id|nct_id|mesh_term|downcase_mesh_term|mesh_type
65262255|NCT05122481|Vitamins|vitamins|mesh-ancestor
65533181|NCT02125318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533182|NCT02125318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65533183|NCT02128126|Vaccines|vaccines|mesh-list
65533184|NCT02128126|Immunologic Factors|immunologic factors|mesh-ancestor
65533185|NCT02128126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533186|NCT02128204|Lidocaine|lidocaine|mesh-list
65533187|NCT02128204|Anesthetics, Local|anesthetics, local|mesh-ancestor
65533188|NCT02128204|Anesthetics|anesthetics|mesh-ancestor
65533189|NCT02128204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65533190|NCT02128204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533191|NCT02128204|Sensory System Agents|sensory system agents|mesh-ancestor
65533192|NCT02128204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65533193|NCT02128204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65533194|NCT02128204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65533195|NCT02128204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65533196|NCT02128204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65533197|NCT02128204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533198|NCT02128282|Gemcitabine|gemcitabine|mesh-list
65533199|NCT02128282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533200|NCT02128282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65533201|NCT02128282|Antimetabolites|antimetabolites|mesh-ancestor
65533202|NCT02128282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533203|NCT02128282|Antiviral Agents|antiviral agents|mesh-ancestor
65533204|NCT02128282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65533205|NCT02128282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533206|NCT02128282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65533207|NCT02128282|Immunologic Factors|immunologic factors|mesh-ancestor
65533208|NCT02128282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533209|NCT02125630|Hormones|hormones|mesh-list
65533210|NCT02125630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65533211|NCT02125630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533212|NCT03551548|Spironolactone|spironolactone|mesh-list
65533213|NCT03551548|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65533214|NCT03551548|Hormone Antagonists|hormone antagonists|mesh-ancestor
65533215|NCT03551548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65533216|NCT03551548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533217|NCT03551548|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65533218|NCT03551548|Diuretics|diuretics|mesh-ancestor
65533219|NCT03551548|Natriuretic Agents|natriuretic agents|mesh-ancestor
65533220|NCT02542293|Gemcitabine|gemcitabine|mesh-list
65533221|NCT02542293|Paclitaxel|paclitaxel|mesh-list
65533222|NCT02542293|Cisplatin|cisplatin|mesh-list
65533223|NCT02542293|Carboplatin|carboplatin|mesh-list
65533224|NCT02542293|Pemetrexed|pemetrexed|mesh-list
65533225|NCT02542293|Durvalumab|durvalumab|mesh-list
65533226|NCT02542293|Tremelimumab|tremelimumab|mesh-list
65533227|NCT02542293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65533228|NCT02542293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533229|NCT02542293|Tubulin Modulators|tubulin modulators|mesh-ancestor
65533230|NCT02542293|Antimitotic Agents|antimitotic agents|mesh-ancestor
65533231|NCT02542293|Mitosis Modulators|mitosis modulators|mesh-ancestor
65533232|NCT02542293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533233|NCT02542293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65533234|NCT02542293|Antimetabolites|antimetabolites|mesh-ancestor
65533235|NCT02542293|Antiviral Agents|antiviral agents|mesh-ancestor
65533236|NCT02542293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65533237|NCT02542293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533238|NCT02542293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65533239|NCT02542293|Immunologic Factors|immunologic factors|mesh-ancestor
65533240|NCT02542293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533241|NCT02542293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65533242|NCT02542293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65533243|NCT02542293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65533244|NCT02128360|Letrozole|letrozole|mesh-list
65533245|NCT02128360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533246|NCT02128360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65533247|NCT02128360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65533248|NCT02128360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533249|NCT02128360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533250|NCT02128360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65533251|NCT02128360|Hormone Antagonists|hormone antagonists|mesh-ancestor
65533252|NCT02128360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65262388|NCT00929669|Hormones|hormones|mesh-ancestor
65533253|NCT02128360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533254|NCT02126020|Infliximab|infliximab|mesh-list
65533255|NCT02126020|Dermatologic Agents|dermatologic agents|mesh-ancestor
65533256|NCT02126020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65533257|NCT02126020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65533258|NCT00688376|Donepezil|donepezil|mesh-list
65533259|NCT00688376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65533260|NCT00688376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533261|NCT00688376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533262|NCT00688376|Cholinergic Agents|cholinergic agents|mesh-ancestor
65533263|NCT00688376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65533264|NCT00688376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533265|NCT00688376|Nootropic Agents|nootropic agents|mesh-ancestor
65533266|NCT02126332|Acetaminophen|acetaminophen|mesh-list
65533267|NCT02126332|Sufentanil|sufentanil|mesh-list
65533268|NCT02126332|Nefopam|nefopam|mesh-list
65533269|NCT02126332|Tramadol|tramadol|mesh-list
65533270|NCT02126332|Ropivacaine|ropivacaine|mesh-list
65533271|NCT02126332|Anesthetics, Local|anesthetics, local|mesh-ancestor
65533272|NCT02126332|Anesthetics|anesthetics|mesh-ancestor
65533273|NCT02126332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65533274|NCT02126332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533275|NCT02126332|Sensory System Agents|sensory system agents|mesh-ancestor
65533276|NCT02126332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65533277|NCT02126332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65533278|NCT02126332|Analgesics|analgesics|mesh-ancestor
65533279|NCT02126332|Antipyretics|antipyretics|mesh-ancestor
65533280|NCT02126332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65533281|NCT02126332|Narcotics|narcotics|mesh-ancestor
65533282|NCT02126332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65533283|NCT02126332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65533284|NCT02126332|Anesthetics, General|anesthetics, general|mesh-ancestor
65330797|NCT00737438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533285|NCT01996436|Verapamil|verapamil|mesh-list
65533286|NCT01996436|Nicardipine|nicardipine|mesh-list
65533287|NCT01996436|Nitroglycerin|nitroglycerin|mesh-list
65533288|NCT01996436|Vasodilator Agents|vasodilator agents|mesh-ancestor
65533289|NCT01996436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65533290|NCT01996436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65533291|NCT01996436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65533292|NCT01996436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533293|NCT01996436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65533294|NCT01996436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533295|NCT01996436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65533296|NCT02131246|Insulin|insulin|mesh-list
65533297|NCT02131246|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65533298|NCT02131246|Insulin Aspart|insulin aspart|mesh-list
65533299|NCT02131246|Insulin, Long-Acting|insulin, long-acting|mesh-list
65533300|NCT02131246|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65533301|NCT02131246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65533302|NCT02131246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533303|NCT02126644|Glycolic acid|glycolic acid|mesh-list
65533304|NCT02126644|Keratolytic Agents|keratolytic agents|mesh-ancestor
65533305|NCT02126644|Dermatologic Agents|dermatologic agents|mesh-ancestor
65533306|NCT03550534|Calcium Carbonate|calcium carbonate|mesh-list
65533307|NCT03550534|Calcium|calcium|mesh-list
65533308|NCT03550534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65533309|NCT03550534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533310|NCT03550534|Antacids|antacids|mesh-ancestor
65533311|NCT03550534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533312|NCT03550534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65533313|NCT02131480|Doxorubicin|doxorubicin|mesh-list
65533314|NCT02131480|Trabectedin|trabectedin|mesh-list
65533315|NCT02131480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65533316|NCT02131480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533317|NCT02131480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65533318|NCT02131480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65533319|NCT02131480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533320|NCT02131480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533321|NCT02131480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65533322|NCT02131480|Alkylating Agents|alkylating agents|mesh-ancestor
65533323|NCT02128906|Docetaxel|docetaxel|mesh-list
65533324|NCT02128906|Cetuximab|cetuximab|mesh-list
65533325|NCT02128906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533326|NCT02128906|Tubulin Modulators|tubulin modulators|mesh-ancestor
65533327|NCT02128906|Antimitotic Agents|antimitotic agents|mesh-ancestor
65533328|NCT02128906|Mitosis Modulators|mitosis modulators|mesh-ancestor
65533329|NCT02128906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533330|NCT02128906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65533331|NCT02128984|Antioxidants|antioxidants|mesh-list
65533332|NCT02128984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533333|NCT02128984|Protective Agents|protective agents|mesh-ancestor
65533334|NCT02128984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533335|NCT05243290|Niacinamide|niacinamide|mesh-list
65533336|NCT05243290|Niacin|niacin|mesh-list
65533337|NCT05243290|Nicotinic Acids|nicotinic acids|mesh-list
65533338|NCT05243290|Vitamin B Complex|vitamin b complex|mesh-ancestor
65533339|NCT05243290|Vitamins|vitamins|mesh-ancestor
65533340|NCT05243290|Micronutrients|micronutrients|mesh-ancestor
65533341|NCT05243290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533342|NCT05243290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65533343|NCT05243290|Antimetabolites|antimetabolites|mesh-ancestor
65533344|NCT05243290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533345|NCT05243290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65533346|NCT05243290|Vasodilator Agents|vasodilator agents|mesh-ancestor
65533347|NCT02252302|Albuterol|albuterol|mesh-list
65533348|NCT02252302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65533349|NCT02252302|Autonomic Agents|autonomic agents|mesh-ancestor
65533350|NCT02252302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65533351|NCT02252302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533352|NCT02252302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65533353|NCT02252302|Respiratory System Agents|respiratory system agents|mesh-ancestor
65533354|NCT02252302|Tocolytic Agents|tocolytic agents|mesh-ancestor
65533355|NCT02252302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65533356|NCT02252302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65533357|NCT02252302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65533358|NCT02252302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65533359|NCT02252302|Adrenergic Agents|adrenergic agents|mesh-ancestor
65533360|NCT02252302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65533361|NCT02252302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330885|NCT02787642|Olaparib|olaparib|mesh-list
65533362|NCT02252614|Acetaminophen|acetaminophen|mesh-list
65533364|NCT02252614|Codeine|codeine|mesh-list
65533365|NCT02252614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65533366|NCT02252614|Analgesics|analgesics|mesh-ancestor
65533367|NCT02252614|Sensory System Agents|sensory system agents|mesh-ancestor
65533368|NCT02252614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65533369|NCT02252614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533370|NCT02252614|Antipyretics|antipyretics|mesh-ancestor
65533371|NCT02252614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65533372|NCT02252614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65533373|NCT02252614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65533374|NCT02252614|Gout Suppressants|gout suppressants|mesh-ancestor
65533375|NCT02252614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65533376|NCT02252614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533377|NCT02252614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533378|NCT02252614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65533379|NCT02252614|Narcotics|narcotics|mesh-ancestor
65533380|NCT02252614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65533381|NCT02252614|Antitussive Agents|antitussive agents|mesh-ancestor
65533382|NCT02252614|Respiratory System Agents|respiratory system agents|mesh-ancestor
65533383|NCT02260570|Tolcapone|tolcapone|mesh-list
65533384|NCT02260570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65533385|NCT02260570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65533386|NCT02260570|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65533387|NCT02260570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533388|NCT02260570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533389|NCT03681951|Pembrolizumab|pembrolizumab|mesh-list
65533390|NCT03681951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65533391|NCT03681951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533392|NCT02131948|Insulin|insulin|mesh-list
65533393|NCT02131948|Insulin Lispro|insulin lispro|mesh-list
65533394|NCT02131948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65533395|NCT02131948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533396|NCT02132026|Denosumab|denosumab|mesh-list
65533397|NCT02132026|Alendronate|alendronate|mesh-list
65533398|NCT02132026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65533399|NCT02132026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533400|NCT03735771|Bupivacaine|bupivacaine|mesh-list
65533401|NCT03735771|Anesthetics, Local|anesthetics, local|mesh-ancestor
65533402|NCT03735771|Anesthetics|anesthetics|mesh-ancestor
65533403|NCT03735771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65533404|NCT03735771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533405|NCT03735771|Sensory System Agents|sensory system agents|mesh-ancestor
65533406|NCT03735771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65533407|NCT02132104|Hormones|hormones|mesh-list
65533408|NCT02132104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65533409|NCT02132104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533410|NCT00174785|Dronedarone|dronedarone|mesh-list
65533411|NCT00174785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65533412|NCT03681093|Indoleacetic Acids|indoleacetic acids|mesh-list
65533413|NCT03681093|Plant Growth Regulators|plant growth regulators|mesh-ancestor
65533414|NCT03681093|Growth Substances|growth substances|mesh-ancestor
65533415|NCT03681093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533416|NCT00166439|Cytarabine|cytarabine|mesh-list
65533417|NCT00166439|Dexamethasone|dexamethasone|mesh-list
65533418|NCT00166439|Oxaliplatin|oxaliplatin|mesh-list
65533419|NCT00166439|Rituximab|rituximab|mesh-list
65533420|NCT00166439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65533421|NCT00166439|Antiemetics|antiemetics|mesh-ancestor
65533422|NCT00166439|Autonomic Agents|autonomic agents|mesh-ancestor
65533423|NCT00166439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65533424|NCT00166439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533425|NCT00166439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65533426|NCT00166439|Glucocorticoids|glucocorticoids|mesh-ancestor
65533427|NCT00166439|Hormones|hormones|mesh-ancestor
65533428|NCT00166439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65533429|NCT00166439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65533430|NCT00166439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533431|NCT00166439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65533432|NCT00166439|Immunologic Factors|immunologic factors|mesh-ancestor
65533433|NCT00166439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65533434|NCT00166439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65533435|NCT00166439|Antimetabolites|antimetabolites|mesh-ancestor
65533436|NCT00166439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533437|NCT00166439|Antiviral Agents|antiviral agents|mesh-ancestor
65533438|NCT00166439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65533439|NCT00166439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65533441|NCT01074905|Chloroquine|chloroquine|mesh-list
65533442|NCT01074905|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65533443|NCT01074905|Primaquine|primaquine|mesh-list
65533444|NCT01074905|Antimalarials|antimalarials|mesh-ancestor
65533445|NCT01074905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65533446|NCT01074905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65533447|NCT01074905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65533448|NCT01074905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533449|NCT01074905|Antiviral Agents|antiviral agents|mesh-ancestor
65533450|NCT01074905|Schistosomicides|schistosomicides|mesh-ancestor
65533451|NCT01074905|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65533452|NCT01074905|Anthelmintics|anthelmintics|mesh-ancestor
65533453|NCT01074905|Amebicides|amebicides|mesh-ancestor
65533454|NCT01074905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65533455|NCT01074905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65533456|NCT01074905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65533457|NCT01074905|Analgesics|analgesics|mesh-ancestor
65533458|NCT01074905|Sensory System Agents|sensory system agents|mesh-ancestor
65533459|NCT01074905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65533460|NCT01074905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533461|NCT01074905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65533462|NCT01074905|Filaricides|filaricides|mesh-ancestor
65533463|NCT01074905|Antinematodal Agents|antinematodal agents|mesh-ancestor
65533464|NCT03968237|Buprenorphine|buprenorphine|mesh-list
65533465|NCT03968237|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65533466|NCT03968237|Naloxone|naloxone|mesh-list
65533467|NCT03968237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65533468|NCT03968237|Narcotics|narcotics|mesh-ancestor
65533469|NCT03968237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65533470|NCT03968237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533471|NCT03968237|Analgesics|analgesics|mesh-ancestor
65533472|NCT03968237|Sensory System Agents|sensory system agents|mesh-ancestor
65533473|NCT03968237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65533474|NCT03968237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65533475|NCT00138671|Insulin|insulin|mesh-list
65533476|NCT00138671|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65533477|NCT00138671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65533478|NCT00138671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533479|NCT01367158|Vaccines|vaccines|mesh-list
65533480|NCT01367158|Immunologic Factors|immunologic factors|mesh-ancestor
65533481|NCT01367158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533482|NCT00130637|Daclizumab|daclizumab|mesh-list
65533483|NCT00130637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65262551|NCT04259333|Sensory System Agents|sensory system agents|mesh-ancestor
65533484|NCT00130637|Immunologic Factors|immunologic factors|mesh-ancestor
65533485|NCT00130637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533486|NCT01077479|Metformin|metformin|mesh-list
65533487|NCT01077479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65533488|NCT01077479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533489|NCT02136784|Morphine|morphine|mesh-list
65533490|NCT02136784|Oxycodone|oxycodone|mesh-list
65533491|NCT02136784|Buprenorphine|buprenorphine|mesh-list
65533492|NCT02136784|Hydromorphone|hydromorphone|mesh-list
65533493|NCT02136784|Hydrocodone|hydrocodone|mesh-list
65533494|NCT02136784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65533495|NCT02136784|Narcotics|narcotics|mesh-ancestor
65533496|NCT02136784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65533497|NCT02136784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533498|NCT02136784|Analgesics|analgesics|mesh-ancestor
65533499|NCT02136784|Sensory System Agents|sensory system agents|mesh-ancestor
65533500|NCT02136784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65533501|NCT02136784|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65533502|NCT02136784|Antitussive Agents|antitussive agents|mesh-ancestor
65533503|NCT02136784|Respiratory System Agents|respiratory system agents|mesh-ancestor
65533504|NCT02129764|Prednisone|prednisone|mesh-list
65533505|NCT02129764|Allopurinol|allopurinol|mesh-list
65533506|NCT02129764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65533507|NCT02129764|Glucocorticoids|glucocorticoids|mesh-ancestor
65533508|NCT02129764|Hormones|hormones|mesh-ancestor
65533509|NCT02129764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65533510|NCT02129764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533511|NCT02129764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65533512|NCT02129764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533513|NCT02129764|Antimetabolites|antimetabolites|mesh-ancestor
65533514|NCT02129764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533515|NCT02129764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533516|NCT02129764|Gout Suppressants|gout suppressants|mesh-ancestor
65533517|NCT02129764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65533518|NCT02129764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65533519|NCT02129764|Antioxidants|antioxidants|mesh-ancestor
65533520|NCT02129764|Protective Agents|protective agents|mesh-ancestor
65533522|NCT00130247|Isoniazid|isoniazid|mesh-list
65533523|NCT00130247|Pyrazinamide|pyrazinamide|mesh-list
65533524|NCT00130247|Ethambutol|ethambutol|mesh-list
65533525|NCT00130247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65533526|NCT00130247|Antitubercular Agents|antitubercular agents|mesh-ancestor
65533527|NCT00130247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65533528|NCT00130247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65533529|NCT00130247|Leprostatic Agents|leprostatic agents|mesh-ancestor
65533530|NCT00130247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65533531|NCT00130247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533532|NCT00130247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533533|NCT00130247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65533534|NCT00130247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65533535|NCT00130247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65533536|NCT00130247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65533537|NCT00130247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65533538|NCT00130247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65533539|NCT00130247|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65533540|NCT00130247|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65533541|NCT00130247|Antimetabolites|antimetabolites|mesh-ancestor
65533542|NCT00130247|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65533543|NCT02252926|Acetaminophen|acetaminophen|mesh-list
65533544|NCT02252926|Lidocaine|lidocaine|mesh-list
65533545|NCT02252926|Morphine|morphine|mesh-list
65533546|NCT02252926|Gabapentin|gabapentin|mesh-list
65533547|NCT02252926|Bupivacaine|bupivacaine|mesh-list
65533548|NCT02252926|Anesthetics, Local|anesthetics, local|mesh-ancestor
65533549|NCT02252926|Anesthetics|anesthetics|mesh-ancestor
65533550|NCT02252926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65533551|NCT02252926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533552|NCT02252926|Sensory System Agents|sensory system agents|mesh-ancestor
65533553|NCT02252926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65533554|NCT02252926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65533555|NCT02252926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65533556|NCT02252926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65533557|NCT02252926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65533558|NCT02252926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533559|NCT02252926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65533560|NCT02252926|Narcotics|narcotics|mesh-ancestor
65533561|NCT02252926|Analgesics|analgesics|mesh-ancestor
65533562|NCT02252926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65533563|NCT02252926|Antipyretics|antipyretics|mesh-ancestor
65533564|NCT02252926|Anticonvulsants|anticonvulsants|mesh-ancestor
65533565|NCT02252926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65533566|NCT02252926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65533567|NCT02252926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65533568|NCT02252926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65533569|NCT02252926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65533570|NCT02252926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65533571|NCT02252926|Antimanic Agents|antimanic agents|mesh-ancestor
65533572|NCT02253004|Cilostazol|cilostazol|mesh-list
65533573|NCT02253004|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65533574|NCT02253004|Autonomic Agents|autonomic agents|mesh-ancestor
65533575|NCT02253004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65533576|NCT02253004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533577|NCT02253004|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65533578|NCT02253004|Respiratory System Agents|respiratory system agents|mesh-ancestor
65533579|NCT02253004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65533580|NCT02253004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65533581|NCT02253004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533582|NCT02253004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65533583|NCT02253004|Vasodilator Agents|vasodilator agents|mesh-ancestor
65533584|NCT02253004|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65533585|NCT02253004|Protective Agents|protective agents|mesh-ancestor
65533586|NCT02253004|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65533587|NCT02253004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65533588|NCT02253004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533589|NCT02252458|Fentanyl|fentanyl|mesh-list
65533590|NCT02252458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65533591|NCT02252458|Narcotics|narcotics|mesh-ancestor
65533592|NCT02252458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65533593|NCT02252458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533594|NCT02252458|Analgesics|analgesics|mesh-ancestor
65533595|NCT02252458|Sensory System Agents|sensory system agents|mesh-ancestor
65533596|NCT02252458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65533597|NCT02252458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65533598|NCT02252458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65533599|NCT02252458|Anesthetics, General|anesthetics, general|mesh-ancestor
65533600|NCT02252458|Anesthetics|anesthetics|mesh-ancestor
65533601|NCT04032171|Interferon beta-1a|interferon beta-1a|mesh-list
65533602|NCT04032171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65533603|NCT04032171|Immunologic Factors|immunologic factors|mesh-ancestor
65533604|NCT04032171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533605|NCT04032171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533606|NCT04032171|Antiviral Agents|antiviral agents|mesh-ancestor
65533607|NCT04032171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65533608|NCT02130154|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65533609|NCT02130154|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65533610|NCT02130154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533611|NCT02132260|Naftifine|naftifine|mesh-list
65533612|NCT02132260|Antifungal Agents|antifungal agents|mesh-ancestor
65533613|NCT02132260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65533614|NCT02132416|Acetaminophen|acetaminophen|mesh-list
65533615|NCT02132416|Ibuprofen|ibuprofen|mesh-list
65533616|NCT02132416|Diclofenac|diclofenac|mesh-list
65533617|NCT02132416|Morphine|morphine|mesh-list
65533618|NCT02132416|Oxycodone|oxycodone|mesh-list
65533619|NCT02132416|Tramadol|tramadol|mesh-list
65533620|NCT02132416|Anesthetics|anesthetics|mesh-list
65533621|NCT02132416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65533622|NCT02132416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533623|NCT02132416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65533624|NCT02132416|Narcotics|narcotics|mesh-ancestor
65533625|NCT02132416|Analgesics|analgesics|mesh-ancestor
65533626|NCT02132416|Sensory System Agents|sensory system agents|mesh-ancestor
65533627|NCT02132416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65533628|NCT02132416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65533629|NCT02132416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65533630|NCT02132416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65533631|NCT02132416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65533632|NCT02132416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65533633|NCT02132416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533634|NCT02132416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533635|NCT02132416|Antipyretics|antipyretics|mesh-ancestor
65533636|NCT00137423|Sunitinib|sunitinib|mesh-list
65533637|NCT00137423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533638|NCT00137423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65533639|NCT00137423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65533640|NCT00137423|Growth Substances|growth substances|mesh-ancestor
65533641|NCT00137423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533642|NCT00137423|Growth Inhibitors|growth inhibitors|mesh-ancestor
65533643|NCT00137423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65533644|NCT00137423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533645|NCT00137423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533646|NCT01077557|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65533647|NCT01077557|Antiviral Agents|antiviral agents|mesh-ancestor
65533648|NCT01077557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65533649|NCT02130700|Seviteronel|seviteronel|mesh-list
65533650|NCT02130700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533651|NCT02130700|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65533652|NCT02130700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533653|NCT02130700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533654|NCT02137954|Lidocaine|lidocaine|mesh-list
65533655|NCT02137954|Anesthetics, Local|anesthetics, local|mesh-ancestor
65533656|NCT02137954|Anesthetics|anesthetics|mesh-ancestor
65533657|NCT02137954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65533658|NCT02137954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533659|NCT02137954|Sensory System Agents|sensory system agents|mesh-ancestor
65533660|NCT02137954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65533661|NCT02137954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65533662|NCT02137954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65533663|NCT02137954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65533664|NCT02137954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65533665|NCT02137954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533666|NCT02131012|Celecoxib|celecoxib|mesh-list
65533667|NCT02131012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65533668|NCT02131012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65533669|NCT02131012|Analgesics|analgesics|mesh-ancestor
65533670|NCT02131012|Sensory System Agents|sensory system agents|mesh-ancestor
65533671|NCT02131012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65533672|NCT02131012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533673|NCT02131012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65533674|NCT02131012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65533675|NCT02131012|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65533676|NCT02131012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65533677|NCT02131012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533678|NCT02131012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533679|NCT02138500|PF-06372865|pf-06372865|mesh-list
65533680|NCT02138500|GABA Modulators|gaba modulators|mesh-ancestor
65533681|NCT02138500|GABA Agents|gaba agents|mesh-ancestor
65533682|NCT02138500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65533683|NCT02138500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533684|NCT02138500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533685|NCT01561768|Vaccines|vaccines|mesh-list
65533686|NCT01561768|Immunologic Factors|immunologic factors|mesh-ancestor
65533687|NCT01561768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533688|NCT00137111|Cytarabine|cytarabine|mesh-list
65533689|NCT00137111|Dexamethasone|dexamethasone|mesh-list
65533690|NCT00137111|Prednisone|prednisone|mesh-list
65533691|NCT00137111|Cyclophosphamide|cyclophosphamide|mesh-list
65533692|NCT00137111|Doxorubicin|doxorubicin|mesh-list
65533693|NCT00137111|Methotrexate|methotrexate|mesh-list
65533694|NCT00137111|Etoposide|etoposide|mesh-list
65533695|NCT00137111|Vincristine|vincristine|mesh-list
65533696|NCT00137111|Daunorubicin|daunorubicin|mesh-list
65533697|NCT00137111|Asparaginase|asparaginase|mesh-list
65533698|NCT00137111|Mercaptopurine|mercaptopurine|mesh-list
65533699|NCT00137111|Pegaspargase|pegaspargase|mesh-list
65533700|NCT00137111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65533701|NCT00137111|Immunologic Factors|immunologic factors|mesh-ancestor
65533702|NCT00137111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533703|NCT00137111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65533704|NCT00137111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65533705|NCT00137111|Alkylating Agents|alkylating agents|mesh-ancestor
65533706|NCT00137111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533707|NCT00137111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533708|NCT00137111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65533709|NCT00137111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65533710|NCT00137111|Antiemetics|antiemetics|mesh-ancestor
65533711|NCT00137111|Autonomic Agents|autonomic agents|mesh-ancestor
65533712|NCT00137111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65533713|NCT00137111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65533714|NCT00137111|Glucocorticoids|glucocorticoids|mesh-ancestor
65533715|NCT00137111|Hormones|hormones|mesh-ancestor
65533716|NCT00137111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65533717|NCT00137111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65533718|NCT00137111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65533719|NCT00137111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65533720|NCT00137111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65533721|NCT00137111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533722|NCT00137111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65533723|NCT00137111|Abortifacient Agents|abortifacient agents|mesh-ancestor
65533724|NCT00137111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65533725|NCT00137111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65533726|NCT00137111|Antimetabolites|antimetabolites|mesh-ancestor
65533727|NCT00137111|Dermatologic Agents|dermatologic agents|mesh-ancestor
65533728|NCT00137111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65533729|NCT00137111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65533730|NCT00137111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65533731|NCT00137111|Antiviral Agents|antiviral agents|mesh-ancestor
65533732|NCT00137111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65533733|NCT00137111|Tubulin Modulators|tubulin modulators|mesh-ancestor
65533734|NCT00137111|Antimitotic Agents|antimitotic agents|mesh-ancestor
65533735|NCT00137111|Mitosis Modulators|mitosis modulators|mesh-ancestor
65533736|NCT02133118|Pioglitazone|pioglitazone|mesh-list
65533737|NCT02133118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65533738|NCT02133118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533739|NCT02138812|Paclitaxel|paclitaxel|mesh-list
65533740|NCT02138812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65533741|NCT02138812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533742|NCT02138812|Tubulin Modulators|tubulin modulators|mesh-ancestor
65533743|NCT02138812|Antimitotic Agents|antimitotic agents|mesh-ancestor
65533744|NCT02138812|Mitosis Modulators|mitosis modulators|mesh-ancestor
65533745|NCT02138812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533747|NCT00136955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65533748|NCT00136955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65533749|NCT00136955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533750|NCT00136955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533751|NCT00136955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533752|NCT00135707|Vitamins|vitamins|mesh-list
65533753|NCT00135707|Ascorbic Acid|ascorbic acid|mesh-list
65533754|NCT00135707|Vitamin E|vitamin e|mesh-list
65533755|NCT00135707|alpha-Tocopherol|alpha-tocopherol|mesh-list
65533756|NCT00135707|Micronutrients|micronutrients|mesh-ancestor
65533757|NCT00135707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533758|NCT00135707|Antioxidants|antioxidants|mesh-ancestor
65533759|NCT00135707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533760|NCT00135707|Protective Agents|protective agents|mesh-ancestor
65533761|NCT03548818|Interferons|interferons|mesh-list
65533762|NCT03548818|Interferon-gamma|interferon-gamma|mesh-list
65533763|NCT03548818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533764|NCT03548818|Antiviral Agents|antiviral agents|mesh-ancestor
65533765|NCT03548818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65533766|NCT02252692|Enalapril|enalapril|mesh-list
65533767|NCT02252692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65533768|NCT02252692|Protease Inhibitors|protease inhibitors|mesh-ancestor
65533769|NCT02252692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533770|NCT02252692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533771|NCT02252692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65533772|NCT03548662|Hyaluronic Acid|hyaluronic acid|mesh-list
65533773|NCT03548662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65533774|NCT03548662|Immunologic Factors|immunologic factors|mesh-ancestor
65533775|NCT03548662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533776|NCT03548662|Viscosupplements|viscosupplements|mesh-ancestor
65533777|NCT03548662|Protective Agents|protective agents|mesh-ancestor
65533778|NCT03966209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65533779|NCT03966209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533780|NCT03966209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533781|NCT02252770|Nitric Oxide|nitric oxide|mesh-list
65533782|NCT02252770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65533783|NCT02252770|Autonomic Agents|autonomic agents|mesh-ancestor
65533784|NCT02252770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65533785|NCT02252770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533786|NCT02252770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65533787|NCT02252770|Respiratory System Agents|respiratory system agents|mesh-ancestor
65533788|NCT02252770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65533789|NCT02252770|Antioxidants|antioxidants|mesh-ancestor
65533790|NCT02252770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533791|NCT02252770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65533792|NCT02252770|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65533793|NCT02252770|Vasodilator Agents|vasodilator agents|mesh-ancestor
65533794|NCT02252770|Gasotransmitters|gasotransmitters|mesh-ancestor
65533795|NCT02252770|Protective Agents|protective agents|mesh-ancestor
65533796|NCT05578456|Aspirin|aspirin|mesh-list
65533797|NCT05578456|Prednisone|prednisone|mesh-list
65533798|NCT05578456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65533799|NCT05578456|Glucocorticoids|glucocorticoids|mesh-ancestor
65533800|NCT05578456|Hormones|hormones|mesh-ancestor
65533801|NCT05578456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65533802|NCT05578456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533803|NCT05578456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65533804|NCT05578456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533805|NCT05578456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65533806|NCT05578456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65533807|NCT05578456|Analgesics|analgesics|mesh-ancestor
65533808|NCT05578456|Sensory System Agents|sensory system agents|mesh-ancestor
65533809|NCT05578456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65533810|NCT05578456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65533811|NCT05578456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65533812|NCT05578456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65533813|NCT05578456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533814|NCT05578456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65533815|NCT05578456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65533816|NCT05578456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533817|NCT05578456|Antipyretics|antipyretics|mesh-ancestor
65533818|NCT02133820|Analgesics|analgesics|mesh-list
65533819|NCT02133820|Sensory System Agents|sensory system agents|mesh-ancestor
65533820|NCT02133820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65533821|NCT02133820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533822|NCT05578378|Cytarabine|cytarabine|mesh-list
65533823|NCT05578378|Methotrexate|methotrexate|mesh-list
65533824|NCT05578378|Fludarabine|fludarabine|mesh-list
65533825|NCT05578378|Cladribine|cladribine|mesh-list
65533826|NCT05578378|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65533827|NCT05578378|Abortifacient Agents|abortifacient agents|mesh-ancestor
65533828|NCT05578378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65533829|NCT05578378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533830|NCT05578378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65533831|NCT05578378|Antimetabolites|antimetabolites|mesh-ancestor
65533832|NCT05578378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533833|NCT05578378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533834|NCT05578378|Dermatologic Agents|dermatologic agents|mesh-ancestor
65533835|NCT05578378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533836|NCT05578378|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65533837|NCT05578378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65533838|NCT05578378|Immunologic Factors|immunologic factors|mesh-ancestor
65533839|NCT05578378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65533840|NCT05578378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65533841|NCT05578378|Antiviral Agents|antiviral agents|mesh-ancestor
65533842|NCT05578378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65533843|NCT00129623|Ibandronic Acid|ibandronic acid|mesh-list
65533844|NCT00129623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65533845|NCT00129623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533846|NCT02139904|Vinorelbine|vinorelbine|mesh-list
65533847|NCT02139904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65533848|NCT02139904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533849|NCT02139904|Tubulin Modulators|tubulin modulators|mesh-ancestor
65533850|NCT02139904|Antimitotic Agents|antimitotic agents|mesh-ancestor
65533851|NCT02139904|Mitosis Modulators|mitosis modulators|mesh-ancestor
65533852|NCT02139904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533853|NCT05578222|Pembrolizumab|pembrolizumab|mesh-list
65533854|NCT05578222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65533855|NCT05578222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533856|NCT05201638|Calcium, Dietary|calcium, dietary|mesh-list
65533857|NCT05201638|Calcium|calcium|mesh-list
65533858|NCT05201638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65533859|NCT05201638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533860|NCT05201638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65533861|NCT00129545|Warfarin|warfarin|mesh-list
65533862|NCT00129545|Anticoagulants|anticoagulants|mesh-ancestor
65533863|NCT02134288|Everolimus|everolimus|mesh-list
65533864|NCT02134288|Abatacept|abatacept|mesh-list
65533865|NCT02134288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533866|NCT02134288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65533867|NCT02134288|Immunologic Factors|immunologic factors|mesh-ancestor
65533868|NCT02134288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533869|NCT02134288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65533870|NCT02134288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533871|NCT02134288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65533872|NCT00129467|Methylphenidate|methylphenidate|mesh-list
65533873|NCT00129467|Serotonin|serotonin|mesh-list
65533874|NCT00129467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65533875|NCT00129467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65533876|NCT00129467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533877|NCT00129467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65533878|NCT00129467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65533879|NCT00129467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65533880|NCT00129467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533881|NCT00129467|Dopamine Agents|dopamine agents|mesh-ancestor
65533882|NCT00129467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65533883|NCT00129467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65533884|NCT00129467|Serotonin Agents|serotonin agents|mesh-ancestor
65533885|NCT00129311|Selegiline|selegiline|mesh-list
65533886|NCT00129311|Antidepressive Agents|antidepressive agents|mesh-ancestor
65533887|NCT00129311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65533888|NCT00129311|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65533889|NCT00129311|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65533890|NCT00129311|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65533891|NCT00129311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533892|NCT00129311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331406|NCT00745953|Valsartan|valsartan|mesh-list
65533893|NCT00129311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65533894|NCT00129311|Protective Agents|protective agents|mesh-ancestor
65533895|NCT00129311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533896|NCT01076621|Norethindrone|norethindrone|mesh-list
65533897|NCT01076621|Norethindrone Acetate|norethindrone acetate|mesh-list
65533898|NCT01076621|Estradiol|estradiol|mesh-list
65533899|NCT01076621|Estrogens|estrogens|mesh-ancestor
65533900|NCT01076621|Hormones|hormones|mesh-ancestor
65533901|NCT01076621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65533902|NCT01076621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533903|NCT01076621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65533904|NCT01076621|Contraceptive Agents|contraceptive agents|mesh-ancestor
65533905|NCT01076621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65533906|NCT01076621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65533907|NCT01076621|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65533908|NCT01076621|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65533909|NCT01076621|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65533910|NCT03965819|Acetaminophen|acetaminophen|mesh-list
65533911|NCT03965819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65533912|NCT03965819|Analgesics|analgesics|mesh-ancestor
65533913|NCT03965819|Sensory System Agents|sensory system agents|mesh-ancestor
65533914|NCT03965819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65533915|NCT03965819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533916|NCT03965819|Antipyretics|antipyretics|mesh-ancestor
65533917|NCT02134366|Lorazepam|lorazepam|mesh-list
65533918|NCT02134366|Clonazepam|clonazepam|mesh-list
65533919|NCT02134366|Clobazam|clobazam|mesh-list
65533920|NCT02134366|Anticonvulsants|anticonvulsants|mesh-ancestor
65533921|NCT02134366|Antiemetics|antiemetics|mesh-ancestor
65533922|NCT02134366|Autonomic Agents|autonomic agents|mesh-ancestor
65533923|NCT02134366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65533924|NCT02134366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533925|NCT02134366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65533926|NCT02134366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65533927|NCT02134366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65533928|NCT02134366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65533929|NCT02134366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65533930|NCT02134366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65533931|NCT02134366|GABA Modulators|gaba modulators|mesh-ancestor
65533932|NCT02134366|GABA Agents|gaba agents|mesh-ancestor
65533933|NCT02134366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65533934|NCT02134366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533935|NCT02134366|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65533936|NCT02134366|GABA Agonists|gaba agonists|mesh-ancestor
65533937|NCT01077947|Anesthetics|anesthetics|mesh-list
65533938|NCT01077947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65533939|NCT01077947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262967|NCT00938821|Anesthetics, Local|anesthetics, local|mesh-ancestor
65533940|NCT00133991|Leucovorin|leucovorin|mesh-list
65533941|NCT00133991|Cytarabine|cytarabine|mesh-list
65533942|NCT00133991|Prednisone|prednisone|mesh-list
65533943|NCT00133991|Hydrocortisone|hydrocortisone|mesh-list
65533944|NCT00133991|Cyclophosphamide|cyclophosphamide|mesh-list
65533945|NCT00133991|Rituximab|rituximab|mesh-list
65533946|NCT00133991|Methotrexate|methotrexate|mesh-list
65533947|NCT00133991|Vincristine|vincristine|mesh-list
65533948|NCT00133991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65533949|NCT00133991|Immunologic Factors|immunologic factors|mesh-ancestor
65533950|NCT00133991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533951|NCT00133991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65533952|NCT00133991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65533953|NCT00133991|Alkylating Agents|alkylating agents|mesh-ancestor
65533954|NCT00133991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533955|NCT00133991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533956|NCT00133991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65533957|NCT00133991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65533958|NCT00133991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65533959|NCT00133991|Glucocorticoids|glucocorticoids|mesh-ancestor
65533960|NCT00133991|Hormones|hormones|mesh-ancestor
65533961|NCT00133991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65533962|NCT00133991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65533963|NCT00133991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65533964|NCT00133991|Abortifacient Agents|abortifacient agents|mesh-ancestor
65533965|NCT00133991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65533966|NCT00133991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65533967|NCT00133991|Antimetabolites|antimetabolites|mesh-ancestor
65533968|NCT00133991|Dermatologic Agents|dermatologic agents|mesh-ancestor
65533969|NCT00133991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533970|NCT00133991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65533971|NCT00133991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65533972|NCT00133991|Antiviral Agents|antiviral agents|mesh-ancestor
65533973|NCT00133991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65533974|NCT00133991|Antidotes|antidotes|mesh-ancestor
65533975|NCT00133991|Protective Agents|protective agents|mesh-ancestor
65533976|NCT00133991|Vitamin B Complex|vitamin b complex|mesh-ancestor
65533978|NCT00133991|Micronutrients|micronutrients|mesh-ancestor
65533979|NCT00133991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65533980|NCT00133991|Tubulin Modulators|tubulin modulators|mesh-ancestor
65533981|NCT00133991|Antimitotic Agents|antimitotic agents|mesh-ancestor
65533982|NCT00133991|Mitosis Modulators|mitosis modulators|mesh-ancestor
65533983|NCT03549208|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65533984|NCT03549208|Immunologic Factors|immunologic factors|mesh-ancestor
65533985|NCT03549208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533986|NCT02140450|Timolol|timolol|mesh-list
65533987|NCT02140450|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65533988|NCT02140450|Mannitol|mannitol|mesh-list
65533989|NCT02140450|Acetazolamide|acetazolamide|mesh-list
65533990|NCT02140450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65533991|NCT02140450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65533992|NCT02140450|Adrenergic Agents|adrenergic agents|mesh-ancestor
65533993|NCT02140450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65533994|NCT02140450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533995|NCT02140450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533996|NCT02140450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65533997|NCT02140450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65533998|NCT02140450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65533999|NCT02140450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65534000|NCT02140450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65534001|NCT02140450|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65534002|NCT02140450|Diuretics|diuretics|mesh-ancestor
65534003|NCT02140450|Natriuretic Agents|natriuretic agents|mesh-ancestor
65534004|NCT02140450|Anticonvulsants|anticonvulsants|mesh-ancestor
65534005|NCT02140450|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65534006|NCT02140450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534007|NCT05577676|Triamcinolone|triamcinolone|mesh-list
65534008|NCT05577676|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65534009|NCT05577676|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65534010|NCT05577676|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65534011|NCT05577676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65534012|NCT05577676|Glucocorticoids|glucocorticoids|mesh-ancestor
65534013|NCT05577676|Hormones|hormones|mesh-ancestor
65534014|NCT05577676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65534015|NCT05577676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534016|NCT05577676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65534017|NCT05577676|Immunologic Factors|immunologic factors|mesh-ancestor
65534018|NCT05577676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534019|NCT05577676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534020|NCT03549832|Ritonavir|ritonavir|mesh-list
65534021|NCT03549832|Ribavirin|ribavirin|mesh-list
65534022|NCT03549832|Sofosbuvir|sofosbuvir|mesh-list
65534023|NCT03549832|Simeprevir|simeprevir|mesh-list
65534024|NCT03549832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65534025|NCT03549832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65534026|NCT03549832|Protease Inhibitors|protease inhibitors|mesh-ancestor
65534027|NCT03549832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534028|NCT03549832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534029|NCT03549832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65534030|NCT03549832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65534031|NCT03549832|Antiviral Agents|antiviral agents|mesh-ancestor
65534032|NCT03549832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65534033|NCT03549832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65534034|NCT03549832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65534035|NCT03549832|Antimetabolites|antimetabolites|mesh-ancestor
65534036|NCT02134990|Docetaxel|docetaxel|mesh-list
65534037|NCT02134990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534038|NCT02134990|Tubulin Modulators|tubulin modulators|mesh-ancestor
65534039|NCT02134990|Antimitotic Agents|antimitotic agents|mesh-ancestor
65534040|NCT02134990|Mitosis Modulators|mitosis modulators|mesh-ancestor
65534041|NCT02134990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534042|NCT02135224|Fentanyl|fentanyl|mesh-list
65534043|NCT02135224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65534044|NCT02135224|Narcotics|narcotics|mesh-ancestor
65534045|NCT02135224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65534046|NCT02135224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534047|NCT02135224|Analgesics|analgesics|mesh-ancestor
65534048|NCT02135224|Sensory System Agents|sensory system agents|mesh-ancestor
65534049|NCT02135224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65534050|NCT02135224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65534051|NCT02135224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65534052|NCT02135224|Anesthetics, General|anesthetics, general|mesh-ancestor
65534053|NCT02135224|Anesthetics|anesthetics|mesh-ancestor
65534054|NCT05508100|Pembrolizumab|pembrolizumab|mesh-list
65534055|NCT05508100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65534056|NCT05508100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534057|NCT02785900|Azacitidine|azacitidine|mesh-list
65534058|NCT02785900|Decitabine|decitabine|mesh-list
65534059|NCT02785900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65534060|NCT02785900|Antimetabolites|antimetabolites|mesh-ancestor
65534061|NCT02785900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534062|NCT02785900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534063|NCT02785900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534064|NCT00127205|Zoledronic Acid|zoledronic acid|mesh-list
65534065|NCT00127205|Ibandronic Acid|ibandronic acid|mesh-list
65534066|NCT00127205|Clodronic Acid|clodronic acid|mesh-list
65534067|NCT00127205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65534068|NCT00127205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534069|NCT02135770|Heparin|heparin|mesh-list
65534070|NCT02135770|Calcium heparin|calcium heparin|mesh-list
65534071|NCT02135770|Anticoagulants|anticoagulants|mesh-ancestor
65534072|NCT02135770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65534073|NCT02135770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65534074|NCT02135770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534075|NCT05478850|Anesthetics|anesthetics|mesh-list
65534076|NCT05478850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65534077|NCT05478850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534078|NCT05575180|Acetazolamide|acetazolamide|mesh-list
65534079|NCT05575180|Methazolamide|methazolamide|mesh-list
65534080|NCT05575180|Anticonvulsants|anticonvulsants|mesh-ancestor
65534081|NCT05575180|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65534082|NCT05575180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534083|NCT05575180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534084|NCT05575180|Diuretics|diuretics|mesh-ancestor
65534085|NCT05575180|Natriuretic Agents|natriuretic agents|mesh-ancestor
65534086|NCT05575180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534087|NCT01560754|Nicotine|nicotine|mesh-list
65534088|NCT01560754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65534089|NCT01560754|Autonomic Agents|autonomic agents|mesh-ancestor
65534090|NCT01560754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65534091|NCT01560754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534092|NCT01560754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65534093|NCT01560754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65534094|NCT01560754|Cholinergic Agents|cholinergic agents|mesh-ancestor
65534095|NCT01560754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65534096|NCT01560754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534097|NCT04768504|Tofacitinib|tofacitinib|mesh-list
65534098|NCT04768504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65534099|NCT04768504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534100|NCT04768504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534101|NCT03547804|Apatinib|apatinib|mesh-list
65534102|NCT03547804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534103|NCT03547804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65534104|NCT03547804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534105|NCT03547804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534106|NCT02217267|Lidocaine|lidocaine|mesh-list
65534107|NCT02217267|Anesthetics, Local|anesthetics, local|mesh-ancestor
65534108|NCT02217267|Anesthetics|anesthetics|mesh-ancestor
65534109|NCT02217267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65534110|NCT02217267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534111|NCT02217267|Sensory System Agents|sensory system agents|mesh-ancestor
65534112|NCT02217267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65534113|NCT02217267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65534114|NCT02217267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65534115|NCT02217267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65534116|NCT02217267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65534117|NCT02217267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534118|NCT03670641|Insulin Glargine|insulin glargine|mesh-list
65534119|NCT03670641|Insulin Lispro|insulin lispro|mesh-list
65534120|NCT03670641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65534121|NCT03670641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534122|NCT03546400|Methylphenidate|methylphenidate|mesh-list
65534123|NCT03546400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65534124|NCT03546400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534125|NCT03546400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65534126|NCT03546400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65534127|NCT03546400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65534128|NCT03546400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534129|NCT03546400|Dopamine Agents|dopamine agents|mesh-ancestor
65534130|NCT03546400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65534131|NCT03669861|Abatacept|abatacept|mesh-list
65534132|NCT03669861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65534133|NCT03669861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534134|NCT03669861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534135|NCT03669861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65534136|NCT03669861|Immunologic Factors|immunologic factors|mesh-ancestor
65534137|NCT03669861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534138|NCT03669861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65534139|NCT00127127|Vorinostat|vorinostat|mesh-list
65534140|NCT00127127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534141|NCT00127127|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65534142|NCT00127127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534143|NCT00127127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534144|NCT00126659|Sorafenib|sorafenib|mesh-list
65534145|NCT00126659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534146|NCT00126659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65534147|NCT00126659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534148|NCT00126659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534149|NCT03669081|Ketorolac|ketorolac|mesh-list
65534150|NCT03669081|Pregabalin|pregabalin|mesh-list
65534151|NCT03669081|Analgesics|analgesics|mesh-ancestor
65534152|NCT03669081|Sensory System Agents|sensory system agents|mesh-ancestor
65534153|NCT03669081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65534154|NCT03669081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534155|NCT03669081|Anticonvulsants|anticonvulsants|mesh-ancestor
65534156|NCT03669081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65534157|NCT03669081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65534158|NCT03669081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534159|NCT03669081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65534160|NCT03669081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65534161|NCT03669081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65534162|NCT03669081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65534163|NCT03669081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65534164|NCT03669081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65263202|NCT02690012|Antacids|antacids|mesh-ancestor
65534165|NCT03669081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65534166|NCT03669081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65534167|NCT03669081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65534168|NCT03669081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65534169|NCT03669081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534170|NCT02253940|Ritonavir|ritonavir|mesh-list
65534171|NCT02253940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65534172|NCT02253940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65534173|NCT02253940|Protease Inhibitors|protease inhibitors|mesh-ancestor
65534174|NCT02253940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534175|NCT02253940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534176|NCT02253940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65534177|NCT02253940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65534178|NCT02253940|Antiviral Agents|antiviral agents|mesh-ancestor
65534179|NCT02253940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65534180|NCT02253940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65534181|NCT02253940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65534182|NCT02253550|Sofosbuvir|sofosbuvir|mesh-list
65534183|NCT02253550|Simeprevir|simeprevir|mesh-list
65534184|NCT02253550|Antiviral Agents|antiviral agents|mesh-ancestor
65534185|NCT02253550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65534186|NCT02253550|Protease Inhibitors|protease inhibitors|mesh-ancestor
65534187|NCT02253550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534188|NCT02253550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534189|NCT05203432|Atropine|atropine|mesh-list
65534190|NCT05203432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65534191|NCT05203432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65534192|NCT05203432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65534193|NCT05203432|Autonomic Agents|autonomic agents|mesh-ancestor
65534194|NCT05203432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65534195|NCT05203432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534196|NCT05203432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65534197|NCT05203432|Respiratory System Agents|respiratory system agents|mesh-ancestor
65534198|NCT05203432|Mydriatics|mydriatics|mesh-ancestor
65534199|NCT05203432|Parasympatholytics|parasympatholytics|mesh-ancestor
65534200|NCT05203432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65534201|NCT05203432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65534202|NCT05203432|Cholinergic Agents|cholinergic agents|mesh-ancestor
65534203|NCT05203432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65534204|NCT05203432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534205|NCT03667053|Glucagon|glucagon|mesh-list
65534206|NCT03667053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65534207|NCT03667053|Hormones|hormones|mesh-ancestor
65534208|NCT03667053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65534209|NCT03667053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534210|NCT04589728|Venetoclax|venetoclax|mesh-list
65534211|NCT04589728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534212|NCT05557240|Poly I-C|poly i-c|mesh-list
65534213|NCT05557240|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65534214|NCT05557240|Vaccines|vaccines|mesh-list
65534215|NCT05557240|Poly ICLC|poly iclc|mesh-list
65534216|NCT05557240|Immunologic Factors|immunologic factors|mesh-ancestor
65534217|NCT05557240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534218|NCT05557240|Interferon Inducers|interferon inducers|mesh-ancestor
65534219|NCT05557240|Laxatives|laxatives|mesh-ancestor
65534220|NCT05557240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65534221|NCT05557240|Antiviral Agents|antiviral agents|mesh-ancestor
65534222|NCT05557240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65534223|NCT03631407|Pembrolizumab|pembrolizumab|mesh-list
65534224|NCT03631407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65534225|NCT03631407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534226|NCT03547024|Midazolam|midazolam|mesh-list
65534227|NCT03547024|Dextromethorphan|dextromethorphan|mesh-list
65534228|NCT03547024|Omeprazole|omeprazole|mesh-list
65534229|NCT03547024|Levonorgestrel|levonorgestrel|mesh-list
65534230|NCT03547024|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65534231|NCT03547024|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65534232|NCT03547024|JNJ-55308942|jnj-55308942|mesh-list
65534233|NCT03547024|Estradiol|estradiol|mesh-list
65534234|NCT03547024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65534235|NCT03547024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65534236|NCT03547024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65534237|NCT03547024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534238|NCT03547024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65534239|NCT03547024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65534240|NCT03547024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65263275|NCT04405999|Bromhexine|bromhexine|mesh-list
65534241|NCT03547024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65534242|NCT03547024|Anesthetics, General|anesthetics, general|mesh-ancestor
65534243|NCT03547024|Anesthetics|anesthetics|mesh-ancestor
65534244|NCT03547024|GABA Modulators|gaba modulators|mesh-ancestor
65534245|NCT03547024|GABA Agents|gaba agents|mesh-ancestor
65534246|NCT03547024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65534247|NCT03547024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534248|NCT03547024|Estrogens|estrogens|mesh-ancestor
65534249|NCT03547024|Hormones|hormones|mesh-ancestor
65534250|NCT03547024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65534251|NCT03547024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65534252|NCT03547024|Contraceptive Agents|contraceptive agents|mesh-ancestor
65534253|NCT03547024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65534254|NCT03547024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65534255|NCT03547024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65534256|NCT03547024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65534257|NCT03547024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65534258|NCT03547024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534259|NCT03547024|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65534260|NCT03547024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65534261|NCT03547024|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65534262|NCT03547024|Antitussive Agents|antitussive agents|mesh-ancestor
65534263|NCT03547024|Respiratory System Agents|respiratory system agents|mesh-ancestor
65534264|NCT03547024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65534265|NCT03547024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65534266|NCT03547024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65534267|NCT03547024|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
65534268|NCT03547024|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65534269|NCT03547024|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65534270|NCT03547024|Purinergic Agents|purinergic agents|mesh-ancestor
65331772|NCT00745173|Hormones|hormones|mesh-ancestor
65534271|NCT05115994|Antihypertensive Agents|antihypertensive agents|mesh-list
65534272|NCT04012996|Meloxicam|meloxicam|mesh-list
65534273|NCT04012996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65534274|NCT04012996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65534275|NCT04012996|Analgesics|analgesics|mesh-ancestor
65534276|NCT04012996|Sensory System Agents|sensory system agents|mesh-ancestor
65534277|NCT04012996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65534278|NCT04012996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534279|NCT04012996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65534280|NCT04012996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65534281|NCT04012996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65534282|NCT04012996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65534283|NCT04012996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534284|NCT04012996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534285|NCT02253784|Dexamethasone|dexamethasone|mesh-list
65534286|NCT02253784|Bupivacaine|bupivacaine|mesh-list
65534287|NCT02253784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65534288|NCT02253784|Antiemetics|antiemetics|mesh-ancestor
65534289|NCT02253784|Autonomic Agents|autonomic agents|mesh-ancestor
65534290|NCT02253784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65534291|NCT02253784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534292|NCT02253784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65534293|NCT02253784|Glucocorticoids|glucocorticoids|mesh-ancestor
65534294|NCT02253784|Hormones|hormones|mesh-ancestor
65534295|NCT02253784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65534296|NCT02253784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65534297|NCT02253784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534298|NCT02253784|Anesthetics, Local|anesthetics, local|mesh-ancestor
65534299|NCT02253784|Anesthetics|anesthetics|mesh-ancestor
65534300|NCT02253784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65534301|NCT02253784|Sensory System Agents|sensory system agents|mesh-ancestor
65534302|NCT03734445|Vitamins|vitamins|mesh-list
65534303|NCT03734445|Micronutrients|micronutrients|mesh-ancestor
65534304|NCT03734445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534305|NCT04538092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65534306|NCT04538092|Analgesics|analgesics|mesh-list
65534307|NCT04538092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65534308|NCT04538092|Sensory System Agents|sensory system agents|mesh-ancestor
65534309|NCT04538092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65534310|NCT04538092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534311|NCT03546088|Anesthetics|anesthetics|mesh-list
65534312|NCT03546088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65534313|NCT03546088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534314|NCT04522336|Docetaxel|docetaxel|mesh-list
65534315|NCT04522336|Pembrolizumab|pembrolizumab|mesh-list
65534316|NCT04522336|Fluorouracil|fluorouracil|mesh-list
65534317|NCT04522336|Oxaliplatin|oxaliplatin|mesh-list
65534318|NCT04522336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534319|NCT04522336|Tubulin Modulators|tubulin modulators|mesh-ancestor
65534320|NCT04522336|Antimitotic Agents|antimitotic agents|mesh-ancestor
65534321|NCT04522336|Mitosis Modulators|mitosis modulators|mesh-ancestor
65534322|NCT04522336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534323|NCT04522336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65534324|NCT04522336|Antimetabolites|antimetabolites|mesh-ancestor
65534325|NCT04522336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65534326|NCT04522336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65534327|NCT04522336|Immunologic Factors|immunologic factors|mesh-ancestor
65534328|NCT04522336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534329|NCT03875872|Propofol|propofol|mesh-list
65534330|NCT03875872|Anesthetics|anesthetics|mesh-list
65534331|NCT03875872|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
65534332|NCT03875872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65534333|NCT03875872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65534334|NCT03875872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534335|NCT03875872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65534336|NCT03875872|Anesthetics, General|anesthetics, general|mesh-ancestor
65534337|NCT03866980|Carboplatin|carboplatin|mesh-list
65534338|NCT03866980|Pemetrexed|pemetrexed|mesh-list
65534339|NCT03866980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534340|NCT03866980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534341|NCT03866980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534342|NCT03866980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65534343|NCT03866980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65534344|NCT02253862|Ritonavir|ritonavir|mesh-list
65534345|NCT02253862|Tipranavir|tipranavir|mesh-list
65534346|NCT02253862|Tadalafil|tadalafil|mesh-list
65534347|NCT02253862|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65331850|NCT00723554|Iloprost|iloprost|mesh-list
65534348|NCT02253862|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65534349|NCT02253862|Protease Inhibitors|protease inhibitors|mesh-ancestor
65534351|NCT02253862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534352|NCT02253862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65534353|NCT02253862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65534354|NCT02253862|Antiviral Agents|antiviral agents|mesh-ancestor
65534355|NCT02253862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65534356|NCT02253862|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65534357|NCT02253862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65534358|NCT02253862|Vasodilator Agents|vasodilator agents|mesh-ancestor
65534359|NCT02253862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65534360|NCT02253862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65534361|NCT02253862|Urological Agents|urological agents|mesh-ancestor
65534362|NCT03627195|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65534363|NCT03627195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65534364|NCT03627195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65534365|NCT03627195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65534366|NCT03627195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534367|NCT03627195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65534368|NCT03627195|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65534369|NCT03627195|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65534370|NCT03627195|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65534371|NCT03627195|Adrenergic Agents|adrenergic agents|mesh-ancestor
65534372|NCT03627195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65534373|NCT03627195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534374|NCT03627195|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65534375|NCT03627195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65534376|NCT03627195|Serotonin Agents|serotonin agents|mesh-ancestor
65534377|NCT03627195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65534378|NCT03627195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65534379|NCT03627195|Dopamine Agents|dopamine agents|mesh-ancestor
65534380|NCT03776656|Allopurinol|allopurinol|mesh-list
65534381|NCT03776656|Antimetabolites|antimetabolites|mesh-ancestor
65534382|NCT03776656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534383|NCT03776656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534384|NCT03776656|Gout Suppressants|gout suppressants|mesh-ancestor
65534385|NCT03776656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65534386|NCT03776656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65534387|NCT03776656|Antioxidants|antioxidants|mesh-ancestor
65534388|NCT03776656|Protective Agents|protective agents|mesh-ancestor
65534389|NCT03776656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534390|NCT03733587|Cyclophosphamide|cyclophosphamide|mesh-list
65534391|NCT03733587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65534392|NCT03733587|Immunologic Factors|immunologic factors|mesh-ancestor
65534393|NCT03733587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534394|NCT03733587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65534395|NCT03733587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65534396|NCT03733587|Alkylating Agents|alkylating agents|mesh-ancestor
65534397|NCT03733587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534398|NCT03733587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534399|NCT03733587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65534400|NCT00126581|Paclitaxel|paclitaxel|mesh-list
65534401|NCT00126581|Carboplatin|carboplatin|mesh-list
65534402|NCT00126581|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65534403|NCT00126581|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65534404|NCT00126581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65534405|NCT00126581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534406|NCT00126581|Tubulin Modulators|tubulin modulators|mesh-ancestor
65534407|NCT00126581|Antimitotic Agents|antimitotic agents|mesh-ancestor
65534408|NCT00126581|Mitosis Modulators|mitosis modulators|mesh-ancestor
65534409|NCT00126581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534410|NCT00126581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65534411|NCT00126581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534412|NCT03704584|Methylprednisolone|methylprednisolone|mesh-list
65534413|NCT03704584|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65534414|NCT03704584|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65534415|NCT03704584|Prednisolone|prednisolone|mesh-list
65534416|NCT03704584|Prednisolone acetate|prednisolone acetate|mesh-list
65534417|NCT03704584|Lidocaine|lidocaine|mesh-list
65534418|NCT03704584|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65534419|NCT03704584|Prednisolone phosphate|prednisolone phosphate|mesh-list
65534420|NCT03704584|Anesthetics, Local|anesthetics, local|mesh-ancestor
65534421|NCT03704584|Anesthetics|anesthetics|mesh-ancestor
65534422|NCT03704584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65331925|NCT00752037|Ritonavir|ritonavir|mesh-list
65534423|NCT03704584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534424|NCT03704584|Sensory System Agents|sensory system agents|mesh-ancestor
65534425|NCT03704584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65534426|NCT03704584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65534427|NCT03704584|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65534428|NCT03704584|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65534429|NCT03704584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65534430|NCT03704584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534431|NCT03704584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65534433|NCT03704584|Autonomic Agents|autonomic agents|mesh-ancestor
65534434|NCT03704584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65534435|NCT03704584|Glucocorticoids|glucocorticoids|mesh-ancestor
65534436|NCT03704584|Hormones|hormones|mesh-ancestor
65534437|NCT03704584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65534438|NCT03704584|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65534439|NCT03704584|Protective Agents|protective agents|mesh-ancestor
65534440|NCT03704584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65534441|NCT03704584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534442|NCT03643510|Fulvestrant|fulvestrant|mesh-list
65534443|NCT03643510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65534444|NCT03643510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534445|NCT03643510|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65534446|NCT03643510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65534447|NCT03643510|Hormone Antagonists|hormone antagonists|mesh-ancestor
65534448|NCT03643510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65534449|NCT03643510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534450|NCT03737721|Avelumab|avelumab|mesh-list
65534451|NCT03737721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65534452|NCT03737721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534453|NCT03647709|Analgesics, Opioid|analgesics, opioid|mesh-list
65534454|NCT03647709|Narcotics|narcotics|mesh-ancestor
65534455|NCT03647709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65534456|NCT03647709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534457|NCT03647709|Analgesics|analgesics|mesh-ancestor
65534458|NCT03647709|Sensory System Agents|sensory system agents|mesh-ancestor
65534459|NCT03647709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65534460|NCT03546634|Vaccines|vaccines|mesh-list
65534461|NCT03546634|Immunologic Factors|immunologic factors|mesh-ancestor
65534462|NCT03546634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534463|NCT03621748|Anesthetics|anesthetics|mesh-list
65534464|NCT03621748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65534465|NCT03621748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534466|NCT03661983|Aripiprazole|aripiprazole|mesh-list
65534467|NCT03661983|Antidepressive Agents|antidepressive agents|mesh-ancestor
65534468|NCT03661983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65534469|NCT03661983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65534470|NCT03661983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65534471|NCT03661983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65534472|NCT03661983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534473|NCT03661983|Dopamine Agonists|dopamine agonists|mesh-ancestor
65534474|NCT03661983|Dopamine Agents|dopamine agents|mesh-ancestor
65534475|NCT03661983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65534476|NCT03661983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534477|NCT03661983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65534478|NCT03661983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65534479|NCT03661983|Serotonin Agents|serotonin agents|mesh-ancestor
65534480|NCT03661983|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65534481|NCT03661983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65534482|NCT03661983|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65534483|NCT03661983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65534484|NCT02783170|Vaccines|vaccines|mesh-list
65534485|NCT02783170|Immunologic Factors|immunologic factors|mesh-ancestor
65534486|NCT02783170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534487|NCT04307134|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65534488|NCT04307134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65534489|NCT04307134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534490|NCT04307134|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65534491|NCT02254018|Maytansine|maytansine|mesh-list
65534492|NCT02254018|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
65534493|NCT02254018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65534494|NCT02254018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534495|NCT02254018|Tubulin Modulators|tubulin modulators|mesh-ancestor
65534496|NCT02254018|Antimitotic Agents|antimitotic agents|mesh-ancestor
65534497|NCT02254018|Mitosis Modulators|mitosis modulators|mesh-ancestor
65534498|NCT02254018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534499|NCT02254018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65534501|NCT04249882|Varenicline|varenicline|mesh-list
65534502|NCT04249882|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65534503|NCT04249882|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65534504|NCT04249882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534505|NCT04249882|Sensory System Agents|sensory system agents|mesh-ancestor
65534506|NCT04249882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65534507|NCT04249882|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65534508|NCT04249882|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65534509|NCT04249882|Cholinergic Agents|cholinergic agents|mesh-ancestor
65534510|NCT04249882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65534511|NCT04249882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534512|NCT05138614|Analgesics, Opioid|analgesics, opioid|mesh-list
65534513|NCT05138614|Narcotics|narcotics|mesh-ancestor
65534514|NCT05138614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65534515|NCT05138614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534516|NCT05138614|Analgesics|analgesics|mesh-ancestor
65534517|NCT05138614|Sensory System Agents|sensory system agents|mesh-ancestor
65534518|NCT05138614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65534519|NCT03396952|Aspirin|aspirin|mesh-list
65534520|NCT03396952|Pembrolizumab|pembrolizumab|mesh-list
65534521|NCT03396952|Ipilimumab|ipilimumab|mesh-list
65534522|NCT03396952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65534523|NCT03396952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534524|NCT03396952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65534525|NCT03396952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65534526|NCT03396952|Analgesics|analgesics|mesh-ancestor
65534527|NCT03396952|Sensory System Agents|sensory system agents|mesh-ancestor
65534528|NCT03396952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65534529|NCT03396952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534530|NCT03396952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65534531|NCT03396952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65534532|NCT03396952|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65534533|NCT03396952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65534534|NCT03396952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534535|NCT03396952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65534536|NCT03396952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65534537|NCT03396952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534538|NCT03396952|Antipyretics|antipyretics|mesh-ancestor
65534539|NCT03396952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65534540|NCT03378934|Aspirin|aspirin|mesh-list
65534541|NCT03378934|Clopidogrel|clopidogrel|mesh-list
65534542|NCT03378934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65534543|NCT03378934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65534544|NCT03378934|Analgesics|analgesics|mesh-ancestor
65534545|NCT03378934|Sensory System Agents|sensory system agents|mesh-ancestor
65534546|NCT03378934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65534547|NCT03378934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534548|NCT03378934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65534549|NCT03378934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65534550|NCT03378934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65534551|NCT03378934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65534552|NCT03378934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534553|NCT03378934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65534554|NCT03378934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65534555|NCT03378934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534556|NCT03378934|Antipyretics|antipyretics|mesh-ancestor
65534557|NCT03378934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65534558|NCT03378934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65534559|NCT03378934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65534560|NCT03378934|Purinergic Agents|purinergic agents|mesh-ancestor
65534561|NCT03378934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65534562|NCT00126503|Bevacizumab|bevacizumab|mesh-list
65534563|NCT00126503|Sorafenib|sorafenib|mesh-list
65534564|NCT00126503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65534565|NCT00126503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534566|NCT00126503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65534567|NCT00126503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65534568|NCT00126503|Growth Substances|growth substances|mesh-ancestor
65534569|NCT00126503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534570|NCT00126503|Growth Inhibitors|growth inhibitors|mesh-ancestor
65534571|NCT00126503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65534572|NCT00126503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534573|NCT00126503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534574|NCT00126425|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65534575|NCT00126425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534576|NCT00126425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534577|NCT00126425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534578|NCT00126425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65534579|NCT00126191|Leucovorin|leucovorin|mesh-list
65534580|NCT00126191|Cytarabine|cytarabine|mesh-list
65534581|NCT00126191|Cyclophosphamide|cyclophosphamide|mesh-list
65534582|NCT00126191|Ifosfamide|ifosfamide|mesh-list
65534583|NCT00126191|Rituximab|rituximab|mesh-list
65534584|NCT00126191|Doxorubicin|doxorubicin|mesh-list
65534585|NCT00126191|Methotrexate|methotrexate|mesh-list
65534586|NCT00126191|Etoposide|etoposide|mesh-list
65534587|NCT00126191|Vincristine|vincristine|mesh-list
65534588|NCT00126191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65534589|NCT00126191|Immunologic Factors|immunologic factors|mesh-ancestor
65534590|NCT00126191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534591|NCT00126191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65534592|NCT00126191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65534593|NCT00126191|Alkylating Agents|alkylating agents|mesh-ancestor
65534594|NCT00126191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534595|NCT00126191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534596|NCT00126191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65534597|NCT00126191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65534598|NCT00126191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65534599|NCT00126191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65534600|NCT00126191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65534601|NCT00126191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534602|NCT00126191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65534603|NCT00126191|Abortifacient Agents|abortifacient agents|mesh-ancestor
65534604|NCT00126191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65534605|NCT00126191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65534606|NCT00126191|Antimetabolites|antimetabolites|mesh-ancestor
65534607|NCT00126191|Dermatologic Agents|dermatologic agents|mesh-ancestor
65534608|NCT00126191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65534609|NCT00126191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65534610|NCT00126191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65534611|NCT00126191|Antiviral Agents|antiviral agents|mesh-ancestor
65534612|NCT00126191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65534613|NCT00126191|Antidotes|antidotes|mesh-ancestor
65534614|NCT00126191|Protective Agents|protective agents|mesh-ancestor
65534615|NCT00126191|Vitamin B Complex|vitamin b complex|mesh-ancestor
65534616|NCT00126191|Vitamins|vitamins|mesh-ancestor
65534617|NCT00126191|Micronutrients|micronutrients|mesh-ancestor
65534618|NCT00126191|Tubulin Modulators|tubulin modulators|mesh-ancestor
65534619|NCT00126191|Antimitotic Agents|antimitotic agents|mesh-ancestor
65534620|NCT00126191|Mitosis Modulators|mitosis modulators|mesh-ancestor
65534621|NCT03207958|Belimumab|belimumab|mesh-list
65534622|NCT03207958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65534623|NCT03207958|Immunologic Factors|immunologic factors|mesh-ancestor
65534624|NCT03207958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534625|NCT00124943|Paclitaxel|paclitaxel|mesh-list
65534626|NCT00124943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65534627|NCT00124943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65534628|NCT00124943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534629|NCT00124943|Tubulin Modulators|tubulin modulators|mesh-ancestor
65534630|NCT00124943|Antimitotic Agents|antimitotic agents|mesh-ancestor
65534631|NCT00124943|Mitosis Modulators|mitosis modulators|mesh-ancestor
65534632|NCT00124943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534633|NCT00124709|Pimecrolimus|pimecrolimus|mesh-list
65534634|NCT00124709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65534635|NCT00124709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65534636|NCT00124709|Analgesics|analgesics|mesh-ancestor
65534637|NCT00124709|Sensory System Agents|sensory system agents|mesh-ancestor
65534638|NCT00124709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65534639|NCT00124709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534640|NCT00124709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65534641|NCT00124709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65534642|NCT00124709|Dermatologic Agents|dermatologic agents|mesh-ancestor
65534643|NCT00124709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65534644|NCT00124709|Immunologic Factors|immunologic factors|mesh-ancestor
65534645|NCT00124709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65534646|NCT00124709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534647|NCT00124709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534648|NCT04139434|Azacitidine|azacitidine|mesh-list
65534649|NCT04139434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65534650|NCT04139434|Antimetabolites|antimetabolites|mesh-ancestor
65534651|NCT04139434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534652|NCT04139434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534653|NCT04139434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534655|NCT04130464|Ropivacaine|ropivacaine|mesh-list
65534656|NCT04130464|Anesthetics, Local|anesthetics, local|mesh-ancestor
65534657|NCT04130464|Anesthetics|anesthetics|mesh-ancestor
65534658|NCT04130464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65534659|NCT04130464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534660|NCT04130464|Sensory System Agents|sensory system agents|mesh-ancestor
65534661|NCT04130464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65534662|NCT04130464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65534663|NCT04130464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65534664|NCT04130464|Analgesics|analgesics|mesh-ancestor
65534665|NCT04130464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65534666|NCT04130464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65534667|NCT04130464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65534668|NCT04130464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534669|NCT04130464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534670|NCT03058354|Propofol|propofol|mesh-list
65534671|NCT03058354|Anesthetics|anesthetics|mesh-ancestor
65534672|NCT03058354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65534673|NCT03058354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534674|NCT03058354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65534675|NCT03058354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65534676|NCT03058354|Anesthetics, General|anesthetics, general|mesh-ancestor
65534677|NCT02911792|Metformin|metformin|mesh-list
65534678|NCT02911792|Dapagliflozin|dapagliflozin|mesh-list
65534679|NCT02911792|Glipizide|glipizide|mesh-list
65534680|NCT02911792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65534681|NCT02911792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534682|NCT02911792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65534683|NCT02911792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534684|NCT02143570|Darifenacin|darifenacin|mesh-list
65534685|NCT02143570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65534686|NCT02143570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65534687|NCT02143570|Cholinergic Agents|cholinergic agents|mesh-ancestor
65534688|NCT02143570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65534689|NCT02143570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263720|NCT02792426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65534690|NCT02143570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534691|NCT02143570|Urological Agents|urological agents|mesh-ancestor
65534692|NCT02143804|Molgramostim|molgramostim|mesh-list
65534693|NCT02143804|Sargramostim|sargramostim|mesh-list
65534694|NCT02143804|Immunologic Factors|immunologic factors|mesh-ancestor
65534695|NCT02143804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534696|NCT02143804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534697|NCT03544996|Insulin|insulin|mesh-list
65534698|NCT03544996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65534699|NCT03544996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534700|NCT00564850|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65534701|NCT00564850|Luteolytic Agents|luteolytic agents|mesh-ancestor
65534702|NCT00564850|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65534703|NCT00564850|Contraceptive Agents|contraceptive agents|mesh-ancestor
65534704|NCT00564850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65534705|NCT00564850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534706|NCT00564850|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65534707|NCT00564850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65534708|NCT00564850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534709|NCT00006256|Paclitaxel|paclitaxel|mesh-list
65534710|NCT00006256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65534711|NCT00006256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534712|NCT00006256|Tubulin Modulators|tubulin modulators|mesh-ancestor
65534713|NCT00006256|Antimitotic Agents|antimitotic agents|mesh-ancestor
65534714|NCT00006256|Mitosis Modulators|mitosis modulators|mesh-ancestor
65534715|NCT00006256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534716|NCT02144194|Docetaxel|docetaxel|mesh-list
65534717|NCT02144194|Vinorelbine|vinorelbine|mesh-list
65534718|NCT02144194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534719|NCT02144194|Tubulin Modulators|tubulin modulators|mesh-ancestor
65534720|NCT02144194|Antimitotic Agents|antimitotic agents|mesh-ancestor
65534721|NCT02144194|Mitosis Modulators|mitosis modulators|mesh-ancestor
65534722|NCT02144194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534723|NCT02144194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65534724|NCT02140840|Trametinib|trametinib|mesh-list
65534725|NCT02140840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534726|NCT02140840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65534727|NCT02140840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534728|NCT02140840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534729|NCT02140918|Fludrocortisone|fludrocortisone|mesh-list
65534730|NCT02140918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65534731|NCT00108160|Mupirocin|mupirocin|mesh-list
65534732|NCT00108160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65534733|NCT00108160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65534734|NCT00108160|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65534735|NCT00108160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534736|NCT00108160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534737|NCT02254174|Tiotropium Bromide|tiotropium bromide|mesh-list
65534738|NCT02254174|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65534739|NCT02254174|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65534740|NCT02254174|Autonomic Agents|autonomic agents|mesh-ancestor
65534741|NCT02254174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65534742|NCT02254174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534743|NCT02254174|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65534744|NCT02254174|Respiratory System Agents|respiratory system agents|mesh-ancestor
65534745|NCT02254174|Parasympatholytics|parasympatholytics|mesh-ancestor
65534746|NCT02254174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65534747|NCT02254174|Cholinergic Agents|cholinergic agents|mesh-ancestor
65534748|NCT02254174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65534749|NCT02254174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534750|NCT02254174|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65534751|NCT02254174|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65534752|NCT02254174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65534753|NCT02254174|Adrenergic Agents|adrenergic agents|mesh-ancestor
65534754|NCT03545308|Rocuronium|rocuronium|mesh-list
65534755|NCT03545308|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65534756|NCT03545308|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65534757|NCT03545308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65534758|NCT03545308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65534759|NCT03545308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534760|NCT00108082|Atenolol|atenolol|mesh-list
65534761|NCT00108082|Carvedilol|carvedilol|mesh-list
65534762|NCT00108082|Lisinopril|lisinopril|mesh-list
65263795|NCT04256525|Analgesics|analgesics|mesh-ancestor
65534763|NCT00108082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65534764|NCT00108082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65534765|NCT00108082|Adrenergic Agents|adrenergic agents|mesh-ancestor
65534766|NCT00108082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65534767|NCT00108082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534768|NCT00108082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534769|NCT00108082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65534770|NCT00108082|Antioxidants|antioxidants|mesh-ancestor
65534771|NCT00108082|Protective Agents|protective agents|mesh-ancestor
65534772|NCT00108082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65534773|NCT00108082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65534774|NCT00108082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65534775|NCT00108082|Vasodilator Agents|vasodilator agents|mesh-ancestor
65534776|NCT00108082|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65534777|NCT00108082|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65534778|NCT00108082|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65534779|NCT00108082|Protease Inhibitors|protease inhibitors|mesh-ancestor
65534780|NCT00108082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534781|NCT00108082|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65534782|NCT00108082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65534783|NCT00108082|Sympatholytics|sympatholytics|mesh-ancestor
65534784|NCT00108082|Autonomic Agents|autonomic agents|mesh-ancestor
65534785|NCT00108082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65534786|NCT00108082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65534787|NCT02144662|Ranibizumab|ranibizumab|mesh-list
65534788|NCT02144662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65534789|NCT02144662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65534790|NCT02144662|Growth Substances|growth substances|mesh-ancestor
65534791|NCT02144662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534792|NCT02144662|Growth Inhibitors|growth inhibitors|mesh-ancestor
65534793|NCT02144662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534794|NCT02141698|Esomeprazole|esomeprazole|mesh-list
65332300|NCT02560935|Hydroxyurea|hydroxyurea|mesh-list
65534795|NCT02141698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65534796|NCT02141698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65534797|NCT02141698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65534798|NCT02141698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534799|NCT02141698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534800|NCT02144818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65534801|NCT02144818|Luteolytic Agents|luteolytic agents|mesh-ancestor
65534802|NCT02144818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65534803|NCT02144818|Contraceptive Agents|contraceptive agents|mesh-ancestor
65534804|NCT02144818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65534805|NCT02144818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534806|NCT02144818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65534807|NCT02144818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65534808|NCT02144818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534809|NCT02147938|Tacrolimus|tacrolimus|mesh-list
65534810|NCT02147938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65534811|NCT02147938|Immunologic Factors|immunologic factors|mesh-ancestor
65534812|NCT02147938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534813|NCT02147938|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65534814|NCT02147938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534815|NCT02147938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534816|NCT02148016|Levofloxacin|levofloxacin|mesh-list
65534817|NCT02148016|Ofloxacin|ofloxacin|mesh-list
65534818|NCT02148016|Betamethasone|betamethasone|mesh-list
65534819|NCT02148016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65534820|NCT02148016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65534821|NCT02148016|Renal Agents|renal agents|mesh-ancestor
65534822|NCT02148016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65534823|NCT02148016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65534824|NCT02148016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65534825|NCT02148016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534826|NCT02148016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534827|NCT02148016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534828|NCT02148016|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65534829|NCT02148016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65534830|NCT02148016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65534831|NCT02148016|Glucocorticoids|glucocorticoids|mesh-ancestor
65534832|NCT02148016|Hormones|hormones|mesh-ancestor
65534833|NCT02148016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65534834|NCT02148016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534835|NCT02148016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65534836|NCT02148016|Respiratory System Agents|respiratory system agents|mesh-ancestor
65534837|NCT02148094|Tenofovir|tenofovir|mesh-list
65534838|NCT02148094|Emtricitabine|emtricitabine|mesh-list
65534839|NCT02148094|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65534840|NCT02148094|Antiviral Agents|antiviral agents|mesh-ancestor
65534841|NCT02148094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65534842|NCT02148094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65534843|NCT02148094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65534844|NCT02148094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534845|NCT02148094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534846|NCT02148094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65534847|NCT02148094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65534848|NCT00104884|Romidepsin|romidepsin|mesh-list
65534849|NCT00104884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65534850|NCT00104884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534851|NCT02148328|Vaccines|vaccines|mesh-list
65534852|NCT02148328|Immunologic Factors|immunologic factors|mesh-ancestor
65534853|NCT02148328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534854|NCT02142010|Paclitaxel|paclitaxel|mesh-list
65534855|NCT02142010|Cisplatin|cisplatin|mesh-list
65534856|NCT02142010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65534857|NCT02142010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534858|NCT02142010|Tubulin Modulators|tubulin modulators|mesh-ancestor
65534859|NCT02142010|Antimitotic Agents|antimitotic agents|mesh-ancestor
65534860|NCT02142010|Mitosis Modulators|mitosis modulators|mesh-ancestor
65534861|NCT02142010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534862|NCT02142166|Dialysis Solutions|dialysis solutions|mesh-list
65534863|NCT02142166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65534864|NCT05054140|Calcium|calcium|mesh-list
65534865|NCT05054140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65534866|NCT05054140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534867|NCT03543826|Rocuronium|rocuronium|mesh-list
65534868|NCT03543826|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65534869|NCT03543826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65534870|NCT03543826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65534871|NCT03543826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65534872|NCT03543826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534874|NCT02148640|Dermatologic Agents|dermatologic agents|mesh-ancestor
65534875|NCT02148640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65534876|NCT02148640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65534877|NCT02142556|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65534878|NCT02142556|Antidepressive Agents|antidepressive agents|mesh-ancestor
65534879|NCT02142556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65534880|NCT02142556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65534881|NCT02142556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65534882|NCT02142556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65534883|NCT02142556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534884|NCT02142634|Budesonide|budesonide|mesh-list
65534885|NCT02142634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65534886|NCT02142634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65534887|NCT02142634|Autonomic Agents|autonomic agents|mesh-ancestor
65534888|NCT02142634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65534889|NCT02142634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534890|NCT02142634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65534891|NCT02142634|Respiratory System Agents|respiratory system agents|mesh-ancestor
65534892|NCT02142634|Glucocorticoids|glucocorticoids|mesh-ancestor
65534893|NCT02142634|Hormones|hormones|mesh-ancestor
65534894|NCT02142634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65534895|NCT02142790|Paclitaxel|paclitaxel|mesh-list
65534896|NCT02142790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65534897|NCT02142790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534898|NCT02142790|Tubulin Modulators|tubulin modulators|mesh-ancestor
65534899|NCT02142790|Antimitotic Agents|antimitotic agents|mesh-ancestor
65534900|NCT02142790|Mitosis Modulators|mitosis modulators|mesh-ancestor
65534901|NCT02142790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534902|NCT02142868|Letrozole|letrozole|mesh-list
65534903|NCT02142868|Palbociclib|palbociclib|mesh-list
65534904|NCT02142868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534905|NCT02142868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65534906|NCT02142868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65534907|NCT02142868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534908|NCT02142868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534909|NCT02142868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65264014|NCT00944359|Zinc|zinc|mesh-list
65534910|NCT02142868|Hormone Antagonists|hormone antagonists|mesh-ancestor
65534911|NCT02142868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65534912|NCT02142868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534913|NCT02142868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65534914|NCT02145520|Magnesium Sulfate|magnesium sulfate|mesh-list
65534915|NCT02145520|Analgesics|analgesics|mesh-ancestor
65534916|NCT02145520|Sensory System Agents|sensory system agents|mesh-ancestor
65534917|NCT02145520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65534918|NCT02145520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534919|NCT02145520|Anesthetics|anesthetics|mesh-ancestor
65534920|NCT02145520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65534921|NCT02145520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65534922|NCT02145520|Anticonvulsants|anticonvulsants|mesh-ancestor
65534923|NCT02145520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65534924|NCT02145520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65534925|NCT02145520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534926|NCT02145520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65534927|NCT02145520|Tocolytic Agents|tocolytic agents|mesh-ancestor
65534928|NCT02145520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65534929|NCT02145598|Lenalidomide|lenalidomide|mesh-list
65534930|NCT02145598|Immunologic Factors|immunologic factors|mesh-ancestor
65534931|NCT02145598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534932|NCT02145598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65534933|NCT02145598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65534934|NCT02145598|Growth Substances|growth substances|mesh-ancestor
65534935|NCT02145598|Growth Inhibitors|growth inhibitors|mesh-ancestor
65534936|NCT02145598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534937|NCT02145832|Fluconazole|fluconazole|mesh-list
65534938|NCT02145832|Micafungin|micafungin|mesh-list
65534939|NCT02145832|Antifungal Agents|antifungal agents|mesh-list
65534940|NCT02145832|Clotrimazole|clotrimazole|mesh-list
65534941|NCT02145832|Miconazole|miconazole|mesh-list
65534942|NCT02145832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65332448|NCT04056039|Colchicine|colchicine|mesh-list
65534943|NCT02145832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65534944|NCT02145832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65534945|NCT02145832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534946|NCT02145832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534947|NCT02145832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65534948|NCT02145832|Hormone Antagonists|hormone antagonists|mesh-ancestor
65534949|NCT02145832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65534950|NCT02145832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534951|NCT02145832|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65534952|NCT02145832|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65534953|NCT02145832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65534954|NCT02145832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65534955|NCT00104728|Gefitinib|gefitinib|mesh-list
65534956|NCT00104728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534957|NCT00104728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65534958|NCT00104728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534959|NCT00104728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534960|NCT02145910|Vemurafenib|vemurafenib|mesh-list
65534961|NCT02145910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534962|NCT02145910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65534963|NCT02145910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534964|NCT02145910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534965|NCT02146222|Docetaxel|docetaxel|mesh-list
65534966|NCT02146222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534967|NCT02146222|Tubulin Modulators|tubulin modulators|mesh-ancestor
65534968|NCT02146222|Antimitotic Agents|antimitotic agents|mesh-ancestor
65534969|NCT02146222|Mitosis Modulators|mitosis modulators|mesh-ancestor
65534970|NCT02146222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534971|NCT02146300|Xylometazoline|xylometazoline|mesh-list
65534972|NCT02146300|Nasal Decongestants|nasal decongestants|mesh-ancestor
65534973|NCT02146300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65534974|NCT02146300|Respiratory System Agents|respiratory system agents|mesh-ancestor
65534975|NCT02146456|Tranexamic Acid|tranexamic acid|mesh-list
65534976|NCT02146456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65534977|NCT02146456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65534978|NCT02146456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534979|NCT02146456|Hemostatics|hemostatics|mesh-ancestor
65534980|NCT02146456|Coagulants|coagulants|mesh-ancestor
65264020|NCT02791256|Antimetabolites|antimetabolites|mesh-ancestor
65534981|NCT02146534|4-Aminopyridine|4-aminopyridine|mesh-list
65534982|NCT02146534|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65534983|NCT02146534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65534984|NCT02146534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534985|NCT02151916|Fluorides|fluorides|mesh-list
65534986|NCT02151916|Fluorides, Topical|fluorides, topical|mesh-list
65534987|NCT02151916|Cariostatic Agents|cariostatic agents|mesh-ancestor
65534988|NCT02151916|Protective Agents|protective agents|mesh-ancestor
65534989|NCT02151916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65534990|NCT02146846|Imatinib Mesylate|imatinib mesylate|mesh-list
65534991|NCT02146846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65534992|NCT02146846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65534993|NCT02146846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534994|NCT02146846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65534995|NCT02152228|Teriparatide|teriparatide|mesh-list
65534996|NCT02152228|Hormones|hormones|mesh-list
65534997|NCT02152228|Parathyroid Hormone|parathyroid hormone|mesh-list
65534998|NCT02152228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65534999|NCT02152228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535000|NCT02152228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65535001|NCT02152228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65535002|NCT02152306|Amlodipine|amlodipine|mesh-list
65535003|NCT02152306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65535004|NCT02152306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65535005|NCT02152306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65535006|NCT02152306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535007|NCT02152306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65535008|NCT02152306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535009|NCT02152306|Vasodilator Agents|vasodilator agents|mesh-ancestor
65535010|NCT02261116|Telmisartan|telmisartan|mesh-list
65535011|NCT02261116|Candesartan|candesartan|mesh-list
65535012|NCT02261116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65535013|NCT02261116|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65332524|NCT00918554|Antimetabolites|antimetabolites|mesh-ancestor
65535014|NCT02261116|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65535015|NCT02261116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535016|NCT02254720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65535017|NCT02147548|Lorazepam|lorazepam|mesh-list
65535018|NCT02147548|Etifoxine|etifoxine|mesh-list
65535019|NCT02147548|Anticonvulsants|anticonvulsants|mesh-ancestor
65535020|NCT02147548|Antiemetics|antiemetics|mesh-ancestor
65535021|NCT02147548|Autonomic Agents|autonomic agents|mesh-ancestor
65535022|NCT02147548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65535023|NCT02147548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535024|NCT02147548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65535025|NCT02147548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65535026|NCT02147548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65535027|NCT02147548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65535028|NCT02147548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65535029|NCT02147548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65535030|NCT02147548|GABA Modulators|gaba modulators|mesh-ancestor
65535031|NCT02147548|GABA Agents|gaba agents|mesh-ancestor
65535032|NCT02147548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65535033|NCT02147548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535034|NCT03622593|Aflibercept|aflibercept|mesh-list
65535035|NCT03622593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65535036|NCT03622593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65535037|NCT03622593|Growth Substances|growth substances|mesh-ancestor
65535038|NCT03622593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535039|NCT03622593|Growth Inhibitors|growth inhibitors|mesh-ancestor
65535040|NCT03622593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535041|NCT00122681|Vaccines|vaccines|mesh-list
65535042|NCT00122681|Immunologic Factors|immunologic factors|mesh-ancestor
65535043|NCT00122681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535044|NCT02774278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65535045|NCT02774278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535046|NCT02774278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65535047|NCT02774278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535048|NCT02774278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535049|NCT05666349|Niraparib|niraparib|mesh-list
65535050|NCT05666349|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65535051|NCT05666349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65264105|NCT00754065|Dienogest|dienogest|mesh-list
65535052|NCT05666349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535053|NCT05666349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535054|NCT03733275|Lidocaine|lidocaine|mesh-list
65535055|NCT03733275|Bupivacaine|bupivacaine|mesh-list
65535056|NCT03733275|Anesthetics, Local|anesthetics, local|mesh-ancestor
65535057|NCT03733275|Anesthetics|anesthetics|mesh-ancestor
65535058|NCT03733275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65535059|NCT03733275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535060|NCT03733275|Sensory System Agents|sensory system agents|mesh-ancestor
65535061|NCT03733275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65535062|NCT03733275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65535063|NCT03733275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65535064|NCT03733275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65535065|NCT03733275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65535066|NCT03733275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535067|NCT03542422|Apatinib|apatinib|mesh-list
65535068|NCT03542422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535069|NCT03542422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65535070|NCT03542422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535071|NCT03542422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535072|NCT01077011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65535073|NCT01077011|Lubricant Eye Drops|lubricant eye drops|mesh-list
65535074|NCT01077011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65535075|NCT02153866|Vaccines|vaccines|mesh-list
65535076|NCT02153866|Immunologic Factors|immunologic factors|mesh-ancestor
65535077|NCT02153866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535078|NCT03645057|Tacrolimus|tacrolimus|mesh-list
65535079|NCT03645057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65535080|NCT03645057|Immunologic Factors|immunologic factors|mesh-ancestor
65535081|NCT03645057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535082|NCT03645057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65535083|NCT03645057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535084|NCT03645057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535085|NCT04863430|Oxaliplatin|oxaliplatin|mesh-list
65535086|NCT04863430|Apatinib|apatinib|mesh-list
65535087|NCT04863430|Tegafur|tegafur|mesh-list
65535088|NCT04863430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535089|NCT04863430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65535090|NCT04863430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535091|NCT04863430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535092|NCT04863430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65535093|NCT04863430|Antimetabolites|antimetabolites|mesh-ancestor
65535094|NCT05665881|Phenylephrine|phenylephrine|mesh-list
65535095|NCT05665881|Oxymetazoline|oxymetazoline|mesh-list
65535096|NCT05665881|Norepinephrine|norepinephrine|mesh-list
65535097|NCT05665881|Ephedrine|ephedrine|mesh-list
65535098|NCT05665881|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65535099|NCT05665881|Mydriatics|mydriatics|mesh-ancestor
65535100|NCT05665881|Autonomic Agents|autonomic agents|mesh-ancestor
65535101|NCT05665881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65535102|NCT05665881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535103|NCT05665881|Sympathomimetics|sympathomimetics|mesh-ancestor
65535104|NCT05665881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65535105|NCT05665881|Nasal Decongestants|nasal decongestants|mesh-ancestor
65535106|NCT05665881|Respiratory System Agents|respiratory system agents|mesh-ancestor
65535107|NCT05665881|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65535108|NCT05665881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65535109|NCT05665881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65535110|NCT05665881|Adrenergic Agents|adrenergic agents|mesh-ancestor
65535111|NCT05665881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65535112|NCT05665881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535113|NCT05665881|Protective Agents|protective agents|mesh-ancestor
65535114|NCT05665881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65535115|NCT03643575|Phenylpropanolamine|phenylpropanolamine|mesh-list
65535116|NCT03643575|Guaifenesin|guaifenesin|mesh-list
65535117|NCT03643575|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
65535118|NCT03643575|Expectorants|expectorants|mesh-ancestor
65535119|NCT03643575|Respiratory System Agents|respiratory system agents|mesh-ancestor
65535120|NCT03643575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65535121|NCT03643575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65535122|NCT03643575|Adrenergic Agents|adrenergic agents|mesh-ancestor
65535123|NCT03643575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65535124|NCT03643575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264170|NCT04094805|Vitamins|vitamins|mesh-ancestor
65535125|NCT03643575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535126|NCT03643575|Appetite Depressants|appetite depressants|mesh-ancestor
65535127|NCT03643575|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65535128|NCT03643575|Sympathomimetics|sympathomimetics|mesh-ancestor
65535129|NCT03643575|Autonomic Agents|autonomic agents|mesh-ancestor
65535130|NCT03643575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65535131|NCT03643575|Nasal Decongestants|nasal decongestants|mesh-ancestor
65535132|NCT03643575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65535133|NCT02768194|Fluorides|fluorides|mesh-list
65535134|NCT02768194|Tin Fluorides|tin fluorides|mesh-list
65535135|NCT02768194|Fluorophosphate|fluorophosphate|mesh-list
65535136|NCT02768194|Cariostatic Agents|cariostatic agents|mesh-ancestor
65535137|NCT02768194|Protective Agents|protective agents|mesh-ancestor
65535138|NCT02768194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535139|NCT02254954|Temozolomide|temozolomide|mesh-list
65535140|NCT02254954|Macitentan|macitentan|mesh-list
65535141|NCT02254954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65535142|NCT02254954|Alkylating Agents|alkylating agents|mesh-ancestor
65535143|NCT02254954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535144|NCT02254954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535145|NCT02254954|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65535146|NCT02254954|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65535147|NCT02254954|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65535148|NCT00130793|Vaccines|vaccines|mesh-list
65535149|NCT00130793|Immunologic Factors|immunologic factors|mesh-ancestor
65535150|NCT00130793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535151|NCT03732105|Apatinib|apatinib|mesh-list
65535152|NCT03732105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
65535153|NCT03732105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535154|NCT03732105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65535155|NCT03732105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535156|NCT03732105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535157|NCT03732105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65535158|NCT03732105|Growth Substances|growth substances|mesh-ancestor
65535159|NCT03732105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535160|NCT03732105|Growth Inhibitors|growth inhibitors|mesh-ancestor
65535161|NCT02154334|Mometasone Furoate|mometasone furoate|mesh-list
65535162|NCT02154334|Phenylephrine|phenylephrine|mesh-list
65535163|NCT02154334|Oxymetazoline|oxymetazoline|mesh-list
65535164|NCT02154334|Esketamine|esketamine|mesh-list
65535165|NCT02154334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65535166|NCT02154334|Dermatologic Agents|dermatologic agents|mesh-ancestor
65535167|NCT02154334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65535168|NCT02154334|Antidepressive Agents|antidepressive agents|mesh-ancestor
65535169|NCT02154334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65535170|NCT02154334|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65535171|NCT02154334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65535172|NCT02154334|Adrenergic Agents|adrenergic agents|mesh-ancestor
65535173|NCT02154334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65535174|NCT02154334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535175|NCT02154334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535176|NCT02154334|Sympathomimetics|sympathomimetics|mesh-ancestor
65535177|NCT02154334|Autonomic Agents|autonomic agents|mesh-ancestor
65535178|NCT02154334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65535179|NCT02154334|Nasal Decongestants|nasal decongestants|mesh-ancestor
65535180|NCT02154334|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65535181|NCT02154334|Respiratory System Agents|respiratory system agents|mesh-ancestor
65535182|NCT02154334|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65535183|NCT02154334|Mydriatics|mydriatics|mesh-ancestor
65535184|NCT02154334|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65535185|NCT02154334|Protective Agents|protective agents|mesh-ancestor
65535186|NCT01078961|Bortezomib|bortezomib|mesh-list
65535187|NCT01078961|Sorafenib|sorafenib|mesh-list
65535188|NCT01078961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535189|NCT01078961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65535190|NCT01078961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535191|NCT01078961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535192|NCT03818399|Buprenorphine|buprenorphine|mesh-list
65535193|NCT03818399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65535194|NCT03818399|Narcotics|narcotics|mesh-ancestor
65535195|NCT03818399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65535196|NCT03818399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535197|NCT03818399|Analgesics|analgesics|mesh-ancestor
65535198|NCT03818399|Sensory System Agents|sensory system agents|mesh-ancestor
65535199|NCT03818399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65535200|NCT03818399|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65535201|NCT02154646|Gemcitabine|gemcitabine|mesh-list
65535202|NCT02154646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65535203|NCT02154646|Antimetabolites|antimetabolites|mesh-ancestor
65535204|NCT02154646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535205|NCT02154646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535206|NCT02154646|Antiviral Agents|antiviral agents|mesh-ancestor
65535207|NCT02154646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65535208|NCT02154646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535209|NCT02154646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65535210|NCT02154646|Immunologic Factors|immunologic factors|mesh-ancestor
65535211|NCT02154646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535212|NCT03642873|Phenylpropanolamine|phenylpropanolamine|mesh-list
65535213|NCT03642873|Hydrocodone|hydrocodone|mesh-list
65535214|NCT03642873|Guaifenesin|guaifenesin|mesh-list
65535215|NCT03642873|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
65535216|NCT03642873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65535217|NCT03642873|Narcotics|narcotics|mesh-ancestor
65535218|NCT03642873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65535219|NCT03642873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535220|NCT03642873|Analgesics|analgesics|mesh-ancestor
65535221|NCT03642873|Sensory System Agents|sensory system agents|mesh-ancestor
65535222|NCT03642873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65535223|NCT03642873|Antitussive Agents|antitussive agents|mesh-ancestor
65535224|NCT03642873|Respiratory System Agents|respiratory system agents|mesh-ancestor
65535225|NCT03642873|Expectorants|expectorants|mesh-ancestor
65535226|NCT03642873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65535227|NCT03642873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65535228|NCT03642873|Adrenergic Agents|adrenergic agents|mesh-ancestor
65535229|NCT03642873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65535230|NCT03642873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535231|NCT03642873|Appetite Depressants|appetite depressants|mesh-ancestor
65535232|NCT03642873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65535233|NCT03642873|Sympathomimetics|sympathomimetics|mesh-ancestor
65535234|NCT03642873|Autonomic Agents|autonomic agents|mesh-ancestor
65535235|NCT03642873|Nasal Decongestants|nasal decongestants|mesh-ancestor
65535236|NCT03642873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65535237|NCT02156596|Ketoprofen|ketoprofen|mesh-list
65535238|NCT02156596|Morphine|morphine|mesh-list
65332746|NCT05113784|Antiviral Agents|antiviral agents|mesh-ancestor
65535239|NCT02156596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65535240|NCT02156596|Narcotics|narcotics|mesh-ancestor
65535241|NCT02156596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65535242|NCT02156596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535243|NCT02156596|Analgesics|analgesics|mesh-ancestor
65535244|NCT02156596|Sensory System Agents|sensory system agents|mesh-ancestor
65535245|NCT02156596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65535246|NCT02156596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65535247|NCT02156596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65535248|NCT02156596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65535249|NCT02156596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65535250|NCT02156596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65535251|NCT02156596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535252|NCT02156596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535253|NCT01079117|Morphine|morphine|mesh-list
65535254|NCT01079117|Methadone|methadone|mesh-list
65535255|NCT01079117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65535256|NCT01079117|Narcotics|narcotics|mesh-ancestor
65535257|NCT01079117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65535258|NCT01079117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535259|NCT01079117|Analgesics|analgesics|mesh-ancestor
65535260|NCT01079117|Sensory System Agents|sensory system agents|mesh-ancestor
65535261|NCT01079117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65535262|NCT01079117|Antitussive Agents|antitussive agents|mesh-ancestor
65535263|NCT01079117|Respiratory System Agents|respiratory system agents|mesh-ancestor
65535264|NCT03732963|Melatonin|melatonin|mesh-list
65535265|NCT03732963|Antioxidants|antioxidants|mesh-ancestor
65535266|NCT03732963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535267|NCT03732963|Protective Agents|protective agents|mesh-ancestor
65535268|NCT03732963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535269|NCT03732963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65535270|NCT03729687|Capecitabine|capecitabine|mesh-list
65535271|NCT03729687|Oxaliplatin|oxaliplatin|mesh-list
65535272|NCT03729687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65535273|NCT03729687|Antimetabolites|antimetabolites|mesh-ancestor
65535274|NCT03729687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535275|NCT03729687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535276|NCT03818321|Methenamine|methenamine|mesh-list
65535277|NCT03818321|Methenamine hippurate|methenamine hippurate|mesh-list
65535278|NCT03818321|Methenamine mandelate|methenamine mandelate|mesh-list
65535279|NCT03818321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65535280|NCT03818321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65535281|NCT03818321|Renal Agents|renal agents|mesh-ancestor
65535282|NCT03818321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65535283|NCT03616977|Insulin Lispro|insulin lispro|mesh-list
65535284|NCT03616977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65535285|NCT03616977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535286|NCT04996719|Sirolimus|sirolimus|mesh-list
65535287|NCT04996719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65535288|NCT04996719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65535289|NCT04996719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65535290|NCT04996719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535291|NCT04996719|Antifungal Agents|antifungal agents|mesh-ancestor
65535292|NCT04996719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65535293|NCT04996719|Immunologic Factors|immunologic factors|mesh-ancestor
65535294|NCT04996719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535295|NCT03816761|Insulin Aspart|insulin aspart|mesh-list
65535296|NCT03816761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65535297|NCT03816761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535298|NCT02770612|Analgesics, Opioid|analgesics, opioid|mesh-list
65535299|NCT02770612|Narcotics|narcotics|mesh-ancestor
65535300|NCT02770612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65535301|NCT02770612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535302|NCT02770612|Analgesics|analgesics|mesh-ancestor
65535303|NCT02770612|Sensory System Agents|sensory system agents|mesh-ancestor
65535304|NCT02770612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65535305|NCT03575871|Abrocitinib|abrocitinib|mesh-list
65535306|NCT03575871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65535307|NCT03575871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535308|NCT03575871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535309|NCT02155504|Itraconazole|itraconazole|mesh-list
65535310|NCT02155504|Antifungal Agents|antifungal agents|mesh-ancestor
65535311|NCT02155504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65535312|NCT02155504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65535313|NCT02155504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65535314|NCT02155504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535315|NCT02155504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535316|NCT02155504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65535317|NCT02155504|Hormone Antagonists|hormone antagonists|mesh-ancestor
65535318|NCT02155504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65535319|NCT02155504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535320|NCT02155504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65535321|NCT03642717|Empagliflozin|empagliflozin|mesh-list
65535322|NCT03642717|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65535323|NCT03642717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535324|NCT03642717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65535325|NCT03642717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535326|NCT02766478|Genistein|genistein|mesh-list
65535327|NCT02766478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65535328|NCT02766478|Protective Agents|protective agents|mesh-ancestor
65535329|NCT02766478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535330|NCT02766478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535331|NCT02766478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65535332|NCT02766478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535333|NCT02766478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535334|NCT02766478|Phytoestrogens|phytoestrogens|mesh-ancestor
65535335|NCT02766478|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65535336|NCT02766478|Estrogens|estrogens|mesh-ancestor
65535337|NCT02766478|Hormones|hormones|mesh-ancestor
65535338|NCT02766478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65535339|NCT03729375|Bupivacaine|bupivacaine|mesh-list
65535340|NCT03729375|Anesthetics, Local|anesthetics, local|mesh-ancestor
65535341|NCT03729375|Anesthetics|anesthetics|mesh-ancestor
65535342|NCT03729375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65535343|NCT03729375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535344|NCT03729375|Sensory System Agents|sensory system agents|mesh-ancestor
65535345|NCT03729375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65535346|NCT02159326|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65535347|NCT02159326|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
65264389|NCT02783222|Tubulin Modulators|tubulin modulators|mesh-ancestor
65264390|NCT02783222|Antimitotic Agents|antimitotic agents|mesh-ancestor
65264391|NCT02783222|Mitosis Modulators|mitosis modulators|mesh-ancestor
65535348|NCT02159326|Riociguat|riociguat|mesh-list
65535349|NCT02159326|Enzyme Activators|enzyme activators|mesh-ancestor
65535350|NCT02159326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535351|NCT02159326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65535352|NCT02159326|Contraceptive Agents|contraceptive agents|mesh-ancestor
65535353|NCT02159326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65535354|NCT02159326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535355|NCT02159326|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65535356|NCT02159326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65535357|NCT02159326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65535358|NCT02159326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65535359|NCT02159326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65535360|NCT02159326|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
65535361|NCT02159326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65535362|NCT02159326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65535363|NCT02255266|Liraglutide|liraglutide|mesh-list
65535364|NCT02255266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65535365|NCT02255266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535366|NCT02255266|Incretins|incretins|mesh-ancestor
65535367|NCT02255266|Hormones|hormones|mesh-ancestor
65535368|NCT02255266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65535369|NCT00104650|Diphosphonates|diphosphonates|mesh-list
65535370|NCT00104650|Denosumab|denosumab|mesh-list
65535371|NCT00104650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65535372|NCT00104650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535373|NCT02158078|Insulin|insulin|mesh-list
65535374|NCT02158078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65535375|NCT02158078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535376|NCT00104416|Lamotrigine|lamotrigine|mesh-list
65535377|NCT00104416|Anticonvulsants|anticonvulsants|mesh-ancestor
65535378|NCT00104416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65535379|NCT00104416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65535380|NCT00104416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535381|NCT00104416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65535382|NCT00104416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535383|NCT00104416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65535384|NCT00104416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65535385|NCT00104416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65332897|NCT00758277|Levetiracetam|levetiracetam|mesh-list
65535386|NCT00104416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65535387|NCT00104416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65535388|NCT04817254|Nivolumab|nivolumab|mesh-list
65535389|NCT04817254|Ipilimumab|ipilimumab|mesh-list
65535390|NCT04817254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65535391|NCT04817254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535392|NCT04817254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65535393|NCT04817254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535394|NCT02149888|Tenofovir|tenofovir|mesh-list
65535395|NCT02149888|Emtricitabine|emtricitabine|mesh-list
65535396|NCT02149888|Antiviral Agents|antiviral agents|mesh-ancestor
65535397|NCT02149888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65535398|NCT02149888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65535399|NCT02149888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65535400|NCT02149888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535401|NCT02149888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535402|NCT02149888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65535403|NCT02149888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65535404|NCT03639675|Aflibercept|aflibercept|mesh-list
65535405|NCT03639675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65535406|NCT03639675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65535407|NCT03639675|Growth Substances|growth substances|mesh-ancestor
65535408|NCT03639675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535409|NCT03639675|Growth Inhibitors|growth inhibitors|mesh-ancestor
65535410|NCT03639675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535411|NCT03543436|Meropenem|meropenem|mesh-list
65535412|NCT03543436|Imipenem|imipenem|mesh-list
65535413|NCT03543436|Temocillin|temocillin|mesh-list
65535414|NCT03543436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65535415|NCT03543436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65535416|NCT03729063|Carbon Monoxide|carbon monoxide|mesh-list
65535417|NCT03729063|Antimetabolites|antimetabolites|mesh-ancestor
65535418|NCT03729063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535419|NCT03729063|Gasotransmitters|gasotransmitters|mesh-ancestor
65535420|NCT03729063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65535421|NCT03729063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535422|NCT01310361|Amoxicillin|amoxicillin|mesh-list
65535423|NCT01310361|Penicillins|penicillins|mesh-list
65535424|NCT01310361|Penicillin G|penicillin g|mesh-list
65535425|NCT01310361|Penicillin G Benzathine|penicillin g benzathine|mesh-list
65535426|NCT01310361|Penicillin G Procaine|penicillin g procaine|mesh-list
65535427|NCT01310361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65535428|NCT01310361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65535429|NCT03541798|Anesthetics|anesthetics|mesh-list
65535430|NCT03541798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65535431|NCT03541798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535432|NCT02150122|Vitamin D|vitamin d|mesh-list
65535433|NCT02150122|Cholecalciferol|cholecalciferol|mesh-list
65535434|NCT02150122|Vitamins|vitamins|mesh-ancestor
65535435|NCT02150122|Micronutrients|micronutrients|mesh-ancestor
65535436|NCT02150122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535437|NCT02150122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65535438|NCT02150122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65535439|NCT03728829|Carboplatin|carboplatin|mesh-list
65535440|NCT03728829|Docetaxel|docetaxel|mesh-list
65535441|NCT03728829|Trastuzumab|trastuzumab|mesh-list
65535442|NCT03728829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535443|NCT03728829|Tubulin Modulators|tubulin modulators|mesh-ancestor
65535444|NCT03728829|Antimitotic Agents|antimitotic agents|mesh-ancestor
65535445|NCT03728829|Mitosis Modulators|mitosis modulators|mesh-ancestor
65535446|NCT03728829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535447|NCT03728829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65535448|NCT00121667|Metformin|metformin|mesh-list
65535449|NCT00121667|Pioglitazone|pioglitazone|mesh-list
65535450|NCT00121667|Saxagliptin|saxagliptin|mesh-list
65535451|NCT00121667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65535452|NCT00121667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535453|NCT00121667|Incretins|incretins|mesh-ancestor
65535454|NCT00121667|Hormones|hormones|mesh-ancestor
65535455|NCT00121667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65535456|NCT00121667|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65535457|NCT00121667|Protease Inhibitors|protease inhibitors|mesh-ancestor
65535458|NCT00121667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535459|NCT00121667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535460|NCT02954601|Insulin|insulin|mesh-list
65535461|NCT02954601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65535462|NCT02954601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65535463|NCT02954601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535465|NCT00121199|Cyclophosphamide|cyclophosphamide|mesh-list
65535466|NCT00121199|Bevacizumab|bevacizumab|mesh-list
65535467|NCT00121199|Rituximab|rituximab|mesh-list
65535468|NCT00121199|Doxorubicin|doxorubicin|mesh-list
65535469|NCT00121199|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65535470|NCT00121199|Vincristine|vincristine|mesh-list
65535471|NCT00121199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65535472|NCT00121199|Antibodies|antibodies|mesh-list
65535473|NCT00121199|Immunoglobulins|immunoglobulins|mesh-list
65535474|NCT00121199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65535475|NCT00121199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65535476|NCT00121199|Immunologic Factors|immunologic factors|mesh-ancestor
65535477|NCT00121199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535478|NCT00121199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65535479|NCT00121199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65535480|NCT00121199|Alkylating Agents|alkylating agents|mesh-ancestor
65535481|NCT00121199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535482|NCT00121199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535483|NCT00121199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65535484|NCT00121199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65535485|NCT00121199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65535486|NCT00121199|Growth Substances|growth substances|mesh-ancestor
65535487|NCT00121199|Growth Inhibitors|growth inhibitors|mesh-ancestor
65535488|NCT00121199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65535489|NCT00121199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65535490|NCT00121199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65535491|NCT00121199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535492|NCT00121199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65535493|NCT00121199|Glucocorticoids|glucocorticoids|mesh-ancestor
65535494|NCT00121199|Hormones|hormones|mesh-ancestor
65535495|NCT00121199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65535496|NCT00121199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65535497|NCT00121199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65535498|NCT00121199|Tubulin Modulators|tubulin modulators|mesh-ancestor
65535499|NCT00121199|Antimitotic Agents|antimitotic agents|mesh-ancestor
65535500|NCT00121199|Mitosis Modulators|mitosis modulators|mesh-ancestor
65535501|NCT01079897|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
65535502|NCT01079897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65535503|NCT00119015|Fluticasone|fluticasone|mesh-list
65535504|NCT00119015|Xhance|xhance|mesh-list
65535505|NCT00119015|Montelukast|montelukast|mesh-list
65535506|NCT00119015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65535507|NCT00119015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65535508|NCT00119015|Autonomic Agents|autonomic agents|mesh-ancestor
65535509|NCT00119015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65535510|NCT00119015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535511|NCT00119015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65535512|NCT00119015|Respiratory System Agents|respiratory system agents|mesh-ancestor
65535513|NCT00119015|Dermatologic Agents|dermatologic agents|mesh-ancestor
65535514|NCT00119015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65535515|NCT00119015|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65535516|NCT00119015|Hormone Antagonists|hormone antagonists|mesh-ancestor
65535517|NCT00119015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65535518|NCT00119015|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65535519|NCT00119015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65535520|NCT00119015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535521|NCT03557307|Benralizumab|benralizumab|mesh-list
65535522|NCT03557307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65535523|NCT03557307|Respiratory System Agents|respiratory system agents|mesh-ancestor
65535524|NCT01079351|Carbamazepine|carbamazepine|mesh-list
65535525|NCT01079351|Anticonvulsants|anticonvulsants|mesh-ancestor
65535526|NCT01079351|Antimanic Agents|antimanic agents|mesh-ancestor
65535527|NCT01079351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65535528|NCT01079351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65535529|NCT01079351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535530|NCT01079351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65535531|NCT01079351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65535532|NCT01079351|Analgesics|analgesics|mesh-ancestor
65535533|NCT01079351|Sensory System Agents|sensory system agents|mesh-ancestor
65535534|NCT01079351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65535535|NCT01079351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65535536|NCT01079351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65535537|NCT01079351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333049|NCT04082858|GABA Agents|gaba agents|mesh-ancestor
65535538|NCT01079351|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65535539|NCT01079351|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65535540|NCT00104104|Zoledronic Acid|zoledronic acid|mesh-list
65535541|NCT00104104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65535542|NCT00104104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535543|NCT02158624|Ranibizumab|ranibizumab|mesh-list
65535544|NCT02158624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65535545|NCT02158624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65535546|NCT02158624|Growth Substances|growth substances|mesh-ancestor
65535547|NCT02158624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535548|NCT02158624|Growth Inhibitors|growth inhibitors|mesh-ancestor
65535549|NCT02158624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535550|NCT00115739|Imatinib Mesylate|imatinib mesylate|mesh-list
65535551|NCT00115739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535552|NCT00115739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65535553|NCT00115739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535554|NCT00115739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535555|NCT03639519|Ascorbic Acid|ascorbic acid|mesh-list
65535556|NCT03639519|Antioxidants|antioxidants|mesh-ancestor
65535557|NCT03639519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535558|NCT03639519|Protective Agents|protective agents|mesh-ancestor
65535559|NCT03639519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535560|NCT03639519|Vitamins|vitamins|mesh-ancestor
65535561|NCT03639519|Micronutrients|micronutrients|mesh-ancestor
65535562|NCT02158702|Dexamethasone|dexamethasone|mesh-list
65535563|NCT02158702|Pomalidomide|pomalidomide|mesh-list
65535564|NCT02158702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65535565|NCT02158702|Antiemetics|antiemetics|mesh-ancestor
65535566|NCT02158702|Autonomic Agents|autonomic agents|mesh-ancestor
65535567|NCT02158702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65535568|NCT02158702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535569|NCT02158702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65535570|NCT02158702|Glucocorticoids|glucocorticoids|mesh-ancestor
65535571|NCT02158702|Hormones|hormones|mesh-ancestor
65535572|NCT02158702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65535573|NCT02158702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65535574|NCT02158702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535575|NCT02158702|Immunologic Factors|immunologic factors|mesh-ancestor
65535576|NCT02158702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65535577|NCT02158702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65535578|NCT02158702|Growth Substances|growth substances|mesh-ancestor
65535579|NCT02158702|Growth Inhibitors|growth inhibitors|mesh-ancestor
65535580|NCT03725709|Anesthetics|anesthetics|mesh-list
65535581|NCT03725709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65535582|NCT03725709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535583|NCT01761890|Dasatinib|dasatinib|mesh-list
65535584|NCT01761890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535585|NCT01761890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65535586|NCT01761890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535587|NCT01761890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535588|NCT02160028|Anesthetics|anesthetics|mesh-list
65535589|NCT02160028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65535590|NCT02160028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535591|NCT03246152|Bevacizumab|bevacizumab|mesh-list
65535592|NCT03246152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65535593|NCT03246152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535594|NCT03246152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65535595|NCT03246152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65535596|NCT03246152|Growth Substances|growth substances|mesh-ancestor
65535597|NCT03246152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535598|NCT03246152|Growth Inhibitors|growth inhibitors|mesh-ancestor
65535599|NCT03541564|Moxifloxacin|moxifloxacin|mesh-list
65535600|NCT03541564|BMS-986165|bms-986165|mesh-list
65535601|NCT03541564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65535602|NCT03541564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65535603|NCT03541564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65535604|NCT03541564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65535605|NCT03541564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535606|NCT03541564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535607|NCT03541564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535608|NCT03541564|Dermatologic Agents|dermatologic agents|mesh-ancestor
65535609|NCT03541564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65535610|NCT00115349|Deferiprone|deferiprone|mesh-list
65535611|NCT00115349|Deferoxamine|deferoxamine|mesh-list
65535612|NCT00115349|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65535613|NCT00115349|Chelating Agents|chelating agents|mesh-ancestor
65535614|NCT00115349|Sequestering Agents|sequestering agents|mesh-ancestor
65535615|NCT00115349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535616|NCT00115349|Siderophores|siderophores|mesh-ancestor
65535617|NCT04804696|Paclitaxel|paclitaxel|mesh-list
65535618|NCT04804696|Cisplatin|cisplatin|mesh-list
65535619|NCT04804696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65535620|NCT04804696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535621|NCT04804696|Tubulin Modulators|tubulin modulators|mesh-ancestor
65535622|NCT04804696|Antimitotic Agents|antimitotic agents|mesh-ancestor
65535623|NCT04804696|Mitosis Modulators|mitosis modulators|mesh-ancestor
65535624|NCT04804696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535625|NCT00115037|Naltrexone|naltrexone|mesh-list
65535626|NCT00115037|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65535627|NCT00115037|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65535628|NCT00115037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535629|NCT00115037|Sensory System Agents|sensory system agents|mesh-ancestor
65535630|NCT00115037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65535631|NCT02160184|Pancrelipase|pancrelipase|mesh-list
65535632|NCT02160184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65535633|NCT03725553|Vasopressins|vasopressins|mesh-list
65535634|NCT03725553|Arginine Vasopressin|arginine vasopressin|mesh-list
65535635|NCT03725553|Hemostatics|hemostatics|mesh-ancestor
65535636|NCT03725553|Coagulants|coagulants|mesh-ancestor
65535637|NCT03725553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65535638|NCT03725553|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65535639|NCT03725553|Natriuretic Agents|natriuretic agents|mesh-ancestor
65535640|NCT03725553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535641|NCT03213626|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65535642|NCT03213626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535643|NCT03213626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65535644|NCT03213626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535645|NCT03213626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535646|NCT03604341|Dronabinol|dronabinol|mesh-list
65535647|NCT03604341|Hallucinogens|hallucinogens|mesh-ancestor
65535648|NCT03604341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535649|NCT03604341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65535650|NCT03604341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65535651|NCT03604341|Analgesics|analgesics|mesh-ancestor
65535652|NCT03604341|Sensory System Agents|sensory system agents|mesh-ancestor
65535653|NCT03604341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65535654|NCT03604341|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65535655|NCT03604341|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65535656|NCT03604341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65535657|NCT03604341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535658|NCT03604341|Hormones|hormones|mesh-ancestor
65535659|NCT03604341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65535660|NCT02160574|Chlorhexidine|chlorhexidine|mesh-list
65535661|NCT02160574|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65535662|NCT02160574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65535663|NCT02160574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65535664|NCT02160574|Disinfectants|disinfectants|mesh-ancestor
65535665|NCT02160574|Dermatologic Agents|dermatologic agents|mesh-ancestor
65535666|NCT03560960|Pramlintide|pramlintide|mesh-list
65535667|NCT03560960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65535668|NCT03560960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535669|NCT01186640|Cyclophosphamide|cyclophosphamide|mesh-list
65535670|NCT01186640|Fludarabine|fludarabine|mesh-list
65535671|NCT01186640|Fludarabine phosphate|fludarabine phosphate|mesh-list
65535672|NCT01186640|Mitoxantrone|mitoxantrone|mesh-list
65535673|NCT01186640|Alemtuzumab|alemtuzumab|mesh-list
65535674|NCT01186640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65535675|NCT01186640|Immunologic Factors|immunologic factors|mesh-ancestor
65535676|NCT01186640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535677|NCT01186640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65535678|NCT01186640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65535679|NCT01186640|Alkylating Agents|alkylating agents|mesh-ancestor
65535680|NCT01186640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535681|NCT01186640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535682|NCT01186640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65535683|NCT01186640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65535684|NCT01186640|Antimetabolites|antimetabolites|mesh-ancestor
65535685|NCT01186640|Analgesics|analgesics|mesh-ancestor
65535686|NCT01186640|Sensory System Agents|sensory system agents|mesh-ancestor
65535687|NCT01186640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65535688|NCT01186640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65535689|NCT01186640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65535690|NCT01186640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535691|NCT01186640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65535692|NCT04949516|Aspirin|aspirin|mesh-list
65535693|NCT04949516|Colchicine|colchicine|mesh-list
65535694|NCT04949516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65535695|NCT04949516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65535696|NCT04949516|Analgesics|analgesics|mesh-ancestor
65535697|NCT04949516|Sensory System Agents|sensory system agents|mesh-ancestor
65535698|NCT04949516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65535699|NCT04949516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535700|NCT04949516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65535701|NCT04949516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65535702|NCT04949516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65535703|NCT04949516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65535704|NCT04949516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535705|NCT04949516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65535706|NCT04949516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65535707|NCT04949516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535708|NCT04949516|Antipyretics|antipyretics|mesh-ancestor
65535709|NCT04949516|Gout Suppressants|gout suppressants|mesh-ancestor
65535710|NCT04949516|Tubulin Modulators|tubulin modulators|mesh-ancestor
65535711|NCT04949516|Antimitotic Agents|antimitotic agents|mesh-ancestor
65535712|NCT04949516|Mitosis Modulators|mitosis modulators|mesh-ancestor
65535713|NCT04949516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535714|NCT00114959|Imatinib Mesylate|imatinib mesylate|mesh-list
65535715|NCT00114959|Homoharringtonine|homoharringtonine|mesh-list
65535716|NCT00114959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535717|NCT00114959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65535718|NCT00114959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535719|NCT00114959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535720|NCT00114959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65535721|NCT00114959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65535722|NCT02778100|Phenylephrine|phenylephrine|mesh-list
65535723|NCT02778100|Oxymetazoline|oxymetazoline|mesh-list
65535724|NCT02778100|Glucagon|glucagon|mesh-list
65535725|NCT02778100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65535726|NCT02778100|Hormones|hormones|mesh-ancestor
65535727|NCT02778100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65535728|NCT02778100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535729|NCT02778100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65535730|NCT02778100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65535731|NCT02778100|Adrenergic Agents|adrenergic agents|mesh-ancestor
65535732|NCT02778100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65535733|NCT02778100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535734|NCT02778100|Sympathomimetics|sympathomimetics|mesh-ancestor
65535735|NCT02778100|Autonomic Agents|autonomic agents|mesh-ancestor
65535736|NCT02778100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65535737|NCT02778100|Nasal Decongestants|nasal decongestants|mesh-ancestor
65535738|NCT02778100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65535739|NCT02778100|Respiratory System Agents|respiratory system agents|mesh-ancestor
65535740|NCT02778100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65535741|NCT02778100|Mydriatics|mydriatics|mesh-ancestor
65535742|NCT02778100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65535743|NCT02778100|Protective Agents|protective agents|mesh-ancestor
65535744|NCT02159248|Gemcitabine|gemcitabine|mesh-list
65535745|NCT02159248|Tolfenamic acid|tolfenamic acid|mesh-list
65535746|NCT02159248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65535747|NCT02159248|Antimetabolites|antimetabolites|mesh-ancestor
65535748|NCT02159248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535749|NCT02159248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535750|NCT02159248|Antiviral Agents|antiviral agents|mesh-ancestor
65535751|NCT02159248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65535752|NCT02159248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535753|NCT02159248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65535754|NCT02159248|Immunologic Factors|immunologic factors|mesh-ancestor
65535755|NCT02159248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535756|NCT02159248|Analgesics|analgesics|mesh-ancestor
65535757|NCT02159248|Sensory System Agents|sensory system agents|mesh-ancestor
65535758|NCT02159248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65535759|NCT02159248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65535760|NCT02159248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65535761|NCT02159248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65535762|NCT02159248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65333269|NCT04081376|Narcotics|narcotics|mesh-ancestor
65535763|NCT02159248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65535764|NCT02159248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65535765|NCT02159248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65535766|NCT02159248|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
65535767|NCT02159248|Hormone Antagonists|hormone antagonists|mesh-ancestor
65535768|NCT02159248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65535769|NCT02159248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65535770|NCT02159248|Serotonin Agents|serotonin agents|mesh-ancestor
65535771|NCT02159248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65535772|NCT00118157|Tamoxifen|tamoxifen|mesh-list
65535773|NCT00118157|Lapatinib|lapatinib|mesh-list
65535774|NCT00118157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535775|NCT00118157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65535776|NCT00118157|Hormone Antagonists|hormone antagonists|mesh-ancestor
65535777|NCT00118157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65535778|NCT00118157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535779|NCT00118157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65535780|NCT00118157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535781|NCT00118157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65535782|NCT00118157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65535783|NCT00118157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65535784|NCT00118157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65535785|NCT00118157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535786|NCT03543202|Anesthetics|anesthetics|mesh-list
65535787|NCT03543202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65535788|NCT03543202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535789|NCT03552549|Interferons|interferons|mesh-list
65535790|NCT03552549|Interferon-alpha|interferon-alpha|mesh-list
65535791|NCT03552549|Interferon alpha-2|interferon alpha-2|mesh-list
65535792|NCT03552549|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65535793|NCT03552549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535794|NCT03552549|Antiviral Agents|antiviral agents|mesh-ancestor
65535795|NCT03552549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65535796|NCT03552549|Immunologic Factors|immunologic factors|mesh-ancestor
65535797|NCT03552549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535798|NCT00117845|Denileukin diftitox|denileukin diftitox|mesh-list
65535799|NCT00117845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535800|NCT02761642|Epoetin Alfa|epoetin alfa|mesh-list
65535801|NCT02761642|Hematinics|hematinics|mesh-ancestor
65535802|NCT03731403|Fluorides|fluorides|mesh-list
65535803|NCT03731403|Cariostatic Agents|cariostatic agents|mesh-ancestor
65535804|NCT03731403|Protective Agents|protective agents|mesh-ancestor
65535805|NCT03731403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535806|NCT03189524|Zanubrutinib|zanubrutinib|mesh-list
65535807|NCT03189524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535808|NCT03189524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65535809|NCT03189524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535810|NCT03189524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535811|NCT03600909|Cyclophosphamide|cyclophosphamide|mesh-list
65535812|NCT03600909|Busulfan|busulfan|mesh-list
65535813|NCT03600909|Fludarabine|fludarabine|mesh-list
65535814|NCT03600909|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65535815|NCT03600909|Thymoglobulin|thymoglobulin|mesh-list
65535816|NCT03600909|Lenograstim|lenograstim|mesh-list
65535817|NCT03600909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65535818|NCT03600909|Immunologic Factors|immunologic factors|mesh-ancestor
65535819|NCT03600909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535820|NCT03600909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65535821|NCT03600909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65535822|NCT03600909|Alkylating Agents|alkylating agents|mesh-ancestor
65535823|NCT03600909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535824|NCT03600909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535825|NCT03600909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65535826|NCT03600909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65535827|NCT03189446|Paclitaxel|paclitaxel|mesh-list
65535828|NCT03189446|Carboplatin|carboplatin|mesh-list
65535829|NCT03189446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65535830|NCT03189446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535831|NCT03189446|Tubulin Modulators|tubulin modulators|mesh-ancestor
65535832|NCT03189446|Antimitotic Agents|antimitotic agents|mesh-ancestor
65535833|NCT03189446|Mitosis Modulators|mitosis modulators|mesh-ancestor
65535834|NCT03189446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535835|NCT01314482|Minocycline|minocycline|mesh-list
65535836|NCT01314482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65333345|NCT02583464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535837|NCT01314482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65535838|NCT03188120|Tiotropium Bromide|tiotropium bromide|mesh-list
65535839|NCT03188120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65535840|NCT03188120|Autonomic Agents|autonomic agents|mesh-ancestor
65535841|NCT03188120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65535842|NCT03188120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535843|NCT03188120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65535844|NCT03188120|Respiratory System Agents|respiratory system agents|mesh-ancestor
65535845|NCT03188120|Parasympatholytics|parasympatholytics|mesh-ancestor
65535846|NCT03188120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65535847|NCT03188120|Cholinergic Agents|cholinergic agents|mesh-ancestor
65535848|NCT03188120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65535849|NCT03188120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535850|NCT02895945|Factor VIII|factor viii|mesh-list
65535851|NCT02895945|Coagulants|coagulants|mesh-ancestor
65535852|NCT03229538|Methylprednisolone|methylprednisolone|mesh-list
65535853|NCT03229538|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65535854|NCT03229538|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65535855|NCT03229538|Prednisolone|prednisolone|mesh-list
65535856|NCT03229538|Prednisolone acetate|prednisolone acetate|mesh-list
65535857|NCT03229538|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65535858|NCT03229538|Prednisolone phosphate|prednisolone phosphate|mesh-list
65535859|NCT03229538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65535860|NCT03229538|Antiemetics|antiemetics|mesh-ancestor
65535861|NCT03229538|Autonomic Agents|autonomic agents|mesh-ancestor
65535862|NCT03229538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65535863|NCT03229538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535864|NCT03229538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65535865|NCT03229538|Glucocorticoids|glucocorticoids|mesh-ancestor
65535867|NCT03229538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65535868|NCT03229538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65535869|NCT03229538|Protective Agents|protective agents|mesh-ancestor
65535870|NCT03229538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65535871|NCT03229538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535872|NCT02777554|Thalidomide|thalidomide|mesh-list
65535873|NCT02777554|Apremilast|apremilast|mesh-list
65535874|NCT02777554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65535875|NCT02777554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65535876|NCT02777554|Analgesics|analgesics|mesh-ancestor
65535877|NCT02777554|Sensory System Agents|sensory system agents|mesh-ancestor
65535878|NCT02777554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65535879|NCT02777554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535880|NCT02777554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65535881|NCT02777554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65535882|NCT02777554|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65535883|NCT02777554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65535884|NCT02777554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535885|NCT02777554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535886|NCT02777554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65535887|NCT02777554|Immunologic Factors|immunologic factors|mesh-ancestor
65535888|NCT02777554|Leprostatic Agents|leprostatic agents|mesh-ancestor
65535889|NCT02777554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65535890|NCT02777554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65535891|NCT02777554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65535892|NCT02777554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65535893|NCT02777554|Growth Substances|growth substances|mesh-ancestor
65535894|NCT02777554|Growth Inhibitors|growth inhibitors|mesh-ancestor
65535895|NCT02777554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535896|NCT03220178|Letrozole|letrozole|mesh-list
65535897|NCT03220178|Fulvestrant|fulvestrant|mesh-list
65535898|NCT03220178|Palbociclib|palbociclib|mesh-list
65535899|NCT03220178|Anastrozole|anastrozole|mesh-list
65535900|NCT03220178|Exemestane|exemestane|mesh-list
65535901|NCT03220178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535902|NCT03220178|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65535903|NCT03220178|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65535904|NCT03220178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535905|NCT03220178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535906|NCT03220178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65535907|NCT03220178|Hormone Antagonists|hormone antagonists|mesh-ancestor
65535908|NCT03220178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65535909|NCT03220178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535910|NCT03220178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65535911|NCT03220178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65535912|NCT03220178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65535913|NCT02764762|Adalimumab|adalimumab|mesh-list
65535914|NCT02764762|Methotrexate|methotrexate|mesh-list
65535915|NCT02764762|Vedolizumab|vedolizumab|mesh-list
65535916|NCT02764762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65535917|NCT02764762|Abortifacient Agents|abortifacient agents|mesh-ancestor
65535918|NCT02764762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65535919|NCT02764762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535920|NCT02764762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65535921|NCT02764762|Antimetabolites|antimetabolites|mesh-ancestor
65535922|NCT02764762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535923|NCT02764762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535924|NCT02764762|Dermatologic Agents|dermatologic agents|mesh-ancestor
65535925|NCT02764762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535926|NCT02764762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65535927|NCT02764762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65535928|NCT02764762|Immunologic Factors|immunologic factors|mesh-ancestor
65535929|NCT02764762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65535930|NCT02764762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65535931|NCT02764762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65535932|NCT02764762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65535933|NCT03032510|Levofloxacin|levofloxacin|mesh-list
65535934|NCT03032510|Ofloxacin|ofloxacin|mesh-list
65535935|NCT03032510|Ertapenem|ertapenem|mesh-list
65535936|NCT03032510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65535937|NCT03032510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65535938|NCT03032510|Renal Agents|renal agents|mesh-ancestor
65535939|NCT03032510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65535940|NCT03032510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65535941|NCT03032510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65535942|NCT03032510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65535943|NCT03032510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535944|NCT03032510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535945|NCT03032510|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65535946|NCT03032510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65535947|NCT03022292|Aflibercept|aflibercept|mesh-list
65535948|NCT03022292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65535949|NCT03022292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65535950|NCT03022292|Growth Substances|growth substances|mesh-ancestor
65535951|NCT03022292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535952|NCT03022292|Growth Inhibitors|growth inhibitors|mesh-ancestor
65535953|NCT03022292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535954|NCT03599193|Nicotinic Acids|nicotinic acids|mesh-list
65535955|NCT03599193|Tazarotene|tazarotene|mesh-list
65535956|NCT03599193|Dermatologic Agents|dermatologic agents|mesh-ancestor
65535957|NCT03599193|Keratolytic Agents|keratolytic agents|mesh-ancestor
65535958|NCT03599193|Vitamin B Complex|vitamin b complex|mesh-ancestor
65535959|NCT03599193|Vitamins|vitamins|mesh-ancestor
65535960|NCT03599193|Micronutrients|micronutrients|mesh-ancestor
65535961|NCT03599193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535962|NCT02161354|Buprenorphine|buprenorphine|mesh-list
65535963|NCT02161354|Naloxone|naloxone|mesh-list
65535964|NCT02161354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65535965|NCT02161354|Narcotics|narcotics|mesh-ancestor
65535966|NCT02161354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65535967|NCT02161354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535968|NCT02161354|Analgesics|analgesics|mesh-ancestor
65535969|NCT02161354|Sensory System Agents|sensory system agents|mesh-ancestor
65535970|NCT02161354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65535971|NCT02161354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65535972|NCT03166124|Insulin Lispro|insulin lispro|mesh-list
65535973|NCT03166124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65535974|NCT03166124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535975|NCT02777242|Methyltestosterone|methyltestosterone|mesh-list
65535976|NCT02777242|Testosterone|testosterone|mesh-list
65535977|NCT02777242|Testosterone undecanoate|testosterone undecanoate|mesh-list
65535978|NCT02777242|Testosterone enanthate|testosterone enanthate|mesh-list
65535979|NCT02777242|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65535980|NCT02777242|Androgens|androgens|mesh-ancestor
65535981|NCT02777242|Hormones|hormones|mesh-ancestor
65535982|NCT02777242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65535983|NCT02777242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535984|NCT02777242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65535985|NCT02777242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535986|NCT02777242|Anabolic Agents|anabolic agents|mesh-ancestor
65535987|NCT02163070|Vitamins|vitamins|mesh-list
65535988|NCT02163070|Vitamin E|vitamin e|mesh-list
65535989|NCT02163070|Micronutrients|micronutrients|mesh-ancestor
65535990|NCT02163070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65535992|NCT02163070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65535993|NCT02163070|Protective Agents|protective agents|mesh-ancestor
65535994|NCT03484520|Venetoclax|venetoclax|mesh-list
65535995|NCT03484520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65535996|NCT03566979|Naproxen|naproxen|mesh-list
65535997|NCT03566979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65535998|NCT03566979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65535999|NCT03566979|Analgesics|analgesics|mesh-ancestor
65536000|NCT03566979|Sensory System Agents|sensory system agents|mesh-ancestor
65536001|NCT03566979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65536002|NCT03566979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536003|NCT03566979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65536004|NCT03566979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65536005|NCT03566979|Gout Suppressants|gout suppressants|mesh-ancestor
65536006|NCT03566979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65536007|NCT03566979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536008|NCT03566979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536009|NCT00116831|Rosiglitazone|rosiglitazone|mesh-list
65536010|NCT00116831|Glipizide|glipizide|mesh-list
65536011|NCT00116831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65536012|NCT00116831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536013|NCT02784704|Meropenem|meropenem|mesh-list
65536014|NCT02784704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65536015|NCT02784704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65536016|NCT03165734|Hydroxyurea|hydroxyurea|mesh-list
65536017|NCT03165734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65536018|NCT03165734|Antisickling Agents|antisickling agents|mesh-ancestor
65536019|NCT03165734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536020|NCT03165734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265061|NCT02712528|Narcotics|narcotics|mesh-ancestor
65536021|NCT03165734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65536022|NCT03540472|Tacrolimus|tacrolimus|mesh-list
65536023|NCT03540472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65536024|NCT03540472|Immunologic Factors|immunologic factors|mesh-ancestor
65536025|NCT03540472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536026|NCT03540472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65536027|NCT03540472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536028|NCT03540472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536029|NCT02166814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65536030|NCT02166814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65536031|NCT02166814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65536032|NCT02166814|Antimetabolites|antimetabolites|mesh-ancestor
65536033|NCT02166814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536034|NCT02166814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65536035|NCT02166814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65536036|NCT02166814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536037|NCT01310283|Fluorides|fluorides|mesh-list
65536038|NCT01310283|Fluorides, Topical|fluorides, topical|mesh-list
65536039|NCT01310283|Cariostatic Agents|cariostatic agents|mesh-ancestor
65536040|NCT01310283|Protective Agents|protective agents|mesh-ancestor
65536041|NCT01310283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536042|NCT02161822|Simvastatin|simvastatin|mesh-list
65536043|NCT02161822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65536044|NCT02161822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65536045|NCT02161822|Antimetabolites|antimetabolites|mesh-ancestor
65536046|NCT02161822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536047|NCT02161822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65536048|NCT02161822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65536049|NCT02161822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536050|NCT03183908|Vaccines|vaccines|mesh-list
65536051|NCT03183908|Immunologic Factors|immunologic factors|mesh-ancestor
65536052|NCT03183908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536053|NCT03565887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65536054|NCT03565887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65536055|NCT00113399|Paclitaxel|paclitaxel|mesh-list
65536056|NCT00113399|Docetaxel|docetaxel|mesh-list
65536057|NCT00113399|Fluorouracil|fluorouracil|mesh-list
65536058|NCT00113399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65536059|NCT00113399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65536060|NCT00113399|Tubulin Modulators|tubulin modulators|mesh-ancestor
65536061|NCT00113399|Antimitotic Agents|antimitotic agents|mesh-ancestor
65536062|NCT00113399|Mitosis Modulators|mitosis modulators|mesh-ancestor
65536063|NCT00113399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536064|NCT00113399|Antimetabolites|antimetabolites|mesh-ancestor
65536065|NCT00113399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65536066|NCT00113399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65536068|NCT00113399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536069|NCT01326611|Clarithromycin|clarithromycin|mesh-list
65536070|NCT01326611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65536071|NCT01326611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65536072|NCT01326611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65536073|NCT01326611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536074|NCT01326611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536075|NCT01326611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65536076|NCT01326611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65536077|NCT00113087|Enalapril|enalapril|mesh-list
65536078|NCT00113087|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65536079|NCT00113087|Protease Inhibitors|protease inhibitors|mesh-ancestor
65536080|NCT00113087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536081|NCT00113087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536082|NCT00113087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65536083|NCT00112463|Romidepsin|romidepsin|mesh-list
65536084|NCT00112463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65536085|NCT00112463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65536086|NCT01083017|Chlorthalidone|chlorthalidone|mesh-list
65536087|NCT01083017|Antihypertensive Agents|antihypertensive agents|mesh-list
65536088|NCT01083017|Diuretics|diuretics|mesh-ancestor
65536089|NCT01083017|Natriuretic Agents|natriuretic agents|mesh-ancestor
65536090|NCT01083017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536091|NCT01083017|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65536092|NCT01083017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65536093|NCT01083017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265138|NCT02711982|Antiemetics|antiemetics|mesh-ancestor
65536094|NCT00112385|Etanercept|etanercept|mesh-list
65536095|NCT00112385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65536096|NCT00112385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65536097|NCT00112385|Analgesics|analgesics|mesh-ancestor
65536098|NCT00112385|Sensory System Agents|sensory system agents|mesh-ancestor
65536099|NCT00112385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65536100|NCT00112385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536101|NCT00112385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65536102|NCT00112385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65536103|NCT00112385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65536104|NCT00112385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65536105|NCT00112385|Immunologic Factors|immunologic factors|mesh-ancestor
65536106|NCT03731169|Voriconazole|voriconazole|mesh-list
65536107|NCT03731169|Antifungal Agents|antifungal agents|mesh-ancestor
65536108|NCT03731169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65536109|NCT03731169|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65536110|NCT03731169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65536111|NCT03731169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536112|NCT03731169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536113|NCT03731169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65536114|NCT03731169|Hormone Antagonists|hormone antagonists|mesh-ancestor
65536115|NCT03731169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65536116|NCT03731169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536117|NCT03731169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65536118|NCT03731091|Calcitriol|calcitriol|mesh-list
65536119|NCT03731091|Betamethasone|betamethasone|mesh-list
65536120|NCT03731091|Betamethasone Valerate|betamethasone valerate|mesh-list
65536121|NCT03731091|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65536122|NCT03731091|Betamethasone benzoate|betamethasone benzoate|mesh-list
65536123|NCT03731091|Calcipotriene|calcipotriene|mesh-list
65536124|NCT03731091|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65536125|NCT03731091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65536126|NCT03731091|Glucocorticoids|glucocorticoids|mesh-ancestor
65536127|NCT03731091|Hormones|hormones|mesh-ancestor
65536128|NCT03731091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65536129|NCT03731091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536130|NCT03731091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65536131|NCT03731091|Respiratory System Agents|respiratory system agents|mesh-ancestor
65536132|NCT03731091|Dermatologic Agents|dermatologic agents|mesh-ancestor
65536133|NCT03731091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65536134|NCT03731091|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65536135|NCT03731091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65333653|NCT00762099|Analgesics|analgesics|mesh-ancestor
65536136|NCT03731091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536137|NCT03731091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65536138|NCT03731091|Vitamins|vitamins|mesh-ancestor
65536139|NCT03731091|Micronutrients|micronutrients|mesh-ancestor
65536140|NCT03731091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65536141|NCT03547167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65536142|NCT03547167|Immunologic Factors|immunologic factors|mesh-ancestor
65536143|NCT03547167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536144|NCT03560739|Ofatumumab|ofatumumab|mesh-list
65536145|NCT03560739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65536146|NCT03560739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65536147|NCT03560739|Immunologic Factors|immunologic factors|mesh-ancestor
65536148|NCT03560739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536149|NCT01310673|Allopurinol|allopurinol|mesh-list
65536150|NCT01310673|Antimetabolites|antimetabolites|mesh-ancestor
65536151|NCT01310673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536152|NCT01310673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536153|NCT01310673|Gout Suppressants|gout suppressants|mesh-ancestor
65536154|NCT01310673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65536155|NCT01310673|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65536156|NCT01310673|Antioxidants|antioxidants|mesh-ancestor
65536157|NCT01310673|Protective Agents|protective agents|mesh-ancestor
65536158|NCT01310673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536159|NCT00101686|Bevacizumab|bevacizumab|mesh-list
65536160|NCT00101686|Capecitabine|capecitabine|mesh-list
65536161|NCT00101686|Irinotecan|irinotecan|mesh-list
65536162|NCT00101686|Fluorouracil|fluorouracil|mesh-list
65536163|NCT00101686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65536164|NCT00101686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65536165|NCT00101686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65536166|NCT00101686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65536167|NCT00101686|Growth Substances|growth substances|mesh-ancestor
65536168|NCT00101686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536169|NCT00101686|Growth Inhibitors|growth inhibitors|mesh-ancestor
65536170|NCT00101686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65536171|NCT00101686|Antimetabolites|antimetabolites|mesh-ancestor
65536172|NCT00101686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536173|NCT00101686|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65536174|NCT00101686|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65536175|NCT00101686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536176|NCT00101686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65536177|NCT00101686|Immunologic Factors|immunologic factors|mesh-ancestor
65536178|NCT02163616|Misoprostol|misoprostol|mesh-list
65536179|NCT02163616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65536180|NCT02163616|Abortifacient Agents|abortifacient agents|mesh-ancestor
65536181|NCT02163616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65536182|NCT02163616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536183|NCT02163616|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65536184|NCT02163616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65536185|NCT02163616|Oxytocics|oxytocics|mesh-ancestor
65536186|NCT00101452|Citalopram|citalopram|mesh-list
65536187|NCT00101452|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65536188|NCT00101452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65536189|NCT00101452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65536190|NCT00101452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536191|NCT00101452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65536192|NCT00101452|Serotonin Agents|serotonin agents|mesh-ancestor
65536193|NCT00101452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536194|NCT00101452|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65536195|NCT00101452|Antidepressive Agents|antidepressive agents|mesh-ancestor
65536196|NCT00101452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65536197|NCT02162134|Cefuroxime|cefuroxime|mesh-list
65536198|NCT02162134|Cefuroxime axetil|cefuroxime axetil|mesh-list
65536199|NCT02162134|Ketorolac|ketorolac|mesh-list
65536200|NCT02162134|Midazolam|midazolam|mesh-list
65536201|NCT02162134|Propofol|propofol|mesh-list
65536202|NCT02162134|Sevoflurane|sevoflurane|mesh-list
65536203|NCT02162134|Atracurium|atracurium|mesh-list
65536204|NCT02162134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65536205|NCT02162134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65536206|NCT02162134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536207|NCT02162134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65536208|NCT02162134|Anesthetics, General|anesthetics, general|mesh-ancestor
65536209|NCT02162134|Anesthetics|anesthetics|mesh-ancestor
65536210|NCT02162134|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65536211|NCT02162134|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65536212|NCT02162134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65536214|NCT02162134|GABA Modulators|gaba modulators|mesh-ancestor
65536215|NCT02162134|GABA Agents|gaba agents|mesh-ancestor
65536216|NCT02162134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65536217|NCT02162134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536218|NCT02162134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65536219|NCT02162134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65536220|NCT02162134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65536221|NCT02162134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65536222|NCT02162134|Analgesics|analgesics|mesh-ancestor
65536223|NCT02162134|Sensory System Agents|sensory system agents|mesh-ancestor
65536224|NCT02162134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65536225|NCT02162134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65536226|NCT02162134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65536227|NCT02162134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65536228|NCT02162134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536229|NCT02162134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65536230|NCT02162134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65536231|NCT02162134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65536232|NCT02162134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65536233|NCT02162134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65536234|NCT02162134|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65536235|NCT02162134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65536236|NCT02162134|Cholinergic Agents|cholinergic agents|mesh-ancestor
65536237|NCT02164006|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65536238|NCT02164006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65536239|NCT02164006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65536240|NCT02164006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65536241|NCT02164006|Immunologic Factors|immunologic factors|mesh-ancestor
65536242|NCT02164006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536243|NCT03546621|Tenofovir|tenofovir|mesh-list
65536244|NCT03546621|Antiviral Agents|antiviral agents|mesh-ancestor
65536245|NCT03546621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65536246|NCT03546621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65536247|NCT03546621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65536248|NCT03546621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536249|NCT03546621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536250|NCT03546621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65536251|NCT03546621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65536252|NCT02761330|Ketamine|ketamine|mesh-list
65536253|NCT02761330|Analgesics|analgesics|mesh-ancestor
65536254|NCT02761330|Sensory System Agents|sensory system agents|mesh-ancestor
65536255|NCT02761330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65536256|NCT02761330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536257|NCT02761330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65536258|NCT02761330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65536259|NCT02761330|Anesthetics, General|anesthetics, general|mesh-ancestor
65536260|NCT02761330|Anesthetics|anesthetics|mesh-ancestor
65536261|NCT02761330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65536262|NCT02761330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65536263|NCT02761330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65536264|NCT02761330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65536265|NCT02761330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536266|NCT03724071|Flucytosine|flucytosine|mesh-list
65536267|NCT03724071|Antifungal Agents|antifungal agents|mesh-ancestor
65536268|NCT03724071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65536269|NCT03724071|Antimetabolites|antimetabolites|mesh-ancestor
65536270|NCT03724071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536271|NCT03730857|Olanzapine|olanzapine|mesh-list
65536272|NCT03730857|Risperidone|risperidone|mesh-list
65536273|NCT03730857|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65536274|NCT03730857|Antipsychotic Agents|antipsychotic agents|mesh-list
65536275|NCT03730857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65536276|NCT03730857|Serotonin Agents|serotonin agents|mesh-ancestor
65536277|NCT03730857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65536278|NCT03730857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536279|NCT03730857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536280|NCT03730857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65536281|NCT03730857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65536282|NCT03730857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65536283|NCT03730857|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65536284|NCT03730857|Dopamine Agents|dopamine agents|mesh-ancestor
65536285|NCT03730857|Antiemetics|antiemetics|mesh-ancestor
65536286|NCT03730857|Autonomic Agents|autonomic agents|mesh-ancestor
65536287|NCT03730857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65536288|NCT03730857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65536289|NCT03730857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65536290|NCT03730857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65536291|NCT03730857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65536292|NCT03730857|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65536293|NCT03730857|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65536294|NCT03726177|Aspirin|aspirin|mesh-list
65536295|NCT03726177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65536296|NCT03726177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65536297|NCT03726177|Analgesics|analgesics|mesh-ancestor
65536298|NCT03726177|Sensory System Agents|sensory system agents|mesh-ancestor
65536299|NCT03726177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65536300|NCT03726177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536301|NCT03726177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65536302|NCT03726177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65536303|NCT03726177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65536304|NCT03726177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65536305|NCT03726177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536306|NCT03726177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65536307|NCT03726177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65536308|NCT03726177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536309|NCT03726177|Antipyretics|antipyretics|mesh-ancestor
65536310|NCT03726099|Amoxicillin|amoxicillin|mesh-list
65536311|NCT03726099|Tetracycline|tetracycline|mesh-list
65536312|NCT03726099|Furazolidone|furazolidone|mesh-list
65536313|NCT03726099|Esomeprazole|esomeprazole|mesh-list
65536314|NCT03726099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65536315|NCT03726099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65536316|NCT03726099|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65536317|NCT03726099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65536318|NCT03726099|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65536319|NCT03726099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536320|NCT03726099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536321|NCT03726099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65536322|NCT03726099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65536323|NCT03726099|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65536324|NCT03726099|Renal Agents|renal agents|mesh-ancestor
65536325|NCT03726099|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65536326|NCT03726099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65536327|NCT03726099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65536328|NCT03726099|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65536329|NCT03723759|Insulin Aspart|insulin aspart|mesh-list
65536330|NCT03723759|Insulin, Long-Acting|insulin, long-acting|mesh-list
65536331|NCT03723759|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65536332|NCT03723759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65536333|NCT03723759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536334|NCT03558555|Acetaminophen|acetaminophen|mesh-list
65536335|NCT03558555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65536336|NCT03558555|Analgesics|analgesics|mesh-ancestor
65536337|NCT03558555|Sensory System Agents|sensory system agents|mesh-ancestor
65536338|NCT03558555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65536339|NCT03558555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536340|NCT03558555|Antipyretics|antipyretics|mesh-ancestor
65536341|NCT03726021|Oxaliplatin|oxaliplatin|mesh-list
65536342|NCT03726021|Irinotecan|irinotecan|mesh-list
65536343|NCT03726021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65536344|NCT03726021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65536345|NCT03726021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65536346|NCT03726021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536347|NCT03726021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536348|NCT05665023|Bevacizumab|bevacizumab|mesh-list
65536349|NCT05665023|Folfirinox|folfirinox|mesh-list
65536350|NCT05665023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65536351|NCT05665023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65536352|NCT05665023|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65536353|NCT05665023|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65536354|NCT05665023|Growth Substances|growth substances|mesh-ancestor
65536355|NCT05665023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536356|NCT05665023|Growth Inhibitors|growth inhibitors|mesh-ancestor
65536357|NCT03557931|Olanzapine|olanzapine|mesh-list
65536358|NCT03557931|Risperidone|risperidone|mesh-list
65536359|NCT03557931|Aripiprazole|aripiprazole|mesh-list
65536360|NCT03557931|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65536361|NCT03557931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65536362|NCT03557931|Ziprasidone|ziprasidone|mesh-list
65536363|NCT03557931|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65536364|NCT03557931|Brexpiprazole|brexpiprazole|mesh-list
65536365|NCT03557931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65536366|NCT03557931|Serotonin Agents|serotonin agents|mesh-ancestor
65536367|NCT03557931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65536368|NCT03557931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536369|NCT03557931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536370|NCT03557931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65536371|NCT03557931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65536372|NCT03557931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65536373|NCT03557931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65536374|NCT03557931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65536375|NCT03557931|Dopamine Agents|dopamine agents|mesh-ancestor
65536376|NCT03557931|Antiemetics|antiemetics|mesh-ancestor
65536377|NCT03557931|Autonomic Agents|autonomic agents|mesh-ancestor
65536378|NCT03557931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65536379|NCT03557931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65536380|NCT03557931|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65536381|NCT03557931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65536382|NCT03557931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65536383|NCT03557931|Antidepressive Agents|antidepressive agents|mesh-ancestor
65536384|NCT03557931|Dopamine Agonists|dopamine agonists|mesh-ancestor
65536385|NCT03557931|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65536386|NCT03557931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65536387|NCT03557931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65536388|NCT03557931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65536389|NCT03557931|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65536390|NCT03557931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65536391|NCT03557931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65265435|NCT00952003|Growth Substances|growth substances|mesh-ancestor
65536392|NCT03557931|Adrenergic Agents|adrenergic agents|mesh-ancestor
65536393|NCT03977675|Ketamine|ketamine|mesh-list
65536394|NCT03977675|Analgesics|analgesics|mesh-ancestor
65536395|NCT03977675|Sensory System Agents|sensory system agents|mesh-ancestor
65536396|NCT03977675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65536397|NCT03977675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536398|NCT03977675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65536399|NCT03977675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65536400|NCT03977675|Anesthetics, General|anesthetics, general|mesh-ancestor
65536401|NCT03977675|Anesthetics|anesthetics|mesh-ancestor
65536402|NCT03977675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65536403|NCT03977675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65536404|NCT03977675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65536405|NCT03977675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65536406|NCT03977675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536407|NCT01066559|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
65536408|NCT01066559|Vasodilator Agents|vasodilator agents|mesh-ancestor
65536409|NCT01066559|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65536410|NCT01066559|Protective Agents|protective agents|mesh-ancestor
65536411|NCT01066559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536412|NCT00293813|Denosumab|denosumab|mesh-list
65536413|NCT00293813|Alendronate|alendronate|mesh-list
65536414|NCT00293813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65536415|NCT00293813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536416|NCT00293579|Pemetrexed|pemetrexed|mesh-list
65536417|NCT00293579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65536418|NCT00293579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536419|NCT00293579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536420|NCT00293579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65536421|NCT00293579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65536422|NCT00293423|polysaccharide-K|polysaccharide-k|mesh-list
65536423|NCT00293423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65536424|NCT00293423|Immunologic Factors|immunologic factors|mesh-ancestor
65536425|NCT00293423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536426|NCT00293423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65536427|NCT00293423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65536428|NCT00293423|Antiviral Agents|antiviral agents|mesh-ancestor
65536429|NCT00293423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65536430|NCT00293423|Interferon Inducers|interferon inducers|mesh-ancestor
65536431|NCT00293423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65536432|NCT00293423|Protective Agents|protective agents|mesh-ancestor
65536433|NCT03521817|Ethanol|ethanol|mesh-list
65536434|NCT03521817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65536435|NCT03521817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65536436|NCT03521817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65536437|NCT03521817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536439|NCT03538431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65536440|NCT03538431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65536441|NCT03538431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65536442|NCT03538431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536443|NCT03538431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65536444|NCT03538431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65536445|NCT03538431|Serotonin Agents|serotonin agents|mesh-ancestor
65536446|NCT03538431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65536447|NCT03538431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536448|NCT03521193|Aspirin|aspirin|mesh-list
65536449|NCT03521193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65536450|NCT03521193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65536451|NCT03521193|Analgesics|analgesics|mesh-ancestor
65536452|NCT03521193|Sensory System Agents|sensory system agents|mesh-ancestor
65536453|NCT03521193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65536454|NCT03521193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536455|NCT03521193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65536456|NCT03521193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65536457|NCT03521193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65536458|NCT03521193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65536459|NCT03521193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536460|NCT03521193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65536461|NCT03521193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65536462|NCT03521193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536463|NCT03521193|Antipyretics|antipyretics|mesh-ancestor
65536464|NCT00293267|Raltegravir Potassium|raltegravir potassium|mesh-list
65265511|NCT00948649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536465|NCT00293267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65536466|NCT00293267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65536467|NCT00293267|Antiviral Agents|antiviral agents|mesh-ancestor
65536468|NCT00293267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65536469|NCT00293267|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65536470|NCT00293267|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65536471|NCT00293267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536472|NCT00293267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536473|NCT03977441|Pramipexole|pramipexole|mesh-list
65536474|NCT03977441|S 20098|s 20098|mesh-list
65536475|NCT03977441|Antioxidants|antioxidants|mesh-ancestor
65536476|NCT03977441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536477|NCT03977441|Protective Agents|protective agents|mesh-ancestor
65536478|NCT03977441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536479|NCT03977441|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65536480|NCT03977441|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65536481|NCT03977441|Dopamine Agonists|dopamine agonists|mesh-ancestor
65536482|NCT03977441|Dopamine Agents|dopamine agents|mesh-ancestor
65536483|NCT03977441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65536484|NCT03977441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65536485|NCT03977441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65536486|NCT03536949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65536487|NCT03536949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65536488|NCT01080443|Mycophenolic Acid|mycophenolic acid|mesh-list
65536489|NCT01080443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65536490|NCT01080443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65536491|NCT01080443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65536492|NCT01080443|Antitubercular Agents|antitubercular agents|mesh-ancestor
65536493|NCT01080443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65536494|NCT01080443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65536495|NCT01080443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536496|NCT01080443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536497|NCT00111917|Infliximab|infliximab|mesh-list
65536498|NCT00111917|Dermatologic Agents|dermatologic agents|mesh-ancestor
65536499|NCT00111917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65536500|NCT00111917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65536501|NCT01067417|Hydroxychloroquine|hydroxychloroquine|mesh-list
65536502|NCT01067417|Antimalarials|antimalarials|mesh-ancestor
65536503|NCT01067417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65536504|NCT01067417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65536505|NCT01067417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65536506|NCT01067417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536507|NCT01067417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536508|NCT01067417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65536509|NCT03520569|Octreotide|octreotide|mesh-list
65536510|NCT03520569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65536511|NCT03520569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65536512|NCT03520569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65536513|NCT00111839|Pemetrexed|pemetrexed|mesh-list
65536514|NCT00111839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65536515|NCT00111839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536516|NCT00111839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536517|NCT00111839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65536518|NCT00111839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65536519|NCT03723291|Tocopherols|tocopherols|mesh-list
65536520|NCT03723291|Vitamin E|vitamin e|mesh-list
65536521|NCT03723291|Tocotrienols|tocotrienols|mesh-list
65536522|NCT03723291|alpha-Tocopherol|alpha-tocopherol|mesh-list
65536523|NCT03723291|Pentoxifylline|pentoxifylline|mesh-list
65536524|NCT03723291|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65536525|NCT03723291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536526|NCT03723291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536527|NCT03723291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65536528|NCT03723291|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65536529|NCT03723291|Protective Agents|protective agents|mesh-ancestor
65536530|NCT03723291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536531|NCT03723291|Vasodilator Agents|vasodilator agents|mesh-ancestor
65536532|NCT03723291|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65536533|NCT03723291|Antioxidants|antioxidants|mesh-ancestor
65536534|NCT03723291|Vitamins|vitamins|mesh-ancestor
65536535|NCT03723291|Micronutrients|micronutrients|mesh-ancestor
65536536|NCT00111761|Leucovorin|leucovorin|mesh-list
65536537|NCT00111761|Fluorouracil|fluorouracil|mesh-list
65536538|NCT00111761|Irinotecan|irinotecan|mesh-list
65536539|NCT00111761|Panitumumab|panitumumab|mesh-list
65536540|NCT00111761|Antimetabolites|antimetabolites|mesh-ancestor
65536541|NCT00111761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536542|NCT00111761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65536543|NCT00111761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65536544|NCT00111761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65536545|NCT00111761|Immunologic Factors|immunologic factors|mesh-ancestor
65536546|NCT00111761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536547|NCT00111761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65536548|NCT00111761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65536549|NCT00111761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536550|NCT00111761|Antidotes|antidotes|mesh-ancestor
65536551|NCT00111761|Protective Agents|protective agents|mesh-ancestor
65536552|NCT00111761|Vitamin B Complex|vitamin b complex|mesh-ancestor
65536553|NCT00111761|Vitamins|vitamins|mesh-ancestor
65536554|NCT00111761|Micronutrients|micronutrients|mesh-ancestor
65536555|NCT00111761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65536556|NCT03519867|Bromides|bromides|mesh-list
65536557|NCT03519867|Rocuronium|rocuronium|mesh-list
65536558|NCT03519867|Anticonvulsants|anticonvulsants|mesh-ancestor
65536559|NCT03519867|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65536560|NCT03519867|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65536561|NCT03519867|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65536562|NCT03519867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65536563|NCT03519867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536564|NCT03977285|Chlorhexidine|chlorhexidine|mesh-list
65536565|NCT03977285|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65536566|NCT03977285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65536567|NCT03977285|Disinfectants|disinfectants|mesh-ancestor
65536568|NCT03730311|Elsulfavirine|elsulfavirine|mesh-list
65536569|NCT03730311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65536570|NCT03730311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65536571|NCT03730311|Antiviral Agents|antiviral agents|mesh-ancestor
65536572|NCT03730311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65536573|NCT02763046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65536574|NCT02763046|Immunologic Factors|immunologic factors|mesh-ancestor
65536575|NCT02763046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536576|NCT02164552|Vitamin D|vitamin d|mesh-list
65536577|NCT02164552|Ergocalciferols|ergocalciferols|mesh-list
65536578|NCT02164552|Cholecalciferol|cholecalciferol|mesh-list
65536579|NCT02164552|Vitamins|vitamins|mesh-list
65536580|NCT02164552|Micronutrients|micronutrients|mesh-ancestor
65536581|NCT02164552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536582|NCT02164552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65536583|NCT02164552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65536584|NCT03723135|Azacitidine|azacitidine|mesh-list
65536585|NCT03723135|Cc-486|cc-486|mesh-list
65334103|NCT00760695|Analgesics|analgesics|mesh-ancestor
65536586|NCT03723135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65536587|NCT03723135|Antimetabolites|antimetabolites|mesh-ancestor
65536588|NCT03723135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536589|NCT03723135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65536590|NCT03723135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536591|NCT02762578|Insulin|insulin|mesh-list
65536592|NCT02762578|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65536593|NCT02762578|Insulin Aspart|insulin aspart|mesh-list
65536594|NCT02762578|Insulin, Long-Acting|insulin, long-acting|mesh-list
65536595|NCT02762578|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65536596|NCT02762578|Biphasic Insulins|biphasic insulins|mesh-list
65536597|NCT02762578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65536598|NCT02762578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536599|NCT03540628|Thiamine|thiamine|mesh-list
65536600|NCT03540628|Vitamins|vitamins|mesh-ancestor
65536601|NCT03540628|Micronutrients|micronutrients|mesh-ancestor
65536602|NCT03540628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536603|NCT03540628|Vitamin B Complex|vitamin b complex|mesh-ancestor
65536604|NCT02170948|Dexmedetomidine|dexmedetomidine|mesh-list
65536605|NCT02170948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65536606|NCT02170948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65536607|NCT02170948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536608|NCT02170948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65536609|NCT02170948|Analgesics|analgesics|mesh-ancestor
65536610|NCT02170948|Sensory System Agents|sensory system agents|mesh-ancestor
65536611|NCT02170948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65536612|NCT02170948|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65536613|NCT02170948|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65536614|NCT02170948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65536615|NCT02170948|Adrenergic Agents|adrenergic agents|mesh-ancestor
65536616|NCT02170948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65536617|NCT02170948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536618|NCT02171026|Amiodarone|amiodarone|mesh-list
65536619|NCT02171026|Dabigatran|dabigatran|mesh-list
65536620|NCT02171026|Antithrombins|antithrombins|mesh-ancestor
65536621|NCT02171026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65536622|NCT02171026|Protease Inhibitors|protease inhibitors|mesh-ancestor
65536623|NCT02171026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536624|NCT02171026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536625|NCT02171026|Anticoagulants|anticoagulants|mesh-ancestor
65536626|NCT02171026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65536627|NCT02171026|Vasodilator Agents|vasodilator agents|mesh-ancestor
65536628|NCT02171026|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65536629|NCT02171026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65536630|NCT02171026|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65536631|NCT02171026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65536632|NCT02171026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65536633|NCT02171026|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65536634|NCT02171026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65536635|NCT02171026|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65536636|NCT02165020|Hyaluronic Acid|hyaluronic acid|mesh-list
65536637|NCT02165020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65536638|NCT02165020|Immunologic Factors|immunologic factors|mesh-ancestor
65536639|NCT02165020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536640|NCT02165020|Viscosupplements|viscosupplements|mesh-ancestor
65536641|NCT02165020|Protective Agents|protective agents|mesh-ancestor
65536642|NCT03514641|Bexagliflozin|bexagliflozin|mesh-list
65536643|NCT03514641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65536644|NCT03514641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536645|NCT03539224|Lamivudine|lamivudine|mesh-list
65536646|NCT03539224|Dolutegravir|dolutegravir|mesh-list
65536647|NCT03539224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65536648|NCT03539224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65536649|NCT03539224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536650|NCT03539224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536651|NCT03539224|Antiviral Agents|antiviral agents|mesh-ancestor
65536652|NCT03539224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65536653|NCT03539224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65536654|NCT03539224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65536655|NCT03539224|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65536656|NCT03539224|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65536657|NCT02171182|Capsaicin|capsaicin|mesh-list
65536658|NCT02171182|Antipruritics|antipruritics|mesh-ancestor
65536659|NCT02171182|Dermatologic Agents|dermatologic agents|mesh-ancestor
65536660|NCT02171182|Sensory System Agents|sensory system agents|mesh-ancestor
65536661|NCT02171182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65536662|NCT02171182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536663|NCT00100828|Irinotecan|irinotecan|mesh-list
65536664|NCT00100828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65536665|NCT00100828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65536666|NCT00100828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536667|NCT00100828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536668|NCT00100828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65536669|NCT02165098|Cariprazine|cariprazine|mesh-list
65536670|NCT02165098|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65536671|NCT02165098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65536672|NCT02165098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65536673|NCT02165098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536674|NCT02165098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65536675|NCT02171338|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65536676|NCT02171338|Azithromycin|azithromycin|mesh-list
65536677|NCT02171338|Clarithromycin|clarithromycin|mesh-list
65536678|NCT02171338|Ciprofloxacin|ciprofloxacin|mesh-list
65536679|NCT02171338|Tazobactam|tazobactam|mesh-list
65536680|NCT02171338|Piperacillin|piperacillin|mesh-list
65536681|NCT02171338|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65536682|NCT02171338|Penicillin G|penicillin g|mesh-list
65536683|NCT02171338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65536684|NCT02171338|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65536685|NCT02171338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536686|NCT02171338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536687|NCT02171338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65536688|NCT02171338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65536689|NCT02171338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65536690|NCT02171338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65536691|NCT02171338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65536692|NCT02171338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65536693|NCT02171338|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65536694|NCT02171416|Rilonacept|rilonacept|mesh-list
65536695|NCT02171416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65536696|NCT02171494|Warfarin|warfarin|mesh-list
65536697|NCT02171494|Anticoagulants|anticoagulants|mesh-ancestor
65536698|NCT02165332|Moxifloxacin|moxifloxacin|mesh-list
65536699|NCT02165332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65536700|NCT02165332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65536701|NCT02165332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65536702|NCT02165332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65536703|NCT02165332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65536704|NCT02165332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536705|NCT02165332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536706|NCT02165332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65536707|NCT02165332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65536708|NCT02165332|Contraceptive Agents|contraceptive agents|mesh-ancestor
65536709|NCT02165332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65536710|NCT02165332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536711|NCT02165332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65536712|NCT02165332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65536713|NCT02165332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65536714|NCT02171572|Dabigatran|dabigatran|mesh-list
65536715|NCT02171572|Antithrombins|antithrombins|mesh-ancestor
65536716|NCT02171572|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65536717|NCT02171572|Protease Inhibitors|protease inhibitors|mesh-ancestor
65536718|NCT02171572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536719|NCT02171572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536720|NCT02171572|Anticoagulants|anticoagulants|mesh-ancestor
65536721|NCT02255578|Clomiphene|clomiphene|mesh-list
65536722|NCT02255578|Enclomiphene|enclomiphene|mesh-list
65536723|NCT02255578|Zuclomiphene|zuclomiphene|mesh-list
65536724|NCT02255578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65536725|NCT02255578|Hormone Antagonists|hormone antagonists|mesh-ancestor
65536726|NCT02255578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65536727|NCT02255578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536728|NCT02255578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65536729|NCT02255578|Fertility Agents|fertility agents|mesh-ancestor
65536730|NCT02255578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65536731|NCT02255578|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65536732|NCT02255578|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65536733|NCT02169154|Diclofenac|diclofenac|mesh-list
65536734|NCT02169154|Menthol|menthol|mesh-list
65536735|NCT02169154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65536736|NCT02169154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65536737|NCT02169154|Analgesics|analgesics|mesh-ancestor
65536738|NCT02169154|Sensory System Agents|sensory system agents|mesh-ancestor
65536739|NCT02169154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65536740|NCT02169154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536741|NCT02169154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65536742|NCT02169154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65536743|NCT02169154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65536744|NCT02169154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536745|NCT02169154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536746|NCT02169154|Antipruritics|antipruritics|mesh-ancestor
65536747|NCT02169154|Dermatologic Agents|dermatologic agents|mesh-ancestor
65536748|NCT00100048|Tenofovir|tenofovir|mesh-list
65536749|NCT00100048|Lamivudine|lamivudine|mesh-list
65536750|NCT00100048|Efavirenz|efavirenz|mesh-list
65536751|NCT00100048|Raltegravir Potassium|raltegravir potassium|mesh-list
65536752|NCT00100048|Antiviral Agents|antiviral agents|mesh-ancestor
65536753|NCT00100048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65536754|NCT00100048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65536755|NCT00100048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65536756|NCT00100048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536757|NCT00100048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536758|NCT00100048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65536759|NCT00100048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65536760|NCT00100048|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65536761|NCT00100048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65536762|NCT00100048|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65536763|NCT00100048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65536764|NCT00100048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65536765|NCT00100048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65265815|NCT00744237|Sympatholytics|sympatholytics|mesh-ancestor
65536766|NCT00100048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65536767|NCT00100048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65536768|NCT02171650|Afatinib|afatinib|mesh-list
65536769|NCT02171650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65536770|NCT02171650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65536771|NCT02171650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536772|NCT02171650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536773|NCT02165566|Insulin|insulin|mesh-list
65536774|NCT02165566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65536775|NCT02165566|Insulin Lispro|insulin lispro|mesh-list
65536776|NCT02165566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65536777|NCT02165566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536778|NCT02171728|Afatinib|afatinib|mesh-list
65536779|NCT02171728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65536780|NCT02171728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65536781|NCT02171728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536782|NCT02171728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536783|NCT02165644|Nimodipine|nimodipine|mesh-list
65536784|NCT02165644|Acetazolamide|acetazolamide|mesh-list
65536785|NCT02165644|Anticonvulsants|anticonvulsants|mesh-ancestor
65536786|NCT02165644|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65536787|NCT02165644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536788|NCT02165644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536789|NCT02165644|Diuretics|diuretics|mesh-ancestor
65536790|NCT02165644|Natriuretic Agents|natriuretic agents|mesh-ancestor
65536791|NCT02165644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536792|NCT02165644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65536793|NCT02165644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65536794|NCT02165644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65536795|NCT02165644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65536796|NCT02165644|Vasodilator Agents|vasodilator agents|mesh-ancestor
65536797|NCT02171806|Olodaterol|olodaterol|mesh-list
65536798|NCT02171806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65536799|NCT02171806|Autonomic Agents|autonomic agents|mesh-ancestor
65536800|NCT02171806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65536801|NCT02171806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536802|NCT02171806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65536803|NCT02171806|Respiratory System Agents|respiratory system agents|mesh-ancestor
65536804|NCT02169544|Abatacept|abatacept|mesh-list
65536805|NCT02169544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65536806|NCT02169544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536807|NCT02169544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65536808|NCT02169544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65536809|NCT02169544|Immunologic Factors|immunologic factors|mesh-ancestor
65536810|NCT02169544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536811|NCT02169544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65536812|NCT02169856|Cefuroxime|cefuroxime|mesh-list
65536813|NCT02169856|Cefuroxime axetil|cefuroxime axetil|mesh-list
65536814|NCT02169856|Ketorolac|ketorolac|mesh-list
65536815|NCT02169856|Midazolam|midazolam|mesh-list
65536816|NCT02169856|Propofol|propofol|mesh-list
65536817|NCT02169856|Sevoflurane|sevoflurane|mesh-list
65536818|NCT02169856|Atracurium|atracurium|mesh-list
65536819|NCT02169856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65536820|NCT02169856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65536821|NCT02169856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536822|NCT02169856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65536823|NCT02169856|Anesthetics, General|anesthetics, general|mesh-ancestor
65536824|NCT02169856|Anesthetics|anesthetics|mesh-ancestor
65536825|NCT02169856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65536826|NCT02169856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65536827|NCT02169856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65536828|NCT02169856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65536829|NCT02169856|GABA Modulators|gaba modulators|mesh-ancestor
65536830|NCT02169856|GABA Agents|gaba agents|mesh-ancestor
65536831|NCT02169856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65536832|NCT02169856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536833|NCT02169856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65536834|NCT02169856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65536835|NCT02169856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65536836|NCT02169856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65536837|NCT02169856|Analgesics|analgesics|mesh-ancestor
65536838|NCT02169856|Sensory System Agents|sensory system agents|mesh-ancestor
65536839|NCT02169856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65536840|NCT02169856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65536841|NCT02169856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65536842|NCT02169856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65536843|NCT02169856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536844|NCT02169856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65536845|NCT02169856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65536846|NCT02169856|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65536847|NCT02169856|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65536848|NCT02169856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65536849|NCT02169856|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65536850|NCT02169856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65536851|NCT02169856|Cholinergic Agents|cholinergic agents|mesh-ancestor
65536852|NCT02170246|Telmisartan|telmisartan|mesh-list
65536853|NCT02170246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65536854|NCT02170246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65536855|NCT02170246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65536856|NCT02170246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536857|NCT02170324|Exenatide|exenatide|mesh-list
65536858|NCT02170324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65536859|NCT02170324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536860|NCT02170324|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65536861|NCT02170324|Incretins|incretins|mesh-ancestor
65536862|NCT02170324|Hormones|hormones|mesh-ancestor
65536863|NCT02170324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65536864|NCT02170402|Factor VIII|factor viii|mesh-list
65536865|NCT02170402|Coagulants|coagulants|mesh-ancestor
65536866|NCT02172196|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65536867|NCT02172196|Empagliflozin|empagliflozin|mesh-list
65536868|NCT02172196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65536869|NCT02172196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536870|NCT02172196|Incretins|incretins|mesh-ancestor
65536871|NCT02172196|Hormones|hormones|mesh-ancestor
65536872|NCT02172196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65536873|NCT02172196|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65536874|NCT02172196|Protease Inhibitors|protease inhibitors|mesh-ancestor
65536875|NCT02172196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536876|NCT02172196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536877|NCT02172196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65536878|NCT02172274|Empagliflozin|empagliflozin|mesh-list
65536879|NCT02172274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65536880|NCT02172274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536881|NCT02172274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65536882|NCT02172274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536883|NCT02172352|Tiotropium Bromide|tiotropium bromide|mesh-list
65536884|NCT02172352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65536885|NCT02172352|Autonomic Agents|autonomic agents|mesh-ancestor
65536886|NCT02172352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65536887|NCT02172352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536888|NCT02172352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65536889|NCT02172352|Respiratory System Agents|respiratory system agents|mesh-ancestor
65536890|NCT02172352|Parasympatholytics|parasympatholytics|mesh-ancestor
65536891|NCT02172352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65536892|NCT02172352|Cholinergic Agents|cholinergic agents|mesh-ancestor
65536893|NCT02172352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65536894|NCT02172352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536895|NCT02757352|Ixekizumab|ixekizumab|mesh-list
65536896|NCT02757352|Dermatologic Agents|dermatologic agents|mesh-ancestor
65536897|NCT02172430|Tiotropium Bromide|tiotropium bromide|mesh-list
65536898|NCT02172430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65536899|NCT02172430|Autonomic Agents|autonomic agents|mesh-ancestor
65536900|NCT02172430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65536901|NCT02172430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536902|NCT02172430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65536903|NCT02172430|Respiratory System Agents|respiratory system agents|mesh-ancestor
65536904|NCT02172430|Parasympatholytics|parasympatholytics|mesh-ancestor
65536905|NCT02172430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65536906|NCT02172430|Cholinergic Agents|cholinergic agents|mesh-ancestor
65536907|NCT02172430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65536908|NCT02172430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536909|NCT02172508|Tiotropium Bromide|tiotropium bromide|mesh-list
65536910|NCT02172508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65536911|NCT02172508|Autonomic Agents|autonomic agents|mesh-ancestor
65536912|NCT02172508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65536913|NCT02172508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265966|NCT05207358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536914|NCT02172508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65536915|NCT02172508|Respiratory System Agents|respiratory system agents|mesh-ancestor
65536916|NCT02172508|Parasympatholytics|parasympatholytics|mesh-ancestor
65536917|NCT02172508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65536918|NCT02172508|Cholinergic Agents|cholinergic agents|mesh-ancestor
65536919|NCT02172508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65536920|NCT02172508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536921|NCT02172586|Losartan|losartan|mesh-list
65536922|NCT02172586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65536923|NCT02172586|Telmisartan|telmisartan|mesh-list
65536924|NCT02172586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65536925|NCT02172586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65536926|NCT02172586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65536927|NCT02172586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65536928|NCT02172586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536929|NCT02172586|Diuretics|diuretics|mesh-ancestor
65536930|NCT02172586|Natriuretic Agents|natriuretic agents|mesh-ancestor
65536931|NCT02172586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536932|NCT02172586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65536933|NCT02172586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65536934|NCT02170636|Pantoprazole|pantoprazole|mesh-list
65536935|NCT02170636|Dabigatran|dabigatran|mesh-list
65536936|NCT02170636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65536937|NCT02170636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65536938|NCT02170636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65536939|NCT02170636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536940|NCT02170636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536941|NCT02170636|Antithrombins|antithrombins|mesh-ancestor
65536942|NCT02170636|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65536943|NCT02170636|Protease Inhibitors|protease inhibitors|mesh-ancestor
65536944|NCT02170636|Anticoagulants|anticoagulants|mesh-ancestor
65536945|NCT02255734|Acyclovir|acyclovir|mesh-list
65536946|NCT02255734|Antiviral Agents|antiviral agents|mesh-ancestor
65536947|NCT02255734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65536948|NCT02255812|Quinine|quinine|mesh-list
65536949|NCT02255812|Citric Acid|citric acid|mesh-list
65536950|NCT02255812|Sodium Citrate|sodium citrate|mesh-list
65536951|NCT02255812|Antimalarials|antimalarials|mesh-ancestor
65536952|NCT02255812|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65536953|NCT02255812|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65536954|NCT02255812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65536955|NCT02255812|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65536956|NCT02255812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536957|NCT02255812|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65536958|NCT02255812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65536959|NCT02255812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65536960|NCT02255812|Analgesics|analgesics|mesh-ancestor
65536961|NCT02255812|Sensory System Agents|sensory system agents|mesh-ancestor
65536962|NCT02255812|Anticoagulants|anticoagulants|mesh-ancestor
65536963|NCT02255812|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65536964|NCT02255812|Chelating Agents|chelating agents|mesh-ancestor
65536965|NCT02255812|Sequestering Agents|sequestering agents|mesh-ancestor
65536966|NCT02255812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536967|NCT02170792|Ranitidine|ranitidine|mesh-list
65536968|NCT02170792|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65536969|NCT02170792|Dabigatran|dabigatran|mesh-list
65536970|NCT02170792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65536971|NCT02170792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65536972|NCT02170792|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65536973|NCT02170792|Histamine Antagonists|histamine antagonists|mesh-ancestor
65536974|NCT02170792|Histamine Agents|histamine agents|mesh-ancestor
65536975|NCT02170792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65536976|NCT02170792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536977|NCT02170792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536978|NCT02170792|Antithrombins|antithrombins|mesh-ancestor
65536979|NCT02170792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65536980|NCT02170792|Protease Inhibitors|protease inhibitors|mesh-ancestor
65536981|NCT02170792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536982|NCT02170792|Anticoagulants|anticoagulants|mesh-ancestor
65536983|NCT02172976|Gemcitabine|gemcitabine|mesh-list
65536984|NCT02172976|Fluorouracil|fluorouracil|mesh-list
65536985|NCT02172976|Oxaliplatin|oxaliplatin|mesh-list
65536986|NCT02172976|Irinotecan|irinotecan|mesh-list
65536987|NCT02172976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65536988|NCT02172976|Antimetabolites|antimetabolites|mesh-ancestor
65536989|NCT02172976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65536990|NCT02172976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65536991|NCT02172976|Antiviral Agents|antiviral agents|mesh-ancestor
65536992|NCT02172976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65536993|NCT02172976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65536994|NCT02172976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65536995|NCT02172976|Immunologic Factors|immunologic factors|mesh-ancestor
65536996|NCT02172976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65536997|NCT02172976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65536998|NCT02172976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65536999|NCT02173132|Acetylcarnitine|acetylcarnitine|mesh-list
65537000|NCT02173132|Vitamin B Complex|vitamin b complex|mesh-ancestor
65537001|NCT02173132|Vitamins|vitamins|mesh-ancestor
65537002|NCT02173132|Micronutrients|micronutrients|mesh-ancestor
65537003|NCT02173132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537004|NCT02173132|Nootropic Agents|nootropic agents|mesh-ancestor
65537005|NCT02173288|Furosemide|furosemide|mesh-list
65537006|NCT02173288|Spironolactone|spironolactone|mesh-list
65537007|NCT02173288|Tolvaptan|tolvaptan|mesh-list
65537008|NCT02173288|Midodrine|midodrine|mesh-list
65537009|NCT02173288|Diuretics|diuretics|mesh-ancestor
65537010|NCT02173288|Natriuretic Agents|natriuretic agents|mesh-ancestor
65537011|NCT02173288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537012|NCT02173288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65537013|NCT02173288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65537014|NCT02173288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537015|NCT02173288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65537016|NCT02173288|Hormone Antagonists|hormone antagonists|mesh-ancestor
65537017|NCT02173288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65537018|NCT02173288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65537019|NCT02173288|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65537020|NCT02173288|Sympathomimetics|sympathomimetics|mesh-ancestor
65537021|NCT02173288|Autonomic Agents|autonomic agents|mesh-ancestor
65537022|NCT02173288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65537023|NCT02173288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65537024|NCT02173288|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65537025|NCT02173288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65537026|NCT02173288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65537027|NCT02173288|Adrenergic Agents|adrenergic agents|mesh-ancestor
65537028|NCT02173288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65537029|NCT02175394|Linagliptin|linagliptin|mesh-list
65537030|NCT02175394|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65537031|NCT02175394|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
65537032|NCT02175394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65537033|NCT02175394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537034|NCT02175394|Incretins|incretins|mesh-ancestor
65537035|NCT02175394|Hormones|hormones|mesh-ancestor
65537036|NCT02175394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65537037|NCT02175394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65334548|NCT00779805|Ephedrine|ephedrine|mesh-list
65537038|NCT02175394|Protease Inhibitors|protease inhibitors|mesh-ancestor
65537039|NCT02175394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537040|NCT02175394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537041|NCT02175394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65537042|NCT02175394|Contraceptive Agents|contraceptive agents|mesh-ancestor
65537043|NCT02175394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65537044|NCT02175394|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65537045|NCT02175394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65537046|NCT02175394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65537047|NCT02175394|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65537048|NCT02175394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65537049|NCT02175394|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
65537050|NCT02175394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65537051|NCT02175394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65537052|NCT02256124|Lamotrigine|lamotrigine|mesh-list
65537053|NCT02256124|Anticonvulsants|anticonvulsants|mesh-ancestor
65537054|NCT02256124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65537055|NCT02256124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65537056|NCT02256124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537057|NCT02256124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65537058|NCT02256124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537059|NCT02256124|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65266181|NCT00924287|Mesna|mesna|mesh-list
65537060|NCT02256124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65537061|NCT02256124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65537062|NCT02256124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65537063|NCT02256124|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65537064|NCT02173756|Morphine|morphine|mesh-list
65537065|NCT02173756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65537066|NCT02173756|Narcotics|narcotics|mesh-ancestor
65537067|NCT02173756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65537068|NCT02173756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537069|NCT02173756|Analgesics|analgesics|mesh-ancestor
65537070|NCT02173756|Sensory System Agents|sensory system agents|mesh-ancestor
65537071|NCT02173756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65537072|NCT00102466|Metformin|metformin|mesh-list
65537073|NCT00102466|Vildagliptin|vildagliptin|mesh-list
65537074|NCT00102466|Gliclazide|gliclazide|mesh-list
65537075|NCT00102466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65537076|NCT00102466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537077|NCT00102466|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65537078|NCT00102466|Protease Inhibitors|protease inhibitors|mesh-ancestor
65537079|NCT00102466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537080|NCT00102466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537081|NCT02173834|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65537082|NCT02173834|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65537083|NCT02173834|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65537084|NCT02173834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537085|NCT02173834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65537086|NCT02173834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537087|NCT02173912|Amlodipine|amlodipine|mesh-list
65537088|NCT02173912|Candesartan|candesartan|mesh-list
65537089|NCT02173912|Candesartan cilexetil|candesartan cilexetil|mesh-list
65537090|NCT02173912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65537091|NCT02173912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65537092|NCT02173912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65537093|NCT02173912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537094|NCT02173912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65537095|NCT02173912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537096|NCT02173912|Vasodilator Agents|vasodilator agents|mesh-ancestor
65537097|NCT02173912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65537098|NCT02173912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65537099|NCT02173990|Aflibercept|aflibercept|mesh-list
65537100|NCT02173990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65537101|NCT02173990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65537102|NCT02173990|Growth Substances|growth substances|mesh-ancestor
65537103|NCT02173990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537104|NCT02173990|Growth Inhibitors|growth inhibitors|mesh-ancestor
65537105|NCT02173990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65537106|NCT02175784|Ipragliflozin|ipragliflozin|mesh-list
65537107|NCT02175784|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65537108|NCT02175784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537109|NCT02175784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65537110|NCT02175784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537111|NCT02256280|Neostigmine|neostigmine|mesh-list
65537112|NCT02256280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65537113|NCT02256280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537114|NCT02256280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537115|NCT02256280|Cholinergic Agents|cholinergic agents|mesh-ancestor
65537116|NCT02256280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65537117|NCT02256280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537118|NCT02256280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65537119|NCT02256280|Autonomic Agents|autonomic agents|mesh-ancestor
65537120|NCT02256280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65537121|NCT02174068|Acetaminophen|acetaminophen|mesh-list
65537122|NCT02174068|Nefopam|nefopam|mesh-list
65537123|NCT02174068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65537124|NCT02174068|Analgesics|analgesics|mesh-ancestor
65537125|NCT02174068|Sensory System Agents|sensory system agents|mesh-ancestor
65537126|NCT02174068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65537127|NCT02174068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537128|NCT02174068|Antipyretics|antipyretics|mesh-ancestor
65537129|NCT02179294|Meperidine|meperidine|mesh-list
65537130|NCT02179294|Remifentanil|remifentanil|mesh-list
65537131|NCT02179294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65537132|NCT02179294|Narcotics|narcotics|mesh-ancestor
65537133|NCT02179294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65537134|NCT02179294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537135|NCT02179294|Analgesics|analgesics|mesh-ancestor
65537136|NCT02179294|Sensory System Agents|sensory system agents|mesh-ancestor
65537137|NCT02179294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65537138|NCT02179294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65537139|NCT02179528|Etoposide|etoposide|mesh-list
65537140|NCT02179528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65537141|NCT02179528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65537142|NCT02179528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65537143|NCT02179528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65537144|NCT02179528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537145|NCT02179528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537146|NCT02176564|Bronchodilator Agents|bronchodilator agents|mesh-list
65537147|NCT02176564|Autonomic Agents|autonomic agents|mesh-ancestor
65537148|NCT02176564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65537149|NCT02176564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537150|NCT02176564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65537151|NCT02176564|Respiratory System Agents|respiratory system agents|mesh-ancestor
65537152|NCT02182102|Pemetrexed|pemetrexed|mesh-list
65537153|NCT02182102|Nintedanib|nintedanib|mesh-list
65537154|NCT02182102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65537155|NCT02182102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537156|NCT02182102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537157|NCT02182102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65537158|NCT02182102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65537159|NCT02182102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65537160|NCT02176720|Fluorides|fluorides|mesh-list
65537161|NCT02176720|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
65537162|NCT02176720|Cariostatic Agents|cariostatic agents|mesh-ancestor
65537163|NCT02176720|Protective Agents|protective agents|mesh-ancestor
65537164|NCT02176720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537165|NCT02176720|Dopamine Agents|dopamine agents|mesh-ancestor
65537166|NCT02176720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65537167|NCT02176720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537168|NCT02176876|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65537169|NCT02176876|Immunologic Factors|immunologic factors|mesh-ancestor
65537170|NCT02176876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537171|NCT03537196|Ribavirin|ribavirin|mesh-list
65537172|NCT03537196|Sofosbuvir|sofosbuvir|mesh-list
65537173|NCT03537196|Antimetabolites|antimetabolites|mesh-ancestor
65537174|NCT03537196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537175|NCT03537196|Antiviral Agents|antiviral agents|mesh-ancestor
65537176|NCT03537196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65537177|NCT02182258|Nintedanib|nintedanib|mesh-list
65537178|NCT02182258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65537179|NCT02182258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65537180|NCT02182258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537181|NCT02182258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537182|NCT02182336|Vitamin K|vitamin k|mesh-list
65537183|NCT02182336|Digoxin|digoxin|mesh-list
65537184|NCT02182336|Midazolam|midazolam|mesh-list
65537185|NCT02182336|Dextromethorphan|dextromethorphan|mesh-list
65537186|NCT02182336|Caffeine|caffeine|mesh-list
65537187|NCT02182336|Omeprazole|omeprazole|mesh-list
65537188|NCT02182336|Warfarin|warfarin|mesh-list
65537189|NCT02182336|Vitamins|vitamins|mesh-ancestor
65537190|NCT02182336|Micronutrients|micronutrients|mesh-ancestor
65537191|NCT02182336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537192|NCT02182336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65537193|NCT02182336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65537194|NCT02182336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65537195|NCT02182336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65537196|NCT02182336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65537197|NCT02182336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65537198|NCT02182336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65537199|NCT02182336|Anesthetics, General|anesthetics, general|mesh-ancestor
65537200|NCT02182336|Anesthetics|anesthetics|mesh-ancestor
65537201|NCT02182336|GABA Modulators|gaba modulators|mesh-ancestor
65537202|NCT02182336|GABA Agents|gaba agents|mesh-ancestor
65537203|NCT02182336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65537204|NCT02182336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537205|NCT02182336|Anticoagulants|anticoagulants|mesh-ancestor
65537206|NCT02182336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65537207|NCT02182336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65537208|NCT02182336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537209|NCT02182336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65537210|NCT02182336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65266267|NCT00637871|Bicalutamide|bicalutamide|mesh-list
65537211|NCT02182336|Purinergic Agents|purinergic agents|mesh-ancestor
65537212|NCT02182336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65537213|NCT02182336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65537214|NCT02182336|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65537215|NCT02182336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65537216|NCT02182336|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65537217|NCT02182336|Protective Agents|protective agents|mesh-ancestor
65537218|NCT02182336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65537219|NCT02182336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65537220|NCT02182336|Hemostatics|hemostatics|mesh-ancestor
65537221|NCT02182336|Coagulants|coagulants|mesh-ancestor
65537222|NCT02182336|Antitussive Agents|antitussive agents|mesh-ancestor
65537223|NCT02182336|Respiratory System Agents|respiratory system agents|mesh-ancestor
65537224|NCT02182336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65537225|NCT02182336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65537227|NCT02182570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65537228|NCT02182570|Histamine Antagonists|histamine antagonists|mesh-ancestor
65537229|NCT02182570|Histamine Agents|histamine agents|mesh-ancestor
65537230|NCT02182570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65537231|NCT02182570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537232|NCT02182570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537233|NCT02182648|Propofol|propofol|mesh-list
65537234|NCT02182648|Etomidate|etomidate|mesh-list
65537235|NCT02182648|Sevoflurane|sevoflurane|mesh-list
65537236|NCT02182648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65537237|NCT02182648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65537238|NCT02182648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537239|NCT02182648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65537240|NCT02182648|Anesthetics, General|anesthetics, general|mesh-ancestor
65537241|NCT02182648|Anesthetics|anesthetics|mesh-ancestor
65537242|NCT02182648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65537243|NCT02182648|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65537244|NCT02179996|Vaccines|vaccines|mesh-list
65537245|NCT02179996|Immunologic Factors|immunologic factors|mesh-ancestor
65537246|NCT02179996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537247|NCT02177344|Bromides|bromides|mesh-list
65537248|NCT02177344|Ipratropium|ipratropium|mesh-list
65537249|NCT02177344|Anticonvulsants|anticonvulsants|mesh-ancestor
65537250|NCT02177344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65537251|NCT02177344|Autonomic Agents|autonomic agents|mesh-ancestor
65537252|NCT02177344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65537253|NCT02177344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537254|NCT02177344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65537255|NCT02177344|Respiratory System Agents|respiratory system agents|mesh-ancestor
65537256|NCT02177344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65537257|NCT02177344|Cholinergic Agents|cholinergic agents|mesh-ancestor
65537258|NCT02177344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65537259|NCT02177344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537260|NCT03536494|Mirabegron|mirabegron|mesh-list
65537261|NCT03536494|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65537262|NCT03536494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65537263|NCT03536494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65537264|NCT03536494|Adrenergic Agents|adrenergic agents|mesh-ancestor
65537265|NCT03536494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65334772|NCT02556723|Aflibercept|aflibercept|mesh-list
65537266|NCT03536494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537267|NCT03536494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537268|NCT03536494|Urological Agents|urological agents|mesh-ancestor
65537269|NCT02177422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65537270|NCT02177422|Telmisartan|telmisartan|mesh-list
65537271|NCT02177422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65537272|NCT02177422|Diuretics|diuretics|mesh-ancestor
65537273|NCT02177422|Natriuretic Agents|natriuretic agents|mesh-ancestor
65537274|NCT02177422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537275|NCT02177422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65537276|NCT02177422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65537277|NCT02177422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537278|NCT02177422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65537279|NCT02177422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65537280|NCT02182960|Ibuprofen|ibuprofen|mesh-list
65537281|NCT02182960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65537282|NCT02182960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65537283|NCT02182960|Analgesics|analgesics|mesh-ancestor
65537284|NCT02182960|Sensory System Agents|sensory system agents|mesh-ancestor
65266344|NCT00643071|Tacrolimus|tacrolimus|mesh-list
65537285|NCT02182960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65537286|NCT02182960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537287|NCT02182960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65537288|NCT02182960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65537289|NCT02182960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65537290|NCT02182960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537291|NCT02182960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537292|NCT05141968|Vitamin D|vitamin d|mesh-list
65537293|NCT05141968|Vitamins|vitamins|mesh-ancestor
65537294|NCT05141968|Micronutrients|micronutrients|mesh-ancestor
65537295|NCT05141968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537296|NCT05141968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65537297|NCT00110357|Irinotecan|irinotecan|mesh-list
65537298|NCT00110357|Cetuximab|cetuximab|mesh-list
65537299|NCT00110357|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65537300|NCT00110357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65537301|NCT00110357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537302|NCT00110357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537303|NCT00110357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65537304|NCT00110357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65537305|NCT02183038|Naproxen|naproxen|mesh-list
65537306|NCT02183038|Meloxicam|meloxicam|mesh-list
65537307|NCT02183038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65537308|NCT02183038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65537309|NCT02183038|Analgesics|analgesics|mesh-ancestor
65537310|NCT02183038|Sensory System Agents|sensory system agents|mesh-ancestor
65537311|NCT02183038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65537312|NCT02183038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537313|NCT02183038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65537314|NCT02183038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65537315|NCT02183038|Gout Suppressants|gout suppressants|mesh-ancestor
65537316|NCT02183038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65537317|NCT02183038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537318|NCT02183038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537319|NCT02183038|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65537320|NCT02752906|Vaccines|vaccines|mesh-list
65537321|NCT02752906|Immunologic Factors|immunologic factors|mesh-ancestor
65537322|NCT02752906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537323|NCT00293033|Fentanyl|fentanyl|mesh-list
65537324|NCT00293033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65537325|NCT00293033|Narcotics|narcotics|mesh-ancestor
65537326|NCT00293033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65537327|NCT00293033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537328|NCT00293033|Analgesics|analgesics|mesh-ancestor
65537329|NCT00293033|Sensory System Agents|sensory system agents|mesh-ancestor
65537330|NCT00293033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65537331|NCT00293033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65537332|NCT00293033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65537333|NCT00293033|Anesthetics, General|anesthetics, general|mesh-ancestor
65537334|NCT00293033|Anesthetics|anesthetics|mesh-ancestor
65537335|NCT02183116|Meloxicam|meloxicam|mesh-list
65537336|NCT02183116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65537337|NCT02183116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65537338|NCT02183116|Analgesics|analgesics|mesh-ancestor
65537339|NCT02183116|Sensory System Agents|sensory system agents|mesh-ancestor
65537340|NCT02183116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65537341|NCT02183116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537342|NCT02183116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65537343|NCT02183116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65537344|NCT02183116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65537345|NCT02183116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65537346|NCT02183116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537347|NCT02183116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537349|NCT02183194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65537350|NCT02183194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65537351|NCT02183194|Tubulin Modulators|tubulin modulators|mesh-ancestor
65537352|NCT02183194|Antimitotic Agents|antimitotic agents|mesh-ancestor
65537353|NCT02183194|Mitosis Modulators|mitosis modulators|mesh-ancestor
65537354|NCT02183194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537355|NCT02183272|Ketamine|ketamine|mesh-list
65537356|NCT02183272|Analgesics|analgesics|mesh-ancestor
65537357|NCT02183272|Sensory System Agents|sensory system agents|mesh-ancestor
65537358|NCT02183272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65537359|NCT02183272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537360|NCT02183272|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65537361|NCT02183272|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65537362|NCT02183272|Anesthetics, General|anesthetics, general|mesh-ancestor
65537363|NCT02183272|Anesthetics|anesthetics|mesh-ancestor
65537364|NCT02183272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65537365|NCT02183272|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65537366|NCT02183272|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65537367|NCT02183272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65537368|NCT02183272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537369|NCT02177500|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65537370|NCT02177500|Telmisartan|telmisartan|mesh-list
65537371|NCT02177500|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
65537372|NCT02177500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65537373|NCT02177500|Diuretics|diuretics|mesh-ancestor
65537374|NCT02177500|Natriuretic Agents|natriuretic agents|mesh-ancestor
65537375|NCT02177500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537376|NCT02177500|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65537377|NCT02177500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65537378|NCT02177500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537379|NCT02177500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65537380|NCT02177500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65537381|NCT02183350|Linagliptin|linagliptin|mesh-list
65537382|NCT02183350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65537383|NCT02183350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537384|NCT02183350|Incretins|incretins|mesh-ancestor
65537385|NCT02183350|Hormones|hormones|mesh-ancestor
65537386|NCT02183350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65537387|NCT02183350|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65537388|NCT02183350|Protease Inhibitors|protease inhibitors|mesh-ancestor
65537389|NCT02183350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537390|NCT02183350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537391|NCT03537898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65537392|NCT03537898|Plasma-lyte 148|plasma-lyte 148|mesh-list
65537393|NCT03537898|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65537394|NCT02183428|Glyburide|glyburide|mesh-list
65537395|NCT02183428|Linagliptin|linagliptin|mesh-list
65537396|NCT02183428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65537397|NCT02183428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537398|NCT02183428|Incretins|incretins|mesh-ancestor
65537399|NCT02183428|Hormones|hormones|mesh-ancestor
65537400|NCT02183428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65537401|NCT02183428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65537402|NCT02183428|Protease Inhibitors|protease inhibitors|mesh-ancestor
65537403|NCT02183428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537404|NCT02183428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537405|NCT01080911|Morphine|morphine|mesh-list
65537406|NCT01080911|Analgesics, Opioid|analgesics, opioid|mesh-list
65537407|NCT01080911|Narcotics|narcotics|mesh-ancestor
65537408|NCT01080911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65537409|NCT01080911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537410|NCT01080911|Analgesics|analgesics|mesh-ancestor
65537411|NCT01080911|Sensory System Agents|sensory system agents|mesh-ancestor
65537412|NCT01080911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65537413|NCT02183506|Metformin|metformin|mesh-list
65537414|NCT02183506|Linagliptin|linagliptin|mesh-list
65537415|NCT02183506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65537416|NCT02183506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537417|NCT02183506|Incretins|incretins|mesh-ancestor
65537418|NCT02183506|Hormones|hormones|mesh-ancestor
65537419|NCT02183506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65537420|NCT02183506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65537421|NCT02183506|Protease Inhibitors|protease inhibitors|mesh-ancestor
65537422|NCT02183506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537423|NCT02183506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537424|NCT02177734|Vaccines|vaccines|mesh-list
65537425|NCT02177734|Immunologic Factors|immunologic factors|mesh-ancestor
65537426|NCT02177734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537427|NCT02183584|Linagliptin|linagliptin|mesh-list
65537428|NCT02183584|Rifampin|rifampin|mesh-list
65537429|NCT02183584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65537430|NCT02183584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537431|NCT02183584|Incretins|incretins|mesh-ancestor
65537432|NCT02183584|Hormones|hormones|mesh-ancestor
65537433|NCT02183584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65537434|NCT02183584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65537435|NCT02183584|Protease Inhibitors|protease inhibitors|mesh-ancestor
65537436|NCT02183584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537437|NCT02183584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537438|NCT02183584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65537439|NCT02183584|Antitubercular Agents|antitubercular agents|mesh-ancestor
65537440|NCT02183584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65537441|NCT02183584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65537442|NCT02183584|Leprostatic Agents|leprostatic agents|mesh-ancestor
65537443|NCT02183584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65537444|NCT02183584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65537445|NCT02183584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65537446|NCT02183584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65537447|NCT02183584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65537448|NCT02183584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65537449|NCT02183584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65537450|NCT03964493|Vancomycin|vancomycin|mesh-list
65537451|NCT03964493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65537452|NCT03964493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65537453|NCT01068353|Etanercept|etanercept|mesh-list
65537454|NCT01068353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65537455|NCT01068353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65537456|NCT01068353|Analgesics|analgesics|mesh-ancestor
65537457|NCT01068353|Sensory System Agents|sensory system agents|mesh-ancestor
65537458|NCT01068353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65537459|NCT01068353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537460|NCT01068353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65537461|NCT01068353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65537462|NCT01068353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65537463|NCT01068353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65537464|NCT01068353|Immunologic Factors|immunologic factors|mesh-ancestor
65537465|NCT01083251|Vitamin D|vitamin d|mesh-list
65537466|NCT01083251|Ergocalciferols|ergocalciferols|mesh-list
65537467|NCT01083251|Cholecalciferol|cholecalciferol|mesh-list
65537468|NCT01083251|Vitamins|vitamins|mesh-list
65537469|NCT01083251|Entecavir|entecavir|mesh-list
65537470|NCT01083251|Micronutrients|micronutrients|mesh-ancestor
65537471|NCT01083251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537472|NCT01083251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65537473|NCT01083251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65537474|NCT01083251|Antiviral Agents|antiviral agents|mesh-ancestor
65537475|NCT01083251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65537476|NCT02184052|Meloxicam|meloxicam|mesh-list
65537477|NCT02184052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65537478|NCT02184052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65537479|NCT02184052|Analgesics|analgesics|mesh-ancestor
65537480|NCT02184052|Sensory System Agents|sensory system agents|mesh-ancestor
65537481|NCT02184052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65537482|NCT02184052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537483|NCT02184052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65537484|NCT02184052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65537485|NCT02184052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65537486|NCT02184052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65537487|NCT02184052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537488|NCT02184052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537489|NCT01083329|Nicotinic Acids|nicotinic acids|mesh-list
65537490|NCT01083329|Niacin|niacin|mesh-list
65537491|NCT01083329|Niacinamide|niacinamide|mesh-list
65537492|NCT01083329|Vitamin B Complex|vitamin b complex|mesh-ancestor
65537493|NCT01083329|Vitamins|vitamins|mesh-ancestor
65537494|NCT01083329|Micronutrients|micronutrients|mesh-ancestor
65537495|NCT01083329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537496|NCT01083329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65537497|NCT01083329|Antimetabolites|antimetabolites|mesh-ancestor
65537498|NCT01083329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537499|NCT01083329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65537500|NCT01083329|Vasodilator Agents|vasodilator agents|mesh-ancestor
65537501|NCT01083407|Chlorhexidine|chlorhexidine|mesh-list
65537502|NCT01083407|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65537503|NCT01083407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65537504|NCT01083407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65537505|NCT01083407|Disinfectants|disinfectants|mesh-ancestor
65537506|NCT01083407|Dermatologic Agents|dermatologic agents|mesh-ancestor
65537507|NCT02181322|Meloxicam|meloxicam|mesh-list
65537508|NCT02181322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65537509|NCT02181322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65537510|NCT02181322|Analgesics|analgesics|mesh-ancestor
65537511|NCT02181322|Sensory System Agents|sensory system agents|mesh-ancestor
65537512|NCT02181322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65537513|NCT02181322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537514|NCT02181322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65537515|NCT02181322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65537516|NCT02181322|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65537517|NCT02181322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65537518|NCT02181322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537519|NCT02181322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537520|NCT02184286|Nevirapine|nevirapine|mesh-list
65537521|NCT02184286|Saquinavir|saquinavir|mesh-list
65537522|NCT02184286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65537523|NCT02184286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65537524|NCT02184286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537525|NCT02184286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537526|NCT02184286|Antiviral Agents|antiviral agents|mesh-ancestor
65537527|NCT02184286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65537528|NCT02184286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65537529|NCT02184286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65537530|NCT02184286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65537531|NCT02184286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65537532|NCT02184286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65537533|NCT02184286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65537534|NCT02184286|Protease Inhibitors|protease inhibitors|mesh-ancestor
65537535|NCT02184286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65537536|NCT02184286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65537537|NCT02178124|Donepezil|donepezil|mesh-list
65537538|NCT02178124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65537539|NCT02178124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537540|NCT02178124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537541|NCT02178124|Cholinergic Agents|cholinergic agents|mesh-ancestor
65537542|NCT02178124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65537543|NCT02178124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537544|NCT02178124|Nootropic Agents|nootropic agents|mesh-ancestor
65537545|NCT02030314|Chlorthalidone|chlorthalidone|mesh-list
65537546|NCT02030314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65537547|NCT02030314|Diuretics|diuretics|mesh-ancestor
65537548|NCT02030314|Natriuretic Agents|natriuretic agents|mesh-ancestor
65537549|NCT02030314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537550|NCT02030314|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65537551|NCT02030314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65537552|NCT02030314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537553|NCT02184364|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65537554|NCT02184364|Estrogens|estrogens|mesh-ancestor
65537555|NCT02184364|Hormones|hormones|mesh-ancestor
65537556|NCT02184364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65537557|NCT02184364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537558|NCT02181478|Cyclosporine|cyclosporine|mesh-list
65537559|NCT02181478|Mycophenolic Acid|mycophenolic acid|mesh-list
65537560|NCT02181478|Cyclophosphamide|cyclophosphamide|mesh-list
65537561|NCT02181478|Fludarabine|fludarabine|mesh-list
65537562|NCT02181478|Fludarabine phosphate|fludarabine phosphate|mesh-list
65537563|NCT02181478|Cyclosporins|cyclosporins|mesh-list
65537564|NCT02181478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65537565|NCT02181478|Immunologic Factors|immunologic factors|mesh-ancestor
65537566|NCT02181478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537567|NCT02181478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65537568|NCT02181478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65537569|NCT02181478|Alkylating Agents|alkylating agents|mesh-ancestor
65537570|NCT02181478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537571|NCT02181478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65537572|NCT02181478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65537573|NCT02181478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65537575|NCT02181478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537576|NCT02181478|Antifungal Agents|antifungal agents|mesh-ancestor
65537577|NCT02181478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65537578|NCT02181478|Dermatologic Agents|dermatologic agents|mesh-ancestor
65537579|NCT02181478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65537580|NCT02181478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65537581|NCT02181478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65537582|NCT02181478|Antitubercular Agents|antitubercular agents|mesh-ancestor
65537583|NCT02181478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65537584|NCT02755090|Nitrous Oxide|nitrous oxide|mesh-list
65537585|NCT02755090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65537586|NCT02755090|Anesthetics, General|anesthetics, general|mesh-ancestor
65537587|NCT02755090|Anesthetics|anesthetics|mesh-ancestor
65537588|NCT02755090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65537589|NCT02755090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537590|NCT02755090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65537591|NCT02755090|Analgesics|analgesics|mesh-ancestor
65537592|NCT02755090|Sensory System Agents|sensory system agents|mesh-ancestor
65537593|NCT02755090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65537594|NCT00109343|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65537595|NCT00109343|Immunologic Factors|immunologic factors|mesh-ancestor
65537596|NCT00109343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537597|NCT02185690|Carboplatin|carboplatin|mesh-list
65537598|NCT02185690|Pemetrexed|pemetrexed|mesh-list
65537599|NCT02185690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65537600|NCT02185690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537601|NCT02185690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537602|NCT02185690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65537603|NCT02185690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65537604|NCT03536806|Canrenone|canrenone|mesh-list
65537605|NCT03536806|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65537606|NCT03536806|Hormone Antagonists|hormone antagonists|mesh-ancestor
65537607|NCT03536806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65537608|NCT03536806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537609|NCT03536806|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65537610|NCT03536806|Diuretics|diuretics|mesh-ancestor
65537611|NCT03536806|Natriuretic Agents|natriuretic agents|mesh-ancestor
65537612|NCT00108485|Niacin|niacin|mesh-list
65537613|NCT00108485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65537614|NCT00108485|Antimetabolites|antimetabolites|mesh-ancestor
65537615|NCT00108485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537616|NCT00108485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65537617|NCT00108485|Vasodilator Agents|vasodilator agents|mesh-ancestor
65537618|NCT00108485|Vitamin B Complex|vitamin b complex|mesh-ancestor
65537619|NCT00108485|Vitamins|vitamins|mesh-ancestor
65537620|NCT00108485|Micronutrients|micronutrients|mesh-ancestor
65537621|NCT00108485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537622|NCT01068587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65537623|NCT01068587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65537624|NCT01068587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65537625|NCT01068587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537626|NCT01068587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537627|NCT02181946|Fluconazole|fluconazole|mesh-list
65537628|NCT02181946|Nevirapine|nevirapine|mesh-list
65537629|NCT02181946|Antifungal Agents|antifungal agents|mesh-ancestor
65537630|NCT02181946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65537631|NCT02181946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65537632|NCT02181946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65537633|NCT02181946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537634|NCT02181946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537635|NCT02181946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65537636|NCT02181946|Hormone Antagonists|hormone antagonists|mesh-ancestor
65537637|NCT02181946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65537638|NCT02181946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537639|NCT02181946|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65537640|NCT02181946|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65537641|NCT02181946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65537642|NCT02181946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65537643|NCT02181946|Antiviral Agents|antiviral agents|mesh-ancestor
65537644|NCT02181946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65537645|NCT02181946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65537646|NCT02181946|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65537647|NCT02181946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65537648|NCT00107783|Nitisinone|nitisinone|mesh-list
65537649|NCT00107783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537650|NCT00107783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537651|NCT02185768|Idarubicin|idarubicin|mesh-list
65537652|NCT02185768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65537653|NCT02185768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65537654|NCT02185768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65266711|NCT04691726|Dipyrone|dipyrone|mesh-list
65537655|NCT02185768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65537656|NCT02185768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537657|NCT02185768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537658|NCT02182024|Dabigatran|dabigatran|mesh-list
65537659|NCT02182024|Antithrombins|antithrombins|mesh-ancestor
65537660|NCT02182024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65537661|NCT02182024|Protease Inhibitors|protease inhibitors|mesh-ancestor
65537662|NCT02182024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537663|NCT02182024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537664|NCT02182024|Anticoagulants|anticoagulants|mesh-ancestor
65537665|NCT02185846|Dirithromycin|dirithromycin|mesh-list
65537666|NCT02185846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65537667|NCT02185846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65537668|NCT02184832|Metformin|metformin|mesh-list
65537669|NCT02184832|Tryptophan|tryptophan|mesh-list
65537670|NCT02184832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65537671|NCT02184832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537672|NCT02184832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65537673|NCT02184832|Antidepressive Agents|antidepressive agents|mesh-ancestor
65537674|NCT02184832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65537675|NCT01083797|Dexmedetomidine|dexmedetomidine|mesh-list
65537676|NCT01083797|Chloral Hydrate|chloral hydrate|mesh-list
65537677|NCT01083797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65537678|NCT01083797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65537679|NCT01083797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537680|NCT01083797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65537681|NCT01083797|Analgesics|analgesics|mesh-ancestor
65537682|NCT01083797|Sensory System Agents|sensory system agents|mesh-ancestor
65537683|NCT01083797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65537684|NCT01083797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65537685|NCT01083797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65537686|NCT01083797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65537687|NCT01083797|Adrenergic Agents|adrenergic agents|mesh-ancestor
65537688|NCT01083797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65537689|NCT01083797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537690|NCT01083875|Amlexanox|amlexanox|mesh-list
65537691|NCT01083875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65537692|NCT01068977|Bevacizumab|bevacizumab|mesh-list
65537693|NCT01068977|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65537694|NCT01068977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65537695|NCT01068977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65537696|NCT01068977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65537697|NCT01068977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65537698|NCT01068977|Growth Substances|growth substances|mesh-ancestor
65537699|NCT01068977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537700|NCT01068977|Growth Inhibitors|growth inhibitors|mesh-ancestor
65537701|NCT01068977|Immunologic Factors|immunologic factors|mesh-ancestor
65537702|NCT02184910|Gastrins|gastrins|mesh-list
65537703|NCT02184910|Hormones|hormones|mesh-ancestor
65537704|NCT02184910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65537705|NCT02184910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537706|NCT02185924|Parecoxib|parecoxib|mesh-list
65537707|NCT02185924|Ropivacaine|ropivacaine|mesh-list
65537708|NCT02185924|Anesthetics, Local|anesthetics, local|mesh-ancestor
65537709|NCT02185924|Anesthetics|anesthetics|mesh-ancestor
65537710|NCT02185924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65537711|NCT02185924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537712|NCT02185924|Sensory System Agents|sensory system agents|mesh-ancestor
65537713|NCT02185924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65537714|NCT02185924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65537715|NCT02185924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65537716|NCT02185924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537717|NCT02185924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537718|NCT02185924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65537719|NCT02185924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65537720|NCT02185924|Analgesics|analgesics|mesh-ancestor
65537721|NCT02185924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65537722|NCT02185924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65537723|NCT02185066|Metformin|metformin|mesh-list
65537724|NCT02185066|Atorvastatin|atorvastatin|mesh-list
65537725|NCT02185066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65537726|NCT02185066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537727|NCT02185066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65537728|NCT02185066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65537729|NCT02185066|Antimetabolites|antimetabolites|mesh-ancestor
65537730|NCT02185066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537731|NCT02185066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65537732|NCT02185066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65537733|NCT02185066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537734|NCT01081223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
65537735|NCT01081223|Immunologic Factors|immunologic factors|mesh-ancestor
65537736|NCT01081223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537737|NCT01069055|Acetaminophen|acetaminophen|mesh-list
65537738|NCT01069055|Lornoxicam|lornoxicam|mesh-list
65537739|NCT01069055|Piroxicam|piroxicam|mesh-list
65537740|NCT01069055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65537741|NCT01069055|Analgesics|analgesics|mesh-ancestor
65537742|NCT01069055|Sensory System Agents|sensory system agents|mesh-ancestor
65537743|NCT01069055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65537744|NCT01069055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537745|NCT01069055|Antipyretics|antipyretics|mesh-ancestor
65537746|NCT01069055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65537747|NCT01069055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65537748|NCT01069055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65537749|NCT01069055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65537750|NCT01069055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537751|NCT01069055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537752|NCT01083953|Sevoflurane|sevoflurane|mesh-list
65537753|NCT01083953|Desflurane|desflurane|mesh-list
65537754|NCT01083953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65537755|NCT01083953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65537756|NCT01083953|Anesthetics, General|anesthetics, general|mesh-ancestor
65537757|NCT01083953|Anesthetics|anesthetics|mesh-ancestor
65537758|NCT01083953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65537759|NCT01083953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537760|NCT02190526|Mesalamine|mesalamine|mesh-list
65537761|NCT02190526|Amitriptyline|amitriptyline|mesh-list
65537762|NCT02190526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65537763|NCT02190526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65537764|NCT02190526|Analgesics|analgesics|mesh-ancestor
65537765|NCT02190526|Sensory System Agents|sensory system agents|mesh-ancestor
65537766|NCT02190526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65537767|NCT02190526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537768|NCT02190526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65537769|NCT02190526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65537770|NCT02190526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65537771|NCT02190526|Antidepressive Agents|antidepressive agents|mesh-ancestor
65537772|NCT02190526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65537773|NCT02190526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65537774|NCT02190526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65537775|NCT02190526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65537776|NCT02190526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537777|NCT02190526|Adrenergic Agents|adrenergic agents|mesh-ancestor
65537778|NCT02190526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65537779|NCT01084031|Propofol|propofol|mesh-list
65537780|NCT01084031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65537781|NCT01084031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65537782|NCT01084031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537783|NCT01084031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65537784|NCT01084031|Anesthetics, General|anesthetics, general|mesh-ancestor
65537785|NCT01084031|Anesthetics|anesthetics|mesh-ancestor
65537786|NCT02185222|Cholecalciferol|cholecalciferol|mesh-list
65537787|NCT02185222|Vitamin D|vitamin d|mesh-list
65537788|NCT02185222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65537789|NCT02185222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537791|NCT02185222|Micronutrients|micronutrients|mesh-ancestor
65537792|NCT02185222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65537793|NCT01084187|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65537794|NCT01084187|Vasodilator Agents|vasodilator agents|mesh-ancestor
65537795|NCT01084187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65537796|NCT01084187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65537797|NCT01084187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537798|NCT01084187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537799|NCT01084187|Urological Agents|urological agents|mesh-ancestor
65537800|NCT02185300|Dolutegravir|dolutegravir|mesh-list
65537801|NCT02185300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65537802|NCT02185300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65537803|NCT02185300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266861|NCT02670135|Antimetabolites|antimetabolites|mesh-ancestor
65537804|NCT02185300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537805|NCT02185300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65537806|NCT02185300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65537807|NCT02185300|Antiviral Agents|antiviral agents|mesh-ancestor
65537808|NCT02185300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65537809|NCT02190760|Dexamethasone|dexamethasone|mesh-list
65537810|NCT02190760|Bupivacaine|bupivacaine|mesh-list
65537811|NCT02190760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65537812|NCT02190760|Antiemetics|antiemetics|mesh-ancestor
65537813|NCT02190760|Autonomic Agents|autonomic agents|mesh-ancestor
65537814|NCT02190760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65537815|NCT02190760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537816|NCT02190760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65537817|NCT02190760|Glucocorticoids|glucocorticoids|mesh-ancestor
65537818|NCT02190760|Hormones|hormones|mesh-ancestor
65537819|NCT02190760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65537820|NCT02190760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65537821|NCT02190760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65537822|NCT02190760|Anesthetics, Local|anesthetics, local|mesh-ancestor
65537823|NCT02190760|Anesthetics|anesthetics|mesh-ancestor
65537824|NCT02190760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65537825|NCT02190760|Sensory System Agents|sensory system agents|mesh-ancestor
65537826|NCT02190838|Metformin|metformin|mesh-list
65537827|NCT02190838|Dacarbazine|dacarbazine|mesh-list
65537828|NCT02190838|Melatonin|melatonin|mesh-list
65537829|NCT02190838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65537830|NCT02190838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537831|NCT02190838|Antioxidants|antioxidants|mesh-ancestor
65537832|NCT02190838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537833|NCT02190838|Protective Agents|protective agents|mesh-ancestor
65537834|NCT02190838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65537835|NCT02190838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65537836|NCT02190838|Alkylating Agents|alkylating agents|mesh-ancestor
65537837|NCT02190838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65537838|NCT02185456|Metronidazole|metronidazole|mesh-list
65537839|NCT02185456|Miconazole|miconazole|mesh-list
65537840|NCT02185456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65537841|NCT02185456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65537842|NCT02185456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65537843|NCT02185456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65537844|NCT02185456|Antifungal Agents|antifungal agents|mesh-ancestor
65537845|NCT02185456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65537846|NCT02185456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65537847|NCT02185456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537848|NCT02185456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537849|NCT02185456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65537850|NCT02185456|Hormone Antagonists|hormone antagonists|mesh-ancestor
65537851|NCT02185456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65537852|NCT02185456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537853|NCT02185456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65537854|NCT02185456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65537855|NCT02190994|Prednisone|prednisone|mesh-list
65537856|NCT02190994|Hydrocortisone|hydrocortisone|mesh-list
65537857|NCT02190994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65537858|NCT02190994|Glucocorticoids|glucocorticoids|mesh-ancestor
65537859|NCT02190994|Hormones|hormones|mesh-ancestor
65537860|NCT02190994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65537861|NCT02190994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537862|NCT02190994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65537863|NCT02190994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65537864|NCT02193568|Anesthetics|anesthetics|mesh-list
65537865|NCT02193568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65537866|NCT02193568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537868|NCT02191072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65537869|NCT02191072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65537870|NCT02191072|Respiratory System Agents|respiratory system agents|mesh-ancestor
65537871|NCT02191228|Linagliptin|linagliptin|mesh-list
65537872|NCT02191228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65537873|NCT02191228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537874|NCT02191228|Incretins|incretins|mesh-ancestor
65537875|NCT02191228|Hormones|hormones|mesh-ancestor
65537876|NCT02191228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65537877|NCT02191228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65537878|NCT02191228|Protease Inhibitors|protease inhibitors|mesh-ancestor
65537879|NCT02191228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537880|NCT02191228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537881|NCT02186782|Citric Acid|citric acid|mesh-list
65537882|NCT02186782|Sodium Citrate|sodium citrate|mesh-list
65537883|NCT02186782|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65537884|NCT02186782|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65537885|NCT02186782|Clomiphene|clomiphene|mesh-list
65537886|NCT02186782|Enclomiphene|enclomiphene|mesh-list
65537887|NCT02186782|Zuclomiphene|zuclomiphene|mesh-list
65537888|NCT02186782|Estradiol|estradiol|mesh-list
65537889|NCT02186782|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65537890|NCT02186782|Anticoagulants|anticoagulants|mesh-ancestor
65537891|NCT02186782|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65537892|NCT02186782|Chelating Agents|chelating agents|mesh-ancestor
65537893|NCT02186782|Sequestering Agents|sequestering agents|mesh-ancestor
65537894|NCT02186782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537895|NCT02186782|Estrogens|estrogens|mesh-ancestor
65537896|NCT02186782|Hormones|hormones|mesh-ancestor
65537897|NCT02186782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65537898|NCT02186782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537899|NCT02186782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65537900|NCT02186782|Contraceptive Agents|contraceptive agents|mesh-ancestor
65537901|NCT02186782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65537902|NCT02186782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65537903|NCT02186782|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65537904|NCT02186782|Hormone Antagonists|hormone antagonists|mesh-ancestor
65537905|NCT02186782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65537906|NCT02186782|Fertility Agents|fertility agents|mesh-ancestor
65537907|NCT02186782|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65537908|NCT02186782|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65537909|NCT02187250|Metformin|metformin|mesh-list
65537910|NCT02187250|Liraglutide|liraglutide|mesh-list
65537911|NCT02187250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65537912|NCT02187250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537913|NCT02187250|Incretins|incretins|mesh-ancestor
65537914|NCT02187250|Hormones|hormones|mesh-ancestor
65537915|NCT02187250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65537916|NCT03535480|Lenograstim|lenograstim|mesh-list
65537917|NCT03535480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65537918|NCT03535480|Immunologic Factors|immunologic factors|mesh-ancestor
65537919|NCT03535480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537920|NCT02187484|Telmisartan|telmisartan|mesh-list
65537921|NCT02187484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65537922|NCT02187484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65537923|NCT02187484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65537924|NCT02187484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537925|NCT02256748|Midazolam|midazolam|mesh-list
65537926|NCT02256748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65537927|NCT02256748|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65537928|NCT02256748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65537929|NCT02256748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537930|NCT02256748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65537931|NCT02256748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65537932|NCT02256748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65537933|NCT02256748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65537934|NCT02256748|Anesthetics, General|anesthetics, general|mesh-ancestor
65537935|NCT02256748|Anesthetics|anesthetics|mesh-ancestor
65537936|NCT02256748|GABA Modulators|gaba modulators|mesh-ancestor
65537937|NCT02256748|GABA Agents|gaba agents|mesh-ancestor
65537938|NCT02256748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65537939|NCT02256748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537940|NCT02187562|Aspirin|aspirin|mesh-list
65537941|NCT02187562|Meloxicam|meloxicam|mesh-list
65537942|NCT02187562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65537943|NCT02187562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65537944|NCT02187562|Analgesics|analgesics|mesh-ancestor
65537945|NCT02187562|Sensory System Agents|sensory system agents|mesh-ancestor
65537946|NCT02187562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65537947|NCT02187562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537948|NCT02187562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65537949|NCT02187562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65537950|NCT02187562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65537951|NCT02187562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65537952|NCT02187562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267016|NCT04679012|Hormones|hormones|mesh-ancestor
65537953|NCT02187562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65537954|NCT02187562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65537955|NCT02187562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537956|NCT02187562|Antipyretics|antipyretics|mesh-ancestor
65537957|NCT02187562|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65537958|NCT02187718|Anesthetics|anesthetics|mesh-list
65537959|NCT02187718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65537960|NCT02187718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537961|NCT03535168|Midazolam|midazolam|mesh-list
65537962|NCT03535168|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65537963|NCT03535168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65537964|NCT03535168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65537965|NCT03535168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537966|NCT03535168|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65537967|NCT03535168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65537968|NCT03535168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65537969|NCT03535168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65537970|NCT03535168|Anesthetics, General|anesthetics, general|mesh-ancestor
65537971|NCT03535168|Anesthetics|anesthetics|mesh-ancestor
65537972|NCT03535168|GABA Modulators|gaba modulators|mesh-ancestor
65537973|NCT03535168|GABA Agents|gaba agents|mesh-ancestor
65537974|NCT03535168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65537975|NCT03535168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537976|NCT02192320|Dexamethasone|dexamethasone|mesh-list
65537977|NCT02192320|Atorvastatin|atorvastatin|mesh-list
65537978|NCT02192320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65537979|NCT02192320|Antiemetics|antiemetics|mesh-ancestor
65537980|NCT02192320|Autonomic Agents|autonomic agents|mesh-ancestor
65537981|NCT02192320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65537982|NCT02192320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65537983|NCT02192320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65537984|NCT02192320|Glucocorticoids|glucocorticoids|mesh-ancestor
65537985|NCT02192320|Hormones|hormones|mesh-ancestor
65537986|NCT02192320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65537987|NCT02192320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65537988|NCT02192320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65537989|NCT02192320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65537990|NCT02192320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65537991|NCT02192320|Antimetabolites|antimetabolites|mesh-ancestor
65537992|NCT02192320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65537993|NCT02192320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65537994|NCT02192320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65537995|NCT02192320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65537996|NCT02187874|Oxytocin|oxytocin|mesh-list
65537997|NCT02187874|Oxytocics|oxytocics|mesh-ancestor
65537998|NCT02187874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65537999|NCT02187874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538000|NCT04870138|Azithromycin|azithromycin|mesh-list
65538001|NCT04870138|Ciprofloxacin|ciprofloxacin|mesh-list
65538002|NCT04870138|Ceftriaxone|ceftriaxone|mesh-list
65538003|NCT04870138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65538004|NCT04870138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65538005|NCT04870138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65538006|NCT04870138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65538007|NCT04870138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538008|NCT04870138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538009|NCT04870138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65538010|NCT04870138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65335528|NCT02430194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65538011|NCT04870138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65538012|NCT02188186|Metformin|metformin|mesh-list
65538013|NCT02188186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65538014|NCT02188186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65538015|NCT02188186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538016|NCT02188186|Incretins|incretins|mesh-ancestor
65538017|NCT02188186|Hormones|hormones|mesh-ancestor
65538018|NCT02188186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65538019|NCT02188186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65538020|NCT02188186|Protease Inhibitors|protease inhibitors|mesh-ancestor
65538021|NCT02188186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538022|NCT02188186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538023|NCT02192632|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
65538024|NCT02192632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65267087|NCT02696642|Tubulin Modulators|tubulin modulators|mesh-ancestor
65538025|NCT02192632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65538026|NCT02192632|Analgesics|analgesics|mesh-ancestor
65538027|NCT02192632|Sensory System Agents|sensory system agents|mesh-ancestor
65538028|NCT02192632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538029|NCT02192632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538030|NCT02192632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65538031|NCT02192632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65538032|NCT02192632|Dermatologic Agents|dermatologic agents|mesh-ancestor
65538033|NCT03535090|Methylprednisolone|methylprednisolone|mesh-list
65538034|NCT03535090|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65538035|NCT03535090|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65538036|NCT03535090|Prednisolone|prednisolone|mesh-list
65538037|NCT03535090|Prednisolone acetate|prednisolone acetate|mesh-list
65538038|NCT03535090|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65538039|NCT03535090|Prednisolone phosphate|prednisolone phosphate|mesh-list
65538040|NCT03535090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65538041|NCT03535090|Antiemetics|antiemetics|mesh-ancestor
65538042|NCT03535090|Autonomic Agents|autonomic agents|mesh-ancestor
65538043|NCT03535090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538044|NCT03535090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538045|NCT03535090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65538046|NCT03535090|Glucocorticoids|glucocorticoids|mesh-ancestor
65538047|NCT03535090|Hormones|hormones|mesh-ancestor
65538048|NCT03535090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65538049|NCT03535090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65538050|NCT03535090|Protective Agents|protective agents|mesh-ancestor
65538051|NCT03535090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65538052|NCT03535090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65538053|NCT03535870|Fluticasone|fluticasone|mesh-list
65538054|NCT03535870|Xhance|xhance|mesh-list
65538055|NCT03535870|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65538056|NCT03535870|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65538057|NCT03535870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65538058|NCT03535870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65538059|NCT03535870|Autonomic Agents|autonomic agents|mesh-ancestor
65538060|NCT03535870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538061|NCT03535870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538062|NCT03535870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65538063|NCT03535870|Respiratory System Agents|respiratory system agents|mesh-ancestor
65538064|NCT03535870|Dermatologic Agents|dermatologic agents|mesh-ancestor
65538065|NCT03535870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65538066|NCT03535870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65538067|NCT03535870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65538068|NCT03535870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65538069|NCT03535870|Adrenergic Agents|adrenergic agents|mesh-ancestor
65538070|NCT03535870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65538071|NCT03535870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538072|NCT03535870|Glucocorticoids|glucocorticoids|mesh-ancestor
65538073|NCT03535870|Hormones|hormones|mesh-ancestor
65538074|NCT03535870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65538075|NCT03535870|Sympathomimetics|sympathomimetics|mesh-ancestor
65538076|NCT02192710|Midazolam|midazolam|mesh-list
65538077|NCT02192710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65538078|NCT02192710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65538079|NCT02192710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65538080|NCT02192710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538081|NCT02192710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65538082|NCT02192710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65538083|NCT02192710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65538084|NCT02192710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65538085|NCT02192710|Anesthetics, General|anesthetics, general|mesh-ancestor
65538086|NCT02192710|Anesthetics|anesthetics|mesh-ancestor
65538087|NCT02192710|GABA Modulators|gaba modulators|mesh-ancestor
65538088|NCT02192710|GABA Agents|gaba agents|mesh-ancestor
65538089|NCT02192710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65538090|NCT02192710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538091|NCT02188654|Metformin|metformin|mesh-list
65538092|NCT02188654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65538093|NCT02188654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538094|NCT02192944|Chloroquine|chloroquine|mesh-list
65538095|NCT02192944|Piperaquine|piperaquine|mesh-list
65538096|NCT02192944|Artenimol|artenimol|mesh-list
65538097|NCT02192944|Amebicides|amebicides|mesh-ancestor
65538098|NCT02192944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65538099|NCT02192944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65538100|NCT02192944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65538101|NCT02192944|Antimalarials|antimalarials|mesh-ancestor
65538102|NCT02192944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65538103|NCT02193022|Miltefosine|miltefosine|mesh-list
65538104|NCT02193022|Antifungal Agents|antifungal agents|mesh-ancestor
65538105|NCT02193022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65538106|NCT02193022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65538107|NCT02193022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65538108|NCT02193022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65538109|NCT02188810|Vaccines|vaccines|mesh-list
65538110|NCT02188810|Immunologic Factors|immunologic factors|mesh-ancestor
65538111|NCT02188810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538112|NCT02188888|Esmolol|esmolol|mesh-list
65538113|NCT02188888|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65538114|NCT02188888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65538115|NCT02188888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65538116|NCT02188888|Adrenergic Agents|adrenergic agents|mesh-ancestor
65538117|NCT02188888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65538118|NCT02188888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538119|NCT02188888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538120|NCT02256826|Ritonavir|ritonavir|mesh-list
65538121|NCT02256826|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65538122|NCT02256826|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65538123|NCT02256826|Protease Inhibitors|protease inhibitors|mesh-ancestor
65538124|NCT02256826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538125|NCT02256826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538126|NCT02256826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65538127|NCT02256826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65538128|NCT02256826|Antiviral Agents|antiviral agents|mesh-ancestor
65538129|NCT02256826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65538130|NCT02256826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65538131|NCT02256826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65538132|NCT03535792|Fentanyl|fentanyl|mesh-list
65538133|NCT03535792|Nalbuphine|nalbuphine|mesh-list
65538134|NCT03535792|Bupivacaine|bupivacaine|mesh-list
65538135|NCT03535792|Anesthetics, Local|anesthetics, local|mesh-ancestor
65538136|NCT03535792|Anesthetics|anesthetics|mesh-ancestor
65538137|NCT03535792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65538138|NCT03535792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538139|NCT03535792|Sensory System Agents|sensory system agents|mesh-ancestor
65538140|NCT03535792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538141|NCT03535792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65538142|NCT03535792|Narcotics|narcotics|mesh-ancestor
65538143|NCT03535792|Analgesics|analgesics|mesh-ancestor
65538144|NCT03535792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65538145|NCT03535792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65538146|NCT03535792|Anesthetics, General|anesthetics, general|mesh-ancestor
65538147|NCT02193256|Prazosin|prazosin|mesh-list
65538148|NCT02193256|Varenicline|varenicline|mesh-list
65538149|NCT02193256|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65538150|NCT02193256|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65538151|NCT02193256|Cholinergic Agents|cholinergic agents|mesh-ancestor
65538152|NCT02193256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65538153|NCT02193256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538154|NCT02193256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538155|NCT02193256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65538156|NCT02193256|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65538157|NCT02193256|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65538158|NCT02193256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65538159|NCT02193256|Adrenergic Agents|adrenergic agents|mesh-ancestor
65538160|NCT03535558|Azithromycin|azithromycin|mesh-list
65538161|NCT03535558|Fluoroquinolones|fluoroquinolones|mesh-list
65538162|NCT03535558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65538163|NCT03535558|Trimethoprim|trimethoprim|mesh-list
65538164|NCT03535558|Sulfamethoxazole|sulfamethoxazole|mesh-list
65538165|NCT03535558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65538166|NCT03535558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65538167|NCT03535558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65538169|NCT03535558|Antimalarials|antimalarials|mesh-ancestor
65538170|NCT03535558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65538171|NCT03535558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65538172|NCT03535558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65538173|NCT03535558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538174|NCT03535558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538175|NCT03535558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65538176|NCT03535558|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65267241|NCT00647751|Lamotrigine|lamotrigine|mesh-list
65538177|NCT03535558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65538178|NCT03535558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65538179|NCT02193334|Mitogens|mitogens|mesh-list
65538180|NCT02193334|Mitosis Modulators|mitosis modulators|mesh-ancestor
65538181|NCT02193334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538182|NCT04247542|Vancomycin|vancomycin|mesh-list
65538183|NCT04247542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65538184|NCT04247542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65538185|NCT02194192|Ephedrine|ephedrine|mesh-list
65538186|NCT02194192|Ondansetron|ondansetron|mesh-list
65538187|NCT02194192|Antiemetics|antiemetics|mesh-ancestor
65538188|NCT02194192|Autonomic Agents|autonomic agents|mesh-ancestor
65538189|NCT02194192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538190|NCT02194192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538191|NCT02194192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65538192|NCT02194192|Antipruritics|antipruritics|mesh-ancestor
65538193|NCT02194192|Dermatologic Agents|dermatologic agents|mesh-ancestor
65538194|NCT02194192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65538195|NCT02194192|Serotonin Agents|serotonin agents|mesh-ancestor
65538196|NCT02194192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65538197|NCT02194192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538198|NCT02194192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65538199|NCT02194192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65538200|NCT02194192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65538201|NCT02194192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65538202|NCT02194192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65538203|NCT02194192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65538204|NCT02194192|Sympathomimetics|sympathomimetics|mesh-ancestor
65538205|NCT02194192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65538206|NCT02194192|Adrenergic Agents|adrenergic agents|mesh-ancestor
65538207|NCT02194270|Ambroxol|ambroxol|mesh-list
65538208|NCT02194270|Expectorants|expectorants|mesh-ancestor
65538209|NCT02194270|Respiratory System Agents|respiratory system agents|mesh-ancestor
65538210|NCT02190058|DS-1971a|ds-1971a|mesh-list
65538211|NCT02190058|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65538212|NCT02190058|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65538213|NCT02190058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65538214|NCT02190058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538215|NCT02195908|Antiemetics|antiemetics|mesh-list
65538216|NCT02195908|Autonomic Agents|autonomic agents|mesh-ancestor
65538217|NCT02195908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538218|NCT02195908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538219|NCT02195908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65538220|NCT02197000|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
65538221|NCT02197000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65538222|NCT02197000|Protective Agents|protective agents|mesh-ancestor
65538223|NCT02197000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538224|NCT02197000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65538225|NCT02196142|Hydrocortisone|hydrocortisone|mesh-list
65538226|NCT02196142|Mannitol|mannitol|mesh-list
65538227|NCT02196142|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65538228|NCT02196142|Diuretics|diuretics|mesh-ancestor
65538229|NCT02196142|Natriuretic Agents|natriuretic agents|mesh-ancestor
65538230|NCT02196142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538231|NCT02196142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65538232|NCT02257294|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65538233|NCT02257294|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65538234|NCT02257294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65538235|NCT02257294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538236|NCT03534388|Sodium Hypochlorite|sodium hypochlorite|mesh-list
65538237|NCT03534388|Eusol|eusol|mesh-list
65538238|NCT03534388|Disinfectants|disinfectants|mesh-ancestor
65538239|NCT03534388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65538240|NCT04308694|Methadone|methadone|mesh-list
65538241|NCT04308694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65538242|NCT04308694|Narcotics|narcotics|mesh-ancestor
65538243|NCT04308694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65538244|NCT04308694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538245|NCT04308694|Analgesics|analgesics|mesh-ancestor
65538246|NCT04308694|Sensory System Agents|sensory system agents|mesh-ancestor
65538247|NCT04308694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538248|NCT04308694|Antitussive Agents|antitussive agents|mesh-ancestor
65538249|NCT04308694|Respiratory System Agents|respiratory system agents|mesh-ancestor
65538250|NCT03534310|Liraglutide|liraglutide|mesh-list
65538251|NCT03534310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65538252|NCT03534310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538253|NCT03534310|Incretins|incretins|mesh-ancestor
65538254|NCT03534310|Hormones|hormones|mesh-ancestor
65538255|NCT03534310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65538256|NCT02194894|Acetaminophen|acetaminophen|mesh-list
65538257|NCT02194894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65538258|NCT02194894|Analgesics|analgesics|mesh-ancestor
65538259|NCT02194894|Sensory System Agents|sensory system agents|mesh-ancestor
65538260|NCT02194894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538261|NCT02194894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538262|NCT02194894|Antipyretics|antipyretics|mesh-ancestor
65538263|NCT02197702|Vitamin D|vitamin d|mesh-list
65538264|NCT02197702|Cholecalciferol|cholecalciferol|mesh-list
65538265|NCT02197702|Vitamins|vitamins|mesh-ancestor
65538266|NCT02197702|Micronutrients|micronutrients|mesh-ancestor
65538267|NCT02197702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538268|NCT02197702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65538269|NCT02197702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65538270|NCT02031016|Fentanyl|fentanyl|mesh-list
65538271|NCT02031016|Remifentanil|remifentanil|mesh-list
65538272|NCT02031016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65538273|NCT02031016|Narcotics|narcotics|mesh-ancestor
65538274|NCT02031016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65538275|NCT02031016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538276|NCT02031016|Analgesics|analgesics|mesh-ancestor
65538277|NCT02031016|Sensory System Agents|sensory system agents|mesh-ancestor
65538278|NCT02031016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538279|NCT02031016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65538280|NCT02031016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65538281|NCT02031016|Anesthetics, General|anesthetics, general|mesh-ancestor
65538282|NCT02031016|Anesthetics|anesthetics|mesh-ancestor
65538283|NCT00095147|Methotrexate|methotrexate|mesh-list
65538284|NCT00095147|Abatacept|abatacept|mesh-list
65538285|NCT00095147|Infliximab|infliximab|mesh-list
65538286|NCT00095147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65538287|NCT00095147|Abortifacient Agents|abortifacient agents|mesh-ancestor
65538288|NCT00095147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65538289|NCT00095147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538290|NCT00095147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65538291|NCT00095147|Antimetabolites|antimetabolites|mesh-ancestor
65538292|NCT00095147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538293|NCT00095147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65538294|NCT00095147|Dermatologic Agents|dermatologic agents|mesh-ancestor
65538295|NCT00095147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538296|NCT00095147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65538297|NCT00095147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65538298|NCT00095147|Immunologic Factors|immunologic factors|mesh-ancestor
65538299|NCT00095147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65538300|NCT00095147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65538301|NCT00095147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65538302|NCT00095147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65538303|NCT02198170|Ketoconazole|ketoconazole|mesh-list
65538304|NCT02198170|Lenvatinib|lenvatinib|mesh-list
65538305|NCT02198170|Antifungal Agents|antifungal agents|mesh-ancestor
65538306|NCT02198170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65538307|NCT02198170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65538308|NCT02198170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65538309|NCT02198170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538310|NCT02198170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538311|NCT02198170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65538312|NCT02198170|Hormone Antagonists|hormone antagonists|mesh-ancestor
65538313|NCT02198170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65538314|NCT02198170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335833|NCT00791349|Serotonin Agents|serotonin agents|mesh-ancestor
65538315|NCT02198170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65538316|NCT02198170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65538317|NCT02198170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65538318|NCT02198248|Prednisolone|prednisolone|mesh-list
65538319|NCT02198248|Rituximab|rituximab|mesh-list
65538320|NCT02198248|Glucocorticoids|glucocorticoids|mesh-list
65538321|NCT02198248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65538322|NCT02198248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65538323|NCT02198248|Immunologic Factors|immunologic factors|mesh-ancestor
65538324|NCT02198248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538325|NCT02198248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65538326|NCT02198248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65267382|NCT00648297|Nadolol|nadolol|mesh-list
65538327|NCT02198248|Hormones|hormones|mesh-ancestor
65538328|NCT02198248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65538329|NCT02198248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65538330|NCT01069133|Rifaximin|rifaximin|mesh-list
65538331|NCT01069133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65538332|NCT01069133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65538333|NCT01069133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65538334|NCT02198404|Propofol|propofol|mesh-list
65538335|NCT02198404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65538336|NCT02198404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65538337|NCT02198404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538338|NCT02198404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65538339|NCT02198404|Anesthetics, General|anesthetics, general|mesh-ancestor
65538340|NCT02198404|Anesthetics|anesthetics|mesh-ancestor
65538341|NCT02198482|Cytarabine|cytarabine|mesh-list
65538342|NCT02198482|Daunorubicin|daunorubicin|mesh-list
65538343|NCT02198482|Mitoxantrone|mitoxantrone|mesh-list
65538344|NCT02198482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65538345|NCT02198482|Antimetabolites|antimetabolites|mesh-ancestor
65538346|NCT02198482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538347|NCT02198482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65538348|NCT02198482|Antiviral Agents|antiviral agents|mesh-ancestor
65538349|NCT02198482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65538350|NCT02198482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65538351|NCT02198482|Immunologic Factors|immunologic factors|mesh-ancestor
65538352|NCT02198482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538353|NCT02198482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65538354|NCT02198482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65538355|NCT02198482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65538356|NCT02198482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538357|NCT02198482|Analgesics|analgesics|mesh-ancestor
65538358|NCT02198482|Sensory System Agents|sensory system agents|mesh-ancestor
65538359|NCT02198482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538360|NCT03961841|Oxaliplatin|oxaliplatin|mesh-list
65538361|NCT03961841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65538362|NCT02201134|Sevoflurane|sevoflurane|mesh-list
65538363|NCT02201134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65538364|NCT02201134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65538365|NCT02201134|Anesthetics, General|anesthetics, general|mesh-ancestor
65538366|NCT02201134|Anesthetics|anesthetics|mesh-ancestor
65538367|NCT02201134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65538368|NCT02201134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538369|NCT02201602|Gliclazide|gliclazide|mesh-list
65538370|NCT02201602|Glyburide|glyburide|mesh-list
65538371|NCT02201602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65538372|NCT02201602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538373|NCT02201914|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65538374|NCT02201914|Clomiphene|clomiphene|mesh-list
65538375|NCT02201914|Enclomiphene|enclomiphene|mesh-list
65538376|NCT02201914|Zuclomiphene|zuclomiphene|mesh-list
65538377|NCT02201914|Cetrorelix|cetrorelix|mesh-list
65538378|NCT02201914|Luteolytic Agents|luteolytic agents|mesh-ancestor
65538379|NCT02201914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65538380|NCT02201914|Contraceptive Agents|contraceptive agents|mesh-ancestor
65538381|NCT02201914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65538382|NCT02201914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538383|NCT02201914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65538384|NCT02201914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65538385|NCT02201914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65538386|NCT02201914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65538387|NCT02201914|Hormone Antagonists|hormone antagonists|mesh-ancestor
65538388|NCT02201914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65538389|NCT02201914|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65538390|NCT02201914|Fertility Agents|fertility agents|mesh-ancestor
65538391|NCT02201914|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65335909|NCT00426127|Docetaxel|docetaxel|mesh-list
65538392|NCT02201914|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65538393|NCT02202070|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65538394|NCT02202070|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65538395|NCT02202070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65538396|NCT02202070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538397|NCT02202070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538398|NCT02202070|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65538399|NCT02202070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65267456|NCT05343702|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65267457|NCT05343702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65267458|NCT05343702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65267459|NCT05343702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267460|NCT02659761|Lamivudine|lamivudine|mesh-list
65267461|NCT02659761|Abacavir|abacavir|mesh-list
65267462|NCT02659761|Dolutegravir|dolutegravir|mesh-list
65267463|NCT02659761|Triumeq|triumeq|mesh-list
65267464|NCT02659761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65267465|NCT02659761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65267466|NCT02659761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267467|NCT02659761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267468|NCT02659761|Antiviral Agents|antiviral agents|mesh-ancestor
65267469|NCT02659761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65267470|NCT02659761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65267471|NCT02659761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65267472|NCT02659761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65267474|NCT05343546|Copper|copper|mesh-list
65538400|NCT02202070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538401|NCT02202070|Cholinergic Agents|cholinergic agents|mesh-ancestor
65538402|NCT02202070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65538403|NCT02202304|Chlorhexidine|chlorhexidine|mesh-list
65538404|NCT02202304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65538405|NCT02202304|Thymol|thymol|mesh-list
65538406|NCT02202304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65538407|NCT02202304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65538408|NCT02202304|Disinfectants|disinfectants|mesh-ancestor
65538409|NCT02202304|Dermatologic Agents|dermatologic agents|mesh-ancestor
65538410|NCT02202304|Antifungal Agents|antifungal agents|mesh-ancestor
65538411|NCT02207452|Albuterol|albuterol|mesh-list
65538412|NCT02207452|Ipratropium|ipratropium|mesh-list
65538413|NCT02207452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65538414|NCT02207452|Autonomic Agents|autonomic agents|mesh-ancestor
65538415|NCT02207452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538416|NCT02207452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538417|NCT02207452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65538418|NCT02207452|Respiratory System Agents|respiratory system agents|mesh-ancestor
65538419|NCT02207452|Tocolytic Agents|tocolytic agents|mesh-ancestor
65538420|NCT02207452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65538421|NCT02207452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65538422|NCT02207452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65538423|NCT02207452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65538424|NCT02207452|Adrenergic Agents|adrenergic agents|mesh-ancestor
65538425|NCT02207452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65538426|NCT02207452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538427|NCT02207452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65538428|NCT02207452|Cholinergic Agents|cholinergic agents|mesh-ancestor
65538429|NCT03533062|Botulinum Toxins|botulinum toxins|mesh-list
65538430|NCT03533062|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65538431|NCT03533062|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65538432|NCT03533062|Cholinergic Antagonists|cholinergic antagonists|mesh-list
65538433|NCT03533062|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65538434|NCT03533062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65538435|NCT03533062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538436|NCT03533062|Cholinergic Agents|cholinergic agents|mesh-ancestor
65538437|NCT03533062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65538438|NCT03533062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538439|NCT03533062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65538440|NCT03533062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538441|NCT02207920|Vaccines|vaccines|mesh-list
65538442|NCT02207920|Immunologic Factors|immunologic factors|mesh-ancestor
65538443|NCT02207920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538444|NCT02208154|Chlorhexidine|chlorhexidine|mesh-list
65538445|NCT02208154|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65538446|NCT02208154|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65538447|NCT02208154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65538448|NCT02208154|Disinfectants|disinfectants|mesh-ancestor
65538449|NCT02208154|Dermatologic Agents|dermatologic agents|mesh-ancestor
65538450|NCT03532906|Bupivacaine|bupivacaine|mesh-list
65538451|NCT03532906|Anesthetics, Local|anesthetics, local|mesh-ancestor
65538452|NCT03532906|Anesthetics|anesthetics|mesh-ancestor
65538453|NCT03532906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65538454|NCT03532906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538455|NCT03532906|Sensory System Agents|sensory system agents|mesh-ancestor
65538456|NCT03532906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538457|NCT02199418|Paclitaxel|paclitaxel|mesh-list
65538458|NCT02199418|Cisplatin|cisplatin|mesh-list
65538459|NCT02199418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65538460|NCT02199418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65538461|NCT02199418|Tubulin Modulators|tubulin modulators|mesh-ancestor
65538462|NCT02199418|Antimitotic Agents|antimitotic agents|mesh-ancestor
65538463|NCT02199418|Mitosis Modulators|mitosis modulators|mesh-ancestor
65538464|NCT02199418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538465|NCT02208778|Remifentanil|remifentanil|mesh-list
65538466|NCT02208778|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65538467|NCT02208778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65538468|NCT02208778|Narcotics|narcotics|mesh-ancestor
65538469|NCT02208778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65538470|NCT02208778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538471|NCT02208778|Analgesics|analgesics|mesh-ancestor
65538472|NCT02208778|Sensory System Agents|sensory system agents|mesh-ancestor
65538473|NCT02208778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538474|NCT02208778|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65538475|NCT02208778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65538476|NCT02208778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65538477|NCT02208778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538478|NCT02208778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65538479|NCT02208778|Antidepressive Agents|antidepressive agents|mesh-ancestor
65538480|NCT02208778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65538481|NCT02208778|Dopamine Agents|dopamine agents|mesh-ancestor
65538482|NCT02203396|Cyclosporine|cyclosporine|mesh-list
65538484|NCT02203396|Cyclosporins|cyclosporins|mesh-list
65538485|NCT02203396|Thymoglobulin|thymoglobulin|mesh-list
65538486|NCT02203396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538487|NCT02203396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538488|NCT02203396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65538489|NCT02203396|Immunologic Factors|immunologic factors|mesh-ancestor
65538490|NCT02203396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538491|NCT02203396|Antifungal Agents|antifungal agents|mesh-ancestor
65538492|NCT02203396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65538493|NCT02203396|Dermatologic Agents|dermatologic agents|mesh-ancestor
65538494|NCT02203396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65538495|NCT02203396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65538496|NCT02203396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65538497|NCT02203396|Antinematodal Agents|antinematodal agents|mesh-ancestor
65538498|NCT02203396|Anthelmintics|anthelmintics|mesh-ancestor
65538499|NCT02203396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65538500|NCT02203552|Minocycline|minocycline|mesh-list
65538501|NCT02203552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65538502|NCT02203552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65538503|NCT02209012|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65538504|NCT02209012|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65538505|NCT02209012|Dermatologic Agents|dermatologic agents|mesh-ancestor
65538506|NCT02200354|Bevacizumab|bevacizumab|mesh-list
65538507|NCT02200354|Pemetrexed|pemetrexed|mesh-list
65538508|NCT02200354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65538509|NCT02200354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65538510|NCT02200354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65538511|NCT02200354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65538512|NCT02200354|Growth Substances|growth substances|mesh-ancestor
65538513|NCT02200354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538514|NCT02200354|Growth Inhibitors|growth inhibitors|mesh-ancestor
65538515|NCT02200354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538516|NCT02200354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538517|NCT02200354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65538518|NCT02200354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65538519|NCT02204020|Azacitidine|azacitidine|mesh-list
65538520|NCT02204020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65538521|NCT02204020|Antimetabolites|antimetabolites|mesh-ancestor
65538522|NCT02204020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538523|NCT02204020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65538524|NCT02204020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538525|NCT02200822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65538526|NCT02200822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65538527|NCT02200822|Adrenergic Agents|adrenergic agents|mesh-ancestor
65538528|NCT02200822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65538529|NCT02200822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538530|NCT02200822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538531|NCT02220634|Regadenoson|regadenoson|mesh-list
65538532|NCT02220634|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65538533|NCT02220634|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65538534|NCT02220634|Purinergic Agonists|purinergic agonists|mesh-ancestor
65538535|NCT02220634|Purinergic Agents|purinergic agents|mesh-ancestor
65538536|NCT02220634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65538537|NCT02220634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538538|NCT02220634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538539|NCT02204644|Imatinib Mesylate|imatinib mesylate|mesh-list
65538540|NCT02204644|HH-GV-678|hh-gv-678|mesh-list
65336048|NCT04895280|Triamcinolone|triamcinolone|mesh-list
65538541|NCT02204644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65538542|NCT02204644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65538543|NCT02204644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538544|NCT02204644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538545|NCT02204722|Imatinib Mesylate|imatinib mesylate|mesh-list
65538546|NCT02204722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65538547|NCT02204722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65538548|NCT02204722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538549|NCT02204722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538550|NCT02204878|Parecoxib|parecoxib|mesh-list
65538551|NCT02204878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65538552|NCT02204878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65538553|NCT02204878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538554|NCT02204878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538555|NCT02204878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65538556|NCT02204878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65538557|NCT02204878|Analgesics|analgesics|mesh-ancestor
65538558|NCT02204878|Sensory System Agents|sensory system agents|mesh-ancestor
65538559|NCT02204878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538560|NCT02204878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538561|NCT02204878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65538562|NCT02204878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65538563|NCT02205034|Oxytocin|oxytocin|mesh-list
65538564|NCT02205034|Oxytocics|oxytocics|mesh-ancestor
65538565|NCT02205034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65538566|NCT02205034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538567|NCT02210728|Methylphenidate|methylphenidate|mesh-list
65538568|NCT02210728|Amphetamine|amphetamine|mesh-list
65538569|NCT02210728|Adderall|adderall|mesh-list
65538570|NCT02210728|Dextroamphetamine|dextroamphetamine|mesh-list
65538571|NCT02210728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65538572|NCT02210728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538573|NCT02210728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65538574|NCT02210728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65538575|NCT02210728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65538576|NCT02210728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538577|NCT02210728|Dopamine Agents|dopamine agents|mesh-ancestor
65538578|NCT02210728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65538579|NCT02210728|Sympathomimetics|sympathomimetics|mesh-ancestor
65538580|NCT02210728|Autonomic Agents|autonomic agents|mesh-ancestor
65538581|NCT02210728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538582|NCT02210728|Adrenergic Agents|adrenergic agents|mesh-ancestor
65538583|NCT02210728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65538584|NCT02220868|Ribavirin|ribavirin|mesh-list
65538585|NCT02220868|Sofosbuvir|sofosbuvir|mesh-list
65538586|NCT02220868|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65538587|NCT02220868|Antimetabolites|antimetabolites|mesh-ancestor
65538588|NCT02220868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538589|NCT02220868|Antiviral Agents|antiviral agents|mesh-ancestor
65538590|NCT02220868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65538591|NCT02220868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65538592|NCT02220868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65538593|NCT02221024|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65538594|NCT02221102|Aspirin|aspirin|mesh-list
65538595|NCT02221102|Edoxaban|edoxaban|mesh-list
65538596|NCT02221102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65538597|NCT02221102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65538598|NCT02221102|Analgesics|analgesics|mesh-ancestor
65538599|NCT02221102|Sensory System Agents|sensory system agents|mesh-ancestor
65538600|NCT02221102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538601|NCT02221102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538602|NCT02221102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65538603|NCT02221102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65538604|NCT02221102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65538605|NCT02221102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65538606|NCT02221102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538607|NCT02221102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65538608|NCT02221102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65538609|NCT02221102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538610|NCT02221102|Antipyretics|antipyretics|mesh-ancestor
65538611|NCT02221102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65538612|NCT02221102|Antithrombins|antithrombins|mesh-ancestor
65538613|NCT02221102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65538614|NCT02221102|Protease Inhibitors|protease inhibitors|mesh-ancestor
65538615|NCT02221102|Anticoagulants|anticoagulants|mesh-ancestor
65538616|NCT02213302|Midazolam|midazolam|mesh-list
65538617|NCT02213302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65538618|NCT02213302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65538619|NCT02213302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65538620|NCT02213302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538621|NCT02213302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65538622|NCT02213302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65538623|NCT02213302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65538624|NCT02213302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65538625|NCT02213302|Anesthetics, General|anesthetics, general|mesh-ancestor
65538626|NCT02213302|Anesthetics|anesthetics|mesh-ancestor
65538627|NCT02213302|GABA Modulators|gaba modulators|mesh-ancestor
65538628|NCT02213302|GABA Agents|gaba agents|mesh-ancestor
65538629|NCT02213302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65538630|NCT02213302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538631|NCT02221180|Metformin|metformin|mesh-list
65538632|NCT02221180|Canagliflozin|canagliflozin|mesh-list
65538633|NCT02221180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65538634|NCT02221180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538635|NCT02221180|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65538636|NCT02221180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538637|NCT02205112|Levofloxacin|levofloxacin|mesh-list
65538638|NCT02205112|Ofloxacin|ofloxacin|mesh-list
65538639|NCT02205112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65538640|NCT02205112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65538641|NCT02205112|Renal Agents|renal agents|mesh-ancestor
65538642|NCT02205112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65538643|NCT02205112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65538644|NCT02205112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65538645|NCT02205112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538646|NCT02205112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538647|NCT02205112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65538648|NCT02205112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65538649|NCT02205112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65538650|NCT02205190|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65538651|NCT02205190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65538652|NCT02205190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65538653|NCT02205190|Antimetabolites|antimetabolites|mesh-ancestor
65538654|NCT02205190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538655|NCT02205190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65538656|NCT02205190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65538657|NCT02205190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538658|NCT02257918|Ceftriaxone|ceftriaxone|mesh-list
65538659|NCT02257918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65538660|NCT02257918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65538661|NCT02221414|Metformin|metformin|mesh-list
65538662|NCT02221414|Linagliptin|linagliptin|mesh-list
65538663|NCT02221414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65538664|NCT02221414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538665|NCT02221414|Incretins|incretins|mesh-ancestor
65538666|NCT02221414|Hormones|hormones|mesh-ancestor
65538667|NCT02221414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65538668|NCT02221414|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65538669|NCT02221414|Protease Inhibitors|protease inhibitors|mesh-ancestor
65538670|NCT02221414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538671|NCT02221414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538672|NCT02221492|Plerixafor|plerixafor|mesh-list
65538673|NCT02221492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65538674|NCT02221492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65538675|NCT02221492|Antiviral Agents|antiviral agents|mesh-ancestor
65538676|NCT02221492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65538677|NCT05164978|Antibodies|antibodies|mesh-list
65538678|NCT05164978|Immunologic Factors|immunologic factors|mesh-ancestor
65538679|NCT05164978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538680|NCT02221570|Baclofen|baclofen|mesh-list
65538681|NCT02221570|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65538682|NCT02221570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538683|NCT02221570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65538684|NCT02221570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538685|NCT02221570|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65538686|NCT02221570|GABA Agonists|gaba agonists|mesh-ancestor
65538687|NCT02221570|GABA Agents|gaba agents|mesh-ancestor
65538688|NCT02221570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65538689|NCT02221570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538690|NCT05151484|Alendronate|alendronate|mesh-list
65538692|NCT05151484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65538693|NCT05151484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538694|NCT05151484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65538695|NCT02205502|Lidocaine|lidocaine|mesh-list
65538696|NCT02205502|Anesthetics, Local|anesthetics, local|mesh-ancestor
65538697|NCT02205502|Anesthetics|anesthetics|mesh-ancestor
65538698|NCT02205502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65538699|NCT02205502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538700|NCT02205502|Sensory System Agents|sensory system agents|mesh-ancestor
65538701|NCT02205502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538702|NCT02205502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65538703|NCT02205502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65538704|NCT02205502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65538705|NCT02205502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65538706|NCT02205502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538707|NCT02219698|Acetaminophen|acetaminophen|mesh-list
65538708|NCT02219698|Ibuprofen|ibuprofen|mesh-list
65538709|NCT02219698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65538710|NCT02219698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65538711|NCT02219698|Analgesics|analgesics|mesh-ancestor
65538712|NCT02219698|Sensory System Agents|sensory system agents|mesh-ancestor
65538713|NCT02219698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538714|NCT02219698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538715|NCT02219698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65538716|NCT02219698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65538717|NCT02219698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65538718|NCT02219698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538719|NCT02219698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538720|NCT02219698|Antipyretics|antipyretics|mesh-ancestor
65538721|NCT02205580|Sufentanil|sufentanil|mesh-list
65538722|NCT02205580|Dsuvia|dsuvia|mesh-list
65538723|NCT02205580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65538724|NCT02205580|Narcotics|narcotics|mesh-ancestor
65538725|NCT02205580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65538726|NCT02205580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538727|NCT02205580|Analgesics|analgesics|mesh-ancestor
65538728|NCT02205580|Sensory System Agents|sensory system agents|mesh-ancestor
65538729|NCT02205580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538730|NCT02205580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65538731|NCT02205580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65538732|NCT02205580|Anesthetics, General|anesthetics, general|mesh-ancestor
65538733|NCT02205580|Anesthetics|anesthetics|mesh-ancestor
65538734|NCT02221960|Durvalumab|durvalumab|mesh-list
65538735|NCT02221960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65538736|NCT02221960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65538737|NCT02220088|Leucovorin|leucovorin|mesh-list
65538738|NCT02220088|Fluorouracil|fluorouracil|mesh-list
65538739|NCT02220088|Oxaliplatin|oxaliplatin|mesh-list
65538740|NCT02220088|Sorafenib|sorafenib|mesh-list
65538741|NCT02220088|Antimetabolites|antimetabolites|mesh-ancestor
65538742|NCT02220088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538743|NCT02220088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65538744|NCT02220088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65538745|NCT02220088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65538746|NCT02220088|Immunologic Factors|immunologic factors|mesh-ancestor
65538747|NCT02220088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538748|NCT02220088|Antidotes|antidotes|mesh-ancestor
65538749|NCT02220088|Protective Agents|protective agents|mesh-ancestor
65538750|NCT02220088|Vitamin B Complex|vitamin b complex|mesh-ancestor
65538751|NCT02220088|Vitamins|vitamins|mesh-ancestor
65538752|NCT02220088|Micronutrients|micronutrients|mesh-ancestor
65538753|NCT02220088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65538754|NCT02220088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538755|NCT02220400|Ketamine|ketamine|mesh-list
65538756|NCT02220400|Analgesics|analgesics|mesh-ancestor
65538757|NCT02220400|Sensory System Agents|sensory system agents|mesh-ancestor
65538758|NCT02220400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538759|NCT02220400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538760|NCT02220400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65538761|NCT02220400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65538762|NCT02220400|Anesthetics, General|anesthetics, general|mesh-ancestor
65538763|NCT02220400|Anesthetics|anesthetics|mesh-ancestor
65538764|NCT02220400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65538765|NCT02220400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65336275|NCT04070690|Dialysis Solutions|dialysis solutions|mesh-list
65538766|NCT02220400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65538767|NCT02220400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65538768|NCT02220400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538769|NCT02205892|Lupeol|lupeol|mesh-list
65538770|NCT02205892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65538771|NCT02224768|Ipilimumab|ipilimumab|mesh-list
65538772|NCT02224768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65538773|NCT02224768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65538774|NCT02224768|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65538775|NCT02224768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538776|NCT05262166|Dexmedetomidine|dexmedetomidine|mesh-list
65538777|NCT05262166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65538778|NCT05262166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65538779|NCT05262166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538780|NCT05262166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65538781|NCT05262166|Analgesics|analgesics|mesh-ancestor
65538782|NCT05262166|Sensory System Agents|sensory system agents|mesh-ancestor
65538783|NCT05262166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538784|NCT05262166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65538785|NCT05262166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65538786|NCT05262166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65538787|NCT05262166|Adrenergic Agents|adrenergic agents|mesh-ancestor
65538788|NCT05262166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65538789|NCT05262166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538790|NCT02206204|Moxifloxacin|moxifloxacin|mesh-list
65538791|NCT02206204|Selexipag|selexipag|mesh-list
65538792|NCT02206204|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65538793|NCT02206204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65538794|NCT02206204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65538795|NCT02206204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65538796|NCT02206204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65538797|NCT02206204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538798|NCT02206204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538799|NCT02206204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65538800|NCT02206204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65538801|NCT02206204|Contraceptive Agents|contraceptive agents|mesh-ancestor
65538802|NCT02206204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65538803|NCT02206204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538804|NCT02206204|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65538805|NCT02206204|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65538806|NCT02206204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65538807|NCT02206204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65538808|NCT02230930|Hydrocortisone|hydrocortisone|mesh-list
65538809|NCT02230930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65538810|NCT02230930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65538811|NCT02230930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65538812|NCT02230930|Apomorphine|apomorphine|mesh-list
65538813|NCT02230930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65538814|NCT02230930|Emetics|emetics|mesh-ancestor
65538815|NCT02230930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538816|NCT02230930|Autonomic Agents|autonomic agents|mesh-ancestor
65538817|NCT02230930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538818|NCT02230930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65538819|NCT02230930|Dopamine Agonists|dopamine agonists|mesh-ancestor
65538820|NCT02230930|Dopamine Agents|dopamine agents|mesh-ancestor
65538821|NCT02230930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65538822|NCT02230930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538823|NCT02222350|Firuglipel|firuglipel|mesh-list
65538824|NCT02222350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65538825|NCT02222350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538826|NCT02222428|Olodaterol|olodaterol|mesh-list
65538827|NCT02222428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65538828|NCT02222428|Autonomic Agents|autonomic agents|mesh-ancestor
65538829|NCT02222428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538830|NCT02222428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538831|NCT02222428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65538832|NCT02222428|Respiratory System Agents|respiratory system agents|mesh-ancestor
65538833|NCT02231320|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
65538834|NCT02231320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65538835|NCT02231320|Autonomic Agents|autonomic agents|mesh-ancestor
65538836|NCT02231320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538837|NCT02231320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538838|NCT02231320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65538839|NCT02231320|Respiratory System Agents|respiratory system agents|mesh-ancestor
65538841|NCT02225470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65538842|NCT02225470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65538843|NCT02225470|Tubulin Modulators|tubulin modulators|mesh-ancestor
65538844|NCT02225470|Antimitotic Agents|antimitotic agents|mesh-ancestor
65538845|NCT02225470|Mitosis Modulators|mitosis modulators|mesh-ancestor
65538846|NCT02225470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538847|NCT02225548|Tadalafil|tadalafil|mesh-list
65538848|NCT02225548|Selegiline|selegiline|mesh-list
65538849|NCT02225548|Vasodilator Agents|vasodilator agents|mesh-ancestor
65538850|NCT02225548|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65538851|NCT02225548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65538852|NCT02225548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538853|NCT02225548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538854|NCT02225548|Urological Agents|urological agents|mesh-ancestor
65538855|NCT02225548|Antidepressive Agents|antidepressive agents|mesh-ancestor
65538856|NCT02225548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65538857|NCT02225548|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65538858|NCT02225548|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65538859|NCT02225548|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65538860|NCT02225548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65538861|NCT02225548|Protective Agents|protective agents|mesh-ancestor
65538862|NCT02225548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538863|NCT02223052|Azacitidine|azacitidine|mesh-list
65538864|NCT02223052|Cc-486|cc-486|mesh-list
65538865|NCT02223052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65538866|NCT02223052|Antimetabolites|antimetabolites|mesh-ancestor
65538867|NCT02223052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538868|NCT02223052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65538869|NCT02223052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538870|NCT02231632|Vaccines|vaccines|mesh-list
65538871|NCT02231632|Immunologic Factors|immunologic factors|mesh-ancestor
65538872|NCT02231632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538873|NCT02225782|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65538874|NCT02225782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65538875|NCT02225782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65538876|NCT02225782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538877|NCT02231788|Amlodipine|amlodipine|mesh-list
65538878|NCT02231788|Telmisartan|telmisartan|mesh-list
65538879|NCT02231788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65538880|NCT02231788|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65538881|NCT02231788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65538882|NCT02231788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538883|NCT02231788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65538884|NCT02231788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538885|NCT02231788|Vasodilator Agents|vasodilator agents|mesh-ancestor
65538886|NCT02231788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65538887|NCT02231788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65538888|NCT02258620|Isosorbide|isosorbide|mesh-list
65538889|NCT02258620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65538890|NCT02258620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65538891|NCT02258620|Nitroglycerin|nitroglycerin|mesh-list
65538892|NCT02258620|Vasodilator Agents|vasodilator agents|mesh-ancestor
65538893|NCT02258620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65538894|NCT02258620|Diuretics|diuretics|mesh-ancestor
65538895|NCT02258620|Natriuretic Agents|natriuretic agents|mesh-ancestor
65538896|NCT02258620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538897|NCT02258620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65538898|NCT02258620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538899|NCT02223598|Dexamethasone|dexamethasone|mesh-list
65538900|NCT02223598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65538901|NCT02223598|Antiemetics|antiemetics|mesh-ancestor
65538902|NCT02223598|Autonomic Agents|autonomic agents|mesh-ancestor
65538903|NCT02223598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538904|NCT02223598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538905|NCT02223598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65538906|NCT02223598|Glucocorticoids|glucocorticoids|mesh-ancestor
65538907|NCT02223598|Hormones|hormones|mesh-ancestor
65538908|NCT02223598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65538909|NCT02223598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65538910|NCT02223598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65538911|NCT00094835|Paclitaxel|paclitaxel|mesh-list
65538912|NCT00094835|Carboplatin|carboplatin|mesh-list
65538913|NCT00094835|Panitumumab|panitumumab|mesh-list
65538914|NCT00094835|Motesanib diphosphate|motesanib diphosphate|mesh-list
65538915|NCT00094835|Imetelstat|imetelstat|mesh-list
65538916|NCT00094835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65538917|NCT00094835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65538918|NCT00094835|Tubulin Modulators|tubulin modulators|mesh-ancestor
65538919|NCT00094835|Antimitotic Agents|antimitotic agents|mesh-ancestor
65538920|NCT00094835|Mitosis Modulators|mitosis modulators|mesh-ancestor
65538921|NCT00094835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538922|NCT00094835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65538923|NCT00094835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65538924|NCT00094835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538925|NCT02226328|Fentanyl|fentanyl|mesh-list
65538926|NCT02226328|Midazolam|midazolam|mesh-list
65538927|NCT02226328|Propofol|propofol|mesh-list
65538928|NCT02226328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65538929|NCT02226328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65538930|NCT02226328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538931|NCT02226328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65538932|NCT02226328|Anesthetics, General|anesthetics, general|mesh-ancestor
65538933|NCT02226328|Anesthetics|anesthetics|mesh-ancestor
65538934|NCT02226328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65538935|NCT02226328|Narcotics|narcotics|mesh-ancestor
65538936|NCT02226328|Analgesics|analgesics|mesh-ancestor
65538937|NCT02226328|Sensory System Agents|sensory system agents|mesh-ancestor
65538938|NCT02226328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538939|NCT02226328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65538940|NCT02226328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65538941|NCT02226328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65538942|NCT02226328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65538943|NCT02226328|GABA Modulators|gaba modulators|mesh-ancestor
65538944|NCT02226328|GABA Agents|gaba agents|mesh-ancestor
65538945|NCT02226328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65538946|NCT02226328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538947|NCT03962777|Chlorhexidine|chlorhexidine|mesh-list
65538948|NCT03962777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65538949|NCT03962777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65538950|NCT03962777|Disinfectants|disinfectants|mesh-ancestor
65538951|NCT02226484|Quercetin|quercetin|mesh-list
65538952|NCT02226484|Antioxidants|antioxidants|mesh-ancestor
65538953|NCT02226484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538954|NCT02226484|Protective Agents|protective agents|mesh-ancestor
65538955|NCT02226484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538956|NCT04453852|Vaccines|vaccines|mesh-list
65538957|NCT04453852|Immunologic Factors|immunologic factors|mesh-ancestor
65538958|NCT04453852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538959|NCT00094757|Pioglitazone|pioglitazone|mesh-list
65538960|NCT00094757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65538961|NCT00094757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65538962|NCT00094757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538963|NCT00094757|Incretins|incretins|mesh-ancestor
65538964|NCT00094757|Hormones|hormones|mesh-ancestor
65538965|NCT00094757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65268053|NCT04220996|Vortioxetine|vortioxetine|mesh-list
65538966|NCT00094757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65538967|NCT00094757|Protease Inhibitors|protease inhibitors|mesh-ancestor
65538968|NCT00094757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538969|NCT00094757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538970|NCT02223832|Ponesimod|ponesimod|mesh-list
65538971|NCT02223832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65538972|NCT02223832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538973|NCT02223832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65538974|NCT02223832|Immunologic Factors|immunologic factors|mesh-ancestor
65538975|NCT02223832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538976|NCT02224066|Aspirin|aspirin|mesh-list
65538977|NCT02224066|Clopidogrel|clopidogrel|mesh-list
65538978|NCT02224066|Ticagrelor|ticagrelor|mesh-list
65538979|NCT02224066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65538980|NCT02224066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65538981|NCT02224066|Analgesics|analgesics|mesh-ancestor
65538982|NCT02224066|Sensory System Agents|sensory system agents|mesh-ancestor
65538983|NCT02224066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65538984|NCT02224066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65538985|NCT02224066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65538986|NCT02224066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65538987|NCT02224066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65538988|NCT02224066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65538989|NCT02224066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65538990|NCT02224066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65538991|NCT02224066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65538992|NCT02224066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65538993|NCT02224066|Antipyretics|antipyretics|mesh-ancestor
65538994|NCT02224066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65538995|NCT02224066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65538996|NCT02224066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65538997|NCT02224066|Purinergic Agents|purinergic agents|mesh-ancestor
65538998|NCT02224066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65538999|NCT02227030|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65539000|NCT04378114|Acetaminophen|acetaminophen|mesh-list
65539001|NCT04378114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65539002|NCT04378114|Analgesics|analgesics|mesh-ancestor
65539003|NCT04378114|Sensory System Agents|sensory system agents|mesh-ancestor
65539004|NCT04378114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65539005|NCT04378114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539006|NCT04378114|Antipyretics|antipyretics|mesh-ancestor
65539007|NCT00082433|Capecitabine|capecitabine|mesh-list
65539008|NCT00082433|Epothilones|epothilones|mesh-list
65539009|NCT00082433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65539010|NCT00082433|Antimetabolites|antimetabolites|mesh-ancestor
65539011|NCT00082433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539012|NCT00082433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539013|NCT00082433|Tubulin Modulators|tubulin modulators|mesh-ancestor
65539014|NCT00082433|Antimitotic Agents|antimitotic agents|mesh-ancestor
65539015|NCT00082433|Mitosis Modulators|mitosis modulators|mesh-ancestor
65539016|NCT00094445|Curcumin|curcumin|mesh-list
65539017|NCT00094445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65539018|NCT00094445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65539019|NCT00094445|Analgesics|analgesics|mesh-ancestor
65539020|NCT00094445|Sensory System Agents|sensory system agents|mesh-ancestor
65539021|NCT00094445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65539022|NCT00094445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539023|NCT00094445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65539024|NCT00094445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65539025|NCT00094445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539026|NCT00094445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539027|NCT00094445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539028|NCT01081535|Ketorolac|ketorolac|mesh-list
65539029|NCT01081535|Fentanyl|fentanyl|mesh-list
65539030|NCT01081535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65539031|NCT01081535|Narcotics|narcotics|mesh-ancestor
65539032|NCT01081535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65539033|NCT01081535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539034|NCT01081535|Analgesics|analgesics|mesh-ancestor
65539035|NCT01081535|Sensory System Agents|sensory system agents|mesh-ancestor
65539036|NCT01081535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65539037|NCT01081535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65539038|NCT01081535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65539039|NCT01081535|Anesthetics, General|anesthetics, general|mesh-ancestor
65539040|NCT01081535|Anesthetics|anesthetics|mesh-ancestor
65539041|NCT01081535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65539042|NCT01081535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65539043|NCT01081535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65539044|NCT01081535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65539045|NCT01081535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65539046|NCT01081535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539047|NCT01081535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539048|NCT01087229|Nitrous Oxide|nitrous oxide|mesh-list
65539049|NCT01087229|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65539050|NCT01087229|Anesthetics, General|anesthetics, general|mesh-ancestor
65539051|NCT01087229|Anesthetics|anesthetics|mesh-ancestor
65539052|NCT01087229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65539053|NCT01087229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539054|NCT01087229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65539055|NCT01087229|Analgesics|analgesics|mesh-ancestor
65539056|NCT01087229|Sensory System Agents|sensory system agents|mesh-ancestor
65539057|NCT01087229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65539058|NCT00082355|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65539059|NCT00082355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65539060|NCT00082355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65539061|NCT00082355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539062|NCT01084577|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65539063|NCT01084577|Laxatives|laxatives|mesh-ancestor
65539064|NCT01084577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65539065|NCT00094055|Axitinib|axitinib|mesh-list
65539066|NCT00094055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539067|NCT00094055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65539068|NCT00094055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539069|NCT00094055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539070|NCT02531165|Aspirin|aspirin|mesh-list
65539071|NCT02531165|Heparin|heparin|mesh-list
65539072|NCT02531165|Fentanyl|fentanyl|mesh-list
65539073|NCT02531165|Morphine|morphine|mesh-list
65539074|NCT02531165|Ticagrelor|ticagrelor|mesh-list
65539075|NCT02531165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65539076|NCT02531165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65539077|NCT02531165|Analgesics|analgesics|mesh-ancestor
65539078|NCT02531165|Sensory System Agents|sensory system agents|mesh-ancestor
65539079|NCT02531165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65539080|NCT02531165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539081|NCT02531165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65539082|NCT02531165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65539083|NCT02531165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65539084|NCT02531165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65539085|NCT02531165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539086|NCT02531165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65539087|NCT02531165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65539088|NCT02531165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539089|NCT02531165|Antipyretics|antipyretics|mesh-ancestor
65539090|NCT02531165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65539091|NCT02531165|Narcotics|narcotics|mesh-ancestor
65539092|NCT02531165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65539093|NCT02531165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65539094|NCT02531165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65539095|NCT02531165|Anesthetics, General|anesthetics, general|mesh-ancestor
65539096|NCT02531165|Anesthetics|anesthetics|mesh-ancestor
65539097|NCT02531165|Anticoagulants|anticoagulants|mesh-ancestor
65539098|NCT02531165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65539099|NCT02531165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65539100|NCT02531165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65539101|NCT02531165|Purinergic Agents|purinergic agents|mesh-ancestor
65539102|NCT02531165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65539103|NCT00099983|Risperidone|risperidone|mesh-list
65539104|NCT00099983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65539105|NCT00099983|Serotonin Agents|serotonin agents|mesh-ancestor
65539106|NCT00099983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65539107|NCT00099983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539108|NCT00099983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539109|NCT00099983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65539110|NCT00099983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65539111|NCT00099983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65539112|NCT00099983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65539113|NCT00099983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65539114|NCT00099983|Dopamine Agents|dopamine agents|mesh-ancestor
65539115|NCT00099359|Lamivudine|lamivudine|mesh-list
65539116|NCT00099359|Zidovudine|zidovudine|mesh-list
65539117|NCT00099359|Nevirapine|nevirapine|mesh-list
65539118|NCT00099359|Nelfinavir|nelfinavir|mesh-list
65539119|NCT00099359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65539120|NCT00099359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65539121|NCT00099359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539122|NCT00099359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539123|NCT00099359|Antiviral Agents|antiviral agents|mesh-ancestor
65539124|NCT00099359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65539125|NCT00099359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65539126|NCT00099359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65539127|NCT00099359|Antimetabolites|antimetabolites|mesh-ancestor
65539128|NCT00099359|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65539129|NCT00099359|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65539130|NCT00099359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65539131|NCT00099359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65539132|NCT00099359|Protease Inhibitors|protease inhibitors|mesh-ancestor
65539133|NCT00092417|Vaccines|vaccines|mesh-list
65539134|NCT00092417|Immunologic Factors|immunologic factors|mesh-ancestor
65539135|NCT00092417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539136|NCT00091949|Pioglitazone|pioglitazone|mesh-list
65539137|NCT00091949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65539138|NCT00091949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539139|NCT02258542|Benralizumab|benralizumab|mesh-list
65539140|NCT02258542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65539141|NCT02258542|Respiratory System Agents|respiratory system agents|mesh-ancestor
65539142|NCT00091793|Denosumab|denosumab|mesh-list
65539143|NCT00091793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65539144|NCT00091793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539145|NCT00098813|Romidepsin|romidepsin|mesh-list
65539146|NCT00098813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65539147|NCT00098813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539148|NCT01081613|Bevacizumab|bevacizumab|mesh-list
65539149|NCT01081613|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
65539150|NCT01081613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65539151|NCT01081613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539152|NCT01081613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65539153|NCT01081613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65539154|NCT01081613|Growth Substances|growth substances|mesh-ancestor
65539155|NCT01081613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539156|NCT01081613|Growth Inhibitors|growth inhibitors|mesh-ancestor
65539157|NCT01081613|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65539158|NCT01081613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539159|NCT02227264|Parathyroid Hormone|parathyroid hormone|mesh-list
65539160|NCT02227264|Cinacalcet|cinacalcet|mesh-list
65539161|NCT02227264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65539162|NCT02227264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539163|NCT02227264|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65539164|NCT02227264|Hormone Antagonists|hormone antagonists|mesh-ancestor
65539165|NCT02227264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65539166|NCT02227420|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65539167|NCT02227420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65539168|NCT04772248|Adalimumab|adalimumab|mesh-list
65539169|NCT04772248|Etanercept|etanercept|mesh-list
65539170|NCT04772248|Golimumab|golimumab|mesh-list
65539171|NCT04772248|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
65539172|NCT04772248|Infliximab|infliximab|mesh-list
65539173|NCT04772248|Certolizumab Pegol|certolizumab pegol|mesh-list
65539174|NCT04772248|Tofacitinib|tofacitinib|mesh-list
65539175|NCT04772248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65539176|NCT04772248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65539177|NCT04772248|Dermatologic Agents|dermatologic agents|mesh-ancestor
65539178|NCT04772248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65539179|NCT04772248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65539180|NCT04772248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65539181|NCT04772248|Analgesics|analgesics|mesh-ancestor
65539182|NCT04772248|Sensory System Agents|sensory system agents|mesh-ancestor
65539183|NCT04772248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65539184|NCT04772248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539185|NCT04772248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65539186|NCT04772248|Immunologic Factors|immunologic factors|mesh-ancestor
65539187|NCT04772248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65539188|NCT04772248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539189|NCT04772248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539190|NCT00090857|Letrozole|letrozole|mesh-list
65539191|NCT00090857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539192|NCT00090857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65539193|NCT00090857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65539194|NCT00090857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539195|NCT00090857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539196|NCT00090857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65539197|NCT00090857|Hormone Antagonists|hormone antagonists|mesh-ancestor
65539198|NCT00090857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65539199|NCT00090857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539200|NCT01775644|Bevacizumab|bevacizumab|mesh-list
65539201|NCT01775644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65539202|NCT01775644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539203|NCT01775644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65539204|NCT01775644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65539205|NCT01775644|Growth Substances|growth substances|mesh-ancestor
65539206|NCT01775644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539207|NCT01775644|Growth Inhibitors|growth inhibitors|mesh-ancestor
65539208|NCT04259086|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65539209|NCT04259086|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65539210|NCT04259086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65539211|NCT04259086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65539212|NCT04259086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539213|NCT04259086|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65539214|NCT04259086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65539215|NCT04259086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539216|NCT04259086|Cholinergic Agents|cholinergic agents|mesh-ancestor
65539217|NCT04259086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65539218|NCT04229368|Vitamin D|vitamin d|mesh-list
65539219|NCT04229368|Cholecalciferol|cholecalciferol|mesh-list
65539220|NCT04229368|Vitamins|vitamins|mesh-ancestor
65539221|NCT04229368|Micronutrients|micronutrients|mesh-ancestor
65539222|NCT04229368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539223|NCT04229368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65539224|NCT04229368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65539225|NCT00090779|Ritonavir|ritonavir|mesh-list
65539226|NCT00090779|Lopinavir|lopinavir|mesh-list
65539227|NCT00090779|Tenofovir|tenofovir|mesh-list
65539228|NCT00090779|Emtricitabine|emtricitabine|mesh-list
65539229|NCT00090779|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65539230|NCT00090779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65539231|NCT00090779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65539232|NCT00090779|Protease Inhibitors|protease inhibitors|mesh-ancestor
65539233|NCT00090779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539234|NCT00090779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539235|NCT00090779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65539236|NCT00090779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65539237|NCT00090779|Antiviral Agents|antiviral agents|mesh-ancestor
65539238|NCT00090779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65539239|NCT00090779|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65539240|NCT00090779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65539241|NCT00090779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65539242|NCT00090779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65539243|NCT01081691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65539244|NCT01081691|Immunologic Factors|immunologic factors|mesh-ancestor
65539245|NCT01081691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539246|NCT01081847|Mannitol|mannitol|mesh-list
65539247|NCT01081847|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65539248|NCT01081847|Freund's Adjuvant|freund's adjuvant|mesh-list
65539249|NCT01081847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65539250|NCT01081847|Immunologic Factors|immunologic factors|mesh-ancestor
65539251|NCT01081847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539252|NCT01081847|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65539253|NCT01081847|Diuretics|diuretics|mesh-ancestor
65539254|NCT01081847|Natriuretic Agents|natriuretic agents|mesh-ancestor
65539255|NCT02224456|Tenofovir|tenofovir|mesh-list
65539256|NCT02224456|Antiviral Agents|antiviral agents|mesh-ancestor
65539257|NCT02224456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65539258|NCT02224456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65539259|NCT02224456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65539260|NCT02224456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539261|NCT02224456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539262|NCT02224456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65539263|NCT02224456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65539264|NCT02224534|Clopidogrel|clopidogrel|mesh-list
65268366|NCT00635960|Hormones|hormones|mesh-list
65539265|NCT02224534|Ticagrelor|ticagrelor|mesh-list
65539266|NCT02224534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65539267|NCT02224534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65539268|NCT02224534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65539269|NCT02224534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65539270|NCT02224534|Purinergic Agents|purinergic agents|mesh-ancestor
65539271|NCT02224534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65539272|NCT02224534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539273|NCT02224534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539274|NCT04174612|Cytarabine|cytarabine|mesh-list
65539275|NCT04174612|Daunorubicin|daunorubicin|mesh-list
65539276|NCT04174612|Midostaurin|midostaurin|mesh-list
65539277|NCT04174612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65539278|NCT04174612|Antimetabolites|antimetabolites|mesh-ancestor
65539279|NCT04174612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539280|NCT04174612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539281|NCT04174612|Antiviral Agents|antiviral agents|mesh-ancestor
65539282|NCT04174612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65539283|NCT04174612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65539284|NCT04174612|Immunologic Factors|immunologic factors|mesh-ancestor
65539285|NCT04174612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539286|NCT04174612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65539287|NCT04174612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65539288|NCT04174612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65539289|NCT04174612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539290|NCT04174612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65539291|NCT01082003|Pentoxifylline|pentoxifylline|mesh-list
65539292|NCT01082003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65539293|NCT01082003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539294|NCT01082003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539295|NCT01082003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65539296|NCT01082003|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65539297|NCT01082003|Protective Agents|protective agents|mesh-ancestor
65539298|NCT01082003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539299|NCT01082003|Vasodilator Agents|vasodilator agents|mesh-ancestor
65539300|NCT01082003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65539301|NCT01082003|Antioxidants|antioxidants|mesh-ancestor
65539302|NCT01082237|Citalopram|citalopram|mesh-list
65539303|NCT01082237|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65539304|NCT01082237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65539305|NCT01082237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65539306|NCT01082237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539307|NCT01082237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65539308|NCT01082237|Serotonin Agents|serotonin agents|mesh-ancestor
65539309|NCT01082237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539310|NCT01082237|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65539311|NCT01082237|Antidepressive Agents|antidepressive agents|mesh-ancestor
65539312|NCT01082237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65539313|NCT02228122|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65539314|NCT02228122|Laxatives|laxatives|mesh-ancestor
65539315|NCT02228122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65539316|NCT01082315|Cetuximab|cetuximab|mesh-list
65539317|NCT01082315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65539318|NCT01082315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539319|NCT01082471|Morphine|morphine|mesh-list
65539320|NCT01082471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65539321|NCT01082471|Narcotics|narcotics|mesh-ancestor
65539322|NCT01082471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65539323|NCT01082471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539324|NCT01082471|Analgesics|analgesics|mesh-ancestor
65539325|NCT01082471|Sensory System Agents|sensory system agents|mesh-ancestor
65539326|NCT01082471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65539327|NCT03553498|Acetaminophen|acetaminophen|mesh-list
65539328|NCT03553498|Hydromorphone|hydromorphone|mesh-list
65539329|NCT03553498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65539330|NCT03553498|Analgesics|analgesics|mesh-ancestor
65539331|NCT03553498|Sensory System Agents|sensory system agents|mesh-ancestor
65539332|NCT03553498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65539333|NCT03553498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539334|NCT03553498|Antipyretics|antipyretics|mesh-ancestor
65539335|NCT03553498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65539336|NCT03553498|Narcotics|narcotics|mesh-ancestor
65539337|NCT03553498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65539338|NCT01589393|Enoxaparin|enoxaparin|mesh-list
65539339|NCT01589393|Anticoagulants|anticoagulants|mesh-ancestor
65539340|NCT01589393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65539341|NCT01589393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65539342|NCT01589393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539343|NCT01589471|Botulinum Toxins|botulinum toxins|mesh-list
65539344|NCT01589471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65539345|NCT01589471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65539346|NCT01589471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65539347|NCT01589471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65539348|NCT01589471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539349|NCT01589471|Cholinergic Agents|cholinergic agents|mesh-ancestor
65539350|NCT01589471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65539351|NCT01589471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539352|NCT01589471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65539353|NCT01589471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65539354|NCT00096941|Pertuzumab|pertuzumab|mesh-list
65539355|NCT00096941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65539356|NCT00096941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539357|NCT00096785|Entecavir|entecavir|mesh-list
65539358|NCT00096785|Adefovir|adefovir|mesh-list
65539359|NCT00096785|Antiviral Agents|antiviral agents|mesh-ancestor
65539360|NCT00096785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65539361|NCT00096785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65539362|NCT00096785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65539363|NCT00096785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539364|NCT00096785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539365|NCT01326767|Paclitaxel|paclitaxel|mesh-list
65539366|NCT01326767|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65539367|NCT01326767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65539368|NCT01326767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539369|NCT01326767|Tubulin Modulators|tubulin modulators|mesh-ancestor
65539370|NCT01326767|Antimitotic Agents|antimitotic agents|mesh-ancestor
65539371|NCT01326767|Mitosis Modulators|mitosis modulators|mesh-ancestor
65539372|NCT01326767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539373|NCT03963479|Vitamin B 6|vitamin b 6|mesh-list
65539374|NCT03963479|Pyridoxal|pyridoxal|mesh-list
65539375|NCT03963479|Pyridoxine|pyridoxine|mesh-list
65539376|NCT03963479|Vitamins|vitamins|mesh-ancestor
65539377|NCT03963479|Micronutrients|micronutrients|mesh-ancestor
65539378|NCT03963479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539379|NCT03963479|Vitamin B Complex|vitamin b complex|mesh-ancestor
65539380|NCT02228512|Prednisone|prednisone|mesh-list
65539381|NCT02228512|Cyclophosphamide|cyclophosphamide|mesh-list
65539382|NCT02228512|Rituximab|rituximab|mesh-list
65539383|NCT02228512|Doxorubicin|doxorubicin|mesh-list
65539384|NCT02228512|Etoposide|etoposide|mesh-list
65539385|NCT02228512|Vincristine|vincristine|mesh-list
65539386|NCT02228512|Pomalidomide|pomalidomide|mesh-list
65539387|NCT02228512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65539388|NCT02228512|Immunologic Factors|immunologic factors|mesh-ancestor
65539389|NCT02228512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539390|NCT02228512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65539391|NCT02228512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65539392|NCT02228512|Alkylating Agents|alkylating agents|mesh-ancestor
65539393|NCT02228512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539394|NCT02228512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539395|NCT02228512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65539396|NCT02228512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65539397|NCT02228512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65539398|NCT02228512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65539399|NCT02228512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65539400|NCT02228512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539401|NCT02228512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65539402|NCT02228512|Glucocorticoids|glucocorticoids|mesh-ancestor
65539403|NCT02228512|Hormones|hormones|mesh-ancestor
65539404|NCT02228512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65539405|NCT02228512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65539406|NCT02228512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65539407|NCT02228512|Tubulin Modulators|tubulin modulators|mesh-ancestor
65539408|NCT02228512|Antimitotic Agents|antimitotic agents|mesh-ancestor
65539409|NCT02228512|Mitosis Modulators|mitosis modulators|mesh-ancestor
65539410|NCT02228512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65539411|NCT02228512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65539412|NCT02228512|Growth Substances|growth substances|mesh-ancestor
65539413|NCT02228512|Growth Inhibitors|growth inhibitors|mesh-ancestor
65539414|NCT01082627|Somatostatin|somatostatin|mesh-list
65268506|NCT04213716|Calcium|calcium|mesh-list
65539415|NCT01082627|Hormones|hormones|mesh-ancestor
65539416|NCT01082627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65539417|NCT01082627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539418|NCT03515044|Rifaximin|rifaximin|mesh-list
65539419|NCT03515044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65539420|NCT03515044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65539421|NCT03515044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65539422|NCT01082705|Lumefantrine|lumefantrine|mesh-list
65539423|NCT01082705|Artemether|artemether|mesh-list
65539424|NCT01082705|Piperaquine|piperaquine|mesh-list
65539425|NCT01082705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65539426|NCT01082705|Artenimol|artenimol|mesh-list
65539427|NCT01082705|Antimalarials|antimalarials|mesh-ancestor
65539428|NCT01082705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65539429|NCT01082705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65539430|NCT01082705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65539431|NCT01582997|Dabrafenib|dabrafenib|mesh-list
65539432|NCT01582997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539433|NCT01582997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65539434|NCT01582997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539435|NCT01582997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539436|NCT01090505|Oxaliplatin|oxaliplatin|mesh-list
65539437|NCT01090505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539438|NCT01085981|Niacin|niacin|mesh-list
65539439|NCT01085981|Niacinamide|niacinamide|mesh-list
65539440|NCT01085981|Nicotinic Acids|nicotinic acids|mesh-list
65539441|NCT01085981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65539442|NCT01085981|Antimetabolites|antimetabolites|mesh-ancestor
65539443|NCT01085981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539444|NCT01085981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65539446|NCT01085981|Vitamin B Complex|vitamin b complex|mesh-ancestor
65539447|NCT01085981|Vitamins|vitamins|mesh-ancestor
65539448|NCT01085981|Micronutrients|micronutrients|mesh-ancestor
65539449|NCT01085981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539450|NCT03345082|Ranibizumab|ranibizumab|mesh-list
65539451|NCT03345082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65539452|NCT03345082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65539453|NCT03345082|Growth Substances|growth substances|mesh-ancestor
65539454|NCT03345082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539455|NCT03345082|Growth Inhibitors|growth inhibitors|mesh-ancestor
65539456|NCT03345082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539457|NCT02228902|Ferrous fumarate|ferrous fumarate|mesh-list
65539458|NCT02228902|Ferrous gluconate|ferrous gluconate|mesh-list
65539459|NCT02228902|Trace Elements|trace elements|mesh-ancestor
65539460|NCT02228902|Micronutrients|micronutrients|mesh-ancestor
65539461|NCT02228902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539462|NCT02228902|Hematinics|hematinics|mesh-ancestor
65539463|NCT03288454|Apixaban|apixaban|mesh-list
65539464|NCT03288454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65539465|NCT03288454|Antithrombins|antithrombins|mesh-ancestor
65539466|NCT03288454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65539467|NCT03288454|Protease Inhibitors|protease inhibitors|mesh-ancestor
65539468|NCT03288454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539469|NCT03288454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539470|NCT03288454|Anticoagulants|anticoagulants|mesh-ancestor
65539471|NCT00090545|Sorafenib|sorafenib|mesh-list
65539472|NCT00090545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539473|NCT00090545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65539474|NCT00090545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539475|NCT00090545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539476|NCT02829814|Cyclobenzaprine|cyclobenzaprine|mesh-list
65539477|NCT02829814|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65539478|NCT02829814|Antidepressive Agents|antidepressive agents|mesh-ancestor
65539479|NCT02829814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65539480|NCT02829814|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65539481|NCT02829814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539482|NCT02829814|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65539483|NCT02829814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65539484|NCT02829814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65539485|NCT02829814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65539486|NCT03916042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65539487|NCT03916042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65539488|NCT02229058|Paclitaxel|paclitaxel|mesh-list
65539489|NCT02229058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65539490|NCT02229058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65539491|NCT02229058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539492|NCT02229058|Tubulin Modulators|tubulin modulators|mesh-ancestor
65539493|NCT02229058|Antimitotic Agents|antimitotic agents|mesh-ancestor
65539494|NCT02229058|Mitosis Modulators|mitosis modulators|mesh-ancestor
65539495|NCT02229058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539496|NCT02229292|Tranexamic Acid|tranexamic acid|mesh-list
65539497|NCT02229292|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65539498|NCT02229292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65539499|NCT02229292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539500|NCT02229292|Hemostatics|hemostatics|mesh-ancestor
65539501|NCT02229292|Coagulants|coagulants|mesh-ancestor
65539502|NCT00070109|Trabectedin|trabectedin|mesh-list
65539503|NCT00070109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65539504|NCT00070109|Alkylating Agents|alkylating agents|mesh-ancestor
65539505|NCT00070109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539506|NCT00070109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539507|NCT00069953|Paclitaxel|paclitaxel|mesh-list
65539508|NCT00069953|Fluorouracil|fluorouracil|mesh-list
65539509|NCT00069953|Lenograstim|lenograstim|mesh-list
65539510|NCT00069953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65539511|NCT00069953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539512|NCT00069953|Tubulin Modulators|tubulin modulators|mesh-ancestor
65539513|NCT00069953|Antimitotic Agents|antimitotic agents|mesh-ancestor
65539514|NCT00069953|Mitosis Modulators|mitosis modulators|mesh-ancestor
65539515|NCT00069953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539516|NCT00069953|Antimetabolites|antimetabolites|mesh-ancestor
65539517|NCT00069953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65539518|NCT00069953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65539519|NCT00069953|Immunologic Factors|immunologic factors|mesh-ancestor
65337029|NCT00772031|Topiramate|topiramate|mesh-list
65539520|NCT00069953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539521|NCT00069953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65539522|NCT03118570|Vitamin D|vitamin d|mesh-list
65539523|NCT03118570|Zoledronic Acid|zoledronic acid|mesh-list
65539524|NCT03118570|Calcium|calcium|mesh-list
65539525|NCT03118570|Vitamins|vitamins|mesh-ancestor
65539526|NCT03118570|Micronutrients|micronutrients|mesh-ancestor
65539527|NCT03118570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539528|NCT03118570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65539529|NCT03118570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65539530|NCT02750800|Adalimumab|adalimumab|mesh-list
65539531|NCT02750800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65539532|NCT02750800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65539533|NCT02229760|Ritonavir|ritonavir|mesh-list
65539534|NCT02229760|Tipranavir|tipranavir|mesh-list
65539535|NCT02229760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65539536|NCT02229760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65539537|NCT02229760|Protease Inhibitors|protease inhibitors|mesh-ancestor
65539538|NCT02229760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539539|NCT02229760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539540|NCT02229760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65539541|NCT02229760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65539542|NCT02229760|Antiviral Agents|antiviral agents|mesh-ancestor
65539543|NCT02229760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65539544|NCT02229760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65539545|NCT02229760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65539546|NCT03662542|Golimumab|golimumab|mesh-list
65539547|NCT03662542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65539548|NCT03662542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65539549|NCT03662542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65539550|NCT03662542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65539551|NCT03662542|Immunologic Factors|immunologic factors|mesh-ancestor
65539552|NCT03662542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539553|NCT01329562|Naproxen|naproxen|mesh-list
65539554|NCT01329562|Sumatriptan|sumatriptan|mesh-list
65539555|NCT01329562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65539556|NCT01329562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65539557|NCT01329562|Analgesics|analgesics|mesh-ancestor
65539558|NCT01329562|Sensory System Agents|sensory system agents|mesh-ancestor
65539559|NCT01329562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65539560|NCT01329562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539561|NCT01329562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65539562|NCT01329562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65539563|NCT01329562|Gout Suppressants|gout suppressants|mesh-ancestor
65539564|NCT01329562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65539565|NCT01329562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539566|NCT01329562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268649|NCT02749136|Folfirinox|folfirinox|mesh-list
65539567|NCT01329562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65539568|NCT01329562|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65539569|NCT01329562|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65539570|NCT01329562|Serotonin Agents|serotonin agents|mesh-ancestor
65539571|NCT01329562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65539572|NCT02230228|Vitamin A|vitamin a|mesh-list
65539573|NCT02230228|Retinol acetate|retinol acetate|mesh-list
65539574|NCT02230228|Vitamins|vitamins|mesh-ancestor
65539575|NCT02230228|Micronutrients|micronutrients|mesh-ancestor
65539576|NCT02230228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539577|NCT02230228|Protective Agents|protective agents|mesh-ancestor
65539578|NCT02230228|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65539579|NCT02230228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539580|NCT02230228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65539581|NCT02230228|Immunologic Factors|immunologic factors|mesh-ancestor
65539582|NCT01090661|Moxifloxacin|moxifloxacin|mesh-list
65539583|NCT01090661|Mipomersen|mipomersen|mesh-list
65539584|NCT01090661|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65539585|NCT01090661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65539586|NCT01090661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65539587|NCT01090661|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65539588|NCT01090661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65539589|NCT01090661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539590|NCT01090661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539591|NCT01090661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539592|NCT01090661|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65539593|NCT01090661|Contraceptive Agents|contraceptive agents|mesh-ancestor
65539594|NCT01090661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65539595|NCT01090661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539596|NCT01090661|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65539597|NCT01090661|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65539598|NCT01090661|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65539599|NCT01090661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65539600|NCT01090661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65539601|NCT01090661|Antimetabolites|antimetabolites|mesh-ancestor
65539602|NCT01090661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65539603|NCT05563480|Gemcitabine|gemcitabine|mesh-list
65539604|NCT05563480|Cisplatin|cisplatin|mesh-list
65539605|NCT05563480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539606|NCT05563480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65539607|NCT05563480|Antimetabolites|antimetabolites|mesh-ancestor
65539608|NCT05563480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539609|NCT05563480|Antiviral Agents|antiviral agents|mesh-ancestor
65539610|NCT05563480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65539611|NCT05563480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539612|NCT05563480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65539613|NCT05563480|Immunologic Factors|immunologic factors|mesh-ancestor
65539614|NCT05563480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539615|NCT05546398|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
65539616|NCT05546398|Ezetimibe|ezetimibe|mesh-list
65539617|NCT05546398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65539618|NCT05546398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65539619|NCT05546398|Antimetabolites|antimetabolites|mesh-ancestor
65539620|NCT05546398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539621|NCT05546398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65539622|NCT05546398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539623|NCT05546398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65539624|NCT05546398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539625|NCT05472766|Anticoagulants|anticoagulants|mesh-list
65539626|NCT05472766|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
65539627|NCT05472766|Antithrombins|antithrombins|mesh-ancestor
65539628|NCT05472766|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65539629|NCT05472766|Protease Inhibitors|protease inhibitors|mesh-ancestor
65539630|NCT05472766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539631|NCT05472766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539632|NCT03653026|Upadacitinib|upadacitinib|mesh-list
65539633|NCT03653026|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65539634|NCT03653026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65539635|NCT03653026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539636|NCT03653026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539637|NCT03653026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65539638|NCT02232724|Choline|choline|mesh-list
65539639|NCT02232724|Lipotropic Agents|lipotropic agents|mesh-ancestor
65539640|NCT02232724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65539641|NCT02232724|Antimetabolites|antimetabolites|mesh-ancestor
65539642|NCT02232724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539643|NCT02232724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65539644|NCT02232724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65539645|NCT02232724|Nootropic Agents|nootropic agents|mesh-ancestor
65539646|NCT02234440|Metformin|metformin|mesh-list
65539647|NCT02234440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65539648|NCT02234440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539649|NCT04981678|Buprenorphine|buprenorphine|mesh-list
65539650|NCT04981678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65539651|NCT04981678|Narcotics|narcotics|mesh-ancestor
65539652|NCT04981678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65539653|NCT04981678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539654|NCT04981678|Analgesics|analgesics|mesh-ancestor
65539655|NCT04981678|Sensory System Agents|sensory system agents|mesh-ancestor
65539656|NCT04981678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65539657|NCT04981678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65539658|NCT04966546|Memantine|memantine|mesh-list
65539659|NCT04966546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65539660|NCT04966546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65539661|NCT04966546|Dopamine Agents|dopamine agents|mesh-ancestor
65539662|NCT04966546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65539663|NCT04966546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539664|NCT04966546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539665|NCT04966546|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65539666|NCT04966546|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65539667|NCT02230618|Insulin|insulin|mesh-list
65539668|NCT02230618|Insulin Aspart|insulin aspart|mesh-list
65539669|NCT02230618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65539670|NCT02230618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337184|NCT00801879|Mupirocin|mupirocin|mesh-list
65539671|NCT01337986|4-Aminopyridine|4-aminopyridine|mesh-list
65539672|NCT01337986|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65539673|NCT01337986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65539674|NCT01337986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539675|NCT04669288|Azithromycin|azithromycin|mesh-list
65539676|NCT04669288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65539677|NCT04669288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65539678|NCT02262520|Digoxin|digoxin|mesh-list
65539679|NCT02262520|Apixaban|apixaban|mesh-list
65539680|NCT02262520|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65539681|NCT02262520|Antithrombins|antithrombins|mesh-ancestor
65539682|NCT02262520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65539683|NCT02262520|Protease Inhibitors|protease inhibitors|mesh-ancestor
65539684|NCT02262520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539685|NCT02262520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539686|NCT02262520|Anticoagulants|anticoagulants|mesh-ancestor
65539687|NCT02262520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65539688|NCT02262520|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65539689|NCT02262520|Protective Agents|protective agents|mesh-ancestor
65539690|NCT02262520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539691|NCT02233504|Deferasirox|deferasirox|mesh-list
65539692|NCT02233504|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65539693|NCT02233504|Chelating Agents|chelating agents|mesh-ancestor
65539694|NCT02233504|Sequestering Agents|sequestering agents|mesh-ancestor
65539695|NCT02233504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539696|NCT02262598|Telmisartan|telmisartan|mesh-list
65539697|NCT02262598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65539698|NCT02262598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65539699|NCT02262598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65539700|NCT02262598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65539701|NCT02262598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539702|NCT02262598|Diuretics|diuretics|mesh-ancestor
65539703|NCT02262598|Natriuretic Agents|natriuretic agents|mesh-ancestor
65539704|NCT02262598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539705|NCT02262598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65539706|NCT02262598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65539707|NCT04542382|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65539708|NCT04542382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65539709|NCT04542382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65539710|NCT04542382|Antimetabolites|antimetabolites|mesh-ancestor
65539711|NCT04542382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539712|NCT04542382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65539713|NCT04542382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65539714|NCT04542382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539715|NCT03723538|Dexmedetomidine|dexmedetomidine|mesh-list
65539716|NCT03723538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65539717|NCT03723538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65539718|NCT03723538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539719|NCT03723538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65539720|NCT03723538|Analgesics|analgesics|mesh-ancestor
65539721|NCT03723538|Sensory System Agents|sensory system agents|mesh-ancestor
65539722|NCT03723538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65539723|NCT03723538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65539724|NCT03723538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65539725|NCT03723538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65539726|NCT03723538|Adrenergic Agents|adrenergic agents|mesh-ancestor
65539727|NCT03723538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65539728|NCT03723538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539729|NCT01337674|Metoprolol|metoprolol|mesh-list
65539730|NCT01337674|Amlodipine|amlodipine|mesh-list
65539731|NCT01337674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65539732|NCT01337674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65539733|NCT01337674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65539734|NCT01337674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539735|NCT01337674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65539736|NCT01337674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539737|NCT01337674|Vasodilator Agents|vasodilator agents|mesh-ancestor
65539738|NCT01337674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65539739|NCT01337674|Sympatholytics|sympatholytics|mesh-ancestor
65539740|NCT01337674|Autonomic Agents|autonomic agents|mesh-ancestor
65539741|NCT01337674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65539742|NCT01337674|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65337256|NCT00656799|Bromides|bromides|mesh-list
65539743|NCT01337674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65539744|NCT01337674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65539745|NCT01337674|Adrenergic Agents|adrenergic agents|mesh-ancestor
65539746|NCT01337674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65539747|NCT02262676|Rivaroxaban|rivaroxaban|mesh-list
65539748|NCT02262676|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65539749|NCT02262676|Antithrombins|antithrombins|mesh-ancestor
65539750|NCT02262676|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65539751|NCT02262676|Protease Inhibitors|protease inhibitors|mesh-ancestor
65539752|NCT02262676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539753|NCT02262676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539754|NCT02262676|Anticoagulants|anticoagulants|mesh-ancestor
65539756|NCT02233582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65539757|NCT02233582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65539758|NCT02233582|Analgesics|analgesics|mesh-ancestor
65539759|NCT02233582|Sensory System Agents|sensory system agents|mesh-ancestor
65539760|NCT02233582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65539761|NCT02233582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539762|NCT02233582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65539763|NCT02233582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65539764|NCT02233582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65539765|NCT02233582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539766|NCT02233582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539767|NCT02580370|Botulinum Toxins|botulinum toxins|mesh-list
65539768|NCT02580370|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65539769|NCT02580370|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65539770|NCT02580370|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65539771|NCT02580370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65539772|NCT02580370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539773|NCT02580370|Cholinergic Agents|cholinergic agents|mesh-ancestor
65539774|NCT02580370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65539775|NCT02580370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539776|NCT02580370|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65539777|NCT02580370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65539778|NCT02233816|Vaccines|vaccines|mesh-list
65539779|NCT02233816|Immunologic Factors|immunologic factors|mesh-ancestor
65539780|NCT02233816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539781|NCT02750410|Dulaglutide|dulaglutide|mesh-list
65539782|NCT02750410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65539783|NCT02750410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539784|NCT02750332|Nitisinone|nitisinone|mesh-list
65539785|NCT02750332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539786|NCT02750332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539787|NCT02233894|Ipratropium|ipratropium|mesh-list
65539788|NCT02233894|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65539789|NCT02233894|Autonomic Agents|autonomic agents|mesh-ancestor
65539790|NCT02233894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65539791|NCT02233894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539792|NCT02233894|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65539793|NCT02233894|Respiratory System Agents|respiratory system agents|mesh-ancestor
65539794|NCT02233894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65539795|NCT02233894|Cholinergic Agents|cholinergic agents|mesh-ancestor
65539796|NCT02233894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65539797|NCT02233894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539798|NCT02233972|Midazolam|midazolam|mesh-list
65539799|NCT02233972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65539800|NCT02233972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65539801|NCT02233972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65539802|NCT02233972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539803|NCT02233972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65539804|NCT02233972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65539805|NCT02233972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65539806|NCT02233972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65539807|NCT02233972|Anesthetics, General|anesthetics, general|mesh-ancestor
65539808|NCT02233972|Anesthetics|anesthetics|mesh-ancestor
65539809|NCT02233972|GABA Modulators|gaba modulators|mesh-ancestor
65539810|NCT02233972|GABA Agents|gaba agents|mesh-ancestor
65539811|NCT02233972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65539812|NCT02233972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539813|NCT02234050|Trabectedin|trabectedin|mesh-list
65539814|NCT02234050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65539815|NCT02234050|Alkylating Agents|alkylating agents|mesh-ancestor
65539816|NCT02234050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539817|NCT02234050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539819|NCT04385290|Daunorubicin|daunorubicin|mesh-list
65539820|NCT04385290|Gemtuzumab|gemtuzumab|mesh-list
65539821|NCT04385290|Midostaurin|midostaurin|mesh-list
65539822|NCT04385290|Staurosporine|staurosporine|mesh-list
65539823|NCT04385290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65539824|NCT04385290|Antimetabolites|antimetabolites|mesh-ancestor
65539825|NCT04385290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539826|NCT04385290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539827|NCT04385290|Antiviral Agents|antiviral agents|mesh-ancestor
65539828|NCT04385290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65539829|NCT04385290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65539830|NCT04385290|Immunologic Factors|immunologic factors|mesh-ancestor
65539831|NCT04385290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539832|NCT04385290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65539833|NCT04385290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65539834|NCT04385290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65539835|NCT04385290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539836|NCT04385290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65539837|NCT04385290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65539838|NCT02263066|Factor VIII|factor viii|mesh-list
65539839|NCT02263066|Coagulants|coagulants|mesh-ancestor
65539840|NCT02235532|Fluorides|fluorides|mesh-list
65539841|NCT02235532|Cariostatic Agents|cariostatic agents|mesh-ancestor
65539842|NCT02235532|Protective Agents|protective agents|mesh-ancestor
65539843|NCT02235532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539844|NCT00069095|Leucovorin|leucovorin|mesh-list
65539845|NCT00069095|Bevacizumab|bevacizumab|mesh-list
65539846|NCT00069095|Fluorouracil|fluorouracil|mesh-list
65539847|NCT00069095|Capecitabine|capecitabine|mesh-list
65539848|NCT00069095|Oxaliplatin|oxaliplatin|mesh-list
65539849|NCT00069095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65539850|NCT00069095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539851|NCT00069095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65539852|NCT00069095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65539853|NCT00069095|Growth Substances|growth substances|mesh-ancestor
65539854|NCT00069095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539855|NCT00069095|Growth Inhibitors|growth inhibitors|mesh-ancestor
65539856|NCT00069095|Antimetabolites|antimetabolites|mesh-ancestor
65539857|NCT00069095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539858|NCT00069095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65539859|NCT00069095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65539860|NCT00069095|Immunologic Factors|immunologic factors|mesh-ancestor
65539861|NCT00069095|Antidotes|antidotes|mesh-ancestor
65539862|NCT00069095|Protective Agents|protective agents|mesh-ancestor
65539863|NCT00069095|Vitamin B Complex|vitamin b complex|mesh-ancestor
65539864|NCT00069095|Vitamins|vitamins|mesh-ancestor
65539865|NCT00069095|Micronutrients|micronutrients|mesh-ancestor
65539866|NCT00086411|Bupropion|bupropion|mesh-list
65539867|NCT00086411|Nicotine|nicotine|mesh-list
65539868|NCT00086411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65539869|NCT00086411|Autonomic Agents|autonomic agents|mesh-ancestor
65539870|NCT00086411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65539871|NCT00086411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539872|NCT00086411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65539873|NCT00086411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65539874|NCT00086411|Cholinergic Agents|cholinergic agents|mesh-ancestor
65539875|NCT00086411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65539876|NCT00086411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539877|NCT00086411|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65539878|NCT00086411|Antidepressive Agents|antidepressive agents|mesh-ancestor
65539879|NCT00086411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65539880|NCT00086411|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65539881|NCT00086411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65539882|NCT00086411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65539883|NCT00086411|Dopamine Agents|dopamine agents|mesh-ancestor
65539884|NCT00086411|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65539885|NCT00086411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65539886|NCT00086411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539887|NCT00068393|Gemcitabine|gemcitabine|mesh-list
65539888|NCT00068393|Doxorubicin|doxorubicin|mesh-list
65539889|NCT00068393|Lenograstim|lenograstim|mesh-list
65539890|NCT00068393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65539891|NCT00068393|Antimetabolites|antimetabolites|mesh-ancestor
65337402|NCT00836368|Vitamins|vitamins|mesh-ancestor
65539892|NCT00068393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539893|NCT00068393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539894|NCT00068393|Antiviral Agents|antiviral agents|mesh-ancestor
65539895|NCT00068393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65539896|NCT00068393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539897|NCT00068393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65539898|NCT00068393|Immunologic Factors|immunologic factors|mesh-ancestor
65539899|NCT00068393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539900|NCT00068393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65539901|NCT00068393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65539902|NCT00068393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65539903|NCT00068393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65539904|NCT01086527|Montelukast|montelukast|mesh-list
65539905|NCT01086527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65539906|NCT01086527|Respiratory System Agents|respiratory system agents|mesh-ancestor
65539907|NCT01086527|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65539908|NCT01086527|Hormone Antagonists|hormone antagonists|mesh-ancestor
65539909|NCT01086527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65539910|NCT01086527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539911|NCT01086527|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65539912|NCT01086527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65539913|NCT01086527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539914|NCT01093937|Varenicline|varenicline|mesh-list
65539915|NCT01093937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65539916|NCT01093937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65539917|NCT01093937|Cholinergic Agents|cholinergic agents|mesh-ancestor
65539918|NCT01093937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65539919|NCT01093937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539920|NCT01093937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539921|NCT01094015|Lidocaine|lidocaine|mesh-list
65539922|NCT01094015|Prilocaine|prilocaine|mesh-list
65539923|NCT01094015|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65539924|NCT01094015|Anesthetics, Local|anesthetics, local|mesh-ancestor
65539925|NCT01094015|Anesthetics|anesthetics|mesh-ancestor
65539926|NCT01094015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65539927|NCT01094015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539928|NCT01094015|Sensory System Agents|sensory system agents|mesh-ancestor
65539929|NCT01094015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65539930|NCT01094015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65539931|NCT01094015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65539932|NCT01094015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65539933|NCT01094015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65539934|NCT01094015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539935|NCT01094015|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65539936|NCT01090895|Ascorbic Acid|ascorbic acid|mesh-list
65539937|NCT01090895|Vitamins|vitamins|mesh-ancestor
65539938|NCT01090895|Micronutrients|micronutrients|mesh-ancestor
65539939|NCT01090895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539940|NCT01090895|Antioxidants|antioxidants|mesh-ancestor
65539941|NCT01090895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539942|NCT01090895|Protective Agents|protective agents|mesh-ancestor
65539943|NCT03956303|Levobupivacaine|levobupivacaine|mesh-list
65539944|NCT03956303|Anesthetics, Local|anesthetics, local|mesh-ancestor
65539945|NCT03956303|Anesthetics|anesthetics|mesh-ancestor
65539946|NCT03956303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65539947|NCT03956303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539948|NCT03956303|Sensory System Agents|sensory system agents|mesh-ancestor
65539949|NCT03956303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65539950|NCT01094249|Valproic Acid|valproic acid|mesh-list
65539951|NCT01094249|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65539952|NCT01094249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65539953|NCT01094249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65539954|NCT01094249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65539955|NCT01094249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539956|NCT01094249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65539957|NCT01094249|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65539958|NCT01094249|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65539959|NCT01094249|Serotonin Agents|serotonin agents|mesh-ancestor
65539960|NCT01094249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65539961|NCT01094249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539962|NCT01094249|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65539963|NCT01094249|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65539964|NCT01094249|Dopamine Agents|dopamine agents|mesh-ancestor
65539965|NCT01094249|Anticonvulsants|anticonvulsants|mesh-ancestor
65539966|NCT01094249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539968|NCT01094249|Antimanic Agents|antimanic agents|mesh-ancestor
65539969|NCT00055601|Gemcitabine|gemcitabine|mesh-list
65539970|NCT00055601|Paclitaxel|paclitaxel|mesh-list
65539971|NCT00055601|Fluorouracil|fluorouracil|mesh-list
65539972|NCT00055601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65539973|NCT00055601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65539974|NCT00055601|Tubulin Modulators|tubulin modulators|mesh-ancestor
65539975|NCT00055601|Antimitotic Agents|antimitotic agents|mesh-ancestor
65539976|NCT00055601|Mitosis Modulators|mitosis modulators|mesh-ancestor
65539977|NCT00055601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65539978|NCT00055601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65539979|NCT00055601|Antimetabolites|antimetabolites|mesh-ancestor
65539980|NCT00055601|Antiviral Agents|antiviral agents|mesh-ancestor
65539981|NCT00055601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65539982|NCT00055601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65539983|NCT00055601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65539984|NCT00055601|Immunologic Factors|immunologic factors|mesh-ancestor
65539985|NCT00055601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539986|NCT01583621|Cholecalciferol|cholecalciferol|mesh-list
65539987|NCT01583621|Vitamin D|vitamin d|mesh-list
65539988|NCT01583621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65539989|NCT01583621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539990|NCT01583621|Vitamins|vitamins|mesh-ancestor
65539991|NCT01583621|Micronutrients|micronutrients|mesh-ancestor
65539992|NCT01583621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65539993|NCT03806231|Dinoprostone|dinoprostone|mesh-list
65539994|NCT03806231|Oxytocics|oxytocics|mesh-ancestor
65539995|NCT03806231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65539996|NCT03806231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65539997|NCT01091051|Ustekinumab|ustekinumab|mesh-list
65539998|NCT01091051|Dermatologic Agents|dermatologic agents|mesh-ancestor
65539999|NCT01327079|Methadone|methadone|mesh-list
65540000|NCT01327079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65540001|NCT01327079|Narcotics|narcotics|mesh-ancestor
65540002|NCT01327079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65540003|NCT01327079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540004|NCT01327079|Analgesics|analgesics|mesh-ancestor
65540005|NCT01327079|Sensory System Agents|sensory system agents|mesh-ancestor
65540006|NCT01327079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65540007|NCT01327079|Antitussive Agents|antitussive agents|mesh-ancestor
65540008|NCT01327079|Respiratory System Agents|respiratory system agents|mesh-ancestor
65540009|NCT01091207|Sorafenib|sorafenib|mesh-list
65540010|NCT01091207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540011|NCT01091207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65540012|NCT01091207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540013|NCT01091207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540014|NCT00054275|Docetaxel|docetaxel|mesh-list
65540015|NCT00054275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65540016|NCT00054275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269096|NCT02387099|Everolimus|everolimus|mesh-list
65540017|NCT00054275|Tubulin Modulators|tubulin modulators|mesh-ancestor
65540018|NCT00054275|Antimitotic Agents|antimitotic agents|mesh-ancestor
65540019|NCT00054275|Mitosis Modulators|mitosis modulators|mesh-ancestor
65540020|NCT00054275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540021|NCT00054275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65540022|NCT00054275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540023|NCT01095185|Simvastatin|simvastatin|mesh-list
65540024|NCT01095185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65540025|NCT01095185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65540026|NCT01095185|Antimetabolites|antimetabolites|mesh-ancestor
65540027|NCT01095185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540028|NCT01095185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65540029|NCT01095185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65540030|NCT01095185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540031|NCT01583777|Belinostat|belinostat|mesh-list
65540032|NCT01583777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540033|NCT01583777|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65540034|NCT01583777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540035|NCT01583777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540036|NCT00053417|4-Aminopyridine|4-aminopyridine|mesh-list
65540037|NCT00053417|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65540038|NCT00053417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65540039|NCT00053417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540040|NCT00052715|Poly ICLC|poly iclc|mesh-list
65540041|NCT00052715|Interferon Inducers|interferon inducers|mesh-ancestor
65540042|NCT00052715|Immunologic Factors|immunologic factors|mesh-ancestor
65540043|NCT00052715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540044|NCT03955601|Cyclophosphamide|cyclophosphamide|mesh-list
65540045|NCT03955601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65540046|NCT03955601|Immunologic Factors|immunologic factors|mesh-ancestor
65540047|NCT03955601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540048|NCT03955601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65540049|NCT03955601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65540050|NCT03955601|Alkylating Agents|alkylating agents|mesh-ancestor
65540051|NCT03955601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540052|NCT03955601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540053|NCT03955601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65540054|NCT00051311|Cyclosporine|cyclosporine|mesh-list
65540055|NCT00051311|Prednisone|prednisone|mesh-list
65540056|NCT00051311|Cyclophosphamide|cyclophosphamide|mesh-list
65540057|NCT00051311|Doxorubicin|doxorubicin|mesh-list
65540058|NCT00051311|Methotrexate|methotrexate|mesh-list
65540059|NCT00051311|Fludarabine|fludarabine|mesh-list
65540060|NCT00051311|Etoposide|etoposide|mesh-list
65540061|NCT00051311|Vincristine|vincristine|mesh-list
65540062|NCT00051311|Cyclosporins|cyclosporins|mesh-list
65540063|NCT00051311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65540064|NCT00051311|Immunologic Factors|immunologic factors|mesh-ancestor
65540065|NCT00051311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540066|NCT00051311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65540067|NCT00051311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65540068|NCT00051311|Alkylating Agents|alkylating agents|mesh-ancestor
65540069|NCT00051311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540070|NCT00051311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540071|NCT00051311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65540072|NCT00051311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65540073|NCT00051311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65540074|NCT00051311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65540075|NCT00051311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540076|NCT00051311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65540077|NCT00051311|Glucocorticoids|glucocorticoids|mesh-ancestor
65540078|NCT00051311|Hormones|hormones|mesh-ancestor
65540079|NCT00051311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65540080|NCT00051311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65540081|NCT00051311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65540082|NCT00051311|Abortifacient Agents|abortifacient agents|mesh-ancestor
65540083|NCT00051311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65540084|NCT00051311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65540085|NCT00051311|Antimetabolites|antimetabolites|mesh-ancestor
65540086|NCT00051311|Dermatologic Agents|dermatologic agents|mesh-ancestor
65540087|NCT00051311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65540088|NCT00051311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65540089|NCT00051311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65540090|NCT00051311|Tubulin Modulators|tubulin modulators|mesh-ancestor
65540091|NCT00051311|Antimitotic Agents|antimitotic agents|mesh-ancestor
65540092|NCT00051311|Mitosis Modulators|mitosis modulators|mesh-ancestor
65540093|NCT00051311|Antifungal Agents|antifungal agents|mesh-ancestor
65540094|NCT00051311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65540095|NCT00051311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65540096|NCT01091753|Amlodipine|amlodipine|mesh-list
65540097|NCT01091753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65540098|NCT01091753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65540099|NCT01091753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65540100|NCT01091753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540101|NCT01091753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65540102|NCT01091753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540103|NCT01091753|Vasodilator Agents|vasodilator agents|mesh-ancestor
65540104|NCT00049673|Thalidomide|thalidomide|mesh-list
65540105|NCT00049673|Prednisone|prednisone|mesh-list
65540106|NCT00049673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65540107|NCT00049673|Glucocorticoids|glucocorticoids|mesh-ancestor
65540108|NCT00049673|Hormones|hormones|mesh-ancestor
65540109|NCT00049673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65540110|NCT00049673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540111|NCT00049673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65540112|NCT00049673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540113|NCT00049673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65540114|NCT00049673|Immunologic Factors|immunologic factors|mesh-ancestor
65540115|NCT00049673|Leprostatic Agents|leprostatic agents|mesh-ancestor
65540116|NCT00049673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65540117|NCT00049673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65540118|NCT00049673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65540119|NCT00049673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65540120|NCT00049673|Growth Substances|growth substances|mesh-ancestor
65540121|NCT00049673|Growth Inhibitors|growth inhibitors|mesh-ancestor
65540122|NCT00049517|Cytarabine|cytarabine|mesh-list
65540123|NCT00049517|Cyclophosphamide|cyclophosphamide|mesh-list
65540124|NCT00049517|Busulfan|busulfan|mesh-list
65540125|NCT00049517|Daunorubicin|daunorubicin|mesh-list
65540126|NCT00049517|Gemtuzumab|gemtuzumab|mesh-list
65540127|NCT00049517|Sargramostim|sargramostim|mesh-list
65540128|NCT00049517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65540129|NCT00049517|Immunologic Factors|immunologic factors|mesh-ancestor
65540130|NCT00049517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540131|NCT00049517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65540132|NCT00049517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65540133|NCT00049517|Alkylating Agents|alkylating agents|mesh-ancestor
65540134|NCT00049517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540135|NCT00049517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540136|NCT00049517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65540137|NCT00049517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65540138|NCT00049517|Antimetabolites|antimetabolites|mesh-ancestor
65540139|NCT00049517|Antiviral Agents|antiviral agents|mesh-ancestor
65540140|NCT00049517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65540141|NCT00049517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65540142|NCT00049517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65540143|NCT00049517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65540144|NCT00049517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540145|NCT00049517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65540146|NCT00049127|Imatinib Mesylate|imatinib mesylate|mesh-list
65540147|NCT00049127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540148|NCT00049127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65540149|NCT00049127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540150|NCT00049127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540151|NCT00066365|Molgramostim|molgramostim|mesh-list
65540152|NCT00066365|Sargramostim|sargramostim|mesh-list
65540153|NCT00066365|Immunologic Factors|immunologic factors|mesh-ancestor
65540154|NCT00066365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540155|NCT00066365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540156|NCT00048581|Abatacept|abatacept|mesh-list
65540157|NCT00048581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65540158|NCT00048581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540159|NCT00048581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540160|NCT00048581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65540161|NCT00048581|Immunologic Factors|immunologic factors|mesh-ancestor
65540162|NCT00048581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540163|NCT00048581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65540164|NCT00048347|Interferon beta-1a|interferon beta-1a|mesh-list
65540165|NCT00048347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65540166|NCT00048347|Immunologic Factors|immunologic factors|mesh-ancestor
65540167|NCT00048347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540168|NCT00048347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540169|NCT00048347|Antiviral Agents|antiviral agents|mesh-ancestor
65540170|NCT00048347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65540171|NCT03957629|Interferons|interferons|mesh-list
65540172|NCT03957629|Tenofovir|tenofovir|mesh-list
65540173|NCT03957629|Interferon-alpha|interferon-alpha|mesh-list
65540174|NCT03957629|Interferon alpha-2|interferon alpha-2|mesh-list
65540175|NCT03957629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65540176|NCT03957629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540177|NCT03957629|Antiviral Agents|antiviral agents|mesh-ancestor
65540178|NCT03957629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65540179|NCT03957629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65540180|NCT03957629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65540181|NCT03957629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540182|NCT03957629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540183|NCT03957629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65540184|NCT03957629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65540185|NCT03957629|Immunologic Factors|immunologic factors|mesh-ancestor
65540186|NCT03957629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540187|NCT00065507|Entecavir|entecavir|mesh-list
65540188|NCT00065507|Adefovir|adefovir|mesh-list
65540189|NCT00065507|Antiviral Agents|antiviral agents|mesh-ancestor
65540190|NCT00065507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65540191|NCT00065507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65540192|NCT00065507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65540193|NCT00065507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540194|NCT00065507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540196|NCT01095575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65540197|NCT01095575|Narcotics|narcotics|mesh-ancestor
65540198|NCT01095575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65540199|NCT01095575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540200|NCT01095575|Analgesics|analgesics|mesh-ancestor
65540201|NCT01095575|Sensory System Agents|sensory system agents|mesh-ancestor
65540202|NCT01095575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65540203|NCT00065429|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
65540204|NCT00065429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65540205|NCT00065429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540206|NCT00065429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65540207|NCT01095731|Acetic Acid|acetic acid|mesh-list
65540208|NCT01095731|Retinol acetate|retinol acetate|mesh-list
65540209|NCT01095731|Glycine|glycine|mesh-list
65540210|NCT01095731|Glycine Agents|glycine agents|mesh-ancestor
65540211|NCT01095731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65540212|NCT01095731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540213|NCT01095731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540214|NCT01095731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65540215|NCT01095731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65540216|NCT01095731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65540217|NCT01095731|Immunologic Factors|immunologic factors|mesh-ancestor
65540218|NCT01095731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65540219|NCT01095731|Protective Agents|protective agents|mesh-ancestor
65540220|NCT01095731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540221|NCT01095809|Triamcinolone|triamcinolone|mesh-list
65540222|NCT01095809|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65540223|NCT01095809|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65540224|NCT01095809|Bevacizumab|bevacizumab|mesh-list
65540225|NCT01095809|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65540226|NCT01095809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65540227|NCT01095809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540228|NCT01095809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65540229|NCT01095809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65540230|NCT01095809|Growth Substances|growth substances|mesh-ancestor
65540231|NCT01095809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540232|NCT01095809|Growth Inhibitors|growth inhibitors|mesh-ancestor
65540233|NCT01095809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65540234|NCT01095809|Glucocorticoids|glucocorticoids|mesh-ancestor
65540235|NCT01095809|Hormones|hormones|mesh-ancestor
65540236|NCT01095809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65540237|NCT01095809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65540238|NCT01095809|Immunologic Factors|immunologic factors|mesh-ancestor
65540239|NCT01095809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540240|NCT01095809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540241|NCT00048035|Epoetin Alfa|epoetin alfa|mesh-list
65540242|NCT00048035|Hematinics|hematinics|mesh-ancestor
65540243|NCT01092221|Allopurinol|allopurinol|mesh-list
65540244|NCT01092221|Antimetabolites|antimetabolites|mesh-ancestor
65540245|NCT01092221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540246|NCT01092221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540247|NCT01092221|Gout Suppressants|gout suppressants|mesh-ancestor
65540248|NCT01092221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65540249|NCT01092221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65540250|NCT01092221|Antioxidants|antioxidants|mesh-ancestor
65540251|NCT01092221|Protective Agents|protective agents|mesh-ancestor
65540252|NCT01092221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540253|NCT00047879|Interferons|interferons|mesh-list
65540254|NCT00047879|Interferon-alpha|interferon-alpha|mesh-list
65540255|NCT00047879|Interferon alpha-2|interferon alpha-2|mesh-list
65540256|NCT00047879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65540257|NCT00047879|Thalidomide|thalidomide|mesh-list
65540258|NCT00047879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540259|NCT00047879|Antiviral Agents|antiviral agents|mesh-ancestor
65540260|NCT00047879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65540261|NCT00047879|Immunologic Factors|immunologic factors|mesh-ancestor
65540262|NCT00047879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540263|NCT00047879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65540264|NCT00047879|Leprostatic Agents|leprostatic agents|mesh-ancestor
65540265|NCT00047879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65540266|NCT00047879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65540267|NCT00047879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65540268|NCT00047879|Growth Substances|growth substances|mesh-ancestor
65540269|NCT00047879|Growth Inhibitors|growth inhibitors|mesh-ancestor
65540271|NCT00064337|Dexamethasone|dexamethasone|mesh-list
65540272|NCT00064337|Cyclophosphamide|cyclophosphamide|mesh-list
65540273|NCT00064337|Melphalan|melphalan|mesh-list
65540274|NCT00064337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65540275|NCT00064337|Immunologic Factors|immunologic factors|mesh-ancestor
65540276|NCT00064337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540277|NCT00064337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65540278|NCT00064337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65540279|NCT00064337|Alkylating Agents|alkylating agents|mesh-ancestor
65540280|NCT00064337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540281|NCT00064337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540282|NCT00064337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65540283|NCT00064337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65540284|NCT00064337|Antiemetics|antiemetics|mesh-ancestor
65540285|NCT00064337|Autonomic Agents|autonomic agents|mesh-ancestor
65540286|NCT00064337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65540287|NCT00064337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65540288|NCT00064337|Glucocorticoids|glucocorticoids|mesh-ancestor
65540289|NCT00064337|Hormones|hormones|mesh-ancestor
65540290|NCT00064337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65540291|NCT00064337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65540292|NCT00064337|Leprostatic Agents|leprostatic agents|mesh-ancestor
65540293|NCT00064337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65540294|NCT00064337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65540295|NCT00064337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65540296|NCT00064337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65540297|NCT00064337|Growth Substances|growth substances|mesh-ancestor
65540298|NCT00064337|Growth Inhibitors|growth inhibitors|mesh-ancestor
65540299|NCT00045305|Cyclosporine|cyclosporine|mesh-list
65540300|NCT00045305|Mycophenolic Acid|mycophenolic acid|mesh-list
65540301|NCT00045305|Methotrexate|methotrexate|mesh-list
65540302|NCT00045305|Pentostatin|pentostatin|mesh-list
65540303|NCT00045305|Methoxsalen|methoxsalen|mesh-list
65540304|NCT00045305|Cyclosporins|cyclosporins|mesh-list
65540305|NCT00045305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65540306|NCT00045305|Abortifacient Agents|abortifacient agents|mesh-ancestor
65540307|NCT00045305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65540308|NCT00045305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540309|NCT00045305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65540310|NCT00045305|Antimetabolites|antimetabolites|mesh-ancestor
65540311|NCT00045305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540312|NCT00045305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540313|NCT00045305|Dermatologic Agents|dermatologic agents|mesh-ancestor
65540314|NCT00045305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540315|NCT00045305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65540316|NCT00045305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65540317|NCT00045305|Immunologic Factors|immunologic factors|mesh-ancestor
65540318|NCT00045305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65540319|NCT00045305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65540320|NCT00045305|Antifungal Agents|antifungal agents|mesh-ancestor
65269402|NCT03724994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65540321|NCT00045305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65540322|NCT00045305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65540323|NCT00045305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65540324|NCT00045305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65540325|NCT00045305|Antitubercular Agents|antitubercular agents|mesh-ancestor
65540326|NCT00045305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65540327|NCT00045305|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65540328|NCT00045305|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65540329|NCT01096121|Enalapril|enalapril|mesh-list
65540330|NCT01096121|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65540331|NCT01096121|Protease Inhibitors|protease inhibitors|mesh-ancestor
65540332|NCT01096121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540333|NCT01096121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540334|NCT01096121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65540335|NCT00064259|Fluorouracil|fluorouracil|mesh-list
65540336|NCT00064259|Oblimersen|oblimersen|mesh-list
65540337|NCT00064259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540338|NCT00064259|Antimetabolites|antimetabolites|mesh-ancestor
65540339|NCT00064259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540340|NCT00064259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65540341|NCT00064259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65540342|NCT00064259|Immunologic Factors|immunologic factors|mesh-ancestor
65540343|NCT00064259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540344|NCT03954197|Hormones|hormones|mesh-list
65540345|NCT03954197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65540346|NCT03954197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540348|NCT00044213|Edetic Acid|edetic acid|mesh-list
65540349|NCT00044213|Pentetic Acid|pentetic acid|mesh-list
65540350|NCT00044213|Micronutrients|micronutrients|mesh-ancestor
65540351|NCT00044213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540352|NCT00044213|Anticoagulants|anticoagulants|mesh-ancestor
65540353|NCT00044213|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65540354|NCT00044213|Chelating Agents|chelating agents|mesh-ancestor
65540355|NCT00044213|Sequestering Agents|sequestering agents|mesh-ancestor
65540356|NCT00044213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540357|NCT00044213|Antidotes|antidotes|mesh-ancestor
65540358|NCT00044213|Protective Agents|protective agents|mesh-ancestor
65540359|NCT00044213|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65540360|NCT00064025|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65540361|NCT00064025|Medroxyprogesterone|medroxyprogesterone|mesh-list
65540362|NCT00064025|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65540363|NCT00064025|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65540364|NCT00064025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65540365|NCT00064025|Contraceptive Agents|contraceptive agents|mesh-ancestor
65540366|NCT00064025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65540367|NCT00064025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540368|NCT00064025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65540369|NCT00064025|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65540370|NCT00064025|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65540371|NCT00064025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65540372|NCT00064025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540373|NCT01096199|Cisplatin|cisplatin|mesh-list
65540374|NCT01096199|Everolimus|everolimus|mesh-list
65540375|NCT01096199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540376|NCT01096199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65540377|NCT01096199|Immunologic Factors|immunologic factors|mesh-ancestor
65540378|NCT01096199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540379|NCT01096277|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65540380|NCT01096277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65540381|NCT01096277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540382|NCT01096277|Incretins|incretins|mesh-ancestor
65540383|NCT01096277|Hormones|hormones|mesh-ancestor
65540384|NCT01096277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65540385|NCT01096277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65540386|NCT01096277|Protease Inhibitors|protease inhibitors|mesh-ancestor
65540387|NCT01096277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540388|NCT01096277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540389|NCT01096355|R04929097|r04929097|mesh-list
65540390|NCT01096355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540391|NCT01096355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540392|NCT01096511|Moxifloxacin|moxifloxacin|mesh-list
65540393|NCT01096511|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65269481|NCT04247867|Psyllium|psyllium|mesh-list
65540394|NCT01096511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65540395|NCT01096511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65540396|NCT01096511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65540397|NCT01096511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65540398|NCT01096511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540399|NCT01096511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540400|NCT01096511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540401|NCT01096511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65540402|NCT01096511|Contraceptive Agents|contraceptive agents|mesh-ancestor
65540403|NCT01096511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65540404|NCT01096511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540405|NCT01096511|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65540406|NCT01096511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65540407|NCT01096511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65540408|NCT01092455|Heparin|heparin|mesh-list
65540409|NCT01092455|Calcium heparin|calcium heparin|mesh-list
65540410|NCT01092455|Anticoagulants|anticoagulants|mesh-ancestor
65540411|NCT01092455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65540412|NCT01092455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65540413|NCT01092455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540414|NCT02095132|Irinotecan|irinotecan|mesh-list
65540415|NCT02095132|Camptothecin|camptothecin|mesh-list
65540416|NCT02095132|Adavosertib|adavosertib|mesh-list
65540417|NCT02095132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65337929|NCT00806871|Prednisolone|prednisolone|mesh-list
65540418|NCT02095132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65540419|NCT02095132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540420|NCT02095132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540421|NCT02095132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540422|NCT02095132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65540423|NCT02264938|Antioxidants|antioxidants|mesh-list
65540424|NCT02264938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540425|NCT02264938|Protective Agents|protective agents|mesh-ancestor
65540426|NCT02264938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540427|NCT02511886|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
65540428|NCT02511886|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65540429|NCT02511886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540430|NCT02511886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65540431|NCT02511886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65540432|NCT02511886|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65540433|NCT02511886|GABA Agonists|gaba agonists|mesh-ancestor
65540434|NCT02511886|GABA Agents|gaba agents|mesh-ancestor
65540435|NCT02511886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65540436|NCT02511886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540437|NCT04235140|Ivacaftor|ivacaftor|mesh-list
65540438|NCT04235140|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65540439|NCT04235140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65540440|NCT04235140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540441|NCT00043979|Cyclosporine|cyclosporine|mesh-list
65540442|NCT00043979|Sirolimus|sirolimus|mesh-list
65540443|NCT00043979|Prednisone|prednisone|mesh-list
65540444|NCT00043979|Cyclophosphamide|cyclophosphamide|mesh-list
65540445|NCT00043979|Melphalan|melphalan|mesh-list
65540446|NCT00043979|Doxorubicin|doxorubicin|mesh-list
65540447|NCT00043979|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65540448|NCT00043979|Fludarabine|fludarabine|mesh-list
65540449|NCT00043979|Fludarabine phosphate|fludarabine phosphate|mesh-list
65540450|NCT00043979|Etoposide|etoposide|mesh-list
65540451|NCT00043979|Vincristine|vincristine|mesh-list
65540452|NCT00043979|Tacrolimus|tacrolimus|mesh-list
65540453|NCT00043979|Cyclosporins|cyclosporins|mesh-list
65540454|NCT00043979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65540455|NCT00043979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65540456|NCT00043979|Immunologic Factors|immunologic factors|mesh-ancestor
65540457|NCT00043979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540458|NCT00043979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65540459|NCT00043979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65540460|NCT00043979|Alkylating Agents|alkylating agents|mesh-ancestor
65540461|NCT00043979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540462|NCT00043979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540463|NCT00043979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65540464|NCT00043979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65540465|NCT00043979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65540466|NCT00043979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65540467|NCT00043979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540468|NCT00043979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65540469|NCT00043979|Glucocorticoids|glucocorticoids|mesh-ancestor
65540470|NCT00043979|Hormones|hormones|mesh-ancestor
65540471|NCT00043979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65540472|NCT00043979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65540473|NCT00043979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65540474|NCT00043979|Antimetabolites|antimetabolites|mesh-ancestor
65540475|NCT00043979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65540476|NCT00043979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65540477|NCT00043979|Tubulin Modulators|tubulin modulators|mesh-ancestor
65540478|NCT00043979|Antimitotic Agents|antimitotic agents|mesh-ancestor
65540479|NCT00043979|Mitosis Modulators|mitosis modulators|mesh-ancestor
65540480|NCT00043979|Antifungal Agents|antifungal agents|mesh-ancestor
65540481|NCT00043979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65540482|NCT00043979|Dermatologic Agents|dermatologic agents|mesh-ancestor
65540483|NCT00043979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65540484|NCT00043979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65540485|NCT01436032|Ketorolac|ketorolac|mesh-list
65540486|NCT01436032|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65540487|NCT01436032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65540488|NCT01436032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65540489|NCT01436032|Analgesics|analgesics|mesh-ancestor
65540490|NCT01436032|Sensory System Agents|sensory system agents|mesh-ancestor
65540491|NCT01436032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65540492|NCT01436032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540493|NCT01436032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65540494|NCT01436032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65540495|NCT01436032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65540496|NCT01436032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540497|NCT01436032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540498|NCT01092533|Mycophenolic Acid|mycophenolic acid|mesh-list
65540499|NCT01092533|Prednisolone|prednisolone|mesh-list
65540500|NCT01092533|Prednisone|prednisone|mesh-list
65540501|NCT01092533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65540502|NCT01092533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540503|NCT01092533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65540504|NCT01092533|Antitubercular Agents|antitubercular agents|mesh-ancestor
65540505|NCT01092533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65540506|NCT01092533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65540507|NCT01092533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540508|NCT01092533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540509|NCT01092533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65540510|NCT01092533|Glucocorticoids|glucocorticoids|mesh-ancestor
65540511|NCT01092533|Hormones|hormones|mesh-ancestor
65540512|NCT01092533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65540513|NCT01092533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540514|NCT01092533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65540515|NCT01431820|Luliconazole|luliconazole|mesh-list
65540516|NCT01431820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65540517|NCT01431820|Antifungal Agents|antifungal agents|mesh-ancestor
65540518|NCT01431820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65540519|NCT01425970|Interferons|interferons|mesh-list
65540520|NCT01425970|Ribavirin|ribavirin|mesh-list
65540521|NCT01425970|Interferon-alpha|interferon-alpha|mesh-list
65540522|NCT01425970|Interferon alpha-2|interferon alpha-2|mesh-list
65540523|NCT01425970|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65540524|NCT01425970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540525|NCT01425970|Antiviral Agents|antiviral agents|mesh-ancestor
65540526|NCT01425970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65540527|NCT01425970|Antimetabolites|antimetabolites|mesh-ancestor
65540528|NCT01425970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540529|NCT01425970|Immunologic Factors|immunologic factors|mesh-ancestor
65540530|NCT01425970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540531|NCT01619332|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65540532|NCT01619332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65540533|NCT01619332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540534|NCT01619332|Incretins|incretins|mesh-ancestor
65540535|NCT01619332|Hormones|hormones|mesh-ancestor
65540536|NCT01619332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65540537|NCT01619332|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65540538|NCT01619332|Protease Inhibitors|protease inhibitors|mesh-ancestor
65540539|NCT01619332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540540|NCT01619332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540541|NCT01616524|Interferons|interferons|mesh-list
65540542|NCT01616524|Ribavirin|ribavirin|mesh-list
65269624|NCT03195374|Sensory System Agents|sensory system agents|mesh-ancestor
65540543|NCT01616524|Interferon-alpha|interferon-alpha|mesh-list
65540544|NCT01616524|Interferon alpha-2|interferon alpha-2|mesh-list
65540545|NCT01616524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65540546|NCT01616524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540547|NCT01616524|Antiviral Agents|antiviral agents|mesh-ancestor
65540548|NCT01616524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65540549|NCT01616524|Antimetabolites|antimetabolites|mesh-ancestor
65540550|NCT01616524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540551|NCT01616524|Immunologic Factors|immunologic factors|mesh-ancestor
65540552|NCT01616524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540553|NCT02265328|Prednisolone|prednisolone|mesh-list
65540554|NCT02265328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65540555|NCT02265328|Glucocorticoids|glucocorticoids|mesh-ancestor
65540556|NCT02265328|Hormones|hormones|mesh-ancestor
65540557|NCT02265328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65540558|NCT02265328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540559|NCT02265328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65540560|NCT02265328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540561|NCT02265406|Anti-Infective Agents|anti-infective agents|mesh-list
65540562|NCT01422148|Minocycline|minocycline|mesh-list
65540563|NCT01422148|Amiodarone|amiodarone|mesh-list
65540564|NCT01422148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65540565|NCT01422148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65540566|NCT01422148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65338094|NCT00722852|Ketoprofen|ketoprofen|mesh-list
65540567|NCT01422148|Vasodilator Agents|vasodilator agents|mesh-ancestor
65540568|NCT01422148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65540569|NCT01422148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65540570|NCT01422148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540571|NCT01422148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65540572|NCT01422148|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65540573|NCT01422148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65540574|NCT01422148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540575|NCT01422148|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65540576|NCT01422148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65540577|NCT01422148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65540578|NCT01421056|Flurbiprofen|flurbiprofen|mesh-list
65540579|NCT01421056|Analgesics|analgesics|mesh-ancestor
65540580|NCT01421056|Sensory System Agents|sensory system agents|mesh-ancestor
65540581|NCT01421056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65540582|NCT01421056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540583|NCT01421056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65540584|NCT01421056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65540585|NCT01421056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65540586|NCT01421056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65540587|NCT01421056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65540588|NCT01421056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540589|NCT01421056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540590|NCT03971734|Regadenoson|regadenoson|mesh-list
65540591|NCT03971734|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65540592|NCT03971734|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65540593|NCT03971734|Purinergic Agonists|purinergic agonists|mesh-ancestor
65540594|NCT03971734|Purinergic Agents|purinergic agents|mesh-ancestor
65540595|NCT03971734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65540596|NCT03971734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540597|NCT03971734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540598|NCT01416064|Molindone|molindone|mesh-list
65540599|NCT01416064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65540600|NCT01416064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65540601|NCT01416064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65540602|NCT01416064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540603|NCT01416064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65540604|NCT01594216|Exemestane|exemestane|mesh-list
65540605|NCT01594216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540606|NCT01594216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65540607|NCT01594216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65540608|NCT01594216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540609|NCT01594216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540610|NCT01594216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65540611|NCT01594216|Hormone Antagonists|hormone antagonists|mesh-ancestor
65540612|NCT01594216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65540613|NCT01594216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540614|NCT02263690|Lidocaine|lidocaine|mesh-list
65540615|NCT02263690|Anesthetics, Local|anesthetics, local|mesh-ancestor
65540616|NCT02263690|Anesthetics|anesthetics|mesh-ancestor
65540617|NCT02263690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65540618|NCT02263690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540619|NCT02263690|Sensory System Agents|sensory system agents|mesh-ancestor
65540620|NCT02263690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65540621|NCT02263690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65540622|NCT02263690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65540623|NCT02263690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65540624|NCT02263690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65540625|NCT02263690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540626|NCT02265562|Alprostadil|alprostadil|mesh-list
65540627|NCT02265562|Misoprostol|misoprostol|mesh-list
65540628|NCT02265562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65540629|NCT02265562|Abortifacient Agents|abortifacient agents|mesh-ancestor
65540630|NCT02265562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65540631|NCT02265562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540632|NCT02265562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65540633|NCT02265562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65540634|NCT02265562|Oxytocics|oxytocics|mesh-ancestor
65540635|NCT02265562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65540636|NCT02265562|Vasodilator Agents|vasodilator agents|mesh-ancestor
65540637|NCT02265562|Urological Agents|urological agents|mesh-ancestor
65540638|NCT01399684|Leucovorin|leucovorin|mesh-list
65540639|NCT01399684|Folic Acid|folic acid|mesh-list
65540640|NCT01399684|Bevacizumab|bevacizumab|mesh-list
65540641|NCT01399684|Fluorouracil|fluorouracil|mesh-list
65540643|NCT01399684|Levoleucovorin|levoleucovorin|mesh-list
65540644|NCT01399684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65540645|NCT01399684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540646|NCT01399684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65540647|NCT01399684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65540648|NCT01399684|Growth Substances|growth substances|mesh-ancestor
65540649|NCT01399684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540650|NCT01399684|Growth Inhibitors|growth inhibitors|mesh-ancestor
65540651|NCT01399684|Antimetabolites|antimetabolites|mesh-ancestor
65540652|NCT01399684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540653|NCT01399684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65540654|NCT01399684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65540655|NCT01399684|Immunologic Factors|immunologic factors|mesh-ancestor
65540656|NCT01399684|Antidotes|antidotes|mesh-ancestor
65540657|NCT01399684|Protective Agents|protective agents|mesh-ancestor
65540658|NCT01399684|Vitamin B Complex|vitamin b complex|mesh-ancestor
65540659|NCT01399684|Vitamins|vitamins|mesh-ancestor
65540660|NCT01399684|Micronutrients|micronutrients|mesh-ancestor
65540661|NCT01399684|Hematinics|hematinics|mesh-ancestor
65540662|NCT01397968|Cenobamate|cenobamate|mesh-list
65540663|NCT01397968|Anticonvulsants|anticonvulsants|mesh-ancestor
65540664|NCT01397578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65540665|NCT01397578|Immunologic Factors|immunologic factors|mesh-ancestor
65540666|NCT01397578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540667|NCT02265718|Methylphenidate|methylphenidate|mesh-list
65540668|NCT02265718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65540669|NCT02265718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540670|NCT02265718|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65540671|NCT02265718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65540672|NCT02265718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65540673|NCT02265718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540674|NCT02265718|Dopamine Agents|dopamine agents|mesh-ancestor
65540675|NCT02265718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65540676|NCT02265874|Nicotine|nicotine|mesh-list
65540677|NCT02265874|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65540678|NCT02265874|Autonomic Agents|autonomic agents|mesh-ancestor
65540679|NCT02265874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65540680|NCT02265874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540681|NCT02265874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65540682|NCT02265874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65540683|NCT02265874|Cholinergic Agents|cholinergic agents|mesh-ancestor
65540684|NCT02265874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65540685|NCT02265874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540686|NCT01381666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65540687|NCT02266030|Aspirin|aspirin|mesh-list
65540688|NCT02266030|Cilostazol|cilostazol|mesh-list
65540689|NCT02266030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65269772|NCT02733380|Thalidomide|thalidomide|mesh-list
65540690|NCT02266030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65540691|NCT02266030|Analgesics|analgesics|mesh-ancestor
65540692|NCT02266030|Sensory System Agents|sensory system agents|mesh-ancestor
65540693|NCT02266030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65540694|NCT02266030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540695|NCT02266030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65540696|NCT02266030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65540697|NCT02266030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65540698|NCT02266030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65540699|NCT02266030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540700|NCT02266030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65540701|NCT02266030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65540702|NCT02266030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540703|NCT02266030|Antipyretics|antipyretics|mesh-ancestor
65540704|NCT02266030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65540705|NCT02266030|Autonomic Agents|autonomic agents|mesh-ancestor
65540706|NCT02266030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65540707|NCT02266030|Respiratory System Agents|respiratory system agents|mesh-ancestor
65540708|NCT02266030|Vasodilator Agents|vasodilator agents|mesh-ancestor
65540709|NCT02266030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65540710|NCT02266030|Protective Agents|protective agents|mesh-ancestor
65540711|NCT02266030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65540712|NCT02266030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65540713|NCT01527916|Donepezil|donepezil|mesh-list
65540714|NCT01527916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65540715|NCT01527916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338234|NCT01037491|Antipyretics|antipyretics|mesh-ancestor
65540716|NCT01527916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540717|NCT01527916|Cholinergic Agents|cholinergic agents|mesh-ancestor
65540718|NCT01527916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65540719|NCT01527916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540720|NCT01527916|Nootropic Agents|nootropic agents|mesh-ancestor
65540721|NCT01373086|Eplerenone|eplerenone|mesh-list
65540722|NCT01373086|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65540723|NCT01373086|Hormone Antagonists|hormone antagonists|mesh-ancestor
65540724|NCT01373086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65540725|NCT01373086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540726|NCT01373086|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65540727|NCT01373086|Diuretics|diuretics|mesh-ancestor
65540728|NCT01373086|Natriuretic Agents|natriuretic agents|mesh-ancestor
65540729|NCT01373086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65540730|NCT01519804|Paclitaxel|paclitaxel|mesh-list
65540731|NCT01519804|Carboplatin|carboplatin|mesh-list
65540732|NCT01519804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65540733|NCT01519804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540734|NCT01519804|Tubulin Modulators|tubulin modulators|mesh-ancestor
65540735|NCT01519804|Antimitotic Agents|antimitotic agents|mesh-ancestor
65540736|NCT01519804|Mitosis Modulators|mitosis modulators|mesh-ancestor
65540737|NCT01519804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540738|NCT02263924|Tocotrienols|tocotrienols|mesh-list
65540739|NCT02263924|Vitamin E|vitamin e|mesh-list
65540740|NCT02263924|Tocopherols|tocopherols|mesh-list
65540741|NCT02263924|Antioxidants|antioxidants|mesh-ancestor
65540742|NCT02263924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540743|NCT02263924|Protective Agents|protective agents|mesh-ancestor
65540744|NCT02263924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540745|NCT02263924|Vitamins|vitamins|mesh-ancestor
65540746|NCT02263924|Micronutrients|micronutrients|mesh-ancestor
65540747|NCT02264002|Metoprolol|metoprolol|mesh-list
65540748|NCT02264002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65540749|NCT02264002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65540750|NCT02264002|Sympatholytics|sympatholytics|mesh-ancestor
65540751|NCT02264002|Autonomic Agents|autonomic agents|mesh-ancestor
65540752|NCT02264002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65540753|NCT02264002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540754|NCT02264002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65540755|NCT02264002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65540756|NCT02264002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65540757|NCT02264002|Adrenergic Agents|adrenergic agents|mesh-ancestor
65540758|NCT02264002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65540759|NCT02264002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540760|NCT01517776|Temozolomide|temozolomide|mesh-list
65540761|NCT01517776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65540762|NCT01517776|Alkylating Agents|alkylating agents|mesh-ancestor
65269851|NCT02732522|Oxytocics|oxytocics|mesh-ancestor
65540763|NCT01517776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540764|NCT01517776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540765|NCT02266264|Hydrocortisone|hydrocortisone|mesh-list
65540766|NCT02266264|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65540767|NCT02266264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65540768|NCT01516918|Ribavirin|ribavirin|mesh-list
65540769|NCT01516918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65540770|NCT01516918|Antimetabolites|antimetabolites|mesh-ancestor
65540771|NCT01516918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540772|NCT01516918|Antiviral Agents|antiviral agents|mesh-ancestor
65540773|NCT01516918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65540774|NCT01508026|Valsartan|valsartan|mesh-list
65540775|NCT01508026|Nebivolol|nebivolol|mesh-list
65540776|NCT01508026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65540777|NCT01508026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65540778|NCT01508026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65540779|NCT01508026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540780|NCT01508026|Vasodilator Agents|vasodilator agents|mesh-ancestor
65540781|NCT01508026|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65540782|NCT01508026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65540783|NCT01508026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65540784|NCT01508026|Adrenergic Agents|adrenergic agents|mesh-ancestor
65540785|NCT01508026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65540786|NCT01508026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540787|NCT01357642|Epinephrine|epinephrine|mesh-list
65540788|NCT01357642|Racepinephrine|racepinephrine|mesh-list
65540789|NCT01357642|Epinephryl borate|epinephryl borate|mesh-list
65338307|NCT00128856|Paclitaxel|paclitaxel|mesh-list
65540790|NCT01357642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65540791|NCT01357642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65540792|NCT01357642|Adrenergic Agents|adrenergic agents|mesh-ancestor
65540793|NCT01357642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65540794|NCT01357642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540795|NCT01357642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540796|NCT01357642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65540797|NCT01357642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65540798|NCT01357642|Autonomic Agents|autonomic agents|mesh-ancestor
65540799|NCT01357642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65540800|NCT01357642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65540801|NCT01357642|Respiratory System Agents|respiratory system agents|mesh-ancestor
65540802|NCT01357642|Mydriatics|mydriatics|mesh-ancestor
65540803|NCT01357642|Sympathomimetics|sympathomimetics|mesh-ancestor
65540804|NCT01357642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65540805|NCT03135340|Anesthetics|anesthetics|mesh-list
65540806|NCT03135340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65540807|NCT03135340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540808|NCT01356160|Ribavirin|ribavirin|mesh-list
65540809|NCT01356160|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65540810|NCT01356160|Ledipasvir|ledipasvir|mesh-list
65540811|NCT01356160|Antimetabolites|antimetabolites|mesh-ancestor
65540812|NCT01356160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540813|NCT01356160|Antiviral Agents|antiviral agents|mesh-ancestor
65540814|NCT01356160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65540815|NCT02264158|Telmisartan|telmisartan|mesh-list
65540816|NCT02264158|Lacidipine|lacidipine|mesh-list
65540817|NCT02264158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65540818|NCT02264158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65540819|NCT02264158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65540820|NCT02264158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540821|NCT02264158|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65540822|NCT02264158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65540823|NCT02264158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65540824|NCT02264158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540825|NCT02264236|Vaccines|vaccines|mesh-list
65540826|NCT02264236|Immunologic Factors|immunologic factors|mesh-ancestor
65540827|NCT02264236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540828|NCT01476904|Epinephrine|epinephrine|mesh-list
65540829|NCT01476904|Racepinephrine|racepinephrine|mesh-list
65540830|NCT01476904|Epinephryl borate|epinephryl borate|mesh-list
65540831|NCT01476904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65540832|NCT01476904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65540833|NCT01476904|Adrenergic Agents|adrenergic agents|mesh-ancestor
65540834|NCT01476904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65540835|NCT01476904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269922|NCT02737124|Sensory System Agents|sensory system agents|mesh-ancestor
65540836|NCT01476904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540837|NCT01476904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65540838|NCT01476904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65540839|NCT01476904|Autonomic Agents|autonomic agents|mesh-ancestor
65540840|NCT01476904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65540841|NCT01476904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65540842|NCT01476904|Respiratory System Agents|respiratory system agents|mesh-ancestor
65540843|NCT01476904|Mydriatics|mydriatics|mesh-ancestor
65540844|NCT01476904|Sympathomimetics|sympathomimetics|mesh-ancestor
65540845|NCT01476904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65540846|NCT01337752|Dexamethasone|dexamethasone|mesh-list
65540847|NCT01337752|Bortezomib|bortezomib|mesh-list
65540848|NCT01337752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65540849|NCT01337752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65540850|NCT01337752|Antiemetics|antiemetics|mesh-ancestor
65540851|NCT01337752|Autonomic Agents|autonomic agents|mesh-ancestor
65540852|NCT01337752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65540853|NCT01337752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540854|NCT01337752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65540855|NCT01337752|Glucocorticoids|glucocorticoids|mesh-ancestor
65540856|NCT01337752|Hormones|hormones|mesh-ancestor
65540857|NCT01337752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65540858|NCT01337752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65540859|NCT01337752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540860|NCT01337752|Immunologic Factors|immunologic factors|mesh-ancestor
65540861|NCT01318642|Gemcitabine|gemcitabine|mesh-list
65540862|NCT01318642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65540863|NCT01318642|Antimetabolites|antimetabolites|mesh-ancestor
65540864|NCT01318642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540866|NCT01318642|Antiviral Agents|antiviral agents|mesh-ancestor
65540867|NCT01318642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65540868|NCT01318642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540869|NCT01318642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65540870|NCT01318642|Immunologic Factors|immunologic factors|mesh-ancestor
65540871|NCT01318642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540872|NCT01318252|Latanoprost|latanoprost|mesh-list
65540873|NCT01318252|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65540874|NCT01318252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65540875|NCT01313572|Adenosine|adenosine|mesh-list
65540876|NCT01313572|Analgesics|analgesics|mesh-ancestor
65540877|NCT01313572|Sensory System Agents|sensory system agents|mesh-ancestor
65540878|NCT01313572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65540879|NCT01313572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540880|NCT01313572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65540881|NCT01313572|Vasodilator Agents|vasodilator agents|mesh-ancestor
65540882|NCT01313572|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65540883|NCT01313572|Purinergic Agonists|purinergic agonists|mesh-ancestor
65540884|NCT01313572|Purinergic Agents|purinergic agents|mesh-ancestor
65540885|NCT01313572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65540886|NCT01313572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540887|NCT02265484|Rifaximin|rifaximin|mesh-list
65540888|NCT02265484|Bromocriptine|bromocriptine|mesh-list
65540889|NCT02265484|Lactulose|lactulose|mesh-list
65540890|NCT02265484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65540891|NCT02265484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65540892|NCT02265484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65540893|NCT02265484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65540894|NCT02265484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65540895|NCT02265484|Hormone Antagonists|hormone antagonists|mesh-ancestor
65540896|NCT02265484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65540897|NCT02265484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540898|NCT02265484|Dopamine Agonists|dopamine agonists|mesh-ancestor
65540899|NCT02265484|Dopamine Agents|dopamine agents|mesh-ancestor
65540900|NCT02265484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65540901|NCT02265484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540902|NCT02264626|Remifentanil|remifentanil|mesh-list
65540903|NCT02264626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65540904|NCT02264626|Narcotics|narcotics|mesh-ancestor
65540905|NCT02264626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65540906|NCT02264626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540907|NCT02264626|Analgesics|analgesics|mesh-ancestor
65540908|NCT02264626|Sensory System Agents|sensory system agents|mesh-ancestor
65540909|NCT02264626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65540910|NCT03993262|Bortezomib|bortezomib|mesh-list
65540911|NCT03993262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540912|NCT02267044|Ropivacaine|ropivacaine|mesh-list
65540913|NCT02267044|Anesthetics, Local|anesthetics, local|mesh-ancestor
65540914|NCT02267044|Anesthetics|anesthetics|mesh-ancestor
65540915|NCT02267044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65540916|NCT02267044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540917|NCT02267044|Sensory System Agents|sensory system agents|mesh-ancestor
65540918|NCT02267044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65540919|NCT02267122|Mupirocin|mupirocin|mesh-list
65540920|NCT02267122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65540921|NCT02267122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65540922|NCT02267122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65540923|NCT02267122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540924|NCT02267122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540925|NCT01261312|Guadecitabine|guadecitabine|mesh-list
65540926|NCT01261312|Azacitidine|azacitidine|mesh-list
65540927|NCT01261312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540928|NCT01261312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65540929|NCT01261312|Antimetabolites|antimetabolites|mesh-ancestor
65540930|NCT01261312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540931|NCT01261312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540932|NCT01254370|Travoprost|travoprost|mesh-list
65540933|NCT01254370|Latanoprost|latanoprost|mesh-list
65540934|NCT01254370|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65540935|NCT01254370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65540936|NCT01254370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65540937|NCT01254136|Trastuzumab|trastuzumab|mesh-list
65540938|NCT01254136|Vinorelbine|vinorelbine|mesh-list
65540939|NCT01254136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65540940|NCT01254136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540942|NCT01254136|Tubulin Modulators|tubulin modulators|mesh-ancestor
65540943|NCT01254136|Antimitotic Agents|antimitotic agents|mesh-ancestor
65540944|NCT01254136|Mitosis Modulators|mitosis modulators|mesh-ancestor
65540945|NCT01254136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540946|NCT02268370|Dasatinib|dasatinib|mesh-list
65540947|NCT02268370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540948|NCT02268370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65540949|NCT02268370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540950|NCT02268370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540951|NCT00039377|Leucovorin|leucovorin|mesh-list
65540952|NCT00039377|Cytarabine|cytarabine|mesh-list
65540953|NCT00039377|Cyclophosphamide|cyclophosphamide|mesh-list
65540954|NCT00039377|Methotrexate|methotrexate|mesh-list
65540955|NCT00039377|Etoposide|etoposide|mesh-list
65540956|NCT00039377|Vincristine|vincristine|mesh-list
65540957|NCT00039377|Etoposide phosphate|etoposide phosphate|mesh-list
65540958|NCT00039377|Imatinib Mesylate|imatinib mesylate|mesh-list
65540959|NCT00039377|Tacrolimus|tacrolimus|mesh-list
65540960|NCT00039377|Levoleucovorin|levoleucovorin|mesh-list
65540961|NCT00039377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65540962|NCT00039377|Immunologic Factors|immunologic factors|mesh-ancestor
65540963|NCT00039377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65540964|NCT00039377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65540965|NCT00039377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65540966|NCT00039377|Alkylating Agents|alkylating agents|mesh-ancestor
65540967|NCT00039377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65540968|NCT00039377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540969|NCT00039377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65540970|NCT00039377|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65540971|NCT00039377|Abortifacient Agents|abortifacient agents|mesh-ancestor
65540972|NCT00039377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65540973|NCT00039377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65540974|NCT00039377|Antimetabolites|antimetabolites|mesh-ancestor
65540975|NCT00039377|Dermatologic Agents|dermatologic agents|mesh-ancestor
65540976|NCT00039377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65540977|NCT00039377|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65540978|NCT00039377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65540979|NCT00039377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65540980|NCT00039377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65540981|NCT00039377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65540982|NCT00039377|Antiviral Agents|antiviral agents|mesh-ancestor
65540983|NCT00039377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65540984|NCT00039377|Antidotes|antidotes|mesh-ancestor
65540985|NCT00039377|Protective Agents|protective agents|mesh-ancestor
65540986|NCT00039377|Vitamin B Complex|vitamin b complex|mesh-ancestor
65540987|NCT00039377|Vitamins|vitamins|mesh-ancestor
65540988|NCT00039377|Micronutrients|micronutrients|mesh-ancestor
65540989|NCT00039377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65540990|NCT00039377|Tubulin Modulators|tubulin modulators|mesh-ancestor
65540991|NCT00039377|Antimitotic Agents|antimitotic agents|mesh-ancestor
65540992|NCT00039377|Mitosis Modulators|mitosis modulators|mesh-ancestor
65540993|NCT00039377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65540994|NCT01096745|Gemcitabine|gemcitabine|mesh-list
65540995|NCT01096745|Cisplatin|cisplatin|mesh-list
65540996|NCT01096745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540997|NCT01096745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65540998|NCT01096745|Antimetabolites|antimetabolites|mesh-ancestor
65540999|NCT01096745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541000|NCT01096745|Antiviral Agents|antiviral agents|mesh-ancestor
65541001|NCT01096745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541002|NCT01096745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541003|NCT01096745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65541004|NCT01096745|Immunologic Factors|immunologic factors|mesh-ancestor
65541005|NCT01096745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541006|NCT03953729|Ibuprofen|ibuprofen|mesh-list
65541007|NCT03953729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65541008|NCT03953729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65541009|NCT03953729|Analgesics|analgesics|mesh-ancestor
65541010|NCT03953729|Sensory System Agents|sensory system agents|mesh-ancestor
65541011|NCT03953729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65541012|NCT03953729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541013|NCT03953729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65541014|NCT03953729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65541015|NCT03953729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65541016|NCT03953729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541017|NCT03953729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541018|NCT01097213|Ethanol|ethanol|mesh-list
65541019|NCT01097213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65541020|NCT01097213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541021|NCT01097213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65541022|NCT01097213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541023|NCT00154102|Leucovorin|leucovorin|mesh-list
65541024|NCT00154102|Folic Acid|folic acid|mesh-list
65541025|NCT00154102|Fluorouracil|fluorouracil|mesh-list
65541026|NCT00154102|Irinotecan|irinotecan|mesh-list
65541027|NCT00154102|Cetuximab|cetuximab|mesh-list
65541028|NCT00154102|Levoleucovorin|levoleucovorin|mesh-list
65541029|NCT00154102|Antimetabolites|antimetabolites|mesh-ancestor
65541030|NCT00154102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541031|NCT00154102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65541032|NCT00154102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541033|NCT00154102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65541034|NCT00154102|Immunologic Factors|immunologic factors|mesh-ancestor
65541035|NCT00154102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541036|NCT00154102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65541037|NCT00154102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65541038|NCT00154102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541039|NCT00154102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65541040|NCT00154102|Antidotes|antidotes|mesh-ancestor
65541041|NCT00154102|Protective Agents|protective agents|mesh-ancestor
65541042|NCT00154102|Vitamin B Complex|vitamin b complex|mesh-ancestor
65541043|NCT00154102|Vitamins|vitamins|mesh-ancestor
65541044|NCT00154102|Micronutrients|micronutrients|mesh-ancestor
65541045|NCT00154102|Hematinics|hematinics|mesh-ancestor
65541046|NCT01269658|Azithromycin|azithromycin|mesh-list
65541047|NCT01269658|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65541048|NCT01269658|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65541049|NCT01269658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65541050|NCT01269658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541051|NCT01229644|Crenolanib|crenolanib|mesh-list
65541052|NCT01229644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541053|NCT02267980|Ketamine|ketamine|mesh-list
65541054|NCT02267980|Sevoflurane|sevoflurane|mesh-list
65541055|NCT02267980|Analgesics|analgesics|mesh-ancestor
65541056|NCT02267980|Sensory System Agents|sensory system agents|mesh-ancestor
65541057|NCT02267980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65541058|NCT02267980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541059|NCT02267980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65541060|NCT02267980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65541061|NCT02267980|Anesthetics, General|anesthetics, general|mesh-ancestor
65541062|NCT02267980|Anesthetics|anesthetics|mesh-ancestor
65541063|NCT02267980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65541064|NCT02267980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65541065|NCT02267980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65541066|NCT02267980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65541067|NCT02267980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541068|NCT02267980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65541069|NCT02267980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65541070|NCT01224262|Vaccines|vaccines|mesh-list
65541071|NCT01224262|Immunologic Factors|immunologic factors|mesh-ancestor
65541072|NCT01224262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541073|NCT01222702|Vancomycin|vancomycin|mesh-list
65541074|NCT01222702|Oxazolidinones|oxazolidinones|mesh-list
65541075|NCT01222702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65541076|NCT01222702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541077|NCT01222702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65541078|NCT01222702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541079|NCT01222702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541080|NCT01204762|Entecavir|entecavir|mesh-list
65541081|NCT01204762|Antiviral Agents|antiviral agents|mesh-ancestor
65541082|NCT01204762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541083|NCT02236078|Isoniazid|isoniazid|mesh-list
65541084|NCT02236078|Antitubercular Agents|antitubercular agents|mesh-ancestor
65541085|NCT02236078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65541086|NCT02236078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541087|NCT02236078|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65541088|NCT02236078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65338613|NCT05809609|Sensory System Agents|sensory system agents|mesh-ancestor
65541089|NCT02236078|Antimetabolites|antimetabolites|mesh-ancestor
65541090|NCT02236078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541091|NCT02236078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65541092|NCT01198834|Etodolac|etodolac|mesh-list
65541093|NCT01198834|Lidocaine|lidocaine|mesh-list
65541094|NCT01198834|Anesthetics, Local|anesthetics, local|mesh-ancestor
65541095|NCT01198834|Anesthetics|anesthetics|mesh-ancestor
65541096|NCT01198834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65541097|NCT01198834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541098|NCT01198834|Sensory System Agents|sensory system agents|mesh-ancestor
65541099|NCT01198834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65541100|NCT01198834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65541101|NCT01198834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65541102|NCT01198834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65541103|NCT01198834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65541104|NCT01198834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541105|NCT01198834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65541106|NCT01198834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65541107|NCT01198834|Analgesics|analgesics|mesh-ancestor
65541108|NCT01198834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65541109|NCT01198834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65541110|NCT01198834|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65541111|NCT01198834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65541112|NCT01198834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541113|NCT01193140|Temozolomide|temozolomide|mesh-list
65541114|NCT01193140|Veliparib|veliparib|mesh-list
65541115|NCT01193140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65541116|NCT01193140|Alkylating Agents|alkylating agents|mesh-ancestor
65541117|NCT01193140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541118|NCT01193140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541119|NCT01193140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65541120|NCT01193140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541121|NCT01189396|Albuterol|albuterol|mesh-list
65541122|NCT01189396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65541123|NCT01189396|Autonomic Agents|autonomic agents|mesh-ancestor
65541124|NCT01189396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65541125|NCT01189396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541126|NCT01189396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65541127|NCT01189396|Respiratory System Agents|respiratory system agents|mesh-ancestor
65541128|NCT01189396|Tocolytic Agents|tocolytic agents|mesh-ancestor
65541129|NCT01189396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65541130|NCT01189396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65541131|NCT01189396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65541132|NCT01189396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65541133|NCT01189396|Adrenergic Agents|adrenergic agents|mesh-ancestor
65541134|NCT01189396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65541135|NCT01189396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541136|NCT05626972|Tenecteplase|tenecteplase|mesh-list
65541137|NCT05626972|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65541138|NCT05626972|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65541139|NCT05626972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270224|NCT02717780|Analgesics|analgesics|mesh-ancestor
65541140|NCT01174732|Albuterol|albuterol|mesh-list
65541141|NCT01174732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65541142|NCT01174732|Autonomic Agents|autonomic agents|mesh-ancestor
65541143|NCT01174732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65541144|NCT01174732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541145|NCT01174732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65541146|NCT01174732|Respiratory System Agents|respiratory system agents|mesh-ancestor
65541147|NCT01174732|Tocolytic Agents|tocolytic agents|mesh-ancestor
65541148|NCT01174732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65541149|NCT01174732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65541150|NCT01174732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65541151|NCT01174732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65541152|NCT01174732|Adrenergic Agents|adrenergic agents|mesh-ancestor
65541153|NCT01174732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65541154|NCT01174732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541155|NCT01076764|Heparin|heparin|mesh-list
65541156|NCT01076764|Calcium heparin|calcium heparin|mesh-list
65541157|NCT01076764|Otamixaban|otamixaban|mesh-list
65541158|NCT01076764|Eptifibatide|eptifibatide|mesh-list
65541159|NCT01076764|Anticoagulants|anticoagulants|mesh-ancestor
65541160|NCT01076764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65541161|NCT01076764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65541162|NCT01076764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541163|NCT01076764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65541164|NCT01076764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65541165|NCT01076764|Antithrombins|antithrombins|mesh-ancestor
65541166|NCT01076764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65338689|NCT05809024|Letrozole|letrozole|mesh-list
65541167|NCT01076764|Protease Inhibitors|protease inhibitors|mesh-ancestor
65541168|NCT01076764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541169|NCT02269072|Anastrozole|anastrozole|mesh-list
65541170|NCT02269072|Leuprolide|leuprolide|mesh-list
65541171|NCT02269072|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65541172|NCT02269072|Testosterone|testosterone|mesh-list
65541173|NCT02269072|Androgens|androgens|mesh-ancestor
65541174|NCT02269072|Hormones|hormones|mesh-ancestor
65541175|NCT02269072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65541176|NCT02269072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541177|NCT02269072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65541178|NCT02269072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541179|NCT02269072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65541180|NCT02269072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65541181|NCT02269072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541182|NCT02269072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541183|NCT02269072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65541184|NCT02269072|Hormone Antagonists|hormone antagonists|mesh-ancestor
65541185|NCT02269072|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65541186|NCT02269072|Fertility Agents|fertility agents|mesh-ancestor
65541187|NCT02269072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65541188|NCT02269072|Natriuretic Agents|natriuretic agents|mesh-ancestor
65541189|NCT01071850|Metformin|metformin|mesh-list
65541190|NCT01071850|Ipragliflozin|ipragliflozin|mesh-list
65541191|NCT01071850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65541192|NCT01071850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541193|NCT01071850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65541194|NCT01071850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541195|NCT02269228|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
65541196|NCT02269228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65541197|NCT01037062|Entecavir|entecavir|mesh-list
65541198|NCT01037062|Antiviral Agents|antiviral agents|mesh-ancestor
65541199|NCT01037062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541200|NCT01167166|ON 01910|on 01910|mesh-list
65541201|NCT01167166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541202|NCT01167166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65541203|NCT01167166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541204|NCT01167166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541205|NCT01035502|Idarubicin|idarubicin|mesh-list
65541206|NCT01035502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65541207|NCT01035502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541208|NCT01035502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65541209|NCT01035502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65541210|NCT01035502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541211|NCT01035502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541212|NCT01030432|Ribavirin|ribavirin|mesh-list
65541213|NCT01030432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65541214|NCT01030432|Interferon-alpha|interferon-alpha|mesh-list
65541215|NCT01030432|Asunaprevir|asunaprevir|mesh-list
65541216|NCT01030432|Antimetabolites|antimetabolites|mesh-ancestor
65541217|NCT01030432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541218|NCT01030432|Antiviral Agents|antiviral agents|mesh-ancestor
65541219|NCT01030432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541220|NCT01030432|Immunologic Factors|immunologic factors|mesh-ancestor
65541221|NCT01030432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541222|NCT01030432|Protease Inhibitors|protease inhibitors|mesh-ancestor
65541223|NCT01030432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541224|NCT02269462|Efavirenz|efavirenz|mesh-list
65541225|NCT02269462|Nevirapine|nevirapine|mesh-list
65541226|NCT02269462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65541227|NCT02269462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65541228|NCT02269462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541229|NCT02269462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541230|NCT02269462|Antiviral Agents|antiviral agents|mesh-ancestor
65541231|NCT02269462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541232|NCT02269462|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65541233|NCT02269462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65541234|NCT02269462|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65541235|NCT02269462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65541236|NCT02269462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65541237|NCT02269462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65541238|NCT02269462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65541239|NCT02269462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65541240|NCT02261506|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65338766|NCT05781711|Metformin|metformin|mesh-list
65541241|NCT02261506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65541242|NCT02261506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541243|NCT02261506|Antitubercular Agents|antitubercular agents|mesh-ancestor
65541244|NCT02269540|Acetylcysteine|acetylcysteine|mesh-list
65541245|NCT02269540|Sertraline|sertraline|mesh-list
65541246|NCT02269540|Citalopram|citalopram|mesh-list
65541247|NCT02269540|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65541248|NCT02269540|Antiviral Agents|antiviral agents|mesh-ancestor
65541249|NCT02269540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541250|NCT02269540|Expectorants|expectorants|mesh-ancestor
65541251|NCT02269540|Respiratory System Agents|respiratory system agents|mesh-ancestor
65541252|NCT02269540|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65541253|NCT02269540|Antioxidants|antioxidants|mesh-ancestor
65541254|NCT02269540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541255|NCT02269540|Protective Agents|protective agents|mesh-ancestor
65541256|NCT02269540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541257|NCT02269540|Antidotes|antidotes|mesh-ancestor
65541258|NCT02269540|Antidepressive Agents|antidepressive agents|mesh-ancestor
65541259|NCT02269540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65541260|NCT02269540|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65541261|NCT02269540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65541262|NCT02269540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65541263|NCT02269540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65541264|NCT02269540|Serotonin Agents|serotonin agents|mesh-ancestor
65541265|NCT02269540|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65541266|NCT01023880|Delanzomib|delanzomib|mesh-list
65541267|NCT01023880|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
65541268|NCT01023880|Protease Inhibitors|protease inhibitors|mesh-ancestor
65541269|NCT01023880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541270|NCT01023880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541271|NCT02650804|Coenzyme Q10|coenzyme q10|mesh-list
65541272|NCT02650804|Gemcitabine|gemcitabine|mesh-list
65541273|NCT02650804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65541274|NCT02650804|Antimetabolites|antimetabolites|mesh-ancestor
65541275|NCT02650804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541276|NCT02650804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541277|NCT02650804|Antiviral Agents|antiviral agents|mesh-ancestor
65541278|NCT02650804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541279|NCT02650804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541280|NCT02650804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65541281|NCT02650804|Immunologic Factors|immunologic factors|mesh-ancestor
65541282|NCT02650804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541283|NCT02650804|Vitamins|vitamins|mesh-ancestor
65541284|NCT02650804|Micronutrients|micronutrients|mesh-ancestor
65541285|NCT02269696|Metoprolol|metoprolol|mesh-list
65541286|NCT02269696|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65541287|NCT02269696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65541288|NCT02269696|Sympatholytics|sympatholytics|mesh-ancestor
65541289|NCT02269696|Autonomic Agents|autonomic agents|mesh-ancestor
65541290|NCT02269696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65541291|NCT02269696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541292|NCT02269696|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65541293|NCT02269696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65541294|NCT02269696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65541295|NCT02269696|Adrenergic Agents|adrenergic agents|mesh-ancestor
65541296|NCT02269696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65541297|NCT02269696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541298|NCT03135184|Coal Tar|coal tar|mesh-list
65541299|NCT03135184|Keratolytic Agents|keratolytic agents|mesh-ancestor
65541300|NCT03135184|Dermatologic Agents|dermatologic agents|mesh-ancestor
65541301|NCT05613400|Simvastatin|simvastatin|mesh-list
65541302|NCT05613400|Ezetimibe|ezetimibe|mesh-list
65541303|NCT05613400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65541304|NCT05613400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65541305|NCT05613400|Antimetabolites|antimetabolites|mesh-ancestor
65541306|NCT05613400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541307|NCT05613400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65541308|NCT05613400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65541309|NCT05613400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541310|NCT02261662|Ribavirin|ribavirin|mesh-list
65541311|NCT02261662|Betamethasone|betamethasone|mesh-list
65541312|NCT02261662|Antimetabolites|antimetabolites|mesh-ancestor
65541313|NCT02261662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541314|NCT02261662|Antiviral Agents|antiviral agents|mesh-ancestor
65541315|NCT02261662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541316|NCT02261662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65541317|NCT02261662|Glucocorticoids|glucocorticoids|mesh-ancestor
65541319|NCT02261662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65541320|NCT02261662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541321|NCT02261662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65541322|NCT02261662|Respiratory System Agents|respiratory system agents|mesh-ancestor
65541323|NCT02261896|Ciprofloxacin|ciprofloxacin|mesh-list
65541324|NCT02261896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65541325|NCT02261896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541326|NCT02261896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65541327|NCT02261896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65541328|NCT02261896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541329|NCT02261896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541330|NCT02261896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541331|NCT02261896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65541332|NCT02261896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65541333|NCT00035555|Cyclosporine|cyclosporine|mesh-list
65541334|NCT00035555|Mycophenolic Acid|mycophenolic acid|mesh-list
65541335|NCT00035555|Abatacept|abatacept|mesh-list
65541336|NCT00035555|Cyclosporins|cyclosporins|mesh-list
65541337|NCT00035555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541338|NCT00035555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541339|NCT00035555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65541340|NCT00035555|Immunologic Factors|immunologic factors|mesh-ancestor
65541341|NCT00035555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541342|NCT00035555|Antifungal Agents|antifungal agents|mesh-ancestor
65541343|NCT00035555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541344|NCT00035555|Dermatologic Agents|dermatologic agents|mesh-ancestor
65541345|NCT00035555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65541346|NCT00035555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65541347|NCT00035555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65541348|NCT00035555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541349|NCT00035555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65541350|NCT00035555|Antitubercular Agents|antitubercular agents|mesh-ancestor
65541351|NCT00035555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65541352|NCT00035555|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65541353|NCT01093157|Hormones|hormones|mesh-list
65541354|NCT01093157|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65541355|NCT01093157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65541356|NCT01093157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541357|NCT01093235|Cyclophosphamide|cyclophosphamide|mesh-list
65541358|NCT01093235|Bevacizumab|bevacizumab|mesh-list
65541359|NCT01093235|Docetaxel|docetaxel|mesh-list
65541360|NCT01093235|Fluorouracil|fluorouracil|mesh-list
65541361|NCT01093235|Epirubicin|epirubicin|mesh-list
65541362|NCT01093235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65541363|NCT01093235|Immunologic Factors|immunologic factors|mesh-ancestor
65541364|NCT01093235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541365|NCT01093235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65541366|NCT01093235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65541367|NCT01093235|Alkylating Agents|alkylating agents|mesh-ancestor
65541368|NCT01093235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541369|NCT01093235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541370|NCT01093235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65541371|NCT01093235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65541372|NCT01093235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65541373|NCT01093235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65541374|NCT01093235|Growth Substances|growth substances|mesh-ancestor
65541375|NCT01093235|Growth Inhibitors|growth inhibitors|mesh-ancestor
65541376|NCT01093235|Tubulin Modulators|tubulin modulators|mesh-ancestor
65541377|NCT01093235|Antimitotic Agents|antimitotic agents|mesh-ancestor
65541378|NCT01093235|Mitosis Modulators|mitosis modulators|mesh-ancestor
65541379|NCT01093235|Antimetabolites|antimetabolites|mesh-ancestor
65541380|NCT01093235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65541381|NCT01093235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65541382|NCT01093235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65541383|NCT01093235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65541384|NCT01093235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541385|NCT01097681|Ipragliflozin|ipragliflozin|mesh-list
65541386|NCT01097681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65541387|NCT01097681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541388|NCT01097681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65541389|NCT01097681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541390|NCT01088009|Lamivudine|lamivudine|mesh-list
65541391|NCT01088009|Adefovir|adefovir|mesh-list
65541392|NCT01088009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65541393|NCT01088009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65541394|NCT01088009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541395|NCT01088009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541396|NCT01088009|Antiviral Agents|antiviral agents|mesh-ancestor
65541397|NCT01088009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541398|NCT01088009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65541399|NCT01088009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65541400|NCT03894046|Imipenem|imipenem|mesh-list
65541401|NCT03894046|Colistin|colistin|mesh-list
65541402|NCT03894046|Sulbactam|sulbactam|mesh-list
65541403|NCT03894046|Cilastatin|cilastatin|mesh-list
65541404|NCT03894046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65541405|NCT03894046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541406|NCT03894046|Protease Inhibitors|protease inhibitors|mesh-ancestor
65541407|NCT03894046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541408|NCT03894046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541409|NCT03894046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65541410|NCT04475614|Vitamin B Complex|vitamin b complex|mesh-list
65541411|NCT04475614|Vitamins|vitamins|mesh-ancestor
65541412|NCT04475614|Micronutrients|micronutrients|mesh-ancestor
65541413|NCT04475614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541414|NCT01143064|Progesterone|progesterone|mesh-list
65541415|NCT01143064|Progestins|progestins|mesh-ancestor
65541416|NCT01143064|Hormones|hormones|mesh-ancestor
65541417|NCT01143064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65541418|NCT01143064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541419|NCT00033371|Eflornithine|eflornithine|mesh-list
65541420|NCT00033371|Celecoxib|celecoxib|mesh-list
65541421|NCT00033371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65541422|NCT00033371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65541423|NCT00033371|Analgesics|analgesics|mesh-ancestor
65541424|NCT00033371|Sensory System Agents|sensory system agents|mesh-ancestor
65541425|NCT00033371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65541426|NCT00033371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541427|NCT00033371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65541428|NCT00033371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65541429|NCT00033371|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65541430|NCT00033371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65541431|NCT00033371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541432|NCT00033371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541433|NCT00033371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541434|NCT00033371|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65541435|NCT00033371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65541436|NCT00033371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65541437|NCT00033371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541438|NCT00033371|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
65270520|NCT00650871|Casopitant|casopitant|mesh-list
65541439|NCT01001338|Allopurinol|allopurinol|mesh-list
65541440|NCT01001338|Lesinurad|lesinurad|mesh-list
65541441|NCT01001338|Antimetabolites|antimetabolites|mesh-ancestor
65541442|NCT01001338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541443|NCT01001338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541444|NCT01001338|Gout Suppressants|gout suppressants|mesh-ancestor
65541445|NCT01001338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65541446|NCT01001338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65541447|NCT01001338|Antioxidants|antioxidants|mesh-ancestor
65541448|NCT01001338|Protective Agents|protective agents|mesh-ancestor
65541449|NCT01001338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541450|NCT01001338|Uricosuric Agents|uricosuric agents|mesh-ancestor
65541451|NCT01001338|Renal Agents|renal agents|mesh-ancestor
65541452|NCT03952715|Ibuprofen|ibuprofen|mesh-list
65541453|NCT03952715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65541454|NCT03952715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65541455|NCT03952715|Analgesics|analgesics|mesh-ancestor
65541456|NCT03952715|Sensory System Agents|sensory system agents|mesh-ancestor
65541457|NCT03952715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65541458|NCT03952715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541459|NCT03952715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65541460|NCT03952715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65541461|NCT03952715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65541462|NCT03952715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541463|NCT03952715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541464|NCT01137526|Donepezil|donepezil|mesh-list
65541465|NCT01137526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65541466|NCT01137526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541467|NCT01137526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541468|NCT01137526|Cholinergic Agents|cholinergic agents|mesh-ancestor
65541469|NCT01137526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65541470|NCT01137526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541471|NCT01137526|Nootropic Agents|nootropic agents|mesh-ancestor
65541472|NCT00993382|Amiodarone|amiodarone|mesh-list
65541473|NCT00993382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65541474|NCT00993382|Vasodilator Agents|vasodilator agents|mesh-ancestor
65541475|NCT00993382|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65541476|NCT00993382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65541477|NCT00993382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541478|NCT00993382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65541479|NCT00993382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65541480|NCT00993382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65541481|NCT00993382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541482|NCT00993382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65541483|NCT00993382|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65541484|NCT00993382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65541485|NCT00081731|Candesartan cilexetil|candesartan cilexetil|mesh-list
65541486|NCT00081731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65541487|NCT00081731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65541488|NCT00081731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65541489|NCT00081731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541490|NCT05628610|Paclitaxel|paclitaxel|mesh-list
65541491|NCT05628610|Carboplatin|carboplatin|mesh-list
65541492|NCT05628610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65541493|NCT05628610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541494|NCT05628610|Tubulin Modulators|tubulin modulators|mesh-ancestor
65541495|NCT05628610|Antimitotic Agents|antimitotic agents|mesh-ancestor
65541496|NCT05628610|Mitosis Modulators|mitosis modulators|mesh-ancestor
65541497|NCT05628610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541498|NCT00079937|Fluticasone|fluticasone|mesh-list
65541499|NCT00079937|Omalizumab|omalizumab|mesh-list
65541500|NCT00079937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65541501|NCT00079937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65541502|NCT00079937|Autonomic Agents|autonomic agents|mesh-ancestor
65541503|NCT00079937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65541504|NCT00079937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541505|NCT00079937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65541506|NCT00079937|Respiratory System Agents|respiratory system agents|mesh-ancestor
65541507|NCT00079937|Dermatologic Agents|dermatologic agents|mesh-ancestor
65541508|NCT00079937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65541509|NCT00909610|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65541510|NCT00909610|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65270593|NCT00302744|Niacin|niacin|mesh-list
65541511|NCT00909610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65541512|NCT03961607|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65541513|NCT03961607|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65541514|NCT03961607|Dermatologic Agents|dermatologic agents|mesh-ancestor
65541515|NCT03126110|Nivolumab|nivolumab|mesh-list
65541516|NCT03126110|Ipilimumab|ipilimumab|mesh-list
65541517|NCT03126110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65541518|NCT03126110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541519|NCT03126110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65541520|NCT03126110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541521|NCT00908128|Mycophenolic Acid|mycophenolic acid|mesh-list
65541522|NCT00908128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65541523|NCT00908128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541524|NCT00908128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65541525|NCT00908128|Antitubercular Agents|antitubercular agents|mesh-ancestor
65541526|NCT00908128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65541527|NCT00908128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541528|NCT00908128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541529|NCT00908128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541530|NCT00906334|ON 01910|on 01910|mesh-list
65541531|NCT00906334|Glycine|glycine|mesh-list
65541532|NCT00906334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541533|NCT00906334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65541534|NCT00906334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541535|NCT00906334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541536|NCT00906334|Glycine Agents|glycine agents|mesh-ancestor
65541537|NCT00906334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65541538|NCT00906334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541539|NCT00905164|Topiramate|topiramate|mesh-list
65541540|NCT00905164|Anticonvulsants|anticonvulsants|mesh-ancestor
65541541|NCT00905164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65541542|NCT00905164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541543|NCT00978016|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
65541544|NCT00978016|Baclofen|baclofen|mesh-list
65541545|NCT00978016|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65541546|NCT00978016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541547|NCT00978016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541548|NCT00978016|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65541549|NCT00978016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541550|NCT00978016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65541551|NCT00978016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65541552|NCT00978016|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65541553|NCT00978016|GABA Agonists|gaba agonists|mesh-ancestor
65541554|NCT00978016|GABA Agents|gaba agents|mesh-ancestor
65541555|NCT00978016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65541556|NCT01129648|Allopurinol|allopurinol|mesh-list
65541557|NCT01129648|Antimetabolites|antimetabolites|mesh-ancestor
65541558|NCT01129648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541559|NCT01129648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541560|NCT01129648|Gout Suppressants|gout suppressants|mesh-ancestor
65541561|NCT01129648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65541562|NCT01129648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65541563|NCT01129648|Antioxidants|antioxidants|mesh-ancestor
65541564|NCT01129648|Protective Agents|protective agents|mesh-ancestor
65541565|NCT01129648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541566|NCT04438720|Nifedipine|nifedipine|mesh-list
65541567|NCT04438720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65541568|NCT04438720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65541569|NCT04438720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541570|NCT04438720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65541571|NCT04438720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541572|NCT04438720|Vasodilator Agents|vasodilator agents|mesh-ancestor
65541573|NCT04438720|Tocolytic Agents|tocolytic agents|mesh-ancestor
65541574|NCT04438720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65541575|NCT05464810|Letrozole|letrozole|mesh-list
65541576|NCT05464810|Simvastatin|simvastatin|mesh-list
65541577|NCT05464810|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65541578|NCT05464810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65541579|NCT05464810|Antimetabolites|antimetabolites|mesh-ancestor
65541580|NCT05464810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541581|NCT05464810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65541582|NCT05464810|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65541583|NCT05464810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541584|NCT05464810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541585|NCT05464810|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65541586|NCT05464810|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65541587|NCT05464810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65541588|NCT05464810|Hormone Antagonists|hormone antagonists|mesh-ancestor
65541589|NCT05464810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65541590|NCT05464810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541591|NCT03176966|Vitamin E|vitamin e|mesh-list
65541592|NCT03176966|Ropinirole|ropinirole|mesh-list
65541593|NCT03176966|Vitamins|vitamins|mesh-ancestor
65541594|NCT03176966|Micronutrients|micronutrients|mesh-ancestor
65541595|NCT03176966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541596|NCT03176966|Antioxidants|antioxidants|mesh-ancestor
65541597|NCT03176966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541598|NCT03176966|Protective Agents|protective agents|mesh-ancestor
65541599|NCT03176966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65541600|NCT03176966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65541601|NCT03176966|Dopamine Agonists|dopamine agonists|mesh-ancestor
65541602|NCT03176966|Dopamine Agents|dopamine agents|mesh-ancestor
65541603|NCT03176966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65541604|NCT03209570|Zinc Oxide|zinc oxide|mesh-list
65541605|NCT03209570|Dermatologic Agents|dermatologic agents|mesh-ancestor
65541606|NCT03209570|Sunscreening Agents|sunscreening agents|mesh-ancestor
65541607|NCT03209570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65541608|NCT03209570|Protective Agents|protective agents|mesh-ancestor
65541609|NCT03209570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541610|NCT04405102|Ozanimod|ozanimod|mesh-list
65541611|NCT04405102|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65541612|NCT04405102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541613|NCT04405102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65541614|NCT04405102|Immunologic Factors|immunologic factors|mesh-ancestor
65541615|NCT04405102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339148|NCT05554133|Proflavine|proflavine|mesh-list
65541616|NCT03209492|Leuprolide|leuprolide|mesh-list
65541617|NCT03209492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65541618|NCT03209492|Fertility Agents|fertility agents|mesh-ancestor
65541619|NCT03209492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65541620|NCT03209492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541621|NCT03209492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65541622|NCT03209492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541623|NCT00894868|Vildagliptin|vildagliptin|mesh-list
65541624|NCT00894868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65541625|NCT00894868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541626|NCT00894868|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65541627|NCT00894868|Protease Inhibitors|protease inhibitors|mesh-ancestor
65541628|NCT00894868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541629|NCT00894868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541630|NCT05097326|Misoprostol|misoprostol|mesh-list
65541631|NCT05097326|Mifepristone|mifepristone|mesh-list
65541632|NCT05097326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65541633|NCT05097326|Abortifacient Agents|abortifacient agents|mesh-ancestor
65541634|NCT05097326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65541635|NCT05097326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541636|NCT05097326|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65541637|NCT05097326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65541638|NCT05097326|Oxytocics|oxytocics|mesh-ancestor
65541639|NCT05097326|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65541640|NCT05097326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65541641|NCT05097326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65541642|NCT05097326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65541643|NCT05097326|Contraceptive Agents|contraceptive agents|mesh-ancestor
65541644|NCT05097326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65541645|NCT05097326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65541646|NCT05097326|Hormone Antagonists|hormone antagonists|mesh-ancestor
65541647|NCT05097326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65541648|NCT05097326|Luteolytic Agents|luteolytic agents|mesh-ancestor
65541649|NCT05097326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65541650|NCT05097326|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65541651|NCT01122784|Vaccines|vaccines|mesh-list
65541652|NCT01122784|Immunologic Factors|immunologic factors|mesh-ancestor
65541653|NCT01122784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541654|NCT03208244|Antiviral Agents|antiviral agents|mesh-list
65541655|NCT03208244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541656|NCT01088165|Adalimumab|adalimumab|mesh-list
65541657|NCT01088165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65541658|NCT01088165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65541659|NCT00892762|Travoprost|travoprost|mesh-list
65541660|NCT00892762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65541661|NCT00892762|Latanoprost|latanoprost|mesh-list
65541662|NCT00892762|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65541663|NCT00892762|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65541664|NCT00890968|Triamcinolone|triamcinolone|mesh-list
65541665|NCT00890968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65541666|NCT00890968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65541667|NCT00890968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65541668|NCT00890968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65541669|NCT00890968|Glucocorticoids|glucocorticoids|mesh-ancestor
65541670|NCT00890968|Hormones|hormones|mesh-ancestor
65541671|NCT00890968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65541672|NCT00890968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541673|NCT00890968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65541674|NCT00890968|Immunologic Factors|immunologic factors|mesh-ancestor
65541675|NCT00890968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541676|NCT00890968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541677|NCT01098383|Acetylcholine|acetylcholine|mesh-list
65541678|NCT01098383|Donepezil|donepezil|mesh-list
65541679|NCT01098383|Choline|choline|mesh-list
65541680|NCT01098383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65541681|NCT01098383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541682|NCT01098383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541683|NCT01098383|Cholinergic Agents|cholinergic agents|mesh-ancestor
65541684|NCT01098383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65541685|NCT01098383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541686|NCT01098383|Nootropic Agents|nootropic agents|mesh-ancestor
65541687|NCT01098383|Lipotropic Agents|lipotropic agents|mesh-ancestor
65541688|NCT01098383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65541689|NCT01098383|Antimetabolites|antimetabolites|mesh-ancestor
65541690|NCT01098383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65541691|NCT01098383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65541692|NCT01098383|Vasodilator Agents|vasodilator agents|mesh-ancestor
65541693|NCT01098383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65541694|NCT03175172|Pembrolizumab|pembrolizumab|mesh-list
65541695|NCT03175172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65541696|NCT03175172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541697|NCT00961090|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65541698|NCT00961090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65541699|NCT00961090|Dermatologic Agents|dermatologic agents|mesh-ancestor
65541700|NCT01088477|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65541701|NCT01088477|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65541702|NCT01088477|Estradiol|estradiol|mesh-list
65541703|NCT01088477|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65541704|NCT01088477|Estrogens|estrogens|mesh-ancestor
65541705|NCT01088477|Hormones|hormones|mesh-ancestor
65541706|NCT01088477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65541707|NCT01088477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541708|NCT01088477|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65541709|NCT01088477|Contraceptive Agents|contraceptive agents|mesh-ancestor
65541710|NCT01088477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65541711|NCT01088477|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65541712|NCT01088555|Sodium thiosulfate|sodium thiosulfate|mesh-list
65541713|NCT01088555|Antidotes|antidotes|mesh-ancestor
65541714|NCT01088555|Protective Agents|protective agents|mesh-ancestor
65541715|NCT01088555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541716|NCT01088555|Antioxidants|antioxidants|mesh-ancestor
65541717|NCT01088555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541718|NCT01088555|Antitubercular Agents|antitubercular agents|mesh-ancestor
65541719|NCT01088555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65541720|NCT01088555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541721|NCT01088555|Chelating Agents|chelating agents|mesh-ancestor
65541722|NCT01088555|Sequestering Agents|sequestering agents|mesh-ancestor
65541723|NCT04474210|JNJ-56136379|jnj-56136379|mesh-list
65541724|NCT04474210|Antiviral Agents|antiviral agents|mesh-ancestor
65541725|NCT04474210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541726|NCT00078767|Sertraline|sertraline|mesh-list
65541727|NCT00078767|Antidepressive Agents|antidepressive agents|mesh-ancestor
65541728|NCT00078767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65541729|NCT00078767|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65541730|NCT00078767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65541731|NCT00078767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65541732|NCT00078767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541733|NCT00078767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65541734|NCT00078767|Serotonin Agents|serotonin agents|mesh-ancestor
65541735|NCT00078767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541736|NCT04474288|Antibodies|antibodies|mesh-list
65541737|NCT04474288|Immunologic Factors|immunologic factors|mesh-ancestor
65541738|NCT04474288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541739|NCT00078377|Modafinil|modafinil|mesh-list
65541740|NCT00078377|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65541741|NCT00078377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541742|NCT00078377|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65541743|NCT00078377|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65541744|NCT00078377|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65541745|NCT00078377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541746|NCT01107496|Viloxazine|viloxazine|mesh-list
65541747|NCT01107496|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65541748|NCT01107496|Antidepressive Agents|antidepressive agents|mesh-ancestor
65541749|NCT01107496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65541750|NCT01107496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65541751|NCT01107496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65541752|NCT01107496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65541753|NCT01107496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541754|NCT01107496|Adrenergic Agents|adrenergic agents|mesh-ancestor
65541755|NCT01107496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65541756|NCT01107496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541757|NCT00886600|Losartan|losartan|mesh-list
65541758|NCT00886600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65541759|NCT00886600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65541760|NCT00886600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65541761|NCT00886600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65541762|NCT00886600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65541763|NCT00886600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541764|NCT00886600|Diuretics|diuretics|mesh-ancestor
65541765|NCT00886600|Natriuretic Agents|natriuretic agents|mesh-ancestor
65541766|NCT00886600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541767|NCT00886600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65541768|NCT00886600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65541769|NCT02591654|Pembrolizumab|pembrolizumab|mesh-list
65541770|NCT02591654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65541771|NCT02591654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541772|NCT03134872|Carboplatin|carboplatin|mesh-list
65541773|NCT03134872|Pemetrexed|pemetrexed|mesh-list
65541774|NCT03134872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541775|NCT03134872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541776|NCT03134872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541777|NCT03134872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65541778|NCT03134872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65541779|NCT03952481|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65541780|NCT03952481|Lifitegrast|lifitegrast|mesh-list
65541781|NCT03952481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65541782|NCT05135312|Etanercept|etanercept|mesh-list
65541783|NCT05135312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65541784|NCT05135312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65541785|NCT05135312|Analgesics|analgesics|mesh-ancestor
65541786|NCT05135312|Sensory System Agents|sensory system agents|mesh-ancestor
65541787|NCT05135312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65541788|NCT05135312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541789|NCT05135312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65541790|NCT05135312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65541791|NCT05135312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65541792|NCT05135312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65541793|NCT05135312|Immunologic Factors|immunologic factors|mesh-ancestor
65541794|NCT00881452|Citric Acid|citric acid|mesh-list
65541795|NCT00881452|Anticoagulants|anticoagulants|mesh-ancestor
65541796|NCT00881452|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65541797|NCT00881452|Chelating Agents|chelating agents|mesh-ancestor
65541798|NCT00881452|Sequestering Agents|sequestering agents|mesh-ancestor
65541799|NCT00881452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541800|NCT03952325|Pembrolizumab|pembrolizumab|mesh-list
65541801|NCT03952325|Nivolumab|nivolumab|mesh-list
65541802|NCT03952325|Atezolizumab|atezolizumab|mesh-list
65541803|NCT03952325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65541804|NCT03952325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541805|NCT03952325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65541806|NCT03952325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541807|NCT04958486|Trastuzumab|trastuzumab|mesh-list
65541808|NCT04958486|Azacitidine|azacitidine|mesh-list
65541809|NCT04958486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65541810|NCT04958486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541811|NCT04958486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65541812|NCT04958486|Antimetabolites|antimetabolites|mesh-ancestor
65541813|NCT04958486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541814|NCT04958486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541815|NCT00948142|Linezolid|linezolid|mesh-list
65541816|NCT00948142|Fusidic Acid|fusidic acid|mesh-list
65541817|NCT00948142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65541818|NCT00948142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541819|NCT00948142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65541820|NCT00948142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541821|NCT00948142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541822|NCT00947518|Chlorhexidine|chlorhexidine|mesh-list
65541823|NCT00947518|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65541824|NCT00947518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541825|NCT00947518|Disinfectants|disinfectants|mesh-ancestor
65541826|NCT00945802|Ciprofloxacin|ciprofloxacin|mesh-list
65541827|NCT00945802|Dexamethasone|dexamethasone|mesh-list
65541828|NCT00945802|Dexamethasone acetate|dexamethasone acetate|mesh-list
65541829|NCT00945802|BB 1101|bb 1101|mesh-list
65541830|NCT00945802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65541831|NCT00945802|Antiemetics|antiemetics|mesh-ancestor
65541832|NCT00945802|Autonomic Agents|autonomic agents|mesh-ancestor
65541833|NCT00945802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65541834|NCT00945802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541835|NCT00945802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65541836|NCT00945802|Glucocorticoids|glucocorticoids|mesh-ancestor
65541837|NCT00945802|Hormones|hormones|mesh-ancestor
65541838|NCT00945802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65541839|NCT00945802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65541840|NCT00945802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541841|NCT00945802|Protease Inhibitors|protease inhibitors|mesh-ancestor
65541842|NCT00945802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541843|NCT00945802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541844|NCT00945802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65541845|NCT00945802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541846|NCT00945802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65541847|NCT00945802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65541848|NCT00945802|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65541849|NCT00945802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65541850|NCT01105624|Azithromycin|azithromycin|mesh-list
65541851|NCT01105624|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65541852|NCT01105624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65541853|NCT01105624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65541854|NCT01105624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541855|NCT01102660|Naproxen|naproxen|mesh-list
65541856|NCT01102660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65541857|NCT01102660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65541858|NCT01102660|Analgesics|analgesics|mesh-ancestor
65541859|NCT01102660|Sensory System Agents|sensory system agents|mesh-ancestor
65541860|NCT01102660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65541861|NCT01102660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541862|NCT01102660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65541863|NCT01102660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65541864|NCT01102660|Gout Suppressants|gout suppressants|mesh-ancestor
65541865|NCT01102660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65541866|NCT01102660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541867|NCT01102660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541868|NCT03135106|Itraconazole|itraconazole|mesh-list
65541869|NCT03135106|Fluconazole|fluconazole|mesh-list
65541870|NCT03135106|Antifungal Agents|antifungal agents|mesh-ancestor
65541871|NCT03135106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541872|NCT03135106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65541873|NCT03135106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65541874|NCT03135106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541875|NCT03135106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541876|NCT03135106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65541877|NCT03135106|Hormone Antagonists|hormone antagonists|mesh-ancestor
65541878|NCT03135106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65541879|NCT03135106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541880|NCT03135106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65541881|NCT03135106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65541882|NCT03135106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65541883|NCT00872014|Sorafenib|sorafenib|mesh-list
65541884|NCT00872014|Trebananib|trebananib|mesh-list
65541885|NCT00872014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541886|NCT00872014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65541887|NCT00872014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541888|NCT00872014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541889|NCT00872014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65541890|NCT00872014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65541891|NCT00872014|Growth Substances|growth substances|mesh-ancestor
65541892|NCT00872014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541893|NCT00872014|Growth Inhibitors|growth inhibitors|mesh-ancestor
65541894|NCT00871936|Metformin|metformin|mesh-list
65541895|NCT00871936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65541896|NCT00871936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541897|NCT05122546|Nivolumab|nivolumab|mesh-list
65541898|NCT05122546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65541899|NCT05122546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541900|NCT05122546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65541901|NCT05122546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541902|NCT00870688|Valproic Acid|valproic acid|mesh-list
65541903|NCT00870688|Anticonvulsants|anticonvulsants|mesh-ancestor
65541904|NCT00870688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541905|NCT00870688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541906|NCT00870688|GABA Agents|gaba agents|mesh-ancestor
65541907|NCT00870688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65541908|NCT00870688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541909|NCT00870688|Antimanic Agents|antimanic agents|mesh-ancestor
65541910|NCT00870688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65541911|NCT00870688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65541912|NCT00870688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65541913|NCT00870454|Pregabalin|pregabalin|mesh-list
65541914|NCT00870454|Analgesics|analgesics|mesh-ancestor
65541915|NCT00870454|Sensory System Agents|sensory system agents|mesh-ancestor
65541916|NCT00870454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65541917|NCT00870454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541918|NCT00870454|Anticonvulsants|anticonvulsants|mesh-ancestor
65541919|NCT00870454|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65541920|NCT00870454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65541921|NCT00870454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541922|NCT00870454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65541923|NCT00870454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65541924|NCT00870454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65541925|NCT00870454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65541926|NCT00870454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65541927|NCT05096962|Antibodies|antibodies|mesh-list
65541928|NCT05096962|Immunologic Factors|immunologic factors|mesh-ancestor
65541929|NCT05096962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541930|NCT00869128|Melatonin|melatonin|mesh-list
65541931|NCT00869128|Antioxidants|antioxidants|mesh-ancestor
65541932|NCT00869128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541933|NCT00869128|Protective Agents|protective agents|mesh-ancestor
65541934|NCT00869128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541935|NCT00869128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65541936|NCT00945646|Dexamethasone|dexamethasone|mesh-list
65541937|NCT00945646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65541938|NCT00945646|Antiemetics|antiemetics|mesh-ancestor
65541939|NCT00945646|Autonomic Agents|autonomic agents|mesh-ancestor
65541940|NCT00945646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65541941|NCT00945646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541942|NCT00945646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65541943|NCT00945646|Glucocorticoids|glucocorticoids|mesh-ancestor
65541944|NCT00945646|Hormones|hormones|mesh-ancestor
65541945|NCT00945646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65541946|NCT00945646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65541947|NCT00945646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541948|NCT00077675|Vancomycin|vancomycin|mesh-list
65541949|NCT00077675|Penicillins|penicillins|mesh-list
65541950|NCT00077675|Telavancin|telavancin|mesh-list
65541951|NCT00077675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65541952|NCT00077675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65541953|NCT00934180|Ondansetron|ondansetron|mesh-list
65541954|NCT00934180|Antiemetics|antiemetics|mesh-ancestor
65541955|NCT00934180|Autonomic Agents|autonomic agents|mesh-ancestor
65541956|NCT00934180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65541957|NCT00934180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541958|NCT00934180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65541959|NCT00934180|Antipruritics|antipruritics|mesh-ancestor
65541960|NCT00934180|Dermatologic Agents|dermatologic agents|mesh-ancestor
65541961|NCT00934180|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65541962|NCT00934180|Serotonin Agents|serotonin agents|mesh-ancestor
65541963|NCT00934180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65541964|NCT00934180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541965|NCT00934180|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65541966|NCT00934180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65541967|NCT00934180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65541968|NCT00934180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65541969|NCT00934180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65541970|NCT02576444|Olaparib|olaparib|mesh-list
65541971|NCT02576444|Adavosertib|adavosertib|mesh-list
65541972|NCT02576444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65541973|NCT02576444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65541974|NCT02576444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65541975|NCT02576444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65541976|NCT00929968|Fluticasone|fluticasone|mesh-list
65541977|NCT00929968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65541978|NCT00929968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65541979|NCT00929968|Autonomic Agents|autonomic agents|mesh-ancestor
65541980|NCT00929968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65541981|NCT00929968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541982|NCT00929968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65541983|NCT00929968|Respiratory System Agents|respiratory system agents|mesh-ancestor
65541984|NCT00929968|Dermatologic Agents|dermatologic agents|mesh-ancestor
65541985|NCT00929968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65541986|NCT03957083|Oxytocin|oxytocin|mesh-list
65541987|NCT03957083|Oxytocics|oxytocics|mesh-ancestor
65541988|NCT03957083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65541989|NCT03957083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541990|NCT04945616|Aspirin|aspirin|mesh-list
65541991|NCT04945616|Clopidogrel|clopidogrel|mesh-list
65541992|NCT04945616|Ticagrelor|ticagrelor|mesh-list
65541993|NCT04945616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65541994|NCT04945616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65541995|NCT04945616|Analgesics|analgesics|mesh-ancestor
65541996|NCT04945616|Sensory System Agents|sensory system agents|mesh-ancestor
65541997|NCT04945616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65541998|NCT04945616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65541999|NCT04945616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65542000|NCT04945616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65542001|NCT04945616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65542002|NCT04945616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65542003|NCT04945616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542004|NCT04945616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65542005|NCT04945616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65542006|NCT04945616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542007|NCT04945616|Antipyretics|antipyretics|mesh-ancestor
65542008|NCT04945616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65542009|NCT04945616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65542010|NCT04945616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65542011|NCT04945616|Purinergic Agents|purinergic agents|mesh-ancestor
65542012|NCT04945616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65542013|NCT04473820|Lidocaine|lidocaine|mesh-list
65542014|NCT04473820|Prilocaine|prilocaine|mesh-list
65542015|NCT04473820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65542016|NCT04473820|Anesthetics, Local|anesthetics, local|mesh-ancestor
65542017|NCT04473820|Anesthetics|anesthetics|mesh-ancestor
65542018|NCT04473820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65542019|NCT04473820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542020|NCT04473820|Sensory System Agents|sensory system agents|mesh-ancestor
65542021|NCT04473820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65542022|NCT04473820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65542023|NCT04473820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65542024|NCT04473820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65542025|NCT04473820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65542026|NCT04473820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542027|NCT04473820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65542028|NCT05064332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65542029|NCT05064332|Contraceptive Agents|contraceptive agents|mesh-list
65542030|NCT05064332|Contraceptives, Oral|contraceptives, oral|mesh-list
65542031|NCT05064332|Estradiol|estradiol|mesh-list
65271123|NCT02693210|Rituximab|rituximab|mesh-list
65542032|NCT05064332|Estrogens|estrogens|mesh-ancestor
65542033|NCT05064332|Hormones|hormones|mesh-ancestor
65542034|NCT05064332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65542035|NCT05064332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542036|NCT05064332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65542037|NCT05064332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65542038|NCT05064332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65542039|NCT05064332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65542040|NCT00855712|Cardioplegic Solutions|cardioplegic solutions|mesh-list
65542041|NCT00855712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65542042|NCT00850174|Oxcarbazepine|oxcarbazepine|mesh-list
65542043|NCT00850174|Anticonvulsants|anticonvulsants|mesh-ancestor
65542044|NCT00850174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65542045|NCT00850174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65542046|NCT00850174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65542047|NCT00850174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542048|NCT00850174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65542049|NCT00850174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65542050|NCT00849862|Levetiracetam|levetiracetam|mesh-list
65542051|NCT00849862|Anticonvulsants|anticonvulsants|mesh-ancestor
65542052|NCT00849862|Nootropic Agents|nootropic agents|mesh-ancestor
65542053|NCT00077207|Carboplatin|carboplatin|mesh-list
65542054|NCT00077207|Vincristine|vincristine|mesh-list
65542055|NCT00077207|Temozolomide|temozolomide|mesh-list
65542056|NCT00077207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542057|NCT00077207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65542058|NCT00077207|Tubulin Modulators|tubulin modulators|mesh-ancestor
65542059|NCT00077207|Antimitotic Agents|antimitotic agents|mesh-ancestor
65542060|NCT00077207|Mitosis Modulators|mitosis modulators|mesh-ancestor
65542061|NCT00077207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542062|NCT00077207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65542063|NCT00077207|Alkylating Agents|alkylating agents|mesh-ancestor
65339607|NCT05171075|Dalteparin|dalteparin|mesh-list
65542064|NCT01099085|Simvastatin|simvastatin|mesh-list
65542065|NCT01099085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65542066|NCT01099085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65542067|NCT01099085|Antimetabolites|antimetabolites|mesh-ancestor
65542068|NCT01099085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542069|NCT01099085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65542070|NCT01099085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65542071|NCT01099085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542072|NCT03206918|Zanubrutinib|zanubrutinib|mesh-list
65542073|NCT03206918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542074|NCT03206918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65542075|NCT03206918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542076|NCT03206918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542077|NCT05283226|Paclitaxel|paclitaxel|mesh-list
65542078|NCT05283226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65542079|NCT05283226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542080|NCT05283226|Tubulin Modulators|tubulin modulators|mesh-ancestor
65542081|NCT05283226|Antimitotic Agents|antimitotic agents|mesh-ancestor
65542082|NCT05283226|Mitosis Modulators|mitosis modulators|mesh-ancestor
65542083|NCT05283226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542084|NCT05095064|Irinotecan|irinotecan|mesh-list
65542085|NCT05095064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65542086|NCT05095064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65542087|NCT05095064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542088|NCT05095064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542089|NCT05095064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542090|NCT03169244|Bupropion|bupropion|mesh-list
65542091|NCT03169244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65542092|NCT03169244|Antidepressive Agents|antidepressive agents|mesh-ancestor
65542093|NCT03169244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65542094|NCT03169244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65542095|NCT03169244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65542096|NCT03169244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65542097|NCT03169244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542098|NCT03169244|Dopamine Agents|dopamine agents|mesh-ancestor
65542099|NCT03169244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65542100|NCT03169244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542101|NCT03169244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65542102|NCT03169244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65542103|NCT03169244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542104|NCT02486042|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65542105|NCT02486042|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65542106|NCT02486042|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65542107|NCT02486042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65542108|NCT00920764|Atrasentan|atrasentan|mesh-list
65542109|NCT00920764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542110|NCT00920764|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65542111|NCT00920764|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65542112|NCT00920764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542113|NCT05376046|Thrombin|thrombin|mesh-list
65542114|NCT05376046|Hemostatics|hemostatics|mesh-ancestor
65542115|NCT05376046|Coagulants|coagulants|mesh-ancestor
65542116|NCT03034304|Gemcitabine|gemcitabine|mesh-list
65542117|NCT03034304|Carboplatin|carboplatin|mesh-list
65542118|NCT03034304|Doxorubicin|doxorubicin|mesh-list
65542119|NCT03034304|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65542120|NCT03034304|Ifosfamide|ifosfamide|mesh-list
65542121|NCT03034304|Antibodies|antibodies|mesh-list
65542122|NCT03034304|Immunologic Factors|immunologic factors|mesh-ancestor
65542123|NCT03034304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542124|NCT03034304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542125|NCT03034304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65542126|NCT03034304|Antimetabolites|antimetabolites|mesh-ancestor
65542127|NCT03034304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542128|NCT03034304|Antiviral Agents|antiviral agents|mesh-ancestor
65542129|NCT03034304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65542130|NCT03034304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542131|NCT03034304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65542132|NCT03034304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65542133|NCT03034304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65542134|NCT03034304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65542135|NCT03034304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65542136|NCT03034304|Alkylating Agents|alkylating agents|mesh-ancestor
65339668|NCT05098210|Interferon Inducers|interferon inducers|mesh-ancestor
65542137|NCT00914602|Levodopa|levodopa|mesh-list
65542138|NCT00914602|Carbidopa|carbidopa|mesh-list
65542139|NCT00914602|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65542140|NCT00914602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65542141|NCT00914602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65542142|NCT00914602|Dopamine Agents|dopamine agents|mesh-ancestor
65542143|NCT00914602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65542144|NCT00914602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542145|NCT00914602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542146|NCT00914602|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65542147|NCT00914602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542148|NCT00914602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65542149|NCT00914602|Immunologic Factors|immunologic factors|mesh-ancestor
65542150|NCT00914602|Dopamine Agonists|dopamine agonists|mesh-ancestor
65542151|NCT00914290|Baclofen|baclofen|mesh-list
65542152|NCT00914290|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65542153|NCT00914290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542154|NCT00914290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65542155|NCT00914290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65542156|NCT00914290|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65542157|NCT00914290|GABA Agonists|gaba agonists|mesh-ancestor
65542158|NCT00914290|GABA Agents|gaba agents|mesh-ancestor
65542159|NCT00914290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65542160|NCT00914290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542161|NCT00057941|Fulvestrant|fulvestrant|mesh-list
65542162|NCT00057941|Anastrozole|anastrozole|mesh-list
65542163|NCT00057941|Gefitinib|gefitinib|mesh-list
65542164|NCT00057941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65542165|NCT00057941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542166|NCT00057941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65542167|NCT00057941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65542168|NCT00057941|Hormone Antagonists|hormone antagonists|mesh-ancestor
65542169|NCT00057941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65542170|NCT00057941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542171|NCT00057941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65542172|NCT00057941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542173|NCT00057941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542174|NCT00057941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65542175|NCT00057941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65271270|NCT03769766|Analgesics|analgesics|mesh-ancestor
65542176|NCT03005522|Dexamethasone|dexamethasone|mesh-list
65542177|NCT03005522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65542178|NCT03005522|Antiemetics|antiemetics|mesh-ancestor
65542179|NCT03005522|Autonomic Agents|autonomic agents|mesh-ancestor
65542180|NCT03005522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65542181|NCT03005522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542182|NCT03005522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65542183|NCT03005522|Glucocorticoids|glucocorticoids|mesh-ancestor
65542184|NCT03005522|Hormones|hormones|mesh-ancestor
65542185|NCT03005522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65542186|NCT03005522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65542187|NCT03005522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542188|NCT02998736|Tadalafil|tadalafil|mesh-list
65542189|NCT02998736|Vasodilator Agents|vasodilator agents|mesh-ancestor
65542190|NCT02998736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65542191|NCT02998736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65542192|NCT02998736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542193|NCT02998736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542194|NCT02998736|Urological Agents|urological agents|mesh-ancestor
65542195|NCT00075881|Bortezomib|bortezomib|mesh-list
65542196|NCT00075881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542197|NCT00838630|Cilostazol|cilostazol|mesh-list
65542198|NCT00838630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65542199|NCT00838630|Autonomic Agents|autonomic agents|mesh-ancestor
65542200|NCT00838630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65542201|NCT00838630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542202|NCT00838630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65542203|NCT00838630|Respiratory System Agents|respiratory system agents|mesh-ancestor
65542204|NCT00838630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65542205|NCT00838630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65542206|NCT00838630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542207|NCT00838630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65542208|NCT00838630|Vasodilator Agents|vasodilator agents|mesh-ancestor
65542209|NCT00838630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65542210|NCT00838630|Protective Agents|protective agents|mesh-ancestor
65542211|NCT00838630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65542212|NCT00838630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65542213|NCT00838630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542214|NCT02996474|Pembrolizumab|pembrolizumab|mesh-list
65542215|NCT02996474|Decitabine|decitabine|mesh-list
65542216|NCT02996474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65542217|NCT02996474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542218|NCT02996474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65542219|NCT02996474|Antimetabolites|antimetabolites|mesh-ancestor
65542220|NCT02996474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542221|NCT02996474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542222|NCT00821002|Latanoprost|latanoprost|mesh-list
65542223|NCT00821002|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65542224|NCT00821002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65542225|NCT00820924|Lapatinib|lapatinib|mesh-list
65542226|NCT00820924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542227|NCT00820924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65542228|NCT00820924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542229|NCT00820924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542230|NCT00820300|Latanoprost|latanoprost|mesh-list
65542231|NCT00820300|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65542232|NCT00820300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65542233|NCT00814372|Metformin|metformin|mesh-list
65542234|NCT00814372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65542235|NCT00814372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542236|NCT03134638|Carboplatin|carboplatin|mesh-list
65542237|NCT03134638|Fulvestrant|fulvestrant|mesh-list
65542238|NCT03134638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542239|NCT03134638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65542240|NCT03134638|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65542241|NCT03134638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65542242|NCT03134638|Hormone Antagonists|hormone antagonists|mesh-ancestor
65542243|NCT03134638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65542244|NCT03134638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542245|NCT03205046|Acalabrutinib|acalabrutinib|mesh-list
65542246|NCT03205046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542247|NCT04855526|Dronabinol|dronabinol|mesh-list
65542248|NCT04855526|Hallucinogens|hallucinogens|mesh-ancestor
65542249|NCT04855526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271347|NCT00884793|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65542250|NCT04855526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65542251|NCT04855526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65542252|NCT04855526|Analgesics|analgesics|mesh-ancestor
65542253|NCT04855526|Sensory System Agents|sensory system agents|mesh-ancestor
65542254|NCT04855526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65542255|NCT04855526|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65542256|NCT04855526|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65542257|NCT04855526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65542258|NCT04855526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542259|NCT04855526|Hormones|hormones|mesh-ancestor
65542260|NCT04855526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65542261|NCT03204812|Durvalumab|durvalumab|mesh-list
65542262|NCT03204812|Ipilimumab|ipilimumab|mesh-list
65542263|NCT03204812|Tremelimumab|tremelimumab|mesh-list
65542264|NCT03204812|Immunoglobulins|immunoglobulins|mesh-list
65542265|NCT03204812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65542266|NCT03204812|Immunoglobulin G|immunoglobulin g|mesh-list
65542267|NCT03204812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65542268|NCT03204812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542269|NCT03204812|Immunologic Factors|immunologic factors|mesh-ancestor
65542270|NCT03204812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542271|NCT03204812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65542272|NCT03204812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542273|NCT02339090|Hormones|hormones|mesh-list
65542274|NCT02339090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65542275|NCT02339090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542276|NCT05442008|Erenumab|erenumab|mesh-list
65542277|NCT05442008|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65542278|NCT05442008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542279|NCT05442008|Analgesics|analgesics|mesh-ancestor
65542280|NCT05442008|Sensory System Agents|sensory system agents|mesh-ancestor
65542281|NCT05442008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65542282|NCT05442008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542283|NCT03524092|Mirikizumab|mirikizumab|mesh-list
65542284|NCT03524092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65542286|NCT03524092|Analgesics|analgesics|mesh-ancestor
65542287|NCT03524092|Sensory System Agents|sensory system agents|mesh-ancestor
65542288|NCT03524092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65542289|NCT03524092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542290|NCT03524092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65542291|NCT03524092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65542292|NCT03524092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65542293|NCT03524092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65542294|NCT03331562|Ergocalciferols|ergocalciferols|mesh-list
65542295|NCT03331562|Pembrolizumab|pembrolizumab|mesh-list
65542296|NCT03331562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65542297|NCT03331562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542298|NCT03331562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65542299|NCT03331562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542300|NCT03331562|Vitamins|vitamins|mesh-ancestor
65542301|NCT03331562|Micronutrients|micronutrients|mesh-ancestor
65542302|NCT03331562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65542303|NCT00814294|Insulin|insulin|mesh-list
65542304|NCT00814294|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65542305|NCT00814294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65542306|NCT00814294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542307|NCT02038634|Betamethasone|betamethasone|mesh-list
65542308|NCT02038634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65542309|NCT02038634|Glucocorticoids|glucocorticoids|mesh-ancestor
65542310|NCT02038634|Hormones|hormones|mesh-ancestor
65542311|NCT02038634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65542312|NCT02038634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542313|NCT02038634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65542314|NCT02038634|Respiratory System Agents|respiratory system agents|mesh-ancestor
65542315|NCT00808288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65542316|NCT00808288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65542317|NCT00808288|Autonomic Agents|autonomic agents|mesh-ancestor
65542318|NCT00808288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65542319|NCT00808288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542320|NCT00808288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65542321|NCT00808288|Respiratory System Agents|respiratory system agents|mesh-ancestor
65542322|NCT00808288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65542323|NCT00808288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65542324|NCT00808288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65542325|NCT00808288|Adrenergic Agents|adrenergic agents|mesh-ancestor
65542326|NCT00808288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65542327|NCT00808288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542328|NCT03636308|Gemcitabine|gemcitabine|mesh-list
65542329|NCT03636308|Paclitaxel|paclitaxel|mesh-list
65542330|NCT03636308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65542331|NCT03636308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65542332|NCT03636308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542333|NCT03636308|Tubulin Modulators|tubulin modulators|mesh-ancestor
65542334|NCT03636308|Antimitotic Agents|antimitotic agents|mesh-ancestor
65542335|NCT03636308|Mitosis Modulators|mitosis modulators|mesh-ancestor
65542336|NCT03636308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542337|NCT03636308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65542338|NCT03636308|Antimetabolites|antimetabolites|mesh-ancestor
65542339|NCT03636308|Antiviral Agents|antiviral agents|mesh-ancestor
65542340|NCT03636308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65542341|NCT03636308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542342|NCT03636308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65542343|NCT03636308|Immunologic Factors|immunologic factors|mesh-ancestor
65542344|NCT03636308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542345|NCT00836056|Clindamycin|clindamycin|mesh-list
65542346|NCT00836056|Clindamycin palmitate|clindamycin palmitate|mesh-list
65542347|NCT00836056|Clindamycin phosphate|clindamycin phosphate|mesh-list
65542348|NCT00836056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65542349|NCT00836056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65542350|NCT00836056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65542351|NCT00836056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542352|NCT00836056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542353|NCT00835666|Finasteride|finasteride|mesh-list
65542354|NCT00835666|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65542355|NCT00835666|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65542356|NCT00835666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542357|NCT00835666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542358|NCT00835666|Hormone Antagonists|hormone antagonists|mesh-ancestor
65542359|NCT00835666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65542360|NCT00835666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542361|NCT00835666|Urological Agents|urological agents|mesh-ancestor
65542363|NCT00835588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65542364|NCT00835588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65542365|NCT00835588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65542366|NCT00835588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542367|NCT00835588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542368|NCT00713518|Ranibizumab|ranibizumab|mesh-list
65542369|NCT00713518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65542370|NCT00713518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65542371|NCT00713518|Growth Substances|growth substances|mesh-ancestor
65542372|NCT00713518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542373|NCT00713518|Growth Inhibitors|growth inhibitors|mesh-ancestor
65542374|NCT00713518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542375|NCT04468958|Immunoglobulins|immunoglobulins|mesh-list
65542376|NCT04468958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65542377|NCT04468958|Immunologic Factors|immunologic factors|mesh-ancestor
65542378|NCT04468958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542379|NCT00708292|Dexamethasone|dexamethasone|mesh-list
65542380|NCT00708292|Bortezomib|bortezomib|mesh-list
65542381|NCT00708292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65542382|NCT00708292|Antiemetics|antiemetics|mesh-ancestor
65542383|NCT00708292|Autonomic Agents|autonomic agents|mesh-ancestor
65542384|NCT00708292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65542385|NCT00708292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542386|NCT00708292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65542387|NCT00708292|Glucocorticoids|glucocorticoids|mesh-ancestor
65542388|NCT00708292|Hormones|hormones|mesh-ancestor
65542389|NCT00708292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65542390|NCT00708292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65542391|NCT00708292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542392|NCT00790660|Ipragliflozin|ipragliflozin|mesh-list
65542393|NCT00790660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65542394|NCT00790660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542395|NCT00790660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65542396|NCT00790660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542397|NCT01330082|Photosensitizing Agents|photosensitizing agents|mesh-list
65542398|NCT01330082|Dermatologic Agents|dermatologic agents|mesh-ancestor
65542399|NCT00835354|Cefprozil|cefprozil|mesh-list
65542400|NCT00835354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65542401|NCT00835354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65542402|NCT04874480|Decitabine|decitabine|mesh-list
65542403|NCT04874480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65542404|NCT04874480|Antimetabolites|antimetabolites|mesh-ancestor
65542405|NCT04874480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542406|NCT04874480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542407|NCT04874480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542408|NCT00698230|Metformin|metformin|mesh-list
65542409|NCT00698230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65542410|NCT00698230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542411|NCT01330238|Zoledronic Acid|zoledronic acid|mesh-list
65542412|NCT01330238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65542413|NCT01330238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542414|NCT01330472|Alprazolam|alprazolam|mesh-list
65542415|NCT01330472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65542416|NCT01330472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65542417|NCT01330472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542418|NCT01330472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65542419|NCT01330472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65542420|NCT01330472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65542421|NCT01330472|GABA Modulators|gaba modulators|mesh-ancestor
65542422|NCT01330472|GABA Agents|gaba agents|mesh-ancestor
65542423|NCT01330472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65542424|NCT01330472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542425|NCT00835276|Fexofenadine|fexofenadine|mesh-list
65542426|NCT00835276|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65542427|NCT00835276|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65542428|NCT00835276|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65542429|NCT00835276|Histamine Antagonists|histamine antagonists|mesh-ancestor
65542430|NCT00835276|Histamine Agents|histamine agents|mesh-ancestor
65542431|NCT00835276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65542432|NCT00835276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542433|NCT00835276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542434|NCT01860170|Cyclophosphamide|cyclophosphamide|mesh-list
65542435|NCT01860170|Bortezomib|bortezomib|mesh-list
65542436|NCT01860170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65542437|NCT01860170|Immunologic Factors|immunologic factors|mesh-ancestor
65542438|NCT01860170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542439|NCT01860170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65542440|NCT01860170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65542441|NCT01860170|Alkylating Agents|alkylating agents|mesh-ancestor
65542442|NCT01860170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542443|NCT01860170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542444|NCT01860170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65542445|NCT04718740|Vitamin K|vitamin k|mesh-list
65542446|NCT04718740|Repaglinide|repaglinide|mesh-list
65542447|NCT04718740|Midazolam|midazolam|mesh-list
65542448|NCT04718740|Caffeine|caffeine|mesh-list
65542449|NCT04718740|Bupropion|bupropion|mesh-list
65542450|NCT04718740|Omeprazole|omeprazole|mesh-list
65542451|NCT04718740|Warfarin|warfarin|mesh-list
65542452|NCT04718740|Vitamins|vitamins|mesh-ancestor
65542453|NCT04718740|Micronutrients|micronutrients|mesh-ancestor
65542454|NCT04718740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542455|NCT04718740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65542456|NCT04718740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65542457|NCT04718740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65542458|NCT04718740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65542459|NCT04718740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65542460|NCT04718740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65542461|NCT04718740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65542462|NCT04718740|Anesthetics, General|anesthetics, general|mesh-ancestor
65542463|NCT04718740|Anesthetics|anesthetics|mesh-ancestor
65542464|NCT04718740|GABA Modulators|gaba modulators|mesh-ancestor
65542465|NCT04718740|GABA Agents|gaba agents|mesh-ancestor
65542466|NCT04718740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65542467|NCT04718740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542468|NCT04718740|Anticoagulants|anticoagulants|mesh-ancestor
65542469|NCT04718740|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65542470|NCT04718740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65542471|NCT04718740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542472|NCT04718740|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65542473|NCT04718740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65542474|NCT04718740|Purinergic Agents|purinergic agents|mesh-ancestor
65542475|NCT04718740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65542476|NCT04718740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65542477|NCT04718740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65542478|NCT04718740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65542479|NCT04718740|Antidepressive Agents|antidepressive agents|mesh-ancestor
65542480|NCT04718740|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65542481|NCT04718740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65542482|NCT04718740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65542483|NCT04718740|Dopamine Agents|dopamine agents|mesh-ancestor
65542484|NCT04718740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65542485|NCT04718740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65542486|NCT04718740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65542487|NCT04718740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65542488|NCT04718740|Hemostatics|hemostatics|mesh-ancestor
65542489|NCT04718740|Coagulants|coagulants|mesh-ancestor
65542490|NCT04718740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65542491|NCT03344536|Fulvestrant|fulvestrant|mesh-list
65542492|NCT03344536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65542493|NCT03344536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542494|NCT03344536|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65542495|NCT03344536|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65542496|NCT03344536|Hormone Antagonists|hormone antagonists|mesh-ancestor
65542497|NCT03344536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65542498|NCT03344536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542499|NCT01759238|Bevacizumab|bevacizumab|mesh-list
65542500|NCT01759238|Capecitabine|capecitabine|mesh-list
65542501|NCT01759238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65542502|NCT01759238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542503|NCT01759238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65542504|NCT01759238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65542505|NCT01759238|Growth Substances|growth substances|mesh-ancestor
65542506|NCT01759238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542507|NCT01759238|Growth Inhibitors|growth inhibitors|mesh-ancestor
65542508|NCT01759238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65542509|NCT01759238|Antimetabolites|antimetabolites|mesh-ancestor
65542510|NCT01759238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542511|NCT00835042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65542512|NCT00835042|Moexipril|moexipril|mesh-list
65542513|NCT00835042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65542514|NCT00835042|Diuretics|diuretics|mesh-ancestor
65542515|NCT00835042|Natriuretic Agents|natriuretic agents|mesh-ancestor
65542516|NCT00835042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542517|NCT00835042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65542518|NCT00835042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65542519|NCT00835042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542520|NCT00835042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65542521|NCT00835042|Protease Inhibitors|protease inhibitors|mesh-ancestor
65542522|NCT00835042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542523|NCT00834964|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65542524|NCT00834964|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65542525|NCT00834964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65542526|NCT00834964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65542527|NCT00834964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542528|NCT00834964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65542529|NCT00834964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542530|NCT00834964|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65542531|NCT00834964|Antidepressive Agents|antidepressive agents|mesh-ancestor
65542532|NCT00834964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65542533|NCT03180502|Temozolomide|temozolomide|mesh-list
65542534|NCT03180502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65542535|NCT03180502|Alkylating Agents|alkylating agents|mesh-ancestor
65542536|NCT03180502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542537|NCT03180502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542538|NCT03070522|Prednisone|prednisone|mesh-list
65542539|NCT03070522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65542540|NCT03070522|Glucocorticoids|glucocorticoids|mesh-ancestor
65542541|NCT03070522|Hormones|hormones|mesh-ancestor
65542542|NCT03070522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65542543|NCT03070522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271667|NCT00880191|Gabapentin|gabapentin|mesh-list
65542544|NCT03070522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65542545|NCT03070522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542546|NCT00834574|Cefdinir|cefdinir|mesh-list
65542547|NCT00834574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65542548|NCT00834574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65542549|NCT04879966|Infliximab|infliximab|mesh-list
65542550|NCT04879966|Dermatologic Agents|dermatologic agents|mesh-ancestor
65542551|NCT04879966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65542552|NCT04879966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65542553|NCT00834418|Leflunomide|leflunomide|mesh-list
65542554|NCT00834418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542555|NCT00834418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542556|NCT00834418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65542557|NCT00834418|Immunologic Factors|immunologic factors|mesh-ancestor
65542558|NCT00834418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542559|NCT04621318|Denosumab|denosumab|mesh-list
65542560|NCT04621318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65542561|NCT04621318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542562|NCT00834340|Glimepiride|glimepiride|mesh-list
65542563|NCT00834340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65542564|NCT00834340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65542565|NCT00834340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542566|NCT00834340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65542567|NCT00834340|Immunologic Factors|immunologic factors|mesh-ancestor
65542568|NCT00683722|Remestemcel-l|remestemcel-l|mesh-list
65542569|NCT00683722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65542570|NCT00683722|Antiviral Agents|antiviral agents|mesh-ancestor
65542571|NCT00683722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65542572|NCT04473274|Pioglitazone|pioglitazone|mesh-list
65542573|NCT04473274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65542574|NCT04473274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542575|NCT00679588|Enoxaparin|enoxaparin|mesh-list
65542576|NCT00679588|Semuloparin|semuloparin|mesh-list
65542577|NCT00679588|Enoxaparin sodium|enoxaparin sodium|mesh-list
65542578|NCT00679588|Anticoagulants|anticoagulants|mesh-ancestor
65542579|NCT00679588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65542580|NCT00679588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65542581|NCT00679588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340117|NCT04577001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65542583|NCT00151996|Methylphenidate|methylphenidate|mesh-list
65542584|NCT00151996|Amphetamine|amphetamine|mesh-list
65542585|NCT00151996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65542586|NCT00151996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542587|NCT00151996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65542588|NCT00151996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65542589|NCT00151996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65542590|NCT00151996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542591|NCT00151996|Dopamine Agents|dopamine agents|mesh-ancestor
65542592|NCT00151996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65542593|NCT00151996|Sympathomimetics|sympathomimetics|mesh-ancestor
65542594|NCT00151996|Autonomic Agents|autonomic agents|mesh-ancestor
65542595|NCT00151996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65542596|NCT00151996|Adrenergic Agents|adrenergic agents|mesh-ancestor
65542597|NCT00151996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65542598|NCT00151996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65542599|NCT00151996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65542600|NCT00151996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65542601|NCT00151996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65542602|NCT00830206|Azithromycin|azithromycin|mesh-list
65542603|NCT00830206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65542604|NCT00830206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65542605|NCT04464070|Aspirin|aspirin|mesh-list
65542606|NCT04464070|Niacin|niacin|mesh-list
65542607|NCT04464070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65542608|NCT04464070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65542609|NCT04464070|Analgesics|analgesics|mesh-ancestor
65542610|NCT04464070|Sensory System Agents|sensory system agents|mesh-ancestor
65542611|NCT04464070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65542612|NCT04464070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542613|NCT04464070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65542614|NCT04464070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65542615|NCT04464070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65542616|NCT04464070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65542617|NCT04464070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542618|NCT04464070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65542619|NCT04464070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65542620|NCT04464070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542621|NCT04464070|Antipyretics|antipyretics|mesh-ancestor
65542622|NCT04464070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65542623|NCT04464070|Antimetabolites|antimetabolites|mesh-ancestor
65542624|NCT04464070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65542625|NCT04464070|Vasodilator Agents|vasodilator agents|mesh-ancestor
65542626|NCT04464070|Vitamin B Complex|vitamin b complex|mesh-ancestor
65542627|NCT04464070|Vitamins|vitamins|mesh-ancestor
65542628|NCT04464070|Micronutrients|micronutrients|mesh-ancestor
65542629|NCT00829504|Ropinirole|ropinirole|mesh-list
65542630|NCT00829504|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65542631|NCT00829504|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65542632|NCT00829504|Dopamine Agonists|dopamine agonists|mesh-ancestor
65542633|NCT00829504|Dopamine Agents|dopamine agents|mesh-ancestor
65542634|NCT00829504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65542635|NCT00829504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542636|NCT00829504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542637|NCT00829426|Alprazolam|alprazolam|mesh-list
65542638|NCT00829426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65542639|NCT00829426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65542640|NCT00829426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542641|NCT00829426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65542642|NCT00829426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65542643|NCT00829426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65542644|NCT00829426|GABA Modulators|gaba modulators|mesh-ancestor
65542645|NCT00829426|GABA Agents|gaba agents|mesh-ancestor
65542646|NCT00829426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65542647|NCT00829426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542648|NCT00152464|Levocetirizine|levocetirizine|mesh-list
65542649|NCT00152464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65542650|NCT00152464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65542651|NCT00152464|Histamine Antagonists|histamine antagonists|mesh-ancestor
65542652|NCT00152464|Histamine Agents|histamine agents|mesh-ancestor
65542653|NCT00152464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65542654|NCT00152464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542655|NCT00152464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340196|NCT04550260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65542657|NCT00675844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65542658|NCT00675844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65542659|NCT00675844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542660|NCT00675844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542661|NCT00675844|Antiviral Agents|antiviral agents|mesh-ancestor
65542662|NCT00675844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65542663|NCT00675844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65542664|NCT00675844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65542665|NCT04472806|Endostar protein|endostar protein|mesh-list
65542666|NCT04472806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65542667|NCT04472806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65542668|NCT04472806|Growth Substances|growth substances|mesh-ancestor
65542669|NCT04472806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542670|NCT04472806|Growth Inhibitors|growth inhibitors|mesh-ancestor
65542671|NCT04472806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542672|NCT00674440|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
65542673|NCT00674440|Dopamine Agents|dopamine agents|mesh-ancestor
65542674|NCT00674440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65542675|NCT00674440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542676|NCT00674440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542677|NCT01858948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65542678|NCT01858948|Antidepressive Agents|antidepressive agents|mesh-ancestor
65542679|NCT01858948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65542680|NCT01858948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65542681|NCT01858948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65542682|NCT01858948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65542683|NCT01858948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542684|NCT00770848|Prednisone|prednisone|mesh-list
65542685|NCT00770848|Mitoxantrone|mitoxantrone|mesh-list
65542686|NCT00770848|Rilotumumab|rilotumumab|mesh-list
65542687|NCT00770848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65542688|NCT00770848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65542689|NCT00770848|Glucocorticoids|glucocorticoids|mesh-ancestor
65542690|NCT00770848|Hormones|hormones|mesh-ancestor
65542691|NCT00770848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65542692|NCT00770848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542693|NCT00770848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65542694|NCT00770848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542695|NCT00770848|Analgesics|analgesics|mesh-ancestor
65542696|NCT00770848|Sensory System Agents|sensory system agents|mesh-ancestor
65542697|NCT00770848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65542698|NCT00770848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65542699|NCT00770848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65542700|NCT00770848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542701|NCT00770848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542702|NCT00770848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65542703|NCT00770848|Immunologic Factors|immunologic factors|mesh-ancestor
65542704|NCT00672412|Lamivudine|lamivudine|mesh-list
65542705|NCT00672412|Zidovudine|zidovudine|mesh-list
65542706|NCT00672412|Nevirapine|nevirapine|mesh-list
65542707|NCT00672412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65542708|NCT00672412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65542709|NCT00672412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542710|NCT00672412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542711|NCT00672412|Antiviral Agents|antiviral agents|mesh-ancestor
65542712|NCT00672412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65542713|NCT00672412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65542714|NCT00672412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65542715|NCT00672412|Antimetabolites|antimetabolites|mesh-ancestor
65542716|NCT00672412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65542717|NCT00672412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65542718|NCT01315262|Sildenafil Citrate|sildenafil citrate|mesh-list
65542719|NCT01315262|Vasodilator Agents|vasodilator agents|mesh-ancestor
65542720|NCT01315262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65542721|NCT01315262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65542722|NCT01315262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542723|NCT01315262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542724|NCT01315262|Urological Agents|urological agents|mesh-ancestor
65542725|NCT03197324|Bexagliflozin|bexagliflozin|mesh-list
65542726|NCT03197324|Digoxin|digoxin|mesh-list
65542727|NCT03197324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65542728|NCT03197324|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65542729|NCT03197324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542730|NCT03197324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542732|NCT03197324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542733|NCT03197324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65542734|NCT01330706|Polihexanide|polihexanide|mesh-list
65542735|NCT01330706|Disinfectants|disinfectants|mesh-ancestor
65542736|NCT01330706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65542737|NCT01156220|Furosemide|furosemide|mesh-list
65542738|NCT01156220|Diuretics|diuretics|mesh-ancestor
65542739|NCT01156220|Natriuretic Agents|natriuretic agents|mesh-ancestor
65542740|NCT01156220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542741|NCT01156220|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65542742|NCT01156220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65542743|NCT01156220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542744|NCT03192488|Cetirizine|cetirizine|mesh-list
65542745|NCT03192488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65542746|NCT03192488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65542747|NCT03192488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65542748|NCT03192488|Histamine Antagonists|histamine antagonists|mesh-ancestor
65542749|NCT03192488|Histamine Agents|histamine agents|mesh-ancestor
65542750|NCT03192488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65542751|NCT03192488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542752|NCT03192488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542753|NCT01642004|Docetaxel|docetaxel|mesh-list
65542754|NCT01642004|Nivolumab|nivolumab|mesh-list
65542755|NCT01642004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542756|NCT01642004|Tubulin Modulators|tubulin modulators|mesh-ancestor
65542757|NCT01642004|Antimitotic Agents|antimitotic agents|mesh-ancestor
65542758|NCT01642004|Mitosis Modulators|mitosis modulators|mesh-ancestor
65542759|NCT01642004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542760|NCT01642004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65542761|NCT01642004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65542762|NCT03907826|Antibodies|antibodies|mesh-list
65542763|NCT03907826|Antibodies, Blocking|antibodies, blocking|mesh-list
65542764|NCT03907826|Immunologic Factors|immunologic factors|mesh-ancestor
65542765|NCT03907826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542766|NCT00042289|Ritonavir|ritonavir|mesh-list
65542767|NCT00042289|Lopinavir|lopinavir|mesh-list
65542768|NCT00042289|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65542769|NCT00042289|Darunavir|darunavir|mesh-list
65542770|NCT00042289|Nelfinavir|nelfinavir|mesh-list
65542771|NCT00042289|Indinavir|indinavir|mesh-list
65542772|NCT00042289|Fosamprenavir|fosamprenavir|mesh-list
65542773|NCT00042289|Amprenavir|amprenavir|mesh-list
65542774|NCT00042289|Tenofovir|tenofovir|mesh-list
65542775|NCT00042289|Emtricitabine|emtricitabine|mesh-list
65542776|NCT00042289|Raltegravir Potassium|raltegravir potassium|mesh-list
65542777|NCT00042289|Nevirapine|nevirapine|mesh-list
65542778|NCT00042289|Maraviroc|maraviroc|mesh-list
65542779|NCT00042289|Dolutegravir|dolutegravir|mesh-list
65542780|NCT00042289|Abacavir|abacavir|mesh-list
65542781|NCT00042289|Didanosine|didanosine|mesh-list
65542782|NCT00042289|Cobicistat|cobicistat|mesh-list
65542783|NCT00042289|Rilpivirine|rilpivirine|mesh-list
65542784|NCT00042289|Tipranavir|tipranavir|mesh-list
65542785|NCT00042289|Elvitegravir|elvitegravir|mesh-list
65542786|NCT00042289|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
65542787|NCT00042289|Moxifloxacin|moxifloxacin|mesh-list
65542788|NCT00042289|Efavirenz|efavirenz|mesh-list
65542789|NCT00042289|Rifampin|rifampin|mesh-list
65542790|NCT00042289|Isoniazid|isoniazid|mesh-list
65542791|NCT00042289|Linezolid|linezolid|mesh-list
65542792|NCT00042289|Cycloserine|cycloserine|mesh-list
65542793|NCT00042289|Amikacin|amikacin|mesh-list
65542794|NCT00042289|Pyrazinamide|pyrazinamide|mesh-list
65542795|NCT00042289|Ethambutol|ethambutol|mesh-list
65542796|NCT00042289|Bedaquiline|bedaquiline|mesh-list
65542797|NCT00042289|Etravirine|etravirine|mesh-list
65542798|NCT00042289|Clofazimine|clofazimine|mesh-list
65542799|NCT00042289|Ofloxacin|ofloxacin|mesh-list
65542800|NCT00042289|Aminosalicylic Acid|aminosalicylic acid|mesh-list
65542801|NCT00042289|Ethionamide|ethionamide|mesh-list
65542802|NCT00042289|Kanamycin|kanamycin|mesh-list
65542803|NCT00042289|Capreomycin|capreomycin|mesh-list
65542804|NCT00042289|Prothionamide|prothionamide|mesh-list
65542805|NCT00042289|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65542806|NCT00042289|Etonogestrel|etonogestrel|mesh-list
65542807|NCT00042289|Estradiol|estradiol|mesh-list
65542808|NCT00042289|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65542809|NCT00042289|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65542810|NCT00042289|Protease Inhibitors|protease inhibitors|mesh-ancestor
65542811|NCT00042289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542812|NCT00042289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542813|NCT00042289|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65542814|NCT00042289|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65542815|NCT00042289|Antiviral Agents|antiviral agents|mesh-ancestor
65542816|NCT00042289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65542817|NCT00042289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65542818|NCT00042289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65542819|NCT00042289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65542820|NCT00042289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65542821|NCT00042289|Estrogens|estrogens|mesh-ancestor
65542822|NCT00042289|Hormones|hormones|mesh-ancestor
65542823|NCT00042289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65542824|NCT00042289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542825|NCT00042289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65542826|NCT00042289|Contraceptive Agents|contraceptive agents|mesh-ancestor
65542827|NCT00042289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65542828|NCT00042289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65542829|NCT00042289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65542830|NCT00042289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65542831|NCT00042289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65542832|NCT00042289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542833|NCT00042289|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65542834|NCT00042289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65542835|NCT00042289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65542836|NCT00042289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65542837|NCT00042289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65542838|NCT00042289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65542839|NCT00042289|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65542840|NCT00042289|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65542841|NCT00042289|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65542842|NCT00042289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65542843|NCT00042289|Antitubercular Agents|antitubercular agents|mesh-ancestor
65542844|NCT00042289|Leprostatic Agents|leprostatic agents|mesh-ancestor
65542845|NCT00042289|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65542846|NCT00042289|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65542847|NCT00042289|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65542848|NCT00042289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65542849|NCT00042289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65542850|NCT00042289|Antimetabolites|antimetabolites|mesh-ancestor
65542851|NCT00042289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65271936|NCT00666939|Anticonvulsants|anticonvulsants|mesh-ancestor
65542852|NCT00042289|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65542853|NCT00042289|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65542854|NCT00042289|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65542855|NCT00042289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65542856|NCT00042289|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65542857|NCT00042289|Renal Agents|renal agents|mesh-ancestor
65542858|NCT00042289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65542859|NCT00042289|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65542860|NCT00039871|Ribavirin|ribavirin|mesh-list
65542861|NCT00039871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65542862|NCT00039871|Interferon-alpha|interferon-alpha|mesh-list
65542863|NCT00039871|Antimetabolites|antimetabolites|mesh-ancestor
65542864|NCT00039871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542865|NCT00039871|Antiviral Agents|antiviral agents|mesh-ancestor
65542866|NCT00039871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65542867|NCT00039871|Immunologic Factors|immunologic factors|mesh-ancestor
65542868|NCT00039871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542869|NCT01096693|Substance P|substance p|mesh-list
65542870|NCT01096693|Neurokinin A|neurokinin a|mesh-list
65542871|NCT01096693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65542872|NCT01096693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542873|NCT01096693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542874|NCT00015457|Amlodipine|amlodipine|mesh-list
65542875|NCT00015457|Botulinum Toxins|botulinum toxins|mesh-list
65542876|NCT00015457|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65542877|NCT00015457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65542878|NCT00015457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542879|NCT00015457|Cholinergic Agents|cholinergic agents|mesh-ancestor
65542880|NCT00015457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65542881|NCT00015457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542882|NCT00015457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65542883|NCT00015457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65542884|NCT00015457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65542885|NCT00015457|Vasodilator Agents|vasodilator agents|mesh-ancestor
65542887|NCT03564470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542888|NCT03564470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65542889|NCT03564470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542890|NCT03564470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542891|NCT03191396|Liraglutide|liraglutide|mesh-list
65542892|NCT03191396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65542893|NCT03191396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542894|NCT03191396|Incretins|incretins|mesh-ancestor
65542895|NCT03191396|Hormones|hormones|mesh-ancestor
65542896|NCT03191396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65542897|NCT01333670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65542898|NCT00007345|Romidepsin|romidepsin|mesh-list
65542899|NCT00007345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65542900|NCT00007345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542901|NCT01584271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65542902|NCT01584271|Carbamide Peroxide|carbamide peroxide|mesh-list
65542903|NCT01584271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65542904|NCT01584271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65542905|NCT00031447|Acyclovir|acyclovir|mesh-list
65542906|NCT00031447|Antiviral Agents|antiviral agents|mesh-ancestor
65542907|NCT00031447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65542908|NCT00006721|Prednisone|prednisone|mesh-list
65542909|NCT00006721|Cyclophosphamide|cyclophosphamide|mesh-list
65542910|NCT00006721|Rituximab|rituximab|mesh-list
65542911|NCT00006721|Doxorubicin|doxorubicin|mesh-list
65542912|NCT00006721|Vincristine|vincristine|mesh-list
65542913|NCT00006721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65542914|NCT00006721|Immunologic Factors|immunologic factors|mesh-ancestor
65542915|NCT00006721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542916|NCT00006721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65542917|NCT00006721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65542918|NCT00006721|Alkylating Agents|alkylating agents|mesh-ancestor
65542919|NCT00006721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542920|NCT00006721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542921|NCT00006721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65542922|NCT00006721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65542923|NCT00006721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65542924|NCT00006721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65542925|NCT00006721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65272012|NCT03481556|Glucocorticoids|glucocorticoids|mesh-ancestor
65542926|NCT00006721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542927|NCT00006721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65542928|NCT00006721|Glucocorticoids|glucocorticoids|mesh-ancestor
65542929|NCT00006721|Hormones|hormones|mesh-ancestor
65542930|NCT00006721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65542931|NCT00006721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65542932|NCT00006721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65542933|NCT00006721|Tubulin Modulators|tubulin modulators|mesh-ancestor
65542934|NCT00006721|Antimitotic Agents|antimitotic agents|mesh-ancestor
65542935|NCT00006721|Mitosis Modulators|mitosis modulators|mesh-ancestor
65542936|NCT00006289|Neurotropin|neurotropin|mesh-list
65542937|NCT00006289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65542938|NCT00006289|Immunologic Factors|immunologic factors|mesh-ancestor
65542939|NCT00006289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542940|NCT00006289|Analgesics|analgesics|mesh-ancestor
65542941|NCT00006289|Sensory System Agents|sensory system agents|mesh-ancestor
65542942|NCT00006289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65542943|NCT00006289|Anticonvulsants|anticonvulsants|mesh-ancestor
65542944|NCT05625841|Propolis|propolis|mesh-list
65542945|NCT05625841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65542946|NCT01103401|Tobramycin|tobramycin|mesh-list
65542947|NCT01103401|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
65542948|NCT01103401|Dexamethasone|dexamethasone|mesh-list
65542949|NCT01103401|Dexamethasone acetate|dexamethasone acetate|mesh-list
65542950|NCT01103401|Ketorolac|ketorolac|mesh-list
65542951|NCT01103401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65542952|NCT01103401|BB 1101|bb 1101|mesh-list
65542953|NCT01103401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65542954|NCT01103401|Antiemetics|antiemetics|mesh-ancestor
65542955|NCT01103401|Autonomic Agents|autonomic agents|mesh-ancestor
65542956|NCT01103401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65542957|NCT01103401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542958|NCT01103401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65542959|NCT01103401|Glucocorticoids|glucocorticoids|mesh-ancestor
65542960|NCT01103401|Hormones|hormones|mesh-ancestor
65542961|NCT01103401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65542962|NCT01103401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65542963|NCT01103401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542964|NCT01103401|Protease Inhibitors|protease inhibitors|mesh-ancestor
65542965|NCT01103401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542966|NCT01103401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542967|NCT01103401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65542968|NCT01103401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65542969|NCT01103401|Analgesics|analgesics|mesh-ancestor
65542970|NCT01103401|Sensory System Agents|sensory system agents|mesh-ancestor
65542971|NCT01103401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65542972|NCT01103401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65542973|NCT01103401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65542974|NCT01103401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65542975|NCT01103401|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65542976|NCT01103401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65542977|NCT00005047|Doxorubicin|doxorubicin|mesh-list
65542978|NCT00005047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65542979|NCT00005047|Methotrexate|methotrexate|mesh-list
65542980|NCT00005047|Vinblastine|vinblastine|mesh-list
65542981|NCT00005047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65542982|NCT00005047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65542983|NCT00005047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65542984|NCT00005047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65542985|NCT00005047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65542986|NCT00005047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65542987|NCT00005047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65542988|NCT00005047|Abortifacient Agents|abortifacient agents|mesh-ancestor
65542989|NCT00005047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65542990|NCT00005047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65542991|NCT00005047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65542992|NCT00005047|Antimetabolites|antimetabolites|mesh-ancestor
65542993|NCT00005047|Dermatologic Agents|dermatologic agents|mesh-ancestor
65542994|NCT00005047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65542995|NCT00005047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65542996|NCT00005047|Immunologic Factors|immunologic factors|mesh-ancestor
65542997|NCT00005047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65542998|NCT00005047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65542999|NCT00005047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65543000|NCT00005047|Tubulin Modulators|tubulin modulators|mesh-ancestor
65543001|NCT00005047|Antimitotic Agents|antimitotic agents|mesh-ancestor
65543002|NCT00005047|Mitosis Modulators|mitosis modulators|mesh-ancestor
65543003|NCT01103635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65543004|NCT01103635|Ipilimumab|ipilimumab|mesh-list
65543005|NCT01103635|Tremelimumab|tremelimumab|mesh-list
65543006|NCT01103635|Antibodies|antibodies|mesh-list
65543007|NCT01103635|Immunoglobulins|immunoglobulins|mesh-list
65543008|NCT01103635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65543009|NCT01103635|Immunologic Factors|immunologic factors|mesh-ancestor
65543010|NCT01103635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543011|NCT01103635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543012|NCT01103635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65543013|NCT01103635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543014|NCT03949075|Enalapril|enalapril|mesh-list
65543015|NCT03949075|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65543016|NCT03949075|Protease Inhibitors|protease inhibitors|mesh-ancestor
65543017|NCT03949075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543018|NCT03949075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543019|NCT03949075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65543020|NCT01101529|Aprepitant|aprepitant|mesh-list
65543021|NCT01101529|Antiemetics|antiemetics|mesh-ancestor
65543022|NCT01101529|Autonomic Agents|autonomic agents|mesh-ancestor
65543023|NCT01101529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65543024|NCT01101529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543025|NCT01101529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65543026|NCT01101529|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65543027|NCT01101529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65543028|NCT01101529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543029|NCT00003907|Cisplatin|cisplatin|mesh-list
65543030|NCT00003907|Doxorubicin|doxorubicin|mesh-list
65543031|NCT00003907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65543032|NCT00003907|Mitomycins|mitomycins|mesh-list
65543033|NCT00003907|Mitomycin|mitomycin|mesh-list
65340581|NCT04003103|Islatravir|islatravir|mesh-list
65543034|NCT00003907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543035|NCT00003907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65543036|NCT00003907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65543037|NCT00003907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65543038|NCT00003907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543039|NCT00003907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543040|NCT00003907|Alkylating Agents|alkylating agents|mesh-ancestor
65543041|NCT00003907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65543042|NCT01100125|Insulin|insulin|mesh-list
65543043|NCT01100125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65543044|NCT01100125|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65543045|NCT01100125|Insulin, Long-Acting|insulin, long-acting|mesh-list
65543046|NCT01100125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65543047|NCT01100125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543048|NCT01100125|Incretins|incretins|mesh-ancestor
65543049|NCT01100125|Hormones|hormones|mesh-ancestor
65543050|NCT01100125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65543051|NCT01100125|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65543052|NCT01100125|Protease Inhibitors|protease inhibitors|mesh-ancestor
65543053|NCT01100125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543054|NCT01100125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543055|NCT01100203|Eplerenone|eplerenone|mesh-list
65543056|NCT01100203|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65543057|NCT01100203|Hormone Antagonists|hormone antagonists|mesh-ancestor
65543058|NCT01100203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65543059|NCT01100203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543060|NCT01100203|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65543061|NCT01100203|Diuretics|diuretics|mesh-ancestor
65543062|NCT01100203|Natriuretic Agents|natriuretic agents|mesh-ancestor
65543063|NCT01100203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65543064|NCT03948685|Carvedilol|carvedilol|mesh-list
65543065|NCT03948685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65543066|NCT03948685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65543067|NCT03948685|Adrenergic Agents|adrenergic agents|mesh-ancestor
65543068|NCT03948685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65543069|NCT03948685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543070|NCT03948685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543071|NCT03948685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65543072|NCT03948685|Antioxidants|antioxidants|mesh-ancestor
65543073|NCT03948685|Protective Agents|protective agents|mesh-ancestor
65543074|NCT03948685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65543075|NCT03948685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65543076|NCT03948685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65543077|NCT03948685|Vasodilator Agents|vasodilator agents|mesh-ancestor
65543078|NCT03948685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65543079|NCT03948685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65543080|NCT01585051|Vitamin D|vitamin d|mesh-list
65543081|NCT01585051|Vitamins|vitamins|mesh-ancestor
65543082|NCT01585051|Micronutrients|micronutrients|mesh-ancestor
65543083|NCT01585051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543084|NCT01585051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65543085|NCT01103791|Docetaxel|docetaxel|mesh-list
65543086|NCT01103791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543087|NCT01103791|Tubulin Modulators|tubulin modulators|mesh-ancestor
65543088|NCT01103791|Antimitotic Agents|antimitotic agents|mesh-ancestor
65543089|NCT01103791|Mitosis Modulators|mitosis modulators|mesh-ancestor
65543090|NCT01103791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543091|NCT03800173|Galidesivir|galidesivir|mesh-list
65543092|NCT03800173|Antiviral Agents|antiviral agents|mesh-ancestor
65543093|NCT03800173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543094|NCT00003631|Cytarabine|cytarabine|mesh-list
65543095|NCT00003631|Cyclophosphamide|cyclophosphamide|mesh-list
65543096|NCT00003631|Melphalan|melphalan|mesh-list
65543097|NCT00003631|Ifosfamide|ifosfamide|mesh-list
65543098|NCT00003631|Carmustine|carmustine|mesh-list
65543099|NCT00003631|Carboplatin|carboplatin|mesh-list
65543100|NCT00003631|Etoposide|etoposide|mesh-list
65543101|NCT00003631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65543102|NCT00003631|Immunologic Factors|immunologic factors|mesh-ancestor
65543103|NCT00003631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543104|NCT00003631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65543105|NCT00003631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65543106|NCT00003631|Alkylating Agents|alkylating agents|mesh-ancestor
65543107|NCT00003631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543108|NCT00003631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543109|NCT00003631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65543110|NCT00003631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65543111|NCT00003631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65543112|NCT00003631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65543114|NCT00003631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65543115|NCT00003631|Antimetabolites|antimetabolites|mesh-ancestor
65543116|NCT00003631|Antiviral Agents|antiviral agents|mesh-ancestor
65543117|NCT00003631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543118|NCT01101685|Citalopram|citalopram|mesh-list
65543119|NCT01101685|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65543120|NCT01101685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65543121|NCT01101685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65543122|NCT01101685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543123|NCT01101685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65543124|NCT01101685|Serotonin Agents|serotonin agents|mesh-ancestor
65543125|NCT01101685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543126|NCT01101685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65543127|NCT01101685|Antidepressive Agents|antidepressive agents|mesh-ancestor
65543128|NCT01101685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65543129|NCT00030901|Selenium|selenium|mesh-list
65543130|NCT00030901|Antioxidants|antioxidants|mesh-ancestor
65543131|NCT00030901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543132|NCT00030901|Protective Agents|protective agents|mesh-ancestor
65543133|NCT00030901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543134|NCT00030901|Trace Elements|trace elements|mesh-ancestor
65543135|NCT00030901|Micronutrients|micronutrients|mesh-ancestor
65543136|NCT01104259|Vinorelbine|vinorelbine|mesh-list
65543137|NCT01104259|Veliparib|veliparib|mesh-list
65543138|NCT01104259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543139|NCT01104259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65543140|NCT01104259|Tubulin Modulators|tubulin modulators|mesh-ancestor
65543141|NCT01104259|Antimitotic Agents|antimitotic agents|mesh-ancestor
65543142|NCT01104259|Mitosis Modulators|mitosis modulators|mesh-ancestor
65543143|NCT01104259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543144|NCT01104259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65543145|NCT01104259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543146|NCT01104337|Acetaminophen|acetaminophen|mesh-list
65543147|NCT01104337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65543148|NCT01104337|Analgesics|analgesics|mesh-ancestor
65543149|NCT01104337|Sensory System Agents|sensory system agents|mesh-ancestor
65543150|NCT01104337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65543151|NCT01104337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543152|NCT01104337|Antipyretics|antipyretics|mesh-ancestor
65543153|NCT01100359|Carboplatin|carboplatin|mesh-list
65543154|NCT01100359|Doxorubicin|doxorubicin|mesh-list
65543155|NCT01100359|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65543156|NCT01100359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543157|NCT01100359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65543158|NCT01100359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65543159|NCT01100359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65543160|NCT01100359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543161|NCT01100359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543162|NCT00003199|Tamoxifen|tamoxifen|mesh-list
65543163|NCT00003199|Aldesleukin|aldesleukin|mesh-list
65543164|NCT00003199|Melphalan|melphalan|mesh-list
65543165|NCT00003199|Busulfan|busulfan|mesh-list
65543166|NCT00003199|Thiotepa|thiotepa|mesh-list
65543167|NCT00003199|Interleukin-2|interleukin-2|mesh-list
65543168|NCT00003199|Sargramostim|sargramostim|mesh-list
65543169|NCT00003199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543170|NCT00003199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65543171|NCT00003199|Alkylating Agents|alkylating agents|mesh-ancestor
65543172|NCT00003199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543173|NCT00003199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65543174|NCT00003199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65543175|NCT00003199|Immunologic Factors|immunologic factors|mesh-ancestor
65543176|NCT00003199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543177|NCT00003199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65543178|NCT00003199|Analgesics|analgesics|mesh-ancestor
65543179|NCT00003199|Sensory System Agents|sensory system agents|mesh-ancestor
65543180|NCT00003199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65543181|NCT00003199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65543182|NCT00003199|Hormone Antagonists|hormone antagonists|mesh-ancestor
65543183|NCT00003199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65543184|NCT00003199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65543185|NCT00003199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65543186|NCT00003199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65340729|NCT03713528|Vancomycin|vancomycin|mesh-list
65543187|NCT00003199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65543188|NCT00003199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65543189|NCT00003199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65543190|NCT00003199|Antiviral Agents|antiviral agents|mesh-ancestor
65543191|NCT00003199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543192|NCT01327261|Levodopa|levodopa|mesh-list
65543193|NCT01327261|Benserazide|benserazide|mesh-list
65543194|NCT01327261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65543195|NCT01327261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65543196|NCT01327261|Dopamine Agents|dopamine agents|mesh-ancestor
65543197|NCT01327261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65543198|NCT01327261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543199|NCT01327261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543200|NCT01327261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543201|NCT01101919|Tofacitinib|tofacitinib|mesh-list
65543202|NCT01101919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65543203|NCT01101919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543204|NCT01101919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543205|NCT03951415|Durvalumab|durvalumab|mesh-list
65543206|NCT03951415|Olaparib|olaparib|mesh-list
65543207|NCT03951415|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65543208|NCT03951415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65543209|NCT03951415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543210|NCT03951415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543211|NCT03951415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543212|NCT00001849|Edetic Acid|edetic acid|mesh-list
65543213|NCT00001849|Pentetic Acid|pentetic acid|mesh-list
65543214|NCT00001849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543215|NCT00001849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543216|NCT00001849|Antidotes|antidotes|mesh-ancestor
65543217|NCT00001849|Protective Agents|protective agents|mesh-ancestor
65543218|NCT00001849|Chelating Agents|chelating agents|mesh-ancestor
65543219|NCT00001849|Sequestering Agents|sequestering agents|mesh-ancestor
65543220|NCT00001849|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65543221|NCT00001849|Anticoagulants|anticoagulants|mesh-ancestor
65543222|NCT00001849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65543223|NCT01104571|Trastuzumab|trastuzumab|mesh-list
65543224|NCT01104571|Lapatinib|lapatinib|mesh-list
65543225|NCT01104571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65543226|NCT01104571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543227|NCT01104571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65543228|NCT01104571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543229|NCT01104571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543230|NCT01104649|Riluzole|riluzole|mesh-list
65543231|NCT01104649|Anticonvulsants|anticonvulsants|mesh-ancestor
65543232|NCT01104649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65543233|NCT01104649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65543234|NCT01104649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65543235|NCT01104649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543236|NCT01104649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543237|NCT01104649|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65543238|NCT01104649|Protective Agents|protective agents|mesh-ancestor
65543239|NCT01327729|Interferons|interferons|mesh-list
65543240|NCT01327729|Interferon-alpha|interferon-alpha|mesh-list
65543241|NCT01327729|Interferon alpha-2|interferon alpha-2|mesh-list
65543242|NCT01327729|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65543243|NCT01327729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543244|NCT01327729|Antiviral Agents|antiviral agents|mesh-ancestor
65543245|NCT01327729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543246|NCT01327729|Immunologic Factors|immunologic factors|mesh-ancestor
65543247|NCT01327729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543248|NCT01342952|Ambrisentan|ambrisentan|mesh-list
65543249|NCT01342952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65543250|NCT01104883|Iodine|iodine|mesh-list
65543251|NCT01104883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65543252|NCT01104883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543253|NCT01104883|Trace Elements|trace elements|mesh-ancestor
65543254|NCT01104883|Micronutrients|micronutrients|mesh-ancestor
65543255|NCT01104883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543256|NCT01104961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65543257|NCT04371380|Rilpivirine|rilpivirine|mesh-list
65543258|NCT04371380|Cabotegravir|cabotegravir|mesh-list
65543259|NCT04371380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65543260|NCT04371380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65543261|NCT04371380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543262|NCT04371380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543263|NCT04371380|Antiviral Agents|antiviral agents|mesh-ancestor
65543264|NCT04371380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543265|NCT04371380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65543266|NCT04371380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65543267|NCT04371380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65543268|NCT04371380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65543269|NCT01341080|Varenicline|varenicline|mesh-list
65543270|NCT01341080|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65543271|NCT01341080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65543272|NCT01341080|Cholinergic Agents|cholinergic agents|mesh-ancestor
65543273|NCT01341080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65543274|NCT01341080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543275|NCT01341080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543276|NCT01333982|Amoxicillin|amoxicillin|mesh-list
65543277|NCT01333982|Gentamicins|gentamicins|mesh-list
65543278|NCT01333982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65543279|NCT01333982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543280|NCT01333982|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65543281|NCT01333982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543282|NCT01333982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543283|NCT01334060|Vaccines|vaccines|mesh-list
65543284|NCT01334060|Immunologic Factors|immunologic factors|mesh-ancestor
65543285|NCT01334060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543286|NCT04250636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65543287|NCT04250636|Antibodies|antibodies|mesh-list
65543288|NCT04250636|Immunoglobulins|immunoglobulins|mesh-list
65543289|NCT04250636|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65543290|NCT04250636|Immunologic Factors|immunologic factors|mesh-ancestor
65543291|NCT04250636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543292|NCT04250636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543293|NCT04130828|Ferrous fumarate|ferrous fumarate|mesh-list
65543294|NCT04130828|Trace Elements|trace elements|mesh-ancestor
65543295|NCT04130828|Micronutrients|micronutrients|mesh-ancestor
65543296|NCT04130828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543297|NCT01241708|Bortezomib|bortezomib|mesh-list
65543298|NCT01241708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543299|NCT01332344|Fluticasone|fluticasone|mesh-list
65543300|NCT01332344|Xhance|xhance|mesh-list
65543301|NCT01332344|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65543302|NCT01332344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65543303|NCT01332344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65543304|NCT01332344|Autonomic Agents|autonomic agents|mesh-ancestor
65543305|NCT01332344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65543306|NCT01332344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543307|NCT01332344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65543308|NCT01332344|Respiratory System Agents|respiratory system agents|mesh-ancestor
65543309|NCT01332344|Dermatologic Agents|dermatologic agents|mesh-ancestor
65543310|NCT01332344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65543311|NCT01332344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65543312|NCT01332344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65543313|NCT01332344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65543314|NCT01332344|Adrenergic Agents|adrenergic agents|mesh-ancestor
65543315|NCT01332344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65543316|NCT01332344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543317|NCT01112306|Selexipag|selexipag|mesh-list
65543318|NCT01112306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65543319|NCT01332422|Fluticasone|fluticasone|mesh-list
65543320|NCT01332422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65543321|NCT01332422|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65543322|NCT01332422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65543323|NCT01332422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65543324|NCT01332422|Autonomic Agents|autonomic agents|mesh-ancestor
65543325|NCT01332422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65543326|NCT01332422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543327|NCT01332422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65543328|NCT01332422|Respiratory System Agents|respiratory system agents|mesh-ancestor
65543329|NCT01332422|Dermatologic Agents|dermatologic agents|mesh-ancestor
65543330|NCT01332422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65543331|NCT01332422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65543332|NCT01332422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65543333|NCT01332422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65543334|NCT01332422|Adrenergic Agents|adrenergic agents|mesh-ancestor
65543335|NCT01332422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65543336|NCT01332422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543337|NCT01332422|Glucocorticoids|glucocorticoids|mesh-ancestor
65543338|NCT01332422|Hormones|hormones|mesh-ancestor
65340882|NCT03152890|Insulin|insulin|mesh-list
65543339|NCT01332422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65543341|NCT03162224|Durvalumab|durvalumab|mesh-list
65543342|NCT03162224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65543343|NCT03162224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543344|NCT00904046|Pioglitazone|pioglitazone|mesh-list
65543345|NCT00904046|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
65543346|NCT00904046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65543347|NCT00904046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543348|NCT01332734|Magnesium Sulfate|magnesium sulfate|mesh-list
65543349|NCT01332734|Analgesics|analgesics|mesh-ancestor
65543350|NCT01332734|Sensory System Agents|sensory system agents|mesh-ancestor
65543351|NCT01332734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65543352|NCT01332734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543353|NCT01332734|Anesthetics|anesthetics|mesh-ancestor
65543354|NCT01332734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65543355|NCT01332734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65543356|NCT01332734|Anticonvulsants|anticonvulsants|mesh-ancestor
65543357|NCT01332734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65543358|NCT01332734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65543359|NCT01332734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543360|NCT01332734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65543361|NCT01332734|Tocolytic Agents|tocolytic agents|mesh-ancestor
65543362|NCT01332734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65543363|NCT00719888|Cyclosporine|cyclosporine|mesh-list
65543364|NCT00719888|Mycophenolic Acid|mycophenolic acid|mesh-list
65543365|NCT00719888|Cyclophosphamide|cyclophosphamide|mesh-list
65543366|NCT00719888|Thiotepa|thiotepa|mesh-list
65543367|NCT00719888|Fludarabine|fludarabine|mesh-list
65543368|NCT00719888|Cyclosporins|cyclosporins|mesh-list
65543369|NCT00719888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65543370|NCT00719888|Immunologic Factors|immunologic factors|mesh-ancestor
65543371|NCT00719888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543372|NCT00719888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65543373|NCT00719888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65543374|NCT00719888|Alkylating Agents|alkylating agents|mesh-ancestor
65543375|NCT00719888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543376|NCT00719888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543377|NCT00719888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65543378|NCT00719888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543379|NCT00719888|Antifungal Agents|antifungal agents|mesh-ancestor
65543380|NCT00719888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543381|NCT00719888|Dermatologic Agents|dermatologic agents|mesh-ancestor
65543382|NCT00719888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65543383|NCT00719888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65543384|NCT00719888|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65543385|NCT00719888|Antitubercular Agents|antitubercular agents|mesh-ancestor
65543386|NCT00719888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65543387|NCT03326492|Antivenins|antivenins|mesh-list
65543388|NCT03326492|Immunologic Factors|immunologic factors|mesh-ancestor
65543389|NCT03326492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543390|NCT01524536|Prednisone|prednisone|mesh-list
65543391|NCT01524536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65543392|NCT01524536|Glucocorticoids|glucocorticoids|mesh-ancestor
65543393|NCT01524536|Hormones|hormones|mesh-ancestor
65543394|NCT01524536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65543395|NCT01524536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543396|NCT01524536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65543397|NCT01524536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543398|NCT00533468|Lidocaine|lidocaine|mesh-list
65543399|NCT00533468|Anesthetics, Local|anesthetics, local|mesh-ancestor
65543400|NCT00533468|Anesthetics|anesthetics|mesh-ancestor
65543401|NCT00533468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65543402|NCT00533468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543403|NCT00533468|Sensory System Agents|sensory system agents|mesh-ancestor
65543404|NCT00533468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65543405|NCT00533468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65543406|NCT00533468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65543407|NCT00533468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65543408|NCT00533468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65543409|NCT00533468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543410|NCT01333124|Gemcitabine|gemcitabine|mesh-list
65543411|NCT01333124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65543412|NCT01333124|Antimetabolites|antimetabolites|mesh-ancestor
65543413|NCT01333124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543414|NCT01333124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543415|NCT01333124|Antiviral Agents|antiviral agents|mesh-ancestor
65543416|NCT01333124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543417|NCT01333124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543418|NCT01333124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65543419|NCT01333124|Immunologic Factors|immunologic factors|mesh-ancestor
65543420|NCT01333124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543422|NCT03035630|Avelumab|avelumab|mesh-list
65543423|NCT03035630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543424|NCT03035630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65543425|NCT03035630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65543426|NCT03035630|Growth Substances|growth substances|mesh-ancestor
65543427|NCT03035630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543428|NCT03035630|Growth Inhibitors|growth inhibitors|mesh-ancestor
65543429|NCT03035630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65543430|NCT03035630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543431|NCT03035630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543432|NCT03035630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65543433|NCT00004124|Prednisone|prednisone|mesh-list
65543434|NCT00004124|Goserelin|goserelin|mesh-list
65543435|NCT00004124|Mitoxantrone|mitoxantrone|mesh-list
65543436|NCT00004124|Bicalutamide|bicalutamide|mesh-list
65543437|NCT00004124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65543438|NCT00004124|Glucocorticoids|glucocorticoids|mesh-ancestor
65543439|NCT00004124|Hormones|hormones|mesh-ancestor
65543440|NCT00004124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65543441|NCT00004124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543442|NCT00004124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65543443|NCT00004124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543444|NCT00004124|Analgesics|analgesics|mesh-ancestor
65543445|NCT00004124|Sensory System Agents|sensory system agents|mesh-ancestor
65543446|NCT00004124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65543447|NCT00004124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65543448|NCT00004124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65543449|NCT00004124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543450|NCT00004124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543451|NCT00004124|Androgen Antagonists|androgen antagonists|mesh-ancestor
65543452|NCT00004124|Hormone Antagonists|hormone antagonists|mesh-ancestor
65543453|NCT01333358|Alemtuzumab|alemtuzumab|mesh-list
65272548|NCT02703272|Rituximab|rituximab|mesh-list
65543454|NCT01333358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65543455|NCT01333358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543456|NCT01333514|Insulin Aspart|insulin aspart|mesh-list
65543457|NCT01333514|Insulin, Long-Acting|insulin, long-acting|mesh-list
65543458|NCT01333514|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65543459|NCT01333514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65543460|NCT01333514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543461|NCT01334684|Metformin|metformin|mesh-list
65543462|NCT01334684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65543463|NCT01334684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543464|NCT01334762|Letrozole|letrozole|mesh-list
65543465|NCT01334762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543466|NCT01334762|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65543467|NCT01334762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65543468|NCT01334762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543469|NCT01334762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543470|NCT01334762|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65543471|NCT01334762|Hormone Antagonists|hormone antagonists|mesh-ancestor
65543472|NCT01334762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65543473|NCT01334762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543474|NCT00383552|Mometasone Furoate|mometasone furoate|mesh-list
65543475|NCT00383552|Formoterol Fumarate|formoterol fumarate|mesh-list
65543476|NCT00383552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65543477|NCT00383552|Autonomic Agents|autonomic agents|mesh-ancestor
65543478|NCT00383552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65543479|NCT00383552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543480|NCT00383552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65543481|NCT00383552|Respiratory System Agents|respiratory system agents|mesh-ancestor
65543482|NCT00383552|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65543483|NCT00383552|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65543484|NCT00383552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65543485|NCT00383552|Adrenergic Agents|adrenergic agents|mesh-ancestor
65543486|NCT00383552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65543487|NCT00383552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543488|NCT00383552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65543489|NCT00383552|Dermatologic Agents|dermatologic agents|mesh-ancestor
65543490|NCT00383552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65543491|NCT01335074|Sirolimus|sirolimus|mesh-list
65543492|NCT01335074|Sorafenib|sorafenib|mesh-list
65543493|NCT01335074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543494|NCT01335074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65543495|NCT01335074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543496|NCT01335074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543497|NCT01335074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65543498|NCT01335074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543499|NCT01335074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65543500|NCT01335074|Antifungal Agents|antifungal agents|mesh-ancestor
65543501|NCT01335074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65543502|NCT01335074|Immunologic Factors|immunologic factors|mesh-ancestor
65543503|NCT01335074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543504|NCT01337492|Sorafenib|sorafenib|mesh-list
65543505|NCT01337492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543506|NCT01337492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65543507|NCT01337492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543508|NCT01337492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543509|NCT01337570|Dapivirine|dapivirine|mesh-list
65543510|NCT01337570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65543511|NCT01337570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65543512|NCT01337570|Antiviral Agents|antiviral agents|mesh-ancestor
65543513|NCT01337570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543514|NCT01337804|Omeprazole|omeprazole|mesh-list
65543515|NCT01337804|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
65543516|NCT01337804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65543517|NCT01337804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65543518|NCT01337804|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65543519|NCT01337804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543520|NCT01337804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543521|NCT01776424|Aspirin|aspirin|mesh-list
65543522|NCT01776424|Pantoprazole|pantoprazole|mesh-list
65543523|NCT01776424|Rivaroxaban|rivaroxaban|mesh-list
65543524|NCT01776424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65543525|NCT01776424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65543526|NCT01776424|Analgesics|analgesics|mesh-ancestor
65272617|NCT02702960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543527|NCT01776424|Sensory System Agents|sensory system agents|mesh-ancestor
65543528|NCT01776424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65543529|NCT01776424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543530|NCT01776424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65543531|NCT01776424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65543532|NCT01776424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65543533|NCT01776424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65543534|NCT01776424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543535|NCT01776424|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65543536|NCT01776424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65543537|NCT01776424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543538|NCT01776424|Antipyretics|antipyretics|mesh-ancestor
65543539|NCT01776424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65543540|NCT01776424|Antithrombins|antithrombins|mesh-ancestor
65543541|NCT01776424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65543542|NCT01776424|Protease Inhibitors|protease inhibitors|mesh-ancestor
65543543|NCT01776424|Anticoagulants|anticoagulants|mesh-ancestor
65543544|NCT01776424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65543545|NCT01776424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65543546|NCT01776424|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65543547|NCT00642148|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65543548|NCT00642148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65543549|NCT00642148|Autonomic Agents|autonomic agents|mesh-ancestor
65543550|NCT00642148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65543551|NCT00642148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543552|NCT00642148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65543553|NCT00642148|Respiratory System Agents|respiratory system agents|mesh-ancestor
65543554|NCT00642148|Glucocorticoids|glucocorticoids|mesh-ancestor
65543555|NCT00642148|Hormones|hormones|mesh-ancestor
65543556|NCT00642148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65543557|NCT00642148|Sympathomimetics|sympathomimetics|mesh-ancestor
65543558|NCT00629980|Azithromycin|azithromycin|mesh-list
65543559|NCT00629980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65543560|NCT00629980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543561|NCT00629590|Azithromycin|azithromycin|mesh-list
65341118|NCT01805804|Valsartan|valsartan|mesh-list
65543562|NCT00629590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65543563|NCT00629590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543564|NCT00626704|Doxorubicin|doxorubicin|mesh-list
65543565|NCT00626704|Conatumumab|conatumumab|mesh-list
65543566|NCT00626704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65543567|NCT00626704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543568|NCT00626704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65543569|NCT00626704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65543570|NCT00626704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543571|NCT00626704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543572|NCT00626704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65543574|NCT00765700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65543575|NCT00765700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65543576|NCT00765700|Analgesics|analgesics|mesh-ancestor
65543577|NCT00765700|Sensory System Agents|sensory system agents|mesh-ancestor
65543578|NCT00765700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65543579|NCT00765700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543580|NCT00765700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65543581|NCT00765700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65543582|NCT00765700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65543583|NCT00765700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543584|NCT00765700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543585|NCT02280694|Celecoxib|celecoxib|mesh-list
65543586|NCT02280694|Cyclophosphamide|cyclophosphamide|mesh-list
65543587|NCT02280694|Capecitabine|capecitabine|mesh-list
65543588|NCT02280694|Methotrexate|methotrexate|mesh-list
65543589|NCT02280694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65543590|NCT02280694|Immunologic Factors|immunologic factors|mesh-ancestor
65543591|NCT02280694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543592|NCT02280694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65543593|NCT02280694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65543594|NCT02280694|Alkylating Agents|alkylating agents|mesh-ancestor
65543595|NCT02280694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543596|NCT02280694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543597|NCT02280694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65543598|NCT02280694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65543599|NCT02280694|Antimetabolites|antimetabolites|mesh-ancestor
65543600|NCT02280694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65543601|NCT02280694|Abortifacient Agents|abortifacient agents|mesh-ancestor
65543602|NCT02280694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65543603|NCT02280694|Dermatologic Agents|dermatologic agents|mesh-ancestor
65543604|NCT02280694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543605|NCT02280694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65543606|NCT02280694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65543607|NCT02280694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65543608|NCT02280694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65543609|NCT02280694|Analgesics|analgesics|mesh-ancestor
65543610|NCT02280694|Sensory System Agents|sensory system agents|mesh-ancestor
65543611|NCT02280694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65543612|NCT02280694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65543613|NCT02280694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65543614|NCT02280694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65543615|NCT02280772|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
65543616|NCT02280772|Cathartics|cathartics|mesh-ancestor
65543617|NCT02280772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65543618|NCT02280850|Nitroglycerin|nitroglycerin|mesh-list
65543619|NCT02280850|Vasodilator Agents|vasodilator agents|mesh-ancestor
65543620|NCT00799864|Tenofovir|tenofovir|mesh-list
65543621|NCT00799864|Lamivudine|lamivudine|mesh-list
65543622|NCT00799864|Zidovudine|zidovudine|mesh-list
65543623|NCT00799864|Emtricitabine|emtricitabine|mesh-list
65543624|NCT00799864|Abacavir|abacavir|mesh-list
65543625|NCT00799864|Rilpivirine|rilpivirine|mesh-list
65543626|NCT00799864|Antiviral Agents|antiviral agents|mesh-ancestor
65543627|NCT00799864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543628|NCT00799864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65543629|NCT00799864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65543630|NCT00799864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543631|NCT00799864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543632|NCT00799864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65543633|NCT00799864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65543634|NCT00799864|Antimetabolites|antimetabolites|mesh-ancestor
65543635|NCT02281006|Sodium thiosulfate|sodium thiosulfate|mesh-list
65543636|NCT02281006|Antidotes|antidotes|mesh-ancestor
65341182|NCT01297400|Silver Sulfadiazine|silver sulfadiazine|mesh-list
65543637|NCT02281006|Protective Agents|protective agents|mesh-ancestor
65543638|NCT02281006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543639|NCT02281006|Antioxidants|antioxidants|mesh-ancestor
65543640|NCT02281006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543641|NCT02281006|Antitubercular Agents|antitubercular agents|mesh-ancestor
65543642|NCT02281006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65543643|NCT02281006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543644|NCT02281006|Chelating Agents|chelating agents|mesh-ancestor
65543645|NCT02281006|Sequestering Agents|sequestering agents|mesh-ancestor
65543646|NCT00758290|Triclosan|triclosan|mesh-list
65543647|NCT00758290|Fluorides|fluorides|mesh-list
65543648|NCT00758290|Cariostatic Agents|cariostatic agents|mesh-ancestor
65543649|NCT00758290|Protective Agents|protective agents|mesh-ancestor
65543650|NCT00758290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543651|NCT00758290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65543652|NCT00758290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543653|NCT00758290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65543654|NCT00758290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65543655|NCT00758290|Antimetabolites|antimetabolites|mesh-ancestor
65543656|NCT00758290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543657|NCT00758290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65543658|NCT03799627|Epoetin Alfa|epoetin alfa|mesh-list
65543659|NCT03799627|Glycine|glycine|mesh-list
65543660|NCT03799627|Hematinics|hematinics|mesh-ancestor
65543661|NCT03799627|Glycine Agents|glycine agents|mesh-ancestor
65543662|NCT03799627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65543663|NCT03799627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543664|NCT03799627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543665|NCT02274142|Methamphetamine|methamphetamine|mesh-list
65543666|NCT02274142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65543667|NCT02274142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543668|NCT02274142|Sympathomimetics|sympathomimetics|mesh-ancestor
65543669|NCT02274142|Autonomic Agents|autonomic agents|mesh-ancestor
65543670|NCT02274142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65543671|NCT02274142|Dopamine Agents|dopamine agents|mesh-ancestor
65543672|NCT02274142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65543673|NCT02274142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543674|NCT02274142|Adrenergic Agents|adrenergic agents|mesh-ancestor
65543675|NCT02274142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65543676|NCT02274142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65543677|NCT02274142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65543678|NCT02274142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65543679|NCT00752050|Botulinum Toxins|botulinum toxins|mesh-list
65543680|NCT00752050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65543681|NCT00752050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65543682|NCT00752050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65543683|NCT00752050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65543684|NCT00752050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543685|NCT00752050|Cholinergic Agents|cholinergic agents|mesh-ancestor
65543686|NCT00752050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65543687|NCT00752050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543688|NCT00752050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65543689|NCT00752050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65543690|NCT02276014|Beta Carotene|beta carotene|mesh-list
65543691|NCT02276014|Carotenoids|carotenoids|mesh-list
65543692|NCT02276014|Antioxidants|antioxidants|mesh-ancestor
65543693|NCT02276014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543694|NCT02276014|Protective Agents|protective agents|mesh-ancestor
65543695|NCT02276014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543696|NCT02276014|Provitamins|provitamins|mesh-ancestor
65543697|NCT02276014|Vitamins|vitamins|mesh-ancestor
65543698|NCT02276014|Micronutrients|micronutrients|mesh-ancestor
65543699|NCT01102387|Octenidine|octenidine|mesh-list
65543700|NCT01102387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543701|NCT01102387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65543702|NCT02277808|Amikacin|amikacin|mesh-list
65543703|NCT02277808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65543704|NCT02277808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543705|NCT02281240|Oprelvekin|oprelvekin|mesh-list
65543706|NCT02281240|Heparin|heparin|mesh-list
65543707|NCT02281240|Anticoagulants|anticoagulants|mesh-ancestor
65543708|NCT02281240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65543709|NCT02281240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65543710|NCT02281240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543711|NCT02281240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543712|NCT01102465|Losartan|losartan|mesh-list
65543713|NCT01102465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65543714|NCT01102465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65543715|NCT01102465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65543716|NCT01102465|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65543717|NCT01102465|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65543718|NCT01102465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543719|NCT01102465|Diuretics|diuretics|mesh-ancestor
65543720|NCT01102465|Natriuretic Agents|natriuretic agents|mesh-ancestor
65543721|NCT01102465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543722|NCT01102465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65543723|NCT01102465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65543724|NCT01105819|Chlorhexidine|chlorhexidine|mesh-list
65543725|NCT01105819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65543726|NCT01105819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543727|NCT01105819|Disinfectants|disinfectants|mesh-ancestor
65543728|NCT00749632|Mandelic Acids|mandelic acids|mesh-list
65543729|NCT00749632|Oxybutynin|oxybutynin|mesh-list
65543730|NCT00749632|Parasympatholytics|parasympatholytics|mesh-ancestor
65543731|NCT00749632|Autonomic Agents|autonomic agents|mesh-ancestor
65543732|NCT00749632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65543733|NCT00749632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543734|NCT00749632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65543735|NCT00749632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65543736|NCT00749632|Cholinergic Agents|cholinergic agents|mesh-ancestor
65543737|NCT00749632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65543738|NCT00749632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543739|NCT00749632|Urological Agents|urological agents|mesh-ancestor
65543740|NCT00749632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65543741|NCT00749632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543742|NCT00749632|Renal Agents|renal agents|mesh-ancestor
65543743|NCT01105273|Cyclophosphamide|cyclophosphamide|mesh-list
65543744|NCT01105273|Fludarabine|fludarabine|mesh-list
65543745|NCT01105273|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65543746|NCT01105273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65543747|NCT01105273|Immunologic Factors|immunologic factors|mesh-ancestor
65543748|NCT01105273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543749|NCT01105273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65543750|NCT01105273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65543751|NCT01105273|Alkylating Agents|alkylating agents|mesh-ancestor
65543752|NCT01105273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543753|NCT01105273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543754|NCT01105273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65543755|NCT05215327|Vaccines|vaccines|mesh-list
65543756|NCT05215327|Immunologic Factors|immunologic factors|mesh-ancestor
65543757|NCT05215327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543758|NCT00743938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65543759|NCT00743938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543760|NCT00743938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65543761|NCT00743938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543762|NCT00743938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543763|NCT00662740|Tiotropium Bromide|tiotropium bromide|mesh-list
65543764|NCT00662740|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65543765|NCT00662740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65543766|NCT00662740|Autonomic Agents|autonomic agents|mesh-ancestor
65543767|NCT00662740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65543768|NCT00662740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543769|NCT00662740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65543770|NCT00662740|Respiratory System Agents|respiratory system agents|mesh-ancestor
65543771|NCT00662740|Parasympatholytics|parasympatholytics|mesh-ancestor
65543772|NCT00662740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65543773|NCT00662740|Cholinergic Agents|cholinergic agents|mesh-ancestor
65543774|NCT00662740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65543775|NCT00662740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543776|NCT00662740|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65543777|NCT00662740|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65543778|NCT00662740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65543779|NCT00662740|Adrenergic Agents|adrenergic agents|mesh-ancestor
65543780|NCT01105351|Folic Acid|folic acid|mesh-list
65543781|NCT01105351|Vitamin B Complex|vitamin b complex|mesh-list
65543782|NCT01105351|Hematinics|hematinics|mesh-ancestor
65543783|NCT01105351|Vitamins|vitamins|mesh-ancestor
65543784|NCT01105351|Micronutrients|micronutrients|mesh-ancestor
65543785|NCT01105351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543786|NCT00662506|Deoxyglucose|deoxyglucose|mesh-list
65543787|NCT00662506|Temozolomide|temozolomide|mesh-list
65543788|NCT00662506|Cediranib|cediranib|mesh-list
65543789|NCT00662506|Maleic acid|maleic acid|mesh-list
65543790|NCT00662506|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65543791|NCT00662506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65543792|NCT00662506|Alkylating Agents|alkylating agents|mesh-ancestor
65543793|NCT00662506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543794|NCT00662506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543795|NCT00662506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543796|NCT00662506|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65543797|NCT00662506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65543798|NCT00662506|Antimetabolites|antimetabolites|mesh-ancestor
65543799|NCT00662506|Antiviral Agents|antiviral agents|mesh-ancestor
65543800|NCT00662506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543801|NCT03947125|Buprenorphine|buprenorphine|mesh-list
65543802|NCT03947125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65543803|NCT03947125|Narcotics|narcotics|mesh-ancestor
65543804|NCT03947125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65543805|NCT03947125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543806|NCT03947125|Analgesics|analgesics|mesh-ancestor
65543807|NCT03947125|Sensory System Agents|sensory system agents|mesh-ancestor
65543808|NCT03947125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65543809|NCT03947125|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65543810|NCT00658762|Paroxetine|paroxetine|mesh-list
65543811|NCT00658762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65543812|NCT00658762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65543813|NCT00658762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65543814|NCT00658762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543815|NCT00658762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65543816|NCT00658762|Serotonin Agents|serotonin agents|mesh-ancestor
65543817|NCT00658762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543818|NCT00658762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65543819|NCT00658762|Antidepressive Agents|antidepressive agents|mesh-ancestor
65543820|NCT00658762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65543821|NCT00658762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65543822|NCT00658762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65543823|NCT00658762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543824|NCT00658372|Paroxetine|paroxetine|mesh-list
65543825|NCT00658372|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65543826|NCT00658372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65272919|NCT00616070|Hormones|hormones|mesh-ancestor
65543827|NCT00658372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65543828|NCT00658372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543829|NCT00658372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65543830|NCT00658372|Serotonin Agents|serotonin agents|mesh-ancestor
65543831|NCT00658372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543832|NCT00658372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65543833|NCT00658372|Antidepressive Agents|antidepressive agents|mesh-ancestor
65543834|NCT00658372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65543835|NCT00658372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65543836|NCT00658372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65543837|NCT00658372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543838|NCT03946657|Anesthetics|anesthetics|mesh-list
65543839|NCT03946657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
65543840|NCT03946657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65543841|NCT03946657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543842|NCT03946657|Anesthetics, General|anesthetics, general|mesh-ancestor
65543843|NCT00616798|Antipsychotic Agents|antipsychotic agents|mesh-list
65543844|NCT00616798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65543845|NCT00616798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65543846|NCT00616798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543847|NCT00616798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65543848|NCT01106053|Pramipexole|pramipexole|mesh-list
65543849|NCT01106053|Antioxidants|antioxidants|mesh-ancestor
65543850|NCT01106053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543851|NCT01106053|Protective Agents|protective agents|mesh-ancestor
65543852|NCT01106053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543853|NCT01106053|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65543854|NCT01106053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65543855|NCT01106053|Dopamine Agonists|dopamine agonists|mesh-ancestor
65543856|NCT01106053|Dopamine Agents|dopamine agents|mesh-ancestor
65543857|NCT01106053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65543858|NCT00616330|Clindamycin|clindamycin|mesh-list
65543859|NCT00616330|Clindamycin palmitate|clindamycin palmitate|mesh-list
65543860|NCT00616330|Clindamycin phosphate|clindamycin phosphate|mesh-list
65543861|NCT00616330|Butoconazole|butoconazole|mesh-list
65341423|NCT02545972|Tacrolimus|tacrolimus|mesh-list
65543862|NCT00616330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65543863|NCT00616330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543864|NCT00616330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65543865|NCT00616330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543866|NCT00616330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543867|NCT00616330|Antifungal Agents|antifungal agents|mesh-ancestor
65543868|NCT00612820|Fluticasone|fluticasone|mesh-list
65543869|NCT00612820|Xhance|xhance|mesh-list
65543870|NCT00612820|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
65543871|NCT00612820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65543872|NCT00612820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65543873|NCT00612820|Autonomic Agents|autonomic agents|mesh-ancestor
65543874|NCT00612820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65543875|NCT00612820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543876|NCT00612820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65543877|NCT00612820|Respiratory System Agents|respiratory system agents|mesh-ancestor
65543878|NCT00612820|Dermatologic Agents|dermatologic agents|mesh-ancestor
65543879|NCT00612820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65543880|NCT00612820|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65543881|NCT00612820|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65543882|NCT00612820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543883|NCT00612820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543884|NCT00612742|Testosterone|testosterone|mesh-list
65543885|NCT00612742|Androgens|androgens|mesh-ancestor
65543886|NCT00612742|Hormones|hormones|mesh-ancestor
65543887|NCT00612742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65543888|NCT00612742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543889|NCT05016895|Azithromycin|azithromycin|mesh-list
65543890|NCT05016895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65543891|NCT05016895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543892|NCT01106131|Pioglitazone|pioglitazone|mesh-list
65543893|NCT01106131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65543894|NCT01106131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543895|NCT00612118|Azelastine|azelastine|mesh-list
65569516|NCT01238705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543896|NCT00612118|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
65543897|NCT00612118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65543898|NCT00612118|Autonomic Agents|autonomic agents|mesh-ancestor
65543899|NCT00612118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65543900|NCT00612118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543901|NCT00612118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65543902|NCT00612118|Respiratory System Agents|respiratory system agents|mesh-ancestor
65543903|NCT00612118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65543904|NCT00612118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543905|NCT00612118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543906|NCT00612118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65543907|NCT00612118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65543908|NCT00612118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65543909|NCT00612118|Histamine Antagonists|histamine antagonists|mesh-ancestor
65543910|NCT00612118|Histamine Agents|histamine agents|mesh-ancestor
65543911|NCT00612118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65543912|NCT00612118|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65543913|NCT00612118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65543914|NCT00743002|Metformin|metformin|mesh-list
65543915|NCT00743002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65543916|NCT00743002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543917|NCT03944863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65543918|NCT03944863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543919|NCT01102699|Lenograstim|lenograstim|mesh-list
65543920|NCT01102699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65543921|NCT01102699|Immunologic Factors|immunologic factors|mesh-ancestor
65543922|NCT01102699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543923|NCT00603616|Rifaximin|rifaximin|mesh-list
65543924|NCT00603616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65543925|NCT00603616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543926|NCT00603616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65543927|NCT02280070|Leucovorin|leucovorin|mesh-list
65543928|NCT02280070|Fluorouracil|fluorouracil|mesh-list
65543929|NCT02280070|Tegafur|tegafur|mesh-list
65543930|NCT02280070|Oxaliplatin|oxaliplatin|mesh-list
65543931|NCT02280070|Antibodies|antibodies|mesh-list
65543932|NCT02280070|Immunoglobulins|immunoglobulins|mesh-list
65543933|NCT02280070|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
65543934|NCT02280070|Immunologic Factors|immunologic factors|mesh-ancestor
65543935|NCT02280070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543936|NCT02280070|Antimetabolites|antimetabolites|mesh-ancestor
65543937|NCT02280070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543938|NCT02280070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65543939|NCT02280070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543940|NCT02280070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65543941|NCT02280070|Antidotes|antidotes|mesh-ancestor
65543942|NCT02280070|Protective Agents|protective agents|mesh-ancestor
65543943|NCT02280070|Vitamin B Complex|vitamin b complex|mesh-ancestor
65543944|NCT02280070|Vitamins|vitamins|mesh-ancestor
65543945|NCT02280070|Micronutrients|micronutrients|mesh-ancestor
65543946|NCT01108783|Desloratadine|desloratadine|mesh-list
65543947|NCT01108783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65543948|NCT01108783|Cholinergic Agents|cholinergic agents|mesh-ancestor
65543949|NCT01108783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65543950|NCT01108783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543951|NCT01108783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543952|NCT01108783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65543953|NCT01108783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65543954|NCT01108783|Histamine Antagonists|histamine antagonists|mesh-ancestor
65543955|NCT01108783|Histamine Agents|histamine agents|mesh-ancestor
65543957|NCT02743780|Enzyme Activators|enzyme activators|mesh-ancestor
65543958|NCT02743780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543959|NCT02280148|Propofol|propofol|mesh-list
65543960|NCT02280148|Anesthetics|anesthetics|mesh-ancestor
65543961|NCT02280148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65543962|NCT02280148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543963|NCT02280148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65543964|NCT02280148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65543965|NCT02280148|Anesthetics, General|anesthetics, general|mesh-ancestor
65543966|NCT00602602|Gemcitabine|gemcitabine|mesh-list
65543967|NCT00602602|Bevacizumab|bevacizumab|mesh-list
65543968|NCT00602602|Fluorouracil|fluorouracil|mesh-list
65543969|NCT00602602|Oxaliplatin|oxaliplatin|mesh-list
65543970|NCT00602602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65543971|NCT00602602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543972|NCT00602602|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65543973|NCT00602602|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65543974|NCT00602602|Growth Substances|growth substances|mesh-ancestor
65543975|NCT00602602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65543976|NCT00602602|Growth Inhibitors|growth inhibitors|mesh-ancestor
65543977|NCT00602602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65543978|NCT00602602|Antimetabolites|antimetabolites|mesh-ancestor
65543979|NCT00602602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543980|NCT00602602|Antiviral Agents|antiviral agents|mesh-ancestor
65543981|NCT00602602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543982|NCT00602602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543983|NCT00602602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65543984|NCT00602602|Immunologic Factors|immunologic factors|mesh-ancestor
65543985|NCT04177654|Albendazole|albendazole|mesh-list
65543986|NCT04177654|Mebendazole|mebendazole|mesh-list
65543987|NCT04177654|Benzimidazole|benzimidazole|mesh-list
65543988|NCT04177654|Anthelmintics|anthelmintics|mesh-ancestor
65543989|NCT04177654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65543990|NCT04177654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65543991|NCT04177654|Anticestodal Agents|anticestodal agents|mesh-ancestor
65543992|NCT04177654|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65543993|NCT04177654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65543994|NCT04177654|Tubulin Modulators|tubulin modulators|mesh-ancestor
65543995|NCT04177654|Antimitotic Agents|antimitotic agents|mesh-ancestor
65543996|NCT04177654|Mitosis Modulators|mitosis modulators|mesh-ancestor
65543997|NCT04177654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65543998|NCT04177654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65543999|NCT04177654|Antinematodal Agents|antinematodal agents|mesh-ancestor
65544000|NCT03726775|Durvalumab|durvalumab|mesh-list
65544001|NCT03726775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65544002|NCT03726775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544003|NCT02281396|Vaccines|vaccines|mesh-list
65544004|NCT02281396|Immunologic Factors|immunologic factors|mesh-ancestor
65544005|NCT02281396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544006|NCT04471480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65544007|NCT04471480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544008|NCT04471480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544009|NCT02880956|Tilavonemab|tilavonemab|mesh-list
65544010|NCT02880956|Nootropic Agents|nootropic agents|mesh-ancestor
65544011|NCT01111513|Analgesics|analgesics|mesh-list
65544012|NCT01111513|Ropivacaine|ropivacaine|mesh-list
65544013|NCT01111513|Anesthetics, Local|anesthetics, local|mesh-ancestor
65544014|NCT01111513|Anesthetics|anesthetics|mesh-ancestor
65544015|NCT01111513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65544016|NCT01111513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544017|NCT01111513|Sensory System Agents|sensory system agents|mesh-ancestor
65544018|NCT01111513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65544019|NCT01111591|Celecoxib|celecoxib|mesh-list
65544020|NCT01111591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
65544021|NCT01111591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65544022|NCT01111591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65544023|NCT01111591|Analgesics|analgesics|mesh-ancestor
65544024|NCT01111591|Sensory System Agents|sensory system agents|mesh-ancestor
65544025|NCT01111591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65544026|NCT01111591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544027|NCT01111591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65544028|NCT01111591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65544029|NCT01111591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65544030|NCT01111591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544031|NCT01111591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544032|NCT04161898|Prednisolone|prednisolone|mesh-list
65544033|NCT04161898|Upadacitinib|upadacitinib|mesh-list
65544034|NCT04161898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65544035|NCT04161898|Glucocorticoids|glucocorticoids|mesh-ancestor
65544036|NCT04161898|Hormones|hormones|mesh-ancestor
65544037|NCT04161898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65544038|NCT04161898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544039|NCT04161898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65544040|NCT04161898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544041|NCT04161898|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65544042|NCT04161898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65544043|NCT04161898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544044|NCT04161898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544045|NCT04161898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65544046|NCT01111669|Tranexamic Acid|tranexamic acid|mesh-list
65544047|NCT01111669|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65544048|NCT01111669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65544049|NCT01111669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544050|NCT01111669|Hemostatics|hemostatics|mesh-ancestor
65544051|NCT01111669|Coagulants|coagulants|mesh-ancestor
65544052|NCT01108939|Antimalarials|antimalarials|mesh-list
65544053|NCT01108939|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65544054|NCT01108939|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65544055|NCT01108939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65544056|NCT00654706|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65544057|NCT00654706|Sertindole|sertindole|mesh-list
65544058|NCT00654706|Antidepressive Agents|antidepressive agents|mesh-ancestor
65544059|NCT00654706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65544060|NCT00654706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65544061|NCT00654706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65544062|NCT00654706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65544063|NCT00654706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544064|NCT03944473|Neostigmine|neostigmine|mesh-list
65544065|NCT03944473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65544066|NCT03944473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544067|NCT03944473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544068|NCT03944473|Cholinergic Agents|cholinergic agents|mesh-ancestor
65544069|NCT03944473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65544070|NCT03944473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544071|NCT03944473|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65544072|NCT03944473|Autonomic Agents|autonomic agents|mesh-ancestor
65544073|NCT03944473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65544074|NCT03944317|Azithromycin|azithromycin|mesh-list
65544075|NCT03944317|Pyrimethamine|pyrimethamine|mesh-list
65544076|NCT03944317|Sulfadoxine|sulfadoxine|mesh-list
65544077|NCT03944317|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65544078|NCT03944317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65544079|NCT03944317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65544080|NCT03944317|Antimalarials|antimalarials|mesh-ancestor
65544081|NCT03944317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65544082|NCT03944317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65544083|NCT03944317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65544084|NCT03944317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544085|NCT03944317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341636|NCT00712686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65544086|NCT03944317|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65544087|NCT03944317|Renal Agents|renal agents|mesh-ancestor
65544088|NCT02280538|Hyaluronic Acid|hyaluronic acid|mesh-list
65544089|NCT02280538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65544090|NCT02280538|Immunologic Factors|immunologic factors|mesh-ancestor
65544091|NCT02280538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544092|NCT02280538|Viscosupplements|viscosupplements|mesh-ancestor
65544093|NCT02280538|Protective Agents|protective agents|mesh-ancestor
65544094|NCT01111747|Mitogens|mitogens|mesh-list
65544095|NCT01111747|Mitosis Modulators|mitosis modulators|mesh-ancestor
65544096|NCT01111747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544097|NCT02281708|Cisplatin|cisplatin|mesh-list
65544098|NCT02281708|Vinorelbine|vinorelbine|mesh-list
65544099|NCT02281708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544100|NCT02281708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65544101|NCT02281708|Tubulin Modulators|tubulin modulators|mesh-ancestor
65544102|NCT02281708|Antimitotic Agents|antimitotic agents|mesh-ancestor
65544103|NCT02281708|Mitosis Modulators|mitosis modulators|mesh-ancestor
65544104|NCT02281708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544105|NCT01111903|Lenalidomide|lenalidomide|mesh-list
65544106|NCT01111903|Immunologic Factors|immunologic factors|mesh-ancestor
65544107|NCT01111903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544108|NCT01111903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65544109|NCT01111903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65544110|NCT01111903|Growth Substances|growth substances|mesh-ancestor
65544111|NCT01111903|Growth Inhibitors|growth inhibitors|mesh-ancestor
65544112|NCT01111903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544113|NCT02280616|Budesonide|budesonide|mesh-list
65544114|NCT02280616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65544115|NCT02280616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65544116|NCT02280616|Autonomic Agents|autonomic agents|mesh-ancestor
65544117|NCT02280616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65544118|NCT02280616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544119|NCT02280616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65544120|NCT02280616|Respiratory System Agents|respiratory system agents|mesh-ancestor
65544121|NCT02280616|Glucocorticoids|glucocorticoids|mesh-ancestor
65544122|NCT02280616|Hormones|hormones|mesh-ancestor
65544123|NCT02280616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65544124|NCT01111981|Clobetasol|clobetasol|mesh-list
65544125|NCT01111981|Emollients|emollients|mesh-list
65544126|NCT01111981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65544127|NCT01111981|Glucocorticoids|glucocorticoids|mesh-ancestor
65544128|NCT01111981|Hormones|hormones|mesh-ancestor
65544129|NCT01111981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65544130|NCT01111981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544131|NCT01111981|Dermatologic Agents|dermatologic agents|mesh-ancestor
65544132|NCT02283424|Carboplatin|carboplatin|mesh-list
65544133|NCT02283424|Docetaxel|docetaxel|mesh-list
65544134|NCT02283424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544135|NCT02283424|Tubulin Modulators|tubulin modulators|mesh-ancestor
65544136|NCT02283424|Antimitotic Agents|antimitotic agents|mesh-ancestor
65544137|NCT02283424|Mitosis Modulators|mitosis modulators|mesh-ancestor
65544138|NCT02283424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544139|NCT03942601|Sirolimus|sirolimus|mesh-list
65544140|NCT03942601|Dexamethasone|dexamethasone|mesh-list
65544141|NCT03942601|Dexamethasone acetate|dexamethasone acetate|mesh-list
65544142|NCT03942601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65544143|NCT03942601|BB 1101|bb 1101|mesh-list
65544144|NCT03942601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65544145|NCT03942601|Antiemetics|antiemetics|mesh-ancestor
65544146|NCT03942601|Autonomic Agents|autonomic agents|mesh-ancestor
65544147|NCT03942601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65544148|NCT03942601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544149|NCT03942601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65544150|NCT03942601|Glucocorticoids|glucocorticoids|mesh-ancestor
65544151|NCT03942601|Hormones|hormones|mesh-ancestor
65544152|NCT03942601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65544153|NCT03942601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65544154|NCT03942601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544155|NCT03942601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65544156|NCT03942601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65544157|NCT03942601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65544158|NCT03942601|Antifungal Agents|antifungal agents|mesh-ancestor
65544159|NCT03942601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65544160|NCT03942601|Immunologic Factors|immunologic factors|mesh-ancestor
65544161|NCT03942601|Protease Inhibitors|protease inhibitors|mesh-ancestor
65544162|NCT03942601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544163|NCT03942601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544164|NCT00598312|Leuprolide|leuprolide|mesh-list
65544165|NCT00598312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65544166|NCT00598312|Fertility Agents|fertility agents|mesh-ancestor
65544167|NCT00598312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65544168|NCT00598312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544169|NCT00598312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65544170|NCT00598312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544171|NCT00595426|Warfarin|warfarin|mesh-list
65544172|NCT00595426|Anticoagulants|anticoagulants|mesh-ancestor
65544173|NCT01112137|Clopidogrel|clopidogrel|mesh-list
65544174|NCT01112137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65544175|NCT01112137|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65544176|NCT01112137|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65544177|NCT01112137|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65544178|NCT01112137|Purinergic Agents|purinergic agents|mesh-ancestor
65544179|NCT01112137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65544180|NCT01112137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544181|NCT01112137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544182|NCT02282098|Colchicine|colchicine|mesh-list
65544183|NCT02282098|Gout Suppressants|gout suppressants|mesh-ancestor
65544184|NCT02282098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65544185|NCT02282098|Tubulin Modulators|tubulin modulators|mesh-ancestor
65544186|NCT02282098|Antimitotic Agents|antimitotic agents|mesh-ancestor
65544187|NCT02282098|Mitosis Modulators|mitosis modulators|mesh-ancestor
65544188|NCT02282098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544189|NCT02282098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544190|NCT01208935|Nicotine|nicotine|mesh-list
65544191|NCT01208935|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65544192|NCT01208935|Autonomic Agents|autonomic agents|mesh-ancestor
65544193|NCT01208935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65544194|NCT01208935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544195|NCT01208935|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65544196|NCT01208935|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65544197|NCT01208935|Cholinergic Agents|cholinergic agents|mesh-ancestor
65544198|NCT01208935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65273283|NCT04500665|Gout Suppressants|gout suppressants|mesh-ancestor
65544199|NCT01208935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544200|NCT00584974|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65544201|NCT00584974|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65544202|NCT00584974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65544203|NCT00584974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65544204|NCT00584974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544205|NCT00584974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65544206|NCT00584974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544207|NCT00584974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65544208|NCT00584974|Antidepressive Agents|antidepressive agents|mesh-ancestor
65544209|NCT00584974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65544210|NCT01107067|Testosterone|testosterone|mesh-list
65544211|NCT01107067|Androgens|androgens|mesh-ancestor
65544212|NCT01107067|Hormones|hormones|mesh-ancestor
65544213|NCT01107067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65544214|NCT01107067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544215|NCT02282176|Azithromycin|azithromycin|mesh-list
65544216|NCT02282176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65544217|NCT02282176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65544218|NCT00580216|Biotin|biotin|mesh-list
65544219|NCT00580216|Warfarin|warfarin|mesh-list
65544220|NCT00580216|Idraparinux|idraparinux|mesh-list
65544221|NCT00580216|Idrabiotaparinux|idrabiotaparinux|mesh-list
65544222|NCT00580216|Anticoagulants|anticoagulants|mesh-ancestor
65544223|NCT00580216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65544224|NCT00580216|Antithrombins|antithrombins|mesh-ancestor
65544225|NCT00580216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65544226|NCT00580216|Protease Inhibitors|protease inhibitors|mesh-ancestor
65544227|NCT00580216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544228|NCT00580216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544229|NCT00580216|Vitamin B Complex|vitamin b complex|mesh-ancestor
65544230|NCT00580216|Vitamins|vitamins|mesh-ancestor
65544231|NCT00580216|Micronutrients|micronutrients|mesh-ancestor
65544232|NCT00580216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544233|NCT01107145|Artesunate|artesunate|mesh-list
65544234|NCT01107145|Chloroquine|chloroquine|mesh-list
65544235|NCT01107145|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65544236|NCT01107145|Lumefantrine|lumefantrine|mesh-list
65544237|NCT01107145|Artemether|artemether|mesh-list
65544238|NCT01107145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65544239|NCT01107145|Mefloquine|mefloquine|mesh-list
65544240|NCT01107145|Antimalarials|antimalarials|mesh-ancestor
65544241|NCT01107145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65544242|NCT01107145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65544243|NCT01107145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65544244|NCT01107145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544245|NCT01107145|Antiviral Agents|antiviral agents|mesh-ancestor
65544246|NCT01107145|Schistosomicides|schistosomicides|mesh-ancestor
65544247|NCT01107145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65544248|NCT01107145|Anthelmintics|anthelmintics|mesh-ancestor
65544249|NCT01107145|Amebicides|amebicides|mesh-ancestor
65544250|NCT01107145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65544251|NCT01107145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65544252|NCT01107145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65544253|NCT01107145|Analgesics|analgesics|mesh-ancestor
65544254|NCT01107145|Sensory System Agents|sensory system agents|mesh-ancestor
65544255|NCT01107145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65544256|NCT01107145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544257|NCT01107145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65544258|NCT01107145|Filaricides|filaricides|mesh-ancestor
65544259|NCT01107145|Antinematodal Agents|antinematodal agents|mesh-ancestor
65544260|NCT03944005|Anesthetics|anesthetics|mesh-list
65544261|NCT03944005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65544262|NCT03944005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544263|NCT01209403|Insulin|insulin|mesh-list
65544264|NCT01209403|Insulin Aspart|insulin aspart|mesh-list
65544265|NCT01209403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65544266|NCT01209403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544267|NCT01112215|Mycophenolic Acid|mycophenolic acid|mesh-list
65544268|NCT01112215|Azathioprine|azathioprine|mesh-list
65544269|NCT01112215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65544270|NCT01112215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544271|NCT01112215|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65544272|NCT01112215|Antitubercular Agents|antitubercular agents|mesh-ancestor
65544273|NCT01112215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65544274|NCT01112215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65544275|NCT01112215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544276|NCT01112215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544277|NCT01112215|Antimetabolites|antimetabolites|mesh-ancestor
65544278|NCT01112215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65544279|NCT01112215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65544280|NCT01112215|Immunologic Factors|immunologic factors|mesh-ancestor
65544281|NCT01112215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544282|NCT01112215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65544283|NCT01107223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65544284|NCT01107223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65544285|NCT01107223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65544286|NCT01107223|Antitubercular Agents|antitubercular agents|mesh-ancestor
65544287|NCT02286388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65544288|NCT02286388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65544289|NCT02286544|Atorvastatin|atorvastatin|mesh-list
65544290|NCT02286544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65544291|NCT02286544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65544292|NCT02286544|Antimetabolites|antimetabolites|mesh-ancestor
65544293|NCT02286544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544294|NCT02286544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65544295|NCT02286544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65544296|NCT02286544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544297|NCT01338116|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65544298|NCT01338116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65544299|NCT00384904|Ritonavir|ritonavir|mesh-list
65544300|NCT00384904|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65544301|NCT00384904|Tenofovir|tenofovir|mesh-list
65544302|NCT00384904|Famotidine|famotidine|mesh-list
65544303|NCT00384904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65544304|NCT00384904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65544305|NCT00384904|Protease Inhibitors|protease inhibitors|mesh-ancestor
65544306|NCT00384904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544307|NCT00384904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544308|NCT00384904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65544309|NCT00384904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65544310|NCT00384904|Antiviral Agents|antiviral agents|mesh-ancestor
65544311|NCT00384904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65544312|NCT00384904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65544313|NCT00384904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65544314|NCT00384904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65544315|NCT00384904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65544316|NCT00384904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65544317|NCT00384904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65544318|NCT00384904|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65544319|NCT00384904|Histamine Antagonists|histamine antagonists|mesh-ancestor
65544320|NCT00384904|Histamine Agents|histamine agents|mesh-ancestor
65544321|NCT00384904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65544322|NCT00384904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544323|NCT01335386|Glycerol|glycerol|mesh-list
65544324|NCT01335386|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65544325|NCT01335386|Protective Agents|protective agents|mesh-ancestor
65544326|NCT01335386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544327|NCT00383578|Metformin|metformin|mesh-list
65544328|NCT00383578|Vildagliptin|vildagliptin|mesh-list
65544329|NCT00383578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65544330|NCT00383578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544331|NCT00383578|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65544332|NCT00383578|Protease Inhibitors|protease inhibitors|mesh-ancestor
65544333|NCT00383578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544334|NCT00383578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544335|NCT00383422|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65544336|NCT00383422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65544337|NCT00383422|Hormone Antagonists|hormone antagonists|mesh-ancestor
65544338|NCT00383422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65544339|NCT00383422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544340|NCT00383422|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65544341|NCT00383422|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65544342|NCT00383422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65544343|NCT02286622|Deflazacort|deflazacort|mesh-list
65544344|NCT02286622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65544345|NCT02286622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65544346|NCT02286622|Immunologic Factors|immunologic factors|mesh-ancestor
65544347|NCT02286622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544348|NCT00564226|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65544349|NCT00564226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65544350|NCT00564226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65544351|NCT00564226|Cholinergic Agents|cholinergic agents|mesh-ancestor
65544352|NCT00564226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65544353|NCT00564226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544354|NCT00564226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544355|NCT00564226|Urological Agents|urological agents|mesh-ancestor
65544356|NCT03635684|Acetaminophen|acetaminophen|mesh-list
65544357|NCT03635684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65544358|NCT03635684|Analgesics|analgesics|mesh-ancestor
65544359|NCT03635684|Sensory System Agents|sensory system agents|mesh-ancestor
65544360|NCT03635684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65544361|NCT03635684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544362|NCT03635684|Antipyretics|antipyretics|mesh-ancestor
65544363|NCT00092690|Atorvastatin|atorvastatin|mesh-list
65544364|NCT00092690|Simvastatin|simvastatin|mesh-list
65544365|NCT00092690|Ezetimibe|ezetimibe|mesh-list
65544366|NCT00092690|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65544367|NCT00092690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65544368|NCT00092690|Antimetabolites|antimetabolites|mesh-ancestor
65544369|NCT00092690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544370|NCT00092690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65544371|NCT00092690|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65544372|NCT00092690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544373|NCT02286700|Desonide|desonide|mesh-list
65544374|NCT02286700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65544375|NCT01338896|Rotigotine|rotigotine|mesh-list
65544376|NCT01338896|Dopamine Agonists|dopamine agonists|mesh-ancestor
65544377|NCT01338896|Dopamine Agents|dopamine agents|mesh-ancestor
65544378|NCT01338896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65544379|NCT01338896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544380|NCT01338896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544381|NCT05185544|Pemetrexed|pemetrexed|mesh-list
65544382|NCT05185544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544383|NCT05185544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544384|NCT05185544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544385|NCT05185544|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65544386|NCT05185544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65544387|NCT00382096|Metformin|metformin|mesh-list
65544388|NCT00382096|Vildagliptin|vildagliptin|mesh-list
65544389|NCT00382096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65544390|NCT00382096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544391|NCT00382096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65544392|NCT00382096|Protease Inhibitors|protease inhibitors|mesh-ancestor
65544393|NCT00382096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544394|NCT00382096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544396|NCT00482092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65544397|NCT00482092|Antiviral Agents|antiviral agents|mesh-ancestor
65544398|NCT00482092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65544399|NCT00379990|Prednisolone|prednisolone|mesh-list
65544400|NCT00379990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65544401|NCT00379990|Glucocorticoids|glucocorticoids|mesh-ancestor
65544402|NCT00379990|Hormones|hormones|mesh-ancestor
65544403|NCT00379990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65544404|NCT00379990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544405|NCT00379990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65544406|NCT00379990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544407|NCT00377182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65544408|NCT00377182|Antiviral Agents|antiviral agents|mesh-ancestor
65544409|NCT00377182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65544410|NCT01341938|Nicotine|nicotine|mesh-list
65544411|NCT01341938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65544412|NCT01341938|Autonomic Agents|autonomic agents|mesh-ancestor
65544413|NCT01341938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65544414|NCT01341938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544415|NCT01341938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65544416|NCT01341938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65544417|NCT01341938|Cholinergic Agents|cholinergic agents|mesh-ancestor
65544418|NCT01341938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65544419|NCT01341938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544420|NCT02284048|Ticagrelor|ticagrelor|mesh-list
65544421|NCT02284048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65544422|NCT02284048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65544423|NCT02284048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65273510|NCT02846909|Hormones|hormones|mesh-ancestor
65544424|NCT02284048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65544425|NCT02284048|Purinergic Agents|purinergic agents|mesh-ancestor
65544426|NCT02284048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65544427|NCT02284048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544428|NCT02284048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544429|NCT00374296|Mocetinostat|mocetinostat|mesh-list
65544430|NCT00374296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65544431|NCT00374296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544432|NCT00374296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544433|NCT00547066|Veltuzumab|veltuzumab|mesh-list
65544434|NCT00547066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544435|NCT01315496|Immunoglobulins|immunoglobulins|mesh-list
65544436|NCT01315496|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65544437|NCT01315496|Antibodies|antibodies|mesh-list
65544438|NCT01315496|Immunoglobulin G|immunoglobulin g|mesh-list
65544439|NCT01315496|Immunologic Factors|immunologic factors|mesh-ancestor
65544440|NCT01315496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544441|NCT00544960|Docetaxel|docetaxel|mesh-list
65544442|NCT00544960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544443|NCT00544960|Tubulin Modulators|tubulin modulators|mesh-ancestor
65544444|NCT00544960|Antimitotic Agents|antimitotic agents|mesh-ancestor
65544445|NCT00544960|Mitosis Modulators|mitosis modulators|mesh-ancestor
65544446|NCT00544960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544447|NCT01339286|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65544448|NCT01339286|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65544449|NCT01339286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65544450|NCT01339286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65544451|NCT01339286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544452|NCT01339286|Adrenergic Agents|adrenergic agents|mesh-ancestor
65544453|NCT01339286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65544454|NCT01339286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544455|NCT00468442|Sirolimus|sirolimus|mesh-list
65544456|NCT00468442|Rituximab|rituximab|mesh-list
65544457|NCT00468442|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65544458|NCT00468442|Daclizumab|daclizumab|mesh-list
65544459|NCT00468442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65544460|NCT00468442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544461|NCT00468442|Immunologic Factors|immunologic factors|mesh-ancestor
65544462|NCT00468442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544463|NCT00468442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65544464|NCT00468442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65544465|NCT00468442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65544466|NCT00468442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65544467|NCT00468442|Antifungal Agents|antifungal agents|mesh-ancestor
65544468|NCT00468442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65544469|NCT01339442|Fulvestrant|fulvestrant|mesh-list
65544470|NCT01339442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65544471|NCT01339442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544472|NCT01339442|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65544473|NCT01339442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65544474|NCT01339442|Hormone Antagonists|hormone antagonists|mesh-ancestor
65544475|NCT01339442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65544476|NCT01339442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544477|NCT02286934|Carvedilol|carvedilol|mesh-list
65544478|NCT02286934|Isoproterenol|isoproterenol|mesh-list
65544479|NCT02286934|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65544480|NCT02286934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65544481|NCT02286934|Adrenergic Agents|adrenergic agents|mesh-ancestor
65544482|NCT02286934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65544483|NCT02286934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544484|NCT02286934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544485|NCT02286934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65544486|NCT02286934|Antioxidants|antioxidants|mesh-ancestor
65544487|NCT02286934|Protective Agents|protective agents|mesh-ancestor
65544488|NCT02286934|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65544489|NCT02286934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65544490|NCT02286934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65544491|NCT02286934|Vasodilator Agents|vasodilator agents|mesh-ancestor
65544492|NCT02286934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65544493|NCT02286934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65544494|NCT02286934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65544495|NCT02286934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65273592|NCT02846831|Insulin|insulin|mesh-list
65544496|NCT02286934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65544497|NCT02286934|Autonomic Agents|autonomic agents|mesh-ancestor
65544498|NCT02286934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65544499|NCT02286934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65544500|NCT02286934|Respiratory System Agents|respiratory system agents|mesh-ancestor
65544501|NCT02286934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65544502|NCT02286934|Sympathomimetics|sympathomimetics|mesh-ancestor
65544503|NCT02282410|Factor VIII|factor viii|mesh-list
65544504|NCT02282410|Coagulants|coagulants|mesh-ancestor
65544505|NCT00092612|Ezetimibe|ezetimibe|mesh-list
65544506|NCT00092612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65544507|NCT00092612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65544508|NCT00092612|Antimetabolites|antimetabolites|mesh-ancestor
65544509|NCT00092612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544510|NCT00092612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65544511|NCT00540358|Gemcitabine|gemcitabine|mesh-list
65544512|NCT00540358|Carboplatin|carboplatin|mesh-list
65544513|NCT00540358|Iniparib|iniparib|mesh-list
65544514|NCT00540358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544515|NCT00540358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65544516|NCT00540358|Antimetabolites|antimetabolites|mesh-ancestor
65544517|NCT00540358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544518|NCT00540358|Antiviral Agents|antiviral agents|mesh-ancestor
65544519|NCT00540358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65544520|NCT00540358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544521|NCT00540358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65544522|NCT00540358|Immunologic Factors|immunologic factors|mesh-ancestor
65544523|NCT00540358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544524|NCT00540358|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65544525|NCT00462202|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
65544526|NCT00462202|Anticoagulants|anticoagulants|mesh-ancestor
65544527|NCT00462202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65544528|NCT00462202|Antimetabolites|antimetabolites|mesh-ancestor
65544529|NCT00462202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544530|NCT00462202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65544531|NCT00462202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65544532|NCT00462202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65544533|NCT00462202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65544534|NCT00462202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544535|NCT02287246|Bupivacaine|bupivacaine|mesh-list
65544536|NCT02287246|Anesthetics, Local|anesthetics, local|mesh-ancestor
65544537|NCT02287246|Anesthetics|anesthetics|mesh-ancestor
65544538|NCT02287246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65342088|NCT03816488|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
65544539|NCT02287246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544540|NCT02287246|Sensory System Agents|sensory system agents|mesh-ancestor
65544541|NCT02287246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65544542|NCT04470544|Camostat|camostat|mesh-list
65544543|NCT04470544|Protease Inhibitors|protease inhibitors|mesh-ancestor
65544544|NCT04470544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544545|NCT04470544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544546|NCT04470544|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65544547|NCT04470544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65544548|NCT00535366|Fluticasone|fluticasone|mesh-list
65544549|NCT00535366|Ciclesonide|ciclesonide|mesh-list
65544550|NCT00535366|Tiotropium Bromide|tiotropium bromide|mesh-list
65544551|NCT00535366|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65544552|NCT00535366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65544553|NCT00535366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65544554|NCT00535366|Autonomic Agents|autonomic agents|mesh-ancestor
65544555|NCT00535366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65544556|NCT00535366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544557|NCT00535366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65544558|NCT00535366|Respiratory System Agents|respiratory system agents|mesh-ancestor
65544559|NCT00535366|Dermatologic Agents|dermatologic agents|mesh-ancestor
65544560|NCT00535366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65544561|NCT00535366|Parasympatholytics|parasympatholytics|mesh-ancestor
65544562|NCT00535366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65544563|NCT00535366|Cholinergic Agents|cholinergic agents|mesh-ancestor
65544564|NCT00535366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65544565|NCT00535366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544566|NCT00535366|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65544567|NCT00535366|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65544568|NCT00535366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65544569|NCT00535366|Adrenergic Agents|adrenergic agents|mesh-ancestor
65273658|NCT00618228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65544570|NCT00535366|Glucocorticoids|glucocorticoids|mesh-ancestor
65544571|NCT00535366|Hormones|hormones|mesh-ancestor
65544572|NCT00535366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65544573|NCT00369070|Paclitaxel|paclitaxel|mesh-list
65544574|NCT00369070|Bevacizumab|bevacizumab|mesh-list
65544575|NCT00369070|Carboplatin|carboplatin|mesh-list
65544576|NCT00369070|Motesanib diphosphate|motesanib diphosphate|mesh-list
65544577|NCT00369070|Imetelstat|imetelstat|mesh-list
65544578|NCT00369070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65544579|NCT00369070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544580|NCT00369070|Tubulin Modulators|tubulin modulators|mesh-ancestor
65544581|NCT00369070|Antimitotic Agents|antimitotic agents|mesh-ancestor
65544582|NCT00369070|Mitosis Modulators|mitosis modulators|mesh-ancestor
65544583|NCT00369070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544584|NCT00369070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65544585|NCT00369070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65544586|NCT00369070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65544587|NCT00369070|Growth Substances|growth substances|mesh-ancestor
65544588|NCT00369070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544589|NCT00369070|Growth Inhibitors|growth inhibitors|mesh-ancestor
65544590|NCT00369070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65544591|NCT00369070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544592|NCT02284204|Midazolam|midazolam|mesh-list
65544593|NCT02284204|Ketamine|ketamine|mesh-list
65544594|NCT02284204|Sevoflurane|sevoflurane|mesh-list
65544595|NCT02284204|Analgesics|analgesics|mesh-ancestor
65544596|NCT02284204|Sensory System Agents|sensory system agents|mesh-ancestor
65544597|NCT02284204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65544598|NCT02284204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544599|NCT02284204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65544600|NCT02284204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65544601|NCT02284204|Anesthetics, General|anesthetics, general|mesh-ancestor
65544602|NCT02284204|Anesthetics|anesthetics|mesh-ancestor
65544603|NCT02284204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65544604|NCT02284204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65544605|NCT02284204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65544606|NCT02284204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65544607|NCT02284204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544608|NCT02284204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65544609|NCT02284204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65544610|NCT02284204|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65544611|NCT02284204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65544612|NCT02284204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65544613|NCT02284204|GABA Modulators|gaba modulators|mesh-ancestor
65544614|NCT02284204|GABA Agents|gaba agents|mesh-ancestor
65544615|NCT02284204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65544616|NCT02284204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65544617|NCT01352416|Ranolazine|ranolazine|mesh-list
65544618|NCT01352416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65544619|NCT01352416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65544620|NCT01352416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544621|NCT00531622|Citalopram|citalopram|mesh-list
65544622|NCT00531622|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65544623|NCT00531622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65544624|NCT00531622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65544625|NCT00531622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544626|NCT00531622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65544627|NCT00531622|Serotonin Agents|serotonin agents|mesh-ancestor
65544628|NCT00531622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544629|NCT00531622|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65544630|NCT00531622|Antidepressive Agents|antidepressive agents|mesh-ancestor
65544631|NCT00531622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65544632|NCT00364546|Tapentadol|tapentadol|mesh-list
65544633|NCT00364546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65544634|NCT00364546|Narcotics|narcotics|mesh-ancestor
65544635|NCT00364546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65544636|NCT00364546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544637|NCT00364546|Analgesics|analgesics|mesh-ancestor
65544638|NCT00364546|Sensory System Agents|sensory system agents|mesh-ancestor
65544639|NCT00364546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65544640|NCT00364546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65544641|NCT00364546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65544642|NCT00364546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65544643|NCT00364546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544644|NCT00364546|Adrenergic Agents|adrenergic agents|mesh-ancestor
65544645|NCT00364546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65544646|NCT00361582|Tapentadol|tapentadol|mesh-list
65544647|NCT00361582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65544648|NCT00361582|Narcotics|narcotics|mesh-ancestor
65544649|NCT00361582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65544650|NCT00361582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544651|NCT00361582|Analgesics|analgesics|mesh-ancestor
65544652|NCT00361582|Sensory System Agents|sensory system agents|mesh-ancestor
65544653|NCT00361582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65544654|NCT00361582|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65544655|NCT00361582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65544656|NCT00361582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65544657|NCT00361582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544658|NCT00361582|Adrenergic Agents|adrenergic agents|mesh-ancestor
65544659|NCT00361582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65544660|NCT00450970|Satraplatin|satraplatin|mesh-list
65544661|NCT00450970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544662|NCT02282800|Vitamin D|vitamin d|mesh-list
65544663|NCT02282800|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
65544664|NCT02282800|Vitamins|vitamins|mesh-ancestor
65544665|NCT02282800|Micronutrients|micronutrients|mesh-ancestor
65544666|NCT02282800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544667|NCT02282800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65544668|NCT05208034|Methotrexate|methotrexate|mesh-list
65544669|NCT05208034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65544670|NCT05208034|Abortifacient Agents|abortifacient agents|mesh-ancestor
65544671|NCT05208034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65544672|NCT05208034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544673|NCT05208034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65544674|NCT05208034|Antimetabolites|antimetabolites|mesh-ancestor
65544675|NCT05208034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544676|NCT05208034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544677|NCT05208034|Dermatologic Agents|dermatologic agents|mesh-ancestor
65544678|NCT05208034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544679|NCT05208034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65544680|NCT05208034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65544681|NCT05208034|Immunologic Factors|immunologic factors|mesh-ancestor
65544682|NCT05208034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65544683|NCT05208034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65544684|NCT02284282|Lidocaine|lidocaine|mesh-list
65544685|NCT02284282|Morphine|morphine|mesh-list
65544686|NCT02284282|Bupivacaine|bupivacaine|mesh-list
65544687|NCT02284282|Anesthetics, Local|anesthetics, local|mesh-ancestor
65544688|NCT02284282|Anesthetics|anesthetics|mesh-ancestor
65544689|NCT02284282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65544690|NCT02284282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544691|NCT02284282|Sensory System Agents|sensory system agents|mesh-ancestor
65544692|NCT02284282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65544693|NCT02284282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65544694|NCT02284282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65544695|NCT02284282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65544696|NCT02284282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65544697|NCT02284282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544698|NCT02284282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65544699|NCT02284282|Narcotics|narcotics|mesh-ancestor
65544700|NCT02284282|Analgesics|analgesics|mesh-ancestor
65544701|NCT00359086|Mocetinostat|mocetinostat|mesh-list
65544702|NCT00359086|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65544703|NCT00359086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544704|NCT00359086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544705|NCT03133780|Midazolam|midazolam|mesh-list
65544706|NCT03133780|Ketamine|ketamine|mesh-list
65544707|NCT03133780|Analgesics|analgesics|mesh-ancestor
65544708|NCT03133780|Sensory System Agents|sensory system agents|mesh-ancestor
65544709|NCT03133780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65544710|NCT03133780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544711|NCT03133780|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65544712|NCT03133780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65544713|NCT03133780|Anesthetics, General|anesthetics, general|mesh-ancestor
65544714|NCT03133780|Anesthetics|anesthetics|mesh-ancestor
65544715|NCT03133780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65273810|NCT04474847|Abatacept|abatacept|mesh-list
65544716|NCT03133780|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65544717|NCT03133780|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65544718|NCT03133780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65544719|NCT03133780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544720|NCT03133780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65544721|NCT03133780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65544722|NCT03133780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65544723|NCT03133780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65544724|NCT03133780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65544725|NCT03133780|GABA Modulators|gaba modulators|mesh-ancestor
65544726|NCT03133780|GABA Agents|gaba agents|mesh-ancestor
65544727|NCT02282956|Droperidol|droperidol|mesh-list
65544728|NCT02282956|Morphine|morphine|mesh-list
65544729|NCT02282956|Ropivacaine|ropivacaine|mesh-list
65544730|NCT02282956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65544731|NCT02282956|Narcotics|narcotics|mesh-ancestor
65544732|NCT02282956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65544733|NCT02282956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544734|NCT02282956|Analgesics|analgesics|mesh-ancestor
65544735|NCT02282956|Sensory System Agents|sensory system agents|mesh-ancestor
65544736|NCT02282956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65544737|NCT02282956|Anesthetics, Local|anesthetics, local|mesh-ancestor
65544738|NCT02282956|Anesthetics|anesthetics|mesh-ancestor
65544739|NCT02282956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65544740|NCT02282956|Antiemetics|antiemetics|mesh-ancestor
65544741|NCT02282956|Autonomic Agents|autonomic agents|mesh-ancestor
65544742|NCT02282956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65544743|NCT02282956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65544744|NCT02282956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65544745|NCT02282956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65544746|NCT02282956|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65544747|NCT02282956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65544748|NCT02282956|Dopamine Agents|dopamine agents|mesh-ancestor
65544749|NCT02282956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65544750|NCT02282956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544751|NCT02287558|Pomalidomide|pomalidomide|mesh-list
65544752|NCT02287558|Immunologic Factors|immunologic factors|mesh-ancestor
65544753|NCT02287558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544754|NCT02287558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65544755|NCT02287558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65544756|NCT02287558|Growth Substances|growth substances|mesh-ancestor
65544757|NCT02287558|Growth Inhibitors|growth inhibitors|mesh-ancestor
65544758|NCT02287558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544759|NCT04470076|Gemcitabine|gemcitabine|mesh-list
65544760|NCT04470076|Carboplatin|carboplatin|mesh-list
65544761|NCT04470076|Pemetrexed|pemetrexed|mesh-list
65544762|NCT04470076|Afatinib|afatinib|mesh-list
65544763|NCT04470076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544764|NCT04470076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65544765|NCT04470076|Antimetabolites|antimetabolites|mesh-ancestor
65544766|NCT04470076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544767|NCT04470076|Antiviral Agents|antiviral agents|mesh-ancestor
65544768|NCT04470076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65544769|NCT04470076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544770|NCT04470076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65544771|NCT04470076|Immunologic Factors|immunologic factors|mesh-ancestor
65544772|NCT04470076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544773|NCT04470076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65544774|NCT04470076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65544775|NCT04470076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65544776|NCT00445198|Navitoclax|navitoclax|mesh-list
65544777|NCT00445198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544778|NCT00345748|Abatacept|abatacept|mesh-list
65544779|NCT00345748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65544780|NCT00345748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544781|NCT00345748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544782|NCT00345748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65544783|NCT00345748|Immunologic Factors|immunologic factors|mesh-ancestor
65544784|NCT00345748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544785|NCT00345748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65544786|NCT00439738|Amlodipine|amlodipine|mesh-list
65544787|NCT00439738|Valsartan|valsartan|mesh-list
65544788|NCT00439738|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65544789|NCT00439738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65544790|NCT00439738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65544791|NCT00439738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65544792|NCT00439738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544793|NCT00439738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65544794|NCT00439738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544795|NCT00439738|Vasodilator Agents|vasodilator agents|mesh-ancestor
65544796|NCT00439738|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65544797|NCT00439738|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65544798|NCT00439738|Diuretics|diuretics|mesh-ancestor
65544799|NCT00439738|Natriuretic Agents|natriuretic agents|mesh-ancestor
65544800|NCT00439738|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65544801|NCT00435916|Dacetuzumab|dacetuzumab|mesh-list
65544802|NCT00435916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65544803|NCT00435916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544804|NCT00523042|Insulin|insulin|mesh-list
65544805|NCT00523042|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65544806|NCT00523042|Insulin Aspart|insulin aspart|mesh-list
65544807|NCT00523042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65544808|NCT00523042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544809|NCT05203276|Endostar protein|endostar protein|mesh-list
65544810|NCT05203276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65544811|NCT05203276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65544812|NCT05203276|Growth Substances|growth substances|mesh-ancestor
65544813|NCT05203276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544814|NCT05203276|Growth Inhibitors|growth inhibitors|mesh-ancestor
65544815|NCT05203276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544816|NCT00338104|Insulin|insulin|mesh-list
65544817|NCT00338104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65544818|NCT00338104|Insulin Glargine|insulin glargine|mesh-list
65544819|NCT00338104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65544820|NCT00338104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544821|NCT00519142|Mitiglinide|mitiglinide|mesh-list
65544822|NCT00519142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65544823|NCT00519142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544824|NCT02284672|Dexmedetomidine|dexmedetomidine|mesh-list
65544825|NCT02284672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65544826|NCT02284672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65544827|NCT02284672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544828|NCT02284672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65544829|NCT02284672|Analgesics|analgesics|mesh-ancestor
65544830|NCT02284672|Sensory System Agents|sensory system agents|mesh-ancestor
65544831|NCT02284672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65544832|NCT02284672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65544833|NCT02284672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65544834|NCT02284672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65544835|NCT02284672|Adrenergic Agents|adrenergic agents|mesh-ancestor
65544836|NCT02284672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65544837|NCT02284672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544838|NCT02283190|Asparaginase|asparaginase|mesh-list
65544839|NCT02283190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544840|NCT00333502|Camptothecin|camptothecin|mesh-list
65544841|NCT00333502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65544842|NCT00333502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544843|NCT00333502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65544844|NCT00333502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65544845|NCT00333502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544846|NCT00333502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544847|NCT00332956|Vaccines|vaccines|mesh-list
65544848|NCT00332956|Immunologic Factors|immunologic factors|mesh-ancestor
65544849|NCT00332956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544850|NCT00324220|Mocetinostat|mocetinostat|mesh-list
65544851|NCT00324220|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65544852|NCT00324220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544853|NCT00324220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544854|NCT02287792|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65544855|NCT02287792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65544856|NCT02287792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544857|NCT00417118|Citalopram|citalopram|mesh-list
65544858|NCT00417118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65544859|NCT00417118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65544860|NCT00417118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65544861|NCT00417118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544862|NCT00417118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65544863|NCT00417118|Serotonin Agents|serotonin agents|mesh-ancestor
65544864|NCT00417118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544865|NCT00417118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65544866|NCT00417118|Antidepressive Agents|antidepressive agents|mesh-ancestor
65544867|NCT00417118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65544868|NCT02883452|Infliximab|infliximab|mesh-list
65544869|NCT02883452|Dermatologic Agents|dermatologic agents|mesh-ancestor
65544870|NCT02883452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65544871|NCT02883452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65544872|NCT00508066|Bupivacaine|bupivacaine|mesh-list
65544873|NCT00508066|Anesthetics, Local|anesthetics, local|mesh-ancestor
65544874|NCT00508066|Anesthetics|anesthetics|mesh-ancestor
65544875|NCT00508066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65544876|NCT00508066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544877|NCT00508066|Sensory System Agents|sensory system agents|mesh-ancestor
65544878|NCT00508066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65544879|NCT01336010|Ribavirin|ribavirin|mesh-list
65544880|NCT01336010|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65544881|NCT01336010|Antimetabolites|antimetabolites|mesh-ancestor
65544882|NCT01336010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544883|NCT01336010|Antiviral Agents|antiviral agents|mesh-ancestor
65544884|NCT01336010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65544885|NCT02207504|Crizotinib|crizotinib|mesh-list
65544886|NCT02207504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544887|NCT02207504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65544888|NCT02207504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544889|NCT02207504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544890|NCT01342016|Prednisone|prednisone|mesh-list
65544891|NCT01342016|Tacrolimus|tacrolimus|mesh-list
65544892|NCT01342016|Leflunomide|leflunomide|mesh-list
65544893|NCT01342016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65544894|NCT01342016|Glucocorticoids|glucocorticoids|mesh-ancestor
65544895|NCT01342016|Hormones|hormones|mesh-ancestor
65544896|NCT01342016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65544897|NCT01342016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544898|NCT01342016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65544899|NCT01342016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544900|NCT01342016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65544901|NCT01342016|Immunologic Factors|immunologic factors|mesh-ancestor
65544902|NCT01342016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65544903|NCT01342016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544904|NCT01342016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544905|NCT01336166|Vaccines|vaccines|mesh-list
65544906|NCT01336166|Immunologic Factors|immunologic factors|mesh-ancestor
65544907|NCT01336166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544908|NCT04470310|Pioglitazone|pioglitazone|mesh-list
65544909|NCT04470310|Glimepiride|glimepiride|mesh-list
65544910|NCT04470310|Alogliptin|alogliptin|mesh-list
65544911|NCT04470310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65544912|NCT04470310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544913|NCT04470310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65544914|NCT04470310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65544915|NCT04470310|Immunologic Factors|immunologic factors|mesh-ancestor
65544916|NCT04470310|Incretins|incretins|mesh-ancestor
65544917|NCT04470310|Hormones|hormones|mesh-ancestor
65544918|NCT04470310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65544919|NCT04470310|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65544920|NCT04470310|Protease Inhibitors|protease inhibitors|mesh-ancestor
65544921|NCT04470310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544922|NCT04470310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544923|NCT02083250|Fludarabine|fludarabine|mesh-list
65544924|NCT02083250|Fludarabine phosphate|fludarabine phosphate|mesh-list
65544925|NCT02083250|Busulfan|busulfan|mesh-list
65544926|NCT02083250|Vorinostat|vorinostat|mesh-list
65544927|NCT02083250|Clofarabine|clofarabine|mesh-list
65544928|NCT02083250|Thymoglobulin|thymoglobulin|mesh-list
65544929|NCT02083250|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65544930|NCT02083250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544931|NCT02083250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65544932|NCT02083250|Antimetabolites|antimetabolites|mesh-ancestor
65544933|NCT02083250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544934|NCT02083250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65544935|NCT02083250|Immunologic Factors|immunologic factors|mesh-ancestor
65544936|NCT02083250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544937|NCT02083250|Alkylating Agents|alkylating agents|mesh-ancestor
65544938|NCT02083250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65544939|NCT02083250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65544940|NCT02083250|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65544941|NCT02083250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544942|NCT00412828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
65544943|NCT00412828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65544944|NCT00412828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544945|NCT00315640|Hydrocortisone|hydrocortisone|mesh-list
65544946|NCT00315640|Anecortave|anecortave|mesh-list
65544947|NCT00315640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65544948|NCT00315640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65544949|NCT00315640|Growth Substances|growth substances|mesh-ancestor
65544950|NCT00315640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544951|NCT00315640|Growth Inhibitors|growth inhibitors|mesh-ancestor
65544952|NCT00315640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544953|NCT00315640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65544954|NCT00411892|Insulin|insulin|mesh-list
65544955|NCT00411892|Pioglitazone|pioglitazone|mesh-list
65544956|NCT00411892|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65544957|NCT00411892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65544958|NCT00411892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544959|NCT01336322|Metformin|metformin|mesh-list
65544960|NCT01336322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65544961|NCT01336322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65544962|NCT01336322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544963|NCT01336322|Incretins|incretins|mesh-ancestor
65544964|NCT01336322|Hormones|hormones|mesh-ancestor
65544965|NCT01336322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65544966|NCT01336322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65544967|NCT01336322|Protease Inhibitors|protease inhibitors|mesh-ancestor
65544968|NCT01336322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65544969|NCT01336322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544970|NCT01339676|Vitamin D|vitamin d|mesh-list
65544971|NCT01339676|Cholecalciferol|cholecalciferol|mesh-list
65544972|NCT01339676|Vitamins|vitamins|mesh-ancestor
65544973|NCT01339676|Micronutrients|micronutrients|mesh-ancestor
65544974|NCT01339676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544975|NCT01339676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65544976|NCT01339676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65544977|NCT01339754|Trabectedin|trabectedin|mesh-list
65544978|NCT01339754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65544979|NCT01339754|Alkylating Agents|alkylating agents|mesh-ancestor
65544980|NCT01339754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544981|NCT01339754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544982|NCT00313768|Paclitaxel|paclitaxel|mesh-list
65544983|NCT00313768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65544984|NCT00313768|Bevacizumab|bevacizumab|mesh-list
65544985|NCT00313768|Carboplatin|carboplatin|mesh-list
65544986|NCT00313768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65544987|NCT00313768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65544988|NCT00313768|Tubulin Modulators|tubulin modulators|mesh-ancestor
65544989|NCT00313768|Antimitotic Agents|antimitotic agents|mesh-ancestor
65544990|NCT00313768|Mitosis Modulators|mitosis modulators|mesh-ancestor
65544991|NCT00313768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65544992|NCT00313768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65544993|NCT00313768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65544994|NCT00313768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65544995|NCT00313768|Growth Substances|growth substances|mesh-ancestor
65544996|NCT00313768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65544997|NCT00313768|Growth Inhibitors|growth inhibitors|mesh-ancestor
65544998|NCT01339988|Cyclophosphamide|cyclophosphamide|mesh-list
65544999|NCT01339988|Busulfan|busulfan|mesh-list
65545000|NCT01339988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65545001|NCT01339988|Immunologic Factors|immunologic factors|mesh-ancestor
65545002|NCT01339988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545003|NCT01339988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65545004|NCT01339988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65545005|NCT01339988|Alkylating Agents|alkylating agents|mesh-ancestor
65545006|NCT01339988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545007|NCT01339988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545008|NCT01339988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65545009|NCT00406588|Levodopa|levodopa|mesh-list
65545010|NCT00406588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65545011|NCT00406588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65545012|NCT00406588|Dopamine Agents|dopamine agents|mesh-ancestor
65545013|NCT00406588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65545014|NCT00406588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545015|NCT00406588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545016|NCT01342328|Dexmedetomidine|dexmedetomidine|mesh-list
65545017|NCT01342328|Propofol|propofol|mesh-list
65274102|NCT03691493|Fulvestrant|fulvestrant|mesh-list
65545018|NCT01342328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65545019|NCT01342328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65545020|NCT01342328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545021|NCT01342328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65545022|NCT01342328|Anesthetics, General|anesthetics, general|mesh-ancestor
65545023|NCT01342328|Anesthetics|anesthetics|mesh-ancestor
65545024|NCT01342328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65545025|NCT01342328|Analgesics|analgesics|mesh-ancestor
65545026|NCT01342328|Sensory System Agents|sensory system agents|mesh-ancestor
65545027|NCT01342328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65545028|NCT01342328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65545029|NCT01342328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65545030|NCT01342328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65545031|NCT01342328|Adrenergic Agents|adrenergic agents|mesh-ancestor
65545032|NCT01342328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65545033|NCT01342328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545034|NCT00313222|Bosentan|bosentan|mesh-list
65545035|NCT00313222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65545036|NCT00313222|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65545037|NCT00313222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545038|NCT05726032|Empagliflozin|empagliflozin|mesh-list
65545039|NCT05726032|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65545040|NCT05726032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545041|NCT05726032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65545042|NCT05726032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545043|NCT05184530|Evolocumab|evolocumab|mesh-list
65545044|NCT05184530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65545045|NCT05184530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65545046|NCT05184530|Antimetabolites|antimetabolites|mesh-ancestor
65545047|NCT05184530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545048|NCT05184530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65545049|NCT05184374|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65545050|NCT05184374|Hormones|hormones|mesh-ancestor
65545051|NCT05184374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65545052|NCT05184374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545053|NCT05187494|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65545054|NCT05187494|Anesthetics, Local|anesthetics, local|mesh-ancestor
65545055|NCT05187494|Anesthetics|anesthetics|mesh-ancestor
65545056|NCT05187494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65545057|NCT05187494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545058|NCT05187494|Sensory System Agents|sensory system agents|mesh-ancestor
65545059|NCT05187494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65545060|NCT05187494|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65545061|NCT01342562|Anesthetics|anesthetics|mesh-list
65545062|NCT01342562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65545063|NCT01342562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545064|NCT00116116|Lamivudine|lamivudine|mesh-list
65545065|NCT00116116|Efavirenz|efavirenz|mesh-list
65545066|NCT00116116|Stavudine|stavudine|mesh-list
65545067|NCT00116116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65545068|NCT00116116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65545069|NCT00116116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545070|NCT00116116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545071|NCT00116116|Antiviral Agents|antiviral agents|mesh-ancestor
65545072|NCT00116116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65545073|NCT00116116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65545074|NCT00116116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65545075|NCT00116116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65545076|NCT00116116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65545077|NCT00116116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65545078|NCT00116116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65545079|NCT00116116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65545080|NCT00116116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65545081|NCT00116116|Antimetabolites|antimetabolites|mesh-ancestor
65545082|NCT02287870|Lidocaine|lidocaine|mesh-list
65545083|NCT02287870|Chloroprocaine|chloroprocaine|mesh-list
65545084|NCT02287870|Procaine|procaine|mesh-list
65545085|NCT02287870|Anesthetics, Local|anesthetics, local|mesh-ancestor
65545086|NCT02287870|Anesthetics|anesthetics|mesh-ancestor
65545087|NCT02287870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65545088|NCT02287870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274177|NCT02153645|Amantadine|amantadine|mesh-list
65545089|NCT02287870|Sensory System Agents|sensory system agents|mesh-ancestor
65545090|NCT02287870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65545091|NCT02287870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65545092|NCT02287870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65545093|NCT02287870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65545094|NCT02287870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65545095|NCT02287870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545096|NCT01340456|Rifampin|rifampin|mesh-list
65545097|NCT01340456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65545098|NCT01340456|Antitubercular Agents|antitubercular agents|mesh-ancestor
65545099|NCT01340456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65545100|NCT01340456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65545101|NCT01340456|Leprostatic Agents|leprostatic agents|mesh-ancestor
65545102|NCT01340456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65545103|NCT01340456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545104|NCT01340456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545105|NCT01340456|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65545106|NCT01340456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65545107|NCT01340456|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65545108|NCT01340456|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65545109|NCT01340456|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65545110|NCT01340456|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65545111|NCT00110422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65545112|NCT00110422|Irbesartan|irbesartan|mesh-list
65545113|NCT00110422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65545114|NCT00110422|Diuretics|diuretics|mesh-ancestor
65545115|NCT00110422|Natriuretic Agents|natriuretic agents|mesh-ancestor
65545116|NCT00110422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545117|NCT00110422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65545118|NCT00110422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65545119|NCT00110422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545120|NCT00110422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65545121|NCT00110422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65545122|NCT00305656|Cediranib|cediranib|mesh-list
65545123|NCT00305656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545124|NCT00305656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545125|NCT00305656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545126|NCT00305656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65545127|NCT02284984|Rituximab|rituximab|mesh-list
65545128|NCT02284984|Belimumab|belimumab|mesh-list
65545129|NCT02284984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65545130|NCT02284984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545131|NCT02284984|Immunologic Factors|immunologic factors|mesh-ancestor
65545132|NCT02284984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545133|NCT02284984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65545134|NCT02284984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65545135|NCT00305188|Leucovorin|leucovorin|mesh-list
65545136|NCT00305188|Fluorouracil|fluorouracil|mesh-list
65342693|NCT00804297|Octreotide|octreotide|mesh-list
65545137|NCT00305188|Oxaliplatin|oxaliplatin|mesh-list
65545138|NCT00305188|Xaliproden|xaliproden|mesh-list
65545139|NCT00305188|Antimetabolites|antimetabolites|mesh-ancestor
65545140|NCT00305188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545141|NCT00305188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65545142|NCT00305188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545143|NCT00305188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65545144|NCT00305188|Immunologic Factors|immunologic factors|mesh-ancestor
65545145|NCT00305188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545146|NCT00305188|Antidotes|antidotes|mesh-ancestor
65545147|NCT00305188|Protective Agents|protective agents|mesh-ancestor
65545148|NCT00305188|Vitamin B Complex|vitamin b complex|mesh-ancestor
65545149|NCT00305188|Vitamins|vitamins|mesh-ancestor
65545150|NCT00305188|Micronutrients|micronutrients|mesh-ancestor
65545151|NCT00305188|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65545152|NCT00305188|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65545153|NCT00305188|Serotonin Agents|serotonin agents|mesh-ancestor
65545154|NCT00305188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65545155|NCT05725876|Ustekinumab|ustekinumab|mesh-list
65545156|NCT05725876|Dermatologic Agents|dermatologic agents|mesh-ancestor
65545157|NCT00297310|Tacrolimus|tacrolimus|mesh-list
65545158|NCT00297310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65545159|NCT00297310|Immunologic Factors|immunologic factors|mesh-ancestor
65545160|NCT00297310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274250|NCT00092729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65545161|NCT00297310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65545162|NCT00297310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545163|NCT00297310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545164|NCT00095290|Ramipril|ramipril|mesh-list
65545165|NCT00095290|Irbesartan|irbesartan|mesh-list
65545166|NCT00095290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65545167|NCT00095290|Protease Inhibitors|protease inhibitors|mesh-ancestor
65545168|NCT00095290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545169|NCT00095290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545170|NCT00095290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65545171|NCT00095290|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65545172|NCT00095290|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65545173|NCT01340846|Ketoconazole|ketoconazole|mesh-list
65545174|NCT01340846|Dabrafenib|dabrafenib|mesh-list
65545175|NCT01340846|Warfarin|warfarin|mesh-list
65545176|NCT01340846|Gemfibrozil|gemfibrozil|mesh-list
65545177|NCT01340846|Anticoagulants|anticoagulants|mesh-ancestor
65545178|NCT01340846|Antifungal Agents|antifungal agents|mesh-ancestor
65545179|NCT01340846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65545180|NCT01340846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65545181|NCT01340846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65545182|NCT01340846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545183|NCT01340846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545184|NCT01340846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65545185|NCT01340846|Hormone Antagonists|hormone antagonists|mesh-ancestor
65545186|NCT01340846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65545187|NCT01340846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545188|NCT01340846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65545189|NCT01340846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545190|NCT01340846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65545191|NCT01340846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65545192|NCT01340846|Antimetabolites|antimetabolites|mesh-ancestor
65545193|NCT01340846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65545194|NCT01340846|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65545195|NCT01342874|Inositol|inositol|mesh-list
65545196|NCT01342874|Vitamin B Complex|vitamin b complex|mesh-ancestor
65545197|NCT01342874|Vitamins|vitamins|mesh-ancestor
65545198|NCT01342874|Micronutrients|micronutrients|mesh-ancestor
65545199|NCT01342874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545200|NCT01337258|Dutasteride|dutasteride|mesh-list
65545201|NCT01337258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65545202|NCT01337258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65545203|NCT01337258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545204|NCT01337258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545205|NCT01337258|Hormone Antagonists|hormone antagonists|mesh-ancestor
65545206|NCT01337258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65545207|NCT01337258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545208|NCT02603809|Lisinopril|lisinopril|mesh-list
65545209|NCT02603809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65545210|NCT02603809|Protease Inhibitors|protease inhibitors|mesh-ancestor
65342778|NCT00865462|Bupropion|bupropion|mesh-list
65545212|NCT02603809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545213|NCT02603809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65545214|NCT02603809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65545215|NCT02603809|Protective Agents|protective agents|mesh-ancestor
65545216|NCT02603809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545217|NCT01341158|Interferons|interferons|mesh-list
65545218|NCT01341158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545219|NCT01341158|Antiviral Agents|antiviral agents|mesh-ancestor
65545220|NCT01341158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65545221|NCT00393952|Fluticasone|fluticasone|mesh-list
65545222|NCT00393952|Xhance|xhance|mesh-list
65545223|NCT00393952|Formoterol Fumarate|formoterol fumarate|mesh-list
65545224|NCT00393952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65545225|NCT00393952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65545226|NCT00393952|Autonomic Agents|autonomic agents|mesh-ancestor
65545227|NCT00393952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65545228|NCT00393952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545229|NCT00393952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65545230|NCT00393952|Respiratory System Agents|respiratory system agents|mesh-ancestor
65545231|NCT00393952|Dermatologic Agents|dermatologic agents|mesh-ancestor
65545232|NCT00393952|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65545233|NCT00393952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65545234|NCT00393952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65545235|NCT00393952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65545236|NCT00393952|Adrenergic Agents|adrenergic agents|mesh-ancestor
65545237|NCT00393952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65545238|NCT00393952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545239|NCT02285374|Tenofovir|tenofovir|mesh-list
65545240|NCT02285374|Emtricitabine|emtricitabine|mesh-list
65545241|NCT02285374|Efavirenz|efavirenz|mesh-list
65545242|NCT02285374|Dolutegravir|dolutegravir|mesh-list
65545243|NCT02285374|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65545244|NCT02285374|Antiviral Agents|antiviral agents|mesh-ancestor
65545245|NCT02285374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65545246|NCT02285374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65545247|NCT02285374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65545248|NCT02285374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545249|NCT02285374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545250|NCT02285374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65545251|NCT02285374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65545252|NCT02285374|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65545253|NCT02285374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65545254|NCT02285374|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65545255|NCT02285374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65545256|NCT02285374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65545257|NCT02285374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65545258|NCT02285374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65545259|NCT02285374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65545260|NCT01112449|Selenium|selenium|mesh-list
65545261|NCT01112449|Antioxidants|antioxidants|mesh-ancestor
65545262|NCT01112449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545263|NCT01112449|Protective Agents|protective agents|mesh-ancestor
65545264|NCT01112449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545265|NCT01112449|Trace Elements|trace elements|mesh-ancestor
65545266|NCT01112449|Micronutrients|micronutrients|mesh-ancestor
65545267|NCT01341392|Amlodipine|amlodipine|mesh-list
65545268|NCT01341392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65545269|NCT01341392|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65545270|NCT01341392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65545271|NCT01341392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545272|NCT01341392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65545273|NCT01341392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545274|NCT01341392|Vasodilator Agents|vasodilator agents|mesh-ancestor
65545275|NCT04390958|Paclitaxel|paclitaxel|mesh-list
65545276|NCT04390958|Capecitabine|capecitabine|mesh-list
65545277|NCT04390958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65545278|NCT04390958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545279|NCT04390958|Tubulin Modulators|tubulin modulators|mesh-ancestor
65545280|NCT04390958|Antimitotic Agents|antimitotic agents|mesh-ancestor
65545281|NCT04390958|Mitosis Modulators|mitosis modulators|mesh-ancestor
65545282|NCT04390958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342843|NCT00865540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545283|NCT04390958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65545284|NCT04390958|Antimetabolites|antimetabolites|mesh-ancestor
65545285|NCT03943459|Atorvastatin|atorvastatin|mesh-list
65545286|NCT03943459|Quercetin|quercetin|mesh-list
65545287|NCT03943459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65545288|NCT03943459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65545289|NCT03943459|Antimetabolites|antimetabolites|mesh-ancestor
65545290|NCT03943459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545291|NCT03943459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65545292|NCT03943459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65545293|NCT03943459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545294|NCT03943459|Antioxidants|antioxidants|mesh-ancestor
65545295|NCT03943459|Protective Agents|protective agents|mesh-ancestor
65545296|NCT03943459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545297|NCT04832438|Carboplatin|carboplatin|mesh-list
65545298|NCT04832438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545299|NCT05182970|Metformin|metformin|mesh-list
65545300|NCT05182970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65545301|NCT05182970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545302|NCT01315886|Fentanyl|fentanyl|mesh-list
65545303|NCT01315886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65545304|NCT01315886|Narcotics|narcotics|mesh-ancestor
65545305|NCT01315886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65545306|NCT01315886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545307|NCT01315886|Analgesics|analgesics|mesh-ancestor
65545308|NCT01315886|Sensory System Agents|sensory system agents|mesh-ancestor
65545309|NCT01315886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65545310|NCT01315886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65545311|NCT01315886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65545312|NCT01315886|Anesthetics, General|anesthetics, general|mesh-ancestor
65545313|NCT01315886|Anesthetics|anesthetics|mesh-ancestor
65545314|NCT05725798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65545315|NCT05725798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65545316|NCT05725798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545317|NCT05725798|Incretins|incretins|mesh-ancestor
65545318|NCT05725798|Hormones|hormones|mesh-ancestor
65545319|NCT05725798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65545320|NCT05725798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65545321|NCT05725798|Protease Inhibitors|protease inhibitors|mesh-ancestor
65545322|NCT05725798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545323|NCT05725798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545324|NCT00065728|Anecortave|anecortave|mesh-list
65545325|NCT00065728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65545326|NCT00065728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65545327|NCT00065728|Growth Substances|growth substances|mesh-ancestor
65545328|NCT00065728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545329|NCT00065728|Growth Inhibitors|growth inhibitors|mesh-ancestor
65545330|NCT00065728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545331|NCT00064714|Exenatide|exenatide|mesh-list
65545332|NCT00064714|Daclizumab|daclizumab|mesh-list
65545333|NCT00064714|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65545334|NCT00064714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65545335|NCT00064714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545336|NCT00064714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65545337|NCT00064714|Incretins|incretins|mesh-ancestor
65545338|NCT00064714|Hormones|hormones|mesh-ancestor
65545339|NCT00064714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65545340|NCT00064714|Immunologic Factors|immunologic factors|mesh-ancestor
65545341|NCT01109485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
65545342|NCT01109485|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65545343|NCT01109485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65545344|NCT01109485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65545345|NCT01109485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65545346|NCT01109485|Analgesics|analgesics|mesh-ancestor
65545347|NCT01109485|Sensory System Agents|sensory system agents|mesh-ancestor
65545348|NCT01109485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65545349|NCT01109485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545350|NCT01109485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65545351|NCT01109485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65545352|NCT01109485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65545353|NCT01109485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65545354|NCT01109485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65545355|NCT01109485|Histamine Antagonists|histamine antagonists|mesh-ancestor
65545356|NCT01109485|Histamine Agents|histamine agents|mesh-ancestor
65545357|NCT01109485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65545358|NCT01109485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545359|NCT00292396|Antibodies|antibodies|mesh-list
65545360|NCT00292396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65545361|NCT00292396|Immunologic Factors|immunologic factors|mesh-ancestor
65545362|NCT00292396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545363|NCT03942289|Norepinephrine|norepinephrine|mesh-list
65545364|NCT03942289|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65545365|NCT03942289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65545366|NCT03942289|Adrenergic Agents|adrenergic agents|mesh-ancestor
65545367|NCT03942289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65545368|NCT03942289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545369|NCT03942289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545370|NCT03942289|Sympathomimetics|sympathomimetics|mesh-ancestor
65545371|NCT03942289|Autonomic Agents|autonomic agents|mesh-ancestor
65545372|NCT03942289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65545373|NCT03942289|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65545374|NCT00284128|Losartan|losartan|mesh-list
65545375|NCT00284128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65545376|NCT00284128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65545377|NCT00284128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65545378|NCT00284128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65545379|NCT00284128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545380|NCT00035542|Metformin|metformin|mesh-list
65545381|NCT00035542|Glyburide|glyburide|mesh-list
65545382|NCT00035542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65545383|NCT00035542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545384|NCT01209715|Fluticasone|fluticasone|mesh-list
65545385|NCT01209715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65545386|NCT01209715|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65545387|NCT01209715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65545388|NCT01209715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65545389|NCT01209715|Autonomic Agents|autonomic agents|mesh-ancestor
65545390|NCT01209715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65545391|NCT01209715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545392|NCT01209715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65545393|NCT01209715|Respiratory System Agents|respiratory system agents|mesh-ancestor
65545394|NCT01209715|Dermatologic Agents|dermatologic agents|mesh-ancestor
65545395|NCT01209715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65545396|NCT01209715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65545397|NCT01209715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65545398|NCT01209715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65545399|NCT01209715|Adrenergic Agents|adrenergic agents|mesh-ancestor
65545400|NCT01209715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65545401|NCT01209715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545402|NCT01209715|Glucocorticoids|glucocorticoids|mesh-ancestor
65545403|NCT01209715|Hormones|hormones|mesh-ancestor
65545404|NCT01209715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65545405|NCT01209715|Sympathomimetics|sympathomimetics|mesh-ancestor
65545406|NCT03740893|Durvalumab|durvalumab|mesh-list
65545407|NCT03740893|Olaparib|olaparib|mesh-list
65545408|NCT03740893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65545409|NCT03740893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545410|NCT03740893|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65545411|NCT03740893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545412|NCT03740893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545413|NCT00005788|Aldesleukin|aldesleukin|mesh-list
65545414|NCT00005788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545415|NCT00005788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65545416|NCT00005788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65545417|NCT00005788|Antiviral Agents|antiviral agents|mesh-ancestor
65545418|NCT00005788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65545419|NCT03945955|Melatonin|melatonin|mesh-list
65545420|NCT03945955|Antioxidants|antioxidants|mesh-ancestor
65545421|NCT03945955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545422|NCT03945955|Protective Agents|protective agents|mesh-ancestor
65545423|NCT03945955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545424|NCT03945955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65545425|NCT00005608|Leucovorin|leucovorin|mesh-list
65545426|NCT00005608|Tegafur|tegafur|mesh-list
65545427|NCT00005608|Calcium|calcium|mesh-list
65545428|NCT00005608|Levoleucovorin|levoleucovorin|mesh-list
65545429|NCT00005608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65545430|NCT00005608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545431|NCT00005608|Antidotes|antidotes|mesh-ancestor
65545432|NCT00005608|Protective Agents|protective agents|mesh-ancestor
65545433|NCT00005608|Vitamin B Complex|vitamin b complex|mesh-ancestor
65545434|NCT00005608|Vitamins|vitamins|mesh-ancestor
65545435|NCT00005608|Micronutrients|micronutrients|mesh-ancestor
65545436|NCT00005608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65545437|NCT00005608|Antimetabolites|antimetabolites|mesh-ancestor
65545438|NCT00005608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545439|NCT00005608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545440|NCT02288338|Atorvastatin|atorvastatin|mesh-list
65545441|NCT02288338|Ezetimibe|ezetimibe|mesh-list
65545442|NCT02288338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65545443|NCT02288338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65545444|NCT02288338|Antimetabolites|antimetabolites|mesh-ancestor
65545445|NCT02288338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545446|NCT02288338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65545447|NCT02288338|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65545448|NCT02288338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545449|NCT00388960|Etoposide|etoposide|mesh-list
65545450|NCT00388960|Amrubicin|amrubicin|mesh-list
65545451|NCT00388960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545452|NCT00388960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65545453|NCT00388960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65545454|NCT00388960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65545455|NCT00388960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545456|NCT00388960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545457|NCT03941899|Levobupivacaine|levobupivacaine|mesh-list
65545458|NCT03941899|Anesthetics, Local|anesthetics, local|mesh-ancestor
65545459|NCT03941899|Anesthetics|anesthetics|mesh-ancestor
65545460|NCT03941899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65545461|NCT03941899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545462|NCT03941899|Sensory System Agents|sensory system agents|mesh-ancestor
65545463|NCT03941899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65545464|NCT00004912|Megestrol|megestrol|mesh-list
65545465|NCT00004912|Megestrol Acetate|megestrol acetate|mesh-list
65545466|NCT00004912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65545467|NCT00004912|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65545468|NCT00004912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65545469|NCT00004912|Contraceptive Agents|contraceptive agents|mesh-ancestor
65545470|NCT00004912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65545471|NCT00004912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545472|NCT00004912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65545473|NCT00004912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65545474|NCT00004912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65545475|NCT00004912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545476|NCT00004912|Appetite Stimulants|appetite stimulants|mesh-ancestor
65545477|NCT00004912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65545478|NCT02529787|Dexlansoprazole|dexlansoprazole|mesh-list
65545479|NCT02529787|Lansoprazole|lansoprazole|mesh-list
65545480|NCT02529787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65545481|NCT02529787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65545482|NCT02529787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65545483|NCT02529787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545484|NCT02529787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545485|NCT00267592|Temozolomide|temozolomide|mesh-list
65545486|NCT00267592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65545487|NCT00267592|Alkylating Agents|alkylating agents|mesh-ancestor
65545488|NCT00267592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545489|NCT00267592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545490|NCT00267280|Atorvastatin|atorvastatin|mesh-list
65545491|NCT00267280|Simvastatin|simvastatin|mesh-list
65545492|NCT00267280|Torcetrapib|torcetrapib|mesh-list
65545493|NCT00267280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65545494|NCT00267280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65545495|NCT00267280|Antimetabolites|antimetabolites|mesh-ancestor
65545496|NCT00267280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545497|NCT00267280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65545498|NCT00267280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65545499|NCT00267280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545500|NCT03530488|Lidocaine|lidocaine|mesh-list
65545501|NCT03530488|Anesthetics, Local|anesthetics, local|mesh-ancestor
65545502|NCT03530488|Anesthetics|anesthetics|mesh-ancestor
65545503|NCT03530488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65545504|NCT03530488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545505|NCT03530488|Sensory System Agents|sensory system agents|mesh-ancestor
65545506|NCT03530488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65545507|NCT03530488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65545508|NCT03530488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65545509|NCT03530488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65545510|NCT03530488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65545511|NCT03530488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545512|NCT00262990|Doxorubicin|doxorubicin|mesh-list
65545513|NCT00262990|Epothilone B|epothilone b|mesh-list
65545514|NCT00262990|Epothilones|epothilones|mesh-list
65545515|NCT00262990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65545516|NCT00262990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545517|NCT00262990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65545518|NCT00262990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65545519|NCT00262990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545520|NCT00262990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545521|NCT00262990|Tubulin Modulators|tubulin modulators|mesh-ancestor
65545522|NCT00262990|Antimitotic Agents|antimitotic agents|mesh-ancestor
65545523|NCT00262990|Mitosis Modulators|mitosis modulators|mesh-ancestor
65545524|NCT01110031|Ofatumumab|ofatumumab|mesh-list
65545525|NCT01110031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545526|NCT02741596|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65545527|NCT02741596|Immunologic Factors|immunologic factors|mesh-ancestor
65545528|NCT02741596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545529|NCT01210339|Esomeprazole|esomeprazole|mesh-list
65545530|NCT01210339|Clopidogrel|clopidogrel|mesh-list
65545531|NCT01210339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65545532|NCT01210339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65545533|NCT01210339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65545534|NCT01210339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65545535|NCT01210339|Purinergic Agents|purinergic agents|mesh-ancestor
65545536|NCT01210339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65545537|NCT01210339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545538|NCT01210339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545539|NCT01210339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65545540|NCT01210339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65545541|NCT01210339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65545542|NCT01210339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545543|NCT03684694|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
65545544|NCT03684694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65545545|NCT03684694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545546|NCT03147248|Infliximab|infliximab|mesh-list
65545547|NCT03147248|Dermatologic Agents|dermatologic agents|mesh-ancestor
65545548|NCT03147248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65545549|NCT03147248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65545550|NCT00250822|Gemcitabine|gemcitabine|mesh-list
65545551|NCT00250822|Oxaliplatin|oxaliplatin|mesh-list
65545552|NCT00250822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65545553|NCT00250822|Antimetabolites|antimetabolites|mesh-ancestor
65545554|NCT00250822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545555|NCT00250822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545556|NCT00250822|Antiviral Agents|antiviral agents|mesh-ancestor
65545557|NCT00250822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65545558|NCT00250822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545559|NCT00250822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65545560|NCT00250822|Immunologic Factors|immunologic factors|mesh-ancestor
65545561|NCT00250822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545562|NCT00004096|Carboplatin|carboplatin|mesh-list
65545563|NCT00004096|Vinorelbine|vinorelbine|mesh-list
65545564|NCT00004096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545565|NCT00004096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65545566|NCT00004096|Tubulin Modulators|tubulin modulators|mesh-ancestor
65545567|NCT00004096|Antimitotic Agents|antimitotic agents|mesh-ancestor
65545568|NCT00004096|Mitosis Modulators|mitosis modulators|mesh-ancestor
65545569|NCT00004096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545570|NCT00002224|Nelfinavir|nelfinavir|mesh-list
65545571|NCT00002224|Didanosine|didanosine|mesh-list
65545572|NCT00002224|Stavudine|stavudine|mesh-list
65545573|NCT00002224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65545574|NCT00002224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65545575|NCT00002224|Protease Inhibitors|protease inhibitors|mesh-ancestor
65545576|NCT00002224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545577|NCT00002224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545578|NCT00002224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65545579|NCT00002224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65545580|NCT00002224|Antiviral Agents|antiviral agents|mesh-ancestor
65545581|NCT00002224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65545582|NCT00002224|Antimetabolites|antimetabolites|mesh-ancestor
65545583|NCT00002224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65545584|NCT00002224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65545585|NCT01207921|Lenalidomide|lenalidomide|mesh-list
65545586|NCT01207921|Immunologic Factors|immunologic factors|mesh-ancestor
65545587|NCT01207921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545588|NCT01207921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65545589|NCT01207921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65545590|NCT01207921|Growth Substances|growth substances|mesh-ancestor
65545591|NCT01207921|Growth Inhibitors|growth inhibitors|mesh-ancestor
65545592|NCT01207921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545593|NCT01108393|S 20098|s 20098|mesh-list
65545594|NCT01108393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65545595|NCT01108393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65545596|NCT01108393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545597|NCT01113229|Misoprostol|misoprostol|mesh-list
65545598|NCT01113229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65545599|NCT01113229|Abortifacient Agents|abortifacient agents|mesh-ancestor
65545600|NCT01113229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65545601|NCT01113229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545602|NCT01113229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65545603|NCT01113229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65545604|NCT01113229|Oxytocics|oxytocics|mesh-ancestor
65545605|NCT03530176|Listerine|listerine|mesh-list
65545606|NCT03530176|Fluorides|fluorides|mesh-list
65545607|NCT03530176|Sodium Fluoride|sodium fluoride|mesh-list
65545608|NCT03530176|Cariostatic Agents|cariostatic agents|mesh-ancestor
65545609|NCT03530176|Protective Agents|protective agents|mesh-ancestor
65545610|NCT03530176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545611|NCT03530176|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65545612|NCT03530176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65545613|NCT03151304|Azacitidine|azacitidine|mesh-list
65545614|NCT03151304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65545615|NCT03151304|Antimetabolites|antimetabolites|mesh-ancestor
65545616|NCT03151304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545617|NCT03151304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545618|NCT03151304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545619|NCT03530020|Lithium Carbonate|lithium carbonate|mesh-list
65545620|NCT03530020|Antidepressive Agents|antidepressive agents|mesh-ancestor
65545621|NCT03530020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65545622|NCT03530020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545623|NCT03530020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545624|NCT03530020|Antimanic Agents|antimanic agents|mesh-ancestor
65545625|NCT03530020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65545626|NCT03530020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65545627|NCT03530020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545628|NCT02288962|Cabergoline|cabergoline|mesh-list
65545629|NCT02288962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65545630|NCT02288962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65545631|NCT02288962|Dopamine Agonists|dopamine agonists|mesh-ancestor
65545632|NCT02288962|Dopamine Agents|dopamine agents|mesh-ancestor
65545633|NCT02288962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65545634|NCT02288962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545635|NCT02288962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545636|NCT03942991|Mepivacaine|mepivacaine|mesh-list
65545637|NCT03942991|Carticaine|carticaine|mesh-list
65545638|NCT03942991|Anesthetics, Local|anesthetics, local|mesh-ancestor
65545639|NCT03942991|Anesthetics|anesthetics|mesh-ancestor
65545640|NCT03942991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65545641|NCT03942991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545642|NCT03942991|Sensory System Agents|sensory system agents|mesh-ancestor
65545643|NCT03942991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65545644|NCT01108627|Formoterol Fumarate|formoterol fumarate|mesh-list
65545645|NCT01108627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65545646|NCT01108627|Autonomic Agents|autonomic agents|mesh-ancestor
65545647|NCT01108627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65545648|NCT01108627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545649|NCT01108627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65545650|NCT01108627|Respiratory System Agents|respiratory system agents|mesh-ancestor
65545651|NCT01108627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65545652|NCT01108627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65545653|NCT01108627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65545654|NCT01108627|Adrenergic Agents|adrenergic agents|mesh-ancestor
65545655|NCT01108627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65545656|NCT01108627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545657|NCT00162292|Methotrexate|methotrexate|mesh-list
65545658|NCT00162292|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65343218|NCT00577824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65545659|NCT00162292|Abortifacient Agents|abortifacient agents|mesh-ancestor
65545660|NCT00162292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65545661|NCT00162292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545662|NCT00162292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65545663|NCT00162292|Antimetabolites|antimetabolites|mesh-ancestor
65545664|NCT00162292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545665|NCT00162292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545666|NCT00162292|Dermatologic Agents|dermatologic agents|mesh-ancestor
65545667|NCT00162292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545668|NCT00162292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65545669|NCT00162292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65545670|NCT00162292|Immunologic Factors|immunologic factors|mesh-ancestor
65545671|NCT00162292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65545672|NCT00162292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65545673|NCT00135382|Efavirenz|efavirenz|mesh-list
65545674|NCT00135382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65545675|NCT00135382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65545676|NCT00135382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545677|NCT00135382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545678|NCT00135382|Antiviral Agents|antiviral agents|mesh-ancestor
65545679|NCT00135382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65545680|NCT00135382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65545681|NCT00135382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65545682|NCT00135382|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65545683|NCT00135382|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65545684|NCT00135382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65545685|NCT00135382|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65545686|NCT03531970|Dexamethasone|dexamethasone|mesh-list
65545687|NCT03531970|Dexamethasone acetate|dexamethasone acetate|mesh-list
65545688|NCT03531970|Lidocaine|lidocaine|mesh-list
65545689|NCT03531970|Epinephrine|epinephrine|mesh-list
65545690|NCT03531970|BB 1101|bb 1101|mesh-list
65545691|NCT03531970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65545692|NCT03531970|Antiemetics|antiemetics|mesh-ancestor
65545693|NCT03531970|Autonomic Agents|autonomic agents|mesh-ancestor
65545694|NCT03531970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65545695|NCT03531970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545696|NCT03531970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65545697|NCT03531970|Glucocorticoids|glucocorticoids|mesh-ancestor
65545698|NCT03531970|Hormones|hormones|mesh-ancestor
65545699|NCT03531970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65545700|NCT03531970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65545701|NCT03531970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545702|NCT03531970|Protease Inhibitors|protease inhibitors|mesh-ancestor
65545703|NCT03531970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545704|NCT03531970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545705|NCT03531970|Anesthetics, Local|anesthetics, local|mesh-ancestor
65545706|NCT03531970|Anesthetics|anesthetics|mesh-ancestor
65545707|NCT03531970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65545708|NCT03531970|Sensory System Agents|sensory system agents|mesh-ancestor
65545709|NCT03531970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65545710|NCT03531970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65545711|NCT03531970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65545712|NCT03531970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65545713|NCT03531970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65545714|NCT03531970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65545715|NCT03531970|Adrenergic Agents|adrenergic agents|mesh-ancestor
65545716|NCT03531970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65545717|NCT03531970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65545718|NCT03531970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65545719|NCT03531970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65545720|NCT03531970|Respiratory System Agents|respiratory system agents|mesh-ancestor
65545721|NCT03531970|Mydriatics|mydriatics|mesh-ancestor
65545722|NCT03531970|Sympathomimetics|sympathomimetics|mesh-ancestor
65545723|NCT03531970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65545724|NCT05726110|Cytarabine|cytarabine|mesh-list
65545725|NCT05726110|Daunorubicin|daunorubicin|mesh-list
65545726|NCT05726110|Homoharringtonine|homoharringtonine|mesh-list
65545727|NCT05726110|Aclacinomycins|aclacinomycins|mesh-list
65545728|NCT05726110|Lenograstim|lenograstim|mesh-list
65545729|NCT05726110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65545730|NCT05726110|Antimetabolites|antimetabolites|mesh-ancestor
65545731|NCT05726110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545732|NCT05726110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545733|NCT05726110|Antiviral Agents|antiviral agents|mesh-ancestor
65545734|NCT05726110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65545735|NCT05726110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65545736|NCT05726110|Immunologic Factors|immunologic factors|mesh-ancestor
65545737|NCT05726110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545738|NCT05726110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65545739|NCT05726110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65545740|NCT05726110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65545741|NCT05726110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545742|NCT05726110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65545743|NCT05726110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65545744|NCT05726110|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65545745|NCT01211821|Metoprolol|metoprolol|mesh-list
65545746|NCT01211821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65545747|NCT01211821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65545748|NCT01211821|Sympatholytics|sympatholytics|mesh-ancestor
65545749|NCT01211821|Autonomic Agents|autonomic agents|mesh-ancestor
65545750|NCT01211821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65545751|NCT01211821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545752|NCT01211821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65545753|NCT01211821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65545754|NCT01211821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65545755|NCT01211821|Adrenergic Agents|adrenergic agents|mesh-ancestor
65545756|NCT01211821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65545757|NCT01211821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545758|NCT03527836|Lidocaine|lidocaine|mesh-list
65545759|NCT03527836|Bupivacaine|bupivacaine|mesh-list
65545760|NCT03527836|Anesthetics, Local|anesthetics, local|mesh-ancestor
65545761|NCT03527836|Anesthetics|anesthetics|mesh-ancestor
65545762|NCT03527836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65545763|NCT03527836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545764|NCT03527836|Sensory System Agents|sensory system agents|mesh-ancestor
65545765|NCT03527836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65545766|NCT03527836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65545767|NCT03527836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65545768|NCT03527836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65545769|NCT03527836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65545770|NCT03527836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545771|NCT05724862|Anesthetics|anesthetics|mesh-list
65545772|NCT05724862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65545773|NCT05724862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545774|NCT03940651|Anesthetics|anesthetics|mesh-list
65545775|NCT03940651|Anesthetics, General|anesthetics, general|mesh-list
65545776|NCT03940651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65545777|NCT03940651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545778|NCT03152552|Empagliflozin|empagliflozin|mesh-list
65545779|NCT03152552|Licogliflozin|licogliflozin|mesh-list
65545780|NCT03152552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65545781|NCT03152552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545782|NCT03152552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65545783|NCT03152552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545784|NCT01211275|Cisplatin|cisplatin|mesh-list
65545785|NCT01211275|Pemetrexed|pemetrexed|mesh-list
65545786|NCT01211275|Axitinib|axitinib|mesh-list
65545787|NCT01211275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545788|NCT01211275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545789|NCT01211275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545790|NCT01211275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65545791|NCT01211275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65545792|NCT01211275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65545793|NCT03529084|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65545794|NCT03529084|Gefitinib|gefitinib|mesh-list
65545795|NCT03529084|Nazartinib|nazartinib|mesh-list
65545796|NCT03529084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545797|NCT03529084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65545798|NCT03529084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545799|NCT03529084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545800|NCT03942757|Bilirubin|bilirubin|mesh-list
65545801|NCT03942757|Antioxidants|antioxidants|mesh-ancestor
65545802|NCT03942757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545803|NCT03942757|Protective Agents|protective agents|mesh-ancestor
65545804|NCT03942757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545805|NCT05609578|Pembrolizumab|pembrolizumab|mesh-list
65545806|NCT05609578|Adagrasib|adagrasib|mesh-list
65545807|NCT05609578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65545808|NCT05609578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545809|NCT05724628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65545810|NCT05724628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65545811|NCT01208701|Atorvastatin|atorvastatin|mesh-list
65545812|NCT01208701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65545813|NCT01208701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65545814|NCT01208701|Antimetabolites|antimetabolites|mesh-ancestor
65545815|NCT01208701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545816|NCT01208701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65545817|NCT01208701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65545818|NCT01208701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545819|NCT03528772|Minoxidil|minoxidil|mesh-list
65545820|NCT03528772|Nitroglycerin|nitroglycerin|mesh-list
65545821|NCT03528772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65545822|NCT03528772|Vasodilator Agents|vasodilator agents|mesh-ancestor
65545823|NCT01316744|Ketamine|ketamine|mesh-list
65545824|NCT01316744|Analgesics|analgesics|mesh-ancestor
65545825|NCT01316744|Sensory System Agents|sensory system agents|mesh-ancestor
65545826|NCT01316744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65545827|NCT01316744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545828|NCT01316744|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65545829|NCT01316744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65545830|NCT01316744|Anesthetics, General|anesthetics, general|mesh-ancestor
65545831|NCT01316744|Anesthetics|anesthetics|mesh-ancestor
65545832|NCT01316744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65545833|NCT01316744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65545834|NCT01316744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65545835|NCT01316744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65545836|NCT01316744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545837|NCT01213381|Gemcitabine|gemcitabine|mesh-list
65545838|NCT01213381|Carboplatin|carboplatin|mesh-list
65545839|NCT01213381|Iniparib|iniparib|mesh-list
65545840|NCT01213381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545841|NCT01213381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65545842|NCT01213381|Antimetabolites|antimetabolites|mesh-ancestor
65545843|NCT01213381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545844|NCT01213381|Antiviral Agents|antiviral agents|mesh-ancestor
65545845|NCT01213381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65545846|NCT01213381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545847|NCT01213381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65545848|NCT01213381|Immunologic Factors|immunologic factors|mesh-ancestor
65545849|NCT01213381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545850|NCT01213381|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65545851|NCT01316978|Ibuprofen|ibuprofen|mesh-list
65545852|NCT01316978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65545853|NCT01316978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65545854|NCT01316978|Analgesics|analgesics|mesh-ancestor
65545855|NCT01316978|Sensory System Agents|sensory system agents|mesh-ancestor
65545856|NCT01316978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65545857|NCT01316978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545858|NCT01316978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65545859|NCT01316978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65545860|NCT01316978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65545861|NCT01316978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545862|NCT01316978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545863|NCT01317212|Carboplatin|carboplatin|mesh-list
65545864|NCT01317212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545865|NCT05250752|Dapagliflozin|dapagliflozin|mesh-list
65545866|NCT05250752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65545867|NCT05250752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545868|NCT05250752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65545869|NCT05250752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545870|NCT01211509|Montelukast|montelukast|mesh-list
65545871|NCT01211509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65545872|NCT01211509|Respiratory System Agents|respiratory system agents|mesh-ancestor
65545873|NCT01211509|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65545874|NCT01211509|Hormone Antagonists|hormone antagonists|mesh-ancestor
65545875|NCT01211509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65545876|NCT01211509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545877|NCT01211509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65545878|NCT01211509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65545879|NCT01211509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343445|NCT00862420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65545880|NCT04791176|Lenvatinib|lenvatinib|mesh-list
65545881|NCT04791176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545882|NCT04791176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65545883|NCT04791176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545884|NCT04791176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545885|NCT05072600|Pembrolizumab|pembrolizumab|mesh-list
65545886|NCT05072600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65545887|NCT05072600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65545888|NCT05072600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545889|NCT05072600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545890|NCT04441528|Hyaluronic Acid|hyaluronic acid|mesh-list
65545891|NCT04441528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65545892|NCT04441528|Immunologic Factors|immunologic factors|mesh-ancestor
65545893|NCT04441528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545894|NCT04441528|Viscosupplements|viscosupplements|mesh-ancestor
65545895|NCT04441528|Protective Agents|protective agents|mesh-ancestor
65545896|NCT01344512|Ciprofloxacin|ciprofloxacin|mesh-list
65545897|NCT01344512|Ceftazidime|ceftazidime|mesh-list
65545898|NCT01344512|Voriconazole|voriconazole|mesh-list
65545899|NCT01344512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65545900|NCT01344512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65545901|NCT01344512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65274998|NCT00633035|Esomeprazole|esomeprazole|mesh-list
65545902|NCT01344512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65545903|NCT01344512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545904|NCT01344512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545905|NCT01344512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545906|NCT01344512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65545907|NCT01344512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65545908|NCT01344512|Antifungal Agents|antifungal agents|mesh-ancestor
65545909|NCT01344512|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65545910|NCT01344512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65545911|NCT01344512|Hormone Antagonists|hormone antagonists|mesh-ancestor
65545912|NCT01344512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65545913|NCT01344512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545914|NCT01344512|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65545915|NCT05064488|Metformin|metformin|mesh-list
65545916|NCT05064488|Digoxin|digoxin|mesh-list
65545917|NCT05064488|Sumatriptan|sumatriptan|mesh-list
65545918|NCT05064488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65545919|NCT05064488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65545920|NCT05064488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545921|NCT05064488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65545922|NCT05064488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65545923|NCT05064488|Antimetabolites|antimetabolites|mesh-ancestor
65545924|NCT05064488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545925|NCT05064488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65545926|NCT05064488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65545927|NCT05064488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545928|NCT05064488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65545929|NCT05064488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65545930|NCT05064488|Protective Agents|protective agents|mesh-ancestor
65545931|NCT05064488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65545932|NCT05064488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65545933|NCT05064488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65545934|NCT05064488|Serotonin Agents|serotonin agents|mesh-ancestor
65545935|NCT05064488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65545936|NCT01344590|Ethanol|ethanol|mesh-list
65545937|NCT01344590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65545938|NCT01344590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65545939|NCT01344590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65545940|NCT01344590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545941|NCT01114087|Imatinib Mesylate|imatinib mesylate|mesh-list
65545942|NCT01114087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545943|NCT01114087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65545944|NCT01114087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545945|NCT01114087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545946|NCT01212133|Liraglutide|liraglutide|mesh-list
65545947|NCT01212133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65545948|NCT01212133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545949|NCT01212133|Incretins|incretins|mesh-ancestor
65545950|NCT01212133|Hormones|hormones|mesh-ancestor
65545951|NCT01212133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65545952|NCT04269356|Magnesium Oxide|magnesium oxide|mesh-list
65545953|NCT04269356|Magnesium Hydroxide|magnesium hydroxide|mesh-list
65545954|NCT04269356|Antacids|antacids|mesh-ancestor
65545955|NCT04269356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545956|NCT04269356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65545957|NCT05214820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65545958|NCT05214820|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
65545959|NCT05214820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545960|NCT01118065|Everolimus|everolimus|mesh-list
65545961|NCT01118065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65545962|NCT01118065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65545963|NCT01118065|Immunologic Factors|immunologic factors|mesh-ancestor
65545964|NCT01118065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545965|NCT03528616|Propranolol|propranolol|mesh-list
65545966|NCT03528616|Digoxin|digoxin|mesh-list
65545967|NCT03528616|Adenosine|adenosine|mesh-list
65545968|NCT03528616|Amiodarone|amiodarone|mesh-list
65545969|NCT03528616|Flecainide|flecainide|mesh-list
65545970|NCT03528616|Procainamide|procainamide|mesh-list
65545971|NCT03528616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65545972|NCT03528616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65545973|NCT03528616|Adrenergic Agents|adrenergic agents|mesh-ancestor
65545974|NCT03528616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65545975|NCT03528616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65545976|NCT03528616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65545977|NCT03528616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65545978|NCT03528616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65545979|NCT03528616|Vasodilator Agents|vasodilator agents|mesh-ancestor
65545980|NCT03528616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65545981|NCT03528616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65545982|NCT03528616|Protective Agents|protective agents|mesh-ancestor
65545983|NCT03528616|Analgesics|analgesics|mesh-ancestor
65545984|NCT03528616|Sensory System Agents|sensory system agents|mesh-ancestor
65545985|NCT03528616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65545986|NCT03528616|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65545987|NCT03528616|Purinergic Agonists|purinergic agonists|mesh-ancestor
65545988|NCT03528616|Purinergic Agents|purinergic agents|mesh-ancestor
65545989|NCT03528616|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65545990|NCT03528616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65545991|NCT03528616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65545992|NCT03528616|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65545993|NCT03528616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65545994|NCT03528616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65545995|NCT03528616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65545996|NCT03528616|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65545997|NCT03528616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65545998|NCT02529631|Orlistat|orlistat|mesh-list
65545999|NCT02529631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546000|NCT02529631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546001|NCT02529631|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65546002|NCT02529631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65546003|NCT04469062|Mirikizumab|mirikizumab|mesh-list
65546004|NCT04469062|Vedolizumab|vedolizumab|mesh-list
65546005|NCT04469062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65546006|NCT04469062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65546007|NCT04469062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65546008|NCT04469062|Analgesics|analgesics|mesh-ancestor
65546009|NCT04469062|Sensory System Agents|sensory system agents|mesh-ancestor
65546010|NCT04469062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546011|NCT04469062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546012|NCT04469062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65546013|NCT04469062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65546014|NCT04469062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65546015|NCT03528538|Fenugreek seed meal|fenugreek seed meal|mesh-list
65546016|NCT03528538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65546017|NCT03528538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546018|NCT03145766|Immunoglobulins|immunoglobulins|mesh-list
65546019|NCT03145766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65546020|NCT03145766|Antibodies|antibodies|mesh-list
65546021|NCT03145766|Immunologic Factors|immunologic factors|mesh-ancestor
65546022|NCT03145766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546023|NCT01115179|Propofol|propofol|mesh-list
65546024|NCT01115179|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65546025|NCT01115179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65546026|NCT01115179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65546027|NCT01115179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546028|NCT01115179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65546029|NCT01115179|Anesthetics, General|anesthetics, general|mesh-ancestor
65546031|NCT01115179|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65546032|NCT01115179|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65546033|NCT01115179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65546034|NCT04468438|Estrogens|estrogens|mesh-list
65546035|NCT04468438|Hormones|hormones|mesh-ancestor
65546036|NCT04468438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65546037|NCT04468438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546038|NCT04468282|Vigabatrin|vigabatrin|mesh-list
65546039|NCT04468282|Anticonvulsants|anticonvulsants|mesh-ancestor
65546040|NCT04468282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546041|NCT04468282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546042|NCT04468282|GABA Agents|gaba agents|mesh-ancestor
65546043|NCT04468282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65546044|NCT04468282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546045|NCT01121731|Interferons|interferons|mesh-list
65546046|NCT01121731|Interferon alpha-2|interferon alpha-2|mesh-list
65546047|NCT01121731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546048|NCT01121731|Antiviral Agents|antiviral agents|mesh-ancestor
65546049|NCT01121731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65546050|NCT01215799|Bafetinib|bafetinib|mesh-list
65546051|NCT01215799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65546052|NCT01215799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546053|NCT01215799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546054|NCT03145064|Zanubrutinib|zanubrutinib|mesh-list
65546055|NCT03145064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546056|NCT03145064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65546057|NCT03145064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546058|NCT03145064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546059|NCT03527134|Amantadine|amantadine|mesh-list
65546060|NCT03527134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65546061|NCT03527134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65546062|NCT03527134|Antiviral Agents|antiviral agents|mesh-ancestor
65546063|NCT03527134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65546064|NCT03527134|Dopamine Agents|dopamine agents|mesh-ancestor
65546065|NCT03527134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65546066|NCT03527134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546067|NCT03527134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546068|NCT03527134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65546069|NCT03527134|Analgesics|analgesics|mesh-ancestor
65546070|NCT03527134|Sensory System Agents|sensory system agents|mesh-ancestor
65546071|NCT03527134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546072|NCT01213693|Fluticasone|fluticasone|mesh-list
65546073|NCT01213693|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65546074|NCT01213693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65546075|NCT01213693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65546076|NCT01213693|Autonomic Agents|autonomic agents|mesh-ancestor
65546077|NCT01213693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546078|NCT01213693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546079|NCT01213693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65546080|NCT01213693|Respiratory System Agents|respiratory system agents|mesh-ancestor
65546081|NCT01213693|Dermatologic Agents|dermatologic agents|mesh-ancestor
65546082|NCT01213693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65546083|NCT01213693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65546084|NCT01213693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65546085|NCT01213693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65546086|NCT01213693|Adrenergic Agents|adrenergic agents|mesh-ancestor
65546087|NCT01213693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65546088|NCT01213693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546089|NCT01213849|Fluticasone|fluticasone|mesh-list
65546090|NCT01213849|Xhance|xhance|mesh-list
65546091|NCT01213849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65546092|NCT01213849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65546093|NCT01213849|Autonomic Agents|autonomic agents|mesh-ancestor
65546094|NCT01213849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546095|NCT01213849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546096|NCT01213849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65546097|NCT01213849|Respiratory System Agents|respiratory system agents|mesh-ancestor
65546098|NCT01213849|Dermatologic Agents|dermatologic agents|mesh-ancestor
65546099|NCT01213849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65546100|NCT01121809|Raltegravir Potassium|raltegravir potassium|mesh-list
65546101|NCT01121809|Etravirine|etravirine|mesh-list
65546102|NCT01121809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65546103|NCT01121809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65546104|NCT01121809|Antiviral Agents|antiviral agents|mesh-ancestor
65546106|NCT01121809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65546107|NCT01121809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65546108|NCT01121809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546109|NCT01121809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546110|NCT01121809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65546111|NCT01121809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65546112|NCT03937687|Caffeine|caffeine|mesh-list
65546113|NCT03937687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65546114|NCT03937687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546115|NCT03937687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65546116|NCT03937687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546117|NCT03937687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546118|NCT03937687|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65546119|NCT03937687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65546120|NCT03937687|Purinergic Agents|purinergic agents|mesh-ancestor
65546121|NCT03937687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65546122|NCT05110144|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65546123|NCT05110144|Amitriptyline|amitriptyline|mesh-list
65546124|NCT05110144|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65546125|NCT05110144|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65546126|NCT05110144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65546127|NCT05110144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546128|NCT05110144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65546129|NCT05110144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546130|NCT05110144|Analgesics|analgesics|mesh-ancestor
65546131|NCT05110144|Sensory System Agents|sensory system agents|mesh-ancestor
65546132|NCT05110144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546133|NCT05110144|Antidepressive Agents|antidepressive agents|mesh-ancestor
65546134|NCT05110144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65546135|NCT05110144|Dopamine Agents|dopamine agents|mesh-ancestor
65546136|NCT05110144|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65546137|NCT05110144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65546138|NCT05110144|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65546139|NCT05110144|Adrenergic Agents|adrenergic agents|mesh-ancestor
65546140|NCT01212367|Interferons|interferons|mesh-list
65546141|NCT01212367|Interferon-alpha|interferon-alpha|mesh-list
65546142|NCT01212367|Interferon alpha-2|interferon alpha-2|mesh-list
65546143|NCT01212367|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65546144|NCT01212367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546145|NCT01212367|Antiviral Agents|antiviral agents|mesh-ancestor
65546146|NCT01212367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65546147|NCT01212367|Immunologic Factors|immunologic factors|mesh-ancestor
65546148|NCT01212367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546149|NCT01216111|Paclitaxel|paclitaxel|mesh-list
65546150|NCT01216111|Docetaxel|docetaxel|mesh-list
65546151|NCT01216111|Cyclophosphamide|cyclophosphamide|mesh-list
65546152|NCT01216111|Fluorouracil|fluorouracil|mesh-list
65546153|NCT01216111|Epirubicin|epirubicin|mesh-list
65546154|NCT01216111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65546155|NCT01216111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546156|NCT01216111|Tubulin Modulators|tubulin modulators|mesh-ancestor
65546157|NCT01216111|Antimitotic Agents|antimitotic agents|mesh-ancestor
65546158|NCT01216111|Mitosis Modulators|mitosis modulators|mesh-ancestor
65546159|NCT01216111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546160|NCT01216111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65546161|NCT01216111|Immunologic Factors|immunologic factors|mesh-ancestor
65546162|NCT01216111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546163|NCT01216111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65546164|NCT01216111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65546165|NCT01216111|Alkylating Agents|alkylating agents|mesh-ancestor
65546166|NCT01216111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65546167|NCT01216111|Antimetabolites|antimetabolites|mesh-ancestor
65546168|NCT01216111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65546169|NCT01216111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65546170|NCT01216111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65546171|NCT01216111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65546172|NCT01216111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546173|NCT01216267|Lansoprazole|lansoprazole|mesh-list
65546174|NCT01216267|Dexlansoprazole|dexlansoprazole|mesh-list
65546175|NCT01216267|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65546176|NCT01216267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65546177|NCT01216267|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65546178|NCT01216267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546179|NCT01216267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546181|NCT01216345|Oxaliplatin|oxaliplatin|mesh-list
65546182|NCT01216345|Cetuximab|cetuximab|mesh-list
65546183|NCT01216345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65546184|NCT01216345|Antimetabolites|antimetabolites|mesh-ancestor
65546185|NCT01216345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546186|NCT01216345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546187|NCT01216345|Antiviral Agents|antiviral agents|mesh-ancestor
65546188|NCT01216345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65546189|NCT01216345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546190|NCT01216345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65546191|NCT01216345|Immunologic Factors|immunologic factors|mesh-ancestor
65546192|NCT01216345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546193|NCT01216345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65546194|NCT01118533|Pyrithione zinc|pyrithione zinc|mesh-list
65546195|NCT01118533|Keratolytic Agents|keratolytic agents|mesh-ancestor
65546196|NCT01118533|Dermatologic Agents|dermatologic agents|mesh-ancestor
65546197|NCT01118611|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65546198|NCT01118611|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65546199|NCT01118611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546200|NCT01212523|Propofol|propofol|mesh-list
65546201|NCT01212523|Isoflurane|isoflurane|mesh-list
65546202|NCT01212523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65546203|NCT01212523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65546204|NCT01212523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546205|NCT01212523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65546206|NCT01212523|Anesthetics, General|anesthetics, general|mesh-ancestor
65546207|NCT01212523|Anesthetics|anesthetics|mesh-ancestor
65546208|NCT01212523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65546209|NCT01122121|Leuprolide|leuprolide|mesh-list
65546210|NCT01122121|Flutamide|flutamide|mesh-list
65546211|NCT01122121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65546212|NCT01122121|Fertility Agents|fertility agents|mesh-ancestor
65546213|NCT01122121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65546214|NCT01122121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546215|NCT01122121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65546216|NCT01122121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546217|NCT01122121|Androgen Antagonists|androgen antagonists|mesh-ancestor
65546218|NCT01122121|Hormone Antagonists|hormone antagonists|mesh-ancestor
65546219|NCT01122121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65546220|NCT01115725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65546221|NCT01115725|Hormones|hormones|mesh-ancestor
65546222|NCT01115725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65546223|NCT01115725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546224|NCT01122199|Everolimus|everolimus|mesh-list
65546225|NCT01122199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546226|NCT01122199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65546227|NCT01122199|Immunologic Factors|immunologic factors|mesh-ancestor
65546228|NCT01122199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546229|NCT01118923|Magnesium Hydroxide|magnesium hydroxide|mesh-list
65546230|NCT01118923|Antacids|antacids|mesh-ancestor
65546231|NCT01118923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546232|NCT01118923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65546233|NCT01119079|Anesthetics|anesthetics|mesh-list
65546234|NCT01119079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65546235|NCT01119079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546236|NCT04503616|Cyclophosphamide|cyclophosphamide|mesh-list
65546237|NCT04503616|Abatacept|abatacept|mesh-list
65546238|NCT04503616|Tacrolimus|tacrolimus|mesh-list
65546239|NCT04503616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65546240|NCT04503616|Immunologic Factors|immunologic factors|mesh-ancestor
65546241|NCT04503616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546242|NCT04503616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65546243|NCT04503616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65546244|NCT04503616|Alkylating Agents|alkylating agents|mesh-ancestor
65546245|NCT04503616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546246|NCT04503616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546247|NCT04503616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65546248|NCT04503616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65546249|NCT04503616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546250|NCT04503616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65546251|NCT01119157|Vaccines|vaccines|mesh-list
65546252|NCT01119157|Immunologic Factors|immunologic factors|mesh-ancestor
65343817|NCT00732914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546253|NCT01119157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546254|NCT01120015|Diacetylrhein|diacetylrhein|mesh-list
65546255|NCT01120015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65546256|NCT05405452|Ethyl Chloride|ethyl chloride|mesh-list
65546257|NCT05405452|Anesthetics|anesthetics|mesh-ancestor
65546258|NCT05405452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65546259|NCT05405452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546260|NCT05405452|Anesthetics, Local|anesthetics, local|mesh-ancestor
65546261|NCT05405452|Sensory System Agents|sensory system agents|mesh-ancestor
65546262|NCT05405452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546263|NCT01216579|Mannitol|mannitol|mesh-list
65546264|NCT01216579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65546265|NCT01216579|Diuretics|diuretics|mesh-ancestor
65546266|NCT01216579|Natriuretic Agents|natriuretic agents|mesh-ancestor
65546267|NCT01216579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546268|NCT03528070|Tranilast|tranilast|mesh-list
65546269|NCT03528070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65546270|NCT03528070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65546271|NCT03528070|Analgesics|analgesics|mesh-ancestor
65546272|NCT03528070|Sensory System Agents|sensory system agents|mesh-ancestor
65546273|NCT03528070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546274|NCT03528070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546275|NCT03528070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65546276|NCT03528070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65275377|NCT02675868|Phenylephrine|phenylephrine|mesh-list
65546277|NCT03528070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65546278|NCT03528070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65546279|NCT03528070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546280|NCT03528070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65546281|NCT03528070|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65546282|NCT03528070|Histamine Antagonists|histamine antagonists|mesh-ancestor
65546283|NCT03528070|Histamine Agents|histamine agents|mesh-ancestor
65546284|NCT03528070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65546285|NCT03528070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65546286|NCT03528070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65546287|NCT03935815|Ropivacaine|ropivacaine|mesh-list
65546288|NCT03935815|Anesthetics, Local|anesthetics, local|mesh-ancestor
65546289|NCT03935815|Anesthetics|anesthetics|mesh-ancestor
65546290|NCT03935815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65546291|NCT03935815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546292|NCT03935815|Sensory System Agents|sensory system agents|mesh-ancestor
65546293|NCT03935815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546294|NCT01216657|Sunitinib|sunitinib|mesh-list
65546295|NCT01216657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546296|NCT01216657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65546297|NCT01216657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65546298|NCT01216657|Growth Substances|growth substances|mesh-ancestor
65546299|NCT01216657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546300|NCT01216657|Growth Inhibitors|growth inhibitors|mesh-ancestor
65546301|NCT01216657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65546302|NCT01216657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546303|NCT01216657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546304|NCT04400188|Temozolomide|temozolomide|mesh-list
65546305|NCT04400188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65546306|NCT04400188|Alkylating Agents|alkylating agents|mesh-ancestor
65546307|NCT04400188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546308|NCT04400188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546309|NCT04163458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65546310|NCT04163458|Menotropins|menotropins|mesh-list
65546311|NCT04163458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65546312|NCT04163458|Fertility Agents|fertility agents|mesh-ancestor
65546313|NCT04163458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65546314|NCT04163458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546315|NCT04902040|Pembrolizumab|pembrolizumab|mesh-list
65546316|NCT04902040|Nivolumab|nivolumab|mesh-list
65546317|NCT04902040|Durvalumab|durvalumab|mesh-list
65546318|NCT04902040|Avelumab|avelumab|mesh-list
65546319|NCT04902040|Atezolizumab|atezolizumab|mesh-list
65546320|NCT04902040|Immunoglobulins|immunoglobulins|mesh-list
65546321|NCT04902040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65546322|NCT04902040|Immunoglobulin G|immunoglobulin g|mesh-list
65546323|NCT04902040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65546324|NCT04902040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546325|NCT04902040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65546326|NCT04902040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546327|NCT04902040|Immunologic Factors|immunologic factors|mesh-ancestor
65343892|NCT04066088|Guanfacine|guanfacine|mesh-list
65546329|NCT01115959|Valproic Acid|valproic acid|mesh-list
65546330|NCT01115959|Anticonvulsants|anticonvulsants|mesh-ancestor
65546331|NCT01115959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546332|NCT01115959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546333|NCT01115959|GABA Agents|gaba agents|mesh-ancestor
65546334|NCT01115959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65546335|NCT01115959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546336|NCT01115959|Antimanic Agents|antimanic agents|mesh-ancestor
65546337|NCT01115959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65546338|NCT01115959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65546339|NCT01115959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65546340|NCT03936907|Nabiximols|nabiximols|mesh-list
65546341|NCT03936907|Analgesics|analgesics|mesh-ancestor
65546342|NCT03936907|Sensory System Agents|sensory system agents|mesh-ancestor
65546343|NCT03936907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546344|NCT03936907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546345|NCT01217125|Sirolimus|sirolimus|mesh-list
65546346|NCT01217125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65546347|NCT01217125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65546348|NCT01217125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65546349|NCT01217125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546350|NCT01217125|Antifungal Agents|antifungal agents|mesh-ancestor
65546351|NCT01217125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65546352|NCT01217125|Immunologic Factors|immunologic factors|mesh-ancestor
65546353|NCT01217125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546354|NCT01116115|Palmitic Acid|palmitic acid|mesh-list
65546355|NCT01116115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546356|NCT01116115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546357|NCT01217203|Lenalidomide|lenalidomide|mesh-list
65546358|NCT01217203|Immunologic Factors|immunologic factors|mesh-ancestor
65546359|NCT01217203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546360|NCT01217203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65546361|NCT01217203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65546362|NCT01217203|Growth Substances|growth substances|mesh-ancestor
65546363|NCT01217203|Growth Inhibitors|growth inhibitors|mesh-ancestor
65546364|NCT01217203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546365|NCT01120171|Cyclophosphamide|cyclophosphamide|mesh-list
65546366|NCT01120171|Doxorubicin|doxorubicin|mesh-list
65546367|NCT01120171|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65546368|NCT01120171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65546369|NCT01120171|Immunologic Factors|immunologic factors|mesh-ancestor
65546370|NCT01120171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546371|NCT01120171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65546372|NCT01120171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65546373|NCT01120171|Alkylating Agents|alkylating agents|mesh-ancestor
65546374|NCT01120171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546375|NCT01120171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546376|NCT01120171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65546377|NCT01120171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65546378|NCT01120171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65546379|NCT01120171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65546380|NCT01120171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546381|NCT01116193|Dexamethasone|dexamethasone|mesh-list
65546382|NCT01116193|Lenalidomide|lenalidomide|mesh-list
65546383|NCT01116193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65546384|NCT01116193|Antiemetics|antiemetics|mesh-ancestor
65546385|NCT01116193|Autonomic Agents|autonomic agents|mesh-ancestor
65546386|NCT01116193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546387|NCT01116193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546388|NCT01116193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65546389|NCT01116193|Glucocorticoids|glucocorticoids|mesh-ancestor
65546390|NCT01116193|Hormones|hormones|mesh-ancestor
65546391|NCT01116193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65546392|NCT01116193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65546393|NCT01116193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546394|NCT01116193|Immunologic Factors|immunologic factors|mesh-ancestor
65546395|NCT01116193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65546396|NCT01116193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65546397|NCT01116193|Growth Substances|growth substances|mesh-ancestor
65546398|NCT01116193|Growth Inhibitors|growth inhibitors|mesh-ancestor
65546399|NCT01120327|Amlodipine|amlodipine|mesh-list
65546400|NCT01120327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65546401|NCT01120327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65546402|NCT01120327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65546403|NCT01120327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546404|NCT01120327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65546405|NCT01120327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546406|NCT01120327|Vasodilator Agents|vasodilator agents|mesh-ancestor
65546407|NCT01116271|Irinotecan|irinotecan|mesh-list
65546408|NCT01116271|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65546409|NCT01116271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65546410|NCT01116271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546411|NCT01116271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546412|NCT01116271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546413|NCT01217359|Interferons|interferons|mesh-list
65546414|NCT01217359|Interferon-alpha|interferon-alpha|mesh-list
65546415|NCT01217359|Interferon alpha-2|interferon alpha-2|mesh-list
65546416|NCT01217359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546417|NCT01217359|Antiviral Agents|antiviral agents|mesh-ancestor
65546418|NCT01217359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65546419|NCT01217359|Immunologic Factors|immunologic factors|mesh-ancestor
65546420|NCT01217359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546421|NCT03225664|Pembrolizumab|pembrolizumab|mesh-list
65546422|NCT03225664|Trametinib|trametinib|mesh-list
65546423|NCT03225664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65546424|NCT03225664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546425|NCT03225664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65275526|NCT00645060|Antibodies|antibodies|mesh-list
65546426|NCT03225664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546427|NCT03225664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546428|NCT01212679|Mitogens|mitogens|mesh-list
65546429|NCT01212679|Mitosis Modulators|mitosis modulators|mesh-ancestor
65546430|NCT01212679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546431|NCT03193684|Empagliflozin|empagliflozin|mesh-list
65546432|NCT03193684|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65546433|NCT03193684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546434|NCT03193684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65546435|NCT03193684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546436|NCT03190954|Raclopride|raclopride|mesh-list
65546437|NCT03190954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65546438|NCT03190954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65546439|NCT03190954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65546440|NCT03190954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546441|NCT03190954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65546442|NCT03190954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65546443|NCT03190954|Dopamine Agents|dopamine agents|mesh-ancestor
65546444|NCT03190954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65546445|NCT03190954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546446|NCT01217671|Protease Inhibitors|protease inhibitors|mesh-list
65546447|NCT01217671|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65546448|NCT01217671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546449|NCT01217671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546450|NCT01217671|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65546451|NCT01217671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65546452|NCT04339270|Azithromycin|azithromycin|mesh-list
65546453|NCT04339270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65546454|NCT04339270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65546455|NCT01116583|Gabapentin|gabapentin|mesh-list
65546456|NCT01116583|Analgesics|analgesics|mesh-ancestor
65546457|NCT01116583|Sensory System Agents|sensory system agents|mesh-ancestor
65546458|NCT01116583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546459|NCT01116583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546460|NCT01116583|Anticonvulsants|anticonvulsants|mesh-ancestor
65546461|NCT01116583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65546462|NCT01116583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65546463|NCT01116583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65546464|NCT01116583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65546465|NCT01116583|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65546466|NCT01116583|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65546467|NCT01116583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65546468|NCT01116583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546469|NCT01116583|Antimanic Agents|antimanic agents|mesh-ancestor
65546470|NCT04299490|Analgesics|analgesics|mesh-list
65546471|NCT04299490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546472|NCT04299490|Sensory System Agents|sensory system agents|mesh-ancestor
65546473|NCT04299490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546474|NCT03935347|Vidarabine|vidarabine|mesh-list
65546475|NCT03935347|Aldesleukin|aldesleukin|mesh-list
65546476|NCT03935347|Cyclophosphamide|cyclophosphamide|mesh-list
65546477|NCT03935347|Pembrolizumab|pembrolizumab|mesh-list
65546478|NCT03935347|Fludarabine|fludarabine|mesh-list
65546479|NCT03935347|Fludarabine phosphate|fludarabine phosphate|mesh-list
65546480|NCT03935347|Interleukin-2|interleukin-2|mesh-list
65546481|NCT03935347|Immunoglobulins|immunoglobulins|mesh-list
65546482|NCT03935347|Immunoglobulin G|immunoglobulin g|mesh-list
65546483|NCT03935347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65546484|NCT03935347|Immunologic Factors|immunologic factors|mesh-ancestor
65546485|NCT03935347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546486|NCT03935347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65546487|NCT03935347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65546488|NCT03935347|Alkylating Agents|alkylating agents|mesh-ancestor
65546489|NCT03935347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546490|NCT03935347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546491|NCT03935347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65546492|NCT03935347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65546493|NCT03935347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65546494|NCT03935347|Antimetabolites|antimetabolites|mesh-ancestor
65546495|NCT03935347|Antiviral Agents|antiviral agents|mesh-ancestor
65546496|NCT03935347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65546497|NCT03935347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65546498|NCT03935347|Analgesics|analgesics|mesh-ancestor
65546499|NCT03935347|Sensory System Agents|sensory system agents|mesh-ancestor
65275600|NCT00910416|Cholinergic Agents|cholinergic agents|mesh-ancestor
65546500|NCT03935347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546501|NCT03935347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65546502|NCT03935347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65546503|NCT04467346|Temozolomide|temozolomide|mesh-list
65546504|NCT04467346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65546505|NCT04467346|Alkylating Agents|alkylating agents|mesh-ancestor
65546506|NCT04467346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546507|NCT04467346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546508|NCT03939871|Vinorelbine|vinorelbine|mesh-list
65546509|NCT03939871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65546510|NCT03939871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546511|NCT03939871|Tubulin Modulators|tubulin modulators|mesh-ancestor
65546512|NCT03939871|Antimitotic Agents|antimitotic agents|mesh-ancestor
65546513|NCT03939871|Mitosis Modulators|mitosis modulators|mesh-ancestor
65546514|NCT03939871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546515|NCT01122667|Anacetrapib|anacetrapib|mesh-list
65546516|NCT01122667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65546517|NCT01122667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65546518|NCT01122667|Antimetabolites|antimetabolites|mesh-ancestor
65546519|NCT01122667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546520|NCT01122667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65546521|NCT01120561|Trastuzumab|trastuzumab|mesh-list
65546522|NCT01120561|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65546523|NCT01120561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65546524|NCT01120561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546525|NCT01120561|Tubulin Modulators|tubulin modulators|mesh-ancestor
65546526|NCT01120561|Antimitotic Agents|antimitotic agents|mesh-ancestor
65546527|NCT01120561|Mitosis Modulators|mitosis modulators|mesh-ancestor
65546528|NCT01120561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546529|NCT03936517|Prednisolone|prednisolone|mesh-list
65546530|NCT03936517|Hydrocortisone|hydrocortisone|mesh-list
65546531|NCT03936517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65546532|NCT03936517|Glucocorticoids|glucocorticoids|mesh-ancestor
65546533|NCT03936517|Hormones|hormones|mesh-ancestor
65546534|NCT03936517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65546535|NCT03936517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546536|NCT03936517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65546537|NCT03936517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546538|NCT03635372|Sucralfate|sucralfate|mesh-list
65546539|NCT03635372|Hydrotalcite|hydrotalcite|mesh-list
65546540|NCT03635372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65546541|NCT03635372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65546542|NCT03635372|Antacids|antacids|mesh-ancestor
65546543|NCT03635372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546544|NCT01116817|Ritonavir|ritonavir|mesh-list
65546545|NCT01116817|Lopinavir|lopinavir|mesh-list
65546546|NCT01116817|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65546547|NCT01116817|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65546548|NCT01116817|Protease Inhibitors|protease inhibitors|mesh-ancestor
65546549|NCT01116817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546550|NCT01116817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546551|NCT01116817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65546552|NCT01116817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65546553|NCT01116817|Antiviral Agents|antiviral agents|mesh-ancestor
65546554|NCT01116817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65546555|NCT01116817|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65546556|NCT01116817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65546557|NCT01120795|Interferons|interferons|mesh-list
65546558|NCT01120795|Ribavirin|ribavirin|mesh-list
65546559|NCT01120795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65546560|NCT01120795|Interferon-alpha|interferon-alpha|mesh-list
65546561|NCT01120795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546562|NCT01120795|Antiviral Agents|antiviral agents|mesh-ancestor
65546563|NCT01120795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65546564|NCT01120795|Antimetabolites|antimetabolites|mesh-ancestor
65546565|NCT01120795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546566|NCT01120795|Immunologic Factors|immunologic factors|mesh-ancestor
65546567|NCT01120795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546568|NCT03008278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65546569|NCT03008278|Olaparib|olaparib|mesh-list
65546570|NCT03008278|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65546571|NCT03008278|Ramucirumab|ramucirumab|mesh-list
65546572|NCT03008278|Antibodies|antibodies|mesh-list
65546573|NCT03008278|Immunoglobulins|immunoglobulins|mesh-list
65275715|NCT04173858|Naloxegol|naloxegol|mesh-list
65546574|NCT03008278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65546575|NCT03008278|Lexatumumab|lexatumumab|mesh-list
65546576|NCT03008278|Immunologic Factors|immunologic factors|mesh-ancestor
65546577|NCT03008278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546578|NCT03008278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546579|NCT03008278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546580|NCT03008278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546581|NCT04467892|Methylprednisolone|methylprednisolone|mesh-list
65546582|NCT04467892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65546583|NCT04467892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65546584|NCT04467892|Prednisolone|prednisolone|mesh-list
65546585|NCT04467892|Prednisolone acetate|prednisolone acetate|mesh-list
65546586|NCT04467892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65546587|NCT04467892|Prednisolone phosphate|prednisolone phosphate|mesh-list
65546588|NCT04467892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65546589|NCT04467892|Antiemetics|antiemetics|mesh-ancestor
65546590|NCT04467892|Autonomic Agents|autonomic agents|mesh-ancestor
65546591|NCT04467892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546592|NCT04467892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546593|NCT04467892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65546594|NCT04467892|Glucocorticoids|glucocorticoids|mesh-ancestor
65546595|NCT04467892|Hormones|hormones|mesh-ancestor
65546596|NCT04467892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65546597|NCT04467892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65546598|NCT04467892|Protective Agents|protective agents|mesh-ancestor
65546599|NCT04467892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65546600|NCT04467892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546601|NCT01122979|Insulin|insulin|mesh-list
65546602|NCT01122979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65546603|NCT01122979|Insulin Glargine|insulin glargine|mesh-list
65546604|NCT01122979|Insulin glulisine|insulin glulisine|mesh-list
65546605|NCT01122979|Insulin, Isophane|insulin, isophane|mesh-list
65546606|NCT01122979|Isophane Insulin, Human|isophane insulin, human|mesh-list
65546607|NCT01122979|Isophane insulin, beef|isophane insulin, beef|mesh-list
65546608|NCT01122979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65546609|NCT01122979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546610|NCT04179110|Pembrolizumab|pembrolizumab|mesh-list
65546611|NCT04179110|Ramucirumab|ramucirumab|mesh-list
65546612|NCT04179110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65546613|NCT04179110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546614|NCT01123057|Riboflavin|riboflavin|mesh-list
65546615|NCT01123057|Vitamin B Complex|vitamin b complex|mesh-ancestor
65546616|NCT01123057|Vitamins|vitamins|mesh-ancestor
65546617|NCT01123057|Micronutrients|micronutrients|mesh-ancestor
65546618|NCT01123057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546619|NCT01123057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65546620|NCT01123057|Dermatologic Agents|dermatologic agents|mesh-ancestor
65546621|NCT03524950|Dexmedetomidine|dexmedetomidine|mesh-list
65546622|NCT03524950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65546623|NCT03524950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65546624|NCT03524950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546625|NCT03524950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65546626|NCT03524950|Analgesics|analgesics|mesh-ancestor
65546627|NCT03524950|Sensory System Agents|sensory system agents|mesh-ancestor
65546628|NCT03524950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546629|NCT03524950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65546630|NCT03524950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65546631|NCT03524950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65546632|NCT03524950|Adrenergic Agents|adrenergic agents|mesh-ancestor
65546633|NCT03524950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65546634|NCT03524950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546635|NCT04714190|Paclitaxel|paclitaxel|mesh-list
65546636|NCT04714190|Irinotecan|irinotecan|mesh-list
65546637|NCT04714190|Apatinib|apatinib|mesh-list
65546638|NCT04714190|Trastuzumab|trastuzumab|mesh-list
65546639|NCT04714190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65546640|NCT04714190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546641|NCT04714190|Tubulin Modulators|tubulin modulators|mesh-ancestor
65546642|NCT04714190|Antimitotic Agents|antimitotic agents|mesh-ancestor
65546643|NCT04714190|Mitosis Modulators|mitosis modulators|mesh-ancestor
65546644|NCT04714190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546645|NCT04714190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65546646|NCT04714190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65546647|NCT04714190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546648|NCT04714190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65546649|NCT04714190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65546650|NCT03524872|Analgesics|analgesics|mesh-list
65546651|NCT03524872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546652|NCT03524872|Sensory System Agents|sensory system agents|mesh-ancestor
65546653|NCT03524872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546654|NCT04143724|Luspatercept|luspatercept|mesh-list
65546655|NCT04143724|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
65546656|NCT04143724|Hematinics|hematinics|mesh-ancestor
65546657|NCT04143724|Immunologic Factors|immunologic factors|mesh-ancestor
65546658|NCT04143724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546659|NCT01345370|Temozolomide|temozolomide|mesh-list
65546660|NCT01345370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65546661|NCT01345370|Alkylating Agents|alkylating agents|mesh-ancestor
65546662|NCT01345370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546663|NCT01345370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546664|NCT04702802|Hyaluronic Acid|hyaluronic acid|mesh-list
65546665|NCT04702802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65546666|NCT04702802|Immunologic Factors|immunologic factors|mesh-ancestor
65546667|NCT04702802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546668|NCT04702802|Viscosupplements|viscosupplements|mesh-ancestor
65546669|NCT04702802|Protective Agents|protective agents|mesh-ancestor
65546670|NCT03522688|Dexmedetomidine|dexmedetomidine|mesh-list
65546671|NCT03522688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65546672|NCT03522688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65546673|NCT03522688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546674|NCT03522688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65546675|NCT03522688|Analgesics|analgesics|mesh-ancestor
65546676|NCT03522688|Sensory System Agents|sensory system agents|mesh-ancestor
65546677|NCT03522688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546678|NCT03522688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65546679|NCT03522688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65546680|NCT03522688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65546681|NCT03522688|Adrenergic Agents|adrenergic agents|mesh-ancestor
65546682|NCT03522688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65546683|NCT03522688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546684|NCT01214941|Itraconazole|itraconazole|mesh-list
65546685|NCT01214941|Ticlopidine|ticlopidine|mesh-list
65546686|NCT01214941|Antifungal Agents|antifungal agents|mesh-ancestor
65546687|NCT01214941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65546688|NCT01214941|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65546689|NCT01214941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65546690|NCT01214941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546691|NCT01214941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546692|NCT01214941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65546693|NCT01214941|Hormone Antagonists|hormone antagonists|mesh-ancestor
65546694|NCT01214941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65546695|NCT01214941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546696|NCT01214941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65546697|NCT01214941|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65546698|NCT01214941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65546699|NCT01214941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65546700|NCT01214941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65546701|NCT01214941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65546702|NCT01214941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65546703|NCT01214941|Purinergic Agents|purinergic agents|mesh-ancestor
65546704|NCT01214941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65546705|NCT01214941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65546706|NCT05301634|Bupivacaine|bupivacaine|mesh-list
65546707|NCT05301634|Anesthetics, Local|anesthetics, local|mesh-ancestor
65546708|NCT05301634|Anesthetics|anesthetics|mesh-ancestor
65546709|NCT05301634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65546710|NCT05301634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546711|NCT05301634|Sensory System Agents|sensory system agents|mesh-ancestor
65546712|NCT05301634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546713|NCT01328821|Pentoxifylline|pentoxifylline|mesh-list
65546714|NCT01328821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65546715|NCT01328821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546716|NCT01328821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546717|NCT01328821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65546718|NCT01328821|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65546719|NCT01328821|Protective Agents|protective agents|mesh-ancestor
65546720|NCT01328821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546721|NCT01328821|Vasodilator Agents|vasodilator agents|mesh-ancestor
65546722|NCT01328821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65546723|NCT01328821|Antioxidants|antioxidants|mesh-ancestor
65546724|NCT04082572|Pembrolizumab|pembrolizumab|mesh-list
65546725|NCT04082572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65546726|NCT04082572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546727|NCT01345448|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65546728|NCT01345448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65546729|NCT01345448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65546730|NCT01345448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65546731|NCT01345448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65546732|NCT01345448|Adrenergic Agents|adrenergic agents|mesh-ancestor
65546733|NCT01345448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65546734|NCT01345448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546735|NCT01345448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546736|NCT04072822|Prednisone|prednisone|mesh-list
65546737|NCT04072822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65546738|NCT04072822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65546739|NCT04072822|Glucocorticoids|glucocorticoids|mesh-ancestor
65546740|NCT04072822|Hormones|hormones|mesh-ancestor
65546741|NCT04072822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65546742|NCT04072822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546743|NCT04072822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65546744|NCT04072822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546745|NCT04072822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65546746|NCT04001894|Clopidogrel|clopidogrel|mesh-list
65546747|NCT04001894|Ticagrelor|ticagrelor|mesh-list
65546748|NCT04001894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65546749|NCT04001894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65546750|NCT04001894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65546751|NCT04001894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65546752|NCT04001894|Purinergic Agents|purinergic agents|mesh-ancestor
65546753|NCT04001894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65546754|NCT04001894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546755|NCT04001894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546756|NCT04066114|Mycophenolic Acid|mycophenolic acid|mesh-list
65546757|NCT04066114|Prednisone|prednisone|mesh-list
65546758|NCT04066114|Methylprednisolone|methylprednisolone|mesh-list
65546759|NCT04066114|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65546760|NCT04066114|Everolimus|everolimus|mesh-list
65546761|NCT04066114|Abatacept|abatacept|mesh-list
65546762|NCT04066114|Thymoglobulin|thymoglobulin|mesh-list
65546763|NCT04066114|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65546764|NCT04066114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65546765|NCT04066114|Glucocorticoids|glucocorticoids|mesh-ancestor
65546766|NCT04066114|Hormones|hormones|mesh-ancestor
65546767|NCT04066114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65546768|NCT04066114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546769|NCT04066114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65546770|NCT04066114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546771|NCT04066114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65546772|NCT04066114|Immunologic Factors|immunologic factors|mesh-ancestor
65546773|NCT04066114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65546774|NCT04066114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65546775|NCT04066114|Antitubercular Agents|antitubercular agents|mesh-ancestor
65546776|NCT04066114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65546777|NCT04066114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65546778|NCT04066114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546779|NCT04066114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546780|NCT04066114|Antiemetics|antiemetics|mesh-ancestor
65546781|NCT04066114|Autonomic Agents|autonomic agents|mesh-ancestor
65546782|NCT04066114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546783|NCT04066114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65546784|NCT04066114|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65546785|NCT04066114|Protective Agents|protective agents|mesh-ancestor
65546786|NCT04066114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65546787|NCT04066114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65546788|NCT01212913|Insulin|insulin|mesh-list
65546789|NCT01212913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65546790|NCT01212913|Insulin Glargine|insulin glargine|mesh-list
65546791|NCT01212913|Insulin Aspart|insulin aspart|mesh-list
65546792|NCT01212913|Insulin glulisine|insulin glulisine|mesh-list
65546793|NCT01212913|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65546794|NCT01212913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65546795|NCT01212913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546796|NCT01345604|Ropivacaine|ropivacaine|mesh-list
65546797|NCT01345604|Anesthetics, Local|anesthetics, local|mesh-ancestor
65546798|NCT01345604|Anesthetics|anesthetics|mesh-ancestor
65546799|NCT01345604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65546800|NCT01345604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546801|NCT01345604|Sensory System Agents|sensory system agents|mesh-ancestor
65546802|NCT01345604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546803|NCT01218217|Rifampin|rifampin|mesh-list
65546804|NCT01218217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65546805|NCT01218217|Antitubercular Agents|antitubercular agents|mesh-ancestor
65546806|NCT01218217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65546807|NCT01218217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65546808|NCT01218217|Leprostatic Agents|leprostatic agents|mesh-ancestor
65546809|NCT01218217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65546810|NCT01218217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546811|NCT01218217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546812|NCT01218217|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65546813|NCT01218217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65546814|NCT01218217|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65546815|NCT01218217|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65546816|NCT01218217|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65546817|NCT01218217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65546818|NCT03522532|Zinc|zinc|mesh-list
65546819|NCT03522532|Trace Elements|trace elements|mesh-ancestor
65546820|NCT03522532|Micronutrients|micronutrients|mesh-ancestor
65546821|NCT03522532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546822|NCT01215019|Mannitol|mannitol|mesh-list
65546823|NCT01215019|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65546824|NCT01215019|Diuretics|diuretics|mesh-ancestor
65546825|NCT01215019|Natriuretic Agents|natriuretic agents|mesh-ancestor
65546826|NCT01215019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546827|NCT03795428|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
65546828|NCT03795428|Vasodilator Agents|vasodilator agents|mesh-ancestor
65546829|NCT01215331|Insulin|insulin|mesh-list
65546830|NCT01215331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65546831|NCT01215331|Metformin|metformin|mesh-list
65546832|NCT01215331|Glyburide|glyburide|mesh-list
65546833|NCT01215331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65546834|NCT01215331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546835|NCT03526276|Fluorides|fluorides|mesh-list
65546836|NCT03526276|Cariostatic Agents|cariostatic agents|mesh-ancestor
65546837|NCT03526276|Protective Agents|protective agents|mesh-ancestor
65546838|NCT03526276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546839|NCT04466254|Cetuximab|cetuximab|mesh-list
65546840|NCT04466254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65546841|NCT04466254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546842|NCT04466176|Fluticasone|fluticasone|mesh-list
65546843|NCT04466176|Xhance|xhance|mesh-list
65546844|NCT04466176|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65546845|NCT04466176|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65546846|NCT04466176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65546847|NCT04466176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65546848|NCT04466176|Autonomic Agents|autonomic agents|mesh-ancestor
65546849|NCT04466176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546850|NCT04466176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546851|NCT04466176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65546852|NCT04466176|Respiratory System Agents|respiratory system agents|mesh-ancestor
65344418|NCT00871156|Chloroquine|chloroquine|mesh-list
65546853|NCT04466176|Dermatologic Agents|dermatologic agents|mesh-ancestor
65546855|NCT04466176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65546856|NCT04466176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65546857|NCT04466176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65546858|NCT04466176|Adrenergic Agents|adrenergic agents|mesh-ancestor
65546859|NCT04466176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65546860|NCT04466176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546861|NCT04466176|Glucocorticoids|glucocorticoids|mesh-ancestor
65546862|NCT04466176|Hormones|hormones|mesh-ancestor
65546863|NCT04466176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65546864|NCT04466176|Sympathomimetics|sympathomimetics|mesh-ancestor
65546865|NCT04656652|Docetaxel|docetaxel|mesh-list
65546866|NCT04656652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546867|NCT04656652|Tubulin Modulators|tubulin modulators|mesh-ancestor
65546868|NCT04656652|Antimitotic Agents|antimitotic agents|mesh-ancestor
65546869|NCT04656652|Mitosis Modulators|mitosis modulators|mesh-ancestor
65546870|NCT04656652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546871|NCT01215409|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65546872|NCT01215409|Vasodilator Agents|vasodilator agents|mesh-ancestor
65546873|NCT01215409|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65546874|NCT01215409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65546875|NCT01215409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546876|NCT01215409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546877|NCT01215409|Urological Agents|urological agents|mesh-ancestor
65546878|NCT03936205|Dexmedetomidine|dexmedetomidine|mesh-list
65546879|NCT03936205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65546880|NCT03936205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65546881|NCT03936205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546882|NCT03936205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65546883|NCT03936205|Analgesics|analgesics|mesh-ancestor
65546884|NCT03936205|Sensory System Agents|sensory system agents|mesh-ancestor
65546885|NCT03936205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546886|NCT03936205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65546887|NCT03936205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65546888|NCT03936205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65546889|NCT03936205|Adrenergic Agents|adrenergic agents|mesh-ancestor
65546890|NCT03936205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65546891|NCT03936205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546892|NCT03936049|Liraglutide|liraglutide|mesh-list
65546893|NCT03936049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65546894|NCT03936049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65546895|NCT03936049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546896|NCT03936049|Incretins|incretins|mesh-ancestor
65546897|NCT03936049|Hormones|hormones|mesh-ancestor
65546898|NCT03936049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65546899|NCT03936049|Protease Inhibitors|protease inhibitors|mesh-ancestor
65546900|NCT03936049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546901|NCT03936049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546902|NCT04674020|Erenumab|erenumab|mesh-list
65546903|NCT04674020|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65546904|NCT04674020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546905|NCT04674020|Analgesics|analgesics|mesh-ancestor
65546906|NCT04674020|Sensory System Agents|sensory system agents|mesh-ancestor
65546907|NCT04674020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546908|NCT04674020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546909|NCT01123525|Adenosine|adenosine|mesh-list
65546910|NCT01123525|Analgesics|analgesics|mesh-ancestor
65546911|NCT01123525|Sensory System Agents|sensory system agents|mesh-ancestor
65546912|NCT01123525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546913|NCT01123525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546914|NCT01123525|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65546915|NCT01123525|Vasodilator Agents|vasodilator agents|mesh-ancestor
65546916|NCT01123525|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65546917|NCT01123525|Purinergic Agonists|purinergic agonists|mesh-ancestor
65546918|NCT01123525|Purinergic Agents|purinergic agents|mesh-ancestor
65546919|NCT01123525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65546920|NCT01123525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546921|NCT01215565|Sunitinib|sunitinib|mesh-list
65546922|NCT01215565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546923|NCT01215565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65546924|NCT01215565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65546925|NCT01215565|Growth Substances|growth substances|mesh-ancestor
65546926|NCT01215565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546927|NCT01215565|Growth Inhibitors|growth inhibitors|mesh-ancestor
65546928|NCT01215565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65546929|NCT01215565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546930|NCT01215565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546931|NCT01121497|Physostigmine|physostigmine|mesh-list
65546932|NCT01121497|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65546933|NCT01121497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546934|NCT01121497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546935|NCT01121497|Cholinergic Agents|cholinergic agents|mesh-ancestor
65546936|NCT01121497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65546937|NCT01121497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546938|NCT01121497|Miotics|miotics|mesh-ancestor
65546939|NCT01121497|Autonomic Agents|autonomic agents|mesh-ancestor
65546940|NCT01121497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546941|NCT01213147|Clomiphene|clomiphene|mesh-list
65546942|NCT01213147|Enclomiphene|enclomiphene|mesh-list
65546943|NCT01213147|Zuclomiphene|zuclomiphene|mesh-list
65546944|NCT01213147|Buserelin|buserelin|mesh-list
65546945|NCT01213147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65276054|NCT04558866|Androgens|androgens|mesh-ancestor
65546946|NCT01213147|Hormone Antagonists|hormone antagonists|mesh-ancestor
65546947|NCT01213147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65546948|NCT01213147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546949|NCT01213147|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65546950|NCT01213147|Fertility Agents|fertility agents|mesh-ancestor
65546951|NCT01213147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65546952|NCT01213147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65546953|NCT01213147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65546954|NCT03143816|Insulin|insulin|mesh-list
65546955|NCT03143816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65546956|NCT03143816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546957|NCT01117129|Rituximab|rituximab|mesh-list
65546958|NCT01117129|Methotrexate|methotrexate|mesh-list
65546959|NCT01117129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65546960|NCT01117129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546961|NCT01117129|Immunologic Factors|immunologic factors|mesh-ancestor
65546962|NCT01117129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546963|NCT01117129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65546964|NCT01117129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65546965|NCT01117129|Abortifacient Agents|abortifacient agents|mesh-ancestor
65546966|NCT01117129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65546967|NCT01117129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65546968|NCT01117129|Antimetabolites|antimetabolites|mesh-ancestor
65546969|NCT01117129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546970|NCT01117129|Dermatologic Agents|dermatologic agents|mesh-ancestor
65546971|NCT01117129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546972|NCT01117129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65546973|NCT01117129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65546974|NCT01117129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65546975|NCT03133988|Margetuximab|margetuximab|mesh-list
65546976|NCT03133988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546977|NCT03934411|Tramadol|tramadol|mesh-list
65546978|NCT03934411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65546979|NCT03934411|Narcotics|narcotics|mesh-ancestor
65546980|NCT03934411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65546981|NCT03934411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546982|NCT03934411|Analgesics|analgesics|mesh-ancestor
65546983|NCT03934411|Sensory System Agents|sensory system agents|mesh-ancestor
65546984|NCT03934411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65546985|NCT01218451|Vaccines|vaccines|mesh-list
65546986|NCT01218451|Immunologic Factors|immunologic factors|mesh-ancestor
65546987|NCT01218451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546988|NCT01346930|Macitentan|macitentan|mesh-list
65546989|NCT01346930|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65546990|NCT01346930|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65546991|NCT01346930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65546992|NCT01346930|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65546993|NCT01219153|Letrozole|letrozole|mesh-list
65546994|NCT01219153|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
65546995|NCT01219153|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65546996|NCT01219153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65546997|NCT01219153|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65546998|NCT01219153|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65546999|NCT01219153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547000|NCT01219153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547001|NCT01219153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65547002|NCT01219153|Hormone Antagonists|hormone antagonists|mesh-ancestor
65547003|NCT01219153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65547004|NCT01219153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547005|NCT01219153|Hormones|hormones|mesh-ancestor
65547006|NCT03526042|Losartan|losartan|mesh-list
65547007|NCT03526042|Enalapril|enalapril|mesh-list
65547008|NCT03526042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65547009|NCT03526042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65547010|NCT03526042|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65547011|NCT03526042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65547012|NCT03526042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65547013|NCT03526042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65547014|NCT03526042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547015|NCT03526042|Protease Inhibitors|protease inhibitors|mesh-ancestor
65276136|NCT04170270|Omeprazole|omeprazole|mesh-list
65547016|NCT01124539|Camptothecin|camptothecin|mesh-list
65547017|NCT01124539|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
65547018|NCT01124539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65547019|NCT01124539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547020|NCT01124539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65547021|NCT01124539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65547022|NCT01124539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547023|NCT01124539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547024|NCT03781375|Etanercept|etanercept|mesh-list
65547025|NCT03781375|Methotrexate|methotrexate|mesh-list
65547026|NCT03781375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65547027|NCT03781375|Abortifacient Agents|abortifacient agents|mesh-ancestor
65547028|NCT03781375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65547029|NCT03781375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547030|NCT03781375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65547031|NCT03781375|Antimetabolites|antimetabolites|mesh-ancestor
65547032|NCT03781375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547033|NCT03781375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547034|NCT03781375|Dermatologic Agents|dermatologic agents|mesh-ancestor
65547035|NCT03781375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547036|NCT03781375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65547037|NCT03781375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65547038|NCT03781375|Immunologic Factors|immunologic factors|mesh-ancestor
65547039|NCT03781375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65547040|NCT03781375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65547041|NCT03781375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65547042|NCT03781375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65547043|NCT03781375|Analgesics|analgesics|mesh-ancestor
65547044|NCT03781375|Sensory System Agents|sensory system agents|mesh-ancestor
65547045|NCT03781375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65547046|NCT03781375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65547047|NCT03781375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65547048|NCT01123915|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
65547049|NCT01123915|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65547050|NCT01123915|Protective Agents|protective agents|mesh-ancestor
65547051|NCT01123915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547052|NCT01123915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65547053|NCT01123915|Antioxidants|antioxidants|mesh-ancestor
65547054|NCT01123915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547055|NCT01218529|Lapatinib|lapatinib|mesh-list
65547056|NCT01218529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547057|NCT01218529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65547058|NCT01218529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547059|NCT01218529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547060|NCT03938467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
65547061|NCT03938467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65547062|NCT01218607|Bosentan|bosentan|mesh-list
65547063|NCT01218607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65547064|NCT01218607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65547065|NCT01218607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547066|NCT03933787|Saxagliptin|saxagliptin|mesh-list
65547067|NCT03933787|Incretins|incretins|mesh-ancestor
65547068|NCT03933787|Hormones|hormones|mesh-ancestor
65547069|NCT03933787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65547070|NCT03933787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344648|NCT04039828|Zinc|zinc|mesh-list
65547071|NCT03933787|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65547072|NCT03933787|Protease Inhibitors|protease inhibitors|mesh-ancestor
65547073|NCT03933787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547074|NCT03933787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547075|NCT03933787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65547076|NCT03934333|Budesonide|budesonide|mesh-list
65547077|NCT03934333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65547078|NCT03934333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65547079|NCT03934333|Autonomic Agents|autonomic agents|mesh-ancestor
65547080|NCT03934333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65547081|NCT03934333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547082|NCT03934333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65547083|NCT03934333|Respiratory System Agents|respiratory system agents|mesh-ancestor
65547084|NCT03934333|Glucocorticoids|glucocorticoids|mesh-ancestor
65547085|NCT03934333|Hormones|hormones|mesh-ancestor
65547086|NCT03934333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65547087|NCT01124227|Icodextrin|icodextrin|mesh-list
65547088|NCT01124227|Dialysis Solutions|dialysis solutions|mesh-ancestor
65547089|NCT01124227|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65547090|NCT03931915|Leuprolide|leuprolide|mesh-list
65547091|NCT03931915|Relugolix|relugolix|mesh-list
65547092|NCT03931915|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65547093|NCT03931915|Fertility Agents|fertility agents|mesh-ancestor
65547094|NCT03931915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65547095|NCT03931915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547096|NCT03931915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65547097|NCT03931915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547098|NCT03931915|Androgen Antagonists|androgen antagonists|mesh-ancestor
65547099|NCT03931915|Hormone Antagonists|hormone antagonists|mesh-ancestor
65547100|NCT03931915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65547101|NCT03932071|Zoledronic Acid|zoledronic acid|mesh-list
65547102|NCT03932071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65547103|NCT03932071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547104|NCT01124383|Lidocaine|lidocaine|mesh-list
65547105|NCT01124383|Ephedrine|ephedrine|mesh-list
65547106|NCT01124383|Midazolam|midazolam|mesh-list
65547107|NCT01124383|Sufentanil|sufentanil|mesh-list
65547108|NCT01124383|Dsuvia|dsuvia|mesh-list
65547109|NCT01124383|Anesthetics|anesthetics|mesh-list
65547110|NCT01124383|Propofol|propofol|mesh-list
65547111|NCT01124383|Sevoflurane|sevoflurane|mesh-list
65547112|NCT01124383|Rocuronium|rocuronium|mesh-list
65547113|NCT01124383|Anesthetics, Local|anesthetics, local|mesh-ancestor
65547114|NCT01124383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65547115|NCT01124383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547116|NCT01124383|Sensory System Agents|sensory system agents|mesh-ancestor
65547117|NCT01124383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65547118|NCT01124383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65547119|NCT01124383|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65547120|NCT01124383|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65547121|NCT01124383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65547122|NCT01124383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547123|NCT01124383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65547124|NCT01124383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65547125|NCT01124383|Anesthetics, General|anesthetics, general|mesh-ancestor
65547126|NCT01124383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65547127|NCT01124383|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65547128|NCT01124383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65547129|NCT01124383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65547130|NCT01124383|GABA Modulators|gaba modulators|mesh-ancestor
65547131|NCT01124383|GABA Agents|gaba agents|mesh-ancestor
65547132|NCT01124383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65547133|NCT01124383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65547134|NCT01124383|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65547135|NCT01124383|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65547136|NCT01124383|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65547137|NCT01124383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65547138|NCT01124383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65547139|NCT01124383|Narcotics|narcotics|mesh-ancestor
65547140|NCT01124383|Analgesics|analgesics|mesh-ancestor
65547141|NCT01124383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65547142|NCT01124383|Sympathomimetics|sympathomimetics|mesh-ancestor
65547143|NCT01124383|Autonomic Agents|autonomic agents|mesh-ancestor
65547144|NCT01124383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65547145|NCT01124383|Adrenergic Agents|adrenergic agents|mesh-ancestor
65344722|NCT05157412|Antiemetics|antiemetics|mesh-ancestor
65547146|NCT01226017|Oxytocin|oxytocin|mesh-list
65547147|NCT01226017|Oxytocics|oxytocics|mesh-ancestor
65547148|NCT01226017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65547149|NCT01226017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547150|NCT01222819|Lenograstim|lenograstim|mesh-list
65547151|NCT01222819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65547152|NCT01222819|Immunologic Factors|immunologic factors|mesh-ancestor
65547153|NCT01222819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547154|NCT01222897|Valacyclovir|valacyclovir|mesh-list
65547155|NCT01222897|Antiviral Agents|antiviral agents|mesh-ancestor
65547156|NCT01222897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65547157|NCT03150056|Prednisone|prednisone|mesh-list
65547158|NCT03150056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65547159|NCT03150056|Glucocorticoids|glucocorticoids|mesh-ancestor
65547160|NCT03150056|Hormones|hormones|mesh-ancestor
65547161|NCT03150056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65547162|NCT03150056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547163|NCT03150056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65547164|NCT03150056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547165|NCT01329367|Antioxidants|antioxidants|mesh-list
65547166|NCT01329367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547167|NCT01329367|Protective Agents|protective agents|mesh-ancestor
65547168|NCT01329367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547169|NCT01222975|Risperidone|risperidone|mesh-list
65547170|NCT01222975|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65547171|NCT01222975|Serotonin Agents|serotonin agents|mesh-ancestor
65547172|NCT01222975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65547173|NCT01222975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547174|NCT01222975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547175|NCT01222975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65547176|NCT01222975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65547177|NCT01222975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65547178|NCT01222975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65547179|NCT01222975|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65547180|NCT01222975|Dopamine Agents|dopamine agents|mesh-ancestor
65547181|NCT01129063|Clopidogrel|clopidogrel|mesh-list
65547182|NCT01129063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65547183|NCT01129063|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65547184|NCT01129063|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65547185|NCT01129063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65547186|NCT01129063|Purinergic Agents|purinergic agents|mesh-ancestor
65547187|NCT01129063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65547188|NCT01129063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547189|NCT01129063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547190|NCT01317368|Ropivacaine|ropivacaine|mesh-list
65547191|NCT01317368|Anesthetics, Local|anesthetics, local|mesh-ancestor
65547192|NCT01317368|Anesthetics|anesthetics|mesh-ancestor
65547193|NCT01317368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65547194|NCT01317368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547195|NCT01317368|Sensory System Agents|sensory system agents|mesh-ancestor
65547196|NCT01317368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65547197|NCT01219699|Fulvestrant|fulvestrant|mesh-list
65547198|NCT01219699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65547199|NCT01219699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547200|NCT01219699|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65547201|NCT01219699|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65547202|NCT01219699|Hormone Antagonists|hormone antagonists|mesh-ancestor
65547203|NCT01219699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65547204|NCT01219699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547205|NCT03933319|Doxorubicin|doxorubicin|mesh-list
65547206|NCT03933319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65547207|NCT03933319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65547208|NCT03933319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547209|NCT03933319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65547210|NCT03933319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65547211|NCT03933319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547212|NCT03933319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547213|NCT01223053|Ketoprofen|ketoprofen|mesh-list
65547214|NCT01223053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65547215|NCT01223053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65547216|NCT01223053|Analgesics|analgesics|mesh-ancestor
65547217|NCT01223053|Sensory System Agents|sensory system agents|mesh-ancestor
65547218|NCT01223053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65547219|NCT01223053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547220|NCT01223053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65547221|NCT01223053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65547222|NCT01223053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65547223|NCT01223053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547224|NCT01223053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547225|NCT01223131|Insulin|insulin|mesh-list
65547226|NCT01223131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65547227|NCT01223131|Insulin Glargine|insulin glargine|mesh-list
65547228|NCT01223131|Insulin, Isophane|insulin, isophane|mesh-list
65547229|NCT01223131|Isophane Insulin, Human|isophane insulin, human|mesh-list
65547230|NCT01223131|Isophane insulin, beef|isophane insulin, beef|mesh-list
65547231|NCT01223131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65547232|NCT01223131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547233|NCT01125553|Insulin|insulin|mesh-list
65547234|NCT01125553|Insulin Aspart|insulin aspart|mesh-list
65547235|NCT01125553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65547236|NCT01125553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547237|NCT02640664|Ranibizumab|ranibizumab|mesh-list
65547238|NCT02640664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65547239|NCT02640664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65547240|NCT02640664|Growth Substances|growth substances|mesh-ancestor
65547241|NCT02640664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547242|NCT02640664|Growth Inhibitors|growth inhibitors|mesh-ancestor
65547243|NCT02640664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547244|NCT01317446|Fluorides|fluorides|mesh-list
65547245|NCT01317446|Tin Fluorides|tin fluorides|mesh-list
65547246|NCT01317446|Cariostatic Agents|cariostatic agents|mesh-ancestor
65547247|NCT01317446|Protective Agents|protective agents|mesh-ancestor
65547248|NCT01317446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547249|NCT02529241|Delpazolid|delpazolid|mesh-list
65547250|NCT02529241|Oxazolidinones|oxazolidinones|mesh-list
65547251|NCT02529241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65547252|NCT02529241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65547253|NCT02529241|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65547254|NCT02529241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547255|NCT02529241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547256|NCT02456012|Esomeprazole|esomeprazole|mesh-list
65547257|NCT02456012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65547258|NCT02456012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65547259|NCT02456012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65547260|NCT02456012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547261|NCT02456012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547262|NCT00812006|Rizatriptan|rizatriptan|mesh-list
65547263|NCT00812006|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65547264|NCT00812006|Serotonin Agents|serotonin agents|mesh-ancestor
65547265|NCT00812006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65547266|NCT00812006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547267|NCT00812006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547268|NCT03133234|Osimertinib|osimertinib|mesh-list
65547269|NCT03133234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547270|NCT03133234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65547271|NCT03133234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547272|NCT03133234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547273|NCT01125787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65547274|NCT01125787|Ofatumumab|ofatumumab|mesh-list
65547275|NCT01125787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65547276|NCT01125787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65547277|NCT01125787|Alkylating Agents|alkylating agents|mesh-ancestor
65547278|NCT01125787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547279|NCT01125787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547280|NCT01125787|Immunologic Factors|immunologic factors|mesh-ancestor
65547281|NCT01125787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547282|NCT02457442|Remifentanil|remifentanil|mesh-list
65547283|NCT02457442|Propofol|propofol|mesh-list
65547284|NCT02457442|Sevoflurane|sevoflurane|mesh-list
65547285|NCT02457442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65547286|NCT02457442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65547287|NCT02457442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547288|NCT02457442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65547289|NCT02457442|Anesthetics, General|anesthetics, general|mesh-ancestor
65547290|NCT02457442|Anesthetics|anesthetics|mesh-ancestor
65547291|NCT02457442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65547292|NCT02457442|Narcotics|narcotics|mesh-ancestor
65547293|NCT02457442|Analgesics|analgesics|mesh-ancestor
65547294|NCT02457442|Sensory System Agents|sensory system agents|mesh-ancestor
65547295|NCT02457442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65547296|NCT02457442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65547297|NCT02457442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65547298|NCT03132038|Nivolumab|nivolumab|mesh-list
65547299|NCT03132038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65547300|NCT03132038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547301|NCT03132038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65547302|NCT03132038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547303|NCT01129375|Omeprazole|omeprazole|mesh-list
65547304|NCT01129375|Clopidogrel|clopidogrel|mesh-list
65547305|NCT01129375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65547306|NCT01129375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65547307|NCT01129375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65547308|NCT01129375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65547309|NCT01129375|Purinergic Agents|purinergic agents|mesh-ancestor
65547310|NCT01129375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65547311|NCT01129375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547312|NCT01129375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547313|NCT01129375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65547314|NCT01129375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65547315|NCT01129375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65547316|NCT01129375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547317|NCT01352702|Dabigatran|dabigatran|mesh-list
65547318|NCT01352702|Phenprocoumon|phenprocoumon|mesh-list
65547319|NCT01352702|Antithrombins|antithrombins|mesh-ancestor
65547320|NCT01352702|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65547321|NCT01352702|Protease Inhibitors|protease inhibitors|mesh-ancestor
65547322|NCT01352702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547323|NCT01352702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547324|NCT01352702|Anticoagulants|anticoagulants|mesh-ancestor
65547325|NCT03525730|Pyrimethamine|pyrimethamine|mesh-list
65547326|NCT03525730|Valproic Acid|valproic acid|mesh-list
65547327|NCT03525730|Antimalarials|antimalarials|mesh-ancestor
65547328|NCT03525730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65547329|NCT03525730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65547330|NCT03525730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65547331|NCT03525730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65547332|NCT03525730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547333|NCT03525730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547334|NCT03525730|Anticonvulsants|anticonvulsants|mesh-ancestor
65547335|NCT03525730|GABA Agents|gaba agents|mesh-ancestor
65547336|NCT03525730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65547337|NCT03525730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547338|NCT03525730|Antimanic Agents|antimanic agents|mesh-ancestor
65547339|NCT03525730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65547340|NCT03525730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65547341|NCT03525730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65547342|NCT01223443|Paclitaxel|paclitaxel|mesh-list
65547343|NCT01223443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65547344|NCT01223443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547345|NCT01223443|Tubulin Modulators|tubulin modulators|mesh-ancestor
65547346|NCT01223443|Antimitotic Agents|antimitotic agents|mesh-ancestor
65547347|NCT01223443|Mitosis Modulators|mitosis modulators|mesh-ancestor
65547348|NCT01223443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547349|NCT03525652|Vaccines|vaccines|mesh-list
65547350|NCT03525652|Immunologic Factors|immunologic factors|mesh-ancestor
65547351|NCT03525652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547352|NCT02290054|Anesthetics|anesthetics|mesh-list
65547353|NCT02290054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65547354|NCT02290054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547355|NCT01347944|Lenalidomide|lenalidomide|mesh-list
65547356|NCT01347944|Immunologic Factors|immunologic factors|mesh-ancestor
65547357|NCT01347944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547358|NCT01347944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65547359|NCT01347944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65547360|NCT01347944|Growth Substances|growth substances|mesh-ancestor
65547361|NCT01347944|Growth Inhibitors|growth inhibitors|mesh-ancestor
65547362|NCT01347944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547363|NCT02290132|Thymoglobulin|thymoglobulin|mesh-list
65547364|NCT02290132|Immunologic Factors|immunologic factors|mesh-ancestor
65547365|NCT02290132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547366|NCT02290132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65547367|NCT01220245|Heparin|heparin|mesh-list
65547368|NCT01220245|Anticoagulants|anticoagulants|mesh-ancestor
65547369|NCT01220245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65547370|NCT01220245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65547371|NCT01220245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547372|NCT03931135|Dexamethasone|dexamethasone|mesh-list
65547373|NCT03931135|Morphine|morphine|mesh-list
65547375|NCT03931135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65547376|NCT03931135|Antiemetics|antiemetics|mesh-ancestor
65547377|NCT03931135|Autonomic Agents|autonomic agents|mesh-ancestor
65547378|NCT03931135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65547379|NCT03931135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547380|NCT03931135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65547381|NCT03931135|Glucocorticoids|glucocorticoids|mesh-ancestor
65547382|NCT03931135|Hormones|hormones|mesh-ancestor
65547383|NCT03931135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65547384|NCT03931135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65547385|NCT03931135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547386|NCT03931135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65547387|NCT03931135|Narcotics|narcotics|mesh-ancestor
65547388|NCT03931135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65547389|NCT03931135|Analgesics|analgesics|mesh-ancestor
65547390|NCT03931135|Sensory System Agents|sensory system agents|mesh-ancestor
65276510|NCT00649740|Topiramate|topiramate|mesh-list
65547391|NCT03931135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65547392|NCT03931135|Histamine Antagonists|histamine antagonists|mesh-ancestor
65547393|NCT03931135|Histamine Agents|histamine agents|mesh-ancestor
65547394|NCT03931135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65547395|NCT03931135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547396|NCT01353170|Dialysis Solutions|dialysis solutions|mesh-list
65547397|NCT01353170|Calcium|calcium|mesh-list
65547398|NCT01353170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65547399|NCT01353170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547400|NCT01353170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65547401|NCT03701308|Cytarabine|cytarabine|mesh-list
65547402|NCT03701308|Daunorubicin|daunorubicin|mesh-list
65547403|NCT03701308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65547404|NCT03701308|Antimetabolites|antimetabolites|mesh-ancestor
65547405|NCT03701308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547406|NCT03701308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547407|NCT03701308|Antiviral Agents|antiviral agents|mesh-ancestor
65547408|NCT03701308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65547409|NCT03701308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65547410|NCT03701308|Immunologic Factors|immunologic factors|mesh-ancestor
65547411|NCT03701308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547412|NCT03701308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65547413|NCT03701308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65547414|NCT03701308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65547415|NCT03701308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547416|NCT03620318|Crenolanib|crenolanib|mesh-list
65547417|NCT03620318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547418|NCT01125943|Bevacizumab|bevacizumab|mesh-list
65547419|NCT01125943|Nitroprusside|nitroprusside|mesh-list
65547420|NCT01125943|Acetylcholine|acetylcholine|mesh-list
65547421|NCT01125943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65547422|NCT01125943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547423|NCT01125943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65547424|NCT01125943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65547425|NCT01125943|Growth Substances|growth substances|mesh-ancestor
65547426|NCT01125943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547427|NCT01125943|Growth Inhibitors|growth inhibitors|mesh-ancestor
65547428|NCT01125943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65547429|NCT01125943|Vasodilator Agents|vasodilator agents|mesh-ancestor
65547430|NCT01125943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65547431|NCT01125943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547432|NCT01125943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65547433|NCT01125943|Cholinergic Agents|cholinergic agents|mesh-ancestor
65547434|NCT01125943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65547435|NCT05635708|Paclitaxel|paclitaxel|mesh-list
65547436|NCT05635708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65547437|NCT05635708|Carboplatin|carboplatin|mesh-list
65547438|NCT05635708|Pemetrexed|pemetrexed|mesh-list
65547439|NCT05635708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65547440|NCT05635708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547441|NCT05635708|Tubulin Modulators|tubulin modulators|mesh-ancestor
65547442|NCT05635708|Antimitotic Agents|antimitotic agents|mesh-ancestor
65547443|NCT05635708|Mitosis Modulators|mitosis modulators|mesh-ancestor
65547444|NCT05635708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547445|NCT05635708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547446|NCT05635708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65547447|NCT05635708|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65547448|NCT01223755|Sirolimus|sirolimus|mesh-list
65547449|NCT01223755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65547450|NCT01223755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65547451|NCT01223755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65547452|NCT01223755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547453|NCT01223755|Antifungal Agents|antifungal agents|mesh-ancestor
65547454|NCT01223755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65547455|NCT01223755|Immunologic Factors|immunologic factors|mesh-ancestor
65547456|NCT01223755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547457|NCT01126177|Interferons|interferons|mesh-list
65547458|NCT01126177|Interferon-beta|interferon-beta|mesh-list
65547459|NCT01126177|Interferon beta-1a|interferon beta-1a|mesh-list
65547460|NCT01126177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547461|NCT01126177|Antiviral Agents|antiviral agents|mesh-ancestor
65547462|NCT01126177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65547463|NCT01126177|Immunologic Factors|immunologic factors|mesh-ancestor
65547464|NCT01126177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547465|NCT01126177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65547466|NCT03680092|Cyclophosphamide|cyclophosphamide|mesh-list
65547467|NCT03680092|Methotrexate|methotrexate|mesh-list
65547469|NCT03680092|Tacrolimus|tacrolimus|mesh-list
65547470|NCT03680092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65547471|NCT03680092|Immunologic Factors|immunologic factors|mesh-ancestor
65547472|NCT03680092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547473|NCT03680092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65547474|NCT03680092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65547475|NCT03680092|Alkylating Agents|alkylating agents|mesh-ancestor
65547476|NCT03680092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547477|NCT03680092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547478|NCT03680092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65547479|NCT03680092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65547480|NCT03680092|Abortifacient Agents|abortifacient agents|mesh-ancestor
65547481|NCT03680092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65547482|NCT03680092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65547483|NCT03680092|Antimetabolites|antimetabolites|mesh-ancestor
65547484|NCT03680092|Dermatologic Agents|dermatologic agents|mesh-ancestor
65547485|NCT03680092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547486|NCT03680092|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65547487|NCT03680092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65547488|NCT03680092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65547489|NCT03680092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65547490|NCT03671044|Docetaxel|docetaxel|mesh-list
65547491|NCT03671044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547492|NCT03671044|Tubulin Modulators|tubulin modulators|mesh-ancestor
65547493|NCT03671044|Antimitotic Agents|antimitotic agents|mesh-ancestor
65547494|NCT03671044|Mitosis Modulators|mitosis modulators|mesh-ancestor
65547495|NCT03671044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547496|NCT05790070|Betaine|betaine|mesh-list
65547497|NCT05790070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65547498|NCT05790070|Lipotropic Agents|lipotropic agents|mesh-ancestor
65547499|NCT05790070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65547500|NCT05790070|Antimetabolites|antimetabolites|mesh-ancestor
65547501|NCT05790070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547502|NCT05790070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65547503|NCT05790044|Clonidine|clonidine|mesh-list
65547504|NCT05790044|Bupivacaine|bupivacaine|mesh-list
65547505|NCT05790044|Anesthetics, Local|anesthetics, local|mesh-ancestor
65547506|NCT05790044|Anesthetics|anesthetics|mesh-ancestor
65547507|NCT05790044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65547508|NCT05790044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547509|NCT05790044|Sensory System Agents|sensory system agents|mesh-ancestor
65547510|NCT05790044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65547511|NCT05790044|Analgesics|analgesics|mesh-ancestor
65547512|NCT05790044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65547513|NCT05790044|Sympatholytics|sympatholytics|mesh-ancestor
65547514|NCT05790044|Autonomic Agents|autonomic agents|mesh-ancestor
65547515|NCT05790044|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65547516|NCT05790044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65547517|NCT05790044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65547518|NCT05790044|Adrenergic Agents|adrenergic agents|mesh-ancestor
65547519|NCT05790044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65547520|NCT05790044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547521|NCT05789992|Remifentanil|remifentanil|mesh-list
65547522|NCT05789992|Propofol|propofol|mesh-list
65547523|NCT05789992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65547524|NCT05789992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65547525|NCT05789992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547526|NCT05789992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65547527|NCT05789992|Anesthetics, General|anesthetics, general|mesh-ancestor
65547528|NCT05789992|Anesthetics|anesthetics|mesh-ancestor
65547529|NCT05789992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65547530|NCT05789992|Narcotics|narcotics|mesh-ancestor
65547531|NCT05789992|Analgesics|analgesics|mesh-ancestor
65547532|NCT05789992|Sensory System Agents|sensory system agents|mesh-ancestor
65547533|NCT05789992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65547534|NCT05789680|Parathyroid Hormone|parathyroid hormone|mesh-list
65547535|NCT05789680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65547536|NCT05789680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547537|NCT05789667|Lenvatinib|lenvatinib|mesh-list
65547538|NCT05789667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547539|NCT05789667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65547540|NCT05789667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547541|NCT05789667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547542|NCT05789589|Dexamethasone|dexamethasone|mesh-list
65547543|NCT05789589|Methylprednisolone|methylprednisolone|mesh-list
65547544|NCT05789589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65547545|NCT05789589|Antiemetics|antiemetics|mesh-ancestor
65547546|NCT05789589|Autonomic Agents|autonomic agents|mesh-ancestor
65547547|NCT05789589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65547548|NCT05789589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547549|NCT05789589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65547550|NCT05789589|Glucocorticoids|glucocorticoids|mesh-ancestor
65547551|NCT05789589|Hormones|hormones|mesh-ancestor
65547552|NCT05789589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65547553|NCT05789589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65547554|NCT05789589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547555|NCT05789589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65547556|NCT05789589|Protective Agents|protective agents|mesh-ancestor
65547557|NCT05789537|Protein C|protein c|mesh-list
65547558|NCT05789537|Anticoagulants|anticoagulants|mesh-ancestor
65547559|NCT05789537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65547560|NCT05789537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65547561|NCT05789537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547562|NCT05789524|Protein C|protein c|mesh-list
65547563|NCT05789524|Anticoagulants|anticoagulants|mesh-ancestor
65547564|NCT05789524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65547565|NCT05789524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65547566|NCT05789524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547567|NCT05789342|Itraconazole|itraconazole|mesh-list
65547568|NCT05789342|Oseltamivir|oseltamivir|mesh-list
65547569|NCT05789342|Digoxin|digoxin|mesh-list
65547570|NCT05789342|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65547571|NCT05789342|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65547572|NCT05789342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65547573|NCT05789342|Antimetabolites|antimetabolites|mesh-ancestor
65547574|NCT05789342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547575|NCT05789342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65547576|NCT05789342|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65547577|NCT05789342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547578|NCT05789342|Antifungal Agents|antifungal agents|mesh-ancestor
65547579|NCT05789342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65547580|NCT05789342|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65547581|NCT05789342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65547582|NCT05789342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65547583|NCT05789342|Hormone Antagonists|hormone antagonists|mesh-ancestor
65547584|NCT05789342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65547585|NCT05789342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547586|NCT05789342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65547587|NCT05789342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65547588|NCT05789342|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65547589|NCT05789342|Protective Agents|protective agents|mesh-ancestor
65547590|NCT05789342|Antiviral Agents|antiviral agents|mesh-ancestor
65547591|NCT05789186|Fluoxetine|fluoxetine|mesh-list
65547592|NCT05789186|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65547593|NCT05789186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65547594|NCT05789186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65547595|NCT05789186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547596|NCT05789186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65547597|NCT05789186|Serotonin Agents|serotonin agents|mesh-ancestor
65547598|NCT05789186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547599|NCT05789186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65547600|NCT05789186|Antidepressive Agents|antidepressive agents|mesh-ancestor
65547601|NCT05789186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65547602|NCT05789186|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65547603|NCT05789186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65547604|NCT05789186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547606|NCT05789043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547607|NCT05789043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65547608|NCT05789043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547609|NCT05789043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547610|NCT05789030|Prednisone|prednisone|mesh-list
65547611|NCT05789030|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
65547612|NCT05789030|Betamethasone|betamethasone|mesh-list
65547613|NCT05789030|Leflunomide|leflunomide|mesh-list
65547614|NCT05789030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65547615|NCT05789030|Glucocorticoids|glucocorticoids|mesh-ancestor
65547616|NCT05789030|Hormones|hormones|mesh-ancestor
65276731|NCT00890825|Docetaxel|docetaxel|mesh-list
65547617|NCT05789030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65547618|NCT05789030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547619|NCT05789030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65547620|NCT05789030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547621|NCT05789030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547622|NCT05789030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547623|NCT05789030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65547624|NCT05789030|Immunologic Factors|immunologic factors|mesh-ancestor
65547625|NCT05789030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65547626|NCT05789030|Respiratory System Agents|respiratory system agents|mesh-ancestor
65547627|NCT05789017|Mycophenolic Acid|mycophenolic acid|mesh-list
65547628|NCT05789017|Prednisone|prednisone|mesh-list
65547629|NCT05789017|Leflunomide|leflunomide|mesh-list
65547630|NCT05789017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65547631|NCT05789017|Glucocorticoids|glucocorticoids|mesh-ancestor
65547632|NCT05789017|Hormones|hormones|mesh-ancestor
65547633|NCT05789017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65547634|NCT05789017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547635|NCT05789017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65547636|NCT05789017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547637|NCT05789017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65547638|NCT05789017|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65547639|NCT05789017|Antitubercular Agents|antitubercular agents|mesh-ancestor
65547640|NCT05789017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65547641|NCT05789017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65547642|NCT05789017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547643|NCT05789017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547644|NCT05789017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65547645|NCT05789017|Immunologic Factors|immunologic factors|mesh-ancestor
65547646|NCT05788991|Metronidazole|metronidazole|mesh-list
65547647|NCT05788991|Dequalinium|dequalinium|mesh-list
65547648|NCT05788991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65547649|NCT05788991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65547650|NCT05788991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65547651|NCT05788991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65547652|NCT05788991|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65547653|NCT05788913|Heparin|heparin|mesh-list
65547654|NCT05788913|Anticoagulants|anticoagulants|mesh-ancestor
65547655|NCT05788913|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65547656|NCT05788913|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65547657|NCT05788913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547658|NCT05788900|Heparin|heparin|mesh-list
65547659|NCT05788900|Anticoagulants|anticoagulants|mesh-ancestor
65547660|NCT05788900|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65547661|NCT05788900|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65547662|NCT05788900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547663|NCT05788835|Chlorotrianisene|chlorotrianisene|mesh-list
65547664|NCT05788835|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65547665|NCT05788835|Estrogens|estrogens|mesh-ancestor
65547666|NCT05788835|Hormones|hormones|mesh-ancestor
65547667|NCT05788835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65547668|NCT05788835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547669|NCT05788835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65547670|NCT05788835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547671|NCT05788705|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
65547672|NCT05788705|Boswellic acid|boswellic acid|mesh-list
65547673|NCT05788705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65547674|NCT05788705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65547675|NCT05788705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65547677|NCT05788705|Sensory System Agents|sensory system agents|mesh-ancestor
65547678|NCT05788705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65547679|NCT05788705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547680|NCT05788705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65547681|NCT05788679|Azacitidine|azacitidine|mesh-list
65547682|NCT05788679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65547683|NCT05788679|Antimetabolites|antimetabolites|mesh-ancestor
65547684|NCT05788679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547685|NCT05788679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547686|NCT05788679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547687|NCT05788510|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65547688|NCT05788510|Immunologic Factors|immunologic factors|mesh-ancestor
65547689|NCT05788510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276810|NCT04208594|Propranolol|propranolol|mesh-list
65547690|NCT05783219|Lidocaine|lidocaine|mesh-list
65547691|NCT05783219|Anesthetics, Local|anesthetics, local|mesh-ancestor
65547692|NCT05783219|Anesthetics|anesthetics|mesh-ancestor
65547693|NCT05783219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65547694|NCT05783219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547695|NCT05783219|Sensory System Agents|sensory system agents|mesh-ancestor
65547696|NCT05783219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65547697|NCT05783219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65547698|NCT05783219|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65547699|NCT05783219|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65547700|NCT05783219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65547701|NCT05783219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547702|NCT05770544|Entrectinib|entrectinib|mesh-list
65547703|NCT05770544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65547704|NCT05770544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547705|NCT05770544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547706|NCT05767086|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65547707|NCT05767086|Medroxyprogesterone|medroxyprogesterone|mesh-list
65547708|NCT05767086|Cetrorelix|cetrorelix|mesh-list
65547709|NCT05767086|Hormones|hormones|mesh-list
65547710|NCT05767086|Dydrogesterone|dydrogesterone|mesh-list
65547711|NCT05767086|Hormone Antagonists|hormone antagonists|mesh-list
65547712|NCT05767086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65547713|NCT05767086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547714|NCT05767086|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65547715|NCT05767086|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65547716|NCT05767086|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65547717|NCT05767086|Contraceptive Agents|contraceptive agents|mesh-ancestor
65547718|NCT05767086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65547719|NCT05767086|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65547720|NCT05767086|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65547721|NCT05767086|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65547722|NCT05767086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65547723|NCT05767086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547724|NCT05767086|Progestins|progestins|mesh-ancestor
65547725|NCT05767086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65547726|NCT05767086|Fertility Agents|fertility agents|mesh-ancestor
65547727|NCT05755282|Hand Sanitizers|hand sanitizers|mesh-list
65547728|NCT05755282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65547729|NCT05755282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65547730|NCT05755282|Disinfectants|disinfectants|mesh-ancestor
65547731|NCT05742841|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65547732|NCT05742841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65547733|NCT05742841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65547734|NCT05742841|Antimetabolites|antimetabolites|mesh-ancestor
65547735|NCT05742841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547736|NCT05742841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65547737|NCT05742841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65547738|NCT05742841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547739|NCT05732077|Dopamine|dopamine|mesh-list
65547740|NCT05732077|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65547741|NCT05732077|Sympathomimetics|sympathomimetics|mesh-ancestor
65547742|NCT05732077|Autonomic Agents|autonomic agents|mesh-ancestor
65547743|NCT05732077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65547744|NCT05732077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547745|NCT05732077|Dopamine Agents|dopamine agents|mesh-ancestor
65547746|NCT05732077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65547747|NCT05732077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547748|NCT05732077|Protective Agents|protective agents|mesh-ancestor
65547749|NCT05722886|Trastuzumab|trastuzumab|mesh-list
65547750|NCT05722886|Pertuzumab|pertuzumab|mesh-list
65547751|NCT05722886|Atezolizumab|atezolizumab|mesh-list
65547752|NCT05722886|Vemurafenib|vemurafenib|mesh-list
65547753|NCT05722886|Entrectinib|entrectinib|mesh-list
65547754|NCT05722886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65547755|NCT05722886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547756|NCT05722886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65547757|NCT05722886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547758|NCT05722886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547759|NCT05707351|Factor VIII|factor viii|mesh-list
65547760|NCT05707351|BAX 855|bax 855|mesh-list
65547761|NCT05707351|Coagulants|coagulants|mesh-ancestor
65547762|NCT05702905|Metformin|metformin|mesh-list
65547763|NCT05702905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65547764|NCT05702905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547765|NCT05697471|Dienogest|dienogest|mesh-list
65547766|NCT05697471|Danazol|danazol|mesh-list
65547767|NCT05697471|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65547768|NCT05697471|Contraceptive Agents|contraceptive agents|mesh-ancestor
65547769|NCT05697471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65547770|NCT05697471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547771|NCT05697471|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65547772|NCT05697471|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65547773|NCT05697471|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65547774|NCT05697471|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65547775|NCT05697471|Hormone Antagonists|hormone antagonists|mesh-ancestor
65547776|NCT05697471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65547777|NCT05697471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65547778|NCT05697471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547779|NCT05697471|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65547780|NCT05696236|Tin Fluorides|tin fluorides|mesh-list
65547781|NCT05696236|Cariostatic Agents|cariostatic agents|mesh-ancestor
65547782|NCT05696236|Protective Agents|protective agents|mesh-ancestor
65547783|NCT05696236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547784|NCT05683977|Durvalumab|durvalumab|mesh-list
65547785|NCT05683977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65547786|NCT05683977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547787|NCT05670561|Sufentanil|sufentanil|mesh-list
65547788|NCT05670561|Esketamine|esketamine|mesh-list
65547789|NCT05670561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65547790|NCT05670561|Narcotics|narcotics|mesh-ancestor
65547791|NCT05670561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65547792|NCT05670561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547793|NCT05670561|Analgesics|analgesics|mesh-ancestor
65547794|NCT05670561|Sensory System Agents|sensory system agents|mesh-ancestor
65547795|NCT05670561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65547796|NCT05670561|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65547797|NCT05670561|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65547798|NCT05670561|Anesthetics, General|anesthetics, general|mesh-ancestor
65547799|NCT05670561|Anesthetics|anesthetics|mesh-ancestor
65547800|NCT05670561|Antidepressive Agents|antidepressive agents|mesh-ancestor
65547801|NCT05670561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65547802|NCT05656521|Dexamethasone|dexamethasone|mesh-list
65547803|NCT05656521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65547804|NCT05656521|Antiemetics|antiemetics|mesh-ancestor
65547805|NCT05656521|Autonomic Agents|autonomic agents|mesh-ancestor
65547806|NCT05656521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65547807|NCT05656521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547808|NCT05656521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65547809|NCT05656521|Glucocorticoids|glucocorticoids|mesh-ancestor
65547810|NCT05656521|Hormones|hormones|mesh-ancestor
65547811|NCT05656521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65547812|NCT05656521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65547813|NCT05656521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547814|NCT05655182|Vaccines|vaccines|mesh-list
65547815|NCT05655182|Immunologic Factors|immunologic factors|mesh-ancestor
65547816|NCT05655182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547817|NCT05635877|Esmolol|esmolol|mesh-list
65547818|NCT05635877|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65547819|NCT05635877|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65547820|NCT05635877|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65547821|NCT05635877|Adrenergic Agents|adrenergic agents|mesh-ancestor
65547822|NCT05635877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65547823|NCT05635877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547824|NCT05635877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547826|NCT05630183|Paclitaxel|paclitaxel|mesh-list
65547827|NCT05630183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65547828|NCT05630183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547829|NCT05630183|Tubulin Modulators|tubulin modulators|mesh-ancestor
65547830|NCT05630183|Antimitotic Agents|antimitotic agents|mesh-ancestor
65547831|NCT05630183|Mitosis Modulators|mitosis modulators|mesh-ancestor
65547832|NCT05630183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547833|NCT05630183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65547834|NCT05630183|Antimetabolites|antimetabolites|mesh-ancestor
65547835|NCT05630183|Antiviral Agents|antiviral agents|mesh-ancestor
65547836|NCT05630183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65547837|NCT05630183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547838|NCT05630183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65547839|NCT05630183|Immunologic Factors|immunologic factors|mesh-ancestor
65547840|NCT05630183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547841|NCT05629546|Nivolumab|nivolumab|mesh-list
65547842|NCT05629546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65547843|NCT05629546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547844|NCT05629546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65547845|NCT05629546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547846|NCT05617820|Estradiol|estradiol|mesh-list
65547847|NCT05617820|Estrogens|estrogens|mesh-ancestor
65547848|NCT05617820|Hormones|hormones|mesh-ancestor
65547849|NCT05617820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65547850|NCT05617820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547851|NCT05603702|Lacosamide|lacosamide|mesh-list
65547852|NCT05603702|Anticonvulsants|anticonvulsants|mesh-ancestor
65547853|NCT05603702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65547854|NCT05603702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65547855|NCT05603702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65547856|NCT05603702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547857|NCT05596006|Domperidone|domperidone|mesh-list
65547858|NCT05596006|Antiemetics|antiemetics|mesh-ancestor
65547859|NCT05596006|Autonomic Agents|autonomic agents|mesh-ancestor
65547860|NCT05596006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65547861|NCT05596006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547862|NCT05596006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65547863|NCT05596006|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65547864|NCT05596006|Dopamine Agents|dopamine agents|mesh-ancestor
65547865|NCT05596006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65547866|NCT05596006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547867|NCT05587374|Gemcitabine|gemcitabine|mesh-list
65547868|NCT05587374|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65547869|NCT05587374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547870|NCT05587374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65547871|NCT05587374|Antimetabolites|antimetabolites|mesh-ancestor
65547872|NCT05587374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547873|NCT05587374|Antiviral Agents|antiviral agents|mesh-ancestor
65547874|NCT05587374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65547875|NCT05587374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547876|NCT05587374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65547877|NCT05587374|Immunologic Factors|immunologic factors|mesh-ancestor
65547878|NCT05587374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547879|NCT05586529|Cholecalciferol|cholecalciferol|mesh-list
65547880|NCT05586529|Vitamin D|vitamin d|mesh-list
65547881|NCT05586529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65547882|NCT05586529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547883|NCT05586529|Vitamins|vitamins|mesh-ancestor
65547884|NCT05586529|Micronutrients|micronutrients|mesh-ancestor
65547885|NCT05586529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65547886|NCT05558280|Dinutuximab|dinutuximab|mesh-list
65547887|NCT05558280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547888|NCT05555303|Amikacin|amikacin|mesh-list
65547889|NCT05555303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65547890|NCT05555303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65547891|NCT05549752|Amiodarone|amiodarone|mesh-list
65547892|NCT05549752|Flecainide|flecainide|mesh-list
65547893|NCT05549752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65547894|NCT05549752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65547895|NCT05549752|Vasodilator Agents|vasodilator agents|mesh-ancestor
65547896|NCT05549752|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65547897|NCT05549752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65547898|NCT05549752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547899|NCT05549752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65547900|NCT05549752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65547901|NCT05549752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65547902|NCT05549752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547903|NCT05549752|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65547904|NCT05549752|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65547905|NCT05549752|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65547906|NCT05549752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65547908|NCT05538091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547909|NCT05524935|Pembrolizumab|pembrolizumab|mesh-list
65547910|NCT05524935|Olaparib|olaparib|mesh-list
65547911|NCT05524935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65547912|NCT05524935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547913|NCT05524935|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65547914|NCT05524935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547915|NCT05524935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547916|NCT05515029|Cyclophosphamide|cyclophosphamide|mesh-list
65547917|NCT05515029|Abatacept|abatacept|mesh-list
65547918|NCT05515029|Vedolizumab|vedolizumab|mesh-list
65547919|NCT05515029|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
65547920|NCT05515029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65547921|NCT05515029|Immunologic Factors|immunologic factors|mesh-ancestor
65547922|NCT05515029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547923|NCT05515029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65547924|NCT05515029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65547925|NCT05515029|Alkylating Agents|alkylating agents|mesh-ancestor
65547926|NCT05515029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547927|NCT05515029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547928|NCT05515029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65547929|NCT05515029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65547930|NCT05515029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65547931|NCT05515029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547932|NCT05499832|Tenecteplase|tenecteplase|mesh-list
65547933|NCT05499832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65547934|NCT05499832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65547935|NCT05499832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547936|NCT05487755|Tadalafil|tadalafil|mesh-list
65547937|NCT05487755|Pentoxifylline|pentoxifylline|mesh-list
65547938|NCT05487755|Vasodilator Agents|vasodilator agents|mesh-ancestor
65547939|NCT05487755|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65547940|NCT05487755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65547941|NCT05487755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547942|NCT05487755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547943|NCT05487755|Urological Agents|urological agents|mesh-ancestor
65547944|NCT05487755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65547945|NCT05487755|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65547946|NCT05487755|Protective Agents|protective agents|mesh-ancestor
65547947|NCT05487755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547948|NCT05487755|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65547949|NCT05487755|Antioxidants|antioxidants|mesh-ancestor
65547950|NCT05461755|Tretinoin|tretinoin|mesh-list
65547951|NCT05461755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547952|NCT05461755|Keratolytic Agents|keratolytic agents|mesh-ancestor
65547953|NCT05461755|Dermatologic Agents|dermatologic agents|mesh-ancestor
65547954|NCT05461456|Fexofenadine|fexofenadine|mesh-list
65547955|NCT05461456|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65547956|NCT05461456|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65547957|NCT05461456|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65547958|NCT05461456|Histamine Antagonists|histamine antagonists|mesh-ancestor
65547959|NCT05461456|Histamine Agents|histamine agents|mesh-ancestor
65547960|NCT05461456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65547961|NCT05461456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547962|NCT05461456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547963|NCT05441930|Levofloxacin|levofloxacin|mesh-list
65547964|NCT05441930|Ofloxacin|ofloxacin|mesh-list
65547965|NCT05441930|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65547966|NCT05441930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65547967|NCT05441930|Renal Agents|renal agents|mesh-ancestor
65547968|NCT05441930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65547969|NCT05441930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65547970|NCT05441930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65547971|NCT05441930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345545|NCT00741234|Azacitidine|azacitidine|mesh-list
65547972|NCT05441930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547974|NCT05441930|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65547975|NCT05441930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65547976|NCT05405751|Tenofovir|tenofovir|mesh-list
65547977|NCT05405751|Emtricitabine|emtricitabine|mesh-list
65547978|NCT05405751|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65547979|NCT05405751|Antiviral Agents|antiviral agents|mesh-ancestor
65547980|NCT05405751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65547981|NCT05405751|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65547982|NCT05405751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65547983|NCT05405751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65547984|NCT05405751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65547985|NCT05405751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65547986|NCT05405751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65547987|NCT05394727|Insulin|insulin|mesh-list
65547988|NCT05394727|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65547989|NCT05394727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65277115|NCT00891371|Lanreotide|lanreotide|mesh-list
65547990|NCT05394727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547991|NCT05381948|Aflibercept|aflibercept|mesh-list
65547992|NCT05381948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65547993|NCT05381948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65547994|NCT05381948|Growth Substances|growth substances|mesh-ancestor
65547995|NCT05381948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65547996|NCT05381948|Growth Inhibitors|growth inhibitors|mesh-ancestor
65547997|NCT05381948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65547998|NCT05375994|Adagrasib|adagrasib|mesh-list
65547999|NCT05375994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548000|NCT05374291|Dapagliflozin|dapagliflozin|mesh-list
65548001|NCT05374291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65548002|NCT05374291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548003|NCT05374291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65548004|NCT05374291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548005|NCT05350501|Nivolumab|nivolumab|mesh-list
65548006|NCT05350501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65548007|NCT05350501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548008|NCT05350501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65548009|NCT05350501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548010|NCT05322512|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65548011|NCT05322512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65548012|NCT05322512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548013|NCT05268926|Dapagliflozin|dapagliflozin|mesh-list
65548014|NCT05268926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65548015|NCT05268926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548016|NCT05268926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65548017|NCT05268926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548018|NCT05267366|Bevacizumab|bevacizumab|mesh-list
65548019|NCT05267366|Carboplatin|carboplatin|mesh-list
65548020|NCT05267366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65548021|NCT05267366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65548022|NCT05267366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548023|NCT05267366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65548024|NCT05267366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65548025|NCT05267366|Growth Substances|growth substances|mesh-ancestor
65548026|NCT05267366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548027|NCT05267366|Growth Inhibitors|growth inhibitors|mesh-ancestor
65548028|NCT05267366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548029|NCT05267288|Afatinib|afatinib|mesh-list
65548030|NCT05267288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548031|NCT05267288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65548032|NCT05267288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548033|NCT05267288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548034|NCT05263206|Loratadine|loratadine|mesh-list
65548035|NCT05263206|Fexofenadine|fexofenadine|mesh-list
65548036|NCT05263206|Antipruritics|antipruritics|mesh-ancestor
65548037|NCT05263206|Dermatologic Agents|dermatologic agents|mesh-ancestor
65548038|NCT05263206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65548039|NCT05263206|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65548040|NCT05263206|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65548041|NCT05263206|Histamine Antagonists|histamine antagonists|mesh-ancestor
65548042|NCT05263206|Histamine Agents|histamine agents|mesh-ancestor
65548043|NCT05263206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65548044|NCT05263206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548045|NCT05263206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548047|NCT05222984|Venetoclax|venetoclax|mesh-list
65548048|NCT05222984|Navitoclax|navitoclax|mesh-list
65548049|NCT05222984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65548050|NCT05222984|Antimetabolites|antimetabolites|mesh-ancestor
65548051|NCT05222984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548052|NCT05222984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548053|NCT05222984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548054|NCT05218629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65548055|NCT05218629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548056|NCT05218629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548057|NCT05191667|Paclitaxel|paclitaxel|mesh-list
65548058|NCT05191667|Carboplatin|carboplatin|mesh-list
65548059|NCT05191667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65548060|NCT05191667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548061|NCT05191667|Tubulin Modulators|tubulin modulators|mesh-ancestor
65548062|NCT05191667|Antimitotic Agents|antimitotic agents|mesh-ancestor
65548063|NCT05191667|Mitosis Modulators|mitosis modulators|mesh-ancestor
65548064|NCT05191667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548065|NCT05188508|Pembrolizumab|pembrolizumab|mesh-list
65548066|NCT05188508|Temozolomide|temozolomide|mesh-list
65548067|NCT05188508|Olaparib|olaparib|mesh-list
65548068|NCT05188508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65548069|NCT05188508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548070|NCT05188508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65548071|NCT05188508|Alkylating Agents|alkylating agents|mesh-ancestor
65548072|NCT05188508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548073|NCT05188508|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65548074|NCT05188508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548075|NCT05112263|Cyclosporine|cyclosporine|mesh-list
65548076|NCT05112263|Cyclosporins|cyclosporins|mesh-list
65548077|NCT05112263|Tofacitinib|tofacitinib|mesh-list
65548078|NCT05112263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548079|NCT05112263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548080|NCT05112263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65548081|NCT05112263|Immunologic Factors|immunologic factors|mesh-ancestor
65548082|NCT05112263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548083|NCT05112263|Antifungal Agents|antifungal agents|mesh-ancestor
65548084|NCT05112263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65548085|NCT05112263|Dermatologic Agents|dermatologic agents|mesh-ancestor
65548086|NCT05112263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65548087|NCT05112263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65548088|NCT05112263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65548089|NCT05104281|Osimertinib|osimertinib|mesh-list
65548090|NCT05104281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548091|NCT05104281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65548092|NCT05104281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548093|NCT05104281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548094|NCT05103605|Osimertinib|osimertinib|mesh-list
65548095|NCT05103605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548096|NCT05103605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65548097|NCT05103605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548098|NCT05103605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548099|NCT05096884|Metoprolol|metoprolol|mesh-list
65548100|NCT05096884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65548101|NCT05096884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65548102|NCT05096884|Sympatholytics|sympatholytics|mesh-ancestor
65548103|NCT05096884|Autonomic Agents|autonomic agents|mesh-ancestor
65548104|NCT05096884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65548105|NCT05096884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548106|NCT05096884|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65548107|NCT05096884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65548108|NCT05096884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65548109|NCT05096884|Adrenergic Agents|adrenergic agents|mesh-ancestor
65548110|NCT05096884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65548111|NCT05096884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548112|NCT05084378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65548113|NCT05084378|Chlorhexidine|chlorhexidine|mesh-list
65548114|NCT05084378|Povidone-Iodine|povidone-iodine|mesh-list
65548115|NCT05084378|Povidone|povidone|mesh-list
65548116|NCT05084378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65548117|NCT05084378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65548118|NCT05084378|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65548119|NCT05084378|Disinfectants|disinfectants|mesh-ancestor
65548120|NCT05084378|Plasma Substitutes|plasma substitutes|mesh-ancestor
65548121|NCT05084378|Blood Substitutes|blood substitutes|mesh-ancestor
65548122|NCT05072249|Naloxone|naloxone|mesh-list
65548123|NCT05072249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65548124|NCT05072249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548125|NCT05072249|Sensory System Agents|sensory system agents|mesh-ancestor
65548126|NCT05072249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65548127|NCT05065918|Ethanol|ethanol|mesh-list
65548128|NCT05065918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65548129|NCT05065918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65548130|NCT05065918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65548131|NCT05065918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548132|NCT05048017|Pembrolizumab|pembrolizumab|mesh-list
65548133|NCT05048017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65548134|NCT05048017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65548135|NCT05048017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548136|NCT05048017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548137|NCT05040984|Solifenacin Succinate|solifenacin succinate|mesh-list
65548138|NCT05040984|Mirabegron|mirabegron|mesh-list
65548139|NCT05040984|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65548140|NCT05040984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65548141|NCT05040984|Cholinergic Agents|cholinergic agents|mesh-ancestor
65548142|NCT05040984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65548143|NCT05040984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548144|NCT05040984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548145|NCT05040984|Urological Agents|urological agents|mesh-ancestor
65548146|NCT05040984|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65548147|NCT05040984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65548148|NCT05040984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65548149|NCT05040984|Adrenergic Agents|adrenergic agents|mesh-ancestor
65548150|NCT05017272|Analgesics, Opioid|analgesics, opioid|mesh-list
65548151|NCT05017272|Narcotics|narcotics|mesh-ancestor
65548152|NCT05017272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65548153|NCT05017272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548154|NCT05017272|Analgesics|analgesics|mesh-ancestor
65548155|NCT05017272|Sensory System Agents|sensory system agents|mesh-ancestor
65548156|NCT05017272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65548157|NCT04998604|Omalizumab|omalizumab|mesh-list
65548158|NCT04998604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65548159|NCT04998604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65548160|NCT04998604|Respiratory System Agents|respiratory system agents|mesh-ancestor
65548161|NCT04981912|Rituximab|rituximab|mesh-list
65548162|NCT04981912|Venetoclax|venetoclax|mesh-list
65548163|NCT04981912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65548164|NCT04981912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548165|NCT04981912|Immunologic Factors|immunologic factors|mesh-ancestor
65548166|NCT04981912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548167|NCT04981912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65548168|NCT04974879|Osimertinib|osimertinib|mesh-list
65548169|NCT04974879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548170|NCT04974879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65548171|NCT04974879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548172|NCT04974879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548173|NCT04933058|Acetaminophen|acetaminophen|mesh-list
65548174|NCT04933058|Fentanyl|fentanyl|mesh-list
65548175|NCT04933058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65548176|NCT04933058|Narcotics|narcotics|mesh-ancestor
65548177|NCT04933058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65548178|NCT04933058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548179|NCT04933058|Analgesics|analgesics|mesh-ancestor
65548180|NCT04933058|Sensory System Agents|sensory system agents|mesh-ancestor
65548181|NCT04933058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65548182|NCT04933058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65548183|NCT04933058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65548184|NCT04933058|Anesthetics, General|anesthetics, general|mesh-ancestor
65548185|NCT04933058|Anesthetics|anesthetics|mesh-ancestor
65548186|NCT04933058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65548187|NCT04933058|Antipyretics|antipyretics|mesh-ancestor
65548188|NCT04918810|Docetaxel|docetaxel|mesh-list
65548189|NCT04918810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548190|NCT04918810|Tubulin Modulators|tubulin modulators|mesh-ancestor
65548191|NCT04918810|Antimitotic Agents|antimitotic agents|mesh-ancestor
65548192|NCT04918810|Mitosis Modulators|mitosis modulators|mesh-ancestor
65548193|NCT04918810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548194|NCT04899388|Fentanyl|fentanyl|mesh-list
65548195|NCT04899388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65548196|NCT04899388|Narcotics|narcotics|mesh-ancestor
65548197|NCT04899388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65548198|NCT04899388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548199|NCT04899388|Analgesics|analgesics|mesh-ancestor
65548200|NCT04899388|Sensory System Agents|sensory system agents|mesh-ancestor
65548201|NCT04899388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65548202|NCT04899388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65548203|NCT04899388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65548204|NCT04899388|Anesthetics, General|anesthetics, general|mesh-ancestor
65548205|NCT04899388|Anesthetics|anesthetics|mesh-ancestor
65548206|NCT04894864|Analgesics, Opioid|analgesics, opioid|mesh-list
65548207|NCT04894864|Anesthetics|anesthetics|mesh-list
65548208|NCT04894864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65548209|NCT04894864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548210|NCT04894864|Narcotics|narcotics|mesh-ancestor
65548211|NCT04894864|Analgesics|analgesics|mesh-ancestor
65548212|NCT04894864|Sensory System Agents|sensory system agents|mesh-ancestor
65548213|NCT04894864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65548214|NCT04894435|Vaccines|vaccines|mesh-list
65277334|NCT02647086|Anticoagulants|anticoagulants|mesh-ancestor
65548215|NCT04894435|Immunologic Factors|immunologic factors|mesh-ancestor
65548216|NCT04894435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548217|NCT04880395|Lamivudine|lamivudine|mesh-list
65548218|NCT04880395|Emtricitabine|emtricitabine|mesh-list
65548219|NCT04880395|Dolutegravir|dolutegravir|mesh-list
65548220|NCT04880395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65548221|NCT04880395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65548222|NCT04880395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548223|NCT04880395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548224|NCT04880395|Antiviral Agents|antiviral agents|mesh-ancestor
65548225|NCT04880395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65548226|NCT04880395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65548227|NCT04880395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65548228|NCT04880395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65548229|NCT04880395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65548230|NCT04849013|Ketanserin|ketanserin|mesh-list
65548231|NCT04849013|Mescaline|mescaline|mesh-list
65548232|NCT04849013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65548233|NCT04849013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65548234|NCT04849013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65548235|NCT04849013|Serotonin Agents|serotonin agents|mesh-ancestor
65548236|NCT04849013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65548237|NCT04849013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548238|NCT04849013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548239|NCT04849013|Hallucinogens|hallucinogens|mesh-ancestor
65548240|NCT04849013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65548241|NCT04849013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65548242|NCT04827576|Docetaxel|docetaxel|mesh-list
65548243|NCT04827576|Magrolimab|magrolimab|mesh-list
65548244|NCT04827576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548245|NCT04827576|Tubulin Modulators|tubulin modulators|mesh-ancestor
65548246|NCT04827576|Antimitotic Agents|antimitotic agents|mesh-ancestor
65548247|NCT04827576|Mitosis Modulators|mitosis modulators|mesh-ancestor
65548248|NCT04827576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548249|NCT04827576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65548250|NCT04808245|Atezolizumab|atezolizumab|mesh-list
65548251|NCT04808245|Imiquimod|imiquimod|mesh-list
65548252|NCT04808245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548253|NCT04808245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65548254|NCT04808245|Immunologic Factors|immunologic factors|mesh-ancestor
65548255|NCT04808245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548256|NCT04808245|Interferon Inducers|interferon inducers|mesh-ancestor
65548257|NCT04790513|Evolocumab|evolocumab|mesh-list
65548258|NCT04790513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65548259|NCT04790513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65548260|NCT04790513|Antimetabolites|antimetabolites|mesh-ancestor
65548261|NCT04790513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548262|NCT04790513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65548263|NCT04777071|Edetic Acid|edetic acid|mesh-list
65548264|NCT04777071|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65548265|NCT04777071|Chelating Agents|chelating agents|mesh-ancestor
65548266|NCT04777071|Sequestering Agents|sequestering agents|mesh-ancestor
65548267|NCT04777071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548268|NCT04777071|Anticoagulants|anticoagulants|mesh-ancestor
65548269|NCT04777071|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65548270|NCT04777071|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65548271|NCT04759833|Prucalopride|prucalopride|mesh-list
65548272|NCT04759833|Laxatives|laxatives|mesh-ancestor
65548273|NCT04759833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65548274|NCT04759833|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65548275|NCT04759833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65548276|NCT04759833|Serotonin Agents|serotonin agents|mesh-ancestor
65548277|NCT04759833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65548278|NCT04759833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548279|NCT04759833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548280|NCT04747847|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65548281|NCT04747847|Atorvastatin|atorvastatin|mesh-list
65548282|NCT04747847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65548283|NCT04747847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65548284|NCT04747847|Antimetabolites|antimetabolites|mesh-ancestor
65548285|NCT04747847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548286|NCT04747847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65548287|NCT04747847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65548288|NCT04747847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548289|NCT04747847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65548290|NCT04662086|Camostat|camostat|mesh-list
65548291|NCT04662086|Protease Inhibitors|protease inhibitors|mesh-ancestor
65548292|NCT04662086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548293|NCT04662086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548294|NCT04662086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65548295|NCT04662086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65548296|NCT04646837|Paclitaxel|paclitaxel|mesh-list
65548297|NCT04646837|Carboplatin|carboplatin|mesh-list
65548298|NCT04646837|Durvalumab|durvalumab|mesh-list
65548299|NCT04646837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65548300|NCT04646837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548301|NCT04646837|Tubulin Modulators|tubulin modulators|mesh-ancestor
65548302|NCT04646837|Antimitotic Agents|antimitotic agents|mesh-ancestor
65548303|NCT04646837|Mitosis Modulators|mitosis modulators|mesh-ancestor
65548304|NCT04646837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548305|NCT04646837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65548306|NCT04640636|Midazolam|midazolam|mesh-list
65548307|NCT04640636|Ketamine|ketamine|mesh-list
65548308|NCT04640636|Analgesics|analgesics|mesh-ancestor
65548309|NCT04640636|Sensory System Agents|sensory system agents|mesh-ancestor
65548310|NCT04640636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65548311|NCT04640636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548312|NCT04640636|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65548313|NCT04640636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65548314|NCT04640636|Anesthetics, General|anesthetics, general|mesh-ancestor
65548315|NCT04640636|Anesthetics|anesthetics|mesh-ancestor
65548316|NCT04640636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65548317|NCT04640636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65548318|NCT04640636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65548319|NCT04640636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65548320|NCT04640636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548321|NCT04640636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65548322|NCT04640636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65548323|NCT04640636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65548324|NCT04640636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65548325|NCT04640636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65548326|NCT04640636|GABA Modulators|gaba modulators|mesh-ancestor
65548327|NCT04640636|GABA Agents|gaba agents|mesh-ancestor
65548328|NCT04600167|Isoniazid|isoniazid|mesh-list
65548329|NCT04600167|Rifapentine|rifapentine|mesh-list
65548330|NCT04600167|Antitubercular Agents|antitubercular agents|mesh-ancestor
65548331|NCT04600167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65548332|NCT04600167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65548333|NCT04600167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65548334|NCT04600167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65548335|NCT04600167|Antimetabolites|antimetabolites|mesh-ancestor
65548336|NCT04600167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548337|NCT04600167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65548338|NCT04600167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65548339|NCT04600167|Leprostatic Agents|leprostatic agents|mesh-ancestor
65548340|NCT04593927|Siponimod|siponimod|mesh-list
65548341|NCT04593927|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65548342|NCT04593927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548343|NCT04593927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65548344|NCT04593927|Immunologic Factors|immunologic factors|mesh-ancestor
65548345|NCT04593927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548346|NCT04560725|Choline|choline|mesh-list
65548347|NCT04560725|Lipotropic Agents|lipotropic agents|mesh-ancestor
65548348|NCT04560725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65548349|NCT04560725|Antimetabolites|antimetabolites|mesh-ancestor
65548350|NCT04560725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548351|NCT04560725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65548352|NCT04560725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65548353|NCT04560725|Nootropic Agents|nootropic agents|mesh-ancestor
65548354|NCT04539366|Cyclophosphamide|cyclophosphamide|mesh-list
65548355|NCT04539366|Fludarabine|fludarabine|mesh-list
65548356|NCT04539366|Fludarabine phosphate|fludarabine phosphate|mesh-list
65548357|NCT04539366|Immunologic Factors|immunologic factors|mesh-ancestor
65548358|NCT04539366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548359|NCT04539366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65548360|NCT04539366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65548361|NCT04539366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65548362|NCT04539366|Alkylating Agents|alkylating agents|mesh-ancestor
65548363|NCT04539366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548364|NCT04539366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548365|NCT04539366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65548366|NCT04539366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65548367|NCT04539366|Antimetabolites|antimetabolites|mesh-ancestor
65548368|NCT04522284|Capecitabine|capecitabine|mesh-list
65548369|NCT04522284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65548370|NCT04522284|Antimetabolites|antimetabolites|mesh-ancestor
65548371|NCT04522284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548372|NCT04522284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548373|NCT04492891|Cyclosporine|cyclosporine|mesh-list
65548374|NCT04492891|Cyclosporins|cyclosporins|mesh-list
65548375|NCT04492891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548376|NCT04492891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548377|NCT04492891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65548378|NCT04492891|Immunologic Factors|immunologic factors|mesh-ancestor
65548379|NCT04492891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548380|NCT04492891|Antifungal Agents|antifungal agents|mesh-ancestor
65548381|NCT04492891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65548382|NCT04492891|Dermatologic Agents|dermatologic agents|mesh-ancestor
65548383|NCT04492891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65548384|NCT04492891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65548385|NCT04489888|Paclitaxel|paclitaxel|mesh-list
65548386|NCT04489888|Carboplatin|carboplatin|mesh-list
65548387|NCT04489888|Pembrolizumab|pembrolizumab|mesh-list
65548388|NCT04489888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65548389|NCT04489888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548390|NCT04489888|Tubulin Modulators|tubulin modulators|mesh-ancestor
65548391|NCT04489888|Antimitotic Agents|antimitotic agents|mesh-ancestor
65548392|NCT04489888|Mitosis Modulators|mitosis modulators|mesh-ancestor
65548393|NCT04489888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548394|NCT04489888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65548395|NCT04443309|Lenvatinib|lenvatinib|mesh-list
65548396|NCT04443309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548397|NCT04443309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65548398|NCT04443309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548399|NCT04443309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548400|NCT04435834|Propofol|propofol|mesh-list
65548401|NCT04435834|Sevoflurane|sevoflurane|mesh-list
65548402|NCT04435834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65548403|NCT04435834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65548404|NCT04435834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548405|NCT04435834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65548406|NCT04435834|Anesthetics, General|anesthetics, general|mesh-ancestor
65548407|NCT04435834|Anesthetics|anesthetics|mesh-ancestor
65548408|NCT04435834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65548409|NCT04435834|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65548410|NCT04431258|Folfirinox|folfirinox|mesh-list
65548411|NCT04431258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548412|NCT04401800|Lenvatinib|lenvatinib|mesh-list
65548413|NCT04401800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548414|NCT04401800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65548415|NCT04401800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548416|NCT04401800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548417|NCT04400110|Amoxicillin|amoxicillin|mesh-list
65548418|NCT04400110|Clavulanic Acids|clavulanic acids|mesh-list
65548419|NCT04400110|Clavulanic Acid|clavulanic acid|mesh-list
65548420|NCT04400110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65548421|NCT04400110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65548422|NCT04400110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548423|NCT04400110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548424|NCT04400110|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65548425|NCT04387227|Carboplatin|carboplatin|mesh-list
65548426|NCT04387227|Pembrolizumab|pembrolizumab|mesh-list
65548427|NCT04387227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548428|NCT04387227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65548429|NCT04368078|Lenvatinib|lenvatinib|mesh-list
65548430|NCT04368078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548431|NCT04368078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65548432|NCT04368078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548433|NCT04368078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548434|NCT04350463|Nivolumab|nivolumab|mesh-list
65548435|NCT04350463|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
65548436|NCT04350463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65548437|NCT04350463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548438|NCT04350463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65277562|NCT02646540|Metolazone|metolazone|mesh-list
65548439|NCT04350463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548440|NCT04350463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548441|NCT04347616|Aldesleukin|aldesleukin|mesh-list
65548442|NCT04347616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548443|NCT04347616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65548444|NCT04347616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65548445|NCT04347616|Antiviral Agents|antiviral agents|mesh-ancestor
65548446|NCT04347616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65548447|NCT04338763|Gemcitabine|gemcitabine|mesh-list
65548448|NCT04338763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65548449|NCT04338763|Antimetabolites|antimetabolites|mesh-ancestor
65548450|NCT04338763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548451|NCT04338763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548452|NCT04338763|Antiviral Agents|antiviral agents|mesh-ancestor
65548453|NCT04338763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65548454|NCT04338763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548455|NCT04338763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65548456|NCT04338763|Immunologic Factors|immunologic factors|mesh-ancestor
65548457|NCT04338763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548458|NCT04329728|Dexamethasone|dexamethasone|mesh-list
65548459|NCT04329728|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65548460|NCT04329728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65548461|NCT04329728|Antiemetics|antiemetics|mesh-ancestor
65548462|NCT04329728|Autonomic Agents|autonomic agents|mesh-ancestor
65548463|NCT04329728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65548464|NCT04329728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548465|NCT04329728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65548466|NCT04329728|Glucocorticoids|glucocorticoids|mesh-ancestor
65548467|NCT04329728|Hormones|hormones|mesh-ancestor
65548468|NCT04329728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65548469|NCT04329728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65548470|NCT04329728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548471|NCT04317105|Nivolumab|nivolumab|mesh-list
65548472|NCT04317105|Ipilimumab|ipilimumab|mesh-list
65548473|NCT04317105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65548474|NCT04317105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548475|NCT04317105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65548476|NCT04317105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548477|NCT04313634|Dasatinib|dasatinib|mesh-list
65548478|NCT04313634|Quercetin|quercetin|mesh-list
65548479|NCT04313634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548480|NCT04313634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65548481|NCT04313634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548482|NCT04313634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548483|NCT04313634|Antioxidants|antioxidants|mesh-ancestor
65548484|NCT04313634|Protective Agents|protective agents|mesh-ancestor
65548485|NCT04313634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548486|NCT04278781|Ivosidenib|ivosidenib|mesh-list
65548487|NCT04278781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548488|NCT04278781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548489|NCT04278781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548490|NCT04265950|Vaccines|vaccines|mesh-list
65548491|NCT04265950|Immunologic Factors|immunologic factors|mesh-ancestor
65548492|NCT04265950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548493|NCT04249778|Dapagliflozin|dapagliflozin|mesh-list
65548494|NCT04249778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65548495|NCT04249778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346112|NCT02543710|Taxane|taxane|mesh-list
65548496|NCT04249778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65548497|NCT04249778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548498|NCT04247815|Methotrexate|methotrexate|mesh-list
65548499|NCT04247815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65548500|NCT04247815|Abortifacient Agents|abortifacient agents|mesh-ancestor
65548501|NCT04247815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65548502|NCT04247815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548503|NCT04247815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65548504|NCT04247815|Antimetabolites|antimetabolites|mesh-ancestor
65548505|NCT04247815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548506|NCT04247815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548507|NCT04247815|Dermatologic Agents|dermatologic agents|mesh-ancestor
65548508|NCT04247815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548509|NCT04247815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65548510|NCT04247815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65548511|NCT04247815|Immunologic Factors|immunologic factors|mesh-ancestor
65548512|NCT04247815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65548513|NCT04247815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65548514|NCT04227522|Rucaparib|rucaparib|mesh-list
65548515|NCT04227522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65548516|NCT04227522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548517|NCT04227522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548518|NCT04227522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548519|NCT04216953|Atezolizumab|atezolizumab|mesh-list
65548520|NCT04216953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548521|NCT04211168|Lenvatinib|lenvatinib|mesh-list
65548522|NCT04211168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548523|NCT04211168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65548524|NCT04211168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548525|NCT04211168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548526|NCT04196257|Paclitaxel|paclitaxel|mesh-list
65548527|NCT04196257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65548528|NCT04196257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548529|NCT04196257|Tubulin Modulators|tubulin modulators|mesh-ancestor
65548530|NCT04196257|Antimitotic Agents|antimitotic agents|mesh-ancestor
65548531|NCT04196257|Mitosis Modulators|mitosis modulators|mesh-ancestor
65548532|NCT04196257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548533|NCT04193553|Lenvatinib|lenvatinib|mesh-list
65548534|NCT04193553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548535|NCT04193553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65548536|NCT04193553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548537|NCT04193553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548538|NCT04188548|Trastuzumab|trastuzumab|mesh-list
65548539|NCT04188548|Pertuzumab|pertuzumab|mesh-list
65548540|NCT04188548|Everolimus|everolimus|mesh-list
65548541|NCT04188548|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65548542|NCT04188548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65548543|NCT04188548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548544|NCT04188548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65548545|NCT04188548|Immunologic Factors|immunologic factors|mesh-ancestor
65548546|NCT04188548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548547|NCT04188548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65548548|NCT04188548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548549|NCT04188548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548550|NCT04188548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65548551|NCT04188548|Hormone Antagonists|hormone antagonists|mesh-ancestor
65548552|NCT04188548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65548553|NCT04183101|Enalapril|enalapril|mesh-list
65548554|NCT04183101|Enalaprilat|enalaprilat|mesh-list
65548555|NCT04183101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65548556|NCT04183101|Protease Inhibitors|protease inhibitors|mesh-ancestor
65548557|NCT04183101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548558|NCT04183101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548559|NCT04183101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65548560|NCT04165772|Capecitabine|capecitabine|mesh-list
65548561|NCT04165772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65548562|NCT04165772|Antimetabolites|antimetabolites|mesh-ancestor
65548563|NCT04165772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548564|NCT04165772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548565|NCT04155632|Acetylcysteine|acetylcysteine|mesh-list
65548566|NCT04155632|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65548567|NCT04155632|Antiviral Agents|antiviral agents|mesh-ancestor
65548568|NCT04155632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65346145|NCT00612352|Ethanol|ethanol|mesh-list
65548569|NCT04155632|Expectorants|expectorants|mesh-ancestor
65548570|NCT04155632|Respiratory System Agents|respiratory system agents|mesh-ancestor
65548571|NCT04155632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65548572|NCT04155632|Antioxidants|antioxidants|mesh-ancestor
65548573|NCT04155632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548574|NCT04155632|Protective Agents|protective agents|mesh-ancestor
65548575|NCT04155632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548576|NCT04155632|Antidotes|antidotes|mesh-ancestor
65548577|NCT04088630|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65548578|NCT04088630|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65548579|NCT04088630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548580|NCT04088630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65548581|NCT04088630|Immunologic Factors|immunologic factors|mesh-ancestor
65548582|NCT04088630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548583|NCT04075136|Triamcinolone|triamcinolone|mesh-list
65548584|NCT04075136|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65548585|NCT04075136|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65548586|NCT04075136|Ranibizumab|ranibizumab|mesh-list
65548587|NCT04075136|Verteporfin|verteporfin|mesh-list
65548588|NCT04075136|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65548589|NCT04075136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65548590|NCT04075136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65548591|NCT04075136|Growth Substances|growth substances|mesh-ancestor
65548592|NCT04075136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548593|NCT04075136|Growth Inhibitors|growth inhibitors|mesh-ancestor
65548594|NCT04075136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548595|NCT04075136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65548596|NCT04075136|Glucocorticoids|glucocorticoids|mesh-ancestor
65548597|NCT04075136|Hormones|hormones|mesh-ancestor
65548598|NCT04075136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65548599|NCT04075136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65548600|NCT04075136|Immunologic Factors|immunologic factors|mesh-ancestor
65548601|NCT04075136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548602|NCT04075136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548603|NCT04075136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65548604|NCT04075136|Dermatologic Agents|dermatologic agents|mesh-ancestor
65548605|NCT04073134|Evolocumab|evolocumab|mesh-list
65548606|NCT04073134|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65548607|NCT04073134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65548608|NCT04073134|Antimetabolites|antimetabolites|mesh-ancestor
65548609|NCT04073134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548610|NCT04073134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65548611|NCT04044690|Immunoglobulins|immunoglobulins|mesh-list
65548612|NCT04044690|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65548613|NCT04044690|Antibodies|antibodies|mesh-list
65548614|NCT04044690|Immunoglobulin G|immunoglobulin g|mesh-list
65548615|NCT04044690|Immunologic Factors|immunologic factors|mesh-ancestor
65548616|NCT04044690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548617|NCT04037254|Niraparib|niraparib|mesh-list
65548618|NCT04037254|Hormones|hormones|mesh-list
65548619|NCT04037254|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65548620|NCT04037254|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65548621|NCT04037254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65548622|NCT04037254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548623|NCT04037254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65548624|NCT04037254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548625|NCT04037254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548626|NCT04037254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548627|NCT04034485|Evolocumab|evolocumab|mesh-list
65548628|NCT04034485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65548629|NCT04034485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65548630|NCT04034485|Antimetabolites|antimetabolites|mesh-ancestor
65548631|NCT04034485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548632|NCT04034485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65548633|NCT04019327|Temozolomide|temozolomide|mesh-list
65548634|NCT04019327|Talazoparib|talazoparib|mesh-list
65548635|NCT04019327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65548636|NCT04019327|Alkylating Agents|alkylating agents|mesh-ancestor
65548637|NCT04019327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548638|NCT04019327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548639|NCT04019327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65548640|NCT04019327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548641|NCT04010071|Axitinib|axitinib|mesh-list
65346222|NCT02542852|Protease Inhibitors|protease inhibitors|mesh-ancestor
65548642|NCT04010071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548643|NCT04010071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65548644|NCT04010071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548645|NCT04010071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548646|NCT03989414|Dexamethasone|dexamethasone|mesh-list
65548647|NCT03989414|Bortezomib|bortezomib|mesh-list
65548648|NCT03989414|Daratumumab|daratumumab|mesh-list
65548649|NCT03989414|Elotuzumab|elotuzumab|mesh-list
65548650|NCT03989414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65548651|NCT03989414|Antiemetics|antiemetics|mesh-ancestor
65548652|NCT03989414|Autonomic Agents|autonomic agents|mesh-ancestor
65548653|NCT03989414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65548654|NCT03989414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548655|NCT03989414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65548656|NCT03989414|Glucocorticoids|glucocorticoids|mesh-ancestor
65548657|NCT03989414|Hormones|hormones|mesh-ancestor
65548658|NCT03989414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65548659|NCT03989414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65548660|NCT03989414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548661|NCT03988920|Sevelamer|sevelamer|mesh-list
65548662|NCT03988920|Chelating Agents|chelating agents|mesh-ancestor
65548663|NCT03988920|Sequestering Agents|sequestering agents|mesh-ancestor
65548664|NCT03988920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548665|NCT03986034|Venetoclax|venetoclax|mesh-list
65548666|NCT03986034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548667|NCT03925402|Ertapenem|ertapenem|mesh-list
65548668|NCT03925402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65548669|NCT03925402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65548670|NCT03875079|Pembrolizumab|pembrolizumab|mesh-list
65548671|NCT03875079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65548672|NCT03875079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548673|NCT03866252|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
65548674|NCT03866252|Hallucinogens|hallucinogens|mesh-ancestor
65548675|NCT03866252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548676|NCT03866252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65548677|NCT03866252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65548678|NCT03866252|Serotonin Agents|serotonin agents|mesh-ancestor
65548679|NCT03866252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65548680|NCT03866252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548681|NCT03866252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65548682|NCT03769298|Tacrolimus|tacrolimus|mesh-list
65548683|NCT03769298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65548684|NCT03769298|Immunologic Factors|immunologic factors|mesh-ancestor
65548685|NCT03769298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548686|NCT03769298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65548687|NCT03769298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548688|NCT03769298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548689|NCT03729869|Progesterone|progesterone|mesh-list
65548690|NCT03729869|Progestins|progestins|mesh-ancestor
65548691|NCT03729869|Hormones|hormones|mesh-ancestor
65548692|NCT03729869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65548693|NCT03729869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548694|NCT03711604|Tenalisib|tenalisib|mesh-list
65548695|NCT03711604|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
65548696|NCT03711604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548697|NCT03711604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548698|NCT03688451|Rituximab|rituximab|mesh-list
65548699|NCT03688451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65548700|NCT03688451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548701|NCT03688451|Immunologic Factors|immunologic factors|mesh-ancestor
65548702|NCT03688451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548703|NCT03688451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65548704|NCT03626064|Nicotine|nicotine|mesh-list
65548705|NCT03626064|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65548706|NCT03626064|Autonomic Agents|autonomic agents|mesh-ancestor
65548707|NCT03626064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65548708|NCT03626064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548709|NCT03626064|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65548710|NCT03626064|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65548711|NCT03626064|Cholinergic Agents|cholinergic agents|mesh-ancestor
65548712|NCT03626064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65548713|NCT03626064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548714|NCT03613532|Fludarabine|fludarabine|mesh-list
65548715|NCT03613532|Azacitidine|azacitidine|mesh-list
65346296|NCT05093322|Gemcitabine|gemcitabine|mesh-list
65548716|NCT03613532|Busulfan|busulfan|mesh-list
65548717|NCT03613532|Decitabine|decitabine|mesh-list
65548718|NCT03613532|Venetoclax|venetoclax|mesh-list
65548719|NCT03613532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548720|NCT03613532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65548721|NCT03613532|Antimetabolites|antimetabolites|mesh-ancestor
65548722|NCT03613532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548723|NCT03613532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65548724|NCT03613532|Immunologic Factors|immunologic factors|mesh-ancestor
65548725|NCT03613532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548726|NCT03613532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548727|NCT03613532|Alkylating Agents|alkylating agents|mesh-ancestor
65548728|NCT03613532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65548729|NCT03613532|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65548730|NCT03593018|Gemcitabine|gemcitabine|mesh-list
65548731|NCT03593018|Azacitidine|azacitidine|mesh-list
65548732|NCT03593018|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65548733|NCT03593018|Romidepsin|romidepsin|mesh-list
65548734|NCT03593018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65548735|NCT03593018|Antimetabolites|antimetabolites|mesh-ancestor
65548736|NCT03593018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548737|NCT03593018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548738|NCT03593018|Antiviral Agents|antiviral agents|mesh-ancestor
65548739|NCT03593018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65548740|NCT03593018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548741|NCT03593018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65548742|NCT03593018|Immunologic Factors|immunologic factors|mesh-ancestor
65548743|NCT03593018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548744|NCT03593018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65548745|NCT03593018|Alkylating Agents|alkylating agents|mesh-ancestor
65548746|NCT03593018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65548747|NCT03570099|Naloxone|naloxone|mesh-list
65548748|NCT03570099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65548749|NCT03570099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548750|NCT03570099|Sensory System Agents|sensory system agents|mesh-ancestor
65548751|NCT03570099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65548752|NCT03550391|Memantine|memantine|mesh-list
65548753|NCT03550391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65548754|NCT03550391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65548755|NCT03550391|Dopamine Agents|dopamine agents|mesh-ancestor
65548756|NCT03550391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65548757|NCT03550391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548758|NCT03550391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548759|NCT03550391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65548760|NCT03550391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65548761|NCT03529396|Chloroquine|chloroquine|mesh-list
65548762|NCT03529396|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65548763|NCT03529396|Primaquine|primaquine|mesh-list
65548764|NCT03529396|Amebicides|amebicides|mesh-ancestor
65548765|NCT03529396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65548766|NCT03529396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65548767|NCT03529396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65548768|NCT03529396|Antimalarials|antimalarials|mesh-ancestor
65548769|NCT03529396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65548770|NCT03529396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65548771|NCT03529396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65548772|NCT03529396|Analgesics|analgesics|mesh-ancestor
65548773|NCT03529396|Sensory System Agents|sensory system agents|mesh-ancestor
65548774|NCT03529396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65548775|NCT03529396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548776|NCT03529396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65548777|NCT03529396|Filaricides|filaricides|mesh-ancestor
65548778|NCT03529396|Antinematodal Agents|antinematodal agents|mesh-ancestor
65548779|NCT03529396|Anthelmintics|anthelmintics|mesh-ancestor
65548780|NCT03515837|Carboplatin|carboplatin|mesh-list
65548781|NCT03515837|Pembrolizumab|pembrolizumab|mesh-list
65548782|NCT03515837|Pemetrexed|pemetrexed|mesh-list
65548783|NCT03515837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65548784|NCT03515837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548785|NCT03515837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65548786|NCT03515837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548787|NCT03515837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548788|NCT03515837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65548789|NCT03515837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65548790|NCT03441113|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
65548791|NCT03441113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65346382|NCT00811083|Succimer|succimer|mesh-list
65548792|NCT03441113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548793|NCT03441113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548794|NCT03436563|Atezolizumab|atezolizumab|mesh-list
65548795|NCT03436563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548796|NCT03426254|Talazoparib|talazoparib|mesh-list
65548797|NCT03426254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65548798|NCT03426254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548799|NCT03426254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548800|NCT03426254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548801|NCT03422536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65548802|NCT03422536|Cetuximab|cetuximab|mesh-list
65548803|NCT03422536|Antibodies|antibodies|mesh-list
65548804|NCT03422536|Immunoglobulins|immunoglobulins|mesh-list
65548805|NCT03422536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65548806|NCT03422536|Immunologic Factors|immunologic factors|mesh-ancestor
65548807|NCT03422536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277924|NCT02653014|Mineralocorticoids|mineralocorticoids|mesh-list
65548808|NCT03422536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548809|NCT03411031|Thalidomide|thalidomide|mesh-list
65548810|NCT03411031|Dexamethasone|dexamethasone|mesh-list
65548811|NCT03411031|Lenalidomide|lenalidomide|mesh-list
65548812|NCT03411031|Elotuzumab|elotuzumab|mesh-list
65548813|NCT03411031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65548814|NCT03411031|Antiemetics|antiemetics|mesh-ancestor
65548815|NCT03411031|Autonomic Agents|autonomic agents|mesh-ancestor
65548816|NCT03411031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65548817|NCT03411031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548818|NCT03411031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65548819|NCT03411031|Glucocorticoids|glucocorticoids|mesh-ancestor
65548820|NCT03411031|Hormones|hormones|mesh-ancestor
65548821|NCT03411031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65548822|NCT03411031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65548823|NCT03411031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548824|NCT03411031|Immunologic Factors|immunologic factors|mesh-ancestor
65548825|NCT03411031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65548826|NCT03411031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65548827|NCT03411031|Growth Substances|growth substances|mesh-ancestor
65548828|NCT03411031|Growth Inhibitors|growth inhibitors|mesh-ancestor
65548829|NCT03411031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65548830|NCT03411031|Leprostatic Agents|leprostatic agents|mesh-ancestor
65548831|NCT03411031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65548832|NCT03411031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65548833|NCT03358017|Zoledronic Acid|zoledronic acid|mesh-list
65548834|NCT03358017|Atorvastatin|atorvastatin|mesh-list
65548835|NCT03358017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65548836|NCT03358017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65548837|NCT03358017|Antimetabolites|antimetabolites|mesh-ancestor
65548838|NCT03358017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548839|NCT03358017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65548840|NCT03358017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65548841|NCT03358017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548842|NCT03358017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65548843|NCT03358017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548844|NCT03289351|Tazobactam|tazobactam|mesh-list
65548845|NCT03289351|Piperacillin|piperacillin|mesh-list
65548846|NCT03289351|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65548847|NCT03289351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65548848|NCT03289351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65548849|NCT03289351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65548850|NCT03289351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548851|NCT03289351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548852|NCT03280667|Denosumab|denosumab|mesh-list
65548853|NCT03280667|Pembrolizumab|pembrolizumab|mesh-list
65548854|NCT03280667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65548855|NCT03280667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548856|NCT03280667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65548857|NCT03280667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548858|NCT03272347|Tenofovir|tenofovir|mesh-list
65548859|NCT03272347|Lamivudine|lamivudine|mesh-list
65548860|NCT03272347|Islatravir|islatravir|mesh-list
65548861|NCT03272347|Antiviral Agents|antiviral agents|mesh-ancestor
65548862|NCT03272347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65548863|NCT03272347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65548864|NCT03272347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65548865|NCT03272347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548866|NCT03272347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548867|NCT03272347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65548868|NCT03272347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65548869|NCT03251300|Mirabegron|mirabegron|mesh-list
65548870|NCT03251300|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65548871|NCT03251300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65548872|NCT03251300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65548873|NCT03251300|Adrenergic Agents|adrenergic agents|mesh-ancestor
65548874|NCT03251300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65548875|NCT03251300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548876|NCT03251300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548877|NCT03251300|Urological Agents|urological agents|mesh-ancestor
65548878|NCT03228693|Triamcinolone|triamcinolone|mesh-list
65548879|NCT03228693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65548880|NCT03228693|Glucocorticoids|glucocorticoids|mesh-ancestor
65548881|NCT03228693|Hormones|hormones|mesh-ancestor
65548882|NCT03228693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65548883|NCT03228693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548884|NCT03201458|Atezolizumab|atezolizumab|mesh-list
65548885|NCT03201458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65548886|NCT03201458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548887|NCT03201458|Immunologic Factors|immunologic factors|mesh-ancestor
65548888|NCT03201458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548889|NCT03108690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65548890|NCT03108690|Meropenem|meropenem|mesh-list
65548891|NCT03108690|Tazobactam|tazobactam|mesh-list
65548892|NCT03108690|Piperacillin|piperacillin|mesh-list
65548893|NCT03108690|Ampicillin|ampicillin|mesh-list
65548894|NCT03108690|Cefuroxime|cefuroxime|mesh-list
65548895|NCT03108690|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65548896|NCT03108690|Lactams|lactams|mesh-list
65548897|NCT03108690|beta-Lactams|beta-lactams|mesh-list
65548898|NCT03108690|Penicillin G|penicillin g|mesh-list
65548899|NCT03108690|Dicloxacillin|dicloxacillin|mesh-list
65548900|NCT03108690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65548901|NCT03108690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65548902|NCT03108690|Antitubercular Agents|antitubercular agents|mesh-ancestor
65548903|NCT03108690|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65548904|NCT03108690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548905|NCT03108690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548906|NCT03103152|Aspirin|aspirin|mesh-list
65548907|NCT03103152|Vitamin D|vitamin d|mesh-list
65548908|NCT03103152|Ergocalciferols|ergocalciferols|mesh-list
65548909|NCT03103152|Cholecalciferol|cholecalciferol|mesh-list
65548910|NCT03103152|Vitamins|vitamins|mesh-list
65548911|NCT03103152|Micronutrients|micronutrients|mesh-ancestor
65548912|NCT03103152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548913|NCT03103152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65548914|NCT03103152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65548915|NCT03103152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65548916|NCT03103152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65548917|NCT03103152|Analgesics|analgesics|mesh-ancestor
65548918|NCT03103152|Sensory System Agents|sensory system agents|mesh-ancestor
65548919|NCT03103152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65548920|NCT03103152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65548921|NCT03103152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65548922|NCT03103152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65548923|NCT03103152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65548924|NCT03103152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548925|NCT03103152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65548926|NCT03103152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65548927|NCT03103152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548928|NCT03103152|Antipyretics|antipyretics|mesh-ancestor
65548929|NCT02988297|RNS60|rns60|mesh-list
65548930|NCT02988297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65548931|NCT02988297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65548932|NCT02988297|Analgesics|analgesics|mesh-ancestor
65548933|NCT02988297|Sensory System Agents|sensory system agents|mesh-ancestor
65548934|NCT02988297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65548935|NCT02988297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548936|NCT02988297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65548937|NCT02988297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65548938|NCT02988297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65548939|NCT02937285|Interferons|interferons|mesh-list
65548940|NCT02937285|Interferon-beta|interferon-beta|mesh-list
65548941|NCT02937285|Interferon beta-1a|interferon beta-1a|mesh-list
65346519|NCT00422227|Antimalarials|antimalarials|mesh-ancestor
65548942|NCT02937285|Mitoxantrone|mitoxantrone|mesh-list
65548943|NCT02937285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548944|NCT02937285|Antiviral Agents|antiviral agents|mesh-ancestor
65548945|NCT02937285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65548946|NCT02937285|Analgesics|analgesics|mesh-ancestor
65548947|NCT02937285|Sensory System Agents|sensory system agents|mesh-ancestor
65548948|NCT02937285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65548949|NCT02937285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548950|NCT02937285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65548951|NCT02937285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65548952|NCT02937285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548953|NCT02937285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548954|NCT02937285|Immunologic Factors|immunologic factors|mesh-ancestor
65548955|NCT02937285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65548956|NCT02878785|Decitabine|decitabine|mesh-list
65548957|NCT02878785|Talazoparib|talazoparib|mesh-list
65548958|NCT02878785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65548959|NCT02878785|Antimetabolites|antimetabolites|mesh-ancestor
65548960|NCT02878785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548961|NCT02878785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548962|NCT02878785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548963|NCT02878785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65548964|NCT02861573|Dexamethasone|dexamethasone|mesh-list
65548965|NCT02861573|Prednisone|prednisone|mesh-list
65548966|NCT02861573|Carboplatin|carboplatin|mesh-list
65548967|NCT02861573|Docetaxel|docetaxel|mesh-list
65548968|NCT02861573|Pembrolizumab|pembrolizumab|mesh-list
65548969|NCT02861573|Etoposide|etoposide|mesh-list
65548970|NCT02861573|Lenvatinib|lenvatinib|mesh-list
65548971|NCT02861573|Olaparib|olaparib|mesh-list
65548972|NCT02861573|Abiraterone Acetate|abiraterone acetate|mesh-list
65548973|NCT02861573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65548974|NCT02861573|Antiemetics|antiemetics|mesh-ancestor
65548975|NCT02861573|Autonomic Agents|autonomic agents|mesh-ancestor
65548976|NCT02861573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65548977|NCT02861573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65548978|NCT02861573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65548979|NCT02861573|Glucocorticoids|glucocorticoids|mesh-ancestor
65548980|NCT02861573|Hormones|hormones|mesh-ancestor
65548981|NCT02861573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65548982|NCT02861573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65548983|NCT02861573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548984|NCT02861573|Tubulin Modulators|tubulin modulators|mesh-ancestor
65548985|NCT02861573|Antimitotic Agents|antimitotic agents|mesh-ancestor
65548986|NCT02861573|Mitosis Modulators|mitosis modulators|mesh-ancestor
65548987|NCT02861573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65548988|NCT02861573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65548989|NCT02861573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65548990|NCT02861573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65548991|NCT02861573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65548992|NCT02861573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65548993|NCT02861573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65548994|NCT02861573|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65548995|NCT02861573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65548996|NCT02861573|Hormone Antagonists|hormone antagonists|mesh-ancestor
65548997|NCT02861573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65548998|NCT02825576|Glycopyrrolate|glycopyrrolate|mesh-list
65548999|NCT02825576|Neostigmine|neostigmine|mesh-list
65549000|NCT02825576|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65549001|NCT02825576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549002|NCT02825576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549003|NCT02825576|Cholinergic Agents|cholinergic agents|mesh-ancestor
65549004|NCT02825576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65549005|NCT02825576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549006|NCT02825576|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65549007|NCT02825576|Autonomic Agents|autonomic agents|mesh-ancestor
65549008|NCT02825576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549009|NCT02825576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65549010|NCT02825576|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65549011|NCT02825576|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65549012|NCT02719613|Dexamethasone|dexamethasone|mesh-list
65549013|NCT02719613|Dexamethasone acetate|dexamethasone acetate|mesh-list
65549014|NCT02719613|Nivolumab|nivolumab|mesh-list
65549015|NCT02719613|Lenalidomide|lenalidomide|mesh-list
65549016|NCT02719613|Bortezomib|bortezomib|mesh-list
65549017|NCT02719613|Pomalidomide|pomalidomide|mesh-list
65549018|NCT02719613|Elotuzumab|elotuzumab|mesh-list
65549019|NCT02719613|BB 1101|bb 1101|mesh-list
65549020|NCT02719613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65549021|NCT02719613|Antiemetics|antiemetics|mesh-ancestor
65549022|NCT02719613|Autonomic Agents|autonomic agents|mesh-ancestor
65549023|NCT02719613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549024|NCT02719613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549025|NCT02719613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65549026|NCT02719613|Glucocorticoids|glucocorticoids|mesh-ancestor
65549027|NCT02719613|Hormones|hormones|mesh-ancestor
65549028|NCT02719613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65549029|NCT02719613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65549030|NCT02719613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549031|NCT02719613|Protease Inhibitors|protease inhibitors|mesh-ancestor
65549032|NCT02719613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549033|NCT02719613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549034|NCT02719613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65549035|NCT02719613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65549036|NCT02719613|Immunologic Factors|immunologic factors|mesh-ancestor
65549037|NCT02719613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65549038|NCT02719613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65549039|NCT02719613|Growth Substances|growth substances|mesh-ancestor
65549040|NCT02719613|Growth Inhibitors|growth inhibitors|mesh-ancestor
65549041|NCT02660645|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65549042|NCT02660645|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65549043|NCT02660645|Dermatologic Agents|dermatologic agents|mesh-ancestor
65549044|NCT02659930|Doxorubicin|doxorubicin|mesh-list
65549045|NCT02659930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65549046|NCT02659930|Pomalidomide|pomalidomide|mesh-list
65549047|NCT02659930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65549048|NCT02659930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549049|NCT02659930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65549050|NCT02659930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65549051|NCT02659930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549052|NCT02659930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549053|NCT02659930|Immunologic Factors|immunologic factors|mesh-ancestor
65549054|NCT02659930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549055|NCT02659930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65549056|NCT02659930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65549057|NCT02659930|Growth Substances|growth substances|mesh-ancestor
65549058|NCT02659930|Growth Inhibitors|growth inhibitors|mesh-ancestor
65549059|NCT02603887|Pembrolizumab|pembrolizumab|mesh-list
65549060|NCT02603887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65549061|NCT02603887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549062|NCT02475681|Obinutuzumab|obinutuzumab|mesh-list
65549063|NCT02475681|Acalabrutinib|acalabrutinib|mesh-list
65549064|NCT02475681|Chlorambucil|chlorambucil|mesh-list
65549065|NCT02475681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65549066|NCT02475681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549067|NCT02475681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65549068|NCT02475681|Alkylating Agents|alkylating agents|mesh-ancestor
65549069|NCT02475681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549070|NCT02315196|Paclitaxel|paclitaxel|mesh-list
65549071|NCT02315196|Carboplatin|carboplatin|mesh-list
65549072|NCT02315196|Doxorubicin|doxorubicin|mesh-list
65549073|NCT02315196|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65549074|NCT02315196|Epirubicin|epirubicin|mesh-list
65549075|NCT02315196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65549076|NCT02315196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549077|NCT02315196|Tubulin Modulators|tubulin modulators|mesh-ancestor
65549078|NCT02315196|Antimitotic Agents|antimitotic agents|mesh-ancestor
65549079|NCT02315196|Mitosis Modulators|mitosis modulators|mesh-ancestor
65549080|NCT02315196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549081|NCT02315196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65549082|NCT02315196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65549083|NCT02315196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65549084|NCT02315196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549085|NCT02273375|Durvalumab|durvalumab|mesh-list
65549086|NCT02273375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65549087|NCT02273375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549088|NCT02207712|Ranibizumab|ranibizumab|mesh-list
65549089|NCT02207712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65549090|NCT02207712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65549091|NCT02207712|Growth Substances|growth substances|mesh-ancestor
65549092|NCT02207712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549093|NCT02207712|Growth Inhibitors|growth inhibitors|mesh-ancestor
65549094|NCT02207712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549095|NCT02179853|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65549096|NCT02179853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65346675|NCT01041235|Docetaxel|docetaxel|mesh-list
65549097|NCT02133573|Progesterone|progesterone|mesh-list
65549098|NCT02133573|Progestins|progestins|mesh-ancestor
65549099|NCT02133573|Hormones|hormones|mesh-ancestor
65549100|NCT02133573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65549101|NCT02133573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549102|NCT01917877|Dexamethasone|dexamethasone|mesh-list
65549103|NCT01917877|Bevacizumab|bevacizumab|mesh-list
65549104|NCT01917877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65549105|NCT01917877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549106|NCT01917877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65549107|NCT01917877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65549108|NCT01917877|Growth Substances|growth substances|mesh-ancestor
65549109|NCT01917877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278229|NCT02642874|Methocarbamol|methocarbamol|mesh-list
65549110|NCT01917877|Growth Inhibitors|growth inhibitors|mesh-ancestor
65549111|NCT01917877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65549112|NCT01917877|Antiemetics|antiemetics|mesh-ancestor
65549113|NCT01917877|Autonomic Agents|autonomic agents|mesh-ancestor
65549114|NCT01917877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549115|NCT01917877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65549116|NCT01917877|Glucocorticoids|glucocorticoids|mesh-ancestor
65549117|NCT01917877|Hormones|hormones|mesh-ancestor
65549118|NCT01917877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65549119|NCT01917877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65549120|NCT01698840|Vitamin D|vitamin d|mesh-list
65549121|NCT01698840|Vitamins|vitamins|mesh-ancestor
65549122|NCT01698840|Micronutrients|micronutrients|mesh-ancestor
65549123|NCT01698840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549124|NCT01698840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65549125|NCT01570296|Gefitinib|gefitinib|mesh-list
65549126|NCT01570296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549127|NCT01570296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65549128|NCT01570296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549129|NCT01570296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549130|NCT01199575|Rituximab|rituximab|mesh-list
65549131|NCT01199575|Lenalidomide|lenalidomide|mesh-list
65549132|NCT01199575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65549133|NCT01199575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549134|NCT01199575|Immunologic Factors|immunologic factors|mesh-ancestor
65549135|NCT01199575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549136|NCT01199575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65549137|NCT01199575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65549138|NCT01199575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65549139|NCT01199575|Growth Substances|growth substances|mesh-ancestor
65549140|NCT01199575|Growth Inhibitors|growth inhibitors|mesh-ancestor
65549141|NCT01087619|Parathyroid Hormone|parathyroid hormone|mesh-list
65549142|NCT01087619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65549143|NCT01087619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549144|NCT00496873|Cyclophosphamide|cyclophosphamide|mesh-list
65549145|NCT00496873|Rituximab|rituximab|mesh-list
65549146|NCT00496873|Pentostatin|pentostatin|mesh-list
65549147|NCT00496873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65549148|NCT00496873|Immunologic Factors|immunologic factors|mesh-ancestor
65549149|NCT00496873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549150|NCT00496873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65549151|NCT00496873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65549152|NCT00496873|Alkylating Agents|alkylating agents|mesh-ancestor
65549153|NCT00496873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549154|NCT00496873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549155|NCT00496873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65549156|NCT00496873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65549157|NCT00496873|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65549158|NCT00496873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549159|NCT00492778|Cisplatin|cisplatin|mesh-list
65549160|NCT00492778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549161|NCT03931369|Tolvaptan|tolvaptan|mesh-list
65549162|NCT03931369|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65549163|NCT03931369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549164|NCT03931369|Natriuretic Agents|natriuretic agents|mesh-ancestor
65549165|NCT03931369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549166|NCT00359216|Mometasone Furoate|mometasone furoate|mesh-list
65549167|NCT00359216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65549168|NCT00359216|Dermatologic Agents|dermatologic agents|mesh-ancestor
65549169|NCT00359216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65346772|NCT00886678|Pemetrexed|pemetrexed|mesh-list
65549170|NCT01239550|Insulin Detemir|insulin detemir|mesh-list
65549171|NCT01239550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65549172|NCT01239550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549173|NCT03721328|Vancomycin|vancomycin|mesh-list
65549174|NCT03721328|Tobramycin|tobramycin|mesh-list
65549175|NCT03721328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65549176|NCT03721328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65549177|NCT01220791|Progesterone|progesterone|mesh-list
65549178|NCT01220791|Progestins|progestins|mesh-ancestor
65549179|NCT01220791|Hormones|hormones|mesh-ancestor
65549180|NCT01220791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65549181|NCT01220791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549182|NCT01353482|Pemetrexed|pemetrexed|mesh-list
65549183|NCT01353482|Vorinostat|vorinostat|mesh-list
65549184|NCT01353482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549185|NCT01353482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549186|NCT01353482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549187|NCT01353482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65549188|NCT01353482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65549189|NCT01353482|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65549190|NCT04028986|Ulipristal acetate|ulipristal acetate|mesh-list
65549191|NCT04028986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65549192|NCT04028986|Contraceptive Agents|contraceptive agents|mesh-ancestor
65549193|NCT04028986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65549194|NCT04028986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549195|NCT04028986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65549196|NCT02291380|Botulinum Toxins|botulinum toxins|mesh-list
65549197|NCT02291380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65549198|NCT02291380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65549199|NCT02291380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65549200|NCT02291380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65549201|NCT02291380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549202|NCT02291380|Cholinergic Agents|cholinergic agents|mesh-ancestor
65549203|NCT02291380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65549204|NCT02291380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549205|NCT02291380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65549206|NCT02291380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549207|NCT01353716|Dolutegravir|dolutegravir|mesh-list
65549208|NCT01353716|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65549209|NCT01353716|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65549210|NCT01353716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549211|NCT01353716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549212|NCT01353716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65549213|NCT01353716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65549214|NCT01353716|Antiviral Agents|antiviral agents|mesh-ancestor
65549215|NCT01353716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65549216|NCT04481672|Magnesium Sulfate|magnesium sulfate|mesh-list
65549217|NCT04481672|Analgesics|analgesics|mesh-ancestor
65549218|NCT04481672|Sensory System Agents|sensory system agents|mesh-ancestor
65549219|NCT04481672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549220|NCT04481672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549221|NCT04481672|Anesthetics|anesthetics|mesh-ancestor
65549222|NCT04481672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65549223|NCT04481672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65549224|NCT04481672|Anticonvulsants|anticonvulsants|mesh-ancestor
65549225|NCT04481672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65549226|NCT04481672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65549227|NCT04481672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549228|NCT04481672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65549229|NCT04481672|Tocolytic Agents|tocolytic agents|mesh-ancestor
65549230|NCT04481672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65549231|NCT01224067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65549232|NCT01224067|Antidepressive Agents|antidepressive agents|mesh-ancestor
65549233|NCT01224067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65549234|NCT01224067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65549235|NCT01224067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65549236|NCT01224067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65549237|NCT01224067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549238|NCT04465942|Paclitaxel|paclitaxel|mesh-list
65549239|NCT04465942|Pembrolizumab|pembrolizumab|mesh-list
65549240|NCT04465942|Nivolumab|nivolumab|mesh-list
65549241|NCT04465942|Pemetrexed|pemetrexed|mesh-list
65549242|NCT04465942|Atezolizumab|atezolizumab|mesh-list
65549243|NCT04465942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65549244|NCT04465942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549245|NCT04465942|Tubulin Modulators|tubulin modulators|mesh-ancestor
65549246|NCT04465942|Antimitotic Agents|antimitotic agents|mesh-ancestor
65549247|NCT04465942|Mitosis Modulators|mitosis modulators|mesh-ancestor
65549248|NCT04465942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549249|NCT04465942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65549250|NCT04465942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65549251|NCT04465942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549252|NCT04465942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65549253|NCT04465942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65549255|NCT01126645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549256|NCT01126645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65549257|NCT01126645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549258|NCT01126645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549259|NCT01343186|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65549260|NCT01343186|Interferon-alpha|interferon-alpha|mesh-list
65549261|NCT01343186|Antiviral Agents|antiviral agents|mesh-ancestor
65549262|NCT01343186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65549263|NCT01343186|Immunologic Factors|immunologic factors|mesh-ancestor
65549264|NCT01343186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549265|NCT01329289|Dexamethasone|dexamethasone|mesh-list
65549266|NCT01329289|Dexamethasone acetate|dexamethasone acetate|mesh-list
65549267|NCT01329289|Bortezomib|bortezomib|mesh-list
65549268|NCT01329289|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65549269|NCT01329289|Pasireotide|pasireotide|mesh-list
65549270|NCT01329289|BB 1101|bb 1101|mesh-list
65549271|NCT01329289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65549272|NCT01329289|Antiemetics|antiemetics|mesh-ancestor
65549273|NCT01329289|Autonomic Agents|autonomic agents|mesh-ancestor
65549274|NCT01329289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549275|NCT01329289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549276|NCT01329289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65549277|NCT01329289|Glucocorticoids|glucocorticoids|mesh-ancestor
65549278|NCT01329289|Hormones|hormones|mesh-ancestor
65549279|NCT01329289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65549280|NCT01329289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65549281|NCT01329289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549282|NCT01329289|Protease Inhibitors|protease inhibitors|mesh-ancestor
65549283|NCT01329289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549284|NCT01329289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549285|NCT02291536|Dronabinol|dronabinol|mesh-list
65549286|NCT02291536|Cannabidiol|cannabidiol|mesh-list
65549287|NCT02291536|Anticonvulsants|anticonvulsants|mesh-ancestor
65549288|NCT02291536|Hallucinogens|hallucinogens|mesh-ancestor
65549289|NCT02291536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549290|NCT02291536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65549291|NCT02291536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65549292|NCT02291536|Analgesics|analgesics|mesh-ancestor
65549293|NCT02291536|Sensory System Agents|sensory system agents|mesh-ancestor
65549294|NCT02291536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549295|NCT02291536|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65549296|NCT02291536|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65549297|NCT02291536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65549298|NCT02291536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549299|NCT02291536|Hormones|hormones|mesh-ancestor
65549300|NCT02291536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65549301|NCT01317992|Ibudilast|ibudilast|mesh-list
65549302|NCT01317992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65549303|NCT01317992|Autonomic Agents|autonomic agents|mesh-ancestor
65549304|NCT01317992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549305|NCT01317992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549306|NCT01317992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65549307|NCT01317992|Respiratory System Agents|respiratory system agents|mesh-ancestor
65549308|NCT01317992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65549309|NCT01317992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549310|NCT01317992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549311|NCT01317992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65549312|NCT01317992|Vasodilator Agents|vasodilator agents|mesh-ancestor
65549313|NCT03635788|Rilpivirine|rilpivirine|mesh-list
65549314|NCT03635788|Cabotegravir|cabotegravir|mesh-list
65549315|NCT03635788|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65549316|NCT03635788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65549317|NCT03635788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549318|NCT03635788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549319|NCT03635788|Antiviral Agents|antiviral agents|mesh-ancestor
65346895|NCT02541526|Histamine Agents|histamine agents|mesh-ancestor
65549320|NCT03635788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65549321|NCT03635788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65549322|NCT03635788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65549323|NCT03635788|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65549324|NCT03635788|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65549325|NCT01348412|Oxaliplatin|oxaliplatin|mesh-list
65549326|NCT01348412|Raltitrexed|raltitrexed|mesh-list
65549327|NCT01348412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549328|NCT01348412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65549329|NCT01348412|Antimetabolites|antimetabolites|mesh-ancestor
65549330|NCT01348412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549331|NCT01348412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65278450|NCT04239755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65549332|NCT01348412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549333|NCT01353794|Sorafenib|sorafenib|mesh-list
65549334|NCT01353794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549335|NCT01353794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65549336|NCT01353794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549337|NCT01353794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549338|NCT01224301|Vaccines|vaccines|mesh-list
65549339|NCT01224301|Immunologic Factors|immunologic factors|mesh-ancestor
65549340|NCT01224301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549341|NCT01221025|Parecoxib|parecoxib|mesh-list
65549342|NCT01221025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65549343|NCT01221025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65549344|NCT01221025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549345|NCT01221025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549346|NCT01221025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65549347|NCT01221025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65549348|NCT01221025|Analgesics|analgesics|mesh-ancestor
65549349|NCT01221025|Sensory System Agents|sensory system agents|mesh-ancestor
65549350|NCT01221025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549351|NCT01221025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549352|NCT01221025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65549353|NCT01221025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65549354|NCT03523390|Avelumab|avelumab|mesh-list
65549355|NCT03523390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65549356|NCT03523390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549357|NCT01221103|Dexamethasone|dexamethasone|mesh-list
65549358|NCT01221103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65549359|NCT01221103|Ofatumumab|ofatumumab|mesh-list
65549360|NCT01221103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65549361|NCT01221103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65549362|NCT01221103|Antiemetics|antiemetics|mesh-ancestor
65549363|NCT01221103|Autonomic Agents|autonomic agents|mesh-ancestor
65549364|NCT01221103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549365|NCT01221103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549366|NCT01221103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65549367|NCT01221103|Glucocorticoids|glucocorticoids|mesh-ancestor
65549368|NCT01221103|Hormones|hormones|mesh-ancestor
65549369|NCT01221103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65549370|NCT01221103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65549371|NCT01221103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549372|NCT01221103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65549373|NCT01221103|Alkylating Agents|alkylating agents|mesh-ancestor
65549374|NCT01221103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549375|NCT01221103|Immunologic Factors|immunologic factors|mesh-ancestor
65549376|NCT03706898|Sofosbuvir|sofosbuvir|mesh-list
65549377|NCT03706898|Dolutegravir|dolutegravir|mesh-list
65549378|NCT03706898|Elsulfavirine|elsulfavirine|mesh-list
65549379|NCT03706898|Antiviral Agents|antiviral agents|mesh-ancestor
65549380|NCT03706898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65549381|NCT03706898|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65549382|NCT03706898|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65549383|NCT03706898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549384|NCT03706898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549385|NCT03706898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65549386|NCT03706898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65549387|NCT03927313|Aspirin|aspirin|mesh-list
65549388|NCT03927313|Rifampin|rifampin|mesh-list
65549389|NCT03927313|Linezolid|linezolid|mesh-list
65549390|NCT03927313|Dexamethasone|dexamethasone|mesh-list
65549391|NCT03927313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65549392|NCT03927313|Antiemetics|antiemetics|mesh-ancestor
65549393|NCT03927313|Autonomic Agents|autonomic agents|mesh-ancestor
65549394|NCT03927313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549395|NCT03927313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549396|NCT03927313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65549397|NCT03927313|Glucocorticoids|glucocorticoids|mesh-ancestor
65549399|NCT03927313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65549400|NCT03927313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65549401|NCT03927313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549402|NCT03927313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65549403|NCT03927313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65549404|NCT03927313|Analgesics|analgesics|mesh-ancestor
65549405|NCT03927313|Sensory System Agents|sensory system agents|mesh-ancestor
65549406|NCT03927313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65278524|NCT00680511|Sympathomimetics|sympathomimetics|mesh-ancestor
65549407|NCT03927313|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65549408|NCT03927313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65549409|NCT03927313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549410|NCT03927313|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65549411|NCT03927313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65549412|NCT03927313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549413|NCT03927313|Antipyretics|antipyretics|mesh-ancestor
65549414|NCT03927313|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65549415|NCT03927313|Antitubercular Agents|antitubercular agents|mesh-ancestor
65549416|NCT03927313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65549417|NCT03927313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65549418|NCT03927313|Leprostatic Agents|leprostatic agents|mesh-ancestor
65549419|NCT03927313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65549420|NCT03927313|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65549421|NCT03927313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65549422|NCT03927313|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65549423|NCT03927313|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65549424|NCT03927313|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65549425|NCT03927313|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65549426|NCT03927313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65549427|NCT01224457|Phenobarbital|phenobarbital|mesh-list
65549428|NCT01224457|Anticonvulsants|anticonvulsants|mesh-ancestor
65549429|NCT01224457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65549430|NCT01224457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65549431|NCT01224457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549432|NCT01224457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65549433|NCT01224457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65549434|NCT01224457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65549435|NCT01224457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549436|NCT01224457|GABA Modulators|gaba modulators|mesh-ancestor
65549437|NCT01224457|GABA Agents|gaba agents|mesh-ancestor
65549438|NCT01224457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65549439|NCT01224457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65549440|NCT01224457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65549441|NCT03133312|Chlorhexidine|chlorhexidine|mesh-list
65549442|NCT03133312|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65549443|NCT03133312|Povidone-Iodine|povidone-iodine|mesh-list
65549444|NCT03133312|Povidone|povidone|mesh-list
65549445|NCT03133312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65549446|NCT03133312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65549447|NCT03133312|Disinfectants|disinfectants|mesh-ancestor
65549448|NCT03133312|Dermatologic Agents|dermatologic agents|mesh-ancestor
65549449|NCT03133312|Plasma Substitutes|plasma substitutes|mesh-ancestor
65549450|NCT03133312|Blood Substitutes|blood substitutes|mesh-ancestor
65549451|NCT01318148|Caspofungin|caspofungin|mesh-list
65549452|NCT01318148|Antifungal Agents|antifungal agents|mesh-ancestor
65549453|NCT01318148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65549454|NCT01318148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549455|NCT01318148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549456|NCT01354262|Vitamin D|vitamin d|mesh-list
65549457|NCT01354262|Ergocalciferols|ergocalciferols|mesh-list
65549458|NCT01354262|Cholecalciferol|cholecalciferol|mesh-list
65549459|NCT01354262|Vitamins|vitamins|mesh-list
65549460|NCT01354262|Micronutrients|micronutrients|mesh-ancestor
65549461|NCT01354262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549462|NCT01354262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65549463|NCT01354262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65549464|NCT01343498|Dactolisib|dactolisib|mesh-list
65549465|NCT01343498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549466|NCT01221337|Heparin|heparin|mesh-list
65549467|NCT01221337|Anticoagulants|anticoagulants|mesh-ancestor
65549468|NCT01221337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65549469|NCT01221337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65549470|NCT01221337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549471|NCT01354418|Phenylephrine|phenylephrine|mesh-list
65549472|NCT01354418|Oxymetazoline|oxymetazoline|mesh-list
65549473|NCT01354418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65549474|NCT01354418|Mydriatics|mydriatics|mesh-ancestor
65549475|NCT01354418|Autonomic Agents|autonomic agents|mesh-ancestor
65549476|NCT01354418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549477|NCT01354418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549478|NCT01354418|Sympathomimetics|sympathomimetics|mesh-ancestor
65549479|NCT01354418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65549480|NCT01354418|Nasal Decongestants|nasal decongestants|mesh-ancestor
65549481|NCT01354418|Respiratory System Agents|respiratory system agents|mesh-ancestor
65549482|NCT01354418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65549483|NCT01354418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65549484|NCT01354418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65549485|NCT01354418|Adrenergic Agents|adrenergic agents|mesh-ancestor
65549486|NCT01354418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65549487|NCT01354418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549488|NCT01354418|Protective Agents|protective agents|mesh-ancestor
65549489|NCT02818868|Apixaban|apixaban|mesh-list
65549490|NCT02818868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65549491|NCT02818868|Antithrombins|antithrombins|mesh-ancestor
65549492|NCT02818868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65549493|NCT02818868|Protease Inhibitors|protease inhibitors|mesh-ancestor
65549494|NCT02818868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549495|NCT02818868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549496|NCT02818868|Anticoagulants|anticoagulants|mesh-ancestor
65549497|NCT01224535|Micronutrients|micronutrients|mesh-list
65549498|NCT01224535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549499|NCT02289274|Aceclofenac|aceclofenac|mesh-list
65549500|NCT02289274|Eperisone|eperisone|mesh-list
65549501|NCT02289274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65549502|NCT02289274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65549503|NCT02289274|Analgesics|analgesics|mesh-ancestor
65549504|NCT02289274|Sensory System Agents|sensory system agents|mesh-ancestor
65549505|NCT02289274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549506|NCT02289274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549507|NCT02289274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65549508|NCT02289274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65549509|NCT02289274|Anticonvulsants|anticonvulsants|mesh-ancestor
65549510|NCT02289274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65549511|NCT02289274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65549512|NCT02289274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549513|NCT02289274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65549514|NCT02289274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65549515|NCT02289274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65549516|NCT02289274|Parasympatholytics|parasympatholytics|mesh-ancestor
65549517|NCT02289274|Autonomic Agents|autonomic agents|mesh-ancestor
65549518|NCT02289274|Vasodilator Agents|vasodilator agents|mesh-ancestor
65549519|NCT01224613|Vaccines|vaccines|mesh-list
65549520|NCT01224613|Immunologic Factors|immunologic factors|mesh-ancestor
65549521|NCT01224613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549522|NCT03930433|Nebivolol|nebivolol|mesh-list
65549523|NCT03930433|Diltiazem|diltiazem|mesh-list
65549524|NCT03930433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65549525|NCT03930433|Vasodilator Agents|vasodilator agents|mesh-ancestor
65549526|NCT03930433|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65549527|NCT03930433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65549528|NCT03930433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65549529|NCT03930433|Adrenergic Agents|adrenergic agents|mesh-ancestor
65549530|NCT03930433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65549531|NCT03930433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549532|NCT03930433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549533|NCT03930433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65549534|NCT03930433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65549535|NCT03930433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65549536|NCT01224769|Rituximab|rituximab|mesh-list
65549537|NCT01224769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65549538|NCT01224769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65549539|NCT01224769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549540|NCT01224769|Immunologic Factors|immunologic factors|mesh-ancestor
65549541|NCT01224769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549542|NCT01224769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65549543|NCT01224769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65549544|NCT01224769|Alkylating Agents|alkylating agents|mesh-ancestor
65347110|NCT00815373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65549545|NCT01224769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549546|NCT02289430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65549547|NCT02289430|Ezetimibe|ezetimibe|mesh-list
65549548|NCT02289430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65549549|NCT02289430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65549550|NCT02289430|Antimetabolites|antimetabolites|mesh-ancestor
65549551|NCT02289430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549552|NCT02289430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65549553|NCT02289430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65278669|NCT00681213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549554|NCT02289430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549555|NCT01224847|Lidocaine|lidocaine|mesh-list
65549556|NCT01224847|Cocaine|cocaine|mesh-list
65549557|NCT01224847|Tetracaine|tetracaine|mesh-list
65549558|NCT01224847|Anesthetics, Local|anesthetics, local|mesh-ancestor
65549559|NCT01224847|Anesthetics|anesthetics|mesh-ancestor
65549560|NCT01224847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65549561|NCT01224847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549562|NCT01224847|Sensory System Agents|sensory system agents|mesh-ancestor
65549563|NCT01224847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549564|NCT01224847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65549565|NCT01224847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65549566|NCT01224847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65549567|NCT01224847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65549568|NCT01224847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549569|NCT01224847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65549570|NCT01224847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65549571|NCT01224847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65549572|NCT01224847|Dopamine Agents|dopamine agents|mesh-ancestor
65549573|NCT01224847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65549574|NCT02289586|Fentanyl|fentanyl|mesh-list
65549575|NCT02289586|Midazolam|midazolam|mesh-list
65549576|NCT02289586|Remifentanil|remifentanil|mesh-list
65549577|NCT02289586|Dezocine|dezocine|mesh-list
65549578|NCT02289586|Propofol|propofol|mesh-list
65549579|NCT02289586|Rocuronium|rocuronium|mesh-list
65549580|NCT02289586|Anesthetics|anesthetics|mesh-ancestor
65549581|NCT02289586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65549582|NCT02289586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549583|NCT02289586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65549584|NCT02289586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65549585|NCT02289586|Anesthetics, General|anesthetics, general|mesh-ancestor
65549586|NCT02289586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65549587|NCT02289586|Narcotics|narcotics|mesh-ancestor
65549588|NCT02289586|Analgesics|analgesics|mesh-ancestor
65549589|NCT02289586|Sensory System Agents|sensory system agents|mesh-ancestor
65549590|NCT02289586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549591|NCT02289586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65549592|NCT02289586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65549593|NCT02289586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65549594|NCT02289586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65549595|NCT02289586|GABA Modulators|gaba modulators|mesh-ancestor
65549596|NCT02289586|GABA Agents|gaba agents|mesh-ancestor
65549597|NCT02289586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65549598|NCT02289586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549599|NCT02289586|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65549600|NCT02289586|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65549601|NCT02289586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65549602|NCT03740581|Insulin|insulin|mesh-list
65549603|NCT03740581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65549604|NCT03740581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549605|NCT03874897|Antibodies|antibodies|mesh-list
65549606|NCT03874897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65549607|NCT03874897|Immunologic Factors|immunologic factors|mesh-ancestor
65549608|NCT03874897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549609|NCT02294266|Ethanol|ethanol|mesh-list
65549610|NCT02294266|Methamphetamine|methamphetamine|mesh-list
65549611|NCT02294266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65549612|NCT02294266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65549613|NCT02294266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65549614|NCT02294266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549615|NCT02294266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65549616|NCT02294266|Sympathomimetics|sympathomimetics|mesh-ancestor
65549617|NCT02294266|Autonomic Agents|autonomic agents|mesh-ancestor
65549618|NCT02294266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549619|NCT02294266|Dopamine Agents|dopamine agents|mesh-ancestor
65549620|NCT02294266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65549621|NCT02294266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549622|NCT02294266|Adrenergic Agents|adrenergic agents|mesh-ancestor
65549623|NCT02294266|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65549624|NCT02294266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65549625|NCT02294266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65549626|NCT02294266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65549628|NCT02294344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65549629|NCT02294344|Immunologic Factors|immunologic factors|mesh-ancestor
65549630|NCT02294344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549631|NCT02294344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65549632|NCT02294344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65549633|NCT02294344|Alkylating Agents|alkylating agents|mesh-ancestor
65549634|NCT02294344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549635|NCT02294344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549636|NCT02294344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65549637|NCT01130311|Vitamin D|vitamin d|mesh-list
65549638|NCT01130311|Cholecalciferol|cholecalciferol|mesh-list
65549639|NCT01130311|Vitamins|vitamins|mesh-ancestor
65549640|NCT01130311|Micronutrients|micronutrients|mesh-ancestor
65549641|NCT01130311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549642|NCT01130311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65549643|NCT01130311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65549644|NCT03926377|Clobetasol|clobetasol|mesh-list
65549645|NCT03926377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65549646|NCT03926377|Glucocorticoids|glucocorticoids|mesh-ancestor
65549647|NCT03926377|Hormones|hormones|mesh-ancestor
65549648|NCT03926377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65549649|NCT03926377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549650|NCT03132688|Propofol|propofol|mesh-list
65549651|NCT03132688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65549652|NCT03132688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65549653|NCT03132688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549654|NCT03132688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65549655|NCT03132688|Anesthetics, General|anesthetics, general|mesh-ancestor
65549656|NCT03132688|Anesthetics|anesthetics|mesh-ancestor
65549657|NCT01227811|Darifenacin|darifenacin|mesh-list
65549658|NCT01227811|Muscarinic Antagonists|muscarinic antagonists|mesh-list
65549659|NCT01227811|Cholinergic Agents|cholinergic agents|mesh-list
65549660|NCT01227811|Cholinergic Antagonists|cholinergic antagonists|mesh-list
65549661|NCT01227811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65549662|NCT01227811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549663|NCT01227811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549664|NCT01227811|Urological Agents|urological agents|mesh-ancestor
65549665|NCT01225081|Pioglitazone|pioglitazone|mesh-list
65549666|NCT01225081|Ipragliflozin|ipragliflozin|mesh-list
65549667|NCT01225081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65549668|NCT01225081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549669|NCT01225081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65549670|NCT01225081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549671|NCT02298166|Cytarabine|cytarabine|mesh-list
65549672|NCT02298166|Mitoxantrone|mitoxantrone|mesh-list
65549673|NCT02298166|Crenolanib|crenolanib|mesh-list
65549674|NCT02298166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65549675|NCT02298166|Antimetabolites|antimetabolites|mesh-ancestor
65549676|NCT02298166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549677|NCT02298166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549678|NCT02298166|Antiviral Agents|antiviral agents|mesh-ancestor
65549679|NCT02298166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65549680|NCT02298166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65549681|NCT02298166|Immunologic Factors|immunologic factors|mesh-ancestor
65549682|NCT02298166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549683|NCT02298166|Analgesics|analgesics|mesh-ancestor
65549684|NCT02298166|Sensory System Agents|sensory system agents|mesh-ancestor
65549685|NCT02298166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549686|NCT02298166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65549687|NCT02298166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65549688|NCT02298166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549689|NCT01127269|Insulin Glargine|insulin glargine|mesh-list
65549690|NCT01127269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65549691|NCT01127269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549692|NCT01221883|Diazepam|diazepam|mesh-list
65549693|NCT01221883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65549694|NCT01221883|Anticonvulsants|anticonvulsants|mesh-ancestor
65549695|NCT01221883|Antiemetics|antiemetics|mesh-ancestor
65549696|NCT01221883|Autonomic Agents|autonomic agents|mesh-ancestor
65549697|NCT01221883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549698|NCT01221883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549699|NCT01221883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65549700|NCT01221883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65549701|NCT01221883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65549702|NCT01221883|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65549703|NCT01221883|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65549704|NCT01221883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65549705|NCT01221883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65549706|NCT01221883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65549707|NCT01221883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65549708|NCT01221883|Anesthetics, General|anesthetics, general|mesh-ancestor
65549709|NCT01221883|Anesthetics|anesthetics|mesh-ancestor
65549710|NCT01221883|GABA Modulators|gaba modulators|mesh-ancestor
65549711|NCT01221883|GABA Agents|gaba agents|mesh-ancestor
65549712|NCT01221883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65549713|NCT01221883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549714|NCT02294656|Triamcinolone|triamcinolone|mesh-list
65549715|NCT02294656|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65549716|NCT02294656|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65549717|NCT02294656|Ranibizumab|ranibizumab|mesh-list
65549718|NCT02294656|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65549719|NCT02294656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65549720|NCT02294656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65549721|NCT02294656|Growth Substances|growth substances|mesh-ancestor
65549722|NCT02294656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549723|NCT02294656|Growth Inhibitors|growth inhibitors|mesh-ancestor
65549724|NCT02294656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549725|NCT02294656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65549726|NCT02294656|Glucocorticoids|glucocorticoids|mesh-ancestor
65549727|NCT02294656|Hormones|hormones|mesh-ancestor
65549728|NCT02294656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65549729|NCT02294656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65549730|NCT02294656|Immunologic Factors|immunologic factors|mesh-ancestor
65549731|NCT02294656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549732|NCT02294656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549733|NCT01225237|Ramosetron|ramosetron|mesh-list
65549734|NCT01225237|Antiemetics|antiemetics|mesh-ancestor
65549735|NCT01225237|Autonomic Agents|autonomic agents|mesh-ancestor
65549736|NCT01225237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549737|NCT01225237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549738|NCT01225237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65549739|NCT01225237|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65549740|NCT01225237|Serotonin Agents|serotonin agents|mesh-ancestor
65549741|NCT01225237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65549742|NCT01225237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549743|NCT03517930|Loratadine|loratadine|mesh-list
65549744|NCT03517930|Pseudoephedrine|pseudoephedrine|mesh-list
65549745|NCT03517930|Ephedrine|ephedrine|mesh-list
65549746|NCT03517930|Antipruritics|antipruritics|mesh-ancestor
65549747|NCT03517930|Dermatologic Agents|dermatologic agents|mesh-ancestor
65549748|NCT03517930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65549749|NCT03517930|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65549750|NCT03517930|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65549751|NCT03517930|Histamine Antagonists|histamine antagonists|mesh-ancestor
65549752|NCT03517930|Histamine Agents|histamine agents|mesh-ancestor
65549753|NCT03517930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65549754|NCT03517930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549755|NCT03517930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549756|NCT03517930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65549757|NCT03517930|Autonomic Agents|autonomic agents|mesh-ancestor
65549758|NCT03517930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549759|NCT03517930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65549760|NCT03517930|Respiratory System Agents|respiratory system agents|mesh-ancestor
65549761|NCT03517930|Nasal Decongestants|nasal decongestants|mesh-ancestor
65549762|NCT03517930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65549763|NCT03517930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65549764|NCT03517930|Sympathomimetics|sympathomimetics|mesh-ancestor
65549765|NCT03517930|Adrenergic Agents|adrenergic agents|mesh-ancestor
65549766|NCT01130467|Methylphenidate|methylphenidate|mesh-list
65549767|NCT01130467|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65549768|NCT01130467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65549769|NCT01130467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549770|NCT01130467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65549771|NCT01130467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65549772|NCT01130467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65549773|NCT01130467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549774|NCT01130467|Dopamine Agents|dopamine agents|mesh-ancestor
65549775|NCT01130467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65549776|NCT01130467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65549777|NCT01130467|Adrenergic Agents|adrenergic agents|mesh-ancestor
65549778|NCT02295046|Amlodipine|amlodipine|mesh-list
65549779|NCT02295046|Atorvastatin|atorvastatin|mesh-list
65549780|NCT02295046|Calcium|calcium|mesh-list
65278896|NCT00681993|Trastuzumab|trastuzumab|mesh-list
65549781|NCT02295046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65549782|NCT02295046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549783|NCT02295046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65549784|NCT02295046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65549785|NCT02295046|Antimetabolites|antimetabolites|mesh-ancestor
65549786|NCT02295046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549787|NCT02295046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65549788|NCT02295046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65549789|NCT02295046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549790|NCT02295046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65549791|NCT02295046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65549792|NCT02295046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65549793|NCT02295046|Vasodilator Agents|vasodilator agents|mesh-ancestor
65549794|NCT03517618|Leucovorin|leucovorin|mesh-list
65549795|NCT03517618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549796|NCT03517618|Antidotes|antidotes|mesh-ancestor
65549797|NCT03517618|Protective Agents|protective agents|mesh-ancestor
65549798|NCT03517618|Vitamin B Complex|vitamin b complex|mesh-ancestor
65549799|NCT03517618|Vitamins|vitamins|mesh-ancestor
65549800|NCT03517618|Micronutrients|micronutrients|mesh-ancestor
65549801|NCT02295124|Oxycodone|oxycodone|mesh-list
65549802|NCT02295124|Hydromorphone|hydromorphone|mesh-list
65549803|NCT02295124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65549804|NCT02295124|Narcotics|narcotics|mesh-ancestor
65549805|NCT02295124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65549806|NCT02295124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549807|NCT02295124|Analgesics|analgesics|mesh-ancestor
65549808|NCT02295124|Sensory System Agents|sensory system agents|mesh-ancestor
65549809|NCT02295124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549810|NCT03925051|Denosumab|denosumab|mesh-list
65549811|NCT03925051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65549812|NCT03925051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549813|NCT03514576|Pasireotide|pasireotide|mesh-list
65549814|NCT03514576|Hormones|hormones|mesh-ancestor
65549815|NCT03514576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65549816|NCT03514576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549817|NCT02299024|Analgesics, Opioid|analgesics, opioid|mesh-list
65549818|NCT02299024|Narcotics|narcotics|mesh-ancestor
65549819|NCT02299024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65549820|NCT02299024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549821|NCT02299024|Analgesics|analgesics|mesh-ancestor
65549822|NCT02299024|Sensory System Agents|sensory system agents|mesh-ancestor
65549823|NCT02299024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549824|NCT03929419|Insulin|insulin|mesh-list
65549825|NCT03929419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65549826|NCT03929419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549827|NCT01228279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65549828|NCT01228279|Icodextrin|icodextrin|mesh-list
65549829|NCT01228279|Dialysis Solutions|dialysis solutions|mesh-ancestor
65549830|NCT03514342|Ropivacaine|ropivacaine|mesh-list
65549831|NCT03514342|Anesthetics, Local|anesthetics, local|mesh-ancestor
65549832|NCT03514342|Anesthetics|anesthetics|mesh-ancestor
65549833|NCT03514342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65549834|NCT03514342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549835|NCT03514342|Sensory System Agents|sensory system agents|mesh-ancestor
65549836|NCT03514342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549837|NCT01228045|Trastuzumab|trastuzumab|mesh-list
65549838|NCT01228045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549839|NCT01228045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65549840|NCT03514030|Antibodies|antibodies|mesh-list
65549841|NCT03514030|Immunologic Factors|immunologic factors|mesh-ancestor
65549842|NCT03514030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549843|NCT03517462|Ivermectin|ivermectin|mesh-list
65549844|NCT03517462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65549845|NCT03517462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65549846|NCT03929575|Calcium|calcium|mesh-list
65549847|NCT03929575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65549848|NCT03929575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549849|NCT02292472|Botulinum Toxins|botulinum toxins|mesh-list
65549850|NCT02292472|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65549851|NCT02292472|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65549852|NCT02292472|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65549853|NCT02292472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65549854|NCT02292472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549855|NCT02292472|Cholinergic Agents|cholinergic agents|mesh-ancestor
65549856|NCT02292472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65549857|NCT02292472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549858|NCT02292472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65549859|NCT02292472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549860|NCT01131247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65549862|NCT01131247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65549863|NCT01131247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65549864|NCT01131247|Alkylating Agents|alkylating agents|mesh-ancestor
65549865|NCT01131247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549866|NCT01131247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549867|NCT01131247|Immunologic Factors|immunologic factors|mesh-ancestor
65549868|NCT01131247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549869|NCT03513874|Metformin|metformin|mesh-list
65549870|NCT03513874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65549871|NCT03513874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549872|NCT01228357|Milnacipran|milnacipran|mesh-list
65549873|NCT01228357|Mirtazapine|mirtazapine|mesh-list
65549874|NCT01228357|Sertraline|sertraline|mesh-list
65549875|NCT01228357|Fluoxetine|fluoxetine|mesh-list
65549876|NCT01228357|Paroxetine|paroxetine|mesh-list
65549877|NCT01228357|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65549878|NCT01228357|Nortriptyline|nortriptyline|mesh-list
65549879|NCT01228357|Antidepressive Agents|antidepressive agents|mesh-ancestor
65549880|NCT01228357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65549881|NCT01228357|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65549882|NCT01228357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65549883|NCT01228357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65549884|NCT01228357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549885|NCT01228357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65549886|NCT01228357|Serotonin Agents|serotonin agents|mesh-ancestor
65549887|NCT01228357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549888|NCT01228357|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65549889|NCT01228357|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65549890|NCT01228357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65549891|NCT01228357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549892|NCT01228357|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65549893|NCT01228357|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65549894|NCT01228357|Histamine Antagonists|histamine antagonists|mesh-ancestor
65549895|NCT01228357|Histamine Agents|histamine agents|mesh-ancestor
65549896|NCT01228357|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65549897|NCT01228357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65549898|NCT01228357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65549899|NCT01228357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65549900|NCT01228357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65549901|NCT01228357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65549902|NCT01228357|Adrenergic Agents|adrenergic agents|mesh-ancestor
65549903|NCT01228357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65549904|NCT01228357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65549905|NCT01228357|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65549906|NCT01228357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65549907|NCT01228357|Analgesics|analgesics|mesh-ancestor
65549908|NCT01228357|Sensory System Agents|sensory system agents|mesh-ancestor
65549909|NCT01228357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549910|NCT01228357|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65549911|NCT01228357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65549912|NCT01130701|Capecitabine|capecitabine|mesh-list
65549913|NCT01130701|Panitumumab|panitumumab|mesh-list
65549914|NCT01130701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65549915|NCT01130701|Antimetabolites|antimetabolites|mesh-ancestor
65549916|NCT01130701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549917|NCT01130701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549918|NCT01130701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65549919|NCT02292550|Ceritinib|ceritinib|mesh-list
65549920|NCT02292550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549921|NCT02292550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65549922|NCT02292550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549923|NCT02292550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549925|NCT03925285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65549926|NCT03925285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549927|NCT03925285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65549928|NCT03925285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65549929|NCT03925285|Growth Substances|growth substances|mesh-ancestor
65279042|NCT00639938|Immunoglobulins|immunoglobulins|mesh-list
65549930|NCT03925285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549931|NCT03925285|Growth Inhibitors|growth inhibitors|mesh-ancestor
65549932|NCT04464694|Ranibizumab|ranibizumab|mesh-list
65549933|NCT04464694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65549934|NCT04464694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65549935|NCT04464694|Growth Substances|growth substances|mesh-ancestor
65549936|NCT04464694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549937|NCT04464694|Growth Inhibitors|growth inhibitors|mesh-ancestor
65549938|NCT04464694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549939|NCT01130779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65549940|NCT01130779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549941|NCT01130779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65549942|NCT01130779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549943|NCT01130779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549944|NCT03513484|Azacitidine|azacitidine|mesh-list
65549945|NCT03513484|Nintedanib|nintedanib|mesh-list
65549946|NCT03513484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65549947|NCT03513484|Antimetabolites|antimetabolites|mesh-ancestor
65549948|NCT03513484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549949|NCT03513484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549950|NCT03513484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549951|NCT03513484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65549952|NCT03519724|Neostigmine|neostigmine|mesh-list
65549953|NCT03519724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65549954|NCT03519724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549955|NCT03519724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549956|NCT03519724|Cholinergic Agents|cholinergic agents|mesh-ancestor
65549957|NCT03519724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65549958|NCT03519724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549959|NCT03519724|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65549960|NCT03519724|Autonomic Agents|autonomic agents|mesh-ancestor
65549961|NCT03519724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65549962|NCT03920449|Botulinum Toxins|botulinum toxins|mesh-list
65549963|NCT03920449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65549964|NCT03920449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65549965|NCT03920449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549966|NCT03920449|Cholinergic Agents|cholinergic agents|mesh-ancestor
65549967|NCT03920449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65549968|NCT03920449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549969|NCT03920059|Mycophenolic Acid|mycophenolic acid|mesh-list
65549970|NCT03920059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65549971|NCT03920059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65549972|NCT03920059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65549973|NCT03920059|Antitubercular Agents|antitubercular agents|mesh-ancestor
65549974|NCT03920059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65549975|NCT03920059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65549976|NCT03920059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549977|NCT03920059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549978|NCT01132027|Tacrolimus|tacrolimus|mesh-list
65549979|NCT01132027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65549980|NCT01132027|Immunologic Factors|immunologic factors|mesh-ancestor
65549981|NCT01132027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549982|NCT01132027|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65549983|NCT01132027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549984|NCT01132027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549985|NCT03136484|Canagliflozin|canagliflozin|mesh-list
65549986|NCT03136484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65549987|NCT03136484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549988|NCT03136484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65549989|NCT03136484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549990|NCT01132183|Valproic Acid|valproic acid|mesh-list
65549991|NCT01132183|Anticonvulsants|anticonvulsants|mesh-ancestor
65549992|NCT01132183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65549993|NCT01132183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65549994|NCT01132183|GABA Agents|gaba agents|mesh-ancestor
65549995|NCT01132183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65549996|NCT01132183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65549998|NCT01132183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65549999|NCT01132183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65550000|NCT01132183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65550001|NCT03923881|Cetuximab|cetuximab|mesh-list
65550002|NCT03923881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65550003|NCT03923881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65550004|NCT02295748|Deflazacort|deflazacort|mesh-list
65550005|NCT02295748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65550006|NCT02295748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65550007|NCT02295748|Immunologic Factors|immunologic factors|mesh-ancestor
65550008|NCT02295748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550009|NCT03923803|Calcitonin|calcitonin|mesh-list
65550010|NCT03923803|Salmon calcitonin|salmon calcitonin|mesh-list
65550011|NCT03923803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
65550012|NCT03923803|Katacalcin|katacalcin|mesh-list
65550013|NCT03923803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65550014|NCT03923803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550015|NCT03923803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65550016|NCT03923803|Vasodilator Agents|vasodilator agents|mesh-ancestor
65550017|NCT02295826|Aspirin|aspirin|mesh-list
65550018|NCT02295826|Dabigatran|dabigatran|mesh-list
65550019|NCT02295826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65550020|NCT02295826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65550021|NCT02295826|Analgesics|analgesics|mesh-ancestor
65550022|NCT02295826|Sensory System Agents|sensory system agents|mesh-ancestor
65550023|NCT02295826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550024|NCT02295826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550025|NCT02295826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65550026|NCT02295826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65550027|NCT02295826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65550028|NCT02295826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65550029|NCT02295826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550030|NCT02295826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65550031|NCT02295826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65550032|NCT02295826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550033|NCT02295826|Antipyretics|antipyretics|mesh-ancestor
65550034|NCT02295826|Antithrombins|antithrombins|mesh-ancestor
65550035|NCT02295826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65550036|NCT02295826|Protease Inhibitors|protease inhibitors|mesh-ancestor
65550037|NCT02295826|Anticoagulants|anticoagulants|mesh-ancestor
65550038|NCT01348724|Naloxegol|naloxegol|mesh-list
65550039|NCT01348724|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65550040|NCT01348724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550041|NCT01348724|Sensory System Agents|sensory system agents|mesh-ancestor
65550042|NCT01348724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550043|NCT03519022|Cocaine|cocaine|mesh-list
65550044|NCT03519022|Methylphenidate|methylphenidate|mesh-list
65550045|NCT03519022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65550046|NCT03519022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550047|NCT03519022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65550048|NCT03519022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65550049|NCT03519022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65550050|NCT03519022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550051|NCT03519022|Dopamine Agents|dopamine agents|mesh-ancestor
65550052|NCT03519022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65550053|NCT03519022|Anesthetics, Local|anesthetics, local|mesh-ancestor
65550054|NCT03519022|Anesthetics|anesthetics|mesh-ancestor
65550055|NCT03519022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65550056|NCT03519022|Sensory System Agents|sensory system agents|mesh-ancestor
65550057|NCT03519022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550058|NCT03519022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65550059|NCT03923257|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65550060|NCT03923257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65550061|NCT03923257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550062|NCT03516526|Natalizumab|natalizumab|mesh-list
65550063|NCT03516526|Immunologic Factors|immunologic factors|mesh-ancestor
65550064|NCT03516526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550065|NCT02730416|Paclitaxel|paclitaxel|mesh-list
65550066|NCT02730416|Carboplatin|carboplatin|mesh-list
65550067|NCT02730416|Nintedanib|nintedanib|mesh-list
65550068|NCT02730416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65550069|NCT02730416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65550070|NCT02730416|Tubulin Modulators|tubulin modulators|mesh-ancestor
65550071|NCT02730416|Antimitotic Agents|antimitotic agents|mesh-ancestor
65550072|NCT02730416|Mitosis Modulators|mitosis modulators|mesh-ancestor
65550073|NCT02730416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550074|NCT02730416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65550075|NCT02730416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550077|NCT02293330|Anesthetics, Local|anesthetics, local|mesh-ancestor
65550078|NCT02293330|Anesthetics|anesthetics|mesh-ancestor
65550079|NCT02293330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65550080|NCT02293330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550081|NCT02293330|Sensory System Agents|sensory system agents|mesh-ancestor
65550082|NCT02293330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550083|NCT01348880|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65550084|NCT01348880|Vasodilator Agents|vasodilator agents|mesh-ancestor
65550085|NCT01348880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65550086|NCT01348880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65550087|NCT01348880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550088|NCT01348880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550089|NCT01348880|Urological Agents|urological agents|mesh-ancestor
65550090|NCT03923179|Etoposide|etoposide|mesh-list
65550091|NCT03923179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65550092|NCT03923179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65550093|NCT03923179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65550094|NCT03923179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65550095|NCT03923179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550096|NCT03923179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550097|NCT01318460|Simendan|simendan|mesh-list
65550098|NCT01318460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65550099|NCT01318460|Vasodilator Agents|vasodilator agents|mesh-ancestor
65550100|NCT01318460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65550101|NCT01318460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65550102|NCT01318460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550103|NCT01318460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550104|NCT01318460|Protective Agents|protective agents|mesh-ancestor
65550105|NCT01318460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550106|NCT02299726|Spironolactone|spironolactone|mesh-list
65550107|NCT02299726|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65550108|NCT02299726|Hormone Antagonists|hormone antagonists|mesh-ancestor
65550109|NCT02299726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65550110|NCT02299726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550111|NCT02299726|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65550112|NCT02299726|Diuretics|diuretics|mesh-ancestor
65550113|NCT02299726|Natriuretic Agents|natriuretic agents|mesh-ancestor
65550114|NCT03647852|Methylprednisolone|methylprednisolone|mesh-list
65550115|NCT03647852|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65550116|NCT03647852|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65550117|NCT03647852|Prednisolone|prednisolone|mesh-list
65550118|NCT03647852|Prednisolone acetate|prednisolone acetate|mesh-list
65550119|NCT03647852|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65550120|NCT03647852|Prednisolone phosphate|prednisolone phosphate|mesh-list
65550121|NCT03647852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65550122|NCT03647852|Antiemetics|antiemetics|mesh-ancestor
65550123|NCT03647852|Autonomic Agents|autonomic agents|mesh-ancestor
65550124|NCT03647852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550125|NCT03647852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550126|NCT03647852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65550127|NCT03647852|Glucocorticoids|glucocorticoids|mesh-ancestor
65550128|NCT03647852|Hormones|hormones|mesh-ancestor
65550129|NCT03647852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65550130|NCT03647852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65550131|NCT03647852|Protective Agents|protective agents|mesh-ancestor
65550132|NCT03647852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65550133|NCT03647852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65550134|NCT01354886|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65550135|NCT01354886|Hormones|hormones|mesh-ancestor
65550136|NCT01354886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65550137|NCT01354886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550138|NCT02299882|Vancomycin|vancomycin|mesh-list
65550139|NCT02299882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65550140|NCT02299882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65550141|NCT01355120|Ipilimumab|ipilimumab|mesh-list
65550142|NCT01355120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65550143|NCT01355120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65550144|NCT01355120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65550145|NCT01355120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550146|NCT02300038|Lidocaine|lidocaine|mesh-list
65550147|NCT02300038|Anesthetics, Local|anesthetics, local|mesh-ancestor
65550148|NCT02300038|Anesthetics|anesthetics|mesh-ancestor
65550149|NCT02300038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65550150|NCT02300038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550151|NCT02300038|Sensory System Agents|sensory system agents|mesh-ancestor
65550152|NCT02300038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550153|NCT02300038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65550154|NCT02300038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65550155|NCT02300038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65550156|NCT02300038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65550157|NCT02300038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550158|NCT01355198|Acetylcysteine|acetylcysteine|mesh-list
65550159|NCT01355198|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65550160|NCT01355198|Glycine|glycine|mesh-list
65550161|NCT01355198|Antiviral Agents|antiviral agents|mesh-ancestor
65550162|NCT01355198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65550163|NCT01355198|Expectorants|expectorants|mesh-ancestor
65550164|NCT01355198|Respiratory System Agents|respiratory system agents|mesh-ancestor
65550165|NCT01355198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65550166|NCT01355198|Antioxidants|antioxidants|mesh-ancestor
65550167|NCT01355198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550168|NCT01355198|Protective Agents|protective agents|mesh-ancestor
65550169|NCT01355198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550170|NCT01355198|Antidotes|antidotes|mesh-ancestor
65550171|NCT01355198|Glycine Agents|glycine agents|mesh-ancestor
65550172|NCT01355198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65550173|NCT01355276|Domperidone|domperidone|mesh-list
65550174|NCT01355276|Cinitapride|cinitapride|mesh-list
65550175|NCT01355276|Antiemetics|antiemetics|mesh-ancestor
65550176|NCT01355276|Autonomic Agents|autonomic agents|mesh-ancestor
65550177|NCT01355276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550178|NCT01355276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550179|NCT01355276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65550180|NCT01355276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65550181|NCT01355276|Dopamine Agents|dopamine agents|mesh-ancestor
65550182|NCT01355276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65550183|NCT01355276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550184|NCT01355276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65550185|NCT02589860|Melphalan|melphalan|mesh-list
65550186|NCT02589860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65550187|NCT02589860|Alkylating Agents|alkylating agents|mesh-ancestor
65550188|NCT02589860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550189|NCT02589860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65550190|NCT02589860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65550191|NCT02589860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65550192|NCT02589860|Immunologic Factors|immunologic factors|mesh-ancestor
65550193|NCT02589860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550194|NCT01355354|Digoxin|digoxin|mesh-list
65550195|NCT01355354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65550196|NCT01355354|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65550197|NCT01355354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550198|NCT01355354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550199|NCT01355354|Protective Agents|protective agents|mesh-ancestor
65550200|NCT01355354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550201|NCT03513172|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65550202|NCT03513172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65550203|NCT03513172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65550204|NCT03513172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65550205|NCT03513172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65550206|NCT03513172|Adrenergic Agents|adrenergic agents|mesh-ancestor
65550207|NCT03513172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65550208|NCT03513172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550209|NCT03513172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550210|NCT01349270|Prednisone|prednisone|mesh-list
65550211|NCT01349270|Immunoglobulins|immunoglobulins|mesh-list
65550212|NCT01349270|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65550213|NCT01349270|Antibodies|antibodies|mesh-list
65550214|NCT01349270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65550215|NCT01349270|Glucocorticoids|glucocorticoids|mesh-ancestor
65550216|NCT01349270|Hormones|hormones|mesh-ancestor
65550217|NCT01349270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65550218|NCT01349270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550219|NCT01349270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65550220|NCT01349270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65550221|NCT01349270|Immunologic Factors|immunologic factors|mesh-ancestor
65550222|NCT01132417|Tigecycline|tigecycline|mesh-list
65550223|NCT01132417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65550224|NCT01132417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65550225|NCT01132417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65279350|NCT00683319|Antimetabolites|antimetabolites|mesh-ancestor
65550226|NCT01132417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550227|NCT01132417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550228|NCT02300194|Morphine|morphine|mesh-list
65550229|NCT02300194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65550230|NCT02300194|Narcotics|narcotics|mesh-ancestor
65550231|NCT02300194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65550232|NCT02300194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550233|NCT02300194|Analgesics|analgesics|mesh-ancestor
65550234|NCT02300194|Sensory System Agents|sensory system agents|mesh-ancestor
65550235|NCT02300194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550236|NCT01225705|Ritonavir|ritonavir|mesh-list
65550237|NCT01225705|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65550238|NCT01225705|Raltegravir Potassium|raltegravir potassium|mesh-list
65550239|NCT01225705|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65550240|NCT01225705|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65550241|NCT01225705|Protease Inhibitors|protease inhibitors|mesh-ancestor
65550242|NCT01225705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550243|NCT01225705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550244|NCT01225705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65550245|NCT01225705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65550246|NCT01225705|Antiviral Agents|antiviral agents|mesh-ancestor
65550247|NCT01225705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65550248|NCT01225705|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65550249|NCT01225705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65550250|NCT01225705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65550251|NCT01225705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65550252|NCT01128985|Canagliflozin|canagliflozin|mesh-list
65550253|NCT01128985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65550254|NCT01128985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550255|NCT01128985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65550256|NCT01128985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550257|NCT03512860|Valproic Acid|valproic acid|mesh-list
65550258|NCT03512860|Anticonvulsants|anticonvulsants|mesh-ancestor
65550259|NCT03512860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550260|NCT03512860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550261|NCT03512860|GABA Agents|gaba agents|mesh-ancestor
65550262|NCT03512860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65550263|NCT03512860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550264|NCT03512860|Antimanic Agents|antimanic agents|mesh-ancestor
65550265|NCT03512860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65550266|NCT03512860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65550267|NCT03512860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65550268|NCT01357694|Psychotropic Drugs|psychotropic drugs|mesh-list
65550269|NCT02528695|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65550270|NCT02528695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550271|NCT02296762|Sirolimus|sirolimus|mesh-list
65550272|NCT02296762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65550273|NCT02296762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65550274|NCT02296762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65550275|NCT02296762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65550276|NCT02296762|Antifungal Agents|antifungal agents|mesh-ancestor
65550277|NCT02296762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65550278|NCT02296762|Immunologic Factors|immunologic factors|mesh-ancestor
65550279|NCT02296762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550280|NCT01132573|Clofarabine|clofarabine|mesh-list
65550281|NCT01132573|Entinostat|entinostat|mesh-list
65550282|NCT01132573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65550283|NCT01132573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65550284|NCT01132573|Antimetabolites|antimetabolites|mesh-ancestor
65550285|NCT01132573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550286|NCT01132573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65550287|NCT01132573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550288|NCT01131559|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65550289|NCT01131559|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65550290|NCT01131559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347875|NCT01034917|Etravirine|etravirine|mesh-list
65550291|NCT01131559|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65550292|NCT01131559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65550293|NCT01131559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65550294|NCT01131559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550295|NCT01131559|Dopamine Agents|dopamine agents|mesh-ancestor
65550296|NCT01131559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65550298|NCT03518320|Nivolumab|nivolumab|mesh-list
65550299|NCT03518320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65550300|NCT03518320|Antimetabolites|antimetabolites|mesh-ancestor
65550301|NCT03518320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550302|NCT03518320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65550303|NCT03518320|Antiviral Agents|antiviral agents|mesh-ancestor
65550304|NCT03518320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65550305|NCT03518320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550306|NCT03518320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65550307|NCT03518320|Immunologic Factors|immunologic factors|mesh-ancestor
65550308|NCT03518320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550309|NCT03518320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65550310|NCT03518320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65550311|NCT01134289|Bupivacaine|bupivacaine|mesh-list
65550312|NCT01134289|Levobupivacaine|levobupivacaine|mesh-list
65550313|NCT01134289|Anesthetics, Local|anesthetics, local|mesh-ancestor
65550314|NCT01134289|Anesthetics|anesthetics|mesh-ancestor
65550315|NCT01134289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65550316|NCT01134289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550317|NCT01134289|Sensory System Agents|sensory system agents|mesh-ancestor
65550318|NCT01134289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550319|NCT02300350|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65550320|NCT02300350|Digoxin|digoxin|mesh-list
65550321|NCT02300350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65550322|NCT02300350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65550323|NCT02300350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550324|NCT02300350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550325|NCT02300350|Protective Agents|protective agents|mesh-ancestor
65550326|NCT02300350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550327|NCT02300350|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65550328|NCT02300350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65550329|NCT01349348|Tolvaptan|tolvaptan|mesh-list
65550330|NCT01349348|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65550331|NCT01349348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550332|NCT01349348|Natriuretic Agents|natriuretic agents|mesh-ancestor
65550333|NCT01349348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550334|NCT02300428|Ferrous fumarate|ferrous fumarate|mesh-list
65550335|NCT02300428|Ferrous gluconate|ferrous gluconate|mesh-list
65550336|NCT02300428|Trace Elements|trace elements|mesh-ancestor
65550337|NCT02300428|Micronutrients|micronutrients|mesh-ancestor
65550338|NCT02300428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550339|NCT02300428|Hematinics|hematinics|mesh-ancestor
65550340|NCT02293876|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65550341|NCT02293876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65550342|NCT02296996|Trametinib|trametinib|mesh-list
65550343|NCT02296996|Dabrafenib|dabrafenib|mesh-list
65550344|NCT02296996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65550345|NCT02296996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65550346|NCT02296996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550347|NCT02296996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550348|NCT01132729|Valacyclovir|valacyclovir|mesh-list
65550349|NCT01132729|Antiviral Agents|antiviral agents|mesh-ancestor
65550350|NCT01132729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65550351|NCT02294110|Anesthetics|anesthetics|mesh-list
65550352|NCT02294110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65550353|NCT02294110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550354|NCT03512548|Itraconazole|itraconazole|mesh-list
65550355|NCT03512548|Antifungal Agents|antifungal agents|mesh-ancestor
65550356|NCT03512548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65550357|NCT03512548|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65550358|NCT03512548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65550359|NCT03512548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550360|NCT03512548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550361|NCT03512548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65550362|NCT03512548|Hormone Antagonists|hormone antagonists|mesh-ancestor
65550363|NCT03512548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65550364|NCT03512548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550365|NCT03512548|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65550366|NCT03515668|Methylphenidate|methylphenidate|mesh-list
65550367|NCT03515668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65550368|NCT03515668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550369|NCT03515668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65550370|NCT03515668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65279494|NCT02809469|Apixaban|apixaban|mesh-list
65550371|NCT03515668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65550372|NCT03515668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550373|NCT03515668|Dopamine Agents|dopamine agents|mesh-ancestor
65550374|NCT03515668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65550375|NCT01356212|Ketorolac|ketorolac|mesh-list
65550376|NCT01356212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65550377|NCT01356212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65550378|NCT01356212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65550379|NCT01356212|Analgesics|analgesics|mesh-ancestor
65550380|NCT01356212|Sensory System Agents|sensory system agents|mesh-ancestor
65550381|NCT01356212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550382|NCT01356212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550383|NCT01356212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65550384|NCT01356212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65550385|NCT01356212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65550386|NCT01356212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550387|NCT01356212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550388|NCT02302378|Bupivacaine|bupivacaine|mesh-list
65550389|NCT02302378|Anesthetics, Local|anesthetics, local|mesh-ancestor
65550390|NCT02302378|Anesthetics|anesthetics|mesh-ancestor
65550391|NCT02302378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65550392|NCT02302378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550393|NCT02302378|Sensory System Agents|sensory system agents|mesh-ancestor
65550394|NCT02302378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550395|NCT01356368|Docetaxel|docetaxel|mesh-list
65550396|NCT01356368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65550397|NCT01356368|Tubulin Modulators|tubulin modulators|mesh-ancestor
65550398|NCT01356368|Antimitotic Agents|antimitotic agents|mesh-ancestor
65550399|NCT01356368|Mitosis Modulators|mitosis modulators|mesh-ancestor
65550400|NCT01356368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550401|NCT02302456|Tranexamic Acid|tranexamic acid|mesh-list
65550402|NCT02302456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65550403|NCT02302456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65550404|NCT02302456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550405|NCT02302456|Hemostatics|hemostatics|mesh-ancestor
65550406|NCT02302456|Coagulants|coagulants|mesh-ancestor
65550407|NCT01356524|Progesterone|progesterone|mesh-list
65550408|NCT01356524|Progestins|progestins|mesh-ancestor
65550409|NCT01356524|Hormones|hormones|mesh-ancestor
65550410|NCT01356524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65550411|NCT01356524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550412|NCT01232023|Indobufen|indobufen|mesh-list
65550413|NCT01232023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65550414|NCT01232023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65550415|NCT01232023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550416|NCT01232023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550417|NCT01232023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65550418|NCT01232023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65550419|NCT01232023|Analgesics|analgesics|mesh-ancestor
65550420|NCT01232023|Sensory System Agents|sensory system agents|mesh-ancestor
65550421|NCT01232023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550422|NCT01232023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550423|NCT01232023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65550424|NCT01232023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65550425|NCT02300740|Niacinamide|niacinamide|mesh-list
65550426|NCT02300740|Niacin|niacin|mesh-list
65550427|NCT02300740|Nicotinic Acids|nicotinic acids|mesh-list
65550428|NCT02300740|Vitamin B Complex|vitamin b complex|mesh-ancestor
65550429|NCT02300740|Vitamins|vitamins|mesh-ancestor
65550430|NCT02300740|Micronutrients|micronutrients|mesh-ancestor
65550431|NCT02300740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550432|NCT02300740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65550433|NCT02300740|Antimetabolites|antimetabolites|mesh-ancestor
65550434|NCT02300740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550435|NCT02300740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65550436|NCT02300740|Vasodilator Agents|vasodilator agents|mesh-ancestor
65550437|NCT02300818|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65550438|NCT02300818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65550439|NCT02297386|Testosterone|testosterone|mesh-list
65550440|NCT02297386|Dihydrotestosterone|dihydrotestosterone|mesh-list
65550441|NCT02297386|Androgens|androgens|mesh-ancestor
65550442|NCT02297386|Hormones|hormones|mesh-ancestor
65550443|NCT02297386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65550444|NCT02297386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550445|NCT04464616|Anesthetics|anesthetics|mesh-list
65550446|NCT04464616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65550447|NCT04464616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550448|NCT01356680|Prednisone|prednisone|mesh-list
65550449|NCT01356680|Cyclophosphamide|cyclophosphamide|mesh-list
65550450|NCT01356680|Dacarbazine|dacarbazine|mesh-list
65550451|NCT01356680|Etoposide|etoposide|mesh-list
65550452|NCT01356680|Vincristine|vincristine|mesh-list
65550453|NCT01356680|Doxorubicin|doxorubicin|mesh-list
65550454|NCT01356680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65550455|NCT01356680|Bleomycin|bleomycin|mesh-list
65550456|NCT01356680|Vinblastine|vinblastine|mesh-list
65550457|NCT01356680|Procarbazine|procarbazine|mesh-list
65550458|NCT01356680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65550459|NCT01356680|Immunologic Factors|immunologic factors|mesh-ancestor
65550460|NCT01356680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550461|NCT01356680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65550462|NCT01356680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65550463|NCT01356680|Alkylating Agents|alkylating agents|mesh-ancestor
65550464|NCT01356680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550465|NCT01356680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65550466|NCT01356680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65550467|NCT01356680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65550468|NCT01356680|Glucocorticoids|glucocorticoids|mesh-ancestor
65550469|NCT01356680|Hormones|hormones|mesh-ancestor
65550470|NCT01356680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65550471|NCT01356680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65550472|NCT01356680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65550473|NCT01356680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65550474|NCT01356680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65550475|NCT01356680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550476|NCT01356680|Tubulin Modulators|tubulin modulators|mesh-ancestor
65550477|NCT01356680|Antimitotic Agents|antimitotic agents|mesh-ancestor
65550478|NCT01356680|Mitosis Modulators|mitosis modulators|mesh-ancestor
65550479|NCT01356680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65550480|NCT04464850|Iron|iron|mesh-list
65550481|NCT04464850|Ferrous fumarate|ferrous fumarate|mesh-list
65550482|NCT04464850|Folic Acid|folic acid|mesh-list
65550483|NCT04464850|Trace Elements|trace elements|mesh-ancestor
65550484|NCT04464850|Micronutrients|micronutrients|mesh-ancestor
65550485|NCT04464850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550486|NCT04464850|Hematinics|hematinics|mesh-ancestor
65550487|NCT04464850|Vitamin B Complex|vitamin b complex|mesh-ancestor
65550488|NCT04464850|Vitamins|vitamins|mesh-ancestor
65550489|NCT01356758|Adalimumab|adalimumab|mesh-list
65550490|NCT01356758|Etanercept|etanercept|mesh-list
65550491|NCT01356758|Infliximab|infliximab|mesh-list
65550492|NCT01356758|Ustekinumab|ustekinumab|mesh-list
65550493|NCT01356758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65550494|NCT01356758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65550495|NCT01356758|Dermatologic Agents|dermatologic agents|mesh-ancestor
65550496|NCT01356758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65550497|NCT01356758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65550498|NCT01356758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65550499|NCT01356758|Analgesics|analgesics|mesh-ancestor
65550500|NCT01356758|Sensory System Agents|sensory system agents|mesh-ancestor
65550501|NCT01356758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550502|NCT01356758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550503|NCT01356758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65550504|NCT01356758|Immunologic Factors|immunologic factors|mesh-ancestor
65550505|NCT01134523|Paclitaxel|paclitaxel|mesh-list
65550506|NCT01134523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65550507|NCT01134523|Epirubicin|epirubicin|mesh-list
65550508|NCT01134523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65550509|NCT01134523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65550510|NCT01134523|Tubulin Modulators|tubulin modulators|mesh-ancestor
65348081|NCT00631917|Ramipril|ramipril|mesh-list
65550511|NCT01134523|Antimitotic Agents|antimitotic agents|mesh-ancestor
65550512|NCT01134523|Mitosis Modulators|mitosis modulators|mesh-ancestor
65550513|NCT01134523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550514|NCT01134523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65550515|NCT01134523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65550516|NCT01134523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65550517|NCT01134523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550518|NCT01349738|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65550519|NCT01349738|Ciprofloxacin|ciprofloxacin|mesh-list
65550520|NCT01349738|Levofloxacin|levofloxacin|mesh-list
65550521|NCT01349738|Ofloxacin|ofloxacin|mesh-list
65550522|NCT01349738|Gentamicins|gentamicins|mesh-list
65550523|NCT01349738|Cefazolin|cefazolin|mesh-list
65550524|NCT01349738|Tobramycin|tobramycin|mesh-list
65550525|NCT01349738|Ampicillin|ampicillin|mesh-list
65550526|NCT01349738|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65550527|NCT01349738|Nitrofurantoin|nitrofurantoin|mesh-list
65550528|NCT01349738|Sulbactam|sulbactam|mesh-list
65550529|NCT01349738|Trimethoprim|trimethoprim|mesh-list
65550530|NCT01349738|Sulfamethoxazole|sulfamethoxazole|mesh-list
65550531|NCT01349738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65550532|NCT01349738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65550533|NCT01349738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65550534|NCT01349738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550535|NCT01349738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550536|NCT01349738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65550537|NCT01349738|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65550538|NCT01349738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65550539|NCT01349738|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65550540|NCT01349738|Renal Agents|renal agents|mesh-ancestor
65550541|NCT01349738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65550542|NCT01349738|Antimalarials|antimalarials|mesh-ancestor
65550543|NCT01349738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65550544|NCT01349738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65550545|NCT01349738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65550546|NCT01349738|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65550547|NCT01349738|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65550548|NCT01349738|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65550549|NCT02302768|Selenium|selenium|mesh-list
65550550|NCT02302768|Antioxidants|antioxidants|mesh-ancestor
65550551|NCT02302768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550552|NCT02302768|Protective Agents|protective agents|mesh-ancestor
65550553|NCT02302768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550554|NCT02302768|Trace Elements|trace elements|mesh-ancestor
65550555|NCT02302768|Micronutrients|micronutrients|mesh-ancestor
65550556|NCT03921775|Propofol|propofol|mesh-list
65550557|NCT03921775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65550558|NCT03921775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65550559|NCT03921775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550560|NCT03921775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65550561|NCT03921775|Anesthetics, General|anesthetics, general|mesh-ancestor
65550562|NCT03921775|Anesthetics|anesthetics|mesh-ancestor
65550563|NCT01356992|Enoxaparin|enoxaparin|mesh-list
65550564|NCT01356992|Anticoagulants|anticoagulants|mesh-ancestor
65550565|NCT01356992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65550566|NCT01356992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65550567|NCT01356992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550568|NCT01350050|Carticaine|carticaine|mesh-list
65550569|NCT01350050|Anesthetics, Local|anesthetics, local|mesh-ancestor
65550570|NCT01350050|Anesthetics|anesthetics|mesh-ancestor
65550571|NCT01350050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65550572|NCT01350050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550573|NCT01350050|Sensory System Agents|sensory system agents|mesh-ancestor
65550574|NCT01350050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550575|NCT03918889|Midazolam|midazolam|mesh-list
65550576|NCT03918889|Dexmedetomidine|dexmedetomidine|mesh-list
65550577|NCT03918889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65550578|NCT03918889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65550579|NCT03918889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550580|NCT03918889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65550581|NCT03918889|Analgesics|analgesics|mesh-ancestor
65550582|NCT03918889|Sensory System Agents|sensory system agents|mesh-ancestor
65550583|NCT03918889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550584|NCT03918889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65550585|NCT03918889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65550586|NCT03918889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65550587|NCT03918889|Adrenergic Agents|adrenergic agents|mesh-ancestor
65550588|NCT03918889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65550589|NCT03918889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550590|NCT03918889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65550591|NCT03918889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65550592|NCT03918889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65550593|NCT03918889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65550594|NCT03918889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65550595|NCT03918889|Anesthetics, General|anesthetics, general|mesh-ancestor
65550596|NCT03918889|Anesthetics|anesthetics|mesh-ancestor
65550597|NCT03918889|GABA Modulators|gaba modulators|mesh-ancestor
65550598|NCT03918889|GABA Agents|gaba agents|mesh-ancestor
65550599|NCT02297620|Ipragliflozin|ipragliflozin|mesh-list
65550600|NCT02297620|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65279711|NCT02682680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65550601|NCT02297620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550602|NCT02297620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65550603|NCT02297620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550604|NCT03739801|Irinotecan|irinotecan|mesh-list
65550605|NCT03739801|Ramucirumab|ramucirumab|mesh-list
65550606|NCT03739801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65550607|NCT03739801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65550608|NCT03739801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550609|NCT03739801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550610|NCT03739801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65550611|NCT03512236|Insulin Lispro|insulin lispro|mesh-list
65550612|NCT03512236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65550613|NCT03512236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550614|NCT02303002|Botulinum Toxins|botulinum toxins|mesh-list
65550615|NCT02303002|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65550616|NCT02303002|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65550617|NCT02303002|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65550618|NCT02303002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65550619|NCT02303002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550620|NCT02303002|Cholinergic Agents|cholinergic agents|mesh-ancestor
65550621|NCT02303002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65550622|NCT02303002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550623|NCT02303002|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65550624|NCT02303002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550625|NCT02297854|Valganciclovir|valganciclovir|mesh-list
65550626|NCT02297854|Antiviral Agents|antiviral agents|mesh-ancestor
65550627|NCT02297854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65550628|NCT03511768|Octreotide|octreotide|mesh-list
65550629|NCT03511768|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
65550630|NCT03511768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65550631|NCT03511768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65550632|NCT03511768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65550633|NCT03511768|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65550634|NCT03511768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550635|NCT01134991|Minocycline|minocycline|mesh-list
65550636|NCT01134991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65550637|NCT01134991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65550638|NCT03515200|Cytarabine|cytarabine|mesh-list
65550639|NCT03515200|Dexamethasone|dexamethasone|mesh-list
65550640|NCT03515200|Hydrocortisone|hydrocortisone|mesh-list
65550641|NCT03515200|Doxorubicin|doxorubicin|mesh-list
65550642|NCT03515200|Methotrexate|methotrexate|mesh-list
65550643|NCT03515200|Bortezomib|bortezomib|mesh-list
65550644|NCT03515200|Dasatinib|dasatinib|mesh-list
65550645|NCT03515200|Palbociclib|palbociclib|mesh-list
65550646|NCT03515200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65550647|NCT03515200|Antiemetics|antiemetics|mesh-ancestor
65550648|NCT03515200|Autonomic Agents|autonomic agents|mesh-ancestor
65550649|NCT03515200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550650|NCT03515200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550651|NCT03515200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65550652|NCT03515200|Glucocorticoids|glucocorticoids|mesh-ancestor
65550653|NCT03515200|Hormones|hormones|mesh-ancestor
65550654|NCT03515200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65550655|NCT03515200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65550656|NCT03515200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65550657|NCT03515200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65550658|NCT03515200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65550659|NCT03515200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65550660|NCT03515200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550661|NCT03515200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550662|NCT03515200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65550663|NCT03515200|Abortifacient Agents|abortifacient agents|mesh-ancestor
65550664|NCT03515200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65550665|NCT03515200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65348231|NCT03592576|Venetoclax|venetoclax|mesh-list
65550666|NCT03515200|Antimetabolites|antimetabolites|mesh-ancestor
65550667|NCT03515200|Dermatologic Agents|dermatologic agents|mesh-ancestor
65550668|NCT03515200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65550669|NCT03515200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65550670|NCT03515200|Immunologic Factors|immunologic factors|mesh-ancestor
65550671|NCT03515200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65550672|NCT03515200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65550673|NCT03515200|Antiviral Agents|antiviral agents|mesh-ancestor
65279787|NCT02806817|Bevacizumab|bevacizumab|mesh-list
65550674|NCT03515200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65550675|NCT03515200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65550676|NCT03918265|Tacrolimus|tacrolimus|mesh-list
65550677|NCT03918265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65550678|NCT03918265|Immunologic Factors|immunologic factors|mesh-ancestor
65550679|NCT03918265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550680|NCT03918265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65550681|NCT03918265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550682|NCT03918265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550683|NCT03920839|Gemcitabine|gemcitabine|mesh-list
65550684|NCT03920839|Paclitaxel|paclitaxel|mesh-list
65550685|NCT03920839|Carboplatin|carboplatin|mesh-list
65550686|NCT03920839|Pemetrexed|pemetrexed|mesh-list
65550687|NCT03920839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65550688|NCT03920839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65550689|NCT03920839|Tubulin Modulators|tubulin modulators|mesh-ancestor
65550690|NCT03920839|Antimitotic Agents|antimitotic agents|mesh-ancestor
65550691|NCT03920839|Mitosis Modulators|mitosis modulators|mesh-ancestor
65550692|NCT03920839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550693|NCT03920839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65550694|NCT03920839|Antimetabolites|antimetabolites|mesh-ancestor
65550695|NCT03920839|Antiviral Agents|antiviral agents|mesh-ancestor
65550696|NCT03920839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65550697|NCT03920839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550698|NCT03920839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65550699|NCT03920839|Immunologic Factors|immunologic factors|mesh-ancestor
65550700|NCT03920839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550701|NCT03920839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65550702|NCT03920839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65550703|NCT02301130|Durvalumab|durvalumab|mesh-list
65550704|NCT02301130|Tremelimumab|tremelimumab|mesh-list
65550705|NCT02301130|Mogamulizumab|mogamulizumab|mesh-list
65550706|NCT02301130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65550707|NCT02301130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65550708|NCT02301130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65550709|NCT02301130|Immunologic Factors|immunologic factors|mesh-ancestor
65550710|NCT02301130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550711|NCT03920605|Tenofovir|tenofovir|mesh-list
65550712|NCT03920605|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65550713|NCT03920605|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65550714|NCT03920605|Antiviral Agents|antiviral agents|mesh-ancestor
65550715|NCT03920605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65550716|NCT03920605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65550717|NCT03920605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65550718|NCT03920605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550719|NCT03920605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550720|NCT03920605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65550721|NCT03920605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65550722|NCT02301208|Nedaplatin|nedaplatin|mesh-list
65550723|NCT02301208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65550724|NCT02298010|Capecitabine|capecitabine|mesh-list
65550725|NCT02298010|Oxaliplatin|oxaliplatin|mesh-list
65550726|NCT02298010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65550727|NCT02298010|Antimetabolites|antimetabolites|mesh-ancestor
65550728|NCT02298010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550729|NCT02298010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65550730|NCT01229605|Cyclophosphamide|cyclophosphamide|mesh-list
65550731|NCT01229605|Docetaxel|docetaxel|mesh-list
65550732|NCT01229605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65550733|NCT01229605|Immunologic Factors|immunologic factors|mesh-ancestor
65550734|NCT01229605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550735|NCT01229605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65550736|NCT01229605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65550737|NCT01229605|Alkylating Agents|alkylating agents|mesh-ancestor
65550738|NCT01229605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550739|NCT01229605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65550740|NCT01229605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65550741|NCT01229605|Tubulin Modulators|tubulin modulators|mesh-ancestor
65348331|NCT00895960|Dasatinib|dasatinib|mesh-list
65550742|NCT01229605|Antimitotic Agents|antimitotic agents|mesh-ancestor
65550743|NCT01229605|Mitosis Modulators|mitosis modulators|mesh-ancestor
65550744|NCT01319006|Glycine|glycine|mesh-list
65550745|NCT01319006|Glycine Agents|glycine agents|mesh-ancestor
65550746|NCT01319006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65550747|NCT01319006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279848|NCT02826434|Durvalumab|durvalumab|mesh-list
65550748|NCT01319006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550749|NCT01358240|Econazole|econazole|mesh-list
65550750|NCT01358240|Antifungal Agents|antifungal agents|mesh-ancestor
65550751|NCT01358240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65550752|NCT01358240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65550753|NCT01358240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65550754|NCT01358240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550755|NCT01358240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550756|NCT01358240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65550757|NCT01358240|Hormone Antagonists|hormone antagonists|mesh-ancestor
65550758|NCT01358240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65550759|NCT01358240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550760|NCT01131949|Lamotrigine|lamotrigine|mesh-list
65550761|NCT01131949|Anticonvulsants|anticonvulsants|mesh-ancestor
65550762|NCT01131949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65550763|NCT01131949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65550764|NCT01131949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550765|NCT01131949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65550766|NCT01131949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550767|NCT01131949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65550768|NCT01131949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65550769|NCT01131949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65550770|NCT01131949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65550771|NCT01131949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65550772|NCT03511222|Pembrolizumab|pembrolizumab|mesh-list
65550773|NCT03511222|Nivolumab|nivolumab|mesh-list
65550774|NCT03511222|Vorolanib|vorolanib|mesh-list
65550775|NCT03511222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65550776|NCT03511222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65550777|NCT03511222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65550778|NCT03511222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550779|NCT03511222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65550780|NCT03511222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550781|NCT01230463|Ketorolac|ketorolac|mesh-list
65550782|NCT01230463|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65550783|NCT01230463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65550784|NCT01230463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65550785|NCT01230463|Analgesics|analgesics|mesh-ancestor
65550786|NCT01230463|Sensory System Agents|sensory system agents|mesh-ancestor
65550787|NCT01230463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550788|NCT01230463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550789|NCT01230463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65550790|NCT01230463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65550791|NCT01230463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65550792|NCT01230463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550793|NCT01230463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550794|NCT01358396|Chrysarobin|chrysarobin|mesh-list
65550795|NCT01358396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65550796|NCT01358396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65550797|NCT01358396|Analgesics|analgesics|mesh-ancestor
65550798|NCT01358396|Sensory System Agents|sensory system agents|mesh-ancestor
65550799|NCT01358396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550800|NCT01358396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550801|NCT01358396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65550802|NCT01358396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65550803|NCT01135615|Calcium|calcium|mesh-list
65550804|NCT01135615|Sevelamer|sevelamer|mesh-list
65550805|NCT01135615|Calcium acetate|calcium acetate|mesh-list
65550806|NCT01135615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65550807|NCT01135615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550808|NCT01135615|Chelating Agents|chelating agents|mesh-ancestor
65550809|NCT01135615|Sequestering Agents|sequestering agents|mesh-ancestor
65550810|NCT01135615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550811|NCT01361516|Anesthetics|anesthetics|mesh-list
65550812|NCT01361516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65550813|NCT01361516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550814|NCT03920137|Nicotine|nicotine|mesh-list
65550815|NCT03920137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65550816|NCT03920137|Autonomic Agents|autonomic agents|mesh-ancestor
65348378|NCT04486716|Ofatumumab|ofatumumab|mesh-list
65550817|NCT03920137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550818|NCT03920137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279918|NCT04236323|Analgesics|analgesics|mesh-ancestor
65550819|NCT03920137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65550820|NCT03920137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65550821|NCT03920137|Cholinergic Agents|cholinergic agents|mesh-ancestor
65550822|NCT03920137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65550823|NCT03920137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550825|NCT03132610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65550826|NCT03132610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65550827|NCT03132610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65550828|NCT03132610|Analgesics|analgesics|mesh-ancestor
65550829|NCT03132610|Sensory System Agents|sensory system agents|mesh-ancestor
65550830|NCT03132610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550831|NCT03132610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550832|NCT03132610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65550833|NCT03132610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65550834|NCT03132610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65550835|NCT03132610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65550836|NCT03132610|Antiviral Agents|antiviral agents|mesh-ancestor
65550837|NCT03132610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65550838|NCT02298088|Clopidogrel|clopidogrel|mesh-list
65550839|NCT02298088|Ticagrelor|ticagrelor|mesh-list
65550840|NCT02298088|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65550841|NCT02298088|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65550842|NCT02298088|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65550843|NCT02298088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65550844|NCT02298088|Purinergic Agents|purinergic agents|mesh-ancestor
65550845|NCT02298088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65550846|NCT02298088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550847|NCT02298088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550848|NCT01133119|Bupivacaine|bupivacaine|mesh-list
65550849|NCT01133119|Anesthetics, Local|anesthetics, local|mesh-ancestor
65550850|NCT01133119|Anesthetics|anesthetics|mesh-ancestor
65550851|NCT01133119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65550852|NCT01133119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550853|NCT01133119|Sensory System Agents|sensory system agents|mesh-ancestor
65550854|NCT01133119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550855|NCT01230541|Udenafil|udenafil|mesh-list
65550856|NCT01230541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65550857|NCT01230541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65550858|NCT01230541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550859|NCT01230541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550860|NCT01229761|Trimethoprim|trimethoprim|mesh-list
65550861|NCT01229761|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65550862|NCT01229761|Sulfamethoxazole|sulfamethoxazole|mesh-list
65550863|NCT01229761|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65550864|NCT01229761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65550865|NCT01229761|Renal Agents|renal agents|mesh-ancestor
65550866|NCT01229761|Antimalarials|antimalarials|mesh-ancestor
65550867|NCT01229761|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65550868|NCT01229761|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65550869|NCT01229761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65550870|NCT01229761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550871|NCT01229761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550872|NCT01229761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65550873|NCT01229761|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65550874|NCT01229761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65550875|NCT01229761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65550876|NCT01229839|Ethiodized Oil|ethiodized oil|mesh-list
65550877|NCT01229839|Antineoplastic Agents|antineoplastic agents|mesh-list
65550878|NCT03514810|Ketoprofen|ketoprofen|mesh-list
65550879|NCT03514810|Sertraline|sertraline|mesh-list
65550880|NCT03514810|Antidepressive Agents|antidepressive agents|mesh-ancestor
65550881|NCT03514810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65550882|NCT03514810|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65550883|NCT03514810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65550884|NCT03514810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65550885|NCT03514810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550886|NCT03514810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65550887|NCT03514810|Serotonin Agents|serotonin agents|mesh-ancestor
65550888|NCT03514810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348465|NCT00409747|Minocycline|minocycline|mesh-list
65550889|NCT03514810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65550890|NCT03514810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65279995|NCT00641030|Antimetabolites|antimetabolites|mesh-ancestor
65550891|NCT03514810|Analgesics|analgesics|mesh-ancestor
65550892|NCT03514810|Sensory System Agents|sensory system agents|mesh-ancestor
65550893|NCT03514810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550894|NCT03514810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65550895|NCT03514810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65550896|NCT03514810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65550897|NCT03514810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65550898|NCT02301676|Dexmedetomidine|dexmedetomidine|mesh-list
65550899|NCT02301676|Propofol|propofol|mesh-list
65550900|NCT02301676|Sevoflurane|sevoflurane|mesh-list
65550901|NCT02301676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65550902|NCT02301676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65550903|NCT02301676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550904|NCT02301676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65550905|NCT02301676|Anesthetics, General|anesthetics, general|mesh-ancestor
65550906|NCT02301676|Anesthetics|anesthetics|mesh-ancestor
65550907|NCT02301676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65550908|NCT02301676|Analgesics|analgesics|mesh-ancestor
65550909|NCT02301676|Sensory System Agents|sensory system agents|mesh-ancestor
65550910|NCT02301676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550911|NCT02301676|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65550912|NCT02301676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65550913|NCT02301676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65550914|NCT02301676|Adrenergic Agents|adrenergic agents|mesh-ancestor
65550915|NCT02301676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65550916|NCT02301676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550917|NCT02301676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65550918|NCT02301676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65550919|NCT01135771|Insulin|insulin|mesh-list
65550920|NCT01135771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65550921|NCT01135771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550922|NCT01133353|Tetrabenazine|tetrabenazine|mesh-list
65550923|NCT01133353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65550924|NCT01133353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65550925|NCT01133353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65550926|NCT01133353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550927|NCT01133353|Adrenergic Agents|adrenergic agents|mesh-ancestor
65550928|NCT01133353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65550929|NCT01133353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550930|NCT01135927|Insulin|insulin|mesh-list
65550931|NCT01135927|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65550932|NCT01135927|Insulin Detemir|insulin detemir|mesh-list
65550933|NCT01135927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65550934|NCT01135927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550935|NCT02301910|Tenecteplase|tenecteplase|mesh-list
65550936|NCT02301910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65550937|NCT02301910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65550938|NCT02301910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550939|NCT01585753|Maraviroc|maraviroc|mesh-list
65550940|NCT01585753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65550941|NCT01585753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65550942|NCT01585753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550943|NCT01585753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65550944|NCT01585753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65550945|NCT01585753|Antiviral Agents|antiviral agents|mesh-ancestor
65550946|NCT01585753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65550947|NCT01585753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65550948|NCT01136005|Provitamins|provitamins|mesh-list
65550949|NCT01136005|Vitamins|vitamins|mesh-ancestor
65550950|NCT01136005|Micronutrients|micronutrients|mesh-ancestor
65550951|NCT01136005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550952|NCT03509740|Acetaminophen|acetaminophen|mesh-list
65550953|NCT03509740|Tramadol|tramadol|mesh-list
65550954|NCT03509740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65550955|NCT03509740|Analgesics|analgesics|mesh-ancestor
65550956|NCT03509740|Sensory System Agents|sensory system agents|mesh-ancestor
65550957|NCT03509740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550958|NCT03509740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550959|NCT03509740|Antipyretics|antipyretics|mesh-ancestor
65550960|NCT03509740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65550961|NCT03509740|Narcotics|narcotics|mesh-ancestor
65550962|NCT03509740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65550963|NCT03918187|Midazolam|midazolam|mesh-list
65550964|NCT03918187|Nalbuphine|nalbuphine|mesh-list
65348530|NCT00894634|Histamine Agents|histamine agents|mesh-ancestor
65280097|NCT03549715|Durvalumab|durvalumab|mesh-list
65550965|NCT03918187|Bupivacaine|bupivacaine|mesh-list
65550966|NCT03918187|Anesthetics, Local|anesthetics, local|mesh-ancestor
65550967|NCT03918187|Anesthetics|anesthetics|mesh-ancestor
65550968|NCT03918187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65550969|NCT03918187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550970|NCT03918187|Sensory System Agents|sensory system agents|mesh-ancestor
65550971|NCT03918187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550972|NCT03918187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65550973|NCT03918187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65550974|NCT03918187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65550975|NCT03918187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65550976|NCT03918187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65550977|NCT03918187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65550978|NCT03918187|Anesthetics, General|anesthetics, general|mesh-ancestor
65550979|NCT03918187|GABA Modulators|gaba modulators|mesh-ancestor
65550980|NCT03918187|GABA Agents|gaba agents|mesh-ancestor
65550981|NCT03918187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65550982|NCT03918187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65550983|NCT03918187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65550984|NCT03918187|Narcotics|narcotics|mesh-ancestor
65550985|NCT03918187|Analgesics|analgesics|mesh-ancestor
65550986|NCT03507634|Lidocaine|lidocaine|mesh-list
65550987|NCT03507634|Fentanyl|fentanyl|mesh-list
65550988|NCT03507634|Dexmedetomidine|dexmedetomidine|mesh-list
65550989|NCT03507634|Remifentanil|remifentanil|mesh-list
65550990|NCT03507634|Analgesics, Opioid|analgesics, opioid|mesh-list
65550991|NCT03507634|Anesthetics|anesthetics|mesh-list
65550992|NCT03507634|Anesthetics, Local|anesthetics, local|mesh-ancestor
65550993|NCT03507634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65550994|NCT03507634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65550995|NCT03507634|Sensory System Agents|sensory system agents|mesh-ancestor
65550996|NCT03507634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65550997|NCT03507634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65550998|NCT03507634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65550999|NCT03507634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65551000|NCT03507634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65551001|NCT03507634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551002|NCT03507634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65551003|NCT03507634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65551004|NCT03507634|Analgesics|analgesics|mesh-ancestor
65551005|NCT03507634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65551006|NCT03507634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65551007|NCT03507634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65551008|NCT03507634|Adrenergic Agents|adrenergic agents|mesh-ancestor
65551009|NCT03507634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65551010|NCT03507634|Narcotics|narcotics|mesh-ancestor
65551011|NCT03507634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65551012|NCT03507634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65551013|NCT03507634|Anesthetics, General|anesthetics, general|mesh-ancestor
65551014|NCT03507556|Metronidazole|metronidazole|mesh-list
65551015|NCT03507556|Ciprofloxacin|ciprofloxacin|mesh-list
65551016|NCT03507556|Minocycline|minocycline|mesh-list
65551017|NCT03507556|Zinc Oxide|zinc oxide|mesh-list
65551018|NCT03507556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65551019|NCT03507556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65551020|NCT03507556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65551021|NCT03507556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65551022|NCT03507556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65551023|NCT03507556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65551024|NCT03507556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551025|NCT03507556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551026|NCT03507556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551027|NCT03507556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65551028|NCT03507556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65551029|NCT03507556|Dermatologic Agents|dermatologic agents|mesh-ancestor
65551030|NCT03507556|Sunscreening Agents|sunscreening agents|mesh-ancestor
65551031|NCT03507556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65551032|NCT03507556|Protective Agents|protective agents|mesh-ancestor
65551033|NCT03507556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551034|NCT01232257|Acetylcysteine|acetylcysteine|mesh-list
65551035|NCT01232257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65551036|NCT01232257|Antiviral Agents|antiviral agents|mesh-ancestor
65551037|NCT01232257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65551038|NCT01232257|Expectorants|expectorants|mesh-ancestor
65348605|NCT04044417|Analgesics|analgesics|mesh-ancestor
65551039|NCT01232257|Respiratory System Agents|respiratory system agents|mesh-ancestor
65551040|NCT01232257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65551041|NCT01232257|Antioxidants|antioxidants|mesh-ancestor
65551042|NCT01232257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551044|NCT01232257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551045|NCT01232257|Antidotes|antidotes|mesh-ancestor
65551046|NCT03509662|Ascorbic Acid|ascorbic acid|mesh-list
65551047|NCT03509662|Thiamine|thiamine|mesh-list
65551048|NCT03509662|Vitamins|vitamins|mesh-ancestor
65551049|NCT03509662|Micronutrients|micronutrients|mesh-ancestor
65551050|NCT03509662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551051|NCT03509662|Antioxidants|antioxidants|mesh-ancestor
65551052|NCT03509662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551053|NCT03509662|Protective Agents|protective agents|mesh-ancestor
65551054|NCT03509662|Vitamin B Complex|vitamin b complex|mesh-ancestor
65551055|NCT05461573|Drospirenone|drospirenone|mesh-list
65551056|NCT05461573|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65551057|NCT05461573|Hormone Antagonists|hormone antagonists|mesh-ancestor
65551058|NCT05461573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65551059|NCT05461573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551060|NCT05461573|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65551061|NCT05461573|Diuretics|diuretics|mesh-ancestor
65551062|NCT05461573|Natriuretic Agents|natriuretic agents|mesh-ancestor
65551063|NCT03504982|Moxifloxacin|moxifloxacin|mesh-list
65551064|NCT03504982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65551065|NCT03504982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65551066|NCT03504982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65551067|NCT03504982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65551068|NCT03504982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551069|NCT03504982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551070|NCT03504982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551071|NCT01133431|Glimepiride|glimepiride|mesh-list
65551072|NCT01133431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65551073|NCT01133431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65551074|NCT01133431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551075|NCT01133431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65551076|NCT01133431|Immunologic Factors|immunologic factors|mesh-ancestor
65551077|NCT05610007|Prilocaine|prilocaine|mesh-list
65551078|NCT05610007|Anesthetics, Local|anesthetics, local|mesh-ancestor
65551079|NCT05610007|Anesthetics|anesthetics|mesh-ancestor
65551080|NCT05610007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65551081|NCT05610007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551082|NCT05610007|Sensory System Agents|sensory system agents|mesh-ancestor
65551083|NCT05610007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551084|NCT01232413|Ipragliflozin|ipragliflozin|mesh-list
65551085|NCT01232413|Moxifloxacin|moxifloxacin|mesh-list
65551086|NCT01232413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65551087|NCT01232413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65551088|NCT01232413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65551089|NCT01232413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65551090|NCT01232413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551091|NCT01232413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551092|NCT01232413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551093|NCT01232413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551094|NCT01232413|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65551095|NCT01232413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65551096|NCT02303782|Azacitidine|azacitidine|mesh-list
65551097|NCT02303782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65551098|NCT02303782|Antimetabolites|antimetabolites|mesh-ancestor
65551099|NCT02303782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551100|NCT02303782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551101|NCT02303782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551102|NCT01233505|Capecitabine|capecitabine|mesh-list
65551103|NCT01233505|Oxaliplatin|oxaliplatin|mesh-list
65551104|NCT01233505|Veliparib|veliparib|mesh-list
65551105|NCT01233505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65551106|NCT01233505|Antimetabolites|antimetabolites|mesh-ancestor
65551107|NCT01233505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551108|NCT01233505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551109|NCT01233505|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65551110|NCT01233505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551111|NCT04925180|Cyproterone Acetate|cyproterone acetate|mesh-list
65551112|NCT04925180|Cyproterone|cyproterone|mesh-list
65551113|NCT04925180|Androgen Antagonists|androgen antagonists|mesh-ancestor
65551114|NCT04925180|Hormone Antagonists|hormone antagonists|mesh-ancestor
65551115|NCT04925180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65551116|NCT04925180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551117|NCT04925180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551118|NCT04925180|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65551119|NCT04925180|Contraceptive Agents|contraceptive agents|mesh-ancestor
65551120|NCT04925180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65551121|NCT01133509|Vaccines|vaccines|mesh-list
65551122|NCT01133509|Immunologic Factors|immunologic factors|mesh-ancestor
65551123|NCT01133509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551124|NCT02306902|Fenofibrate|fenofibrate|mesh-list
65551125|NCT02306902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65551126|NCT02306902|Antimetabolites|antimetabolites|mesh-ancestor
65551127|NCT02306902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551128|NCT02306902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65551129|NCT01230697|Sorafenib|sorafenib|mesh-list
65551130|NCT01230697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551131|NCT01230697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65551132|NCT01230697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551133|NCT01230697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551134|NCT01361984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65551135|NCT01361984|Formoterol Fumarate|formoterol fumarate|mesh-list
65551136|NCT01361984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65551137|NCT01361984|Autonomic Agents|autonomic agents|mesh-ancestor
65551138|NCT01361984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551139|NCT01361984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551140|NCT01361984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65551141|NCT01361984|Respiratory System Agents|respiratory system agents|mesh-ancestor
65551142|NCT01361984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65551143|NCT01361984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65551144|NCT01361984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65551145|NCT01361984|Adrenergic Agents|adrenergic agents|mesh-ancestor
65551146|NCT01361984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65551147|NCT01361984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551148|NCT01230775|Anagrelide|anagrelide|mesh-list
65551149|NCT01230775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65551150|NCT01230775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65551151|NCT01230775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551152|NCT01230775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65551153|NCT01136317|Omeprazole|omeprazole|mesh-list
65551154|NCT01136317|Rabeprazole|rabeprazole|mesh-list
65551155|NCT01136317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65551156|NCT01136317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65551157|NCT01136317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65551158|NCT01136317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551159|NCT01136317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551160|NCT03507244|Dexamethasone|dexamethasone|mesh-list
65551161|NCT03507244|Pemetrexed|pemetrexed|mesh-list
65551162|NCT03507244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65551163|NCT03507244|Antiemetics|antiemetics|mesh-ancestor
65551164|NCT03507244|Autonomic Agents|autonomic agents|mesh-ancestor
65551165|NCT03507244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551166|NCT03507244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551167|NCT03507244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65551168|NCT03507244|Glucocorticoids|glucocorticoids|mesh-ancestor
65551169|NCT03507244|Hormones|hormones|mesh-ancestor
65551170|NCT03507244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65551171|NCT03507244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65551172|NCT03507244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551173|NCT03507244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551174|NCT03507244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551175|NCT03507244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65551176|NCT03507244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65551177|NCT01136395|Rituximab|rituximab|mesh-list
65551178|NCT01136395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65551179|NCT01136395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551180|NCT01136395|Immunologic Factors|immunologic factors|mesh-ancestor
65551181|NCT01136395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551182|NCT01136395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65551183|NCT02304094|Methylprednisolone|methylprednisolone|mesh-list
65551184|NCT02304094|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65551185|NCT02304094|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65551186|NCT02304094|Prednisolone|prednisolone|mesh-list
65551187|NCT02304094|Prednisolone acetate|prednisolone acetate|mesh-list
65551188|NCT02304094|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65551189|NCT02304094|Prednisolone phosphate|prednisolone phosphate|mesh-list
65551190|NCT02304094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65551191|NCT02304094|Antiemetics|antiemetics|mesh-ancestor
65551192|NCT02304094|Autonomic Agents|autonomic agents|mesh-ancestor
65551193|NCT02304094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551194|NCT02304094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551195|NCT02304094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65551196|NCT02304094|Glucocorticoids|glucocorticoids|mesh-ancestor
65551197|NCT02304094|Hormones|hormones|mesh-ancestor
65551198|NCT02304094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65551199|NCT02304094|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65551200|NCT02304094|Protective Agents|protective agents|mesh-ancestor
65551201|NCT02304094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65551202|NCT02304094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551203|NCT03507166|Trastuzumab|trastuzumab|mesh-list
65551204|NCT03507166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65551205|NCT03507166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551206|NCT01233583|Adalimumab|adalimumab|mesh-list
65551207|NCT01233583|Etanercept|etanercept|mesh-list
65551208|NCT01233583|Infliximab|infliximab|mesh-list
65551209|NCT01233583|Acitretin|acitretin|mesh-list
65551210|NCT01233583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65551211|NCT01233583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65551212|NCT01233583|Dermatologic Agents|dermatologic agents|mesh-ancestor
65551213|NCT01233583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65551214|NCT01233583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65551215|NCT01233583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65551216|NCT01233583|Analgesics|analgesics|mesh-ancestor
65551217|NCT01233583|Sensory System Agents|sensory system agents|mesh-ancestor
65551218|NCT01233583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551219|NCT01233583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551220|NCT01233583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65551221|NCT01233583|Immunologic Factors|immunologic factors|mesh-ancestor
65551222|NCT01233583|Keratolytic Agents|keratolytic agents|mesh-ancestor
65551223|NCT02304250|Dexamethasone|dexamethasone|mesh-list
65551224|NCT02304250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65551225|NCT02304250|Antiemetics|antiemetics|mesh-ancestor
65551226|NCT02304250|Autonomic Agents|autonomic agents|mesh-ancestor
65551227|NCT02304250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551228|NCT02304250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551229|NCT02304250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65551230|NCT02304250|Glucocorticoids|glucocorticoids|mesh-ancestor
65551231|NCT02304250|Hormones|hormones|mesh-ancestor
65551232|NCT02304250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65551233|NCT02304250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65551234|NCT02304250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551235|NCT01136551|Huperzine A|huperzine a|mesh-list
65551236|NCT01136551|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65551237|NCT01136551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551238|NCT01136551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551239|NCT01136551|Cholinergic Agents|cholinergic agents|mesh-ancestor
65551240|NCT01136551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65551241|NCT01136551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551242|NCT01136551|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65551243|NCT01136551|Protective Agents|protective agents|mesh-ancestor
65551244|NCT03132142|Cinnamaldehyde|cinnamaldehyde|mesh-list
65551245|NCT03132142|Capsaicin|capsaicin|mesh-list
65551246|NCT03132142|Menthol|menthol|mesh-list
65551247|NCT03132142|Antipruritics|antipruritics|mesh-ancestor
65551248|NCT03132142|Dermatologic Agents|dermatologic agents|mesh-ancestor
65551249|NCT03132142|Sensory System Agents|sensory system agents|mesh-ancestor
65551250|NCT03132142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551251|NCT03132142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551252|NCT03132142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65551253|NCT03132142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551254|NCT03132142|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65551255|NCT03132142|Protective Agents|protective agents|mesh-ancestor
65551256|NCT01232647|Vitamins|vitamins|mesh-list
65551257|NCT01232647|Vitamin K|vitamin k|mesh-list
65551258|NCT01232647|Vitamin K 2|vitamin k 2|mesh-list
65551259|NCT01232647|Vitamin K 1|vitamin k 1|mesh-list
65551260|NCT01232647|Menatetrenone|menatetrenone|mesh-list
65551261|NCT01232647|Micronutrients|micronutrients|mesh-ancestor
65551262|NCT01232647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551263|NCT01232647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65551264|NCT01232647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65551265|NCT01232647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551266|NCT01232647|Hemostatics|hemostatics|mesh-ancestor
65551267|NCT01232647|Coagulants|coagulants|mesh-ancestor
65551268|NCT03917095|Mesalamine|mesalamine|mesh-list
65280372|NCT04032834|Hormones|hormones|mesh-ancestor
65551269|NCT03917095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65551270|NCT03917095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65551271|NCT03917095|Analgesics|analgesics|mesh-ancestor
65551272|NCT03917095|Sensory System Agents|sensory system agents|mesh-ancestor
65551273|NCT03917095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551274|NCT03917095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551275|NCT03917095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65551276|NCT03917095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65551277|NCT01133743|Thalidomide|thalidomide|mesh-list
65551278|NCT01133743|Dexamethasone|dexamethasone|mesh-list
65551279|NCT01133743|Lenalidomide|lenalidomide|mesh-list
65551280|NCT01133743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65551281|NCT01133743|Antiemetics|antiemetics|mesh-ancestor
65551282|NCT01133743|Autonomic Agents|autonomic agents|mesh-ancestor
65551283|NCT01133743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551284|NCT01133743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551285|NCT01133743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65551286|NCT01133743|Glucocorticoids|glucocorticoids|mesh-ancestor
65551288|NCT01133743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65551289|NCT01133743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65551290|NCT01133743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551291|NCT01133743|Immunologic Factors|immunologic factors|mesh-ancestor
65551292|NCT01133743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65551293|NCT01133743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65551294|NCT01133743|Growth Substances|growth substances|mesh-ancestor
65551295|NCT01133743|Growth Inhibitors|growth inhibitors|mesh-ancestor
65551296|NCT01133743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65551297|NCT01133743|Leprostatic Agents|leprostatic agents|mesh-ancestor
65551298|NCT01133743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65551299|NCT01133743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65551300|NCT01138423|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65551301|NCT01138423|Moxonidine|moxonidine|mesh-list
65551302|NCT01138423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65551303|NCT01138423|Diuretics|diuretics|mesh-ancestor
65551304|NCT01138423|Natriuretic Agents|natriuretic agents|mesh-ancestor
65551305|NCT01138423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551306|NCT01138423|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65551307|NCT01138423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65551308|NCT01138423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551309|NCT01136863|Felodipine|felodipine|mesh-list
65551310|NCT01136863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65551311|NCT01136863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65551312|NCT01136863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65551313|NCT01136863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65551314|NCT01136863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551315|NCT01136863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65551316|NCT01136863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551317|NCT01136863|Vasodilator Agents|vasodilator agents|mesh-ancestor
65551318|NCT03961516|Pancrelipase|pancrelipase|mesh-list
65551319|NCT03961516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65551320|NCT03508882|Botulinum Toxins|botulinum toxins|mesh-list
65551321|NCT03508882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65551322|NCT03508882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65551323|NCT03508882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65551324|NCT03508882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65551325|NCT03508882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551326|NCT03508882|Cholinergic Agents|cholinergic agents|mesh-ancestor
65551327|NCT03508882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65551328|NCT03508882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551329|NCT03508882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65551330|NCT03508882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551331|NCT05553145|Antibodies|antibodies|mesh-list
65551332|NCT05553145|Autoantibodies|autoantibodies|mesh-list
65551333|NCT05553145|Immunologic Factors|immunologic factors|mesh-ancestor
65551334|NCT05553145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551335|NCT03504280|Cholecalciferol|cholecalciferol|mesh-list
65551336|NCT03504280|Vitamin D|vitamin d|mesh-list
65551337|NCT03504280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65551338|NCT03504280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551339|NCT03504280|Vitamins|vitamins|mesh-ancestor
65551340|NCT03504280|Micronutrients|micronutrients|mesh-ancestor
65348905|NCT00605722|Bevacizumab|bevacizumab|mesh-list
65551341|NCT03504280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65551342|NCT03504202|Trimetazidine|trimetazidine|mesh-list
65551343|NCT03504202|Vasodilator Agents|vasodilator agents|mesh-ancestor
65551345|NCT01136941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65551346|NCT01136941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65551347|NCT01136941|Analgesics|analgesics|mesh-ancestor
65551348|NCT01136941|Sensory System Agents|sensory system agents|mesh-ancestor
65551349|NCT01136941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551350|NCT01136941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551351|NCT01136941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65551352|NCT01136941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65551353|NCT01136941|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65551354|NCT01136941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551355|NCT01136941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551356|NCT01136941|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65551357|NCT01136941|Hormone Antagonists|hormone antagonists|mesh-ancestor
65551358|NCT01136941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65551359|NCT01232803|Tenofovir|tenofovir|mesh-list
65551360|NCT01232803|Antiviral Agents|antiviral agents|mesh-ancestor
65551361|NCT01232803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65551362|NCT01232803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65551363|NCT01232803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65551364|NCT01232803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551365|NCT01232803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551366|NCT01232803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65551367|NCT01232803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65551368|NCT03504046|Pancrelipase|pancrelipase|mesh-list
65551369|NCT03504046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65551370|NCT01139203|Lamivudine|lamivudine|mesh-list
65551371|NCT01139203|Adefovir|adefovir|mesh-list
65551372|NCT01139203|Entecavir|entecavir|mesh-list
65551373|NCT01139203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65551374|NCT01139203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65551375|NCT01139203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551376|NCT01139203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551377|NCT01139203|Antiviral Agents|antiviral agents|mesh-ancestor
65551378|NCT01139203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65551379|NCT01139203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65551380|NCT01139203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65551381|NCT05187715|Simvastatin|simvastatin|mesh-list
65551382|NCT05187715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65551383|NCT05187715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65551384|NCT05187715|Antimetabolites|antimetabolites|mesh-ancestor
65551385|NCT05187715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551386|NCT05187715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65551387|NCT05187715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65551388|NCT05187715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551389|NCT02312440|Tranexamic Acid|tranexamic acid|mesh-list
65551390|NCT02312440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65551391|NCT02312440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65551392|NCT02312440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551393|NCT02312440|Hemostatics|hemostatics|mesh-ancestor
65551394|NCT02312440|Coagulants|coagulants|mesh-ancestor
65551395|NCT01137019|Everolimus|everolimus|mesh-list
65551396|NCT01137019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551397|NCT01137019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65551398|NCT01137019|Immunologic Factors|immunologic factors|mesh-ancestor
65551399|NCT01137019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551400|NCT02308072|Olaparib|olaparib|mesh-list
65551401|NCT02308072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551402|NCT02308072|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65551403|NCT02308072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551404|NCT02308072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551405|NCT03508804|Lidocaine|lidocaine|mesh-list
65551406|NCT03508804|Prilocaine|prilocaine|mesh-list
65551407|NCT03508804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65551408|NCT03508804|Anesthetics, Local|anesthetics, local|mesh-ancestor
65551409|NCT03508804|Anesthetics|anesthetics|mesh-ancestor
65551410|NCT03508804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65551411|NCT03508804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551412|NCT03508804|Sensory System Agents|sensory system agents|mesh-ancestor
65551413|NCT03508804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551414|NCT03508804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65551415|NCT03508804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65348979|NCT00900172|Growth Inhibitors|growth inhibitors|mesh-ancestor
65551416|NCT03508804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65551417|NCT03508804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65551418|NCT03508804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551419|NCT03508804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65551420|NCT01231165|Aspirin|aspirin|mesh-list
65551421|NCT01231165|Amiloride|amiloride|mesh-list
65551422|NCT01231165|Clopidogrel|clopidogrel|mesh-list
65551423|NCT01231165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65551424|NCT01231165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65551425|NCT01231165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65551426|NCT01231165|Analgesics|analgesics|mesh-ancestor
65551427|NCT01231165|Sensory System Agents|sensory system agents|mesh-ancestor
65551428|NCT01231165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551429|NCT01231165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551430|NCT01231165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65551431|NCT01231165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65551432|NCT01231165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65551433|NCT01231165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65551434|NCT01231165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551435|NCT01231165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65551436|NCT01231165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65551437|NCT01231165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551438|NCT01231165|Antipyretics|antipyretics|mesh-ancestor
65551439|NCT01231165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65551440|NCT01231165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65551441|NCT01231165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65551442|NCT01231165|Purinergic Agents|purinergic agents|mesh-ancestor
65551443|NCT01231165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65551444|NCT01231165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65551445|NCT01231165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65551446|NCT01231165|Antimetabolites|antimetabolites|mesh-ancestor
65551447|NCT01231165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65551448|NCT01231165|Diuretics|diuretics|mesh-ancestor
65551449|NCT01231165|Natriuretic Agents|natriuretic agents|mesh-ancestor
65551450|NCT01231165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65551451|NCT01231165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65551452|NCT01231165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65551453|NCT01231165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65551454|NCT01231165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65551455|NCT01231243|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65551456|NCT01231243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65551457|NCT01231243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65551458|NCT01233895|Bortezomib|bortezomib|mesh-list
65551459|NCT01233895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551460|NCT05221645|Rituximab|rituximab|mesh-list
65551461|NCT05221645|Pembrolizumab|pembrolizumab|mesh-list
65551462|NCT05221645|Carboplatin|carboplatin|mesh-list
65551463|NCT05221645|Etoposide|etoposide|mesh-list
65551464|NCT05221645|Ifosfamide|ifosfamide|mesh-list
65551465|NCT05221645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65551466|NCT05221645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551467|NCT05221645|Immunologic Factors|immunologic factors|mesh-ancestor
65551468|NCT05221645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551469|NCT05221645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65551470|NCT05221645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65551471|NCT05221645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65551472|NCT05221645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65551473|NCT05221645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551474|NCT05221645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551475|NCT05221645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65551476|NCT05221645|Alkylating Agents|alkylating agents|mesh-ancestor
65551477|NCT05219929|Tetracycline|tetracycline|mesh-list
65551478|NCT05219929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65551479|NCT05219929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65551480|NCT05219929|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65551481|NCT05219929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551482|NCT05219929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551483|NCT03506620|Ropivacaine|ropivacaine|mesh-list
65551484|NCT03506620|Anesthetics, Local|anesthetics, local|mesh-ancestor
65551485|NCT03506620|Anesthetics|anesthetics|mesh-ancestor
65551486|NCT03506620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65551487|NCT03506620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551488|NCT03506620|Sensory System Agents|sensory system agents|mesh-ancestor
65551489|NCT03506620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551490|NCT02305030|Opicapone|opicapone|mesh-list
65551491|NCT02305030|Warfarin|warfarin|mesh-list
65551492|NCT02305030|Anticoagulants|anticoagulants|mesh-ancestor
65551493|NCT02305030|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65551494|NCT02305030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551495|NCT02305030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551496|NCT02305030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65551497|NCT02305030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65551498|NCT01139437|Vaccines|vaccines|mesh-list
65551499|NCT01139437|Immunologic Factors|immunologic factors|mesh-ancestor
65551500|NCT01139437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551501|NCT01137253|Trimethaphan|trimethaphan|mesh-list
65551502|NCT01137253|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
65551503|NCT01137253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65551504|NCT01137253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65551505|NCT01137253|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
65551506|NCT01137253|Autonomic Agents|autonomic agents|mesh-ancestor
65551507|NCT01137253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551508|NCT01137253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551509|NCT01137253|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65551510|NCT01137253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65551511|NCT01137253|Cholinergic Agents|cholinergic agents|mesh-ancestor
65551512|NCT01137253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65551513|NCT01137253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551514|NCT01137253|Vasodilator Agents|vasodilator agents|mesh-ancestor
65551515|NCT05493163|Fibrinolytic Agents|fibrinolytic agents|mesh-list
65551516|NCT05493163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65551517|NCT05493163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551518|NCT03506542|Mitomycins|mitomycins|mesh-list
65551519|NCT03506542|Mitomycin|mitomycin|mesh-list
65551520|NCT03506542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65551521|NCT03506542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551522|NCT03506542|Alkylating Agents|alkylating agents|mesh-ancestor
65551523|NCT03506542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551524|NCT03506542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65551525|NCT03506542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551526|NCT02305186|Pembrolizumab|pembrolizumab|mesh-list
65551527|NCT02305186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65551528|NCT02305186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551529|NCT02312908|Clonazepam|clonazepam|mesh-list
65551530|NCT02312908|Anticonvulsants|anticonvulsants|mesh-ancestor
65551531|NCT02312908|GABA Modulators|gaba modulators|mesh-ancestor
65551532|NCT02312908|GABA Agents|gaba agents|mesh-ancestor
65551533|NCT02312908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65551534|NCT02312908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551535|NCT02312908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551536|NCT02308930|Vitamin D|vitamin d|mesh-list
65551537|NCT02308930|Vitamins|vitamins|mesh-list
65551538|NCT02308930|Vitamin A|vitamin a|mesh-list
65551539|NCT02308930|Retinol palmitate|retinol palmitate|mesh-list
65551540|NCT02308930|Micronutrients|micronutrients|mesh-ancestor
65551541|NCT02308930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551542|NCT02308930|Antioxidants|antioxidants|mesh-ancestor
65551543|NCT02308930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551544|NCT02308930|Protective Agents|protective agents|mesh-ancestor
65551545|NCT02308930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65551546|NCT02308930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551547|NCT02308930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65551548|NCT01139671|Remifentanil|remifentanil|mesh-list
65551549|NCT01139671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65551550|NCT01139671|Narcotics|narcotics|mesh-ancestor
65551551|NCT01139671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65551552|NCT01139671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551553|NCT01139671|Analgesics|analgesics|mesh-ancestor
65551554|NCT01139671|Sensory System Agents|sensory system agents|mesh-ancestor
65551555|NCT01139671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551556|NCT02313064|CXA-10|cxa-10|mesh-list
65551557|NCT02313064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65551558|NCT05088889|Nivolumab|nivolumab|mesh-list
65551559|NCT05088889|Ipilimumab|ipilimumab|mesh-list
65551560|NCT05088889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65551561|NCT05088889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551562|NCT05088889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65551563|NCT05088889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551564|NCT01234051|Docetaxel|docetaxel|mesh-list
65551565|NCT01234051|Oxaliplatin|oxaliplatin|mesh-list
65551566|NCT01234051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551567|NCT01234051|Tubulin Modulators|tubulin modulators|mesh-ancestor
65551568|NCT01234051|Antimitotic Agents|antimitotic agents|mesh-ancestor
65551569|NCT01234051|Mitosis Modulators|mitosis modulators|mesh-ancestor
65551570|NCT01234051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551571|NCT03341962|Calcium|calcium|mesh-list
65551572|NCT03341962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65551573|NCT03341962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551574|NCT01234597|Insulin|insulin|mesh-list
65551575|NCT01234597|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65551576|NCT01234597|Insulin Glargine|insulin glargine|mesh-list
65551577|NCT01234597|Insulin glulisine|insulin glulisine|mesh-list
65551578|NCT01234597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65551579|NCT01234597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551580|NCT02313220|Dapagliflozin|dapagliflozin|mesh-list
65551581|NCT02313220|Exenatide|exenatide|mesh-list
65551582|NCT02313220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65551583|NCT02313220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551584|NCT02313220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65551585|NCT02313220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551586|NCT02313220|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65551587|NCT02313220|Incretins|incretins|mesh-ancestor
65551588|NCT02313220|Hormones|hormones|mesh-ancestor
65551589|NCT02313220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65551590|NCT05177731|Cytarabine|cytarabine|mesh-list
65551591|NCT05177731|Decitabine|decitabine|mesh-list
65551592|NCT05177731|Venetoclax|venetoclax|mesh-list
65551593|NCT05177731|Idarubicin|idarubicin|mesh-list
65551594|NCT05177731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65551595|NCT05177731|Antimetabolites|antimetabolites|mesh-ancestor
65551596|NCT05177731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551597|NCT05177731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551598|NCT05177731|Antiviral Agents|antiviral agents|mesh-ancestor
65551599|NCT05177731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65551600|NCT05177731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65551601|NCT05177731|Immunologic Factors|immunologic factors|mesh-ancestor
65551602|NCT05177731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551603|NCT05177731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551604|NCT05177731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65551605|NCT05177731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65551606|NCT05177731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65551607|NCT02309320|Gontivimab|gontivimab|mesh-list
65551608|NCT02309320|Antiviral Agents|antiviral agents|mesh-ancestor
65551609|NCT02309320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65551610|NCT01139749|Salicylic Acid|salicylic acid|mesh-list
65551611|NCT01139749|Ciclopirox|ciclopirox|mesh-list
65551612|NCT01139749|Salicylates|salicylates|mesh-list
65551613|NCT01139749|Isotretinoin|isotretinoin|mesh-list
65551614|NCT01139749|Dermatologic Agents|dermatologic agents|mesh-ancestor
65551615|NCT01139749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65551616|NCT01139749|Antifungal Agents|antifungal agents|mesh-ancestor
65551617|NCT01139749|Keratolytic Agents|keratolytic agents|mesh-ancestor
65551618|NCT01139749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65551619|NCT01139749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65551620|NCT01139749|Analgesics|analgesics|mesh-ancestor
65551621|NCT01139749|Sensory System Agents|sensory system agents|mesh-ancestor
65551622|NCT01139749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551623|NCT01139749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551624|NCT01139749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65551625|NCT01139749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65551626|NCT01139749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65551627|NCT01139749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551628|NCT01139749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551629|NCT04748419|Durvalumab|durvalumab|mesh-list
65551630|NCT04748419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65551631|NCT04748419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551632|NCT02305810|Everolimus|everolimus|mesh-list
65551633|NCT02305810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551634|NCT02305810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65551635|NCT02305810|Immunologic Factors|immunologic factors|mesh-ancestor
65551636|NCT02305810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551637|NCT01142869|Cetuximab|cetuximab|mesh-list
65551638|NCT01142869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65551639|NCT01142869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551640|NCT01139905|Ritonavir|ritonavir|mesh-list
65551641|NCT01139905|Lopinavir|lopinavir|mesh-list
65551642|NCT01139905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65551643|NCT01139905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65551644|NCT01139905|Protease Inhibitors|protease inhibitors|mesh-ancestor
65551645|NCT01139905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551646|NCT01139905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551647|NCT01139905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65551648|NCT01139905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65551649|NCT01139905|Antiviral Agents|antiviral agents|mesh-ancestor
65551650|NCT01139905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65551651|NCT01139905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65551652|NCT01139905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65551653|NCT05044429|Lidocaine|lidocaine|mesh-list
65551654|NCT05044429|Anesthetics, Local|anesthetics, local|mesh-ancestor
65551655|NCT05044429|Anesthetics|anesthetics|mesh-ancestor
65551656|NCT05044429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65551657|NCT05044429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551658|NCT05044429|Sensory System Agents|sensory system agents|mesh-ancestor
65551659|NCT05044429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551660|NCT05044429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65551661|NCT05044429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65551662|NCT05044429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65551663|NCT05044429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65551664|NCT05044429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551665|NCT02309554|Nonoxynol|nonoxynol|mesh-list
65551666|NCT02309554|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
65551667|NCT02309554|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
65551668|NCT02309554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551669|NCT02309554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65551670|NCT02309554|Contraceptive Agents|contraceptive agents|mesh-ancestor
65551671|NCT02309554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65551672|NCT02309554|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65551673|NCT01143025|Ropivacaine|ropivacaine|mesh-list
65551674|NCT01143025|Anesthetics, Local|anesthetics, local|mesh-ancestor
65551675|NCT01143025|Anesthetics|anesthetics|mesh-ancestor
65551676|NCT01143025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65551677|NCT01143025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551678|NCT01143025|Sensory System Agents|sensory system agents|mesh-ancestor
65551679|NCT01143025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551680|NCT03502642|Morphine|morphine|mesh-list
65551681|NCT03502642|Ropivacaine|ropivacaine|mesh-list
65551682|NCT03502642|Anesthetics|anesthetics|mesh-ancestor
65551683|NCT03502642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65551684|NCT03502642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551685|NCT03502642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65551686|NCT03502642|Narcotics|narcotics|mesh-ancestor
65551687|NCT03502642|Analgesics|analgesics|mesh-ancestor
65551688|NCT03502642|Sensory System Agents|sensory system agents|mesh-ancestor
65551689|NCT03502642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551690|NCT03502642|Anesthetics, Local|anesthetics, local|mesh-ancestor
65551691|NCT02306278|Gabapentin|gabapentin|mesh-list
65551692|NCT02306278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551693|NCT02306278|Analgesics|analgesics|mesh-ancestor
65551694|NCT02306278|Sensory System Agents|sensory system agents|mesh-ancestor
65551695|NCT02306278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551696|NCT02306278|Anticonvulsants|anticonvulsants|mesh-ancestor
65551697|NCT02306278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65551698|NCT02306278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65551699|NCT02306278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65551700|NCT02306278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65551701|NCT02306278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65551702|NCT02306278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65551703|NCT02306278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65551704|NCT02306278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551705|NCT02306278|Antimanic Agents|antimanic agents|mesh-ancestor
65551706|NCT01234129|Zoledronic Acid|zoledronic acid|mesh-list
65551707|NCT01234129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65551708|NCT01234129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551709|NCT02313922|Etanercept|etanercept|mesh-list
65551710|NCT02313922|Methotrexate|methotrexate|mesh-list
65551711|NCT02313922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65551712|NCT02313922|Abortifacient Agents|abortifacient agents|mesh-ancestor
65551713|NCT02313922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65551714|NCT02313922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551715|NCT02313922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65551716|NCT02313922|Antimetabolites|antimetabolites|mesh-ancestor
65551717|NCT02313922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349275|NCT04035070|Clindamycin phosphate|clindamycin phosphate|mesh-list
65551718|NCT02313922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551719|NCT02313922|Dermatologic Agents|dermatologic agents|mesh-ancestor
65551720|NCT02313922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551721|NCT02313922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65551722|NCT02313922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65551723|NCT02313922|Immunologic Factors|immunologic factors|mesh-ancestor
65551724|NCT02313922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65551725|NCT02313922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65551726|NCT02313922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65551727|NCT02313922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65551728|NCT02313922|Analgesics|analgesics|mesh-ancestor
65551729|NCT02313922|Sensory System Agents|sensory system agents|mesh-ancestor
65551730|NCT02313922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551731|NCT02313922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65551732|NCT02313922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65551733|NCT03627013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65551734|NCT04629781|Docetaxel|docetaxel|mesh-list
65551735|NCT04629781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551736|NCT04629781|Tubulin Modulators|tubulin modulators|mesh-ancestor
65551737|NCT04629781|Antimitotic Agents|antimitotic agents|mesh-ancestor
65551738|NCT04629781|Mitosis Modulators|mitosis modulators|mesh-ancestor
65551739|NCT04629781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551740|NCT03508102|Remifentanil|remifentanil|mesh-list
65551741|NCT03508102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65551742|NCT03508102|Narcotics|narcotics|mesh-ancestor
65551743|NCT03508102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65551744|NCT03508102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551745|NCT03508102|Analgesics|analgesics|mesh-ancestor
65551746|NCT03508102|Sensory System Agents|sensory system agents|mesh-ancestor
65551747|NCT03508102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551748|NCT03505528|Paclitaxel|paclitaxel|mesh-list
65551749|NCT03505528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65551750|NCT03505528|Phenelzine|phenelzine|mesh-list
65551751|NCT03505528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65551752|NCT03505528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551753|NCT03505528|Tubulin Modulators|tubulin modulators|mesh-ancestor
65551754|NCT03505528|Antimitotic Agents|antimitotic agents|mesh-ancestor
65551755|NCT03505528|Mitosis Modulators|mitosis modulators|mesh-ancestor
65551756|NCT03505528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551757|NCT03505528|Antidepressive Agents|antidepressive agents|mesh-ancestor
65551758|NCT03505528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65551759|NCT03505528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65551760|NCT03505528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551761|NCT01234285|Heparin|heparin|mesh-list
65551762|NCT01234285|Calcium heparin|calcium heparin|mesh-list
65551763|NCT01234285|Anticoagulants|anticoagulants|mesh-ancestor
65551764|NCT01234285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65551765|NCT01234285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65551766|NCT01234285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551767|NCT02314312|Cyclosporine|cyclosporine|mesh-list
65551768|NCT02314312|Prednisolone|prednisolone|mesh-list
65551769|NCT02314312|Everolimus|everolimus|mesh-list
65551770|NCT02314312|Cyclosporins|cyclosporins|mesh-list
65551771|NCT02314312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551772|NCT02314312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551773|NCT02314312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65551774|NCT02314312|Immunologic Factors|immunologic factors|mesh-ancestor
65551775|NCT02314312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551776|NCT02314312|Antifungal Agents|antifungal agents|mesh-ancestor
65551777|NCT02314312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65551778|NCT02314312|Dermatologic Agents|dermatologic agents|mesh-ancestor
65551779|NCT02314312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65551780|NCT02314312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65551781|NCT02314312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551782|NCT02314312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65551783|NCT02314312|Glucocorticoids|glucocorticoids|mesh-ancestor
65551784|NCT02314312|Hormones|hormones|mesh-ancestor
65551785|NCT02314312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65551786|NCT02314312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65551787|NCT02316340|Hydroxychloroquine|hydroxychloroquine|mesh-list
65551788|NCT02316340|Vorinostat|vorinostat|mesh-list
65551789|NCT02316340|Antimalarials|antimalarials|mesh-ancestor
65551790|NCT02316340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65551791|NCT02316340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65551792|NCT02316340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65551793|NCT02316340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551794|NCT02316340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551795|NCT02316340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65551796|NCT02316340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551797|NCT02316340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65551798|NCT01140997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65551799|NCT01140997|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65551800|NCT01140997|Antiviral Agents|antiviral agents|mesh-ancestor
65551801|NCT01140997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65551802|NCT02310490|Mannitol|mannitol|mesh-list
65551803|NCT02310490|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65551804|NCT02310490|Diuretics|diuretics|mesh-ancestor
65551805|NCT02310490|Natriuretic Agents|natriuretic agents|mesh-ancestor
65551806|NCT02310490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551807|NCT02316496|Irinotecan|irinotecan|mesh-list
65551808|NCT02316496|Cetuximab|cetuximab|mesh-list
65551809|NCT02316496|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65551810|NCT02316496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65551811|NCT02316496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551812|NCT02316496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551813|NCT02316496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551814|NCT02316496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65551815|NCT01140529|Dexmedetomidine|dexmedetomidine|mesh-list
65551816|NCT01140529|Haloperidol|haloperidol|mesh-list
65551817|NCT01140529|Haloperidol decanoate|haloperidol decanoate|mesh-list
65551818|NCT01140529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65551819|NCT01140529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65551820|NCT01140529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551821|NCT01140529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65551822|NCT01140529|Analgesics|analgesics|mesh-ancestor
65551823|NCT01140529|Sensory System Agents|sensory system agents|mesh-ancestor
65551824|NCT01140529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551825|NCT01140529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65551826|NCT01140529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65551827|NCT01140529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65551828|NCT01140529|Adrenergic Agents|adrenergic agents|mesh-ancestor
65551829|NCT01140529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65551830|NCT01140529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551831|NCT01140529|Antiemetics|antiemetics|mesh-ancestor
65551832|NCT01140529|Autonomic Agents|autonomic agents|mesh-ancestor
65551833|NCT01140529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65551834|NCT01140529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65551835|NCT01140529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65551836|NCT01140529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65551837|NCT01140529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65551838|NCT01140529|Dopamine Agents|dopamine agents|mesh-ancestor
65551839|NCT01140529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65551840|NCT01141153|Aspirin|aspirin|mesh-list
65551841|NCT01141153|Acenocoumarol|acenocoumarol|mesh-list
65551842|NCT01141153|Clopidogrel|clopidogrel|mesh-list
65551843|NCT01141153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65551844|NCT01141153|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65551845|NCT01141153|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65551846|NCT01141153|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65551847|NCT01141153|Purinergic Agents|purinergic agents|mesh-ancestor
65551848|NCT01141153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65551849|NCT01141153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551850|NCT01141153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551851|NCT01141153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65551852|NCT01141153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65551853|NCT01141153|Analgesics|analgesics|mesh-ancestor
65551854|NCT01141153|Sensory System Agents|sensory system agents|mesh-ancestor
65551855|NCT01141153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551856|NCT01141153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65551857|NCT01141153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65551858|NCT01141153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65551859|NCT01141153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65551860|NCT01141153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65551861|NCT01141153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551862|NCT01141153|Antipyretics|antipyretics|mesh-ancestor
65551863|NCT01141153|Anticoagulants|anticoagulants|mesh-ancestor
65551864|NCT01235143|Sevoflurane|sevoflurane|mesh-list
65551865|NCT01235143|Desflurane|desflurane|mesh-list
65551866|NCT01235143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65551867|NCT01235143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65551868|NCT01235143|Anesthetics, General|anesthetics, general|mesh-ancestor
65551869|NCT01235143|Anesthetics|anesthetics|mesh-ancestor
65551870|NCT01235143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65551871|NCT01235143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551872|NCT01238029|Capecitabine|capecitabine|mesh-list
65280980|NCT00644306|Thalidomide|thalidomide|mesh-list
65551874|NCT01238029|Lapatinib|lapatinib|mesh-list
65551875|NCT01238029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65551876|NCT01238029|Antimetabolites|antimetabolites|mesh-ancestor
65551877|NCT01238029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551878|NCT01238029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551879|NCT01238029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65551880|NCT01238029|Tubulin Modulators|tubulin modulators|mesh-ancestor
65551881|NCT01238029|Antimitotic Agents|antimitotic agents|mesh-ancestor
65551882|NCT01238029|Mitosis Modulators|mitosis modulators|mesh-ancestor
65551883|NCT01238029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65551884|NCT01238029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551885|NCT01235221|4-Aminopyridine|4-aminopyridine|mesh-list
65551886|NCT01235221|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65551887|NCT01235221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65551888|NCT01235221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551889|NCT03139604|Prednisone|prednisone|mesh-list
65551890|NCT03139604|Methylprednisolone|methylprednisolone|mesh-list
65551891|NCT03139604|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65551892|NCT03139604|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65551893|NCT03139604|Prednisolone|prednisolone|mesh-list
65551894|NCT03139604|Prednisolone acetate|prednisolone acetate|mesh-list
65551895|NCT03139604|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65551896|NCT03139604|Prednisolone phosphate|prednisolone phosphate|mesh-list
65551897|NCT03139604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65551898|NCT03139604|Glucocorticoids|glucocorticoids|mesh-ancestor
65551899|NCT03139604|Hormones|hormones|mesh-ancestor
65551900|NCT03139604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65551901|NCT03139604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551902|NCT03139604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65551903|NCT03139604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551904|NCT03139604|Antiemetics|antiemetics|mesh-ancestor
65551905|NCT03139604|Autonomic Agents|autonomic agents|mesh-ancestor
65551906|NCT03139604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551907|NCT03139604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65551908|NCT03139604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65551909|NCT03139604|Protective Agents|protective agents|mesh-ancestor
65551910|NCT01350596|Ibuprofen|ibuprofen|mesh-list
65551911|NCT01350596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65551912|NCT01350596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65551913|NCT01350596|Analgesics|analgesics|mesh-ancestor
65551914|NCT01350596|Sensory System Agents|sensory system agents|mesh-ancestor
65551915|NCT01350596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551916|NCT01350596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551917|NCT01350596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65551918|NCT01350596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65551919|NCT01350596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65551920|NCT01350596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551921|NCT01350596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551922|NCT04462588|Metronidazole|metronidazole|mesh-list
65551923|NCT04462588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65551924|NCT04462588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65551925|NCT04462588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65551926|NCT04462588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65551927|NCT04462822|Fluticasone|fluticasone|mesh-list
65551928|NCT04462822|Xhance|xhance|mesh-list
65551929|NCT04462822|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65551930|NCT04462822|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65551931|NCT04462822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65551932|NCT04462822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65551933|NCT04462822|Autonomic Agents|autonomic agents|mesh-ancestor
65551934|NCT04462822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551935|NCT04462822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551936|NCT04462822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65551937|NCT04462822|Respiratory System Agents|respiratory system agents|mesh-ancestor
65551938|NCT04462822|Dermatologic Agents|dermatologic agents|mesh-ancestor
65551939|NCT04462822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65551940|NCT04462822|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65551941|NCT04462822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65551942|NCT04462822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65551943|NCT04462822|Adrenergic Agents|adrenergic agents|mesh-ancestor
65551944|NCT04462822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65551945|NCT04462822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551946|NCT04462822|Glucocorticoids|glucocorticoids|mesh-ancestor
65551947|NCT04462822|Hormones|hormones|mesh-ancestor
65551948|NCT04462822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65551949|NCT04462822|Sympathomimetics|sympathomimetics|mesh-ancestor
65551950|NCT01362218|Aspirin|aspirin|mesh-list
65551951|NCT01362218|Ramipril|ramipril|mesh-list
65551952|NCT01362218|Simvastatin|simvastatin|mesh-list
65551953|NCT01362218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65551954|NCT01362218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65551955|NCT01362218|Antimetabolites|antimetabolites|mesh-ancestor
65551956|NCT01362218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551957|NCT01362218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65551958|NCT01362218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65551959|NCT01362218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551960|NCT01362218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65551961|NCT01362218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65551962|NCT01362218|Analgesics|analgesics|mesh-ancestor
65551963|NCT01362218|Sensory System Agents|sensory system agents|mesh-ancestor
65551964|NCT01362218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551965|NCT01362218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551966|NCT01362218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65551967|NCT01362218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65551968|NCT01362218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65551969|NCT01362218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65551970|NCT01362218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65551971|NCT01362218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65551972|NCT01362218|Antipyretics|antipyretics|mesh-ancestor
65551973|NCT01362218|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65551974|NCT01362218|Protease Inhibitors|protease inhibitors|mesh-ancestor
65551975|NCT01362218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65551976|NCT02316964|Aldesleukin|aldesleukin|mesh-list
65551977|NCT02316964|Decitabine|decitabine|mesh-list
65551978|NCT02316964|Azacitidine|azacitidine|mesh-list
65551979|NCT02316964|Interleukin-2|interleukin-2|mesh-list
65551980|NCT02316964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65551981|NCT02316964|Antimetabolites|antimetabolites|mesh-ancestor
65551982|NCT02316964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551983|NCT02316964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65551984|NCT02316964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65551985|NCT02316964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65551986|NCT02316964|Analgesics|analgesics|mesh-ancestor
65551987|NCT02316964|Sensory System Agents|sensory system agents|mesh-ancestor
65551988|NCT02316964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65551989|NCT02316964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65551990|NCT02316964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65551991|NCT02316964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65551992|NCT02316964|Antiviral Agents|antiviral agents|mesh-ancestor
65551993|NCT02316964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65551994|NCT02875340|Risperidone|risperidone|mesh-list
65551995|NCT02875340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65551996|NCT02875340|Serotonin Agents|serotonin agents|mesh-ancestor
65551997|NCT02875340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65551998|NCT02875340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65551999|NCT02875340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552000|NCT02875340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65552001|NCT02875340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65552002|NCT02875340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65552003|NCT02875340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65552004|NCT02875340|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65552005|NCT02875340|Dopamine Agents|dopamine agents|mesh-ancestor
65552006|NCT03236857|Venetoclax|venetoclax|mesh-list
65552007|NCT03236857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552008|NCT04462666|Etoricoxib|etoricoxib|mesh-list
65552009|NCT04462666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65552010|NCT04462666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65552011|NCT04462666|Analgesics|analgesics|mesh-ancestor
65552012|NCT04462666|Sensory System Agents|sensory system agents|mesh-ancestor
65552013|NCT04462666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65552014|NCT04462666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552015|NCT04462666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65552016|NCT04462666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65552017|NCT04462666|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65552018|NCT04462666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65552019|NCT04462666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552020|NCT04462666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552021|NCT01359020|Acetaminophen|acetaminophen|mesh-list
65552022|NCT01359020|Dipyrone|dipyrone|mesh-list
65349574|NCT00394771|Estradiol|estradiol|mesh-list
65281124|NCT00644384|Acitretin|acitretin|mesh-list
65552023|NCT01359020|Ibuprofen|ibuprofen|mesh-list
65552024|NCT01359020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65552025|NCT01359020|Analgesics|analgesics|mesh-ancestor
65552026|NCT01359020|Sensory System Agents|sensory system agents|mesh-ancestor
65552027|NCT01359020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65552028|NCT01359020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552029|NCT01359020|Antipyretics|antipyretics|mesh-ancestor
65552030|NCT01359020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65552031|NCT01359020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65552032|NCT01359020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65552033|NCT01359020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65552034|NCT01359020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552035|NCT01359020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552036|NCT01359098|Ciprofloxacin|ciprofloxacin|mesh-list
65552037|NCT01359098|Dexamethasone|dexamethasone|mesh-list
65552038|NCT01359098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65552039|NCT01359098|Antiemetics|antiemetics|mesh-ancestor
65552040|NCT01359098|Autonomic Agents|autonomic agents|mesh-ancestor
65552041|NCT01359098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65552042|NCT01359098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552043|NCT01359098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65552044|NCT01359098|Glucocorticoids|glucocorticoids|mesh-ancestor
65552045|NCT01359098|Hormones|hormones|mesh-ancestor
65552046|NCT01359098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65552047|NCT01359098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65552048|NCT01359098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552049|NCT01359098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552050|NCT01359098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552051|NCT01359098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65552052|NCT01359098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65552053|NCT01359098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65552054|NCT01359098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65552055|NCT01359098|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65552056|NCT01359098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65552057|NCT05382871|Vaccines|vaccines|mesh-list
65552058|NCT05382871|Immunologic Factors|immunologic factors|mesh-ancestor
65552059|NCT05382871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552060|NCT01319240|Insulin|insulin|mesh-list
65552061|NCT01319240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65552062|NCT01319240|Liraglutide|liraglutide|mesh-list
65552063|NCT01319240|Insulin, Long-Acting|insulin, long-acting|mesh-list
65552064|NCT01319240|Xultophy|xultophy|mesh-list
65552065|NCT01319240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65552066|NCT01319240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552067|NCT01319240|Incretins|incretins|mesh-ancestor
65552068|NCT01319240|Hormones|hormones|mesh-ancestor
65552069|NCT01319240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65552070|NCT04463056|Eculizumab|eculizumab|mesh-list
65552071|NCT04463056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65552072|NCT04463056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65552073|NCT04463056|Immunologic Factors|immunologic factors|mesh-ancestor
65552074|NCT04463056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552075|NCT02315950|Botulinum Toxins|botulinum toxins|mesh-list
65552076|NCT02315950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65552077|NCT02315950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65552078|NCT02315950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552079|NCT02315950|Cholinergic Agents|cholinergic agents|mesh-ancestor
65552080|NCT02315950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65552081|NCT02315950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552082|NCT03319316|Durvalumab|durvalumab|mesh-list
65552083|NCT03319316|Tremelimumab|tremelimumab|mesh-list
65552084|NCT03319316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65552085|NCT03319316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552086|NCT02316028|Decitabine|decitabine|mesh-list
65552087|NCT02316028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65552088|NCT02316028|Antimetabolites|antimetabolites|mesh-ancestor
65552089|NCT02316028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552090|NCT02316028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552091|NCT02316028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552092|NCT01359488|Hormones|hormones|mesh-list
65552093|NCT01359488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
65552094|NCT01359488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65552095|NCT01359488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281197|NCT00959335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552096|NCT01141465|Fluticasone|fluticasone|mesh-list
65552097|NCT01141465|Xhance|xhance|mesh-list
65552098|NCT01141465|Budesonide|budesonide|mesh-list
65552099|NCT01141465|Formoterol Fumarate|formoterol fumarate|mesh-list
65552100|NCT01141465|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65552101|NCT01141465|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65552102|NCT01141465|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65552103|NCT01141465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65552104|NCT01141465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65552105|NCT01141465|Autonomic Agents|autonomic agents|mesh-ancestor
65552106|NCT01141465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65552107|NCT01141465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552108|NCT01141465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65552109|NCT01141465|Respiratory System Agents|respiratory system agents|mesh-ancestor
65552110|NCT01141465|Dermatologic Agents|dermatologic agents|mesh-ancestor
65552111|NCT01141465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65552112|NCT01141465|Glucocorticoids|glucocorticoids|mesh-ancestor
65552113|NCT01141465|Hormones|hormones|mesh-ancestor
65552114|NCT01141465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65552115|NCT01141465|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65552116|NCT01141465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65552117|NCT01141465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65552118|NCT01141465|Adrenergic Agents|adrenergic agents|mesh-ancestor
65552119|NCT01141465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65552120|NCT01141465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552121|NCT01141465|Sympathomimetics|sympathomimetics|mesh-ancestor
65552122|NCT01141543|Plerixafor|plerixafor|mesh-list
65552123|NCT01141543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65552124|NCT01141543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65552125|NCT01141543|Antiviral Agents|antiviral agents|mesh-ancestor
65552126|NCT01141543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65552127|NCT03300518|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65552128|NCT03300518|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65552129|NCT03300518|Estradiol|estradiol|mesh-list
65552130|NCT03300518|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65552131|NCT03300518|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65552132|NCT03300518|Ganirelix|ganirelix|mesh-list
65552133|NCT03300518|Estrogens|estrogens|mesh-ancestor
65552134|NCT03300518|Hormones|hormones|mesh-ancestor
65552135|NCT03300518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65552136|NCT03300518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552137|NCT03300518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65552138|NCT03300518|Contraceptive Agents|contraceptive agents|mesh-ancestor
65552139|NCT03300518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65552140|NCT03300518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65552141|NCT03300518|Hormone Antagonists|hormone antagonists|mesh-ancestor
65552142|NCT02317198|Clopidogrel|clopidogrel|mesh-list
65552143|NCT02317198|Ticagrelor|ticagrelor|mesh-list
65552144|NCT02317198|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65552145|NCT02317198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65552146|NCT02317198|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65552147|NCT02317198|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65552148|NCT02317198|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65552149|NCT02317198|Purinergic Agents|purinergic agents|mesh-ancestor
65552150|NCT02317198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65552151|NCT02317198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552152|NCT02317198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552153|NCT01359722|Acetylcysteine|acetylcysteine|mesh-list
65552154|NCT01359722|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65552155|NCT01359722|Antiviral Agents|antiviral agents|mesh-ancestor
65552156|NCT01359722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65552157|NCT01359722|Expectorants|expectorants|mesh-ancestor
65552158|NCT01359722|Respiratory System Agents|respiratory system agents|mesh-ancestor
65552159|NCT01359722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65552160|NCT01359722|Antioxidants|antioxidants|mesh-ancestor
65552161|NCT01359722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552162|NCT01359722|Protective Agents|protective agents|mesh-ancestor
65552163|NCT01359722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552164|NCT01359722|Antidotes|antidotes|mesh-ancestor
65552165|NCT01238185|Aspirin|aspirin|mesh-list
65552166|NCT01238185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65552167|NCT01238185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65552168|NCT01238185|Analgesics|analgesics|mesh-ancestor
65552169|NCT01238185|Sensory System Agents|sensory system agents|mesh-ancestor
65552170|NCT01238185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65552171|NCT01238185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552172|NCT01238185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65552173|NCT01238185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65552174|NCT01238185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65552175|NCT01238185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65552176|NCT01238185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552177|NCT01238185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65552178|NCT01238185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65552179|NCT01238185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552180|NCT01238185|Antipyretics|antipyretics|mesh-ancestor
65552181|NCT01143805|Tofacitinib|tofacitinib|mesh-list
65552182|NCT01143805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65552183|NCT01143805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552184|NCT01143805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552185|NCT01362764|Abiraterone Acetate|abiraterone acetate|mesh-list
65552186|NCT01362764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552187|NCT01362764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65552188|NCT01362764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552189|NCT01362764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552190|NCT01362764|Hormone Antagonists|hormone antagonists|mesh-ancestor
65552191|NCT01362764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65552192|NCT01362764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552193|NCT01362764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65552194|NCT03498118|Bupivacaine|bupivacaine|mesh-list
65552195|NCT03498118|Anesthetics, Local|anesthetics, local|mesh-ancestor
65552196|NCT03498118|Anesthetics|anesthetics|mesh-ancestor
65552197|NCT03498118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65552198|NCT03498118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552199|NCT03498118|Sensory System Agents|sensory system agents|mesh-ancestor
65552200|NCT03498118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65552201|NCT05188742|Mirabegron|mirabegron|mesh-list
65552202|NCT05188742|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65552203|NCT05188742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65552204|NCT05188742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65552205|NCT05188742|Adrenergic Agents|adrenergic agents|mesh-ancestor
65552206|NCT05188742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65552207|NCT05188742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552208|NCT05188742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552209|NCT05188742|Urological Agents|urological agents|mesh-ancestor
65552210|NCT02324452|Fluorouracil|fluorouracil|mesh-list
65552211|NCT02324452|Capecitabine|capecitabine|mesh-list
65552212|NCT02324452|Antimetabolites|antimetabolites|mesh-ancestor
65552213|NCT02324452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552214|NCT02324452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65552215|NCT02324452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552216|NCT02324452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65552217|NCT02324452|Immunologic Factors|immunologic factors|mesh-ancestor
65552218|NCT02324452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552219|NCT02321176|Resveratrol|resveratrol|mesh-list
65552220|NCT02321176|Antioxidants|antioxidants|mesh-ancestor
65552221|NCT02321176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552222|NCT02321176|Protective Agents|protective agents|mesh-ancestor
65552223|NCT02321176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552224|NCT02321176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552225|NCT02321176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65552226|NCT01351298|Lidocaine|lidocaine|mesh-list
65552227|NCT01351298|Xylometazoline|xylometazoline|mesh-list
65552228|NCT01351298|Anesthetics, Local|anesthetics, local|mesh-ancestor
65552229|NCT01351298|Anesthetics|anesthetics|mesh-ancestor
65552230|NCT01351298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65552231|NCT01351298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552232|NCT01351298|Sensory System Agents|sensory system agents|mesh-ancestor
65552233|NCT01351298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65552234|NCT01351298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65552235|NCT01351298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65552236|NCT01351298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65552237|NCT01351298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65552238|NCT01351298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552239|NCT01351298|Nasal Decongestants|nasal decongestants|mesh-ancestor
65552240|NCT01351298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65552241|NCT01351298|Respiratory System Agents|respiratory system agents|mesh-ancestor
65552242|NCT02324686|Vitamin K|vitamin k|mesh-list
65552243|NCT02324686|Vitamin K 1|vitamin k 1|mesh-list
65552244|NCT02324686|Vitamins|vitamins|mesh-ancestor
65552245|NCT02324686|Micronutrients|micronutrients|mesh-ancestor
65349800|NCT00931840|Irinotecan|irinotecan|mesh-list
65552246|NCT02324686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552247|NCT02324686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65552248|NCT02324686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65552249|NCT02324686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552250|NCT02324686|Hemostatics|hemostatics|mesh-ancestor
65552251|NCT02324686|Coagulants|coagulants|mesh-ancestor
65552252|NCT01360034|Indomethacin|indomethacin|mesh-list
65552253|NCT01360034|Nifedipine|nifedipine|mesh-list
65552254|NCT01360034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65552255|NCT01360034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65552256|NCT01360034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552257|NCT01360034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65552258|NCT01360034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552259|NCT01360034|Vasodilator Agents|vasodilator agents|mesh-ancestor
65552260|NCT01360034|Tocolytic Agents|tocolytic agents|mesh-ancestor
65552261|NCT01360034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65552262|NCT01360034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65552263|NCT01360034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65552264|NCT01360034|Analgesics|analgesics|mesh-ancestor
65552265|NCT01360034|Sensory System Agents|sensory system agents|mesh-ancestor
65552266|NCT01360034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65552267|NCT01360034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65552268|NCT01360034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65552269|NCT01360034|Gout Suppressants|gout suppressants|mesh-ancestor
65552270|NCT01360034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65552271|NCT01360034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552272|NCT01363310|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65552273|NCT01363310|Citalopram|citalopram|mesh-list
65552274|NCT01363310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65552275|NCT01363310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65552276|NCT01363310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65552277|NCT01363310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552278|NCT01363310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65552279|NCT01363310|Serotonin Agents|serotonin agents|mesh-ancestor
65552280|NCT01363310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552281|NCT01363310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65552282|NCT01363310|Antidepressive Agents|antidepressive agents|mesh-ancestor
65552283|NCT01363310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65552284|NCT01363310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65552285|NCT01363310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65552286|NCT01363310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65552287|NCT01363544|Methylphenidate|methylphenidate|mesh-list
65552288|NCT01363544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65552289|NCT01363544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552290|NCT01363544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65552291|NCT01363544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65552292|NCT01363544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65552293|NCT01363544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552294|NCT01363544|Dopamine Agents|dopamine agents|mesh-ancestor
65552295|NCT01363544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65552296|NCT03257618|Temozolomide|temozolomide|mesh-list
65552297|NCT03257618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65552298|NCT03257618|Alkylating Agents|alkylating agents|mesh-ancestor
65552299|NCT03257618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552300|NCT03257618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552301|NCT04175834|Cetirizine|cetirizine|mesh-list
65552302|NCT04175834|Histamine Antagonists|histamine antagonists|mesh-list
65552303|NCT04175834|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
65552304|NCT04175834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65552305|NCT04175834|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65552306|NCT04175834|Histamine Agents|histamine agents|mesh-ancestor
65552307|NCT04175834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65552308|NCT04175834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552309|NCT04175834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552310|NCT02324998|Olaparib|olaparib|mesh-list
65552311|NCT02324998|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65552312|NCT02324998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552313|NCT02324998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552314|NCT02324998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552315|NCT03500848|Mycophenolic Acid|mycophenolic acid|mesh-list
65552316|NCT03500848|Sirolimus|sirolimus|mesh-list
65552317|NCT03500848|Tacrolimus|tacrolimus|mesh-list
65349885|NCT04014634|Hormones|hormones|mesh-ancestor
65552318|NCT03500848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65552319|NCT03500848|Immunologic Factors|immunologic factors|mesh-ancestor
65552320|NCT03500848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552321|NCT03500848|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65552322|NCT03500848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552323|NCT03500848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552324|NCT03500848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65552325|NCT03500848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552326|NCT03500848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65552327|NCT03500848|Antitubercular Agents|antitubercular agents|mesh-ancestor
65552328|NCT03500848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65552329|NCT03500848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65552330|NCT03500848|Antifungal Agents|antifungal agents|mesh-ancestor
65552332|NCT01360190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65552333|NCT01360190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65552334|NCT01360190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65552335|NCT01360190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552336|NCT01360190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65552337|NCT01360190|Serotonin Agents|serotonin agents|mesh-ancestor
65552338|NCT01360190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552339|NCT01360190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65552340|NCT01360190|Antidepressive Agents|antidepressive agents|mesh-ancestor
65552341|NCT01360190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65552342|NCT01360190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65552343|NCT01360190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65552344|NCT01360190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552345|NCT01363934|Darbepoetin alfa|darbepoetin alfa|mesh-list
65552346|NCT01363934|Hematinics|hematinics|mesh-ancestor
65552347|NCT03132376|Caseins|caseins|mesh-list
65552348|NCT03132376|Chelating Agents|chelating agents|mesh-ancestor
65552349|NCT03132376|Sequestering Agents|sequestering agents|mesh-ancestor
65552350|NCT03132376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552351|NCT01364012|Paclitaxel|paclitaxel|mesh-list
65552352|NCT01364012|Bevacizumab|bevacizumab|mesh-list
65552353|NCT01364012|Carboplatin|carboplatin|mesh-list
65552354|NCT01364012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65552355|NCT01364012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552356|NCT01364012|Tubulin Modulators|tubulin modulators|mesh-ancestor
65552357|NCT01364012|Antimitotic Agents|antimitotic agents|mesh-ancestor
65552358|NCT01364012|Mitosis Modulators|mitosis modulators|mesh-ancestor
65552359|NCT01364012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552360|NCT01364012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65552361|NCT01364012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65552362|NCT01364012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65552363|NCT01364012|Growth Substances|growth substances|mesh-ancestor
65552364|NCT01364012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552365|NCT01364012|Growth Inhibitors|growth inhibitors|mesh-ancestor
65552366|NCT02318056|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65552367|NCT02318056|Bacitracin|bacitracin|mesh-list
65552368|NCT02318056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65552369|NCT02318056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65552370|NCT02318056|Laxatives|laxatives|mesh-ancestor
65552371|NCT02318056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65552372|NCT02318056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65552373|NCT05188118|Nivolumab|nivolumab|mesh-list
65552374|NCT05188118|Ipilimumab|ipilimumab|mesh-list
65552375|NCT05188118|Everolimus|everolimus|mesh-list
65552376|NCT05188118|Lenvatinib|lenvatinib|mesh-list
65552377|NCT05188118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65552378|NCT05188118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552379|NCT05188118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65552380|NCT05188118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552381|NCT05188118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65552382|NCT05188118|Immunologic Factors|immunologic factors|mesh-ancestor
65552383|NCT05188118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552384|NCT05188118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65552385|NCT05188118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552386|NCT01360424|Teriparatide|teriparatide|mesh-list
65552387|NCT01360424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65552388|NCT01360424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552389|NCT01360424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65552390|NCT01364324|Antitubercular Agents|antitubercular agents|mesh-list
65552391|NCT01364324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65552392|NCT01364324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65552393|NCT01364402|Epoetin Alfa|epoetin alfa|mesh-list
65552394|NCT01364402|Hematinics|hematinics|mesh-ancestor
65552395|NCT03552380|Nivolumab|nivolumab|mesh-list
65552396|NCT03552380|Ipilimumab|ipilimumab|mesh-list
65552397|NCT03552380|Entinostat|entinostat|mesh-list
65552398|NCT03552380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65552399|NCT03552380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552400|NCT03552380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65552401|NCT03552380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552402|NCT03552380|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65552403|NCT03552380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552404|NCT02318290|Analgesics|analgesics|mesh-list
65552405|NCT02318290|Narcotics|narcotics|mesh-list
65552406|NCT02318290|Sensory System Agents|sensory system agents|mesh-ancestor
65552407|NCT02318290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65552408|NCT02318290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552409|NCT02318290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65552410|NCT03467360|Etoposide|etoposide|mesh-list
65552411|NCT03467360|Acetazolamide|acetazolamide|mesh-list
65552412|NCT03467360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65552413|NCT03467360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552414|NCT03467360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65552415|NCT03467360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65552416|NCT03467360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552417|NCT03467360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552418|NCT03467360|Anticonvulsants|anticonvulsants|mesh-ancestor
65552419|NCT03467360|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65552420|NCT03467360|Diuretics|diuretics|mesh-ancestor
65552421|NCT03467360|Natriuretic Agents|natriuretic agents|mesh-ancestor
65552422|NCT03467360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552423|NCT03452072|Timolol|timolol|mesh-list
65552424|NCT03452072|Petrolatum|petrolatum|mesh-list
65552425|NCT03452072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65552426|NCT03452072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65552427|NCT03452072|Adrenergic Agents|adrenergic agents|mesh-ancestor
65552428|NCT03452072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65552429|NCT03452072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552430|NCT03452072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552431|NCT03452072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65552432|NCT03452072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65552433|NCT03452072|Emollients|emollients|mesh-ancestor
65552434|NCT03452072|Dermatologic Agents|dermatologic agents|mesh-ancestor
65552435|NCT03433040|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
65552436|NCT03433040|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
65552437|NCT03433040|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65552438|NCT03433040|Hormone Antagonists|hormone antagonists|mesh-ancestor
65552439|NCT03433040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65552440|NCT03433040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552441|NCT03433040|Progestins|progestins|mesh-ancestor
65552442|NCT03433040|Hormones|hormones|mesh-ancestor
65552443|NCT02318446|Folic Acid|folic acid|mesh-list
65552444|NCT02318446|Hematinics|hematinics|mesh-ancestor
65552445|NCT02318446|Vitamin B Complex|vitamin b complex|mesh-ancestor
65552446|NCT02318446|Vitamins|vitamins|mesh-ancestor
65552447|NCT02318446|Micronutrients|micronutrients|mesh-ancestor
65552448|NCT02318446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552449|NCT02325934|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65552450|NCT02325934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65552451|NCT02325934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65552452|NCT02325934|Antiviral Agents|antiviral agents|mesh-ancestor
65552453|NCT02325934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65552454|NCT01360658|Immunoglobulins|immunoglobulins|mesh-list
65552455|NCT01360658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65552456|NCT01360658|Antibodies|antibodies|mesh-list
65552457|NCT01360658|gamma-Globulins|gamma-globulins|mesh-list
65552458|NCT01360658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65552459|NCT01360658|Immunologic Factors|immunologic factors|mesh-ancestor
65552460|NCT01360658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552461|NCT02318758|Ethanol|ethanol|mesh-list
65552462|NCT02318758|Treprostinil|treprostinil|mesh-list
65552463|NCT02318758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65552464|NCT02318758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65281576|NCT01563289|Ibuprofen|ibuprofen|mesh-list
65552465|NCT02318758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65552466|NCT02318758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552467|NCT02318758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65552468|NCT02441686|Dexamethasone|dexamethasone|mesh-list
65552469|NCT02441686|Lenalidomide|lenalidomide|mesh-list
65552470|NCT02441686|Bortezomib|bortezomib|mesh-list
65552471|NCT02441686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65552472|NCT02441686|Antiemetics|antiemetics|mesh-ancestor
65552473|NCT02441686|Autonomic Agents|autonomic agents|mesh-ancestor
65552474|NCT02441686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65552475|NCT02441686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552476|NCT02441686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65552477|NCT02441686|Glucocorticoids|glucocorticoids|mesh-ancestor
65552478|NCT02441686|Hormones|hormones|mesh-ancestor
65552479|NCT02441686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65552480|NCT02441686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65552481|NCT02441686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552482|NCT02441686|Immunologic Factors|immunologic factors|mesh-ancestor
65552483|NCT02441686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65552484|NCT02441686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65552485|NCT02441686|Growth Substances|growth substances|mesh-ancestor
65552486|NCT02441686|Growth Inhibitors|growth inhibitors|mesh-ancestor
65552487|NCT03500146|Cholinergic Antagonists|cholinergic antagonists|mesh-list
65552488|NCT03500146|Cholinergic Agents|cholinergic agents|mesh-ancestor
65552489|NCT03500146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65552490|NCT03500146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552491|NCT03500146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552492|NCT01352234|Aspirin|aspirin|mesh-list
65552493|NCT01352234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65552494|NCT01352234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65552495|NCT01352234|Analgesics|analgesics|mesh-ancestor
65552496|NCT01352234|Sensory System Agents|sensory system agents|mesh-ancestor
65552497|NCT01352234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65552498|NCT01352234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552499|NCT01352234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65552500|NCT01352234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65552501|NCT01352234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65552502|NCT01352234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65552503|NCT01352234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552504|NCT01352234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65552505|NCT01352234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65552506|NCT01352234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552507|NCT01352234|Antipyretics|antipyretics|mesh-ancestor
65552508|NCT01364792|Valacyclovir|valacyclovir|mesh-list
65552509|NCT01364792|Antiviral Agents|antiviral agents|mesh-ancestor
65552510|NCT01364792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65552511|NCT02318836|Lofexidine|lofexidine|mesh-list
65552512|NCT02318836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65552513|NCT02318836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65552514|NCT02318836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552515|NCT02318836|Sensory System Agents|sensory system agents|mesh-ancestor
65552516|NCT02318836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65552517|NCT02318836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65552518|NCT02318836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65552519|NCT02318836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65552520|NCT02318836|Adrenergic Agents|adrenergic agents|mesh-ancestor
65552521|NCT02318836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65552522|NCT02318836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552523|NCT01352312|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65552524|NCT01352312|Ofatumumab|ofatumumab|mesh-list
65552525|NCT01352312|Pentostatin|pentostatin|mesh-list
65552526|NCT01352312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65552527|NCT01352312|Alkylating Agents|alkylating agents|mesh-ancestor
65552528|NCT01352312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552529|NCT01352312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552530|NCT01352312|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65552531|NCT01352312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552532|NCT02939209|Hydromorphone|hydromorphone|mesh-list
65552533|NCT02939209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65552534|NCT02939209|Narcotics|narcotics|mesh-ancestor
65552535|NCT02939209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65552536|NCT02939209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552537|NCT02939209|Analgesics|analgesics|mesh-ancestor
65552538|NCT02939209|Sensory System Agents|sensory system agents|mesh-ancestor
65552539|NCT02939209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65552540|NCT01141855|Varenicline|varenicline|mesh-list
65552541|NCT01141855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65552542|NCT01141855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65552543|NCT01141855|Cholinergic Agents|cholinergic agents|mesh-ancestor
65552544|NCT01141855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65552545|NCT01141855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552546|NCT01141855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552547|NCT01236859|Gabapentin|gabapentin|mesh-list
65552548|NCT01236859|Analgesics|analgesics|mesh-ancestor
65552549|NCT01236859|Sensory System Agents|sensory system agents|mesh-ancestor
65552550|NCT01236859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65552551|NCT01236859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552552|NCT01236859|Anticonvulsants|anticonvulsants|mesh-ancestor
65552553|NCT01236859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65552554|NCT01236859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65552555|NCT01236859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65552556|NCT01236859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65552557|NCT01236859|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65552558|NCT01236859|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65552559|NCT01236859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65552560|NCT01236859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552561|NCT01236859|Antimanic Agents|antimanic agents|mesh-ancestor
65552562|NCT01145365|Anesthetics|anesthetics|mesh-list
65552563|NCT01145365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65552564|NCT01145365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552565|NCT04967092|Anti-Allergic Agents|anti-allergic agents|mesh-list
65552566|NCT01365104|Deferoxamine|deferoxamine|mesh-list
65552567|NCT01365104|Siderophores|siderophores|mesh-ancestor
65552568|NCT01365104|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65552569|NCT01365104|Chelating Agents|chelating agents|mesh-ancestor
65552570|NCT01365104|Sequestering Agents|sequestering agents|mesh-ancestor
65552571|NCT01365104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552572|NCT03492970|Melatonin|melatonin|mesh-list
65552573|NCT03492970|Antioxidants|antioxidants|mesh-ancestor
65552574|NCT03492970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552575|NCT03492970|Protective Agents|protective agents|mesh-ancestor
65552576|NCT03492970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552577|NCT03492970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65552578|NCT01362374|Leucovorin|leucovorin|mesh-list
65552579|NCT01362374|Paclitaxel|paclitaxel|mesh-list
65552580|NCT01362374|Docetaxel|docetaxel|mesh-list
65552581|NCT01362374|Oxaliplatin|oxaliplatin|mesh-list
65552582|NCT01362374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65552583|NCT01362374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552584|NCT01362374|Tubulin Modulators|tubulin modulators|mesh-ancestor
65552585|NCT01362374|Antimitotic Agents|antimitotic agents|mesh-ancestor
65552586|NCT01362374|Mitosis Modulators|mitosis modulators|mesh-ancestor
65552587|NCT01362374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552588|NCT01362374|Antidotes|antidotes|mesh-ancestor
65552589|NCT01362374|Protective Agents|protective agents|mesh-ancestor
65552590|NCT01362374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552591|NCT01362374|Vitamin B Complex|vitamin b complex|mesh-ancestor
65552592|NCT01362374|Vitamins|vitamins|mesh-ancestor
65552593|NCT01362374|Micronutrients|micronutrients|mesh-ancestor
65552594|NCT01142011|Belimumab|belimumab|mesh-list
65552595|NCT01142011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65552596|NCT01142011|Immunologic Factors|immunologic factors|mesh-ancestor
65552597|NCT01142011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552598|NCT02319460|Thrombin|thrombin|mesh-list
65552599|NCT02319460|Hemostatics|hemostatics|mesh-ancestor
65552600|NCT02319460|Coagulants|coagulants|mesh-ancestor
65552601|NCT04722952|Cytarabine|cytarabine|mesh-list
65552602|NCT04722952|Azacitidine|azacitidine|mesh-list
65552603|NCT04722952|Homoharringtonine|homoharringtonine|mesh-list
65552604|NCT04722952|Visilizumab|visilizumab|mesh-list
65552605|NCT04722952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65552606|NCT04722952|Antimetabolites|antimetabolites|mesh-ancestor
65552607|NCT04722952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552608|NCT04722952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552609|NCT04722952|Antiviral Agents|antiviral agents|mesh-ancestor
65552610|NCT04722952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65552611|NCT04722952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65552612|NCT04722952|Immunologic Factors|immunologic factors|mesh-ancestor
65552613|NCT04722952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552614|NCT04722952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281728|NCT00659412|Methotrexate|methotrexate|mesh-list
65552615|NCT04722952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65552616|NCT04722952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65552617|NCT01365260|Hyaluronic Acid|hyaluronic acid|mesh-list
65552618|NCT01365260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65552619|NCT01365260|Immunologic Factors|immunologic factors|mesh-ancestor
65552620|NCT01365260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552621|NCT01365260|Viscosupplements|viscosupplements|mesh-ancestor
65552622|NCT01365260|Protective Agents|protective agents|mesh-ancestor
65552623|NCT01235455|Interferons|interferons|mesh-list
65552624|NCT01235455|Interferon-beta|interferon-beta|mesh-list
65552625|NCT01235455|Interferon beta-1b|interferon beta-1b|mesh-list
65552626|NCT01235455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552627|NCT01235455|Antiviral Agents|antiviral agents|mesh-ancestor
65552628|NCT01235455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65552629|NCT01235455|Immunologic Factors|immunologic factors|mesh-ancestor
65552630|NCT01235455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552631|NCT01235455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65552632|NCT01145677|Topiramate|topiramate|mesh-list
65552633|NCT01145677|Anticonvulsants|anticonvulsants|mesh-ancestor
65552634|NCT01145677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65552635|NCT01145677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552636|NCT03499444|Rucaparib|rucaparib|mesh-list
65552637|NCT03499444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65552638|NCT03499444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552639|NCT03499444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552640|NCT03499444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552641|NCT02319616|Clobetasol|clobetasol|mesh-list
65552642|NCT02319616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65552643|NCT02319616|Glucocorticoids|glucocorticoids|mesh-ancestor
65552644|NCT02319616|Hormones|hormones|mesh-ancestor
65552645|NCT02319616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65552646|NCT02319616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552647|NCT01142245|Esomeprazole|esomeprazole|mesh-list
65552648|NCT01142245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65552649|NCT01142245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65552650|NCT01142245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65552651|NCT01142245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552652|NCT01142245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552653|NCT02319772|Galidesivir|galidesivir|mesh-list
65552654|NCT02319772|Antiviral Agents|antiviral agents|mesh-ancestor
65552655|NCT02319772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65552656|NCT03959527|Azithromycin|azithromycin|mesh-list
65552657|NCT03959527|Ceftriaxone|ceftriaxone|mesh-list
65552658|NCT03959527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65552659|NCT03959527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65552660|NCT03499132|Anesthetics|anesthetics|mesh-list
65552661|NCT03499132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65552662|NCT03499132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552663|NCT01142401|Bortezomib|bortezomib|mesh-list
65552664|NCT01142401|Fulvestrant|fulvestrant|mesh-list
65552665|NCT01142401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552666|NCT01142401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65552667|NCT01142401|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65552668|NCT01142401|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65552669|NCT01142401|Hormone Antagonists|hormone antagonists|mesh-ancestor
65552670|NCT01142401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65552671|NCT01142401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552672|NCT03498898|Adrenergic Agents|adrenergic agents|mesh-list
65552673|NCT03498898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65552674|NCT03498898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552675|NCT03498898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552676|NCT03498820|Remifentanil|remifentanil|mesh-list
65552677|NCT03498820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65552678|NCT03498820|Narcotics|narcotics|mesh-ancestor
65552679|NCT03498820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65552680|NCT03498820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552681|NCT03498820|Analgesics|analgesics|mesh-ancestor
65552682|NCT03498820|Sensory System Agents|sensory system agents|mesh-ancestor
65552683|NCT03498820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65552684|NCT05158309|Capsaicin|capsaicin|mesh-list
65552685|NCT05158309|Antipruritics|antipruritics|mesh-ancestor
65552686|NCT05158309|Dermatologic Agents|dermatologic agents|mesh-ancestor
65552687|NCT05158309|Sensory System Agents|sensory system agents|mesh-ancestor
65552688|NCT05158309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65552689|NCT05158309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552690|NCT02320084|Nitisinone|nitisinone|mesh-list
65552691|NCT02320084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552692|NCT02320084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552693|NCT02320240|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65552694|NCT02320240|Fluvoxamine|fluvoxamine|mesh-list
65552695|NCT02320240|Citalopram|citalopram|mesh-list
65552696|NCT02320240|Fluoxetine|fluoxetine|mesh-list
65350244|NCT00391027|Insulin|insulin|mesh-list
65552697|NCT02320240|Paroxetine|paroxetine|mesh-list
65552698|NCT02320240|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65552699|NCT02320240|Sertraline|sertraline|mesh-list
65552700|NCT02320240|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65552701|NCT02320240|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65552702|NCT02320240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65552703|NCT02320240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65552704|NCT02320240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552705|NCT02320240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65552706|NCT02320240|Serotonin Agents|serotonin agents|mesh-ancestor
65552707|NCT02320240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552708|NCT02320240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65552709|NCT02320240|Antidepressive Agents|antidepressive agents|mesh-ancestor
65552710|NCT02320240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65552711|NCT02320240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65552712|NCT02320240|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65552713|NCT02320240|Analgesics|analgesics|mesh-ancestor
65552714|NCT02320240|Sensory System Agents|sensory system agents|mesh-ancestor
65552715|NCT02320240|Dopamine Agents|dopamine agents|mesh-ancestor
65552716|NCT02320240|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65552717|NCT02320240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65552718|NCT02320240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552719|NCT02320240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65552720|NCT02320240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65552721|NCT02320240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65552722|NCT02320240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65552723|NCT02320240|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65552724|NCT03492736|Melatonin|melatonin|mesh-list
65552725|NCT03492736|Antioxidants|antioxidants|mesh-ancestor
65552726|NCT03492736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552727|NCT03492736|Protective Agents|protective agents|mesh-ancestor
65552728|NCT03492736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552729|NCT03492736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65552730|NCT02320474|Aflibercept|aflibercept|mesh-list
65552731|NCT02320474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65552732|NCT02320474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65552733|NCT02320474|Growth Substances|growth substances|mesh-ancestor
65552734|NCT02320474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552735|NCT02320474|Growth Inhibitors|growth inhibitors|mesh-ancestor
65552736|NCT02320474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552737|NCT03492580|Dapagliflozin|dapagliflozin|mesh-list
65552738|NCT03492580|Empagliflozin|empagliflozin|mesh-list
65552739|NCT03492580|Canagliflozin|canagliflozin|mesh-list
65552740|NCT03492580|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
65552741|NCT03492580|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65552742|NCT03492580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65552743|NCT03492580|Glucagon|glucagon|mesh-list
65552744|NCT03492580|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65552745|NCT03492580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552746|NCT03492580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65552747|NCT03492580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552748|NCT03492580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65552749|NCT03492580|Hormones|hormones|mesh-ancestor
65552750|NCT03492580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65552751|NCT03492580|Incretins|incretins|mesh-ancestor
65552752|NCT03492580|Protease Inhibitors|protease inhibitors|mesh-ancestor
65552753|NCT03492580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552754|NCT01238965|Calcium, Dietary|calcium, dietary|mesh-list
65552755|NCT01238965|Leucovorin|leucovorin|mesh-list
65552756|NCT01238965|Fluorouracil|fluorouracil|mesh-list
65552757|NCT01238965|Panobinostat|panobinostat|mesh-list
65552758|NCT01238965|Calcium|calcium|mesh-list
65552759|NCT01238965|Levoleucovorin|levoleucovorin|mesh-list
65552760|NCT01238965|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65552761|NCT01238965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65552762|NCT01238965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552763|NCT01238965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65552764|NCT01238965|Antimetabolites|antimetabolites|mesh-ancestor
65552765|NCT01238965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552766|NCT01238965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65552767|NCT01238965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552768|NCT01238965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65552769|NCT01238965|Immunologic Factors|immunologic factors|mesh-ancestor
65350329|NCT02548923|Propofol|propofol|mesh-list
65552770|NCT01238965|Antidotes|antidotes|mesh-ancestor
65552771|NCT01238965|Protective Agents|protective agents|mesh-ancestor
65552772|NCT01238965|Vitamin B Complex|vitamin b complex|mesh-ancestor
65552773|NCT01238965|Vitamins|vitamins|mesh-ancestor
65552774|NCT01238965|Micronutrients|micronutrients|mesh-ancestor
65552775|NCT01238965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552776|NCT01142557|Interferons|interferons|mesh-list
65552777|NCT01142557|Interferon-beta|interferon-beta|mesh-list
65552778|NCT01142557|Interferon beta-1a|interferon beta-1a|mesh-list
65552779|NCT01142557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552780|NCT01142557|Antiviral Agents|antiviral agents|mesh-ancestor
65552781|NCT01142557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65552782|NCT01142557|Immunologic Factors|immunologic factors|mesh-ancestor
65552783|NCT01142557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552784|NCT01142557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65552785|NCT04496908|Misoprostol|misoprostol|mesh-list
65552786|NCT04496908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65552787|NCT04496908|Abortifacient Agents|abortifacient agents|mesh-ancestor
65552788|NCT04496908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65552789|NCT04496908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552790|NCT04496908|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65552791|NCT04496908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65552792|NCT04496908|Oxytocics|oxytocics|mesh-ancestor
65552793|NCT01144117|Epoetin Alfa|epoetin alfa|mesh-list
65552794|NCT01144117|Hematinics|hematinics|mesh-ancestor
65552795|NCT04987294|Rasburicase|rasburicase|mesh-list
65552796|NCT04987294|Gout Suppressants|gout suppressants|mesh-ancestor
65552797|NCT04987294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65552798|NCT04371640|Sirolimus|sirolimus|mesh-list
65552799|NCT04371640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65552800|NCT04371640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65552801|NCT04371640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65552802|NCT04371640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552803|NCT04371640|Antifungal Agents|antifungal agents|mesh-ancestor
65552804|NCT04371640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65552805|NCT04371640|Immunologic Factors|immunologic factors|mesh-ancestor
65552806|NCT04371640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552807|NCT04356196|Verapamil|verapamil|mesh-list
65552808|NCT04356196|Bisoprolol|bisoprolol|mesh-list
65552809|NCT04356196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65552810|NCT04356196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65552811|NCT04356196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65552812|NCT04356196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552813|NCT04356196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65552814|NCT04356196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552815|NCT04356196|Vasodilator Agents|vasodilator agents|mesh-ancestor
65552816|NCT04356196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65552817|NCT04356196|Sympatholytics|sympatholytics|mesh-ancestor
65552818|NCT04356196|Autonomic Agents|autonomic agents|mesh-ancestor
65552819|NCT04356196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65552820|NCT04356196|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65552821|NCT04356196|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65552822|NCT04356196|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65552823|NCT04356196|Adrenergic Agents|adrenergic agents|mesh-ancestor
65552824|NCT04356196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65552825|NCT02115139|Ipilimumab|ipilimumab|mesh-list
65552826|NCT02115139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65552827|NCT02115139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552828|NCT02115139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65552829|NCT02115139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552830|NCT02047981|Azithromycin|azithromycin|mesh-list
65552831|NCT02047981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65552832|NCT02047981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65552833|NCT04802356|Dexamethasone|dexamethasone|mesh-list
65552834|NCT04802356|Lenalidomide|lenalidomide|mesh-list
65552835|NCT04802356|Bortezomib|bortezomib|mesh-list
65552836|NCT04802356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65552837|NCT04802356|Antiemetics|antiemetics|mesh-ancestor
65552838|NCT04802356|Autonomic Agents|autonomic agents|mesh-ancestor
65552839|NCT04802356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65552840|NCT04802356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552841|NCT04802356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65552842|NCT04802356|Glucocorticoids|glucocorticoids|mesh-ancestor
65552843|NCT04802356|Hormones|hormones|mesh-ancestor
65552844|NCT04802356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65552845|NCT04802356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65552846|NCT04802356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552847|NCT04802356|Immunologic Factors|immunologic factors|mesh-ancestor
65552848|NCT04802356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65552849|NCT04802356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65552850|NCT04802356|Growth Substances|growth substances|mesh-ancestor
65552851|NCT04802356|Growth Inhibitors|growth inhibitors|mesh-ancestor
65552852|NCT01142635|Bromides|bromides|mesh-list
65552853|NCT01142635|Rocuronium|rocuronium|mesh-list
65552854|NCT01142635|Anticonvulsants|anticonvulsants|mesh-ancestor
65552855|NCT01142635|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65552856|NCT01142635|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65552857|NCT01142635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65552858|NCT01142635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65552859|NCT01142635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552860|NCT01144195|Panitumumab|panitumumab|mesh-list
65552861|NCT01144195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65552862|NCT01144195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552863|NCT05631769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65552864|NCT02528383|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65552865|NCT02528383|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65552866|NCT02528383|Estradiol|estradiol|mesh-list
65552867|NCT02528383|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65552868|NCT02528383|Estrogens|estrogens|mesh-ancestor
65552869|NCT02528383|Hormones|hormones|mesh-ancestor
65552870|NCT02528383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65552871|NCT02528383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552872|NCT02528383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65552873|NCT02528383|Contraceptive Agents|contraceptive agents|mesh-ancestor
65552874|NCT02528383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65552875|NCT02528383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65552876|NCT01146067|Rivastigmine|rivastigmine|mesh-list
65552877|NCT01146067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65552878|NCT01146067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552879|NCT01146067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552880|NCT01146067|Cholinergic Agents|cholinergic agents|mesh-ancestor
65552881|NCT01146067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65552882|NCT01146067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552883|NCT01146067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65552884|NCT01146067|Protective Agents|protective agents|mesh-ancestor
65552885|NCT01237249|Dexamethasone|dexamethasone|mesh-list
65552886|NCT01237249|Prednisone|prednisone|mesh-list
65552887|NCT01237249|Melphalan|melphalan|mesh-list
65552888|NCT01237249|Lenalidomide|lenalidomide|mesh-list
65552889|NCT01237249|Bortezomib|bortezomib|mesh-list
65552890|NCT01237249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65552891|NCT01237249|Antiemetics|antiemetics|mesh-ancestor
65552892|NCT01237249|Autonomic Agents|autonomic agents|mesh-ancestor
65552893|NCT01237249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65552894|NCT01237249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552895|NCT01237249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65552896|NCT01237249|Glucocorticoids|glucocorticoids|mesh-ancestor
65552897|NCT01237249|Hormones|hormones|mesh-ancestor
65552898|NCT01237249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65552899|NCT01237249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65552900|NCT01237249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552901|NCT01237249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65552902|NCT01237249|Alkylating Agents|alkylating agents|mesh-ancestor
65552903|NCT01237249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552904|NCT01237249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65552905|NCT01237249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65552906|NCT01237249|Immunologic Factors|immunologic factors|mesh-ancestor
65552907|NCT01237249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65552908|NCT01237249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65552909|NCT01237249|Growth Substances|growth substances|mesh-ancestor
65552910|NCT01237249|Growth Inhibitors|growth inhibitors|mesh-ancestor
65552911|NCT03646162|Zuclomiphene|zuclomiphene|mesh-list
65552912|NCT03646162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65552913|NCT03646162|Hormone Antagonists|hormone antagonists|mesh-ancestor
65552914|NCT03646162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65282021|NCT00967057|Methotrexate|methotrexate|mesh-list
65552915|NCT03646162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552916|NCT03646162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65552917|NCT03646162|Fertility Agents|fertility agents|mesh-ancestor
65552918|NCT03646162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65552919|NCT03646162|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65552920|NCT03646162|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65552921|NCT01244347|Folic Acid|folic acid|mesh-list
65552922|NCT01244347|Vitamin B Complex|vitamin b complex|mesh-list
65552924|NCT01244347|Vitamins|vitamins|mesh-ancestor
65552925|NCT01244347|Micronutrients|micronutrients|mesh-ancestor
65552926|NCT01244347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552927|NCT05000047|Silicon|silicon|mesh-list
65552928|NCT05000047|Trace Elements|trace elements|mesh-ancestor
65552929|NCT05000047|Micronutrients|micronutrients|mesh-ancestor
65552930|NCT05000047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552931|NCT01763827|Ezetimibe|ezetimibe|mesh-list
65552932|NCT01763827|Evolocumab|evolocumab|mesh-list
65552933|NCT01763827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65552934|NCT01763827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65552935|NCT01763827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65552936|NCT01763827|Antimetabolites|antimetabolites|mesh-ancestor
65552937|NCT01763827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552938|NCT01763827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65552939|NCT01763827|Immunologic Factors|immunologic factors|mesh-ancestor
65552940|NCT01763827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552941|NCT01146145|Ketamine|ketamine|mesh-list
65552942|NCT01146145|Morphine|morphine|mesh-list
65552943|NCT01146145|Analgesics|analgesics|mesh-ancestor
65552944|NCT01146145|Sensory System Agents|sensory system agents|mesh-ancestor
65552945|NCT01146145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65552946|NCT01146145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552947|NCT01146145|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65552948|NCT01146145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65552949|NCT01146145|Anesthetics, General|anesthetics, general|mesh-ancestor
65552950|NCT01146145|Anesthetics|anesthetics|mesh-ancestor
65552951|NCT01146145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65552952|NCT01146145|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65552953|NCT01146145|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65552954|NCT01146145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65552955|NCT01146145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552956|NCT01146145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65552957|NCT01146145|Narcotics|narcotics|mesh-ancestor
65552958|NCT01146535|Interferons|interferons|mesh-list
65552959|NCT01146535|Interferon-alpha|interferon-alpha|mesh-list
65552960|NCT01146535|Oseltamivir|oseltamivir|mesh-list
65552961|NCT01146535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552962|NCT01146535|Antiviral Agents|antiviral agents|mesh-ancestor
65552963|NCT01146535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65552964|NCT01146535|Immunologic Factors|immunologic factors|mesh-ancestor
65552965|NCT01146535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552966|NCT01146535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65552967|NCT01146535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552968|NCT01732783|Panitumumab|panitumumab|mesh-list
65552969|NCT01732783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65552970|NCT01732783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552971|NCT04355728|Heparin|heparin|mesh-list
65552972|NCT04355728|Calcium heparin|calcium heparin|mesh-list
65552973|NCT04355728|Anticoagulants|anticoagulants|mesh-ancestor
65552974|NCT04355728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65552975|NCT04355728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65552976|NCT04355728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552977|NCT01693783|Ipilimumab|ipilimumab|mesh-list
65552978|NCT01693783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65552979|NCT01693783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552980|NCT01693783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65552981|NCT01693783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65552982|NCT02528461|Sofosbuvir|sofosbuvir|mesh-list
65552983|NCT02528461|Liver Extracts|liver extracts|mesh-list
65552984|NCT02528461|Hematinics|hematinics|mesh-ancestor
65552985|NCT02528461|Antiviral Agents|antiviral agents|mesh-ancestor
65552986|NCT02528461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65552987|NCT01237483|Cetuximab|cetuximab|mesh-list
65552988|NCT01237483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65552989|NCT01237483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65552990|NCT01240213|Vitamin D|vitamin d|mesh-list
65552991|NCT01240213|Vitamins|vitamins|mesh-ancestor
65552992|NCT01240213|Micronutrients|micronutrients|mesh-ancestor
65282114|NCT00967135|Pregabalin|pregabalin|mesh-list
65552993|NCT01240213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65552994|NCT01240213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65552995|NCT01375777|Ezetimibe|ezetimibe|mesh-list
65552996|NCT01375777|Evolocumab|evolocumab|mesh-list
65552997|NCT01375777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65552998|NCT01375777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65552999|NCT01375777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65553000|NCT01375777|Antimetabolites|antimetabolites|mesh-ancestor
65553001|NCT01375777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553002|NCT01375777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65553003|NCT01375777|Immunologic Factors|immunologic factors|mesh-ancestor
65553004|NCT01375777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553005|NCT02431702|Haloperidol|haloperidol|mesh-list
65553006|NCT02431702|Olanzapine|olanzapine|mesh-list
65553007|NCT02431702|Risperidone|risperidone|mesh-list
65553008|NCT02431702|Aripiprazole|aripiprazole|mesh-list
65553009|NCT02431702|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65553010|NCT02431702|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65553011|NCT02431702|Haloperidol decanoate|haloperidol decanoate|mesh-list
65553012|NCT02431702|Perphenazine|perphenazine|mesh-list
65553013|NCT02431702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65553014|NCT02431702|Serotonin Agents|serotonin agents|mesh-ancestor
65553015|NCT02431702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65553016|NCT02431702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553017|NCT02431702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553018|NCT02431702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65553019|NCT02431702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65553020|NCT02431702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65553021|NCT02431702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65553022|NCT02431702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65553023|NCT02431702|Dopamine Agents|dopamine agents|mesh-ancestor
65553024|NCT02431702|Antiemetics|antiemetics|mesh-ancestor
65553025|NCT02431702|Autonomic Agents|autonomic agents|mesh-ancestor
65553026|NCT02431702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553027|NCT02431702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65553028|NCT02431702|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65553029|NCT02431702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65553030|NCT02431702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65553031|NCT02431702|Antidepressive Agents|antidepressive agents|mesh-ancestor
65553032|NCT02431702|Dopamine Agonists|dopamine agonists|mesh-ancestor
65553033|NCT02431702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65553034|NCT02431702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65553035|NCT02431702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65553036|NCT02431702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65553037|NCT02431702|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65553038|NCT01145209|Cyclophosphamide|cyclophosphamide|mesh-list
65553039|NCT01145209|Fludarabine|fludarabine|mesh-list
65553040|NCT01145209|Fludarabine phosphate|fludarabine phosphate|mesh-list
65553041|NCT01145209|Ofatumumab|ofatumumab|mesh-list
65553042|NCT01145209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65553043|NCT01145209|Immunologic Factors|immunologic factors|mesh-ancestor
65553044|NCT01145209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553045|NCT01145209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65553046|NCT01145209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65553047|NCT01145209|Alkylating Agents|alkylating agents|mesh-ancestor
65553048|NCT01145209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553049|NCT01145209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553050|NCT01145209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65553051|NCT01145209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65553052|NCT01145209|Antimetabolites|antimetabolites|mesh-ancestor
65553053|NCT02086552|Lenalidomide|lenalidomide|mesh-list
65553054|NCT02086552|Immunologic Factors|immunologic factors|mesh-ancestor
65553055|NCT02086552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553056|NCT02086552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65553057|NCT02086552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65553058|NCT02086552|Growth Substances|growth substances|mesh-ancestor
65553059|NCT02086552|Growth Inhibitors|growth inhibitors|mesh-ancestor
65553060|NCT02086552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553061|NCT02321878|Liraglutide|liraglutide|mesh-list
65553062|NCT02321878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65553063|NCT02321878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553064|NCT02321878|Incretins|incretins|mesh-ancestor
65553065|NCT02321878|Hormones|hormones|mesh-ancestor
65553066|NCT02321878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65553067|NCT03625141|Atezolizumab|atezolizumab|mesh-list
65553068|NCT03625141|Vemurafenib|vemurafenib|mesh-list
65553069|NCT03625141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553070|NCT03625141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65553071|NCT03625141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553072|NCT03625141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553073|NCT03491410|Aspirin|aspirin|mesh-list
65553074|NCT03491410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65553075|NCT03491410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65553076|NCT03491410|Analgesics|analgesics|mesh-ancestor
65553077|NCT03491410|Sensory System Agents|sensory system agents|mesh-ancestor
65553078|NCT03491410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553079|NCT03491410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553080|NCT03491410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65553081|NCT03491410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65553082|NCT03491410|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65553083|NCT03491410|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65553084|NCT03491410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553085|NCT03491410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65553086|NCT03491410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65553087|NCT03491410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553088|NCT03491410|Antipyretics|antipyretics|mesh-ancestor
65553089|NCT00876031|Etoposide|etoposide|mesh-list
65553090|NCT00876031|Idarubicin|idarubicin|mesh-list
65553091|NCT00876031|Trofosfamide|trofosfamide|mesh-list
65553092|NCT00876031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65553093|NCT00876031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553094|NCT00876031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65553095|NCT00876031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65553096|NCT00876031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553097|NCT00876031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553098|NCT00876031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65553099|NCT00876031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65553100|NCT00876031|Immunologic Factors|immunologic factors|mesh-ancestor
65553101|NCT00876031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553102|NCT00876031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65553103|NCT00876031|Alkylating Agents|alkylating agents|mesh-ancestor
65553104|NCT02322346|Levobupivacaine|levobupivacaine|mesh-list
65553105|NCT02322346|Anesthetics, Local|anesthetics, local|mesh-ancestor
65553106|NCT02322346|Anesthetics|anesthetics|mesh-ancestor
65553107|NCT02322346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65553108|NCT02322346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553109|NCT02322346|Sensory System Agents|sensory system agents|mesh-ancestor
65553110|NCT02322346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553111|NCT01146301|Clopidogrel|clopidogrel|mesh-list
65553112|NCT01146301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65553113|NCT01146301|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65553114|NCT01146301|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65553115|NCT01146301|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65553116|NCT01146301|Purinergic Agents|purinergic agents|mesh-ancestor
65553117|NCT01146301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65553118|NCT01146301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553119|NCT01146301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553120|NCT00807859|Paclitaxel|paclitaxel|mesh-list
65553121|NCT00807859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65553122|NCT00807859|Capecitabine|capecitabine|mesh-list
65553123|NCT00807859|Trastuzumab|trastuzumab|mesh-list
65553124|NCT00807859|Lapatinib|lapatinib|mesh-list
65553125|NCT00807859|Trebananib|trebananib|mesh-list
65553126|NCT00807859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65553127|NCT00807859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553128|NCT00807859|Tubulin Modulators|tubulin modulators|mesh-ancestor
65553129|NCT00807859|Antimitotic Agents|antimitotic agents|mesh-ancestor
65553130|NCT00807859|Mitosis Modulators|mitosis modulators|mesh-ancestor
65553131|NCT00807859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553132|NCT00807859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65553133|NCT00807859|Antimetabolites|antimetabolites|mesh-ancestor
65553134|NCT00807859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65553135|NCT00807859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65553136|NCT00807859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553137|NCT00807859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65553138|NCT00807859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65553139|NCT00807859|Growth Substances|growth substances|mesh-ancestor
65553140|NCT00807859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553141|NCT00807859|Growth Inhibitors|growth inhibitors|mesh-ancestor
65282251|NCT02666534|Anesthetics|anesthetics|mesh-ancestor
65553142|NCT01246453|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65553143|NCT01246453|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65553144|NCT01246453|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65553145|NCT01246453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553146|NCT03491098|Mometasone Furoate|mometasone furoate|mesh-list
65553147|NCT03491098|Prednisolone|prednisolone|mesh-list
65553148|NCT03491098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65553149|NCT03491098|Methylprednisolone|methylprednisolone|mesh-list
65553150|NCT03491098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65553151|NCT03491098|Prednisolone acetate|prednisolone acetate|mesh-list
65553152|NCT03491098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65553153|NCT03491098|Prednisolone phosphate|prednisolone phosphate|mesh-list
65553154|NCT03491098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65553155|NCT03491098|Glucocorticoids|glucocorticoids|mesh-ancestor
65553156|NCT03491098|Hormones|hormones|mesh-ancestor
65553157|NCT03491098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65553158|NCT03491098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553159|NCT03491098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65553160|NCT03491098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553161|NCT03491098|Antiemetics|antiemetics|mesh-ancestor
65553162|NCT03491098|Autonomic Agents|autonomic agents|mesh-ancestor
65553163|NCT03491098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553164|NCT03491098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65553165|NCT03491098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65553166|NCT03491098|Protective Agents|protective agents|mesh-ancestor
65553167|NCT03491098|Dermatologic Agents|dermatologic agents|mesh-ancestor
65553168|NCT03491098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65553169|NCT02322502|Propofol|propofol|mesh-list
65553170|NCT02322502|Sevoflurane|sevoflurane|mesh-list
65553171|NCT02322502|Desflurane|desflurane|mesh-list
65553172|NCT02322502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65553173|NCT02322502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65553174|NCT02322502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553175|NCT02322502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65553176|NCT02322502|Anesthetics, General|anesthetics, general|mesh-ancestor
65553177|NCT02322502|Anesthetics|anesthetics|mesh-ancestor
65553178|NCT02322502|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65553179|NCT02322502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65553180|NCT02322580|Etanercept|etanercept|mesh-list
65553181|NCT02322580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65553182|NCT02322580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65553183|NCT02322580|Analgesics|analgesics|mesh-ancestor
65553184|NCT02322580|Sensory System Agents|sensory system agents|mesh-ancestor
65553185|NCT02322580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553186|NCT02322580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553187|NCT02322580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65553188|NCT02322580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65553189|NCT02322580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65553190|NCT02322580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65553191|NCT02322580|Immunologic Factors|immunologic factors|mesh-ancestor
65553192|NCT03190174|Sirolimus|sirolimus|mesh-list
65553193|NCT03190174|Nivolumab|nivolumab|mesh-list
65553194|NCT03190174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65553195|NCT03190174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553196|NCT03190174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65553197|NCT03190174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553198|NCT03190174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65553199|NCT03190174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65553200|NCT03190174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65553201|NCT03190174|Antifungal Agents|antifungal agents|mesh-ancestor
65553202|NCT03190174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65553203|NCT03190174|Immunologic Factors|immunologic factors|mesh-ancestor
65553204|NCT03190174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553205|NCT03490708|Tranilast|tranilast|mesh-list
65553206|NCT03490708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65553207|NCT03490708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65553208|NCT03490708|Analgesics|analgesics|mesh-ancestor
65553209|NCT03490708|Sensory System Agents|sensory system agents|mesh-ancestor
65553210|NCT03490708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553211|NCT03490708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553212|NCT03490708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65553213|NCT03490708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65553214|NCT03490708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65553215|NCT03490708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65553216|NCT03490708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553217|NCT03490708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65553218|NCT03490708|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65553219|NCT03490708|Histamine Antagonists|histamine antagonists|mesh-ancestor
65553220|NCT03490708|Histamine Agents|histamine agents|mesh-ancestor
65553221|NCT03490708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65553222|NCT03490708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65553223|NCT03490708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65553224|NCT00924326|Vidarabine|vidarabine|mesh-list
65553225|NCT00924326|Aldesleukin|aldesleukin|mesh-list
65553226|NCT00924326|Cyclophosphamide|cyclophosphamide|mesh-list
65553227|NCT00924326|Fludarabine|fludarabine|mesh-list
65553228|NCT00924326|Fludarabine phosphate|fludarabine phosphate|mesh-list
65553229|NCT00924326|Interleukin-2|interleukin-2|mesh-list
65553230|NCT00924326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65553231|NCT00924326|Immunologic Factors|immunologic factors|mesh-ancestor
65553232|NCT00924326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553233|NCT00924326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65553234|NCT00924326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65553235|NCT00924326|Alkylating Agents|alkylating agents|mesh-ancestor
65553236|NCT00924326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553237|NCT00924326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553238|NCT00924326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65553239|NCT00924326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65553240|NCT00924326|Antimetabolites|antimetabolites|mesh-ancestor
65553241|NCT00924326|Antiviral Agents|antiviral agents|mesh-ancestor
65553242|NCT00924326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65553243|NCT00924326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65553244|NCT00924326|Analgesics|analgesics|mesh-ancestor
65553245|NCT00924326|Sensory System Agents|sensory system agents|mesh-ancestor
65553246|NCT00924326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553247|NCT00924326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65553248|NCT00924326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65553249|NCT03496870|Levodopa|levodopa|mesh-list
65553250|NCT03496870|Carbidopa|carbidopa|mesh-list
65553251|NCT03496870|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65553252|NCT03496870|Opicapone|opicapone|mesh-list
65553253|NCT03496870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65553254|NCT03496870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65553255|NCT03496870|Dopamine Agents|dopamine agents|mesh-ancestor
65553256|NCT03496870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65553257|NCT03496870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553258|NCT03496870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553259|NCT03496870|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65553260|NCT03496870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553261|NCT03496870|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65553262|NCT03496870|Immunologic Factors|immunologic factors|mesh-ancestor
65553263|NCT03496870|Dopamine Agonists|dopamine agonists|mesh-ancestor
65553264|NCT03496870|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65553265|NCT01370096|Epoprostenol|epoprostenol|mesh-list
65553266|NCT01370096|Vasopressins|vasopressins|mesh-list
65553267|NCT01370096|Arginine Vasopressin|arginine vasopressin|mesh-list
65553268|NCT01370096|Tezosentan|tezosentan|mesh-list
65553269|NCT01370096|Hemostatics|hemostatics|mesh-ancestor
65553270|NCT01370096|Coagulants|coagulants|mesh-ancestor
65553271|NCT01370096|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65553272|NCT01370096|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65553273|NCT01370096|Natriuretic Agents|natriuretic agents|mesh-ancestor
65553274|NCT01370096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553275|NCT01370096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65553276|NCT01370096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65553277|NCT01370096|Vasodilator Agents|vasodilator agents|mesh-ancestor
65553278|NCT03131570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65553279|NCT03131570|Immunologic Factors|immunologic factors|mesh-ancestor
65553280|NCT03131570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553281|NCT05160896|Bevacizumab|bevacizumab|mesh-list
65553282|NCT05160896|Cetuximab|cetuximab|mesh-list
65553283|NCT05160896|Irinotecan|irinotecan|mesh-list
65553284|NCT05160896|Raltitrexed|raltitrexed|mesh-list
65553285|NCT05160896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65553286|NCT05160896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553287|NCT05160896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65553288|NCT05160896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65553289|NCT05160896|Growth Substances|growth substances|mesh-ancestor
65553290|NCT05160896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553291|NCT05160896|Growth Inhibitors|growth inhibitors|mesh-ancestor
65553292|NCT05160896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65553293|NCT05160896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65553294|NCT05160896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553295|NCT05160896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553296|NCT05160896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65553297|NCT05160896|Antimetabolites|antimetabolites|mesh-ancestor
65553298|NCT05160896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65553299|NCT01370876|Oxaliplatin|oxaliplatin|mesh-list
65553300|NCT01370876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553301|NCT04297592|Doxycycline|doxycycline|mesh-list
65350847|NCT00743496|Antibodies|antibodies|mesh-list
65553302|NCT04297592|Cephalexin|cephalexin|mesh-list
65553303|NCT04297592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65553304|NCT04297592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65553305|NCT04297592|Antimalarials|antimalarials|mesh-ancestor
65553306|NCT04297592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65553307|NCT04297592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65553308|NCT02875028|Vorapaxar|vorapaxar|mesh-list
65553309|NCT02875028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65553310|NCT01371344|Tacrolimus|tacrolimus|mesh-list
65553311|NCT01371344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65553312|NCT01371344|Immunologic Factors|immunologic factors|mesh-ancestor
65553313|NCT01371344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553314|NCT01371344|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65553315|NCT01371344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553316|NCT01371344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553317|NCT03631004|Olanzapine|olanzapine|mesh-list
65553318|NCT03631004|Antiemetics|antiemetics|mesh-ancestor
65553319|NCT03631004|Autonomic Agents|autonomic agents|mesh-ancestor
65553320|NCT03631004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553321|NCT03631004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553322|NCT03631004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65553323|NCT03631004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65553324|NCT03631004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65553325|NCT03631004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65553326|NCT03631004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65553327|NCT03631004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65553328|NCT03631004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65553329|NCT03631004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65553330|NCT03631004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553331|NCT03631004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65553332|NCT03631004|Serotonin Agents|serotonin agents|mesh-ancestor
65553333|NCT01366118|Oxaliplatin|oxaliplatin|mesh-list
65553334|NCT01366118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553335|NCT00943618|Bupropion|bupropion|mesh-list
65553336|NCT00943618|Varenicline|varenicline|mesh-list
65553337|NCT00943618|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65553338|NCT00943618|Antidepressive Agents|antidepressive agents|mesh-ancestor
65553339|NCT00943618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65553340|NCT00943618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65553341|NCT00943618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65553342|NCT00943618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65553343|NCT00943618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553344|NCT00943618|Dopamine Agents|dopamine agents|mesh-ancestor
65553345|NCT00943618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65553346|NCT00943618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553347|NCT00943618|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65553348|NCT00943618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65553349|NCT00943618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553350|NCT00943618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65553351|NCT00943618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65553352|NCT00943618|Cholinergic Agents|cholinergic agents|mesh-ancestor
65553353|NCT01372670|Hydroxyzine|hydroxyzine|mesh-list
65553354|NCT01372670|Antipruritics|antipruritics|mesh-ancestor
65553355|NCT01372670|Dermatologic Agents|dermatologic agents|mesh-ancestor
65553356|NCT01372670|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65553357|NCT01372670|Histamine Antagonists|histamine antagonists|mesh-ancestor
65553358|NCT01372670|Histamine Agents|histamine agents|mesh-ancestor
65553359|NCT01372670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65553360|NCT01372670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553361|NCT01372670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553362|NCT02322658|Eszopiclone|eszopiclone|mesh-list
65553363|NCT02322658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65553364|NCT02322658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65553365|NCT02322658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553366|NCT04218656|Rivaroxaban|rivaroxaban|mesh-list
65553367|NCT04218656|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65553368|NCT04218656|Antithrombins|antithrombins|mesh-ancestor
65553369|NCT04218656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65553370|NCT04218656|Protease Inhibitors|protease inhibitors|mesh-ancestor
65553371|NCT04218656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553372|NCT04218656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553373|NCT04218656|Anticoagulants|anticoagulants|mesh-ancestor
65553374|NCT03229382|Obinutuzumab|obinutuzumab|mesh-list
65553375|NCT03229382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65553376|NCT03229382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553377|NCT02710084|Oxytocin|oxytocin|mesh-list
65553378|NCT02710084|Oxytocics|oxytocics|mesh-ancestor
65553379|NCT02710084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65553380|NCT02710084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553381|NCT02849990|Prednisone|prednisone|mesh-list
65553382|NCT02849990|Cortisone|cortisone|mesh-list
65553383|NCT02849990|Indomethacin|indomethacin|mesh-list
65553384|NCT02849990|Abiraterone Acetate|abiraterone acetate|mesh-list
65553385|NCT02849990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65553386|NCT02849990|Glucocorticoids|glucocorticoids|mesh-ancestor
65553387|NCT02849990|Hormones|hormones|mesh-ancestor
65553388|NCT02849990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65553389|NCT02849990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553390|NCT02849990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65553391|NCT02849990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553392|NCT02849990|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65553393|NCT02849990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553394|NCT02849990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553395|NCT02849990|Hormone Antagonists|hormone antagonists|mesh-ancestor
65553396|NCT02849990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65553397|NCT02849990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65553398|NCT02849990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65553399|NCT02849990|Analgesics|analgesics|mesh-ancestor
65553400|NCT02849990|Sensory System Agents|sensory system agents|mesh-ancestor
65553401|NCT02849990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553402|NCT02849990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65553403|NCT02849990|Gout Suppressants|gout suppressants|mesh-ancestor
65553404|NCT02849990|Tocolytic Agents|tocolytic agents|mesh-ancestor
65553405|NCT02849990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65553406|NCT02849990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65553407|NCT01366352|Methylnaltrexone|methylnaltrexone|mesh-list
65553408|NCT01366352|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65553409|NCT01366352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553410|NCT01366352|Sensory System Agents|sensory system agents|mesh-ancestor
65553411|NCT01366352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553412|NCT03490396|Povidone|povidone|mesh-list
65553413|NCT03490396|Hyaluronic Acid|hyaluronic acid|mesh-list
65553414|NCT03490396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65553415|NCT03490396|Immunologic Factors|immunologic factors|mesh-ancestor
65553416|NCT03490396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553417|NCT03490396|Viscosupplements|viscosupplements|mesh-ancestor
65553418|NCT03490396|Protective Agents|protective agents|mesh-ancestor
65553419|NCT03490396|Plasma Substitutes|plasma substitutes|mesh-ancestor
65553420|NCT03490396|Blood Substitutes|blood substitutes|mesh-ancestor
65553421|NCT05136040|Bupivacaine|bupivacaine|mesh-list
65553422|NCT05136040|Anesthetics, Local|anesthetics, local|mesh-ancestor
65553423|NCT05136040|Anesthetics|anesthetics|mesh-ancestor
65553424|NCT05136040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65553425|NCT05136040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553426|NCT05136040|Sensory System Agents|sensory system agents|mesh-ancestor
65553427|NCT05136040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553428|NCT03496246|Vitamin D|vitamin d|mesh-list
65553429|NCT03496246|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65553430|NCT03496246|Alfacalcidol|alfacalcidol|mesh-list
65553431|NCT03496246|Calcifediol|calcifediol|mesh-list
65553432|NCT03496246|Calcium|calcium|mesh-list
65553433|NCT03496246|Vitamins|vitamins|mesh-ancestor
65553434|NCT03496246|Micronutrients|micronutrients|mesh-ancestor
65553435|NCT03496246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553436|NCT03496246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65553437|NCT03496246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65553438|NCT02017964|Cyclophosphamide|cyclophosphamide|mesh-list
65553439|NCT02017964|Carboplatin|carboplatin|mesh-list
65553440|NCT02017964|Methotrexate|methotrexate|mesh-list
65553441|NCT02017964|Etoposide|etoposide|mesh-list
65553442|NCT02017964|Vincristine|vincristine|mesh-list
65553443|NCT02017964|Etoposide phosphate|etoposide phosphate|mesh-list
65553444|NCT02017964|Podophyllotoxin|podophyllotoxin|mesh-list
65553445|NCT02017964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65553446|NCT02017964|Immunologic Factors|immunologic factors|mesh-ancestor
65553447|NCT02017964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553448|NCT02017964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65553449|NCT02017964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65553450|NCT02017964|Alkylating Agents|alkylating agents|mesh-ancestor
65350988|NCT00743964|Epirubicin|epirubicin|mesh-list
65553451|NCT02017964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553452|NCT02017964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553453|NCT02017964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65553454|NCT02017964|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65553455|NCT02017964|Abortifacient Agents|abortifacient agents|mesh-ancestor
65553456|NCT02017964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65553457|NCT02017964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65553458|NCT02017964|Antimetabolites|antimetabolites|mesh-ancestor
65553459|NCT02017964|Dermatologic Agents|dermatologic agents|mesh-ancestor
65553460|NCT02017964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553461|NCT02017964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65553462|NCT02017964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65553463|NCT02017964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65553464|NCT02017964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65553465|NCT02017964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65553466|NCT02017964|Tubulin Modulators|tubulin modulators|mesh-ancestor
65553467|NCT02017964|Antimitotic Agents|antimitotic agents|mesh-ancestor
65553468|NCT02017964|Mitosis Modulators|mitosis modulators|mesh-ancestor
65553469|NCT02017964|Keratolytic Agents|keratolytic agents|mesh-ancestor
65553470|NCT05121298|Upadacitinib|upadacitinib|mesh-list
65553471|NCT05121298|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65553472|NCT05121298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65553473|NCT05121298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553474|NCT05121298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553475|NCT05121298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65553476|NCT01956110|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65553477|NCT01956110|Hormones|hormones|mesh-ancestor
65553478|NCT01956110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65553479|NCT01956110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553480|NCT03489928|Misoprostol|misoprostol|mesh-list
65553481|NCT03489928|Dinoprostone|dinoprostone|mesh-list
65553482|NCT03489928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65553483|NCT03489928|Abortifacient Agents|abortifacient agents|mesh-ancestor
65553484|NCT03489928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65553485|NCT03489928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553486|NCT03489928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65553487|NCT03489928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65553488|NCT03489928|Oxytocics|oxytocics|mesh-ancestor
65553489|NCT02323282|Ropivacaine|ropivacaine|mesh-list
65553490|NCT02323282|Anesthetics, Local|anesthetics, local|mesh-ancestor
65553491|NCT02323282|Anesthetics|anesthetics|mesh-ancestor
65553492|NCT02323282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65553493|NCT02323282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553494|NCT02323282|Sensory System Agents|sensory system agents|mesh-ancestor
65553495|NCT02323282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553496|NCT01802086|Lidocaine|lidocaine|mesh-list
65553497|NCT01802086|Prilocaine|prilocaine|mesh-list
65553498|NCT01802086|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65553499|NCT01802086|Anesthetics, Local|anesthetics, local|mesh-ancestor
65553500|NCT01802086|Anesthetics|anesthetics|mesh-ancestor
65553501|NCT01802086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65553502|NCT01802086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553503|NCT01802086|Sensory System Agents|sensory system agents|mesh-ancestor
65553504|NCT01802086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553505|NCT01802086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65553506|NCT01802086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65553507|NCT01802086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65553508|NCT01802086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65553509|NCT01802086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553510|NCT01802086|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65553511|NCT05347316|Colchicine|colchicine|mesh-list
65553512|NCT05347316|Gout Suppressants|gout suppressants|mesh-ancestor
65553513|NCT05347316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65553514|NCT05347316|Tubulin Modulators|tubulin modulators|mesh-ancestor
65553515|NCT05347316|Antimitotic Agents|antimitotic agents|mesh-ancestor
65553516|NCT05347316|Mitosis Modulators|mitosis modulators|mesh-ancestor
65553517|NCT05347316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553518|NCT05347316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553519|NCT03495466|Anesthetics|anesthetics|mesh-list
65553520|NCT03495466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65553521|NCT03495466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553522|NCT01372826|Naloxegol|naloxegol|mesh-list
65553523|NCT01372826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65553524|NCT01372826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553525|NCT01372826|Sensory System Agents|sensory system agents|mesh-ancestor
65553526|NCT01372826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553527|NCT01371968|Alfentanil|alfentanil|mesh-list
65553528|NCT01371968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65553529|NCT01371968|Narcotics|narcotics|mesh-ancestor
65553530|NCT01371968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65553531|NCT01371968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553532|NCT01371968|Analgesics|analgesics|mesh-ancestor
65553533|NCT01371968|Sensory System Agents|sensory system agents|mesh-ancestor
65553534|NCT01371968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553535|NCT01371968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65553536|NCT01371968|Anesthetics, General|anesthetics, general|mesh-ancestor
65553537|NCT01371968|Anesthetics|anesthetics|mesh-ancestor
65553538|NCT04989322|Carboplatin|carboplatin|mesh-list
65553539|NCT04989322|Pembrolizumab|pembrolizumab|mesh-list
65553540|NCT04989322|Pemetrexed|pemetrexed|mesh-list
65553541|NCT04989322|Lenvatinib|lenvatinib|mesh-list
65553542|NCT04989322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553543|NCT04989322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65553544|NCT04989322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553545|NCT04989322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553546|NCT04989322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65553547|NCT04989322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65553548|NCT04989322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65553549|NCT01367054|Metformin|metformin|mesh-list
65553550|NCT01367054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65553551|NCT01367054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553552|NCT03634514|Hormones|hormones|mesh-list
65553553|NCT03634514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65553554|NCT03634514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553555|NCT02323438|Menthol|menthol|mesh-list
65553556|NCT02323438|Nicotine|nicotine|mesh-list
65553557|NCT02323438|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65553558|NCT02323438|Autonomic Agents|autonomic agents|mesh-ancestor
65553559|NCT02323438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553560|NCT02323438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553561|NCT02323438|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65553562|NCT02323438|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65553563|NCT02323438|Cholinergic Agents|cholinergic agents|mesh-ancestor
65553564|NCT02323438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65553565|NCT02323438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553566|NCT02323438|Antipruritics|antipruritics|mesh-ancestor
65553567|NCT02323438|Dermatologic Agents|dermatologic agents|mesh-ancestor
65553568|NCT01372904|Dexamethasone|dexamethasone|mesh-list
65553569|NCT01372904|Dexamethasone acetate|dexamethasone acetate|mesh-list
65553570|NCT01372904|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65553571|NCT01372904|BB 1101|bb 1101|mesh-list
65553572|NCT01372904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65553573|NCT01372904|Antiemetics|antiemetics|mesh-ancestor
65553574|NCT01372904|Autonomic Agents|autonomic agents|mesh-ancestor
65553575|NCT01372904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553576|NCT01372904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553577|NCT01372904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65553578|NCT01372904|Glucocorticoids|glucocorticoids|mesh-ancestor
65553579|NCT01372904|Hormones|hormones|mesh-ancestor
65553580|NCT01372904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65553581|NCT01372904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65553582|NCT01372904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553583|NCT01372904|Protease Inhibitors|protease inhibitors|mesh-ancestor
65553584|NCT01372904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553585|NCT01372904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553586|NCT01372982|Letrozole|letrozole|mesh-list
65553587|NCT01372982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553588|NCT01372982|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65553589|NCT01372982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65553590|NCT01372982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553591|NCT01372982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553592|NCT01372982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65553593|NCT01372982|Hormone Antagonists|hormone antagonists|mesh-ancestor
65553594|NCT01372982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65553595|NCT01372982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553596|NCT02323516|Aspirin|aspirin|mesh-list
65553597|NCT02323516|Loperamide|loperamide|mesh-list
65553598|NCT02323516|Antidiarrheals|antidiarrheals|mesh-list
65553599|NCT02323516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65553600|NCT02323516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65553601|NCT02323516|Analgesics|analgesics|mesh-ancestor
65351152|NCT00835107|Ziprasidone|ziprasidone|mesh-list
65553602|NCT02323516|Sensory System Agents|sensory system agents|mesh-ancestor
65553603|NCT02323516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553604|NCT02323516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553605|NCT02323516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65553606|NCT02323516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65553607|NCT02323516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65553608|NCT02323516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65553609|NCT02323516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553610|NCT02323516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65553611|NCT02323516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65553612|NCT02323516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553613|NCT02323516|Antipyretics|antipyretics|mesh-ancestor
65553614|NCT02323516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65553615|NCT01367210|Maraviroc|maraviroc|mesh-list
65553616|NCT01367210|Darunavir|darunavir|mesh-list
65553617|NCT01367210|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65553618|NCT01367210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65553619|NCT01367210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65553620|NCT01367210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553621|NCT01367210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65553622|NCT01367210|Antiviral Agents|antiviral agents|mesh-ancestor
65553623|NCT01367210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65553624|NCT01367210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65553625|NCT01367210|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65553626|NCT01367210|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65553627|NCT01367210|Protease Inhibitors|protease inhibitors|mesh-ancestor
65553628|NCT01367210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553629|NCT02323594|Asunaprevir|asunaprevir|mesh-list
65553630|NCT02323594|Protease Inhibitors|protease inhibitors|mesh-ancestor
65553631|NCT02323594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553632|NCT02323594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553633|NCT01372280|Galantamine|galantamine|mesh-list
65553634|NCT01372280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65553635|NCT01372280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553636|NCT01372280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553637|NCT01372280|Cholinergic Agents|cholinergic agents|mesh-ancestor
65553638|NCT01372280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65553639|NCT01372280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553640|NCT01372280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65553641|NCT01372280|Autonomic Agents|autonomic agents|mesh-ancestor
65553642|NCT01372280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553643|NCT01372280|Nootropic Agents|nootropic agents|mesh-ancestor
65553644|NCT01373060|Ipragliflozin|ipragliflozin|mesh-list
65553645|NCT01373060|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65553646|NCT01373060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553647|NCT01373060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65553648|NCT01373060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553649|NCT04742140|Magnesium Sulfate|magnesium sulfate|mesh-list
65553650|NCT04742140|Analgesics|analgesics|mesh-ancestor
65553651|NCT04742140|Sensory System Agents|sensory system agents|mesh-ancestor
65553652|NCT04742140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553653|NCT04742140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553654|NCT04742140|Anesthetics|anesthetics|mesh-ancestor
65553655|NCT04742140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65553656|NCT04742140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65553657|NCT04742140|Anticonvulsants|anticonvulsants|mesh-ancestor
65553658|NCT04742140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65553659|NCT04742140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65553660|NCT04742140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553661|NCT04742140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65553662|NCT04742140|Tocolytic Agents|tocolytic agents|mesh-ancestor
65553663|NCT04742140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65553664|NCT04580992|Ajmaline|ajmaline|mesh-list
65553665|NCT04580992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65553666|NCT04580992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65553667|NCT04580992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65553668|NCT04580992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65553669|NCT04580992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553670|NCT04590274|Azithromycin|azithromycin|mesh-list
65553671|NCT04590274|Hydroxychloroquine|hydroxychloroquine|mesh-list
65553672|NCT04590274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65553673|NCT04590274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65553674|NCT04590274|Antimalarials|antimalarials|mesh-ancestor
65553675|NCT04590274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65553676|NCT04590274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65553677|NCT04590274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553678|NCT04590274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553679|NCT04590274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65553680|NCT01367288|Zoledronic Acid|zoledronic acid|mesh-list
65553681|NCT01367288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65553682|NCT01367288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553683|NCT04455178|Indapamide|indapamide|mesh-list
65553684|NCT04455178|Spironolactone|spironolactone|mesh-list
65553685|NCT04455178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65553686|NCT04455178|Hormone Antagonists|hormone antagonists|mesh-ancestor
65553687|NCT04455178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65553688|NCT04455178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553689|NCT04455178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65553690|NCT04455178|Diuretics|diuretics|mesh-ancestor
65553691|NCT04455178|Natriuretic Agents|natriuretic agents|mesh-ancestor
65553692|NCT04455178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65553693|NCT04455178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65553694|NCT04455178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65553695|NCT04455178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553696|NCT01367522|Methylnaltrexone|methylnaltrexone|mesh-list
65553697|NCT01367522|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65553698|NCT01367522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553699|NCT01367522|Sensory System Agents|sensory system agents|mesh-ancestor
65553700|NCT01367522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553701|NCT02446834|Metformin|metformin|mesh-list
65553702|NCT02446834|Acarbose|acarbose|mesh-list
65553703|NCT02446834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65553704|NCT02446834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553705|NCT02446834|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65553706|NCT02446834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553707|NCT02446834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553708|NCT03489616|Pemetrexed|pemetrexed|mesh-list
65553709|NCT03489616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553710|NCT03489616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553711|NCT03489616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553712|NCT03489616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65553713|NCT03489616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65553714|NCT02323906|Sorafenib|sorafenib|mesh-list
65553715|NCT02323906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553716|NCT02323906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65553717|NCT02323906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553718|NCT02323906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553719|NCT03116828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
65553720|NCT03116828|Anticonvulsants|anticonvulsants|mesh-ancestor
65553721|NCT03116828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65553722|NCT03116828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65553723|NCT03116828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65553724|NCT03116828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553725|NCT01319942|Sorafenib|sorafenib|mesh-list
65553726|NCT01319942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553727|NCT01319942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65553728|NCT01319942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553729|NCT01319942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553730|NCT01373138|Pseudoephedrine|pseudoephedrine|mesh-list
65553731|NCT01373138|Ephedrine|ephedrine|mesh-list
65553732|NCT01373138|Desloratadine|desloratadine|mesh-list
65553733|NCT01373138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65553734|NCT01373138|Cholinergic Agents|cholinergic agents|mesh-ancestor
65553735|NCT01373138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65553736|NCT01373138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553737|NCT01373138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553738|NCT01373138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65282847|NCT02782559|Sildenafil Citrate|sildenafil citrate|mesh-list
65553739|NCT01373138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65553740|NCT01373138|Histamine Antagonists|histamine antagonists|mesh-ancestor
65553741|NCT01373138|Histamine Agents|histamine agents|mesh-ancestor
65553742|NCT01373138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65553743|NCT01373138|Autonomic Agents|autonomic agents|mesh-ancestor
65553744|NCT01373138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553745|NCT01373138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65553746|NCT01373138|Respiratory System Agents|respiratory system agents|mesh-ancestor
65553747|NCT01373138|Nasal Decongestants|nasal decongestants|mesh-ancestor
65553748|NCT01373138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65553749|NCT01373138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65553750|NCT01373138|Sympathomimetics|sympathomimetics|mesh-ancestor
65553751|NCT01373138|Adrenergic Agents|adrenergic agents|mesh-ancestor
65553752|NCT01373216|Exenatide|exenatide|mesh-list
65553753|NCT01373216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65553754|NCT01373216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553755|NCT01373216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65553756|NCT01373216|Incretins|incretins|mesh-ancestor
65553757|NCT01373216|Hormones|hormones|mesh-ancestor
65553758|NCT01373216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65553759|NCT03487354|Misoprostol|misoprostol|mesh-list
65553760|NCT03487354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65553761|NCT03487354|Abortifacient Agents|abortifacient agents|mesh-ancestor
65553762|NCT03487354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65553763|NCT03487354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553764|NCT03487354|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65553765|NCT03487354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65553766|NCT03487354|Oxytocics|oxytocics|mesh-ancestor
65553767|NCT04461340|Sirolimus|sirolimus|mesh-list
65553768|NCT04461340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65553769|NCT04461340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65553770|NCT04461340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65553771|NCT04461340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553772|NCT04461340|Antifungal Agents|antifungal agents|mesh-ancestor
65553773|NCT04461340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65553774|NCT04461340|Immunologic Factors|immunologic factors|mesh-ancestor
65553775|NCT04461340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553776|NCT05154968|Mannitol|mannitol|mesh-list
65553777|NCT05154968|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65553778|NCT05154968|Diuretics|diuretics|mesh-ancestor
65553779|NCT05154968|Natriuretic Agents|natriuretic agents|mesh-ancestor
65553780|NCT05154968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553781|NCT01373372|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
65553782|NCT01373372|Hormones|hormones|mesh-ancestor
65553783|NCT01373372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65553784|NCT01373372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553785|NCT04146142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65553786|NCT04146142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65553787|NCT02324296|Cisplatin|cisplatin|mesh-list
65553788|NCT02324296|Etoposide|etoposide|mesh-list
65553789|NCT02324296|Ifosfamide|ifosfamide|mesh-list
65553790|NCT02324296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553791|NCT02324296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65553792|NCT02324296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65553793|NCT02324296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65553794|NCT02324296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553795|NCT02324296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553796|NCT02324296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65553797|NCT02324296|Alkylating Agents|alkylating agents|mesh-ancestor
65553798|NCT03494686|Anesthetics|anesthetics|mesh-list
65553799|NCT03494686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65553800|NCT03494686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553801|NCT03487198|Brexpiprazole|brexpiprazole|mesh-list
65553802|NCT03487198|Serotonin Agents|serotonin agents|mesh-ancestor
65553803|NCT03487198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65553804|NCT03487198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553805|NCT03487198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553806|NCT03487198|Dopamine Agonists|dopamine agonists|mesh-ancestor
65553807|NCT03487198|Dopamine Agents|dopamine agents|mesh-ancestor
65553808|NCT02565914|Ivacaftor|ivacaftor|mesh-list
65553809|NCT02565914|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65553810|NCT02565914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65553811|NCT02565914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553812|NCT03881020|Fluorides|fluorides|mesh-list
65553813|NCT03881020|Cariostatic Agents|cariostatic agents|mesh-ancestor
65553814|NCT03881020|Protective Agents|protective agents|mesh-ancestor
65553815|NCT03881020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553816|NCT01367600|Methylnaltrexone|methylnaltrexone|mesh-list
65553817|NCT01367600|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65553818|NCT01367600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553819|NCT01367600|Sensory System Agents|sensory system agents|mesh-ancestor
65553820|NCT01367600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553821|NCT01367678|Chlorhexidine|chlorhexidine|mesh-list
65553822|NCT01367678|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65553823|NCT01367678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65553824|NCT01367678|Disinfectants|disinfectants|mesh-ancestor
65553825|NCT03487042|Bimatoprost|bimatoprost|mesh-list
65553826|NCT03487042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65553827|NCT03487042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65553828|NCT03487042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65553829|NCT03115294|Theophylline|theophylline|mesh-list
65553830|NCT03115294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65553831|NCT03115294|Autonomic Agents|autonomic agents|mesh-ancestor
65553832|NCT03115294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553833|NCT03115294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553834|NCT03115294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65553835|NCT03115294|Respiratory System Agents|respiratory system agents|mesh-ancestor
65553836|NCT03115294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65553837|NCT03115294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553838|NCT03115294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553839|NCT03115294|Vasodilator Agents|vasodilator agents|mesh-ancestor
65553840|NCT03115294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65553841|NCT03115294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65553842|NCT03115294|Purinergic Agents|purinergic agents|mesh-ancestor
65553843|NCT03115294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65553844|NCT01367756|Citalopram|citalopram|mesh-list
65553845|NCT01367756|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65553846|NCT01367756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65553847|NCT01367756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65553848|NCT01367756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553849|NCT01367756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65553850|NCT01367756|Serotonin Agents|serotonin agents|mesh-ancestor
65553851|NCT01367756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553852|NCT01367756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65553853|NCT01367756|Antidepressive Agents|antidepressive agents|mesh-ancestor
65553854|NCT01367756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65553855|NCT04624958|Rituximab|rituximab|mesh-list
65553856|NCT04624958|Zanubrutinib|zanubrutinib|mesh-list
65553857|NCT04624958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65553858|NCT04624958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553859|NCT04624958|Immunologic Factors|immunologic factors|mesh-ancestor
65553860|NCT04624958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553861|NCT04624958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65553862|NCT04624958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65553863|NCT04624958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553864|NCT04624958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553865|NCT03485482|Bisoprolol|bisoprolol|mesh-list
65553866|NCT03485482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65553867|NCT03485482|Sympatholytics|sympatholytics|mesh-ancestor
65553868|NCT03485482|Autonomic Agents|autonomic agents|mesh-ancestor
65553869|NCT03485482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553870|NCT03485482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553871|NCT03485482|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65553872|NCT03485482|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65553873|NCT03485482|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65553874|NCT03485482|Adrenergic Agents|adrenergic agents|mesh-ancestor
65553875|NCT03485482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65553876|NCT03485482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553877|NCT02946424|Simvastatin|simvastatin|mesh-list
65553878|NCT02946424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65553879|NCT02946424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65553880|NCT02946424|Antimetabolites|antimetabolites|mesh-ancestor
65553881|NCT02946424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553882|NCT02946424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65553883|NCT02946424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65553884|NCT02946424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553885|NCT00783536|Etanercept|etanercept|mesh-list
65553886|NCT00783536|Methotrexate|methotrexate|mesh-list
65553887|NCT00783536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65553888|NCT00783536|Abortifacient Agents|abortifacient agents|mesh-ancestor
65553889|NCT00783536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65553890|NCT00783536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553891|NCT00783536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65553892|NCT00783536|Antimetabolites|antimetabolites|mesh-ancestor
65553893|NCT00783536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553894|NCT00783536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553895|NCT00783536|Dermatologic Agents|dermatologic agents|mesh-ancestor
65553896|NCT00783536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553897|NCT00783536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65553898|NCT00783536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65553899|NCT00783536|Immunologic Factors|immunologic factors|mesh-ancestor
65553900|NCT00783536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65553901|NCT00783536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65553902|NCT00783536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65553903|NCT00783536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65553904|NCT00783536|Analgesics|analgesics|mesh-ancestor
65553905|NCT00783536|Sensory System Agents|sensory system agents|mesh-ancestor
65553906|NCT00783536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553907|NCT00783536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65553908|NCT00783536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65553909|NCT01367912|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65553910|NCT01367912|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65553911|NCT01367912|Estradiol|estradiol|mesh-list
65553912|NCT01367912|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65553913|NCT01367912|Estrogens|estrogens|mesh-ancestor
65553914|NCT01367912|Hormones|hormones|mesh-ancestor
65553915|NCT01367912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65553916|NCT01367912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553917|NCT01367912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65553918|NCT01367912|Contraceptive Agents|contraceptive agents|mesh-ancestor
65553919|NCT01367912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65553920|NCT01367912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65553921|NCT03115112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65553922|NCT03115112|Bexagliflozin|bexagliflozin|mesh-list
65553923|NCT03115112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65553924|NCT03115112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553925|NCT03115112|Incretins|incretins|mesh-ancestor
65553926|NCT03115112|Hormones|hormones|mesh-ancestor
65553927|NCT03115112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65553928|NCT03115112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65553929|NCT03115112|Protease Inhibitors|protease inhibitors|mesh-ancestor
65553930|NCT03115112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553931|NCT03115112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553932|NCT01373528|Budesonide|budesonide|mesh-list
65553933|NCT01373528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65553934|NCT01373528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65553935|NCT01373528|Autonomic Agents|autonomic agents|mesh-ancestor
65553936|NCT01373528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553937|NCT01373528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553938|NCT01373528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65553939|NCT01373528|Respiratory System Agents|respiratory system agents|mesh-ancestor
65553940|NCT01373528|Glucocorticoids|glucocorticoids|mesh-ancestor
65553941|NCT01373528|Hormones|hormones|mesh-ancestor
65553942|NCT01373528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65553943|NCT03634202|Capecitabine|capecitabine|mesh-list
65553944|NCT03634202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65553945|NCT03634202|Antimetabolites|antimetabolites|mesh-ancestor
65553946|NCT03634202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553947|NCT03634202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553948|NCT05019560|Sevoflurane|sevoflurane|mesh-list
65553949|NCT05019560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65553950|NCT05019560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65553951|NCT05019560|Anesthetics, General|anesthetics, general|mesh-ancestor
65553952|NCT05019560|Anesthetics|anesthetics|mesh-ancestor
65553953|NCT05019560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65553954|NCT05019560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553955|NCT01373606|Terlipressin|terlipressin|mesh-list
65553956|NCT01373606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65553957|NCT01373606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65553958|NCT01367990|Norepinephrine|norepinephrine|mesh-list
65553959|NCT01367990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65553960|NCT01367990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65283076|NCT04008043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65553961|NCT01367990|Adrenergic Agents|adrenergic agents|mesh-ancestor
65553962|NCT01367990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65553963|NCT01367990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553964|NCT01367990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553965|NCT01367990|Sympathomimetics|sympathomimetics|mesh-ancestor
65553966|NCT01367990|Autonomic Agents|autonomic agents|mesh-ancestor
65553967|NCT01367990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65553968|NCT01367990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65553969|NCT03556358|Paclitaxel|paclitaxel|mesh-list
65553970|NCT03556358|Cyclophosphamide|cyclophosphamide|mesh-list
65553971|NCT03556358|Trastuzumab|trastuzumab|mesh-list
65553972|NCT03556358|Epirubicin|epirubicin|mesh-list
65553973|NCT03556358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65553974|NCT03556358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553975|NCT03556358|Tubulin Modulators|tubulin modulators|mesh-ancestor
65553976|NCT03556358|Antimitotic Agents|antimitotic agents|mesh-ancestor
65553977|NCT03556358|Mitosis Modulators|mitosis modulators|mesh-ancestor
65553978|NCT03556358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65553979|NCT03556358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65553980|NCT03556358|Immunologic Factors|immunologic factors|mesh-ancestor
65553981|NCT03556358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65553982|NCT03556358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65553983|NCT03556358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65553984|NCT03556358|Alkylating Agents|alkylating agents|mesh-ancestor
65553985|NCT03556358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65553986|NCT03556358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65553987|NCT03556358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65553988|NCT03556358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65553989|NCT03556358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65553990|NCT03556358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65553991|NCT01374308|Interferons|interferons|mesh-list
65553992|NCT01374308|Interferon-alpha|interferon-alpha|mesh-list
65553993|NCT01374308|Interferon alpha-2|interferon alpha-2|mesh-list
65553994|NCT01374308|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65553995|NCT01374308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65553996|NCT01374308|Antiviral Agents|antiviral agents|mesh-ancestor
65553997|NCT01374308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65553998|NCT01374308|Immunologic Factors|immunologic factors|mesh-ancestor
65553999|NCT01374308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554000|NCT01368068|Tibolone|tibolone|mesh-list
65554001|NCT01368068|Citalopram|citalopram|mesh-list
65554002|NCT01368068|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65554003|NCT01368068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65554004|NCT01368068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65554005|NCT01368068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554006|NCT01368068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65554007|NCT01368068|Serotonin Agents|serotonin agents|mesh-ancestor
65554008|NCT01368068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554009|NCT01368068|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65554010|NCT01368068|Antidepressive Agents|antidepressive agents|mesh-ancestor
65554011|NCT01368068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65554012|NCT01368068|Androgen Antagonists|androgen antagonists|mesh-ancestor
65554013|NCT01368068|Hormone Antagonists|hormone antagonists|mesh-ancestor
65554014|NCT01368068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65554015|NCT01368068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65554016|NCT01368068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65554017|NCT01368068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65554018|NCT01368068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65554019|NCT01368068|Anabolic Agents|anabolic agents|mesh-ancestor
65554020|NCT01368068|Hormones|hormones|mesh-ancestor
65554021|NCT03228680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65554022|NCT03228680|Hormones|hormones|mesh-ancestor
65554023|NCT03228680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65554024|NCT03228680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554025|NCT01373684|Tenofovir|tenofovir|mesh-list
65554026|NCT01373684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65554027|NCT01373684|Entecavir|entecavir|mesh-list
65554028|NCT01373684|Adefovir|adefovir|mesh-list
65554029|NCT01373684|Antiviral Agents|antiviral agents|mesh-ancestor
65554030|NCT01373684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65554031|NCT01373684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65554032|NCT01373684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65554033|NCT01373684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283150|NCT00693849|Citalopram|citalopram|mesh-list
65554034|NCT01373684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554035|NCT01373684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65554036|NCT01373684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65554037|NCT04490018|Vaccines|vaccines|mesh-list
65554038|NCT04490018|Immunologic Factors|immunologic factors|mesh-ancestor
65554039|NCT04490018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554040|NCT02891798|Dexamethasone|dexamethasone|mesh-list
65554041|NCT02891798|Dexamethasone acetate|dexamethasone acetate|mesh-list
65554042|NCT02891798|Clonidine|clonidine|mesh-list
65554043|NCT02891798|Buprenorphine|buprenorphine|mesh-list
65554044|NCT02891798|Bupivacaine|bupivacaine|mesh-list
65554045|NCT02891798|BB 1101|bb 1101|mesh-list
65554046|NCT02891798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65554047|NCT02891798|Antiemetics|antiemetics|mesh-ancestor
65554048|NCT02891798|Autonomic Agents|autonomic agents|mesh-ancestor
65554049|NCT02891798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65554050|NCT02891798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554051|NCT02891798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65554052|NCT02891798|Glucocorticoids|glucocorticoids|mesh-ancestor
65554053|NCT02891798|Hormones|hormones|mesh-ancestor
65554054|NCT02891798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65554055|NCT02891798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65554056|NCT02891798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65554057|NCT02891798|Protease Inhibitors|protease inhibitors|mesh-ancestor
65554058|NCT02891798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554059|NCT02891798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554060|NCT02891798|Anesthetics, Local|anesthetics, local|mesh-ancestor
65554061|NCT02891798|Anesthetics|anesthetics|mesh-ancestor
65554062|NCT02891798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65554063|NCT02891798|Sensory System Agents|sensory system agents|mesh-ancestor
65554064|NCT02891798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65554065|NCT02891798|Narcotics|narcotics|mesh-ancestor
65554066|NCT02891798|Analgesics|analgesics|mesh-ancestor
65554067|NCT02891798|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65554068|NCT02891798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65554069|NCT02891798|Sympatholytics|sympatholytics|mesh-ancestor
65554070|NCT02891798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65554071|NCT02891798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65554072|NCT02891798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65554073|NCT02891798|Adrenergic Agents|adrenergic agents|mesh-ancestor
65554074|NCT02891798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65554075|NCT01374464|Levobupivacaine|levobupivacaine|mesh-list
65554076|NCT01374464|Anesthetics, Local|anesthetics, local|mesh-ancestor
65554077|NCT01374464|Anesthetics|anesthetics|mesh-ancestor
65554078|NCT01374464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65554079|NCT01374464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554080|NCT01374464|Sensory System Agents|sensory system agents|mesh-ancestor
65554081|NCT01374464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65554082|NCT01374620|Paclitaxel|paclitaxel|mesh-list
65554083|NCT01374620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65554084|NCT01374620|Cyclophosphamide|cyclophosphamide|mesh-list
65554085|NCT01374620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65554086|NCT01374620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65554087|NCT01374620|Tubulin Modulators|tubulin modulators|mesh-ancestor
65554088|NCT01374620|Antimitotic Agents|antimitotic agents|mesh-ancestor
65554089|NCT01374620|Mitosis Modulators|mitosis modulators|mesh-ancestor
65554090|NCT01374620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554091|NCT01374620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65554092|NCT01374620|Immunologic Factors|immunologic factors|mesh-ancestor
65554093|NCT01374620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554094|NCT01374620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65554095|NCT01374620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65554096|NCT01374620|Alkylating Agents|alkylating agents|mesh-ancestor
65554097|NCT01374620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65554098|NCT01374698|Aspirin|aspirin|mesh-list
65554099|NCT01374698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65554100|NCT01374698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65554101|NCT01374698|Analgesics|analgesics|mesh-ancestor
65554102|NCT01374698|Sensory System Agents|sensory system agents|mesh-ancestor
65554103|NCT01374698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65554104|NCT01374698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554105|NCT01374698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65554106|NCT01374698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65554107|NCT01374698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65554108|NCT01374698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65554109|NCT01374698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554110|NCT01374698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65554111|NCT01374698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65554112|NCT01374698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554113|NCT01374698|Antipyretics|antipyretics|mesh-ancestor
65554114|NCT01368458|Antipsychotic Agents|antipsychotic agents|mesh-list
65554115|NCT01368458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65554116|NCT01368458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65554117|NCT01368458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554118|NCT01368458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65554119|NCT05197088|Tamsulosin|tamsulosin|mesh-list
65554120|NCT05197088|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65554121|NCT05197088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65554122|NCT05197088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65554123|NCT05197088|Adrenergic Agents|adrenergic agents|mesh-ancestor
65554124|NCT05197088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65554125|NCT05197088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554126|NCT05197088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554127|NCT05197088|Urological Agents|urological agents|mesh-ancestor
65554128|NCT01375088|Propolis|propolis|mesh-list
65554129|NCT01375088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65554130|NCT01368848|Bevacizumab|bevacizumab|mesh-list
65554131|NCT01368848|Docetaxel|docetaxel|mesh-list
65554132|NCT01368848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65554133|NCT01368848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65554134|NCT01368848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65554135|NCT01368848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65554136|NCT01368848|Growth Substances|growth substances|mesh-ancestor
65554137|NCT01368848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554138|NCT01368848|Growth Inhibitors|growth inhibitors|mesh-ancestor
65554139|NCT01368848|Tubulin Modulators|tubulin modulators|mesh-ancestor
65554140|NCT01368848|Antimitotic Agents|antimitotic agents|mesh-ancestor
65554141|NCT01368848|Mitosis Modulators|mitosis modulators|mesh-ancestor
65554142|NCT01368848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554143|NCT03604874|Oxytocin|oxytocin|mesh-list
65554144|NCT03604874|Oxytocics|oxytocics|mesh-ancestor
65554145|NCT03604874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65554146|NCT03604874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554147|NCT01369082|Cyclosporine|cyclosporine|mesh-list
65554148|NCT01369082|Sirolimus|sirolimus|mesh-list
65554149|NCT01369082|Mycophenolic Acid|mycophenolic acid|mesh-list
65554150|NCT01369082|Tacrolimus|tacrolimus|mesh-list
65554151|NCT01369082|Cyclosporins|cyclosporins|mesh-list
65554152|NCT01369082|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65554153|NCT01369082|Immunologic Factors|immunologic factors|mesh-ancestor
65554154|NCT01369082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554155|NCT01369082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65554156|NCT01369082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554157|NCT01369082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554158|NCT01369082|Antifungal Agents|antifungal agents|mesh-ancestor
65554159|NCT01369082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65554160|NCT01369082|Dermatologic Agents|dermatologic agents|mesh-ancestor
65554161|NCT01369082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65554162|NCT01369082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65554163|NCT01369082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65554164|NCT01369082|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65554165|NCT01369082|Antitubercular Agents|antitubercular agents|mesh-ancestor
65554166|NCT01369082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65554167|NCT03382730|Chlorhexidine|chlorhexidine|mesh-list
65554168|NCT03382730|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65554169|NCT03382730|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65554170|NCT03382730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65554171|NCT03382730|Disinfectants|disinfectants|mesh-ancestor
65554172|NCT03382730|Dermatologic Agents|dermatologic agents|mesh-ancestor
65554173|NCT03135262|Rituximab|rituximab|mesh-list
65554174|NCT03135262|Obinutuzumab|obinutuzumab|mesh-list
65554175|NCT03135262|Venetoclax|venetoclax|mesh-list
65554176|NCT03135262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65554177|NCT03135262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65554178|NCT03135262|Immunologic Factors|immunologic factors|mesh-ancestor
65554179|NCT03135262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554180|NCT03135262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65554181|NCT01375244|Lisinopril|lisinopril|mesh-list
65554182|NCT01375244|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65554183|NCT01375244|Protease Inhibitors|protease inhibitors|mesh-ancestor
65554184|NCT01375244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283304|NCT04229459|Nivolumab|nivolumab|mesh-list
65554185|NCT01375244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554186|NCT01375244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65554187|NCT01375244|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65554188|NCT01375244|Protective Agents|protective agents|mesh-ancestor
65554189|NCT01375244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554190|NCT01375322|Amlodipine|amlodipine|mesh-list
65554191|NCT01375322|Valsartan|valsartan|mesh-list
65554192|NCT01375322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65554193|NCT01375322|Benazepril|benazepril|mesh-list
65554194|NCT01375322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65554195|NCT01375322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65554196|NCT01375322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65554197|NCT01375322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554198|NCT01375322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65554199|NCT01375322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554200|NCT01375322|Vasodilator Agents|vasodilator agents|mesh-ancestor
65554201|NCT01375322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65554202|NCT01375322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65554203|NCT01375322|Diuretics|diuretics|mesh-ancestor
65554204|NCT01375322|Natriuretic Agents|natriuretic agents|mesh-ancestor
65554205|NCT01375322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65554206|NCT01375322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65554207|NCT01375322|Protease Inhibitors|protease inhibitors|mesh-ancestor
65554208|NCT01375322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554209|NCT01369238|Pyranoprofen|pyranoprofen|mesh-list
65554210|NCT01369238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65554211|NCT01369238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65554212|NCT01369238|Analgesics|analgesics|mesh-ancestor
65554213|NCT01369238|Sensory System Agents|sensory system agents|mesh-ancestor
65554214|NCT01369238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65554215|NCT01369238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554216|NCT01369238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65554217|NCT01369238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65554218|NCT01369238|Gout Suppressants|gout suppressants|mesh-ancestor
65554219|NCT03485404|Vitamins|vitamins|mesh-list
65554220|NCT03485404|Folic Acid|folic acid|mesh-list
65554221|NCT03485404|Vitamin B 12|vitamin b 12|mesh-list
65554222|NCT03485404|Vitamin B Complex|vitamin b complex|mesh-list
65554223|NCT03485404|Micronutrients|micronutrients|mesh-ancestor
65554224|NCT03485404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554225|NCT03485404|Hematinics|hematinics|mesh-ancestor
65554226|NCT05195294|Lenvatinib|lenvatinib|mesh-list
65554227|NCT05195294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65554228|NCT05195294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65554229|NCT05195294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554230|NCT05195294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554231|NCT03072628|Nicotine|nicotine|mesh-list
65554232|NCT03072628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65554233|NCT03072628|Autonomic Agents|autonomic agents|mesh-ancestor
65554234|NCT03072628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65554235|NCT03072628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554236|NCT03072628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65554237|NCT03072628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65554238|NCT03072628|Cholinergic Agents|cholinergic agents|mesh-ancestor
65554239|NCT03072628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65554240|NCT03072628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554241|NCT03535194|Mirikizumab|mirikizumab|mesh-list
65554242|NCT03535194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65554243|NCT03535194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65554244|NCT03535194|Analgesics|analgesics|mesh-ancestor
65554245|NCT03535194|Sensory System Agents|sensory system agents|mesh-ancestor
65554246|NCT03535194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65554247|NCT03535194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554248|NCT03535194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65554249|NCT03535194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65554250|NCT03535194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65554251|NCT03535194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65554252|NCT03633812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65554253|NCT03633812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65554254|NCT03633812|Adrenergic Agents|adrenergic agents|mesh-ancestor
65554255|NCT03633812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65554256|NCT03633812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554257|NCT03633812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554258|NCT05194904|Ketorolac|ketorolac|mesh-list
65554259|NCT05194904|Dexmedetomidine|dexmedetomidine|mesh-list
65554260|NCT05194904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65554261|NCT05194904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65554262|NCT05194904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554263|NCT05194904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65554264|NCT05194904|Analgesics|analgesics|mesh-ancestor
65554265|NCT05194904|Sensory System Agents|sensory system agents|mesh-ancestor
65554266|NCT05194904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65554267|NCT05194904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65554268|NCT05194904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65554269|NCT05194904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65554270|NCT05194904|Adrenergic Agents|adrenergic agents|mesh-ancestor
65554271|NCT05194904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65554272|NCT05194904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554273|NCT05194904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65554274|NCT05194904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65554275|NCT05194904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65554276|NCT05194904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65554277|NCT05194904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554279|NCT01375400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65554280|NCT01375400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65554281|NCT01375400|Analgesics|analgesics|mesh-ancestor
65554282|NCT01375400|Sensory System Agents|sensory system agents|mesh-ancestor
65554283|NCT01375400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65554284|NCT01375400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554285|NCT01375400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65554286|NCT01375400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65554287|NCT01375400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65554288|NCT01375400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65554289|NCT01375400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554290|NCT01375400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65554291|NCT01375400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65554292|NCT01375400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554293|NCT01375400|Antipyretics|antipyretics|mesh-ancestor
65554294|NCT01319864|Plerixafor|plerixafor|mesh-list
65554295|NCT01319864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65554296|NCT01319864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65554297|NCT01319864|Antiviral Agents|antiviral agents|mesh-ancestor
65554298|NCT01319864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65554299|NCT05194046|Amoxicillin|amoxicillin|mesh-list
65554300|NCT05194046|Clarithromycin|clarithromycin|mesh-list
65554301|NCT05194046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65554302|NCT05194046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65554303|NCT05194046|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65554304|NCT05194046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554305|NCT05194046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554306|NCT05194046|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65554307|NCT05194046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65554308|NCT01369472|Carvedilol|carvedilol|mesh-list
65554309|NCT01369472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65554310|NCT01369472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65554311|NCT01369472|Adrenergic Agents|adrenergic agents|mesh-ancestor
65554312|NCT01369472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65554313|NCT01369472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554314|NCT01369472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554315|NCT01369472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65554316|NCT01369472|Antioxidants|antioxidants|mesh-ancestor
65554317|NCT01369472|Protective Agents|protective agents|mesh-ancestor
65554318|NCT01369472|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65554319|NCT01369472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65554320|NCT01369472|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65554321|NCT01369472|Vasodilator Agents|vasodilator agents|mesh-ancestor
65554322|NCT01369472|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65554323|NCT01369472|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65554324|NCT03559530|Anti-Infective Agents|anti-infective agents|mesh-list
65554325|NCT03559530|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65554326|NCT05193734|Hemagglutinins|hemagglutinins|mesh-list
65554327|NCT05193734|Agglutinins|agglutinins|mesh-ancestor
65554328|NCT05193734|Immunologic Factors|immunologic factors|mesh-ancestor
65554329|NCT05193734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554330|NCT01375556|Ethanol|ethanol|mesh-list
65554331|NCT01375556|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65554332|NCT01375556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65554333|NCT01375556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65554334|NCT01375556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554335|NCT03486496|Gefitinib|gefitinib|mesh-list
65554336|NCT03486496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65554337|NCT03486496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65554338|NCT03486496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554339|NCT03486496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554340|NCT02091934|Dipivefrin|dipivefrin|mesh-list
65554341|NCT02091934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65554342|NCT02091934|Adrenergic Agents|adrenergic agents|mesh-ancestor
65554343|NCT02091934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65554344|NCT02091934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554345|NCT02091934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554346|NCT01375634|Midazolam|midazolam|mesh-list
65554347|NCT01375634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65554348|NCT01375634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65554349|NCT01375634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65554350|NCT01375634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554351|NCT01375634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65554352|NCT01375634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65554353|NCT01375634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65554354|NCT01375634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65554355|NCT01375634|Anesthetics, General|anesthetics, general|mesh-ancestor
65554356|NCT01375634|Anesthetics|anesthetics|mesh-ancestor
65554357|NCT01375634|GABA Modulators|gaba modulators|mesh-ancestor
65554358|NCT01375634|GABA Agents|gaba agents|mesh-ancestor
65554359|NCT01375634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65554360|NCT01375634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554361|NCT05388448|Amoxicillin|amoxicillin|mesh-list
65554363|NCT05388448|Clavulanic Acids|clavulanic acids|mesh-list
65554364|NCT05388448|Clavulanic Acid|clavulanic acid|mesh-list
65554365|NCT05388448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65554366|NCT05388448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65554367|NCT05388448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65554368|NCT05388448|Antitubercular Agents|antitubercular agents|mesh-ancestor
65554369|NCT05388448|Leprostatic Agents|leprostatic agents|mesh-ancestor
65554370|NCT05388448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65554371|NCT05388448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554372|NCT05388448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554373|NCT05388448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65554374|NCT05388448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65554375|NCT05388448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65554376|NCT05388448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65554377|NCT05388448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65554378|NCT05388448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65554379|NCT05388448|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65554380|NCT05108740|Everolimus|everolimus|mesh-list
65554381|NCT05108740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65554382|NCT05108740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65554383|NCT05108740|Immunologic Factors|immunologic factors|mesh-ancestor
65554384|NCT05108740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554385|NCT05105750|Aspirin|aspirin|mesh-list
65554386|NCT05105750|Indobufen|indobufen|mesh-list
65554387|NCT05105750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65554388|NCT05105750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65554389|NCT05105750|Analgesics|analgesics|mesh-ancestor
65554390|NCT05105750|Sensory System Agents|sensory system agents|mesh-ancestor
65554391|NCT05105750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65554392|NCT05105750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554393|NCT05105750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65554394|NCT05105750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65554395|NCT05105750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65554396|NCT05105750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65554397|NCT05105750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554398|NCT05105750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65554399|NCT05105750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65554400|NCT05105750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554401|NCT05105750|Antipyretics|antipyretics|mesh-ancestor
65554402|NCT03485170|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65554403|NCT03485170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65554404|NCT03485170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554405|NCT05152264|Analgesics|analgesics|mesh-list
65554406|NCT05152264|Sensory System Agents|sensory system agents|mesh-ancestor
65554407|NCT05152264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65554408|NCT05152264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554409|NCT02286154|Hydroxyurea|hydroxyurea|mesh-list
65554410|NCT02286154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65554411|NCT02286154|Antisickling Agents|antisickling agents|mesh-ancestor
65554412|NCT02286154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554413|NCT02286154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554414|NCT02286154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65554415|NCT05152186|Disinfectants|disinfectants|mesh-list
65554416|NCT05152186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65554417|NCT03485092|Empagliflozin|empagliflozin|mesh-list
65554418|NCT03485092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65554419|NCT03485092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554420|NCT03485092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65554421|NCT03485092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554422|NCT03481582|Nitroglycerin|nitroglycerin|mesh-list
65554423|NCT03481582|Vasodilator Agents|vasodilator agents|mesh-ancestor
65554424|NCT01376102|Ibandronic Acid|ibandronic acid|mesh-list
65554425|NCT01376102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65554426|NCT01376102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554427|NCT05064800|Ritonavir|ritonavir|mesh-list
65554428|NCT05064800|Dabigatran|dabigatran|mesh-list
65554429|NCT05064800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65554430|NCT05064800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65554431|NCT05064800|Protease Inhibitors|protease inhibitors|mesh-ancestor
65554432|NCT05064800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554433|NCT05064800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554434|NCT05064800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65554435|NCT05064800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65554436|NCT05064800|Antiviral Agents|antiviral agents|mesh-ancestor
65554437|NCT05064800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65554438|NCT05064800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65554439|NCT05064800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65554440|NCT05064800|Antithrombins|antithrombins|mesh-ancestor
65554441|NCT05064800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65554442|NCT05064800|Anticoagulants|anticoagulants|mesh-ancestor
65554443|NCT01376180|Lamotrigine|lamotrigine|mesh-list
65554444|NCT01376180|Anticonvulsants|anticonvulsants|mesh-ancestor
65554445|NCT01376180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65554446|NCT01376180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65554447|NCT01376180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554448|NCT01376180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65554449|NCT01376180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554450|NCT01376180|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65554451|NCT01376180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65554452|NCT01376180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65554453|NCT01376180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65554454|NCT01376180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65554455|NCT03633734|Folfirinox|folfirinox|mesh-list
65554456|NCT03633734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65554457|NCT01376258|Finasteride|finasteride|mesh-list
65554458|NCT01376258|Dutasteride|dutasteride|mesh-list
65554459|NCT01376258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65554460|NCT01376258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65554461|NCT01376258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554462|NCT01376258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554463|NCT01376258|Hormone Antagonists|hormone antagonists|mesh-ancestor
65554464|NCT01376258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65554465|NCT01376258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554466|NCT01376258|Urological Agents|urological agents|mesh-ancestor
65554467|NCT05151874|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65554468|NCT05151874|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65554469|NCT05151874|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65554470|NCT05151874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65554471|NCT05151874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554472|NCT05151874|Cholinergic Agents|cholinergic agents|mesh-ancestor
65554473|NCT05151874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65554474|NCT05151874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554475|NCT05151874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65554476|NCT05151874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65554477|NCT03531840|Olaparib|olaparib|mesh-list
65554478|NCT03531840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65554479|NCT03531840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554480|NCT03531840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554481|NCT03531840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65554482|NCT05151796|Aspirin|aspirin|mesh-list
65554483|NCT05151796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65554484|NCT05151796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65554485|NCT05151796|Analgesics|analgesics|mesh-ancestor
65554486|NCT05151796|Sensory System Agents|sensory system agents|mesh-ancestor
65554487|NCT05151796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65554488|NCT05151796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554489|NCT05151796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65554490|NCT05151796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65554491|NCT05151796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65554492|NCT05151796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65554493|NCT05151796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554494|NCT05151796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65554495|NCT05151796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65554496|NCT05151796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554497|NCT05151796|Antipyretics|antipyretics|mesh-ancestor
65554498|NCT04460092|Insulin|insulin|mesh-list
65554500|NCT04460092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65554501|NCT04460092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554502|NCT03110900|Lorazepam|lorazepam|mesh-list
65554503|NCT03110900|Haloperidol|haloperidol|mesh-list
65554504|NCT03110900|Haloperidol decanoate|haloperidol decanoate|mesh-list
65554505|NCT03110900|Loxapine|loxapine|mesh-list
65554506|NCT03110900|Antiemetics|antiemetics|mesh-ancestor
65554507|NCT03110900|Autonomic Agents|autonomic agents|mesh-ancestor
65554508|NCT03110900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65554509|NCT03110900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554510|NCT03110900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65554511|NCT03110900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65554512|NCT03110900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65554513|NCT03110900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65554514|NCT03110900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65554515|NCT03110900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65554516|NCT03110900|Dopamine Agents|dopamine agents|mesh-ancestor
65554517|NCT03110900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65554518|NCT03110900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554519|NCT03110900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65554520|NCT03110900|Anticonvulsants|anticonvulsants|mesh-ancestor
65554521|NCT03110900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65554522|NCT03110900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65554523|NCT03110900|GABA Modulators|gaba modulators|mesh-ancestor
65554524|NCT03110900|GABA Agents|gaba agents|mesh-ancestor
65554525|NCT03486184|Cystatins|cystatins|mesh-list
65554526|NCT03486184|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65554527|NCT03486184|Protease Inhibitors|protease inhibitors|mesh-ancestor
65554528|NCT03486184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554529|NCT03486184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554530|NCT03486106|Propofol|propofol|mesh-list
65554531|NCT03486106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65554532|NCT03486106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65554533|NCT03486106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554534|NCT03486106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65554535|NCT03486106|Anesthetics, General|anesthetics, general|mesh-ancestor
65554536|NCT03486106|Anesthetics|anesthetics|mesh-ancestor
65554537|NCT03109756|Gaboxadol|gaboxadol|mesh-list
65554538|NCT03109756|Analgesics|analgesics|mesh-ancestor
65554539|NCT03109756|Sensory System Agents|sensory system agents|mesh-ancestor
65554540|NCT03109756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65554541|NCT03109756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554542|NCT03109756|Anticonvulsants|anticonvulsants|mesh-ancestor
65554543|NCT03109756|GABA Agonists|gaba agonists|mesh-ancestor
65554544|NCT03109756|GABA Agents|gaba agents|mesh-ancestor
65554545|NCT03109756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65554546|NCT03109756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554547|NCT03867734|Aztreonam|aztreonam|mesh-list
65554548|NCT03867734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65554549|NCT03867734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65554550|NCT05759546|Fulvestrant|fulvestrant|mesh-list
65554551|NCT05759546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65554552|NCT05759546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65554553|NCT05759546|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65554554|NCT05759546|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65554555|NCT05759546|Hormone Antagonists|hormone antagonists|mesh-ancestor
65554556|NCT05759546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65554557|NCT05759546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554558|NCT05151016|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65554559|NCT05151016|Mifepristone|mifepristone|mesh-list
65554560|NCT05151016|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65554561|NCT05151016|Abortifacient Agents|abortifacient agents|mesh-ancestor
65554562|NCT05151016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65554563|NCT05151016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554564|NCT05151016|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65554565|NCT05151016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65554566|NCT05151016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65554567|NCT05151016|Contraceptive Agents|contraceptive agents|mesh-ancestor
65554568|NCT05151016|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65554569|NCT05151016|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65554570|NCT05151016|Hormone Antagonists|hormone antagonists|mesh-ancestor
65554571|NCT05151016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65554572|NCT05151016|Luteolytic Agents|luteolytic agents|mesh-ancestor
65554573|NCT05151016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65554574|NCT05151016|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65554575|NCT05151016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65554576|NCT05151016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65554577|NCT04459312|Antibodies|antibodies|mesh-list
65554578|NCT04459312|Immunologic Factors|immunologic factors|mesh-ancestor
65554579|NCT04459312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554580|NCT04871360|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65554581|NCT04871360|Laxatives|laxatives|mesh-ancestor
65554582|NCT04871360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65554583|NCT05153200|Adalimumab|adalimumab|mesh-list
65554584|NCT05153200|Upadacitinib|upadacitinib|mesh-list
65554585|NCT05153200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65554586|NCT05153200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65554587|NCT05153200|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65554588|NCT05153200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65554589|NCT05153200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554590|NCT05153200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554591|NCT03481036|Antiviral Agents|antiviral agents|mesh-list
65554592|NCT03481036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65554593|NCT03477136|Vitamin D|vitamin d|mesh-list
65554594|NCT03477136|Vitamins|vitamins|mesh-ancestor
65554595|NCT03477136|Micronutrients|micronutrients|mesh-ancestor
65554596|NCT03477136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554597|NCT03477136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65554598|NCT03552068|Clonidine|clonidine|mesh-list
65554599|NCT03552068|Analgesics|analgesics|mesh-ancestor
65554600|NCT03552068|Sensory System Agents|sensory system agents|mesh-ancestor
65554601|NCT03552068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65554602|NCT03552068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554603|NCT03552068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65554604|NCT03552068|Sympatholytics|sympatholytics|mesh-ancestor
65554605|NCT03552068|Autonomic Agents|autonomic agents|mesh-ancestor
65554606|NCT03552068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65554607|NCT03552068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65554608|NCT03552068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65554609|NCT03552068|Adrenergic Agents|adrenergic agents|mesh-ancestor
65554610|NCT03552068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65554611|NCT03552068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554612|NCT00702988|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65554613|NCT00702988|Hormones|hormones|mesh-ancestor
65554614|NCT00702988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65554615|NCT00702988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554616|NCT05759312|Metformin|metformin|mesh-list
65554617|NCT05759312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65554618|NCT05759312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554619|NCT03446456|Vasopressins|vasopressins|mesh-list
65554620|NCT03446456|Arginine Vasopressin|arginine vasopressin|mesh-list
65554621|NCT03446456|Hemostatics|hemostatics|mesh-ancestor
65554622|NCT03446456|Coagulants|coagulants|mesh-ancestor
65554623|NCT03446456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65554624|NCT03446456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65554625|NCT03446456|Natriuretic Agents|natriuretic agents|mesh-ancestor
65554626|NCT03446456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554627|NCT03396692|Morphine|morphine|mesh-list
65554628|NCT03396692|Ropivacaine|ropivacaine|mesh-list
65554629|NCT03396692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65554630|NCT03396692|Narcotics|narcotics|mesh-ancestor
65554631|NCT03396692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65554632|NCT03396692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554633|NCT03396692|Analgesics|analgesics|mesh-ancestor
65554634|NCT03396692|Sensory System Agents|sensory system agents|mesh-ancestor
65554635|NCT03396692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65554636|NCT03396692|Anesthetics, Local|anesthetics, local|mesh-ancestor
65554637|NCT03396692|Anesthetics|anesthetics|mesh-ancestor
65554638|NCT04796948|Leucovorin|leucovorin|mesh-list
65554639|NCT04796948|Fluorouracil|fluorouracil|mesh-list
65554640|NCT04796948|Oxaliplatin|oxaliplatin|mesh-list
65554641|NCT04796948|Irinotecan|irinotecan|mesh-list
65554642|NCT04796948|Calcium|calcium|mesh-list
65554643|NCT04796948|Levoleucovorin|levoleucovorin|mesh-list
65554644|NCT04796948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65554645|NCT04796948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554646|NCT04796948|Antimetabolites|antimetabolites|mesh-ancestor
65554647|NCT04796948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554648|NCT04796948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65554649|NCT04796948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65554650|NCT04796948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65554651|NCT04796948|Immunologic Factors|immunologic factors|mesh-ancestor
65554652|NCT04796948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65554653|NCT04796948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65554654|NCT04796948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554655|NCT04796948|Antidotes|antidotes|mesh-ancestor
65554656|NCT04796948|Protective Agents|protective agents|mesh-ancestor
65554657|NCT04796948|Vitamin B Complex|vitamin b complex|mesh-ancestor
65554658|NCT04796948|Vitamins|vitamins|mesh-ancestor
65554659|NCT04796948|Micronutrients|micronutrients|mesh-ancestor
65554660|NCT03480958|Morphine|morphine|mesh-list
65554661|NCT03480958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65554662|NCT03480958|Narcotics|narcotics|mesh-ancestor
65554663|NCT03480958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65554664|NCT03480958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554665|NCT03480958|Analgesics|analgesics|mesh-ancestor
65554666|NCT03480958|Sensory System Agents|sensory system agents|mesh-ancestor
65554667|NCT03480958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65554668|NCT03495102|Dulaglutide|dulaglutide|mesh-list
65554669|NCT03495102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65554670|NCT03495102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554671|NCT04859608|Eculizumab|eculizumab|mesh-list
65554672|NCT04859608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65554673|NCT04859608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65554674|NCT04859608|Immunologic Factors|immunologic factors|mesh-ancestor
65554675|NCT04859608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554676|NCT04754386|Antibodies|antibodies|mesh-list
65554677|NCT04754386|Immunologic Factors|immunologic factors|mesh-ancestor
65554678|NCT04754386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554679|NCT05198180|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65554680|NCT05198180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65554681|NCT05198180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65554682|NCT05198180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65554683|NCT03253172|Potassium Citrate|potassium citrate|mesh-list
65554684|NCT03253172|Diuretics|diuretics|mesh-ancestor
65554685|NCT03253172|Natriuretic Agents|natriuretic agents|mesh-ancestor
65554686|NCT03253172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554687|NCT03253172|Expectorants|expectorants|mesh-ancestor
65554688|NCT03253172|Respiratory System Agents|respiratory system agents|mesh-ancestor
65554689|NCT03483376|Anti-Infective Agents|anti-infective agents|mesh-list
65554690|NCT03483376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65554691|NCT03480646|Prednisone|prednisone|mesh-list
65554692|NCT03480646|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
65554693|NCT03480646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65554694|NCT03480646|Glucocorticoids|glucocorticoids|mesh-ancestor
65554695|NCT03480646|Hormones|hormones|mesh-ancestor
65554696|NCT03480646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65554697|NCT03480646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554698|NCT03480646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65554699|NCT03480646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65554700|NCT03480646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554701|NCT03480646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554702|NCT03483142|Misoprostol|misoprostol|mesh-list
65554703|NCT03483142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65554704|NCT03483142|Abortifacient Agents|abortifacient agents|mesh-ancestor
65554705|NCT03483142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65554706|NCT03483142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554707|NCT03483142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65554708|NCT03483142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65554709|NCT03483142|Oxytocics|oxytocics|mesh-ancestor
65554710|NCT03726372|Bromides|bromides|mesh-list
65554711|NCT03726372|Rocuronium|rocuronium|mesh-list
65554712|NCT03726372|Anticonvulsants|anticonvulsants|mesh-ancestor
65554713|NCT03726372|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65554714|NCT03726372|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65554715|NCT03726372|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65554716|NCT03726372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65554717|NCT03726372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554718|NCT03104816|Acetaminophen|acetaminophen|mesh-list
65554719|NCT03104816|Hydromorphone|hydromorphone|mesh-list
65554720|NCT03104816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65554721|NCT03104816|Analgesics|analgesics|mesh-ancestor
65554722|NCT03104816|Sensory System Agents|sensory system agents|mesh-ancestor
65554723|NCT03104816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65554724|NCT03104816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554725|NCT03104816|Antipyretics|antipyretics|mesh-ancestor
65554726|NCT03104816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65352271|NCT00849537|Triamcinolone|triamcinolone|mesh-list
65554727|NCT03104816|Narcotics|narcotics|mesh-ancestor
65554728|NCT03104816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65554729|NCT04720976|Pembrolizumab|pembrolizumab|mesh-list
65554730|NCT04720976|Osimertinib|osimertinib|mesh-list
65554731|NCT04720976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65554732|NCT04720976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65554733|NCT04720976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65554734|NCT04720976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554735|NCT04720976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554736|NCT03480568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65554737|NCT03480568|Immunologic Factors|immunologic factors|mesh-ancestor
65554738|NCT03480568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554739|NCT04707326|Lamivudine|lamivudine|mesh-list
65554740|NCT04707326|Dolutegravir|dolutegravir|mesh-list
65554741|NCT04707326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65554742|NCT04707326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65554743|NCT04707326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554744|NCT04707326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554745|NCT04707326|Antiviral Agents|antiviral agents|mesh-ancestor
65554746|NCT04707326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65554747|NCT04707326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65554748|NCT04707326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65554749|NCT04707326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65554750|NCT04707326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65554751|NCT03559062|Ivacaftor|ivacaftor|mesh-list
65554752|NCT03559062|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65554753|NCT03559062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65554754|NCT03559062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554755|NCT05759000|Dapagliflozin|dapagliflozin|mesh-list
65554756|NCT05759000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65554757|NCT05759000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554758|NCT05759000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65554759|NCT05759000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554760|NCT03726216|Dalbavancin|dalbavancin|mesh-list
65554761|NCT03726216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65554762|NCT03726216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65554763|NCT00089791|Denosumab|denosumab|mesh-list
65554764|NCT00089791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65554765|NCT00089791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554766|NCT02876510|Aldesleukin|aldesleukin|mesh-list
65554767|NCT02876510|Cyclophosphamide|cyclophosphamide|mesh-list
65554768|NCT02876510|Fludarabine|fludarabine|mesh-list
65554769|NCT02876510|Fludarabine phosphate|fludarabine phosphate|mesh-list
65554770|NCT02876510|Atezolizumab|atezolizumab|mesh-list
65554771|NCT02876510|Interleukin-2|interleukin-2|mesh-list
65554772|NCT02876510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65554773|NCT02876510|Immunologic Factors|immunologic factors|mesh-ancestor
65554774|NCT02876510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554775|NCT02876510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65554776|NCT02876510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65554777|NCT02876510|Alkylating Agents|alkylating agents|mesh-ancestor
65554778|NCT02876510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554779|NCT02876510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65554780|NCT02876510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65554781|NCT02876510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65554782|NCT02876510|Antimetabolites|antimetabolites|mesh-ancestor
65554783|NCT02876510|Antiviral Agents|antiviral agents|mesh-ancestor
65554784|NCT02876510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65554785|NCT02876510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65554786|NCT02876510|Analgesics|analgesics|mesh-ancestor
65554787|NCT02876510|Sensory System Agents|sensory system agents|mesh-ancestor
65554788|NCT02876510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65554789|NCT02876510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65554790|NCT02876510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65554791|NCT03380455|Cimetidine|cimetidine|mesh-list
65554792|NCT03380455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65554793|NCT03380455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65554794|NCT03380455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65554795|NCT03380455|Histamine Antagonists|histamine antagonists|mesh-ancestor
65554796|NCT03380455|Histamine Agents|histamine agents|mesh-ancestor
65554797|NCT03380455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65554798|NCT03380455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554799|NCT03380455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554800|NCT03380455|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65554801|NCT03380455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65554802|NCT03380455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554803|NCT02815280|Minocycline|minocycline|mesh-list
65554804|NCT02815280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65554805|NCT02815280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65554806|NCT03482752|Molgramostim|molgramostim|mesh-list
65554807|NCT03482752|Sargramostim|sargramostim|mesh-list
65554808|NCT03482752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65554809|NCT03482752|Immunologic Factors|immunologic factors|mesh-ancestor
65554810|NCT03482752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554811|NCT04729543|Azacitidine|azacitidine|mesh-list
65554812|NCT04729543|Interleukin-2|interleukin-2|mesh-list
65554813|NCT04729543|Valproic Acid|valproic acid|mesh-list
65554814|NCT04729543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65554815|NCT04729543|Antimetabolites|antimetabolites|mesh-ancestor
65554816|NCT04729543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554817|NCT04729543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65554818|NCT04729543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554819|NCT04729543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65554820|NCT04729543|Analgesics|analgesics|mesh-ancestor
65554821|NCT04729543|Sensory System Agents|sensory system agents|mesh-ancestor
65554822|NCT04729543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65554823|NCT04729543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554824|NCT04729543|Anticonvulsants|anticonvulsants|mesh-ancestor
65554825|NCT04729543|GABA Agents|gaba agents|mesh-ancestor
65554826|NCT04729543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65554827|NCT04729543|Antimanic Agents|antimanic agents|mesh-ancestor
65554828|NCT04729543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65554829|NCT04729543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65554830|NCT04729543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65554831|NCT01310712|Oxybutynin|oxybutynin|mesh-list
65554832|NCT01310712|Parasympatholytics|parasympatholytics|mesh-ancestor
65554833|NCT01310712|Autonomic Agents|autonomic agents|mesh-ancestor
65554834|NCT01310712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65554835|NCT01310712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554836|NCT01310712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65554837|NCT01310712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65554838|NCT01310712|Cholinergic Agents|cholinergic agents|mesh-ancestor
65554839|NCT01310712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65554840|NCT01310712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554841|NCT01310712|Urological Agents|urological agents|mesh-ancestor
65554842|NCT02737930|Fluoxetine|fluoxetine|mesh-list
65554843|NCT02737930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65554844|NCT02737930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65554845|NCT02737930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65554846|NCT02737930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554847|NCT02737930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65554848|NCT02737930|Serotonin Agents|serotonin agents|mesh-ancestor
65554849|NCT02737930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554850|NCT02737930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65554851|NCT02737930|Antidepressive Agents|antidepressive agents|mesh-ancestor
65554852|NCT02737930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65554853|NCT02737930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65554854|NCT02737930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65554855|NCT02737930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554856|NCT04707391|Vaccines|vaccines|mesh-list
65554857|NCT04707391|Immunologic Factors|immunologic factors|mesh-ancestor
65554858|NCT04707391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554859|NCT01242787|Entecavir|entecavir|mesh-list
65554860|NCT01242787|Antiviral Agents|antiviral agents|mesh-ancestor
65554861|NCT01242787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65554862|NCT03476356|Clomiphene|clomiphene|mesh-list
65554863|NCT03476356|Enclomiphene|enclomiphene|mesh-list
65554864|NCT03476356|Zuclomiphene|zuclomiphene|mesh-list
65554865|NCT03476356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65554866|NCT03476356|Hormone Antagonists|hormone antagonists|mesh-ancestor
65554867|NCT03476356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65554868|NCT03476356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554869|NCT03476356|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65554870|NCT03476356|Fertility Agents|fertility agents|mesh-ancestor
65554871|NCT03476356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65554872|NCT03476356|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65554873|NCT03476356|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65554874|NCT03723096|Pomalidomide|pomalidomide|mesh-list
65554875|NCT03723096|Immunologic Factors|immunologic factors|mesh-ancestor
65554876|NCT03723096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554877|NCT03723096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65554878|NCT03723096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65554879|NCT03723096|Growth Substances|growth substances|mesh-ancestor
65554880|NCT03723096|Growth Inhibitors|growth inhibitors|mesh-ancestor
65554881|NCT03723096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65554882|NCT02534012|Anesthetics|anesthetics|mesh-list
65554883|NCT02534012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65554884|NCT02534012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554885|NCT05626387|Mycophenolic Acid|mycophenolic acid|mesh-list
65554886|NCT05626387|Prednisolone|prednisolone|mesh-list
65554887|NCT05626387|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65554888|NCT05626387|Methylprednisolone|methylprednisolone|mesh-list
65554889|NCT05626387|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65554890|NCT05626387|Prednisolone acetate|prednisolone acetate|mesh-list
65554891|NCT05626387|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65554892|NCT05626387|Prednisolone phosphate|prednisolone phosphate|mesh-list
65554893|NCT05626387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65554894|NCT05626387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65554895|NCT05626387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65554896|NCT05626387|Antitubercular Agents|antitubercular agents|mesh-ancestor
65554897|NCT05626387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65554898|NCT05626387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65554899|NCT05626387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554900|NCT05626387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554901|NCT05626387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65554902|NCT05626387|Glucocorticoids|glucocorticoids|mesh-ancestor
65554903|NCT05626387|Hormones|hormones|mesh-ancestor
65554904|NCT05626387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65554905|NCT05626387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554906|NCT05626387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65554907|NCT05626387|Antiemetics|antiemetics|mesh-ancestor
65554908|NCT05626387|Autonomic Agents|autonomic agents|mesh-ancestor
65554909|NCT05626387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65554910|NCT05626387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65554911|NCT05626387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65554912|NCT05626387|Protective Agents|protective agents|mesh-ancestor
65554913|NCT03722940|Magnesium Sulfate|magnesium sulfate|mesh-list
65554914|NCT03722940|Analgesics|analgesics|mesh-ancestor
65554915|NCT03722940|Sensory System Agents|sensory system agents|mesh-ancestor
65554916|NCT03722940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65554917|NCT03722940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554918|NCT03722940|Anesthetics|anesthetics|mesh-ancestor
65554919|NCT03722940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65554920|NCT03722940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65554921|NCT03722940|Anticonvulsants|anticonvulsants|mesh-ancestor
65554922|NCT03722940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65554923|NCT03722940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65554924|NCT03722940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554925|NCT03722940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65554926|NCT03722940|Tocolytic Agents|tocolytic agents|mesh-ancestor
65554927|NCT03722940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65554928|NCT01146925|Deferiprone|deferiprone|mesh-list
65554929|NCT01146925|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65554930|NCT01146925|Chelating Agents|chelating agents|mesh-ancestor
65554931|NCT01146925|Sequestering Agents|sequestering agents|mesh-ancestor
65554932|NCT01146925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554933|NCT04635254|Histamine|histamine|mesh-list
65554934|NCT04635254|Histamine Agonists|histamine agonists|mesh-ancestor
65554935|NCT04635254|Histamine Agents|histamine agents|mesh-ancestor
65554936|NCT04635254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65554937|NCT04635254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554938|NCT04635254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554939|NCT03476044|Selenium|selenium|mesh-list
65554940|NCT03476044|Antioxidants|antioxidants|mesh-ancestor
65554941|NCT03476044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554942|NCT03476044|Protective Agents|protective agents|mesh-ancestor
65554943|NCT03476044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554944|NCT03476044|Trace Elements|trace elements|mesh-ancestor
65554945|NCT03476044|Micronutrients|micronutrients|mesh-ancestor
65554946|NCT01250821|Menotropins|menotropins|mesh-list
65554947|NCT01250821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65554948|NCT01250821|Fertility Agents|fertility agents|mesh-ancestor
65554949|NCT01250821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65554950|NCT01250821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554951|NCT03493698|Midazolam|midazolam|mesh-list
65554952|NCT03493698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65554954|NCT03493698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65554955|NCT03493698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554956|NCT03493698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65554957|NCT03493698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65554958|NCT03493698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65554959|NCT03493698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65554960|NCT03493698|Anesthetics, General|anesthetics, general|mesh-ancestor
65554961|NCT03493698|Anesthetics|anesthetics|mesh-ancestor
65554962|NCT03493698|GABA Modulators|gaba modulators|mesh-ancestor
65554963|NCT03493698|GABA Agents|gaba agents|mesh-ancestor
65554964|NCT03493698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65554965|NCT03493698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554966|NCT01148173|Ifosfamide|ifosfamide|mesh-list
65554967|NCT01148173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65554968|NCT01148173|Alkylating Agents|alkylating agents|mesh-ancestor
65554969|NCT01148173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554970|NCT01148173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65554971|NCT01898312|Mifepristone|mifepristone|mesh-list
65554972|NCT01898312|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65554973|NCT01898312|Abortifacient Agents|abortifacient agents|mesh-ancestor
65554974|NCT01898312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65554975|NCT01898312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554976|NCT01898312|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65554977|NCT01898312|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65554978|NCT01898312|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65554979|NCT01898312|Contraceptive Agents|contraceptive agents|mesh-ancestor
65554980|NCT01898312|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65554981|NCT01898312|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65554982|NCT01898312|Hormone Antagonists|hormone antagonists|mesh-ancestor
65554983|NCT01898312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65554984|NCT01898312|Luteolytic Agents|luteolytic agents|mesh-ancestor
65554985|NCT01898312|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65554986|NCT01898312|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65554987|NCT03528174|Pancrelipase|pancrelipase|mesh-list
65554988|NCT03528174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65554989|NCT05756660|Sodium thiosulfate|sodium thiosulfate|mesh-list
65554990|NCT05756660|Cisplatin|cisplatin|mesh-list
65554991|NCT05756660|Vorinostat|vorinostat|mesh-list
65554992|NCT05756660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65554993|NCT05756660|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65554994|NCT05756660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65554995|NCT05756660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65554996|NCT05756660|Antidotes|antidotes|mesh-ancestor
65554997|NCT05756660|Protective Agents|protective agents|mesh-ancestor
65554998|NCT05756660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65554999|NCT05756660|Antioxidants|antioxidants|mesh-ancestor
65555000|NCT05756660|Antitubercular Agents|antitubercular agents|mesh-ancestor
65555001|NCT05756660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65555002|NCT05756660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65555003|NCT05756660|Chelating Agents|chelating agents|mesh-ancestor
65555004|NCT05756660|Sequestering Agents|sequestering agents|mesh-ancestor
65555005|NCT03482440|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
65555006|NCT03482440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65555007|NCT03482440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65555008|NCT03482440|Analgesics|analgesics|mesh-ancestor
65555009|NCT03482440|Sensory System Agents|sensory system agents|mesh-ancestor
65555010|NCT03482440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555011|NCT03482440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284124|NCT02778425|Hormones|hormones|mesh-ancestor
65555012|NCT03482440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65555013|NCT03482440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65555014|NCT04638634|Immunoglobulins|immunoglobulins|mesh-list
65555015|NCT04638634|Immunologic Factors|immunologic factors|mesh-ancestor
65555016|NCT04638634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555017|NCT01253473|Budesonide|budesonide|mesh-list
65555018|NCT01253473|Albuterol|albuterol|mesh-list
65555019|NCT01253473|Formoterol Fumarate|formoterol fumarate|mesh-list
65555020|NCT01253473|Ipratropium|ipratropium|mesh-list
65555021|NCT01253473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65555022|NCT01253473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65555023|NCT01253473|Autonomic Agents|autonomic agents|mesh-ancestor
65555024|NCT01253473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555025|NCT01253473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352567|NCT00752154|Analgesics|analgesics|mesh-ancestor
65555026|NCT01253473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65555027|NCT01253473|Respiratory System Agents|respiratory system agents|mesh-ancestor
65555028|NCT01253473|Glucocorticoids|glucocorticoids|mesh-ancestor
65555029|NCT01253473|Hormones|hormones|mesh-ancestor
65555030|NCT01253473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65555031|NCT01253473|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65555032|NCT01253473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65555033|NCT01253473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65555034|NCT01253473|Adrenergic Agents|adrenergic agents|mesh-ancestor
65555035|NCT01253473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65555036|NCT01253473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555037|NCT01253473|Tocolytic Agents|tocolytic agents|mesh-ancestor
65555038|NCT01253473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65555039|NCT01253473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65555040|NCT01253473|Cholinergic Agents|cholinergic agents|mesh-ancestor
65555041|NCT01883804|Methyldopa|methyldopa|mesh-list
65555042|NCT01883804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65555043|NCT01883804|Sympatholytics|sympatholytics|mesh-ancestor
65555044|NCT01883804|Autonomic Agents|autonomic agents|mesh-ancestor
65555045|NCT01883804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555046|NCT01883804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555047|NCT01883804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65555048|NCT01883804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65555049|NCT01883804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65555050|NCT01883804|Adrenergic Agents|adrenergic agents|mesh-ancestor
65555051|NCT01883804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65555052|NCT01883804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555053|NCT01247935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65555054|NCT01247935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65555055|NCT01247935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555056|NCT03475810|Midazolam|midazolam|mesh-list
65555057|NCT03475810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65555058|NCT03475810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65555059|NCT03475810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65555060|NCT03475810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555061|NCT03475810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65555062|NCT03475810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65555063|NCT03475810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65555064|NCT03475810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65555065|NCT03475810|Anesthetics, General|anesthetics, general|mesh-ancestor
65555066|NCT03475810|Anesthetics|anesthetics|mesh-ancestor
65555067|NCT03475810|GABA Modulators|gaba modulators|mesh-ancestor
65555068|NCT03475810|GABA Agents|gaba agents|mesh-ancestor
65555069|NCT03475810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65555070|NCT03475810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555071|NCT03480100|Xylometazoline|xylometazoline|mesh-list
65555072|NCT03480100|Nasal Decongestants|nasal decongestants|mesh-ancestor
65555073|NCT03480100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65555074|NCT03480100|Respiratory System Agents|respiratory system agents|mesh-ancestor
65555075|NCT02348203|Aspirin|aspirin|mesh-list
65555076|NCT02348203|Zileuton|zileuton|mesh-list
65555077|NCT02348203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65555078|NCT02348203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65555079|NCT02348203|Analgesics|analgesics|mesh-ancestor
65555080|NCT02348203|Sensory System Agents|sensory system agents|mesh-ancestor
65555081|NCT02348203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555082|NCT02348203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555083|NCT02348203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65555084|NCT02348203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65555085|NCT02348203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65555086|NCT02348203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65555087|NCT02348203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555088|NCT02348203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65555089|NCT02348203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65555090|NCT02348203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65555091|NCT02348203|Antipyretics|antipyretics|mesh-ancestor
65555092|NCT02348203|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65555093|NCT02348203|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65555094|NCT02348203|Hormone Antagonists|hormone antagonists|mesh-ancestor
65555095|NCT02348203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65555096|NCT03493542|Vaccines|vaccines|mesh-list
65555097|NCT03493542|Immunologic Factors|immunologic factors|mesh-ancestor
65555098|NCT03493542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555099|NCT04365088|Deflazacort|deflazacort|mesh-list
65555100|NCT04365088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65352641|NCT02560974|Capecitabine|capecitabine|mesh-list
65555101|NCT04365088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65555102|NCT04365088|Immunologic Factors|immunologic factors|mesh-ancestor
65555103|NCT04365088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555104|NCT03482362|Vinorelbine|vinorelbine|mesh-list
65555105|NCT03482362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65555106|NCT03482362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65555107|NCT03482362|Tubulin Modulators|tubulin modulators|mesh-ancestor
65555108|NCT03482362|Antimitotic Agents|antimitotic agents|mesh-ancestor
65555109|NCT03482362|Mitosis Modulators|mitosis modulators|mesh-ancestor
65555110|NCT03482362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555111|NCT04500470|Ketoprofen|ketoprofen|mesh-list
65555112|NCT04500470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65555113|NCT04500470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65555114|NCT04500470|Analgesics|analgesics|mesh-ancestor
65555115|NCT04500470|Sensory System Agents|sensory system agents|mesh-ancestor
65555116|NCT04500470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555117|NCT04500470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555118|NCT04500470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65555119|NCT04500470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65555120|NCT04500470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65555121|NCT04500470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65555122|NCT04500470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555123|NCT03493386|Glycine|glycine|mesh-list
65555124|NCT03493386|Glycine Agents|glycine agents|mesh-ancestor
65555125|NCT03493386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65555126|NCT03493386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555127|NCT03493386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555128|NCT04937816|Empagliflozin|empagliflozin|mesh-list
65555129|NCT04937816|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65555130|NCT04937816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555131|NCT04937816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65555132|NCT04937816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555133|NCT01366898|Methotrexate|methotrexate|mesh-list
65555134|NCT01366898|Idarubicin|idarubicin|mesh-list
65555135|NCT01366898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65555136|NCT01366898|Abortifacient Agents|abortifacient agents|mesh-ancestor
65555137|NCT01366898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65555138|NCT01366898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555139|NCT01366898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65555140|NCT01366898|Antimetabolites|antimetabolites|mesh-ancestor
65555141|NCT01366898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555142|NCT01366898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65555143|NCT01366898|Dermatologic Agents|dermatologic agents|mesh-ancestor
65555144|NCT01366898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65555145|NCT01366898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65555146|NCT01366898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65555147|NCT01366898|Immunologic Factors|immunologic factors|mesh-ancestor
65555148|NCT01366898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65555149|NCT01366898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65555150|NCT01366898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65555151|NCT01366898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65555152|NCT01366898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65555153|NCT01248871|Sufentanil|sufentanil|mesh-list
65555154|NCT01248871|Remifentanil|remifentanil|mesh-list
65555155|NCT01248871|Dsuvia|dsuvia|mesh-list
65555156|NCT01248871|Propofol|propofol|mesh-list
65555157|NCT01248871|Sevoflurane|sevoflurane|mesh-list
65555158|NCT01248871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65555159|NCT01248871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65555160|NCT01248871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555161|NCT01248871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65555162|NCT01248871|Anesthetics, General|anesthetics, general|mesh-ancestor
65555163|NCT01248871|Anesthetics|anesthetics|mesh-ancestor
65555164|NCT01248871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65555165|NCT01248871|Narcotics|narcotics|mesh-ancestor
65555166|NCT01248871|Analgesics|analgesics|mesh-ancestor
65555167|NCT01248871|Sensory System Agents|sensory system agents|mesh-ancestor
65555168|NCT01248871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555169|NCT01248871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65555170|NCT01248871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65555171|NCT01248871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65555172|NCT01251133|Vaccines|vaccines|mesh-list
65555173|NCT01251133|Immunologic Factors|immunologic factors|mesh-ancestor
65555174|NCT01251133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352731|NCT00943930|Hormones|hormones|mesh-ancestor
65555175|NCT03720288|Acetazolamide|acetazolamide|mesh-list
65555176|NCT03720288|Anticonvulsants|anticonvulsants|mesh-ancestor
65555177|NCT03720288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65555178|NCT03720288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65555179|NCT03720288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555180|NCT03720288|Diuretics|diuretics|mesh-ancestor
65555181|NCT03720288|Natriuretic Agents|natriuretic agents|mesh-ancestor
65555182|NCT03720288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555183|NCT03907813|Bupivacaine|bupivacaine|mesh-list
65555184|NCT03907813|Anesthetics, Local|anesthetics, local|mesh-ancestor
65555185|NCT03907813|Anesthetics|anesthetics|mesh-ancestor
65555186|NCT03907813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65555187|NCT03907813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555188|NCT03907813|Sensory System Agents|sensory system agents|mesh-ancestor
65555189|NCT03907813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555190|NCT00938912|Lacosamide|lacosamide|mesh-list
65555191|NCT00938912|Anticonvulsants|anticonvulsants|mesh-ancestor
65555192|NCT00938912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65555193|NCT00938912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65555194|NCT00938912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65555195|NCT00938912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555196|NCT01251211|Botulinum Toxins|botulinum toxins|mesh-list
65555197|NCT01251211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65555198|NCT01251211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65555199|NCT01251211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65555200|NCT01251211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65555201|NCT01251211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555202|NCT01251211|Cholinergic Agents|cholinergic agents|mesh-ancestor
65555203|NCT01251211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65555204|NCT01251211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555205|NCT01251211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65555206|NCT01251211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555207|NCT03473340|Pirfenidone|pirfenidone|mesh-list
65555208|NCT03473340|Analgesics|analgesics|mesh-ancestor
65555209|NCT03473340|Sensory System Agents|sensory system agents|mesh-ancestor
65555210|NCT03473340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555211|NCT03473340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555212|NCT03473340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65555213|NCT03473340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65555214|NCT03473340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65555215|NCT03473340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65555216|NCT03473340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65555217|NCT01147705|Allopurinol|allopurinol|mesh-list
65555218|NCT01147705|Antimetabolites|antimetabolites|mesh-ancestor
65555219|NCT01147705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555220|NCT01147705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65555221|NCT01147705|Gout Suppressants|gout suppressants|mesh-ancestor
65555222|NCT01147705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65555223|NCT01147705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65555224|NCT01147705|Antioxidants|antioxidants|mesh-ancestor
65555225|NCT01147705|Protective Agents|protective agents|mesh-ancestor
65555226|NCT01147705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555227|NCT03907111|Chitosan|chitosan|mesh-list
65555228|NCT03907111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65555229|NCT03907111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65555230|NCT03907111|Antimetabolites|antimetabolites|mesh-ancestor
65555231|NCT03907111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555232|NCT03907111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65555233|NCT03907111|Chelating Agents|chelating agents|mesh-ancestor
65555234|NCT03907111|Sequestering Agents|sequestering agents|mesh-ancestor
65555235|NCT03907111|Hemostatics|hemostatics|mesh-ancestor
65555236|NCT03907111|Coagulants|coagulants|mesh-ancestor
65555237|NCT03912727|Thioctic Acid|thioctic acid|mesh-list
65555238|NCT03912727|Antioxidants|antioxidants|mesh-ancestor
65555239|NCT03912727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555240|NCT03912727|Protective Agents|protective agents|mesh-ancestor
65555241|NCT03912727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555242|NCT03912727|Vitamin B Complex|vitamin b complex|mesh-ancestor
65555243|NCT03912727|Vitamins|vitamins|mesh-ancestor
65555244|NCT03912727|Micronutrients|micronutrients|mesh-ancestor
65555245|NCT03661567|Methylprednisolone|methylprednisolone|mesh-list
65555246|NCT03661567|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65555247|NCT03661567|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65555248|NCT03661567|Prednisolone|prednisolone|mesh-list
65555249|NCT03661567|Prednisolone acetate|prednisolone acetate|mesh-list
65555250|NCT03661567|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65555251|NCT03661567|Prednisolone phosphate|prednisolone phosphate|mesh-list
65555252|NCT03661567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65555253|NCT03661567|Antiemetics|antiemetics|mesh-ancestor
65555254|NCT03661567|Autonomic Agents|autonomic agents|mesh-ancestor
65555255|NCT03661567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555256|NCT03661567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555257|NCT03661567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65555258|NCT03661567|Glucocorticoids|glucocorticoids|mesh-ancestor
65555259|NCT03661567|Hormones|hormones|mesh-ancestor
65555260|NCT03661567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65555261|NCT03661567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65555262|NCT03661567|Protective Agents|protective agents|mesh-ancestor
65555263|NCT03661567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65555264|NCT03661567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65555265|NCT03739138|Pembrolizumab|pembrolizumab|mesh-list
65555266|NCT03739138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65555267|NCT03739138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65555268|NCT03472326|GS-9131|gs-9131|mesh-list
65555269|NCT03472326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65555270|NCT03472326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555271|NCT03472326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65555272|NCT03472326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65555273|NCT03472326|Antiviral Agents|antiviral agents|mesh-ancestor
65555274|NCT03472326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65555275|NCT03472326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65555276|NCT03472326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65555277|NCT04182100|Aspirin|aspirin|mesh-list
65555278|NCT04182100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65555279|NCT04182100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65555280|NCT04182100|Analgesics|analgesics|mesh-ancestor
65555281|NCT04182100|Sensory System Agents|sensory system agents|mesh-ancestor
65555282|NCT04182100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555283|NCT04182100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555284|NCT04182100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65555285|NCT04182100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65555286|NCT04182100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65555287|NCT04182100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65555288|NCT04182100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555289|NCT04182100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65555290|NCT04182100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65555291|NCT04182100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65555292|NCT04182100|Antipyretics|antipyretics|mesh-ancestor
65555293|NCT03479320|Lidocaine|lidocaine|mesh-list
65555294|NCT03479320|Anesthetics, Local|anesthetics, local|mesh-ancestor
65555295|NCT03479320|Anesthetics|anesthetics|mesh-ancestor
65555296|NCT03479320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65555297|NCT03479320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555298|NCT03479320|Sensory System Agents|sensory system agents|mesh-ancestor
65555299|NCT03479320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555300|NCT03479320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65555301|NCT03479320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65555302|NCT03479320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65555303|NCT03479320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65555304|NCT03479320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555305|NCT03912415|Paclitaxel|paclitaxel|mesh-list
65555306|NCT03912415|Bevacizumab|bevacizumab|mesh-list
65555307|NCT03912415|Carboplatin|carboplatin|mesh-list
65555308|NCT03912415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65284425|NCT02660762|Autonomic Agents|autonomic agents|mesh-ancestor
65555309|NCT03912415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65555310|NCT03912415|Tubulin Modulators|tubulin modulators|mesh-ancestor
65555311|NCT03912415|Antimitotic Agents|antimitotic agents|mesh-ancestor
65555312|NCT03912415|Mitosis Modulators|mitosis modulators|mesh-ancestor
65555313|NCT03912415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555314|NCT03912415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65555315|NCT03912415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65555316|NCT03912415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65555317|NCT03912415|Growth Substances|growth substances|mesh-ancestor
65555318|NCT03912415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555319|NCT03912415|Growth Inhibitors|growth inhibitors|mesh-ancestor
65555320|NCT03525834|Everolimus|everolimus|mesh-list
65555321|NCT03525834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65555322|NCT03525834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65555323|NCT03525834|Immunologic Factors|immunologic factors|mesh-ancestor
65555324|NCT03525834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555325|NCT00925652|Cyclophosphamide|cyclophosphamide|mesh-list
65555326|NCT00925652|Bevacizumab|bevacizumab|mesh-list
65555327|NCT00925652|Methotrexate|methotrexate|mesh-list
65555328|NCT00925652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65555329|NCT00925652|Immunologic Factors|immunologic factors|mesh-ancestor
65555330|NCT00925652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555331|NCT00925652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65555332|NCT00925652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65555333|NCT00925652|Alkylating Agents|alkylating agents|mesh-ancestor
65555334|NCT00925652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555335|NCT00925652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65555336|NCT00925652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65555337|NCT00925652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65555338|NCT00925652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65555339|NCT00925652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65555340|NCT00925652|Growth Substances|growth substances|mesh-ancestor
65555341|NCT00925652|Growth Inhibitors|growth inhibitors|mesh-ancestor
65555342|NCT00925652|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65555343|NCT00925652|Abortifacient Agents|abortifacient agents|mesh-ancestor
65555344|NCT00925652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65555345|NCT00925652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65555346|NCT00925652|Antimetabolites|antimetabolites|mesh-ancestor
65555347|NCT00925652|Dermatologic Agents|dermatologic agents|mesh-ancestor
65555348|NCT00925652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65555349|NCT00925652|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65555350|NCT00925652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65555351|NCT04872686|Povidone-Iodine|povidone-iodine|mesh-list
65555352|NCT04872686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65555353|NCT04872686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65555354|NCT03954106|Defibrotide|defibrotide|mesh-list
65555355|NCT03954106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65555356|NCT03954106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65555357|NCT03954106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555358|NCT03954106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65555359|NCT03525444|Ivacaftor|ivacaftor|mesh-list
65555360|NCT03525444|Elexacaftor|elexacaftor|mesh-list
65555361|NCT03525444|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65555362|NCT03525444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65555363|NCT03525444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555364|NCT05656352|Chrysarobin|chrysarobin|mesh-list
65555365|NCT05656352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65555366|NCT05656352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65555367|NCT05656352|Analgesics|analgesics|mesh-ancestor
65555368|NCT05656352|Sensory System Agents|sensory system agents|mesh-ancestor
65555369|NCT05656352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555370|NCT05656352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555371|NCT05656352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65555372|NCT05656352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65555373|NCT01251835|Rifampin|rifampin|mesh-list
65555374|NCT01251835|Sitaxsentan|sitaxsentan|mesh-list
65555375|NCT01251835|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65555376|NCT01251835|Antitubercular Agents|antitubercular agents|mesh-ancestor
65555377|NCT01251835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65555378|NCT01251835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65555379|NCT01251835|Leprostatic Agents|leprostatic agents|mesh-ancestor
65555380|NCT01251835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65284499|NCT04132557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65555381|NCT01251835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65555382|NCT01251835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555383|NCT01251835|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65555384|NCT01251835|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65555385|NCT01251835|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65555386|NCT01251835|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65555387|NCT01251835|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65555388|NCT01251835|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65555389|NCT01251835|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65555390|NCT03632876|Vitamin A|vitamin a|mesh-list
65555391|NCT03632876|Retinol palmitate|retinol palmitate|mesh-list
65555392|NCT03632876|Antioxidants|antioxidants|mesh-ancestor
65555393|NCT03632876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555394|NCT03632876|Protective Agents|protective agents|mesh-ancestor
65555395|NCT03632876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555396|NCT03632876|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65555397|NCT03632876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352941|NCT00862095|Vasodilator Agents|vasodilator agents|mesh-ancestor
65555399|NCT03632876|Micronutrients|micronutrients|mesh-ancestor
65555400|NCT03914755|Tucatinib|tucatinib|mesh-list
65555401|NCT03914755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65555402|NCT03914755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65555403|NCT03914755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65555404|NCT03914755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555405|NCT03905317|Bevacizumab|bevacizumab|mesh-list
65555406|NCT03905317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65555407|NCT03905317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65555408|NCT03905317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65555409|NCT03905317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65555410|NCT03905317|Growth Substances|growth substances|mesh-ancestor
65555411|NCT03905317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555412|NCT03905317|Growth Inhibitors|growth inhibitors|mesh-ancestor
65555413|NCT03921424|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65555414|NCT03921424|Immunologic Factors|immunologic factors|mesh-ancestor
65555415|NCT03921424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555416|NCT03487848|Sofosbuvir|sofosbuvir|mesh-list
65555417|NCT03487848|Antiviral Agents|antiviral agents|mesh-ancestor
65555418|NCT03487848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65555419|NCT01251991|Psyllium|psyllium|mesh-list
65555420|NCT01251991|Calcium polycarbophil|calcium polycarbophil|mesh-list
65555421|NCT01251991|Cathartics|cathartics|mesh-ancestor
65555422|NCT01251991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65555423|NCT01251991|Antidiarrheals|antidiarrheals|mesh-ancestor
65555424|NCT04458454|Methocarbamol|methocarbamol|mesh-list
65555425|NCT04458454|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65555426|NCT04458454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555427|NCT04458454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65555428|NCT04458454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555429|NCT03914677|Mecamylamine|mecamylamine|mesh-list
65555430|NCT03914677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65555431|NCT03914677|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
65555432|NCT03914677|Autonomic Agents|autonomic agents|mesh-ancestor
65555433|NCT03914677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555434|NCT03914677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555435|NCT03914677|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65555436|NCT03914677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65555437|NCT03914677|Cholinergic Agents|cholinergic agents|mesh-ancestor
65555438|NCT03914677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65555439|NCT03914677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555440|NCT03479086|Topiramate|topiramate|mesh-list
65555441|NCT03479086|Naltrexone|naltrexone|mesh-list
65555442|NCT03479086|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65555443|NCT03479086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65555444|NCT03479086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555445|NCT03479086|Sensory System Agents|sensory system agents|mesh-ancestor
65555446|NCT03479086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555447|NCT03479086|Anticonvulsants|anticonvulsants|mesh-ancestor
65555448|NCT03479086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65555449|NCT01252069|Ulipristal acetate|ulipristal acetate|mesh-list
65555450|NCT01252069|Progestins|progestins|mesh-list
65555451|NCT01252069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65555452|NCT01252069|Contraceptive Agents|contraceptive agents|mesh-ancestor
65555453|NCT01252069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65284573|NCT05325346|Anticoagulants|anticoagulants|mesh-ancestor
65555454|NCT01252069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555455|NCT01252069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65555456|NCT01252069|Hormones|hormones|mesh-ancestor
65555457|NCT01252069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65555458|NCT01252225|Lidocaine|lidocaine|mesh-list
65555459|NCT01252225|Anesthetics, Local|anesthetics, local|mesh-ancestor
65555460|NCT01252225|Anesthetics|anesthetics|mesh-ancestor
65555461|NCT01252225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65555462|NCT01252225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555463|NCT01252225|Sensory System Agents|sensory system agents|mesh-ancestor
65555464|NCT01252225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555465|NCT01252225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65555466|NCT01252225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65555467|NCT01252225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65555468|NCT01252225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65555469|NCT01252225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555470|NCT04459702|Ritonavir|ritonavir|mesh-list
65555471|NCT04459702|Lopinavir|lopinavir|mesh-list
65555472|NCT04459702|Azithromycin|azithromycin|mesh-list
65555473|NCT04459702|Hydroxychloroquine|hydroxychloroquine|mesh-list
65555474|NCT04459702|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65555475|NCT04459702|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65555476|NCT04459702|Protease Inhibitors|protease inhibitors|mesh-ancestor
65555477|NCT04459702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65555478|NCT04459702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555479|NCT04459702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65555480|NCT04459702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65555481|NCT04459702|Antiviral Agents|antiviral agents|mesh-ancestor
65555482|NCT04459702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65555483|NCT04459702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65555484|NCT04459702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65555485|NCT04459702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65555486|NCT04459702|Antimalarials|antimalarials|mesh-ancestor
65555487|NCT04459702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65555488|NCT04459702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65555489|NCT04459702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65555491|NCT03574792|Methadone|methadone|mesh-list
65555492|NCT03574792|Gabapentin|gabapentin|mesh-list
65555493|NCT03574792|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65555494|NCT03574792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65555495|NCT03574792|Narcotics|narcotics|mesh-ancestor
65555496|NCT03574792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65555497|NCT03574792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555498|NCT03574792|Analgesics|analgesics|mesh-ancestor
65555499|NCT03574792|Sensory System Agents|sensory system agents|mesh-ancestor
65555500|NCT03574792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555501|NCT03574792|Anticonvulsants|anticonvulsants|mesh-ancestor
65555502|NCT03574792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65555503|NCT03574792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65555504|NCT03574792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65555505|NCT03574792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65555506|NCT03574792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65555507|NCT03574792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65555508|NCT03574792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555509|NCT03574792|Antimanic Agents|antimanic agents|mesh-ancestor
65555510|NCT03574792|Antitussive Agents|antitussive agents|mesh-ancestor
65555511|NCT03574792|Respiratory System Agents|respiratory system agents|mesh-ancestor
65555512|NCT03574792|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65555513|NCT03574792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65555514|NCT03574792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65555515|NCT03574792|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65555516|NCT03574792|Antidepressive Agents|antidepressive agents|mesh-ancestor
65555517|NCT03904849|Cannabidiol|cannabidiol|mesh-list
65555518|NCT03904849|Anticonvulsants|anticonvulsants|mesh-ancestor
65555519|NCT01250743|Vitamins|vitamins|mesh-list
65555520|NCT01250743|Ascorbic Acid|ascorbic acid|mesh-list
65555521|NCT01250743|Micronutrients|micronutrients|mesh-ancestor
65555522|NCT01250743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555523|NCT01250743|Antioxidants|antioxidants|mesh-ancestor
65555524|NCT01250743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555525|NCT01250743|Protective Agents|protective agents|mesh-ancestor
65555526|NCT01254175|Vaccines|vaccines|mesh-list
65555527|NCT01254175|Immunologic Factors|immunologic factors|mesh-ancestor
65555528|NCT01254175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555529|NCT04377620|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
65555530|NCT04377620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65555531|NCT04377620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65555532|NCT04377620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555533|NCT03478540|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65555534|NCT03478540|Antiviral Agents|antiviral agents|mesh-ancestor
65555535|NCT03478540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65555536|NCT03903367|Fentanyl|fentanyl|mesh-list
65555537|NCT03903367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65555538|NCT03903367|Narcotics|narcotics|mesh-ancestor
65555539|NCT03903367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65555540|NCT03903367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555541|NCT03903367|Analgesics|analgesics|mesh-ancestor
65555542|NCT03903367|Sensory System Agents|sensory system agents|mesh-ancestor
65555543|NCT03903367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555544|NCT03903367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65555545|NCT03903367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65555546|NCT03903367|Anesthetics, General|anesthetics, general|mesh-ancestor
65555547|NCT03903367|Anesthetics|anesthetics|mesh-ancestor
65555548|NCT03486834|Vaccines|vaccines|mesh-list
65555549|NCT03486834|Immunologic Factors|immunologic factors|mesh-ancestor
65555550|NCT03486834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555551|NCT02523664|Hydrocortisone|hydrocortisone|mesh-list
65555552|NCT02523664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65555553|NCT03177460|Daratumumab|daratumumab|mesh-list
65555554|NCT03177460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65555555|NCT03717168|Hormones|hormones|mesh-list
65555556|NCT03717168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65555557|NCT03717168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555558|NCT05553301|Vaccines|vaccines|mesh-list
65555559|NCT05553301|Immunologic Factors|immunologic factors|mesh-ancestor
65555560|NCT05553301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555561|NCT00708448|Bevacizumab|bevacizumab|mesh-list
65555562|NCT00708448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65555563|NCT00708448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65555564|NCT00708448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65555565|NCT00708448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65555566|NCT00708448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65555567|NCT00708448|Growth Substances|growth substances|mesh-ancestor
65555568|NCT00708448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555569|NCT00708448|Growth Inhibitors|growth inhibitors|mesh-ancestor
65555570|NCT00708448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65555571|NCT00708448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65555572|NCT00708448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555573|NCT02892604|Insulin|insulin|mesh-list
65555574|NCT02892604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65555575|NCT02892604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555576|NCT03478306|Melatonin|melatonin|mesh-list
65555577|NCT03478306|Antioxidants|antioxidants|mesh-ancestor
65555578|NCT03478306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555579|NCT03478306|Protective Agents|protective agents|mesh-ancestor
65555580|NCT03478306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555581|NCT03478306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65555582|NCT03103100|Lidocaine|lidocaine|mesh-list
65555583|NCT03103100|Bupivacaine|bupivacaine|mesh-list
65555584|NCT03103100|Anesthetics, Local|anesthetics, local|mesh-ancestor
65555585|NCT03103100|Anesthetics|anesthetics|mesh-ancestor
65555586|NCT03103100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65555587|NCT03103100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555588|NCT03103100|Sensory System Agents|sensory system agents|mesh-ancestor
65555589|NCT03103100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555590|NCT03103100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65555591|NCT03103100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65555592|NCT03103100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65555593|NCT03103100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65555594|NCT03103100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555595|NCT02940496|Ribavirin|ribavirin|mesh-list
65555596|NCT02940496|Grazoprevir|grazoprevir|mesh-list
65555597|NCT02940496|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65555598|NCT02940496|Pembrolizumab|pembrolizumab|mesh-list
65555599|NCT02940496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65555600|NCT02940496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65555601|NCT02940496|Antimetabolites|antimetabolites|mesh-ancestor
65555602|NCT02940496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555603|NCT02940496|Antiviral Agents|antiviral agents|mesh-ancestor
65555604|NCT02940496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65555605|NCT03639168|Cisplatin|cisplatin|mesh-list
65555606|NCT03639168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65555607|NCT03131050|Scopolamine|scopolamine|mesh-list
65555608|NCT03131050|Citalopram|citalopram|mesh-list
65555609|NCT03131050|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65555610|NCT03131050|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65555611|NCT03131050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65555612|NCT03131050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65555613|NCT03131050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555614|NCT03131050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65555615|NCT03131050|Serotonin Agents|serotonin agents|mesh-ancestor
65555616|NCT03131050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555617|NCT03131050|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65555618|NCT03131050|Antidepressive Agents|antidepressive agents|mesh-ancestor
65555619|NCT03131050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65555620|NCT03131050|Parasympatholytics|parasympatholytics|mesh-ancestor
65555621|NCT03131050|Autonomic Agents|autonomic agents|mesh-ancestor
65353167|NCT00866073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65555622|NCT03131050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555623|NCT03131050|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65555624|NCT03131050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65555625|NCT03131050|Cholinergic Agents|cholinergic agents|mesh-ancestor
65555626|NCT03131050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65555628|NCT03131050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65555629|NCT03131050|Mydriatics|mydriatics|mesh-ancestor
65555630|NCT03719820|Clopidogrel|clopidogrel|mesh-list
65555631|NCT03719820|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65555632|NCT03719820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555633|NCT03719820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555634|NCT03719820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65555635|NCT03719820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65555636|NCT03719820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65555637|NCT03719820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65555638|NCT03719820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65555639|NCT03719820|Purinergic Agents|purinergic agents|mesh-ancestor
65555640|NCT03719820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65555641|NCT03719820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65555642|NCT03719820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65555643|NCT03719820|Antimetabolites|antimetabolites|mesh-ancestor
65555644|NCT03719820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65555645|NCT03719820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65555646|NCT04206020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65555647|NCT04206020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65555648|NCT03466086|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65555649|NCT03466086|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65555650|NCT03903133|Vitamin E|vitamin e|mesh-list
65555651|NCT03903133|Antioxidants|antioxidants|mesh-list
65555652|NCT03903133|Vitamins|vitamins|mesh-ancestor
65555653|NCT03903133|Micronutrients|micronutrients|mesh-ancestor
65555654|NCT03903133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555655|NCT03903133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555656|NCT03903133|Protective Agents|protective agents|mesh-ancestor
65555657|NCT01254799|Doxycycline|doxycycline|mesh-list
65555658|NCT01254799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65555659|NCT01254799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65555660|NCT01254799|Antimalarials|antimalarials|mesh-ancestor
65555661|NCT01254799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65555662|NCT01254799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65555663|NCT05553938|Empagliflozin|empagliflozin|mesh-list
65555664|NCT05553938|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65555665|NCT05553938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555666|NCT05553938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65555667|NCT05553938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555668|NCT03718884|Mirikizumab|mirikizumab|mesh-list
65555669|NCT03718884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65555670|NCT03718884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65555671|NCT03718884|Analgesics|analgesics|mesh-ancestor
65555672|NCT03718884|Sensory System Agents|sensory system agents|mesh-ancestor
65555673|NCT03718884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555674|NCT03718884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555675|NCT03718884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65555676|NCT03718884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65555677|NCT03718884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65284797|NCT02772653|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65555678|NCT03718884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65555679|NCT05760248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65555680|NCT03716856|Cyclophosphamide|cyclophosphamide|mesh-list
65555681|NCT03716856|Fludarabine|fludarabine|mesh-list
65555682|NCT03716856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65555683|NCT03716856|Immunologic Factors|immunologic factors|mesh-ancestor
65555684|NCT03716856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555685|NCT03716856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65555686|NCT03716856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65555687|NCT03716856|Alkylating Agents|alkylating agents|mesh-ancestor
65555688|NCT03716856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555689|NCT03716856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65555690|NCT03716856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65555691|NCT03910543|Tofacitinib|tofacitinib|mesh-list
65555692|NCT03910543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65555693|NCT03910543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65555694|NCT03910543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555695|NCT03101462|Vaccines|vaccines|mesh-list
65555696|NCT03101462|Immunologic Factors|immunologic factors|mesh-ancestor
65353244|NCT00752544|Simeprevir|simeprevir|mesh-list
65555697|NCT03101462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555698|NCT03904537|Antibodies|antibodies|mesh-list
65555699|NCT03904537|Immunologic Factors|immunologic factors|mesh-ancestor
65555700|NCT03904537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555701|NCT05416580|Metformin|metformin|mesh-list
65555702|NCT05416580|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65555703|NCT05416580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65555704|NCT05416580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555705|NCT05416580|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65555706|NCT05416580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65555707|NCT03904225|Tegafur|tegafur|mesh-list
65555708|NCT03904225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65555709|NCT03904225|Antimetabolites|antimetabolites|mesh-ancestor
65555710|NCT03904225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555711|NCT03904225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65555712|NCT03910231|Tolvaptan|tolvaptan|mesh-list
65555713|NCT03910231|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65555714|NCT03910231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555715|NCT03910231|Natriuretic Agents|natriuretic agents|mesh-ancestor
65555716|NCT03910231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555717|NCT01149109|Temozolomide|temozolomide|mesh-list
65555718|NCT01149109|Lomustine|lomustine|mesh-list
65555719|NCT01149109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65555720|NCT01149109|Alkylating Agents|alkylating agents|mesh-ancestor
65555721|NCT01149109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555722|NCT01149109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65555723|NCT05667415|Cisplatin|cisplatin|mesh-list
65555724|NCT05667415|Disulfiram|disulfiram|mesh-list
65555725|NCT05667415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65555726|NCT05667415|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65555727|NCT05667415|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65555728|NCT05667415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65555729|NCT05667415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555730|NCT01586143|Acetaminophen|acetaminophen|mesh-list
65555731|NCT01586143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65555732|NCT01586143|Analgesics|analgesics|mesh-ancestor
65555733|NCT01586143|Sensory System Agents|sensory system agents|mesh-ancestor
65555734|NCT01586143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555735|NCT01586143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555736|NCT01586143|Antipyretics|antipyretics|mesh-ancestor
65555737|NCT01256359|Docetaxel|docetaxel|mesh-list
65555738|NCT01256359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65555739|NCT01256359|Tubulin Modulators|tubulin modulators|mesh-ancestor
65555740|NCT01256359|Antimitotic Agents|antimitotic agents|mesh-ancestor
65555741|NCT01256359|Mitosis Modulators|mitosis modulators|mesh-ancestor
65555742|NCT01256359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555743|NCT02527993|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65555744|NCT02527993|Liraglutide|liraglutide|mesh-list
65555745|NCT02527993|Acarbose|acarbose|mesh-list
65555746|NCT02527993|Verapamil|verapamil|mesh-list
65555747|NCT02527993|Pasireotide|pasireotide|mesh-list
65555748|NCT02527993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65555749|NCT02527993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555750|NCT02527993|Incretins|incretins|mesh-ancestor
65555751|NCT02527993|Hormones|hormones|mesh-ancestor
65284876|NCT04072198|Leucovorin|leucovorin|mesh-list
65555752|NCT02527993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65555753|NCT02527993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65555754|NCT02527993|Protease Inhibitors|protease inhibitors|mesh-ancestor
65555755|NCT02527993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65555756|NCT02527993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555757|NCT02527993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65555758|NCT02527993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65555759|NCT02527993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65555760|NCT02527993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65555761|NCT02527993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65555762|NCT02527993|Vasodilator Agents|vasodilator agents|mesh-ancestor
65555763|NCT03909529|Digoxin|digoxin|mesh-list
65555764|NCT03909529|Spironolactone|spironolactone|mesh-list
65555765|NCT03909529|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65555766|NCT03909529|Hormone Antagonists|hormone antagonists|mesh-ancestor
65555767|NCT03909529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65555768|NCT03909529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555769|NCT03909529|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65555770|NCT03909529|Diuretics|diuretics|mesh-ancestor
65555771|NCT03909529|Natriuretic Agents|natriuretic agents|mesh-ancestor
65555772|NCT03909529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65555773|NCT03909529|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65555774|NCT03909529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65555775|NCT03909529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555776|NCT03909529|Protective Agents|protective agents|mesh-ancestor
65555778|NCT04927052|Anesthetics, Local|anesthetics, local|mesh-ancestor
65555779|NCT04927052|Anesthetics|anesthetics|mesh-ancestor
65555780|NCT04927052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65555781|NCT04927052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555782|NCT04927052|Sensory System Agents|sensory system agents|mesh-ancestor
65555783|NCT04927052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555784|NCT04927052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65555785|NCT04927052|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65555786|NCT04927052|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65555787|NCT04927052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65555788|NCT04927052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555789|NCT01149499|Valacyclovir|valacyclovir|mesh-list
65555790|NCT01149499|Antiviral Agents|antiviral agents|mesh-ancestor
65555791|NCT01149499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65555792|NCT03900871|Aspirin|aspirin|mesh-list
65555793|NCT03900871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65555794|NCT03900871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65555795|NCT03900871|Analgesics|analgesics|mesh-ancestor
65555796|NCT03900871|Sensory System Agents|sensory system agents|mesh-ancestor
65555797|NCT03900871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555798|NCT03900871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555799|NCT03900871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65555800|NCT03900871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65555801|NCT03900871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65555802|NCT03900871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65555803|NCT03900871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555804|NCT03900871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65555805|NCT03900871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65555806|NCT03900871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65555807|NCT03900871|Antipyretics|antipyretics|mesh-ancestor
65555808|NCT01149577|Olanzapine|olanzapine|mesh-list
65555809|NCT01149577|Antiemetics|antiemetics|mesh-ancestor
65555810|NCT01149577|Autonomic Agents|autonomic agents|mesh-ancestor
65555811|NCT01149577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555812|NCT01149577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555813|NCT01149577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65555814|NCT01149577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65555815|NCT01149577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65555816|NCT01149577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65555817|NCT01149577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65555818|NCT01149577|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65555819|NCT01149577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65555820|NCT01149577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65555821|NCT01149577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555822|NCT01149577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65555823|NCT01149577|Serotonin Agents|serotonin agents|mesh-ancestor
65555824|NCT03894007|Maytansine|maytansine|mesh-list
65555825|NCT03894007|Docetaxel|docetaxel|mesh-list
65555826|NCT03894007|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65555827|NCT03894007|Cyclophosphamide|cyclophosphamide|mesh-list
65555828|NCT03894007|Carboplatin|carboplatin|mesh-list
65555829|NCT03894007|Trastuzumab|trastuzumab|mesh-list
65555830|NCT03894007|Atezolizumab|atezolizumab|mesh-list
65555831|NCT03894007|Epirubicin|epirubicin|mesh-list
65555832|NCT03894007|Pertuzumab|pertuzumab|mesh-list
65555833|NCT03894007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65555834|NCT03894007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65555835|NCT03894007|Tubulin Modulators|tubulin modulators|mesh-ancestor
65555836|NCT03894007|Antimitotic Agents|antimitotic agents|mesh-ancestor
65555837|NCT03894007|Mitosis Modulators|mitosis modulators|mesh-ancestor
65555838|NCT03894007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555839|NCT03894007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65555840|NCT03894007|Immunologic Factors|immunologic factors|mesh-ancestor
65555841|NCT03894007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555842|NCT03894007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65555843|NCT03894007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65555844|NCT03894007|Alkylating Agents|alkylating agents|mesh-ancestor
65555845|NCT03894007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65353398|NCT00695864|Ondansetron|ondansetron|mesh-list
65555846|NCT03894007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65555847|NCT03894007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65555848|NCT03894007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65555849|NCT03894007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65555851|NCT01150747|Azithromycin|azithromycin|mesh-list
65555852|NCT01150747|Ceftriaxone|ceftriaxone|mesh-list
65555853|NCT01150747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65555854|NCT01150747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65555855|NCT03893695|Nivolumab|nivolumab|mesh-list
65555856|NCT03893695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65555857|NCT03893695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65555858|NCT03893695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65555859|NCT03893695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555860|NCT01258309|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
65555861|NCT01258309|Ketorolac|ketorolac|mesh-list
65555862|NCT01258309|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65555863|NCT01258309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65555864|NCT01258309|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65555865|NCT01258309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65555866|NCT01258309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65555867|NCT01258309|Analgesics|analgesics|mesh-ancestor
65555868|NCT01258309|Sensory System Agents|sensory system agents|mesh-ancestor
65555869|NCT01258309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555870|NCT01258309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555871|NCT01258309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65555872|NCT01258309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65555873|NCT01258309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65555874|NCT01258309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65555875|NCT01258309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555876|NCT01258309|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65555877|NCT01258309|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65555878|NCT01258309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65555879|NCT01258309|Histamine Antagonists|histamine antagonists|mesh-ancestor
65555880|NCT01258309|Histamine Agents|histamine agents|mesh-ancestor
65555881|NCT01258309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65555882|NCT01256905|Modafinil|modafinil|mesh-list
65555883|NCT01256905|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65555884|NCT01256905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555885|NCT01256905|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65555886|NCT01256905|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65555887|NCT01256905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65555888|NCT01256905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555889|NCT01586299|Acetaminophen|acetaminophen|mesh-list
65555890|NCT01586299|Ibuprofen|ibuprofen|mesh-list
65555891|NCT01586299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65555892|NCT01586299|Analgesics|analgesics|mesh-ancestor
65555893|NCT01586299|Sensory System Agents|sensory system agents|mesh-ancestor
65555894|NCT01586299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555895|NCT01586299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555896|NCT01586299|Antipyretics|antipyretics|mesh-ancestor
65555897|NCT01586299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65555898|NCT01586299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65285023|NCT00984217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65555899|NCT01586299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65555900|NCT01586299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65555901|NCT01586299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65555902|NCT01586299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555903|NCT02874794|Valsartan|valsartan|mesh-list
65555904|NCT02874794|Enalapril|enalapril|mesh-list
65555905|NCT02874794|Enalaprilat|enalaprilat|mesh-list
65555906|NCT02874794|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65555907|NCT02874794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65555908|NCT02874794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65555909|NCT02874794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65555910|NCT02874794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555911|NCT02874794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65555912|NCT02874794|Protease Inhibitors|protease inhibitors|mesh-ancestor
65555913|NCT02874794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65555914|NCT03102710|Lidocaine|lidocaine|mesh-list
65555915|NCT03102710|Capsaicin|capsaicin|mesh-list
65555916|NCT03102710|Anesthetics, Local|anesthetics, local|mesh-ancestor
65555917|NCT03102710|Anesthetics|anesthetics|mesh-ancestor
65555918|NCT03102710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65555919|NCT03102710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555920|NCT03102710|Sensory System Agents|sensory system agents|mesh-ancestor
65555921|NCT03102710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555922|NCT03102710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65555923|NCT03102710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65555924|NCT03102710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65555925|NCT03102710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65555926|NCT03102710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555927|NCT03102710|Antipruritics|antipruritics|mesh-ancestor
65555928|NCT03102710|Dermatologic Agents|dermatologic agents|mesh-ancestor
65555929|NCT01149967|Dexetimide|dexetimide|mesh-list
65555930|NCT01149967|Citalopram|citalopram|mesh-list
65555931|NCT01149967|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65555932|NCT01149967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65555933|NCT01149967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65555934|NCT01149967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555935|NCT01149967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65555936|NCT01149967|Serotonin Agents|serotonin agents|mesh-ancestor
65555937|NCT01149967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555938|NCT01149967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65555939|NCT01149967|Antidepressive Agents|antidepressive agents|mesh-ancestor
65555940|NCT01149967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65555941|NCT01149967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65555942|NCT01149967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65555943|NCT01149967|Parasympatholytics|parasympatholytics|mesh-ancestor
65555944|NCT01149967|Autonomic Agents|autonomic agents|mesh-ancestor
65555945|NCT01149967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555946|NCT01149967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65555947|NCT01149967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65555948|NCT01149967|Cholinergic Agents|cholinergic agents|mesh-ancestor
65555949|NCT05505409|Pirfenidone|pirfenidone|mesh-list
65555950|NCT05505409|Glucocorticoids|glucocorticoids|mesh-list
65555951|NCT05505409|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65555952|NCT05505409|Hormones|hormones|mesh-ancestor
65555953|NCT05505409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65555954|NCT05505409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555955|NCT05505409|Analgesics|analgesics|mesh-ancestor
65555956|NCT05505409|Sensory System Agents|sensory system agents|mesh-ancestor
65555957|NCT05505409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65555958|NCT05505409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65555959|NCT05505409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65555960|NCT05505409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65555961|NCT05505409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65555962|NCT05505409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65555963|NCT05505409|Immunologic Factors|immunologic factors|mesh-ancestor
65555964|NCT04770740|Vitamin K|vitamin k|mesh-list
65555965|NCT04770740|Vitamin K 2|vitamin k 2|mesh-list
65555966|NCT04770740|Vitamin MK 7|vitamin mk 7|mesh-list
65555967|NCT04770740|Vitamins|vitamins|mesh-ancestor
65555968|NCT04770740|Micronutrients|micronutrients|mesh-ancestor
65555969|NCT04770740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555970|NCT04770740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65555971|NCT04770740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65555972|NCT04770740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555973|NCT04770740|Hemostatics|hemostatics|mesh-ancestor
65555974|NCT04770740|Coagulants|coagulants|mesh-ancestor
65555975|NCT03896971|Cyclosporine|cyclosporine|mesh-list
65555976|NCT03896971|Cyclosporins|cyclosporins|mesh-list
65555977|NCT03896971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65555978|NCT03896971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65555979|NCT03896971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65555980|NCT03896971|Immunologic Factors|immunologic factors|mesh-ancestor
65555981|NCT03896971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555982|NCT03896971|Antifungal Agents|antifungal agents|mesh-ancestor
65555983|NCT03896971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65555984|NCT03896971|Dermatologic Agents|dermatologic agents|mesh-ancestor
65555985|NCT03896971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65555986|NCT03896971|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65555987|NCT01258777|Golimumab|golimumab|mesh-list
65555988|NCT01258777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65555989|NCT01258777|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65555990|NCT01258777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65555991|NCT01258777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65555992|NCT01258777|Immunologic Factors|immunologic factors|mesh-ancestor
65555993|NCT01258777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65555994|NCT03896893|Emollients|emollients|mesh-list
65555995|NCT03896893|Dermatologic Agents|dermatologic agents|mesh-ancestor
65555996|NCT01257373|Cobalt|cobalt|mesh-list
65555997|NCT01257373|Chromium|chromium|mesh-list
65555998|NCT01257373|Sirolimus|sirolimus|mesh-list
65555999|NCT01257373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65556000|NCT01257373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65556001|NCT01257373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65556002|NCT01257373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65556003|NCT01257373|Antifungal Agents|antifungal agents|mesh-ancestor
65556004|NCT01257373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65556005|NCT01257373|Immunologic Factors|immunologic factors|mesh-ancestor
65556006|NCT01257373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556007|NCT01257373|Trace Elements|trace elements|mesh-ancestor
65556008|NCT01257373|Micronutrients|micronutrients|mesh-ancestor
65556009|NCT03899233|Tranexamic Acid|tranexamic acid|mesh-list
65556010|NCT03899233|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65556011|NCT03899233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65556012|NCT03899233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556013|NCT03899233|Hemostatics|hemostatics|mesh-ancestor
65556014|NCT03899233|Coagulants|coagulants|mesh-ancestor
65556015|NCT03101150|Vitamin D|vitamin d|mesh-list
65556016|NCT03101150|Ergocalciferols|ergocalciferols|mesh-list
65556017|NCT03101150|Cholecalciferol|cholecalciferol|mesh-list
65556018|NCT03101150|Vitamins|vitamins|mesh-list
65556019|NCT03101150|Micronutrients|micronutrients|mesh-ancestor
65556020|NCT03101150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556021|NCT03101150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65556022|NCT03101150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65556023|NCT03899077|Goserelin|goserelin|mesh-list
65556024|NCT03899077|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65556025|NCT03899077|Leuprolide|leuprolide|mesh-list
65556026|NCT03899077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65556027|NCT03899077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65556028|NCT03899077|Luteolytic Agents|luteolytic agents|mesh-ancestor
65556029|NCT03899077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65556030|NCT03899077|Contraceptive Agents|contraceptive agents|mesh-ancestor
65556031|NCT03899077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65556032|NCT03899077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556033|NCT03899077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65556034|NCT03899077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65556035|NCT03899077|Fertility Agents|fertility agents|mesh-ancestor
65556036|NCT01255579|Fluticasone|fluticasone|mesh-list
65556037|NCT01255579|Beclomethasone|beclomethasone|mesh-list
65556038|NCT01255579|Formoterol Fumarate|formoterol fumarate|mesh-list
65556039|NCT01255579|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65556040|NCT01255579|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65556041|NCT01255579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65556042|NCT01255579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65556043|NCT01255579|Autonomic Agents|autonomic agents|mesh-ancestor
65556044|NCT01255579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65556045|NCT01255579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556046|NCT01255579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65556047|NCT01255579|Respiratory System Agents|respiratory system agents|mesh-ancestor
65556048|NCT01255579|Dermatologic Agents|dermatologic agents|mesh-ancestor
65285170|NCT00986713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65556049|NCT01255579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65556050|NCT01255579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65556051|NCT01255579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65556052|NCT01255579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65556053|NCT01255579|Adrenergic Agents|adrenergic agents|mesh-ancestor
65556054|NCT01255579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65556055|NCT01255579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556056|NCT01255579|Glucocorticoids|glucocorticoids|mesh-ancestor
65556057|NCT01255579|Hormones|hormones|mesh-ancestor
65556058|NCT01255579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65556059|NCT01255579|Sympathomimetics|sympathomimetics|mesh-ancestor
65556060|NCT03101930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65556061|NCT03101930|Liraglutide|liraglutide|mesh-list
65556062|NCT03101930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65556063|NCT03101930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556064|NCT03101930|Incretins|incretins|mesh-ancestor
65556065|NCT03101930|Hormones|hormones|mesh-ancestor
65556066|NCT03101930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65556067|NCT03101930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65556068|NCT03101930|Protease Inhibitors|protease inhibitors|mesh-ancestor
65556069|NCT03101930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556070|NCT03101930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556071|NCT04239950|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
65556072|NCT04239950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65556073|NCT04239950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65556074|NCT05415254|Calcitriol|calcitriol|mesh-list
65556075|NCT05415254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65556076|NCT05415254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556077|NCT05415254|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65556078|NCT05415254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65556079|NCT05415254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556080|NCT05415254|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65556081|NCT05415254|Vitamins|vitamins|mesh-ancestor
65556082|NCT05415254|Micronutrients|micronutrients|mesh-ancestor
65556083|NCT05415254|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65556084|NCT01150201|Losartan|losartan|mesh-list
65556085|NCT01150201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65556086|NCT01150201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65556087|NCT01150201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65556088|NCT01150201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65556089|NCT01150201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556090|NCT03464136|Adalimumab|adalimumab|mesh-list
65556091|NCT03464136|Ustekinumab|ustekinumab|mesh-list
65556092|NCT03464136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65556093|NCT03464136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65556094|NCT03464136|Dermatologic Agents|dermatologic agents|mesh-ancestor
65556095|NCT01257451|Vildagliptin|vildagliptin|mesh-list
65556096|NCT01257451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65556097|NCT01257451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556098|NCT01257451|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65556099|NCT01257451|Protease Inhibitors|protease inhibitors|mesh-ancestor
65556100|NCT01257451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556101|NCT01257451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556102|NCT01257529|Pregabalin|pregabalin|mesh-list
65556103|NCT01257529|Analgesics|analgesics|mesh-ancestor
65556104|NCT01257529|Sensory System Agents|sensory system agents|mesh-ancestor
65556105|NCT01257529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65556106|NCT01257529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556107|NCT01257529|Anticonvulsants|anticonvulsants|mesh-ancestor
65556108|NCT01257529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65556109|NCT01257529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65556110|NCT01257529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556111|NCT01257529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65556112|NCT01257529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65556113|NCT01257529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65556114|NCT01257529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65556115|NCT01257529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65556116|NCT03896113|Celecoxib|celecoxib|mesh-list
65556117|NCT03896113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65556118|NCT03896113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65556119|NCT03896113|Analgesics|analgesics|mesh-ancestor
65556120|NCT03896113|Sensory System Agents|sensory system agents|mesh-ancestor
65556121|NCT03896113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65556122|NCT03896113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556123|NCT03896113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65556124|NCT03896113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65556125|NCT03896113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65556126|NCT03896113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65556127|NCT03896113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556128|NCT03896113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556129|NCT03100838|Nifedipine|nifedipine|mesh-list
65556130|NCT03100838|Omeprazole|omeprazole|mesh-list
65556131|NCT03100838|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
65556132|NCT03100838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65556133|NCT03100838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65556134|NCT03100838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65556135|NCT03100838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556136|NCT03100838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556137|NCT03100838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65556138|NCT03100838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65556139|NCT03100838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65556140|NCT03100838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556141|NCT03100838|Vasodilator Agents|vasodilator agents|mesh-ancestor
65556142|NCT03100838|Tocolytic Agents|tocolytic agents|mesh-ancestor
65353699|NCT00921804|Dopamine Agents|dopamine agents|mesh-ancestor
65556143|NCT03100838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65556144|NCT01260025|Endostatins|endostatins|mesh-list
65556145|NCT01260025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65556146|NCT01260025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65556147|NCT01260025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65556148|NCT01260025|Growth Substances|growth substances|mesh-ancestor
65556149|NCT01260025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556150|NCT01260025|Growth Inhibitors|growth inhibitors|mesh-ancestor
65556151|NCT03984578|Pembrolizumab|pembrolizumab|mesh-list
65556152|NCT03984578|Capecitabine|capecitabine|mesh-list
65556153|NCT03984578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65556154|NCT03984578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65556155|NCT03984578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65556156|NCT03984578|Antimetabolites|antimetabolites|mesh-ancestor
65556157|NCT03984578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556158|NCT03892525|Atezolizumab|atezolizumab|mesh-list
65556159|NCT03892525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65556160|NCT05418452|Metformin|metformin|mesh-list
65556161|NCT05418452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65556162|NCT05418452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556163|NCT01260103|Temozolomide|temozolomide|mesh-list
65556164|NCT01260103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65556165|NCT01260103|Alkylating Agents|alkylating agents|mesh-ancestor
65556166|NCT01260103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556167|NCT01260103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65556168|NCT03480750|Carboplatin|carboplatin|mesh-list
65556169|NCT03480750|Doxorubicin|doxorubicin|mesh-list
65556170|NCT03480750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65556171|NCT03480750|Trientine|trientine|mesh-list
65556172|NCT03480750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65556173|NCT03480750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65556174|NCT03480750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65556175|NCT03480750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65556176|NCT03480750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556177|NCT03480750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556178|NCT03480750|Chelating Agents|chelating agents|mesh-ancestor
65556179|NCT03480750|Sequestering Agents|sequestering agents|mesh-ancestor
65556180|NCT03892447|Ferulic acid|ferulic acid|mesh-list
65556181|NCT03892447|Dopamine|dopamine|mesh-list
65556182|NCT03892447|Alprostadil|alprostadil|mesh-list
65556183|NCT03892447|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65556184|NCT03892447|Sympathomimetics|sympathomimetics|mesh-ancestor
65556185|NCT03892447|Autonomic Agents|autonomic agents|mesh-ancestor
65556186|NCT03892447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65556187|NCT03892447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556188|NCT03892447|Dopamine Agents|dopamine agents|mesh-ancestor
65556189|NCT03892447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65556190|NCT03892447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556191|NCT03892447|Protective Agents|protective agents|mesh-ancestor
65556192|NCT03892447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65556193|NCT03892447|Vasodilator Agents|vasodilator agents|mesh-ancestor
65556194|NCT03892447|Urological Agents|urological agents|mesh-ancestor
65556195|NCT03892447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65556196|NCT03892447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65556197|NCT03892447|Analgesics|analgesics|mesh-ancestor
65556198|NCT03892447|Sensory System Agents|sensory system agents|mesh-ancestor
65556199|NCT03892447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65556200|NCT03892447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65556201|NCT03892447|Anticoagulants|anticoagulants|mesh-ancestor
65556202|NCT03892447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65556203|NCT03892447|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65556204|NCT03892447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65556205|NCT03892447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65556206|NCT03892447|Antioxidants|antioxidants|mesh-ancestor
65556207|NCT03716700|Immunoglobulins|immunoglobulins|mesh-list
65556208|NCT03716700|gamma-Globulins|gamma-globulins|mesh-list
65556209|NCT03716700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65556210|NCT03716700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65556211|NCT03716700|Immunologic Factors|immunologic factors|mesh-ancestor
65556212|NCT03716700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556213|NCT05250596|Colchicine|colchicine|mesh-list
65556214|NCT05250596|Atorvastatin|atorvastatin|mesh-list
65556215|NCT05250596|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65556216|NCT05250596|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65556217|NCT05250596|Antimetabolites|antimetabolites|mesh-ancestor
65556218|NCT05250596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556219|NCT05250596|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65556220|NCT05250596|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65556221|NCT05250596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556222|NCT05250596|Gout Suppressants|gout suppressants|mesh-ancestor
65556223|NCT05250596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65556224|NCT05250596|Tubulin Modulators|tubulin modulators|mesh-ancestor
65556225|NCT05250596|Antimitotic Agents|antimitotic agents|mesh-ancestor
65556226|NCT05250596|Mitosis Modulators|mitosis modulators|mesh-ancestor
65556227|NCT05250596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65556228|NCT04788914|Charcoal|charcoal|mesh-list
65556229|NCT04788914|Antidotes|antidotes|mesh-ancestor
65556230|NCT04788914|Protective Agents|protective agents|mesh-ancestor
65556231|NCT04788914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556232|NCT03716622|Clarithromycin|clarithromycin|mesh-list
65556233|NCT03716622|Furazolidone|furazolidone|mesh-list
65556234|NCT03716622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65556235|NCT03716622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65556236|NCT03716622|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65556237|NCT03716622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556238|NCT03716622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556239|NCT03716622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65556240|NCT03716622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65556241|NCT03716622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65556242|NCT03716622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65556243|NCT03716622|Renal Agents|renal agents|mesh-ancestor
65556244|NCT03716622|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65556245|NCT03716622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65556246|NCT03716622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65556247|NCT03716622|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65556248|NCT03892213|Benzonidazole|benzonidazole|mesh-list
65556249|NCT03892213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65556250|NCT03892213|Immunologic Factors|immunologic factors|mesh-ancestor
65556251|NCT03892213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556252|NCT03892213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65556253|NCT03892213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65556254|NCT03892213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65556255|NCT03892213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65556256|NCT03412734|Chlorhexidine|chlorhexidine|mesh-list
65556257|NCT03412734|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65556258|NCT03412734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65556259|NCT03412734|Disinfectants|disinfectants|mesh-ancestor
65556260|NCT01257919|Azelaic acid|azelaic acid|mesh-list
65556261|NCT01257919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65556262|NCT01257919|Dermatologic Agents|dermatologic agents|mesh-ancestor
65556263|NCT04881032|Temozolomide|temozolomide|mesh-list
65556264|NCT04881032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65556265|NCT04881032|Alkylating Agents|alkylating agents|mesh-ancestor
65556266|NCT04881032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556267|NCT04881032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65556268|NCT03891979|Metronidazole|metronidazole|mesh-list
65556269|NCT03891979|Ciprofloxacin|ciprofloxacin|mesh-list
65556270|NCT03891979|Pembrolizumab|pembrolizumab|mesh-list
65556271|NCT03891979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65556272|NCT03891979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65556273|NCT03891979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65556274|NCT03891979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65556275|NCT03891979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65556276|NCT03891979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65556277|NCT03891979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65556278|NCT03891979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65556279|NCT03891979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556280|NCT03891979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556281|NCT03891979|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65556282|NCT03891979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65556283|NCT01260415|Oxaliplatin|oxaliplatin|mesh-list
65556284|NCT01260415|Panitumumab|panitumumab|mesh-list
65556285|NCT01260415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65556286|NCT01260415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65556287|NCT04608344|Atorvastatin|atorvastatin|mesh-list
65556288|NCT04608344|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65556289|NCT04608344|Pravastatin|pravastatin|mesh-list
65556290|NCT04608344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65556291|NCT04608344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65556292|NCT04608344|Antimetabolites|antimetabolites|mesh-ancestor
65556293|NCT04608344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556294|NCT04608344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65556295|NCT04608344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65556296|NCT04608344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556297|NCT03891433|Meropenem|meropenem|mesh-list
65556298|NCT03891433|Tazobactam|tazobactam|mesh-list
65556299|NCT03891433|Piperacillin|piperacillin|mesh-list
65556300|NCT03891433|Ertapenem|ertapenem|mesh-list
65556301|NCT03891433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65556302|NCT03891433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65556303|NCT03891433|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65556304|NCT03891433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556305|NCT03891433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556306|NCT03895411|Sotalol|sotalol|mesh-list
65556307|NCT03895411|Propafenone|propafenone|mesh-list
65556308|NCT03895411|Metoprolol|metoprolol|mesh-list
65556309|NCT03895411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65556310|NCT03895411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65556311|NCT03895411|Adrenergic Agents|adrenergic agents|mesh-ancestor
65556312|NCT03895411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65556313|NCT03895411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556314|NCT03895411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556315|NCT03895411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65556316|NCT03895411|Sympatholytics|sympatholytics|mesh-ancestor
65556317|NCT03895411|Autonomic Agents|autonomic agents|mesh-ancestor
65556318|NCT03895411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65556319|NCT03895411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65556320|NCT03895411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65556321|NCT03895411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65556322|NCT03895411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65556323|NCT03895411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65556324|NCT01259323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65556325|NCT01259323|Immunologic Factors|immunologic factors|mesh-ancestor
65556326|NCT01259323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556327|NCT03891277|Ferrous succinate|ferrous succinate|mesh-list
65556328|NCT03891277|Hematinics|hematinics|mesh-ancestor
65556329|NCT03888157|Liraglutide|liraglutide|mesh-list
65556330|NCT03888157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65556331|NCT03888157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556332|NCT03888157|Incretins|incretins|mesh-ancestor
65556333|NCT03888157|Hormones|hormones|mesh-ancestor
65556334|NCT03888157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65556335|NCT01154491|Epoetin Alfa|epoetin alfa|mesh-list
65556336|NCT01154491|Hematinics|hematinics|mesh-ancestor
65556337|NCT01260571|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65556338|NCT01260571|Dermatologic Agents|dermatologic agents|mesh-ancestor
65556339|NCT02527603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65556340|NCT02527603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65556341|NCT02527603|Analgesics|analgesics|mesh-ancestor
65556342|NCT02527603|Sensory System Agents|sensory system agents|mesh-ancestor
65556343|NCT02527603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65556344|NCT02527603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556345|NCT02527603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65285470|NCT00662220|Immunologic Factors|immunologic factors|mesh-ancestor
65556346|NCT02527603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65556347|NCT01259479|Satraplatin|satraplatin|mesh-list
65556348|NCT01259479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65556349|NCT01260727|Vaccines|vaccines|mesh-list
65556350|NCT01260727|Immunologic Factors|immunologic factors|mesh-ancestor
65556351|NCT01260727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556352|NCT03890809|BMS-986165|bms-986165|mesh-list
65556353|NCT03890809|Dermatologic Agents|dermatologic agents|mesh-ancestor
65556354|NCT03890809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65556355|NCT03890809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556356|NCT03890809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556357|NCT03891121|Botulinum Toxins|botulinum toxins|mesh-list
65556358|NCT03891121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65556359|NCT03891121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65556360|NCT03891121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65556361|NCT03891121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65556362|NCT03891121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556363|NCT03891121|Cholinergic Agents|cholinergic agents|mesh-ancestor
65556364|NCT03891121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65556365|NCT03891121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556366|NCT03891121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65556367|NCT03891121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65556368|NCT01154569|Azithromycin|azithromycin|mesh-list
65556369|NCT01154569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65556370|NCT01154569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65556371|NCT03891043|Selenium|selenium|mesh-list
65556372|NCT03891043|Antioxidants|antioxidants|mesh-ancestor
65556373|NCT03891043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556374|NCT03891043|Protective Agents|protective agents|mesh-ancestor
65556375|NCT03891043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556376|NCT03891043|Trace Elements|trace elements|mesh-ancestor
65556377|NCT03891043|Micronutrients|micronutrients|mesh-ancestor
65556378|NCT03890341|Drospirenone|drospirenone|mesh-list
65556379|NCT03890341|Midazolam|midazolam|mesh-list
65556380|NCT03890341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65556381|NCT03890341|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65556382|NCT03890341|Betadex|betadex|mesh-list
65556383|NCT03890341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65556384|NCT03890341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65556385|NCT03890341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65556386|NCT03890341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556387|NCT03890341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65556388|NCT03890341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65556389|NCT03890341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65556390|NCT03890341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65556391|NCT03890341|Anesthetics, General|anesthetics, general|mesh-ancestor
65556392|NCT03890341|Anesthetics|anesthetics|mesh-ancestor
65556393|NCT03890341|GABA Modulators|gaba modulators|mesh-ancestor
65556394|NCT03890341|GABA Agents|gaba agents|mesh-ancestor
65556395|NCT03890341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65556396|NCT03890341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556397|NCT03890341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65556398|NCT03890341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65556399|NCT03890341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65556400|NCT03890341|Contraceptive Agents|contraceptive agents|mesh-ancestor
65556401|NCT03890341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65556402|NCT03890341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65556403|NCT03890341|Estrogens|estrogens|mesh-ancestor
65556404|NCT03890341|Hormones|hormones|mesh-ancestor
65556405|NCT03890341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65556406|NCT03890341|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65556407|NCT03890341|Hormone Antagonists|hormone antagonists|mesh-ancestor
65556408|NCT03890341|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65556409|NCT03890341|Diuretics|diuretics|mesh-ancestor
65556410|NCT03890341|Natriuretic Agents|natriuretic agents|mesh-ancestor
65556411|NCT03890341|Sequestering Agents|sequestering agents|mesh-ancestor
65556412|NCT01259557|Botulinum Toxins|botulinum toxins|mesh-list
65556413|NCT01259557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65556414|NCT01259557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65556415|NCT01259557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65556416|NCT01259557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65556417|NCT01259557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556418|NCT01259557|Cholinergic Agents|cholinergic agents|mesh-ancestor
65556419|NCT01259557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65556420|NCT01259557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556421|NCT01259557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65556422|NCT01259557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65556423|NCT03894085|Paroxetine|paroxetine|mesh-list
65556424|NCT03894085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65556425|NCT03894085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65556426|NCT03894085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65556427|NCT03894085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556428|NCT03894085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65556429|NCT03894085|Serotonin Agents|serotonin agents|mesh-ancestor
65556430|NCT03894085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556431|NCT03894085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65556432|NCT03894085|Antidepressive Agents|antidepressive agents|mesh-ancestor
65556433|NCT03894085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65556434|NCT03894085|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65556435|NCT03894085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65556436|NCT03894085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556437|NCT01152931|Vitamins|vitamins|mesh-list
65556438|NCT01152931|Vitamin E|vitamin e|mesh-list
65556439|NCT01152931|Tocopherols|tocopherols|mesh-list
65556440|NCT01152931|Tocotrienols|tocotrienols|mesh-list
65556441|NCT01152931|alpha-Tocopherol|alpha-tocopherol|mesh-list
65556442|NCT01152931|Vitamin A|vitamin a|mesh-list
65556443|NCT01152931|Zinc|zinc|mesh-list
65556444|NCT01152931|Selenium|selenium|mesh-list
65556445|NCT01152931|Artesunate|artesunate|mesh-list
65556446|NCT01152931|Lumefantrine|lumefantrine|mesh-list
65353994|NCT00955318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65556447|NCT01152931|Artemether|artemether|mesh-list
65556448|NCT01152931|Amodiaquine|amodiaquine|mesh-list
65556450|NCT01152931|Micronutrients|micronutrients|mesh-ancestor
65556451|NCT01152931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556452|NCT01152931|Trace Elements|trace elements|mesh-ancestor
65556453|NCT01152931|Antioxidants|antioxidants|mesh-ancestor
65556454|NCT01152931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556455|NCT01152931|Protective Agents|protective agents|mesh-ancestor
65556456|NCT01152931|Antimalarials|antimalarials|mesh-ancestor
65556457|NCT01152931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65556458|NCT01152931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65556459|NCT01152931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65556460|NCT01152931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65556461|NCT01152931|Antiviral Agents|antiviral agents|mesh-ancestor
65556462|NCT01152931|Schistosomicides|schistosomicides|mesh-ancestor
65556463|NCT01152931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65556464|NCT01152931|Anthelmintics|anthelmintics|mesh-ancestor
65556465|NCT01152931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65556466|NCT01261117|Ibuprofen|ibuprofen|mesh-list
65556467|NCT01261117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65556468|NCT01261117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65556469|NCT01261117|Analgesics|analgesics|mesh-ancestor
65556470|NCT01261117|Sensory System Agents|sensory system agents|mesh-ancestor
65556471|NCT01261117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65556472|NCT01261117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556473|NCT01261117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65556474|NCT01261117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65556475|NCT01261117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65556476|NCT01261117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556477|NCT01261117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556478|NCT03889717|Vitamin D|vitamin d|mesh-list
65556479|NCT03889717|Vitamins|vitamins|mesh-ancestor
65556480|NCT03889717|Micronutrients|micronutrients|mesh-ancestor
65556481|NCT03889717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556482|NCT03889717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65556483|NCT03885895|Tranexamic Acid|tranexamic acid|mesh-list
65556484|NCT03885895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65556485|NCT03885895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65556486|NCT03885895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556487|NCT03885895|Hemostatics|hemostatics|mesh-ancestor
65556488|NCT03885895|Coagulants|coagulants|mesh-ancestor
65556489|NCT01154647|Citalopram|citalopram|mesh-list
65556490|NCT01154647|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65556491|NCT01154647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65556492|NCT01154647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65556493|NCT01154647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556494|NCT01154647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65556495|NCT01154647|Serotonin Agents|serotonin agents|mesh-ancestor
65556496|NCT01154647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285625|NCT04225325|Dolutegravir|dolutegravir|mesh-list
65556497|NCT01154647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65556498|NCT01154647|Antidepressive Agents|antidepressive agents|mesh-ancestor
65556499|NCT01154647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65556500|NCT01153165|Citalopram|citalopram|mesh-list
65556501|NCT01153165|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65556502|NCT01153165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65556503|NCT01153165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65556504|NCT01153165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556505|NCT01153165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65556506|NCT01153165|Serotonin Agents|serotonin agents|mesh-ancestor
65556507|NCT01153165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556508|NCT01153165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65556509|NCT01153165|Antidepressive Agents|antidepressive agents|mesh-ancestor
65556510|NCT01153165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65556511|NCT01155505|Lenalidomide|lenalidomide|mesh-list
65556512|NCT01155505|Immunologic Factors|immunologic factors|mesh-ancestor
65556513|NCT01155505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556514|NCT01155505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65556515|NCT01155505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65556516|NCT01155505|Growth Substances|growth substances|mesh-ancestor
65556517|NCT01155505|Growth Inhibitors|growth inhibitors|mesh-ancestor
65556518|NCT01155505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65556519|NCT01153243|Vitamin D|vitamin d|mesh-list
65556520|NCT01153243|Ergocalciferols|ergocalciferols|mesh-list
65556521|NCT01153243|Vitamins|vitamins|mesh-ancestor
65556522|NCT01153243|Micronutrients|micronutrients|mesh-ancestor
65556523|NCT01153243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556524|NCT01153243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65556525|NCT01153243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65556527|NCT03432858|Cefazolin|cefazolin|mesh-list
65556528|NCT03432858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65556529|NCT03432858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65556530|NCT05659914|Durvalumab|durvalumab|mesh-list
65556531|NCT05659914|Olaparib|olaparib|mesh-list
65556532|NCT05659914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65556533|NCT05659914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65556534|NCT05659914|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65556535|NCT05659914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556536|NCT05659914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556537|NCT01154803|Micronutrients|micronutrients|mesh-list
65556538|NCT01154803|Trace Elements|trace elements|mesh-list
65556539|NCT01154803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556540|NCT03885427|Ketamine|ketamine|mesh-list
65556541|NCT03885427|Analgesics|analgesics|mesh-ancestor
65556542|NCT03885427|Sensory System Agents|sensory system agents|mesh-ancestor
65556543|NCT03885427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65556544|NCT03885427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556545|NCT03885427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65556546|NCT03885427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65556547|NCT03885427|Anesthetics, General|anesthetics, general|mesh-ancestor
65556548|NCT03885427|Anesthetics|anesthetics|mesh-ancestor
65556549|NCT03885427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65556550|NCT03885427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65556551|NCT03885427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65556552|NCT03885427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65556553|NCT03885427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556554|NCT03456960|Aspirin|aspirin|mesh-list
65556555|NCT03456960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65556556|NCT03456960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65556557|NCT03456960|Analgesics|analgesics|mesh-ancestor
65556558|NCT03456960|Sensory System Agents|sensory system agents|mesh-ancestor
65556559|NCT03456960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65556560|NCT03456960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556561|NCT03456960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65556562|NCT03456960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65556563|NCT03456960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65556564|NCT03456960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65556565|NCT03456960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556566|NCT03456960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65556567|NCT03456960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65556568|NCT03456960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556569|NCT03456960|Antipyretics|antipyretics|mesh-ancestor
65556570|NCT03716388|Mesalamine|mesalamine|mesh-list
65556571|NCT03716388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65556572|NCT03716388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65556573|NCT03716388|Analgesics|analgesics|mesh-ancestor
65556574|NCT03716388|Sensory System Agents|sensory system agents|mesh-ancestor
65556575|NCT03716388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65556576|NCT03716388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556577|NCT03716388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65556578|NCT03716388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65556579|NCT01311336|Loratadine|loratadine|mesh-list
65556580|NCT01311336|Antipruritics|antipruritics|mesh-ancestor
65556581|NCT01311336|Dermatologic Agents|dermatologic agents|mesh-ancestor
65556582|NCT01311336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65556583|NCT01311336|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65556584|NCT01311336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65556585|NCT01311336|Histamine Antagonists|histamine antagonists|mesh-ancestor
65556586|NCT01311336|Histamine Agents|histamine agents|mesh-ancestor
65556587|NCT01311336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65556588|NCT01311336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556589|NCT01311336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556590|NCT03430986|Lidocaine|lidocaine|mesh-list
65556591|NCT03430986|Anesthetics, Local|anesthetics, local|mesh-ancestor
65556592|NCT03430986|Anesthetics|anesthetics|mesh-ancestor
65556593|NCT03430986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65556594|NCT03430986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556595|NCT03430986|Sensory System Agents|sensory system agents|mesh-ancestor
65556596|NCT03430986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65556597|NCT03430986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65556598|NCT03430986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65556600|NCT03430986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65556601|NCT03430986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556602|NCT01261741|Memantine|memantine|mesh-list
65556603|NCT01261741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65556604|NCT01261741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65556605|NCT01261741|Dopamine Agents|dopamine agents|mesh-ancestor
65556606|NCT01261741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65556607|NCT01261741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556608|NCT01261741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556609|NCT01261741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65556610|NCT01261741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65556611|NCT05645718|Cytarabine|cytarabine|mesh-list
65556612|NCT05645718|Dexamethasone|dexamethasone|mesh-list
65556613|NCT05645718|Prednisone|prednisone|mesh-list
65556614|NCT05645718|Cyclophosphamide|cyclophosphamide|mesh-list
65556615|NCT05645718|Rituximab|rituximab|mesh-list
65556616|NCT05645718|Methotrexate|methotrexate|mesh-list
65556617|NCT05645718|Vincristine|vincristine|mesh-list
65556618|NCT05645718|Mercaptopurine|mercaptopurine|mesh-list
65556619|NCT05645718|Blinatumomab|blinatumomab|mesh-list
65556620|NCT05645718|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65556621|NCT05645718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65556622|NCT05645718|Immunologic Factors|immunologic factors|mesh-ancestor
65556623|NCT05645718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556624|NCT05645718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65556625|NCT05645718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65556626|NCT05645718|Alkylating Agents|alkylating agents|mesh-ancestor
65556627|NCT05645718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556628|NCT05645718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65556629|NCT05645718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65556630|NCT05645718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65556631|NCT05645718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65556632|NCT05645718|Antiemetics|antiemetics|mesh-ancestor
65556633|NCT05645718|Autonomic Agents|autonomic agents|mesh-ancestor
65556634|NCT05645718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65556635|NCT05645718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65556636|NCT05645718|Glucocorticoids|glucocorticoids|mesh-ancestor
65556637|NCT05645718|Hormones|hormones|mesh-ancestor
65556638|NCT05645718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65556639|NCT05645718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65556640|NCT05645718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65556641|NCT05645718|Abortifacient Agents|abortifacient agents|mesh-ancestor
65556642|NCT05645718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65556643|NCT05645718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65556644|NCT05645718|Antimetabolites|antimetabolites|mesh-ancestor
65556645|NCT05645718|Dermatologic Agents|dermatologic agents|mesh-ancestor
65556646|NCT05645718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556647|NCT05645718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65556648|NCT05645718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65556649|NCT05645718|Antiviral Agents|antiviral agents|mesh-ancestor
65556650|NCT05645718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65556651|NCT05645718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65556652|NCT05645718|Tubulin Modulators|tubulin modulators|mesh-ancestor
65556653|NCT05645718|Antimitotic Agents|antimitotic agents|mesh-ancestor
65556654|NCT05645718|Mitosis Modulators|mitosis modulators|mesh-ancestor
65556655|NCT05645718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65556656|NCT01157455|Aspirin|aspirin|mesh-list
65556657|NCT01157455|Everolimus|everolimus|mesh-list
65556658|NCT01157455|Heparin|heparin|mesh-list
65556659|NCT01157455|Bivalirudin|bivalirudin|mesh-list
65556660|NCT01157455|Clopidogrel|clopidogrel|mesh-list
65556661|NCT01157455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65556662|NCT01157455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65556663|NCT01157455|Analgesics|analgesics|mesh-ancestor
65556664|NCT01157455|Sensory System Agents|sensory system agents|mesh-ancestor
65556665|NCT01157455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65556666|NCT01157455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556667|NCT01157455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65556668|NCT01157455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65556669|NCT01157455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65556670|NCT01157455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65556671|NCT01157455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556672|NCT01157455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65556673|NCT01157455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65556674|NCT01157455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556675|NCT01157455|Antipyretics|antipyretics|mesh-ancestor
65556676|NCT01157455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65556677|NCT01157455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65556678|NCT01157455|Immunologic Factors|immunologic factors|mesh-ancestor
65556679|NCT01157455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65556680|NCT01157455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65556681|NCT01157455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65556682|NCT01157455|Purinergic Agents|purinergic agents|mesh-ancestor
65556683|NCT01157455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65556684|NCT01157455|Anticoagulants|anticoagulants|mesh-ancestor
65556685|NCT01157455|Antithrombins|antithrombins|mesh-ancestor
65556686|NCT01157455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65556687|NCT01157455|Protease Inhibitors|protease inhibitors|mesh-ancestor
65556688|NCT03713892|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65556689|NCT03713892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556690|NCT03713892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556691|NCT03884881|Meropenem|meropenem|mesh-list
65556692|NCT03884881|Imipenem|imipenem|mesh-list
65556693|NCT03884881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65556694|NCT03884881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65556695|NCT01154881|Insulin|insulin|mesh-list
65556696|NCT01154881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65556697|NCT01154881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556698|NCT03886441|Beclomethasone|beclomethasone|mesh-list
65556699|NCT03886441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65556700|NCT03886441|Glucocorticoids|glucocorticoids|mesh-ancestor
65556701|NCT03886441|Hormones|hormones|mesh-ancestor
65556702|NCT03886441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65556703|NCT03886441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556704|NCT03886441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65556705|NCT03886441|Respiratory System Agents|respiratory system agents|mesh-ancestor
65556706|NCT03713346|Caseins|caseins|mesh-list
65556707|NCT03713346|Chelating Agents|chelating agents|mesh-ancestor
65556708|NCT03713346|Sequestering Agents|sequestering agents|mesh-ancestor
65556709|NCT03713346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556710|NCT01154959|Moxifloxacin|moxifloxacin|mesh-list
65556711|NCT01154959|Rifampin|rifampin|mesh-list
65556712|NCT01154959|Isoniazid|isoniazid|mesh-list
65556713|NCT01154959|Pyrazinamide|pyrazinamide|mesh-list
65556714|NCT01154959|Ethambutol|ethambutol|mesh-list
65556715|NCT01154959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65556716|NCT01154959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65556717|NCT01154959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65556718|NCT01154959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65556719|NCT01154959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556720|NCT01154959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556721|NCT01154959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65556722|NCT01154959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65556723|NCT01154959|Antitubercular Agents|antitubercular agents|mesh-ancestor
65285847|NCT02765009|Furosemide|furosemide|mesh-list
65556724|NCT01154959|Leprostatic Agents|leprostatic agents|mesh-ancestor
65556725|NCT01154959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65556726|NCT01154959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65556727|NCT01154959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65556728|NCT01154959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65556729|NCT01154959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65556730|NCT01154959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65556731|NCT01154959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65556732|NCT01154959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65556733|NCT01154959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65556734|NCT01154959|Antimetabolites|antimetabolites|mesh-ancestor
65556735|NCT01154959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65556736|NCT03881293|Lidocaine|lidocaine|mesh-list
65556737|NCT03881293|Anesthetics, Local|anesthetics, local|mesh-ancestor
65556738|NCT03881293|Anesthetics|anesthetics|mesh-ancestor
65556739|NCT03881293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65556740|NCT03881293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556741|NCT03881293|Sensory System Agents|sensory system agents|mesh-ancestor
65556742|NCT03881293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65556743|NCT03881293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65556744|NCT03881293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65556745|NCT03881293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65556746|NCT03881293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65556747|NCT03881293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556748|NCT01155037|Vaccines|vaccines|mesh-list
65556749|NCT01155037|Immunologic Factors|immunologic factors|mesh-ancestor
65556750|NCT01155037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556751|NCT01261897|Ropivacaine|ropivacaine|mesh-list
65556752|NCT01261897|Anesthetics, Local|anesthetics, local|mesh-ancestor
65556753|NCT01261897|Anesthetics|anesthetics|mesh-ancestor
65556754|NCT01261897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65556755|NCT01261897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556756|NCT01261897|Sensory System Agents|sensory system agents|mesh-ancestor
65556757|NCT01261897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65556758|NCT03448536|Acetaminophen|acetaminophen|mesh-list
65556759|NCT03448536|Naproxen|naproxen|mesh-list
65556760|NCT03448536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65556761|NCT03448536|Analgesics|analgesics|mesh-ancestor
65556762|NCT03448536|Sensory System Agents|sensory system agents|mesh-ancestor
65556763|NCT03448536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65556764|NCT03448536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556765|NCT03448536|Antipyretics|antipyretics|mesh-ancestor
65556766|NCT03448536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65556767|NCT03448536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65556768|NCT03448536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65556769|NCT03448536|Gout Suppressants|gout suppressants|mesh-ancestor
65556770|NCT03448536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65556771|NCT03448536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556772|NCT03448536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556773|NCT01155115|Nitric Oxide|nitric oxide|mesh-list
65556774|NCT01155115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65556775|NCT01155115|Autonomic Agents|autonomic agents|mesh-ancestor
65556776|NCT01155115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65556777|NCT01155115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556778|NCT01155115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65556779|NCT01155115|Respiratory System Agents|respiratory system agents|mesh-ancestor
65556780|NCT01155115|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65556781|NCT01155115|Antioxidants|antioxidants|mesh-ancestor
65556782|NCT01155115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556783|NCT01155115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65556784|NCT01155115|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65556785|NCT01155115|Vasodilator Agents|vasodilator agents|mesh-ancestor
65556786|NCT01155115|Gasotransmitters|gasotransmitters|mesh-ancestor
65556787|NCT01155115|Protective Agents|protective agents|mesh-ancestor
65556788|NCT03713190|Empagliflozin|empagliflozin|mesh-list
65556789|NCT03713190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65556790|NCT03713190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556791|NCT03713190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65556792|NCT03713190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556793|NCT03718182|Cholecalciferol|cholecalciferol|mesh-list
65556794|NCT03718182|Vitamin D|vitamin d|mesh-list
65556795|NCT03718182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65556796|NCT03718182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556797|NCT03718182|Vitamins|vitamins|mesh-ancestor
65556798|NCT03718182|Micronutrients|micronutrients|mesh-ancestor
65556799|NCT03718182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65556800|NCT03881449|Aripiprazole|aripiprazole|mesh-list
65556801|NCT03881449|Antidepressive Agents|antidepressive agents|mesh-ancestor
65556802|NCT03881449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65556803|NCT03881449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65556804|NCT03881449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65556805|NCT03881449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65556806|NCT03881449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556807|NCT03881449|Dopamine Agonists|dopamine agonists|mesh-ancestor
65556808|NCT03881449|Dopamine Agents|dopamine agents|mesh-ancestor
65556809|NCT03881449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65556810|NCT03881449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556811|NCT03881449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65556812|NCT03881449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65556813|NCT03881449|Serotonin Agents|serotonin agents|mesh-ancestor
65556814|NCT03881449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65556815|NCT03881449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65556816|NCT03881449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65556817|NCT03881449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65556818|NCT03884491|Vortioxetine|vortioxetine|mesh-list
65556819|NCT03884491|Antidepressive Agents|antidepressive agents|mesh-ancestor
65556820|NCT03884491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65556821|NCT03884491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65556822|NCT03884491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65556823|NCT03884491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65556824|NCT03884491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556825|NCT03884491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65556826|NCT03884491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65556827|NCT03884491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65556828|NCT03884491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556829|NCT03884491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65556830|NCT03884491|Serotonin Agents|serotonin agents|mesh-ancestor
65556831|NCT03884491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65556832|NCT03884491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65556833|NCT03884491|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65556834|NCT03884491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65556835|NCT03712956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65556836|NCT03712956|Doxorubicin|doxorubicin|mesh-list
65556837|NCT03712956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65556838|NCT03712956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65556839|NCT03712956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65556840|NCT03712956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65556841|NCT03712956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556842|NCT03712956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556843|NCT03880981|Acetaminophen|acetaminophen|mesh-list
65556844|NCT03880981|Ibuprofen|ibuprofen|mesh-list
65556845|NCT03880981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65556846|NCT03880981|Analgesics|analgesics|mesh-ancestor
65556847|NCT03880981|Sensory System Agents|sensory system agents|mesh-ancestor
65556848|NCT03880981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65556849|NCT03880981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556850|NCT03880981|Antipyretics|antipyretics|mesh-ancestor
65556851|NCT03880981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65556852|NCT03880981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65556853|NCT03880981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65556854|NCT03880981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65556855|NCT03880981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556856|NCT03880981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556857|NCT03424044|Glucagon|glucagon|mesh-list
65556858|NCT03424044|Pancrelipase|pancrelipase|mesh-list
65556859|NCT03424044|Pancreatin|pancreatin|mesh-list
65556860|NCT03424044|Hormones|hormones|mesh-list
65556861|NCT03424044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65556862|NCT03424044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556863|NCT03424044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65556864|NCT03880903|Albuterol|albuterol|mesh-list
65556865|NCT03880903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65556866|NCT03880903|Autonomic Agents|autonomic agents|mesh-ancestor
65556867|NCT03880903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65556868|NCT03880903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556869|NCT03880903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65556870|NCT03880903|Respiratory System Agents|respiratory system agents|mesh-ancestor
65556871|NCT03880903|Tocolytic Agents|tocolytic agents|mesh-ancestor
65556872|NCT03880903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65556873|NCT03880903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65556874|NCT03880903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65556875|NCT03880903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65556876|NCT03880903|Adrenergic Agents|adrenergic agents|mesh-ancestor
65556877|NCT03880903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65556878|NCT03880903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556879|NCT01155895|Amlodipine|amlodipine|mesh-list
65556880|NCT01155895|Benazepril|benazepril|mesh-list
65556881|NCT01155895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65556882|NCT01155895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65556883|NCT01155895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65556884|NCT01155895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556885|NCT01155895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65556886|NCT01155895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556887|NCT01155895|Vasodilator Agents|vasodilator agents|mesh-ancestor
65556888|NCT01155895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65556889|NCT01155895|Protease Inhibitors|protease inhibitors|mesh-ancestor
65556890|NCT01155895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556891|NCT01265641|Moxifloxacin|moxifloxacin|mesh-list
65556892|NCT01265641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65556893|NCT01265641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65556894|NCT01265641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65354452|NCT05350384|Prednisolone|prednisolone|mesh-list
65556895|NCT01265641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65556896|NCT01265641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556897|NCT01265641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556898|NCT01265641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65556899|NCT01589809|Niacinamide|niacinamide|mesh-list
65556900|NCT01589809|Niacin|niacin|mesh-list
65556901|NCT01589809|Nicotinic Acids|nicotinic acids|mesh-list
65556902|NCT01589809|Vitamins|vitamins|mesh-ancestor
65556903|NCT01589809|Micronutrients|micronutrients|mesh-ancestor
65556904|NCT01589809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556905|NCT01589809|Vitamin B Complex|vitamin b complex|mesh-ancestor
65556906|NCT01589809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65556907|NCT01589809|Antimetabolites|antimetabolites|mesh-ancestor
65556908|NCT01589809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556909|NCT01589809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65556910|NCT01589809|Vasodilator Agents|vasodilator agents|mesh-ancestor
65556911|NCT01264237|Etoricoxib|etoricoxib|mesh-list
65556912|NCT01264237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65556913|NCT01264237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65556914|NCT01264237|Analgesics|analgesics|mesh-ancestor
65556915|NCT01264237|Sensory System Agents|sensory system agents|mesh-ancestor
65556916|NCT01264237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65556917|NCT01264237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556918|NCT01264237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65556919|NCT01264237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65556920|NCT01264237|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65556921|NCT01264237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65556922|NCT01264237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556923|NCT01264237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556924|NCT03880825|Metformin|metformin|mesh-list
65556925|NCT03880825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65556926|NCT03880825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556927|NCT01159639|Clopidogrel|clopidogrel|mesh-list
65556928|NCT01159639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65556929|NCT01159639|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65556930|NCT01159639|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65556931|NCT01159639|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65556932|NCT01159639|Purinergic Agents|purinergic agents|mesh-ancestor
65556933|NCT01159639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65556934|NCT01159639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556935|NCT01159639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556936|NCT03880357|Betamethasone|betamethasone|mesh-list
65556937|NCT03880357|Betamethasone Valerate|betamethasone valerate|mesh-list
65556938|NCT03880357|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65556939|NCT03880357|Betamethasone benzoate|betamethasone benzoate|mesh-list
65556940|NCT03880357|Calcipotriene|calcipotriene|mesh-list
65556941|NCT03880357|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65556942|NCT03880357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65556943|NCT03880357|Glucocorticoids|glucocorticoids|mesh-ancestor
65556944|NCT03880357|Hormones|hormones|mesh-ancestor
65556945|NCT03880357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65556946|NCT03880357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556947|NCT03880357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65556948|NCT03880357|Respiratory System Agents|respiratory system agents|mesh-ancestor
65556949|NCT03880357|Dermatologic Agents|dermatologic agents|mesh-ancestor
65556950|NCT01264315|Lenalidomide|lenalidomide|mesh-list
65556951|NCT01264315|Immunologic Factors|immunologic factors|mesh-ancestor
65556952|NCT01264315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556953|NCT01264315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65556954|NCT01264315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65556955|NCT01264315|Growth Substances|growth substances|mesh-ancestor
65556956|NCT01264315|Growth Inhibitors|growth inhibitors|mesh-ancestor
65556957|NCT01264315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65556958|NCT01266031|Bevacizumab|bevacizumab|mesh-list
65556959|NCT01266031|Vorinostat|vorinostat|mesh-list
65556960|NCT01266031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65556961|NCT01266031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65556962|NCT01266031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65556963|NCT01266031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65556964|NCT01266031|Growth Substances|growth substances|mesh-ancestor
65556965|NCT01266031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556966|NCT01266031|Growth Inhibitors|growth inhibitors|mesh-ancestor
65556967|NCT01266031|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65556968|NCT01266031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354528|NCT00956176|Cidofovir|cidofovir|mesh-list
65556969|NCT01266031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556970|NCT03880045|Vasopressins|vasopressins|mesh-list
65556971|NCT03880045|Arginine Vasopressin|arginine vasopressin|mesh-list
65556972|NCT03880045|Hemostatics|hemostatics|mesh-ancestor
65556973|NCT03880045|Coagulants|coagulants|mesh-ancestor
65556974|NCT03880045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65556975|NCT03880045|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65556976|NCT03880045|Natriuretic Agents|natriuretic agents|mesh-ancestor
65556977|NCT03880045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556978|NCT03879889|Nicotine|nicotine|mesh-list
65556979|NCT03879889|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65556980|NCT03879889|Autonomic Agents|autonomic agents|mesh-ancestor
65556981|NCT03879889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65556982|NCT03879889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65556983|NCT03879889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65556984|NCT03879889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65556985|NCT03879889|Cholinergic Agents|cholinergic agents|mesh-ancestor
65556986|NCT03879889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65556987|NCT03879889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556988|NCT01266187|Leucovorin|leucovorin|mesh-list
65556989|NCT01266187|Cetuximab|cetuximab|mesh-list
65556990|NCT01266187|Fluorouracil|fluorouracil|mesh-list
65556991|NCT01266187|Oxaliplatin|oxaliplatin|mesh-list
65556992|NCT01266187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65556993|NCT01266187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65556994|NCT01266187|Antimetabolites|antimetabolites|mesh-ancestor
65556995|NCT01266187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65556996|NCT01266187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65556997|NCT01266187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65556998|NCT01266187|Immunologic Factors|immunologic factors|mesh-ancestor
65556999|NCT01266187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557000|NCT01266187|Antidotes|antidotes|mesh-ancestor
65557001|NCT01266187|Protective Agents|protective agents|mesh-ancestor
65557002|NCT01266187|Vitamin B Complex|vitamin b complex|mesh-ancestor
65557003|NCT01266187|Vitamins|vitamins|mesh-ancestor
65557004|NCT01266187|Micronutrients|micronutrients|mesh-ancestor
65557005|NCT01586533|Mesalamine|mesalamine|mesh-list
65557006|NCT01586533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65557007|NCT01586533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65557008|NCT01586533|Analgesics|analgesics|mesh-ancestor
65557009|NCT01586533|Sensory System Agents|sensory system agents|mesh-ancestor
65557010|NCT01586533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65557011|NCT01586533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557012|NCT01586533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65557013|NCT01586533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65557014|NCT03880123|Ixazomib|ixazomib|mesh-list
65557015|NCT03880123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557016|NCT03880123|Protease Inhibitors|protease inhibitors|mesh-ancestor
65557017|NCT03880123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65557018|NCT03880123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557019|NCT01266499|Colistin|colistin|mesh-list
65557020|NCT01266499|Polymyxins|polymyxins|mesh-list
65557021|NCT01266499|Gentamicins|gentamicins|mesh-list
65557022|NCT01266499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65557023|NCT01266499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65557024|NCT01266499|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65557025|NCT01266499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65557026|NCT01266499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557027|NCT00075725|Calcium, Dietary|calcium, dietary|mesh-list
65557028|NCT00075725|Leucovorin|leucovorin|mesh-list
65557029|NCT00075725|Folic Acid|folic acid|mesh-list
65557030|NCT00075725|Cytarabine|cytarabine|mesh-list
65557031|NCT00075725|Dexamethasone|dexamethasone|mesh-list
65557032|NCT00075725|Dexamethasone acetate|dexamethasone acetate|mesh-list
65557033|NCT00075725|Prednisone|prednisone|mesh-list
65557034|NCT00075725|Cortisone|cortisone|mesh-list
65557035|NCT00075725|Cyclophosphamide|cyclophosphamide|mesh-list
65557036|NCT00075725|Doxorubicin|doxorubicin|mesh-list
65557037|NCT00075725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65557038|NCT00075725|Methotrexate|methotrexate|mesh-list
65557039|NCT00075725|Vincristine|vincristine|mesh-list
65557040|NCT00075725|Daunorubicin|daunorubicin|mesh-list
65557041|NCT00075725|Asparaginase|asparaginase|mesh-list
65557042|NCT00075725|Mercaptopurine|mercaptopurine|mesh-list
65557043|NCT00075725|Pegaspargase|pegaspargase|mesh-list
65557044|NCT00075725|Thioguanine|thioguanine|mesh-list
65354594|NCT00962026|Rilonacept|rilonacept|mesh-list
65557045|NCT00075725|BB 1101|bb 1101|mesh-list
65557046|NCT00075725|Calcium|calcium|mesh-list
65557047|NCT00075725|2-Aminopurine|2-aminopurine|mesh-list
65557048|NCT00075725|Levoleucovorin|levoleucovorin|mesh-list
65557049|NCT00075725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65557050|NCT00075725|Immunologic Factors|immunologic factors|mesh-ancestor
65557051|NCT00075725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557052|NCT00075725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65557053|NCT00075725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65557054|NCT00075725|Alkylating Agents|alkylating agents|mesh-ancestor
65557055|NCT00075725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557056|NCT00075725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557057|NCT00075725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65557058|NCT00075725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65557059|NCT00075725|Antiemetics|antiemetics|mesh-ancestor
65557060|NCT00075725|Autonomic Agents|autonomic agents|mesh-ancestor
65557061|NCT00075725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65557062|NCT00075725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65557063|NCT00075725|Glucocorticoids|glucocorticoids|mesh-ancestor
65557064|NCT00075725|Hormones|hormones|mesh-ancestor
65557065|NCT00075725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65557066|NCT00075725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65557067|NCT00075725|Protease Inhibitors|protease inhibitors|mesh-ancestor
65557068|NCT00075725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65557069|NCT00075725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65557070|NCT00075725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65557071|NCT00075725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65557072|NCT00075725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65557073|NCT00075725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65557074|NCT00075725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65557075|NCT00075725|Abortifacient Agents|abortifacient agents|mesh-ancestor
65557076|NCT00075725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65557077|NCT00075725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65557078|NCT00075725|Antimetabolites|antimetabolites|mesh-ancestor
65557079|NCT00075725|Dermatologic Agents|dermatologic agents|mesh-ancestor
65557080|NCT00075725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65557081|NCT00075725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65557082|NCT00075725|Antiviral Agents|antiviral agents|mesh-ancestor
65557083|NCT00075725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65557084|NCT00075725|Antidotes|antidotes|mesh-ancestor
65557085|NCT00075725|Protective Agents|protective agents|mesh-ancestor
65557086|NCT00075725|Vitamin B Complex|vitamin b complex|mesh-ancestor
65557087|NCT00075725|Vitamins|vitamins|mesh-ancestor
65557088|NCT00075725|Micronutrients|micronutrients|mesh-ancestor
65557089|NCT00075725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65557090|NCT00075725|Tubulin Modulators|tubulin modulators|mesh-ancestor
65557091|NCT00075725|Antimitotic Agents|antimitotic agents|mesh-ancestor
65557092|NCT00075725|Mitosis Modulators|mitosis modulators|mesh-ancestor
65557093|NCT00075725|Hematinics|hematinics|mesh-ancestor
65557094|NCT02953782|Cetuximab|cetuximab|mesh-list
65557095|NCT02953782|Magrolimab|magrolimab|mesh-list
65557096|NCT02953782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65557097|NCT02953782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557098|NCT01264783|RNS60|rns60|mesh-list
65557099|NCT01264783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65557100|NCT01264783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65557101|NCT01264783|Analgesics|analgesics|mesh-ancestor
65557102|NCT01264783|Sensory System Agents|sensory system agents|mesh-ancestor
65557103|NCT01264783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65557104|NCT01264783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557105|NCT01264783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65557106|NCT01264783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65557107|NCT01264783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65557108|NCT01156129|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
65557109|NCT01156129|Antidiarrheals|antidiarrheals|mesh-ancestor
65557110|NCT01156129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65557111|NCT01160029|Nateglinide|nateglinide|mesh-list
65557112|NCT01160029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65557113|NCT01160029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557114|NCT00057863|Paclitaxel|paclitaxel|mesh-list
65557115|NCT00057863|Oxaliplatin|oxaliplatin|mesh-list
65557116|NCT00057863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65557117|NCT00057863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557118|NCT00057863|Tubulin Modulators|tubulin modulators|mesh-ancestor
65557119|NCT00057863|Antimitotic Agents|antimitotic agents|mesh-ancestor
65557120|NCT00057863|Mitosis Modulators|mitosis modulators|mesh-ancestor
65557121|NCT00057863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557122|NCT01266655|Baclofen|baclofen|mesh-list
65557123|NCT01266655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65354668|NCT00877227|Vitamins|vitamins|mesh-ancestor
65557124|NCT01266655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557125|NCT01266655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65557126|NCT01266655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65557127|NCT01266655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65557128|NCT01266655|GABA Agonists|gaba agonists|mesh-ancestor
65557129|NCT01266655|GABA Agents|gaba agents|mesh-ancestor
65557130|NCT01266655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65557131|NCT01266655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557132|NCT00075023|Thalidomide|thalidomide|mesh-list
65557133|NCT00075023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65557134|NCT00075023|Immunologic Factors|immunologic factors|mesh-ancestor
65557135|NCT00075023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557136|NCT00075023|Leprostatic Agents|leprostatic agents|mesh-ancestor
65557137|NCT00075023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65557138|NCT00075023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65557139|NCT00075023|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65557140|NCT00075023|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65557141|NCT00075023|Growth Substances|growth substances|mesh-ancestor
65557142|NCT00075023|Growth Inhibitors|growth inhibitors|mesh-ancestor
65557143|NCT00075023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557144|NCT01100801|Cisplatin|cisplatin|mesh-list
65557145|NCT01100801|Oxaliplatin|oxaliplatin|mesh-list
65557146|NCT01100801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557147|NCT01263145|Paclitaxel|paclitaxel|mesh-list
65557148|NCT01263145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65557149|NCT01263145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557150|NCT01263145|Tubulin Modulators|tubulin modulators|mesh-ancestor
65557151|NCT01263145|Antimitotic Agents|antimitotic agents|mesh-ancestor
65557152|NCT01263145|Mitosis Modulators|mitosis modulators|mesh-ancestor
65557153|NCT01263145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557154|NCT03717558|Ivermectin|ivermectin|mesh-list
65557155|NCT03717558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65557156|NCT03717558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65557157|NCT00074711|Calcium, Dietary|calcium, dietary|mesh-list
65557158|NCT00074711|Calcium Carbonate|calcium carbonate|mesh-list
65557159|NCT00074711|Calcium|calcium|mesh-list
65557160|NCT00074711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65557161|NCT00074711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557162|NCT00074711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65557163|NCT00074711|Antacids|antacids|mesh-ancestor
65557164|NCT00074711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557165|NCT00074711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65557166|NCT03960905|Meropenem|meropenem|mesh-list
65557167|NCT03960905|Ceftazidime|ceftazidime|mesh-list
65557168|NCT03960905|Cefepime|cefepime|mesh-list
65557169|NCT03960905|Anti-Infective Agents|anti-infective agents|mesh-list
65557170|NCT03960905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65557171|NCT05619120|Mexiletine|mexiletine|mesh-list
65557172|NCT05619120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65557173|NCT05619120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65557174|NCT05619120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65557175|NCT05619120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65557176|NCT05619120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557177|NCT01265017|Hydrocortisone|hydrocortisone|mesh-list
65557178|NCT01265017|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65557179|NCT01265017|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65557180|NCT01265017|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65557181|NCT01265017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65557182|NCT01265017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65557183|NCT01265017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65557184|NCT01265017|Medroxyprogesterone|medroxyprogesterone|mesh-list
65557185|NCT01265017|Estradiol|estradiol|mesh-list
65557186|NCT01265017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65557187|NCT01265017|Hormones|hormones|mesh-ancestor
65557188|NCT01265017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65557189|NCT01265017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557190|NCT01265017|Estrogens|estrogens|mesh-ancestor
65557191|NCT01265017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65557192|NCT01265017|Contraceptive Agents|contraceptive agents|mesh-ancestor
65557193|NCT01265017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65557194|NCT01265017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65557195|NCT01265017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65557196|NCT01265017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65557197|NCT01265017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65354736|NCT00872625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65557198|NCT01265017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65557199|NCT01265017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65557200|NCT01265017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65557201|NCT01265017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557202|NCT03420300|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65557203|NCT03420300|Antiviral Agents|antiviral agents|mesh-ancestor
65557204|NCT03420300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65557205|NCT03879811|Nivolumab|nivolumab|mesh-list
65557206|NCT03879811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65557207|NCT03879811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557208|NCT03879811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65557209|NCT03879811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557210|NCT01158859|Pregabalin|pregabalin|mesh-list
65557211|NCT01158859|Analgesics|analgesics|mesh-ancestor
65557212|NCT01158859|Sensory System Agents|sensory system agents|mesh-ancestor
65557213|NCT01158859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65557214|NCT01158859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557215|NCT01158859|Anticonvulsants|anticonvulsants|mesh-ancestor
65557216|NCT01158859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65557217|NCT01158859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65557218|NCT01158859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557219|NCT01158859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65557220|NCT01158859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65557221|NCT01158859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65557222|NCT01158859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65557223|NCT01158859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65557224|NCT01100021|Doxazosin|doxazosin|mesh-list
65557225|NCT01100021|Tamsulosin|tamsulosin|mesh-list
65557226|NCT01100021|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65557227|NCT01100021|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65557228|NCT01100021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65557229|NCT01100021|Adrenergic Agents|adrenergic agents|mesh-ancestor
65557230|NCT01100021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65557231|NCT01100021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557232|NCT01100021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557233|NCT01100021|Urological Agents|urological agents|mesh-ancestor
65557234|NCT01100021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65557235|NCT03407430|Pregabalin|pregabalin|mesh-list
65557236|NCT03407430|Analgesics|analgesics|mesh-ancestor
65557237|NCT03407430|Sensory System Agents|sensory system agents|mesh-ancestor
65557238|NCT03407430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65557239|NCT03407430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557240|NCT03407430|Anticonvulsants|anticonvulsants|mesh-ancestor
65557241|NCT03407430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65557242|NCT03407430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65557243|NCT03407430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557244|NCT03407430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65557245|NCT03407430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65557246|NCT03407430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65557247|NCT03407430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65557248|NCT03407430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65557249|NCT01266811|Dexamethasone|dexamethasone|mesh-list
65557250|NCT01266811|Dexamethasone acetate|dexamethasone acetate|mesh-list
65557251|NCT01266811|Bortezomib|bortezomib|mesh-list
65557252|NCT01266811|Siltuximab|siltuximab|mesh-list
65557253|NCT01266811|BB 1101|bb 1101|mesh-list
65557254|NCT01266811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65557255|NCT01266811|Antiemetics|antiemetics|mesh-ancestor
65557256|NCT01266811|Autonomic Agents|autonomic agents|mesh-ancestor
65557257|NCT01266811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65557258|NCT01266811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557259|NCT01266811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65557260|NCT01266811|Glucocorticoids|glucocorticoids|mesh-ancestor
65557261|NCT01266811|Hormones|hormones|mesh-ancestor
65557262|NCT01266811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65557263|NCT01266811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65557264|NCT01266811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557265|NCT01266811|Protease Inhibitors|protease inhibitors|mesh-ancestor
65557266|NCT01266811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65557267|NCT01266811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557268|NCT01158937|Meropenem|meropenem|mesh-list
65557269|NCT01158937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65557270|NCT01158937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65557271|NCT03407118|Insulin Lispro|insulin lispro|mesh-list
65557272|NCT03407118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65557273|NCT03407118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354811|NCT00383149|Cetuximab|cetuximab|mesh-list
65557275|NCT01100177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557276|NCT01100177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65557277|NCT01100177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65557278|NCT01100177|Growth Substances|growth substances|mesh-ancestor
65557279|NCT01100177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557280|NCT01100177|Growth Inhibitors|growth inhibitors|mesh-ancestor
65557281|NCT01100177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65557282|NCT01100177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65557283|NCT01100177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557284|NCT01100333|Hormones|hormones|mesh-list
65557285|NCT01100333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65557286|NCT01100333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65557287|NCT01100333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557288|NCT01327235|Cisplatin|cisplatin|mesh-list
65557289|NCT01327235|Endostar protein|endostar protein|mesh-list
65557290|NCT01327235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557291|NCT01327235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65557292|NCT01327235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65557293|NCT01327235|Growth Substances|growth substances|mesh-ancestor
65557294|NCT01327235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557295|NCT01327235|Growth Inhibitors|growth inhibitors|mesh-ancestor
65557296|NCT03406260|Lasmiditan|lasmiditan|mesh-list
65557297|NCT03406260|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65557298|NCT03406260|Serotonin Agents|serotonin agents|mesh-ancestor
65557299|NCT03406260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65557300|NCT03406260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557301|NCT03406260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557302|NCT01089179|Metformin|metformin|mesh-list
65557303|NCT01089179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65557304|NCT01089179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557305|NCT01160185|Paclitaxel|paclitaxel|mesh-list
65557306|NCT01160185|Topotecan|topotecan|mesh-list
65557307|NCT01160185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65557308|NCT01160185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557309|NCT01160185|Tubulin Modulators|tubulin modulators|mesh-ancestor
65557310|NCT01160185|Antimitotic Agents|antimitotic agents|mesh-ancestor
65557311|NCT01160185|Mitosis Modulators|mitosis modulators|mesh-ancestor
65557312|NCT01160185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557313|NCT01160185|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65557314|NCT01160185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65557315|NCT01160185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65557316|NCT03419364|Niacinamide|niacinamide|mesh-list
65557317|NCT03419364|Niacin|niacin|mesh-list
65557318|NCT03419364|Nicotinic Acids|nicotinic acids|mesh-list
65557319|NCT03419364|Vitamin B Complex|vitamin b complex|mesh-ancestor
65557320|NCT03419364|Vitamins|vitamins|mesh-ancestor
65557321|NCT03419364|Micronutrients|micronutrients|mesh-ancestor
65286451|NCT02758067|Dopamine Agents|dopamine agents|mesh-ancestor
65557322|NCT03419364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557323|NCT03419364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65557324|NCT03419364|Antimetabolites|antimetabolites|mesh-ancestor
65557325|NCT03419364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557326|NCT03419364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65557327|NCT03419364|Vasodilator Agents|vasodilator agents|mesh-ancestor
65557328|NCT01265173|Ciprofloxacin|ciprofloxacin|mesh-list
65557329|NCT01265173|Ceftriaxone|ceftriaxone|mesh-list
65557330|NCT01265173|Cefotaxime|cefotaxime|mesh-list
65557331|NCT01265173|Cefoxitin|cefoxitin|mesh-list
65557332|NCT01265173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65557333|NCT01265173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65557334|NCT01265173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65557335|NCT01265173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65557336|NCT01265173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65557337|NCT01265173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557338|NCT01265173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557339|NCT01265173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65557340|NCT01265173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65557341|NCT01159327|Sorafenib|sorafenib|mesh-list
65557342|NCT01159327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557343|NCT01159327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65557344|NCT01159327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65557345|NCT01159327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557346|NCT01160341|Methyltestosterone|methyltestosterone|mesh-list
65557347|NCT01160341|Testosterone|testosterone|mesh-list
65354885|NCT01050517|Ivermectin|ivermectin|mesh-list
65557348|NCT01160341|Testosterone undecanoate|testosterone undecanoate|mesh-list
65557349|NCT01160341|Testosterone enanthate|testosterone enanthate|mesh-list
65557350|NCT01160341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65557351|NCT01160341|Androgens|androgens|mesh-ancestor
65557352|NCT01160341|Hormones|hormones|mesh-ancestor
65557353|NCT01160341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65557354|NCT01160341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557355|NCT01160341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65557356|NCT01160341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557357|NCT01160341|Anabolic Agents|anabolic agents|mesh-ancestor
65557358|NCT03882775|Heparin|heparin|mesh-list
65557359|NCT03882775|Bivalirudin|bivalirudin|mesh-list
65557360|NCT03882775|Anticoagulants|anticoagulants|mesh-ancestor
65557361|NCT03882775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65557362|NCT03882775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65557363|NCT03882775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557364|NCT03882775|Antithrombins|antithrombins|mesh-ancestor
65557365|NCT03882775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65557366|NCT03882775|Protease Inhibitors|protease inhibitors|mesh-ancestor
65557367|NCT03882775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65557368|NCT03877705|Listerine|listerine|mesh-list
65557369|NCT03877705|Sodium Fluoride|sodium fluoride|mesh-list
65557370|NCT03877705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65557371|NCT03877705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65557372|NCT03877705|Cariostatic Agents|cariostatic agents|mesh-ancestor
65557373|NCT03877705|Protective Agents|protective agents|mesh-ancestor
65557374|NCT03877705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557375|NCT01160419|Leucovorin|leucovorin|mesh-list
65557376|NCT01160419|Folic Acid|folic acid|mesh-list
65557377|NCT01160419|Docetaxel|docetaxel|mesh-list
65557378|NCT01160419|Oxaliplatin|oxaliplatin|mesh-list
65557379|NCT01160419|Levoleucovorin|levoleucovorin|mesh-list
65557380|NCT01160419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557381|NCT01160419|Tubulin Modulators|tubulin modulators|mesh-ancestor
65557382|NCT01160419|Antimitotic Agents|antimitotic agents|mesh-ancestor
65557383|NCT01160419|Mitosis Modulators|mitosis modulators|mesh-ancestor
65557384|NCT01160419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557385|NCT01160419|Antidotes|antidotes|mesh-ancestor
65557386|NCT01160419|Protective Agents|protective agents|mesh-ancestor
65557387|NCT01160419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557388|NCT01160419|Vitamin B Complex|vitamin b complex|mesh-ancestor
65557389|NCT01160419|Vitamins|vitamins|mesh-ancestor
65557390|NCT01160419|Micronutrients|micronutrients|mesh-ancestor
65557391|NCT01160419|Hematinics|hematinics|mesh-ancestor
65557392|NCT02954172|Paclitaxel|paclitaxel|mesh-list
65557393|NCT02954172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65557394|NCT02954172|Bevacizumab|bevacizumab|mesh-list
65557395|NCT02954172|Carboplatin|carboplatin|mesh-list
65557396|NCT02954172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65557397|NCT02954172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557398|NCT02954172|Tubulin Modulators|tubulin modulators|mesh-ancestor
65557399|NCT02954172|Antimitotic Agents|antimitotic agents|mesh-ancestor
65557400|NCT02954172|Mitosis Modulators|mitosis modulators|mesh-ancestor
65557401|NCT02954172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557402|NCT02954172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65557403|NCT02954172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65557404|NCT02954172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65557405|NCT02954172|Growth Substances|growth substances|mesh-ancestor
65557406|NCT02954172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557407|NCT02954172|Growth Inhibitors|growth inhibitors|mesh-ancestor
65557408|NCT01156519|Hydrocortisone|hydrocortisone|mesh-list
65557409|NCT01156519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65557410|NCT02953938|Ranibizumab|ranibizumab|mesh-list
65557411|NCT02953938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65557412|NCT02953938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65557413|NCT02953938|Growth Substances|growth substances|mesh-ancestor
65557414|NCT02953938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557415|NCT02953938|Growth Inhibitors|growth inhibitors|mesh-ancestor
65557416|NCT02953938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557417|NCT01161667|Naratriptan|naratriptan|mesh-list
65557418|NCT01161667|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65557419|NCT01161667|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65557420|NCT01161667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65557421|NCT01161667|Serotonin Agents|serotonin agents|mesh-ancestor
65557422|NCT01161667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65557423|NCT01161667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354960|NCT00879099|Serotonin Agents|serotonin agents|mesh-ancestor
65557424|NCT01161667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557425|NCT02526979|Mirabegron|mirabegron|mesh-list
65557426|NCT02526979|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65557427|NCT02526979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65557428|NCT02526979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65557429|NCT02526979|Adrenergic Agents|adrenergic agents|mesh-ancestor
65557430|NCT02526979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65557431|NCT02526979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557432|NCT02526979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557433|NCT02526979|Urological Agents|urological agents|mesh-ancestor
65557434|NCT03882541|Midazolam|midazolam|mesh-list
65557435|NCT03882541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65557436|NCT03882541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65557437|NCT03882541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65557438|NCT03882541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557439|NCT03882541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65557440|NCT03882541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65557441|NCT03882541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65557442|NCT03882541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65557443|NCT03882541|Anesthetics, General|anesthetics, general|mesh-ancestor
65557444|NCT03882541|Anesthetics|anesthetics|mesh-ancestor
65557445|NCT03882541|GABA Modulators|gaba modulators|mesh-ancestor
65557446|NCT03882541|GABA Agents|gaba agents|mesh-ancestor
65557447|NCT03882541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65557448|NCT03882541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557449|NCT01267903|Vaccines|vaccines|mesh-list
65557450|NCT01267903|Immunologic Factors|immunologic factors|mesh-ancestor
65557451|NCT01267903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557452|NCT03576313|Ivermectin|ivermectin|mesh-list
65557453|NCT03576313|Piperaquine|piperaquine|mesh-list
65557454|NCT03576313|Artenimol|artenimol|mesh-list
65557455|NCT03576313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65557456|NCT03576313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65557457|NCT03576313|Antimalarials|antimalarials|mesh-ancestor
65557458|NCT03576313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65557459|NCT01161979|Zonisamide|zonisamide|mesh-list
65557460|NCT01161979|Anticonvulsants|anticonvulsants|mesh-ancestor
65557461|NCT01161979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65557462|NCT01161979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65557463|NCT01161979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557464|NCT01161979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65557465|NCT01161979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557466|NCT01160731|Etoposide|etoposide|mesh-list
65557467|NCT01160731|Panobinostat|panobinostat|mesh-list
65557468|NCT01160731|Etoposide phosphate|etoposide phosphate|mesh-list
65557469|NCT01160731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557470|NCT01160731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65557471|NCT01160731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65557472|NCT01160731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65557473|NCT01160731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65557474|NCT01160731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557475|NCT01160731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65557476|NCT01160965|Ropivacaine|ropivacaine|mesh-list
65557477|NCT01160965|Levobupivacaine|levobupivacaine|mesh-list
65557478|NCT01160965|Anesthetics, Local|anesthetics, local|mesh-ancestor
65557479|NCT01160965|Anesthetics|anesthetics|mesh-ancestor
65557480|NCT01160965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65557481|NCT01160965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557482|NCT01160965|Sensory System Agents|sensory system agents|mesh-ancestor
65557483|NCT01160965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65557484|NCT01156909|Rituximab|rituximab|mesh-list
65557485|NCT01156909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65557486|NCT01156909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557487|NCT01156909|Immunologic Factors|immunologic factors|mesh-ancestor
65557488|NCT01156909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557489|NCT01156909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65557490|NCT01162603|Latanoprost|latanoprost|mesh-list
65557491|NCT01162603|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65557492|NCT01162603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65557493|NCT03881995|Insulin Glargine|insulin glargine|mesh-list
65557494|NCT03881995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65557495|NCT03881995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557496|NCT02527213|Sodium thiosulfate|sodium thiosulfate|mesh-list
65557497|NCT02527213|Antidotes|antidotes|mesh-ancestor
65557498|NCT02527213|Protective Agents|protective agents|mesh-ancestor
65557499|NCT02527213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557500|NCT02527213|Antioxidants|antioxidants|mesh-ancestor
65557501|NCT02527213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557502|NCT02527213|Antitubercular Agents|antitubercular agents|mesh-ancestor
65557503|NCT02527213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65557504|NCT02527213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65557505|NCT02527213|Chelating Agents|chelating agents|mesh-ancestor
65557506|NCT02527213|Sequestering Agents|sequestering agents|mesh-ancestor
65557507|NCT01161277|Haloperidol|haloperidol|mesh-list
65557508|NCT01161277|Aripiprazole|aripiprazole|mesh-list
65557509|NCT01161277|Haloperidol decanoate|haloperidol decanoate|mesh-list
65557510|NCT01161277|Antidepressive Agents|antidepressive agents|mesh-ancestor
65557511|NCT01161277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65557512|NCT01161277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65557513|NCT01161277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65557514|NCT01161277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65557515|NCT01161277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557516|NCT01161277|Dopamine Agonists|dopamine agonists|mesh-ancestor
65557517|NCT01161277|Dopamine Agents|dopamine agents|mesh-ancestor
65557518|NCT01161277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65557519|NCT01161277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557520|NCT01161277|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65557521|NCT01161277|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65557522|NCT01161277|Serotonin Agents|serotonin agents|mesh-ancestor
65557523|NCT01161277|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65557524|NCT01161277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65557525|NCT01161277|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65557526|NCT01161277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65557527|NCT01161277|Antiemetics|antiemetics|mesh-ancestor
65557528|NCT01161277|Autonomic Agents|autonomic agents|mesh-ancestor
65557529|NCT01161277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65557530|NCT01161277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65557531|NCT01161277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65557532|NCT01268215|Budesonide|budesonide|mesh-list
65557533|NCT01268215|Calfactant|calfactant|mesh-list
65557534|NCT01268215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65557535|NCT01268215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65557536|NCT01268215|Autonomic Agents|autonomic agents|mesh-ancestor
65557537|NCT01268215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65557538|NCT01268215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557539|NCT01268215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65557540|NCT01268215|Respiratory System Agents|respiratory system agents|mesh-ancestor
65557541|NCT01268215|Glucocorticoids|glucocorticoids|mesh-ancestor
65557542|NCT01268215|Hormones|hormones|mesh-ancestor
65557543|NCT01268215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65557544|NCT01268215|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
65557545|NCT01269307|Ketamine|ketamine|mesh-list
65557546|NCT01269307|Propofol|propofol|mesh-list
65557547|NCT01269307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65557548|NCT01269307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65286668|NCT04071262|Prednisolone|prednisolone|mesh-list
65557549|NCT01269307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557550|NCT01269307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65557551|NCT01269307|Anesthetics, General|anesthetics, general|mesh-ancestor
65557552|NCT01269307|Anesthetics|anesthetics|mesh-ancestor
65557553|NCT01269307|Analgesics|analgesics|mesh-ancestor
65557554|NCT01269307|Sensory System Agents|sensory system agents|mesh-ancestor
65557555|NCT01269307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65557556|NCT01269307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65557557|NCT01269307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65557558|NCT01269307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65557559|NCT01269307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65557560|NCT01269307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557561|NCT03874585|Nicotine|nicotine|mesh-list
65557562|NCT03874585|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65557563|NCT03874585|Autonomic Agents|autonomic agents|mesh-ancestor
65557564|NCT03874585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65557565|NCT03874585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557566|NCT03874585|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65557567|NCT03874585|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65557568|NCT03874585|Cholinergic Agents|cholinergic agents|mesh-ancestor
65557569|NCT03874585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65557570|NCT03874585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557571|NCT01268371|Everolimus|everolimus|mesh-list
65557572|NCT01268371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557573|NCT01268371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65557574|NCT01268371|Immunologic Factors|immunologic factors|mesh-ancestor
65557575|NCT01268371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557576|NCT01267669|Somatostatin|somatostatin|mesh-list
65557577|NCT01267669|Hormones|hormones|mesh-ancestor
65557578|NCT01267669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65557579|NCT01267669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557580|NCT05666869|Esketamine|esketamine|mesh-list
65557581|NCT05666869|Antidepressive Agents|antidepressive agents|mesh-ancestor
65557582|NCT05666869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65557583|NCT01164943|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65557584|NCT01164943|Hormones|hormones|mesh-ancestor
65557585|NCT01164943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65557586|NCT01164943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557587|NCT01269541|Rifampin|rifampin|mesh-list
65557588|NCT01269541|Mupirocin|mupirocin|mesh-list
65557589|NCT01269541|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65557590|NCT01269541|Antitubercular Agents|antitubercular agents|mesh-ancestor
65557591|NCT01269541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65557592|NCT01269541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65557593|NCT01269541|Leprostatic Agents|leprostatic agents|mesh-ancestor
65557594|NCT01269541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65557595|NCT01269541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65557596|NCT01269541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557597|NCT01269541|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65557598|NCT01269541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65557599|NCT01269541|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65557600|NCT01269541|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65557601|NCT01269541|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65557602|NCT01269541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65557603|NCT01269541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65557604|NCT03877003|Choline|choline|mesh-list
65557605|NCT03877003|Lipotropic Agents|lipotropic agents|mesh-ancestor
65557606|NCT03877003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65557607|NCT03877003|Antimetabolites|antimetabolites|mesh-ancestor
65557608|NCT03877003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557609|NCT03877003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65557610|NCT03877003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65557611|NCT03877003|Nootropic Agents|nootropic agents|mesh-ancestor
65557612|NCT01280149|Substance P|substance p|mesh-list
65557613|NCT01280149|Neurokinin A|neurokinin a|mesh-list
65557614|NCT01280149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65557615|NCT01280149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557616|NCT01280149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557617|NCT01165255|Bupropion|bupropion|mesh-list
65557618|NCT01165255|Antidepressive Agents|antidepressive agents|mesh-list
65557619|NCT01165255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65557620|NCT01165255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65557621|NCT01165255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65557622|NCT01165255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65557623|NCT01165255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65557624|NCT01165255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557625|NCT01165255|Dopamine Agents|dopamine agents|mesh-ancestor
65557626|NCT01165255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65557627|NCT01165255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557628|NCT01165255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65557629|NCT01165255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65557630|NCT01165255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65557631|NCT01167049|Capecitabine|capecitabine|mesh-list
65557632|NCT01167049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65557633|NCT01167049|Antimetabolites|antimetabolites|mesh-ancestor
65557634|NCT01167049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557635|NCT01167049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557636|NCT01311414|Urapidil|urapidil|mesh-list
65557637|NCT01311414|Cafedrine|cafedrine|mesh-list
65557638|NCT01311414|Theodrenaline|theodrenaline|mesh-list
65557639|NCT01311414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65557640|NCT01311414|Vasodilator Agents|vasodilator agents|mesh-ancestor
65557641|NCT01311414|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65557642|NCT01311414|Serotonin Agents|serotonin agents|mesh-ancestor
65557643|NCT01311414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65557644|NCT01311414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557645|NCT01311414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557646|NCT01311414|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65557647|NCT01311414|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65557648|NCT01311414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65557649|NCT01311414|Adrenergic Agents|adrenergic agents|mesh-ancestor
65557650|NCT03715296|Lenalidomide|lenalidomide|mesh-list
65557651|NCT03715296|Immunologic Factors|immunologic factors|mesh-ancestor
65557652|NCT03715296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557653|NCT03715296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65557654|NCT03715296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65557655|NCT03715296|Growth Substances|growth substances|mesh-ancestor
65557656|NCT03715296|Growth Inhibitors|growth inhibitors|mesh-ancestor
65557657|NCT03715296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557658|NCT01347762|Nabilone|nabilone|mesh-list
65557659|NCT01347762|Antiemetics|antiemetics|mesh-ancestor
65557660|NCT01347762|Autonomic Agents|autonomic agents|mesh-ancestor
65557661|NCT01347762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65557662|NCT01347762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557663|NCT01347762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65557664|NCT01347762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65557665|NCT01347762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65557666|NCT01347762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65557667|NCT01347762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65557668|NCT03874273|Crizotinib|crizotinib|mesh-list
65557669|NCT03874273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557670|NCT03874273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65557671|NCT03874273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65557672|NCT03874273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557673|NCT05657652|Cytarabine|cytarabine|mesh-list
65557674|NCT05657652|Venetoclax|venetoclax|mesh-list
65557675|NCT05657652|Cladribine|cladribine|mesh-list
65557676|NCT05657652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65557677|NCT05657652|Antimetabolites|antimetabolites|mesh-ancestor
65557678|NCT05657652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557679|NCT05657652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557680|NCT05657652|Antiviral Agents|antiviral agents|mesh-ancestor
65557681|NCT05657652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65557682|NCT05657652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65557683|NCT05657652|Immunologic Factors|immunologic factors|mesh-ancestor
65557684|NCT05657652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557685|NCT01167127|Oxycodone|oxycodone|mesh-list
65557686|NCT01167127|Naloxone|naloxone|mesh-list
65557687|NCT01167127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65557688|NCT01167127|Narcotics|narcotics|mesh-ancestor
65557689|NCT01167127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65557690|NCT01167127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557691|NCT01167127|Analgesics|analgesics|mesh-ancestor
65557692|NCT01167127|Sensory System Agents|sensory system agents|mesh-ancestor
65557693|NCT01167127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65557694|NCT01167127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65557695|NCT01280305|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65557696|NCT01280305|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65557697|NCT01280305|Hormone Antagonists|hormone antagonists|mesh-ancestor
65557698|NCT01280305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65557699|NCT01280305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557700|NCT01280305|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65557701|NCT01280305|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65557702|NCT01280305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65557703|NCT03872011|Vitamins|vitamins|mesh-list
65557704|NCT03872011|Ascorbic Acid|ascorbic acid|mesh-list
65557705|NCT03872011|Thiamine|thiamine|mesh-list
65557706|NCT03872011|Hydrocortisone|hydrocortisone|mesh-list
65557707|NCT03872011|Micronutrients|micronutrients|mesh-ancestor
65557708|NCT03872011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557709|NCT03872011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65557710|NCT03872011|Antioxidants|antioxidants|mesh-ancestor
65557711|NCT03872011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557712|NCT03872011|Protective Agents|protective agents|mesh-ancestor
65557713|NCT03872011|Vitamin B Complex|vitamin b complex|mesh-ancestor
65557714|NCT03438396|Tisotumab vedotin|tisotumab vedotin|mesh-list
65557715|NCT03438396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65557716|NCT03438396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557717|NCT03876067|Cardioplegic Solutions|cardioplegic solutions|mesh-list
65557718|NCT03876067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65557719|NCT01163929|Paclitaxel|paclitaxel|mesh-list
65557720|NCT01163929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65557721|NCT01163929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557722|NCT01163929|Tubulin Modulators|tubulin modulators|mesh-ancestor
65557723|NCT01163929|Antimitotic Agents|antimitotic agents|mesh-ancestor
65557724|NCT01163929|Mitosis Modulators|mitosis modulators|mesh-ancestor
65557725|NCT01163929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557726|NCT03871777|Chlorhexidine|chlorhexidine|mesh-list
65557727|NCT03871777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65557728|NCT03871777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65557729|NCT03871777|Disinfectants|disinfectants|mesh-ancestor
65557730|NCT00073307|Sorafenib|sorafenib|mesh-list
65557731|NCT00073307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557732|NCT00073307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65557733|NCT00073307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65557734|NCT00073307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557735|NCT01270789|Liraglutide|liraglutide|mesh-list
65557736|NCT01270789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65557737|NCT01270789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557738|NCT01270789|Incretins|incretins|mesh-ancestor
65557739|NCT01270789|Hormones|hormones|mesh-ancestor
65557740|NCT01270789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65557741|NCT01164085|Ketorolac|ketorolac|mesh-list
65557742|NCT01164085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65557743|NCT01164085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65557744|NCT01164085|Analgesics|analgesics|mesh-ancestor
65557745|NCT01164085|Sensory System Agents|sensory system agents|mesh-ancestor
65557746|NCT01164085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65557747|NCT01164085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557748|NCT01164085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65557749|NCT01164085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65557750|NCT01164085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65557751|NCT01164085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65557752|NCT01164085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557753|NCT01271179|Insulin|insulin|mesh-list
65557754|NCT01271179|Allopurinol|allopurinol|mesh-list
65557755|NCT01271179|Adenosine|adenosine|mesh-list
65557756|NCT01271179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65557757|NCT01271179|Analgesics|analgesics|mesh-ancestor
65557758|NCT01271179|Sensory System Agents|sensory system agents|mesh-ancestor
65557759|NCT01271179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65557760|NCT01271179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557761|NCT01271179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65557762|NCT01271179|Vasodilator Agents|vasodilator agents|mesh-ancestor
65557763|NCT01271179|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65557764|NCT01271179|Purinergic Agonists|purinergic agonists|mesh-ancestor
65557765|NCT01271179|Purinergic Agents|purinergic agents|mesh-ancestor
65557766|NCT01271179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65557767|NCT01271179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557768|NCT01271179|Antimetabolites|antimetabolites|mesh-ancestor
65557769|NCT01271179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65557770|NCT01271179|Gout Suppressants|gout suppressants|mesh-ancestor
65557771|NCT01271179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65557772|NCT01271179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65557773|NCT01271179|Antioxidants|antioxidants|mesh-ancestor
65557774|NCT01271179|Protective Agents|protective agents|mesh-ancestor
65557775|NCT01271179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65557776|NCT03388164|Dexetimide|dexetimide|mesh-list
65557777|NCT03388164|Citalopram|citalopram|mesh-list
65557778|NCT03388164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65557779|NCT03388164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65557780|NCT03388164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65557781|NCT03388164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557782|NCT03388164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65557783|NCT03388164|Serotonin Agents|serotonin agents|mesh-ancestor
65557784|NCT03388164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557785|NCT03388164|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65557786|NCT03388164|Antidepressive Agents|antidepressive agents|mesh-ancestor
65557787|NCT03388164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65557788|NCT03388164|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65557789|NCT03388164|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65557790|NCT03388164|Parasympatholytics|parasympatholytics|mesh-ancestor
65557791|NCT03388164|Autonomic Agents|autonomic agents|mesh-ancestor
65557792|NCT03388164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65557793|NCT03388164|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65557794|NCT03388164|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65557795|NCT03388164|Cholinergic Agents|cholinergic agents|mesh-ancestor
65557796|NCT01268761|Cetrorelix|cetrorelix|mesh-list
65557797|NCT01268761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65557798|NCT01268761|Fertility Agents|fertility agents|mesh-ancestor
65557799|NCT01268761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65355335|NCT00883155|Bupropion|bupropion|mesh-list
65557800|NCT01268761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557801|NCT01268761|Hormone Antagonists|hormone antagonists|mesh-ancestor
65557802|NCT01268761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65557803|NCT01268839|Efavirenz|efavirenz|mesh-list
65557804|NCT01268839|Rilpivirine|rilpivirine|mesh-list
65557805|NCT01268839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65557806|NCT01268839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65557807|NCT01268839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65557808|NCT01268839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557809|NCT01268839|Antiviral Agents|antiviral agents|mesh-ancestor
65557810|NCT01268839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65557811|NCT01268839|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65557812|NCT01268839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65557813|NCT01268839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65557814|NCT01268839|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65557815|NCT01268839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65557816|NCT01268839|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65557817|NCT01268839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65557818|NCT01268839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65557819|NCT03403374|Evolocumab|evolocumab|mesh-list
65557820|NCT03403374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65557821|NCT03403374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65557822|NCT03403374|Antimetabolites|antimetabolites|mesh-ancestor
65557823|NCT03403374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557824|NCT03403374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65557825|NCT01165567|Sarpogrelate|sarpogrelate|mesh-list
65557826|NCT01165567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65557827|NCT01165567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65557828|NCT01165567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557829|NCT01165567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65557830|NCT01165567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65557831|NCT01165567|Serotonin Agents|serotonin agents|mesh-ancestor
65557832|NCT01165567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65557833|NCT01165567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557834|NCT03387462|Tenofovir|tenofovir|mesh-list
65557835|NCT03387462|Emtricitabine|emtricitabine|mesh-list
65557836|NCT03387462|Antiviral Agents|antiviral agents|mesh-ancestor
65557837|NCT03387462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65557838|NCT03387462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65557839|NCT03387462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65557840|NCT03387462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65557841|NCT03387462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557842|NCT03387462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65557843|NCT03387462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65286971|NCT02760095|Micronutrients|micronutrients|mesh-ancestor
65557844|NCT03756883|Fluticasone|fluticasone|mesh-list
65557845|NCT03756883|Xhance|xhance|mesh-list
65557846|NCT03756883|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65557847|NCT03756883|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65557848|NCT03756883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65557849|NCT03756883|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65557850|NCT03756883|Autonomic Agents|autonomic agents|mesh-ancestor
65557851|NCT03756883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65557852|NCT03756883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557853|NCT03756883|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65557854|NCT03756883|Respiratory System Agents|respiratory system agents|mesh-ancestor
65557855|NCT03756883|Dermatologic Agents|dermatologic agents|mesh-ancestor
65557856|NCT03756883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65557857|NCT03756883|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65557858|NCT03756883|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65557859|NCT03756883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65557860|NCT03756883|Adrenergic Agents|adrenergic agents|mesh-ancestor
65557861|NCT03756883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65557862|NCT03756883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557863|NCT03756883|Glucocorticoids|glucocorticoids|mesh-ancestor
65557864|NCT03756883|Hormones|hormones|mesh-ancestor
65557865|NCT03756883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65557866|NCT03756883|Sympathomimetics|sympathomimetics|mesh-ancestor
65557867|NCT01586611|Leucovorin|leucovorin|mesh-list
65557868|NCT01586611|Gemcitabine|gemcitabine|mesh-list
65557869|NCT01586611|Oxaliplatin|oxaliplatin|mesh-list
65557870|NCT01586611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65557871|NCT01586611|Antimetabolites|antimetabolites|mesh-ancestor
65557872|NCT01586611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557873|NCT01586611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557874|NCT01586611|Antiviral Agents|antiviral agents|mesh-ancestor
65557875|NCT01586611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65557876|NCT01586611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65557877|NCT01586611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65557878|NCT01586611|Immunologic Factors|immunologic factors|mesh-ancestor
65557879|NCT01586611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557880|NCT01586611|Antidotes|antidotes|mesh-ancestor
65557881|NCT01586611|Protective Agents|protective agents|mesh-ancestor
65557882|NCT01586611|Vitamin B Complex|vitamin b complex|mesh-ancestor
65557883|NCT01586611|Vitamins|vitamins|mesh-ancestor
65557884|NCT01586611|Micronutrients|micronutrients|mesh-ancestor
65557885|NCT03386448|Scopolamine|scopolamine|mesh-list
65557886|NCT03386448|Naltrexone|naltrexone|mesh-list
65557887|NCT03386448|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65557888|NCT03386448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65557889|NCT03386448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65557890|NCT03386448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557891|NCT03386448|Sensory System Agents|sensory system agents|mesh-ancestor
65557892|NCT03386448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65557893|NCT03386448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65557894|NCT03386448|Antiemetics|antiemetics|mesh-ancestor
65557895|NCT03386448|Autonomic Agents|autonomic agents|mesh-ancestor
65557896|NCT03386448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65557897|NCT03386448|Mydriatics|mydriatics|mesh-ancestor
65557898|NCT03386448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65557899|NCT03386448|Cholinergic Agents|cholinergic agents|mesh-ancestor
65557900|NCT03386448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65557901|NCT03386448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557902|NCT03386448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65557903|NCT03386448|Parasympatholytics|parasympatholytics|mesh-ancestor
65557904|NCT01280929|Ranibizumab|ranibizumab|mesh-list
65557905|NCT01280929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65557906|NCT01280929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65557907|NCT01280929|Growth Substances|growth substances|mesh-ancestor
65557908|NCT01280929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557909|NCT01280929|Growth Inhibitors|growth inhibitors|mesh-ancestor
65557910|NCT01280929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557911|NCT01268917|Aspirin|aspirin|mesh-list
65557912|NCT01268917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65557913|NCT01268917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65557914|NCT01268917|Analgesics|analgesics|mesh-ancestor
65557915|NCT01268917|Sensory System Agents|sensory system agents|mesh-ancestor
65557916|NCT01268917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65557917|NCT01268917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557918|NCT01268917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65557919|NCT01268917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65557920|NCT01268917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65557921|NCT01268917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65557922|NCT01268917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557923|NCT01268917|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65557924|NCT01268917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65557925|NCT01268917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65557926|NCT01268917|Antipyretics|antipyretics|mesh-ancestor
65557927|NCT01281163|Lapatinib|lapatinib|mesh-list
65557928|NCT01281163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557929|NCT01281163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65557930|NCT01281163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65557931|NCT01281163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557932|NCT01268995|Cyclosporine|cyclosporine|mesh-list
65557933|NCT01268995|Tacrolimus|tacrolimus|mesh-list
65557934|NCT01268995|Cyclosporins|cyclosporins|mesh-list
65557935|NCT01268995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65557936|NCT01268995|Immunologic Factors|immunologic factors|mesh-ancestor
65557937|NCT01268995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557938|NCT01268995|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65557939|NCT01268995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65557940|NCT01268995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557941|NCT01268995|Antifungal Agents|antifungal agents|mesh-ancestor
65557942|NCT01268995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65557943|NCT01268995|Dermatologic Agents|dermatologic agents|mesh-ancestor
65557944|NCT01268995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65557945|NCT00009737|Leucovorin|leucovorin|mesh-list
65557946|NCT00009737|Fluorouracil|fluorouracil|mesh-list
65557947|NCT00009737|Capecitabine|capecitabine|mesh-list
65557948|NCT00009737|Antimetabolites|antimetabolites|mesh-ancestor
65355483|NCT00882531|Isotretinoin|isotretinoin|mesh-list
65557949|NCT00009737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557950|NCT00009737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65557951|NCT00009737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557952|NCT00009737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65557953|NCT00009737|Immunologic Factors|immunologic factors|mesh-ancestor
65557954|NCT00009737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557955|NCT00009737|Antidotes|antidotes|mesh-ancestor
65557956|NCT00009737|Protective Agents|protective agents|mesh-ancestor
65557957|NCT00009737|Vitamin B Complex|vitamin b complex|mesh-ancestor
65557958|NCT00009737|Vitamins|vitamins|mesh-ancestor
65557959|NCT00009737|Micronutrients|micronutrients|mesh-ancestor
65557960|NCT03711240|Leucovorin|leucovorin|mesh-list
65557961|NCT03711240|Bevacizumab|bevacizumab|mesh-list
65557962|NCT03711240|Oxaliplatin|oxaliplatin|mesh-list
65557963|NCT03711240|Irinotecan|irinotecan|mesh-list
65557964|NCT03711240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65557965|NCT03711240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557966|NCT03711240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65557967|NCT03711240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65557968|NCT03711240|Growth Substances|growth substances|mesh-ancestor
65557969|NCT03711240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557970|NCT03711240|Growth Inhibitors|growth inhibitors|mesh-ancestor
65557971|NCT03711240|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65557972|NCT03711240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65557973|NCT03711240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65557974|NCT03711240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557975|NCT03711240|Antidotes|antidotes|mesh-ancestor
65557976|NCT03711240|Protective Agents|protective agents|mesh-ancestor
65557977|NCT03711240|Vitamin B Complex|vitamin b complex|mesh-ancestor
65557978|NCT03711240|Vitamins|vitamins|mesh-ancestor
65557979|NCT03711240|Micronutrients|micronutrients|mesh-ancestor
65557980|NCT01271881|Heparin|heparin|mesh-list
65557981|NCT01271881|Anticoagulants|anticoagulants|mesh-ancestor
65557982|NCT01271881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65557983|NCT01271881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65557984|NCT01271881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557985|NCT05459844|Octreotide|octreotide|mesh-list
65557986|NCT05459844|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65557987|NCT05459844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65557988|NCT05459844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65557989|NCT05459844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65557990|NCT05459844|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65557991|NCT05459844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65557992|NCT03874975|Vitamin D|vitamin d|mesh-list
65557993|NCT03874975|Vitamins|vitamins|mesh-ancestor
65557994|NCT03874975|Micronutrients|micronutrients|mesh-ancestor
65557995|NCT03874975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65557996|NCT03874975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65557997|NCT01164709|Nelfinavir|nelfinavir|mesh-list
65557998|NCT01164709|Bortezomib|bortezomib|mesh-list
65557999|NCT01164709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558000|NCT01164709|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65558001|NCT01164709|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65558002|NCT01164709|Protease Inhibitors|protease inhibitors|mesh-ancestor
65558003|NCT01164709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558004|NCT01164709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558005|NCT01164709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65558006|NCT01164709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65558007|NCT01164709|Antiviral Agents|antiviral agents|mesh-ancestor
65558008|NCT01164709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65558009|NCT03960671|Midazolam|midazolam|mesh-list
65558010|NCT03960671|Diazepam|diazepam|mesh-list
65558011|NCT03960671|Propofol|propofol|mesh-list
65558012|NCT03960671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65558013|NCT03960671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65558014|NCT03960671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558015|NCT03960671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65558016|NCT03960671|Anesthetics, General|anesthetics, general|mesh-ancestor
65558017|NCT03960671|Anesthetics|anesthetics|mesh-ancestor
65558018|NCT03960671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65558019|NCT03960671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65558020|NCT03960671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65558021|NCT03960671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65558022|NCT03960671|GABA Modulators|gaba modulators|mesh-ancestor
65558023|NCT03960671|GABA Agents|gaba agents|mesh-ancestor
65558024|NCT03960671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65558025|NCT03960671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558026|NCT03960671|Anticonvulsants|anticonvulsants|mesh-ancestor
65558027|NCT03960671|Antiemetics|antiemetics|mesh-ancestor
65558028|NCT03960671|Autonomic Agents|autonomic agents|mesh-ancestor
65558029|NCT03960671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65558030|NCT03960671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65558031|NCT03960671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65558032|NCT03960671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65558033|NCT01281553|Cisapride|cisapride|mesh-list
65558034|NCT01281553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65558035|NCT01281553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65558036|NCT01281553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65558037|NCT01281553|Serotonin Agents|serotonin agents|mesh-ancestor
65558038|NCT01281553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65558039|NCT01281553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558040|NCT01281553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558041|NCT01164787|Trandolapril|trandolapril|mesh-list
65558042|NCT01164787|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65558043|NCT01164787|Protease Inhibitors|protease inhibitors|mesh-ancestor
65558044|NCT01164787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558045|NCT01164787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558046|NCT01164787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65558047|NCT01269151|Ranibizumab|ranibizumab|mesh-list
65558048|NCT01269151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65558049|NCT01269151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65558050|NCT01269151|Growth Substances|growth substances|mesh-ancestor
65558051|NCT01269151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558052|NCT01269151|Growth Inhibitors|growth inhibitors|mesh-ancestor
65558053|NCT01269151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558054|NCT00028769|Paclitaxel|paclitaxel|mesh-list
65558055|NCT00028769|Etoposide|etoposide|mesh-list
65558056|NCT00028769|Leuprolide|leuprolide|mesh-list
65558057|NCT00028769|Goserelin|goserelin|mesh-list
65558058|NCT00028769|Bicalutamide|bicalutamide|mesh-list
65558059|NCT00028769|Flutamide|flutamide|mesh-list
65558060|NCT00028769|Estramustine|estramustine|mesh-list
65558061|NCT00028769|Nilutamide|nilutamide|mesh-list
65558062|NCT00028769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65558063|NCT00028769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558064|NCT00028769|Tubulin Modulators|tubulin modulators|mesh-ancestor
65558065|NCT00028769|Antimitotic Agents|antimitotic agents|mesh-ancestor
65558066|NCT00028769|Mitosis Modulators|mitosis modulators|mesh-ancestor
65558067|NCT00028769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558068|NCT00028769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65558069|NCT00028769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65558070|NCT00028769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558071|NCT00028769|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65558072|NCT00028769|Fertility Agents|fertility agents|mesh-ancestor
65558073|NCT00028769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65558074|NCT00028769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558075|NCT00028769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65558076|NCT00028769|Androgen Antagonists|androgen antagonists|mesh-ancestor
65558077|NCT00028769|Hormone Antagonists|hormone antagonists|mesh-ancestor
65558078|NCT00028769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65558079|NCT00028769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65558080|NCT00028769|Alkylating Agents|alkylating agents|mesh-ancestor
65558081|NCT01281787|Losartan|losartan|mesh-list
65558082|NCT01281787|Metoprolol|metoprolol|mesh-list
65558083|NCT01281787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65558084|NCT01281787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65558085|NCT01281787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65558086|NCT01281787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65558087|NCT01281787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558088|NCT01281787|Sympatholytics|sympatholytics|mesh-ancestor
65558089|NCT01281787|Autonomic Agents|autonomic agents|mesh-ancestor
65558090|NCT01281787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65558091|NCT01281787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558092|NCT01281787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65558093|NCT01281787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65558094|NCT01281787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65558095|NCT01281787|Adrenergic Agents|adrenergic agents|mesh-ancestor
65558096|NCT01281787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65558097|NCT02953314|Ivacaftor|ivacaftor|mesh-list
65558098|NCT02953314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65558099|NCT02953314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65558100|NCT02953314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558101|NCT00007475|Cyclophosphamide|cyclophosphamide|mesh-list
65558102|NCT00007475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65558103|NCT00007475|Immunologic Factors|immunologic factors|mesh-ancestor
65558104|NCT00007475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355643|NCT00675948|Nabiximols|nabiximols|mesh-list
65558105|NCT00007475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65558106|NCT00007475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65558107|NCT00007475|Alkylating Agents|alkylating agents|mesh-ancestor
65558108|NCT00007475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558109|NCT00007475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558110|NCT00007475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65558111|NCT01273441|Amoxicillin|amoxicillin|mesh-list
65558112|NCT01273441|Metronidazole|metronidazole|mesh-list
65558113|NCT01273441|Clarithromycin|clarithromycin|mesh-list
65558114|NCT01273441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65558115|NCT01273441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65558116|NCT01273441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65558117|NCT01273441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65558118|NCT01273441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65558119|NCT01273441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558120|NCT01273441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558121|NCT01273441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65558122|NCT01273441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65558123|NCT03714360|Tranexamic Acid|tranexamic acid|mesh-list
65558124|NCT03714360|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65558125|NCT03714360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65558126|NCT03714360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558127|NCT03714360|Hemostatics|hemostatics|mesh-ancestor
65558128|NCT03714360|Coagulants|coagulants|mesh-ancestor
65558129|NCT01169857|Bortezomib|bortezomib|mesh-list
65558130|NCT01169857|Proteasome Inhibitors|proteasome inhibitors|mesh-list
65558131|NCT01169857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558132|NCT01169857|Protease Inhibitors|protease inhibitors|mesh-ancestor
65558133|NCT01169857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558134|NCT01169857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558135|NCT01169935|Dextrans|dextrans|mesh-list
65558136|NCT01169935|Anticoagulants|anticoagulants|mesh-ancestor
65558137|NCT01169935|Plasma Substitutes|plasma substitutes|mesh-ancestor
65558138|NCT01169935|Blood Substitutes|blood substitutes|mesh-ancestor
65558139|NCT01168063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65558140|NCT01168063|Amoxicillin|amoxicillin|mesh-list
65558141|NCT01168063|Metronidazole|metronidazole|mesh-list
65558142|NCT01168063|Clarithromycin|clarithromycin|mesh-list
65558143|NCT01168063|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65558144|NCT01168063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65558145|NCT01168063|Antitubercular Agents|antitubercular agents|mesh-ancestor
65558146|NCT01168063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65558147|NCT01168063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65558148|NCT01168063|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65558149|NCT01168063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558150|NCT01168063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558151|NCT01168063|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65558152|NCT01168063|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65558153|NCT01166035|Lenalidomide|lenalidomide|mesh-list
65558154|NCT01166035|Cetuximab|cetuximab|mesh-list
65558155|NCT01166035|Immunologic Factors|immunologic factors|mesh-ancestor
65558156|NCT01166035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558157|NCT01166035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65558158|NCT01166035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65558159|NCT01166035|Growth Substances|growth substances|mesh-ancestor
65558160|NCT01166035|Growth Inhibitors|growth inhibitors|mesh-ancestor
65558161|NCT01166035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558162|NCT01166035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65558163|NCT01168375|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65558164|NCT01168375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65558165|NCT03869281|Pancrelipase|pancrelipase|mesh-list
65558166|NCT03869281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65558167|NCT01281943|Sirolimus|sirolimus|mesh-list
65558168|NCT01281943|Doxorubicin|doxorubicin|mesh-list
65558169|NCT01281943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65558170|NCT01281943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65558171|NCT01281943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558172|NCT01281943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65558173|NCT01281943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65558174|NCT01281943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558175|NCT01281943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558176|NCT01281943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65558177|NCT01281943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65558178|NCT01281943|Antifungal Agents|antifungal agents|mesh-ancestor
65558179|NCT01281943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65355709|NCT02543697|Mydriatics|mydriatics|mesh-ancestor
65558180|NCT01281943|Immunologic Factors|immunologic factors|mesh-ancestor
65558181|NCT01281943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558182|NCT03869047|Dexmedetomidine|dexmedetomidine|mesh-list
65558183|NCT03869047|Bupivacaine|bupivacaine|mesh-list
65558184|NCT03869047|Anesthetics, Local|anesthetics, local|mesh-ancestor
65558185|NCT03869047|Anesthetics|anesthetics|mesh-ancestor
65558186|NCT03869047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65558187|NCT03869047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558188|NCT03869047|Sensory System Agents|sensory system agents|mesh-ancestor
65558189|NCT03869047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65558190|NCT03869047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65558191|NCT03869047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65558192|NCT03869047|Analgesics|analgesics|mesh-ancestor
65558193|NCT03869047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65558194|NCT03869047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65558195|NCT03869047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65558196|NCT03869047|Adrenergic Agents|adrenergic agents|mesh-ancestor
65558197|NCT03869047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65558198|NCT03869047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558199|NCT01168531|Dexamethasone|dexamethasone|mesh-list
65558200|NCT01168531|Pregabalin|pregabalin|mesh-list
65558201|NCT01168531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65558202|NCT01168531|Antiemetics|antiemetics|mesh-ancestor
65558203|NCT01168531|Autonomic Agents|autonomic agents|mesh-ancestor
65558204|NCT01168531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65558205|NCT01168531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558206|NCT01168531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65558207|NCT01168531|Glucocorticoids|glucocorticoids|mesh-ancestor
65558208|NCT01168531|Hormones|hormones|mesh-ancestor
65558209|NCT01168531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65558210|NCT01168531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65558211|NCT01168531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558212|NCT01168531|Analgesics|analgesics|mesh-ancestor
65558213|NCT01168531|Sensory System Agents|sensory system agents|mesh-ancestor
65558214|NCT01168531|Anticonvulsants|anticonvulsants|mesh-ancestor
65558215|NCT01168531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65558216|NCT01168531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65558217|NCT01168531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558218|NCT01168531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65558219|NCT01168531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65558220|NCT01168531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65558221|NCT01168531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65558222|NCT01168531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65558223|NCT01170169|Omeprazole|omeprazole|mesh-list
65558224|NCT01170169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65558225|NCT01170169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65558226|NCT01170169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65558227|NCT01170169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558228|NCT01170169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558229|NCT01587313|Hydralazine|hydralazine|mesh-list
65558230|NCT01587313|Isosorbide|isosorbide|mesh-list
65558231|NCT01587313|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65558232|NCT01587313|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65558233|NCT01587313|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65558234|NCT01587313|Diuretics|diuretics|mesh-ancestor
65558235|NCT01587313|Natriuretic Agents|natriuretic agents|mesh-ancestor
65558236|NCT01587313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558237|NCT01587313|Vasodilator Agents|vasodilator agents|mesh-ancestor
65558238|NCT01587313|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65558239|NCT01587313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558240|NCT01587313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65558241|NCT01282333|Gemcitabine|gemcitabine|mesh-list
65558242|NCT01282333|Veliparib|veliparib|mesh-list
65558243|NCT01282333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558244|NCT01282333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65558245|NCT01282333|Antimetabolites|antimetabolites|mesh-ancestor
65558246|NCT01282333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558247|NCT01282333|Antiviral Agents|antiviral agents|mesh-ancestor
65558248|NCT01282333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65558249|NCT01282333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558250|NCT01282333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65558251|NCT01282333|Immunologic Factors|immunologic factors|mesh-ancestor
65558252|NCT01282333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558253|NCT01282333|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65355791|NCT00887211|Sirolimus|sirolimus|mesh-list
65558254|NCT01166425|Lithium Carbonate|lithium carbonate|mesh-list
65558255|NCT01166425|Antidepressive Agents|antidepressive agents|mesh-ancestor
65558256|NCT01166425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65558257|NCT01166425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558258|NCT01166425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558259|NCT01166425|Antimanic Agents|antimanic agents|mesh-ancestor
65558260|NCT01166425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65558261|NCT01166425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65558262|NCT01166425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558263|NCT03868969|Fosfomycin|fosfomycin|mesh-list
65558264|NCT03868969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65558265|NCT03868969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65558266|NCT01311570|Buprenorphine|buprenorphine|mesh-list
65558267|NCT01311570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65558268|NCT01311570|Narcotics|narcotics|mesh-ancestor
65558269|NCT01311570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65558270|NCT01311570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558271|NCT01311570|Analgesics|analgesics|mesh-ancestor
65558272|NCT01311570|Sensory System Agents|sensory system agents|mesh-ancestor
65558273|NCT01311570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65558274|NCT01311570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65558275|NCT01170325|Valproic Acid|valproic acid|mesh-list
65558276|NCT01170325|Anticonvulsants|anticonvulsants|mesh-ancestor
65558277|NCT01170325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558278|NCT01170325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558279|NCT01170325|GABA Agents|gaba agents|mesh-ancestor
65558280|NCT01170325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65558281|NCT01170325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558282|NCT01170325|Antimanic Agents|antimanic agents|mesh-ancestor
65558283|NCT01170325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65558284|NCT01170325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65558285|NCT01170325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65558286|NCT05542446|Colistin|colistin|mesh-list
65558287|NCT05542446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65558288|NCT05542446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65558289|NCT03355326|Glycerol|glycerol|mesh-list
65558290|NCT03355326|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65558291|NCT03355326|Protective Agents|protective agents|mesh-ancestor
65558292|NCT03355326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558293|NCT01170637|Ibuprofen|ibuprofen|mesh-list
65558294|NCT01170637|Pseudoephedrine|pseudoephedrine|mesh-list
65558295|NCT01170637|Ephedrine|ephedrine|mesh-list
65558296|NCT01170637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65558297|NCT01170637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65558298|NCT01170637|Analgesics|analgesics|mesh-ancestor
65558299|NCT01170637|Sensory System Agents|sensory system agents|mesh-ancestor
65558300|NCT01170637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65558301|NCT01170637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558302|NCT01170637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65558303|NCT01170637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65558304|NCT01170637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65558305|NCT01170637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558306|NCT01170637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558307|NCT01170637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65558308|NCT01170637|Autonomic Agents|autonomic agents|mesh-ancestor
65558309|NCT01170637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65558310|NCT01170637|Respiratory System Agents|respiratory system agents|mesh-ancestor
65558311|NCT01170637|Nasal Decongestants|nasal decongestants|mesh-ancestor
65558312|NCT01170637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65558313|NCT01170637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65558314|NCT01170637|Sympathomimetics|sympathomimetics|mesh-ancestor
65558315|NCT01170637|Adrenergic Agents|adrenergic agents|mesh-ancestor
65558316|NCT01170637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65558317|NCT03873025|Pembrolizumab|pembrolizumab|mesh-list
65558318|NCT03873025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65558319|NCT03873025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558320|NCT02526745|Vaccines|vaccines|mesh-list
65558321|NCT02526745|Immunologic Factors|immunologic factors|mesh-ancestor
65558322|NCT02526745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558323|NCT01169389|Bupivacaine|bupivacaine|mesh-list
65558324|NCT01169389|Anesthetics, Local|anesthetics, local|mesh-ancestor
65558325|NCT01169389|Anesthetics|anesthetics|mesh-ancestor
65558326|NCT01169389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65558327|NCT01169389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558328|NCT01169389|Sensory System Agents|sensory system agents|mesh-ancestor
65558329|NCT01169389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65558330|NCT01170871|Pemetrexed|pemetrexed|mesh-list
65558331|NCT01170871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558332|NCT01170871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558333|NCT01170871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558334|NCT01170871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65558335|NCT01170871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65558336|NCT03868111|Sufentanil|sufentanil|mesh-list
65558337|NCT03868111|Remifentanil|remifentanil|mesh-list
65558338|NCT03868111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65558339|NCT03868111|Narcotics|narcotics|mesh-ancestor
65558340|NCT03868111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65558341|NCT03868111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558342|NCT03868111|Analgesics|analgesics|mesh-ancestor
65558343|NCT03868111|Sensory System Agents|sensory system agents|mesh-ancestor
65558344|NCT03868111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65558345|NCT03868111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65558346|NCT03868111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65558347|NCT03868111|Anesthetics, General|anesthetics, general|mesh-ancestor
65558348|NCT03868111|Anesthetics|anesthetics|mesh-ancestor
65558349|NCT01282879|Itraconazole|itraconazole|mesh-list
65558350|NCT01282879|Antifungal Agents|antifungal agents|mesh-ancestor
65558351|NCT01282879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65558352|NCT01282879|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65558353|NCT01282879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65558354|NCT01282879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558355|NCT01282879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558356|NCT01282879|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65558357|NCT01282879|Hormone Antagonists|hormone antagonists|mesh-ancestor
65558358|NCT01282879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65558359|NCT01282879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558360|NCT01282879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65558361|NCT03868033|Zoledronic Acid|zoledronic acid|mesh-list
65558362|NCT03868033|Denosumab|denosumab|mesh-list
65558363|NCT03868033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65558364|NCT03868033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558365|NCT01166815|Zinc Sulfate|zinc sulfate|mesh-list
65558366|NCT01166815|Astringents|astringents|mesh-ancestor
65558367|NCT01166815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558368|NCT01166815|Dermatologic Agents|dermatologic agents|mesh-ancestor
65558369|NCT03751657|Insulin|insulin|mesh-list
65558370|NCT03751657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65558371|NCT03751657|Metformin|metformin|mesh-list
65558372|NCT03751657|Insulin Glargine|insulin glargine|mesh-list
65558373|NCT03751657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65287497|NCT04068766|Bupivacaine|bupivacaine|mesh-list
65558374|NCT03751657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65558375|NCT03751657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558376|NCT03751657|Protease Inhibitors|protease inhibitors|mesh-ancestor
65558377|NCT03751657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558378|NCT03751657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558379|NCT03873415|BMS-986165|bms-986165|mesh-list
65558380|NCT03873415|Dermatologic Agents|dermatologic agents|mesh-ancestor
65558381|NCT03873415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65558382|NCT03873415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558383|NCT03873415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558384|NCT00025259|Cytarabine|cytarabine|mesh-list
65558385|NCT00025259|Dexamethasone|dexamethasone|mesh-list
65558386|NCT00025259|Prednisone|prednisone|mesh-list
65558387|NCT00025259|Dexamethasone acetate|dexamethasone acetate|mesh-list
65558388|NCT00025259|Cortisone|cortisone|mesh-list
65558389|NCT00025259|Cyclophosphamide|cyclophosphamide|mesh-list
65558390|NCT00025259|Cisplatin|cisplatin|mesh-list
65558391|NCT00025259|Doxorubicin|doxorubicin|mesh-list
65558392|NCT00025259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65558393|NCT00025259|Etoposide|etoposide|mesh-list
65558394|NCT00025259|Vincristine|vincristine|mesh-list
65558395|NCT00025259|Etoposide phosphate|etoposide phosphate|mesh-list
65558396|NCT00025259|Bleomycin|bleomycin|mesh-list
65558397|NCT00025259|Podophyllotoxin|podophyllotoxin|mesh-list
65558398|NCT00025259|Lenograstim|lenograstim|mesh-list
65558399|NCT00025259|BB 1101|bb 1101|mesh-list
65558400|NCT00025259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65558401|NCT00025259|Immunologic Factors|immunologic factors|mesh-ancestor
65558402|NCT00025259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558403|NCT00025259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65558404|NCT00025259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65558405|NCT00025259|Alkylating Agents|alkylating agents|mesh-ancestor
65355930|NCT00673920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65558406|NCT00025259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558407|NCT00025259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558408|NCT00025259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65558409|NCT00025259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65558410|NCT00025259|Antiemetics|antiemetics|mesh-ancestor
65558411|NCT00025259|Autonomic Agents|autonomic agents|mesh-ancestor
65558412|NCT00025259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65558413|NCT00025259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65558414|NCT00025259|Glucocorticoids|glucocorticoids|mesh-ancestor
65558416|NCT00025259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65558417|NCT00025259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65558418|NCT00025259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65558419|NCT00025259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65558420|NCT00025259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65558421|NCT00025259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558422|NCT00025259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65558423|NCT00025259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65558424|NCT00025259|Antimetabolites|antimetabolites|mesh-ancestor
65558425|NCT00025259|Antiviral Agents|antiviral agents|mesh-ancestor
65558426|NCT00025259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65558427|NCT00025259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65558428|NCT00025259|Tubulin Modulators|tubulin modulators|mesh-ancestor
65558429|NCT00025259|Antimitotic Agents|antimitotic agents|mesh-ancestor
65558430|NCT00025259|Mitosis Modulators|mitosis modulators|mesh-ancestor
65558431|NCT00025259|Protease Inhibitors|protease inhibitors|mesh-ancestor
65558432|NCT00025259|Keratolytic Agents|keratolytic agents|mesh-ancestor
65558433|NCT00025259|Dermatologic Agents|dermatologic agents|mesh-ancestor
65558434|NCT01171651|Sorafenib|sorafenib|mesh-list
65558435|NCT01171651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558436|NCT01171651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65558437|NCT01171651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558438|NCT01171651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558439|NCT03866629|Lifitegrast|lifitegrast|mesh-list
65558440|NCT03866629|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65558441|NCT03866629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65558442|NCT01280071|Aminophylline|aminophylline|mesh-list
65558443|NCT01280071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65558444|NCT01280071|Autonomic Agents|autonomic agents|mesh-ancestor
65558445|NCT01280071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65558446|NCT01280071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558447|NCT01280071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65558448|NCT01280071|Respiratory System Agents|respiratory system agents|mesh-ancestor
65558449|NCT01280071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65558450|NCT01280071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65558451|NCT01280071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558452|NCT01280071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558453|NCT01280071|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65558454|NCT01280071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65558455|NCT01280071|Purinergic Agents|purinergic agents|mesh-ancestor
65558456|NCT01280071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65558457|NCT01280071|Protective Agents|protective agents|mesh-ancestor
65558458|NCT02526199|Dexamethasone|dexamethasone|mesh-list
65558459|NCT02526199|Epinephrine|epinephrine|mesh-list
65558460|NCT02526199|Bupivacaine|bupivacaine|mesh-list
65558461|NCT02526199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65558462|NCT02526199|Antiemetics|antiemetics|mesh-ancestor
65558463|NCT02526199|Autonomic Agents|autonomic agents|mesh-ancestor
65558464|NCT02526199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65558465|NCT02526199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558466|NCT02526199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65558467|NCT02526199|Glucocorticoids|glucocorticoids|mesh-ancestor
65558468|NCT02526199|Hormones|hormones|mesh-ancestor
65558469|NCT02526199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65558470|NCT02526199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65558471|NCT02526199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558472|NCT02526199|Anesthetics, Local|anesthetics, local|mesh-ancestor
65558473|NCT02526199|Anesthetics|anesthetics|mesh-ancestor
65558474|NCT02526199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65558475|NCT02526199|Sensory System Agents|sensory system agents|mesh-ancestor
65558476|NCT02526199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65558477|NCT02526199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65558478|NCT02526199|Adrenergic Agents|adrenergic agents|mesh-ancestor
65558479|NCT02526199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65558480|NCT02526199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558481|NCT02526199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65558482|NCT02526199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65558483|NCT02526199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65558484|NCT02526199|Respiratory System Agents|respiratory system agents|mesh-ancestor
65558485|NCT02526199|Mydriatics|mydriatics|mesh-ancestor
65558486|NCT02526199|Sympathomimetics|sympathomimetics|mesh-ancestor
65558487|NCT02526199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65558488|NCT01284049|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65558489|NCT01284049|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65558490|NCT01284049|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65558491|NCT01284049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65558492|NCT03863977|Dexamethasone|dexamethasone|mesh-list
65558493|NCT03863977|Dexamethasone acetate|dexamethasone acetate|mesh-list
65558494|NCT03863977|Bupivacaine|bupivacaine|mesh-list
65558495|NCT03863977|BB 1101|bb 1101|mesh-list
65558496|NCT03863977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65558497|NCT03863977|Antiemetics|antiemetics|mesh-ancestor
65558498|NCT03863977|Autonomic Agents|autonomic agents|mesh-ancestor
65558499|NCT03863977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65558500|NCT03863977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558501|NCT03863977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65558502|NCT03863977|Glucocorticoids|glucocorticoids|mesh-ancestor
65558503|NCT03863977|Hormones|hormones|mesh-ancestor
65558504|NCT03863977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65558505|NCT03863977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65558506|NCT03863977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558507|NCT03863977|Protease Inhibitors|protease inhibitors|mesh-ancestor
65558508|NCT03863977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558509|NCT03863977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558510|NCT03863977|Anesthetics, Local|anesthetics, local|mesh-ancestor
65558511|NCT03863977|Anesthetics|anesthetics|mesh-ancestor
65558512|NCT03863977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65558513|NCT03863977|Sensory System Agents|sensory system agents|mesh-ancestor
65558514|NCT01171807|Dexamethasone|dexamethasone|mesh-list
65558515|NCT01171807|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65558516|NCT01171807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65558517|NCT01171807|Antiemetics|antiemetics|mesh-ancestor
65558518|NCT01171807|Autonomic Agents|autonomic agents|mesh-ancestor
65558519|NCT01171807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65558520|NCT01171807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558521|NCT01171807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65558522|NCT01171807|Glucocorticoids|glucocorticoids|mesh-ancestor
65558523|NCT01171807|Hormones|hormones|mesh-ancestor
65558524|NCT01171807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65287676|NCT02750969|Lidocaine|lidocaine|mesh-list
65558525|NCT01171807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65558526|NCT01171807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558527|NCT01171885|Ropivacaine|ropivacaine|mesh-list
65558528|NCT01171885|Anesthetics, Local|anesthetics, local|mesh-ancestor
65558529|NCT01171885|Anesthetics|anesthetics|mesh-ancestor
65558530|NCT01171885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65558531|NCT01171885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558532|NCT01171885|Sensory System Agents|sensory system agents|mesh-ancestor
65558533|NCT01171885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65558534|NCT01286233|Metformin|metformin|mesh-list
65558535|NCT01286233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65558536|NCT01286233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558537|NCT01175161|Copper|copper|mesh-list
65558538|NCT01175161|Trace Elements|trace elements|mesh-ancestor
65558539|NCT01175161|Micronutrients|micronutrients|mesh-ancestor
65558540|NCT01175161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558541|NCT01172041|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65558542|NCT01172041|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65558543|NCT01172041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558544|NCT01284907|Vitamin D|vitamin d|mesh-list
65558545|NCT01284907|Cholecalciferol|cholecalciferol|mesh-list
65558546|NCT01284907|Vitamins|vitamins|mesh-ancestor
65558547|NCT01284907|Micronutrients|micronutrients|mesh-ancestor
65558548|NCT01284907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558549|NCT01284907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65558550|NCT01284907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65558551|NCT01284205|BCG Vaccine|bcg vaccine|mesh-list
65558552|NCT01284205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65558553|NCT01284205|Immunologic Factors|immunologic factors|mesh-ancestor
65558554|NCT01284205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558555|NCT00024167|Ketoconazole|ketoconazole|mesh-list
65558556|NCT00024167|Dexamethasone|dexamethasone|mesh-list
65558557|NCT00024167|Prednisone|prednisone|mesh-list
65558558|NCT00024167|Estramustine|estramustine|mesh-list
65558559|NCT00024167|Docetaxel|docetaxel|mesh-list
65558560|NCT00024167|Doxorubicin|doxorubicin|mesh-list
65558561|NCT00024167|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65558562|NCT00024167|Vinblastine|vinblastine|mesh-list
65558563|NCT00024167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65558564|NCT00024167|Antiemetics|antiemetics|mesh-ancestor
65558565|NCT00024167|Autonomic Agents|autonomic agents|mesh-ancestor
65558566|NCT00024167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65558567|NCT00024167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558568|NCT00024167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65558569|NCT00024167|Glucocorticoids|glucocorticoids|mesh-ancestor
65558570|NCT00024167|Hormones|hormones|mesh-ancestor
65558571|NCT00024167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65558572|NCT00024167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65558573|NCT00024167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558574|NCT00024167|Tubulin Modulators|tubulin modulators|mesh-ancestor
65558575|NCT00024167|Antimitotic Agents|antimitotic agents|mesh-ancestor
65558576|NCT00024167|Mitosis Modulators|mitosis modulators|mesh-ancestor
65558577|NCT00024167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558578|NCT00024167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65558579|NCT00024167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65558580|NCT00024167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65558581|NCT00024167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558582|NCT00024167|Antifungal Agents|antifungal agents|mesh-ancestor
65558583|NCT00024167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65558584|NCT00024167|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65558585|NCT00024167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65558586|NCT00024167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65558587|NCT00024167|Hormone Antagonists|hormone antagonists|mesh-ancestor
65558588|NCT00024167|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65558589|NCT00024167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65558590|NCT00024167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65558591|NCT00024167|Alkylating Agents|alkylating agents|mesh-ancestor
65558592|NCT03867097|Iloprost|iloprost|mesh-list
65558593|NCT03867097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65558594|NCT03867097|Vasodilator Agents|vasodilator agents|mesh-ancestor
65558595|NCT00022763|Enfuvirtide|enfuvirtide|mesh-list
65558596|NCT00022763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65558597|NCT00022763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65558598|NCT00022763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558599|NCT00022763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65558600|NCT00022763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65558601|NCT00022763|Antiviral Agents|antiviral agents|mesh-ancestor
65558602|NCT00022763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65558603|NCT01285141|polysaccharide-K|polysaccharide-k|mesh-list
65558604|NCT01285141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65558605|NCT01285141|Immunologic Factors|immunologic factors|mesh-ancestor
65558606|NCT01285141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558607|NCT01285141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65558608|NCT01285141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558609|NCT01285141|Antiviral Agents|antiviral agents|mesh-ancestor
65558610|NCT01285141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65558611|NCT01285141|Interferon Inducers|interferon inducers|mesh-ancestor
65558612|NCT01285141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65558613|NCT01285141|Protective Agents|protective agents|mesh-ancestor
65558614|NCT01285219|Lenograstim|lenograstim|mesh-list
65558615|NCT01285219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65558616|NCT01285219|Immunologic Factors|immunologic factors|mesh-ancestor
65558617|NCT01285219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558618|NCT01284439|Hyaluronic Acid|hyaluronic acid|mesh-list
65558619|NCT01284439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65558620|NCT01284439|Immunologic Factors|immunologic factors|mesh-ancestor
65558621|NCT01284439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558622|NCT01284439|Viscosupplements|viscosupplements|mesh-ancestor
65558623|NCT01284439|Protective Agents|protective agents|mesh-ancestor
65558624|NCT00071981|Molgramostim|molgramostim|mesh-list
65558625|NCT00071981|Vaccines|vaccines|mesh-list
65558626|NCT00071981|Sargramostim|sargramostim|mesh-list
65558627|NCT00071981|Freund's Adjuvant|freund's adjuvant|mesh-list
65558628|NCT00071981|Immunologic Factors|immunologic factors|mesh-ancestor
65558629|NCT00071981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558630|NCT00071981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558631|NCT00071981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65558632|NCT01172431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65558633|NCT01172431|Indapamide|indapamide|mesh-list
65558634|NCT01172431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65558635|NCT01172431|Diuretics|diuretics|mesh-ancestor
65558636|NCT01172431|Natriuretic Agents|natriuretic agents|mesh-ancestor
65558637|NCT01172431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558638|NCT01172431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65558639|NCT01172431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65558640|NCT01172431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558641|NCT01172509|Baclofen|baclofen|mesh-list
65558642|NCT01172509|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65558643|NCT01172509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558644|NCT01172509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65558645|NCT01172509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65558646|NCT01172509|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65558647|NCT01172509|GABA Agonists|gaba agonists|mesh-ancestor
65558648|NCT01172509|GABA Agents|gaba agents|mesh-ancestor
65558649|NCT01172509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65558650|NCT01172509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558651|NCT01089959|Esomeprazole|esomeprazole|mesh-list
65558652|NCT01089959|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65558653|NCT01089959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65558654|NCT01089959|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65558655|NCT01089959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558656|NCT01089959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558657|NCT01090037|Epoprostenol|epoprostenol|mesh-list
65558658|NCT01090037|Beraprost|beraprost|mesh-list
65558659|NCT01090037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65558660|NCT01090037|Vasodilator Agents|vasodilator agents|mesh-ancestor
65558661|NCT01090037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65558662|NCT01285375|Curcumin|curcumin|mesh-list
65558663|NCT01285375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65558664|NCT01285375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65558665|NCT01285375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65558666|NCT01285375|Analgesics|analgesics|mesh-ancestor
65558667|NCT01285375|Sensory System Agents|sensory system agents|mesh-ancestor
65558668|NCT01285375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65558669|NCT01285375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558670|NCT01285375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65558671|NCT01285375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65558672|NCT01285375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558673|NCT01285375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558674|NCT01285375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558675|NCT05625893|Bevacizumab|bevacizumab|mesh-list
65558676|NCT05625893|Atezolizumab|atezolizumab|mesh-list
65287807|NCT00652886|Hormones|hormones|mesh-ancestor
65558677|NCT05625893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65558678|NCT05625893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558679|NCT05625893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65558680|NCT05625893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65558681|NCT05625893|Growth Substances|growth substances|mesh-ancestor
65558682|NCT05625893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558683|NCT05625893|Growth Inhibitors|growth inhibitors|mesh-ancestor
65558684|NCT01178047|Rasagiline|rasagiline|mesh-list
65558685|NCT01178047|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65558686|NCT01178047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558687|NCT01178047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558688|NCT01178047|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65558689|NCT01178047|Protective Agents|protective agents|mesh-ancestor
65558690|NCT01178047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558691|NCT01101113|Cinacalcet|cinacalcet|mesh-list
65558692|NCT01101113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65558693|NCT01101113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558694|NCT01101113|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65558695|NCT01101113|Hormone Antagonists|hormone antagonists|mesh-ancestor
65558696|NCT01101113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65558697|NCT01288261|Paclitaxel|paclitaxel|mesh-list
65558698|NCT01288261|Bavituximab|bavituximab|mesh-list
65558699|NCT01288261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65558700|NCT01288261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558701|NCT01288261|Tubulin Modulators|tubulin modulators|mesh-ancestor
65558702|NCT01288261|Antimitotic Agents|antimitotic agents|mesh-ancestor
65558703|NCT01288261|Mitosis Modulators|mitosis modulators|mesh-ancestor
65558704|NCT01288261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558705|NCT01288261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65558706|NCT01174303|Insulin|insulin|mesh-list
65558707|NCT01174303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65558708|NCT01174303|Insulin Aspart|insulin aspart|mesh-list
65558709|NCT01174303|Insulin, Long-Acting|insulin, long-acting|mesh-list
65558710|NCT01174303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65356226|NCT00966004|Mirabegron|mirabegron|mesh-list
65558711|NCT01174303|Biphasic Insulins|biphasic insulins|mesh-list
65558712|NCT01174303|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65558713|NCT01174303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65558714|NCT01174303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558715|NCT01285453|Vadimezan|vadimezan|mesh-list
65558716|NCT01285453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558717|NCT01288339|Leucovorin|leucovorin|mesh-list
65558718|NCT01288339|Fluorouracil|fluorouracil|mesh-list
65558719|NCT01288339|Oxaliplatin|oxaliplatin|mesh-list
65558720|NCT01288339|Panitumumab|panitumumab|mesh-list
65558721|NCT01288339|Antimetabolites|antimetabolites|mesh-ancestor
65558722|NCT01288339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558723|NCT01288339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65558724|NCT01288339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558725|NCT01288339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65558726|NCT01288339|Immunologic Factors|immunologic factors|mesh-ancestor
65558727|NCT01288339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558728|NCT01288339|Antidotes|antidotes|mesh-ancestor
65558729|NCT01288339|Protective Agents|protective agents|mesh-ancestor
65558730|NCT01288339|Vitamin B Complex|vitamin b complex|mesh-ancestor
65558731|NCT01288339|Vitamins|vitamins|mesh-ancestor
65558732|NCT01288339|Micronutrients|micronutrients|mesh-ancestor
65558733|NCT01288339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65558734|NCT00006389|Bryostatin 1|bryostatin 1|mesh-list
65558735|NCT00006389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558736|NCT00006389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65558737|NCT00006389|Immunologic Factors|immunologic factors|mesh-ancestor
65558738|NCT00006389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558739|NCT04965311|Botulinum Toxins|botulinum toxins|mesh-list
65558740|NCT04965311|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65558741|NCT04965311|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65558742|NCT04965311|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65558743|NCT04965311|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65558744|NCT04965311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65558745|NCT04965311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558746|NCT04965311|Cholinergic Agents|cholinergic agents|mesh-ancestor
65558747|NCT04965311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65558748|NCT04965311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558749|NCT04965311|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65558750|NCT04965311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65558751|NCT01105481|Amisulpride|amisulpride|mesh-list
65558752|NCT01105481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65558753|NCT01105481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65558754|NCT01105481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65558755|NCT01105481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558756|NCT01105481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65558757|NCT01105481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65558758|NCT01105481|Dopamine Agents|dopamine agents|mesh-ancestor
65558759|NCT01105481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65558760|NCT01105481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558761|NCT01105481|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65558762|NCT01105481|Antidepressive Agents|antidepressive agents|mesh-ancestor
65558763|NCT01178203|Naproxen|naproxen|mesh-list
65558764|NCT01178203|Tramadol|tramadol|mesh-list
65558765|NCT01178203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65558766|NCT01178203|Narcotics|narcotics|mesh-ancestor
65558767|NCT01178203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65558768|NCT01178203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558769|NCT01178203|Analgesics|analgesics|mesh-ancestor
65558770|NCT01178203|Sensory System Agents|sensory system agents|mesh-ancestor
65558771|NCT01178203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65558772|NCT01178203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65558773|NCT01178203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65558774|NCT01178203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65558775|NCT01178203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65558776|NCT01178203|Gout Suppressants|gout suppressants|mesh-ancestor
65558777|NCT01178203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65558778|NCT01178203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558779|NCT01178203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558780|NCT01286701|Terbinafine|terbinafine|mesh-list
65558781|NCT01286701|Antifungal Agents|antifungal agents|mesh-ancestor
65558782|NCT01286701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65558783|NCT01286701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558784|NCT01286701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356310|NCT00966316|Antipyretics|antipyretics|mesh-ancestor
65558785|NCT00006305|Biguanides|biguanides|mesh-list
65558786|NCT00006305|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
65558787|NCT00006305|Calcium Channel Blockers|calcium channel blockers|mesh-list
65558788|NCT00006305|Calcium|calcium|mesh-list
65558789|NCT00006305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65558790|NCT00006305|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65558791|NCT00006305|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65558792|NCT00006305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65558793|NCT00006305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558794|NCT00006305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65558795|NCT00006305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65558796|NCT00006305|Adrenergic Agents|adrenergic agents|mesh-ancestor
65558797|NCT00006305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65558798|NCT00006305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558799|NCT00006305|Protease Inhibitors|protease inhibitors|mesh-ancestor
65558800|NCT00006305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558801|NCT00006305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65558802|NCT01286857|Silicon|silicon|mesh-list
65558803|NCT01286857|Trace Elements|trace elements|mesh-ancestor
65558804|NCT01286857|Micronutrients|micronutrients|mesh-ancestor
65558805|NCT01286857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558806|NCT01101269|Lisinopril|lisinopril|mesh-list
65558807|NCT01101269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65558808|NCT01101269|Protease Inhibitors|protease inhibitors|mesh-ancestor
65558809|NCT01101269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558810|NCT01101269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558811|NCT01101269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65558812|NCT01101269|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65558813|NCT01101269|Protective Agents|protective agents|mesh-ancestor
65558814|NCT01101269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558815|NCT01103375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65558816|NCT01103375|Isotretinoin|isotretinoin|mesh-list
65558817|NCT01103375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558818|NCT01103375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65558819|NCT01103375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558820|NCT01103375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558821|NCT01103375|Dermatologic Agents|dermatologic agents|mesh-ancestor
65558822|NCT03949049|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
65558823|NCT03949049|Nootropic Agents|nootropic agents|mesh-ancestor
65558824|NCT01288417|Raltegravir Potassium|raltegravir potassium|mesh-list
65558825|NCT01288417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65558826|NCT01288417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65558827|NCT01288417|Antiviral Agents|antiviral agents|mesh-ancestor
65558828|NCT01288417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65558829|NCT01288417|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65558830|NCT01288417|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65558831|NCT01288417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558832|NCT01288417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558833|NCT01285765|Rituximab|rituximab|mesh-list
65558834|NCT01285765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65558835|NCT01285765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558836|NCT01285765|Immunologic Factors|immunologic factors|mesh-ancestor
65558837|NCT01285765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558838|NCT01285765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65558839|NCT03864913|Testosterone|testosterone|mesh-list
65558840|NCT03864913|Androgens|androgens|mesh-ancestor
65558841|NCT03864913|Hormones|hormones|mesh-ancestor
65558842|NCT03864913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65558843|NCT03864913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558844|NCT03865147|Acetaminophen|acetaminophen|mesh-list
65558845|NCT03865147|Cetrimonium|cetrimonium|mesh-list
65558846|NCT03865147|Ibuprofen|ibuprofen|mesh-list
65558847|NCT03865147|Lidocaine|lidocaine|mesh-list
65558848|NCT03865147|Epinephrine|epinephrine|mesh-list
65558849|NCT03865147|Racepinephrine|racepinephrine|mesh-list
65558850|NCT03865147|Bupivacaine|bupivacaine|mesh-list
65558851|NCT03865147|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65558852|NCT03865147|Epinephryl borate|epinephryl borate|mesh-list
65558853|NCT03865147|Anesthetics, Local|anesthetics, local|mesh-ancestor
65558854|NCT03865147|Anesthetics|anesthetics|mesh-ancestor
65558855|NCT03865147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65558856|NCT03865147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558857|NCT03865147|Sensory System Agents|sensory system agents|mesh-ancestor
65558858|NCT03865147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65558859|NCT03865147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65558860|NCT03865147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65558861|NCT03865147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65558862|NCT03865147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65558863|NCT03865147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558864|NCT03865147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65558865|NCT03865147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65558866|NCT03865147|Analgesics|analgesics|mesh-ancestor
65558867|NCT03865147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65558868|NCT03865147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65558869|NCT03865147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65558870|NCT03865147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558871|NCT03865147|Antipyretics|antipyretics|mesh-ancestor
65558872|NCT03865147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65558873|NCT03865147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65558874|NCT03865147|Adrenergic Agents|adrenergic agents|mesh-ancestor
65558875|NCT03865147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65558876|NCT03865147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65558877|NCT03865147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65558878|NCT03865147|Autonomic Agents|autonomic agents|mesh-ancestor
65558879|NCT03865147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65558880|NCT03865147|Respiratory System Agents|respiratory system agents|mesh-ancestor
65558881|NCT03865147|Mydriatics|mydriatics|mesh-ancestor
65558882|NCT03865147|Sympathomimetics|sympathomimetics|mesh-ancestor
65558883|NCT03865147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65558884|NCT03865147|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65558885|NCT03865147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65558886|NCT03865147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65558887|NCT03722823|Tucatinib|tucatinib|mesh-list
65558888|NCT03722823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558889|NCT03722823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65558890|NCT03722823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558891|NCT03722823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558892|NCT03862651|Cangrelor|cangrelor|mesh-list
65558893|NCT03862651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65558894|NCT03862651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65558895|NCT03862651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65558896|NCT03862651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65558897|NCT03862651|Purinergic Agents|purinergic agents|mesh-ancestor
65558898|NCT03862651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65558899|NCT03862651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558900|NCT03862651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558901|NCT03349710|Nivolumab|nivolumab|mesh-list
65558902|NCT03349710|Cetuximab|cetuximab|mesh-list
65558903|NCT03349710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558904|NCT03349710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65558905|NCT03349710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65558906|NCT03349710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558907|NCT01288495|Psyllium|psyllium|mesh-list
65558908|NCT01288495|Cathartics|cathartics|mesh-ancestor
65558909|NCT01288495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65558910|NCT01105793|Danazol|danazol|mesh-list
65558911|NCT01105793|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65558912|NCT01105793|Hormone Antagonists|hormone antagonists|mesh-ancestor
65558913|NCT01105793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65558914|NCT01105793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558915|NCT04934579|Rituximab|rituximab|mesh-list
65558916|NCT04934579|Methotrexate|methotrexate|mesh-list
65558917|NCT04934579|Lenalidomide|lenalidomide|mesh-list
65558918|NCT04934579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65558919|NCT04934579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558920|NCT04934579|Immunologic Factors|immunologic factors|mesh-ancestor
65558921|NCT04934579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558922|NCT04934579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65558923|NCT04934579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65558924|NCT04934579|Abortifacient Agents|abortifacient agents|mesh-ancestor
65558925|NCT04934579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65558926|NCT04934579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65558927|NCT04934579|Antimetabolites|antimetabolites|mesh-ancestor
65558928|NCT04934579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558929|NCT04934579|Dermatologic Agents|dermatologic agents|mesh-ancestor
65558930|NCT04934579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558931|NCT04934579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65558932|NCT04934579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65558933|NCT04934579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65558934|NCT04934579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65558935|NCT04934579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65558937|NCT04934579|Growth Inhibitors|growth inhibitors|mesh-ancestor
65558938|NCT03134131|TIC10 compound|tic10 compound|mesh-list
65558939|NCT03134131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558940|NCT01103609|Warfarin|warfarin|mesh-list
65558941|NCT01103609|Anticoagulants|anticoagulants|mesh-ancestor
65558942|NCT03528369|Capsaicin|capsaicin|mesh-list
65558943|NCT03528369|Antipruritics|antipruritics|mesh-ancestor
65558944|NCT03528369|Dermatologic Agents|dermatologic agents|mesh-ancestor
65558945|NCT03528369|Sensory System Agents|sensory system agents|mesh-ancestor
65558946|NCT03528369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65558947|NCT03528369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558948|NCT01288573|Plerixafor|plerixafor|mesh-list
65558949|NCT01288573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65558950|NCT01288573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65558951|NCT01288573|Antiviral Agents|antiviral agents|mesh-ancestor
65558952|NCT01288573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65558953|NCT01174693|Clopidogrel|clopidogrel|mesh-list
65558954|NCT01174693|Triflusal|triflusal|mesh-list
65558955|NCT01174693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65558956|NCT01174693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65558957|NCT01174693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65558958|NCT01174693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65558959|NCT01174693|Purinergic Agents|purinergic agents|mesh-ancestor
65558960|NCT01174693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65558961|NCT01174693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558962|NCT01174693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558963|NCT00006011|Paclitaxel|paclitaxel|mesh-list
65558964|NCT00006011|Doxorubicin|doxorubicin|mesh-list
65558965|NCT00006011|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65558966|NCT00006011|Lenograstim|lenograstim|mesh-list
65558967|NCT00006011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65558968|NCT00006011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558969|NCT00006011|Tubulin Modulators|tubulin modulators|mesh-ancestor
65558970|NCT00006011|Antimitotic Agents|antimitotic agents|mesh-ancestor
65558971|NCT00006011|Mitosis Modulators|mitosis modulators|mesh-ancestor
65558972|NCT00006011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558973|NCT00006011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65558974|NCT00006011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65558975|NCT00006011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65558976|NCT00006011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558977|NCT00006011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65558978|NCT00006011|Immunologic Factors|immunologic factors|mesh-ancestor
65558979|NCT00006011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558980|NCT01105871|Naloxone|naloxone|mesh-list
65558981|NCT01105871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65558982|NCT01105871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558983|NCT01105871|Sensory System Agents|sensory system agents|mesh-ancestor
65558984|NCT01105871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65558985|NCT03377556|Talazoparib|talazoparib|mesh-list
65558986|NCT03377556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65558987|NCT03377556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65558988|NCT03377556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558989|NCT03377556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65558990|NCT05625581|Cyclophosphamide|cyclophosphamide|mesh-list
65558991|NCT05625581|Tofacitinib|tofacitinib|mesh-list
65558992|NCT05625581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65558993|NCT05625581|Immunologic Factors|immunologic factors|mesh-ancestor
65558994|NCT05625581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65558995|NCT05625581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65558996|NCT05625581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65558997|NCT05625581|Alkylating Agents|alkylating agents|mesh-ancestor
65558998|NCT05625581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65558999|NCT05625581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559000|NCT05625581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65559001|NCT05625581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65559002|NCT05625581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65559003|NCT05625503|Verapamil|verapamil|mesh-list
65559004|NCT05625503|Nicardipine|nicardipine|mesh-list
65559005|NCT05625503|Calcium Channel Blockers|calcium channel blockers|mesh-list
65559006|NCT05625503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65559007|NCT05625503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559008|NCT05625503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65559009|NCT05625503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65559010|NCT05625503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559012|NCT05625503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65559013|NCT01176175|Progesterone|progesterone|mesh-list
65559014|NCT01176175|Progestins|progestins|mesh-ancestor
65559015|NCT01176175|Hormones|hormones|mesh-ancestor
65559016|NCT01176175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65559017|NCT01176175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559018|NCT05624099|Paclitaxel|paclitaxel|mesh-list
65559019|NCT05624099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65559020|NCT05624099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559021|NCT05624099|Tubulin Modulators|tubulin modulators|mesh-ancestor
65559022|NCT05624099|Antimitotic Agents|antimitotic agents|mesh-ancestor
65559023|NCT05624099|Mitosis Modulators|mitosis modulators|mesh-ancestor
65559024|NCT05624099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559025|NCT03864601|JNJ-56136379|jnj-56136379|mesh-list
65559026|NCT03864601|Antiviral Agents|antiviral agents|mesh-ancestor
65559027|NCT03864601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65559028|NCT03864523|Pioglitazone|pioglitazone|mesh-list
65559029|NCT03864523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65559030|NCT03864523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559031|NCT03527745|Albendazole|albendazole|mesh-list
65559032|NCT03527745|Anthelmintics|anthelmintics|mesh-ancestor
65559033|NCT03527745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65559034|NCT03527745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65559035|NCT03527745|Anticestodal Agents|anticestodal agents|mesh-ancestor
65559036|NCT03527745|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65559037|NCT03527745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65559038|NCT03527745|Tubulin Modulators|tubulin modulators|mesh-ancestor
65559039|NCT03527745|Antimitotic Agents|antimitotic agents|mesh-ancestor
65559040|NCT03527745|Mitosis Modulators|mitosis modulators|mesh-ancestor
65559041|NCT03527745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559042|NCT03527745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559043|NCT01174849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65559044|NCT01174849|Immunologic Factors|immunologic factors|mesh-ancestor
65559045|NCT01174849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559046|NCT03583359|Lidocaine|lidocaine|mesh-list
65559047|NCT03583359|Anesthetics, Local|anesthetics, local|mesh-ancestor
65559048|NCT03583359|Anesthetics|anesthetics|mesh-ancestor
65559049|NCT03583359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65559050|NCT03583359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559051|NCT03583359|Sensory System Agents|sensory system agents|mesh-ancestor
65559052|NCT03583359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559053|NCT03583359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65559054|NCT03583359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65559055|NCT03583359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65559056|NCT03583359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65559057|NCT03583359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559058|NCT05619887|Fentanyl|fentanyl|mesh-list
65559059|NCT05619887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65559060|NCT05619887|Narcotics|narcotics|mesh-ancestor
65559061|NCT05619887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65559062|NCT05619887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559063|NCT05619887|Analgesics|analgesics|mesh-ancestor
65559064|NCT05619887|Sensory System Agents|sensory system agents|mesh-ancestor
65559065|NCT05619887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559066|NCT05619887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65559067|NCT05619887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65559068|NCT05619887|Anesthetics, General|anesthetics, general|mesh-ancestor
65559069|NCT05619887|Anesthetics|anesthetics|mesh-ancestor
65559070|NCT01174927|Heroin|heroin|mesh-list
65559071|NCT01174927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65559072|NCT01174927|Narcotics|narcotics|mesh-ancestor
65559073|NCT01174927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65559074|NCT01174927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559075|NCT01174927|Analgesics|analgesics|mesh-ancestor
65559076|NCT01174927|Sensory System Agents|sensory system agents|mesh-ancestor
65559077|NCT01174927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559078|NCT03510663|Moxifloxacin|moxifloxacin|mesh-list
65559079|NCT03510663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65559080|NCT03510663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65559081|NCT03510663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65559082|NCT03510663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65559083|NCT03510663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356626|NCT00890643|Prazosin|prazosin|mesh-list
65559084|NCT03510663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559085|NCT03510663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559086|NCT03948737|Tocopherols|tocopherols|mesh-list
65559087|NCT03948737|Vitamin E|vitamin e|mesh-list
65559088|NCT03948737|Tocotrienols|tocotrienols|mesh-list
65559089|NCT03948737|alpha-Tocopherol|alpha-tocopherol|mesh-list
65559090|NCT03948737|Antioxidants|antioxidants|mesh-ancestor
65559091|NCT03948737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559092|NCT03948737|Protective Agents|protective agents|mesh-ancestor
65559093|NCT03948737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559094|NCT03948737|Vitamins|vitamins|mesh-ancestor
65559095|NCT03948737|Micronutrients|micronutrients|mesh-ancestor
65559096|NCT01287247|Botulinum Toxins|botulinum toxins|mesh-list
65559097|NCT01287247|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65559098|NCT01287247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65559099|NCT01287247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65559100|NCT01287247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559101|NCT01287247|Cholinergic Agents|cholinergic agents|mesh-ancestor
65559102|NCT01287247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65559103|NCT01287247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559104|NCT01287247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65559105|NCT01287247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559106|NCT01327859|Donepezil|donepezil|mesh-list
65559107|NCT01327859|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65559108|NCT01327859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65559109|NCT01327859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559110|NCT01327859|Cholinergic Agents|cholinergic agents|mesh-ancestor
65559111|NCT01327859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65559112|NCT01327859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559113|NCT01327859|Nootropic Agents|nootropic agents|mesh-ancestor
65559114|NCT01176409|Valacyclovir|valacyclovir|mesh-list
65559115|NCT01176409|Antiviral Agents|antiviral agents|mesh-ancestor
65559116|NCT01176409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65559117|NCT03480009|Oxycodone|oxycodone|mesh-list
65559118|NCT03480009|Dextromethorphan|dextromethorphan|mesh-list
65559119|NCT03480009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65559120|NCT03480009|Narcotics|narcotics|mesh-ancestor
65559121|NCT03480009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65559122|NCT03480009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559123|NCT03480009|Analgesics|analgesics|mesh-ancestor
65559124|NCT03480009|Sensory System Agents|sensory system agents|mesh-ancestor
65559125|NCT03480009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559126|NCT03480009|Antitussive Agents|antitussive agents|mesh-ancestor
65559127|NCT03480009|Respiratory System Agents|respiratory system agents|mesh-ancestor
65559128|NCT03480009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65559129|NCT03480009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65559130|NCT03480009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65559131|NCT03480009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559132|NCT03859375|Disinfectants|disinfectants|mesh-list
65559133|NCT03859375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65559134|NCT01310751|Iloprost|iloprost|mesh-list
65559135|NCT01310751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65559136|NCT01310751|Vasodilator Agents|vasodilator agents|mesh-ancestor
65559137|NCT01180933|Folic Acid|folic acid|mesh-list
65559138|NCT01180933|Vitamin B Complex|vitamin b complex|mesh-list
65559139|NCT01180933|Hematinics|hematinics|mesh-ancestor
65559140|NCT01180933|Vitamins|vitamins|mesh-ancestor
65559141|NCT01180933|Micronutrients|micronutrients|mesh-ancestor
65559142|NCT01180933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559143|NCT03639363|Chlorhexidine|chlorhexidine|mesh-list
65559144|NCT03639363|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65559145|NCT03639363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65559146|NCT03639363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65559147|NCT03639363|Disinfectants|disinfectants|mesh-ancestor
65559148|NCT03639363|Dermatologic Agents|dermatologic agents|mesh-ancestor
65559149|NCT03859141|Vaccines|vaccines|mesh-list
65559150|NCT03859141|Immunologic Factors|immunologic factors|mesh-ancestor
65559151|NCT03859141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559152|NCT03859219|Rozanolixizumab|rozanolixizumab|mesh-list
65559153|NCT03859219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65559154|NCT03859219|Immunologic Factors|immunologic factors|mesh-ancestor
65559155|NCT03859219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559156|NCT03374358|Raltegravir Potassium|raltegravir potassium|mesh-list
65559157|NCT03374358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65559158|NCT03374358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65559159|NCT03374358|Antiviral Agents|antiviral agents|mesh-ancestor
65559160|NCT03374358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65559161|NCT03374358|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65559162|NCT03374358|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65559163|NCT03374358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65559164|NCT03374358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559165|NCT03711708|Sertraline|sertraline|mesh-list
65559166|NCT03711708|Antidepressive Agents|antidepressive agents|mesh-ancestor
65559167|NCT03711708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65559168|NCT03711708|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65559169|NCT03711708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65559170|NCT03711708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65559171|NCT03711708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559172|NCT03711708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65559173|NCT03711708|Serotonin Agents|serotonin agents|mesh-ancestor
65559174|NCT03711708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559175|NCT01179529|Omalizumab|omalizumab|mesh-list
65559176|NCT01179529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65559177|NCT01179529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65559178|NCT01179529|Respiratory System Agents|respiratory system agents|mesh-ancestor
65559179|NCT00004859|Thalidomide|thalidomide|mesh-list
65559180|NCT00004859|Paclitaxel|paclitaxel|mesh-list
65559181|NCT00004859|Carboplatin|carboplatin|mesh-list
65559182|NCT00004859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65559183|NCT00004859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559184|NCT00004859|Tubulin Modulators|tubulin modulators|mesh-ancestor
65559185|NCT00004859|Antimitotic Agents|antimitotic agents|mesh-ancestor
65559186|NCT00004859|Mitosis Modulators|mitosis modulators|mesh-ancestor
65559187|NCT00004859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559188|NCT00004859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65559189|NCT00004859|Immunologic Factors|immunologic factors|mesh-ancestor
65559190|NCT00004859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559191|NCT00004859|Leprostatic Agents|leprostatic agents|mesh-ancestor
65559192|NCT00004859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65559193|NCT00004859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65559194|NCT00004859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65559195|NCT00004859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65559196|NCT00004859|Growth Substances|growth substances|mesh-ancestor
65559197|NCT00004859|Growth Inhibitors|growth inhibitors|mesh-ancestor
65559198|NCT03348930|Tolcapone|tolcapone|mesh-list
65559199|NCT03348930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65559200|NCT03348930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65559201|NCT03348930|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65559202|NCT03348930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65559203|NCT03348930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559204|NCT03500211|Lidocaine|lidocaine|mesh-list
65559205|NCT03500211|Anesthetics, Local|anesthetics, local|mesh-ancestor
65559206|NCT03500211|Anesthetics|anesthetics|mesh-ancestor
65559207|NCT03500211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65559208|NCT03500211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559209|NCT03500211|Sensory System Agents|sensory system agents|mesh-ancestor
65559210|NCT03500211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559211|NCT03500211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65559212|NCT03500211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65559213|NCT03500211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65559214|NCT03500211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65559215|NCT03500211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559216|NCT01288885|Ipragliflozin|ipragliflozin|mesh-list
65559217|NCT01288885|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65559218|NCT01288885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559219|NCT01288885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65559220|NCT01288885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559221|NCT04760717|Spironolactone|spironolactone|mesh-list
65559222|NCT04760717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65559223|NCT04760717|Hormone Antagonists|hormone antagonists|mesh-ancestor
65559224|NCT04760717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65559225|NCT04760717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559226|NCT04760717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65559227|NCT04760717|Diuretics|diuretics|mesh-ancestor
65559228|NCT04760717|Natriuretic Agents|natriuretic agents|mesh-ancestor
65559229|NCT03478683|Budesonide|budesonide|mesh-list
65559230|NCT03478683|Albuterol|albuterol|mesh-list
65559231|NCT03478683|Formoterol Fumarate|formoterol fumarate|mesh-list
65559232|NCT03478683|Tiotropium Bromide|tiotropium bromide|mesh-list
65559233|NCT03478683|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65559234|NCT03478683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65559235|NCT03478683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65559236|NCT03478683|Autonomic Agents|autonomic agents|mesh-ancestor
65559237|NCT03478683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559238|NCT03478683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559239|NCT03478683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65559240|NCT03478683|Respiratory System Agents|respiratory system agents|mesh-ancestor
65559241|NCT03478683|Glucocorticoids|glucocorticoids|mesh-ancestor
65559242|NCT03478683|Hormones|hormones|mesh-ancestor
65559243|NCT03478683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65559244|NCT03478683|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65559245|NCT03478683|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65559246|NCT03478683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65559247|NCT03478683|Adrenergic Agents|adrenergic agents|mesh-ancestor
65559248|NCT03478683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65559249|NCT03478683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559250|NCT03478683|Parasympatholytics|parasympatholytics|mesh-ancestor
65559251|NCT03478683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65559252|NCT03478683|Cholinergic Agents|cholinergic agents|mesh-ancestor
65559253|NCT03478683|Tocolytic Agents|tocolytic agents|mesh-ancestor
65559254|NCT03478683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65559255|NCT04744883|Naloxone|naloxone|mesh-list
65559256|NCT04744883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65559257|NCT04744883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559258|NCT04744883|Sensory System Agents|sensory system agents|mesh-ancestor
65559259|NCT04744883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559260|NCT01288963|Aldesleukin|aldesleukin|mesh-list
65559261|NCT01288963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559262|NCT01288963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65559263|NCT01288963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65559264|NCT01288963|Antiviral Agents|antiviral agents|mesh-ancestor
65559265|NCT01288963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65559266|NCT01176799|Cyclophosphamide|cyclophosphamide|mesh-list
65559267|NCT01176799|Doxorubicin|doxorubicin|mesh-list
65559268|NCT01176799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65559269|NCT01176799|Sunitinib|sunitinib|mesh-list
65559270|NCT01176799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65559271|NCT01176799|Immunologic Factors|immunologic factors|mesh-ancestor
65559272|NCT01176799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559273|NCT01176799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65559274|NCT01176799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65559275|NCT01176799|Alkylating Agents|alkylating agents|mesh-ancestor
65559276|NCT01176799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559277|NCT01176799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559278|NCT01176799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65559279|NCT01176799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65559280|NCT01176799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65559281|NCT01176799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65559282|NCT01176799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65559283|NCT01176799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65559284|NCT01176799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65559285|NCT01176799|Growth Substances|growth substances|mesh-ancestor
65559286|NCT01176799|Growth Inhibitors|growth inhibitors|mesh-ancestor
65559287|NCT01176799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65559288|NCT03861403|Cyclophosphamide|cyclophosphamide|mesh-list
65559289|NCT03861403|Avelumab|avelumab|mesh-list
65559290|NCT03861403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65559291|NCT03861403|Immunologic Factors|immunologic factors|mesh-ancestor
65559292|NCT03861403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559293|NCT03861403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65559294|NCT03861403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65559295|NCT03861403|Alkylating Agents|alkylating agents|mesh-ancestor
65559296|NCT03861403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559297|NCT03861403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559298|NCT03861403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65559299|NCT03861403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65559300|NCT03477903|Metoclopramide|metoclopramide|mesh-list
65559301|NCT03477903|Antiemetics|antiemetics|mesh-ancestor
65559302|NCT03477903|Autonomic Agents|autonomic agents|mesh-ancestor
65559303|NCT03477903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559304|NCT03477903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559305|NCT03477903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65559306|NCT03477903|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65559307|NCT03477903|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65559308|NCT03477903|Dopamine Agents|dopamine agents|mesh-ancestor
65559309|NCT03477903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65559310|NCT03477903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559311|NCT04728425|Immunoglobulins|immunoglobulins|mesh-list
65559312|NCT04728425|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65559313|NCT04728425|Antibodies|antibodies|mesh-list
65559314|NCT04728425|gamma-Globulins|gamma-globulins|mesh-list
65559315|NCT04728425|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65559316|NCT04728425|Immunoglobulin G|immunoglobulin g|mesh-list
65559317|NCT04728425|Immunologic Factors|immunologic factors|mesh-ancestor
65559318|NCT04728425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559319|NCT01181401|Cisplatin|cisplatin|mesh-list
65559320|NCT01181401|Docetaxel|docetaxel|mesh-list
65559321|NCT01181401|Cetuximab|cetuximab|mesh-list
65559322|NCT01181401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559323|NCT01181401|Tubulin Modulators|tubulin modulators|mesh-ancestor
65559324|NCT01181401|Antimitotic Agents|antimitotic agents|mesh-ancestor
65559325|NCT01181401|Mitosis Modulators|mitosis modulators|mesh-ancestor
65559326|NCT01181401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559327|NCT01181401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65559328|NCT01287715|Etanercept|etanercept|mesh-list
65559329|NCT01287715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65559330|NCT01287715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65559331|NCT01287715|Analgesics|analgesics|mesh-ancestor
65559332|NCT01287715|Sensory System Agents|sensory system agents|mesh-ancestor
65559333|NCT01287715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559334|NCT01287715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559335|NCT01287715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65559336|NCT01287715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65559337|NCT01287715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65559338|NCT01287715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65559339|NCT01287715|Immunologic Factors|immunologic factors|mesh-ancestor
65559340|NCT03474081|Albuterol|albuterol|mesh-list
65559341|NCT03474081|Tiotropium Bromide|tiotropium bromide|mesh-list
65559342|NCT03474081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65559343|NCT03474081|Autonomic Agents|autonomic agents|mesh-ancestor
65559344|NCT03474081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559345|NCT03474081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559346|NCT03474081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65559347|NCT03474081|Respiratory System Agents|respiratory system agents|mesh-ancestor
65559348|NCT03474081|Parasympatholytics|parasympatholytics|mesh-ancestor
65559349|NCT03474081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65559350|NCT03474081|Cholinergic Agents|cholinergic agents|mesh-ancestor
65559351|NCT03474081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65559352|NCT03474081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559353|NCT03474081|Tocolytic Agents|tocolytic agents|mesh-ancestor
65559354|NCT03474081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65559355|NCT03474081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65559356|NCT03474081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65559357|NCT03474081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65559358|NCT03474081|Adrenergic Agents|adrenergic agents|mesh-ancestor
65559359|NCT03393000|Vitamin A|vitamin a|mesh-list
65559360|NCT03393000|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
65559361|NCT03393000|Antioxidants|antioxidants|mesh-ancestor
65559362|NCT03393000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559363|NCT03393000|Protective Agents|protective agents|mesh-ancestor
65559364|NCT03393000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559365|NCT03393000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65559366|NCT03393000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559367|NCT03393000|Vitamins|vitamins|mesh-ancestor
65559368|NCT03393000|Micronutrients|micronutrients|mesh-ancestor
65559369|NCT01311804|Parecoxib|parecoxib|mesh-list
65559370|NCT01311804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65559371|NCT01311804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65559372|NCT01311804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65559373|NCT01311804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559374|NCT01311804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65559375|NCT01311804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65559376|NCT01311804|Analgesics|analgesics|mesh-ancestor
65559377|NCT01311804|Sensory System Agents|sensory system agents|mesh-ancestor
65559378|NCT01311804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559379|NCT01311804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559380|NCT01311804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65559381|NCT01311804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65559382|NCT03370770|Osimertinib|osimertinib|mesh-list
65559383|NCT03370770|Afatinib|afatinib|mesh-list
65559384|NCT03370770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559385|NCT03370770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65559386|NCT03370770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65559387|NCT03370770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559389|NCT01180075|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65559390|NCT01180075|Tenofovir|tenofovir|mesh-list
65559391|NCT01180075|Emtricitabine|emtricitabine|mesh-list
65559392|NCT01180075|Efavirenz|efavirenz|mesh-list
65559393|NCT01180075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65559394|NCT01180075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65559395|NCT01180075|Protease Inhibitors|protease inhibitors|mesh-ancestor
65559396|NCT01180075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65559397|NCT01180075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559398|NCT01180075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65559399|NCT01180075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65559400|NCT01180075|Antiviral Agents|antiviral agents|mesh-ancestor
65559401|NCT01180075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65559402|NCT01180075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65559403|NCT01180075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65559404|NCT01180075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65559405|NCT01180075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65559406|NCT01180075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65559407|NCT01180075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65559408|NCT01180075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65559409|NCT01180075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65559410|NCT01180075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65559411|NCT01311882|Zopiclone|zopiclone|mesh-list
65559412|NCT01311882|Suvorexant|suvorexant|mesh-list
65559413|NCT01311882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65559414|NCT01311882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65559415|NCT01311882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559416|NCT01311882|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65559417|NCT01311882|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65559418|NCT01311882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65559419|NCT01311882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559420|NCT01287793|Moxifloxacin|moxifloxacin|mesh-list
65559421|NCT01287793|Tigecycline|tigecycline|mesh-list
65559422|NCT01287793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65559423|NCT01287793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65559424|NCT01287793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65559425|NCT01287793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65559426|NCT01287793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288540|NCT00679146|Ketoprofen|ketoprofen|mesh-list
65559427|NCT01287793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559428|NCT01287793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559429|NCT01287793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65559430|NCT03391284|Acetaminophen|acetaminophen|mesh-list
65559431|NCT03391284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65559432|NCT03391284|Analgesics|analgesics|mesh-ancestor
65559433|NCT03391284|Sensory System Agents|sensory system agents|mesh-ancestor
65559434|NCT03391284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559435|NCT03391284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559436|NCT03391284|Antipyretics|antipyretics|mesh-ancestor
65559437|NCT01180153|Oxaliplatin|oxaliplatin|mesh-list
65559438|NCT01180153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559439|NCT03719625|Norepinephrine|norepinephrine|mesh-list
65559440|NCT03719625|Ephedrine|ephedrine|mesh-list
65559441|NCT03719625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65559442|NCT03719625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65559443|NCT03719625|Adrenergic Agents|adrenergic agents|mesh-ancestor
65559444|NCT03719625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65559445|NCT03719625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559446|NCT03719625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559447|NCT03719625|Sympathomimetics|sympathomimetics|mesh-ancestor
65559448|NCT03719625|Autonomic Agents|autonomic agents|mesh-ancestor
65559449|NCT03719625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559450|NCT03719625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65559451|NCT03719625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65559452|NCT01289743|Etanercept|etanercept|mesh-list
65559453|NCT01289743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65559454|NCT01289743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65559455|NCT01289743|Analgesics|analgesics|mesh-ancestor
65559456|NCT01289743|Sensory System Agents|sensory system agents|mesh-ancestor
65559457|NCT01289743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559458|NCT01289743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559459|NCT01289743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65559460|NCT01289743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65559461|NCT01289743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65559462|NCT01289743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65559463|NCT01289743|Immunologic Factors|immunologic factors|mesh-ancestor
65559464|NCT03390426|Anesthetics|anesthetics|mesh-list
65559465|NCT03390426|Mepivacaine|mepivacaine|mesh-list
65559466|NCT03390426|Anesthetics, Local|anesthetics, local|mesh-list
65559467|NCT03390426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65559468|NCT03390426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559469|NCT03390426|Sensory System Agents|sensory system agents|mesh-ancestor
65559470|NCT03390426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559471|NCT03472521|Gabapentin|gabapentin|mesh-list
65559472|NCT03472521|Analgesics|analgesics|mesh-ancestor
65559473|NCT03472521|Sensory System Agents|sensory system agents|mesh-ancestor
65559474|NCT03472521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559475|NCT03472521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559476|NCT03472521|Anticonvulsants|anticonvulsants|mesh-ancestor
65559477|NCT03472521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65559478|NCT03472521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65559479|NCT03472521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65559480|NCT03472521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65559481|NCT03472521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65559482|NCT03472521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65559483|NCT03472521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65559484|NCT03472521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559485|NCT03472521|Antimanic Agents|antimanic agents|mesh-ancestor
65559486|NCT01177423|Anesthetics|anesthetics|mesh-list
65559487|NCT01177423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65559488|NCT01177423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559489|NCT01180231|Moxonidine|moxonidine|mesh-list
65559490|NCT01180231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65559491|NCT01177501|Topotecan|topotecan|mesh-list
65559492|NCT01177501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65559493|NCT01177501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65559494|NCT01177501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65559495|NCT01177501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559496|NCT01177501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559497|NCT03478150|Zinc Oxide|zinc oxide|mesh-list
65559498|NCT03478150|Dermatologic Agents|dermatologic agents|mesh-ancestor
65559499|NCT03478150|Sunscreening Agents|sunscreening agents|mesh-ancestor
65559500|NCT03478150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65559501|NCT03478150|Protective Agents|protective agents|mesh-ancestor
65559502|NCT03478150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559503|NCT03499353|Talazoparib|talazoparib|mesh-list
65559504|NCT03499353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65559505|NCT03499353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65559506|NCT03499353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559507|NCT03499353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559508|NCT03368664|Interferons|interferons|mesh-list
65559509|NCT03368664|Acyclovir|acyclovir|mesh-list
65559510|NCT03368664|Interferon-beta|interferon-beta|mesh-list
65559511|NCT03368664|Methylprednisolone|methylprednisolone|mesh-list
65559512|NCT03368664|Prednisolone|prednisolone|mesh-list
65559513|NCT03368664|Alemtuzumab|alemtuzumab|mesh-list
65559514|NCT03368664|Glatiramer Acetate|glatiramer acetate|mesh-list
65559515|NCT03368664|Ranitidine|ranitidine|mesh-list
65559516|NCT03368664|(T,G)-A-L|(t,g)-a-l|mesh-list
65559517|NCT03368664|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
65559518|NCT03368664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559519|NCT03368664|Antiviral Agents|antiviral agents|mesh-ancestor
65559520|NCT03368664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65559521|NCT03368664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65559522|NCT03368664|Antiemetics|antiemetics|mesh-ancestor
65559523|NCT03368664|Autonomic Agents|autonomic agents|mesh-ancestor
65559524|NCT03368664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559525|NCT03368664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559526|NCT03368664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65559527|NCT03368664|Glucocorticoids|glucocorticoids|mesh-ancestor
65559528|NCT03368664|Hormones|hormones|mesh-ancestor
65559529|NCT03368664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65559530|NCT03368664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65559531|NCT03368664|Protective Agents|protective agents|mesh-ancestor
65559532|NCT03368664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65559533|NCT03368664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65559534|NCT03368664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65559535|NCT03368664|Immunologic Factors|immunologic factors|mesh-ancestor
65559536|NCT03368664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65559537|NCT03368664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65559538|NCT03368664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65559539|NCT03368664|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65559540|NCT03368664|Histamine Antagonists|histamine antagonists|mesh-ancestor
65559541|NCT03368664|Histamine Agents|histamine agents|mesh-ancestor
65559542|NCT03368664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65559543|NCT03368664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559544|NCT03368664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65559545|NCT00004259|Carmustine|carmustine|mesh-list
65559546|NCT00004259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65559547|NCT00004259|Alkylating Agents|alkylating agents|mesh-ancestor
65559548|NCT00004259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559549|NCT00004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559550|NCT01177579|Copper|copper|mesh-list
65559551|NCT01177579|Trace Elements|trace elements|mesh-ancestor
65559552|NCT01177579|Micronutrients|micronutrients|mesh-ancestor
65559553|NCT01177579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559554|NCT03722355|Carmustine|carmustine|mesh-list
65559555|NCT03722355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65559556|NCT03722355|Alkylating Agents|alkylating agents|mesh-ancestor
65559557|NCT03722355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559558|NCT03722355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559559|NCT03857815|Antibodies|antibodies|mesh-list
65559560|NCT03857815|Immunologic Factors|immunologic factors|mesh-ancestor
65559561|NCT03857815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559562|NCT03365934|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65559563|NCT03365934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65559564|NCT04682405|Melphalan|melphalan|mesh-list
65559565|NCT04682405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65559566|NCT04682405|Alkylating Agents|alkylating agents|mesh-ancestor
65559567|NCT04682405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559568|NCT04682405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559569|NCT04682405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65559570|NCT04682405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65559571|NCT04682405|Immunologic Factors|immunologic factors|mesh-ancestor
65559572|NCT04682405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559573|NCT03477994|Clonidine|clonidine|mesh-list
65559574|NCT03477994|Dexmedetomidine|dexmedetomidine|mesh-list
65559575|NCT03477994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65559576|NCT03477994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65288695|NCT02747537|Irinotecan|irinotecan|mesh-list
65559577|NCT03477994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559578|NCT03477994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65559579|NCT03477994|Analgesics|analgesics|mesh-ancestor
65559580|NCT03477994|Sensory System Agents|sensory system agents|mesh-ancestor
65559581|NCT03477994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559582|NCT03477994|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65559583|NCT03477994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65559584|NCT03477994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65559585|NCT03477994|Adrenergic Agents|adrenergic agents|mesh-ancestor
65559586|NCT03477994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65559587|NCT03477994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559588|NCT03477994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65559589|NCT03477994|Sympatholytics|sympatholytics|mesh-ancestor
65559590|NCT03477994|Autonomic Agents|autonomic agents|mesh-ancestor
65559591|NCT04668131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65559592|NCT04668131|Lubricant Eye Drops|lubricant eye drops|mesh-list
65559593|NCT04668131|Hyaluronic Acid|hyaluronic acid|mesh-list
65559594|NCT04668131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65559595|NCT04668131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65559596|NCT04668131|Immunologic Factors|immunologic factors|mesh-ancestor
65559597|NCT04668131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559598|NCT04668131|Viscosupplements|viscosupplements|mesh-ancestor
65559599|NCT04668131|Protective Agents|protective agents|mesh-ancestor
65559600|NCT03857581|Olanzapine|olanzapine|mesh-list
65559601|NCT03857581|Clozapine|clozapine|mesh-list
65559602|NCT03857581|Antiemetics|antiemetics|mesh-ancestor
65559603|NCT03857581|Autonomic Agents|autonomic agents|mesh-ancestor
65559604|NCT03857581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559605|NCT03857581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559606|NCT03857581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65559607|NCT03857581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65559608|NCT03857581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65559609|NCT03857581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65559610|NCT03857581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65357121|NCT00979966|Sirolimus|sirolimus|mesh-list
65559611|NCT03857581|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65559612|NCT03857581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65559613|NCT03857581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65559614|NCT03857581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559615|NCT03857581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65559616|NCT03857581|Serotonin Agents|serotonin agents|mesh-ancestor
65559617|NCT03857581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65559618|NCT03857581|GABA Antagonists|gaba antagonists|mesh-ancestor
65559619|NCT03857581|GABA Agents|gaba agents|mesh-ancestor
65559620|NCT01103843|Clopidogrel|clopidogrel|mesh-list
65559621|NCT01103843|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65559622|NCT01103843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65559623|NCT01103843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65559624|NCT01103843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65559625|NCT01103843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65559626|NCT01103843|Purinergic Agents|purinergic agents|mesh-ancestor
65559627|NCT01103843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65559628|NCT01103843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559629|NCT01103843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559630|NCT03738865|Glucagon|glucagon|mesh-list
65559631|NCT03738865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65559632|NCT03738865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65559633|NCT03738865|Hormones|hormones|mesh-ancestor
65559634|NCT03738865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65559635|NCT03738865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559636|NCT03738865|Incretins|incretins|mesh-ancestor
65559637|NCT03524157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65559638|NCT03524157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65559639|NCT03524157|Hyaluronic Acid|hyaluronic acid|mesh-list
65559640|NCT03524157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65559641|NCT03524157|Immunologic Factors|immunologic factors|mesh-ancestor
65559642|NCT03524157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559643|NCT03524157|Viscosupplements|viscosupplements|mesh-ancestor
65559644|NCT03524157|Protective Agents|protective agents|mesh-ancestor
65559645|NCT03719391|Nicotine|nicotine|mesh-list
65559646|NCT03719391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65559647|NCT03719391|Autonomic Agents|autonomic agents|mesh-ancestor
65559648|NCT03719391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559649|NCT03719391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559650|NCT03719391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65559651|NCT03719391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65559652|NCT03719391|Cholinergic Agents|cholinergic agents|mesh-ancestor
65559653|NCT03719391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65559654|NCT03719391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559655|NCT03468543|Memantine|memantine|mesh-list
65559656|NCT03468543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65559657|NCT03468543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65559658|NCT03468543|Dopamine Agents|dopamine agents|mesh-ancestor
65559659|NCT03468543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65559660|NCT03468543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559661|NCT03468543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559662|NCT03468543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65559663|NCT03468543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65559664|NCT03467763|Metformin|metformin|mesh-list
65559665|NCT03467763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65559666|NCT03467763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559667|NCT00004031|Prednisone|prednisone|mesh-list
65559668|NCT00004031|Cyclophosphamide|cyclophosphamide|mesh-list
65559669|NCT00004031|Carmustine|carmustine|mesh-list
65559670|NCT00004031|Rituximab|rituximab|mesh-list
65559671|NCT00004031|Doxorubicin|doxorubicin|mesh-list
65559672|NCT00004031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65559673|NCT00004031|Etoposide|etoposide|mesh-list
65559674|NCT00004031|Vincristine|vincristine|mesh-list
65559675|NCT00004031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65559676|NCT00004031|Immunologic Factors|immunologic factors|mesh-ancestor
65559677|NCT00004031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559678|NCT00004031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65559679|NCT00004031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65559680|NCT00004031|Alkylating Agents|alkylating agents|mesh-ancestor
65559681|NCT00004031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559682|NCT00004031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559683|NCT00004031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65559684|NCT00004031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65559685|NCT00004031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65559686|NCT00004031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65559687|NCT00004031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65559688|NCT00004031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65559689|NCT00004031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65559690|NCT00004031|Glucocorticoids|glucocorticoids|mesh-ancestor
65559692|NCT00004031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65559693|NCT00004031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65559694|NCT00004031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65559695|NCT00004031|Tubulin Modulators|tubulin modulators|mesh-ancestor
65559696|NCT00004031|Antimitotic Agents|antimitotic agents|mesh-ancestor
65559697|NCT00004031|Mitosis Modulators|mitosis modulators|mesh-ancestor
65559698|NCT01184443|Olanzapine|olanzapine|mesh-list
65559699|NCT01184443|Antiemetics|antiemetics|mesh-ancestor
65559700|NCT01184443|Autonomic Agents|autonomic agents|mesh-ancestor
65559701|NCT01184443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559702|NCT01184443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559703|NCT01184443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65559704|NCT01184443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65559705|NCT01184443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65559706|NCT01184443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65559707|NCT01184443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65559708|NCT01184443|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65559709|NCT01184443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65559710|NCT01184443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65559711|NCT01184443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559712|NCT01184443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65559713|NCT01184443|Serotonin Agents|serotonin agents|mesh-ancestor
65559714|NCT01180621|Vaccines|vaccines|mesh-list
65559715|NCT01180621|Immunologic Factors|immunologic factors|mesh-ancestor
65559716|NCT01180621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559717|NCT01290133|Vestipitant|vestipitant|mesh-list
65559718|NCT01290133|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65559719|NCT01290133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65559720|NCT01290133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559721|NCT01290133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559722|NCT03467217|Losartan|losartan|mesh-list
65559723|NCT03467217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65559724|NCT03467217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65559725|NCT03467217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65559726|NCT03467217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65559727|NCT03467217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559728|NCT00003875|Aldesleukin|aldesleukin|mesh-list
65559729|NCT00003875|Etoposide|etoposide|mesh-list
65559730|NCT00003875|Etoposide phosphate|etoposide phosphate|mesh-list
65559731|NCT00003875|Busulfan|busulfan|mesh-list
65559732|NCT00003875|Interleukin-2|interleukin-2|mesh-list
65559733|NCT00003875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65559734|NCT00003875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559735|NCT00003875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65559736|NCT00003875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65559737|NCT00003875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65559738|NCT00003875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559739|NCT00003875|Alkylating Agents|alkylating agents|mesh-ancestor
65559740|NCT00003875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65559741|NCT00003875|Immunologic Factors|immunologic factors|mesh-ancestor
65559742|NCT00003875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559743|NCT00003875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65559744|NCT00003875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65559745|NCT00003875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65559746|NCT00003875|Analgesics|analgesics|mesh-ancestor
65559747|NCT00003875|Sensory System Agents|sensory system agents|mesh-ancestor
65559748|NCT00003875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559749|NCT00003875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65559750|NCT00003875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65559751|NCT00003875|Antiviral Agents|antiviral agents|mesh-ancestor
65559752|NCT00003875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65559753|NCT01327625|Azithromycin|azithromycin|mesh-list
65559754|NCT01327625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65559755|NCT01327625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65559756|NCT01290211|Ritonavir|ritonavir|mesh-list
65559757|NCT01290211|Fosamprenavir|fosamprenavir|mesh-list
65559758|NCT01290211|Maraviroc|maraviroc|mesh-list
65559759|NCT01290211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65559760|NCT01290211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65357271|NCT00970450|Acetaminophen|acetaminophen|mesh-list
65559761|NCT01290211|Protease Inhibitors|protease inhibitors|mesh-ancestor
65559762|NCT01290211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65559763|NCT01290211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559764|NCT01290211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65559765|NCT01290211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65559766|NCT01290211|Antiviral Agents|antiviral agents|mesh-ancestor
65559767|NCT01290211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65559768|NCT01290211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65559769|NCT01290211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65559770|NCT01290211|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65559771|NCT01290211|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65559772|NCT01290211|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65559773|NCT03720873|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65559774|NCT03720873|Gefitinib|gefitinib|mesh-list
65559775|NCT03720873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559776|NCT03720873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65559777|NCT03720873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65559778|NCT03720873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559779|NCT04633889|Deferoxamine|deferoxamine|mesh-list
65559780|NCT04633889|Siderophores|siderophores|mesh-ancestor
65559781|NCT04633889|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65559782|NCT04633889|Chelating Agents|chelating agents|mesh-ancestor
65559783|NCT04633889|Sequestering Agents|sequestering agents|mesh-ancestor
65559784|NCT04633889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559785|NCT01311960|Bevacizumab|bevacizumab|mesh-list
65559786|NCT01311960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65559787|NCT01311960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65559788|NCT01311960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559789|NCT01311960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65559790|NCT01311960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65559791|NCT01311960|Growth Substances|growth substances|mesh-ancestor
65559792|NCT01311960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559793|NCT01311960|Growth Inhibitors|growth inhibitors|mesh-ancestor
65559794|NCT01311960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65559795|NCT03709056|Propofol|propofol|mesh-list
65559796|NCT03709056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65559797|NCT03709056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65559798|NCT03709056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559799|NCT03709056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65559800|NCT03709056|Anesthetics, General|anesthetics, general|mesh-ancestor
65559801|NCT03709056|Anesthetics|anesthetics|mesh-ancestor
65559802|NCT05663307|Aspirin|aspirin|mesh-list
65559803|NCT05663307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65559804|NCT05663307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65559805|NCT05663307|Analgesics|analgesics|mesh-ancestor
65559806|NCT05663307|Sensory System Agents|sensory system agents|mesh-ancestor
65559807|NCT05663307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559808|NCT05663307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559809|NCT05663307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65559810|NCT05663307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65559811|NCT05663307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65559812|NCT05663307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65559813|NCT05663307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559814|NCT05663307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65559815|NCT05663307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65559816|NCT05663307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65559817|NCT05663307|Antipyretics|antipyretics|mesh-ancestor
65559818|NCT01106495|Simvastatin|simvastatin|mesh-list
65559819|NCT01106495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65559820|NCT01106495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65559821|NCT01106495|Antimetabolites|antimetabolites|mesh-ancestor
65559822|NCT01106495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559823|NCT01106495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65559824|NCT01106495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65559825|NCT01106495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65559826|NCT01184833|Interferons|interferons|mesh-list
65559827|NCT01184833|Interferon-beta|interferon-beta|mesh-list
65559828|NCT01184833|Interferon beta-1b|interferon beta-1b|mesh-list
65559829|NCT01184833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559830|NCT01184833|Antiviral Agents|antiviral agents|mesh-ancestor
65559831|NCT01184833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65559832|NCT01184833|Immunologic Factors|immunologic factors|mesh-ancestor
65559833|NCT01184833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559834|NCT01184833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65357357|NCT00970996|Interferons|interferons|mesh-list
65559835|NCT01184911|Pyrimethamine|pyrimethamine|mesh-list
65559836|NCT01184911|Sulfadoxine|sulfadoxine|mesh-list
65559837|NCT01184911|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65559838|NCT01184911|Antimalarials|antimalarials|mesh-ancestor
65559839|NCT01184911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65559840|NCT01184911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65559841|NCT01184911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65559842|NCT01184911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65559843|NCT01184911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65559844|NCT01184911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559845|NCT01184911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65559846|NCT01184911|Renal Agents|renal agents|mesh-ancestor
65559847|NCT01185067|Grape Seed Extract|grape seed extract|mesh-list
65559848|NCT01185067|Resveratrol|resveratrol|mesh-list
65559849|NCT01185067|Antioxidants|antioxidants|mesh-list
65559850|NCT01185067|Quercetin|quercetin|mesh-list
65559851|NCT01185067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559852|NCT01185067|Protective Agents|protective agents|mesh-ancestor
65559853|NCT01185067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559854|NCT01185067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65559855|NCT01185067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65559856|NCT01185067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65559857|NCT01185067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559858|NCT03364686|Biotin|biotin|mesh-list
65559859|NCT03364686|Vitamin B Complex|vitamin b complex|mesh-ancestor
65559860|NCT03364686|Vitamins|vitamins|mesh-ancestor
65559861|NCT03364686|Micronutrients|micronutrients|mesh-ancestor
65559862|NCT03364686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559863|NCT03437577|Tacrolimus|tacrolimus|mesh-list
65559864|NCT03437577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65559865|NCT03437577|Immunologic Factors|immunologic factors|mesh-ancestor
65559866|NCT03437577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559867|NCT03437577|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65559868|NCT03437577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65559869|NCT03437577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559870|NCT03336528|Insulin Glargine|insulin glargine|mesh-list
65559871|NCT03336528|Insulin Aspart|insulin aspart|mesh-list
65559872|NCT03336528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65559873|NCT03336528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559874|NCT03364608|Albuterol|albuterol|mesh-list
65559875|NCT03364608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65559876|NCT03364608|Autonomic Agents|autonomic agents|mesh-ancestor
65559877|NCT03364608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559878|NCT03364608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559879|NCT03364608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65559880|NCT03364608|Respiratory System Agents|respiratory system agents|mesh-ancestor
65559881|NCT03364608|Tocolytic Agents|tocolytic agents|mesh-ancestor
65559882|NCT03364608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65559883|NCT03364608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65559884|NCT03364608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65559885|NCT03364608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65559886|NCT03364608|Adrenergic Agents|adrenergic agents|mesh-ancestor
65559887|NCT03364608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65559888|NCT03364608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559889|NCT03719157|Anesthetics|anesthetics|mesh-list
65559890|NCT03719157|Anesthetics, Local|anesthetics, local|mesh-list
65559891|NCT03719157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65559892|NCT03719157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559893|NCT03719157|Sensory System Agents|sensory system agents|mesh-ancestor
65559894|NCT03719157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65559895|NCT01185223|Valganciclovir|valganciclovir|mesh-list
65559896|NCT01185223|Ganciclovir|ganciclovir|mesh-list
65559897|NCT01185223|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65559898|NCT01185223|Antiviral Agents|antiviral agents|mesh-ancestor
65559899|NCT01185223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65559900|NCT01185223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65559901|NCT01185223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65559902|NCT01185223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559903|NCT03852979|Paclitaxel|paclitaxel|mesh-list
65559904|NCT03852979|Carboplatin|carboplatin|mesh-list
65559905|NCT03852979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65559906|NCT03852979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559907|NCT03852979|Tubulin Modulators|tubulin modulators|mesh-ancestor
65559908|NCT03852979|Antimitotic Agents|antimitotic agents|mesh-ancestor
65559909|NCT03852979|Mitosis Modulators|mitosis modulators|mesh-ancestor
65559910|NCT03852979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559912|NCT01188031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65559913|NCT01188031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65559914|NCT01188031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559915|NCT01188031|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65559916|NCT01188031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65559917|NCT01188031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65559918|NCT01188031|GABA Modulators|gaba modulators|mesh-ancestor
65559919|NCT01188031|GABA Agents|gaba agents|mesh-ancestor
65559920|NCT01188031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65559921|NCT01188031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559922|NCT01182883|Sirolimus|sirolimus|mesh-list
65559923|NCT01182883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65559924|NCT01182883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65559925|NCT01182883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65559926|NCT01182883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559927|NCT01182883|Antifungal Agents|antifungal agents|mesh-ancestor
65559928|NCT01182883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65559929|NCT01182883|Immunologic Factors|immunologic factors|mesh-ancestor
65559930|NCT01182883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559931|NCT01188265|Valproic Acid|valproic acid|mesh-list
65559932|NCT01188265|Dextromethorphan|dextromethorphan|mesh-list
65559933|NCT01188265|Antitussive Agents|antitussive agents|mesh-ancestor
65559934|NCT01188265|Respiratory System Agents|respiratory system agents|mesh-ancestor
65559935|NCT01188265|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65559936|NCT01188265|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65559937|NCT01188265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65559938|NCT01188265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559939|NCT01188265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559940|NCT01188265|Anticonvulsants|anticonvulsants|mesh-ancestor
65559941|NCT01188265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65559942|NCT01188265|GABA Agents|gaba agents|mesh-ancestor
65559943|NCT01188265|Antimanic Agents|antimanic agents|mesh-ancestor
65559944|NCT01188265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65559945|NCT01188265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65559946|NCT01188265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65559947|NCT01291069|Tadalafil|tadalafil|mesh-list
65559948|NCT01291069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559949|NCT01291069|Vasodilator Agents|vasodilator agents|mesh-ancestor
65559950|NCT01291069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65559951|NCT01291069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65559952|NCT01291069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65559953|NCT01291069|Urological Agents|urological agents|mesh-ancestor
65559954|NCT00003869|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
65559955|NCT00003869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559956|NCT00003869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65559957|NCT00003869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65559958|NCT00003869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559959|NCT00003869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65559960|NCT00003869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559961|NCT01588639|Insulin|insulin|mesh-list
65559962|NCT01588639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65559963|NCT01588639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65559964|NCT01588639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559965|NCT02524639|Sirolimus|sirolimus|mesh-list
65559966|NCT02524639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65559967|NCT02524639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65559968|NCT02524639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65559969|NCT02524639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559970|NCT02524639|Antifungal Agents|antifungal agents|mesh-ancestor
65559971|NCT02524639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65559972|NCT02524639|Immunologic Factors|immunologic factors|mesh-ancestor
65559973|NCT02524639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559974|NCT01185535|Anesthetics|anesthetics|mesh-list
65559975|NCT01185535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65559976|NCT01185535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65559977|NCT00003659|Cyclophosphamide|cyclophosphamide|mesh-list
65559978|NCT00003659|Rituximab|rituximab|mesh-list
65559979|NCT00003659|Fludarabine|fludarabine|mesh-list
65559980|NCT00003659|Fludarabine phosphate|fludarabine phosphate|mesh-list
65559981|NCT00003659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65559982|NCT00003659|Immunologic Factors|immunologic factors|mesh-ancestor
65559983|NCT00003659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357498|NCT04008784|Triamcinolone|triamcinolone|mesh-list
65559984|NCT00003659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65559985|NCT00003659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65559987|NCT00003659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65559988|NCT00003659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559989|NCT00003659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65559990|NCT00003659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65559991|NCT00003659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65559992|NCT00003659|Antimetabolites|antimetabolites|mesh-ancestor
65559993|NCT01101581|Epratuzumab|epratuzumab|mesh-list
65559994|NCT01101581|Veltuzumab|veltuzumab|mesh-list
65559995|NCT01101581|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
65559996|NCT01101581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65559997|NCT01101581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65559998|NCT01101581|Chelating Agents|chelating agents|mesh-ancestor
65559999|NCT01101581|Sequestering Agents|sequestering agents|mesh-ancestor
65560000|NCT01101581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560001|NCT01183585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65560002|NCT01183585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65560003|NCT01183585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65560004|NCT01183585|Antimetabolites|antimetabolites|mesh-ancestor
65560005|NCT01183585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560006|NCT01183585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65560007|NCT01183585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65560008|NCT01183585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560009|NCT03494985|Muramidase|muramidase|mesh-list
65560010|NCT03494985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65560011|NCT01185769|Tocotrienols|tocotrienols|mesh-list
65560012|NCT01185769|Vitamin E|vitamin e|mesh-list
65560013|NCT01185769|Tocopherols|tocopherols|mesh-list
65560014|NCT01185769|Antioxidants|antioxidants|mesh-ancestor
65560015|NCT01185769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560016|NCT01185769|Protective Agents|protective agents|mesh-ancestor
65560017|NCT01185769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560018|NCT01185769|Vitamins|vitamins|mesh-ancestor
65560019|NCT01185769|Micronutrients|micronutrients|mesh-ancestor
65560020|NCT01185847|Gemcitabine|gemcitabine|mesh-list
65560021|NCT01185847|Pemetrexed|pemetrexed|mesh-list
65560022|NCT01185847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560023|NCT01185847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65560024|NCT01185847|Antimetabolites|antimetabolites|mesh-ancestor
65560025|NCT01185847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560026|NCT01185847|Antiviral Agents|antiviral agents|mesh-ancestor
65560027|NCT01185847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65560028|NCT01185847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560029|NCT01185847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65560030|NCT01185847|Immunologic Factors|immunologic factors|mesh-ancestor
65560031|NCT01185847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560032|NCT01185847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65560033|NCT01185847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65560034|NCT03720483|Acetylcysteine|acetylcysteine|mesh-list
65560035|NCT03720483|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65560036|NCT03720483|Antiviral Agents|antiviral agents|mesh-ancestor
65560037|NCT03720483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65560038|NCT03720483|Expectorants|expectorants|mesh-ancestor
65560039|NCT03720483|Respiratory System Agents|respiratory system agents|mesh-ancestor
65560040|NCT03720483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65560041|NCT03720483|Antioxidants|antioxidants|mesh-ancestor
65560042|NCT03720483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560043|NCT03720483|Protective Agents|protective agents|mesh-ancestor
65560044|NCT03720483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560045|NCT03720483|Antidotes|antidotes|mesh-ancestor
65560046|NCT01183663|Leucovorin|leucovorin|mesh-list
65560047|NCT01183663|Sirolimus|sirolimus|mesh-list
65560048|NCT01183663|Bevacizumab|bevacizumab|mesh-list
65560049|NCT01183663|Lenalidomide|lenalidomide|mesh-list
65560050|NCT01183663|Fluorouracil|fluorouracil|mesh-list
65560051|NCT01183663|Oxaliplatin|oxaliplatin|mesh-list
65560052|NCT01183663|Sorafenib|sorafenib|mesh-list
65560053|NCT01183663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65560054|NCT01183663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560055|NCT01183663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65560056|NCT01183663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65560057|NCT01183663|Growth Substances|growth substances|mesh-ancestor
65560058|NCT01183663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560059|NCT01183663|Growth Inhibitors|growth inhibitors|mesh-ancestor
65560060|NCT01183663|Antimetabolites|antimetabolites|mesh-ancestor
65560061|NCT01183663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560062|NCT01183663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65560063|NCT01183663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65560064|NCT01183663|Immunologic Factors|immunologic factors|mesh-ancestor
65560065|NCT01183663|Antidotes|antidotes|mesh-ancestor
65560066|NCT01183663|Protective Agents|protective agents|mesh-ancestor
65560067|NCT01183663|Vitamin B Complex|vitamin b complex|mesh-ancestor
65560068|NCT01183663|Vitamins|vitamins|mesh-ancestor
65560069|NCT01183663|Micronutrients|micronutrients|mesh-ancestor
65560070|NCT01183663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65560071|NCT01183663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560072|NCT01183663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65560073|NCT01183663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65560074|NCT01183663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65560075|NCT01183663|Antifungal Agents|antifungal agents|mesh-ancestor
65560076|NCT01291927|Pancrelipase|pancrelipase|mesh-list
65560077|NCT01291927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65560078|NCT03344172|Gemcitabine|gemcitabine|mesh-list
65560079|NCT03344172|Hydroxychloroquine|hydroxychloroquine|mesh-list
65560080|NCT03344172|Paclitaxel|paclitaxel|mesh-list
65560081|NCT03344172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65560082|NCT03344172|Avelumab|avelumab|mesh-list
65560083|NCT03344172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65560084|NCT03344172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560085|NCT03344172|Tubulin Modulators|tubulin modulators|mesh-ancestor
65560086|NCT03344172|Antimitotic Agents|antimitotic agents|mesh-ancestor
65560087|NCT03344172|Mitosis Modulators|mitosis modulators|mesh-ancestor
65560088|NCT03344172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560089|NCT03344172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65560090|NCT03344172|Antimetabolites|antimetabolites|mesh-ancestor
65560091|NCT03344172|Antiviral Agents|antiviral agents|mesh-ancestor
65560092|NCT03344172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65560093|NCT03344172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560094|NCT03344172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65560095|NCT03344172|Immunologic Factors|immunologic factors|mesh-ancestor
65560096|NCT03344172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560097|NCT03344172|Antimalarials|antimalarials|mesh-ancestor
65560098|NCT03344172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65560099|NCT03344172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65560100|NCT03344172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65560101|NCT03344172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65560102|NCT01188733|Octreotide|octreotide|mesh-list
65560103|NCT01188733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65560104|NCT01188733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65560105|NCT01188733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560106|NCT01101659|Ketamine|ketamine|mesh-list
65560107|NCT01101659|Analgesics|analgesics|mesh-ancestor
65560108|NCT01101659|Sensory System Agents|sensory system agents|mesh-ancestor
65560109|NCT01101659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65560110|NCT01101659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560111|NCT01101659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65560112|NCT01101659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65560113|NCT01101659|Anesthetics, General|anesthetics, general|mesh-ancestor
65560114|NCT01101659|Anesthetics|anesthetics|mesh-ancestor
65560115|NCT01101659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65560116|NCT01101659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65560117|NCT01101659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65560118|NCT01101659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65560119|NCT01101659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560120|NCT03855865|Vortioxetine|vortioxetine|mesh-list
65560121|NCT03855865|Antidepressive Agents|antidepressive agents|mesh-ancestor
65560122|NCT03855865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65560123|NCT03855865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65560124|NCT03855865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65560125|NCT03855865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65560126|NCT03855865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560127|NCT03855865|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65560128|NCT03855865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65560129|NCT03855865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65560130|NCT03855865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560131|NCT03855865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65560132|NCT03855865|Serotonin Agents|serotonin agents|mesh-ancestor
65560133|NCT03855865|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65357643|NCT00367237|Abortifacient Agents|abortifacient agents|mesh-ancestor
65560134|NCT03855865|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65560135|NCT03855865|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65560136|NCT03855865|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65560137|NCT01290367|Hyaluronic Acid|hyaluronic acid|mesh-list
65560138|NCT01290367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65560139|NCT01290367|Immunologic Factors|immunologic factors|mesh-ancestor
65560140|NCT01290367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560141|NCT01290367|Viscosupplements|viscosupplements|mesh-ancestor
65560142|NCT01290367|Protective Agents|protective agents|mesh-ancestor
65560143|NCT03465891|Atezolizumab|atezolizumab|mesh-list
65560144|NCT03465891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560145|NCT03363906|Dulaglutide|dulaglutide|mesh-list
65560146|NCT03363906|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
65560147|NCT03363906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65560148|NCT03363906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560149|NCT03363906|Immunologic Factors|immunologic factors|mesh-ancestor
65560150|NCT03948191|Methylene diphosphonate|methylene diphosphonate|mesh-list
65560151|NCT03948191|Methylprednisolone|methylprednisolone|mesh-list
65560152|NCT03948191|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65560153|NCT03948191|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65560154|NCT03948191|Prednisolone|prednisolone|mesh-list
65560155|NCT03948191|Prednisolone acetate|prednisolone acetate|mesh-list
65560156|NCT03948191|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65560157|NCT03948191|Prednisolone phosphate|prednisolone phosphate|mesh-list
65560158|NCT03948191|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
65560159|NCT03948191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65560160|NCT03948191|Antiemetics|antiemetics|mesh-ancestor
65560161|NCT03948191|Autonomic Agents|autonomic agents|mesh-ancestor
65560162|NCT03948191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65560163|NCT03948191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560164|NCT03948191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65560165|NCT03948191|Glucocorticoids|glucocorticoids|mesh-ancestor
65560167|NCT03948191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65560168|NCT03948191|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65560169|NCT03948191|Protective Agents|protective agents|mesh-ancestor
65560170|NCT03948191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65560171|NCT03948191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560172|NCT03948191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65560173|NCT03948191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65560174|NCT03948191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560175|NCT01292083|Azacitidine|azacitidine|mesh-list
65560176|NCT01292083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65560177|NCT01292083|Antimetabolites|antimetabolites|mesh-ancestor
65560178|NCT01292083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560179|NCT01292083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560180|NCT01292083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560181|NCT01104467|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
65560182|NCT01104467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65560183|NCT01104467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65560184|NCT01104467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560185|NCT01292161|Silymarin|silymarin|mesh-list
65560186|NCT01292161|Antioxidants|antioxidants|mesh-ancestor
65560187|NCT01292161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560188|NCT01292161|Protective Agents|protective agents|mesh-ancestor
65560189|NCT01292161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560190|NCT01185925|Sildenafil Citrate|sildenafil citrate|mesh-list
65560191|NCT01185925|Vasodilator Agents|vasodilator agents|mesh-ancestor
65560192|NCT01185925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65560193|NCT01185925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65560194|NCT01185925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560195|NCT01185925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560196|NCT01185925|Urological Agents|urological agents|mesh-ancestor
65560197|NCT01188889|Imatinib Mesylate|imatinib mesylate|mesh-list
65560198|NCT01188889|Everolimus|everolimus|mesh-list
65560199|NCT01188889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560200|NCT01188889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65560201|NCT01188889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560202|NCT01188889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560203|NCT01188889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65560204|NCT01188889|Immunologic Factors|immunologic factors|mesh-ancestor
65560205|NCT01188889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560206|NCT01184287|Ranpirnase|ranpirnase|mesh-list
65560207|NCT01184287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357724|NCT00544882|Progestins|progestins|mesh-ancestor
65560208|NCT01184287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65560209|NCT01184287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560210|NCT01184287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560211|NCT01107431|Chromium|chromium|mesh-list
65560212|NCT01107431|Trace Elements|trace elements|mesh-ancestor
65560213|NCT01107431|Micronutrients|micronutrients|mesh-ancestor
65560214|NCT01107431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560215|NCT01186159|Parecoxib|parecoxib|mesh-list
65560216|NCT01186159|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65560217|NCT01186159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65560218|NCT01186159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560219|NCT01186159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560220|NCT01186159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65560221|NCT01186159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65560222|NCT01186159|Analgesics|analgesics|mesh-ancestor
65560223|NCT01186159|Sensory System Agents|sensory system agents|mesh-ancestor
65560224|NCT01186159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65560225|NCT01186159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560226|NCT01186159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65560227|NCT01186159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65560228|NCT01107509|Everolimus|everolimus|mesh-list
65560229|NCT01107509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560230|NCT01107509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65560231|NCT01107509|Immunologic Factors|immunologic factors|mesh-ancestor
65560232|NCT01107509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560233|NCT01101815|Naltrexone|naltrexone|mesh-list
65560234|NCT01101815|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65560235|NCT01101815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65560236|NCT01101815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560237|NCT01101815|Sensory System Agents|sensory system agents|mesh-ancestor
65560238|NCT01101815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65560239|NCT01104935|Trastuzumab|trastuzumab|mesh-list
65560240|NCT01104935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65560241|NCT01104935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560242|NCT01293643|Clindamycin|clindamycin|mesh-list
65560243|NCT01293643|Clindamycin palmitate|clindamycin palmitate|mesh-list
65560244|NCT01293643|Clindamycin phosphate|clindamycin phosphate|mesh-list
65560245|NCT01293643|Amphotericin B|amphotericin b|mesh-list
65560246|NCT01293643|Tetracycline|tetracycline|mesh-list
65560247|NCT01293643|Ketoconazole|ketoconazole|mesh-list
65560248|NCT01293643|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65560249|NCT01293643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65560250|NCT01293643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65560251|NCT01293643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65560252|NCT01293643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560253|NCT01293643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560254|NCT01293643|Antifungal Agents|antifungal agents|mesh-ancestor
65560255|NCT01293643|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65560256|NCT01293643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65560257|NCT01293643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65560258|NCT01293643|Hormone Antagonists|hormone antagonists|mesh-ancestor
65560259|NCT01293643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65560260|NCT01293643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560261|NCT01293643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65560262|NCT01293643|Amebicides|amebicides|mesh-ancestor
65560263|NCT01293643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65560264|NCT01293643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65560265|NCT01105013|Clotrimazole|clotrimazole|mesh-list
65560266|NCT01105013|Miconazole|miconazole|mesh-list
65560267|NCT01105013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65560268|NCT01105013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65560269|NCT01105013|Antifungal Agents|antifungal agents|mesh-ancestor
65560270|NCT01105013|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65560271|NCT01105013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65560272|NCT01105013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560273|NCT01105013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560274|NCT01105013|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65560275|NCT01105013|Hormone Antagonists|hormone antagonists|mesh-ancestor
65560276|NCT01105013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65560277|NCT01105013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560278|NCT01105013|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65560279|NCT01105013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65357791|NCT00985270|Leprostatic Agents|leprostatic agents|mesh-ancestor
65560280|NCT03851731|Naltrexone|naltrexone|mesh-list
65560281|NCT03851731|Naloxone|naloxone|mesh-list
65560282|NCT03851731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65560283|NCT03851731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65560284|NCT03851731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560285|NCT03851731|Sensory System Agents|sensory system agents|mesh-ancestor
65560286|NCT03851731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65560287|NCT03707652|Vitamins|vitamins|mesh-list
65560288|NCT03707652|Niacinamide|niacinamide|mesh-list
65560289|NCT03707652|Niacin|niacin|mesh-list
65560290|NCT03707652|Nicotinic Acids|nicotinic acids|mesh-list
65560291|NCT03707652|Vitamin B Complex|vitamin b complex|mesh-list
65560292|NCT03707652|Micronutrients|micronutrients|mesh-ancestor
65560293|NCT03707652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560294|NCT03707652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65560295|NCT03707652|Antimetabolites|antimetabolites|mesh-ancestor
65560296|NCT03707652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560297|NCT03707652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65560298|NCT03707652|Vasodilator Agents|vasodilator agents|mesh-ancestor
65560299|NCT01588093|Mecasermin|mecasermin|mesh-list
65560300|NCT01588093|Growth Substances|growth substances|mesh-ancestor
65560301|NCT01588093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560302|NCT01186471|Nicotine|nicotine|mesh-list
65560303|NCT01186471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65560304|NCT01186471|Autonomic Agents|autonomic agents|mesh-ancestor
65560305|NCT01186471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65560306|NCT01186471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560307|NCT01186471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65560308|NCT01186471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65560309|NCT01186471|Cholinergic Agents|cholinergic agents|mesh-ancestor
65560310|NCT01186471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65560311|NCT01186471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560312|NCT01292551|Bosentan|bosentan|mesh-list
65560313|NCT01292551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65560314|NCT01292551|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65560315|NCT01292551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560316|NCT03854383|Isosorbide|isosorbide|mesh-list
65560317|NCT03854383|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65560318|NCT03854383|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65560319|NCT03854383|Misoprostol|misoprostol|mesh-list
65560320|NCT03854383|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65560321|NCT03854383|Abortifacient Agents|abortifacient agents|mesh-ancestor
65560322|NCT03854383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65560323|NCT03854383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560324|NCT03854383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65560325|NCT03854383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65560326|NCT03854383|Oxytocics|oxytocics|mesh-ancestor
65560327|NCT03854383|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65560328|NCT03854383|Diuretics|diuretics|mesh-ancestor
65560329|NCT03854383|Natriuretic Agents|natriuretic agents|mesh-ancestor
65560330|NCT03854383|Vasodilator Agents|vasodilator agents|mesh-ancestor
65560331|NCT03854383|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65560332|NCT03854383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560333|NCT03854617|Vinorelbine|vinorelbine|mesh-list
65560334|NCT03854617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65560335|NCT03854617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560336|NCT03854617|Tubulin Modulators|tubulin modulators|mesh-ancestor
65560337|NCT03854617|Antimitotic Agents|antimitotic agents|mesh-ancestor
65560338|NCT03854617|Mitosis Modulators|mitosis modulators|mesh-ancestor
65560339|NCT03854617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560340|NCT01186549|Lidocaine|lidocaine|mesh-list
65560341|NCT01186549|Ephedrine|ephedrine|mesh-list
65560342|NCT01186549|Pseudoephedrine|pseudoephedrine|mesh-list
65560343|NCT01186549|Anesthetics, Local|anesthetics, local|mesh-ancestor
65560344|NCT01186549|Anesthetics|anesthetics|mesh-ancestor
65560345|NCT01186549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65560346|NCT01186549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560347|NCT01186549|Sensory System Agents|sensory system agents|mesh-ancestor
65560348|NCT01186549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65560349|NCT01186549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65560350|NCT01186549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65560351|NCT01186549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65560352|NCT01186549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65357885|NCT00982540|Miconazole|miconazole|mesh-list
65560353|NCT01186549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560354|NCT01186549|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65560355|NCT01186549|Sympathomimetics|sympathomimetics|mesh-ancestor
65560357|NCT01186549|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65560358|NCT01186549|Adrenergic Agents|adrenergic agents|mesh-ancestor
65560359|NCT01186549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65560360|NCT01186549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65560361|NCT01186549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65560362|NCT01186549|Respiratory System Agents|respiratory system agents|mesh-ancestor
65560363|NCT01186549|Nasal Decongestants|nasal decongestants|mesh-ancestor
65560364|NCT03851341|Metformin|metformin|mesh-list
65560365|NCT03851341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65560366|NCT03851341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65560367|NCT03851341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560368|NCT03851341|Incretins|incretins|mesh-ancestor
65560369|NCT03851341|Hormones|hormones|mesh-ancestor
65560370|NCT03851341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65560371|NCT03851341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65560372|NCT03851341|Protease Inhibitors|protease inhibitors|mesh-ancestor
65560373|NCT03851341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560374|NCT03851341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560375|NCT04788108|Dydrogesterone|dydrogesterone|mesh-list
65560376|NCT04788108|Progestins|progestins|mesh-ancestor
65560377|NCT04788108|Hormones|hormones|mesh-ancestor
65560378|NCT04788108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65560379|NCT04788108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560380|NCT00003389|Prednisone|prednisone|mesh-list
65560381|NCT00003389|Cyclophosphamide|cyclophosphamide|mesh-list
65560382|NCT00003389|Dacarbazine|dacarbazine|mesh-list
65560383|NCT00003389|Mechlorethamine|mechlorethamine|mesh-list
65560384|NCT00003389|Doxorubicin|doxorubicin|mesh-list
65560385|NCT00003389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65560386|NCT00003389|Etoposide|etoposide|mesh-list
65560387|NCT00003389|Vincristine|vincristine|mesh-list
65560388|NCT00003389|Etoposide phosphate|etoposide phosphate|mesh-list
65560389|NCT00003389|Bleomycin|bleomycin|mesh-list
65560390|NCT00003389|Vinblastine|vinblastine|mesh-list
65560391|NCT00003389|Podophyllotoxin|podophyllotoxin|mesh-list
65560392|NCT00003389|Imidazole|imidazole|mesh-list
65560393|NCT00003389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65560394|NCT00003389|Immunologic Factors|immunologic factors|mesh-ancestor
65560395|NCT00003389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560396|NCT00003389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65560397|NCT00003389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65560398|NCT00003389|Alkylating Agents|alkylating agents|mesh-ancestor
65560399|NCT00003389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289523|NCT04137978|Potassium Citrate|potassium citrate|mesh-list
65560400|NCT00003389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560401|NCT00003389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65560402|NCT00003389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65560403|NCT00003389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65560404|NCT00003389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65560405|NCT00003389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560406|NCT00003389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65560407|NCT00003389|Glucocorticoids|glucocorticoids|mesh-ancestor
65560408|NCT00003389|Hormones|hormones|mesh-ancestor
65560409|NCT00003389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65560410|NCT00003389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65560411|NCT00003389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65560412|NCT00003389|Tubulin Modulators|tubulin modulators|mesh-ancestor
65560413|NCT00003389|Antimitotic Agents|antimitotic agents|mesh-ancestor
65560414|NCT00003389|Mitosis Modulators|mitosis modulators|mesh-ancestor
65560415|NCT00003389|Keratolytic Agents|keratolytic agents|mesh-ancestor
65560416|NCT00003389|Dermatologic Agents|dermatologic agents|mesh-ancestor
65560417|NCT03362190|Ranibizumab|ranibizumab|mesh-list
65560418|NCT03362190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65560419|NCT03362190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65560420|NCT03362190|Growth Substances|growth substances|mesh-ancestor
65560421|NCT03362190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560422|NCT03362190|Growth Inhibitors|growth inhibitors|mesh-ancestor
65560423|NCT03362190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560424|NCT01292785|Hormones|hormones|mesh-list
65560425|NCT01292785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65560426|NCT01292785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560427|NCT02323126|Nivolumab|nivolumab|mesh-list
65560428|NCT02323126|Nazartinib|nazartinib|mesh-list
65560429|NCT02323126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65560430|NCT02323126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560431|NCT02323126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65560432|NCT02323126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560434|NCT01291459|Emtricitabine|emtricitabine|mesh-list
65560435|NCT01291459|Raltegravir Potassium|raltegravir potassium|mesh-list
65560436|NCT01291459|Maraviroc|maraviroc|mesh-list
65560437|NCT01291459|Antiviral Agents|antiviral agents|mesh-ancestor
65560438|NCT01291459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65560439|NCT01291459|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65560440|NCT01291459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65560441|NCT01291459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560442|NCT01291459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560443|NCT01291459|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65560444|NCT01291459|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65560445|NCT01291459|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65560446|NCT01291459|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65560447|NCT01291459|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65560448|NCT01291459|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65560449|NCT01291459|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65560450|NCT00003377|Paclitaxel|paclitaxel|mesh-list
65560451|NCT00003377|Cisplatin|cisplatin|mesh-list
65560452|NCT00003377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65560453|NCT00003377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560454|NCT00003377|Tubulin Modulators|tubulin modulators|mesh-ancestor
65560455|NCT00003377|Antimitotic Agents|antimitotic agents|mesh-ancestor
65560456|NCT00003377|Mitosis Modulators|mitosis modulators|mesh-ancestor
65560457|NCT00003377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560458|NCT01291537|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65560459|NCT01291537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65560460|NCT01291537|Immunologic Factors|immunologic factors|mesh-ancestor
65560461|NCT01291537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560462|NCT01291537|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65560463|NCT01291537|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65560464|NCT01291537|Dopamine Agonists|dopamine agonists|mesh-ancestor
65560465|NCT01291537|Dopamine Agents|dopamine agents|mesh-ancestor
65560466|NCT01291537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65560467|NCT01291537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560468|NCT01328015|Oxybutynin|oxybutynin|mesh-list
65560469|NCT01328015|Cholinergic Antagonists|cholinergic antagonists|mesh-list
65560470|NCT01328015|Parasympatholytics|parasympatholytics|mesh-ancestor
65560471|NCT01328015|Autonomic Agents|autonomic agents|mesh-ancestor
65560472|NCT01328015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65560473|NCT01328015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289600|NCT00717808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65560474|NCT01328015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65560475|NCT01328015|Cholinergic Agents|cholinergic agents|mesh-ancestor
65560476|NCT01328015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65560477|NCT01328015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560478|NCT01328015|Urological Agents|urological agents|mesh-ancestor
65560479|NCT01101893|Raltegravir Potassium|raltegravir potassium|mesh-list
65560480|NCT01101893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65560481|NCT01101893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65560482|NCT01101893|Antiviral Agents|antiviral agents|mesh-ancestor
65560483|NCT01101893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65560484|NCT01101893|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65560485|NCT01101893|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65560486|NCT01101893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560487|NCT01101893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560488|NCT01292863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65560489|NCT01292863|Dialysis Solutions|dialysis solutions|mesh-list
65560490|NCT00002651|Goserelin|goserelin|mesh-list
65560491|NCT00002651|Bicalutamide|bicalutamide|mesh-list
65560492|NCT00002651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65560493|NCT00002651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560494|NCT00002651|Androgen Antagonists|androgen antagonists|mesh-ancestor
65560495|NCT00002651|Hormone Antagonists|hormone antagonists|mesh-ancestor
65560496|NCT00002651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65560497|NCT00002651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560498|NCT03853993|Vaccines|vaccines|mesh-list
65560499|NCT03853993|Immunologic Factors|immunologic factors|mesh-ancestor
65560500|NCT03853993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560501|NCT03473626|Alicaforsen|alicaforsen|mesh-list
65560502|NCT03473626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65560503|NCT03473626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65560504|NCT03473626|Immunologic Factors|immunologic factors|mesh-ancestor
65560505|NCT03473626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358039|NCT00895323|Antibodies|antibodies|mesh-list
65560507|NCT05154682|Naproxen|naproxen|mesh-list
65560508|NCT05154682|Oxycodone|oxycodone|mesh-list
65560509|NCT05154682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65560510|NCT05154682|Analgesics|analgesics|mesh-ancestor
65560511|NCT05154682|Sensory System Agents|sensory system agents|mesh-ancestor
65560512|NCT05154682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65560513|NCT05154682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560514|NCT05154682|Antipyretics|antipyretics|mesh-ancestor
65560515|NCT05154682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65560516|NCT05154682|Narcotics|narcotics|mesh-ancestor
65560517|NCT05154682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65560518|NCT05154682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65560519|NCT05154682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65560520|NCT05154682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65560521|NCT05154682|Gout Suppressants|gout suppressants|mesh-ancestor
65560522|NCT05154682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65560523|NCT05154682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560524|NCT05154682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560525|NCT04312841|Acetic Acid|acetic acid|mesh-list
65560526|NCT04312841|Letermovir|letermovir|mesh-list
65560527|NCT04312841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65560528|NCT04312841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65560529|NCT04312841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560530|NCT04312841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560531|NCT04312841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560532|NCT04312841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65560533|NCT04312841|Antiviral Agents|antiviral agents|mesh-ancestor
65560534|NCT01294735|Temozolomide|temozolomide|mesh-list
65560535|NCT01294735|Niraparib|niraparib|mesh-list
65560536|NCT01294735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65560537|NCT01294735|Alkylating Agents|alkylating agents|mesh-ancestor
65560538|NCT01294735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560539|NCT01294735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560540|NCT01294735|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65560541|NCT01294735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560542|NCT03851263|Evolocumab|evolocumab|mesh-list
65560543|NCT03851263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65560544|NCT03851263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65560545|NCT03851263|Antimetabolites|antimetabolites|mesh-ancestor
65560546|NCT03851263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560547|NCT03851263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65560548|NCT03849235|Glucagon|glucagon|mesh-list
65560549|NCT03849235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65560550|NCT03849235|Hormones|hormones|mesh-ancestor
65560551|NCT03849235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65560552|NCT03849235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560553|NCT03477448|Bleomycin|bleomycin|mesh-list
65560554|NCT03477448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65560555|NCT03477448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560556|NCT01187485|Methyltestosterone|methyltestosterone|mesh-list
65560557|NCT01187485|Testosterone|testosterone|mesh-list
65560558|NCT01187485|Testosterone undecanoate|testosterone undecanoate|mesh-list
65560559|NCT01187485|Testosterone enanthate|testosterone enanthate|mesh-list
65560560|NCT01187485|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65560561|NCT01187485|Androgens|androgens|mesh-ancestor
65560562|NCT01187485|Hormones|hormones|mesh-ancestor
65560563|NCT01187485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65560564|NCT01187485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560565|NCT01187485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65560566|NCT01187485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560567|NCT01187485|Anabolic Agents|anabolic agents|mesh-ancestor
65560568|NCT00002597|Leuprolide|leuprolide|mesh-list
65560569|NCT00002597|Goserelin|goserelin|mesh-list
65560570|NCT00002597|Flutamide|flutamide|mesh-list
65560571|NCT00002597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65560572|NCT00002597|Fertility Agents|fertility agents|mesh-ancestor
65560573|NCT00002597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65560574|NCT00002597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560575|NCT00002597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65560576|NCT00002597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560577|NCT00002597|Androgen Antagonists|androgen antagonists|mesh-ancestor
65560578|NCT00002597|Hormone Antagonists|hormone antagonists|mesh-ancestor
65560579|NCT00002597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65560580|NCT03853525|Petrolatum|petrolatum|mesh-list
65560581|NCT03853525|Emollients|emollients|mesh-ancestor
65560582|NCT03853525|Dermatologic Agents|dermatologic agents|mesh-ancestor
65560583|NCT03716583|Melatonin|melatonin|mesh-list
65560584|NCT03716583|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
65560585|NCT03716583|Antioxidants|antioxidants|mesh-ancestor
65560586|NCT03716583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560587|NCT03716583|Protective Agents|protective agents|mesh-ancestor
65560588|NCT03716583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560589|NCT03716583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65560590|NCT03716583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65560591|NCT03716583|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65560592|NCT02738008|Tenofovir|tenofovir|mesh-list
65560593|NCT02738008|Entecavir|entecavir|mesh-list
65560594|NCT02738008|Histamine Antagonists|histamine antagonists|mesh-list
65560595|NCT02738008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
65560596|NCT02738008|Antiviral Agents|antiviral agents|mesh-ancestor
65560597|NCT02738008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65560598|NCT02738008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65560599|NCT02738008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65560600|NCT02738008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560601|NCT02738008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560602|NCT02738008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65560603|NCT02738008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65560604|NCT02738008|Histamine Agents|histamine agents|mesh-ancestor
65560605|NCT02738008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65560606|NCT02738008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560607|NCT03720249|Vitamins|vitamins|mesh-list
65560608|NCT03720249|Vitamin B 12|vitamin b 12|mesh-list
65560609|NCT03720249|Vitamin B 6|vitamin b 6|mesh-list
65560610|NCT03720249|Vitamin B Complex|vitamin b complex|mesh-list
65560611|NCT03720249|Betaine|betaine|mesh-list
65560612|NCT03720249|Micronutrients|micronutrients|mesh-ancestor
65560613|NCT03720249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560614|NCT03720249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65560615|NCT03720249|Lipotropic Agents|lipotropic agents|mesh-ancestor
65560616|NCT03720249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65560617|NCT03720249|Antimetabolites|antimetabolites|mesh-ancestor
65560618|NCT03720249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560619|NCT03720249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65560620|NCT01294969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
65560621|NCT01294969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65560622|NCT01294969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65560623|NCT01294969|Analgesics|analgesics|mesh-ancestor
65560624|NCT01294969|Sensory System Agents|sensory system agents|mesh-ancestor
65560625|NCT01294969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65560626|NCT01294969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560627|NCT01294969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65560628|NCT01294969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65560629|NCT01294969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65560630|NCT01294969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65560631|NCT01294969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65560632|NCT01294969|Histamine Antagonists|histamine antagonists|mesh-ancestor
65560633|NCT01294969|Histamine Agents|histamine agents|mesh-ancestor
65560634|NCT01294969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65560635|NCT01294969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560636|NCT03850561|Ubiquinone|ubiquinone|mesh-list
65560637|NCT03850561|Coenzyme Q10|coenzyme q10|mesh-list
65560638|NCT03850561|Micronutrients|micronutrients|mesh-ancestor
65560639|NCT03850561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560640|NCT03850561|Vitamins|vitamins|mesh-ancestor
65560641|NCT00002525|Leucovorin|leucovorin|mesh-list
65560642|NCT00002525|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
65560643|NCT00002525|Tetrahydrofolates|tetrahydrofolates|mesh-list
65560644|NCT00002525|Fluorouracil|fluorouracil|mesh-list
65560645|NCT00002525|Calcium|calcium|mesh-list
65560646|NCT00002525|Levoleucovorin|levoleucovorin|mesh-list
65560647|NCT00002525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65560648|NCT00002525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560649|NCT00002525|Antimetabolites|antimetabolites|mesh-ancestor
65560650|NCT00002525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560651|NCT00002525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65560652|NCT00002525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560653|NCT00002525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65560654|NCT00002525|Immunologic Factors|immunologic factors|mesh-ancestor
65560655|NCT00002525|Antidotes|antidotes|mesh-ancestor
65560656|NCT00002525|Protective Agents|protective agents|mesh-ancestor
65560657|NCT00002525|Vitamin B Complex|vitamin b complex|mesh-ancestor
65560658|NCT00002525|Vitamins|vitamins|mesh-ancestor
65560659|NCT00002525|Micronutrients|micronutrients|mesh-ancestor
65560660|NCT01190137|Cholecalciferol|cholecalciferol|mesh-list
65560661|NCT01190137|Vitamin D|vitamin d|mesh-list
65560662|NCT01190137|Ergocalciferols|ergocalciferols|mesh-list
65560663|NCT01190137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65560664|NCT01190137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560665|NCT01190137|Vitamins|vitamins|mesh-ancestor
65560666|NCT01190137|Micronutrients|micronutrients|mesh-ancestor
65560667|NCT01190137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65560668|NCT02529839|Cyclophosphamide|cyclophosphamide|mesh-list
65560669|NCT02529839|Fludarabine|fludarabine|mesh-list
65560670|NCT02529839|Alemtuzumab|alemtuzumab|mesh-list
65560671|NCT02529839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65560672|NCT02529839|Immunologic Factors|immunologic factors|mesh-ancestor
65560673|NCT02529839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560674|NCT02529839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65560675|NCT02529839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65560676|NCT02529839|Alkylating Agents|alkylating agents|mesh-ancestor
65560677|NCT02529839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560678|NCT02529839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560679|NCT02529839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65560680|NCT02529839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65560681|NCT03473314|Nitric Oxide|nitric oxide|mesh-list
65560682|NCT03473314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65560683|NCT03473314|Autonomic Agents|autonomic agents|mesh-ancestor
65560684|NCT03473314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65560685|NCT03473314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560686|NCT03473314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65560687|NCT03473314|Respiratory System Agents|respiratory system agents|mesh-ancestor
65560688|NCT03473314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65560689|NCT03473314|Antioxidants|antioxidants|mesh-ancestor
65560690|NCT03473314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560691|NCT03473314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65560692|NCT03473314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65560693|NCT03473314|Vasodilator Agents|vasodilator agents|mesh-ancestor
65560694|NCT03473314|Gasotransmitters|gasotransmitters|mesh-ancestor
65560695|NCT03473314|Protective Agents|protective agents|mesh-ancestor
65560696|NCT03945539|Itraconazole|itraconazole|mesh-list
65560697|NCT03945539|JNJ-56136379|jnj-56136379|mesh-list
65560698|NCT03945539|Antifungal Agents|antifungal agents|mesh-ancestor
65560699|NCT03945539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65560700|NCT03945539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65560701|NCT03945539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65289825|NCT00536809|Antimetabolites|antimetabolites|mesh-ancestor
65560702|NCT03945539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560703|NCT03945539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560704|NCT03945539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65560705|NCT03945539|Hormone Antagonists|hormone antagonists|mesh-ancestor
65560706|NCT03945539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65560707|NCT03945539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560708|NCT03945539|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65560709|NCT03945539|Antiviral Agents|antiviral agents|mesh-ancestor
65560710|NCT01190293|Efavirenz|efavirenz|mesh-list
65560711|NCT01190293|Maraviroc|maraviroc|mesh-list
65560712|NCT01190293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65560713|NCT01190293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65560714|NCT01190293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560715|NCT01190293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560716|NCT01190293|Antiviral Agents|antiviral agents|mesh-ancestor
65560717|NCT01190293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65560718|NCT01190293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65560719|NCT01190293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65560720|NCT01190293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65560721|NCT01190293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65560722|NCT01190293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65560723|NCT01190293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65560724|NCT01190293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65560725|NCT01190293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65560726|NCT01190293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65560727|NCT01190293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65560728|NCT01190293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65560729|NCT03945227|Spartalizumab|spartalizumab|mesh-list
65560730|NCT03945227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65560731|NCT03945227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560732|NCT03945227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560733|NCT01108133|Dexamethasone|dexamethasone|mesh-list
65560734|NCT01108133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65560735|NCT01108133|Antiemetics|antiemetics|mesh-ancestor
65560736|NCT01108133|Autonomic Agents|autonomic agents|mesh-ancestor
65560737|NCT01108133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65560738|NCT01108133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560739|NCT01108133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65560740|NCT01108133|Glucocorticoids|glucocorticoids|mesh-ancestor
65560741|NCT01108133|Hormones|hormones|mesh-ancestor
65560742|NCT01108133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65560743|NCT01108133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65560744|NCT01108133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560745|NCT01108289|Oxytocin|oxytocin|mesh-list
65560746|NCT01108289|Oxytocics|oxytocics|mesh-ancestor
65560747|NCT01108289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65560748|NCT01108289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560749|NCT03947489|Sarpogrelate|sarpogrelate|mesh-list
65560750|NCT03947489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65560751|NCT03947489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65560752|NCT03947489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560753|NCT03947489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65560754|NCT03947489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65560755|NCT03947489|Serotonin Agents|serotonin agents|mesh-ancestor
65560756|NCT03947489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65560757|NCT03947489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560758|NCT03947411|Oseltamivir|oseltamivir|mesh-list
65560759|NCT03947411|Antiviral Agents|antiviral agents|mesh-ancestor
65560760|NCT03947411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65560761|NCT03947411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560762|NCT03947411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560763|NCT03257254|Polidocanol|polidocanol|mesh-list
65560764|NCT03257254|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65560765|NCT03257254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65560766|NCT01327469|Albendazole|albendazole|mesh-list
65560767|NCT01327469|Mebendazole|mebendazole|mesh-list
65560768|NCT01327469|Piperazine|piperazine|mesh-list
65560769|NCT01327469|Piperazine citrate|piperazine citrate|mesh-list
65560770|NCT01327469|Pyrantel|pyrantel|mesh-list
65560771|NCT01327469|Oxantel|oxantel|mesh-list
65560772|NCT01327469|DMP 777|dmp 777|mesh-list
65560773|NCT01327469|Anthelmintics|anthelmintics|mesh-ancestor
65560774|NCT01327469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65289906|NCT03214250|Paclitaxel|paclitaxel|mesh-list
65560775|NCT01327469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65560776|NCT01327469|Anticestodal Agents|anticestodal agents|mesh-ancestor
65560777|NCT01327469|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65560778|NCT01327469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65560779|NCT01327469|Tubulin Modulators|tubulin modulators|mesh-ancestor
65560780|NCT01327469|Antimitotic Agents|antimitotic agents|mesh-ancestor
65560781|NCT01327469|Mitosis Modulators|mitosis modulators|mesh-ancestor
65560782|NCT01327469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560783|NCT01327469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560784|NCT01327469|Antinematodal Agents|antinematodal agents|mesh-ancestor
65560785|NCT01327469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560786|NCT01327469|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
65560787|NCT01327469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65560788|NCT01327469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65560789|NCT01327469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65560790|NCT01327469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560791|NCT03950141|Apatinib|apatinib|mesh-list
65560792|NCT03950141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560793|NCT03950141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65560794|NCT03950141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560795|NCT03950141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560796|NCT01328171|Folic Acid|folic acid|mesh-list
65560797|NCT01328171|Vitamin B Complex|vitamin b complex|mesh-list
65560798|NCT01328171|Oxaliplatin|oxaliplatin|mesh-list
65560799|NCT01328171|Irinotecan|irinotecan|mesh-list
65560800|NCT01328171|Panitumumab|panitumumab|mesh-list
65560801|NCT01328171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560802|NCT01328171|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65560803|NCT01328171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65560804|NCT01328171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560805|NCT01328171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560806|NCT01328171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560807|NCT01328171|Hematinics|hematinics|mesh-ancestor
65560808|NCT01328171|Vitamins|vitamins|mesh-ancestor
65560809|NCT01328171|Micronutrients|micronutrients|mesh-ancestor
65560810|NCT01328171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65560811|NCT01108601|Ciprofloxacin|ciprofloxacin|mesh-list
65560812|NCT01108601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65560813|NCT01108601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65560814|NCT01108601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65560815|NCT01108601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65560816|NCT01108601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560817|NCT01108601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560818|NCT01108601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560819|NCT01108601|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65560820|NCT01108601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65560821|NCT03084718|Beclomethasone|beclomethasone|mesh-list
65560822|NCT03084718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65560823|NCT03084718|Glucocorticoids|glucocorticoids|mesh-ancestor
65560824|NCT03084718|Hormones|hormones|mesh-ancestor
65560825|NCT03084718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65560826|NCT03084718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560827|NCT03084718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65560828|NCT03084718|Respiratory System Agents|respiratory system agents|mesh-ancestor
65560829|NCT03638999|Ketorolac|ketorolac|mesh-list
65560830|NCT03638999|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65560831|NCT03638999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65560832|NCT03638999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65560833|NCT03638999|Analgesics|analgesics|mesh-ancestor
65560834|NCT03638999|Sensory System Agents|sensory system agents|mesh-ancestor
65560835|NCT03638999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65560836|NCT03638999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560837|NCT03638999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65560838|NCT03638999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65560839|NCT03638999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65560840|NCT03638999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560841|NCT03638999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560842|NCT02938624|Pembrolizumab|pembrolizumab|mesh-list
65560843|NCT02938624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65560844|NCT02938624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560845|NCT03469804|Pembrolizumab|pembrolizumab|mesh-list
65560846|NCT03469804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65560847|NCT03469804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560848|NCT03944291|Bupivacaine|bupivacaine|mesh-list
65560849|NCT03944291|Anesthetics, Local|anesthetics, local|mesh-ancestor
65560850|NCT03944291|Anesthetics|anesthetics|mesh-ancestor
65560851|NCT03944291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65560852|NCT03944291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560853|NCT03944291|Sensory System Agents|sensory system agents|mesh-ancestor
65560854|NCT03944291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65560855|NCT03067571|Daratumumab|daratumumab|mesh-list
65560856|NCT03067571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560857|NCT01102439|Aspirin|aspirin|mesh-list
65560858|NCT01102439|Clopidogrel|clopidogrel|mesh-list
65560859|NCT01102439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65560860|NCT01102439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65560861|NCT01102439|Analgesics|analgesics|mesh-ancestor
65560862|NCT01102439|Sensory System Agents|sensory system agents|mesh-ancestor
65560863|NCT01102439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65560864|NCT01102439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560865|NCT01102439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65560866|NCT01102439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65560867|NCT01102439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65560868|NCT01102439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65560869|NCT01102439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560870|NCT01102439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65560871|NCT01102439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65560872|NCT01102439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560873|NCT01102439|Antipyretics|antipyretics|mesh-ancestor
65560874|NCT01102439|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65560875|NCT01102439|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65560876|NCT01102439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65560877|NCT01102439|Purinergic Agents|purinergic agents|mesh-ancestor
65560878|NCT01102439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65560879|NCT03949985|Hemostatics|hemostatics|mesh-list
65560880|NCT03949985|Contraceptive Agents|contraceptive agents|mesh-list
65560881|NCT03949985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65560882|NCT03949985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560883|NCT03949985|Coagulants|coagulants|mesh-ancestor
65358400|NCT00336583|Antiemetics|antiemetics|mesh-ancestor
65560885|NCT01584791|Clopidogrel|clopidogrel|mesh-list
65560886|NCT01584791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65560887|NCT01584791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65560888|NCT01584791|Analgesics|analgesics|mesh-ancestor
65560889|NCT01584791|Sensory System Agents|sensory system agents|mesh-ancestor
65560890|NCT01584791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65560891|NCT01584791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560892|NCT01584791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65560893|NCT01584791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65560894|NCT01584791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65560895|NCT01584791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65560896|NCT01584791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560897|NCT01584791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65560898|NCT01584791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65560899|NCT01584791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560900|NCT01584791|Antipyretics|antipyretics|mesh-ancestor
65560901|NCT01584791|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65560902|NCT01584791|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65560903|NCT01584791|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65560904|NCT01584791|Purinergic Agents|purinergic agents|mesh-ancestor
65560905|NCT01584791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65560906|NCT04285684|Ketamine|ketamine|mesh-list
65560907|NCT04285684|Analgesics|analgesics|mesh-ancestor
65560908|NCT04285684|Sensory System Agents|sensory system agents|mesh-ancestor
65560909|NCT04285684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65560910|NCT04285684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560911|NCT04285684|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65560912|NCT04285684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65560913|NCT04285684|Anesthetics, General|anesthetics, general|mesh-ancestor
65560914|NCT04285684|Anesthetics|anesthetics|mesh-ancestor
65560915|NCT04285684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65560916|NCT04285684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65560917|NCT04285684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65560918|NCT04285684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65560919|NCT04285684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560920|NCT01310985|Capecitabine|capecitabine|mesh-list
65560921|NCT01310985|Cetuximab|cetuximab|mesh-list
65560922|NCT01310985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65560923|NCT01310985|Antimetabolites|antimetabolites|mesh-ancestor
65560924|NCT01310985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560925|NCT01310985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560926|NCT01310985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65560927|NCT03433677|Insulin Lispro|insulin lispro|mesh-list
65560928|NCT03433677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65560929|NCT03433677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560930|NCT02492711|Trastuzumab|trastuzumab|mesh-list
65560931|NCT02492711|Margetuximab|margetuximab|mesh-list
65560932|NCT02492711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65560933|NCT02492711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560934|NCT03716427|Tolbutamide|tolbutamide|mesh-list
65560935|NCT03716427|Midazolam|midazolam|mesh-list
65560936|NCT03716427|Dextromethorphan|dextromethorphan|mesh-list
65560937|NCT03716427|Omeprazole|omeprazole|mesh-list
65560938|NCT03716427|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65560939|NCT03716427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65560940|NCT03716427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65560941|NCT03716427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560942|NCT03716427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65560943|NCT03716427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65560944|NCT03716427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65560945|NCT03716427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65560946|NCT03716427|Anesthetics, General|anesthetics, general|mesh-ancestor
65560947|NCT03716427|Anesthetics|anesthetics|mesh-ancestor
65560948|NCT03716427|GABA Modulators|gaba modulators|mesh-ancestor
65560949|NCT03716427|GABA Agents|gaba agents|mesh-ancestor
65560950|NCT03716427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65560951|NCT03716427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560952|NCT03716427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65560953|NCT03716427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65560954|NCT03716427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65560955|NCT03716427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560956|NCT03716427|Antitussive Agents|antitussive agents|mesh-ancestor
65560957|NCT03716427|Respiratory System Agents|respiratory system agents|mesh-ancestor
65358465|NCT01059955|Autonomic Agents|autonomic agents|mesh-ancestor
65560958|NCT03716427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65560959|NCT03716427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65560960|NCT03716427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65560961|NCT01147822|Sunitinib|sunitinib|mesh-list
65560962|NCT01147822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560963|NCT01147822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65560964|NCT01147822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65560965|NCT01147822|Growth Substances|growth substances|mesh-ancestor
65560966|NCT01147822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560967|NCT01147822|Growth Inhibitors|growth inhibitors|mesh-ancestor
65560968|NCT01147822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65560969|NCT01147822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560970|NCT01147822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560971|NCT03431337|Amoxicillin|amoxicillin|mesh-list
65560972|NCT03431337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65560973|NCT03431337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65560974|NCT01293097|Atorvastatin|atorvastatin|mesh-list
65560975|NCT01293097|Pravastatin|pravastatin|mesh-list
65560976|NCT01293097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65560977|NCT01293097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65560978|NCT01293097|Antimetabolites|antimetabolites|mesh-ancestor
65560979|NCT01293097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560980|NCT01293097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65560981|NCT01293097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65560982|NCT01293097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560983|NCT03516292|Mitogens|mitogens|mesh-list
65560984|NCT03516292|Mitosis Modulators|mitosis modulators|mesh-ancestor
65560985|NCT03516292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560986|NCT01291615|Gemcitabine|gemcitabine|mesh-list
65560987|NCT01291615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65560988|NCT01291615|Antimetabolites|antimetabolites|mesh-ancestor
65560989|NCT01291615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65560990|NCT01291615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65560991|NCT01291615|Antiviral Agents|antiviral agents|mesh-ancestor
65560992|NCT01291615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65560993|NCT01291615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65560994|NCT01291615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65560995|NCT01291615|Immunologic Factors|immunologic factors|mesh-ancestor
65560996|NCT01291615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65560997|NCT01295047|Atenolol|atenolol|mesh-list
65560998|NCT01295047|Verapamil|verapamil|mesh-list
65560999|NCT01295047|Perindopril|perindopril|mesh-list
65561000|NCT01295047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65561001|NCT01295047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65561002|NCT01295047|Sympatholytics|sympatholytics|mesh-ancestor
65561003|NCT01295047|Autonomic Agents|autonomic agents|mesh-ancestor
65561004|NCT01295047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65561005|NCT01295047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561006|NCT01295047|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65561007|NCT01295047|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65561008|NCT01295047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65561009|NCT01295047|Adrenergic Agents|adrenergic agents|mesh-ancestor
65561010|NCT01295047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65561011|NCT01295047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561012|NCT01295047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65561013|NCT01295047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65561014|NCT01295047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65561015|NCT01295047|Vasodilator Agents|vasodilator agents|mesh-ancestor
65561016|NCT01295047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65561017|NCT01295047|Protease Inhibitors|protease inhibitors|mesh-ancestor
65561018|NCT01295047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561019|NCT03472846|Teriparatide|teriparatide|mesh-list
65561020|NCT03472846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65561021|NCT03472846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561022|NCT03472846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65561023|NCT01190371|Artesunate|artesunate|mesh-list
65561024|NCT01190371|Antimalarials|antimalarials|mesh-ancestor
65561025|NCT01190371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65561026|NCT01190371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65561027|NCT01190371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65561028|NCT01190371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561029|NCT01190371|Antiviral Agents|antiviral agents|mesh-ancestor
65561030|NCT01190371|Schistosomicides|schistosomicides|mesh-ancestor
65561031|NCT01190371|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65561032|NCT01190371|Anthelmintics|anthelmintics|mesh-ancestor
65561033|NCT05158426|Propofol|propofol|mesh-list
65561034|NCT05158426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65561035|NCT05158426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65561036|NCT05158426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561037|NCT05158426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65561038|NCT05158426|Anesthetics, General|anesthetics, general|mesh-ancestor
65561039|NCT05158426|Anesthetics|anesthetics|mesh-ancestor
65561040|NCT03853369|Nifekalant|nifekalant|mesh-list
65561041|NCT03853369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65561042|NCT05158348|Lidocaine|lidocaine|mesh-list
65561043|NCT05158348|Dexmedetomidine|dexmedetomidine|mesh-list
65561044|NCT05158348|Anesthetics, Local|anesthetics, local|mesh-ancestor
65561045|NCT05158348|Anesthetics|anesthetics|mesh-ancestor
65561046|NCT05158348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65561047|NCT05158348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561048|NCT05158348|Sensory System Agents|sensory system agents|mesh-ancestor
65561049|NCT05158348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65561050|NCT05158348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65561051|NCT05158348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65561052|NCT05158348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65561053|NCT05158348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65561054|NCT05158348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561055|NCT05158348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65561056|NCT05158348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65561057|NCT05158348|Analgesics|analgesics|mesh-ancestor
65561058|NCT05158348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65561059|NCT05158348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65561060|NCT05158348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65561061|NCT05158348|Adrenergic Agents|adrenergic agents|mesh-ancestor
65561062|NCT05158348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65561063|NCT01187719|Phenytoin|phenytoin|mesh-list
65561064|NCT01187719|Anticonvulsants|anticonvulsants|mesh-ancestor
65561065|NCT01187719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65561066|NCT01187719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65561067|NCT01187719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65561068|NCT01187719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561069|NCT01187719|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65561070|NCT01187719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65561071|NCT01102595|Bevacizumab|bevacizumab|mesh-list
65561072|NCT01102595|Temozolomide|temozolomide|mesh-list
65561073|NCT01102595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65561074|NCT01102595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561075|NCT01102595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65561076|NCT01102595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65561077|NCT01102595|Growth Substances|growth substances|mesh-ancestor
65561078|NCT01102595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561079|NCT01102595|Growth Inhibitors|growth inhibitors|mesh-ancestor
65561080|NCT01102595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65561081|NCT01102595|Alkylating Agents|alkylating agents|mesh-ancestor
65561082|NCT01102595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561083|NCT03949517|Piperidine|piperidine|mesh-list
65561084|NCT03949517|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65561085|NCT03949517|Bombesin|bombesin|mesh-list
65561086|NCT03949517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561087|NCT03949517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65561088|NCT03949517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65561089|NCT03949517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561090|NCT03949517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65561091|NCT03949517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65561092|NCT03949517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65561093|NCT03848611|Vorolanib|vorolanib|mesh-list
65561094|NCT03848611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65561095|NCT03848611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561096|NCT03848611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561097|NCT01584947|Bupivacaine|bupivacaine|mesh-list
65561098|NCT01584947|Anesthetics, Local|anesthetics, local|mesh-ancestor
65561099|NCT01584947|Anesthetics|anesthetics|mesh-ancestor
65561100|NCT01584947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65561101|NCT01584947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561102|NCT01584947|Sensory System Agents|sensory system agents|mesh-ancestor
65561103|NCT01584947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65561104|NCT03848767|Insulin Lispro|insulin lispro|mesh-list
65561105|NCT03848767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65561106|NCT03848767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561107|NCT01109615|Gemcitabine|gemcitabine|mesh-list
65561108|NCT01109615|Pemetrexed|pemetrexed|mesh-list
65561109|NCT01109615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65561110|NCT01109615|Antimetabolites|antimetabolites|mesh-ancestor
65561111|NCT01109615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561112|NCT01109615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561113|NCT01109615|Antiviral Agents|antiviral agents|mesh-ancestor
65561114|NCT01109615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65561115|NCT01109615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561116|NCT01109615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65561117|NCT01109615|Immunologic Factors|immunologic factors|mesh-ancestor
65561118|NCT01109615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561119|NCT01109615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65561120|NCT01109615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65561121|NCT01209065|Ritonavir|ritonavir|mesh-list
65561122|NCT01209065|Fosamprenavir|fosamprenavir|mesh-list
65561123|NCT01209065|Dolutegravir|dolutegravir|mesh-list
65561124|NCT01209065|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65561125|NCT01209065|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65561126|NCT01209065|Protease Inhibitors|protease inhibitors|mesh-ancestor
65561127|NCT01209065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561128|NCT01209065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561129|NCT01209065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65561130|NCT01209065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65561131|NCT01209065|Antiviral Agents|antiviral agents|mesh-ancestor
65561132|NCT01209065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65561133|NCT01209065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65561134|NCT01209065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65561135|NCT01209065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65561136|NCT01209065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65561137|NCT02782702|Botulinum Toxins|botulinum toxins|mesh-list
65561138|NCT02782702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65561139|NCT02782702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65561140|NCT02782702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561141|NCT02782702|Cholinergic Agents|cholinergic agents|mesh-ancestor
65561142|NCT02782702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65561143|NCT02782702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561144|NCT01102673|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
65561145|NCT01102673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290271|NCT04166786|Hormones|hormones|mesh-ancestor
65561146|NCT01102673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561147|NCT03481725|Coal Tar|coal tar|mesh-list
65561148|NCT03481725|Keratolytic Agents|keratolytic agents|mesh-ancestor
65561149|NCT03481725|Dermatologic Agents|dermatologic agents|mesh-ancestor
65561150|NCT03472456|Eugenol|eugenol|mesh-list
65561151|NCT03472456|Carticaine|carticaine|mesh-list
65561152|NCT03472456|Anesthetics, Local|anesthetics, local|mesh-ancestor
65561153|NCT03472456|Anesthetics|anesthetics|mesh-ancestor
65561154|NCT03472456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65561155|NCT03472456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561156|NCT03472456|Sensory System Agents|sensory system agents|mesh-ancestor
65561157|NCT03472456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65561158|NCT03472456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65561159|NCT01193881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65561160|NCT01193881|R04929097|r04929097|mesh-list
65561161|NCT01193881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561162|NCT01193881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65561163|NCT01193881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561164|NCT01193881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561165|NCT01194037|Interferons|interferons|mesh-list
65561166|NCT01194037|Interferon-alpha|interferon-alpha|mesh-list
65561167|NCT01194037|Interferon alpha-2|interferon alpha-2|mesh-list
65561168|NCT01194037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65561169|NCT01194037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561170|NCT01194037|Antiviral Agents|antiviral agents|mesh-ancestor
65561171|NCT01194037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65561172|NCT01194037|Immunologic Factors|immunologic factors|mesh-ancestor
65561173|NCT01194037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561174|NCT03480243|Erythromycin|erythromycin|mesh-list
65561175|NCT03480243|Erythromycin Estolate|erythromycin estolate|mesh-list
65561176|NCT03480243|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65561177|NCT03480243|Erythromycin stearate|erythromycin stearate|mesh-list
65561178|NCT03480243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65561179|NCT03480243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65561180|NCT03480243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65561181|NCT03480243|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65561182|NCT03480243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561183|NCT03480243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561185|NCT01109693|Sertraline|sertraline|mesh-list
65561186|NCT01109693|Antidepressive Agents|antidepressive agents|mesh-ancestor
65561187|NCT01109693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65561188|NCT01109693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65561189|NCT01109693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65561190|NCT01109693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65561191|NCT01109693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561192|NCT01109693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65561193|NCT01109693|Serotonin Agents|serotonin agents|mesh-ancestor
65561194|NCT01109693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561195|NCT01109693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65561196|NCT01109693|Histamine Antagonists|histamine antagonists|mesh-ancestor
65561197|NCT01109693|Histamine Agents|histamine agents|mesh-ancestor
65561198|NCT01109693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65561199|NCT01109693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65561200|NCT01109693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65561201|NCT01109693|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65561202|NCT01109693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65561203|NCT01109693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65561204|NCT01109693|Adrenergic Agents|adrenergic agents|mesh-ancestor
65561205|NCT01109693|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65561206|NCT01109693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65561207|NCT01109693|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65561208|NCT01190683|Calcium, Dietary|calcium, dietary|mesh-list
65561209|NCT01190683|Vitamin D|vitamin d|mesh-list
65561210|NCT01190683|Ergocalciferols|ergocalciferols|mesh-list
65561211|NCT01190683|Cholecalciferol|cholecalciferol|mesh-list
65561212|NCT01190683|Vitamins|vitamins|mesh-list
65561213|NCT01190683|Calcium Carbonate|calcium carbonate|mesh-list
65561214|NCT01190683|Calcium|calcium|mesh-list
65561215|NCT01190683|Micronutrients|micronutrients|mesh-ancestor
65561216|NCT01190683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561217|NCT01190683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65561218|NCT01190683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65561219|NCT01190683|Antacids|antacids|mesh-ancestor
65561220|NCT01190683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290349|NCT00723658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65561221|NCT01190683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65561222|NCT01190761|Galantamine|galantamine|mesh-list
65561223|NCT01190761|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65561224|NCT01190761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561225|NCT01190761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561226|NCT01190761|Cholinergic Agents|cholinergic agents|mesh-ancestor
65561227|NCT01190761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65561228|NCT01190761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561229|NCT01190761|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65561230|NCT01190761|Autonomic Agents|autonomic agents|mesh-ancestor
65561231|NCT01190761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65561232|NCT01190761|Nootropic Agents|nootropic agents|mesh-ancestor
65561233|NCT01209455|Acetaminophen|acetaminophen|mesh-list
65561234|NCT01209455|Chlorpheniramine|chlorpheniramine|mesh-list
65561235|NCT01209455|Ranitidine|ranitidine|mesh-list
65561236|NCT01209455|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65561237|NCT01209455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65561238|NCT01209455|Analgesics|analgesics|mesh-ancestor
65561239|NCT01209455|Sensory System Agents|sensory system agents|mesh-ancestor
65561240|NCT01209455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65561241|NCT01209455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561242|NCT01209455|Antipyretics|antipyretics|mesh-ancestor
65561243|NCT01209455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65561244|NCT01209455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65561245|NCT01209455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65561246|NCT01209455|Histamine Antagonists|histamine antagonists|mesh-ancestor
65561247|NCT01209455|Histamine Agents|histamine agents|mesh-ancestor
65561248|NCT01209455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65561249|NCT01209455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561250|NCT01209455|Antipruritics|antipruritics|mesh-ancestor
65561251|NCT01209455|Dermatologic Agents|dermatologic agents|mesh-ancestor
65561252|NCT01209455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65561253|NCT01209455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65561254|NCT01194115|Metronidazole|metronidazole|mesh-list
65561255|NCT01194115|Cephalexin|cephalexin|mesh-list
65358772|NCT00986284|Gefitinib|gefitinib|mesh-list
65561256|NCT01194115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65561257|NCT01194115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65561258|NCT01194115|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65561259|NCT01194115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65561260|NCT01209533|Iloprost|iloprost|mesh-list
65561261|NCT01209533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65561262|NCT01209533|Vasodilator Agents|vasodilator agents|mesh-ancestor
65561263|NCT03847363|Anesthetics|anesthetics|mesh-list
65561264|NCT03847363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65561265|NCT03847363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561266|NCT01207739|Hydroxychloroquine|hydroxychloroquine|mesh-list
65561267|NCT01207739|Doxycycline|doxycycline|mesh-list
65561268|NCT01207739|Clarithromycin|clarithromycin|mesh-list
65561269|NCT01207739|Antimalarials|antimalarials|mesh-ancestor
65561270|NCT01207739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65561271|NCT01207739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65561272|NCT01207739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65561273|NCT01207739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561274|NCT01207739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561275|NCT01207739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65561276|NCT01207739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65561277|NCT01207739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65561278|NCT01207739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65561279|NCT01207739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65561280|NCT03941951|Anti-Infective Agents|anti-infective agents|mesh-list
65561281|NCT03941951|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65561282|NCT03847207|Pasireotide|pasireotide|mesh-list
65561283|NCT03847207|Hormones|hormones|mesh-ancestor
65561284|NCT03847207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65561285|NCT03847207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561286|NCT01192087|Cetuximab|cetuximab|mesh-list
65561287|NCT01192087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65561288|NCT01192087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561289|NCT03942029|Fluconazole|fluconazole|mesh-list
65561290|NCT03942029|Antifungal Agents|antifungal agents|mesh-ancestor
65561291|NCT03942029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65561292|NCT03942029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65561293|NCT03942029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65561294|NCT03942029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561295|NCT03942029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561296|NCT03942029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65561297|NCT03942029|Hormone Antagonists|hormone antagonists|mesh-ancestor
65561298|NCT03942029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65561299|NCT03942029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561300|NCT03942029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65561301|NCT03942029|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65561302|NCT03740945|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65561303|NCT03740945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65561304|NCT03740945|Immunologic Factors|immunologic factors|mesh-ancestor
65561305|NCT03740945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561306|NCT01192165|Paclitaxel|paclitaxel|mesh-list
65561307|NCT01192165|Docetaxel|docetaxel|mesh-list
65561308|NCT01192165|Carboplatin|carboplatin|mesh-list
65561309|NCT01192165|Pemetrexed|pemetrexed|mesh-list
65561310|NCT01192165|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65561311|NCT01192165|Trametinib|trametinib|mesh-list
65561312|NCT01192165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65561313|NCT01192165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561314|NCT01192165|Tubulin Modulators|tubulin modulators|mesh-ancestor
65561315|NCT01192165|Antimitotic Agents|antimitotic agents|mesh-ancestor
65561316|NCT01192165|Mitosis Modulators|mitosis modulators|mesh-ancestor
65561317|NCT01192165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561318|NCT01192165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561319|NCT01192165|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65561320|NCT01192165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65561321|NCT01192165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65561322|NCT01192243|Carboplatin|carboplatin|mesh-list
65561323|NCT01192243|Pemetrexed|pemetrexed|mesh-list
65561324|NCT01192243|Gefitinib|gefitinib|mesh-list
65561325|NCT01192243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561326|NCT01192243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561327|NCT01192243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561328|NCT01192243|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65561329|NCT01192243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65561330|NCT01192243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65561331|NCT01209845|Ketamine|ketamine|mesh-list
65561332|NCT01209845|Analgesics|analgesics|mesh-ancestor
65561333|NCT01209845|Sensory System Agents|sensory system agents|mesh-ancestor
65561334|NCT01209845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65561335|NCT01209845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561336|NCT01209845|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65561337|NCT01209845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65561338|NCT01209845|Anesthetics, General|anesthetics, general|mesh-ancestor
65561339|NCT01209845|Anesthetics|anesthetics|mesh-ancestor
65561340|NCT01209845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65561341|NCT01209845|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65561342|NCT01209845|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65561343|NCT01209845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65561344|NCT01209845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561345|NCT01112813|Lithium Carbonate|lithium carbonate|mesh-list
65561346|NCT01112813|Antidepressive Agents|antidepressive agents|mesh-ancestor
65561347|NCT01112813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65561348|NCT01112813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561349|NCT01112813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561350|NCT01112813|Antimanic Agents|antimanic agents|mesh-ancestor
65561351|NCT01112813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65561352|NCT01112813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65561353|NCT01112813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561354|NCT01196767|Ropivacaine|ropivacaine|mesh-list
65561355|NCT01196767|Anesthetics, Local|anesthetics, local|mesh-ancestor
65561356|NCT01196767|Anesthetics|anesthetics|mesh-ancestor
65561357|NCT01196767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65561358|NCT01196767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561359|NCT01196767|Sensory System Agents|sensory system agents|mesh-ancestor
65561360|NCT01196767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65561361|NCT01211795|Ketoprofen|ketoprofen|mesh-list
65561362|NCT01211795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65561363|NCT01211795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65561364|NCT01211795|Analgesics|analgesics|mesh-ancestor
65561365|NCT01211795|Sensory System Agents|sensory system agents|mesh-ancestor
65561366|NCT01211795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65561367|NCT01211795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561368|NCT01211795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65290493|NCT00723970|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65561369|NCT01211795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65561370|NCT01211795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65561371|NCT01211795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561372|NCT01211795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561373|NCT03451773|Gemcitabine|gemcitabine|mesh-list
65561374|NCT03451773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65561375|NCT03451773|Antimetabolites|antimetabolites|mesh-ancestor
65561376|NCT03451773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561377|NCT03451773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561378|NCT03451773|Antiviral Agents|antiviral agents|mesh-ancestor
65561379|NCT03451773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65561380|NCT03451773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561381|NCT03451773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65561382|NCT03451773|Immunologic Factors|immunologic factors|mesh-ancestor
65561383|NCT03451773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561384|NCT01112891|Vitamin D|vitamin d|mesh-list
65561385|NCT01112891|Ergocalciferols|ergocalciferols|mesh-list
65561386|NCT01112891|Cholecalciferol|cholecalciferol|mesh-list
65561387|NCT01112891|Vitamins|vitamins|mesh-list
65561388|NCT01112891|Micronutrients|micronutrients|mesh-ancestor
65561389|NCT01112891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561390|NCT01112891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65561391|NCT01112891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65561392|NCT03847441|Vitamin D|vitamin d|mesh-list
65561393|NCT03847441|Cholecalciferol|cholecalciferol|mesh-list
65561394|NCT03847441|Calcipotriene|calcipotriene|mesh-list
65561395|NCT03847441|Vitamins|vitamins|mesh-ancestor
65561396|NCT03847441|Micronutrients|micronutrients|mesh-ancestor
65561397|NCT03847441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561398|NCT03847441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65561399|NCT03847441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65561400|NCT03847441|Dermatologic Agents|dermatologic agents|mesh-ancestor
65561401|NCT02529683|NuvaRing|nuvaring|mesh-list
65561402|NCT02529683|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65561403|NCT02529683|Contraceptive Agents|contraceptive agents|mesh-ancestor
65561404|NCT02529683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65561405|NCT02529683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358921|NCT00769548|Goserelin|goserelin|mesh-list
65561406|NCT05406895|Lidocaine|lidocaine|mesh-list
65561407|NCT05406895|Epinephrine|epinephrine|mesh-list
65561408|NCT05406895|Anesthetics, Local|anesthetics, local|mesh-ancestor
65561409|NCT05406895|Anesthetics|anesthetics|mesh-ancestor
65561410|NCT05406895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65561411|NCT05406895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561412|NCT05406895|Sensory System Agents|sensory system agents|mesh-ancestor
65561413|NCT05406895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65561414|NCT05406895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65561415|NCT05406895|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65561416|NCT05406895|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65561417|NCT05406895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65561418|NCT05406895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561419|NCT05406895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65561420|NCT05406895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65561421|NCT05406895|Adrenergic Agents|adrenergic agents|mesh-ancestor
65561422|NCT05406895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65561423|NCT05406895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65561424|NCT05406895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65561425|NCT05406895|Autonomic Agents|autonomic agents|mesh-ancestor
65561426|NCT05406895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65561427|NCT05406895|Respiratory System Agents|respiratory system agents|mesh-ancestor
65561428|NCT05406895|Mydriatics|mydriatics|mesh-ancestor
65561429|NCT05406895|Sympathomimetics|sympathomimetics|mesh-ancestor
65561430|NCT05406895|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65561431|NCT03425253|Lidocaine|lidocaine|mesh-list
65561432|NCT03425253|Anesthetics, Local|anesthetics, local|mesh-ancestor
65561433|NCT03425253|Anesthetics|anesthetics|mesh-ancestor
65561434|NCT03425253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65561435|NCT03425253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561436|NCT03425253|Sensory System Agents|sensory system agents|mesh-ancestor
65561437|NCT03425253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65561438|NCT03425253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65561439|NCT03425253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65561440|NCT03425253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65561441|NCT03425253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65290570|NCT00687258|Vitamin E|vitamin e|mesh-list
65561442|NCT03425253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561443|NCT03941561|Tegafur|tegafur|mesh-list
65561444|NCT03941561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65561445|NCT03941561|Antimetabolites|antimetabolites|mesh-ancestor
65561446|NCT03941561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561447|NCT03941561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561448|NCT05403229|Topiramate|topiramate|mesh-list
65561449|NCT05403229|Anticonvulsants|anticonvulsants|mesh-ancestor
65561450|NCT05403229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65561451|NCT05403229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561452|NCT03424239|Vitamin D|vitamin d|mesh-list
65561453|NCT03424239|Ergocalciferols|ergocalciferols|mesh-list
65561454|NCT03424239|Cholecalciferol|cholecalciferol|mesh-list
65561455|NCT03424239|Zoledronic Acid|zoledronic acid|mesh-list
65561456|NCT03424239|Vitamins|vitamins|mesh-list
65561457|NCT03424239|Micronutrients|micronutrients|mesh-ancestor
65561458|NCT03424239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561459|NCT03424239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65561460|NCT03424239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65561461|NCT03941795|Axitinib|axitinib|mesh-list
65561462|NCT03941795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561463|NCT03941795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65561464|NCT03941795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561465|NCT03941795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561466|NCT01197001|Losartan|losartan|mesh-list
65561467|NCT01197001|Amlodipine|amlodipine|mesh-list
65561468|NCT01197001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65561469|NCT01197001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65561470|NCT01197001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65561471|NCT01197001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561472|NCT01197001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65561473|NCT01197001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561474|NCT01197001|Vasodilator Agents|vasodilator agents|mesh-ancestor
65561475|NCT01197001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65561476|NCT01197001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65561477|NCT01197001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65561478|NCT01113047|Amlodipine|amlodipine|mesh-list
65561479|NCT01113047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65358995|NCT00908817|Hormones|hormones|mesh-ancestor
65561480|NCT01113047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65561481|NCT01113047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65561482|NCT01113047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561483|NCT01113047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65561484|NCT01113047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561485|NCT01113047|Vasodilator Agents|vasodilator agents|mesh-ancestor
65561486|NCT01113125|Fusidic Acid|fusidic acid|mesh-list
65561487|NCT01113125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65561488|NCT01113125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65561489|NCT01113125|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65561490|NCT01113125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561491|NCT01113125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561492|NCT01210391|Caseins|caseins|mesh-list
65561493|NCT01210391|Chelating Agents|chelating agents|mesh-ancestor
65561494|NCT01210391|Sequestering Agents|sequestering agents|mesh-ancestor
65561495|NCT01210391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561496|NCT03846739|Oxytocin|oxytocin|mesh-list
65561497|NCT03846739|Oxytocics|oxytocics|mesh-ancestor
65561498|NCT03846739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65561499|NCT03846739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561500|NCT03716115|Budesonide|budesonide|mesh-list
65561501|NCT03716115|Teduglutide|teduglutide|mesh-list
65561502|NCT03716115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65561503|NCT03716115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65561504|NCT03716115|Autonomic Agents|autonomic agents|mesh-ancestor
65561505|NCT03716115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65561506|NCT03716115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561507|NCT03716115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65561508|NCT03716115|Respiratory System Agents|respiratory system agents|mesh-ancestor
65561509|NCT03716115|Glucocorticoids|glucocorticoids|mesh-ancestor
65561510|NCT03716115|Hormones|hormones|mesh-ancestor
65561511|NCT03716115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65561512|NCT03716115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65561513|NCT03716115|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65561514|NCT03716115|Protective Agents|protective agents|mesh-ancestor
65561515|NCT01113281|Vaccines|vaccines|mesh-list
65561516|NCT01113281|Immunologic Factors|immunologic factors|mesh-ancestor
65561517|NCT01113281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561518|NCT01295593|Cladribine|cladribine|mesh-list
65561519|NCT01295593|Valproic Acid|valproic acid|mesh-list
65561520|NCT01295593|Anticonvulsants|anticonvulsants|mesh-ancestor
65561521|NCT01295593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561522|NCT01295593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561523|NCT01295593|GABA Agents|gaba agents|mesh-ancestor
65561524|NCT01295593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65561525|NCT01295593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561526|NCT01295593|Antimanic Agents|antimanic agents|mesh-ancestor
65561527|NCT01295593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65561528|NCT01295593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65561529|NCT01295593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65561530|NCT01295593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561531|NCT01295593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65561532|NCT01295593|Immunologic Factors|immunologic factors|mesh-ancestor
65561533|NCT03845881|Oxycodone|oxycodone|mesh-list
65561534|NCT03845881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65561535|NCT03845881|Narcotics|narcotics|mesh-ancestor
65561536|NCT03845881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65561537|NCT03845881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561538|NCT03845881|Analgesics|analgesics|mesh-ancestor
65561539|NCT03845881|Sensory System Agents|sensory system agents|mesh-ancestor
65561540|NCT03845881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65561541|NCT01197157|Nitazoxanide|nitazoxanide|mesh-list
65561542|NCT01197157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65561543|NCT01197157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65561544|NCT01296997|Calcium|calcium|mesh-list
65561545|NCT01296997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65561546|NCT01296997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561547|NCT01114841|Tazarotene|tazarotene|mesh-list
65561548|NCT01114841|Dermatologic Agents|dermatologic agents|mesh-ancestor
65561549|NCT01114841|Keratolytic Agents|keratolytic agents|mesh-ancestor
65561550|NCT01113437|Omalizumab|omalizumab|mesh-list
65561551|NCT01113437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65561552|NCT01113437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65561553|NCT01113437|Respiratory System Agents|respiratory system agents|mesh-ancestor
65561554|NCT01197235|Darbepoetin alfa|darbepoetin alfa|mesh-list
65561555|NCT01197235|Hematinics|hematinics|mesh-ancestor
65561556|NCT01192789|Amoxicillin|amoxicillin|mesh-list
65561557|NCT01192789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65561558|NCT01192789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65561559|NCT01211171|Telmisartan|telmisartan|mesh-list
65561560|NCT01211171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65561561|NCT01211171|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65561562|NCT01211171|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65561563|NCT01211171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561564|NCT03846973|Tranexamic Acid|tranexamic acid|mesh-list
65561565|NCT03846973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65561566|NCT03846973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65561567|NCT03846973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561568|NCT03846973|Hemostatics|hemostatics|mesh-ancestor
65561569|NCT03846973|Coagulants|coagulants|mesh-ancestor
65561570|NCT01113515|Esmolol|esmolol|mesh-list
65561571|NCT01113515|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65561572|NCT01113515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65561573|NCT01113515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65561574|NCT01113515|Adrenergic Agents|adrenergic agents|mesh-ancestor
65561575|NCT01113515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65561576|NCT01113515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561577|NCT01113515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561578|NCT01211327|Cyclosporine|cyclosporine|mesh-list
65561579|NCT01211327|Dexamethasone|dexamethasone|mesh-list
65561580|NCT01211327|Cyclosporins|cyclosporins|mesh-list
65561581|NCT01211327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65561582|NCT01211327|Antiemetics|antiemetics|mesh-ancestor
65561583|NCT01211327|Autonomic Agents|autonomic agents|mesh-ancestor
65561584|NCT01211327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65561585|NCT01211327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561586|NCT01211327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65561587|NCT01211327|Glucocorticoids|glucocorticoids|mesh-ancestor
65561588|NCT01211327|Hormones|hormones|mesh-ancestor
65561589|NCT01211327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65561590|NCT01211327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65290717|NCT00992797|Micronutrients|micronutrients|mesh-ancestor
65561591|NCT01211327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561592|NCT01211327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561593|NCT01211327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561594|NCT01211327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65561595|NCT01211327|Immunologic Factors|immunologic factors|mesh-ancestor
65561596|NCT01211327|Antifungal Agents|antifungal agents|mesh-ancestor
65561597|NCT01211327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65561598|NCT01211327|Dermatologic Agents|dermatologic agents|mesh-ancestor
65561599|NCT01211327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65561600|NCT01211327|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65561601|NCT05601895|Sorafenib|sorafenib|mesh-list
65561602|NCT05601895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561603|NCT05601895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65561604|NCT05601895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561605|NCT05601895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561606|NCT01113671|Vitamin E|vitamin e|mesh-list
65561607|NCT01113671|Tocopherols|tocopherols|mesh-list
65561608|NCT01113671|alpha-Tocopherol|alpha-tocopherol|mesh-list
65561609|NCT01113671|Vitamins|vitamins|mesh-ancestor
65561610|NCT01113671|Micronutrients|micronutrients|mesh-ancestor
65561611|NCT01113671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561612|NCT01113671|Antioxidants|antioxidants|mesh-ancestor
65561613|NCT01113671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561614|NCT01113671|Protective Agents|protective agents|mesh-ancestor
65561615|NCT03943043|Gemcitabine|gemcitabine|mesh-list
65561616|NCT03943043|Paclitaxel|paclitaxel|mesh-list
65561617|NCT03943043|Oxaliplatin|oxaliplatin|mesh-list
65561618|NCT03943043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65561619|NCT03943043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561620|NCT03943043|Tubulin Modulators|tubulin modulators|mesh-ancestor
65561621|NCT03943043|Antimitotic Agents|antimitotic agents|mesh-ancestor
65561622|NCT03943043|Mitosis Modulators|mitosis modulators|mesh-ancestor
65561623|NCT03943043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561624|NCT03943043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65561625|NCT03943043|Antimetabolites|antimetabolites|mesh-ancestor
65561626|NCT03943043|Antiviral Agents|antiviral agents|mesh-ancestor
65561627|NCT03943043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65561628|NCT03943043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561629|NCT03943043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65561630|NCT03943043|Immunologic Factors|immunologic factors|mesh-ancestor
65561631|NCT03943043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359155|NCT00927693|Calcium|calcium|mesh-list
65561632|NCT01109927|Insulin|insulin|mesh-list
65561633|NCT01109927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65561634|NCT01109927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561635|NCT03940235|Androgens|androgens|mesh-list
65561636|NCT03940235|Hormones|hormones|mesh-ancestor
65561637|NCT03940235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65561638|NCT03940235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561639|NCT03848533|Metformin|metformin|mesh-list
65561640|NCT03848533|Melatonin|melatonin|mesh-list
65561641|NCT03848533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65561642|NCT03848533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561643|NCT03848533|Antioxidants|antioxidants|mesh-ancestor
65561644|NCT03848533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561645|NCT03848533|Protective Agents|protective agents|mesh-ancestor
65561646|NCT03848533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65561647|NCT01193491|Geldanamycin|geldanamycin|mesh-list
65561648|NCT01193491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65561649|NCT01193491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561650|NCT01193491|Antiviral Agents|antiviral agents|mesh-ancestor
65561651|NCT01193491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65561652|NCT01193491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561653|NCT01193491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561654|NCT01193491|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65561655|NCT01193491|Protease Inhibitors|protease inhibitors|mesh-ancestor
65561656|NCT01110317|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65561657|NCT01110317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65561658|NCT01110317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65561659|NCT01110317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65561660|NCT01110317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561661|NCT01110317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65561662|NCT01110317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65561663|NCT01110317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65561664|NCT01110317|Serotonin Agents|serotonin agents|mesh-ancestor
65290798|NCT03415828|Hormones|hormones|mesh-ancestor
65561665|NCT01110317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65561666|NCT01110317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561667|NCT01110317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65561668|NCT01110317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65561669|NCT01110317|Dopamine Agents|dopamine agents|mesh-ancestor
65561670|NCT01208285|Ivacaftor|ivacaftor|mesh-list
65561671|NCT01208285|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65561672|NCT01208285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65561673|NCT01208285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561674|NCT01208363|Fe(III)-EDTA|fe(iii)-edta|mesh-list
65561675|NCT01208363|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65561676|NCT01208363|Chelating Agents|chelating agents|mesh-ancestor
65561677|NCT01208363|Sequestering Agents|sequestering agents|mesh-ancestor
65561678|NCT01208363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561679|NCT01208441|Letrozole|letrozole|mesh-list
65561680|NCT01208441|R04929097|r04929097|mesh-list
65561681|NCT01208441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561682|NCT01208441|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65561683|NCT01208441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65561684|NCT01208441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561685|NCT01208441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561686|NCT01208441|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65561687|NCT01208441|Hormone Antagonists|hormone antagonists|mesh-ancestor
65561688|NCT01208441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65561689|NCT01208441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561690|NCT03718377|Anesthetics|anesthetics|mesh-list
65561691|NCT03718377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65561692|NCT03718377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561693|NCT01197469|Tadalafil|tadalafil|mesh-list
65561694|NCT01197469|Vasodilator Agents|vasodilator agents|mesh-ancestor
65561695|NCT01197469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65561696|NCT01197469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65561697|NCT01197469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561698|NCT01197469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561699|NCT01197469|Urological Agents|urological agents|mesh-ancestor
65561700|NCT01211561|Selenium|selenium|mesh-list
65561701|NCT01211561|Antioxidants|antioxidants|mesh-ancestor
65561702|NCT01211561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561703|NCT01211561|Protective Agents|protective agents|mesh-ancestor
65561704|NCT01211561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561705|NCT01211561|Trace Elements|trace elements|mesh-ancestor
65561707|NCT05358535|Propofol|propofol|mesh-list
65561708|NCT05358535|Etomidate|etomidate|mesh-list
65561709|NCT05358535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65561710|NCT05358535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65561711|NCT05358535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561712|NCT05358535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65561713|NCT05358535|Anesthetics, General|anesthetics, general|mesh-ancestor
65561714|NCT05358535|Anesthetics|anesthetics|mesh-ancestor
65561715|NCT01213355|Scopolamine|scopolamine|mesh-list
65561716|NCT01213355|Donepezil|donepezil|mesh-list
65561717|NCT01213355|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65561718|NCT01213355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65561719|NCT01213355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561720|NCT01213355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561721|NCT01213355|Cholinergic Agents|cholinergic agents|mesh-ancestor
65561722|NCT01213355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65561723|NCT01213355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561724|NCT01213355|Nootropic Agents|nootropic agents|mesh-ancestor
65561725|NCT01213355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65561726|NCT01213355|Antiemetics|antiemetics|mesh-ancestor
65561727|NCT01213355|Autonomic Agents|autonomic agents|mesh-ancestor
65561728|NCT01213355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65561729|NCT01213355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65561730|NCT01213355|Mydriatics|mydriatics|mesh-ancestor
65561731|NCT01213355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65561732|NCT01213355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65561733|NCT01213355|Parasympatholytics|parasympatholytics|mesh-ancestor
65561734|NCT03938363|Botulinum Toxins|botulinum toxins|mesh-list
65561735|NCT03938363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65561736|NCT03938363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65561737|NCT03938363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561738|NCT03938363|Cholinergic Agents|cholinergic agents|mesh-ancestor
65561739|NCT03938363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65561740|NCT03938363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561741|NCT03848065|Vaccines|vaccines|mesh-list
65561742|NCT03848065|Immunologic Factors|immunologic factors|mesh-ancestor
65561743|NCT03848065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561744|NCT01110473|Azacitidine|azacitidine|mesh-list
65561745|NCT01110473|Ilorasertib|ilorasertib|mesh-list
65561746|NCT01110473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65561747|NCT01110473|Antimetabolites|antimetabolites|mesh-ancestor
65561748|NCT01110473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561749|NCT01110473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561750|NCT01110473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561751|NCT01110473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65561752|NCT05558761|Pentoxifylline|pentoxifylline|mesh-list
65561753|NCT05558761|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65561754|NCT05558761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561755|NCT05558761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561756|NCT05558761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65561757|NCT05558761|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65561758|NCT05558761|Protective Agents|protective agents|mesh-ancestor
65561759|NCT05558761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561760|NCT05558761|Vasodilator Agents|vasodilator agents|mesh-ancestor
65561761|NCT05558761|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65561762|NCT05558761|Antioxidants|antioxidants|mesh-ancestor
65561763|NCT03940391|Chlorpheniramine|chlorpheniramine|mesh-list
65561764|NCT03940391|Midazolam|midazolam|mesh-list
65561765|NCT03940391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65561766|NCT03940391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65561767|NCT03940391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65561768|NCT03940391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561769|NCT03940391|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65561770|NCT03940391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65561771|NCT03940391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65561772|NCT03940391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65561773|NCT03940391|Anesthetics, General|anesthetics, general|mesh-ancestor
65561774|NCT03940391|Anesthetics|anesthetics|mesh-ancestor
65561775|NCT03940391|GABA Modulators|gaba modulators|mesh-ancestor
65561776|NCT03940391|GABA Agents|gaba agents|mesh-ancestor
65561777|NCT03940391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65561778|NCT03940391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561779|NCT03940391|Antipruritics|antipruritics|mesh-ancestor
65561780|NCT03940391|Dermatologic Agents|dermatologic agents|mesh-ancestor
65561781|NCT03940391|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65561782|NCT03940391|Histamine Antagonists|histamine antagonists|mesh-ancestor
65561783|NCT03940391|Histamine Agents|histamine agents|mesh-ancestor
65561784|NCT03940391|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65561785|NCT03715881|Prednisolone|prednisolone|mesh-list
65561786|NCT03715881|Epoetin Alfa|epoetin alfa|mesh-list
65561787|NCT03715881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65561788|NCT03715881|Glucocorticoids|glucocorticoids|mesh-ancestor
65561789|NCT03715881|Hormones|hormones|mesh-ancestor
65561790|NCT03715881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65561791|NCT03715881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561792|NCT03715881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65561793|NCT03715881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561794|NCT03715881|Hematinics|hematinics|mesh-ancestor
65561795|NCT01197781|Verapamil|verapamil|mesh-list
65561796|NCT01197781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65561797|NCT01197781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65561798|NCT01197781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65561799|NCT01197781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561800|NCT01197781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65561801|NCT01197781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561802|NCT01197781|Vasodilator Agents|vasodilator agents|mesh-ancestor
65561803|NCT01110551|Vaccines|vaccines|mesh-list
65561804|NCT01110551|Immunologic Factors|immunologic factors|mesh-ancestor
65561805|NCT01110551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561806|NCT01296139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65561807|NCT01296139|Hematinics|hematinics|mesh-ancestor
65561808|NCT01296139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65561809|NCT01296139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65561810|NCT03940469|Dexamethasone|dexamethasone|mesh-list
65561811|NCT03940469|Dexamethasone acetate|dexamethasone acetate|mesh-list
65561812|NCT03940469|Dexmedetomidine|dexmedetomidine|mesh-list
65561813|NCT03940469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65561814|NCT03940469|Antiemetics|antiemetics|mesh-ancestor
65561815|NCT03940469|Autonomic Agents|autonomic agents|mesh-ancestor
65561816|NCT03940469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65561817|NCT03940469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561818|NCT03940469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65561819|NCT03940469|Glucocorticoids|glucocorticoids|mesh-ancestor
65561820|NCT03940469|Hormones|hormones|mesh-ancestor
65561821|NCT03940469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65561822|NCT03940469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65561823|NCT03940469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561824|NCT03940469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65561825|NCT03940469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65561826|NCT03940469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65561827|NCT03940469|Analgesics|analgesics|mesh-ancestor
65561828|NCT03940469|Sensory System Agents|sensory system agents|mesh-ancestor
65561829|NCT03940469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65561830|NCT03940469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65561831|NCT03940469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65561832|NCT03940469|Adrenergic Agents|adrenergic agents|mesh-ancestor
65561833|NCT03940469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65561834|NCT03940469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561835|NCT01110785|Panitumumab|panitumumab|mesh-list
65561836|NCT01110785|Simvastatin|simvastatin|mesh-list
65561837|NCT01110785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65561838|NCT01110785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65561839|NCT01110785|Antimetabolites|antimetabolites|mesh-ancestor
65561840|NCT01110785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561841|NCT01110785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65561842|NCT01110785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65561843|NCT01110785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561844|NCT01110785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65561845|NCT01110785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561846|NCT03846271|Oxytocin|oxytocin|mesh-list
65561847|NCT03846271|Oxytocics|oxytocics|mesh-ancestor
65561848|NCT03846271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65561849|NCT03846271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561850|NCT01110941|Leucovorin|leucovorin|mesh-list
65561851|NCT01110941|Oxaliplatin|oxaliplatin|mesh-list
65561852|NCT01110941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561853|NCT01110941|Antidotes|antidotes|mesh-ancestor
65561854|NCT01110941|Protective Agents|protective agents|mesh-ancestor
65561855|NCT01110941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561856|NCT01110941|Vitamin B Complex|vitamin b complex|mesh-ancestor
65561857|NCT01110941|Vitamins|vitamins|mesh-ancestor
65561858|NCT01110941|Micronutrients|micronutrients|mesh-ancestor
65561859|NCT03448419|Empagliflozin|empagliflozin|mesh-list
65561860|NCT03448419|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65561861|NCT03448419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561862|NCT03448419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65561863|NCT03448419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561864|NCT01118039|Sunitinib|sunitinib|mesh-list
65561865|NCT01118039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561866|NCT01118039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65561867|NCT01118039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65561868|NCT01118039|Growth Substances|growth substances|mesh-ancestor
65561869|NCT01118039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561870|NCT01118039|Growth Inhibitors|growth inhibitors|mesh-ancestor
65561871|NCT01118039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65561872|NCT01118039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561873|NCT01118039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561874|NCT01213433|Artesunate|artesunate|mesh-list
65561875|NCT01213433|Amodiaquine|amodiaquine|mesh-list
65561876|NCT01213433|Antimalarials|antimalarials|mesh-ancestor
65561877|NCT01213433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65561878|NCT01213433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65561879|NCT01213433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65561880|NCT01213433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561881|NCT01213433|Antiviral Agents|antiviral agents|mesh-ancestor
65561882|NCT01213433|Schistosomicides|schistosomicides|mesh-ancestor
65561883|NCT01213433|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65561884|NCT01213433|Anthelmintics|anthelmintics|mesh-ancestor
65561885|NCT01111253|Amoxicillin|amoxicillin|mesh-list
65561886|NCT01111253|Clavulanic Acid|clavulanic acid|mesh-list
65561887|NCT01111253|Clavulanic Acids|clavulanic acids|mesh-list
65561888|NCT01111253|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65561889|NCT01111253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65561890|NCT01111253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65561891|NCT01111253|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65561892|NCT01111253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561893|NCT01111253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561894|NCT01213667|Ranibizumab|ranibizumab|mesh-list
65561895|NCT01213667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65561896|NCT01213667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65561897|NCT01213667|Growth Substances|growth substances|mesh-ancestor
65561898|NCT01213667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561899|NCT01213667|Growth Inhibitors|growth inhibitors|mesh-ancestor
65561900|NCT01213667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561901|NCT01196065|Memantine|memantine|mesh-list
65561902|NCT01196065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65561903|NCT01196065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65561904|NCT01196065|Dopamine Agents|dopamine agents|mesh-ancestor
65561905|NCT01196065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65561906|NCT01196065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561907|NCT01196065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561908|NCT01196065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65561909|NCT01196065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65561910|NCT05258773|Azasetron|azasetron|mesh-list
65561911|NCT05258773|Antiemetics|antiemetics|mesh-ancestor
65561912|NCT05258773|Autonomic Agents|autonomic agents|mesh-ancestor
65561913|NCT05258773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65561914|NCT05258773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561915|NCT05258773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65561916|NCT05258773|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65561917|NCT05258773|Serotonin Agents|serotonin agents|mesh-ancestor
65561918|NCT05258773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65561919|NCT05258773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561920|NCT03845179|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65561921|NCT03845179|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65561922|NCT03845179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65561923|NCT03845179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561924|NCT03845179|Incretins|incretins|mesh-ancestor
65561925|NCT03845179|Hormones|hormones|mesh-ancestor
65561926|NCT03845179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65561927|NCT03845179|Protease Inhibitors|protease inhibitors|mesh-ancestor
65561928|NCT03845179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561929|NCT03845179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561930|NCT03936023|Saxagliptin|saxagliptin|mesh-list
65561931|NCT03936023|Incretins|incretins|mesh-ancestor
65359446|NCT04864444|Piperaquine|piperaquine|mesh-list
65561932|NCT03936023|Hormones|hormones|mesh-ancestor
65561933|NCT03936023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65561934|NCT03936023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561935|NCT03936023|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65561936|NCT03936023|Protease Inhibitors|protease inhibitors|mesh-ancestor
65561937|NCT03936023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561938|NCT03936023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561939|NCT03936023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65561940|NCT01121705|Interferons|interferons|mesh-list
65561941|NCT01121705|Ribavirin|ribavirin|mesh-list
65561942|NCT01121705|Interferon-alpha|interferon-alpha|mesh-list
65561943|NCT01121705|Interferon alpha-2|interferon alpha-2|mesh-list
65561944|NCT01121705|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65561945|NCT01121705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561946|NCT01121705|Antiviral Agents|antiviral agents|mesh-ancestor
65561947|NCT01121705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65561948|NCT01121705|Antimetabolites|antimetabolites|mesh-ancestor
65561949|NCT01121705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561950|NCT01121705|Immunologic Factors|immunologic factors|mesh-ancestor
65561951|NCT01121705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561952|NCT01196455|Capecitabine|capecitabine|mesh-list
65561953|NCT01196455|Mitomycins|mitomycins|mesh-list
65561954|NCT01196455|Mitomycin|mitomycin|mesh-list
65561955|NCT01196455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65561956|NCT01196455|Antimetabolites|antimetabolites|mesh-ancestor
65561957|NCT01196455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561958|NCT01196455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561959|NCT01196455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65561960|NCT01196455|Alkylating Agents|alkylating agents|mesh-ancestor
65561961|NCT01196455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65561962|NCT01196455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561963|NCT03846583|Trastuzumab|trastuzumab|mesh-list
65561964|NCT03846583|Tucatinib|tucatinib|mesh-list
65561965|NCT03846583|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65561966|NCT03846583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65561967|NCT03846583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65561968|NCT03846583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65561969|NCT03846583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65561970|NCT03846583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561971|NCT03846583|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65561972|NCT03846583|Hormone Antagonists|hormone antagonists|mesh-ancestor
65561973|NCT03846583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65561974|NCT03846583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561975|NCT03846583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65561976|NCT01115543|Calcitriol|calcitriol|mesh-list
65561977|NCT01115543|Alfacalcidol|alfacalcidol|mesh-list
65561978|NCT01115543|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65561979|NCT01115543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65561980|NCT01115543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561981|NCT01115543|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65561982|NCT01115543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65561983|NCT01115543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561984|NCT01115543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65561985|NCT01115543|Vitamins|vitamins|mesh-ancestor
65561986|NCT01115543|Micronutrients|micronutrients|mesh-ancestor
65561987|NCT01115543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65561988|NCT01118429|Oxybutynin|oxybutynin|mesh-list
65561989|NCT01118429|Parasympatholytics|parasympatholytics|mesh-ancestor
65561990|NCT01118429|Autonomic Agents|autonomic agents|mesh-ancestor
65561991|NCT01118429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65561992|NCT01118429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65561993|NCT01118429|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65561994|NCT01118429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65561995|NCT01118429|Cholinergic Agents|cholinergic agents|mesh-ancestor
65561996|NCT01118429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65561997|NCT01118429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65561998|NCT01118429|Urological Agents|urological agents|mesh-ancestor
65561999|NCT01216007|Propofol|propofol|mesh-list
65562000|NCT01216007|Sevoflurane|sevoflurane|mesh-list
65562001|NCT01216007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65562002|NCT01216007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65562003|NCT01216007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562004|NCT01216007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65562005|NCT01216007|Anesthetics, General|anesthetics, general|mesh-ancestor
65562006|NCT01216007|Anesthetics|anesthetics|mesh-ancestor
65562007|NCT01216007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65562008|NCT01216007|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65562010|NCT01198249|Amlodipine|amlodipine|mesh-list
65562011|NCT01198249|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65562012|NCT01198249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65562013|NCT01198249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65562014|NCT01198249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65562015|NCT01198249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562016|NCT01198249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65562017|NCT01198249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562018|NCT01198249|Vasodilator Agents|vasodilator agents|mesh-ancestor
65562019|NCT01198249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65562020|NCT01198249|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65562021|NCT01198249|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65562022|NCT01198249|Diuretics|diuretics|mesh-ancestor
65562023|NCT01198249|Natriuretic Agents|natriuretic agents|mesh-ancestor
65562024|NCT01198249|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65562025|NCT02529761|Sorafenib|sorafenib|mesh-list
65562026|NCT02529761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562027|NCT02529761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65562028|NCT02529761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562029|NCT02529761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562030|NCT03844243|Mitogens|mitogens|mesh-list
65562031|NCT03844243|Mitosis Modulators|mitosis modulators|mesh-ancestor
65562032|NCT03844243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562033|NCT05479591|Xultophy|xultophy|mesh-list
65562034|NCT05479591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65562035|NCT05479591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562036|NCT05479591|Incretins|incretins|mesh-ancestor
65562037|NCT05479591|Hormones|hormones|mesh-ancestor
65562038|NCT05479591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65562039|NCT01119209|Ropivacaine|ropivacaine|mesh-list
65562040|NCT01119209|Anesthetics, Local|anesthetics, local|mesh-ancestor
65562041|NCT01119209|Anesthetics|anesthetics|mesh-ancestor
65562042|NCT01119209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65562043|NCT01119209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562044|NCT01119209|Sensory System Agents|sensory system agents|mesh-ancestor
65562045|NCT01119209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65562046|NCT01213901|Insulin Lispro|insulin lispro|mesh-list
65562047|NCT01213901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65562048|NCT01213901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562049|NCT01116167|Letrozole|letrozole|mesh-list
65562050|NCT01116167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562051|NCT01116167|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65562052|NCT01116167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65562053|NCT01116167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562054|NCT01116167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562055|NCT01116167|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65562056|NCT01116167|Hormone Antagonists|hormone antagonists|mesh-ancestor
65562057|NCT01116167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65562058|NCT01116167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562059|NCT01119521|Isoniazid|isoniazid|mesh-list
65562060|NCT01119521|Antitubercular Agents|antitubercular agents|mesh-ancestor
65562061|NCT01119521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65562062|NCT01119521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65562063|NCT01119521|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65562064|NCT01119521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65562065|NCT01119521|Antimetabolites|antimetabolites|mesh-ancestor
65562066|NCT01119521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562067|NCT01119521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65562068|NCT03939923|Glycopyrrolate|glycopyrrolate|mesh-list
65562069|NCT03939923|Rocuronium|rocuronium|mesh-list
65562070|NCT03939923|Neostigmine|neostigmine|mesh-list
65562071|NCT03939923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65562072|NCT03939923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65562073|NCT03939923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65562074|NCT03939923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65562075|NCT03939923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562076|NCT03939923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65562077|NCT03939923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562078|NCT03939923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562079|NCT03939923|Cholinergic Agents|cholinergic agents|mesh-ancestor
65562080|NCT03939923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65562081|NCT03939923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65562082|NCT03939923|Autonomic Agents|autonomic agents|mesh-ancestor
65562083|NCT03939923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65562084|NCT03939923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65562085|NCT03939923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65562086|NCT01119599|Temozolomide|temozolomide|mesh-list
65562087|NCT01119599|R04929097|r04929097|mesh-list
65562088|NCT01119599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65562089|NCT01119599|Alkylating Agents|alkylating agents|mesh-ancestor
65562090|NCT01119599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562091|NCT01119599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562092|NCT01119599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562093|NCT03419403|Temozolomide|temozolomide|mesh-list
65562094|NCT03419403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65562095|NCT03419403|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65562096|NCT03419403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65562097|NCT03419403|Alkylating Agents|alkylating agents|mesh-ancestor
65562098|NCT03419403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562099|NCT03419403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562100|NCT03419403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65562101|NCT05156437|Amoxicillin|amoxicillin|mesh-list
65562102|NCT05156437|Vancomycin|vancomycin|mesh-list
65562103|NCT05156437|Levofloxacin|levofloxacin|mesh-list
65562104|NCT05156437|Rifampin|rifampin|mesh-list
65562105|NCT05156437|Ceftriaxone|ceftriaxone|mesh-list
65562106|NCT05156437|Linezolid|linezolid|mesh-list
65562107|NCT05156437|Daptomycin|daptomycin|mesh-list
65562108|NCT05156437|Cephalexin|cephalexin|mesh-list
65562109|NCT05156437|Ampicillin|ampicillin|mesh-list
65562110|NCT05156437|Cefepime|cefepime|mesh-list
65562111|NCT05156437|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
65562112|NCT05156437|Oxacillin|oxacillin|mesh-list
65562113|NCT05156437|Dicloxacillin|dicloxacillin|mesh-list
65562114|NCT05156437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65562115|NCT05156437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65562116|NCT05156437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65562117|NCT05156437|Renal Agents|renal agents|mesh-ancestor
65562118|NCT05156437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65562119|NCT05156437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65562120|NCT05156437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562121|NCT05156437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562122|NCT05156437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562123|NCT05156437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65562124|NCT05156437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65562125|NCT05156437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65562126|NCT05156437|Antitubercular Agents|antitubercular agents|mesh-ancestor
65562127|NCT05156437|Leprostatic Agents|leprostatic agents|mesh-ancestor
65562128|NCT05156437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65562129|NCT05156437|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65562130|NCT05156437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65562131|NCT05156437|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65562132|NCT05156437|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65562133|NCT05156437|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65562134|NCT05156437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65562135|NCT05156437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65562136|NCT01119677|Interferon beta-1a|interferon beta-1a|mesh-list
65562137|NCT01119677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65562138|NCT01119677|Immunologic Factors|immunologic factors|mesh-ancestor
65562139|NCT01119677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562140|NCT01119677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562141|NCT01119677|Antiviral Agents|antiviral agents|mesh-ancestor
65562142|NCT01119677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65562143|NCT03715725|Warfarin|warfarin|mesh-list
65562144|NCT03715725|Rivaroxaban|rivaroxaban|mesh-list
65562145|NCT03715725|Dabigatran|dabigatran|mesh-list
65562146|NCT03715725|Apixaban|apixaban|mesh-list
65562147|NCT03715725|Anticoagulants|anticoagulants|mesh-ancestor
65562148|NCT03715725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65562149|NCT03715725|Antithrombins|antithrombins|mesh-ancestor
65562150|NCT03715725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65562151|NCT03715725|Protease Inhibitors|protease inhibitors|mesh-ancestor
65562152|NCT03715725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562153|NCT03715725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562154|NCT01212653|Golimumab|golimumab|mesh-list
65562155|NCT01212653|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65562156|NCT01212653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65562157|NCT01212653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65562158|NCT01212653|Immunologic Factors|immunologic factors|mesh-ancestor
65562159|NCT01212653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562160|NCT01213979|Iron|iron|mesh-list
65562161|NCT01213979|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65562162|NCT01213979|Ferric Compounds|ferric compounds|mesh-list
65562163|NCT01213979|Trace Elements|trace elements|mesh-ancestor
65562164|NCT01213979|Micronutrients|micronutrients|mesh-ancestor
65562165|NCT01213979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562166|NCT01213979|Hematinics|hematinics|mesh-ancestor
65562167|NCT05282719|Azacitidine|azacitidine|mesh-list
65562168|NCT05282719|Venetoclax|venetoclax|mesh-list
65562169|NCT05282719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65562170|NCT05282719|Antimetabolites|antimetabolites|mesh-ancestor
65562171|NCT05282719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562172|NCT05282719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562173|NCT05282719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562174|NCT03447249|Ivacaftor|ivacaftor|mesh-list
65562175|NCT03447249|VX-659|vx-659|mesh-list
65562176|NCT03447249|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65562177|NCT03447249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65562178|NCT03447249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562179|NCT04156555|Amoxicillin|amoxicillin|mesh-list
65562180|NCT04156555|Clavulanic Acid|clavulanic acid|mesh-list
65562181|NCT04156555|Clavulanic Acids|clavulanic acids|mesh-list
65562182|NCT04156555|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65562183|NCT04156555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65562184|NCT04156555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65562185|NCT04156555|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65562186|NCT04156555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562187|NCT04156555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562188|NCT01200121|Bevacizumab|bevacizumab|mesh-list
65562189|NCT01200121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65562190|NCT01200121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562191|NCT01200121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65562192|NCT01200121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65562193|NCT01200121|Growth Substances|growth substances|mesh-ancestor
65562194|NCT01200121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562195|NCT01200121|Growth Inhibitors|growth inhibitors|mesh-ancestor
65562196|NCT01214291|Toremifene|toremifene|mesh-list
65562197|NCT01214291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65562198|NCT01214291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562199|NCT01214291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65562200|NCT01214291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65562201|NCT01214291|Hormone Antagonists|hormone antagonists|mesh-ancestor
65562202|NCT01214291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65562203|NCT01214291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562204|NCT01214291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65562205|NCT01116635|Doxorubicin|doxorubicin|mesh-list
65562206|NCT01116635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65562207|NCT01116635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562208|NCT01116635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65562209|NCT01116635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65562210|NCT01116635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562211|NCT01116635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562212|NCT01566799|Metformin|metformin|mesh-list
65562213|NCT01566799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65562214|NCT01566799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562215|NCT04642807|Calpastatin|calpastatin|mesh-list
65562216|NCT04642807|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65562217|NCT04642807|Protease Inhibitors|protease inhibitors|mesh-ancestor
65562218|NCT04642807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562219|NCT04642807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562220|NCT01216085|Imatinib Mesylate|imatinib mesylate|mesh-list
65562221|NCT01216085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562222|NCT01216085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65562223|NCT01216085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562224|NCT01216085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562225|NCT01198639|Remifentanil|remifentanil|mesh-list
65562226|NCT01198639|Propofol|propofol|mesh-list
65562227|NCT01198639|Anesthetics|anesthetics|mesh-list
65562228|NCT01198639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65562229|NCT01198639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65562230|NCT01198639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562231|NCT01198639|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65359760|NCT04047654|Anticoagulants|anticoagulants|mesh-list
65562232|NCT01198639|Anesthetics, General|anesthetics, general|mesh-ancestor
65562233|NCT01198639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65562234|NCT01198639|Narcotics|narcotics|mesh-ancestor
65562235|NCT01198639|Analgesics|analgesics|mesh-ancestor
65562236|NCT01198639|Sensory System Agents|sensory system agents|mesh-ancestor
65562237|NCT01198639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65562238|NCT01116713|Dexamethasone|dexamethasone|mesh-list
65562239|NCT01116713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65562240|NCT01116713|Antiemetics|antiemetics|mesh-ancestor
65562241|NCT01116713|Autonomic Agents|autonomic agents|mesh-ancestor
65562242|NCT01116713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65562243|NCT01116713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562244|NCT01116713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65562245|NCT01116713|Glucocorticoids|glucocorticoids|mesh-ancestor
65562246|NCT01116713|Hormones|hormones|mesh-ancestor
65562247|NCT01116713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65562248|NCT01116713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65562249|NCT01116713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562250|NCT01202149|Pimecrolimus|pimecrolimus|mesh-list
65562251|NCT01202149|Emollients|emollients|mesh-list
65562252|NCT01202149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65562253|NCT01202149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65562254|NCT01202149|Analgesics|analgesics|mesh-ancestor
65562255|NCT01202149|Sensory System Agents|sensory system agents|mesh-ancestor
65562256|NCT01202149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65562257|NCT01202149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562258|NCT01202149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65562259|NCT01202149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65562260|NCT01202149|Dermatologic Agents|dermatologic agents|mesh-ancestor
65562261|NCT01202149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65562262|NCT01202149|Immunologic Factors|immunologic factors|mesh-ancestor
65562263|NCT01202149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65562264|NCT01202149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562265|NCT01202149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562266|NCT01116791|Cisplatin|cisplatin|mesh-list
65562267|NCT01116791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562268|NCT03717909|Valproic Acid|valproic acid|mesh-list
65562269|NCT03717909|Anticonvulsants|anticonvulsants|mesh-ancestor
65562270|NCT03717909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562271|NCT03717909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562272|NCT03717909|GABA Agents|gaba agents|mesh-ancestor
65562273|NCT03717909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65562274|NCT03717909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562275|NCT03717909|Antimanic Agents|antimanic agents|mesh-ancestor
65562276|NCT03717909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65562277|NCT03717909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65562278|NCT03717909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65562279|NCT03940001|Paclitaxel|paclitaxel|mesh-list
65562280|NCT03940001|Carboplatin|carboplatin|mesh-list
65562281|NCT03940001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65562282|NCT03940001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562283|NCT03940001|Tubulin Modulators|tubulin modulators|mesh-ancestor
65562284|NCT03940001|Antimitotic Agents|antimitotic agents|mesh-ancestor
65562285|NCT03940001|Mitosis Modulators|mitosis modulators|mesh-ancestor
65562286|NCT03940001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562287|NCT01120769|Acetaminophen|acetaminophen|mesh-list
65562288|NCT01120769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65562289|NCT01120769|Analgesics|analgesics|mesh-ancestor
65562290|NCT01120769|Sensory System Agents|sensory system agents|mesh-ancestor
65562291|NCT01120769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65562292|NCT01120769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562293|NCT01120769|Antipyretics|antipyretics|mesh-ancestor
65562294|NCT03715413|Tamoxifen|tamoxifen|mesh-list
65562295|NCT03715413|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65562296|NCT03715413|Hormone Antagonists|hormone antagonists|mesh-ancestor
65562297|NCT03715413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65562298|NCT03715413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562299|NCT03715413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65562300|NCT03715413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562301|NCT03715413|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65562302|NCT03715413|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65562303|NCT03715413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65562304|NCT01122251|Valsartan|valsartan|mesh-list
65562305|NCT01122251|Lercanidipine|lercanidipine|mesh-list
65562306|NCT01122251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65562307|NCT01122251|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65562308|NCT01122251|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65562309|NCT01122251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562310|NCT01122251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65562311|NCT01122251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65562312|NCT01122251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65562313|NCT01122251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562314|NCT04600999|Favipiravir|favipiravir|mesh-list
65562315|NCT04600999|Antiviral Agents|antiviral agents|mesh-ancestor
65562316|NCT04600999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65562317|NCT01199029|Prednisone|prednisone|mesh-list
65562318|NCT01199029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65562319|NCT01199029|Glucocorticoids|glucocorticoids|mesh-ancestor
65562320|NCT01199029|Hormones|hormones|mesh-ancestor
65562321|NCT01199029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65562322|NCT01199029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562323|NCT01199029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65562324|NCT01199029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562325|NCT01200745|Capsaicin|capsaicin|mesh-list
65562326|NCT01200745|Antipruritics|antipruritics|mesh-ancestor
65562327|NCT01200745|Dermatologic Agents|dermatologic agents|mesh-ancestor
65562328|NCT01200745|Sensory System Agents|sensory system agents|mesh-ancestor
65562329|NCT01200745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65562330|NCT01200745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562331|NCT01585415|Aldesleukin|aldesleukin|mesh-list
65562332|NCT01585415|Cyclophosphamide|cyclophosphamide|mesh-list
65562333|NCT01585415|Fludarabine|fludarabine|mesh-list
65562334|NCT01585415|Vemurafenib|vemurafenib|mesh-list
65562335|NCT01585415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65562336|NCT01585415|Immunologic Factors|immunologic factors|mesh-ancestor
65562337|NCT01585415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562338|NCT01585415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65562339|NCT01585415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65562340|NCT01585415|Alkylating Agents|alkylating agents|mesh-ancestor
65562341|NCT01585415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562342|NCT01585415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562343|NCT01585415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65562344|NCT01585415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65562345|NCT01585415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65562346|NCT01585415|Antiviral Agents|antiviral agents|mesh-ancestor
65562347|NCT01585415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65562348|NCT01585415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65562349|NCT01585415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562350|NCT01566643|Metronidazole|metronidazole|mesh-list
65562351|NCT01566643|Rabeprazole|rabeprazole|mesh-list
65562352|NCT01566643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65562353|NCT01566643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65562354|NCT01566643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65562355|NCT01566643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65562356|NCT01566643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65562357|NCT01566643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65562358|NCT01566643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65562359|NCT01566643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562360|NCT01566643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562361|NCT03841747|Paclitaxel|paclitaxel|mesh-list
65562362|NCT03841747|Pembrolizumab|pembrolizumab|mesh-list
65562363|NCT03841747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65562364|NCT03841747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562365|NCT03841747|Tubulin Modulators|tubulin modulators|mesh-ancestor
65562366|NCT03841747|Antimitotic Agents|antimitotic agents|mesh-ancestor
65562367|NCT03841747|Mitosis Modulators|mitosis modulators|mesh-ancestor
65562368|NCT03841747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562369|NCT03841747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65562370|NCT01121237|Epoetin Alfa|epoetin alfa|mesh-list
65562371|NCT01121237|Hematinics|hematinics|mesh-ancestor
65562372|NCT03841591|Metformin|metformin|mesh-list
65562373|NCT03841591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65562374|NCT03841591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562375|NCT05667727|Epinephrine|epinephrine|mesh-list
65562376|NCT05667727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65562377|NCT05667727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65562378|NCT05667727|Adrenergic Agents|adrenergic agents|mesh-ancestor
65562379|NCT05667727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65562380|NCT05667727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359909|NCT02533219|Dopamine Agents|dopamine agents|mesh-ancestor
65562381|NCT05667727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562382|NCT05667727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65562383|NCT05667727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65562384|NCT05667727|Autonomic Agents|autonomic agents|mesh-ancestor
65562385|NCT05667727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65562386|NCT05667727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65562387|NCT05667727|Respiratory System Agents|respiratory system agents|mesh-ancestor
65562389|NCT05667727|Sympathomimetics|sympathomimetics|mesh-ancestor
65562390|NCT05667727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65562391|NCT01200901|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65562392|NCT01200901|Antidepressive Agents|antidepressive agents|mesh-ancestor
65562393|NCT01200901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65562394|NCT01200901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65562395|NCT01200901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65562396|NCT01200901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65562397|NCT01200901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562398|NCT01212809|Hyaluronic Acid|hyaluronic acid|mesh-list
65562399|NCT01212809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65562400|NCT01212809|Immunologic Factors|immunologic factors|mesh-ancestor
65562401|NCT01212809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562402|NCT01212809|Viscosupplements|viscosupplements|mesh-ancestor
65562403|NCT01212809|Protective Agents|protective agents|mesh-ancestor
65562404|NCT01214993|Dolutegravir|dolutegravir|mesh-list
65562405|NCT01214993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65562406|NCT01214993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65562407|NCT01214993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562408|NCT01214993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562409|NCT01214993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65562410|NCT01214993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65562411|NCT01214993|Antiviral Agents|antiviral agents|mesh-ancestor
65562412|NCT01214993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65562413|NCT03843229|Bufanolides|bufanolides|mesh-list
65562414|NCT03843229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65562415|NCT03843229|Protective Agents|protective agents|mesh-ancestor
65562416|NCT03843229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562417|NCT04042753|Nivolumab|nivolumab|mesh-list
65562418|NCT04042753|Ipilimumab|ipilimumab|mesh-list
65562419|NCT04042753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65562420|NCT04042753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562421|NCT04042753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65562422|NCT04042753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562423|NCT01212887|Aldesleukin|aldesleukin|mesh-list
65562424|NCT01212887|Cyclophosphamide|cyclophosphamide|mesh-list
65562425|NCT01212887|Fludarabine|fludarabine|mesh-list
65562426|NCT01212887|Fludarabine phosphate|fludarabine phosphate|mesh-list
65562427|NCT01212887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65562428|NCT01212887|Immunologic Factors|immunologic factors|mesh-ancestor
65562429|NCT01212887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562430|NCT01212887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65562431|NCT01212887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65562432|NCT01212887|Alkylating Agents|alkylating agents|mesh-ancestor
65562433|NCT01212887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562434|NCT01212887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562435|NCT01212887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65562436|NCT01212887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65562437|NCT01212887|Antimetabolites|antimetabolites|mesh-ancestor
65562438|NCT01212887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65562439|NCT01212887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65562440|NCT01212887|Antiviral Agents|antiviral agents|mesh-ancestor
65562441|NCT01212887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65562442|NCT01215149|Vaccines|vaccines|mesh-list
65562443|NCT01215149|Immunologic Factors|immunologic factors|mesh-ancestor
65562444|NCT01215149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562445|NCT03843307|Immunologic Factors|immunologic factors|mesh-list
65562446|NCT03843307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562447|NCT04961281|Triamcinolone|triamcinolone|mesh-list
65562448|NCT04961281|Dexmedetomidine|dexmedetomidine|mesh-list
65562449|NCT04961281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65562450|NCT04961281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65562451|NCT04961281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562452|NCT04961281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65562453|NCT04961281|Analgesics|analgesics|mesh-ancestor
65562454|NCT04961281|Sensory System Agents|sensory system agents|mesh-ancestor
65562455|NCT04961281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65562456|NCT04961281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65562457|NCT04961281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65562458|NCT04961281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65562459|NCT04961281|Adrenergic Agents|adrenergic agents|mesh-ancestor
65562460|NCT04961281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65562461|NCT04961281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562462|NCT04961281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65562463|NCT04961281|Glucocorticoids|glucocorticoids|mesh-ancestor
65562464|NCT04961281|Hormones|hormones|mesh-ancestor
65562465|NCT04961281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65562466|NCT01212965|Selenium|selenium|mesh-list
65562467|NCT01212965|Antioxidants|antioxidants|mesh-ancestor
65562468|NCT01212965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562469|NCT01212965|Protective Agents|protective agents|mesh-ancestor
65562470|NCT01212965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562471|NCT01212965|Trace Elements|trace elements|mesh-ancestor
65562472|NCT01212965|Micronutrients|micronutrients|mesh-ancestor
65562473|NCT02529449|Ipragliflozin|ipragliflozin|mesh-list
65562474|NCT02529449|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65562475|NCT02529449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562476|NCT02529449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65562477|NCT02529449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562478|NCT01216709|Iron|iron|mesh-list
65562479|NCT01216709|Trace Elements|trace elements|mesh-ancestor
65562480|NCT01216709|Micronutrients|micronutrients|mesh-ancestor
65562481|NCT01216709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562482|NCT01216787|R04929097|r04929097|mesh-list
65562483|NCT01216787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562484|NCT01216787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562485|NCT05282251|Bupivacaine|bupivacaine|mesh-list
65562486|NCT05282251|Anesthetics, Local|anesthetics, local|mesh-ancestor
65562487|NCT05282251|Anesthetics|anesthetics|mesh-ancestor
65562488|NCT05282251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65562489|NCT05282251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562490|NCT05282251|Sensory System Agents|sensory system agents|mesh-ancestor
65291623|NCT00675714|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65562491|NCT05282251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65562492|NCT01199341|Warfarin|warfarin|mesh-list
65562493|NCT01199341|Anticoagulants|anticoagulants|mesh-ancestor
65562494|NCT01215539|Panitumumab|panitumumab|mesh-list
65562495|NCT01215539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65562496|NCT01215539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562497|NCT01203709|Mycophenolic Acid|mycophenolic acid|mesh-list
65562498|NCT01203709|Tacrolimus|tacrolimus|mesh-list
65562499|NCT01203709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65562500|NCT01203709|Immunologic Factors|immunologic factors|mesh-ancestor
65562501|NCT01203709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562502|NCT01203709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65562503|NCT01203709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562504|NCT01203709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562505|NCT01203709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65562506|NCT01203709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562507|NCT01203709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65562508|NCT01203709|Antitubercular Agents|antitubercular agents|mesh-ancestor
65562509|NCT01203709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65562510|NCT01203709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65562511|NCT01122407|Trimethaphan|trimethaphan|mesh-list
65562512|NCT01122407|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
65562513|NCT01122407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562514|NCT01122407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65562515|NCT01122407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65562516|NCT01122407|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
65562517|NCT01122407|Autonomic Agents|autonomic agents|mesh-ancestor
65562518|NCT01122407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65562519|NCT01122407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562520|NCT01122407|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65562521|NCT01122407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65562522|NCT01122407|Cholinergic Agents|cholinergic agents|mesh-ancestor
65562523|NCT01122407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65562524|NCT01122407|Vasodilator Agents|vasodilator agents|mesh-ancestor
65562525|NCT01213121|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65562526|NCT01213121|Antidepressive Agents|antidepressive agents|mesh-ancestor
65562527|NCT01213121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65562528|NCT01213121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65562529|NCT01213121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65562530|NCT01213121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65562531|NCT01213121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562532|NCT01124435|Celecoxib|celecoxib|mesh-list
65360081|NCT00776724|Docetaxel|docetaxel|mesh-list
65562533|NCT01124435|Carboplatin|carboplatin|mesh-list
65562534|NCT01124435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562535|NCT01124435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65562536|NCT01124435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65562537|NCT01124435|Analgesics|analgesics|mesh-ancestor
65562538|NCT01124435|Sensory System Agents|sensory system agents|mesh-ancestor
65562539|NCT01124435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65562540|NCT01124435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562541|NCT01124435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65562542|NCT01124435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65562543|NCT01124435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65562544|NCT01124435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65562545|NCT01124435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562546|NCT01124435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562547|NCT03294304|Gemcitabine|gemcitabine|mesh-list
65562548|NCT03294304|Nivolumab|nivolumab|mesh-list
65562549|NCT03294304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562550|NCT03294304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65562551|NCT03294304|Antimetabolites|antimetabolites|mesh-ancestor
65562552|NCT03294304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562553|NCT03294304|Antiviral Agents|antiviral agents|mesh-ancestor
65562554|NCT03294304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65562555|NCT03294304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562556|NCT03294304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65562557|NCT03294304|Immunologic Factors|immunologic factors|mesh-ancestor
65562558|NCT03294304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562559|NCT03294304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65562560|NCT03294304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65562561|NCT01201213|Anesthetics|anesthetics|mesh-list
65562562|NCT01201213|Anesthetics, Local|anesthetics, local|mesh-list
65562563|NCT01201213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65562564|NCT01201213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562565|NCT01201213|Sensory System Agents|sensory system agents|mesh-ancestor
65562566|NCT01201213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65562567|NCT03472378|Celecoxib|celecoxib|mesh-list
65562568|NCT03472378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65562569|NCT03472378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65562570|NCT03472378|Analgesics|analgesics|mesh-ancestor
65562571|NCT03472378|Sensory System Agents|sensory system agents|mesh-ancestor
65562572|NCT03472378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65562573|NCT03472378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562574|NCT03472378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65562575|NCT03472378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65562576|NCT03472378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65562577|NCT03472378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65562578|NCT03472378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562579|NCT03472378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562580|NCT03408873|Aripiprazole|aripiprazole|mesh-list
65562581|NCT03408873|Antidepressive Agents|antidepressive agents|mesh-ancestor
65562582|NCT03408873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65562583|NCT03408873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65562584|NCT03408873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65562585|NCT03408873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65562586|NCT03408873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562587|NCT03408873|Dopamine Agonists|dopamine agonists|mesh-ancestor
65562588|NCT03408873|Dopamine Agents|dopamine agents|mesh-ancestor
65562589|NCT03408873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65562590|NCT03408873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562591|NCT03408873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65562592|NCT03408873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65562593|NCT03408873|Serotonin Agents|serotonin agents|mesh-ancestor
65562594|NCT03408873|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65562595|NCT03408873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65562596|NCT03408873|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65562597|NCT03408873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65562598|NCT03715101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65562599|NCT03715101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65562600|NCT03715101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65562601|NCT03715101|Antimetabolites|antimetabolites|mesh-ancestor
65562602|NCT03715101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562603|NCT03715101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65562604|NCT03715101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65562605|NCT03715101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562606|NCT03780959|Etanercept|etanercept|mesh-list
65562607|NCT03780959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65562608|NCT03780959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65562609|NCT03780959|Analgesics|analgesics|mesh-ancestor
65562610|NCT03780959|Sensory System Agents|sensory system agents|mesh-ancestor
65562611|NCT03780959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65562612|NCT03780959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562613|NCT03780959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65562614|NCT03780959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65562615|NCT03780959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65562616|NCT03780959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65562617|NCT03780959|Immunologic Factors|immunologic factors|mesh-ancestor
65562618|NCT03838783|Insulin|insulin|mesh-list
65562619|NCT03838783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65562620|NCT03838783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562621|NCT03408639|Vitamin B 12|vitamin b 12|mesh-list
65562622|NCT03408639|Hydroxocobalamin|hydroxocobalamin|mesh-list
65562623|NCT03408639|Epoetin Alfa|epoetin alfa|mesh-list
65562624|NCT03408639|Vitamins|vitamins|mesh-ancestor
65562625|NCT03408639|Micronutrients|micronutrients|mesh-ancestor
65562626|NCT03408639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562627|NCT03408639|Vitamin B Complex|vitamin b complex|mesh-ancestor
65562628|NCT03408639|Hematinics|hematinics|mesh-ancestor
65562629|NCT01219205|Bevacizumab|bevacizumab|mesh-list
65562630|NCT01219205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65562631|NCT01219205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562632|NCT01219205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65562633|NCT01219205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65562634|NCT01219205|Growth Substances|growth substances|mesh-ancestor
65562635|NCT01219205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562636|NCT01219205|Growth Inhibitors|growth inhibitors|mesh-ancestor
65562637|NCT03810235|Lidocaine|lidocaine|mesh-list
65291774|NCT02723279|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65562638|NCT03810235|Anesthetics, Local|anesthetics, local|mesh-ancestor
65562639|NCT03810235|Anesthetics|anesthetics|mesh-ancestor
65562640|NCT03810235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65562641|NCT03810235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562642|NCT03810235|Sensory System Agents|sensory system agents|mesh-ancestor
65562643|NCT03810235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65562644|NCT03810235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65562645|NCT03810235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65562646|NCT03810235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65562647|NCT03810235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65562648|NCT03810235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562649|NCT03408483|Epinephrine|epinephrine|mesh-list
65562650|NCT03408483|Analgesics, Opioid|analgesics, opioid|mesh-list
65562651|NCT03408483|Bupivacaine|bupivacaine|mesh-list
65562652|NCT03408483|Anesthetics, Local|anesthetics, local|mesh-ancestor
65562653|NCT03408483|Anesthetics|anesthetics|mesh-ancestor
65562654|NCT03408483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65562655|NCT03408483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562656|NCT03408483|Sensory System Agents|sensory system agents|mesh-ancestor
65562657|NCT03408483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65562658|NCT03408483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65562659|NCT03408483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65562660|NCT03408483|Adrenergic Agents|adrenergic agents|mesh-ancestor
65562661|NCT03408483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65562662|NCT03408483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562663|NCT03408483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65562664|NCT03408483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65562665|NCT03408483|Autonomic Agents|autonomic agents|mesh-ancestor
65562666|NCT03408483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65562667|NCT03408483|Respiratory System Agents|respiratory system agents|mesh-ancestor
65562668|NCT03408483|Mydriatics|mydriatics|mesh-ancestor
65562669|NCT03408483|Sympathomimetics|sympathomimetics|mesh-ancestor
65562670|NCT03408483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65562671|NCT03408483|Narcotics|narcotics|mesh-ancestor
65562672|NCT03408483|Analgesics|analgesics|mesh-ancestor
65562673|NCT03777917|Hyaluronic Acid|hyaluronic acid|mesh-list
65562674|NCT03777917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65562675|NCT03777917|Immunologic Factors|immunologic factors|mesh-ancestor
65562676|NCT03777917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562677|NCT03777917|Viscosupplements|viscosupplements|mesh-ancestor
65562678|NCT03777917|Protective Agents|protective agents|mesh-ancestor
65562679|NCT03715023|PC-786|pc-786|mesh-list
65562680|NCT03715023|Antiviral Agents|antiviral agents|mesh-ancestor
65562681|NCT03715023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65562682|NCT03715023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562683|NCT03715023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562684|NCT03714867|Pregabalin|pregabalin|mesh-list
65562685|NCT03714867|Analgesics|analgesics|mesh-ancestor
65562686|NCT03714867|Sensory System Agents|sensory system agents|mesh-ancestor
65562687|NCT03714867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65562688|NCT03714867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562689|NCT03714867|Anticonvulsants|anticonvulsants|mesh-ancestor
65562690|NCT03714867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65562691|NCT03714867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65562692|NCT03714867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562693|NCT03714867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65562694|NCT03714867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65562695|NCT03714867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65562696|NCT03714867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65562697|NCT03714867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65562698|NCT01204177|Sorafenib|sorafenib|mesh-list
65562699|NCT01204177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562700|NCT01204177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65562701|NCT01204177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562702|NCT01204177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562703|NCT01217099|Azithromycin|azithromycin|mesh-list
65562704|NCT01217099|Methylprednisolone|methylprednisolone|mesh-list
65562705|NCT01217099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65562706|NCT01217099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65562707|NCT01217099|Prednisolone|prednisolone|mesh-list
65562708|NCT01217099|Prednisolone acetate|prednisolone acetate|mesh-list
65562709|NCT01217099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65562710|NCT01217099|Prednisolone phosphate|prednisolone phosphate|mesh-list
65291851|NCT02723435|Midostaurin|midostaurin|mesh-list
65562711|NCT01217099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65562712|NCT01217099|Antiemetics|antiemetics|mesh-ancestor
65562713|NCT01217099|Autonomic Agents|autonomic agents|mesh-ancestor
65562714|NCT01217099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65562715|NCT01217099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562716|NCT01217099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65562717|NCT01217099|Glucocorticoids|glucocorticoids|mesh-ancestor
65562718|NCT01217099|Hormones|hormones|mesh-ancestor
65562719|NCT01217099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65562720|NCT01217099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65562721|NCT01217099|Protective Agents|protective agents|mesh-ancestor
65562722|NCT01217099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65562723|NCT01217099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562724|NCT01217099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65562725|NCT01217099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65562726|NCT04305457|Nitric Oxide|nitric oxide|mesh-list
65562727|NCT04305457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65562728|NCT04305457|Autonomic Agents|autonomic agents|mesh-ancestor
65562729|NCT04305457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65562730|NCT04305457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562731|NCT04305457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65562732|NCT04305457|Respiratory System Agents|respiratory system agents|mesh-ancestor
65562733|NCT04305457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65562734|NCT04305457|Antioxidants|antioxidants|mesh-ancestor
65562735|NCT04305457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562736|NCT04305457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65562737|NCT04305457|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65562738|NCT04305457|Vasodilator Agents|vasodilator agents|mesh-ancestor
65562739|NCT04305457|Gasotransmitters|gasotransmitters|mesh-ancestor
65562740|NCT04305457|Protective Agents|protective agents|mesh-ancestor
65562741|NCT01122563|Solifenacin Succinate|solifenacin succinate|mesh-list
65562742|NCT01122563|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65562743|NCT01122563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65562744|NCT01122563|Cholinergic Agents|cholinergic agents|mesh-ancestor
65562745|NCT01122563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65562746|NCT01122563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562747|NCT01122563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562748|NCT01122563|Urological Agents|urological agents|mesh-ancestor
65562749|NCT01217177|Everolimus|everolimus|mesh-list
65562750|NCT01217177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562751|NCT01217177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65562752|NCT01217177|Immunologic Factors|immunologic factors|mesh-ancestor
65562753|NCT01217177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562754|NCT01204333|Heparin|heparin|mesh-list
65562755|NCT01204333|Anticoagulants|anticoagulants|mesh-ancestor
65562756|NCT01204333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65562757|NCT01204333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65562758|NCT01204333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562760|NCT02529059|Emtricitabine|emtricitabine|mesh-list
65562761|NCT02529059|Rilpivirine|rilpivirine|mesh-list
65562762|NCT02529059|Antiviral Agents|antiviral agents|mesh-ancestor
65562763|NCT02529059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65562764|NCT02529059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65562765|NCT02529059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65562766|NCT02529059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562767|NCT02529059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562768|NCT02529059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65562769|NCT02529059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65562770|NCT03100058|Licogliflozin|licogliflozin|mesh-list
65562771|NCT03100058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65562772|NCT03100058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562773|NCT03100058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65562774|NCT03100058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562775|NCT03932123|Vancomycin|vancomycin|mesh-list
65562776|NCT03932123|Meropenem|meropenem|mesh-list
65562777|NCT03932123|Tazobactam|tazobactam|mesh-list
65562778|NCT03932123|Piperacillin|piperacillin|mesh-list
65562779|NCT03932123|Cefotaxime|cefotaxime|mesh-list
65562780|NCT03932123|Cefoxitin|cefoxitin|mesh-list
65562781|NCT03932123|Azlocillin|azlocillin|mesh-list
65562782|NCT03932123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65562783|NCT03932123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65562784|NCT03932123|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65562785|NCT03932123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562786|NCT03932123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562787|NCT02866279|Contraceptive Agents|contraceptive agents|mesh-list
65562788|NCT02866279|Etonogestrel|etonogestrel|mesh-list
65562789|NCT02866279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65562790|NCT02866279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562791|NCT02866279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65562792|NCT02866279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65562793|NCT01222169|Propofol|propofol|mesh-list
65562794|NCT01222169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65562795|NCT01222169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65562796|NCT01222169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562797|NCT01222169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65562798|NCT01222169|Anesthetics, General|anesthetics, general|mesh-ancestor
65562799|NCT01222169|Anesthetics|anesthetics|mesh-ancestor
65562800|NCT02871778|Ivacaftor|ivacaftor|mesh-list
65562801|NCT02871778|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65562802|NCT02871778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65562803|NCT02871778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562804|NCT04947592|Fluconazole|fluconazole|mesh-list
65562805|NCT04947592|Antifungal Agents|antifungal agents|mesh-ancestor
65562806|NCT04947592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65562807|NCT04947592|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65562808|NCT04947592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65562809|NCT04947592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562810|NCT04947592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562811|NCT04947592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65562812|NCT04947592|Hormone Antagonists|hormone antagonists|mesh-ancestor
65562813|NCT04947592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65562814|NCT04947592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562815|NCT04947592|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65562816|NCT04947592|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65562817|NCT02735473|Choline|choline|mesh-list
65562818|NCT02735473|Lipotropic Agents|lipotropic agents|mesh-ancestor
65562819|NCT02735473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65562820|NCT02735473|Antimetabolites|antimetabolites|mesh-ancestor
65562821|NCT02735473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562822|NCT02735473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65562823|NCT02735473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65562824|NCT02735473|Nootropic Agents|nootropic agents|mesh-ancestor
65562825|NCT05156788|Lenvatinib|lenvatinib|mesh-list
65562826|NCT05156788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562827|NCT05156788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65562828|NCT05156788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562829|NCT05156788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562830|NCT04199767|Insulin|insulin|mesh-list
65562831|NCT04199767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65562832|NCT04199767|Insulin, Isophane|insulin, isophane|mesh-list
65562833|NCT04199767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65562834|NCT04199767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562835|NCT01125059|Methadone|methadone|mesh-list
65562836|NCT01125059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65562837|NCT01125059|Narcotics|narcotics|mesh-ancestor
65562838|NCT01125059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65562839|NCT01125059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562840|NCT01125059|Analgesics|analgesics|mesh-ancestor
65562841|NCT01125059|Sensory System Agents|sensory system agents|mesh-ancestor
65562842|NCT01125059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65562843|NCT01125059|Antitussive Agents|antitussive agents|mesh-ancestor
65562844|NCT01125059|Respiratory System Agents|respiratory system agents|mesh-ancestor
65562845|NCT01204411|Artesunate|artesunate|mesh-list
65562846|NCT01204411|Amodiaquine|amodiaquine|mesh-list
65562847|NCT01204411|Antimalarials|antimalarials|mesh-ancestor
65562848|NCT01204411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65562849|NCT01204411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65562850|NCT01204411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65562851|NCT01204411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562852|NCT01204411|Antiviral Agents|antiviral agents|mesh-ancestor
65562853|NCT01204411|Schistosomicides|schistosomicides|mesh-ancestor
65562854|NCT01204411|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65562855|NCT01204411|Anthelmintics|anthelmintics|mesh-ancestor
65562856|NCT01471444|Methotrexate|methotrexate|mesh-list
65562857|NCT01471444|Fludarabine phosphate|fludarabine phosphate|mesh-list
65562858|NCT01471444|Clofarabine|clofarabine|mesh-list
65562859|NCT01471444|Fludarabine|fludarabine|mesh-list
65562860|NCT01471444|Busulfan|busulfan|mesh-list
65562861|NCT01471444|Tacrolimus|tacrolimus|mesh-list
65292001|NCT02722421|Efavirenz|efavirenz|mesh-list
65562862|NCT01471444|Thymoglobulin|thymoglobulin|mesh-list
65562863|NCT01471444|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65562864|NCT01471444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65562865|NCT01471444|Abortifacient Agents|abortifacient agents|mesh-ancestor
65562866|NCT01471444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65562867|NCT01471444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562868|NCT01471444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65562869|NCT01471444|Antimetabolites|antimetabolites|mesh-ancestor
65562870|NCT01471444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562871|NCT01471444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562872|NCT01471444|Dermatologic Agents|dermatologic agents|mesh-ancestor
65562873|NCT01471444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562874|NCT01471444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65562875|NCT01471444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65562876|NCT01471444|Immunologic Factors|immunologic factors|mesh-ancestor
65562877|NCT01471444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65562878|NCT01471444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65562879|NCT01471444|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65562880|NCT01471444|Alkylating Agents|alkylating agents|mesh-ancestor
65562881|NCT01471444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65562882|NCT01471444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65562883|NCT05282407|Tenofovir|tenofovir|mesh-list
65562884|NCT05282407|Antiviral Agents|antiviral agents|mesh-ancestor
65562885|NCT05282407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65562886|NCT05282407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65562887|NCT05282407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65562888|NCT05282407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562889|NCT05282407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562890|NCT05282407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65562891|NCT05282407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65562892|NCT04209686|Paclitaxel|paclitaxel|mesh-list
65562893|NCT04209686|Pembrolizumab|pembrolizumab|mesh-list
65562894|NCT04209686|Olaparib|olaparib|mesh-list
65562895|NCT04209686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65562896|NCT04209686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562897|NCT04209686|Tubulin Modulators|tubulin modulators|mesh-ancestor
65562898|NCT04209686|Antimitotic Agents|antimitotic agents|mesh-ancestor
65562899|NCT04209686|Mitosis Modulators|mitosis modulators|mesh-ancestor
65562900|NCT04209686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562901|NCT04209686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65562902|NCT04209686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65562903|NCT04209686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562904|NCT01125215|Capsaicin|capsaicin|mesh-list
65562905|NCT01125215|Antipruritics|antipruritics|mesh-ancestor
65562906|NCT01125215|Dermatologic Agents|dermatologic agents|mesh-ancestor
65562907|NCT01125215|Sensory System Agents|sensory system agents|mesh-ancestor
65562908|NCT01125215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65562909|NCT01125215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562910|NCT01217723|Thymoglobulin|thymoglobulin|mesh-list
65562911|NCT01217723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65562912|NCT01217723|Immunologic Factors|immunologic factors|mesh-ancestor
65562913|NCT01217723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562914|NCT01217723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65562916|NCT05162872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65562917|NCT05162872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562918|NCT05162872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562919|NCT05162872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562920|NCT01567111|Metomidate|metomidate|mesh-list
65562921|NCT01567111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65562922|NCT01567111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65562923|NCT01567111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562924|NCT03955211|Acetaminophen|acetaminophen|mesh-list
65562925|NCT03955211|Ibuprofen|ibuprofen|mesh-list
65562926|NCT03955211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65562927|NCT03955211|Analgesics|analgesics|mesh-ancestor
65562928|NCT03955211|Sensory System Agents|sensory system agents|mesh-ancestor
65562929|NCT03955211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65562930|NCT03955211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562931|NCT03955211|Antipyretics|antipyretics|mesh-ancestor
65562932|NCT03955211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65562933|NCT03955211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65562934|NCT03955211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65562935|NCT03955211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65562936|NCT03955211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562937|NCT03955211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562938|NCT03933605|Midazolam|midazolam|mesh-list
65562939|NCT03933605|Palonosetron|palonosetron|mesh-list
65562940|NCT03933605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65562941|NCT03933605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65562942|NCT03933605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65562943|NCT03933605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562944|NCT03933605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65562945|NCT03933605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65562946|NCT03933605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65562947|NCT03933605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65562948|NCT03933605|Anesthetics, General|anesthetics, general|mesh-ancestor
65562949|NCT03933605|Anesthetics|anesthetics|mesh-ancestor
65562950|NCT03933605|GABA Modulators|gaba modulators|mesh-ancestor
65562951|NCT03933605|GABA Agents|gaba agents|mesh-ancestor
65562952|NCT03933605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65562953|NCT03933605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562954|NCT03933605|Antiemetics|antiemetics|mesh-ancestor
65562955|NCT03933605|Autonomic Agents|autonomic agents|mesh-ancestor
65562956|NCT03933605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65562957|NCT03933605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65562958|NCT03933605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65562959|NCT03933605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65562960|NCT03933605|Serotonin Agents|serotonin agents|mesh-ancestor
65562961|NCT03714789|Dialysis Solutions|dialysis solutions|mesh-list
65562962|NCT03714789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65562963|NCT01127477|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65562964|NCT01127477|Plasma Substitutes|plasma substitutes|mesh-ancestor
65562965|NCT01127477|Blood Substitutes|blood substitutes|mesh-ancestor
65562966|NCT05281861|Lithium Carbonate|lithium carbonate|mesh-list
65562967|NCT05281861|Antidepressive Agents|antidepressive agents|mesh-ancestor
65562968|NCT05281861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65562969|NCT05281861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562970|NCT05281861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562971|NCT05281861|Antimanic Agents|antimanic agents|mesh-ancestor
65562972|NCT05281861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65562973|NCT05281861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65562974|NCT05281861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562975|NCT01311141|Doripenem|doripenem|mesh-list
65562976|NCT01311141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65562977|NCT01311141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65562978|NCT01122641|Vildagliptin|vildagliptin|mesh-list
65562979|NCT01122641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65562980|NCT01122641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65562981|NCT01122641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65562982|NCT01122641|Protease Inhibitors|protease inhibitors|mesh-ancestor
65562983|NCT01122641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65562984|NCT01122641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562985|NCT03423979|Paclitaxel|paclitaxel|mesh-list
65562986|NCT03423979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65562987|NCT03423979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65562988|NCT03423979|Tubulin Modulators|tubulin modulators|mesh-ancestor
65562989|NCT03423979|Antimitotic Agents|antimitotic agents|mesh-ancestor
65562990|NCT03423979|Mitosis Modulators|mitosis modulators|mesh-ancestor
65562991|NCT03423979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65562992|NCT03714555|Copper|copper|mesh-list
65562993|NCT03714555|Gemcitabine|gemcitabine|mesh-list
65562994|NCT03714555|Paclitaxel|paclitaxel|mesh-list
65562995|NCT03714555|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65562996|NCT03714555|Folfirinox|folfirinox|mesh-list
65562997|NCT03714555|Disulfiram|disulfiram|mesh-list
65562998|NCT03714555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65562999|NCT03714555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563000|NCT03714555|Tubulin Modulators|tubulin modulators|mesh-ancestor
65563001|NCT03714555|Antimitotic Agents|antimitotic agents|mesh-ancestor
65563002|NCT03714555|Mitosis Modulators|mitosis modulators|mesh-ancestor
65563003|NCT03714555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563004|NCT03714555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65563005|NCT03714555|Antimetabolites|antimetabolites|mesh-ancestor
65563006|NCT03714555|Antiviral Agents|antiviral agents|mesh-ancestor
65563007|NCT03714555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65563008|NCT03714555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563009|NCT03714555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65563010|NCT03714555|Immunologic Factors|immunologic factors|mesh-ancestor
65563011|NCT03714555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292150|NCT02704156|Gemcitabine|gemcitabine|mesh-list
65563012|NCT03714555|Trace Elements|trace elements|mesh-ancestor
65563013|NCT03714555|Micronutrients|micronutrients|mesh-ancestor
65563014|NCT03714555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65563015|NCT03714555|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65563016|NCT01125449|Ascorbic Acid|ascorbic acid|mesh-list
65563017|NCT01125449|Vitamins|vitamins|mesh-ancestor
65563018|NCT01125449|Micronutrients|micronutrients|mesh-ancestor
65563019|NCT01125449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563020|NCT01125449|Antioxidants|antioxidants|mesh-ancestor
65563021|NCT01125449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563022|NCT01125449|Protective Agents|protective agents|mesh-ancestor
65563023|NCT01206049|Gemcitabine|gemcitabine|mesh-list
65563024|NCT01206049|Bevacizumab|bevacizumab|mesh-list
65563025|NCT01206049|Panitumumab|panitumumab|mesh-list
65563026|NCT01206049|Capecitabine|capecitabine|mesh-list
65563027|NCT01206049|Oxaliplatin|oxaliplatin|mesh-list
65563028|NCT01206049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65563029|NCT01206049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563030|NCT01206049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65563031|NCT01206049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65563032|NCT01206049|Growth Substances|growth substances|mesh-ancestor
65563033|NCT01206049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563034|NCT01206049|Growth Inhibitors|growth inhibitors|mesh-ancestor
65563035|NCT01206049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65563036|NCT01206049|Antimetabolites|antimetabolites|mesh-ancestor
65563037|NCT01206049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563038|NCT01206049|Antiviral Agents|antiviral agents|mesh-ancestor
65563039|NCT01206049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65563040|NCT01206049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563041|NCT01206049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65563042|NCT01206049|Immunologic Factors|immunologic factors|mesh-ancestor
65563043|NCT03931889|Vitamin D|vitamin d|mesh-list
65563044|NCT03931889|Cholecalciferol|cholecalciferol|mesh-list
65563045|NCT03931889|Vitamins|vitamins|mesh-ancestor
65563046|NCT03931889|Micronutrients|micronutrients|mesh-ancestor
65563047|NCT03931889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563048|NCT03931889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65563049|NCT03931889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65563050|NCT02953821|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65563051|NCT02953821|Hormones|hormones|mesh-ancestor
65563052|NCT02953821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65563053|NCT02953821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563054|NCT01206205|Lenalidomide|lenalidomide|mesh-list
65563055|NCT01206205|Bortezomib|bortezomib|mesh-list
65563056|NCT01206205|Immunologic Factors|immunologic factors|mesh-ancestor
65563057|NCT01206205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563058|NCT01206205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65563059|NCT01206205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65563060|NCT01206205|Growth Substances|growth substances|mesh-ancestor
65563061|NCT01206205|Growth Inhibitors|growth inhibitors|mesh-ancestor
65563062|NCT01206205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360588|NCT00926757|Entecavir|entecavir|mesh-list
65563063|NCT03783923|Deflazacort|deflazacort|mesh-list
65563064|NCT03783923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65563065|NCT03783923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65563066|NCT03783923|Immunologic Factors|immunologic factors|mesh-ancestor
65563067|NCT03783923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563068|NCT03472144|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65563069|NCT03472144|Levofloxacin|levofloxacin|mesh-list
65563070|NCT03472144|Ofloxacin|ofloxacin|mesh-list
65563071|NCT03472144|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65563072|NCT03472144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65563073|NCT03472144|Antitubercular Agents|antitubercular agents|mesh-ancestor
65563074|NCT03472144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65563075|NCT03472144|Renal Agents|renal agents|mesh-ancestor
65563076|NCT03472144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65563077|NCT03472144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65563078|NCT03472144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563079|NCT03472144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563080|NCT03472144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563081|NCT03472144|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65563082|NCT03472144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65563083|NCT03417141|Mechlorethamine|mechlorethamine|mesh-list
65563084|NCT03417141|Alkylating Agents|alkylating agents|mesh-ancestor
65563085|NCT03417141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563086|NCT03417141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65563087|NCT03417141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563088|NCT01219751|Sunitinib|sunitinib|mesh-list
65563089|NCT01219751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563090|NCT01219751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65563091|NCT01219751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65563092|NCT01219751|Growth Substances|growth substances|mesh-ancestor
65563093|NCT01219751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563094|NCT01219751|Growth Inhibitors|growth inhibitors|mesh-ancestor
65563095|NCT01219751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65563096|NCT01219751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563097|NCT01219751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563098|NCT04823091|Cyclophosphamide|cyclophosphamide|mesh-list
65563099|NCT04823091|Fludarabine|fludarabine|mesh-list
65563100|NCT04823091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65563101|NCT04823091|Immunologic Factors|immunologic factors|mesh-ancestor
65563102|NCT04823091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563103|NCT04823091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65563104|NCT04823091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65563105|NCT04823091|Alkylating Agents|alkylating agents|mesh-ancestor
65563106|NCT04823091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563107|NCT04823091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563108|NCT04823091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65563109|NCT01125527|Vaccines|vaccines|mesh-list
65563110|NCT01125527|Immunologic Factors|immunologic factors|mesh-ancestor
65563111|NCT01125527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563112|NCT01298401|Gemcitabine|gemcitabine|mesh-list
65563113|NCT01298401|Capecitabine|capecitabine|mesh-list
65563114|NCT01298401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65563115|NCT01298401|Antimetabolites|antimetabolites|mesh-ancestor
65563116|NCT01298401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563117|NCT01298401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563118|NCT01298401|Antiviral Agents|antiviral agents|mesh-ancestor
65563119|NCT01298401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65563120|NCT01298401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563121|NCT01298401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65563122|NCT01298401|Immunologic Factors|immunologic factors|mesh-ancestor
65563123|NCT01298401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563124|NCT03931343|Epinephrine|epinephrine|mesh-list
65563125|NCT03931343|Racepinephrine|racepinephrine|mesh-list
65563126|NCT03931343|Bupivacaine|bupivacaine|mesh-list
65563127|NCT03931343|Epinephryl borate|epinephryl borate|mesh-list
65563128|NCT03931343|Anesthetics, Local|anesthetics, local|mesh-ancestor
65563129|NCT03931343|Anesthetics|anesthetics|mesh-ancestor
65563130|NCT03931343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65563131|NCT03931343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563132|NCT03931343|Sensory System Agents|sensory system agents|mesh-ancestor
65563133|NCT03931343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65563134|NCT03931343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65563135|NCT03931343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65563136|NCT03931343|Adrenergic Agents|adrenergic agents|mesh-ancestor
65563137|NCT03931343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65360663|NCT04060550|Omalizumab|omalizumab|mesh-list
65563138|NCT03931343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563140|NCT03931343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65563141|NCT03931343|Autonomic Agents|autonomic agents|mesh-ancestor
65563142|NCT03931343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65563143|NCT03931343|Respiratory System Agents|respiratory system agents|mesh-ancestor
65563144|NCT03931343|Mydriatics|mydriatics|mesh-ancestor
65563145|NCT03931343|Sympathomimetics|sympathomimetics|mesh-ancestor
65563146|NCT03931343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65563147|NCT04046614|Nivolumab|nivolumab|mesh-list
65563148|NCT04046614|Nintedanib|nintedanib|mesh-list
65563149|NCT04046614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65563150|NCT04046614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563151|NCT04046614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65563152|NCT04046614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563153|NCT04046614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65563154|NCT04046614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563155|NCT04867798|Tenofovir|tenofovir|mesh-list
65563156|NCT04867798|Lamivudine|lamivudine|mesh-list
65563157|NCT04867798|Antiviral Agents|antiviral agents|mesh-ancestor
65563158|NCT04867798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65563159|NCT04867798|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65563160|NCT04867798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65563161|NCT04867798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563162|NCT04867798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563163|NCT04867798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65563164|NCT04867798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65563165|NCT01122953|Phenytoin|phenytoin|mesh-list
65563166|NCT01122953|Anticonvulsants|anticonvulsants|mesh-ancestor
65563167|NCT01122953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65563168|NCT01122953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65563169|NCT01122953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65563170|NCT01122953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563171|NCT01122953|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65563172|NCT01122953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65563173|NCT01125683|Donepezil|donepezil|mesh-list
65563174|NCT01125683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65563175|NCT01125683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563176|NCT01125683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563177|NCT01125683|Cholinergic Agents|cholinergic agents|mesh-ancestor
65563178|NCT01125683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65563179|NCT01125683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563180|NCT01125683|Nootropic Agents|nootropic agents|mesh-ancestor
65563181|NCT01127555|Leucovorin|leucovorin|mesh-list
65563182|NCT01127555|Fluorouracil|fluorouracil|mesh-list
65563183|NCT01127555|Oxaliplatin|oxaliplatin|mesh-list
65563184|NCT01127555|Antimetabolites|antimetabolites|mesh-ancestor
65563185|NCT01127555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563186|NCT01127555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65563187|NCT01127555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563188|NCT01127555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65563189|NCT01127555|Immunologic Factors|immunologic factors|mesh-ancestor
65563190|NCT01127555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563191|NCT01127555|Antidotes|antidotes|mesh-ancestor
65563192|NCT01127555|Protective Agents|protective agents|mesh-ancestor
65563193|NCT01127555|Vitamin B Complex|vitamin b complex|mesh-ancestor
65563194|NCT01127555|Vitamins|vitamins|mesh-ancestor
65563195|NCT01127555|Micronutrients|micronutrients|mesh-ancestor
65563196|NCT01219907|Cyclophosphamide|cyclophosphamide|mesh-list
65563197|NCT01219907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65563198|NCT01219907|Immunologic Factors|immunologic factors|mesh-ancestor
65563199|NCT01219907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563200|NCT01219907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65563201|NCT01219907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65563202|NCT01219907|Alkylating Agents|alkylating agents|mesh-ancestor
65563203|NCT01219907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563204|NCT01219907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563205|NCT01219907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65563206|NCT03471988|Voriconazole|voriconazole|mesh-list
65563207|NCT03471988|Antifungal Agents|antifungal agents|mesh-ancestor
65563208|NCT03471988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65563209|NCT03471988|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65563210|NCT03471988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65563211|NCT03471988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563212|NCT03471988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563213|NCT03471988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65563214|NCT03471988|Hormone Antagonists|hormone antagonists|mesh-ancestor
65563215|NCT03471988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65563216|NCT03471988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563217|NCT03471988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65563218|NCT03724981|Dulaglutide|dulaglutide|mesh-list
65563219|NCT03724981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65563220|NCT03724981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563221|NCT03442569|Nivolumab|nivolumab|mesh-list
65563222|NCT03442569|Ipilimumab|ipilimumab|mesh-list
65563223|NCT03442569|Panitumumab|panitumumab|mesh-list
65563224|NCT03442569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65563225|NCT03442569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563226|NCT03442569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65563227|NCT03442569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563228|NCT01123031|Esomeprazole|esomeprazole|mesh-list
65563229|NCT01123031|Lansoprazole|lansoprazole|mesh-list
65563230|NCT01123031|Dexlansoprazole|dexlansoprazole|mesh-list
65563231|NCT01123031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65563232|NCT01123031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65563233|NCT01123031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65563234|NCT01123031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563235|NCT01123031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563236|NCT01220063|Irinotecan|irinotecan|mesh-list
65563237|NCT01220063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65563238|NCT01220063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65563239|NCT01220063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563240|NCT01220063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563241|NCT01220063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563242|NCT01298713|Tamoxifen|tamoxifen|mesh-list
65563243|NCT01298713|Everolimus|everolimus|mesh-list
65563244|NCT01298713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563245|NCT01298713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65563246|NCT01298713|Immunologic Factors|immunologic factors|mesh-ancestor
65563247|NCT01298713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563248|NCT01298713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65563249|NCT01298713|Hormone Antagonists|hormone antagonists|mesh-ancestor
65563250|NCT01298713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65563251|NCT01298713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65563252|NCT01298713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65563253|NCT01298713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65563254|NCT01298713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65563255|NCT01223339|Ertugliflozin|ertugliflozin|mesh-list
65563256|NCT01223339|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65563257|NCT01223339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563258|NCT01223339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65563259|NCT01223339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563260|NCT04496596|Suramin|suramin|mesh-list
65563261|NCT04496596|Antinematodal Agents|antinematodal agents|mesh-ancestor
65563262|NCT04496596|Anthelmintics|anthelmintics|mesh-ancestor
65563263|NCT04496596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65563264|NCT04496596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65563265|NCT04496596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563266|NCT04496596|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65563267|NCT04496596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65563268|NCT01217879|Telmisartan|telmisartan|mesh-list
65563269|NCT01217879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65563270|NCT01217879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65563271|NCT01217879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65563272|NCT01217879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563273|NCT01218035|Zoledronic Acid|zoledronic acid|mesh-list
65563274|NCT01218035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65563275|NCT01218035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563276|NCT04249310|Tiotropium Bromide|tiotropium bromide|mesh-list
65563277|NCT04249310|Olodaterol|olodaterol|mesh-list
65563278|NCT04249310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65563279|NCT04249310|Autonomic Agents|autonomic agents|mesh-ancestor
65563280|NCT04249310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65563281|NCT04249310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563282|NCT04249310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65563283|NCT04249310|Respiratory System Agents|respiratory system agents|mesh-ancestor
65563284|NCT04249310|Parasympatholytics|parasympatholytics|mesh-ancestor
65563285|NCT04249310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65563286|NCT04249310|Cholinergic Agents|cholinergic agents|mesh-ancestor
65563287|NCT04249310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65563288|NCT04249310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563289|NCT05665075|Cytarabine|cytarabine|mesh-list
65563290|NCT05665075|Cyclophosphamide|cyclophosphamide|mesh-list
65563291|NCT05665075|Fludarabine|fludarabine|mesh-list
65563292|NCT05665075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65563293|NCT05665075|Immunologic Factors|immunologic factors|mesh-ancestor
65563294|NCT05665075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563295|NCT05665075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65563296|NCT05665075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65563297|NCT05665075|Alkylating Agents|alkylating agents|mesh-ancestor
65563298|NCT05665075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563299|NCT05665075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563300|NCT05665075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65563301|NCT05665075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65563302|NCT05665075|Antimetabolites|antimetabolites|mesh-ancestor
65563303|NCT05665075|Antiviral Agents|antiviral agents|mesh-ancestor
65563304|NCT05665075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65563305|NCT03714165|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65563306|NCT03714165|alpha-Defensins|alpha-defensins|mesh-list
65563307|NCT03714165|Defensins|defensins|mesh-list
65563308|NCT03714165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65563309|NCT03442101|Antipsychotic Agents|antipsychotic agents|mesh-list
65563310|NCT03442101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65563311|NCT03442101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65563312|NCT03442101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563313|NCT03442101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65563314|NCT03932825|Nitrous Oxide|nitrous oxide|mesh-list
65563315|NCT03932825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65563316|NCT03932825|Anesthetics, General|anesthetics, general|mesh-ancestor
65563317|NCT03932825|Anesthetics|anesthetics|mesh-ancestor
65563318|NCT03932825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65563319|NCT03932825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563320|NCT03932825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65563321|NCT03932825|Analgesics|analgesics|mesh-ancestor
65563322|NCT03932825|Sensory System Agents|sensory system agents|mesh-ancestor
65563323|NCT03932825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65563324|NCT03932981|Temozolomide|temozolomide|mesh-list
65563325|NCT03932981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65563326|NCT03932981|Alkylating Agents|alkylating agents|mesh-ancestor
65563327|NCT03932981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563328|NCT03932981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563329|NCT01220219|Pregabalin|pregabalin|mesh-list
65563330|NCT01220219|Analgesics|analgesics|mesh-ancestor
65563331|NCT01220219|Sensory System Agents|sensory system agents|mesh-ancestor
65563332|NCT01220219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65563333|NCT01220219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563334|NCT01220219|Anticonvulsants|anticonvulsants|mesh-ancestor
65563335|NCT01220219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65563336|NCT01220219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65563337|NCT01220219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563338|NCT01220219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65563339|NCT01220219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65563340|NCT01220219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65563341|NCT01220219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65563342|NCT01220219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65563343|NCT03441789|Betamethasone|betamethasone|mesh-list
65563344|NCT03441789|Betamethasone Valerate|betamethasone valerate|mesh-list
65563345|NCT03441789|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65563346|NCT03441789|Betamethasone benzoate|betamethasone benzoate|mesh-list
65563347|NCT03441789|Calcipotriene|calcipotriene|mesh-list
65563348|NCT03441789|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65563349|NCT03441789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65563350|NCT03441789|Glucocorticoids|glucocorticoids|mesh-ancestor
65563351|NCT03441789|Hormones|hormones|mesh-ancestor
65563352|NCT03441789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65563353|NCT03441789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563354|NCT03441789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65563355|NCT03441789|Respiratory System Agents|respiratory system agents|mesh-ancestor
65563356|NCT03441789|Dermatologic Agents|dermatologic agents|mesh-ancestor
65563357|NCT03359005|Vincristine|vincristine|mesh-list
65563358|NCT03359005|Temozolomide|temozolomide|mesh-list
65563359|NCT03359005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65563360|NCT03359005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563361|NCT03359005|Tubulin Modulators|tubulin modulators|mesh-ancestor
65563362|NCT03359005|Antimitotic Agents|antimitotic agents|mesh-ancestor
65563363|NCT03359005|Mitosis Modulators|mitosis modulators|mesh-ancestor
65563364|NCT03359005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563365|NCT03359005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65563366|NCT03359005|Alkylating Agents|alkylating agents|mesh-ancestor
65563367|NCT04321174|Ritonavir|ritonavir|mesh-list
65563368|NCT04321174|Lopinavir|lopinavir|mesh-list
65563369|NCT04321174|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65563370|NCT04321174|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65563371|NCT04321174|Protease Inhibitors|protease inhibitors|mesh-ancestor
65563372|NCT04321174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563373|NCT04321174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563374|NCT04321174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65563375|NCT04321174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65563376|NCT04321174|Antiviral Agents|antiviral agents|mesh-ancestor
65563377|NCT04321174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65563378|NCT04321174|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65563379|NCT04321174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65563380|NCT01123265|Methotrexate|methotrexate|mesh-list
65563381|NCT01123265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65563382|NCT01123265|Abortifacient Agents|abortifacient agents|mesh-ancestor
65563383|NCT01123265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65563384|NCT01123265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563385|NCT01123265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65563386|NCT01123265|Antimetabolites|antimetabolites|mesh-ancestor
65563387|NCT01123265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563388|NCT01123265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563389|NCT01123265|Dermatologic Agents|dermatologic agents|mesh-ancestor
65563390|NCT01123265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563391|NCT01123265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65563392|NCT01123265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65563393|NCT01123265|Immunologic Factors|immunologic factors|mesh-ancestor
65563394|NCT01123265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65563395|NCT01123265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65563396|NCT01204723|Aprepitant|aprepitant|mesh-list
65563397|NCT01204723|Fosaprepitant|fosaprepitant|mesh-list
65563398|NCT01204723|Antiemetics|antiemetics|mesh-ancestor
65563399|NCT01204723|Autonomic Agents|autonomic agents|mesh-ancestor
65563400|NCT01204723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65563401|NCT01204723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563402|NCT01204723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65563403|NCT01204723|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65563404|NCT01204723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65563405|NCT01204723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563406|NCT01204801|Doxorubicin|doxorubicin|mesh-list
65563407|NCT01204801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65563408|NCT01204801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65563409|NCT01204801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563410|NCT01204801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65563411|NCT01204801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65563412|NCT01204801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563413|NCT01204801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563414|NCT04194814|Betamethasone|betamethasone|mesh-list
65563415|NCT04194814|Betamethasone Valerate|betamethasone valerate|mesh-list
65563416|NCT04194814|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65563417|NCT04194814|Betamethasone benzoate|betamethasone benzoate|mesh-list
65563418|NCT04194814|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65563419|NCT04194814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65563420|NCT04194814|Glucocorticoids|glucocorticoids|mesh-ancestor
65563421|NCT04194814|Hormones|hormones|mesh-ancestor
65563422|NCT04194814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65563423|NCT04194814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563424|NCT04194814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65563425|NCT04194814|Respiratory System Agents|respiratory system agents|mesh-ancestor
65563426|NCT03832621|Nivolumab|nivolumab|mesh-list
65563427|NCT03832621|Ipilimumab|ipilimumab|mesh-list
65563428|NCT03832621|Temozolomide|temozolomide|mesh-list
65563429|NCT03832621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65563430|NCT03832621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563431|NCT03832621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65563432|NCT03832621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563433|NCT03832621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65563434|NCT03832621|Alkylating Agents|alkylating agents|mesh-ancestor
65563436|NCT01220375|Vinorelbine|vinorelbine|mesh-list
65563437|NCT01220375|Lenograstim|lenograstim|mesh-list
65563438|NCT01220375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65563439|NCT01220375|Immunologic Factors|immunologic factors|mesh-ancestor
65563440|NCT01220375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563441|NCT01220375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65563442|NCT01220375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563443|NCT01220375|Tubulin Modulators|tubulin modulators|mesh-ancestor
65563444|NCT01220375|Antimitotic Agents|antimitotic agents|mesh-ancestor
65563445|NCT01220375|Mitosis Modulators|mitosis modulators|mesh-ancestor
65563446|NCT01220375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563447|NCT01220375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65563448|NCT01220375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65563449|NCT01220375|Antiviral Agents|antiviral agents|mesh-ancestor
65563450|NCT01220375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65563451|NCT01223729|Acetylcarnitine|acetylcarnitine|mesh-list
65563452|NCT01223729|Vitamin B Complex|vitamin b complex|mesh-ancestor
65563453|NCT01223729|Vitamins|vitamins|mesh-ancestor
65563454|NCT01223729|Micronutrients|micronutrients|mesh-ancestor
65563455|NCT01223729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563456|NCT01223729|Nootropic Agents|nootropic agents|mesh-ancestor
65563457|NCT01126073|Niacin|niacin|mesh-list
65563458|NCT01126073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65563459|NCT01126073|Antimetabolites|antimetabolites|mesh-ancestor
65563460|NCT01126073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563461|NCT01126073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65563462|NCT01126073|Vasodilator Agents|vasodilator agents|mesh-ancestor
65563463|NCT01126073|Vitamin B Complex|vitamin b complex|mesh-ancestor
65563464|NCT01126073|Vitamins|vitamins|mesh-ancestor
65563465|NCT01126073|Micronutrients|micronutrients|mesh-ancestor
65563466|NCT01126073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563467|NCT03287050|Pembrolizumab|pembrolizumab|mesh-list
65563468|NCT03287050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65563469|NCT03287050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563470|NCT05470881|Atropine|atropine|mesh-list
65563471|NCT05470881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65563472|NCT05470881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65563473|NCT05470881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65563474|NCT05470881|Autonomic Agents|autonomic agents|mesh-ancestor
65563475|NCT05470881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65563476|NCT05470881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563477|NCT05470881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65563478|NCT05470881|Respiratory System Agents|respiratory system agents|mesh-ancestor
65563479|NCT05470881|Mydriatics|mydriatics|mesh-ancestor
65563480|NCT05470881|Parasympatholytics|parasympatholytics|mesh-ancestor
65563481|NCT05470881|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65563482|NCT05470881|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65563483|NCT05470881|Cholinergic Agents|cholinergic agents|mesh-ancestor
65563484|NCT05470881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65563485|NCT05470881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563486|NCT03130504|Progesterone|progesterone|mesh-list
65563487|NCT03130504|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
65563488|NCT03130504|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
65563489|NCT03130504|Progestins|progestins|mesh-ancestor
65563490|NCT03130504|Hormones|hormones|mesh-ancestor
65563491|NCT03130504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65563492|NCT03130504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563493|NCT03130504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65563494|NCT03130504|Hormone Antagonists|hormone antagonists|mesh-ancestor
65563495|NCT03819127|Metformin|metformin|mesh-list
65563496|NCT03819127|Vildagliptin|vildagliptin|mesh-list
65563497|NCT03819127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65563498|NCT03819127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563499|NCT03819127|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65563500|NCT03819127|Protease Inhibitors|protease inhibitors|mesh-ancestor
65563501|NCT03819127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563502|NCT03819127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563503|NCT02908789|Anti-Infective Agents|anti-infective agents|mesh-list
65563504|NCT02908789|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65563505|NCT05607550|Aflutinib|aflutinib|mesh-list
65563506|NCT05607550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65563507|NCT05607550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563508|NCT05607550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563509|NCT01299181|Atorvastatin|atorvastatin|mesh-list
65361064|NCT04498923|Hormones|hormones|mesh-ancestor
65563510|NCT01299181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65563511|NCT01299181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65563512|NCT01299181|Antimetabolites|antimetabolites|mesh-ancestor
65563513|NCT01299181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563514|NCT01299181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65563515|NCT01299181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65563516|NCT01299181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563517|NCT04075292|Rituximab|rituximab|mesh-list
65563518|NCT04075292|Acalabrutinib|acalabrutinib|mesh-list
65563519|NCT04075292|Chlorambucil|chlorambucil|mesh-list
65563520|NCT04075292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65563521|NCT04075292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563522|NCT04075292|Immunologic Factors|immunologic factors|mesh-ancestor
65563523|NCT04075292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563524|NCT04075292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65563525|NCT04075292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65563526|NCT04075292|Alkylating Agents|alkylating agents|mesh-ancestor
65563527|NCT04075292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563528|NCT03930875|Aspirin|aspirin|mesh-list
65563529|NCT03930875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65563530|NCT03930875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65563531|NCT03930875|Analgesics|analgesics|mesh-ancestor
65563532|NCT03930875|Sensory System Agents|sensory system agents|mesh-ancestor
65563533|NCT03930875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65563534|NCT03930875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563535|NCT03930875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65563536|NCT03930875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65563537|NCT03930875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65563538|NCT03930875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65563539|NCT03930875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563540|NCT03930875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65563541|NCT03930875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65563542|NCT03930875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563543|NCT03930875|Antipyretics|antipyretics|mesh-ancestor
65563544|NCT01206907|Oxymorphone|oxymorphone|mesh-list
65563545|NCT01206907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65563546|NCT01206907|Narcotics|narcotics|mesh-ancestor
65563547|NCT01206907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65563548|NCT01206907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563549|NCT01206907|Analgesics|analgesics|mesh-ancestor
65563550|NCT01206907|Sensory System Agents|sensory system agents|mesh-ancestor
65563551|NCT01206907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65563552|NCT01206907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65563553|NCT03925246|Nivolumab|nivolumab|mesh-list
65563554|NCT03925246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65563555|NCT03925246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563556|NCT03925246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65563557|NCT03925246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563558|NCT01218347|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65563559|NCT01218347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65563560|NCT01218347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65563561|NCT01218347|Antimetabolites|antimetabolites|mesh-ancestor
65563562|NCT01218347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563563|NCT01218347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65563564|NCT01218347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65563565|NCT01218347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563566|NCT01126229|Resveratrol|resveratrol|mesh-list
65563567|NCT01126229|Antioxidants|antioxidants|mesh-ancestor
65563568|NCT01126229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563569|NCT01126229|Protective Agents|protective agents|mesh-ancestor
65563570|NCT01126229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563571|NCT01126229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563572|NCT01126229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65563573|NCT03474640|Antibodies|antibodies|mesh-list
65563574|NCT03474640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65563575|NCT03474640|Immunologic Factors|immunologic factors|mesh-ancestor
65563576|NCT03474640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563577|NCT01126307|Verapamil|verapamil|mesh-list
65563578|NCT01126307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65563579|NCT01126307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65563580|NCT01126307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65563581|NCT01126307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563582|NCT01126307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65563583|NCT01126307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563584|NCT01126307|Vasodilator Agents|vasodilator agents|mesh-ancestor
65563585|NCT03439137|Darbepoetin alfa|darbepoetin alfa|mesh-list
65563586|NCT03439137|Hematinics|hematinics|mesh-ancestor
65563587|NCT04173338|Pemetrexed|pemetrexed|mesh-list
65563588|NCT04173338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563589|NCT04173338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563590|NCT04173338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563591|NCT04173338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65563592|NCT04173338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65563593|NCT03936491|Methylphenidate|methylphenidate|mesh-list
65563594|NCT03936491|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65563595|NCT03936491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65563596|NCT03936491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563597|NCT03936491|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65563598|NCT03936491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65563599|NCT03936491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65563600|NCT03936491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563601|NCT03936491|Dopamine Agents|dopamine agents|mesh-ancestor
65563602|NCT03936491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65563603|NCT03936491|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65563604|NCT03936491|Adrenergic Agents|adrenergic agents|mesh-ancestor
65563605|NCT00890617|Prednisone|prednisone|mesh-list
65563606|NCT00890617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65563607|NCT00890617|Glucocorticoids|glucocorticoids|mesh-ancestor
65563608|NCT00890617|Hormones|hormones|mesh-ancestor
65563609|NCT00890617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65563610|NCT00890617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563611|NCT00890617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65563612|NCT00890617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563613|NCT00610051|Alprostadil|alprostadil|mesh-list
65563614|NCT00610051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65563615|NCT00610051|Vasodilator Agents|vasodilator agents|mesh-ancestor
65563616|NCT00610051|Urological Agents|urological agents|mesh-ancestor
65563617|NCT03468946|Caffeine|caffeine|mesh-list
65563618|NCT03468946|Citric Acid|citric acid|mesh-list
65563619|NCT03468946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65563620|NCT03468946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563621|NCT03468946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65563622|NCT03468946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563623|NCT03468946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563624|NCT03468946|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65563625|NCT03468946|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65563626|NCT03468946|Purinergic Agents|purinergic agents|mesh-ancestor
65563627|NCT03468946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65563628|NCT03468946|Anticoagulants|anticoagulants|mesh-ancestor
65563629|NCT03468946|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65563630|NCT03468946|Chelating Agents|chelating agents|mesh-ancestor
65563631|NCT03468946|Sequestering Agents|sequestering agents|mesh-ancestor
65563632|NCT01218425|Levodopa|levodopa|mesh-list
65563633|NCT01218425|Carbidopa|carbidopa|mesh-list
65563634|NCT01218425|Domperidone|domperidone|mesh-list
65563635|NCT01218425|Methylphenidate|methylphenidate|mesh-list
65563636|NCT01218425|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65563637|NCT01218425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563638|NCT01218425|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65563639|NCT01218425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65563640|NCT01218425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65563641|NCT01218425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563642|NCT01218425|Dopamine Agents|dopamine agents|mesh-ancestor
65563643|NCT01218425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65563644|NCT01218425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65563645|NCT01218425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65563646|NCT01218425|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65563647|NCT01218425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563648|NCT01218425|Antiemetics|antiemetics|mesh-ancestor
65563649|NCT01218425|Autonomic Agents|autonomic agents|mesh-ancestor
65563650|NCT01218425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65563651|NCT01218425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65563652|NCT01218425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65563653|NCT05621005|Rifaximin|rifaximin|mesh-list
65563654|NCT05621005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65563655|NCT05621005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65563656|NCT05621005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65361194|NCT00932685|Midazolam|midazolam|mesh-list
65563658|NCT01224041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65563659|NCT01224041|Immunologic Factors|immunologic factors|mesh-ancestor
65563660|NCT01224041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563661|NCT01224041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65563662|NCT01224041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563663|NCT01224041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563664|NCT03181828|Acetohydroxamic acid|acetohydroxamic acid|mesh-list
65563665|NCT03181828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563666|NCT03181828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563667|NCT05081492|Antibodies|antibodies|mesh-list
65563668|NCT05081492|Immunoglobulins|immunoglobulins|mesh-list
65563669|NCT05081492|Immunologic Factors|immunologic factors|mesh-ancestor
65563670|NCT05081492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563671|NCT01123811|Cetuximab|cetuximab|mesh-list
65563672|NCT01123811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65563673|NCT01123811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563674|NCT01128101|Spironolactone|spironolactone|mesh-list
65563675|NCT01128101|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65563676|NCT01128101|Hormone Antagonists|hormone antagonists|mesh-ancestor
65563677|NCT01128101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65563678|NCT01128101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563679|NCT01128101|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65563680|NCT01128101|Diuretics|diuretics|mesh-ancestor
65563681|NCT01128101|Natriuretic Agents|natriuretic agents|mesh-ancestor
65563682|NCT01299415|Vadimezan|vadimezan|mesh-list
65563683|NCT01299415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563684|NCT01123967|Nicotine|nicotine|mesh-list
65563685|NCT01123967|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65563686|NCT01123967|Autonomic Agents|autonomic agents|mesh-ancestor
65563687|NCT01123967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65563688|NCT01123967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563689|NCT01123967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65563690|NCT01123967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65563691|NCT01123967|Cholinergic Agents|cholinergic agents|mesh-ancestor
65563692|NCT01123967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65563693|NCT01123967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563694|NCT01126463|Ethiodized Oil|ethiodized oil|mesh-list
65563695|NCT01126463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563696|NCT01126697|Ubiquinone|ubiquinone|mesh-list
65563697|NCT01126697|Coenzyme Q10|coenzyme q10|mesh-list
65563698|NCT01126697|Lisinopril|lisinopril|mesh-list
65563699|NCT01126697|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65563700|NCT01126697|Protease Inhibitors|protease inhibitors|mesh-ancestor
65563701|NCT01126697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563702|NCT01126697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563703|NCT01126697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65563704|NCT01126697|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65563705|NCT01126697|Protective Agents|protective agents|mesh-ancestor
65563706|NCT01126697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563707|NCT01126697|Micronutrients|micronutrients|mesh-ancestor
65563708|NCT01126697|Vitamins|vitamins|mesh-ancestor
65563709|NCT01220843|Sevelamer|sevelamer|mesh-list
65563710|NCT01220843|Chelating Agents|chelating agents|mesh-ancestor
65563711|NCT01220843|Sequestering Agents|sequestering agents|mesh-ancestor
65563712|NCT01220843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563713|NCT02804932|Methamphetamine|methamphetamine|mesh-list
65563714|NCT02804932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65563715|NCT02804932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563716|NCT02804932|Sympathomimetics|sympathomimetics|mesh-ancestor
65563717|NCT02804932|Autonomic Agents|autonomic agents|mesh-ancestor
65563718|NCT02804932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65563719|NCT02804932|Dopamine Agents|dopamine agents|mesh-ancestor
65563720|NCT02804932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65563721|NCT02804932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563722|NCT02804932|Adrenergic Agents|adrenergic agents|mesh-ancestor
65563723|NCT02804932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65563724|NCT02804932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65563725|NCT02804932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65563726|NCT02804932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65563727|NCT03468790|Fluticasone|fluticasone|mesh-list
65563728|NCT03468790|Xhance|xhance|mesh-list
65563729|NCT03468790|Budesonide|budesonide|mesh-list
65563730|NCT03468790|Albuterol|albuterol|mesh-list
65563731|NCT03468790|Formoterol Fumarate|formoterol fumarate|mesh-list
65563732|NCT03468790|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65563733|NCT03468790|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65563734|NCT03468790|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65563735|NCT03468790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65563736|NCT03468790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65563737|NCT03468790|Autonomic Agents|autonomic agents|mesh-ancestor
65563738|NCT03468790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65563739|NCT03468790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563740|NCT03468790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65563741|NCT03468790|Respiratory System Agents|respiratory system agents|mesh-ancestor
65563742|NCT03468790|Dermatologic Agents|dermatologic agents|mesh-ancestor
65563743|NCT03468790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65563744|NCT03468790|Glucocorticoids|glucocorticoids|mesh-ancestor
65563745|NCT03468790|Hormones|hormones|mesh-ancestor
65563746|NCT03468790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65563747|NCT03468790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65563748|NCT03468790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65563749|NCT03468790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65563750|NCT03468790|Adrenergic Agents|adrenergic agents|mesh-ancestor
65563751|NCT03468790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65563752|NCT03468790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563753|NCT03468790|Tocolytic Agents|tocolytic agents|mesh-ancestor
65563754|NCT03468790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65563755|NCT03468790|Sympathomimetics|sympathomimetics|mesh-ancestor
65563756|NCT01224197|Simeprevir|simeprevir|mesh-list
65563757|NCT01224197|Antiviral Agents|antiviral agents|mesh-ancestor
65563758|NCT01224197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65563759|NCT01224197|Protease Inhibitors|protease inhibitors|mesh-ancestor
65563760|NCT01224197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563761|NCT01224197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563762|NCT01224353|Thioctic Acid|thioctic acid|mesh-list
65563763|NCT01224353|Antioxidants|antioxidants|mesh-ancestor
65563764|NCT01224353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563765|NCT01224353|Protective Agents|protective agents|mesh-ancestor
65563766|NCT01224353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563767|NCT01224353|Vitamin B Complex|vitamin b complex|mesh-ancestor
65563768|NCT01224353|Vitamins|vitamins|mesh-ancestor
65563769|NCT01224353|Micronutrients|micronutrients|mesh-ancestor
65563770|NCT01218581|Letrozole|letrozole|mesh-list
65563771|NCT01218581|Goserelin|goserelin|mesh-list
65563772|NCT01218581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563773|NCT01218581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65563774|NCT01218581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65563775|NCT01218581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563776|NCT01218581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563777|NCT01218581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65563778|NCT01218581|Hormone Antagonists|hormone antagonists|mesh-ancestor
65563779|NCT01218581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65563780|NCT01218581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563781|NCT01218581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65563782|NCT01207297|Cyclophosphamide|cyclophosphamide|mesh-list
65563783|NCT01207297|Tacrolimus|tacrolimus|mesh-list
65563784|NCT01207297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65563785|NCT01207297|Immunologic Factors|immunologic factors|mesh-ancestor
65563786|NCT01207297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563787|NCT01207297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65563788|NCT01207297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65563789|NCT01207297|Alkylating Agents|alkylating agents|mesh-ancestor
65563790|NCT01207297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563791|NCT01207297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563792|NCT01207297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65563793|NCT01207297|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65563794|NCT01207297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563795|NCT03932435|Bepotastine besilate|bepotastine besilate|mesh-list
65563796|NCT03932435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65563797|NCT03720847|Estradiol|estradiol|mesh-list
65563798|NCT03720847|Progesterone|progesterone|mesh-list
65563799|NCT03720847|Estrogens|estrogens|mesh-ancestor
65563800|NCT03720847|Hormones|hormones|mesh-ancestor
65563801|NCT03720847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65563802|NCT03720847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563803|NCT03720847|Progestins|progestins|mesh-ancestor
65563804|NCT01128257|Alendronate|alendronate|mesh-list
65563805|NCT01128257|Ibandronic Acid|ibandronic acid|mesh-list
65563806|NCT01128257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65563807|NCT01128257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563808|NCT01205347|Simvastatin|simvastatin|mesh-list
65563809|NCT01205347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65563810|NCT01205347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65563811|NCT01205347|Antimetabolites|antimetabolites|mesh-ancestor
65563812|NCT01205347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563813|NCT01205347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65563814|NCT01205347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65563815|NCT01205347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563816|NCT01218737|Gatifloxacin|gatifloxacin|mesh-list
65563817|NCT01218737|Prednisolone|prednisolone|mesh-list
65563818|NCT01218737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65563819|NCT01218737|Methylprednisolone|methylprednisolone|mesh-list
65563820|NCT01218737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65563821|NCT01218737|Prednisolone acetate|prednisolone acetate|mesh-list
65563822|NCT01218737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65563823|NCT01218737|Prednisolone phosphate|prednisolone phosphate|mesh-list
65563824|NCT01218737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65563825|NCT01218737|Glucocorticoids|glucocorticoids|mesh-ancestor
65563826|NCT01218737|Hormones|hormones|mesh-ancestor
65563827|NCT01218737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65563828|NCT01218737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563829|NCT01218737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65563830|NCT01218737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563831|NCT01218737|Antiemetics|antiemetics|mesh-ancestor
65563832|NCT01218737|Autonomic Agents|autonomic agents|mesh-ancestor
65563833|NCT01218737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65563834|NCT01218737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65563835|NCT01218737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65563836|NCT01218737|Protective Agents|protective agents|mesh-ancestor
65563837|NCT01218737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65563838|NCT01218737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65563839|NCT01218737|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65563840|NCT01218737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65563841|NCT01218737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65563842|NCT01218737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65563843|NCT01218737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563844|NCT01218737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563845|NCT03818113|Cardioplegic Solutions|cardioplegic solutions|mesh-list
65563846|NCT03818113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65563847|NCT01224509|Mifepristone|mifepristone|mesh-list
65563848|NCT01224509|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65563849|NCT01224509|Abortifacient Agents|abortifacient agents|mesh-ancestor
65563850|NCT01224509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65563851|NCT01224509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563852|NCT01224509|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65563853|NCT01224509|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65563854|NCT01224509|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65563855|NCT01224509|Contraceptive Agents|contraceptive agents|mesh-ancestor
65563856|NCT01224509|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65563857|NCT01224509|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65563858|NCT01224509|Hormone Antagonists|hormone antagonists|mesh-ancestor
65563859|NCT01224509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65563860|NCT01224509|Luteolytic Agents|luteolytic agents|mesh-ancestor
65563861|NCT01224509|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65563862|NCT01224509|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65563863|NCT01301053|Insulin|insulin|mesh-list
65563864|NCT01301053|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65563865|NCT01301053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65563866|NCT01301053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563867|NCT03825133|Hyaluronic Acid|hyaluronic acid|mesh-list
65563868|NCT03825133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65563869|NCT03825133|Immunologic Factors|immunologic factors|mesh-ancestor
65563870|NCT03825133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563871|NCT03825133|Viscosupplements|viscosupplements|mesh-ancestor
65563872|NCT03825133|Protective Agents|protective agents|mesh-ancestor
65563873|NCT03817567|Antibodies|antibodies|mesh-list
65563874|NCT03817567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65563875|NCT03817567|Immunologic Factors|immunologic factors|mesh-ancestor
65563876|NCT03817567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563877|NCT01127009|Cytarabine|cytarabine|mesh-list
65563878|NCT01127009|Etoposide|etoposide|mesh-list
65563879|NCT01127009|Podophyllotoxin|podophyllotoxin|mesh-list
65563880|NCT01127009|Mitoxantrone|mitoxantrone|mesh-list
65563881|NCT01127009|Etoposide phosphate|etoposide phosphate|mesh-list
65563882|NCT01127009|Bortezomib|bortezomib|mesh-list
65563883|NCT01127009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65563884|NCT01127009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563885|NCT01127009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65563886|NCT01127009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65563887|NCT01127009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563888|NCT01127009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563889|NCT01127009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65563890|NCT01127009|Antimetabolites|antimetabolites|mesh-ancestor
65563891|NCT01127009|Antiviral Agents|antiviral agents|mesh-ancestor
65563892|NCT01127009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65563893|NCT01127009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65563894|NCT01127009|Immunologic Factors|immunologic factors|mesh-ancestor
65563895|NCT01127009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563896|NCT01127009|Analgesics|analgesics|mesh-ancestor
65563897|NCT01127009|Sensory System Agents|sensory system agents|mesh-ancestor
65563898|NCT01127009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65563899|NCT01127009|Keratolytic Agents|keratolytic agents|mesh-ancestor
65563900|NCT01127009|Dermatologic Agents|dermatologic agents|mesh-ancestor
65563901|NCT01127009|Tubulin Modulators|tubulin modulators|mesh-ancestor
65563902|NCT01127009|Antimitotic Agents|antimitotic agents|mesh-ancestor
65563903|NCT01127009|Mitosis Modulators|mitosis modulators|mesh-ancestor
65563904|NCT03817411|Capecitabine|capecitabine|mesh-list
65563905|NCT03817411|Oxaliplatin|oxaliplatin|mesh-list
65563906|NCT03817411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65563907|NCT03817411|Antimetabolites|antimetabolites|mesh-ancestor
65563908|NCT03817411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563909|NCT03817411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563910|NCT01205737|Rituximab|rituximab|mesh-list
65563911|NCT01205737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65563912|NCT01205737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563913|NCT01205737|Immunologic Factors|immunologic factors|mesh-ancestor
65563914|NCT01205737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563915|NCT01205737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65563916|NCT01218893|Chloroquine|chloroquine|mesh-list
65563917|NCT01218893|Proguanil|proguanil|mesh-list
65563918|NCT01218893|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
65563919|NCT01218893|Amebicides|amebicides|mesh-ancestor
65563920|NCT01218893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65563921|NCT01218893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65563922|NCT01218893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65563923|NCT01218893|Antimalarials|antimalarials|mesh-ancestor
65563924|NCT01218893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65563925|NCT01218893|Antimetabolites|antimetabolites|mesh-ancestor
65563926|NCT01218893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563927|NCT03824119|Ibuprofen|ibuprofen|mesh-list
65563928|NCT03824119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65563929|NCT03824119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65563930|NCT03824119|Analgesics|analgesics|mesh-ancestor
65563931|NCT03824119|Sensory System Agents|sensory system agents|mesh-ancestor
65563932|NCT03824119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65563933|NCT03824119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563934|NCT03824119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65563935|NCT03824119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65563936|NCT03824119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65563937|NCT03824119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563938|NCT03824119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563939|NCT03823417|Tranexamic Acid|tranexamic acid|mesh-list
65563940|NCT03823417|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65563941|NCT03823417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65563942|NCT03823417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563943|NCT03823417|Hemostatics|hemostatics|mesh-ancestor
65563944|NCT03823417|Coagulants|coagulants|mesh-ancestor
65563945|NCT01297777|Imatinib Mesylate|imatinib mesylate|mesh-list
65563946|NCT01297777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65563947|NCT01297777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65563948|NCT01297777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65563949|NCT01297777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563950|NCT01225913|Fluticasone|fluticasone|mesh-list
65563951|NCT01225913|Xhance|xhance|mesh-list
65563952|NCT01225913|Budesonide|budesonide|mesh-list
65563953|NCT01225913|Formoterol Fumarate|formoterol fumarate|mesh-list
65563954|NCT01225913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65563955|NCT01225913|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65563956|NCT01225913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65563957|NCT01225913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65563958|NCT01225913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65563959|NCT01225913|Autonomic Agents|autonomic agents|mesh-ancestor
65563960|NCT01225913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65563961|NCT01225913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563962|NCT01225913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65563963|NCT01225913|Respiratory System Agents|respiratory system agents|mesh-ancestor
65563964|NCT01225913|Dermatologic Agents|dermatologic agents|mesh-ancestor
65563965|NCT01225913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65563966|NCT01225913|Glucocorticoids|glucocorticoids|mesh-ancestor
65563967|NCT01225913|Hormones|hormones|mesh-ancestor
65563968|NCT01225913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65563969|NCT01225913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65563970|NCT01225913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65563971|NCT01225913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65563972|NCT01225913|Adrenergic Agents|adrenergic agents|mesh-ancestor
65563973|NCT01225913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65563974|NCT01225913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563975|NCT01225913|Sympathomimetics|sympathomimetics|mesh-ancestor
65563976|NCT01224977|Azithromycin|azithromycin|mesh-list
65563977|NCT01224977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65563978|NCT01224977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65563979|NCT01226069|Magnesium Sulfate|magnesium sulfate|mesh-list
65563980|NCT01226069|Glycerol|glycerol|mesh-list
65563981|NCT01226069|Analgesics|analgesics|mesh-ancestor
65563982|NCT01226069|Sensory System Agents|sensory system agents|mesh-ancestor
65563983|NCT01226069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65563984|NCT01226069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65563985|NCT01226069|Anesthetics|anesthetics|mesh-ancestor
65563986|NCT01226069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65563987|NCT01226069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65563988|NCT01226069|Anticonvulsants|anticonvulsants|mesh-ancestor
65563989|NCT01226069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65563990|NCT01226069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65563991|NCT01226069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65563992|NCT01226069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65563993|NCT01226069|Tocolytic Agents|tocolytic agents|mesh-ancestor
65563994|NCT01226069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65563995|NCT01226069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65563996|NCT01226069|Protective Agents|protective agents|mesh-ancestor
65563997|NCT03928691|Magnesium Sulfate|magnesium sulfate|mesh-list
65563998|NCT03928691|Analgesics|analgesics|mesh-ancestor
65563999|NCT03928691|Sensory System Agents|sensory system agents|mesh-ancestor
65564000|NCT03928691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65564001|NCT03928691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564002|NCT03928691|Anesthetics|anesthetics|mesh-ancestor
65564003|NCT03928691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65564004|NCT03928691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65564005|NCT03928691|Anticonvulsants|anticonvulsants|mesh-ancestor
65564006|NCT03928691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65564007|NCT03928691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65564008|NCT03928691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564009|NCT03928691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65564010|NCT03928691|Tocolytic Agents|tocolytic agents|mesh-ancestor
65564011|NCT03928691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65564012|NCT01297855|Rifampin|rifampin|mesh-list
65564013|NCT01297855|Colistin|colistin|mesh-list
65564014|NCT01297855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65564015|NCT01297855|Antitubercular Agents|antitubercular agents|mesh-ancestor
65564016|NCT01297855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65564017|NCT01297855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65564018|NCT01297855|Leprostatic Agents|leprostatic agents|mesh-ancestor
65564019|NCT01297855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65564020|NCT01297855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564021|NCT01297855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564022|NCT01297855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65564023|NCT01297855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65564024|NCT01297855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65564025|NCT01297855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65564026|NCT01297855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65564027|NCT01297855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65564028|NCT02631070|Luspatercept|luspatercept|mesh-list
65564029|NCT02631070|Hematinics|hematinics|mesh-ancestor
65564030|NCT01298011|Gemcitabine|gemcitabine|mesh-list
65564031|NCT01298011|Paclitaxel|paclitaxel|mesh-list
65564032|NCT01298011|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65564033|NCT01298011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65564034|NCT01298011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564035|NCT01298011|Tubulin Modulators|tubulin modulators|mesh-ancestor
65564036|NCT01298011|Antimitotic Agents|antimitotic agents|mesh-ancestor
65564037|NCT01298011|Mitosis Modulators|mitosis modulators|mesh-ancestor
65564038|NCT01298011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564039|NCT01298011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65564040|NCT01298011|Antimetabolites|antimetabolites|mesh-ancestor
65564041|NCT01298011|Antiviral Agents|antiviral agents|mesh-ancestor
65564042|NCT01298011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65564043|NCT01298011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564044|NCT01298011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65564045|NCT01298011|Immunologic Factors|immunologic factors|mesh-ancestor
65564046|NCT01298011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564047|NCT01221935|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65564048|NCT01221935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
65564049|NCT01221935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65564050|NCT01221935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65564051|NCT01221935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564052|NCT01221935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65564053|NCT01221935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564054|NCT01221935|Antidepressive Agents|antidepressive agents|mesh-ancestor
65564055|NCT01221935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65564056|NCT05137678|Glyburide|glyburide|mesh-list
65564057|NCT05137678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65293221|NCT01004497|Hormones|hormones|mesh-ancestor
65564058|NCT05137678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564059|NCT01226303|Tretinoin|tretinoin|mesh-list
65564060|NCT01226303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564061|NCT01226303|Keratolytic Agents|keratolytic agents|mesh-ancestor
65564062|NCT01226303|Dermatologic Agents|dermatologic agents|mesh-ancestor
65564063|NCT03814759|Cisplatin|cisplatin|mesh-list
65564064|NCT03814759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564065|NCT05101018|Denosumab|denosumab|mesh-list
65564066|NCT05101018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65564067|NCT05101018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564068|NCT03929861|Fluconazole|fluconazole|mesh-list
65564069|NCT03929861|Antifungal Agents|antifungal agents|mesh-ancestor
65564070|NCT03929861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65564071|NCT03929861|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65564072|NCT03929861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65564073|NCT03929861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564074|NCT03929861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564075|NCT03929861|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65564076|NCT03929861|Hormone Antagonists|hormone antagonists|mesh-ancestor
65564077|NCT03929861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65564078|NCT03929861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564079|NCT03929861|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65564080|NCT03929861|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65564081|NCT03821623|Niacinamide|niacinamide|mesh-list
65564082|NCT03821623|Niacin|niacin|mesh-list
65564083|NCT03821623|Nicotinic Acids|nicotinic acids|mesh-list
65564084|NCT03821623|Vitamin B Complex|vitamin b complex|mesh-ancestor
65564085|NCT03821623|Vitamins|vitamins|mesh-ancestor
65564086|NCT03821623|Micronutrients|micronutrients|mesh-ancestor
65564087|NCT03821623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564088|NCT03821623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65564089|NCT03821623|Antimetabolites|antimetabolites|mesh-ancestor
65564090|NCT03821623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564091|NCT03821623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65564092|NCT03821623|Vasodilator Agents|vasodilator agents|mesh-ancestor
65564093|NCT03928145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65564094|NCT03928145|Chlorthalidone|chlorthalidone|mesh-list
65564095|NCT03928145|Amiloride|amiloride|mesh-list
65564096|NCT03928145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65564097|NCT03928145|Diuretics|diuretics|mesh-ancestor
65564098|NCT03928145|Natriuretic Agents|natriuretic agents|mesh-ancestor
65564099|NCT03928145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564100|NCT03928145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65564101|NCT03928145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65564102|NCT03928145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564103|NCT03928145|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65564104|NCT03928145|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65564105|NCT03928145|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65564106|NCT03928145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65564107|NCT01129271|Clopidogrel|clopidogrel|mesh-list
65564108|NCT01129271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65564109|NCT01129271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65564110|NCT01129271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65564111|NCT01129271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65564112|NCT01129271|Purinergic Agents|purinergic agents|mesh-ancestor
65564113|NCT01129271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65564114|NCT01129271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564115|NCT01129271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564116|NCT01222013|Imatinib Mesylate|imatinib mesylate|mesh-list
65564117|NCT01222013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564118|NCT01222013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65564119|NCT01222013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564120|NCT01222013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564121|NCT00741988|Bevacizumab|bevacizumab|mesh-list
65564122|NCT00741988|Carboplatin|carboplatin|mesh-list
65564123|NCT00741988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65564124|NCT00741988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564125|NCT00741988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65564126|NCT00741988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65564127|NCT00741988|Growth Substances|growth substances|mesh-ancestor
65564128|NCT00741988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564129|NCT00741988|Growth Inhibitors|growth inhibitors|mesh-ancestor
65293298|NCT02714075|Astringents|astringents|mesh-ancestor
65564130|NCT01131377|Acetazolamide|acetazolamide|mesh-list
65564131|NCT01131377|Anticonvulsants|anticonvulsants|mesh-ancestor
65564132|NCT01131377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65564133|NCT01131377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564134|NCT01131377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564135|NCT01131377|Diuretics|diuretics|mesh-ancestor
65564136|NCT01131377|Natriuretic Agents|natriuretic agents|mesh-ancestor
65564137|NCT01131377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564138|NCT04457050|Ribavirin|ribavirin|mesh-list
65564139|NCT04457050|Sofosbuvir|sofosbuvir|mesh-list
65564140|NCT04457050|Ledipasvir|ledipasvir|mesh-list
65564141|NCT04457050|Antimetabolites|antimetabolites|mesh-ancestor
65564142|NCT04457050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564143|NCT04457050|Antiviral Agents|antiviral agents|mesh-ancestor
65564144|NCT04457050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65564145|NCT01228409|Acitretin|acitretin|mesh-list
65564146|NCT01228409|Keratolytic Agents|keratolytic agents|mesh-ancestor
65564147|NCT01228409|Dermatologic Agents|dermatologic agents|mesh-ancestor
65564148|NCT03470350|Capecitabine|capecitabine|mesh-list
65564149|NCT03470350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65564150|NCT03470350|Antimetabolites|antimetabolites|mesh-ancestor
65564151|NCT03470350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564152|NCT03470350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564153|NCT04565392|Famotidine|famotidine|mesh-list
65564154|NCT04565392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65564155|NCT04565392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65564156|NCT04565392|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65564157|NCT04565392|Histamine Antagonists|histamine antagonists|mesh-ancestor
65564158|NCT04565392|Histamine Agents|histamine agents|mesh-ancestor
65564159|NCT04565392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65564160|NCT04565392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564161|NCT04565392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564162|NCT05654233|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
65564163|NCT05654233|Anticoagulants|anticoagulants|mesh-ancestor
65564164|NCT05654233|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65564165|NCT05654233|Antimetabolites|antimetabolites|mesh-ancestor
65564166|NCT05654233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564167|NCT05654233|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65564168|NCT05654233|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65564169|NCT05654233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65564170|NCT05654233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65564171|NCT05654233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564172|NCT01226771|Ribavirin|ribavirin|mesh-list
65564173|NCT01226771|Antimetabolites|antimetabolites|mesh-ancestor
65564174|NCT01226771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564175|NCT01226771|Antiviral Agents|antiviral agents|mesh-ancestor
65564176|NCT01226771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65564177|NCT03814447|Cyclophosphamide|cyclophosphamide|mesh-list
65564178|NCT03814447|Fludarabine|fludarabine|mesh-list
65564179|NCT03814447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65564180|NCT03814447|Immunologic Factors|immunologic factors|mesh-ancestor
65564181|NCT03814447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564182|NCT03814447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65564183|NCT03814447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65564184|NCT03814447|Alkylating Agents|alkylating agents|mesh-ancestor
65564185|NCT03814447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564186|NCT03814447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564187|NCT03814447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65564189|NCT01129427|Clopidogrel|clopidogrel|mesh-list
65564190|NCT01129427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65564191|NCT01129427|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65564192|NCT01129427|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65564193|NCT01129427|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65564194|NCT01129427|Purinergic Agents|purinergic agents|mesh-ancestor
65564195|NCT01129427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65564196|NCT01129427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564197|NCT01129427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564198|NCT01129427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65564199|NCT01129427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65564200|NCT01129427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65564201|NCT01129427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564202|NCT03814291|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
65564203|NCT03814291|Immunologic Factors|immunologic factors|mesh-ancestor
65564204|NCT03814291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564205|NCT03354429|Ticagrelor|ticagrelor|mesh-list
65564206|NCT03354429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65564207|NCT03354429|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65564208|NCT03354429|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65564209|NCT03354429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65564210|NCT03354429|Purinergic Agents|purinergic agents|mesh-ancestor
65564211|NCT03354429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65564212|NCT03354429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564213|NCT03354429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564214|NCT05160298|Ropivacaine|ropivacaine|mesh-list
65564215|NCT05160298|Anesthetics, Local|anesthetics, local|mesh-ancestor
65564216|NCT05160298|Anesthetics|anesthetics|mesh-ancestor
65564217|NCT05160298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65564218|NCT05160298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564219|NCT05160298|Sensory System Agents|sensory system agents|mesh-ancestor
65564220|NCT05160298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65564221|NCT05164198|Adalimumab|adalimumab|mesh-list
65564222|NCT05164198|Etanercept|etanercept|mesh-list
65564223|NCT05164198|Golimumab|golimumab|mesh-list
65564224|NCT05164198|Infliximab|infliximab|mesh-list
65564225|NCT05164198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65564226|NCT05164198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65564227|NCT05164198|Dermatologic Agents|dermatologic agents|mesh-ancestor
65564228|NCT05164198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65564229|NCT05164198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65564230|NCT05164198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65564231|NCT05164198|Analgesics|analgesics|mesh-ancestor
65564232|NCT05164198|Sensory System Agents|sensory system agents|mesh-ancestor
65564233|NCT05164198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65564234|NCT05164198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564235|NCT05164198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65564236|NCT05164198|Immunologic Factors|immunologic factors|mesh-ancestor
65564237|NCT05164198|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65564238|NCT03740399|Anesthetics|anesthetics|mesh-list
65564239|NCT03740399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65564240|NCT03740399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564241|NCT05160220|Psilocybin|psilocybin|mesh-list
65564242|NCT05160220|Hallucinogens|hallucinogens|mesh-ancestor
65564243|NCT05160220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564244|NCT05160220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65564245|NCT03924245|Olaparib|olaparib|mesh-list
65564246|NCT03924245|Entinostat|entinostat|mesh-list
65564247|NCT03924245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65564248|NCT03924245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564249|NCT03924245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564250|NCT03924245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564251|NCT03924245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65564252|NCT05647447|SR 142801|sr 142801|mesh-list
65564253|NCT05647447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65564254|NCT05647447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65564255|NCT05647447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65361789|NCT00688064|Analgesics|analgesics|mesh-ancestor
65564256|NCT05647447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564258|NCT01225445|Ramipril|ramipril|mesh-list
65564259|NCT01225445|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65564260|NCT01225445|Protease Inhibitors|protease inhibitors|mesh-ancestor
65564261|NCT01225445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564262|NCT01225445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564263|NCT01225445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65564264|NCT05623111|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65564265|NCT05623111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65564266|NCT05623111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65564267|NCT05623111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564268|NCT05623111|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65564269|NCT05623111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65564270|NCT05623111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564271|NCT05623111|Cholinergic Agents|cholinergic agents|mesh-ancestor
65564272|NCT05623111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65564273|NCT05555329|Thalidomide|thalidomide|mesh-list
65564274|NCT05555329|Pomalidomide|pomalidomide|mesh-list
65564275|NCT05555329|Immunologic Factors|immunologic factors|mesh-ancestor
65564276|NCT05555329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564277|NCT05555329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65293452|NCT01005121|Colchicine|colchicine|mesh-list
65564278|NCT05555329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65564279|NCT05555329|Growth Substances|growth substances|mesh-ancestor
65564280|NCT05555329|Growth Inhibitors|growth inhibitors|mesh-ancestor
65564281|NCT05555329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564282|NCT05555329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65564283|NCT05555329|Leprostatic Agents|leprostatic agents|mesh-ancestor
65564284|NCT05555329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65564285|NCT05555329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65564286|NCT05390710|Paclitaxel|paclitaxel|mesh-list
65564287|NCT05390710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65564288|NCT05390710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65564289|NCT05390710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564290|NCT05390710|Tubulin Modulators|tubulin modulators|mesh-ancestor
65564291|NCT05390710|Antimitotic Agents|antimitotic agents|mesh-ancestor
65564292|NCT05390710|Mitosis Modulators|mitosis modulators|mesh-ancestor
65564293|NCT05390710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564294|NCT01228565|Cetuximab|cetuximab|mesh-list
65564295|NCT01228565|OTD70DERM|otd70derm|mesh-list
65564296|NCT01228565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65564297|NCT01228565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564298|NCT01228565|Protective Agents|protective agents|mesh-ancestor
65564299|NCT01228565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564300|NCT01226849|Rituximab|rituximab|mesh-list
65564301|NCT01226849|Carboplatin|carboplatin|mesh-list
65564302|NCT01226849|Etoposide|etoposide|mesh-list
65564303|NCT01226849|Bortezomib|bortezomib|mesh-list
65564304|NCT01226849|Ifosfamide|ifosfamide|mesh-list
65564305|NCT01226849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65564306|NCT01226849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564307|NCT01226849|Immunologic Factors|immunologic factors|mesh-ancestor
65564308|NCT01226849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564309|NCT01226849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65564310|NCT01226849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65564311|NCT01226849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65564312|NCT01226849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65564313|NCT01226849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564314|NCT01226849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564315|NCT01226849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65564316|NCT01226849|Alkylating Agents|alkylating agents|mesh-ancestor
65564317|NCT05159674|Dexmedetomidine|dexmedetomidine|mesh-list
65564318|NCT05159674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65564319|NCT05159674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564320|NCT05159674|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65564321|NCT05159674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65564322|NCT05159674|Analgesics|analgesics|mesh-ancestor
65564323|NCT05159674|Sensory System Agents|sensory system agents|mesh-ancestor
65564324|NCT05159674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65564325|NCT05159674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65564326|NCT05159674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65564327|NCT05159674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65564328|NCT05159674|Adrenergic Agents|adrenergic agents|mesh-ancestor
65564329|NCT05159674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65564330|NCT05159674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564331|NCT03813979|Dolutegravir|dolutegravir|mesh-list
65564332|NCT03813979|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65564333|NCT03813979|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65564334|NCT03813979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564335|NCT03813979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564336|NCT03813979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65564337|NCT03813979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65564338|NCT03813979|Antiviral Agents|antiviral agents|mesh-ancestor
65564339|NCT03813979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65564340|NCT05555121|Progesterone|progesterone|mesh-list
65564341|NCT05555121|Progestins|progestins|mesh-ancestor
65564342|NCT05555121|Hormones|hormones|mesh-ancestor
65564343|NCT05555121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65564344|NCT05555121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564345|NCT05446467|Pembrolizumab|pembrolizumab|mesh-list
65564346|NCT05446467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564347|NCT05446467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65564348|NCT05553613|Clopidogrel|clopidogrel|mesh-list
65564349|NCT05553613|Ticagrelor|ticagrelor|mesh-list
65564350|NCT05553613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65564351|NCT05553613|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65564352|NCT05553613|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65564353|NCT05553613|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65564354|NCT05553613|Purinergic Agents|purinergic agents|mesh-ancestor
65564355|NCT05553613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65564356|NCT05553613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564357|NCT05553613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564358|NCT03901144|Glycerol|glycerol|mesh-list
65564359|NCT03901144|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65564360|NCT03901144|Protective Agents|protective agents|mesh-ancestor
65564361|NCT03901144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564362|NCT01129739|Cyclosporine|cyclosporine|mesh-list
65564363|NCT01129739|Cyclosporins|cyclosporins|mesh-list
65564364|NCT01129739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564365|NCT01129739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564366|NCT01129739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65564367|NCT01129739|Immunologic Factors|immunologic factors|mesh-ancestor
65564368|NCT01129739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564369|NCT01129739|Antifungal Agents|antifungal agents|mesh-ancestor
65564370|NCT01129739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65564371|NCT01129739|Dermatologic Agents|dermatologic agents|mesh-ancestor
65564372|NCT01129739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65564373|NCT01129739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65564374|NCT01301599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
65564375|NCT01301599|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
65564376|NCT01301599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65564377|NCT01301599|Adrenergic Agents|adrenergic agents|mesh-ancestor
65564378|NCT01301599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65564379|NCT01301599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564380|NCT01301599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564381|NCT01301599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65564382|NCT01301599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564383|NCT01301599|Hormone Antagonists|hormone antagonists|mesh-ancestor
65564384|NCT01301599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65564385|NCT03384693|Defibrotide|defibrotide|mesh-list
65564386|NCT03384693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65564387|NCT03384693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65564388|NCT03384693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564389|NCT03384693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65564390|NCT05533281|Dexamethasone|dexamethasone|mesh-list
65564391|NCT05533281|Metoclopramide|metoclopramide|mesh-list
65564392|NCT05533281|Tropisetron|tropisetron|mesh-list
65564393|NCT05533281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65564394|NCT05533281|Antiemetics|antiemetics|mesh-ancestor
65564395|NCT05533281|Autonomic Agents|autonomic agents|mesh-ancestor
65564396|NCT05533281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65564397|NCT05533281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564398|NCT05533281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65564399|NCT05533281|Glucocorticoids|glucocorticoids|mesh-ancestor
65564400|NCT05533281|Hormones|hormones|mesh-ancestor
65564401|NCT05533281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65564402|NCT05533281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65564403|NCT05533281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564404|NCT05533281|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65564406|NCT05533281|Dopamine Agents|dopamine agents|mesh-ancestor
65564407|NCT05533281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65564408|NCT05533281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564409|NCT05533281|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65564410|NCT05533281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65564411|NCT05533281|Serotonin Agents|serotonin agents|mesh-ancestor
65564412|NCT04455802|Morphine|morphine|mesh-list
65564413|NCT04455802|Buprenorphine|buprenorphine|mesh-list
65564414|NCT04455802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65564415|NCT04455802|Narcotics|narcotics|mesh-ancestor
65564416|NCT04455802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65564417|NCT04455802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564418|NCT04455802|Analgesics|analgesics|mesh-ancestor
65564419|NCT04455802|Sensory System Agents|sensory system agents|mesh-ancestor
65564420|NCT04455802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65564421|NCT04455802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65564422|NCT03923075|Dexmedetomidine|dexmedetomidine|mesh-list
65564423|NCT03923075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65564424|NCT03923075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65564425|NCT03923075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564426|NCT03923075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65564427|NCT03923075|Analgesics|analgesics|mesh-ancestor
65564428|NCT03923075|Sensory System Agents|sensory system agents|mesh-ancestor
65564429|NCT03923075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65564430|NCT03923075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65564431|NCT03923075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65564432|NCT03923075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65564433|NCT03923075|Adrenergic Agents|adrenergic agents|mesh-ancestor
65564434|NCT03923075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65564435|NCT03923075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564436|NCT03923231|Ritonavir|ritonavir|mesh-list
65564437|NCT03923231|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65564438|NCT03923231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65564439|NCT03923231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65564440|NCT03923231|Protease Inhibitors|protease inhibitors|mesh-ancestor
65564441|NCT03923231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564442|NCT03923231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564443|NCT03923231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65564444|NCT03923231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65564445|NCT03923231|Antiviral Agents|antiviral agents|mesh-ancestor
65564446|NCT03923231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65564447|NCT03923231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65564448|NCT03923231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65564449|NCT01227239|Oxaliplatin|oxaliplatin|mesh-list
65564450|NCT01227239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564451|NCT01301677|Hydrocortisone|hydrocortisone|mesh-list
65564452|NCT01301677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65564453|NCT02618980|Hemostatics|hemostatics|mesh-list
65564454|NCT02618980|Coagulants|coagulants|mesh-ancestor
65564455|NCT02613598|Bortezomib|bortezomib|mesh-list
65564456|NCT02613598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564457|NCT03718429|Rivaroxaban|rivaroxaban|mesh-list
65564458|NCT03718429|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65564459|NCT03718429|Antithrombins|antithrombins|mesh-ancestor
65564460|NCT03718429|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65564461|NCT03718429|Protease Inhibitors|protease inhibitors|mesh-ancestor
65564462|NCT03718429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564463|NCT03718429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564464|NCT03718429|Anticoagulants|anticoagulants|mesh-ancestor
65564465|NCT01225523|Paclitaxel|paclitaxel|mesh-list
65564466|NCT01225523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65564467|NCT01225523|Cisplatin|cisplatin|mesh-list
65564468|NCT01225523|Fluorouracil|fluorouracil|mesh-list
65564469|NCT01225523|Capecitabine|capecitabine|mesh-list
65564470|NCT01225523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65564471|NCT01225523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564472|NCT01225523|Tubulin Modulators|tubulin modulators|mesh-ancestor
65564473|NCT01225523|Antimitotic Agents|antimitotic agents|mesh-ancestor
65564474|NCT01225523|Mitosis Modulators|mitosis modulators|mesh-ancestor
65564475|NCT01225523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564476|NCT01225523|Antimetabolites|antimetabolites|mesh-ancestor
65564477|NCT01225523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65564478|NCT01225523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65564479|NCT01225523|Immunologic Factors|immunologic factors|mesh-ancestor
65564480|NCT01225523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564481|NCT03815539|Hyaluronic Acid|hyaluronic acid|mesh-list
65564482|NCT03815539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65564483|NCT03815539|Immunologic Factors|immunologic factors|mesh-ancestor
65564484|NCT03815539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564485|NCT03815539|Viscosupplements|viscosupplements|mesh-ancestor
65564486|NCT03815539|Protective Agents|protective agents|mesh-ancestor
65564488|NCT03922919|Cefotaxime|cefotaxime|mesh-list
65564489|NCT03922919|Cefoxitin|cefoxitin|mesh-list
65564490|NCT03922919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65564491|NCT03922919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65564492|NCT03813277|Dexmedetomidine|dexmedetomidine|mesh-list
65564493|NCT03813277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65564494|NCT03813277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65564495|NCT03813277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564496|NCT03813277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65564497|NCT03813277|Analgesics|analgesics|mesh-ancestor
65564498|NCT03813277|Sensory System Agents|sensory system agents|mesh-ancestor
65564499|NCT03813277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65564500|NCT03813277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65564501|NCT03813277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65564502|NCT03813277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65564503|NCT03813277|Adrenergic Agents|adrenergic agents|mesh-ancestor
65564504|NCT03813277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65564505|NCT03813277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564506|NCT03815461|Paclitaxel|paclitaxel|mesh-list
65564507|NCT03815461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65564508|NCT03815461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564509|NCT03815461|Tubulin Modulators|tubulin modulators|mesh-ancestor
65564510|NCT03815461|Antimitotic Agents|antimitotic agents|mesh-ancestor
65564511|NCT03815461|Mitosis Modulators|mitosis modulators|mesh-ancestor
65564512|NCT03815461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564513|NCT01285102|Irinotecan|irinotecan|mesh-list
65564514|NCT01285102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65564515|NCT01285102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65564516|NCT01285102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564517|NCT01285102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564518|NCT01285102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564519|NCT03740243|Buprenorphine|buprenorphine|mesh-list
65564520|NCT03740243|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65564521|NCT03740243|Naloxone|naloxone|mesh-list
65564522|NCT03740243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65564523|NCT03740243|Narcotics|narcotics|mesh-ancestor
65564524|NCT03740243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65564525|NCT03740243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564526|NCT03740243|Analgesics|analgesics|mesh-ancestor
65564527|NCT03740243|Sensory System Agents|sensory system agents|mesh-ancestor
65564528|NCT03740243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65564529|NCT03740243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65564530|NCT03813043|Midazolam|midazolam|mesh-list
65564531|NCT03813043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65564532|NCT03813043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65564533|NCT03813043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65564534|NCT03813043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564535|NCT03813043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65564536|NCT03813043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65564537|NCT03813043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65564538|NCT03813043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65564539|NCT03813043|Anesthetics, General|anesthetics, general|mesh-ancestor
65564540|NCT03813043|Anesthetics|anesthetics|mesh-ancestor
65564541|NCT03813043|GABA Modulators|gaba modulators|mesh-ancestor
65564542|NCT03813043|GABA Agents|gaba agents|mesh-ancestor
65564543|NCT03813043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65564544|NCT03813043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564545|NCT03812965|Botulinum Toxins|botulinum toxins|mesh-list
65564546|NCT03812965|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65564547|NCT03812965|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65564548|NCT03812965|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65564549|NCT03812965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65564550|NCT03812965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564551|NCT03812965|Cholinergic Agents|cholinergic agents|mesh-ancestor
65564552|NCT03812965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65564553|NCT03812965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564554|NCT03812965|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65564555|NCT03812965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65564556|NCT03382899|Pembrolizumab|pembrolizumab|mesh-list
65564557|NCT03382899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65564558|NCT03382899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564559|NCT03815305|Petrolatum|petrolatum|mesh-list
65564560|NCT03815305|Emollients|emollients|mesh-ancestor
65564561|NCT03815305|Dermatologic Agents|dermatologic agents|mesh-ancestor
65564562|NCT01560013|Naltrexone|naltrexone|mesh-list
65564563|NCT01560013|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65564564|NCT01560013|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65564565|NCT01560013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564566|NCT01560013|Sensory System Agents|sensory system agents|mesh-ancestor
65564567|NCT01560013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65564568|NCT01302145|Metformin|metformin|mesh-list
65564569|NCT01302145|Ipragliflozin|ipragliflozin|mesh-list
65564570|NCT01302145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65564571|NCT01302145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564572|NCT01302145|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65564573|NCT01302145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564574|NCT01560091|Tamsulosin|tamsulosin|mesh-list
65564575|NCT01560091|Silodosin|silodosin|mesh-list
65564576|NCT01560091|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65564577|NCT01560091|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65564578|NCT01560091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65564579|NCT01560091|Adrenergic Agents|adrenergic agents|mesh-ancestor
65293732|NCT00913029|Latanoprost|latanoprost|mesh-list
65564580|NCT01560091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65564581|NCT01560091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564582|NCT01560091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564583|NCT01560091|Urological Agents|urological agents|mesh-ancestor
65564584|NCT03382041|Carbon Fiber|carbon fiber|mesh-list
65564585|NCT03382041|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65564586|NCT03382041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65564587|NCT03807271|Anesthetics|anesthetics|mesh-list
65564588|NCT03807271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65564589|NCT03807271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564590|NCT03812731|Fentanyl|fentanyl|mesh-list
65564591|NCT03812731|Ropivacaine|ropivacaine|mesh-list
65564592|NCT03812731|Anesthetics, Local|anesthetics, local|mesh-ancestor
65564593|NCT03812731|Anesthetics|anesthetics|mesh-ancestor
65564594|NCT03812731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65564595|NCT03812731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564596|NCT03812731|Sensory System Agents|sensory system agents|mesh-ancestor
65564597|NCT03812731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65564598|NCT03812731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65564599|NCT03812731|Narcotics|narcotics|mesh-ancestor
65564600|NCT03812731|Analgesics|analgesics|mesh-ancestor
65564601|NCT03812731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65564602|NCT03812731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65564603|NCT03812731|Anesthetics, General|anesthetics, general|mesh-ancestor
65564604|NCT03351231|Nivolumab|nivolumab|mesh-list
65564605|NCT03351231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65564606|NCT03351231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564607|NCT03351231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65564608|NCT03351231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564609|NCT03922373|Benzonatate|benzonatate|mesh-list
65564610|NCT03922373|Antitussive Agents|antitussive agents|mesh-ancestor
65564611|NCT03922373|Respiratory System Agents|respiratory system agents|mesh-ancestor
65564612|NCT03709719|Blinatumomab|blinatumomab|mesh-list
65564613|NCT03709719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564614|NCT03926663|Dexmedetomidine|dexmedetomidine|mesh-list
65564615|NCT03926663|Bupivacaine|bupivacaine|mesh-list
65564616|NCT03926663|Anesthetics, Local|anesthetics, local|mesh-ancestor
65564617|NCT03926663|Anesthetics|anesthetics|mesh-ancestor
65564618|NCT03926663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65564619|NCT03926663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564620|NCT03926663|Sensory System Agents|sensory system agents|mesh-ancestor
65564621|NCT03926663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65564622|NCT03926663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65564623|NCT03926663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65564624|NCT03926663|Analgesics|analgesics|mesh-ancestor
65564625|NCT03926663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65564626|NCT03926663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65564627|NCT03926663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65564628|NCT03926663|Adrenergic Agents|adrenergic agents|mesh-ancestor
65564629|NCT03926663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65564630|NCT03926663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564631|NCT05165914|Midazolam|midazolam|mesh-list
65564632|NCT05165914|Anesthetics|anesthetics|mesh-list
65564633|NCT05165914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65564634|NCT05165914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564635|NCT05165914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65564636|NCT05165914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65564637|NCT05165914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65564638|NCT05165914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65564639|NCT05165914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65564640|NCT05165914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65564641|NCT05165914|Anesthetics, General|anesthetics, general|mesh-ancestor
65564642|NCT05165914|GABA Modulators|gaba modulators|mesh-ancestor
65564643|NCT05165914|GABA Agents|gaba agents|mesh-ancestor
65564644|NCT05165914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65564645|NCT05165914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564646|NCT04420975|Nivolumab|nivolumab|mesh-list
65564647|NCT04420975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65564648|NCT04420975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564649|NCT04420975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65564650|NCT04420975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564651|NCT01132157|Propofol|propofol|mesh-list
65564652|NCT01132157|Desflurane|desflurane|mesh-list
65564653|NCT01132157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65293814|NCT02706977|Dopamine Agents|dopamine agents|mesh-ancestor
65564654|NCT01132157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65564655|NCT01132157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564656|NCT01132157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65564657|NCT01132157|Anesthetics, General|anesthetics, general|mesh-ancestor
65564658|NCT01132157|Anesthetics|anesthetics|mesh-ancestor
65564659|NCT01132157|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65564660|NCT05389150|Pregabalin|pregabalin|mesh-list
65564661|NCT05389150|Tramadol|tramadol|mesh-list
65564662|NCT05389150|Analgesics|analgesics|mesh-ancestor
65564663|NCT05389150|Sensory System Agents|sensory system agents|mesh-ancestor
65564664|NCT05389150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65564665|NCT05389150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564666|NCT05389150|Anticonvulsants|anticonvulsants|mesh-ancestor
65564667|NCT05389150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65564668|NCT05389150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65564669|NCT05389150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564670|NCT05389150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65564671|NCT05389150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65564672|NCT05389150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65564673|NCT05389150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65564674|NCT05389150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65564675|NCT05389150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65564676|NCT05389150|Narcotics|narcotics|mesh-ancestor
65564677|NCT03806101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65564678|NCT03806101|Abrocitinib|abrocitinib|mesh-list
65564679|NCT03806101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65564680|NCT03806101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65564681|NCT03806101|Antimetabolites|antimetabolites|mesh-ancestor
65564682|NCT03806101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564683|NCT03806101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65564684|NCT03806101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65564685|NCT03806101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564686|NCT03806101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65564687|NCT03812419|Esomeprazole|esomeprazole|mesh-list
65564688|NCT03812419|Pantoprazole|pantoprazole|mesh-list
65564689|NCT03812419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65564690|NCT03812419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65564691|NCT03812419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65564692|NCT03812419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564693|NCT03812419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564694|NCT01132235|Etanercept|etanercept|mesh-list
65564695|NCT01132235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65564696|NCT01132235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65564697|NCT01132235|Analgesics|analgesics|mesh-ancestor
65564698|NCT01132235|Sensory System Agents|sensory system agents|mesh-ancestor
65564699|NCT01132235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65564700|NCT01132235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564701|NCT01132235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65564702|NCT01132235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65564703|NCT01132235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65564704|NCT01132235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65564705|NCT01132235|Immunologic Factors|immunologic factors|mesh-ancestor
65362241|NCT00755534|Capecitabine|capecitabine|mesh-list
65564706|NCT01131689|Sorafenib|sorafenib|mesh-list
65564707|NCT01131689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564708|NCT01131689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65564709|NCT01131689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564710|NCT01131689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564711|NCT03401229|Mometasone Furoate|mometasone furoate|mesh-list
65564712|NCT03401229|Benralizumab|benralizumab|mesh-list
65564713|NCT03401229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65564714|NCT03401229|Dermatologic Agents|dermatologic agents|mesh-ancestor
65564715|NCT03401229|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65564716|NCT03401229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65564717|NCT03401229|Respiratory System Agents|respiratory system agents|mesh-ancestor
65564718|NCT05435053|Nivolumab|nivolumab|mesh-list
65564719|NCT05435053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65564720|NCT05435053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564721|NCT05435053|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65564722|NCT05435053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564723|NCT01132391|Nitroglycerin|nitroglycerin|mesh-list
65564724|NCT01132391|Vasodilator Agents|vasodilator agents|mesh-ancestor
65564725|NCT05281081|Morphine|morphine|mesh-list
65564726|NCT05281081|Levobupivacaine|levobupivacaine|mesh-list
65293885|NCT04318210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65564727|NCT05281081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65564728|NCT05281081|Narcotics|narcotics|mesh-ancestor
65564729|NCT05281081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65564730|NCT05281081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564731|NCT05281081|Analgesics|analgesics|mesh-ancestor
65564732|NCT05281081|Sensory System Agents|sensory system agents|mesh-ancestor
65564733|NCT05281081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65564734|NCT05281081|Anesthetics, Local|anesthetics, local|mesh-ancestor
65564735|NCT05281081|Anesthetics|anesthetics|mesh-ancestor
65564736|NCT01303237|Cetuximab|cetuximab|mesh-list
65564737|NCT01303237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65564738|NCT01303237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564739|NCT01227863|Dexamethasone, neomycin, polymyxin B drug combination|dexamethasone, neomycin, polymyxin b drug combination|mesh-list
65564740|NCT01227863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65564741|NCT01227863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65564742|NCT03349515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65564743|NCT01227941|Doxorubicin|doxorubicin|mesh-list
65564744|NCT01227941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65564745|NCT01227941|Niraparib|niraparib|mesh-list
65564746|NCT01227941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65564747|NCT01227941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564748|NCT01227941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65564749|NCT01227941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65564750|NCT01227941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564751|NCT01227941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564752|NCT01227941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65564753|NCT03919565|Tenofovir|tenofovir|mesh-list
65564754|NCT03919565|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65564755|NCT03919565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65564756|NCT03919565|Antiviral Agents|antiviral agents|mesh-ancestor
65564757|NCT03919565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65564758|NCT03919565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65564759|NCT03919565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65564760|NCT03919565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564761|NCT03919565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564762|NCT03919565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65564763|NCT03919565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65564764|NCT03380091|Vitamin D|vitamin d|mesh-list
65564765|NCT03380091|Cholecalciferol|cholecalciferol|mesh-list
65564766|NCT03380091|Metformin|metformin|mesh-list
65564767|NCT03380091|Vitamins|vitamins|mesh-ancestor
65564768|NCT03380091|Micronutrients|micronutrients|mesh-ancestor
65564769|NCT03380091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564770|NCT03380091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65564771|NCT03380091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65564772|NCT03380091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65564773|NCT02529293|Insulin Lispro|insulin lispro|mesh-list
65564774|NCT02529293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65564775|NCT02529293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564776|NCT03919253|Paclitaxel|paclitaxel|mesh-list
65564777|NCT03919253|Maleic acid|maleic acid|mesh-list
65564778|NCT03919253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65564779|NCT03919253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564780|NCT03919253|Tubulin Modulators|tubulin modulators|mesh-ancestor
65564781|NCT03919253|Antimitotic Agents|antimitotic agents|mesh-ancestor
65564782|NCT03919253|Mitosis Modulators|mitosis modulators|mesh-ancestor
65564783|NCT03919253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564784|NCT03919253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564785|NCT05165290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65564786|NCT05165290|Latanoprost|latanoprost|mesh-list
65564787|NCT05165290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65564788|NCT01132703|Glyburide|glyburide|mesh-list
65564789|NCT01132703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65564790|NCT01132703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564791|NCT01377922|Amifampridine|amifampridine|mesh-list
65564792|NCT01377922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65564793|NCT01377922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65564794|NCT01377922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564795|NCT01377922|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65564796|NCT01377922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65564797|NCT01377922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564798|NCT03919175|Rituximab|rituximab|mesh-list
65564799|NCT03919175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65564800|NCT03919175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564801|NCT03919175|Immunologic Factors|immunologic factors|mesh-ancestor
65564802|NCT03919175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564803|NCT03919175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65564804|NCT01303471|Remifentanil|remifentanil|mesh-list
65564805|NCT01303471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65564806|NCT01303471|Narcotics|narcotics|mesh-ancestor
65564807|NCT01303471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65564808|NCT01303471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564809|NCT01303471|Analgesics|analgesics|mesh-ancestor
65564810|NCT01303471|Sensory System Agents|sensory system agents|mesh-ancestor
65564811|NCT01303471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65564812|NCT03804541|Ensartinib|ensartinib|mesh-list
65564813|NCT03804541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564814|NCT03804541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65564815|NCT03804541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564816|NCT03804541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564817|NCT01377844|Bexagliflozin|bexagliflozin|mesh-list
65564818|NCT01377844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65564819|NCT01377844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564820|NCT03710811|Insulin|insulin|mesh-list
65564821|NCT03710811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65564822|NCT03710811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564823|NCT01303549|Amphotericin B|amphotericin b|mesh-list
65564824|NCT01303549|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65564825|NCT01303549|Anidulafungin|anidulafungin|mesh-list
65564826|NCT01303549|Amebicides|amebicides|mesh-ancestor
65564827|NCT01303549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65564828|NCT01303549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65564829|NCT01303549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65564830|NCT01303549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65564831|NCT01303549|Antifungal Agents|antifungal agents|mesh-ancestor
65564832|NCT03796975|Metformin|metformin|mesh-list
65564833|NCT03796975|Pioglitazone|pioglitazone|mesh-list
65564834|NCT03796975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65564835|NCT03796975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564836|NCT01130753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65564837|NCT01130753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564838|NCT01130753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65564839|NCT01130753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564840|NCT01130753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564841|NCT05400070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65564842|NCT05400070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564843|NCT05400070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564844|NCT01302613|Leucovorin|leucovorin|mesh-list
65564845|NCT01302613|Capecitabine|capecitabine|mesh-list
65564846|NCT01302613|Oxaliplatin|oxaliplatin|mesh-list
65564847|NCT01302613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65564848|NCT01302613|Antimetabolites|antimetabolites|mesh-ancestor
65564849|NCT01302613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564850|NCT01302613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564851|NCT01302613|Antidotes|antidotes|mesh-ancestor
65564852|NCT01302613|Protective Agents|protective agents|mesh-ancestor
65564853|NCT01302613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564854|NCT01302613|Vitamin B Complex|vitamin b complex|mesh-ancestor
65564855|NCT01302613|Vitamins|vitamins|mesh-ancestor
65564856|NCT01302613|Micronutrients|micronutrients|mesh-ancestor
65564857|NCT05443035|Anti-Infective Agents|anti-infective agents|mesh-list
65564858|NCT05443035|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65564859|NCT03803371|Acetaminophen|acetaminophen|mesh-list
65564860|NCT03803371|Tramadol|tramadol|mesh-list
65564861|NCT03803371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65564862|NCT03803371|Analgesics|analgesics|mesh-ancestor
65564863|NCT03803371|Sensory System Agents|sensory system agents|mesh-ancestor
65564864|NCT03803371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65564865|NCT03803371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564866|NCT03803371|Antipyretics|antipyretics|mesh-ancestor
65564867|NCT03803371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65564868|NCT03803371|Narcotics|narcotics|mesh-ancestor
65564869|NCT03803371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65564870|NCT01130909|Ketamine|ketamine|mesh-list
65564871|NCT01130909|Analgesics|analgesics|mesh-ancestor
65564872|NCT01130909|Sensory System Agents|sensory system agents|mesh-ancestor
65564873|NCT01130909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65564874|NCT01130909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564875|NCT01130909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65564876|NCT01130909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65564877|NCT01130909|Anesthetics, General|anesthetics, general|mesh-ancestor
65564878|NCT01130909|Anesthetics|anesthetics|mesh-ancestor
65294034|NCT00612287|Narcotics|narcotics|mesh-ancestor
65564879|NCT01130909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65564880|NCT01130909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65564881|NCT01130909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65564882|NCT01130909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65564883|NCT01130909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564884|NCT03918551|Febuxostat|febuxostat|mesh-list
65564885|NCT03918551|Gout Suppressants|gout suppressants|mesh-ancestor
65564886|NCT03918551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65564887|NCT04453930|Irinotecan|irinotecan|mesh-list
65564888|NCT04453930|Apatinib|apatinib|mesh-list
65564889|NCT04453930|Antibodies|antibodies|mesh-list
65564890|NCT04453930|Immunologic Factors|immunologic factors|mesh-ancestor
65564891|NCT04453930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564892|NCT04453930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65564893|NCT04453930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65564894|NCT04453930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564895|NCT04453930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564896|NCT04453930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564897|NCT04453930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65564898|NCT03796507|Temozolomide|temozolomide|mesh-list
65564899|NCT03796507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65564900|NCT03796507|Alkylating Agents|alkylating agents|mesh-ancestor
65564901|NCT03796507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564902|NCT03796507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564903|NCT04586062|Plasminogen|plasminogen|mesh-list
65564904|NCT04586062|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65564905|NCT04586062|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65564906|NCT04586062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564907|NCT01132781|Theophylline|theophylline|mesh-list
65564908|NCT01132781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65564909|NCT01132781|Autonomic Agents|autonomic agents|mesh-ancestor
65564910|NCT01132781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65564911|NCT01132781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564912|NCT01132781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65564913|NCT01132781|Respiratory System Agents|respiratory system agents|mesh-ancestor
65564914|NCT01132781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65564915|NCT01132781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564916|NCT01132781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564917|NCT01132781|Vasodilator Agents|vasodilator agents|mesh-ancestor
65564918|NCT01132781|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65564919|NCT01132781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65564920|NCT01132781|Purinergic Agents|purinergic agents|mesh-ancestor
65564921|NCT01132781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65564922|NCT03497767|Osimertinib|osimertinib|mesh-list
65564923|NCT03497767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564924|NCT03497767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65564925|NCT03497767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564926|NCT03497767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564927|NCT05397652|Tranexamic Acid|tranexamic acid|mesh-list
65564928|NCT05397652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65564929|NCT05397652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65564930|NCT05397652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564931|NCT05397652|Hemostatics|hemostatics|mesh-ancestor
65564932|NCT05397652|Coagulants|coagulants|mesh-ancestor
65564933|NCT01303705|Cyclophosphamide|cyclophosphamide|mesh-list
65564934|NCT01303705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65564935|NCT01303705|Immunologic Factors|immunologic factors|mesh-ancestor
65564936|NCT01303705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564937|NCT01303705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65564938|NCT01303705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65564939|NCT01303705|Alkylating Agents|alkylating agents|mesh-ancestor
65564940|NCT01303705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564941|NCT01303705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564942|NCT01303705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65564943|NCT01134341|Vitamins|vitamins|mesh-list
65564944|NCT01134341|Folic Acid|folic acid|mesh-list
65564945|NCT01134341|Vitamin B 12|vitamin b 12|mesh-list
65564946|NCT01134341|Vitamin B Complex|vitamin b complex|mesh-list
65564947|NCT01134341|Bexarotene|bexarotene|mesh-list
65564948|NCT01134341|10-deazaaminopterin|10-deazaaminopterin|mesh-list
65564949|NCT01134341|Aminopterin|aminopterin|mesh-list
65564950|NCT01134341|Micronutrients|micronutrients|mesh-ancestor
65564951|NCT01134341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564952|NCT01134341|Hematinics|hematinics|mesh-ancestor
65564953|NCT01134341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65564954|NCT01134341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564955|NCT01134341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564956|NCT01134341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564957|NCT04308304|Donepezil|donepezil|mesh-list
65564958|NCT04308304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65564959|NCT04308304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65564960|NCT04308304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564961|NCT04308304|Cholinergic Agents|cholinergic agents|mesh-ancestor
65564962|NCT04308304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65564963|NCT04308304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564964|NCT04308304|Nootropic Agents|nootropic agents|mesh-ancestor
65564965|NCT05397262|Fluorouracil|fluorouracil|mesh-list
65564966|NCT05397262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65564967|NCT05397262|Antimetabolites|antimetabolites|mesh-ancestor
65564968|NCT05397262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564969|NCT05397262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65564970|NCT05397262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65564971|NCT05397262|Immunologic Factors|immunologic factors|mesh-ancestor
65564972|NCT05397262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564973|NCT01230359|Pyridoxine|pyridoxine|mesh-list
65564974|NCT01230359|Vitamin B 6|vitamin b 6|mesh-list
65564975|NCT01230359|Vitamins|vitamins|mesh-ancestor
65564976|NCT01230359|Micronutrients|micronutrients|mesh-ancestor
65564977|NCT01230359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564978|NCT01230359|Vitamin B Complex|vitamin b complex|mesh-ancestor
65564979|NCT04218409|Oxycodone|oxycodone|mesh-list
65564980|NCT04218409|Oxytocin|oxytocin|mesh-list
65564981|NCT04218409|Oxytocics|oxytocics|mesh-ancestor
65564982|NCT04218409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65564983|NCT04218409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65564984|NCT04218409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65564985|NCT04218409|Narcotics|narcotics|mesh-ancestor
65564986|NCT04218409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65564987|NCT04218409|Analgesics|analgesics|mesh-ancestor
65564988|NCT04218409|Sensory System Agents|sensory system agents|mesh-ancestor
65564989|NCT04218409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65564990|NCT05591677|Cycloserine|cycloserine|mesh-list
65564991|NCT05591677|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65564992|NCT05591677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65564993|NCT05591677|Renal Agents|renal agents|mesh-ancestor
65564994|NCT05591677|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65564995|NCT05591677|Antitubercular Agents|antitubercular agents|mesh-ancestor
65564996|NCT05591677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65564997|NCT05591677|Antimetabolites|antimetabolites|mesh-ancestor
65564998|NCT05591677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65564999|NCT05396326|Oxaliplatin|oxaliplatin|mesh-list
65565000|NCT05396326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565001|NCT03795571|Gemcitabine|gemcitabine|mesh-list
65565002|NCT03795571|Dexamethasone|dexamethasone|mesh-list
65565003|NCT03795571|Rituximab|rituximab|mesh-list
65565004|NCT03795571|Oxaliplatin|oxaliplatin|mesh-list
65565005|NCT03795571|Lenalidomide|lenalidomide|mesh-list
65565006|NCT03795571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65565007|NCT03795571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565008|NCT03795571|Immunologic Factors|immunologic factors|mesh-ancestor
65565009|NCT03795571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565010|NCT03795571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65565011|NCT03795571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65565012|NCT03795571|Antiemetics|antiemetics|mesh-ancestor
65565013|NCT03795571|Autonomic Agents|autonomic agents|mesh-ancestor
65565014|NCT03795571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65565015|NCT03795571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65565017|NCT03795571|Hormones|hormones|mesh-ancestor
65565018|NCT03795571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65565019|NCT03795571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65565020|NCT03795571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65565021|NCT03795571|Antimetabolites|antimetabolites|mesh-ancestor
65565022|NCT03795571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565023|NCT03795571|Antiviral Agents|antiviral agents|mesh-ancestor
65565024|NCT03795571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65565025|NCT03795571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565026|NCT03795571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65565027|NCT03795571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65565028|NCT03795571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65565029|NCT03795571|Growth Substances|growth substances|mesh-ancestor
65565030|NCT03795571|Growth Inhibitors|growth inhibitors|mesh-ancestor
65565031|NCT04280848|Temozolomide|temozolomide|mesh-list
65565032|NCT04280848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65565033|NCT04280848|Alkylating Agents|alkylating agents|mesh-ancestor
65565034|NCT04280848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565035|NCT04280848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565036|NCT03795649|Tranexamic Acid|tranexamic acid|mesh-list
65565037|NCT03795649|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65565038|NCT03795649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65565039|NCT03795649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565040|NCT03795649|Hemostatics|hemostatics|mesh-ancestor
65565041|NCT03795649|Coagulants|coagulants|mesh-ancestor
65565042|NCT04211272|Sildenafil Citrate|sildenafil citrate|mesh-list
65565043|NCT04211272|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65565044|NCT04211272|Macitentan|macitentan|mesh-list
65565045|NCT04211272|Riociguat|riociguat|mesh-list
65565046|NCT04211272|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65565047|NCT04211272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65565048|NCT04211272|Antimetabolites|antimetabolites|mesh-ancestor
65565049|NCT04211272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565050|NCT04211272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65565051|NCT04211272|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65565052|NCT04211272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565053|NCT04211272|Vasodilator Agents|vasodilator agents|mesh-ancestor
65565054|NCT04211272|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65565055|NCT04211272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65565056|NCT04211272|Urological Agents|urological agents|mesh-ancestor
65565057|NCT04211272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65565058|NCT04211272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65565059|NCT04211272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65565060|NCT04211272|Enzyme Activators|enzyme activators|mesh-ancestor
65565061|NCT05402189|Fentanyl|fentanyl|mesh-list
65565062|NCT05402189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65565063|NCT05402189|Narcotics|narcotics|mesh-ancestor
65565064|NCT05402189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65565065|NCT05402189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565066|NCT05402189|Analgesics|analgesics|mesh-ancestor
65565067|NCT05402189|Sensory System Agents|sensory system agents|mesh-ancestor
65565068|NCT05402189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65565069|NCT05402189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65565070|NCT05402189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65565071|NCT05402189|Anesthetics, General|anesthetics, general|mesh-ancestor
65565072|NCT05402189|Anesthetics|anesthetics|mesh-ancestor
65565073|NCT01304563|Vaccines|vaccines|mesh-list
65565074|NCT01304563|Immunologic Factors|immunologic factors|mesh-ancestor
65565075|NCT01304563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565076|NCT01231997|Udenafil|udenafil|mesh-list
65565077|NCT01231997|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65565078|NCT01231997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65565079|NCT01231997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565080|NCT01231997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565081|NCT03795805|Lidocaine|lidocaine|mesh-list
65565082|NCT03795805|Anesthetics, Local|anesthetics, local|mesh-ancestor
65565083|NCT03795805|Anesthetics|anesthetics|mesh-ancestor
65565084|NCT03795805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65565085|NCT03795805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565086|NCT03795805|Sensory System Agents|sensory system agents|mesh-ancestor
65565087|NCT03795805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65565088|NCT03795805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65565089|NCT03795805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65565090|NCT03795805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65565091|NCT03795805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65565092|NCT03795805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565093|NCT04072042|Apatinib|apatinib|mesh-list
65565094|NCT04072042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565095|NCT04072042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65565096|NCT04072042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565097|NCT04072042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565098|NCT03799315|Nicotine|nicotine|mesh-list
65565099|NCT03799315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65565100|NCT03799315|Autonomic Agents|autonomic agents|mesh-ancestor
65565101|NCT03799315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65565102|NCT03799315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565103|NCT03799315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65565104|NCT03799315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65294258|NCT04899791|Antioxidants|antioxidants|mesh-ancestor
65565105|NCT03799315|Cholinergic Agents|cholinergic agents|mesh-ancestor
65565106|NCT03799315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65565107|NCT03799315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565108|NCT05387200|Alendronate|alendronate|mesh-list
65565109|NCT05387200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65565110|NCT05387200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565111|NCT05386810|Vaccines|vaccines|mesh-list
65565112|NCT05386810|Immunologic Factors|immunologic factors|mesh-ancestor
65565113|NCT05386810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565114|NCT04910269|Immunoglobulins|immunoglobulins|mesh-list
65565115|NCT04910269|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65565116|NCT04910269|Antibodies|antibodies|mesh-list
65565117|NCT04910269|Immunologic Factors|immunologic factors|mesh-ancestor
65565118|NCT04910269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565119|NCT03442972|Teduglutide|teduglutide|mesh-list
65565120|NCT03442972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65565121|NCT03442972|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65565122|NCT03442972|Protective Agents|protective agents|mesh-ancestor
65565123|NCT03442972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565124|NCT03921671|Paclitaxel|paclitaxel|mesh-list
65565125|NCT03921671|Carboplatin|carboplatin|mesh-list
65565126|NCT03921671|Ramucirumab|ramucirumab|mesh-list
65565127|NCT03921671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65565128|NCT03921671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565129|NCT03921671|Tubulin Modulators|tubulin modulators|mesh-ancestor
65565130|NCT03921671|Antimitotic Agents|antimitotic agents|mesh-ancestor
65565131|NCT03921671|Mitosis Modulators|mitosis modulators|mesh-ancestor
65565132|NCT03921671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565133|NCT05374954|Vaccines|vaccines|mesh-list
65565134|NCT05374954|Immunologic Factors|immunologic factors|mesh-ancestor
65565135|NCT05374954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565136|NCT03921593|Pancrelipase|pancrelipase|mesh-list
65565137|NCT03921593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65565138|NCT03369951|Minocycline|minocycline|mesh-list
65565139|NCT03369951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65565140|NCT03369951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65565141|NCT01131767|Naproxen|naproxen|mesh-list
65565142|NCT01131767|Pseudoephedrine|pseudoephedrine|mesh-list
65565143|NCT01131767|Ephedrine|ephedrine|mesh-list
65565144|NCT01131767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65565145|NCT01131767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65565146|NCT01131767|Analgesics|analgesics|mesh-ancestor
65565147|NCT01131767|Sensory System Agents|sensory system agents|mesh-ancestor
65565148|NCT01131767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65565149|NCT01131767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565150|NCT01131767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65565151|NCT01131767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65565152|NCT01131767|Gout Suppressants|gout suppressants|mesh-ancestor
65565153|NCT01131767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65565154|NCT01131767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565155|NCT01131767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565156|NCT01131767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65565157|NCT01131767|Autonomic Agents|autonomic agents|mesh-ancestor
65565158|NCT01131767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65565159|NCT01131767|Respiratory System Agents|respiratory system agents|mesh-ancestor
65565160|NCT01131767|Nasal Decongestants|nasal decongestants|mesh-ancestor
65565161|NCT01131767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65565162|NCT01131767|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65565163|NCT01131767|Sympathomimetics|sympathomimetics|mesh-ancestor
65565164|NCT01131767|Adrenergic Agents|adrenergic agents|mesh-ancestor
65565165|NCT01131767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65565166|NCT03795259|Rocuronium|rocuronium|mesh-list
65565167|NCT03795259|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65565168|NCT03795259|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65565169|NCT03795259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65565170|NCT03795259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65565171|NCT03795259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565172|NCT01229189|Vitamin D|vitamin d|mesh-list
65565173|NCT01229189|Vitamins|vitamins|mesh-ancestor
65565174|NCT01229189|Micronutrients|micronutrients|mesh-ancestor
65565175|NCT01229189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565176|NCT01229189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65565177|NCT05481489|Atropine|atropine|mesh-list
65565178|NCT05481489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65565179|NCT05481489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65565180|NCT05481489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65565181|NCT05481489|Autonomic Agents|autonomic agents|mesh-ancestor
65565182|NCT05481489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65565183|NCT05481489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565184|NCT05481489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65565185|NCT05481489|Respiratory System Agents|respiratory system agents|mesh-ancestor
65565186|NCT05481489|Mydriatics|mydriatics|mesh-ancestor
65565187|NCT05481489|Parasympatholytics|parasympatholytics|mesh-ancestor
65565188|NCT05481489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65565189|NCT05481489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65565190|NCT05481489|Cholinergic Agents|cholinergic agents|mesh-ancestor
65565191|NCT05481489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65565192|NCT05481489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565193|NCT05341180|Lactulose|lactulose|mesh-list
65565194|NCT05341180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65565195|NCT05341180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65565196|NCT01133483|Fexofenadine|fexofenadine|mesh-list
65565197|NCT01133483|Pseudoephedrine|pseudoephedrine|mesh-list
65565198|NCT01133483|Ephedrine|ephedrine|mesh-list
65565199|NCT01133483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65565200|NCT01133483|Autonomic Agents|autonomic agents|mesh-ancestor
65565201|NCT01133483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65565202|NCT01133483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565203|NCT01133483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65565204|NCT01133483|Respiratory System Agents|respiratory system agents|mesh-ancestor
65565205|NCT01133483|Nasal Decongestants|nasal decongestants|mesh-ancestor
65565206|NCT01133483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65565207|NCT01133483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65565208|NCT01133483|Sympathomimetics|sympathomimetics|mesh-ancestor
65565209|NCT01133483|Adrenergic Agents|adrenergic agents|mesh-ancestor
65565210|NCT01133483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65565211|NCT01133483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565212|NCT01133483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65565213|NCT01133483|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65565214|NCT01133483|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65565215|NCT01133483|Histamine Antagonists|histamine antagonists|mesh-ancestor
65565216|NCT01133483|Histamine Agents|histamine agents|mesh-ancestor
65565217|NCT05401721|Arginine Vasopressin|arginine vasopressin|mesh-list
65565218|NCT05401721|Hemostatics|hemostatics|mesh-ancestor
65565219|NCT05401721|Coagulants|coagulants|mesh-ancestor
65565220|NCT05401721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65565221|NCT05401721|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65565222|NCT05401721|Natriuretic Agents|natriuretic agents|mesh-ancestor
65565223|NCT05401721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565224|NCT01560481|Metformin|metformin|mesh-list
65565225|NCT01560481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65565226|NCT01560481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565227|NCT04795531|Insulin|insulin|mesh-list
65565228|NCT04795531|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65565229|NCT04795531|Insulin, Long-Acting|insulin, long-acting|mesh-list
65565230|NCT04795531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65565231|NCT04795531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565232|NCT03229408|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
65565233|NCT03229408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65565234|NCT03229408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65565235|NCT03229408|Analgesics|analgesics|mesh-ancestor
65565236|NCT03229408|Sensory System Agents|sensory system agents|mesh-ancestor
65565237|NCT03229408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65565238|NCT03229408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565239|NCT03229408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65565240|NCT03229408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65565241|NCT05238844|Tenofovir|tenofovir|mesh-list
65565242|NCT05238844|Antiviral Agents|antiviral agents|mesh-ancestor
65565243|NCT05238844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65565244|NCT05238844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65565245|NCT05238844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65565246|NCT05238844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565247|NCT05238844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565248|NCT05238844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65565249|NCT05238844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65565250|NCT04785625|Bupivacaine|bupivacaine|mesh-list
65565251|NCT04785625|Anesthetics, Local|anesthetics, local|mesh-ancestor
65565252|NCT04785625|Anesthetics|anesthetics|mesh-ancestor
65565253|NCT04785625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65565254|NCT04785625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565255|NCT04785625|Sensory System Agents|sensory system agents|mesh-ancestor
65294417|NCT00597584|Epoetin Alfa|epoetin alfa|mesh-list
65565256|NCT04785625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65565257|NCT03368859|Leucovorin|leucovorin|mesh-list
65565258|NCT03368859|Bevacizumab|bevacizumab|mesh-list
65565259|NCT03368859|Fluorouracil|fluorouracil|mesh-list
65565260|NCT03368859|Irinotecan|irinotecan|mesh-list
65565261|NCT03368859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65565262|NCT03368859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565263|NCT03368859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65565264|NCT03368859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65565265|NCT03368859|Growth Substances|growth substances|mesh-ancestor
65565266|NCT03368859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565267|NCT03368859|Growth Inhibitors|growth inhibitors|mesh-ancestor
65565268|NCT03368859|Antimetabolites|antimetabolites|mesh-ancestor
65565269|NCT03368859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565270|NCT03368859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65565271|NCT03368859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65565272|NCT03368859|Immunologic Factors|immunologic factors|mesh-ancestor
65565273|NCT03368859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65565274|NCT03368859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65565275|NCT03368859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565276|NCT03368859|Antidotes|antidotes|mesh-ancestor
65565277|NCT03368859|Protective Agents|protective agents|mesh-ancestor
65565278|NCT03368859|Vitamin B Complex|vitamin b complex|mesh-ancestor
65565279|NCT03368859|Vitamins|vitamins|mesh-ancestor
65565280|NCT03368859|Micronutrients|micronutrients|mesh-ancestor
65565281|NCT01134965|Digoxin|digoxin|mesh-list
65565282|NCT01134965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65565283|NCT01134965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65565284|NCT01134965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565285|NCT01134965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565286|NCT01134965|Protective Agents|protective agents|mesh-ancestor
65565287|NCT01134965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565288|NCT03810547|Ketamine|ketamine|mesh-list
65565289|NCT03810547|Propofol|propofol|mesh-list
65565290|NCT03810547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65565291|NCT03810547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65565292|NCT03810547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565293|NCT03810547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65565294|NCT03810547|Anesthetics, General|anesthetics, general|mesh-ancestor
65565295|NCT03810547|Anesthetics|anesthetics|mesh-ancestor
65565296|NCT03810547|Analgesics|analgesics|mesh-ancestor
65565297|NCT03810547|Sensory System Agents|sensory system agents|mesh-ancestor
65565298|NCT03810547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65565299|NCT03810547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65565300|NCT03810547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65565301|NCT03810547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65565302|NCT03810547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65565303|NCT03810547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565304|NCT03096314|Vitamin D|vitamin d|mesh-list
65565305|NCT03096314|Cholecalciferol|cholecalciferol|mesh-list
65565306|NCT03096314|Vitamins|vitamins|mesh-ancestor
65565307|NCT03096314|Micronutrients|micronutrients|mesh-ancestor
65565308|NCT03096314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565309|NCT03096314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65565310|NCT03096314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65565311|NCT03917459|Enalapril|enalapril|mesh-list
65565312|NCT03917459|Enalaprilat|enalaprilat|mesh-list
65565313|NCT03917459|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65565314|NCT03917459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65565315|NCT03917459|Protease Inhibitors|protease inhibitors|mesh-ancestor
65565316|NCT03917459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565317|NCT03917459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565318|NCT03917459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65565319|NCT03917459|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65565320|NCT03920813|Mercaptopurine|mercaptopurine|mesh-list
65565321|NCT03920813|Antimetabolites|antimetabolites|mesh-ancestor
65565322|NCT03920813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565323|NCT03920813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65565324|NCT03920813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565325|NCT03920813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65565326|NCT03920813|Immunologic Factors|immunologic factors|mesh-ancestor
65565327|NCT03920813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565328|NCT03920813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65565329|NCT03920813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565330|NCT03129646|Paromomycin|paromomycin|mesh-list
65565331|NCT03129646|Miltefosine|miltefosine|mesh-list
65565332|NCT03129646|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
65565333|NCT03129646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65565334|NCT03129646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65565335|NCT03129646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65565336|NCT03129646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65565337|NCT03129646|Antifungal Agents|antifungal agents|mesh-ancestor
65565338|NCT03129646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565339|NCT03129646|Schistosomicides|schistosomicides|mesh-ancestor
65565340|NCT03129646|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65565341|NCT03129646|Anthelmintics|anthelmintics|mesh-ancestor
65565342|NCT03710655|Histamine|histamine|mesh-list
65565343|NCT03710655|Histamine Agonists|histamine agonists|mesh-ancestor
65565344|NCT03710655|Histamine Agents|histamine agents|mesh-ancestor
65565345|NCT03710655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65565346|NCT03710655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565347|NCT03710655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565348|NCT01135199|Pomalidomide|pomalidomide|mesh-list
65565349|NCT01135199|Immunologic Factors|immunologic factors|mesh-ancestor
65565350|NCT01135199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565351|NCT01135199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65565352|NCT01135199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65565353|NCT01135199|Growth Substances|growth substances|mesh-ancestor
65565354|NCT01135199|Growth Inhibitors|growth inhibitors|mesh-ancestor
65565355|NCT01135199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565356|NCT04027946|Pembrolizumab|pembrolizumab|mesh-list
65565357|NCT04027946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65565358|NCT04027946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565359|NCT03917537|Nivolumab|nivolumab|mesh-list
65565360|NCT03917537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65565361|NCT03917537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565362|NCT03917537|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65565363|NCT03917537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565364|NCT03335163|Topiramate|topiramate|mesh-list
65565365|NCT03335163|Anticonvulsants|anticonvulsants|mesh-ancestor
65565366|NCT03335163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65565367|NCT03335163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565368|NCT03982030|Dalbavancin|dalbavancin|mesh-list
65565369|NCT03982030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65565370|NCT03982030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65565371|NCT04749602|Nivolumab|nivolumab|mesh-list
65565372|NCT04749602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65565373|NCT04749602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565374|NCT04749602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65565375|NCT04749602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565376|NCT03461302|Coal Tar|coal tar|mesh-list
65565377|NCT03461302|Keratolytic Agents|keratolytic agents|mesh-ancestor
65565378|NCT03461302|Dermatologic Agents|dermatologic agents|mesh-ancestor
65565379|NCT03128359|Mycophenolic Acid|mycophenolic acid|mesh-list
65565380|NCT03128359|Cyclophosphamide|cyclophosphamide|mesh-list
65565381|NCT03128359|Melphalan|melphalan|mesh-list
65565382|NCT03128359|Busulfan|busulfan|mesh-list
65565383|NCT03128359|Fludarabine|fludarabine|mesh-list
65565384|NCT03128359|Fludarabine phosphate|fludarabine phosphate|mesh-list
65565385|NCT03128359|Tacrolimus|tacrolimus|mesh-list
65565386|NCT03128359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65565387|NCT03128359|Immunologic Factors|immunologic factors|mesh-ancestor
65565388|NCT03128359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565389|NCT03128359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65565390|NCT03128359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65565391|NCT03128359|Alkylating Agents|alkylating agents|mesh-ancestor
65565392|NCT03128359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565394|NCT03128359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65565395|NCT03128359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65565396|NCT03128359|Antimetabolites|antimetabolites|mesh-ancestor
65565397|NCT03128359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65565398|NCT03128359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565399|NCT03128359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65565400|NCT03128359|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65565401|NCT03128359|Antitubercular Agents|antitubercular agents|mesh-ancestor
65565402|NCT03128359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65565403|NCT03128359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65565404|NCT01232075|Letrozole|letrozole|mesh-list
65565405|NCT01232075|Citric Acid|citric acid|mesh-list
65565406|NCT01232075|Sodium Citrate|sodium citrate|mesh-list
65565407|NCT01232075|Clomiphene|clomiphene|mesh-list
65565408|NCT01232075|Enclomiphene|enclomiphene|mesh-list
65565409|NCT01232075|Zuclomiphene|zuclomiphene|mesh-list
65565410|NCT01232075|Anticoagulants|anticoagulants|mesh-ancestor
65565411|NCT01232075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65565412|NCT01232075|Chelating Agents|chelating agents|mesh-ancestor
65565413|NCT01232075|Sequestering Agents|sequestering agents|mesh-ancestor
65565414|NCT01232075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565415|NCT01232075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565416|NCT01232075|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65565417|NCT01232075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65565418|NCT01232075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565419|NCT01232075|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65565420|NCT01232075|Hormone Antagonists|hormone antagonists|mesh-ancestor
65565421|NCT01232075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65565422|NCT01232075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565423|NCT01232075|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65565424|NCT01232075|Fertility Agents|fertility agents|mesh-ancestor
65565425|NCT01232075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65565426|NCT01232075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65565427|NCT01232075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65565428|NCT03773822|Hydrocortisone|hydrocortisone|mesh-list
65565429|NCT03773822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65565430|NCT01131845|Treprostinil|treprostinil|mesh-list
65565431|NCT01131845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65565432|NCT03711422|Afatinib|afatinib|mesh-list
65565433|NCT03711422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565434|NCT03711422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65565435|NCT03711422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565436|NCT03711422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565437|NCT03460678|Pemetrexed|pemetrexed|mesh-list
65565438|NCT03460678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65565439|NCT03460678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565440|NCT03460678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565441|NCT03460678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565442|NCT03460678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65565443|NCT03460678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65565444|NCT03460678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65565445|NCT03810391|Butorphanol|butorphanol|mesh-list
65565446|NCT03810391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65565447|NCT03810391|Narcotics|narcotics|mesh-ancestor
65565448|NCT03810391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65565449|NCT03810391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565450|NCT03810391|Analgesics|analgesics|mesh-ancestor
65565451|NCT03810391|Sensory System Agents|sensory system agents|mesh-ancestor
65565452|NCT03810391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65565453|NCT03810391|Antitussive Agents|antitussive agents|mesh-ancestor
65565454|NCT03810391|Respiratory System Agents|respiratory system agents|mesh-ancestor
65565455|NCT03810391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65565456|NCT01229579|Zinc Sulfate|zinc sulfate|mesh-list
65565457|NCT01229579|Astringents|astringents|mesh-ancestor
65565458|NCT01229579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565459|NCT01229579|Dermatologic Agents|dermatologic agents|mesh-ancestor
65565460|NCT01131923|Amlodipine|amlodipine|mesh-list
65565461|NCT01131923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65565462|NCT01131923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65565463|NCT01131923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65565464|NCT01131923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565465|NCT01131923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65565466|NCT01131923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565467|NCT01131923|Vasodilator Agents|vasodilator agents|mesh-ancestor
65565468|NCT03794557|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
65565469|NCT03794557|Respiratory System Agents|respiratory system agents|mesh-ancestor
65565471|NCT01230983|Cytarabine|cytarabine|mesh-list
65565472|NCT01230983|Prednisone|prednisone|mesh-list
65565473|NCT01230983|Hydrocortisone|hydrocortisone|mesh-list
65565474|NCT01230983|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65565475|NCT01230983|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65565476|NCT01230983|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65565477|NCT01230983|Doxorubicin|doxorubicin|mesh-list
65565478|NCT01230983|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65565479|NCT01230983|Dexrazoxane|dexrazoxane|mesh-list
65565480|NCT01230983|Methotrexate|methotrexate|mesh-list
65565481|NCT01230983|Vincristine|vincristine|mesh-list
65565482|NCT01230983|Asparaginase|asparaginase|mesh-list
65565483|NCT01230983|Mercaptopurine|mercaptopurine|mesh-list
65565484|NCT01230983|Razoxane|razoxane|mesh-list
65565485|NCT01230983|Levoleucovorin|levoleucovorin|mesh-list
65565486|NCT01230983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65565487|NCT01230983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565488|NCT01230983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65565489|NCT01230983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65565490|NCT01230983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565491|NCT01230983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565492|NCT01230983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565493|NCT01230983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65565494|NCT01230983|Glucocorticoids|glucocorticoids|mesh-ancestor
65565495|NCT01230983|Hormones|hormones|mesh-ancestor
65565496|NCT01230983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65565497|NCT01230983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65565498|NCT01230983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65565499|NCT01230983|Abortifacient Agents|abortifacient agents|mesh-ancestor
65565500|NCT01230983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65565501|NCT01230983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65565502|NCT01230983|Antimetabolites|antimetabolites|mesh-ancestor
65565503|NCT01230983|Dermatologic Agents|dermatologic agents|mesh-ancestor
65565504|NCT01230983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65565505|NCT01230983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65565506|NCT01230983|Immunologic Factors|immunologic factors|mesh-ancestor
65565507|NCT01230983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65565508|NCT01230983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65565509|NCT01230983|Antiviral Agents|antiviral agents|mesh-ancestor
65565510|NCT01230983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65565511|NCT01230983|Antidotes|antidotes|mesh-ancestor
65565512|NCT01230983|Protective Agents|protective agents|mesh-ancestor
65565513|NCT01230983|Vitamin B Complex|vitamin b complex|mesh-ancestor
65565514|NCT01230983|Vitamins|vitamins|mesh-ancestor
65565515|NCT01230983|Micronutrients|micronutrients|mesh-ancestor
65565516|NCT01230983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65565517|NCT01230983|Tubulin Modulators|tubulin modulators|mesh-ancestor
65565518|NCT01230983|Antimitotic Agents|antimitotic agents|mesh-ancestor
65565519|NCT01230983|Mitosis Modulators|mitosis modulators|mesh-ancestor
65565520|NCT01230983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65565521|NCT01304797|Cyclophosphamide|cyclophosphamide|mesh-list
65565522|NCT01304797|Trastuzumab|trastuzumab|mesh-list
65565523|NCT01304797|Doxorubicin|doxorubicin|mesh-list
65565524|NCT01304797|Immunoconjugates|immunoconjugates|mesh-list
65565525|NCT01304797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65565526|NCT01304797|Immunologic Factors|immunologic factors|mesh-ancestor
65565527|NCT01304797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565528|NCT01304797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65565529|NCT01304797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65565530|NCT01304797|Alkylating Agents|alkylating agents|mesh-ancestor
65565531|NCT01304797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565532|NCT01304797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565533|NCT01304797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65565534|NCT01304797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65565535|NCT01304797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65565536|NCT01304797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65565537|NCT01304797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65565538|NCT01304797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565539|NCT03707535|Infliximab|infliximab|mesh-list
65565540|NCT03707535|Dermatologic Agents|dermatologic agents|mesh-ancestor
65565541|NCT03707535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65565542|NCT03707535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65565543|NCT01133795|Midodrine|midodrine|mesh-list
65565544|NCT01133795|Sympathomimetics|sympathomimetics|mesh-ancestor
65565545|NCT01133795|Autonomic Agents|autonomic agents|mesh-ancestor
65565546|NCT01133795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65565547|NCT01133795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565548|NCT01133795|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65565549|NCT01133795|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65565550|NCT01133795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65565551|NCT01133795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65565552|NCT01133795|Adrenergic Agents|adrenergic agents|mesh-ancestor
65565553|NCT01133795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65565554|NCT01133795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565555|NCT01133873|Dextropropoxyphene|dextropropoxyphene|mesh-list
65565556|NCT01133873|Levopropoxyphene|levopropoxyphene|mesh-list
65565557|NCT01133873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65565558|NCT01133873|Narcotics|narcotics|mesh-ancestor
65565559|NCT01133873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65565560|NCT01133873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565561|NCT01133873|Analgesics|analgesics|mesh-ancestor
65565562|NCT01133873|Sensory System Agents|sensory system agents|mesh-ancestor
65565563|NCT01133873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65565564|NCT01133873|Antitussive Agents|antitussive agents|mesh-ancestor
65565565|NCT01133873|Respiratory System Agents|respiratory system agents|mesh-ancestor
65565566|NCT01229813|Bevacizumab|bevacizumab|mesh-list
65565567|NCT01229813|Capecitabine|capecitabine|mesh-list
65565568|NCT01229813|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65565569|NCT01229813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65565570|NCT01229813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565571|NCT01229813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65565572|NCT01229813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65565573|NCT01229813|Growth Substances|growth substances|mesh-ancestor
65565574|NCT01229813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565575|NCT01229813|Growth Inhibitors|growth inhibitors|mesh-ancestor
65565576|NCT01229813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65565577|NCT01229813|Antimetabolites|antimetabolites|mesh-ancestor
65565578|NCT01229813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565579|NCT01229813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65565580|NCT01229813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565581|NCT01649947|Hydroxychloroquine|hydroxychloroquine|mesh-list
65565582|NCT01649947|Paclitaxel|paclitaxel|mesh-list
65565583|NCT01649947|Bevacizumab|bevacizumab|mesh-list
65565584|NCT01649947|Carboplatin|carboplatin|mesh-list
65565585|NCT01649947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65565586|NCT01649947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565587|NCT01649947|Tubulin Modulators|tubulin modulators|mesh-ancestor
65565588|NCT01649947|Antimitotic Agents|antimitotic agents|mesh-ancestor
65565589|NCT01649947|Mitosis Modulators|mitosis modulators|mesh-ancestor
65565590|NCT01649947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565591|NCT01649947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65565592|NCT01649947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65565593|NCT01649947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65565594|NCT01649947|Growth Substances|growth substances|mesh-ancestor
65565595|NCT01649947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565596|NCT01649947|Growth Inhibitors|growth inhibitors|mesh-ancestor
65565597|NCT01649947|Antimalarials|antimalarials|mesh-ancestor
65565598|NCT01649947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65565599|NCT01649947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65565600|NCT01649947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65565601|NCT01649947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565602|NCT01649947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65565603|NCT03793075|Ketamine|ketamine|mesh-list
65565604|NCT03793075|Propofol|propofol|mesh-list
65565605|NCT03793075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65565606|NCT03793075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65565607|NCT03793075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565608|NCT03793075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65565609|NCT03793075|Anesthetics, General|anesthetics, general|mesh-ancestor
65565610|NCT03793075|Anesthetics|anesthetics|mesh-ancestor
65565611|NCT03793075|Analgesics|analgesics|mesh-ancestor
65565612|NCT03793075|Sensory System Agents|sensory system agents|mesh-ancestor
65565613|NCT03793075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65565614|NCT03793075|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65565615|NCT03793075|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65565616|NCT03793075|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65565617|NCT03793075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65565618|NCT03793075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565619|NCT01233167|Clopidogrel|clopidogrel|mesh-list
65363143|NCT01060969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565620|NCT01233167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65565621|NCT01233167|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65565622|NCT01233167|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65565623|NCT01233167|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65565624|NCT01233167|Purinergic Agents|purinergic agents|mesh-ancestor
65565625|NCT01233167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65565626|NCT01233167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565627|NCT01233167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565628|NCT01304095|Ranolazine|ranolazine|mesh-list
65565629|NCT01304095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65565630|NCT01304095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65565631|NCT01304095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565632|NCT03707457|Nivolumab|nivolumab|mesh-list
65565633|NCT03707457|Ipilimumab|ipilimumab|mesh-list
65565634|NCT03707457|Antibodies|antibodies|mesh-list
65565635|NCT03707457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65565636|NCT03707457|Immunologic Factors|immunologic factors|mesh-ancestor
65565637|NCT03707457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565638|NCT03707457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65565639|NCT03707457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565640|NCT03707457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65565641|NCT03707457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565642|NCT01568294|Pomalidomide|pomalidomide|mesh-list
65565643|NCT01568294|Immunologic Factors|immunologic factors|mesh-ancestor
65565644|NCT01568294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565645|NCT01568294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65565646|NCT01568294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65565647|NCT01568294|Growth Substances|growth substances|mesh-ancestor
65565648|NCT01568294|Growth Inhibitors|growth inhibitors|mesh-ancestor
65565649|NCT01568294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565650|NCT03422666|Teduglutide|teduglutide|mesh-list
65565651|NCT03422666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65565652|NCT03422666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65565653|NCT03422666|Protective Agents|protective agents|mesh-ancestor
65565654|NCT03422666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565655|NCT03453190|Apremilast|apremilast|mesh-list
65565656|NCT03453190|Clobetasol|clobetasol|mesh-list
65565657|NCT03453190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65565658|NCT03453190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65565659|NCT03453190|Analgesics|analgesics|mesh-ancestor
65565660|NCT03453190|Sensory System Agents|sensory system agents|mesh-ancestor
65565661|NCT03453190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65565662|NCT03453190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565663|NCT03453190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65565664|NCT03453190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65565665|NCT03453190|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65565666|NCT03453190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65565667|NCT03453190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565668|NCT03453190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565669|NCT03453190|Glucocorticoids|glucocorticoids|mesh-ancestor
65565670|NCT03453190|Hormones|hormones|mesh-ancestor
65565671|NCT03453190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65565672|NCT01231139|Acetaminophen|acetaminophen|mesh-list
65565673|NCT01231139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65565674|NCT01231139|Analgesics|analgesics|mesh-ancestor
65565675|NCT01231139|Sensory System Agents|sensory system agents|mesh-ancestor
65565676|NCT01231139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65565677|NCT01231139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565678|NCT01231139|Antipyretics|antipyretics|mesh-ancestor
65565679|NCT03382574|Denosumab|denosumab|mesh-list
65565680|NCT03382574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65565681|NCT03382574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565682|NCT01137695|Pramlintide|pramlintide|mesh-list
65565683|NCT01137695|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
65565684|NCT01137695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65565685|NCT01137695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565686|NCT01137695|Appetite Depressants|appetite depressants|mesh-ancestor
65565687|NCT01137695|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65565688|NCT01137695|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
65565689|NCT01137695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565690|NCT03451396|Lifitegrast|lifitegrast|mesh-list
65565691|NCT03451396|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65565692|NCT03451396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65565693|NCT02528825|Remifentanil|remifentanil|mesh-list
65363221|NCT00562965|Hormones|hormones|mesh-ancestor
65565694|NCT02528825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65565695|NCT02528825|Narcotics|narcotics|mesh-ancestor
65565696|NCT02528825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65565697|NCT02528825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565698|NCT02528825|Analgesics|analgesics|mesh-ancestor
65565699|NCT02528825|Sensory System Agents|sensory system agents|mesh-ancestor
65565700|NCT02528825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65565701|NCT01233245|Interferons|interferons|mesh-list
65565702|NCT01233245|Interferon-beta|interferon-beta|mesh-list
65565703|NCT01233245|Interferon beta-1b|interferon beta-1b|mesh-list
65565704|NCT01233245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565705|NCT01233245|Antiviral Agents|antiviral agents|mesh-ancestor
65565706|NCT01233245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65565707|NCT01233245|Immunologic Factors|immunologic factors|mesh-ancestor
65565708|NCT01233245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565709|NCT01233245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65565710|NCT03776812|Paclitaxel|paclitaxel|mesh-list
65565711|NCT03776812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65565712|NCT03776812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65565713|NCT03776812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565714|NCT03776812|Tubulin Modulators|tubulin modulators|mesh-ancestor
65565715|NCT03776812|Antimitotic Agents|antimitotic agents|mesh-ancestor
65565716|NCT03776812|Mitosis Modulators|mitosis modulators|mesh-ancestor
65565717|NCT03776812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565718|NCT03361605|Propofol|propofol|mesh-list
65565719|NCT03361605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65565720|NCT03361605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65565721|NCT03361605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565722|NCT03361605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65565723|NCT03361605|Anesthetics, General|anesthetics, general|mesh-ancestor
65565724|NCT03361605|Anesthetics|anesthetics|mesh-ancestor
65565725|NCT03794167|Cyclophosphamide|cyclophosphamide|mesh-list
65565726|NCT03794167|Melphalan|melphalan|mesh-list
65565727|NCT03794167|Busulfan|busulfan|mesh-list
65565728|NCT03794167|Etoposide|etoposide|mesh-list
65565729|NCT03794167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65565730|NCT03794167|Immunologic Factors|immunologic factors|mesh-ancestor
65565731|NCT03794167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565732|NCT03794167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65565733|NCT03794167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65565734|NCT03794167|Alkylating Agents|alkylating agents|mesh-ancestor
65565735|NCT03794167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565736|NCT03794167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565737|NCT03794167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65565738|NCT03794167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65565739|NCT03794167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65565740|NCT03794167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65565741|NCT03794167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565742|NCT05332821|Bevacizumab|bevacizumab|mesh-list
65565743|NCT05332821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65565744|NCT05332821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65565745|NCT05332821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565746|NCT05332821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65565747|NCT05332821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65565748|NCT05332821|Growth Substances|growth substances|mesh-ancestor
65565749|NCT05332821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565750|NCT05332821|Growth Inhibitors|growth inhibitors|mesh-ancestor
65565751|NCT05332821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565752|NCT05331651|Glycopyrrolate|glycopyrrolate|mesh-list
65565753|NCT05331651|Tropisetron|tropisetron|mesh-list
65565754|NCT05331651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65565755|NCT05331651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65565756|NCT05331651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65565757|NCT05331651|Cholinergic Agents|cholinergic agents|mesh-ancestor
65565758|NCT05331651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65565759|NCT05331651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565760|NCT05331651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565761|NCT05331651|Antiemetics|antiemetics|mesh-ancestor
65565762|NCT05331651|Autonomic Agents|autonomic agents|mesh-ancestor
65565763|NCT05331651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65565764|NCT05331651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65565765|NCT05331651|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65565766|NCT05331651|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65565767|NCT05331651|Serotonin Agents|serotonin agents|mesh-ancestor
65565768|NCT01134185|Prucalopride|prucalopride|mesh-list
65565769|NCT01134185|Laxatives|laxatives|mesh-ancestor
65565770|NCT01134185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65565771|NCT01134185|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65565772|NCT01134185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65565773|NCT01134185|Serotonin Agents|serotonin agents|mesh-ancestor
65565774|NCT01134185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65565775|NCT01134185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565776|NCT01134185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565777|NCT03829046|Evolocumab|evolocumab|mesh-list
65565778|NCT03829046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65565779|NCT03829046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65565780|NCT03829046|Antimetabolites|antimetabolites|mesh-ancestor
65565781|NCT03829046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565782|NCT03829046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65565783|NCT05320588|Pembrolizumab|pembrolizumab|mesh-list
65565784|NCT05320588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65294936|NCT00695994|Antiviral Agents|antiviral agents|mesh-ancestor
65565785|NCT05320588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565786|NCT01231529|Dolutegravir|dolutegravir|mesh-list
65565787|NCT01231529|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65565788|NCT01231529|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65565789|NCT01231529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565790|NCT01231529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565791|NCT01231529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65565792|NCT01231529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65565793|NCT01231529|Antiviral Agents|antiviral agents|mesh-ancestor
65565794|NCT01231529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65565795|NCT03836209|Cytarabine|cytarabine|mesh-list
65565796|NCT03836209|Daunorubicin|daunorubicin|mesh-list
65565797|NCT03836209|Midostaurin|midostaurin|mesh-list
65565798|NCT03836209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65565799|NCT03836209|Antimetabolites|antimetabolites|mesh-ancestor
65565800|NCT03836209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565801|NCT03836209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565802|NCT03836209|Antiviral Agents|antiviral agents|mesh-ancestor
65565803|NCT03836209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65565804|NCT03836209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65565805|NCT03836209|Immunologic Factors|immunologic factors|mesh-ancestor
65565806|NCT03836209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565807|NCT03836209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65565808|NCT03836209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65565809|NCT03836209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65565810|NCT03836209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565811|NCT03836209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65565812|NCT03801902|Durvalumab|durvalumab|mesh-list
65565813|NCT03801902|Immunoglobulins|immunoglobulins|mesh-list
65565814|NCT03801902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65565815|NCT03801902|Immunoglobulin G|immunoglobulin g|mesh-list
65565816|NCT03801902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65565817|NCT03801902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565818|NCT03801902|Immunologic Factors|immunologic factors|mesh-ancestor
65565819|NCT03801902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565820|NCT05306704|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65565821|NCT05306704|Calcifediol|calcifediol|mesh-list
65565822|NCT05306704|Vitamins|vitamins|mesh-ancestor
65565823|NCT05306704|Micronutrients|micronutrients|mesh-ancestor
65565824|NCT05306704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565825|NCT05306704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65565826|NCT01231685|Ritonavir|ritonavir|mesh-list
65565827|NCT01231685|Lopinavir|lopinavir|mesh-list
65565828|NCT01231685|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65565829|NCT01231685|Darunavir|darunavir|mesh-list
65565830|NCT01231685|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
65565831|NCT01231685|Raltegravir Potassium|raltegravir potassium|mesh-list
65565832|NCT01231685|Protease Inhibitors|protease inhibitors|mesh-list
65565833|NCT01231685|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65565834|NCT01231685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565835|NCT01231685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565836|NCT01231685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65565837|NCT01231685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65565838|NCT01231685|Antiviral Agents|antiviral agents|mesh-ancestor
65565839|NCT01231685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65565840|NCT01231685|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65565841|NCT01231685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65565842|NCT01231685|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65565843|NCT01231685|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65565844|NCT05402735|Uric Acid|uric acid|mesh-list
65363374|NCT00935571|Remifentanil|remifentanil|mesh-list
65565845|NCT05402735|Antioxidants|antioxidants|mesh-ancestor
65565846|NCT05402735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565847|NCT05402735|Protective Agents|protective agents|mesh-ancestor
65565848|NCT05402735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565849|NCT01138085|Trametinib|trametinib|mesh-list
65565850|NCT01138085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565851|NCT01138085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65565852|NCT01138085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565853|NCT01138085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565854|NCT05278858|Triamcinolone|triamcinolone|mesh-list
65565855|NCT05278858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65565856|NCT05278858|Glucocorticoids|glucocorticoids|mesh-ancestor
65565857|NCT05278858|Hormones|hormones|mesh-ancestor
65565858|NCT05278858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65295015|NCT00711646|Nabiximols|nabiximols|mesh-list
65565859|NCT05278858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565860|NCT05260528|Cytarabine|cytarabine|mesh-list
65565861|NCT05260528|Idarubicin|idarubicin|mesh-list
65565862|NCT05260528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65565863|NCT05260528|Antimetabolites|antimetabolites|mesh-ancestor
65565864|NCT05260528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565865|NCT05260528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565866|NCT05260528|Antiviral Agents|antiviral agents|mesh-ancestor
65565867|NCT05260528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65565868|NCT05260528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65565869|NCT05260528|Immunologic Factors|immunologic factors|mesh-ancestor
65565870|NCT05260528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565871|NCT05260528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65565872|NCT05260528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65565873|NCT05260528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65565874|NCT05260528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565875|NCT03792217|Sodium Hypochlorite|sodium hypochlorite|mesh-list
65565876|NCT03792217|Eusol|eusol|mesh-list
65565877|NCT03792217|Disinfectants|disinfectants|mesh-ancestor
65565878|NCT03792217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65565879|NCT03359811|Bupivacaine|bupivacaine|mesh-list
65565880|NCT03359811|Anesthetics, Local|anesthetics, local|mesh-list
65565881|NCT03359811|Anesthetics|anesthetics|mesh-list
65565882|NCT03359811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65565883|NCT03359811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565884|NCT03359811|Sensory System Agents|sensory system agents|mesh-ancestor
65565885|NCT03359811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65565886|NCT03728426|Letermovir|letermovir|mesh-list
65565887|NCT03728426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65565888|NCT03728426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565889|NCT03728426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565890|NCT03728426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565891|NCT03728426|Antiviral Agents|antiviral agents|mesh-ancestor
65565892|NCT03728426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65565893|NCT01140581|Dronedarone|dronedarone|mesh-list
65565894|NCT01140581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65565895|NCT03792139|Itraconazole|itraconazole|mesh-list
65565896|NCT03792139|Antifungal Agents|antifungal agents|mesh-ancestor
65565897|NCT03792139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65565898|NCT03792139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65565899|NCT03792139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65565900|NCT03792139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565901|NCT03792139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565902|NCT03792139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65565903|NCT03792139|Hormone Antagonists|hormone antagonists|mesh-ancestor
65565904|NCT03792139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65565905|NCT03792139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565906|NCT03792139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65565907|NCT04664738|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65565908|NCT04664738|Hemostatics|hemostatics|mesh-ancestor
65565909|NCT04664738|Coagulants|coagulants|mesh-ancestor
65565910|NCT03792295|Acetaminophen|acetaminophen|mesh-list
65565911|NCT03792295|Ibuprofen|ibuprofen|mesh-list
65565912|NCT03792295|Oxycodone|oxycodone|mesh-list
65565913|NCT03792295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65565914|NCT03792295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65565915|NCT03792295|Analgesics|analgesics|mesh-ancestor
65565916|NCT03792295|Sensory System Agents|sensory system agents|mesh-ancestor
65565917|NCT03792295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65565918|NCT03792295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565919|NCT03792295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65363446|NCT00935805|Vasodilator Agents|vasodilator agents|mesh-ancestor
65565920|NCT03792295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65565921|NCT03792295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65565922|NCT03792295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65565923|NCT03792295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565924|NCT03792295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65565925|NCT03792295|Narcotics|narcotics|mesh-ancestor
65565926|NCT03792295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65565927|NCT03792295|Antipyretics|antipyretics|mesh-ancestor
65565928|NCT03449056|Albuterol|albuterol|mesh-list
65565929|NCT03449056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65565930|NCT03449056|Autonomic Agents|autonomic agents|mesh-ancestor
65565931|NCT03449056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65565932|NCT03449056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565933|NCT03449056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65565934|NCT03449056|Respiratory System Agents|respiratory system agents|mesh-ancestor
65565935|NCT03449056|Tocolytic Agents|tocolytic agents|mesh-ancestor
65565936|NCT03449056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65565937|NCT03449056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65565938|NCT03449056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65565939|NCT03449056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65565940|NCT03449056|Adrenergic Agents|adrenergic agents|mesh-ancestor
65565941|NCT03449056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65565942|NCT03449056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565943|NCT01135433|Metformin|metformin|mesh-list
65565944|NCT01135433|Ipragliflozin|ipragliflozin|mesh-list
65565945|NCT01135433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65565946|NCT01135433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565947|NCT01135433|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65565948|NCT01135433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565949|NCT04745273|Ondansetron|ondansetron|mesh-list
65565950|NCT04745273|Antiemetics|antiemetics|mesh-ancestor
65565951|NCT04745273|Autonomic Agents|autonomic agents|mesh-ancestor
65565952|NCT04745273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65565953|NCT04745273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565954|NCT04745273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65565955|NCT04745273|Antipruritics|antipruritics|mesh-ancestor
65565956|NCT04745273|Dermatologic Agents|dermatologic agents|mesh-ancestor
65565957|NCT04745273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65565958|NCT04745273|Serotonin Agents|serotonin agents|mesh-ancestor
65565959|NCT04745273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65565960|NCT04745273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565961|NCT04745273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65565962|NCT04745273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65565963|NCT04745273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65565964|NCT04745273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65565965|NCT04745273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65565966|NCT01305187|Hyaluronic Acid|hyaluronic acid|mesh-list
65565967|NCT01305187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65565968|NCT01305187|Immunologic Factors|immunologic factors|mesh-ancestor
65565969|NCT01305187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565970|NCT01305187|Viscosupplements|viscosupplements|mesh-ancestor
65565971|NCT01305187|Protective Agents|protective agents|mesh-ancestor
65565972|NCT01138397|Vaccines|vaccines|mesh-list
65565973|NCT01138397|Immunologic Factors|immunologic factors|mesh-ancestor
65565974|NCT01138397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565975|NCT03448744|Entecavir|entecavir|mesh-list
65565976|NCT03448744|Thymalfasin|thymalfasin|mesh-list
65565977|NCT03448744|Antiviral Agents|antiviral agents|mesh-ancestor
65565978|NCT03448744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65565979|NCT03448744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65565980|NCT03448744|Immunologic Factors|immunologic factors|mesh-ancestor
65565981|NCT03448744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565982|NCT03448588|Selenium|selenium|mesh-list
65565983|NCT03448588|Antioxidants|antioxidants|mesh-ancestor
65565984|NCT03448588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565985|NCT03448588|Protective Agents|protective agents|mesh-ancestor
65565986|NCT03448588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65565987|NCT03448588|Trace Elements|trace elements|mesh-ancestor
65565988|NCT03448588|Micronutrients|micronutrients|mesh-ancestor
65565989|NCT03797443|Ascorbic Acid|ascorbic acid|mesh-list
65565990|NCT03797443|Gemcitabine|gemcitabine|mesh-list
65565991|NCT03797443|Paclitaxel|paclitaxel|mesh-list
65565992|NCT03797443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65565993|NCT03797443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565994|NCT03797443|Tubulin Modulators|tubulin modulators|mesh-ancestor
65565995|NCT03797443|Antimitotic Agents|antimitotic agents|mesh-ancestor
65565996|NCT03797443|Mitosis Modulators|mitosis modulators|mesh-ancestor
65565997|NCT03797443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65565999|NCT03797443|Micronutrients|micronutrients|mesh-ancestor
65566000|NCT03797443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566001|NCT03797443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65566002|NCT03797443|Antimetabolites|antimetabolites|mesh-ancestor
65566003|NCT03797443|Antiviral Agents|antiviral agents|mesh-ancestor
65566004|NCT03797443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65566005|NCT03797443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566006|NCT03797443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65566007|NCT03797443|Immunologic Factors|immunologic factors|mesh-ancestor
65566008|NCT03797443|Antioxidants|antioxidants|mesh-ancestor
65566009|NCT03797443|Protective Agents|protective agents|mesh-ancestor
65295163|NCT00654680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65566010|NCT01135589|Micafungin|micafungin|mesh-list
65566011|NCT01135589|Antifungal Agents|antifungal agents|mesh-ancestor
65566012|NCT01135589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65566013|NCT01915810|Nicotine|nicotine|mesh-list
65566014|NCT01915810|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65566015|NCT01915810|Autonomic Agents|autonomic agents|mesh-ancestor
65566016|NCT01915810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65566017|NCT01915810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566018|NCT01915810|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65566019|NCT01915810|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65566020|NCT01915810|Cholinergic Agents|cholinergic agents|mesh-ancestor
65566021|NCT01915810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65566022|NCT01915810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566023|NCT01140737|Axitinib|axitinib|mesh-list
65566024|NCT01140737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566025|NCT01140737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65566026|NCT01140737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566027|NCT01140737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566028|NCT05594095|Everolimus|everolimus|mesh-list
65566029|NCT05594095|Fulvestrant|fulvestrant|mesh-list
65566030|NCT05594095|Goserelin|goserelin|mesh-list
65566031|NCT05594095|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65566032|NCT05594095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566033|NCT05594095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65566034|NCT05594095|Immunologic Factors|immunologic factors|mesh-ancestor
65566035|NCT05594095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566036|NCT05594095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65566037|NCT05594095|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65566038|NCT05594095|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65566039|NCT05594095|Hormone Antagonists|hormone antagonists|mesh-ancestor
65566040|NCT05594095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65566041|NCT05594095|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65566042|NCT05594095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566043|NCT05594095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566044|NCT05624671|Fentanyl|fentanyl|mesh-list
65566045|NCT05624671|Bupivacaine|bupivacaine|mesh-list
65566046|NCT05624671|Anesthetics, Local|anesthetics, local|mesh-ancestor
65566047|NCT05624671|Anesthetics|anesthetics|mesh-ancestor
65566048|NCT05624671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65566049|NCT05624671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566050|NCT05624671|Sensory System Agents|sensory system agents|mesh-ancestor
65566051|NCT05624671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65566052|NCT05624671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65566053|NCT05624671|Narcotics|narcotics|mesh-ancestor
65566054|NCT05624671|Analgesics|analgesics|mesh-ancestor
65566055|NCT05624671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65566056|NCT05624671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65566057|NCT05624671|Anesthetics, General|anesthetics, general|mesh-ancestor
65566058|NCT03578965|Cefazolin|cefazolin|mesh-list
65566059|NCT03578965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65566060|NCT03578965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65566061|NCT03791905|Leucovorin|leucovorin|mesh-list
65566062|NCT03791905|Paclitaxel|paclitaxel|mesh-list
65566063|NCT03791905|Fluorouracil|fluorouracil|mesh-list
65566064|NCT03791905|Oxaliplatin|oxaliplatin|mesh-list
65566065|NCT03791905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65566066|NCT03791905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566067|NCT03791905|Tubulin Modulators|tubulin modulators|mesh-ancestor
65566068|NCT03791905|Antimitotic Agents|antimitotic agents|mesh-ancestor
65566069|NCT03791905|Mitosis Modulators|mitosis modulators|mesh-ancestor
65566070|NCT03791905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566071|NCT03791905|Antimetabolites|antimetabolites|mesh-ancestor
65363598|NCT03988075|Ibuprofen|ibuprofen|mesh-list
65566072|NCT03791905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65566073|NCT03791905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65566074|NCT03791905|Immunologic Factors|immunologic factors|mesh-ancestor
65566075|NCT03791905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566076|NCT03791905|Antidotes|antidotes|mesh-ancestor
65566077|NCT03791905|Protective Agents|protective agents|mesh-ancestor
65566078|NCT03791905|Vitamin B Complex|vitamin b complex|mesh-ancestor
65566080|NCT03791905|Micronutrients|micronutrients|mesh-ancestor
65566081|NCT01138553|Mifepristone|mifepristone|mesh-list
65566082|NCT01138553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65566083|NCT01138553|Abortifacient Agents|abortifacient agents|mesh-ancestor
65566084|NCT01138553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65295238|NCT00882362|Aripiprazole|aripiprazole|mesh-list
65566085|NCT01138553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566086|NCT01138553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65566087|NCT01138553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65566088|NCT01138553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65566089|NCT01138553|Contraceptive Agents|contraceptive agents|mesh-ancestor
65566090|NCT01138553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65566091|NCT01138553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65566092|NCT01138553|Hormone Antagonists|hormone antagonists|mesh-ancestor
65566093|NCT01138553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65566094|NCT01138553|Luteolytic Agents|luteolytic agents|mesh-ancestor
65566095|NCT01138553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65566096|NCT01138553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65566097|NCT05171374|Trametinib|trametinib|mesh-list
65566098|NCT05171374|Dabrafenib|dabrafenib|mesh-list
65566099|NCT05171374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566100|NCT05171374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65566101|NCT05171374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566102|NCT05171374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566103|NCT03447184|Androgens|androgens|mesh-list
65566104|NCT03447184|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65566105|NCT03447184|Hormones|hormones|mesh-ancestor
65566106|NCT03447184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65566107|NCT03447184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566108|NCT03447184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65566109|NCT03447184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566110|NCT03447184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566111|NCT03447184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65566112|NCT03447184|Hormone Antagonists|hormone antagonists|mesh-ancestor
65566113|NCT03739541|Benzonidazole|benzonidazole|mesh-list
65566114|NCT03739541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65566115|NCT03739541|Immunologic Factors|immunologic factors|mesh-ancestor
65566116|NCT03739541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566117|NCT03739541|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65566118|NCT03739541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65566119|NCT03739541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65566120|NCT03739541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65566121|NCT01135667|Clopidogrel|clopidogrel|mesh-list
65566122|NCT01135667|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65566123|NCT01135667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65566124|NCT01135667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65566125|NCT01135667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65566126|NCT01135667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65566127|NCT01135667|Purinergic Agents|purinergic agents|mesh-ancestor
65566128|NCT01135667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65566129|NCT01135667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566130|NCT01135667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566131|NCT03446872|Leucovorin|leucovorin|mesh-list
65566132|NCT03446872|Fluorouracil|fluorouracil|mesh-list
65566133|NCT03446872|Antimetabolites|antimetabolites|mesh-ancestor
65566134|NCT03446872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566135|NCT03446872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65566136|NCT03446872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566137|NCT03446872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65566138|NCT03446872|Immunologic Factors|immunologic factors|mesh-ancestor
65566139|NCT03446872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566140|NCT03446872|Antidotes|antidotes|mesh-ancestor
65566141|NCT03446872|Protective Agents|protective agents|mesh-ancestor
65566142|NCT03446872|Vitamin B Complex|vitamin b complex|mesh-ancestor
65566143|NCT03446872|Vitamins|vitamins|mesh-ancestor
65566144|NCT03446872|Micronutrients|micronutrients|mesh-ancestor
65566145|NCT03446638|Cytarabine|cytarabine|mesh-list
65566146|NCT03446638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65363667|NCT02558972|Droxidopa|droxidopa|mesh-list
65566147|NCT03446638|Antimetabolites|antimetabolites|mesh-ancestor
65566148|NCT03446638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566149|NCT03446638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566150|NCT03446638|Antiviral Agents|antiviral agents|mesh-ancestor
65566151|NCT03446638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65566152|NCT03446638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65566153|NCT03446638|Immunologic Factors|immunologic factors|mesh-ancestor
65566154|NCT03446638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566155|NCT05401019|Pramipexole|pramipexole|mesh-list
65566156|NCT05401019|Risperidone|risperidone|mesh-list
65566157|NCT05401019|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65566158|NCT05401019|Serotonin Agents|serotonin agents|mesh-ancestor
65566159|NCT05401019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65566160|NCT05401019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566161|NCT05401019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566162|NCT05401019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65566163|NCT05401019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65566164|NCT05401019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65566165|NCT05401019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65566166|NCT05401019|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65566167|NCT05401019|Dopamine Agents|dopamine agents|mesh-ancestor
65566168|NCT05401019|Antioxidants|antioxidants|mesh-ancestor
65566169|NCT05401019|Protective Agents|protective agents|mesh-ancestor
65566170|NCT05401019|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65566171|NCT05401019|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65566172|NCT05401019|Dopamine Agonists|dopamine agonists|mesh-ancestor
65566173|NCT03788863|Diflucortolone|diflucortolone|mesh-list
65566174|NCT03788863|Diflucortolone valerate|diflucortolone valerate|mesh-list
65566175|NCT03788863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65566176|NCT03788863|Glucocorticoids|glucocorticoids|mesh-ancestor
65566177|NCT03788863|Hormones|hormones|mesh-ancestor
65566178|NCT03788863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65566179|NCT03788863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566180|NCT04659161|Xanomeline|xanomeline|mesh-list
65566181|NCT04659161|Trospium chloride|trospium chloride|mesh-list
65566182|NCT04659161|Parasympatholytics|parasympatholytics|mesh-ancestor
65566183|NCT04659161|Autonomic Agents|autonomic agents|mesh-ancestor
65566184|NCT04659161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65566185|NCT04659161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566186|NCT04659161|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65566187|NCT04659161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65566188|NCT04659161|Cholinergic Agents|cholinergic agents|mesh-ancestor
65566189|NCT04659161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65566190|NCT04659161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566191|NCT04659161|Urological Agents|urological agents|mesh-ancestor
65566192|NCT04659161|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65566193|NCT04659161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65566194|NCT04659161|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65566195|NCT04659161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65566196|NCT03129256|Apatinib|apatinib|mesh-list
65566197|NCT03129256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566198|NCT03129256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65566199|NCT03129256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566200|NCT03129256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566201|NCT05682807|Caffeine|caffeine|mesh-list
65566202|NCT05682807|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65566203|NCT05682807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566204|NCT05682807|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65566205|NCT05682807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566206|NCT05682807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566207|NCT05682807|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65566208|NCT05682807|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65566209|NCT05682807|Purinergic Agents|purinergic agents|mesh-ancestor
65566210|NCT05682807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65566211|NCT03445780|Ethyl Chloride|ethyl chloride|mesh-list
65566212|NCT03445780|Anesthetics, Local|anesthetics, local|mesh-ancestor
65566213|NCT03445780|Anesthetics|anesthetics|mesh-ancestor
65566214|NCT03445780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65566215|NCT03445780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566216|NCT03445780|Sensory System Agents|sensory system agents|mesh-ancestor
65566217|NCT03445780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65566218|NCT05364099|Triamcinolone|triamcinolone|mesh-list
65566219|NCT05364099|Lidocaine|lidocaine|mesh-list
65566220|NCT05364099|Anesthetics, Local|anesthetics, local|mesh-ancestor
65566221|NCT05364099|Anesthetics|anesthetics|mesh-ancestor
65566222|NCT05364099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65566223|NCT05364099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566224|NCT05364099|Sensory System Agents|sensory system agents|mesh-ancestor
65566225|NCT05364099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65566226|NCT05364099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65566227|NCT05364099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65566228|NCT05364099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65566229|NCT05364099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65566230|NCT05364099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566231|NCT05364099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65566233|NCT05364099|Hormones|hormones|mesh-ancestor
65566234|NCT05364099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65566235|NCT03445702|Metformin|metformin|mesh-list
65566236|NCT03445702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65566237|NCT03445702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566238|NCT03445624|Infliximab|infliximab|mesh-list
65566239|NCT03445624|Dermatologic Agents|dermatologic agents|mesh-ancestor
65566240|NCT03445624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65566241|NCT03445624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65566242|NCT01312077|Morphine|morphine|mesh-list
65566243|NCT01312077|Levobupivacaine|levobupivacaine|mesh-list
65566244|NCT01312077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65566245|NCT01312077|Narcotics|narcotics|mesh-ancestor
65566246|NCT01312077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65566247|NCT01312077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566248|NCT01312077|Analgesics|analgesics|mesh-ancestor
65566249|NCT01312077|Sensory System Agents|sensory system agents|mesh-ancestor
65566250|NCT01312077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65566251|NCT01312077|Anesthetics, Local|anesthetics, local|mesh-ancestor
65566252|NCT01312077|Anesthetics|anesthetics|mesh-ancestor
65566253|NCT03793309|Vitamin D|vitamin d|mesh-list
65566254|NCT03793309|Ergocalciferols|ergocalciferols|mesh-list
65566255|NCT03793309|Cholecalciferol|cholecalciferol|mesh-list
65566256|NCT03793309|Vitamins|vitamins|mesh-list
65566257|NCT03793309|Micronutrients|micronutrients|mesh-ancestor
65566258|NCT03793309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566259|NCT03793309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65566260|NCT03793309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65566261|NCT01140893|Exenatide|exenatide|mesh-list
65566262|NCT01140893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65566263|NCT01140893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566264|NCT01140893|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65566265|NCT01140893|Incretins|incretins|mesh-ancestor
65566266|NCT01140893|Hormones|hormones|mesh-ancestor
65566267|NCT01140893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65566268|NCT03445468|Vaccines|vaccines|mesh-list
65566269|NCT03445468|Immunologic Factors|immunologic factors|mesh-ancestor
65566270|NCT03445468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566271|NCT03791827|Cyclosporine|cyclosporine|mesh-list
65566272|NCT03791827|Mycophenolic Acid|mycophenolic acid|mesh-list
65566273|NCT03791827|Hydroxychloroquine|hydroxychloroquine|mesh-list
65566274|NCT03791827|Prednisone|prednisone|mesh-list
65566275|NCT03791827|Prednisolone|prednisolone|mesh-list
65566276|NCT03791827|Cyclophosphamide|cyclophosphamide|mesh-list
65566277|NCT03791827|Rituximab|rituximab|mesh-list
65566278|NCT03791827|Azathioprine|azathioprine|mesh-list
65566279|NCT03791827|Tacrolimus|tacrolimus|mesh-list
65566280|NCT03791827|Cyclosporins|cyclosporins|mesh-list
65566281|NCT03791827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65566282|NCT03791827|Immunologic Factors|immunologic factors|mesh-ancestor
65566283|NCT03791827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566284|NCT03791827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65566285|NCT03791827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65566286|NCT03791827|Alkylating Agents|alkylating agents|mesh-ancestor
65566287|NCT03791827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566288|NCT03791827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566289|NCT03791827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65566290|NCT03791827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65566291|NCT03791827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65566292|NCT03791827|Glucocorticoids|glucocorticoids|mesh-ancestor
65566293|NCT03791827|Hormones|hormones|mesh-ancestor
65566294|NCT03791827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65566295|NCT03791827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65566296|NCT03791827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65566297|NCT03791827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566298|NCT03791827|Antifungal Agents|antifungal agents|mesh-ancestor
65566299|NCT03791827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65566300|NCT03791827|Dermatologic Agents|dermatologic agents|mesh-ancestor
65566301|NCT03791827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65566302|NCT03791827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65566303|NCT03791827|Antitubercular Agents|antitubercular agents|mesh-ancestor
65566304|NCT03791827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65566305|NCT03791827|Antimalarials|antimalarials|mesh-ancestor
65566306|NCT03791827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65566307|NCT03791827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65566308|NCT03791827|Antimetabolites|antimetabolites|mesh-ancestor
65566309|NCT03791827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65566310|NCT03708861|Ritonavir|ritonavir|mesh-list
65295456|NCT04865939|Antiviral Agents|antiviral agents|mesh-ancestor
65566311|NCT03708861|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65566312|NCT03708861|Maraviroc|maraviroc|mesh-list
65566313|NCT03708861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65566314|NCT03708861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65566315|NCT03708861|Protease Inhibitors|protease inhibitors|mesh-ancestor
65566316|NCT03708861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566317|NCT03708861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566318|NCT03708861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65566319|NCT03708861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65566320|NCT03708861|Antiviral Agents|antiviral agents|mesh-ancestor
65566321|NCT03708861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65566322|NCT03708861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65566323|NCT03708861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65566324|NCT03708861|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65566325|NCT03708861|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65566326|NCT03708861|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65566327|NCT04798755|Adalimumab|adalimumab|mesh-list
65566328|NCT04798755|Methotrexate|methotrexate|mesh-list
65566329|NCT04798755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65566330|NCT04798755|Abortifacient Agents|abortifacient agents|mesh-ancestor
65566331|NCT04798755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65566332|NCT04798755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566333|NCT04798755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65566334|NCT04798755|Antimetabolites|antimetabolites|mesh-ancestor
65566335|NCT04798755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566336|NCT04798755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566337|NCT04798755|Dermatologic Agents|dermatologic agents|mesh-ancestor
65566338|NCT04798755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566339|NCT04798755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65566340|NCT04798755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65566341|NCT04798755|Immunologic Factors|immunologic factors|mesh-ancestor
65566342|NCT04798755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65566343|NCT04798755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65566344|NCT04798755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65566345|NCT01308229|Paclitaxel|paclitaxel|mesh-list
65566346|NCT01308229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65566347|NCT01308229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566348|NCT01308229|Tubulin Modulators|tubulin modulators|mesh-ancestor
65566349|NCT01308229|Antimitotic Agents|antimitotic agents|mesh-ancestor
65566350|NCT01308229|Mitosis Modulators|mitosis modulators|mesh-ancestor
65566351|NCT01308229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566352|NCT03445078|Selenium|selenium|mesh-list
65566353|NCT03445078|Antioxidants|antioxidants|mesh-ancestor
65566354|NCT03445078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566355|NCT03445078|Protective Agents|protective agents|mesh-ancestor
65566356|NCT03445078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566357|NCT03445078|Trace Elements|trace elements|mesh-ancestor
65566358|NCT03445078|Micronutrients|micronutrients|mesh-ancestor
65566359|NCT05252585|Everolimus|everolimus|mesh-list
65566360|NCT05252585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566361|NCT05252585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65566362|NCT05252585|Immunologic Factors|immunologic factors|mesh-ancestor
65566363|NCT05252585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566364|NCT01233791|Diazepam|diazepam|mesh-list
65566365|NCT01233791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65566366|NCT01233791|Anticonvulsants|anticonvulsants|mesh-ancestor
65566367|NCT01233791|Antiemetics|antiemetics|mesh-ancestor
65566368|NCT01233791|Autonomic Agents|autonomic agents|mesh-ancestor
65566369|NCT01233791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65566370|NCT01233791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566371|NCT01233791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65566372|NCT01233791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65566373|NCT01233791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65566374|NCT01233791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65566375|NCT01233791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65566376|NCT01233791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65566377|NCT01233791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65566378|NCT01233791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65566379|NCT01233791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65566380|NCT01233791|Anesthetics, General|anesthetics, general|mesh-ancestor
65566381|NCT01233791|Anesthetics|anesthetics|mesh-ancestor
65566382|NCT01233791|GABA Modulators|gaba modulators|mesh-ancestor
65566383|NCT01233791|GABA Agents|gaba agents|mesh-ancestor
65566384|NCT01233791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65566385|NCT01233791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566386|NCT01140971|Misoprostol|misoprostol|mesh-list
65566387|NCT01140971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65566388|NCT01140971|Abortifacient Agents|abortifacient agents|mesh-ancestor
65566389|NCT01140971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65566390|NCT01140971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566391|NCT01140971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65566392|NCT01140971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65566393|NCT01140971|Oxytocics|oxytocics|mesh-ancestor
65566394|NCT01306357|Hormones|hormones|mesh-list
65566395|NCT01306357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65566396|NCT01306357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566397|NCT03129022|Anesthetics|anesthetics|mesh-list
65566398|NCT03129022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65566399|NCT03129022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566400|NCT03342963|Aripiprazole|aripiprazole|mesh-list
65566401|NCT03342963|Sertraline|sertraline|mesh-list
65566402|NCT03342963|Antidepressive Agents|antidepressive agents|mesh-ancestor
65566403|NCT03342963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65566404|NCT03342963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65566405|NCT03342963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65566406|NCT03342963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65566407|NCT03342963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566408|NCT03342963|Dopamine Agonists|dopamine agonists|mesh-ancestor
65566409|NCT03342963|Dopamine Agents|dopamine agents|mesh-ancestor
65566410|NCT03342963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65566411|NCT03342963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566412|NCT03342963|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65566413|NCT03342963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65566414|NCT03342963|Serotonin Agents|serotonin agents|mesh-ancestor
65566415|NCT03342963|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65566416|NCT03342963|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65566417|NCT03342963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65566418|NCT03342963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65566419|NCT03342963|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65566420|NCT03342963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65566421|NCT03342963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65566422|NCT03706755|Norepinephrine|norepinephrine|mesh-list
65566423|NCT03706755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65566424|NCT03706755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65566425|NCT03706755|Adrenergic Agents|adrenergic agents|mesh-ancestor
65566426|NCT03706755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65566427|NCT03706755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566428|NCT03706755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566429|NCT03706755|Sympathomimetics|sympathomimetics|mesh-ancestor
65566430|NCT03706755|Autonomic Agents|autonomic agents|mesh-ancestor
65566431|NCT03706755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65566432|NCT03706755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65566433|NCT03791515|Calcitonin|calcitonin|mesh-list
65566434|NCT03791515|Salmon calcitonin|salmon calcitonin|mesh-list
65566435|NCT03791515|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
65566436|NCT03791515|Katacalcin|katacalcin|mesh-list
65566437|NCT03791515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65566438|NCT03791515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566439|NCT03791515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65566440|NCT03791515|Vasodilator Agents|vasodilator agents|mesh-ancestor
65566441|NCT03361956|JNJ-56136379|jnj-56136379|mesh-list
65566442|NCT03361956|Antiviral Agents|antiviral agents|mesh-ancestor
65566443|NCT03361956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65566444|NCT04595591|Remifentanil|remifentanil|mesh-list
65566445|NCT04595591|Rocuronium|rocuronium|mesh-list
65566446|NCT04595591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65566447|NCT04595591|Narcotics|narcotics|mesh-ancestor
65566448|NCT04595591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65566449|NCT04595591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363962|NCT03985969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65566450|NCT04595591|Analgesics|analgesics|mesh-ancestor
65566451|NCT04595591|Sensory System Agents|sensory system agents|mesh-ancestor
65566452|NCT04595591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65566453|NCT04595591|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65566454|NCT04595591|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65566455|NCT04595591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65566456|NCT03709953|Apatinib|apatinib|mesh-list
65566457|NCT03709953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566458|NCT03709953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65566459|NCT03709953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566460|NCT03709953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566461|NCT03444142|Exenatide|exenatide|mesh-list
65566462|NCT03444142|Dulaglutide|dulaglutide|mesh-list
65566463|NCT03444142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65566464|NCT03444142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566465|NCT03444142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65566466|NCT03444142|Incretins|incretins|mesh-ancestor
65566467|NCT03444142|Hormones|hormones|mesh-ancestor
65566468|NCT03444142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65566469|NCT01305733|Ketorolac|ketorolac|mesh-list
65566470|NCT01305733|Epinephrine|epinephrine|mesh-list
65566471|NCT01305733|Racepinephrine|racepinephrine|mesh-list
65566472|NCT01305733|Levobupivacaine|levobupivacaine|mesh-list
65566473|NCT01305733|Epinephryl borate|epinephryl borate|mesh-list
65566474|NCT01305733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65566475|NCT01305733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65566476|NCT01305733|Analgesics|analgesics|mesh-ancestor
65566477|NCT01305733|Sensory System Agents|sensory system agents|mesh-ancestor
65566478|NCT01305733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65566479|NCT01305733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566480|NCT01305733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65566481|NCT01305733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65566482|NCT01305733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65566483|NCT01305733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566484|NCT01305733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566485|NCT01305733|Anesthetics, Local|anesthetics, local|mesh-ancestor
65566486|NCT01305733|Anesthetics|anesthetics|mesh-ancestor
65566487|NCT01305733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65566488|NCT01305733|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65566489|NCT01305733|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65566490|NCT01305733|Adrenergic Agents|adrenergic agents|mesh-ancestor
65566491|NCT01305733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65566492|NCT01305733|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65566493|NCT01305733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65566494|NCT01305733|Autonomic Agents|autonomic agents|mesh-ancestor
65566495|NCT01305733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65566496|NCT01305733|Respiratory System Agents|respiratory system agents|mesh-ancestor
65566497|NCT01305733|Mydriatics|mydriatics|mesh-ancestor
65566498|NCT01305733|Sympathomimetics|sympathomimetics|mesh-ancestor
65566499|NCT01305733|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65566500|NCT05210153|Sertraline|sertraline|mesh-list
65566501|NCT05210153|Antidepressive Agents|antidepressive agents|mesh-ancestor
65566502|NCT05210153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65566503|NCT05210153|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65566504|NCT05210153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65566505|NCT05210153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65566506|NCT05210153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566507|NCT05210153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65566508|NCT05210153|Serotonin Agents|serotonin agents|mesh-ancestor
65566509|NCT05210153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566510|NCT04451746|Contraceptive Agents|contraceptive agents|mesh-list
65566511|NCT04451746|Contraceptives, Oral|contraceptives, oral|mesh-list
65566512|NCT04451746|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65566513|NCT04451746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65566514|NCT04451746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566515|NCT04451746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65566516|NCT04749459|Sunscreening Agents|sunscreening agents|mesh-list
65566517|NCT04749459|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65566518|NCT04749459|Protective Agents|protective agents|mesh-ancestor
65566519|NCT04749459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566520|NCT04749459|Dermatologic Agents|dermatologic agents|mesh-ancestor
65566521|NCT04585295|Betaine|betaine|mesh-list
65566522|NCT04585295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65566523|NCT04585295|Lipotropic Agents|lipotropic agents|mesh-ancestor
65364043|NCT02559674|Paclitaxel|paclitaxel|mesh-list
65566524|NCT04585295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65566526|NCT04585295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566527|NCT04585295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65566528|NCT05693545|Penicillins|penicillins|mesh-list
65566529|NCT05693545|Penicillin G|penicillin g|mesh-list
65566530|NCT05693545|Penicillin G Benzathine|penicillin g benzathine|mesh-list
65566531|NCT05693545|Penicillin G Procaine|penicillin g procaine|mesh-list
65566532|NCT05693545|Penicillin V|penicillin v|mesh-list
65566533|NCT05693545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65566534|NCT05693545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65566535|NCT01136213|Fluoxetine|fluoxetine|mesh-list
65566536|NCT01136213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65566537|NCT01136213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65566538|NCT01136213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65566539|NCT01136213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566540|NCT01136213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65566541|NCT01136213|Serotonin Agents|serotonin agents|mesh-ancestor
65566542|NCT01136213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566543|NCT01136213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65566544|NCT01136213|Antidepressive Agents|antidepressive agents|mesh-ancestor
65566545|NCT01136213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65566546|NCT01136213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65566547|NCT01136213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65566548|NCT01136213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566549|NCT03361176|Triamcinolone|triamcinolone|mesh-list
65566550|NCT03361176|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65566551|NCT03361176|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65566552|NCT03361176|Deoxycholic Acid|deoxycholic acid|mesh-list
65566553|NCT03361176|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65566554|NCT03361176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65566555|NCT03361176|Glucocorticoids|glucocorticoids|mesh-ancestor
65566556|NCT03361176|Hormones|hormones|mesh-ancestor
65566557|NCT03361176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65566558|NCT03361176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566559|NCT03361176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65566560|NCT03361176|Immunologic Factors|immunologic factors|mesh-ancestor
65566561|NCT03361176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566562|NCT03361176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566563|NCT03361176|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65566564|NCT03361176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65566565|NCT03438214|Vancomycin|vancomycin|mesh-list
65566566|NCT03438214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65566567|NCT03438214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65566568|NCT01141127|Tranexamic Acid|tranexamic acid|mesh-list
65566569|NCT01141127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65566570|NCT01141127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65566571|NCT01141127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566572|NCT01141127|Hemostatics|hemostatics|mesh-ancestor
65566573|NCT01141127|Coagulants|coagulants|mesh-ancestor
65566574|NCT05693467|Dexamethasone|dexamethasone|mesh-list
65566575|NCT05693467|Ropivacaine|ropivacaine|mesh-list
65566576|NCT05693467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65566577|NCT05693467|Antiemetics|antiemetics|mesh-ancestor
65566578|NCT05693467|Autonomic Agents|autonomic agents|mesh-ancestor
65566579|NCT05693467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65566580|NCT05693467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566581|NCT05693467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65566582|NCT05693467|Glucocorticoids|glucocorticoids|mesh-ancestor
65566583|NCT05693467|Hormones|hormones|mesh-ancestor
65566584|NCT05693467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65566585|NCT05693467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65566586|NCT05693467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566587|NCT05693467|Anesthetics, Local|anesthetics, local|mesh-ancestor
65566588|NCT05693467|Anesthetics|anesthetics|mesh-ancestor
65566589|NCT05693467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65566590|NCT05693467|Sensory System Agents|sensory system agents|mesh-ancestor
65566591|NCT04613206|Vaccines|vaccines|mesh-list
65566592|NCT04613206|Immunologic Factors|immunologic factors|mesh-ancestor
65566593|NCT04613206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566594|NCT03708822|Docetaxel|docetaxel|mesh-list
65566595|NCT03708822|Nimotuzumab|nimotuzumab|mesh-list
65566596|NCT03708822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566597|NCT03708822|Tubulin Modulators|tubulin modulators|mesh-ancestor
65566598|NCT03708822|Antimitotic Agents|antimitotic agents|mesh-ancestor
65566599|NCT03708822|Mitosis Modulators|mitosis modulators|mesh-ancestor
65566600|NCT03708822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566601|NCT03708822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65566602|NCT05280444|Idarubicin|idarubicin|mesh-list
65566603|NCT05280444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65566604|NCT05280444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566605|NCT05280444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65566606|NCT05280444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65566607|NCT05280444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566608|NCT05280444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566609|NCT01308541|Propofol|propofol|mesh-list
65566610|NCT01308541|Fospropofol|fospropofol|mesh-list
65566611|NCT01308541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65566612|NCT01308541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65566613|NCT01308541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566614|NCT01308541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65566615|NCT01308541|Anesthetics, General|anesthetics, general|mesh-ancestor
65566616|NCT01308541|Anesthetics|anesthetics|mesh-ancestor
65566617|NCT05679765|Dexamethasone|dexamethasone|mesh-list
65566618|NCT05679765|Dexamethasone acetate|dexamethasone acetate|mesh-list
65566619|NCT05679765|Lidocaine|lidocaine|mesh-list
65566620|NCT05679765|BB 1101|bb 1101|mesh-list
65566621|NCT05679765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65566622|NCT05679765|Antiemetics|antiemetics|mesh-ancestor
65566623|NCT05679765|Autonomic Agents|autonomic agents|mesh-ancestor
65566624|NCT05679765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65566625|NCT05679765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566626|NCT05679765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65566627|NCT05679765|Glucocorticoids|glucocorticoids|mesh-ancestor
65566628|NCT05679765|Hormones|hormones|mesh-ancestor
65566629|NCT05679765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65566630|NCT05679765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65566631|NCT05679765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566632|NCT05679765|Protease Inhibitors|protease inhibitors|mesh-ancestor
65566633|NCT05679765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566634|NCT05679765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566635|NCT05679765|Anesthetics, Local|anesthetics, local|mesh-ancestor
65566636|NCT05679765|Anesthetics|anesthetics|mesh-ancestor
65566637|NCT05679765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65566638|NCT05679765|Sensory System Agents|sensory system agents|mesh-ancestor
65566639|NCT05679765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65566640|NCT05679765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65566641|NCT05679765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65566642|NCT05679765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65566643|NCT03437980|Propofol|propofol|mesh-list
65566644|NCT03437980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65566645|NCT03437980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65566646|NCT03437980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566647|NCT03437980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65566648|NCT03437980|Anesthetics, General|anesthetics, general|mesh-ancestor
65566649|NCT03437980|Anesthetics|anesthetics|mesh-ancestor
65566650|NCT05176119|Ketamine|ketamine|mesh-list
65566651|NCT05176119|Nalbuphine|nalbuphine|mesh-list
65566652|NCT05176119|Analgesics|analgesics|mesh-ancestor
65566653|NCT05176119|Sensory System Agents|sensory system agents|mesh-ancestor
65566654|NCT05176119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65566655|NCT05176119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566656|NCT05176119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65566657|NCT05176119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65566658|NCT05176119|Anesthetics, General|anesthetics, general|mesh-ancestor
65566659|NCT05176119|Anesthetics|anesthetics|mesh-ancestor
65566660|NCT05176119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65566661|NCT05176119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65566662|NCT05176119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65566663|NCT05176119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65566664|NCT05176119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566665|NCT05176119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65566666|NCT05176119|Narcotics|narcotics|mesh-ancestor
65566667|NCT03437902|Vitamins|vitamins|mesh-list
65566668|NCT03437902|Ascorbic Acid|ascorbic acid|mesh-list
65566669|NCT03437902|Micronutrients|micronutrients|mesh-ancestor
65566670|NCT03437902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566671|NCT03437902|Antioxidants|antioxidants|mesh-ancestor
65566672|NCT03437902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566673|NCT03437902|Protective Agents|protective agents|mesh-ancestor
65566674|NCT05283499|Analgesics, Opioid|analgesics, opioid|mesh-list
65566675|NCT05283499|Analgesics|analgesics|mesh-list
65566677|NCT05283499|Narcotics|narcotics|mesh-ancestor
65566678|NCT05283499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65566679|NCT05283499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566680|NCT05283499|Sensory System Agents|sensory system agents|mesh-ancestor
65566681|NCT05283499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65566682|NCT03437824|Vitamin B 12|vitamin b 12|mesh-list
65566683|NCT03437824|Hydroxocobalamin|hydroxocobalamin|mesh-list
65566684|NCT03437824|Vitamins|vitamins|mesh-ancestor
65566685|NCT03437824|Micronutrients|micronutrients|mesh-ancestor
65566686|NCT03437824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566687|NCT03437824|Vitamin B Complex|vitamin b complex|mesh-ancestor
65566688|NCT03437824|Hematinics|hematinics|mesh-ancestor
65566689|NCT03437590|JNJ-55308942|jnj-55308942|mesh-list
65566690|NCT03437590|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
65566691|NCT03437590|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65566692|NCT03437590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65566693|NCT03437590|Purinergic Agents|purinergic agents|mesh-ancestor
65566694|NCT03437590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65566695|NCT03437590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566696|NCT03437590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566697|NCT01136525|Valacyclovir|valacyclovir|mesh-list
65566698|NCT01136525|Antiviral Agents|antiviral agents|mesh-ancestor
65566699|NCT01136525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65566700|NCT05632445|Apixaban|apixaban|mesh-list
65566701|NCT05632445|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65566702|NCT05632445|Antithrombins|antithrombins|mesh-ancestor
65566703|NCT05632445|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65566704|NCT05632445|Protease Inhibitors|protease inhibitors|mesh-ancestor
65566705|NCT05632445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566706|NCT05632445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566707|NCT05632445|Anticoagulants|anticoagulants|mesh-ancestor
65566708|NCT04422652|Bupropion|bupropion|mesh-list
65566709|NCT04422652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65566710|NCT04422652|Antidepressive Agents|antidepressive agents|mesh-ancestor
65566711|NCT04422652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65566712|NCT04422652|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65566713|NCT04422652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65566714|NCT04422652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65566715|NCT04422652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566716|NCT04422652|Dopamine Agents|dopamine agents|mesh-ancestor
65566717|NCT04422652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65566718|NCT04422652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566719|NCT04422652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65566720|NCT04422652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65566721|NCT04422652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566722|NCT01235117|Azacitidine|azacitidine|mesh-list
65566723|NCT01235117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65566724|NCT01235117|Antimetabolites|antimetabolites|mesh-ancestor
65566725|NCT01235117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566726|NCT01235117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566727|NCT01235117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566728|NCT01306591|Bevacizumab|bevacizumab|mesh-list
65566729|NCT01306591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65566730|NCT01306591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566731|NCT01306591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65566732|NCT01306591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65566733|NCT01306591|Growth Substances|growth substances|mesh-ancestor
65566734|NCT01306591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566735|NCT01306591|Growth Inhibitors|growth inhibitors|mesh-ancestor
65566736|NCT03098030|Irinotecan|irinotecan|mesh-list
65566737|NCT03098030|Topotecan|topotecan|mesh-list
65566738|NCT03098030|Dinutuximab|dinutuximab|mesh-list
65566739|NCT03098030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65566740|NCT03098030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65566741|NCT03098030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566742|NCT03098030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566743|NCT03098030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566744|NCT01233947|Fulvestrant|fulvestrant|mesh-list
65566745|NCT01233947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65566746|NCT01233947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566747|NCT01233947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65566748|NCT01233947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65566749|NCT01233947|Hormone Antagonists|hormone antagonists|mesh-ancestor
65566750|NCT01233947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65566751|NCT01233947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566753|NCT01139645|Rabeprazole|rabeprazole|mesh-list
65566754|NCT01139645|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65566755|NCT01139645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65566756|NCT01139645|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65566757|NCT01139645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566758|NCT01139645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566759|NCT03706287|Cisplatin|cisplatin|mesh-list
65566760|NCT03706287|Carboplatin|carboplatin|mesh-list
65295907|NCT04576546|Vitamins|vitamins|mesh-ancestor
65566761|NCT03706287|Pemetrexed|pemetrexed|mesh-list
65566762|NCT03706287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566763|NCT03706287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566764|NCT03706287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566765|NCT03706287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65566766|NCT03706287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65566767|NCT05109611|Nitric Oxide|nitric oxide|mesh-list
65566768|NCT05109611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65566769|NCT05109611|Autonomic Agents|autonomic agents|mesh-ancestor
65566770|NCT05109611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65566771|NCT05109611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566772|NCT05109611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65566773|NCT05109611|Respiratory System Agents|respiratory system agents|mesh-ancestor
65566774|NCT05109611|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65566775|NCT05109611|Antioxidants|antioxidants|mesh-ancestor
65566776|NCT05109611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566777|NCT05109611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65566778|NCT05109611|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65566779|NCT05109611|Vasodilator Agents|vasodilator agents|mesh-ancestor
65566780|NCT05109611|Gasotransmitters|gasotransmitters|mesh-ancestor
65566781|NCT05109611|Protective Agents|protective agents|mesh-ancestor
65566782|NCT05115201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65566783|NCT05115201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65566784|NCT05107193|Afatinib|afatinib|mesh-list
65566785|NCT05107193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566786|NCT05107193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65566787|NCT05107193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566788|NCT05107193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566789|NCT03788395|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65566790|NCT03788395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65566791|NCT03788395|Respiratory System Agents|respiratory system agents|mesh-ancestor
65566792|NCT02522650|Amiloride|amiloride|mesh-list
65566793|NCT02522650|Triamterene|triamterene|mesh-list
65566794|NCT02522650|Diuretics|diuretics|mesh-ancestor
65566795|NCT02522650|Natriuretic Agents|natriuretic agents|mesh-ancestor
65566796|NCT02522650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566797|NCT02522650|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65566798|NCT02522650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65566799|NCT02522650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65566800|NCT02522650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566801|NCT02522650|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65566802|NCT02522650|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65566803|NCT05681871|Folic Acid|folic acid|mesh-list
65566804|NCT05681871|Ferrous fumarate|ferrous fumarate|mesh-list
65566805|NCT05681871|Ferrous gluconate|ferrous gluconate|mesh-list
65566806|NCT05681871|Hematinics|hematinics|mesh-ancestor
65566807|NCT05681871|Vitamin B Complex|vitamin b complex|mesh-ancestor
65566808|NCT05681871|Vitamins|vitamins|mesh-ancestor
65566809|NCT05681871|Micronutrients|micronutrients|mesh-ancestor
65566810|NCT05681871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566811|NCT05681871|Trace Elements|trace elements|mesh-ancestor
65566812|NCT04455958|Ritonavir|ritonavir|mesh-list
65566813|NCT04455958|Lopinavir|lopinavir|mesh-list
65566814|NCT04455958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65566815|NCT04455958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65566816|NCT04455958|Protease Inhibitors|protease inhibitors|mesh-ancestor
65566817|NCT04455958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566818|NCT04455958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566819|NCT04455958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65566820|NCT04455958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65566821|NCT04455958|Antiviral Agents|antiviral agents|mesh-ancestor
65566822|NCT04455958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65566823|NCT04455958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65364339|NCT00945789|Hematinics|hematinics|mesh-ancestor
65566824|NCT04455958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65566825|NCT05361382|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
65566826|NCT05361382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566827|NCT03791125|Salvianolic acid A|salvianolic acid a|mesh-list
65566828|NCT03791125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566829|NCT03791125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566830|NCT03791125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566831|NCT03791125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65566832|NCT03788317|Botulinum Toxins|botulinum toxins|mesh-list
65295982|NCT00737542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65566833|NCT03788317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65566834|NCT03788317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65566835|NCT03788317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65566836|NCT03788317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65566837|NCT03788317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566838|NCT03788317|Cholinergic Agents|cholinergic agents|mesh-ancestor
65566839|NCT03788317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65566840|NCT03788317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566841|NCT03788317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65566842|NCT03788317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65566843|NCT01378858|Varenicline|varenicline|mesh-list
65566844|NCT01378858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65566845|NCT01378858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65566846|NCT01378858|Cholinergic Agents|cholinergic agents|mesh-ancestor
65566847|NCT01378858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65566848|NCT01378858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566849|NCT01378858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566850|NCT02891850|Sildenafil Citrate|sildenafil citrate|mesh-list
65566851|NCT02891850|Tadalafil|tadalafil|mesh-list
65566852|NCT02891850|Riociguat|riociguat|mesh-list
65566853|NCT02891850|Vasodilator Agents|vasodilator agents|mesh-ancestor
65566854|NCT02891850|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65566855|NCT02891850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65566856|NCT02891850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566857|NCT02891850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566858|NCT02891850|Urological Agents|urological agents|mesh-ancestor
65566859|NCT02891850|Enzyme Activators|enzyme activators|mesh-ancestor
65566860|NCT05175027|Povidone-Iodine|povidone-iodine|mesh-list
65566861|NCT05175027|Povidone|povidone|mesh-list
65566862|NCT05175027|Plasma Substitutes|plasma substitutes|mesh-ancestor
65566863|NCT05175027|Blood Substitutes|blood substitutes|mesh-ancestor
65566864|NCT05175027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65566865|NCT05175027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65566866|NCT05089630|Vaccines|vaccines|mesh-list
65566867|NCT05089630|Immunologic Factors|immunologic factors|mesh-ancestor
65566868|NCT05089630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566869|NCT03707418|Heparin|heparin|mesh-list
65566870|NCT03707418|Calcium heparin|calcium heparin|mesh-list
65566871|NCT03707418|Bivalirudin|bivalirudin|mesh-list
65566872|NCT03707418|Anticoagulants|anticoagulants|mesh-ancestor
65566873|NCT03707418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65566874|NCT03707418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65566875|NCT03707418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566876|NCT03707418|Antithrombins|antithrombins|mesh-ancestor
65566877|NCT03707418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65566878|NCT03707418|Protease Inhibitors|protease inhibitors|mesh-ancestor
65566879|NCT03707418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566880|NCT05681481|Prednisone|prednisone|mesh-list
65566881|NCT05681481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65566882|NCT05681481|Glucocorticoids|glucocorticoids|mesh-ancestor
65566883|NCT05681481|Hormones|hormones|mesh-ancestor
65566884|NCT05681481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65566885|NCT05681481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566886|NCT05681481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65566887|NCT05681481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566888|NCT03785041|Tramadol|tramadol|mesh-list
65566889|NCT03785041|Levobupivacaine|levobupivacaine|mesh-list
65566890|NCT03785041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65566891|NCT03785041|Narcotics|narcotics|mesh-ancestor
65566892|NCT03785041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65566893|NCT03785041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566894|NCT03785041|Analgesics|analgesics|mesh-ancestor
65566895|NCT03785041|Sensory System Agents|sensory system agents|mesh-ancestor
65566896|NCT03785041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65566897|NCT03785041|Anesthetics, Local|anesthetics, local|mesh-ancestor
65566898|NCT03785041|Anesthetics|anesthetics|mesh-ancestor
65566899|NCT03710304|Misoprostol|misoprostol|mesh-list
65566900|NCT03710304|Tranexamic Acid|tranexamic acid|mesh-list
65566901|NCT03710304|Oxytocin|oxytocin|mesh-list
65566902|NCT03710304|Oxytocics|oxytocics|mesh-ancestor
65566903|NCT03710304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65566904|NCT03710304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566905|NCT03710304|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65566906|NCT03710304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65566907|NCT03710304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296056|NCT04063540|Amiloride|amiloride|mesh-list
65566908|NCT03710304|Hemostatics|hemostatics|mesh-ancestor
65566909|NCT03710304|Coagulants|coagulants|mesh-ancestor
65566910|NCT03710304|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65566911|NCT03710304|Abortifacient Agents|abortifacient agents|mesh-ancestor
65566912|NCT03710304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65566913|NCT03710304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65566914|NCT02949219|Pembrolizumab|pembrolizumab|mesh-list
65566915|NCT02949219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65566916|NCT02949219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566917|NCT05605639|Bupivacaine|bupivacaine|mesh-list
65566918|NCT05605639|Anesthetics, Local|anesthetics, local|mesh-ancestor
65566919|NCT05605639|Anesthetics|anesthetics|mesh-ancestor
65566920|NCT05605639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65566921|NCT05605639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566922|NCT05605639|Sensory System Agents|sensory system agents|mesh-ancestor
65566923|NCT05605639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65566924|NCT03790345|Vitamins|vitamins|mesh-list
65566925|NCT03790345|Vitamin B 12|vitamin b 12|mesh-list
65566926|NCT03790345|Pyridoxine|pyridoxine|mesh-list
65566927|NCT03790345|Vitamin B 6|vitamin b 6|mesh-list
65566928|NCT03790345|Vitamin B Complex|vitamin b complex|mesh-list
65566929|NCT03790345|Micronutrients|micronutrients|mesh-ancestor
65566930|NCT03790345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566931|NCT05416190|Anticoagulants|anticoagulants|mesh-list
65566932|NCT05416190|Lupus Coagulation Inhibitor|lupus coagulation inhibitor|mesh-list
65566933|NCT05416190|Immunologic Factors|immunologic factors|mesh-ancestor
65566934|NCT05416190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566935|NCT04454788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65566936|NCT04454788|Tenecteplase|tenecteplase|mesh-list
65566937|NCT04454788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65566938|NCT04454788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65566939|NCT04454788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566940|NCT03691064|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65566941|NCT03691064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65566942|NCT03691064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566943|NCT04862650|Paclitaxel|paclitaxel|mesh-list
65566944|NCT04862650|Carboplatin|carboplatin|mesh-list
65566945|NCT04862650|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65566946|NCT04862650|Cemiplimab|cemiplimab|mesh-list
65566947|NCT04862650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65566948|NCT04862650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566949|NCT04862650|Tubulin Modulators|tubulin modulators|mesh-ancestor
65566950|NCT04862650|Antimitotic Agents|antimitotic agents|mesh-ancestor
65566951|NCT04862650|Mitosis Modulators|mitosis modulators|mesh-ancestor
65566952|NCT04862650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566953|NCT04862650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65566954|NCT05163561|Vaccines|vaccines|mesh-list
65566955|NCT05163561|Immunologic Factors|immunologic factors|mesh-ancestor
65566956|NCT05163561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566957|NCT05174637|Immunoconjugates|immunoconjugates|mesh-list
65566958|NCT05174637|Immunologic Factors|immunologic factors|mesh-ancestor
65566959|NCT05174637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566960|NCT05681403|Cytarabine|cytarabine|mesh-list
65566961|NCT05681403|Carmustine|carmustine|mesh-list
65566962|NCT05681403|Melphalan|melphalan|mesh-list
65566963|NCT05681403|Etoposide|etoposide|mesh-list
65566964|NCT05681403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65566965|NCT05681403|Alkylating Agents|alkylating agents|mesh-ancestor
65566966|NCT05681403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65566967|NCT05681403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65566968|NCT05681403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65566969|NCT05681403|Antimetabolites|antimetabolites|mesh-ancestor
65566970|NCT05681403|Antiviral Agents|antiviral agents|mesh-ancestor
65566971|NCT05681403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65566972|NCT05681403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65566973|NCT05681403|Immunologic Factors|immunologic factors|mesh-ancestor
65566974|NCT05681403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566975|NCT05681403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65566976|NCT05681403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65566977|NCT05681403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65566978|NCT05681403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65566979|NCT05681403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65566980|NCT01309009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65566981|NCT01309009|MEN 11420|men 11420|mesh-list
65566982|NCT01309009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65566983|NCT01309009|Autonomic Agents|autonomic agents|mesh-ancestor
65296127|NCT02623452|Insulin Lispro|insulin lispro|mesh-list
65566984|NCT01309009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65566985|NCT01309009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566986|NCT01309009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65566987|NCT01309009|Respiratory System Agents|respiratory system agents|mesh-ancestor
65566988|NCT03339453|Glucagon|glucagon|mesh-list
65566989|NCT03339453|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65566990|NCT03339453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65566991|NCT03339453|Hormones|hormones|mesh-ancestor
65566992|NCT03339453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65566993|NCT03339453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65566994|NCT03339453|Incretins|incretins|mesh-ancestor
65566995|NCT05418686|Colchicine|colchicine|mesh-list
65566996|NCT05418686|Gout Suppressants|gout suppressants|mesh-ancestor
65566997|NCT05418686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65566998|NCT05418686|Tubulin Modulators|tubulin modulators|mesh-ancestor
65566999|NCT05418686|Antimitotic Agents|antimitotic agents|mesh-ancestor
65567000|NCT05418686|Mitosis Modulators|mitosis modulators|mesh-ancestor
65567001|NCT05418686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567002|NCT05418686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567003|NCT01306981|Ranibizumab|ranibizumab|mesh-list
65567004|NCT01306981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65567005|NCT01306981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65567006|NCT01306981|Growth Substances|growth substances|mesh-ancestor
65567007|NCT01306981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567008|NCT01306981|Growth Inhibitors|growth inhibitors|mesh-ancestor
65567009|NCT01306981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567010|NCT05552157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65567011|NCT05552157|Immunologic Factors|immunologic factors|mesh-ancestor
65567012|NCT05552157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567013|NCT05076799|Lactulose|lactulose|mesh-list
65567014|NCT05076799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65567015|NCT03784495|Melatonin|melatonin|mesh-list
65567016|NCT03784495|Antioxidants|antioxidants|mesh-ancestor
65567017|NCT03784495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567018|NCT03784495|Protective Agents|protective agents|mesh-ancestor
65567019|NCT03784495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567020|NCT03784495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65567021|NCT04120246|Acetic Acid|acetic acid|mesh-list
65567022|NCT04120246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65567023|NCT04120246|Trastuzumab|trastuzumab|mesh-list
65567024|NCT04120246|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
65567025|NCT04120246|Antibodies|antibodies|mesh-list
65567026|NCT04120246|Immunoglobulins|immunoglobulins|mesh-list
65567027|NCT04120246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65567028|NCT04120246|Immunologic Factors|immunologic factors|mesh-ancestor
65567029|NCT04120246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567030|NCT04120246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567031|NCT04120246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65567032|NCT04120246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65567033|NCT05659147|Secretin|secretin|mesh-list
65567034|NCT05659147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65567035|NCT05659147|Hormones|hormones|mesh-ancestor
65567036|NCT05659147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65567037|NCT05659147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567038|NCT05234697|Remifentanil|remifentanil|mesh-list
65567039|NCT05234697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65567040|NCT05234697|Narcotics|narcotics|mesh-ancestor
65567041|NCT05234697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65567042|NCT05234697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567043|NCT05234697|Analgesics|analgesics|mesh-ancestor
65567044|NCT05234697|Sensory System Agents|sensory system agents|mesh-ancestor
65567045|NCT05234697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567046|NCT03490760|Durvalumab|durvalumab|mesh-list
65567047|NCT03490760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65567048|NCT03490760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567049|NCT02133404|Cinacalcet|cinacalcet|mesh-list
65567050|NCT02133404|ASP7991|asp7991|mesh-list
65567051|NCT02133404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65567052|NCT02133404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567053|NCT02133404|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65567054|NCT02133404|Hormone Antagonists|hormone antagonists|mesh-ancestor
65567055|NCT02133404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65567056|NCT01307215|Ropivacaine|ropivacaine|mesh-list
65567057|NCT01307215|Anesthetics, Local|anesthetics, local|mesh-ancestor
65567058|NCT01307215|Anesthetics|anesthetics|mesh-ancestor
65567059|NCT01307215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65567060|NCT01307215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567061|NCT01307215|Sensory System Agents|sensory system agents|mesh-ancestor
65567062|NCT01307215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567063|NCT03761056|Cyclophosphamide|cyclophosphamide|mesh-list
65567064|NCT03761056|Fludarabine|fludarabine|mesh-list
65567065|NCT03761056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65567066|NCT03761056|Immunologic Factors|immunologic factors|mesh-ancestor
65567067|NCT03761056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567068|NCT03761056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65567069|NCT03761056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65567070|NCT03761056|Alkylating Agents|alkylating agents|mesh-ancestor
65567071|NCT03761056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567072|NCT03761056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567073|NCT03761056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65567074|NCT05177601|Cycloserine|cycloserine|mesh-list
65567075|NCT05177601|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65567076|NCT05177601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65567077|NCT05177601|Renal Agents|renal agents|mesh-ancestor
65567078|NCT05177601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65567079|NCT05177601|Antitubercular Agents|antitubercular agents|mesh-ancestor
65567080|NCT05177601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65567081|NCT05177601|Antimetabolites|antimetabolites|mesh-ancestor
65567082|NCT05177601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567083|NCT03420794|Analgesics|analgesics|mesh-list
65567084|NCT03420794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
65567085|NCT03420794|Sensory System Agents|sensory system agents|mesh-ancestor
65567086|NCT03420794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567087|NCT03420794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567088|NCT01568450|Oxycodone|oxycodone|mesh-list
65567089|NCT01568450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65567090|NCT01568450|Narcotics|narcotics|mesh-ancestor
65567091|NCT01568450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65567092|NCT01568450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567093|NCT01568450|Analgesics|analgesics|mesh-ancestor
65567094|NCT01568450|Sensory System Agents|sensory system agents|mesh-ancestor
65567095|NCT01568450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567096|NCT05410496|Tenofovir|tenofovir|mesh-list
65567097|NCT05410496|Antiviral Agents|antiviral agents|mesh-ancestor
65567098|NCT05410496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65567099|NCT05410496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65567100|NCT05410496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65567101|NCT05410496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567102|NCT05410496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567103|NCT05410496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65567104|NCT05410496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65567105|NCT03784105|Codeine|codeine|mesh-list
65567106|NCT03784105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65567107|NCT03784105|Narcotics|narcotics|mesh-ancestor
65567108|NCT03784105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65567109|NCT03784105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567110|NCT03784105|Analgesics|analgesics|mesh-ancestor
65567111|NCT03784105|Sensory System Agents|sensory system agents|mesh-ancestor
65567112|NCT03784105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567113|NCT03784105|Antitussive Agents|antitussive agents|mesh-ancestor
65567114|NCT03784105|Respiratory System Agents|respiratory system agents|mesh-ancestor
65567115|NCT03366142|Ustekinumab|ustekinumab|mesh-list
65567116|NCT03366142|Dermatologic Agents|dermatologic agents|mesh-ancestor
65567117|NCT01508312|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65567118|NCT01508312|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65567119|NCT01508312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65567120|NCT01508312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567121|NCT01508312|Immunologic Factors|immunologic factors|mesh-ancestor
65567122|NCT01508312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567123|NCT03784261|Abatacept|abatacept|mesh-list
65567124|NCT03784261|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65567125|NCT03784261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567126|NCT03784261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567127|NCT03784261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65567128|NCT03784261|Immunologic Factors|immunologic factors|mesh-ancestor
65567129|NCT03784261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567130|NCT03784261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65567132|NCT02989402|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65567133|NCT02989402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567134|NCT02989402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567135|NCT02989402|Cholinergic Agents|cholinergic agents|mesh-ancestor
65567136|NCT02989402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65567137|NCT02989402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567138|NCT02989402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65567139|NCT02989402|Protective Agents|protective agents|mesh-ancestor
65567140|NCT03783949|Gemcitabine|gemcitabine|mesh-list
65567141|NCT03783949|Paclitaxel|paclitaxel|mesh-list
65567142|NCT03783949|Carboplatin|carboplatin|mesh-list
65567143|NCT03783949|Niraparib|niraparib|mesh-list
65567144|NCT03783949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65567145|NCT03783949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567146|NCT03783949|Tubulin Modulators|tubulin modulators|mesh-ancestor
65567147|NCT03783949|Antimitotic Agents|antimitotic agents|mesh-ancestor
65567148|NCT03783949|Mitosis Modulators|mitosis modulators|mesh-ancestor
65567149|NCT03783949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567150|NCT03783949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65567151|NCT03783949|Antimetabolites|antimetabolites|mesh-ancestor
65567152|NCT03783949|Antiviral Agents|antiviral agents|mesh-ancestor
65567153|NCT03783949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65567154|NCT03783949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567155|NCT03783949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65567156|NCT03783949|Immunologic Factors|immunologic factors|mesh-ancestor
65567157|NCT03783949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567158|NCT03783949|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65567159|NCT02861950|Bupivacaine|bupivacaine|mesh-list
65567160|NCT02861950|Ropivacaine|ropivacaine|mesh-list
65567161|NCT02861950|Anesthetics, Local|anesthetics, local|mesh-ancestor
65567162|NCT02861950|Anesthetics|anesthetics|mesh-ancestor
65567163|NCT02861950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65567164|NCT02861950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567165|NCT02861950|Sensory System Agents|sensory system agents|mesh-ancestor
65567166|NCT02861950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567167|NCT05681247|Ezetimibe|ezetimibe|mesh-list
65567168|NCT05681247|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65567169|NCT05681247|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65567170|NCT05681247|Antimetabolites|antimetabolites|mesh-ancestor
65567171|NCT05681247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567172|NCT05681247|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65567173|NCT03787927|Aspirin|aspirin|mesh-list
65567174|NCT03787927|Clopidogrel|clopidogrel|mesh-list
65567175|NCT03787927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65567176|NCT03787927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65567177|NCT03787927|Analgesics|analgesics|mesh-ancestor
65567178|NCT03787927|Sensory System Agents|sensory system agents|mesh-ancestor
65567179|NCT03787927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567180|NCT03787927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567181|NCT03787927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65567182|NCT03787927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65567183|NCT03787927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65567184|NCT03787927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65567185|NCT03787927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567186|NCT03787927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65567187|NCT03787927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65567188|NCT03787927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567189|NCT03787927|Antipyretics|antipyretics|mesh-ancestor
65567190|NCT03787927|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65567191|NCT03787927|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65567192|NCT03787927|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65567193|NCT03787927|Purinergic Agents|purinergic agents|mesh-ancestor
65567194|NCT03787927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65567195|NCT00602576|Temozolomide|temozolomide|mesh-list
65567196|NCT00602576|Sorafenib|sorafenib|mesh-list
65567197|NCT00602576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65567198|NCT00602576|Alkylating Agents|alkylating agents|mesh-ancestor
65567199|NCT00602576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567200|NCT00602576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567201|NCT00602576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65567202|NCT00602576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567203|NCT04807972|Folfirinox|folfirinox|mesh-list
65567205|NCT05694871|Palbociclib|palbociclib|mesh-list
65567206|NCT05694871|Cemiplimab|cemiplimab|mesh-list
65567207|NCT05694871|Immunoglobulins|immunoglobulins|mesh-list
65567208|NCT05694871|Immunoglobulin G|immunoglobulin g|mesh-list
65567209|NCT05694871|Immunologic Factors|immunologic factors|mesh-ancestor
65567210|NCT05694871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296352|NCT00660140|Carboplatin|carboplatin|mesh-list
65567211|NCT05694871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567212|NCT05694871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65567213|NCT05694871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567214|NCT05694871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567215|NCT05694871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65567216|NCT03359850|Niraparib|niraparib|mesh-list
65567217|NCT03359850|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65567218|NCT03359850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567219|NCT03359850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567220|NCT03359850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567221|NCT01306123|Vitamin B 12|vitamin b 12|mesh-list
65567222|NCT01306123|Hydroxocobalamin|hydroxocobalamin|mesh-list
65567223|NCT01306123|Vitamins|vitamins|mesh-ancestor
65567224|NCT01306123|Micronutrients|micronutrients|mesh-ancestor
65567225|NCT01306123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567226|NCT01306123|Vitamin B Complex|vitamin b complex|mesh-ancestor
65567227|NCT01306123|Hematinics|hematinics|mesh-ancestor
65567228|NCT04803994|Bevacizumab|bevacizumab|mesh-list
65567229|NCT04803994|Atezolizumab|atezolizumab|mesh-list
65567230|NCT04803994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65567231|NCT04803994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567232|NCT04803994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65567233|NCT04803994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65567234|NCT04803994|Growth Substances|growth substances|mesh-ancestor
65567235|NCT04803994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567236|NCT04803994|Growth Inhibitors|growth inhibitors|mesh-ancestor
65567237|NCT03130426|Insulin|insulin|mesh-list
65567238|NCT03130426|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65567239|NCT03130426|Metformin|metformin|mesh-list
65567240|NCT03130426|Insulin Glargine|insulin glargine|mesh-list
65567241|NCT03130426|Lixisenatide|lixisenatide|mesh-list
65567242|NCT03130426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65567243|NCT03130426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567244|NCT00114140|Temozolomide|temozolomide|mesh-list
65567245|NCT00114140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65567246|NCT00114140|Alkylating Agents|alkylating agents|mesh-ancestor
65567247|NCT00114140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567248|NCT00114140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567249|NCT03342690|Eplerenone|eplerenone|mesh-list
65567250|NCT03342690|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65567251|NCT03342690|Hormone Antagonists|hormone antagonists|mesh-ancestor
65567252|NCT03342690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65567253|NCT03342690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567254|NCT03342690|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65567255|NCT03342690|Diuretics|diuretics|mesh-ancestor
65567256|NCT03342690|Natriuretic Agents|natriuretic agents|mesh-ancestor
65567257|NCT03342690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65567258|NCT03130582|Etoposide|etoposide|mesh-list
65567259|NCT03130582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65567260|NCT03130582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567261|NCT03130582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65567262|NCT03130582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65567263|NCT03130582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567264|NCT03130582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567265|NCT04752540|Olorofim|olorofim|mesh-list
65567266|NCT04752540|Antifungal Agents|antifungal agents|mesh-ancestor
65567267|NCT04752540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65567268|NCT03712345|Vilobelimab|vilobelimab|mesh-list
65567269|NCT03712345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65567270|NCT03712345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65567271|NCT03712345|Immunologic Factors|immunologic factors|mesh-ancestor
65567272|NCT03712345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567273|NCT03130348|Dexamethasone|dexamethasone|mesh-list
65567274|NCT03130348|Dexamethasone acetate|dexamethasone acetate|mesh-list
65567275|NCT03130348|Bortezomib|bortezomib|mesh-list
65567276|NCT03130348|Ichthammol|ichthammol|mesh-list
65567277|NCT03130348|BB 1101|bb 1101|mesh-list
65567278|NCT03130348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65567279|NCT03130348|Antiemetics|antiemetics|mesh-ancestor
65567280|NCT03130348|Autonomic Agents|autonomic agents|mesh-ancestor
65567281|NCT03130348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567282|NCT03130348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567283|NCT03130348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65567284|NCT03130348|Glucocorticoids|glucocorticoids|mesh-ancestor
65567285|NCT03130348|Hormones|hormones|mesh-ancestor
65567286|NCT03130348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65567287|NCT03130348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65567288|NCT03130348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567289|NCT03130348|Protease Inhibitors|protease inhibitors|mesh-ancestor
65567290|NCT03130348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567291|NCT03130348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567292|NCT03130348|Dermatologic Agents|dermatologic agents|mesh-ancestor
65567293|NCT01307527|Riboflavin|riboflavin|mesh-list
65567294|NCT01307527|Vitamin B Complex|vitamin b complex|mesh-ancestor
65567295|NCT01307527|Vitamins|vitamins|mesh-ancestor
65567296|NCT01307527|Micronutrients|micronutrients|mesh-ancestor
65567297|NCT01307527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567298|NCT01307527|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65567299|NCT01307527|Dermatologic Agents|dermatologic agents|mesh-ancestor
65567300|NCT03789799|Titanium dioxide|titanium dioxide|mesh-list
65567301|NCT03789799|Sunscreening Agents|sunscreening agents|mesh-ancestor
65567302|NCT03789799|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65567303|NCT03789799|Protective Agents|protective agents|mesh-ancestor
65567304|NCT03789799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567305|NCT03789799|Dermatologic Agents|dermatologic agents|mesh-ancestor
65567306|NCT03789799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65567307|NCT05439772|Ondansetron|ondansetron|mesh-list
65567308|NCT05439772|Antiemetics|antiemetics|mesh-ancestor
65567309|NCT05439772|Autonomic Agents|autonomic agents|mesh-ancestor
65567310|NCT05439772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567311|NCT05439772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567312|NCT05439772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65567313|NCT05439772|Antipruritics|antipruritics|mesh-ancestor
65567314|NCT05439772|Dermatologic Agents|dermatologic agents|mesh-ancestor
65567315|NCT05439772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65567316|NCT05439772|Serotonin Agents|serotonin agents|mesh-ancestor
65567317|NCT05439772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65567318|NCT05439772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567319|NCT05439772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65567320|NCT05439772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65567321|NCT05439772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65567322|NCT05439772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65567323|NCT05439772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65567324|NCT05694715|Irinotecan|irinotecan|mesh-list
65567325|NCT05694715|Niraparib|niraparib|mesh-list
65567326|NCT05694715|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65567327|NCT05694715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65567328|NCT05694715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567329|NCT05694715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567330|NCT05694715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567331|NCT05694715|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65567332|NCT01309399|Teriparatide|teriparatide|mesh-list
65567333|NCT01309399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65567334|NCT01309399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567335|NCT01309399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65567336|NCT03311828|Daratumumab|daratumumab|mesh-list
65567337|NCT03311828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567338|NCT01309477|Tacrolimus|tacrolimus|mesh-list
65567339|NCT01309477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65567340|NCT01309477|Immunologic Factors|immunologic factors|mesh-ancestor
65567341|NCT01309477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567342|NCT01309477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65567343|NCT01309477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567344|NCT01309477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567345|NCT03709992|Tamsulosin|tamsulosin|mesh-list
65567346|NCT03709992|Trospium chloride|trospium chloride|mesh-list
65567347|NCT03709992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65567348|NCT03709992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65567349|NCT03709992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65567350|NCT03709992|Adrenergic Agents|adrenergic agents|mesh-ancestor
65567351|NCT03709992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65567352|NCT03709992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567353|NCT03709992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567354|NCT03709992|Urological Agents|urological agents|mesh-ancestor
65567355|NCT03709992|Parasympatholytics|parasympatholytics|mesh-ancestor
65567356|NCT03709992|Autonomic Agents|autonomic agents|mesh-ancestor
65567357|NCT03709992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567358|NCT03709992|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65567359|NCT03709992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65567360|NCT03709992|Cholinergic Agents|cholinergic agents|mesh-ancestor
65567361|NCT05438992|Bupivacaine|bupivacaine|mesh-list
65567362|NCT05438992|Anesthetics, Local|anesthetics, local|mesh-ancestor
65567363|NCT05438992|Anesthetics|anesthetics|mesh-ancestor
65567364|NCT05438992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65567365|NCT05438992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567366|NCT05438992|Sensory System Agents|sensory system agents|mesh-ancestor
65567367|NCT05438992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567369|NCT05361486|Tafenoquine|tafenoquine|mesh-list
65567370|NCT05361486|Antimalarials|antimalarials|mesh-ancestor
65567371|NCT05361486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65567372|NCT05361486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65567373|NCT05361486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65567374|NCT03089216|Calcium Carbonate|calcium carbonate|mesh-list
65567375|NCT03089216|Calcium|calcium|mesh-list
65567376|NCT03089216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65567377|NCT03089216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567378|NCT03089216|Antacids|antacids|mesh-ancestor
65567379|NCT03089216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567380|NCT03089216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65567381|NCT03339726|Phenylephrine|phenylephrine|mesh-list
65567382|NCT03339726|Oxymetazoline|oxymetazoline|mesh-list
65567383|NCT03339726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65567384|NCT03339726|Mydriatics|mydriatics|mesh-ancestor
65567385|NCT03339726|Autonomic Agents|autonomic agents|mesh-ancestor
65567386|NCT03339726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567387|NCT03339726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567388|NCT03339726|Sympathomimetics|sympathomimetics|mesh-ancestor
65567389|NCT03339726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65567390|NCT03339726|Nasal Decongestants|nasal decongestants|mesh-ancestor
65567391|NCT03339726|Respiratory System Agents|respiratory system agents|mesh-ancestor
65567392|NCT03339726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65567393|NCT03339726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65567394|NCT03339726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65567395|NCT03339726|Adrenergic Agents|adrenergic agents|mesh-ancestor
65567396|NCT03339726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65567397|NCT03339726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567398|NCT03339726|Protective Agents|protective agents|mesh-ancestor
65567399|NCT03339297|Defibrotide|defibrotide|mesh-list
65567400|NCT03339297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65567401|NCT03339297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65567402|NCT03339297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567403|NCT03339297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65567404|NCT05434624|Midazolam|midazolam|mesh-list
65567405|NCT05434624|Propofol|propofol|mesh-list
65567406|NCT05434624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65567407|NCT05434624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65567408|NCT05434624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567409|NCT05434624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65567410|NCT05434624|Anesthetics, General|anesthetics, general|mesh-ancestor
65567411|NCT05434624|Anesthetics|anesthetics|mesh-ancestor
65567412|NCT05434624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65567413|NCT05434624|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65567414|NCT05434624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65567415|NCT05434624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65567416|NCT05434624|GABA Modulators|gaba modulators|mesh-ancestor
65567417|NCT05434624|GABA Agents|gaba agents|mesh-ancestor
65567418|NCT05434624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65567419|NCT05434624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567420|NCT01309633|Gemcitabine|gemcitabine|mesh-list
65567421|NCT01309633|Bevacizumab|bevacizumab|mesh-list
65567422|NCT01309633|Sunitinib|sunitinib|mesh-list
65567423|NCT01309633|Cisplatin|cisplatin|mesh-list
65567424|NCT01309633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65567425|NCT01309633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567426|NCT01309633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65567427|NCT01309633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65567428|NCT01309633|Growth Substances|growth substances|mesh-ancestor
65567429|NCT01309633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364935|NCT04048226|Analgesics|analgesics|mesh-ancestor
65567430|NCT01309633|Growth Inhibitors|growth inhibitors|mesh-ancestor
65567431|NCT01309633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65567433|NCT01309633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567434|NCT01309633|Antiviral Agents|antiviral agents|mesh-ancestor
65567435|NCT01309633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65567436|NCT01309633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567437|NCT01309633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65567438|NCT01309633|Immunologic Factors|immunologic factors|mesh-ancestor
65296574|NCT02096159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65567439|NCT01309633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65567440|NCT05215431|Antioxidants|antioxidants|mesh-list
65567441|NCT05215431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567442|NCT05215431|Protective Agents|protective agents|mesh-ancestor
65567443|NCT05215431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567444|NCT03706950|Elsulfavirine|elsulfavirine|mesh-list
65567445|NCT03706950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65567446|NCT03706950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65567447|NCT03706950|Antiviral Agents|antiviral agents|mesh-ancestor
65567448|NCT03706950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65567449|NCT01310647|Estradiol|estradiol|mesh-list
65567450|NCT01310647|Testosterone|testosterone|mesh-list
65567451|NCT01310647|Estrogens|estrogens|mesh-ancestor
65567452|NCT01310647|Hormones|hormones|mesh-ancestor
65567453|NCT01310647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65567454|NCT01310647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567455|NCT01310647|Androgens|androgens|mesh-ancestor
65567456|NCT05560399|Dexamethasone|dexamethasone|mesh-list
65567457|NCT05560399|Elotuzumab|elotuzumab|mesh-list
65567458|NCT05560399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65567459|NCT05560399|Antiemetics|antiemetics|mesh-ancestor
65567460|NCT05560399|Autonomic Agents|autonomic agents|mesh-ancestor
65567461|NCT05560399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567462|NCT05560399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567463|NCT05560399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65567464|NCT05560399|Glucocorticoids|glucocorticoids|mesh-ancestor
65567465|NCT05560399|Hormones|hormones|mesh-ancestor
65567466|NCT05560399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65567467|NCT05560399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65567468|NCT05560399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567469|NCT02949024|Triamcinolone|triamcinolone|mesh-list
65567470|NCT02949024|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65567471|NCT02949024|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65567472|NCT02949024|Aflibercept|aflibercept|mesh-list
65567473|NCT02949024|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65567474|NCT02949024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65567475|NCT02949024|Glucocorticoids|glucocorticoids|mesh-ancestor
65567476|NCT02949024|Hormones|hormones|mesh-ancestor
65567477|NCT02949024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65567478|NCT02949024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567479|NCT02949024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65567480|NCT02949024|Immunologic Factors|immunologic factors|mesh-ancestor
65567481|NCT02949024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567482|NCT02949024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567483|NCT02949024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65567484|NCT02949024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65567485|NCT02949024|Growth Substances|growth substances|mesh-ancestor
65567486|NCT02949024|Growth Inhibitors|growth inhibitors|mesh-ancestor
65567487|NCT02949024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567488|NCT04394481|Dexamethasone|dexamethasone|mesh-list
65567489|NCT04394481|Dexmedetomidine|dexmedetomidine|mesh-list
65567490|NCT04394481|Ropivacaine|ropivacaine|mesh-list
65567491|NCT04394481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65567492|NCT04394481|Antiemetics|antiemetics|mesh-ancestor
65567493|NCT04394481|Autonomic Agents|autonomic agents|mesh-ancestor
65567494|NCT04394481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567495|NCT04394481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567496|NCT04394481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65567497|NCT04394481|Glucocorticoids|glucocorticoids|mesh-ancestor
65567498|NCT04394481|Hormones|hormones|mesh-ancestor
65567499|NCT04394481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65567500|NCT04394481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65567501|NCT04394481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567502|NCT04394481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65567503|NCT04394481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65567504|NCT04394481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65567505|NCT04394481|Analgesics|analgesics|mesh-ancestor
65365009|NCT02557490|Oxaliplatin|oxaliplatin|mesh-list
65567506|NCT04394481|Sensory System Agents|sensory system agents|mesh-ancestor
65567507|NCT04394481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65567509|NCT04394481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65567510|NCT04394481|Adrenergic Agents|adrenergic agents|mesh-ancestor
65567511|NCT04394481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65567512|NCT04394481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567513|NCT04394481|Anesthetics, Local|anesthetics, local|mesh-ancestor
65567514|NCT04394481|Anesthetics|anesthetics|mesh-ancestor
65567515|NCT03782935|Choline|choline|mesh-list
65567516|NCT03782935|Lipotropic Agents|lipotropic agents|mesh-ancestor
65567517|NCT03782935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65567518|NCT03782935|Antimetabolites|antimetabolites|mesh-ancestor
65567519|NCT03782935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567520|NCT03782935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65567521|NCT03782935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65567522|NCT03782935|Nootropic Agents|nootropic agents|mesh-ancestor
65567523|NCT04370847|Ephedrine|ephedrine|mesh-list
65567524|NCT04370847|Fentanyl|fentanyl|mesh-list
65567525|NCT04370847|Bupivacaine|bupivacaine|mesh-list
65567526|NCT04370847|Oxytocin|oxytocin|mesh-list
65567527|NCT04370847|Anesthetics, Local|anesthetics, local|mesh-ancestor
65567528|NCT04370847|Anesthetics|anesthetics|mesh-ancestor
65567529|NCT04370847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65567530|NCT04370847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567531|NCT04370847|Sensory System Agents|sensory system agents|mesh-ancestor
65567532|NCT04370847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567533|NCT04370847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65567534|NCT04370847|Narcotics|narcotics|mesh-ancestor
65567535|NCT04370847|Analgesics|analgesics|mesh-ancestor
65567536|NCT04370847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65567537|NCT04370847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65567538|NCT04370847|Anesthetics, General|anesthetics, general|mesh-ancestor
65567539|NCT04370847|Oxytocics|oxytocics|mesh-ancestor
65567540|NCT04370847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65567541|NCT04370847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65567542|NCT04370847|Sympathomimetics|sympathomimetics|mesh-ancestor
65567543|NCT04370847|Autonomic Agents|autonomic agents|mesh-ancestor
65567544|NCT04370847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65567545|NCT04370847|Adrenergic Agents|adrenergic agents|mesh-ancestor
65567546|NCT04370847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65567547|NCT04370847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567548|NCT03708120|Insect Repellents|insect repellents|mesh-list
65567549|NCT03708120|Protective Agents|protective agents|mesh-ancestor
65567550|NCT03708120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567551|NCT03093428|Pembrolizumab|pembrolizumab|mesh-list
65567552|NCT03093428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65567553|NCT03093428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567554|NCT01309789|Prednisone|prednisone|mesh-list
65567555|NCT01309789|Cyclophosphamide|cyclophosphamide|mesh-list
65567556|NCT01309789|Doxorubicin|doxorubicin|mesh-list
65567557|NCT01309789|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65567558|NCT01309789|Vincristine|vincristine|mesh-list
65567559|NCT01309789|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65567560|NCT01309789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65567561|NCT01309789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65567562|NCT01309789|Immunologic Factors|immunologic factors|mesh-ancestor
65567563|NCT01309789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567564|NCT01309789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65567565|NCT01309789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65567566|NCT01309789|Alkylating Agents|alkylating agents|mesh-ancestor
65567567|NCT01309789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567568|NCT01309789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567569|NCT01309789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65567570|NCT01309789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65567571|NCT01309789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65567572|NCT01309789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65567573|NCT01309789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567574|NCT01309789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65567575|NCT01309789|Glucocorticoids|glucocorticoids|mesh-ancestor
65567576|NCT01309789|Hormones|hormones|mesh-ancestor
65567577|NCT01309789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65567578|NCT01309789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65567579|NCT01309789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65567580|NCT01309789|Tubulin Modulators|tubulin modulators|mesh-ancestor
65567581|NCT01309789|Antimitotic Agents|antimitotic agents|mesh-ancestor
65567582|NCT01309789|Mitosis Modulators|mitosis modulators|mesh-ancestor
65567583|NCT01309789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65567584|NCT04532528|Dabigatran|dabigatran|mesh-list
65567585|NCT04532528|Antithrombins|antithrombins|mesh-ancestor
65567586|NCT04532528|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65567587|NCT04532528|Protease Inhibitors|protease inhibitors|mesh-ancestor
65567588|NCT04532528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567589|NCT04532528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567590|NCT04532528|Anticoagulants|anticoagulants|mesh-ancestor
65567591|NCT03707847|Etoposide|etoposide|mesh-list
65567592|NCT03707847|Crizotinib|crizotinib|mesh-list
65567593|NCT03707847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65567594|NCT03707847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567595|NCT03707847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65567596|NCT03707847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65567597|NCT03707847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567598|NCT03707847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567599|NCT03707847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65567600|NCT03338400|Dexamethasone|dexamethasone|mesh-list
65567601|NCT03338400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65567602|NCT03338400|Antiemetics|antiemetics|mesh-ancestor
65567603|NCT03338400|Autonomic Agents|autonomic agents|mesh-ancestor
65567604|NCT03338400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567605|NCT03338400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567606|NCT03338400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65567607|NCT03338400|Glucocorticoids|glucocorticoids|mesh-ancestor
65567608|NCT03338400|Hormones|hormones|mesh-ancestor
65567609|NCT03338400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65567610|NCT03338400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65567611|NCT03338400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567612|NCT04511702|Methotrexate|methotrexate|mesh-list
65567613|NCT04511702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65567614|NCT04511702|Abortifacient Agents|abortifacient agents|mesh-ancestor
65567615|NCT04511702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65567616|NCT04511702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567617|NCT04511702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65567618|NCT04511702|Antimetabolites|antimetabolites|mesh-ancestor
65567619|NCT04511702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567620|NCT04511702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567621|NCT04511702|Dermatologic Agents|dermatologic agents|mesh-ancestor
65567622|NCT04511702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567623|NCT04511702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65567624|NCT04511702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65567625|NCT04511702|Immunologic Factors|immunologic factors|mesh-ancestor
65567626|NCT04511702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65567627|NCT04511702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65567628|NCT03787147|Lidocaine|lidocaine|mesh-list
65567629|NCT03787147|Bupivacaine|bupivacaine|mesh-list
65567630|NCT03787147|Anesthetics, Local|anesthetics, local|mesh-ancestor
65567631|NCT03787147|Anesthetics|anesthetics|mesh-ancestor
65567632|NCT03787147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65567633|NCT03787147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567634|NCT03787147|Sensory System Agents|sensory system agents|mesh-ancestor
65567635|NCT03787147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567636|NCT03787147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65567637|NCT03787147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65567638|NCT03787147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65567639|NCT03787147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65567640|NCT03787147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567641|NCT02620306|Losartan|losartan|mesh-list
65567642|NCT02620306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65567643|NCT02620306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65567644|NCT02620306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65567645|NCT02620306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65567646|NCT02620306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567647|NCT03781843|Lidocaine|lidocaine|mesh-list
65567648|NCT03781843|Anesthetics, Local|anesthetics, local|mesh-ancestor
65567649|NCT03781843|Anesthetics|anesthetics|mesh-ancestor
65567650|NCT03781843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65567651|NCT03781843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567652|NCT03781843|Sensory System Agents|sensory system agents|mesh-ancestor
65567653|NCT03781843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567654|NCT03781843|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65567655|NCT03781843|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65567657|NCT03781843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65567658|NCT03781843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567659|NCT05205447|Itraconazole|itraconazole|mesh-list
65567660|NCT05205447|Carbamazepine|carbamazepine|mesh-list
65567661|NCT05205447|Antifungal Agents|antifungal agents|mesh-ancestor
65567662|NCT05205447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65567663|NCT05205447|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65567664|NCT05205447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65567665|NCT05205447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567666|NCT05205447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567667|NCT05205447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65567668|NCT05205447|Hormone Antagonists|hormone antagonists|mesh-ancestor
65567669|NCT05205447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65567670|NCT05205447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567671|NCT05205447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65567672|NCT05205447|Anticonvulsants|anticonvulsants|mesh-ancestor
65567673|NCT05205447|Antimanic Agents|antimanic agents|mesh-ancestor
65567674|NCT05205447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65567675|NCT05205447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65567676|NCT05205447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65567677|NCT05205447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65567678|NCT05205447|Analgesics|analgesics|mesh-ancestor
65567679|NCT05205447|Sensory System Agents|sensory system agents|mesh-ancestor
65567680|NCT05205447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567681|NCT05205447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65567682|NCT05205447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65567683|NCT05205447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65567684|NCT05205447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65567685|NCT03781687|Morphine|morphine|mesh-list
65567686|NCT03781687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65567687|NCT03781687|Narcotics|narcotics|mesh-ancestor
65567688|NCT03781687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65567689|NCT03781687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567690|NCT03781687|Analgesics|analgesics|mesh-ancestor
65567691|NCT03781687|Sensory System Agents|sensory system agents|mesh-ancestor
65567692|NCT03781687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567693|NCT03092726|ASP8062|asp8062|mesh-list
65567694|NCT03092726|Analgesics|analgesics|mesh-ancestor
65567695|NCT03092726|Sensory System Agents|sensory system agents|mesh-ancestor
65567696|NCT03092726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567697|NCT03092726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567698|NCT03092726|GABA Modulators|gaba modulators|mesh-ancestor
65567699|NCT03092726|GABA Agents|gaba agents|mesh-ancestor
65567700|NCT03092726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65567701|NCT03092726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567702|NCT05328154|Diphosphonates|diphosphonates|mesh-list
65567703|NCT05328154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65567704|NCT05328154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567705|NCT03786757|Rivaroxaban|rivaroxaban|mesh-list
65567706|NCT03786757|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65567707|NCT03786757|Antithrombins|antithrombins|mesh-ancestor
65567708|NCT03786757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65567709|NCT03786757|Protease Inhibitors|protease inhibitors|mesh-ancestor
65567710|NCT03786757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567711|NCT03786757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567712|NCT03786757|Anticoagulants|anticoagulants|mesh-ancestor
65567713|NCT05126511|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65567714|NCT05126511|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
65567715|NCT05126511|beta-Endorphin|beta-endorphin|mesh-list
65567716|NCT05126511|Hormones|hormones|mesh-ancestor
65567717|NCT05126511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65567718|NCT05126511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567719|NCT05126511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65567720|NCT05126511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567721|NCT05598242|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65567722|NCT05598242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65567723|NCT04494789|Fludrocortisone|fludrocortisone|mesh-list
65567724|NCT04494789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65567725|NCT05598164|Botulinum Toxins|botulinum toxins|mesh-list
65567726|NCT05598164|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65567727|NCT05598164|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65365233|NCT00537238|Analgesics|analgesics|mesh-ancestor
65567728|NCT05598164|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65567729|NCT05598164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65567730|NCT05598164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567731|NCT05598164|Cholinergic Agents|cholinergic agents|mesh-ancestor
65567732|NCT05598164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65567733|NCT05598164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567734|NCT05598164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65567735|NCT05598164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567736|NCT03787069|Lidocaine|lidocaine|mesh-list
65567737|NCT03787069|Anesthetics, Local|anesthetics, local|mesh-ancestor
65567738|NCT03787069|Anesthetics|anesthetics|mesh-ancestor
65567739|NCT03787069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65567740|NCT03787069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567741|NCT03787069|Sensory System Agents|sensory system agents|mesh-ancestor
65567742|NCT03787069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567743|NCT03787069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65567744|NCT03787069|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65567745|NCT03787069|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65567746|NCT03787069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65567747|NCT03787069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567748|NCT05251090|Factor VIII|factor viii|mesh-list
65567749|NCT05251090|Coagulants|coagulants|mesh-ancestor
65567750|NCT04447118|Docetaxel|docetaxel|mesh-list
65567751|NCT04447118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567752|NCT04447118|Tubulin Modulators|tubulin modulators|mesh-ancestor
65567753|NCT04447118|Antimitotic Agents|antimitotic agents|mesh-ancestor
65567754|NCT04447118|Mitosis Modulators|mitosis modulators|mesh-ancestor
65567755|NCT04447118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567756|NCT05532319|Lenvatinib|lenvatinib|mesh-list
65567757|NCT05532319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567758|NCT05532319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65567759|NCT05532319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567760|NCT05532319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567761|NCT01553032|Cetuximab|cetuximab|mesh-list
65567762|NCT01553032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65567763|NCT01553032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567764|NCT05181124|Naproxen|naproxen|mesh-list
65567765|NCT05181124|Meloxicam|meloxicam|mesh-list
65567766|NCT05181124|Aceclofenac|aceclofenac|mesh-list
65567767|NCT05181124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65567768|NCT05181124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65567769|NCT05181124|Analgesics|analgesics|mesh-ancestor
65567770|NCT05181124|Sensory System Agents|sensory system agents|mesh-ancestor
65567771|NCT05181124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567772|NCT05181124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567773|NCT05181124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65567774|NCT05181124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65567775|NCT05181124|Gout Suppressants|gout suppressants|mesh-ancestor
65567776|NCT05181124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65567777|NCT05181124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567778|NCT05181124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567779|NCT05181124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65567780|NCT02897648|Lactams|lactams|mesh-list
65567781|NCT02897648|beta-Lactams|beta-lactams|mesh-list
65567782|NCT02897648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65567783|NCT02897648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65567784|NCT03338010|Insulin Glargine|insulin glargine|mesh-list
65567785|NCT03338010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65567786|NCT03338010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567787|NCT04424966|Infigratinib|infigratinib|mesh-list
65567788|NCT04424966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567789|NCT04959591|Acetaminophen|acetaminophen|mesh-list
65567790|NCT04959591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65567791|NCT04959591|Analgesics|analgesics|mesh-ancestor
65567792|NCT04959591|Sensory System Agents|sensory system agents|mesh-ancestor
65567793|NCT04959591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567794|NCT04959591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567795|NCT04959591|Antipyretics|antipyretics|mesh-ancestor
65567796|NCT05598086|Tranexamic Acid|tranexamic acid|mesh-list
65567797|NCT05598086|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65567798|NCT05598086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65567799|NCT05598086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567800|NCT05598086|Hemostatics|hemostatics|mesh-ancestor
65567801|NCT05598086|Coagulants|coagulants|mesh-ancestor
65567802|NCT00753532|Vitamin E|vitamin e|mesh-list
65365315|NCT00552669|Sirolimus|sirolimus|mesh-list
65567803|NCT00753532|Tocopherols|tocopherols|mesh-list
65567804|NCT00753532|Tocotrienols|tocotrienols|mesh-list
65567805|NCT00753532|Tocovid|tocovid|mesh-list
65567806|NCT00753532|Vitamins|vitamins|mesh-ancestor
65567807|NCT00753532|Micronutrients|micronutrients|mesh-ancestor
65567808|NCT00753532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567809|NCT00753532|Antioxidants|antioxidants|mesh-ancestor
65567810|NCT00753532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567811|NCT00753532|Protective Agents|protective agents|mesh-ancestor
65567812|NCT03632408|Zopiclone|zopiclone|mesh-list
65297004|NCT02702843|Xenon|xenon|mesh-list
65567813|NCT03632408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65567814|NCT03632408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65567815|NCT03632408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567816|NCT01307839|Lidocaine|lidocaine|mesh-list
65567817|NCT01307839|Anesthetics, Local|anesthetics, local|mesh-ancestor
65567818|NCT01307839|Anesthetics|anesthetics|mesh-ancestor
65567819|NCT01307839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65567820|NCT01307839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567821|NCT01307839|Sensory System Agents|sensory system agents|mesh-ancestor
65567822|NCT01307839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567823|NCT01307839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65567824|NCT01307839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65567825|NCT01307839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65567826|NCT01307839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65567827|NCT01307839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567828|NCT03777085|Rituximab|rituximab|mesh-list
65567829|NCT03777085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65567830|NCT03777085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567831|NCT03777085|Immunologic Factors|immunologic factors|mesh-ancestor
65567832|NCT03777085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567833|NCT03777085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65567834|NCT01328548|Vaccines|vaccines|mesh-list
65567835|NCT01328548|Immunologic Factors|immunologic factors|mesh-ancestor
65567836|NCT01328548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567837|NCT04453306|Topiramate|topiramate|mesh-list
65567838|NCT04453306|Anticonvulsants|anticonvulsants|mesh-ancestor
65567839|NCT04453306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65567840|NCT04453306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567841|NCT03777163|Vaccines|vaccines|mesh-list
65567842|NCT03777163|Immunologic Factors|immunologic factors|mesh-ancestor
65567843|NCT03777163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567844|NCT03786289|Epoetin Alfa|epoetin alfa|mesh-list
65567845|NCT03786289|Hematinics|hematinics|mesh-ancestor
65567846|NCT05597540|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65567847|NCT05597540|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65567848|NCT05597540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65567849|NCT05597540|Antitubercular Agents|antitubercular agents|mesh-ancestor
65567850|NCT03776851|Epoetin Alfa|epoetin alfa|mesh-list
65567851|NCT03776851|Hematinics|hematinics|mesh-ancestor
65567852|NCT03337308|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
65567853|NCT03337308|Ezetimibe|ezetimibe|mesh-list
65567854|NCT03337308|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65567855|NCT03337308|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65567856|NCT03337308|Antimetabolites|antimetabolites|mesh-ancestor
65567857|NCT03337308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567858|NCT03337308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65567859|NCT03337308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567860|NCT03337308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65567861|NCT03337308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567862|NCT03631862|Apatinib|apatinib|mesh-list
65567863|NCT03631862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567864|NCT03631862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65567865|NCT03631862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567866|NCT03631862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567867|NCT02761070|Bevacizumab|bevacizumab|mesh-list
65567868|NCT02761070|Temozolomide|temozolomide|mesh-list
65567869|NCT02761070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65567870|NCT02761070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567871|NCT02761070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65567872|NCT02761070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65567873|NCT02761070|Growth Substances|growth substances|mesh-ancestor
65567874|NCT02761070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567875|NCT02761070|Growth Inhibitors|growth inhibitors|mesh-ancestor
65567876|NCT02761070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65567877|NCT02761070|Alkylating Agents|alkylating agents|mesh-ancestor
65567878|NCT02761070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567879|NCT03468010|Paclitaxel|paclitaxel|mesh-list
65567880|NCT03468010|Cisplatin|cisplatin|mesh-list
65567881|NCT03468010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65567882|NCT03468010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567883|NCT03468010|Tubulin Modulators|tubulin modulators|mesh-ancestor
65567884|NCT03468010|Antimitotic Agents|antimitotic agents|mesh-ancestor
65567885|NCT03468010|Mitosis Modulators|mitosis modulators|mesh-ancestor
65297034|NCT00615875|Naproxen|naproxen|mesh-list
65567886|NCT03468010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567887|NCT03780673|Rifaximin|rifaximin|mesh-list
65567888|NCT03780673|Simvastatin|simvastatin|mesh-list
65567889|NCT03780673|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65567890|NCT03780673|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65567891|NCT03780673|Antimetabolites|antimetabolites|mesh-ancestor
65567892|NCT03780673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567893|NCT03780673|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65567894|NCT03780673|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65567895|NCT03780673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567896|NCT03780673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65567897|NCT03780673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65567898|NCT03780673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65567899|NCT03337152|Chloroquine|chloroquine|mesh-list
65567900|NCT03337152|Primaquine|primaquine|mesh-list
65567901|NCT03337152|Amebicides|amebicides|mesh-ancestor
65567902|NCT03337152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65567903|NCT03337152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65567904|NCT03337152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65567905|NCT03337152|Antimalarials|antimalarials|mesh-ancestor
65567906|NCT03337152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65567907|NCT03467620|Cannabidiol|cannabidiol|mesh-list
65567908|NCT03467620|Anticonvulsants|anticonvulsants|mesh-ancestor
65567909|NCT03780205|Methamphetamine|methamphetamine|mesh-list
65567910|NCT03780205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65567911|NCT03780205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567912|NCT03780205|Sympathomimetics|sympathomimetics|mesh-ancestor
65567913|NCT03780205|Autonomic Agents|autonomic agents|mesh-ancestor
65567914|NCT03780205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65567915|NCT03780205|Dopamine Agents|dopamine agents|mesh-ancestor
65567916|NCT03780205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65567917|NCT03780205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567918|NCT03780205|Adrenergic Agents|adrenergic agents|mesh-ancestor
65567919|NCT03780205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65567920|NCT03780205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65567921|NCT03780205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65567922|NCT03780205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65567923|NCT04751500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65567924|NCT04751500|Metronidazole|metronidazole|mesh-list
65567925|NCT04751500|Clindamycin|clindamycin|mesh-list
65567926|NCT04751500|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65567927|NCT04751500|Misoprostol|misoprostol|mesh-list
65567928|NCT04751500|Mifepristone|mifepristone|mesh-list
65567929|NCT04751500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65567930|NCT04751500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65567931|NCT04751500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65567932|NCT04751500|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65567933|NCT04751500|Abortifacient Agents|abortifacient agents|mesh-ancestor
65567934|NCT04751500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65567935|NCT04751500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567936|NCT04751500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65567937|NCT04751500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65567938|NCT04751500|Oxytocics|oxytocics|mesh-ancestor
65567939|NCT04751500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65567940|NCT04751500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567941|NCT04751500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567942|NCT04751500|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65567943|NCT04751500|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65567944|NCT04751500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65567945|NCT04751500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65567946|NCT04751500|Contraceptive Agents|contraceptive agents|mesh-ancestor
65567947|NCT04751500|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65567948|NCT04751500|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65567949|NCT04751500|Hormone Antagonists|hormone antagonists|mesh-ancestor
65567950|NCT04751500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65567951|NCT04751500|Luteolytic Agents|luteolytic agents|mesh-ancestor
65567952|NCT04751500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65567953|NCT04751500|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65567954|NCT04751500|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65567955|NCT04305249|Nivolumab|nivolumab|mesh-list
65567956|NCT04305249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65567957|NCT04305249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567958|NCT04305249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65297095|NCT00666692|Bevacizumab|bevacizumab|mesh-list
65567959|NCT04305249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567960|NCT03710161|Vitamin D|vitamin d|mesh-list
65567961|NCT03710161|Vitamins|vitamins|mesh-ancestor
65567962|NCT03710161|Micronutrients|micronutrients|mesh-ancestor
65567963|NCT03710161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567964|NCT03710161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65567965|NCT02719574|Cytarabine|cytarabine|mesh-list
65567966|NCT02719574|Azacitidine|azacitidine|mesh-list
65567967|NCT02719574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65567968|NCT02719574|Antimetabolites|antimetabolites|mesh-ancestor
65567969|NCT02719574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567970|NCT02719574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567971|NCT02719574|Antiviral Agents|antiviral agents|mesh-ancestor
65567972|NCT02719574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65567973|NCT02719574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65567974|NCT02719574|Immunologic Factors|immunologic factors|mesh-ancestor
65567975|NCT02719574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567976|NCT02719574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567977|NCT04947501|Cyclophosphamide|cyclophosphamide|mesh-list
65567978|NCT04947501|Ifosfamide|ifosfamide|mesh-list
65567979|NCT04947501|Carboplatin|carboplatin|mesh-list
65567980|NCT04947501|Doxorubicin|doxorubicin|mesh-list
65567981|NCT04947501|Etoposide|etoposide|mesh-list
65567982|NCT04947501|Vincristine|vincristine|mesh-list
65567983|NCT04947501|Topotecan|topotecan|mesh-list
65567984|NCT04947501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65567985|NCT04947501|Immunologic Factors|immunologic factors|mesh-ancestor
65567986|NCT04947501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65567987|NCT04947501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65567988|NCT04947501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65567989|NCT04947501|Alkylating Agents|alkylating agents|mesh-ancestor
65567990|NCT04947501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65567991|NCT04947501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567992|NCT04947501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65567993|NCT04947501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65567994|NCT04947501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65567995|NCT04947501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65567996|NCT04947501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65567997|NCT04947501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65567998|NCT04947501|Tubulin Modulators|tubulin modulators|mesh-ancestor
65567999|NCT04947501|Antimitotic Agents|antimitotic agents|mesh-ancestor
65568000|NCT04947501|Mitosis Modulators|mitosis modulators|mesh-ancestor
65568001|NCT04947501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65568002|NCT03707808|Nivolumab|nivolumab|mesh-list
65568003|NCT03707808|Ipilimumab|ipilimumab|mesh-list
65568004|NCT03707808|Avelumab|avelumab|mesh-list
65568005|NCT03707808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65568006|NCT03707808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568007|NCT03707808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65568008|NCT03707808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568009|NCT03091400|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65568010|NCT03091400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65568011|NCT03091400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65568012|NCT03091400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65568013|NCT03091400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568014|NCT03091400|Adrenergic Agents|adrenergic agents|mesh-ancestor
65568015|NCT03091400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65568016|NCT03091400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568017|NCT05638620|Bupivacaine|bupivacaine|mesh-list
65568018|NCT05638620|Anesthetics, Local|anesthetics, local|mesh-ancestor
65568019|NCT05638620|Anesthetics|anesthetics|mesh-ancestor
65568020|NCT05638620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65568021|NCT05638620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568022|NCT05638620|Sensory System Agents|sensory system agents|mesh-ancestor
65568023|NCT05638620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65568024|NCT04673422|Montelukast|montelukast|mesh-list
65568025|NCT04673422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65365534|NCT00570908|Antimetabolites|antimetabolites|mesh-ancestor
65568026|NCT04673422|Respiratory System Agents|respiratory system agents|mesh-ancestor
65568027|NCT04673422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65568028|NCT04673422|Hormone Antagonists|hormone antagonists|mesh-ancestor
65568029|NCT04673422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65568030|NCT04673422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297180|NCT02701673|Pyridoxine|pyridoxine|mesh-list
65568031|NCT04673422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65568032|NCT04673422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65568033|NCT04673422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568034|NCT03090152|Bupivacaine|bupivacaine|mesh-list
65568035|NCT03090152|Anesthetics, Local|anesthetics, local|mesh-ancestor
65568036|NCT03090152|Anesthetics|anesthetics|mesh-ancestor
65568037|NCT03090152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65568038|NCT03090152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568039|NCT03090152|Sensory System Agents|sensory system agents|mesh-ancestor
65568040|NCT03090152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65568041|NCT03466528|Thiamine|thiamine|mesh-list
65568042|NCT03466528|Vitamin B Complex|vitamin b complex|mesh-list
65568043|NCT03466528|Magnesium Sulfate|magnesium sulfate|mesh-list
65568044|NCT03466528|Vitamins|vitamins|mesh-ancestor
65568045|NCT03466528|Micronutrients|micronutrients|mesh-ancestor
65568046|NCT03466528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568047|NCT03466528|Analgesics|analgesics|mesh-ancestor
65568048|NCT03466528|Sensory System Agents|sensory system agents|mesh-ancestor
65568049|NCT03466528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65568050|NCT03466528|Anesthetics|anesthetics|mesh-ancestor
65568051|NCT03466528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65568052|NCT03466528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65568053|NCT03466528|Anticonvulsants|anticonvulsants|mesh-ancestor
65568054|NCT03466528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65568055|NCT03466528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65568056|NCT03466528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568057|NCT03466528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65568058|NCT03466528|Tocolytic Agents|tocolytic agents|mesh-ancestor
65568059|NCT03466528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65568060|NCT05090280|Nafamostat|nafamostat|mesh-list
65568061|NCT05090280|Naltrexone|naltrexone|mesh-list
65568062|NCT05090280|Oxycodone|oxycodone|mesh-list
65568063|NCT05090280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65568064|NCT05090280|Narcotics|narcotics|mesh-ancestor
65568065|NCT05090280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65568066|NCT05090280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568067|NCT05090280|Analgesics|analgesics|mesh-ancestor
65568068|NCT05090280|Sensory System Agents|sensory system agents|mesh-ancestor
65568069|NCT05090280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65568070|NCT05090280|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65568071|NCT05090280|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65568072|NCT05090280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65568073|NCT05090280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65568074|NCT05090280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65568075|NCT05090280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65568076|NCT05090280|Anticoagulants|anticoagulants|mesh-ancestor
65568077|NCT05090280|Protease Inhibitors|protease inhibitors|mesh-ancestor
65568078|NCT05090280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65568079|NCT05090280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568080|NCT05090280|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65568081|NCT05090280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65568082|NCT05090280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65568083|NCT05090280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65568084|NCT05090280|Immunologic Factors|immunologic factors|mesh-ancestor
65568085|NCT03466216|Octreotide|octreotide|mesh-list
65568086|NCT03466216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65568087|NCT03466216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65568088|NCT03466216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568089|NCT03098654|Metformin|metformin|mesh-list
65568090|NCT03098654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65568091|NCT03098654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568092|NCT05175066|Bisoprolol|bisoprolol|mesh-list
65568093|NCT05175066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65568094|NCT05175066|Sympatholytics|sympatholytics|mesh-ancestor
65568095|NCT05175066|Autonomic Agents|autonomic agents|mesh-ancestor
65568096|NCT05175066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65568097|NCT05175066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568098|NCT05175066|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65568099|NCT05175066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65568100|NCT05175066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65568101|NCT05175066|Adrenergic Agents|adrenergic agents|mesh-ancestor
65568102|NCT05175066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65365608|NCT02556866|Prednisone|prednisone|mesh-list
65568103|NCT05175066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297291|NCT00662714|Insulin|insulin|mesh-list
65568104|NCT03130114|Azithromycin|azithromycin|mesh-list
65568105|NCT03130114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65568106|NCT03130114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65568107|NCT05294341|Norethindrone|norethindrone|mesh-list
65568108|NCT05294341|Norethindrone Acetate|norethindrone acetate|mesh-list
65568109|NCT05294341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65568110|NCT05294341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65568111|NCT05294341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65568112|NCT05294341|Contraceptive Agents|contraceptive agents|mesh-ancestor
65568113|NCT05294341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65568114|NCT05294341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568115|NCT05294341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65568116|NCT05294341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65568117|NCT03130270|Apatinib|apatinib|mesh-list
65568118|NCT03130270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568119|NCT03130270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65568120|NCT03130270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65568121|NCT03130270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568122|NCT03780361|Aflibercept|aflibercept|mesh-list
65568123|NCT03780361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65568124|NCT03780361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65568125|NCT03780361|Growth Substances|growth substances|mesh-ancestor
65568126|NCT03780361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568127|NCT03780361|Growth Inhibitors|growth inhibitors|mesh-ancestor
65568128|NCT03780361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568129|NCT05183646|Proxigermanium|proxigermanium|mesh-list
65568130|NCT05183646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568131|NCT05183646|Interferon Inducers|interferon inducers|mesh-ancestor
65568132|NCT05183646|Immunologic Factors|immunologic factors|mesh-ancestor
65568133|NCT05183646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568134|NCT04943445|Paclitaxel|paclitaxel|mesh-list
65568135|NCT04943445|Carboplatin|carboplatin|mesh-list
65568136|NCT04943445|Pembrolizumab|pembrolizumab|mesh-list
65568137|NCT04943445|Immunologic Factors|immunologic factors|mesh-list
65568138|NCT04943445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65568139|NCT04943445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568140|NCT04943445|Tubulin Modulators|tubulin modulators|mesh-ancestor
65568141|NCT04943445|Antimitotic Agents|antimitotic agents|mesh-ancestor
65568142|NCT04943445|Mitosis Modulators|mitosis modulators|mesh-ancestor
65568143|NCT04943445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568144|NCT04943445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65568145|NCT04943445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568146|NCT02522572|Plerixafor|plerixafor|mesh-list
65568147|NCT02522572|Bortezomib|bortezomib|mesh-list
65568148|NCT02522572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568149|NCT02522572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65568150|NCT02522572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65568151|NCT02522572|Antiviral Agents|antiviral agents|mesh-ancestor
65568152|NCT02522572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65568153|NCT04602507|Ivermectin|ivermectin|mesh-list
65568154|NCT04602507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65568155|NCT04602507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65568156|NCT04657666|Nabiximols|nabiximols|mesh-list
65568157|NCT04657666|Analgesics|analgesics|mesh-ancestor
65568158|NCT04657666|Sensory System Agents|sensory system agents|mesh-ancestor
65568159|NCT04657666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65568160|NCT04657666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568161|NCT04645966|Acetaminophen|acetaminophen|mesh-list
65568162|NCT04645966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65568163|NCT04645966|Analgesics|analgesics|mesh-ancestor
65568164|NCT04645966|Sensory System Agents|sensory system agents|mesh-ancestor
65568165|NCT04645966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65568166|NCT04645966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568167|NCT04645966|Antipyretics|antipyretics|mesh-ancestor
65568168|NCT03773809|Vitamin D|vitamin d|mesh-list
65568169|NCT03773809|Ergocalciferols|ergocalciferols|mesh-list
65568170|NCT03773809|Cholecalciferol|cholecalciferol|mesh-list
65568171|NCT03773809|Vitamins|vitamins|mesh-list
65568172|NCT03773809|Micronutrients|micronutrients|mesh-ancestor
65568173|NCT03773809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568174|NCT03773809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65568175|NCT03773809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65568176|NCT01313611|Rituximab|rituximab|mesh-list
65568177|NCT01313611|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65568178|NCT01313611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65568179|NCT01313611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297321|NCT00668096|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65568180|NCT01313611|Immunologic Factors|immunologic factors|mesh-ancestor
65568181|NCT01313611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568182|NCT01313611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65568183|NCT01313611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65568184|NCT01313611|Alkylating Agents|alkylating agents|mesh-ancestor
65568185|NCT01313611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568186|NCT04998786|Dexamethasone|dexamethasone|mesh-list
65568187|NCT04998786|Ixazomib|ixazomib|mesh-list
65568188|NCT04998786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65568189|NCT04998786|Antiemetics|antiemetics|mesh-ancestor
65568190|NCT04998786|Autonomic Agents|autonomic agents|mesh-ancestor
65568191|NCT04998786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65568192|NCT04998786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568193|NCT04998786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65568194|NCT04998786|Glucocorticoids|glucocorticoids|mesh-ancestor
65568195|NCT04998786|Hormones|hormones|mesh-ancestor
65568196|NCT04998786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65568197|NCT04998786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65568198|NCT04998786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568199|NCT04998786|Protease Inhibitors|protease inhibitors|mesh-ancestor
65568200|NCT04998786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65568201|NCT04998786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568202|NCT03776383|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65568203|NCT03776383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65568204|NCT04534582|Denosumab|denosumab|mesh-list
65568205|NCT04534582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65568206|NCT04534582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568207|NCT03780049|Leucovorin|leucovorin|mesh-list
65568208|NCT03780049|Fluorouracil|fluorouracil|mesh-list
65568209|NCT03780049|Oxaliplatin|oxaliplatin|mesh-list
65568210|NCT03780049|Antimetabolites|antimetabolites|mesh-ancestor
65568211|NCT03780049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568212|NCT03780049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65568213|NCT03780049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568214|NCT03780049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65568215|NCT03780049|Immunologic Factors|immunologic factors|mesh-ancestor
65568216|NCT03780049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568217|NCT03780049|Antidotes|antidotes|mesh-ancestor
65568218|NCT03780049|Protective Agents|protective agents|mesh-ancestor
65568219|NCT03780049|Vitamin B Complex|vitamin b complex|mesh-ancestor
65568220|NCT03780049|Vitamins|vitamins|mesh-ancestor
65568221|NCT03780049|Micronutrients|micronutrients|mesh-ancestor
65568222|NCT04252287|Canagliflozin|canagliflozin|mesh-list
65568223|NCT04252287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65568224|NCT04252287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568225|NCT04252287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65568226|NCT04252287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568227|NCT05681754|Calcium, Dietary|calcium, dietary|mesh-list
65568228|NCT05681754|Calcium|calcium|mesh-list
65568229|NCT05681754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65568230|NCT05681754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568231|NCT05681754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65568232|NCT03465202|Capecitabine|capecitabine|mesh-list
65568233|NCT03465202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65568234|NCT03465202|Antimetabolites|antimetabolites|mesh-ancestor
65568235|NCT03465202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568236|NCT03465202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568237|NCT04195958|Omalizumab|omalizumab|mesh-list
65568238|NCT04195958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65568239|NCT04195958|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65568240|NCT04195958|Respiratory System Agents|respiratory system agents|mesh-ancestor
65568241|NCT05540262|Edaravone|edaravone|mesh-list
65568242|NCT05540262|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65568243|NCT05540262|Antioxidants|antioxidants|mesh-ancestor
65568244|NCT05540262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568245|NCT05540262|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65568246|NCT05540262|Protective Agents|protective agents|mesh-ancestor
65568247|NCT05540262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568248|NCT04245423|Analgesics, Opioid|analgesics, opioid|mesh-list
65568249|NCT04245423|Narcotics|narcotics|mesh-ancestor
65568250|NCT04245423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65568251|NCT04245423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568252|NCT04245423|Analgesics|analgesics|mesh-ancestor
65568253|NCT04245423|Sensory System Agents|sensory system agents|mesh-ancestor
65568254|NCT04245423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65568255|NCT02735200|Vitamin D|vitamin d|mesh-list
65568256|NCT02735200|Ergocalciferols|ergocalciferols|mesh-list
65568257|NCT02735200|Cholecalciferol|cholecalciferol|mesh-list
65568258|NCT02735200|Vitamins|vitamins|mesh-list
65568259|NCT02735200|Micronutrients|micronutrients|mesh-ancestor
65568260|NCT02735200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568261|NCT02735200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65568262|NCT02735200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65568263|NCT01312311|Docetaxel|docetaxel|mesh-list
65568264|NCT01312311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568265|NCT01312311|Tubulin Modulators|tubulin modulators|mesh-ancestor
65568266|NCT01312311|Antimitotic Agents|antimitotic agents|mesh-ancestor
65568267|NCT01312311|Mitosis Modulators|mitosis modulators|mesh-ancestor
65568268|NCT01312311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568269|NCT03464968|Leucovorin|leucovorin|mesh-list
65568270|NCT03464968|Oxaliplatin|oxaliplatin|mesh-list
65568271|NCT03464968|Irinotecan|irinotecan|mesh-list
65568272|NCT03464968|Fluorouracil|fluorouracil|mesh-list
65568273|NCT03464968|Levoleucovorin|levoleucovorin|mesh-list
65568274|NCT03464968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568275|NCT03464968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65568276|NCT03464968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65568277|NCT03464968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65568278|NCT03464968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568279|NCT03464968|Antidotes|antidotes|mesh-ancestor
65568280|NCT03464968|Protective Agents|protective agents|mesh-ancestor
65568281|NCT03464968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568282|NCT03464968|Vitamin B Complex|vitamin b complex|mesh-ancestor
65568283|NCT03464968|Vitamins|vitamins|mesh-ancestor
65568284|NCT03464968|Micronutrients|micronutrients|mesh-ancestor
65568285|NCT03464968|Antimetabolites|antimetabolites|mesh-ancestor
65568286|NCT03464968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65568287|NCT03464968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65568288|NCT03464968|Immunologic Factors|immunologic factors|mesh-ancestor
65568289|NCT05073744|Morphine|morphine|mesh-list
65568290|NCT05073744|Nalbuphine|nalbuphine|mesh-list
65568291|NCT05073744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65568292|NCT05073744|Narcotics|narcotics|mesh-ancestor
65568293|NCT05073744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65568294|NCT05073744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568295|NCT05073744|Analgesics|analgesics|mesh-ancestor
65568296|NCT05073744|Sensory System Agents|sensory system agents|mesh-ancestor
65568297|NCT05073744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65568298|NCT05681598|Hydroxyurea|hydroxyurea|mesh-list
65568299|NCT05681598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568300|NCT05681598|Antisickling Agents|antisickling agents|mesh-ancestor
65568301|NCT05681598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65568302|NCT05681598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568303|NCT05681598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65568304|NCT01312350|Docetaxel|docetaxel|mesh-list
65568305|NCT01312350|Fluorouracil|fluorouracil|mesh-list
65568306|NCT01312350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568307|NCT01312350|Tubulin Modulators|tubulin modulators|mesh-ancestor
65568308|NCT01312350|Antimitotic Agents|antimitotic agents|mesh-ancestor
65568309|NCT01312350|Mitosis Modulators|mitosis modulators|mesh-ancestor
65568310|NCT01312350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568311|NCT01312350|Antimetabolites|antimetabolites|mesh-ancestor
65568312|NCT01312350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65568313|NCT01312350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65568314|NCT01312350|Immunologic Factors|immunologic factors|mesh-ancestor
65568315|NCT01312350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568316|NCT03464656|Antioxidants|antioxidants|mesh-list
65568317|NCT03464656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568318|NCT03464656|Protective Agents|protective agents|mesh-ancestor
65568319|NCT03464656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568320|NCT04343248|Nitazoxanide|nitazoxanide|mesh-list
65568321|NCT04343248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65568322|NCT04343248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65568323|NCT03705858|Lintuzumab|lintuzumab|mesh-list
65568324|NCT03705858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65568325|NCT03705858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568326|NCT05156658|Etonogestrel|etonogestrel|mesh-list
65568327|NCT05156658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65568328|NCT05156658|Contraceptive Agents|contraceptive agents|mesh-ancestor
65365834|NCT00812370|Anticoagulants|anticoagulants|mesh-ancestor
65568329|NCT05156658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65568330|NCT05156658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568331|NCT05156658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65568332|NCT03463642|Vitamin D|vitamin d|mesh-list
65568333|NCT03463642|Cholecalciferol|cholecalciferol|mesh-list
65568334|NCT03463642|Mineral Oil|mineral oil|mesh-list
65568335|NCT03463642|Vitamins|vitamins|mesh-ancestor
65568336|NCT03463642|Micronutrients|micronutrients|mesh-ancestor
65568337|NCT03463642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568338|NCT03463642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65568339|NCT03463642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65568340|NCT03463642|Emollients|emollients|mesh-ancestor
65568341|NCT03463642|Dermatologic Agents|dermatologic agents|mesh-ancestor
65568342|NCT03463564|Insulin|insulin|mesh-list
65568343|NCT03463564|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65568344|NCT03463564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65568345|NCT03463564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568346|NCT05092386|Vaccines|vaccines|mesh-list
65568347|NCT05092386|Immunologic Factors|immunologic factors|mesh-ancestor
65568348|NCT05092386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568349|NCT03463252|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65568350|NCT03463252|Medroxyprogesterone|medroxyprogesterone|mesh-list
65568351|NCT03463252|Progesterone|progesterone|mesh-list
65568352|NCT03463252|Progestins|progestins|mesh-ancestor
65568353|NCT03463252|Hormones|hormones|mesh-ancestor
65568354|NCT03463252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65568355|NCT03463252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568356|NCT03463252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65568357|NCT03463252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65568358|NCT03463252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65568359|NCT03463252|Contraceptive Agents|contraceptive agents|mesh-ancestor
65568360|NCT03463252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65568361|NCT03463252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65568362|NCT03463252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65568363|NCT03463252|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65568364|NCT03463252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65568365|NCT03463252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568366|NCT05309538|Betahistine|betahistine|mesh-list
65568367|NCT05309538|Vasodilator Agents|vasodilator agents|mesh-ancestor
65568368|NCT05309538|Histamine Agonists|histamine agonists|mesh-ancestor
65568369|NCT05309538|Histamine Agents|histamine agents|mesh-ancestor
65568370|NCT05309538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65568371|NCT05309538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568372|NCT05309538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568373|NCT03462940|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
65568374|NCT03462940|Antiviral Agents|antiviral agents|mesh-ancestor
65568375|NCT03462940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65568376|NCT03462940|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65568377|NCT03462940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65568378|NCT03011450|Fenofibrate|fenofibrate|mesh-list
65568379|NCT03011450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65568380|NCT03011450|Antimetabolites|antimetabolites|mesh-ancestor
65568381|NCT03011450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568382|NCT03011450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65568383|NCT03638856|Misoprostol|misoprostol|mesh-list
65568384|NCT03638856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65568385|NCT03638856|Abortifacient Agents|abortifacient agents|mesh-ancestor
65568386|NCT03638856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65568387|NCT03638856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568388|NCT03638856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65568389|NCT03638856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65568390|NCT03638856|Oxytocics|oxytocics|mesh-ancestor
65568391|NCT03705780|Fentanyl|fentanyl|mesh-list
65568392|NCT03705780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65568393|NCT03705780|Narcotics|narcotics|mesh-ancestor
65568394|NCT03705780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65568395|NCT03705780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568396|NCT03705780|Analgesics|analgesics|mesh-ancestor
65568397|NCT03705780|Sensory System Agents|sensory system agents|mesh-ancestor
65568398|NCT03705780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65568399|NCT03705780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65568400|NCT03705780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65568401|NCT03705780|Anesthetics, General|anesthetics, general|mesh-ancestor
65568402|NCT03705780|Anesthetics|anesthetics|mesh-ancestor
65568403|NCT04976790|Flurbiprofen|flurbiprofen|mesh-list
65568404|NCT04976790|Analgesics|analgesics|mesh-ancestor
65568405|NCT04976790|Sensory System Agents|sensory system agents|mesh-ancestor
65568406|NCT04976790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65568407|NCT04976790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365914|NCT04100447|Hemostatics|hemostatics|mesh-ancestor
65568408|NCT04976790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65568409|NCT04976790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65568410|NCT04976790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65568411|NCT04976790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65568412|NCT04976790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65568413|NCT04976790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65568414|NCT04976790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568415|NCT03678688|Bedaquiline|bedaquiline|mesh-list
65568416|NCT03678688|Diarylquinolines|diarylquinolines|mesh-list
65568417|NCT03678688|Antitubercular Agents|antitubercular agents|mesh-ancestor
65568418|NCT03678688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65568419|NCT03678688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65568420|NCT04452838|Fesoterodine|fesoterodine|mesh-list
65568421|NCT04452838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65568422|NCT04452838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65568423|NCT04452838|Cholinergic Agents|cholinergic agents|mesh-ancestor
65568424|NCT04452838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65568425|NCT04452838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568426|NCT04452838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568427|NCT04452838|Urological Agents|urological agents|mesh-ancestor
65568428|NCT02967848|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
65568429|NCT02967848|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65568430|NCT02967848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568431|NCT04188860|Paclitaxel|paclitaxel|mesh-list
65568432|NCT04188860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65568433|NCT04188860|Antibodies|antibodies|mesh-list
65568434|NCT04188860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65568435|NCT04188860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568436|NCT04188860|Tubulin Modulators|tubulin modulators|mesh-ancestor
65568437|NCT04188860|Antimitotic Agents|antimitotic agents|mesh-ancestor
65568438|NCT04188860|Mitosis Modulators|mitosis modulators|mesh-ancestor
65568439|NCT04188860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568440|NCT04188860|Immunologic Factors|immunologic factors|mesh-ancestor
65568441|NCT04188860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568442|NCT05425862|Talazoparib|talazoparib|mesh-list
65568443|NCT05425862|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65568444|NCT05425862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65568445|NCT05425862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568446|NCT05425862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568447|NCT01383668|Sirolimus|sirolimus|mesh-list
65568448|NCT01383668|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
65568449|NCT01383668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65568450|NCT01383668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65568451|NCT01383668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65568452|NCT01383668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568453|NCT01383668|Antifungal Agents|antifungal agents|mesh-ancestor
65568454|NCT01383668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65568455|NCT01383668|Immunologic Factors|immunologic factors|mesh-ancestor
65568456|NCT01383668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568457|NCT01383668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65568458|NCT03656068|Nitazoxanide|nitazoxanide|mesh-list
65568459|NCT03656068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65568460|NCT03656068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65568461|NCT01381796|Sumatriptan|sumatriptan|mesh-list
65568462|NCT01381796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65568463|NCT01381796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65568464|NCT01381796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65568465|NCT01381796|Serotonin Agents|serotonin agents|mesh-ancestor
65568466|NCT01381796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65568467|NCT01381796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568468|NCT01381796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568469|NCT04375228|Rituximab|rituximab|mesh-list
65568470|NCT04375228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65568471|NCT04375228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568472|NCT04375228|Immunologic Factors|immunologic factors|mesh-ancestor
65568473|NCT04375228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568474|NCT04375228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65568475|NCT02521714|Lenalidomide|lenalidomide|mesh-list
65568476|NCT02521714|Immunologic Factors|immunologic factors|mesh-ancestor
65568477|NCT02521714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568478|NCT02521714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65568479|NCT02521714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65568480|NCT02521714|Growth Substances|growth substances|mesh-ancestor
65568481|NCT02521714|Growth Inhibitors|growth inhibitors|mesh-ancestor
65568482|NCT02521714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568483|NCT02096588|Cyclophosphamide|cyclophosphamide|mesh-list
65568484|NCT02096588|Doxorubicin|doxorubicin|mesh-list
65568485|NCT02096588|Simvastatin|simvastatin|mesh-list
65568486|NCT02096588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65568487|NCT02096588|Immunologic Factors|immunologic factors|mesh-ancestor
65568488|NCT02096588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568489|NCT02096588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65568490|NCT02096588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65568491|NCT02096588|Alkylating Agents|alkylating agents|mesh-ancestor
65568492|NCT02096588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568493|NCT02096588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568494|NCT02096588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65568495|NCT02096588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65568496|NCT02096588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65568497|NCT02096588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65568498|NCT02096588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65568499|NCT02096588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65568500|NCT02096588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65568501|NCT02096588|Antimetabolites|antimetabolites|mesh-ancestor
65568502|NCT02096588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65568503|NCT02096588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65568504|NCT03768089|Ivacaftor|ivacaftor|mesh-list
65568505|NCT03768089|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65568506|NCT03768089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65568507|NCT03768089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568508|NCT03548584|Brexpiprazole|brexpiprazole|mesh-list
65568509|NCT03548584|Serotonin Agents|serotonin agents|mesh-ancestor
65568510|NCT03548584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65568511|NCT03548584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568512|NCT03548584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568513|NCT03548584|Dopamine Agonists|dopamine agonists|mesh-ancestor
65568514|NCT03548584|Dopamine Agents|dopamine agents|mesh-ancestor
65568515|NCT01381640|Acetaminophen|acetaminophen|mesh-list
65568516|NCT01381640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65568517|NCT01381640|Analgesics|analgesics|mesh-ancestor
65568518|NCT01381640|Sensory System Agents|sensory system agents|mesh-ancestor
65568519|NCT01381640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65568520|NCT01381640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568521|NCT01381640|Antipyretics|antipyretics|mesh-ancestor
65568522|NCT04483973|Ebselen|ebselen|mesh-list
65568523|NCT04483973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65568524|NCT04483973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65568525|NCT04483973|Analgesics|analgesics|mesh-ancestor
65568526|NCT04483973|Sensory System Agents|sensory system agents|mesh-ancestor
65568527|NCT04483973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65568528|NCT04483973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568529|NCT04483973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65568530|NCT04483973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65568531|NCT04483973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65568532|NCT04483973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65568533|NCT04483973|Antioxidants|antioxidants|mesh-ancestor
65568534|NCT04483973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568535|NCT04483973|Protective Agents|protective agents|mesh-ancestor
65568536|NCT04483973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65568537|NCT04483973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65568538|NCT04483973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65568539|NCT04283890|Nivolumab|nivolumab|mesh-list
65568540|NCT04283890|Ipilimumab|ipilimumab|mesh-list
65568541|NCT04283890|Melphalan|melphalan|mesh-list
65568542|NCT04283890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65568543|NCT04283890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568544|NCT04283890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65568545|NCT04283890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568546|NCT04283890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65568547|NCT04283890|Alkylating Agents|alkylating agents|mesh-ancestor
65568548|NCT04283890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65568549|NCT04283890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65568550|NCT04283890|Immunologic Factors|immunologic factors|mesh-ancestor
65568551|NCT04283890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568552|NCT01139723|Bevacizumab|bevacizumab|mesh-list
65568553|NCT01139723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65568554|NCT01139723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568555|NCT01139723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65568556|NCT01139723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65568557|NCT01139723|Growth Substances|growth substances|mesh-ancestor
65568558|NCT01139723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568559|NCT01139723|Growth Inhibitors|growth inhibitors|mesh-ancestor
65568561|NCT05068037|Autonomic Agents|autonomic agents|mesh-ancestor
65568562|NCT05068037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65568563|NCT05068037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568564|NCT05068037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65568565|NCT01136759|Tenofovir|tenofovir|mesh-list
65568566|NCT01136759|Antiviral Agents|antiviral agents|mesh-ancestor
65568567|NCT01136759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65568568|NCT01136759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65568569|NCT01136759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65568570|NCT01136759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65568571|NCT01136759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568572|NCT01136759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65568573|NCT01136759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65568574|NCT03436654|Prednisone|prednisone|mesh-list
65568575|NCT03436654|Abiraterone Acetate|abiraterone acetate|mesh-list
65568576|NCT03436654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65568577|NCT03436654|Glucocorticoids|glucocorticoids|mesh-ancestor
65568578|NCT03436654|Hormones|hormones|mesh-ancestor
65568579|NCT03436654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65568580|NCT03436654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568581|NCT03436654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65568582|NCT03436654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568583|NCT03436654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65568584|NCT03436654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65568585|NCT03436654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568586|NCT03436654|Hormone Antagonists|hormone antagonists|mesh-ancestor
65568587|NCT03436654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65568588|NCT01141439|Fluticasone|fluticasone|mesh-list
65568589|NCT01141439|Xhance|xhance|mesh-list
65568590|NCT01141439|Beclomethasone|beclomethasone|mesh-list
65568591|NCT01141439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65568592|NCT01141439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65568593|NCT01141439|Autonomic Agents|autonomic agents|mesh-ancestor
65568594|NCT01141439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65568595|NCT01141439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568596|NCT01141439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65568597|NCT01141439|Respiratory System Agents|respiratory system agents|mesh-ancestor
65568598|NCT01141439|Dermatologic Agents|dermatologic agents|mesh-ancestor
65568599|NCT01141439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65568600|NCT01141439|Glucocorticoids|glucocorticoids|mesh-ancestor
65568601|NCT01141439|Hormones|hormones|mesh-ancestor
65568602|NCT01141439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65568603|NCT05549531|Itraconazole|itraconazole|mesh-list
65568604|NCT05549531|Antifungal Agents|antifungal agents|mesh-ancestor
65568605|NCT05549531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65568606|NCT05549531|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65568607|NCT05549531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65568608|NCT05549531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65568609|NCT05549531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568610|NCT05549531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65568611|NCT05549531|Hormone Antagonists|hormone antagonists|mesh-ancestor
65568612|NCT05549531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65568613|NCT05549531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568614|NCT05549531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65568615|NCT02953834|Insulin|insulin|mesh-list
65568616|NCT02953834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65568617|NCT02953834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568618|NCT04452370|Etoposide|etoposide|mesh-list
65568619|NCT04452370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65568620|NCT04452370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568621|NCT04452370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65568622|NCT04452370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65568623|NCT04452370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65568624|NCT04452370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568625|NCT03819088|Zinc|zinc|mesh-list
65568626|NCT03819088|Zinc Sulfate|zinc sulfate|mesh-list
65568627|NCT03819088|Trace Elements|trace elements|mesh-ancestor
65568628|NCT03819088|Micronutrients|micronutrients|mesh-ancestor
65568629|NCT03819088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297777|NCT00669890|Busulfan|busulfan|mesh-list
65568630|NCT03819088|Astringents|astringents|mesh-ancestor
65568631|NCT03819088|Dermatologic Agents|dermatologic agents|mesh-ancestor
65568633|NCT01232777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65568634|NCT01232777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568635|NCT01232777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65568636|NCT01232777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65568637|NCT01232777|Growth Substances|growth substances|mesh-ancestor
65568638|NCT01232777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568639|NCT01232777|Growth Inhibitors|growth inhibitors|mesh-ancestor
65568640|NCT03634228|Cytarabine|cytarabine|mesh-list
65568641|NCT03634228|Venetoclax|venetoclax|mesh-list
65568642|NCT03634228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65568643|NCT03634228|Antimetabolites|antimetabolites|mesh-ancestor
65568644|NCT03634228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568645|NCT03634228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568646|NCT03634228|Antiviral Agents|antiviral agents|mesh-ancestor
65568647|NCT03634228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65568648|NCT03634228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65568649|NCT03634228|Immunologic Factors|immunologic factors|mesh-ancestor
65568650|NCT03634228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568651|NCT03248271|Insulin Lispro|insulin lispro|mesh-list
65568652|NCT03248271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65568653|NCT03248271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568654|NCT04213677|Dapagliflozin|dapagliflozin|mesh-list
65568655|NCT04213677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65568656|NCT04213677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568657|NCT04213677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65568658|NCT04213677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568659|NCT03247036|Fibrinolytic Agents|fibrinolytic agents|mesh-list
65568660|NCT03247036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65568661|NCT03247036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568662|NCT03119584|Linaclotide|linaclotide|mesh-list
65568663|NCT03119584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65568664|NCT03119584|Enzyme Activators|enzyme activators|mesh-ancestor
65568665|NCT03119584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568666|NCT03119584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65568667|NCT03129867|Ticagrelor|ticagrelor|mesh-list
65568668|NCT03129867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65568669|NCT03129867|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65568670|NCT03129867|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65568671|NCT03129867|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65568672|NCT03129867|Purinergic Agents|purinergic agents|mesh-ancestor
65568673|NCT03129867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65568674|NCT03129867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568675|NCT03129867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568676|NCT01235273|Hormones|hormones|mesh-list
65568677|NCT01235273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65568678|NCT01235273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568679|NCT01140035|Insulin|insulin|mesh-list
65568680|NCT01140035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65568681|NCT01140035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568682|NCT02525692|TIC10 compound|tic10 compound|mesh-list
65568683|NCT02525692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568684|NCT02168140|Thioctic Acid|thioctic acid|mesh-list
65568685|NCT02168140|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65568686|NCT02168140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65568687|NCT02168140|Alkylating Agents|alkylating agents|mesh-ancestor
65568688|NCT02168140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568689|NCT02168140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568690|NCT02168140|Antioxidants|antioxidants|mesh-ancestor
65568691|NCT02168140|Protective Agents|protective agents|mesh-ancestor
65568692|NCT02168140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568693|NCT02168140|Vitamin B Complex|vitamin b complex|mesh-ancestor
65568694|NCT02168140|Vitamins|vitamins|mesh-ancestor
65568695|NCT02168140|Micronutrients|micronutrients|mesh-ancestor
65568696|NCT00872950|Amifampridine|amifampridine|mesh-list
65568697|NCT00872950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65568698|NCT00872950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65568699|NCT00872950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568700|NCT00872950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65568701|NCT00872950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65568702|NCT00872950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297855|NCT00673088|Ropinirole|ropinirole|mesh-list
65568703|NCT03233217|Vaccines|vaccines|mesh-list
65568704|NCT03233217|Immunologic Factors|immunologic factors|mesh-ancestor
65568705|NCT03233217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568706|NCT01568996|Sulforaphane|sulforaphane|mesh-list
65568707|NCT01568996|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65568708|NCT01568996|Protective Agents|protective agents|mesh-ancestor
65568709|NCT01568996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568710|NCT01568996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568711|NCT02943993|Edoxaban|edoxaban|mesh-list
65568712|NCT02943993|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65568713|NCT02943993|Antithrombins|antithrombins|mesh-ancestor
65568714|NCT02943993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65568715|NCT02943993|Protease Inhibitors|protease inhibitors|mesh-ancestor
65568716|NCT02943993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65568717|NCT02943993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568718|NCT02943993|Anticoagulants|anticoagulants|mesh-ancestor
65568719|NCT02620150|Citalopram|citalopram|mesh-list
65568720|NCT02620150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65568721|NCT02620150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65568722|NCT02620150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65568723|NCT02620150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568724|NCT02620150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65568725|NCT02620150|Serotonin Agents|serotonin agents|mesh-ancestor
65568726|NCT02620150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568727|NCT02620150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65568728|NCT02620150|Antidepressive Agents|antidepressive agents|mesh-ancestor
65568729|NCT02620150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65568730|NCT04098302|Dutasteride|dutasteride|mesh-list
65568731|NCT04098302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65568732|NCT04098302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65568733|NCT04098302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65568734|NCT04098302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568735|NCT04098302|Hormone Antagonists|hormone antagonists|mesh-ancestor
65568736|NCT04098302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65568737|NCT04098302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568738|NCT02596126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65568739|NCT05488613|Midostaurin|midostaurin|mesh-list
65568740|NCT05488613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568741|NCT05488613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65568742|NCT05488613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65568743|NCT05488613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568744|NCT05420168|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65568745|NCT05420168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65568746|NCT01137383|Interferons|interferons|mesh-list
65568747|NCT01137383|Ribavirin|ribavirin|mesh-list
65568748|NCT01137383|Interferon-alpha|interferon-alpha|mesh-list
65568749|NCT01137383|Interferon alpha-2|interferon alpha-2|mesh-list
65568750|NCT01137383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65568751|NCT01137383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568752|NCT01137383|Antiviral Agents|antiviral agents|mesh-ancestor
65568753|NCT01137383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65568754|NCT01137383|Antimetabolites|antimetabolites|mesh-ancestor
65568755|NCT01137383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568756|NCT01137383|Immunologic Factors|immunologic factors|mesh-ancestor
65568757|NCT01137383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568758|NCT03449836|Fluticasone|fluticasone|mesh-list
65568759|NCT03449836|Mometasone Furoate|mometasone furoate|mesh-list
65568760|NCT03449836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65568761|NCT03449836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65568762|NCT03449836|Autonomic Agents|autonomic agents|mesh-ancestor
65568763|NCT03449836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65568764|NCT03449836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568765|NCT03449836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65568766|NCT03449836|Respiratory System Agents|respiratory system agents|mesh-ancestor
65568767|NCT03449836|Dermatologic Agents|dermatologic agents|mesh-ancestor
65568768|NCT03449836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65568770|NCT03449524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65568771|NCT03961256|Exenatide|exenatide|mesh-list
65568772|NCT03961256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65568773|NCT03961256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568774|NCT03961256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65568775|NCT03961256|Incretins|incretins|mesh-ancestor
65568776|NCT03961256|Hormones|hormones|mesh-ancestor
65568777|NCT03961256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65366288|NCT00779792|Triamcinolone|triamcinolone|mesh-list
65568778|NCT03443518|Remifentanil|remifentanil|mesh-list
65568779|NCT03443518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65568780|NCT03443518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568781|NCT03443518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65568782|NCT03443518|Narcotics|narcotics|mesh-ancestor
65568783|NCT03443518|Analgesics|analgesics|mesh-ancestor
65568784|NCT03443518|Sensory System Agents|sensory system agents|mesh-ancestor
65568785|NCT03443518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65568786|NCT01142843|Propolis|propolis|mesh-list
65568787|NCT01142843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65568788|NCT04330625|Volagidemab|volagidemab|mesh-list
65568789|NCT04330625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65568790|NCT04330625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568791|NCT03747497|Linezolid|linezolid|mesh-list
65568792|NCT03747497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65568793|NCT03747497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65568794|NCT03747497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65568795|NCT03747497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65568796|NCT03747497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568797|NCT03109600|Vaccines|vaccines|mesh-list
65568798|NCT03109600|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65568799|NCT03109600|Immunologic Factors|immunologic factors|mesh-ancestor
65568800|NCT03109600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568801|NCT03679013|Acetaminophen|acetaminophen|mesh-list
65568802|NCT03679013|Gabapentin|gabapentin|mesh-list
65568803|NCT03679013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65568804|NCT03679013|Analgesics|analgesics|mesh-ancestor
65568805|NCT03679013|Sensory System Agents|sensory system agents|mesh-ancestor
65568806|NCT03679013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65568807|NCT03679013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568808|NCT03679013|Antipyretics|antipyretics|mesh-ancestor
65568809|NCT03679013|Anticonvulsants|anticonvulsants|mesh-ancestor
65568810|NCT03679013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65568811|NCT03679013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65568812|NCT03679013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65568813|NCT03679013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65568814|NCT03679013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65568815|NCT03679013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65568816|NCT03679013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65568817|NCT03679013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568818|NCT03679013|Antimanic Agents|antimanic agents|mesh-ancestor
65568819|NCT01140425|Moxifloxacin|moxifloxacin|mesh-list
65568820|NCT01140425|PF 232798|pf 232798|mesh-list
65568821|NCT01140425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65568822|NCT01140425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65568823|NCT01140425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65568824|NCT01140425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65568825|NCT01140425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65568826|NCT01140425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568827|NCT01140425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568828|NCT01140425|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65568829|NCT01140425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65568830|NCT01140425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65568831|NCT01140425|Antiviral Agents|antiviral agents|mesh-ancestor
65568832|NCT04884412|Anesthetics|anesthetics|mesh-list
65568833|NCT04884412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65568834|NCT04884412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568835|NCT03991013|Dolutegravir|dolutegravir|mesh-list
65568836|NCT03991013|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65568837|NCT03991013|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65568838|NCT03991013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65568839|NCT03991013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568840|NCT03991013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65568841|NCT03991013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65568842|NCT03991013|Antiviral Agents|antiviral agents|mesh-ancestor
65568843|NCT03991013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65568844|NCT03441412|Metoprolol|metoprolol|mesh-list
65568845|NCT03441412|Epinephrine|epinephrine|mesh-list
65568846|NCT03441412|Ticagrelor|ticagrelor|mesh-list
65568847|NCT03441412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65568848|NCT03441412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65568849|NCT03441412|Adrenergic Agents|adrenergic agents|mesh-ancestor
65568850|NCT03441412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65568851|NCT03441412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568852|NCT03441412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366358|NCT00815022|Anesthetics, General|anesthetics, general|mesh-ancestor
65568853|NCT03441412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65568854|NCT03441412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65568855|NCT03441412|Autonomic Agents|autonomic agents|mesh-ancestor
65568856|NCT03441412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65568857|NCT03441412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65568858|NCT03441412|Respiratory System Agents|respiratory system agents|mesh-ancestor
65568859|NCT03441412|Mydriatics|mydriatics|mesh-ancestor
65568860|NCT03441412|Sympathomimetics|sympathomimetics|mesh-ancestor
65568861|NCT03441412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65568862|NCT03441412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65568863|NCT03441412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65568864|NCT03441412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65568865|NCT03441412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65568866|NCT03441412|Purinergic Agents|purinergic agents|mesh-ancestor
65568867|NCT03441412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65568868|NCT03441412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65568869|NCT03441412|Sympatholytics|sympatholytics|mesh-ancestor
65568870|NCT03441412|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65568871|NCT03441412|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65568872|NCT03441412|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65568873|NCT01235819|Insulin|insulin|mesh-list
65568874|NCT01235819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65568875|NCT01235819|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65568876|NCT01235819|Exenatide|exenatide|mesh-list
65568877|NCT01235819|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65568878|NCT01235819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65568879|NCT01235819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568880|NCT01235819|Incretins|incretins|mesh-ancestor
65568881|NCT01235819|Hormones|hormones|mesh-ancestor
65568882|NCT01235819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65568883|NCT01235819|Protease Inhibitors|protease inhibitors|mesh-ancestor
65568884|NCT01235819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65568885|NCT01235819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568886|NCT01235819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65568887|NCT05275569|Antiemetics|antiemetics|mesh-list
65568888|NCT05275569|Autonomic Agents|autonomic agents|mesh-ancestor
65568889|NCT05275569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65568890|NCT05275569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568891|NCT05275569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65568892|NCT04599933|Pilocarpine|pilocarpine|mesh-list
65568893|NCT04599933|Miotics|miotics|mesh-ancestor
65568894|NCT04599933|Autonomic Agents|autonomic agents|mesh-ancestor
65568895|NCT04599933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65568896|NCT04599933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568897|NCT04599933|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65568898|NCT04599933|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65568899|NCT04599933|Cholinergic Agents|cholinergic agents|mesh-ancestor
65568900|NCT04599933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65568901|NCT04599933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568902|NCT03440788|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65568903|NCT03440788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65568904|NCT03440788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568905|NCT02824575|Paclitaxel|paclitaxel|mesh-list
65568906|NCT02824575|Rebastinib|rebastinib|mesh-list
65568907|NCT02824575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65568908|NCT02824575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568909|NCT02824575|Tubulin Modulators|tubulin modulators|mesh-ancestor
65568910|NCT02824575|Antimitotic Agents|antimitotic agents|mesh-ancestor
65568911|NCT02824575|Mitosis Modulators|mitosis modulators|mesh-ancestor
65568912|NCT02824575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568913|NCT02824575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65568914|NCT02824575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65568915|NCT03780608|Durvalumab|durvalumab|mesh-list
65568916|NCT03780608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65568917|NCT03780608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568918|NCT03631316|Valganciclovir|valganciclovir|mesh-list
65568919|NCT03631316|Antiviral Agents|antiviral agents|mesh-ancestor
65568920|NCT03631316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65568921|NCT03608865|Durvalumab|durvalumab|mesh-list
65568922|NCT03608865|Tremelimumab|tremelimumab|mesh-list
65568923|NCT03608865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65568924|NCT03608865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568925|NCT03532451|Nivolumab|nivolumab|mesh-list
65568926|NCT03532451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65568927|NCT03532451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568928|NCT03532451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65366440|NCT00815256|Riboflavin|riboflavin|mesh-list
65568929|NCT03532451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568931|NCT04704531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65568932|NCT04704531|Immunologic Factors|immunologic factors|mesh-ancestor
65568933|NCT04704531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568934|NCT04704531|Viscosupplements|viscosupplements|mesh-ancestor
65568935|NCT04704531|Protective Agents|protective agents|mesh-ancestor
65568936|NCT02637531|Nivolumab|nivolumab|mesh-list
65568937|NCT02637531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65568938|NCT02637531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568939|NCT02637531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65568940|NCT02637531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568941|NCT01237925|Chlorpheniramine|chlorpheniramine|mesh-list
65568942|NCT01237925|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
65568943|NCT01237925|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65568944|NCT01237925|Histamine Antagonists|histamine antagonists|mesh-ancestor
65568945|NCT01237925|Histamine Agents|histamine agents|mesh-ancestor
65568946|NCT01237925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65568947|NCT01237925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568948|NCT01237925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568949|NCT01237925|Antipruritics|antipruritics|mesh-ancestor
65568950|NCT01237925|Dermatologic Agents|dermatologic agents|mesh-ancestor
65568951|NCT01237925|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65568952|NCT01380548|Iron|iron|mesh-list
65568953|NCT01380548|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65568954|NCT01380548|Trace Elements|trace elements|mesh-ancestor
65568955|NCT01380548|Micronutrients|micronutrients|mesh-ancestor
65568956|NCT01380548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568957|NCT01380548|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65568958|NCT01380548|Dermatologic Agents|dermatologic agents|mesh-ancestor
65568959|NCT01313247|Acetaminophen|acetaminophen|mesh-list
65568960|NCT01313247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65568961|NCT01313247|Analgesics|analgesics|mesh-ancestor
65568962|NCT01313247|Sensory System Agents|sensory system agents|mesh-ancestor
65568963|NCT01313247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65568964|NCT01313247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568965|NCT01313247|Antipyretics|antipyretics|mesh-ancestor
65568966|NCT01142453|Interferons|interferons|mesh-list
65568967|NCT01142453|Interferon-beta|interferon-beta|mesh-list
65568968|NCT01142453|Interferon beta-1a|interferon beta-1a|mesh-list
65568969|NCT01142453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568970|NCT01142453|Antiviral Agents|antiviral agents|mesh-ancestor
65568971|NCT01142453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65568972|NCT01142453|Immunologic Factors|immunologic factors|mesh-ancestor
65568973|NCT01142453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568974|NCT01142453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65568975|NCT04701424|Insulin|insulin|mesh-list
65568976|NCT04701424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65568977|NCT04701424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568978|NCT03560193|Chlorhexidine|chlorhexidine|mesh-list
65568979|NCT03560193|Ethanol|ethanol|mesh-list
65568980|NCT03560193|Povidone-Iodine|povidone-iodine|mesh-list
65568981|NCT03560193|Povidone|povidone|mesh-list
65568982|NCT03560193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65568983|NCT03560193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65568984|NCT03560193|Disinfectants|disinfectants|mesh-ancestor
65568985|NCT03560193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65568986|NCT03560193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568987|NCT03560193|Plasma Substitutes|plasma substitutes|mesh-ancestor
65568988|NCT03560193|Blood Substitutes|blood substitutes|mesh-ancestor
65568989|NCT04451200|Busulfan|busulfan|mesh-list
65568990|NCT04451200|Alkylating Agents|alkylating agents|mesh-ancestor
65568991|NCT04451200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65568992|NCT04451200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65568993|NCT04451200|Immunologic Factors|immunologic factors|mesh-ancestor
65568994|NCT04451200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65568995|NCT04451200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65568996|NCT04451200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65568997|NCT04451200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65568998|NCT04678479|Ganaxolone|ganaxolone|mesh-list
65568999|NCT04678479|Neurosteroids|neurosteroids|mesh-ancestor
65569000|NCT04678479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65569001|NCT04678479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569002|NCT04678479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569003|NCT04678479|GABA Modulators|gaba modulators|mesh-ancestor
65366512|NCT03978559|Antiemetics|antiemetics|mesh-ancestor
65569004|NCT04678479|GABA Agents|gaba agents|mesh-ancestor
65569005|NCT03431831|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
65569006|NCT03431831|Naltrexone|naltrexone|mesh-list
65569007|NCT03431831|Bupropion|bupropion|mesh-list
65569008|NCT03431831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65569009|NCT03431831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65569010|NCT03431831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65569011|NCT03431831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569012|NCT03431831|Sensory System Agents|sensory system agents|mesh-ancestor
65569013|NCT03431831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65569014|NCT03431831|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65569015|NCT03431831|Antidepressive Agents|antidepressive agents|mesh-ancestor
65569016|NCT03431831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65569017|NCT03431831|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65569018|NCT03431831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65569019|NCT03431831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65569020|NCT03431831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569021|NCT03431831|Dopamine Agents|dopamine agents|mesh-ancestor
65569022|NCT03431831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65569023|NCT03431831|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65569024|NCT03431831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65569025|NCT03431831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569026|NCT04668118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65569027|NCT04668118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65569028|NCT03442556|Carboplatin|carboplatin|mesh-list
65569029|NCT03442556|Docetaxel|docetaxel|mesh-list
65569030|NCT03442556|Rucaparib|rucaparib|mesh-list
65569031|NCT03442556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569032|NCT03442556|Tubulin Modulators|tubulin modulators|mesh-ancestor
65569033|NCT03442556|Antimitotic Agents|antimitotic agents|mesh-ancestor
65569034|NCT03442556|Mitosis Modulators|mitosis modulators|mesh-ancestor
65569035|NCT03442556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569036|NCT03442556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65569037|NCT03442556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569038|NCT02251821|Mycophenolic Acid|mycophenolic acid|mesh-list
65569039|NCT02251821|Cyclophosphamide|cyclophosphamide|mesh-list
65569040|NCT02251821|Melphalan|melphalan|mesh-list
65569041|NCT02251821|Busulfan|busulfan|mesh-list
65569042|NCT02251821|Mechlorethamine|mechlorethamine|mesh-list
65569043|NCT02251821|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65569044|NCT02251821|Methotrexate|methotrexate|mesh-list
65569045|NCT02251821|Fludarabine|fludarabine|mesh-list
65569046|NCT02251821|Fludarabine phosphate|fludarabine phosphate|mesh-list
65569047|NCT02251821|Tacrolimus|tacrolimus|mesh-list
65569048|NCT02251821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65569049|NCT02251821|Immunologic Factors|immunologic factors|mesh-ancestor
65569050|NCT02251821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569051|NCT02251821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65569052|NCT02251821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65569053|NCT02251821|Alkylating Agents|alkylating agents|mesh-ancestor
65569054|NCT02251821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569055|NCT02251821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569056|NCT02251821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65569057|NCT02251821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65569058|NCT02251821|Abortifacient Agents|abortifacient agents|mesh-ancestor
65569059|NCT02251821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65569060|NCT02251821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65569061|NCT02251821|Antimetabolites|antimetabolites|mesh-ancestor
65569062|NCT02251821|Dermatologic Agents|dermatologic agents|mesh-ancestor
65569063|NCT02251821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569064|NCT02251821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65569065|NCT02251821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65569066|NCT02251821|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65569067|NCT02251821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65569068|NCT02251821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65569069|NCT02251821|Antitubercular Agents|antitubercular agents|mesh-ancestor
65569070|NCT02251821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65569071|NCT02251821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65569072|NCT03784781|Dimercaprol|dimercaprol|mesh-list
65569073|NCT03784781|Chelating Agents|chelating agents|mesh-ancestor
65569074|NCT03784781|Sequestering Agents|sequestering agents|mesh-ancestor
65569075|NCT03784781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569076|NCT03428477|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
65569077|NCT03428477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65569078|NCT03428477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65569079|NCT03425201|Niraparib|niraparib|mesh-list
65298224|NCT00920998|Z 338|z 338|mesh-list
65569080|NCT03425201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65569081|NCT03425201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569082|NCT03425201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569083|NCT03425201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569084|NCT03438604|Donepezil|donepezil|mesh-list
65569085|NCT03438604|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65569086|NCT03438604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569087|NCT03438604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569088|NCT03438604|Cholinergic Agents|cholinergic agents|mesh-ancestor
65569089|NCT03438604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65569090|NCT03438604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569091|NCT03438604|Nootropic Agents|nootropic agents|mesh-ancestor
65569092|NCT03433378|Tretinoin|tretinoin|mesh-list
65569093|NCT03433378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569094|NCT03433378|Keratolytic Agents|keratolytic agents|mesh-ancestor
65569095|NCT03433378|Dermatologic Agents|dermatologic agents|mesh-ancestor
65569096|NCT03433222|Coal Tar|coal tar|mesh-list
65569097|NCT03433222|Keratolytic Agents|keratolytic agents|mesh-ancestor
65569098|NCT03433222|Dermatologic Agents|dermatologic agents|mesh-ancestor
65569099|NCT05016076|Dexamethasone|dexamethasone|mesh-list
65569100|NCT05016076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65569101|NCT05016076|Antiemetics|antiemetics|mesh-ancestor
65569102|NCT05016076|Autonomic Agents|autonomic agents|mesh-ancestor
65569103|NCT05016076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65569104|NCT05016076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569105|NCT05016076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65569106|NCT05016076|Glucocorticoids|glucocorticoids|mesh-ancestor
65569107|NCT05016076|Hormones|hormones|mesh-ancestor
65569108|NCT05016076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65569109|NCT05016076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65569110|NCT05016076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569111|NCT03319953|Antipsychotic Agents|antipsychotic agents|mesh-list
65569112|NCT03319953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65569113|NCT03319953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65569114|NCT03319953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569115|NCT03319953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65569116|NCT03433144|Tranexamic Acid|tranexamic acid|mesh-list
65569117|NCT03433144|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65569118|NCT03433144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65569119|NCT03433144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569120|NCT03433144|Hemostatics|hemostatics|mesh-ancestor
65569121|NCT03433144|Coagulants|coagulants|mesh-ancestor
65569122|NCT01384214|Botulinum Toxins|botulinum toxins|mesh-list
65569123|NCT01384214|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65569124|NCT01384214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65569125|NCT01384214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65569126|NCT01384214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65569127|NCT01384214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569128|NCT01384214|Cholinergic Agents|cholinergic agents|mesh-ancestor
65569129|NCT01384214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65569130|NCT01384214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569131|NCT01384214|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65569132|NCT01384214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65569133|NCT02927834|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65569134|NCT02927834|Prednisone|prednisone|mesh-list
65569135|NCT02927834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65569136|NCT02927834|Glucocorticoids|glucocorticoids|mesh-ancestor
65569137|NCT02927834|Hormones|hormones|mesh-ancestor
65569138|NCT02927834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65569139|NCT02927834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569140|NCT02927834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65569141|NCT02927834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569142|NCT02927834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65569143|NCT02927834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65569144|NCT02927834|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65569145|NCT02927834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569146|NCT02927834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569147|NCT03170180|Sunitinib|sunitinib|mesh-list
65569148|NCT03170180|Imatinib Mesylate|imatinib mesylate|mesh-list
65569149|NCT03170180|Gefitinib|gefitinib|mesh-list
65569150|NCT03170180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569151|NCT03170180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65366663|NCT00780728|Sildenafil Citrate|sildenafil citrate|mesh-list
65569152|NCT03170180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65569153|NCT03170180|Growth Substances|growth substances|mesh-ancestor
65569154|NCT03170180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569155|NCT03170180|Growth Inhibitors|growth inhibitors|mesh-ancestor
65569156|NCT03170180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65569157|NCT03170180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569158|NCT03170180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569159|NCT03319667|Dexamethasone|dexamethasone|mesh-list
65569160|NCT03319667|Lenalidomide|lenalidomide|mesh-list
65569161|NCT03319667|Bortezomib|bortezomib|mesh-list
65569162|NCT03319667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65569163|NCT03319667|Antiemetics|antiemetics|mesh-ancestor
65569164|NCT03319667|Autonomic Agents|autonomic agents|mesh-ancestor
65569165|NCT03319667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65569166|NCT03319667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569167|NCT03319667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65569168|NCT03319667|Glucocorticoids|glucocorticoids|mesh-ancestor
65569169|NCT03319667|Hormones|hormones|mesh-ancestor
65569170|NCT03319667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65569171|NCT03319667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65569172|NCT03319667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569173|NCT03319667|Immunologic Factors|immunologic factors|mesh-ancestor
65569174|NCT03319667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65569175|NCT03319667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65569176|NCT03319667|Growth Substances|growth substances|mesh-ancestor
65569177|NCT03319667|Growth Inhibitors|growth inhibitors|mesh-ancestor
65569178|NCT03432676|Pembrolizumab|pembrolizumab|mesh-list
65569179|NCT03432676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65569180|NCT03432676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569181|NCT03432598|Gemcitabine|gemcitabine|mesh-list
65569182|NCT03432598|Paclitaxel|paclitaxel|mesh-list
65569183|NCT03432598|Etoposide|etoposide|mesh-list
65569184|NCT03432598|Carboplatin|carboplatin|mesh-list
65569185|NCT03432598|Pemetrexed|pemetrexed|mesh-list
65569186|NCT03432598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65569187|NCT03432598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569188|NCT03432598|Tubulin Modulators|tubulin modulators|mesh-ancestor
65569189|NCT03432598|Antimitotic Agents|antimitotic agents|mesh-ancestor
65569190|NCT03432598|Mitosis Modulators|mitosis modulators|mesh-ancestor
65569191|NCT03432598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569192|NCT03432598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65569193|NCT03432598|Antimetabolites|antimetabolites|mesh-ancestor
65569194|NCT03432598|Antiviral Agents|antiviral agents|mesh-ancestor
65569195|NCT03432598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65569196|NCT03432598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569197|NCT03432598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65569198|NCT03432598|Immunologic Factors|immunologic factors|mesh-ancestor
65569199|NCT03432598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569200|NCT03432598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65569201|NCT03432598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65569202|NCT03432598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65569203|NCT03432598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65569204|NCT03432442|Ivermectin|ivermectin|mesh-list
65569205|NCT03432442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65569206|NCT03432442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65569207|NCT01964547|Nabiximols|nabiximols|mesh-list
65569208|NCT01964547|Analgesics|analgesics|mesh-ancestor
65569209|NCT01964547|Sensory System Agents|sensory system agents|mesh-ancestor
65569210|NCT01964547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65569211|NCT01964547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569212|NCT01380314|Miltefosine|miltefosine|mesh-list
65569213|NCT01380314|Imiquimod|imiquimod|mesh-list
65569214|NCT01380314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65569215|NCT01380314|Immunologic Factors|immunologic factors|mesh-ancestor
65569216|NCT01380314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569217|NCT01380314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569218|NCT01380314|Interferon Inducers|interferon inducers|mesh-ancestor
65569219|NCT01380314|Antifungal Agents|antifungal agents|mesh-ancestor
65569220|NCT01380314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65569221|NCT01380314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65569222|NCT01380314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65569223|NCT03110510|Leucovorin|leucovorin|mesh-list
65569224|NCT03110510|Fluorouracil|fluorouracil|mesh-list
65569225|NCT03110510|Irinotecan|irinotecan|mesh-list
65569226|NCT03110510|Calcium|calcium|mesh-list
65569227|NCT03110510|Levoleucovorin|levoleucovorin|mesh-list
65569228|NCT03110510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65569229|NCT03110510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298375|NCT00677144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569230|NCT03110510|Antimetabolites|antimetabolites|mesh-ancestor
65569231|NCT03110510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569232|NCT03110510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65569233|NCT03110510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569234|NCT03110510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65569235|NCT03110510|Immunologic Factors|immunologic factors|mesh-ancestor
65569236|NCT03110510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65569237|NCT03110510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65569238|NCT03110510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569239|NCT03110510|Antidotes|antidotes|mesh-ancestor
65569240|NCT03110510|Protective Agents|protective agents|mesh-ancestor
65569241|NCT03110510|Vitamin B Complex|vitamin b complex|mesh-ancestor
65569242|NCT03110510|Vitamins|vitamins|mesh-ancestor
65569243|NCT03110510|Micronutrients|micronutrients|mesh-ancestor
65569244|NCT01238237|Cetuximab|cetuximab|mesh-list
65569245|NCT01238237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65569246|NCT01238237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569247|NCT03319719|Lidocaine|lidocaine|mesh-list
65569248|NCT03319719|Hyaluronic Acid|hyaluronic acid|mesh-list
65569249|NCT03319719|Anesthetics, Local|anesthetics, local|mesh-ancestor
65569250|NCT03319719|Anesthetics|anesthetics|mesh-ancestor
65569251|NCT03319719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65569252|NCT03319719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569253|NCT03319719|Sensory System Agents|sensory system agents|mesh-ancestor
65569254|NCT03319719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65569255|NCT03319719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65569256|NCT03319719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65569257|NCT03319719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65569258|NCT03319719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65569259|NCT03319719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569260|NCT03319719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65569261|NCT03319719|Immunologic Factors|immunologic factors|mesh-ancestor
65569262|NCT03319719|Viscosupplements|viscosupplements|mesh-ancestor
65569263|NCT03319719|Protective Agents|protective agents|mesh-ancestor
65569264|NCT03128242|Oxytocin|oxytocin|mesh-list
65569265|NCT03128242|Oxytocics|oxytocics|mesh-ancestor
65569266|NCT03128242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65569267|NCT03128242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569268|NCT01313689|Ofatumumab|ofatumumab|mesh-list
65569269|NCT01313689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569270|NCT04564157|Paclitaxel|paclitaxel|mesh-list
65569271|NCT04564157|Carboplatin|carboplatin|mesh-list
65569272|NCT04564157|Nivolumab|nivolumab|mesh-list
65569273|NCT04564157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65569274|NCT04564157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569275|NCT04564157|Tubulin Modulators|tubulin modulators|mesh-ancestor
65569276|NCT04564157|Antimitotic Agents|antimitotic agents|mesh-ancestor
65569277|NCT04564157|Mitosis Modulators|mitosis modulators|mesh-ancestor
65569278|NCT04564157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569279|NCT04564157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65569280|NCT04564157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65569281|NCT03431272|Lifitegrast|lifitegrast|mesh-list
65569282|NCT03431272|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65569283|NCT03431272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65569284|NCT02528513|Fentanyl|fentanyl|mesh-list
65569285|NCT02528513|Midazolam|midazolam|mesh-list
65569286|NCT02528513|Dexmedetomidine|dexmedetomidine|mesh-list
65569287|NCT02528513|Propofol|propofol|mesh-list
65569288|NCT02528513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65569289|NCT02528513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65569290|NCT02528513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569291|NCT02528513|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65569292|NCT02528513|Anesthetics, General|anesthetics, general|mesh-ancestor
65569293|NCT02528513|Anesthetics|anesthetics|mesh-ancestor
65569294|NCT02528513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65569295|NCT02528513|Analgesics|analgesics|mesh-ancestor
65569296|NCT02528513|Sensory System Agents|sensory system agents|mesh-ancestor
65569297|NCT02528513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65569298|NCT02528513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65569299|NCT02528513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65569300|NCT02528513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65569301|NCT02528513|Adrenergic Agents|adrenergic agents|mesh-ancestor
65569302|NCT02528513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65569303|NCT02528513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569304|NCT02528513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65501337|NCT01178658|Antimetabolites|antimetabolites|mesh-ancestor
65501405|NCT05598580|Growth Inhibitors|growth inhibitors|mesh-ancestor
65501704|NCT01177566|Analgesics|analgesics|mesh-ancestor
65501934|NCT01185444|Viscosupplements|viscosupplements|mesh-ancestor
65502008|NCT01182246|Phytoestrogens|phytoestrogens|mesh-ancestor
65502081|NCT01182636|Adapalene|adapalene|mesh-list
65502159|NCT01291524|Pregabalin|pregabalin|mesh-list
65502304|NCT03849612|Insulin Lispro|insulin lispro|mesh-list
65502837|NCT04731376|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65503065|NCT01200264|Apremilast|apremilast|mesh-list
65503139|NCT01200732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503211|NCT04427904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65503661|NCT01206972|Enoxaparin|enoxaparin|mesh-list
65503672|NCT03817476|BI 425809|bi 425809|mesh-list
65503736|NCT03719586|Antimetabolites|antimetabolites|mesh-ancestor
65503814|NCT03823482|Lidocaine|lidocaine|mesh-list
65503889|NCT01205724|Factor VIII|factor viii|mesh-list
65503961|NCT01298076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504126|NCT03799536|Sotalol|sotalol|mesh-list
65504196|NCT01381354|Riboflavin|riboflavin|mesh-list
65504341|NCT04182360|Carbetocin|carbetocin|mesh-list
65504492|NCT00579826|Letrozole|letrozole|mesh-list
65504791|NCT05320120|Esketamine|esketamine|mesh-list
65505094|NCT03781908|Silver Nitrate|silver nitrate|mesh-list
65505551|NCT03778008|Micronutrients|micronutrients|mesh-ancestor
65505709|NCT02574286|Vitamin D|vitamin d|mesh-list
65505852|NCT03768024|Narcotics|narcotics|mesh-ancestor
65505911|NCT03770208|Anesthetics, Local|anesthetics, local|mesh-ancestor
65506218|NCT04920838|Analgesics|analgesics|mesh-ancestor
65506449|NCT05422612|Fluoxetine|fluoxetine|mesh-list
65506592|NCT04252586|Cannabidiol|cannabidiol|mesh-list
65506754|NCT03779074|Antacids|antacids|mesh-ancestor
65507584|NCT04578106|Pertuzumab|pertuzumab|mesh-list
65507723|NCT04136548|Analgesics|analgesics|mesh-ancestor
65507799|NCT03579160|Emollients|emollients|mesh-ancestor
65507878|NCT04118166|Nivolumab|nivolumab|mesh-list
65508102|NCT03938584|Micronutrients|micronutrients|mesh-ancestor
65508335|NCT03673670|Olodaterol|olodaterol|mesh-list
65508404|NCT03771586|Anesthetics, General|anesthetics, general|mesh-ancestor
65508478|NCT05217160|Analgesics|analgesics|mesh-ancestor
65508644|NCT05641324|Hormones|hormones|mesh-ancestor
65508857|NCT02955602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65509006|NCT02955212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65509168|NCT03629054|Metformin|metformin|mesh-list
65509384|NCT03042910|Talazoparib|talazoparib|mesh-list
65509536|NCT01415674|Afatinib|afatinib|mesh-list
65509678|NCT04985266|Anastrozole|anastrozole|mesh-list
65509829|NCT03731780|Disinfectants|disinfectants|mesh-ancestor
65510053|NCT01086345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65510275|NCT04987372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65510353|NCT05666336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510502|NCT03629184|Baloxavir|baloxavir|mesh-list
65510581|NCT03840616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510655|NCT00086307|Serotonin Agents|serotonin agents|mesh-ancestor
65510877|NCT00541684|Atenolol|atenolol|mesh-list
65512826|NCT03680716|Anesthetics, Local|anesthetics, local|mesh-ancestor
65513139|NCT03025828|Hormones|hormones|mesh-ancestor
65513440|NCT02553460|Mitosis Modulators|mitosis modulators|mesh-ancestor
65513667|NCT03955341|Disinfectants|disinfectants|mesh-ancestor
65513891|NCT03954873|Glucagon|glucagon|mesh-list
65513968|NCT03667066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65514198|NCT03665740|Resveratrol|resveratrol|mesh-list
65515095|NCT00004635|Leprostatic Agents|leprostatic agents|mesh-ancestor
65516224|NCT03941535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65516452|NCT01216371|Growth Substances|growth substances|mesh-ancestor
65516905|NCT01222611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65516981|NCT03648970|Pravastatin|pravastatin|mesh-list
65517126|NCT03648658|Analgesics|analgesics|mesh-ancestor
65517809|NCT03643666|Hormones|hormones|mesh-ancestor
65517880|NCT03921567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65518037|NCT03919383|Lenvatinib|lenvatinib|mesh-list
65518114|NCT03920319|Bupropion|bupropion|mesh-list
65518555|NCT05402865|Denosumab|denosumab|mesh-list
65519154|NCT01336738|Hormones|hormones|mesh-ancestor
65519231|NCT01237275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519462|NCT02446600|Paclitaxel|paclitaxel|mesh-list
65519847|NCT01758328|Melphalan|melphalan|mesh-list
65519915|NCT00358215|Darbepoetin alfa|darbepoetin alfa|mesh-list
65519987|NCT03603418|Protease Inhibitors|protease inhibitors|mesh-ancestor
65520136|NCT03601624|Growth Substances|growth substances|mesh-ancestor
65520211|NCT03592498|Sulfadiazine|sulfadiazine|mesh-list
65520284|NCT03707678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65521061|NCT03342638|Hormones|hormones|mesh-ancestor
65521265|NCT01239849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65521417|NCT03908619|Omeprazole|omeprazole|mesh-list
65521566|NCT03914235|Anesthetics|anesthetics|mesh-ancestor
65522167|NCT01261065|Vasodilator Agents|vasodilator agents|mesh-ancestor
65522252|NCT01259817|Aspirin|aspirin|mesh-list
65522776|NCT01159275|Lopinavir|lopinavir|mesh-list
65523448|NCT03638726|Autonomic Agents|autonomic agents|mesh-ancestor
65523520|NCT00135226|Aspirin|aspirin|mesh-list
65523675|NCT01169805|Ramosetron|ramosetron|mesh-list
65523758|NCT03872661|Bevacizumab|bevacizumab|mesh-list
65523826|NCT01170507|Vitamin D|vitamin d|mesh-list
65523894|NCT03870711|Anesthetics|anesthetics|mesh-ancestor
65524276|NCT03756129|Ketamine|ketamine|mesh-list
65524343|NCT01169415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524723|NCT01287741|Hormones|hormones|mesh-ancestor
65524799|NCT01181193|Vitamin D|vitamin d|mesh-list
65524944|NCT01185405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65525022|NCT01180179|Famotidine|famotidine|mesh-list
65525092|NCT01186887|Celecoxib|celecoxib|mesh-list
65525389|NCT03325556|Pimavanserin|pimavanserin|mesh-list
65525539|NCT03942224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525616|NCT01188759|Hormone Antagonists|hormone antagonists|mesh-ancestor
65525691|NCT01295307|Clofarabine|clofarabine|mesh-list
65526293|NCT05669781|Metoclopramide|metoclopramide|mesh-list
65526669|NCT04427072|Docetaxel|docetaxel|mesh-list
65526815|NCT01205997|Analgesics|analgesics|mesh-ancestor
65527044|NCT05281107|Calcium|calcium|mesh-list
65527200|NCT01303497|Paclitaxel|paclitaxel|mesh-list
65527346|NCT02049970|Analgesics|analgesics|mesh-ancestor
65527423|NCT03718143|Adavosertib|adavosertib|mesh-list
65527498|NCT02048644|Glucocorticoids|glucocorticoids|mesh-ancestor
65527595|NCT02049580|Thiotepa|thiotepa|mesh-list
65527723|NCT04639011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65527799|NCT03323151|Ixazomib|ixazomib|mesh-list
65528251|NCT03712917|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65528550|NCT01560663|Docetaxel|docetaxel|mesh-list
65528626|NCT01316445|Anesthetics|anesthetics|mesh-ancestor
65528796|NCT03777423|Cobalt|cobalt|mesh-list
65528857|NCT03710889|Abaloparatide|abaloparatide|mesh-list
65528929|NCT03776409|Lactams|lactams|mesh-list
65529005|NCT05669001|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65529456|NCT01561911|Antibodies|antibodies|mesh-list
65529605|NCT03764241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529685|NCT04646109|Azithromycin|azithromycin|mesh-list
65529829|NCT05359731|Hormones|hormones|mesh-ancestor
65529902|NCT02066662|Anticoagulants|anticoagulants|mesh-ancestor
65530131|NCT02071966|Purinergic Agents|purinergic agents|mesh-ancestor
65530289|NCT04842045|Anesthetics|anesthetics|mesh-ancestor
65530366|NCT02071342|Everolimus|everolimus|mesh-list
65530589|NCT04940338|Glucocorticoids|glucocorticoids|mesh-ancestor
65530885|NCT04160091|FX006|fx006|mesh-list
65531039|NCT02088502|Acetylcysteine|acetylcysteine|mesh-list
65531116|NCT00187889|Diuretics|diuretics|mesh-ancestor
65531188|NCT02087722|Melatonin|melatonin|mesh-list
65531267|NCT05571332|Cyclosporine|cyclosporine|mesh-list
65531415|NCT02089438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65531489|NCT02094274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65532097|NCT03258710|Tenofovir|tenofovir|mesh-list
65532629|NCT03253796|Golimumab|golimumab|mesh-list
65532913|NCT03552406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65533067|NCT00574496|Prednisone|prednisone|mesh-list
65533143|NCT02127736|Analgesics|analgesics|mesh-ancestor
65533363|NCT02252614|Naproxen|naproxen|mesh-list
65533440|NCT01074905|Artesunate|artesunate|mesh-list
65533521|NCT00130247|Rifampin|rifampin|mesh-list
65533746|NCT00136955|Irinotecan|irinotecan|mesh-list
65533977|NCT00133991|Vitamins|vitamins|mesh-ancestor
65534350|NCT02253862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65534432|NCT03704584|Antiemetics|antiemetics|mesh-ancestor
65534500|NCT04249882|Naltrexone|naltrexone|mesh-list
65534654|NCT04130464|Ketorolac|ketorolac|mesh-list
65534873|NCT02148640|Infliximab|infliximab|mesh-list
65535464|NCT00121199|Prednisone|prednisone|mesh-list
65535866|NCT03229538|Hormones|hormones|mesh-ancestor
65535991|NCT02163070|Antioxidants|antioxidants|mesh-ancestor
65536067|NCT00113399|Immunologic Factors|immunologic factors|mesh-ancestor
65536213|NCT02162134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65536438|NCT03538431|Buspirone|buspirone|mesh-list
65537226|NCT02182570|Epinastine|epinastine|mesh-list
65537348|NCT02183194|Paclitaxel|paclitaxel|mesh-list
65537574|NCT02181478|Antimetabolites|antimetabolites|mesh-ancestor
65537790|NCT02185222|Vitamins|vitamins|mesh-ancestor
65537867|NCT02191072|Omalizumab|omalizumab|mesh-list
65538168|NCT03535558|Renal Agents|renal agents|mesh-ancestor
65538483|NCT02203396|Levamisole|levamisole|mesh-list
65538691|NCT05151484|Teriparatide|teriparatide|mesh-list
65538840|NCT02225470|Vinorelbine|vinorelbine|mesh-list
65539445|NCT01085981|Vasodilator Agents|vasodilator agents|mesh-ancestor
65539755|NCT02233582|Ibuprofen|ibuprofen|mesh-list
65539818|NCT04385290|Cytarabine|cytarabine|mesh-list
65539967|NCT01094249|GABA Agents|gaba agents|mesh-ancestor
65540195|NCT01095575|Morphine|morphine|mesh-list
65540270|NCT00064337|Thalidomide|thalidomide|mesh-list
65540347|NCT00044213|Vitamins|vitamins|mesh-list
65540642|NCT01399684|Oxaliplatin|oxaliplatin|mesh-list
65540865|NCT01318642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65540941|NCT01254136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65541318|NCT02261662|Hormones|hormones|mesh-ancestor
65542285|NCT03524092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65542362|NCT00835588|Pantoprazole|pantoprazole|mesh-list
65542582|NCT00151996|Guanfacine|guanfacine|mesh-list
65542656|NCT00675844|Dexelvucitabine|dexelvucitabine|mesh-list
65542731|NCT03197324|Protective Agents|protective agents|mesh-ancestor
65542886|NCT03564470|Dasatinib|dasatinib|mesh-list
65543113|NCT00003631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65543340|NCT01332422|Sympathomimetics|sympathomimetics|mesh-ancestor
65543421|NCT03035630|Sunitinib|sunitinib|mesh-list
65543573|NCT00765700|Ketoprofen|ketoprofen|mesh-list
65543956|NCT02743780|MGV354|mgv354|mesh-list
65544395|NCT00482092|Remestemcel-l|remestemcel-l|mesh-list
65545211|NCT02603809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65546030|NCT01115179|Anesthetics|anesthetics|mesh-ancestor
65546105|NCT01121809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65546180|NCT01216345|Gemcitabine|gemcitabine|mesh-list
65546328|NCT04902040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65546854|NCT04466176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65547374|NCT03931135|Cyclizine|cyclizine|mesh-list
65547468|NCT03680092|Abatacept|abatacept|mesh-list
65547605|NCT05789043|Apatinib|apatinib|mesh-list
65547676|NCT05788705|Analgesics|analgesics|mesh-ancestor
65547825|NCT05630183|Gemcitabine|gemcitabine|mesh-list
65547907|NCT05538091|Atezolizumab|atezolizumab|mesh-list
65547973|NCT05441930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65548046|NCT05222984|Decitabine|decitabine|mesh-list
65346013|NCT05500170|Niacin|niacin|mesh-list
65549254|NCT01126645|Sorafenib|sorafenib|mesh-list
65549398|NCT03927313|Hormones|hormones|mesh-ancestor
65549627|NCT02294344|Cyclophosphamide|cyclophosphamide|mesh-list
65549861|NCT01131247|Ofatumumab|ofatumumab|mesh-list
65549924|NCT03925285|Bevacizumab|bevacizumab|mesh-list
65549997|NCT01132183|Antimanic Agents|antimanic agents|mesh-ancestor
65550076|NCT02293330|Levobupivacaine|levobupivacaine|mesh-list
65550297|NCT03518320|Gemcitabine|gemcitabine|mesh-list
65550824|NCT03132610|Andrographolide|andrographolide|mesh-list
65551043|NCT01232257|Protective Agents|protective agents|mesh-ancestor
65551287|NCT01133743|Hormones|hormones|mesh-ancestor
65551344|NCT01136941|Zileuton|zileuton|mesh-list
65551873|NCT01238029|Vinorelbine|vinorelbine|mesh-list
65552331|NCT01360190|Fluoxetine|fluoxetine|mesh-list
65552923|NCT01244347|Hematinics|hematinics|mesh-ancestor
65554278|NCT01375400|Aspirin|aspirin|mesh-list
65554362|NCT05388448|Rifampin|rifampin|mesh-list
65554499|NCT04460092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65554953|NCT03493698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65555398|NCT03632876|Vitamins|vitamins|mesh-ancestor
65555490|NCT03574792|Oxycodone|oxycodone|mesh-list
65555627|NCT03131050|Antiemetics|antiemetics|mesh-ancestor
65555777|NCT04927052|Lidocaine|lidocaine|mesh-list
65555850|NCT03894007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65556449|NCT01152931|Retinol palmitate|retinol palmitate|mesh-list
65556526|NCT03432858|Vancomycin|vancomycin|mesh-list
65556599|NCT03430986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65557274|NCT01100177|Sunitinib|sunitinib|mesh-list
65558415|NCT00025259|Hormones|hormones|mesh-ancestor
65558936|NCT04934579|Growth Substances|growth substances|mesh-ancestor
65559011|NCT05625503|Vasodilator Agents|vasodilator agents|mesh-ancestor
65559388|NCT01180075|Ritonavir|ritonavir|mesh-list
65559691|NCT00004031|Hormones|hormones|mesh-ancestor
65559911|NCT01188031|Alprazolam|alprazolam|mesh-list
65559986|NCT00003659|Alkylating Agents|alkylating agents|mesh-ancestor
65560166|NCT03948191|Hormones|hormones|mesh-ancestor
65560356|NCT01186549|Autonomic Agents|autonomic agents|mesh-ancestor
65560433|NCT01291459|Tenofovir|tenofovir|mesh-list
65560506|NCT05154682|Acetaminophen|acetaminophen|mesh-list
65560884|NCT01584791|Aspirin|aspirin|mesh-list
65561184|NCT01109693|Mirtazapine|mirtazapine|mesh-list
65561706|NCT01211561|Micronutrients|micronutrients|mesh-ancestor
65562009|NCT01198249|Losartan|losartan|mesh-list
65562388|NCT05667727|Mydriatics|mydriatics|mesh-ancestor
65562759|NCT02529059|Tenofovir|tenofovir|mesh-list
65562915|NCT05162872|Niraparib|niraparib|mesh-list
65563139|NCT03931343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65563435|NCT01220375|Plerixafor|plerixafor|mesh-list
65563657|NCT01224041|Tacrolimus|tacrolimus|mesh-list
65564188|NCT01129427|Pantoprazole|pantoprazole|mesh-list
65564257|NCT05647447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65564405|NCT05533281|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65564487|NCT03922919|Ceftriaxone|ceftriaxone|mesh-list
65565016|NCT03795571|Glucocorticoids|glucocorticoids|mesh-ancestor
65565393|NCT03128359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65565470|NCT01230983|Leucovorin|leucovorin|mesh-list
65565998|NCT03797443|Vitamins|vitamins|mesh-ancestor
65566079|NCT03791905|Vitamins|vitamins|mesh-ancestor
65566232|NCT05364099|Glucocorticoids|glucocorticoids|mesh-ancestor
65566525|NCT04585295|Antimetabolites|antimetabolites|mesh-ancestor
65566676|NCT05283499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
65566752|NCT01139645|Esomeprazole|esomeprazole|mesh-list
65567131|NCT02989402|Rivastigmine|rivastigmine|mesh-list
65567204|NCT04807972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65567368|NCT05361486|Primaquine|primaquine|mesh-list
65567432|NCT01309633|Antimetabolites|antimetabolites|mesh-ancestor
65567508|NCT04394481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65567656|NCT03781843|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65568560|NCT05068037|Antiemetics|antiemetics|mesh-list
65568632|NCT01232777|Bevacizumab|bevacizumab|mesh-list
65568769|NCT03449524|CXA-10|cxa-10|mesh-list
65568930|NCT04704531|Hyaluronic Acid|hyaluronic acid|mesh-list
65569305|NCT02528513|Narcotics|narcotics|mesh-ancestor
65569537|NCT01143545|Celecoxib|celecoxib|mesh-list
65569985|NCT05309070|Acetylcysteine|acetylcysteine|mesh-list
65570753|NCT02913612|Timolol|timolol|mesh-list
65570894|NCT02327455|Sympathomimetics|sympathomimetics|mesh-ancestor
65571193|NCT03425656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571645|NCT03393364|Analgesics|analgesics|mesh-ancestor
65571720|NCT01974609|Hydrocodone|hydrocodone|mesh-list
65571940|NCT04447378|PENTA|penta|mesh-list
65572096|NCT03297021|Ondansetron|ondansetron|mesh-list
65572240|NCT04755595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65572355|NCT03395002|Xhance|xhance|mesh-list
65572602|NCT03754543|Iron|iron|mesh-list
65569306|NCT02528513|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65569307|NCT02528513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65569308|NCT02528513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65569309|NCT02528513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65569310|NCT02528513|GABA Modulators|gaba modulators|mesh-ancestor
65569311|NCT02528513|GABA Agents|gaba agents|mesh-ancestor
65569312|NCT01320007|Furosemide|furosemide|mesh-list
65569313|NCT01320007|Diuretics|diuretics|mesh-ancestor
65569314|NCT01320007|Natriuretic Agents|natriuretic agents|mesh-ancestor
65569315|NCT01320007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569316|NCT01320007|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65569317|NCT01320007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65569318|NCT01320007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569319|NCT03318315|Vaccines|vaccines|mesh-list
65569320|NCT03318315|Immunologic Factors|immunologic factors|mesh-ancestor
65569321|NCT03318315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569322|NCT04460183|Nitric Oxide|nitric oxide|mesh-list
65572614|NCT04918147|Prednisone|prednisone|mesh-list
65572668|NCT02761694|Paclitaxel|paclitaxel|mesh-list
65572824|NCT04080804|Nivolumab|nivolumab|mesh-list
65573132|NCT01382498|Calcium|calcium|mesh-list
65573195|NCT01382342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573498|NCT05121714|Antidepressive Agents|antidepressive agents|mesh-ancestor
65573723|NCT01147289|Analgesics|analgesics|mesh-ancestor
65574179|NCT04566692|Immunoglobulins|immunoglobulins|mesh-list
65574249|NCT05205122|Mitomycins|mitomycins|mesh-list
65574572|NCT04320745|Hormones|hormones|mesh-ancestor
65574922|NCT05211050|Autonomic Agents|autonomic agents|mesh-ancestor
65575402|NCT01155791|Prednisone|prednisone|mesh-list
65575759|NCT03241173|Nivolumab|nivolumab|mesh-list
65576043|NCT03878771|Clobetasol|clobetasol|mesh-list
65576271|NCT02526875|Amlodipine|amlodipine|mesh-list
65576351|NCT04652206|Antimetabolites|antimetabolites|mesh-ancestor
65576569|NCT03125746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576889|NCT03379012|Hormones|hormones|mesh-ancestor
65576952|NCT01283789|Everolimus|everolimus|mesh-list
65577331|NCT01127256|Zonisamide|zonisamide|mesh-list
65577412|NCT01282073|Cyclosporine|cyclosporine|mesh-list
65577633|NCT05179512|Autonomic Agents|autonomic agents|mesh-ancestor
65577779|NCT05331911|Anesthetics|anesthetics|mesh-ancestor
65577931|NCT05142735|Antidotes|antidotes|mesh-ancestor
65569323|NCT04460183|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65569324|NCT04460183|Autonomic Agents|autonomic agents|mesh-ancestor
65578386|NCT03375580|Antimetabolites|antimetabolites|mesh-ancestor
65578610|NCT03748823|Ravulizumab|ravulizumab|mesh-list
65569325|NCT04460183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65578913|NCT03682705|Upadacitinib|upadacitinib|mesh-list
65579590|NCT01188005|Expectorants|expectorants|mesh-ancestor
65580123|NCT03856853|Pirfenidone|pirfenidone|mesh-list
65580268|NCT01291511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580347|NCT03349606|Sympathomimetics|sympathomimetics|mesh-ancestor
65580570|NCT02752191|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65580659|NCT05303727|Antimetabolites|antimetabolites|mesh-ancestor
65580721|NCT05224089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65580811|NCT04469595|Hormones|hormones|mesh-ancestor
65581017|NCT04454424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65581330|NCT03055988|Xhance|xhance|mesh-list
65581392|NCT03128866|Coagulants|coagulants|mesh-ancestor
65581765|NCT01193387|Insulin|insulin|mesh-list
65582293|NCT02892409|Amoxicillin|amoxicillin|mesh-list
65582525|NCT05420454|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65583051|NCT01205243|Abacavir|abacavir|mesh-list
65583126|NCT03176238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65583209|NCT03343678|Venetoclax|venetoclax|mesh-list
65583276|NCT03589885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65583810|NCT03814343|Antioxidants|antioxidants|mesh-ancestor
65584181|NCT02492308|Basiliximab|basiliximab|mesh-list
65569326|NCT04460183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584478|NCT04851522|Eusol|eusol|mesh-list
65584787|NCT01303601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65584872|NCT03337282|Anesthetics|anesthetics|mesh-list
65584938|NCT02497222|RNS60|rns60|mesh-list
65585093|NCT02496910|Amlodipine|amlodipine|mesh-list
65585167|NCT03324490|Analgesics|analgesics|mesh-ancestor
65585236|NCT03794765|Metronidazole|metronidazole|mesh-list
65585766|NCT04551950|Paclitaxel|paclitaxel|mesh-list
65585837|NCT03322150|Mydriatics|mydriatics|mesh-ancestor
65585919|NCT01305707|Autonomic Agents|autonomic agents|mesh-ancestor
65586062|NCT03326050|Gemifloxacin|gemifloxacin|mesh-list
65586141|NCT01307046|Losartan|losartan|mesh-list
65586294|NCT03788681|Estradiol|estradiol|mesh-list
65586442|NCT02486848|Minoxidil|minoxidil|mesh-list
65586663|NCT02489266|Aldesleukin|aldesleukin|mesh-list
65569327|NCT04460183|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65586813|NCT03317548|Progesterone|progesterone|mesh-list
65586962|NCT05029115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65587034|NCT03781115|Serotonin Agents|serotonin agents|mesh-ancestor
65587255|NCT05462470|Liver Extracts|liver extracts|mesh-list
65587332|NCT03785015|Antipyretics|antipyretics|mesh-ancestor
65587703|NCT01316952|Adrenergic Agents|adrenergic agents|mesh-list
65587933|NCT02477956|Vitamin D|vitamin d|mesh-list
65588080|NCT03766997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65588301|NCT03756233|Remifentanil|remifentanil|mesh-list
65588375|NCT03760445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65588525|NCT05358626|Antibodies|antibodies|mesh-list
65588607|NCT02473900|Oseltamivir|oseltamivir|mesh-list
65589137|NCT05183334|Tramadol|tramadol|mesh-list
65589375|NCT03311542|Pembrolizumab|pembrolizumab|mesh-list
65589577|NCT03144804|Lamivudine|lamivudine|mesh-list
65589725|NCT05245006|Immunoglobulins|immunoglobulins|mesh-list
65589876|NCT01318044|Thiopental|thiopental|mesh-list
65569328|NCT04460183|Respiratory System Agents|respiratory system agents|mesh-ancestor
65590177|NCT03136068|Protective Agents|protective agents|mesh-ancestor
65590330|NCT00644228|Protease Inhibitors|protease inhibitors|mesh-ancestor
65590482|NCT04235686|Amphetamine|amphetamine|mesh-list
65590714|NCT05550142|Vaccines|vaccines|mesh-list
65591015|NCT01656434|Ferrous fumarate|ferrous fumarate|mesh-list
65591175|NCT03382977|Carmustine|carmustine|mesh-list
65591536|NCT04479566|Calcium|calcium|mesh-list
65592207|NCT02457208|Antimetabolites|antimetabolites|mesh-ancestor
65569329|NCT04460183|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65569330|NCT04460183|Antioxidants|antioxidants|mesh-ancestor
65592656|NCT02459158|Arbekacin|arbekacin|mesh-list
65593108|NCT01364376|Leucovorin|leucovorin|mesh-list
65593185|NCT01369368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593332|NCT03147040|Carboplatin|carboplatin|mesh-list
65593557|NCT03244540|Dipyrone|dipyrone|mesh-list
65593705|NCT03242278|Protease Inhibitors|protease inhibitors|mesh-ancestor
65593930|NCT04251585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65594308|NCT04234464|Glucocorticoids|glucocorticoids|mesh-ancestor
65595286|NCT03203668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65595588|NCT03107338|Analgesics|analgesics|mesh-ancestor
65595733|NCT02727998|Midazolam|midazolam|mesh-list
65596039|NCT05358548|Paclitaxel|paclitaxel|mesh-list
65596194|NCT03698474|Ascorbic Acid|ascorbic acid|mesh-list
65596344|NCT03031496|Amiloride|amiloride|mesh-list
65596500|NCT04483492|Caffeine|caffeine|mesh-list
65596571|NCT02433730|Testosterone|testosterone|mesh-list
65597098|NCT03691688|Antipyretics|antipyretics|mesh-ancestor
65597316|NCT04147715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65597554|NCT03182140|Levonorgestrel|levonorgestrel|mesh-list
65597937|NCT03698630|Hormones|hormones|mesh-ancestor
65598005|NCT05137860|Bortezomib|bortezomib|mesh-list
65598074|NCT01376154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598159|NCT02877927|Linezolid|linezolid|mesh-list
65598242|NCT01442649|Vitamins|vitamins|mesh-ancestor
65598330|NCT04059536|Aspirin|aspirin|mesh-list
65598457|NCT04054193|Serotonin Agents|serotonin agents|mesh-ancestor
65598682|NCT02427334|Fluoxetine|fluoxetine|mesh-list
65598757|NCT01358253|Hormones|hormones|mesh-ancestor
65569331|NCT04460183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599431|NCT02422108|Denosumab|denosumab|mesh-list
65599731|NCT02409862|Oxytocin|oxytocin|mesh-list
65599800|NCT04885530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65600025|NCT01367535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65600102|NCT02408926|Vaccines|vaccines|mesh-list
65600173|NCT02408146|Dermatologic Agents|dermatologic agents|mesh-ancestor
65600310|NCT02407834|Eusol|eusol|mesh-list
65600564|NCT03169504|Xhance|xhance|mesh-list
65600864|NCT05074290|Taxane|taxane|mesh-list
65600935|NCT03731117|Natriuretic Agents|natriuretic agents|mesh-ancestor
65601158|NCT02399800|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65601762|NCT05741632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601912|NCT04792801|Choline|choline|mesh-list
65602076|NCT02949271|Fentanyl|fentanyl|mesh-list
65602369|NCT05199571|Ofatumumab|ofatumumab|mesh-list
65602441|NCT01312441|Ergocalciferols|ergocalciferols|mesh-list
65602669|NCT05597280|Rifampin|rifampin|mesh-list
65603044|NCT04303507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65603119|NCT03668054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603261|NCT03557281|GSK656|gsk656|mesh-list
65603493|NCT03476551|Diuretics|diuretics|mesh-ancestor
65603568|NCT03751163|Antioxidants|antioxidants|mesh-ancestor
65603646|NCT03001076|Ezetimibe|ezetimibe|mesh-list
65604242|NCT04397354|Hormones|hormones|mesh-ancestor
65604471|NCT02389582|Enoxaparin|enoxaparin|mesh-list
65604542|NCT02387086|Growth Substances|growth substances|mesh-ancestor
65604990|NCT04949269|BMS-986165|bms-986165|mesh-list
65605225|NCT04483960|Nafamostat|nafamostat|mesh-list
65569332|NCT04460183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65605695|NCT02358850|Oxycodone|oxycodone|mesh-list
65605900|NCT03085914|Leucovorin|leucovorin|mesh-list
65606128|NCT02361502|Mirabegron|mirabegron|mesh-list
65606203|NCT02981342|Gemcitabine|gemcitabine|mesh-list
65606350|NCT01378884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65606501|NCT02351908|Tenofovir|tenofovir|mesh-list
65607475|NCT02039362|Antiviral Agents|antiviral agents|mesh-ancestor
65607704|NCT04344444|Azithromycin|azithromycin|mesh-list
65608200|NCT03697408|Everolimus|everolimus|mesh-list
65608697|NCT02327728|Cholinergic Agents|cholinergic agents|mesh-ancestor
65608846|NCT03122145|Capsaicin|capsaicin|mesh-list
65609149|NCT05761470|Paclitaxel|paclitaxel|mesh-list
65609399|NCT05197101|Oxytocin|oxytocin|mesh-list
65609517|NCT04585893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65610273|NCT01759836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65610420|NCT04360980|Gout Suppressants|gout suppressants|mesh-ancestor
65610498|NCT04315038|Anesthetics|anesthetics|mesh-list
65610872|NCT03414983|Protective Agents|protective agents|mesh-ancestor
65611028|NCT03054870|Xenon|xenon|mesh-list
65611323|NCT01313143|Esmolol|esmolol|mesh-list
65611472|NCT03046446|FX006|fx006|mesh-list
65611707|NCT03043560|Ezogabine|ezogabine|mesh-list
65611846|NCT03240133|Berotralstat|berotralstat|mesh-list
65612443|NCT03532555|Zinc|zinc|mesh-list
65612525|NCT03706157|Doxorubicin|doxorubicin|mesh-list
65612814|NCT05283954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65612892|NCT05030441|Ivosidenib|ivosidenib|mesh-list
65613113|NCT03629873|Antimetabolites|antimetabolites|mesh-ancestor
65613201|NCT02710331|Hormones|hormones|mesh-ancestor
65613342|NCT04689347|Growth Inhibitors|growth inhibitors|mesh-ancestor
65613415|NCT04108104|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65614014|NCT01498770|Clozapine|clozapine|mesh-list
65614164|NCT03261167|Botulinum Toxins|botulinum toxins|mesh-list
65614833|NCT05378763|Docetaxel|docetaxel|mesh-list
65614909|NCT03336333|Rituximab|rituximab|mesh-list
65614982|NCT03692754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65615060|NCT05598411|Hormones|hormones|mesh-ancestor
65615356|NCT03197935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615670|NCT03680976|CXA-10|cxa-10|mesh-list
65615884|NCT03678792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65616039|NCT05420467|Tubulin Modulators|tubulin modulators|mesh-ancestor
65616119|NCT03670212|Hydrocortisone|hydrocortisone|mesh-list
65617029|NCT03231371|Adenosine|adenosine|mesh-list
65617645|NCT03203447|Hormones|hormones|mesh-ancestor
65617936|NCT01764633|Antimetabolites|antimetabolites|mesh-ancestor
65618492|NCT03082677|Ixazomib|ixazomib|mesh-list
65618544|NCT03609086|Melatonin|melatonin|mesh-list
65618616|NCT03179891|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65618690|NCT01334905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618770|NCT01333267|Hormones|hormones|mesh-list
65618923|NCT03655392|Antioxidants|antioxidants|mesh-ancestor
65619140|NCT03653520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65619598|NCT03606590|Sorafenib|sorafenib|mesh-list
65619756|NCT05461365|Insulin|insulin|mesh-list
65619820|NCT03600974|Domperidone|domperidone|mesh-list
65619895|NCT02237924|Growth Substances|growth substances|mesh-ancestor
65620354|NCT02903238|Dopamine Agents|dopamine agents|mesh-ancestor
65620572|NCT03647670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65620806|NCT03647280|Epirubicin|epirubicin|mesh-list
65621102|NCT01333423|Antiviral Agents|antiviral agents|mesh-ancestor
65621177|NCT03619785|Sensory System Agents|sensory system agents|mesh-ancestor
65621330|NCT03575780|Tirbanibulin|tirbanibulin|mesh-list
65621409|NCT03575234|Cyclophosphamide|cyclophosphamide|mesh-list
65621631|NCT01336543|Cisplatin|cisplatin|mesh-list
65621704|NCT05163535|Elsulfavirine|elsulfavirine|mesh-list
65621943|NCT01339481|Abatacept|abatacept|mesh-list
65621998|NCT03000374|Oxaliplatin|oxaliplatin|mesh-list
65622461|NCT01317433|Cetuximab|cetuximab|mesh-list
65622523|NCT01348243|Clodronic Acid|clodronic acid|mesh-list
65622691|NCT02823470|Ivacaftor|ivacaftor|mesh-list
65622900|NCT02036060|Hormones|hormones|mesh-ancestor
65622993|NCT01353235|Hormones|hormones|mesh-ancestor
65623426|NCT03640650|Hormones|hormones|mesh-ancestor
65623950|NCT02062112|Laxatives|laxatives|mesh-list
65624628|NCT05190627|Antipruritics|antipruritics|mesh-ancestor
65624707|NCT01359085|Pregabalin|pregabalin|mesh-list
65624954|NCT05249933|Benzocaine|benzocaine|mesh-list
65625078|NCT03911661|Warfarin|warfarin|mesh-list
65625608|NCT03628443|Mitogens|mitogens|mesh-list
65626810|NCT02086994|Oxytocics|oxytocics|mesh-ancestor
65626969|NCT03125941|Hormones|hormones|mesh-ancestor
65627365|NCT02099240|Anesthetics|anesthetics|mesh-ancestor
65627605|NCT05168527|Paclitaxel|paclitaxel|mesh-list
65627754|NCT02102828|Aspirin|aspirin|mesh-list
65627975|NCT05081089|Pyrimethamine|pyrimethamine|mesh-list
65628198|NCT02104778|Antiemetics|antiemetics|mesh-ancestor
65628422|NCT05432115|Amoxicillin|amoxicillin|mesh-list
65629543|NCT05461131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65629696|NCT03118765|Respiratory System Agents|respiratory system agents|mesh-ancestor
65629777|NCT01373983|Ziconotide|ziconotide|mesh-list
65630152|NCT05644665|Ozanimod|ozanimod|mesh-list
65630301|NCT05440786|Alkylating Agents|alkylating agents|mesh-ancestor
65630457|NCT05334004|Ritonavir|ritonavir|mesh-list
65630748|NCT05052931|Paclitaxel|paclitaxel|mesh-list
65631045|NCT04789070|Antifungal Agents|antifungal agents|mesh-ancestor
65631350|NCT04535544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65631427|NCT04435782|Selexipag|selexipag|mesh-list
65631500|NCT04314375|Hormones|hormones|mesh-ancestor
65631950|NCT03843463|Dexetimide|dexetimide|mesh-list
65632104|NCT03623854|Immunologic Factors|immunologic factors|mesh-ancestor
65632406|NCT03201939|Protease Inhibitors|protease inhibitors|mesh-ancestor
65632938|NCT01837862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633321|NCT02132234|Adalimumab|adalimumab|mesh-list
65633539|NCT02137928|Etoposide|etoposide|mesh-list
65633690|NCT02539693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65633766|NCT02139098|Amitriptyline|amitriptyline|mesh-list
65633841|NCT01356329|Heparin|heparin|mesh-list
65634067|NCT02140268|GABA Modulators|gaba modulators|mesh-ancestor
65634897|NCT01366001|Analgesics|analgesics|mesh-ancestor
65634995|NCT04871165|Antibodies|antibodies|mesh-list
65635126|NCT02241018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635219|NCT03756896|Hormones|hormones|mesh-ancestor
65635351|NCT01366547|Abacavir|abacavir|mesh-list
65635503|NCT02254148|Caffeine|caffeine|mesh-list
65635886|NCT01373021|Fentanyl|fentanyl|mesh-list
65635959|NCT02140814|Nicotinic Acids|nicotinic acids|mesh-list
65636935|NCT01343043|Fludarabine|fludarabine|mesh-list
65637003|NCT05354128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65637305|NCT05057247|Docetaxel|docetaxel|mesh-list
65637376|NCT02470585|Antimitotic Agents|antimitotic agents|mesh-ancestor
65637525|NCT03041181|Gemcitabine|gemcitabine|mesh-list
65637749|NCT04509336|GABA Agents|gaba agents|mesh-ancestor
65637899|NCT05707572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65637975|NCT03278509|Metoprolol|metoprolol|mesh-list
65638124|NCT04589351|Antimetabolites|antimetabolites|mesh-ancestor
65638197|NCT02817828|Diuretics|diuretics|mesh-ancestor
65638276|NCT02883049|Glucocorticoids|glucocorticoids|mesh-ancestor
65638357|NCT03632161|Analgesics|analgesics|mesh-ancestor
65638507|NCT03632915|GABA Modulators|gaba modulators|mesh-ancestor
65638806|NCT05071703|Carboplatin|carboplatin|mesh-list
65639405|NCT03033095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65639932|NCT02156960|Denosumab|denosumab|mesh-list
65640381|NCT03918915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65640457|NCT02159690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640611|NCT05422183|Lenvatinib|lenvatinib|mesh-list
65640757|NCT03542552|Nifedipine|nifedipine|mesh-list
65641373|NCT04649229|Aprepitant|aprepitant|mesh-list
65641433|NCT02163980|Anesthetics|anesthetics|mesh-ancestor
65641582|NCT02164448|Dexmedetomidine|dexmedetomidine|mesh-list
65641964|NCT02164838|Axitinib|axitinib|mesh-list
65642036|NCT02255942|Protective Agents|protective agents|mesh-ancestor
65642208|NCT00106808|Pioglitazone|pioglitazone|mesh-list
65642265|NCT04305327|Ustekinumab|ustekinumab|mesh-list
65642337|NCT03694587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65642411|NCT02173652|Incretins|incretins|mesh-ancestor
65642487|NCT02175602|Serotonin Agents|serotonin agents|mesh-ancestor
65642932|NCT04062279|Immunologic Factors|immunologic factors|mesh-ancestor
65643305|NCT02185430|Analgesics|analgesics|mesh-ancestor
65644042|NCT03679455|Obinutuzumab|obinutuzumab|mesh-list
65644191|NCT02195180|Leucovorin|leucovorin|mesh-list
65644652|NCT02068170|Azithromycin|azithromycin|mesh-list
65569333|NCT04460183|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65569334|NCT04460183|Vasodilator Agents|vasodilator agents|mesh-ancestor
65569335|NCT04460183|Gasotransmitters|gasotransmitters|mesh-ancestor
65569336|NCT04460183|Protective Agents|protective agents|mesh-ancestor
65569337|NCT01243697|Desogestrel|desogestrel|mesh-list
65569338|NCT01243697|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65569339|NCT01243697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65569340|NCT01243697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65569341|NCT01243697|Contraceptive Agents|contraceptive agents|mesh-ancestor
65569342|NCT01243697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65569343|NCT01243697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569344|NCT01243697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65569345|NCT01243697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65569346|NCT01243697|Progestins|progestins|mesh-ancestor
65569347|NCT01243697|Hormones|hormones|mesh-ancestor
65569348|NCT01243697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65569349|NCT04703101|Leucovorin|leucovorin|mesh-list
65569350|NCT04703101|Fluorouracil|fluorouracil|mesh-list
65569351|NCT04703101|Capecitabine|capecitabine|mesh-list
65569352|NCT04703101|Oxaliplatin|oxaliplatin|mesh-list
65569353|NCT04703101|Antimetabolites|antimetabolites|mesh-ancestor
65569354|NCT04703101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569355|NCT04703101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65569356|NCT04703101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569357|NCT04703101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65569358|NCT04703101|Immunologic Factors|immunologic factors|mesh-ancestor
65569359|NCT04703101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569360|NCT04703101|Antidotes|antidotes|mesh-ancestor
65569361|NCT04703101|Protective Agents|protective agents|mesh-ancestor
65569362|NCT04703101|Vitamin B Complex|vitamin b complex|mesh-ancestor
65569363|NCT04703101|Vitamins|vitamins|mesh-ancestor
65569364|NCT04703101|Micronutrients|micronutrients|mesh-ancestor
65569365|NCT01145573|Calcium|calcium|mesh-list
65569366|NCT01145573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65569367|NCT01145573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569368|NCT01320709|Piroxicam|piroxicam|mesh-list
65569369|NCT01320709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65569370|NCT01320709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65569371|NCT01320709|Analgesics|analgesics|mesh-ancestor
65569372|NCT01320709|Sensory System Agents|sensory system agents|mesh-ancestor
65569373|NCT01320709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65569374|NCT01320709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569375|NCT01320709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65569376|NCT01320709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65569377|NCT01320709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65569378|NCT01320709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644823|NCT01827553|Gemcitabine|gemcitabine|mesh-list
65645126|NCT03054363|Letrozole|letrozole|mesh-list
65645271|NCT03669783|Dactinomycin|dactinomycin|mesh-list
65645575|NCT02076828|Zinc|zinc|mesh-list
65645647|NCT02073552|Vitamins|vitamins|mesh-ancestor
65646029|NCT02222480|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65646117|NCT02220530|Fentanyl|fentanyl|mesh-list
65646401|NCT02751320|Citric Acid|citric acid|mesh-list
65646484|NCT02258828|Memantine|memantine|mesh-list
65646557|NCT02079558|Oxytocin|oxytocin|mesh-list
65646853|NCT03646994|Crizotinib|crizotinib|mesh-list
65647001|NCT02233244|Midazolam|midazolam|mesh-list
65647076|NCT02726659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65647449|NCT04539808|Losartan|losartan|mesh-list
65647535|NCT04477018|Iron|iron|mesh-list
65647601|NCT02636582|Molgramostim|molgramostim|mesh-list
65647751|NCT01418222|Vitamins|vitamins|mesh-ancestor
65647827|NCT05200663|Tamoxifen|tamoxifen|mesh-list
65569379|NCT01320709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647979|NCT02263976|Bromides|bromides|mesh-list
65569380|NCT01238393|Ranibizumab|ranibizumab|mesh-list
65648569|NCT04475120|Lactoferrin|lactoferrin|mesh-list
65649169|NCT01468831|Minocycline|minocycline|mesh-list
65649320|NCT02880371|Pembrolizumab|pembrolizumab|mesh-list
65650218|NCT05106400|Sensory System Agents|sensory system agents|mesh-ancestor
65650289|NCT05261464|Metoprolol|metoprolol|mesh-list
65650363|NCT00835640|Fexofenadine|fexofenadine|mesh-list
65650440|NCT04369937|Pembrolizumab|pembrolizumab|mesh-list
65650965|NCT02911935|Azithromycin|azithromycin|mesh-list
65651134|NCT05156879|Aspirin|aspirin|mesh-list
65651262|NCT02947165|Spartalizumab|spartalizumab|mesh-list
65651339|NCT05116228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65651644|NCT05068336|Anesthetics|anesthetics|mesh-list
65652016|NCT02273804|Anticonvulsants|anticonvulsants|mesh-ancestor
65652391|NCT03950245|Glucagon|glucagon|mesh-list
65652766|NCT02921763|Hormones|hormones|mesh-ancestor
65653071|NCT02097342|Voglibose|voglibose|mesh-list
65653297|NCT05036434|Pembrolizumab|pembrolizumab|mesh-list
65653372|NCT00036608|Entecavir|entecavir|mesh-list
65653526|NCT02104128|Bupropion|bupropion|mesh-list
65653745|NCT00004172|Ifosfamide|ifosfamide|mesh-list
65654281|NCT02109510|Analgesics|analgesics|mesh-ancestor
65654346|NCT02115204|Docetaxel|docetaxel|mesh-list
65654657|NCT03622047|Sufentanil|sufentanil|mesh-list
65654947|NCT05258110|Midazolam|midazolam|mesh-list
65655025|NCT02973087|Factor VIII|factor viii|mesh-list
65655106|NCT04053543|CXA-10|cxa-10|mesh-list
65655180|NCT00263042|Hormones|hormones|mesh-ancestor
65655335|NCT02971683|Abatacept|abatacept|mesh-list
65655552|NCT02125500|Antiviral Agents|antiviral agents|mesh-ancestor
65655747|NCT05031442|Zinc Oxide|zinc oxide|mesh-list
65655784|NCT02128308|Ofloxacin|ofloxacin|mesh-list
65655852|NCT02252328|Simvastatin|simvastatin|mesh-list
65656151|NCT05137522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65656381|NCT02129322|Sorafenib|sorafenib|mesh-list
65656449|NCT02133378|Hemostatics|hemostatics|mesh-list
65656599|NCT05134558|Xenon|xenon|mesh-list
65656676|NCT02642042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656975|NCT05284851|Vaccines|vaccines|mesh-list
65657046|NCT03384784|Autonomic Agents|autonomic agents|mesh-ancestor
65657121|NCT02899377|Chelating Agents|chelating agents|mesh-ancestor
65657413|NCT03806985|Psilocybin|psilocybin|mesh-list
65657562|NCT00432094|Mesna|mesna|mesh-list
65657866|NCT03869944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65657945|NCT03843970|Bupivacaine|bupivacaine|mesh-list
65658021|NCT01344759|Propofol|propofol|mesh-list
65658242|NCT03516656|Heparin|heparin|mesh-list
65658540|NCT02298062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65658841|NCT00109590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65659066|NCT05070598|Tegafur|tegafur|mesh-list
65659141|NCT03506516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65659225|NCT02312804|Paclitaxel|paclitaxel|mesh-list
65659742|NCT02144922|Pitavastatin|pitavastatin|mesh-list
65659828|NCT05055544|Fosfomycin|fosfomycin|mesh-list
65660115|NCT02318888|Icodextrin|icodextrin|mesh-list
65660428|NCT03493412|Verapamil|verapamil|mesh-list
65660971|NCT01673386|Sunitinib|sunitinib|mesh-list
65661096|NCT02872311|Vaccines|vaccines|mesh-list
65661298|NCT03611985|Taxane|taxane|mesh-list
65661328|NCT00354835|Dactinomycin|dactinomycin|mesh-list
65661394|NCT03542214|Calcium|calcium|mesh-list
65662004|NCT03723967|Paclitaxel|paclitaxel|mesh-list
65459502|NCT01301248|Cisplatin|cisplatin|mesh-list
65662149|NCT02765490|Simeprevir|simeprevir|mesh-list
65662973|NCT03072082|Analgesics|analgesics|mesh-ancestor
65663049|NCT04991194|Zamicastat|zamicastat|mesh-list
65663422|NCT03625531|Letrozole|letrozole|mesh-list
65569381|NCT01238393|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65663788|NCT04994236|Antidotes|antidotes|mesh-ancestor
65664760|NCT04794790|Buprenorphine|buprenorphine|mesh-list
65664832|NCT02171988|Sympatholytics|sympatholytics|mesh-ancestor
65664987|NCT02172144|Autonomic Agents|autonomic agents|mesh-ancestor
65665733|NCT02239107|Expectorants|expectorants|mesh-ancestor
65665956|NCT03182179|Antiemetics|antiemetics|mesh-ancestor
65666044|NCT03571737|Analgesics|analgesics|mesh-ancestor
65666255|NCT03940690|Growth Substances|growth substances|mesh-ancestor
65666337|NCT04767217|Artemether|artemether|mesh-list
65666868|NCT03700333|Pemetrexed|pemetrexed|mesh-list
65666927|NCT03700177|Glucocorticoids|glucocorticoids|mesh-ancestor
65667783|NCT02201082|Amikacin|amikacin|mesh-list
65668117|NCT02199678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65668346|NCT03060070|Analgesics|analgesics|mesh-ancestor
65668807|NCT04445688|Adrenergic Agents|adrenergic agents|mesh-ancestor
65669029|NCT01329900|Etoposide|etoposide|mesh-list
65669329|NCT04942834|Sympatholytics|sympatholytics|mesh-ancestor
65669487|NCT03479996|Bupivacaine|bupivacaine|mesh-list
65669711|NCT01338987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65669870|NCT03473210|Hormones|hormones|mesh-ancestor
65670021|NCT03473600|Hormones|hormones|mesh-ancestor
65670091|NCT04929652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65670321|NCT04432558|Acetaminophen|acetaminophen|mesh-list
65569382|NCT01238393|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65569383|NCT01238393|Growth Substances|growth substances|mesh-ancestor
65670618|NCT04432402|Gemcitabine|gemcitabine|mesh-list
65670695|NCT04917250|Antimetabolites|antimetabolites|mesh-ancestor
65671014|NCT03054610|Hormones|hormones|mesh-ancestor
65671066|NCT04908982|Aspirin|aspirin|mesh-list
65671292|NCT04890418|Anesthetics|anesthetics|mesh-ancestor
65671368|NCT04101890|Zinc Oxide|zinc oxide|mesh-list
65671592|NCT02522858|Atropine|atropine|mesh-list
65366887|NCT00992914|Lidocaine|lidocaine|mesh-list
65672040|NCT02053779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65672273|NCT02613910|Analgesics|analgesics|mesh-ancestor
65672341|NCT05255848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65673031|NCT03180684|Imiquimod|imiquimod|mesh-list
65673093|NCT05072262|Analgesics|analgesics|mesh-ancestor
65673319|NCT04648020|Clonidine|clonidine|mesh-list
65673616|NCT02263248|Buprenorphine|buprenorphine|mesh-list
65673845|NCT04835116|Antiemetics|antiemetics|mesh-ancestor
65674902|NCT01281462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674980|NCT01016808|Morphine|morphine|mesh-list
65569384|NCT01238393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569385|NCT01238393|Growth Inhibitors|growth inhibitors|mesh-ancestor
65675937|NCT00835614|Cefprozil|cefprozil|mesh-list
65676329|NCT00765804|Hormones|hormones|mesh-ancestor
65676594|NCT00747318|Xhance|xhance|mesh-list
65676761|NCT00734292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65677099|NCT05616754|Vaccines|vaccines|mesh-list
65677359|NCT02253810|Tranexamic Acid|tranexamic acid|mesh-list
65677436|NCT02065401|Antacids|antacids|mesh-ancestor
65677509|NCT00668772|Autonomic Agents|autonomic agents|mesh-ancestor
65677807|NCT00451152|Anecortave|anecortave|mesh-list
65677885|NCT00583674|Cisplatin|cisplatin|mesh-list
65569386|NCT01238393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679684|NCT05816668|Hemostatics|hemostatics|mesh-ancestor
65569387|NCT01244399|Inositol|inositol|mesh-list
65569388|NCT01244399|Vitamin B Complex|vitamin b complex|mesh-ancestor
65680586|NCT05071183|Trametinib|trametinib|mesh-list
65680667|NCT04994977|Melphalan|melphalan|mesh-list
65569389|NCT01244399|Vitamins|vitamins|mesh-ancestor
65681037|NCT04569032|Hormones|hormones|mesh-ancestor
65569390|NCT01244399|Micronutrients|micronutrients|mesh-ancestor
65681634|NCT03909165|Glycopyrrolate|glycopyrrolate|mesh-list
65569391|NCT01244399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569392|NCT03776305|Imipenem|imipenem|mesh-list
65682309|NCT02364713|Gemcitabine|gemcitabine|mesh-list
65682382|NCT02231775|Trametinib|trametinib|mesh-list
65682690|NCT02097147|Paroxetine|paroxetine|mesh-list
65682989|NCT02095119|Antiviral Agents|antiviral agents|mesh-ancestor
65683139|NCT05613478|Apatinib|apatinib|mesh-list
65683214|NCT04339036|Alkylating Agents|alkylating agents|mesh-ancestor
65683299|NCT04748224|Bupivacaine|bupivacaine|mesh-list
65683359|NCT02588248|Peppermint oil|peppermint oil|mesh-list
65683657|NCT03393728|Propranolol|propranolol|mesh-list
65683731|NCT02102139|Anesthetics, General|anesthetics, general|mesh-ancestor
65684113|NCT02113137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65684192|NCT02118987|Omalizumab|omalizumab|mesh-list
65684415|NCT02118285|Analgesics|analgesics|mesh-ancestor
65684485|NCT05717400|Ribavirin|ribavirin|mesh-list
65569393|NCT03776305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65685088|NCT02125305|Metformin|metformin|mesh-list
65685242|NCT05549284|Rituximab|rituximab|mesh-list
65685399|NCT02132091|Vitamins|vitamins|mesh-list
65685617|NCT03549663|Prednisone|prednisone|mesh-list
65685765|NCT03228732|Immunologic Factors|immunologic factors|mesh-ancestor
65685943|NCT05177796|Paclitaxel|paclitaxel|mesh-list
65686970|NCT04350021|Cyclophosphamide|cyclophosphamide|mesh-list
65687040|NCT05696548|Nivolumab|nivolumab|mesh-list
65687343|NCT03389126|Avelumab|avelumab|mesh-list
65569394|NCT03776305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65687794|NCT03391856|Acetylcysteine|acetylcysteine|mesh-list
65688318|NCT02142075|Daptomycin|daptomycin|mesh-list
65688687|NCT03554044|Paclitaxel|paclitaxel|mesh-list
65688778|NCT03111212|Iloprost|iloprost|mesh-list
65569395|NCT01146509|Donepezil|donepezil|mesh-list
65689011|NCT02778867|Xhance|xhance|mesh-list
65569396|NCT01146509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65689432|NCT02302326|Micronutrients|micronutrients|mesh-ancestor
65569397|NCT01146509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689806|NCT03362684|Cetuximab|cetuximab|mesh-list
65690334|NCT04508816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690454|NCT05210374|Copper|copper|mesh-list
65690941|NCT03498222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691103|NCT03122756|Hormones|hormones|mesh-ancestor
65691243|NCT04505228|Mydriatics|mydriatics|mesh-ancestor
65691321|NCT02319018|Antimetabolites|antimetabolites|mesh-ancestor
65691465|NCT03496506|Selexipag|selexipag|mesh-list
65691541|NCT05515354|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65691619|NCT05042128|Antimetabolites|antimetabolites|mesh-ancestor
65691844|NCT04188314|Desflurane|desflurane|mesh-list
65691921|NCT02516774|Adalimumab|adalimumab|mesh-list
65692001|NCT02050308|Nicotine|nicotine|mesh-list
65692147|NCT04500002|Oxytocics|oxytocics|mesh-ancestor
65692229|NCT02515526|Ethanol|ethanol|mesh-list
65692550|NCT02504138|Propofol|propofol|mesh-list
65692764|NCT02172417|Ranitidine|ranitidine|mesh-list
65693062|NCT02173665|Linagliptin|linagliptin|mesh-list
65693296|NCT02178813|Minocycline|minocycline|mesh-list
65693357|NCT02170701|Anticoagulants|anticoagulants|mesh-ancestor
65693660|NCT00706628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693975|NCT02491970|Xhance|xhance|mesh-list
65694267|NCT05500690|Folic Acid|folic acid|mesh-list
65694633|NCT02186145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65695024|NCT02484170|Mannitol|mannitol|mesh-list
65695159|NCT02189343|Ricolinostat|ricolinostat|mesh-list
65695627|NCT02474654|Mydriatics|mydriatics|mesh-ancestor
65695923|NCT04730258|Azacitidine|azacitidine|mesh-list
65695996|NCT02195271|Melatonin|melatonin|mesh-list
65696145|NCT02198859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65696222|NCT04078737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65696374|NCT02206425|Hormones|hormones|mesh-ancestor
65696451|NCT03533127|Bevacizumab|bevacizumab|mesh-list
65696749|NCT02211729|Pyrimethamine|pyrimethamine|mesh-list
65696898|NCT02205489|Autonomic Agents|autonomic agents|mesh-ancestor
65696977|NCT03476616|Hormone Antagonists|hormone antagonists|mesh-ancestor
65697126|NCT03475680|Ornidazole|ornidazole|mesh-list
65697196|NCT02231931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65697496|NCT05783479|Viscosupplements|viscosupplements|mesh-ancestor
65697969|NCT05351346|Prednisone|prednisone|mesh-list
65698330|NCT04541355|Antitubercular Agents|antitubercular agents|mesh-ancestor
65698798|NCT02734290|Paclitaxel|paclitaxel|mesh-list
65699094|NCT01628211|Vitamins|vitamins|mesh-ancestor
65699243|NCT00431704|Carboplatin|carboplatin|mesh-list
65699317|NCT04458948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65699918|NCT04458636|Hormones|hormones|mesh-ancestor
65699990|NCT03832179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65700157|NCT03302390|Lidocaine|lidocaine|mesh-list
65700216|NCT02259543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700296|NCT00702650|Hormones|hormones|mesh-ancestor
65569398|NCT01146509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700517|NCT04476459|Apatinib|apatinib|mesh-list
65569399|NCT01146509|Cholinergic Agents|cholinergic agents|mesh-ancestor
65701115|NCT01390545|Veltuzumab|veltuzumab|mesh-list
65701416|NCT01116141|Folic Acid|folic acid|mesh-list
65701564|NCT01444365|Analgesics|analgesics|mesh-ancestor
65701736|NCT05151471|Edaravone|edaravone|mesh-list
65701786|NCT01018875|Donepezil|donepezil|mesh-list
65701861|NCT05115903|Adalimumab|adalimumab|mesh-list
65702015|NCT00843687|Dopamine Agents|dopamine agents|mesh-ancestor
65702177|NCT00840879|Meloxicam|meloxicam|mesh-list
65702465|NCT04551352|Adalimumab|adalimumab|mesh-list
65702694|NCT04279054|Morphine|morphine|mesh-list
65702769|NCT00948909|Donepezil|donepezil|mesh-list
65703580|NCT02460146|CXA-10|cxa-10|mesh-list
65704419|NCT05498896|Paclitaxel|paclitaxel|mesh-list
65704494|NCT03256292|Testosterone|testosterone|mesh-list
65704579|NCT03251768|Lenograstim|lenograstim|mesh-list
65569400|NCT01146509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65705757|NCT03235700|Sensory System Agents|sensory system agents|mesh-ancestor
65705915|NCT03221816|Folic Acid|folic acid|mesh-list
65707270|NCT02448290|Docetaxel|docetaxel|mesh-list
65707712|NCT02287857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569401|NCT01146509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708243|NCT05720871|Capsaicin|capsaicin|mesh-list
65708311|NCT00135369|Antiviral Agents|antiviral agents|mesh-ancestor
65569402|NCT01146509|Nootropic Agents|nootropic agents|mesh-ancestor
65709535|NCT03522207|Trazodone|trazodone|mesh-list
65709599|NCT02291367|Analgesics|analgesics|mesh-ancestor
65569403|NCT03775993|Hormones|hormones|mesh-list
65710577|NCT03179384|Ceftriaxone|ceftriaxone|mesh-list
65710806|NCT02410460|Anesthetics, General|anesthetics, general|mesh-ancestor
65710879|NCT02417090|Metformin|metformin|mesh-list
65711031|NCT01564537|Antiemetics|antiemetics|mesh-ancestor
65711260|NCT03172988|Glucocorticoids|glucocorticoids|mesh-ancestor
65711634|NCT02401880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65712235|NCT02300649|Adrenergic Agents|adrenergic agents|mesh-ancestor
65712524|NCT03505047|Copper|copper|mesh-list
65712602|NCT05454358|Letrozole|letrozole|mesh-list
65712676|NCT03504735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65712822|NCT02393066|Analgesics|analgesics|mesh-ancestor
65028850|NCT04826562|Lamivudine|lamivudine|mesh-list
65713043|NCT02545504|Antidotes|antidotes|mesh-ancestor
65713662|NCT04423510|Phenol|phenol|mesh-list
65713807|NCT03565991|Avelumab|avelumab|mesh-list
65714627|NCT02143414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65714701|NCT03493269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65714927|NCT01373151|Abortifacient Agents|abortifacient agents|mesh-ancestor
65715150|NCT04247165|Paclitaxel|paclitaxel|mesh-list
65715300|NCT03666325|Cetuximab|cetuximab|mesh-list
65715535|NCT05597098|Cantharidin|cantharidin|mesh-list
65715677|NCT04572815|Ustekinumab|ustekinumab|mesh-list
65715986|NCT03694535|Mitomycins|mitomycins|mesh-list
65716053|NCT02691572|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65716148|NCT04140305|Ozanimod|ozanimod|mesh-list
65716357|NCT03689465|Methotrexate|methotrexate|mesh-list
65716431|NCT03165500|Midazolam|midazolam|mesh-list
65716508|NCT03680495|Prednisolone|prednisolone|mesh-list
65569404|NCT03775993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65569405|NCT03775993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569406|NCT03316131|Dapagliflozin|dapagliflozin|mesh-list
65569407|NCT03316131|Febuxostat|febuxostat|mesh-list
65569408|NCT03316131|Verinurad|verinurad|mesh-list
65569409|NCT03316131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65569410|NCT03316131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569411|NCT03316131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65569412|NCT03316131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569413|NCT03316131|Gout Suppressants|gout suppressants|mesh-ancestor
65569414|NCT03316131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65569415|NCT03779659|Anesthetics|anesthetics|mesh-list
65569416|NCT03779659|Benzocaine|benzocaine|mesh-list
65569417|NCT03779659|Anesthetics, Local|anesthetics, local|mesh-list
65569418|NCT03779659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65569419|NCT03779659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569420|NCT03779659|Sensory System Agents|sensory system agents|mesh-ancestor
65569421|NCT03779659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65569422|NCT01145807|Terbinafine|terbinafine|mesh-list
65569423|NCT01145807|Antifungal Agents|antifungal agents|mesh-ancestor
65569424|NCT01145807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65569425|NCT01145807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569426|NCT01145807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569427|NCT03898895|Antibodies|antibodies|mesh-list
65569428|NCT03898895|Immunologic Factors|immunologic factors|mesh-ancestor
65569429|NCT03898895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569430|NCT01245569|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65569431|NCT01245569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65569432|NCT01245569|Autonomic Agents|autonomic agents|mesh-ancestor
65569433|NCT01245569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65569434|NCT01245569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569435|NCT01245569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65569436|NCT01245569|Respiratory System Agents|respiratory system agents|mesh-ancestor
65569437|NCT01245569|Glucocorticoids|glucocorticoids|mesh-ancestor
65569438|NCT01245569|Hormones|hormones|mesh-ancestor
65569439|NCT01245569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65569440|NCT01245569|Sympathomimetics|sympathomimetics|mesh-ancestor
65569441|NCT01314859|Nifedipine|nifedipine|mesh-list
65569442|NCT01314859|Atosiban|atosiban|mesh-list
65569443|NCT01314859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65569444|NCT01314859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65569445|NCT01314859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569446|NCT01314859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65569447|NCT01314859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569448|NCT01314859|Vasodilator Agents|vasodilator agents|mesh-ancestor
65569449|NCT01314859|Tocolytic Agents|tocolytic agents|mesh-ancestor
65569450|NCT01314859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65569451|NCT01314859|Hormone Antagonists|hormone antagonists|mesh-ancestor
65569452|NCT01314859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65569453|NCT02528279|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65569454|NCT02528279|Antimalarials|antimalarials|mesh-ancestor
65569455|NCT02528279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65569456|NCT02528279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65569457|NCT02528279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65569458|NCT01238627|Nicotine|nicotine|mesh-list
65569459|NCT01238627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65569460|NCT01238627|Autonomic Agents|autonomic agents|mesh-ancestor
65569461|NCT01238627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65716582|NCT02136069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65716751|NCT05368090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65716897|NCT05339386|Xenon|xenon|mesh-list
65717127|NCT03483207|Heparin|heparin|mesh-list
65717274|NCT03131583|Febuxostat|febuxostat|mesh-list
65717420|NCT05275426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717500|NCT04953104|Nivolumab|nivolumab|mesh-list
65717722|NCT03023423|Atezolizumab|atezolizumab|mesh-list
65717874|NCT03674333|Folic Acid|folic acid|mesh-list
65718254|NCT03478605|Hormones|hormones|mesh-ancestor
65718327|NCT02390258|S66913|s66913|mesh-list
65718404|NCT04058743|Cobalt|cobalt|mesh-list
65718488|NCT04057261|Hormones|hormones|mesh-ancestor
65718632|NCT03662113|Emollients|emollients|mesh-ancestor
65718786|NCT05797584|Dobutamine|dobutamine|mesh-list
65718931|NCT05768139|Fulvestrant|fulvestrant|mesh-list
65719229|NCT05582434|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65719305|NCT05503355|Venetoclax|venetoclax|mesh-list
65719609|NCT05226351|Hormones|hormones|mesh-ancestor
65719915|NCT04738487|Pembrolizumab|pembrolizumab|mesh-list
65720070|NCT04430738|Tucatinib|tucatinib|mesh-list
65720223|NCT04207931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720300|NCT04118855|Axitinib|axitinib|mesh-list
65720376|NCT03971253|Peficitinib|peficitinib|mesh-list
65569462|NCT01238627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720529|NCT03594110|Empagliflozin|empagliflozin|mesh-list
65720603|NCT03363464|Empagliflozin|empagliflozin|mesh-list
65569463|NCT01238627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65569464|NCT01238627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65720908|NCT02501096|Pembrolizumab|pembrolizumab|mesh-list
65569465|NCT01238627|Cholinergic Agents|cholinergic agents|mesh-ancestor
65721219|NCT01492972|Hormones|hormones|mesh-ancestor
65721452|NCT00977574|Immunoglobulins|immunoglobulins|mesh-list
65721911|NCT05063500|Antimetabolites|antimetabolites|mesh-ancestor
65722451|NCT02370680|Antipyretics|antipyretics|mesh-ancestor
65722746|NCT02788981|Paclitaxel|paclitaxel|mesh-list
65722974|NCT02356705|Lidocaine|lidocaine|mesh-list
65723265|NCT01066819|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65723937|NCT03576261|Polygeline|polygeline|mesh-list
65569466|NCT01238627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65724466|NCT04455711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65724927|NCT05424315|Dapagliflozin|dapagliflozin|mesh-list
65725077|NCT04343651|Leronlimab|leronlimab|mesh-list
65725149|NCT03463317|Analgesics|analgesics|mesh-ancestor
65725334|NCT02980133|Xhance|xhance|mesh-list
65725596|NCT04205968|Camptothecin|camptothecin|mesh-list
65725674|NCT03719001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65725900|NCT03640273|Loratadine|loratadine|mesh-list
65725974|NCT03652415|Lubricant Eye Drops|lubricant eye drops|mesh-list
65726201|NCT03444519|Mannitol|mannitol|mesh-list
65726347|NCT02481310|Hormones|hormones|mesh-ancestor
65726422|NCT05665647|Ritonavir|ritonavir|mesh-list
65042326|NCT00196586|Analgesics|analgesics|mesh-ancestor
65726875|NCT03618589|Anticonvulsants|anticonvulsants|mesh-ancestor
65727476|NCT02362256|Clonidine|clonidine|mesh-list
65727641|NCT03640403|Artesunate|artesunate|mesh-list
65727858|NCT02359214|Vitamin D|vitamin d|mesh-list
65728608|NCT02347046|Renal Agents|renal agents|mesh-ancestor
65728692|NCT02871791|Everolimus|everolimus|mesh-list
65728768|NCT02343614|Celecoxib|celecoxib|mesh-list
65729663|NCT02866175|Antithrombins|antithrombins|mesh-ancestor
65729744|NCT03389295|Cisplatin|cisplatin|mesh-list
65730349|NCT03380403|Ciprofloxacin|ciprofloxacin|mesh-list
65730628|NCT03382743|Lidocaine|lidocaine|mesh-list
65730930|NCT05080010|Carboplatin|carboplatin|mesh-list
65731453|NCT03602287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65732006|NCT02733133|Hormones|hormones|mesh-ancestor
65732217|NCT04444011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65732292|NCT04362566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732517|NCT03885713|Adalimumab|adalimumab|mesh-list
65569467|NCT01238627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732896|NCT02517957|Loperamide|loperamide|mesh-list
65733503|NCT04682522|Metronidazole|metronidazole|mesh-list
65569468|NCT03733145|Angiotensin II|angiotensin ii|mesh-list
65733876|NCT00406393|Antimetabolites|antimetabolites|mesh-ancestor
65734250|NCT04725032|Propofol|propofol|mesh-list
65734340|NCT02246179|Autonomic Agents|autonomic agents|mesh-ancestor
65735305|NCT02496741|Amebicides|amebicides|mesh-ancestor
65735761|NCT02122718|Antioxidants|antioxidants|mesh-ancestor
65737281|NCT01355575|Rifaximin|rifaximin|mesh-list
65569469|NCT03733145|Giapreza|giapreza|mesh-list
65569470|NCT03733145|Angiotensinogen|angiotensinogen|mesh-list
65569471|NCT03733145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65569472|NCT03733145|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65569473|NCT03733145|Protease Inhibitors|protease inhibitors|mesh-ancestor
65569474|NCT03733145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569475|NCT03733145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569476|NCT01321021|Diphenhydramine|diphenhydramine|mesh-list
65569477|NCT01321021|Promethazine|promethazine|mesh-list
65569478|NCT01321021|Losartan|losartan|mesh-list
65569479|NCT01321021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65569480|NCT01321021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65569481|NCT01321021|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65569482|NCT01321021|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65569483|NCT01321021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569484|NCT01321021|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65569485|NCT01321021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65569486|NCT01321021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65569487|NCT01321021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569488|NCT01321021|Anesthetics, Local|anesthetics, local|mesh-ancestor
65569489|NCT01321021|Anesthetics|anesthetics|mesh-ancestor
65569490|NCT01321021|Sensory System Agents|sensory system agents|mesh-ancestor
65569491|NCT01321021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65569492|NCT01321021|Antiemetics|antiemetics|mesh-ancestor
65569493|NCT01321021|Autonomic Agents|autonomic agents|mesh-ancestor
65569494|NCT01321021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65569495|NCT01321021|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65569496|NCT01321021|Histamine Antagonists|histamine antagonists|mesh-ancestor
65569497|NCT01321021|Histamine Agents|histamine agents|mesh-ancestor
65569498|NCT01321021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65569499|NCT01321021|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65569500|NCT01321021|Antipruritics|antipruritics|mesh-ancestor
65569501|NCT01321021|Dermatologic Agents|dermatologic agents|mesh-ancestor
65569502|NCT01238705|Metoprolol|metoprolol|mesh-list
65569503|NCT01238705|Felodipine|felodipine|mesh-list
65569504|NCT01238705|Irbesartan|irbesartan|mesh-list
65569505|NCT01238705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65569506|NCT01238705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65569507|NCT01238705|Sympatholytics|sympatholytics|mesh-ancestor
65569508|NCT01238705|Autonomic Agents|autonomic agents|mesh-ancestor
65569509|NCT01238705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65569510|NCT01238705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569511|NCT01238705|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65500655|NCT01170078|Epoetin Alfa|epoetin alfa|mesh-list
65500656|NCT01170078|Hematinics|hematinics|mesh-ancestor
65500657|NCT01283646|Vitamins|vitamins|mesh-list
65500658|NCT01283646|Folic Acid|folic acid|mesh-list
65500659|NCT01283646|Vitamin B Complex|vitamin b complex|mesh-list
65500660|NCT01283646|Micronutrients|micronutrients|mesh-ancestor
65500661|NCT01283646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500662|NCT01283646|Hematinics|hematinics|mesh-ancestor
65500663|NCT01283724|Dienogest|dienogest|mesh-list
65500664|NCT01283724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65500665|NCT01283724|Contraceptive Agents|contraceptive agents|mesh-ancestor
65500666|NCT01283724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65500667|NCT01283724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500668|NCT01283724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65500669|NCT01283724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65500670|NCT01283724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65500671|NCT01283724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65500672|NCT01283724|Hormone Antagonists|hormone antagonists|mesh-ancestor
65500673|NCT01283724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65500674|NCT01283724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65500675|NCT01283724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500676|NCT01586442|Eplerenone|eplerenone|mesh-list
65500677|NCT01586442|Spironolactone|spironolactone|mesh-list
65500678|NCT01586442|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65500679|NCT01586442|Hormone Antagonists|hormone antagonists|mesh-ancestor
65500680|NCT01586442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65500681|NCT01586442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500682|NCT01586442|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65500683|NCT01586442|Diuretics|diuretics|mesh-ancestor
65500684|NCT01586442|Natriuretic Agents|natriuretic agents|mesh-ancestor
65500685|NCT01586442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65500686|NCT01587066|Valproic Acid|valproic acid|mesh-list
65500687|NCT01587066|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65500688|NCT01587066|Antidepressive Agents|antidepressive agents|mesh-ancestor
65500689|NCT01587066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65500690|NCT01587066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65500691|NCT01587066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65500692|NCT01587066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65500693|NCT01587066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500694|NCT01587066|Anticonvulsants|anticonvulsants|mesh-ancestor
65500695|NCT01587066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500696|NCT01587066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500697|NCT01587066|GABA Agents|gaba agents|mesh-ancestor
65500698|NCT01587066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65500699|NCT01587066|Antimanic Agents|antimanic agents|mesh-ancestor
65500700|NCT01587144|Lucanthone|lucanthone|mesh-list
65500701|NCT01587144|Temozolomide|temozolomide|mesh-list
65500702|NCT01587144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65500703|NCT01587144|Alkylating Agents|alkylating agents|mesh-ancestor
65500704|NCT01587144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500705|NCT01587144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500706|NCT01587144|Schistosomicides|schistosomicides|mesh-ancestor
65500707|NCT01587144|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65500708|NCT01587144|Anthelmintics|anthelmintics|mesh-ancestor
65500709|NCT01587144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65500710|NCT01587144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65500711|NCT01587222|Octreotide|octreotide|mesh-list
65500712|NCT01587222|Midodrine|midodrine|mesh-list
65500713|NCT01587222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65500714|NCT01587222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65500715|NCT01587222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500716|NCT01587222|Sympathomimetics|sympathomimetics|mesh-ancestor
65500717|NCT01587222|Autonomic Agents|autonomic agents|mesh-ancestor
65500718|NCT01587222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65500719|NCT01587222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500720|NCT01587222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65500721|NCT01587222|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65500722|NCT01587222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65500723|NCT01587222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65500724|NCT01587222|Adrenergic Agents|adrenergic agents|mesh-ancestor
65500725|NCT01587222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65500726|NCT01587222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500727|NCT01167738|Metformin|metformin|mesh-list
65500728|NCT01167738|Gemcitabine|gemcitabine|mesh-list
65500729|NCT01167738|Capecitabine|capecitabine|mesh-list
65500730|NCT01167738|Epirubicin|epirubicin|mesh-list
65500731|NCT01167738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500732|NCT01167738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65500733|NCT01167738|Antimetabolites|antimetabolites|mesh-ancestor
65500734|NCT01167738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500735|NCT01167738|Antiviral Agents|antiviral agents|mesh-ancestor
65500736|NCT01167738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65500737|NCT01167738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500738|NCT01167738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65500739|NCT01167738|Immunologic Factors|immunologic factors|mesh-ancestor
65500740|NCT01167738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500741|NCT01167738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65500742|NCT01167738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65500743|NCT01167738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65500744|NCT01167738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65500745|NCT01167816|Azacitidine|azacitidine|mesh-list
65500746|NCT01167816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65500747|NCT01167816|Antimetabolites|antimetabolites|mesh-ancestor
65500748|NCT01167816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500749|NCT01167816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500750|NCT01167816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500751|NCT01167894|Simvastatin|simvastatin|mesh-list
65500752|NCT01167894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65500753|NCT01167894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65500754|NCT01167894|Antimetabolites|antimetabolites|mesh-ancestor
65500755|NCT01167894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500756|NCT01167894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65500757|NCT01167894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65500758|NCT01167894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500759|NCT03870828|Dimercaprol|dimercaprol|mesh-list
65500760|NCT03870828|Chelating Agents|chelating agents|mesh-ancestor
65500761|NCT03870828|Sequestering Agents|sequestering agents|mesh-ancestor
65500762|NCT03870828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500763|NCT03870594|Chrysarobin|chrysarobin|mesh-list
65500764|NCT03870594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65500765|NCT03870594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65500766|NCT03870594|Analgesics|analgesics|mesh-ancestor
65500767|NCT03870594|Sensory System Agents|sensory system agents|mesh-ancestor
65500768|NCT03870594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65500769|NCT03870594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500770|NCT03870594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65500771|NCT03870594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65500772|NCT01165866|Ondansetron|ondansetron|mesh-list
65500773|NCT01165866|Metoclopramide|metoclopramide|mesh-list
65500774|NCT01165866|Antiemetics|antiemetics|mesh-ancestor
65500775|NCT01165866|Autonomic Agents|autonomic agents|mesh-ancestor
65500776|NCT01165866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65500777|NCT01165866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500778|NCT01165866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65500779|NCT01165866|Antipruritics|antipruritics|mesh-ancestor
65500780|NCT01165866|Dermatologic Agents|dermatologic agents|mesh-ancestor
65500781|NCT01165866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65500782|NCT01165866|Serotonin Agents|serotonin agents|mesh-ancestor
65500783|NCT01165866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65500784|NCT01165866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500785|NCT01165866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65500786|NCT01165866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65500787|NCT01165866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65500788|NCT01165866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65500789|NCT01165866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65500790|NCT01165866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65500791|NCT01165866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65500792|NCT01165866|Dopamine Agents|dopamine agents|mesh-ancestor
65500793|NCT01170468|Vitamin D|vitamin d|mesh-list
65500794|NCT01170468|Cholecalciferol|cholecalciferol|mesh-list
65500795|NCT01170468|Vitamins|vitamins|mesh-ancestor
65500796|NCT01170468|Micronutrients|micronutrients|mesh-ancestor
65500797|NCT01170468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500798|NCT01170468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65500799|NCT01170468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65500800|NCT01273584|Metformin|metformin|mesh-list
65500801|NCT01273584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65500802|NCT01273584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500803|NCT01281852|Paclitaxel|paclitaxel|mesh-list
65500804|NCT01281852|Cisplatin|cisplatin|mesh-list
65500805|NCT01281852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65500806|NCT01281852|Veliparib|veliparib|mesh-list
65053245|NCT00179959|Eusol|eusol|mesh-list
65500807|NCT01281852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65500808|NCT01281852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500809|NCT01281852|Tubulin Modulators|tubulin modulators|mesh-ancestor
65500810|NCT01281852|Antimitotic Agents|antimitotic agents|mesh-ancestor
65500811|NCT01281852|Mitosis Modulators|mitosis modulators|mesh-ancestor
65500812|NCT01281852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500813|NCT01281852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65500814|NCT01281852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500815|NCT01168440|Sunitinib|sunitinib|mesh-list
65500816|NCT01168440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500817|NCT01168440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65500818|NCT01168440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65500819|NCT01168440|Growth Substances|growth substances|mesh-ancestor
65500820|NCT01168440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500821|NCT01168440|Growth Inhibitors|growth inhibitors|mesh-ancestor
65500822|NCT01168440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65500823|NCT01168440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500824|NCT01168440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500825|NCT01170780|Dexamethasone|dexamethasone|mesh-list
65500826|NCT01170780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65500827|NCT01170780|Antiemetics|antiemetics|mesh-ancestor
65500828|NCT01170780|Autonomic Agents|autonomic agents|mesh-ancestor
65500829|NCT01170780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65500830|NCT01170780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500831|NCT01170780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65500832|NCT01170780|Glucocorticoids|glucocorticoids|mesh-ancestor
65500833|NCT01170780|Hormones|hormones|mesh-ancestor
65500834|NCT01170780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65500835|NCT01170780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65500836|NCT01170780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500837|NCT01165944|Pramlintide|pramlintide|mesh-list
65500838|NCT01165944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65500839|NCT01165944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500840|NCT01170858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65500841|NCT01170858|Icodextrin|icodextrin|mesh-list
65500842|NCT01170858|Dialysis Solutions|dialysis solutions|mesh-ancestor
65500843|NCT01171092|Bortezomib|bortezomib|mesh-list
65500844|NCT01171092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500845|NCT03753204|Furosemide|furosemide|mesh-list
65500846|NCT03753204|Diuretics|diuretics|mesh-ancestor
65500847|NCT03753204|Natriuretic Agents|natriuretic agents|mesh-ancestor
65500848|NCT03753204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500849|NCT03753204|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65500850|NCT03753204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65500851|NCT03753204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500852|NCT01171170|Paclitaxel|paclitaxel|mesh-list
65500853|NCT01171170|Bevacizumab|bevacizumab|mesh-list
65500854|NCT01171170|Carboplatin|carboplatin|mesh-list
65500855|NCT01171170|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65500856|NCT01171170|Nitroglycerin|nitroglycerin|mesh-list
65500857|NCT01171170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65500858|NCT01171170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500859|NCT01171170|Tubulin Modulators|tubulin modulators|mesh-ancestor
65500860|NCT01171170|Antimitotic Agents|antimitotic agents|mesh-ancestor
65500861|NCT01171170|Mitosis Modulators|mitosis modulators|mesh-ancestor
65500862|NCT01171170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500863|NCT01171170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65500864|NCT01171170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65500865|NCT01171170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65500866|NCT01171170|Growth Substances|growth substances|mesh-ancestor
65500867|NCT01171170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500868|NCT01171170|Growth Inhibitors|growth inhibitors|mesh-ancestor
65500869|NCT01171170|Vasodilator Agents|vasodilator agents|mesh-ancestor
65500870|NCT01166100|Fluoxetine|fluoxetine|mesh-list
65500871|NCT01166100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65500872|NCT01166100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65500873|NCT01166100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65500874|NCT01166100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500875|NCT01166100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65500876|NCT01166100|Serotonin Agents|serotonin agents|mesh-ancestor
65500877|NCT01166100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500878|NCT01166100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65500879|NCT01166100|Antidepressive Agents|antidepressive agents|mesh-ancestor
65500880|NCT01166100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65298603|NCT05255146|Nitrous Oxide|nitrous oxide|mesh-list
65500881|NCT01166100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65500882|NCT01166100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65500883|NCT01166100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500884|NCT01277016|Melphalan|melphalan|mesh-list
65500885|NCT01277016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65500886|NCT01277016|Alkylating Agents|alkylating agents|mesh-ancestor
65500887|NCT01277016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500888|NCT01277016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500889|NCT01277016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65500890|NCT01277016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65500891|NCT01277016|Immunologic Factors|immunologic factors|mesh-ancestor
65500892|NCT01277016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500893|NCT01171326|Minocycline|minocycline|mesh-list
65500894|NCT01171326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65500895|NCT01171326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65500896|NCT01171482|Fluorouracil|fluorouracil|mesh-list
65500897|NCT01171482|Sorafenib|sorafenib|mesh-list
65500898|NCT01171482|Mitomycins|mitomycins|mesh-list
65500899|NCT01171482|Mitomycin|mitomycin|mesh-list
65500900|NCT01171482|Antimetabolites|antimetabolites|mesh-ancestor
65500901|NCT01171482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500902|NCT01171482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65500903|NCT01171482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500904|NCT01171482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65500905|NCT01171482|Immunologic Factors|immunologic factors|mesh-ancestor
65500906|NCT01171482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500907|NCT01171482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65500908|NCT01171482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500909|NCT01171482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65500910|NCT01171482|Alkylating Agents|alkylating agents|mesh-ancestor
65500911|NCT01171482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65500912|NCT01282398|Simvastatin|simvastatin|mesh-list
65500913|NCT01282398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65500914|NCT01282398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65500915|NCT01282398|Antimetabolites|antimetabolites|mesh-ancestor
65500916|NCT01282398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500917|NCT01282398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65500918|NCT01282398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65500919|NCT01282398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500920|NCT01169142|Vitamin D|vitamin d|mesh-list
65500921|NCT01169142|Ergocalciferols|ergocalciferols|mesh-list
65500922|NCT01169142|Cholecalciferol|cholecalciferol|mesh-list
65500923|NCT01169142|Vitamins|vitamins|mesh-list
65500924|NCT01169142|Micronutrients|micronutrients|mesh-ancestor
65500925|NCT01169142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500926|NCT01169142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65500927|NCT01169142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65500928|NCT01169298|Lenalidomide|lenalidomide|mesh-list
65500929|NCT01169298|Immunologic Factors|immunologic factors|mesh-ancestor
65500930|NCT01169298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500931|NCT01169298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65500932|NCT01169298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65500933|NCT01169298|Growth Substances|growth substances|mesh-ancestor
65500934|NCT01169298|Growth Inhibitors|growth inhibitors|mesh-ancestor
65500935|NCT01169298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500936|NCT01277484|Decitabine|decitabine|mesh-list
65500937|NCT01277484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65500938|NCT01277484|Antimetabolites|antimetabolites|mesh-ancestor
65500939|NCT01277484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500940|NCT01277484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500941|NCT01277484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500942|NCT01282632|Olanzapine|olanzapine|mesh-list
65500943|NCT01282632|Risperidone|risperidone|mesh-list
65500944|NCT01282632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65500945|NCT01282632|Serotonin Agents|serotonin agents|mesh-ancestor
65500946|NCT01282632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65500947|NCT01282632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500948|NCT01282632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500949|NCT01282632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65500950|NCT01282632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65500951|NCT01282632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65500952|NCT01282632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65500953|NCT01282632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65500954|NCT01282632|Dopamine Agents|dopamine agents|mesh-ancestor
65500955|NCT01282632|Antiemetics|antiemetics|mesh-ancestor
65500956|NCT01282632|Autonomic Agents|autonomic agents|mesh-ancestor
65500957|NCT01282632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65500958|NCT01282632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65500959|NCT01282632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65500960|NCT01282632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65500961|NCT01282632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65500962|NCT01172028|Docetaxel|docetaxel|mesh-list
65500963|NCT01172028|Pemetrexed|pemetrexed|mesh-list
65500964|NCT01172028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500965|NCT01172028|Tubulin Modulators|tubulin modulators|mesh-ancestor
65500966|NCT01172028|Antimitotic Agents|antimitotic agents|mesh-ancestor
65500967|NCT01172028|Mitosis Modulators|mitosis modulators|mesh-ancestor
65500968|NCT01172028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500969|NCT01172028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500970|NCT01172028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65500971|NCT01172028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65500972|NCT01278186|Paclitaxel|paclitaxel|mesh-list
65500973|NCT01278186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65500974|NCT01278186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500975|NCT01278186|Tubulin Modulators|tubulin modulators|mesh-ancestor
65500976|NCT01278186|Antimitotic Agents|antimitotic agents|mesh-ancestor
65500977|NCT01278186|Mitosis Modulators|mitosis modulators|mesh-ancestor
65500978|NCT01278186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500979|NCT01169688|Phenylephrine|phenylephrine|mesh-list
65500980|NCT01169688|Oxymetazoline|oxymetazoline|mesh-list
65500981|NCT01169688|Cyclopentolate|cyclopentolate|mesh-list
65500982|NCT01169688|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65500983|NCT01169688|Mydriatics|mydriatics|mesh-ancestor
65500984|NCT01169688|Autonomic Agents|autonomic agents|mesh-ancestor
65500985|NCT01169688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65500986|NCT01169688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500987|NCT01169688|Sympathomimetics|sympathomimetics|mesh-ancestor
65500988|NCT01169688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65500989|NCT01169688|Nasal Decongestants|nasal decongestants|mesh-ancestor
65500990|NCT01169688|Respiratory System Agents|respiratory system agents|mesh-ancestor
65500991|NCT01169688|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65500992|NCT01169688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65500993|NCT01169688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65500994|NCT01169688|Adrenergic Agents|adrenergic agents|mesh-ancestor
65500995|NCT01169688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65500996|NCT01169688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500997|NCT01169688|Protective Agents|protective agents|mesh-ancestor
65500998|NCT01169688|Parasympatholytics|parasympatholytics|mesh-ancestor
65500999|NCT01169688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65501000|NCT01169688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65501001|NCT01169688|Cholinergic Agents|cholinergic agents|mesh-ancestor
65501002|NCT01278264|Ropivacaine|ropivacaine|mesh-list
65501003|NCT01278264|Anesthetics, Local|anesthetics, local|mesh-ancestor
65501004|NCT01278264|Anesthetics|anesthetics|mesh-ancestor
65501005|NCT01278264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65501006|NCT01278264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501007|NCT01278264|Sensory System Agents|sensory system agents|mesh-ancestor
65501008|NCT01278264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65501009|NCT01172652|Ziprasidone|ziprasidone|mesh-list
65501010|NCT01172652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65501011|NCT01172652|Serotonin Agents|serotonin agents|mesh-ancestor
65501012|NCT01172652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65501013|NCT01172652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501014|NCT01172652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501015|NCT01172652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65501016|NCT01172652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65501017|NCT01172652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65501018|NCT01172652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65501019|NCT01172652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65501020|NCT01172652|Dopamine Agents|dopamine agents|mesh-ancestor
65501021|NCT02526030|Aripiprazole|aripiprazole|mesh-list
65501022|NCT02526030|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65501023|NCT02526030|Ziprasidone|ziprasidone|mesh-list
65501024|NCT02526030|Antidepressive Agents|antidepressive agents|mesh-ancestor
65501025|NCT02526030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65501026|NCT02526030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65501027|NCT02526030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65501028|NCT02526030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65298749|NCT00679250|Cetirizine|cetirizine|mesh-list
65501029|NCT02526030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501030|NCT02526030|Dopamine Agonists|dopamine agonists|mesh-ancestor
65501031|NCT02526030|Dopamine Agents|dopamine agents|mesh-ancestor
65501032|NCT02526030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65501033|NCT02526030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501034|NCT02526030|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65501035|NCT02526030|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65501036|NCT02526030|Serotonin Agents|serotonin agents|mesh-ancestor
65501037|NCT02526030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65501038|NCT02526030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65501039|NCT02526030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65501040|NCT02526030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65501041|NCT03867240|Gabapentin|gabapentin|mesh-list
65501042|NCT03867240|Analgesics|analgesics|mesh-ancestor
65501043|NCT03867240|Sensory System Agents|sensory system agents|mesh-ancestor
65501044|NCT03867240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65501045|NCT03867240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501046|NCT03867240|Anticonvulsants|anticonvulsants|mesh-ancestor
65501047|NCT03867240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65501048|NCT03867240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65501049|NCT03867240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65501050|NCT03867240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65501051|NCT03867240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65501052|NCT03867240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65501053|NCT03867240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65501054|NCT03867240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501055|NCT03867240|Antimanic Agents|antimanic agents|mesh-ancestor
65501056|NCT01172964|Flucytosine|flucytosine|mesh-list
65501057|NCT01172964|Antifungal Agents|antifungal agents|mesh-ancestor
65501058|NCT01172964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65501059|NCT01172964|Antimetabolites|antimetabolites|mesh-ancestor
65501060|NCT01172964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501061|NCT03866928|Stiripentol|stiripentol|mesh-list
65501062|NCT03866928|Anticonvulsants|anticonvulsants|mesh-ancestor
65501063|NCT01172496|Treprostinil|treprostinil|mesh-list
65501064|NCT01172496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65501065|NCT01178034|Warfarin|warfarin|mesh-list
65501066|NCT01178034|Anticoagulants|anticoagulants|mesh-ancestor
65501067|NCT01288170|Tobramycin|tobramycin|mesh-list
65501068|NCT01288170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65501069|NCT01288170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65501070|NCT01178112|Carboplatin|carboplatin|mesh-list
65501071|NCT01178112|Trientine|trientine|mesh-list
65501072|NCT01178112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501073|NCT01178112|Chelating Agents|chelating agents|mesh-ancestor
65501074|NCT01178112|Sequestering Agents|sequestering agents|mesh-ancestor
65501075|NCT01178112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501076|NCT01175460|Nedaplatin|nedaplatin|mesh-list
65501077|NCT01175460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501078|NCT01175538|Lactulose|lactulose|mesh-list
65501079|NCT01175538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65501080|NCT01288326|Liraglutide|liraglutide|mesh-list
65501081|NCT01288326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65501082|NCT01288326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501083|NCT01288326|Incretins|incretins|mesh-ancestor
65501084|NCT01288326|Hormones|hormones|mesh-ancestor
65501085|NCT01288326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65501086|NCT01173510|Raltegravir Potassium|raltegravir potassium|mesh-list
65501087|NCT01173510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65501088|NCT01173510|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65501089|NCT01173510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65501090|NCT01173510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65501091|NCT01173510|Antiviral Agents|antiviral agents|mesh-ancestor
65501092|NCT01173510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65501093|NCT01173510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65501094|NCT01173510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65501095|NCT01173510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65501096|NCT01173510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501097|NCT01173510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65501098|NCT01173510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65501099|NCT03435640|Nivolumab|nivolumab|mesh-list
65501100|NCT03435640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65501101|NCT03435640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501102|NCT03435640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65501103|NCT03435640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501104|NCT01175772|Celecoxib|celecoxib|mesh-list
65501105|NCT01175772|Methotrexate|methotrexate|mesh-list
65501106|NCT01175772|Cyclophosphamide|cyclophosphamide|mesh-list
65501107|NCT01175772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65501108|NCT01175772|Abortifacient Agents|abortifacient agents|mesh-ancestor
65501109|NCT01175772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65501110|NCT01175772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501111|NCT01175772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65501112|NCT01175772|Antimetabolites|antimetabolites|mesh-ancestor
65501113|NCT01175772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501114|NCT01175772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501115|NCT01175772|Dermatologic Agents|dermatologic agents|mesh-ancestor
65501116|NCT01175772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65501117|NCT01175772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65501118|NCT01175772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65501119|NCT01175772|Immunologic Factors|immunologic factors|mesh-ancestor
65501120|NCT01175772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65501121|NCT01175772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65501122|NCT01175772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65501123|NCT01175772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65501124|NCT01175772|Analgesics|analgesics|mesh-ancestor
65501125|NCT01175772|Sensory System Agents|sensory system agents|mesh-ancestor
65501126|NCT01175772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65501127|NCT01175772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65501128|NCT01175772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65501129|NCT01175772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65501130|NCT01175772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65501131|NCT01175772|Alkylating Agents|alkylating agents|mesh-ancestor
65501132|NCT01175772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65501133|NCT03395392|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65501134|NCT03395392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65501135|NCT03395392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65501136|NCT03395392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65501137|NCT03395392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501138|NCT03395392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65501139|NCT03395392|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65501140|NCT03395392|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65501141|NCT03395392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65501142|NCT03395392|Adrenergic Agents|adrenergic agents|mesh-ancestor
65501143|NCT03395392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65501144|NCT03395392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501145|NCT03395392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65501146|NCT03395392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65501147|NCT03395392|Serotonin Agents|serotonin agents|mesh-ancestor
65501148|NCT03395392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65501149|NCT03395392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65501150|NCT03395392|Dopamine Agents|dopamine agents|mesh-ancestor
65501151|NCT01536964|Morphine|morphine|mesh-list
65501152|NCT01536964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65501153|NCT01536964|Narcotics|narcotics|mesh-ancestor
65501154|NCT01536964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65501155|NCT01536964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501156|NCT01536964|Analgesics|analgesics|mesh-ancestor
65501157|NCT01536964|Sensory System Agents|sensory system agents|mesh-ancestor
65501158|NCT01536964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65501159|NCT01288404|Fluorometholone|fluorometholone|mesh-list
65501160|NCT01288404|Bevacizumab|bevacizumab|mesh-list
65501161|NCT01288404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65501162|NCT01288404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501163|NCT01288404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65501164|NCT01288404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65501165|NCT01288404|Growth Substances|growth substances|mesh-ancestor
65501166|NCT01288404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501167|NCT01288404|Growth Inhibitors|growth inhibitors|mesh-ancestor
65501168|NCT01288404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65501169|NCT01288404|Glucocorticoids|glucocorticoids|mesh-ancestor
65501170|NCT01288404|Hormones|hormones|mesh-ancestor
65501171|NCT01288404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65501172|NCT01288404|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65501173|NCT03860220|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
65501174|NCT03860220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65501175|NCT03860220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65501176|NCT03860220|Antimetabolites|antimetabolites|mesh-ancestor
65501177|NCT03860220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501178|NCT03860220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65501179|NCT03860220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65501180|NCT03860220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65501181|NCT03860220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65501182|NCT03860220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65501183|NCT03860220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501184|NCT03860220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65501185|NCT03860220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65501186|NCT03859908|Ethanol|ethanol|mesh-list
65501187|NCT03859908|Chlorhexidine|chlorhexidine|mesh-list
65501188|NCT03859908|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65501189|NCT03859908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65501190|NCT03859908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65501191|NCT03859908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65501192|NCT03859908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501193|NCT03859908|Disinfectants|disinfectants|mesh-ancestor
65501194|NCT03859908|Dermatologic Agents|dermatologic agents|mesh-ancestor
65501195|NCT01286688|Terbinafine|terbinafine|mesh-list
65501196|NCT01286688|Antifungal Agents|antifungal agents|mesh-ancestor
65501197|NCT01286688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65501198|NCT01286688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65501199|NCT01286688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501200|NCT01286766|Cisplatin|cisplatin|mesh-list
65501201|NCT01286766|Docetaxel|docetaxel|mesh-list
65501202|NCT01286766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501203|NCT01286766|Tubulin Modulators|tubulin modulators|mesh-ancestor
65501204|NCT01286766|Antimitotic Agents|antimitotic agents|mesh-ancestor
65501205|NCT01286766|Mitosis Modulators|mitosis modulators|mesh-ancestor
65501206|NCT01286766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501207|NCT02525484|Pirfenidone|pirfenidone|mesh-list
65501208|NCT02525484|Analgesics|analgesics|mesh-ancestor
65501209|NCT02525484|Sensory System Agents|sensory system agents|mesh-ancestor
65501210|NCT02525484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65501211|NCT02525484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501212|NCT02525484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65501213|NCT02525484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65501214|NCT02525484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65501215|NCT02525484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65501216|NCT02525484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501217|NCT01173978|Prednisolone|prednisolone|mesh-list
65501218|NCT01173978|Hormones|hormones|mesh-list
65501219|NCT01173978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65501220|NCT01173978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501221|NCT01173978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65501222|NCT01173978|Glucocorticoids|glucocorticoids|mesh-ancestor
65501223|NCT01173978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65501224|NCT01173978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501225|NCT01174056|Pioglitazone|pioglitazone|mesh-list
65501226|NCT01174056|Zileuton|zileuton|mesh-list
65501227|NCT01174056|Hydroxyurea|hydroxyurea|mesh-list
65501228|NCT01174056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65501229|NCT01174056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501230|NCT01174056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65501231|NCT01174056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65501232|NCT01174056|Analgesics|analgesics|mesh-ancestor
65501233|NCT01174056|Sensory System Agents|sensory system agents|mesh-ancestor
65501234|NCT01174056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65501235|NCT01174056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65501236|NCT01174056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65501237|NCT01174056|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65501238|NCT01174056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65501239|NCT01174056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501240|NCT01174056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65501241|NCT01174056|Hormone Antagonists|hormone antagonists|mesh-ancestor
65501242|NCT01174056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65501243|NCT01174056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501244|NCT01174056|Antisickling Agents|antisickling agents|mesh-ancestor
65501245|NCT01174056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65501246|NCT01174212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65501247|NCT01174212|Vancomycin|vancomycin|mesh-list
65501248|NCT01174212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65501249|NCT01174212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65501250|NCT01174212|Antitubercular Agents|antitubercular agents|mesh-ancestor
65501251|NCT01174290|Haloperidol|haloperidol|mesh-list
65501252|NCT01174290|Haloperidol decanoate|haloperidol decanoate|mesh-list
65501253|NCT01174290|Antiemetics|antiemetics|mesh-ancestor
65298978|NCT00680654|Riociguat|riociguat|mesh-list
65501254|NCT01174290|Autonomic Agents|autonomic agents|mesh-ancestor
65501255|NCT01174290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65501256|NCT01174290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501257|NCT01174290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65501258|NCT01174290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65501259|NCT01174290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65501260|NCT01174290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65501261|NCT01174290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65501262|NCT01174290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65501263|NCT01174290|Dopamine Agents|dopamine agents|mesh-ancestor
65501264|NCT01174290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65501265|NCT01174290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501266|NCT01174290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65501267|NCT03862404|Epinephrine|epinephrine|mesh-list
65501268|NCT03862404|Bupivacaine|bupivacaine|mesh-list
65501269|NCT03862404|Anesthetics, Local|anesthetics, local|mesh-ancestor
65501270|NCT03862404|Anesthetics|anesthetics|mesh-ancestor
65501271|NCT03862404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65501272|NCT03862404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501273|NCT03862404|Sensory System Agents|sensory system agents|mesh-ancestor
65501274|NCT03862404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65501275|NCT03862404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65501276|NCT03862404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65501277|NCT03862404|Adrenergic Agents|adrenergic agents|mesh-ancestor
65501278|NCT03862404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65501279|NCT03862404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501280|NCT03862404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65501281|NCT03862404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65501282|NCT03862404|Autonomic Agents|autonomic agents|mesh-ancestor
65501283|NCT03862404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65501284|NCT03862404|Respiratory System Agents|respiratory system agents|mesh-ancestor
65501285|NCT03862404|Mydriatics|mydriatics|mesh-ancestor
65501286|NCT03862404|Sympathomimetics|sympathomimetics|mesh-ancestor
65501287|NCT03862404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65501288|NCT03865680|Fluorides|fluorides|mesh-list
65501289|NCT03865680|Sodium Fluoride|sodium fluoride|mesh-list
65501290|NCT03865680|Fluorides, Topical|fluorides, topical|mesh-list
65501291|NCT03865680|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
65501292|NCT03865680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501293|NCT03865680|Cariostatic Agents|cariostatic agents|mesh-ancestor
65501294|NCT03865680|Protective Agents|protective agents|mesh-ancestor
65501295|NCT01288716|Baclofen|baclofen|mesh-list
65501296|NCT01288716|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65501297|NCT01288716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501298|NCT01288716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65501299|NCT01288716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65501300|NCT01288716|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65501301|NCT01288716|GABA Agonists|gaba agonists|mesh-ancestor
65501302|NCT01288716|GABA Agents|gaba agents|mesh-ancestor
65501303|NCT01288716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65501304|NCT01288716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501305|NCT01285596|Mirabegron|mirabegron|mesh-list
65501306|NCT01285596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65501307|NCT01285596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65501308|NCT01285596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65501309|NCT01285596|Adrenergic Agents|adrenergic agents|mesh-ancestor
65501310|NCT01285596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65501311|NCT01285596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501312|NCT01285596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501313|NCT01285596|Urological Agents|urological agents|mesh-ancestor
65501314|NCT00655876|Paclitaxel|paclitaxel|mesh-list
65501315|NCT00655876|Cetuximab|cetuximab|mesh-list
65501316|NCT00655876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65501317|NCT00655876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501318|NCT00655876|Tubulin Modulators|tubulin modulators|mesh-ancestor
65501319|NCT00655876|Antimitotic Agents|antimitotic agents|mesh-ancestor
65501320|NCT00655876|Mitosis Modulators|mitosis modulators|mesh-ancestor
65501321|NCT00655876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501322|NCT00655876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65501323|NCT01176318|Erdosteine|erdosteine|mesh-list
65501324|NCT01176318|Expectorants|expectorants|mesh-ancestor
65501325|NCT01176318|Respiratory System Agents|respiratory system agents|mesh-ancestor
65501326|NCT01178658|Cytarabine|cytarabine|mesh-list
65053751|NCT00201305|Gemcitabine|gemcitabine|mesh-list
65299048|NCT00708591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65501327|NCT01178658|Etoposide|etoposide|mesh-list
65501328|NCT01178658|Melphalan|melphalan|mesh-list
65501329|NCT01178658|Busulfan|busulfan|mesh-list
65501330|NCT01178658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65501331|NCT01178658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501332|NCT01178658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65501333|NCT01178658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65501334|NCT01178658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65501335|NCT01178658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501336|NCT01178658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65501338|NCT01178658|Antiviral Agents|antiviral agents|mesh-ancestor
65501339|NCT01178658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65501340|NCT01178658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65501341|NCT01178658|Immunologic Factors|immunologic factors|mesh-ancestor
65501342|NCT01178658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501343|NCT01178658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65501344|NCT01178658|Alkylating Agents|alkylating agents|mesh-ancestor
65501345|NCT01178658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65501346|NCT03092752|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65501347|NCT03092752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501348|NCT01174524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65501349|NCT01174524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65501350|NCT01174524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65501351|NCT01174524|Gestodene|gestodene|mesh-list
65501352|NCT01174524|Femovan|femovan|mesh-list
65501353|NCT01174524|Contraceptive Agents|contraceptive agents|mesh-list
65501354|NCT01174524|Contraceptives, Oral|contraceptives, oral|mesh-list
65501355|NCT01174524|Estradiol|estradiol|mesh-list
65501356|NCT01174524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65501357|NCT01174524|Estrogens|estrogens|mesh-ancestor
65501358|NCT01174524|Hormones|hormones|mesh-ancestor
65501359|NCT01174524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65501360|NCT01174524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501361|NCT01174524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65501362|NCT01174524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65501363|NCT01174524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65501364|NCT01174524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65501365|NCT01174524|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65501366|NCT01174524|Progestins|progestins|mesh-ancestor
65501367|NCT01174524|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65501368|NCT02525172|Rituximab|rituximab|mesh-list
65501369|NCT02525172|Methotrexate|methotrexate|mesh-list
65501370|NCT02525172|Bortezomib|bortezomib|mesh-list
65501371|NCT02525172|Immunoglobulins|immunoglobulins|mesh-list
65501372|NCT02525172|Antibodies|antibodies|mesh-list
65501373|NCT02525172|gamma-Globulins|gamma-globulins|mesh-list
65501374|NCT02525172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65501375|NCT02525172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65501376|NCT02525172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65501377|NCT02525172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501378|NCT02525172|Immunologic Factors|immunologic factors|mesh-ancestor
65501379|NCT02525172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501380|NCT02525172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65501381|NCT02525172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65501382|NCT02525172|Abortifacient Agents|abortifacient agents|mesh-ancestor
65501383|NCT02525172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65501384|NCT02525172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65501385|NCT02525172|Antimetabolites|antimetabolites|mesh-ancestor
65501386|NCT02525172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501387|NCT02525172|Dermatologic Agents|dermatologic agents|mesh-ancestor
65501388|NCT02525172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65501389|NCT02525172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65501390|NCT02525172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65501391|NCT02525172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65501392|NCT00047008|Cisplatin|cisplatin|mesh-list
65501393|NCT00047008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501394|NCT01285674|Cisplatin|cisplatin|mesh-list
65501395|NCT01285674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501396|NCT03859362|Ertapenem|ertapenem|mesh-list
65501397|NCT03859362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65501398|NCT03859362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65501399|NCT05598580|Lenalidomide|lenalidomide|mesh-list
65501400|NCT05598580|Immunologic Factors|immunologic factors|mesh-ancestor
65501401|NCT05598580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501402|NCT05598580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65299123|NCT00685100|Triamcinolone|triamcinolone|mesh-list
65501403|NCT05598580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65501404|NCT05598580|Growth Substances|growth substances|mesh-ancestor
65501406|NCT05598580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501407|NCT01287546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65501408|NCT01287546|Trametinib|trametinib|mesh-list
65501409|NCT01287546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501410|NCT01287546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65501411|NCT01287546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65501412|NCT01287546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501413|NCT03182166|Golimumab|golimumab|mesh-list
65501414|NCT03182166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65501415|NCT03182166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65501416|NCT03182166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65501417|NCT03182166|Immunologic Factors|immunologic factors|mesh-ancestor
65501418|NCT03182166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501419|NCT03193216|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
65501420|NCT03193216|Antacids|antacids|mesh-ancestor
65501421|NCT03193216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501422|NCT03193216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65501423|NCT03864978|Rifaximin|rifaximin|mesh-list
65501424|NCT03864978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65501425|NCT03864978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65501426|NCT03864978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65501427|NCT01568788|Vaccines|vaccines|mesh-list
65501428|NCT01568788|Immunologic Factors|immunologic factors|mesh-ancestor
65501429|NCT01568788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501430|NCT01287624|Gemcitabine|gemcitabine|mesh-list
65501431|NCT01287624|Paclitaxel|paclitaxel|mesh-list
65501432|NCT01287624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65501433|NCT01287624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501434|NCT01287624|Tubulin Modulators|tubulin modulators|mesh-ancestor
65501435|NCT01287624|Antimitotic Agents|antimitotic agents|mesh-ancestor
65501436|NCT01287624|Mitosis Modulators|mitosis modulators|mesh-ancestor
65501437|NCT01287624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501438|NCT01287624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65501439|NCT01287624|Antimetabolites|antimetabolites|mesh-ancestor
65501440|NCT01287624|Antiviral Agents|antiviral agents|mesh-ancestor
65501441|NCT01287624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65501442|NCT01287624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65501443|NCT01287624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65501444|NCT01287624|Immunologic Factors|immunologic factors|mesh-ancestor
65501445|NCT01287624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501446|NCT05597800|Nivolumab|nivolumab|mesh-list
65501447|NCT05597800|Ipilimumab|ipilimumab|mesh-list
65501448|NCT05597800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65501449|NCT05597800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501450|NCT05597800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65501451|NCT05597800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501452|NCT01176552|Interferon-alpha|interferon-alpha|mesh-list
65501453|NCT01176552|Interferon alpha-2|interferon alpha-2|mesh-list
65501454|NCT01176552|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65501455|NCT01176552|Antiviral Agents|antiviral agents|mesh-ancestor
65501456|NCT01176552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65501457|NCT01176552|Immunologic Factors|immunologic factors|mesh-ancestor
65501458|NCT01176552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501459|NCT01176552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501460|NCT01179438|Dexmedetomidine|dexmedetomidine|mesh-list
65501461|NCT01179438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65501462|NCT01179438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65501463|NCT01179438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501464|NCT01179438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65501465|NCT01179438|Analgesics|analgesics|mesh-ancestor
65501466|NCT01179438|Sensory System Agents|sensory system agents|mesh-ancestor
65501467|NCT01179438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65501468|NCT01179438|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65501469|NCT01179438|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65501470|NCT01179438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65501471|NCT01179438|Adrenergic Agents|adrenergic agents|mesh-ancestor
65501472|NCT01179438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65501473|NCT01179438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501474|NCT03864666|Cilostazol|cilostazol|mesh-list
65501475|NCT03864666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65501476|NCT03864666|Autonomic Agents|autonomic agents|mesh-ancestor
65501477|NCT03864666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65299198|NCT02325011|Hormones|hormones|mesh-ancestor
65501478|NCT03864666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501479|NCT03864666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65501480|NCT03864666|Respiratory System Agents|respiratory system agents|mesh-ancestor
65501481|NCT03864666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65501482|NCT03864666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65501483|NCT03864666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501484|NCT03864666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65501485|NCT03864666|Vasodilator Agents|vasodilator agents|mesh-ancestor
65501486|NCT03864666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65501487|NCT03864666|Protective Agents|protective agents|mesh-ancestor
65501488|NCT03864666|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65501489|NCT03864666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65501490|NCT03864666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65501491|NCT03858972|Capecitabine|capecitabine|mesh-list
65501492|NCT03858972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65501493|NCT03858972|Antimetabolites|antimetabolites|mesh-ancestor
65501494|NCT03858972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501495|NCT03858972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501496|NCT03091348|Methyltestosterone|methyltestosterone|mesh-list
65501497|NCT03091348|Testosterone|testosterone|mesh-list
65501498|NCT03091348|Testosterone undecanoate|testosterone undecanoate|mesh-list
65501499|NCT03091348|Testosterone enanthate|testosterone enanthate|mesh-list
65501500|NCT03091348|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65501501|NCT03091348|Androgens|androgens|mesh-ancestor
65501502|NCT03091348|Hormones|hormones|mesh-ancestor
65501503|NCT03091348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65501504|NCT03091348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501505|NCT03091348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65501506|NCT03091348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501507|NCT03091348|Anabolic Agents|anabolic agents|mesh-ancestor
65501508|NCT02525016|Lidocaine|lidocaine|mesh-list
65501509|NCT02525016|Anesthetics, Local|anesthetics, local|mesh-ancestor
65501510|NCT02525016|Anesthetics|anesthetics|mesh-ancestor
65501511|NCT02525016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65501512|NCT02525016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501513|NCT02525016|Sensory System Agents|sensory system agents|mesh-ancestor
65501514|NCT02525016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65501515|NCT02525016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65501516|NCT02525016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65501517|NCT02525016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65501518|NCT02525016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65501519|NCT02525016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501520|NCT01179594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65501521|NCT01179594|Interferon-alpha|interferon-alpha|mesh-list
65501522|NCT01179594|Entecavir|entecavir|mesh-list
65501523|NCT01179594|Antiviral Agents|antiviral agents|mesh-ancestor
65501524|NCT01179594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65501525|NCT01179594|Immunologic Factors|immunologic factors|mesh-ancestor
65501526|NCT01179594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501527|NCT05597254|Niacin|niacin|mesh-list
65501528|NCT05597254|Niacinamide|niacinamide|mesh-list
65501529|NCT05597254|Nicotinic Acids|nicotinic acids|mesh-list
65501530|NCT05597254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65501531|NCT05597254|Antimetabolites|antimetabolites|mesh-ancestor
65501532|NCT05597254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501533|NCT05597254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65501534|NCT05597254|Vasodilator Agents|vasodilator agents|mesh-ancestor
65501535|NCT05597254|Vitamin B Complex|vitamin b complex|mesh-ancestor
65501536|NCT05597254|Vitamins|vitamins|mesh-ancestor
65501537|NCT05597254|Micronutrients|micronutrients|mesh-ancestor
65501538|NCT05597254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501539|NCT03751098|Phenylephrine|phenylephrine|mesh-list
65501540|NCT03751098|Oxymetazoline|oxymetazoline|mesh-list
65501541|NCT03751098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65501542|NCT03751098|Tropicamide|tropicamide|mesh-list
65501543|NCT03751098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65501544|NCT03751098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65501545|NCT03751098|Mydriatics|mydriatics|mesh-ancestor
65501546|NCT03751098|Autonomic Agents|autonomic agents|mesh-ancestor
65501547|NCT03751098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65501548|NCT03751098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501549|NCT03751098|Sympathomimetics|sympathomimetics|mesh-ancestor
65501550|NCT03751098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65501551|NCT03751098|Nasal Decongestants|nasal decongestants|mesh-ancestor
65501552|NCT03751098|Respiratory System Agents|respiratory system agents|mesh-ancestor
65054012|NCT00266058|Ritonavir|ritonavir|mesh-list
65501553|NCT03751098|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65501554|NCT03751098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65501555|NCT03751098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65501556|NCT03751098|Adrenergic Agents|adrenergic agents|mesh-ancestor
65501557|NCT03751098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65501558|NCT03751098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501559|NCT03751098|Protective Agents|protective agents|mesh-ancestor
65501560|NCT03751098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65501561|NCT03751098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65501562|NCT03751098|Cholinergic Agents|cholinergic agents|mesh-ancestor
65501563|NCT01176708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65501564|NCT01176708|Protease Inhibitors|protease inhibitors|mesh-ancestor
65501565|NCT01176708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65501566|NCT01176708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501567|NCT01176708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65501568|NCT01176708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501569|NCT01288794|Furosemide|furosemide|mesh-list
65501570|NCT01288794|Diuretics|diuretics|mesh-list
65501571|NCT01288794|Natriuretic Agents|natriuretic agents|mesh-ancestor
65501572|NCT01288794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501573|NCT01288794|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65501574|NCT01288794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65501575|NCT01288794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501576|NCT01288872|Praziquantel|praziquantel|mesh-list
65501577|NCT01288872|Anthelmintics|anthelmintics|mesh-ancestor
65501578|NCT01288872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65501579|NCT01288872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65501580|NCT03864588|Ropivacaine|ropivacaine|mesh-list
65501581|NCT03864588|Anesthetics, Local|anesthetics, local|mesh-ancestor
65501582|NCT03864588|Anesthetics|anesthetics|mesh-ancestor
65501583|NCT03864588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65501584|NCT03864588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501585|NCT03864588|Sensory System Agents|sensory system agents|mesh-ancestor
65501586|NCT03864588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65501587|NCT01288950|Vitamin D|vitamin d|mesh-list
65501588|NCT01288950|Ergocalciferols|ergocalciferols|mesh-list
65501589|NCT01288950|Cholecalciferol|cholecalciferol|mesh-list
65501590|NCT01288950|Vitamins|vitamins|mesh-list
65501591|NCT01288950|Micronutrients|micronutrients|mesh-ancestor
65501592|NCT01288950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501593|NCT01288950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65501594|NCT01288950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65501595|NCT01174914|Tenofovir|tenofovir|mesh-list
65501596|NCT01174914|Lamivudine|lamivudine|mesh-list
65501597|NCT01174914|Emtricitabine|emtricitabine|mesh-list
65501598|NCT01174914|Efavirenz|efavirenz|mesh-list
65501599|NCT01174914|Lopinavir|lopinavir|mesh-list
65501600|NCT01174914|Nevirapine|nevirapine|mesh-list
65501601|NCT01174914|Stavudine|stavudine|mesh-list
65501602|NCT01174914|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
65501603|NCT01174914|Naltrexone|naltrexone|mesh-list
65501604|NCT01174914|Antiviral Agents|antiviral agents|mesh-ancestor
65501605|NCT01174914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65501606|NCT01174914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65501607|NCT01174914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65501608|NCT01174914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65501609|NCT01174914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501610|NCT01174914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65501611|NCT01174914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65501612|NCT01174914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65501613|NCT01174914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65501614|NCT01174914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501615|NCT01174914|Sensory System Agents|sensory system agents|mesh-ancestor
65501616|NCT01174914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65501617|NCT01174914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65501618|NCT01174914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65501619|NCT01174914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65501620|NCT01174914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65501621|NCT01174914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65501622|NCT01174914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65501623|NCT01174914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65501624|NCT01174914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65501625|NCT01174914|Protease Inhibitors|protease inhibitors|mesh-ancestor
65501626|NCT01174914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65501627|NCT01174914|Antimetabolites|antimetabolites|mesh-ancestor
65299349|NCT03466450|Alkylating Agents|alkylating agents|mesh-ancestor
65501628|NCT05548426|Linezolid|linezolid|mesh-list
65501629|NCT05548426|Penicillins|penicillins|mesh-list
65501630|NCT05548426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65501631|NCT05548426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65501632|NCT05548426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65501633|NCT05548426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65501634|NCT05548426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501635|NCT03102892|Anti-Infective Agents|anti-infective agents|mesh-list
65501636|NCT03102892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65501637|NCT01177176|Bupropion|bupropion|mesh-list
65501638|NCT01177176|Nicotine|nicotine|mesh-list
65501639|NCT01177176|Varenicline|varenicline|mesh-list
65501640|NCT01177176|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65501641|NCT01177176|Autonomic Agents|autonomic agents|mesh-ancestor
65501642|NCT01177176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65501643|NCT01177176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501644|NCT01177176|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65501645|NCT01177176|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65501646|NCT01177176|Cholinergic Agents|cholinergic agents|mesh-ancestor
65501647|NCT01177176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65501648|NCT01177176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501649|NCT01177176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65501650|NCT01177176|Antidepressive Agents|antidepressive agents|mesh-ancestor
65501651|NCT01177176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65501652|NCT01177176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65501653|NCT01177176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65501654|NCT01177176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65501655|NCT01177176|Dopamine Agents|dopamine agents|mesh-ancestor
65501656|NCT01177176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65501657|NCT01177176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65501658|NCT01177176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65501659|NCT01287780|Gentamicins|gentamicins|mesh-list
65501660|NCT01287780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65501661|NCT01287780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65501662|NCT01287780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65501663|NCT01287780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65501664|NCT01287780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501665|NCT01179828|Oxycodone|oxycodone|mesh-list
65501666|NCT01179828|Clobazam|clobazam|mesh-list
65501667|NCT01179828|Imipramine|imipramine|mesh-list
65501668|NCT01179828|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65501669|NCT01179828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65501670|NCT01179828|Narcotics|narcotics|mesh-ancestor
65501671|NCT01179828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65501672|NCT01179828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501673|NCT01179828|Analgesics|analgesics|mesh-ancestor
65501674|NCT01179828|Sensory System Agents|sensory system agents|mesh-ancestor
65501675|NCT01179828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65501676|NCT01179828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65501677|NCT01179828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65501678|NCT01179828|Cholinergic Agents|cholinergic agents|mesh-ancestor
65501679|NCT01179828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65501680|NCT01179828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501681|NCT01179828|Urological Agents|urological agents|mesh-ancestor
65501682|NCT01179828|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65501683|NCT01179828|Antidepressive Agents|antidepressive agents|mesh-ancestor
65501684|NCT01179828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65501685|NCT01179828|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65501686|NCT01179828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65501687|NCT01179828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65501688|NCT01179828|Adrenergic Agents|adrenergic agents|mesh-ancestor
65501689|NCT01179828|Anticonvulsants|anticonvulsants|mesh-ancestor
65501690|NCT01179828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65501691|NCT01179828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65501692|NCT01179828|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65501693|NCT01179828|GABA Agonists|gaba agonists|mesh-ancestor
65501694|NCT01179828|GABA Agents|gaba agents|mesh-ancestor
65501695|NCT01180062|Latanoprost|latanoprost|mesh-list
65501696|NCT01180062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65501697|NCT01180062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65501698|NCT03858582|Pembrolizumab|pembrolizumab|mesh-list
65501699|NCT03858582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65501700|NCT03858582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501701|NCT01177566|Pimecrolimus|pimecrolimus|mesh-list
65501702|NCT01177566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65501703|NCT01177566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65501705|NCT01177566|Sensory System Agents|sensory system agents|mesh-ancestor
65501706|NCT01177566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65501707|NCT01177566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501708|NCT01177566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65501709|NCT01177566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65501710|NCT01177566|Dermatologic Agents|dermatologic agents|mesh-ancestor
65501711|NCT01177566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65501712|NCT01177566|Immunologic Factors|immunologic factors|mesh-ancestor
65501713|NCT01177566|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65501714|NCT01177566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65501715|NCT01177566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501716|NCT01181154|Rituximab|rituximab|mesh-list
65501717|NCT01181154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65501718|NCT01181154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501719|NCT01181154|Immunologic Factors|immunologic factors|mesh-ancestor
65501720|NCT01181154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501721|NCT01181154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65501722|NCT03101566|Gemcitabine|gemcitabine|mesh-list
65501723|NCT03101566|Nivolumab|nivolumab|mesh-list
65501724|NCT03101566|Ipilimumab|ipilimumab|mesh-list
65501725|NCT03101566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501726|NCT03101566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65501727|NCT03101566|Antimetabolites|antimetabolites|mesh-ancestor
65501728|NCT03101566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501729|NCT03101566|Antiviral Agents|antiviral agents|mesh-ancestor
65501730|NCT03101566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65501731|NCT03101566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65501732|NCT03101566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65501733|NCT03101566|Immunologic Factors|immunologic factors|mesh-ancestor
65501734|NCT03101566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501735|NCT03101566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65501736|NCT03101566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65501737|NCT01289496|Interferons|interferons|mesh-list
65501738|NCT01289496|Ribavirin|ribavirin|mesh-list
65501739|NCT01289496|Interferon-alpha|interferon-alpha|mesh-list
65501740|NCT01289496|Interferon alpha-2|interferon alpha-2|mesh-list
65501741|NCT01289496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65501742|NCT01289496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501743|NCT01289496|Antiviral Agents|antiviral agents|mesh-ancestor
65501744|NCT01289496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65501745|NCT01289496|Antimetabolites|antimetabolites|mesh-ancestor
65501746|NCT01289496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501747|NCT01289496|Immunologic Factors|immunologic factors|mesh-ancestor
65501748|NCT01289496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501749|NCT01181232|Zolpidem|zolpidem|mesh-list
65501750|NCT01181232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65501751|NCT01181232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65501752|NCT01181232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65501753|NCT01181232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501754|NCT01181232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65501755|NCT01181232|GABA Agonists|gaba agonists|mesh-ancestor
65501756|NCT01181232|GABA Agents|gaba agents|mesh-ancestor
65501757|NCT01181232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65501758|NCT01181232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501759|NCT01181310|Scopolamine|scopolamine|mesh-list
65501760|NCT01181310|Donepezil|donepezil|mesh-list
65501761|NCT01181310|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65501762|NCT01181310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65501763|NCT01181310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65501764|NCT01181310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501765|NCT01181310|Cholinergic Agents|cholinergic agents|mesh-ancestor
65501766|NCT01181310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65501767|NCT01181310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501768|NCT01181310|Nootropic Agents|nootropic agents|mesh-ancestor
65501769|NCT01181310|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65501770|NCT01181310|Antiemetics|antiemetics|mesh-ancestor
65501771|NCT01181310|Autonomic Agents|autonomic agents|mesh-ancestor
65501772|NCT01181310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65501773|NCT01181310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65501774|NCT01181310|Mydriatics|mydriatics|mesh-ancestor
65501775|NCT01181310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65501776|NCT01181310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65501777|NCT01181310|Parasympatholytics|parasympatholytics|mesh-ancestor
65501778|NCT02525250|Lenalidomide|lenalidomide|mesh-list
65501779|NCT02525250|Immunologic Factors|immunologic factors|mesh-ancestor
65501780|NCT02525250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501781|NCT02525250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65501782|NCT02525250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65501783|NCT02525250|Growth Substances|growth substances|mesh-ancestor
65501784|NCT02525250|Growth Inhibitors|growth inhibitors|mesh-ancestor
65501785|NCT02525250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501786|NCT01288092|Dactolisib|dactolisib|mesh-list
65501787|NCT01288092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501788|NCT01290744|Clofazimine|clofazimine|mesh-list
65501789|NCT01290744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65501790|NCT01290744|Leprostatic Agents|leprostatic agents|mesh-ancestor
65501791|NCT01290744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65501792|NCT01290744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65501793|NCT01181388|Tirofiban|tirofiban|mesh-list
65501794|NCT01181388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65501795|NCT01181388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65501796|NCT01181388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501797|NCT01181388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65501798|NCT01181544|Heparin|heparin|mesh-list
65501799|NCT01181544|Anticoagulants|anticoagulants|mesh-ancestor
65501800|NCT01181544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65501801|NCT01181544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65501802|NCT01181544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501803|NCT01184664|Nicotine|nicotine|mesh-list
65501804|NCT01184664|Varenicline|varenicline|mesh-list
65501805|NCT01184664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65501806|NCT01184664|Autonomic Agents|autonomic agents|mesh-ancestor
65501807|NCT01184664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65501808|NCT01184664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501809|NCT01184664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65501810|NCT01184664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65501811|NCT01184664|Cholinergic Agents|cholinergic agents|mesh-ancestor
65501812|NCT01184664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65501813|NCT01184664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501814|NCT03858192|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65501815|NCT03858192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65501816|NCT01184820|Factor VIII|factor viii|mesh-list
65501817|NCT01184820|Coagulants|coagulants|mesh-ancestor
65501818|NCT03858270|Memantine|memantine|mesh-list
65501819|NCT03858270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65501820|NCT03858270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65501821|NCT03858270|Dopamine Agents|dopamine agents|mesh-ancestor
65501822|NCT03858270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65501823|NCT03858270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501824|NCT03858270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501825|NCT03858270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65501826|NCT03858270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65501827|NCT01289730|Etanercept|etanercept|mesh-list
65501828|NCT01289730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65501829|NCT01289730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65501830|NCT01289730|Analgesics|analgesics|mesh-ancestor
65501831|NCT01289730|Sensory System Agents|sensory system agents|mesh-ancestor
65501832|NCT01289730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65501833|NCT01289730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501834|NCT01289730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65501835|NCT01289730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65501836|NCT01289730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65501837|NCT01289730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65501838|NCT01289730|Immunologic Factors|immunologic factors|mesh-ancestor
65501839|NCT01290900|Moxifloxacin|moxifloxacin|mesh-list
65501840|NCT01290900|Ceftazidime|ceftazidime|mesh-list
65501841|NCT01290900|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
65501842|NCT01290900|Avibactam|avibactam|mesh-list
65501843|NCT01290900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65501844|NCT01290900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65501845|NCT01290900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65501846|NCT01290900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65501847|NCT01290900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65501848|NCT01290900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501849|NCT01290900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501850|NCT01290900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65501851|NCT03855306|Glyburide|glyburide|mesh-list
65501852|NCT03855306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65501853|NCT03855306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501854|NCT03855384|Cisplatin|cisplatin|mesh-list
65501855|NCT03855384|Carboplatin|carboplatin|mesh-list
65501856|NCT03855384|Fluorouracil|fluorouracil|mesh-list
65501857|NCT03855384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501858|NCT03855384|Antimetabolites|antimetabolites|mesh-ancestor
65501859|NCT03855384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501860|NCT03855384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65501861|NCT03855384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65501862|NCT03855384|Immunologic Factors|immunologic factors|mesh-ancestor
65501863|NCT03855384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501864|NCT01181934|Nicotine|nicotine|mesh-list
65501865|NCT01181934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65501866|NCT01181934|Autonomic Agents|autonomic agents|mesh-ancestor
65501867|NCT01181934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65501868|NCT01181934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501869|NCT01181934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65501870|NCT01181934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65501871|NCT01181934|Cholinergic Agents|cholinergic agents|mesh-ancestor
65501872|NCT01181934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65501873|NCT01181934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501874|NCT01187862|Efavirenz|efavirenz|mesh-list
65501875|NCT01187862|Losartan|losartan|mesh-list
65501876|NCT01187862|Metoprolol|metoprolol|mesh-list
65501877|NCT01187862|Midazolam|midazolam|mesh-list
65501878|NCT01187862|Caffeine|caffeine|mesh-list
65501879|NCT01187862|Chlorzoxazone|chlorzoxazone|mesh-list
65501880|NCT01187862|Omeprazole|omeprazole|mesh-list
65501881|NCT01187862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65501882|NCT01187862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65501883|NCT01187862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65501884|NCT01187862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501885|NCT01187862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65501886|NCT01187862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65501887|NCT01187862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65501888|NCT01187862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65501889|NCT01187862|Anesthetics, General|anesthetics, general|mesh-ancestor
65501890|NCT01187862|Anesthetics|anesthetics|mesh-ancestor
65501891|NCT01187862|GABA Modulators|gaba modulators|mesh-ancestor
65501892|NCT01187862|GABA Agents|gaba agents|mesh-ancestor
65501893|NCT01187862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65501894|NCT01187862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501895|NCT01187862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65501896|NCT01187862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65501897|NCT01187862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65501898|NCT01187862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65501899|NCT01187862|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65501900|NCT01187862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65501901|NCT01187862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65501902|NCT01187862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65501903|NCT01187862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65501904|NCT01187862|Purinergic Agents|purinergic agents|mesh-ancestor
65501905|NCT01187862|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65501906|NCT01187862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65501907|NCT01187862|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65501908|NCT01187862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65501909|NCT01187862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65501910|NCT01187862|Antiviral Agents|antiviral agents|mesh-ancestor
65501911|NCT01187862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65501912|NCT01187862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65501913|NCT01187862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65501914|NCT01187862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65501915|NCT01187862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65501916|NCT01187862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65501917|NCT01187862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65501918|NCT01187862|Sympatholytics|sympatholytics|mesh-ancestor
65501919|NCT01187862|Autonomic Agents|autonomic agents|mesh-ancestor
65501920|NCT01187862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65501921|NCT01187862|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65501922|NCT01187862|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65501923|NCT01187862|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65501924|NCT01187862|Adrenergic Agents|adrenergic agents|mesh-ancestor
65501925|NCT01187862|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65501926|NCT01187862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65501927|NCT01290042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65501928|NCT01290042|Immunologic Factors|immunologic factors|mesh-ancestor
65501929|NCT01290042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501930|NCT01185444|Hyaluronic Acid|hyaluronic acid|mesh-list
65299651|NCT00620867|Ibuprofen|ibuprofen|mesh-list
65501931|NCT01185444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65501932|NCT01185444|Immunologic Factors|immunologic factors|mesh-ancestor
65501933|NCT01185444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501935|NCT01185444|Protective Agents|protective agents|mesh-ancestor
65501936|NCT03857334|Cortivazol|cortivazol|mesh-list
65501937|NCT03857334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65501938|NCT01185678|Contraceptive Agents|contraceptive agents|mesh-list
65501939|NCT01185678|Desogestrel|desogestrel|mesh-list
65501940|NCT01185678|Contraceptives, Oral|contraceptives, oral|mesh-list
65501941|NCT01185678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65501942|NCT01185678|Progestins|progestins|mesh-list
65501943|NCT01185678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65501944|NCT01185678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501945|NCT01185678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65501946|NCT01185678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65501947|NCT01185678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65501948|NCT01185678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65501949|NCT01185678|Hormones|hormones|mesh-ancestor
65501950|NCT01185678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65501951|NCT01188174|Clofarabine|clofarabine|mesh-list
65501952|NCT01188174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65501953|NCT01188174|Antimetabolites|antimetabolites|mesh-ancestor
65501954|NCT01188174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501955|NCT01188174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501956|NCT01588002|Ritonavir|ritonavir|mesh-list
65501957|NCT01588002|Efavirenz|efavirenz|mesh-list
65501958|NCT01588002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65501959|NCT01588002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65501960|NCT01588002|Protease Inhibitors|protease inhibitors|mesh-ancestor
65501961|NCT01588002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65501962|NCT01588002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501963|NCT01588002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65501964|NCT01588002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65501965|NCT01588002|Antiviral Agents|antiviral agents|mesh-ancestor
65501966|NCT01588002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65501967|NCT01588002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65501968|NCT01588002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65501969|NCT01588002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65501970|NCT01588002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65501971|NCT01588002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65501972|NCT01588002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65501973|NCT01588002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65501974|NCT01588002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65501975|NCT01588002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65501976|NCT01291212|Methyltestosterone|methyltestosterone|mesh-list
65501977|NCT01291212|Testosterone|testosterone|mesh-list
65501978|NCT01291212|Testosterone undecanoate|testosterone undecanoate|mesh-list
65501979|NCT01291212|Testosterone enanthate|testosterone enanthate|mesh-list
65501980|NCT01291212|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65501981|NCT01291212|Androgens|androgens|mesh-ancestor
65501982|NCT01291212|Hormones|hormones|mesh-ancestor
65501983|NCT01291212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65501984|NCT01291212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65501985|NCT01291212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65501986|NCT01291212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501987|NCT01291212|Anabolic Agents|anabolic agents|mesh-ancestor
65501988|NCT01182168|Gemcitabine|gemcitabine|mesh-list
65501989|NCT01182168|Everolimus|everolimus|mesh-list
65501990|NCT01182168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65501991|NCT01182168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65501992|NCT01182168|Antimetabolites|antimetabolites|mesh-ancestor
65501993|NCT01182168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65501994|NCT01182168|Antiviral Agents|antiviral agents|mesh-ancestor
65501995|NCT01182168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65501996|NCT01182168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65501997|NCT01182168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65501998|NCT01182168|Immunologic Factors|immunologic factors|mesh-ancestor
65501999|NCT01182168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502000|NCT01182246|Genistein|genistein|mesh-list
65502001|NCT01182246|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65502002|NCT01182246|Protective Agents|protective agents|mesh-ancestor
65502003|NCT01182246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299723|NCT00698724|Analgesics|analgesics|mesh-ancestor
65502004|NCT01182246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502005|NCT01182246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65502006|NCT01182246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502007|NCT01182246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502009|NCT01182246|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65502010|NCT01182246|Estrogens|estrogens|mesh-ancestor
65502011|NCT01182246|Hormones|hormones|mesh-ancestor
65502012|NCT01182246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65502013|NCT01588626|Ticagrelor|ticagrelor|mesh-list
65502014|NCT01588626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65502015|NCT01588626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65502016|NCT01588626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65502017|NCT01588626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65502018|NCT01588626|Purinergic Agents|purinergic agents|mesh-ancestor
65502019|NCT01588626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65502020|NCT01588626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502021|NCT01588626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502022|NCT01290120|Rituximab|rituximab|mesh-list
65502023|NCT01290120|Doxorubicin|doxorubicin|mesh-list
65502024|NCT01290120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65502025|NCT01290120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502026|NCT01290120|Immunologic Factors|immunologic factors|mesh-ancestor
65502027|NCT01290120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502028|NCT01290120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65502029|NCT01290120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65502030|NCT01290120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65502031|NCT01290120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65502032|NCT01290120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502033|NCT01290120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502034|NCT01290198|Fluconazole|fluconazole|mesh-list
65502035|NCT01290198|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
65502036|NCT01290198|Antifungal Agents|antifungal agents|mesh-ancestor
65502037|NCT01290198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65502038|NCT01290198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65502039|NCT01290198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65502040|NCT01290198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502041|NCT01290198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502042|NCT01290198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65502043|NCT01290198|Hormone Antagonists|hormone antagonists|mesh-ancestor
65502044|NCT01290198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65502045|NCT01290198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502046|NCT01290198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65502047|NCT01290198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65502048|NCT01290276|Ondansetron|ondansetron|mesh-list
65502049|NCT01290276|Methylphenidate|methylphenidate|mesh-list
65502050|NCT01290276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65502051|NCT01290276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502052|NCT01290276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65502053|NCT01290276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65502054|NCT01290276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65502055|NCT01290276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502056|NCT01290276|Dopamine Agents|dopamine agents|mesh-ancestor
65502057|NCT01290276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65502058|NCT01290276|Antiemetics|antiemetics|mesh-ancestor
65502059|NCT01290276|Autonomic Agents|autonomic agents|mesh-ancestor
65502060|NCT01290276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65502061|NCT01290276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65502062|NCT01290276|Antipruritics|antipruritics|mesh-ancestor
65502063|NCT01290276|Dermatologic Agents|dermatologic agents|mesh-ancestor
65502064|NCT01290276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65502065|NCT01290276|Serotonin Agents|serotonin agents|mesh-ancestor
65502066|NCT01290276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65502067|NCT01290276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65502068|NCT01290276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65502069|NCT01290276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65502070|NCT01290276|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65502071|NCT03856866|Hydroxychloroquine|hydroxychloroquine|mesh-list
65502072|NCT03856866|Antimalarials|antimalarials|mesh-ancestor
65502073|NCT03856866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65502074|NCT03856866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65502075|NCT03856866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65502076|NCT03856866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502077|NCT03856866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502078|NCT03856866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65502079|NCT01587768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65502080|NCT01587768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65502082|NCT01182636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65502083|NCT01182636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65502084|NCT01182636|Analgesics|analgesics|mesh-ancestor
65502085|NCT01182636|Sensory System Agents|sensory system agents|mesh-ancestor
65502086|NCT01182636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65502087|NCT01182636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502088|NCT01182636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65502089|NCT01182636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65502090|NCT01182636|Dermatologic Agents|dermatologic agents|mesh-ancestor
65502091|NCT01290354|Lapatinib|lapatinib|mesh-list
65502092|NCT01290354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502093|NCT01290354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65502094|NCT01290354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502095|NCT01290354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502096|NCT01188408|Docetaxel|docetaxel|mesh-list
65502097|NCT01188408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502098|NCT01188408|Tubulin Modulators|tubulin modulators|mesh-ancestor
65502099|NCT01188408|Antimitotic Agents|antimitotic agents|mesh-ancestor
65502100|NCT01188408|Mitosis Modulators|mitosis modulators|mesh-ancestor
65502101|NCT01188408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502102|NCT01186146|Aspirin|aspirin|mesh-list
65502103|NCT01186146|Clopidogrel|clopidogrel|mesh-list
65502104|NCT01186146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65502105|NCT01186146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65502106|NCT01186146|Analgesics|analgesics|mesh-ancestor
65502107|NCT01186146|Sensory System Agents|sensory system agents|mesh-ancestor
65502108|NCT01186146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65502109|NCT01186146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502110|NCT01186146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65502111|NCT01186146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65502112|NCT01186146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65502113|NCT01186146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65502114|NCT01186146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502115|NCT01186146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65502116|NCT01186146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65502117|NCT01186146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502118|NCT01186146|Antipyretics|antipyretics|mesh-ancestor
65502119|NCT01186146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65502120|NCT01186146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65502121|NCT01186146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65502122|NCT01186146|Purinergic Agents|purinergic agents|mesh-ancestor
65502123|NCT01186146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65502124|NCT01186224|Plerixafor|plerixafor|mesh-list
65502125|NCT01186224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65502126|NCT01186224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65502127|NCT01186224|Antiviral Agents|antiviral agents|mesh-ancestor
65502128|NCT01186224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65502129|NCT01183494|Irinotecan|irinotecan|mesh-list
65502130|NCT01183494|Bevacizumab|bevacizumab|mesh-list
65502131|NCT01183494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65502132|NCT01183494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65502133|NCT01183494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502134|NCT01183494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502135|NCT01183494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502136|NCT01183494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65502137|NCT01183494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65502138|NCT01183494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65502139|NCT01183494|Growth Substances|growth substances|mesh-ancestor
65502140|NCT01183494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502141|NCT01183494|Growth Inhibitors|growth inhibitors|mesh-ancestor
65502142|NCT01183572|Iron|iron|mesh-list
65502143|NCT01183572|Folic Acid|folic acid|mesh-list
65502144|NCT01183572|Vitamin B Complex|vitamin b complex|mesh-list
65502145|NCT01183572|Trace Elements|trace elements|mesh-ancestor
65502146|NCT01183572|Micronutrients|micronutrients|mesh-ancestor
65502147|NCT01183572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502148|NCT01183572|Hematinics|hematinics|mesh-ancestor
65502149|NCT01183572|Vitamins|vitamins|mesh-ancestor
65502150|NCT03856242|Tamsulosin|tamsulosin|mesh-list
65502151|NCT03856242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65502152|NCT03856242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65502153|NCT03856242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65502154|NCT03856242|Adrenergic Agents|adrenergic agents|mesh-ancestor
65502155|NCT03856242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65502156|NCT03856242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502157|NCT03856242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502158|NCT03856242|Urological Agents|urological agents|mesh-ancestor
65502160|NCT01291524|Analgesics|analgesics|mesh-ancestor
65502161|NCT01291524|Sensory System Agents|sensory system agents|mesh-ancestor
65502162|NCT01291524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65502163|NCT01291524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502164|NCT01291524|Anticonvulsants|anticonvulsants|mesh-ancestor
65502165|NCT01291524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65502166|NCT01291524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65502167|NCT01291524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502168|NCT01291524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65502169|NCT01291524|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65502170|NCT01291524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65502171|NCT01291524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65502172|NCT01291524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65502173|NCT01183806|Rivastigmine|rivastigmine|mesh-list
65502174|NCT01183806|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65502175|NCT01183806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502176|NCT01183806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502177|NCT01183806|Cholinergic Agents|cholinergic agents|mesh-ancestor
65502178|NCT01183806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65502179|NCT01183806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502180|NCT01183806|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65502181|NCT01183806|Protective Agents|protective agents|mesh-ancestor
65502182|NCT01188954|Doxycycline|doxycycline|mesh-list
65502183|NCT01188954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65502184|NCT01188954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65502185|NCT01188954|Antimalarials|antimalarials|mesh-ancestor
65502186|NCT01188954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65502187|NCT01188954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65502188|NCT01183962|Vitamin D|vitamin d|mesh-list
65502189|NCT01183962|Vitamins|vitamins|mesh-ancestor
65502190|NCT01183962|Micronutrients|micronutrients|mesh-ancestor
65502191|NCT01183962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502192|NCT01183962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65502193|NCT01187238|Cisplatin|cisplatin|mesh-list
65502194|NCT01187238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502195|NCT01588314|Gabapentin|gabapentin|mesh-list
65502196|NCT01588314|Analgesics|analgesics|mesh-ancestor
65502197|NCT01588314|Sensory System Agents|sensory system agents|mesh-ancestor
65502198|NCT01588314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65502199|NCT01588314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502200|NCT01588314|Anticonvulsants|anticonvulsants|mesh-ancestor
65502201|NCT01588314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65502202|NCT01588314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65502203|NCT01588314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65502204|NCT01588314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65502205|NCT01588314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65502206|NCT01588314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65502207|NCT01588314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65502208|NCT01588314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502209|NCT01588314|Antimanic Agents|antimanic agents|mesh-ancestor
65502210|NCT01290432|Folic Acid|folic acid|mesh-list
65502211|NCT01290432|Melatonin|melatonin|mesh-list
65502212|NCT01290432|Antioxidants|antioxidants|mesh-ancestor
65502213|NCT01290432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502214|NCT01290432|Protective Agents|protective agents|mesh-ancestor
65502215|NCT01290432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502216|NCT01290432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65502217|NCT01290432|Hematinics|hematinics|mesh-ancestor
65502218|NCT01290432|Vitamin B Complex|vitamin b complex|mesh-ancestor
65502219|NCT01290432|Vitamins|vitamins|mesh-ancestor
65502220|NCT01290432|Micronutrients|micronutrients|mesh-ancestor
65502221|NCT01290510|Hyaluronic Acid|hyaluronic acid|mesh-list
65502222|NCT01290510|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65502223|NCT01290510|Immunologic Factors|immunologic factors|mesh-ancestor
65502224|NCT01290510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502225|NCT01290510|Viscosupplements|viscosupplements|mesh-ancestor
65502226|NCT01290510|Protective Agents|protective agents|mesh-ancestor
65299961|NCT00622115|Enoxaparin|enoxaparin|mesh-list
65502227|NCT01184196|Povidone-Iodine|povidone-iodine|mesh-list
65502228|NCT01184196|Povidone|povidone|mesh-list
65502229|NCT01184196|Plasma Substitutes|plasma substitutes|mesh-ancestor
65502230|NCT01184196|Blood Substitutes|blood substitutes|mesh-ancestor
65502231|NCT01184196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65502232|NCT01184196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65502233|NCT01292460|Timolol|timolol|mesh-list
65502234|NCT01292460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65502235|NCT01292460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65502236|NCT01292460|Adrenergic Agents|adrenergic agents|mesh-ancestor
65502237|NCT01292460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65502238|NCT01292460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502239|NCT01292460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502240|NCT01292460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65502241|NCT01292460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65502242|NCT01292616|Antirheumatic Agents|antirheumatic agents|mesh-list
65502243|NCT01292694|Losartan|losartan|mesh-list
65502244|NCT01292694|Captopril|captopril|mesh-list
65502245|NCT01292694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65502246|NCT01292694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65502247|NCT01292694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65502248|NCT01292694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65502249|NCT01292694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502250|NCT01292694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65502251|NCT01292694|Protease Inhibitors|protease inhibitors|mesh-ancestor
65502252|NCT01292694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502253|NCT03851562|Alprostadil|alprostadil|mesh-list
65502254|NCT03851562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65502255|NCT03851562|Vasodilator Agents|vasodilator agents|mesh-ancestor
65502256|NCT03851562|Urological Agents|urological agents|mesh-ancestor
65502257|NCT01293630|Paclitaxel|paclitaxel|mesh-list
65502258|NCT01293630|Carboplatin|carboplatin|mesh-list
65502259|NCT01293630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65502260|NCT01293630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502261|NCT01293630|Tubulin Modulators|tubulin modulators|mesh-ancestor
65502262|NCT01293630|Antimitotic Agents|antimitotic agents|mesh-ancestor
65502263|NCT01293630|Mitosis Modulators|mitosis modulators|mesh-ancestor
65502264|NCT01293630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502265|NCT01191060|Lenalidomide|lenalidomide|mesh-list
65502266|NCT01191060|Bortezomib|bortezomib|mesh-list
65502267|NCT01191060|Immunologic Factors|immunologic factors|mesh-ancestor
65502268|NCT01191060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502269|NCT01191060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65502270|NCT01191060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65502271|NCT01191060|Growth Substances|growth substances|mesh-ancestor
65502272|NCT01191060|Growth Inhibitors|growth inhibitors|mesh-ancestor
65502273|NCT01191060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502274|NCT01291602|Avibactam|avibactam|mesh-list
65502275|NCT01291602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65502276|NCT01291602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502277|NCT01291602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502278|NCT01291602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65502279|NCT01291602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65502280|NCT03851172|Ketorolac|ketorolac|mesh-list
65502281|NCT03851172|Nepafenac|nepafenac|mesh-list
65502282|NCT03851172|Cyclopentolate|cyclopentolate|mesh-list
65502283|NCT03851172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65502284|NCT03851172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65502285|NCT03851172|Analgesics|analgesics|mesh-ancestor
65502286|NCT03851172|Sensory System Agents|sensory system agents|mesh-ancestor
65502287|NCT03851172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65502288|NCT03851172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502289|NCT03851172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65502290|NCT03851172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65502291|NCT03851172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65502292|NCT03851172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502293|NCT03851172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502294|NCT03851172|Mydriatics|mydriatics|mesh-ancestor
65502295|NCT03851172|Autonomic Agents|autonomic agents|mesh-ancestor
65502296|NCT03851172|Parasympatholytics|parasympatholytics|mesh-ancestor
65502297|NCT03851172|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65502298|NCT03851172|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65502299|NCT03851172|Cholinergic Agents|cholinergic agents|mesh-ancestor
65502300|NCT03851172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65502301|NCT03853512|Petrolatum|petrolatum|mesh-list
65502302|NCT03853512|Emollients|emollients|mesh-ancestor
65502303|NCT03853512|Dermatologic Agents|dermatologic agents|mesh-ancestor
65502305|NCT03849612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65502306|NCT03849612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502307|NCT03853200|Chlorhexidine|chlorhexidine|mesh-list
65502308|NCT03853200|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65502309|NCT03853200|Acetic Acid|acetic acid|mesh-list
65502310|NCT03853200|Root Canal Irrigants|root canal irrigants|mesh-list
65502311|NCT03853200|Edetic Acid|edetic acid|mesh-list
65502312|NCT03853200|Pentetic Acid|pentetic acid|mesh-list
65502313|NCT03853200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65502314|NCT03853200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65502315|NCT03853200|Disinfectants|disinfectants|mesh-ancestor
65502316|NCT03853200|Dermatologic Agents|dermatologic agents|mesh-ancestor
65502317|NCT03853200|Anticoagulants|anticoagulants|mesh-ancestor
65502318|NCT03853200|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65502319|NCT03853200|Chelating Agents|chelating agents|mesh-ancestor
65502320|NCT03853200|Sequestering Agents|sequestering agents|mesh-ancestor
65502321|NCT03853200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502322|NCT03853200|Antidotes|antidotes|mesh-ancestor
65502323|NCT03853200|Protective Agents|protective agents|mesh-ancestor
65502324|NCT03853200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502325|NCT03853200|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65502326|NCT03853200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65502327|NCT03853200|Dental Disinfectants|dental disinfectants|mesh-ancestor
65502328|NCT01293942|Bevacizumab|bevacizumab|mesh-list
65502329|NCT01293942|Capecitabine|capecitabine|mesh-list
65502330|NCT01293942|Oxaliplatin|oxaliplatin|mesh-list
65502331|NCT01293942|Irinotecan|irinotecan|mesh-list
65502332|NCT01293942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65502333|NCT01293942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502334|NCT01293942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65502335|NCT01293942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65502336|NCT01293942|Growth Substances|growth substances|mesh-ancestor
65502337|NCT01293942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502338|NCT01293942|Growth Inhibitors|growth inhibitors|mesh-ancestor
65502339|NCT01293942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65502340|NCT01293942|Antimetabolites|antimetabolites|mesh-ancestor
65502341|NCT01293942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502342|NCT01293942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65502343|NCT01293942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65502344|NCT01293942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502345|NCT01189656|Vaccines|vaccines|mesh-list
65502346|NCT01189656|Immunologic Factors|immunologic factors|mesh-ancestor
65502347|NCT01189656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502348|NCT01581138|Ribavirin|ribavirin|mesh-list
65502349|NCT01581138|Antimetabolites|antimetabolites|mesh-ancestor
65502350|NCT01581138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502351|NCT01581138|Antiviral Agents|antiviral agents|mesh-ancestor
65502352|NCT01581138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65502353|NCT01191216|Docetaxel|docetaxel|mesh-list
65502354|NCT01191216|Tryptophan|tryptophan|mesh-list
65502355|NCT01191216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502356|NCT01191216|Tubulin Modulators|tubulin modulators|mesh-ancestor
65502357|NCT01191216|Antimitotic Agents|antimitotic agents|mesh-ancestor
65502358|NCT01191216|Mitosis Modulators|mitosis modulators|mesh-ancestor
65502359|NCT01191216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502360|NCT01191216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65502361|NCT01191216|Antidepressive Agents|antidepressive agents|mesh-ancestor
65502362|NCT01191216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65502363|NCT01294176|Thioctic Acid|thioctic acid|mesh-list
65502364|NCT01294176|Antioxidants|antioxidants|mesh-ancestor
65502365|NCT01294176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502366|NCT01294176|Protective Agents|protective agents|mesh-ancestor
65502367|NCT01294176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502368|NCT01294176|Vitamin B Complex|vitamin b complex|mesh-ancestor
65502369|NCT01294176|Vitamins|vitamins|mesh-ancestor
65502370|NCT01294176|Micronutrients|micronutrients|mesh-ancestor
65502371|NCT03847818|Carboplatin|carboplatin|mesh-list
65502372|NCT03847818|Docetaxel|docetaxel|mesh-list
65502373|NCT03847818|Trastuzumab|trastuzumab|mesh-list
65502374|NCT03847818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502375|NCT03847818|Tubulin Modulators|tubulin modulators|mesh-ancestor
65502376|NCT03847818|Antimitotic Agents|antimitotic agents|mesh-ancestor
65502377|NCT03847818|Mitosis Modulators|mitosis modulators|mesh-ancestor
65502378|NCT03847818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502379|NCT03847818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65502380|NCT01294410|Antibodies|antibodies|mesh-list
65502381|NCT01294410|Immunoglobulins|immunoglobulins|mesh-list
65502382|NCT01294410|Immunologic Factors|immunologic factors|mesh-ancestor
65502383|NCT01294410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502384|NCT01191450|Chlorthalidone|chlorthalidone|mesh-list
65502385|NCT01191450|Amiloride|amiloride|mesh-list
65502386|NCT01191450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65502387|NCT01191450|Diuretics|diuretics|mesh-ancestor
65502388|NCT01191450|Natriuretic Agents|natriuretic agents|mesh-ancestor
65502389|NCT01191450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502390|NCT01191450|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65502391|NCT01191450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65502392|NCT01191450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502393|NCT01191450|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65502394|NCT01191450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65502395|NCT01191450|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65502396|NCT01191450|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65502397|NCT01194336|Huperzine A|huperzine a|mesh-list
65502398|NCT01194336|Donepezil|donepezil|mesh-list
65502399|NCT01194336|Galantamine|galantamine|mesh-list
65502400|NCT01194336|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65502401|NCT01194336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502402|NCT01194336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502403|NCT01194336|Cholinergic Agents|cholinergic agents|mesh-ancestor
65502404|NCT01194336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65502405|NCT01194336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502406|NCT01194336|Nootropic Agents|nootropic agents|mesh-ancestor
65502407|NCT01194336|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65502408|NCT01194336|Autonomic Agents|autonomic agents|mesh-ancestor
65502409|NCT01194336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65502410|NCT01194336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65502411|NCT01194336|Protective Agents|protective agents|mesh-ancestor
65502412|NCT02660710|Rituximab|rituximab|mesh-list
65502413|NCT02660710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65502414|NCT02660710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502415|NCT02660710|Immunologic Factors|immunologic factors|mesh-ancestor
65502416|NCT02660710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502417|NCT02660710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65502418|NCT01294878|Omalizumab|omalizumab|mesh-list
65502419|NCT01294878|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65502420|NCT01294878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65502421|NCT01294878|Respiratory System Agents|respiratory system agents|mesh-ancestor
65502422|NCT01296438|Insulin|insulin|mesh-list
65502423|NCT01296438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65502424|NCT01296438|Insulin Aspart|insulin aspart|mesh-list
65502425|NCT01296438|Insulin, Long-Acting|insulin, long-acting|mesh-list
65502426|NCT01296438|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65502427|NCT01296438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65502428|NCT01296438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502429|NCT03847272|Prednisone|prednisone|mesh-list
65502430|NCT03847272|Ustekinumab|ustekinumab|mesh-list
65502431|NCT03847272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65502432|NCT03847272|Glucocorticoids|glucocorticoids|mesh-ancestor
65502433|NCT03847272|Hormones|hormones|mesh-ancestor
65502434|NCT03847272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65502435|NCT03847272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502436|NCT03847272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65502437|NCT03847272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502438|NCT03847272|Dermatologic Agents|dermatologic agents|mesh-ancestor
65502439|NCT01294956|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65502440|NCT01294956|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65502441|NCT01294956|Lubricant Eye Drops|lubricant eye drops|mesh-list
65502442|NCT01294956|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65502443|NCT01294956|Laxatives|laxatives|mesh-ancestor
65502444|NCT01294956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65502445|NCT01190358|Grape Seed Extract|grape seed extract|mesh-list
65502446|NCT01190358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65502447|NCT01190358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502448|NCT01190358|Antioxidants|antioxidants|mesh-ancestor
65502449|NCT01190358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502450|NCT01190358|Protective Agents|protective agents|mesh-ancestor
65502451|NCT01190358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502452|NCT01293162|Folic Acid|folic acid|mesh-list
65502453|NCT01293162|Policosanol|policosanol|mesh-list
65502454|NCT01293162|Hematinics|hematinics|mesh-ancestor
65502455|NCT01293162|Vitamin B Complex|vitamin b complex|mesh-ancestor
65502456|NCT01293162|Vitamins|vitamins|mesh-ancestor
65502457|NCT01293162|Micronutrients|micronutrients|mesh-ancestor
65502458|NCT01293162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502459|NCT01293162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65502460|NCT01293162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65502461|NCT01293162|Antimetabolites|antimetabolites|mesh-ancestor
65502462|NCT01293162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502463|NCT01293162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65502464|NCT01293162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65502465|NCT01190670|Tacrolimus|tacrolimus|mesh-list
65502466|NCT01190670|Peficitinib|peficitinib|mesh-list
65502467|NCT01190670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65502468|NCT01190670|Immunologic Factors|immunologic factors|mesh-ancestor
65502469|NCT01190670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502470|NCT01190670|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65502471|NCT01190670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502472|NCT01190670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502473|NCT01194882|Insulin|insulin|mesh-list
65502474|NCT01194882|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65502475|NCT01194882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65502476|NCT01194882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502477|NCT01191684|Vaccines|vaccines|mesh-list
65502478|NCT01191684|Immunologic Factors|immunologic factors|mesh-ancestor
65502479|NCT01191684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502480|NCT02659540|Nivolumab|nivolumab|mesh-list
65502481|NCT02659540|Ipilimumab|ipilimumab|mesh-list
65502482|NCT02659540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65502483|NCT02659540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502484|NCT02659540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65502485|NCT02659540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502486|NCT01295268|Emu Oil|emu oil|mesh-list
65502487|NCT01295268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65502488|NCT01295268|Dermatologic Agents|dermatologic agents|mesh-ancestor
65502489|NCT01383694|Piperine|piperine|mesh-list
65502490|NCT01383694|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65502491|NCT01383694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502492|NCT01383694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502493|NCT01191918|Lithium Carbonate|lithium carbonate|mesh-list
65502494|NCT01191918|Donepezil|donepezil|mesh-list
65502495|NCT01191918|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65502496|NCT01191918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502497|NCT01191918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502498|NCT01191918|Cholinergic Agents|cholinergic agents|mesh-ancestor
65502499|NCT01191918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65502500|NCT01191918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502501|NCT01191918|Nootropic Agents|nootropic agents|mesh-ancestor
65502502|NCT01191918|Antidepressive Agents|antidepressive agents|mesh-ancestor
65502503|NCT01191918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65502504|NCT01191918|Antimanic Agents|antimanic agents|mesh-ancestor
65502505|NCT01191918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65502506|NCT01191918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65502507|NCT03850314|Glycine|glycine|mesh-list
65502508|NCT03850314|Glycine Agents|glycine agents|mesh-ancestor
65502509|NCT03850314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65502510|NCT03850314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502511|NCT03850314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502512|NCT01097746|Paclitaxel|paclitaxel|mesh-list
65502513|NCT01097746|Bevacizumab|bevacizumab|mesh-list
65502514|NCT01097746|Carboplatin|carboplatin|mesh-list
65502515|NCT01097746|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65502516|NCT01097746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65502517|NCT01097746|Endothelial Growth Factors|endothelial growth factors|mesh-list
65502518|NCT01097746|Antibodies|antibodies|mesh-list
65502519|NCT01097746|Immunoglobulins|immunoglobulins|mesh-list
65502520|NCT01097746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65502521|NCT01097746|Immunoglobulin G|immunoglobulin g|mesh-list
65502522|NCT01097746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65502523|NCT01097746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502524|NCT01097746|Tubulin Modulators|tubulin modulators|mesh-ancestor
65502525|NCT01097746|Antimitotic Agents|antimitotic agents|mesh-ancestor
65502526|NCT01097746|Mitosis Modulators|mitosis modulators|mesh-ancestor
65502527|NCT01097746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502528|NCT01097746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65502529|NCT01097746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65502530|NCT01097746|Growth Substances|growth substances|mesh-ancestor
65502531|NCT01097746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502532|NCT01097746|Growth Inhibitors|growth inhibitors|mesh-ancestor
65502533|NCT01097746|Immunologic Factors|immunologic factors|mesh-ancestor
65502534|NCT01190748|Galantamine|galantamine|mesh-list
65502535|NCT01190748|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65502536|NCT01190748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502537|NCT01190748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502538|NCT01190748|Cholinergic Agents|cholinergic agents|mesh-ancestor
65502539|NCT01190748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65502540|NCT01190748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502541|NCT01190748|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65502542|NCT01190748|Autonomic Agents|autonomic agents|mesh-ancestor
65502543|NCT01190748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65502544|NCT01190748|Nootropic Agents|nootropic agents|mesh-ancestor
65502545|NCT01383538|Leucovorin|leucovorin|mesh-list
65502546|NCT01383538|Oxaliplatin|oxaliplatin|mesh-list
65502547|NCT01383538|Irinotecan|irinotecan|mesh-list
65502548|NCT01383538|Folfirinox|folfirinox|mesh-list
65502549|NCT01383538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502550|NCT01383538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65502551|NCT01383538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65502552|NCT01383538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502553|NCT01383538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502554|NCT01383538|Antidotes|antidotes|mesh-ancestor
65502555|NCT01383538|Protective Agents|protective agents|mesh-ancestor
65502556|NCT01383538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502557|NCT01383538|Vitamin B Complex|vitamin b complex|mesh-ancestor
65502558|NCT01383538|Vitamins|vitamins|mesh-ancestor
65502559|NCT01383538|Micronutrients|micronutrients|mesh-ancestor
65502560|NCT01383460|Epoetin Alfa|epoetin alfa|mesh-list
65502561|NCT01383460|Lenograstim|lenograstim|mesh-list
65502562|NCT01383460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65502563|NCT01383460|Immunologic Factors|immunologic factors|mesh-ancestor
65502564|NCT01383460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502565|NCT01383460|Hematinics|hematinics|mesh-ancestor
65502566|NCT01192230|Docetaxel|docetaxel|mesh-list
65502567|NCT01192230|Endostatins|endostatins|mesh-list
65502568|NCT01192230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502569|NCT01192230|Tubulin Modulators|tubulin modulators|mesh-ancestor
65502570|NCT01192230|Antimitotic Agents|antimitotic agents|mesh-ancestor
65502571|NCT01192230|Mitosis Modulators|mitosis modulators|mesh-ancestor
65502572|NCT01192230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502573|NCT01192230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65502574|NCT01192230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65502575|NCT01192230|Growth Substances|growth substances|mesh-ancestor
65502576|NCT01192230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502577|NCT01192230|Growth Inhibitors|growth inhibitors|mesh-ancestor
65502578|NCT05416840|Amlodipine|amlodipine|mesh-list
65502579|NCT05416840|Clonidine|clonidine|mesh-list
65502580|NCT05416840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65502581|NCT05416840|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65502582|NCT05416840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65502583|NCT05416840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502584|NCT05416840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65502585|NCT05416840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502586|NCT05416840|Vasodilator Agents|vasodilator agents|mesh-ancestor
65502587|NCT05416840|Analgesics|analgesics|mesh-ancestor
65502588|NCT05416840|Sensory System Agents|sensory system agents|mesh-ancestor
65502589|NCT05416840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65502590|NCT05416840|Sympatholytics|sympatholytics|mesh-ancestor
65502591|NCT05416840|Autonomic Agents|autonomic agents|mesh-ancestor
65502592|NCT05416840|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65502593|NCT05416840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65502594|NCT05416840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65502595|NCT05416840|Adrenergic Agents|adrenergic agents|mesh-ancestor
65502596|NCT05416840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65502597|NCT01192308|Tamoxifen|tamoxifen|mesh-list
65502598|NCT01192308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65502599|NCT01192308|Hormone Antagonists|hormone antagonists|mesh-ancestor
65502600|NCT01192308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65502601|NCT01192308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502602|NCT01192308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65502603|NCT01192308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502604|NCT01192308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65502605|NCT01192308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65502606|NCT01192308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65502607|NCT01190982|Paclitaxel|paclitaxel|mesh-list
65300330|NCT00500539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65502608|NCT01190982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65502609|NCT01190982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502610|NCT01190982|Tubulin Modulators|tubulin modulators|mesh-ancestor
65502611|NCT01190982|Antimitotic Agents|antimitotic agents|mesh-ancestor
65502612|NCT01190982|Mitosis Modulators|mitosis modulators|mesh-ancestor
65502613|NCT01190982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502614|NCT04170556|Nivolumab|nivolumab|mesh-list
65502615|NCT04170556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65502616|NCT04170556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502617|NCT04170556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65502618|NCT04170556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502619|NCT03846960|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65502620|NCT03846960|Respiratory System Agents|respiratory system agents|mesh-ancestor
65502621|NCT01196754|Sevoflurane|sevoflurane|mesh-list
65502622|NCT01196754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65502623|NCT01196754|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65502624|NCT01196754|Anesthetics, General|anesthetics, general|mesh-ancestor
65502625|NCT01196754|Anesthetics|anesthetics|mesh-ancestor
65502626|NCT01196754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65502627|NCT01196754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502628|NCT01295502|Paclitaxel|paclitaxel|mesh-list
65502629|NCT01295502|Cisplatin|cisplatin|mesh-list
65502630|NCT01295502|Carboplatin|carboplatin|mesh-list
65502631|NCT01295502|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65502632|NCT01295502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65502633|NCT01295502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502634|NCT01295502|Tubulin Modulators|tubulin modulators|mesh-ancestor
65502635|NCT01295502|Antimitotic Agents|antimitotic agents|mesh-ancestor
65502636|NCT01295502|Mitosis Modulators|mitosis modulators|mesh-ancestor
65502637|NCT01295502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502638|NCT05207644|Letrozole|letrozole|mesh-list
65502639|NCT05207644|Misoprostol|misoprostol|mesh-list
65502640|NCT05207644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502641|NCT05207644|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65502642|NCT05207644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65502643|NCT05207644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502644|NCT05207644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502645|NCT05207644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65502646|NCT05207644|Hormone Antagonists|hormone antagonists|mesh-ancestor
65502647|NCT05207644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65502648|NCT05207644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502649|NCT05207644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65502650|NCT05207644|Abortifacient Agents|abortifacient agents|mesh-ancestor
65502651|NCT05207644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65502652|NCT05207644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65502653|NCT05207644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65502654|NCT05207644|Oxytocics|oxytocics|mesh-ancestor
65502655|NCT03846102|Acetaminophen|acetaminophen|mesh-list
65502656|NCT03846102|Morphine|morphine|mesh-list
65502657|NCT03846102|Levobupivacaine|levobupivacaine|mesh-list
65502658|NCT03846102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65502659|NCT03846102|Narcotics|narcotics|mesh-ancestor
65502660|NCT03846102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65502661|NCT03846102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502662|NCT03846102|Analgesics|analgesics|mesh-ancestor
65502663|NCT03846102|Sensory System Agents|sensory system agents|mesh-ancestor
65502664|NCT03846102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65502665|NCT03846102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65502666|NCT03846102|Antipyretics|antipyretics|mesh-ancestor
65502667|NCT03846102|Anesthetics, Local|anesthetics, local|mesh-ancestor
65502668|NCT03846102|Anesthetics|anesthetics|mesh-ancestor
65502669|NCT01383148|Gemcitabine|gemcitabine|mesh-list
65502670|NCT01383148|Paclitaxel|paclitaxel|mesh-list
65502671|NCT01383148|Cisplatin|cisplatin|mesh-list
65502672|NCT01383148|Carboplatin|carboplatin|mesh-list
65502673|NCT01383148|Pemetrexed|pemetrexed|mesh-list
65502674|NCT01383148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65502675|NCT01383148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502676|NCT01383148|Tubulin Modulators|tubulin modulators|mesh-ancestor
65502677|NCT01383148|Antimitotic Agents|antimitotic agents|mesh-ancestor
65502678|NCT01383148|Mitosis Modulators|mitosis modulators|mesh-ancestor
65502679|NCT01383148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502680|NCT01383148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300421|NCT00681902|Lidocaine|lidocaine|mesh-list
65502681|NCT01383148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65502682|NCT01383148|Antimetabolites|antimetabolites|mesh-ancestor
65502683|NCT01383148|Antiviral Agents|antiviral agents|mesh-ancestor
65502684|NCT01383148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65502685|NCT01383148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502686|NCT01383148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65502687|NCT01383148|Immunologic Factors|immunologic factors|mesh-ancestor
65502688|NCT01383148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65502689|NCT01383148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65502690|NCT05131828|Metformin|metformin|mesh-list
65502691|NCT05131828|Clemastine|clemastine|mesh-list
65502692|NCT05131828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65502693|NCT05131828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502694|NCT05131828|Antipruritics|antipruritics|mesh-ancestor
65502695|NCT05131828|Dermatologic Agents|dermatologic agents|mesh-ancestor
65502696|NCT05131828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65502697|NCT05131828|Histamine Antagonists|histamine antagonists|mesh-ancestor
65502698|NCT05131828|Histamine Agents|histamine agents|mesh-ancestor
65502699|NCT05131828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65502700|NCT05131828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502701|NCT05131828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65502702|NCT01192854|Adefovir|adefovir|mesh-list
65502703|NCT01192854|Clevudine|clevudine|mesh-list
65502704|NCT01192854|Antiviral Agents|antiviral agents|mesh-ancestor
65502705|NCT01192854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65502706|NCT01192854|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65502707|NCT01192854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65502708|NCT01192854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502709|NCT01192854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502710|NCT01382914|Chlorhexidine|chlorhexidine|mesh-list
65502711|NCT01382914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65502712|NCT01382914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65502713|NCT01382914|Disinfectants|disinfectants|mesh-ancestor
65502714|NCT04905810|Azacitidine|azacitidine|mesh-list
65502715|NCT04905810|Decitabine|decitabine|mesh-list
65502716|NCT04905810|Venetoclax|venetoclax|mesh-list
65502717|NCT04905810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65502718|NCT04905810|Antimetabolites|antimetabolites|mesh-ancestor
65502719|NCT04905810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502720|NCT04905810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502721|NCT04905810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502722|NCT03912064|Ipilimumab|ipilimumab|mesh-list
65502723|NCT03912064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65502724|NCT03912064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502725|NCT03912064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65502726|NCT03912064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502727|NCT01195428|Simvastatin|simvastatin|mesh-list
65502728|NCT01195428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65502729|NCT01195428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65502730|NCT01195428|Antimetabolites|antimetabolites|mesh-ancestor
65502731|NCT01195428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502732|NCT01195428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65502733|NCT01195428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65502734|NCT01195428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502735|NCT03439462|Sirolimus|sirolimus|mesh-list
65502736|NCT03439462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502737|NCT03439462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502738|NCT03439462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65502739|NCT03439462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65502740|NCT03439462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65502741|NCT03439462|Antifungal Agents|antifungal agents|mesh-ancestor
65502742|NCT03439462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65502743|NCT03439462|Immunologic Factors|immunologic factors|mesh-ancestor
65502744|NCT01193166|Olanzapine|olanzapine|mesh-list
65502745|NCT01193166|Risperidone|risperidone|mesh-list
65502746|NCT01193166|Aripiprazole|aripiprazole|mesh-list
65502747|NCT01193166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65502748|NCT01193166|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65502749|NCT01193166|Perphenazine|perphenazine|mesh-list
65502750|NCT01193166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65502751|NCT01193166|Serotonin Agents|serotonin agents|mesh-ancestor
65502752|NCT01193166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65502753|NCT01193166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502754|NCT01193166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502755|NCT01193166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65502756|NCT01193166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65502757|NCT01193166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65300481|NCT01016665|Anastrozole|anastrozole|mesh-list
65502758|NCT01193166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65502759|NCT01193166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65502760|NCT01193166|Dopamine Agents|dopamine agents|mesh-ancestor
65502761|NCT01193166|Antiemetics|antiemetics|mesh-ancestor
65502762|NCT01193166|Autonomic Agents|autonomic agents|mesh-ancestor
65502763|NCT01193166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65502764|NCT01193166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65502765|NCT01193166|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65502766|NCT01193166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65502767|NCT01193166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65502768|NCT01193166|Antidepressive Agents|antidepressive agents|mesh-ancestor
65502769|NCT01193166|Dopamine Agonists|dopamine agonists|mesh-ancestor
65502770|NCT01193166|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65502771|NCT01193166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65502772|NCT01193166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65502773|NCT01193166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65502774|NCT01197144|Adalimumab|adalimumab|mesh-list
65502775|NCT01197144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65502776|NCT01197144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65502777|NCT01193400|Cytarabine|cytarabine|mesh-list
65502778|NCT01193400|Clofarabine|clofarabine|mesh-list
65502779|NCT01193400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65502780|NCT01193400|Antimetabolites|antimetabolites|mesh-ancestor
65502781|NCT01193400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502782|NCT01193400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502783|NCT01193400|Antiviral Agents|antiviral agents|mesh-ancestor
65502784|NCT01193400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65502785|NCT01193400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65502786|NCT01193400|Immunologic Factors|immunologic factors|mesh-ancestor
65502787|NCT01193400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502788|NCT03904888|Anesthetics|anesthetics|mesh-list
65502789|NCT03904888|Anesthetics, Local|anesthetics, local|mesh-list
65502790|NCT03904888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65502791|NCT03904888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502792|NCT03904888|Sensory System Agents|sensory system agents|mesh-ancestor
65502793|NCT03904888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65502794|NCT03846258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65502795|NCT01193478|Ledipasvir|ledipasvir|mesh-list
65502796|NCT01193478|Antiviral Agents|antiviral agents|mesh-ancestor
65502797|NCT01193478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65502798|NCT03726268|Fentanyl|fentanyl|mesh-list
65502799|NCT03726268|Sufentanil|sufentanil|mesh-list
65502800|NCT03726268|Morphine|morphine|mesh-list
65502801|NCT03726268|Methadone|methadone|mesh-list
65502802|NCT03726268|Hydromorphone|hydromorphone|mesh-list
65502803|NCT03726268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65502804|NCT03726268|Narcotics|narcotics|mesh-ancestor
65502805|NCT03726268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65502806|NCT03726268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502807|NCT03726268|Analgesics|analgesics|mesh-ancestor
65502808|NCT03726268|Sensory System Agents|sensory system agents|mesh-ancestor
65502809|NCT03726268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65502810|NCT03726268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65502811|NCT03726268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65502812|NCT03726268|Anesthetics, General|anesthetics, general|mesh-ancestor
65502813|NCT03726268|Anesthetics|anesthetics|mesh-ancestor
65502814|NCT03726268|Antitussive Agents|antitussive agents|mesh-ancestor
65502815|NCT03726268|Respiratory System Agents|respiratory system agents|mesh-ancestor
65502816|NCT01295736|Sildenafil Citrate|sildenafil citrate|mesh-list
65502817|NCT01295736|Vasodilator Agents|vasodilator agents|mesh-ancestor
65502818|NCT01295736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65502819|NCT01295736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65502820|NCT01295736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502821|NCT01295736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502822|NCT01295736|Urological Agents|urological agents|mesh-ancestor
65502823|NCT03733470|Sildenafil Citrate|sildenafil citrate|mesh-list
65502824|NCT03733470|Vasodilator Agents|vasodilator agents|mesh-ancestor
65502825|NCT03733470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65502826|NCT03733470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65502827|NCT03733470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502828|NCT03733470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502829|NCT03733470|Urological Agents|urological agents|mesh-ancestor
65502830|NCT01195974|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65502831|NCT01195974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65502832|NCT01195974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502833|NCT04731376|Methyltestosterone|methyltestosterone|mesh-list
65502834|NCT04731376|Testosterone|testosterone|mesh-list
65502835|NCT04731376|Testosterone undecanoate|testosterone undecanoate|mesh-list
65300549|NCT00682136|Ropivacaine|ropivacaine|mesh-list
65502836|NCT04731376|Testosterone enanthate|testosterone enanthate|mesh-list
65502838|NCT04731376|Androgens|androgens|mesh-ancestor
65502839|NCT04731376|Hormones|hormones|mesh-ancestor
65502840|NCT04731376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65502841|NCT04731376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502842|NCT04731376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65502843|NCT04731376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502844|NCT04731376|Anabolic Agents|anabolic agents|mesh-ancestor
65502845|NCT01196208|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65502846|NCT01196208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65502847|NCT01196208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502848|NCT01295892|Estrogens|estrogens|mesh-list
65502849|NCT01295892|Hormones|hormones|mesh-ancestor
65502850|NCT01295892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65502851|NCT01295892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502852|NCT03018418|Mitomycins|mitomycins|mesh-list
65502853|NCT03018418|Mitomycin|mitomycin|mesh-list
65502854|NCT03018418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65502855|NCT03018418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502856|NCT03018418|Alkylating Agents|alkylating agents|mesh-ancestor
65502857|NCT03018418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502858|NCT03018418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65502859|NCT03018418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502860|NCT03255252|Cisplatin|cisplatin|mesh-list
65502861|NCT03255252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502862|NCT01296204|Antibodies|antibodies|mesh-list
65502863|NCT01296204|Immunologic Factors|immunologic factors|mesh-ancestor
65502864|NCT01296204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502865|NCT01197846|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65502866|NCT01197846|Antidepressive Agents|antidepressive agents|mesh-ancestor
65502867|NCT01197846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65502868|NCT01197846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65502869|NCT01197846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65502870|NCT01197846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65502871|NCT01197846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502872|NCT05670678|Lactoferrin|lactoferrin|mesh-list
65502873|NCT05670678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65502874|NCT02914366|Ambroxol|ambroxol|mesh-list
65502875|NCT02914366|Expectorants|expectorants|mesh-ancestor
65502876|NCT02914366|Respiratory System Agents|respiratory system agents|mesh-ancestor
65502877|NCT03846180|Octreotide|octreotide|mesh-list
65502878|NCT03846180|Terlipressin|terlipressin|mesh-list
65502879|NCT03846180|Somatostatin|somatostatin|mesh-list
65502880|NCT03846180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65502881|NCT03846180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65502882|NCT03846180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502883|NCT03846180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65502884|NCT03846180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65502885|NCT03846180|Hormones|hormones|mesh-ancestor
65502886|NCT03846180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65502887|NCT03846180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502888|NCT01199406|Levobupivacaine|levobupivacaine|mesh-list
65502889|NCT01199406|Anesthetics, Local|anesthetics, local|mesh-ancestor
65502890|NCT01199406|Anesthetics|anesthetics|mesh-ancestor
65502891|NCT01199406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65502892|NCT01199406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502893|NCT01199406|Sensory System Agents|sensory system agents|mesh-ancestor
65502894|NCT01199406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65502895|NCT02729116|Ertapenem|ertapenem|mesh-list
65502896|NCT02729116|Sitafloxacin|sitafloxacin|mesh-list
65502897|NCT02729116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65502898|NCT02729116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65502899|NCT02729116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65502900|NCT02729116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65502901|NCT02729116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502902|NCT02729116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502903|NCT02729116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502904|NCT02627092|Copper|copper|mesh-list
65502905|NCT02627092|Trace Elements|trace elements|mesh-ancestor
65502906|NCT02627092|Micronutrients|micronutrients|mesh-ancestor
65502907|NCT02627092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502908|NCT02567422|Cisplatin|cisplatin|mesh-list
65502909|NCT02567422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502910|NCT05289648|Niraparib|niraparib|mesh-list
65502911|NCT05289648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65502912|NCT05289648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502913|NCT05289648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502914|NCT05289648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502915|NCT01199562|Valganciclovir|valganciclovir|mesh-list
65502916|NCT01199562|Ganciclovir|ganciclovir|mesh-list
65502917|NCT01199562|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65502918|NCT01199562|Antiviral Agents|antiviral agents|mesh-list
65502919|NCT01199562|Foscarnet|foscarnet|mesh-list
65502920|NCT01199562|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
65502921|NCT01199562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65502922|NCT01199562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65502923|NCT01199562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502924|NCT01199562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502925|NCT01199562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65502926|NCT03845322|Curcumin|curcumin|mesh-list
65502927|NCT03845322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65502928|NCT03845322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65502929|NCT03845322|Analgesics|analgesics|mesh-ancestor
65502930|NCT03845322|Sensory System Agents|sensory system agents|mesh-ancestor
65502931|NCT03845322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65502932|NCT03845322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502933|NCT03845322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65502934|NCT03845322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65502935|NCT03845322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502936|NCT03845322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502937|NCT03845322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502938|NCT03844932|Cyclosporine|cyclosporine|mesh-list
65502939|NCT03844932|Cyclosporins|cyclosporins|mesh-list
65502940|NCT03844932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502941|NCT03844932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502942|NCT03844932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65502943|NCT03844932|Immunologic Factors|immunologic factors|mesh-ancestor
65502944|NCT03844932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502945|NCT03844932|Antifungal Agents|antifungal agents|mesh-ancestor
65502946|NCT03844932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65502947|NCT03844932|Dermatologic Agents|dermatologic agents|mesh-ancestor
65502948|NCT03844932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65502949|NCT03844932|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65502950|NCT03726996|Desipramine|desipramine|mesh-list
65502951|NCT03726996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65502952|NCT03726996|Antidepressive Agents|antidepressive agents|mesh-ancestor
65502953|NCT03726996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65502954|NCT03726996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65502955|NCT03726996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502956|NCT03726996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65502957|NCT03726996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65502958|NCT03726996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65502959|NCT03726996|Adrenergic Agents|adrenergic agents|mesh-ancestor
65502960|NCT03726996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65502961|NCT03726996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502962|NCT01202058|Sirolimus|sirolimus|mesh-list
65502963|NCT01202058|Everolimus|everolimus|mesh-list
65502964|NCT01202058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65502965|NCT01202058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65502966|NCT01202058|Immunologic Factors|immunologic factors|mesh-ancestor
65502967|NCT01202058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502968|NCT01202058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65502969|NCT01202058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65502970|NCT01202058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65502971|NCT01202058|Antifungal Agents|antifungal agents|mesh-ancestor
65502972|NCT03844854|Salicylic Acid|salicylic acid|mesh-list
65502973|NCT03844854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65502974|NCT03844854|Antifungal Agents|antifungal agents|mesh-ancestor
65502975|NCT03844854|Keratolytic Agents|keratolytic agents|mesh-ancestor
65502976|NCT03844854|Dermatologic Agents|dermatologic agents|mesh-ancestor
65502977|NCT03842046|Phenylephrine|phenylephrine|mesh-list
65502978|NCT03842046|Oxymetazoline|oxymetazoline|mesh-list
65502979|NCT03842046|Norepinephrine|norepinephrine|mesh-list
65502980|NCT03842046|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65502981|NCT03842046|Mydriatics|mydriatics|mesh-ancestor
65502982|NCT03842046|Autonomic Agents|autonomic agents|mesh-ancestor
65502983|NCT03842046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65502984|NCT03842046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65502985|NCT03842046|Sympathomimetics|sympathomimetics|mesh-ancestor
65502986|NCT03842046|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65502987|NCT03842046|Nasal Decongestants|nasal decongestants|mesh-ancestor
65502988|NCT03842046|Respiratory System Agents|respiratory system agents|mesh-ancestor
65502989|NCT03842046|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65502990|NCT03842046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65502991|NCT03842046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65502992|NCT03842046|Adrenergic Agents|adrenergic agents|mesh-ancestor
65502993|NCT03842046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65502994|NCT03842046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65502995|NCT03842046|Protective Agents|protective agents|mesh-ancestor
65502996|NCT01198236|Itraconazole|itraconazole|mesh-list
65502997|NCT01198236|Antifungal Agents|antifungal agents|mesh-ancestor
65502998|NCT01198236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65502999|NCT01198236|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65503000|NCT01198236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65503001|NCT01198236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503002|NCT01198236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503003|NCT01198236|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65503004|NCT01198236|Hormone Antagonists|hormone antagonists|mesh-ancestor
65503005|NCT01198236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65503006|NCT01198236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503007|NCT01198236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65503008|NCT01198314|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65503009|NCT01198314|Immunologic Factors|immunologic factors|mesh-ancestor
65503010|NCT01198314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503011|NCT04091490|Nivolumab|nivolumab|mesh-list
65503012|NCT04091490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65503013|NCT04091490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503014|NCT04091490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65503015|NCT04091490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503016|NCT05184816|Deferoxamine|deferoxamine|mesh-list
65503017|NCT05184816|Siderophores|siderophores|mesh-ancestor
65503018|NCT05184816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65503019|NCT05184816|Chelating Agents|chelating agents|mesh-ancestor
65503020|NCT05184816|Sequestering Agents|sequestering agents|mesh-ancestor
65503021|NCT05184816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503022|NCT03841890|Tolnaftate|tolnaftate|mesh-list
65503023|NCT03841890|Antifungal Agents|antifungal agents|mesh-ancestor
65503024|NCT03841890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65503025|NCT01200108|Budesonide|budesonide|mesh-list
65503026|NCT01200108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65503027|NCT01200108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65503028|NCT01200108|Autonomic Agents|autonomic agents|mesh-ancestor
65503029|NCT01200108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65503030|NCT01200108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503031|NCT01200108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65503032|NCT01200108|Respiratory System Agents|respiratory system agents|mesh-ancestor
65503033|NCT01200108|Glucocorticoids|glucocorticoids|mesh-ancestor
65503034|NCT01200108|Hormones|hormones|mesh-ancestor
65503035|NCT01200108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65503036|NCT01200186|Progestins|progestins|mesh-list
65503037|NCT01200186|Hormones|hormones|mesh-ancestor
65503038|NCT01200186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65503039|NCT01200186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503040|NCT03841812|Propofol|propofol|mesh-list
65503041|NCT03841812|Sevoflurane|sevoflurane|mesh-list
65503042|NCT03841812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65503043|NCT03841812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65503044|NCT03841812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503045|NCT03841812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65503046|NCT03841812|Anesthetics, General|anesthetics, general|mesh-ancestor
65503047|NCT03841812|Anesthetics|anesthetics|mesh-ancestor
65503048|NCT03841812|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65503049|NCT03841812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65503050|NCT03882970|Tirzepatide|tirzepatide|mesh-list
65503051|NCT03882970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65503052|NCT03882970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503053|NCT03882970|Incretins|incretins|mesh-ancestor
65503054|NCT03882970|Hormones|hormones|mesh-ancestor
65503055|NCT03882970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65503056|NCT05111808|Methylene Blue|methylene blue|mesh-list
65503057|NCT05111808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503058|NCT05111808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503059|NCT01198392|Cisplatin|cisplatin|mesh-list
65503060|NCT01198392|Tegafur|tegafur|mesh-list
65503061|NCT01198392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503062|NCT01198392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65503063|NCT01198392|Antimetabolites|antimetabolites|mesh-ancestor
65503064|NCT01198392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503066|NCT01200264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65503067|NCT01200264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65503068|NCT01200264|Analgesics|analgesics|mesh-ancestor
65503069|NCT01200264|Sensory System Agents|sensory system agents|mesh-ancestor
65503070|NCT01200264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65503071|NCT01200264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503072|NCT01200264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65503073|NCT01200264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65503074|NCT01200264|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65503075|NCT01200264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65503076|NCT01200264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503077|NCT01200264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503078|NCT04799236|Amphotericin B|amphotericin b|mesh-list
65503079|NCT04799236|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65503080|NCT04799236|Miltefosine|miltefosine|mesh-list
65503081|NCT04799236|Amebicides|amebicides|mesh-ancestor
65503082|NCT04799236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65503083|NCT04799236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65503084|NCT04799236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65503085|NCT04799236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65503086|NCT04799236|Antifungal Agents|antifungal agents|mesh-ancestor
65503087|NCT04799236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503088|NCT03796156|Aspirin|aspirin|mesh-list
65503089|NCT03796156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65503090|NCT03796156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65503091|NCT03796156|Analgesics|analgesics|mesh-ancestor
65503092|NCT03796156|Sensory System Agents|sensory system agents|mesh-ancestor
65503093|NCT03796156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65503094|NCT03796156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503095|NCT03796156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65503096|NCT03796156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65503097|NCT03796156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65503098|NCT03796156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65503099|NCT03796156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503100|NCT03796156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65503101|NCT03796156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65503102|NCT03796156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503103|NCT03796156|Antipyretics|antipyretics|mesh-ancestor
65503104|NCT05759572|Apatinib|apatinib|mesh-list
65503105|NCT05759572|Fulvestrant|fulvestrant|mesh-list
65503106|NCT05759572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503107|NCT05759572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65503108|NCT05759572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503109|NCT05759572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503110|NCT05759572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65503111|NCT05759572|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65503112|NCT05759572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65503113|NCT05759572|Hormone Antagonists|hormone antagonists|mesh-ancestor
65503114|NCT05759572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65503115|NCT05759572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503116|NCT01202370|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
65503117|NCT01202370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65503118|NCT01202370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503119|NCT03630952|Aflibercept|aflibercept|mesh-list
65503120|NCT03630952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65503121|NCT03630952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65503122|NCT03630952|Growth Substances|growth substances|mesh-ancestor
65503123|NCT03630952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503124|NCT03630952|Growth Inhibitors|growth inhibitors|mesh-ancestor
65503125|NCT03630952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503126|NCT01198782|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65503127|NCT01198782|Lubricant Eye Drops|lubricant eye drops|mesh-list
65503128|NCT01198782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65503129|NCT01200654|Linezolid|linezolid|mesh-list
65503130|NCT01200654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65503131|NCT01200654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65503132|NCT01200654|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65503133|NCT01200654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503134|NCT01200654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503135|NCT01200732|Tadalafil|tadalafil|mesh-list
65503136|NCT01200732|Vasodilator Agents|vasodilator agents|mesh-ancestor
65503137|NCT01200732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65503138|NCT01200732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65503140|NCT01200732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503141|NCT01200732|Urological Agents|urological agents|mesh-ancestor
65503142|NCT01198860|Ascorbic Acid|ascorbic acid|mesh-list
65503143|NCT01198860|Tenofovir|tenofovir|mesh-list
65503144|NCT01198860|Antiviral Agents|antiviral agents|mesh-ancestor
65503145|NCT01198860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65503146|NCT01198860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65503147|NCT01198860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65503148|NCT01198860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503149|NCT01198860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503150|NCT01198860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65503151|NCT01198860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65503152|NCT01198860|Antioxidants|antioxidants|mesh-ancestor
65503153|NCT01198860|Protective Agents|protective agents|mesh-ancestor
65503154|NCT01198860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503155|NCT01198860|Vitamins|vitamins|mesh-ancestor
65503156|NCT01198860|Micronutrients|micronutrients|mesh-ancestor
65503157|NCT01198938|Melatonin|melatonin|mesh-list
65503158|NCT01198938|Antioxidants|antioxidants|mesh-ancestor
65503159|NCT01198938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503160|NCT01198938|Protective Agents|protective agents|mesh-ancestor
65503161|NCT01198938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503162|NCT01198938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65503163|NCT01201044|Gemcitabine|gemcitabine|mesh-list
65503164|NCT01201044|Nedaplatin|nedaplatin|mesh-list
65503165|NCT01201044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65503166|NCT01201044|Antimetabolites|antimetabolites|mesh-ancestor
65503167|NCT01201044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503168|NCT01201044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503169|NCT01201044|Antiviral Agents|antiviral agents|mesh-ancestor
65503170|NCT01201044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65503171|NCT01201044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503172|NCT01201044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65503173|NCT01201044|Immunologic Factors|immunologic factors|mesh-ancestor
65503174|NCT01201044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503175|NCT03843060|Itraconazole|itraconazole|mesh-list
65503176|NCT03843060|Antifungal Agents|antifungal agents|mesh-ancestor
65503177|NCT03843060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65503178|NCT03843060|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65503179|NCT03843060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65503180|NCT03843060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503181|NCT03843060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503182|NCT03843060|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65503183|NCT03843060|Hormone Antagonists|hormone antagonists|mesh-ancestor
65503184|NCT03843060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65503185|NCT03843060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503186|NCT03843060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65503187|NCT04497012|Iron|iron|mesh-list
65503188|NCT04497012|Trace Elements|trace elements|mesh-ancestor
65503189|NCT04497012|Micronutrients|micronutrients|mesh-ancestor
65503190|NCT04497012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503191|NCT04427904|Lidocaine|lidocaine|mesh-list
65503192|NCT04427904|Epinephrine|epinephrine|mesh-list
65503193|NCT04427904|Racepinephrine|racepinephrine|mesh-list
65503194|NCT04427904|Bupivacaine|bupivacaine|mesh-list
65503195|NCT04427904|Epinephryl borate|epinephryl borate|mesh-list
65503196|NCT04427904|Anesthetics, Local|anesthetics, local|mesh-ancestor
65503197|NCT04427904|Anesthetics|anesthetics|mesh-ancestor
65503198|NCT04427904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65503199|NCT04427904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503200|NCT04427904|Sensory System Agents|sensory system agents|mesh-ancestor
65503201|NCT04427904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65503202|NCT04427904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65503203|NCT04427904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65503204|NCT04427904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65503205|NCT04427904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65503206|NCT04427904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503207|NCT04427904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65503208|NCT04427904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65503209|NCT04427904|Adrenergic Agents|adrenergic agents|mesh-ancestor
65503210|NCT04427904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65503212|NCT04427904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65503213|NCT04427904|Autonomic Agents|autonomic agents|mesh-ancestor
65503214|NCT04427904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65503215|NCT04427904|Respiratory System Agents|respiratory system agents|mesh-ancestor
65503216|NCT04427904|Mydriatics|mydriatics|mesh-ancestor
65503217|NCT04427904|Sympathomimetics|sympathomimetics|mesh-ancestor
65503218|NCT04427904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65503219|NCT03792516|Artesunate|artesunate|mesh-list
65503220|NCT03792516|Antimalarials|antimalarials|mesh-ancestor
65503221|NCT03792516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65503222|NCT03792516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65503223|NCT03792516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65503224|NCT03792516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503225|NCT03792516|Antiviral Agents|antiviral agents|mesh-ancestor
65503226|NCT03792516|Schistosomicides|schistosomicides|mesh-ancestor
65503227|NCT03792516|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65503228|NCT03792516|Anthelmintics|anthelmintics|mesh-ancestor
65503229|NCT01201122|Mesalamine|mesalamine|mesh-list
65503230|NCT01201122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65503231|NCT01201122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65503232|NCT01201122|Analgesics|analgesics|mesh-ancestor
65503233|NCT01201122|Sensory System Agents|sensory system agents|mesh-ancestor
65503234|NCT01201122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65503235|NCT01201122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503236|NCT01201122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65503237|NCT01201122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65503238|NCT03674112|Trastuzumab|trastuzumab|mesh-list
65503239|NCT03674112|Pertuzumab|pertuzumab|mesh-list
65503240|NCT03674112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65503241|NCT03674112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503242|NCT03668808|Insulin|insulin|mesh-list
65503243|NCT03668808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65503244|NCT03668808|Insulin Glargine|insulin glargine|mesh-list
65503245|NCT03668808|Insulin, Long-Acting|insulin, long-acting|mesh-list
65503246|NCT03668808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65503247|NCT03668808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503248|NCT05281926|Nivolumab|nivolumab|mesh-list
65503249|NCT05281926|Poly ICLC|poly iclc|mesh-list
65503250|NCT05281926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65503251|NCT05281926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503252|NCT05281926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65503253|NCT05281926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503254|NCT05281926|Interferon Inducers|interferon inducers|mesh-ancestor
65503255|NCT05281926|Immunologic Factors|immunologic factors|mesh-ancestor
65503256|NCT05281926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503257|NCT03844776|Acetaminophen|acetaminophen|mesh-list
65503258|NCT03844776|Amoxicillin|amoxicillin|mesh-list
65503259|NCT03844776|Metronidazole|metronidazole|mesh-list
65503260|NCT03844776|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65503261|NCT03844776|Chlorhexidine|chlorhexidine|mesh-list
65503262|NCT03844776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65503263|NCT03844776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65503264|NCT03844776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65503265|NCT03844776|Analgesics|analgesics|mesh-ancestor
65503266|NCT03844776|Sensory System Agents|sensory system agents|mesh-ancestor
65503267|NCT03844776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65503268|NCT03844776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503269|NCT03844776|Antipyretics|antipyretics|mesh-ancestor
65503270|NCT03844776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65503271|NCT03844776|Disinfectants|disinfectants|mesh-ancestor
65503272|NCT03844776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65503273|NCT03844776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65503274|NCT03844776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65503275|NCT03844776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503276|NCT03844776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503277|NCT01566942|Oxaliplatin|oxaliplatin|mesh-list
65503278|NCT01566942|Irinotecan|irinotecan|mesh-list
65503279|NCT01566942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503280|NCT01566942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65503281|NCT01566942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65503282|NCT01566942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503283|NCT01566942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503284|NCT01201278|Insulin|insulin|mesh-list
65301000|NCT02624570|Midostaurin|midostaurin|mesh-list
65503285|NCT01201278|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65503286|NCT01201278|Insulin Lispro|insulin lispro|mesh-list
65503287|NCT01201278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65503288|NCT01201278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503289|NCT01199328|Aspirin|aspirin|mesh-list
65503290|NCT01199328|Esomeprazole|esomeprazole|mesh-list
65503291|NCT01199328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65503292|NCT01199328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65503293|NCT01199328|Analgesics|analgesics|mesh-ancestor
65503294|NCT01199328|Sensory System Agents|sensory system agents|mesh-ancestor
65503295|NCT01199328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65503296|NCT01199328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503297|NCT01199328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65503298|NCT01199328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65503299|NCT01199328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65503300|NCT01199328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65503301|NCT01199328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503302|NCT01199328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65503303|NCT01199328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65503304|NCT01199328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503305|NCT01199328|Antipyretics|antipyretics|mesh-ancestor
65503306|NCT01199328|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65503307|NCT01199328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65503308|NCT01199328|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65503309|NCT02982954|Nivolumab|nivolumab|mesh-list
65503310|NCT02982954|Ipilimumab|ipilimumab|mesh-list
65503311|NCT02982954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65503312|NCT02982954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503313|NCT02982954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65503314|NCT02982954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503315|NCT01203228|Cyclophosphamide|cyclophosphamide|mesh-list
65503316|NCT01203228|Busulfan|busulfan|mesh-list
65503317|NCT01203228|Fludarabine phosphate|fludarabine phosphate|mesh-list
65503318|NCT01203228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65503319|NCT01203228|Immunologic Factors|immunologic factors|mesh-ancestor
65503320|NCT01203228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503321|NCT01203228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65503322|NCT01203228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65503323|NCT01203228|Alkylating Agents|alkylating agents|mesh-ancestor
65503324|NCT01203228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503325|NCT01203228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503326|NCT01203228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65503327|NCT01203228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65503328|NCT01203228|Antimetabolites|antimetabolites|mesh-ancestor
65503329|NCT01203696|Amlodipine|amlodipine|mesh-list
65503330|NCT01203696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65503331|NCT01203696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65503332|NCT01203696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65503333|NCT01203696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503334|NCT01203696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65503335|NCT01203696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503336|NCT01203696|Vasodilator Agents|vasodilator agents|mesh-ancestor
65503337|NCT01203306|Bevacizumab|bevacizumab|mesh-list
65503338|NCT01203306|Capecitabine|capecitabine|mesh-list
65503339|NCT01203306|Octreotide|octreotide|mesh-list
65503340|NCT01203306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65503341|NCT01203306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503342|NCT01203306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65503343|NCT01203306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65503344|NCT01203306|Growth Substances|growth substances|mesh-ancestor
65503345|NCT01203306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503346|NCT01203306|Growth Inhibitors|growth inhibitors|mesh-ancestor
65503347|NCT01203306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65503348|NCT01203306|Antimetabolites|antimetabolites|mesh-ancestor
65503349|NCT01203306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503350|NCT01203306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65503351|NCT01203306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65503352|NCT01203384|Flurbiprofen|flurbiprofen|mesh-list
65503353|NCT01203384|Analgesics|analgesics|mesh-ancestor
65503354|NCT01203384|Sensory System Agents|sensory system agents|mesh-ancestor
65503355|NCT01203384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65503356|NCT01203384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503357|NCT01203384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65503358|NCT01203384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65503359|NCT01203384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65503360|NCT01203384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65503361|NCT01203384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65503362|NCT01203384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503363|NCT01203384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503364|NCT03724968|Nivolumab|nivolumab|mesh-list
65503365|NCT03724968|Ipilimumab|ipilimumab|mesh-list
65503366|NCT03724968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65503367|NCT03724968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503368|NCT03724968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65503369|NCT03724968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503370|NCT05121324|Midazolam|midazolam|mesh-list
65503371|NCT05121324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65503372|NCT05121324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65503373|NCT05121324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65503374|NCT05121324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503375|NCT05121324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65503376|NCT05121324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65503377|NCT05121324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65503378|NCT05121324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65503379|NCT05121324|Anesthetics, General|anesthetics, general|mesh-ancestor
65503380|NCT05121324|Anesthetics|anesthetics|mesh-ancestor
65503381|NCT05121324|GABA Modulators|gaba modulators|mesh-ancestor
65503382|NCT05121324|GABA Agents|gaba agents|mesh-ancestor
65503383|NCT05121324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65503384|NCT05121324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503385|NCT01204086|Fluoxetine|fluoxetine|mesh-list
65503386|NCT01204086|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65503387|NCT01204086|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65503388|NCT01204086|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65503389|NCT01204086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65503390|NCT01204086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503391|NCT01204086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65503392|NCT01204086|Serotonin Agents|serotonin agents|mesh-ancestor
65503393|NCT01204086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503394|NCT01204086|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65503395|NCT01204086|Antidepressive Agents|antidepressive agents|mesh-ancestor
65503396|NCT01204086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65503397|NCT01204086|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65503398|NCT01204086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65503399|NCT01204086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503400|NCT01204086|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65503401|NCT01201902|Vaccines|vaccines|mesh-list
65503402|NCT01201902|Immunologic Factors|immunologic factors|mesh-ancestor
65503403|NCT01201902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503404|NCT01204164|Dexamethasone|dexamethasone|mesh-list
65503405|NCT01204164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65503406|NCT01204164|Antiemetics|antiemetics|mesh-ancestor
65503407|NCT01204164|Autonomic Agents|autonomic agents|mesh-ancestor
65503408|NCT01204164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65503409|NCT01204164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503410|NCT01204164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65503411|NCT01204164|Glucocorticoids|glucocorticoids|mesh-ancestor
65503412|NCT01204164|Hormones|hormones|mesh-ancestor
65503413|NCT01204164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65503414|NCT01204164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65503415|NCT01204164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503416|NCT01206036|Sirolimus|sirolimus|mesh-list
65503417|NCT01206036|Docetaxel|docetaxel|mesh-list
65503418|NCT01206036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503419|NCT01206036|Tubulin Modulators|tubulin modulators|mesh-ancestor
65503420|NCT01206036|Antimitotic Agents|antimitotic agents|mesh-ancestor
65503421|NCT01206036|Mitosis Modulators|mitosis modulators|mesh-ancestor
65503422|NCT01206036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503423|NCT01206036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65503424|NCT01206036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65503425|NCT01206036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65503426|NCT01206036|Antifungal Agents|antifungal agents|mesh-ancestor
65503427|NCT01206036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65503428|NCT01206036|Immunologic Factors|immunologic factors|mesh-ancestor
65503429|NCT01206036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503430|NCT01204320|Paclitaxel|paclitaxel|mesh-list
65503431|NCT01204320|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65503432|NCT01204320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65503433|NCT01204320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503434|NCT01204320|Tubulin Modulators|tubulin modulators|mesh-ancestor
65503435|NCT01204320|Antimitotic Agents|antimitotic agents|mesh-ancestor
65503436|NCT01204320|Mitosis Modulators|mitosis modulators|mesh-ancestor
65503437|NCT01204320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503438|NCT03722238|Ibuprofen|ibuprofen|mesh-list
65503439|NCT03722238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65503440|NCT03722238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65503441|NCT03722238|Analgesics|analgesics|mesh-ancestor
65503442|NCT03722238|Sensory System Agents|sensory system agents|mesh-ancestor
65503443|NCT03722238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65503444|NCT03722238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503445|NCT03722238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65503446|NCT03722238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65503447|NCT03722238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65503448|NCT03722238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503449|NCT03722238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503450|NCT01203540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65503451|NCT01203540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65503452|NCT01203618|Farletuzumab|farletuzumab|mesh-list
65503453|NCT01203618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503454|NCT01206270|Methyltestosterone|methyltestosterone|mesh-list
65503455|NCT01206270|Castor Oil|castor oil|mesh-list
65503456|NCT01206270|Testosterone|testosterone|mesh-list
65503457|NCT01206270|Testosterone undecanoate|testosterone undecanoate|mesh-list
65503458|NCT01206270|Testosterone enanthate|testosterone enanthate|mesh-list
65503459|NCT01206270|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65503460|NCT01206270|Androgens|androgens|mesh-ancestor
65503461|NCT01206270|Hormones|hormones|mesh-ancestor
65503462|NCT01206270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65503463|NCT01206270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503464|NCT01206270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65503465|NCT01206270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503466|NCT01206270|Anabolic Agents|anabolic agents|mesh-ancestor
65503467|NCT01206270|Cathartics|cathartics|mesh-ancestor
65503468|NCT01206270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65503469|NCT01298310|Lidocaine|lidocaine|mesh-list
65503470|NCT01298310|Anesthetics, Local|anesthetics, local|mesh-ancestor
65503471|NCT01298310|Anesthetics|anesthetics|mesh-ancestor
65503472|NCT01298310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65503473|NCT01298310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503474|NCT01298310|Sensory System Agents|sensory system agents|mesh-ancestor
65503475|NCT01298310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65503476|NCT01298310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65503477|NCT01298310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65503478|NCT01298310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65503479|NCT01298310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65503480|NCT01298310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503481|NCT01298466|Pregabalin|pregabalin|mesh-list
65503482|NCT01298466|Analgesics|analgesics|mesh-ancestor
65503483|NCT01298466|Sensory System Agents|sensory system agents|mesh-ancestor
65503484|NCT01298466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65503485|NCT01298466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503486|NCT01298466|Anticonvulsants|anticonvulsants|mesh-ancestor
65503487|NCT01298466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65503488|NCT01298466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65503489|NCT01298466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503490|NCT01298466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65503491|NCT01298466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65503492|NCT01298466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65503493|NCT01298466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65503494|NCT01298466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65503495|NCT01206348|Minocycline|minocycline|mesh-list
65503496|NCT01206348|Clindamycin|clindamycin|mesh-list
65503497|NCT01206348|Clindamycin palmitate|clindamycin palmitate|mesh-list
65503498|NCT01206348|Clindamycin phosphate|clindamycin phosphate|mesh-list
65503499|NCT01206348|Tretinoin|tretinoin|mesh-list
65503500|NCT01206348|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65503501|NCT01206348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65503502|NCT01206348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65503503|NCT01206348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65503504|NCT01206348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503505|NCT01206348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503506|NCT01206348|Dermatologic Agents|dermatologic agents|mesh-ancestor
65503507|NCT01206348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503508|NCT01206348|Keratolytic Agents|keratolytic agents|mesh-ancestor
65503509|NCT05669352|Pembrolizumab|pembrolizumab|mesh-list
65503510|NCT05669352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65503511|NCT05669352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503512|NCT01204476|Everolimus|everolimus|mesh-list
65503513|NCT01204476|Octreotide|octreotide|mesh-list
65503514|NCT01204476|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65503515|NCT01204476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503516|NCT01204476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65503517|NCT01204476|Immunologic Factors|immunologic factors|mesh-ancestor
65503518|NCT01204476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503519|NCT01204476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65503520|NCT01204476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65503521|NCT03633292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
65503522|NCT03633292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65503523|NCT04630210|Atezolizumab|atezolizumab|mesh-list
65503524|NCT04630210|Letrozole|letrozole|mesh-list
65503525|NCT04630210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503526|NCT04630210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65503527|NCT04630210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65503528|NCT04630210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503529|NCT04630210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503530|NCT04630210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65503531|NCT04630210|Hormone Antagonists|hormone antagonists|mesh-ancestor
65503532|NCT04630210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65503533|NCT04630210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503534|NCT02051218|Denosumab|denosumab|mesh-list
65503535|NCT02051218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65503536|NCT02051218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503537|NCT01382368|Sildenafil Citrate|sildenafil citrate|mesh-list
65503538|NCT01382368|Vasodilator Agents|vasodilator agents|mesh-ancestor
65503539|NCT01382368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65503540|NCT01382368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65503541|NCT01382368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503542|NCT01382368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503543|NCT01382368|Urological Agents|urological agents|mesh-ancestor
65503544|NCT04546828|Gemcitabine|gemcitabine|mesh-list
65503545|NCT04546828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503546|NCT04546828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65503547|NCT04546828|Antimetabolites|antimetabolites|mesh-ancestor
65503548|NCT04546828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503549|NCT04546828|Antiviral Agents|antiviral agents|mesh-ancestor
65503550|NCT04546828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65503551|NCT04546828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503552|NCT04546828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65503553|NCT04546828|Immunologic Factors|immunologic factors|mesh-ancestor
65503554|NCT04546828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503555|NCT01382134|Aspirin|aspirin|mesh-list
65503556|NCT01382134|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65503557|NCT01382134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65503558|NCT01382134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65503559|NCT01382134|Analgesics|analgesics|mesh-ancestor
65503560|NCT01382134|Sensory System Agents|sensory system agents|mesh-ancestor
65503561|NCT01382134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65503562|NCT01382134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503563|NCT01382134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65503564|NCT01382134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65503565|NCT01382134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65503566|NCT01382134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65503567|NCT01382134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503568|NCT01382134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65503569|NCT01382134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65503570|NCT01382134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503571|NCT01382134|Antipyretics|antipyretics|mesh-ancestor
65503572|NCT01382134|Hemostatics|hemostatics|mesh-ancestor
65503573|NCT01382134|Coagulants|coagulants|mesh-ancestor
65503574|NCT01382134|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65503575|NCT01382134|Natriuretic Agents|natriuretic agents|mesh-ancestor
65503576|NCT02563002|Bevacizumab|bevacizumab|mesh-list
65503577|NCT02563002|Pembrolizumab|pembrolizumab|mesh-list
65503578|NCT02563002|Cetuximab|cetuximab|mesh-list
65503579|NCT02563002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65503580|NCT02563002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503581|NCT02563002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65503582|NCT02563002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65503583|NCT02563002|Growth Substances|growth substances|mesh-ancestor
65056066|NCT02213653|Iron|iron|mesh-list
65503584|NCT02563002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503585|NCT02563002|Growth Inhibitors|growth inhibitors|mesh-ancestor
65503586|NCT05077488|Lidocaine|lidocaine|mesh-list
65503587|NCT05077488|Anesthetics, Local|anesthetics, local|mesh-ancestor
65503588|NCT05077488|Anesthetics|anesthetics|mesh-ancestor
65503589|NCT05077488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65503590|NCT05077488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503591|NCT05077488|Sensory System Agents|sensory system agents|mesh-ancestor
65503592|NCT05077488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65503593|NCT05077488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65503594|NCT05077488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65503595|NCT05077488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65503596|NCT05077488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65503597|NCT05077488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503598|NCT05668572|Vaccines|vaccines|mesh-list
65503599|NCT05668572|Immunologic Factors|immunologic factors|mesh-ancestor
65503600|NCT05668572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503601|NCT02410980|Tretinoin|tretinoin|mesh-list
65503602|NCT02410980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503603|NCT02410980|Keratolytic Agents|keratolytic agents|mesh-ancestor
65503604|NCT02410980|Dermatologic Agents|dermatologic agents|mesh-ancestor
65503605|NCT01298934|Panobinostat|panobinostat|mesh-list
65503606|NCT01298934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503607|NCT01298934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65503608|NCT01298934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503609|NCT01298934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503610|NCT01300962|Capecitabine|capecitabine|mesh-list
65503611|NCT01300962|Trastuzumab|trastuzumab|mesh-list
65503612|NCT01300962|Lapatinib|lapatinib|mesh-list
65503613|NCT01300962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65503614|NCT01300962|Antimetabolites|antimetabolites|mesh-ancestor
65503615|NCT01300962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503616|NCT01300962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503617|NCT01300962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65503618|NCT01300962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65503619|NCT01300962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503620|NCT01299012|Liraglutide|liraglutide|mesh-list
65503621|NCT01299012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65503622|NCT01299012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503623|NCT01299012|Incretins|incretins|mesh-ancestor
65503624|NCT01299012|Hormones|hormones|mesh-ancestor
65503625|NCT01299012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65503626|NCT02155920|Everolimus|everolimus|mesh-list
65503627|NCT02155920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503628|NCT02155920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65503629|NCT02155920|Immunologic Factors|immunologic factors|mesh-ancestor
65503630|NCT02155920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503631|NCT01301040|Cyclophosphamide|cyclophosphamide|mesh-list
65503632|NCT01301040|Docetaxel|docetaxel|mesh-list
65503633|NCT01301040|Epirubicin|epirubicin|mesh-list
65503634|NCT01301040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65503635|NCT01301040|Immunologic Factors|immunologic factors|mesh-ancestor
65503636|NCT01301040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503637|NCT01301040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65503638|NCT01301040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65503639|NCT01301040|Alkylating Agents|alkylating agents|mesh-ancestor
65503640|NCT01301040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503641|NCT01301040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503642|NCT01301040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65503643|NCT01301040|Tubulin Modulators|tubulin modulators|mesh-ancestor
65503644|NCT01301040|Antimitotic Agents|antimitotic agents|mesh-ancestor
65503645|NCT01301040|Mitosis Modulators|mitosis modulators|mesh-ancestor
65503646|NCT01301040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65503647|NCT01301040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65503648|NCT01301040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65503649|NCT01301040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503650|NCT03818334|Cyclophosphamide|cyclophosphamide|mesh-list
65503651|NCT03818334|Thymoglobulin|thymoglobulin|mesh-list
65503652|NCT03818334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65503653|NCT03818334|Immunologic Factors|immunologic factors|mesh-ancestor
65503654|NCT03818334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503655|NCT03818334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65503656|NCT03818334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65503657|NCT03818334|Alkylating Agents|alkylating agents|mesh-ancestor
65503658|NCT03818334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503659|NCT03818334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503660|NCT03818334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65301381|NCT00286169|Amrubicin|amrubicin|mesh-list
65503662|NCT01206972|Rivaroxaban|rivaroxaban|mesh-list
65503663|NCT01206972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65503664|NCT01206972|Antithrombins|antithrombins|mesh-ancestor
65503665|NCT01206972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65503666|NCT01206972|Protease Inhibitors|protease inhibitors|mesh-ancestor
65503667|NCT01206972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503668|NCT01206972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503669|NCT01206972|Anticoagulants|anticoagulants|mesh-ancestor
65503670|NCT01206972|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65503671|NCT01206972|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65503673|NCT03817476|Nootropic Agents|nootropic agents|mesh-ancestor
65503674|NCT02918292|Mycophenolic Acid|mycophenolic acid|mesh-list
65503675|NCT02918292|Cyclophosphamide|cyclophosphamide|mesh-list
65503676|NCT02918292|Fludarabine|fludarabine|mesh-list
65503677|NCT02918292|Tacrolimus|tacrolimus|mesh-list
65503678|NCT02918292|Thymoglobulin|thymoglobulin|mesh-list
65503679|NCT02918292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65503680|NCT02918292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65503681|NCT02918292|Immunologic Factors|immunologic factors|mesh-ancestor
65503682|NCT02918292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503683|NCT02918292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65503684|NCT02918292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65503685|NCT02918292|Alkylating Agents|alkylating agents|mesh-ancestor
65503686|NCT02918292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503687|NCT02918292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503688|NCT02918292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65503689|NCT02918292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65503690|NCT02918292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503691|NCT02918292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65503692|NCT02918292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65503693|NCT02918292|Antitubercular Agents|antitubercular agents|mesh-ancestor
65503694|NCT02918292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65503695|NCT02918292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65503696|NCT01207128|Voriconazole|voriconazole|mesh-list
65503697|NCT01207128|Micafungin|micafungin|mesh-list
65503698|NCT01207128|Antifungal Agents|antifungal agents|mesh-ancestor
65503699|NCT01207128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65503700|NCT01207128|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65503701|NCT01207128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65503702|NCT01207128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503703|NCT01207128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503704|NCT01207128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65503705|NCT01207128|Hormone Antagonists|hormone antagonists|mesh-ancestor
65503706|NCT01207128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65503707|NCT01207128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503708|NCT01207128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65503709|NCT01299558|Fluticasone|fluticasone|mesh-list
65503710|NCT01299558|Xhance|xhance|mesh-list
65503711|NCT01299558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65503712|NCT01299558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65503713|NCT01299558|Autonomic Agents|autonomic agents|mesh-ancestor
65503714|NCT01299558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65503715|NCT01299558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503716|NCT01299558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65503717|NCT01299558|Respiratory System Agents|respiratory system agents|mesh-ancestor
65503718|NCT01299558|Dermatologic Agents|dermatologic agents|mesh-ancestor
65503719|NCT01299558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65503720|NCT01207206|Ketamine|ketamine|mesh-list
65503721|NCT01207206|Analgesics|analgesics|mesh-ancestor
65503722|NCT01207206|Sensory System Agents|sensory system agents|mesh-ancestor
65503723|NCT01207206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65503724|NCT01207206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503725|NCT01207206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65503726|NCT01207206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65503727|NCT01207206|Anesthetics, General|anesthetics, general|mesh-ancestor
65503728|NCT01207206|Anesthetics|anesthetics|mesh-ancestor
65503729|NCT01207206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65503730|NCT01207206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65503731|NCT01207206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65503732|NCT01207206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65503733|NCT01207206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503734|NCT03719586|Remdesivir|remdesivir|mesh-list
65301469|NCT01011751|Fertility Agents|fertility agents|mesh-ancestor
65503735|NCT03719586|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
65503737|NCT03719586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503738|NCT03719586|Antiviral Agents|antiviral agents|mesh-ancestor
65503739|NCT03719586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65503740|NCT05602818|Alprazolam|alprazolam|mesh-list
65503741|NCT05602818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65503742|NCT05602818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65503743|NCT05602818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503744|NCT05602818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65503745|NCT05602818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65503746|NCT05602818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65503747|NCT05602818|GABA Modulators|gaba modulators|mesh-ancestor
65503748|NCT05602818|GABA Agents|gaba agents|mesh-ancestor
65503749|NCT05602818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65503750|NCT05602818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503751|NCT00843882|Lenalidomide|lenalidomide|mesh-list
65503752|NCT00843882|Epoetin Alfa|epoetin alfa|mesh-list
65503753|NCT00843882|Immunologic Factors|immunologic factors|mesh-ancestor
65503754|NCT00843882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503755|NCT00843882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65503756|NCT00843882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65503757|NCT00843882|Growth Substances|growth substances|mesh-ancestor
65503758|NCT00843882|Growth Inhibitors|growth inhibitors|mesh-ancestor
65503759|NCT00843882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503760|NCT00843882|Hematinics|hematinics|mesh-ancestor
65503761|NCT01205022|Calcium, Dietary|calcium, dietary|mesh-list
65503762|NCT01205022|Leucovorin|leucovorin|mesh-list
65503763|NCT01205022|Bevacizumab|bevacizumab|mesh-list
65503764|NCT01205022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65503765|NCT01205022|Fluorouracil|fluorouracil|mesh-list
65503766|NCT01205022|Irinotecan|irinotecan|mesh-list
65503767|NCT01205022|Camptothecin|camptothecin|mesh-list
65503768|NCT01205022|Antibodies|antibodies|mesh-list
65503769|NCT01205022|Immunoglobulins|immunoglobulins|mesh-list
65503770|NCT01205022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65503771|NCT01205022|Calcium|calcium|mesh-list
65503772|NCT01205022|Levoleucovorin|levoleucovorin|mesh-list
65503773|NCT01205022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503774|NCT01205022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65503775|NCT01205022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65503776|NCT01205022|Growth Substances|growth substances|mesh-ancestor
65503777|NCT01205022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503778|NCT01205022|Growth Inhibitors|growth inhibitors|mesh-ancestor
65503779|NCT01205022|Immunologic Factors|immunologic factors|mesh-ancestor
65503780|NCT01205022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65503781|NCT01205022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65503782|NCT01205022|Antimetabolites|antimetabolites|mesh-ancestor
65503783|NCT01205022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503784|NCT01205022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65503785|NCT01205022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65503786|NCT01205022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65503787|NCT01205022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65503788|NCT01205022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503789|NCT01205022|Antidotes|antidotes|mesh-ancestor
65503790|NCT01205022|Protective Agents|protective agents|mesh-ancestor
65503791|NCT01205022|Vitamin B Complex|vitamin b complex|mesh-ancestor
65503792|NCT01205022|Vitamins|vitamins|mesh-ancestor
65503793|NCT01205022|Micronutrients|micronutrients|mesh-ancestor
65503794|NCT01205022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65503795|NCT01205178|Chloroquine|chloroquine|mesh-list
65503796|NCT01205178|Primaquine|primaquine|mesh-list
65503797|NCT01205178|Tafenoquine|tafenoquine|mesh-list
65503798|NCT01205178|Amebicides|amebicides|mesh-ancestor
65503799|NCT01205178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65503800|NCT01205178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65503801|NCT01205178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65503802|NCT01205178|Antimalarials|antimalarials|mesh-ancestor
65503803|NCT01205178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65503804|NCT01205256|Methadone|methadone|mesh-list
65503805|NCT01205256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65503806|NCT01205256|Narcotics|narcotics|mesh-ancestor
65503807|NCT01205256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65503808|NCT01205256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503809|NCT01205256|Analgesics|analgesics|mesh-ancestor
65503810|NCT01205256|Sensory System Agents|sensory system agents|mesh-ancestor
65503811|NCT01205256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65503812|NCT01205256|Antitussive Agents|antitussive agents|mesh-ancestor
65503813|NCT01205256|Respiratory System Agents|respiratory system agents|mesh-ancestor
65503815|NCT03823482|Anesthetics, Local|anesthetics, local|mesh-ancestor
65503816|NCT03823482|Anesthetics|anesthetics|mesh-ancestor
65503817|NCT03823482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65503818|NCT03823482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503819|NCT03823482|Sensory System Agents|sensory system agents|mesh-ancestor
65503820|NCT03823482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65503821|NCT03823482|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65503822|NCT03823482|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65503823|NCT03823482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65503824|NCT03823482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65503825|NCT03823482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503826|NCT03816306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65503827|NCT03816306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65503828|NCT03816306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503829|NCT03816072|Phenylephrine|phenylephrine|mesh-list
65503830|NCT03816072|Oxymetazoline|oxymetazoline|mesh-list
65503831|NCT03816072|Propofol|propofol|mesh-list
65503832|NCT03816072|Sevoflurane|sevoflurane|mesh-list
65503833|NCT03816072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65503834|NCT03816072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65503835|NCT03816072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503836|NCT03816072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65503837|NCT03816072|Anesthetics, General|anesthetics, general|mesh-ancestor
65503838|NCT03816072|Anesthetics|anesthetics|mesh-ancestor
65503839|NCT03816072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65503840|NCT03816072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65503841|NCT03816072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65503842|NCT03816072|Mydriatics|mydriatics|mesh-ancestor
65503843|NCT03816072|Autonomic Agents|autonomic agents|mesh-ancestor
65503844|NCT03816072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65503845|NCT03816072|Sympathomimetics|sympathomimetics|mesh-ancestor
65503846|NCT03816072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65503847|NCT03816072|Nasal Decongestants|nasal decongestants|mesh-ancestor
65503848|NCT03816072|Respiratory System Agents|respiratory system agents|mesh-ancestor
65503849|NCT03816072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65503850|NCT03816072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65503851|NCT03816072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65503852|NCT03816072|Adrenergic Agents|adrenergic agents|mesh-ancestor
65503853|NCT03816072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65503854|NCT03816072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503855|NCT03816072|Protective Agents|protective agents|mesh-ancestor
65503856|NCT01299948|Prednisolone|prednisolone|mesh-list
65503857|NCT01299948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65503858|NCT01299948|Glucocorticoids|glucocorticoids|mesh-ancestor
65503859|NCT01299948|Hormones|hormones|mesh-ancestor
65503860|NCT01299948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65503861|NCT01299948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503862|NCT01299948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65503863|NCT01299948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503864|NCT01300026|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
65503865|NCT01300026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503866|NCT01300026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503867|NCT01297452|Paclitaxel|paclitaxel|mesh-list
65503868|NCT01297452|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65503869|NCT01297452|Carboplatin|carboplatin|mesh-list
65503870|NCT01297452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65503871|NCT01297452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503872|NCT01297452|Tubulin Modulators|tubulin modulators|mesh-ancestor
65503873|NCT01297452|Antimitotic Agents|antimitotic agents|mesh-ancestor
65503874|NCT01297452|Mitosis Modulators|mitosis modulators|mesh-ancestor
65503875|NCT01297452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503876|NCT01301586|Doxycycline|doxycycline|mesh-list
65503877|NCT01301586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65503878|NCT01301586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65503879|NCT01301586|Antimalarials|antimalarials|mesh-ancestor
65503880|NCT01301586|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65503881|NCT01301586|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65503882|NCT03815838|Fallypride|fallypride|mesh-list
65503883|NCT03815838|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65503884|NCT03815838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65503885|NCT03815838|Dopamine Agents|dopamine agents|mesh-ancestor
65503886|NCT03815838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65503887|NCT03815838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503888|NCT03815838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503890|NCT01205724|Coagulants|coagulants|mesh-ancestor
65503891|NCT01301820|Lenalidomide|lenalidomide|mesh-list
65503892|NCT01301820|Azacitidine|azacitidine|mesh-list
65503893|NCT01301820|Immunologic Factors|immunologic factors|mesh-ancestor
65503894|NCT01301820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503895|NCT01301820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65503896|NCT01301820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65503897|NCT01301820|Growth Substances|growth substances|mesh-ancestor
65503898|NCT01301820|Growth Inhibitors|growth inhibitors|mesh-ancestor
65503899|NCT01301820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503900|NCT01301820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65503901|NCT01301820|Antimetabolites|antimetabolites|mesh-ancestor
65503902|NCT01301820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503903|NCT01301820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503904|NCT01297686|Dexamethasone|dexamethasone|mesh-list
65503905|NCT01297686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65503906|NCT01297686|Antiemetics|antiemetics|mesh-ancestor
65503907|NCT01297686|Autonomic Agents|autonomic agents|mesh-ancestor
65503908|NCT01297686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65503909|NCT01297686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503910|NCT01297686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65503911|NCT01297686|Glucocorticoids|glucocorticoids|mesh-ancestor
65503912|NCT01297686|Hormones|hormones|mesh-ancestor
65503913|NCT01297686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65503914|NCT01297686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65503915|NCT01297686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503916|NCT01205880|Calcitriol|calcitriol|mesh-list
65503917|NCT01205880|Clobetasol|clobetasol|mesh-list
65503918|NCT01205880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65503919|NCT01205880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503920|NCT01205880|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65503921|NCT01205880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65503922|NCT01205880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503923|NCT01205880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65503924|NCT01205880|Vitamins|vitamins|mesh-ancestor
65503925|NCT01205880|Micronutrients|micronutrients|mesh-ancestor
65503926|NCT01205880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65503927|NCT01205880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65503928|NCT01205880|Glucocorticoids|glucocorticoids|mesh-ancestor
65503929|NCT01205880|Hormones|hormones|mesh-ancestor
65503930|NCT01205880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65503931|NCT01205958|Pyranoprofen|pyranoprofen|mesh-list
65503932|NCT01205958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65503933|NCT01205958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65503934|NCT01205958|Analgesics|analgesics|mesh-ancestor
65503935|NCT01205958|Sensory System Agents|sensory system agents|mesh-ancestor
65503936|NCT01205958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65503937|NCT01205958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503938|NCT01205958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65503939|NCT01205958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65503940|NCT01205958|Gout Suppressants|gout suppressants|mesh-ancestor
65503941|NCT01297842|Meropenem|meropenem|mesh-list
65503942|NCT01297842|Imipenem|imipenem|mesh-list
65503943|NCT01297842|Ertapenem|ertapenem|mesh-list
65503944|NCT01297842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65503945|NCT01297842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65503946|NCT01297998|Gemcitabine|gemcitabine|mesh-list
65503947|NCT01297998|Cisplatin|cisplatin|mesh-list
65503948|NCT01297998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65503949|NCT01297998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65503950|NCT01297998|Antimetabolites|antimetabolites|mesh-ancestor
65503951|NCT01297998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503952|NCT01297998|Antiviral Agents|antiviral agents|mesh-ancestor
65503953|NCT01297998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65503954|NCT01297998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503955|NCT01297998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65503956|NCT01297998|Immunologic Factors|immunologic factors|mesh-ancestor
65503957|NCT01297998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503958|NCT01298076|Dexamethasone|dexamethasone|mesh-list
65503959|NCT01298076|Bevacizumab|bevacizumab|mesh-list
65503960|NCT01298076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65301684|NCT00603239|Exenatide|exenatide|mesh-list
65503962|NCT01298076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65503963|NCT01298076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65503964|NCT01298076|Growth Substances|growth substances|mesh-ancestor
65503965|NCT01298076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503966|NCT01298076|Growth Inhibitors|growth inhibitors|mesh-ancestor
65503967|NCT01298076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65503968|NCT01298076|Antiemetics|antiemetics|mesh-ancestor
65503969|NCT01298076|Autonomic Agents|autonomic agents|mesh-ancestor
65503970|NCT01298076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65503971|NCT01298076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65503972|NCT01298076|Glucocorticoids|glucocorticoids|mesh-ancestor
65503973|NCT01298076|Hormones|hormones|mesh-ancestor
65503974|NCT01298076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65503975|NCT01298076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65503976|NCT03819348|Antifungal Agents|antifungal agents|mesh-list
65503977|NCT03819348|Clotrimazole|clotrimazole|mesh-list
65503978|NCT03819348|Miconazole|miconazole|mesh-list
65503979|NCT03819348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65503980|NCT03819348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65503981|NCT03819348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65503982|NCT03819348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65503983|NCT03819348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65503984|NCT03819348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65503985|NCT03819348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65503986|NCT03819348|Hormone Antagonists|hormone antagonists|mesh-ancestor
65503987|NCT03819348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65503988|NCT03819348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503989|NCT03819348|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65503990|NCT03819348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65503991|NCT01560390|Ketamine|ketamine|mesh-list
65503992|NCT01560390|Analgesics|analgesics|mesh-ancestor
65503993|NCT01560390|Sensory System Agents|sensory system agents|mesh-ancestor
65503994|NCT01560390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65503995|NCT01560390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65503996|NCT01560390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65503997|NCT01560390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65503998|NCT01560390|Anesthetics, General|anesthetics, general|mesh-ancestor
65503999|NCT01560390|Anesthetics|anesthetics|mesh-ancestor
65504000|NCT01560390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504001|NCT01560390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65504002|NCT01560390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65504003|NCT01560390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65504004|NCT01560390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504005|NCT03807882|Clozapine|clozapine|mesh-list
65504006|NCT03807882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65504007|NCT03807882|Serotonin Agents|serotonin agents|mesh-ancestor
65504008|NCT03807882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65504009|NCT03807882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504010|NCT03807882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504011|NCT03807882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65504012|NCT03807882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65504013|NCT03807882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504014|NCT03807882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65504015|NCT03807882|GABA Antagonists|gaba antagonists|mesh-ancestor
65504016|NCT03807882|GABA Agents|gaba agents|mesh-ancestor
65504017|NCT03796572|Ropivacaine|ropivacaine|mesh-list
65504018|NCT03796572|Anesthetics, Local|anesthetics, local|mesh-ancestor
65504019|NCT03796572|Anesthetics|anesthetics|mesh-ancestor
65504020|NCT03796572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504021|NCT03796572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504022|NCT03796572|Sensory System Agents|sensory system agents|mesh-ancestor
65504023|NCT03796572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504024|NCT01304472|Clopidogrel|clopidogrel|mesh-list
65504025|NCT01304472|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65504026|NCT01304472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65504027|NCT01304472|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65504028|NCT01304472|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65504029|NCT01304472|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65504030|NCT01304472|Purinergic Agents|purinergic agents|mesh-ancestor
65504031|NCT01304472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65504032|NCT01304472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504033|NCT01304472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504034|NCT03795792|Curcumin|curcumin|mesh-list
65504035|NCT03795792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65504036|NCT03795792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65504037|NCT03795792|Analgesics|analgesics|mesh-ancestor
65504038|NCT03795792|Sensory System Agents|sensory system agents|mesh-ancestor
65504039|NCT03795792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504040|NCT03795792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504041|NCT03795792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65504042|NCT03795792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65504043|NCT03795792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504044|NCT03795792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504045|NCT03795792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504046|NCT01303536|Ondansetron|ondansetron|mesh-list
65504047|NCT01303536|Antiemetics|antiemetics|mesh-ancestor
65504048|NCT01303536|Autonomic Agents|autonomic agents|mesh-ancestor
65504049|NCT01303536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504050|NCT01303536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504051|NCT01303536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65504052|NCT01303536|Antipruritics|antipruritics|mesh-ancestor
65504053|NCT01303536|Dermatologic Agents|dermatologic agents|mesh-ancestor
65504054|NCT01303536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65504055|NCT01303536|Serotonin Agents|serotonin agents|mesh-ancestor
65504056|NCT01303536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65504057|NCT01303536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504058|NCT01303536|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65504059|NCT01303536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65504060|NCT01303536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504061|NCT01303536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65504062|NCT01303536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65504063|NCT01303614|Lidocaine|lidocaine|mesh-list
65504064|NCT01303614|Prilocaine|prilocaine|mesh-list
65504065|NCT01303614|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65504066|NCT01303614|Anesthetics, Local|anesthetics, local|mesh-ancestor
65504067|NCT01303614|Anesthetics|anesthetics|mesh-ancestor
65504068|NCT01303614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504069|NCT01303614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504070|NCT01303614|Sensory System Agents|sensory system agents|mesh-ancestor
65504071|NCT01303614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504072|NCT01303614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65504073|NCT01303614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65504074|NCT01303614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65504075|NCT01303614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65504076|NCT01303614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504077|NCT01303614|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65504078|NCT03347838|Nivolumab|nivolumab|mesh-list
65504079|NCT03347838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65504080|NCT03347838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504081|NCT03347838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65504082|NCT03347838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504083|NCT03795090|Anti-Infective Agents|anti-infective agents|mesh-list
65504084|NCT03795090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65504085|NCT03802422|Vitamin B 12|vitamin b 12|mesh-list
65504086|NCT03802422|Hydroxocobalamin|hydroxocobalamin|mesh-list
65504087|NCT03802422|Vitamins|vitamins|mesh-ancestor
65504088|NCT03802422|Micronutrients|micronutrients|mesh-ancestor
65504089|NCT03802422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504090|NCT03802422|Vitamin B Complex|vitamin b complex|mesh-ancestor
65504091|NCT03802422|Hematinics|hematinics|mesh-ancestor
65504092|NCT03801564|Hyaluronic Acid|hyaluronic acid|mesh-list
65504093|NCT03801564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65504094|NCT03801564|Immunologic Factors|immunologic factors|mesh-ancestor
65504095|NCT03801564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504096|NCT03801564|Viscosupplements|viscosupplements|mesh-ancestor
65504097|NCT03801564|Protective Agents|protective agents|mesh-ancestor
65504098|NCT03813186|Decitabine|decitabine|mesh-list
65504099|NCT03813186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65504100|NCT03813186|Antimetabolites|antimetabolites|mesh-ancestor
65504101|NCT03813186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504102|NCT03813186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504103|NCT03813186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504104|NCT03293784|Nivolumab|nivolumab|mesh-list
65504105|NCT03293784|Ipilimumab|ipilimumab|mesh-list
65504106|NCT03293784|Infliximab|infliximab|mesh-list
65504107|NCT03293784|Certolizumab Pegol|certolizumab pegol|mesh-list
65504108|NCT03293784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65504109|NCT03293784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504110|NCT03293784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65504111|NCT03293784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504112|NCT03293784|Dermatologic Agents|dermatologic agents|mesh-ancestor
65504113|NCT03293784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65504114|NCT03293784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65504115|NCT03293784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65504116|NCT03293784|Immunologic Factors|immunologic factors|mesh-ancestor
65504117|NCT03293784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504118|NCT03353350|Efpeglenatide|efpeglenatide|mesh-list
65504119|NCT03353350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65504120|NCT03353350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504121|NCT01302132|Ipragliflozin|ipragliflozin|mesh-list
65504122|NCT01302132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65504123|NCT01302132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504124|NCT01302132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65504125|NCT01302132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504127|NCT03799536|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65504128|NCT03799536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65504129|NCT03799536|Adrenergic Agents|adrenergic agents|mesh-ancestor
65504130|NCT03799536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65504131|NCT03799536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504132|NCT03799536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504133|NCT03799536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65504134|NCT03799536|Sympatholytics|sympatholytics|mesh-ancestor
65504135|NCT03799536|Autonomic Agents|autonomic agents|mesh-ancestor
65504136|NCT03799536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504137|NCT03229278|Pembrolizumab|pembrolizumab|mesh-list
65504138|NCT03229278|Nivolumab|nivolumab|mesh-list
65504139|NCT03229278|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65504140|NCT03229278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65504141|NCT03229278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504142|NCT03229278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65504143|NCT03229278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504144|NCT03812796|Avelumab|avelumab|mesh-list
65504145|NCT03812796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65504146|NCT03812796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504147|NCT05759104|Adalimumab|adalimumab|mesh-list
65504148|NCT05759104|Infliximab|infliximab|mesh-list
65504149|NCT05759104|Ustekinumab|ustekinumab|mesh-list
65504150|NCT05759104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65504151|NCT05759104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65504152|NCT05759104|Dermatologic Agents|dermatologic agents|mesh-ancestor
65504153|NCT05759104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65504154|NCT01384240|Proflavine|proflavine|mesh-list
65504155|NCT01384240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65504156|NCT01384240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65504157|NCT01381510|Finasteride|finasteride|mesh-list
65504158|NCT01381510|Dutasteride|dutasteride|mesh-list
65504159|NCT01381510|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
65504160|NCT01381510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65504161|NCT01381510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504162|NCT01381510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504163|NCT01381510|Hormone Antagonists|hormone antagonists|mesh-ancestor
65504164|NCT01381510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65504165|NCT01381510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504166|NCT01381510|Urological Agents|urological agents|mesh-ancestor
65504167|NCT02984800|Anesthetics|anesthetics|mesh-list
65504168|NCT02984800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504169|NCT02984800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504170|NCT04188730|Lofexidine|lofexidine|mesh-list
65504171|NCT04188730|Clonidine|clonidine|mesh-list
65504172|NCT04188730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65504173|NCT04188730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65504174|NCT04188730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504175|NCT04188730|Sensory System Agents|sensory system agents|mesh-ancestor
65504176|NCT04188730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504177|NCT04188730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65504178|NCT04188730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65504179|NCT04188730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65504180|NCT04188730|Adrenergic Agents|adrenergic agents|mesh-ancestor
65504181|NCT04188730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65504182|NCT04188730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504183|NCT04188730|Analgesics|analgesics|mesh-ancestor
65504184|NCT04188730|Sympatholytics|sympatholytics|mesh-ancestor
65504185|NCT04188730|Autonomic Agents|autonomic agents|mesh-ancestor
65504186|NCT01381432|Azathioprine|azathioprine|mesh-list
65504187|NCT01381432|Antimetabolites|antimetabolites|mesh-ancestor
65056600|NCT04539106|Ranibizumab|ranibizumab|mesh-list
65504188|NCT01381432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504189|NCT01381432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65504190|NCT01381432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504191|NCT01381432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65504192|NCT01381432|Immunologic Factors|immunologic factors|mesh-ancestor
65504193|NCT01381432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504194|NCT01381432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65504195|NCT01381354|Thioctic Acid|thioctic acid|mesh-list
65504197|NCT01381354|Thiamine|thiamine|mesh-list
65504198|NCT01381354|Niacinamide|niacinamide|mesh-list
65504199|NCT01381354|Niacin|niacin|mesh-list
65504200|NCT01381354|Nicotinic Acids|nicotinic acids|mesh-list
65504201|NCT01381354|Acetylcarnitine|acetylcarnitine|mesh-list
65504202|NCT01381354|Ubiquinone|ubiquinone|mesh-list
65504203|NCT01381354|Acetylcysteine|acetylcysteine|mesh-list
65504204|NCT01381354|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
65504205|NCT01381354|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65504206|NCT01381354|Vitamins|vitamins|mesh-ancestor
65504207|NCT01381354|Micronutrients|micronutrients|mesh-ancestor
65504208|NCT01381354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504209|NCT01381354|Antiviral Agents|antiviral agents|mesh-ancestor
65504210|NCT01381354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65504211|NCT01381354|Expectorants|expectorants|mesh-ancestor
65504212|NCT01381354|Respiratory System Agents|respiratory system agents|mesh-ancestor
65504213|NCT01381354|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65504214|NCT01381354|Antioxidants|antioxidants|mesh-ancestor
65504215|NCT01381354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504216|NCT01381354|Protective Agents|protective agents|mesh-ancestor
65504217|NCT01381354|Antidotes|antidotes|mesh-ancestor
65504218|NCT01381354|Vitamin B Complex|vitamin b complex|mesh-ancestor
65504219|NCT01381354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65504220|NCT01381354|Dermatologic Agents|dermatologic agents|mesh-ancestor
65504221|NCT01381354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65504222|NCT01381354|Antimetabolites|antimetabolites|mesh-ancestor
65504223|NCT01381354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65504224|NCT01381354|Vasodilator Agents|vasodilator agents|mesh-ancestor
65504225|NCT01381354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65504226|NCT01381354|Nootropic Agents|nootropic agents|mesh-ancestor
65504227|NCT01381276|Beta Carotene|beta carotene|mesh-list
65504228|NCT01381276|Vitamin A|vitamin a|mesh-list
65504229|NCT01381276|Retinol palmitate|retinol palmitate|mesh-list
65504230|NCT01381276|Carotenoids|carotenoids|mesh-list
65504231|NCT01381276|Antioxidants|antioxidants|mesh-ancestor
65504232|NCT01381276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504233|NCT01381276|Protective Agents|protective agents|mesh-ancestor
65504234|NCT01381276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504235|NCT01381276|Provitamins|provitamins|mesh-ancestor
65504236|NCT01381276|Vitamins|vitamins|mesh-ancestor
65504237|NCT01381276|Micronutrients|micronutrients|mesh-ancestor
65504238|NCT01381276|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65504239|NCT01381276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504240|NCT02661022|Dexamethasone|dexamethasone|mesh-list
65504241|NCT02661022|Pomalidomide|pomalidomide|mesh-list
65504242|NCT02661022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65504243|NCT02661022|Antiemetics|antiemetics|mesh-ancestor
65504244|NCT02661022|Autonomic Agents|autonomic agents|mesh-ancestor
65504245|NCT02661022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504246|NCT02661022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504247|NCT02661022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65504248|NCT02661022|Glucocorticoids|glucocorticoids|mesh-ancestor
65504249|NCT02661022|Hormones|hormones|mesh-ancestor
65504250|NCT02661022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65504251|NCT02661022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65504252|NCT02661022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504253|NCT02661022|Immunologic Factors|immunologic factors|mesh-ancestor
65504254|NCT02661022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65504255|NCT02661022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65504256|NCT02661022|Growth Substances|growth substances|mesh-ancestor
65504257|NCT02661022|Growth Inhibitors|growth inhibitors|mesh-ancestor
65301975|NCT00870584|Omalizumab|omalizumab|mesh-list
65504258|NCT01569256|Cabergoline|cabergoline|mesh-list
65504259|NCT01569256|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65504260|NCT01569256|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65504261|NCT01569256|Dopamine Agonists|dopamine agonists|mesh-ancestor
65504262|NCT01569256|Dopamine Agents|dopamine agents|mesh-ancestor
65504263|NCT01569256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65504264|NCT01569256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504265|NCT01569256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504266|NCT03794544|Durvalumab|durvalumab|mesh-list
65504267|NCT03794544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65504268|NCT03794544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504269|NCT01380808|Capecitabine|capecitabine|mesh-list
65504270|NCT01380808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65504271|NCT01380808|Antimetabolites|antimetabolites|mesh-ancestor
65504272|NCT01380808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504273|NCT01380808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504274|NCT03799224|Decitabine|decitabine|mesh-list
65504275|NCT03799224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65504276|NCT03799224|Antimetabolites|antimetabolites|mesh-ancestor
65504277|NCT03799224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504278|NCT03799224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504279|NCT03799224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504280|NCT03798912|Octreotide|octreotide|mesh-list
65504281|NCT03798912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65504282|NCT03798912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65504283|NCT03798912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504284|NCT01302210|Mupirocin|mupirocin|mesh-list
65504285|NCT01302210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65504286|NCT01302210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65504287|NCT01302210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65504288|NCT01302210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504289|NCT01302210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504290|NCT03798834|Anesthetics|anesthetics|mesh-list
65504291|NCT03798834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504292|NCT03798834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504293|NCT03812562|Nivolumab|nivolumab|mesh-list
65504294|NCT03812562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65504295|NCT03812562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504296|NCT03812562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65504297|NCT03812562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504298|NCT01304784|Paclitaxel|paclitaxel|mesh-list
65504299|NCT01304784|Docetaxel|docetaxel|mesh-list
65504300|NCT01304784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65504301|NCT01304784|Capecitabine|capecitabine|mesh-list
65504302|NCT01304784|Trastuzumab|trastuzumab|mesh-list
65504303|NCT01304784|Lapatinib|lapatinib|mesh-list
65504304|NCT01304784|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65504305|NCT01304784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65504306|NCT01304784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504307|NCT01304784|Tubulin Modulators|tubulin modulators|mesh-ancestor
65504308|NCT01304784|Antimitotic Agents|antimitotic agents|mesh-ancestor
65504309|NCT01304784|Mitosis Modulators|mitosis modulators|mesh-ancestor
65504310|NCT01304784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504311|NCT01304784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65504312|NCT01304784|Antimetabolites|antimetabolites|mesh-ancestor
65504313|NCT01304784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65504314|NCT01304784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65504315|NCT01304784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504316|NCT01304784|Immunologic Factors|immunologic factors|mesh-ancestor
65504317|NCT01304784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504318|NCT03798600|Caspofungin|caspofungin|mesh-list
65504319|NCT03798600|Antifungal Agents|antifungal agents|mesh-ancestor
65504320|NCT03798600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65504321|NCT03798600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504322|NCT03798600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504323|NCT03798522|Nalbuphine|nalbuphine|mesh-list
65504324|NCT03798522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65504325|NCT03798522|Narcotics|narcotics|mesh-ancestor
65504326|NCT03798522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504327|NCT03798522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504328|NCT03798522|Analgesics|analgesics|mesh-ancestor
65504329|NCT03798522|Sensory System Agents|sensory system agents|mesh-ancestor
65504330|NCT03798522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504331|NCT01308034|Sunitinib|sunitinib|mesh-list
65504332|NCT01308034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504333|NCT01308034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65504334|NCT01308034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65504335|NCT01308034|Growth Substances|growth substances|mesh-ancestor
65504336|NCT01308034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504337|NCT01308034|Growth Inhibitors|growth inhibitors|mesh-ancestor
65504338|NCT01308034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65504339|NCT01308034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504340|NCT01308034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504342|NCT04182360|Oxytocics|oxytocics|mesh-ancestor
65056747|NCT00269763|Fentanyl|fentanyl|mesh-list
65504343|NCT04182360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65504344|NCT04182360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504345|NCT00005044|Bicalutamide|bicalutamide|mesh-list
65504346|NCT00005044|Flutamide|flutamide|mesh-list
65504347|NCT00005044|Hormones|hormones|mesh-list
65504348|NCT00005044|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65504349|NCT00005044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65504350|NCT00005044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504351|NCT00005044|Androgen Antagonists|androgen antagonists|mesh-ancestor
65504352|NCT00005044|Hormone Antagonists|hormone antagonists|mesh-ancestor
65504353|NCT00005044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504354|NCT00005044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65504355|NCT03794154|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65504356|NCT03794154|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65504357|NCT03794154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65504358|NCT03794154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65504359|NCT03794154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504360|NCT03794154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65504361|NCT03794154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504362|NCT03794154|Analgesics|analgesics|mesh-ancestor
65504363|NCT03794154|Sensory System Agents|sensory system agents|mesh-ancestor
65504364|NCT03794154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504365|NCT03794154|Antidepressive Agents|antidepressive agents|mesh-ancestor
65504366|NCT03794154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65504367|NCT03794154|Dopamine Agents|dopamine agents|mesh-ancestor
65504368|NCT03811860|Lithium Carbonate|lithium carbonate|mesh-list
65504369|NCT03811860|Antidepressive Agents|antidepressive agents|mesh-ancestor
65504370|NCT03811860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65504371|NCT03811860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504372|NCT03811860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504373|NCT03811860|Antimanic Agents|antimanic agents|mesh-ancestor
65504374|NCT03811860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65504375|NCT03811860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504376|NCT03811860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504377|NCT02722668|Mycophenolic Acid|mycophenolic acid|mesh-list
65504378|NCT02722668|Sirolimus|sirolimus|mesh-list
65504379|NCT02722668|Cyclophosphamide|cyclophosphamide|mesh-list
65504380|NCT02722668|Fludarabine|fludarabine|mesh-list
65504381|NCT02722668|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65504382|NCT02722668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65504383|NCT02722668|Immunologic Factors|immunologic factors|mesh-ancestor
65504384|NCT02722668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504385|NCT02722668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65504386|NCT02722668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65504387|NCT02722668|Alkylating Agents|alkylating agents|mesh-ancestor
65504388|NCT02722668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504389|NCT02722668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504390|NCT02722668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65504391|NCT02722668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65504392|NCT02722668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65504393|NCT02722668|Antitubercular Agents|antitubercular agents|mesh-ancestor
65504394|NCT02722668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65504395|NCT02722668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65504396|NCT02722668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504397|NCT02722668|Antifungal Agents|antifungal agents|mesh-ancestor
65504398|NCT01303926|Paclitaxel|paclitaxel|mesh-list
65504399|NCT01303926|Bevacizumab|bevacizumab|mesh-list
65504400|NCT01303926|Carboplatin|carboplatin|mesh-list
65504401|NCT01303926|Pemetrexed|pemetrexed|mesh-list
65504402|NCT01303926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65504403|NCT01303926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504404|NCT01303926|Tubulin Modulators|tubulin modulators|mesh-ancestor
65504405|NCT01303926|Antimitotic Agents|antimitotic agents|mesh-ancestor
65504406|NCT01303926|Mitosis Modulators|mitosis modulators|mesh-ancestor
65504407|NCT01303926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504408|NCT01303926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65504409|NCT01303926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65504410|NCT01303926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65302134|NCT02619266|Megestrol|megestrol|mesh-list
65504411|NCT01303926|Growth Substances|growth substances|mesh-ancestor
65504412|NCT01303926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504413|NCT01303926|Growth Inhibitors|growth inhibitors|mesh-ancestor
65504414|NCT01303926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504415|NCT01303926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65504416|NCT01303926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65504417|NCT03084796|Bromides|bromides|mesh-list
65504418|NCT03084796|Tiotropium Bromide|tiotropium bromide|mesh-list
65504419|NCT03084796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65504420|NCT03084796|Autonomic Agents|autonomic agents|mesh-ancestor
65504421|NCT03084796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504422|NCT03084796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504423|NCT03084796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65504424|NCT03084796|Respiratory System Agents|respiratory system agents|mesh-ancestor
65504425|NCT03084796|Parasympatholytics|parasympatholytics|mesh-ancestor
65504426|NCT03084796|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65504427|NCT03084796|Cholinergic Agents|cholinergic agents|mesh-ancestor
65504428|NCT03084796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65504429|NCT03084796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504430|NCT03084796|Anticonvulsants|anticonvulsants|mesh-ancestor
65504431|NCT03717012|Nintedanib|nintedanib|mesh-list
65504432|NCT03717012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504433|NCT03717012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65504434|NCT03717012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504435|NCT03717012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504436|NCT01302756|Folic Acid|folic acid|mesh-list
65504437|NCT01302756|Hematinics|hematinics|mesh-ancestor
65504438|NCT01302756|Vitamin B Complex|vitamin b complex|mesh-ancestor
65504439|NCT01302756|Vitamins|vitamins|mesh-ancestor
65504440|NCT01302756|Micronutrients|micronutrients|mesh-ancestor
65504441|NCT01302756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504442|NCT04893252|Durvalumab|durvalumab|mesh-list
65504443|NCT04893252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65504444|NCT04893252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504445|NCT03797508|Progesterone|progesterone|mesh-list
65504446|NCT03797508|Progestins|progestins|mesh-ancestor
65504447|NCT03797508|Hormones|hormones|mesh-ancestor
65504448|NCT03797508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65504449|NCT03797508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504450|NCT01380496|Doxycycline|doxycycline|mesh-list
65504451|NCT01380496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65504452|NCT01380496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65504453|NCT01380496|Antimalarials|antimalarials|mesh-ancestor
65504454|NCT01380496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65504455|NCT01380496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65504456|NCT01304316|Phenylephrine|phenylephrine|mesh-list
65504457|NCT01304316|Oxymetazoline|oxymetazoline|mesh-list
65504458|NCT01304316|Tetracaine|tetracaine|mesh-list
65504459|NCT01304316|Anesthetics, Local|anesthetics, local|mesh-ancestor
65504460|NCT01304316|Anesthetics|anesthetics|mesh-ancestor
65504461|NCT01304316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504462|NCT01304316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504463|NCT01304316|Sensory System Agents|sensory system agents|mesh-ancestor
65504464|NCT01304316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504465|NCT01304316|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65504466|NCT01304316|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65504467|NCT01304316|Adrenergic Agents|adrenergic agents|mesh-ancestor
65504468|NCT01304316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65504469|NCT01304316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504470|NCT01304316|Sympathomimetics|sympathomimetics|mesh-ancestor
65504471|NCT01304316|Autonomic Agents|autonomic agents|mesh-ancestor
65504472|NCT01304316|Nasal Decongestants|nasal decongestants|mesh-ancestor
65504473|NCT01304316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65504474|NCT01304316|Respiratory System Agents|respiratory system agents|mesh-ancestor
65504475|NCT01304316|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65504476|NCT01304316|Mydriatics|mydriatics|mesh-ancestor
65504477|NCT01304316|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65504478|NCT01304316|Protective Agents|protective agents|mesh-ancestor
65504479|NCT03792828|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65504480|NCT03792828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65504481|NCT03792828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65504482|NCT03792828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65504483|NCT03792828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504484|NCT03792828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65504485|NCT03792828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504486|NCT03792828|Analgesics|analgesics|mesh-ancestor
65504487|NCT03792828|Sensory System Agents|sensory system agents|mesh-ancestor
65504488|NCT03792828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504489|NCT03792828|Antidepressive Agents|antidepressive agents|mesh-ancestor
65504490|NCT03792828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65504491|NCT03792828|Dopamine Agents|dopamine agents|mesh-ancestor
65504493|NCT00579826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504494|NCT00579826|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65504495|NCT00579826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65504496|NCT00579826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504497|NCT00579826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504498|NCT00579826|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65504499|NCT00579826|Hormone Antagonists|hormone antagonists|mesh-ancestor
65504500|NCT00579826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65504501|NCT00579826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504502|NCT01379326|Mebendazole|mebendazole|mesh-list
65504503|NCT01379326|Piperazine|piperazine|mesh-list
65504504|NCT01379326|Piperazine citrate|piperazine citrate|mesh-list
65504505|NCT01379326|DMP 777|dmp 777|mesh-list
65504506|NCT01379326|Antinematodal Agents|antinematodal agents|mesh-ancestor
65504507|NCT01379326|Anthelmintics|anthelmintics|mesh-ancestor
65504508|NCT01379326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65504509|NCT01379326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65504510|NCT01379326|Tubulin Modulators|tubulin modulators|mesh-ancestor
65504511|NCT01379326|Antimitotic Agents|antimitotic agents|mesh-ancestor
65504512|NCT01379326|Mitosis Modulators|mitosis modulators|mesh-ancestor
65504513|NCT01379326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504514|NCT01379326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504515|NCT01379326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504516|NCT01560546|Testosterone|testosterone|mesh-list
65504517|NCT01560546|Androgens|androgens|mesh-ancestor
65504518|NCT01560546|Hormones|hormones|mesh-ancestor
65504519|NCT01560546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65504520|NCT01560546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504521|NCT03792984|Vitamin D|vitamin d|mesh-list
65504522|NCT03792984|Cholecalciferol|cholecalciferol|mesh-list
65504523|NCT03792984|Metformin|metformin|mesh-list
65504524|NCT03792984|Calcium Carbonate|calcium carbonate|mesh-list
65504525|NCT03792984|Calcium|calcium|mesh-list
65504526|NCT03792984|Vitamins|vitamins|mesh-ancestor
65504527|NCT03792984|Micronutrients|micronutrients|mesh-ancestor
65504528|NCT03792984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504529|NCT03792984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65504530|NCT03792984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65504531|NCT03792984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65504532|NCT03792984|Antacids|antacids|mesh-ancestor
65504533|NCT03792984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504534|NCT03792984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65504535|NCT03792906|Norepinephrine|norepinephrine|mesh-list
65504536|NCT03792906|Bupivacaine|bupivacaine|mesh-list
65504537|NCT03792906|Anesthetics, Local|anesthetics, local|mesh-ancestor
65504538|NCT03792906|Anesthetics|anesthetics|mesh-ancestor
65504539|NCT03792906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504540|NCT03792906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504541|NCT03792906|Sensory System Agents|sensory system agents|mesh-ancestor
65504542|NCT03792906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504543|NCT03792906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65504544|NCT03792906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65504545|NCT03792906|Adrenergic Agents|adrenergic agents|mesh-ancestor
65504546|NCT03792906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65504547|NCT03792906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504548|NCT03792906|Sympathomimetics|sympathomimetics|mesh-ancestor
65504549|NCT03792906|Autonomic Agents|autonomic agents|mesh-ancestor
65504550|NCT03792906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65504551|NCT03078556|Lamivudine|lamivudine|mesh-list
65504552|NCT03078556|Dolutegravir|dolutegravir|mesh-list
65504553|NCT03078556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65504554|NCT03078556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65504555|NCT03078556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504556|NCT03078556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504557|NCT03078556|Antiviral Agents|antiviral agents|mesh-ancestor
65504558|NCT03078556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65504559|NCT03078556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65504560|NCT03078556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65504561|NCT03078556|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65504562|NCT03078556|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65504563|NCT03949894|Tolvaptan|tolvaptan|mesh-list
65504564|NCT03949894|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65504565|NCT03949894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504566|NCT03949894|Natriuretic Agents|natriuretic agents|mesh-ancestor
65504567|NCT03949894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504568|NCT03714672|Diclofenac|diclofenac|mesh-list
65504569|NCT03714672|Tramadol|tramadol|mesh-list
65504570|NCT03714672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65504571|NCT03714672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65504572|NCT03714672|Analgesics|analgesics|mesh-ancestor
65504573|NCT03714672|Sensory System Agents|sensory system agents|mesh-ancestor
65504574|NCT03714672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504575|NCT03714672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504576|NCT03714672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65504577|NCT03714672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65504578|NCT03714672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65504579|NCT03714672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504580|NCT03714672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504581|NCT03714672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65504582|NCT03714672|Narcotics|narcotics|mesh-ancestor
65504583|NCT03714672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504584|NCT03083470|Paclitaxel|paclitaxel|mesh-list
65504585|NCT03083470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65504586|NCT03083470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504587|NCT03083470|Tubulin Modulators|tubulin modulators|mesh-ancestor
65504588|NCT03083470|Antimitotic Agents|antimitotic agents|mesh-ancestor
65504589|NCT03083470|Mitosis Modulators|mitosis modulators|mesh-ancestor
65504590|NCT03083470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504591|NCT01377610|Naltrexone|naltrexone|mesh-list
65504592|NCT01377610|Buprenorphine|buprenorphine|mesh-list
65504593|NCT01377610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65504594|NCT01377610|Narcotics|narcotics|mesh-ancestor
65504595|NCT01377610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504596|NCT01377610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504597|NCT01377610|Analgesics|analgesics|mesh-ancestor
65504598|NCT01377610|Sensory System Agents|sensory system agents|mesh-ancestor
65504599|NCT01377610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504600|NCT01377610|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65504601|NCT01377610|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65504602|NCT01377532|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65504603|NCT01377532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504604|NCT01377532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504605|NCT01377532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504606|NCT01377532|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65504607|NCT03810976|Gemcitabine|gemcitabine|mesh-list
65504608|NCT03810976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65504609|NCT03810976|Antimetabolites|antimetabolites|mesh-ancestor
65504610|NCT03810976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504611|NCT03810976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504612|NCT03810976|Antiviral Agents|antiviral agents|mesh-ancestor
65504613|NCT03810976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65504614|NCT03810976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504615|NCT03810976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65504616|NCT03810976|Immunologic Factors|immunologic factors|mesh-ancestor
65504617|NCT03810976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504618|NCT05405244|Bromocriptine|bromocriptine|mesh-list
65504619|NCT05405244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504620|NCT05405244|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65504621|NCT05405244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65504622|NCT05405244|Hormone Antagonists|hormone antagonists|mesh-ancestor
65504623|NCT05405244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65504624|NCT05405244|Dopamine Agonists|dopamine agonists|mesh-ancestor
65504625|NCT05405244|Dopamine Agents|dopamine agents|mesh-ancestor
65504626|NCT05405244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65504627|NCT05405244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504628|NCT03788694|Ketamine|ketamine|mesh-list
65504629|NCT03788694|Analgesics|analgesics|mesh-ancestor
65504630|NCT03788694|Sensory System Agents|sensory system agents|mesh-ancestor
65504631|NCT03788694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504632|NCT03788694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504633|NCT03788694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65504634|NCT03788694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65504635|NCT03788694|Anesthetics, General|anesthetics, general|mesh-ancestor
65504636|NCT03788694|Anesthetics|anesthetics|mesh-ancestor
65504637|NCT03788694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504638|NCT03788694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65504639|NCT03788694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65504640|NCT03788694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65504641|NCT03788694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504642|NCT03789006|Interleukin-2|interleukin-2|mesh-list
65504643|NCT03789006|Immunoglobulins|immunoglobulins|mesh-list
65504644|NCT03789006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65504645|NCT03789006|Antibodies|antibodies|mesh-list
65504646|NCT03789006|Basiliximab|basiliximab|mesh-list
65504647|NCT03789006|Thymoglobulin|thymoglobulin|mesh-list
65504648|NCT03789006|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65504649|NCT03789006|Immunologic Factors|immunologic factors|mesh-ancestor
65504650|NCT03789006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504651|NCT03789006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504652|NCT03789006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65504653|NCT03789006|Analgesics|analgesics|mesh-ancestor
65504654|NCT03789006|Sensory System Agents|sensory system agents|mesh-ancestor
65504655|NCT03789006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504656|NCT03789006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65504657|NCT01306266|Rizatriptan|rizatriptan|mesh-list
65504658|NCT01306266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65504659|NCT01306266|Serotonin Agents|serotonin agents|mesh-ancestor
65504660|NCT01306266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65504661|NCT01306266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504662|NCT01306266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504663|NCT03516214|Trametinib|trametinib|mesh-list
65504664|NCT03516214|Nazartinib|nazartinib|mesh-list
65504665|NCT03516214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504666|NCT03516214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65504667|NCT03516214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504668|NCT03516214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504669|NCT03630796|Sevoflurane|sevoflurane|mesh-list
65504670|NCT03630796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65504671|NCT03630796|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65504672|NCT03630796|Anesthetics, General|anesthetics, general|mesh-ancestor
65504673|NCT03630796|Anesthetics|anesthetics|mesh-ancestor
65504674|NCT03630796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504675|NCT03630796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504676|NCT05202964|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65504677|NCT05202964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65504678|NCT01096966|Bupivacaine|bupivacaine|mesh-list
65504679|NCT01096966|Anesthetics, Local|anesthetics, local|mesh-ancestor
65504680|NCT01096966|Anesthetics|anesthetics|mesh-ancestor
65504681|NCT01096966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504682|NCT01096966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504683|NCT01096966|Sensory System Agents|sensory system agents|mesh-ancestor
65504684|NCT01096966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504685|NCT01379560|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
65504686|NCT01379560|Dinoprost|dinoprost|mesh-list
65504687|NCT01379560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65504688|NCT01379560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65504689|NCT01379560|Abortifacient Agents|abortifacient agents|mesh-ancestor
65504690|NCT01379560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65504691|NCT01379560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504692|NCT01379560|Oxytocics|oxytocics|mesh-ancestor
65504693|NCT01379482|Paclitaxel|paclitaxel|mesh-list
65504694|NCT01379482|Docetaxel|docetaxel|mesh-list
65504695|NCT01379482|Cisplatin|cisplatin|mesh-list
65504696|NCT01379482|Doxorubicin|doxorubicin|mesh-list
65504697|NCT01379482|Oxaliplatin|oxaliplatin|mesh-list
65504698|NCT01379482|Irinotecan|irinotecan|mesh-list
65504699|NCT01379482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65504700|NCT01379482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504701|NCT01379482|Tubulin Modulators|tubulin modulators|mesh-ancestor
65504702|NCT01379482|Antimitotic Agents|antimitotic agents|mesh-ancestor
65504703|NCT01379482|Mitosis Modulators|mitosis modulators|mesh-ancestor
65504704|NCT01379482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504705|NCT01379482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65504706|NCT01379482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65504707|NCT01379482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65504708|NCT01379482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504709|NCT01379482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65504710|NCT05624424|Sufentanil|sufentanil|mesh-list
65504711|NCT05624424|Remifentanil|remifentanil|mesh-list
65504712|NCT05624424|Propofol|propofol|mesh-list
65504713|NCT05624424|Sevoflurane|sevoflurane|mesh-list
65504714|NCT05624424|Cisatracurium|cisatracurium|mesh-list
65504715|NCT05624424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65504716|NCT05624424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504717|NCT05624424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504718|NCT05624424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65504719|NCT05624424|Anesthetics, General|anesthetics, general|mesh-ancestor
65504720|NCT05624424|Anesthetics|anesthetics|mesh-ancestor
65504721|NCT05624424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65504722|NCT05624424|Narcotics|narcotics|mesh-ancestor
65504723|NCT05624424|Analgesics|analgesics|mesh-ancestor
65504724|NCT05624424|Sensory System Agents|sensory system agents|mesh-ancestor
65504725|NCT05624424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504726|NCT05624424|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65504727|NCT05624424|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65504728|NCT05624424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65504729|NCT05624424|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65504730|NCT05624424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65504731|NCT05461690|Niraparib|niraparib|mesh-list
65504732|NCT05461690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65504733|NCT05461690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504734|NCT05461690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504735|NCT05461690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504736|NCT05456230|Midazolam|midazolam|mesh-list
65504737|NCT05456230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65504738|NCT05456230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65504739|NCT05456230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504740|NCT05456230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504741|NCT05456230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65504742|NCT05456230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65504743|NCT05456230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65504744|NCT05456230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65504745|NCT05456230|Anesthetics, General|anesthetics, general|mesh-ancestor
65504746|NCT05456230|Anesthetics|anesthetics|mesh-ancestor
65504747|NCT05456230|GABA Modulators|gaba modulators|mesh-ancestor
65504748|NCT05456230|GABA Agents|gaba agents|mesh-ancestor
65504749|NCT05456230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65504750|NCT05456230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504751|NCT03791814|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65504752|NCT03791814|Antiviral Agents|antiviral agents|mesh-ancestor
65504753|NCT03791814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65504754|NCT05404048|Atezolizumab|atezolizumab|mesh-list
65504755|NCT05404048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504756|NCT01377376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65504757|NCT01377376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504758|NCT01377376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65504759|NCT01377376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504760|NCT01377376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504761|NCT03788538|Dexmedetomidine|dexmedetomidine|mesh-list
65504762|NCT03788538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65504763|NCT03788538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504764|NCT03788538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504765|NCT03788538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65504766|NCT03788538|Analgesics|analgesics|mesh-ancestor
65504767|NCT03788538|Sensory System Agents|sensory system agents|mesh-ancestor
65504768|NCT03788538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504769|NCT03788538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65504770|NCT03788538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65504771|NCT03788538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65504772|NCT03788538|Adrenergic Agents|adrenergic agents|mesh-ancestor
65504773|NCT03788538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65504774|NCT03788538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504775|NCT05342584|Cytarabine|cytarabine|mesh-list
65504776|NCT05342584|Daunorubicin|daunorubicin|mesh-list
65504777|NCT05342584|Venetoclax|venetoclax|mesh-list
65504778|NCT05342584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65504779|NCT05342584|Antimetabolites|antimetabolites|mesh-ancestor
65504780|NCT05342584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504781|NCT05342584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504782|NCT05342584|Antiviral Agents|antiviral agents|mesh-ancestor
65504783|NCT05342584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65504784|NCT05342584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65504785|NCT05342584|Immunologic Factors|immunologic factors|mesh-ancestor
65504786|NCT05342584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504787|NCT05342584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65504788|NCT05342584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65504789|NCT05342584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65504790|NCT05342584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504792|NCT05320120|Antidepressive Agents|antidepressive agents|mesh-ancestor
65504793|NCT05320120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65504794|NCT03077698|Megestrol|megestrol|mesh-list
65504795|NCT03077698|Megestrol Acetate|megestrol acetate|mesh-list
65504796|NCT03077698|Progestins|progestins|mesh-list
65504797|NCT03077698|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
65504798|NCT03077698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65504799|NCT03077698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65504800|NCT03077698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65504801|NCT03077698|Contraceptive Agents|contraceptive agents|mesh-ancestor
65504802|NCT03077698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65504803|NCT03077698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504804|NCT03077698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65504805|NCT03077698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65504806|NCT03077698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65504807|NCT03077698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504808|NCT03077698|Appetite Stimulants|appetite stimulants|mesh-ancestor
65504809|NCT03077698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65504810|NCT03077698|Hormones|hormones|mesh-ancestor
65504811|NCT03077698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65504812|NCT03077698|Interferon Inducers|interferon inducers|mesh-ancestor
65504813|NCT03077698|Immunologic Factors|immunologic factors|mesh-ancestor
65504814|NCT01377220|Choline|choline|mesh-list
65504815|NCT01377220|Lipotropic Agents|lipotropic agents|mesh-ancestor
65504816|NCT01377220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65504817|NCT01377220|Antimetabolites|antimetabolites|mesh-ancestor
65504818|NCT01377220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504819|NCT01377220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65504820|NCT01377220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65504821|NCT01377220|Nootropic Agents|nootropic agents|mesh-ancestor
65504822|NCT03079102|Nitric Oxide|nitric oxide|mesh-list
65504823|NCT03079102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65504824|NCT03079102|Autonomic Agents|autonomic agents|mesh-ancestor
65504825|NCT03079102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504826|NCT03079102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504827|NCT03079102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65504828|NCT03079102|Respiratory System Agents|respiratory system agents|mesh-ancestor
65504829|NCT03079102|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65504830|NCT03079102|Antioxidants|antioxidants|mesh-ancestor
65504831|NCT03079102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504832|NCT03079102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65504833|NCT03079102|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65504834|NCT03079102|Vasodilator Agents|vasodilator agents|mesh-ancestor
65504835|NCT03079102|Gasotransmitters|gasotransmitters|mesh-ancestor
65504836|NCT03079102|Protective Agents|protective agents|mesh-ancestor
65504837|NCT03791424|Midazolam|midazolam|mesh-list
65504838|NCT03791424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65504839|NCT03791424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65504840|NCT03791424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504841|NCT03791424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504842|NCT03791424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65504843|NCT03791424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65504844|NCT03791424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65504845|NCT03791424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65504846|NCT03791424|Anesthetics, General|anesthetics, general|mesh-ancestor
65504847|NCT03791424|Anesthetics|anesthetics|mesh-ancestor
65504848|NCT03791424|GABA Modulators|gaba modulators|mesh-ancestor
65504849|NCT03791424|GABA Agents|gaba agents|mesh-ancestor
65504850|NCT03791424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65504851|NCT03791424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504852|NCT03787992|Gefitinib|gefitinib|mesh-list
65504853|NCT03787992|Aflutinib|aflutinib|mesh-list
65504854|NCT03787992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504855|NCT03787992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65504856|NCT03787992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504857|NCT03787992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504858|NCT02434354|Pembrolizumab|pembrolizumab|mesh-list
65504859|NCT02434354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65504860|NCT02434354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504861|NCT05693454|Tramadol|tramadol|mesh-list
65504862|NCT05693454|Levobupivacaine|levobupivacaine|mesh-list
65504863|NCT05693454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65504864|NCT05693454|Narcotics|narcotics|mesh-ancestor
65302577|NCT00697892|Protease Inhibitors|protease inhibitors|mesh-ancestor
65504865|NCT05693454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504866|NCT05693454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504867|NCT05693454|Analgesics|analgesics|mesh-ancestor
65504868|NCT05693454|Sensory System Agents|sensory system agents|mesh-ancestor
65504869|NCT05693454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504870|NCT05693454|Anesthetics, Local|anesthetics, local|mesh-ancestor
65504871|NCT05693454|Anesthetics|anesthetics|mesh-ancestor
65504872|NCT05764018|Caffeine|caffeine|mesh-list
65504873|NCT05764018|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65504874|NCT05764018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504875|NCT05764018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65504876|NCT05764018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504877|NCT05764018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504878|NCT05764018|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65504879|NCT05764018|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65504880|NCT05764018|Purinergic Agents|purinergic agents|mesh-ancestor
65504881|NCT05764018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65504882|NCT01308528|Enoxaparin|enoxaparin|mesh-list
65504883|NCT01308528|Enoxaparin sodium|enoxaparin sodium|mesh-list
65504884|NCT01308528|Anticoagulants|anticoagulants|mesh-ancestor
65504885|NCT01308528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65504886|NCT01308528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65504887|NCT01308528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504888|NCT04839328|Hemay005|hemay005|mesh-list
65504889|NCT04839328|Dermatologic Agents|dermatologic agents|mesh-ancestor
65504890|NCT04839328|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65504891|NCT04839328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65504892|NCT04839328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504893|NCT04839328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504894|NCT03785496|Spartalizumab|spartalizumab|mesh-list
65504895|NCT03785496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65504896|NCT03785496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504897|NCT03785496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504898|NCT01307202|Gabapentin|gabapentin|mesh-list
65504899|NCT01307202|Analgesics|analgesics|mesh-ancestor
65504900|NCT01307202|Sensory System Agents|sensory system agents|mesh-ancestor
65504901|NCT01307202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504902|NCT01307202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504903|NCT01307202|Anticonvulsants|anticonvulsants|mesh-ancestor
65504904|NCT01307202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65504905|NCT01307202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65504906|NCT01307202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504907|NCT01307202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65504908|NCT01307202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65504909|NCT01307202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65504910|NCT01307202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65504911|NCT01307202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504912|NCT01307202|Antimanic Agents|antimanic agents|mesh-ancestor
65504913|NCT04294576|Pembrolizumab|pembrolizumab|mesh-list
65504914|NCT04294576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65504915|NCT04294576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504916|NCT01308606|Simeprevir|simeprevir|mesh-list
65504917|NCT01308606|Antiviral Agents|antiviral agents|mesh-ancestor
65504918|NCT01308606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65504919|NCT01308606|Protease Inhibitors|protease inhibitors|mesh-ancestor
65504920|NCT01308606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65504921|NCT01308606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504922|NCT04637386|Anesthetics|anesthetics|mesh-list
65504923|NCT04637386|Anesthetics, Local|anesthetics, local|mesh-list
65504924|NCT04637386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504925|NCT04637386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504926|NCT04637386|Sensory System Agents|sensory system agents|mesh-ancestor
65504927|NCT04637386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504928|NCT01308684|Bevacizumab|bevacizumab|mesh-list
65504929|NCT01308684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65504930|NCT01308684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504931|NCT01308684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65504932|NCT01308684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65504933|NCT01308684|Growth Substances|growth substances|mesh-ancestor
65504934|NCT01308684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504935|NCT01308684|Growth Inhibitors|growth inhibitors|mesh-ancestor
65504936|NCT05613114|4-Aminopyridine|4-aminopyridine|mesh-list
65504937|NCT05613114|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65504938|NCT05613114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65504939|NCT05613114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504940|NCT03790566|Bupivacaine|bupivacaine|mesh-list
65504941|NCT03790566|Anesthetics, Local|anesthetics, local|mesh-ancestor
65504942|NCT03790566|Anesthetics|anesthetics|mesh-ancestor
65504943|NCT03790566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504944|NCT03790566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504945|NCT03790566|Sensory System Agents|sensory system agents|mesh-ancestor
65504946|NCT03790566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504947|NCT04436224|Fentanyl|fentanyl|mesh-list
65504948|NCT04436224|Hydromorphone|hydromorphone|mesh-list
65504949|NCT04436224|Butorphanol|butorphanol|mesh-list
65504950|NCT04436224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65504951|NCT04436224|Narcotics|narcotics|mesh-ancestor
65504952|NCT04436224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504953|NCT04436224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504954|NCT04436224|Analgesics|analgesics|mesh-ancestor
65504955|NCT04436224|Sensory System Agents|sensory system agents|mesh-ancestor
65504956|NCT04436224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504957|NCT04436224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65504958|NCT04436224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65504959|NCT04436224|Anesthetics, General|anesthetics, general|mesh-ancestor
65504960|NCT04436224|Anesthetics|anesthetics|mesh-ancestor
65504961|NCT04436224|Antitussive Agents|antitussive agents|mesh-ancestor
65504962|NCT04436224|Respiratory System Agents|respiratory system agents|mesh-ancestor
65504963|NCT04436224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65504964|NCT03785184|Dexamethasone|dexamethasone|mesh-list
65504965|NCT03785184|Lenalidomide|lenalidomide|mesh-list
65504966|NCT03785184|Venetoclax|venetoclax|mesh-list
65504967|NCT03785184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65504968|NCT03785184|Antiemetics|antiemetics|mesh-ancestor
65504969|NCT03785184|Autonomic Agents|autonomic agents|mesh-ancestor
65504970|NCT03785184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504971|NCT03785184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504972|NCT03785184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65504973|NCT03785184|Glucocorticoids|glucocorticoids|mesh-ancestor
65504974|NCT03785184|Hormones|hormones|mesh-ancestor
65504975|NCT03785184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65504976|NCT03785184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65504977|NCT03785184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65504978|NCT03785184|Immunologic Factors|immunologic factors|mesh-ancestor
65504979|NCT03785184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65504980|NCT03785184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65504981|NCT03785184|Growth Substances|growth substances|mesh-ancestor
65504982|NCT03785184|Growth Inhibitors|growth inhibitors|mesh-ancestor
65504983|NCT03784794|Thrombin|thrombin|mesh-list
65504984|NCT03784794|Hemostatics|hemostatics|mesh-ancestor
65504985|NCT03784794|Coagulants|coagulants|mesh-ancestor
65504986|NCT01378546|Amifampridine|amifampridine|mesh-list
65504987|NCT01378546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65504988|NCT01378546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65504989|NCT01378546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504990|NCT01378546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65504991|NCT01378546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65504992|NCT01378546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65504993|NCT05688384|Alfentanil|alfentanil|mesh-list
65504994|NCT05688384|Propofol|propofol|mesh-list
65504995|NCT05688384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65504996|NCT05688384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65504997|NCT05688384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65504998|NCT05688384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65504999|NCT05688384|Anesthetics, General|anesthetics, general|mesh-ancestor
65505000|NCT05688384|Anesthetics|anesthetics|mesh-ancestor
65505001|NCT05688384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65505002|NCT05688384|Narcotics|narcotics|mesh-ancestor
65505003|NCT05688384|Analgesics|analgesics|mesh-ancestor
65505004|NCT05688384|Sensory System Agents|sensory system agents|mesh-ancestor
65505005|NCT05688384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65505006|NCT01307592|Gemcitabine|gemcitabine|mesh-list
65505007|NCT01307592|Rituximab|rituximab|mesh-list
65505008|NCT01307592|Oxaliplatin|oxaliplatin|mesh-list
65505009|NCT01307592|Lenalidomide|lenalidomide|mesh-list
65505010|NCT01307592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65505011|NCT01307592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505012|NCT01307592|Immunologic Factors|immunologic factors|mesh-ancestor
65505013|NCT01307592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505014|NCT01307592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65505015|NCT01307592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65505016|NCT01307592|Antimetabolites|antimetabolites|mesh-ancestor
65505017|NCT01307592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505018|NCT01307592|Antiviral Agents|antiviral agents|mesh-ancestor
65505019|NCT01307592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65505020|NCT01307592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505021|NCT01307592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65505022|NCT01307592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65505023|NCT01307592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65505024|NCT01307592|Growth Substances|growth substances|mesh-ancestor
65505025|NCT01307592|Growth Inhibitors|growth inhibitors|mesh-ancestor
65505026|NCT05687058|Empagliflozin|empagliflozin|mesh-list
65505027|NCT05687058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65505028|NCT05687058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505029|NCT05687058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65505030|NCT05687058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505031|NCT03790020|Bupivacaine|bupivacaine|mesh-list
65505032|NCT03790020|Anesthetics, Local|anesthetics, local|mesh-ancestor
65505033|NCT03790020|Anesthetics|anesthetics|mesh-ancestor
65505034|NCT03790020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65505035|NCT03790020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505036|NCT03790020|Sensory System Agents|sensory system agents|mesh-ancestor
65505037|NCT03790020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65505038|NCT03075826|Guadecitabine|guadecitabine|mesh-list
65505039|NCT03075826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505040|NCT04749108|Folfirinox|folfirinox|mesh-list
65505041|NCT04749108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505042|NCT01378156|Vaccines|vaccines|mesh-list
65505043|NCT01378156|Immunologic Factors|immunologic factors|mesh-ancestor
65505044|NCT01378156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505045|NCT04108234|Ketamine|ketamine|mesh-list
65505046|NCT04108234|Analgesics|analgesics|mesh-ancestor
65505047|NCT04108234|Sensory System Agents|sensory system agents|mesh-ancestor
65505048|NCT04108234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65505049|NCT04108234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505050|NCT04108234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65505051|NCT04108234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65505052|NCT04108234|Anesthetics, General|anesthetics, general|mesh-ancestor
65505053|NCT04108234|Anesthetics|anesthetics|mesh-ancestor
65505054|NCT04108234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65505055|NCT04108234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65505056|NCT04108234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65505057|NCT04108234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65505058|NCT04108234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505059|NCT03687814|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65505060|NCT03687814|Laxatives|laxatives|mesh-ancestor
65505061|NCT03687814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65505062|NCT05763550|Pregabalin|pregabalin|mesh-list
65505063|NCT05763550|Analgesics|analgesics|mesh-ancestor
65505064|NCT05763550|Sensory System Agents|sensory system agents|mesh-ancestor
65505065|NCT05763550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65505066|NCT05763550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505067|NCT05763550|Anticonvulsants|anticonvulsants|mesh-ancestor
65505068|NCT05763550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65505069|NCT05763550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65505070|NCT05763550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505071|NCT05763550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65505072|NCT05763550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65505073|NCT05763550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65505074|NCT05763550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65505075|NCT05763550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65505076|NCT03783936|Leucovorin|leucovorin|mesh-list
65505077|NCT03783936|Fluorouracil|fluorouracil|mesh-list
65505078|NCT03783936|Oxaliplatin|oxaliplatin|mesh-list
65505079|NCT03783936|Trastuzumab|trastuzumab|mesh-list
65505080|NCT03783936|Avelumab|avelumab|mesh-list
65505081|NCT03783936|Antimetabolites|antimetabolites|mesh-ancestor
65505082|NCT03783936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505083|NCT03783936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65505084|NCT03783936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505085|NCT03783936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65505086|NCT03783936|Immunologic Factors|immunologic factors|mesh-ancestor
65505087|NCT03783936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505088|NCT03783936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65505089|NCT03783936|Antidotes|antidotes|mesh-ancestor
65505090|NCT03783936|Protective Agents|protective agents|mesh-ancestor
65505091|NCT03783936|Vitamin B Complex|vitamin b complex|mesh-ancestor
65505092|NCT03783936|Vitamins|vitamins|mesh-ancestor
65505093|NCT03783936|Micronutrients|micronutrients|mesh-ancestor
65505095|NCT03781908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65505096|NCT03781908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65505097|NCT03781596|Fluticasone|fluticasone|mesh-list
65505098|NCT03781596|Omeprazole|omeprazole|mesh-list
65505099|NCT03781596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65505100|NCT03781596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65505101|NCT03781596|Autonomic Agents|autonomic agents|mesh-ancestor
65505102|NCT03781596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65505103|NCT03781596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505104|NCT03781596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65505105|NCT03781596|Respiratory System Agents|respiratory system agents|mesh-ancestor
65505106|NCT03781596|Dermatologic Agents|dermatologic agents|mesh-ancestor
65505107|NCT03781596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65505108|NCT03781596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65505109|NCT03781596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65505110|NCT03781596|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65505111|NCT03781596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505112|NCT03781596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505113|NCT03284866|Vaccines|vaccines|mesh-list
65505114|NCT03284866|Immunologic Factors|immunologic factors|mesh-ancestor
65505115|NCT03284866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505116|NCT03781674|Progesterone|progesterone|mesh-list
65505117|NCT03781674|Progestins|progestins|mesh-ancestor
65505118|NCT03781674|Hormones|hormones|mesh-ancestor
65505119|NCT03781674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65505120|NCT03781674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505121|NCT03786120|Zolpidem|zolpidem|mesh-list
65505122|NCT03786120|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65505123|NCT03786120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65505124|NCT03786120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65505125|NCT03786120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505126|NCT03786120|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65505127|NCT03786120|GABA Agonists|gaba agonists|mesh-ancestor
65505128|NCT03786120|GABA Agents|gaba agents|mesh-ancestor
65505129|NCT03786120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65505130|NCT03786120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505131|NCT05517642|Vaccines|vaccines|mesh-list
65505132|NCT05517642|Immunologic Factors|immunologic factors|mesh-ancestor
65505133|NCT05517642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505134|NCT01561014|Fluorouracil|fluorouracil|mesh-list
65505135|NCT01561014|Oxaliplatin|oxaliplatin|mesh-list
65505136|NCT01561014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65505137|NCT01561014|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65505138|NCT01561014|Antimetabolites|antimetabolites|mesh-ancestor
65505139|NCT01561014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505140|NCT01561014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65505141|NCT01561014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505142|NCT01561014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65505143|NCT01561014|Immunologic Factors|immunologic factors|mesh-ancestor
65505144|NCT01561014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505145|NCT01561014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65505146|NCT01561014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505147|NCT01561014|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65505148|NCT01561092|Citalopram|citalopram|mesh-list
65505149|NCT01561092|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65505150|NCT01561092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65505151|NCT01561092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65505152|NCT01561092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505153|NCT01561092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65505154|NCT01561092|Serotonin Agents|serotonin agents|mesh-ancestor
65505155|NCT01561092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505156|NCT01561092|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65505157|NCT01561092|Antidepressive Agents|antidepressive agents|mesh-ancestor
65505158|NCT01561092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65505159|NCT05494866|Cobicistat|cobicistat|mesh-list
65505160|NCT05494866|Gemcitabine|gemcitabine|mesh-list
65505161|NCT05494866|Paclitaxel|paclitaxel|mesh-list
65505162|NCT05494866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65505163|NCT05494866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505164|NCT05494866|Tubulin Modulators|tubulin modulators|mesh-ancestor
65505165|NCT05494866|Antimitotic Agents|antimitotic agents|mesh-ancestor
65505166|NCT05494866|Mitosis Modulators|mitosis modulators|mesh-ancestor
65505167|NCT05494866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505168|NCT05494866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65505169|NCT05494866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65505170|NCT05494866|Antiviral Agents|antiviral agents|mesh-ancestor
65505171|NCT05494866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65505172|NCT05494866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65505173|NCT05494866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65505174|NCT05494866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505175|NCT05494866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65505176|NCT05494866|Antimetabolites|antimetabolites|mesh-ancestor
65505177|NCT05494866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65505178|NCT05494866|Immunologic Factors|immunologic factors|mesh-ancestor
65505179|NCT05494866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505180|NCT01316874|Valrubicin|valrubicin|mesh-list
65505181|NCT01316874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505182|NCT01316874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65505183|NCT01316874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65505184|NCT01316874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505185|NCT01316874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505186|NCT01309542|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65505187|NCT01309542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65505188|NCT01309542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65505189|NCT01309542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65505190|NCT01309542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505191|NCT01309542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65505192|NCT01309542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505193|NCT01309542|Antidepressive Agents|antidepressive agents|mesh-ancestor
65505194|NCT01309542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65505195|NCT01309620|Zinc|zinc|mesh-list
65505196|NCT01309620|Trace Elements|trace elements|mesh-ancestor
65505197|NCT01309620|Micronutrients|micronutrients|mesh-ancestor
65505198|NCT01309620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505199|NCT05585034|Pembrolizumab|pembrolizumab|mesh-list
65505200|NCT05585034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65505201|NCT05585034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505202|NCT05129670|Calcium Carbonate|calcium carbonate|mesh-list
65505203|NCT05129670|Antacids|antacids|mesh-ancestor
65505204|NCT05129670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505205|NCT05129670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65505206|NCT03783312|Acetaminophen|acetaminophen|mesh-list
65505207|NCT03783312|Ibuprofen|ibuprofen|mesh-list
65505208|NCT03783312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65505209|NCT03783312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65505210|NCT03783312|Analgesics|analgesics|mesh-ancestor
65505211|NCT03783312|Sensory System Agents|sensory system agents|mesh-ancestor
65505212|NCT03783312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65505213|NCT03783312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505214|NCT03783312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65505215|NCT03783312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65505216|NCT03783312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65505217|NCT03783312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505218|NCT03783312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505219|NCT03783312|Antipyretics|antipyretics|mesh-ancestor
65505220|NCT03776916|Simethicone|simethicone|mesh-list
65505221|NCT03776916|Antifoaming Agents|antifoaming agents|mesh-ancestor
65505222|NCT03776916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505223|NCT03776916|Emollients|emollients|mesh-ancestor
65505224|NCT03776916|Dermatologic Agents|dermatologic agents|mesh-ancestor
65505225|NCT01560702|Epinephrine|epinephrine|mesh-list
65505226|NCT01560702|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65505227|NCT01560702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65505228|NCT01560702|Adrenergic Agents|adrenergic agents|mesh-ancestor
65505229|NCT01560702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65505230|NCT01560702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505231|NCT01560702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505232|NCT01560702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65505233|NCT01560702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65505234|NCT01560702|Autonomic Agents|autonomic agents|mesh-ancestor
65505235|NCT01560702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65505236|NCT01560702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65505237|NCT01560702|Respiratory System Agents|respiratory system agents|mesh-ancestor
65505238|NCT01560702|Mydriatics|mydriatics|mesh-ancestor
65505239|NCT01560702|Sympathomimetics|sympathomimetics|mesh-ancestor
65505240|NCT01560702|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65505241|NCT03776838|Fentanyl|fentanyl|mesh-list
65505242|NCT03776838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65505243|NCT03776838|Narcotics|narcotics|mesh-ancestor
65505244|NCT03776838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65505245|NCT03776838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505246|NCT03776838|Analgesics|analgesics|mesh-ancestor
65505247|NCT03776838|Sensory System Agents|sensory system agents|mesh-ancestor
65505248|NCT03776838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65505249|NCT03776838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65505250|NCT03776838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65505251|NCT03776838|Anesthetics, General|anesthetics, general|mesh-ancestor
65505252|NCT03776838|Anesthetics|anesthetics|mesh-ancestor
65505253|NCT03781050|Sirolimus|sirolimus|mesh-list
65505254|NCT03781050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65505255|NCT03781050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65505256|NCT03781050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65505257|NCT03781050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505258|NCT03781050|Antifungal Agents|antifungal agents|mesh-ancestor
65505259|NCT03781050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65505260|NCT03781050|Immunologic Factors|immunologic factors|mesh-ancestor
65505261|NCT03781050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505262|NCT02865850|Darbepoetin alfa|darbepoetin alfa|mesh-list
65505263|NCT02865850|Hematinics|hematinics|mesh-ancestor
65505264|NCT01309698|Inositol|inositol|mesh-list
65505265|NCT01309698|Vildagliptin|vildagliptin|mesh-list
65505266|NCT01309698|Voglibose|voglibose|mesh-list
65505267|NCT01309698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65505268|NCT01309698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505269|NCT01309698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65505270|NCT01309698|Protease Inhibitors|protease inhibitors|mesh-ancestor
65505271|NCT01309698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505272|NCT01309698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505273|NCT01309698|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65505274|NCT01309698|Vitamin B Complex|vitamin b complex|mesh-ancestor
65505275|NCT01309698|Vitamins|vitamins|mesh-ancestor
65505276|NCT01309698|Micronutrients|micronutrients|mesh-ancestor
65505277|NCT01142284|Cilostazol|cilostazol|mesh-list
65505278|NCT01142284|Probucol|probucol|mesh-list
65505279|NCT01142284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65505280|NCT01142284|Autonomic Agents|autonomic agents|mesh-ancestor
65505281|NCT01142284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65505282|NCT01142284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505283|NCT01142284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65505284|NCT01142284|Respiratory System Agents|respiratory system agents|mesh-ancestor
65505285|NCT01142284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65505286|NCT01142284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65505287|NCT01142284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505288|NCT01142284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65505289|NCT01142284|Vasodilator Agents|vasodilator agents|mesh-ancestor
65505290|NCT01142284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65505291|NCT01142284|Protective Agents|protective agents|mesh-ancestor
65505292|NCT01142284|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65505293|NCT01142284|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65505294|NCT01142284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505295|NCT01142284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65505296|NCT01142284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65505297|NCT01142284|Antimetabolites|antimetabolites|mesh-ancestor
65505298|NCT01142284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65505299|NCT01142284|Antioxidants|antioxidants|mesh-ancestor
65505300|NCT01309776|Citalopram|citalopram|mesh-list
65505301|NCT01309776|Tianeptine|tianeptine|mesh-list
65505302|NCT01309776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65505303|NCT01309776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65505304|NCT01309776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65505305|NCT01309776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505306|NCT01309776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65505307|NCT01309776|Serotonin Agents|serotonin agents|mesh-ancestor
65505308|NCT01309776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505309|NCT01309776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65505310|NCT01309776|Antidepressive Agents|antidepressive agents|mesh-ancestor
65505311|NCT01309776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65505312|NCT01309776|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65505313|NCT03783000|BI 425809|bi 425809|mesh-list
65505314|NCT03783000|Nootropic Agents|nootropic agents|mesh-ancestor
65505315|NCT01309854|Pioglitazone|pioglitazone|mesh-list
65505316|NCT01309854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65505317|NCT01309854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505318|NCT03780192|Sirolimus|sirolimus|mesh-list
65505319|NCT03780192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65505320|NCT03780192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65505321|NCT03780192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65505322|NCT03780192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505323|NCT03780192|Antifungal Agents|antifungal agents|mesh-ancestor
65505324|NCT03780192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65505325|NCT03780192|Immunologic Factors|immunologic factors|mesh-ancestor
65505326|NCT03780192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505327|NCT05305560|Ivermectin|ivermectin|mesh-list
65505328|NCT05305560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65505329|NCT05305560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65505330|NCT05285904|Ofatumumab|ofatumumab|mesh-list
65505331|NCT05285904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505332|NCT03776448|Charcoal|charcoal|mesh-list
65505333|NCT03776448|Antidotes|antidotes|mesh-ancestor
65505334|NCT03776448|Protective Agents|protective agents|mesh-ancestor
65505335|NCT03776448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505336|NCT03780270|Fluorides|fluorides|mesh-list
65505337|NCT03780270|Fluorides, Topical|fluorides, topical|mesh-list
65505338|NCT03780270|Cariostatic Agents|cariostatic agents|mesh-ancestor
65505339|NCT03780270|Protective Agents|protective agents|mesh-ancestor
65505340|NCT03780270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505341|NCT03072160|Pembrolizumab|pembrolizumab|mesh-list
65505342|NCT03072160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65505343|NCT03072160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505344|NCT05517486|Bupivacaine|bupivacaine|mesh-list
65505345|NCT05517486|Anesthetics, Local|anesthetics, local|mesh-ancestor
65505346|NCT05517486|Anesthetics|anesthetics|mesh-ancestor
65505347|NCT05517486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65505348|NCT05517486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505349|NCT05517486|Sensory System Agents|sensory system agents|mesh-ancestor
65505350|NCT05517486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65505351|NCT01019356|Rosiglitazone|rosiglitazone|mesh-list
65505352|NCT01019356|Acarbose|acarbose|mesh-list
65505353|NCT01019356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65505354|NCT01019356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505355|NCT01019356|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65505356|NCT01019356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505357|NCT01019356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505358|NCT01314066|Bevacizumab|bevacizumab|mesh-list
65505359|NCT01314066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65505360|NCT01314066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505361|NCT01314066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65505362|NCT01314066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65505363|NCT01314066|Growth Substances|growth substances|mesh-ancestor
65505364|NCT01314066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505365|NCT01314066|Growth Inhibitors|growth inhibitors|mesh-ancestor
65505366|NCT01314300|Lidocaine|lidocaine|mesh-list
65505367|NCT01314300|Anesthetics, Local|anesthetics, local|mesh-ancestor
65505368|NCT01314300|Anesthetics|anesthetics|mesh-ancestor
65505369|NCT01314300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65505370|NCT01314300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505371|NCT01314300|Sensory System Agents|sensory system agents|mesh-ancestor
65505372|NCT01314300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65505373|NCT01314300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65505374|NCT01314300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65505375|NCT01314300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65505376|NCT01314300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65505377|NCT01314300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505378|NCT05762536|Docetaxel|docetaxel|mesh-list
65505379|NCT05762536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505380|NCT05762536|Tubulin Modulators|tubulin modulators|mesh-ancestor
65505381|NCT05762536|Antimitotic Agents|antimitotic agents|mesh-ancestor
65505382|NCT05762536|Mitosis Modulators|mitosis modulators|mesh-ancestor
65505383|NCT05762536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505384|NCT03776058|Cinacalcet|cinacalcet|mesh-list
65505385|NCT03776058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65505386|NCT03776058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505387|NCT03776058|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65505388|NCT03776058|Hormone Antagonists|hormone antagonists|mesh-ancestor
65505389|NCT03776058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65505390|NCT05202496|Calcitriol|calcitriol|mesh-list
65505391|NCT05202496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65505392|NCT05202496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303102|NCT01759459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505393|NCT05202496|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65505394|NCT05202496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65505395|NCT05202496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505396|NCT05202496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65505397|NCT05202496|Vitamins|vitamins|mesh-ancestor
65505398|NCT05202496|Micronutrients|micronutrients|mesh-ancestor
65505399|NCT05202496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65505400|NCT03779568|Bupivacaine|bupivacaine|mesh-list
65505401|NCT03779568|Anesthetics, Local|anesthetics, local|mesh-ancestor
65505402|NCT03779568|Anesthetics|anesthetics|mesh-ancestor
65505403|NCT03779568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65505404|NCT03779568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505405|NCT03779568|Sensory System Agents|sensory system agents|mesh-ancestor
65505406|NCT03779568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65505407|NCT05201560|Fentanyl|fentanyl|mesh-list
65505408|NCT05201560|Butorphanol|butorphanol|mesh-list
65505409|NCT05201560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65505410|NCT05201560|Narcotics|narcotics|mesh-ancestor
65505411|NCT05201560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65505412|NCT05201560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505413|NCT05201560|Analgesics|analgesics|mesh-ancestor
65505414|NCT05201560|Sensory System Agents|sensory system agents|mesh-ancestor
65505415|NCT05201560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65505416|NCT05201560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65505417|NCT05201560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65505418|NCT05201560|Anesthetics, General|anesthetics, general|mesh-ancestor
65505419|NCT05201560|Anesthetics|anesthetics|mesh-ancestor
65505420|NCT05201560|Antitussive Agents|antitussive agents|mesh-ancestor
65505421|NCT05201560|Respiratory System Agents|respiratory system agents|mesh-ancestor
65505422|NCT05201560|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65505423|NCT05201326|Bevacizumab|bevacizumab|mesh-list
65505424|NCT05201326|Irinotecan|irinotecan|mesh-list
65505425|NCT05201326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65505426|NCT05201326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505427|NCT05201326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65505428|NCT05201326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65505429|NCT05201326|Growth Substances|growth substances|mesh-ancestor
65505430|NCT05201326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505431|NCT05201326|Growth Inhibitors|growth inhibitors|mesh-ancestor
65505432|NCT05201326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65505433|NCT05201326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65505434|NCT05201326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505435|NCT05201326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505436|NCT03775668|Enmetazobactam|enmetazobactam|mesh-list
65505437|NCT03775668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65505438|NCT03775668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505439|NCT03775668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505440|NCT03775668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65505441|NCT03775668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65505442|NCT01561404|Everolimus|everolimus|mesh-list
65505443|NCT01561404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505444|NCT01561404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65505445|NCT01561404|Immunologic Factors|immunologic factors|mesh-ancestor
65505446|NCT01561404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505447|NCT03775902|Nicorandil|nicorandil|mesh-list
65505448|NCT03775902|Glimepiride|glimepiride|mesh-list
65505449|NCT03775902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65505450|NCT03775902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65505451|NCT03775902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505452|NCT03775902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65505453|NCT03775902|Immunologic Factors|immunologic factors|mesh-ancestor
65505454|NCT03775902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65505455|NCT03775902|Vasodilator Agents|vasodilator agents|mesh-ancestor
65505456|NCT03775902|Vitamin B Complex|vitamin b complex|mesh-ancestor
65505457|NCT03775902|Vitamins|vitamins|mesh-ancestor
65505458|NCT03775902|Micronutrients|micronutrients|mesh-ancestor
65505459|NCT03775590|Acetic Acid|acetic acid|mesh-list
65505460|NCT03775590|Retinol acetate|retinol acetate|mesh-list
65505461|NCT03775590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65505462|NCT03775590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65505463|NCT03775590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65505464|NCT03775590|Immunologic Factors|immunologic factors|mesh-ancestor
65505465|NCT03775590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505466|NCT03775590|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65505467|NCT03775590|Protective Agents|protective agents|mesh-ancestor
65505468|NCT03775590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505469|NCT03775746|Rivaroxaban|rivaroxaban|mesh-list
65505470|NCT03775746|Clopidogrel|clopidogrel|mesh-list
65505471|NCT03775746|Ticagrelor|ticagrelor|mesh-list
65505472|NCT03775746|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65505473|NCT03775746|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65505474|NCT03775746|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65505475|NCT03775746|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65505476|NCT03775746|Purinergic Agents|purinergic agents|mesh-ancestor
65505477|NCT03775746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65505478|NCT03775746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505479|NCT03775746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505480|NCT03775746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65505481|NCT03775746|Antithrombins|antithrombins|mesh-ancestor
65505482|NCT03775746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65505483|NCT03775746|Protease Inhibitors|protease inhibitors|mesh-ancestor
65505484|NCT03775746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505485|NCT03775746|Anticoagulants|anticoagulants|mesh-ancestor
65505486|NCT03779178|Landiolol|landiolol|mesh-list
65505487|NCT03779178|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65505488|NCT03779178|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65505489|NCT03779178|Adrenergic Agents|adrenergic agents|mesh-ancestor
65505490|NCT03779178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65505491|NCT03779178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505492|NCT03779178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505493|NCT03779178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65505494|NCT03779100|Lenvatinib|lenvatinib|mesh-list
65505495|NCT03779100|Antibodies|antibodies|mesh-list
65505496|NCT03779100|Immunoglobulins|immunoglobulins|mesh-list
65505497|NCT03779100|Immunologic Factors|immunologic factors|mesh-ancestor
65505498|NCT03779100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505499|NCT03779100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505500|NCT03779100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65505501|NCT03779100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505502|NCT03779100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505503|NCT05213884|Cisplatin|cisplatin|mesh-list
65505504|NCT05213884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505505|NCT05711212|Xanthohumol|xanthohumol|mesh-list
65505506|NCT05711212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505507|NCT05711212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65505508|NCT05711212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65505509|NCT05711212|Growth Substances|growth substances|mesh-ancestor
65505510|NCT05711212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505511|NCT05711212|Growth Inhibitors|growth inhibitors|mesh-ancestor
65505512|NCT05212636|Antidepressive Agents|antidepressive agents|mesh-list
65505513|NCT05212636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65505514|NCT03773094|Chlorhexidine|chlorhexidine|mesh-list
65505515|NCT03773094|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65505516|NCT03773094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65505517|NCT03773094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65505518|NCT03773094|Disinfectants|disinfectants|mesh-ancestor
65505519|NCT03773094|Dermatologic Agents|dermatologic agents|mesh-ancestor
65505520|NCT03775356|Anesthetics|anesthetics|mesh-list
65505521|NCT03775356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65505522|NCT03775356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505523|NCT05211622|Thioctic Acid|thioctic acid|mesh-list
65505524|NCT05211622|Chlorhexidine|chlorhexidine|mesh-list
65505525|NCT05211622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65505526|NCT05211622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65505527|NCT05211622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65505528|NCT05211622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65505529|NCT05211622|Disinfectants|disinfectants|mesh-ancestor
65505530|NCT05211622|Dermatologic Agents|dermatologic agents|mesh-ancestor
65505531|NCT05211622|Antioxidants|antioxidants|mesh-ancestor
65505532|NCT05211622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505533|NCT05211622|Protective Agents|protective agents|mesh-ancestor
65505534|NCT05211622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505535|NCT05211622|Vitamin B Complex|vitamin b complex|mesh-ancestor
65505536|NCT05211622|Vitamins|vitamins|mesh-ancestor
65505537|NCT05211622|Micronutrients|micronutrients|mesh-ancestor
65505538|NCT05705518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65505539|NCT05705518|Lubricant Eye Drops|lubricant eye drops|mesh-list
65505540|NCT05705518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65505541|NCT05191264|Analgesics|analgesics|mesh-list
65505542|NCT05191264|Sensory System Agents|sensory system agents|mesh-ancestor
65505543|NCT05191264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65505544|NCT05191264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505545|NCT03778008|Vitamin B 12|vitamin b 12|mesh-list
65505546|NCT03778008|Gentamicins|gentamicins|mesh-list
65505547|NCT03778008|Dexamethasone|dexamethasone|mesh-list
65505548|NCT03778008|Lidocaine|lidocaine|mesh-list
65505549|NCT03778008|Mitogens|mitogens|mesh-list
65505550|NCT03778008|Vitamins|vitamins|mesh-ancestor
65505552|NCT03778008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505553|NCT03778008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65505554|NCT03778008|Antiemetics|antiemetics|mesh-ancestor
65505555|NCT03778008|Autonomic Agents|autonomic agents|mesh-ancestor
65505556|NCT03778008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65505557|NCT03778008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65505558|NCT03778008|Glucocorticoids|glucocorticoids|mesh-ancestor
65505559|NCT03778008|Hormones|hormones|mesh-ancestor
65505560|NCT03778008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65505561|NCT03778008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65505562|NCT03778008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505563|NCT03778008|Anesthetics, Local|anesthetics, local|mesh-ancestor
65505564|NCT03778008|Anesthetics|anesthetics|mesh-ancestor
65505565|NCT03778008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65505566|NCT03778008|Sensory System Agents|sensory system agents|mesh-ancestor
65505567|NCT03778008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65505568|NCT03778008|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65505569|NCT03778008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65505570|NCT03778008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65505571|NCT03778008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505572|NCT03778008|Mitosis Modulators|mitosis modulators|mesh-ancestor
65505573|NCT03778008|Vitamin B Complex|vitamin b complex|mesh-ancestor
65505574|NCT03778008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65505575|NCT03778008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65505576|NCT03778008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65505577|NCT03778008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505578|NCT05697328|Pseudoephedrine|pseudoephedrine|mesh-list
65505579|NCT05697328|Ephedrine|ephedrine|mesh-list
65505580|NCT05697328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65505581|NCT05697328|Autonomic Agents|autonomic agents|mesh-ancestor
65505582|NCT05697328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65505583|NCT05697328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505584|NCT05697328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65505585|NCT05697328|Respiratory System Agents|respiratory system agents|mesh-ancestor
65505586|NCT05697328|Nasal Decongestants|nasal decongestants|mesh-ancestor
65505587|NCT05697328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65505588|NCT05697328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65505589|NCT05697328|Sympathomimetics|sympathomimetics|mesh-ancestor
65505590|NCT05697328|Adrenergic Agents|adrenergic agents|mesh-ancestor
65505591|NCT05697328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65505592|NCT05697328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505593|NCT05159778|Pembrolizumab|pembrolizumab|mesh-list
65505594|NCT05159778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65505595|NCT05159778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505596|NCT03777930|Thalidomide|thalidomide|mesh-list
65505597|NCT03777930|Megestrol|megestrol|mesh-list
65505598|NCT03777930|Megestrol Acetate|megestrol acetate|mesh-list
65505599|NCT03777930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65505600|NCT03777930|Immunologic Factors|immunologic factors|mesh-ancestor
65505601|NCT03777930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505602|NCT03777930|Leprostatic Agents|leprostatic agents|mesh-ancestor
65505603|NCT03777930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65505604|NCT03777930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65505605|NCT03777930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65505606|NCT03777930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65505607|NCT03777930|Growth Substances|growth substances|mesh-ancestor
65505608|NCT03777930|Growth Inhibitors|growth inhibitors|mesh-ancestor
65505609|NCT03777930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505610|NCT03777930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65505611|NCT03777930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65505612|NCT03777930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65505613|NCT03777930|Contraceptive Agents|contraceptive agents|mesh-ancestor
65505614|NCT03777930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65505615|NCT03777930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65505616|NCT03777930|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65505617|NCT03777930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65505618|NCT03777930|Appetite Stimulants|appetite stimulants|mesh-ancestor
65505619|NCT03777930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65505620|NCT03777696|Misoprostol|misoprostol|mesh-list
65505621|NCT03777696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65505622|NCT03777696|Abortifacient Agents|abortifacient agents|mesh-ancestor
65505623|NCT03777696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65303327|NCT00642161|Budesonide|budesonide|mesh-list
65505624|NCT03777696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505625|NCT03777696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65505626|NCT03777696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65505627|NCT03777696|Oxytocics|oxytocics|mesh-ancestor
65505628|NCT04581148|Antibodies|antibodies|mesh-list
65505629|NCT04581148|Immunoglobulins|immunoglobulins|mesh-list
65505630|NCT04581148|Immunologic Factors|immunologic factors|mesh-ancestor
65505631|NCT04581148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505632|NCT03708744|Oxazolidinones|oxazolidinones|mesh-list
65505633|NCT03708744|Zolmitriptan|zolmitriptan|mesh-list
65505634|NCT03708744|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65505635|NCT03708744|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65505636|NCT03708744|Serotonin Agents|serotonin agents|mesh-ancestor
65505637|NCT03708744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65505638|NCT03708744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505639|NCT03708744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505640|NCT03708744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65505641|NCT03708744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65505642|NCT03708744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505643|NCT03774108|Metformin|metformin|mesh-list
65505644|NCT03774108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65505645|NCT03774108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505646|NCT03438526|Melatonin|melatonin|mesh-list
65505647|NCT03438526|Antioxidants|antioxidants|mesh-ancestor
65505648|NCT03438526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505649|NCT03438526|Protective Agents|protective agents|mesh-ancestor
65505650|NCT03438526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505651|NCT03438526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65505652|NCT02575144|Clarithromycin|clarithromycin|mesh-list
65505653|NCT02575144|Dexamethasone|dexamethasone|mesh-list
65505654|NCT02575144|Lenalidomide|lenalidomide|mesh-list
65505655|NCT02575144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65505656|NCT02575144|Antiemetics|antiemetics|mesh-ancestor
65505657|NCT02575144|Autonomic Agents|autonomic agents|mesh-ancestor
65505658|NCT02575144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65505659|NCT02575144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505660|NCT02575144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65505661|NCT02575144|Glucocorticoids|glucocorticoids|mesh-ancestor
65505662|NCT02575144|Hormones|hormones|mesh-ancestor
65505663|NCT02575144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65505664|NCT02575144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65505665|NCT02575144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505666|NCT02575144|Immunologic Factors|immunologic factors|mesh-ancestor
65505667|NCT02575144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65505668|NCT02575144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65505669|NCT02575144|Growth Substances|growth substances|mesh-ancestor
65505670|NCT02575144|Growth Inhibitors|growth inhibitors|mesh-ancestor
65505671|NCT02575144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65505672|NCT02575144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65505673|NCT02575144|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65505674|NCT02575144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505675|NCT02575144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505676|NCT02575144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65505677|NCT02575144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65505678|NCT04140162|Dexamethasone|dexamethasone|mesh-list
65505679|NCT04140162|Lenalidomide|lenalidomide|mesh-list
65505680|NCT04140162|Bortezomib|bortezomib|mesh-list
65505681|NCT04140162|Daratumumab|daratumumab|mesh-list
65505682|NCT04140162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65505683|NCT04140162|Antiemetics|antiemetics|mesh-ancestor
65505684|NCT04140162|Autonomic Agents|autonomic agents|mesh-ancestor
65505685|NCT04140162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65505686|NCT04140162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505687|NCT04140162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65505688|NCT04140162|Glucocorticoids|glucocorticoids|mesh-ancestor
65505689|NCT04140162|Hormones|hormones|mesh-ancestor
65505690|NCT04140162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65505691|NCT04140162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65505692|NCT04140162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505693|NCT04140162|Immunologic Factors|immunologic factors|mesh-ancestor
65505694|NCT04140162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65505695|NCT04140162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65505696|NCT04140162|Growth Substances|growth substances|mesh-ancestor
65505697|NCT04140162|Growth Inhibitors|growth inhibitors|mesh-ancestor
65505698|NCT03768882|Acetaminophen|acetaminophen|mesh-list
65505699|NCT03768882|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65505700|NCT03768882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65505701|NCT03768882|Analgesics|analgesics|mesh-ancestor
65505702|NCT03768882|Sensory System Agents|sensory system agents|mesh-ancestor
65505703|NCT03768882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65505704|NCT03768882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505705|NCT03768882|Antipyretics|antipyretics|mesh-ancestor
65505706|NCT03768882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65505707|NCT03768882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65505708|NCT03768882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65505710|NCT02574286|Vitamins|vitamins|mesh-ancestor
65505711|NCT02574286|Micronutrients|micronutrients|mesh-ancestor
65505712|NCT02574286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505713|NCT02574286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65505714|NCT01321944|Nicotine|nicotine|mesh-list
65505715|NCT01321944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65505716|NCT01321944|Autonomic Agents|autonomic agents|mesh-ancestor
65505717|NCT01321944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65505718|NCT01321944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505719|NCT01321944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65505720|NCT01321944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65505721|NCT01321944|Cholinergic Agents|cholinergic agents|mesh-ancestor
65505722|NCT01321944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65505723|NCT01321944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505724|NCT03771846|Leucovorin|leucovorin|mesh-list
65505725|NCT03771846|Gemcitabine|gemcitabine|mesh-list
65505726|NCT03771846|Fluorouracil|fluorouracil|mesh-list
65505727|NCT03771846|Oxaliplatin|oxaliplatin|mesh-list
65505728|NCT03771846|Irinotecan|irinotecan|mesh-list
65505729|NCT03771846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65505730|NCT03771846|Antimetabolites|antimetabolites|mesh-ancestor
65505731|NCT03771846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505732|NCT03771846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505733|NCT03771846|Antiviral Agents|antiviral agents|mesh-ancestor
65505734|NCT03771846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65505735|NCT03771846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505736|NCT03771846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65505737|NCT03771846|Immunologic Factors|immunologic factors|mesh-ancestor
65505738|NCT03771846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505739|NCT03771846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65505740|NCT03771846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65505741|NCT03771846|Antidotes|antidotes|mesh-ancestor
65505742|NCT03771846|Protective Agents|protective agents|mesh-ancestor
65505743|NCT03771846|Vitamin B Complex|vitamin b complex|mesh-ancestor
65505744|NCT03771846|Vitamins|vitamins|mesh-ancestor
65505745|NCT03771846|Micronutrients|micronutrients|mesh-ancestor
65505746|NCT03763110|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65505747|NCT03763110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65505748|NCT03763110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65505749|NCT03763110|Antitubercular Agents|antitubercular agents|mesh-ancestor
65505750|NCT03771768|Triamcinolone|triamcinolone|mesh-list
65505751|NCT03771768|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65505752|NCT03771768|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65505753|NCT03771768|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65505754|NCT03771768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65505755|NCT03771768|Glucocorticoids|glucocorticoids|mesh-ancestor
65505756|NCT03771768|Hormones|hormones|mesh-ancestor
65505757|NCT03771768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65505758|NCT03771768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505759|NCT03771768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65505760|NCT03771768|Immunologic Factors|immunologic factors|mesh-ancestor
65505761|NCT03771768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505762|NCT03771768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505763|NCT04393350|Pembrolizumab|pembrolizumab|mesh-list
65505764|NCT04393350|Lenvatinib|lenvatinib|mesh-list
65505765|NCT04393350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65505766|NCT04393350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505767|NCT04393350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65505768|NCT04393350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505769|NCT04393350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505770|NCT03745326|Aldesleukin|aldesleukin|mesh-list
65505771|NCT03745326|Cyclophosphamide|cyclophosphamide|mesh-list
65505772|NCT03745326|Fludarabine|fludarabine|mesh-list
65505773|NCT03745326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65505774|NCT03745326|Immunologic Factors|immunologic factors|mesh-ancestor
65505775|NCT03745326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505776|NCT03745326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65505777|NCT03745326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65505778|NCT03745326|Alkylating Agents|alkylating agents|mesh-ancestor
65505779|NCT03745326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505780|NCT03745326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505781|NCT03745326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65505782|NCT03745326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65505783|NCT03745326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65505784|NCT03745326|Antiviral Agents|antiviral agents|mesh-ancestor
65505785|NCT03745326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65505786|NCT03768258|Methyltestosterone|methyltestosterone|mesh-list
65505787|NCT03768258|Anastrozole|anastrozole|mesh-list
65505788|NCT03768258|Testosterone|testosterone|mesh-list
65505789|NCT03768258|Testosterone undecanoate|testosterone undecanoate|mesh-list
65505790|NCT03768258|Testosterone enanthate|testosterone enanthate|mesh-list
65505791|NCT03768258|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65505792|NCT03768258|Androgens|androgens|mesh-ancestor
65505793|NCT03768258|Hormones|hormones|mesh-ancestor
65505794|NCT03768258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65505795|NCT03768258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505796|NCT03768258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65505797|NCT03768258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505798|NCT03768258|Anabolic Agents|anabolic agents|mesh-ancestor
65505799|NCT03768258|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65505800|NCT03768258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65505801|NCT03768258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505802|NCT03768258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505803|NCT03768258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65505804|NCT03768258|Hormone Antagonists|hormone antagonists|mesh-ancestor
65505805|NCT03771222|Decitabine|decitabine|mesh-list
65505806|NCT03771222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65505807|NCT03771222|Antimetabolites|antimetabolites|mesh-ancestor
65505808|NCT03771222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505809|NCT03771222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505810|NCT03771222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505811|NCT02366728|Temozolomide|temozolomide|mesh-list
65505812|NCT02366728|Basiliximab|basiliximab|mesh-list
65505813|NCT02366728|Immunologic Factors|immunologic factors|mesh-ancestor
65505814|NCT02366728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505815|NCT02366728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65505816|NCT02366728|Alkylating Agents|alkylating agents|mesh-ancestor
65505817|NCT02366728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505818|NCT02366728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505819|NCT02366728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65505820|NCT03771066|Bisphenol A|bisphenol a|mesh-list
65505821|NCT03771066|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65505822|NCT03771066|Estrogens|estrogens|mesh-ancestor
65505823|NCT03771066|Hormones|hormones|mesh-ancestor
65505824|NCT03771066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65505825|NCT03771066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505826|NCT03771066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65505827|NCT03771066|Antioxidants|antioxidants|mesh-ancestor
65505828|NCT03771066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505829|NCT03771066|Protective Agents|protective agents|mesh-ancestor
65505830|NCT04478838|Olanzapine|olanzapine|mesh-list
65505831|NCT04478838|Risperidone|risperidone|mesh-list
65505832|NCT04478838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65505833|NCT04478838|Serotonin Agents|serotonin agents|mesh-ancestor
65505834|NCT04478838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65505835|NCT04478838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505836|NCT04478838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505837|NCT04478838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65505838|NCT04478838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65505839|NCT04478838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65505840|NCT04478838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65505841|NCT04478838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65505842|NCT04478838|Dopamine Agents|dopamine agents|mesh-ancestor
65505843|NCT04478838|Antiemetics|antiemetics|mesh-ancestor
65505844|NCT04478838|Autonomic Agents|autonomic agents|mesh-ancestor
65505845|NCT04478838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65505846|NCT04478838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65505847|NCT04478838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65505848|NCT04478838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65505849|NCT04478838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65505850|NCT03768024|Hydromorphone|hydromorphone|mesh-list
65505851|NCT03768024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65505853|NCT03768024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65505854|NCT03768024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505855|NCT03768024|Analgesics|analgesics|mesh-ancestor
65505856|NCT03768024|Sensory System Agents|sensory system agents|mesh-ancestor
65505857|NCT03768024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65505858|NCT03999684|Tretinoin|tretinoin|mesh-list
65505859|NCT03999684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505860|NCT03999684|Keratolytic Agents|keratolytic agents|mesh-ancestor
65505861|NCT03999684|Dermatologic Agents|dermatologic agents|mesh-ancestor
65505862|NCT02083354|Trametinib|trametinib|mesh-list
65505863|NCT02083354|Dabrafenib|dabrafenib|mesh-list
65505864|NCT02083354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505865|NCT02083354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65505866|NCT02083354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505867|NCT02083354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505868|NCT01399918|Bevacizumab|bevacizumab|mesh-list
65505869|NCT01399918|Everolimus|everolimus|mesh-list
65505870|NCT01399918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65505871|NCT01399918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505872|NCT01399918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65505873|NCT01399918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65505874|NCT01399918|Growth Substances|growth substances|mesh-ancestor
65505875|NCT01399918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505876|NCT01399918|Growth Inhibitors|growth inhibitors|mesh-ancestor
65505877|NCT01399918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65505878|NCT01399918|Immunologic Factors|immunologic factors|mesh-ancestor
65505879|NCT03761472|Hyaluronic Acid|hyaluronic acid|mesh-list
65505880|NCT03761472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65505881|NCT03761472|Immunologic Factors|immunologic factors|mesh-ancestor
65505882|NCT03761472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505883|NCT03761472|Viscosupplements|viscosupplements|mesh-ancestor
65505884|NCT03761472|Protective Agents|protective agents|mesh-ancestor
65505885|NCT03767322|Allopurinol|allopurinol|mesh-list
65505886|NCT03767322|Febuxostat|febuxostat|mesh-list
65505887|NCT03767322|Antimetabolites|antimetabolites|mesh-ancestor
65505888|NCT03767322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505889|NCT03767322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505890|NCT03767322|Gout Suppressants|gout suppressants|mesh-ancestor
65505891|NCT03767322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65505892|NCT03767322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65505893|NCT03767322|Antioxidants|antioxidants|mesh-ancestor
65505894|NCT03767322|Protective Agents|protective agents|mesh-ancestor
65505895|NCT03767322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505896|NCT03761004|Levodopa|levodopa|mesh-list
65505897|NCT03761004|Carbidopa|carbidopa|mesh-list
65505898|NCT03761004|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65505899|NCT03761004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65505900|NCT03761004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65505901|NCT03761004|Dopamine Agents|dopamine agents|mesh-ancestor
65505902|NCT03761004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65505903|NCT03761004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505904|NCT03761004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505905|NCT03761004|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65505906|NCT03761004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505907|NCT03761004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65505908|NCT03761004|Immunologic Factors|immunologic factors|mesh-ancestor
65505909|NCT03761004|Dopamine Agonists|dopamine agonists|mesh-ancestor
65505910|NCT03770208|Lidocaine|lidocaine|mesh-list
65303623|NCT00643799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303624|NCT00643799|Gout Suppressants|gout suppressants|mesh-ancestor
65303625|NCT05348213|Decitabine|decitabine|mesh-list
65303626|NCT05348213|Pomalidomide|pomalidomide|mesh-list
65303627|NCT05348213|Zanubrutinib|zanubrutinib|mesh-list
65303628|NCT05348213|Tofacitinib|tofacitinib|mesh-list
65303629|NCT05348213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65303630|NCT05348213|Antimetabolites|antimetabolites|mesh-ancestor
65303631|NCT05348213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303632|NCT05348213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303633|NCT05348213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303634|NCT05348213|Immunologic Factors|immunologic factors|mesh-ancestor
65303635|NCT05348213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303636|NCT05348213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65303637|NCT05348213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65303638|NCT05348213|Growth Substances|growth substances|mesh-ancestor
65303639|NCT05348213|Growth Inhibitors|growth inhibitors|mesh-ancestor
65505912|NCT03770208|Anesthetics|anesthetics|mesh-ancestor
65505913|NCT03770208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65505914|NCT03770208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505915|NCT03770208|Sensory System Agents|sensory system agents|mesh-ancestor
65505916|NCT03770208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65505917|NCT03770208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65505918|NCT03770208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65505919|NCT03770208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65505920|NCT03770208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65505921|NCT03770208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505922|NCT03766854|Insulin|insulin|mesh-list
65505923|NCT03766854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65505924|NCT03766854|Insulin Glargine|insulin glargine|mesh-list
65505925|NCT03766854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65505926|NCT03766854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505927|NCT01322100|Bleomycin|bleomycin|mesh-list
65505928|NCT01322100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65505929|NCT01322100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505930|NCT03760848|Midazolam|midazolam|mesh-list
65505931|NCT03760848|Atorvastatin|atorvastatin|mesh-list
65505932|NCT03760848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65505933|NCT03760848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65505934|NCT03760848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65505935|NCT03760848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505936|NCT03760848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65505937|NCT03760848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65505938|NCT03760848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65505939|NCT03760848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65505940|NCT03760848|Anesthetics, General|anesthetics, general|mesh-ancestor
65505941|NCT03760848|Anesthetics|anesthetics|mesh-ancestor
65505942|NCT03760848|GABA Modulators|gaba modulators|mesh-ancestor
65505943|NCT03760848|GABA Agents|gaba agents|mesh-ancestor
65505944|NCT03760848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65505945|NCT03760848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505946|NCT03760848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65505947|NCT03760848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65505948|NCT03760848|Antimetabolites|antimetabolites|mesh-ancestor
65505949|NCT03760848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65505950|NCT03760848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65505951|NCT03760848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505952|NCT01567488|Everolimus|everolimus|mesh-list
65505953|NCT01567488|Octreotide|octreotide|mesh-list
65505954|NCT01567488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505955|NCT01567488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65505956|NCT01567488|Immunologic Factors|immunologic factors|mesh-ancestor
65505957|NCT01567488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505958|NCT01567488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65505959|NCT01567488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65505960|NCT03760770|Riboflavin|riboflavin|mesh-list
65505961|NCT03760770|Vitamin B Complex|vitamin b complex|mesh-ancestor
65505962|NCT03760770|Vitamins|vitamins|mesh-ancestor
65505963|NCT03760770|Micronutrients|micronutrients|mesh-ancestor
65505964|NCT03760770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505965|NCT03760770|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65505966|NCT03760770|Dermatologic Agents|dermatologic agents|mesh-ancestor
65505967|NCT01561794|Ciprofloxacin|ciprofloxacin|mesh-list
65505968|NCT01561794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65505969|NCT01561794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65505970|NCT01561794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65505971|NCT01561794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65505972|NCT01561794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505973|NCT01561794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505974|NCT01561794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505975|NCT01561794|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65505976|NCT01561794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65505977|NCT01322178|Cetuximab|cetuximab|mesh-list
65505978|NCT01322178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65505979|NCT01322178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505980|NCT03760614|Entinostat|entinostat|mesh-list
65505981|NCT03760614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505982|NCT03760614|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65505983|NCT03760614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65505984|NCT03760614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65505985|NCT00112840|Bevacizumab|bevacizumab|mesh-list
65505986|NCT00112840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65505987|NCT00112840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65505988|NCT00112840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65505989|NCT00112840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65505990|NCT00112840|Growth Substances|growth substances|mesh-ancestor
65505991|NCT00112840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65505992|NCT00112840|Growth Inhibitors|growth inhibitors|mesh-ancestor
65505993|NCT03769818|Dexamethasone|dexamethasone|mesh-list
65505994|NCT03769818|Dexamethasone acetate|dexamethasone acetate|mesh-list
65505995|NCT03769818|Bupivacaine|bupivacaine|mesh-list
65505996|NCT03769818|BB 1101|bb 1101|mesh-list
65505997|NCT03769818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65505998|NCT03769818|Antiemetics|antiemetics|mesh-ancestor
65505999|NCT03769818|Autonomic Agents|autonomic agents|mesh-ancestor
65506000|NCT03769818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65506001|NCT03769818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506002|NCT03769818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65506003|NCT03769818|Glucocorticoids|glucocorticoids|mesh-ancestor
65506004|NCT03769818|Hormones|hormones|mesh-ancestor
65506005|NCT03769818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65506006|NCT03769818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65506007|NCT03769818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65506008|NCT03769818|Protease Inhibitors|protease inhibitors|mesh-ancestor
65506009|NCT03769818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506010|NCT03769818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506011|NCT03769818|Anesthetics, Local|anesthetics, local|mesh-ancestor
65506012|NCT03769818|Anesthetics|anesthetics|mesh-ancestor
65506013|NCT03769818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65506014|NCT03769818|Sensory System Agents|sensory system agents|mesh-ancestor
65506015|NCT05223244|Triamcinolone|triamcinolone|mesh-list
65506016|NCT05223244|Heparin|heparin|mesh-list
65506017|NCT05223244|Bupivacaine|bupivacaine|mesh-list
65506018|NCT05223244|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
65506019|NCT05223244|Anesthetics, Local|anesthetics, local|mesh-ancestor
65506020|NCT05223244|Anesthetics|anesthetics|mesh-ancestor
65506021|NCT05223244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65506022|NCT05223244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506023|NCT05223244|Sensory System Agents|sensory system agents|mesh-ancestor
65506024|NCT05223244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65506025|NCT05223244|Anticoagulants|anticoagulants|mesh-ancestor
65506026|NCT05223244|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65506027|NCT05223244|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65506028|NCT05223244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506029|NCT05223244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65506030|NCT05223244|Glucocorticoids|glucocorticoids|mesh-ancestor
65506031|NCT05223244|Hormones|hormones|mesh-ancestor
65506032|NCT05223244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65506033|NCT05223244|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65506034|NCT05223244|Protective Agents|protective agents|mesh-ancestor
65506035|NCT05223244|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65506036|NCT05223244|Antioxidants|antioxidants|mesh-ancestor
65506037|NCT04336098|Gemcitabine|gemcitabine|mesh-list
65506038|NCT04336098|Paclitaxel|paclitaxel|mesh-list
65506039|NCT04336098|Pembrolizumab|pembrolizumab|mesh-list
65506040|NCT04336098|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65506041|NCT04336098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65506042|NCT04336098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65506043|NCT04336098|Tubulin Modulators|tubulin modulators|mesh-ancestor
65506044|NCT04336098|Antimitotic Agents|antimitotic agents|mesh-ancestor
65506045|NCT04336098|Mitosis Modulators|mitosis modulators|mesh-ancestor
65506046|NCT04336098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506047|NCT04336098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65506048|NCT04336098|Antimetabolites|antimetabolites|mesh-ancestor
65506049|NCT04336098|Antiviral Agents|antiviral agents|mesh-ancestor
65506050|NCT04336098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506051|NCT04336098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506052|NCT04336098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65506053|NCT04336098|Immunologic Factors|immunologic factors|mesh-ancestor
65506054|NCT04336098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506055|NCT04336098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65506056|NCT05223010|Sevoflurane|sevoflurane|mesh-list
65506057|NCT05223010|Melatonin|melatonin|mesh-list
65506058|NCT05223010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65506059|NCT05223010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65506060|NCT05223010|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65506061|NCT05223010|Anesthetics, General|anesthetics, general|mesh-ancestor
65506062|NCT05223010|Anesthetics|anesthetics|mesh-ancestor
65506063|NCT05223010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65506064|NCT05223010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506065|NCT05223010|Antioxidants|antioxidants|mesh-ancestor
65506066|NCT05223010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506067|NCT05223010|Protective Agents|protective agents|mesh-ancestor
65506068|NCT03760302|Analgesics|analgesics|mesh-list
65506069|NCT03760302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65506070|NCT03760302|Sensory System Agents|sensory system agents|mesh-ancestor
65506071|NCT03760302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65506072|NCT03760302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506073|NCT03760302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65506074|NCT03766074|Vitamin D|vitamin d|mesh-list
65506075|NCT03766074|Vitamins|vitamins|mesh-ancestor
65506076|NCT03766074|Micronutrients|micronutrients|mesh-ancestor
65506077|NCT03766074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506078|NCT03766074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65506079|NCT05219656|Cyclosporine|cyclosporine|mesh-list
65506080|NCT05219656|Cyclosporins|cyclosporins|mesh-list
65506081|NCT05219656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506082|NCT05219656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506083|NCT05219656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65506084|NCT05219656|Immunologic Factors|immunologic factors|mesh-ancestor
65506085|NCT05219656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506086|NCT05219656|Antifungal Agents|antifungal agents|mesh-ancestor
65506087|NCT05219656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506088|NCT05219656|Dermatologic Agents|dermatologic agents|mesh-ancestor
65506089|NCT05219656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65506090|NCT05219656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65506091|NCT05168644|Niclosamide|niclosamide|mesh-list
65506092|NCT05168644|Anticestodal Agents|anticestodal agents|mesh-ancestor
65506093|NCT05168644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65506094|NCT05168644|Anthelmintics|anthelmintics|mesh-ancestor
65506095|NCT05168644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65506096|NCT05168644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506097|NCT05168644|Antinematodal Agents|antinematodal agents|mesh-ancestor
65506098|NCT05645536|Tamoxifen|tamoxifen|mesh-list
65506099|NCT05645536|Letrozole|letrozole|mesh-list
65506100|NCT05645536|Anastrozole|anastrozole|mesh-list
65506101|NCT05645536|Exemestane|exemestane|mesh-list
65506102|NCT05645536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65506103|NCT05645536|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65506104|NCT05645536|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65506105|NCT05645536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506106|NCT05645536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506107|NCT05645536|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65506108|NCT05645536|Hormone Antagonists|hormone antagonists|mesh-ancestor
65506109|NCT05645536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65506110|NCT05645536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506111|NCT05645536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65506112|NCT05645536|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65506113|NCT05645536|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65506114|NCT05645536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65506115|NCT05412888|Coenzyme Q10|coenzyme q10|mesh-list
65506116|NCT05412888|Ubiquinone|ubiquinone|mesh-list
65506117|NCT05412888|Vitamins|vitamins|mesh-ancestor
65506118|NCT05412888|Micronutrients|micronutrients|mesh-ancestor
65506119|NCT05412888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506120|NCT02105766|Sirolimus|sirolimus|mesh-list
65506121|NCT02105766|Cyclophosphamide|cyclophosphamide|mesh-list
65506122|NCT02105766|Alemtuzumab|alemtuzumab|mesh-list
65506123|NCT02105766|Pentostatin|pentostatin|mesh-list
65506124|NCT02105766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65506125|NCT02105766|Immunologic Factors|immunologic factors|mesh-ancestor
65506126|NCT02105766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506127|NCT02105766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65506128|NCT02105766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65506129|NCT02105766|Alkylating Agents|alkylating agents|mesh-ancestor
65506130|NCT02105766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506131|NCT02105766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65506132|NCT02105766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65506133|NCT02105766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65506134|NCT02105766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506135|NCT02105766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65506136|NCT02105766|Antifungal Agents|antifungal agents|mesh-ancestor
65506137|NCT02105766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65506138|NCT02105766|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65506139|NCT02105766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506140|NCT05558410|Acetaminophen|acetaminophen|mesh-list
65506141|NCT05558410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65506142|NCT05558410|Analgesics|analgesics|mesh-ancestor
65506143|NCT05558410|Sensory System Agents|sensory system agents|mesh-ancestor
65506144|NCT05558410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65506145|NCT05558410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506146|NCT05558410|Antipyretics|antipyretics|mesh-ancestor
65506147|NCT03176784|Nicotine|nicotine|mesh-list
65506148|NCT03176784|Varenicline|varenicline|mesh-list
65506149|NCT03176784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65506150|NCT03176784|Autonomic Agents|autonomic agents|mesh-ancestor
65506151|NCT03176784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65506152|NCT03176784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506153|NCT03176784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65506154|NCT03176784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65506155|NCT03176784|Cholinergic Agents|cholinergic agents|mesh-ancestor
65506156|NCT03176784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65506157|NCT03176784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506158|NCT05087212|Plerixafor|plerixafor|mesh-list
65506159|NCT05087212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65506160|NCT05087212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65506161|NCT05087212|Antiviral Agents|antiviral agents|mesh-ancestor
65506162|NCT05087212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506163|NCT01532310|Belimumab|belimumab|mesh-list
65506164|NCT01532310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65506165|NCT01532310|Immunologic Factors|immunologic factors|mesh-ancestor
65506166|NCT01532310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506167|NCT01321788|Tinzaparin|tinzaparin|mesh-list
65506168|NCT01321788|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65506169|NCT01321788|Dalteparin|dalteparin|mesh-list
65506170|NCT01321788|Anticoagulants|anticoagulants|mesh-ancestor
65506171|NCT01321788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65506172|NCT01321788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65506173|NCT01321788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506174|NCT05053828|Clopidogrel|clopidogrel|mesh-list
65506175|NCT05053828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65506176|NCT05053828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65506177|NCT05053828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65506178|NCT05053828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65506179|NCT05053828|Purinergic Agents|purinergic agents|mesh-ancestor
65506180|NCT05053828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65506181|NCT05053828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506182|NCT05053828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506183|NCT03120780|Fentanyl|fentanyl|mesh-list
65506184|NCT03120780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65506185|NCT03120780|Narcotics|narcotics|mesh-ancestor
65506186|NCT03120780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65506187|NCT03120780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506188|NCT03120780|Analgesics|analgesics|mesh-ancestor
65506189|NCT03120780|Sensory System Agents|sensory system agents|mesh-ancestor
65506190|NCT03120780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65506191|NCT03120780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65506192|NCT03120780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65506193|NCT03120780|Anesthetics, General|anesthetics, general|mesh-ancestor
65506194|NCT03120780|Anesthetics|anesthetics|mesh-ancestor
65506195|NCT03118986|Olanzapine|olanzapine|mesh-list
65506196|NCT03118986|Antiemetics|antiemetics|mesh-ancestor
65506197|NCT03118986|Autonomic Agents|autonomic agents|mesh-ancestor
65506198|NCT03118986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65506199|NCT03118986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506200|NCT03118986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65506201|NCT03118986|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65506202|NCT03118986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65506203|NCT03118986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65506204|NCT03118986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65506205|NCT03118986|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65506206|NCT03118986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65506207|NCT03118986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65506208|NCT03118986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506209|NCT03118986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65506210|NCT03118986|Serotonin Agents|serotonin agents|mesh-ancestor
65506211|NCT04920838|Acetaminophen|acetaminophen|mesh-list
65506212|NCT04920838|Ciclesonide|ciclesonide|mesh-list
65506213|NCT04920838|Nitazoxanide|nitazoxanide|mesh-list
65506214|NCT04920838|Budesonide|budesonide|mesh-list
65506215|NCT04920838|Telmisartan|telmisartan|mesh-list
65506216|NCT04920838|Fluoxetine|fluoxetine|mesh-list
65506217|NCT04920838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65506219|NCT04920838|Sensory System Agents|sensory system agents|mesh-ancestor
65506220|NCT04920838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65506221|NCT04920838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506222|NCT04920838|Antipyretics|antipyretics|mesh-ancestor
65506223|NCT04920838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65506224|NCT04920838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65506225|NCT04920838|Autonomic Agents|autonomic agents|mesh-ancestor
65506226|NCT04920838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65506227|NCT04920838|Respiratory System Agents|respiratory system agents|mesh-ancestor
65506228|NCT04920838|Glucocorticoids|glucocorticoids|mesh-ancestor
65506229|NCT04920838|Hormones|hormones|mesh-ancestor
65506230|NCT04920838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65506231|NCT04920838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65506232|NCT04920838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65506233|NCT04920838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65506234|NCT04920838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506235|NCT04920838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65506236|NCT04920838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65506237|NCT04920838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65506238|NCT04920838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65506239|NCT04920838|Serotonin Agents|serotonin agents|mesh-ancestor
65506240|NCT04920838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65506241|NCT04920838|Antidepressive Agents|antidepressive agents|mesh-ancestor
65506242|NCT04920838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65506243|NCT04920838|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65506244|NCT04920838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65506245|NCT04920838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506246|NCT04920838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65506247|NCT04920838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506248|NCT04920838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65506249|NCT03764280|Insulin|insulin|mesh-list
65506250|NCT03764280|Insulin, Short-Acting|insulin, short-acting|mesh-list
65506251|NCT03764280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65506252|NCT03764280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506253|NCT05133804|Methylphenidate|methylphenidate|mesh-list
65506254|NCT05133804|Reboxetine|reboxetine|mesh-list
65506255|NCT05133804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65506256|NCT05133804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506257|NCT05133804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65506258|NCT05133804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65506259|NCT05133804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65506260|NCT05133804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506261|NCT05133804|Dopamine Agents|dopamine agents|mesh-ancestor
65506262|NCT05133804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65506263|NCT05133804|Antidepressive Agents|antidepressive agents|mesh-ancestor
65506264|NCT05133804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65506265|NCT05133804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65506266|NCT05133804|Adrenergic Agents|adrenergic agents|mesh-ancestor
65506267|NCT03764202|Sufentanil|sufentanil|mesh-list
65506268|NCT03764202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65506269|NCT03764202|Narcotics|narcotics|mesh-ancestor
65506270|NCT03764202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65506271|NCT03764202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506272|NCT03764202|Analgesics|analgesics|mesh-ancestor
65506273|NCT03764202|Sensory System Agents|sensory system agents|mesh-ancestor
65506274|NCT03764202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65506275|NCT03764202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65506276|NCT03764202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65506277|NCT03764202|Anesthetics, General|anesthetics, general|mesh-ancestor
65506278|NCT03764202|Anesthetics|anesthetics|mesh-ancestor
65506279|NCT04680910|Propofol|propofol|mesh-list
65506280|NCT04680910|Anesthetics|anesthetics|mesh-list
65506281|NCT04680910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65506282|NCT04680910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65506283|NCT04680910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506284|NCT04680910|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65506285|NCT04680910|Anesthetics, General|anesthetics, general|mesh-ancestor
65506286|NCT05115630|Mycophenolic Acid|mycophenolic acid|mesh-list
65506287|NCT05115630|Cyclophosphamide|cyclophosphamide|mesh-list
65506288|NCT05115630|Melphalan|melphalan|mesh-list
65506289|NCT05115630|Fludarabine|fludarabine|mesh-list
65506290|NCT05115630|Fludarabine phosphate|fludarabine phosphate|mesh-list
65506291|NCT05115630|Tacrolimus|tacrolimus|mesh-list
65506292|NCT05115630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65506293|NCT05115630|Immunologic Factors|immunologic factors|mesh-ancestor
65506294|NCT05115630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506295|NCT05115630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65506296|NCT05115630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65506297|NCT05115630|Alkylating Agents|alkylating agents|mesh-ancestor
65506298|NCT05115630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506299|NCT05115630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65506300|NCT05115630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65506301|NCT05115630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65506302|NCT05115630|Antimetabolites|antimetabolites|mesh-ancestor
65506303|NCT05115630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65506304|NCT05115630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506305|NCT05115630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65506306|NCT05115630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65506307|NCT05115630|Antitubercular Agents|antitubercular agents|mesh-ancestor
65506308|NCT05115630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65506309|NCT05115630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506310|NCT04678492|Amoxicillin|amoxicillin|mesh-list
65506311|NCT04678492|Tetracycline|tetracycline|mesh-list
65506312|NCT04678492|Furazolidone|furazolidone|mesh-list
65506313|NCT04678492|Esomeprazole|esomeprazole|mesh-list
65506314|NCT04678492|Bismuth|bismuth|mesh-list
65506315|NCT04678492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65506316|NCT04678492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506317|NCT04678492|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65506318|NCT04678492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65506319|NCT04678492|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65506320|NCT04678492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506321|NCT04678492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506322|NCT04678492|Antacids|antacids|mesh-ancestor
65506323|NCT04678492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65506324|NCT04678492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65506325|NCT04678492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65506326|NCT04678492|Renal Agents|renal agents|mesh-ancestor
65506327|NCT04678492|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65506328|NCT04678492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65506329|NCT04678492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65506330|NCT04678492|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65506331|NCT05091528|Capecitabine|capecitabine|mesh-list
65506332|NCT05091528|Trastuzumab|trastuzumab|mesh-list
65506333|NCT05091528|Tucatinib|tucatinib|mesh-list
65506334|NCT05091528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65506335|NCT05091528|Antimetabolites|antimetabolites|mesh-ancestor
65506336|NCT05091528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506337|NCT05091528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65506338|NCT05091528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65506339|NCT05091528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65506340|NCT05091528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506341|NCT04236258|Enalapril|enalapril|mesh-list
65506342|NCT04236258|Nifedipine|nifedipine|mesh-list
65506343|NCT04236258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65506344|NCT04236258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65506345|NCT04236258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506346|NCT04236258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65506347|NCT04236258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506348|NCT04236258|Vasodilator Agents|vasodilator agents|mesh-ancestor
65506349|NCT04236258|Tocolytic Agents|tocolytic agents|mesh-ancestor
65506350|NCT04236258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65506351|NCT04236258|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65506352|NCT04236258|Protease Inhibitors|protease inhibitors|mesh-ancestor
65506353|NCT04236258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506354|NCT04236258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65506355|NCT01317004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65506356|NCT01317004|Interferon beta-1b|interferon beta-1b|mesh-list
65506357|NCT01317004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65506358|NCT01317004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506359|NCT01317004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65506360|NCT01317004|Immunologic Factors|immunologic factors|mesh-ancestor
65506361|NCT01317004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506362|NCT01317004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65506363|NCT03049618|Pembrolizumab|pembrolizumab|mesh-list
65506364|NCT03049618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65506365|NCT03049618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65506366|NCT05536102|Doxorubicin|doxorubicin|mesh-list
65506367|NCT05536102|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65506368|NCT05536102|Capecitabine|capecitabine|mesh-list
65506369|NCT05536102|Oxaliplatin|oxaliplatin|mesh-list
65506370|NCT05536102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65506371|NCT05536102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65506372|NCT05536102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65506373|NCT05536102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65506374|NCT05536102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506375|NCT05536102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506376|NCT05536102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65506377|NCT05536102|Antimetabolites|antimetabolites|mesh-ancestor
65506378|NCT04493320|Levodopa|levodopa|mesh-list
65506379|NCT04493320|Carbidopa|carbidopa|mesh-list
65506380|NCT04493320|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65506381|NCT04493320|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65506382|NCT04493320|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65506383|NCT04493320|Dopamine Agents|dopamine agents|mesh-ancestor
65506384|NCT04493320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65506385|NCT04493320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506386|NCT04493320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506387|NCT04493320|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65506388|NCT04493320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506389|NCT04493320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65506390|NCT04493320|Immunologic Factors|immunologic factors|mesh-ancestor
65506391|NCT04493320|Dopamine Agonists|dopamine agonists|mesh-ancestor
65506392|NCT04493164|Cytarabine|cytarabine|mesh-list
65506393|NCT04493164|Daunorubicin|daunorubicin|mesh-list
65506394|NCT04493164|Ivosidenib|ivosidenib|mesh-list
65506395|NCT04493164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65506396|NCT04493164|Antimetabolites|antimetabolites|mesh-ancestor
65506397|NCT04493164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506398|NCT04493164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65506399|NCT04493164|Antiviral Agents|antiviral agents|mesh-ancestor
65506400|NCT04493164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506401|NCT04493164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65506402|NCT04493164|Immunologic Factors|immunologic factors|mesh-ancestor
65506403|NCT04493164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506404|NCT04493164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65506405|NCT04493164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65506406|NCT04493164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65506407|NCT04493164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506408|NCT05524714|Xanthohumol|xanthohumol|mesh-list
65506409|NCT05524714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65506410|NCT05524714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65506411|NCT05524714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65506412|NCT05524714|Growth Substances|growth substances|mesh-ancestor
65506413|NCT05524714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506414|NCT05524714|Growth Inhibitors|growth inhibitors|mesh-ancestor
65506415|NCT05692804|Protein S|protein s|mesh-list
65506416|NCT05692804|Anticoagulants|anticoagulants|mesh-ancestor
65506417|NCT01316380|Tiotropium Bromide|tiotropium bromide|mesh-list
65506418|NCT01316380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65506419|NCT01316380|Autonomic Agents|autonomic agents|mesh-ancestor
65506420|NCT01316380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65506421|NCT01316380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506422|NCT01316380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65506423|NCT01316380|Respiratory System Agents|respiratory system agents|mesh-ancestor
65506424|NCT01316380|Parasympatholytics|parasympatholytics|mesh-ancestor
65506425|NCT01316380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65506426|NCT01316380|Cholinergic Agents|cholinergic agents|mesh-ancestor
65506427|NCT01316380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65506428|NCT01316380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506429|NCT05692570|Ritonavir|ritonavir|mesh-list
65506430|NCT05692570|Cobicistat|cobicistat|mesh-list
65506431|NCT05692570|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65506432|NCT05692570|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65506433|NCT05692570|Protease Inhibitors|protease inhibitors|mesh-ancestor
65506434|NCT05692570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506435|NCT05692570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506436|NCT05692570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65506437|NCT05692570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65506438|NCT05692570|Antiviral Agents|antiviral agents|mesh-ancestor
65506439|NCT05692570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506440|NCT05692570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65304150|NCT00647777|Serotonin Agents|serotonin agents|mesh-ancestor
65506441|NCT05692570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65506442|NCT05691556|Botulinum Toxins|botulinum toxins|mesh-list
65506443|NCT05691556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65506444|NCT05691556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65506445|NCT05691556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506446|NCT05691556|Cholinergic Agents|cholinergic agents|mesh-ancestor
65506447|NCT05691556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65506448|NCT05691556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506450|NCT05422612|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
65506451|NCT05422612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65506452|NCT05422612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65506453|NCT05422612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65506454|NCT05422612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506455|NCT05422612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65506456|NCT05422612|Serotonin Agents|serotonin agents|mesh-ancestor
65506457|NCT05422612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506458|NCT05422612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65506459|NCT05422612|Antidepressive Agents|antidepressive agents|mesh-ancestor
65506460|NCT05422612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65506461|NCT05422612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65506462|NCT05422612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65506463|NCT05422612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506464|NCT05422612|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65506465|NCT05422612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65506466|NCT05689450|Amikacin|amikacin|mesh-list
65506467|NCT05689450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65506468|NCT05689450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506469|NCT05417308|Minoxidil|minoxidil|mesh-list
65506470|NCT05417308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65506471|NCT05417308|Vasodilator Agents|vasodilator agents|mesh-ancestor
65506472|NCT05425732|Vaccines|vaccines|mesh-list
65506473|NCT05425732|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65506474|NCT05425732|Immunologic Factors|immunologic factors|mesh-ancestor
65506475|NCT05425732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506476|NCT04650542|Paroxetine|paroxetine|mesh-list
65506477|NCT04650542|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65506478|NCT04650542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65506479|NCT04650542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65506480|NCT04650542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506481|NCT04650542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65506482|NCT04650542|Serotonin Agents|serotonin agents|mesh-ancestor
65506483|NCT04650542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506484|NCT04650542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65506485|NCT04650542|Antidepressive Agents|antidepressive agents|mesh-ancestor
65506486|NCT04650542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65506487|NCT04650542|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65506488|NCT04650542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65506489|NCT04650542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506490|NCT04621058|Vitamin D|vitamin d|mesh-list
65506491|NCT04621058|Vitamins|vitamins|mesh-list
65506492|NCT04621058|Micronutrients|micronutrients|mesh-ancestor
65506493|NCT04621058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506494|NCT04621058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65506495|NCT04308668|Hydroxychloroquine|hydroxychloroquine|mesh-list
65506496|NCT04308668|Antimalarials|antimalarials|mesh-ancestor
65506497|NCT04308668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65506498|NCT04308668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65506499|NCT04308668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506500|NCT04308668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506501|NCT04308668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506502|NCT04308668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65506503|NCT04451330|Doxycycline|doxycycline|mesh-list
65506504|NCT04451330|Trifarotene|trifarotene|mesh-list
65506505|NCT04451330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65506506|NCT04451330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506507|NCT04451330|Antimalarials|antimalarials|mesh-ancestor
65506508|NCT04451330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65506509|NCT04451330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65506510|NCT04451330|Dermatologic Agents|dermatologic agents|mesh-ancestor
65506511|NCT02493426|Oxytocin|oxytocin|mesh-list
65506512|NCT02493426|Oxytocics|oxytocics|mesh-ancestor
65506513|NCT02493426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65506514|NCT02493426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506515|NCT05063994|Hydrocortisone|hydrocortisone|mesh-list
65506516|NCT05063994|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65506517|NCT05063994|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65506518|NCT05063994|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65506519|NCT05063994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65506520|NCT03763734|Dexamethasone|dexamethasone|mesh-list
65506521|NCT03763734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65506522|NCT03763734|Antiemetics|antiemetics|mesh-ancestor
65506523|NCT03763734|Autonomic Agents|autonomic agents|mesh-ancestor
65506524|NCT03763734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65506525|NCT03763734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506526|NCT03763734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65506527|NCT03763734|Glucocorticoids|glucocorticoids|mesh-ancestor
65506528|NCT03763734|Hormones|hormones|mesh-ancestor
65506529|NCT03763734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65506530|NCT03763734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65506531|NCT03763734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65506532|NCT05063136|Capecitabine|capecitabine|mesh-list
65506533|NCT05063136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65506534|NCT05063136|Antimetabolites|antimetabolites|mesh-ancestor
65506535|NCT05063136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506536|NCT05063136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65506537|NCT03756324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65506538|NCT03756324|Cefdinir|cefdinir|mesh-list
65506539|NCT03756324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65506540|NCT03756324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506541|NCT03756324|Antitubercular Agents|antitubercular agents|mesh-ancestor
65506542|NCT03751202|Fluticasone|fluticasone|mesh-list
65506543|NCT03751202|Xhance|xhance|mesh-list
65506544|NCT03751202|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65506545|NCT03751202|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65506546|NCT03751202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65506547|NCT03751202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65506548|NCT03751202|Autonomic Agents|autonomic agents|mesh-ancestor
65506549|NCT03751202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65506550|NCT03751202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506551|NCT03751202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65506552|NCT03751202|Respiratory System Agents|respiratory system agents|mesh-ancestor
65506553|NCT03751202|Dermatologic Agents|dermatologic agents|mesh-ancestor
65506554|NCT03751202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65506555|NCT03751202|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65506556|NCT03751202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65506557|NCT03751202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65506558|NCT03751202|Adrenergic Agents|adrenergic agents|mesh-ancestor
65506559|NCT03751202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65506560|NCT03751202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506561|NCT03751202|Glucocorticoids|glucocorticoids|mesh-ancestor
65506562|NCT03751202|Hormones|hormones|mesh-ancestor
65506563|NCT03751202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65506564|NCT03751202|Sympathomimetics|sympathomimetics|mesh-ancestor
65506565|NCT03749408|Mannitol|mannitol|mesh-list
65506566|NCT03749408|Bupivacaine|bupivacaine|mesh-list
65506567|NCT03749408|Anesthetics, Local|anesthetics, local|mesh-ancestor
65506568|NCT03749408|Anesthetics|anesthetics|mesh-ancestor
65506569|NCT03749408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65506570|NCT03749408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506571|NCT03749408|Sensory System Agents|sensory system agents|mesh-ancestor
65506572|NCT03749408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65506573|NCT03749408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65506574|NCT03749408|Diuretics|diuretics|mesh-ancestor
65506575|NCT03749408|Natriuretic Agents|natriuretic agents|mesh-ancestor
65506576|NCT04387136|Sufentanil|sufentanil|mesh-list
65506577|NCT04387136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65506578|NCT04387136|Narcotics|narcotics|mesh-ancestor
65506579|NCT04387136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65506580|NCT04387136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506581|NCT04387136|Analgesics|analgesics|mesh-ancestor
65506582|NCT04387136|Sensory System Agents|sensory system agents|mesh-ancestor
65506583|NCT04387136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65506584|NCT04387136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65506585|NCT04387136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65506586|NCT04387136|Anesthetics, General|anesthetics, general|mesh-ancestor
65506587|NCT04387136|Anesthetics|anesthetics|mesh-ancestor
65506588|NCT04658784|Cyclopropane|cyclopropane|mesh-list
65506589|NCT04658784|Anesthetics|anesthetics|mesh-ancestor
65506590|NCT04658784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65506591|NCT04658784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506593|NCT04252586|Anticonvulsants|anticonvulsants|mesh-ancestor
65506594|NCT04507776|Etanercept|etanercept|mesh-list
65506595|NCT04507776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65506596|NCT04507776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65506597|NCT04507776|Analgesics|analgesics|mesh-ancestor
65506598|NCT04507776|Sensory System Agents|sensory system agents|mesh-ancestor
65506599|NCT04507776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65506600|NCT04507776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506601|NCT04507776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65506602|NCT04507776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65506603|NCT04507776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65506604|NCT04507776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65506605|NCT04507776|Immunologic Factors|immunologic factors|mesh-ancestor
65506606|NCT04504032|Rivaroxaban|rivaroxaban|mesh-list
65506607|NCT04504032|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65506608|NCT04504032|Antithrombins|antithrombins|mesh-ancestor
65506609|NCT04504032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65506610|NCT04504032|Protease Inhibitors|protease inhibitors|mesh-ancestor
65506611|NCT04504032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506612|NCT04504032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506613|NCT04504032|Anticoagulants|anticoagulants|mesh-ancestor
65506614|NCT03756246|Vaccines|vaccines|mesh-list
65506615|NCT03756246|Immunologic Factors|immunologic factors|mesh-ancestor
65506616|NCT03756246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506617|NCT05460858|Acetylcysteine|acetylcysteine|mesh-list
65506618|NCT05460858|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65506619|NCT05460858|Antiviral Agents|antiviral agents|mesh-ancestor
65506620|NCT05460858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506621|NCT05460858|Expectorants|expectorants|mesh-ancestor
65506622|NCT05460858|Respiratory System Agents|respiratory system agents|mesh-ancestor
65506623|NCT05460858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65506624|NCT05460858|Antioxidants|antioxidants|mesh-ancestor
65506625|NCT05460858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506626|NCT05460858|Protective Agents|protective agents|mesh-ancestor
65506627|NCT05460858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506628|NCT05460858|Antidotes|antidotes|mesh-ancestor
65506629|NCT05359224|Clopidogrel|clopidogrel|mesh-list
65506630|NCT05359224|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65506631|NCT05359224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65506632|NCT05359224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65506633|NCT05359224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65506634|NCT05359224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65506635|NCT05359224|Purinergic Agents|purinergic agents|mesh-ancestor
65506636|NCT05359224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65506637|NCT05359224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506638|NCT05359224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506639|NCT03758118|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
65506640|NCT03758118|Nootropic Agents|nootropic agents|mesh-ancestor
65506641|NCT03756090|Paclitaxel|paclitaxel|mesh-list
65506642|NCT03756090|Cyclophosphamide|cyclophosphamide|mesh-list
65506643|NCT03756090|Epirubicin|epirubicin|mesh-list
65506644|NCT03756090|Palbociclib|palbociclib|mesh-list
65506645|NCT03756090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65506646|NCT03756090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65506647|NCT03756090|Tubulin Modulators|tubulin modulators|mesh-ancestor
65506648|NCT03756090|Antimitotic Agents|antimitotic agents|mesh-ancestor
65506649|NCT03756090|Mitosis Modulators|mitosis modulators|mesh-ancestor
65506650|NCT03756090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506651|NCT03756090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65506652|NCT03756090|Immunologic Factors|immunologic factors|mesh-ancestor
65506653|NCT03756090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506654|NCT03756090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65506655|NCT03756090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65506656|NCT03756090|Alkylating Agents|alkylating agents|mesh-ancestor
65506657|NCT03756090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65506658|NCT03756090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65506659|NCT03756090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65506660|NCT03756090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65506661|NCT03756090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506662|NCT03756090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65506663|NCT04605588|Ribavirin|ribavirin|mesh-list
65506664|NCT04605588|Hydroxychloroquine|hydroxychloroquine|mesh-list
65506665|NCT04605588|Nitazoxanide|nitazoxanide|mesh-list
65506666|NCT04605588|Antimetabolites|antimetabolites|mesh-ancestor
65506667|NCT04605588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506668|NCT04605588|Antiviral Agents|antiviral agents|mesh-ancestor
65506669|NCT04605588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506670|NCT04605588|Antimalarials|antimalarials|mesh-ancestor
65506671|NCT04605588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65506672|NCT04605588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65506673|NCT04605588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506674|NCT04605588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65506675|NCT03752736|Sunscreening Agents|sunscreening agents|mesh-list
65506676|NCT03752736|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65506677|NCT03752736|Protective Agents|protective agents|mesh-ancestor
65506678|NCT03752736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506679|NCT03752736|Dermatologic Agents|dermatologic agents|mesh-ancestor
65506680|NCT03752658|Tenofovir|tenofovir|mesh-list
65506681|NCT03752658|Antiviral Agents|antiviral agents|mesh-ancestor
65506682|NCT03752658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506683|NCT03752658|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65506684|NCT03752658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65506685|NCT03752658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506686|NCT03752658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506687|NCT03752658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65506688|NCT03752658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65506689|NCT04582266|Remdesivir|remdesivir|mesh-list
65506690|NCT04582266|Antimetabolites|antimetabolites|mesh-ancestor
65506691|NCT04582266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506692|NCT04582266|Antiviral Agents|antiviral agents|mesh-ancestor
65506693|NCT04582266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506694|NCT03752424|Anti-Infective Agents|anti-infective agents|mesh-list
65506695|NCT03752424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65506696|NCT03755778|Itraconazole|itraconazole|mesh-list
65506697|NCT03755778|Rifampin|rifampin|mesh-list
65506698|NCT03755778|Quinidine|quinidine|mesh-list
65506699|NCT03755778|Antifungal Agents|antifungal agents|mesh-ancestor
65506700|NCT03755778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506701|NCT03755778|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65506702|NCT03755778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65506703|NCT03755778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506704|NCT03755778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506705|NCT03755778|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65506706|NCT03755778|Hormone Antagonists|hormone antagonists|mesh-ancestor
65506707|NCT03755778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65506708|NCT03755778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506709|NCT03755778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65506710|NCT03755778|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65506711|NCT03755778|Antitubercular Agents|antitubercular agents|mesh-ancestor
65506712|NCT03755778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65506713|NCT03755778|Leprostatic Agents|leprostatic agents|mesh-ancestor
65506714|NCT03755778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65506715|NCT03755778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65506716|NCT03755778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65506717|NCT03755778|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65506718|NCT03755778|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65506719|NCT03755778|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65506720|NCT03755778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65506721|NCT03755778|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65506722|NCT03755778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65506723|NCT03755778|Adrenergic Agents|adrenergic agents|mesh-ancestor
65506724|NCT03755778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65506725|NCT03755778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65506726|NCT03755778|Antimalarials|antimalarials|mesh-ancestor
65506727|NCT03755778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65506728|NCT03755778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65506729|NCT03755778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65506730|NCT03755778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65506731|NCT03755778|Cholinergic Agents|cholinergic agents|mesh-ancestor
65506732|NCT03755778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65506733|NCT03755778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65506734|NCT03755778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65506735|NCT03755778|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65506736|NCT03779074|Amoxicillin|amoxicillin|mesh-list
65506737|NCT03779074|Metronidazole|metronidazole|mesh-list
65506738|NCT03779074|Clarithromycin|clarithromycin|mesh-list
65506739|NCT03779074|Tetracycline|tetracycline|mesh-list
65506740|NCT03779074|Rabeprazole|rabeprazole|mesh-list
65506741|NCT03779074|Bismuth|bismuth|mesh-list
65304440|NCT00650039|Analgesics|analgesics|mesh-ancestor
65506742|NCT03779074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65506743|NCT03779074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506744|NCT03779074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65506745|NCT03779074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65506746|NCT03779074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65506747|NCT03779074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506748|NCT03779074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506749|NCT03779074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65506750|NCT03779074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65506751|NCT03779074|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65506752|NCT03779074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65506753|NCT03779074|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65506755|NCT03755700|Vitamin E|vitamin e|mesh-list
65506756|NCT03755700|Acetylcysteine|acetylcysteine|mesh-list
65506757|NCT03755700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65506758|NCT03755700|Vitamins|vitamins|mesh-ancestor
65506759|NCT03755700|Micronutrients|micronutrients|mesh-ancestor
65506760|NCT03755700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506761|NCT03755700|Antioxidants|antioxidants|mesh-ancestor
65506762|NCT03755700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506763|NCT03755700|Protective Agents|protective agents|mesh-ancestor
65506764|NCT03755700|Antiviral Agents|antiviral agents|mesh-ancestor
65506765|NCT03755700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506766|NCT03755700|Expectorants|expectorants|mesh-ancestor
65506767|NCT03755700|Respiratory System Agents|respiratory system agents|mesh-ancestor
65506768|NCT03755700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65506769|NCT03755700|Antidotes|antidotes|mesh-ancestor
65506770|NCT03757650|Amoxicillin|amoxicillin|mesh-list
65506771|NCT03757650|Clarithromycin|clarithromycin|mesh-list
65506772|NCT03757650|Omeprazole|omeprazole|mesh-list
65506773|NCT03757650|Bismuth|bismuth|mesh-list
65506774|NCT03757650|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
65506775|NCT03757650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65506776|NCT03757650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506777|NCT03757650|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65506778|NCT03757650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65506779|NCT03757650|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65506780|NCT03757650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506781|NCT03757650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506782|NCT03757650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65506783|NCT03757650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65506784|NCT03757650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65506785|NCT03757650|Antacids|antacids|mesh-ancestor
65506786|NCT03757650|Antidiarrheals|antidiarrheals|mesh-ancestor
65506787|NCT04432376|Miconazole|miconazole|mesh-list
65506788|NCT04432376|Antifungal Agents|antifungal agents|mesh-ancestor
65506789|NCT04432376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506790|NCT04432376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65506791|NCT04432376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65506792|NCT04432376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506793|NCT04432376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506794|NCT04432376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65506795|NCT04432376|Hormone Antagonists|hormone antagonists|mesh-ancestor
65506796|NCT04432376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65506797|NCT04432376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506798|NCT04432376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65506799|NCT04432376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65506800|NCT05180968|Dronabinol|dronabinol|mesh-list
65506801|NCT05180968|Nabilone|nabilone|mesh-list
65506802|NCT05180968|Antiemetics|antiemetics|mesh-ancestor
65506803|NCT05180968|Autonomic Agents|autonomic agents|mesh-ancestor
65506804|NCT05180968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65506805|NCT05180968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506806|NCT05180968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65506807|NCT05180968|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65506808|NCT05180968|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65506809|NCT05180968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65506810|NCT05180968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65506811|NCT05180968|Hallucinogens|hallucinogens|mesh-ancestor
65506812|NCT05180968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65506813|NCT05180968|Analgesics|analgesics|mesh-ancestor
65506814|NCT05180968|Sensory System Agents|sensory system agents|mesh-ancestor
65304514|NCT02654561|Heparin|heparin|mesh-list
65506815|NCT05180968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65506816|NCT05180968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65506817|NCT05180968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65506818|NCT05180968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506819|NCT05180968|Hormones|hormones|mesh-ancestor
65506820|NCT05180968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65506821|NCT03693404|Ketorolac|ketorolac|mesh-list
65506822|NCT03693404|Morphine|morphine|mesh-list
65506823|NCT03693404|Bupivacaine|bupivacaine|mesh-list
65506824|NCT03693404|Anesthetics|anesthetics|mesh-list
65506825|NCT03693404|Anesthetics, General|anesthetics, general|mesh-list
65506826|NCT03693404|Anesthetics, Local|anesthetics, local|mesh-ancestor
65506827|NCT03693404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65506828|NCT03693404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506829|NCT03693404|Sensory System Agents|sensory system agents|mesh-ancestor
65506830|NCT03693404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65506831|NCT03693404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65506832|NCT03693404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65506833|NCT03693404|Analgesics|analgesics|mesh-ancestor
65506834|NCT03693404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65506835|NCT03693404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65506836|NCT03693404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65506837|NCT03693404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506838|NCT03693404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506839|NCT03693404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65506840|NCT03693404|Narcotics|narcotics|mesh-ancestor
65506841|NCT04219358|Imiquimod|imiquimod|mesh-list
65506842|NCT04219358|Sunscreening Agents|sunscreening agents|mesh-list
65506843|NCT04219358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65506844|NCT04219358|Immunologic Factors|immunologic factors|mesh-ancestor
65506845|NCT04219358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506846|NCT04219358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65506847|NCT04219358|Interferon Inducers|interferon inducers|mesh-ancestor
65506848|NCT04219358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65506849|NCT04219358|Protective Agents|protective agents|mesh-ancestor
65506850|NCT04219358|Dermatologic Agents|dermatologic agents|mesh-ancestor
65506851|NCT04218110|Ethanol|ethanol|mesh-list
65506852|NCT04218110|Chlorhexidine|chlorhexidine|mesh-list
65506853|NCT04218110|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65506854|NCT04218110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
65506855|NCT04218110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506856|NCT04218110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65506857|NCT04218110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506858|NCT04218110|Disinfectants|disinfectants|mesh-ancestor
65506859|NCT04218110|Dermatologic Agents|dermatologic agents|mesh-ancestor
65506860|NCT05154994|Durvalumab|durvalumab|mesh-list
65506861|NCT05154994|Ipilimumab|ipilimumab|mesh-list
65506862|NCT05154994|Tremelimumab|tremelimumab|mesh-list
65506863|NCT05154994|Belinostat|belinostat|mesh-list
65506864|NCT05154994|Immunoglobulins|immunoglobulins|mesh-list
65506865|NCT05154994|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65506866|NCT05154994|Immunoglobulin G|immunoglobulin g|mesh-list
65506867|NCT05154994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65506868|NCT05154994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65506869|NCT05154994|Immunologic Factors|immunologic factors|mesh-ancestor
65506870|NCT05154994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506871|NCT05154994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65506872|NCT05154994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506873|NCT05154994|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65506874|NCT05154994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506875|NCT03752190|Cosyntropin|cosyntropin|mesh-list
65506876|NCT03752190|Hormones|hormones|mesh-ancestor
65506877|NCT03752190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65506878|NCT03752190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506879|NCT04210310|Oxytocin|oxytocin|mesh-list
65506880|NCT04210310|Oxytocics|oxytocics|mesh-ancestor
65506881|NCT04210310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65506882|NCT04210310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506883|NCT03755466|Tofacitinib|tofacitinib|mesh-list
65506884|NCT03755466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65506885|NCT03755466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506886|NCT03755466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506887|NCT03755310|Suvorexant|suvorexant|mesh-list
65506888|NCT03755310|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65506889|NCT03755310|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65506890|NCT03755310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65304586|NCT04168619|Antimetabolites|antimetabolites|mesh-ancestor
65506891|NCT03755310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506892|NCT03755310|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65506893|NCT03755310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65506894|NCT03755310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506895|NCT05145010|Infigratinib|infigratinib|mesh-list
65506896|NCT05145010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65506897|NCT04381988|Hydroxychloroquine|hydroxychloroquine|mesh-list
65506898|NCT04381988|Antimalarials|antimalarials|mesh-ancestor
65506899|NCT04381988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65506900|NCT04381988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65506901|NCT04381988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506902|NCT04381988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506903|NCT04381988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506904|NCT04381988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65506905|NCT03668392|Asparaginase|asparaginase|mesh-list
65506906|NCT03668392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65506907|NCT04176016|Edetic Acid|edetic acid|mesh-list
65506908|NCT04176016|Pentetic Acid|pentetic acid|mesh-list
65506909|NCT04176016|Antidotes|antidotes|mesh-ancestor
65506910|NCT04176016|Protective Agents|protective agents|mesh-ancestor
65506911|NCT04176016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506912|NCT04176016|Chelating Agents|chelating agents|mesh-ancestor
65506913|NCT04176016|Sequestering Agents|sequestering agents|mesh-ancestor
65506914|NCT04176016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506915|NCT04176016|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65506916|NCT04176016|Anticoagulants|anticoagulants|mesh-ancestor
65506917|NCT04176016|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65506918|NCT03695094|Lamotrigine|lamotrigine|mesh-list
65506919|NCT03695094|Oxcarbazepine|oxcarbazepine|mesh-list
65506920|NCT03695094|Levetiracetam|levetiracetam|mesh-list
65506921|NCT03695094|Brivaracetam|brivaracetam|mesh-list
65506922|NCT03695094|Anticonvulsants|anticonvulsants|mesh-ancestor
65506923|NCT03695094|Nootropic Agents|nootropic agents|mesh-ancestor
65506924|NCT03695094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65506925|NCT03695094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65506926|NCT03695094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506927|NCT03695094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65506928|NCT03695094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506929|NCT03695094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65506930|NCT03695094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65506931|NCT03695094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65506932|NCT03695094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65506933|NCT03695094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65506934|NCT03695094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65506935|NCT03695094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65506936|NCT03695094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65506937|NCT04497948|Acalabrutinib|acalabrutinib|mesh-list
65506938|NCT04497948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65506939|NCT04495374|Pregabalin|pregabalin|mesh-list
65506940|NCT04495374|Analgesics|analgesics|mesh-ancestor
65506941|NCT04495374|Sensory System Agents|sensory system agents|mesh-ancestor
65506942|NCT04495374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65506943|NCT04495374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506944|NCT04495374|Anticonvulsants|anticonvulsants|mesh-ancestor
65506945|NCT04495374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65506946|NCT04495374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65506947|NCT04495374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506948|NCT04495374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65506949|NCT04495374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65506950|NCT04495374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65506951|NCT04495374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65506952|NCT04495374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65506953|NCT03752112|Penicillins|penicillins|mesh-list
65506954|NCT03752112|Cefixime|cefixime|mesh-list
65506955|NCT03752112|Penicillin G Benzathine|penicillin g benzathine|mesh-list
65506956|NCT03752112|Penicillin G|penicillin g|mesh-list
65506957|NCT03752112|Penicillin G Procaine|penicillin g procaine|mesh-list
65506958|NCT03752112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65506959|NCT03752112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65506960|NCT04324606|Acetaminophen|acetaminophen|mesh-list
65506961|NCT04324606|Vaccines|vaccines|mesh-list
65506962|NCT04324606|Immunologic Factors|immunologic factors|mesh-ancestor
65506963|NCT04324606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506964|NCT04324606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65506965|NCT04324606|Analgesics|analgesics|mesh-ancestor
65506966|NCT04324606|Sensory System Agents|sensory system agents|mesh-ancestor
65506967|NCT04324606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65506968|NCT04324606|Antipyretics|antipyretics|mesh-ancestor
65506969|NCT03757338|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65506970|NCT03757338|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65506971|NCT03757338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506972|NCT03757338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65506973|NCT03757338|Immunologic Factors|immunologic factors|mesh-ancestor
65506974|NCT03757338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506975|NCT03757260|Anti-Infective Agents|anti-infective agents|mesh-list
65506976|NCT03757260|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65506977|NCT04168190|Vaccines|vaccines|mesh-list
65506978|NCT04168190|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65506979|NCT04168190|Immunologic Factors|immunologic factors|mesh-ancestor
65506980|NCT04168190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506981|NCT03939520|Pirfenidone|pirfenidone|mesh-list
65506982|NCT03939520|Nintedanib|nintedanib|mesh-list
65506983|NCT03939520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65506984|NCT03939520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65506985|NCT03939520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65506986|NCT03939520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65506987|NCT03939520|Analgesics|analgesics|mesh-ancestor
65506988|NCT03939520|Sensory System Agents|sensory system agents|mesh-ancestor
65506989|NCT03939520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65506990|NCT03939520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65506991|NCT03939520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65506992|NCT03939520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65506993|NCT03939520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65506994|NCT03939520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65506995|NCT03529942|FX006|fx006|mesh-list
65506996|NCT03529942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65506997|NCT03529942|Glucocorticoids|glucocorticoids|mesh-ancestor
65506998|NCT03529942|Hormones|hormones|mesh-ancestor
65506999|NCT03529942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65507000|NCT03529942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507001|NCT03529942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65507002|NCT03529942|Immunologic Factors|immunologic factors|mesh-ancestor
65507003|NCT03501940|Fluorides|fluorides|mesh-list
65507004|NCT03501940|Cariostatic Agents|cariostatic agents|mesh-ancestor
65507005|NCT03501940|Protective Agents|protective agents|mesh-ancestor
65507006|NCT03501940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507007|NCT03754842|Niacinamide|niacinamide|mesh-list
65507008|NCT03754842|Niacin|niacin|mesh-list
65507009|NCT03754842|Nicotinic Acids|nicotinic acids|mesh-list
65507010|NCT03754842|Vitamin B Complex|vitamin b complex|mesh-ancestor
65507011|NCT03754842|Vitamins|vitamins|mesh-ancestor
65507012|NCT03754842|Micronutrients|micronutrients|mesh-ancestor
65507013|NCT03754842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507014|NCT03754842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65507015|NCT03754842|Antimetabolites|antimetabolites|mesh-ancestor
65507016|NCT03754842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507017|NCT03754842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65507018|NCT03754842|Vasodilator Agents|vasodilator agents|mesh-ancestor
65507019|NCT01562210|Olaparib|olaparib|mesh-list
65507020|NCT01562210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507021|NCT01562210|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65507022|NCT01562210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507023|NCT01562210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507024|NCT04189952|Rituximab|rituximab|mesh-list
65507025|NCT04189952|Carboplatin|carboplatin|mesh-list
65507026|NCT04189952|Etoposide|etoposide|mesh-list
65507027|NCT04189952|Ifosfamide|ifosfamide|mesh-list
65507028|NCT04189952|Acalabrutinib|acalabrutinib|mesh-list
65507029|NCT04189952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65507030|NCT04189952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507031|NCT04189952|Immunologic Factors|immunologic factors|mesh-ancestor
65507032|NCT04189952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507033|NCT04189952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65507034|NCT04189952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65507035|NCT04189952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65507036|NCT04189952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65507037|NCT04189952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507038|NCT04189952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507039|NCT04189952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65507040|NCT04189952|Alkylating Agents|alkylating agents|mesh-ancestor
65507041|NCT04716426|Tetracycline|tetracycline|mesh-list
65507042|NCT04716426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65507043|NCT04716426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65507044|NCT04716426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65507045|NCT04716426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507046|NCT04716426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507047|NCT05761756|Caffeine|caffeine|mesh-list
65507048|NCT05761756|Methylphenidate|methylphenidate|mesh-list
65507049|NCT05761756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65507050|NCT05761756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507051|NCT05761756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65507052|NCT05761756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507053|NCT05761756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507054|NCT05761756|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65507055|NCT05761756|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65507056|NCT05761756|Purinergic Agents|purinergic agents|mesh-ancestor
65507057|NCT05761756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65507058|NCT05761756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65507059|NCT05761756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65507060|NCT05761756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65507061|NCT05761756|Dopamine Agents|dopamine agents|mesh-ancestor
65507062|NCT04164758|Pimavanserin|pimavanserin|mesh-list
65507063|NCT04164758|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65507064|NCT04164758|Antidepressive Agents|antidepressive agents|mesh-ancestor
65507065|NCT04164758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65507066|NCT04164758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65507067|NCT04164758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65507068|NCT04164758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65507069|NCT04164758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507070|NCT04164758|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65507071|NCT04164758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65507072|NCT04164758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65507073|NCT04164758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65507074|NCT04164758|Serotonin Agents|serotonin agents|mesh-ancestor
65507075|NCT04164758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65507076|NCT04164758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507077|NCT03754686|Acetaminophen|acetaminophen|mesh-list
65507078|NCT03754686|Oseltamivir|oseltamivir|mesh-list
65507079|NCT03754686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65507080|NCT03754686|Analgesics|analgesics|mesh-ancestor
65507081|NCT03754686|Sensory System Agents|sensory system agents|mesh-ancestor
65507082|NCT03754686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65507083|NCT03754686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507084|NCT03754686|Antipyretics|antipyretics|mesh-ancestor
65507085|NCT03754686|Antiviral Agents|antiviral agents|mesh-ancestor
65507086|NCT03754686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65507087|NCT03754686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507088|NCT03754686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507089|NCT05200884|Lidocaine|lidocaine|mesh-list
65507090|NCT05200884|Carticaine|carticaine|mesh-list
65507091|NCT05200884|Anesthetics, Local|anesthetics, local|mesh-ancestor
65507092|NCT05200884|Anesthetics|anesthetics|mesh-ancestor
65507093|NCT05200884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65507094|NCT05200884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507095|NCT05200884|Sensory System Agents|sensory system agents|mesh-ancestor
65507096|NCT05200884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65507097|NCT05200884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65507098|NCT05200884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65507099|NCT05200884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65507100|NCT05200884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65507101|NCT05200884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507102|NCT03746444|Anesthetics|anesthetics|mesh-list
65507103|NCT03746444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65507104|NCT03746444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507105|NCT03749096|Immunoglobulins|immunoglobulins|mesh-list
65507106|NCT03749096|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65507107|NCT03749096|Antibodies|antibodies|mesh-list
65507108|NCT03749096|gamma-Globulins|gamma-globulins|mesh-list
65507109|NCT03749096|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65507110|NCT03749096|Immunologic Factors|immunologic factors|mesh-ancestor
65507111|NCT03749096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507112|NCT03748940|Mirikizumab|mirikizumab|mesh-list
65507113|NCT03748940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65507114|NCT03748940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65507115|NCT03748940|Analgesics|analgesics|mesh-ancestor
65507116|NCT03748940|Sensory System Agents|sensory system agents|mesh-ancestor
65507117|NCT03748940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65507118|NCT03748940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507119|NCT03748940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65507120|NCT03748940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65507121|NCT03748940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65507122|NCT03748940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65507123|NCT04177862|Fentanyl|fentanyl|mesh-list
65507124|NCT04177862|Sufentanil|sufentanil|mesh-list
65507125|NCT04177862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65507126|NCT04177862|Narcotics|narcotics|mesh-ancestor
65507127|NCT04177862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65507128|NCT04177862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507129|NCT04177862|Analgesics|analgesics|mesh-ancestor
65507130|NCT04177862|Sensory System Agents|sensory system agents|mesh-ancestor
65507131|NCT04177862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65507132|NCT04177862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65507133|NCT04177862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65507134|NCT04177862|Anesthetics, General|anesthetics, general|mesh-ancestor
65507135|NCT04177862|Anesthetics|anesthetics|mesh-ancestor
65507136|NCT03746366|Corticosterone|corticosterone|mesh-list
65507137|NCT03746366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65507138|NCT04157738|Insulin|insulin|mesh-list
65507139|NCT04157738|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65507140|NCT04157738|Insulin, Short-Acting|insulin, short-acting|mesh-list
65507141|NCT04157738|Insulin, Long-Acting|insulin, long-acting|mesh-list
65507142|NCT04157738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65507143|NCT04157738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507144|NCT04156646|Esomeprazole|esomeprazole|mesh-list
65507145|NCT04156646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65507146|NCT04156646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65507147|NCT04156646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65507148|NCT04156646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507149|NCT04156646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507150|NCT04676412|Pembrolizumab|pembrolizumab|mesh-list
65507151|NCT04676412|Lenvatinib|lenvatinib|mesh-list
65507152|NCT04676412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65507153|NCT04676412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507154|NCT04676412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65507155|NCT04676412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507156|NCT04676412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507157|NCT03751488|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65507158|NCT03751488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65507159|NCT03751488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65507160|NCT03751488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65507161|NCT03751488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507162|NCT03751488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65507163|NCT03751488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65507164|NCT03751488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65507165|NCT03751488|Serotonin Agents|serotonin agents|mesh-ancestor
65507166|NCT03751488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65507167|NCT03751488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507168|NCT03751488|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65507169|NCT03751488|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65507170|NCT03751488|Dopamine Agents|dopamine agents|mesh-ancestor
65507171|NCT04150250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65507172|NCT04150250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65507173|NCT04537806|Pregnanolone|pregnanolone|mesh-list
65507174|NCT04537806|Brexanolone|brexanolone|mesh-list
65507175|NCT04537806|Anesthetics|anesthetics|mesh-ancestor
65507176|NCT04537806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65507177|NCT04537806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507178|NCT04537806|Neurosteroids|neurosteroids|mesh-ancestor
65507179|NCT04537806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65507180|NCT04537806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507181|NCT04537806|GABA Modulators|gaba modulators|mesh-ancestor
65507182|NCT04537806|GABA Agents|gaba agents|mesh-ancestor
65507183|NCT03744806|Bevacizumab|bevacizumab|mesh-list
65507184|NCT03744806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65507185|NCT03744806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507186|NCT03744806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65507187|NCT03744806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65507188|NCT03744806|Growth Substances|growth substances|mesh-ancestor
65507189|NCT03744806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507190|NCT03744806|Growth Inhibitors|growth inhibitors|mesh-ancestor
65507191|NCT04531098|Vaccines|vaccines|mesh-list
65507192|NCT04531098|Immunologic Factors|immunologic factors|mesh-ancestor
65507193|NCT04531098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507194|NCT04529850|Avasopasem manganese|avasopasem manganese|mesh-list
65507195|NCT04529850|Antioxidants|antioxidants|mesh-ancestor
65507196|NCT04529850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507197|NCT04529850|Protective Agents|protective agents|mesh-ancestor
65507198|NCT04529850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507199|NCT01561950|Clopidogrel|clopidogrel|mesh-list
65507200|NCT01561950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65507201|NCT01561950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65507202|NCT01561950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65507203|NCT01561950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65507204|NCT01561950|Purinergic Agents|purinergic agents|mesh-ancestor
65507205|NCT01561950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65507206|NCT01561950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507207|NCT01561950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507208|NCT04139018|Timolol|timolol|mesh-list
65507209|NCT04139018|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65507210|NCT04139018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65507211|NCT04139018|Adrenergic Agents|adrenergic agents|mesh-ancestor
65507212|NCT04139018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65507213|NCT04139018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507214|NCT04139018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507215|NCT04139018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65507216|NCT04139018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65507217|NCT05206318|Cysteamine|cysteamine|mesh-list
65507218|NCT05206318|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
65507219|NCT05206318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507220|NCT05027048|Calcium|calcium|mesh-list
65507221|NCT05027048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65507222|NCT05027048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507223|NCT03751332|Tacrolimus|tacrolimus|mesh-list
65507224|NCT03751332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65507225|NCT03751332|Immunologic Factors|immunologic factors|mesh-ancestor
65507226|NCT03751332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507227|NCT03751332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65507228|NCT03751332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507229|NCT03751332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507230|NCT04425252|Brequinar|brequinar|mesh-list
65507231|NCT04425252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507232|NCT04425252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507233|NCT04425252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507234|NCT04425252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65507235|NCT04425252|Immunologic Factors|immunologic factors|mesh-ancestor
65507236|NCT04425252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507237|NCT04003610|Gemcitabine|gemcitabine|mesh-list
65507238|NCT04003610|Carboplatin|carboplatin|mesh-list
65507239|NCT04003610|Pembrolizumab|pembrolizumab|mesh-list
65507240|NCT04003610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507241|NCT04003610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65507242|NCT04003610|Antimetabolites|antimetabolites|mesh-ancestor
65507243|NCT04003610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507244|NCT04003610|Antiviral Agents|antiviral agents|mesh-ancestor
65507245|NCT04003610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65507246|NCT04003610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507247|NCT04003610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65507248|NCT04003610|Immunologic Factors|immunologic factors|mesh-ancestor
65507249|NCT04003610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507250|NCT04003610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65507251|NCT03744104|Vaccines|vaccines|mesh-list
65507252|NCT03744104|Immunologic Factors|immunologic factors|mesh-ancestor
65507253|NCT03744104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507254|NCT03999554|Vaccines|vaccines|mesh-list
65507255|NCT03999554|Immunologic Factors|immunologic factors|mesh-ancestor
65507256|NCT03999554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507257|NCT05280626|Prednisolone|prednisolone|mesh-list
65507258|NCT05280626|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65507259|NCT05280626|Methylprednisolone|methylprednisolone|mesh-list
65507260|NCT05280626|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65507261|NCT05280626|Prednisolone acetate|prednisolone acetate|mesh-list
65507262|NCT05280626|Cyclophosphamide|cyclophosphamide|mesh-list
65507263|NCT05280626|Rituximab|rituximab|mesh-list
65507264|NCT05280626|Doxorubicin|doxorubicin|mesh-list
65507265|NCT05280626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65507266|NCT05280626|Vincristine|vincristine|mesh-list
65507267|NCT05280626|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65507268|NCT05280626|Prednisolone phosphate|prednisolone phosphate|mesh-list
65507269|NCT05280626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65304960|NCT02651753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65507270|NCT05280626|Immunologic Factors|immunologic factors|mesh-ancestor
65507271|NCT05280626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507272|NCT05280626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65507273|NCT05280626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65507274|NCT05280626|Alkylating Agents|alkylating agents|mesh-ancestor
65507275|NCT05280626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507276|NCT05280626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507277|NCT05280626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65507278|NCT05280626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65507279|NCT05280626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65507280|NCT05280626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65507281|NCT05280626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65507282|NCT05280626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507283|NCT05280626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65507284|NCT05280626|Glucocorticoids|glucocorticoids|mesh-ancestor
65507285|NCT05280626|Hormones|hormones|mesh-ancestor
65507286|NCT05280626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65507287|NCT05280626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65507288|NCT05280626|Antiemetics|antiemetics|mesh-ancestor
65507289|NCT05280626|Autonomic Agents|autonomic agents|mesh-ancestor
65507290|NCT05280626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65507291|NCT05280626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65507292|NCT05280626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65507293|NCT05280626|Protective Agents|protective agents|mesh-ancestor
65507294|NCT05280626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65507295|NCT05280626|Tubulin Modulators|tubulin modulators|mesh-ancestor
65507296|NCT05280626|Antimitotic Agents|antimitotic agents|mesh-ancestor
65507297|NCT05280626|Mitosis Modulators|mitosis modulators|mesh-ancestor
65507298|NCT04526574|Vaccines|vaccines|mesh-list
65507299|NCT04526574|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65507300|NCT04526574|Immunologic Factors|immunologic factors|mesh-ancestor
65507301|NCT04526574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507302|NCT03993392|Buprenorphine|buprenorphine|mesh-list
65507303|NCT03993392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65507304|NCT03993392|Narcotics|narcotics|mesh-ancestor
65507305|NCT03993392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65507306|NCT03993392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507307|NCT03993392|Analgesics|analgesics|mesh-ancestor
65507308|NCT03993392|Sensory System Agents|sensory system agents|mesh-ancestor
65507309|NCT03993392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65507310|NCT03993392|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65507311|NCT04145258|Aspirin|aspirin|mesh-list
65507312|NCT04145258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65507313|NCT04145258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65507314|NCT04145258|Analgesics|analgesics|mesh-ancestor
65507315|NCT04145258|Sensory System Agents|sensory system agents|mesh-ancestor
65507316|NCT04145258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65507317|NCT04145258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507318|NCT04145258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65507319|NCT04145258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65507320|NCT04145258|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65507321|NCT04145258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65507322|NCT04145258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507323|NCT04145258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65507324|NCT04145258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65507325|NCT04145258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507326|NCT04145258|Antipyretics|antipyretics|mesh-ancestor
65507327|NCT03751176|Leucovorin|leucovorin|mesh-list
65507328|NCT03751176|Folic Acid|folic acid|mesh-list
65507329|NCT03751176|Fluorouracil|fluorouracil|mesh-list
65507330|NCT03751176|Irinotecan|irinotecan|mesh-list
65507331|NCT03751176|Panitumumab|panitumumab|mesh-list
65507332|NCT03751176|Levoleucovorin|levoleucovorin|mesh-list
65507333|NCT03751176|Antimetabolites|antimetabolites|mesh-ancestor
65507334|NCT03751176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507335|NCT03751176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65507336|NCT03751176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507337|NCT03751176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65507338|NCT03751176|Immunologic Factors|immunologic factors|mesh-ancestor
65507339|NCT03751176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507340|NCT03751176|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65507341|NCT03751176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65507342|NCT03751176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507343|NCT03751176|Antidotes|antidotes|mesh-ancestor
65507344|NCT03751176|Protective Agents|protective agents|mesh-ancestor
65507345|NCT03751176|Vitamin B Complex|vitamin b complex|mesh-ancestor
65507346|NCT03751176|Vitamins|vitamins|mesh-ancestor
65507347|NCT03751176|Micronutrients|micronutrients|mesh-ancestor
65507348|NCT03751176|Hematinics|hematinics|mesh-ancestor
65507349|NCT03751176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65507350|NCT04377308|Fluoxetine|fluoxetine|mesh-list
65507351|NCT04377308|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65507352|NCT04377308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65507353|NCT04377308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65507354|NCT04377308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507355|NCT04377308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65507356|NCT04377308|Serotonin Agents|serotonin agents|mesh-ancestor
65507357|NCT04377308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507358|NCT04377308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65507359|NCT04377308|Antidepressive Agents|antidepressive agents|mesh-ancestor
65507360|NCT04377308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65507361|NCT04377308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65507362|NCT04377308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65507363|NCT04377308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507364|NCT03743870|Bupivacaine|bupivacaine|mesh-list
65507365|NCT03743870|Levobupivacaine|levobupivacaine|mesh-list
65507366|NCT03743870|Anesthetics, Local|anesthetics, local|mesh-ancestor
65507367|NCT03743870|Anesthetics|anesthetics|mesh-ancestor
65507368|NCT03743870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65507369|NCT03743870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507370|NCT03743870|Sensory System Agents|sensory system agents|mesh-ancestor
65507371|NCT03743870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65507372|NCT03988088|Lasmiditan|lasmiditan|mesh-list
65507373|NCT03988088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65507374|NCT03988088|Serotonin Agents|serotonin agents|mesh-ancestor
65507375|NCT03988088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65507376|NCT03988088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507377|NCT03988088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507378|NCT03987620|Ibrexafungerp|ibrexafungerp|mesh-list
65507379|NCT03987620|Antifungal Agents|antifungal agents|mesh-ancestor
65507380|NCT03987620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65507381|NCT03069352|Cytarabine|cytarabine|mesh-list
65507382|NCT03069352|Venetoclax|venetoclax|mesh-list
65507383|NCT03069352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65507384|NCT03069352|Antimetabolites|antimetabolites|mesh-ancestor
65507385|NCT03069352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507386|NCT03069352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507387|NCT03069352|Antiviral Agents|antiviral agents|mesh-ancestor
65507388|NCT03069352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65507389|NCT03069352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65507390|NCT03069352|Immunologic Factors|immunologic factors|mesh-ancestor
65507391|NCT03069352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507392|NCT05204524|Temozolomide|temozolomide|mesh-list
65507393|NCT05204524|Epirubicin|epirubicin|mesh-list
65507394|NCT05204524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65507395|NCT05204524|Alkylating Agents|alkylating agents|mesh-ancestor
65507396|NCT05204524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507397|NCT05204524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507398|NCT05204524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65507399|NCT05204524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65507400|NCT05204524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65507401|NCT05204524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507402|NCT05204056|Epinephrine|epinephrine|mesh-list
65507403|NCT05204056|Morphine|morphine|mesh-list
65507404|NCT05204056|Ropivacaine|ropivacaine|mesh-list
65507405|NCT05204056|Tranexamic Acid|tranexamic acid|mesh-list
65507406|NCT05204056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65507407|NCT05204056|Narcotics|narcotics|mesh-ancestor
65507408|NCT05204056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65507409|NCT05204056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507410|NCT05204056|Analgesics|analgesics|mesh-ancestor
65507411|NCT05204056|Sensory System Agents|sensory system agents|mesh-ancestor
65507412|NCT05204056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65507413|NCT05204056|Anesthetics, Local|anesthetics, local|mesh-ancestor
65507414|NCT05204056|Anesthetics|anesthetics|mesh-ancestor
65507415|NCT05204056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65507416|NCT05204056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65507417|NCT05204056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507418|NCT05204056|Hemostatics|hemostatics|mesh-ancestor
65507419|NCT05204056|Coagulants|coagulants|mesh-ancestor
65507420|NCT05204056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65507421|NCT05204056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65507422|NCT05204056|Adrenergic Agents|adrenergic agents|mesh-ancestor
65507423|NCT05204056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65507424|NCT05204056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65507425|NCT05204056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65507426|NCT05204056|Autonomic Agents|autonomic agents|mesh-ancestor
65507427|NCT05204056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65507428|NCT05204056|Respiratory System Agents|respiratory system agents|mesh-ancestor
65507429|NCT05204056|Mydriatics|mydriatics|mesh-ancestor
65507430|NCT05204056|Sympathomimetics|sympathomimetics|mesh-ancestor
65507431|NCT05204056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65507432|NCT05203744|Tafenoquine|tafenoquine|mesh-list
65507433|NCT05203744|Antimalarials|antimalarials|mesh-ancestor
65507434|NCT05203744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65507435|NCT05203744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65507436|NCT05203744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65507437|NCT03987074|Firsocostat|firsocostat|mesh-list
65507438|NCT03987074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507439|NCT03987074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507440|NCT05761366|PSMA-BCH|psma-bch|mesh-list
65507441|NCT05761366|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65507442|NCT05761366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507443|NCT05302466|Silicon|silicon|mesh-list
65507444|NCT05302466|Trace Elements|trace elements|mesh-ancestor
65507445|NCT05302466|Micronutrients|micronutrients|mesh-ancestor
65507446|NCT05302466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507447|NCT05203588|Vitamin D|vitamin d|mesh-list
65507448|NCT05203588|Denosumab|denosumab|mesh-list
65507449|NCT05203588|Calcium|calcium|mesh-list
65507450|NCT05203588|Vitamins|vitamins|mesh-ancestor
65507451|NCT05203588|Micronutrients|micronutrients|mesh-ancestor
65507452|NCT05203588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507453|NCT05203588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65507454|NCT05203588|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65507455|NCT05203354|Acitretin|acitretin|mesh-list
65507456|NCT05203354|Keratolytic Agents|keratolytic agents|mesh-ancestor
65507457|NCT05203354|Dermatologic Agents|dermatologic agents|mesh-ancestor
65507458|NCT04439214|Nivolumab|nivolumab|mesh-list
65507459|NCT04439214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65507460|NCT04439214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507461|NCT04439214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65507462|NCT04439214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507463|NCT03754062|Haloperidol|haloperidol|mesh-list
65507464|NCT03754062|Haloperidol decanoate|haloperidol decanoate|mesh-list
65507465|NCT03754062|Antiemetics|antiemetics|mesh-ancestor
65507466|NCT03754062|Autonomic Agents|autonomic agents|mesh-ancestor
65507467|NCT03754062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65507468|NCT03754062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507469|NCT03754062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65507470|NCT03754062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65507471|NCT03754062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65507472|NCT03754062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65507473|NCT03754062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65507474|NCT03754062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65507475|NCT03754062|Dopamine Agents|dopamine agents|mesh-ancestor
65507476|NCT03754062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65507477|NCT03754062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507478|NCT03754062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65507479|NCT03696342|Gatifloxacin|gatifloxacin|mesh-list
65507480|NCT03696342|Pazufloxacin|pazufloxacin|mesh-list
65507481|NCT03696342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65507482|NCT03696342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65507483|NCT03696342|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65507484|NCT03696342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65507485|NCT03696342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65507486|NCT03696342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65507487|NCT03696342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507488|NCT03696342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507489|NCT03696342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507490|NCT03696342|Antitubercular Agents|antitubercular agents|mesh-ancestor
65507491|NCT05180032|Denosumab|denosumab|mesh-list
65507492|NCT05180032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65507493|NCT05180032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507494|NCT05761132|Pembrolizumab|pembrolizumab|mesh-list
65507495|NCT05761132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65507496|NCT05761132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507497|NCT04411680|Sargramostim|sargramostim|mesh-list
65507498|NCT04411680|Immunologic Factors|immunologic factors|mesh-ancestor
65507499|NCT04411680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507500|NCT05083780|Hydroxychloroquine|hydroxychloroquine|mesh-list
65507501|NCT05083780|Chlorphenesin|chlorphenesin|mesh-list
65507502|NCT05083780|Antimalarials|antimalarials|mesh-ancestor
65507503|NCT05083780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65507504|NCT05083780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65507505|NCT05083780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65507506|NCT05083780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507507|NCT05083780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507508|NCT05083780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65507509|NCT05083780|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65507510|NCT05083780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507511|NCT05083780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65507512|NCT05083780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65507513|NCT05760976|Cisatracurium|cisatracurium|mesh-list
65507514|NCT05760976|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65507515|NCT05760976|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65507516|NCT05760976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65507517|NCT05760976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507518|NCT05324358|Ketorolac|ketorolac|mesh-list
65507519|NCT05324358|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65507520|NCT05324358|Morphine|morphine|mesh-list
65507521|NCT05324358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65507522|NCT05324358|Narcotics|narcotics|mesh-ancestor
65507523|NCT05324358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65507524|NCT05324358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507525|NCT05324358|Analgesics|analgesics|mesh-ancestor
65507526|NCT05324358|Sensory System Agents|sensory system agents|mesh-ancestor
65507527|NCT05324358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65507528|NCT05324358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65507529|NCT05324358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65507530|NCT05324358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65507531|NCT05324358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65507532|NCT05324358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65507533|NCT05324358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507534|NCT05324358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507535|NCT05384496|Nivolumab|nivolumab|mesh-list
65507536|NCT05384496|Ipilimumab|ipilimumab|mesh-list
65507537|NCT05384496|Axitinib|axitinib|mesh-list
65507538|NCT05384496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65507539|NCT05384496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507540|NCT05384496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65507541|NCT05384496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507542|NCT05384496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65507543|NCT05384496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507544|NCT03747978|Amlodipine|amlodipine|mesh-list
65507545|NCT03747978|Perindopril|perindopril|mesh-list
65507546|NCT03747978|Indapamide|indapamide|mesh-list
65507547|NCT03747978|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
65507548|NCT03747978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65507549|NCT03747978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65507550|NCT03747978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65507551|NCT03747978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507552|NCT03747978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65507553|NCT03747978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507554|NCT03747978|Vasodilator Agents|vasodilator agents|mesh-ancestor
65507555|NCT03747978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65507556|NCT03747978|Protease Inhibitors|protease inhibitors|mesh-ancestor
65507557|NCT03747978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507558|NCT03747978|Diuretics|diuretics|mesh-ancestor
65507559|NCT03747978|Natriuretic Agents|natriuretic agents|mesh-ancestor
65507560|NCT03747978|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65507561|NCT04603846|Paclitaxel|paclitaxel|mesh-list
65507562|NCT04603846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65507563|NCT04603846|Antibodies|antibodies|mesh-list
65507564|NCT04603846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65507565|NCT04603846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507566|NCT04603846|Tubulin Modulators|tubulin modulators|mesh-ancestor
65507567|NCT04603846|Antimitotic Agents|antimitotic agents|mesh-ancestor
65507568|NCT04603846|Mitosis Modulators|mitosis modulators|mesh-ancestor
65507569|NCT04603846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507570|NCT04603846|Immunologic Factors|immunologic factors|mesh-ancestor
65507571|NCT04603846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507572|NCT03747900|Botulinum Toxins|botulinum toxins|mesh-list
65507573|NCT03747900|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65507574|NCT03747900|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65507575|NCT03747900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65507576|NCT03747900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65507577|NCT03747900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507578|NCT03747900|Cholinergic Agents|cholinergic agents|mesh-ancestor
65507579|NCT03747900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65507580|NCT03747900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507581|NCT03747900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65507582|NCT03747900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65507583|NCT04578106|Trastuzumab|trastuzumab|mesh-list
65507585|NCT04578106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65507586|NCT04578106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507587|NCT04472182|Calcium|calcium|mesh-list
65507588|NCT04472182|Fluorides|fluorides|mesh-list
65507589|NCT04472182|Fluorides, Topical|fluorides, topical|mesh-list
65507590|NCT04472182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65507591|NCT04472182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507592|NCT04472182|Cariostatic Agents|cariostatic agents|mesh-ancestor
65507593|NCT04472182|Protective Agents|protective agents|mesh-ancestor
65507594|NCT04423744|Moxifloxacin|moxifloxacin|mesh-list
65507595|NCT04423744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65507596|NCT04423744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65507597|NCT04423744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65507598|NCT04423744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65507599|NCT04423744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507600|NCT04423744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507601|NCT04423744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507602|NCT05759416|Melatonin|melatonin|mesh-list
65507603|NCT05759416|Antioxidants|antioxidants|mesh-ancestor
65507604|NCT05759416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507605|NCT05759416|Protective Agents|protective agents|mesh-ancestor
65507606|NCT05759416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507607|NCT05759416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65507608|NCT04165824|Edaravone|edaravone|mesh-list
65507609|NCT04165824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65507610|NCT04165824|Antioxidants|antioxidants|mesh-ancestor
65507611|NCT04165824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507612|NCT04165824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65507613|NCT04165824|Protective Agents|protective agents|mesh-ancestor
65507614|NCT04165824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507615|NCT03746340|Propofol|propofol|mesh-list
65507616|NCT03746340|Sevoflurane|sevoflurane|mesh-list
65507617|NCT03746340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65507618|NCT03746340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65507619|NCT03746340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507620|NCT03746340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65507621|NCT03746340|Anesthetics, General|anesthetics, general|mesh-ancestor
65507622|NCT03746340|Anesthetics|anesthetics|mesh-ancestor
65507623|NCT03746340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65507624|NCT03746340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65507625|NCT04222816|Lithium Carbonate|lithium carbonate|mesh-list
65507626|NCT04222816|Antidepressive Agents|antidepressive agents|mesh-ancestor
65507627|NCT04222816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65507628|NCT04222816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507629|NCT04222816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507630|NCT04222816|Antimanic Agents|antimanic agents|mesh-ancestor
65507631|NCT04222816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65507632|NCT04222816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65507633|NCT04222816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507634|NCT04161144|Sirolimus|sirolimus|mesh-list
65507635|NCT04161144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65507636|NCT04161144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65507637|NCT04161144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65507638|NCT04161144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507639|NCT04161144|Antifungal Agents|antifungal agents|mesh-ancestor
65507640|NCT04161144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65507641|NCT04161144|Immunologic Factors|immunologic factors|mesh-ancestor
65507642|NCT04161144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507643|NCT03747744|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
65507644|NCT03747744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65507645|NCT03747744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507646|NCT04823364|Neurotransmitter Agents|neurotransmitter agents|mesh-list
65507647|NCT04823364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305334|NCT02643719|Sumatriptan|sumatriptan|mesh-list
65507648|NCT04823364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507649|NCT04764630|Naloxone|naloxone|mesh-list
65507650|NCT04764630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65507651|NCT04764630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507652|NCT04764630|Sensory System Agents|sensory system agents|mesh-ancestor
65507653|NCT04764630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65507654|NCT04153188|Phenylephrine|phenylephrine|mesh-list
65507655|NCT04153188|Oxymetazoline|oxymetazoline|mesh-list
65507656|NCT04153188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65507657|NCT04153188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65507658|NCT04153188|Adrenergic Agents|adrenergic agents|mesh-ancestor
65507659|NCT04153188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65507660|NCT04153188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507661|NCT04153188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507662|NCT04153188|Sympathomimetics|sympathomimetics|mesh-ancestor
65507663|NCT04153188|Autonomic Agents|autonomic agents|mesh-ancestor
65507664|NCT04153188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65507665|NCT04153188|Nasal Decongestants|nasal decongestants|mesh-ancestor
65507666|NCT04153188|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65507667|NCT04153188|Respiratory System Agents|respiratory system agents|mesh-ancestor
65507668|NCT04153188|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65507669|NCT04153188|Mydriatics|mydriatics|mesh-ancestor
65507670|NCT04153188|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65507671|NCT04153188|Protective Agents|protective agents|mesh-ancestor
65507672|NCT03611010|Atorvastatin|atorvastatin|mesh-list
65507673|NCT03611010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65507674|NCT03611010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65507675|NCT03611010|Antimetabolites|antimetabolites|mesh-ancestor
65507676|NCT03611010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507677|NCT03611010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65507678|NCT03611010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65507679|NCT03611010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507680|NCT03749850|Cyclophosphamide|cyclophosphamide|mesh-list
65507681|NCT03749850|Doxorubicin|doxorubicin|mesh-list
65507682|NCT03749850|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65507683|NCT03749850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65507684|NCT03749850|Immunologic Factors|immunologic factors|mesh-ancestor
65507685|NCT03749850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507686|NCT03749850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65507687|NCT03749850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65507688|NCT03749850|Alkylating Agents|alkylating agents|mesh-ancestor
65507689|NCT03749850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507690|NCT03749850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507691|NCT03749850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65507692|NCT03749850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65507693|NCT03749850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65507694|NCT03749850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65507695|NCT03749850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507696|NCT04357782|Ascorbic Acid|ascorbic acid|mesh-list
65507697|NCT04357782|Vitamins|vitamins|mesh-ancestor
65507698|NCT04357782|Micronutrients|micronutrients|mesh-ancestor
65507699|NCT04357782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507700|NCT04357782|Antioxidants|antioxidants|mesh-ancestor
65507701|NCT04357782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507702|NCT04357782|Protective Agents|protective agents|mesh-ancestor
65507703|NCT03980522|Rilonacept|rilonacept|mesh-list
65507704|NCT03980522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65507705|NCT04400682|Favipiravir|favipiravir|mesh-list
65507706|NCT04400682|Antiviral Agents|antiviral agents|mesh-ancestor
65507707|NCT04400682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65507708|NCT03066778|Carboplatin|carboplatin|mesh-list
65507709|NCT03066778|Pembrolizumab|pembrolizumab|mesh-list
65507710|NCT03066778|Etoposide|etoposide|mesh-list
65507711|NCT03066778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507712|NCT03066778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65507713|NCT03066778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65507714|NCT03066778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65507715|NCT03066778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65507716|NCT03066778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507717|NCT03066778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507718|NCT04136548|Fentanyl|fentanyl|mesh-list
65305409|NCT02643017|Dexmedetomidine|dexmedetomidine|mesh-list
65507719|NCT04136548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65507720|NCT04136548|Narcotics|narcotics|mesh-ancestor
65507721|NCT04136548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65507722|NCT04136548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507724|NCT04136548|Sensory System Agents|sensory system agents|mesh-ancestor
65507725|NCT04136548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65507726|NCT04136548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65507727|NCT04136548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65507728|NCT04136548|Anesthetics, General|anesthetics, general|mesh-ancestor
65507729|NCT04136548|Anesthetics|anesthetics|mesh-ancestor
65507730|NCT04347954|Iodine|iodine|mesh-list
65507731|NCT04347954|Cadexomer iodine|cadexomer iodine|mesh-list
65507732|NCT04347954|Povidone-Iodine|povidone-iodine|mesh-list
65507733|NCT04347954|Povidone|povidone|mesh-list
65507734|NCT04347954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65507735|NCT04347954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65507736|NCT04347954|Trace Elements|trace elements|mesh-ancestor
65507737|NCT04347954|Micronutrients|micronutrients|mesh-ancestor
65507738|NCT04347954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507739|NCT04347954|Plasma Substitutes|plasma substitutes|mesh-ancestor
65507740|NCT04347954|Blood Substitutes|blood substitutes|mesh-ancestor
65507741|NCT01565200|Trastuzumab|trastuzumab|mesh-list
65507742|NCT01565200|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65507743|NCT01565200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65507744|NCT01565200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507745|NCT01565200|Tubulin Modulators|tubulin modulators|mesh-ancestor
65507746|NCT01565200|Antimitotic Agents|antimitotic agents|mesh-ancestor
65507747|NCT01565200|Mitosis Modulators|mitosis modulators|mesh-ancestor
65507748|NCT01565200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507749|NCT03065530|Dexmedetomidine|dexmedetomidine|mesh-list
65507750|NCT03065530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65507751|NCT03065530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65507752|NCT03065530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507753|NCT03065530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65507754|NCT03065530|Analgesics|analgesics|mesh-ancestor
65507755|NCT03065530|Sensory System Agents|sensory system agents|mesh-ancestor
65507756|NCT03065530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65507757|NCT03065530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65507758|NCT03065530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65507759|NCT03065530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65507760|NCT03065530|Adrenergic Agents|adrenergic agents|mesh-ancestor
65507761|NCT03065530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65507762|NCT03065530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507763|NCT03979820|Phenelzine|phenelzine|mesh-list
65507764|NCT03979820|Tyramine|tyramine|mesh-list
65507765|NCT03979820|Antidepressive Agents|antidepressive agents|mesh-ancestor
65507766|NCT03979820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65507767|NCT03979820|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65507768|NCT03979820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507769|NCT03979820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507770|NCT03979820|Sympathomimetics|sympathomimetics|mesh-ancestor
65507771|NCT03979820|Autonomic Agents|autonomic agents|mesh-ancestor
65507772|NCT03979820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65507773|NCT03979820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507774|NCT03979820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65507775|NCT03979820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65507776|NCT03979820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65507777|NCT03979820|Adrenergic Agents|adrenergic agents|mesh-ancestor
65507778|NCT03979820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65507779|NCT03647488|Docetaxel|docetaxel|mesh-list
65507780|NCT03647488|Spartalizumab|spartalizumab|mesh-list
65507781|NCT03647488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507782|NCT03647488|Tubulin Modulators|tubulin modulators|mesh-ancestor
65507783|NCT03647488|Antimitotic Agents|antimitotic agents|mesh-ancestor
65507784|NCT03647488|Mitosis Modulators|mitosis modulators|mesh-ancestor
65507785|NCT03647488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507786|NCT03647488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65507787|NCT03693950|Darbepoetin alfa|darbepoetin alfa|mesh-list
65507788|NCT03693950|Hematinics|hematinics|mesh-ancestor
65507789|NCT03579160|Timolol|timolol|mesh-list
65507790|NCT03579160|Petrolatum|petrolatum|mesh-list
65507791|NCT03579160|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65507792|NCT03579160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65507793|NCT03579160|Adrenergic Agents|adrenergic agents|mesh-ancestor
65507794|NCT03579160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65507795|NCT03579160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507796|NCT03579160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507797|NCT03579160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65305484|NCT02641301|Morphine|morphine|mesh-list
65507798|NCT03579160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65507800|NCT03579160|Dermatologic Agents|dermatologic agents|mesh-ancestor
65507801|NCT03531736|Cyclophosphamide|cyclophosphamide|mesh-list
65507802|NCT03531736|Fludarabine|fludarabine|mesh-list
65507803|NCT03531736|Rituximab|rituximab|mesh-list
65507804|NCT03531736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65507805|NCT03531736|Thymoglobulin|thymoglobulin|mesh-list
65507806|NCT03531736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65507807|NCT03531736|Immunologic Factors|immunologic factors|mesh-ancestor
65507808|NCT03531736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060203|NCT00249197|Ofloxacin|ofloxacin|mesh-list
65507809|NCT03531736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65507810|NCT03531736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65507811|NCT03531736|Alkylating Agents|alkylating agents|mesh-ancestor
65507812|NCT03531736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507813|NCT03531736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507814|NCT03531736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65507815|NCT03531736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65507816|NCT04109456|Atezolizumab|atezolizumab|mesh-list
65507817|NCT04109456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507818|NCT04109222|Vaccines|vaccines|mesh-list
65507819|NCT04109222|Immunologic Factors|immunologic factors|mesh-ancestor
65507820|NCT04109222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507821|NCT04128696|Pembrolizumab|pembrolizumab|mesh-list
65507822|NCT04128696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65507823|NCT04128696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507824|NCT03745664|Methylprednisolone|methylprednisolone|mesh-list
65507825|NCT03745664|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65507826|NCT03745664|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65507827|NCT03745664|Prednisolone|prednisolone|mesh-list
65507828|NCT03745664|Prednisolone acetate|prednisolone acetate|mesh-list
65507829|NCT03745664|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65507830|NCT03745664|Prednisolone phosphate|prednisolone phosphate|mesh-list
65507831|NCT03745664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65507832|NCT03745664|Antiemetics|antiemetics|mesh-ancestor
65507833|NCT03745664|Autonomic Agents|autonomic agents|mesh-ancestor
65507834|NCT03745664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65507835|NCT03745664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507836|NCT03745664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65507837|NCT03745664|Glucocorticoids|glucocorticoids|mesh-ancestor
65507838|NCT03745664|Hormones|hormones|mesh-ancestor
65507839|NCT03745664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65507840|NCT03745664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65507841|NCT03745664|Protective Agents|protective agents|mesh-ancestor
65507842|NCT03745664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65507843|NCT03745664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507844|NCT03447262|Ivacaftor|ivacaftor|mesh-list
65507845|NCT03447262|VX-659|vx-659|mesh-list
65507846|NCT03447262|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65507847|NCT03447262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65507848|NCT03447262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507849|NCT04094870|Sertraline|sertraline|mesh-list
65507850|NCT04094870|Antidepressive Agents|antidepressive agents|mesh-ancestor
65507851|NCT04094870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65507852|NCT04094870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65507853|NCT04094870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65507854|NCT04094870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65507855|NCT04094870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507856|NCT04094870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65507857|NCT04094870|Serotonin Agents|serotonin agents|mesh-ancestor
65507858|NCT04094870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507859|NCT04399356|Niclosamide|niclosamide|mesh-list
65507860|NCT04399356|Anticestodal Agents|anticestodal agents|mesh-ancestor
65507861|NCT04399356|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65507862|NCT04399356|Anthelmintics|anthelmintics|mesh-ancestor
65507863|NCT04399356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65507864|NCT04399356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65507865|NCT04399356|Antinematodal Agents|antinematodal agents|mesh-ancestor
65507866|NCT03692676|Tiotropium Bromide|tiotropium bromide|mesh-list
65507867|NCT03692676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65507868|NCT03692676|Autonomic Agents|autonomic agents|mesh-ancestor
65507869|NCT03692676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65507870|NCT03692676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507871|NCT03692676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65507872|NCT03692676|Respiratory System Agents|respiratory system agents|mesh-ancestor
65305569|NCT02640365|Antidotes|antidotes|mesh-ancestor
65507873|NCT03692676|Parasympatholytics|parasympatholytics|mesh-ancestor
65507874|NCT03692676|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65507875|NCT03692676|Cholinergic Agents|cholinergic agents|mesh-ancestor
65507876|NCT03692676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65507877|NCT03692676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507879|NCT04118166|Ipilimumab|ipilimumab|mesh-list
65507880|NCT04118166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65507881|NCT04118166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507882|NCT04118166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65569512|NCT01238705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65507883|NCT04118166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507884|NCT04346628|Favipiravir|favipiravir|mesh-list
65507885|NCT04346628|Antiviral Agents|antiviral agents|mesh-ancestor
65507886|NCT04346628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65507887|NCT03681470|Dapsone|dapsone|mesh-list
65507888|NCT03681470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65507889|NCT03681470|Antimalarials|antimalarials|mesh-ancestor
65507890|NCT03681470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65507891|NCT03681470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65507892|NCT03681470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65507893|NCT03681470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507894|NCT03681470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507895|NCT03681470|Leprostatic Agents|leprostatic agents|mesh-ancestor
65507896|NCT03681470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65507897|NCT02414750|Vemurafenib|vemurafenib|mesh-list
65507898|NCT02414750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507899|NCT02414750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65507900|NCT02414750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507901|NCT02414750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507902|NCT04343976|Interferons|interferons|mesh-list
65507903|NCT04343976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507904|NCT04343976|Antiviral Agents|antiviral agents|mesh-ancestor
65507905|NCT04343976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65507906|NCT03322540|Pembrolizumab|pembrolizumab|mesh-list
65507907|NCT03322540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65507908|NCT03322540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507909|NCT02909452|Pembrolizumab|pembrolizumab|mesh-list
65507910|NCT02909452|Entinostat|entinostat|mesh-list
65507911|NCT02909452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65507912|NCT02909452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507913|NCT02909452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65507914|NCT02909452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507915|NCT02909452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507916|NCT02025556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65507917|NCT02025556|Immunologic Factors|immunologic factors|mesh-ancestor
65507918|NCT02025556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507919|NCT01935466|Pioglitazone|pioglitazone|mesh-list
65507920|NCT01935466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65507921|NCT01935466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507922|NCT04334148|Hydroxychloroquine|hydroxychloroquine|mesh-list
65507923|NCT04334148|Antimalarials|antimalarials|mesh-ancestor
65507924|NCT04334148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65507925|NCT04334148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65507926|NCT04334148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65507927|NCT04334148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507928|NCT04334148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507929|NCT04334148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65507930|NCT04399122|Acetaminophen|acetaminophen|mesh-list
65507931|NCT04399122|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65507932|NCT04399122|Oxycodone|oxycodone|mesh-list
65507933|NCT04399122|Codeine|codeine|mesh-list
65507934|NCT04399122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65507935|NCT04399122|Analgesics|analgesics|mesh-ancestor
65507936|NCT04399122|Sensory System Agents|sensory system agents|mesh-ancestor
65507937|NCT04399122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65507938|NCT04399122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507939|NCT04399122|Antipyretics|antipyretics|mesh-ancestor
65507940|NCT04399122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65507941|NCT04399122|Narcotics|narcotics|mesh-ancestor
65507942|NCT04399122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65507943|NCT04399122|Antitussive Agents|antitussive agents|mesh-ancestor
65507944|NCT04399122|Respiratory System Agents|respiratory system agents|mesh-ancestor
65507945|NCT04399122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65507946|NCT04399122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65507947|NCT04399122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65507948|NCT00826462|Triamcinolone|triamcinolone|mesh-list
65507949|NCT00826462|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65507950|NCT00826462|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65507951|NCT00826462|Naproxen|naproxen|mesh-list
65507952|NCT00826462|Lidocaine|lidocaine|mesh-list
65507953|NCT00826462|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65507954|NCT00826462|Anesthetics, Local|anesthetics, local|mesh-ancestor
65507955|NCT00826462|Anesthetics|anesthetics|mesh-ancestor
65507956|NCT00826462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65507957|NCT00826462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507958|NCT00826462|Sensory System Agents|sensory system agents|mesh-ancestor
65507959|NCT00826462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65507960|NCT00826462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65507961|NCT00826462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65507962|NCT00826462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65507963|NCT00826462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65507964|NCT00826462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507965|NCT00826462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65507966|NCT00826462|Glucocorticoids|glucocorticoids|mesh-ancestor
65507967|NCT00826462|Hormones|hormones|mesh-ancestor
65507968|NCT00826462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65507969|NCT00826462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65507970|NCT00826462|Immunologic Factors|immunologic factors|mesh-ancestor
65507971|NCT00826462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65507972|NCT00826462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65507973|NCT00826462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65507974|NCT00826462|Analgesics|analgesics|mesh-ancestor
65507975|NCT00826462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65507976|NCT00826462|Gout Suppressants|gout suppressants|mesh-ancestor
65507977|NCT00826462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65507978|NCT04398732|Etanercept|etanercept|mesh-list
65507979|NCT04398732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65507980|NCT04398732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65507981|NCT04398732|Analgesics|analgesics|mesh-ancestor
65507982|NCT04398732|Sensory System Agents|sensory system agents|mesh-ancestor
65507983|NCT04398732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65507984|NCT04398732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65507985|NCT04398732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65507986|NCT04398732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65507987|NCT04398732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65507988|NCT04398732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65507989|NCT04398732|Immunologic Factors|immunologic factors|mesh-ancestor
65507990|NCT04322682|Colchicine|colchicine|mesh-list
65507991|NCT04322682|Gout Suppressants|gout suppressants|mesh-ancestor
65507992|NCT04322682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65507993|NCT04322682|Tubulin Modulators|tubulin modulators|mesh-ancestor
65507994|NCT04322682|Antimitotic Agents|antimitotic agents|mesh-ancestor
65507995|NCT04322682|Mitosis Modulators|mitosis modulators|mesh-ancestor
65507996|NCT04322682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65507997|NCT04322682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65507998|NCT04322526|Naltrexone|naltrexone|mesh-list
65507999|NCT04322526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65508000|NCT04322526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65508001|NCT04322526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508002|NCT04322526|Sensory System Agents|sensory system agents|mesh-ancestor
65508003|NCT04322526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508004|NCT05743036|Cetuximab|cetuximab|mesh-list
65508005|NCT05743036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65508006|NCT05743036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65508007|NCT04115358|Hyaluronic Acid|hyaluronic acid|mesh-list
65508008|NCT04115358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65508009|NCT04115358|Immunologic Factors|immunologic factors|mesh-ancestor
65508010|NCT04115358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508011|NCT04115358|Viscosupplements|viscosupplements|mesh-ancestor
65508012|NCT04115358|Protective Agents|protective agents|mesh-ancestor
65508013|NCT05668884|Gemcitabine|gemcitabine|mesh-list
65508014|NCT05668884|Oxaliplatin|oxaliplatin|mesh-list
65508015|NCT05668884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65508016|NCT05668884|Antimetabolites|antimetabolites|mesh-ancestor
65508017|NCT05668884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508018|NCT05668884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65508019|NCT05668884|Antiviral Agents|antiviral agents|mesh-ancestor
65508020|NCT05668884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65508021|NCT05668884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508022|NCT05668884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65508023|NCT05668884|Immunologic Factors|immunologic factors|mesh-ancestor
65508024|NCT05668884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508025|NCT05187208|Niraparib|niraparib|mesh-list
65508026|NCT05187208|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65508027|NCT05187208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508028|NCT05187208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508029|NCT05187208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65508030|NCT05081206|Propofol|propofol|mesh-list
65508031|NCT05081206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65508032|NCT05081206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65508033|NCT05081206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508034|NCT05081206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65508035|NCT05081206|Anesthetics, General|anesthetics, general|mesh-ancestor
65508036|NCT05081206|Anesthetics|anesthetics|mesh-ancestor
65508037|NCT04105998|Oxytocin|oxytocin|mesh-list
65508038|NCT04105998|Oxytocics|oxytocics|mesh-ancestor
65508039|NCT04105998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65508040|NCT04105998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508041|NCT05734690|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65508042|NCT05734690|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65508043|NCT05734690|Adrenergic Agents|adrenergic agents|mesh-ancestor
65508044|NCT05734690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65508045|NCT05734690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508046|NCT05734690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508047|NCT04690192|Gemcitabine|gemcitabine|mesh-list
65508048|NCT04690192|Melphalan|melphalan|mesh-list
65508049|NCT04690192|Busulfan|busulfan|mesh-list
65508050|NCT04690192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65508051|NCT04690192|Antimetabolites|antimetabolites|mesh-ancestor
65508052|NCT04690192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508053|NCT04690192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65508054|NCT04690192|Antiviral Agents|antiviral agents|mesh-ancestor
65508055|NCT04690192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65508056|NCT04690192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508057|NCT04690192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65508058|NCT04690192|Immunologic Factors|immunologic factors|mesh-ancestor
65508059|NCT04690192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508060|NCT04690192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65508061|NCT04690192|Alkylating Agents|alkylating agents|mesh-ancestor
65508062|NCT04690192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65508063|NCT04543968|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
65508064|NCT04543968|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
65508065|NCT04543968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65508066|NCT04543968|Antioxidants|antioxidants|mesh-ancestor
65508067|NCT04543968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508068|NCT04543968|Protective Agents|protective agents|mesh-ancestor
65508069|NCT04543968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508070|NCT04543968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65508071|NCT04543968|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65508072|NCT04543968|Disinfectants|disinfectants|mesh-ancestor
65508073|NCT04368910|Artesunate|artesunate|mesh-list
65508074|NCT04368910|Chloroquine|chloroquine|mesh-list
65508075|NCT04368910|Pyronaridine|pyronaridine|mesh-list
65508076|NCT04368910|Antimalarials|antimalarials|mesh-ancestor
65508077|NCT04368910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65508078|NCT04368910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65508079|NCT04368910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65508080|NCT04368910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65508081|NCT04368910|Antiviral Agents|antiviral agents|mesh-ancestor
65508082|NCT04368910|Schistosomicides|schistosomicides|mesh-ancestor
65508083|NCT04368910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65508084|NCT04368910|Anthelmintics|anthelmintics|mesh-ancestor
65508085|NCT04368910|Amebicides|amebicides|mesh-ancestor
65508086|NCT04368910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65508087|NCT04249258|Dobutamine|dobutamine|mesh-list
65508088|NCT04249258|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65508089|NCT04249258|Sympathomimetics|sympathomimetics|mesh-ancestor
65508090|NCT04249258|Autonomic Agents|autonomic agents|mesh-ancestor
65508091|NCT04249258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508092|NCT04249258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508093|NCT04249258|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65508094|NCT04249258|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65508095|NCT04249258|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65508096|NCT04249258|Adrenergic Agents|adrenergic agents|mesh-ancestor
65508097|NCT04249258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65508098|NCT04249258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508099|NCT04249258|Protective Agents|protective agents|mesh-ancestor
65508100|NCT03938584|Ascorbic Acid|ascorbic acid|mesh-list
65508101|NCT03938584|Vitamins|vitamins|mesh-ancestor
65508103|NCT03938584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508104|NCT03938584|Antioxidants|antioxidants|mesh-ancestor
65508105|NCT03938584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508106|NCT03938584|Protective Agents|protective agents|mesh-ancestor
65508107|NCT03619876|Adalimumab|adalimumab|mesh-list
65508108|NCT03619876|Abatacept|abatacept|mesh-list
65508109|NCT03619876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65508110|NCT03619876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65508111|NCT03619876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65508112|NCT03619876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508113|NCT03619876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65508114|NCT03619876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65508115|NCT03619876|Immunologic Factors|immunologic factors|mesh-ancestor
65508116|NCT03619876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508117|NCT03269344|Gabapentin|gabapentin|mesh-list
65508118|NCT03269344|Analgesics|analgesics|mesh-ancestor
65508119|NCT03269344|Sensory System Agents|sensory system agents|mesh-ancestor
65508120|NCT03269344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508121|NCT03269344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508122|NCT03269344|Anticonvulsants|anticonvulsants|mesh-ancestor
65508123|NCT03269344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65508124|NCT03269344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65508125|NCT03269344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65508126|NCT03269344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65508127|NCT03269344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65508128|NCT03269344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65508129|NCT03269344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65508130|NCT03269344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508131|NCT03269344|Antimanic Agents|antimanic agents|mesh-ancestor
65508132|NCT04389840|Heparin|heparin|mesh-list
65508133|NCT04389840|Anticoagulants|anticoagulants|mesh-ancestor
65508134|NCT04389840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65508135|NCT04389840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65508136|NCT04389840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508137|NCT03747198|Dimethyl sulfone|dimethyl sulfone|mesh-list
65508138|NCT03747198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65508139|NCT02933944|Pembrolizumab|pembrolizumab|mesh-list
65508140|NCT02933944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65508141|NCT02933944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65508142|NCT04307940|Acetaminophen|acetaminophen|mesh-list
65508143|NCT04307940|Naproxen|naproxen|mesh-list
65508144|NCT04307940|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65508145|NCT04307940|Hydrocodone|hydrocodone|mesh-list
65508146|NCT04307940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65508147|NCT04307940|Analgesics|analgesics|mesh-ancestor
65508148|NCT04307940|Sensory System Agents|sensory system agents|mesh-ancestor
65508149|NCT04307940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508150|NCT04307940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508151|NCT04307940|Antipyretics|antipyretics|mesh-ancestor
65508152|NCT04307940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65508153|NCT04307940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65508154|NCT04307940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65508155|NCT04307940|Gout Suppressants|gout suppressants|mesh-ancestor
65508156|NCT04307940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65508157|NCT04307940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508158|NCT04307940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508159|NCT04307940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65508160|NCT04307940|Narcotics|narcotics|mesh-ancestor
65508161|NCT04307940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65508162|NCT04307940|Antitussive Agents|antitussive agents|mesh-ancestor
65508163|NCT04307940|Respiratory System Agents|respiratory system agents|mesh-ancestor
65508164|NCT02717416|Hemostatics|hemostatics|mesh-list
65508165|NCT02717416|Coagulants|coagulants|mesh-ancestor
65508166|NCT02054104|Celecoxib|celecoxib|mesh-list
65508167|NCT02054104|Cyclophosphamide|cyclophosphamide|mesh-list
65508168|NCT02054104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65508169|NCT02054104|Immunologic Factors|immunologic factors|mesh-ancestor
65508170|NCT02054104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508171|NCT02054104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65508172|NCT02054104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65508173|NCT02054104|Alkylating Agents|alkylating agents|mesh-ancestor
65508174|NCT02054104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508175|NCT02054104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65508176|NCT02054104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65508177|NCT02054104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65508178|NCT02054104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65508179|NCT02054104|Analgesics|analgesics|mesh-ancestor
65508180|NCT02054104|Sensory System Agents|sensory system agents|mesh-ancestor
65508181|NCT02054104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508182|NCT02054104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65508183|NCT02054104|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65508184|NCT02054104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65508185|NCT02054104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508186|NCT04331704|Tenofovir|tenofovir|mesh-list
65508187|NCT04331704|Emtricitabine|emtricitabine|mesh-list
65508188|NCT04331704|Antiviral Agents|antiviral agents|mesh-ancestor
65508189|NCT04331704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65508190|NCT04331704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65508191|NCT04331704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65508192|NCT04331704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508193|NCT04331704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508194|NCT04331704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65508195|NCT04331704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65508196|NCT04229290|Dolutegravir|dolutegravir|mesh-list
65508197|NCT04229290|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65508198|NCT04229290|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65508199|NCT04229290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508200|NCT04229290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508201|NCT04229290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65508202|NCT04229290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65508203|NCT04229290|Antiviral Agents|antiviral agents|mesh-ancestor
65508204|NCT04229290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65508205|NCT04181476|Sunscreening Agents|sunscreening agents|mesh-list
65508206|NCT04181476|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65508207|NCT04181476|Protective Agents|protective agents|mesh-ancestor
65508208|NCT04181476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508209|NCT04181476|Dermatologic Agents|dermatologic agents|mesh-ancestor
65508210|NCT03855046|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65508211|NCT03855046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65508212|NCT03855046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508213|NCT03855046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508214|NCT03855046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65508215|NCT03855046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65508216|NCT03855046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508217|NCT03855046|Cholinergic Agents|cholinergic agents|mesh-ancestor
65508218|NCT03855046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65508219|NCT03854110|Gemcitabine|gemcitabine|mesh-list
65508220|NCT03854110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65508221|NCT03854110|Antimetabolites|antimetabolites|mesh-ancestor
65508222|NCT03854110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508223|NCT03854110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65508224|NCT03854110|Antiviral Agents|antiviral agents|mesh-ancestor
65508225|NCT03854110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65508226|NCT03854110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508227|NCT03854110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65508228|NCT03854110|Immunologic Factors|immunologic factors|mesh-ancestor
65508229|NCT03854110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508230|NCT04292730|Remdesivir|remdesivir|mesh-list
65508231|NCT04292730|Antimetabolites|antimetabolites|mesh-ancestor
65508232|NCT04292730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508233|NCT04292730|Antiviral Agents|antiviral agents|mesh-ancestor
65508234|NCT04292730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65508235|NCT04330248|Carbamazepine|carbamazepine|mesh-list
65508236|NCT04330248|Anticonvulsants|anticonvulsants|mesh-ancestor
65508237|NCT04330248|Antimanic Agents|antimanic agents|mesh-ancestor
65508238|NCT04330248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65508239|NCT04330248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65508240|NCT04330248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508241|NCT04330248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65508242|NCT04330248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65508243|NCT04330248|Analgesics|analgesics|mesh-ancestor
65508244|NCT04330248|Sensory System Agents|sensory system agents|mesh-ancestor
65508245|NCT04330248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508246|NCT04330248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65508247|NCT04330248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65508248|NCT04330248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508249|NCT04330248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65508250|NCT04330248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65508251|NCT02861014|Ocrelizumab|ocrelizumab|mesh-list
65508252|NCT02861014|Immunologic Factors|immunologic factors|mesh-ancestor
65508253|NCT02861014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508254|NCT04382586|Zanubrutinib|zanubrutinib|mesh-list
65508255|NCT04382586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65508256|NCT04382586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65508257|NCT04382586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508258|NCT04382586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508259|NCT02737306|Leronlimab|leronlimab|mesh-list
65508260|NCT02737306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65508261|NCT02737306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65508262|NCT02737306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508263|NCT02737306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65508264|NCT02737306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65508265|NCT02737306|Antiviral Agents|antiviral agents|mesh-ancestor
65508266|NCT02737306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65508267|NCT02728648|Oxycodone|oxycodone|mesh-list
65508268|NCT02728648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65508269|NCT02728648|Narcotics|narcotics|mesh-ancestor
65508270|NCT02728648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65508271|NCT02728648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508272|NCT02728648|Analgesics|analgesics|mesh-ancestor
65508273|NCT02728648|Sensory System Agents|sensory system agents|mesh-ancestor
65508274|NCT02728648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508275|NCT04275336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65508276|NCT04275336|Anesthetics, Local|anesthetics, local|mesh-ancestor
65508277|NCT04275336|Anesthetics|anesthetics|mesh-ancestor
65508278|NCT04275336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65508279|NCT04275336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508280|NCT04275336|Sensory System Agents|sensory system agents|mesh-ancestor
65508281|NCT04275336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508282|NCT04275336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65508283|NCT04273776|Zolpidem|zolpidem|mesh-list
65508284|NCT04273776|Suvorexant|suvorexant|mesh-list
65508285|NCT04273776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65508286|NCT04273776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65508287|NCT04273776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65508288|NCT04273776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508289|NCT04273776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65508290|NCT04273776|GABA Agonists|gaba agonists|mesh-ancestor
65508291|NCT04273776|GABA Agents|gaba agents|mesh-ancestor
65508292|NCT04273776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65508293|NCT04273776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508294|NCT04273776|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65508295|NCT01971970|Adalimumab|adalimumab|mesh-list
65508296|NCT01971970|Infliximab|infliximab|mesh-list
65508297|NCT01971970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65508298|NCT01971970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65508299|NCT01971970|Dermatologic Agents|dermatologic agents|mesh-ancestor
65508300|NCT01971970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65508301|NCT01161394|Pioglitazone|pioglitazone|mesh-list
65508302|NCT01161394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65508303|NCT01161394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508304|NCT00921856|Acetylcholine|acetylcholine|mesh-list
65508305|NCT00921856|Vasodilator Agents|vasodilator agents|mesh-ancestor
65508306|NCT00921856|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65508307|NCT00921856|Cholinergic Agents|cholinergic agents|mesh-ancestor
65508308|NCT00921856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65508309|NCT00921856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508310|NCT00921856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508311|NCT03749226|Aztreonam|aztreonam|mesh-list
65508312|NCT03749226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65508313|NCT03749226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65508314|NCT04259346|Ixekizumab|ixekizumab|mesh-list
65508315|NCT04259346|Dermatologic Agents|dermatologic agents|mesh-ancestor
65508316|NCT03745404|Lidocaine|lidocaine|mesh-list
65508317|NCT03745404|Anesthetics, Local|anesthetics, local|mesh-ancestor
65508318|NCT03745404|Anesthetics|anesthetics|mesh-ancestor
65508319|NCT03745404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65508320|NCT03745404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508321|NCT03745404|Sensory System Agents|sensory system agents|mesh-ancestor
65508322|NCT03745404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508323|NCT03745404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65508324|NCT03745404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65508325|NCT03745404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65508326|NCT03745404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65508327|NCT03745404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508328|NCT01348100|Iloperidone|iloperidone|mesh-list
65508329|NCT01348100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65508330|NCT01348100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65508331|NCT01348100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65508332|NCT01348100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508333|NCT01348100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65508334|NCT03673670|Tiotropium Bromide|tiotropium bromide|mesh-list
65508336|NCT03673670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65508337|NCT03673670|Autonomic Agents|autonomic agents|mesh-ancestor
65508338|NCT03673670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508339|NCT03673670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508340|NCT03673670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65508341|NCT03673670|Respiratory System Agents|respiratory system agents|mesh-ancestor
65508342|NCT03673670|Parasympatholytics|parasympatholytics|mesh-ancestor
65508343|NCT03673670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65508344|NCT03673670|Cholinergic Agents|cholinergic agents|mesh-ancestor
65508345|NCT03673670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65508346|NCT03673670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508347|NCT04369742|Hydroxychloroquine|hydroxychloroquine|mesh-list
65508348|NCT04369742|Calcium|calcium|mesh-list
65508349|NCT04369742|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65508350|NCT04369742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508351|NCT04369742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508352|NCT04369742|Antimalarials|antimalarials|mesh-ancestor
65508353|NCT04369742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65508354|NCT04369742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65508355|NCT04369742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65508356|NCT04369742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508357|NCT04369742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65508358|NCT03745586|Glucocorticoids|glucocorticoids|mesh-list
65508359|NCT03745586|Hormones|hormones|mesh-ancestor
65508360|NCT03745586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65508361|NCT03745586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508362|NCT03055936|Levodopa|levodopa|mesh-list
65508363|NCT03055936|Carbidopa|carbidopa|mesh-list
65508364|NCT03055936|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65508365|NCT03055936|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65508366|NCT03055936|Dopamine Agents|dopamine agents|mesh-ancestor
65508367|NCT03055936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65508368|NCT03055936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508369|NCT03055936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508370|NCT03055936|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65508371|NCT03055936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508372|NCT05215366|Arginine Vasopressin|arginine vasopressin|mesh-list
65508373|NCT05215366|Hemostatics|hemostatics|mesh-ancestor
65508374|NCT05215366|Coagulants|coagulants|mesh-ancestor
65508375|NCT05215366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65508376|NCT05215366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65508377|NCT05215366|Natriuretic Agents|natriuretic agents|mesh-ancestor
65508378|NCT05215366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508379|NCT05201170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65508380|NCT03891524|Enoxaparin|enoxaparin|mesh-list
65508381|NCT03891524|Anticoagulants|anticoagulants|mesh-ancestor
65508382|NCT03891524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65508383|NCT03891524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65508384|NCT03891524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508385|NCT04695652|Somatomedin B|somatomedin b|mesh-list
65508386|NCT04695652|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65508387|NCT04695652|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65508388|NCT04695652|Protease Inhibitors|protease inhibitors|mesh-ancestor
65508389|NCT04695652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508390|NCT04695652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508391|NCT04489108|Tranexamic Acid|tranexamic acid|mesh-list
65508392|NCT04489108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65508393|NCT04489108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65508394|NCT04489108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508395|NCT04489108|Hemostatics|hemostatics|mesh-ancestor
65508396|NCT04489108|Coagulants|coagulants|mesh-ancestor
65508397|NCT03771586|Ketamine|ketamine|mesh-list
65508398|NCT03771586|Analgesics|analgesics|mesh-ancestor
65508399|NCT03771586|Sensory System Agents|sensory system agents|mesh-ancestor
65508400|NCT03771586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508401|NCT03771586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508402|NCT03771586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65508403|NCT03771586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65508405|NCT03771586|Anesthetics|anesthetics|mesh-ancestor
65508406|NCT03771586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65508407|NCT03771586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65508408|NCT03771586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65508409|NCT03771586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65508410|NCT03771586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508411|NCT02335060|Acetylcysteine|acetylcysteine|mesh-list
65508412|NCT02335060|Dronabinol|dronabinol|mesh-list
65508413|NCT02335060|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65508414|NCT02335060|Antiviral Agents|antiviral agents|mesh-ancestor
65508415|NCT02335060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65508416|NCT02335060|Expectorants|expectorants|mesh-ancestor
65508417|NCT02335060|Respiratory System Agents|respiratory system agents|mesh-ancestor
65508418|NCT02335060|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65508419|NCT02335060|Antioxidants|antioxidants|mesh-ancestor
65508420|NCT02335060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508421|NCT02335060|Protective Agents|protective agents|mesh-ancestor
65508422|NCT02335060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508423|NCT02335060|Antidotes|antidotes|mesh-ancestor
65508424|NCT02335060|Hallucinogens|hallucinogens|mesh-ancestor
65508425|NCT02335060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65508426|NCT02335060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65508427|NCT02335060|Analgesics|analgesics|mesh-ancestor
65508428|NCT02335060|Sensory System Agents|sensory system agents|mesh-ancestor
65508429|NCT02335060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508430|NCT02335060|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65508431|NCT02335060|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65508432|NCT02335060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65508433|NCT02335060|Hormones|hormones|mesh-ancestor
65508434|NCT02335060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65508435|NCT00284986|Remestemcel-l|remestemcel-l|mesh-list
65508436|NCT00284986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65508437|NCT00284986|Antiviral Agents|antiviral agents|mesh-ancestor
65508438|NCT00284986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65508439|NCT04075604|Nivolumab|nivolumab|mesh-list
65508440|NCT04075604|Palbociclib|palbociclib|mesh-list
65508441|NCT04075604|Anastrozole|anastrozole|mesh-list
65508442|NCT04075604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65508443|NCT04075604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65508444|NCT04075604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65508445|NCT04075604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508446|NCT04075604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65508447|NCT04075604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508448|NCT04075604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65508449|NCT04075604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65508450|NCT04075604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65508451|NCT04075604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65508452|NCT04075604|Hormone Antagonists|hormone antagonists|mesh-ancestor
65508453|NCT04075604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65508454|NCT04075604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508455|NCT01765400|Clopidogrel|clopidogrel|mesh-list
65508456|NCT01765400|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65508457|NCT01765400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65508458|NCT01765400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65508459|NCT01765400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65508460|NCT01765400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65508461|NCT01765400|Purinergic Agents|purinergic agents|mesh-ancestor
65508462|NCT01765400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65508463|NCT01765400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508464|NCT01765400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508465|NCT05217238|Remifentanil|remifentanil|mesh-list
65508466|NCT05217238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65508467|NCT05217238|Narcotics|narcotics|mesh-ancestor
65508468|NCT05217238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65508469|NCT05217238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508470|NCT05217238|Analgesics|analgesics|mesh-ancestor
65508471|NCT05217238|Sensory System Agents|sensory system agents|mesh-ancestor
65508472|NCT05217238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508473|NCT05217160|Morphine|morphine|mesh-list
65508474|NCT05217160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65508475|NCT05217160|Narcotics|narcotics|mesh-ancestor
65508476|NCT05217160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65508477|NCT05217160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508479|NCT05217160|Sensory System Agents|sensory system agents|mesh-ancestor
65508480|NCT05217160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508481|NCT01495676|Gemcitabine|gemcitabine|mesh-list
65508482|NCT01495676|Cisplatin|cisplatin|mesh-list
65508483|NCT01495676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65508484|NCT01495676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65508485|NCT01495676|Antimetabolites|antimetabolites|mesh-ancestor
65508486|NCT01495676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508487|NCT01495676|Antiviral Agents|antiviral agents|mesh-ancestor
65508488|NCT01495676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65508489|NCT01495676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508490|NCT01495676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65508491|NCT01495676|Immunologic Factors|immunologic factors|mesh-ancestor
65508492|NCT01495676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508493|NCT05662228|Lorazepam|lorazepam|mesh-list
65508494|NCT05662228|Immunoglobulins|immunoglobulins|mesh-list
65508495|NCT05662228|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65508496|NCT05662228|Antibodies|antibodies|mesh-list
65508497|NCT05662228|gamma-Globulins|gamma-globulins|mesh-list
65508498|NCT05662228|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65508499|NCT05662228|Tofacitinib|tofacitinib|mesh-list
65508500|NCT05662228|Immunologic Factors|immunologic factors|mesh-ancestor
65508501|NCT05662228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508502|NCT05662228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65508503|NCT05662228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508504|NCT05662228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508505|NCT05662228|Anticonvulsants|anticonvulsants|mesh-ancestor
65508506|NCT05662228|Antiemetics|antiemetics|mesh-ancestor
65508507|NCT05662228|Autonomic Agents|autonomic agents|mesh-ancestor
65508508|NCT05662228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508509|NCT05662228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65508510|NCT05662228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65508511|NCT05662228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65508512|NCT05662228|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65508513|NCT05662228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65508514|NCT05662228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65508515|NCT05662228|GABA Modulators|gaba modulators|mesh-ancestor
65508516|NCT05662228|GABA Agents|gaba agents|mesh-ancestor
65508517|NCT05662228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65508518|NCT05052970|Dexamethasone|dexamethasone|mesh-list
65508519|NCT05052970|Dexamethasone acetate|dexamethasone acetate|mesh-list
65508520|NCT05052970|Bortezomib|bortezomib|mesh-list
65508521|NCT05052970|Mitoxantrone|mitoxantrone|mesh-list
65508522|NCT05052970|BB 1101|bb 1101|mesh-list
65508523|NCT05052970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65508524|NCT05052970|Antiemetics|antiemetics|mesh-ancestor
65508525|NCT05052970|Autonomic Agents|autonomic agents|mesh-ancestor
65508526|NCT05052970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508527|NCT05052970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508528|NCT05052970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65508529|NCT05052970|Glucocorticoids|glucocorticoids|mesh-ancestor
65508530|NCT05052970|Hormones|hormones|mesh-ancestor
65508531|NCT05052970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65508532|NCT05052970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65508533|NCT05052970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65508534|NCT05052970|Protease Inhibitors|protease inhibitors|mesh-ancestor
65508535|NCT05052970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508536|NCT05052970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508537|NCT05052970|Analgesics|analgesics|mesh-ancestor
65508538|NCT05052970|Sensory System Agents|sensory system agents|mesh-ancestor
65508539|NCT05052970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65508540|NCT05052970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65508541|NCT04903210|Niacinamide|niacinamide|mesh-list
65508542|NCT04903210|Niacin|niacin|mesh-list
65508543|NCT04903210|Nicotinic Acids|nicotinic acids|mesh-list
65508544|NCT04903210|Vitamin B Complex|vitamin b complex|mesh-ancestor
65508545|NCT04903210|Vitamins|vitamins|mesh-ancestor
65508546|NCT04903210|Micronutrients|micronutrients|mesh-ancestor
65508547|NCT04903210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508548|NCT04903210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65508549|NCT04903210|Antimetabolites|antimetabolites|mesh-ancestor
65508550|NCT04903210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508551|NCT04903210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65508552|NCT04903210|Vasodilator Agents|vasodilator agents|mesh-ancestor
65508553|NCT04719208|Chlorhexidine|chlorhexidine|mesh-list
65508554|NCT04719208|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65508555|NCT04719208|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65508556|NCT04719208|Povidone-Iodine|povidone-iodine|mesh-list
65508557|NCT04719208|Listerine|listerine|mesh-list
65508558|NCT04719208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65508559|NCT04719208|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65508560|NCT04719208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65508561|NCT04719208|Disinfectants|disinfectants|mesh-ancestor
65508562|NCT04719208|Dermatologic Agents|dermatologic agents|mesh-ancestor
65508563|NCT04701190|Norepinephrine|norepinephrine|mesh-list
65508564|NCT04701190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508565|NCT04701190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65508566|NCT04701190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65508567|NCT04701190|Adrenergic Agents|adrenergic agents|mesh-ancestor
65508568|NCT04701190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65508569|NCT04701190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508570|NCT04701190|Sympathomimetics|sympathomimetics|mesh-ancestor
65508571|NCT04701190|Autonomic Agents|autonomic agents|mesh-ancestor
65508572|NCT04701190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508573|NCT04701190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65508574|NCT04496362|Heparin|heparin|mesh-list
65508575|NCT04496362|Anticoagulants|anticoagulants|mesh-ancestor
65508576|NCT04496362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65508577|NCT04496362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65508578|NCT04496362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508579|NCT04423588|Dexlansoprazole|dexlansoprazole|mesh-list
65508580|NCT04423588|Lansoprazole|lansoprazole|mesh-list
65508581|NCT04423588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65508582|NCT04423588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65508583|NCT04423588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65508584|NCT04423588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508585|NCT04423588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508586|NCT05659576|Sucralfate|sucralfate|mesh-list
65508587|NCT05659576|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65508588|NCT05659576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65508589|NCT04090684|Ciprofloxacin|ciprofloxacin|mesh-list
65508590|NCT04090684|Celecoxib|celecoxib|mesh-list
65508591|NCT04090684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65508592|NCT04090684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65508593|NCT04090684|Analgesics|analgesics|mesh-ancestor
65508594|NCT04090684|Sensory System Agents|sensory system agents|mesh-ancestor
65508595|NCT04090684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508596|NCT04090684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508597|NCT04090684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65508598|NCT04090684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65508599|NCT04090684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65508600|NCT04090684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65508601|NCT04090684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508602|NCT04090684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508603|NCT04090684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65508604|NCT04090684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65508605|NCT04090684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65508606|NCT04090684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65508607|NCT04090684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65508608|NCT04090684|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65508609|NCT04090684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65508610|NCT04963816|Dexamethasone|dexamethasone|mesh-list
65508611|NCT04963816|Dexamethasone acetate|dexamethasone acetate|mesh-list
65508612|NCT04963816|Bupivacaine|bupivacaine|mesh-list
65508613|NCT04963816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65508614|NCT04963816|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65508615|NCT04963816|BB 1101|bb 1101|mesh-list
65508616|NCT04963816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65508617|NCT04963816|Antiemetics|antiemetics|mesh-ancestor
65508618|NCT04963816|Autonomic Agents|autonomic agents|mesh-ancestor
65508619|NCT04963816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508620|NCT04963816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508621|NCT04963816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65508622|NCT04963816|Glucocorticoids|glucocorticoids|mesh-ancestor
65508623|NCT04963816|Hormones|hormones|mesh-ancestor
65508624|NCT04963816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65508625|NCT04963816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65508626|NCT04963816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65508627|NCT04963816|Protease Inhibitors|protease inhibitors|mesh-ancestor
65508628|NCT04963816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508629|NCT04963816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508630|NCT04963816|Anesthetics, Local|anesthetics, local|mesh-ancestor
65508631|NCT04963816|Anesthetics|anesthetics|mesh-ancestor
65508632|NCT04963816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65508633|NCT04963816|Sensory System Agents|sensory system agents|mesh-ancestor
65508634|NCT05641324|Dexamethasone|dexamethasone|mesh-list
65508635|NCT05641324|Lenalidomide|lenalidomide|mesh-list
65508636|NCT05641324|Daratumumab|daratumumab|mesh-list
65508637|NCT05641324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65508638|NCT05641324|Antiemetics|antiemetics|mesh-ancestor
65508639|NCT05641324|Autonomic Agents|autonomic agents|mesh-ancestor
65508640|NCT05641324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508641|NCT05641324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508642|NCT05641324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65508643|NCT05641324|Glucocorticoids|glucocorticoids|mesh-ancestor
65508645|NCT05641324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65508646|NCT05641324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65508647|NCT05641324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65508648|NCT05641324|Immunologic Factors|immunologic factors|mesh-ancestor
65508649|NCT05641324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65508650|NCT05641324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65508651|NCT05641324|Growth Substances|growth substances|mesh-ancestor
65508652|NCT05641324|Growth Inhibitors|growth inhibitors|mesh-ancestor
65508653|NCT04933240|Tamoxifen|tamoxifen|mesh-list
65508654|NCT04933240|Estradiol|estradiol|mesh-list
65508655|NCT04933240|Estrogens|estrogens|mesh-ancestor
65508656|NCT04933240|Hormones|hormones|mesh-ancestor
65508657|NCT04933240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65508658|NCT04933240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508659|NCT04933240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65508660|NCT04933240|Hormone Antagonists|hormone antagonists|mesh-ancestor
65508661|NCT04933240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65508662|NCT04933240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65508663|NCT04933240|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65508664|NCT04933240|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65508665|NCT04933240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65508666|NCT01317940|Calcium, Dietary|calcium, dietary|mesh-list
65508667|NCT01317940|Vitamin D|vitamin d|mesh-list
65508668|NCT01317940|Calcitriol|calcitriol|mesh-list
65508669|NCT01317940|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
65508670|NCT01317940|Calcium Carbonate|calcium carbonate|mesh-list
65508671|NCT01317940|Calcium|calcium|mesh-list
65508672|NCT01317940|Vitamins|vitamins|mesh-ancestor
65508673|NCT01317940|Micronutrients|micronutrients|mesh-ancestor
65508674|NCT01317940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508675|NCT01317940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65508676|NCT01317940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65508677|NCT01317940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508678|NCT01317940|Antacids|antacids|mesh-ancestor
65508679|NCT01317940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65508680|NCT01317940|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65508681|NCT01317940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65508682|NCT01317940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65508683|NCT05707234|Midazolam|midazolam|mesh-list
65508684|NCT05707234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65508685|NCT05707234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65508686|NCT05707234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65508687|NCT05707234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508688|NCT05707234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65508689|NCT05707234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65508690|NCT05707234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65508691|NCT05707234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65508692|NCT05707234|Anesthetics, General|anesthetics, general|mesh-ancestor
65508693|NCT05707234|Anesthetics|anesthetics|mesh-ancestor
65508694|NCT05707234|GABA Modulators|gaba modulators|mesh-ancestor
65508695|NCT05707234|GABA Agents|gaba agents|mesh-ancestor
65508696|NCT05707234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65508697|NCT05707234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508698|NCT05706688|Anesthetics|anesthetics|mesh-list
65508699|NCT05706688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65508700|NCT05706688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508701|NCT05706454|Ramatroban|ramatroban|mesh-list
65508702|NCT05706454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65508703|NCT01317550|Minocycline|minocycline|mesh-list
65508704|NCT01317550|Modafinil|modafinil|mesh-list
65508705|NCT01317550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65508706|NCT01317550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65508707|NCT01317550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65508708|NCT01317550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508709|NCT01317550|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65508710|NCT01317550|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65508711|NCT01317550|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65508712|NCT01317550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508713|NCT01317472|Dexlansoprazole|dexlansoprazole|mesh-list
65508714|NCT01317472|Lansoprazole|lansoprazole|mesh-list
65508715|NCT01317472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65508716|NCT01317472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65508717|NCT01317472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65508718|NCT01317472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061089|NCT02758717|Nivolumab|nivolumab|mesh-list
65508719|NCT01317472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508720|NCT01345630|Ritonavir|ritonavir|mesh-list
65508721|NCT01345630|Darunavir|darunavir|mesh-list
65508722|NCT01345630|Tenofovir|tenofovir|mesh-list
65508723|NCT01345630|Emtricitabine|emtricitabine|mesh-list
65508724|NCT01345630|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65508725|NCT01345630|Maraviroc|maraviroc|mesh-list
65508726|NCT01345630|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65508727|NCT01345630|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65508728|NCT01345630|Protease Inhibitors|protease inhibitors|mesh-ancestor
65508729|NCT01345630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508730|NCT01345630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508731|NCT01345630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65508732|NCT01345630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65508733|NCT01345630|Antiviral Agents|antiviral agents|mesh-ancestor
65508734|NCT01345630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65508735|NCT01345630|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65508736|NCT01345630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65508737|NCT01345630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65508738|NCT01345630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65508739|NCT01345630|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65508740|NCT01345630|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65508741|NCT01345630|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65508742|NCT03693612|Paclitaxel|paclitaxel|mesh-list
65508743|NCT03693612|Docetaxel|docetaxel|mesh-list
65508744|NCT03693612|Cetuximab|cetuximab|mesh-list
65508745|NCT03693612|Tremelimumab|tremelimumab|mesh-list
65508746|NCT03693612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65508747|NCT03693612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65508748|NCT03693612|Tubulin Modulators|tubulin modulators|mesh-ancestor
65508749|NCT03693612|Antimitotic Agents|antimitotic agents|mesh-ancestor
65508750|NCT03693612|Mitosis Modulators|mitosis modulators|mesh-ancestor
65508751|NCT03693612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508752|NCT03693612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65508753|NCT03746652|Dexamethasone|dexamethasone|mesh-list
65508754|NCT03746652|Daratumumab|daratumumab|mesh-list
65508755|NCT03746652|Ixazomib|ixazomib|mesh-list
65508756|NCT03746652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65508757|NCT03746652|Antiemetics|antiemetics|mesh-ancestor
65508758|NCT03746652|Autonomic Agents|autonomic agents|mesh-ancestor
65508759|NCT03746652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508760|NCT03746652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508761|NCT03746652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65508762|NCT03746652|Glucocorticoids|glucocorticoids|mesh-ancestor
65508763|NCT03746652|Hormones|hormones|mesh-ancestor
65508764|NCT03746652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65508765|NCT03746652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65508766|NCT03746652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65508767|NCT03746652|Protease Inhibitors|protease inhibitors|mesh-ancestor
65508768|NCT03746652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508769|NCT03746652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508770|NCT01562808|Aripiprazole|aripiprazole|mesh-list
65508771|NCT01562808|Antidepressive Agents|antidepressive agents|mesh-ancestor
65508772|NCT01562808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65508773|NCT01562808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65508774|NCT01562808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65508775|NCT01562808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65508776|NCT01562808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508777|NCT01562808|Dopamine Agonists|dopamine agonists|mesh-ancestor
65508778|NCT01562808|Dopamine Agents|dopamine agents|mesh-ancestor
65508779|NCT01562808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65508780|NCT01562808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508781|NCT01562808|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65508782|NCT01562808|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65508783|NCT01562808|Serotonin Agents|serotonin agents|mesh-ancestor
65508784|NCT01562808|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65508785|NCT01562808|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65508786|NCT01562808|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65508787|NCT01562808|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65508788|NCT04051944|Rozanolixizumab|rozanolixizumab|mesh-list
65508789|NCT04051944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65508790|NCT04051944|Immunologic Factors|immunologic factors|mesh-ancestor
65508791|NCT04051944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508792|NCT04067492|Diclofenac|diclofenac|mesh-list
65508793|NCT04067492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65508794|NCT04067492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65508795|NCT04067492|Analgesics|analgesics|mesh-ancestor
65508796|NCT04067492|Sensory System Agents|sensory system agents|mesh-ancestor
65508797|NCT04067492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508798|NCT04067492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508799|NCT04067492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65508800|NCT04067492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65508801|NCT04067492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65508802|NCT04067492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508803|NCT04067492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508804|NCT03739112|Vaccines|vaccines|mesh-list
65508805|NCT03739112|Immunologic Factors|immunologic factors|mesh-ancestor
65508806|NCT03739112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508807|NCT04186806|Muramidase|muramidase|mesh-list
65508808|NCT04186806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65508809|NCT03748446|Xenon|xenon|mesh-list
65508810|NCT03748446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65508811|NCT03748446|Anesthetics, General|anesthetics, general|mesh-ancestor
65508812|NCT03748446|Anesthetics|anesthetics|mesh-ancestor
65508813|NCT03748446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65508814|NCT03748446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508815|NCT04036110|Vitamins|vitamins|mesh-list
65508816|NCT04036110|Ascorbic Acid|ascorbic acid|mesh-list
65508817|NCT04036110|Micronutrients|micronutrients|mesh-ancestor
65508818|NCT04036110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508819|NCT04036110|Antioxidants|antioxidants|mesh-ancestor
65508820|NCT04036110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508821|NCT04036110|Protective Agents|protective agents|mesh-ancestor
65508822|NCT03053050|Selonsertib|selonsertib|mesh-list
65508823|NCT03053050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65508824|NCT03053050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508825|NCT03053050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508826|NCT04369950|Lidocaine|lidocaine|mesh-list
65508827|NCT04369950|Epinephrine|epinephrine|mesh-list
65508828|NCT04369950|Morphine|morphine|mesh-list
65508829|NCT04369950|Chloroprocaine|chloroprocaine|mesh-list
65508830|NCT04369950|Anesthetics, Local|anesthetics, local|mesh-ancestor
65508831|NCT04369950|Anesthetics|anesthetics|mesh-ancestor
65508832|NCT04369950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65508833|NCT04369950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508834|NCT04369950|Sensory System Agents|sensory system agents|mesh-ancestor
65508835|NCT04369950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508836|NCT04369950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65508837|NCT04369950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65508838|NCT04369950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65508839|NCT04369950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65508840|NCT04369950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508841|NCT04369950|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65508842|NCT04369950|Narcotics|narcotics|mesh-ancestor
65508843|NCT04369950|Analgesics|analgesics|mesh-ancestor
65508844|NCT04369950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65508845|NCT04369950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65508846|NCT04369950|Adrenergic Agents|adrenergic agents|mesh-ancestor
65508847|NCT04369950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65508848|NCT04369950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65508849|NCT04369950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65508850|NCT04369950|Autonomic Agents|autonomic agents|mesh-ancestor
65508851|NCT04369950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65508852|NCT04369950|Respiratory System Agents|respiratory system agents|mesh-ancestor
65508853|NCT04369950|Mydriatics|mydriatics|mesh-ancestor
65508854|NCT04369950|Sympathomimetics|sympathomimetics|mesh-ancestor
65508855|NCT04369950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65306537|NCT00658931|Analgesics|analgesics|mesh-ancestor
65508856|NCT02955602|Seladelpar|seladelpar|mesh-list
65508858|NCT02955602|Antimetabolites|antimetabolites|mesh-ancestor
65508859|NCT02955602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508860|NCT02955602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65508861|NCT03748290|Pregabalin|pregabalin|mesh-list
65508862|NCT03748290|Analgesics|analgesics|mesh-ancestor
65508863|NCT03748290|Sensory System Agents|sensory system agents|mesh-ancestor
65508864|NCT03748290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508865|NCT03748290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508866|NCT03748290|Anticonvulsants|anticonvulsants|mesh-ancestor
65508867|NCT03748290|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65508868|NCT03748290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65569513|NCT01238705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65508869|NCT03748290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508870|NCT03748290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65508871|NCT03748290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65508872|NCT03748290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65508873|NCT03748290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65508874|NCT03748290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65508875|NCT03052816|Hydromorphone|hydromorphone|mesh-list
65508876|NCT03052816|Analgesics|analgesics|mesh-ancestor
65508877|NCT03052816|Sensory System Agents|sensory system agents|mesh-ancestor
65508878|NCT03052816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508879|NCT03052816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508880|NCT03052816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65508881|NCT03052816|Narcotics|narcotics|mesh-ancestor
65508882|NCT03052816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65508883|NCT05651074|Omeprazole|omeprazole|mesh-list
65508884|NCT05651074|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65508885|NCT05651074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65508886|NCT05651074|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65508887|NCT05651074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508888|NCT05651074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508889|NCT03738956|Tofacitinib|tofacitinib|mesh-list
65508890|NCT03738956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65508891|NCT03738956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508892|NCT03738956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508893|NCT03738800|Trifarotene|trifarotene|mesh-list
65508894|NCT03738800|Dermatologic Agents|dermatologic agents|mesh-ancestor
65508895|NCT05609656|Pembrolizumab|pembrolizumab|mesh-list
65508896|NCT05609656|Calcium|calcium|mesh-list
65508897|NCT05609656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65508898|NCT05609656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65508899|NCT05609656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65508900|NCT05609656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508901|NCT04175808|Moxifloxacin|moxifloxacin|mesh-list
65508902|NCT04175808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65508903|NCT04175808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65508904|NCT04175808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65508905|NCT04175808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65508906|NCT04175808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508907|NCT04175808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508908|NCT04175808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65508909|NCT05598424|Methylprednisolone|methylprednisolone|mesh-list
65508910|NCT05598424|Glucocorticoids|glucocorticoids|mesh-list
65508911|NCT05598424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65508912|NCT05598424|Antiemetics|antiemetics|mesh-ancestor
65508913|NCT05598424|Autonomic Agents|autonomic agents|mesh-ancestor
65508914|NCT05598424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508915|NCT05598424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508916|NCT05598424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65508917|NCT05598424|Hormones|hormones|mesh-ancestor
65508918|NCT05598424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65508919|NCT05598424|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65508920|NCT05598424|Protective Agents|protective agents|mesh-ancestor
65508921|NCT05524168|Gemcitabine|gemcitabine|mesh-list
65508922|NCT05524168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65508923|NCT05524168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65508924|NCT05524168|Antimetabolites|antimetabolites|mesh-ancestor
65508925|NCT05524168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508926|NCT05524168|Antiviral Agents|antiviral agents|mesh-ancestor
65508927|NCT05524168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65508928|NCT05524168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508929|NCT05524168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65508930|NCT05524168|Immunologic Factors|immunologic factors|mesh-ancestor
65508931|NCT05524168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508932|NCT05501860|Carticaine|carticaine|mesh-list
65508933|NCT05501860|Anesthetics, Local|anesthetics, local|mesh-ancestor
65508934|NCT05501860|Anesthetics|anesthetics|mesh-ancestor
65508935|NCT05501860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65508936|NCT05501860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508937|NCT05501860|Sensory System Agents|sensory system agents|mesh-ancestor
65508938|NCT05501860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65508939|NCT03738176|Triamcinolone|triamcinolone|mesh-list
65508940|NCT03738176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65508941|NCT03738176|Glucocorticoids|glucocorticoids|mesh-ancestor
65508942|NCT03738176|Hormones|hormones|mesh-ancestor
65061315|NCT00252824|Budesonide|budesonide|mesh-list
65508943|NCT03738176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65508944|NCT03738176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508945|NCT03051100|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
65508946|NCT03051100|Atorvastatin|atorvastatin|mesh-list
65508947|NCT03051100|Ezetimibe|ezetimibe|mesh-list
65508948|NCT03051100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65508949|NCT03051100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65508950|NCT03051100|Antimetabolites|antimetabolites|mesh-ancestor
65508951|NCT03051100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508952|NCT03051100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65508953|NCT03051100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65508954|NCT03051100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508955|NCT03051100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65508956|NCT03051100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508957|NCT05280028|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65508958|NCT05280028|Tibolone|tibolone|mesh-list
65508959|NCT05280028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65508960|NCT05280028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65508961|NCT05280028|Medroxyprogesterone|medroxyprogesterone|mesh-list
65508962|NCT05280028|Estradiol|estradiol|mesh-list
65508963|NCT05280028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65508964|NCT05280028|Estrogens|estrogens|mesh-ancestor
65508965|NCT05280028|Hormones|hormones|mesh-ancestor
65508966|NCT05280028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65508967|NCT05280028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508968|NCT05280028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65508969|NCT05280028|Contraceptive Agents|contraceptive agents|mesh-ancestor
65508970|NCT05280028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65508971|NCT05280028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65508972|NCT05280028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65508973|NCT05280028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65508974|NCT05280028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65508975|NCT05280028|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65508976|NCT05280028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65508977|NCT05280028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65508978|NCT05280028|Androgen Antagonists|androgen antagonists|mesh-ancestor
65508979|NCT05280028|Hormone Antagonists|hormone antagonists|mesh-ancestor
65508980|NCT05280028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65508981|NCT05280028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65508982|NCT05280028|Anabolic Agents|anabolic agents|mesh-ancestor
65508983|NCT05569876|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65508984|NCT05569876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508985|NCT05564650|Azacitidine|azacitidine|mesh-list
65508986|NCT05564650|Decitabine|decitabine|mesh-list
65508987|NCT05564650|Venetoclax|venetoclax|mesh-list
65508988|NCT05564650|Navitoclax|navitoclax|mesh-list
65508989|NCT05564650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65508990|NCT05564650|Antimetabolites|antimetabolites|mesh-ancestor
65508991|NCT05564650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65508992|NCT05564650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65508993|NCT05564650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65508994|NCT01343368|Leuprolide|leuprolide|mesh-list
65508995|NCT01343368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65508996|NCT01343368|Fertility Agents|fertility agents|mesh-ancestor
65508997|NCT01343368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65508998|NCT01343368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65508999|NCT01343368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65509000|NCT01343368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509001|NCT02955212|Upadacitinib|upadacitinib|mesh-list
65509002|NCT02955212|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65509003|NCT02955212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65509004|NCT02955212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509005|NCT02955212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509007|NCT03050398|Letrozole|letrozole|mesh-list
65509008|NCT03050398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509009|NCT03050398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65509010|NCT03050398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65509011|NCT03050398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509012|NCT03050398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509013|NCT03050398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65509014|NCT03050398|Hormone Antagonists|hormone antagonists|mesh-ancestor
65509015|NCT03050398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65509016|NCT03050398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509017|NCT03626506|Amlodipine|amlodipine|mesh-list
65509018|NCT03626506|Indapamide|indapamide|mesh-list
65509019|NCT03626506|Spironolactone|spironolactone|mesh-list
65509020|NCT03626506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65509021|NCT03626506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65509022|NCT03626506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65509023|NCT03626506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509024|NCT03626506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65509025|NCT03626506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509026|NCT03626506|Vasodilator Agents|vasodilator agents|mesh-ancestor
65509027|NCT03626506|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65509028|NCT03626506|Hormone Antagonists|hormone antagonists|mesh-ancestor
65509029|NCT03626506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65509030|NCT03626506|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65509031|NCT03626506|Diuretics|diuretics|mesh-ancestor
65509032|NCT03626506|Natriuretic Agents|natriuretic agents|mesh-ancestor
65509033|NCT03626506|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65509034|NCT03737708|Adalimumab|adalimumab|mesh-list
65509035|NCT03737708|Methotrexate|methotrexate|mesh-list
65509036|NCT03737708|Abatacept|abatacept|mesh-list
65509037|NCT03737708|Tacrolimus|tacrolimus|mesh-list
65509038|NCT03737708|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65509039|NCT03737708|Abortifacient Agents|abortifacient agents|mesh-ancestor
65509040|NCT03737708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65509041|NCT03737708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509042|NCT03737708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65509043|NCT03737708|Antimetabolites|antimetabolites|mesh-ancestor
65509044|NCT03737708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509045|NCT03737708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509046|NCT03737708|Dermatologic Agents|dermatologic agents|mesh-ancestor
65509047|NCT03737708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509048|NCT03737708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65509049|NCT03737708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65509050|NCT03737708|Immunologic Factors|immunologic factors|mesh-ancestor
65509051|NCT03737708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65509052|NCT03737708|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65509053|NCT03737708|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65509054|NCT03737708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65509055|NCT03737708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65509056|NCT05517928|Omeprazole|omeprazole|mesh-list
65509057|NCT05517928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65509058|NCT05517928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65509059|NCT05517928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65509060|NCT05517928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509061|NCT05517928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509062|NCT04052204|Avelumab|avelumab|mesh-list
65509063|NCT04052204|Talazoparib|talazoparib|mesh-list
65509064|NCT04052204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65509065|NCT04052204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509066|NCT04052204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65509067|NCT04052204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509068|NCT04052204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509069|NCT04050722|Listerine|listerine|mesh-list
65509070|NCT04050722|Sodium Fluoride|sodium fluoride|mesh-list
65509071|NCT04050722|Cariostatic Agents|cariostatic agents|mesh-ancestor
65509072|NCT04050722|Protective Agents|protective agents|mesh-ancestor
65509073|NCT04050722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509074|NCT04050722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65509075|NCT04050722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65509076|NCT04049552|Sirolimus|sirolimus|mesh-list
65509077|NCT04049552|Petrolatum|petrolatum|mesh-list
65509078|NCT04049552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65509079|NCT04049552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65509080|NCT04049552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65509081|NCT04049552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509082|NCT04049552|Antifungal Agents|antifungal agents|mesh-ancestor
65509083|NCT04049552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65509084|NCT04049552|Immunologic Factors|immunologic factors|mesh-ancestor
65509085|NCT04049552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509086|NCT04049552|Emollients|emollients|mesh-ancestor
65509087|NCT04049552|Dermatologic Agents|dermatologic agents|mesh-ancestor
65509088|NCT03737474|Brexpiprazole|brexpiprazole|mesh-list
65509089|NCT03737474|Serotonin Agents|serotonin agents|mesh-ancestor
65509090|NCT03737474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65509091|NCT03737474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509092|NCT03737474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509093|NCT03737474|Dopamine Agonists|dopamine agonists|mesh-ancestor
65509094|NCT03737474|Dopamine Agents|dopamine agents|mesh-ancestor
65509095|NCT03048058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65509096|NCT03048058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65509097|NCT03048058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65509098|NCT03048058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65509099|NCT03048058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65509100|NCT03048058|Adrenergic Agents|adrenergic agents|mesh-ancestor
65509101|NCT03048058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65509102|NCT03048058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509103|NCT03048058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509104|NCT03047980|Sirolimus|sirolimus|mesh-list
65509105|NCT03047980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65509106|NCT03047980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65509107|NCT03047980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65509108|NCT03047980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509109|NCT03047980|Antifungal Agents|antifungal agents|mesh-ancestor
65509110|NCT03047980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65509111|NCT03047980|Immunologic Factors|immunologic factors|mesh-ancestor
65509112|NCT03047980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509113|NCT04032418|Pembrolizumab|pembrolizumab|mesh-list
65509114|NCT04032418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65509115|NCT04032418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509116|NCT04022980|Nivolumab|nivolumab|mesh-list
65509117|NCT04022980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65509118|NCT04022980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509119|NCT04022980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65509120|NCT04022980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509121|NCT03631706|Pembrolizumab|pembrolizumab|mesh-list
65509122|NCT03631706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65509123|NCT03631706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509124|NCT03732482|Temozolomide|temozolomide|mesh-list
65509125|NCT03732482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65509126|NCT03732482|Alkylating Agents|alkylating agents|mesh-ancestor
65509127|NCT03732482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509128|NCT03732482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509129|NCT04047446|Dexamethasone|dexamethasone|mesh-list
65509130|NCT04047446|Bupivacaine|bupivacaine|mesh-list
65509131|NCT04047446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65509132|NCT04047446|Antiemetics|antiemetics|mesh-ancestor
65509133|NCT04047446|Autonomic Agents|autonomic agents|mesh-ancestor
65509134|NCT04047446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65509135|NCT04047446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509136|NCT04047446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65509137|NCT04047446|Glucocorticoids|glucocorticoids|mesh-ancestor
65509138|NCT04047446|Hormones|hormones|mesh-ancestor
65509139|NCT04047446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65509140|NCT04047446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65509141|NCT04047446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509142|NCT04047446|Anesthetics, Local|anesthetics, local|mesh-ancestor
65509143|NCT04047446|Anesthetics|anesthetics|mesh-ancestor
65509144|NCT04047446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65509145|NCT04047446|Sensory System Agents|sensory system agents|mesh-ancestor
65509146|NCT03271372|Avelumab|avelumab|mesh-list
65509147|NCT03271372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65509148|NCT03271372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65509149|NCT03271372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509150|NCT03271372|Immunologic Factors|immunologic factors|mesh-ancestor
65509151|NCT03271372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509152|NCT02782546|Mycophenolic Acid|mycophenolic acid|mesh-list
65509153|NCT02782546|Tacrolimus|tacrolimus|mesh-list
65509154|NCT02782546|Lenograstim|lenograstim|mesh-list
65509155|NCT02782546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65509156|NCT02782546|Immunologic Factors|immunologic factors|mesh-ancestor
65509157|NCT02782546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509158|NCT02782546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65509159|NCT02782546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509160|NCT02782546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509161|NCT02782546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65509162|NCT02782546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509163|NCT02782546|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65509164|NCT02782546|Antitubercular Agents|antitubercular agents|mesh-ancestor
65569514|NCT01238705|Adrenergic Agents|adrenergic agents|mesh-ancestor
65509165|NCT02782546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65509166|NCT02782546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65509167|NCT02782546|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65509169|NCT03629054|Empagliflozin|empagliflozin|mesh-list
65509170|NCT03629054|Linagliptin|linagliptin|mesh-list
65509171|NCT03629054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65509172|NCT03629054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509173|NCT03629054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65509174|NCT03629054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509175|NCT03629054|Incretins|incretins|mesh-ancestor
65509176|NCT03629054|Hormones|hormones|mesh-ancestor
65509177|NCT03629054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65509178|NCT03629054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65509179|NCT03629054|Protease Inhibitors|protease inhibitors|mesh-ancestor
65509180|NCT03629054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509181|NCT02754856|Durvalumab|durvalumab|mesh-list
65509182|NCT02754856|Ipilimumab|ipilimumab|mesh-list
65509183|NCT02754856|Tremelimumab|tremelimumab|mesh-list
65509184|NCT02754856|Immunoglobulins|immunoglobulins|mesh-list
65509185|NCT02754856|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65509186|NCT02754856|Immunoglobulin G|immunoglobulin g|mesh-list
65509187|NCT02754856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65509188|NCT02754856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509189|NCT02754856|Immunologic Factors|immunologic factors|mesh-ancestor
65509190|NCT02754856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509191|NCT02754856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65509192|NCT02754856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509193|NCT02573896|Lenalidomide|lenalidomide|mesh-list
65509194|NCT02573896|Dinutuximab|dinutuximab|mesh-list
65509195|NCT02573896|Immunologic Factors|immunologic factors|mesh-ancestor
65509196|NCT02573896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509197|NCT02573896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65509198|NCT02573896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65509199|NCT02573896|Growth Substances|growth substances|mesh-ancestor
65509200|NCT02573896|Growth Inhibitors|growth inhibitors|mesh-ancestor
65509201|NCT02573896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509202|NCT03045328|Venetoclax|venetoclax|mesh-list
65509203|NCT03045328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509204|NCT02408770|Ulipristal acetate|ulipristal acetate|mesh-list
65509205|NCT02408770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65509206|NCT02408770|Contraceptive Agents|contraceptive agents|mesh-ancestor
65509207|NCT02408770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65509208|NCT02408770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509209|NCT02408770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65509210|NCT02154490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65509211|NCT02154490|Nivolumab|nivolumab|mesh-list
65509212|NCT02154490|Ipilimumab|ipilimumab|mesh-list
65509213|NCT02154490|Durvalumab|durvalumab|mesh-list
65509214|NCT02154490|Rilotumumab|rilotumumab|mesh-list
65509215|NCT02154490|Docetaxel|docetaxel|mesh-list
65509216|NCT02154490|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65509217|NCT02154490|Palbociclib|palbociclib|mesh-list
65509218|NCT02154490|Tremelimumab|tremelimumab|mesh-list
65509219|NCT02154490|Talazoparib|talazoparib|mesh-list
65509220|NCT02154490|Antibodies|antibodies|mesh-list
65509221|NCT02154490|Immunoglobulins|immunoglobulins|mesh-list
65509222|NCT02154490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65509223|NCT02154490|Immunoglobulin G|immunoglobulin g|mesh-list
65509224|NCT02154490|Immunologic Factors|immunologic factors|mesh-ancestor
65509225|NCT02154490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509226|NCT02154490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509227|NCT02154490|Tubulin Modulators|tubulin modulators|mesh-ancestor
65509228|NCT02154490|Antimitotic Agents|antimitotic agents|mesh-ancestor
65509229|NCT02154490|Mitosis Modulators|mitosis modulators|mesh-ancestor
65509230|NCT02154490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509231|NCT02154490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65509232|NCT02154490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65509233|NCT02154490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509234|NCT02154490|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65509235|NCT01512316|Cycloserine|cycloserine|mesh-list
65509236|NCT01512316|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65509237|NCT01512316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65509238|NCT01512316|Renal Agents|renal agents|mesh-ancestor
65509239|NCT01512316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65509240|NCT01512316|Antitubercular Agents|antitubercular agents|mesh-ancestor
65509241|NCT01512316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65509242|NCT01512316|Antimetabolites|antimetabolites|mesh-ancestor
65509243|NCT01512316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509244|NCT01286272|Deoxyglucose|deoxyglucose|mesh-list
65509245|NCT01286272|Bortezomib|bortezomib|mesh-list
65509246|NCT01286272|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65509247|NCT01286272|Ofatumumab|ofatumumab|mesh-list
65509248|NCT01286272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65509249|NCT01286272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65509250|NCT01286272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509251|NCT01286272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65509252|NCT01286272|Alkylating Agents|alkylating agents|mesh-ancestor
65509253|NCT01286272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509254|NCT01286272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65509255|NCT01286272|Antimetabolites|antimetabolites|mesh-ancestor
65509256|NCT01286272|Antiviral Agents|antiviral agents|mesh-ancestor
65509257|NCT01286272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65509258|NCT01286272|Immunologic Factors|immunologic factors|mesh-ancestor
65509259|NCT01286272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509260|NCT03639740|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65509261|NCT03639740|Immunologic Factors|immunologic factors|mesh-ancestor
65509262|NCT03639740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509263|NCT01048138|Biperiden|biperiden|mesh-list
65509264|NCT01048138|Biperiden lactate|biperiden lactate|mesh-list
65509265|NCT01048138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65509266|NCT01048138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65509267|NCT01048138|Parasympatholytics|parasympatholytics|mesh-ancestor
65509268|NCT01048138|Autonomic Agents|autonomic agents|mesh-ancestor
65509269|NCT01048138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65509270|NCT01048138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509271|NCT01048138|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65509272|NCT01048138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65509273|NCT01048138|Cholinergic Agents|cholinergic agents|mesh-ancestor
65509274|NCT01048138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65509275|NCT01048138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509276|NCT00972478|Prednisone|prednisone|mesh-list
65509277|NCT00972478|Cortisone|cortisone|mesh-list
65509278|NCT00972478|Cyclophosphamide|cyclophosphamide|mesh-list
65509279|NCT00972478|Rituximab|rituximab|mesh-list
65509280|NCT00972478|Doxorubicin|doxorubicin|mesh-list
65509281|NCT00972478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65509282|NCT00972478|Vincristine|vincristine|mesh-list
65509283|NCT00972478|Vorinostat|vorinostat|mesh-list
65509284|NCT00972478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65509285|NCT00972478|Antibodies|antibodies|mesh-list
65509286|NCT00972478|Immunoglobulins|immunoglobulins|mesh-list
65509287|NCT00972478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65509288|NCT00972478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65509289|NCT00972478|Immunologic Factors|immunologic factors|mesh-ancestor
65509290|NCT00972478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509291|NCT00972478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65509292|NCT00972478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65509293|NCT00972478|Alkylating Agents|alkylating agents|mesh-ancestor
65509294|NCT00972478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509295|NCT00972478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509296|NCT00972478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65509297|NCT00972478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65509298|NCT00972478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65509299|NCT00972478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65509300|NCT00972478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509301|NCT00972478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65509302|NCT00972478|Glucocorticoids|glucocorticoids|mesh-ancestor
65509303|NCT00972478|Hormones|hormones|mesh-ancestor
65509304|NCT00972478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65509305|NCT00972478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65509306|NCT00972478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65509307|NCT00972478|Tubulin Modulators|tubulin modulators|mesh-ancestor
65509308|NCT00972478|Antimitotic Agents|antimitotic agents|mesh-ancestor
65509309|NCT00972478|Mitosis Modulators|mitosis modulators|mesh-ancestor
65509310|NCT00972478|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65509311|NCT00823342|Tenofovir|tenofovir|mesh-list
65509312|NCT00823342|Clevudine|clevudine|mesh-list
65509313|NCT00823342|Antiviral Agents|antiviral agents|mesh-ancestor
65509314|NCT00823342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65509315|NCT00823342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65509316|NCT00823342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65509317|NCT00823342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509318|NCT00823342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509319|NCT00823342|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65509320|NCT00823342|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65509321|NCT01082445|Acetylcysteine|acetylcysteine|mesh-list
65509322|NCT01082445|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65509323|NCT01082445|Antiviral Agents|antiviral agents|mesh-ancestor
65509324|NCT01082445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65509325|NCT01082445|Expectorants|expectorants|mesh-ancestor
65509326|NCT01082445|Respiratory System Agents|respiratory system agents|mesh-ancestor
65509327|NCT01082445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65509328|NCT01082445|Antioxidants|antioxidants|mesh-ancestor
65509329|NCT01082445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509330|NCT01082445|Protective Agents|protective agents|mesh-ancestor
65509331|NCT01082445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509332|NCT01082445|Antidotes|antidotes|mesh-ancestor
65509333|NCT01085877|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65509334|NCT01085877|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65509335|NCT01085877|Estradiol|estradiol|mesh-list
65509336|NCT01085877|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65509337|NCT01085877|Estrogens|estrogens|mesh-ancestor
65509338|NCT01085877|Hormones|hormones|mesh-ancestor
65509339|NCT01085877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65509340|NCT01085877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509341|NCT01085877|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65509342|NCT01085877|Contraceptive Agents|contraceptive agents|mesh-ancestor
65509343|NCT01085877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65509344|NCT01085877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65509345|NCT01089855|Carbamazepine|carbamazepine|mesh-list
65509346|NCT01089855|Anticonvulsants|anticonvulsants|mesh-ancestor
65509347|NCT01089855|Antimanic Agents|antimanic agents|mesh-ancestor
65509348|NCT01089855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65509349|NCT01089855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65509350|NCT01089855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509351|NCT01089855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65509352|NCT01089855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65509353|NCT01089855|Analgesics|analgesics|mesh-ancestor
65509354|NCT01089855|Sensory System Agents|sensory system agents|mesh-ancestor
65509355|NCT01089855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65509356|NCT01089855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65509357|NCT01089855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65509358|NCT01089855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509359|NCT01089855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65509360|NCT01089855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65509361|NCT03980314|Nivolumab|nivolumab|mesh-list
65509362|NCT03980314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65509363|NCT03980314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509364|NCT03980314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65509365|NCT03980314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509366|NCT03674320|Methyltestosterone|methyltestosterone|mesh-list
65509367|NCT03674320|Testosterone|testosterone|mesh-list
65509368|NCT03674320|Testosterone undecanoate|testosterone undecanoate|mesh-list
65509369|NCT03674320|Testosterone enanthate|testosterone enanthate|mesh-list
65509370|NCT03674320|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65509371|NCT03674320|Androgens|androgens|mesh-ancestor
65509372|NCT03674320|Hormones|hormones|mesh-ancestor
65509373|NCT03674320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65509374|NCT03674320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509375|NCT03674320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65509376|NCT03674320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509377|NCT03674320|Anabolic Agents|anabolic agents|mesh-ancestor
65509378|NCT05457946|Vaccines|vaccines|mesh-list
65509379|NCT05457946|Immunologic Factors|immunologic factors|mesh-ancestor
65509380|NCT05457946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509381|NCT03625960|Cantharidin|cantharidin|mesh-list
65509382|NCT03625960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509383|NCT03625960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509385|NCT03042910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65509386|NCT03042910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509387|NCT03042910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509388|NCT03042910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509389|NCT03243838|Apatinib|apatinib|mesh-list
65509390|NCT03243838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509391|NCT03243838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65509392|NCT03243838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509393|NCT03243838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509394|NCT03059446|Cenicriviroc|cenicriviroc|mesh-list
65509395|NCT03059446|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65509396|NCT03059446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509397|NCT03059446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65509398|NCT03059446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65509399|NCT03059446|Antiviral Agents|antiviral agents|mesh-ancestor
65509400|NCT03059446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65509401|NCT00090519|Ruboxistaurin|ruboxistaurin|mesh-list
65509402|NCT00090519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509403|NCT00090519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509404|NCT02980666|Teduglutide|teduglutide|mesh-list
65509405|NCT02980666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65509406|NCT02980666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65509407|NCT02980666|Protective Agents|protective agents|mesh-ancestor
65509408|NCT02980666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509409|NCT02962102|Calcitriol|calcitriol|mesh-list
65509410|NCT02962102|Calcifediol|calcifediol|mesh-list
65509411|NCT02962102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65509412|NCT02962102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509413|NCT02962102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65509414|NCT02962102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65509415|NCT02962102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509416|NCT02962102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65509417|NCT02962102|Vitamins|vitamins|mesh-ancestor
65509418|NCT02962102|Micronutrients|micronutrients|mesh-ancestor
65509419|NCT02962102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65509420|NCT02947750|Folic Acid|folic acid|mesh-list
65509421|NCT02947750|Hematinics|hematinics|mesh-ancestor
65509422|NCT02947750|Vitamin B Complex|vitamin b complex|mesh-ancestor
65509423|NCT02947750|Vitamins|vitamins|mesh-ancestor
65509424|NCT02947750|Micronutrients|micronutrients|mesh-ancestor
65509425|NCT02947750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509426|NCT02630368|Cyclophosphamide|cyclophosphamide|mesh-list
65509427|NCT02630368|Avelumab|avelumab|mesh-list
65509428|NCT02630368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65509429|NCT02630368|Immunologic Factors|immunologic factors|mesh-ancestor
65509430|NCT02630368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509431|NCT02630368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65509432|NCT02630368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65509433|NCT02630368|Alkylating Agents|alkylating agents|mesh-ancestor
65509434|NCT02630368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509435|NCT02630368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509436|NCT02630368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65509437|NCT02630368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65509438|NCT05692960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65509439|NCT05692960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65509440|NCT05692960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509441|NCT05244460|Diphenhydramine|diphenhydramine|mesh-list
65509442|NCT05244460|Promethazine|promethazine|mesh-list
65509443|NCT05244460|Droperidol|droperidol|mesh-list
65509444|NCT05244460|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65509445|NCT05244460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65509446|NCT05244460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65509447|NCT05244460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509448|NCT05244460|Anesthetics, Local|anesthetics, local|mesh-ancestor
65509449|NCT05244460|Anesthetics|anesthetics|mesh-ancestor
65509450|NCT05244460|Sensory System Agents|sensory system agents|mesh-ancestor
65509451|NCT05244460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65509452|NCT05244460|Antiemetics|antiemetics|mesh-ancestor
65509453|NCT05244460|Autonomic Agents|autonomic agents|mesh-ancestor
65509454|NCT05244460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65509455|NCT05244460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65509456|NCT05244460|Histamine Antagonists|histamine antagonists|mesh-ancestor
65509457|NCT05244460|Histamine Agents|histamine agents|mesh-ancestor
65307127|NCT00596687|Insulin Glargine|insulin glargine|mesh-list
65509458|NCT05244460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65509459|NCT05244460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509460|NCT05244460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65509461|NCT05244460|Antipruritics|antipruritics|mesh-ancestor
65509462|NCT05244460|Dermatologic Agents|dermatologic agents|mesh-ancestor
65509463|NCT05244460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65509464|NCT05244460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65509465|NCT05244460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65509466|NCT05244460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65509467|NCT05244460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65509468|NCT05244460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65509469|NCT05244460|Dopamine Agents|dopamine agents|mesh-ancestor
65509470|NCT00096993|Gemcitabine|gemcitabine|mesh-list
65509471|NCT00096993|Pertuzumab|pertuzumab|mesh-list
65509472|NCT00096993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65509473|NCT00096993|Antimetabolites|antimetabolites|mesh-ancestor
65509474|NCT00096993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509475|NCT00096993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509476|NCT00096993|Antiviral Agents|antiviral agents|mesh-ancestor
65509477|NCT00096993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65509478|NCT00096993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509479|NCT00096993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65509480|NCT00096993|Immunologic Factors|immunologic factors|mesh-ancestor
65509481|NCT00096993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509482|NCT00096993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65509483|NCT00072189|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
65509484|NCT00072189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509485|NCT00072189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65509486|NCT00072189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509487|NCT00072189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509488|NCT03040024|Ketamine|ketamine|mesh-list
65509489|NCT03040024|Analgesics|analgesics|mesh-ancestor
65509490|NCT03040024|Sensory System Agents|sensory system agents|mesh-ancestor
65509491|NCT03040024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65509492|NCT03040024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509493|NCT03040024|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65509494|NCT03040024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65509495|NCT03040024|Anesthetics, General|anesthetics, general|mesh-ancestor
65509496|NCT03040024|Anesthetics|anesthetics|mesh-ancestor
65509497|NCT03040024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65509498|NCT03040024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65509499|NCT03040024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65509500|NCT03040024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65509501|NCT03040024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509502|NCT05053126|Pregabalin|pregabalin|mesh-list
65509503|NCT05053126|Oxycodone|oxycodone|mesh-list
65509504|NCT05053126|Analgesics|analgesics|mesh-ancestor
65509505|NCT05053126|Sensory System Agents|sensory system agents|mesh-ancestor
65509506|NCT05053126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65509507|NCT05053126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509508|NCT05053126|Anticonvulsants|anticonvulsants|mesh-ancestor
65509509|NCT05053126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65509510|NCT05053126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65509511|NCT05053126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509512|NCT05053126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65509513|NCT05053126|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65509514|NCT05053126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65509515|NCT05053126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65509516|NCT05053126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65509517|NCT05053126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65509518|NCT05053126|Narcotics|narcotics|mesh-ancestor
65509519|NCT04716946|Durvalumab|durvalumab|mesh-list
65509520|NCT04716946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65509521|NCT04716946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509522|NCT03038620|Liraglutide|liraglutide|mesh-list
65509523|NCT03038620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65509524|NCT03038620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509525|NCT03038620|Incretins|incretins|mesh-ancestor
65509526|NCT03038620|Hormones|hormones|mesh-ancestor
65509527|NCT03038620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65509528|NCT02032810|Ipilimumab|ipilimumab|mesh-list
65509529|NCT02032810|Panobinostat|panobinostat|mesh-list
65509530|NCT02032810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65509531|NCT02032810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509532|NCT02032810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65509533|NCT02032810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509534|NCT02032810|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65509535|NCT02032810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509537|NCT01415674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509538|NCT01415674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65509539|NCT01415674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509540|NCT01415674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509541|NCT01350934|Vitamin D|vitamin d|mesh-list
65509542|NCT01350934|Cholecalciferol|cholecalciferol|mesh-list
65509543|NCT01350934|Alendronate|alendronate|mesh-list
65509544|NCT01350934|Calcitriol|calcitriol|mesh-list
65509545|NCT01350934|Calcium|calcium|mesh-list
65509546|NCT01350934|Vitamins|vitamins|mesh-ancestor
65509547|NCT01350934|Micronutrients|micronutrients|mesh-ancestor
65509548|NCT01350934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509549|NCT01350934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65509550|NCT01350934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65509551|NCT01350934|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65509552|NCT01350934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65509553|NCT01350934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509554|NCT01350934|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65509555|NCT01146418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65509556|NCT01146418|Hormones|hormones|mesh-ancestor
65509557|NCT01146418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65509558|NCT01146418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509559|NCT05654896|Ceftriaxone|ceftriaxone|mesh-list
65509560|NCT05654896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65509561|NCT05654896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65509562|NCT00745108|Tibolone|tibolone|mesh-list
65509563|NCT00745108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509564|NCT00745108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65509565|NCT00745108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509566|NCT00745108|Hormones|hormones|mesh-ancestor
65509567|NCT00745108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65509568|NCT00745108|Androgen Antagonists|androgen antagonists|mesh-ancestor
65509569|NCT00745108|Hormone Antagonists|hormone antagonists|mesh-ancestor
65509570|NCT00745108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65509571|NCT00745108|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65509572|NCT00745108|Anabolic Agents|anabolic agents|mesh-ancestor
65509573|NCT00725374|Tibolone|tibolone|mesh-list
65509574|NCT00725374|Androgen Antagonists|androgen antagonists|mesh-ancestor
65509575|NCT00725374|Hormone Antagonists|hormone antagonists|mesh-ancestor
65509576|NCT00725374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65509577|NCT00725374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509578|NCT00725374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65509579|NCT00725374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65509580|NCT00725374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509581|NCT00725374|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65509582|NCT00725374|Anabolic Agents|anabolic agents|mesh-ancestor
65509583|NCT00725374|Hormones|hormones|mesh-ancestor
65509584|NCT03622580|Aflibercept|aflibercept|mesh-list
65509585|NCT03622580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65509586|NCT03622580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65509587|NCT03622580|Growth Substances|growth substances|mesh-ancestor
65509588|NCT03622580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509589|NCT03622580|Growth Inhibitors|growth inhibitors|mesh-ancestor
65509590|NCT03622580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509591|NCT00461032|Montelukast|montelukast|mesh-list
65509592|NCT00461032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65509593|NCT00461032|Respiratory System Agents|respiratory system agents|mesh-ancestor
65509594|NCT00461032|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65509595|NCT00461032|Hormone Antagonists|hormone antagonists|mesh-ancestor
65509596|NCT00461032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65509597|NCT00461032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509598|NCT00461032|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65509599|NCT00461032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65509600|NCT00461032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509601|NCT00446056|Ketotifen|ketotifen|mesh-list
65509602|NCT00446056|Montelukast|montelukast|mesh-list
65509603|NCT00446056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65509604|NCT00446056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509605|NCT00446056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509606|NCT00446056|Respiratory System Agents|respiratory system agents|mesh-ancestor
65509607|NCT00446056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65509608|NCT00446056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65509609|NCT00446056|Hormone Antagonists|hormone antagonists|mesh-ancestor
65509610|NCT00446056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65509611|NCT00446056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65509612|NCT00446056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65509613|NCT00446056|Antipruritics|antipruritics|mesh-ancestor
65509614|NCT00446056|Dermatologic Agents|dermatologic agents|mesh-ancestor
65509615|NCT00446056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65509616|NCT00446056|Histamine Antagonists|histamine antagonists|mesh-ancestor
65509617|NCT00446056|Histamine Agents|histamine agents|mesh-ancestor
65509618|NCT00446056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65509619|NCT00389740|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65509620|NCT00389740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509621|NCT00389740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65509622|NCT00389740|Hormone Antagonists|hormone antagonists|mesh-ancestor
65509623|NCT00389740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65509624|NCT00389740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65509625|NCT00389740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65509626|NCT00389740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65509627|NCT00092092|Budesonide|budesonide|mesh-list
65509628|NCT00092092|Montelukast|montelukast|mesh-list
65509629|NCT00092092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65509630|NCT00092092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65509631|NCT00092092|Autonomic Agents|autonomic agents|mesh-ancestor
65509632|NCT00092092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65509633|NCT00092092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509634|NCT00092092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65509635|NCT00092092|Respiratory System Agents|respiratory system agents|mesh-ancestor
65509636|NCT00092092|Glucocorticoids|glucocorticoids|mesh-ancestor
65509637|NCT00092092|Hormones|hormones|mesh-ancestor
65509638|NCT00092092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65509639|NCT00092092|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65509640|NCT00092092|Hormone Antagonists|hormone antagonists|mesh-ancestor
65509641|NCT00092092|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65509642|NCT00092092|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65509643|NCT00092092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509644|NCT00092014|Vitamin D|vitamin d|mesh-list
65509645|NCT00092014|Alendronate|alendronate|mesh-list
65509646|NCT00092014|Risedronic Acid|risedronic acid|mesh-list
65509647|NCT00092014|Calcium|calcium|mesh-list
65509648|NCT00092014|Vitamins|vitamins|mesh-ancestor
65509649|NCT00092014|Micronutrients|micronutrients|mesh-ancestor
65509650|NCT00092014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509651|NCT00092014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65509652|NCT00092014|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65509653|NCT00092014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65509654|NCT00092014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65509655|NCT00092014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509656|NCT00090142|Montelukast|montelukast|mesh-list
65509657|NCT00090142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65509658|NCT00090142|Respiratory System Agents|respiratory system agents|mesh-ancestor
65509659|NCT00090142|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65509660|NCT00090142|Hormone Antagonists|hormone antagonists|mesh-ancestor
65509661|NCT00090142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65509662|NCT00090142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509663|NCT00090142|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65509664|NCT00090142|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65509665|NCT00090142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509666|NCT00043108|Paclitaxel|paclitaxel|mesh-list
65509667|NCT00043108|Carboplatin|carboplatin|mesh-list
65509668|NCT00043108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65509669|NCT00043108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509670|NCT00043108|Tubulin Modulators|tubulin modulators|mesh-ancestor
65509671|NCT00043108|Antimitotic Agents|antimitotic agents|mesh-ancestor
65509672|NCT00043108|Mitosis Modulators|mitosis modulators|mesh-ancestor
65509673|NCT00043108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509674|NCT04985266|Tamoxifen|tamoxifen|mesh-list
65509675|NCT04985266|Letrozole|letrozole|mesh-list
65509676|NCT04985266|Fulvestrant|fulvestrant|mesh-list
65509677|NCT04985266|Palbociclib|palbociclib|mesh-list
65307352|NCT02629835|Protease Inhibitors|protease inhibitors|mesh-ancestor
65509679|NCT04985266|Exemestane|exemestane|mesh-list
65509680|NCT04985266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509681|NCT04985266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65509682|NCT04985266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65509683|NCT04985266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509684|NCT04985266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509685|NCT04985266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65509686|NCT04985266|Hormone Antagonists|hormone antagonists|mesh-ancestor
65509687|NCT04985266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65509688|NCT04985266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509689|NCT04985266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65509690|NCT04985266|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65509691|NCT04985266|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65509692|NCT04985266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65509693|NCT04985266|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65509694|NCT04985266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65509695|NCT03619408|Antacids|antacids|mesh-list
65509696|NCT03619408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509697|NCT03619408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65509698|NCT04032158|Interferon beta-1a|interferon beta-1a|mesh-list
65509699|NCT04032158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65509700|NCT04032158|Immunologic Factors|immunologic factors|mesh-ancestor
65509701|NCT04032158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509702|NCT04032158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509703|NCT04032158|Antiviral Agents|antiviral agents|mesh-ancestor
65509704|NCT04032158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65509705|NCT03620708|Nicotine|nicotine|mesh-list
65509706|NCT03620708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65509707|NCT03620708|Autonomic Agents|autonomic agents|mesh-ancestor
65509708|NCT03620708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65509709|NCT03620708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509710|NCT03620708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65509711|NCT03620708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65509712|NCT03620708|Cholinergic Agents|cholinergic agents|mesh-ancestor
65509713|NCT03620708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65509714|NCT03620708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509715|NCT03654326|Naproxen|naproxen|mesh-list
65509716|NCT03654326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65509717|NCT03654326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65509718|NCT03654326|Analgesics|analgesics|mesh-ancestor
65509719|NCT03654326|Sensory System Agents|sensory system agents|mesh-ancestor
65509720|NCT03654326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65509721|NCT03654326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509722|NCT03654326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65509723|NCT03654326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65509724|NCT03654326|Gout Suppressants|gout suppressants|mesh-ancestor
65509725|NCT03654326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65509726|NCT03654326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509727|NCT03654326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509728|NCT03735446|Cytarabine|cytarabine|mesh-list
65509729|NCT03735446|Etoposide|etoposide|mesh-list
65509730|NCT03735446|Mitoxantrone|mitoxantrone|mesh-list
65509731|NCT03735446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65509732|NCT03735446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509733|NCT03735446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65509734|NCT03735446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65509735|NCT03735446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509736|NCT03735446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509737|NCT03735446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65509738|NCT03735446|Antimetabolites|antimetabolites|mesh-ancestor
65509739|NCT03735446|Antiviral Agents|antiviral agents|mesh-ancestor
65509740|NCT03735446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65509741|NCT03735446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65509742|NCT03735446|Immunologic Factors|immunologic factors|mesh-ancestor
65509743|NCT03735446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509744|NCT03735446|Analgesics|analgesics|mesh-ancestor
65509745|NCT03735446|Sensory System Agents|sensory system agents|mesh-ancestor
65509746|NCT03735446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65509747|NCT03735368|Pregabalin|pregabalin|mesh-list
65509748|NCT03735368|Dexmedetomidine|dexmedetomidine|mesh-list
65509749|NCT03735368|Benoxinate|benoxinate|mesh-list
65509750|NCT03735368|Anesthetics|anesthetics|mesh-ancestor
65509751|NCT03735368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65509752|NCT03735368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509753|NCT03735368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65509754|NCT03735368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65509755|NCT03735368|Analgesics|analgesics|mesh-ancestor
65509756|NCT03735368|Sensory System Agents|sensory system agents|mesh-ancestor
65509757|NCT03735368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65509758|NCT03735368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65509759|NCT03735368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65509760|NCT03735368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65509761|NCT03735368|Adrenergic Agents|adrenergic agents|mesh-ancestor
65509762|NCT03735368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65509763|NCT03735368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509764|NCT03735368|Anticonvulsants|anticonvulsants|mesh-ancestor
65509765|NCT03735368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65509766|NCT03735368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65509767|NCT03735368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65509768|NCT03735368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65509769|NCT03735368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65509770|NCT03735368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65509771|NCT03735368|Anesthetics, Local|anesthetics, local|mesh-ancestor
65509772|NCT00071799|Cytarabine|cytarabine|mesh-list
65509773|NCT00071799|Azacitidine|azacitidine|mesh-list
65509774|NCT00071799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65509775|NCT00071799|Antimetabolites|antimetabolites|mesh-ancestor
65509776|NCT00071799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509777|NCT00071799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509778|NCT00071799|Antiviral Agents|antiviral agents|mesh-ancestor
65509779|NCT00071799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65509780|NCT00071799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65509781|NCT00071799|Immunologic Factors|immunologic factors|mesh-ancestor
65509782|NCT00071799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509783|NCT00071799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509784|NCT03615482|Vaccines|vaccines|mesh-list
65509785|NCT03615482|Immunologic Factors|immunologic factors|mesh-ancestor
65509786|NCT03615482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509787|NCT03652610|Vaccines|vaccines|mesh-list
65509788|NCT03652610|Immunologic Factors|immunologic factors|mesh-ancestor
65509789|NCT03652610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509790|NCT03615404|Molgramostim|molgramostim|mesh-list
65509791|NCT03615404|Sargramostim|sargramostim|mesh-list
65509792|NCT03615404|Immunologic Factors|immunologic factors|mesh-ancestor
65509793|NCT03615404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509794|NCT03615404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509795|NCT03730064|Acetylcysteine|acetylcysteine|mesh-list
65509796|NCT03730064|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65509797|NCT03730064|Antiviral Agents|antiviral agents|mesh-ancestor
65509798|NCT03730064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65509799|NCT03730064|Expectorants|expectorants|mesh-ancestor
65509800|NCT03730064|Respiratory System Agents|respiratory system agents|mesh-ancestor
65509801|NCT03730064|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65509802|NCT03730064|Antioxidants|antioxidants|mesh-ancestor
65509803|NCT03730064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509804|NCT03730064|Protective Agents|protective agents|mesh-ancestor
65509805|NCT03730064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509806|NCT03730064|Antidotes|antidotes|mesh-ancestor
65509807|NCT03580382|Trametinib|trametinib|mesh-list
65509808|NCT03580382|Antibodies|antibodies|mesh-list
65509809|NCT03580382|Immunologic Factors|immunologic factors|mesh-ancestor
65509810|NCT03580382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509811|NCT03580382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509812|NCT03580382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65509813|NCT03580382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509814|NCT03580382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509815|NCT03577730|Caffeine|caffeine|mesh-list
65509816|NCT03577730|Caffeine citrate|caffeine citrate|mesh-list
65509817|NCT03577730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509818|NCT03577730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65509819|NCT03577730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509820|NCT03577730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65509821|NCT03577730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509822|NCT03577730|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65509823|NCT03577730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65509824|NCT03577730|Purinergic Agents|purinergic agents|mesh-ancestor
65509825|NCT03577730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65509826|NCT03731780|Chlorhexidine|chlorhexidine|mesh-list
65509827|NCT03731780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65509828|NCT03731780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65509830|NCT03735134|Colchicine|colchicine|mesh-list
65509831|NCT03735134|Gout Suppressants|gout suppressants|mesh-ancestor
65509832|NCT03735134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65509833|NCT03735134|Tubulin Modulators|tubulin modulators|mesh-ancestor
65509834|NCT03735134|Antimitotic Agents|antimitotic agents|mesh-ancestor
65509835|NCT03735134|Mitosis Modulators|mitosis modulators|mesh-ancestor
65509836|NCT03735134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509837|NCT03735134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509838|NCT03608774|Azithromycin|azithromycin|mesh-list
65509839|NCT03608774|Doxycycline|doxycycline|mesh-list
65509840|NCT03608774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65509841|NCT03608774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65509842|NCT03608774|Antimalarials|antimalarials|mesh-ancestor
65509843|NCT03608774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65509844|NCT03608774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65509845|NCT04021524|Chlorhexidine|chlorhexidine|mesh-list
65509846|NCT04021524|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65509847|NCT04021524|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65509848|NCT04021524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65509849|NCT04021524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65509850|NCT04021524|Disinfectants|disinfectants|mesh-ancestor
65509851|NCT04021524|Dermatologic Agents|dermatologic agents|mesh-ancestor
65509852|NCT03729674|Infliximab|infliximab|mesh-list
65509853|NCT03729674|Dermatologic Agents|dermatologic agents|mesh-ancestor
65509854|NCT03729674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65509855|NCT03729674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65509856|NCT03731468|Dexamethasone|dexamethasone|mesh-list
65509857|NCT03731468|Anesthetics|anesthetics|mesh-list
65509858|NCT03731468|Anesthetics, Local|anesthetics, local|mesh-list
65509859|NCT03731468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65509860|NCT03731468|Antiemetics|antiemetics|mesh-ancestor
65509861|NCT03731468|Autonomic Agents|autonomic agents|mesh-ancestor
65509862|NCT03731468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65509863|NCT03731468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509864|NCT03731468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65509865|NCT03731468|Glucocorticoids|glucocorticoids|mesh-ancestor
65509866|NCT03731468|Hormones|hormones|mesh-ancestor
65509867|NCT03731468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65509868|NCT03731468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65509869|NCT03731468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509870|NCT03731468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65509871|NCT03731468|Sensory System Agents|sensory system agents|mesh-ancestor
65509872|NCT03600428|Vaccines|vaccines|mesh-list
65509873|NCT03600428|Immunologic Factors|immunologic factors|mesh-ancestor
65509874|NCT03600428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509875|NCT03575702|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65509876|NCT03575702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65509877|NCT03575702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65509878|NCT03575702|Cholinergic Agents|cholinergic agents|mesh-ancestor
65509879|NCT03575702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65509880|NCT03575702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509881|NCT03575702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509882|NCT03575702|Urological Agents|urological agents|mesh-ancestor
65509883|NCT03639896|Dexmedetomidine|dexmedetomidine|mesh-list
65509884|NCT03639896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65509885|NCT03639896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65509886|NCT03639896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509887|NCT03639896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65509888|NCT03639896|Analgesics|analgesics|mesh-ancestor
65509889|NCT03639896|Sensory System Agents|sensory system agents|mesh-ancestor
65509890|NCT03639896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65509891|NCT03639896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65509892|NCT03639896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65509893|NCT03639896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65509894|NCT03639896|Adrenergic Agents|adrenergic agents|mesh-ancestor
65509895|NCT03639896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65509896|NCT03639896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509897|NCT03573908|Linaclotide|linaclotide|mesh-list
65509898|NCT03573908|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65509899|NCT03573908|Enzyme Activators|enzyme activators|mesh-ancestor
65509900|NCT03573908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307573|NCT00879437|Antimanic Agents|antimanic agents|mesh-ancestor
65509901|NCT03573908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65509902|NCT03729284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65509903|NCT03729284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65509904|NCT03729284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65509905|NCT03729284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65509906|NCT03729284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509907|NCT03729284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65509908|NCT03729284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509909|NCT03729284|Analgesics|analgesics|mesh-ancestor
65509910|NCT03729284|Sensory System Agents|sensory system agents|mesh-ancestor
65509911|NCT03729284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65509912|NCT03729284|Antidepressive Agents|antidepressive agents|mesh-ancestor
65509913|NCT03729284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65509914|NCT03729284|Dopamine Agents|dopamine agents|mesh-ancestor
65509915|NCT03729128|Memantine|memantine|mesh-list
65509916|NCT03729128|Dextromethorphan|dextromethorphan|mesh-list
65509917|NCT03729128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65509918|NCT03729128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65509919|NCT03729128|Dopamine Agents|dopamine agents|mesh-ancestor
65509920|NCT03729128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65509921|NCT03729128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509922|NCT03729128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509923|NCT03729128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65509924|NCT03729128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65509925|NCT03729128|Antitussive Agents|antitussive agents|mesh-ancestor
65509926|NCT03729128|Respiratory System Agents|respiratory system agents|mesh-ancestor
65509927|NCT03734354|Brexpiprazole|brexpiprazole|mesh-list
65509928|NCT03734354|Serotonin Agents|serotonin agents|mesh-ancestor
65509929|NCT03734354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65509930|NCT03734354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509931|NCT03734354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509932|NCT03734354|Dopamine Agonists|dopamine agonists|mesh-ancestor
65509933|NCT03734354|Dopamine Agents|dopamine agents|mesh-ancestor
65509934|NCT03728894|Midazolam|midazolam|mesh-list
65509935|NCT03728894|Hydroxyzine|hydroxyzine|mesh-list
65509936|NCT03728894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65509937|NCT03728894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65509938|NCT03728894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65509939|NCT03728894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509940|NCT03728894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65509941|NCT03728894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65509942|NCT03728894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65509943|NCT03728894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65509944|NCT03728894|Anesthetics, General|anesthetics, general|mesh-ancestor
65509945|NCT03728894|Anesthetics|anesthetics|mesh-ancestor
65509946|NCT03728894|GABA Modulators|gaba modulators|mesh-ancestor
65509947|NCT03728894|GABA Agents|gaba agents|mesh-ancestor
65509948|NCT03728894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65509949|NCT03728894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509950|NCT03728894|Antipruritics|antipruritics|mesh-ancestor
65509951|NCT03728894|Dermatologic Agents|dermatologic agents|mesh-ancestor
65509952|NCT03728894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65509953|NCT03728894|Histamine Antagonists|histamine antagonists|mesh-ancestor
65509954|NCT03728894|Histamine Agents|histamine agents|mesh-ancestor
65509955|NCT03730766|Amoxicillin|amoxicillin|mesh-list
65509956|NCT03730766|Metronidazole|metronidazole|mesh-list
65509957|NCT03730766|Potassium Citrate|potassium citrate|mesh-list
65509958|NCT03730766|Esomeprazole|esomeprazole|mesh-list
65509959|NCT03730766|Bismuth|bismuth|mesh-list
65509960|NCT03730766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509961|NCT03730766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65509962|NCT03730766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65509963|NCT03730766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65509964|NCT03730766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65509965|NCT03730766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65509966|NCT03730766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65509967|NCT03730766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65509968|NCT03730766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509969|NCT03730766|Antacids|antacids|mesh-ancestor
65509970|NCT03730766|Diuretics|diuretics|mesh-ancestor
65509971|NCT03730766|Natriuretic Agents|natriuretic agents|mesh-ancestor
65509972|NCT03730766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509973|NCT03730766|Expectorants|expectorants|mesh-ancestor
65509974|NCT03730766|Respiratory System Agents|respiratory system agents|mesh-ancestor
65509975|NCT00071487|Belimumab|belimumab|mesh-list
65509976|NCT00071487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65509977|NCT00071487|Immunologic Factors|immunologic factors|mesh-ancestor
65509978|NCT00071487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509979|NCT03962283|Rifaximin|rifaximin|mesh-list
65509980|NCT03962283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65509981|NCT03962283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65509982|NCT03962283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65509983|NCT03591146|Ropivacaine|ropivacaine|mesh-list
65509984|NCT03591146|Anesthetics, Local|anesthetics, local|mesh-ancestor
65509985|NCT03591146|Anesthetics|anesthetics|mesh-ancestor
65509986|NCT03591146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65509987|NCT03591146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65509988|NCT03591146|Sensory System Agents|sensory system agents|mesh-ancestor
65509989|NCT03591146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65509990|NCT00096447|Lapatinib|lapatinib|mesh-list
65509991|NCT00096447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65509992|NCT00096447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65509993|NCT00096447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65509994|NCT00096447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65509995|NCT03588572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65509996|NCT03588572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65509997|NCT03588572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65509998|NCT03588572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65509999|NCT03588572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510000|NCT03588572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65510001|NCT03588572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510002|NCT03588572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65510003|NCT03588572|Antidepressive Agents|antidepressive agents|mesh-ancestor
65510004|NCT03588572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65510005|NCT00070941|Citalopram|citalopram|mesh-list
65510006|NCT00070941|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65510007|NCT00070941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65510008|NCT00070941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65510009|NCT00070941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510010|NCT00070941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65510011|NCT00070941|Serotonin Agents|serotonin agents|mesh-ancestor
65510012|NCT00070941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510013|NCT00070941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65510014|NCT00070941|Antidepressive Agents|antidepressive agents|mesh-ancestor
65510015|NCT00070941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65510016|NCT00070707|Mometasone Furoate|mometasone furoate|mesh-list
65510017|NCT00070707|Albuterol|albuterol|mesh-list
65510018|NCT00070707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65510019|NCT00070707|Autonomic Agents|autonomic agents|mesh-ancestor
65510020|NCT00070707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65510021|NCT00070707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510022|NCT00070707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65510023|NCT00070707|Respiratory System Agents|respiratory system agents|mesh-ancestor
65510024|NCT00070707|Tocolytic Agents|tocolytic agents|mesh-ancestor
65510025|NCT00070707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65510026|NCT00070707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65510027|NCT00070707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65510028|NCT00070707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65510029|NCT00070707|Adrenergic Agents|adrenergic agents|mesh-ancestor
65510030|NCT00070707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65510031|NCT00070707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510032|NCT00070707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65510033|NCT00070707|Dermatologic Agents|dermatologic agents|mesh-ancestor
65510034|NCT00070707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65510035|NCT03036124|Dapagliflozin|dapagliflozin|mesh-list
65510036|NCT03036124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65510037|NCT03036124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510038|NCT03036124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65510039|NCT03036124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510040|NCT00070317|Methylene Blue|methylene blue|mesh-list
65510041|NCT00070317|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
65510042|NCT00070317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510043|NCT00070317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510044|NCT00070317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65510045|NCT01086345|Bevacizumab|bevacizumab|mesh-list
65510046|NCT01086345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65510047|NCT01086345|Irinotecan|irinotecan|mesh-list
65510048|NCT01086345|Camptothecin|camptothecin|mesh-list
65510049|NCT01086345|Antibodies|antibodies|mesh-list
65510050|NCT01086345|Immunoglobulins|immunoglobulins|mesh-list
65510051|NCT01086345|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65510052|NCT01086345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510054|NCT01086345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65510055|NCT01086345|Growth Substances|growth substances|mesh-ancestor
65510056|NCT01086345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510057|NCT01086345|Growth Inhibitors|growth inhibitors|mesh-ancestor
65510058|NCT01086345|Immunologic Factors|immunologic factors|mesh-ancestor
65510059|NCT01086345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65510060|NCT01086345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65510061|NCT01086345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510062|NCT01086345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510063|NCT01086345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65510064|NCT01089933|Anesthetics|anesthetics|mesh-list
65510065|NCT01089933|Anesthetics, Local|anesthetics, local|mesh-list
65510066|NCT01089933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65510067|NCT01089933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510068|NCT01089933|Sensory System Agents|sensory system agents|mesh-ancestor
65510069|NCT01089933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65510070|NCT03960411|Doxycycline|doxycycline|mesh-list
65510071|NCT03960411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65510072|NCT03960411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65510073|NCT03960411|Antimalarials|antimalarials|mesh-ancestor
65510074|NCT03960411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65510075|NCT03960411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65510076|NCT01082679|Buprenorphine|buprenorphine|mesh-list
65510077|NCT01082679|Methadone|methadone|mesh-list
65510078|NCT01082679|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65510079|NCT01082679|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65510080|NCT01082679|Narcotics|narcotics|mesh-ancestor
65510081|NCT01082679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65510082|NCT01082679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510083|NCT01082679|Analgesics|analgesics|mesh-ancestor
65510084|NCT01082679|Sensory System Agents|sensory system agents|mesh-ancestor
65510085|NCT01082679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65510086|NCT01082679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65510087|NCT01082679|Antitussive Agents|antitussive agents|mesh-ancestor
65510088|NCT01082679|Respiratory System Agents|respiratory system agents|mesh-ancestor
65510089|NCT01090167|Clofarabine|clofarabine|mesh-list
65510090|NCT01090167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65510091|NCT01090167|Antimetabolites|antimetabolites|mesh-ancestor
65510092|NCT01090167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510093|NCT01090167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510094|NCT03587636|Bupivacaine|bupivacaine|mesh-list
65510095|NCT03587636|Anesthetics, Local|anesthetics, local|mesh-ancestor
65510096|NCT03587636|Anesthetics|anesthetics|mesh-ancestor
65510097|NCT03587636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65510098|NCT03587636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510099|NCT03587636|Sensory System Agents|sensory system agents|mesh-ancestor
65510100|NCT03587636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65510101|NCT03053362|Vortioxetine|vortioxetine|mesh-list
65510102|NCT03053362|Antidepressive Agents|antidepressive agents|mesh-ancestor
65510103|NCT03053362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65510104|NCT03053362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65510105|NCT03053362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65510106|NCT03053362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65510107|NCT03053362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510108|NCT03053362|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65510109|NCT03053362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65510110|NCT03053362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65510111|NCT03053362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510112|NCT03053362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65510113|NCT03053362|Serotonin Agents|serotonin agents|mesh-ancestor
65510114|NCT03053362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65510115|NCT03053362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65510116|NCT03053362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65510117|NCT03053362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65510118|NCT03733652|Interferons|interferons|mesh-list
65510119|NCT03733652|Interferon-alpha|interferon-alpha|mesh-list
65510120|NCT03733652|Interferon alpha-2|interferon alpha-2|mesh-list
65510121|NCT03733652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510122|NCT03733652|Antiviral Agents|antiviral agents|mesh-ancestor
65510123|NCT03733652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65510124|NCT03733652|Immunologic Factors|immunologic factors|mesh-ancestor
65510125|NCT03733652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510126|NCT03572582|Nivolumab|nivolumab|mesh-list
65510127|NCT03572582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65510128|NCT03572582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510129|NCT03572582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65510130|NCT03572582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510131|NCT03586544|Albuterol|albuterol|mesh-list
65510132|NCT03586544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65510133|NCT03586544|Autonomic Agents|autonomic agents|mesh-ancestor
65510134|NCT03586544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65510135|NCT03586544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510136|NCT03586544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65510137|NCT03586544|Respiratory System Agents|respiratory system agents|mesh-ancestor
65510138|NCT03586544|Tocolytic Agents|tocolytic agents|mesh-ancestor
65062506|NCT04054531|Carboplatin|carboplatin|mesh-list
65510139|NCT03586544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65510140|NCT03586544|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65510141|NCT03586544|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65510142|NCT03586544|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65510143|NCT03586544|Adrenergic Agents|adrenergic agents|mesh-ancestor
65510144|NCT03586544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65510145|NCT03586544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510146|NCT03737448|Trimetazidine|trimetazidine|mesh-list
65510147|NCT03737448|Vasodilator Agents|vasodilator agents|mesh-ancestor
65510148|NCT03733574|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65510149|NCT03733574|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65510150|NCT03733574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65510151|NCT03733574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65510152|NCT03733574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510153|NCT03733574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65510154|NCT03733574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510155|NCT03733574|Antidepressive Agents|antidepressive agents|mesh-ancestor
65510156|NCT03733574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65510157|NCT03728192|Camptothecin|camptothecin|mesh-list
65510158|NCT03728192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65510159|NCT03728192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510160|NCT03728192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65510161|NCT03728192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65510162|NCT03728192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510163|NCT03728192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510164|NCT03589768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65510165|NCT03589768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65510166|NCT03589768|Immunologic Factors|immunologic factors|mesh-ancestor
65510167|NCT03589768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510168|NCT03589768|Antacids|antacids|mesh-ancestor
65510169|NCT03589768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510170|NCT03589768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65510171|NCT03733340|Imipenem|imipenem|mesh-list
65510172|NCT03733340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65510173|NCT03733340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65510174|NCT05183308|Clodronic Acid|clodronic acid|mesh-list
65510175|NCT05183308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65510176|NCT05183308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510177|NCT05137600|Clarithromycin|clarithromycin|mesh-list
65510178|NCT05137600|Midazolam|midazolam|mesh-list
65510179|NCT05137600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65510180|NCT05137600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65510181|NCT05137600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65510182|NCT05137600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510183|NCT05137600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65510184|NCT05137600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65510185|NCT05137600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65510186|NCT05137600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65510187|NCT05137600|Anesthetics, General|anesthetics, general|mesh-ancestor
65510188|NCT05137600|Anesthetics|anesthetics|mesh-ancestor
65510189|NCT05137600|GABA Modulators|gaba modulators|mesh-ancestor
65510190|NCT05137600|GABA Agents|gaba agents|mesh-ancestor
65510191|NCT05137600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65510192|NCT05137600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510193|NCT05137600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65510194|NCT05137600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65510195|NCT05137600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65510196|NCT05137600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510197|NCT05137600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65510198|NCT05137600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65510199|NCT02906332|Dexamethasone|dexamethasone|mesh-list
65510200|NCT02906332|Pembrolizumab|pembrolizumab|mesh-list
65510201|NCT02906332|Lenalidomide|lenalidomide|mesh-list
65510202|NCT02906332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65510203|NCT02906332|Antiemetics|antiemetics|mesh-ancestor
65510204|NCT02906332|Autonomic Agents|autonomic agents|mesh-ancestor
65510205|NCT02906332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65510206|NCT02906332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510207|NCT02906332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65510208|NCT02906332|Glucocorticoids|glucocorticoids|mesh-ancestor
65510209|NCT02906332|Hormones|hormones|mesh-ancestor
65510210|NCT02906332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65510211|NCT02906332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65510212|NCT02906332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510213|NCT02906332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65510214|NCT02906332|Immunologic Factors|immunologic factors|mesh-ancestor
65510215|NCT02906332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65510216|NCT02906332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65510217|NCT02906332|Growth Substances|growth substances|mesh-ancestor
65510218|NCT02906332|Growth Inhibitors|growth inhibitors|mesh-ancestor
65510219|NCT00089505|Ritonavir|ritonavir|mesh-list
65510220|NCT00089505|Lopinavir|lopinavir|mesh-list
65510221|NCT00089505|Tenofovir|tenofovir|mesh-list
65510222|NCT00089505|Emtricitabine|emtricitabine|mesh-list
65510223|NCT00089505|Nevirapine|nevirapine|mesh-list
65510224|NCT00089505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65510225|NCT00089505|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65510226|NCT00089505|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65510227|NCT00089505|Protease Inhibitors|protease inhibitors|mesh-ancestor
65510228|NCT00089505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510229|NCT00089505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510230|NCT00089505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65510231|NCT00089505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65510232|NCT00089505|Antiviral Agents|antiviral agents|mesh-ancestor
65510233|NCT00089505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65510234|NCT00089505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65510235|NCT00089505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65510236|NCT00089505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65510237|NCT00089505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65510238|NCT00089505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65510239|NCT00089505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65510240|NCT04009824|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65510241|NCT04009824|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65510242|NCT04009824|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65510243|NCT04009824|Immunologic Factors|immunologic factors|mesh-ancestor
65510244|NCT04009824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510245|NCT04009824|Antacids|antacids|mesh-ancestor
65510246|NCT04009824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510247|NCT04009824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65510248|NCT05041426|Valganciclovir|valganciclovir|mesh-list
65510249|NCT05041426|Letermovir|letermovir|mesh-list
65510250|NCT05041426|Antiviral Agents|antiviral agents|mesh-ancestor
65510251|NCT05041426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65510252|NCT05041426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65510253|NCT05041426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510254|NCT05041426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510255|NCT05041426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510256|NCT04987372|Lidocaine|lidocaine|mesh-list
65510257|NCT04987372|Magnesium Sulfate|magnesium sulfate|mesh-list
65510258|NCT04987372|Pregabalin|pregabalin|mesh-list
65510259|NCT04987372|Dexmedetomidine|dexmedetomidine|mesh-list
65510260|NCT04987372|Ketamine|ketamine|mesh-list
65510261|NCT04987372|Anesthetics, Local|anesthetics, local|mesh-ancestor
65510262|NCT04987372|Anesthetics|anesthetics|mesh-ancestor
65510263|NCT04987372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65510264|NCT04987372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510265|NCT04987372|Sensory System Agents|sensory system agents|mesh-ancestor
65510266|NCT04987372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65510267|NCT04987372|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65510268|NCT04987372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65510269|NCT04987372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65510270|NCT04987372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65510271|NCT04987372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510272|NCT04987372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65510273|NCT04987372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65510274|NCT04987372|Analgesics|analgesics|mesh-ancestor
65510276|NCT04987372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65510277|NCT04987372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65510278|NCT04987372|Adrenergic Agents|adrenergic agents|mesh-ancestor
65510279|NCT04987372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65510280|NCT04987372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65510281|NCT04987372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65510282|NCT04987372|Anesthetics, General|anesthetics, general|mesh-ancestor
65510283|NCT04987372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65510284|NCT04987372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65510285|NCT04987372|Anticonvulsants|anticonvulsants|mesh-ancestor
65510286|NCT04987372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65510287|NCT04987372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65510288|NCT04987372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65510289|NCT04987372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65510290|NCT04987372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65510291|NCT04987372|Tocolytic Agents|tocolytic agents|mesh-ancestor
65510292|NCT04987372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65510293|NCT03555890|Cetirizine|cetirizine|mesh-list
65510294|NCT03555890|Levocetirizine|levocetirizine|mesh-list
65510295|NCT03555890|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65510296|NCT03555890|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65510297|NCT03555890|Histamine Antagonists|histamine antagonists|mesh-ancestor
65510298|NCT03555890|Histamine Agents|histamine agents|mesh-ancestor
65510299|NCT03555890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65510300|NCT03555890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510301|NCT03555890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510302|NCT03555890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65510303|NCT04905862|Antipyretics|antipyretics|mesh-list
65510304|NCT04905862|Analgesics|analgesics|mesh-list
65510305|NCT04905862|Sensory System Agents|sensory system agents|mesh-ancestor
65510306|NCT04905862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65510307|NCT04905862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510308|NCT03630120|Sorafenib|sorafenib|mesh-list
65510309|NCT03630120|Lenvatinib|lenvatinib|mesh-list
65510310|NCT03630120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510311|NCT03630120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65510312|NCT03630120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510313|NCT03630120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510314|NCT03744702|Ascorbic Acid|ascorbic acid|mesh-list
65510315|NCT03744702|Antioxidants|antioxidants|mesh-ancestor
65510316|NCT03744702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510317|NCT03744702|Protective Agents|protective agents|mesh-ancestor
65510318|NCT03744702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510319|NCT03744702|Vitamins|vitamins|mesh-ancestor
65510320|NCT03744702|Micronutrients|micronutrients|mesh-ancestor
65510321|NCT04004442|Avelumab|avelumab|mesh-list
65510322|NCT04004442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65510323|NCT04004442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510324|NCT03736980|Psilocybin|psilocybin|mesh-list
65510325|NCT03736980|Hallucinogens|hallucinogens|mesh-ancestor
65510326|NCT03736980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510327|NCT03736980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65510328|NCT03727646|Niacinamide|niacinamide|mesh-list
65510329|NCT03727646|Niacin|niacin|mesh-list
65510330|NCT03727646|Nicotinic Acids|nicotinic acids|mesh-list
65510331|NCT03727646|Vitamin B Complex|vitamin b complex|mesh-ancestor
65510332|NCT03727646|Vitamins|vitamins|mesh-ancestor
65510333|NCT03727646|Micronutrients|micronutrients|mesh-ancestor
65510334|NCT03727646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510335|NCT03727646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65510336|NCT03727646|Antimetabolites|antimetabolites|mesh-ancestor
65510337|NCT03727646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510338|NCT03727646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65510339|NCT03727646|Vasodilator Agents|vasodilator agents|mesh-ancestor
65510340|NCT05666336|Mycophenolic Acid|mycophenolic acid|mesh-list
65510341|NCT05666336|Hydroxychloroquine|hydroxychloroquine|mesh-list
65510342|NCT05666336|Prednisone|prednisone|mesh-list
65510343|NCT05666336|Methylprednisolone|methylprednisolone|mesh-list
65510344|NCT05666336|Cyclophosphamide|cyclophosphamide|mesh-list
65510345|NCT05666336|Tacrolimus|tacrolimus|mesh-list
65510346|NCT05666336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65510347|NCT05666336|Immunologic Factors|immunologic factors|mesh-ancestor
65510348|NCT05666336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510349|NCT05666336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65510350|NCT05666336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65510351|NCT05666336|Alkylating Agents|alkylating agents|mesh-ancestor
65510352|NCT05666336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510354|NCT05666336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65510355|NCT05666336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65510356|NCT05666336|Glucocorticoids|glucocorticoids|mesh-ancestor
65510357|NCT05666336|Hormones|hormones|mesh-ancestor
65510358|NCT05666336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65510359|NCT05666336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65510360|NCT05666336|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65510361|NCT05666336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510362|NCT05666336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65510363|NCT05666336|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65510364|NCT05666336|Antitubercular Agents|antitubercular agents|mesh-ancestor
65510365|NCT05666336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65510366|NCT05666336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65510367|NCT05666336|Antiemetics|antiemetics|mesh-ancestor
65510368|NCT05666336|Autonomic Agents|autonomic agents|mesh-ancestor
65510369|NCT05666336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65510370|NCT05666336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65510371|NCT05666336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65510372|NCT05666336|Protective Agents|protective agents|mesh-ancestor
65510373|NCT05666336|Antimalarials|antimalarials|mesh-ancestor
65510374|NCT05666336|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65510375|NCT05666336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65510376|NCT03554486|Insulin|insulin|mesh-list
65510377|NCT03554486|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65510378|NCT03554486|Insulin Aspart|insulin aspart|mesh-list
65510379|NCT03554486|Insulin, Long-Acting|insulin, long-acting|mesh-list
65510380|NCT03554486|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65510381|NCT03554486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65510382|NCT03554486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510383|NCT03554018|Acetaminophen|acetaminophen|mesh-list
65510384|NCT03554018|Ibuprofen|ibuprofen|mesh-list
65510385|NCT03554018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65510386|NCT03554018|Analgesics|analgesics|mesh-ancestor
65510387|NCT03554018|Sensory System Agents|sensory system agents|mesh-ancestor
65510388|NCT03554018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65510389|NCT03554018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510390|NCT03554018|Antipyretics|antipyretics|mesh-ancestor
65510391|NCT03554018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65510392|NCT03554018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65510393|NCT03554018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65510394|NCT03554018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65510395|NCT03554018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510396|NCT03554018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510397|NCT05462938|Dexmedetomidine|dexmedetomidine|mesh-list
65510398|NCT05462938|Propofol|propofol|mesh-list
65510399|NCT05462938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65510400|NCT05462938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65510401|NCT05462938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510402|NCT05462938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65510403|NCT05462938|Anesthetics, General|anesthetics, general|mesh-ancestor
65510404|NCT05462938|Anesthetics|anesthetics|mesh-ancestor
65510405|NCT05462938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65510406|NCT05462938|Analgesics|analgesics|mesh-ancestor
65510407|NCT05462938|Sensory System Agents|sensory system agents|mesh-ancestor
65510408|NCT05462938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65510409|NCT05462938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65510410|NCT05462938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65510411|NCT05462938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65510412|NCT05462938|Adrenergic Agents|adrenergic agents|mesh-ancestor
65510413|NCT05462938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65510414|NCT05462938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510415|NCT04787692|Analgesics, Opioid|analgesics, opioid|mesh-list
65510416|NCT04787692|Narcotics|narcotics|mesh-ancestor
65510417|NCT04787692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65510418|NCT04787692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510419|NCT04787692|Analgesics|analgesics|mesh-ancestor
65510420|NCT04787692|Sensory System Agents|sensory system agents|mesh-ancestor
65510421|NCT04787692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65510422|NCT05462548|Luspatercept|luspatercept|mesh-list
65510423|NCT05462548|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
65510424|NCT05462548|Hematinics|hematinics|mesh-ancestor
65510425|NCT05462548|Immunologic Factors|immunologic factors|mesh-ancestor
65308118|NCT04276857|Vitamins|vitamins|mesh-ancestor
65510426|NCT05462548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510427|NCT03408340|Fentanyl|fentanyl|mesh-list
65510428|NCT03408340|Ketamine|ketamine|mesh-list
65510429|NCT03408340|Propofol|propofol|mesh-list
65510430|NCT03408340|Sevoflurane|sevoflurane|mesh-list
65510431|NCT03408340|Rocuronium|rocuronium|mesh-list
65510432|NCT03408340|Anesthetics|anesthetics|mesh-ancestor
65510433|NCT03408340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65510434|NCT03408340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510435|NCT03408340|Sensory System Agents|sensory system agents|mesh-ancestor
65510436|NCT03408340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65510437|NCT03408340|Analgesics|analgesics|mesh-ancestor
65510438|NCT03408340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65510439|NCT03408340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65510440|NCT03408340|Anesthetics, General|anesthetics, general|mesh-ancestor
65510441|NCT03408340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65510442|NCT03408340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65510443|NCT03408340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65510444|NCT03408340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510445|NCT03408340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65510446|NCT03408340|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65510447|NCT03408340|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65510448|NCT03408340|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65510449|NCT03408340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65510450|NCT03408340|Narcotics|narcotics|mesh-ancestor
65510451|NCT03408340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65510452|NCT03408340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65510453|NCT03408340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65510454|NCT03570554|Acetaminophen|acetaminophen|mesh-list
65510455|NCT03570554|Celecoxib|celecoxib|mesh-list
65510456|NCT03570554|Naproxen|naproxen|mesh-list
65510457|NCT03570554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65510458|NCT03570554|Analgesics|analgesics|mesh-ancestor
65510459|NCT03570554|Sensory System Agents|sensory system agents|mesh-ancestor
65510460|NCT03570554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65510461|NCT03570554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510462|NCT03570554|Antipyretics|antipyretics|mesh-ancestor
65510463|NCT03570554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65510464|NCT03570554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65510465|NCT03570554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65510466|NCT03570554|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65510467|NCT03570554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65510468|NCT03570554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510469|NCT03570554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510470|NCT03570554|Gout Suppressants|gout suppressants|mesh-ancestor
65510471|NCT04004208|Aflibercept|aflibercept|mesh-list
65510472|NCT04004208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65510473|NCT04004208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65510474|NCT04004208|Growth Substances|growth substances|mesh-ancestor
65510475|NCT04004208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510476|NCT04004208|Growth Inhibitors|growth inhibitors|mesh-ancestor
65510477|NCT04004208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510478|NCT03727412|Naproxen|naproxen|mesh-list
65510479|NCT03727412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65510480|NCT03727412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65510481|NCT03727412|Analgesics|analgesics|mesh-ancestor
65510482|NCT03727412|Sensory System Agents|sensory system agents|mesh-ancestor
65510483|NCT03727412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65510484|NCT03727412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510485|NCT03727412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65510486|NCT03727412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65510487|NCT03727412|Gout Suppressants|gout suppressants|mesh-ancestor
65510488|NCT03727412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65510489|NCT03727412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510490|NCT03727412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510491|NCT03643952|Daptomycin|daptomycin|mesh-list
65510492|NCT03643952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65510493|NCT03643952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65510494|NCT03035032|Leuprolide|leuprolide|mesh-list
65510495|NCT03035032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65510496|NCT03035032|Fertility Agents|fertility agents|mesh-ancestor
65510497|NCT03035032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65510498|NCT03035032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510499|NCT03035032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65510500|NCT03035032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510501|NCT03629184|Oseltamivir|oseltamivir|mesh-list
65510503|NCT03629184|Antiviral Agents|antiviral agents|mesh-ancestor
65510504|NCT03629184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65510505|NCT03629184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510506|NCT03629184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510507|NCT03725228|Lidocaine|lidocaine|mesh-list
65510508|NCT03725228|Magnesium Sulfate|magnesium sulfate|mesh-list
65510509|NCT03725228|Anesthetics, Local|anesthetics, local|mesh-ancestor
65510510|NCT03725228|Anesthetics|anesthetics|mesh-ancestor
65510511|NCT03725228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65510512|NCT03725228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510513|NCT03725228|Sensory System Agents|sensory system agents|mesh-ancestor
65510514|NCT03725228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65510515|NCT03725228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65510516|NCT03725228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65510517|NCT03725228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65510518|NCT03725228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65510519|NCT03725228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510520|NCT03725228|Analgesics|analgesics|mesh-ancestor
65510521|NCT03725228|Anticonvulsants|anticonvulsants|mesh-ancestor
65510522|NCT03725228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65510523|NCT03725228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65510524|NCT03725228|Tocolytic Agents|tocolytic agents|mesh-ancestor
65510525|NCT03725228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65510526|NCT03724838|Sildenafil Citrate|sildenafil citrate|mesh-list
65510527|NCT03724838|Esomeprazole|esomeprazole|mesh-list
65510528|NCT03724838|Citric Acid|citric acid|mesh-list
65510529|NCT03724838|Sodium Citrate|sodium citrate|mesh-list
65510530|NCT03724838|Anticoagulants|anticoagulants|mesh-ancestor
65510531|NCT03724838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65510532|NCT03724838|Chelating Agents|chelating agents|mesh-ancestor
65510533|NCT03724838|Sequestering Agents|sequestering agents|mesh-ancestor
65510534|NCT03724838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510535|NCT03724838|Vasodilator Agents|vasodilator agents|mesh-ancestor
65510536|NCT03724838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65510537|NCT03724838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65510538|NCT03724838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510539|NCT03724838|Urological Agents|urological agents|mesh-ancestor
65510540|NCT03724838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65510541|NCT03724838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65510542|NCT03724838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65510543|NCT02892344|Mometasone Furoate|mometasone furoate|mesh-list
65510544|NCT02892344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65510545|NCT02892344|Dermatologic Agents|dermatologic agents|mesh-ancestor
65510546|NCT02892344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65510547|NCT03727100|Clonidine|clonidine|mesh-list
65510548|NCT03727100|Analgesics|analgesics|mesh-ancestor
65510549|NCT03727100|Sensory System Agents|sensory system agents|mesh-ancestor
65510550|NCT03727100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65510551|NCT03727100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510552|NCT03727100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65510553|NCT03727100|Sympatholytics|sympatholytics|mesh-ancestor
65510554|NCT03727100|Autonomic Agents|autonomic agents|mesh-ancestor
65510555|NCT03727100|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65510556|NCT03727100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65510557|NCT03727100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65510558|NCT03727100|Adrenergic Agents|adrenergic agents|mesh-ancestor
65510559|NCT03727100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65510560|NCT03727100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510561|NCT03358030|Riboflavin|riboflavin|mesh-list
65510562|NCT03358030|Vitamin B Complex|vitamin b complex|mesh-ancestor
65510563|NCT03358030|Vitamins|vitamins|mesh-ancestor
65510564|NCT03358030|Micronutrients|micronutrients|mesh-ancestor
65510565|NCT03358030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510566|NCT03358030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65510567|NCT03358030|Dermatologic Agents|dermatologic agents|mesh-ancestor
65510568|NCT03566810|Metformin|metformin|mesh-list
65510569|NCT03566810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65510570|NCT03566810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510571|NCT04924660|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
65510572|NCT04924660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65510573|NCT04924660|Vasodilator Agents|vasodilator agents|mesh-ancestor
65510574|NCT03628716|Atezolizumab|atezolizumab|mesh-list
65510575|NCT03628716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510576|NCT03840616|Fluconazole|fluconazole|mesh-list
65510577|NCT03840616|Antifungal Agents|antifungal agents|mesh-ancestor
65510578|NCT03840616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65510579|NCT03840616|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65510580|NCT03840616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65510582|NCT03840616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510583|NCT03840616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65510584|NCT03840616|Hormone Antagonists|hormone antagonists|mesh-ancestor
65510585|NCT03840616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65510586|NCT03840616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510587|NCT03840616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65510588|NCT03840616|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65510589|NCT00088413|Molgramostim|molgramostim|mesh-list
65510590|NCT00088413|Sargramostim|sargramostim|mesh-list
65510591|NCT00088413|Immunologic Factors|immunologic factors|mesh-ancestor
65510592|NCT00088413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510593|NCT00088413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510594|NCT03787654|Solifenacin Succinate|solifenacin succinate|mesh-list
65510595|NCT03787654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65510596|NCT03787654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65510597|NCT03787654|Cholinergic Agents|cholinergic agents|mesh-ancestor
65510598|NCT03787654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65510599|NCT03787654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510600|NCT03787654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510601|NCT03787654|Urological Agents|urological agents|mesh-ancestor
65510602|NCT00086385|Bupropion|bupropion|mesh-list
65510603|NCT00086385|Nicotine|nicotine|mesh-list
65510604|NCT00086385|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65510605|NCT00086385|Autonomic Agents|autonomic agents|mesh-ancestor
65510606|NCT00086385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65510607|NCT00086385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510608|NCT00086385|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65510609|NCT00086385|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65510610|NCT00086385|Cholinergic Agents|cholinergic agents|mesh-ancestor
65510611|NCT00086385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65510612|NCT00086385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510613|NCT00086385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65510614|NCT00086385|Antidepressive Agents|antidepressive agents|mesh-ancestor
65510615|NCT00086385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65510616|NCT00086385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65510617|NCT00086385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65510618|NCT00086385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65510619|NCT00086385|Dopamine Agents|dopamine agents|mesh-ancestor
65510620|NCT00086385|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65510621|NCT00086385|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65510622|NCT00086385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510623|NCT03993288|Iron|iron|mesh-list
65510624|NCT03993288|Trace Elements|trace elements|mesh-ancestor
65510625|NCT03993288|Micronutrients|micronutrients|mesh-ancestor
65510626|NCT03993288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510627|NCT05093608|Bevacizumab|bevacizumab|mesh-list
65510628|NCT05093608|Atezolizumab|atezolizumab|mesh-list
65510629|NCT05093608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65510630|NCT05093608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510631|NCT05093608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65510632|NCT05093608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65510633|NCT05093608|Growth Substances|growth substances|mesh-ancestor
65510634|NCT05093608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510635|NCT05093608|Growth Inhibitors|growth inhibitors|mesh-ancestor
65510636|NCT03736044|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
65510637|NCT03736044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65510638|NCT03383770|Anesthetics|anesthetics|mesh-list
65510639|NCT03383770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65510640|NCT03383770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510641|NCT04644796|Bupivacaine|bupivacaine|mesh-list
65510642|NCT04644796|Anesthetics, Local|anesthetics, local|mesh-ancestor
65510643|NCT04644796|Anesthetics|anesthetics|mesh-ancestor
65510644|NCT04644796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65510645|NCT04644796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510646|NCT04644796|Sensory System Agents|sensory system agents|mesh-ancestor
65510647|NCT04644796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65510648|NCT00086307|Pramipexole|pramipexole|mesh-list
65510649|NCT00086307|Citalopram|citalopram|mesh-list
65510650|NCT00086307|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65308334|NCT00840996|Lidocaine|lidocaine|mesh-list
65510651|NCT00086307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65510652|NCT00086307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65510653|NCT00086307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510654|NCT00086307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65510656|NCT00086307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510657|NCT00086307|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65510658|NCT00086307|Antidepressive Agents|antidepressive agents|mesh-ancestor
65510659|NCT00086307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65510660|NCT00086307|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65510661|NCT00086307|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65510662|NCT00086307|Antioxidants|antioxidants|mesh-ancestor
65510663|NCT00086307|Protective Agents|protective agents|mesh-ancestor
65510664|NCT00086307|Dopamine Agonists|dopamine agonists|mesh-ancestor
65510665|NCT00086307|Dopamine Agents|dopamine agents|mesh-ancestor
65510666|NCT01086579|Paclitaxel|paclitaxel|mesh-list
65510667|NCT01086579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65063039|NCT02272270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510668|NCT01086579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65510669|NCT01086579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510670|NCT01086579|Tubulin Modulators|tubulin modulators|mesh-ancestor
65510671|NCT01086579|Antimitotic Agents|antimitotic agents|mesh-ancestor
65510672|NCT01086579|Mitosis Modulators|mitosis modulators|mesh-ancestor
65510673|NCT01086579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510674|NCT03743922|Ergocalciferols|ergocalciferols|mesh-list
65510675|NCT03743922|Cholecalciferol|cholecalciferol|mesh-list
65510676|NCT03743922|Vitamin D|vitamin d|mesh-list
65510677|NCT03743922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65510678|NCT03743922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510679|NCT03743922|Vitamins|vitamins|mesh-ancestor
65510680|NCT03743922|Micronutrients|micronutrients|mesh-ancestor
65510681|NCT03743922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65510682|NCT03988842|Heparin|heparin|mesh-list
65510683|NCT03988842|Calcium heparin|calcium heparin|mesh-list
65510684|NCT03988842|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65510685|NCT03988842|Plasminogen|plasminogen|mesh-list
65510686|NCT03988842|Apixaban|apixaban|mesh-list
65510687|NCT03988842|Anticoagulants|anticoagulants|mesh-ancestor
65510688|NCT03988842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65510689|NCT03988842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65510690|NCT03988842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510691|NCT03988842|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65510692|NCT03988842|Antithrombins|antithrombins|mesh-ancestor
65510693|NCT03988842|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65510694|NCT03988842|Protease Inhibitors|protease inhibitors|mesh-ancestor
65510695|NCT03988842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510696|NCT02668822|Ibuprofen|ibuprofen|mesh-list
65510697|NCT02668822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65510698|NCT02668822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65510699|NCT02668822|Analgesics|analgesics|mesh-ancestor
65510700|NCT02668822|Sensory System Agents|sensory system agents|mesh-ancestor
65510701|NCT02668822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65510702|NCT02668822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510703|NCT02668822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65510704|NCT02668822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65510705|NCT02668822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65510706|NCT02668822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510707|NCT02668822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510708|NCT04112589|Cytarabine|cytarabine|mesh-list
65510709|NCT04112589|Fludarabine|fludarabine|mesh-list
65510710|NCT04112589|Idarubicin|idarubicin|mesh-list
65510711|NCT04112589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510712|NCT04112589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65510713|NCT04112589|Antimetabolites|antimetabolites|mesh-ancestor
65510714|NCT04112589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510715|NCT04112589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65510716|NCT04112589|Immunologic Factors|immunologic factors|mesh-ancestor
65510717|NCT04112589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510718|NCT04112589|Antiviral Agents|antiviral agents|mesh-ancestor
65510719|NCT04112589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65510720|NCT04112589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65510721|NCT04112589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65510722|NCT04112589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65510723|NCT04112589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510724|NCT03547154|Interferons|interferons|mesh-list
65510725|NCT03547154|Interferon-alpha|interferon-alpha|mesh-list
65510726|NCT03547154|Interferon alpha-2|interferon alpha-2|mesh-list
65510727|NCT03547154|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65510728|NCT03547154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510729|NCT03547154|Antiviral Agents|antiviral agents|mesh-ancestor
65510730|NCT03547154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65510731|NCT03547154|Immunologic Factors|immunologic factors|mesh-ancestor
65510732|NCT03547154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510733|NCT02275546|NuvaRing|nuvaring|mesh-list
65510734|NCT02275546|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65510735|NCT02275546|Desogestrel|desogestrel|mesh-list
65510736|NCT02275546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65510737|NCT02275546|Contraceptive Agents|contraceptive agents|mesh-ancestor
65510738|NCT02275546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65510739|NCT02275546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510740|NCT02275546|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65510741|NCT02275546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65510742|NCT02275546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65510743|NCT02275546|Estrogens|estrogens|mesh-ancestor
65510744|NCT02275546|Hormones|hormones|mesh-ancestor
65510745|NCT02275546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65510746|NCT02275546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65510747|NCT02275546|Progestins|progestins|mesh-ancestor
65510748|NCT00057837|Cisplatin|cisplatin|mesh-list
65510749|NCT00057837|Irinotecan|irinotecan|mesh-list
65510750|NCT00057837|Etoposide|etoposide|mesh-list
65510751|NCT00057837|Etoposide phosphate|etoposide phosphate|mesh-list
65510752|NCT00057837|Topotecan|topotecan|mesh-list
65510753|NCT00057837|Podophyllotoxin|podophyllotoxin|mesh-list
65510754|NCT00057837|Camptothecin|camptothecin|mesh-list
65510755|NCT00057837|Lenograstim|lenograstim|mesh-list
65510756|NCT00057837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510757|NCT00057837|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65510758|NCT00057837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65510759|NCT00057837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510760|NCT00057837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510761|NCT00057837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65510762|NCT00057837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65510763|NCT00057837|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65510764|NCT00057837|Immunologic Factors|immunologic factors|mesh-ancestor
65510765|NCT00057837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510766|NCT00057837|Keratolytic Agents|keratolytic agents|mesh-ancestor
65510767|NCT00057837|Dermatologic Agents|dermatologic agents|mesh-ancestor
65510768|NCT00057837|Tubulin Modulators|tubulin modulators|mesh-ancestor
65510769|NCT00057837|Antimitotic Agents|antimitotic agents|mesh-ancestor
65510770|NCT00057837|Mitosis Modulators|mitosis modulators|mesh-ancestor
65510771|NCT01090713|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65510772|NCT01090713|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65510773|NCT01090713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510774|NCT01090713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65510775|NCT01090713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65510776|NCT01090713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65510777|NCT01090713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510778|NCT01090713|Dopamine Agents|dopamine agents|mesh-ancestor
65510779|NCT01090713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65510780|NCT01096797|Sevoflurane|sevoflurane|mesh-list
65510781|NCT01096797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65510782|NCT01096797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65510783|NCT01096797|Anesthetics, General|anesthetics, general|mesh-ancestor
65510784|NCT01096797|Anesthetics|anesthetics|mesh-ancestor
65510785|NCT01096797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65510786|NCT01096797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510787|NCT00068601|Cyclophosphamide|cyclophosphamide|mesh-list
65510788|NCT00068601|Goserelin|goserelin|mesh-list
65510789|NCT00068601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65510790|NCT00068601|Immunologic Factors|immunologic factors|mesh-ancestor
65510791|NCT00068601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510792|NCT00068601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65510793|NCT00068601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65510794|NCT00068601|Alkylating Agents|alkylating agents|mesh-ancestor
65510795|NCT00068601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510796|NCT00068601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510797|NCT00068601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65510798|NCT00068601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65510799|NCT01670656|Ibuprofen|ibuprofen|mesh-list
65510800|NCT01670656|Contraceptive Agents|contraceptive agents|mesh-list
65510801|NCT01670656|Etonogestrel|etonogestrel|mesh-list
65510802|NCT01670656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65510803|NCT01670656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65510804|NCT01670656|Analgesics|analgesics|mesh-ancestor
65510805|NCT01670656|Sensory System Agents|sensory system agents|mesh-ancestor
65510806|NCT01670656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65510807|NCT01670656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510808|NCT01670656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65510809|NCT01670656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65510810|NCT01670656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65510811|NCT01670656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510812|NCT01670656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510813|NCT01670656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65510814|NCT01670656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65510815|NCT01670656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65510816|NCT03621696|Cisplatin|cisplatin|mesh-list
65510817|NCT03621696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510818|NCT00068445|Lamotrigine|lamotrigine|mesh-list
65510819|NCT00068445|Anticonvulsants|anticonvulsants|mesh-ancestor
65510820|NCT00068445|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65510821|NCT00068445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65510822|NCT00068445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510823|NCT00068445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65510824|NCT00068445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510825|NCT00068445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65510826|NCT00068445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65510827|NCT00068445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65510828|NCT00068445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65510829|NCT00068445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65510830|NCT03033784|Oxytocin|oxytocin|mesh-list
65510831|NCT03033784|Oxytocics|oxytocics|mesh-ancestor
65510832|NCT03033784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65510833|NCT03033784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510834|NCT00038649|Imatinib Mesylate|imatinib mesylate|mesh-list
65510835|NCT00038649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510836|NCT00038649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65510837|NCT00038649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510838|NCT00038649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510839|NCT02926690|OTS167|ots167|mesh-list
65510840|NCT02926690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65510841|NCT02926690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510842|NCT02926690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510843|NCT03652818|Acetaminophen|acetaminophen|mesh-list
65510844|NCT03652818|Pregabalin|pregabalin|mesh-list
65510845|NCT03652818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65510846|NCT03652818|Analgesics|analgesics|mesh-ancestor
65510847|NCT03652818|Sensory System Agents|sensory system agents|mesh-ancestor
65510848|NCT03652818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65510849|NCT03652818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510850|NCT03652818|Antipyretics|antipyretics|mesh-ancestor
65510851|NCT03652818|Anticonvulsants|anticonvulsants|mesh-ancestor
65510852|NCT03652818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65510853|NCT03652818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65510854|NCT03652818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510855|NCT03652818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65510856|NCT03652818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65510857|NCT03652818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65510858|NCT03652818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65510859|NCT03652818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65510860|NCT03723824|Grazoprevir|grazoprevir|mesh-list
65510861|NCT03723824|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65510862|NCT03723824|Antiviral Agents|antiviral agents|mesh-ancestor
65510863|NCT03723824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65510864|NCT00620464|Etonogestrel|etonogestrel|mesh-list
65510865|NCT00620464|Desogestrel|desogestrel|mesh-list
65510866|NCT00620464|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65510867|NCT00620464|Contraceptive Agents|contraceptive agents|mesh-ancestor
65510868|NCT00620464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65510869|NCT00620464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510870|NCT00620464|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65510871|NCT00620464|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65510872|NCT00620464|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65510873|NCT00620464|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65510874|NCT00620464|Progestins|progestins|mesh-ancestor
65510875|NCT00620464|Hormones|hormones|mesh-ancestor
65510876|NCT00620464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65510878|NCT00541684|Adrenergic Agents|adrenergic agents|mesh-ancestor
65510879|NCT00541684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65510880|NCT00541684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510881|NCT00541684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510882|NCT00541684|Autonomic Agents|autonomic agents|mesh-ancestor
65510883|NCT00541684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65510884|NCT00541684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65510885|NCT00541684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65510886|NCT00541684|Sympatholytics|sympatholytics|mesh-ancestor
65510887|NCT00541684|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65510888|NCT00541684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65510889|NCT00541684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65510890|NCT00413764|Tibolone|tibolone|mesh-list
65510891|NCT00413764|Norethindrone|norethindrone|mesh-list
65510892|NCT00413764|Norethindrone Acetate|norethindrone acetate|mesh-list
65510893|NCT00413764|Estradiol|estradiol|mesh-list
65510894|NCT00413764|Estrogens|estrogens|mesh-ancestor
65510895|NCT00413764|Hormones|hormones|mesh-ancestor
65510896|NCT00413764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65510897|NCT00413764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510898|NCT00413764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65510899|NCT00413764|Contraceptive Agents|contraceptive agents|mesh-ancestor
65510900|NCT00413764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65510901|NCT00413764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65510902|NCT00413764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65510903|NCT00413764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65510904|NCT00413764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65510905|NCT00413764|Androgen Antagonists|androgen antagonists|mesh-ancestor
65510906|NCT00413764|Hormone Antagonists|hormone antagonists|mesh-ancestor
65510907|NCT00413764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65510908|NCT00413764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65510909|NCT00413764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510910|NCT00413764|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65510911|NCT00413764|Anabolic Agents|anabolic agents|mesh-ancestor
65510912|NCT03726788|Triamcinolone|triamcinolone|mesh-list
65510913|NCT03726788|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65510914|NCT03726788|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65510915|NCT03726788|Botulinum Toxins|botulinum toxins|mesh-list
65510916|NCT03726788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65510917|NCT03726788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65510918|NCT03726788|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65510919|NCT03726788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65510920|NCT03726788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65510921|NCT03726788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510922|NCT03726788|Cholinergic Agents|cholinergic agents|mesh-ancestor
65510923|NCT03726788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65510924|NCT03726788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510925|NCT03726788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65510926|NCT03726788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65510927|NCT03726788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65510928|NCT03726788|Glucocorticoids|glucocorticoids|mesh-ancestor
65510929|NCT03726788|Hormones|hormones|mesh-ancestor
65510930|NCT03726788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65510931|NCT03726788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65510932|NCT03726788|Immunologic Factors|immunologic factors|mesh-ancestor
65510933|NCT03726788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510934|NCT03735264|Docetaxel|docetaxel|mesh-list
65510935|NCT03735264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510936|NCT03735264|Tubulin Modulators|tubulin modulators|mesh-ancestor
65510937|NCT03735264|Antimitotic Agents|antimitotic agents|mesh-ancestor
65510938|NCT03735264|Mitosis Modulators|mitosis modulators|mesh-ancestor
65510939|NCT03735264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510940|NCT03560258|Vaccines|vaccines|mesh-list
65510941|NCT03560258|Immunologic Factors|immunologic factors|mesh-ancestor
65510942|NCT03560258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510943|NCT02759380|Phytoestrogens|phytoestrogens|mesh-list
65510944|NCT02759380|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65510945|NCT02759380|Estrogens|estrogens|mesh-ancestor
65510946|NCT02759380|Hormones|hormones|mesh-ancestor
65510947|NCT02759380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65510948|NCT02759380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510949|NCT02707042|Amoxicillin|amoxicillin|mesh-list
65510950|NCT02707042|Azithromycin|azithromycin|mesh-list
65510951|NCT02707042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65510952|NCT02707042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65510953|NCT03539432|Gemfibrozil|gemfibrozil|mesh-list
65510954|NCT03539432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65510955|NCT03539432|Antimetabolites|antimetabolites|mesh-ancestor
65510956|NCT03539432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510957|NCT03539432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65510958|NCT03539432|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65510959|NCT03539432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65510960|NCT03539432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510961|NCT03615924|Ticagrelor|ticagrelor|mesh-list
65510962|NCT03615924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65510963|NCT03615924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65510964|NCT03615924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65510965|NCT03615924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65510966|NCT03615924|Purinergic Agents|purinergic agents|mesh-ancestor
65510967|NCT03615924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65510968|NCT03615924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510969|NCT03615924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510970|NCT05576038|Tryptophan|tryptophan|mesh-list
65510971|NCT05576038|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65510972|NCT05576038|Antidepressive Agents|antidepressive agents|mesh-ancestor
65510973|NCT05576038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65510974|NCT02599714|Fulvestrant|fulvestrant|mesh-list
65510975|NCT02599714|Palbociclib|palbociclib|mesh-list
65510976|NCT02599714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65510977|NCT02599714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510978|NCT02599714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65510979|NCT02599714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65510980|NCT02599714|Hormone Antagonists|hormone antagonists|mesh-ancestor
65510981|NCT02599714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65510982|NCT02599714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510983|NCT02599714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65510984|NCT02599714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65510985|NCT02599714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65510986|NCT04660240|Sirolimus|sirolimus|mesh-list
65510987|NCT04660240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65510988|NCT04660240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65510989|NCT04660240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65510990|NCT04660240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65510991|NCT04660240|Antifungal Agents|antifungal agents|mesh-ancestor
65510992|NCT04660240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65510993|NCT04660240|Immunologic Factors|immunologic factors|mesh-ancestor
65510994|NCT04660240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65510995|NCT03033394|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65510996|NCT03033394|Penicillins|penicillins|mesh-list
65510997|NCT03033394|Lactams|lactams|mesh-list
65510998|NCT03033394|beta-Lactams|beta-lactams|mesh-list
65510999|NCT03033394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65511000|NCT03639428|Midazolam|midazolam|mesh-list
65511001|NCT03639428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65511002|NCT03639428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65511003|NCT03639428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65511004|NCT03639428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511005|NCT03639428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65511006|NCT03639428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65511007|NCT03639428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65511008|NCT03639428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65511009|NCT03639428|Anesthetics, General|anesthetics, general|mesh-ancestor
65511010|NCT03639428|Anesthetics|anesthetics|mesh-ancestor
65511011|NCT03639428|GABA Modulators|gaba modulators|mesh-ancestor
65511012|NCT03639428|GABA Agents|gaba agents|mesh-ancestor
65511013|NCT03639428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65511014|NCT03639428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511015|NCT04575688|Bupivacaine|bupivacaine|mesh-list
65511016|NCT04575688|Anesthetics, Local|anesthetics, local|mesh-ancestor
65511017|NCT04575688|Anesthetics|anesthetics|mesh-ancestor
65511018|NCT04575688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65511019|NCT04575688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511020|NCT04575688|Sensory System Agents|sensory system agents|mesh-ancestor
65511021|NCT04575688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511022|NCT05528848|Fentanyl|fentanyl|mesh-list
65511023|NCT05528848|Carfentanil|carfentanil|mesh-list
65511024|NCT05528848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65511025|NCT05528848|Narcotics|narcotics|mesh-ancestor
65511026|NCT05528848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65511027|NCT05528848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511028|NCT05528848|Analgesics|analgesics|mesh-ancestor
65511029|NCT05528848|Sensory System Agents|sensory system agents|mesh-ancestor
65511030|NCT05528848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511031|NCT05528848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65511032|NCT05528848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65511033|NCT05528848|Anesthetics, General|anesthetics, general|mesh-ancestor
65511034|NCT05528848|Anesthetics|anesthetics|mesh-ancestor
65511035|NCT04561648|Heparin|heparin|mesh-list
65511036|NCT04561648|Calcium heparin|calcium heparin|mesh-list
65511037|NCT04561648|Anticoagulants|anticoagulants|mesh-ancestor
65511038|NCT04561648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65511039|NCT04561648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65511040|NCT04561648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511041|NCT03981822|Cantharidin|cantharidin|mesh-list
65511042|NCT03981822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65511043|NCT03981822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511044|NCT03704818|Dapagliflozin|dapagliflozin|mesh-list
65511045|NCT03704818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65511046|NCT03704818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511047|NCT03704818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65511048|NCT03704818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511049|NCT05506930|Morphine|morphine|mesh-list
65511050|NCT05506930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65511051|NCT05506930|Narcotics|narcotics|mesh-ancestor
65511052|NCT05506930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65511053|NCT05506930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511054|NCT05506930|Analgesics|analgesics|mesh-ancestor
65511055|NCT05506930|Sensory System Agents|sensory system agents|mesh-ancestor
65511056|NCT05506930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511057|NCT05464264|Ketamine|ketamine|mesh-list
65511058|NCT05464264|Analgesics|analgesics|mesh-ancestor
65511059|NCT05464264|Sensory System Agents|sensory system agents|mesh-ancestor
65511060|NCT05464264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511061|NCT05464264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511062|NCT05464264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65511063|NCT05464264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65511064|NCT05464264|Anesthetics, General|anesthetics, general|mesh-ancestor
65511065|NCT05464264|Anesthetics|anesthetics|mesh-ancestor
65511066|NCT05464264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65511067|NCT05464264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65511068|NCT05464264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65511069|NCT05464264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65511070|NCT05464264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511071|NCT01310738|Amphotericin B|amphotericin b|mesh-list
65511072|NCT01310738|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65511073|NCT01310738|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
65511074|NCT01310738|Meglumine Antimoniate|meglumine antimoniate|mesh-list
65511075|NCT01310738|Deoxycholic Acid|deoxycholic acid|mesh-list
65511076|NCT01310738|Amebicides|amebicides|mesh-ancestor
65511077|NCT01310738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65511078|NCT01310738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65511079|NCT01310738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65511080|NCT01310738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65511081|NCT01310738|Antifungal Agents|antifungal agents|mesh-ancestor
65511082|NCT01310738|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65511083|NCT01310738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65511084|NCT03704506|Amoxicillin|amoxicillin|mesh-list
65511085|NCT03704506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65511086|NCT03704506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65511087|NCT05357794|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65511088|NCT05357794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65511089|NCT05357794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511090|NCT03615144|Fludarabine|fludarabine|mesh-list
65511091|NCT03615144|Melphalan|melphalan|mesh-list
65511092|NCT03615144|Thiotepa|thiotepa|mesh-list
65511093|NCT03615144|Clofarabine|clofarabine|mesh-list
65511094|NCT03615144|Thymoglobulin|thymoglobulin|mesh-list
65511095|NCT03615144|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65511096|NCT03615144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511097|NCT03615144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65511098|NCT03615144|Antimetabolites|antimetabolites|mesh-ancestor
65511099|NCT03615144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511100|NCT03615144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65511101|NCT03615144|Immunologic Factors|immunologic factors|mesh-ancestor
65511102|NCT03615144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511103|NCT03615144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65511104|NCT03615144|Alkylating Agents|alkylating agents|mesh-ancestor
65511105|NCT03615144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65511106|NCT05340790|Anti-Infective Agents|anti-infective agents|mesh-list
65511107|NCT05340790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65511108|NCT03682302|Bupivacaine|bupivacaine|mesh-list
65511109|NCT03682302|Anesthetics, Local|anesthetics, local|mesh-ancestor
65511110|NCT03682302|Anesthetics|anesthetics|mesh-ancestor
65511111|NCT03682302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65511112|NCT03682302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511113|NCT03682302|Sensory System Agents|sensory system agents|mesh-ancestor
65511114|NCT03682302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511115|NCT03522506|Modafinil|modafinil|mesh-list
65511116|NCT03522506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65511117|NCT03522506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511118|NCT03522506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65511119|NCT03522506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65511120|NCT03522506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65511121|NCT03522506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511122|NCT03320434|Prednisolone acetate|prednisolone acetate|mesh-list
65511123|NCT03320434|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65511124|NCT03320434|Methylprednisolone|methylprednisolone|mesh-list
65511125|NCT03320434|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65511126|NCT03320434|Prednisolone|prednisolone|mesh-list
65511127|NCT03320434|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65511128|NCT03320434|Prednisolone phosphate|prednisolone phosphate|mesh-list
65511129|NCT03320434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65511130|NCT03320434|Antiemetics|antiemetics|mesh-ancestor
65511131|NCT03320434|Autonomic Agents|autonomic agents|mesh-ancestor
65511132|NCT03320434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511133|NCT03320434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511134|NCT03320434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65511135|NCT03320434|Glucocorticoids|glucocorticoids|mesh-ancestor
65511136|NCT03320434|Hormones|hormones|mesh-ancestor
65511137|NCT03320434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65511138|NCT03320434|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65511139|NCT03320434|Protective Agents|protective agents|mesh-ancestor
65511140|NCT03320434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65511141|NCT03320434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511142|NCT02892734|Nivolumab|nivolumab|mesh-list
65511143|NCT02892734|Ipilimumab|ipilimumab|mesh-list
65511144|NCT02892734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65511145|NCT02892734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511146|NCT02892734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65511147|NCT02892734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511148|NCT05231590|Myeloma Proteins|myeloma proteins|mesh-list
65511149|NCT05231590|Paraproteins|paraproteins|mesh-list
65511150|NCT05231590|Immunologic Factors|immunologic factors|mesh-ancestor
65511151|NCT05231590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511152|NCT00055497|Adalimumab|adalimumab|mesh-list
65511153|NCT00055497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65511154|NCT00055497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65511155|NCT03726398|Macitentan|macitentan|mesh-list
65511156|NCT03726398|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65511157|NCT03726398|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65511158|NCT03726398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511159|NCT03726398|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65511160|NCT04050592|Estradiol|estradiol|mesh-list
65511161|NCT04050592|Estrogens|estrogens|mesh-ancestor
65511162|NCT04050592|Hormones|hormones|mesh-ancestor
65511163|NCT04050592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65511164|NCT04050592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511165|NCT03726242|Cromakalim|cromakalim|mesh-list
65511166|NCT03726242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65511167|NCT03726242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65511168|NCT03726242|Autonomic Agents|autonomic agents|mesh-ancestor
65511169|NCT03726242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511170|NCT03726242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511171|NCT03726242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65511172|NCT03726242|Respiratory System Agents|respiratory system agents|mesh-ancestor
65511173|NCT03726242|Parasympatholytics|parasympatholytics|mesh-ancestor
65511174|NCT03726242|Vasodilator Agents|vasodilator agents|mesh-ancestor
65511175|NCT03731988|Lidocaine|lidocaine|mesh-list
65511176|NCT03731988|Prilocaine|prilocaine|mesh-list
65511177|NCT03731988|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65511178|NCT03731988|Anesthetics, Local|anesthetics, local|mesh-ancestor
65511179|NCT03731988|Anesthetics|anesthetics|mesh-ancestor
65511180|NCT03731988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65511181|NCT03731988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511182|NCT03731988|Sensory System Agents|sensory system agents|mesh-ancestor
65511183|NCT03731988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511184|NCT03731988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65511185|NCT03731988|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65511186|NCT03731988|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65511187|NCT03731988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65511188|NCT03731988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511189|NCT03731988|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65511190|NCT01094457|Aspirin|aspirin|mesh-list
65511191|NCT01094457|Cilostazol|cilostazol|mesh-list
65511192|NCT01094457|Clopidogrel|clopidogrel|mesh-list
65511193|NCT01094457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65511194|NCT01094457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65511195|NCT01094457|Analgesics|analgesics|mesh-ancestor
65511196|NCT01094457|Sensory System Agents|sensory system agents|mesh-ancestor
65511197|NCT01094457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511198|NCT01094457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511199|NCT01094457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65511200|NCT01094457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65511201|NCT01094457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65511202|NCT01094457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65511203|NCT01094457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511204|NCT01094457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65511205|NCT01094457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65511206|NCT01094457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65511207|NCT01094457|Antipyretics|antipyretics|mesh-ancestor
65511208|NCT01094457|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65511209|NCT01094457|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65511210|NCT01094457|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65511211|NCT01094457|Purinergic Agents|purinergic agents|mesh-ancestor
65511212|NCT01094457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65511213|NCT01094457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65511214|NCT01094457|Autonomic Agents|autonomic agents|mesh-ancestor
65511215|NCT01094457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65511216|NCT01094457|Respiratory System Agents|respiratory system agents|mesh-ancestor
65511217|NCT01094457|Vasodilator Agents|vasodilator agents|mesh-ancestor
65511218|NCT01094457|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65511219|NCT01094457|Protective Agents|protective agents|mesh-ancestor
65511220|NCT01094457|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65511221|NCT01094457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65511222|NCT03701698|Methylprednisolone|methylprednisolone|mesh-list
65511223|NCT03701698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65511224|NCT03701698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65511225|NCT03701698|Prednisolone|prednisolone|mesh-list
65511226|NCT03701698|Prednisolone acetate|prednisolone acetate|mesh-list
65511227|NCT03701698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65511228|NCT03701698|Prednisolone phosphate|prednisolone phosphate|mesh-list
65511229|NCT03701698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65511230|NCT03701698|Antiemetics|antiemetics|mesh-ancestor
65511231|NCT03701698|Autonomic Agents|autonomic agents|mesh-ancestor
65511232|NCT03701698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511233|NCT03701698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511234|NCT03701698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65511235|NCT03701698|Glucocorticoids|glucocorticoids|mesh-ancestor
65511236|NCT03701698|Hormones|hormones|mesh-ancestor
65511237|NCT03701698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65511238|NCT03701698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65511239|NCT03701698|Protective Agents|protective agents|mesh-ancestor
65511240|NCT03701698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65511241|NCT03701698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511242|NCT03734562|Amiodarone|amiodarone|mesh-list
65511243|NCT03734562|Sotalol|sotalol|mesh-list
65511244|NCT03734562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
65511245|NCT03734562|Vasodilator Agents|vasodilator agents|mesh-ancestor
65511246|NCT03734562|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65511247|NCT03734562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65511248|NCT03734562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511249|NCT03734562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65511250|NCT03734562|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65511251|NCT03734562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65511252|NCT03734562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65511253|NCT03734562|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65511254|NCT03734562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65511255|NCT03734562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65511256|NCT03734562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65511257|NCT03734562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65511258|NCT03734562|Adrenergic Agents|adrenergic agents|mesh-ancestor
65511259|NCT03734562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65511260|NCT03734562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511261|NCT03734562|Sympatholytics|sympatholytics|mesh-ancestor
65511262|NCT03734562|Autonomic Agents|autonomic agents|mesh-ancestor
65511263|NCT03734562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511264|NCT03034096|Propofol|propofol|mesh-list
65511265|NCT03034096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65511266|NCT03034096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65511267|NCT03034096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511268|NCT03034096|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65511269|NCT03034096|Anesthetics, General|anesthetics, general|mesh-ancestor
65511270|NCT03034096|Anesthetics|anesthetics|mesh-ancestor
65511271|NCT03722498|Leucovorin|leucovorin|mesh-list
65511272|NCT03722498|Fluorouracil|fluorouracil|mesh-list
65511273|NCT03722498|Oxaliplatin|oxaliplatin|mesh-list
65511274|NCT03722498|Sorafenib|sorafenib|mesh-list
65511275|NCT03722498|Antimetabolites|antimetabolites|mesh-ancestor
65511276|NCT03722498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511277|NCT03722498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65511278|NCT03722498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511279|NCT03722498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65511280|NCT03722498|Immunologic Factors|immunologic factors|mesh-ancestor
65511281|NCT03722498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511282|NCT03722498|Antidotes|antidotes|mesh-ancestor
65511283|NCT03722498|Protective Agents|protective agents|mesh-ancestor
65511284|NCT03722498|Vitamin B Complex|vitamin b complex|mesh-ancestor
65511285|NCT03722498|Vitamins|vitamins|mesh-ancestor
65511286|NCT03722498|Micronutrients|micronutrients|mesh-ancestor
65511287|NCT03722498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65511288|NCT03722498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65511289|NCT03722420|Imatinib Mesylate|imatinib mesylate|mesh-list
65511290|NCT03722420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511291|NCT03722420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65511292|NCT03722420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65511293|NCT03722420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511294|NCT03721874|Dapagliflozin|dapagliflozin|mesh-list
65511295|NCT03721874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65511296|NCT03721874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511297|NCT03721874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65511298|NCT03721874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511299|NCT03807843|Vaccines|vaccines|mesh-list
65511300|NCT03807843|Immunologic Factors|immunologic factors|mesh-ancestor
65511301|NCT03807843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511302|NCT01094535|Secretin|secretin|mesh-list
65511303|NCT01094535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65511304|NCT01094535|Hormones|hormones|mesh-ancestor
65511305|NCT01094535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65511306|NCT01094535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511307|NCT02843074|Dexamethasone|dexamethasone|mesh-list
65511308|NCT02843074|Lenalidomide|lenalidomide|mesh-list
65511309|NCT02843074|Elotuzumab|elotuzumab|mesh-list
65511310|NCT02843074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65511311|NCT02843074|Antiemetics|antiemetics|mesh-ancestor
65511312|NCT02843074|Autonomic Agents|autonomic agents|mesh-ancestor
65511313|NCT02843074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511314|NCT02843074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511315|NCT02843074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65511316|NCT02843074|Glucocorticoids|glucocorticoids|mesh-ancestor
65511317|NCT02843074|Hormones|hormones|mesh-ancestor
65511318|NCT02843074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65511319|NCT02843074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65511320|NCT02843074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511321|NCT02843074|Immunologic Factors|immunologic factors|mesh-ancestor
65511322|NCT02843074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65511323|NCT02843074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65511324|NCT02843074|Growth Substances|growth substances|mesh-ancestor
65511325|NCT02843074|Growth Inhibitors|growth inhibitors|mesh-ancestor
65511326|NCT03607422|Upadacitinib|upadacitinib|mesh-list
65511327|NCT03607422|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65511328|NCT03607422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65511329|NCT03607422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65511330|NCT03607422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511331|NCT03607422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65511332|NCT00038103|Celecoxib|celecoxib|mesh-list
65511333|NCT00038103|Exemestane|exemestane|mesh-list
65511334|NCT00038103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65511335|NCT00038103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65511336|NCT00038103|Analgesics|analgesics|mesh-ancestor
65511337|NCT00038103|Sensory System Agents|sensory system agents|mesh-ancestor
65511338|NCT00038103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511339|NCT00038103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511340|NCT00038103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65511341|NCT00038103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65511342|NCT00038103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65511343|NCT00038103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65511344|NCT00038103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65511345|NCT00038103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511346|NCT00038103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511347|NCT00038103|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65511348|NCT00038103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65511349|NCT00038103|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65511350|NCT00038103|Hormone Antagonists|hormone antagonists|mesh-ancestor
65511351|NCT00038103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65511352|NCT03678870|Analgesics, Opioid|analgesics, opioid|mesh-list
65511353|NCT03678870|Narcotics|narcotics|mesh-ancestor
65511354|NCT03678870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65511355|NCT03678870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511356|NCT03678870|Analgesics|analgesics|mesh-ancestor
65511357|NCT03678870|Sensory System Agents|sensory system agents|mesh-ancestor
65511358|NCT03678870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511359|NCT03032380|Meropenem|meropenem|mesh-list
65511360|NCT03032380|Linezolid|linezolid|mesh-list
65511361|NCT03032380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65511362|NCT03032380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65511363|NCT03032380|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65511364|NCT03032380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65511365|NCT03032380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511366|NCT03519854|Bromides|bromides|mesh-list
65511367|NCT03519854|Rocuronium|rocuronium|mesh-list
65511368|NCT03519854|Anticonvulsants|anticonvulsants|mesh-ancestor
65511369|NCT03519854|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65511370|NCT03519854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65511371|NCT03519854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65511372|NCT03519854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511373|NCT03519854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511374|NCT03703960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65511375|NCT03703960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65511376|NCT03703960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511377|NCT03479216|Magnesium Sulfate|magnesium sulfate|mesh-list
65511378|NCT03479216|Dexmedetomidine|dexmedetomidine|mesh-list
65511379|NCT03479216|Bupivacaine|bupivacaine|mesh-list
65511380|NCT03479216|Anesthetics, Local|anesthetics, local|mesh-ancestor
65511381|NCT03479216|Anesthetics|anesthetics|mesh-ancestor
65511382|NCT03479216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65511383|NCT03479216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511384|NCT03479216|Sensory System Agents|sensory system agents|mesh-ancestor
65511385|NCT03479216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511386|NCT03479216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65511387|NCT03479216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65511388|NCT03479216|Analgesics|analgesics|mesh-ancestor
65511389|NCT03479216|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65511390|NCT03479216|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65511391|NCT03479216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65511392|NCT03479216|Adrenergic Agents|adrenergic agents|mesh-ancestor
65511393|NCT03479216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65511394|NCT03479216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511395|NCT03479216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65511396|NCT03479216|Anticonvulsants|anticonvulsants|mesh-ancestor
65511397|NCT03479216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65511398|NCT03479216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65511399|NCT03479216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65511400|NCT03479216|Tocolytic Agents|tocolytic agents|mesh-ancestor
65511401|NCT03479216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65511402|NCT04762888|Edetic Acid|edetic acid|mesh-list
65511403|NCT04762888|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65511404|NCT04762888|Chelating Agents|chelating agents|mesh-ancestor
65511405|NCT04762888|Sequestering Agents|sequestering agents|mesh-ancestor
65511406|NCT04762888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511407|NCT04762888|Anticoagulants|anticoagulants|mesh-ancestor
65511408|NCT04762888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65511409|NCT04762888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65511410|NCT03717116|Parathyroid Hormone|parathyroid hormone|mesh-list
65511411|NCT03717116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65511412|NCT03717116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511413|NCT03717038|Trifluridine|trifluridine|mesh-list
65511414|NCT03717038|Antimetabolites|antimetabolites|mesh-ancestor
65511415|NCT03717038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511416|NCT03717038|Antiviral Agents|antiviral agents|mesh-ancestor
65511417|NCT03717038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65511418|NCT00143182|Olanzapine|olanzapine|mesh-list
65511419|NCT00143182|Asenapine|asenapine|mesh-list
65511420|NCT00143182|Antiemetics|antiemetics|mesh-ancestor
65511421|NCT00143182|Autonomic Agents|autonomic agents|mesh-ancestor
65511422|NCT00143182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511423|NCT00143182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511424|NCT00143182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65511425|NCT00143182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65511426|NCT00143182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65511427|NCT00143182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65511428|NCT00143182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65511429|NCT00143182|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65511430|NCT00143182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65511431|NCT00143182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65511432|NCT00143182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511433|NCT00143182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65511434|NCT00143182|Serotonin Agents|serotonin agents|mesh-ancestor
65511435|NCT03677934|Ranibizumab|ranibizumab|mesh-list
65511436|NCT03677934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65511437|NCT03677934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65511438|NCT03677934|Growth Substances|growth substances|mesh-ancestor
65511439|NCT03677934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511440|NCT03677934|Growth Inhibitors|growth inhibitors|mesh-ancestor
65511441|NCT03677934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511442|NCT03435692|Acetaminophen|acetaminophen|mesh-list
65511443|NCT03435692|Diphenhydramine|diphenhydramine|mesh-list
65511444|NCT03435692|Promethazine|promethazine|mesh-list
65511445|NCT03435692|Fentanyl|fentanyl|mesh-list
65511446|NCT03435692|Morphine|morphine|mesh-list
65511447|NCT03435692|Oxycodone|oxycodone|mesh-list
65511448|NCT03435692|Lorazepam|lorazepam|mesh-list
65511449|NCT03435692|Ondansetron|ondansetron|mesh-list
65511450|NCT03435692|Ropivacaine|ropivacaine|mesh-list
65511451|NCT03435692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65511452|NCT03435692|Narcotics|narcotics|mesh-ancestor
65511453|NCT03435692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65511454|NCT03435692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511455|NCT03435692|Analgesics|analgesics|mesh-ancestor
65511456|NCT03435692|Sensory System Agents|sensory system agents|mesh-ancestor
65511457|NCT03435692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511458|NCT03435692|Anesthetics, Local|anesthetics, local|mesh-ancestor
65511459|NCT03435692|Anesthetics|anesthetics|mesh-ancestor
65511460|NCT03435692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65511461|NCT03435692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65511462|NCT03435692|Anesthetics, General|anesthetics, general|mesh-ancestor
65511463|NCT03435692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65511464|NCT03435692|Antipyretics|antipyretics|mesh-ancestor
65511465|NCT03435692|Antiemetics|antiemetics|mesh-ancestor
65511466|NCT03435692|Autonomic Agents|autonomic agents|mesh-ancestor
65511467|NCT03435692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65511468|NCT03435692|Antipruritics|antipruritics|mesh-ancestor
65511469|NCT03435692|Dermatologic Agents|dermatologic agents|mesh-ancestor
65511470|NCT03435692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65511471|NCT03435692|Serotonin Agents|serotonin agents|mesh-ancestor
65511472|NCT03435692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65511473|NCT03435692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511474|NCT03435692|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65511475|NCT03435692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65511476|NCT03435692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65511477|NCT03435692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65511478|NCT03435692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65511479|NCT03435692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65511480|NCT03435692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65511481|NCT03435692|Histamine Antagonists|histamine antagonists|mesh-ancestor
65511482|NCT03435692|Histamine Agents|histamine agents|mesh-ancestor
65511483|NCT03435692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65511484|NCT03435692|Anticonvulsants|anticonvulsants|mesh-ancestor
65511485|NCT03435692|GABA Modulators|gaba modulators|mesh-ancestor
65511486|NCT03435692|GABA Agents|gaba agents|mesh-ancestor
65511487|NCT03705442|Loperamide|loperamide|mesh-list
65511488|NCT03705442|Antidiarrheals|antidiarrheals|mesh-list
65511489|NCT03705442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65511490|NCT04817410|Naltrexone|naltrexone|mesh-list
65511491|NCT04817410|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65511492|NCT04817410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65511493|NCT04817410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511494|NCT04817410|Sensory System Agents|sensory system agents|mesh-ancestor
65511495|NCT04817410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511496|NCT03673956|Vancomycin|vancomycin|mesh-list
65511497|NCT03673956|Levofloxacin|levofloxacin|mesh-list
65511498|NCT03673956|Ofloxacin|ofloxacin|mesh-list
65511499|NCT03673956|Tobramycin|tobramycin|mesh-list
65511500|NCT03673956|Mupirocin|mupirocin|mesh-list
65511501|NCT03673956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65511502|NCT03673956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65511503|NCT03673956|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65511504|NCT03673956|Renal Agents|renal agents|mesh-ancestor
65511505|NCT03673956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65511506|NCT03673956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65511507|NCT03673956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65511508|NCT03673956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511509|NCT03673956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511510|NCT03673956|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65511511|NCT03673956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65511512|NCT03673956|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65511513|NCT03716804|Ciprofloxacin|ciprofloxacin|mesh-list
65511514|NCT03716804|Cefuroxime|cefuroxime|mesh-list
65511515|NCT03716804|Cefuroxime axetil|cefuroxime axetil|mesh-list
65511516|NCT03716804|Nitrofurantoin|nitrofurantoin|mesh-list
65511517|NCT03716804|Cefixime|cefixime|mesh-list
65511518|NCT03716804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65511519|NCT03716804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65511520|NCT03716804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65511521|NCT03716804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65511522|NCT03716804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65511523|NCT03716804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511524|NCT03716804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511525|NCT03716804|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65511526|NCT03716804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65511527|NCT03716804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65511528|NCT03716804|Renal Agents|renal agents|mesh-ancestor
65511529|NCT01310166|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65511530|NCT01310166|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65511531|NCT01310166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511532|NCT01310166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65511533|NCT01310166|Immunologic Factors|immunologic factors|mesh-ancestor
65511534|NCT01310166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511535|NCT03733860|Alprostadil|alprostadil|mesh-list
65511536|NCT03733860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65511537|NCT03733860|Vasodilator Agents|vasodilator agents|mesh-ancestor
65511538|NCT03733860|Urological Agents|urological agents|mesh-ancestor
65511539|NCT03605862|Nitazoxanide|nitazoxanide|mesh-list
65511540|NCT03605862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65511541|NCT03605862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65511542|NCT01310244|Paclitaxel|paclitaxel|mesh-list
65511543|NCT01310244|Carboplatin|carboplatin|mesh-list
65511544|NCT01310244|Belinostat|belinostat|mesh-list
65511545|NCT01310244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65511546|NCT01310244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511547|NCT01310244|Tubulin Modulators|tubulin modulators|mesh-ancestor
65511548|NCT01310244|Antimitotic Agents|antimitotic agents|mesh-ancestor
65511549|NCT01310244|Mitosis Modulators|mitosis modulators|mesh-ancestor
65511550|NCT01310244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511551|NCT01310244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65511552|NCT01310244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65511553|NCT03672006|Heparin|heparin|mesh-list
65309218|NCT00672646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65511554|NCT03672006|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65511555|NCT03672006|Anticoagulants|anticoagulants|mesh-ancestor
65511556|NCT03672006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65511557|NCT03672006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65511558|NCT03672006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511559|NCT03621072|Fluconazole|fluconazole|mesh-list
65511560|NCT03621072|Antifungal Agents|antifungal agents|mesh-ancestor
65511561|NCT03621072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65511562|NCT03621072|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65511563|NCT03621072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65511564|NCT03621072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65511565|NCT03621072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511566|NCT03621072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65511567|NCT03621072|Hormone Antagonists|hormone antagonists|mesh-ancestor
65511568|NCT03621072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65511569|NCT03621072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511570|NCT03621072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65511571|NCT03621072|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65511572|NCT03512288|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65511573|NCT03512288|Immunologic Factors|immunologic factors|mesh-ancestor
65511574|NCT03512288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511575|NCT01311050|Bevacizumab|bevacizumab|mesh-list
65511576|NCT01311050|Capecitabine|capecitabine|mesh-list
65511577|NCT01311050|Oxaliplatin|oxaliplatin|mesh-list
65511578|NCT01311050|Irinotecan|irinotecan|mesh-list
65511579|NCT01311050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65511580|NCT01311050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511581|NCT01311050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65511582|NCT01311050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65511583|NCT01311050|Growth Substances|growth substances|mesh-ancestor
65511584|NCT01311050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511585|NCT01311050|Growth Inhibitors|growth inhibitors|mesh-ancestor
65511586|NCT01311050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65511587|NCT01311050|Antimetabolites|antimetabolites|mesh-ancestor
65511588|NCT01311050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511589|NCT01311050|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65511590|NCT01311050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65511591|NCT01311050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65511592|NCT04498468|Dexamethasone|dexamethasone|mesh-list
65511593|NCT04498468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65511594|NCT04498468|Antiemetics|antiemetics|mesh-ancestor
65511595|NCT04498468|Autonomic Agents|autonomic agents|mesh-ancestor
65511596|NCT04498468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511597|NCT04498468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511598|NCT04498468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65511599|NCT04498468|Glucocorticoids|glucocorticoids|mesh-ancestor
65511600|NCT04498468|Hormones|hormones|mesh-ancestor
65511601|NCT04498468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65511602|NCT04498468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65511603|NCT04498468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511604|NCT03700450|Cyclophosphamide|cyclophosphamide|mesh-list
65511605|NCT03700450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65511606|NCT03700450|Immunologic Factors|immunologic factors|mesh-ancestor
65511607|NCT03700450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511608|NCT03700450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65511609|NCT03700450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65511610|NCT03700450|Alkylating Agents|alkylating agents|mesh-ancestor
65511611|NCT03700450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511612|NCT03700450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511613|NCT03700450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65511614|NCT03702946|Oxytocin|oxytocin|mesh-list
65511615|NCT03702946|Oxytocics|oxytocics|mesh-ancestor
65511616|NCT03702946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65511617|NCT03702946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511618|NCT04491526|Tamsulosin|tamsulosin|mesh-list
65511619|NCT04491526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65511620|NCT04491526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65511621|NCT04491526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65511622|NCT04491526|Adrenergic Agents|adrenergic agents|mesh-ancestor
65511623|NCT04491526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65511624|NCT04491526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511625|NCT04491526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511626|NCT04491526|Urological Agents|urological agents|mesh-ancestor
65511627|NCT04484350|Enalapril|enalapril|mesh-list
65511628|NCT04484350|Hydralazine|hydralazine|mesh-list
65511629|NCT04484350|Labetalol|labetalol|mesh-list
65309293|NCT00670930|Omalizumab|omalizumab|mesh-list
65511630|NCT04484350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65511631|NCT04484350|Protease Inhibitors|protease inhibitors|mesh-ancestor
65511632|NCT04484350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65511633|NCT04484350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511634|NCT04484350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65511635|NCT04484350|Vasodilator Agents|vasodilator agents|mesh-ancestor
65511636|NCT04484350|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65511637|NCT04484350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65511638|NCT04484350|Adrenergic Agents|adrenergic agents|mesh-ancestor
65511639|NCT04484350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65511640|NCT04484350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511641|NCT04484350|Sympathomimetics|sympathomimetics|mesh-ancestor
65511642|NCT04484350|Autonomic Agents|autonomic agents|mesh-ancestor
65511643|NCT04484350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511644|NCT04484350|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65511645|NCT04484350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65511646|NCT03699904|Valacyclovir|valacyclovir|mesh-list
65511647|NCT03699904|Antiviral Agents|antiviral agents|mesh-ancestor
65511648|NCT03699904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65511649|NCT03697018|Lithium Carbonate|lithium carbonate|mesh-list
65511650|NCT03697018|Antidepressive Agents|antidepressive agents|mesh-ancestor
65511651|NCT03697018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65511652|NCT03697018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65511653|NCT03697018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511654|NCT03697018|Antimanic Agents|antimanic agents|mesh-ancestor
65511655|NCT03697018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65511656|NCT03697018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65511657|NCT03697018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511658|NCT03696940|Atorvastatin|atorvastatin|mesh-list
65511659|NCT03696940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65511660|NCT03696940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65511661|NCT03696940|Antimetabolites|antimetabolites|mesh-ancestor
65511662|NCT03696940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511663|NCT03696940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65511664|NCT03696940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65511665|NCT03696940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65511666|NCT01613118|Irbesartan|irbesartan|mesh-list
65511667|NCT01613118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65511668|NCT01613118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65511669|NCT01613118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65511670|NCT01613118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511671|NCT03731442|Paclitaxel|paclitaxel|mesh-list
65511672|NCT03731442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65511673|NCT03731442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511674|NCT03731442|Tubulin Modulators|tubulin modulators|mesh-ancestor
65511675|NCT03731442|Antimitotic Agents|antimitotic agents|mesh-ancestor
65511676|NCT03731442|Mitosis Modulators|mitosis modulators|mesh-ancestor
65511677|NCT03731442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511678|NCT03702400|Phenylephrine|phenylephrine|mesh-list
65511679|NCT03702400|Oxymetazoline|oxymetazoline|mesh-list
65511680|NCT03702400|Norepinephrine|norepinephrine|mesh-list
65511681|NCT03702400|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65511682|NCT03702400|Mydriatics|mydriatics|mesh-ancestor
65511683|NCT03702400|Autonomic Agents|autonomic agents|mesh-ancestor
65511684|NCT03702400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511685|NCT03702400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511686|NCT03702400|Sympathomimetics|sympathomimetics|mesh-ancestor
65511687|NCT03702400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65511688|NCT03702400|Nasal Decongestants|nasal decongestants|mesh-ancestor
65511689|NCT03702400|Respiratory System Agents|respiratory system agents|mesh-ancestor
65511690|NCT03702400|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65511691|NCT03702400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65511692|NCT03702400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65511693|NCT03702400|Adrenergic Agents|adrenergic agents|mesh-ancestor
65511694|NCT03702400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65511695|NCT03702400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511696|NCT03702400|Protective Agents|protective agents|mesh-ancestor
65511697|NCT04465318|Nicotine|nicotine|mesh-list
65511698|NCT04465318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65511699|NCT04465318|Autonomic Agents|autonomic agents|mesh-ancestor
65511700|NCT04465318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511701|NCT04465318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511702|NCT04465318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65511703|NCT04465318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65511704|NCT04465318|Cholinergic Agents|cholinergic agents|mesh-ancestor
65511705|NCT04465318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65511706|NCT04465318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511707|NCT03699202|Ziresovir|ziresovir|mesh-list
65511708|NCT03699202|Antiviral Agents|antiviral agents|mesh-ancestor
65511709|NCT03699202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65511710|NCT03598140|Sildenafil Citrate|sildenafil citrate|mesh-list
65511711|NCT03598140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511712|NCT03598140|Vasodilator Agents|vasodilator agents|mesh-ancestor
65511713|NCT03598140|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65511714|NCT03598140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65511715|NCT03598140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65511716|NCT03598140|Urological Agents|urological agents|mesh-ancestor
65511717|NCT04457596|Trastuzumab|trastuzumab|mesh-list
65511718|NCT04457596|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65511719|NCT04457596|Maytansine|maytansine|mesh-list
65511720|NCT04457596|Tucatinib|tucatinib|mesh-list
65511721|NCT04457596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65511722|NCT04457596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511723|NCT04457596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65511724|NCT04457596|Tubulin Modulators|tubulin modulators|mesh-ancestor
65511725|NCT04457596|Antimitotic Agents|antimitotic agents|mesh-ancestor
65511726|NCT04457596|Mitosis Modulators|mitosis modulators|mesh-ancestor
65511727|NCT04457596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511728|NCT04457596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65511729|NCT04457596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65511730|NCT03644550|Pembrolizumab|pembrolizumab|mesh-list
65511731|NCT03644550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65511732|NCT03644550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511733|NCT05668650|Pembrolizumab|pembrolizumab|mesh-list
65511734|NCT05668650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65511735|NCT05668650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511736|NCT03511664|177Lu-PSMA-617|177lu-psma-617|mesh-list
65511737|NCT03511664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65511738|NCT03511664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511739|NCT00054717|Ritonavir|ritonavir|mesh-list
65511740|NCT00054717|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
65511741|NCT00054717|Tipranavir|tipranavir|mesh-list
65511742|NCT00054717|Protease Inhibitors|protease inhibitors|mesh-list
65511743|NCT00054717|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65511744|NCT00054717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65511745|NCT00054717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511746|NCT00054717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65511747|NCT00054717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65511748|NCT00054717|Antiviral Agents|antiviral agents|mesh-ancestor
65511749|NCT00054717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65511750|NCT00054717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65511751|NCT00054717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65511752|NCT03430856|Insulin|insulin|mesh-list
65511753|NCT03430856|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65511754|NCT03430856|Insulin Aspart|insulin aspart|mesh-list
65511755|NCT03430856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65511756|NCT03430856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511757|NCT01097265|Capecitabine|capecitabine|mesh-list
65511758|NCT01097265|Oxaliplatin|oxaliplatin|mesh-list
65511759|NCT01097265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65511760|NCT01097265|Antimetabolites|antimetabolites|mesh-ancestor
65511761|NCT01097265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511762|NCT01097265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511763|NCT03731286|Caffeine|caffeine|mesh-list
65511764|NCT03731286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65511765|NCT03731286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511766|NCT03731286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65511767|NCT03731286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65511768|NCT03731286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511769|NCT03731286|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65511770|NCT03731286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65511771|NCT03731286|Purinergic Agents|purinergic agents|mesh-ancestor
65511772|NCT03731286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65511773|NCT00066807|Tamoxifen|tamoxifen|mesh-list
65511774|NCT00066807|Epirubicin|epirubicin|mesh-list
65511775|NCT00066807|Exemestane|exemestane|mesh-list
65309478|NCT00772174|Metformin|metformin|mesh-list
65511776|NCT00066807|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65511777|NCT00066807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65511778|NCT00066807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511779|NCT00066807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65511780|NCT00066807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65511781|NCT00066807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65511782|NCT00066807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511783|NCT00066807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65511784|NCT00066807|Hormone Antagonists|hormone antagonists|mesh-ancestor
65511785|NCT00066807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65511786|NCT00066807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511787|NCT00066807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65511788|NCT00066807|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65511789|NCT00066807|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65511790|NCT00066807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65511791|NCT00066807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65511792|NCT00066807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65511793|NCT00066807|Luteolytic Agents|luteolytic agents|mesh-ancestor
65511794|NCT00066807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65511795|NCT00066807|Contraceptive Agents|contraceptive agents|mesh-ancestor
65511796|NCT00066807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65511797|NCT00066807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65511798|NCT03619330|Liraglutide|liraglutide|mesh-list
65511799|NCT03619330|Testosterone|testosterone|mesh-list
65511800|NCT03619330|Androgens|androgens|mesh-ancestor
65511801|NCT03619330|Hormones|hormones|mesh-ancestor
65511802|NCT03619330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65511803|NCT03619330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511804|NCT03619330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65511805|NCT03619330|Incretins|incretins|mesh-ancestor
65511806|NCT04457284|Nivolumab|nivolumab|mesh-list
65511807|NCT04457284|Temozolomide|temozolomide|mesh-list
65511808|NCT04457284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511809|NCT04457284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65511810|NCT04457284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65511811|NCT04457284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511812|NCT04457284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65511813|NCT04457284|Alkylating Agents|alkylating agents|mesh-ancestor
65511814|NCT00054639|Rituximab|rituximab|mesh-list
65511815|NCT00054639|Oblimersen|oblimersen|mesh-list
65511816|NCT00054639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65511817|NCT00054639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511818|NCT00054639|Immunologic Factors|immunologic factors|mesh-ancestor
65511819|NCT00054639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511820|NCT00054639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65511821|NCT02530359|Pirfenidone|pirfenidone|mesh-list
65511822|NCT02530359|Analgesics|analgesics|mesh-ancestor
65511823|NCT02530359|Sensory System Agents|sensory system agents|mesh-ancestor
65511824|NCT02530359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511825|NCT02530359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511826|NCT02530359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65511827|NCT02530359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65511828|NCT02530359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65511829|NCT02530359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65511830|NCT02530359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511831|NCT03428360|Diazepam|diazepam|mesh-list
65511832|NCT03428360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65511833|NCT03428360|Anticonvulsants|anticonvulsants|mesh-ancestor
65511834|NCT03428360|Antiemetics|antiemetics|mesh-ancestor
65511835|NCT03428360|Autonomic Agents|autonomic agents|mesh-ancestor
65511836|NCT03428360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511837|NCT03428360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511838|NCT03428360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65511839|NCT03428360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65511840|NCT03428360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65511841|NCT03428360|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65511842|NCT03428360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65511843|NCT03428360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65511844|NCT03428360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65511845|NCT03428360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65511846|NCT03428360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65511847|NCT03428360|Anesthetics, General|anesthetics, general|mesh-ancestor
65511848|NCT03428360|Anesthetics|anesthetics|mesh-ancestor
65511849|NCT03428360|GABA Modulators|gaba modulators|mesh-ancestor
65511850|NCT03428360|GABA Agents|gaba agents|mesh-ancestor
65511851|NCT03428360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65511852|NCT03428360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309518|NCT00772798|Paclitaxel|paclitaxel|mesh-list
65511853|NCT03427892|Brexpiprazole|brexpiprazole|mesh-list
65511854|NCT03427892|Serotonin Agents|serotonin agents|mesh-ancestor
65511855|NCT03427892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65511856|NCT03427892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511857|NCT03427892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511858|NCT03427892|Dopamine Agonists|dopamine agonists|mesh-ancestor
65511859|NCT03427892|Dopamine Agents|dopamine agents|mesh-ancestor
65511860|NCT03466658|Anti-Infective Agents|anti-infective agents|mesh-list
65511861|NCT03466658|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65511862|NCT04867928|Azacitidine|azacitidine|mesh-list
65511863|NCT04867928|Venetoclax|venetoclax|mesh-list
65511864|NCT04867928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65511865|NCT04867928|Antimetabolites|antimetabolites|mesh-ancestor
65511866|NCT04867928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511867|NCT04867928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511868|NCT04867928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65511869|NCT04670068|Cyclophosphamide|cyclophosphamide|mesh-list
65511870|NCT04670068|Fludarabine|fludarabine|mesh-list
65511871|NCT04670068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65511872|NCT04670068|Immunologic Factors|immunologic factors|mesh-ancestor
65511873|NCT04670068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511874|NCT04670068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65511875|NCT04670068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65511876|NCT04670068|Alkylating Agents|alkylating agents|mesh-ancestor
65511877|NCT04670068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511878|NCT04670068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511879|NCT04670068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65511880|NCT03425396|Nitrofurantoin|nitrofurantoin|mesh-list
65511881|NCT03425396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65511882|NCT03425396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65511883|NCT03425396|Renal Agents|renal agents|mesh-ancestor
65511884|NCT03425396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65511885|NCT03698734|Evening primrose oil|evening primrose oil|mesh-list
65511886|NCT03698734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65511887|NCT03698734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65511888|NCT03698734|Analgesics|analgesics|mesh-ancestor
65511889|NCT03698734|Sensory System Agents|sensory system agents|mesh-ancestor
65511890|NCT03698734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511891|NCT03698734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511892|NCT03698734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65511893|NCT03698734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65511894|NCT03698734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65511895|NCT03698734|Antimetabolites|antimetabolites|mesh-ancestor
65511896|NCT03698734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511897|NCT03698734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65511898|NCT03698734|Dermatologic Agents|dermatologic agents|mesh-ancestor
65511899|NCT00033657|Paclitaxel|paclitaxel|mesh-list
65511900|NCT00033657|Camptothecin|camptothecin|mesh-list
65511901|NCT00033657|Cisplatin|cisplatin|mesh-list
65511902|NCT00033657|Irinotecan|irinotecan|mesh-list
65511903|NCT00033657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65511904|NCT00033657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511905|NCT00033657|Tubulin Modulators|tubulin modulators|mesh-ancestor
65511906|NCT00033657|Antimitotic Agents|antimitotic agents|mesh-ancestor
65511907|NCT00033657|Mitosis Modulators|mitosis modulators|mesh-ancestor
65511908|NCT00033657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511909|NCT00033657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65511910|NCT00033657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65511911|NCT00033657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65511912|NCT04070157|Lofexidine|lofexidine|mesh-list
65511913|NCT04070157|Clonidine|clonidine|mesh-list
65511914|NCT04070157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65511915|NCT04070157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65511916|NCT04070157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511917|NCT04070157|Sensory System Agents|sensory system agents|mesh-ancestor
65511918|NCT04070157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511919|NCT04070157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65511920|NCT04070157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65511921|NCT04070157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65511922|NCT04070157|Adrenergic Agents|adrenergic agents|mesh-ancestor
65511923|NCT04070157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65511924|NCT04070157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511925|NCT04070157|Analgesics|analgesics|mesh-ancestor
65511926|NCT04070157|Sympatholytics|sympatholytics|mesh-ancestor
65511927|NCT04070157|Autonomic Agents|autonomic agents|mesh-ancestor
65511928|NCT01091337|Albuterol|albuterol|mesh-list
65511929|NCT01091337|Procaterol|procaterol|mesh-list
65511930|NCT01091337|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65511931|NCT01091337|Autonomic Agents|autonomic agents|mesh-ancestor
65511932|NCT01091337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511933|NCT01091337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511934|NCT01091337|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65511935|NCT01091337|Respiratory System Agents|respiratory system agents|mesh-ancestor
65511936|NCT01091337|Tocolytic Agents|tocolytic agents|mesh-ancestor
65511937|NCT01091337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65511938|NCT01091337|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65511939|NCT01091337|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65511940|NCT01091337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65511941|NCT01091337|Adrenergic Agents|adrenergic agents|mesh-ancestor
65511942|NCT01091337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65511943|NCT01091337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511944|NCT01091337|Sympathomimetics|sympathomimetics|mesh-ancestor
65511945|NCT03955809|Ketamine|ketamine|mesh-list
65511946|NCT03955809|Analgesics|analgesics|mesh-ancestor
65511947|NCT03955809|Sensory System Agents|sensory system agents|mesh-ancestor
65511948|NCT03955809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511949|NCT03955809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511950|NCT03955809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65511951|NCT03955809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65511952|NCT03955809|Anesthetics, General|anesthetics, general|mesh-ancestor
65511953|NCT03955809|Anesthetics|anesthetics|mesh-ancestor
65511954|NCT03955809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65511955|NCT03955809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65511956|NCT03955809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65511957|NCT03955809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65511958|NCT03955809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511959|NCT01094613|Mercaptopurine|mercaptopurine|mesh-list
65511960|NCT01094613|Antimetabolites|antimetabolites|mesh-ancestor
65511961|NCT01094613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511962|NCT01094613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65511963|NCT01094613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65511964|NCT01094613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65511965|NCT01094613|Immunologic Factors|immunologic factors|mesh-ancestor
65511966|NCT01094613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511967|NCT01094613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65511968|NCT01094613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65511969|NCT03953001|Lidocaine|lidocaine|mesh-list
65511970|NCT03953001|Epinephrine|epinephrine|mesh-list
65511971|NCT03953001|Anesthetics, Local|anesthetics, local|mesh-list
65511972|NCT03953001|Anesthetics|anesthetics|mesh-list
65511973|NCT03953001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65511974|NCT03953001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511975|NCT03953001|Sensory System Agents|sensory system agents|mesh-ancestor
65511976|NCT03953001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65511977|NCT03953001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65511978|NCT03953001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65511979|NCT03953001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65511980|NCT03953001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65511981|NCT03953001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65511982|NCT03953001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65511983|NCT03953001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65511984|NCT03953001|Adrenergic Agents|adrenergic agents|mesh-ancestor
65511985|NCT03953001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65511986|NCT03953001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65511987|NCT03953001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65511988|NCT03953001|Autonomic Agents|autonomic agents|mesh-ancestor
65511989|NCT03953001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65511990|NCT03953001|Respiratory System Agents|respiratory system agents|mesh-ancestor
65511991|NCT03953001|Mydriatics|mydriatics|mesh-ancestor
65511992|NCT03953001|Sympathomimetics|sympathomimetics|mesh-ancestor
65511993|NCT03953001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65511994|NCT01094769|Moxonidine|moxonidine|mesh-list
65511995|NCT01094769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65511996|NCT01091415|Calcium|calcium|mesh-list
65511997|NCT01091415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65511998|NCT01091415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65511999|NCT00032487|Metformin|metformin|mesh-list
65512000|NCT00032487|Glimepiride|glimepiride|mesh-list
65512001|NCT00032487|Rosiglitazone|rosiglitazone|mesh-list
65512002|NCT00032487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65512003|NCT00032487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309665|NCT00776074|Leuprolide|leuprolide|mesh-list
65512004|NCT00032487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65512005|NCT00032487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65512006|NCT00032487|Immunologic Factors|immunologic factors|mesh-ancestor
65512007|NCT01091493|Moxifloxacin|moxifloxacin|mesh-list
65512008|NCT01091493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65512009|NCT01091493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65512010|NCT01091493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65512011|NCT01091493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65512012|NCT01091493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512013|NCT01091493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512014|NCT01091493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512015|NCT03692416|Prednisone|prednisone|mesh-list
65512016|NCT03692416|Ibuprofen|ibuprofen|mesh-list
65512017|NCT03692416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65512018|NCT03692416|Methotrexate|methotrexate|mesh-list
65512019|NCT03692416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65512020|NCT03692416|Glucocorticoids|glucocorticoids|mesh-ancestor
65512021|NCT03692416|Hormones|hormones|mesh-ancestor
65512022|NCT03692416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65512023|NCT03692416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512024|NCT03692416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65512025|NCT03692416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512026|NCT03692416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65512027|NCT03692416|Abortifacient Agents|abortifacient agents|mesh-ancestor
65512028|NCT03692416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65512029|NCT03692416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65512030|NCT03692416|Antimetabolites|antimetabolites|mesh-ancestor
65512031|NCT03692416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512032|NCT03692416|Dermatologic Agents|dermatologic agents|mesh-ancestor
65512033|NCT03692416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512034|NCT03692416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65512035|NCT03692416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65512036|NCT03692416|Immunologic Factors|immunologic factors|mesh-ancestor
65512037|NCT03692416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65512038|NCT03692416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65512039|NCT03692416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65512040|NCT03692416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65512041|NCT03692416|Analgesics|analgesics|mesh-ancestor
65512042|NCT03692416|Sensory System Agents|sensory system agents|mesh-ancestor
65512043|NCT03692416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512044|NCT03692416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65512045|NCT03692416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65512046|NCT03692416|Protective Agents|protective agents|mesh-ancestor
65512047|NCT03594552|Baclofen|baclofen|mesh-list
65512048|NCT03594552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65512049|NCT03594552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512050|NCT03594552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65512051|NCT03594552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512052|NCT03594552|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65512053|NCT03594552|GABA Agonists|gaba agonists|mesh-ancestor
65512054|NCT03594552|GABA Agents|gaba agents|mesh-ancestor
65512055|NCT03594552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65512056|NCT03594552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512057|NCT03641508|Dexamethasone|dexamethasone|mesh-list
65512058|NCT03641508|Triamcinolone|triamcinolone|mesh-list
65512059|NCT03641508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65512060|NCT03641508|Antiemetics|antiemetics|mesh-ancestor
65512061|NCT03641508|Autonomic Agents|autonomic agents|mesh-ancestor
65512062|NCT03641508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512063|NCT03641508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512064|NCT03641508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65512065|NCT03641508|Glucocorticoids|glucocorticoids|mesh-ancestor
65512066|NCT03641508|Hormones|hormones|mesh-ancestor
65512067|NCT03641508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65512068|NCT03641508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65512069|NCT03641508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512070|NCT03624244|Letrozole|letrozole|mesh-list
65512071|NCT03624244|Exemestane|exemestane|mesh-list
65512072|NCT03624244|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65512073|NCT03624244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512074|NCT03624244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65512075|NCT03624244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512076|NCT03624244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512077|NCT03624244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65309743|NCT02627417|Dapsone|dapsone|mesh-list
65512078|NCT03624244|Hormone Antagonists|hormone antagonists|mesh-ancestor
65512079|NCT03624244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65512080|NCT03624244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512081|NCT00066573|Anastrozole|anastrozole|mesh-list
65512082|NCT00066573|Exemestane|exemestane|mesh-list
65512083|NCT00066573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65512084|NCT00066573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512085|NCT00066573|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65512086|NCT00066573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65512087|NCT00066573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512088|NCT00066573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512089|NCT00066573|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65512090|NCT00066573|Hormone Antagonists|hormone antagonists|mesh-ancestor
65512091|NCT00066573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65064446|NCT00261287|Ciclesonide|ciclesonide|mesh-list
65512092|NCT00066573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512093|NCT03465878|Insulin Lispro|insulin lispro|mesh-list
65512094|NCT03465878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65512095|NCT03465878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512096|NCT01091571|Dipyridamole|dipyridamole|mesh-list
65512097|NCT01091571|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65512098|NCT01091571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512099|NCT01091571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512100|NCT01091571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65512101|NCT01091571|Vasodilator Agents|vasodilator agents|mesh-ancestor
65512102|NCT01091649|Ritonavir|ritonavir|mesh-list
65512103|NCT01091649|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65512104|NCT01091649|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65512105|NCT01091649|Protease Inhibitors|protease inhibitors|mesh-ancestor
65512106|NCT01091649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512107|NCT01091649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512108|NCT01091649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65512109|NCT01091649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65512110|NCT01091649|Antiviral Agents|antiviral agents|mesh-ancestor
65512111|NCT01091649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65512112|NCT01091649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65512113|NCT01091649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65512114|NCT01091727|Botulinum Toxins|botulinum toxins|mesh-list
65512115|NCT01091727|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65512116|NCT01091727|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65512117|NCT01091727|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65512118|NCT01091727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65512119|NCT01091727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512120|NCT01091727|Cholinergic Agents|cholinergic agents|mesh-ancestor
65512121|NCT01091727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65512122|NCT01091727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512123|NCT01091727|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65512124|NCT01091727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512125|NCT03421730|Budesonide|budesonide|mesh-list
65512126|NCT03421730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65512127|NCT03421730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65512128|NCT03421730|Autonomic Agents|autonomic agents|mesh-ancestor
65512129|NCT03421730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512130|NCT03421730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512131|NCT03421730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65512132|NCT03421730|Respiratory System Agents|respiratory system agents|mesh-ancestor
65512133|NCT03421730|Glucocorticoids|glucocorticoids|mesh-ancestor
65512134|NCT03421730|Hormones|hormones|mesh-ancestor
65512135|NCT03421730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65512136|NCT01094925|Gabapentin|gabapentin|mesh-list
65512137|NCT01094925|Analgesics|analgesics|mesh-ancestor
65512138|NCT01094925|Sensory System Agents|sensory system agents|mesh-ancestor
65512139|NCT01094925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512140|NCT01094925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512141|NCT01094925|Anticonvulsants|anticonvulsants|mesh-ancestor
65512142|NCT01094925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65512143|NCT01094925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65512144|NCT01094925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65512145|NCT01094925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65512146|NCT01094925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65512147|NCT01094925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65512148|NCT01094925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65512149|NCT01094925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512150|NCT01094925|Antimanic Agents|antimanic agents|mesh-ancestor
65512151|NCT03718676|Pemetrexed|pemetrexed|mesh-list
65512152|NCT03718676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512153|NCT03718676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512154|NCT03718676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512155|NCT03718676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65512156|NCT03718676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65512157|NCT00054327|Cytarabine|cytarabine|mesh-list
65512158|NCT00054327|Cyclophosphamide|cyclophosphamide|mesh-list
65512159|NCT00054327|Busulfan|busulfan|mesh-list
65512160|NCT00054327|Etoposide|etoposide|mesh-list
65512161|NCT00054327|Etoposide phosphate|etoposide phosphate|mesh-list
65512162|NCT00054327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65512163|NCT00054327|Immunologic Factors|immunologic factors|mesh-ancestor
65512164|NCT00054327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512165|NCT00054327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65512166|NCT00054327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65512167|NCT00054327|Alkylating Agents|alkylating agents|mesh-ancestor
65512168|NCT00054327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512169|NCT00054327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512170|NCT00054327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65512171|NCT00054327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65512172|NCT00054327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65512173|NCT00054327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65512174|NCT00054327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512175|NCT00054327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65512176|NCT00054327|Antimetabolites|antimetabolites|mesh-ancestor
65512177|NCT00054327|Antiviral Agents|antiviral agents|mesh-ancestor
65512178|NCT00054327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65512179|NCT03029650|Scopolamine|scopolamine|mesh-list
65512180|NCT03029650|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65512181|NCT03029650|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65512182|NCT03029650|Antiemetics|antiemetics|mesh-ancestor
65512183|NCT03029650|Autonomic Agents|autonomic agents|mesh-ancestor
65512184|NCT03029650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512185|NCT03029650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512186|NCT03029650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65512187|NCT03029650|Mydriatics|mydriatics|mesh-ancestor
65512188|NCT03029650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65512189|NCT03029650|Cholinergic Agents|cholinergic agents|mesh-ancestor
65512190|NCT03029650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65512191|NCT03029650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512192|NCT03029650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65512193|NCT03029650|Parasympatholytics|parasympatholytics|mesh-ancestor
65512194|NCT03462680|Niacin|niacin|mesh-list
65512195|NCT03462680|Vitamins|vitamins|mesh-ancestor
65512196|NCT03462680|Micronutrients|micronutrients|mesh-ancestor
65512197|NCT03462680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512198|NCT03462680|Vitamin B Complex|vitamin b complex|mesh-ancestor
65512199|NCT03462680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65512200|NCT03462680|Antimetabolites|antimetabolites|mesh-ancestor
65512201|NCT03462680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512202|NCT03462680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65512203|NCT03462680|Vasodilator Agents|vasodilator agents|mesh-ancestor
65512204|NCT03692026|Melatonin|melatonin|mesh-list
65512205|NCT03692026|Hyaluronic Acid|hyaluronic acid|mesh-list
65512206|NCT03692026|Antioxidants|antioxidants|mesh-ancestor
65512207|NCT03692026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512208|NCT03692026|Protective Agents|protective agents|mesh-ancestor
65512209|NCT03692026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512210|NCT03692026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65512211|NCT03692026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65512212|NCT03692026|Immunologic Factors|immunologic factors|mesh-ancestor
65512213|NCT03692026|Viscosupplements|viscosupplements|mesh-ancestor
65512214|NCT03624322|Olanzapine|olanzapine|mesh-list
65512215|NCT03624322|Antiemetics|antiemetics|mesh-ancestor
65512216|NCT03624322|Autonomic Agents|autonomic agents|mesh-ancestor
65512217|NCT03624322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512218|NCT03624322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512219|NCT03624322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65512220|NCT03624322|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65512221|NCT03624322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65512222|NCT03624322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65512223|NCT03624322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65512224|NCT03624322|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65512225|NCT03624322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65512226|NCT03624322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65512227|NCT03624322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512228|NCT03624322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65512229|NCT03624322|Serotonin Agents|serotonin agents|mesh-ancestor
65512230|NCT01097811|Erythromycin|erythromycin|mesh-list
65512231|NCT01097811|Erythromycin Estolate|erythromycin estolate|mesh-list
65512232|NCT01097811|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65512233|NCT01097811|Erythromycin stearate|erythromycin stearate|mesh-list
65512234|NCT01097811|Neomycin|neomycin|mesh-list
65512235|NCT01097811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65512236|NCT01097811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65512237|NCT01097811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65512238|NCT01097811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65512239|NCT01097811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569515|NCT01238705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65512240|NCT01097811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512241|NCT03418922|Nivolumab|nivolumab|mesh-list
65512242|NCT03418922|Lenvatinib|lenvatinib|mesh-list
65512243|NCT03418922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65512244|NCT03418922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512245|NCT03418922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65512246|NCT03418922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512247|NCT03418922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65512248|NCT03418922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512249|NCT03957291|Chlorhexidine|chlorhexidine|mesh-list
65512250|NCT03957291|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65512251|NCT03957291|Povidone-Iodine|povidone-iodine|mesh-list
65512252|NCT03957291|Povidone|povidone|mesh-list
65512253|NCT03957291|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65512254|NCT03957291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65512255|NCT03957291|Disinfectants|disinfectants|mesh-ancestor
65512256|NCT03957291|Dermatologic Agents|dermatologic agents|mesh-ancestor
65512257|NCT03957291|Plasma Substitutes|plasma substitutes|mesh-ancestor
65512258|NCT03957291|Blood Substitutes|blood substitutes|mesh-ancestor
65512259|NCT04044976|Caffeine|caffeine|mesh-list
65512260|NCT04044976|Caffeine citrate|caffeine citrate|mesh-list
65512261|NCT04044976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512262|NCT04044976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65512263|NCT04044976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512264|NCT04044976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65512265|NCT04044976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512266|NCT04044976|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65512267|NCT04044976|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65512268|NCT04044976|Purinergic Agents|purinergic agents|mesh-ancestor
65512269|NCT04044976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65512270|NCT03691636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65512271|NCT03691636|Lifitegrast|lifitegrast|mesh-list
65512272|NCT03691636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65512273|NCT04295902|Pyrithione zinc|pyrithione zinc|mesh-list
65512274|NCT04295902|Keratolytic Agents|keratolytic agents|mesh-ancestor
65512275|NCT04295902|Dermatologic Agents|dermatologic agents|mesh-ancestor
65512276|NCT03956121|Magnesium Sulfate|magnesium sulfate|mesh-list
65512277|NCT03956121|Analgesics|analgesics|mesh-ancestor
65512278|NCT03956121|Sensory System Agents|sensory system agents|mesh-ancestor
65512279|NCT03956121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512280|NCT03956121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512281|NCT03956121|Anesthetics|anesthetics|mesh-ancestor
65512282|NCT03956121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65512283|NCT03956121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65512284|NCT03956121|Anticonvulsants|anticonvulsants|mesh-ancestor
65512285|NCT03956121|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65512286|NCT03956121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65512287|NCT03956121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512288|NCT03956121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65512289|NCT03956121|Tocolytic Agents|tocolytic agents|mesh-ancestor
65512290|NCT03956121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65512291|NCT03636906|Vaccines|vaccines|mesh-list
65512292|NCT03636906|Immunologic Factors|immunologic factors|mesh-ancestor
65512293|NCT03636906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512294|NCT03028870|Naproxen|naproxen|mesh-list
65512295|NCT03028870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65512296|NCT03028870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65512297|NCT03028870|Analgesics|analgesics|mesh-ancestor
65512298|NCT03028870|Sensory System Agents|sensory system agents|mesh-ancestor
65512299|NCT03028870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512300|NCT03028870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512301|NCT03028870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65512302|NCT03028870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65512303|NCT03028870|Gout Suppressants|gout suppressants|mesh-ancestor
65512304|NCT03028870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65512305|NCT03028870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512306|NCT03028870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512307|NCT01098201|Certolizumab Pegol|certolizumab pegol|mesh-list
65512308|NCT01098201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65512309|NCT01098201|Immunologic Factors|immunologic factors|mesh-ancestor
65512310|NCT01098201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512311|NCT01098201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65512312|NCT01092039|Lactoferrin|lactoferrin|mesh-list
65512313|NCT01092039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65512314|NCT03663582|Teduglutide|teduglutide|mesh-list
65512315|NCT03663582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65512316|NCT03663582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65512317|NCT03663582|Protective Agents|protective agents|mesh-ancestor
65512318|NCT03663582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512319|NCT01098357|Becaplermin|becaplermin|mesh-list
65512320|NCT01098357|Anticoagulants|anticoagulants|mesh-ancestor
65512321|NCT01098357|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
65512322|NCT01098357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65512323|NCT01098357|Growth Substances|growth substances|mesh-ancestor
65512324|NCT01098357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512325|NCT03730740|Lenalidomide|lenalidomide|mesh-list
65512326|NCT03730740|Immunologic Factors|immunologic factors|mesh-ancestor
65512327|NCT03730740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512328|NCT03730740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65512329|NCT03730740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65512330|NCT03730740|Growth Substances|growth substances|mesh-ancestor
65512331|NCT03730740|Growth Inhibitors|growth inhibitors|mesh-ancestor
65512332|NCT03730740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512333|NCT01098513|Dolutegravir|dolutegravir|mesh-list
65512334|NCT01098513|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65512335|NCT01098513|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65512336|NCT01098513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512337|NCT01098513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512338|NCT01098513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65512339|NCT01098513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65512340|NCT01098513|Antiviral Agents|antiviral agents|mesh-ancestor
65512341|NCT01098513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65512342|NCT03693976|Xylometazoline|xylometazoline|mesh-list
65512343|NCT03693976|Nasal Decongestants|nasal decongestants|mesh-ancestor
65512344|NCT03693976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65512345|NCT03693976|Respiratory System Agents|respiratory system agents|mesh-ancestor
65512346|NCT03730584|Ropivacaine|ropivacaine|mesh-list
65512347|NCT03730584|Anesthetics, Local|anesthetics, local|mesh-ancestor
65512348|NCT03730584|Anesthetics|anesthetics|mesh-ancestor
65512349|NCT03730584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65512350|NCT03730584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512351|NCT03730584|Sensory System Agents|sensory system agents|mesh-ancestor
65512352|NCT03730584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512353|NCT03502616|Tofacitinib|tofacitinib|mesh-list
65512354|NCT03502616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65512355|NCT03502616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512356|NCT03502616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512357|NCT04003012|Lidocaine|lidocaine|mesh-list
65512358|NCT04003012|Anesthetics, Local|anesthetics, local|mesh-ancestor
65512359|NCT04003012|Anesthetics|anesthetics|mesh-ancestor
65512360|NCT04003012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65512361|NCT04003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512362|NCT04003012|Sensory System Agents|sensory system agents|mesh-ancestor
65512363|NCT04003012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512364|NCT04003012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65512365|NCT04003012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65512366|NCT04003012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65512367|NCT04003012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65512368|NCT04003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512369|NCT04177810|Plerixafor|plerixafor|mesh-list
65512370|NCT04177810|Cemiplimab|cemiplimab|mesh-list
65512371|NCT04177810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65512372|NCT04177810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65512373|NCT04177810|Antiviral Agents|antiviral agents|mesh-ancestor
65512374|NCT04177810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65512375|NCT04177810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65512376|NCT04177810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512377|NCT05666076|Bupivacaine|bupivacaine|mesh-list
65310038|NCT00709332|Vitamin B Complex|vitamin b complex|mesh-ancestor
65512378|NCT05666076|Prilocaine|prilocaine|mesh-list
65512379|NCT05666076|Anesthetics, Local|anesthetics, local|mesh-ancestor
65512380|NCT05666076|Anesthetics|anesthetics|mesh-ancestor
65512381|NCT05666076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65512382|NCT05666076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512383|NCT05666076|Sensory System Agents|sensory system agents|mesh-ancestor
65512384|NCT05666076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512385|NCT03028012|Dexamethasone|dexamethasone|mesh-list
65512386|NCT03028012|Ketorolac|ketorolac|mesh-list
65512387|NCT03028012|Lidocaine|lidocaine|mesh-list
65512388|NCT03028012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65512389|NCT03028012|Antiemetics|antiemetics|mesh-ancestor
65512390|NCT03028012|Autonomic Agents|autonomic agents|mesh-ancestor
65512391|NCT03028012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512392|NCT03028012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512393|NCT03028012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65512394|NCT03028012|Glucocorticoids|glucocorticoids|mesh-ancestor
65512395|NCT03028012|Hormones|hormones|mesh-ancestor
65512396|NCT03028012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65512397|NCT03028012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65512398|NCT03028012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512399|NCT03028012|Anesthetics, Local|anesthetics, local|mesh-ancestor
65512400|NCT03028012|Anesthetics|anesthetics|mesh-ancestor
65512401|NCT03028012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65512402|NCT03028012|Sensory System Agents|sensory system agents|mesh-ancestor
65512403|NCT03028012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65512404|NCT03028012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65512405|NCT03028012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65512406|NCT03028012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65512407|NCT03028012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512408|NCT03028012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65512409|NCT03028012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65512410|NCT03028012|Analgesics|analgesics|mesh-ancestor
65512411|NCT03028012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65512412|NCT03028012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65512413|NCT03028012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512414|NCT03634800|Nivolumab|nivolumab|mesh-list
65512415|NCT03634800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65512416|NCT03634800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512417|NCT03634800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65512418|NCT03634800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512419|NCT03662334|Insulin, Short-Acting|insulin, short-acting|mesh-list
65512420|NCT03662334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65512421|NCT03662334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512422|NCT02955186|Saracatinib|saracatinib|mesh-list
65512423|NCT02955186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512424|NCT02955186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512425|NCT02955186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512426|NCT03693508|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65512427|NCT03693508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65512428|NCT03693508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65512429|NCT03693508|Antiviral Agents|antiviral agents|mesh-ancestor
65512430|NCT03693508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65512431|NCT03690778|Metformin|metformin|mesh-list
65512432|NCT03690778|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65512433|NCT03690778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65512434|NCT03690778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512435|NCT03690778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65512436|NCT03690778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65512437|NCT03690778|Antimetabolites|antimetabolites|mesh-ancestor
65512438|NCT03690778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512439|NCT03690778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65512440|NCT03690778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65512441|NCT03690778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512442|NCT03715634|Buprenorphine|buprenorphine|mesh-list
65512443|NCT03715634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65512444|NCT03715634|Narcotics|narcotics|mesh-ancestor
65512445|NCT03715634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65512446|NCT03715634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512447|NCT03715634|Analgesics|analgesics|mesh-ancestor
65512448|NCT03715634|Sensory System Agents|sensory system agents|mesh-ancestor
65512449|NCT03715634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512450|NCT03715634|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65310116|NCT05758662|Listerine|listerine|mesh-list
65512451|NCT03502070|Tobramycin|tobramycin|mesh-list
65512452|NCT03502070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65512453|NCT03502070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65512454|NCT04158934|Factor VIII|factor viii|mesh-list
65512455|NCT04158934|BAX 855|bax 855|mesh-list
65512456|NCT04158934|Coagulants|coagulants|mesh-ancestor
65512457|NCT03715556|Amiodarone|amiodarone|mesh-list
65512458|NCT03715556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65512459|NCT03715556|Vasodilator Agents|vasodilator agents|mesh-ancestor
65512460|NCT03715556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65512461|NCT03715556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65512462|NCT03715556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512463|NCT03715556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65512464|NCT03715556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65512465|NCT03715556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65512466|NCT03715556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512467|NCT03715556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65512468|NCT03715556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65512469|NCT03715556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65512470|NCT03715478|Dexamethasone|dexamethasone|mesh-list
65512471|NCT03715478|Pomalidomide|pomalidomide|mesh-list
65512472|NCT03715478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65512473|NCT03715478|Antiemetics|antiemetics|mesh-ancestor
65512474|NCT03715478|Autonomic Agents|autonomic agents|mesh-ancestor
65512475|NCT03715478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512476|NCT03715478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512477|NCT03715478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65512478|NCT03715478|Glucocorticoids|glucocorticoids|mesh-ancestor
65512479|NCT03715478|Hormones|hormones|mesh-ancestor
65512480|NCT03715478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65512481|NCT03715478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65512482|NCT03715478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512483|NCT03715478|Immunologic Factors|immunologic factors|mesh-ancestor
65512484|NCT03715478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65512485|NCT03715478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65512486|NCT03715478|Growth Substances|growth substances|mesh-ancestor
65512487|NCT03715478|Growth Inhibitors|growth inhibitors|mesh-ancestor
65512488|NCT03730038|Pitavastatin|pitavastatin|mesh-list
65512489|NCT03730038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65512490|NCT03730038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65512491|NCT03730038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65512492|NCT03730038|Antimetabolites|antimetabolites|mesh-ancestor
65512493|NCT03730038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512494|NCT03730038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512495|NCT03730038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65512496|NCT03725904|Progesterone|progesterone|mesh-list
65512497|NCT03725904|Progestins|progestins|mesh-ancestor
65512498|NCT03725904|Hormones|hormones|mesh-ancestor
65512499|NCT03725904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65512500|NCT03725904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512501|NCT03730272|Analgesics|analgesics|mesh-list
65512502|NCT03730272|Sensory System Agents|sensory system agents|mesh-ancestor
65512503|NCT03730272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512504|NCT03730272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512505|NCT03585504|Contraceptive Agents|contraceptive agents|mesh-list
65512506|NCT03585504|Etonogestrel|etonogestrel|mesh-list
65512507|NCT03585504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65512508|NCT03585504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512509|NCT03585504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65512510|NCT03585504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65512511|NCT03690622|Dexmedetomidine|dexmedetomidine|mesh-list
65512512|NCT03690622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65512513|NCT03690622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65512514|NCT03690622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512515|NCT03690622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65512516|NCT03690622|Analgesics|analgesics|mesh-ancestor
65512517|NCT03690622|Sensory System Agents|sensory system agents|mesh-ancestor
65512518|NCT03690622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512519|NCT03690622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65512520|NCT03690622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65512521|NCT03690622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65512522|NCT03690622|Adrenergic Agents|adrenergic agents|mesh-ancestor
65512523|NCT03690622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65512524|NCT03690622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512525|NCT03715322|Tobramycin|tobramycin|mesh-list
65512526|NCT03715322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65512527|NCT03715322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65512528|NCT03687268|Naloxone|naloxone|mesh-list
65512529|NCT03687268|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65512530|NCT03687268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512531|NCT03687268|Sensory System Agents|sensory system agents|mesh-ancestor
65512532|NCT03687268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512533|NCT03576066|Tenofovir|tenofovir|mesh-list
65512534|NCT03576066|Entecavir|entecavir|mesh-list
65512535|NCT03576066|Antiviral Agents|antiviral agents|mesh-ancestor
65512536|NCT03576066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65512537|NCT03576066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65512538|NCT03576066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65512539|NCT03576066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512540|NCT03576066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512541|NCT03576066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65512542|NCT03576066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65512543|NCT03639480|Amlodipine|amlodipine|mesh-list
65512544|NCT03639480|Valsartan|valsartan|mesh-list
65512545|NCT03639480|Atorvastatin|atorvastatin|mesh-list
65512546|NCT03639480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65512547|NCT03639480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65512548|NCT03639480|Antimetabolites|antimetabolites|mesh-ancestor
65512549|NCT03639480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512550|NCT03639480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65512551|NCT03639480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65512552|NCT03639480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512553|NCT03639480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65512554|NCT03639480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65512555|NCT03639480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65512556|NCT03639480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65512557|NCT03639480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512558|NCT03639480|Vasodilator Agents|vasodilator agents|mesh-ancestor
65512559|NCT03639480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65512560|NCT03639480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65512561|NCT03689998|Melatonin|melatonin|mesh-list
65512562|NCT03689998|Antioxidants|antioxidants|mesh-ancestor
65512563|NCT03689998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512564|NCT03689998|Protective Agents|protective agents|mesh-ancestor
65512565|NCT03689998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512566|NCT03689998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65512567|NCT03948178|Simendan|simendan|mesh-list
65512568|NCT03948178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65512569|NCT03948178|Vasodilator Agents|vasodilator agents|mesh-ancestor
65512570|NCT03948178|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65512571|NCT03948178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65512572|NCT03948178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512573|NCT03948178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512574|NCT03948178|Protective Agents|protective agents|mesh-ancestor
65512575|NCT03948178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512576|NCT03687034|Temozolomide|temozolomide|mesh-list
65512577|NCT03687034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65512578|NCT03687034|Alkylating Agents|alkylating agents|mesh-ancestor
65512579|NCT03687034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512580|NCT03687034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512581|NCT03520920|Rituximab|rituximab|mesh-list
65512582|NCT03520920|Zanubrutinib|zanubrutinib|mesh-list
65512583|NCT03520920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65512584|NCT03520920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512585|NCT03520920|Immunologic Factors|immunologic factors|mesh-ancestor
65512586|NCT03520920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512587|NCT03520920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65512588|NCT03520920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65512589|NCT03520920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512590|NCT03520920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512591|NCT03686878|Lifitegrast|lifitegrast|mesh-list
65512592|NCT03686878|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65512593|NCT03686878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65512594|NCT03682198|Phenylephrine|phenylephrine|mesh-list
65512595|NCT03682198|Oxymetazoline|oxymetazoline|mesh-list
65512596|NCT03682198|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65512597|NCT03682198|Mydriatics|mydriatics|mesh-ancestor
65512598|NCT03682198|Autonomic Agents|autonomic agents|mesh-ancestor
65512599|NCT03682198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512600|NCT03682198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512601|NCT03682198|Sympathomimetics|sympathomimetics|mesh-ancestor
65512602|NCT03682198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65512603|NCT03682198|Nasal Decongestants|nasal decongestants|mesh-ancestor
65512604|NCT03682198|Respiratory System Agents|respiratory system agents|mesh-ancestor
65512605|NCT03682198|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65512606|NCT03682198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65512607|NCT03682198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65512608|NCT03682198|Adrenergic Agents|adrenergic agents|mesh-ancestor
65512609|NCT03682198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65512610|NCT03682198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512611|NCT03682198|Protective Agents|protective agents|mesh-ancestor
65512612|NCT02953340|Cyclophosphamide|cyclophosphamide|mesh-list
65512613|NCT02953340|Docetaxel|docetaxel|mesh-list
65512614|NCT02953340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65512615|NCT02953340|Immunologic Factors|immunologic factors|mesh-ancestor
65512616|NCT02953340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512617|NCT02953340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65512618|NCT02953340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65512619|NCT02953340|Alkylating Agents|alkylating agents|mesh-ancestor
65512620|NCT02953340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512621|NCT02953340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512622|NCT02953340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65512623|NCT02953340|Tubulin Modulators|tubulin modulators|mesh-ancestor
65512624|NCT02953340|Antimitotic Agents|antimitotic agents|mesh-ancestor
65512625|NCT02953340|Mitosis Modulators|mitosis modulators|mesh-ancestor
65512626|NCT03554772|Celecoxib|celecoxib|mesh-list
65512627|NCT03554772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65512628|NCT03554772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65512629|NCT03554772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65512630|NCT03554772|Analgesics|analgesics|mesh-ancestor
65512631|NCT03554772|Sensory System Agents|sensory system agents|mesh-ancestor
65512632|NCT03554772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512633|NCT03554772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512634|NCT03554772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65512635|NCT03554772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65512636|NCT03554772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65512637|NCT03554772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65512638|NCT03554772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512639|NCT03554772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512640|NCT03624010|Simendan|simendan|mesh-list
65512641|NCT03624010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65512642|NCT03624010|Vasodilator Agents|vasodilator agents|mesh-ancestor
65512643|NCT03624010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65512644|NCT03624010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65512645|NCT03624010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512646|NCT03624010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512647|NCT03624010|Protective Agents|protective agents|mesh-ancestor
65512648|NCT03624010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512649|NCT03686722|Metformin|metformin|mesh-list
65512650|NCT03686722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65512651|NCT03686722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512652|NCT04629976|Tenofovir|tenofovir|mesh-list
65512653|NCT04629976|Antiviral Agents|antiviral agents|mesh-ancestor
65512654|NCT04629976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65512655|NCT04629976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65512656|NCT04629976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65512657|NCT04629976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512658|NCT04629976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512659|NCT04629976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65512660|NCT04629976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65512661|NCT03728946|Bupivacaine|bupivacaine|mesh-list
65512662|NCT03728946|Anesthetics, Local|anesthetics, local|mesh-ancestor
65512663|NCT03728946|Anesthetics|anesthetics|mesh-ancestor
65512664|NCT03728946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65512665|NCT03728946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512666|NCT03728946|Sensory System Agents|sensory system agents|mesh-ancestor
65512667|NCT03728946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512668|NCT03553758|Ketamine|ketamine|mesh-list
65512669|NCT03553758|Analgesics|analgesics|mesh-ancestor
65512670|NCT03553758|Sensory System Agents|sensory system agents|mesh-ancestor
65512671|NCT03553758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65310342|NCT00682019|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65512672|NCT03553758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512673|NCT03553758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65512674|NCT03553758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65512675|NCT03553758|Anesthetics, General|anesthetics, general|mesh-ancestor
65512676|NCT03553758|Anesthetics|anesthetics|mesh-ancestor
65512677|NCT03553758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65512678|NCT03553758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65512679|NCT03553758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65512680|NCT03553758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65512681|NCT03553758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512682|NCT02954354|Oseltamivir|oseltamivir|mesh-list
65512683|NCT02954354|Baloxavir|baloxavir|mesh-list
65512684|NCT02954354|Antiviral Agents|antiviral agents|mesh-ancestor
65512685|NCT02954354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65512686|NCT02954354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512687|NCT02954354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512688|NCT03519516|Ciprofloxacin|ciprofloxacin|mesh-list
65512689|NCT03519516|Levofloxacin|levofloxacin|mesh-list
65512690|NCT03519516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65512691|NCT03519516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65512692|NCT03519516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65512693|NCT03519516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65512694|NCT03519516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65512695|NCT03519516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65512696|NCT03519516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512697|NCT03519516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512698|NCT03519516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512699|NCT03519516|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65512700|NCT03519516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65512701|NCT03519516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65512702|NCT03519516|Renal Agents|renal agents|mesh-ancestor
65512703|NCT03681574|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
65512704|NCT03681574|GABA Agents|gaba agents|mesh-ancestor
65512705|NCT03681574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65512706|NCT03681574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512707|NCT03681574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512708|NCT03519204|Lidocaine|lidocaine|mesh-list
65512709|NCT03519204|Anesthetics, Local|anesthetics, local|mesh-ancestor
65512710|NCT03519204|Anesthetics|anesthetics|mesh-ancestor
65512711|NCT03519204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65512712|NCT03519204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512713|NCT03519204|Sensory System Agents|sensory system agents|mesh-ancestor
65512714|NCT03519204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512715|NCT03519204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65512716|NCT03519204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65512717|NCT03519204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65512718|NCT03519204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65512719|NCT03519204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512720|NCT03624166|Ketamine|ketamine|mesh-list
65512721|NCT03624166|Anesthetics|anesthetics|mesh-list
65512722|NCT03624166|Anesthetics, General|anesthetics, general|mesh-list
65512723|NCT03624166|Analgesics|analgesics|mesh-ancestor
65512724|NCT03624166|Sensory System Agents|sensory system agents|mesh-ancestor
65512725|NCT03624166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512726|NCT03624166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512727|NCT03624166|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65512728|NCT03624166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65512729|NCT03624166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65512730|NCT03624166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65512731|NCT03624166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65512732|NCT03624166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65512733|NCT03624166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512734|NCT03518112|Calcium, Dietary|calcium, dietary|mesh-list
65512735|NCT03518112|Leucovorin|leucovorin|mesh-list
65512736|NCT03518112|Folic Acid|folic acid|mesh-list
65512737|NCT03518112|Cytarabine|cytarabine|mesh-list
65512738|NCT03518112|Dexamethasone|dexamethasone|mesh-list
65512739|NCT03518112|Dexamethasone acetate|dexamethasone acetate|mesh-list
65512740|NCT03518112|Cyclophosphamide|cyclophosphamide|mesh-list
65512741|NCT03518112|Rituximab|rituximab|mesh-list
65512742|NCT03518112|Methotrexate|methotrexate|mesh-list
65512743|NCT03518112|Vincristine|vincristine|mesh-list
65512744|NCT03518112|Mercaptopurine|mercaptopurine|mesh-list
65512745|NCT03518112|Blinatumomab|blinatumomab|mesh-list
65512746|NCT03518112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65512747|NCT03518112|Muromonab-CD3|muromonab-cd3|mesh-list
65512748|NCT03518112|Antibodies|antibodies|mesh-list
65512749|NCT03518112|Immunoglobulins|immunoglobulins|mesh-list
65512750|NCT03518112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65512751|NCT03518112|Lenograstim|lenograstim|mesh-list
65512752|NCT03518112|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65512753|NCT03518112|BB 1101|bb 1101|mesh-list
65512754|NCT03518112|Calcium|calcium|mesh-list
65512755|NCT03518112|Levoleucovorin|levoleucovorin|mesh-list
65512756|NCT03518112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65512757|NCT03518112|Immunologic Factors|immunologic factors|mesh-ancestor
65512758|NCT03518112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512759|NCT03518112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65512760|NCT03518112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65512761|NCT03518112|Alkylating Agents|alkylating agents|mesh-ancestor
65512762|NCT03518112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512763|NCT03518112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512764|NCT03518112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65512765|NCT03518112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65512766|NCT03518112|Antiemetics|antiemetics|mesh-ancestor
65512767|NCT03518112|Autonomic Agents|autonomic agents|mesh-ancestor
65512768|NCT03518112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512769|NCT03518112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65512770|NCT03518112|Glucocorticoids|glucocorticoids|mesh-ancestor
65512771|NCT03518112|Hormones|hormones|mesh-ancestor
65512772|NCT03518112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65512773|NCT03518112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65512774|NCT03518112|Protease Inhibitors|protease inhibitors|mesh-ancestor
65512775|NCT03518112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512776|NCT03518112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65512777|NCT03518112|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65512778|NCT03518112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65512779|NCT03518112|Abortifacient Agents|abortifacient agents|mesh-ancestor
65512780|NCT03518112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65512781|NCT03518112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65512782|NCT03518112|Antimetabolites|antimetabolites|mesh-ancestor
65512783|NCT03518112|Dermatologic Agents|dermatologic agents|mesh-ancestor
65512784|NCT03518112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65512785|NCT03518112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65512786|NCT03518112|Antiviral Agents|antiviral agents|mesh-ancestor
65512787|NCT03518112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65512788|NCT03518112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65512789|NCT03518112|Antidotes|antidotes|mesh-ancestor
65512790|NCT03518112|Protective Agents|protective agents|mesh-ancestor
65512791|NCT03518112|Vitamin B Complex|vitamin b complex|mesh-ancestor
65512792|NCT03518112|Vitamins|vitamins|mesh-ancestor
65512793|NCT03518112|Micronutrients|micronutrients|mesh-ancestor
65512794|NCT03518112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65512795|NCT03518112|Tubulin Modulators|tubulin modulators|mesh-ancestor
65512796|NCT03518112|Antimitotic Agents|antimitotic agents|mesh-ancestor
65512797|NCT03518112|Mitosis Modulators|mitosis modulators|mesh-ancestor
65512798|NCT03518112|Hematinics|hematinics|mesh-ancestor
65512799|NCT03686254|Bevacizumab|bevacizumab|mesh-list
65512800|NCT03686254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65512801|NCT03686254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512802|NCT03686254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65512803|NCT03686254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65512804|NCT03686254|Growth Substances|growth substances|mesh-ancestor
65512805|NCT03686254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512806|NCT03686254|Growth Inhibitors|growth inhibitors|mesh-ancestor
65512807|NCT03679780|Nitroprusside|nitroprusside|mesh-list
65512808|NCT03679780|BQ 788|bq 788|mesh-list
65512809|NCT03679780|Nitroarginine|nitroarginine|mesh-list
65512810|NCT03679780|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
65512811|NCT03679780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65512812|NCT03679780|Vasodilator Agents|vasodilator agents|mesh-ancestor
65512813|NCT03679780|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65512814|NCT03679780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512815|NCT03679780|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65512816|NCT03679780|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65512817|NCT03679780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512818|NCT03659734|Analgesics, Opioid|analgesics, opioid|mesh-list
65512819|NCT03659734|Narcotics|narcotics|mesh-ancestor
65512820|NCT03659734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65512821|NCT03659734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512822|NCT03659734|Analgesics|analgesics|mesh-ancestor
65512823|NCT03659734|Sensory System Agents|sensory system agents|mesh-ancestor
65512824|NCT03659734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512825|NCT03680716|Ropivacaine|ropivacaine|mesh-list
65512827|NCT03680716|Anesthetics|anesthetics|mesh-ancestor
65512828|NCT03680716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65512829|NCT03680716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512830|NCT03680716|Sensory System Agents|sensory system agents|mesh-ancestor
65512831|NCT03680716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512832|NCT03680638|Allopurinol|allopurinol|mesh-list
65512833|NCT03680638|Tempol|tempol|mesh-list
65512834|NCT03680638|Antimetabolites|antimetabolites|mesh-ancestor
65512835|NCT03680638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512836|NCT03680638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512837|NCT03680638|Gout Suppressants|gout suppressants|mesh-ancestor
65512838|NCT03680638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65512839|NCT03680638|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65512840|NCT03680638|Antioxidants|antioxidants|mesh-ancestor
65512841|NCT03680638|Protective Agents|protective agents|mesh-ancestor
65512842|NCT03680638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512843|NCT03680638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65512844|NCT03680638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65512845|NCT03680638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65512846|NCT03680560|Trastuzumab|trastuzumab|mesh-list
65512847|NCT03680560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65512848|NCT03680560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512849|NCT03444298|Vitamin E|vitamin e|mesh-list
65512850|NCT03444298|Tocopherols|tocopherols|mesh-list
65512851|NCT03444298|Tocotrienols|tocotrienols|mesh-list
65512852|NCT03444298|alpha-Tocopherol|alpha-tocopherol|mesh-list
65512853|NCT03444298|gamma-Tocopherol|gamma-tocopherol|mesh-list
65512854|NCT03444298|Vitamins|vitamins|mesh-ancestor
65512855|NCT03444298|Micronutrients|micronutrients|mesh-ancestor
65512856|NCT03444298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512857|NCT03444298|Antioxidants|antioxidants|mesh-ancestor
65512858|NCT03444298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512859|NCT03444298|Protective Agents|protective agents|mesh-ancestor
65512860|NCT03640312|Candesartan|candesartan|mesh-list
65512861|NCT03640312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65512862|NCT03640312|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65512863|NCT03640312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65512864|NCT03640312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512865|NCT03639610|Dexamethasone|dexamethasone|mesh-list
65512866|NCT03639610|Melphalan|melphalan|mesh-list
65512867|NCT03639610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65512868|NCT03639610|Antiemetics|antiemetics|mesh-ancestor
65512869|NCT03639610|Autonomic Agents|autonomic agents|mesh-ancestor
65512870|NCT03639610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512871|NCT03639610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512872|NCT03639610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65512873|NCT03639610|Glucocorticoids|glucocorticoids|mesh-ancestor
65512874|NCT03639610|Hormones|hormones|mesh-ancestor
65512875|NCT03639610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65512876|NCT03639610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65512877|NCT03639610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512878|NCT03639610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65512879|NCT03639610|Alkylating Agents|alkylating agents|mesh-ancestor
65512880|NCT03639610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512881|NCT03639610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65512882|NCT03639610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65512883|NCT03639610|Immunologic Factors|immunologic factors|mesh-ancestor
65512884|NCT03680404|Allopurinol|allopurinol|mesh-list
65512885|NCT03680404|Phenylephrine|phenylephrine|mesh-list
65512886|NCT03680404|Oxymetazoline|oxymetazoline|mesh-list
65512887|NCT03680404|Tempol|tempol|mesh-list
65512888|NCT03680404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65512889|NCT03680404|Mydriatics|mydriatics|mesh-ancestor
65512890|NCT03680404|Autonomic Agents|autonomic agents|mesh-ancestor
65512891|NCT03680404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512892|NCT03680404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512893|NCT03680404|Sympathomimetics|sympathomimetics|mesh-ancestor
65512894|NCT03680404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65512895|NCT03680404|Nasal Decongestants|nasal decongestants|mesh-ancestor
65512896|NCT03680404|Respiratory System Agents|respiratory system agents|mesh-ancestor
65512897|NCT03680404|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65512898|NCT03680404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65512899|NCT03680404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65512900|NCT03680404|Adrenergic Agents|adrenergic agents|mesh-ancestor
65512901|NCT03680404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65512902|NCT03680404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512903|NCT03680404|Protective Agents|protective agents|mesh-ancestor
65512904|NCT03680404|Antimetabolites|antimetabolites|mesh-ancestor
65512905|NCT03680404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512906|NCT03680404|Gout Suppressants|gout suppressants|mesh-ancestor
65512907|NCT03680404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65512908|NCT03680404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65512909|NCT03680404|Antioxidants|antioxidants|mesh-ancestor
65512910|NCT03680404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65512911|NCT03680404|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65512912|NCT03680404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65512913|NCT03685630|Brivaracetam|brivaracetam|mesh-list
65512914|NCT03685630|Anticonvulsants|anticonvulsants|mesh-ancestor
65512915|NCT02954406|Gemcitabine|gemcitabine|mesh-list
65512916|NCT02954406|Rituximab|rituximab|mesh-list
65512917|NCT02954406|Lenalidomide|lenalidomide|mesh-list
65512918|NCT02954406|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65512919|NCT02954406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65512920|NCT02954406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512921|NCT02954406|Immunologic Factors|immunologic factors|mesh-ancestor
65512922|NCT02954406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512923|NCT02954406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65512924|NCT02954406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65512925|NCT02954406|Antimetabolites|antimetabolites|mesh-ancestor
65512926|NCT02954406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512927|NCT02954406|Antiviral Agents|antiviral agents|mesh-ancestor
65512928|NCT02954406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65512929|NCT02954406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512930|NCT02954406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65512931|NCT02954406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65512932|NCT02954406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65512933|NCT02954406|Growth Substances|growth substances|mesh-ancestor
65512934|NCT02954406|Growth Inhibitors|growth inhibitors|mesh-ancestor
65512935|NCT02954406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65512936|NCT02954406|Alkylating Agents|alkylating agents|mesh-ancestor
65512937|NCT01310478|Endostatins|endostatins|mesh-list
65512938|NCT01310478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65512939|NCT01310478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65512940|NCT01310478|Growth Substances|growth substances|mesh-ancestor
65512941|NCT01310478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512942|NCT01310478|Growth Inhibitors|growth inhibitors|mesh-ancestor
65512943|NCT01310478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512944|NCT03728244|Hyaluronic Acid|hyaluronic acid|mesh-list
65512945|NCT03728244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65512946|NCT03728244|Immunologic Factors|immunologic factors|mesh-ancestor
65512947|NCT03728244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512948|NCT03728244|Viscosupplements|viscosupplements|mesh-ancestor
65512949|NCT03728244|Protective Agents|protective agents|mesh-ancestor
65512950|NCT03511326|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65512951|NCT03511326|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65512952|NCT03511326|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65512953|NCT03511326|Dermatologic Agents|dermatologic agents|mesh-ancestor
65512954|NCT03721614|Sirolimus|sirolimus|mesh-list
65512955|NCT03721614|Everolimus|everolimus|mesh-list
65512956|NCT03721614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512957|NCT03721614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65512958|NCT03721614|Immunologic Factors|immunologic factors|mesh-ancestor
65512959|NCT03721614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512960|NCT03721614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65512961|NCT03721614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65512962|NCT03721614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65512963|NCT03721614|Antifungal Agents|antifungal agents|mesh-ancestor
65512964|NCT03727620|Amoxicillin|amoxicillin|mesh-list
65512965|NCT03727620|Metronidazole|metronidazole|mesh-list
65512966|NCT03727620|Doxycycline|doxycycline|mesh-list
65512967|NCT03727620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65512968|NCT03727620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65512969|NCT03727620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65512970|NCT03727620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65512971|NCT03727620|Antimalarials|antimalarials|mesh-ancestor
65512972|NCT03727464|Propofol|propofol|mesh-list
65512973|NCT03727464|Sevoflurane|sevoflurane|mesh-list
65512974|NCT03727464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65512975|NCT03727464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65512976|NCT03727464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512977|NCT03727464|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65512978|NCT03727464|Anesthetics, General|anesthetics, general|mesh-ancestor
65512979|NCT03727464|Anesthetics|anesthetics|mesh-ancestor
65512980|NCT03727464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65512981|NCT03727464|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65512982|NCT03508830|Bupivacaine|bupivacaine|mesh-list
65512983|NCT03508830|Anesthetics, Local|anesthetics, local|mesh-ancestor
65512984|NCT03508830|Anesthetics|anesthetics|mesh-ancestor
65512985|NCT03508830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65512986|NCT03508830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65512987|NCT03508830|Sensory System Agents|sensory system agents|mesh-ancestor
65512988|NCT03508830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65512989|NCT03381274|Osimertinib|osimertinib|mesh-list
65065350|NCT00265733|Paclitaxel|paclitaxel|mesh-list
65512990|NCT03381274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65512991|NCT03381274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65512992|NCT03381274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65512993|NCT03381274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65512994|NCT03569202|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65512995|NCT03569202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65512996|NCT03724578|Anti-Infective Agents|anti-infective agents|mesh-list
65512997|NCT03724578|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65512998|NCT03724578|Grape Seed Extract|grape seed extract|mesh-list
65512999|NCT03724578|Fluorides|fluorides|mesh-list
65513000|NCT03724578|Cariostatic Agents|cariostatic agents|mesh-ancestor
65513001|NCT03724578|Protective Agents|protective agents|mesh-ancestor
65513002|NCT03724578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513003|NCT03724578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65513004|NCT03724578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513005|NCT03724578|Antioxidants|antioxidants|mesh-ancestor
65513006|NCT03724578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513007|NCT03721380|Methadone|methadone|mesh-list
65513008|NCT03721380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65513009|NCT03721380|Narcotics|narcotics|mesh-ancestor
65513010|NCT03721380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65513011|NCT03721380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513012|NCT03721380|Analgesics|analgesics|mesh-ancestor
65513013|NCT03721380|Sensory System Agents|sensory system agents|mesh-ancestor
65513014|NCT03721380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65513015|NCT03721380|Antitussive Agents|antitussive agents|mesh-ancestor
65513016|NCT03721380|Respiratory System Agents|respiratory system agents|mesh-ancestor
65513017|NCT03568500|Olanzapine|olanzapine|mesh-list
65513018|NCT03568500|Risperidone|risperidone|mesh-list
65513019|NCT03568500|Aripiprazole|aripiprazole|mesh-list
65513020|NCT03568500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65513021|NCT03568500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65513022|NCT03568500|Serotonin Agents|serotonin agents|mesh-ancestor
65513023|NCT03568500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65513024|NCT03568500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513025|NCT03568500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513026|NCT03568500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65513027|NCT03568500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65513028|NCT03568500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65513029|NCT03568500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65513030|NCT03568500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65513031|NCT03568500|Dopamine Agents|dopamine agents|mesh-ancestor
65513032|NCT03568500|Antiemetics|antiemetics|mesh-ancestor
65513033|NCT03568500|Autonomic Agents|autonomic agents|mesh-ancestor
65513034|NCT03568500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65513035|NCT03568500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65513036|NCT03568500|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65513037|NCT03568500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65513038|NCT03568500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65513039|NCT03568500|Antidepressive Agents|antidepressive agents|mesh-ancestor
65513040|NCT03568500|Dopamine Agonists|dopamine agonists|mesh-ancestor
65513041|NCT03568500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65513042|NCT03568500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65513043|NCT03568500|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65513044|NCT03568500|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65513045|NCT03910738|Methyltestosterone|methyltestosterone|mesh-list
65513046|NCT03910738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65513047|NCT03910738|Testosterone|testosterone|mesh-list
65513048|NCT03910738|Testosterone undecanoate|testosterone undecanoate|mesh-list
65513049|NCT03910738|Testosterone enanthate|testosterone enanthate|mesh-list
65513050|NCT03910738|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65310730|NCT00781300|Hormones|hormones|mesh-ancestor
65513051|NCT03910738|Androgens|androgens|mesh-ancestor
65513052|NCT03910738|Hormones|hormones|mesh-ancestor
65513053|NCT03910738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65513054|NCT03910738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513055|NCT03910738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65513056|NCT03910738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513057|NCT03910738|Anabolic Agents|anabolic agents|mesh-ancestor
65513058|NCT03685084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65513059|NCT03685084|Piperacillin|piperacillin|mesh-list
65513060|NCT03685084|Cefepime|cefepime|mesh-list
65513061|NCT03685084|Lactams|lactams|mesh-list
65513062|NCT03685084|beta-Lactams|beta-lactams|mesh-list
65513063|NCT03685084|Enmetazobactam|enmetazobactam|mesh-list
65513064|NCT03685084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65513065|NCT03685084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65513066|NCT03685084|Antitubercular Agents|antitubercular agents|mesh-ancestor
65513067|NCT03685084|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65513068|NCT03685084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65513069|NCT03685084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513070|NCT03724266|Chitosan|chitosan|mesh-list
65513071|NCT03724266|Calcium|calcium|mesh-list
65513072|NCT03724266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65513073|NCT03724266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513074|NCT03724266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65513075|NCT03724266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65513076|NCT03724266|Antimetabolites|antimetabolites|mesh-ancestor
65513077|NCT03724266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513078|NCT03724266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65513079|NCT03724266|Chelating Agents|chelating agents|mesh-ancestor
65513080|NCT03724266|Sequestering Agents|sequestering agents|mesh-ancestor
65513081|NCT03724266|Hemostatics|hemostatics|mesh-ancestor
65513082|NCT03724266|Coagulants|coagulants|mesh-ancestor
65513083|NCT03679390|Ketamine|ketamine|mesh-list
65513084|NCT03679390|Analgesics|analgesics|mesh-ancestor
65513085|NCT03679390|Sensory System Agents|sensory system agents|mesh-ancestor
65513086|NCT03679390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65513087|NCT03679390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513088|NCT03679390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65513089|NCT03679390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65513090|NCT03679390|Anesthetics, General|anesthetics, general|mesh-ancestor
65513091|NCT03679390|Anesthetics|anesthetics|mesh-ancestor
65513092|NCT03679390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65513093|NCT03679390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65513094|NCT03679390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65513095|NCT03679390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65513096|NCT03679390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513097|NCT03676504|Cyclophosphamide|cyclophosphamide|mesh-list
65513098|NCT03676504|Fludarabine|fludarabine|mesh-list
65513099|NCT03676504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65513100|NCT03676504|Immunologic Factors|immunologic factors|mesh-ancestor
65513101|NCT03676504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513102|NCT03676504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65513103|NCT03676504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65513104|NCT03676504|Alkylating Agents|alkylating agents|mesh-ancestor
65513105|NCT03676504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513106|NCT03676504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513107|NCT03676504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65513108|NCT03684772|Digoxin|digoxin|mesh-list
65513109|NCT03684772|Furosemide|furosemide|mesh-list
65513110|NCT03684772|Diuretics|diuretics|mesh-ancestor
65513111|NCT03684772|Natriuretic Agents|natriuretic agents|mesh-ancestor
65513112|NCT03684772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513113|NCT03684772|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65513114|NCT03684772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65513115|NCT03684772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513116|NCT03684772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65513117|NCT03684772|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65513118|NCT03684772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65513119|NCT03684772|Protective Agents|protective agents|mesh-ancestor
65513120|NCT03676114|Ketamine|ketamine|mesh-list
65513121|NCT03676114|Analgesics|analgesics|mesh-ancestor
65513122|NCT03676114|Sensory System Agents|sensory system agents|mesh-ancestor
65513123|NCT03676114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65513124|NCT03676114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513125|NCT03676114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65513126|NCT03676114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65513127|NCT03676114|Anesthetics, General|anesthetics, general|mesh-ancestor
65513128|NCT03676114|Anesthetics|anesthetics|mesh-ancestor
65513129|NCT03676114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65513130|NCT03676114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65513131|NCT03676114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65513132|NCT03676114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65513133|NCT03676114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513134|NCT03676036|Mometasone Furoate|mometasone furoate|mesh-list
65513135|NCT03676036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65513136|NCT03676036|Dermatologic Agents|dermatologic agents|mesh-ancestor
65513137|NCT03676036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65513138|NCT03025828|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65065488|NCT00415844|Entacapone|entacapone|mesh-list
65513140|NCT03025828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65513141|NCT03025828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513142|NCT03568630|Chrysarobin|chrysarobin|mesh-list
65513143|NCT03568630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65513144|NCT03568630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65513145|NCT03568630|Analgesics|analgesics|mesh-ancestor
65513146|NCT03568630|Sensory System Agents|sensory system agents|mesh-ancestor
65513147|NCT03568630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65513148|NCT03568630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513149|NCT03568630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65513150|NCT03568630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65513151|NCT03546816|Serlopitant|serlopitant|mesh-list
65513152|NCT03546816|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65513153|NCT03546816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65513154|NCT03546816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513155|NCT03546816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513156|NCT03563716|Atezolizumab|atezolizumab|mesh-list
65513157|NCT03563716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513158|NCT03675802|Misoprostol|misoprostol|mesh-list
65513159|NCT03675802|Dinoprostone|dinoprostone|mesh-list
65513160|NCT03675802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65513161|NCT03675802|Abortifacient Agents|abortifacient agents|mesh-ancestor
65513162|NCT03675802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65513163|NCT03675802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513164|NCT03675802|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65513165|NCT03675802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65513166|NCT03675802|Oxytocics|oxytocics|mesh-ancestor
65513167|NCT03678610|Ionomycin|ionomycin|mesh-list
65513168|NCT03678610|Calcium Ionophores|calcium ionophores|mesh-ancestor
65513169|NCT03678610|Ionophores|ionophores|mesh-ancestor
65513170|NCT03678610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65513171|NCT03678610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513172|NCT03675646|Morphine|morphine|mesh-list
65513173|NCT03675646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65513174|NCT03675646|Narcotics|narcotics|mesh-ancestor
65513175|NCT03675646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65513176|NCT03675646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513177|NCT03675646|Analgesics|analgesics|mesh-ancestor
65513178|NCT03675646|Sensory System Agents|sensory system agents|mesh-ancestor
65513179|NCT03675646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65513180|NCT03678532|Midazolam|midazolam|mesh-list
65513181|NCT03678532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65513182|NCT03678532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65513183|NCT03678532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65513184|NCT03678532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513185|NCT03678532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65513186|NCT03678532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65513187|NCT03678532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65513188|NCT03678532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65513189|NCT03678532|Anesthetics, General|anesthetics, general|mesh-ancestor
65513190|NCT03678532|Anesthetics|anesthetics|mesh-ancestor
65513191|NCT03678532|GABA Modulators|gaba modulators|mesh-ancestor
65513192|NCT03678532|GABA Agents|gaba agents|mesh-ancestor
65513193|NCT03678532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65513194|NCT03678532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513195|NCT03675178|Ceftriaxone|ceftriaxone|mesh-list
65513196|NCT03675178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65513197|NCT03675178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65513198|NCT03678142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65513199|NCT03678142|Vancomycin|vancomycin|mesh-list
65513200|NCT03678142|Imipenem|imipenem|mesh-list
65513201|NCT03678142|Floxacillin|floxacillin|mesh-list
65513202|NCT03678142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65513203|NCT03522298|GDC-0084|gdc-0084|mesh-list
65513204|NCT03522298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65513205|NCT03522298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513206|NCT03674866|Insulin|insulin|mesh-list
65513207|NCT03674866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65513208|NCT03674866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513209|NCT03623776|Carboplatin|carboplatin|mesh-list
65513210|NCT03623776|Pemetrexed|pemetrexed|mesh-list
65513211|NCT03623776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513212|NCT03623776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65513213|NCT03623776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513214|NCT03623776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65513215|NCT03623776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65513216|NCT03683914|Dinoprostone|dinoprostone|mesh-list
65513217|NCT03683914|Oxytocics|oxytocics|mesh-ancestor
65513218|NCT03683914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65513219|NCT03683914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513220|NCT03448406|Empagliflozin|empagliflozin|mesh-list
65513221|NCT03448406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65513222|NCT03448406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513223|NCT03448406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65513224|NCT03448406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513225|NCT00064701|Cyclosporine|cyclosporine|mesh-list
65513226|NCT00064701|Mycophenolic Acid|mycophenolic acid|mesh-list
65513227|NCT00064701|Tacrolimus|tacrolimus|mesh-list
65513228|NCT00064701|Cyclosporins|cyclosporins|mesh-list
65513229|NCT00064701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65513230|NCT00064701|Immunologic Factors|immunologic factors|mesh-ancestor
65513231|NCT00064701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513232|NCT00064701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65513233|NCT00064701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65513234|NCT00064701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513235|NCT00064701|Antifungal Agents|antifungal agents|mesh-ancestor
65513236|NCT00064701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65513237|NCT00064701|Dermatologic Agents|dermatologic agents|mesh-ancestor
65513238|NCT00064701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65513239|NCT00064701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65513240|NCT00064701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513241|NCT00064701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65513242|NCT00064701|Antitubercular Agents|antitubercular agents|mesh-ancestor
65513243|NCT00064701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65513244|NCT00064077|Gemcitabine|gemcitabine|mesh-list
65513245|NCT00064077|Paclitaxel|paclitaxel|mesh-list
65513246|NCT00064077|Vinorelbine|vinorelbine|mesh-list
65513247|NCT00064077|Cisplatin|cisplatin|mesh-list
65513248|NCT00064077|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65513249|NCT00064077|Topotecan|topotecan|mesh-list
65513250|NCT00064077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65513251|NCT00064077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513252|NCT00064077|Tubulin Modulators|tubulin modulators|mesh-ancestor
65513253|NCT00064077|Antimitotic Agents|antimitotic agents|mesh-ancestor
65513254|NCT00064077|Mitosis Modulators|mitosis modulators|mesh-ancestor
65513255|NCT00064077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513256|NCT00064077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65513257|NCT00064077|Antimetabolites|antimetabolites|mesh-ancestor
65513258|NCT00064077|Antiviral Agents|antiviral agents|mesh-ancestor
65513259|NCT00064077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65513260|NCT00064077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65513261|NCT00064077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65513262|NCT00064077|Immunologic Factors|immunologic factors|mesh-ancestor
65513263|NCT00064077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513264|NCT00064077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65513265|NCT00064077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65513266|NCT03674008|Propofol|propofol|mesh-list
65513267|NCT03674008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65513268|NCT03674008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65513269|NCT03674008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513270|NCT03674008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65513271|NCT03674008|Anesthetics, General|anesthetics, general|mesh-ancestor
65513272|NCT03674008|Anesthetics|anesthetics|mesh-ancestor
65513273|NCT00063999|Paclitaxel|paclitaxel|mesh-list
65513274|NCT00063999|Cisplatin|cisplatin|mesh-list
65513275|NCT00063999|Carboplatin|carboplatin|mesh-list
65513276|NCT00063999|Doxorubicin|doxorubicin|mesh-list
65513277|NCT00063999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65513278|NCT00063999|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65513279|NCT00063999|Lenograstim|lenograstim|mesh-list
65513280|NCT00063999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65513281|NCT00063999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513282|NCT00063999|Tubulin Modulators|tubulin modulators|mesh-ancestor
65513283|NCT00063999|Antimitotic Agents|antimitotic agents|mesh-ancestor
65513284|NCT00063999|Mitosis Modulators|mitosis modulators|mesh-ancestor
65513285|NCT00063999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513286|NCT00063999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65513287|NCT00063999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65513288|NCT00063999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65513289|NCT00063999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65513290|NCT00063999|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65513291|NCT00063999|Immunologic Factors|immunologic factors|mesh-ancestor
65513292|NCT00063999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513293|NCT01092351|Nitrofurantoin|nitrofurantoin|mesh-list
65513294|NCT01092351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65513295|NCT01092351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65513296|NCT01092351|Renal Agents|renal agents|mesh-ancestor
65513297|NCT01092351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65513298|NCT02910700|Nivolumab|nivolumab|mesh-list
65513299|NCT02910700|Trametinib|trametinib|mesh-list
65513300|NCT02910700|Dabrafenib|dabrafenib|mesh-list
65513301|NCT02910700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65513302|NCT02910700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513303|NCT02910700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65513304|NCT02910700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513305|NCT02910700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65513306|NCT02910700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65513307|NCT02878798|Topiramate|topiramate|mesh-list
65513308|NCT02878798|Anticonvulsants|anticonvulsants|mesh-ancestor
65513309|NCT02878798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65513310|NCT02878798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513311|NCT03673384|Fluticasone|fluticasone|mesh-list
65513312|NCT03673384|Xhance|xhance|mesh-list
65513313|NCT03673384|Histamine|histamine|mesh-list
65513314|NCT03673384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65513315|NCT03673384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65513316|NCT03673384|Autonomic Agents|autonomic agents|mesh-ancestor
65513317|NCT03673384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65513318|NCT03673384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513319|NCT03673384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65513320|NCT03673384|Respiratory System Agents|respiratory system agents|mesh-ancestor
65513321|NCT03673384|Dermatologic Agents|dermatologic agents|mesh-ancestor
65513322|NCT03673384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65513323|NCT03673384|Histamine Agonists|histamine agonists|mesh-ancestor
65513324|NCT03673384|Histamine Agents|histamine agents|mesh-ancestor
65513325|NCT03673384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65513326|NCT03673384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513327|NCT02915302|Vaccines|vaccines|mesh-list
65513328|NCT02915302|Immunologic Factors|immunologic factors|mesh-ancestor
65513329|NCT02915302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513330|NCT03023878|Dexamethasone|dexamethasone|mesh-list
65513331|NCT03023878|Blinatumomab|blinatumomab|mesh-list
65513332|NCT03023878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65513333|NCT03023878|Antiemetics|antiemetics|mesh-ancestor
65513334|NCT03023878|Autonomic Agents|autonomic agents|mesh-ancestor
65513335|NCT03023878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65513336|NCT03023878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513337|NCT03023878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65513338|NCT03023878|Glucocorticoids|glucocorticoids|mesh-ancestor
65513339|NCT03023878|Hormones|hormones|mesh-ancestor
65513340|NCT03023878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65513341|NCT03023878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65513342|NCT03023878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513343|NCT03670888|Rituximab|rituximab|mesh-list
65513344|NCT03670888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65513345|NCT03670888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513346|NCT03670888|Immunologic Factors|immunologic factors|mesh-ancestor
65513347|NCT03670888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513348|NCT03670888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65513349|NCT03023722|Maytansine|maytansine|mesh-list
65513350|NCT03023722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65513351|NCT03023722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513352|NCT03023722|Tubulin Modulators|tubulin modulators|mesh-ancestor
65513353|NCT03023722|Antimitotic Agents|antimitotic agents|mesh-ancestor
65513354|NCT03023722|Mitosis Modulators|mitosis modulators|mesh-ancestor
65513355|NCT03023722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513356|NCT03623230|Bupivacaine|bupivacaine|mesh-list
65513357|NCT03623230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65513358|NCT03623230|Anesthetics, Local|anesthetics, local|mesh-ancestor
65311023|NCT00694967|Progestins|progestins|mesh-ancestor
65513359|NCT03623230|Anesthetics|anesthetics|mesh-ancestor
65513360|NCT03623230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65513361|NCT03623230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513362|NCT03623230|Sensory System Agents|sensory system agents|mesh-ancestor
65513363|NCT03623230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65513364|NCT02624596|Midazolam|midazolam|mesh-list
65513365|NCT02624596|Ketamine|ketamine|mesh-list
65513366|NCT02624596|Analgesics|analgesics|mesh-ancestor
65513367|NCT02624596|Sensory System Agents|sensory system agents|mesh-ancestor
65513368|NCT02624596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65513369|NCT02624596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513370|NCT02624596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65513371|NCT02624596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65513372|NCT02624596|Anesthetics, General|anesthetics, general|mesh-ancestor
65513373|NCT02624596|Anesthetics|anesthetics|mesh-ancestor
65513374|NCT02624596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65513375|NCT02624596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65513376|NCT02624596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65513377|NCT02624596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65513378|NCT02624596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513379|NCT02624596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65513380|NCT02624596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65513381|NCT02624596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65513382|NCT02624596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65513383|NCT02624596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65513384|NCT02624596|GABA Modulators|gaba modulators|mesh-ancestor
65513385|NCT02624596|GABA Agents|gaba agents|mesh-ancestor
65513386|NCT02553460|Leucovorin|leucovorin|mesh-list
65513387|NCT02553460|Cytarabine|cytarabine|mesh-list
65513388|NCT02553460|Dexamethasone|dexamethasone|mesh-list
65513389|NCT02553460|Hydrocortisone|hydrocortisone|mesh-list
65513390|NCT02553460|Cyclophosphamide|cyclophosphamide|mesh-list
65513391|NCT02553460|Methotrexate|methotrexate|mesh-list
65513392|NCT02553460|Etoposide|etoposide|mesh-list
65513393|NCT02553460|Vincristine|vincristine|mesh-list
65513394|NCT02553460|Bortezomib|bortezomib|mesh-list
65513395|NCT02553460|Asparaginase|asparaginase|mesh-list
65513396|NCT02553460|Mitoxantrone|mitoxantrone|mesh-list
65513397|NCT02553460|Mercaptopurine|mercaptopurine|mesh-list
65513398|NCT02553460|Vorinostat|vorinostat|mesh-list
65513399|NCT02553460|Pegaspargase|pegaspargase|mesh-list
65513400|NCT02553460|Levoleucovorin|levoleucovorin|mesh-list
65513401|NCT02553460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65513402|NCT02553460|Immunologic Factors|immunologic factors|mesh-ancestor
65513403|NCT02553460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513404|NCT02553460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65513405|NCT02553460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65513406|NCT02553460|Alkylating Agents|alkylating agents|mesh-ancestor
65513407|NCT02553460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513408|NCT02553460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513409|NCT02553460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65513410|NCT02553460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65513411|NCT02553460|Antiemetics|antiemetics|mesh-ancestor
65513412|NCT02553460|Autonomic Agents|autonomic agents|mesh-ancestor
65513413|NCT02553460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65513414|NCT02553460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65513415|NCT02553460|Glucocorticoids|glucocorticoids|mesh-ancestor
65513416|NCT02553460|Hormones|hormones|mesh-ancestor
65513417|NCT02553460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65513418|NCT02553460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65513419|NCT02553460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65513420|NCT02553460|Abortifacient Agents|abortifacient agents|mesh-ancestor
65513421|NCT02553460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65513422|NCT02553460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65513423|NCT02553460|Antimetabolites|antimetabolites|mesh-ancestor
65513424|NCT02553460|Dermatologic Agents|dermatologic agents|mesh-ancestor
65513425|NCT02553460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65513426|NCT02553460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65513427|NCT02553460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65513428|NCT02553460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65513429|NCT02553460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65513430|NCT02553460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65513431|NCT02553460|Antiviral Agents|antiviral agents|mesh-ancestor
65513432|NCT02553460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65513433|NCT02553460|Antidotes|antidotes|mesh-ancestor
65513434|NCT02553460|Protective Agents|protective agents|mesh-ancestor
65513435|NCT02553460|Vitamin B Complex|vitamin b complex|mesh-ancestor
65513436|NCT02553460|Vitamins|vitamins|mesh-ancestor
65513437|NCT02553460|Micronutrients|micronutrients|mesh-ancestor
65513438|NCT02553460|Tubulin Modulators|tubulin modulators|mesh-ancestor
65513439|NCT02553460|Antimitotic Agents|antimitotic agents|mesh-ancestor
65513441|NCT02553460|Analgesics|analgesics|mesh-ancestor
65513442|NCT02553460|Sensory System Agents|sensory system agents|mesh-ancestor
65513443|NCT02553460|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65513444|NCT03669562|Alprostadil|alprostadil|mesh-list
65513445|NCT03669562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65513446|NCT03669562|Vasodilator Agents|vasodilator agents|mesh-ancestor
65513447|NCT03669562|Urological Agents|urological agents|mesh-ancestor
65513448|NCT03669484|Fentanyl|fentanyl|mesh-list
65513449|NCT03669484|Bromides|bromides|mesh-list
65513450|NCT03669484|Propofol|propofol|mesh-list
65513451|NCT03669484|Rocuronium|rocuronium|mesh-list
65513452|NCT03669484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65513453|NCT03669484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65513454|NCT03669484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513455|NCT03669484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65513456|NCT03669484|Anesthetics, General|anesthetics, general|mesh-ancestor
65513457|NCT03669484|Anesthetics|anesthetics|mesh-ancestor
65513458|NCT03669484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65513459|NCT03669484|Narcotics|narcotics|mesh-ancestor
65513460|NCT03669484|Analgesics|analgesics|mesh-ancestor
65513461|NCT03669484|Sensory System Agents|sensory system agents|mesh-ancestor
65513462|NCT03669484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65513463|NCT03669484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65513464|NCT03669484|Anticonvulsants|anticonvulsants|mesh-ancestor
65513465|NCT03669484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65513466|NCT03669484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65513467|NCT03669484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65513468|NCT01979536|Cytarabine|cytarabine|mesh-list
65513469|NCT01979536|Dexamethasone|dexamethasone|mesh-list
65513470|NCT01979536|Dexamethasone acetate|dexamethasone acetate|mesh-list
65513471|NCT01979536|Cyclophosphamide|cyclophosphamide|mesh-list
65513472|NCT01979536|Ifosfamide|ifosfamide|mesh-list
65513473|NCT01979536|Isophosphamide mustard|isophosphamide mustard|mesh-list
65513474|NCT01979536|Doxorubicin|doxorubicin|mesh-list
65513475|NCT01979536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65513476|NCT01979536|Methotrexate|methotrexate|mesh-list
65513477|NCT01979536|Etoposide|etoposide|mesh-list
65513478|NCT01979536|Etoposide phosphate|etoposide phosphate|mesh-list
65513479|NCT01979536|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65513480|NCT01979536|Podophyllotoxin|podophyllotoxin|mesh-list
65513481|NCT01979536|Crizotinib|crizotinib|mesh-list
65513482|NCT01979536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65513483|NCT01979536|Antibodies|antibodies|mesh-list
65513484|NCT01979536|Immunoglobulins|immunoglobulins|mesh-list
65513485|NCT01979536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65513486|NCT01979536|Immunoconjugates|immunoconjugates|mesh-list
65513487|NCT01979536|BB 1101|bb 1101|mesh-list
65513488|NCT01979536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65513489|NCT01979536|Immunologic Factors|immunologic factors|mesh-ancestor
65513490|NCT01979536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513491|NCT01979536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65513492|NCT01979536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65513493|NCT01979536|Alkylating Agents|alkylating agents|mesh-ancestor
65513494|NCT01979536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513495|NCT01979536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513496|NCT01979536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65513497|NCT01979536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65513498|NCT01979536|Antiemetics|antiemetics|mesh-ancestor
65513499|NCT01979536|Autonomic Agents|autonomic agents|mesh-ancestor
65513500|NCT01979536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65513501|NCT01979536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65513502|NCT01979536|Glucocorticoids|glucocorticoids|mesh-ancestor
65513503|NCT01979536|Hormones|hormones|mesh-ancestor
65513504|NCT01979536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65513505|NCT01979536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65513506|NCT01979536|Protease Inhibitors|protease inhibitors|mesh-ancestor
65513507|NCT01979536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65513508|NCT01979536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65513509|NCT01979536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65513510|NCT01979536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65513511|NCT01979536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65513512|NCT01979536|Abortifacient Agents|abortifacient agents|mesh-ancestor
65513513|NCT01979536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65513514|NCT01979536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65513515|NCT01979536|Antimetabolites|antimetabolites|mesh-ancestor
65513516|NCT01979536|Dermatologic Agents|dermatologic agents|mesh-ancestor
65311165|NCT00783250|Tocolytic Agents|tocolytic agents|mesh-ancestor
65513517|NCT01979536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65513518|NCT01979536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65513519|NCT01979536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65513520|NCT01979536|Antiviral Agents|antiviral agents|mesh-ancestor
65513521|NCT01979536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65513522|NCT01979536|Keratolytic Agents|keratolytic agents|mesh-ancestor
65513523|NCT01979536|Tubulin Modulators|tubulin modulators|mesh-ancestor
65513524|NCT01979536|Antimitotic Agents|antimitotic agents|mesh-ancestor
65513525|NCT01979536|Mitosis Modulators|mitosis modulators|mesh-ancestor
65513526|NCT01979536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65513527|NCT01525966|Paclitaxel|paclitaxel|mesh-list
65513528|NCT01525966|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65513529|NCT01525966|Carboplatin|carboplatin|mesh-list
65513530|NCT01525966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65513531|NCT01525966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513532|NCT01525966|Tubulin Modulators|tubulin modulators|mesh-ancestor
65513533|NCT01525966|Antimitotic Agents|antimitotic agents|mesh-ancestor
65513534|NCT01525966|Mitosis Modulators|mitosis modulators|mesh-ancestor
65513535|NCT01525966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513536|NCT03496298|Efpeglenatide|efpeglenatide|mesh-list
65513537|NCT03496298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65513538|NCT03496298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513539|NCT03668860|Dexamethasone|dexamethasone|mesh-list
65513540|NCT03668860|Dexamethasone acetate|dexamethasone acetate|mesh-list
65513541|NCT03668860|Betamethasone|betamethasone|mesh-list
65513542|NCT03668860|Betamethasone Valerate|betamethasone valerate|mesh-list
65513543|NCT03668860|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65513544|NCT03668860|Betamethasone benzoate|betamethasone benzoate|mesh-list
65513545|NCT03668860|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
65513546|NCT03668860|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65513547|NCT03668860|BB 1101|bb 1101|mesh-list
65513548|NCT03668860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65513549|NCT03668860|Antiemetics|antiemetics|mesh-ancestor
65513550|NCT03668860|Autonomic Agents|autonomic agents|mesh-ancestor
65513551|NCT03668860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65513552|NCT03668860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513553|NCT03668860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65513554|NCT03668860|Glucocorticoids|glucocorticoids|mesh-ancestor
65513555|NCT03668860|Hormones|hormones|mesh-ancestor
65513556|NCT03668860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65513557|NCT03668860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65513558|NCT03668860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513559|NCT03668860|Protease Inhibitors|protease inhibitors|mesh-ancestor
65513560|NCT03668860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65513561|NCT03668860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513562|NCT03668860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65513563|NCT03668860|Respiratory System Agents|respiratory system agents|mesh-ancestor
65513564|NCT03668860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65513565|NCT00062751|Sirolimus|sirolimus|mesh-list
65513566|NCT00062751|Letrozole|letrozole|mesh-list
65513567|NCT00062751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513568|NCT00062751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65513569|NCT00062751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65513570|NCT00062751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65513571|NCT00062751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513572|NCT00062751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65513573|NCT00062751|Hormone Antagonists|hormone antagonists|mesh-ancestor
65513574|NCT00062751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65513575|NCT00062751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513576|NCT00062751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65513577|NCT00062751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65513578|NCT00062751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65513579|NCT00062751|Antifungal Agents|antifungal agents|mesh-ancestor
65513580|NCT00062751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65513581|NCT00062751|Immunologic Factors|immunologic factors|mesh-ancestor
65513582|NCT00945724|Cytarabine|cytarabine|mesh-list
65513583|NCT00945724|Prednisolone|prednisolone|mesh-list
65513584|NCT00945724|Cyclophosphamide|cyclophosphamide|mesh-list
65513585|NCT00945724|Rituximab|rituximab|mesh-list
65513586|NCT00945724|Doxorubicin|doxorubicin|mesh-list
65513587|NCT00945724|Methotrexate|methotrexate|mesh-list
65513588|NCT00945724|Vincristine|vincristine|mesh-list
65513589|NCT00945724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65513590|NCT00945724|Immunologic Factors|immunologic factors|mesh-ancestor
65513591|NCT00945724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513592|NCT00945724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65311245|NCT05298683|Anesthetics|anesthetics|mesh-ancestor
65513593|NCT00945724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65513594|NCT00945724|Alkylating Agents|alkylating agents|mesh-ancestor
65513595|NCT00945724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513596|NCT00945724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513597|NCT00945724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65513598|NCT00945724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65513599|NCT00945724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65513600|NCT00945724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65513601|NCT00945724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65513602|NCT00945724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65513603|NCT00945724|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65513604|NCT00945724|Abortifacient Agents|abortifacient agents|mesh-ancestor
65513605|NCT00945724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65513606|NCT00945724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65513607|NCT00945724|Antimetabolites|antimetabolites|mesh-ancestor
65513608|NCT00945724|Dermatologic Agents|dermatologic agents|mesh-ancestor
65513609|NCT00945724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65513610|NCT00945724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65513611|NCT00945724|Antiviral Agents|antiviral agents|mesh-ancestor
65513612|NCT00945724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65513613|NCT00945724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65513614|NCT00945724|Tubulin Modulators|tubulin modulators|mesh-ancestor
65513615|NCT00945724|Antimitotic Agents|antimitotic agents|mesh-ancestor
65513616|NCT00945724|Mitosis Modulators|mitosis modulators|mesh-ancestor
65513617|NCT00945724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65513618|NCT00945724|Glucocorticoids|glucocorticoids|mesh-ancestor
65513619|NCT00945724|Hormones|hormones|mesh-ancestor
65513620|NCT00945724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65513621|NCT00945724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65513622|NCT00258310|Capecitabine|capecitabine|mesh-list
65513623|NCT00258310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65513624|NCT00258310|Antimetabolites|antimetabolites|mesh-ancestor
65513625|NCT00258310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513626|NCT00258310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513627|NCT00062439|Docetaxel|docetaxel|mesh-list
65513628|NCT00062439|Etoposide|etoposide|mesh-list
65513629|NCT00062439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513630|NCT00062439|Tubulin Modulators|tubulin modulators|mesh-ancestor
65513631|NCT00062439|Antimitotic Agents|antimitotic agents|mesh-ancestor
65513632|NCT00062439|Mitosis Modulators|mitosis modulators|mesh-ancestor
65513633|NCT00062439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513634|NCT00062439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65513635|NCT00062439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65513636|NCT00062439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65513637|NCT00062439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65513638|NCT01099059|Amantadine|amantadine|mesh-list
65513639|NCT01099059|Methylphenidate|methylphenidate|mesh-list
65513640|NCT01099059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65513641|NCT01099059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513642|NCT01099059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65513643|NCT01099059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65513644|NCT01099059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65513645|NCT01099059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513646|NCT01099059|Dopamine Agents|dopamine agents|mesh-ancestor
65513647|NCT01099059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65513648|NCT01099059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65513649|NCT01099059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65513650|NCT01099059|Antiviral Agents|antiviral agents|mesh-ancestor
65513651|NCT01099059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65513652|NCT01099059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65513653|NCT01099059|Analgesics|analgesics|mesh-ancestor
65513654|NCT01099059|Sensory System Agents|sensory system agents|mesh-ancestor
65513655|NCT01099059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65513656|NCT01092741|Imatinib Mesylate|imatinib mesylate|mesh-list
65513657|NCT01092741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513658|NCT01092741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65513659|NCT01092741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65513660|NCT01092741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513661|NCT01095471|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65513662|NCT01095471|Immunologic Factors|immunologic factors|mesh-ancestor
65513663|NCT01095471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513664|NCT03955341|Chlorhexidine|chlorhexidine|mesh-list
65513665|NCT03955341|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65513666|NCT03955341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65513668|NCT00031551|Etanercept|etanercept|mesh-list
65513669|NCT00031551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65513670|NCT00031551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65513671|NCT00031551|Analgesics|analgesics|mesh-ancestor
65513672|NCT00031551|Sensory System Agents|sensory system agents|mesh-ancestor
65513673|NCT00031551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65513674|NCT00031551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513675|NCT00031551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65513676|NCT00031551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65513677|NCT00031551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65513678|NCT00031551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65513679|NCT00031551|Immunologic Factors|immunologic factors|mesh-ancestor
65513680|NCT01099137|Vildagliptin|vildagliptin|mesh-list
65513681|NCT01099137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65513682|NCT01099137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513683|NCT01099137|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65513684|NCT01099137|Protease Inhibitors|protease inhibitors|mesh-ancestor
65513685|NCT01099137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65513686|NCT01099137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513687|NCT01092975|Phenylephrine|phenylephrine|mesh-list
65513688|NCT01092975|Oxymetazoline|oxymetazoline|mesh-list
65513689|NCT01092975|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65513690|NCT01092975|Mydriatics|mydriatics|mesh-ancestor
65513691|NCT01092975|Autonomic Agents|autonomic agents|mesh-ancestor
65513692|NCT01092975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65513693|NCT01092975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513694|NCT01092975|Sympathomimetics|sympathomimetics|mesh-ancestor
65513695|NCT01092975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65513696|NCT01092975|Nasal Decongestants|nasal decongestants|mesh-ancestor
65513697|NCT01092975|Respiratory System Agents|respiratory system agents|mesh-ancestor
65513698|NCT01092975|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65513699|NCT01092975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65513700|NCT01092975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65513701|NCT01092975|Adrenergic Agents|adrenergic agents|mesh-ancestor
65513702|NCT01092975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65513703|NCT01092975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513704|NCT01092975|Protective Agents|protective agents|mesh-ancestor
65513705|NCT01584297|Ketoconazole|ketoconazole|mesh-list
65513706|NCT01584297|Antifungal Agents|antifungal agents|mesh-ancestor
65513707|NCT01584297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65513708|NCT01584297|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65513709|NCT01584297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65513710|NCT01584297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65513711|NCT01584297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513712|NCT01584297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65513713|NCT01584297|Hormone Antagonists|hormone antagonists|mesh-ancestor
65513714|NCT01584297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65513715|NCT01584297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513716|NCT01584297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65513717|NCT00049257|Paclitaxel|paclitaxel|mesh-list
65513718|NCT00049257|Carboplatin|carboplatin|mesh-list
65513719|NCT00049257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65513720|NCT00049257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513721|NCT00049257|Tubulin Modulators|tubulin modulators|mesh-ancestor
65513722|NCT00049257|Antimitotic Agents|antimitotic agents|mesh-ancestor
65513723|NCT00049257|Mitosis Modulators|mitosis modulators|mesh-ancestor
65513724|NCT00049257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513725|NCT03951987|Charcoal|charcoal|mesh-list
65513726|NCT03951987|Antidotes|antidotes|mesh-ancestor
65513727|NCT03951987|Protective Agents|protective agents|mesh-ancestor
65513728|NCT03951987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513729|NCT00601900|Tamoxifen|tamoxifen|mesh-list
65513730|NCT00601900|Bevacizumab|bevacizumab|mesh-list
65513731|NCT00601900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65513732|NCT00601900|Letrozole|letrozole|mesh-list
65513733|NCT00601900|Endothelial Growth Factors|endothelial growth factors|mesh-list
65513734|NCT00601900|Antibodies|antibodies|mesh-list
65513735|NCT00601900|Immunoglobulins|immunoglobulins|mesh-list
65513736|NCT00601900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65513737|NCT00601900|Immunoglobulin G|immunoglobulin g|mesh-list
65513738|NCT00601900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513739|NCT00601900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65513740|NCT00601900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65513741|NCT00601900|Growth Substances|growth substances|mesh-ancestor
65513742|NCT00601900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513743|NCT00601900|Growth Inhibitors|growth inhibitors|mesh-ancestor
65513744|NCT00601900|Immunologic Factors|immunologic factors|mesh-ancestor
65513745|NCT00601900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513746|NCT00601900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65513747|NCT00601900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65513748|NCT00601900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65513749|NCT00601900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65513750|NCT00601900|Hormone Antagonists|hormone antagonists|mesh-ancestor
65513751|NCT00601900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65513752|NCT00601900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65513753|NCT00601900|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65513754|NCT00601900|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65513755|NCT00601900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65513756|NCT03668470|Dulaglutide|dulaglutide|mesh-list
65513757|NCT03668470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65513758|NCT03668470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513759|NCT03020992|Certolizumab Pegol|certolizumab pegol|mesh-list
65513760|NCT03020992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65513761|NCT03020992|Immunologic Factors|immunologic factors|mesh-ancestor
65513762|NCT03020992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513763|NCT03020992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65513764|NCT03020914|Methamphetamine|methamphetamine|mesh-list
65513765|NCT03020914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65513766|NCT03020914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513767|NCT03020914|Sympathomimetics|sympathomimetics|mesh-ancestor
65513768|NCT03020914|Autonomic Agents|autonomic agents|mesh-ancestor
65513769|NCT03020914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65513770|NCT03020914|Dopamine Agents|dopamine agents|mesh-ancestor
65513771|NCT03020914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65513772|NCT03020914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513773|NCT03020914|Adrenergic Agents|adrenergic agents|mesh-ancestor
65513774|NCT03020914|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65513775|NCT03020914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65513776|NCT03020914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65513777|NCT03020914|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65513778|NCT03018340|Pimavanserin|pimavanserin|mesh-list
65513779|NCT03018340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65513780|NCT03018340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65513781|NCT03018340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65513782|NCT03018340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65513783|NCT03018340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65513784|NCT03018340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513785|NCT03018340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65513786|NCT03018340|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65513787|NCT03018340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65513788|NCT03018340|Serotonin Agents|serotonin agents|mesh-ancestor
65513789|NCT03018340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65513790|NCT03018340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513791|NCT00048165|Cyclosporine|cyclosporine|mesh-list
65513792|NCT00048165|Mycophenolic Acid|mycophenolic acid|mesh-list
65513793|NCT00048165|Methylprednisolone|methylprednisolone|mesh-list
65513794|NCT00048165|Cyclosporins|cyclosporins|mesh-list
65513795|NCT00048165|Daclizumab|daclizumab|mesh-list
65513796|NCT00048165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65513797|NCT00048165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513798|NCT00048165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65513799|NCT00048165|Immunologic Factors|immunologic factors|mesh-ancestor
65513800|NCT00048165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513801|NCT00048165|Antifungal Agents|antifungal agents|mesh-ancestor
65513802|NCT00048165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65513803|NCT00048165|Dermatologic Agents|dermatologic agents|mesh-ancestor
65513804|NCT00048165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65513805|NCT00048165|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65513806|NCT00048165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65513807|NCT00048165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513808|NCT00048165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65513809|NCT00048165|Antitubercular Agents|antitubercular agents|mesh-ancestor
65513810|NCT00048165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65513811|NCT00048165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65513812|NCT00048165|Antiemetics|antiemetics|mesh-ancestor
65513813|NCT00048165|Autonomic Agents|autonomic agents|mesh-ancestor
65513814|NCT00048165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65513815|NCT00048165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65513816|NCT00048165|Glucocorticoids|glucocorticoids|mesh-ancestor
65513817|NCT00048165|Hormones|hormones|mesh-ancestor
65513818|NCT00048165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65513819|NCT00048165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65513820|NCT00048165|Protective Agents|protective agents|mesh-ancestor
65513821|NCT01099527|Capecitabine|capecitabine|mesh-list
65513822|NCT01099527|Everolimus|everolimus|mesh-list
65513823|NCT01099527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65513824|NCT01099527|Antimetabolites|antimetabolites|mesh-ancestor
65513825|NCT01099527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513826|NCT01099527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513827|NCT01099527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65513828|NCT01099527|Immunologic Factors|immunologic factors|mesh-ancestor
65513829|NCT01099527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513830|NCT01093365|Varenicline|varenicline|mesh-list
65513831|NCT01093365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65513832|NCT01093365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65513833|NCT01093365|Cholinergic Agents|cholinergic agents|mesh-ancestor
65513834|NCT01093365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65513835|NCT01093365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513836|NCT01093365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513837|NCT03955497|Hyaluronic Acid|hyaluronic acid|mesh-list
65513838|NCT03955497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65513839|NCT03955497|Immunologic Factors|immunologic factors|mesh-ancestor
65513840|NCT03955497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513841|NCT03955497|Viscosupplements|viscosupplements|mesh-ancestor
65513842|NCT03955497|Protective Agents|protective agents|mesh-ancestor
65513843|NCT01099605|Bupivacaine|bupivacaine|mesh-list
65513844|NCT01099605|Anesthetics, Local|anesthetics, local|mesh-ancestor
65513845|NCT01099605|Anesthetics|anesthetics|mesh-ancestor
65513846|NCT01099605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65513847|NCT01099605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513848|NCT01099605|Sensory System Agents|sensory system agents|mesh-ancestor
65513849|NCT01099605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65513850|NCT00059787|Paclitaxel|paclitaxel|mesh-list
65513851|NCT00059787|Carboplatin|carboplatin|mesh-list
65513852|NCT00059787|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65513853|NCT00059787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65513854|NCT00059787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513855|NCT00059787|Tubulin Modulators|tubulin modulators|mesh-ancestor
65513856|NCT00059787|Antimitotic Agents|antimitotic agents|mesh-ancestor
65513857|NCT00059787|Mitosis Modulators|mitosis modulators|mesh-ancestor
65513858|NCT00059787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513859|NCT00059787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65513860|NCT00059787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65513861|NCT01099839|Ipragliflozin|ipragliflozin|mesh-list
65513862|NCT01099839|Miglitol|miglitol|mesh-list
65513863|NCT01099839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65513864|NCT01099839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513865|NCT01099839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65513866|NCT01099839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513867|NCT01099839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65513868|NCT01099839|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65513869|NCT00058539|Pertuzumab|pertuzumab|mesh-list
65513870|NCT00058539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65513871|NCT00058539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513872|NCT03956823|Amlodipine|amlodipine|mesh-list
65513873|NCT03956823|Telmisartan|telmisartan|mesh-list
65513874|NCT03956823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65513875|NCT03956823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65513876|NCT03956823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65513877|NCT03956823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513878|NCT03956823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65513879|NCT03956823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513880|NCT03956823|Vasodilator Agents|vasodilator agents|mesh-ancestor
65513881|NCT03956823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65513882|NCT03956823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65513883|NCT03015532|Bupivacaine|bupivacaine|mesh-list
65513884|NCT03015532|Ropivacaine|ropivacaine|mesh-list
65513885|NCT03015532|Anesthetics, Local|anesthetics, local|mesh-ancestor
65513886|NCT03015532|Anesthetics|anesthetics|mesh-ancestor
65513887|NCT03015532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65513888|NCT03015532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513889|NCT03015532|Sensory System Agents|sensory system agents|mesh-ancestor
65311546|NCT00851630|Lamivudine|lamivudine|mesh-list
65513890|NCT03015532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65513892|NCT03954873|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65513893|NCT03954873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513894|NCT03954873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65513895|NCT03954873|Hormones|hormones|mesh-ancestor
65513896|NCT03954873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65513897|NCT03954873|Incretins|incretins|mesh-ancestor
65513898|NCT03951831|Docetaxel|docetaxel|mesh-list
65513899|NCT03951831|Leuprolide|leuprolide|mesh-list
65513900|NCT03951831|Cemiplimab|cemiplimab|mesh-list
65513901|NCT03951831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513902|NCT03951831|Tubulin Modulators|tubulin modulators|mesh-ancestor
65513903|NCT03951831|Antimitotic Agents|antimitotic agents|mesh-ancestor
65513904|NCT03951831|Mitosis Modulators|mitosis modulators|mesh-ancestor
65513905|NCT03951831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513906|NCT03951831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65513907|NCT03951831|Fertility Agents|fertility agents|mesh-ancestor
65513908|NCT03951831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65513909|NCT03951831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513910|NCT03951831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65513911|NCT03951831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65513912|NCT03954639|Bupivacaine|bupivacaine|mesh-list
65513913|NCT03954639|Anesthetics, Local|anesthetics, local|mesh-ancestor
65513914|NCT03954639|Anesthetics|anesthetics|mesh-ancestor
65513915|NCT03954639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65513916|NCT03954639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513917|NCT03954639|Sensory System Agents|sensory system agents|mesh-ancestor
65513918|NCT03954639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65513919|NCT01095939|Benazepril|benazepril|mesh-list
65513920|NCT01095939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65513921|NCT01095939|Protease Inhibitors|protease inhibitors|mesh-ancestor
65513922|NCT01095939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65513923|NCT01095939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513924|NCT01095939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65513925|NCT03015220|Dulaglutide|dulaglutide|mesh-list
65513926|NCT03015220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65513927|NCT03015220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513928|NCT00022659|Bevacizumab|bevacizumab|mesh-list
65513929|NCT00022659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65513930|NCT00022659|Antibodies|antibodies|mesh-list
65513931|NCT00022659|Immunoglobulins|immunoglobulins|mesh-list
65513932|NCT00022659|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65513933|NCT00022659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513934|NCT00022659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65513935|NCT00022659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65513936|NCT00022659|Growth Substances|growth substances|mesh-ancestor
65513937|NCT00022659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513938|NCT00022659|Growth Inhibitors|growth inhibitors|mesh-ancestor
65513939|NCT00022659|Immunologic Factors|immunologic factors|mesh-ancestor
65513940|NCT03018106|Estrogens|estrogens|mesh-list
65513941|NCT03018106|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65513942|NCT03018106|Hormones|hormones|mesh-ancestor
65513943|NCT03018106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65513944|NCT03018106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513945|NCT03018028|Liraglutide|liraglutide|mesh-list
65513946|NCT03018028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65513947|NCT03018028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513948|NCT03018028|Incretins|incretins|mesh-ancestor
65513949|NCT03018028|Hormones|hormones|mesh-ancestor
65513950|NCT03018028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65513951|NCT03667222|Minocycline|minocycline|mesh-list
65513952|NCT03667222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65513953|NCT03667222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65513954|NCT03667300|Linagliptin|linagliptin|mesh-list
65513955|NCT03667300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65513956|NCT03667300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513957|NCT03667300|Incretins|incretins|mesh-ancestor
65513958|NCT03667300|Hormones|hormones|mesh-ancestor
65513959|NCT03667300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65513960|NCT03667300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65513961|NCT03667300|Protease Inhibitors|protease inhibitors|mesh-ancestor
65513962|NCT03667300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65513963|NCT03667300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513964|NCT03667066|Clopidogrel|clopidogrel|mesh-list
65513965|NCT03667066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65513966|NCT03667066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65513967|NCT03667066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65513969|NCT03667066|Purinergic Agents|purinergic agents|mesh-ancestor
65513970|NCT03667066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65513971|NCT03667066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513972|NCT03667066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513973|NCT00021255|Cyclophosphamide|cyclophosphamide|mesh-list
65513974|NCT00021255|Carboplatin|carboplatin|mesh-list
65513975|NCT00021255|Docetaxel|docetaxel|mesh-list
65513976|NCT00021255|Doxorubicin|doxorubicin|mesh-list
65513977|NCT00021255|Trastuzumab|trastuzumab|mesh-list
65513978|NCT00021255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65513979|NCT00021255|Immunologic Factors|immunologic factors|mesh-ancestor
65513980|NCT00021255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65513981|NCT00021255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65513982|NCT00021255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65513983|NCT00021255|Alkylating Agents|alkylating agents|mesh-ancestor
65513984|NCT00021255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65513985|NCT00021255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65513986|NCT00021255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65513987|NCT00021255|Tubulin Modulators|tubulin modulators|mesh-ancestor
65513988|NCT00021255|Antimitotic Agents|antimitotic agents|mesh-ancestor
65513989|NCT00021255|Mitosis Modulators|mitosis modulators|mesh-ancestor
65513990|NCT00021255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65513991|NCT00021255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65513992|NCT00021255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65513993|NCT00021255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65513994|NCT00021255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65513995|NCT03012334|Alprazolam|alprazolam|mesh-list
65513996|NCT03012334|Lasmiditan|lasmiditan|mesh-list
65513997|NCT03012334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65513998|NCT03012334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65513999|NCT03012334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514000|NCT03012334|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65514001|NCT03012334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65514002|NCT03012334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65514003|NCT03012334|GABA Modulators|gaba modulators|mesh-ancestor
65514004|NCT03012334|GABA Agents|gaba agents|mesh-ancestor
65514005|NCT03012334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65514006|NCT03012334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514007|NCT03012334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65514008|NCT03012334|Serotonin Agents|serotonin agents|mesh-ancestor
65514009|NCT03951285|Niacinamide|niacinamide|mesh-list
65514010|NCT03951285|Vitamin B Complex|vitamin b complex|mesh-ancestor
65514011|NCT03951285|Vitamins|vitamins|mesh-ancestor
65514012|NCT03951285|Micronutrients|micronutrients|mesh-ancestor
65514013|NCT03951285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514014|NCT04571944|Suvorexant|suvorexant|mesh-list
65514015|NCT04571944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65514016|NCT04571944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65514017|NCT04571944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65514018|NCT04571944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514019|NCT04571944|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65514020|NCT04571944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65514021|NCT04571944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514022|NCT04052932|Allopurinol|allopurinol|mesh-list
65514023|NCT04052932|Antimetabolites|antimetabolites|mesh-ancestor
65514024|NCT04052932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514025|NCT04052932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514026|NCT04052932|Gout Suppressants|gout suppressants|mesh-ancestor
65514027|NCT04052932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65514028|NCT04052932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65514029|NCT04052932|Antioxidants|antioxidants|mesh-ancestor
65514030|NCT04052932|Protective Agents|protective agents|mesh-ancestor
65514031|NCT04052932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514032|NCT03006562|Heparin|heparin|mesh-list
65514033|NCT03006562|Anticoagulants|anticoagulants|mesh-ancestor
65514034|NCT03006562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65514035|NCT03006562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65514036|NCT03006562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514037|NCT03666208|Sirolimus|sirolimus|mesh-list
65514038|NCT03666208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65514039|NCT03666208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65514040|NCT03666208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65514041|NCT03666208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514042|NCT03666208|Antifungal Agents|antifungal agents|mesh-ancestor
65514043|NCT03666208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65514044|NCT03666208|Immunologic Factors|immunologic factors|mesh-ancestor
65514045|NCT03666208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514046|NCT03007966|Clonidine|clonidine|mesh-list
65514047|NCT03007966|Epinephrine|epinephrine|mesh-list
65514048|NCT03007966|Bupivacaine|bupivacaine|mesh-list
65514049|NCT03007966|Anesthetics, Local|anesthetics, local|mesh-ancestor
65514050|NCT03007966|Anesthetics|anesthetics|mesh-ancestor
65514051|NCT03007966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65514052|NCT03007966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514053|NCT03007966|Sensory System Agents|sensory system agents|mesh-ancestor
65514054|NCT03007966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65514055|NCT03007966|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65514056|NCT03007966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65514057|NCT03007966|Adrenergic Agents|adrenergic agents|mesh-ancestor
65514058|NCT03007966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65514059|NCT03007966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514060|NCT03007966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65514061|NCT03007966|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65514062|NCT03007966|Autonomic Agents|autonomic agents|mesh-ancestor
65514063|NCT03007966|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65514064|NCT03007966|Respiratory System Agents|respiratory system agents|mesh-ancestor
65514065|NCT03007966|Mydriatics|mydriatics|mesh-ancestor
65514066|NCT03007966|Sympathomimetics|sympathomimetics|mesh-ancestor
65514067|NCT03007966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65514068|NCT03007966|Analgesics|analgesics|mesh-ancestor
65514069|NCT03007966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65514070|NCT03007966|Sympatholytics|sympatholytics|mesh-ancestor
65514071|NCT03007966|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65514072|NCT03007888|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65514073|NCT03007888|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65514074|NCT03007888|Immunologic Factors|immunologic factors|mesh-ancestor
65514075|NCT03007888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514076|NCT03007888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65514077|NCT03007888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65514078|NCT03007888|Dopamine Agonists|dopamine agonists|mesh-ancestor
65514079|NCT03007888|Dopamine Agents|dopamine agents|mesh-ancestor
65514080|NCT03007888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65514081|NCT03007888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514082|NCT03541044|Nicotine|nicotine|mesh-list
65514083|NCT03541044|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65514084|NCT03541044|Autonomic Agents|autonomic agents|mesh-ancestor
65514085|NCT03541044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65514086|NCT03541044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514087|NCT03541044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65514088|NCT03541044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65514089|NCT03541044|Cholinergic Agents|cholinergic agents|mesh-ancestor
65514090|NCT03541044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65514091|NCT03541044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514092|NCT00009945|Clodronic Acid|clodronic acid|mesh-list
65514093|NCT00009945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65514094|NCT00009945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514095|NCT03540030|Acetaminophen|acetaminophen|mesh-list
65514096|NCT03540030|Celecoxib|celecoxib|mesh-list
65514097|NCT03540030|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65514098|NCT03540030|Lidocaine|lidocaine|mesh-list
65514099|NCT03540030|Gabapentin|gabapentin|mesh-list
65514100|NCT03540030|Propofol|propofol|mesh-list
65514101|NCT03540030|Sevoflurane|sevoflurane|mesh-list
65514102|NCT03540030|Desflurane|desflurane|mesh-list
65514103|NCT03540030|Rocuronium|rocuronium|mesh-list
65514104|NCT03540030|Vecuronium Bromide|vecuronium bromide|mesh-list
65514105|NCT03540030|Anesthetics, Local|anesthetics, local|mesh-ancestor
65514106|NCT03540030|Anesthetics|anesthetics|mesh-ancestor
65514107|NCT03540030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65514108|NCT03540030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514109|NCT03540030|Sensory System Agents|sensory system agents|mesh-ancestor
65514110|NCT03540030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65514111|NCT03540030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65514112|NCT03540030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65514113|NCT03540030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65514114|NCT03540030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65514115|NCT03540030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514116|NCT03540030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65514117|NCT03540030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65514118|NCT03540030|Anesthetics, General|anesthetics, general|mesh-ancestor
65514119|NCT03540030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65514120|NCT03540030|Analgesics|analgesics|mesh-ancestor
65514121|NCT03540030|Antipyretics|antipyretics|mesh-ancestor
65514122|NCT03540030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65514123|NCT03540030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65514124|NCT03540030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65514125|NCT03540030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65514126|NCT03540030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65066535|NCT00271349|Budesonide|budesonide|mesh-list
65514127|NCT03540030|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65514128|NCT03540030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65514129|NCT03540030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514130|NCT03540030|Anticonvulsants|anticonvulsants|mesh-ancestor
65514131|NCT03540030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65514132|NCT03540030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65514133|NCT03540030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65514134|NCT03540030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65514135|NCT03540030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65514136|NCT03540030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65514137|NCT03540030|Antimanic Agents|antimanic agents|mesh-ancestor
65514138|NCT03540030|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65514139|NCT03540030|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65514140|NCT03540030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65514141|NCT03540030|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65514142|NCT03540030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65514143|NCT03540030|Cholinergic Agents|cholinergic agents|mesh-ancestor
65514144|NCT00008385|Selenium|selenium|mesh-list
65514145|NCT00008385|Antioxidants|antioxidants|mesh-ancestor
65514146|NCT00008385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514147|NCT00008385|Protective Agents|protective agents|mesh-ancestor
65514148|NCT00008385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514149|NCT00008385|Trace Elements|trace elements|mesh-ancestor
65514150|NCT00008385|Micronutrients|micronutrients|mesh-ancestor
65514151|NCT03003676|Cyclophosphamide|cyclophosphamide|mesh-list
65514152|NCT03003676|Pembrolizumab|pembrolizumab|mesh-list
65514153|NCT03003676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65514154|NCT03003676|Immunologic Factors|immunologic factors|mesh-ancestor
65514155|NCT03003676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514156|NCT03003676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65514157|NCT03003676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65514158|NCT03003676|Alkylating Agents|alkylating agents|mesh-ancestor
65514159|NCT03003676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514160|NCT03003676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514161|NCT03003676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65514162|NCT03003676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65514163|NCT03003520|Prednisone|prednisone|mesh-list
65514164|NCT03003520|Prednisolone|prednisolone|mesh-list
65514165|NCT03003520|Cyclophosphamide|cyclophosphamide|mesh-list
65514166|NCT03003520|Rituximab|rituximab|mesh-list
65514167|NCT03003520|Doxorubicin|doxorubicin|mesh-list
65514168|NCT03003520|Vincristine|vincristine|mesh-list
65514169|NCT03003520|Lenalidomide|lenalidomide|mesh-list
65514170|NCT03003520|Durvalumab|durvalumab|mesh-list
65514171|NCT03003520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65514172|NCT03003520|Immunologic Factors|immunologic factors|mesh-ancestor
65514173|NCT03003520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514174|NCT03003520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65514175|NCT03003520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65514176|NCT03003520|Alkylating Agents|alkylating agents|mesh-ancestor
65514177|NCT03003520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514178|NCT03003520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514179|NCT03003520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65514180|NCT03003520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65514181|NCT03003520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65514182|NCT03003520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65514183|NCT03003520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65514184|NCT03003520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514185|NCT03003520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65514186|NCT03003520|Glucocorticoids|glucocorticoids|mesh-ancestor
65514187|NCT03003520|Hormones|hormones|mesh-ancestor
65514188|NCT03003520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65514189|NCT03003520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65514190|NCT03003520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65514191|NCT03003520|Tubulin Modulators|tubulin modulators|mesh-ancestor
65311842|NCT04134611|Immunologic Factors|immunologic factors|mesh-ancestor
65514192|NCT03003520|Antimitotic Agents|antimitotic agents|mesh-ancestor
65514193|NCT03003520|Mitosis Modulators|mitosis modulators|mesh-ancestor
65514194|NCT03003520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65514195|NCT03003520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65514196|NCT03003520|Growth Substances|growth substances|mesh-ancestor
65514197|NCT03003520|Growth Inhibitors|growth inhibitors|mesh-ancestor
65514199|NCT03665740|Antioxidants|antioxidants|mesh-ancestor
65514200|NCT03665740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514201|NCT03665740|Protective Agents|protective agents|mesh-ancestor
65514202|NCT03665740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514203|NCT03665740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514204|NCT03665740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65514205|NCT03665350|Insulin|insulin|mesh-list
65514206|NCT03665350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65514207|NCT03665350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514208|NCT03665428|Bismuth|bismuth|mesh-list
65514209|NCT03665428|Antacids|antacids|mesh-ancestor
65514210|NCT03665428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514211|NCT03665428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65514212|NCT03669328|Anesthetics|anesthetics|mesh-list
65514213|NCT03669328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65514214|NCT03669328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514215|NCT02912650|Acetaminophen|acetaminophen|mesh-list
65514216|NCT02912650|Ibuprofen|ibuprofen|mesh-list
65514217|NCT02912650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65514218|NCT02912650|Analgesics|analgesics|mesh-ancestor
65514219|NCT02912650|Sensory System Agents|sensory system agents|mesh-ancestor
65514220|NCT02912650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65514221|NCT02912650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514222|NCT02912650|Antipyretics|antipyretics|mesh-ancestor
65514223|NCT02912650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65514224|NCT02912650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65514225|NCT02912650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65514226|NCT02912650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65514227|NCT02912650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514228|NCT02912650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514229|NCT03002038|Rituximab|rituximab|mesh-list
65514230|NCT03002038|Azathioprine|azathioprine|mesh-list
65514231|NCT03002038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65514232|NCT03002038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514233|NCT03002038|Immunologic Factors|immunologic factors|mesh-ancestor
65514234|NCT03002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514235|NCT03002038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65514236|NCT03002038|Antimetabolites|antimetabolites|mesh-ancestor
65514237|NCT03002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514238|NCT03002038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65514239|NCT03002038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65514240|NCT03664414|Pentoxifylline|pentoxifylline|mesh-list
65514241|NCT03664414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65514242|NCT03664414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514243|NCT03664414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514244|NCT03664414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65514245|NCT03664414|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65514246|NCT03664414|Protective Agents|protective agents|mesh-ancestor
65514247|NCT03664414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514248|NCT03664414|Vasodilator Agents|vasodilator agents|mesh-ancestor
65514249|NCT03664414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65514250|NCT03664414|Antioxidants|antioxidants|mesh-ancestor
65514251|NCT02911948|Insulin|insulin|mesh-list
65514252|NCT02911948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65514253|NCT02911948|Liraglutide|liraglutide|mesh-list
65514254|NCT02911948|Insulin, Long-Acting|insulin, long-acting|mesh-list
65514255|NCT02911948|Xultophy|xultophy|mesh-list
65514256|NCT02911948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65514257|NCT02911948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514258|NCT02911948|Incretins|incretins|mesh-ancestor
65514259|NCT02911948|Hormones|hormones|mesh-ancestor
65514260|NCT02911948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65514261|NCT03622918|Rifampin|rifampin|mesh-list
65514262|NCT03622918|Colistin|colistin|mesh-list
65514263|NCT03622918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65514264|NCT03622918|Antitubercular Agents|antitubercular agents|mesh-ancestor
65514265|NCT03622918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65514266|NCT03622918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65514267|NCT03622918|Leprostatic Agents|leprostatic agents|mesh-ancestor
65514268|NCT03622918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65514269|NCT03622918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514270|NCT03622918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514271|NCT03622918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65514272|NCT03622918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65514273|NCT03622918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65514274|NCT03622918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65514275|NCT03622918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65514276|NCT03622918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65514277|NCT03487666|Capecitabine|capecitabine|mesh-list
65514278|NCT03487666|Nivolumab|nivolumab|mesh-list
65514279|NCT03487666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65514280|NCT03487666|Antimetabolites|antimetabolites|mesh-ancestor
65514281|NCT03487666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514282|NCT03487666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514283|NCT03487666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65514284|NCT03487666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65514285|NCT03376672|Dexamethasone|dexamethasone|mesh-list
65514286|NCT03376672|Lenalidomide|lenalidomide|mesh-list
65514287|NCT03376672|Ixazomib|ixazomib|mesh-list
65514288|NCT03376672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65514289|NCT03376672|Antiemetics|antiemetics|mesh-ancestor
65514290|NCT03376672|Autonomic Agents|autonomic agents|mesh-ancestor
65514291|NCT03376672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65514292|NCT03376672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514293|NCT03376672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65514294|NCT03376672|Glucocorticoids|glucocorticoids|mesh-ancestor
65514295|NCT03376672|Hormones|hormones|mesh-ancestor
65514296|NCT03376672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65514297|NCT03376672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65514298|NCT03376672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514299|NCT03376672|Immunologic Factors|immunologic factors|mesh-ancestor
65514300|NCT03376672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65514301|NCT03376672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65514302|NCT03376672|Growth Substances|growth substances|mesh-ancestor
65514303|NCT03376672|Growth Inhibitors|growth inhibitors|mesh-ancestor
65514304|NCT03376672|Protease Inhibitors|protease inhibitors|mesh-ancestor
65514305|NCT03376672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514306|NCT03376672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514307|NCT03367312|Xenon|xenon|mesh-list
65514308|NCT03367312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65514309|NCT03367312|Anesthetics, General|anesthetics, general|mesh-ancestor
65514310|NCT03367312|Anesthetics|anesthetics|mesh-ancestor
65514311|NCT03367312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65514312|NCT03367312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514313|NCT00027027|Pertuzumab|pertuzumab|mesh-list
65514314|NCT00027027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65514315|NCT00027027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514316|NCT00046839|Celecoxib|celecoxib|mesh-list
65514317|NCT00046839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
65514318|NCT00046839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65514319|NCT00046839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65514320|NCT00046839|Analgesics|analgesics|mesh-ancestor
65514321|NCT00046839|Sensory System Agents|sensory system agents|mesh-ancestor
65514322|NCT00046839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65514323|NCT00046839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514324|NCT00046839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65514325|NCT00046839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65514326|NCT00046839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65514327|NCT00046839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514328|NCT00046839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514329|NCT00006903|Fulvestrant|fulvestrant|mesh-list
65514330|NCT00006903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65514331|NCT00006903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514332|NCT00006903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65514333|NCT00006903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65514334|NCT00006903|Hormone Antagonists|hormone antagonists|mesh-ancestor
65514335|NCT00006903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65514336|NCT00006903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514337|NCT03951597|Gemcitabine|gemcitabine|mesh-list
65514338|NCT03951597|Oxaliplatin|oxaliplatin|mesh-list
65514339|NCT03951597|Lenvatinib|lenvatinib|mesh-list
65514340|NCT03951597|Antibodies|antibodies|mesh-list
65514341|NCT03951597|Immunologic Factors|immunologic factors|mesh-ancestor
65514342|NCT03951597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514343|NCT03951597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65514344|NCT03951597|Antimetabolites|antimetabolites|mesh-ancestor
65514345|NCT03951597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514346|NCT03951597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514347|NCT03951597|Antiviral Agents|antiviral agents|mesh-ancestor
65514348|NCT03951597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65514349|NCT03951597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514350|NCT03951597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65514351|NCT03951597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65514352|NCT03539484|Obinutuzumab|obinutuzumab|mesh-list
65514353|NCT03539484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65514354|NCT03539484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514355|NCT01101009|Amlodipine|amlodipine|mesh-list
65514356|NCT01101009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65514357|NCT01101009|Olmesartan|olmesartan|mesh-list
65514358|NCT01101009|Perindopril|perindopril|mesh-list
65514359|NCT01101009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65514360|NCT01101009|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65514361|NCT01101009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65514362|NCT01101009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514363|NCT01101009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65514364|NCT01101009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514365|NCT01101009|Vasodilator Agents|vasodilator agents|mesh-ancestor
65514366|NCT01101009|Diuretics|diuretics|mesh-ancestor
65514367|NCT01101009|Natriuretic Agents|natriuretic agents|mesh-ancestor
65514368|NCT01101009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65514369|NCT01101009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65514370|NCT01101009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65514371|NCT01101009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65514372|NCT01101009|Protease Inhibitors|protease inhibitors|mesh-ancestor
65514373|NCT01101009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514374|NCT02996500|Tofacitinib|tofacitinib|mesh-list
65514375|NCT02996500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65514376|NCT02996500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514377|NCT02996500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514378|NCT00006489|Naltrexone|naltrexone|mesh-list
65514379|NCT00006489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65514380|NCT00006489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65514381|NCT00006489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514382|NCT00006489|Sensory System Agents|sensory system agents|mesh-ancestor
65514383|NCT00006489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65514384|NCT01096095|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
65514385|NCT01096095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514386|NCT03720756|Nickel|nickel|mesh-list
65514387|NCT03720756|Trace Elements|trace elements|mesh-ancestor
65514388|NCT03720756|Micronutrients|micronutrients|mesh-ancestor
65514389|NCT03720756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514390|NCT00025233|Bevacizumab|bevacizumab|mesh-list
65514391|NCT00025233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65514392|NCT00025233|Antibodies|antibodies|mesh-list
65514393|NCT00025233|Immunoglobulins|immunoglobulins|mesh-list
65514394|NCT00025233|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65514395|NCT00025233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514396|NCT00025233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65514397|NCT00025233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65514398|NCT00025233|Growth Substances|growth substances|mesh-ancestor
65514399|NCT00025233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514400|NCT00025233|Growth Inhibitors|growth inhibitors|mesh-ancestor
65514401|NCT00025233|Immunologic Factors|immunologic factors|mesh-ancestor
65514402|NCT00025155|Epothilones|epothilones|mesh-list
65514403|NCT00025155|Epothilone B|epothilone b|mesh-list
65514404|NCT00025155|Tubulin Modulators|tubulin modulators|mesh-ancestor
65514405|NCT00025155|Antimitotic Agents|antimitotic agents|mesh-ancestor
65514406|NCT00025155|Mitosis Modulators|mitosis modulators|mesh-ancestor
65514407|NCT00025155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514408|NCT00025155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514409|NCT02998996|Endocine|endocine|mesh-list
65514410|NCT02998996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65514411|NCT02998996|Immunologic Factors|immunologic factors|mesh-ancestor
65514412|NCT02998996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514413|NCT03663478|Ropivacaine|ropivacaine|mesh-list
65514414|NCT03663478|Anesthetics, Local|anesthetics, local|mesh-ancestor
65514415|NCT03663478|Anesthetics|anesthetics|mesh-ancestor
65514416|NCT03663478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65514417|NCT03663478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514418|NCT03663478|Sensory System Agents|sensory system agents|mesh-ancestor
65514419|NCT03663478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65514420|NCT02994940|Acetaminophen|acetaminophen|mesh-list
65514421|NCT02994940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65514422|NCT02994940|Analgesics|analgesics|mesh-ancestor
65514423|NCT02994940|Sensory System Agents|sensory system agents|mesh-ancestor
65514424|NCT02994940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65514425|NCT02994940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514426|NCT02994940|Antipyretics|antipyretics|mesh-ancestor
65514427|NCT04053322|Durvalumab|durvalumab|mesh-list
65514428|NCT04053322|Olaparib|olaparib|mesh-list
65514429|NCT04053322|Fulvestrant|fulvestrant|mesh-list
65514430|NCT04053322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65514431|NCT04053322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514432|NCT04053322|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65514433|NCT04053322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514434|NCT04053322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514435|NCT04053322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65514436|NCT04053322|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65514437|NCT04053322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65514438|NCT04053322|Hormone Antagonists|hormone antagonists|mesh-ancestor
65514439|NCT04053322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65514440|NCT04053322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514441|NCT02994394|Tolvaptan|tolvaptan|mesh-list
65514442|NCT02994394|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65514443|NCT02994394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514444|NCT02994394|Natriuretic Agents|natriuretic agents|mesh-ancestor
65514445|NCT02994394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514446|NCT01063270|Rifampin|rifampin|mesh-list
65514447|NCT01063270|Clindamycin|clindamycin|mesh-list
65514448|NCT01063270|Clindamycin palmitate|clindamycin palmitate|mesh-list
65514449|NCT01063270|Clindamycin phosphate|clindamycin phosphate|mesh-list
65514450|NCT01063270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65514451|NCT01063270|Antitubercular Agents|antitubercular agents|mesh-ancestor
65514452|NCT01063270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65514453|NCT01063270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65514454|NCT01063270|Leprostatic Agents|leprostatic agents|mesh-ancestor
65514455|NCT01063270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65514456|NCT01063270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514457|NCT01063270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514458|NCT01063270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65514459|NCT01063270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65514460|NCT01063270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65514461|NCT01063270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65514462|NCT01063270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65514463|NCT01063270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65514464|NCT01063270|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65514465|NCT00023673|Paclitaxel|paclitaxel|mesh-list
65514466|NCT00023673|Carboplatin|carboplatin|mesh-list
65514467|NCT00023673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65514468|NCT00023673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514469|NCT00023673|Tubulin Modulators|tubulin modulators|mesh-ancestor
65514470|NCT00023673|Antimitotic Agents|antimitotic agents|mesh-ancestor
65514471|NCT00023673|Mitosis Modulators|mitosis modulators|mesh-ancestor
65514472|NCT00023673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514473|NCT01069900|Amoxicillin|amoxicillin|mesh-list
65514474|NCT01069900|Moxifloxacin|moxifloxacin|mesh-list
65514475|NCT01069900|Clavulanic Acid|clavulanic acid|mesh-list
65514476|NCT01069900|Clavulanic Acids|clavulanic acids|mesh-list
65514477|NCT01069900|Ertapenem|ertapenem|mesh-list
65514478|NCT01069900|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65514479|NCT01069900|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65514480|NCT01069900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65514481|NCT01069900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65514482|NCT01069900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65514483|NCT01069900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65514484|NCT01069900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514485|NCT01069900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514486|NCT01069900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514487|NCT01069900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65514488|NCT01069900|Contraceptive Agents|contraceptive agents|mesh-ancestor
65514489|NCT01069900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65312144|NCT00851318|Antimetabolites|antimetabolites|mesh-ancestor
65514490|NCT01069900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514491|NCT01069900|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65514492|NCT01069900|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65514493|NCT01069900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65514494|NCT01069900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65514495|NCT03417544|Trastuzumab|trastuzumab|mesh-list
65514496|NCT03417544|Pertuzumab|pertuzumab|mesh-list
65514497|NCT03417544|Atezolizumab|atezolizumab|mesh-list
65514498|NCT03417544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65514499|NCT03417544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514500|NCT00006237|Interferons|interferons|mesh-list
65514501|NCT00006237|Interferon-alpha|interferon-alpha|mesh-list
65514502|NCT00006237|Aldesleukin|aldesleukin|mesh-list
65514503|NCT00006237|Interleukin-2|interleukin-2|mesh-list
65514504|NCT00006237|Dacarbazine|dacarbazine|mesh-list
65514505|NCT00006237|Vinblastine|vinblastine|mesh-list
65514506|NCT00006237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514507|NCT00006237|Antiviral Agents|antiviral agents|mesh-ancestor
65514508|NCT00006237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65514509|NCT00006237|Immunologic Factors|immunologic factors|mesh-ancestor
65514510|NCT00006237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514511|NCT00006237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65514512|NCT00006237|Analgesics|analgesics|mesh-ancestor
65514513|NCT00006237|Sensory System Agents|sensory system agents|mesh-ancestor
65514514|NCT00006237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65514515|NCT00006237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65514516|NCT00006237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65514517|NCT00006237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65514518|NCT00006237|Alkylating Agents|alkylating agents|mesh-ancestor
65514519|NCT00006237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514520|NCT00006237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65514521|NCT00006237|Tubulin Modulators|tubulin modulators|mesh-ancestor
65514522|NCT00006237|Antimitotic Agents|antimitotic agents|mesh-ancestor
65514523|NCT00006237|Mitosis Modulators|mitosis modulators|mesh-ancestor
65514524|NCT04056754|Prednisone|prednisone|mesh-list
65514525|NCT04056754|Abiraterone Acetate|abiraterone acetate|mesh-list
65514526|NCT04056754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65514527|NCT04056754|Glucocorticoids|glucocorticoids|mesh-ancestor
65514528|NCT04056754|Hormones|hormones|mesh-ancestor
65514529|NCT04056754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65514530|NCT04056754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514531|NCT04056754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65514532|NCT04056754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514533|NCT04056754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65514534|NCT04056754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514535|NCT04056754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514536|NCT04056754|Hormone Antagonists|hormone antagonists|mesh-ancestor
65514537|NCT04056754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65514538|NCT04056442|Cannabidiol|cannabidiol|mesh-list
65514539|NCT04056442|Anticonvulsants|anticonvulsants|mesh-ancestor
65514540|NCT03662620|Amlodipine|amlodipine|mesh-list
65514541|NCT03662620|Telmisartan|telmisartan|mesh-list
65514542|NCT03662620|Chlorthalidone|chlorthalidone|mesh-list
65514543|NCT03662620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65514544|NCT03662620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65514545|NCT03662620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65514546|NCT03662620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514547|NCT03662620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65514548|NCT03662620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514549|NCT03662620|Vasodilator Agents|vasodilator agents|mesh-ancestor
65514550|NCT03662620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65514551|NCT03662620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65514552|NCT03662620|Diuretics|diuretics|mesh-ancestor
65514553|NCT03662620|Natriuretic Agents|natriuretic agents|mesh-ancestor
65514554|NCT03662620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65514555|NCT03661684|Prednisone|prednisone|mesh-list
65514556|NCT03661684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65514557|NCT03661684|Glucocorticoids|glucocorticoids|mesh-ancestor
65514558|NCT03661684|Hormones|hormones|mesh-ancestor
65514559|NCT03661684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65514560|NCT03661684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514561|NCT03661684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65514562|NCT03661684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514563|NCT02993926|Leuprolide|leuprolide|mesh-list
65514564|NCT02993926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65514565|NCT02993926|Fertility Agents|fertility agents|mesh-ancestor
65514566|NCT02993926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65514567|NCT02993926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514568|NCT02993926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65514569|NCT02993926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514570|NCT04055506|Ritonavir|ritonavir|mesh-list
65514571|NCT04055506|BMS-986165|bms-986165|mesh-list
65514572|NCT04055506|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65514573|NCT04055506|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65514574|NCT04055506|Protease Inhibitors|protease inhibitors|mesh-ancestor
65514575|NCT04055506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514576|NCT04055506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514577|NCT04055506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65514578|NCT04055506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65514579|NCT04055506|Antiviral Agents|antiviral agents|mesh-ancestor
65514580|NCT04055506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65514581|NCT04055506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65514582|NCT04055506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65514583|NCT04055506|Dermatologic Agents|dermatologic agents|mesh-ancestor
65514584|NCT04055506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65514585|NCT02993224|Deferasirox|deferasirox|mesh-list
65514586|NCT02993224|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65514587|NCT02993224|Chelating Agents|chelating agents|mesh-ancestor
65514588|NCT02993224|Sequestering Agents|sequestering agents|mesh-ancestor
65514589|NCT02993224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514590|NCT03447314|Pembrolizumab|pembrolizumab|mesh-list
65514591|NCT03447314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65514592|NCT03447314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514593|NCT03415178|Atorvastatin|atorvastatin|mesh-list
65514594|NCT03415178|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65514595|NCT03415178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65514596|NCT03415178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65514597|NCT03415178|Antimetabolites|antimetabolites|mesh-ancestor
65514598|NCT03415178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514599|NCT03415178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65514600|NCT03415178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65514601|NCT03415178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514602|NCT02992132|Pimavanserin|pimavanserin|mesh-list
65514603|NCT02992132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65514604|NCT02992132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65514605|NCT02992132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65514606|NCT02992132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65514607|NCT02992132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65514608|NCT02992132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514609|NCT02992132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65514610|NCT02992132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65514611|NCT02992132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65514612|NCT02992132|Serotonin Agents|serotonin agents|mesh-ancestor
65514613|NCT02992132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65514614|NCT02992132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514615|NCT03444584|Metformin|metformin|mesh-list
65514616|NCT03444584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65514617|NCT03444584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514618|NCT03717740|Esomeprazole|esomeprazole|mesh-list
65514619|NCT03717740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65514620|NCT03717740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65514621|NCT03717740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65514622|NCT03717740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514623|NCT03717740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514624|NCT03411902|Risedronic Acid|risedronic acid|mesh-list
65514625|NCT03411902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65514626|NCT03411902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65514627|NCT03411902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514628|NCT03411902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65514629|NCT03411902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514630|NCT03411902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65514631|NCT03717662|Nicotine|nicotine|mesh-list
65514632|NCT03717662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65514633|NCT03717662|Autonomic Agents|autonomic agents|mesh-ancestor
65514634|NCT03717662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65514635|NCT03717662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514636|NCT03717662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65514637|NCT03717662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65514638|NCT03717662|Cholinergic Agents|cholinergic agents|mesh-ancestor
65514639|NCT03717662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65514640|NCT03717662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514641|NCT03494816|Axitinib|axitinib|mesh-list
65514642|NCT03494816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514643|NCT03494816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65514644|NCT03494816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514645|NCT03494816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514646|NCT03713918|Lithium Carbonate|lithium carbonate|mesh-list
65514647|NCT03713918|Antidepressive Agents|antidepressive agents|mesh-ancestor
65514648|NCT03713918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65514649|NCT03713918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514650|NCT03713918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514651|NCT03713918|Antimanic Agents|antimanic agents|mesh-ancestor
65514652|NCT03713918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65514653|NCT03713918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65514654|NCT03713918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514655|NCT03713762|Lidocaine|lidocaine|mesh-list
65514656|NCT03713762|Fentanyl|fentanyl|mesh-list
65514657|NCT03713762|Bupivacaine|bupivacaine|mesh-list
65514658|NCT03713762|Anesthetics, Local|anesthetics, local|mesh-ancestor
65514659|NCT03713762|Anesthetics|anesthetics|mesh-ancestor
65514660|NCT03713762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65514661|NCT03713762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514662|NCT03713762|Sensory System Agents|sensory system agents|mesh-ancestor
65514663|NCT03713762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65514664|NCT03713762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65514665|NCT03713762|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65514666|NCT03713762|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65514667|NCT03713762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65514668|NCT03713762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514669|NCT03713762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65514670|NCT03713762|Narcotics|narcotics|mesh-ancestor
65514671|NCT03713762|Analgesics|analgesics|mesh-ancestor
65514672|NCT03713762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65514673|NCT03713762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65514674|NCT03713762|Anesthetics, General|anesthetics, general|mesh-ancestor
65514675|NCT02991118|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
65514676|NCT02991118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65514677|NCT02991118|Antimetabolites|antimetabolites|mesh-ancestor
65514678|NCT02991118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514679|NCT02991118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65514680|NCT02991118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514681|NCT02991118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65514682|NCT02991118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514683|NCT02991040|Lidocaine|lidocaine|mesh-list
65514684|NCT02991040|Anesthetics, Local|anesthetics, local|mesh-ancestor
65514685|NCT02991040|Anesthetics|anesthetics|mesh-ancestor
65514686|NCT02991040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65514687|NCT02991040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514688|NCT02991040|Sensory System Agents|sensory system agents|mesh-ancestor
65514689|NCT02991040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65514690|NCT02991040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65514691|NCT02991040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65514692|NCT02991040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65514693|NCT02991040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65514694|NCT02991040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514695|NCT03660436|Mycophenolic Acid|mycophenolic acid|mesh-list
65514696|NCT03660436|BMS-986165|bms-986165|mesh-list
65514697|NCT03660436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65514698|NCT03660436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514699|NCT03660436|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65514700|NCT03660436|Antitubercular Agents|antitubercular agents|mesh-ancestor
65514701|NCT03660436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65514702|NCT03660436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65514703|NCT03660436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514704|NCT03660436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514705|NCT03660436|Dermatologic Agents|dermatologic agents|mesh-ancestor
65514706|NCT03660436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65514707|NCT01068730|Metformin|metformin|mesh-list
65514708|NCT01068730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65514709|NCT01068730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514710|NCT01068652|Insulin|insulin|mesh-list
65514711|NCT01068652|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65514712|NCT01068652|Metformin|metformin|mesh-list
65514713|NCT01068652|Insulin Aspart|insulin aspart|mesh-list
65514714|NCT01068652|Insulin, Long-Acting|insulin, long-acting|mesh-list
65514715|NCT01068652|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65514716|NCT01068652|Insulin Detemir|insulin detemir|mesh-list
65514717|NCT01068652|Biphasic Insulins|biphasic insulins|mesh-list
65514718|NCT01068652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65514719|NCT01068652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65514720|NCT01068652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514721|NCT03658720|Ibuprofen|ibuprofen|mesh-list
65514722|NCT03658720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65514723|NCT03658720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65514724|NCT03658720|Analgesics|analgesics|mesh-ancestor
65514725|NCT03658720|Sensory System Agents|sensory system agents|mesh-ancestor
65514726|NCT03658720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65514727|NCT03658720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514728|NCT03658720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65514729|NCT03658720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65514730|NCT03658720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65514731|NCT03658720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514732|NCT03658720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514733|NCT03658408|4-Aminopyridine|4-aminopyridine|mesh-list
65514734|NCT03658408|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65514735|NCT03658408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65514736|NCT03658408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514737|NCT03658330|Naltrexone|naltrexone|mesh-list
65514738|NCT03658330|Ketamine|ketamine|mesh-list
65514739|NCT03658330|Analgesics|analgesics|mesh-ancestor
65514740|NCT03658330|Sensory System Agents|sensory system agents|mesh-ancestor
65514741|NCT03658330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65514742|NCT03658330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514743|NCT03658330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65514744|NCT03658330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65514745|NCT03658330|Anesthetics, General|anesthetics, general|mesh-ancestor
65514746|NCT03658330|Anesthetics|anesthetics|mesh-ancestor
65514747|NCT03658330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65514748|NCT03658330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65514749|NCT03658330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65514750|NCT03658330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65514751|NCT03658330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514752|NCT03658330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65514753|NCT03658330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65514754|NCT02920528|Ketamine|ketamine|mesh-list
65514755|NCT02920528|Analgesics|analgesics|mesh-ancestor
65514756|NCT02920528|Sensory System Agents|sensory system agents|mesh-ancestor
65514757|NCT02920528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65514758|NCT02920528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514759|NCT02920528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65514760|NCT02920528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65514761|NCT02920528|Anesthetics, General|anesthetics, general|mesh-ancestor
65514762|NCT02920528|Anesthetics|anesthetics|mesh-ancestor
65514763|NCT02920528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65514764|NCT02920528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65514765|NCT02920528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65514766|NCT02920528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65514767|NCT02920528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514768|NCT01068418|Vitamin D|vitamin d|mesh-list
65514769|NCT01068418|Cholecalciferol|cholecalciferol|mesh-list
65514770|NCT01068418|Vitamins|vitamins|mesh-ancestor
65514771|NCT01068418|Micronutrients|micronutrients|mesh-ancestor
65514772|NCT01068418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514773|NCT01068418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65514774|NCT01068418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65514775|NCT01100619|Rosiglitazone|rosiglitazone|mesh-list
65514776|NCT01100619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65514777|NCT01100619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514778|NCT03657550|Niacin|niacin|mesh-list
65514779|NCT03657550|Amlodipine|amlodipine|mesh-list
65514780|NCT03657550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65514781|NCT03657550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65514782|NCT03657550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65514783|NCT03657550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514784|NCT03657550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65514785|NCT03657550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514786|NCT03657550|Vasodilator Agents|vasodilator agents|mesh-ancestor
65514787|NCT03657550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65514788|NCT03657550|Antimetabolites|antimetabolites|mesh-ancestor
65514789|NCT03657550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65514790|NCT03657550|Vitamin B Complex|vitamin b complex|mesh-ancestor
65514791|NCT03657550|Vitamins|vitamins|mesh-ancestor
65514792|NCT03657550|Micronutrients|micronutrients|mesh-ancestor
65514793|NCT02920450|Paclitaxel|paclitaxel|mesh-list
65514794|NCT02920450|Carboplatin|carboplatin|mesh-list
65514795|NCT02920450|Gedatolisib|gedatolisib|mesh-list
65514796|NCT02920450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65514797|NCT02920450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514798|NCT02920450|Tubulin Modulators|tubulin modulators|mesh-ancestor
65514799|NCT02920450|Antimitotic Agents|antimitotic agents|mesh-ancestor
65514800|NCT02920450|Mitosis Modulators|mitosis modulators|mesh-ancestor
65514801|NCT02920450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514802|NCT02920450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65514803|NCT02920450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514804|NCT03622450|Ciprofloxacin|ciprofloxacin|mesh-list
65514805|NCT03622450|Levofloxacin|levofloxacin|mesh-list
65514806|NCT03622450|Gentamicins|gentamicins|mesh-list
65514807|NCT03622450|Meropenem|meropenem|mesh-list
65514808|NCT03622450|Amikacin|amikacin|mesh-list
65514809|NCT03622450|Colistin|colistin|mesh-list
65514810|NCT03622450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65514811|NCT03622450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65514812|NCT03622450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65514813|NCT03622450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65514814|NCT03622450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514815|NCT03622450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514816|NCT03622450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514817|NCT03622450|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65514818|NCT03622450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65514819|NCT03622450|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65514820|NCT03622450|Renal Agents|renal agents|mesh-ancestor
65514821|NCT03622450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65514822|NCT03657862|Fluorides|fluorides|mesh-list
65514823|NCT03657862|Cariostatic Agents|cariostatic agents|mesh-ancestor
65514824|NCT03657862|Protective Agents|protective agents|mesh-ancestor
65514825|NCT03657862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514826|NCT02730130|Pembrolizumab|pembrolizumab|mesh-list
65514827|NCT02730130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65514828|NCT02730130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514829|NCT02919436|Tamsulosin|tamsulosin|mesh-list
65514830|NCT02919436|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65514831|NCT02919436|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65514832|NCT02919436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65514833|NCT02919436|Adrenergic Agents|adrenergic agents|mesh-ancestor
65514834|NCT02919436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65514835|NCT02919436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514836|NCT02919436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514837|NCT02919436|Urological Agents|urological agents|mesh-ancestor
65514838|NCT03657472|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
65514839|NCT03657472|Atorvastatin|atorvastatin|mesh-list
65514840|NCT03657472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65514841|NCT03657472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65514842|NCT03657472|Antimetabolites|antimetabolites|mesh-ancestor
65514843|NCT03657472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514844|NCT03657472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65514845|NCT03657472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65514846|NCT03657472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514847|NCT03657472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65514848|NCT04440358|Carboplatin|carboplatin|mesh-list
65514849|NCT04440358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514850|NCT04438330|Nickel|nickel|mesh-list
65514851|NCT04438330|Trace Elements|trace elements|mesh-ancestor
65514852|NCT04438330|Micronutrients|micronutrients|mesh-ancestor
65514853|NCT04438330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514854|NCT03803475|Edetic Acid|edetic acid|mesh-list
65514855|NCT03803475|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65514856|NCT03803475|Chelating Agents|chelating agents|mesh-ancestor
65514857|NCT03803475|Sequestering Agents|sequestering agents|mesh-ancestor
65514858|NCT03803475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514859|NCT03803475|Anticoagulants|anticoagulants|mesh-ancestor
65514860|NCT03803475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65514861|NCT03803475|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65514862|NCT02682004|Serotonin|serotonin|mesh-list
65514863|NCT02682004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65514864|NCT02682004|Serotonin Agents|serotonin agents|mesh-ancestor
65514865|NCT02682004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65514866|NCT02682004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514867|NCT02682004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514868|NCT00005937|Cyclosporine|cyclosporine|mesh-list
65514869|NCT00005937|Cyclosporins|cyclosporins|mesh-list
65514870|NCT00005937|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65514871|NCT00005937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514872|NCT00005937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514873|NCT00005937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65514874|NCT00005937|Immunologic Factors|immunologic factors|mesh-ancestor
65514875|NCT00005937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514876|NCT00005937|Antifungal Agents|antifungal agents|mesh-ancestor
65514877|NCT00005937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65514878|NCT00005937|Dermatologic Agents|dermatologic agents|mesh-ancestor
65514879|NCT00005937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65514880|NCT00005937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65514881|NCT01096329|Methyltestosterone|methyltestosterone|mesh-list
65514882|NCT01096329|Testosterone|testosterone|mesh-list
65514883|NCT01096329|Testosterone undecanoate|testosterone undecanoate|mesh-list
65514884|NCT01096329|Testosterone enanthate|testosterone enanthate|mesh-list
65514885|NCT01096329|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65514886|NCT01096329|Androgens|androgens|mesh-ancestor
65514887|NCT01096329|Hormones|hormones|mesh-ancestor
65514888|NCT01096329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65514889|NCT01096329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514890|NCT01096329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65514891|NCT01096329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514892|NCT01096329|Anabolic Agents|anabolic agents|mesh-ancestor
65514893|NCT02908516|Tranexamic Acid|tranexamic acid|mesh-list
65514894|NCT02908516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65514895|NCT02908516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65514896|NCT02908516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514897|NCT02908516|Hemostatics|hemostatics|mesh-ancestor
65514898|NCT02908516|Coagulants|coagulants|mesh-ancestor
65514899|NCT03717350|Meropenem|meropenem|mesh-list
65514900|NCT03717350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65514901|NCT03717350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65514902|NCT03713372|Antibodies|antibodies|mesh-list
65514903|NCT03713372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65514904|NCT03713372|Immunologic Factors|immunologic factors|mesh-ancestor
65514905|NCT03713372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514906|NCT03656614|Neostigmine|neostigmine|mesh-list
65514907|NCT03656614|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65514908|NCT03656614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514909|NCT03656614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514910|NCT03656614|Cholinergic Agents|cholinergic agents|mesh-ancestor
65514911|NCT03656614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65514912|NCT03656614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514913|NCT03656614|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65514914|NCT03656614|Autonomic Agents|autonomic agents|mesh-ancestor
65514915|NCT03656614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65514916|NCT02906644|Nicotine|nicotine|mesh-list
65514917|NCT02906644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65514918|NCT02906644|Autonomic Agents|autonomic agents|mesh-ancestor
65514919|NCT02906644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65514920|NCT02906644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514921|NCT02906644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65514922|NCT02906644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65514923|NCT02906644|Cholinergic Agents|cholinergic agents|mesh-ancestor
65514924|NCT02906644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65514925|NCT02906644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514926|NCT02982772|Nicotine|nicotine|mesh-list
65514927|NCT02982772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65514928|NCT02982772|Autonomic Agents|autonomic agents|mesh-ancestor
65514929|NCT02982772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65514930|NCT02982772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514931|NCT02982772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65514932|NCT02982772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65514933|NCT02982772|Cholinergic Agents|cholinergic agents|mesh-ancestor
65514934|NCT02982772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65514935|NCT02982772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514936|NCT03713216|Morphine|morphine|mesh-list
65514937|NCT03713216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65514938|NCT03713216|Narcotics|narcotics|mesh-ancestor
65514939|NCT03713216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65514940|NCT03713216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514941|NCT03713216|Analgesics|analgesics|mesh-ancestor
65514942|NCT03713216|Sensory System Agents|sensory system agents|mesh-ancestor
65514943|NCT03713216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65514944|NCT02098954|Gemcitabine|gemcitabine|mesh-list
65514945|NCT02098954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65514946|NCT02098954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65514947|NCT02098954|Antimetabolites|antimetabolites|mesh-ancestor
65243975|NCT02619201|Ondansetron|ondansetron|mesh-list
65514948|NCT02098954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514949|NCT02098954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514950|NCT02098954|Antiviral Agents|antiviral agents|mesh-ancestor
65514951|NCT02098954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65514952|NCT02098954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514953|NCT02098954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65514954|NCT02098954|Immunologic Factors|immunologic factors|mesh-ancestor
65514955|NCT02098954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514956|NCT02098954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65514957|NCT03655834|Pemetrexed|pemetrexed|mesh-list
65514958|NCT03655834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514959|NCT03655834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65514960|NCT03655834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514961|NCT03655834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65514962|NCT03655834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65514963|NCT03488108|Minoxidil|minoxidil|mesh-list
65514964|NCT03488108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65514965|NCT03488108|Vasodilator Agents|vasodilator agents|mesh-ancestor
65514966|NCT03712670|Pyranoprofen|pyranoprofen|mesh-list
65514967|NCT03712670|Aflibercept|aflibercept|mesh-list
65514968|NCT03712670|Carotenoids|carotenoids|mesh-list
65514969|NCT03712670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65514970|NCT03712670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65514971|NCT03712670|Growth Substances|growth substances|mesh-ancestor
65514972|NCT03712670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514973|NCT03712670|Growth Inhibitors|growth inhibitors|mesh-ancestor
65514974|NCT03712670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65514975|NCT03712670|Antioxidants|antioxidants|mesh-ancestor
65514976|NCT03712670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65514977|NCT03712670|Protective Agents|protective agents|mesh-ancestor
65514978|NCT03712670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65514979|NCT03712670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65514980|NCT03712670|Analgesics|analgesics|mesh-ancestor
65514981|NCT03712670|Sensory System Agents|sensory system agents|mesh-ancestor
65514982|NCT03712670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65514983|NCT03712670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65514984|NCT03712670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65514985|NCT03712670|Gout Suppressants|gout suppressants|mesh-ancestor
65514986|NCT05658380|Atropine|atropine|mesh-list
65514987|NCT05658380|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65514988|NCT05658380|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65514989|NCT05658380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65514990|NCT05658380|Autonomic Agents|autonomic agents|mesh-ancestor
65514991|NCT05658380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65514992|NCT05658380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65514993|NCT05658380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65514994|NCT05658380|Respiratory System Agents|respiratory system agents|mesh-ancestor
65514995|NCT05658380|Mydriatics|mydriatics|mesh-ancestor
65514996|NCT05658380|Parasympatholytics|parasympatholytics|mesh-ancestor
65514997|NCT05658380|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65514998|NCT05658380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65514999|NCT05658380|Cholinergic Agents|cholinergic agents|mesh-ancestor
65515000|NCT05658380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65515001|NCT05658380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515002|NCT03440918|Anti-Infective Agents|anti-infective agents|mesh-list
65515003|NCT03440918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65515004|NCT03486392|Liraglutide|liraglutide|mesh-list
65515005|NCT03486392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65515006|NCT03486392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515007|NCT03486392|Incretins|incretins|mesh-ancestor
65515008|NCT03486392|Hormones|hormones|mesh-ancestor
65515009|NCT03486392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65515010|NCT02981524|Cyclophosphamide|cyclophosphamide|mesh-list
65515011|NCT02981524|Pembrolizumab|pembrolizumab|mesh-list
65515012|NCT02981524|Immunologic Factors|immunologic factors|mesh-ancestor
65515013|NCT02981524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515014|NCT02981524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65515015|NCT02981524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65515016|NCT02981524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65515017|NCT02981524|Alkylating Agents|alkylating agents|mesh-ancestor
65515018|NCT02981524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515019|NCT02981524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515020|NCT02981524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65515021|NCT02981524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65515022|NCT04297150|Rivaroxaban|rivaroxaban|mesh-list
65515023|NCT04297150|Apixaban|apixaban|mesh-list
65515024|NCT04297150|Edoxaban|edoxaban|mesh-list
65515025|NCT04297150|Dabigatran|dabigatran|mesh-list
65515026|NCT04297150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65515027|NCT04297150|Antithrombins|antithrombins|mesh-ancestor
65515028|NCT04297150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65515029|NCT04297150|Protease Inhibitors|protease inhibitors|mesh-ancestor
65515030|NCT04297150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515031|NCT04297150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515032|NCT04297150|Anticoagulants|anticoagulants|mesh-ancestor
65515033|NCT03486314|Rifampin|rifampin|mesh-list
65515034|NCT03486314|Paclitaxel|paclitaxel|mesh-list
65515035|NCT03486314|Docetaxel|docetaxel|mesh-list
65515036|NCT03486314|Carboplatin|carboplatin|mesh-list
65515037|NCT03486314|Pevonedistat|pevonedistat|mesh-list
65515038|NCT03486314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65515039|NCT03486314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515040|NCT03486314|Tubulin Modulators|tubulin modulators|mesh-ancestor
65515041|NCT03486314|Antimitotic Agents|antimitotic agents|mesh-ancestor
65515042|NCT03486314|Mitosis Modulators|mitosis modulators|mesh-ancestor
65515043|NCT03486314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515044|NCT03486314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65515045|NCT03486314|Antitubercular Agents|antitubercular agents|mesh-ancestor
65515046|NCT03486314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65515047|NCT03486314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65515048|NCT03486314|Leprostatic Agents|leprostatic agents|mesh-ancestor
65515049|NCT03486314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65515050|NCT03486314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515051|NCT03486314|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65515052|NCT03486314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65515053|NCT03486314|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65515054|NCT03486314|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65515055|NCT03486314|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65515056|NCT03486314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65515057|NCT02975206|Serlopitant|serlopitant|mesh-list
65515058|NCT02975206|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65515059|NCT02975206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65515060|NCT02975206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515061|NCT02975206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515062|NCT03654820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65515063|NCT01066156|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65515064|NCT01066156|Antidepressive Agents|antidepressive agents|mesh-ancestor
65515065|NCT01066156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65515066|NCT01066156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65515067|NCT01066156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65515068|NCT01066156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65515069|NCT01066156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515070|NCT02980042|Rituximab|rituximab|mesh-list
65515071|NCT02980042|Ocrelizumab|ocrelizumab|mesh-list
65515072|NCT02980042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65515073|NCT02980042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515074|NCT02980042|Immunologic Factors|immunologic factors|mesh-ancestor
65515075|NCT02980042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515076|NCT02980042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65515077|NCT01066000|Epoetin Alfa|epoetin alfa|mesh-list
65515078|NCT01066000|Hematinics|hematinics|mesh-ancestor
65515079|NCT01065844|Nelfinavir|nelfinavir|mesh-list
65515080|NCT01065844|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65515081|NCT01065844|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65515082|NCT01065844|Protease Inhibitors|protease inhibitors|mesh-ancestor
65515083|NCT01065844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515084|NCT01065844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515085|NCT01065844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65515086|NCT01065844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65515087|NCT01065844|Antiviral Agents|antiviral agents|mesh-ancestor
65515088|NCT01065844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65515089|NCT00004635|Thalidomide|thalidomide|mesh-list
65515090|NCT00004635|Leuprolide|leuprolide|mesh-list
65515091|NCT00004635|Goserelin|goserelin|mesh-list
65515092|NCT00004635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65515093|NCT00004635|Immunologic Factors|immunologic factors|mesh-ancestor
65515094|NCT00004635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515096|NCT00004635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65515097|NCT00004635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65515098|NCT00004635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65515099|NCT00004635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65515100|NCT00004635|Growth Substances|growth substances|mesh-ancestor
65515101|NCT00004635|Growth Inhibitors|growth inhibitors|mesh-ancestor
65515102|NCT00004635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515103|NCT00004635|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65515104|NCT00004635|Fertility Agents|fertility agents|mesh-ancestor
65515105|NCT00004635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65515106|NCT00004635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65515107|NCT00004563|Cyclophosphamide|cyclophosphamide|mesh-list
65515108|NCT00004563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65515109|NCT00004563|Immunologic Factors|immunologic factors|mesh-ancestor
65515110|NCT00004563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515111|NCT00004563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65515112|NCT00004563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65515113|NCT00004563|Alkylating Agents|alkylating agents|mesh-ancestor
65515114|NCT00004563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515115|NCT00004563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515116|NCT00004563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65515117|NCT03951051|Olmesartan|olmesartan|mesh-list
65515118|NCT03951051|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65515119|NCT03951051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65515120|NCT03951051|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65515121|NCT03951051|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65515122|NCT03951051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515123|NCT01103115|Calcium, Dietary|calcium, dietary|mesh-list
65515124|NCT01103115|Vitamin D|vitamin d|mesh-list
65515125|NCT01103115|Calcium Carbonate|calcium carbonate|mesh-list
65515126|NCT01103115|Calcium|calcium|mesh-list
65515127|NCT01103115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65515128|NCT01103115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515129|NCT01103115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65515130|NCT01103115|Vitamins|vitamins|mesh-ancestor
65515131|NCT01103115|Micronutrients|micronutrients|mesh-ancestor
65515132|NCT01103115|Antacids|antacids|mesh-ancestor
65515133|NCT01103115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515134|NCT01103115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65515135|NCT01103193|Remifentanil|remifentanil|mesh-list
65515136|NCT01103193|Sevoflurane|sevoflurane|mesh-list
65515137|NCT01103193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65515138|NCT01103193|Narcotics|narcotics|mesh-ancestor
65515139|NCT01103193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65515140|NCT01103193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515141|NCT01103193|Analgesics|analgesics|mesh-ancestor
65515142|NCT01103193|Sensory System Agents|sensory system agents|mesh-ancestor
65515143|NCT01103193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65515144|NCT01103193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65515145|NCT01103193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65515146|NCT01103193|Anesthetics, General|anesthetics, general|mesh-ancestor
65515147|NCT01103193|Anesthetics|anesthetics|mesh-ancestor
65515148|NCT03949101|Atropine|atropine|mesh-list
65515149|NCT03949101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65515150|NCT03949101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65515151|NCT03949101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65515152|NCT03949101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65515153|NCT03949101|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65515154|NCT03949101|Autonomic Agents|autonomic agents|mesh-ancestor
65515155|NCT03949101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65515156|NCT03949101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515157|NCT03949101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65515158|NCT03949101|Respiratory System Agents|respiratory system agents|mesh-ancestor
65515159|NCT03949101|Mydriatics|mydriatics|mesh-ancestor
65515160|NCT03949101|Parasympatholytics|parasympatholytics|mesh-ancestor
65515161|NCT03949101|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65515162|NCT03949101|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65515163|NCT03949101|Cholinergic Agents|cholinergic agents|mesh-ancestor
65515164|NCT03949101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65515165|NCT03949101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515166|NCT01096485|Levonorgestrel|levonorgestrel|mesh-list
65515167|NCT01096485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65515168|NCT01096485|Contraceptive Agents|contraceptive agents|mesh-ancestor
65515169|NCT01096485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65515170|NCT01096485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515171|NCT01096485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65515172|NCT01096485|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65515173|NCT01096485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65515174|NCT00003645|Leuprolide|leuprolide|mesh-list
65515175|NCT00003645|Goserelin|goserelin|mesh-list
65515176|NCT00003645|Flutamide|flutamide|mesh-list
65515177|NCT00003645|Bicalutamide|bicalutamide|mesh-list
65515178|NCT00003645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65515179|NCT00003645|Fertility Agents|fertility agents|mesh-ancestor
65515180|NCT00003645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65515181|NCT00003645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515182|NCT00003645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65515183|NCT00003645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515184|NCT00003645|Androgen Antagonists|androgen antagonists|mesh-ancestor
65515185|NCT00003645|Hormone Antagonists|hormone antagonists|mesh-ancestor
65515186|NCT00003645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65515187|NCT02918968|Flutamide|flutamide|mesh-list
65515188|NCT02918968|Androgens|androgens|mesh-list
65515189|NCT02918968|Hormones|hormones|mesh-ancestor
65515190|NCT02918968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65515191|NCT02918968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515192|NCT02918968|Androgen Antagonists|androgen antagonists|mesh-ancestor
65515193|NCT02918968|Hormone Antagonists|hormone antagonists|mesh-ancestor
65515194|NCT02918968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65515195|NCT02918968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515196|NCT01065766|Metformin|metformin|mesh-list
65515197|NCT01065766|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65515198|NCT01065766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65515199|NCT01065766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515200|NCT01065766|Incretins|incretins|mesh-ancestor
65515201|NCT01065766|Hormones|hormones|mesh-ancestor
65515202|NCT01065766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65515203|NCT01065766|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65515204|NCT01065766|Protease Inhibitors|protease inhibitors|mesh-ancestor
65515205|NCT01065766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515206|NCT01065766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515207|NCT03653260|Lidocaine|lidocaine|mesh-list
65515208|NCT03653260|Anesthetics, Local|anesthetics, local|mesh-ancestor
65515209|NCT03653260|Anesthetics|anesthetics|mesh-ancestor
65515210|NCT03653260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65515211|NCT03653260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515212|NCT03653260|Sensory System Agents|sensory system agents|mesh-ancestor
65515213|NCT03653260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65515214|NCT03653260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65515215|NCT03653260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65515216|NCT03653260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65515217|NCT03653260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65515218|NCT03653260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515219|NCT03652792|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65515220|NCT03652792|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65515221|NCT03652792|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65515222|NCT03652792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515223|NCT04054960|Levodopa|levodopa|mesh-list
65515224|NCT04054960|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65515225|NCT04054960|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65515226|NCT04054960|Dopamine Agents|dopamine agents|mesh-ancestor
65515227|NCT04054960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65515228|NCT04054960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515229|NCT04054960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515230|NCT00042939|Docetaxel|docetaxel|mesh-list
65515231|NCT00042939|Irinotecan|irinotecan|mesh-list
65515232|NCT00042939|Cetuximab|cetuximab|mesh-list
65515233|NCT00042939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515234|NCT00042939|Tubulin Modulators|tubulin modulators|mesh-ancestor
65515235|NCT00042939|Antimitotic Agents|antimitotic agents|mesh-ancestor
65515236|NCT00042939|Mitosis Modulators|mitosis modulators|mesh-ancestor
65515237|NCT00042939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515238|NCT00042939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65515239|NCT00042939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65515240|NCT00042939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515241|NCT00042939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65312889|NCT00867035|Chlorhexidine|chlorhexidine|mesh-list
65515242|NCT04055194|Tranexamic Acid|tranexamic acid|mesh-list
65515243|NCT04055194|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65515244|NCT04055194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65515245|NCT04055194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515246|NCT04055194|Hemostatics|hemostatics|mesh-ancestor
65515247|NCT04055194|Coagulants|coagulants|mesh-ancestor
65515248|NCT04252612|Pramlintide|pramlintide|mesh-list
65515249|NCT04252612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65515250|NCT04252612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515251|NCT01103583|Hydroxyurea|hydroxyurea|mesh-list
65515252|NCT01103583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515253|NCT01103583|Antisickling Agents|antisickling agents|mesh-ancestor
65515254|NCT01103583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515255|NCT01103583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515256|NCT01103583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65515257|NCT02530047|Interferons|interferons|mesh-list
65515258|NCT02530047|Interferon-beta|interferon-beta|mesh-list
65515259|NCT02530047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515260|NCT02530047|Antiviral Agents|antiviral agents|mesh-ancestor
65515261|NCT02530047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65515262|NCT02530047|Immunologic Factors|immunologic factors|mesh-ancestor
65515263|NCT02530047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515264|NCT02529969|Curcumin|curcumin|mesh-list
65515265|NCT02529969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65515266|NCT02529969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65515267|NCT02529969|Analgesics|analgesics|mesh-ancestor
65515268|NCT02529969|Sensory System Agents|sensory system agents|mesh-ancestor
65515269|NCT02529969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65515270|NCT02529969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515271|NCT02529969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65515272|NCT02529969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65515273|NCT02529969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515274|NCT02529969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515275|NCT02529969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515276|NCT01584687|Omalizumab|omalizumab|mesh-list
65515277|NCT01584687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65515278|NCT01584687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65515279|NCT01584687|Respiratory System Agents|respiratory system agents|mesh-ancestor
65515280|NCT01101789|Triclosan|triclosan|mesh-list
65515281|NCT01101789|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65515282|NCT01101789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65515283|NCT01101789|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65515284|NCT01101789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65515285|NCT01101789|Antimetabolites|antimetabolites|mesh-ancestor
65515286|NCT01101789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515287|NCT01101789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65515288|NCT04185220|Mogamulizumab|mogamulizumab|mesh-list
65515289|NCT04185220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515290|NCT01103739|Simvastatin|simvastatin|mesh-list
65515291|NCT01103739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65515292|NCT01103739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65515293|NCT01103739|Antimetabolites|antimetabolites|mesh-ancestor
65515294|NCT01103739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515295|NCT01103739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65515296|NCT01103739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65515297|NCT01103739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515298|NCT04054024|Erenumab|erenumab|mesh-list
65515299|NCT04054024|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65515300|NCT04054024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515301|NCT04054024|Analgesics|analgesics|mesh-ancestor
65515302|NCT04054024|Sensory System Agents|sensory system agents|mesh-ancestor
65515303|NCT04054024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65515304|NCT04054024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515305|NCT00002931|Paclitaxel|paclitaxel|mesh-list
65515306|NCT00002931|Etoposide|etoposide|mesh-list
65515307|NCT00002931|Carboplatin|carboplatin|mesh-list
65515308|NCT00002931|Ifosfamide|ifosfamide|mesh-list
65515309|NCT00002931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65515310|NCT00002931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515311|NCT00002931|Tubulin Modulators|tubulin modulators|mesh-ancestor
65515312|NCT00002931|Antimitotic Agents|antimitotic agents|mesh-ancestor
65515313|NCT00002931|Mitosis Modulators|mitosis modulators|mesh-ancestor
65515314|NCT00002931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515315|NCT00002931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65515316|NCT00002931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65515317|NCT00002931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515318|NCT00002931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65515319|NCT00002931|Alkylating Agents|alkylating agents|mesh-ancestor
65515320|NCT02918266|Scopolamine|scopolamine|mesh-list
65515321|NCT02918266|Donepezil|donepezil|mesh-list
65244350|NCT00659269|Docetaxel|docetaxel|mesh-list
65515322|NCT02918266|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65515323|NCT02918266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65515324|NCT02918266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515325|NCT02918266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515326|NCT02918266|Cholinergic Agents|cholinergic agents|mesh-ancestor
65515327|NCT02918266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65515328|NCT02918266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515329|NCT02918266|Nootropic Agents|nootropic agents|mesh-ancestor
65515330|NCT02918266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65515331|NCT02918266|Antiemetics|antiemetics|mesh-ancestor
65515332|NCT02918266|Autonomic Agents|autonomic agents|mesh-ancestor
65515333|NCT02918266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65515334|NCT02918266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65515335|NCT02918266|Mydriatics|mydriatics|mesh-ancestor
65515336|NCT02918266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65515337|NCT02918266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65515338|NCT02918266|Parasympatholytics|parasympatholytics|mesh-ancestor
65515339|NCT00041067|Docetaxel|docetaxel|mesh-list
65515340|NCT00041067|Trastuzumab|trastuzumab|mesh-list
65515341|NCT00041067|Vinorelbine|vinorelbine|mesh-list
65515342|NCT00041067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515343|NCT00041067|Tubulin Modulators|tubulin modulators|mesh-ancestor
65515344|NCT00041067|Antimitotic Agents|antimitotic agents|mesh-ancestor
65515345|NCT00041067|Mitosis Modulators|mitosis modulators|mesh-ancestor
65515346|NCT00041067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515347|NCT00041067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65515348|NCT00041067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65515349|NCT01063036|Tenofovir|tenofovir|mesh-list
65515350|NCT01063036|Entecavir|entecavir|mesh-list
65515351|NCT01063036|Antiviral Agents|antiviral agents|mesh-ancestor
65515352|NCT01063036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65515353|NCT01063036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65515354|NCT01063036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65515355|NCT01063036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515356|NCT01063036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515357|NCT01063036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65515358|NCT01063036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65515359|NCT03652480|Methylprednisolone|methylprednisolone|mesh-list
65515360|NCT03652480|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65515361|NCT03652480|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65515362|NCT03652480|Prednisolone|prednisolone|mesh-list
65515363|NCT03652480|Prednisolone acetate|prednisolone acetate|mesh-list
65515364|NCT03652480|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65515365|NCT03652480|Prednisolone phosphate|prednisolone phosphate|mesh-list
65515366|NCT03652480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65515367|NCT03652480|Antiemetics|antiemetics|mesh-ancestor
65515368|NCT03652480|Autonomic Agents|autonomic agents|mesh-ancestor
65515369|NCT03652480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65515370|NCT03652480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515371|NCT03652480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65515372|NCT03652480|Glucocorticoids|glucocorticoids|mesh-ancestor
65515373|NCT03652480|Hormones|hormones|mesh-ancestor
65515374|NCT03652480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65515375|NCT03652480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65515376|NCT03652480|Protective Agents|protective agents|mesh-ancestor
65515377|NCT03652480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65515378|NCT03652480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515379|NCT03622060|Nicardipine|nicardipine|mesh-list
65515380|NCT03622060|Nitroglycerin|nitroglycerin|mesh-list
65515381|NCT03622060|Vasodilator Agents|vasodilator agents|mesh-ancestor
65515382|NCT03622060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65515383|NCT03622060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65515384|NCT03622060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65515385|NCT03622060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515386|NCT03622060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65515387|NCT03622060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515388|NCT00040365|Amifostine|amifostine|mesh-list
65515389|NCT00040365|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65515390|NCT00040365|Protective Agents|protective agents|mesh-ancestor
65515391|NCT00040365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515392|NCT02974114|Acetaminophen|acetaminophen|mesh-list
65515393|NCT02974114|Caffeine|caffeine|mesh-list
65515394|NCT02974114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65515395|NCT02974114|Analgesics|analgesics|mesh-ancestor
65515396|NCT02974114|Sensory System Agents|sensory system agents|mesh-ancestor
65244428|NCT00804271|Memantine|memantine|mesh-list
65515397|NCT02974114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65515398|NCT02974114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515399|NCT02974114|Antipyretics|antipyretics|mesh-ancestor
65515400|NCT02974114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65515401|NCT02974114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65515402|NCT02974114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515403|NCT02974114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515404|NCT02974114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65515405|NCT02974114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65515406|NCT02974114|Purinergic Agents|purinergic agents|mesh-ancestor
65515407|NCT02974114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65515408|NCT00001959|Pirfenidone|pirfenidone|mesh-list
65515409|NCT00001959|Analgesics|analgesics|mesh-ancestor
65515410|NCT00001959|Sensory System Agents|sensory system agents|mesh-ancestor
65515411|NCT00001959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65515412|NCT00001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515413|NCT00001959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65515414|NCT00001959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65515415|NCT00001959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65515416|NCT00001959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65515417|NCT00001959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515418|NCT03950505|Pioglitazone|pioglitazone|mesh-list
65515419|NCT03950505|Alogliptin|alogliptin|mesh-list
65515420|NCT03950505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65515421|NCT03950505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515422|NCT03950505|Incretins|incretins|mesh-ancestor
65515423|NCT03950505|Hormones|hormones|mesh-ancestor
65515424|NCT03950505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65515425|NCT03950505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65515426|NCT03950505|Protease Inhibitors|protease inhibitors|mesh-ancestor
65515427|NCT03950505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515428|NCT03950505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515429|NCT00001941|Daclizumab|daclizumab|mesh-list
65515430|NCT00001941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65515431|NCT00001941|Immunologic Factors|immunologic factors|mesh-ancestor
65515432|NCT00001941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515433|NCT01061866|Thalidomide|thalidomide|mesh-list
65515434|NCT01061866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65515435|NCT01061866|Immunologic Factors|immunologic factors|mesh-ancestor
65515436|NCT01061866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515437|NCT01061866|Leprostatic Agents|leprostatic agents|mesh-ancestor
65515438|NCT01061866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65515439|NCT01061866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65515440|NCT01061866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65515441|NCT01061866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65515442|NCT01061866|Growth Substances|growth substances|mesh-ancestor
65515443|NCT01061866|Growth Inhibitors|growth inhibitors|mesh-ancestor
65515444|NCT01061866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515445|NCT03652714|Anesthetics|anesthetics|mesh-list
65515446|NCT03652714|Anesthetics, Local|anesthetics, local|mesh-list
65515447|NCT03652714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65515448|NCT03652714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515449|NCT03652714|Sensory System Agents|sensory system agents|mesh-ancestor
65515450|NCT03652714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65515451|NCT03948477|Pantoprazole|pantoprazole|mesh-list
65515452|NCT03948477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65515453|NCT03948477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65515454|NCT03948477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65515455|NCT03948477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515456|NCT03948477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515457|NCT03953781|Levetiracetam|levetiracetam|mesh-list
65515458|NCT03953781|Anticonvulsants|anticonvulsants|mesh-ancestor
65515459|NCT03953781|Nootropic Agents|nootropic agents|mesh-ancestor
65515460|NCT01103817|Vitamin D|vitamin d|mesh-list
65515461|NCT01103817|Vitamins|vitamins|mesh-ancestor
65515462|NCT01103817|Micronutrients|micronutrients|mesh-ancestor
65515463|NCT01103817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515464|NCT01103817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65515465|NCT01102101|Remifentanil|remifentanil|mesh-list
65515466|NCT01102101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65515467|NCT01102101|Narcotics|narcotics|mesh-ancestor
65515468|NCT01102101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65515469|NCT01102101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515470|NCT01102101|Analgesics|analgesics|mesh-ancestor
65515471|NCT01102101|Sensory System Agents|sensory system agents|mesh-ancestor
65515472|NCT01102101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65515473|NCT03950271|Capecitabine|capecitabine|mesh-list
65515474|NCT03950271|Oxaliplatin|oxaliplatin|mesh-list
65515475|NCT03950271|Trastuzumab|trastuzumab|mesh-list
65515476|NCT03950271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65515477|NCT03950271|Antimetabolites|antimetabolites|mesh-ancestor
65515478|NCT03950271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515479|NCT03950271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515480|NCT03950271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65515481|NCT01102335|Telbivudine|telbivudine|mesh-list
65515482|NCT01102335|Antiviral Agents|antiviral agents|mesh-ancestor
65515483|NCT01102335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65515484|NCT01102335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65515485|NCT01102335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515486|NCT01102335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515487|NCT02973100|Dulaglutide|dulaglutide|mesh-list
65515488|NCT02973100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65515489|NCT02973100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515490|NCT01105611|Ritonavir|ritonavir|mesh-list
65515491|NCT01105611|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65515492|NCT01105611|Raltegravir Potassium|raltegravir potassium|mesh-list
65515493|NCT01105611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65515494|NCT01105611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65515495|NCT01105611|Protease Inhibitors|protease inhibitors|mesh-ancestor
65515496|NCT01105611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515497|NCT01105611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515498|NCT01105611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65515499|NCT01105611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65515500|NCT01105611|Antiviral Agents|antiviral agents|mesh-ancestor
65515501|NCT01105611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65515502|NCT01105611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65515503|NCT01105611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65515504|NCT01105611|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65515505|NCT01105611|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65515506|NCT05497557|Omeprazole|omeprazole|mesh-list
65515507|NCT05497557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65515508|NCT05497557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65515509|NCT05497557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65515510|NCT05497557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515511|NCT05497557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515512|NCT03948321|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65515513|NCT03948321|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65515514|NCT03948321|Dermatologic Agents|dermatologic agents|mesh-ancestor
65515515|NCT05415267|Vaccines|vaccines|mesh-list
65515516|NCT05415267|Immunologic Factors|immunologic factors|mesh-ancestor
65515517|NCT05415267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515518|NCT03948243|Tolbutamide|tolbutamide|mesh-list
65515519|NCT03948243|Dextromethorphan|dextromethorphan|mesh-list
65515520|NCT03948243|Alprazolam|alprazolam|mesh-list
65515521|NCT03948243|Caffeine|caffeine|mesh-list
65515522|NCT03948243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65515523|NCT03948243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515524|NCT03948243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65515525|NCT03948243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515526|NCT03948243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515527|NCT03948243|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65515528|NCT03948243|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65515529|NCT03948243|Purinergic Agents|purinergic agents|mesh-ancestor
65515530|NCT03948243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65515531|NCT03948243|Antitussive Agents|antitussive agents|mesh-ancestor
65515532|NCT03948243|Respiratory System Agents|respiratory system agents|mesh-ancestor
65515533|NCT03948243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65515534|NCT03948243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65515535|NCT03948243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65515536|NCT03948243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65515537|NCT03948243|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65515538|NCT03948243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65515539|NCT03948243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65515540|NCT03948243|GABA Modulators|gaba modulators|mesh-ancestor
65515541|NCT03948243|GABA Agents|gaba agents|mesh-ancestor
65515542|NCT03948243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65515543|NCT01482286|Metformin|metformin|mesh-list
65515544|NCT01482286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65515545|NCT01482286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515546|NCT03651934|Iron|iron|mesh-list
65515547|NCT03651934|Selenium|selenium|mesh-list
65515548|NCT03651934|Trace Elements|trace elements|mesh-ancestor
65515549|NCT03651934|Micronutrients|micronutrients|mesh-ancestor
65515550|NCT03651934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515551|NCT03651934|Antioxidants|antioxidants|mesh-ancestor
65515552|NCT03651934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515553|NCT03651934|Protective Agents|protective agents|mesh-ancestor
65515554|NCT02972632|Vortioxetine|vortioxetine|mesh-list
65515555|NCT02972632|Antidepressive Agents|antidepressive agents|mesh-ancestor
65515556|NCT02972632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65515557|NCT02972632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65515558|NCT02972632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65515559|NCT02972632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65515560|NCT02972632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515561|NCT02972632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65515562|NCT02972632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65515563|NCT02972632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65515564|NCT02972632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515565|NCT02972632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65515566|NCT02972632|Serotonin Agents|serotonin agents|mesh-ancestor
65515567|NCT02972632|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65515568|NCT02972632|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65515569|NCT02972632|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65515570|NCT02972632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65515571|NCT01106001|Levobupivacaine|levobupivacaine|mesh-list
65515572|NCT01106001|Anesthetics, Local|anesthetics, local|mesh-ancestor
65515573|NCT01106001|Anesthetics|anesthetics|mesh-ancestor
65515574|NCT01106001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65515575|NCT01106001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515576|NCT01106001|Sensory System Agents|sensory system agents|mesh-ancestor
65515577|NCT01106001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65515578|NCT01327521|Gemcitabine|gemcitabine|mesh-list
65515579|NCT01327521|Cisplatin|cisplatin|mesh-list
65515580|NCT01327521|Doxorubicin|doxorubicin|mesh-list
65515581|NCT01327521|Fluorouracil|fluorouracil|mesh-list
65515582|NCT01327521|Epirubicin|epirubicin|mesh-list
65515583|NCT01327521|Mitomycins|mitomycins|mesh-list
65515584|NCT01327521|Mitomycin|mitomycin|mesh-list
65515585|NCT01327521|Maleic acid|maleic acid|mesh-list
65515586|NCT01327521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515587|NCT01327521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65515588|NCT01327521|Antimetabolites|antimetabolites|mesh-ancestor
65515589|NCT01327521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515590|NCT01327521|Antiviral Agents|antiviral agents|mesh-ancestor
65515591|NCT01327521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65515592|NCT01327521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515593|NCT01327521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65515594|NCT01327521|Immunologic Factors|immunologic factors|mesh-ancestor
65515595|NCT01327521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515596|NCT01327521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65515597|NCT01327521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65515598|NCT01327521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65515599|NCT01327521|Alkylating Agents|alkylating agents|mesh-ancestor
65515600|NCT01327521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65515601|NCT04899921|Nivolumab|nivolumab|mesh-list
65515602|NCT04899921|Ipilimumab|ipilimumab|mesh-list
65515603|NCT04899921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65515604|NCT04899921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515605|NCT04899921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65515606|NCT04899921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515607|NCT01104519|Niacin|niacin|mesh-list
65515608|NCT01104519|Nicotinic Acids|nicotinic acids|mesh-list
65515609|NCT01104519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65515610|NCT01104519|Antimetabolites|antimetabolites|mesh-ancestor
65515611|NCT01104519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515612|NCT01104519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65515613|NCT01104519|Vasodilator Agents|vasodilator agents|mesh-ancestor
65515614|NCT01104519|Vitamin B Complex|vitamin b complex|mesh-ancestor
65515615|NCT01104519|Vitamins|vitamins|mesh-ancestor
65515616|NCT01104519|Micronutrients|micronutrients|mesh-ancestor
65515617|NCT01104519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515618|NCT03944733|Iron|iron|mesh-list
65515619|NCT03944733|Trace Elements|trace elements|mesh-ancestor
65515620|NCT03944733|Micronutrients|micronutrients|mesh-ancestor
65515621|NCT03944733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515622|NCT01060384|Lenalidomide|lenalidomide|mesh-list
65515623|NCT01060384|Ofatumumab|ofatumumab|mesh-list
65515624|NCT01060384|Immunologic Factors|immunologic factors|mesh-ancestor
65515625|NCT01060384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515626|NCT01060384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65515627|NCT01060384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65515628|NCT01060384|Growth Substances|growth substances|mesh-ancestor
65515629|NCT01060384|Growth Inhibitors|growth inhibitors|mesh-ancestor
65515630|NCT01060384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515631|NCT01328223|Sorafenib|sorafenib|mesh-list
65515632|NCT01328223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515633|NCT01328223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65515634|NCT01328223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515635|NCT01328223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515636|NCT01060150|Methylphenidate|methylphenidate|mesh-list
65515637|NCT01060150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65515638|NCT01060150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515639|NCT01060150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65515640|NCT01060150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65515641|NCT01060150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65515642|NCT01060150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515643|NCT01060150|Dopamine Agents|dopamine agents|mesh-ancestor
65515644|NCT01060150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65515645|NCT03863223|Docetaxel|docetaxel|mesh-list
65515646|NCT03863223|Trastuzumab|trastuzumab|mesh-list
65515647|NCT03863223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515648|NCT03863223|Tubulin Modulators|tubulin modulators|mesh-ancestor
65515649|NCT03863223|Antimitotic Agents|antimitotic agents|mesh-ancestor
65515650|NCT03863223|Mitosis Modulators|mitosis modulators|mesh-ancestor
65515651|NCT03863223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515652|NCT03863223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65515653|NCT01104597|Nitroglycerin|nitroglycerin|mesh-list
65515654|NCT01104597|Vasodilator Agents|vasodilator agents|mesh-ancestor
65515655|NCT02970292|Pimavanserin|pimavanserin|mesh-list
65515656|NCT02970292|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65515657|NCT02970292|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65515658|NCT02970292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65515659|NCT02970292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65515660|NCT02970292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65515661|NCT02970292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515662|NCT02970292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65515663|NCT02970292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65515664|NCT02970292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65515665|NCT02970292|Serotonin Agents|serotonin agents|mesh-ancestor
65515666|NCT02970292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65515667|NCT02970292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515668|NCT03944655|Anesthetics|anesthetics|mesh-list
65515669|NCT03944655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65515670|NCT03944655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515671|NCT05276895|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
65515672|NCT05276895|Quercetin|quercetin|mesh-list
65515673|NCT05276895|Antioxidants|antioxidants|mesh-ancestor
65515674|NCT05276895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515675|NCT05276895|Protective Agents|protective agents|mesh-ancestor
65515676|NCT05276895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515677|NCT05276895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65515678|NCT02971228|Insulin Lispro|insulin lispro|mesh-list
65515679|NCT02971228|Glucagon|glucagon|mesh-list
65515680|NCT02971228|Pancrelipase|pancrelipase|mesh-list
65515681|NCT02971228|Pancreatin|pancreatin|mesh-list
65515682|NCT02971228|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65515683|NCT02971228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65515684|NCT02971228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515685|NCT02971228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65515686|NCT02971228|Hormones|hormones|mesh-ancestor
65515687|NCT02971228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65515688|NCT02971228|Incretins|incretins|mesh-ancestor
65515689|NCT01060072|Loteprednol Etabonate|loteprednol etabonate|mesh-list
65515690|NCT01060072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65515691|NCT03741075|Tranexamic Acid|tranexamic acid|mesh-list
65515692|NCT03741075|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65515693|NCT03741075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65515694|NCT03741075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515695|NCT03741075|Hemostatics|hemostatics|mesh-ancestor
65313337|NCT00702572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515696|NCT03741075|Coagulants|coagulants|mesh-ancestor
65515697|NCT01104987|Alendronate|alendronate|mesh-list
65515698|NCT01104987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65515699|NCT01104987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515700|NCT01106235|Aldesleukin|aldesleukin|mesh-list
65515701|NCT01106235|Cyclophosphamide|cyclophosphamide|mesh-list
65515702|NCT01106235|Interleukin-2|interleukin-2|mesh-list
65515703|NCT01106235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65515704|NCT01106235|Immunologic Factors|immunologic factors|mesh-ancestor
65515705|NCT01106235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515706|NCT01106235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65515707|NCT01106235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65515708|NCT01106235|Alkylating Agents|alkylating agents|mesh-ancestor
65515709|NCT01106235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515710|NCT01106235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515711|NCT01106235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65515712|NCT01106235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65515713|NCT01106235|Analgesics|analgesics|mesh-ancestor
65515714|NCT01106235|Sensory System Agents|sensory system agents|mesh-ancestor
65515715|NCT01106235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65515716|NCT01106235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65515717|NCT01106235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65515718|NCT01106235|Antiviral Agents|antiviral agents|mesh-ancestor
65515719|NCT01106235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65515720|NCT02969590|Leuprolide|leuprolide|mesh-list
65515721|NCT02969590|Norethindrone|norethindrone|mesh-list
65515722|NCT02969590|Estradiol|estradiol|mesh-list
65515723|NCT02969590|Estrogens|estrogens|mesh-list
65515724|NCT02969590|Progesterone|progesterone|mesh-list
65515725|NCT02969590|Progestins|progestins|mesh-list
65515726|NCT02969590|Hormones|hormones|mesh-ancestor
65515727|NCT02969590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65515728|NCT02969590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515729|NCT02969590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65515730|NCT02969590|Contraceptive Agents|contraceptive agents|mesh-ancestor
65515731|NCT02969590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65515732|NCT02969590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65515733|NCT02969590|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65515734|NCT02969590|Fertility Agents|fertility agents|mesh-ancestor
65515735|NCT02969590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65515736|NCT02969590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515737|NCT02969590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65515738|NCT02969590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65515739|NCT02969590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65515740|NCT03650998|Ropivacaine|ropivacaine|mesh-list
65515741|NCT03650998|Anesthetics, Local|anesthetics, local|mesh-ancestor
65515742|NCT03650998|Anesthetics|anesthetics|mesh-ancestor
65515743|NCT03650998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65515744|NCT03650998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515745|NCT03650998|Sensory System Agents|sensory system agents|mesh-ancestor
65515746|NCT03650998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65515747|NCT04053400|Ketamine|ketamine|mesh-list
65515748|NCT04053400|Analgesics|analgesics|mesh-ancestor
65515749|NCT04053400|Sensory System Agents|sensory system agents|mesh-ancestor
65515750|NCT04053400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65515751|NCT04053400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515752|NCT04053400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65515753|NCT04053400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65515754|NCT04053400|Anesthetics, General|anesthetics, general|mesh-ancestor
65515755|NCT04053400|Anesthetics|anesthetics|mesh-ancestor
65515756|NCT04053400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65515757|NCT04053400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65515758|NCT04053400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65515759|NCT04053400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65515760|NCT04053400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515761|NCT03345849|Upadacitinib|upadacitinib|mesh-list
65515762|NCT03345849|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65515763|NCT03345849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65515764|NCT03345849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515765|NCT03345849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515766|NCT03345849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65515767|NCT01109043|Bisoprolol|bisoprolol|mesh-list
65515768|NCT01109043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65515769|NCT01109043|Sympatholytics|sympatholytics|mesh-ancestor
65515770|NCT01109043|Autonomic Agents|autonomic agents|mesh-ancestor
65515771|NCT01109043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65515772|NCT01109043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515773|NCT01109043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65515774|NCT01109043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65515775|NCT01109043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65515776|NCT01109043|Adrenergic Agents|adrenergic agents|mesh-ancestor
65515777|NCT01109043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65515778|NCT01109043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515779|NCT01109121|Allopurinol|allopurinol|mesh-list
65515780|NCT01109121|Antimetabolites|antimetabolites|mesh-ancestor
65515781|NCT01109121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515782|NCT01109121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515783|NCT01109121|Gout Suppressants|gout suppressants|mesh-ancestor
65515784|NCT01109121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65515785|NCT01109121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65515786|NCT01109121|Antioxidants|antioxidants|mesh-ancestor
65515787|NCT01109121|Protective Agents|protective agents|mesh-ancestor
65515788|NCT01109121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515789|NCT01106547|Methylprednisolone|methylprednisolone|mesh-list
65515790|NCT01106547|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65515791|NCT01106547|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65515792|NCT01106547|Prednisolone|prednisolone|mesh-list
65515793|NCT01106547|Prednisolone acetate|prednisolone acetate|mesh-list
65515794|NCT01106547|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65515795|NCT01106547|Prednisolone phosphate|prednisolone phosphate|mesh-list
65515796|NCT01106547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65515797|NCT01106547|Antiemetics|antiemetics|mesh-ancestor
65515798|NCT01106547|Autonomic Agents|autonomic agents|mesh-ancestor
65515799|NCT01106547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65515800|NCT01106547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515801|NCT01106547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65515802|NCT01106547|Glucocorticoids|glucocorticoids|mesh-ancestor
65515803|NCT01106547|Hormones|hormones|mesh-ancestor
65515804|NCT01106547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65515805|NCT01106547|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65515806|NCT01106547|Protective Agents|protective agents|mesh-ancestor
65515807|NCT01106547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65515808|NCT01106547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515809|NCT01105299|Anastrozole|anastrozole|mesh-list
65515810|NCT01105299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65515811|NCT01105299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515812|NCT01105299|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65515813|NCT01105299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65515814|NCT01105299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515815|NCT01105299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515816|NCT01105299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65515817|NCT01105299|Hormone Antagonists|hormone antagonists|mesh-ancestor
65515818|NCT01105299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65515819|NCT01105299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515820|NCT03947229|Clopidogrel|clopidogrel|mesh-list
65515821|NCT03947229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65515822|NCT03947229|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65515823|NCT03947229|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65515824|NCT03947229|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65515825|NCT03947229|Purinergic Agents|purinergic agents|mesh-ancestor
65515826|NCT03947229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65515827|NCT03947229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515828|NCT03947229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515829|NCT03011307|Oxytocin|oxytocin|mesh-list
65515830|NCT03011307|Oxytocics|oxytocics|mesh-ancestor
65515831|NCT03011307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65515832|NCT03011307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515833|NCT01327755|Selenium|selenium|mesh-list
65515834|NCT01327755|Antioxidants|antioxidants|mesh-ancestor
65515835|NCT01327755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515836|NCT01327755|Protective Agents|protective agents|mesh-ancestor
65515837|NCT01327755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515838|NCT01327755|Trace Elements|trace elements|mesh-ancestor
65515839|NCT01327755|Micronutrients|micronutrients|mesh-ancestor
65515840|NCT01848639|Spironolactone|spironolactone|mesh-list
65515841|NCT01848639|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65515842|NCT01848639|Hormone Antagonists|hormone antagonists|mesh-ancestor
65515843|NCT01848639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65515844|NCT01848639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515845|NCT01848639|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65515846|NCT01848639|Diuretics|diuretics|mesh-ancestor
65515847|NCT01848639|Natriuretic Agents|natriuretic agents|mesh-ancestor
65515848|NCT04537923|Insulin|insulin|mesh-list
65515849|NCT04537923|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65515850|NCT04537923|Insulin Glargine|insulin glargine|mesh-list
65515851|NCT04537923|Insulin Lispro|insulin lispro|mesh-list
65515852|NCT04537923|Tirzepatide|tirzepatide|mesh-list
65515853|NCT04537923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65515854|NCT04537923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515855|NCT04537923|Incretins|incretins|mesh-ancestor
65515856|NCT04537923|Hormones|hormones|mesh-ancestor
65515857|NCT04537923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65515858|NCT04523493|Lenvatinib|lenvatinib|mesh-list
65515859|NCT04523493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515860|NCT04523493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65515861|NCT04523493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515862|NCT04523493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515863|NCT01107093|Ulipristal acetate|ulipristal acetate|mesh-list
65515864|NCT01107093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65515865|NCT01107093|Contraceptive Agents|contraceptive agents|mesh-ancestor
65515866|NCT01107093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65515867|NCT01107093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515868|NCT01107093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65515869|NCT01118793|Clopidogrel|clopidogrel|mesh-list
65515870|NCT01118793|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65515871|NCT01118793|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65515872|NCT01118793|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65515873|NCT01118793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65515874|NCT01118793|Purinergic Agents|purinergic agents|mesh-ancestor
65515875|NCT01118793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65515876|NCT01118793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515877|NCT01118793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515878|NCT00127335|Atorvastatin|atorvastatin|mesh-list
65515879|NCT00127335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65515880|NCT00127335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65515881|NCT00127335|Antimetabolites|antimetabolites|mesh-ancestor
65515882|NCT00127335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515883|NCT00127335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65515884|NCT00127335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65515885|NCT00127335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515886|NCT01109511|Oxycodone|oxycodone|mesh-list
65515887|NCT01109511|Naloxone|naloxone|mesh-list
65515888|NCT01109511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65515889|NCT01109511|Narcotics|narcotics|mesh-ancestor
65515890|NCT01109511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65515891|NCT01109511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515892|NCT01109511|Analgesics|analgesics|mesh-ancestor
65515893|NCT01109511|Sensory System Agents|sensory system agents|mesh-ancestor
65515894|NCT01109511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65515895|NCT01109511|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65515896|NCT04489719|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65515897|NCT04489719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515898|NCT01112085|Ranibizumab|ranibizumab|mesh-list
65515899|NCT01112085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65515900|NCT01112085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65515901|NCT01112085|Growth Substances|growth substances|mesh-ancestor
65515902|NCT01112085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515903|NCT01112085|Growth Inhibitors|growth inhibitors|mesh-ancestor
65515904|NCT01112085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515905|NCT01328301|Methamphetamine|methamphetamine|mesh-list
65515906|NCT01328301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65515907|NCT01328301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515908|NCT01328301|Sympathomimetics|sympathomimetics|mesh-ancestor
65515909|NCT01328301|Autonomic Agents|autonomic agents|mesh-ancestor
65515910|NCT01328301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65515911|NCT01328301|Dopamine Agents|dopamine agents|mesh-ancestor
65515912|NCT01328301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65515913|NCT01328301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515914|NCT01328301|Adrenergic Agents|adrenergic agents|mesh-ancestor
65515915|NCT01328301|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65515916|NCT01328301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65515917|NCT01328301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65515918|NCT01328301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65515919|NCT01328457|Paromomycin|paromomycin|mesh-list
65515920|NCT01328457|Neomycin|neomycin|mesh-list
65515921|NCT01328457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65515922|NCT01328457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65515923|NCT01328457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65515924|NCT01328457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65515925|NCT01328457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65515926|NCT01328457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515927|NCT01328457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515928|NCT01109823|Levofloxacin|levofloxacin|mesh-list
65515929|NCT01109823|Ofloxacin|ofloxacin|mesh-list
65515930|NCT01109823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65515931|NCT01109823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65515932|NCT01109823|Renal Agents|renal agents|mesh-ancestor
65515933|NCT01109823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65515934|NCT01109823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65515935|NCT01109823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65515936|NCT01109823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515937|NCT01109823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515938|NCT01109823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515939|NCT01109823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65515940|NCT01109823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65515941|NCT03943407|Imiquimod|imiquimod|mesh-list
65515942|NCT03943407|Cinnamaldehyde|cinnamaldehyde|mesh-list
65515943|NCT03943407|Doxepin|doxepin|mesh-list
65515944|NCT03943407|Menthol|menthol|mesh-list
65515945|NCT03943407|Histamine|histamine|mesh-list
65515946|NCT03943407|Antipruritics|antipruritics|mesh-ancestor
65515947|NCT03943407|Dermatologic Agents|dermatologic agents|mesh-ancestor
65515948|NCT03943407|Histamine Agonists|histamine agonists|mesh-ancestor
65515949|NCT03943407|Histamine Agents|histamine agents|mesh-ancestor
65515950|NCT03943407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65515951|NCT03943407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515952|NCT03943407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515953|NCT03943407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65515954|NCT03943407|Immunologic Factors|immunologic factors|mesh-ancestor
65515955|NCT03943407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515956|NCT03943407|Interferon Inducers|interferon inducers|mesh-ancestor
65515957|NCT03943407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65515958|NCT03943407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65515959|NCT03943407|Protective Agents|protective agents|mesh-ancestor
65515960|NCT03943407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65515961|NCT03943407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65515962|NCT03943407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65515963|NCT03943407|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65515964|NCT03943407|Antidepressive Agents|antidepressive agents|mesh-ancestor
65515965|NCT03943407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65515966|NCT03943407|Histamine Antagonists|histamine antagonists|mesh-ancestor
65515967|NCT01209351|Teduglutide|teduglutide|mesh-list
65515968|NCT01209351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65515969|NCT01209351|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65515970|NCT01209351|Protective Agents|protective agents|mesh-ancestor
65515971|NCT01209351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515972|NCT02529579|Gemcitabine|gemcitabine|mesh-list
65515973|NCT02529579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65515974|NCT02529579|Antimetabolites|antimetabolites|mesh-ancestor
65515975|NCT02529579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515976|NCT02529579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515977|NCT02529579|Antiviral Agents|antiviral agents|mesh-ancestor
65515978|NCT02529579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65515979|NCT02529579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515980|NCT02529579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65515981|NCT02529579|Immunologic Factors|immunologic factors|mesh-ancestor
65515982|NCT02529579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515983|NCT01209429|Hormones|hormones|mesh-list
65515984|NCT01209429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65515985|NCT01209429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65515986|NCT01110291|Docetaxel|docetaxel|mesh-list
65515987|NCT01110291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65515988|NCT01110291|Tubulin Modulators|tubulin modulators|mesh-ancestor
65515989|NCT01110291|Antimitotic Agents|antimitotic agents|mesh-ancestor
65515990|NCT01110291|Mitosis Modulators|mitosis modulators|mesh-ancestor
65515991|NCT01110291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515992|NCT01207947|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65515993|NCT01207947|Vasodilator Agents|vasodilator agents|mesh-ancestor
65515994|NCT01207947|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65515995|NCT01207947|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65515996|NCT01207947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65515997|NCT01207947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65515998|NCT01207947|Urological Agents|urological agents|mesh-ancestor
65515999|NCT01107639|Docetaxel|docetaxel|mesh-list
65516000|NCT01107639|Cetuximab|cetuximab|mesh-list
65516001|NCT01107639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516002|NCT01107639|Tubulin Modulators|tubulin modulators|mesh-ancestor
65516003|NCT01107639|Antimitotic Agents|antimitotic agents|mesh-ancestor
65516004|NCT01107639|Mitosis Modulators|mitosis modulators|mesh-ancestor
65516005|NCT01107639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516006|NCT01107639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65516007|NCT03942861|Methylprednisolone|methylprednisolone|mesh-list
65516008|NCT03942861|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65516009|NCT03942861|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65516010|NCT03942861|Prednisolone|prednisolone|mesh-list
65516011|NCT03942861|Prednisolone acetate|prednisolone acetate|mesh-list
65516012|NCT03942861|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65516013|NCT03942861|Prednisolone phosphate|prednisolone phosphate|mesh-list
65516014|NCT03942861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65516015|NCT03942861|Antiemetics|antiemetics|mesh-ancestor
65516016|NCT03942861|Autonomic Agents|autonomic agents|mesh-ancestor
65516017|NCT03942861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65516018|NCT03942861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516019|NCT03942861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65516020|NCT03942861|Glucocorticoids|glucocorticoids|mesh-ancestor
65516021|NCT03942861|Hormones|hormones|mesh-ancestor
65516022|NCT03942861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65516023|NCT03942861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65516024|NCT03942861|Protective Agents|protective agents|mesh-ancestor
65516025|NCT03942861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65516026|NCT03942861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516027|NCT01107951|Dexamethasone|dexamethasone|mesh-list
65516028|NCT01107951|Rituximab|rituximab|mesh-list
65516029|NCT01107951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65516030|NCT01107951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516031|NCT01107951|Immunologic Factors|immunologic factors|mesh-ancestor
65516032|NCT01107951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516033|NCT01107951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65516034|NCT01107951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65516035|NCT01107951|Antiemetics|antiemetics|mesh-ancestor
65516036|NCT01107951|Autonomic Agents|autonomic agents|mesh-ancestor
65516037|NCT01107951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65516038|NCT01107951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65516039|NCT01107951|Glucocorticoids|glucocorticoids|mesh-ancestor
65516040|NCT01107951|Hormones|hormones|mesh-ancestor
65516041|NCT01107951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65516042|NCT01107951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65516043|NCT01108029|Memantine|memantine|mesh-list
65516044|NCT01108029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65516045|NCT01108029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65516046|NCT01108029|Dopamine Agents|dopamine agents|mesh-ancestor
65516047|NCT01108029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65516048|NCT01108029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516049|NCT01108029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516050|NCT01108029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65516051|NCT01108029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65516052|NCT03941925|Levan|levan|mesh-list
65516053|NCT03941925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516054|NCT01110603|Paclitaxel|paclitaxel|mesh-list
65516055|NCT01110603|Carboplatin|carboplatin|mesh-list
65516056|NCT01110603|Doxorubicin|doxorubicin|mesh-list
65516057|NCT01110603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65516058|NCT01110603|Niraparib|niraparib|mesh-list
65516059|NCT01110603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65516060|NCT01110603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516061|NCT01110603|Tubulin Modulators|tubulin modulators|mesh-ancestor
65516062|NCT01110603|Antimitotic Agents|antimitotic agents|mesh-ancestor
65516063|NCT01110603|Mitosis Modulators|mitosis modulators|mesh-ancestor
65516064|NCT01110603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516065|NCT01110603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65516066|NCT01110603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65516067|NCT01110603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65516068|NCT01110603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516069|NCT01110603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65516070|NCT04258683|Pembrolizumab|pembrolizumab|mesh-list
65516071|NCT04258683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65516072|NCT04258683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516073|NCT01112787|Tazarotene|tazarotene|mesh-list
65516074|NCT01112787|Dermatologic Agents|dermatologic agents|mesh-ancestor
65516075|NCT01112787|Keratolytic Agents|keratolytic agents|mesh-ancestor
65516076|NCT01108107|Capecitabine|capecitabine|mesh-list
65516077|NCT01108107|Oxaliplatin|oxaliplatin|mesh-list
65516078|NCT01108107|Panitumumab|panitumumab|mesh-list
65516079|NCT01108107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65516080|NCT01108107|Antimetabolites|antimetabolites|mesh-ancestor
65516081|NCT01108107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516082|NCT01108107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516083|NCT01108107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65516084|NCT01111227|Propofol|propofol|mesh-list
65516085|NCT01111227|Isoflurane|isoflurane|mesh-list
65516086|NCT01111227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65516087|NCT01111227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65516088|NCT01111227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516089|NCT01111227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65516090|NCT01111227|Anesthetics, General|anesthetics, general|mesh-ancestor
65516091|NCT01111227|Anesthetics|anesthetics|mesh-ancestor
65516092|NCT01111227|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65516093|NCT01111383|Tobramycin|tobramycin|mesh-list
65516094|NCT01111383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65516095|NCT01111383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516096|NCT01208649|Exenatide|exenatide|mesh-list
65516097|NCT01208649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65516098|NCT01208649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516099|NCT01208649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65516100|NCT01208649|Incretins|incretins|mesh-ancestor
65516101|NCT01208649|Hormones|hormones|mesh-ancestor
65516102|NCT01208649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65516103|NCT01211847|Diazoxide|diazoxide|mesh-list
65516104|NCT01211847|Choline|choline|mesh-list
65516105|NCT01211847|Lipotropic Agents|lipotropic agents|mesh-ancestor
65516106|NCT01211847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65516107|NCT01211847|Antimetabolites|antimetabolites|mesh-ancestor
65516108|NCT01211847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516109|NCT01211847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65516110|NCT01211847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65516111|NCT01211847|Nootropic Agents|nootropic agents|mesh-ancestor
65516112|NCT01211847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65516113|NCT01211847|Vasodilator Agents|vasodilator agents|mesh-ancestor
65516114|NCT01210287|Lamivudine|lamivudine|mesh-list
65516115|NCT01210287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
65516116|NCT01210287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65516117|NCT01210287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516118|NCT01210287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516119|NCT01210287|Antiviral Agents|antiviral agents|mesh-ancestor
65516120|NCT01210287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516121|NCT01210287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65516122|NCT01210287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65516123|NCT01211925|Aspirin|aspirin|mesh-list
65516124|NCT01211925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65516125|NCT01211925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65516126|NCT01211925|Analgesics|analgesics|mesh-ancestor
65516127|NCT01211925|Sensory System Agents|sensory system agents|mesh-ancestor
65516128|NCT01211925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65516129|NCT01211925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516130|NCT01211925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65516131|NCT01211925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65516132|NCT01211925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65516133|NCT01211925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65516134|NCT01211925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516135|NCT01211925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65516136|NCT01211925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65516137|NCT01211925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516138|NCT01211925|Antipyretics|antipyretics|mesh-ancestor
65516139|NCT01114425|Raltegravir Potassium|raltegravir potassium|mesh-list
65516140|NCT01114425|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65516141|NCT01114425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65516142|NCT01114425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65516143|NCT01114425|Antiviral Agents|antiviral agents|mesh-ancestor
65516144|NCT01114425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516145|NCT01114425|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65516146|NCT01114425|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65313791|NCT00803374|Ipilimumab|ipilimumab|mesh-list
65516147|NCT01114425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516148|NCT01114425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516149|NCT01114425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65516150|NCT01114425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65516151|NCT01328145|Aspirin|aspirin|mesh-list
65516152|NCT01328145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65516153|NCT01328145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65516154|NCT01328145|Analgesics|analgesics|mesh-ancestor
65516155|NCT01328145|Sensory System Agents|sensory system agents|mesh-ancestor
65516156|NCT01328145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65516157|NCT01328145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516158|NCT01328145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65516159|NCT01328145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65516160|NCT01328145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65516161|NCT01328145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65516162|NCT01328145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516163|NCT01328145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65516164|NCT01328145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65516165|NCT01328145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516166|NCT01328145|Antipyretics|antipyretics|mesh-ancestor
65516167|NCT01210521|Vitamin D|vitamin d|mesh-list
65516168|NCT01210521|Vitamins|vitamins|mesh-ancestor
65516169|NCT01210521|Micronutrients|micronutrients|mesh-ancestor
65516170|NCT01210521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516171|NCT01210521|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65516172|NCT01210599|Pamidronate|pamidronate|mesh-list
65516173|NCT01210599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65516174|NCT01210599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516175|NCT03944889|Capsaicin|capsaicin|mesh-list
65516176|NCT03944889|Antipruritics|antipruritics|mesh-ancestor
65516177|NCT03944889|Dermatologic Agents|dermatologic agents|mesh-ancestor
65516178|NCT03944889|Sensory System Agents|sensory system agents|mesh-ancestor
65516179|NCT03944889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65516180|NCT03944889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516181|NCT01210677|Prednisone|prednisone|mesh-list
65516182|NCT01210677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65516183|NCT01210677|Glucocorticoids|glucocorticoids|mesh-ancestor
65516184|NCT01210677|Hormones|hormones|mesh-ancestor
65516185|NCT01210677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65516186|NCT01210677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516187|NCT01210677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65516188|NCT01210677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516189|NCT01210755|Rivaroxaban|rivaroxaban|mesh-list
65516190|NCT01210755|Dabigatran|dabigatran|mesh-list
65516191|NCT01210755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65516192|NCT01210755|Antithrombins|antithrombins|mesh-ancestor
65516193|NCT01210755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65516194|NCT01210755|Protease Inhibitors|protease inhibitors|mesh-ancestor
65516195|NCT01210755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516196|NCT01210755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516197|NCT01210755|Anticoagulants|anticoagulants|mesh-ancestor
65516198|NCT01210911|Metformin|metformin|mesh-list
65516199|NCT01210911|Gemcitabine|gemcitabine|mesh-list
65516200|NCT01210911|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65516201|NCT01210911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65516202|NCT01210911|Antimetabolites|antimetabolites|mesh-ancestor
65516203|NCT01210911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516204|NCT01210911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516205|NCT01210911|Antiviral Agents|antiviral agents|mesh-ancestor
65516206|NCT01210911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516207|NCT01210911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516208|NCT01210911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65516209|NCT01210911|Immunologic Factors|immunologic factors|mesh-ancestor
65516210|NCT01210911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516211|NCT01210911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65516212|NCT01210911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65516213|NCT01115049|Chlorhexidine|chlorhexidine|mesh-list
65516214|NCT01115049|Hexetidine|hexetidine|mesh-list
65516215|NCT01115049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65516216|NCT01115049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516217|NCT01115049|Disinfectants|disinfectants|mesh-ancestor
65516218|NCT01115049|Antifungal Agents|antifungal agents|mesh-ancestor
65516219|NCT03941535|Vitamin K|vitamin k|mesh-list
65516220|NCT03941535|Vitamins|vitamins|mesh-ancestor
65516221|NCT03941535|Micronutrients|micronutrients|mesh-ancestor
65313861|NCT05753436|Curcumin|curcumin|mesh-list
65516222|NCT03941535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516223|NCT03941535|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65516225|NCT03941535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516226|NCT03941535|Hemostatics|hemostatics|mesh-ancestor
65516227|NCT03941535|Coagulants|coagulants|mesh-ancestor
65516228|NCT01115127|Inositol|inositol|mesh-list
65516229|NCT01115127|Melatonin|melatonin|mesh-list
65516230|NCT01115127|Antioxidants|antioxidants|mesh-ancestor
65516231|NCT01115127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516232|NCT01115127|Protective Agents|protective agents|mesh-ancestor
65516233|NCT01115127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516234|NCT01115127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65516235|NCT01115127|Vitamin B Complex|vitamin b complex|mesh-ancestor
65516236|NCT01115127|Vitamins|vitamins|mesh-ancestor
65516237|NCT01115127|Micronutrients|micronutrients|mesh-ancestor
65516238|NCT01211223|Amoxicillin|amoxicillin|mesh-list
65516239|NCT01211223|Metronidazole|metronidazole|mesh-list
65516240|NCT01211223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65516241|NCT01211223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516242|NCT01211223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65516243|NCT01211223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65516244|NCT01113489|Beclomethasone|beclomethasone|mesh-list
65516245|NCT01113489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65516246|NCT01113489|Glucocorticoids|glucocorticoids|mesh-ancestor
65516247|NCT01113489|Hormones|hormones|mesh-ancestor
65516248|NCT01113489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65516249|NCT01113489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516250|NCT01113489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65516251|NCT01113489|Respiratory System Agents|respiratory system agents|mesh-ancestor
65516252|NCT01115439|Artesunate|artesunate|mesh-list
65516253|NCT01115439|Pyrimethamine|pyrimethamine|mesh-list
65516254|NCT01115439|Sulfadoxine|sulfadoxine|mesh-list
65516255|NCT01115439|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65516256|NCT01115439|Antimalarials|antimalarials|mesh-ancestor
65516257|NCT01115439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65516258|NCT01115439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65516259|NCT01115439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516260|NCT01115439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516261|NCT01115439|Antiviral Agents|antiviral agents|mesh-ancestor
65516262|NCT01115439|Schistosomicides|schistosomicides|mesh-ancestor
65516263|NCT01115439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65516264|NCT01115439|Anthelmintics|anthelmintics|mesh-ancestor
65516265|NCT01115439|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65516266|NCT01115439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516267|NCT01115439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516268|NCT01115439|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65516269|NCT01115439|Renal Agents|renal agents|mesh-ancestor
65516270|NCT01212315|Triclosan|triclosan|mesh-list
65516271|NCT01212315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65516272|NCT01212315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516273|NCT01212315|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65516274|NCT01212315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65516275|NCT01212315|Antimetabolites|antimetabolites|mesh-ancestor
65516276|NCT01212315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516277|NCT01212315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65516278|NCT03938259|Fentanyl|fentanyl|mesh-list
65516279|NCT03938259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65516280|NCT03938259|Narcotics|narcotics|mesh-ancestor
65516281|NCT03938259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65516282|NCT03938259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516283|NCT03938259|Analgesics|analgesics|mesh-ancestor
65516284|NCT03938259|Sensory System Agents|sensory system agents|mesh-ancestor
65516285|NCT03938259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65516286|NCT03938259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65516287|NCT03938259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65516288|NCT03938259|Anesthetics, General|anesthetics, general|mesh-ancestor
65516289|NCT03938259|Anesthetics|anesthetics|mesh-ancestor
65516290|NCT03939663|Misoprostol|misoprostol|mesh-list
65516291|NCT03939663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65516292|NCT03939663|Abortifacient Agents|abortifacient agents|mesh-ancestor
65516293|NCT03939663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65516294|NCT03939663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516295|NCT03939663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65516296|NCT03939663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65516297|NCT03939663|Oxytocics|oxytocics|mesh-ancestor
65516298|NCT01213407|Temozolomide|temozolomide|mesh-list
65516299|NCT01213407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65516300|NCT01213407|Alkylating Agents|alkylating agents|mesh-ancestor
65516301|NCT01213407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516302|NCT01213407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516303|NCT01211457|Decitabine|decitabine|mesh-list
65516304|NCT01211457|Venetoclax|venetoclax|mesh-list
65516305|NCT01211457|Sapacitabine|sapacitabine|mesh-list
65516306|NCT01211457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65516307|NCT01211457|Antimetabolites|antimetabolites|mesh-ancestor
65516308|NCT01211457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516309|NCT01211457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516310|NCT01211457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516311|NCT01213563|Insulin|insulin|mesh-list
65516312|NCT01213563|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65516313|NCT01213563|Insulin, neutral|insulin, neutral|mesh-list
65516314|NCT01213563|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
65516315|NCT01213563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65516316|NCT01213563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516317|NCT01115985|Atorvastatin|atorvastatin|mesh-list
65516318|NCT01115985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65516319|NCT01115985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65516320|NCT01115985|Antimetabolites|antimetabolites|mesh-ancestor
65516321|NCT01115985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516322|NCT01115985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65516323|NCT01115985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65516324|NCT01115985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516325|NCT01116063|Iloprost|iloprost|mesh-list
65516326|NCT01116063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65516327|NCT01116063|Vasodilator Agents|vasodilator agents|mesh-ancestor
65516328|NCT01116219|Bevacizumab|bevacizumab|mesh-list
65516329|NCT01116219|Pemetrexed|pemetrexed|mesh-list
65516330|NCT01116219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65516331|NCT01116219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65516332|NCT01116219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516333|NCT01116219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65516334|NCT01116219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65516335|NCT01116219|Growth Substances|growth substances|mesh-ancestor
65516336|NCT01116219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516337|NCT01116219|Growth Inhibitors|growth inhibitors|mesh-ancestor
65516338|NCT01116219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516339|NCT01116219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516340|NCT01116219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65516341|NCT01116219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65516342|NCT01116219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65516343|NCT01213719|Betaine|betaine|mesh-list
65516344|NCT01213719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65516345|NCT01213719|Lipotropic Agents|lipotropic agents|mesh-ancestor
65516346|NCT01213719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65516347|NCT01213719|Antimetabolites|antimetabolites|mesh-ancestor
65516348|NCT01213719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516349|NCT01213719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65516350|NCT01114191|Ketoconazole|ketoconazole|mesh-list
65516351|NCT01114191|Antifungal Agents|antifungal agents|mesh-ancestor
65516352|NCT01114191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516353|NCT01114191|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65516354|NCT01114191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65516355|NCT01114191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516356|NCT01114191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516357|NCT01114191|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65516358|NCT01114191|Hormone Antagonists|hormone antagonists|mesh-ancestor
65516359|NCT01114191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65516360|NCT01114191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516361|NCT01114191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65516362|NCT01211691|Antibodies|antibodies|mesh-list
65516363|NCT01211691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65516364|NCT01211691|Immunologic Factors|immunologic factors|mesh-ancestor
65516365|NCT01211691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516366|NCT03937869|Secnidazole|secnidazole|mesh-list
65516367|NCT03937869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65516368|NCT03937869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65516369|NCT03937869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516370|NCT01116531|Pregabalin|pregabalin|mesh-list
65516371|NCT01116531|Tramadol|tramadol|mesh-list
65516372|NCT01116531|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65516373|NCT01116531|Analgesics|analgesics|mesh-ancestor
65516374|NCT01116531|Sensory System Agents|sensory system agents|mesh-ancestor
65516375|NCT01116531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65516376|NCT01116531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516377|NCT01116531|Anticonvulsants|anticonvulsants|mesh-ancestor
65516378|NCT01116531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65516379|NCT01116531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65516380|NCT01116531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516381|NCT01116531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65516382|NCT01116531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65516383|NCT01116531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65516384|NCT01116531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65516385|NCT01116531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65516386|NCT01116531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65516387|NCT01116531|Narcotics|narcotics|mesh-ancestor
65516388|NCT01116531|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65516389|NCT01116531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65516390|NCT01116531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65516391|NCT01116531|Antidepressive Agents|antidepressive agents|mesh-ancestor
65516392|NCT01116531|Dopamine Agents|dopamine agents|mesh-ancestor
65516393|NCT03939975|Pembrolizumab|pembrolizumab|mesh-list
65516394|NCT03939975|Nivolumab|nivolumab|mesh-list
65516395|NCT03939975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65516396|NCT03939975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516397|NCT03939975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65516398|NCT03939975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516399|NCT01116609|Epinephrine|epinephrine|mesh-list
65516400|NCT01116609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65516401|NCT01116609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65516402|NCT01116609|Adrenergic Agents|adrenergic agents|mesh-ancestor
65516403|NCT01116609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65516404|NCT01116609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516405|NCT01116609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516406|NCT01116609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65516407|NCT01116609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65516408|NCT01116609|Autonomic Agents|autonomic agents|mesh-ancestor
65516409|NCT01116609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65516410|NCT01116609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65516411|NCT01116609|Respiratory System Agents|respiratory system agents|mesh-ancestor
65516412|NCT01116609|Mydriatics|mydriatics|mesh-ancestor
65516413|NCT01116609|Sympathomimetics|sympathomimetics|mesh-ancestor
65516414|NCT01116609|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65516415|NCT01118403|Ampicillin|ampicillin|mesh-list
65516416|NCT01118403|Sulbactam|sulbactam|mesh-list
65516417|NCT01118403|Sultamicillin|sultamicillin|mesh-list
65516418|NCT01118403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65516419|NCT01118403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516420|NCT01118403|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65516421|NCT01118403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516422|NCT01118403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516423|NCT01121835|Insulin|insulin|mesh-list
65516424|NCT01121835|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65516425|NCT01121835|Insulin Glargine|insulin glargine|mesh-list
65516426|NCT01121835|Insulin glulisine|insulin glulisine|mesh-list
65516427|NCT01121835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65516428|NCT01121835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516429|NCT03788967|Ertapenem|ertapenem|mesh-list
65516430|NCT03788967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65516431|NCT03788967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516432|NCT01118559|Darexaban|darexaban|mesh-list
65516433|NCT01118559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65516434|NCT01118559|Antithrombins|antithrombins|mesh-ancestor
65516435|NCT01118559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65516436|NCT01118559|Protease Inhibitors|protease inhibitors|mesh-ancestor
65516437|NCT01118559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516438|NCT01118559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516439|NCT01118559|Anticoagulants|anticoagulants|mesh-ancestor
65516440|NCT01216293|Esomeprazole|esomeprazole|mesh-list
65516441|NCT01216293|Dexlansoprazole|dexlansoprazole|mesh-list
65516442|NCT01216293|Lansoprazole|lansoprazole|mesh-list
65516443|NCT01216293|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65516444|NCT01216293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65516445|NCT01216293|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65516446|NCT01216293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516447|NCT01216293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516448|NCT01216371|Sunitinib|sunitinib|mesh-list
65516449|NCT01216371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516450|NCT01216371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65516451|NCT01216371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65516453|NCT01216371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516454|NCT01216371|Growth Inhibitors|growth inhibitors|mesh-ancestor
65516455|NCT01216371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65516456|NCT01216371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516457|NCT01216371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516458|NCT01118871|Ritonavir|ritonavir|mesh-list
65516459|NCT01118871|Darunavir|darunavir|mesh-list
65516460|NCT01118871|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65516461|NCT01118871|Etravirine|etravirine|mesh-list
65516462|NCT01118871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65516463|NCT01118871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65516464|NCT01118871|Protease Inhibitors|protease inhibitors|mesh-ancestor
65516465|NCT01118871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516466|NCT01118871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516467|NCT01118871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65516468|NCT01118871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65516469|NCT01118871|Antiviral Agents|antiviral agents|mesh-ancestor
65516470|NCT01118871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516471|NCT01118871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65516472|NCT01118871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65516473|NCT01118871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65516474|NCT01118871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65516475|NCT01216449|Citalopram|citalopram|mesh-list
65516476|NCT01216449|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65516477|NCT01216449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65516478|NCT01216449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65516479|NCT01216449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516480|NCT01216449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65516481|NCT01216449|Serotonin Agents|serotonin agents|mesh-ancestor
65516482|NCT01216449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516483|NCT01216449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65516484|NCT01216449|Antidepressive Agents|antidepressive agents|mesh-ancestor
65516485|NCT01216449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65516486|NCT03937401|Oxytocin|oxytocin|mesh-list
65516487|NCT03937401|Oxytocics|oxytocics|mesh-ancestor
65516488|NCT03937401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65516489|NCT03937401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516490|NCT03939273|Metronidazole|metronidazole|mesh-list
65516491|NCT03939273|Vancomycin|vancomycin|mesh-list
65516492|NCT03939273|Ciprofloxacin|ciprofloxacin|mesh-list
65516493|NCT03939273|Fluconazole|fluconazole|mesh-list
65516494|NCT03939273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516495|NCT03939273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65516496|NCT03939273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65516497|NCT03939273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65516498|NCT03939273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65516499|NCT03939273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65516500|NCT03939273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516501|NCT03939273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516502|NCT03939273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516503|NCT03939273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65516504|NCT03939273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65516505|NCT03939273|Antifungal Agents|antifungal agents|mesh-ancestor
65516506|NCT03939273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65516507|NCT03939273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65516508|NCT03939273|Hormone Antagonists|hormone antagonists|mesh-ancestor
65516509|NCT03939273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65516510|NCT03939273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516511|NCT03939273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65516512|NCT03939273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65516513|NCT01213017|Certolizumab Pegol|certolizumab pegol|mesh-list
65516514|NCT01213017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65516515|NCT01213017|Immunologic Factors|immunologic factors|mesh-ancestor
65516516|NCT01213017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516517|NCT01213017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65516518|NCT01119417|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
65516519|NCT01119417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65516520|NCT01119417|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65516521|NCT01119417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516522|NCT01216605|Oxytocin|oxytocin|mesh-list
65516523|NCT01216605|Oxytocics|oxytocics|mesh-ancestor
65516524|NCT01216605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65516525|NCT01216605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516526|NCT01213095|Rituximab|rituximab|mesh-list
65516527|NCT01213095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65516528|NCT01213095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516529|NCT01213095|Immunologic Factors|immunologic factors|mesh-ancestor
65516530|NCT01213095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516531|NCT01213095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65516532|NCT03938883|Hyaluronic Acid|hyaluronic acid|mesh-list
65516533|NCT03938883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65516534|NCT03938883|Immunologic Factors|immunologic factors|mesh-ancestor
65516535|NCT03938883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516536|NCT03938883|Viscosupplements|viscosupplements|mesh-ancestor
65516537|NCT03938883|Protective Agents|protective agents|mesh-ancestor
65516538|NCT01216839|Everolimus|everolimus|mesh-list
65516539|NCT01216839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516540|NCT01216839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65516541|NCT01216839|Immunologic Factors|immunologic factors|mesh-ancestor
65516542|NCT01216839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516543|NCT01119651|Tazarotene|tazarotene|mesh-list
65516544|NCT01119651|Dermatologic Agents|dermatologic agents|mesh-ancestor
65516545|NCT01119651|Keratolytic Agents|keratolytic agents|mesh-ancestor
65516546|NCT03971877|Polymyxins|polymyxins|mesh-list
65516547|NCT03971877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65516548|NCT03971877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516549|NCT01328925|Nitazoxanide|nitazoxanide|mesh-list
65516550|NCT01328925|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65516551|NCT01328925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516552|NCT01119885|Fentanyl|fentanyl|mesh-list
65516553|NCT01119885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65516554|NCT01119885|Narcotics|narcotics|mesh-ancestor
65516555|NCT01119885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65516556|NCT01119885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516557|NCT01119885|Analgesics|analgesics|mesh-ancestor
65516558|NCT01119885|Sensory System Agents|sensory system agents|mesh-ancestor
65516559|NCT01119885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65516560|NCT01119885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65516561|NCT01119885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65516562|NCT01119885|Anesthetics, General|anesthetics, general|mesh-ancestor
65516563|NCT01119885|Anesthetics|anesthetics|mesh-ancestor
65516564|NCT03935217|Secnidazole|secnidazole|mesh-list
65516565|NCT03935217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65516566|NCT03935217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65516567|NCT03935217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516568|NCT01219023|Sildenafil Citrate|sildenafil citrate|mesh-list
65516569|NCT01219023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516570|NCT01219023|Vasodilator Agents|vasodilator agents|mesh-ancestor
65516571|NCT01219023|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65516572|NCT01219023|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65516573|NCT01219023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516574|NCT01219023|Urological Agents|urological agents|mesh-ancestor
65516575|NCT01124487|Insulin|insulin|mesh-list
65516576|NCT01124487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65516577|NCT01124487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516578|NCT01120119|Calcitriol|calcitriol|mesh-list
65516579|NCT01120119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65516580|NCT01120119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516581|NCT01120119|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65516582|NCT01120119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65516583|NCT01120119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516584|NCT01120119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65516585|NCT01120119|Vitamins|vitamins|mesh-ancestor
65516586|NCT01120119|Micronutrients|micronutrients|mesh-ancestor
65516587|NCT01120119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65516588|NCT01219101|Citric Acid|citric acid|mesh-list
65516589|NCT01219101|Sodium Citrate|sodium citrate|mesh-list
65516590|NCT01219101|Clomiphene|clomiphene|mesh-list
65516591|NCT01219101|Enclomiphene|enclomiphene|mesh-list
65516592|NCT01219101|Zuclomiphene|zuclomiphene|mesh-list
65516593|NCT01219101|Anticoagulants|anticoagulants|mesh-ancestor
65516594|NCT01219101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65516595|NCT01219101|Chelating Agents|chelating agents|mesh-ancestor
65516596|NCT01219101|Sequestering Agents|sequestering agents|mesh-ancestor
65516597|NCT01219101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516598|NCT01219101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65516599|NCT01219101|Hormone Antagonists|hormone antagonists|mesh-ancestor
65516600|NCT01219101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65516601|NCT01219101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516602|NCT01219101|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65516603|NCT01219101|Fertility Agents|fertility agents|mesh-ancestor
65516604|NCT01219101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65516605|NCT01219101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65516606|NCT01219101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65516607|NCT01217619|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65516608|NCT01217619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516609|NCT01217619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65516610|NCT01217619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516611|NCT01217619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516612|NCT01122615|Sirolimus|sirolimus|mesh-list
65516613|NCT01122615|Sunitinib|sunitinib|mesh-list
65516614|NCT01122615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516615|NCT01122615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65516616|NCT01122615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65516617|NCT01122615|Growth Substances|growth substances|mesh-ancestor
65516618|NCT01122615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516619|NCT01122615|Growth Inhibitors|growth inhibitors|mesh-ancestor
65516620|NCT01122615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65516621|NCT01122615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516622|NCT01122615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516623|NCT01122615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65516624|NCT01122615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516625|NCT01122615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65516626|NCT01122615|Antifungal Agents|antifungal agents|mesh-ancestor
65516627|NCT01122615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65516628|NCT01122615|Immunologic Factors|immunologic factors|mesh-ancestor
65516629|NCT01217697|Prednisone|prednisone|mesh-list
65516630|NCT01217697|Prednisolone|prednisolone|mesh-list
65516631|NCT01217697|Abiraterone Acetate|abiraterone acetate|mesh-list
65516632|NCT01217697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65516633|NCT01217697|Glucocorticoids|glucocorticoids|mesh-ancestor
65516634|NCT01217697|Hormones|hormones|mesh-ancestor
65516635|NCT01217697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65516636|NCT01217697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516637|NCT01217697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65516638|NCT01217697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516639|NCT01217697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65516640|NCT01217697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516641|NCT01217697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516642|NCT01217697|Hormone Antagonists|hormone antagonists|mesh-ancestor
65516643|NCT01217697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65516644|NCT01214343|Sorafenib|sorafenib|mesh-list
65516645|NCT01214343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516646|NCT01214343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65516647|NCT01214343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516648|NCT01214343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516649|NCT01120431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65516650|NCT01124799|Ciprofloxacin|ciprofloxacin|mesh-list
65516651|NCT01124799|Simeprevir|simeprevir|mesh-list
65516652|NCT01124799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65516653|NCT01124799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516654|NCT01124799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65516655|NCT01124799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65516656|NCT01124799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516657|NCT01124799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516658|NCT01124799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516659|NCT01124799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65516660|NCT01124799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65516661|NCT01124799|Antiviral Agents|antiviral agents|mesh-ancestor
65516662|NCT01124799|Protease Inhibitors|protease inhibitors|mesh-ancestor
65516663|NCT01124877|Ziprasidone|ziprasidone|mesh-list
65516664|NCT01124877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65516665|NCT01124877|Serotonin Agents|serotonin agents|mesh-ancestor
65516666|NCT01124877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65516667|NCT01124877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516668|NCT01124877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516669|NCT01124877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65516670|NCT01124877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65516671|NCT01124877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65516672|NCT01124877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65516673|NCT01124877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65516674|NCT01124877|Dopamine Agents|dopamine agents|mesh-ancestor
65516675|NCT01219413|Perindopril|perindopril|mesh-list
65516676|NCT01219413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65516677|NCT01219413|Protease Inhibitors|protease inhibitors|mesh-ancestor
65516678|NCT01219413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516679|NCT01219413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516680|NCT01219413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65516681|NCT03783039|Cellulose, Oxidized|cellulose, oxidized|mesh-list
65516682|NCT03783039|Hemostatics|hemostatics|mesh-ancestor
65516683|NCT03783039|Coagulants|coagulants|mesh-ancestor
65516684|NCT03933501|Amoxicillin|amoxicillin|mesh-list
65516685|NCT03933501|Metronidazole|metronidazole|mesh-list
65516686|NCT03933501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65516687|NCT03933501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516688|NCT03933501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65516689|NCT03933501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65516690|NCT01122771|Amphotericin B|amphotericin b|mesh-list
65516691|NCT01122771|Paromomycin|paromomycin|mesh-list
65516692|NCT01122771|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65516693|NCT01122771|Miltefosine|miltefosine|mesh-list
65516694|NCT01122771|Amebicides|amebicides|mesh-ancestor
65516695|NCT01122771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65516696|NCT01122771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65516697|NCT01122771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516698|NCT01122771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65516699|NCT01122771|Antifungal Agents|antifungal agents|mesh-ancestor
65516700|NCT01122771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516701|NCT01125033|Vitamins|vitamins|mesh-list
65516702|NCT01125033|Ascorbic Acid|ascorbic acid|mesh-list
65516703|NCT01125033|Vitamin E|vitamin e|mesh-list
65516704|NCT01125033|Tocopherols|tocopherols|mesh-list
65516705|NCT01125033|Tocotrienols|tocotrienols|mesh-list
65516706|NCT01125033|alpha-Tocopherol|alpha-tocopherol|mesh-list
65516707|NCT01125033|Micronutrients|micronutrients|mesh-ancestor
65516708|NCT01125033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516709|NCT01125033|Antioxidants|antioxidants|mesh-ancestor
65516710|NCT01125033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516711|NCT01125033|Protective Agents|protective agents|mesh-ancestor
65516712|NCT01120665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65516713|NCT01120665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65516714|NCT01120665|Estradiol|estradiol|mesh-list
65516715|NCT01120665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65516716|NCT01120665|Hormones|hormones|mesh-ancestor
65516717|NCT01120665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65516718|NCT01120665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516719|NCT01120665|Estrogens|estrogens|mesh-ancestor
65516720|NCT01120665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65516721|NCT01120665|Contraceptive Agents|contraceptive agents|mesh-ancestor
65516722|NCT01120665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65516723|NCT01120665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65516724|NCT01120821|Imatinib Mesylate|imatinib mesylate|mesh-list
65516725|NCT01120821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516726|NCT01120821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65516727|NCT01120821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516728|NCT01120821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516729|NCT01125423|Milnacipran|milnacipran|mesh-list
65516730|NCT01125423|Levomilnacipran|levomilnacipran|mesh-list
65516731|NCT01125423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65516732|NCT01125423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65516733|NCT01125423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65516734|NCT01125423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516735|NCT01125423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65516736|NCT01125423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516737|NCT01125423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65516738|NCT01125423|Analgesics|analgesics|mesh-ancestor
65516739|NCT01125423|Sensory System Agents|sensory system agents|mesh-ancestor
65516740|NCT01125423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65516741|NCT01125423|Antidepressive Agents|antidepressive agents|mesh-ancestor
65516742|NCT01125423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65516743|NCT01219569|Propofol|propofol|mesh-list
65516744|NCT01219569|Sevoflurane|sevoflurane|mesh-list
65516745|NCT01219569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65516746|NCT01219569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65245777|NCT00811993|Gemcitabine|gemcitabine|mesh-list
65516747|NCT01219569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516748|NCT01219569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65516749|NCT01219569|Anesthetics, General|anesthetics, general|mesh-ancestor
65516750|NCT01219569|Anesthetics|anesthetics|mesh-ancestor
65516751|NCT01219569|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65516752|NCT01219569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65516753|NCT03933345|Naloxone|naloxone|mesh-list
65516754|NCT03933345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65516755|NCT03933345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516756|NCT03933345|Sensory System Agents|sensory system agents|mesh-ancestor
65516757|NCT03933345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65516758|NCT01121055|Lorazepam|lorazepam|mesh-list
65516759|NCT01121055|Anticonvulsants|anticonvulsants|mesh-ancestor
65516760|NCT01121055|Antiemetics|antiemetics|mesh-ancestor
65516761|NCT01121055|Autonomic Agents|autonomic agents|mesh-ancestor
65516762|NCT01121055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65516763|NCT01121055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516764|NCT01121055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65516765|NCT01121055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65516766|NCT01121055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65516767|NCT01121055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65516768|NCT01121055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65516769|NCT01121055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65516770|NCT01121055|GABA Modulators|gaba modulators|mesh-ancestor
65516771|NCT01121055|GABA Agents|gaba agents|mesh-ancestor
65516772|NCT01121055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65516773|NCT01121055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516774|NCT01121133|Rifampin|rifampin|mesh-list
65516775|NCT01121133|Navitoclax|navitoclax|mesh-list
65516776|NCT01121133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65516777|NCT01121133|Antitubercular Agents|antitubercular agents|mesh-ancestor
65516778|NCT01121133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65516779|NCT01121133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516780|NCT01121133|Leprostatic Agents|leprostatic agents|mesh-ancestor
65516781|NCT01121133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65516782|NCT01121133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516783|NCT01121133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516784|NCT01121133|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65516785|NCT01121133|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65516786|NCT01121133|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65516787|NCT01121133|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65516788|NCT01121133|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65516789|NCT01121133|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65516790|NCT01121133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516791|NCT01218321|Anticonvulsants|anticonvulsants|mesh-list
65516792|NCT01214889|Vaccines|vaccines|mesh-list
65516793|NCT01214889|Immunologic Factors|immunologic factors|mesh-ancestor
65516794|NCT01214889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516795|NCT01123317|Oxytocin|oxytocin|mesh-list
65516796|NCT01123317|Oxytocics|oxytocics|mesh-ancestor
65516797|NCT01123317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65516798|NCT01123317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516799|NCT01121289|Insulin Aspart|insulin aspart|mesh-list
65516800|NCT01121289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65516801|NCT01121289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516802|NCT01123473|Fluorouracil|fluorouracil|mesh-list
65516803|NCT01123473|Capecitabine|capecitabine|mesh-list
65516804|NCT01123473|Epirubicin|epirubicin|mesh-list
65516805|NCT01123473|Lapatinib|lapatinib|mesh-list
65516806|NCT01123473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516807|NCT01123473|Antimetabolites|antimetabolites|mesh-ancestor
65516808|NCT01123473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516809|NCT01123473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65516810|NCT01123473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65516811|NCT01123473|Immunologic Factors|immunologic factors|mesh-ancestor
65516812|NCT01123473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516813|NCT01123473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65516814|NCT01123473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65516815|NCT01123473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65516816|NCT01123473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516817|NCT01123473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65516818|NCT01123551|Morphine|morphine|mesh-list
65516819|NCT01123551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65516820|NCT01123551|Narcotics|narcotics|mesh-ancestor
65516821|NCT01123551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65516822|NCT01123551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516823|NCT01123551|Analgesics|analgesics|mesh-ancestor
65516824|NCT01123551|Sensory System Agents|sensory system agents|mesh-ancestor
65516825|NCT01123551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65516826|NCT01125657|Darexaban|darexaban|mesh-list
65516827|NCT01125657|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65516828|NCT01125657|Antithrombins|antithrombins|mesh-ancestor
65314460|NCT00590538|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
65516829|NCT01125657|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65516830|NCT01125657|Protease Inhibitors|protease inhibitors|mesh-ancestor
65516831|NCT01125657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516832|NCT01125657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516833|NCT01125657|Anticoagulants|anticoagulants|mesh-ancestor
65516834|NCT03934203|Moxifloxacin|moxifloxacin|mesh-list
65516835|NCT03934203|BI 409306|bi 409306|mesh-list
65516836|NCT03934203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65516837|NCT03934203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516838|NCT03934203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65516839|NCT03934203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65516840|NCT03934203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516841|NCT03934203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516842|NCT03934203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516843|NCT03934203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65516844|NCT03934047|Tranexamic Acid|tranexamic acid|mesh-list
65516845|NCT03934047|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65516846|NCT03934047|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65516847|NCT03934047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516848|NCT03934047|Hemostatics|hemostatics|mesh-ancestor
65516849|NCT03934047|Coagulants|coagulants|mesh-ancestor
65516850|NCT01218711|Losartan|losartan|mesh-list
65516851|NCT01218711|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65516852|NCT01218711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65516853|NCT01218711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65516854|NCT01218711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65516855|NCT01218711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65516856|NCT01218711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516857|NCT01218711|Diuretics|diuretics|mesh-ancestor
65516858|NCT01218711|Natriuretic Agents|natriuretic agents|mesh-ancestor
65516859|NCT01218711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516860|NCT01218711|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65516861|NCT01218711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65516862|NCT01125891|Gemcitabine|gemcitabine|mesh-list
65516863|NCT01125891|ON 01910|on 01910|mesh-list
65516864|NCT01125891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65516865|NCT01125891|Antimetabolites|antimetabolites|mesh-ancestor
65516866|NCT01125891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516867|NCT01125891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516868|NCT01125891|Antiviral Agents|antiviral agents|mesh-ancestor
65516869|NCT01125891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516870|NCT01125891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516871|NCT01125891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65516872|NCT01125891|Immunologic Factors|immunologic factors|mesh-ancestor
65516873|NCT01125891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516874|NCT01125891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65516875|NCT01124253|Endostatins|endostatins|mesh-list
65516876|NCT01124253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65516877|NCT01124253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65516878|NCT01124253|Growth Substances|growth substances|mesh-ancestor
65516879|NCT01124253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516880|NCT01124253|Growth Inhibitors|growth inhibitors|mesh-ancestor
65516881|NCT01124253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516882|NCT01215669|Vaccines|vaccines|mesh-list
65516883|NCT01215669|Immunologic Factors|immunologic factors|mesh-ancestor
65516884|NCT01215669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516885|NCT01222221|Temozolomide|temozolomide|mesh-list
65516886|NCT01222221|Sargramostim|sargramostim|mesh-list
65516887|NCT01222221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65516888|NCT01222221|Alkylating Agents|alkylating agents|mesh-ancestor
65516889|NCT01222221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516890|NCT01222221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516891|NCT01222221|Immunologic Factors|immunologic factors|mesh-ancestor
65516892|NCT01222221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516893|NCT01220661|Cefotetan|cefotetan|mesh-list
65516894|NCT01220661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65516895|NCT01220661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516896|NCT02903914|Pembrolizumab|pembrolizumab|mesh-list
65516897|NCT02903914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65516898|NCT02903914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516899|NCT01222611|Fosamprenavir|fosamprenavir|mesh-list
65516900|NCT01222611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65516901|NCT01222611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65516902|NCT01222611|Protease Inhibitors|protease inhibitors|mesh-ancestor
65516903|NCT01222611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516904|NCT01222611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516906|NCT01222611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65516907|NCT01222611|Antiviral Agents|antiviral agents|mesh-ancestor
65516908|NCT01222611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516909|NCT03928353|Ticagrelor|ticagrelor|mesh-list
65516910|NCT03928353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65516911|NCT03928353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65516912|NCT03928353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65516913|NCT03928353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65516914|NCT03928353|Purinergic Agents|purinergic agents|mesh-ancestor
65516915|NCT03928353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65516916|NCT03928353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516917|NCT03928353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516918|NCT03931863|Ondansetron|ondansetron|mesh-list
65516919|NCT03931863|Antiemetics|antiemetics|mesh-ancestor
65516920|NCT03931863|Autonomic Agents|autonomic agents|mesh-ancestor
65516921|NCT03931863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65516922|NCT03931863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516923|NCT03931863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65516924|NCT03931863|Antipruritics|antipruritics|mesh-ancestor
65516925|NCT03931863|Dermatologic Agents|dermatologic agents|mesh-ancestor
65516926|NCT03931863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65516927|NCT03931863|Serotonin Agents|serotonin agents|mesh-ancestor
65516928|NCT03931863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65516929|NCT03931863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516930|NCT03931863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65516931|NCT03931863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65516932|NCT03931863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65516933|NCT03931863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65516934|NCT03931863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65516935|NCT03650608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65516936|NCT03650608|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65516937|NCT01226355|Sirolimus|sirolimus|mesh-list
65516938|NCT01226355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65516939|NCT01226355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65516940|NCT01226355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65516941|NCT01226355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516942|NCT01226355|Antifungal Agents|antifungal agents|mesh-ancestor
65516943|NCT01226355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65516944|NCT01226355|Immunologic Factors|immunologic factors|mesh-ancestor
65516945|NCT01226355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516946|NCT01129089|Micronutrients|micronutrients|mesh-list
65516947|NCT01129089|Trace Elements|trace elements|mesh-list
65516948|NCT01129089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516949|NCT01129323|Cyclophosphamide|cyclophosphamide|mesh-list
65516950|NCT01129323|Fludarabine|fludarabine|mesh-list
65516951|NCT01129323|Thymoglobulin|thymoglobulin|mesh-list
65516952|NCT01129323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65516953|NCT01129323|Immunologic Factors|immunologic factors|mesh-ancestor
65516954|NCT01129323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516955|NCT01129323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65516956|NCT01129323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65516957|NCT01129323|Alkylating Agents|alkylating agents|mesh-ancestor
65516958|NCT01129323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516959|NCT01129323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65516960|NCT01129323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65516961|NCT01221129|Zinc|zinc|mesh-list
65516962|NCT01221129|Trace Elements|trace elements|mesh-ancestor
65516963|NCT01221129|Micronutrients|micronutrients|mesh-ancestor
65516964|NCT01221129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516965|NCT01222923|Risperidone|risperidone|mesh-list
65516966|NCT01222923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65516967|NCT01222923|Serotonin Agents|serotonin agents|mesh-ancestor
65516968|NCT01222923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65516969|NCT01222923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516970|NCT01222923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516971|NCT01222923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65516972|NCT01222923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65516973|NCT01222923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65516974|NCT01222923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65516975|NCT01222923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65516976|NCT01222923|Dopamine Agents|dopamine agents|mesh-ancestor
65516977|NCT01223079|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65516978|NCT01223079|Hormones|hormones|mesh-ancestor
65516979|NCT01223079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65516980|NCT01223079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516982|NCT03648970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65516983|NCT03648970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65516984|NCT03648970|Antimetabolites|antimetabolites|mesh-ancestor
65516985|NCT03648970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65516986|NCT03648970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65516987|NCT03648970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65516988|NCT03648970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65516989|NCT03927963|Dexmedetomidine|dexmedetomidine|mesh-list
65516990|NCT03927963|Propofol|propofol|mesh-list
65516991|NCT03927963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65516992|NCT03927963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65516993|NCT03927963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65516994|NCT03927963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65516995|NCT03927963|Anesthetics, General|anesthetics, general|mesh-ancestor
65516996|NCT03927963|Anesthetics|anesthetics|mesh-ancestor
65516997|NCT03927963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65516998|NCT03927963|Analgesics|analgesics|mesh-ancestor
65516999|NCT03927963|Sensory System Agents|sensory system agents|mesh-ancestor
65517000|NCT03927963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517001|NCT03927963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65517002|NCT03927963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65517003|NCT03927963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65517004|NCT03927963|Adrenergic Agents|adrenergic agents|mesh-ancestor
65517005|NCT03927963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65517006|NCT03927963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517007|NCT03648346|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65517008|NCT01127529|Protein C|protein c|mesh-list
65517009|NCT01127529|Anticoagulants|anticoagulants|mesh-ancestor
65517010|NCT01127529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65517011|NCT01127529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65517012|NCT01127529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517013|NCT01226667|Pregabalin|pregabalin|mesh-list
65517014|NCT01226667|Analgesics|analgesics|mesh-ancestor
65517015|NCT01226667|Sensory System Agents|sensory system agents|mesh-ancestor
65517016|NCT01226667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517017|NCT01226667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517018|NCT01226667|Anticonvulsants|anticonvulsants|mesh-ancestor
65517019|NCT01226667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65517020|NCT01226667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65517021|NCT01226667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517022|NCT01226667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65517023|NCT01226667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65517024|NCT01226667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65517025|NCT01226667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65517026|NCT01226667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65517027|NCT03927807|Misoprostol|misoprostol|mesh-list
65517028|NCT03927807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65517029|NCT03927807|Abortifacient Agents|abortifacient agents|mesh-ancestor
65517030|NCT03927807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65517031|NCT03927807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517032|NCT03927807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65517033|NCT03927807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65517034|NCT03927807|Oxytocics|oxytocics|mesh-ancestor
65517035|NCT05284942|Mycophenolic Acid|mycophenolic acid|mesh-list
65517036|NCT05284942|Prednisone|prednisone|mesh-list
65517037|NCT05284942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65517038|NCT05284942|Glucocorticoids|glucocorticoids|mesh-ancestor
65517039|NCT05284942|Hormones|hormones|mesh-ancestor
65517040|NCT05284942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65517041|NCT05284942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517042|NCT05284942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65517043|NCT05284942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517044|NCT05284942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65517045|NCT05284942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65517046|NCT05284942|Antitubercular Agents|antitubercular agents|mesh-ancestor
65517047|NCT05284942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65517048|NCT05284942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65517049|NCT05284942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65517050|NCT05284942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517051|NCT03648034|Ropivacaine|ropivacaine|mesh-list
65517052|NCT03648034|Anesthetics, Local|anesthetics, local|mesh-ancestor
65517053|NCT03648034|Anesthetics|anesthetics|mesh-ancestor
65517054|NCT03648034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65517055|NCT03648034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517056|NCT03648034|Sensory System Agents|sensory system agents|mesh-ancestor
65517057|NCT03648034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517058|NCT01129479|Galantamine|galantamine|mesh-list
65517059|NCT01129479|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65517060|NCT01129479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65517061|NCT01129479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517062|NCT01129479|Cholinergic Agents|cholinergic agents|mesh-ancestor
65517063|NCT01129479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65517064|NCT01129479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517065|NCT01129479|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65517066|NCT01129479|Autonomic Agents|autonomic agents|mesh-ancestor
65517067|NCT01129479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517068|NCT01129479|Nootropic Agents|nootropic agents|mesh-ancestor
65517069|NCT03647956|Bevacizumab|bevacizumab|mesh-list
65517070|NCT03647956|Carboplatin|carboplatin|mesh-list
65517071|NCT03647956|Pemetrexed|pemetrexed|mesh-list
65517072|NCT03647956|Atezolizumab|atezolizumab|mesh-list
65517073|NCT03647956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65517074|NCT03647956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517075|NCT03647956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65517076|NCT03647956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65517077|NCT03647956|Growth Substances|growth substances|mesh-ancestor
65517078|NCT03647956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517079|NCT03647956|Growth Inhibitors|growth inhibitors|mesh-ancestor
65517080|NCT03647956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65517081|NCT03647956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517082|NCT03647956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65517083|NCT03647956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65517084|NCT01221675|Antibodies|antibodies|mesh-list
65517085|NCT01221675|Immunologic Factors|immunologic factors|mesh-ancestor
65517086|NCT01221675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517087|NCT03927729|Methoxyflurane|methoxyflurane|mesh-list
65517088|NCT03927729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65517089|NCT03927729|Anesthetics, General|anesthetics, general|mesh-ancestor
65517090|NCT03927729|Anesthetics|anesthetics|mesh-ancestor
65517091|NCT03927729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65517092|NCT03927729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517093|NCT01226823|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65517094|NCT01226823|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65517095|NCT01226823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65517096|NCT02968576|Tenofovir|tenofovir|mesh-list
65517097|NCT02968576|Emtricitabine|emtricitabine|mesh-list
65517098|NCT02968576|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65517099|NCT02968576|Antiviral Agents|antiviral agents|mesh-ancestor
65517100|NCT02968576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65517101|NCT02968576|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65517102|NCT02968576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65517103|NCT02968576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65517104|NCT02968576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517105|NCT02968576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65517106|NCT02968576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65517107|NCT01127217|Losartan|losartan|mesh-list
65517108|NCT01127217|Amlodipine|amlodipine|mesh-list
65517109|NCT01127217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65517110|NCT01127217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65517111|NCT01127217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65517112|NCT01127217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517113|NCT01127217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65517114|NCT01127217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517115|NCT01127217|Vasodilator Agents|vasodilator agents|mesh-ancestor
65517116|NCT01127217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65517117|NCT01127217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65517118|NCT01127217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65517119|NCT01226901|Niraparib|niraparib|mesh-list
65517120|NCT01226901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65517121|NCT01226901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65517122|NCT01226901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517123|NCT01226901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517124|NCT03648658|Acetaminophen|acetaminophen|mesh-list
65314759|NCT03746275|Protease Inhibitors|protease inhibitors|mesh-ancestor
65517125|NCT03648658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65517127|NCT03648658|Sensory System Agents|sensory system agents|mesh-ancestor
65517128|NCT03648658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517129|NCT03648658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517130|NCT03648658|Antipyretics|antipyretics|mesh-ancestor
65517131|NCT03931239|Vaccines|vaccines|mesh-list
65517132|NCT03931239|Immunologic Factors|immunologic factors|mesh-ancestor
65517133|NCT03931239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517134|NCT03927495|Paclitaxel|paclitaxel|mesh-list
65517135|NCT03927495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65517136|NCT03927495|Cisplatin|cisplatin|mesh-list
65517137|NCT03927495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65517138|NCT03927495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517139|NCT03927495|Tubulin Modulators|tubulin modulators|mesh-ancestor
65517140|NCT03927495|Antimitotic Agents|antimitotic agents|mesh-ancestor
65517141|NCT03927495|Mitosis Modulators|mitosis modulators|mesh-ancestor
65517142|NCT03927495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517143|NCT02966002|Aspirin|aspirin|mesh-list
65517144|NCT02966002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65517145|NCT02966002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65517146|NCT02966002|Analgesics|analgesics|mesh-ancestor
65517147|NCT02966002|Sensory System Agents|sensory system agents|mesh-ancestor
65517148|NCT02966002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517149|NCT02966002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517150|NCT02966002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65517151|NCT02966002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65517152|NCT02966002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65517153|NCT02966002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65517154|NCT02966002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517155|NCT02966002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65517156|NCT02966002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65517157|NCT02966002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65517158|NCT02966002|Antipyretics|antipyretics|mesh-ancestor
65517159|NCT01127295|Tamoxifen|tamoxifen|mesh-list
65517160|NCT01127295|Letrozole|letrozole|mesh-list
65517161|NCT01127295|Anastrozole|anastrozole|mesh-list
65517162|NCT01127295|Exemestane|exemestane|mesh-list
65517163|NCT01127295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517164|NCT01127295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65517165|NCT01127295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65517166|NCT01127295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65517167|NCT01127295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517168|NCT01127295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65517169|NCT01127295|Hormone Antagonists|hormone antagonists|mesh-ancestor
65517170|NCT01127295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65517171|NCT01127295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517172|NCT01127295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65517173|NCT01127295|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65517174|NCT01127295|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65517175|NCT01127295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65517176|NCT01129713|Esomeprazole|esomeprazole|mesh-list
65517177|NCT01129713|Omeprazole|omeprazole|mesh-list
65517178|NCT01129713|Lansoprazole|lansoprazole|mesh-list
65517179|NCT01129713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65517180|NCT01129713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65517181|NCT01129713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65517182|NCT01129713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65517183|NCT01129713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517184|NCT01221831|Dienogest|dienogest|mesh-list
65517185|NCT01221831|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65517186|NCT01221831|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65517187|NCT01221831|Estradiol|estradiol|mesh-list
65517188|NCT01221831|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65517189|NCT01221831|Estrogens|estrogens|mesh-ancestor
65517190|NCT01221831|Hormones|hormones|mesh-ancestor
65517191|NCT01221831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65517192|NCT01221831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517193|NCT01221831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65517194|NCT01221831|Contraceptive Agents|contraceptive agents|mesh-ancestor
65517195|NCT01221831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65517196|NCT01221831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65517197|NCT01221831|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65517198|NCT01221831|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65517199|NCT01221831|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65517200|NCT01221831|Hormone Antagonists|hormone antagonists|mesh-ancestor
65517201|NCT01221831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65517202|NCT01221831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517203|NCT03931317|Timolol|timolol|mesh-list
65517204|NCT03931317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517205|NCT03931317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65517206|NCT03931317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65517207|NCT03931317|Adrenergic Agents|adrenergic agents|mesh-ancestor
65517208|NCT03931317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65517209|NCT03931317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517210|NCT03931317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65517211|NCT03931317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65517212|NCT01221909|Tranexamic Acid|tranexamic acid|mesh-list
65517213|NCT01221909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65517214|NCT01221909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65517215|NCT01221909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517216|NCT01221909|Hemostatics|hemostatics|mesh-ancestor
65517217|NCT01221909|Coagulants|coagulants|mesh-ancestor
65517218|NCT02900092|Ganaxolone|ganaxolone|mesh-list
65517219|NCT02900092|Neurosteroids|neurosteroids|mesh-ancestor
65517220|NCT02900092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65517221|NCT02900092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517222|NCT02900092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517223|NCT02900092|GABA Modulators|gaba modulators|mesh-ancestor
65517224|NCT02900092|GABA Agents|gaba agents|mesh-ancestor
65517225|NCT01130025|Tinzaparin|tinzaparin|mesh-list
65517226|NCT01130025|Warfarin|warfarin|mesh-list
65517227|NCT01130025|Anticoagulants|anticoagulants|mesh-ancestor
65517228|NCT01130025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65517229|NCT01130025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65517230|NCT01130025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517231|NCT03925155|Iodine|iodine|mesh-list
65517232|NCT03925155|Chlorhexidine|chlorhexidine|mesh-list
65517233|NCT03925155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65517234|NCT03925155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65517235|NCT03925155|Disinfectants|disinfectants|mesh-ancestor
65517236|NCT03925155|Trace Elements|trace elements|mesh-ancestor
65517237|NCT03925155|Micronutrients|micronutrients|mesh-ancestor
65517238|NCT03925155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517239|NCT01131195|Paclitaxel|paclitaxel|mesh-list
65517240|NCT01131195|Cyclophosphamide|cyclophosphamide|mesh-list
65517241|NCT01131195|Bevacizumab|bevacizumab|mesh-list
65517242|NCT01131195|Capecitabine|capecitabine|mesh-list
65517243|NCT01131195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65517244|NCT01131195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517245|NCT01131195|Tubulin Modulators|tubulin modulators|mesh-ancestor
65517246|NCT01131195|Antimitotic Agents|antimitotic agents|mesh-ancestor
65517247|NCT01131195|Mitosis Modulators|mitosis modulators|mesh-ancestor
65517248|NCT01131195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517249|NCT01131195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65517250|NCT01131195|Immunologic Factors|immunologic factors|mesh-ancestor
65517251|NCT01131195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517252|NCT01131195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65517253|NCT01131195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65517254|NCT01131195|Alkylating Agents|alkylating agents|mesh-ancestor
65517255|NCT01131195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65517256|NCT01131195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65517257|NCT01131195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65517258|NCT01131195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65517259|NCT01131195|Growth Substances|growth substances|mesh-ancestor
65517260|NCT01131195|Growth Inhibitors|growth inhibitors|mesh-ancestor
65517261|NCT01131195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65517262|NCT01131195|Antimetabolites|antimetabolites|mesh-ancestor
65517263|NCT01227135|Hydroxychloroquine|hydroxychloroquine|mesh-list
65517264|NCT01227135|Imatinib Mesylate|imatinib mesylate|mesh-list
65517265|NCT01227135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517266|NCT01227135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65517267|NCT01227135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65517268|NCT01227135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517269|NCT01227135|Antimalarials|antimalarials|mesh-ancestor
65517270|NCT01227135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65517271|NCT01227135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65517272|NCT01227135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65517273|NCT01227135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65517274|NCT01223625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65517275|NCT01223625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65517276|NCT01223625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65517277|NCT01223625|Antimetabolites|antimetabolites|mesh-ancestor
65517278|NCT01223625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517279|NCT01223625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65517280|NCT01223625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65517281|NCT01223625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65517282|NCT01228227|Atorvastatin|atorvastatin|mesh-list
65517283|NCT01228227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65517284|NCT01228227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65517285|NCT01228227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65517286|NCT01228227|Antimetabolites|antimetabolites|mesh-ancestor
65517287|NCT01228227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517288|NCT01228227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65517289|NCT01228227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65517290|NCT01228227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65517291|NCT04052854|Zanubrutinib|zanubrutinib|mesh-list
65517292|NCT04052854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517293|NCT04052854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65517294|NCT04052854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65517295|NCT04052854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517296|NCT03740373|Budesonide|budesonide|mesh-list
65517297|NCT03740373|Glycopyrrolate|glycopyrrolate|mesh-list
65517298|NCT03740373|Formoterol Fumarate|formoterol fumarate|mesh-list
65517299|NCT03740373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65517300|NCT03740373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65517301|NCT03740373|Autonomic Agents|autonomic agents|mesh-ancestor
65517302|NCT03740373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517303|NCT03740373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517304|NCT03740373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65517305|NCT03740373|Respiratory System Agents|respiratory system agents|mesh-ancestor
65517306|NCT03740373|Glucocorticoids|glucocorticoids|mesh-ancestor
65517307|NCT03740373|Hormones|hormones|mesh-ancestor
65517308|NCT03740373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65517309|NCT03740373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65517310|NCT03740373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65517311|NCT03740373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65517312|NCT03740373|Adrenergic Agents|adrenergic agents|mesh-ancestor
65517313|NCT03740373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65517314|NCT03740373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517315|NCT03740373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65517316|NCT03740373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65517317|NCT03740373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65517318|NCT03740373|Cholinergic Agents|cholinergic agents|mesh-ancestor
65517319|NCT01228305|Acetaminophen|acetaminophen|mesh-list
65517320|NCT01228305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65517321|NCT01228305|Analgesics|analgesics|mesh-ancestor
65517322|NCT01228305|Sensory System Agents|sensory system agents|mesh-ancestor
65517323|NCT01228305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517324|NCT01228305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517325|NCT01228305|Antipyretics|antipyretics|mesh-ancestor
65517326|NCT02902120|Grazoprevir|grazoprevir|mesh-list
65517327|NCT02902120|Antiviral Agents|antiviral agents|mesh-ancestor
65517328|NCT02902120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65517329|NCT03646396|Sofosbuvir|sofosbuvir|mesh-list
65517330|NCT03646396|Antiviral Agents|antiviral agents|mesh-ancestor
65517331|NCT03646396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65517332|NCT01131273|Buprenorphine|buprenorphine|mesh-list
65517333|NCT01131273|Methadone|methadone|mesh-list
65517334|NCT01131273|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65517335|NCT01131273|Naloxone|naloxone|mesh-list
65517336|NCT01131273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65517337|NCT01131273|Narcotics|narcotics|mesh-ancestor
65517338|NCT01131273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65517339|NCT01131273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517340|NCT01131273|Analgesics|analgesics|mesh-ancestor
65517341|NCT01131273|Sensory System Agents|sensory system agents|mesh-ancestor
65517342|NCT01131273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517343|NCT01131273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65517344|NCT01131273|Antitussive Agents|antitussive agents|mesh-ancestor
65517345|NCT01131273|Respiratory System Agents|respiratory system agents|mesh-ancestor
65517346|NCT03646318|Ketanserin|ketanserin|mesh-list
65517347|NCT03646318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65517348|NCT03646318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65517349|NCT03646318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65517350|NCT03646318|Serotonin Agents|serotonin agents|mesh-ancestor
65517351|NCT03646318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65314984|NCT01026961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65517352|NCT03646318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517353|NCT03646318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517354|NCT01130181|Cholecalciferol|cholecalciferol|mesh-list
65517355|NCT01130181|Vitamin D|vitamin d|mesh-list
65517356|NCT01130181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65517357|NCT01130181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517358|NCT01130181|Vitamins|vitamins|mesh-ancestor
65517359|NCT01130181|Micronutrients|micronutrients|mesh-ancestor
65517360|NCT01130181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65517361|NCT03621514|Lidocaine|lidocaine|mesh-list
65517362|NCT03621514|Anesthetics, Local|anesthetics, local|mesh-ancestor
65517363|NCT03621514|Anesthetics|anesthetics|mesh-ancestor
65517364|NCT03621514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65517365|NCT03621514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517366|NCT03621514|Sensory System Agents|sensory system agents|mesh-ancestor
65517367|NCT03621514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517368|NCT03621514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65517369|NCT03621514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65517370|NCT03621514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65517371|NCT03621514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65517372|NCT03621514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517373|NCT01127841|Rituximab|rituximab|mesh-list
65517374|NCT01127841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65517375|NCT01127841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65517376|NCT01127841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517377|NCT01127841|Immunologic Factors|immunologic factors|mesh-ancestor
65517378|NCT01127841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517379|NCT01127841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65517380|NCT01127841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65517381|NCT01127841|Alkylating Agents|alkylating agents|mesh-ancestor
65517382|NCT01127841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517383|NCT01227603|Candesartan|candesartan|mesh-list
65517384|NCT01227603|Candesartan cilexetil|candesartan cilexetil|mesh-list
65517385|NCT01227603|Nifedipine|nifedipine|mesh-list
65517386|NCT01227603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65517387|NCT01227603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65517388|NCT01227603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65517389|NCT01227603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517390|NCT01227603|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65517391|NCT01227603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65517392|NCT01227603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65517393|NCT01227603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517394|NCT01227603|Vasodilator Agents|vasodilator agents|mesh-ancestor
65517395|NCT01227603|Tocolytic Agents|tocolytic agents|mesh-ancestor
65517396|NCT01227603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65517397|NCT01130259|Iniparib|iniparib|mesh-list
65517398|NCT01130259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65517399|NCT01130259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65517400|NCT01130259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517401|NCT01130259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517402|NCT01585623|Metoprolol|metoprolol|mesh-list
65517403|NCT01585623|Midazolam|midazolam|mesh-list
65517404|NCT01585623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65517405|NCT01585623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65517406|NCT01585623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65517407|NCT01585623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517408|NCT01585623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65517409|NCT01585623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65517410|NCT01585623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65517411|NCT01585623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65517412|NCT01585623|Anesthetics, General|anesthetics, general|mesh-ancestor
65517413|NCT01585623|Anesthetics|anesthetics|mesh-ancestor
65517414|NCT01585623|GABA Modulators|gaba modulators|mesh-ancestor
65517415|NCT01585623|GABA Agents|gaba agents|mesh-ancestor
65517416|NCT01585623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65517417|NCT01585623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517418|NCT01585623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65517419|NCT01585623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65517420|NCT01585623|Sympatholytics|sympatholytics|mesh-ancestor
65517421|NCT01585623|Autonomic Agents|autonomic agents|mesh-ancestor
65517422|NCT01585623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517423|NCT01585623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65517424|NCT01585623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65517425|NCT01585623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65517426|NCT01585623|Adrenergic Agents|adrenergic agents|mesh-ancestor
65517427|NCT03926559|Morphine|morphine|mesh-list
65517428|NCT03926559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65517429|NCT03926559|Narcotics|narcotics|mesh-ancestor
65517430|NCT03926559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65517431|NCT03926559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517432|NCT03926559|Analgesics|analgesics|mesh-ancestor
65517433|NCT03926559|Sensory System Agents|sensory system agents|mesh-ancestor
65517434|NCT03926559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517435|NCT01228617|Nicotine|nicotine|mesh-list
65517436|NCT01228617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65517437|NCT01228617|Autonomic Agents|autonomic agents|mesh-ancestor
65517438|NCT01228617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517439|NCT01228617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517440|NCT01228617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65517441|NCT01228617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65517442|NCT01228617|Cholinergic Agents|cholinergic agents|mesh-ancestor
65517443|NCT01228617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65517444|NCT01228617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517445|NCT01227759|Tyrothricin|tyrothricin|mesh-list
65517446|NCT01227759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65517447|NCT01227759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65517448|NCT01227759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65517449|NCT03923829|Zinc|zinc|mesh-list
65517450|NCT03923829|Zinc Sulfate|zinc sulfate|mesh-list
65517451|NCT03923829|Trace Elements|trace elements|mesh-ancestor
65517452|NCT03923829|Micronutrients|micronutrients|mesh-ancestor
65517453|NCT03923829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517454|NCT03923829|Astringents|astringents|mesh-ancestor
65517455|NCT03923829|Dermatologic Agents|dermatologic agents|mesh-ancestor
65517456|NCT01128075|Interferon beta-1a|interferon beta-1a|mesh-list
65517457|NCT01128075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65517458|NCT01128075|Immunologic Factors|immunologic factors|mesh-ancestor
65517459|NCT01128075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517460|NCT01128075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517461|NCT01128075|Antiviral Agents|antiviral agents|mesh-ancestor
65517462|NCT01128075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65517463|NCT03923751|Anesthetics|anesthetics|mesh-list
65517464|NCT03923751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65517465|NCT03923751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517466|NCT03923361|Propofol|propofol|mesh-list
65517467|NCT03923361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65517468|NCT03923361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65517469|NCT03923361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517470|NCT03923361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65517471|NCT03923361|Anesthetics, General|anesthetics, general|mesh-ancestor
65517472|NCT03923361|Anesthetics|anesthetics|mesh-ancestor
65517473|NCT03740295|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65517474|NCT03740295|Antioxidants|antioxidants|mesh-ancestor
65517475|NCT03740295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517476|NCT03740295|Protective Agents|protective agents|mesh-ancestor
65517477|NCT03740295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517478|NCT03740295|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65517479|NCT03740295|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65517480|NCT03740295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517481|NCT03740295|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65517482|NCT02965378|Docetaxel|docetaxel|mesh-list
65517483|NCT02965378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517484|NCT02965378|Tubulin Modulators|tubulin modulators|mesh-ancestor
65517485|NCT02965378|Antimitotic Agents|antimitotic agents|mesh-ancestor
65517486|NCT02965378|Mitosis Modulators|mitosis modulators|mesh-ancestor
65517487|NCT02965378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517488|NCT01224093|Rituximab|rituximab|mesh-list
65517489|NCT01224093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65517490|NCT01224093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517491|NCT01224093|Immunologic Factors|immunologic factors|mesh-ancestor
65517492|NCT01224093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517493|NCT01224093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65517494|NCT03772041|Tolvaptan|tolvaptan|mesh-list
65517495|NCT03772041|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65517496|NCT03772041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517497|NCT03772041|Natriuretic Agents|natriuretic agents|mesh-ancestor
65246534|NCT04400383|Antibodies|antibodies|mesh-list
65517498|NCT03772041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517499|NCT03922815|Fentanyl|fentanyl|mesh-list
65517500|NCT03922815|Propofol|propofol|mesh-list
65517501|NCT03922815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65517502|NCT03922815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65517503|NCT03922815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517504|NCT03922815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65517505|NCT03922815|Anesthetics, General|anesthetics, general|mesh-ancestor
65517506|NCT03922815|Anesthetics|anesthetics|mesh-ancestor
65517507|NCT03922815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65517508|NCT03922815|Narcotics|narcotics|mesh-ancestor
65517509|NCT03922815|Analgesics|analgesics|mesh-ancestor
65517510|NCT03922815|Sensory System Agents|sensory system agents|mesh-ancestor
65517511|NCT03922815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517512|NCT03922815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65517513|NCT01227915|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
65517514|NCT01227915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65517515|NCT01227915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65517516|NCT01227915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65517517|NCT01227915|Glucocorticoids|glucocorticoids|mesh-ancestor
65517518|NCT01227915|Hormones|hormones|mesh-ancestor
65517519|NCT01227915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65517520|NCT01227915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517521|NCT01227915|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65517522|NCT01227915|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65517523|NCT01224405|Docetaxel|docetaxel|mesh-list
65517524|NCT01224405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517525|NCT01224405|Tubulin Modulators|tubulin modulators|mesh-ancestor
65517526|NCT01224405|Antimitotic Agents|antimitotic agents|mesh-ancestor
65517527|NCT01224405|Mitosis Modulators|mitosis modulators|mesh-ancestor
65517528|NCT01224405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517529|NCT02899156|Flumazenil|flumazenil|mesh-list
65517530|NCT02899156|Antidotes|antidotes|mesh-ancestor
65517531|NCT02899156|Protective Agents|protective agents|mesh-ancestor
65517532|NCT02899156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517533|NCT02899156|GABA Modulators|gaba modulators|mesh-ancestor
65517534|NCT02899156|GABA Agents|gaba agents|mesh-ancestor
65517535|NCT02899156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65517536|NCT02899156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517537|NCT01131429|Cisplatin|cisplatin|mesh-list
65517538|NCT01131429|Docetaxel|docetaxel|mesh-list
65517539|NCT01131429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65517540|NCT01131429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517541|NCT01131429|Tubulin Modulators|tubulin modulators|mesh-ancestor
65517542|NCT01131429|Antimitotic Agents|antimitotic agents|mesh-ancestor
65517543|NCT01131429|Mitosis Modulators|mitosis modulators|mesh-ancestor
65517544|NCT01131429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517545|NCT01131429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65517546|NCT01131429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65517547|NCT03645304|Ropivacaine|ropivacaine|mesh-list
65517548|NCT03645304|Anesthetics, Local|anesthetics, local|mesh-ancestor
65517549|NCT03645304|Anesthetics|anesthetics|mesh-ancestor
65517550|NCT03645304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65517551|NCT03645304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517552|NCT03645304|Sensory System Agents|sensory system agents|mesh-ancestor
65517553|NCT03645304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517554|NCT03773133|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
65517555|NCT03773133|Chelating Agents|chelating agents|mesh-ancestor
65517556|NCT03773133|Sequestering Agents|sequestering agents|mesh-ancestor
65517557|NCT03773133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517558|NCT02969356|Botulinum Toxins|botulinum toxins|mesh-list
65517559|NCT02969356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65517560|NCT02969356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65517561|NCT02969356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65517562|NCT02969356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65517563|NCT02969356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517564|NCT02969356|Cholinergic Agents|cholinergic agents|mesh-ancestor
65517565|NCT02969356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65517566|NCT02969356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517567|NCT02969356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65517568|NCT02969356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517569|NCT03646006|Bupivacaine|bupivacaine|mesh-list
65517570|NCT03646006|Anesthetics, Local|anesthetics, local|mesh-ancestor
65517571|NCT03646006|Anesthetics|anesthetics|mesh-ancestor
65517572|NCT03646006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65517573|NCT03646006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517574|NCT03646006|Sensory System Agents|sensory system agents|mesh-ancestor
65517575|NCT03646006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517576|NCT03854344|Lidocaine|lidocaine|mesh-list
65517577|NCT03854344|Bupivacaine|bupivacaine|mesh-list
65517578|NCT03854344|Anesthetics, Local|anesthetics, local|mesh-ancestor
65517579|NCT03854344|Anesthetics|anesthetics|mesh-ancestor
65517580|NCT03854344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65517581|NCT03854344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517582|NCT03854344|Sensory System Agents|sensory system agents|mesh-ancestor
65517583|NCT03854344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517584|NCT03854344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65517585|NCT03854344|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65517586|NCT03854344|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65517587|NCT03854344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65517588|NCT03854344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517589|NCT03912220|Niacinamide|niacinamide|mesh-list
65517590|NCT03912220|Niacin|niacin|mesh-list
65517591|NCT03912220|Nicotinic Acids|nicotinic acids|mesh-list
65517592|NCT03912220|Vitamin B Complex|vitamin b complex|mesh-ancestor
65517593|NCT03912220|Vitamins|vitamins|mesh-ancestor
65517594|NCT03912220|Micronutrients|micronutrients|mesh-ancestor
65517595|NCT03912220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517596|NCT03912220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65517597|NCT03912220|Antimetabolites|antimetabolites|mesh-ancestor
65517598|NCT03912220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517599|NCT03912220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65517600|NCT03912220|Vasodilator Agents|vasodilator agents|mesh-ancestor
65517601|NCT05284318|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65517602|NCT05284318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65517603|NCT03609424|Imatinib Mesylate|imatinib mesylate|mesh-list
65517604|NCT03609424|Spartalizumab|spartalizumab|mesh-list
65517605|NCT03609424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517606|NCT03609424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65517607|NCT03609424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65517608|NCT03609424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517609|NCT03609424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65517610|NCT03645850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65517611|NCT03645850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65517612|NCT03644446|Bisoprolol|bisoprolol|mesh-list
65517613|NCT03644446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65517614|NCT03644446|Sympatholytics|sympatholytics|mesh-ancestor
65517615|NCT03644446|Autonomic Agents|autonomic agents|mesh-ancestor
65517616|NCT03644446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517617|NCT03644446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517618|NCT03644446|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65517619|NCT03644446|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65517620|NCT03644446|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65517621|NCT03644446|Adrenergic Agents|adrenergic agents|mesh-ancestor
65517622|NCT03644446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65517623|NCT03644446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517624|NCT02898454|Mometasone Furoate|mometasone furoate|mesh-list
65517625|NCT02898454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65517626|NCT02898454|Dermatologic Agents|dermatologic agents|mesh-ancestor
65517627|NCT02898454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65517628|NCT05283850|Calcium, Dietary|calcium, dietary|mesh-list
65517629|NCT05283850|Calcium|calcium|mesh-list
65517630|NCT05283850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65517631|NCT05283850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517632|NCT05283850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65517633|NCT03925779|Dexmedetomidine|dexmedetomidine|mesh-list
65517634|NCT03925779|Remifentanil|remifentanil|mesh-list
65517635|NCT03925779|Propofol|propofol|mesh-list
65517636|NCT03925779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65517637|NCT03925779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65517638|NCT03925779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517639|NCT03925779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65517640|NCT03925779|Anesthetics, General|anesthetics, general|mesh-ancestor
65517641|NCT03925779|Anesthetics|anesthetics|mesh-ancestor
65517642|NCT03925779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65517643|NCT03925779|Analgesics|analgesics|mesh-ancestor
65517644|NCT03925779|Sensory System Agents|sensory system agents|mesh-ancestor
65517645|NCT03925779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246676|NCT00634933|Prednisolone|prednisolone|mesh-list
65517646|NCT03925779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65517647|NCT03925779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65517648|NCT03925779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65517649|NCT03925779|Adrenergic Agents|adrenergic agents|mesh-ancestor
65517650|NCT03925779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65517651|NCT03925779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517652|NCT03925779|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65517653|NCT03925779|Narcotics|narcotics|mesh-ancestor
65517654|NCT05283694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65517655|NCT05283694|Immunologic Factors|immunologic factors|mesh-ancestor
65517656|NCT05283694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517657|NCT03925701|Metformin|metformin|mesh-list
65517658|NCT03925701|Vildagliptin|vildagliptin|mesh-list
65517659|NCT03925701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65517660|NCT03925701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517661|NCT03925701|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65517662|NCT03925701|Protease Inhibitors|protease inhibitors|mesh-ancestor
65517663|NCT03925701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65517664|NCT03925701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517665|NCT01224717|Teriparatide|teriparatide|mesh-list
65517666|NCT01224717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65517667|NCT01224717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517668|NCT01224717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65517669|NCT03925233|Tamoxifen|tamoxifen|mesh-list
65517670|NCT03925233|Toremifene|toremifene|mesh-list
65517671|NCT03925233|Gemcitabine|gemcitabine|mesh-list
65517672|NCT03925233|Vinorelbine|vinorelbine|mesh-list
65517673|NCT03925233|Cyclophosphamide|cyclophosphamide|mesh-list
65517674|NCT03925233|Bevacizumab|bevacizumab|mesh-list
65517675|NCT03925233|Carboplatin|carboplatin|mesh-list
65517676|NCT03925233|Doxorubicin|doxorubicin|mesh-list
65517677|NCT03925233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65517678|NCT03925233|Fluorouracil|fluorouracil|mesh-list
65517679|NCT03925233|Capecitabine|capecitabine|mesh-list
65517680|NCT03925233|Methotrexate|methotrexate|mesh-list
65517681|NCT03925233|Trastuzumab|trastuzumab|mesh-list
65517682|NCT03925233|Letrozole|letrozole|mesh-list
65517683|NCT03925233|Apatinib|apatinib|mesh-list
65517684|NCT03925233|Epirubicin|epirubicin|mesh-list
65517685|NCT03925233|Olaparib|olaparib|mesh-list
65517686|NCT03925233|Fulvestrant|fulvestrant|mesh-list
65517687|NCT03925233|Anastrozole|anastrozole|mesh-list
65517688|NCT03925233|Exemestane|exemestane|mesh-list
65517689|NCT03925233|Endostatins|endostatins|mesh-list
65517690|NCT03925233|Pirarubicin|pirarubicin|mesh-list
65517691|NCT03925233|Citric Acid|citric acid|mesh-list
65517692|NCT03925233|Sodium Citrate|sodium citrate|mesh-list
65517693|NCT03925233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65517694|NCT03925233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517695|NCT03925233|Tubulin Modulators|tubulin modulators|mesh-ancestor
65517696|NCT03925233|Antimitotic Agents|antimitotic agents|mesh-ancestor
65517697|NCT03925233|Mitosis Modulators|mitosis modulators|mesh-ancestor
65517698|NCT03925233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517699|NCT03925233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65517700|NCT03925233|Immunologic Factors|immunologic factors|mesh-ancestor
65517701|NCT03925233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517702|NCT03925233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65517703|NCT03925233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65517704|NCT03925233|Alkylating Agents|alkylating agents|mesh-ancestor
65517705|NCT03925233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65517706|NCT03925233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65517707|NCT03925233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65517708|NCT03925233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65517709|NCT03925233|Growth Substances|growth substances|mesh-ancestor
65517710|NCT03925233|Growth Inhibitors|growth inhibitors|mesh-ancestor
65517711|NCT03925233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65517712|NCT03925233|Antimetabolites|antimetabolites|mesh-ancestor
65517713|NCT03925233|Antiviral Agents|antiviral agents|mesh-ancestor
65517714|NCT03925233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65517715|NCT03925233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65517716|NCT03925233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65517717|NCT03925233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65517718|NCT03925233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65517719|NCT03925233|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65517720|NCT03925233|Abortifacient Agents|abortifacient agents|mesh-ancestor
65517721|NCT03925233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65517722|NCT03925233|Dermatologic Agents|dermatologic agents|mesh-ancestor
65517723|NCT03925233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65517724|NCT03925233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65517725|NCT03925233|Anticoagulants|anticoagulants|mesh-ancestor
65517726|NCT03925233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65517727|NCT03925233|Chelating Agents|chelating agents|mesh-ancestor
65517728|NCT03925233|Sequestering Agents|sequestering agents|mesh-ancestor
65517729|NCT03925233|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65517730|NCT03925233|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65517731|NCT03925233|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65517732|NCT03925233|Hormone Antagonists|hormone antagonists|mesh-ancestor
65517733|NCT03925233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65517734|NCT03925233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65517735|NCT03925233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65517736|NCT03925233|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65517737|NCT03925233|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65517738|NCT03925233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65517739|NCT03925233|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65517740|NCT03925233|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65517741|NCT01130805|Capecitabine|capecitabine|mesh-list
65517742|NCT01130805|Oxaliplatin|oxaliplatin|mesh-list
65517743|NCT01130805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65517744|NCT01130805|Antimetabolites|antimetabolites|mesh-ancestor
65517745|NCT01130805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517746|NCT01130805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517747|NCT01345162|Ketorolac|ketorolac|mesh-list
65517748|NCT01345162|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65517749|NCT01345162|Tramadol|tramadol|mesh-list
65517750|NCT01345162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65517751|NCT01345162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65517752|NCT01345162|Analgesics|analgesics|mesh-ancestor
65517753|NCT01345162|Sensory System Agents|sensory system agents|mesh-ancestor
65517754|NCT01345162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517755|NCT01345162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517756|NCT01345162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65517757|NCT01345162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65517758|NCT01345162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65517759|NCT01345162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65517760|NCT01345162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517761|NCT01345162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65517762|NCT01345162|Narcotics|narcotics|mesh-ancestor
65517763|NCT01345162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65517764|NCT01131039|Gemcitabine|gemcitabine|mesh-list
65517765|NCT01131039|Bevacizumab|bevacizumab|mesh-list
65517766|NCT01131039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65517767|NCT01131039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517768|NCT01131039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65517769|NCT01131039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65517770|NCT01131039|Growth Substances|growth substances|mesh-ancestor
65517771|NCT01131039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517772|NCT01131039|Growth Inhibitors|growth inhibitors|mesh-ancestor
65517773|NCT01131039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65517774|NCT01131039|Antimetabolites|antimetabolites|mesh-ancestor
65517775|NCT01131039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517776|NCT01131039|Antiviral Agents|antiviral agents|mesh-ancestor
65517777|NCT01131039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65517778|NCT01131039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65517779|NCT01131039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65517780|NCT01131039|Immunologic Factors|immunologic factors|mesh-ancestor
65517781|NCT01229085|Salicylic Acid|salicylic acid|mesh-list
65517782|NCT01229085|Salicylates|salicylates|mesh-list
65517783|NCT01229085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65517784|NCT01229085|Antifungal Agents|antifungal agents|mesh-ancestor
65517785|NCT01229085|Keratolytic Agents|keratolytic agents|mesh-ancestor
65517786|NCT01229085|Dermatologic Agents|dermatologic agents|mesh-ancestor
65517787|NCT01229085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65517788|NCT01229085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65517789|NCT01229085|Analgesics|analgesics|mesh-ancestor
65517790|NCT01229085|Sensory System Agents|sensory system agents|mesh-ancestor
65517791|NCT01229085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517792|NCT01229085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517793|NCT01229085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65517794|NCT01229085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65517795|NCT01229085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65517796|NCT01229085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65517797|NCT01229085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517798|NCT03921645|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65517799|NCT03921645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65517800|NCT03643666|Dexamethasone|dexamethasone|mesh-list
65517801|NCT03643666|Magnesium Sulfate|magnesium sulfate|mesh-list
65517802|NCT03643666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65517803|NCT03643666|Antiemetics|antiemetics|mesh-ancestor
65517804|NCT03643666|Autonomic Agents|autonomic agents|mesh-ancestor
65517805|NCT03643666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517806|NCT03643666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517807|NCT03643666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65517808|NCT03643666|Glucocorticoids|glucocorticoids|mesh-ancestor
65517810|NCT03643666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65517811|NCT03643666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65517812|NCT03643666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517813|NCT03643666|Analgesics|analgesics|mesh-ancestor
65517814|NCT03643666|Sensory System Agents|sensory system agents|mesh-ancestor
65517815|NCT03643666|Anesthetics|anesthetics|mesh-ancestor
65517816|NCT03643666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65517817|NCT03643666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65517818|NCT03643666|Anticonvulsants|anticonvulsants|mesh-ancestor
65517819|NCT03643666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65517820|NCT03643666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65517821|NCT03643666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517822|NCT03643666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65517823|NCT03643666|Tocolytic Agents|tocolytic agents|mesh-ancestor
65517824|NCT03643666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65517825|NCT03643588|Hyaluronic Acid|hyaluronic acid|mesh-list
65517826|NCT03643588|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65517827|NCT03643588|Immunologic Factors|immunologic factors|mesh-ancestor
65517828|NCT03643588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517829|NCT03643588|Viscosupplements|viscosupplements|mesh-ancestor
65517830|NCT03643588|Protective Agents|protective agents|mesh-ancestor
65517831|NCT01224951|Beclomethasone|beclomethasone|mesh-list
65517832|NCT01224951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65517833|NCT01224951|Glucocorticoids|glucocorticoids|mesh-ancestor
65517834|NCT01224951|Hormones|hormones|mesh-ancestor
65517835|NCT01224951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65517836|NCT01224951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517837|NCT01224951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65517838|NCT01224951|Respiratory System Agents|respiratory system agents|mesh-ancestor
65517839|NCT03641404|Ergothioneine|ergothioneine|mesh-list
65517840|NCT03641404|Antioxidants|antioxidants|mesh-ancestor
65517841|NCT03641404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517842|NCT03641404|Protective Agents|protective agents|mesh-ancestor
65517843|NCT03641404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517844|NCT01131741|Epinephrine|epinephrine|mesh-list
65517845|NCT01131741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65517846|NCT01131741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65517847|NCT01131741|Adrenergic Agents|adrenergic agents|mesh-ancestor
65517848|NCT01131741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65517849|NCT01131741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517850|NCT01131741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517851|NCT01131741|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65517852|NCT01131741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65517853|NCT01131741|Autonomic Agents|autonomic agents|mesh-ancestor
65517854|NCT01131741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517855|NCT01131741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65517856|NCT01131741|Respiratory System Agents|respiratory system agents|mesh-ancestor
65517857|NCT01131741|Mydriatics|mydriatics|mesh-ancestor
65517858|NCT01131741|Sympathomimetics|sympathomimetics|mesh-ancestor
65517859|NCT01131741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65517860|NCT03919851|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65517861|NCT03919851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65517862|NCT03921567|Lidocaine|lidocaine|mesh-list
65517863|NCT03921567|Ketamine|ketamine|mesh-list
65517864|NCT03921567|Anesthetics, Local|anesthetics, local|mesh-ancestor
65517865|NCT03921567|Anesthetics|anesthetics|mesh-ancestor
65517866|NCT03921567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65517867|NCT03921567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517868|NCT03921567|Sensory System Agents|sensory system agents|mesh-ancestor
65517869|NCT03921567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517870|NCT03921567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65517871|NCT03921567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65517872|NCT03921567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65517873|NCT03921567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65517874|NCT03921567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517875|NCT03921567|Analgesics|analgesics|mesh-ancestor
65517876|NCT03921567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65517877|NCT03921567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65517878|NCT03921567|Anesthetics, General|anesthetics, general|mesh-ancestor
65315525|NCT00810862|Pimecrolimus|pimecrolimus|mesh-list
65517879|NCT03921567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65517881|NCT03921567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65517882|NCT01229241|Anesthetics|anesthetics|mesh-list
65517883|NCT01229241|Anesthetics, Local|anesthetics, local|mesh-list
65517884|NCT01229241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65517885|NCT01229241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517886|NCT01229241|Sensory System Agents|sensory system agents|mesh-ancestor
65517887|NCT01229241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517888|NCT05252884|Calcium, Dietary|calcium, dietary|mesh-list
65517889|NCT05252884|Calcitriol|calcitriol|mesh-list
65517890|NCT05252884|Calcium Carbonate|calcium carbonate|mesh-list
65517891|NCT05252884|Calcium|calcium|mesh-list
65517892|NCT05252884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65517893|NCT05252884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517894|NCT05252884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65517895|NCT05252884|Antacids|antacids|mesh-ancestor
65517896|NCT05252884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517897|NCT05252884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65517898|NCT05252884|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65517899|NCT05252884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65517900|NCT05252884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65517901|NCT05252884|Vitamins|vitamins|mesh-ancestor
65517902|NCT05252884|Micronutrients|micronutrients|mesh-ancestor
65517903|NCT03921177|Micronutrients|micronutrients|mesh-list
65517904|NCT03921177|Trace Elements|trace elements|mesh-list
65517905|NCT03921177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517906|NCT01229319|Imiquimod|imiquimod|mesh-list
65517907|NCT01229319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65517908|NCT01229319|Immunologic Factors|immunologic factors|mesh-ancestor
65517909|NCT01229319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517910|NCT01229319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517911|NCT01229319|Interferon Inducers|interferon inducers|mesh-ancestor
65517912|NCT03921099|Ascorbic Acid|ascorbic acid|mesh-list
65517913|NCT03921099|Vitamins|vitamins|mesh-ancestor
65517914|NCT03921099|Micronutrients|micronutrients|mesh-ancestor
65517915|NCT03921099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517916|NCT03921099|Antioxidants|antioxidants|mesh-ancestor
65517917|NCT03921099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517918|NCT03921099|Protective Agents|protective agents|mesh-ancestor
65517919|NCT02962648|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65517920|NCT02962648|Hematinics|hematinics|mesh-ancestor
65517921|NCT03920631|Nivolumab|nivolumab|mesh-list
65517922|NCT03920631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65517923|NCT03920631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517924|NCT03920631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65517925|NCT03920631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517926|NCT03930069|Vasopressins|vasopressins|mesh-list
65517927|NCT03930069|Arginine Vasopressin|arginine vasopressin|mesh-list
65517928|NCT03930069|Misoprostol|misoprostol|mesh-list
65517929|NCT03930069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65517930|NCT03930069|Abortifacient Agents|abortifacient agents|mesh-ancestor
65517931|NCT03930069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65517932|NCT03930069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517933|NCT03930069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65517934|NCT03930069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65517935|NCT03930069|Oxytocics|oxytocics|mesh-ancestor
65517936|NCT03930069|Hemostatics|hemostatics|mesh-ancestor
65517937|NCT03930069|Coagulants|coagulants|mesh-ancestor
65517938|NCT03930069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65517939|NCT03930069|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65517940|NCT03930069|Natriuretic Agents|natriuretic agents|mesh-ancestor
65517941|NCT01132443|Clindamycin|clindamycin|mesh-list
65517942|NCT01132443|Clindamycin palmitate|clindamycin palmitate|mesh-list
65517943|NCT01132443|Clindamycin phosphate|clindamycin phosphate|mesh-list
65517944|NCT01132443|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65517945|NCT01132443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65517946|NCT01132443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65517947|NCT01132443|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65517948|NCT01132443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65517949|NCT01132443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246974|NCT02847338|Amlodipine|amlodipine|mesh-list
65517950|NCT01132443|Dermatologic Agents|dermatologic agents|mesh-ancestor
65517951|NCT01132521|Urinastatin|urinastatin|mesh-list
65517952|NCT01132521|Trypsin Inhibitors|trypsin inhibitors|mesh-list
65517953|NCT01132521|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65517954|NCT01132521|Protease Inhibitors|protease inhibitors|mesh-ancestor
65517955|NCT01132521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65517956|NCT01132521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517957|NCT01132599|Choline|choline|mesh-list
65517958|NCT01132599|Lipotropic Agents|lipotropic agents|mesh-ancestor
65517959|NCT01132599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65517960|NCT01132599|Antimetabolites|antimetabolites|mesh-ancestor
65517961|NCT01132599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65517962|NCT01132599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65517963|NCT01132599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65517964|NCT01132599|Nootropic Agents|nootropic agents|mesh-ancestor
65517965|NCT03929835|Chlorophyllin|chlorophyllin|mesh-list
65517966|NCT03929835|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65517967|NCT03929835|Protective Agents|protective agents|mesh-ancestor
65517968|NCT03929835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517969|NCT01132677|Methylprednisolone|methylprednisolone|mesh-list
65517970|NCT01132677|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65517971|NCT01132677|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65517972|NCT01132677|Prednisolone|prednisolone|mesh-list
65517973|NCT01132677|Prednisolone acetate|prednisolone acetate|mesh-list
65517974|NCT01132677|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65517975|NCT01132677|Prednisolone phosphate|prednisolone phosphate|mesh-list
65517976|NCT01132677|Hylan|hylan|mesh-list
65517977|NCT01132677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65517978|NCT01132677|Antiemetics|antiemetics|mesh-ancestor
65517979|NCT01132677|Autonomic Agents|autonomic agents|mesh-ancestor
65517980|NCT01132677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517981|NCT01132677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517982|NCT01132677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65517983|NCT01132677|Glucocorticoids|glucocorticoids|mesh-ancestor
65517984|NCT01132677|Hormones|hormones|mesh-ancestor
65517985|NCT01132677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65517986|NCT01132677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65517987|NCT01132677|Protective Agents|protective agents|mesh-ancestor
65517988|NCT01132677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65517989|NCT01132677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65517990|NCT01132677|Viscosupplements|viscosupplements|mesh-ancestor
65517991|NCT02961790|Mandelic Acids|mandelic acids|mesh-list
65517992|NCT02961790|Oxybutynin|oxybutynin|mesh-list
65517993|NCT02961790|Parasympatholytics|parasympatholytics|mesh-ancestor
65517994|NCT02961790|Autonomic Agents|autonomic agents|mesh-ancestor
65517995|NCT02961790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65517996|NCT02961790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65517997|NCT02961790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65517998|NCT02961790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65517999|NCT02961790|Cholinergic Agents|cholinergic agents|mesh-ancestor
65518000|NCT02961790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65518001|NCT02961790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518002|NCT02961790|Urological Agents|urological agents|mesh-ancestor
65518003|NCT02961790|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65518004|NCT02961790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518005|NCT02961790|Renal Agents|renal agents|mesh-ancestor
65518006|NCT01225341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65518007|NCT01225341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65518008|NCT01225341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65518009|NCT01225341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518010|NCT01225341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518011|NCT01225341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65518012|NCT01225341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65518013|NCT01225341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518014|NCT01225341|Cholinergic Agents|cholinergic agents|mesh-ancestor
65518015|NCT01225341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65518016|NCT03920553|Hyaluronic Acid|hyaluronic acid|mesh-list
65518017|NCT03920553|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65518018|NCT03920553|Immunologic Factors|immunologic factors|mesh-ancestor
65518019|NCT03920553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518020|NCT03920553|Viscosupplements|viscosupplements|mesh-ancestor
65518021|NCT03920553|Protective Agents|protective agents|mesh-ancestor
65518022|NCT03643900|Indomethacin|indomethacin|mesh-list
65518023|NCT03643900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65518024|NCT03643900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65518025|NCT03643900|Analgesics|analgesics|mesh-ancestor
65518026|NCT03643900|Sensory System Agents|sensory system agents|mesh-ancestor
65518027|NCT03643900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518028|NCT03643900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518029|NCT03643900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65518030|NCT03643900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65518031|NCT03643900|Gout Suppressants|gout suppressants|mesh-ancestor
65518032|NCT03643900|Tocolytic Agents|tocolytic agents|mesh-ancestor
65518033|NCT03643900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65518034|NCT03643900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65518035|NCT03643900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518036|NCT03643900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518038|NCT03919383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518039|NCT03919383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65518040|NCT03919383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518041|NCT03919383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518042|NCT01131897|Levetiracetam|levetiracetam|mesh-list
65518043|NCT01131897|Anticonvulsants|anticonvulsants|mesh-ancestor
65518044|NCT01131897|Nootropic Agents|nootropic agents|mesh-ancestor
65518045|NCT01225419|Plerixafor|plerixafor|mesh-list
65518046|NCT01225419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65518047|NCT01225419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65518048|NCT01225419|Antiviral Agents|antiviral agents|mesh-ancestor
65518049|NCT01225419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518050|NCT03919461|Etodolac|etodolac|mesh-list
65518051|NCT03919461|Propranolol|propranolol|mesh-list
65518052|NCT03919461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65518053|NCT03919461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65518054|NCT03919461|Adrenergic Agents|adrenergic agents|mesh-ancestor
65518055|NCT03919461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65518056|NCT03919461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518057|NCT03919461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518058|NCT03919461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65518059|NCT03919461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65518060|NCT03919461|Vasodilator Agents|vasodilator agents|mesh-ancestor
65518061|NCT03919461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65518062|NCT03919461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65518063|NCT03919461|Analgesics|analgesics|mesh-ancestor
65518064|NCT03919461|Sensory System Agents|sensory system agents|mesh-ancestor
65518065|NCT03919461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518066|NCT03919461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65518067|NCT03919461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65518068|NCT03919461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65518069|NCT03919461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65518070|NCT03919461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518071|NCT02528877|Sirolimus|sirolimus|mesh-list
65518072|NCT02528877|Fludarabine|fludarabine|mesh-list
65518073|NCT02528877|Fludarabine phosphate|fludarabine phosphate|mesh-list
65518074|NCT02528877|Melphalan|melphalan|mesh-list
65518075|NCT02528877|Mechlorethamine|mechlorethamine|mesh-list
65518076|NCT02528877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65518077|NCT02528877|Tacrolimus|tacrolimus|mesh-list
65518078|NCT02528877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518079|NCT02528877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65518080|NCT02528877|Antimetabolites|antimetabolites|mesh-ancestor
65518081|NCT02528877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518082|NCT02528877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65518083|NCT02528877|Immunologic Factors|immunologic factors|mesh-ancestor
65518084|NCT02528877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518085|NCT02528877|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65518086|NCT02528877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518087|NCT02528877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65518088|NCT02528877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518089|NCT02528877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65518090|NCT02528877|Antifungal Agents|antifungal agents|mesh-ancestor
65518091|NCT02528877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65518092|NCT02528877|Alkylating Agents|alkylating agents|mesh-ancestor
65518093|NCT02528877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65518094|NCT03918993|Tadalafil|tadalafil|mesh-list
65518095|NCT03918993|Vasodilator Agents|vasodilator agents|mesh-ancestor
65518096|NCT03918993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65518097|NCT03918993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65518098|NCT03918993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518099|NCT03918993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518100|NCT03918993|Urological Agents|urological agents|mesh-ancestor
65518101|NCT03920475|Sertraline|sertraline|mesh-list
65518102|NCT03920475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65518103|NCT03920475|Antidepressive Agents|antidepressive agents|mesh-ancestor
65518104|NCT03920475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65518105|NCT03920475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65315695|NCT00654940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65518106|NCT03920475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65518107|NCT03920475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65518108|NCT03920475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518109|NCT03920475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65518110|NCT03920475|Serotonin Agents|serotonin agents|mesh-ancestor
65518111|NCT03920475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518112|NCT03920475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65518113|NCT03920475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65518115|NCT03920319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65518116|NCT03920319|Antidepressive Agents|antidepressive agents|mesh-ancestor
65518117|NCT03920319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65518118|NCT03920319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65518119|NCT03920319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65518120|NCT03920319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65518121|NCT03920319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518122|NCT03920319|Dopamine Agents|dopamine agents|mesh-ancestor
65518123|NCT03920319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65518124|NCT03920319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518125|NCT03920319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65518126|NCT03920319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65518127|NCT03920319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518128|NCT03920397|Cholecalciferol|cholecalciferol|mesh-list
65518129|NCT03920397|Vitamin D|vitamin d|mesh-list
65518130|NCT03920397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65518131|NCT03920397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518132|NCT03920397|Vitamins|vitamins|mesh-ancestor
65518133|NCT03920397|Micronutrients|micronutrients|mesh-ancestor
65518134|NCT03920397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65518135|NCT01131975|Lamotrigine|lamotrigine|mesh-list
65518136|NCT01131975|Anticonvulsants|anticonvulsants|mesh-ancestor
65518137|NCT01131975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65518138|NCT01131975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65518139|NCT01131975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518140|NCT01131975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65518141|NCT01131975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518142|NCT01131975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65518143|NCT01131975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65518144|NCT01131975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65518145|NCT01131975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65518146|NCT01131975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65518147|NCT01231737|Prulifloxacin|prulifloxacin|mesh-list
65518148|NCT01231737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65518149|NCT01231737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518150|NCT01231737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65518151|NCT01231737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65518152|NCT01231737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518153|NCT01231737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518154|NCT01231737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518155|NCT01128699|Bevacizumab|bevacizumab|mesh-list
65518156|NCT01128699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65518157|NCT01128699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518158|NCT01128699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65518159|NCT01128699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65518160|NCT01128699|Growth Substances|growth substances|mesh-ancestor
65518161|NCT01128699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518162|NCT01128699|Growth Inhibitors|growth inhibitors|mesh-ancestor
65518163|NCT01329627|Paclitaxel|paclitaxel|mesh-list
65518164|NCT01329627|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65518165|NCT01329627|Cyclophosphamide|cyclophosphamide|mesh-list
65518166|NCT01329627|Doxorubicin|doxorubicin|mesh-list
65518167|NCT01329627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65518168|NCT01329627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65518169|NCT01329627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518170|NCT01329627|Tubulin Modulators|tubulin modulators|mesh-ancestor
65518171|NCT01329627|Antimitotic Agents|antimitotic agents|mesh-ancestor
65518172|NCT01329627|Mitosis Modulators|mitosis modulators|mesh-ancestor
65518173|NCT01329627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518174|NCT01329627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65518175|NCT01329627|Immunologic Factors|immunologic factors|mesh-ancestor
65518176|NCT01329627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518177|NCT01329627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65493891|NCT03991403|Paclitaxel|paclitaxel|mesh-list
65518178|NCT01329627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65518179|NCT01329627|Alkylating Agents|alkylating agents|mesh-ancestor
65518180|NCT01329627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65518181|NCT01329627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65518182|NCT01329627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65518183|NCT01329627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65518184|NCT01329627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518185|NCT03929211|Hydroxychloroquine|hydroxychloroquine|mesh-list
65518186|NCT03929211|Antimalarials|antimalarials|mesh-ancestor
65518187|NCT03929211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65518188|NCT03929211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65518189|NCT03929211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518190|NCT03929211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518191|NCT03929211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518192|NCT03929211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65518193|NCT01132911|Bortezomib|bortezomib|mesh-list
65518194|NCT01132911|Vorinostat|vorinostat|mesh-list
65518195|NCT01132911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518196|NCT01132911|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65518197|NCT01132911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518198|NCT01132911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518199|NCT05402319|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65518200|NCT05402319|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65518201|NCT05402319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518202|NCT05402319|Antitubercular Agents|antitubercular agents|mesh-ancestor
65518203|NCT01132989|Lenalidomide|lenalidomide|mesh-list
65518204|NCT01132989|Immunologic Factors|immunologic factors|mesh-ancestor
65518205|NCT01132989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518206|NCT01132989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65518207|NCT01132989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65518208|NCT01132989|Growth Substances|growth substances|mesh-ancestor
65518209|NCT01132989|Growth Inhibitors|growth inhibitors|mesh-ancestor
65518210|NCT01132989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518211|NCT01225653|Latanoprost|latanoprost|mesh-list
65518212|NCT01225653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65518213|NCT01225653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65518214|NCT01134861|Cisplatin|cisplatin|mesh-list
65518215|NCT01134861|Etoposide|etoposide|mesh-list
65518216|NCT01134861|Vinblastine|vinblastine|mesh-list
65518217|NCT01134861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518218|NCT01134861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65518219|NCT01134861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65518220|NCT01134861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65518221|NCT01134861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518222|NCT01134861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518223|NCT01134861|Tubulin Modulators|tubulin modulators|mesh-ancestor
65518224|NCT01134861|Antimitotic Agents|antimitotic agents|mesh-ancestor
65518225|NCT01134861|Mitosis Modulators|mitosis modulators|mesh-ancestor
65518226|NCT01133223|Plasminogen|plasminogen|mesh-list
65518227|NCT01133223|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65518228|NCT01133223|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65518229|NCT01133223|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65518230|NCT01133223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518231|NCT01233219|Morphine|morphine|mesh-list
65518232|NCT01233219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65518233|NCT01233219|Narcotics|narcotics|mesh-ancestor
65518234|NCT01233219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65518235|NCT01233219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518236|NCT01233219|Analgesics|analgesics|mesh-ancestor
65518237|NCT01233219|Sensory System Agents|sensory system agents|mesh-ancestor
65518238|NCT01233219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518239|NCT02960854|Nivolumab|nivolumab|mesh-list
65518240|NCT02960854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65518241|NCT02960854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518242|NCT02960854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65518243|NCT02960854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518244|NCT01133301|Naltrexone|naltrexone|mesh-list
65518245|NCT01133301|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65518246|NCT01133301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65518247|NCT01133301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518248|NCT01133301|Sensory System Agents|sensory system agents|mesh-ancestor
65518249|NCT01133301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518250|NCT03918135|Acetaminophen|acetaminophen|mesh-list
65518251|NCT03918135|Ibuprofen|ibuprofen|mesh-list
65315777|NCT00811330|Atorvastatin|atorvastatin|mesh-list
65518252|NCT03918135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65518253|NCT03918135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65518254|NCT03918135|Analgesics|analgesics|mesh-ancestor
65518255|NCT03918135|Sensory System Agents|sensory system agents|mesh-ancestor
65518256|NCT03918135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518257|NCT03918135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518258|NCT03918135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65518259|NCT03918135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65518260|NCT03918135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65518261|NCT03918135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518262|NCT03918135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518263|NCT03918135|Antipyretics|antipyretics|mesh-ancestor
65518264|NCT05480475|Dabigatran|dabigatran|mesh-list
65518265|NCT05480475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65518266|NCT05480475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65518267|NCT05480475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65518268|NCT05480475|Antimetabolites|antimetabolites|mesh-ancestor
65518269|NCT05480475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518270|NCT05480475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65518271|NCT05480475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65518272|NCT05480475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518273|NCT05480475|Antithrombins|antithrombins|mesh-ancestor
65518274|NCT05480475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65518275|NCT05480475|Protease Inhibitors|protease inhibitors|mesh-ancestor
65518276|NCT05480475|Anticoagulants|anticoagulants|mesh-ancestor
65518277|NCT03642184|Empagliflozin|empagliflozin|mesh-list
65518278|NCT03642184|Linagliptin|linagliptin|mesh-list
65518279|NCT03642184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65518280|NCT03642184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518281|NCT03642184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65518282|NCT03642184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518283|NCT03642184|Incretins|incretins|mesh-ancestor
65518284|NCT03642184|Hormones|hormones|mesh-ancestor
65518285|NCT03642184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65518286|NCT03642184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65518287|NCT03642184|Protease Inhibitors|protease inhibitors|mesh-ancestor
65518288|NCT03642184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518289|NCT01137591|Acetaminophen|acetaminophen|mesh-list
65518290|NCT01137591|Acetylcysteine|acetylcysteine|mesh-list
65518291|NCT01137591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65518292|NCT01137591|Analgesics|analgesics|mesh-ancestor
65518293|NCT01137591|Sensory System Agents|sensory system agents|mesh-ancestor
65518294|NCT01137591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518295|NCT01137591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518296|NCT01137591|Antipyretics|antipyretics|mesh-ancestor
65518297|NCT01137591|Antiviral Agents|antiviral agents|mesh-ancestor
65518298|NCT01137591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518299|NCT01137591|Expectorants|expectorants|mesh-ancestor
65518300|NCT01137591|Respiratory System Agents|respiratory system agents|mesh-ancestor
65518301|NCT01137591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65518302|NCT01137591|Antioxidants|antioxidants|mesh-ancestor
65518303|NCT01137591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518304|NCT01137591|Protective Agents|protective agents|mesh-ancestor
65518305|NCT01133457|Finasteride|finasteride|mesh-list
65518306|NCT01133457|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65518307|NCT01133457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65518308|NCT01133457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518309|NCT01133457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518310|NCT01133457|Hormone Antagonists|hormone antagonists|mesh-ancestor
65518311|NCT01133457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65518312|NCT01133457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518313|NCT01133457|Urological Agents|urological agents|mesh-ancestor
65518314|NCT01135563|Sirolimus|sirolimus|mesh-list
65518315|NCT01135563|Vinblastine|vinblastine|mesh-list
65518316|NCT01135563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65518317|NCT01135563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518318|NCT01135563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65518319|NCT01135563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518320|NCT01135563|Antifungal Agents|antifungal agents|mesh-ancestor
65518321|NCT01135563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65518322|NCT01135563|Immunologic Factors|immunologic factors|mesh-ancestor
65518323|NCT01135563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518324|NCT01135563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65518325|NCT01135563|Tubulin Modulators|tubulin modulators|mesh-ancestor
65518326|NCT01135563|Antimitotic Agents|antimitotic agents|mesh-ancestor
65518327|NCT01135563|Mitosis Modulators|mitosis modulators|mesh-ancestor
65518328|NCT01135563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518329|NCT03641950|Botulinum Toxins|botulinum toxins|mesh-list
65518330|NCT03641950|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65518331|NCT03641950|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65518332|NCT03641950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65518333|NCT03641950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65518334|NCT03641950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518335|NCT03641950|Cholinergic Agents|cholinergic agents|mesh-ancestor
65518336|NCT03641950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65518337|NCT03641950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518338|NCT03641950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65518339|NCT03641950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518340|NCT03764631|Empagliflozin|empagliflozin|mesh-list
65518341|NCT03764631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65518342|NCT03764631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65518343|NCT03764631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518344|NCT03764631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65518345|NCT03764631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518346|NCT03764631|Protease Inhibitors|protease inhibitors|mesh-ancestor
65518347|NCT03764631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518348|NCT01135641|Cyclosporine|cyclosporine|mesh-list
65518349|NCT01135641|Rituximab|rituximab|mesh-list
65518350|NCT01135641|Cyclosporins|cyclosporins|mesh-list
65518351|NCT01135641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65518352|NCT01135641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518353|NCT01135641|Immunologic Factors|immunologic factors|mesh-ancestor
65518354|NCT01135641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518355|NCT01135641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65518356|NCT01135641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518357|NCT01135641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518358|NCT01135641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65518359|NCT01135641|Antifungal Agents|antifungal agents|mesh-ancestor
65518360|NCT01135641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518361|NCT01135641|Dermatologic Agents|dermatologic agents|mesh-ancestor
65518362|NCT01135641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65518363|NCT03640156|Oxytocin|oxytocin|mesh-list
65518364|NCT03640156|Oxytocics|oxytocics|mesh-ancestor
65518365|NCT03640156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65518366|NCT03640156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518367|NCT01230723|Everolimus|everolimus|mesh-list
65518368|NCT01230723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518369|NCT01230723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65518370|NCT01230723|Immunologic Factors|immunologic factors|mesh-ancestor
65518371|NCT01230723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518372|NCT05401071|Rifapentine|rifapentine|mesh-list
65518373|NCT05401071|Rifampin|rifampin|mesh-list
65518374|NCT05401071|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65518375|NCT05401071|Antitubercular Agents|antitubercular agents|mesh-ancestor
65518376|NCT05401071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65518377|NCT05401071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518378|NCT05401071|Leprostatic Agents|leprostatic agents|mesh-ancestor
65518379|NCT05401071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65518380|NCT05401071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518381|NCT05401071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518382|NCT05401071|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65518383|NCT05401071|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65518384|NCT05401071|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65518385|NCT05401071|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65518386|NCT05401071|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65518387|NCT05401071|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65518388|NCT01135953|Cycloserine|cycloserine|mesh-list
65518389|NCT01135953|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65518390|NCT01135953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518391|NCT01135953|Renal Agents|renal agents|mesh-ancestor
65518392|NCT01135953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65518393|NCT01135953|Antitubercular Agents|antitubercular agents|mesh-ancestor
65518394|NCT01135953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65518395|NCT01135953|Antimetabolites|antimetabolites|mesh-ancestor
65518396|NCT01135953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518397|NCT01136031|Paclitaxel|paclitaxel|mesh-list
65518398|NCT01136031|Irinotecan|irinotecan|mesh-list
65518399|NCT01136031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65518400|NCT01136031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315967|NCT00814216|Xhance|xhance|mesh-list
65518401|NCT01136031|Tubulin Modulators|tubulin modulators|mesh-ancestor
65518402|NCT01136031|Antimitotic Agents|antimitotic agents|mesh-ancestor
65518403|NCT01136031|Mitosis Modulators|mitosis modulators|mesh-ancestor
65518404|NCT01136031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518405|NCT01136031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65518406|NCT01136031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65518407|NCT01136031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518408|NCT05400915|Paclitaxel|paclitaxel|mesh-list
65518409|NCT05400915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65518410|NCT05400915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518411|NCT05400915|Tubulin Modulators|tubulin modulators|mesh-ancestor
65518412|NCT05400915|Antimitotic Agents|antimitotic agents|mesh-ancestor
65518413|NCT05400915|Mitosis Modulators|mitosis modulators|mesh-ancestor
65518414|NCT05400915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518415|NCT01137903|Amoxicillin|amoxicillin|mesh-list
65518416|NCT01137903|Ciprofloxacin|ciprofloxacin|mesh-list
65518417|NCT01137903|Clavulanic Acid|clavulanic acid|mesh-list
65518418|NCT01137903|Clavulanic Acids|clavulanic acids|mesh-list
65518419|NCT01137903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65518420|NCT01137903|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65518421|NCT01137903|Trimethoprim|trimethoprim|mesh-list
65518422|NCT01137903|Sulfamethoxazole|sulfamethoxazole|mesh-list
65518423|NCT01137903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65518424|NCT01137903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518425|NCT01137903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65518426|NCT01137903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65518427|NCT01137903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518428|NCT01137903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518429|NCT01137903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518430|NCT01137903|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65518431|NCT01137903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65518432|NCT01137903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65518433|NCT01137903|Renal Agents|renal agents|mesh-ancestor
65518434|NCT01137903|Antimalarials|antimalarials|mesh-ancestor
65518435|NCT01137903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65518436|NCT01137903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65518437|NCT01137903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65518438|NCT01137903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65518439|NCT01137903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65518440|NCT01137903|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65518441|NCT03739671|Vitamin D|vitamin d|mesh-list
65518442|NCT03739671|Ergocalciferols|ergocalciferols|mesh-list
65518443|NCT03739671|Cholecalciferol|cholecalciferol|mesh-list
65518444|NCT03739671|Vitamins|vitamins|mesh-list
65518445|NCT03739671|Micronutrients|micronutrients|mesh-ancestor
65518446|NCT03739671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518447|NCT03739671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65518448|NCT03739671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65518449|NCT01233453|Umirolimus|umirolimus|mesh-list
65518450|NCT01233453|Everolimus|everolimus|mesh-list
65518451|NCT01233453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518452|NCT01233453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65518453|NCT01233453|Immunologic Factors|immunologic factors|mesh-ancestor
65518454|NCT01233453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518455|NCT01233453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65518456|NCT01133925|Sirolimus|sirolimus|mesh-list
65518457|NCT01133925|Paclitaxel|paclitaxel|mesh-list
65518458|NCT01133925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65518459|NCT01133925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518460|NCT01133925|Tubulin Modulators|tubulin modulators|mesh-ancestor
65518461|NCT01133925|Antimitotic Agents|antimitotic agents|mesh-ancestor
65518462|NCT01133925|Mitosis Modulators|mitosis modulators|mesh-ancestor
65518463|NCT01133925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518464|NCT01133925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65518465|NCT01133925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518466|NCT01133925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65518467|NCT01133925|Antifungal Agents|antifungal agents|mesh-ancestor
65518468|NCT01133925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65518469|NCT01133925|Immunologic Factors|immunologic factors|mesh-ancestor
65518470|NCT01133925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518471|NCT01232439|Aticaprant|aticaprant|mesh-list
65518472|NCT01232439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518473|NCT01232439|Sensory System Agents|sensory system agents|mesh-ancestor
65518474|NCT01232439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518475|NCT01232439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65316004|NCT00808054|Lidocaine|lidocaine|mesh-list
65518476|NCT01138137|Acetylcysteine|acetylcysteine|mesh-list
65518477|NCT01138137|Paclitaxel|paclitaxel|mesh-list
65518478|NCT01138137|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65518479|NCT01138137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65518480|NCT01138137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518481|NCT01138137|Tubulin Modulators|tubulin modulators|mesh-ancestor
65518482|NCT01138137|Antimitotic Agents|antimitotic agents|mesh-ancestor
65518483|NCT01138137|Mitosis Modulators|mitosis modulators|mesh-ancestor
65518484|NCT01138137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518485|NCT01138137|Antiviral Agents|antiviral agents|mesh-ancestor
65518486|NCT01138137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518487|NCT01138137|Expectorants|expectorants|mesh-ancestor
65518488|NCT01138137|Respiratory System Agents|respiratory system agents|mesh-ancestor
65518489|NCT01138137|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65518490|NCT01138137|Antioxidants|antioxidants|mesh-ancestor
65518491|NCT01138137|Protective Agents|protective agents|mesh-ancestor
65518492|NCT01138137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518493|NCT01138137|Antidotes|antidotes|mesh-ancestor
65518494|NCT05410821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65518495|NCT05410821|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
65518496|NCT05410821|Chelating Agents|chelating agents|mesh-ancestor
65518497|NCT05410821|Sequestering Agents|sequestering agents|mesh-ancestor
65518498|NCT05410821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518499|NCT01231113|Artesunate|artesunate|mesh-list
65518500|NCT01231113|Piperaquine|piperaquine|mesh-list
65518501|NCT01231113|Amodiaquine|amodiaquine|mesh-list
65518502|NCT01231113|Artenimol|artenimol|mesh-list
65518503|NCT01231113|Antimalarials|antimalarials|mesh-ancestor
65518504|NCT01231113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65518505|NCT01231113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65518506|NCT01231113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518507|NCT01231113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518508|NCT01231113|Antiviral Agents|antiviral agents|mesh-ancestor
65518509|NCT01231113|Schistosomicides|schistosomicides|mesh-ancestor
65518510|NCT01231113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65518511|NCT01231113|Anthelmintics|anthelmintics|mesh-ancestor
65518512|NCT01136421|Magnesium Sulfate|magnesium sulfate|mesh-list
65518513|NCT01136421|Bromides|bromides|mesh-list
65518514|NCT01136421|Ipratropium|ipratropium|mesh-list
65518515|NCT01136421|Anticonvulsants|anticonvulsants|mesh-ancestor
65518516|NCT01136421|Analgesics|analgesics|mesh-ancestor
65518517|NCT01136421|Sensory System Agents|sensory system agents|mesh-ancestor
65518518|NCT01136421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518519|NCT01136421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518520|NCT01136421|Anesthetics|anesthetics|mesh-ancestor
65518521|NCT01136421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65518522|NCT01136421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65518523|NCT01136421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65518524|NCT01136421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65518525|NCT01136421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518526|NCT01136421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65518527|NCT01136421|Tocolytic Agents|tocolytic agents|mesh-ancestor
65518528|NCT01136421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65518529|NCT01136421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65518530|NCT01136421|Autonomic Agents|autonomic agents|mesh-ancestor
65518531|NCT01136421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65518532|NCT01136421|Respiratory System Agents|respiratory system agents|mesh-ancestor
65518533|NCT01136421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65518534|NCT01136421|Cholinergic Agents|cholinergic agents|mesh-ancestor
65518535|NCT01136421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65518536|NCT03769311|Cetuximab|cetuximab|mesh-list
65518537|NCT03769311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65518538|NCT03769311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518539|NCT01136499|Panobinostat|panobinostat|mesh-list
65518540|NCT01136499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518541|NCT01136499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65518542|NCT01136499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518543|NCT01136499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518544|NCT01231191|Acetaminophen|acetaminophen|mesh-list
65518545|NCT01231191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65518546|NCT01231191|Analgesics|analgesics|mesh-ancestor
65316079|NCT00812266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65518547|NCT01231191|Sensory System Agents|sensory system agents|mesh-ancestor
65518548|NCT01231191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518549|NCT01231191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518550|NCT01231191|Antipyretics|antipyretics|mesh-ancestor
65518551|NCT01138449|Vitamin A|vitamin a|mesh-list
65518552|NCT01138449|Vitamins|vitamins|mesh-ancestor
65518553|NCT01138449|Micronutrients|micronutrients|mesh-ancestor
65518554|NCT01138449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518556|NCT05402865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65518557|NCT05402865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518558|NCT01138605|Ritonavir|ritonavir|mesh-list
65518559|NCT01138605|Darunavir|darunavir|mesh-list
65518560|NCT01138605|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65518561|NCT01138605|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65518562|NCT01138605|Protease Inhibitors|protease inhibitors|mesh-ancestor
65518563|NCT01138605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518564|NCT01138605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518565|NCT01138605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65518566|NCT01138605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65518567|NCT01138605|Antiviral Agents|antiviral agents|mesh-ancestor
65518568|NCT01138605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518569|NCT01138605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65518570|NCT01138605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65518571|NCT01138683|Diuretics|diuretics|mesh-list
65518572|NCT01138683|Natriuretic Agents|natriuretic agents|mesh-ancestor
65518573|NCT01138683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518574|NCT04767243|Methamphetamine|methamphetamine|mesh-list
65518575|NCT04767243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65518576|NCT04767243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518577|NCT04767243|Sympathomimetics|sympathomimetics|mesh-ancestor
65518578|NCT04767243|Autonomic Agents|autonomic agents|mesh-ancestor
65518579|NCT04767243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518580|NCT04767243|Dopamine Agents|dopamine agents|mesh-ancestor
65518581|NCT04767243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65518582|NCT04767243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518583|NCT04767243|Adrenergic Agents|adrenergic agents|mesh-ancestor
65518584|NCT04767243|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65518585|NCT04767243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65518586|NCT04767243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65518587|NCT04767243|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65518588|NCT01138839|Dexamethasone|dexamethasone|mesh-list
65518589|NCT01138839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65518590|NCT01138839|Antiemetics|antiemetics|mesh-ancestor
65518591|NCT01138839|Autonomic Agents|autonomic agents|mesh-ancestor
65518592|NCT01138839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518593|NCT01138839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518594|NCT01138839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65518595|NCT01138839|Glucocorticoids|glucocorticoids|mesh-ancestor
65518596|NCT01138839|Hormones|hormones|mesh-ancestor
65518597|NCT01138839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65518598|NCT01138839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65518599|NCT01138839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518600|NCT01234623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65518601|NCT01234623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65518602|NCT01234701|Liver Extracts|liver extracts|mesh-list
65518603|NCT01234701|Hematinics|hematinics|mesh-ancestor
65518604|NCT04721613|Melatonin|melatonin|mesh-list
65518605|NCT04721613|Antioxidants|antioxidants|mesh-ancestor
65518606|NCT04721613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518607|NCT04721613|Protective Agents|protective agents|mesh-ancestor
65518608|NCT04721613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518609|NCT04721613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65518610|NCT05275179|Posaconazole|posaconazole|mesh-list
65518611|NCT05275179|Antifungal Agents|antifungal agents|mesh-ancestor
65518612|NCT05275179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518613|NCT05275179|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65518614|NCT05275179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65518615|NCT05275179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65518616|NCT05275179|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65518617|NCT05275179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65518618|NCT05275179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518619|NCT05275179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518620|NCT05275179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65518621|NCT05275179|Hormone Antagonists|hormone antagonists|mesh-ancestor
65518622|NCT05275179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65518623|NCT05275179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518624|NCT01139151|Cytarabine|cytarabine|mesh-list
65518625|NCT01139151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65518626|NCT01139151|Antimetabolites|antimetabolites|mesh-ancestor
65518627|NCT01139151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518628|NCT01139151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518629|NCT01139151|Antiviral Agents|antiviral agents|mesh-ancestor
65518630|NCT01139151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518631|NCT01139151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65518632|NCT01139151|Immunologic Factors|immunologic factors|mesh-ancestor
65518633|NCT01139151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518634|NCT01234857|Sirolimus|sirolimus|mesh-list
65518635|NCT01234857|Exemestane|exemestane|mesh-list
65518636|NCT01234857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65518637|NCT01234857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518638|NCT01234857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65518639|NCT01234857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65518640|NCT01234857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518641|NCT01234857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518642|NCT01234857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65518643|NCT01234857|Hormone Antagonists|hormone antagonists|mesh-ancestor
65518644|NCT01234857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65518645|NCT01234857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518646|NCT01234857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65518647|NCT01234857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518648|NCT01234857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65518649|NCT01234857|Antifungal Agents|antifungal agents|mesh-ancestor
65518650|NCT01234857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65518651|NCT01234857|Immunologic Factors|immunologic factors|mesh-ancestor
65518652|NCT01233843|Carboplatin|carboplatin|mesh-list
65518653|NCT01233843|Fluorouracil|fluorouracil|mesh-list
65518654|NCT01233843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518655|NCT01233843|Antimetabolites|antimetabolites|mesh-ancestor
65518656|NCT01233843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518657|NCT01233843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65518658|NCT01233843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65518659|NCT01233843|Immunologic Factors|immunologic factors|mesh-ancestor
65518660|NCT01233843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518661|NCT01234935|Gemcitabine|gemcitabine|mesh-list
65518662|NCT01234935|Dasatinib|dasatinib|mesh-list
65518663|NCT01234935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65518664|NCT01234935|Antimetabolites|antimetabolites|mesh-ancestor
65518665|NCT01234935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518666|NCT01234935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518667|NCT01234935|Antiviral Agents|antiviral agents|mesh-ancestor
65518668|NCT01234935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518669|NCT01234935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518670|NCT01234935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65518671|NCT01234935|Immunologic Factors|immunologic factors|mesh-ancestor
65518672|NCT01234935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518673|NCT01234935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65518674|NCT03674541|Bromides|bromides|mesh-list
65518675|NCT03674541|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
65518676|NCT03674541|Anticonvulsants|anticonvulsants|mesh-ancestor
65518677|NCT03674541|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65518678|NCT03674541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518679|NCT03674541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518680|NCT03674541|Cholinergic Agents|cholinergic agents|mesh-ancestor
65518681|NCT03674541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65518682|NCT03674541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518683|NCT01235013|Maraviroc|maraviroc|mesh-list
65518684|NCT01235013|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65518685|NCT01235013|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65518686|NCT01235013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518687|NCT01235013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65518688|NCT01235013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65518689|NCT01235013|Antiviral Agents|antiviral agents|mesh-ancestor
65518690|NCT01235013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518691|NCT01235013|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65518692|NCT01236495|Morphine|morphine|mesh-list
65518693|NCT01236495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65518694|NCT01236495|Narcotics|narcotics|mesh-ancestor
65518695|NCT01236495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65518696|NCT01236495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518697|NCT01236495|Analgesics|analgesics|mesh-ancestor
65518698|NCT01236495|Sensory System Agents|sensory system agents|mesh-ancestor
65518699|NCT01236495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518700|NCT01143129|Dexamethasone|dexamethasone|mesh-list
65518701|NCT01143129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65518702|NCT01143129|Antiemetics|antiemetics|mesh-ancestor
65518703|NCT01143129|Autonomic Agents|autonomic agents|mesh-ancestor
65518704|NCT01143129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518705|NCT01143129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518706|NCT01143129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65518707|NCT01143129|Glucocorticoids|glucocorticoids|mesh-ancestor
65518708|NCT01143129|Hormones|hormones|mesh-ancestor
65518709|NCT01143129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65518710|NCT01143129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65518711|NCT01143129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518712|NCT01139463|Haloperidol|haloperidol|mesh-list
65518713|NCT01139463|Olanzapine|olanzapine|mesh-list
65518714|NCT01139463|Haloperidol decanoate|haloperidol decanoate|mesh-list
65518715|NCT01139463|Antiemetics|antiemetics|mesh-ancestor
65518716|NCT01139463|Autonomic Agents|autonomic agents|mesh-ancestor
65518717|NCT01139463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518718|NCT01139463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518719|NCT01139463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65518720|NCT01139463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65518721|NCT01139463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65518722|NCT01139463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65518723|NCT01139463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65518724|NCT01139463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65518725|NCT01139463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65518726|NCT01139463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65518727|NCT01139463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518728|NCT01139463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65518729|NCT01139463|Serotonin Agents|serotonin agents|mesh-ancestor
65518730|NCT01139463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65518731|NCT01139463|Dopamine Agents|dopamine agents|mesh-ancestor
65518732|NCT01139463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65518733|NCT03640468|Lidocaine|lidocaine|mesh-list
65518734|NCT03640468|Midazolam|midazolam|mesh-list
65518735|NCT03640468|Ketamine|ketamine|mesh-list
65518736|NCT03640468|Anesthetics, Local|anesthetics, local|mesh-ancestor
65518737|NCT03640468|Anesthetics|anesthetics|mesh-ancestor
65518738|NCT03640468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65518739|NCT03640468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518740|NCT03640468|Sensory System Agents|sensory system agents|mesh-ancestor
65518741|NCT03640468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518742|NCT03640468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65518743|NCT03640468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65518744|NCT03640468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65518745|NCT03640468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65518746|NCT03640468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518747|NCT03640468|Analgesics|analgesics|mesh-ancestor
65518748|NCT03640468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65518749|NCT03640468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65518750|NCT03640468|Anesthetics, General|anesthetics, general|mesh-ancestor
65518751|NCT03640468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65518752|NCT03640468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65518753|NCT03640468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65518754|NCT03640468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65518755|NCT03640468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65518756|NCT03640468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65518757|NCT03640468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65518758|NCT03640468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65518759|NCT03640468|GABA Modulators|gaba modulators|mesh-ancestor
65518760|NCT03640468|GABA Agents|gaba agents|mesh-ancestor
65518761|NCT03640390|Magnesium Sulfate|magnesium sulfate|mesh-list
65518762|NCT03640390|Dexmedetomidine|dexmedetomidine|mesh-list
65518763|NCT03640390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65518764|NCT03640390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65518765|NCT03640390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518766|NCT03640390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65518767|NCT03640390|Analgesics|analgesics|mesh-ancestor
65518768|NCT03640390|Sensory System Agents|sensory system agents|mesh-ancestor
65518769|NCT03640390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518770|NCT03640390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65518771|NCT03640390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65518772|NCT03640390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65518773|NCT03640390|Adrenergic Agents|adrenergic agents|mesh-ancestor
65518774|NCT03640390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65518775|NCT03640390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518776|NCT03640390|Anesthetics|anesthetics|mesh-ancestor
65518777|NCT03640390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65518778|NCT03640390|Anticonvulsants|anticonvulsants|mesh-ancestor
65518779|NCT03640390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65518780|NCT03640390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65518781|NCT03640390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65518782|NCT03640390|Tocolytic Agents|tocolytic agents|mesh-ancestor
65518783|NCT03640390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65518784|NCT03618472|Metformin|metformin|mesh-list
65518785|NCT03618472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65518786|NCT03618472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518787|NCT00001984|Alemtuzumab|alemtuzumab|mesh-list
65518788|NCT00001984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65518789|NCT00001984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518790|NCT03618316|Cimetidine|cimetidine|mesh-list
65518791|NCT03618316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65518792|NCT03618316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65518793|NCT03618316|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65518794|NCT03618316|Histamine Antagonists|histamine antagonists|mesh-ancestor
65518795|NCT03618316|Histamine Agents|histamine agents|mesh-ancestor
65518796|NCT03618316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65518797|NCT03618316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518798|NCT03618316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518799|NCT03618316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65518800|NCT03618316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65518801|NCT03618316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518802|NCT03445533|Ipilimumab|ipilimumab|mesh-list
65518803|NCT03445533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65518804|NCT03445533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518805|NCT03445533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65518806|NCT03445533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518807|NCT01336972|Tolvaptan|tolvaptan|mesh-list
65518808|NCT01336972|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65518809|NCT01336972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518810|NCT01336972|Natriuretic Agents|natriuretic agents|mesh-ancestor
65518811|NCT01336972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518812|NCT03537508|Vaccines|vaccines|mesh-list
65518813|NCT03537508|Immunologic Factors|immunologic factors|mesh-ancestor
65518814|NCT03537508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518815|NCT03618082|Desflurane|desflurane|mesh-list
65518816|NCT03618082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65518817|NCT03618082|Anesthetics, General|anesthetics, general|mesh-ancestor
65518818|NCT03618082|Anesthetics|anesthetics|mesh-ancestor
65518819|NCT03618082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65518820|NCT03618082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518821|NCT01236651|Drotaverin|drotaverin|mesh-list
65518822|NCT01236651|Meperidine|meperidine|mesh-list
65518823|NCT01236651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65518824|NCT01236651|Narcotics|narcotics|mesh-ancestor
65518825|NCT01236651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65518826|NCT01236651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518827|NCT01236651|Analgesics|analgesics|mesh-ancestor
65518828|NCT01236651|Sensory System Agents|sensory system agents|mesh-ancestor
65518829|NCT01236651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518830|NCT01236651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65518831|NCT01236651|Parasympatholytics|parasympatholytics|mesh-ancestor
65518832|NCT01236651|Autonomic Agents|autonomic agents|mesh-ancestor
65518833|NCT01236651|Vasodilator Agents|vasodilator agents|mesh-ancestor
65518834|NCT04484025|Ebselen|ebselen|mesh-list
65518835|NCT04484025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65518836|NCT04484025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65518837|NCT04484025|Analgesics|analgesics|mesh-ancestor
65518838|NCT04484025|Sensory System Agents|sensory system agents|mesh-ancestor
65518839|NCT04484025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518840|NCT04484025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518841|NCT04484025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65518842|NCT04484025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65518843|NCT04484025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65518844|NCT04484025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65518845|NCT04484025|Antioxidants|antioxidants|mesh-ancestor
65518846|NCT04484025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518847|NCT04484025|Protective Agents|protective agents|mesh-ancestor
65518848|NCT04484025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65518849|NCT04484025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518850|NCT04484025|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65518851|NCT03370276|Nivolumab|nivolumab|mesh-list
65518852|NCT03370276|Cetuximab|cetuximab|mesh-list
65518853|NCT03370276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65518854|NCT03370276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518855|NCT03370276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65518856|NCT03370276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518857|NCT01064518|Botulinum Toxins|botulinum toxins|mesh-list
65518858|NCT01064518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65518859|NCT01064518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65518860|NCT01064518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65518861|NCT01064518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65518862|NCT01064518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518863|NCT01064518|Cholinergic Agents|cholinergic agents|mesh-ancestor
65518864|NCT01064518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65518865|NCT01064518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518866|NCT01064518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65518867|NCT01064518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518868|NCT03318094|Nitroprusside|nitroprusside|mesh-list
65518869|NCT03318094|Phentolamine|phentolamine|mesh-list
65518870|NCT03318094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
65518871|NCT03318094|Adrenergic Antagonists|adrenergic antagonists|mesh-list
65518872|NCT03318094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65518873|NCT03318094|Vasodilator Agents|vasodilator agents|mesh-ancestor
65518874|NCT03318094|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65518875|NCT03318094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518876|NCT03318094|Adrenergic Agents|adrenergic agents|mesh-ancestor
65518877|NCT03318094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65518878|NCT03318094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518879|NCT03616288|Thiamine|thiamine|mesh-list
65518880|NCT03616288|Vitamin B Complex|vitamin b complex|mesh-ancestor
65518881|NCT03616288|Vitamins|vitamins|mesh-ancestor
65518882|NCT03616288|Micronutrients|micronutrients|mesh-ancestor
65518883|NCT03616288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518884|NCT02873338|Cytarabine|cytarabine|mesh-list
65518885|NCT02873338|Idarubicin|idarubicin|mesh-list
65518886|NCT02873338|Heparin|heparin|mesh-list
65518887|NCT02873338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65518888|NCT02873338|Antimetabolites|antimetabolites|mesh-ancestor
65518889|NCT02873338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518890|NCT02873338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518891|NCT02873338|Antiviral Agents|antiviral agents|mesh-ancestor
65518892|NCT02873338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518893|NCT02873338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65518894|NCT02873338|Immunologic Factors|immunologic factors|mesh-ancestor
65518895|NCT02873338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518896|NCT02873338|Anticoagulants|anticoagulants|mesh-ancestor
65518897|NCT02873338|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65518898|NCT02873338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65518899|NCT02873338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65518900|NCT02873338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65518901|NCT02873338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65518902|NCT02873338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518903|NCT03616132|Sirolimus|sirolimus|mesh-list
65518904|NCT03616132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65518905|NCT03616132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518906|NCT03616132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65518907|NCT03616132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518908|NCT03616132|Antifungal Agents|antifungal agents|mesh-ancestor
65518909|NCT03616132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65518910|NCT03616132|Immunologic Factors|immunologic factors|mesh-ancestor
65518911|NCT03616132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518912|NCT02872012|Lidocaine|lidocaine|mesh-list
65518913|NCT02872012|Anesthetics, Local|anesthetics, local|mesh-ancestor
65518914|NCT02872012|Anesthetics|anesthetics|mesh-ancestor
65518915|NCT02872012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65518916|NCT02872012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518917|NCT02872012|Sensory System Agents|sensory system agents|mesh-ancestor
65518918|NCT02872012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518919|NCT02872012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65247950|NCT00837213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518920|NCT02872012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65518921|NCT02872012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65518922|NCT02872012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65518923|NCT02872012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518924|NCT03617224|Pembrolizumab|pembrolizumab|mesh-list
65518925|NCT03617224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65518926|NCT03617224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518927|NCT03615430|Anesthetics|anesthetics|mesh-list
65518928|NCT03615430|Anesthetics, Local|anesthetics, local|mesh-list
65518929|NCT03615430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65518930|NCT03615430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518931|NCT03615430|Sensory System Agents|sensory system agents|mesh-ancestor
65518932|NCT03615430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518933|NCT01344226|Loteprednol Etabonate|loteprednol etabonate|mesh-list
65518934|NCT01344226|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65518935|NCT01344226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65518936|NCT01344226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65518937|NCT03615196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65518938|NCT03615196|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65518939|NCT03613792|Fentanyl|fentanyl|mesh-list
65518940|NCT03613792|Midazolam|midazolam|mesh-list
65518941|NCT03613792|Ketamine|ketamine|mesh-list
65518942|NCT03613792|Remifentanil|remifentanil|mesh-list
65518943|NCT03613792|Analgesics|analgesics|mesh-ancestor
65518944|NCT03613792|Sensory System Agents|sensory system agents|mesh-ancestor
65518945|NCT03613792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518946|NCT03613792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518947|NCT03613792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65518948|NCT03613792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65518949|NCT03613792|Anesthetics, General|anesthetics, general|mesh-ancestor
65518950|NCT03613792|Anesthetics|anesthetics|mesh-ancestor
65518951|NCT03613792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65518952|NCT03613792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65518953|NCT03613792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65518954|NCT03613792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65518955|NCT03613792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518956|NCT03613792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65518957|NCT03613792|Narcotics|narcotics|mesh-ancestor
65518958|NCT03613792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65518959|NCT03613792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65518960|NCT03613792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65518961|NCT03613792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65518962|NCT03613792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65518963|NCT03613792|GABA Modulators|gaba modulators|mesh-ancestor
65518964|NCT03613792|GABA Agents|gaba agents|mesh-ancestor
65518965|NCT04837768|Progesterone|progesterone|mesh-list
65518966|NCT04837768|Progestins|progestins|mesh-ancestor
65518967|NCT04837768|Hormones|hormones|mesh-ancestor
65518968|NCT04837768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65518969|NCT04837768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518970|NCT02869438|Benralizumab|benralizumab|mesh-list
65518971|NCT02869438|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65518972|NCT02869438|Respiratory System Agents|respiratory system agents|mesh-ancestor
65518973|NCT02868892|Pemetrexed|pemetrexed|mesh-list
65518974|NCT02868892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65518975|NCT02868892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518976|NCT02868892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518977|NCT02868892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65518978|NCT02868892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65518979|NCT03613558|Dexmedetomidine|dexmedetomidine|mesh-list
65518980|NCT03613558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65518981|NCT03613558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65518982|NCT03613558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65518983|NCT03613558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65518984|NCT03613558|Analgesics|analgesics|mesh-ancestor
65518985|NCT03613558|Sensory System Agents|sensory system agents|mesh-ancestor
65518986|NCT03613558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65518987|NCT03613558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65518988|NCT03613558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65518989|NCT03613558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65518990|NCT03613558|Adrenergic Agents|adrenergic agents|mesh-ancestor
65518991|NCT03613558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65518992|NCT03613558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65518993|NCT03244072|Moxifloxacin|moxifloxacin|mesh-list
65518994|NCT03244072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65518995|NCT03244072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65518996|NCT03244072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65518997|NCT03244072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65518998|NCT03244072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65518999|NCT03244072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519000|NCT03244072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316530|NCT00809068|Anabolic Agents|anabolic agents|mesh-ancestor
65519001|NCT03310125|Colchicine|colchicine|mesh-list
65519002|NCT03310125|Gout Suppressants|gout suppressants|mesh-ancestor
65519003|NCT03310125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65519004|NCT03310125|Tubulin Modulators|tubulin modulators|mesh-ancestor
65519005|NCT03310125|Antimitotic Agents|antimitotic agents|mesh-ancestor
65519006|NCT03310125|Mitosis Modulators|mitosis modulators|mesh-ancestor
65519007|NCT03310125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519008|NCT03310125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519009|NCT03613168|Trastuzumab|trastuzumab|mesh-list
65519010|NCT03613168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65519011|NCT03613168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519012|NCT01141881|Bevacizumab|bevacizumab|mesh-list
65519013|NCT01141881|Plasminogen|plasminogen|mesh-list
65519014|NCT01141881|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65519015|NCT01141881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65519016|NCT01141881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519017|NCT01141881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65519018|NCT01141881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65519019|NCT01141881|Growth Substances|growth substances|mesh-ancestor
65519020|NCT01141881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519021|NCT01141881|Growth Inhibitors|growth inhibitors|mesh-ancestor
65519022|NCT01141881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65519023|NCT01141881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65519024|NCT01141881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519025|NCT04707430|Progesterone|progesterone|mesh-list
65519026|NCT04707430|Progestins|progestins|mesh-ancestor
65519027|NCT04707430|Hormones|hormones|mesh-ancestor
65519028|NCT04707430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65519029|NCT04707430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519030|NCT03611920|Tetracycline|tetracycline|mesh-list
65519031|NCT03611920|Dexamethasone|dexamethasone|mesh-list
65519032|NCT03611920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65519033|NCT03611920|Antiemetics|antiemetics|mesh-ancestor
65519034|NCT03611920|Autonomic Agents|autonomic agents|mesh-ancestor
65519035|NCT03611920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65519036|NCT03611920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519037|NCT03611920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65519038|NCT03611920|Glucocorticoids|glucocorticoids|mesh-ancestor
65519039|NCT03611920|Hormones|hormones|mesh-ancestor
65519040|NCT03611920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65519041|NCT03611920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65519042|NCT03611920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519043|NCT03611920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65519044|NCT03611920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65519045|NCT03611920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65519046|NCT03611920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519047|NCT03611920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519048|NCT03611530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65519049|NCT03611530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65519050|NCT02936752|Pembrolizumab|pembrolizumab|mesh-list
65519051|NCT02936752|Entinostat|entinostat|mesh-list
65519052|NCT02936752|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65519053|NCT02936752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65519054|NCT02936752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519055|NCT02936752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519056|NCT02936752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519057|NCT05383534|Propofol|propofol|mesh-list
65519058|NCT05383534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65519059|NCT05383534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65519060|NCT05383534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519061|NCT05383534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65519062|NCT05383534|Anesthetics, General|anesthetics, general|mesh-ancestor
65519063|NCT05383534|Anesthetics|anesthetics|mesh-ancestor
65519064|NCT01235325|Vitamin K|vitamin k|mesh-list
65519065|NCT01235325|Vitamin K 1|vitamin k 1|mesh-list
65519066|NCT01235325|Vitamins|vitamins|mesh-ancestor
65519067|NCT01235325|Micronutrients|micronutrients|mesh-ancestor
65519068|NCT01235325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519069|NCT01235325|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65519070|NCT01235325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65519071|NCT01235325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519072|NCT01235325|Hemostatics|hemostatics|mesh-ancestor
65519073|NCT01235325|Coagulants|coagulants|mesh-ancestor
65519074|NCT01140009|Vaccines|vaccines|mesh-list
65519075|NCT01140009|Immunologic Factors|immunologic factors|mesh-ancestor
65519076|NCT01140009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519077|NCT01235637|Sufentanil|sufentanil|mesh-list
65519078|NCT01235637|Alfentanil|alfentanil|mesh-list
65519079|NCT01235637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65519080|NCT01235637|Narcotics|narcotics|mesh-ancestor
65519081|NCT01235637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65519082|NCT01235637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519083|NCT01235637|Analgesics|analgesics|mesh-ancestor
65519084|NCT01235637|Sensory System Agents|sensory system agents|mesh-ancestor
65519085|NCT01235637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65519086|NCT01235637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65519087|NCT01235637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65519088|NCT01235637|Anesthetics, General|anesthetics, general|mesh-ancestor
65519089|NCT01235637|Anesthetics|anesthetics|mesh-ancestor
65519090|NCT01143831|Vitamins|vitamins|mesh-list
65519091|NCT01143831|Vitamin K|vitamin k|mesh-list
65519092|NCT01143831|Vitamin K 2|vitamin k 2|mesh-list
65519093|NCT01143831|Menatetrenone|menatetrenone|mesh-list
65519094|NCT01143831|Micronutrients|micronutrients|mesh-ancestor
65519095|NCT01143831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519096|NCT01143831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65519097|NCT01143831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65519098|NCT01143831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519099|NCT01143831|Hemostatics|hemostatics|mesh-ancestor
65519100|NCT01143831|Coagulants|coagulants|mesh-ancestor
65519101|NCT04966299|Erythritol|erythritol|mesh-list
65519102|NCT04966299|Vasodilator Agents|vasodilator agents|mesh-ancestor
65519103|NCT01143987|Cinacalcet|cinacalcet|mesh-list
65519104|NCT01143987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65519105|NCT01143987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519106|NCT01143987|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65519107|NCT01143987|Hormone Antagonists|hormone antagonists|mesh-ancestor
65519108|NCT01143987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65519109|NCT01144065|Hydrocortisone|hydrocortisone|mesh-list
65519110|NCT01144065|Testosterone|testosterone|mesh-list
65519111|NCT01144065|Androgens|androgens|mesh-ancestor
65519112|NCT01144065|Hormones|hormones|mesh-ancestor
65519113|NCT01144065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65519114|NCT01144065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519115|NCT01144065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65519116|NCT01142505|Mannitol|mannitol|mesh-list
65519117|NCT01142505|Montelukast|montelukast|mesh-list
65519118|NCT01142505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65519119|NCT01142505|Respiratory System Agents|respiratory system agents|mesh-ancestor
65519120|NCT01142505|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65519121|NCT01142505|Hormone Antagonists|hormone antagonists|mesh-ancestor
65519122|NCT01142505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65519123|NCT01142505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519124|NCT01142505|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65519125|NCT01142505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65519126|NCT01142505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519127|NCT01142505|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65519128|NCT01142505|Diuretics|diuretics|mesh-ancestor
65519129|NCT01142505|Natriuretic Agents|natriuretic agents|mesh-ancestor
65519130|NCT01236963|Listerine|listerine|mesh-list
65519131|NCT01236963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65519132|NCT01236963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65519133|NCT02908672|Atezolizumab|atezolizumab|mesh-list
65519134|NCT02908672|Vemurafenib|vemurafenib|mesh-list
65519135|NCT02908672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65519136|NCT02908672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519137|NCT02908672|Immunologic Factors|immunologic factors|mesh-ancestor
65519138|NCT02908672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519139|NCT02908672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65519140|NCT02908672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519141|NCT02908672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519142|NCT02572167|Nivolumab|nivolumab|mesh-list
65519143|NCT02572167|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65519144|NCT02572167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65519145|NCT02572167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519146|NCT02572167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65519147|NCT02572167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519148|NCT01336738|Nicotinic Acids|nicotinic acids|mesh-list
65519149|NCT01336738|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65519150|NCT01336738|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
65519151|NCT01336738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65519152|NCT01336738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519153|NCT01336738|Incretins|incretins|mesh-ancestor
65519155|NCT01336738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65519156|NCT01336738|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65519157|NCT01336738|Protease Inhibitors|protease inhibitors|mesh-ancestor
65519158|NCT01336738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519159|NCT01336738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519160|NCT01336738|Vitamin B Complex|vitamin b complex|mesh-ancestor
65519161|NCT01336738|Vitamins|vitamins|mesh-ancestor
65519162|NCT01336738|Micronutrients|micronutrients|mesh-ancestor
65519163|NCT01140399|Dopamine|dopamine|mesh-list
65519164|NCT01140399|Furosemide|furosemide|mesh-list
65519165|NCT01140399|Diuretics|diuretics|mesh-ancestor
65519166|NCT01140399|Natriuretic Agents|natriuretic agents|mesh-ancestor
65519167|NCT01140399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519168|NCT01140399|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65519169|NCT01140399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65519170|NCT01140399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519171|NCT01140399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65519172|NCT01140399|Sympathomimetics|sympathomimetics|mesh-ancestor
65519173|NCT01140399|Autonomic Agents|autonomic agents|mesh-ancestor
65519174|NCT01140399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65519175|NCT01140399|Dopamine Agents|dopamine agents|mesh-ancestor
65519176|NCT01140399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65519177|NCT01140399|Protective Agents|protective agents|mesh-ancestor
65519178|NCT02410317|Morphine|morphine|mesh-list
65519179|NCT02410317|Ropivacaine|ropivacaine|mesh-list
65519180|NCT02410317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65519181|NCT02410317|Narcotics|narcotics|mesh-ancestor
65519182|NCT02410317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65519183|NCT02410317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519184|NCT02410317|Analgesics|analgesics|mesh-ancestor
65519185|NCT02410317|Sensory System Agents|sensory system agents|mesh-ancestor
65519186|NCT02410317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65519187|NCT02410317|Anesthetics, Local|anesthetics, local|mesh-ancestor
65519188|NCT02410317|Anesthetics|anesthetics|mesh-ancestor
65519189|NCT02258451|Everolimus|everolimus|mesh-list
65519190|NCT02258451|Exemestane|exemestane|mesh-list
65519191|NCT02258451|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65519192|NCT02258451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519193|NCT02258451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65519194|NCT02258451|Immunologic Factors|immunologic factors|mesh-ancestor
65519195|NCT02258451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519196|NCT02258451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65519197|NCT02258451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65519198|NCT02258451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519199|NCT02258451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519200|NCT02258451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65519201|NCT02258451|Hormone Antagonists|hormone antagonists|mesh-ancestor
65519202|NCT02258451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65519203|NCT01237119|Liraglutide|liraglutide|mesh-list
65519204|NCT01237119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65519205|NCT01237119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519206|NCT01237119|Incretins|incretins|mesh-ancestor
65519207|NCT01237119|Hormones|hormones|mesh-ancestor
65519208|NCT01237119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65519209|NCT03760263|Tacrolimus|tacrolimus|mesh-list
65519210|NCT03760263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65519211|NCT03760263|Immunologic Factors|immunologic factors|mesh-ancestor
65519212|NCT03760263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519213|NCT03760263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65519214|NCT03760263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519215|NCT03760263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519216|NCT01237275|Sertraline|sertraline|mesh-list
65519217|NCT01237275|Fluoxetine|fluoxetine|mesh-list
65519218|NCT01237275|Paroxetine|paroxetine|mesh-list
65519219|NCT01237275|Antidepressive Agents|antidepressive agents|mesh-ancestor
65519220|NCT01237275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65519221|NCT01237275|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65519222|NCT01237275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65519223|NCT01237275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65519224|NCT01237275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519225|NCT01237275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65519226|NCT01237275|Serotonin Agents|serotonin agents|mesh-ancestor
65519227|NCT01237275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519228|NCT01237275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65519229|NCT01237275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65519230|NCT01237275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65519232|NCT04880499|Folic Acid|folic acid|mesh-list
65519233|NCT04880499|Riboflavin|riboflavin|mesh-list
65519234|NCT04880499|Vitamins|vitamins|mesh-ancestor
65519235|NCT04880499|Micronutrients|micronutrients|mesh-ancestor
65519236|NCT04880499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519237|NCT04880499|Hematinics|hematinics|mesh-ancestor
65519238|NCT04880499|Vitamin B Complex|vitamin b complex|mesh-ancestor
65519239|NCT04880499|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65519240|NCT04880499|Dermatologic Agents|dermatologic agents|mesh-ancestor
65519241|NCT04867785|Dulaglutide|dulaglutide|mesh-list
65519242|NCT04867785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65519243|NCT04867785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519244|NCT01237977|Botulinum Toxins|botulinum toxins|mesh-list
65519245|NCT01237977|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65519246|NCT01237977|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65519247|NCT01237977|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65519248|NCT01237977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65519249|NCT01237977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519250|NCT01237977|Cholinergic Agents|cholinergic agents|mesh-ancestor
65519251|NCT01237977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65519252|NCT01237977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519253|NCT01237977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65519254|NCT01237977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65519255|NCT02033434|Ketamine|ketamine|mesh-list
65519256|NCT02033434|Analgesics|analgesics|mesh-ancestor
65519257|NCT02033434|Sensory System Agents|sensory system agents|mesh-ancestor
65519258|NCT02033434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65519259|NCT02033434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519260|NCT02033434|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65519261|NCT02033434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65519262|NCT02033434|Anesthetics, General|anesthetics, general|mesh-ancestor
65519263|NCT02033434|Anesthetics|anesthetics|mesh-ancestor
65519264|NCT02033434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65519265|NCT02033434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65519266|NCT02033434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65519267|NCT02033434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65519268|NCT02033434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519269|NCT02033512|Hormones|hormones|mesh-list
65519270|NCT02033512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65519271|NCT02033512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519272|NCT02712112|Imatinib Mesylate|imatinib mesylate|mesh-list
65519273|NCT02712112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519274|NCT02712112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65519275|NCT02712112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519276|NCT02712112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519277|NCT02860546|Nivolumab|nivolumab|mesh-list
65519278|NCT02860546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65519279|NCT02860546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519280|NCT02860546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65519281|NCT02860546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519282|NCT01982955|Carboplatin|carboplatin|mesh-list
65519283|NCT01982955|Pemetrexed|pemetrexed|mesh-list
65519284|NCT01982955|Gefitinib|gefitinib|mesh-list
65519285|NCT01982955|Tepotinib|tepotinib|mesh-list
65519286|NCT01982955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519287|NCT01982955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519288|NCT01982955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519289|NCT01982955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65519290|NCT01982955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65519291|NCT01982955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65519292|NCT01144533|Hyaluronic Acid|hyaluronic acid|mesh-list
65519293|NCT01144533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65519294|NCT01144533|Immunologic Factors|immunologic factors|mesh-ancestor
65519295|NCT01144533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519296|NCT01144533|Viscosupplements|viscosupplements|mesh-ancestor
65519297|NCT01144533|Protective Agents|protective agents|mesh-ancestor
65519298|NCT01238055|Docetaxel|docetaxel|mesh-list
65519299|NCT01238055|Sunitinib|sunitinib|mesh-list
65519300|NCT01238055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519301|NCT01238055|Tubulin Modulators|tubulin modulators|mesh-ancestor
65519302|NCT01238055|Antimitotic Agents|antimitotic agents|mesh-ancestor
65519303|NCT01238055|Mitosis Modulators|mitosis modulators|mesh-ancestor
65519304|NCT01238055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519305|NCT01238055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65519306|NCT01238055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65519307|NCT01238055|Growth Substances|growth substances|mesh-ancestor
65519308|NCT01238055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519309|NCT01238055|Growth Inhibitors|growth inhibitors|mesh-ancestor
65519310|NCT01238055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65519311|NCT01238055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519312|NCT01144923|Gabapentin|gabapentin|mesh-list
65519313|NCT01144923|Nortriptyline|nortriptyline|mesh-list
65519314|NCT01144923|Analgesics|analgesics|mesh-ancestor
65519315|NCT01144923|Sensory System Agents|sensory system agents|mesh-ancestor
65519316|NCT01144923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65519317|NCT01144923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519318|NCT01144923|Anticonvulsants|anticonvulsants|mesh-ancestor
65519319|NCT01144923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65519320|NCT01144923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65519321|NCT01144923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65519322|NCT01144923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65519323|NCT01144923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65519324|NCT01144923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65519325|NCT01144923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65519326|NCT01144923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519327|NCT01144923|Antimanic Agents|antimanic agents|mesh-ancestor
65519328|NCT01144923|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65519329|NCT01144923|Antidepressive Agents|antidepressive agents|mesh-ancestor
65519330|NCT01144923|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65519331|NCT01144923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65519332|NCT01144923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65519333|NCT01144923|Adrenergic Agents|adrenergic agents|mesh-ancestor
65519334|NCT01329783|Maraviroc|maraviroc|mesh-list
65519335|NCT01329783|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65519336|NCT01329783|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65519337|NCT01329783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519338|NCT01329783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65519339|NCT01329783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65519340|NCT01329783|Antiviral Agents|antiviral agents|mesh-ancestor
65519341|NCT01329783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65519342|NCT01329783|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65519343|NCT01238133|Paclitaxel|paclitaxel|mesh-list
65519344|NCT01238133|Carboplatin|carboplatin|mesh-list
65519345|NCT01238133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65519346|NCT01238133|R04929097|r04929097|mesh-list
65519347|NCT01238133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65519348|NCT01238133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519349|NCT01238133|Tubulin Modulators|tubulin modulators|mesh-ancestor
65519350|NCT01238133|Antimitotic Agents|antimitotic agents|mesh-ancestor
65519351|NCT01238133|Mitosis Modulators|mitosis modulators|mesh-ancestor
65519352|NCT01238133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519353|NCT01238133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519354|NCT01145079|Sirolimus|sirolimus|mesh-list
65519355|NCT01145079|Everolimus|everolimus|mesh-list
65519356|NCT01145079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519357|NCT01145079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65519358|NCT01145079|Immunologic Factors|immunologic factors|mesh-ancestor
65519359|NCT01145079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519360|NCT01145079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65519361|NCT01145079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65519362|NCT01145079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65519363|NCT01145079|Antifungal Agents|antifungal agents|mesh-ancestor
65519364|NCT01146483|Pantoprazole|pantoprazole|mesh-list
65519365|NCT01146483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65519366|NCT01146483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65519367|NCT01146483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65519368|NCT01146483|Antimetabolites|antimetabolites|mesh-ancestor
65519369|NCT01146483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519370|NCT01146483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65519371|NCT01146483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65519372|NCT01146483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519373|NCT01146483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65519374|NCT01146483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65519375|NCT01146483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65519376|NCT00396279|Vitamin D|vitamin d|mesh-list
65316901|NCT03840811|Ciprofloxacin|ciprofloxacin|mesh-list
65519377|NCT00396279|Denosumab|denosumab|mesh-list
65519378|NCT00396279|Calcium|calcium|mesh-list
65519379|NCT00396279|Vitamins|vitamins|mesh-ancestor
65519380|NCT00396279|Micronutrients|micronutrients|mesh-ancestor
65519381|NCT00396279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519382|NCT00396279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65519383|NCT00396279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65519384|NCT01238367|Factor VIII|factor viii|mesh-list
65519385|NCT01238367|Coagulants|coagulants|mesh-ancestor
65519386|NCT01347866|Irinotecan|irinotecan|mesh-list
65519387|NCT01347866|Gedatolisib|gedatolisib|mesh-list
65519388|NCT01347866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65519389|NCT01347866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65519390|NCT01347866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519391|NCT01347866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519392|NCT01347866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519393|NCT01347866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65519394|NCT01347710|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
65519395|NCT01347710|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
65519396|NCT01347710|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65519397|NCT01347710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519398|NCT05470868|Naphazoline|naphazoline|mesh-list
65519399|NCT05470868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65519400|NCT05470868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65519401|NCT05470868|Adrenergic Agents|adrenergic agents|mesh-ancestor
65519402|NCT05470868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65519403|NCT05470868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519404|NCT05470868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519405|NCT05470868|Nasal Decongestants|nasal decongestants|mesh-ancestor
65519406|NCT05470868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65519407|NCT05470868|Respiratory System Agents|respiratory system agents|mesh-ancestor
65519408|NCT03485222|Empagliflozin|empagliflozin|mesh-list
65519409|NCT03485222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65519410|NCT03485222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519411|NCT03485222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65519412|NCT03485222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519413|NCT01347554|Everolimus|everolimus|mesh-list
65519414|NCT01347554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519415|NCT01347554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65519416|NCT01347554|Immunologic Factors|immunologic factors|mesh-ancestor
65519417|NCT01347554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519418|NCT05567354|Oxycodone|oxycodone|mesh-list
65519419|NCT05567354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65519420|NCT05567354|Narcotics|narcotics|mesh-ancestor
65519421|NCT05567354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65519422|NCT05567354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519423|NCT05567354|Analgesics|analgesics|mesh-ancestor
65519424|NCT05567354|Sensory System Agents|sensory system agents|mesh-ancestor
65519425|NCT05567354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65519426|NCT03482882|Pimavanserin|pimavanserin|mesh-list
65519427|NCT03482882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65519428|NCT03482882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65519429|NCT03482882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65519430|NCT03482882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65519431|NCT03482882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65519432|NCT03482882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519433|NCT03482882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65519434|NCT03482882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65519435|NCT03482882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65519436|NCT03482882|Serotonin Agents|serotonin agents|mesh-ancestor
65519437|NCT03482882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65519438|NCT03482882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519439|NCT03480932|Interferons|interferons|mesh-list
65519440|NCT03480932|Interferon-alpha|interferon-alpha|mesh-list
65519441|NCT03480932|Interferon alpha-2|interferon alpha-2|mesh-list
65519442|NCT03480932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65519443|NCT03480932|Sofosbuvir|sofosbuvir|mesh-list
65519444|NCT03480932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519445|NCT03480932|Antiviral Agents|antiviral agents|mesh-ancestor
65519446|NCT03480932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65519447|NCT03480932|Immunologic Factors|immunologic factors|mesh-ancestor
65519448|NCT03480932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519449|NCT03387020|Everolimus|everolimus|mesh-list
65519450|NCT03387020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519451|NCT03387020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65519452|NCT03387020|Immunologic Factors|immunologic factors|mesh-ancestor
65519453|NCT03387020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519454|NCT03386474|Aflibercept|aflibercept|mesh-list
65519455|NCT03386474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65519456|NCT03386474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65519457|NCT03386474|Growth Substances|growth substances|mesh-ancestor
65519458|NCT03386474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519459|NCT03386474|Growth Inhibitors|growth inhibitors|mesh-ancestor
65519460|NCT03386474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519461|NCT02446600|Gemcitabine|gemcitabine|mesh-list
65519463|NCT02446600|Carboplatin|carboplatin|mesh-list
65519464|NCT02446600|Doxorubicin|doxorubicin|mesh-list
65519465|NCT02446600|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65519466|NCT02446600|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65519467|NCT02446600|Olaparib|olaparib|mesh-list
65519468|NCT02446600|Cediranib|cediranib|mesh-list
65519469|NCT02446600|Maleic acid|maleic acid|mesh-list
65519470|NCT02446600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65519471|NCT02446600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519472|NCT02446600|Tubulin Modulators|tubulin modulators|mesh-ancestor
65519473|NCT02446600|Antimitotic Agents|antimitotic agents|mesh-ancestor
65519474|NCT02446600|Mitosis Modulators|mitosis modulators|mesh-ancestor
65519475|NCT02446600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519476|NCT02446600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65519477|NCT02446600|Antimetabolites|antimetabolites|mesh-ancestor
65519478|NCT02446600|Antiviral Agents|antiviral agents|mesh-ancestor
65519479|NCT02446600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65519480|NCT02446600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519481|NCT02446600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65519482|NCT02446600|Immunologic Factors|immunologic factors|mesh-ancestor
65519483|NCT02446600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519484|NCT02446600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65519485|NCT02446600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65519486|NCT02446600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65519487|NCT02446600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65519488|NCT02446600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65519489|NCT03405818|Tavaborole|tavaborole|mesh-list
65519490|NCT03405818|Antifungal Agents|antifungal agents|mesh-ancestor
65519491|NCT03405818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65519492|NCT03403634|Interferons|interferons|mesh-list
65519493|NCT03403634|Interferon-alpha|interferon-alpha|mesh-list
65519494|NCT03403634|Interferon alpha-2|interferon alpha-2|mesh-list
65519495|NCT03403634|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
65519496|NCT03403634|Celecoxib|celecoxib|mesh-list
65519497|NCT03403634|Benzenesulfonamide|benzenesulfonamide|mesh-list
65519498|NCT03403634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519499|NCT03403634|Antiviral Agents|antiviral agents|mesh-ancestor
65519500|NCT03403634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65519501|NCT03403634|Immunologic Factors|immunologic factors|mesh-ancestor
65519502|NCT03403634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519503|NCT03403634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65519504|NCT03403634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65519505|NCT03403634|Analgesics|analgesics|mesh-ancestor
65519506|NCT03403634|Sensory System Agents|sensory system agents|mesh-ancestor
65519507|NCT03403634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65519508|NCT03403634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65519509|NCT03403634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65519510|NCT03403634|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65519511|NCT03403634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65519512|NCT03403634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519513|NCT03403634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519514|NCT03403634|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65519515|NCT02863354|Aflibercept|aflibercept|mesh-list
65519516|NCT02863354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65519517|NCT02863354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65519518|NCT02863354|Growth Substances|growth substances|mesh-ancestor
65519519|NCT02863354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519520|NCT02863354|Growth Inhibitors|growth inhibitors|mesh-ancestor
65519521|NCT02863354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519522|NCT02859454|Avelumab|avelumab|mesh-list
65519523|NCT02859454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65519524|NCT02859454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519525|NCT02862730|Pancrelipase|pancrelipase|mesh-list
65519526|NCT02862730|Pancreatin|pancreatin|mesh-list
65519527|NCT02862730|Hormones|hormones|mesh-list
65519528|NCT02862730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317046|NCT00807014|Adapalene|adapalene|mesh-list
65519529|NCT02862730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65519530|NCT02862730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65519531|NCT03401450|Bupivacaine|bupivacaine|mesh-list
65519532|NCT03401450|Anesthetics, Local|anesthetics, local|mesh-ancestor
65519533|NCT03401450|Anesthetics|anesthetics|mesh-ancestor
65519534|NCT03401450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65519535|NCT03401450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519536|NCT03401450|Sensory System Agents|sensory system agents|mesh-ancestor
65519537|NCT03401450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65519538|NCT03609970|Vitamin D|vitamin d|mesh-list
65519539|NCT03609970|Vitamins|vitamins|mesh-ancestor
65519540|NCT03609970|Micronutrients|micronutrients|mesh-ancestor
65519541|NCT03609970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519542|NCT03609970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65519543|NCT03610282|Propofol|propofol|mesh-list
65519544|NCT03610282|Methylphenidate|methylphenidate|mesh-list
65519545|NCT03610282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65519546|NCT03610282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65519547|NCT03610282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519548|NCT03610282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65519549|NCT03610282|Anesthetics, General|anesthetics, general|mesh-ancestor
65519550|NCT03610282|Anesthetics|anesthetics|mesh-ancestor
65519551|NCT03610282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65519552|NCT03610282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65519553|NCT03610282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65519554|NCT03610282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65519555|NCT03610282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519556|NCT03610282|Dopamine Agents|dopamine agents|mesh-ancestor
65519557|NCT03610282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65519558|NCT02862574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
65519559|NCT02862574|Methotrexate|methotrexate|mesh-list
65519560|NCT02862574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65519561|NCT02862574|Abortifacient Agents|abortifacient agents|mesh-ancestor
65519562|NCT02862574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65519563|NCT02862574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519564|NCT02862574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65519565|NCT02862574|Antimetabolites|antimetabolites|mesh-ancestor
65519566|NCT02862574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519567|NCT02862574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519568|NCT02862574|Dermatologic Agents|dermatologic agents|mesh-ancestor
65519569|NCT02862574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519570|NCT02862574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65519571|NCT02862574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65519572|NCT02862574|Immunologic Factors|immunologic factors|mesh-ancestor
65519573|NCT02862574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65519574|NCT02862574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65519575|NCT02862574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65519576|NCT05383300|Oxytocin|oxytocin|mesh-list
65519577|NCT05383300|Oxytocics|oxytocics|mesh-ancestor
65519578|NCT05383300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65519579|NCT05383300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519580|NCT03712046|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65519581|NCT03712046|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65519582|NCT03712046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519583|NCT02862106|Vaccines|vaccines|mesh-list
65519584|NCT02862106|Immunologic Factors|immunologic factors|mesh-ancestor
65519585|NCT02862106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519586|NCT03609892|Amoxicillin|amoxicillin|mesh-list
65519587|NCT03609892|Tetracycline|tetracycline|mesh-list
65519588|NCT03609892|Furazolidone|furazolidone|mesh-list
65519589|NCT03609892|Esomeprazole|esomeprazole|mesh-list
65519590|NCT03609892|Bismuth|bismuth|mesh-list
65519591|NCT03609892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65519592|NCT03609892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65519593|NCT03609892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65519594|NCT03609892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65519595|NCT03609892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65519596|NCT03609892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519597|NCT03609892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519598|NCT03609892|Antacids|antacids|mesh-ancestor
65519599|NCT03609892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65519600|NCT03609892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65519601|NCT03609892|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65519602|NCT03609892|Renal Agents|renal agents|mesh-ancestor
65519603|NCT03609892|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65519604|NCT03609892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65519605|NCT03609892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65519606|NCT03609892|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65519607|NCT03609814|Fludarabine|fludarabine|mesh-list
65519608|NCT03609814|Clofarabine|clofarabine|mesh-list
65519609|NCT03609814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519610|NCT03609814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65519611|NCT03609814|Antimetabolites|antimetabolites|mesh-ancestor
65519612|NCT03609814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519613|NCT02457598|Obinutuzumab|obinutuzumab|mesh-list
65519614|NCT02457598|Idelalisib|idelalisib|mesh-list
65519615|NCT02457598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65519616|NCT02457598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519617|NCT02457598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519618|NCT02457598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519619|NCT02859142|Nicotine|nicotine|mesh-list
65519620|NCT02859142|Varenicline|varenicline|mesh-list
65519621|NCT02859142|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65519622|NCT02859142|Autonomic Agents|autonomic agents|mesh-ancestor
65519623|NCT02859142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65519624|NCT02859142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519625|NCT02859142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65519626|NCT02859142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65519627|NCT02859142|Cholinergic Agents|cholinergic agents|mesh-ancestor
65519628|NCT02859142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65519629|NCT02859142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519630|NCT01863550|Dexamethasone|dexamethasone|mesh-list
65519631|NCT01863550|Dexamethasone acetate|dexamethasone acetate|mesh-list
65519632|NCT01863550|Lenalidomide|lenalidomide|mesh-list
65519633|NCT01863550|Bortezomib|bortezomib|mesh-list
65519634|NCT01863550|Ichthammol|ichthammol|mesh-list
65519635|NCT01863550|BB 1101|bb 1101|mesh-list
65519636|NCT01863550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65519637|NCT01863550|Antiemetics|antiemetics|mesh-ancestor
65519638|NCT01863550|Autonomic Agents|autonomic agents|mesh-ancestor
65519639|NCT01863550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65519640|NCT01863550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519641|NCT01863550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65519642|NCT01863550|Glucocorticoids|glucocorticoids|mesh-ancestor
65519643|NCT01863550|Hormones|hormones|mesh-ancestor
65519644|NCT01863550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65519645|NCT01863550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65519646|NCT01863550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519647|NCT01863550|Immunologic Factors|immunologic factors|mesh-ancestor
65519648|NCT01863550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65519649|NCT01863550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65519650|NCT01863550|Growth Substances|growth substances|mesh-ancestor
65519651|NCT01863550|Growth Inhibitors|growth inhibitors|mesh-ancestor
65519652|NCT01863550|Protease Inhibitors|protease inhibitors|mesh-ancestor
65519653|NCT01863550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519654|NCT01863550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519655|NCT01863550|Dermatologic Agents|dermatologic agents|mesh-ancestor
65519656|NCT03351608|Atropine|atropine|mesh-list
65519657|NCT03351608|Glycopyrrolate|glycopyrrolate|mesh-list
65519658|NCT03351608|Neostigmine|neostigmine|mesh-list
65519659|NCT03351608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65519660|NCT03351608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65519661|NCT03351608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65519662|NCT03351608|Autonomic Agents|autonomic agents|mesh-ancestor
65519663|NCT03351608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65519664|NCT03351608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519665|NCT03351608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65519666|NCT03351608|Respiratory System Agents|respiratory system agents|mesh-ancestor
65519667|NCT03351608|Mydriatics|mydriatics|mesh-ancestor
65519668|NCT03351608|Parasympatholytics|parasympatholytics|mesh-ancestor
65519669|NCT03351608|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65519670|NCT03351608|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65519671|NCT03351608|Cholinergic Agents|cholinergic agents|mesh-ancestor
65519672|NCT03351608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65519673|NCT03351608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519674|NCT03351608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65519675|NCT03351608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519676|NCT03351608|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65519677|NCT03382418|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65519678|NCT03382418|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65519679|NCT03382418|Immunologic Factors|immunologic factors|mesh-ancestor
65519680|NCT03382418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519681|NCT03382418|Antacids|antacids|mesh-ancestor
65519682|NCT03382418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519683|NCT03382418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65519684|NCT03382262|Triamcinolone|triamcinolone|mesh-list
65519685|NCT03382262|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65519686|NCT03382262|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65519687|NCT03382262|FX006|fx006|mesh-list
65519688|NCT03382262|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65519689|NCT03382262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65519690|NCT03382262|Glucocorticoids|glucocorticoids|mesh-ancestor
65519691|NCT03382262|Hormones|hormones|mesh-ancestor
65519692|NCT03382262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65519693|NCT03382262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519694|NCT03382262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65519695|NCT03382262|Immunologic Factors|immunologic factors|mesh-ancestor
65519696|NCT03382262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519697|NCT03382262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519698|NCT02236936|Cetuximab|cetuximab|mesh-list
65519699|NCT02236936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519700|NCT02236936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65519701|NCT03638960|Bupivacaine|bupivacaine|mesh-list
65519702|NCT03638960|Anesthetics, Local|anesthetics, local|mesh-ancestor
65519703|NCT03638960|Anesthetics|anesthetics|mesh-ancestor
65519704|NCT03638960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65519705|NCT03638960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519706|NCT03638960|Sensory System Agents|sensory system agents|mesh-ancestor
65519707|NCT03638960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65519708|NCT02259790|Amlodipine|amlodipine|mesh-list
65519709|NCT02259790|Telmisartan|telmisartan|mesh-list
65519710|NCT02259790|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
65519711|NCT02259790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65519712|NCT02259790|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65519713|NCT02259790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65519714|NCT02259790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519715|NCT02259790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65519716|NCT02259790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519717|NCT02259790|Vasodilator Agents|vasodilator agents|mesh-ancestor
65519718|NCT02259790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65519719|NCT02259790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65519720|NCT02857270|Gemcitabine|gemcitabine|mesh-list
65519721|NCT02857270|Paclitaxel|paclitaxel|mesh-list
65519722|NCT02857270|Cetuximab|cetuximab|mesh-list
65519723|NCT02857270|Midazolam|midazolam|mesh-list
65519724|NCT02857270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65519725|NCT02857270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519726|NCT02857270|Tubulin Modulators|tubulin modulators|mesh-ancestor
65519727|NCT02857270|Antimitotic Agents|antimitotic agents|mesh-ancestor
65519728|NCT02857270|Mitosis Modulators|mitosis modulators|mesh-ancestor
65519729|NCT02857270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519730|NCT02857270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65519731|NCT02857270|Antimetabolites|antimetabolites|mesh-ancestor
65519732|NCT02857270|Antiviral Agents|antiviral agents|mesh-ancestor
65519733|NCT02857270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65519734|NCT02857270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519735|NCT02857270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65519736|NCT02857270|Immunologic Factors|immunologic factors|mesh-ancestor
65519737|NCT02857270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519738|NCT02857270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65519739|NCT02857270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65519740|NCT02857270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65519741|NCT02857270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65519742|NCT02857270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65519743|NCT02857270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65519744|NCT02857270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65519745|NCT02857270|Anesthetics, General|anesthetics, general|mesh-ancestor
65519746|NCT02857270|Anesthetics|anesthetics|mesh-ancestor
65519747|NCT02857270|GABA Modulators|gaba modulators|mesh-ancestor
65519748|NCT02857270|GABA Agents|gaba agents|mesh-ancestor
65519749|NCT02857270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65519750|NCT02857270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65519751|NCT03609190|Ketamine|ketamine|mesh-list
65519752|NCT03609190|Analgesics|analgesics|mesh-ancestor
65519753|NCT03609190|Sensory System Agents|sensory system agents|mesh-ancestor
65519754|NCT03609190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65519755|NCT03609190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519756|NCT03609190|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65519757|NCT03609190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65519758|NCT03609190|Anesthetics, General|anesthetics, general|mesh-ancestor
65519759|NCT03609190|Anesthetics|anesthetics|mesh-ancestor
65519760|NCT03609190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65519761|NCT03609190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65519762|NCT03609190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65519763|NCT03609190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65519764|NCT03609190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519765|NCT02856880|Zinc|zinc|mesh-list
65519766|NCT02856880|Trace Elements|trace elements|mesh-ancestor
65519767|NCT02856880|Micronutrients|micronutrients|mesh-ancestor
65519768|NCT02856880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519769|NCT02856802|Sumatriptan|sumatriptan|mesh-list
65519770|NCT02856802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65519771|NCT02856802|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65519772|NCT02856802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65519773|NCT02856802|Serotonin Agents|serotonin agents|mesh-ancestor
65519774|NCT02856802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65519775|NCT02856802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519776|NCT02856802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519777|NCT03381248|Hyaluronic Acid|hyaluronic acid|mesh-list
65519778|NCT03381248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65519779|NCT03381248|Immunologic Factors|immunologic factors|mesh-ancestor
65519780|NCT03381248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519781|NCT03381248|Viscosupplements|viscosupplements|mesh-ancestor
65519782|NCT03381248|Protective Agents|protective agents|mesh-ancestor
65519783|NCT02024230|Warfarin|warfarin|mesh-list
65519784|NCT02024230|Rivaroxaban|rivaroxaban|mesh-list
65519785|NCT02024230|Anticoagulants|anticoagulants|mesh-ancestor
65519786|NCT02024230|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65519787|NCT02024230|Antithrombins|antithrombins|mesh-ancestor
65519788|NCT02024230|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65519789|NCT02024230|Protease Inhibitors|protease inhibitors|mesh-ancestor
65519790|NCT02024230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519791|NCT02024230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519792|NCT03380390|Phenylephrine|phenylephrine|mesh-list
65519793|NCT03380390|Oxymetazoline|oxymetazoline|mesh-list
65519794|NCT03380390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65519795|NCT03380390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65519796|NCT03380390|Adrenergic Agents|adrenergic agents|mesh-ancestor
65519797|NCT03380390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65519798|NCT03380390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519799|NCT03380390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519800|NCT03380390|Sympathomimetics|sympathomimetics|mesh-ancestor
65519801|NCT03380390|Autonomic Agents|autonomic agents|mesh-ancestor
65519802|NCT03380390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65519803|NCT03380390|Nasal Decongestants|nasal decongestants|mesh-ancestor
65519804|NCT03380390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65519805|NCT03380390|Respiratory System Agents|respiratory system agents|mesh-ancestor
65519806|NCT03380390|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65519807|NCT03380390|Mydriatics|mydriatics|mesh-ancestor
65519808|NCT03380390|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65519809|NCT03380390|Protective Agents|protective agents|mesh-ancestor
65519810|NCT01935778|Docetaxel|docetaxel|mesh-list
65519811|NCT01935778|Capecitabine|capecitabine|mesh-list
65519812|NCT01935778|Oxaliplatin|oxaliplatin|mesh-list
65519813|NCT01935778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519814|NCT01935778|Tubulin Modulators|tubulin modulators|mesh-ancestor
65519815|NCT01935778|Antimitotic Agents|antimitotic agents|mesh-ancestor
65519816|NCT01935778|Mitosis Modulators|mitosis modulators|mesh-ancestor
65519817|NCT01935778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519818|NCT01935778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65519819|NCT01935778|Antimetabolites|antimetabolites|mesh-ancestor
65519820|NCT02034292|Aspirin|aspirin|mesh-list
65519821|NCT02034292|Clopidogrel|clopidogrel|mesh-list
65519822|NCT02034292|APD791|apd791|mesh-list
65519823|NCT02034292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65519824|NCT02034292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65519825|NCT02034292|Analgesics|analgesics|mesh-ancestor
65519826|NCT02034292|Sensory System Agents|sensory system agents|mesh-ancestor
65519827|NCT02034292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65519828|NCT02034292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519829|NCT02034292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65519830|NCT02034292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65519831|NCT02034292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65519832|NCT02034292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65519833|NCT02034292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519834|NCT02034292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65519835|NCT02034292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65519836|NCT02034292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519837|NCT02034292|Antipyretics|antipyretics|mesh-ancestor
65519838|NCT02034292|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65519839|NCT02034292|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65519840|NCT02034292|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65519841|NCT02034292|Purinergic Agents|purinergic agents|mesh-ancestor
65519842|NCT02034292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65519843|NCT02034292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65519844|NCT02034292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65519845|NCT02034292|Serotonin Agents|serotonin agents|mesh-ancestor
65519846|NCT01758328|Fludarabine|fludarabine|mesh-list
65519848|NCT01758328|Busulfan|busulfan|mesh-list
65519849|NCT01758328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65519850|NCT01758328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519851|NCT01758328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519852|NCT01758328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65519853|NCT01758328|Immunologic Factors|immunologic factors|mesh-ancestor
65519854|NCT01758328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519855|NCT01758328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65519856|NCT01758328|Alkylating Agents|alkylating agents|mesh-ancestor
65519857|NCT01758328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65519858|NCT04125550|Propofol|propofol|mesh-list
65519859|NCT04125550|Sevoflurane|sevoflurane|mesh-list
65519860|NCT04125550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65519861|NCT04125550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65519862|NCT04125550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519863|NCT04125550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65519864|NCT04125550|Anesthetics, General|anesthetics, general|mesh-ancestor
65519865|NCT04125550|Anesthetics|anesthetics|mesh-ancestor
65519866|NCT04125550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65519867|NCT04125550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65519868|NCT02237326|Acetic Acid|acetic acid|mesh-list
65519869|NCT02237326|Retinol acetate|retinol acetate|mesh-list
65519870|NCT02237326|Lugol's solution|lugol's solution|mesh-list
65519871|NCT02237326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65519872|NCT02237326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65519873|NCT02237326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65519874|NCT02237326|Immunologic Factors|immunologic factors|mesh-ancestor
65519875|NCT02237326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519876|NCT02237326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65519877|NCT02237326|Protective Agents|protective agents|mesh-ancestor
65519878|NCT02237326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519879|NCT02237326|Hemostatics|hemostatics|mesh-ancestor
65519880|NCT02237326|Coagulants|coagulants|mesh-ancestor
65519881|NCT02034604|Tamsulosin|tamsulosin|mesh-list
65519882|NCT02034604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65519883|NCT02034604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65519884|NCT02034604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65519885|NCT02034604|Adrenergic Agents|adrenergic agents|mesh-ancestor
65519886|NCT02034604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65519887|NCT02034604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519888|NCT02034604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519889|NCT02034604|Urological Agents|urological agents|mesh-ancestor
65519890|NCT03608098|Oxymetazoline|oxymetazoline|mesh-list
65519891|NCT03608098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65519892|NCT03608098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65519893|NCT03608098|Adrenergic Agents|adrenergic agents|mesh-ancestor
65519894|NCT03608098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65519895|NCT03608098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519896|NCT03608098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519897|NCT03608098|Sympathomimetics|sympathomimetics|mesh-ancestor
65519898|NCT03608098|Autonomic Agents|autonomic agents|mesh-ancestor
65519899|NCT03608098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65519900|NCT03608098|Nasal Decongestants|nasal decongestants|mesh-ancestor
65519901|NCT03608098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65519902|NCT03608098|Respiratory System Agents|respiratory system agents|mesh-ancestor
65519903|NCT02035072|Gemcitabine|gemcitabine|mesh-list
65519904|NCT02035072|Oxaliplatin|oxaliplatin|mesh-list
65248929|NCT00838669|Serotonin Agents|serotonin agents|mesh-ancestor
65519905|NCT02035072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65519906|NCT02035072|Antimetabolites|antimetabolites|mesh-ancestor
65519907|NCT02035072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519908|NCT02035072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317416|NCT04104204|Morphine|morphine|mesh-list
65519909|NCT02035072|Antiviral Agents|antiviral agents|mesh-ancestor
65519910|NCT02035072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65519911|NCT02035072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519912|NCT02035072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65519913|NCT02035072|Immunologic Factors|immunologic factors|mesh-ancestor
65519914|NCT02035072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519916|NCT00358215|Hematinics|hematinics|mesh-ancestor
65519917|NCT03605758|Ivermectin|ivermectin|mesh-list
65519918|NCT03605758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65519919|NCT03605758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65519920|NCT03605056|Dexamethasone|dexamethasone|mesh-list
65519921|NCT03605056|Lenalidomide|lenalidomide|mesh-list
65519922|NCT03605056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65519923|NCT03605056|Antiemetics|antiemetics|mesh-ancestor
65519924|NCT03605056|Autonomic Agents|autonomic agents|mesh-ancestor
65519925|NCT03605056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65519926|NCT03605056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519927|NCT03605056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65519928|NCT03605056|Glucocorticoids|glucocorticoids|mesh-ancestor
65519929|NCT03605056|Hormones|hormones|mesh-ancestor
65519930|NCT03605056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65519931|NCT03605056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65519932|NCT03605056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519933|NCT03605056|Immunologic Factors|immunologic factors|mesh-ancestor
65519934|NCT03605056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65519935|NCT03605056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65519936|NCT03605056|Growth Substances|growth substances|mesh-ancestor
65519937|NCT03605056|Growth Inhibitors|growth inhibitors|mesh-ancestor
65519938|NCT01002742|Mycophenolic Acid|mycophenolic acid|mesh-list
65519939|NCT01002742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65519940|NCT01002742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519941|NCT01002742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65519942|NCT01002742|Antitubercular Agents|antitubercular agents|mesh-ancestor
65519943|NCT01002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65519944|NCT01002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65519945|NCT01002742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519946|NCT01002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519947|NCT03604744|Psilocybin|psilocybin|mesh-list
65519948|NCT03604744|Hallucinogens|hallucinogens|mesh-ancestor
65519949|NCT03604744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519950|NCT03604744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65519951|NCT03604354|Pregabalin|pregabalin|mesh-list
65519952|NCT03604354|Tapentadol|tapentadol|mesh-list
65519953|NCT03604354|Analgesics|analgesics|mesh-ancestor
65519954|NCT03604354|Sensory System Agents|sensory system agents|mesh-ancestor
65519955|NCT03604354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65519956|NCT03604354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519957|NCT03604354|Anticonvulsants|anticonvulsants|mesh-ancestor
65519958|NCT03604354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65519959|NCT03604354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65519960|NCT03604354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519961|NCT03604354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65519962|NCT03604354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65519963|NCT03604354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65519964|NCT03604354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65519965|NCT03604354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65519966|NCT03604354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65519967|NCT03604354|Narcotics|narcotics|mesh-ancestor
65519968|NCT03604354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65519969|NCT03604354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65519970|NCT03604354|Adrenergic Agents|adrenergic agents|mesh-ancestor
65519971|NCT03604354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65519972|NCT03603418|Dexamethasone|dexamethasone|mesh-list
65519973|NCT03603418|Dexamethasone acetate|dexamethasone acetate|mesh-list
65519974|NCT03603418|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65519975|NCT03603418|BB 1101|bb 1101|mesh-list
65519976|NCT03603418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65519977|NCT03603418|Antiemetics|antiemetics|mesh-ancestor
65519978|NCT03603418|Autonomic Agents|autonomic agents|mesh-ancestor
65519979|NCT03603418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65519980|NCT03603418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65519981|NCT03603418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65519982|NCT03603418|Glucocorticoids|glucocorticoids|mesh-ancestor
65519983|NCT03603418|Hormones|hormones|mesh-ancestor
65519984|NCT03603418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65519985|NCT03603418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65519986|NCT03603418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65519988|NCT03603418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519989|NCT03603418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519990|NCT02034838|Ritonavir|ritonavir|mesh-list
65519991|NCT02034838|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65519992|NCT02034838|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65519993|NCT02034838|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65519994|NCT02034838|Protease Inhibitors|protease inhibitors|mesh-ancestor
65519995|NCT02034838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65519996|NCT02034838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65519997|NCT02034838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65519998|NCT02034838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65519999|NCT02034838|Antiviral Agents|antiviral agents|mesh-ancestor
65520000|NCT02034838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65520001|NCT02034838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65520002|NCT02034838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65520003|NCT03287908|Dexamethasone|dexamethasone|mesh-list
65520004|NCT03287908|Pomalidomide|pomalidomide|mesh-list
65520005|NCT03287908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65520006|NCT03287908|Antiemetics|antiemetics|mesh-ancestor
65520007|NCT03287908|Autonomic Agents|autonomic agents|mesh-ancestor
65520008|NCT03287908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520009|NCT03287908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520010|NCT03287908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65520011|NCT03287908|Glucocorticoids|glucocorticoids|mesh-ancestor
65520012|NCT03287908|Hormones|hormones|mesh-ancestor
65520013|NCT03287908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65520014|NCT03287908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65520015|NCT03287908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520016|NCT03287908|Immunologic Factors|immunologic factors|mesh-ancestor
65520017|NCT03287908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65520018|NCT03287908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65520019|NCT03287908|Growth Substances|growth substances|mesh-ancestor
65520020|NCT03287908|Growth Inhibitors|growth inhibitors|mesh-ancestor
65520021|NCT02852434|Lidocaine|lidocaine|mesh-list
65520022|NCT02852434|Anesthetics, Local|anesthetics, local|mesh-ancestor
65520023|NCT02852434|Anesthetics|anesthetics|mesh-ancestor
65520024|NCT02852434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65520025|NCT02852434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520026|NCT02852434|Sensory System Agents|sensory system agents|mesh-ancestor
65520027|NCT02852434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520028|NCT02852434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65520029|NCT02852434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65520030|NCT02852434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65520031|NCT02852434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65520032|NCT02852434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520033|NCT03606928|Leucovorin|leucovorin|mesh-list
65520034|NCT03606928|Docetaxel|docetaxel|mesh-list
65520035|NCT03606928|Oxaliplatin|oxaliplatin|mesh-list
65520036|NCT03606928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520037|NCT03606928|Tubulin Modulators|tubulin modulators|mesh-ancestor
65520038|NCT03606928|Antimitotic Agents|antimitotic agents|mesh-ancestor
65520039|NCT03606928|Mitosis Modulators|mitosis modulators|mesh-ancestor
65520040|NCT03606928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520041|NCT03606928|Antidotes|antidotes|mesh-ancestor
65520042|NCT03606928|Protective Agents|protective agents|mesh-ancestor
65520043|NCT03606928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520044|NCT03606928|Vitamin B Complex|vitamin b complex|mesh-ancestor
65520045|NCT03606928|Vitamins|vitamins|mesh-ancestor
65520046|NCT03606928|Micronutrients|micronutrients|mesh-ancestor
65520047|NCT02903368|Prednisone|prednisone|mesh-list
65520048|NCT02903368|Leuprolide|leuprolide|mesh-list
65520049|NCT02903368|Abiraterone Acetate|abiraterone acetate|mesh-list
65520050|NCT02903368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65520051|NCT02903368|Glucocorticoids|glucocorticoids|mesh-ancestor
65520052|NCT02903368|Hormones|hormones|mesh-ancestor
65520053|NCT02903368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65520054|NCT02903368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520055|NCT02903368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65520056|NCT02903368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520057|NCT02903368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65520058|NCT02903368|Fertility Agents|fertility agents|mesh-ancestor
65520059|NCT02903368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65520060|NCT02903368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65520061|NCT02903368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520062|NCT02903368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520063|NCT02903368|Hormone Antagonists|hormone antagonists|mesh-ancestor
65520064|NCT02903368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65520065|NCT03602248|Methamphetamine|methamphetamine|mesh-list
65520066|NCT03602248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65520067|NCT03602248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520068|NCT03602248|Sympathomimetics|sympathomimetics|mesh-ancestor
65520069|NCT03602248|Autonomic Agents|autonomic agents|mesh-ancestor
65520070|NCT03602248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520071|NCT03602248|Dopamine Agents|dopamine agents|mesh-ancestor
65520072|NCT03602248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65520073|NCT03602248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520074|NCT03602248|Adrenergic Agents|adrenergic agents|mesh-ancestor
65520075|NCT03602248|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65520076|NCT03602248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65520077|NCT03602248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65520078|NCT03602248|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65520079|NCT03602638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65520080|NCT03602638|Acarbose|acarbose|mesh-list
65520081|NCT03602638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65520082|NCT03602638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520083|NCT03602638|Incretins|incretins|mesh-ancestor
65520084|NCT03602638|Hormones|hormones|mesh-ancestor
65520085|NCT03602638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65520086|NCT03602638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65520087|NCT03602638|Protease Inhibitors|protease inhibitors|mesh-ancestor
65520088|NCT03602638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520089|NCT03602638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520090|NCT03602638|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65520091|NCT02237560|Camphor|camphor|mesh-list
65520092|NCT02237560|Salicylates|salicylates|mesh-list
65520093|NCT02237560|Methyl salicylate|methyl salicylate|mesh-list
65520094|NCT02237560|Menthol|menthol|mesh-list
65520095|NCT02237560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65520096|NCT02237560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65520097|NCT02237560|Antipruritics|antipruritics|mesh-ancestor
65520098|NCT02237560|Dermatologic Agents|dermatologic agents|mesh-ancestor
65520099|NCT02237560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65520100|NCT02237560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65520101|NCT02237560|Analgesics|analgesics|mesh-ancestor
65520102|NCT02237560|Sensory System Agents|sensory system agents|mesh-ancestor
65520103|NCT02237560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520104|NCT02237560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520105|NCT02237560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65520106|NCT02237560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65520107|NCT02237560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65520108|NCT02237560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520109|NCT02237560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520110|NCT03602014|Droxidopa|droxidopa|mesh-list
65520111|NCT03602014|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65520112|NCT03602014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65520113|NCT03601624|Dexamethasone|dexamethasone|mesh-list
65520114|NCT03601624|Cyclophosphamide|cyclophosphamide|mesh-list
65520115|NCT03601624|Pomalidomide|pomalidomide|mesh-list
65520116|NCT03601624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65520117|NCT03601624|Immunologic Factors|immunologic factors|mesh-ancestor
65520118|NCT03601624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520119|NCT03601624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65520120|NCT03601624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65520121|NCT03601624|Alkylating Agents|alkylating agents|mesh-ancestor
65520122|NCT03601624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520123|NCT03601624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520124|NCT03601624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65520125|NCT03601624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65520126|NCT03601624|Antiemetics|antiemetics|mesh-ancestor
65520127|NCT03601624|Autonomic Agents|autonomic agents|mesh-ancestor
65520128|NCT03601624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520129|NCT03601624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65520130|NCT03601624|Glucocorticoids|glucocorticoids|mesh-ancestor
65520131|NCT03601624|Hormones|hormones|mesh-ancestor
65520132|NCT03601624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65520133|NCT03601624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65520134|NCT03601624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65520135|NCT03601624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65520137|NCT03601624|Growth Inhibitors|growth inhibitors|mesh-ancestor
65520138|NCT03899428|Sorafenib|sorafenib|mesh-list
65520139|NCT03899428|Durvalumab|durvalumab|mesh-list
65520140|NCT03899428|Lenvatinib|lenvatinib|mesh-list
65520141|NCT03899428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520142|NCT03899428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65520143|NCT03899428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520144|NCT03899428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520145|NCT03899428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65520146|NCT02238418|Cholecalciferol|cholecalciferol|mesh-list
65520147|NCT02238418|Vitamin D|vitamin d|mesh-list
65520148|NCT02238418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65520149|NCT02238418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520150|NCT02238418|Vitamins|vitamins|mesh-ancestor
65520151|NCT02238418|Micronutrients|micronutrients|mesh-ancestor
65520152|NCT02238418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65520153|NCT00697684|Clofarabine|clofarabine|mesh-list
65520154|NCT00697684|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65520155|NCT00697684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65520156|NCT00697684|Antimetabolites|antimetabolites|mesh-ancestor
65520157|NCT00697684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520158|NCT00697684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520159|NCT00697684|Immunologic Factors|immunologic factors|mesh-ancestor
65520160|NCT00697684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520161|NCT00697684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65520162|NCT02850016|Romidepsin|romidepsin|mesh-list
65520163|NCT02850016|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65520164|NCT02850016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65520165|NCT02850016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520166|NCT02850016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520167|NCT02850016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520168|NCT02849704|Pancrelipase|pancrelipase|mesh-list
65520169|NCT02849704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65520170|NCT03600766|Mirabegron|mirabegron|mesh-list
65520171|NCT03600766|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65520172|NCT03600766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65520173|NCT03600766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65520174|NCT03600766|Adrenergic Agents|adrenergic agents|mesh-ancestor
65520175|NCT03600766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65520176|NCT03600766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520177|NCT03600766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520178|NCT03600766|Urological Agents|urological agents|mesh-ancestor
65520179|NCT03600454|Anesthetics|anesthetics|mesh-list
65520180|NCT03600454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65520181|NCT03600454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520182|NCT03594604|Contraceptive Agents|contraceptive agents|mesh-list
65520183|NCT03594604|Norethindrone|norethindrone|mesh-list
65520184|NCT03594604|Norethindrone Acetate|norethindrone acetate|mesh-list
65520185|NCT03594604|Contraceptives, Oral|contraceptives, oral|mesh-list
65520186|NCT03594604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65520187|NCT03594604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65520188|NCT03594604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520189|NCT03594604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65520190|NCT03594604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65520191|NCT03594604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65520192|NCT03594604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65520193|NCT02689258|Bupivacaine|bupivacaine|mesh-list
65520194|NCT02689258|Anesthetics, Local|anesthetics, local|mesh-ancestor
65520195|NCT02689258|Anesthetics|anesthetics|mesh-ancestor
65520196|NCT02689258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65520197|NCT02689258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520198|NCT02689258|Sensory System Agents|sensory system agents|mesh-ancestor
65520199|NCT02689258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520200|NCT02238184|Ipratropium|ipratropium|mesh-list
65520201|NCT02238184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65520202|NCT02238184|Autonomic Agents|autonomic agents|mesh-ancestor
65520203|NCT02238184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520204|NCT02238184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520205|NCT02238184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65520206|NCT02238184|Respiratory System Agents|respiratory system agents|mesh-ancestor
65520207|NCT02238184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65520208|NCT02238184|Cholinergic Agents|cholinergic agents|mesh-ancestor
65520209|NCT02238184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65520210|NCT02238184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520212|NCT03592498|Silver Sulfadiazine|silver sulfadiazine|mesh-list
65520213|NCT03592498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65520214|NCT03592498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65520215|NCT03592498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65520216|NCT03592498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65520217|NCT03592498|Coccidiostats|coccidiostats|mesh-ancestor
65520218|NCT03592498|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65520219|NCT03600064|Misoprostol|misoprostol|mesh-list
65520220|NCT03600064|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65520221|NCT03600064|Abortifacient Agents|abortifacient agents|mesh-ancestor
65520222|NCT03600064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65520223|NCT03600064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520224|NCT03600064|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65520225|NCT03600064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65520226|NCT03600064|Oxytocics|oxytocics|mesh-ancestor
65520227|NCT02721082|Nicotine|nicotine|mesh-list
65520228|NCT02721082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65520229|NCT02721082|Autonomic Agents|autonomic agents|mesh-ancestor
65520230|NCT02721082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520231|NCT02721082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520232|NCT02721082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65520233|NCT02721082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65520234|NCT02721082|Cholinergic Agents|cholinergic agents|mesh-ancestor
65520235|NCT02721082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65520236|NCT02721082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520237|NCT02238106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65520238|NCT02238106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65520239|NCT02238106|Autonomic Agents|autonomic agents|mesh-ancestor
65520240|NCT02238106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520241|NCT02238106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520242|NCT02238106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65520243|NCT02238106|Respiratory System Agents|respiratory system agents|mesh-ancestor
65520244|NCT02238106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65520245|NCT02238106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65520246|NCT02238106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65520247|NCT02238106|Adrenergic Agents|adrenergic agents|mesh-ancestor
65520248|NCT02238106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65520249|NCT02238106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520250|NCT03577912|Anesthetics|anesthetics|mesh-list
65520251|NCT03577912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65520252|NCT03577912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520253|NCT02238262|Telmisartan|telmisartan|mesh-list
65520254|NCT02238262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65520255|NCT02238262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65520256|NCT02238262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65520257|NCT02238262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520258|NCT03577834|Acetic Acid|acetic acid|mesh-list
65520259|NCT03577834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65520260|NCT03577834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65520261|NCT03373760|Durvalumab|durvalumab|mesh-list
65520262|NCT03373760|Ipilimumab|ipilimumab|mesh-list
65520263|NCT03373760|Tremelimumab|tremelimumab|mesh-list
65520264|NCT03373760|Immunoglobulins|immunoglobulins|mesh-list
65520265|NCT03373760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65520266|NCT03373760|Immunoglobulin G|immunoglobulin g|mesh-list
65520267|NCT03373760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65520268|NCT03373760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520269|NCT03373760|Immunologic Factors|immunologic factors|mesh-ancestor
65520270|NCT03373760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520271|NCT03373760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65520272|NCT03373760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520273|NCT03707678|Albuterol|albuterol|mesh-list
65520274|NCT03707678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65520275|NCT03707678|Autonomic Agents|autonomic agents|mesh-ancestor
65520276|NCT03707678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520277|NCT03707678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520278|NCT03707678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65520279|NCT03707678|Respiratory System Agents|respiratory system agents|mesh-ancestor
65520280|NCT03707678|Tocolytic Agents|tocolytic agents|mesh-ancestor
65520281|NCT03707678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65520282|NCT03707678|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65520283|NCT03707678|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65520285|NCT03707678|Adrenergic Agents|adrenergic agents|mesh-ancestor
65520286|NCT03707678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65520287|NCT03707678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520288|NCT03334448|Insulin Lispro|insulin lispro|mesh-list
65520289|NCT03334448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65520290|NCT03334448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520291|NCT04773002|Anesthetics|anesthetics|mesh-list
65520292|NCT04773002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65520293|NCT04773002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520294|NCT02849080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65520295|NCT02849080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65520296|NCT02849080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520297|NCT02849080|Incretins|incretins|mesh-ancestor
65520298|NCT02849080|Hormones|hormones|mesh-ancestor
65520299|NCT02849080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65520300|NCT02849080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65520301|NCT02849080|Protease Inhibitors|protease inhibitors|mesh-ancestor
65520302|NCT02849080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520303|NCT02849080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520304|NCT03346070|Glycopyrrolate|glycopyrrolate|mesh-list
65520305|NCT03346070|Rocuronium|rocuronium|mesh-list
65520306|NCT03346070|Vecuronium Bromide|vecuronium bromide|mesh-list
65520307|NCT03346070|Neostigmine|neostigmine|mesh-list
65520308|NCT03346070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65520309|NCT03346070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65520310|NCT03346070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65520311|NCT03346070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520312|NCT03346070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520313|NCT03346070|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65520314|NCT03346070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520315|NCT03346070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520316|NCT03346070|Cholinergic Agents|cholinergic agents|mesh-ancestor
65520317|NCT03346070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65520318|NCT03346070|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65520319|NCT03346070|Autonomic Agents|autonomic agents|mesh-ancestor
65520320|NCT03346070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65520321|NCT03346070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65520322|NCT03346070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65520323|NCT03346070|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65520324|NCT03590626|Dulaglutide|dulaglutide|mesh-list
65520325|NCT03590626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65520326|NCT03590626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520327|NCT02238340|Ketoprofen|ketoprofen|mesh-list
65520328|NCT02238340|Morphine|morphine|mesh-list
65520329|NCT02238340|Oxycodone|oxycodone|mesh-list
65520330|NCT02238340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65520331|NCT02238340|Narcotics|narcotics|mesh-ancestor
65520332|NCT02238340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65520333|NCT02238340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520334|NCT02238340|Analgesics|analgesics|mesh-ancestor
65520335|NCT02238340|Sensory System Agents|sensory system agents|mesh-ancestor
65520336|NCT02238340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520337|NCT02238340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65520338|NCT02238340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65520339|NCT02238340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65520340|NCT02238340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65520341|NCT02238340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65520342|NCT02238340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520343|NCT02238340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520344|NCT03577132|Atezolizumab|atezolizumab|mesh-list
65520345|NCT03577132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520346|NCT05194124|alpha-MSH|alpha-msh|mesh-list
65520347|NCT05194124|Hormones|hormones|mesh-ancestor
65520348|NCT05194124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65520349|NCT05194124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520350|NCT02250664|Nicotine|nicotine|mesh-list
65520351|NCT02250664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65520352|NCT02250664|Autonomic Agents|autonomic agents|mesh-ancestor
65520353|NCT02250664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520354|NCT02250664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520355|NCT02250664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65317864|NCT00832234|Hormones|hormones|mesh-ancestor
65520356|NCT02250664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65520357|NCT02250664|Cholinergic Agents|cholinergic agents|mesh-ancestor
65520358|NCT02250664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65520359|NCT02250664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520360|NCT02239276|Stiripentol|stiripentol|mesh-list
65520361|NCT02239276|Anticonvulsants|anticonvulsants|mesh-ancestor
65520362|NCT03576820|Lidocaine|lidocaine|mesh-list
65520363|NCT03576820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65520364|NCT03576820|Anesthetics, Local|anesthetics, local|mesh-ancestor
65520365|NCT03576820|Anesthetics|anesthetics|mesh-ancestor
65520366|NCT03576820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65520367|NCT03576820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520368|NCT03576820|Sensory System Agents|sensory system agents|mesh-ancestor
65520369|NCT03576820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520370|NCT03576820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65520371|NCT03576820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65520372|NCT03576820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65520373|NCT03576820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65520374|NCT03576820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520375|NCT03579082|Decitabine|decitabine|mesh-list
65520376|NCT03579082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65520377|NCT03579082|Antimetabolites|antimetabolites|mesh-ancestor
65520378|NCT03579082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520379|NCT03579082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520380|NCT03579082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520381|NCT03579004|Paclitaxel|paclitaxel|mesh-list
65520382|NCT03579004|Fluorouracil|fluorouracil|mesh-list
65520383|NCT03579004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65520384|NCT03579004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520385|NCT03579004|Tubulin Modulators|tubulin modulators|mesh-ancestor
65520386|NCT03579004|Antimitotic Agents|antimitotic agents|mesh-ancestor
65520387|NCT03579004|Mitosis Modulators|mitosis modulators|mesh-ancestor
65520388|NCT03579004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520389|NCT03579004|Antimetabolites|antimetabolites|mesh-ancestor
65520390|NCT03579004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65520391|NCT03579004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65520392|NCT03579004|Immunologic Factors|immunologic factors|mesh-ancestor
65520393|NCT03579004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520394|NCT03576508|Lidocaine|lidocaine|mesh-list
65520395|NCT03576508|Epinephrine|epinephrine|mesh-list
65520396|NCT03576508|Capsaicin|capsaicin|mesh-list
65520397|NCT03576508|Anesthetics, Local|anesthetics, local|mesh-ancestor
65520398|NCT03576508|Anesthetics|anesthetics|mesh-ancestor
65520399|NCT03576508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65520400|NCT03576508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520401|NCT03576508|Sensory System Agents|sensory system agents|mesh-ancestor
65520402|NCT03576508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520403|NCT03576508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65520404|NCT03576508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65520405|NCT03576508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65520406|NCT03576508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65520407|NCT03576508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520408|NCT03576508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65520409|NCT03576508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65520410|NCT03576508|Adrenergic Agents|adrenergic agents|mesh-ancestor
65520411|NCT03576508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65520412|NCT03576508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65520413|NCT03576508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65520414|NCT03576508|Autonomic Agents|autonomic agents|mesh-ancestor
65520415|NCT03576508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65520416|NCT03576508|Respiratory System Agents|respiratory system agents|mesh-ancestor
65520417|NCT03576508|Mydriatics|mydriatics|mesh-ancestor
65520418|NCT03576508|Sympathomimetics|sympathomimetics|mesh-ancestor
65520419|NCT03576508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65520420|NCT03576508|Antipruritics|antipruritics|mesh-ancestor
65520421|NCT03576508|Dermatologic Agents|dermatologic agents|mesh-ancestor
65520422|NCT02646982|Candesartan|candesartan|mesh-list
65520423|NCT02646982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65520424|NCT02646982|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65520425|NCT02646982|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65520426|NCT02646982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520427|NCT03576040|Edotreotide|edotreotide|mesh-list
65520428|NCT03576040|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65520429|NCT03576040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520430|NCT03574246|Chlorhexidine|chlorhexidine|mesh-list
65520431|NCT03574246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65520432|NCT03574246|Benzydamine|benzydamine|mesh-list
65520433|NCT03574246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65520434|NCT03574246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65520435|NCT03574246|Disinfectants|disinfectants|mesh-ancestor
65520436|NCT03574246|Dermatologic Agents|dermatologic agents|mesh-ancestor
65520437|NCT03574246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65520438|NCT02239900|Ipilimumab|ipilimumab|mesh-list
65520439|NCT02239900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65520440|NCT02239900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520441|NCT02239900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65520442|NCT02239900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520443|NCT03574090|Amoxicillin|amoxicillin|mesh-list
65520444|NCT03574090|Clavulanic Acid|clavulanic acid|mesh-list
65520445|NCT03574090|Clavulanic Acids|clavulanic acids|mesh-list
65520446|NCT03574090|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65520447|NCT03574090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65520448|NCT03574090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65520449|NCT03574090|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65520450|NCT03574090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520451|NCT03574090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520452|NCT03573934|Glucagon|glucagon|mesh-list
65520453|NCT03573934|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65520454|NCT03573934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65520455|NCT03573934|Hormones|hormones|mesh-ancestor
65520456|NCT03573934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65520457|NCT03573934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520458|NCT03573934|Incretins|incretins|mesh-ancestor
65520459|NCT02229136|Prednisolone|prednisolone|mesh-list
65520460|NCT02229136|Hydrocortisone|hydrocortisone|mesh-list
65520461|NCT02229136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65520462|NCT02229136|Glucocorticoids|glucocorticoids|mesh-ancestor
65520463|NCT02229136|Hormones|hormones|mesh-ancestor
65520464|NCT02229136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65520465|NCT02229136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520466|NCT02229136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65520467|NCT02229136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520468|NCT02523898|Metformin|metformin|mesh-list
65520469|NCT02523898|Clomiphene|clomiphene|mesh-list
65520470|NCT02523898|Enclomiphene|enclomiphene|mesh-list
65520471|NCT02523898|Zuclomiphene|zuclomiphene|mesh-list
65520472|NCT02523898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65520473|NCT02523898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520474|NCT02523898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65520475|NCT02523898|Hormone Antagonists|hormone antagonists|mesh-ancestor
65520476|NCT02523898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65520477|NCT02523898|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65520478|NCT02523898|Fertility Agents|fertility agents|mesh-ancestor
65520479|NCT02523898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65520480|NCT02523898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65520481|NCT02523898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65520482|NCT02845336|Celecoxib|celecoxib|mesh-list
65520483|NCT02845336|Lubricant Eye Drops|lubricant eye drops|mesh-list
65520484|NCT02845336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65520485|NCT02845336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65520486|NCT02845336|Analgesics|analgesics|mesh-ancestor
65520487|NCT02845336|Sensory System Agents|sensory system agents|mesh-ancestor
65520488|NCT02845336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520489|NCT02845336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520490|NCT02845336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65520491|NCT02845336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65520492|NCT02845336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65520493|NCT02845336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65520494|NCT02845336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520495|NCT02845336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520496|NCT02845336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65520497|NCT02845336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65520498|NCT02244502|Paclitaxel|paclitaxel|mesh-list
65520499|NCT02244502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65520500|NCT02244502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520501|NCT02244502|Tubulin Modulators|tubulin modulators|mesh-ancestor
65520502|NCT02244502|Antimitotic Agents|antimitotic agents|mesh-ancestor
65520503|NCT02244502|Mitosis Modulators|mitosis modulators|mesh-ancestor
65520504|NCT02244502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520505|NCT03573622|Sarpogrelate|sarpogrelate|mesh-list
65520506|NCT03573622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65520507|NCT03573622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65520508|NCT03573622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520509|NCT03573622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65520510|NCT03573622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65520511|NCT03573622|Serotonin Agents|serotonin agents|mesh-ancestor
65520512|NCT03573622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65520513|NCT03573622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520514|NCT02951156|Gemcitabine|gemcitabine|mesh-list
65520515|NCT02951156|Rituximab|rituximab|mesh-list
65520516|NCT02951156|Avelumab|avelumab|mesh-list
65520517|NCT02951156|Oxaliplatin|oxaliplatin|mesh-list
65520518|NCT02951156|Azacitidine|azacitidine|mesh-list
65520519|NCT02951156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65520520|NCT02951156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65520521|NCT02951156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520522|NCT02951156|Immunologic Factors|immunologic factors|mesh-ancestor
65520523|NCT02951156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520524|NCT02951156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65520525|NCT02951156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65520526|NCT02951156|Antimetabolites|antimetabolites|mesh-ancestor
65520527|NCT02951156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520528|NCT02951156|Antiviral Agents|antiviral agents|mesh-ancestor
65520529|NCT02951156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65520530|NCT02951156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520531|NCT02951156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65520532|NCT02951156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65520533|NCT02951156|Alkylating Agents|alkylating agents|mesh-ancestor
65520534|NCT03571594|Octreotide|octreotide|mesh-list
65520535|NCT03571594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65520536|NCT03571594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65520537|NCT03571594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520538|NCT03571438|Sirolimus|sirolimus|mesh-list
65520539|NCT03571438|Sunitinib|sunitinib|mesh-list
65520540|NCT03571438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520541|NCT03571438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65520542|NCT03571438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65520543|NCT03571438|Growth Substances|growth substances|mesh-ancestor
65520544|NCT03571438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520545|NCT03571438|Growth Inhibitors|growth inhibitors|mesh-ancestor
65520546|NCT03571438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65520547|NCT03571438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520548|NCT03571438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520549|NCT03571438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65520550|NCT03571438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65520551|NCT03571438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65520552|NCT03571438|Antifungal Agents|antifungal agents|mesh-ancestor
65520553|NCT03571438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65520554|NCT03571438|Immunologic Factors|immunologic factors|mesh-ancestor
65520555|NCT01874860|Doxycycline|doxycycline|mesh-list
65520556|NCT01874860|Clindamycin|clindamycin|mesh-list
65520557|NCT01874860|Clindamycin palmitate|clindamycin palmitate|mesh-list
65520558|NCT01874860|Clindamycin phosphate|clindamycin phosphate|mesh-list
65520559|NCT01874860|Hydrocortisone|hydrocortisone|mesh-list
65520560|NCT01874860|Methylprednisolone|methylprednisolone|mesh-list
65520561|NCT01874860|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65520562|NCT01874860|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65520563|NCT01874860|Prednisolone|prednisolone|mesh-list
65520564|NCT01874860|Prednisolone acetate|prednisolone acetate|mesh-list
65520565|NCT01874860|Sunscreening Agents|sunscreening agents|mesh-list
65520566|NCT01874860|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65520567|NCT01874860|Prednisolone phosphate|prednisolone phosphate|mesh-list
65520568|NCT01874860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65520569|NCT01874860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65520570|NCT01874860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65520571|NCT01874860|Antimalarials|antimalarials|mesh-ancestor
65520572|NCT01874860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65520573|NCT01874860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65520574|NCT01874860|Antiemetics|antiemetics|mesh-ancestor
65520575|NCT01874860|Autonomic Agents|autonomic agents|mesh-ancestor
65520576|NCT01874860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520577|NCT01874860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520578|NCT01874860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65520579|NCT01874860|Glucocorticoids|glucocorticoids|mesh-ancestor
65520580|NCT01874860|Hormones|hormones|mesh-ancestor
65249602|NCT02822586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520581|NCT01874860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65520582|NCT01874860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65520583|NCT01874860|Protective Agents|protective agents|mesh-ancestor
65520584|NCT01874860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65520585|NCT01874860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520586|NCT01874860|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65520587|NCT01874860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520588|NCT01874860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520589|NCT01874860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65520590|NCT01874860|Dermatologic Agents|dermatologic agents|mesh-ancestor
65520591|NCT03570346|Hemay005|hemay005|mesh-list
65520592|NCT03570346|Dermatologic Agents|dermatologic agents|mesh-ancestor
65520593|NCT03570346|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65520594|NCT03570346|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65520595|NCT03570346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520596|NCT03570346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520597|NCT03571126|Olanzapine|olanzapine|mesh-list
65520598|NCT03571126|Antiemetics|antiemetics|mesh-ancestor
65520599|NCT03571126|Autonomic Agents|autonomic agents|mesh-ancestor
65520600|NCT03571126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520601|NCT03571126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520602|NCT03571126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65520603|NCT03571126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65520604|NCT03571126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65520605|NCT03571126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65520606|NCT03571126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65520607|NCT03571126|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65520608|NCT03571126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65520609|NCT03571126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65520610|NCT03571126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520611|NCT03571126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65520612|NCT03571126|Serotonin Agents|serotonin agents|mesh-ancestor
65520613|NCT03570112|Sofosbuvir|sofosbuvir|mesh-list
65520614|NCT03570112|Velpatasvir|velpatasvir|mesh-list
65520615|NCT03570112|Antiviral Agents|antiviral agents|mesh-ancestor
65520616|NCT03570112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65520617|NCT03572686|Dexamethasone|dexamethasone|mesh-list
65520618|NCT03572686|Dexamethasone acetate|dexamethasone acetate|mesh-list
65520619|NCT03572686|Ropivacaine|ropivacaine|mesh-list
65520620|NCT03572686|BB 1101|bb 1101|mesh-list
65520621|NCT03572686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65520622|NCT03572686|Antiemetics|antiemetics|mesh-ancestor
65520623|NCT03572686|Autonomic Agents|autonomic agents|mesh-ancestor
65520624|NCT03572686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520625|NCT03572686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520626|NCT03572686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65520627|NCT03572686|Glucocorticoids|glucocorticoids|mesh-ancestor
65520628|NCT03572686|Hormones|hormones|mesh-ancestor
65520629|NCT03572686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65520630|NCT03572686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65520631|NCT03572686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520632|NCT03572686|Protease Inhibitors|protease inhibitors|mesh-ancestor
65520633|NCT03572686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520634|NCT03572686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520635|NCT03572686|Anesthetics, Local|anesthetics, local|mesh-ancestor
65520636|NCT03572686|Anesthetics|anesthetics|mesh-ancestor
65520637|NCT03572686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65520638|NCT03572686|Sensory System Agents|sensory system agents|mesh-ancestor
65520639|NCT02523820|Fluticasone|fluticasone|mesh-list
65520640|NCT02523820|Xhance|xhance|mesh-list
65520641|NCT02523820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65520642|NCT02523820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65520643|NCT02523820|Autonomic Agents|autonomic agents|mesh-ancestor
65520644|NCT02523820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520645|NCT02523820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520646|NCT02523820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65520647|NCT02523820|Respiratory System Agents|respiratory system agents|mesh-ancestor
65520648|NCT02523820|Dermatologic Agents|dermatologic agents|mesh-ancestor
65520649|NCT02523820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65520650|NCT03369704|Omalizumab|omalizumab|mesh-list
65520651|NCT03369704|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65520652|NCT03369704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65520653|NCT03369704|Respiratory System Agents|respiratory system agents|mesh-ancestor
65520654|NCT03709160|Bumetanide|bumetanide|mesh-list
65520655|NCT03709160|Diuretics|diuretics|mesh-ancestor
65520656|NCT03709160|Natriuretic Agents|natriuretic agents|mesh-ancestor
65520657|NCT03709160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520658|NCT03709160|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65520659|NCT03709160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65520660|NCT03709160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520661|NCT05332496|Bevacizumab|bevacizumab|mesh-list
65520662|NCT05332496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65520663|NCT05332496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65520664|NCT05332496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520665|NCT05332496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65520666|NCT05332496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65520667|NCT05332496|Growth Substances|growth substances|mesh-ancestor
65520668|NCT05332496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520669|NCT05332496|Growth Inhibitors|growth inhibitors|mesh-ancestor
65520670|NCT05332496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520671|NCT03567304|Rilpivirine|rilpivirine|mesh-list
65520672|NCT03567304|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65520673|NCT03567304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65520674|NCT03567304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520675|NCT03567304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520676|NCT03567304|Antiviral Agents|antiviral agents|mesh-ancestor
65520677|NCT03567304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65520678|NCT03567304|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65520679|NCT03567304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65520680|NCT05356858|Zanubrutinib|zanubrutinib|mesh-list
65520681|NCT05356858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520682|NCT05356858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65520683|NCT05356858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520684|NCT05356858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520685|NCT03566914|Tadalafil|tadalafil|mesh-list
65520686|NCT03566914|Vasodilator Agents|vasodilator agents|mesh-ancestor
65520687|NCT03566914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65520688|NCT03566914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65520689|NCT03566914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520690|NCT03566914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520691|NCT03566914|Urological Agents|urological agents|mesh-ancestor
65520692|NCT03709082|Trastuzumab|trastuzumab|mesh-list
65520693|NCT03709082|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65520694|NCT03709082|Letrozole|letrozole|mesh-list
65520695|NCT03709082|Palbociclib|palbociclib|mesh-list
65520696|NCT03709082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65520697|NCT03709082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520698|NCT03709082|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65520699|NCT03709082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65520700|NCT03709082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520701|NCT03709082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520702|NCT03709082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65520703|NCT03709082|Hormone Antagonists|hormone antagonists|mesh-ancestor
65520704|NCT03709082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65520705|NCT03709082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520706|NCT03709082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65520707|NCT03709082|Tubulin Modulators|tubulin modulators|mesh-ancestor
65520708|NCT03709082|Antimitotic Agents|antimitotic agents|mesh-ancestor
65520709|NCT03709082|Mitosis Modulators|mitosis modulators|mesh-ancestor
65520710|NCT02839876|Acetaminophen|acetaminophen|mesh-list
65520711|NCT02839876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65520712|NCT02839876|Analgesics|analgesics|mesh-ancestor
65520713|NCT02839876|Sensory System Agents|sensory system agents|mesh-ancestor
65520714|NCT02839876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520715|NCT02839876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520716|NCT02839876|Antipyretics|antipyretics|mesh-ancestor
65520717|NCT01312064|Rituximab|rituximab|mesh-list
65520718|NCT01312064|Everolimus|everolimus|mesh-list
65520719|NCT01312064|Tacrolimus|tacrolimus|mesh-list
65520720|NCT01312064|Thymoglobulin|thymoglobulin|mesh-list
65520721|NCT01312064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65520722|NCT01312064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520723|NCT01312064|Immunologic Factors|immunologic factors|mesh-ancestor
65520724|NCT01312064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520725|NCT01312064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65520726|NCT01312064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65520727|NCT01312064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65520728|NCT01312064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520729|NCT01312064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520730|NCT05682716|Nitroglycerin|nitroglycerin|mesh-list
65520731|NCT05682716|Vasodilator Agents|vasodilator agents|mesh-ancestor
65520732|NCT03566134|Solifenacin Succinate|solifenacin succinate|mesh-list
65520733|NCT03566134|DA-8010|da-8010|mesh-list
65520734|NCT03566134|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65520735|NCT03566134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65520736|NCT03566134|Cholinergic Agents|cholinergic agents|mesh-ancestor
65520737|NCT03566134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65520738|NCT03566134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520739|NCT03566134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520740|NCT03566134|Urological Agents|urological agents|mesh-ancestor
65520741|NCT03101722|Huperzine A|huperzine a|mesh-list
65520742|NCT03101722|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
65520743|NCT03101722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520744|NCT03101722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520745|NCT03101722|Cholinergic Agents|cholinergic agents|mesh-ancestor
65520746|NCT03101722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65520747|NCT03101722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520748|NCT03101722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65520749|NCT03101722|Protective Agents|protective agents|mesh-ancestor
65520750|NCT03088852|Magnesium citrate|magnesium citrate|mesh-list
65520751|NCT03088852|Cathartics|cathartics|mesh-ancestor
65520752|NCT03088852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65520753|NCT03568474|Fluorides|fluorides|mesh-list
65520754|NCT03568474|Cariostatic Agents|cariostatic agents|mesh-ancestor
65520755|NCT03568474|Protective Agents|protective agents|mesh-ancestor
65520756|NCT03568474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520757|NCT03345836|Upadacitinib|upadacitinib|mesh-list
65520758|NCT03345836|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65520759|NCT03345836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65520760|NCT03345836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520761|NCT03345836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520762|NCT03345836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65520763|NCT03708926|Abaloparatide|abaloparatide|mesh-list
65520764|NCT03708926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65520765|NCT03708926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520766|NCT03567928|Propofol|propofol|mesh-list
65520767|NCT03567928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65520768|NCT03567928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65520769|NCT03567928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520770|NCT03567928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65520771|NCT03567928|Anesthetics, General|anesthetics, general|mesh-ancestor
65520772|NCT03567928|Anesthetics|anesthetics|mesh-ancestor
65520773|NCT03565354|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65520774|NCT03565354|Hematinics|hematinics|mesh-ancestor
65520775|NCT03363776|Nivolumab|nivolumab|mesh-list
65520776|NCT03363776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65520777|NCT03363776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520778|NCT03363776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65520779|NCT03363776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520780|NCT03565276|Tranexamic Acid|tranexamic acid|mesh-list
65520781|NCT03565276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65520782|NCT03565276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65520783|NCT03565276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520784|NCT03565276|Hemostatics|hemostatics|mesh-ancestor
65520785|NCT03565276|Coagulants|coagulants|mesh-ancestor
65520786|NCT03564964|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
65520787|NCT03564964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65520788|NCT03564964|Serotonin Agents|serotonin agents|mesh-ancestor
65520789|NCT03564964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65520790|NCT03564964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520791|NCT03564964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520792|NCT03708848|Metronidazole|metronidazole|mesh-list
65520793|NCT03708848|Clarithromycin|clarithromycin|mesh-list
65520794|NCT03708848|Levofloxacin|levofloxacin|mesh-list
65520795|NCT03708848|Ofloxacin|ofloxacin|mesh-list
65520796|NCT03708848|Tetracycline|tetracycline|mesh-list
65520797|NCT03708848|Potassium Citrate|potassium citrate|mesh-list
65520798|NCT03708848|Esomeprazole|esomeprazole|mesh-list
65520799|NCT03708848|Bismuth|bismuth|mesh-list
65520800|NCT03708848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520801|NCT03708848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65520802|NCT03708848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65520803|NCT03708848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65520804|NCT03708848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65249825|NCT02820558|Substance P|substance p|mesh-list
65520805|NCT03708848|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65520806|NCT03708848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65520807|NCT03708848|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65520808|NCT03708848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520809|NCT03708848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65520810|NCT03708848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65520811|NCT03708848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65520812|NCT03708848|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65520813|NCT03708848|Renal Agents|renal agents|mesh-ancestor
65520814|NCT03708848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65520815|NCT03708848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65520816|NCT03708848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520817|NCT03708848|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65520818|NCT03708848|Antacids|antacids|mesh-ancestor
65520819|NCT03708848|Diuretics|diuretics|mesh-ancestor
65520820|NCT03708848|Natriuretic Agents|natriuretic agents|mesh-ancestor
65520821|NCT03708848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520822|NCT03708848|Expectorants|expectorants|mesh-ancestor
65520823|NCT03708848|Respiratory System Agents|respiratory system agents|mesh-ancestor
65520824|NCT05399498|Psilocybin|psilocybin|mesh-list
65520825|NCT05399498|Hallucinogens|hallucinogens|mesh-ancestor
65520826|NCT05399498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520827|NCT05399498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65520828|NCT05395052|Cyclophosphamide|cyclophosphamide|mesh-list
65520829|NCT05395052|Pembrolizumab|pembrolizumab|mesh-list
65520830|NCT05395052|Nivolumab|nivolumab|mesh-list
65520831|NCT05395052|Trastuzumab|trastuzumab|mesh-list
65520832|NCT05395052|Fludarabine|fludarabine|mesh-list
65520833|NCT05395052|Cetuximab|cetuximab|mesh-list
65520834|NCT05395052|Atezolizumab|atezolizumab|mesh-list
65520835|NCT05395052|Interleukin-2|interleukin-2|mesh-list
65520836|NCT05395052|Avelumab|avelumab|mesh-list
65520837|NCT05395052|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
65520838|NCT05395052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65520839|NCT05395052|Immunologic Factors|immunologic factors|mesh-ancestor
65520840|NCT05395052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520841|NCT05395052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65520842|NCT05395052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65520843|NCT05395052|Alkylating Agents|alkylating agents|mesh-ancestor
65520844|NCT05395052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520845|NCT05395052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520846|NCT05395052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65520847|NCT05395052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65520848|NCT05395052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65520849|NCT05395052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65520850|NCT05395052|Analgesics|analgesics|mesh-ancestor
65520851|NCT05395052|Sensory System Agents|sensory system agents|mesh-ancestor
65520852|NCT05395052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520853|NCT03564652|Azithromycin|azithromycin|mesh-list
65520854|NCT03564652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65520855|NCT03564652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65520856|NCT03564574|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65520857|NCT03564574|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65520858|NCT03564574|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65520859|NCT03564574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65520860|NCT05681780|Cyclophosphamide|cyclophosphamide|mesh-list
65520861|NCT05681780|Nivolumab|nivolumab|mesh-list
65520862|NCT05681780|Fludarabine|fludarabine|mesh-list
65520863|NCT05681780|Interleukin-2|interleukin-2|mesh-list
65520864|NCT05681780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65520865|NCT05681780|Immunologic Factors|immunologic factors|mesh-ancestor
65520866|NCT05681780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520867|NCT05681780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65520868|NCT05681780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65520869|NCT05681780|Alkylating Agents|alkylating agents|mesh-ancestor
65520870|NCT05681780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520871|NCT05681780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520872|NCT05681780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65520873|NCT05681780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65520874|NCT05681780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65520875|NCT05681780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65520876|NCT05681780|Analgesics|analgesics|mesh-ancestor
65520877|NCT05681780|Sensory System Agents|sensory system agents|mesh-ancestor
65520878|NCT05681780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520879|NCT03710330|Tranexamic Acid|tranexamic acid|mesh-list
65520880|NCT03710330|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65249903|NCT00964223|Analgesics|analgesics|mesh-ancestor
65520881|NCT03710330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65318388|NCT00772668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65520882|NCT03710330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520883|NCT03710330|Hemostatics|hemostatics|mesh-ancestor
65520884|NCT03710330|Coagulants|coagulants|mesh-ancestor
65520885|NCT03710252|Ritonavir|ritonavir|mesh-list
65520886|NCT03710252|Ribavirin|ribavirin|mesh-list
65520887|NCT03710252|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65520888|NCT03710252|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65520889|NCT03710252|Protease Inhibitors|protease inhibitors|mesh-ancestor
65520890|NCT03710252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520891|NCT03710252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520892|NCT03710252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65520893|NCT03710252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65520894|NCT03710252|Antiviral Agents|antiviral agents|mesh-ancestor
65520895|NCT03710252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65520896|NCT03710252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65520897|NCT03710252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65520898|NCT03710252|Antimetabolites|antimetabolites|mesh-ancestor
65520899|NCT02838628|Tirbanibulin|tirbanibulin|mesh-list
65520900|NCT02838628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520901|NCT02838628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520902|NCT05170334|Belinostat|belinostat|mesh-list
65520903|NCT05170334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520904|NCT05170334|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65520905|NCT05170334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520906|NCT05170334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520907|NCT03705884|Prednisolone|prednisolone|mesh-list
65520908|NCT03705884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65520909|NCT03705884|Glucocorticoids|glucocorticoids|mesh-ancestor
65520910|NCT03705884|Hormones|hormones|mesh-ancestor
65520911|NCT03705884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65520912|NCT03705884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520913|NCT03705884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65520914|NCT03705884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520915|NCT03359174|Tretinoin|tretinoin|mesh-list
65520916|NCT03359174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520917|NCT03359174|Keratolytic Agents|keratolytic agents|mesh-ancestor
65520918|NCT03359174|Dermatologic Agents|dermatologic agents|mesh-ancestor
65520919|NCT03564106|Methylprednisolone|methylprednisolone|mesh-list
65520920|NCT03564106|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65520921|NCT03564106|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65520922|NCT03564106|Prednisolone|prednisolone|mesh-list
65520923|NCT03564106|Prednisolone acetate|prednisolone acetate|mesh-list
65520924|NCT03564106|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65520925|NCT03564106|Prednisolone phosphate|prednisolone phosphate|mesh-list
65520926|NCT03564106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65520927|NCT03564106|Antiemetics|antiemetics|mesh-ancestor
65520928|NCT03564106|Autonomic Agents|autonomic agents|mesh-ancestor
65520929|NCT03564106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520930|NCT03564106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520931|NCT03564106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65520932|NCT03564106|Glucocorticoids|glucocorticoids|mesh-ancestor
65520933|NCT03564106|Hormones|hormones|mesh-ancestor
65520934|NCT03564106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65520935|NCT03564106|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65520936|NCT03564106|Protective Agents|protective agents|mesh-ancestor
65520937|NCT03564106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65520938|NCT03564106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520939|NCT03710174|Salicylic Acid|salicylic acid|mesh-list
65520940|NCT03710174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65520941|NCT03710174|Antifungal Agents|antifungal agents|mesh-ancestor
65520942|NCT03710174|Keratolytic Agents|keratolytic agents|mesh-ancestor
65520943|NCT03710174|Dermatologic Agents|dermatologic agents|mesh-ancestor
65520944|NCT00093015|Darbepoetin alfa|darbepoetin alfa|mesh-list
65520945|NCT00093015|Hematinics|hematinics|mesh-ancestor
65520946|NCT01145703|Vitamin D|vitamin d|mesh-list
65520947|NCT01145703|Ergocalciferols|ergocalciferols|mesh-list
65520948|NCT01145703|Cholecalciferol|cholecalciferol|mesh-list
65520949|NCT01145703|Vitamins|vitamins|mesh-list
65520950|NCT01145703|Micronutrients|micronutrients|mesh-ancestor
65520951|NCT01145703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520952|NCT01145703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65520953|NCT01145703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65520954|NCT05137587|Ketamine|ketamine|mesh-list
65520955|NCT05137587|Propofol|propofol|mesh-list
65520956|NCT05137587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65520957|NCT05137587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65520958|NCT05137587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520959|NCT05137587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65520960|NCT05137587|Anesthetics, General|anesthetics, general|mesh-ancestor
65318472|NCT04120337|Lidocaine|lidocaine|mesh-list
65520961|NCT05137587|Anesthetics|anesthetics|mesh-ancestor
65520962|NCT05137587|Analgesics|analgesics|mesh-ancestor
65520963|NCT05137587|Sensory System Agents|sensory system agents|mesh-ancestor
65520964|NCT05137587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65520965|NCT05137587|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65520966|NCT05137587|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65520967|NCT05137587|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65520968|NCT05137587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65520969|NCT05137587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520970|NCT01145859|Rivaroxaban|rivaroxaban|mesh-list
65520971|NCT01145859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65520972|NCT01145859|Antithrombins|antithrombins|mesh-ancestor
65520973|NCT01145859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65520974|NCT01145859|Protease Inhibitors|protease inhibitors|mesh-ancestor
65520975|NCT01145859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65520976|NCT01145859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520977|NCT01145859|Anticoagulants|anticoagulants|mesh-ancestor
65520978|NCT01250847|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65520979|NCT01250847|Antidepressive Agents|antidepressive agents|mesh-ancestor
65520980|NCT01250847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65520981|NCT01250847|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65520982|NCT01250847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65520983|NCT01250847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65520984|NCT01250847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65520985|NCT03913455|Carboplatin|carboplatin|mesh-list
65520986|NCT03913455|Guadecitabine|guadecitabine|mesh-list
65520987|NCT03913455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520988|NCT03358472|Carboplatin|carboplatin|mesh-list
65520989|NCT03358472|Pembrolizumab|pembrolizumab|mesh-list
65520990|NCT03358472|Fluorouracil|fluorouracil|mesh-list
65520991|NCT03358472|Cetuximab|cetuximab|mesh-list
65520992|NCT03358472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65520993|NCT03358472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65520994|NCT03358472|Antimetabolites|antimetabolites|mesh-ancestor
65520995|NCT03358472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65520996|NCT03358472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65520997|NCT03358472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65520998|NCT03358472|Immunologic Factors|immunologic factors|mesh-ancestor
65520999|NCT03358472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521000|NCT01238523|Calpastatin|calpastatin|mesh-list
65521001|NCT01238523|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65521002|NCT01238523|Protease Inhibitors|protease inhibitors|mesh-ancestor
65521003|NCT01238523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521004|NCT01238523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521005|NCT03708536|Bevacizumab|bevacizumab|mesh-list
65521006|NCT03708536|Capecitabine|capecitabine|mesh-list
65521007|NCT03708536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65521008|NCT03708536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65521009|NCT03708536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65521010|NCT03708536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65521011|NCT03708536|Growth Substances|growth substances|mesh-ancestor
65521012|NCT03708536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521013|NCT03708536|Growth Inhibitors|growth inhibitors|mesh-ancestor
65521014|NCT03708536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65521015|NCT03708536|Antimetabolites|antimetabolites|mesh-ancestor
65521016|NCT03708536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521017|NCT03705728|Remifentanil|remifentanil|mesh-list
65521018|NCT03705728|Propofol|propofol|mesh-list
65521019|NCT03705728|Sevoflurane|sevoflurane|mesh-list
65521020|NCT03705728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65521021|NCT03705728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65521022|NCT03705728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521023|NCT03705728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65521024|NCT03705728|Anesthetics, General|anesthetics, general|mesh-ancestor
65521025|NCT03705728|Anesthetics|anesthetics|mesh-ancestor
65521026|NCT03705728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65521027|NCT03705728|Narcotics|narcotics|mesh-ancestor
65521028|NCT03705728|Analgesics|analgesics|mesh-ancestor
65521029|NCT03705728|Sensory System Agents|sensory system agents|mesh-ancestor
65521030|NCT03705728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521031|NCT03705728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65521032|NCT03705728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65521033|NCT01147419|Blood Substitutes|blood substitutes|mesh-list
65521034|NCT05177666|Trastuzumab|trastuzumab|mesh-list
65521035|NCT05177666|Pertuzumab|pertuzumab|mesh-list
65521036|NCT05177666|Vemurafenib|vemurafenib|mesh-list
65521037|NCT05177666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65521038|NCT05177666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65521039|NCT05177666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65521040|NCT05177666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521041|NCT05177666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521042|NCT03342638|Methylprednisolone|methylprednisolone|mesh-list
65521043|NCT03342638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65521044|NCT03342638|Cyclophosphamide|cyclophosphamide|mesh-list
65521045|NCT03342638|Thymoglobulin|thymoglobulin|mesh-list
65521046|NCT03342638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65521047|NCT03342638|Immunologic Factors|immunologic factors|mesh-ancestor
65521048|NCT03342638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521049|NCT03342638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65521050|NCT03342638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65521051|NCT03342638|Alkylating Agents|alkylating agents|mesh-ancestor
65521052|NCT03342638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521053|NCT03342638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65521054|NCT03342638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65521055|NCT03342638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65521056|NCT03342638|Antiemetics|antiemetics|mesh-ancestor
65521057|NCT03342638|Autonomic Agents|autonomic agents|mesh-ancestor
65521058|NCT03342638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521059|NCT03342638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65521060|NCT03342638|Glucocorticoids|glucocorticoids|mesh-ancestor
65521062|NCT03342638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65521063|NCT03342638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65521064|NCT03342638|Protective Agents|protective agents|mesh-ancestor
65521065|NCT03342638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65521066|NCT01246323|Fentanyl|fentanyl|mesh-list
65521067|NCT01246323|Morphine|morphine|mesh-list
65521068|NCT01246323|Anesthetics|anesthetics|mesh-ancestor
65521069|NCT01246323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65521070|NCT01246323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521071|NCT01246323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65521072|NCT01246323|Narcotics|narcotics|mesh-ancestor
65521073|NCT01246323|Analgesics|analgesics|mesh-ancestor
65521074|NCT01246323|Sensory System Agents|sensory system agents|mesh-ancestor
65521075|NCT01246323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521076|NCT01246323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65521077|NCT01246323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65521078|NCT01246323|Anesthetics, General|anesthetics, general|mesh-ancestor
65521079|NCT05160363|Piperaquine|piperaquine|mesh-list
65521080|NCT05160363|Pyronaridine|pyronaridine|mesh-list
65521081|NCT05160363|Antimalarials|antimalarials|mesh-ancestor
65521082|NCT05160363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65521083|NCT05160363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65521084|NCT05160363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65521085|NCT05177276|Irinotecan|irinotecan|mesh-list
65521086|NCT05177276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65521087|NCT05177276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65521088|NCT05177276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521089|NCT05177276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521090|NCT05177276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65521091|NCT02528175|Capecitabine|capecitabine|mesh-list
65521092|NCT02528175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65521093|NCT02528175|Antimetabolites|antimetabolites|mesh-ancestor
65521094|NCT02528175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521095|NCT02528175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65521096|NCT03708458|Acetylcysteine|acetylcysteine|mesh-list
65521097|NCT03708458|Indomethacin|indomethacin|mesh-list
65521098|NCT03708458|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65521099|NCT03708458|Antiviral Agents|antiviral agents|mesh-ancestor
65521100|NCT03708458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65521101|NCT03708458|Expectorants|expectorants|mesh-ancestor
65521102|NCT03708458|Respiratory System Agents|respiratory system agents|mesh-ancestor
65521103|NCT03708458|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65521104|NCT03708458|Antioxidants|antioxidants|mesh-ancestor
65521105|NCT03708458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521106|NCT03708458|Protective Agents|protective agents|mesh-ancestor
65521107|NCT03708458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521108|NCT03708458|Antidotes|antidotes|mesh-ancestor
65521109|NCT03708458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65521110|NCT03708458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65521111|NCT03708458|Analgesics|analgesics|mesh-ancestor
65521112|NCT03708458|Sensory System Agents|sensory system agents|mesh-ancestor
65521113|NCT03708458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521114|NCT03708458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65521115|NCT03708458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65521116|NCT03708458|Gout Suppressants|gout suppressants|mesh-ancestor
65521117|NCT03708458|Tocolytic Agents|tocolytic agents|mesh-ancestor
65521118|NCT03708458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65521119|NCT03708458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65521120|NCT03708458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521121|NCT05625555|Midazolam|midazolam|mesh-list
65521122|NCT05625555|Ketamine|ketamine|mesh-list
65521123|NCT05625555|Analgesics|analgesics|mesh-ancestor
65521124|NCT05625555|Sensory System Agents|sensory system agents|mesh-ancestor
65521125|NCT05625555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521126|NCT05625555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521127|NCT05625555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65521128|NCT05625555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65521129|NCT05625555|Anesthetics, General|anesthetics, general|mesh-ancestor
65521130|NCT05625555|Anesthetics|anesthetics|mesh-ancestor
65521131|NCT05625555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65521132|NCT05625555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65521133|NCT05625555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65521134|NCT05625555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65521135|NCT05625555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521136|NCT05625555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65521137|NCT05625555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65521138|NCT05625555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65521139|NCT05625555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65521140|NCT05625555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65521141|NCT05625555|GABA Modulators|gaba modulators|mesh-ancestor
65521142|NCT05625555|GABA Agents|gaba agents|mesh-ancestor
65521143|NCT05039073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65521144|NCT05039073|Nivolumab|nivolumab|mesh-list
65521145|NCT05039073|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65521146|NCT05039073|Antibodies|antibodies|mesh-list
65521147|NCT05039073|Immunoglobulins|immunoglobulins|mesh-list
65521148|NCT05039073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65521149|NCT05039073|Immunoconjugates|immunoconjugates|mesh-list
65521150|NCT05039073|Immunologic Factors|immunologic factors|mesh-ancestor
65521151|NCT05039073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521152|NCT05039073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65521153|NCT05039073|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65521154|NCT05039073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521155|NCT01251471|Citalopram|citalopram|mesh-list
65521156|NCT01251471|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65521157|NCT01251471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65521158|NCT01251471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65521159|NCT01251471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521160|NCT01251471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65521161|NCT01251471|Serotonin Agents|serotonin agents|mesh-ancestor
65521162|NCT01251471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521163|NCT01251471|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65521164|NCT01251471|Antidepressive Agents|antidepressive agents|mesh-ancestor
65521165|NCT01251471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65521166|NCT01247805|Sildenafil Citrate|sildenafil citrate|mesh-list
65521167|NCT01247805|Citric Acid|citric acid|mesh-list
65521168|NCT01247805|Sodium Citrate|sodium citrate|mesh-list
65521169|NCT01247805|Anticoagulants|anticoagulants|mesh-ancestor
65521170|NCT01247805|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65521171|NCT01247805|Chelating Agents|chelating agents|mesh-ancestor
65521172|NCT01247805|Sequestering Agents|sequestering agents|mesh-ancestor
65521173|NCT01247805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521174|NCT01247805|Vasodilator Agents|vasodilator agents|mesh-ancestor
65521175|NCT01247805|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65521176|NCT01247805|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65521177|NCT01247805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521178|NCT01247805|Urological Agents|urological agents|mesh-ancestor
65521179|NCT05631717|Aldesleukin|aldesleukin|mesh-list
65521180|NCT05631717|Interleukin-2|interleukin-2|mesh-list
65521181|NCT05631717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65521182|NCT05631717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65521183|NCT05631717|Analgesics|analgesics|mesh-ancestor
65250197|NCT00619801|Levocetirizine|levocetirizine|mesh-list
65521184|NCT05631717|Sensory System Agents|sensory system agents|mesh-ancestor
65521185|NCT05631717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521186|NCT05631717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521187|NCT05631717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65521188|NCT05631717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65521189|NCT05631717|Antiviral Agents|antiviral agents|mesh-ancestor
65521190|NCT05631717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65521191|NCT01239459|Teriflunomide|teriflunomide|mesh-list
65521192|NCT01239459|Cholestyramine Resin|cholestyramine resin|mesh-list
65521193|NCT01239459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65521194|NCT01239459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65521195|NCT01239459|Analgesics|analgesics|mesh-ancestor
65521196|NCT01239459|Sensory System Agents|sensory system agents|mesh-ancestor
65521197|NCT01239459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521198|NCT01239459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521199|NCT01239459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65521200|NCT01239459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65521201|NCT01239459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65521202|NCT01239459|Immunologic Factors|immunologic factors|mesh-ancestor
65521203|NCT01239459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65521204|NCT01239459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65521205|NCT01239459|Antimetabolites|antimetabolites|mesh-ancestor
65521206|NCT01239459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521207|NCT01239459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65521208|NCT01147731|Warfarin|warfarin|mesh-list
65521209|NCT01147731|rGLP-1 protein|rglp-1 protein|mesh-list
65521210|NCT01147731|Anticoagulants|anticoagulants|mesh-ancestor
65521211|NCT01147731|Incretins|incretins|mesh-ancestor
65521212|NCT01147731|Hormones|hormones|mesh-ancestor
65521213|NCT01147731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65521214|NCT01147731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521215|NCT03912285|Losartan|losartan|mesh-list
65521216|NCT03912285|Amlodipine|amlodipine|mesh-list
65521217|NCT03912285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65521218|NCT03912285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65521219|NCT03912285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65521220|NCT03912285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521221|NCT03912285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65521222|NCT03912285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521223|NCT03912285|Vasodilator Agents|vasodilator agents|mesh-ancestor
65521224|NCT03912285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65521225|NCT03912285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65521226|NCT03912285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65521227|NCT01251627|Decitabine|decitabine|mesh-list
65521228|NCT01251627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65521229|NCT01251627|Antimetabolites|antimetabolites|mesh-ancestor
65521230|NCT01251627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521231|NCT01251627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65521232|NCT01251627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521233|NCT01146093|Pravastatin|pravastatin|mesh-list
65521234|NCT01146093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65521235|NCT01146093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65521236|NCT01146093|Antimetabolites|antimetabolites|mesh-ancestor
65521237|NCT01146093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521238|NCT01146093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65521239|NCT01146093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65521240|NCT01146093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521241|NCT02452983|Sertraline|sertraline|mesh-list
65521242|NCT02452983|Antidepressive Agents|antidepressive agents|mesh-ancestor
65521243|NCT02452983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65521244|NCT02452983|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65521245|NCT02452983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65521246|NCT02452983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65521247|NCT02452983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521248|NCT02452983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65521249|NCT02452983|Serotonin Agents|serotonin agents|mesh-ancestor
65521250|NCT02452983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521251|NCT03911817|Midodrine|midodrine|mesh-list
65521252|NCT03911817|Sympathomimetics|sympathomimetics|mesh-ancestor
65521253|NCT03911817|Autonomic Agents|autonomic agents|mesh-ancestor
65521254|NCT03911817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521255|NCT03911817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521256|NCT03911817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65521257|NCT03911817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65521258|NCT03911817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65521259|NCT03911817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65521260|NCT03911817|Adrenergic Agents|adrenergic agents|mesh-ancestor
65521261|NCT03911817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65521262|NCT03911817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521263|NCT01239849|Atorvastatin|atorvastatin|mesh-list
65521264|NCT01239849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65318767|NCT00844649|Paclitaxel|paclitaxel|mesh-list
65521266|NCT01239849|Antimetabolites|antimetabolites|mesh-ancestor
65521267|NCT01239849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521268|NCT01239849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65521269|NCT01239849|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65521270|NCT01239849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521271|NCT04896489|Hydrocortisone|hydrocortisone|mesh-list
65521272|NCT04896489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65521273|NCT01148043|Hydroxychloroquine|hydroxychloroquine|mesh-list
65521274|NCT01148043|Antimalarials|antimalarials|mesh-ancestor
65521275|NCT01148043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65521276|NCT01148043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65521277|NCT01148043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65521278|NCT01148043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521279|NCT01148043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521280|NCT01148043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65521281|NCT04880655|Bacitracin|bacitracin|mesh-list
65521282|NCT04880655|Petrolatum|petrolatum|mesh-list
65521283|NCT04880655|Emollients|emollients|mesh-ancestor
65521284|NCT04880655|Dermatologic Agents|dermatologic agents|mesh-ancestor
65521285|NCT04880655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65521286|NCT04880655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65521287|NCT04880655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65521288|NCT04865835|Metformin|metformin|mesh-list
65521289|NCT04865835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65521290|NCT04865835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521291|NCT03911271|Atropine|atropine|mesh-list
65521292|NCT03911271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65521293|NCT03911271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65521294|NCT03911271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65521295|NCT03911271|Autonomic Agents|autonomic agents|mesh-ancestor
65521296|NCT03911271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521297|NCT03911271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521298|NCT03911271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65521299|NCT03911271|Respiratory System Agents|respiratory system agents|mesh-ancestor
65521300|NCT03911271|Mydriatics|mydriatics|mesh-ancestor
65521301|NCT03911271|Parasympatholytics|parasympatholytics|mesh-ancestor
65521302|NCT03911271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65521303|NCT03911271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65521304|NCT03911271|Cholinergic Agents|cholinergic agents|mesh-ancestor
65521305|NCT03911271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65521306|NCT03911271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521307|NCT01248195|Olanzapine|olanzapine|mesh-list
65521308|NCT01248195|Clozapine|clozapine|mesh-list
65521309|NCT01248195|Amisulpride|amisulpride|mesh-list
65521310|NCT01248195|Antiemetics|antiemetics|mesh-ancestor
65521311|NCT01248195|Autonomic Agents|autonomic agents|mesh-ancestor
65521312|NCT01248195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521313|NCT01248195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521314|NCT01248195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65521315|NCT01248195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65521316|NCT01248195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65521317|NCT01248195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65521318|NCT01248195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65521319|NCT01248195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65521320|NCT01248195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65521321|NCT01248195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65521322|NCT01248195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521323|NCT01248195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65521324|NCT01248195|Serotonin Agents|serotonin agents|mesh-ancestor
65521325|NCT01248195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65521326|NCT01248195|GABA Antagonists|gaba antagonists|mesh-ancestor
65521327|NCT01248195|GABA Agents|gaba agents|mesh-ancestor
65521328|NCT01248195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65521329|NCT01248195|Dopamine Agents|dopamine agents|mesh-ancestor
65521330|NCT01248195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65521331|NCT01248195|Antidepressive Agents|antidepressive agents|mesh-ancestor
65521332|NCT03910803|Brodalumab|brodalumab|mesh-list
65521333|NCT03910803|Dermatologic Agents|dermatologic agents|mesh-ancestor
65521334|NCT04776447|Carboplatin|carboplatin|mesh-list
65521335|NCT04776447|Atezolizumab|atezolizumab|mesh-list
65521336|NCT04776447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65521337|NCT03910647|Pantoprazole|pantoprazole|mesh-list
65521338|NCT03910647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65521339|NCT03910647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65521340|NCT03910647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65521341|NCT03910647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521342|NCT03910647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521343|NCT03709940|Methylphenidate|methylphenidate|mesh-list
65521344|NCT03709940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65521345|NCT03709940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521346|NCT03709940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65521347|NCT03709940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65521348|NCT03709940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65521349|NCT03709940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521350|NCT03709940|Dopamine Agents|dopamine agents|mesh-ancestor
65521351|NCT03709940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65521352|NCT05681312|Amoxicillin|amoxicillin|mesh-list
65521353|NCT05681312|Metronidazole|metronidazole|mesh-list
65521354|NCT05681312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65521355|NCT05681312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65521356|NCT05681312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65521357|NCT05681312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65521358|NCT03341312|Insulin Lispro|insulin lispro|mesh-list
65521359|NCT03341312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65521360|NCT03341312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521361|NCT01147029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
65521362|NCT01147029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65521363|NCT01147029|Growth Substances|growth substances|mesh-ancestor
65521364|NCT01147029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521365|NCT01147029|Growth Inhibitors|growth inhibitors|mesh-ancestor
65521366|NCT01147029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65521367|NCT03915561|Parecoxib|parecoxib|mesh-list
65521368|NCT03915561|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65521369|NCT03915561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65521370|NCT03915561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521371|NCT03915561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521372|NCT03915561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65521373|NCT03915561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65521374|NCT03915561|Analgesics|analgesics|mesh-ancestor
65521375|NCT03915561|Sensory System Agents|sensory system agents|mesh-ancestor
65521376|NCT03915561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521377|NCT03915561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521378|NCT03915561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65521379|NCT03915561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65521380|NCT01148277|Fentanyl|fentanyl|mesh-list
65521381|NCT01148277|Midazolam|midazolam|mesh-list
65521382|NCT01148277|Propofol|propofol|mesh-list
65521383|NCT01148277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65521384|NCT01148277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65521385|NCT01148277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521386|NCT01148277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65521387|NCT01148277|Anesthetics, General|anesthetics, general|mesh-ancestor
65521388|NCT01148277|Anesthetics|anesthetics|mesh-ancestor
65521389|NCT01148277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65521390|NCT01148277|Narcotics|narcotics|mesh-ancestor
65521391|NCT01148277|Analgesics|analgesics|mesh-ancestor
65521392|NCT01148277|Sensory System Agents|sensory system agents|mesh-ancestor
65521393|NCT01148277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521394|NCT01148277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65521395|NCT01148277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65521396|NCT01148277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65521397|NCT01148277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65521398|NCT01148277|GABA Modulators|gaba modulators|mesh-ancestor
65521399|NCT01148277|GABA Agents|gaba agents|mesh-ancestor
65521400|NCT01148277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65521401|NCT01148277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521402|NCT03909477|Xenon|xenon|mesh-list
65521403|NCT03909477|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65521404|NCT03909477|Anesthetics, General|anesthetics, general|mesh-ancestor
65521405|NCT03909477|Anesthetics|anesthetics|mesh-ancestor
65521406|NCT03909477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65521407|NCT03909477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521408|NCT03907371|Donepezil|donepezil|mesh-list
65521409|NCT03907371|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65521410|NCT03907371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521411|NCT03907371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521412|NCT03907371|Cholinergic Agents|cholinergic agents|mesh-ancestor
65521413|NCT03907371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65318905|NCT00703079|Lanreotide|lanreotide|mesh-list
65521414|NCT03907371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521415|NCT03907371|Nootropic Agents|nootropic agents|mesh-ancestor
65521416|NCT03908619|Esomeprazole|esomeprazole|mesh-list
65521418|NCT03908619|Rabeprazole|rabeprazole|mesh-list
65521419|NCT03908619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65521420|NCT03908619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65521421|NCT03908619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65521422|NCT03908619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521423|NCT03908619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521424|NCT01358734|Lenalidomide|lenalidomide|mesh-list
65521425|NCT01358734|Azacitidine|azacitidine|mesh-list
65521426|NCT01358734|Immunologic Factors|immunologic factors|mesh-ancestor
65521427|NCT01358734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521428|NCT01358734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65521429|NCT01358734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65521430|NCT01358734|Growth Substances|growth substances|mesh-ancestor
65521431|NCT01358734|Growth Inhibitors|growth inhibitors|mesh-ancestor
65521432|NCT01358734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65521433|NCT01358734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65521434|NCT01358734|Antimetabolites|antimetabolites|mesh-ancestor
65521435|NCT01358734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521436|NCT01358734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521437|NCT03907215|Citalopram|citalopram|mesh-list
65521438|NCT03907215|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65521439|NCT03907215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65521440|NCT03907215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65521441|NCT03907215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521442|NCT03907215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65521443|NCT03907215|Serotonin Agents|serotonin agents|mesh-ancestor
65521444|NCT03907215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521445|NCT03907215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65521446|NCT03907215|Antidepressive Agents|antidepressive agents|mesh-ancestor
65521447|NCT03907215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65521448|NCT05335954|Norepinephrine|norepinephrine|mesh-list
65521449|NCT05335954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65521450|NCT05335954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65521451|NCT05335954|Adrenergic Agents|adrenergic agents|mesh-ancestor
65521452|NCT05335954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65521453|NCT05335954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521454|NCT05335954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521455|NCT05335954|Sympathomimetics|sympathomimetics|mesh-ancestor
65521456|NCT05335954|Autonomic Agents|autonomic agents|mesh-ancestor
65521457|NCT05335954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521458|NCT05335954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65521459|NCT01250457|Timolol|timolol|mesh-list
65521460|NCT01250457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65521461|NCT01250457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65521462|NCT01250457|Adrenergic Agents|adrenergic agents|mesh-ancestor
65521463|NCT01250457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65521464|NCT01250457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521465|NCT01250457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521466|NCT01250457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65521467|NCT01250457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65521468|NCT03902925|Lidocaine|lidocaine|mesh-list
65521469|NCT03902925|Ropivacaine|ropivacaine|mesh-list
65521470|NCT03902925|Anesthetics, Local|anesthetics, local|mesh-ancestor
65521471|NCT03902925|Anesthetics|anesthetics|mesh-ancestor
65521472|NCT03902925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65521473|NCT03902925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521474|NCT03902925|Sensory System Agents|sensory system agents|mesh-ancestor
65521475|NCT03902925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521476|NCT03902925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65521477|NCT03902925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65521478|NCT03902925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65521479|NCT03902925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65521480|NCT03902925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521481|NCT01250535|Warfarin|warfarin|mesh-list
65521482|NCT01250535|Lovastatin|lovastatin|mesh-list
65521483|NCT01250535|L 647318|l 647318|mesh-list
65521484|NCT01250535|Dihydromevinolin|dihydromevinolin|mesh-list
65521485|NCT01250535|Anticoagulants|anticoagulants|mesh-ancestor
65521486|NCT01250535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65521487|NCT01250535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65521488|NCT01250535|Antimetabolites|antimetabolites|mesh-ancestor
65521489|NCT01250535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521490|NCT01250535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65521491|NCT01250535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65521492|NCT01250535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521493|NCT02527941|Metronidazole|metronidazole|mesh-list
65521494|NCT02527941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65521495|NCT02527941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65521496|NCT02527941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65521497|NCT02527941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65521498|NCT03906669|Tamoxifen|tamoxifen|mesh-list
65521499|NCT03906669|Letrozole|letrozole|mesh-list
65521500|NCT03906669|Progesterone|progesterone|mesh-list
65521501|NCT03906669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65521502|NCT03906669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65521503|NCT03906669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65521504|NCT03906669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521505|NCT03906669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521506|NCT03906669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65521507|NCT03906669|Hormone Antagonists|hormone antagonists|mesh-ancestor
65521508|NCT03906669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65521509|NCT03906669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521510|NCT03906669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65521511|NCT03906669|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65521512|NCT03906669|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65521513|NCT03906669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65521514|NCT03906669|Progestins|progestins|mesh-ancestor
65521515|NCT03906669|Hormones|hormones|mesh-ancestor
65521516|NCT01254825|Ropivacaine|ropivacaine|mesh-list
65521517|NCT01254825|Anesthetics, Local|anesthetics, local|mesh-ancestor
65521518|NCT01254825|Anesthetics|anesthetics|mesh-ancestor
65521519|NCT01254825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65521520|NCT01254825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521521|NCT01254825|Sensory System Agents|sensory system agents|mesh-ancestor
65521522|NCT01254825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521523|NCT03906123|3-n-butylphthalide|3-n-butylphthalide|mesh-list
65521524|NCT03906123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65521525|NCT03906123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65521526|NCT03906123|Protective Agents|protective agents|mesh-ancestor
65521527|NCT03906123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521528|NCT01341652|Molgramostim|molgramostim|mesh-list
65521529|NCT01341652|Sargramostim|sargramostim|mesh-list
65521530|NCT01341652|Immunologic Factors|immunologic factors|mesh-ancestor
65521531|NCT01341652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521532|NCT01341652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65521533|NCT03563794|Insulin Lispro|insulin lispro|mesh-list
65521534|NCT03563794|Vildagliptin|vildagliptin|mesh-list
65521535|NCT03563794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65521536|NCT03563794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521537|NCT03563794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65521538|NCT03563794|Protease Inhibitors|protease inhibitors|mesh-ancestor
65521539|NCT03563794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521540|NCT03563794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521541|NCT03905967|Lenvatinib|lenvatinib|mesh-list
65521542|NCT03905967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65521543|NCT03905967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65521544|NCT03905967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521545|NCT03905967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521546|NCT03563950|Rifampin|rifampin|mesh-list
65521547|NCT03563950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65521548|NCT03563950|Antitubercular Agents|antitubercular agents|mesh-ancestor
65521549|NCT03563950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65521550|NCT03563950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65521551|NCT03563950|Leprostatic Agents|leprostatic agents|mesh-ancestor
65521552|NCT03563950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65521553|NCT03563950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521554|NCT03563950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521555|NCT03563950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65521556|NCT03563950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65521557|NCT03563950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65521558|NCT03563950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65521559|NCT03563950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65521560|NCT03563950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65521561|NCT03905655|Nitazoxanide|nitazoxanide|mesh-list
65521562|NCT03905655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65521563|NCT03905655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65521564|NCT03914235|Lidocaine|lidocaine|mesh-list
65521565|NCT03914235|Anesthetics, Local|anesthetics, local|mesh-ancestor
65521567|NCT03914235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65521568|NCT03914235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521569|NCT03914235|Sensory System Agents|sensory system agents|mesh-ancestor
65521570|NCT03914235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521571|NCT03914235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65521572|NCT03914235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65521573|NCT03914235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65521574|NCT03914235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65521575|NCT03914235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521576|NCT01148667|Caseins|caseins|mesh-list
65521577|NCT01148667|Chelating Agents|chelating agents|mesh-ancestor
65521578|NCT01148667|Sequestering Agents|sequestering agents|mesh-ancestor
65521579|NCT01148667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521580|NCT01254123|Exenatide|exenatide|mesh-list
65521581|NCT01254123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65521582|NCT01254123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521583|NCT01254123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65521584|NCT01254123|Incretins|incretins|mesh-ancestor
65521585|NCT01254123|Hormones|hormones|mesh-ancestor
65521586|NCT01254123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65521587|NCT03898635|Linezolid|linezolid|mesh-list
65521588|NCT03898635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65521589|NCT03898635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65521590|NCT03898635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65521591|NCT03898635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521592|NCT03898635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521593|NCT05116917|Nivolumab|nivolumab|mesh-list
65521594|NCT05116917|Ipilimumab|ipilimumab|mesh-list
65521595|NCT05116917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65521596|NCT05116917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65521597|NCT05116917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65521598|NCT05116917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521599|NCT02528019|Glimepiride|glimepiride|mesh-list
65521600|NCT02528019|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65521601|NCT02528019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65521602|NCT02528019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65521603|NCT02528019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521604|NCT02528019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65521605|NCT02528019|Immunologic Factors|immunologic factors|mesh-ancestor
65521606|NCT02528019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521607|NCT01255215|Nitric Oxide|nitric oxide|mesh-list
65521608|NCT01255215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65521609|NCT01255215|Autonomic Agents|autonomic agents|mesh-ancestor
65521610|NCT01255215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521611|NCT01255215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521612|NCT01255215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65521613|NCT01255215|Respiratory System Agents|respiratory system agents|mesh-ancestor
65521614|NCT01255215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65521615|NCT01255215|Antioxidants|antioxidants|mesh-ancestor
65521616|NCT01255215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521617|NCT01255215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65521618|NCT01255215|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65521619|NCT01255215|Vasodilator Agents|vasodilator agents|mesh-ancestor
65521620|NCT01255215|Gasotransmitters|gasotransmitters|mesh-ancestor
65521621|NCT01255215|Protective Agents|protective agents|mesh-ancestor
65521622|NCT02527785|Oxaliplatin|oxaliplatin|mesh-list
65521623|NCT02527785|Irinotecan|irinotecan|mesh-list
65521624|NCT02527785|Tegafur|tegafur|mesh-list
65521625|NCT02527785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65521626|NCT02527785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65521627|NCT02527785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65521628|NCT02527785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521629|NCT02527785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521630|NCT02527785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65521631|NCT02527785|Antimetabolites|antimetabolites|mesh-ancestor
65521632|NCT02527863|Tolvaptan|tolvaptan|mesh-list
65521633|NCT02527863|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65521634|NCT02527863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521635|NCT02527863|Natriuretic Agents|natriuretic agents|mesh-ancestor
65521636|NCT02527863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521637|NCT01256541|Lactulose|lactulose|mesh-list
65521638|NCT01256541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65521639|NCT03904719|Vorolanib|vorolanib|mesh-list
65521640|NCT03904719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65521641|NCT03904719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521642|NCT03904719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521643|NCT01148901|Infliximab|infliximab|mesh-list
65521644|NCT01148901|Dermatologic Agents|dermatologic agents|mesh-ancestor
65521645|NCT01148901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65521646|NCT01148901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65521647|NCT01150617|Insulin|insulin|mesh-list
65521648|NCT01150617|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65521649|NCT01150617|Insulin Glargine|insulin glargine|mesh-list
65521650|NCT01150617|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65521651|NCT01150617|Insulin, Short-Acting|insulin, short-acting|mesh-list
65521652|NCT01150617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521653|NCT01256619|Desogestrel|desogestrel|mesh-list
65521654|NCT01256619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65521655|NCT01256619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65521656|NCT01256619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65521657|NCT01256619|Contraceptive Agents|contraceptive agents|mesh-ancestor
65521658|NCT01256619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65521659|NCT01256619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521660|NCT01256619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65521661|NCT01256619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65521662|NCT01256619|Progestins|progestins|mesh-ancestor
65521663|NCT01256619|Hormones|hormones|mesh-ancestor
65521664|NCT01256619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65521665|NCT03898011|Lamotrigine|lamotrigine|mesh-list
65521666|NCT03898011|Anticonvulsants|anticonvulsants|mesh-ancestor
65521667|NCT03898011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65521668|NCT03898011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65521669|NCT03898011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521670|NCT03898011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65521671|NCT03898011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521672|NCT03898011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65521673|NCT03898011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65521674|NCT03898011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65521675|NCT03898011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65521676|NCT03898011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65521677|NCT01254513|Prednisone|prednisone|mesh-list
65521678|NCT01254513|Docetaxel|docetaxel|mesh-list
65521679|NCT01254513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65521680|NCT01254513|Tubulin Modulators|tubulin modulators|mesh-ancestor
65521681|NCT01254513|Antimitotic Agents|antimitotic agents|mesh-ancestor
65521682|NCT01254513|Mitosis Modulators|mitosis modulators|mesh-ancestor
65521683|NCT01254513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521684|NCT01254513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65521685|NCT01254513|Glucocorticoids|glucocorticoids|mesh-ancestor
65521686|NCT01254513|Hormones|hormones|mesh-ancestor
65521687|NCT01254513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65521688|NCT01254513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521689|NCT01254513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65521690|NCT01254591|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65521691|NCT01254591|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65521692|NCT01254591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521693|NCT01149993|Mycophenolic Acid|mycophenolic acid|mesh-list
65521694|NCT01149993|Thymoglobulin|thymoglobulin|mesh-list
65521695|NCT01149993|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65521696|NCT01149993|Immunologic Factors|immunologic factors|mesh-ancestor
65521697|NCT01149993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521698|NCT01149993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65521699|NCT01149993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65521700|NCT01149993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65521701|NCT01149993|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65521702|NCT01149993|Antitubercular Agents|antitubercular agents|mesh-ancestor
65521703|NCT01149993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65521704|NCT01149993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65521705|NCT01149993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521706|NCT01149993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521707|NCT01255371|Lopinavir|lopinavir|mesh-list
65521708|NCT01255371|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65521709|NCT01255371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65521710|NCT01255371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65521711|NCT01255371|Protease Inhibitors|protease inhibitors|mesh-ancestor
65521712|NCT01255371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521713|NCT01255371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521714|NCT01255371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65521715|NCT01255371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65521716|NCT01255371|Antiviral Agents|antiviral agents|mesh-ancestor
65521717|NCT01255371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65521718|NCT01255371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65521719|NCT01255371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65521720|NCT03903783|Ceftriaxone|ceftriaxone|mesh-list
65521721|NCT03903783|Cefotaxime|cefotaxime|mesh-list
65521722|NCT03903783|Cefoxitin|cefoxitin|mesh-list
65521723|NCT03903783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65521724|NCT03903783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65521725|NCT03899337|Prednisolone|prednisolone|mesh-list
65521726|NCT03899337|Cyclophosphamide|cyclophosphamide|mesh-list
65521727|NCT03899337|Rituximab|rituximab|mesh-list
65521728|NCT03899337|Doxorubicin|doxorubicin|mesh-list
65521729|NCT03899337|Vincristine|vincristine|mesh-list
65521730|NCT03899337|Acalabrutinib|acalabrutinib|mesh-list
65521731|NCT03899337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65521732|NCT03899337|Immunologic Factors|immunologic factors|mesh-ancestor
65521733|NCT03899337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521734|NCT03899337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65521735|NCT03899337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65521736|NCT03899337|Alkylating Agents|alkylating agents|mesh-ancestor
65521737|NCT03899337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521738|NCT03899337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65521739|NCT03899337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65521740|NCT03899337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65521741|NCT03899337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65521742|NCT03899337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65521743|NCT03899337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65521744|NCT03899337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521745|NCT03899337|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65521746|NCT03899337|Tubulin Modulators|tubulin modulators|mesh-ancestor
65521747|NCT03899337|Antimitotic Agents|antimitotic agents|mesh-ancestor
65521748|NCT03899337|Mitosis Modulators|mitosis modulators|mesh-ancestor
65521749|NCT03899337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65521750|NCT03899337|Glucocorticoids|glucocorticoids|mesh-ancestor
65521751|NCT03899337|Hormones|hormones|mesh-ancestor
65521752|NCT03899337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65521753|NCT03899337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65521754|NCT01586169|Azithromycin|azithromycin|mesh-list
65521755|NCT01586169|Ivermectin|ivermectin|mesh-list
65521756|NCT01586169|Albendazole|albendazole|mesh-list
65521757|NCT01586169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65521758|NCT01586169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65521759|NCT01586169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65521760|NCT01586169|Anthelmintics|anthelmintics|mesh-ancestor
65521761|NCT01586169|Anticestodal Agents|anticestodal agents|mesh-ancestor
65521762|NCT01586169|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65521763|NCT01586169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65521764|NCT01586169|Tubulin Modulators|tubulin modulators|mesh-ancestor
65521765|NCT01586169|Antimitotic Agents|antimitotic agents|mesh-ancestor
65521766|NCT01586169|Mitosis Modulators|mitosis modulators|mesh-ancestor
65521767|NCT01586169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521768|NCT01586169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65521769|NCT01256775|Aspirin|aspirin|mesh-list
65521770|NCT01256775|Nitroaspirin|nitroaspirin|mesh-list
65521771|NCT01256775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65521772|NCT01256775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65521773|NCT01256775|Analgesics|analgesics|mesh-ancestor
65521774|NCT01256775|Sensory System Agents|sensory system agents|mesh-ancestor
65521775|NCT01256775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521776|NCT01256775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521777|NCT01256775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65521778|NCT01256775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65521779|NCT01256775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65521780|NCT01256775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65521781|NCT01256775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521782|NCT01256775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65521783|NCT01256775|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65521784|NCT01256775|Protease Inhibitors|protease inhibitors|mesh-ancestor
65521785|NCT01256775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521786|NCT01256775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65521787|NCT01256775|Antipyretics|antipyretics|mesh-ancestor
65521788|NCT03899571|Oseltamivir|oseltamivir|mesh-list
65521789|NCT03899571|Antiviral Agents|antiviral agents|mesh-ancestor
65521790|NCT03899571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65521791|NCT03899571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521792|NCT03899571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521793|NCT01257009|Atorvastatin|atorvastatin|mesh-list
65521794|NCT01257009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65521795|NCT01257009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65521796|NCT01257009|Antimetabolites|antimetabolites|mesh-ancestor
65521797|NCT01257009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521798|NCT01257009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65521799|NCT01257009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65521800|NCT01257009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521801|NCT01255527|Bortezomib|bortezomib|mesh-list
65521802|NCT01255527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65521803|NCT01151787|Amitriptyline|amitriptyline|mesh-list
65521804|NCT01151787|Cyclobenzaprine|cyclobenzaprine|mesh-list
65521805|NCT01151787|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65521806|NCT01151787|Antidepressive Agents|antidepressive agents|mesh-ancestor
65521807|NCT01151787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65521808|NCT01151787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65521809|NCT01151787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521810|NCT01151787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65521811|NCT01151787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521812|NCT01151787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65521813|NCT01151787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65521814|NCT01151787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65521815|NCT01151787|Analgesics|analgesics|mesh-ancestor
65521816|NCT01151787|Sensory System Agents|sensory system agents|mesh-ancestor
65521817|NCT01151787|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65521818|NCT01151787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65521819|NCT01151787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65521820|NCT01151787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521821|NCT01151787|Adrenergic Agents|adrenergic agents|mesh-ancestor
65521822|NCT01151787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65521823|NCT01151865|Dexmedetomidine|dexmedetomidine|mesh-list
65521824|NCT01151865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65521825|NCT01151865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65521826|NCT01151865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521827|NCT01151865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65521828|NCT01151865|Analgesics|analgesics|mesh-ancestor
65521829|NCT01151865|Sensory System Agents|sensory system agents|mesh-ancestor
65521830|NCT01151865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521831|NCT01151865|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65521832|NCT01151865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65521833|NCT01151865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65521834|NCT01151865|Adrenergic Agents|adrenergic agents|mesh-ancestor
65521835|NCT01151865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65521836|NCT01151865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521837|NCT03893097|Artesunate|artesunate|mesh-list
65521838|NCT03893097|Mefloquine|mefloquine|mesh-list
65521839|NCT03893097|Praziquantel|praziquantel|mesh-list
65521840|NCT03893097|Antimalarials|antimalarials|mesh-ancestor
65521841|NCT03893097|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65521842|NCT03893097|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65521843|NCT03893097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65521844|NCT03893097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65521845|NCT03893097|Antiviral Agents|antiviral agents|mesh-ancestor
65521846|NCT03893097|Schistosomicides|schistosomicides|mesh-ancestor
65521847|NCT03893097|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65521848|NCT03893097|Anthelmintics|anthelmintics|mesh-ancestor
65521849|NCT01258491|Nicotinic Acids|nicotinic acids|mesh-list
65521850|NCT01258491|Niacin|niacin|mesh-list
65521851|NCT01258491|Niacinamide|niacinamide|mesh-list
65521852|NCT01258491|Vitamin B Complex|vitamin b complex|mesh-ancestor
65521853|NCT01258491|Vitamins|vitamins|mesh-ancestor
65521854|NCT01258491|Micronutrients|micronutrients|mesh-ancestor
65521855|NCT01258491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521856|NCT01258491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65521857|NCT01258491|Antimetabolites|antimetabolites|mesh-ancestor
65521858|NCT01258491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250876|NCT02804646|Pemetrexed|pemetrexed|mesh-list
65521859|NCT01258491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65521860|NCT01258491|Vasodilator Agents|vasodilator agents|mesh-ancestor
65521861|NCT01257165|Ethanol|ethanol|mesh-list
65521862|NCT01257165|Zopiclone|zopiclone|mesh-list
65521863|NCT01257165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65521864|NCT01257165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65521865|NCT01257165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65521866|NCT01257165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521867|NCT01257165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65521868|NCT01151943|Anesthetics|anesthetics|mesh-list
65521869|NCT01151943|Anesthetics, Local|anesthetics, local|mesh-list
65521870|NCT01151943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65521871|NCT01151943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521872|NCT01151943|Sensory System Agents|sensory system agents|mesh-ancestor
65521873|NCT01151943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521874|NCT01256151|Alprazolam|alprazolam|mesh-list
65521875|NCT01256151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65521876|NCT01256151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65521877|NCT01256151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521878|NCT01256151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65521879|NCT01256151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65521880|NCT01256151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65521881|NCT01256151|GABA Modulators|gaba modulators|mesh-ancestor
65521882|NCT01256151|GABA Agents|gaba agents|mesh-ancestor
65521883|NCT01256151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65521884|NCT01256151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521885|NCT01259973|Haloperidol|haloperidol|mesh-list
65521886|NCT01259973|Risperidone|risperidone|mesh-list
65521887|NCT01259973|Haloperidol decanoate|haloperidol decanoate|mesh-list
65521888|NCT01259973|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65521889|NCT01259973|Serotonin Agents|serotonin agents|mesh-ancestor
65521890|NCT01259973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65521891|NCT01259973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521892|NCT01259973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521893|NCT01259973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65521894|NCT01259973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65521895|NCT01259973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65521896|NCT01259973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65521897|NCT01259973|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65521898|NCT01259973|Dopamine Agents|dopamine agents|mesh-ancestor
65521899|NCT01259973|Antiemetics|antiemetics|mesh-ancestor
65521900|NCT01259973|Autonomic Agents|autonomic agents|mesh-ancestor
65521901|NCT01259973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521902|NCT01259973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65521903|NCT01259973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65521904|NCT01257243|Potassium iodate|potassium iodate|mesh-list
65521905|NCT01257243|Phenylpropanolamine|phenylpropanolamine|mesh-list
65521906|NCT01257243|Guaifenesin|guaifenesin|mesh-list
65521907|NCT01257243|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
65521908|NCT01257243|Expectorants|expectorants|mesh-ancestor
65521909|NCT01257243|Respiratory System Agents|respiratory system agents|mesh-ancestor
65521910|NCT01257243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65521911|NCT01257243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65521912|NCT01257243|Adrenergic Agents|adrenergic agents|mesh-ancestor
65521913|NCT01257243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65521914|NCT01257243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521915|NCT01257243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521916|NCT01257243|Appetite Depressants|appetite depressants|mesh-ancestor
65521917|NCT01257243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65521918|NCT01257243|Sympathomimetics|sympathomimetics|mesh-ancestor
65521919|NCT01257243|Autonomic Agents|autonomic agents|mesh-ancestor
65521920|NCT01257243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521921|NCT01257243|Nasal Decongestants|nasal decongestants|mesh-ancestor
65521922|NCT01257243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65521923|NCT01257243|Antifungal Agents|antifungal agents|mesh-ancestor
65521924|NCT01257243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65521925|NCT01258569|Alvimopan|alvimopan|mesh-list
65521926|NCT01258569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65521927|NCT01257399|Mesalamine|mesalamine|mesh-list
65521928|NCT01257399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65521929|NCT01257399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65521930|NCT01257399|Analgesics|analgesics|mesh-ancestor
65521931|NCT01257399|Sensory System Agents|sensory system agents|mesh-ancestor
65521932|NCT01257399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521933|NCT01257399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521934|NCT01257399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65521935|NCT01257399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65521936|NCT01258959|Anesthetics|anesthetics|mesh-list
65521937|NCT01258959|Anesthetics, Local|anesthetics, local|mesh-list
65521938|NCT01258959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65319431|NCT00764322|Tamoxifen|tamoxifen|mesh-list
65521939|NCT01258959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521940|NCT01258959|Sensory System Agents|sensory system agents|mesh-ancestor
65521941|NCT01258959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521942|NCT01153659|Esomeprazole|esomeprazole|mesh-list
65521943|NCT01153659|Rabeprazole|rabeprazole|mesh-list
65521944|NCT01153659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65521945|NCT01153659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65521946|NCT01153659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65521947|NCT01153659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521948|NCT01153659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521949|NCT01260129|Silodosin|silodosin|mesh-list
65521950|NCT01260129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65521951|NCT01260129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65521952|NCT01260129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65521953|NCT01260129|Adrenergic Agents|adrenergic agents|mesh-ancestor
65521954|NCT01260129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65521955|NCT01260129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521956|NCT01260129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521957|NCT01260129|Urological Agents|urological agents|mesh-ancestor
65521958|NCT01260285|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65521959|NCT01260285|Vasodilator Agents|vasodilator agents|mesh-ancestor
65521960|NCT01260285|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65521961|NCT01260285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65521962|NCT01260285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521963|NCT01260285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521964|NCT01260285|Urological Agents|urological agents|mesh-ancestor
65521965|NCT03888729|Velpatasvir|velpatasvir|mesh-list
65521966|NCT03888729|Antiviral Agents|antiviral agents|mesh-ancestor
65521967|NCT03888729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65521968|NCT01151241|Anesthetics|anesthetics|mesh-list
65521969|NCT01151241|Anesthetics, Local|anesthetics, local|mesh-list
65521970|NCT01151241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65521971|NCT01151241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521972|NCT01151241|Sensory System Agents|sensory system agents|mesh-ancestor
65521973|NCT01151241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65521974|NCT02949362|Teduglutide|teduglutide|mesh-list
65521975|NCT02949362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65521976|NCT02949362|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65521977|NCT02949362|Protective Agents|protective agents|mesh-ancestor
65521978|NCT02949362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521979|NCT03896217|Simvastatin|simvastatin|mesh-list
65521980|NCT03896217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65521981|NCT03896217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65521982|NCT03896217|Antimetabolites|antimetabolites|mesh-ancestor
65521983|NCT03896217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521984|NCT03896217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65521985|NCT03896217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65521986|NCT03896217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521987|NCT05220410|Psilocybin|psilocybin|mesh-list
65521988|NCT05220410|Hallucinogens|hallucinogens|mesh-ancestor
65521989|NCT05220410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65521990|NCT05220410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65521991|NCT03892161|Ritonavir|ritonavir|mesh-list
65521992|NCT03892161|Darunavir|darunavir|mesh-list
65521993|NCT03892161|Rifampin|rifampin|mesh-list
65521994|NCT03892161|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65521995|NCT03892161|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65521996|NCT03892161|Protease Inhibitors|protease inhibitors|mesh-ancestor
65521997|NCT03892161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65521998|NCT03892161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65521999|NCT03892161|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65522000|NCT03892161|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65522001|NCT03892161|Antiviral Agents|antiviral agents|mesh-ancestor
65522002|NCT03892161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65522003|NCT03892161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65522004|NCT03892161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65522005|NCT03892161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65522006|NCT03892161|Antitubercular Agents|antitubercular agents|mesh-ancestor
65522007|NCT03892161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65522008|NCT03892161|Leprostatic Agents|leprostatic agents|mesh-ancestor
65522009|NCT03892161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65522010|NCT03892161|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65522011|NCT03892161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65522012|NCT03892161|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65522013|NCT03892161|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65522014|NCT03892161|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65522015|NCT03892161|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65522016|NCT01154361|Cortisone|cortisone|mesh-list
65522017|NCT01154361|Icatibant|icatibant|mesh-list
65522018|NCT01154361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65522019|NCT01154361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65522020|NCT01154361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65522021|NCT01154361|Analgesics|analgesics|mesh-ancestor
65522022|NCT01154361|Sensory System Agents|sensory system agents|mesh-ancestor
65522023|NCT01154361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65522024|NCT01154361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522025|NCT01154361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65522026|NCT01154361|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
65522027|NCT01154361|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
65522028|NCT01154361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522029|NCT01154361|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65522030|NCT01154361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65522031|NCT01154361|Immunologic Factors|immunologic factors|mesh-ancestor
65522032|NCT01260519|Heparin|heparin|mesh-list
65522033|NCT01260519|Calcium heparin|calcium heparin|mesh-list
65522034|NCT01260519|Anticoagulants|anticoagulants|mesh-ancestor
65522035|NCT01260519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65522036|NCT01260519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65522037|NCT01260519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522038|NCT03888183|Lubricant Eye Drops|lubricant eye drops|mesh-list
65522039|NCT03888183|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65522040|NCT03888183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65522041|NCT03891615|Niraparib|niraparib|mesh-list
65522042|NCT03891615|Osimertinib|osimertinib|mesh-list
65522043|NCT03891615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65522044|NCT03891615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522045|NCT03891615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522046|NCT03891615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522047|NCT03891615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65522048|NCT02947022|Calcium, Dietary|calcium, dietary|mesh-list
65522049|NCT02947022|Zinc|zinc|mesh-list
65522050|NCT02947022|Edetic Acid|edetic acid|mesh-list
65522051|NCT02947022|Calcium|calcium|mesh-list
65522052|NCT02947022|Pentetic Acid|pentetic acid|mesh-list
65522053|NCT02947022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65522054|NCT02947022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522055|NCT02947022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65522056|NCT02947022|Trace Elements|trace elements|mesh-ancestor
65522057|NCT02947022|Micronutrients|micronutrients|mesh-ancestor
65522058|NCT02947022|Antidotes|antidotes|mesh-ancestor
65522059|NCT02947022|Protective Agents|protective agents|mesh-ancestor
65522060|NCT02947022|Chelating Agents|chelating agents|mesh-ancestor
65522061|NCT02947022|Sequestering Agents|sequestering agents|mesh-ancestor
65522062|NCT02947022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522063|NCT02947022|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65522064|NCT02947022|Anticoagulants|anticoagulants|mesh-ancestor
65522065|NCT02947022|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65522066|NCT01259193|Zoledronic Acid|zoledronic acid|mesh-list
65522067|NCT01259193|Sorafenib|sorafenib|mesh-list
65522068|NCT01259193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522069|NCT01259193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65522070|NCT01259193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522071|NCT01259193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522072|NCT01259193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65522073|NCT01259193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522074|NCT05182892|Dopamine|dopamine|mesh-list
65522075|NCT05182892|Dopamine Agonists|dopamine agonists|mesh-list
65522076|NCT05182892|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65522077|NCT05182892|Sympathomimetics|sympathomimetics|mesh-ancestor
65522078|NCT05182892|Autonomic Agents|autonomic agents|mesh-ancestor
65522079|NCT05182892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65522080|NCT05182892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522081|NCT05182892|Dopamine Agents|dopamine agents|mesh-ancestor
65522082|NCT05182892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65522083|NCT05182892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522084|NCT05182892|Protective Agents|protective agents|mesh-ancestor
65522085|NCT01312376|Cyclophosphamide|cyclophosphamide|mesh-list
65522086|NCT01312376|Bevacizumab|bevacizumab|mesh-list
65522087|NCT01312376|Fludarabine|fludarabine|mesh-list
65522088|NCT01312376|Vaccines|vaccines|mesh-list
65522089|NCT01312376|Immunologic Factors|immunologic factors|mesh-ancestor
65522090|NCT01312376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319583|NCT00759681|Thrombin|thrombin|mesh-list
65522091|NCT01312376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65522092|NCT01312376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65522093|NCT01312376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65522094|NCT01312376|Alkylating Agents|alkylating agents|mesh-ancestor
65522095|NCT01312376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522096|NCT01312376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522097|NCT01312376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65522098|NCT01312376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65522099|NCT01312376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65522100|NCT01312376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65522101|NCT01312376|Growth Substances|growth substances|mesh-ancestor
65522102|NCT01312376|Growth Inhibitors|growth inhibitors|mesh-ancestor
65522103|NCT01260675|Buprenorphine|buprenorphine|mesh-list
65522104|NCT01260675|Naloxone|naloxone|mesh-list
65522105|NCT01260675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65522106|NCT01260675|Narcotics|narcotics|mesh-ancestor
65522107|NCT01260675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65522108|NCT01260675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522109|NCT01260675|Analgesics|analgesics|mesh-ancestor
65522110|NCT01260675|Sensory System Agents|sensory system agents|mesh-ancestor
65522111|NCT01260675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65522112|NCT01260675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65522113|NCT03887871|Tamsulosin|tamsulosin|mesh-list
65522114|NCT03887871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65522115|NCT03887871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65522116|NCT03887871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65522117|NCT03887871|Adrenergic Agents|adrenergic agents|mesh-ancestor
65522118|NCT03887871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65522119|NCT03887871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522120|NCT03887871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522121|NCT03887871|Urological Agents|urological agents|mesh-ancestor
65522122|NCT03708146|Zamicastat|zamicastat|mesh-list
65522123|NCT03708146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522124|NCT03708146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522125|NCT01260753|Fluticasone|fluticasone|mesh-list
65522126|NCT01260753|Xhance|xhance|mesh-list
65522127|NCT01260753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65522128|NCT01260753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65522129|NCT01260753|Autonomic Agents|autonomic agents|mesh-ancestor
65522130|NCT01260753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65522131|NCT01260753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522132|NCT01260753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65522133|NCT01260753|Respiratory System Agents|respiratory system agents|mesh-ancestor
65522134|NCT01260753|Dermatologic Agents|dermatologic agents|mesh-ancestor
65522135|NCT01260753|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65522136|NCT03895671|Azacitidine|azacitidine|mesh-list
65522137|NCT03895671|Ponatinib|ponatinib|mesh-list
65522138|NCT03895671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65522139|NCT03895671|Antimetabolites|antimetabolites|mesh-ancestor
65522140|NCT03895671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522141|NCT03895671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522142|NCT03895671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522143|NCT03895671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65522144|NCT01152723|Nicotine|nicotine|mesh-list
65522145|NCT01152723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65522146|NCT01152723|Autonomic Agents|autonomic agents|mesh-ancestor
65522147|NCT01152723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65522148|NCT01152723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522149|NCT01152723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65522150|NCT01152723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65522151|NCT01152723|Cholinergic Agents|cholinergic agents|mesh-ancestor
65522152|NCT01152723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65522153|NCT01152723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522154|NCT01261065|Carvedilol|carvedilol|mesh-list
65522155|NCT01261065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65522156|NCT01261065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65522157|NCT01261065|Adrenergic Agents|adrenergic agents|mesh-ancestor
65522158|NCT01261065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65522159|NCT01261065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522160|NCT01261065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522161|NCT01261065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65522162|NCT01261065|Antioxidants|antioxidants|mesh-ancestor
65522163|NCT01261065|Protective Agents|protective agents|mesh-ancestor
65522164|NCT01261065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65522165|NCT01261065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65522166|NCT01261065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65522168|NCT01261065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65522169|NCT01261065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65522170|NCT01257867|Lithium Carbonate|lithium carbonate|mesh-list
65522171|NCT01257867|Antidepressive Agents|antidepressive agents|mesh-ancestor
65522172|NCT01257867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65522173|NCT01257867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522174|NCT01257867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522175|NCT01257867|Antimanic Agents|antimanic agents|mesh-ancestor
65522176|NCT01257867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65522177|NCT01257867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65522178|NCT01257867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522179|NCT03338972|Cyclophosphamide|cyclophosphamide|mesh-list
65522180|NCT03338972|Fludarabine|fludarabine|mesh-list
65522181|NCT03338972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65522182|NCT03338972|Immunologic Factors|immunologic factors|mesh-ancestor
65522183|NCT03338972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522184|NCT03338972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65522185|NCT03338972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65522186|NCT03338972|Alkylating Agents|alkylating agents|mesh-ancestor
65522187|NCT03338972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522188|NCT03338972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522189|NCT03338972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65522190|NCT01151397|Vitamin D|vitamin d|mesh-list
65522191|NCT01151397|Ribavirin|ribavirin|mesh-list
65522192|NCT01151397|Vitamins|vitamins|mesh-ancestor
65522193|NCT01151397|Micronutrients|micronutrients|mesh-ancestor
65522194|NCT01151397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522195|NCT01151397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65522196|NCT01151397|Antimetabolites|antimetabolites|mesh-ancestor
65522197|NCT01151397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522198|NCT01151397|Antiviral Agents|antiviral agents|mesh-ancestor
65522199|NCT01151397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65522200|NCT01152801|Everolimus|everolimus|mesh-list
65522201|NCT01152801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522202|NCT01152801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65522203|NCT01152801|Immunologic Factors|immunologic factors|mesh-ancestor
65522204|NCT01152801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522205|NCT03887169|Vitamin B 12|vitamin b 12|mesh-list
65522206|NCT03887169|Hydroxocobalamin|hydroxocobalamin|mesh-list
65522207|NCT03887169|Vitamins|vitamins|mesh-ancestor
65522208|NCT03887169|Micronutrients|micronutrients|mesh-ancestor
65522209|NCT03887169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522210|NCT03887169|Vitamin B Complex|vitamin b complex|mesh-ancestor
65522211|NCT03887169|Hematinics|hematinics|mesh-ancestor
65522212|NCT03886779|Nepafenac|nepafenac|mesh-list
65522213|NCT03886779|Bromfenac|bromfenac|mesh-list
65522214|NCT03886779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65522215|NCT03886779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65522216|NCT03886779|Analgesics|analgesics|mesh-ancestor
65522217|NCT03886779|Sensory System Agents|sensory system agents|mesh-ancestor
65522218|NCT03886779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65522219|NCT03886779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522220|NCT03886779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65522221|NCT03886779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65522222|NCT03887013|Trimetazidine|trimetazidine|mesh-list
65522223|NCT03887013|Vasodilator Agents|vasodilator agents|mesh-ancestor
65522224|NCT01261299|Carboplatin|carboplatin|mesh-list
65522225|NCT01261299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522226|NCT01154829|Aripiprazole|aripiprazole|mesh-list
65522227|NCT01154829|Amisulpride|amisulpride|mesh-list
65522228|NCT01154829|Antidepressive Agents|antidepressive agents|mesh-ancestor
65522229|NCT01154829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65522230|NCT01154829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65522231|NCT01154829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65522232|NCT01154829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65522233|NCT01154829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522234|NCT01154829|Dopamine Agonists|dopamine agonists|mesh-ancestor
65522235|NCT01154829|Dopamine Agents|dopamine agents|mesh-ancestor
65522236|NCT01154829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65522237|NCT01154829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522238|NCT01154829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65522239|NCT01154829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65522240|NCT01154829|Serotonin Agents|serotonin agents|mesh-ancestor
65319730|NCT00758043|Antiviral Agents|antiviral agents|mesh-ancestor
65522241|NCT01154829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65522242|NCT01154829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65522243|NCT01154829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65522244|NCT01154829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65522245|NCT01154829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65522246|NCT01153191|Gentamicins|gentamicins|mesh-list
65522247|NCT01153191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65522248|NCT01153191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65522249|NCT01153191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65522250|NCT01153191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522251|NCT01153191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522253|NCT01259817|Interferons|interferons|mesh-list
65522254|NCT01259817|Interferon-alpha|interferon-alpha|mesh-list
65522255|NCT01259817|Interferon alpha-2|interferon alpha-2|mesh-list
65522256|NCT01259817|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65522257|NCT01259817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522258|NCT01259817|Antiviral Agents|antiviral agents|mesh-ancestor
65522259|NCT01259817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65522260|NCT01259817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65522261|NCT01259817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65522262|NCT01259817|Analgesics|analgesics|mesh-ancestor
65522263|NCT01259817|Sensory System Agents|sensory system agents|mesh-ancestor
65522264|NCT01259817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65522265|NCT01259817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522266|NCT01259817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65522267|NCT01259817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65522268|NCT01259817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65522269|NCT01259817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65522270|NCT01259817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522271|NCT01259817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65522272|NCT01259817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65522273|NCT01259817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522274|NCT01259817|Antipyretics|antipyretics|mesh-ancestor
65522275|NCT01259817|Immunologic Factors|immunologic factors|mesh-ancestor
65522276|NCT01261689|Sufentanil|sufentanil|mesh-list
65522277|NCT01261689|Dsuvia|dsuvia|mesh-list
65522278|NCT01261689|Ropivacaine|ropivacaine|mesh-list
65522279|NCT01261689|Anesthetics, Local|anesthetics, local|mesh-ancestor
65522280|NCT01261689|Anesthetics|anesthetics|mesh-ancestor
65522281|NCT01261689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65522282|NCT01261689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522283|NCT01261689|Sensory System Agents|sensory system agents|mesh-ancestor
65522284|NCT01261689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65522285|NCT01261689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65522286|NCT01261689|Narcotics|narcotics|mesh-ancestor
65522287|NCT01261689|Analgesics|analgesics|mesh-ancestor
65522288|NCT01261689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65522289|NCT01261689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65522290|NCT01261689|Anesthetics, General|anesthetics, general|mesh-ancestor
65522291|NCT01154907|Praziquantel|praziquantel|mesh-list
65522292|NCT01154907|Anthelmintics|anthelmintics|mesh-ancestor
65522293|NCT01154907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65522294|NCT01154907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65522295|NCT01261923|Alitretinoin|alitretinoin|mesh-list
65522296|NCT01261923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522297|NCT01261923|Dermatologic Agents|dermatologic agents|mesh-ancestor
65522298|NCT01157247|Fentanyl|fentanyl|mesh-list
65522299|NCT01157247|Anesthetics|anesthetics|mesh-list
65522300|NCT01157247|Anesthetics, Local|anesthetics, local|mesh-list
65522301|NCT01157247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65522302|NCT01157247|Narcotics|narcotics|mesh-ancestor
65522303|NCT01157247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65522304|NCT01157247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522305|NCT01157247|Analgesics|analgesics|mesh-ancestor
65522306|NCT01157247|Sensory System Agents|sensory system agents|mesh-ancestor
65522307|NCT01157247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65522308|NCT01157247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65522309|NCT01157247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65522310|NCT01157247|Anesthetics, General|anesthetics, general|mesh-ancestor
65522311|NCT03881787|Cetuximab|cetuximab|mesh-list
65522312|NCT03881787|Antibodies|antibodies|mesh-list
65522313|NCT03881787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65522314|NCT03881787|Immunologic Factors|immunologic factors|mesh-ancestor
65522315|NCT03881787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522316|NCT03881787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65522317|NCT03881787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522318|NCT01157481|Nifedipine|nifedipine|mesh-list
65522319|NCT01157481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65522320|NCT01157481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65522321|NCT01157481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522322|NCT01157481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65522323|NCT01157481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522324|NCT01157481|Vasodilator Agents|vasodilator agents|mesh-ancestor
65522325|NCT01157481|Tocolytic Agents|tocolytic agents|mesh-ancestor
65522326|NCT01157481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65522327|NCT03894189|Theophylline|theophylline|mesh-list
65522328|NCT03894189|Doxapram|doxapram|mesh-list
65522329|NCT03894189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65522330|NCT03894189|Autonomic Agents|autonomic agents|mesh-ancestor
65522331|NCT03894189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65522332|NCT03894189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522333|NCT03894189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65522334|NCT03894189|Respiratory System Agents|respiratory system agents|mesh-ancestor
65522335|NCT03894189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65522336|NCT03894189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522337|NCT03894189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522338|NCT03894189|Vasodilator Agents|vasodilator agents|mesh-ancestor
65522339|NCT03894189|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65522340|NCT03894189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65522341|NCT03894189|Purinergic Agents|purinergic agents|mesh-ancestor
65522342|NCT03894189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65522343|NCT03894189|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65522344|NCT03886311|Nivolumab|nivolumab|mesh-list
65522345|NCT03886311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
65522346|NCT03886311|Trabectedin|trabectedin|mesh-list
65522347|NCT03886311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65522348|NCT03886311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522349|NCT03886311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65522350|NCT03886311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522351|NCT03886311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65522352|NCT03886311|Alkylating Agents|alkylating agents|mesh-ancestor
65522353|NCT01155453|Trametinib|trametinib|mesh-list
65522354|NCT01155453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522355|NCT01155453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65522356|NCT01155453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522357|NCT01155453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522358|NCT03886233|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65522359|NCT03886233|Immunologic Factors|immunologic factors|mesh-ancestor
65522360|NCT03886233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522361|NCT03885219|Paclitaxel|paclitaxel|mesh-list
65522362|NCT03885219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65522363|NCT03885219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522364|NCT03885219|Tubulin Modulators|tubulin modulators|mesh-ancestor
65522365|NCT03885219|Antimitotic Agents|antimitotic agents|mesh-ancestor
65522366|NCT03885219|Mitosis Modulators|mitosis modulators|mesh-ancestor
65522367|NCT03885219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522368|NCT01157559|Ziprasidone|ziprasidone|mesh-list
65522369|NCT01157559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65522370|NCT01157559|Serotonin Agents|serotonin agents|mesh-ancestor
65522371|NCT01157559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65522372|NCT01157559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522373|NCT01157559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522374|NCT01157559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65522375|NCT01157559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65522376|NCT01157559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65522377|NCT01157559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65522378|NCT01157559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65522379|NCT01157559|Dopamine Agents|dopamine agents|mesh-ancestor
65522380|NCT01263951|Everolimus|everolimus|mesh-list
65522381|NCT01263951|Sorafenib|sorafenib|mesh-list
65522382|NCT01263951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522383|NCT01263951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65522384|NCT01263951|Immunologic Factors|immunologic factors|mesh-ancestor
65522385|NCT01263951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522386|NCT01263951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65522387|NCT01263951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522388|NCT01263951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522389|NCT01265433|Molgramostim|molgramostim|mesh-list
65522390|NCT01265433|Sargramostim|sargramostim|mesh-list
65319880|NCT02608034|Itraconazole|itraconazole|mesh-list
65522391|NCT01265433|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65522392|NCT01265433|Immunologic Factors|immunologic factors|mesh-ancestor
65522393|NCT01265433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522394|NCT01265433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522395|NCT01265433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65522396|NCT01265589|Vitamin A|vitamin a|mesh-list
65522397|NCT01265589|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65522398|NCT01265589|Vitamins|vitamins|mesh-ancestor
65522399|NCT01265589|Micronutrients|micronutrients|mesh-ancestor
65522400|NCT01265589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522401|NCT01265589|Respiratory System Agents|respiratory system agents|mesh-ancestor
65522402|NCT01159587|Factor VIII|factor viii|mesh-list
65522403|NCT01159587|Coagulants|coagulants|mesh-ancestor
65522404|NCT03885297|Liraglutide|liraglutide|mesh-list
65522405|NCT03885297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65522406|NCT03885297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522407|NCT03885297|Incretins|incretins|mesh-ancestor
65522408|NCT03885297|Hormones|hormones|mesh-ancestor
65522409|NCT03885297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65522410|NCT01159821|Paroxetine|paroxetine|mesh-list
65522411|NCT01159821|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65522412|NCT01159821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65522413|NCT01159821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65522414|NCT01159821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522415|NCT01159821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65522416|NCT01159821|Serotonin Agents|serotonin agents|mesh-ancestor
65522417|NCT01159821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522418|NCT01159821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65522419|NCT01159821|Antidepressive Agents|antidepressive agents|mesh-ancestor
65522420|NCT01159821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65522421|NCT01159821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65522422|NCT01159821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65522423|NCT01159821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522424|NCT03881319|Contraceptive Agents|contraceptive agents|mesh-list
65522425|NCT03881319|Contraceptives, Oral|contraceptives, oral|mesh-list
65522426|NCT03881319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65522427|NCT03881319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522428|NCT03881319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65522429|NCT03885141|Zolpidem|zolpidem|mesh-list
65522430|NCT03885141|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65522431|NCT03885141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65522432|NCT03885141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65522433|NCT03885141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522434|NCT03885141|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65522435|NCT03885141|GABA Agonists|gaba agonists|mesh-ancestor
65522436|NCT03885141|GABA Agents|gaba agents|mesh-ancestor
65522437|NCT03885141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65522438|NCT03885141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522439|NCT03879057|Antibodies|antibodies|mesh-list
65522440|NCT03879057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65522441|NCT03879057|Immunologic Factors|immunologic factors|mesh-ancestor
65522442|NCT03879057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522443|NCT01266057|Sirolimus|sirolimus|mesh-list
65522444|NCT01266057|Hydroxychloroquine|hydroxychloroquine|mesh-list
65522445|NCT01266057|Vorinostat|vorinostat|mesh-list
65522446|NCT01266057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65522447|NCT01266057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65522448|NCT01266057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65522449|NCT01266057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522450|NCT01266057|Antifungal Agents|antifungal agents|mesh-ancestor
65522451|NCT01266057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65522452|NCT01266057|Immunologic Factors|immunologic factors|mesh-ancestor
65522453|NCT01266057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522454|NCT01266057|Antimalarials|antimalarials|mesh-ancestor
65522455|NCT01266057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65522456|NCT01266057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65522457|NCT01266057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522458|NCT01266057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522459|NCT01266057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65522460|NCT01266057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65522461|NCT01266213|Fulvestrant|fulvestrant|mesh-list
65522462|NCT01266213|Anastrozole|anastrozole|mesh-list
65522463|NCT01266213|Goserelin|goserelin|mesh-list
65522464|NCT01266213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65522465|NCT01266213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522466|NCT01266213|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65522467|NCT01266213|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65522468|NCT01266213|Hormone Antagonists|hormone antagonists|mesh-ancestor
65522469|NCT01266213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65522470|NCT01266213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522471|NCT01266213|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65522472|NCT01266213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65522473|NCT01266213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522474|NCT01266213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522475|NCT01262391|Solifenacin Succinate|solifenacin succinate|mesh-list
65522476|NCT01262391|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65522477|NCT01262391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65522478|NCT01262391|Cholinergic Agents|cholinergic agents|mesh-ancestor
65522479|NCT01262391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65522480|NCT01262391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522481|NCT01262391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522482|NCT01262391|Urological Agents|urological agents|mesh-ancestor
65522483|NCT03880695|Doxorubicin|doxorubicin|mesh-list
65522484|NCT03880695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65522485|NCT03880695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65522486|NCT03880695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522487|NCT03880695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65522488|NCT03880695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65522489|NCT03880695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522490|NCT03880695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522491|NCT01155765|Clopidogrel|clopidogrel|mesh-list
65522492|NCT01155765|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65522493|NCT01155765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65522494|NCT01155765|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65522495|NCT01155765|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65522496|NCT01155765|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65522497|NCT01155765|Purinergic Agents|purinergic agents|mesh-ancestor
65522498|NCT01155765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65522499|NCT01155765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522500|NCT01155765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522501|NCT01264341|Sirolimus|sirolimus|mesh-list
65522502|NCT01264341|Bevacizumab|bevacizumab|mesh-list
65522503|NCT01264341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65522504|NCT01264341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522505|NCT01264341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65522506|NCT01264341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65522507|NCT01264341|Growth Substances|growth substances|mesh-ancestor
65522508|NCT01264341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522509|NCT01264341|Growth Inhibitors|growth inhibitors|mesh-ancestor
65522510|NCT01264341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65522511|NCT01264341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65522512|NCT01264341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65522513|NCT01264341|Antifungal Agents|antifungal agents|mesh-ancestor
65522514|NCT01264341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65522515|NCT01264341|Immunologic Factors|immunologic factors|mesh-ancestor
65522516|NCT01264497|Tesamorelin|tesamorelin|mesh-list
65522517|NCT01264497|Growth Substances|growth substances|mesh-ancestor
65522518|NCT01264497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522519|NCT01157949|Thymoglobulin|thymoglobulin|mesh-list
65522520|NCT01157949|Immunologic Factors|immunologic factors|mesh-ancestor
65522521|NCT01157949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522522|NCT01157949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65522523|NCT01262469|Capecitabine|capecitabine|mesh-list
65522524|NCT01262469|Lapatinib|lapatinib|mesh-list
65522525|NCT01262469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65522526|NCT01262469|Antimetabolites|antimetabolites|mesh-ancestor
65522527|NCT01262469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522528|NCT01262469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522529|NCT01262469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65522530|NCT01262469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522531|NCT01155921|Risperidone|risperidone|mesh-list
65522532|NCT01155921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65522533|NCT01155921|Serotonin Agents|serotonin agents|mesh-ancestor
65522534|NCT01155921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65522535|NCT01155921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522536|NCT01155921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522537|NCT01155921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65522538|NCT01155921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65522539|NCT01155921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65522540|NCT01155921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65522541|NCT01155921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65522542|NCT01155921|Dopamine Agents|dopamine agents|mesh-ancestor
65522543|NCT03884127|Orlistat|orlistat|mesh-list
65522544|NCT03884127|Ezetimibe|ezetimibe|mesh-list
65522545|NCT03884127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65522546|NCT03884127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65522547|NCT03884127|Antimetabolites|antimetabolites|mesh-ancestor
65522548|NCT03884127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522549|NCT03884127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65522550|NCT03884127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522551|NCT03884127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65522552|NCT01158105|Bortezomib|bortezomib|mesh-list
65522553|NCT01158105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522554|NCT03337490|Ivermectin|ivermectin|mesh-list
65522555|NCT03337490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65522556|NCT03337490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65522557|NCT01158183|Interferons|interferons|mesh-list
65522558|NCT01158183|Interferon-beta|interferon-beta|mesh-list
65522559|NCT01158183|Interferon beta-1b|interferon beta-1b|mesh-list
65522560|NCT01158183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522561|NCT01158183|Antiviral Agents|antiviral agents|mesh-ancestor
65522562|NCT01158183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65522563|NCT01158183|Immunologic Factors|immunologic factors|mesh-ancestor
65522564|NCT01158183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522565|NCT01158183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65522566|NCT01264575|Epinephrine|epinephrine|mesh-list
65522567|NCT01264575|Racepinephrine|racepinephrine|mesh-list
65522568|NCT01264575|Bupivacaine|bupivacaine|mesh-list
65522569|NCT01264575|Epinephryl borate|epinephryl borate|mesh-list
65522570|NCT01264575|Anesthetics, Local|anesthetics, local|mesh-ancestor
65522571|NCT01264575|Anesthetics|anesthetics|mesh-ancestor
65522572|NCT01264575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65522573|NCT01264575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522574|NCT01264575|Sensory System Agents|sensory system agents|mesh-ancestor
65522575|NCT01264575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65522576|NCT01264575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65522577|NCT01264575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65522578|NCT01264575|Adrenergic Agents|adrenergic agents|mesh-ancestor
65522579|NCT01264575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65522580|NCT01264575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522581|NCT01264575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65522582|NCT01264575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65522583|NCT01264575|Autonomic Agents|autonomic agents|mesh-ancestor
65522584|NCT01264575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65522585|NCT01264575|Respiratory System Agents|respiratory system agents|mesh-ancestor
65522586|NCT01264575|Mydriatics|mydriatics|mesh-ancestor
65522587|NCT01264575|Sympathomimetics|sympathomimetics|mesh-ancestor
65522588|NCT01264575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65522589|NCT04992260|Vaccines|vaccines|mesh-list
65522590|NCT04992260|Immunologic Factors|immunologic factors|mesh-ancestor
65522591|NCT04992260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522592|NCT01266681|Amiodarone|amiodarone|mesh-list
65522593|NCT01266681|Dronedarone|dronedarone|mesh-list
65522594|NCT01266681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65522595|NCT01266681|Vasodilator Agents|vasodilator agents|mesh-ancestor
65522596|NCT01266681|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65522597|NCT01266681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65522598|NCT01266681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522599|NCT01266681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65522600|NCT01266681|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65522601|NCT01266681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65522602|NCT01266681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522603|NCT01266681|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65522604|NCT01266681|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65522605|NCT01266681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65522606|NCT03638648|Capecitabine|capecitabine|mesh-list
65522607|NCT03638648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65522608|NCT03638648|Antimetabolites|antimetabolites|mesh-ancestor
65522609|NCT03638648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522610|NCT03638648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522611|NCT01266759|NuvaRing|nuvaring|mesh-list
65522612|NCT01266759|Norethindrone|norethindrone|mesh-list
65522613|NCT01266759|Norethindrone Acetate|norethindrone acetate|mesh-list
65522614|NCT01266759|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65522615|NCT01266759|Contraceptive Agents|contraceptive agents|mesh-ancestor
65522616|NCT01266759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65522617|NCT01266759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522618|NCT01266759|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65522619|NCT01266759|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65522620|NCT01266759|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65522621|NCT01266759|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65522622|NCT03512223|Dexamethasone|dexamethasone|mesh-list
65522623|NCT03512223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65522624|NCT03512223|Antiemetics|antiemetics|mesh-ancestor
65522625|NCT03512223|Autonomic Agents|autonomic agents|mesh-ancestor
65522626|NCT03512223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65522627|NCT03512223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522628|NCT03512223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65522629|NCT03512223|Glucocorticoids|glucocorticoids|mesh-ancestor
65522630|NCT03512223|Hormones|hormones|mesh-ancestor
65522631|NCT03512223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65522632|NCT03512223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65522633|NCT03512223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522634|NCT03878667|Calcium, Dietary|calcium, dietary|mesh-list
65522635|NCT03878667|Calcium Carbonate|calcium carbonate|mesh-list
65522636|NCT03878667|Calcium|calcium|mesh-list
65522637|NCT03878667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65522638|NCT03878667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522639|NCT03878667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65522640|NCT03878667|Antacids|antacids|mesh-ancestor
65522641|NCT03878667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522642|NCT03878667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65522643|NCT01264653|Epinephrine|epinephrine|mesh-list
65522644|NCT01264653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65522645|NCT01264653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65522646|NCT01264653|Adrenergic Agents|adrenergic agents|mesh-ancestor
65522647|NCT01264653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65522648|NCT01264653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522649|NCT01264653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522650|NCT01264653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65522651|NCT01264653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65522652|NCT01264653|Autonomic Agents|autonomic agents|mesh-ancestor
65522653|NCT01264653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65522654|NCT01264653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65522655|NCT01264653|Respiratory System Agents|respiratory system agents|mesh-ancestor
65522656|NCT01264653|Mydriatics|mydriatics|mesh-ancestor
65522657|NCT01264653|Sympathomimetics|sympathomimetics|mesh-ancestor
65522658|NCT01264653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65522659|NCT01266837|Everolimus|everolimus|mesh-list
65522660|NCT01266837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522661|NCT01266837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65522662|NCT01266837|Immunologic Factors|immunologic factors|mesh-ancestor
65522663|NCT01266837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522664|NCT01264731|Imiquimod|imiquimod|mesh-list
65522665|NCT01264731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65522666|NCT01264731|Immunologic Factors|immunologic factors|mesh-ancestor
65522667|NCT01264731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522668|NCT01264731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522669|NCT01264731|Interferon Inducers|interferon inducers|mesh-ancestor
65522670|NCT03879837|Fluticasone|fluticasone|mesh-list
65522671|NCT03879837|Xhance|xhance|mesh-list
65522672|NCT03879837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65522673|NCT03879837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65522674|NCT03879837|Autonomic Agents|autonomic agents|mesh-ancestor
65522675|NCT03879837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65522676|NCT03879837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522677|NCT03879837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65522678|NCT03879837|Respiratory System Agents|respiratory system agents|mesh-ancestor
65522679|NCT03879837|Dermatologic Agents|dermatologic agents|mesh-ancestor
65522680|NCT03879837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65522681|NCT05308628|Complement C3|complement c3|mesh-list
65522682|NCT05308628|Immunologic Factors|immunologic factors|mesh-ancestor
65522683|NCT05308628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522684|NCT01156077|Tedizolid phosphate|tedizolid phosphate|mesh-list
65522685|NCT01156077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65522686|NCT01156077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65522687|NCT01158729|Antithrombins|antithrombins|mesh-list
65522688|NCT01158729|Antithrombin III|antithrombin iii|mesh-list
65522689|NCT01158729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65522690|NCT01158729|Protease Inhibitors|protease inhibitors|mesh-ancestor
65522691|NCT01158729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522692|NCT01158729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522693|NCT01158729|Anticoagulants|anticoagulants|mesh-ancestor
65522694|NCT05303324|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
65522695|NCT05303324|Choline|choline|mesh-list
65522696|NCT05303324|Lipotropic Agents|lipotropic agents|mesh-ancestor
65522697|NCT05303324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65522698|NCT05303324|Antimetabolites|antimetabolites|mesh-ancestor
65522699|NCT05303324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522700|NCT05303324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65522701|NCT05303324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65522702|NCT05303324|Nootropic Agents|nootropic agents|mesh-ancestor
65522703|NCT05303324|Chelating Agents|chelating agents|mesh-ancestor
65522704|NCT05303324|Sequestering Agents|sequestering agents|mesh-ancestor
65522705|NCT05303324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522706|NCT05303324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65522707|NCT05303324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65522708|NCT05303324|Growth Substances|growth substances|mesh-ancestor
65522709|NCT05303324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522710|NCT05303324|Growth Inhibitors|growth inhibitors|mesh-ancestor
65522711|NCT05303324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522712|NCT01262859|Bevacizumab|bevacizumab|mesh-list
65522713|NCT01262859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65522714|NCT01262859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522715|NCT01262859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65522716|NCT01262859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65522717|NCT01262859|Growth Substances|growth substances|mesh-ancestor
65522718|NCT01262859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522719|NCT01262859|Growth Inhibitors|growth inhibitors|mesh-ancestor
65522720|NCT02527083|Ketamine|ketamine|mesh-list
65522721|NCT02527083|Remifentanil|remifentanil|mesh-list
65522722|NCT02527083|Propofol|propofol|mesh-list
65522723|NCT02527083|Sevoflurane|sevoflurane|mesh-list
65522724|NCT02527083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65522725|NCT02527083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65522726|NCT02527083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522727|NCT02527083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65522728|NCT02527083|Anesthetics, General|anesthetics, general|mesh-ancestor
65522729|NCT02527083|Anesthetics|anesthetics|mesh-ancestor
65522730|NCT02527083|Analgesics|analgesics|mesh-ancestor
65522731|NCT02527083|Sensory System Agents|sensory system agents|mesh-ancestor
65522732|NCT02527083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65522733|NCT02527083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65522734|NCT02527083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65522735|NCT02527083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65522736|NCT02527083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65522737|NCT02527083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522738|NCT02527083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65522739|NCT02527083|Narcotics|narcotics|mesh-ancestor
65522740|NCT02527083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65522741|NCT02527083|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65522742|NCT05156684|Zinc|zinc|mesh-list
65522743|NCT05156684|Pentoxifylline|pentoxifylline|mesh-list
65522744|NCT05156684|Zinc Sulfate|zinc sulfate|mesh-list
65522745|NCT05156684|Trace Elements|trace elements|mesh-ancestor
65522746|NCT05156684|Micronutrients|micronutrients|mesh-ancestor
65522747|NCT05156684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522748|NCT05156684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65522749|NCT05156684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522750|NCT05156684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522751|NCT05156684|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65522752|NCT05156684|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65522753|NCT05156684|Protective Agents|protective agents|mesh-ancestor
65522754|NCT05156684|Vasodilator Agents|vasodilator agents|mesh-ancestor
65522755|NCT05156684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65522756|NCT05156684|Antioxidants|antioxidants|mesh-ancestor
65522757|NCT05156684|Astringents|astringents|mesh-ancestor
65522758|NCT05156684|Dermatologic Agents|dermatologic agents|mesh-ancestor
65522759|NCT03883347|Dexmedetomidine|dexmedetomidine|mesh-list
65522760|NCT03883347|Remifentanil|remifentanil|mesh-list
65522761|NCT03883347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65522762|NCT03883347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65522763|NCT03883347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522764|NCT03883347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65522765|NCT03883347|Analgesics|analgesics|mesh-ancestor
65522766|NCT03883347|Sensory System Agents|sensory system agents|mesh-ancestor
65522767|NCT03883347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65522768|NCT03883347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65522769|NCT03883347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65522770|NCT03883347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65522771|NCT03883347|Adrenergic Agents|adrenergic agents|mesh-ancestor
65522772|NCT03883347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65522773|NCT03883347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522774|NCT03883347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65522775|NCT03883347|Narcotics|narcotics|mesh-ancestor
65522777|NCT01159275|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65522778|NCT01159275|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65522779|NCT01159275|Protease Inhibitors|protease inhibitors|mesh-ancestor
65522780|NCT01159275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522781|NCT01159275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522782|NCT01159275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65522783|NCT01159275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65522784|NCT01159275|Antiviral Agents|antiviral agents|mesh-ancestor
65522785|NCT01159275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65522786|NCT01159275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65522787|NCT01159275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65522788|NCT01159353|Insulin|insulin|mesh-list
65522789|NCT01159353|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65522790|NCT01159353|Insulin Aspart|insulin aspart|mesh-list
65522791|NCT01159353|Insulin glulisine|insulin glulisine|mesh-list
65522792|NCT01159353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65522793|NCT01159353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522794|NCT02943668|Deferasirox|deferasirox|mesh-list
65522795|NCT02943668|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65522796|NCT02943668|Chelating Agents|chelating agents|mesh-ancestor
65522797|NCT02943668|Sequestering Agents|sequestering agents|mesh-ancestor
65522798|NCT02943668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522799|NCT01265199|Cytarabine|cytarabine|mesh-list
65522800|NCT01265199|Daunorubicin|daunorubicin|mesh-list
65522801|NCT01265199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65522802|NCT01265199|Antimetabolites|antimetabolites|mesh-ancestor
65522803|NCT01265199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522804|NCT01265199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522805|NCT01265199|Antiviral Agents|antiviral agents|mesh-ancestor
65522806|NCT01265199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65522807|NCT01265199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65522808|NCT01265199|Immunologic Factors|immunologic factors|mesh-ancestor
65522809|NCT01265199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522810|NCT01265199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65522811|NCT01265199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65522812|NCT01265199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65522813|NCT01265199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522814|NCT01263171|Leucovorin|leucovorin|mesh-list
65522815|NCT01263171|Fluorouracil|fluorouracil|mesh-list
65522816|NCT01263171|Oxaliplatin|oxaliplatin|mesh-list
65522817|NCT01263171|Calcium|calcium|mesh-list
65522818|NCT01263171|Levoleucovorin|levoleucovorin|mesh-list
65522819|NCT01263171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65522820|NCT01263171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522821|NCT01263171|Antimetabolites|antimetabolites|mesh-ancestor
65522822|NCT01263171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522823|NCT01263171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65522824|NCT01263171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522825|NCT01263171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65522826|NCT01263171|Immunologic Factors|immunologic factors|mesh-ancestor
65522827|NCT01263171|Antidotes|antidotes|mesh-ancestor
65522828|NCT01263171|Protective Agents|protective agents|mesh-ancestor
65522829|NCT01263171|Vitamin B Complex|vitamin b complex|mesh-ancestor
65522830|NCT01263171|Vitamins|vitamins|mesh-ancestor
65522831|NCT01263171|Micronutrients|micronutrients|mesh-ancestor
65522832|NCT01156233|Anesthetics|anesthetics|mesh-list
65522833|NCT01156233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65522834|NCT01156233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522835|NCT03883269|Ethanol|ethanol|mesh-list
65522836|NCT03883269|Clindamycin|clindamycin|mesh-list
65522837|NCT03883269|Clindamycin palmitate|clindamycin palmitate|mesh-list
65522838|NCT03883269|Clindamycin phosphate|clindamycin phosphate|mesh-list
65522839|NCT03883269|Erythromycin|erythromycin|mesh-list
65522840|NCT03883269|Erythromycin Estolate|erythromycin estolate|mesh-list
65522841|NCT03883269|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65522842|NCT03883269|Erythromycin stearate|erythromycin stearate|mesh-list
65522843|NCT03883269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65522844|NCT03883269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65522845|NCT03883269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65522846|NCT03883269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522847|NCT03883269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65522848|NCT03883269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65522849|NCT03883269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522850|NCT03883269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522851|NCT03883269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65522852|NCT01267305|Calcium, Dietary|calcium, dietary|mesh-list
65522853|NCT01267305|PENTA|penta|mesh-list
65522854|NCT01267305|Nadroparin|nadroparin|mesh-list
65522855|NCT01267305|Fondaparinux|fondaparinux|mesh-list
65522856|NCT01267305|Calcium|calcium|mesh-list
65522857|NCT01267305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65522858|NCT01267305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522859|NCT01267305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65522860|NCT01267305|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65522861|NCT01267305|Antithrombins|antithrombins|mesh-ancestor
65522862|NCT01267305|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65522863|NCT01267305|Protease Inhibitors|protease inhibitors|mesh-ancestor
65522864|NCT01267305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522865|NCT01267305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522866|NCT01267305|Anticoagulants|anticoagulants|mesh-ancestor
65522867|NCT01267305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65522868|NCT01267305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65522869|NCT02891408|Fenofibrate|fenofibrate|mesh-list
65522870|NCT02891408|Firsocostat|firsocostat|mesh-list
65522871|NCT02891408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65522872|NCT02891408|Antimetabolites|antimetabolites|mesh-ancestor
65522873|NCT02891408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522874|NCT02891408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65522875|NCT02891408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522876|NCT01160991|Olanzapine|olanzapine|mesh-list
65522877|NCT01160991|Amisulpride|amisulpride|mesh-list
65522878|NCT01160991|Antiemetics|antiemetics|mesh-ancestor
65522879|NCT01160991|Autonomic Agents|autonomic agents|mesh-ancestor
65522880|NCT01160991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65522881|NCT01160991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522882|NCT01160991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65522883|NCT01160991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65522884|NCT01160991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65522885|NCT01160991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65522886|NCT01160991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65522887|NCT01160991|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65522888|NCT01160991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65522889|NCT01160991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65522890|NCT01160991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522891|NCT01160991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65522892|NCT01160991|Serotonin Agents|serotonin agents|mesh-ancestor
65522893|NCT01160991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65522894|NCT01160991|Dopamine Agents|dopamine agents|mesh-ancestor
65522895|NCT01160991|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65522896|NCT01160991|Antidepressive Agents|antidepressive agents|mesh-ancestor
65522897|NCT05498480|Nivolumab|nivolumab|mesh-list
65522898|NCT05498480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65522899|NCT05498480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522900|NCT05498480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65522901|NCT05498480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522902|NCT01161069|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
65522903|NCT01161069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65522904|NCT01161069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65522905|NCT01161069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522906|NCT01161069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522907|NCT01161147|Meloxicam|meloxicam|mesh-list
65522908|NCT01161147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65522909|NCT01161147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65522910|NCT01161147|Analgesics|analgesics|mesh-ancestor
65522911|NCT01161147|Sensory System Agents|sensory system agents|mesh-ancestor
65522912|NCT01161147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65522913|NCT01161147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522914|NCT01161147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65522915|NCT01161147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65522916|NCT01161147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65522917|NCT01161147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65522918|NCT01161147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522919|NCT01161147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522920|NCT01161927|Nizatidine|nizatidine|mesh-list
65522921|NCT01161927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65522922|NCT01161927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65522923|NCT01161927|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65522924|NCT01161927|Histamine Antagonists|histamine antagonists|mesh-ancestor
65522925|NCT01161927|Histamine Agents|histamine agents|mesh-ancestor
65522926|NCT01161927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65522927|NCT01161927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522928|NCT01161927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522929|NCT01267383|Sertraline|sertraline|mesh-list
65522930|NCT01267383|Antidepressive Agents|antidepressive agents|mesh-ancestor
65522931|NCT01267383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65522932|NCT01267383|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65522933|NCT01267383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65522934|NCT01267383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65522935|NCT01267383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522936|NCT01267383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65522937|NCT01267383|Serotonin Agents|serotonin agents|mesh-ancestor
65522938|NCT01267383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522939|NCT03283670|Nitrous Oxide|nitrous oxide|mesh-list
65522940|NCT03283670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65522941|NCT03283670|Anesthetics, General|anesthetics, general|mesh-ancestor
65522942|NCT03283670|Anesthetics|anesthetics|mesh-ancestor
65522943|NCT03283670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65522944|NCT03283670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522945|NCT03283670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65522946|NCT03283670|Analgesics|analgesics|mesh-ancestor
65522947|NCT03283670|Sensory System Agents|sensory system agents|mesh-ancestor
65522948|NCT03283670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65522949|NCT03110432|Nicotinic Acids|nicotinic acids|mesh-list
65522950|NCT03110432|Niacin|niacin|mesh-list
65522951|NCT03110432|Ezetimibe|ezetimibe|mesh-list
65522952|NCT03110432|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65522953|NCT03110432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65522954|NCT03110432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65522955|NCT03110432|Antimetabolites|antimetabolites|mesh-ancestor
65522956|NCT03110432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522957|NCT03110432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65522958|NCT03110432|Vitamin B Complex|vitamin b complex|mesh-ancestor
65522959|NCT03110432|Vitamins|vitamins|mesh-ancestor
65522960|NCT03110432|Micronutrients|micronutrients|mesh-ancestor
65522961|NCT03110432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522962|NCT03110432|Vasodilator Agents|vasodilator agents|mesh-ancestor
65522963|NCT03205358|Vaccines|vaccines|mesh-list
65522964|NCT03205358|Immunologic Factors|immunologic factors|mesh-ancestor
65522965|NCT03205358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522966|NCT01358578|Etanercept|etanercept|mesh-list
65522967|NCT01358578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65522968|NCT01358578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65522969|NCT01358578|Analgesics|analgesics|mesh-ancestor
65522970|NCT01358578|Sensory System Agents|sensory system agents|mesh-ancestor
65522971|NCT01358578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65522972|NCT01358578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522973|NCT01358578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65522974|NCT01358578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65522975|NCT01358578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65522976|NCT01358578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65522977|NCT01358578|Immunologic Factors|immunologic factors|mesh-ancestor
65522978|NCT01161459|Prednisone|prednisone|mesh-list
65522979|NCT01161459|Tacrolimus|tacrolimus|mesh-list
65522980|NCT01161459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65522981|NCT01161459|Glucocorticoids|glucocorticoids|mesh-ancestor
65522982|NCT01161459|Hormones|hormones|mesh-ancestor
65522983|NCT01161459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65522984|NCT01161459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522985|NCT01161459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65522986|NCT01161459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65522987|NCT01161459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65522988|NCT01161459|Immunologic Factors|immunologic factors|mesh-ancestor
65522989|NCT01161459|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65522990|NCT01161459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65522991|NCT01161459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65522992|NCT03882489|Chloroprocaine|chloroprocaine|mesh-list
65522993|NCT03882489|Anesthetics, Local|anesthetics, local|mesh-ancestor
65522994|NCT03882489|Anesthetics|anesthetics|mesh-ancestor
65522995|NCT03882489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65522996|NCT03882489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65522997|NCT03882489|Sensory System Agents|sensory system agents|mesh-ancestor
65522998|NCT03882489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65522999|NCT03882099|Vitamin D|vitamin d|mesh-list
65523000|NCT03882099|Vitamins|vitamins|mesh-ancestor
65523001|NCT03882099|Micronutrients|micronutrients|mesh-ancestor
65523002|NCT03882099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523003|NCT03882099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65523004|NCT01268163|Docetaxel|docetaxel|mesh-list
65523005|NCT01268163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523006|NCT01268163|Tubulin Modulators|tubulin modulators|mesh-ancestor
65523007|NCT01268163|Antimitotic Agents|antimitotic agents|mesh-ancestor
65523008|NCT01268163|Mitosis Modulators|mitosis modulators|mesh-ancestor
65523009|NCT01268163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523010|NCT04745780|Inositol|inositol|mesh-list
65523011|NCT04745780|Vitamin B Complex|vitamin b complex|mesh-ancestor
65523012|NCT04745780|Vitamins|vitamins|mesh-ancestor
65523013|NCT04745780|Micronutrients|micronutrients|mesh-ancestor
65523014|NCT04745780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523015|NCT02833948|Aspirin|aspirin|mesh-list
65523016|NCT02833948|Rivaroxaban|rivaroxaban|mesh-list
65523017|NCT02833948|Clopidogrel|clopidogrel|mesh-list
65523018|NCT02833948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65523019|NCT02833948|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65523020|NCT02833948|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65523021|NCT02833948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65523022|NCT02833948|Purinergic Agents|purinergic agents|mesh-ancestor
65523023|NCT02833948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65523024|NCT02833948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523025|NCT02833948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523026|NCT02833948|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65523027|NCT02833948|Antithrombins|antithrombins|mesh-ancestor
65523028|NCT02833948|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65523029|NCT02833948|Protease Inhibitors|protease inhibitors|mesh-ancestor
65523030|NCT02833948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523031|NCT02833948|Anticoagulants|anticoagulants|mesh-ancestor
65523032|NCT02833948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65523033|NCT02833948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65523034|NCT02833948|Analgesics|analgesics|mesh-ancestor
65523035|NCT02833948|Sensory System Agents|sensory system agents|mesh-ancestor
65523036|NCT02833948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65523037|NCT02833948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65523038|NCT02833948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65523039|NCT02833948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65523040|NCT02833948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65523041|NCT02833948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65523042|NCT02833948|Antipyretics|antipyretics|mesh-ancestor
65523043|NCT02527005|Azithromycin|azithromycin|mesh-list
65523044|NCT02527005|Pyrimethamine|pyrimethamine|mesh-list
65523045|NCT02527005|Sulfadoxine|sulfadoxine|mesh-list
65523046|NCT02527005|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65523047|NCT02527005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65523048|NCT02527005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65523049|NCT02527005|Antimalarials|antimalarials|mesh-ancestor
65523050|NCT02527005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65523051|NCT02527005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65523052|NCT02527005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65523053|NCT02527005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523054|NCT02527005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523055|NCT02527005|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65523056|NCT02527005|Renal Agents|renal agents|mesh-ancestor
65523057|NCT01267695|Imatinib Mesylate|imatinib mesylate|mesh-list
65523058|NCT01267695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523059|NCT01267695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65523060|NCT01267695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523061|NCT01267695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523062|NCT02404688|Ethanol|ethanol|mesh-list
65523063|NCT02404688|Dronabinol|dronabinol|mesh-list
65523064|NCT02404688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65523065|NCT02404688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65523066|NCT02404688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65523067|NCT02404688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523068|NCT02404688|Hallucinogens|hallucinogens|mesh-ancestor
65523069|NCT02404688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65523070|NCT02404688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65523071|NCT02404688|Analgesics|analgesics|mesh-ancestor
65523072|NCT02404688|Sensory System Agents|sensory system agents|mesh-ancestor
65523073|NCT02404688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65523074|NCT02404688|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65523075|NCT02404688|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65523076|NCT02404688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65523077|NCT02404688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523078|NCT02404688|Hormones|hormones|mesh-ancestor
65523079|NCT02404688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65523080|NCT04704518|Hyaluronic Acid|hyaluronic acid|mesh-list
65523081|NCT04704518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65523082|NCT04704518|Immunologic Factors|immunologic factors|mesh-ancestor
65523083|NCT04704518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523084|NCT04704518|Viscosupplements|viscosupplements|mesh-ancestor
65523085|NCT04704518|Protective Agents|protective agents|mesh-ancestor
65523086|NCT02624102|Antidepressive Agents|antidepressive agents|mesh-list
65523087|NCT02624102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65523088|NCT01162941|Prednisolone|prednisolone|mesh-list
65523089|NCT01162941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65523090|NCT01162941|Glucocorticoids|glucocorticoids|mesh-ancestor
65523091|NCT01162941|Hormones|hormones|mesh-ancestor
65523092|NCT01162941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65523093|NCT01162941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523094|NCT01162941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65523095|NCT01162941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523096|NCT00161044|Galantamine|galantamine|mesh-list
65523097|NCT00161044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65523098|NCT00161044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523099|NCT00161044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523100|NCT00161044|Cholinergic Agents|cholinergic agents|mesh-ancestor
65523101|NCT00161044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65523102|NCT00161044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523103|NCT00161044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65523104|NCT00161044|Autonomic Agents|autonomic agents|mesh-ancestor
65523105|NCT00161044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65523106|NCT00161044|Nootropic Agents|nootropic agents|mesh-ancestor
65523107|NCT01156779|Exenatide|exenatide|mesh-list
65523108|NCT01156779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65523109|NCT01156779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523110|NCT01156779|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65523111|NCT01156779|Incretins|incretins|mesh-ancestor
65523112|NCT01156779|Hormones|hormones|mesh-ancestor
65523113|NCT01156779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65523114|NCT01156857|Ulipristal acetate|ulipristal acetate|mesh-list
65523115|NCT01156857|Progestins|progestins|mesh-list
65523116|NCT01156857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65523117|NCT01156857|Contraceptive Agents|contraceptive agents|mesh-ancestor
65523118|NCT01156857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65523119|NCT01156857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523120|NCT01156857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65523121|NCT01156857|Hormones|hormones|mesh-ancestor
65523122|NCT01156857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65523123|NCT01269333|Fluvoxamine|fluvoxamine|mesh-list
65523124|NCT01269333|Omeprazole|omeprazole|mesh-list
65523125|NCT01269333|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65523126|NCT01269333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65523127|NCT01269333|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65523128|NCT01269333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523129|NCT01269333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523130|NCT01269333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65523131|NCT01269333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65523132|NCT01269333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65523133|NCT01269333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523134|NCT01269333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65523135|NCT01269333|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65523136|NCT01269333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65523137|NCT01269333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65523138|NCT01269333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65523139|NCT01269333|Serotonin Agents|serotonin agents|mesh-ancestor
65523140|NCT01269333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65523141|NCT01269333|Antidepressive Agents|antidepressive agents|mesh-ancestor
65523142|NCT01269333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65523143|NCT01269333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65523144|NCT01269333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65523145|NCT01269411|R04929097|r04929097|mesh-list
65523146|NCT01269411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320630|NCT00748566|Ziprasidone|ziprasidone|mesh-list
65523147|NCT01269411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523148|NCT03882255|Propranolol|propranolol|mesh-list
65523149|NCT03882255|Ponesimod|ponesimod|mesh-list
65523150|NCT03882255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65523151|NCT03882255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65523152|NCT03882255|Adrenergic Agents|adrenergic agents|mesh-ancestor
65523153|NCT03882255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65523154|NCT03882255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523155|NCT03882255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523156|NCT03882255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65523157|NCT03882255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65523158|NCT03882255|Vasodilator Agents|vasodilator agents|mesh-ancestor
65523159|NCT03882255|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65523160|NCT03882255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65523161|NCT03882255|Immunologic Factors|immunologic factors|mesh-ancestor
65523162|NCT05433272|Vaccines|vaccines|mesh-list
65523163|NCT05433272|Immunologic Factors|immunologic factors|mesh-ancestor
65523164|NCT05433272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523165|NCT01268631|Pregabalin|pregabalin|mesh-list
65523166|NCT01268631|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65523167|NCT01268631|Analgesics|analgesics|mesh-ancestor
65523168|NCT01268631|Sensory System Agents|sensory system agents|mesh-ancestor
65523169|NCT01268631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65523170|NCT01268631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523171|NCT01268631|Anticonvulsants|anticonvulsants|mesh-ancestor
65523172|NCT01268631|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65523173|NCT01268631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65523174|NCT01268631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523175|NCT01268631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65523176|NCT01268631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65523177|NCT01268631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65523178|NCT01268631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65523179|NCT01268631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65523180|NCT01268631|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65523181|NCT01268631|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65523182|NCT01268631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65523183|NCT01268631|Antidepressive Agents|antidepressive agents|mesh-ancestor
65523184|NCT01268631|Dopamine Agents|dopamine agents|mesh-ancestor
65523185|NCT05430230|Naproxen|naproxen|mesh-list
65523186|NCT05430230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65523187|NCT05430230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65523188|NCT05430230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65523189|NCT05430230|Analgesics|analgesics|mesh-ancestor
65523190|NCT05430230|Sensory System Agents|sensory system agents|mesh-ancestor
65523191|NCT05430230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65523192|NCT05430230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523193|NCT05430230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65523194|NCT05430230|Gout Suppressants|gout suppressants|mesh-ancestor
65523195|NCT05430230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65523196|NCT05430230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523197|NCT05430230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523198|NCT01268709|Doxepin|doxepin|mesh-list
65523199|NCT01268709|Nortriptyline|nortriptyline|mesh-list
65523200|NCT01268709|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65523201|NCT01268709|Antidepressive Agents|antidepressive agents|mesh-ancestor
65523202|NCT01268709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65523203|NCT01268709|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65523204|NCT01268709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65523205|NCT01268709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65523206|NCT01268709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523207|NCT01268709|Adrenergic Agents|adrenergic agents|mesh-ancestor
65523208|NCT01268709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65523209|NCT01268709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523210|NCT01268709|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65523211|NCT01268709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65523212|NCT01268709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65523213|NCT01268709|Histamine Antagonists|histamine antagonists|mesh-ancestor
65523214|NCT01268709|Histamine Agents|histamine agents|mesh-ancestor
65523215|NCT03881943|Aspirin|aspirin|mesh-list
65523216|NCT03881943|Ticagrelor|ticagrelor|mesh-list
65523217|NCT03881943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65523218|NCT03881943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65523219|NCT03881943|Analgesics|analgesics|mesh-ancestor
65523220|NCT03881943|Sensory System Agents|sensory system agents|mesh-ancestor
65523221|NCT03881943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65523222|NCT03881943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523223|NCT03881943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65523224|NCT03881943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65523225|NCT03881943|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65523226|NCT03881943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65523227|NCT03881943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523228|NCT03881943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65523229|NCT03881943|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65523230|NCT03881943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523231|NCT03881943|Antipyretics|antipyretics|mesh-ancestor
65523232|NCT03881943|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65523233|NCT03881943|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65523234|NCT03881943|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65523235|NCT03881943|Purinergic Agents|purinergic agents|mesh-ancestor
65523236|NCT03881943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65523237|NCT03760185|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65523238|NCT03760185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65523239|NCT03760185|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65523240|NCT03760185|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65523241|NCT03760185|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65523242|NCT03760185|Adrenergic Agents|adrenergic agents|mesh-ancestor
65523243|NCT03760185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65523244|NCT03760185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523245|NCT03760185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523246|NCT01164969|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65523247|NCT01164969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65523248|NCT04722848|Imatinib Mesylate|imatinib mesylate|mesh-list
65523249|NCT04722848|Blinatumomab|blinatumomab|mesh-list
65523250|NCT04722848|Ponatinib|ponatinib|mesh-list
65523251|NCT04722848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523252|NCT04722848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65523253|NCT04722848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523254|NCT04722848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523255|NCT01157013|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65523256|NCT01157013|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65523257|NCT01157013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523258|NCT01584466|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65523259|NCT01584466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65523260|NCT01584466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65523261|NCT01584466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65523262|NCT01584466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523263|NCT01584466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65523264|NCT01584466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65523265|NCT01584466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65523266|NCT01584466|Serotonin Agents|serotonin agents|mesh-ancestor
65523267|NCT01584466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65523268|NCT01584466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523269|NCT01584466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65523270|NCT01584466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65523271|NCT01584466|Dopamine Agents|dopamine agents|mesh-ancestor
65523272|NCT05363384|Metformin|metformin|mesh-list
65523273|NCT05363384|Alogliptin|alogliptin|mesh-list
65523274|NCT05363384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65523275|NCT05363384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523276|NCT05363384|Incretins|incretins|mesh-ancestor
65523277|NCT05363384|Hormones|hormones|mesh-ancestor
65523278|NCT05363384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65523279|NCT05363384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65523280|NCT05363384|Protease Inhibitors|protease inhibitors|mesh-ancestor
65523281|NCT05363384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523282|NCT05363384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523283|NCT01165125|Ketoconazole|ketoconazole|mesh-list
65523284|NCT01165125|Antifungal Agents|antifungal agents|mesh-ancestor
65523285|NCT01165125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65523286|NCT01165125|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65523287|NCT01165125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65523288|NCT01165125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523289|NCT01165125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523290|NCT01165125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65523291|NCT01165125|Hormone Antagonists|hormone antagonists|mesh-ancestor
65320776|NCT00585975|Bromfenac|bromfenac|mesh-list
65523292|NCT01165125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65523293|NCT01165125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523294|NCT01165125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65523295|NCT01163799|Alefacept|alefacept|mesh-list
65523296|NCT01163799|Dermatologic Agents|dermatologic agents|mesh-ancestor
65523297|NCT01163799|Immunologic Factors|immunologic factors|mesh-ancestor
65523298|NCT01163799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523299|NCT02274662|Cyclosporine|cyclosporine|mesh-list
65523300|NCT02274662|Tacrolimus|tacrolimus|mesh-list
65523301|NCT02274662|Cyclosporins|cyclosporins|mesh-list
65523302|NCT02274662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65523303|NCT02274662|Thymoglobulin|thymoglobulin|mesh-list
65523304|NCT02274662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65523305|NCT02274662|Immunologic Factors|immunologic factors|mesh-ancestor
65523306|NCT02274662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523307|NCT02274662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65523308|NCT02274662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523309|NCT02274662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523310|NCT02274662|Antifungal Agents|antifungal agents|mesh-ancestor
65523311|NCT02274662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65523312|NCT02274662|Dermatologic Agents|dermatologic agents|mesh-ancestor
65523313|NCT02274662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65523314|NCT02891174|Acetaminophen|acetaminophen|mesh-list
65523315|NCT02891174|Ibuprofen|ibuprofen|mesh-list
65523316|NCT02891174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65523317|NCT02891174|Analgesics|analgesics|mesh-ancestor
65523318|NCT02891174|Sensory System Agents|sensory system agents|mesh-ancestor
65523319|NCT02891174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65523320|NCT02891174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523321|NCT02891174|Antipyretics|antipyretics|mesh-ancestor
65523322|NCT02891174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65523323|NCT02891174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65523324|NCT02891174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65523325|NCT02891174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65523326|NCT02891174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523327|NCT02891174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523328|NCT01280175|Charcoal|charcoal|mesh-list
65523329|NCT01280175|Antidotes|antidotes|mesh-ancestor
65523330|NCT01280175|Protective Agents|protective agents|mesh-ancestor
65523331|NCT01280175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523332|NCT01588431|Bevacizumab|bevacizumab|mesh-list
65523333|NCT01588431|Cetuximab|cetuximab|mesh-list
65523334|NCT01588431|Cisplatin|cisplatin|mesh-list
65523335|NCT01588431|Docetaxel|docetaxel|mesh-list
65523336|NCT01588431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65523337|NCT01588431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523338|NCT01588431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65523339|NCT01588431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65523340|NCT01588431|Growth Substances|growth substances|mesh-ancestor
65523341|NCT01588431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523342|NCT01588431|Growth Inhibitors|growth inhibitors|mesh-ancestor
65523343|NCT01588431|Tubulin Modulators|tubulin modulators|mesh-ancestor
65523344|NCT01588431|Antimitotic Agents|antimitotic agents|mesh-ancestor
65523345|NCT01588431|Mitosis Modulators|mitosis modulators|mesh-ancestor
65523346|NCT01588431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523347|NCT01583283|Dexamethasone|dexamethasone|mesh-list
65523348|NCT01583283|Lenalidomide|lenalidomide|mesh-list
65523349|NCT01583283|Ricolinostat|ricolinostat|mesh-list
65523350|NCT01583283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65523351|NCT01583283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65523352|NCT01583283|Antiemetics|antiemetics|mesh-ancestor
65523353|NCT01583283|Autonomic Agents|autonomic agents|mesh-ancestor
65523354|NCT01583283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65523355|NCT01583283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523356|NCT01583283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65523357|NCT01583283|Glucocorticoids|glucocorticoids|mesh-ancestor
65523358|NCT01583283|Hormones|hormones|mesh-ancestor
65252372|NCT04114500|Estradiol|estradiol|mesh-list
65523359|NCT01583283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65523360|NCT01583283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65523361|NCT01583283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523362|NCT01583283|Immunologic Factors|immunologic factors|mesh-ancestor
65523363|NCT01583283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65523364|NCT01583283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65523365|NCT01583283|Growth Substances|growth substances|mesh-ancestor
65523366|NCT01583283|Growth Inhibitors|growth inhibitors|mesh-ancestor
65523367|NCT01583283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320852|NCT05756621|Topiramate|topiramate|mesh-list
65523368|NCT01583283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523369|NCT02076620|Doxorubicin|doxorubicin|mesh-list
65523370|NCT02076620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65523371|NCT02076620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523372|NCT02076620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65523373|NCT02076620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65523374|NCT02076620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523375|NCT02076620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523376|NCT01270737|Daidzein|daidzein|mesh-list
65523377|NCT01270737|Phytoestrogens|phytoestrogens|mesh-ancestor
65523378|NCT01270737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65523379|NCT01270737|Estrogens|estrogens|mesh-ancestor
65523380|NCT01270737|Hormones|hormones|mesh-ancestor
65523381|NCT01270737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65523382|NCT01270737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523383|NCT01270815|Pregabalin|pregabalin|mesh-list
65523384|NCT01270815|Analgesics|analgesics|mesh-ancestor
65523385|NCT01270815|Sensory System Agents|sensory system agents|mesh-ancestor
65523386|NCT01270815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65523387|NCT01270815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523388|NCT01270815|Anticonvulsants|anticonvulsants|mesh-ancestor
65523389|NCT01270815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65523390|NCT01270815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65523391|NCT01270815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523392|NCT01270815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65523393|NCT01270815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65523394|NCT01270815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65523395|NCT01270815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65523396|NCT01270815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65523397|NCT01751984|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
65523398|NCT01751984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65523399|NCT01751984|Antimetabolites|antimetabolites|mesh-ancestor
65523400|NCT01751984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523401|NCT01751984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65523402|NCT01751984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523403|NCT01751984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65523404|NCT01751984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523405|NCT03330236|Anesthetics|anesthetics|mesh-list
65523406|NCT03330236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65523407|NCT03330236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523408|NCT02831764|Tenofovir|tenofovir|mesh-list
65523409|NCT02831764|Lamivudine|lamivudine|mesh-list
65523410|NCT02831764|Emtricitabine|emtricitabine|mesh-list
65523411|NCT02831764|Dolutegravir|dolutegravir|mesh-list
65523412|NCT02831764|Antiviral Agents|antiviral agents|mesh-ancestor
65523413|NCT02831764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65523414|NCT02831764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65523415|NCT02831764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65523416|NCT02831764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523417|NCT02831764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523418|NCT02831764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65523419|NCT02831764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65523420|NCT02831764|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65523421|NCT02831764|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65523422|NCT01271361|Sirolimus|sirolimus|mesh-list
65523423|NCT01271361|Umirolimus|umirolimus|mesh-list
65523424|NCT01271361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65523425|NCT01271361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65523426|NCT01271361|Immunologic Factors|immunologic factors|mesh-ancestor
65523427|NCT01271361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523428|NCT01271361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65523429|NCT01271361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65523430|NCT01271361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65523431|NCT01271361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523432|NCT01271361|Antifungal Agents|antifungal agents|mesh-ancestor
65523433|NCT03638726|Atropine|atropine|mesh-list
65523434|NCT03638726|Phenylephrine|phenylephrine|mesh-list
65523435|NCT03638726|Epinephrine|epinephrine|mesh-list
65523436|NCT03638726|Racepinephrine|racepinephrine|mesh-list
65523437|NCT03638726|Oxymetazoline|oxymetazoline|mesh-list
65523438|NCT03638726|Cyclopentolate|cyclopentolate|mesh-list
65523439|NCT03638726|Epinephryl borate|epinephryl borate|mesh-list
65523440|NCT03638726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65523441|NCT03638726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65523442|NCT03638726|Adrenergic Agents|adrenergic agents|mesh-ancestor
65523443|NCT03638726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65523444|NCT03638726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523445|NCT03638726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523446|NCT03638726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65523447|NCT03638726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65523449|NCT03638726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65523450|NCT03638726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65523451|NCT03638726|Respiratory System Agents|respiratory system agents|mesh-ancestor
65523452|NCT03638726|Mydriatics|mydriatics|mesh-ancestor
65523453|NCT03638726|Sympathomimetics|sympathomimetics|mesh-ancestor
65523454|NCT03638726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65523455|NCT03638726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65523456|NCT03638726|Nasal Decongestants|nasal decongestants|mesh-ancestor
65523457|NCT03638726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65523458|NCT03638726|Protective Agents|protective agents|mesh-ancestor
65523459|NCT03638726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65523460|NCT03638726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65523461|NCT03638726|Parasympatholytics|parasympatholytics|mesh-ancestor
65523462|NCT03638726|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65523463|NCT03638726|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65523464|NCT03638726|Cholinergic Agents|cholinergic agents|mesh-ancestor
65523465|NCT01164189|Bevacizumab|bevacizumab|mesh-list
65523466|NCT01164189|Temozolomide|temozolomide|mesh-list
65523467|NCT01164189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65523468|NCT01164189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523469|NCT01164189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65523470|NCT01164189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65523471|NCT01164189|Growth Substances|growth substances|mesh-ancestor
65523472|NCT01164189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523473|NCT01164189|Growth Inhibitors|growth inhibitors|mesh-ancestor
65523474|NCT01164189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65523475|NCT01164189|Alkylating Agents|alkylating agents|mesh-ancestor
65523476|NCT01164189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523477|NCT01164267|Everolimus|everolimus|mesh-list
65523478|NCT01164267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523479|NCT01164267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65523480|NCT01164267|Immunologic Factors|immunologic factors|mesh-ancestor
65523481|NCT01164267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523482|NCT01164345|Plerixafor|plerixafor|mesh-list
65523483|NCT01164345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65523484|NCT01164345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65523485|NCT01164345|Antiviral Agents|antiviral agents|mesh-ancestor
65523486|NCT01164345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65523487|NCT02948582|Glycopyrrolate|glycopyrrolate|mesh-list
65523488|NCT02948582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65523489|NCT02948582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65523490|NCT02948582|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65523491|NCT02948582|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65523492|NCT02948582|Cholinergic Agents|cholinergic agents|mesh-ancestor
65523493|NCT02948582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65523494|NCT02948582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523495|NCT02948582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523496|NCT02259868|Ritonavir|ritonavir|mesh-list
65523497|NCT02259868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65523498|NCT02259868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65523499|NCT02259868|Protease Inhibitors|protease inhibitors|mesh-ancestor
65523500|NCT02259868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523501|NCT02259868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523502|NCT02259868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65523503|NCT02259868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65523504|NCT02259868|Antiviral Agents|antiviral agents|mesh-ancestor
65523505|NCT02259868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65523506|NCT02259868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65523507|NCT02259868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65523508|NCT01167231|Acarbose|acarbose|mesh-list
65523509|NCT01167231|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65523510|NCT01167231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523511|NCT01167231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523512|NCT01167231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65523513|NCT01167231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523514|NCT03871803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65523515|NCT03871803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65523516|NCT03871803|Adrenergic Agents|adrenergic agents|mesh-ancestor
65523517|NCT03871803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65523518|NCT03871803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523519|NCT03871803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523521|NCT00135226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65523522|NCT00135226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65523523|NCT00135226|Analgesics|analgesics|mesh-ancestor
65523524|NCT00135226|Sensory System Agents|sensory system agents|mesh-ancestor
65523525|NCT00135226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65523526|NCT00135226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523527|NCT00135226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65523528|NCT00135226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65523529|NCT00135226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65523530|NCT00135226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65523531|NCT00135226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523532|NCT00135226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65523533|NCT00135226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65523534|NCT00135226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523535|NCT00135226|Antipyretics|antipyretics|mesh-ancestor
65523536|NCT01587261|Ascorbic Acid|ascorbic acid|mesh-list
65523537|NCT01587261|Vitamins|vitamins|mesh-ancestor
65523538|NCT01587261|Micronutrients|micronutrients|mesh-ancestor
65523539|NCT01587261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523540|NCT01587261|Antioxidants|antioxidants|mesh-ancestor
65523541|NCT01587261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523542|NCT01587261|Protective Agents|protective agents|mesh-ancestor
65523543|NCT01269021|Mycophenolic Acid|mycophenolic acid|mesh-list
65523544|NCT01269021|Prednisone|prednisone|mesh-list
65523545|NCT01269021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65523546|NCT01269021|Glucocorticoids|glucocorticoids|mesh-ancestor
65523547|NCT01269021|Hormones|hormones|mesh-ancestor
65523548|NCT01269021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65523549|NCT01269021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523550|NCT01269021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65523551|NCT01269021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523552|NCT01269021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65523553|NCT01269021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65523554|NCT01269021|Antitubercular Agents|antitubercular agents|mesh-ancestor
65523555|NCT01269021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65523556|NCT01269021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65523557|NCT01269021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523558|NCT01269021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523559|NCT01269099|Fentanyl|fentanyl|mesh-list
65523560|NCT01269099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65523561|NCT01269099|Narcotics|narcotics|mesh-ancestor
65523562|NCT01269099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65523563|NCT01269099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523564|NCT01269099|Analgesics|analgesics|mesh-ancestor
65523565|NCT01269099|Sensory System Agents|sensory system agents|mesh-ancestor
65523566|NCT01269099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65523567|NCT01269099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65523568|NCT01269099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65523569|NCT01269099|Anesthetics, General|anesthetics, general|mesh-ancestor
65523570|NCT01269099|Anesthetics|anesthetics|mesh-ancestor
65523571|NCT01164813|Nabumetone|nabumetone|mesh-list
65523572|NCT01164813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65523573|NCT01164813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65523574|NCT01164813|Analgesics|analgesics|mesh-ancestor
65523575|NCT01164813|Sensory System Agents|sensory system agents|mesh-ancestor
65523576|NCT01164813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65523577|NCT01164813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523578|NCT01164813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65523579|NCT01164813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65523580|NCT01164813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65523581|NCT01164813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65523582|NCT01164813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523583|NCT01164813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523584|NCT01165905|Gemcitabine|gemcitabine|mesh-list
65523585|NCT01165905|ON 01910|on 01910|mesh-list
65523586|NCT01165905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65523587|NCT01165905|Antimetabolites|antimetabolites|mesh-ancestor
65523588|NCT01165905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523589|NCT01165905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523590|NCT01165905|Antiviral Agents|antiviral agents|mesh-ancestor
65523591|NCT01165905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65523592|NCT01165905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523593|NCT01165905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65523594|NCT01165905|Immunologic Factors|immunologic factors|mesh-ancestor
65523595|NCT01165905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523596|NCT01165905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65523597|NCT01339000|Vaccines|vaccines|mesh-list
65523598|NCT01339000|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65523599|NCT01339000|Immunologic Factors|immunologic factors|mesh-ancestor
65523600|NCT01339000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523601|NCT01269255|Cisplatin|cisplatin|mesh-list
65523602|NCT01269255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523603|NCT03563170|Leucovorin|leucovorin|mesh-list
65523604|NCT03563170|Paclitaxel|paclitaxel|mesh-list
65523605|NCT03563170|Cyclophosphamide|cyclophosphamide|mesh-list
65523606|NCT03563170|Fluorouracil|fluorouracil|mesh-list
65523607|NCT03563170|Capecitabine|capecitabine|mesh-list
65523608|NCT03563170|Cetuximab|cetuximab|mesh-list
65523609|NCT03563170|Sorafenib|sorafenib|mesh-list
65523610|NCT03563170|Avelumab|avelumab|mesh-list
65523611|NCT03563170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65523612|NCT03563170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523613|NCT03563170|Tubulin Modulators|tubulin modulators|mesh-ancestor
65523614|NCT03563170|Antimitotic Agents|antimitotic agents|mesh-ancestor
65523615|NCT03563170|Mitosis Modulators|mitosis modulators|mesh-ancestor
65523616|NCT03563170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523617|NCT03563170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65523618|NCT03563170|Immunologic Factors|immunologic factors|mesh-ancestor
65523619|NCT03563170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523620|NCT03563170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65523621|NCT03563170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65523622|NCT03563170|Alkylating Agents|alkylating agents|mesh-ancestor
65523623|NCT03563170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65523624|NCT03563170|Antimetabolites|antimetabolites|mesh-ancestor
65523625|NCT03563170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65523626|NCT03563170|Antidotes|antidotes|mesh-ancestor
65523627|NCT03563170|Protective Agents|protective agents|mesh-ancestor
65523628|NCT03563170|Vitamin B Complex|vitamin b complex|mesh-ancestor
65523629|NCT03563170|Vitamins|vitamins|mesh-ancestor
65523630|NCT03563170|Micronutrients|micronutrients|mesh-ancestor
65523631|NCT03563170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65523632|NCT03563170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65523633|NCT03563170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523634|NCT01281111|Aspirin|aspirin|mesh-list
65523635|NCT01281111|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65523636|NCT01281111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65523637|NCT01281111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65523638|NCT01281111|Analgesics|analgesics|mesh-ancestor
65523639|NCT01281111|Sensory System Agents|sensory system agents|mesh-ancestor
65523640|NCT01281111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65523641|NCT01281111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523642|NCT01281111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65523643|NCT01281111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65523644|NCT01281111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65523645|NCT01281111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65523646|NCT01281111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523647|NCT01281111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65523648|NCT01281111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65523649|NCT01281111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523650|NCT01281111|Antipyretics|antipyretics|mesh-ancestor
65523651|NCT01281111|Dermatologic Agents|dermatologic agents|mesh-ancestor
65523652|NCT01281111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65523653|NCT01281111|Immunologic Factors|immunologic factors|mesh-ancestor
65523654|NCT03869931|Fenofibrate|fenofibrate|mesh-list
65523655|NCT03869931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65523656|NCT03869931|Antimetabolites|antimetabolites|mesh-ancestor
65523657|NCT03869931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523658|NCT03869931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65523659|NCT04876066|Ketamine|ketamine|mesh-list
65523660|NCT04876066|Analgesics|analgesics|mesh-ancestor
65523661|NCT04876066|Sensory System Agents|sensory system agents|mesh-ancestor
65523662|NCT04876066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65523663|NCT04876066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523664|NCT04876066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65523665|NCT04876066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65523666|NCT04876066|Anesthetics, General|anesthetics, general|mesh-ancestor
65321148|NCT05754242|Vitamins|vitamins|mesh-ancestor
65523667|NCT04876066|Anesthetics|anesthetics|mesh-ancestor
65523668|NCT04876066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65523669|NCT04876066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65523670|NCT04876066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65523671|NCT04876066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65523672|NCT04876066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523673|NCT01169805|Ondansetron|ondansetron|mesh-list
65523674|NCT01169805|Palonosetron|palonosetron|mesh-list
65523676|NCT01169805|Antiemetics|antiemetics|mesh-ancestor
65523677|NCT01169805|Autonomic Agents|autonomic agents|mesh-ancestor
65523678|NCT01169805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65523679|NCT01169805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523680|NCT01169805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65523681|NCT01169805|Antipruritics|antipruritics|mesh-ancestor
65523682|NCT01169805|Dermatologic Agents|dermatologic agents|mesh-ancestor
65523683|NCT01169805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65523684|NCT01169805|Serotonin Agents|serotonin agents|mesh-ancestor
65523685|NCT01169805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65523686|NCT01169805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523687|NCT01169805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65523688|NCT01169805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65523689|NCT01169805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65523690|NCT01169805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65523691|NCT01169805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65523692|NCT01169805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65523693|NCT01283061|Zafirlukast|zafirlukast|mesh-list
65523694|NCT01283061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65523695|NCT01283061|Respiratory System Agents|respiratory system agents|mesh-ancestor
65523696|NCT01283061|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65523697|NCT01283061|Hormone Antagonists|hormone antagonists|mesh-ancestor
65523698|NCT01283061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65523699|NCT01283061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523700|NCT03563014|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65523701|NCT03563014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523702|NCT01167465|Zinc Oxide|zinc oxide|mesh-list
65523703|NCT01167465|Dermatologic Agents|dermatologic agents|mesh-ancestor
65523704|NCT01167465|Sunscreening Agents|sunscreening agents|mesh-ancestor
65523705|NCT01167465|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65523706|NCT01167465|Protective Agents|protective agents|mesh-ancestor
65523707|NCT01167465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523708|NCT01283217|Cisplatin|cisplatin|mesh-list
65523709|NCT01283217|Docetaxel|docetaxel|mesh-list
65523710|NCT01283217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523711|NCT01283217|Tubulin Modulators|tubulin modulators|mesh-ancestor
65523712|NCT01283217|Antimitotic Agents|antimitotic agents|mesh-ancestor
65523713|NCT01283217|Mitosis Modulators|mitosis modulators|mesh-ancestor
65523714|NCT01283217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523715|NCT01276431|Buprenorphine|buprenorphine|mesh-list
65523716|NCT01276431|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65523717|NCT01276431|Narcotics|narcotics|mesh-ancestor
65523718|NCT01276431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65523719|NCT01276431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523720|NCT01276431|Analgesics|analgesics|mesh-ancestor
65523721|NCT01276431|Sensory System Agents|sensory system agents|mesh-ancestor
65523722|NCT01276431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65523723|NCT01276431|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65523724|NCT01281579|Canagliflozin|canagliflozin|mesh-list
65523725|NCT01281579|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65523726|NCT01281579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523727|NCT01281579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65523728|NCT01281579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523729|NCT01281657|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65523730|NCT01281657|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65523731|NCT01281657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523732|NCT01281657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65523733|NCT01281657|Immunologic Factors|immunologic factors|mesh-ancestor
65523734|NCT01281657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523735|NCT01166451|Iron|iron|mesh-list
65523736|NCT01166451|Trace Elements|trace elements|mesh-ancestor
65523737|NCT01166451|Micronutrients|micronutrients|mesh-ancestor
65523738|NCT01166451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523739|NCT02526615|Metformin|metformin|mesh-list
65523740|NCT02526615|Rosiglitazone|rosiglitazone|mesh-list
65523741|NCT02526615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65523742|NCT02526615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523743|NCT01283763|Imiquimod|imiquimod|mesh-list
65523744|NCT01283763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65523745|NCT01283763|Immunologic Factors|immunologic factors|mesh-ancestor
65523746|NCT01283763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523747|NCT01283763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523748|NCT01283763|Interferon Inducers|interferon inducers|mesh-ancestor
65523749|NCT01283841|Mycophenolic Acid|mycophenolic acid|mesh-list
65523750|NCT01283841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65523751|NCT01283841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523752|NCT01283841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65523753|NCT01283841|Antitubercular Agents|antitubercular agents|mesh-ancestor
65523754|NCT01283841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65523755|NCT01283841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65523756|NCT01283841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523757|NCT01283841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523759|NCT03872661|Carboplatin|carboplatin|mesh-list
65523760|NCT03872661|Pemetrexed|pemetrexed|mesh-list
65523761|NCT03872661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65523762|NCT03872661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523763|NCT03872661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65523764|NCT03872661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65523765|NCT03872661|Growth Substances|growth substances|mesh-ancestor
65523766|NCT03872661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523767|NCT03872661|Growth Inhibitors|growth inhibitors|mesh-ancestor
65523768|NCT03872661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523769|NCT03872661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523770|NCT03872661|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65523771|NCT03872661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65523772|NCT01167699|Oxycodone|oxycodone|mesh-list
65523773|NCT01167699|Naloxone|naloxone|mesh-list
65523774|NCT01167699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65523775|NCT01167699|Narcotics|narcotics|mesh-ancestor
65523776|NCT01167699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65523777|NCT01167699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523778|NCT01167699|Analgesics|analgesics|mesh-ancestor
65523779|NCT01167699|Sensory System Agents|sensory system agents|mesh-ancestor
65523780|NCT01167699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65523781|NCT01167699|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65523782|NCT02526303|Nadroparin|nadroparin|mesh-list
65523783|NCT02526303|Warfarin|warfarin|mesh-list
65523784|NCT02526303|Calcium|calcium|mesh-list
65523785|NCT02526303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65523786|NCT02526303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523787|NCT02526303|Anticoagulants|anticoagulants|mesh-ancestor
65523788|NCT02526303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65523789|NCT02526303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65523790|NCT02526303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523791|NCT03869073|Evolocumab|evolocumab|mesh-list
65523792|NCT03869073|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65523793|NCT03869073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65523794|NCT03869073|Antimetabolites|antimetabolites|mesh-ancestor
65523795|NCT03869073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523796|NCT03869073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65523797|NCT01587495|Ertapenem|ertapenem|mesh-list
65523798|NCT01587495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65523799|NCT01587495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65523800|NCT01170351|Cyclosporine|cyclosporine|mesh-list
65523801|NCT01170351|Cyclosporins|cyclosporins|mesh-list
65523802|NCT01170351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523803|NCT01170351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523804|NCT01170351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65523805|NCT01170351|Immunologic Factors|immunologic factors|mesh-ancestor
65523806|NCT01170351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523807|NCT01170351|Antifungal Agents|antifungal agents|mesh-ancestor
65523808|NCT01170351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65523809|NCT01170351|Dermatologic Agents|dermatologic agents|mesh-ancestor
65523810|NCT01170351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65523811|NCT01170351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65523812|NCT01170429|Procaterol|procaterol|mesh-list
65523813|NCT01170429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65523814|NCT01170429|Autonomic Agents|autonomic agents|mesh-ancestor
65523815|NCT01170429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65523816|NCT01170429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523817|NCT01170429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65523818|NCT01170429|Respiratory System Agents|respiratory system agents|mesh-ancestor
65321297|NCT03236324|Bupivacaine|bupivacaine|mesh-list
65523819|NCT01170429|Sympathomimetics|sympathomimetics|mesh-ancestor
65523820|NCT01170429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65523821|NCT01170429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65523822|NCT01170429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65523823|NCT01170429|Adrenergic Agents|adrenergic agents|mesh-ancestor
65523824|NCT01170429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65523825|NCT01170429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523827|NCT01170507|Ergocalciferols|ergocalciferols|mesh-list
65523828|NCT01170507|Cholecalciferol|cholecalciferol|mesh-list
65523829|NCT01170507|Vitamins|vitamins|mesh-list
65523830|NCT01170507|Micronutrients|micronutrients|mesh-ancestor
65523831|NCT01170507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523832|NCT01170507|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65523833|NCT01170507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65523834|NCT01170585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65523835|NCT01170585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65523836|NCT01170585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65523837|NCT01170585|Antimetabolites|antimetabolites|mesh-ancestor
65523838|NCT01170585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523839|NCT01170585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65523840|NCT01170585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65523841|NCT01170585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523842|NCT01170819|Dinoprostone|dinoprostone|mesh-list
65523843|NCT01170819|Oxytocics|oxytocics|mesh-ancestor
65523844|NCT01170819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65523845|NCT01170819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523846|NCT03868137|Ibuprofen|ibuprofen|mesh-list
65523847|NCT03868137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65523848|NCT03868137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65523849|NCT03868137|Analgesics|analgesics|mesh-ancestor
65523850|NCT03868137|Sensory System Agents|sensory system agents|mesh-ancestor
65523851|NCT03868137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65523852|NCT03868137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523853|NCT03868137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65523854|NCT03868137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65523855|NCT03868137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65523856|NCT03868137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523857|NCT03868137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523858|NCT01283919|Pantoprazole|pantoprazole|mesh-list
65523859|NCT01283919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65523860|NCT01283919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65523861|NCT01283919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65523862|NCT01283919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523863|NCT01283919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523864|NCT01167933|Simvastatin|simvastatin|mesh-list
65523865|NCT01167933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65523866|NCT01167933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65523867|NCT01167933|Antimetabolites|antimetabolites|mesh-ancestor
65523868|NCT01167933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523869|NCT01167933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65523870|NCT01167933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65523871|NCT01167933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523872|NCT01168011|ON 01910|on 01910|mesh-list
65523873|NCT01168011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523874|NCT01168011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65523875|NCT01168011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523876|NCT01168011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523877|NCT01171209|Interferons|interferons|mesh-list
65523878|NCT01171209|Interferon-beta|interferon-beta|mesh-list
65523879|NCT01171209|Interferon-alpha|interferon-alpha|mesh-list
65523880|NCT01171209|Interferon beta-1b|interferon beta-1b|mesh-list
65523881|NCT01171209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523882|NCT01171209|Antiviral Agents|antiviral agents|mesh-ancestor
65523883|NCT01171209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65523884|NCT01171209|Immunologic Factors|immunologic factors|mesh-ancestor
65523885|NCT01171209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523886|NCT01171209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65523887|NCT01166685|Everolimus|everolimus|mesh-list
65523888|NCT01166685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523889|NCT01166685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65523890|NCT01166685|Immunologic Factors|immunologic factors|mesh-ancestor
65523891|NCT01166685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523892|NCT03870711|Lidocaine|lidocaine|mesh-list
65523893|NCT03870711|Anesthetics, Local|anesthetics, local|mesh-ancestor
65523895|NCT03870711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65523896|NCT03870711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523897|NCT03870711|Sensory System Agents|sensory system agents|mesh-ancestor
65523898|NCT03870711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65523899|NCT03870711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65523900|NCT03870711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65523901|NCT03870711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65523902|NCT03870711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65523903|NCT03870711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523904|NCT03872505|Paclitaxel|paclitaxel|mesh-list
65523905|NCT03872505|Carboplatin|carboplatin|mesh-list
65523906|NCT03872505|Durvalumab|durvalumab|mesh-list
65523907|NCT03872505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65523908|NCT03872505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523909|NCT03872505|Tubulin Modulators|tubulin modulators|mesh-ancestor
65523910|NCT03872505|Antimitotic Agents|antimitotic agents|mesh-ancestor
65523911|NCT03872505|Mitosis Modulators|mitosis modulators|mesh-ancestor
65523912|NCT03872505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523913|NCT03872505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65523914|NCT01171365|Ciclesonide|ciclesonide|mesh-list
65523915|NCT01171365|Glucocorticoids|glucocorticoids|mesh-ancestor
65523916|NCT01171365|Hormones|hormones|mesh-ancestor
65523917|NCT01171365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65523918|NCT01171365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523919|NCT01171365|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65523920|NCT01281891|Morphine|morphine|mesh-list
65523921|NCT01281891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65523922|NCT01281891|Narcotics|narcotics|mesh-ancestor
65523923|NCT01281891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65523924|NCT01281891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523925|NCT01281891|Analgesics|analgesics|mesh-ancestor
65523926|NCT01281891|Sensory System Agents|sensory system agents|mesh-ancestor
65523927|NCT01281891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65523928|NCT01282047|Lenalidomide|lenalidomide|mesh-list
65523929|NCT01282047|Immunologic Factors|immunologic factors|mesh-ancestor
65523930|NCT01282047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523931|NCT01282047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65523932|NCT01282047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65523933|NCT01282047|Growth Substances|growth substances|mesh-ancestor
65523934|NCT01282047|Growth Inhibitors|growth inhibitors|mesh-ancestor
65523935|NCT01282047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523936|NCT02525991|Loxapine|loxapine|mesh-list
65523937|NCT02525991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65523938|NCT02525991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65523939|NCT02525991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65523940|NCT02525991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523941|NCT02525991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65523942|NCT02525991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65523943|NCT02525991|Dopamine Agents|dopamine agents|mesh-ancestor
65523944|NCT02525991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65523945|NCT02525991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523946|NCT01171755|Gemcitabine|gemcitabine|mesh-list
65523947|NCT01171755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65523948|NCT01171755|Antimetabolites|antimetabolites|mesh-ancestor
65523949|NCT01171755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523950|NCT01171755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523951|NCT01171755|Antiviral Agents|antiviral agents|mesh-ancestor
65523952|NCT01171755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65523953|NCT01171755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523954|NCT01171755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65523955|NCT01171755|Immunologic Factors|immunologic factors|mesh-ancestor
65523956|NCT01171755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523957|NCT01172691|Nitric Oxide|nitric oxide|mesh-list
65523958|NCT01172691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65523959|NCT01172691|Autonomic Agents|autonomic agents|mesh-ancestor
65523960|NCT01172691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65523961|NCT01172691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523962|NCT01172691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65523963|NCT01172691|Respiratory System Agents|respiratory system agents|mesh-ancestor
65523964|NCT01172691|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65523965|NCT01172691|Antioxidants|antioxidants|mesh-ancestor
65523966|NCT01172691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321464|NCT04570475|Vitamin D|vitamin d|mesh-list
65523967|NCT01172691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65523968|NCT01172691|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65523969|NCT01172691|Vasodilator Agents|vasodilator agents|mesh-ancestor
65523970|NCT01172691|Gasotransmitters|gasotransmitters|mesh-ancestor
65523971|NCT01172691|Protective Agents|protective agents|mesh-ancestor
65523972|NCT01171833|Sevoflurane|sevoflurane|mesh-list
65523973|NCT01171833|Desflurane|desflurane|mesh-list
65523974|NCT01171833|Isoflurane|isoflurane|mesh-list
65523975|NCT01171833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65523976|NCT01171833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65523977|NCT01171833|Anesthetics, General|anesthetics, general|mesh-ancestor
65523978|NCT01171833|Anesthetics|anesthetics|mesh-ancestor
65523979|NCT01171833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65523980|NCT01171833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523981|NCT01172769|Sirolimus|sirolimus|mesh-list
65523982|NCT01172769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
65523983|NCT01172769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65523984|NCT01172769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65523985|NCT01172769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65523986|NCT01172769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523987|NCT01172769|Antifungal Agents|antifungal agents|mesh-ancestor
65523988|NCT01172769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65523989|NCT01172769|Immunologic Factors|immunologic factors|mesh-ancestor
65523990|NCT01172769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65523991|NCT01172769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523992|NCT01172769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523993|NCT01584531|ON 01910|on 01910|mesh-list
65523994|NCT01584531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65523995|NCT01584531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65523996|NCT01584531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65523997|NCT01584531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65523998|NCT01171911|Nicardipine|nicardipine|mesh-list
65523999|NCT01171911|Calcium Channel Blockers|calcium channel blockers|mesh-list
65524000|NCT01171911|Esmolol|esmolol|mesh-list
65524001|NCT01171911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65524002|NCT01171911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524003|NCT01171911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65524004|NCT01171911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65524005|NCT01171911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65524006|NCT01171911|Adrenergic Agents|adrenergic agents|mesh-ancestor
65524007|NCT01171911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65524008|NCT01171911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524009|NCT01171911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65524010|NCT01171911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65524011|NCT01171911|Vasodilator Agents|vasodilator agents|mesh-ancestor
65524012|NCT01172925|Tiotropium Bromide|tiotropium bromide|mesh-list
65524013|NCT01172925|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65524014|NCT01172925|Autonomic Agents|autonomic agents|mesh-ancestor
65524015|NCT01172925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65524016|NCT01172925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524017|NCT01172925|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65524018|NCT01172925|Respiratory System Agents|respiratory system agents|mesh-ancestor
65524019|NCT01172925|Parasympatholytics|parasympatholytics|mesh-ancestor
65524020|NCT01172925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65524021|NCT01172925|Cholinergic Agents|cholinergic agents|mesh-ancestor
65524022|NCT01172925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65524023|NCT01172925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524024|NCT01173003|Misoprostol|misoprostol|mesh-list
65524025|NCT01173003|Mifepristone|mifepristone|mesh-list
65524026|NCT01173003|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65524027|NCT01173003|Abortifacient Agents|abortifacient agents|mesh-ancestor
65524028|NCT01173003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65524029|NCT01173003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524030|NCT01173003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65524031|NCT01173003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65524032|NCT01173003|Oxytocics|oxytocics|mesh-ancestor
65524033|NCT01173003|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65524034|NCT01173003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65524035|NCT01173003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65524036|NCT01173003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65524037|NCT01173003|Contraceptive Agents|contraceptive agents|mesh-ancestor
65524038|NCT01173003|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65524039|NCT01173003|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65524040|NCT01173003|Hormone Antagonists|hormone antagonists|mesh-ancestor
65524041|NCT01173003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65524042|NCT01173003|Luteolytic Agents|luteolytic agents|mesh-ancestor
65524043|NCT01173003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65524044|NCT01173003|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65524045|NCT03435003|Dexamethasone|dexamethasone|mesh-list
65524046|NCT03435003|Fentanyl|fentanyl|mesh-list
65524047|NCT03435003|Scopolamine|scopolamine|mesh-list
65524048|NCT03435003|Dexmedetomidine|dexmedetomidine|mesh-list
65524049|NCT03435003|Ondansetron|ondansetron|mesh-list
65524050|NCT03435003|Aprepitant|aprepitant|mesh-list
65524051|NCT03435003|Metoclopramide|metoclopramide|mesh-list
65524052|NCT03435003|Prochlorperazine|prochlorperazine|mesh-list
65524053|NCT03435003|Propofol|propofol|mesh-list
65524054|NCT03435003|Sevoflurane|sevoflurane|mesh-list
65524055|NCT03435003|Desflurane|desflurane|mesh-list
65524056|NCT03435003|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65524057|NCT03435003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65524058|NCT03435003|Antiemetics|antiemetics|mesh-ancestor
65524059|NCT03435003|Autonomic Agents|autonomic agents|mesh-ancestor
65524060|NCT03435003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65524061|NCT03435003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524062|NCT03435003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65524063|NCT03435003|Glucocorticoids|glucocorticoids|mesh-ancestor
65524064|NCT03435003|Hormones|hormones|mesh-ancestor
65524065|NCT03435003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65524066|NCT03435003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65524067|NCT03435003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524068|NCT03435003|Anesthetics|anesthetics|mesh-ancestor
65524069|NCT03435003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65524070|NCT03435003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65524071|NCT03435003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65524072|NCT03435003|Anesthetics, General|anesthetics, general|mesh-ancestor
65524073|NCT03435003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65524074|NCT03435003|Analgesics|analgesics|mesh-ancestor
65524075|NCT03435003|Sensory System Agents|sensory system agents|mesh-ancestor
65524076|NCT03435003|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65524077|NCT03435003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65524078|NCT03435003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65524079|NCT03435003|Adrenergic Agents|adrenergic agents|mesh-ancestor
65524080|NCT03435003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65524081|NCT03435003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524082|NCT03435003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65524083|NCT03435003|Narcotics|narcotics|mesh-ancestor
65524084|NCT03435003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65524085|NCT03435003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65524086|NCT03435003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65524087|NCT03435003|Antipruritics|antipruritics|mesh-ancestor
65524088|NCT03435003|Dermatologic Agents|dermatologic agents|mesh-ancestor
65524089|NCT03435003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65524090|NCT03435003|Serotonin Agents|serotonin agents|mesh-ancestor
65524091|NCT03435003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65524092|NCT03435003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65524093|NCT03435003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65524094|NCT03435003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65524095|NCT03435003|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65524096|NCT03435003|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65524097|NCT03435003|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65524098|NCT03435003|Dopamine Agents|dopamine agents|mesh-ancestor
65524099|NCT03435003|Mydriatics|mydriatics|mesh-ancestor
65524100|NCT03435003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65524101|NCT03435003|Cholinergic Agents|cholinergic agents|mesh-ancestor
65524102|NCT03435003|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65524103|NCT03435003|Parasympatholytics|parasympatholytics|mesh-ancestor
65524104|NCT01172223|Paclitaxel|paclitaxel|mesh-list
65524105|NCT01172223|Doxorubicin|doxorubicin|mesh-list
65524106|NCT01172223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65524107|NCT01172223|Lapatinib|lapatinib|mesh-list
65524108|NCT01172223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65524109|NCT01172223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524110|NCT01172223|Tubulin Modulators|tubulin modulators|mesh-ancestor
65524111|NCT01172223|Antimitotic Agents|antimitotic agents|mesh-ancestor
65524112|NCT01172223|Mitosis Modulators|mitosis modulators|mesh-ancestor
65524113|NCT01172223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524114|NCT01172223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65524115|NCT01172223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65524116|NCT01172223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65524117|NCT01172223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524118|NCT01172223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65524119|NCT01173081|Teriparatide|teriparatide|mesh-list
65524120|NCT01173081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65524121|NCT01173081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524122|NCT01173081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65524123|NCT03866733|Narcotics|narcotics|mesh-list
65524124|NCT03866733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65524125|NCT03866733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524126|NCT03866733|Analgesics|analgesics|mesh-ancestor
65524127|NCT03866733|Sensory System Agents|sensory system agents|mesh-ancestor
65524128|NCT03866733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65524129|NCT01168791|Doxorubicin|doxorubicin|mesh-list
65524130|NCT01168791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65524131|NCT01168791|Isophosphamide mustard|isophosphamide mustard|mesh-list
65524132|NCT01168791|Ifosfamide|ifosfamide|mesh-list
65524133|NCT01168791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65524134|NCT01168791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524135|NCT01168791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65524136|NCT01168791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65524137|NCT01168791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524138|NCT01168791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524139|NCT01168791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65524140|NCT01168791|Alkylating Agents|alkylating agents|mesh-ancestor
65524141|NCT01284309|Mirabegron|mirabegron|mesh-list
65524142|NCT01284309|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65524143|NCT01284309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65524144|NCT01284309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65524145|NCT01284309|Adrenergic Agents|adrenergic agents|mesh-ancestor
65524146|NCT01284309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65524147|NCT01284309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524148|NCT01284309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524149|NCT01284309|Urological Agents|urological agents|mesh-ancestor
65524150|NCT01173237|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65524151|NCT01173237|Respiratory System Agents|respiratory system agents|mesh-ancestor
65524152|NCT01169025|Fentanyl|fentanyl|mesh-list
65524153|NCT01169025|Ketamine|ketamine|mesh-list
65524154|NCT01169025|Analgesics|analgesics|mesh-ancestor
65524155|NCT01169025|Sensory System Agents|sensory system agents|mesh-ancestor
65524156|NCT01169025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65524157|NCT01169025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524158|NCT01169025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65524159|NCT01169025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65524160|NCT01169025|Anesthetics, General|anesthetics, general|mesh-ancestor
65524161|NCT01169025|Anesthetics|anesthetics|mesh-ancestor
65524162|NCT01169025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65524163|NCT01169025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65524164|NCT01169025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65524165|NCT01169025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65524166|NCT01169025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524167|NCT01169025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65524168|NCT01169025|Narcotics|narcotics|mesh-ancestor
65524169|NCT01169025|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65524170|NCT01582347|Buprenorphine|buprenorphine|mesh-list
65524171|NCT01582347|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65524172|NCT01582347|Naloxone|naloxone|mesh-list
65524173|NCT01582347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65524174|NCT01582347|Narcotics|narcotics|mesh-ancestor
65524175|NCT01582347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65524176|NCT01582347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524177|NCT01582347|Analgesics|analgesics|mesh-ancestor
65524178|NCT01582347|Sensory System Agents|sensory system agents|mesh-ancestor
65524179|NCT01582347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65524180|NCT01582347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65524181|NCT01336634|Trametinib|trametinib|mesh-list
65524182|NCT01336634|Dabrafenib|dabrafenib|mesh-list
65524183|NCT01336634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524184|NCT01336634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65524185|NCT01336634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524186|NCT01336634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524187|NCT01284855|Antivenins|antivenins|mesh-list
65524188|NCT01284855|Immunologic Factors|immunologic factors|mesh-ancestor
65524189|NCT01284855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524190|NCT05316116|Siltuximab|siltuximab|mesh-list
65524191|NCT05316116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524192|NCT00785798|Doxorubicin|doxorubicin|mesh-list
65524193|NCT00785798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65524194|NCT00785798|Vorinostat|vorinostat|mesh-list
65524195|NCT00785798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65524196|NCT00785798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524197|NCT00785798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65524198|NCT00785798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65524199|NCT00785798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524200|NCT00785798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524201|NCT00785798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65524202|NCT01175109|Imatinib Mesylate|imatinib mesylate|mesh-list
65524203|NCT01175109|Panobinostat|panobinostat|mesh-list
65524204|NCT01175109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524205|NCT01175109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65524206|NCT01175109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524207|NCT01175109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524208|NCT01175109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65524209|NCT01282515|Clobetasol|clobetasol|mesh-list
65524210|NCT01282515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65524211|NCT01282515|Glucocorticoids|glucocorticoids|mesh-ancestor
65524212|NCT01282515|Hormones|hormones|mesh-ancestor
65524213|NCT01282515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65524214|NCT01282515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524215|NCT04732910|Ivacaftor|ivacaftor|mesh-list
65524216|NCT04732910|Elexacaftor|elexacaftor|mesh-list
65524217|NCT04732910|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65524218|NCT04732910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65524219|NCT04732910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524220|NCT03329846|Nivolumab|nivolumab|mesh-list
65524221|NCT03329846|Linrodostat|linrodostat|mesh-list
65524222|NCT03329846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65524223|NCT03329846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524224|NCT03329846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65524225|NCT03329846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524226|NCT03329846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524227|NCT04020848|Melatonin|melatonin|mesh-list
65524228|NCT04020848|Antioxidants|antioxidants|mesh-ancestor
65524229|NCT04020848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524230|NCT04020848|Protective Agents|protective agents|mesh-ancestor
65524231|NCT04020848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524232|NCT04020848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65524233|NCT02823574|Nivolumab|nivolumab|mesh-list
65524234|NCT02823574|Ipilimumab|ipilimumab|mesh-list
65524235|NCT02823574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65524236|NCT02823574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524237|NCT02823574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65524238|NCT02823574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524239|NCT01338610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65524240|NCT01338610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65524241|NCT01355302|Capecitabine|capecitabine|mesh-list
65524242|NCT01355302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524243|NCT01355302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65524244|NCT01355302|Antimetabolites|antimetabolites|mesh-ancestor
65524245|NCT01355302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524246|NCT01355068|Phenytoin|phenytoin|mesh-list
65524247|NCT01355068|Anticonvulsants|anticonvulsants|mesh-ancestor
65524248|NCT01355068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65524249|NCT01355068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65524250|NCT01355068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65524251|NCT01355068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524252|NCT01355068|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65524253|NCT01355068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65524254|NCT03562780|Acetaminophen|acetaminophen|mesh-list
65524255|NCT03562780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65524256|NCT03562780|Analgesics|analgesics|mesh-ancestor
65524257|NCT03562780|Sensory System Agents|sensory system agents|mesh-ancestor
65524258|NCT03562780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65524259|NCT03562780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524260|NCT03562780|Antipyretics|antipyretics|mesh-ancestor
65524261|NCT02259946|Bromides|bromides|mesh-list
65524262|NCT02259946|Tiotropium Bromide|tiotropium bromide|mesh-list
65524263|NCT02259946|Olodaterol|olodaterol|mesh-list
65524264|NCT02259946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65524265|NCT02259946|Autonomic Agents|autonomic agents|mesh-ancestor
65524266|NCT02259946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65524267|NCT02259946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524268|NCT02259946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65524269|NCT02259946|Respiratory System Agents|respiratory system agents|mesh-ancestor
65524270|NCT02259946|Parasympatholytics|parasympatholytics|mesh-ancestor
65524271|NCT02259946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65524272|NCT02259946|Cholinergic Agents|cholinergic agents|mesh-ancestor
65524273|NCT02259946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65524274|NCT02259946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524275|NCT02259946|Anticonvulsants|anticonvulsants|mesh-ancestor
65524277|NCT03756129|Analgesics|analgesics|mesh-ancestor
65524278|NCT03756129|Sensory System Agents|sensory system agents|mesh-ancestor
65524279|NCT03756129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65524280|NCT03756129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524281|NCT03756129|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65524282|NCT03756129|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65524283|NCT03756129|Anesthetics, General|anesthetics, general|mesh-ancestor
65524284|NCT03756129|Anesthetics|anesthetics|mesh-ancestor
65524285|NCT03756129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65524286|NCT03756129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65524287|NCT03756129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65524288|NCT03756129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65524289|NCT03756129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524290|NCT03863691|Amisulpride|amisulpride|mesh-list
65524291|NCT03863691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65524292|NCT03863691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65524293|NCT03863691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65524294|NCT03863691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524295|NCT03863691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65524296|NCT03863691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65524297|NCT03863691|Dopamine Agents|dopamine agents|mesh-ancestor
65524298|NCT03863691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65524299|NCT03863691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524300|NCT03863691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65524301|NCT03863691|Antidepressive Agents|antidepressive agents|mesh-ancestor
65524302|NCT02822794|Ribavirin|ribavirin|mesh-list
65524303|NCT02822794|Sofosbuvir|sofosbuvir|mesh-list
65524304|NCT02822794|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65524305|NCT02822794|Velpatasvir|velpatasvir|mesh-list
65524306|NCT02822794|Antimetabolites|antimetabolites|mesh-ancestor
65524307|NCT02822794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524308|NCT02822794|Antiviral Agents|antiviral agents|mesh-ancestor
65524309|NCT02822794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65524310|NCT01173315|Vitamins|vitamins|mesh-list
65524311|NCT01173315|Micronutrients|micronutrients|mesh-ancestor
65524312|NCT01173315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524313|NCT01173549|Canagliflozin|canagliflozin|mesh-list
65524314|NCT01173549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65524315|NCT01173549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524316|NCT01173549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65524317|NCT01173549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524318|NCT01338298|Aripiprazole|aripiprazole|mesh-list
65524319|NCT01338298|Antidepressive Agents|antidepressive agents|mesh-ancestor
65524320|NCT01338298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65524321|NCT01338298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65524322|NCT01338298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65524323|NCT01338298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65524324|NCT01338298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524325|NCT01338298|Dopamine Agonists|dopamine agonists|mesh-ancestor
65524326|NCT01338298|Dopamine Agents|dopamine agents|mesh-ancestor
65524327|NCT01338298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65524328|NCT01338298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524329|NCT01338298|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65524330|NCT01338298|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65524331|NCT01338298|Serotonin Agents|serotonin agents|mesh-ancestor
65524332|NCT01338298|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65524333|NCT01338298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65524334|NCT01338298|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65524335|NCT01338298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65524336|NCT01169415|Dexamethasone|dexamethasone|mesh-list
65524337|NCT01169415|Dexamethasone acetate|dexamethasone acetate|mesh-list
65524338|NCT01169415|BB 1101|bb 1101|mesh-list
65524339|NCT01169415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65524340|NCT01169415|Antiemetics|antiemetics|mesh-ancestor
65524341|NCT01169415|Autonomic Agents|autonomic agents|mesh-ancestor
65524342|NCT01169415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65524344|NCT01169415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65524345|NCT01169415|Glucocorticoids|glucocorticoids|mesh-ancestor
65524346|NCT01169415|Hormones|hormones|mesh-ancestor
65524347|NCT01169415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65524348|NCT01169415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65524349|NCT01169415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524350|NCT01169415|Protease Inhibitors|protease inhibitors|mesh-ancestor
65524351|NCT01169415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524352|NCT01169415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524353|NCT01173627|Fentanyl|fentanyl|mesh-list
65524354|NCT01173627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65524355|NCT01173627|Narcotics|narcotics|mesh-ancestor
65524356|NCT01173627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65524357|NCT01173627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524358|NCT01173627|Analgesics|analgesics|mesh-ancestor
65524359|NCT01173627|Sensory System Agents|sensory system agents|mesh-ancestor
65524360|NCT01173627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65524361|NCT01173627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65524362|NCT01173627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65524363|NCT01173627|Anesthetics, General|anesthetics, general|mesh-ancestor
65524364|NCT01173627|Anesthetics|anesthetics|mesh-ancestor
65524365|NCT01169571|Dexmedetomidine|dexmedetomidine|mesh-list
65524366|NCT01169571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65524367|NCT01169571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65524368|NCT01169571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524369|NCT01169571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65524370|NCT01169571|Analgesics|analgesics|mesh-ancestor
65524371|NCT01169571|Sensory System Agents|sensory system agents|mesh-ancestor
65524372|NCT01169571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65524373|NCT01169571|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65524374|NCT01169571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65524375|NCT01169571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65524376|NCT01169571|Adrenergic Agents|adrenergic agents|mesh-ancestor
65524377|NCT01169571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65524378|NCT01169571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524379|NCT01354132|Acetylcysteine|acetylcysteine|mesh-list
65524380|NCT01354132|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65524381|NCT01354132|Antiviral Agents|antiviral agents|mesh-ancestor
65524382|NCT01354132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65524383|NCT01354132|Expectorants|expectorants|mesh-ancestor
65524384|NCT01354132|Respiratory System Agents|respiratory system agents|mesh-ancestor
65524385|NCT01354132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65524386|NCT01354132|Antioxidants|antioxidants|mesh-ancestor
65524387|NCT01354132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524388|NCT01354132|Protective Agents|protective agents|mesh-ancestor
65524389|NCT01354132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524390|NCT01354132|Antidotes|antidotes|mesh-ancestor
65524391|NCT05707936|Heparin|heparin|mesh-list
65524392|NCT05707936|Anticoagulants|anticoagulants|mesh-ancestor
65524393|NCT05707936|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65524394|NCT05707936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65524395|NCT05707936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524396|NCT03863613|Progesterone|progesterone|mesh-list
65524397|NCT03863613|Progestins|progestins|mesh-ancestor
65524398|NCT03863613|Hormones|hormones|mesh-ancestor
65524399|NCT03863613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65524400|NCT03863613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524401|NCT01372150|Fluoxetine|fluoxetine|mesh-list
65524402|NCT01372150|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65524403|NCT01372150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65524404|NCT01372150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65524405|NCT01372150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65524406|NCT01372150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524407|NCT01372150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65524408|NCT01372150|Serotonin Agents|serotonin agents|mesh-ancestor
65524409|NCT01372150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524410|NCT01372150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65524411|NCT01372150|Antidepressive Agents|antidepressive agents|mesh-ancestor
65524412|NCT01372150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65524413|NCT01372150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65524414|NCT01372150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65524415|NCT01372150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524416|NCT01372150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65524417|NCT01285245|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65524418|NCT01285245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65524419|NCT01175577|Carotenoids|carotenoids|mesh-list
65524420|NCT01175577|Antioxidants|antioxidants|mesh-ancestor
65524421|NCT01175577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524422|NCT01175577|Protective Agents|protective agents|mesh-ancestor
65524423|NCT01175577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524424|NCT01175733|Panitumumab|panitumumab|mesh-list
65524425|NCT01175733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65524426|NCT01175733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524427|NCT02035930|Dexmedetomidine|dexmedetomidine|mesh-list
65524428|NCT02035930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65524429|NCT02035930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65524430|NCT02035930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524431|NCT02035930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65524432|NCT02035930|Analgesics|analgesics|mesh-ancestor
65524433|NCT02035930|Sensory System Agents|sensory system agents|mesh-ancestor
65524434|NCT02035930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65524435|NCT02035930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65524436|NCT02035930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65524437|NCT02035930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65524438|NCT02035930|Adrenergic Agents|adrenergic agents|mesh-ancestor
65524439|NCT02035930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65524440|NCT02035930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524441|NCT01173939|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65524442|NCT01173939|Pravastatin|pravastatin|mesh-list
65524443|NCT01173939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65524444|NCT01173939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65524445|NCT01173939|Antimetabolites|antimetabolites|mesh-ancestor
65524446|NCT01173939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524447|NCT01173939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65524448|NCT01173939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65524449|NCT01173939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524450|NCT01174017|Iodine|iodine|mesh-list
65524451|NCT01174017|Cadexomer iodine|cadexomer iodine|mesh-list
65524452|NCT01174017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65524453|NCT01174017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65524454|NCT01174017|Trace Elements|trace elements|mesh-ancestor
65524455|NCT01174017|Micronutrients|micronutrients|mesh-ancestor
65524456|NCT01174017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524457|NCT01288131|Cyclosporine|cyclosporine|mesh-list
65524458|NCT01288131|Mycophenolic Acid|mycophenolic acid|mesh-list
65524459|NCT01288131|Cyclophosphamide|cyclophosphamide|mesh-list
65524460|NCT01288131|Cyclosporins|cyclosporins|mesh-list
65524461|NCT01288131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65524462|NCT01288131|Immunologic Factors|immunologic factors|mesh-ancestor
65524463|NCT01288131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524464|NCT01288131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65524465|NCT01288131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65524466|NCT01288131|Alkylating Agents|alkylating agents|mesh-ancestor
65524467|NCT01288131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524468|NCT01288131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524469|NCT01288131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65524470|NCT01288131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524471|NCT01288131|Antifungal Agents|antifungal agents|mesh-ancestor
65524472|NCT01288131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65524473|NCT01288131|Dermatologic Agents|dermatologic agents|mesh-ancestor
65524474|NCT01288131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65524475|NCT01288131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65524476|NCT01288131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65524477|NCT01288131|Antitubercular Agents|antitubercular agents|mesh-ancestor
65524478|NCT01288131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65524479|NCT02525211|Ropivacaine|ropivacaine|mesh-list
65524480|NCT02525211|Anesthetics, Local|anesthetics, local|mesh-ancestor
65524481|NCT02525211|Anesthetics|anesthetics|mesh-ancestor
65524482|NCT02525211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65524483|NCT02525211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524484|NCT02525211|Sensory System Agents|sensory system agents|mesh-ancestor
65524485|NCT02525211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65524486|NCT03865563|Gemcitabine|gemcitabine|mesh-list
65524487|NCT03865563|Ethiodized Oil|ethiodized oil|mesh-list
65524488|NCT03865563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65524489|NCT03865563|Antimetabolites|antimetabolites|mesh-ancestor
65321976|NCT00798590|Incretins|incretins|mesh-ancestor
65524490|NCT03865563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524491|NCT03865563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524492|NCT03865563|Antiviral Agents|antiviral agents|mesh-ancestor
65524493|NCT03865563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65524494|NCT03865563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524495|NCT03865563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65524496|NCT03865563|Immunologic Factors|immunologic factors|mesh-ancestor
65524497|NCT03865563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524498|NCT01178151|Everolimus|everolimus|mesh-list
65524499|NCT01178151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524500|NCT01178151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65524501|NCT01178151|Immunologic Factors|immunologic factors|mesh-ancestor
65524502|NCT01178151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524503|NCT03862287|Lidocaine|lidocaine|mesh-list
65524504|NCT03862287|Bupivacaine|bupivacaine|mesh-list
65524505|NCT03862287|Anesthetics, Local|anesthetics, local|mesh-ancestor
65524506|NCT03862287|Anesthetics|anesthetics|mesh-ancestor
65524507|NCT03862287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65524508|NCT03862287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524509|NCT03862287|Sensory System Agents|sensory system agents|mesh-ancestor
65524510|NCT03862287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65524511|NCT03862287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65524512|NCT03862287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65524513|NCT03862287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65524514|NCT03862287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65524515|NCT03862287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524516|NCT03862053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65524517|NCT03862053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65524518|NCT03749109|Quinagolide|quinagolide|mesh-list
65524519|NCT03749109|Dopamine Agonists|dopamine agonists|mesh-ancestor
65524520|NCT03749109|Dopamine Agents|dopamine agents|mesh-ancestor
65524521|NCT03749109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65524522|NCT03749109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524523|NCT03749109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524524|NCT01287351|Fluticasone|fluticasone|mesh-list
65524525|NCT01287351|Xhance|xhance|mesh-list
65524526|NCT01287351|Beclomethasone|beclomethasone|mesh-list
65524527|NCT01287351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65524528|NCT01287351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65524529|NCT01287351|Autonomic Agents|autonomic agents|mesh-ancestor
65524530|NCT01287351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65524531|NCT01287351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524532|NCT01287351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65524533|NCT01287351|Respiratory System Agents|respiratory system agents|mesh-ancestor
65524534|NCT01287351|Dermatologic Agents|dermatologic agents|mesh-ancestor
65524535|NCT01287351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65524536|NCT01287351|Glucocorticoids|glucocorticoids|mesh-ancestor
65524537|NCT01287351|Hormones|hormones|mesh-ancestor
65524538|NCT01287351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65524539|NCT03864783|Curcumin|curcumin|mesh-list
65524540|NCT03864783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65524541|NCT03864783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65524542|NCT03864783|Analgesics|analgesics|mesh-ancestor
65524543|NCT03864783|Sensory System Agents|sensory system agents|mesh-ancestor
65524544|NCT03864783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65524545|NCT03864783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524546|NCT03864783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65524547|NCT03864783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65524548|NCT03864783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524549|NCT03864783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524550|NCT03864783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524551|NCT01287507|Lactoferrin|lactoferrin|mesh-list
65524552|NCT01287507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65524553|NCT03864705|Metformin|metformin|mesh-list
65524554|NCT03864705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65524555|NCT03864705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524556|NCT01287663|Permethrin|permethrin|mesh-list
65524557|NCT01287663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524558|NCT01287663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524559|NCT01176669|Apatinib|apatinib|mesh-list
65524560|NCT01176669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524561|NCT01176669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65524562|NCT01176669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524563|NCT01176669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524564|NCT01176747|Formoterol Fumarate|formoterol fumarate|mesh-list
65524565|NCT01176747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65524566|NCT01176747|Autonomic Agents|autonomic agents|mesh-ancestor
65524567|NCT01176747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65524568|NCT01176747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524569|NCT01176747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65524570|NCT01176747|Respiratory System Agents|respiratory system agents|mesh-ancestor
65524571|NCT01176747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65524572|NCT01176747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65524573|NCT01176747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65524574|NCT01176747|Adrenergic Agents|adrenergic agents|mesh-ancestor
65524575|NCT01176747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65524576|NCT01176747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524577|NCT01174953|Finasteride|finasteride|mesh-list
65524578|NCT01174953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65524579|NCT01174953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65524580|NCT01174953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524581|NCT01174953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524582|NCT01174953|Hormone Antagonists|hormone antagonists|mesh-ancestor
65524583|NCT01174953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65524584|NCT01174953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524585|NCT01174953|Urological Agents|urological agents|mesh-ancestor
65524586|NCT01286103|Canagliflozin|canagliflozin|mesh-list
65524587|NCT01286103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65524588|NCT01286103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524589|NCT01286103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65524590|NCT01286103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524591|NCT01176903|Glycopyrrolate|glycopyrrolate|mesh-list
65524592|NCT01176903|Tiotropium Bromide|tiotropium bromide|mesh-list
65524593|NCT01176903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65524594|NCT01176903|Autonomic Agents|autonomic agents|mesh-ancestor
65524595|NCT01176903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65524596|NCT01176903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524597|NCT01176903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65524598|NCT01176903|Respiratory System Agents|respiratory system agents|mesh-ancestor
65524599|NCT01176903|Parasympatholytics|parasympatholytics|mesh-ancestor
65524600|NCT01176903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65524601|NCT01176903|Cholinergic Agents|cholinergic agents|mesh-ancestor
65524602|NCT01176903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65524603|NCT01176903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524604|NCT01176903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65524605|NCT01176903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65524606|NCT03863925|Propofol|propofol|mesh-list
65524607|NCT03863925|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65524608|NCT03863925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65524609|NCT03863925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524610|NCT03863925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65524611|NCT03863925|Anesthetics, General|anesthetics, general|mesh-ancestor
65524612|NCT03863925|Anesthetics|anesthetics|mesh-ancestor
65524613|NCT01178697|Triamcinolone|triamcinolone|mesh-list
65524614|NCT01178697|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65524615|NCT01178697|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65524616|NCT01178697|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65524617|NCT01178697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65524618|NCT01178697|Glucocorticoids|glucocorticoids|mesh-ancestor
65524619|NCT01178697|Hormones|hormones|mesh-ancestor
65524620|NCT01178697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65524621|NCT01178697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524622|NCT01178697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65524623|NCT01178697|Immunologic Factors|immunologic factors|mesh-ancestor
65524624|NCT01178697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524625|NCT01178697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524626|NCT03328832|Tranylcypromine|tranylcypromine|mesh-list
65524627|NCT03328832|Rivaroxaban|rivaroxaban|mesh-list
65524628|NCT03328832|Tranexamic Acid|tranexamic acid|mesh-list
65524629|NCT03328832|Thrombin|thrombin|mesh-list
65524630|NCT03328832|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65524631|NCT03328832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65524632|NCT03328832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524633|NCT03328832|Hemostatics|hemostatics|mesh-ancestor
65524634|NCT03328832|Coagulants|coagulants|mesh-ancestor
65524635|NCT03328832|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65524636|NCT03328832|Antithrombins|antithrombins|mesh-ancestor
65524637|NCT03328832|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65524638|NCT03328832|Protease Inhibitors|protease inhibitors|mesh-ancestor
65524639|NCT03328832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524640|NCT03328832|Anticoagulants|anticoagulants|mesh-ancestor
65524641|NCT03328832|Antidepressive Agents|antidepressive agents|mesh-ancestor
65524642|NCT03328832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65524643|NCT03328832|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65524644|NCT03328832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65524645|NCT03328832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65524646|NCT03328832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65524647|NCT03328832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524648|NCT02820844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65524649|NCT02820844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65524650|NCT02942576|Warfarin|warfarin|mesh-list
65524651|NCT02942576|Edoxaban|edoxaban|mesh-list
65524652|NCT02942576|Acenocoumarol|acenocoumarol|mesh-list
65524653|NCT02942576|Phenprocoumon|phenprocoumon|mesh-list
65524654|NCT02942576|Fluindione|fluindione|mesh-list
65524655|NCT02942576|Anticoagulants|anticoagulants|mesh-ancestor
65524656|NCT02942576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65524657|NCT02942576|Antithrombins|antithrombins|mesh-ancestor
65524658|NCT02942576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65524659|NCT02942576|Protease Inhibitors|protease inhibitors|mesh-ancestor
65524660|NCT02942576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524661|NCT02942576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524662|NCT02820298|Bexagliflozin|bexagliflozin|mesh-list
65524663|NCT02820298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65524664|NCT02820298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524665|NCT02036008|Liver Extracts|liver extracts|mesh-list
65524666|NCT02036008|Hematinics|hematinics|mesh-ancestor
65524667|NCT02819440|Tadalafil|tadalafil|mesh-list
65524668|NCT02819440|Vasodilator Agents|vasodilator agents|mesh-ancestor
65524669|NCT02819440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65524670|NCT02819440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65524671|NCT02819440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524672|NCT02819440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524673|NCT02819440|Urological Agents|urological agents|mesh-ancestor
65524674|NCT03562468|Niacinamide|niacinamide|mesh-list
65524675|NCT03562468|Niacin|niacin|mesh-list
65524676|NCT03562468|Nicotinic Acids|nicotinic acids|mesh-list
65524677|NCT03562468|Vitamin B Complex|vitamin b complex|mesh-ancestor
65524678|NCT03562468|Vitamins|vitamins|mesh-ancestor
65524679|NCT03562468|Micronutrients|micronutrients|mesh-ancestor
65524680|NCT03562468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524681|NCT03562468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65524682|NCT03562468|Antimetabolites|antimetabolites|mesh-ancestor
65524683|NCT03562468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524684|NCT03562468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65524685|NCT03562468|Vasodilator Agents|vasodilator agents|mesh-ancestor
65524686|NCT02036164|Paclitaxel|paclitaxel|mesh-list
65524687|NCT02036164|Cisplatin|cisplatin|mesh-list
65524688|NCT02036164|Carboplatin|carboplatin|mesh-list
65524689|NCT02036164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65524690|NCT02036164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524691|NCT02036164|Tubulin Modulators|tubulin modulators|mesh-ancestor
65524692|NCT02036164|Antimitotic Agents|antimitotic agents|mesh-ancestor
65524693|NCT02036164|Mitosis Modulators|mitosis modulators|mesh-ancestor
65524694|NCT02036164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524695|NCT02818036|Naltrexone|naltrexone|mesh-list
65524696|NCT02818036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65524697|NCT02818036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65524698|NCT02818036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524699|NCT02818036|Sensory System Agents|sensory system agents|mesh-ancestor
65524700|NCT02818036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65524701|NCT01287741|Prednisone|prednisone|mesh-list
65524702|NCT01287741|Cyclophosphamide|cyclophosphamide|mesh-list
65524703|NCT01287741|Rituximab|rituximab|mesh-list
65524704|NCT01287741|Doxorubicin|doxorubicin|mesh-list
65524705|NCT01287741|Vincristine|vincristine|mesh-list
65524706|NCT01287741|Obinutuzumab|obinutuzumab|mesh-list
65524707|NCT01287741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65524708|NCT01287741|Immunologic Factors|immunologic factors|mesh-ancestor
65524709|NCT01287741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524710|NCT01287741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65253722|NCT02859077|Carboplatin|carboplatin|mesh-list
65524711|NCT01287741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65524712|NCT01287741|Alkylating Agents|alkylating agents|mesh-ancestor
65524713|NCT01287741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524714|NCT01287741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524715|NCT01287741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65524716|NCT01287741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65524717|NCT01287741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65524718|NCT01287741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65524719|NCT01287741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65524720|NCT01287741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524721|NCT01287741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65524722|NCT01287741|Glucocorticoids|glucocorticoids|mesh-ancestor
65524724|NCT01287741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65524725|NCT01287741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65524726|NCT01287741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65524727|NCT01287741|Tubulin Modulators|tubulin modulators|mesh-ancestor
65524728|NCT01287741|Antimitotic Agents|antimitotic agents|mesh-ancestor
65524729|NCT01287741|Mitosis Modulators|mitosis modulators|mesh-ancestor
65524730|NCT01180959|Bevacizumab|bevacizumab|mesh-list
65524731|NCT01180959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65524732|NCT01180959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65524733|NCT01180959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524734|NCT01180959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65524735|NCT01180959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65524736|NCT01180959|Growth Substances|growth substances|mesh-ancestor
65524737|NCT01180959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524738|NCT01180959|Growth Inhibitors|growth inhibitors|mesh-ancestor
65524739|NCT01180959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65524740|NCT01180959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524741|NCT01180959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524742|NCT01177371|Cyclosporine|cyclosporine|mesh-list
65524743|NCT01177371|Methylprednisolone|methylprednisolone|mesh-list
65524744|NCT01177371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65524745|NCT01177371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65524746|NCT01177371|Prednisolone|prednisolone|mesh-list
65524747|NCT01177371|Prednisolone acetate|prednisolone acetate|mesh-list
65524748|NCT01177371|Cyclophosphamide|cyclophosphamide|mesh-list
65524749|NCT01177371|Busulfan|busulfan|mesh-list
65524750|NCT01177371|Methotrexate|methotrexate|mesh-list
65524751|NCT01177371|Cyclosporins|cyclosporins|mesh-list
65524752|NCT01177371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65524753|NCT01177371|Prednisolone phosphate|prednisolone phosphate|mesh-list
65524754|NCT01177371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65524755|NCT01177371|Immunologic Factors|immunologic factors|mesh-ancestor
65524756|NCT01177371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524757|NCT01177371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65524758|NCT01177371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65524759|NCT01177371|Alkylating Agents|alkylating agents|mesh-ancestor
65524760|NCT01177371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524761|NCT01177371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524762|NCT01177371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65524763|NCT01177371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65524764|NCT01177371|Abortifacient Agents|abortifacient agents|mesh-ancestor
65524765|NCT01177371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65524766|NCT01177371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65524767|NCT01177371|Antimetabolites|antimetabolites|mesh-ancestor
65524768|NCT01177371|Dermatologic Agents|dermatologic agents|mesh-ancestor
65524769|NCT01177371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524770|NCT01177371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65524771|NCT01177371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65524772|NCT01177371|Antifungal Agents|antifungal agents|mesh-ancestor
65524773|NCT01177371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65524774|NCT01177371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65524775|NCT01177371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65524776|NCT01177371|Antiemetics|antiemetics|mesh-ancestor
65524777|NCT01177371|Autonomic Agents|autonomic agents|mesh-ancestor
65524778|NCT01177371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65524779|NCT01177371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65524780|NCT01177371|Glucocorticoids|glucocorticoids|mesh-ancestor
65524781|NCT01177371|Hormones|hormones|mesh-ancestor
65524782|NCT01177371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65524783|NCT01177371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65524784|NCT01177371|Protective Agents|protective agents|mesh-ancestor
65524785|NCT01177371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65524786|NCT01178931|Dydrogesterone|dydrogesterone|mesh-list
65524787|NCT01178931|Progesterone|progesterone|mesh-list
65524788|NCT01178931|Progestins|progestins|mesh-ancestor
65524789|NCT01178931|Hormones|hormones|mesh-ancestor
65524790|NCT01178931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65524791|NCT01178931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524792|NCT01181115|Interferon beta-1a|interferon beta-1a|mesh-list
65524793|NCT01181115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65524794|NCT01181115|Immunologic Factors|immunologic factors|mesh-ancestor
65524795|NCT01181115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524796|NCT01181115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524797|NCT01181115|Antiviral Agents|antiviral agents|mesh-ancestor
65524798|NCT01181115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65524800|NCT01181193|Cholecalciferol|cholecalciferol|mesh-list
65524801|NCT01181193|Temozolomide|temozolomide|mesh-list
65524802|NCT01181193|Vitamins|vitamins|mesh-ancestor
65524803|NCT01181193|Micronutrients|micronutrients|mesh-ancestor
65524804|NCT01181193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524805|NCT01181193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65524806|NCT01181193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65524807|NCT01181193|Alkylating Agents|alkylating agents|mesh-ancestor
65524808|NCT01181193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524809|NCT01181193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524810|NCT01181193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65524811|NCT01177683|Doxorubicin|doxorubicin|mesh-list
65524812|NCT01177683|Bortezomib|bortezomib|mesh-list
65524813|NCT01177683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65524814|NCT01177683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65524815|NCT01177683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524816|NCT01177683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65524817|NCT01177683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65524818|NCT01177683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524819|NCT01177683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524820|NCT01177683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65524821|NCT01177683|Alkylating Agents|alkylating agents|mesh-ancestor
65524822|NCT01181427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-list
65524823|NCT01181427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524824|NCT01181427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524825|NCT03855579|Simendan|simendan|mesh-list
65524826|NCT03855579|Milrinone|milrinone|mesh-list
65524827|NCT03855579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65524828|NCT03855579|Vasodilator Agents|vasodilator agents|mesh-ancestor
65524829|NCT03855579|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65524830|NCT03855579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65524831|NCT03855579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524832|NCT03855579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524833|NCT03855579|Protective Agents|protective agents|mesh-ancestor
65524834|NCT03855579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524835|NCT03855579|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65524836|NCT03855423|Tocotrienols|tocotrienols|mesh-list
65524837|NCT03855423|Vitamin E|vitamin e|mesh-list
65524838|NCT03855423|Tocopherols|tocopherols|mesh-list
65524839|NCT03855423|Tocovid|tocovid|mesh-list
65524840|NCT03855423|Antioxidants|antioxidants|mesh-ancestor
65524841|NCT03855423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524842|NCT03855423|Protective Agents|protective agents|mesh-ancestor
65524843|NCT03855423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524844|NCT03855423|Vitamins|vitamins|mesh-ancestor
65524845|NCT03855423|Micronutrients|micronutrients|mesh-ancestor
65524846|NCT01181505|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65524847|NCT01181505|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65524848|NCT01181505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65524849|NCT01181505|Cholinergic Agents|cholinergic agents|mesh-ancestor
65524850|NCT01181505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65524851|NCT01181505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524852|NCT01181505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524853|NCT01181505|Urological Agents|urological agents|mesh-ancestor
65524854|NCT01290783|Irinotecan|irinotecan|mesh-list
65524855|NCT01290783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65524856|NCT01290783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65524857|NCT01290783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524858|NCT01290783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524859|NCT01290783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524860|NCT03857763|Paclitaxel|paclitaxel|mesh-list
65524861|NCT03857763|Apatinib|apatinib|mesh-list
65524862|NCT03857763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65524863|NCT03857763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524864|NCT03857763|Tubulin Modulators|tubulin modulators|mesh-ancestor
65524865|NCT03857763|Antimitotic Agents|antimitotic agents|mesh-ancestor
65524866|NCT03857763|Mitosis Modulators|mitosis modulators|mesh-ancestor
65524867|NCT03857763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524868|NCT03857763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65524869|NCT03857763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524870|NCT01289769|Dexmedetomidine|dexmedetomidine|mesh-list
65524871|NCT01289769|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65524872|NCT01289769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65524873|NCT01289769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524874|NCT01289769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65524875|NCT01289769|Analgesics|analgesics|mesh-ancestor
65524876|NCT01289769|Sensory System Agents|sensory system agents|mesh-ancestor
65524877|NCT01289769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65524878|NCT01289769|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65524879|NCT01289769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65524880|NCT01289769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65524881|NCT01289769|Adrenergic Agents|adrenergic agents|mesh-ancestor
65524882|NCT01289769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65524883|NCT01289769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524884|NCT01185015|Nicorandil|nicorandil|mesh-list
65524885|NCT01185015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65524886|NCT01185015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65524887|NCT01185015|Vasodilator Agents|vasodilator agents|mesh-ancestor
65524888|NCT01185015|Vitamin B Complex|vitamin b complex|mesh-ancestor
65524889|NCT01185015|Vitamins|vitamins|mesh-ancestor
65524890|NCT01185015|Micronutrients|micronutrients|mesh-ancestor
65524891|NCT01185015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524892|NCT01289925|Selenium|selenium|mesh-list
65524893|NCT01289925|Antioxidants|antioxidants|mesh-ancestor
65524894|NCT01289925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524895|NCT01289925|Protective Agents|protective agents|mesh-ancestor
65524896|NCT01289925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524897|NCT01289925|Trace Elements|trace elements|mesh-ancestor
65524898|NCT01289925|Micronutrients|micronutrients|mesh-ancestor
65524899|NCT01290939|Bevacizumab|bevacizumab|mesh-list
65524900|NCT01290939|Lomustine|lomustine|mesh-list
65524901|NCT01290939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65524902|NCT01290939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524903|NCT01290939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65524904|NCT01290939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65524905|NCT01290939|Growth Substances|growth substances|mesh-ancestor
65524906|NCT01290939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524907|NCT01290939|Growth Inhibitors|growth inhibitors|mesh-ancestor
65524908|NCT01290939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65524909|NCT01290939|Alkylating Agents|alkylating agents|mesh-ancestor
65524910|NCT01290939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524911|NCT01288755|Raltegravir Potassium|raltegravir potassium|mesh-list
65524912|NCT01288755|Rilpivirine|rilpivirine|mesh-list
65524913|NCT01288755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65524914|NCT01288755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65524915|NCT01288755|Antiviral Agents|antiviral agents|mesh-ancestor
65524916|NCT01288755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65524917|NCT01288755|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65524918|NCT01288755|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65524919|NCT01288755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524920|NCT01288755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524921|NCT01288755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65524922|NCT01288755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65524923|NCT01290003|Tazobactam|tazobactam|mesh-list
65524924|NCT01290003|Piperacillin|piperacillin|mesh-list
65524925|NCT01290003|Amikacin|amikacin|mesh-list
65524926|NCT01290003|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65524927|NCT01290003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65524928|NCT01290003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65524929|NCT01290003|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65524930|NCT01290003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524931|NCT01290003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524932|NCT01291095|Cisplatin|cisplatin|mesh-list
65524933|NCT01291095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65524934|NCT03739203|Cariprazine|cariprazine|mesh-list
65524935|NCT03739203|Antidepressive Agents|antidepressive agents|mesh-list
65524936|NCT03739203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65524937|NCT03739203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65524938|NCT03739203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65524939|NCT03739203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65524940|NCT03739203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524941|NCT01185405|Voriconazole|voriconazole|mesh-list
65524942|NCT01185405|Antifungal Agents|antifungal agents|mesh-ancestor
65524943|NCT01185405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65524945|NCT01185405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65524946|NCT01185405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524947|NCT01185405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524948|NCT01185405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65524949|NCT01185405|Hormone Antagonists|hormone antagonists|mesh-ancestor
65524950|NCT01185405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65524951|NCT01185405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524952|NCT01185405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65524953|NCT01182129|Nicotine|nicotine|mesh-list
65524954|NCT01182129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65524955|NCT01182129|Autonomic Agents|autonomic agents|mesh-ancestor
65524956|NCT01182129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65524957|NCT01182129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524958|NCT01182129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65524959|NCT01182129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65524960|NCT01182129|Cholinergic Agents|cholinergic agents|mesh-ancestor
65524961|NCT01182129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65524962|NCT01182129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524963|NCT01587729|Antidepressive Agents|antidepressive agents|mesh-list
65524964|NCT01587729|Serotonin|serotonin|mesh-list
65524965|NCT01587729|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65524966|NCT01587729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65524967|NCT01587729|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65524968|NCT01587729|Serotonin Agents|serotonin agents|mesh-ancestor
65524969|NCT01587729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65524970|NCT01587729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524971|NCT01587729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524972|NCT01587729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65524973|NCT01587729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65524974|NCT03855267|Propofol|propofol|mesh-list
65524975|NCT03855267|Etomidate|etomidate|mesh-list
65524976|NCT03855267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65524977|NCT03855267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65524978|NCT03855267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65524979|NCT03855267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65524980|NCT03855267|Anesthetics, General|anesthetics, general|mesh-ancestor
65524981|NCT03855267|Anesthetics|anesthetics|mesh-ancestor
65524982|NCT01185873|Ritonavir|ritonavir|mesh-list
65524983|NCT01185873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65524984|NCT01185873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65524985|NCT01185873|Protease Inhibitors|protease inhibitors|mesh-ancestor
65524986|NCT01185873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65524987|NCT01185873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65524988|NCT01185873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65524989|NCT01185873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65524990|NCT01185873|Antiviral Agents|antiviral agents|mesh-ancestor
65524991|NCT01185873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65524992|NCT01185873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65524993|NCT01185873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65524994|NCT01182597|Pantoprazole|pantoprazole|mesh-list
65524995|NCT01182597|Lansoprazole|lansoprazole|mesh-list
65524996|NCT01182597|Dexlansoprazole|dexlansoprazole|mesh-list
65524997|NCT01182597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65524998|NCT01182597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65524999|NCT01182597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65525000|NCT01182597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525001|NCT01182597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525002|NCT01185951|Polidocanol|polidocanol|mesh-list
65525003|NCT01185951|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65525004|NCT01185951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65525005|NCT01186029|Aprepitant|aprepitant|mesh-list
65525006|NCT01186029|Antiemetics|antiemetics|mesh-ancestor
65525007|NCT01186029|Autonomic Agents|autonomic agents|mesh-ancestor
65525008|NCT01186029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65525009|NCT01186029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525010|NCT01186029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65525011|NCT01186029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65525012|NCT01186029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65525013|NCT01186029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525014|NCT01587807|Dimercaprol|dimercaprol|mesh-list
65525015|NCT01587807|Chelating Agents|chelating agents|mesh-ancestor
65525016|NCT01587807|Sequestering Agents|sequestering agents|mesh-ancestor
65525017|NCT01587807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525018|NCT01186185|Fludrocortisone|fludrocortisone|mesh-list
65525019|NCT01186185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65525020|NCT01180179|Lansoprazole|lansoprazole|mesh-list
65525021|NCT01180179|Dexlansoprazole|dexlansoprazole|mesh-list
65525023|NCT01180179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65525024|NCT01180179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65525025|NCT01180179|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65525026|NCT01180179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525027|NCT01180179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525028|NCT01180179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65525029|NCT01180179|Histamine Antagonists|histamine antagonists|mesh-ancestor
65525030|NCT01180179|Histamine Agents|histamine agents|mesh-ancestor
65525031|NCT01180179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65525032|NCT01180179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525033|NCT01289223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65525034|NCT01289223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65525035|NCT01289223|Alkylating Agents|alkylating agents|mesh-ancestor
65525036|NCT01289223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525037|NCT01289223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525038|NCT01186497|Rabeprazole|rabeprazole|mesh-list
65525039|NCT01186497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65525040|NCT01186497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65525041|NCT01186497|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65525042|NCT01186497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525043|NCT01186497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525044|NCT03854409|Aripiprazole|aripiprazole|mesh-list
65525045|NCT03854409|Antidepressive Agents|antidepressive agents|mesh-ancestor
65525046|NCT03854409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65525047|NCT03854409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65525048|NCT03854409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65525049|NCT03854409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65525050|NCT03854409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525051|NCT03854409|Dopamine Agonists|dopamine agonists|mesh-ancestor
65525052|NCT03854409|Dopamine Agents|dopamine agents|mesh-ancestor
65525053|NCT03854409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65525054|NCT03854409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525055|NCT03854409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65525056|NCT03854409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65525057|NCT03854409|Serotonin Agents|serotonin agents|mesh-ancestor
65525058|NCT03854409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65525059|NCT03854409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65525060|NCT03854409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65525061|NCT03854409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65525062|NCT01186653|Fluticasone|fluticasone|mesh-list
65525063|NCT01186653|Budesonide|budesonide|mesh-list
65525064|NCT01186653|Formoterol Fumarate|formoterol fumarate|mesh-list
65525065|NCT01186653|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65525066|NCT01186653|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65525067|NCT01186653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65525068|NCT01186653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65525069|NCT01186653|Autonomic Agents|autonomic agents|mesh-ancestor
65525070|NCT01186653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65525071|NCT01186653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525072|NCT01186653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65525073|NCT01186653|Respiratory System Agents|respiratory system agents|mesh-ancestor
65525074|NCT01186653|Dermatologic Agents|dermatologic agents|mesh-ancestor
65525075|NCT01186653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65525076|NCT01186653|Glucocorticoids|glucocorticoids|mesh-ancestor
65525077|NCT01186653|Hormones|hormones|mesh-ancestor
65525078|NCT01186653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65525079|NCT01186653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65525080|NCT01186653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65525081|NCT01186653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65525082|NCT01186653|Adrenergic Agents|adrenergic agents|mesh-ancestor
65525083|NCT01186653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65525084|NCT01186653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525085|NCT01186653|Sympathomimetics|sympathomimetics|mesh-ancestor
65525086|NCT01186731|Docetaxel|docetaxel|mesh-list
65525087|NCT01186731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525088|NCT01186731|Tubulin Modulators|tubulin modulators|mesh-ancestor
65525089|NCT01186731|Antimitotic Agents|antimitotic agents|mesh-ancestor
65525090|NCT01186731|Mitosis Modulators|mitosis modulators|mesh-ancestor
65525091|NCT01186731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525093|NCT01186887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65525094|NCT01186887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65525095|NCT01186887|Analgesics|analgesics|mesh-ancestor
65525096|NCT01186887|Sensory System Agents|sensory system agents|mesh-ancestor
65525097|NCT01186887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65525098|NCT01186887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525099|NCT01186887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65525100|NCT01186887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65525101|NCT01186887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65525102|NCT01186887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65525103|NCT01186887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525104|NCT01186887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525105|NCT01180413|Losartan|losartan|mesh-list
65525106|NCT01180413|Amlodipine|amlodipine|mesh-list
65525107|NCT01180413|Ramipril|ramipril|mesh-list
65525108|NCT01180413|Lercanidipine|lercanidipine|mesh-list
65525109|NCT01180413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65525110|NCT01180413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65525111|NCT01180413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65525112|NCT01180413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525113|NCT01180413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65525114|NCT01180413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525115|NCT01180413|Vasodilator Agents|vasodilator agents|mesh-ancestor
65525116|NCT01180413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65525117|NCT01180413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65525118|NCT01180413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65525119|NCT01180413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65525120|NCT01180413|Protease Inhibitors|protease inhibitors|mesh-ancestor
65525121|NCT01180413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525122|NCT03858387|Meropenem|meropenem|mesh-list
65525123|NCT03858387|Imipenem|imipenem|mesh-list
65525124|NCT03858387|Cilastatin|cilastatin|mesh-list
65525125|NCT03858387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65525126|NCT03858387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65525127|NCT03858387|Protease Inhibitors|protease inhibitors|mesh-ancestor
65525128|NCT03858387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525129|NCT03858387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525130|NCT01289301|Cyclosporine|cyclosporine|mesh-list
65525131|NCT01289301|Sirolimus|sirolimus|mesh-list
65525132|NCT01289301|Everolimus|everolimus|mesh-list
65525133|NCT01289301|Tacrolimus|tacrolimus|mesh-list
65525134|NCT01289301|Cyclosporins|cyclosporins|mesh-list
65525135|NCT01289301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
65525136|NCT01289301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65525137|NCT01289301|Immunologic Factors|immunologic factors|mesh-ancestor
65525138|NCT01289301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525139|NCT01289301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525140|NCT01289301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525141|NCT01289301|Antifungal Agents|antifungal agents|mesh-ancestor
65525142|NCT01289301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65525143|NCT01289301|Dermatologic Agents|dermatologic agents|mesh-ancestor
65525144|NCT01289301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65525145|NCT01289301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525146|NCT01289301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65525147|NCT01289301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65525148|NCT02524899|Guanfacine|guanfacine|mesh-list
65525149|NCT02524899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65525150|NCT02524899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65525151|NCT02524899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65525152|NCT02524899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65525153|NCT02524899|Adrenergic Agents|adrenergic agents|mesh-ancestor
65525154|NCT02524899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65525155|NCT02524899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525156|NCT02524899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525157|NCT02524821|Metformin|metformin|mesh-list
65525158|NCT02524821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65525159|NCT02524821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525160|NCT01183455|Protease Inhibitors|protease inhibitors|mesh-list
65525161|NCT01183455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65525162|NCT01183455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525163|NCT01183455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525164|NCT01183455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65322647|NCT03540017|Cisplatin|cisplatin|mesh-list
65525165|NCT01183455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65525166|NCT03854175|Sildenafil Citrate|sildenafil citrate|mesh-list
65525167|NCT03854175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65525168|NCT03854175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65525169|NCT03854175|Estradiol|estradiol|mesh-list
65525170|NCT03854175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65525171|NCT03854175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525172|NCT03854175|Estrogens|estrogens|mesh-ancestor
65525173|NCT03854175|Hormones|hormones|mesh-ancestor
65525174|NCT03854175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65525175|NCT03854175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525176|NCT03854175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65525177|NCT03854175|Contraceptive Agents|contraceptive agents|mesh-ancestor
65525178|NCT03854175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65525179|NCT03854175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65525180|NCT03854175|Vasodilator Agents|vasodilator agents|mesh-ancestor
65525181|NCT03854175|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65525182|NCT03854175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65525183|NCT03854175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525184|NCT03854175|Urological Agents|urological agents|mesh-ancestor
65525185|NCT01183611|Vaccines|vaccines|mesh-list
65525186|NCT01183611|Immunologic Factors|immunologic factors|mesh-ancestor
65525187|NCT01183611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525188|NCT01180569|Lenalidomide|lenalidomide|mesh-list
65525189|NCT01180569|Immunologic Factors|immunologic factors|mesh-ancestor
65525190|NCT01180569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525191|NCT01180569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65525192|NCT01180569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65525193|NCT01180569|Growth Substances|growth substances|mesh-ancestor
65525194|NCT01180569|Growth Inhibitors|growth inhibitors|mesh-ancestor
65525195|NCT01180569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525196|NCT02942264|Temozolomide|temozolomide|mesh-list
65525197|NCT02942264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65525198|NCT02942264|Alkylating Agents|alkylating agents|mesh-ancestor
65525199|NCT02942264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525200|NCT02942264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525201|NCT01180725|Psyllium|psyllium|mesh-list
65525202|NCT01180725|Cathartics|cathartics|mesh-ancestor
65525203|NCT01180725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65525204|NCT01183767|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65525205|NCT01183767|Antioxidants|antioxidants|mesh-ancestor
65525206|NCT01183767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525207|NCT01183767|Protective Agents|protective agents|mesh-ancestor
65525208|NCT01183767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525209|NCT01183767|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65525210|NCT01183767|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65525211|NCT01183767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525212|NCT01183767|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65525213|NCT03853785|Podophyllin|podophyllin|mesh-list
65525214|NCT03853785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65525215|NCT03853785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525216|NCT03853785|Keratolytic Agents|keratolytic agents|mesh-ancestor
65525217|NCT03853785|Dermatologic Agents|dermatologic agents|mesh-ancestor
65525218|NCT01290471|U3-1565|u3-1565|mesh-list
65525219|NCT01290471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65525220|NCT01290471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525221|NCT01291563|Moxifloxacin|moxifloxacin|mesh-list
65525222|NCT01291563|Bedaquiline|bedaquiline|mesh-list
65525223|NCT01291563|Diarylquinolines|diarylquinolines|mesh-list
65525224|NCT01291563|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65525225|NCT01291563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65525226|NCT01291563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65525227|NCT01291563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65525228|NCT01291563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65525229|NCT01291563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525230|NCT01291563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525231|NCT01291563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525232|NCT01291563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65254242|NCT02836184|Vitamins|vitamins|mesh-ancestor
65525233|NCT01291563|Contraceptive Agents|contraceptive agents|mesh-ancestor
65525234|NCT01291563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65525235|NCT01291563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525236|NCT01291563|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65525237|NCT01291563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65525238|NCT01291563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65322724|NCT00786188|Paroxetine|paroxetine|mesh-list
65525239|NCT01291563|Antitubercular Agents|antitubercular agents|mesh-ancestor
65525240|NCT01187589|Albuterol|albuterol|mesh-list
65525241|NCT01187589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65525242|NCT01187589|Autonomic Agents|autonomic agents|mesh-ancestor
65525243|NCT01187589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65525244|NCT01187589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525245|NCT01187589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65525246|NCT01187589|Respiratory System Agents|respiratory system agents|mesh-ancestor
65525247|NCT01187589|Tocolytic Agents|tocolytic agents|mesh-ancestor
65525248|NCT01187589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65525249|NCT01187589|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65525250|NCT01187589|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65525251|NCT01187589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65525252|NCT01187589|Adrenergic Agents|adrenergic agents|mesh-ancestor
65525253|NCT01187589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65525254|NCT01187589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525255|NCT01290549|Rituximab|rituximab|mesh-list
65525256|NCT01290549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65525257|NCT01290549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525258|NCT01290549|Immunologic Factors|immunologic factors|mesh-ancestor
65525259|NCT01290549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525260|NCT01290549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65525261|NCT01184235|Antipsychotic Agents|antipsychotic agents|mesh-list
65525262|NCT01184235|Antidepressive Agents|antidepressive agents|mesh-list
65525263|NCT01184235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65525264|NCT01184235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65525265|NCT01184235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65525266|NCT01184235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525267|NCT04951947|Lenvatinib|lenvatinib|mesh-list
65525268|NCT04951947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525269|NCT04951947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65525270|NCT04951947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525271|NCT04951947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525272|NCT01184391|Valproic Acid|valproic acid|mesh-list
65525273|NCT01184391|Anticonvulsants|anticonvulsants|mesh-ancestor
65525274|NCT01184391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525275|NCT01184391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525276|NCT01184391|GABA Agents|gaba agents|mesh-ancestor
65525277|NCT01184391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65525278|NCT01184391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525279|NCT01184391|Antimanic Agents|antimanic agents|mesh-ancestor
65525280|NCT01184391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65525281|NCT01184391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65525282|NCT01184391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65525283|NCT02524743|Acetaminophen|acetaminophen|mesh-list
65525284|NCT02524743|Lidocaine|lidocaine|mesh-list
65525285|NCT02524743|Anesthetics, Local|anesthetics, local|mesh-ancestor
65525286|NCT02524743|Anesthetics|anesthetics|mesh-ancestor
65525287|NCT02524743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65525288|NCT02524743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525289|NCT02524743|Sensory System Agents|sensory system agents|mesh-ancestor
65525290|NCT02524743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65525291|NCT02524743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65525292|NCT02524743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65525293|NCT02524743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65525294|NCT02524743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65525295|NCT02524743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525296|NCT02524743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65525297|NCT02524743|Analgesics|analgesics|mesh-ancestor
65525298|NCT02524743|Antipyretics|antipyretics|mesh-ancestor
65525299|NCT01188057|Alprazolam|alprazolam|mesh-list
65525300|NCT01188057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65525301|NCT01188057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65525302|NCT01188057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525303|NCT01188057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65525304|NCT01188057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65525305|NCT01188057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65525306|NCT01188057|GABA Modulators|gaba modulators|mesh-ancestor
65525307|NCT01188057|GABA Agents|gaba agents|mesh-ancestor
65525308|NCT01188057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65525309|NCT01188057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525310|NCT01291641|Cilostazol|cilostazol|mesh-list
65525311|NCT01291641|Probucol|probucol|mesh-list
65525312|NCT01291641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65525313|NCT01291641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65525314|NCT01291641|Autonomic Agents|autonomic agents|mesh-ancestor
65525315|NCT01291641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65525316|NCT01291641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525317|NCT01291641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65525318|NCT01291641|Respiratory System Agents|respiratory system agents|mesh-ancestor
65525319|NCT01291641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65525320|NCT01291641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65525321|NCT01291641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525322|NCT01291641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65525323|NCT01291641|Vasodilator Agents|vasodilator agents|mesh-ancestor
65525324|NCT01291641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65525325|NCT01291641|Protective Agents|protective agents|mesh-ancestor
65525326|NCT01291641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65525327|NCT01291641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65525328|NCT01291641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525329|NCT01291641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65525330|NCT01291641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65525331|NCT01291641|Antimetabolites|antimetabolites|mesh-ancestor
65525332|NCT01291641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65525333|NCT01291641|Antioxidants|antioxidants|mesh-ancestor
65525334|NCT03855501|Calcium|calcium|mesh-list
65525335|NCT03855501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65525336|NCT03855501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525337|NCT01588587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65525338|NCT01588587|Vildagliptin|vildagliptin|mesh-list
65525339|NCT01588587|Alogliptin|alogliptin|mesh-list
65525340|NCT01588587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65525341|NCT01588587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525342|NCT01588587|Incretins|incretins|mesh-ancestor
65525343|NCT01588587|Hormones|hormones|mesh-ancestor
65525344|NCT01588587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65525345|NCT01588587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65525346|NCT01588587|Protease Inhibitors|protease inhibitors|mesh-ancestor
65525347|NCT01588587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525348|NCT01588587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525349|NCT03325712|Midazolam|midazolam|mesh-list
65525350|NCT03325712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65525351|NCT03325712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65525352|NCT03325712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65525353|NCT03325712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525354|NCT03325712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65525355|NCT03325712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65525356|NCT03325712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65525357|NCT03325712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65525358|NCT03325712|Anesthetics, General|anesthetics, general|mesh-ancestor
65525359|NCT03325712|Anesthetics|anesthetics|mesh-ancestor
65525360|NCT03325712|GABA Modulators|gaba modulators|mesh-ancestor
65525361|NCT03325712|GABA Agents|gaba agents|mesh-ancestor
65525362|NCT03325712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65525363|NCT03325712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525364|NCT01293747|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65525365|NCT01293747|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65525366|NCT01293747|Estradiol|estradiol|mesh-list
65525367|NCT01293747|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65525368|NCT01293747|Progesterone|progesterone|mesh-list
65525369|NCT01293747|Estrogens|estrogens|mesh-ancestor
65525370|NCT01293747|Hormones|hormones|mesh-ancestor
65525371|NCT01293747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65525372|NCT01293747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525373|NCT01293747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65525374|NCT01293747|Contraceptive Agents|contraceptive agents|mesh-ancestor
65525375|NCT01293747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65525376|NCT01293747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65525377|NCT01293747|Progestins|progestins|mesh-ancestor
65525378|NCT03849729|Phentermine|phentermine|mesh-list
65525379|NCT03849729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65525380|NCT03849729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525381|NCT03849729|Appetite Depressants|appetite depressants|mesh-ancestor
65525382|NCT03849729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65525383|NCT03849729|Sympathomimetics|sympathomimetics|mesh-ancestor
65525384|NCT03849729|Autonomic Agents|autonomic agents|mesh-ancestor
65525385|NCT03849729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65525386|NCT03849729|Adrenergic Agents|adrenergic agents|mesh-ancestor
65525387|NCT03849729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65525388|NCT03849729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525390|NCT03325556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65525391|NCT03325556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65525392|NCT03325556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65525393|NCT03325556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65525394|NCT03325556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65525395|NCT03325556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525396|NCT03325556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65525397|NCT03325556|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65525398|NCT03325556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65525399|NCT03325556|Serotonin Agents|serotonin agents|mesh-ancestor
65525400|NCT03325556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65525401|NCT03325556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525402|NCT01188213|Dimethyl sulfone|dimethyl sulfone|mesh-list
65525403|NCT01188213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65525404|NCT03320564|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65525405|NCT03320564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65525406|NCT03320564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525407|NCT03852303|Ivermectin|ivermectin|mesh-list
65525408|NCT03852303|Anticonvulsants|anticonvulsants|mesh-list
65525409|NCT03852303|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65525410|NCT03852303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65525411|NCT01291719|Insulin|insulin|mesh-list
65525412|NCT01291719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65525413|NCT01291719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525414|NCT03325166|Pembrolizumab|pembrolizumab|mesh-list
65525415|NCT03325166|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65525416|NCT03325166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65525417|NCT03325166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525418|NCT03325166|Hematinics|hematinics|mesh-ancestor
65525419|NCT03325166|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65525420|NCT03325166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65525421|NCT03847623|Curcumin|curcumin|mesh-list
65525422|NCT03847623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65525423|NCT03847623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65525424|NCT03847623|Analgesics|analgesics|mesh-ancestor
65525425|NCT03847623|Sensory System Agents|sensory system agents|mesh-ancestor
65525426|NCT03847623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65525427|NCT03847623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525428|NCT03847623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65525429|NCT03847623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65525430|NCT03847623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525431|NCT03847623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525432|NCT03847623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525433|NCT01294059|Milnacipran|milnacipran|mesh-list
65525434|NCT01294059|Levomilnacipran|levomilnacipran|mesh-list
65525435|NCT01294059|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65525436|NCT01294059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65525437|NCT01294059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65525438|NCT01294059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525439|NCT01294059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65525440|NCT01294059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525441|NCT01294059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65525442|NCT01294059|Analgesics|analgesics|mesh-ancestor
65525443|NCT01294059|Sensory System Agents|sensory system agents|mesh-ancestor
65525444|NCT01294059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65525445|NCT01294059|Antidepressive Agents|antidepressive agents|mesh-ancestor
65525446|NCT01294059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65525447|NCT03847155|Nicotine|nicotine|mesh-list
65525448|NCT03847155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65525449|NCT03847155|Autonomic Agents|autonomic agents|mesh-ancestor
65525450|NCT03847155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65525451|NCT03847155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525452|NCT03847155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65525453|NCT03847155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65525454|NCT03847155|Cholinergic Agents|cholinergic agents|mesh-ancestor
65525455|NCT03847155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65254470|NCT02774382|Vancomycin|vancomycin|mesh-list
65525456|NCT03847155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525457|NCT01294215|Nifedipine|nifedipine|mesh-list
65525458|NCT01294215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65525459|NCT01294215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65525460|NCT01294215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525461|NCT01294215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65525462|NCT01294215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525463|NCT01294215|Vasodilator Agents|vasodilator agents|mesh-ancestor
65525464|NCT01294215|Tocolytic Agents|tocolytic agents|mesh-ancestor
65525465|NCT01294215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65525466|NCT01296555|Letrozole|letrozole|mesh-list
65525467|NCT01296555|Fulvestrant|fulvestrant|mesh-list
65525468|NCT01296555|Midazolam|midazolam|mesh-list
65525469|NCT01296555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65525470|NCT01296555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65525471|NCT01296555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65525472|NCT01296555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525473|NCT01296555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65525474|NCT01296555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65525475|NCT01296555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65525476|NCT01296555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65525477|NCT01296555|Anesthetics, General|anesthetics, general|mesh-ancestor
65525478|NCT01296555|Anesthetics|anesthetics|mesh-ancestor
65525479|NCT01296555|GABA Modulators|gaba modulators|mesh-ancestor
65525480|NCT01296555|GABA Agents|gaba agents|mesh-ancestor
65525481|NCT01296555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65525482|NCT01296555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525483|NCT01296555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525484|NCT01296555|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65525485|NCT01296555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65525486|NCT01296555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525487|NCT01296555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65525488|NCT01296555|Hormone Antagonists|hormone antagonists|mesh-ancestor
65525489|NCT01296555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65525490|NCT01296555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65525491|NCT01296555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65525492|NCT01294293|Paclitaxel|paclitaxel|mesh-list
65525493|NCT01294293|Doxorubicin|doxorubicin|mesh-list
65525494|NCT01294293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65525495|NCT01294293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65525496|NCT01294293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525497|NCT01294293|Tubulin Modulators|tubulin modulators|mesh-ancestor
65525498|NCT01294293|Antimitotic Agents|antimitotic agents|mesh-ancestor
65525499|NCT01294293|Mitosis Modulators|mitosis modulators|mesh-ancestor
65525500|NCT01294293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525501|NCT01294293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65525502|NCT01294293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65525503|NCT01294293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65525504|NCT01294293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525505|NCT01294605|Edetic Acid|edetic acid|mesh-list
65525506|NCT01294605|Pentetic Acid|pentetic acid|mesh-list
65525507|NCT01294605|Antidotes|antidotes|mesh-ancestor
65525508|NCT01294605|Protective Agents|protective agents|mesh-ancestor
65525509|NCT01294605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525510|NCT01294605|Chelating Agents|chelating agents|mesh-ancestor
65525511|NCT01294605|Sequestering Agents|sequestering agents|mesh-ancestor
65525512|NCT01294605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525513|NCT01294605|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65525514|NCT01294605|Anticoagulants|anticoagulants|mesh-ancestor
65525515|NCT01294605|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65525516|NCT01294761|Raltegravir Potassium|raltegravir potassium|mesh-list
65525517|NCT01294761|Darunavir|darunavir|mesh-list
65525518|NCT01294761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65525519|NCT01294761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65525520|NCT01294761|Antiviral Agents|antiviral agents|mesh-ancestor
65525521|NCT01294761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65525522|NCT01294761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65525523|NCT01294761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65525524|NCT01294761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525525|NCT01294761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525526|NCT01294761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65525527|NCT01294761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65525528|NCT01294761|Protease Inhibitors|protease inhibitors|mesh-ancestor
65525529|NCT03849183|Nitroglycerin|nitroglycerin|mesh-list
65525530|NCT03849183|Vasodilator Agents|vasodilator agents|mesh-ancestor
65525531|NCT03942224|Dexamethasone|dexamethasone|mesh-list
65525532|NCT03942224|Bortezomib|bortezomib|mesh-list
65525533|NCT03942224|Daratumumab|daratumumab|mesh-list
65525534|NCT03942224|Ixazomib|ixazomib|mesh-list
65525535|NCT03942224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65323022|NCT00716625|Sunitinib|sunitinib|mesh-list
65525536|NCT03942224|Antiemetics|antiemetics|mesh-ancestor
65525537|NCT03942224|Autonomic Agents|autonomic agents|mesh-ancestor
65525538|NCT03942224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65525540|NCT03942224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65525541|NCT03942224|Glucocorticoids|glucocorticoids|mesh-ancestor
65525542|NCT03942224|Hormones|hormones|mesh-ancestor
65525543|NCT03942224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65525544|NCT03942224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65525545|NCT03942224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525546|NCT03942224|Protease Inhibitors|protease inhibitors|mesh-ancestor
65525547|NCT03942224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525548|NCT03942224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525549|NCT03305666|Bupivacaine|bupivacaine|mesh-list
65525550|NCT03305666|Anesthetics, Local|anesthetics, local|mesh-ancestor
65525551|NCT03305666|Anesthetics|anesthetics|mesh-ancestor
65525552|NCT03305666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65525553|NCT03305666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525554|NCT03305666|Sensory System Agents|sensory system agents|mesh-ancestor
65525555|NCT03305666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65525556|NCT01194843|Ropivacaine|ropivacaine|mesh-list
65525557|NCT01194843|Anesthetics, Local|anesthetics, local|mesh-ancestor
65525558|NCT01194843|Anesthetics|anesthetics|mesh-ancestor
65525559|NCT01194843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65525560|NCT01194843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525561|NCT01194843|Sensory System Agents|sensory system agents|mesh-ancestor
65525562|NCT01194843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65525563|NCT01297023|Calcium, Dietary|calcium, dietary|mesh-list
65525564|NCT01297023|Vitamin D|vitamin d|mesh-list
65525565|NCT01297023|Ergocalciferols|ergocalciferols|mesh-list
65525566|NCT01297023|Cholecalciferol|cholecalciferol|mesh-list
65525567|NCT01297023|Vitamins|vitamins|mesh-list
65525568|NCT01297023|Calcium|calcium|mesh-list
65525569|NCT01297023|Micronutrients|micronutrients|mesh-ancestor
65525570|NCT01297023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525571|NCT01297023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65525572|NCT01297023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65525573|NCT03846843|Phenylacetic acid|phenylacetic acid|mesh-list
65525574|NCT03846843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65525575|NCT03846843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65525576|NCT03846843|Antimetabolites|antimetabolites|mesh-ancestor
65525577|NCT03846843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525578|NCT03846843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525579|NCT01297101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65525580|NCT01297101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525581|NCT01297101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65525582|NCT01297101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525583|NCT01297101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525584|NCT04781426|Tenofovir|tenofovir|mesh-list
65525585|NCT04781426|Lamivudine|lamivudine|mesh-list
65525586|NCT04781426|Antiviral Agents|antiviral agents|mesh-ancestor
65525587|NCT04781426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65525588|NCT04781426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65525589|NCT04781426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65525590|NCT04781426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525591|NCT04781426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525592|NCT04781426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65525593|NCT04781426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65525594|NCT01292031|Meropenem|meropenem|mesh-list
65525595|NCT01292031|Colistin|colistin|mesh-list
65525596|NCT01292031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65525597|NCT01292031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65525598|NCT04633226|Vaccines|vaccines|mesh-list
65525599|NCT04633226|Immunologic Factors|immunologic factors|mesh-ancestor
65525600|NCT04633226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525601|NCT03849027|Methoxyflurane|methoxyflurane|mesh-list
65525602|NCT03849027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65525603|NCT03849027|Anesthetics, General|anesthetics, general|mesh-ancestor
65525604|NCT03849027|Anesthetics|anesthetics|mesh-ancestor
65525605|NCT03849027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65525606|NCT03849027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525607|NCT01188759|Voriconazole|voriconazole|mesh-list
65525608|NCT01188759|Anidulafungin|anidulafungin|mesh-list
65525609|NCT01188759|Antifungal Agents|antifungal agents|mesh-ancestor
65525610|NCT01188759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65525611|NCT01188759|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65525612|NCT01188759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65525613|NCT01188759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525614|NCT01188759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525615|NCT01188759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65525617|NCT01188759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65525618|NCT01188759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525619|NCT01188759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65525620|NCT03904550|Rocuronium|rocuronium|mesh-list
65525621|NCT03904550|Cisatracurium|cisatracurium|mesh-list
65525622|NCT03904550|Neostigmine|neostigmine|mesh-list
65525623|NCT03904550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65525624|NCT03904550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65525625|NCT03904550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65525626|NCT03904550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65525627|NCT03904550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525628|NCT03904550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65525629|NCT03904550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525630|NCT03904550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525631|NCT03904550|Cholinergic Agents|cholinergic agents|mesh-ancestor
65525632|NCT03904550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65525633|NCT03904550|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65525634|NCT03904550|Autonomic Agents|autonomic agents|mesh-ancestor
65525635|NCT01295073|Trientine|trientine|mesh-list
65525636|NCT01295073|Chelating Agents|chelating agents|mesh-ancestor
65525637|NCT01295073|Sequestering Agents|sequestering agents|mesh-ancestor
65525638|NCT01295073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525639|NCT01292109|Picosulfate sodium|picosulfate sodium|mesh-list
65525640|NCT01292109|Cathartics|cathartics|mesh-ancestor
65525641|NCT01292109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65525642|NCT01191645|Remifentanil|remifentanil|mesh-list
65525643|NCT01191645|Metoclopramide|metoclopramide|mesh-list
65525644|NCT01191645|Naloxone|naloxone|mesh-list
65525645|NCT01191645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65525646|NCT01191645|Narcotics|narcotics|mesh-ancestor
65525647|NCT01191645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65525648|NCT01191645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525649|NCT01191645|Analgesics|analgesics|mesh-ancestor
65525650|NCT01191645|Sensory System Agents|sensory system agents|mesh-ancestor
65525651|NCT01191645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65525652|NCT01191645|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65525653|NCT01191645|Antiemetics|antiemetics|mesh-ancestor
65525654|NCT01191645|Autonomic Agents|autonomic agents|mesh-ancestor
65525655|NCT01191645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65525656|NCT01191645|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65525657|NCT01191645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65525658|NCT01191645|Dopamine Agents|dopamine agents|mesh-ancestor
65525659|NCT01191645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65525660|NCT01191645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525661|NCT03736785|Insulin|insulin|mesh-list
65525662|NCT03736785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65525663|NCT03736785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525664|NCT03734991|Ibrexafungerp|ibrexafungerp|mesh-list
65525665|NCT03734991|Antifungal Agents|antifungal agents|mesh-ancestor
65525666|NCT03734991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65525667|NCT01295151|Adalimumab|adalimumab|mesh-list
65525668|NCT01295151|Etanercept|etanercept|mesh-list
65525669|NCT01295151|Golimumab|golimumab|mesh-list
65525670|NCT01295151|Rituximab|rituximab|mesh-list
65525671|NCT01295151|Abatacept|abatacept|mesh-list
65525672|NCT01295151|Infliximab|infliximab|mesh-list
65525673|NCT01295151|Certolizumab Pegol|certolizumab pegol|mesh-list
65525674|NCT01295151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65525675|NCT01295151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525676|NCT01295151|Immunologic Factors|immunologic factors|mesh-ancestor
65525677|NCT01295151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525678|NCT01295151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65525679|NCT01295151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65525680|NCT01295151|Dermatologic Agents|dermatologic agents|mesh-ancestor
65525681|NCT01295151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65525682|NCT01295151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65525683|NCT01295151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65525684|NCT01295151|Analgesics|analgesics|mesh-ancestor
65525685|NCT01295151|Sensory System Agents|sensory system agents|mesh-ancestor
65525686|NCT01295151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65525687|NCT01295151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65525688|NCT01295151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65525689|NCT01295151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525690|NCT01295151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65525692|NCT01295307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65525693|NCT01295307|Antimetabolites|antimetabolites|mesh-ancestor
65525694|NCT01295307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525695|NCT01295307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525696|NCT01292343|Listerine|listerine|mesh-list
65525697|NCT01292343|Triclosan|triclosan|mesh-list
65525698|NCT01292343|Fluorides|fluorides|mesh-list
65525699|NCT01292343|Sodium Fluoride|sodium fluoride|mesh-list
65525700|NCT01292343|Cariostatic Agents|cariostatic agents|mesh-ancestor
65525701|NCT01292343|Protective Agents|protective agents|mesh-ancestor
65525702|NCT01292343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525703|NCT01292343|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65525704|NCT01292343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65525705|NCT01292343|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65525706|NCT01292343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65525707|NCT01292343|Antimetabolites|antimetabolites|mesh-ancestor
65525708|NCT01292343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525709|NCT01292343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65525710|NCT01192113|Vitamin B 12|vitamin b 12|mesh-list
65525711|NCT01192113|Vitamin B Complex|vitamin b complex|mesh-ancestor
65525712|NCT01192113|Vitamins|vitamins|mesh-ancestor
65525713|NCT01192113|Micronutrients|micronutrients|mesh-ancestor
65525714|NCT01192113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525715|NCT05671029|Moxifloxacin|moxifloxacin|mesh-list
65525716|NCT05671029|Pritelivir|pritelivir|mesh-list
65525717|NCT05671029|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65525718|NCT05671029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65525719|NCT05671029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65525720|NCT05671029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65525721|NCT05671029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65525722|NCT05671029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525723|NCT05671029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525724|NCT05671029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525725|NCT05671029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65525726|NCT05671029|Contraceptive Agents|contraceptive agents|mesh-ancestor
65525727|NCT05671029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65525728|NCT05671029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525729|NCT05671029|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65525730|NCT05671029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65525731|NCT05671029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65525732|NCT05671029|Antiviral Agents|antiviral agents|mesh-ancestor
65525733|NCT03303092|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65525734|NCT03303092|Immunologic Factors|immunologic factors|mesh-ancestor
65525735|NCT03303092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525736|NCT03851679|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65525737|NCT03851679|Natriuretic Agents|natriuretic agents|mesh-ancestor
65525738|NCT03851679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525739|NCT01192503|Rasagiline|rasagiline|mesh-list
65525740|NCT01192503|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65525741|NCT01192503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525742|NCT01192503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525743|NCT01192503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65525744|NCT01192503|Protective Agents|protective agents|mesh-ancestor
65525745|NCT01192503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525746|NCT01192581|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65525747|NCT01192581|Plasma Substitutes|plasma substitutes|mesh-ancestor
65525748|NCT01192581|Blood Substitutes|blood substitutes|mesh-ancestor
65525749|NCT03851289|Calcium|calcium|mesh-list
65525750|NCT03851289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65525751|NCT03851289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525752|NCT03733899|Anesthetics|anesthetics|mesh-list
65525753|NCT03733899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65525754|NCT03733899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525755|NCT01196013|Clofarabine|clofarabine|mesh-list
65525756|NCT01196013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65525757|NCT01196013|Antimetabolites|antimetabolites|mesh-ancestor
65525758|NCT01196013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525759|NCT01196013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525760|NCT01196169|Vancomycin|vancomycin|mesh-list
65525761|NCT01196169|Daptomycin|daptomycin|mesh-list
65525762|NCT01196169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65525763|NCT01196169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65525764|NCT01196481|Carvedilol|carvedilol|mesh-list
65525765|NCT01196481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65525766|NCT01196481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65525767|NCT01196481|Adrenergic Agents|adrenergic agents|mesh-ancestor
65525768|NCT01196481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65525769|NCT01196481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525770|NCT01196481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525771|NCT01196481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65525772|NCT01196481|Antioxidants|antioxidants|mesh-ancestor
65525773|NCT01196481|Protective Agents|protective agents|mesh-ancestor
65525774|NCT01196481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65525775|NCT01196481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65525776|NCT01196481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65525777|NCT01196481|Vasodilator Agents|vasodilator agents|mesh-ancestor
65525778|NCT01196481|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65525779|NCT01196481|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65525780|NCT05283057|Empagliflozin|empagliflozin|mesh-list
65525781|NCT05283057|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65525782|NCT05283057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525783|NCT05283057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65525784|NCT05283057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525785|NCT01193595|Bevacizumab|bevacizumab|mesh-list
65525786|NCT01193595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65525787|NCT01193595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525788|NCT01193595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65525789|NCT01193595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65525790|NCT01193595|Growth Substances|growth substances|mesh-ancestor
65525791|NCT01193595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525792|NCT01193595|Growth Inhibitors|growth inhibitors|mesh-ancestor
65525793|NCT01196559|Gemcitabine|gemcitabine|mesh-list
65525794|NCT01196559|Vinorelbine|vinorelbine|mesh-list
65525795|NCT01196559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65525796|NCT01196559|Antimetabolites|antimetabolites|mesh-ancestor
65525797|NCT01196559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525798|NCT01196559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525799|NCT01196559|Antiviral Agents|antiviral agents|mesh-ancestor
65525800|NCT01196559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65525801|NCT01196559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525802|NCT01196559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65525803|NCT01196559|Immunologic Factors|immunologic factors|mesh-ancestor
65525804|NCT01196559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525805|NCT01196559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65525806|NCT01196559|Tubulin Modulators|tubulin modulators|mesh-ancestor
65525807|NCT01196559|Antimitotic Agents|antimitotic agents|mesh-ancestor
65525808|NCT01196559|Mitosis Modulators|mitosis modulators|mesh-ancestor
65525809|NCT01295775|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
65525810|NCT01295775|Anticoagulants|anticoagulants|mesh-ancestor
65525811|NCT01295775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65525812|NCT01295775|Antimetabolites|antimetabolites|mesh-ancestor
65525813|NCT01295775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525814|NCT01295775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65525815|NCT01295775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65525816|NCT01295775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65525817|NCT01295775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65525818|NCT01295775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525819|NCT01581177|Albuterol|albuterol|mesh-list
65525820|NCT01581177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65525821|NCT01581177|Autonomic Agents|autonomic agents|mesh-ancestor
65525822|NCT01581177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65525823|NCT01581177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525824|NCT01581177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65525825|NCT01581177|Respiratory System Agents|respiratory system agents|mesh-ancestor
65525826|NCT01581177|Tocolytic Agents|tocolytic agents|mesh-ancestor
65525827|NCT01581177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65525828|NCT01581177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65525829|NCT01581177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65525830|NCT01581177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65525831|NCT01581177|Adrenergic Agents|adrenergic agents|mesh-ancestor
65525832|NCT01581177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65525833|NCT01581177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525834|NCT01580007|Cholecalciferol|cholecalciferol|mesh-list
65525835|NCT01580007|Vitamin D|vitamin d|mesh-list
65525836|NCT01580007|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
65525837|NCT01580007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65525838|NCT01580007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525839|NCT01580007|Vitamins|vitamins|mesh-ancestor
65525840|NCT01580007|Micronutrients|micronutrients|mesh-ancestor
65525841|NCT01580007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65525842|NCT01580007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525843|NCT01189695|Ritonavir|ritonavir|mesh-list
65525844|NCT01189695|Lopinavir|lopinavir|mesh-list
65525845|NCT01189695|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65525846|NCT01189695|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65525847|NCT01189695|Protease Inhibitors|protease inhibitors|mesh-ancestor
65525848|NCT01189695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525849|NCT01189695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525850|NCT01189695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65525851|NCT01189695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65525852|NCT01189695|Antiviral Agents|antiviral agents|mesh-ancestor
65525853|NCT01189695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65525854|NCT01189695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65525855|NCT01189695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65525856|NCT01196715|Darbepoetin alfa|darbepoetin alfa|mesh-list
65525857|NCT01196715|Hematinics|hematinics|mesh-ancestor
65525858|NCT03848091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65525859|NCT03848091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65525860|NCT01189773|Ibuprofen|ibuprofen|mesh-list
65525861|NCT01189773|Codeine|codeine|mesh-list
65525862|NCT01189773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65525863|NCT01189773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65525864|NCT01189773|Analgesics|analgesics|mesh-ancestor
65525865|NCT01189773|Sensory System Agents|sensory system agents|mesh-ancestor
65525866|NCT01189773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65525867|NCT01189773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525868|NCT01189773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65525869|NCT01189773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65525870|NCT01189773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65525871|NCT01189773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525872|NCT01189773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525873|NCT01189773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65525874|NCT01189773|Narcotics|narcotics|mesh-ancestor
65525875|NCT01189773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65525876|NCT01189773|Antitussive Agents|antitussive agents|mesh-ancestor
65525877|NCT01189773|Respiratory System Agents|respiratory system agents|mesh-ancestor
65525878|NCT01189929|Gemcitabine|gemcitabine|mesh-list
65525879|NCT01189929|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65525880|NCT01189929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65525881|NCT01189929|Antimetabolites|antimetabolites|mesh-ancestor
65525882|NCT01189929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525883|NCT01189929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525884|NCT01189929|Antiviral Agents|antiviral agents|mesh-ancestor
65525885|NCT01189929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65525886|NCT01189929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525887|NCT01189929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65525888|NCT01189929|Immunologic Factors|immunologic factors|mesh-ancestor
65525889|NCT01189929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525890|NCT03845673|Psyllium|psyllium|mesh-list
65525891|NCT03845673|Cathartics|cathartics|mesh-ancestor
65525892|NCT03845673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65525893|NCT01190163|Oxytocin|oxytocin|mesh-list
65525894|NCT01190163|Dinoprostone|dinoprostone|mesh-list
65525895|NCT01190163|Oxytocics|oxytocics|mesh-ancestor
65525896|NCT01190163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65525897|NCT01190163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525898|NCT01199445|Vitamin A|vitamin a|mesh-list
65525899|NCT01199445|Vitamins|vitamins|mesh-ancestor
65525900|NCT01199445|Micronutrients|micronutrients|mesh-ancestor
65525901|NCT01199445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525902|NCT01199523|Moxifloxacin|moxifloxacin|mesh-list
65525903|NCT01199523|Mirabegron|mirabegron|mesh-list
65525904|NCT01199523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65525905|NCT01199523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65525906|NCT01199523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65525907|NCT01199523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65525908|NCT01199523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525909|NCT01199523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525910|NCT01199523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525911|NCT01199523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254925|NCT02696928|Primaquine|primaquine|mesh-list
65525912|NCT01199523|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65525913|NCT01199523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65525914|NCT01199523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65525915|NCT01199523|Adrenergic Agents|adrenergic agents|mesh-ancestor
65525916|NCT01199523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65525917|NCT01199523|Urological Agents|urological agents|mesh-ancestor
65525918|NCT01190241|Everolimus|everolimus|mesh-list
65525919|NCT01190241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65525920|NCT01190241|Sorafenib|sorafenib|mesh-list
65525921|NCT01190241|Sunitinib|sunitinib|mesh-list
65525922|NCT01190241|Lapatinib|lapatinib|mesh-list
65525923|NCT01190241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525924|NCT01190241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65525925|NCT01190241|Immunologic Factors|immunologic factors|mesh-ancestor
65525926|NCT01190241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525927|NCT01190241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65525928|NCT01190241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525929|NCT01190241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525930|NCT01190241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65525931|NCT01190241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65525932|NCT01190241|Growth Substances|growth substances|mesh-ancestor
65525933|NCT01190241|Growth Inhibitors|growth inhibitors|mesh-ancestor
65525934|NCT01197261|Oxycodone|oxycodone|mesh-list
65525935|NCT01197261|Naloxone|naloxone|mesh-list
65525936|NCT01197261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65525937|NCT01197261|Narcotics|narcotics|mesh-ancestor
65525938|NCT01197261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65525939|NCT01197261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525940|NCT01197261|Analgesics|analgesics|mesh-ancestor
65525941|NCT01197261|Sensory System Agents|sensory system agents|mesh-ancestor
65525942|NCT01197261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65525943|NCT01197261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65525944|NCT01190553|Amantadine|amantadine|mesh-list
65525945|NCT01190553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65525946|NCT01190553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65525947|NCT01190553|Antiviral Agents|antiviral agents|mesh-ancestor
65525948|NCT01190553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65525949|NCT01190553|Dopamine Agents|dopamine agents|mesh-ancestor
65525950|NCT01190553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65525951|NCT01190553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525952|NCT01190553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525953|NCT01190553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65525954|NCT01190553|Analgesics|analgesics|mesh-ancestor
65525955|NCT01190553|Sensory System Agents|sensory system agents|mesh-ancestor
65525956|NCT01190553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65525957|NCT01199757|Fluticasone|fluticasone|mesh-list
65525958|NCT01199757|Xhance|xhance|mesh-list
65525959|NCT01199757|Mometasone Furoate|mometasone furoate|mesh-list
65525960|NCT01199757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65525961|NCT01199757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65525962|NCT01199757|Autonomic Agents|autonomic agents|mesh-ancestor
65525963|NCT01199757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65525964|NCT01199757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525965|NCT01199757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65525966|NCT01199757|Respiratory System Agents|respiratory system agents|mesh-ancestor
65525967|NCT01199757|Dermatologic Agents|dermatologic agents|mesh-ancestor
65525968|NCT01199757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65525969|NCT03302234|Pembrolizumab|pembrolizumab|mesh-list
65525970|NCT03302234|Ipilimumab|ipilimumab|mesh-list
65525971|NCT03302234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65525972|NCT03302234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65525973|NCT03302234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65525974|NCT03302234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525975|NCT03843879|Lidocaine|lidocaine|mesh-list
65525976|NCT03843879|Anesthetics, Local|anesthetics, local|mesh-ancestor
65525977|NCT03843879|Anesthetics|anesthetics|mesh-ancestor
65525978|NCT03843879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65525979|NCT03843879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525980|NCT03843879|Sensory System Agents|sensory system agents|mesh-ancestor
65525981|NCT03843879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65525982|NCT03843879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65525983|NCT03843879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65525984|NCT03843879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65525985|NCT03843879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65525986|NCT03843879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65525987|NCT03850587|Celecoxib|celecoxib|mesh-list
65525988|NCT03850587|Tramadol|tramadol|mesh-list
65525989|NCT03850587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65525990|NCT03850587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65323474|NCT00775190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65525991|NCT03850587|Analgesics|analgesics|mesh-ancestor
65525992|NCT03850587|Sensory System Agents|sensory system agents|mesh-ancestor
65525993|NCT03850587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65525994|NCT03850587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65525995|NCT03850587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65525996|NCT03850587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65525997|NCT03850587|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65525998|NCT03850587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65525999|NCT03850587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526000|NCT03850587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526001|NCT03850587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65526002|NCT03850587|Narcotics|narcotics|mesh-ancestor
65526003|NCT03850587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65526004|NCT01199835|Calcium|calcium|mesh-list
65526005|NCT01199835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65526006|NCT01199835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526007|NCT05671497|Antirheumatic Agents|antirheumatic agents|mesh-list
65526008|NCT05671497|Cilostazol|cilostazol|mesh-list
65526009|NCT05671497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65526010|NCT05671497|Autonomic Agents|autonomic agents|mesh-ancestor
65526011|NCT05671497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65526012|NCT05671497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526013|NCT05671497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65526014|NCT05671497|Respiratory System Agents|respiratory system agents|mesh-ancestor
65526015|NCT05671497|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65526016|NCT05671497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65526017|NCT05671497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526018|NCT05671497|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65526019|NCT05671497|Vasodilator Agents|vasodilator agents|mesh-ancestor
65526020|NCT05671497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65526021|NCT05671497|Protective Agents|protective agents|mesh-ancestor
65526022|NCT05671497|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65526023|NCT05671497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65526024|NCT05671497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526025|NCT03915626|Rivastigmine|rivastigmine|mesh-list
65526026|NCT03915626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65526027|NCT03915626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526028|NCT03915626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526029|NCT03915626|Cholinergic Agents|cholinergic agents|mesh-ancestor
65526030|NCT03915626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65526031|NCT03915626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526032|NCT03915626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65526033|NCT03915626|Protective Agents|protective agents|mesh-ancestor
65526034|NCT04491968|Methadone|methadone|mesh-list
65526035|NCT04491968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65526036|NCT04491968|Narcotics|narcotics|mesh-ancestor
65526037|NCT04491968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65526038|NCT04491968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526039|NCT04491968|Analgesics|analgesics|mesh-ancestor
65526040|NCT04491968|Sensory System Agents|sensory system agents|mesh-ancestor
65526041|NCT04491968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65526042|NCT04491968|Antitussive Agents|antitussive agents|mesh-ancestor
65526043|NCT04491968|Respiratory System Agents|respiratory system agents|mesh-ancestor
65526044|NCT05668455|Dexamethasone|dexamethasone|mesh-list
65526045|NCT05668455|Hydrocortisone|hydrocortisone|mesh-list
65526046|NCT05668455|Povidone|povidone|mesh-list
65526047|NCT05668455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65526048|NCT05668455|Antiemetics|antiemetics|mesh-ancestor
65526049|NCT05668455|Autonomic Agents|autonomic agents|mesh-ancestor
65526050|NCT05668455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65526051|NCT05668455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526052|NCT05668455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65526053|NCT05668455|Glucocorticoids|glucocorticoids|mesh-ancestor
65526054|NCT05668455|Hormones|hormones|mesh-ancestor
65526055|NCT05668455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65526056|NCT05668455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65526057|NCT05668455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526058|NCT05668455|Plasma Substitutes|plasma substitutes|mesh-ancestor
65526059|NCT05668455|Blood Substitutes|blood substitutes|mesh-ancestor
65526060|NCT03313076|Vitamin D|vitamin d|mesh-list
65526061|NCT03313076|Ergocalciferols|ergocalciferols|mesh-list
65526062|NCT03313076|Cholecalciferol|cholecalciferol|mesh-list
65526063|NCT03313076|Vitamins|vitamins|mesh-list
65526064|NCT03313076|Micronutrients|micronutrients|mesh-ancestor
65526065|NCT03313076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526066|NCT03313076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65526067|NCT03313076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65526068|NCT01191021|Propofol|propofol|mesh-list
65526069|NCT01191021|Anesthetics|anesthetics|mesh-ancestor
65526070|NCT01191021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65526071|NCT01191021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526072|NCT01191021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65526073|NCT01191021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65526074|NCT01191021|Anesthetics, General|anesthetics, general|mesh-ancestor
65526075|NCT01200537|Norinyl|norinyl|mesh-list
65526076|NCT01200537|Contraceptive Agents|contraceptive agents|mesh-list
65526077|NCT01200537|Contraceptives, Oral|contraceptives, oral|mesh-list
65526078|NCT01200537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65526079|NCT01200537|Estradiol|estradiol|mesh-list
65526080|NCT01200537|Estrogens|estrogens|mesh-ancestor
65526081|NCT01200537|Hormones|hormones|mesh-ancestor
65526082|NCT01200537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65526083|NCT01200537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526084|NCT01200537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65526085|NCT01200537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65526086|NCT01200537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65526087|NCT01200537|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65526088|NCT01198353|Ziprasidone|ziprasidone|mesh-list
65526089|NCT01198353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65526090|NCT01198353|Serotonin Agents|serotonin agents|mesh-ancestor
65526091|NCT01198353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65526092|NCT01198353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526093|NCT01198353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526094|NCT01198353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65526095|NCT01198353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65526096|NCT01198353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65526097|NCT01198353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65526098|NCT01198353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65526099|NCT01198353|Dopamine Agents|dopamine agents|mesh-ancestor
65526100|NCT01200693|Sirolimus|sirolimus|mesh-list
65526101|NCT01200693|Everolimus|everolimus|mesh-list
65526102|NCT01200693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526103|NCT01200693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65526104|NCT01200693|Immunologic Factors|immunologic factors|mesh-ancestor
65526105|NCT01200693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526106|NCT01200693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65526107|NCT01200693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65526108|NCT01200693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65526109|NCT01200693|Antifungal Agents|antifungal agents|mesh-ancestor
65526110|NCT03844581|Propiverine|propiverine|mesh-list
65526111|NCT03844581|Parasympatholytics|parasympatholytics|mesh-ancestor
65526112|NCT03844581|Autonomic Agents|autonomic agents|mesh-ancestor
65526113|NCT03844581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65526114|NCT03844581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526115|NCT03844581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65526116|NCT03844581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65526117|NCT03844581|Cholinergic Agents|cholinergic agents|mesh-ancestor
65526118|NCT03844581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65526119|NCT03844581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526120|NCT03844581|Urological Agents|urological agents|mesh-ancestor
65526121|NCT01202097|Fluticasone|fluticasone|mesh-list
65526122|NCT01202097|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65526123|NCT01202097|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65526124|NCT01202097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65526125|NCT01202097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65526126|NCT01202097|Autonomic Agents|autonomic agents|mesh-ancestor
65526127|NCT01202097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65526128|NCT01202097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526129|NCT01202097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65526130|NCT01202097|Respiratory System Agents|respiratory system agents|mesh-ancestor
65526131|NCT01202097|Dermatologic Agents|dermatologic agents|mesh-ancestor
65526132|NCT01202097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65526133|NCT01202097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65526134|NCT01202097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65526135|NCT01202097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65526136|NCT01202097|Adrenergic Agents|adrenergic agents|mesh-ancestor
65526137|NCT01202097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65526138|NCT01202097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526139|NCT01202097|Glucocorticoids|glucocorticoids|mesh-ancestor
65526140|NCT01202097|Hormones|hormones|mesh-ancestor
65526141|NCT01202097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65526142|NCT01202097|Sympathomimetics|sympathomimetics|mesh-ancestor
65526143|NCT05670015|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65526144|NCT05670015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65526145|NCT01201005|Hydroxocobalamin|hydroxocobalamin|mesh-list
65526146|NCT01201005|Vitamin B 12|vitamin b 12|mesh-list
65526147|NCT01201005|Hematinics|hematinics|mesh-ancestor
65526148|NCT01201005|Vitamin B Complex|vitamin b complex|mesh-ancestor
65526149|NCT01201005|Vitamins|vitamins|mesh-ancestor
65526150|NCT01201005|Micronutrients|micronutrients|mesh-ancestor
65526151|NCT01201005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526152|NCT01198665|Prednisolone|prednisolone|mesh-list
65526153|NCT01198665|Doxorubicin|doxorubicin|mesh-list
65526154|NCT01198665|Vincristine|vincristine|mesh-list
65526155|NCT01198665|Everolimus|everolimus|mesh-list
65526156|NCT01198665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65526157|NCT01198665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526158|NCT01198665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65526159|NCT01198665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65526160|NCT01198665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526161|NCT01198665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526162|NCT01198665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65526163|NCT01198665|Tubulin Modulators|tubulin modulators|mesh-ancestor
65526164|NCT01198665|Antimitotic Agents|antimitotic agents|mesh-ancestor
65526165|NCT01198665|Mitosis Modulators|mitosis modulators|mesh-ancestor
65526166|NCT01198665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65526167|NCT01198665|Immunologic Factors|immunologic factors|mesh-ancestor
65526168|NCT01198665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526169|NCT01198665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65526170|NCT01198665|Glucocorticoids|glucocorticoids|mesh-ancestor
65526171|NCT01198665|Hormones|hormones|mesh-ancestor
65526172|NCT01198665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65526173|NCT01198665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65526174|NCT05046795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65526175|NCT05030415|Ixekizumab|ixekizumab|mesh-list
65526176|NCT05030415|Dermatologic Agents|dermatologic agents|mesh-ancestor
65526177|NCT01198821|Gemcitabine|gemcitabine|mesh-list
65526178|NCT01198821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65526179|NCT01198821|Antimetabolites|antimetabolites|mesh-ancestor
65526180|NCT01198821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526181|NCT01198821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526182|NCT01198821|Antiviral Agents|antiviral agents|mesh-ancestor
65526183|NCT01198821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65526184|NCT01198821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526185|NCT01198821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65526186|NCT01198821|Immunologic Factors|immunologic factors|mesh-ancestor
65526187|NCT01198821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526188|NCT05013801|Hydroquinone|hydroquinone|mesh-list
65526189|NCT05013801|Antioxidants|antioxidants|mesh-ancestor
65526190|NCT05013801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526191|NCT05013801|Protective Agents|protective agents|mesh-ancestor
65526192|NCT05013801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526193|NCT05013801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65526194|NCT01566669|Parecoxib|parecoxib|mesh-list
65526195|NCT01566669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65526196|NCT01566669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65526197|NCT01566669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526198|NCT01566669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526199|NCT01566669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65526200|NCT01566669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65526201|NCT01566669|Analgesics|analgesics|mesh-ancestor
65526202|NCT01566669|Sensory System Agents|sensory system agents|mesh-ancestor
65526203|NCT01566669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65526204|NCT01566669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526205|NCT01566669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65526206|NCT01566669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65526207|NCT03841773|Cyclobenzaprine|cyclobenzaprine|mesh-list
65526208|NCT03841773|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65526209|NCT03841773|Antidepressive Agents|antidepressive agents|mesh-ancestor
65526210|NCT03841773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65526211|NCT03841773|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65526212|NCT03841773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526213|NCT03841773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65526214|NCT03841773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65526215|NCT03841773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65526216|NCT03841773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65526217|NCT01201161|Ranibizumab|ranibizumab|mesh-list
65526218|NCT01201161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65526219|NCT01201161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65526220|NCT01201161|Growth Substances|growth substances|mesh-ancestor
65526221|NCT01201161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526222|NCT01201161|Growth Inhibitors|growth inhibitors|mesh-ancestor
65526223|NCT01201161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526224|NCT03841383|Dipyridamole|dipyridamole|mesh-list
65526225|NCT03841383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65526226|NCT03841383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526227|NCT03841383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526228|NCT03841383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65526229|NCT03841383|Vasodilator Agents|vasodilator agents|mesh-ancestor
65526230|NCT03841305|Liver Extracts|liver extracts|mesh-list
65526231|NCT03841305|Hematinics|hematinics|mesh-ancestor
65526232|NCT05667987|Lidocaine|lidocaine|mesh-list
65526233|NCT05667987|Anesthetics, Local|anesthetics, local|mesh-ancestor
65526234|NCT05667987|Anesthetics|anesthetics|mesh-ancestor
65526235|NCT05667987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65526236|NCT05667987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526237|NCT05667987|Sensory System Agents|sensory system agents|mesh-ancestor
65526238|NCT05667987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65526239|NCT05667987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65526240|NCT05667987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65526241|NCT05667987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65526242|NCT05667987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65526243|NCT05667987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526244|NCT01201239|Raltegravir Potassium|raltegravir potassium|mesh-list
65526245|NCT01201239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65526246|NCT01201239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65526247|NCT01201239|Antiviral Agents|antiviral agents|mesh-ancestor
65526248|NCT01201239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65526249|NCT01201239|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65526250|NCT01201239|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65526251|NCT01201239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526252|NCT01201239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526253|NCT01199367|Letrozole|letrozole|mesh-list
65526254|NCT01199367|Lapatinib|lapatinib|mesh-list
65526255|NCT01199367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526256|NCT01199367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65526257|NCT01199367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65526258|NCT01199367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526259|NCT01199367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526260|NCT01199367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65526261|NCT01199367|Hormone Antagonists|hormone antagonists|mesh-ancestor
65526262|NCT01199367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65526263|NCT01199367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526264|NCT01199367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65526265|NCT03090165|Bicalutamide|bicalutamide|mesh-list
65526266|NCT03090165|Androgen Antagonists|androgen antagonists|mesh-ancestor
65526267|NCT03090165|Hormone Antagonists|hormone antagonists|mesh-ancestor
65526268|NCT03090165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65526269|NCT03090165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526270|NCT03090165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526271|NCT01203735|Valproic Acid|valproic acid|mesh-list
65526272|NCT01203735|Anticonvulsants|anticonvulsants|mesh-ancestor
65526273|NCT01203735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526274|NCT01203735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526275|NCT01203735|GABA Agents|gaba agents|mesh-ancestor
65526276|NCT01203735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65526277|NCT01203735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526278|NCT01203735|Antimanic Agents|antimanic agents|mesh-ancestor
65526279|NCT01203735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65526280|NCT01203735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65526281|NCT01203735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65526282|NCT03842631|Timolol|timolol|mesh-list
65526283|NCT03842631|Maleic acid|maleic acid|mesh-list
65526284|NCT03842631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526285|NCT03842631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526286|NCT03842631|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65526287|NCT03842631|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65526288|NCT03842631|Adrenergic Agents|adrenergic agents|mesh-ancestor
65526289|NCT03842631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65526290|NCT03842631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526291|NCT03842631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65526292|NCT03842631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65526294|NCT05669781|Antiemetics|antiemetics|mesh-ancestor
65526295|NCT05669781|Autonomic Agents|autonomic agents|mesh-ancestor
65526296|NCT05669781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65526297|NCT05669781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526298|NCT05669781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65526299|NCT05669781|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65526300|NCT05669781|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65526301|NCT05669781|Dopamine Agents|dopamine agents|mesh-ancestor
65526302|NCT05669781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65526303|NCT05669781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526304|NCT01202331|Azithromycin|azithromycin|mesh-list
65526305|NCT01202331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65526306|NCT01202331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65526307|NCT01201551|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65526308|NCT01201551|Latanoprost|latanoprost|mesh-list
65526309|NCT01201551|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65526310|NCT01201551|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65526311|NCT01201551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65526312|NCT01201551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65526313|NCT01201551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65526314|NCT01201551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65526315|NCT01201551|Adrenergic Agents|adrenergic agents|mesh-ancestor
65526316|NCT01201551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65526317|NCT01201551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526318|NCT01201551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526319|NCT01204125|Paclitaxel|paclitaxel|mesh-list
65526320|NCT01204125|Iniparib|iniparib|mesh-list
65526321|NCT01204125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65526322|NCT01204125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526323|NCT01204125|Tubulin Modulators|tubulin modulators|mesh-ancestor
65526324|NCT01204125|Antimitotic Agents|antimitotic agents|mesh-ancestor
65526325|NCT01204125|Mitosis Modulators|mitosis modulators|mesh-ancestor
65526326|NCT01204125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526327|NCT01204125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65526328|NCT01204125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526329|NCT03074240|Anesthetics|anesthetics|mesh-list
65526330|NCT03074240|Anesthetics, General|anesthetics, general|mesh-list
65526331|NCT03074240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65526332|NCT03074240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526333|NCT03725085|Guaifenesin|guaifenesin|mesh-list
65526334|NCT03725085|Expectorants|expectorants|mesh-ancestor
65526335|NCT03725085|Respiratory System Agents|respiratory system agents|mesh-ancestor
65526336|NCT03755804|Prednisone|prednisone|mesh-list
65526337|NCT03755804|Prednisolone|prednisolone|mesh-list
65526338|NCT03755804|Cyclophosphamide|cyclophosphamide|mesh-list
65526339|NCT03755804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65526340|NCT03755804|Dacarbazine|dacarbazine|mesh-list
65526341|NCT03755804|Doxorubicin|doxorubicin|mesh-list
65526342|NCT03755804|Etoposide|etoposide|mesh-list
65526343|NCT03755804|Vincristine|vincristine|mesh-list
65526344|NCT03755804|Bleomycin|bleomycin|mesh-list
65526345|NCT03755804|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65526346|NCT03755804|Vinblastine|vinblastine|mesh-list
65526347|NCT03755804|Imidazole|imidazole|mesh-list
65526348|NCT03755804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65526349|NCT03755804|Immunologic Factors|immunologic factors|mesh-ancestor
65526350|NCT03755804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526351|NCT03755804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65526352|NCT03755804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65526353|NCT03755804|Alkylating Agents|alkylating agents|mesh-ancestor
65526354|NCT03755804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526355|NCT03755804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526356|NCT03755804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65526357|NCT03755804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65526358|NCT03755804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65526359|NCT03755804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65526360|NCT03755804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526361|NCT03755804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65526362|NCT03755804|Glucocorticoids|glucocorticoids|mesh-ancestor
65526363|NCT03755804|Hormones|hormones|mesh-ancestor
65526364|NCT03755804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65526365|NCT03755804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65526366|NCT03755804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65323856|NCT04082559|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65526367|NCT03755804|Tubulin Modulators|tubulin modulators|mesh-ancestor
65526368|NCT03755804|Antimitotic Agents|antimitotic agents|mesh-ancestor
65526369|NCT03755804|Mitosis Modulators|mitosis modulators|mesh-ancestor
65526370|NCT03755804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65526371|NCT01566825|Amitriptyline|amitriptyline|mesh-list
65526372|NCT01566825|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65526373|NCT01566825|Antidepressive Agents|antidepressive agents|mesh-ancestor
65526374|NCT01566825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65526375|NCT01566825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65526376|NCT01566825|Analgesics|analgesics|mesh-ancestor
65526377|NCT01566825|Sensory System Agents|sensory system agents|mesh-ancestor
65526378|NCT01566825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65526379|NCT01566825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526380|NCT01566825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65526381|NCT01566825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65526382|NCT01566825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65526383|NCT01566825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526384|NCT01566825|Adrenergic Agents|adrenergic agents|mesh-ancestor
65526385|NCT01566825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65526386|NCT03559010|Norgestrel|norgestrel|mesh-list
65526387|NCT03559010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65526388|NCT03559010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65526389|NCT03559010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65526390|NCT03559010|Contraceptive Agents|contraceptive agents|mesh-ancestor
65526391|NCT03559010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65526392|NCT03559010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526393|NCT03559010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65526394|NCT03559010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65526395|NCT03298412|Blinatumomab|blinatumomab|mesh-list
65526396|NCT03298412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526397|NCT03297398|Ascorbic Acid|ascorbic acid|mesh-list
65526398|NCT03297398|Methyltestosterone|methyltestosterone|mesh-list
65526399|NCT03297398|Androgens|androgens|mesh-list
65526400|NCT03297398|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65526401|NCT03297398|Hormones|hormones|mesh-ancestor
65526402|NCT03297398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65526403|NCT03297398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526404|NCT03297398|Antioxidants|antioxidants|mesh-ancestor
65526405|NCT03297398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526406|NCT03297398|Protective Agents|protective agents|mesh-ancestor
65526407|NCT03297398|Vitamins|vitamins|mesh-ancestor
65526408|NCT03297398|Micronutrients|micronutrients|mesh-ancestor
65526409|NCT03297398|Estrogens|estrogens|mesh-ancestor
65526410|NCT03297398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65526411|NCT03297398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526412|NCT03297398|Anabolic Agents|anabolic agents|mesh-ancestor
65526413|NCT03293654|Bevacizumab|bevacizumab|mesh-list
65526414|NCT03293654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65526415|NCT03293654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526416|NCT03293654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65526417|NCT03293654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65526418|NCT03293654|Growth Substances|growth substances|mesh-ancestor
65526419|NCT03293654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526420|NCT03293654|Growth Inhibitors|growth inhibitors|mesh-ancestor
65526421|NCT03930615|Letermovir|letermovir|mesh-list
65526422|NCT03930615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65526423|NCT03930615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526424|NCT03930615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526425|NCT03930615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526426|NCT03930615|Antiviral Agents|antiviral agents|mesh-ancestor
65526427|NCT03930615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65526428|NCT03838029|Etodolac|etodolac|mesh-list
65526429|NCT03838029|Propranolol|propranolol|mesh-list
65526430|NCT03838029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65526431|NCT03838029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65526432|NCT03838029|Adrenergic Agents|adrenergic agents|mesh-ancestor
65526433|NCT03838029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65526434|NCT03838029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526435|NCT03838029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526436|NCT03838029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65526437|NCT03838029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65526438|NCT03838029|Vasodilator Agents|vasodilator agents|mesh-ancestor
65526439|NCT03838029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65526440|NCT03838029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65323941|NCT04923867|Estradiol|estradiol|mesh-list
65526441|NCT03838029|Analgesics|analgesics|mesh-ancestor
65526442|NCT03838029|Sensory System Agents|sensory system agents|mesh-ancestor
65526443|NCT03838029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65526444|NCT03838029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65526445|NCT03838029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65526446|NCT03838029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65526447|NCT03838029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65526448|NCT03838029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526449|NCT04708340|Ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combination|ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium d-pantothenate drug combination|mesh-list
65526450|NCT04708340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65526451|NCT04708340|Antioxidants|antioxidants|mesh-ancestor
65526452|NCT04708340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526453|NCT04708340|Protective Agents|protective agents|mesh-ancestor
65526454|NCT04708340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526455|NCT03292640|Nicotinic Acids|nicotinic acids|mesh-list
65526456|NCT03292640|Tazarotene|tazarotene|mesh-list
65526457|NCT03292640|Dermatologic Agents|dermatologic agents|mesh-ancestor
65526458|NCT03292640|Keratolytic Agents|keratolytic agents|mesh-ancestor
65526459|NCT03292640|Vitamin B Complex|vitamin b complex|mesh-ancestor
65526460|NCT03292640|Vitamins|vitamins|mesh-ancestor
65526461|NCT03292640|Micronutrients|micronutrients|mesh-ancestor
65526462|NCT03292640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526463|NCT01567215|Ethanol|ethanol|mesh-list
65526464|NCT01567215|Silver Nitrate|silver nitrate|mesh-list
65526465|NCT01567215|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65526466|NCT01567215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65526467|NCT01567215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65526468|NCT01567215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526469|NCT02871141|Antidepressive Agents|antidepressive agents|mesh-list
65526470|NCT02871141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65526471|NCT02722941|Panobinostat|panobinostat|mesh-list
65526472|NCT02722941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526473|NCT02722941|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65526474|NCT02722941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526475|NCT02722941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526476|NCT01202487|Lidocaine|lidocaine|mesh-list
65526477|NCT01202487|Epinephrine|epinephrine|mesh-list
65526478|NCT01202487|Tetracaine|tetracaine|mesh-list
65526479|NCT01202487|Anesthetics, Local|anesthetics, local|mesh-ancestor
65526480|NCT01202487|Anesthetics|anesthetics|mesh-ancestor
65526481|NCT01202487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65526482|NCT01202487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526483|NCT01202487|Sensory System Agents|sensory system agents|mesh-ancestor
65526484|NCT01202487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65526485|NCT01202487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65526486|NCT01202487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65526487|NCT01202487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65526488|NCT01202487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65526489|NCT01202487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526490|NCT01202487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65526491|NCT01202487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65526492|NCT01202487|Adrenergic Agents|adrenergic agents|mesh-ancestor
65526493|NCT01202487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65526494|NCT01202487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65526495|NCT01202487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65526496|NCT01202487|Autonomic Agents|autonomic agents|mesh-ancestor
65526497|NCT01202487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65526498|NCT01202487|Respiratory System Agents|respiratory system agents|mesh-ancestor
65526499|NCT01202487|Mydriatics|mydriatics|mesh-ancestor
65526500|NCT01202487|Sympathomimetics|sympathomimetics|mesh-ancestor
65526501|NCT01202487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65526502|NCT01204437|Paclitaxel|paclitaxel|mesh-list
65526503|NCT01204437|Cyclophosphamide|cyclophosphamide|mesh-list
65526504|NCT01204437|Capecitabine|capecitabine|mesh-list
65526505|NCT01204437|Methotrexate|methotrexate|mesh-list
65526506|NCT01204437|Epirubicin|epirubicin|mesh-list
65526507|NCT01204437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65526508|NCT01204437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526509|NCT01204437|Tubulin Modulators|tubulin modulators|mesh-ancestor
65526510|NCT01204437|Antimitotic Agents|antimitotic agents|mesh-ancestor
65526511|NCT01204437|Mitosis Modulators|mitosis modulators|mesh-ancestor
65526512|NCT01204437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526513|NCT01204437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65526514|NCT01204437|Immunologic Factors|immunologic factors|mesh-ancestor
65526515|NCT01204437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526516|NCT01204437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65526517|NCT01204437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65526518|NCT01204437|Alkylating Agents|alkylating agents|mesh-ancestor
65526519|NCT01204437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65526520|NCT01204437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65526521|NCT01204437|Antimetabolites|antimetabolites|mesh-ancestor
65526522|NCT01204437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65526523|NCT01204437|Abortifacient Agents|abortifacient agents|mesh-ancestor
65526524|NCT01204437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65526525|NCT01204437|Dermatologic Agents|dermatologic agents|mesh-ancestor
65526526|NCT01204437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526527|NCT01204437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65526528|NCT01204437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65526529|NCT01204437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65526530|NCT01204437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65526531|NCT01204437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65526532|NCT02633241|Dexmedetomidine|dexmedetomidine|mesh-list
65526533|NCT02633241|Propofol|propofol|mesh-list
65526534|NCT02633241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65526535|NCT02633241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65526536|NCT02633241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526537|NCT02633241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65526538|NCT02633241|Anesthetics, General|anesthetics, general|mesh-ancestor
65526539|NCT02633241|Anesthetics|anesthetics|mesh-ancestor
65526540|NCT02633241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65526541|NCT02633241|Analgesics|analgesics|mesh-ancestor
65526542|NCT02633241|Sensory System Agents|sensory system agents|mesh-ancestor
65526543|NCT02633241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65526544|NCT02633241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65526545|NCT02633241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65526546|NCT02633241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65526547|NCT02633241|Adrenergic Agents|adrenergic agents|mesh-ancestor
65526548|NCT02633241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65526549|NCT02633241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526550|NCT03292016|Apomorphine|apomorphine|mesh-list
65526551|NCT03292016|Emetics|emetics|mesh-ancestor
65526552|NCT03292016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526553|NCT03292016|Autonomic Agents|autonomic agents|mesh-ancestor
65526554|NCT03292016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65526555|NCT03292016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65526556|NCT03292016|Dopamine Agonists|dopamine agonists|mesh-ancestor
65526557|NCT03292016|Dopamine Agents|dopamine agents|mesh-ancestor
65526558|NCT03292016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65526559|NCT03292016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526560|NCT05669391|Antidepressive Agents|antidepressive agents|mesh-list
65526561|NCT05669391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65526562|NCT01206075|Plerixafor|plerixafor|mesh-list
65526563|NCT01206075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65526564|NCT01206075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65526565|NCT01206075|Antiviral Agents|antiviral agents|mesh-ancestor
65526566|NCT01206075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65526567|NCT03289676|Nicotine|nicotine|mesh-list
65526568|NCT03289676|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65526569|NCT03289676|Autonomic Agents|autonomic agents|mesh-ancestor
65526570|NCT03289676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65526571|NCT03289676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526572|NCT03289676|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65526573|NCT03289676|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65526574|NCT03289676|Cholinergic Agents|cholinergic agents|mesh-ancestor
65526575|NCT03289676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65526576|NCT03289676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526577|NCT03834831|Selenium|selenium|mesh-list
65526578|NCT03834831|Ubiquinone|ubiquinone|mesh-list
65526579|NCT03834831|Coenzyme Q10|coenzyme q10|mesh-list
65526580|NCT03834831|Antioxidants|antioxidants|mesh-ancestor
65526581|NCT03834831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526582|NCT03834831|Protective Agents|protective agents|mesh-ancestor
65526583|NCT03834831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526584|NCT03834831|Trace Elements|trace elements|mesh-ancestor
65526585|NCT03834831|Micronutrients|micronutrients|mesh-ancestor
65526586|NCT03834831|Vitamins|vitamins|mesh-ancestor
65526587|NCT01206153|Metformin|metformin|mesh-list
65526588|NCT01206153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65526589|NCT01206153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526590|NCT01298271|Propranolol|propranolol|mesh-list
65526591|NCT01298271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65526592|NCT01298271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65526593|NCT01298271|Adrenergic Agents|adrenergic agents|mesh-ancestor
65526594|NCT01298271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65526595|NCT01298271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526596|NCT01298271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526597|NCT01298271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65526598|NCT01298271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65526599|NCT01298271|Vasodilator Agents|vasodilator agents|mesh-ancestor
65526600|NCT05281965|Tretinoin|tretinoin|mesh-list
65526601|NCT05281965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526602|NCT05281965|Keratolytic Agents|keratolytic agents|mesh-ancestor
65526603|NCT05281965|Dermatologic Agents|dermatologic agents|mesh-ancestor
65526604|NCT04251884|Ropivacaine|ropivacaine|mesh-list
65526605|NCT04251884|Anesthetics, Local|anesthetics, local|mesh-list
65526606|NCT04251884|Anesthetics|anesthetics|mesh-list
65526607|NCT04251884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65526608|NCT04251884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526609|NCT04251884|Sensory System Agents|sensory system agents|mesh-ancestor
65526610|NCT04251884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65526611|NCT01202799|Diclofenac|diclofenac|mesh-list
65526612|NCT01202799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65526613|NCT01202799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65526614|NCT01202799|Analgesics|analgesics|mesh-ancestor
65526615|NCT01202799|Sensory System Agents|sensory system agents|mesh-ancestor
65526616|NCT01202799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65526617|NCT01202799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526618|NCT01202799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65526619|NCT01202799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65526620|NCT01202799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65526621|NCT01202799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526622|NCT01202799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526623|NCT03829605|Hydrogen Sulfide|hydrogen sulfide|mesh-list
65526624|NCT03829605|Gasotransmitters|gasotransmitters|mesh-ancestor
65526625|NCT03829605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65526626|NCT03829605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526627|NCT03829605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526628|NCT01298505|Fexofenadine|fexofenadine|mesh-list
65526629|NCT01298505|Terfenadine|terfenadine|mesh-list
65526630|NCT01298505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65526631|NCT01298505|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65526632|NCT01298505|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65526633|NCT01298505|Histamine Antagonists|histamine antagonists|mesh-ancestor
65526634|NCT01298505|Histamine Agents|histamine agents|mesh-ancestor
65526635|NCT01298505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65526636|NCT01298505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526637|NCT01298505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526638|NCT01204593|Insulin|insulin|mesh-list
65526639|NCT01204593|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65526640|NCT01204593|Insulin Glargine|insulin glargine|mesh-list
65526641|NCT01204593|Insulin glulisine|insulin glulisine|mesh-list
65526642|NCT01204593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65526643|NCT01204593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526644|NCT03310970|Lidocaine|lidocaine|mesh-list
65526645|NCT03310970|Anesthetics, Local|anesthetics, local|mesh-ancestor
65526646|NCT03310970|Anesthetics|anesthetics|mesh-ancestor
65526647|NCT03310970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65526648|NCT03310970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526649|NCT03310970|Sensory System Agents|sensory system agents|mesh-ancestor
65526650|NCT03310970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65526651|NCT03310970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65526652|NCT03310970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65526653|NCT03310970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65526654|NCT03310970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65526655|NCT03310970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526656|NCT05281419|Triamcinolone|triamcinolone|mesh-list
65526657|NCT05281419|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65526658|NCT05281419|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65526659|NCT05281419|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65526660|NCT05281419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65526661|NCT05281419|Glucocorticoids|glucocorticoids|mesh-ancestor
65526662|NCT05281419|Hormones|hormones|mesh-ancestor
65526663|NCT05281419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65526664|NCT05281419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526665|NCT05281419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65526666|NCT05281419|Immunologic Factors|immunologic factors|mesh-ancestor
65526667|NCT05281419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526668|NCT05281419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526670|NCT04427072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526671|NCT04427072|Tubulin Modulators|tubulin modulators|mesh-ancestor
65526672|NCT04427072|Antimitotic Agents|antimitotic agents|mesh-ancestor
65526673|NCT04427072|Mitosis Modulators|mitosis modulators|mesh-ancestor
65526674|NCT04427072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526675|NCT03537651|Ivacaftor|ivacaftor|mesh-list
65526676|NCT03537651|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65526677|NCT03537651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65526678|NCT03537651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526679|NCT01203111|Insulin|insulin|mesh-list
65526680|NCT01203111|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65526681|NCT01203111|Insulin Glargine|insulin glargine|mesh-list
65526682|NCT01203111|Insulin glulisine|insulin glulisine|mesh-list
65526683|NCT01203111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65526684|NCT01203111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526685|NCT03420339|Adderall|adderall|mesh-list
65526686|NCT03420339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65526687|NCT03420339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526688|NCT01297179|Levonorgestrel|levonorgestrel|mesh-list
65526689|NCT01297179|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65526690|NCT01297179|Mirabegron|mirabegron|mesh-list
65526691|NCT01297179|Estradiol|estradiol|mesh-list
65526692|NCT01297179|Estrogens|estrogens|mesh-ancestor
65526693|NCT01297179|Hormones|hormones|mesh-ancestor
65526694|NCT01297179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65526695|NCT01297179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526696|NCT01297179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65526697|NCT01297179|Contraceptive Agents|contraceptive agents|mesh-ancestor
65526698|NCT01297179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65526699|NCT01297179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65526700|NCT01297179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65526701|NCT01297179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65526702|NCT01297179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65526703|NCT01297179|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65526704|NCT01297179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65526705|NCT01297179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65526706|NCT01297179|Adrenergic Agents|adrenergic agents|mesh-ancestor
65526707|NCT01297179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65526708|NCT01297179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526709|NCT01297179|Urological Agents|urological agents|mesh-ancestor
65526710|NCT01205139|Simeprevir|simeprevir|mesh-list
65526711|NCT01205139|Rilpivirine|rilpivirine|mesh-list
65526712|NCT01205139|Antiviral Agents|antiviral agents|mesh-ancestor
65526713|NCT01205139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65526714|NCT01205139|Protease Inhibitors|protease inhibitors|mesh-ancestor
65526715|NCT01205139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526716|NCT01205139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526717|NCT01205139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65526718|NCT01205139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65526719|NCT01205139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65526720|NCT01205139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65526721|NCT01205217|Paclitaxel|paclitaxel|mesh-list
65526722|NCT01205217|Cyclophosphamide|cyclophosphamide|mesh-list
65526723|NCT01205217|Trastuzumab|trastuzumab|mesh-list
65526724|NCT01205217|Epirubicin|epirubicin|mesh-list
65526725|NCT01205217|Lapatinib|lapatinib|mesh-list
65526726|NCT01205217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65526727|NCT01205217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526728|NCT01205217|Tubulin Modulators|tubulin modulators|mesh-ancestor
65526729|NCT01205217|Antimitotic Agents|antimitotic agents|mesh-ancestor
65526730|NCT01205217|Mitosis Modulators|mitosis modulators|mesh-ancestor
65526731|NCT01205217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526732|NCT01205217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65526733|NCT01205217|Immunologic Factors|immunologic factors|mesh-ancestor
65526734|NCT01205217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526735|NCT01205217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65526736|NCT01205217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65526737|NCT01205217|Alkylating Agents|alkylating agents|mesh-ancestor
65526738|NCT01205217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65526739|NCT01205217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65324233|NCT04101578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65526740|NCT01205217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65526741|NCT01205217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65526742|NCT01205217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65526743|NCT01205217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526744|NCT01205217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65526745|NCT01203267|Paclitaxel|paclitaxel|mesh-list
65526746|NCT01203267|Carboplatin|carboplatin|mesh-list
65526747|NCT01203267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65526748|NCT01203267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526749|NCT01203267|Tubulin Modulators|tubulin modulators|mesh-ancestor
65526750|NCT01203267|Antimitotic Agents|antimitotic agents|mesh-ancestor
65526751|NCT01203267|Mitosis Modulators|mitosis modulators|mesh-ancestor
65526752|NCT01203267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526753|NCT01207245|Tobramycin|tobramycin|mesh-list
65526754|NCT01207245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65526755|NCT01207245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65526756|NCT01297569|Ranibizumab|ranibizumab|mesh-list
65526757|NCT01297569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65526758|NCT01297569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65526759|NCT01297569|Growth Substances|growth substances|mesh-ancestor
65526760|NCT01297569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526761|NCT01297569|Growth Inhibitors|growth inhibitors|mesh-ancestor
65526762|NCT01297569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526763|NCT01203345|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65526764|NCT01203345|Immunologic Factors|immunologic factors|mesh-ancestor
65526765|NCT01203345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526766|NCT01299597|Atorvastatin|atorvastatin|mesh-list
65526767|NCT01299597|Simvastatin|simvastatin|mesh-list
65526768|NCT01299597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65526769|NCT01299597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65526770|NCT01299597|Antimetabolites|antimetabolites|mesh-ancestor
65526771|NCT01299597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526772|NCT01299597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65526773|NCT01299597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65526774|NCT01299597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526775|NCT03723915|Pembrolizumab|pembrolizumab|mesh-list
65526776|NCT03723915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65526777|NCT03723915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526778|NCT03840057|Azithromycin|azithromycin|mesh-list
65526779|NCT03840057|Metoclopramide|metoclopramide|mesh-list
65526780|NCT03840057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65526781|NCT03840057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65526782|NCT03840057|Antiemetics|antiemetics|mesh-ancestor
65526783|NCT03840057|Autonomic Agents|autonomic agents|mesh-ancestor
65526784|NCT03840057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65526785|NCT03840057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526786|NCT03840057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65526787|NCT03840057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65526788|NCT03840057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65526789|NCT03840057|Dopamine Agents|dopamine agents|mesh-ancestor
65526790|NCT03840057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65526791|NCT03840057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526792|NCT05669547|Hormones|hormones|mesh-list
65526793|NCT05669547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65526794|NCT05669547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526795|NCT01297803|Mitomycins|mitomycins|mesh-list
65526796|NCT01297803|Mitomycin|mitomycin|mesh-list
65526797|NCT01297803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65526798|NCT01297803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526799|NCT01297803|Alkylating Agents|alkylating agents|mesh-ancestor
65526800|NCT01297803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526801|NCT01297803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65526802|NCT01297803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526803|NCT03824691|Durvalumab|durvalumab|mesh-list
65526804|NCT03824691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65526805|NCT03824691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526806|NCT01299831|Hormones|hormones|mesh-list
65526807|NCT01299831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65255820|NCT00798603|Bevacizumab|bevacizumab|mesh-list
65526808|NCT01299831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526809|NCT01205997|Magnesium Sulfate|magnesium sulfate|mesh-list
65526810|NCT01205997|Fentanyl|fentanyl|mesh-list
65526811|NCT01205997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65526812|NCT01205997|Narcotics|narcotics|mesh-ancestor
65526813|NCT01205997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65526814|NCT01205997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526816|NCT01205997|Sensory System Agents|sensory system agents|mesh-ancestor
65526817|NCT01205997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65526818|NCT01205997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65526819|NCT01205997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65526820|NCT01205997|Anesthetics, General|anesthetics, general|mesh-ancestor
65526821|NCT01205997|Anesthetics|anesthetics|mesh-ancestor
65526822|NCT01205997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65526823|NCT01205997|Anticonvulsants|anticonvulsants|mesh-ancestor
65526824|NCT01205997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65526825|NCT01205997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65526826|NCT01205997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526827|NCT01205997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65526828|NCT01205997|Tocolytic Agents|tocolytic agents|mesh-ancestor
65526829|NCT01205997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65526830|NCT03818997|Paclitaxel|paclitaxel|mesh-list
65526831|NCT03818997|Atezolizumab|atezolizumab|mesh-list
65526832|NCT03818997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65526833|NCT03818997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526834|NCT03818997|Tubulin Modulators|tubulin modulators|mesh-ancestor
65526835|NCT03818997|Antimitotic Agents|antimitotic agents|mesh-ancestor
65526836|NCT03818997|Mitosis Modulators|mitosis modulators|mesh-ancestor
65526837|NCT03818997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526838|NCT03818919|Acetaminophen|acetaminophen|mesh-list
65526839|NCT03818919|Celecoxib|celecoxib|mesh-list
65526840|NCT03818919|Ketorolac|ketorolac|mesh-list
65526841|NCT03818919|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65526842|NCT03818919|Diazepam|diazepam|mesh-list
65526843|NCT03818919|Gabapentin|gabapentin|mesh-list
65526844|NCT03818919|Hydrocodone|hydrocodone|mesh-list
65526845|NCT03818919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65526846|NCT03818919|Analgesics|analgesics|mesh-ancestor
65526847|NCT03818919|Sensory System Agents|sensory system agents|mesh-ancestor
65526848|NCT03818919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65526849|NCT03818919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526850|NCT03818919|Antipyretics|antipyretics|mesh-ancestor
65526851|NCT03818919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65526852|NCT03818919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65526853|NCT03818919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65526854|NCT03818919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65526855|NCT03818919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65526856|NCT03818919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526857|NCT03818919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526858|NCT03818919|Anticonvulsants|anticonvulsants|mesh-ancestor
65526859|NCT03818919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65526860|NCT03818919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65526861|NCT03818919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65526862|NCT03818919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65526863|NCT03818919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65526864|NCT03818919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65526865|NCT03818919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65526866|NCT03818919|Antimanic Agents|antimanic agents|mesh-ancestor
65526867|NCT03818919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65526868|NCT03818919|Narcotics|narcotics|mesh-ancestor
65526869|NCT03818919|Antitussive Agents|antitussive agents|mesh-ancestor
65526870|NCT03818919|Respiratory System Agents|respiratory system agents|mesh-ancestor
65526871|NCT03818919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65526872|NCT03818919|Antiemetics|antiemetics|mesh-ancestor
65526873|NCT03818919|Autonomic Agents|autonomic agents|mesh-ancestor
65526874|NCT03818919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65526875|NCT03818919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65526876|NCT03818919|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65526877|NCT03818919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65526878|NCT03818919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65526879|NCT03818919|Anesthetics, General|anesthetics, general|mesh-ancestor
65526880|NCT03818919|Anesthetics|anesthetics|mesh-ancestor
65526881|NCT03818919|GABA Modulators|gaba modulators|mesh-ancestor
65526882|NCT03818919|GABA Agents|gaba agents|mesh-ancestor
65526883|NCT03821493|Itraconazole|itraconazole|mesh-list
65526884|NCT03821493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65526885|NCT03821493|Antifungal Agents|antifungal agents|mesh-ancestor
65526886|NCT03821493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65526887|NCT03821493|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65526888|NCT03821493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65526889|NCT03821493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526890|NCT03821493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526891|NCT03821493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65526892|NCT03821493|Hormone Antagonists|hormone antagonists|mesh-ancestor
65526893|NCT03821493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65526894|NCT03821493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526895|NCT03821493|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65526896|NCT01301937|Meglumine Antimoniate|meglumine antimoniate|mesh-list
65526897|NCT01301937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65526898|NCT01301937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65526899|NCT01301937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65526900|NCT05618223|Dapagliflozin|dapagliflozin|mesh-list
65526901|NCT05618223|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65526902|NCT05618223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526903|NCT05618223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65526904|NCT05618223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526905|NCT03814629|Vitamins|vitamins|mesh-list
65526906|NCT03814629|Micronutrients|micronutrients|mesh-ancestor
65526907|NCT03814629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526908|NCT01585935|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65526909|NCT01585935|SMOFlipid|smoflipid|mesh-list
65526910|NCT01585935|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65526911|NCT01585935|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65526912|NCT01585935|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65526913|NCT01300377|Lidocaine|lidocaine|mesh-list
65526914|NCT01300377|Bupivacaine|bupivacaine|mesh-list
65526915|NCT01300377|Anesthetics, Local|anesthetics, local|mesh-ancestor
65526916|NCT01300377|Anesthetics|anesthetics|mesh-ancestor
65526917|NCT01300377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65526918|NCT01300377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526919|NCT01300377|Sensory System Agents|sensory system agents|mesh-ancestor
65526920|NCT01300377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65526921|NCT01300377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65526922|NCT01300377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65526923|NCT01300377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65526924|NCT01300377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65526925|NCT01300377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526926|NCT03814707|Hyaluronic Acid|hyaluronic acid|mesh-list
65526927|NCT03814707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65526928|NCT03814707|Immunologic Factors|immunologic factors|mesh-ancestor
65526929|NCT03814707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526930|NCT03814707|Viscosupplements|viscosupplements|mesh-ancestor
65526931|NCT03814707|Protective Agents|protective agents|mesh-ancestor
65526932|NCT03818295|Praliciguat|praliciguat|mesh-list
65526933|NCT03818295|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65526934|NCT03818295|Enzyme Activators|enzyme activators|mesh-ancestor
65526935|NCT03818295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526936|NCT03818295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65526937|NCT01300611|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
65526938|NCT01300611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65526939|NCT01300611|Vasodilator Agents|vasodilator agents|mesh-ancestor
65526940|NCT01301313|Simendan|simendan|mesh-list
65526941|NCT01301313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65526942|NCT01301313|Vasodilator Agents|vasodilator agents|mesh-ancestor
65526943|NCT01301313|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65526944|NCT01301313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65526945|NCT01301313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526946|NCT01301313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526947|NCT01301313|Protective Agents|protective agents|mesh-ancestor
65526948|NCT01301313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526949|NCT03817359|Remifentanil|remifentanil|mesh-list
65526950|NCT03817359|Propofol|propofol|mesh-list
65526951|NCT03817359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65526952|NCT03817359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65526953|NCT03817359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526954|NCT03817359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65526955|NCT03817359|Anesthetics, General|anesthetics, general|mesh-ancestor
65526956|NCT03817359|Anesthetics|anesthetics|mesh-ancestor
65526957|NCT03817359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65526958|NCT03817359|Narcotics|narcotics|mesh-ancestor
65526959|NCT03817359|Analgesics|analgesics|mesh-ancestor
65526960|NCT03817359|Sensory System Agents|sensory system agents|mesh-ancestor
65526961|NCT03817359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65526962|NCT03813927|Vitamin D|vitamin d|mesh-list
65526963|NCT03813927|Vitamins|vitamins|mesh-ancestor
65526964|NCT03813927|Micronutrients|micronutrients|mesh-ancestor
65526965|NCT03813927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526966|NCT03813927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65526967|NCT02819518|Gemcitabine|gemcitabine|mesh-list
65526968|NCT02819518|Paclitaxel|paclitaxel|mesh-list
65526969|NCT02819518|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65526970|NCT02819518|Carboplatin|carboplatin|mesh-list
65526971|NCT02819518|Pembrolizumab|pembrolizumab|mesh-list
65526972|NCT02819518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65526973|NCT02819518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65526974|NCT02819518|Tubulin Modulators|tubulin modulators|mesh-ancestor
65526975|NCT02819518|Antimitotic Agents|antimitotic agents|mesh-ancestor
65526976|NCT02819518|Mitosis Modulators|mitosis modulators|mesh-ancestor
65526977|NCT02819518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65526978|NCT02819518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65526979|NCT02819518|Antimetabolites|antimetabolites|mesh-ancestor
65526980|NCT02819518|Antiviral Agents|antiviral agents|mesh-ancestor
65526981|NCT02819518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65526982|NCT02819518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65526983|NCT02819518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65526984|NCT02819518|Immunologic Factors|immunologic factors|mesh-ancestor
65526985|NCT02819518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526986|NCT02819518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65526987|NCT03310580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65526988|NCT03310580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65526989|NCT03813771|Hydroxychloroquine|hydroxychloroquine|mesh-list
65526990|NCT03813771|Sulfasalazine|sulfasalazine|mesh-list
65526991|NCT03813771|Etanercept|etanercept|mesh-list
65526992|NCT03813771|Methotrexate|methotrexate|mesh-list
65526993|NCT03813771|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65526994|NCT03813771|Abortifacient Agents|abortifacient agents|mesh-ancestor
65526995|NCT03813771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65526996|NCT03813771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65526997|NCT03813771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65526998|NCT03813771|Antimetabolites|antimetabolites|mesh-ancestor
65526999|NCT03813771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527000|NCT03813771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527001|NCT03813771|Dermatologic Agents|dermatologic agents|mesh-ancestor
65527002|NCT03813771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527003|NCT03813771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65527004|NCT03813771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65527005|NCT03813771|Immunologic Factors|immunologic factors|mesh-ancestor
65527006|NCT03813771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65527007|NCT03813771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65527008|NCT03813771|Antimalarials|antimalarials|mesh-ancestor
65527009|NCT03813771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65527010|NCT03813771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65527011|NCT03813771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65527012|NCT03813771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65527013|NCT03813771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65527014|NCT03813771|Analgesics|analgesics|mesh-ancestor
65527015|NCT03813771|Sensory System Agents|sensory system agents|mesh-ancestor
65527016|NCT03813771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527017|NCT03813771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65527018|NCT03813771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65527019|NCT03813693|Chlorhexidine|chlorhexidine|mesh-list
65527020|NCT03813693|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65527021|NCT03813693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65527022|NCT03813693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65527023|NCT03813693|Disinfectants|disinfectants|mesh-ancestor
65527024|NCT03813693|Dermatologic Agents|dermatologic agents|mesh-ancestor
65527025|NCT02036242|Sufentanil|sufentanil|mesh-list
65527026|NCT02036242|Ropivacaine|ropivacaine|mesh-list
65527027|NCT02036242|Anesthetics, Local|anesthetics, local|mesh-list
65527028|NCT02036242|Anesthetics|anesthetics|mesh-list
65527029|NCT02036242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65527030|NCT02036242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527031|NCT02036242|Sensory System Agents|sensory system agents|mesh-ancestor
65527032|NCT02036242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527033|NCT02036242|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65527034|NCT02036242|Narcotics|narcotics|mesh-ancestor
65527035|NCT02036242|Analgesics|analgesics|mesh-ancestor
65527036|NCT02036242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65527037|NCT02036242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65527038|NCT02036242|Anesthetics, General|anesthetics, general|mesh-ancestor
65527039|NCT05281107|Calcium, Dietary|calcium, dietary|mesh-list
65527040|NCT05281107|Vitamin D|vitamin d|mesh-list
65527041|NCT05281107|Ergocalciferols|ergocalciferols|mesh-list
65527042|NCT05281107|Cholecalciferol|cholecalciferol|mesh-list
65527043|NCT05281107|Vitamins|vitamins|mesh-list
65527045|NCT05281107|Micronutrients|micronutrients|mesh-ancestor
65527046|NCT05281107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527047|NCT05281107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65527048|NCT05281107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65527049|NCT02812186|Rocuronium|rocuronium|mesh-list
65527050|NCT02812186|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65527051|NCT02812186|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65527052|NCT02812186|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65527053|NCT02812186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527054|NCT02812186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527055|NCT03310268|Listerine|listerine|mesh-list
65527056|NCT03310268|Fluorides|fluorides|mesh-list
65527057|NCT03310268|Sodium Fluoride|sodium fluoride|mesh-list
65527058|NCT03310268|Tin Fluorides|tin fluorides|mesh-list
65527059|NCT03310268|Fluorophosphate|fluorophosphate|mesh-list
65527060|NCT03310268|Cariostatic Agents|cariostatic agents|mesh-ancestor
65527061|NCT03310268|Protective Agents|protective agents|mesh-ancestor
65527062|NCT03310268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527063|NCT03310268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65527064|NCT03310268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65527065|NCT01301469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65527066|NCT02810392|Insulin|insulin|mesh-list
65527067|NCT02810392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65527068|NCT02810392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65527069|NCT02810392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527070|NCT03805035|Chlorpheniramine|chlorpheniramine|mesh-list
65527071|NCT03805035|Maleic acid|maleic acid|mesh-list
65527072|NCT03805035|Histamine Antagonists|histamine antagonists|mesh-list
65527073|NCT03805035|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
65527074|NCT03805035|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
65527075|NCT03805035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527076|NCT03805035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527077|NCT03805035|Histamine Agents|histamine agents|mesh-ancestor
65527078|NCT03805035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65527079|NCT03805035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527080|NCT03805035|Antipruritics|antipruritics|mesh-ancestor
65527081|NCT03805035|Dermatologic Agents|dermatologic agents|mesh-ancestor
65527082|NCT03805035|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65527083|NCT02815540|Cannabidiol|cannabidiol|mesh-list
65527084|NCT02815540|Anticonvulsants|anticonvulsants|mesh-ancestor
65527085|NCT03816267|Albuterol|albuterol|mesh-list
65527086|NCT03816267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65527087|NCT03816267|Autonomic Agents|autonomic agents|mesh-ancestor
65527088|NCT03816267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527089|NCT03816267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527090|NCT03816267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65527091|NCT03816267|Respiratory System Agents|respiratory system agents|mesh-ancestor
65527092|NCT03816267|Tocolytic Agents|tocolytic agents|mesh-ancestor
65527093|NCT03816267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65527094|NCT03816267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65527095|NCT03816267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65527096|NCT03816267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65527097|NCT03816267|Adrenergic Agents|adrenergic agents|mesh-ancestor
65527098|NCT03816267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65527099|NCT03816267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527100|NCT03280550|Omalizumab|omalizumab|mesh-list
65527101|NCT03280550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65527102|NCT03280550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65527103|NCT03280550|Respiratory System Agents|respiratory system agents|mesh-ancestor
65527104|NCT02036554|Mycophenolic Acid|mycophenolic acid|mesh-list
65527105|NCT02036554|Everolimus|everolimus|mesh-list
65527106|NCT02036554|Tacrolimus|tacrolimus|mesh-list
65527107|NCT02036554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65527108|NCT02036554|Immunologic Factors|immunologic factors|mesh-ancestor
65527109|NCT02036554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527110|NCT02036554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65527111|NCT02036554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527112|NCT02036554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527113|NCT02036554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527114|NCT02036554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65527115|NCT02036554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65527116|NCT02036554|Antitubercular Agents|antitubercular agents|mesh-ancestor
65527117|NCT02036554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65527118|NCT02036554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65527119|NCT05577117|Fentanyl|fentanyl|mesh-list
65527120|NCT05577117|Dexmedetomidine|dexmedetomidine|mesh-list
65527121|NCT05577117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65527122|NCT05577117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65527123|NCT05577117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527124|NCT05577117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65527125|NCT05577117|Analgesics|analgesics|mesh-ancestor
65527126|NCT05577117|Sensory System Agents|sensory system agents|mesh-ancestor
65527127|NCT05577117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527128|NCT05577117|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65527129|NCT05577117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65527130|NCT05577117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65527131|NCT05577117|Adrenergic Agents|adrenergic agents|mesh-ancestor
65527132|NCT05577117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65527133|NCT05577117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527134|NCT05577117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65527135|NCT05577117|Narcotics|narcotics|mesh-ancestor
65527136|NCT05577117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65527137|NCT05577117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65527138|NCT05577117|Anesthetics, General|anesthetics, general|mesh-ancestor
65527139|NCT05577117|Anesthetics|anesthetics|mesh-ancestor
65527140|NCT03813303|Fentanyl|fentanyl|mesh-list
65527141|NCT03813303|Midazolam|midazolam|mesh-list
65527142|NCT03813303|Propofol|propofol|mesh-list
65527143|NCT03813303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65527144|NCT03813303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65527145|NCT03813303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527146|NCT03813303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65527147|NCT03813303|Anesthetics, General|anesthetics, general|mesh-ancestor
65527148|NCT03813303|Anesthetics|anesthetics|mesh-ancestor
65527149|NCT03813303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65527150|NCT03813303|Narcotics|narcotics|mesh-ancestor
65527151|NCT03813303|Analgesics|analgesics|mesh-ancestor
65527152|NCT03813303|Sensory System Agents|sensory system agents|mesh-ancestor
65527153|NCT03813303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527154|NCT03813303|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65527155|NCT03813303|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65527156|NCT03813303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65527157|NCT03813303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65527158|NCT03813303|GABA Modulators|gaba modulators|mesh-ancestor
65527159|NCT03813303|GABA Agents|gaba agents|mesh-ancestor
65527160|NCT03813303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65527161|NCT03813303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527162|NCT03384914|Vaccines|vaccines|mesh-list
65527163|NCT03384914|Immunologic Factors|immunologic factors|mesh-list
65527164|NCT03384914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527165|NCT05562063|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65527166|NCT05562063|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65527167|NCT05562063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527168|NCT05562063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65527169|NCT05562063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527170|NCT03637790|Rifampin|rifampin|mesh-list
65527171|NCT03637790|Abrocitinib|abrocitinib|mesh-list
65527172|NCT03637790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65527173|NCT03637790|Antitubercular Agents|antitubercular agents|mesh-ancestor
65527174|NCT03637790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65527175|NCT03637790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65527176|NCT03637790|Leprostatic Agents|leprostatic agents|mesh-ancestor
65527177|NCT03637790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65527178|NCT03637790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527179|NCT03637790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527180|NCT03637790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65527181|NCT03637790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65527182|NCT03637790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65527183|NCT03637790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65527184|NCT03637790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65527185|NCT03637790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65527186|NCT03637790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65527187|NCT03813069|Permethrin|permethrin|mesh-list
65527188|NCT03813069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527189|NCT03813069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527190|NCT03276026|Neostigmine|neostigmine|mesh-list
65527191|NCT03276026|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65527192|NCT03276026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527193|NCT03276026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527194|NCT03276026|Cholinergic Agents|cholinergic agents|mesh-ancestor
65527195|NCT03276026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65527196|NCT03276026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527197|NCT03276026|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65527198|NCT03276026|Autonomic Agents|autonomic agents|mesh-ancestor
65527199|NCT03276026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527201|NCT01303497|Bevacizumab|bevacizumab|mesh-list
65527202|NCT01303497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65527203|NCT01303497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527204|NCT01303497|Tubulin Modulators|tubulin modulators|mesh-ancestor
65527205|NCT01303497|Antimitotic Agents|antimitotic agents|mesh-ancestor
65527206|NCT01303497|Mitosis Modulators|mitosis modulators|mesh-ancestor
65527207|NCT01303497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527208|NCT01303497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65527209|NCT01303497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65527210|NCT01303497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65527211|NCT01303497|Growth Substances|growth substances|mesh-ancestor
65527212|NCT01303497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527213|NCT01303497|Growth Inhibitors|growth inhibitors|mesh-ancestor
65527214|NCT01589523|Cholic Acids|cholic acids|mesh-list
65527215|NCT01589523|Glycocholic Acid|glycocholic acid|mesh-list
65527216|NCT01589523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65527217|NCT01589523|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65527218|NCT03804177|Ascorbic Acid|ascorbic acid|mesh-list
65527219|NCT03804177|Melatonin|melatonin|mesh-list
65527220|NCT03804177|Hyaluronic Acid|hyaluronic acid|mesh-list
65527221|NCT03804177|Antioxidants|antioxidants|mesh-ancestor
65527222|NCT03804177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527223|NCT03804177|Protective Agents|protective agents|mesh-ancestor
65527224|NCT03804177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527225|NCT03804177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65527226|NCT03804177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65527227|NCT03804177|Immunologic Factors|immunologic factors|mesh-ancestor
65527228|NCT03804177|Viscosupplements|viscosupplements|mesh-ancestor
65527229|NCT03804177|Vitamins|vitamins|mesh-ancestor
65527230|NCT03804177|Micronutrients|micronutrients|mesh-ancestor
65527231|NCT03277352|Pembrolizumab|pembrolizumab|mesh-list
65527232|NCT03277352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65527233|NCT03277352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527234|NCT01302093|Racecadotril|racecadotril|mesh-list
65527235|NCT01302093|Thiorphan|thiorphan|mesh-list
65527236|NCT01302093|Antidiarrheals|antidiarrheals|mesh-ancestor
65527237|NCT01302093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65527238|NCT01302093|Protease Inhibitors|protease inhibitors|mesh-ancestor
65527239|NCT01302093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527240|NCT01302093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527241|NCT03803007|Glenzocimab|glenzocimab|mesh-list
65527242|NCT03803007|Anticoagulants|anticoagulants|mesh-ancestor
65527243|NCT03802149|Ulipristal acetate|ulipristal acetate|mesh-list
65527244|NCT03802149|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65527245|NCT03802149|Contraceptive Agents|contraceptive agents|mesh-ancestor
65527246|NCT03802149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65527247|NCT03802149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527248|NCT03802149|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65527249|NCT02047552|Iron|iron|mesh-list
65527250|NCT02047552|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65527251|NCT02047552|Oxandrolone|oxandrolone|mesh-list
65527252|NCT02047552|Trace Elements|trace elements|mesh-ancestor
65527253|NCT02047552|Micronutrients|micronutrients|mesh-ancestor
65527254|NCT02047552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527255|NCT02047552|Hematinics|hematinics|mesh-ancestor
65527256|NCT02047552|Androgens|androgens|mesh-ancestor
65527257|NCT02047552|Hormones|hormones|mesh-ancestor
65527258|NCT02047552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65527259|NCT02047552|Anabolic Agents|anabolic agents|mesh-ancestor
65527260|NCT01303731|Fentanyl|fentanyl|mesh-list
65527261|NCT01303731|Bupivacaine|bupivacaine|mesh-list
65527262|NCT01303731|Anesthetics, Local|anesthetics, local|mesh-ancestor
65527263|NCT01303731|Anesthetics|anesthetics|mesh-ancestor
65527264|NCT01303731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65527265|NCT01303731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256273|NCT00944645|Vitamins|vitamins|mesh-ancestor
65527266|NCT01303731|Sensory System Agents|sensory system agents|mesh-ancestor
65527267|NCT01303731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527268|NCT01303731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65527269|NCT01303731|Narcotics|narcotics|mesh-ancestor
65527270|NCT01303731|Analgesics|analgesics|mesh-ancestor
65527271|NCT01303731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65527272|NCT01303731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65527273|NCT01303731|Anesthetics, General|anesthetics, general|mesh-ancestor
65527274|NCT03815487|Insulin|insulin|mesh-list
65527275|NCT03815487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65527276|NCT03815487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65527277|NCT03815487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527278|NCT03815422|Anesthetics|anesthetics|mesh-list
65527279|NCT03815422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65527280|NCT03815422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527281|NCT02260024|Pramipexole|pramipexole|mesh-list
65527282|NCT02260024|Antioxidants|antioxidants|mesh-ancestor
65527283|NCT02260024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527284|NCT02260024|Protective Agents|protective agents|mesh-ancestor
65527285|NCT02260024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527286|NCT02260024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65527287|NCT02260024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65527288|NCT02260024|Dopamine Agonists|dopamine agonists|mesh-ancestor
65527289|NCT02260024|Dopamine Agents|dopamine agents|mesh-ancestor
65527290|NCT02260024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65527291|NCT03800667|Ascorbic Acid|ascorbic acid|mesh-list
65527292|NCT03800667|Antioxidants|antioxidants|mesh-ancestor
65527293|NCT03800667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527294|NCT03800667|Protective Agents|protective agents|mesh-ancestor
65527295|NCT03800667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527296|NCT03800667|Vitamins|vitamins|mesh-ancestor
65527297|NCT03800667|Micronutrients|micronutrients|mesh-ancestor
65527298|NCT01302171|Lenograstim|lenograstim|mesh-list
65527299|NCT01302171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65527300|NCT01302171|Immunologic Factors|immunologic factors|mesh-ancestor
65527301|NCT01302171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527302|NCT02047630|Latanoprost|latanoprost|mesh-list
65527303|NCT02047630|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65527304|NCT02047630|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65527305|NCT04305470|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65527306|NCT04305470|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65527307|NCT04305470|Dermatologic Agents|dermatologic agents|mesh-ancestor
65527308|NCT03799809|Voriconazole|voriconazole|mesh-list
65527309|NCT03799809|Antifungal Agents|antifungal agents|mesh-ancestor
65527310|NCT03799809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65527311|NCT03799809|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65527312|NCT03799809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65527313|NCT03799809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527314|NCT03799809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527315|NCT03799809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65527316|NCT03799809|Hormone Antagonists|hormone antagonists|mesh-ancestor
65527317|NCT03799809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65527318|NCT03799809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527319|NCT03799809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65527320|NCT03812523|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65527321|NCT03812523|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65527322|NCT03812523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65527323|NCT03812523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65527324|NCT03812523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527325|NCT03812523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65527326|NCT03812523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527327|NCT03812523|Analgesics|analgesics|mesh-ancestor
65527328|NCT03812523|Sensory System Agents|sensory system agents|mesh-ancestor
65527329|NCT03812523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527330|NCT03812523|Antidepressive Agents|antidepressive agents|mesh-ancestor
65527331|NCT03812523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65527332|NCT03812523|Dopamine Agents|dopamine agents|mesh-ancestor
65527333|NCT04216251|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
65527334|NCT04216251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65527335|NCT04216251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65527336|NCT02049970|Dexmedetomidine|dexmedetomidine|mesh-list
65527337|NCT02049970|Bupivacaine|bupivacaine|mesh-list
65527338|NCT02049970|Anesthetics, Local|anesthetics, local|mesh-ancestor
65527339|NCT02049970|Anesthetics|anesthetics|mesh-ancestor
65527340|NCT02049970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65527341|NCT02049970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527342|NCT02049970|Sensory System Agents|sensory system agents|mesh-ancestor
65527343|NCT02049970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527344|NCT02049970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65527345|NCT02049970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65527347|NCT02049970|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65527348|NCT02049970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65527349|NCT02049970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65527350|NCT02049970|Adrenergic Agents|adrenergic agents|mesh-ancestor
65527351|NCT02049970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65527352|NCT02049970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527353|NCT02048020|Paclitaxel|paclitaxel|mesh-list
65527354|NCT02048020|Carboplatin|carboplatin|mesh-list
65527355|NCT02048020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65527356|NCT02048020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527357|NCT02048020|Tubulin Modulators|tubulin modulators|mesh-ancestor
65527358|NCT02048020|Antimitotic Agents|antimitotic agents|mesh-ancestor
65527359|NCT02048020|Mitosis Modulators|mitosis modulators|mesh-ancestor
65527360|NCT02048020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527361|NCT03562390|Irinotecan|irinotecan|mesh-list
65527362|NCT03562390|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65527363|NCT03562390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65527364|NCT03562390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527365|NCT03562390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527366|NCT03562390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527367|NCT02048098|Misoprostol|misoprostol|mesh-list
65527368|NCT02048098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65527369|NCT02048098|Abortifacient Agents|abortifacient agents|mesh-ancestor
65527370|NCT02048098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65527371|NCT02048098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527372|NCT02048098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65527373|NCT02048098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65527374|NCT02048098|Oxytocics|oxytocics|mesh-ancestor
65527375|NCT02050360|Sildenafil Citrate|sildenafil citrate|mesh-list
65527376|NCT02050360|Vasodilator Agents|vasodilator agents|mesh-ancestor
65527377|NCT02050360|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65527378|NCT02050360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65527379|NCT02050360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527380|NCT02050360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527381|NCT02050360|Urological Agents|urological agents|mesh-ancestor
65527382|NCT02940860|Iron|iron|mesh-list
65527383|NCT02940860|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65527384|NCT02940860|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65527385|NCT02940860|Trace Elements|trace elements|mesh-ancestor
65527386|NCT02940860|Micronutrients|micronutrients|mesh-ancestor
65527387|NCT02940860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527388|NCT02940860|Hematinics|hematinics|mesh-ancestor
65527389|NCT01303887|Prednisolone|prednisolone|mesh-list
65527390|NCT01303887|Cyclophosphamide|cyclophosphamide|mesh-list
65527391|NCT01303887|Rituximab|rituximab|mesh-list
65527392|NCT01303887|Fludarabine|fludarabine|mesh-list
65527393|NCT01303887|Vincristine|vincristine|mesh-list
65527394|NCT01303887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65527395|NCT01303887|Immunologic Factors|immunologic factors|mesh-ancestor
65527396|NCT01303887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527397|NCT01303887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65527398|NCT01303887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65527399|NCT01303887|Alkylating Agents|alkylating agents|mesh-ancestor
65527400|NCT01303887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527401|NCT01303887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527402|NCT01303887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65527403|NCT01303887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65527404|NCT01303887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65527405|NCT01303887|Tubulin Modulators|tubulin modulators|mesh-ancestor
65527406|NCT01303887|Antimitotic Agents|antimitotic agents|mesh-ancestor
65527407|NCT01303887|Mitosis Modulators|mitosis modulators|mesh-ancestor
65527408|NCT01303887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65527409|NCT01303887|Glucocorticoids|glucocorticoids|mesh-ancestor
65527410|NCT01303887|Hormones|hormones|mesh-ancestor
65527411|NCT01303887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65527412|NCT01303887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65527413|NCT02050594|Ipilimumab|ipilimumab|mesh-list
65527414|NCT02050594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65527415|NCT02050594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527416|NCT02050594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65527417|NCT02050594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527418|NCT02806960|Glucagon|glucagon|mesh-list
65527419|NCT02806960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65527420|NCT02806960|Hormones|hormones|mesh-ancestor
65527421|NCT02806960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65527422|NCT02806960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527424|NCT03718143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527425|NCT03718143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527426|NCT02955134|Hydrotalcite|hydrotalcite|mesh-list
65527427|NCT02955134|Antacids|antacids|mesh-ancestor
65527428|NCT02955134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527429|NCT02955134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65527430|NCT02048488|Belizatinib|belizatinib|mesh-list
65527431|NCT02048488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65527432|NCT02048488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527433|NCT02048488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527434|NCT02050672|Inositol|inositol|mesh-list
65527435|NCT02050672|Vitamin B Complex|vitamin b complex|mesh-ancestor
65527436|NCT02050672|Vitamins|vitamins|mesh-ancestor
65527437|NCT02050672|Micronutrients|micronutrients|mesh-ancestor
65527438|NCT02050672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527439|NCT03811366|Prednisone|prednisone|mesh-list
65527440|NCT03811366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65527441|NCT03811366|Glucocorticoids|glucocorticoids|mesh-ancestor
65527442|NCT03811366|Hormones|hormones|mesh-ancestor
65527443|NCT03811366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65527444|NCT03811366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527445|NCT03811366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65527446|NCT03811366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527447|NCT03274466|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65527448|NCT03274466|Laxatives|laxatives|mesh-ancestor
65527449|NCT03274466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65527450|NCT02037802|Fentanyl|fentanyl|mesh-list
65527451|NCT02037802|Meperidine|meperidine|mesh-list
65527452|NCT02037802|Bupivacaine|bupivacaine|mesh-list
65527453|NCT02037802|Propofol|propofol|mesh-list
65527454|NCT02037802|Anesthetics, Local|anesthetics, local|mesh-ancestor
65527455|NCT02037802|Anesthetics|anesthetics|mesh-ancestor
65527456|NCT02037802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65527457|NCT02037802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527458|NCT02037802|Sensory System Agents|sensory system agents|mesh-ancestor
65527459|NCT02037802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527460|NCT02037802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65527461|NCT02037802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65527462|NCT02037802|Anesthetics, General|anesthetics, general|mesh-ancestor
65527463|NCT02037802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65527464|NCT02037802|Narcotics|narcotics|mesh-ancestor
65527465|NCT02037802|Analgesics|analgesics|mesh-ancestor
65527466|NCT02037802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65527467|NCT02051530|Tryptophan|tryptophan|mesh-list
65527468|NCT02051530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65527469|NCT02051530|Antidepressive Agents|antidepressive agents|mesh-ancestor
65527470|NCT02051530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65527471|NCT03797703|Lidocaine|lidocaine|mesh-list
65527472|NCT03797703|Anesthetics, Local|anesthetics, local|mesh-ancestor
65527473|NCT03797703|Anesthetics|anesthetics|mesh-ancestor
65527474|NCT03797703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65527475|NCT03797703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527476|NCT03797703|Sensory System Agents|sensory system agents|mesh-ancestor
65527477|NCT03797703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527478|NCT03797703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65527479|NCT03797703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65527480|NCT03797703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65527481|NCT03797703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65527482|NCT03797703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527483|NCT02048644|Beclomethasone|beclomethasone|mesh-list
65527484|NCT02048644|Formoterol Fumarate|formoterol fumarate|mesh-list
65527485|NCT02048644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65527486|NCT02048644|Autonomic Agents|autonomic agents|mesh-ancestor
65527487|NCT02048644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527488|NCT02048644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527489|NCT02048644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65527490|NCT02048644|Respiratory System Agents|respiratory system agents|mesh-ancestor
65527491|NCT02048644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65527492|NCT02048644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65527493|NCT02048644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65527494|NCT02048644|Adrenergic Agents|adrenergic agents|mesh-ancestor
65527495|NCT02048644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65527496|NCT02048644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527497|NCT02048644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65527499|NCT02048644|Hormones|hormones|mesh-ancestor
65527500|NCT02048644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65527501|NCT02048800|Treosulfan|treosulfan|mesh-list
65527502|NCT02048800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65527503|NCT02048800|Alkylating Agents|alkylating agents|mesh-ancestor
65527504|NCT02048800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527505|NCT02048800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527506|NCT03797625|Cisplatin|cisplatin|mesh-list
65527507|NCT03797625|Irinotecan|irinotecan|mesh-list
65527508|NCT03797625|Endostar protein|endostar protein|mesh-list
65527509|NCT03797625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527510|NCT03797625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65527511|NCT03797625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65527512|NCT03797625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527513|NCT03797625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527514|NCT03797625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65527515|NCT03797625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65527516|NCT03797625|Growth Substances|growth substances|mesh-ancestor
65527517|NCT03797625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527518|NCT03797625|Growth Inhibitors|growth inhibitors|mesh-ancestor
65527519|NCT02051842|Metadoxine|metadoxine|mesh-list
65527520|NCT02051842|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65527521|NCT02806414|Ivermectin|ivermectin|mesh-list
65527522|NCT02806414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65527523|NCT02806414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65527524|NCT02049034|Lixisenatide|lixisenatide|mesh-list
65527525|NCT02049034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65527526|NCT02049034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527527|NCT02049190|Onapristone|onapristone|mesh-list
65527528|NCT02049190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527529|NCT02049190|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65527530|NCT02049190|Fertility Agents|fertility agents|mesh-ancestor
65527531|NCT02049190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65527532|NCT02049190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527533|NCT02049190|Hormone Antagonists|hormone antagonists|mesh-ancestor
65527534|NCT02049190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65527535|NCT03811509|Denosumab|denosumab|mesh-list
65527536|NCT03811509|Diphosphonates|diphosphonates|mesh-list
65527537|NCT03811509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65527538|NCT03811509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527539|NCT02037412|Clopidogrel|clopidogrel|mesh-list
65527540|NCT02037412|Ticagrelor|ticagrelor|mesh-list
65527541|NCT02037412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65527542|NCT02037412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65527543|NCT02037412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65527544|NCT02037412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65527545|NCT02037412|Purinergic Agents|purinergic agents|mesh-ancestor
65527546|NCT02037412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65527547|NCT02037412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527548|NCT02037412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527549|NCT02052154|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65527550|NCT02052154|Immunologic Factors|immunologic factors|mesh-ancestor
65527551|NCT02052154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527552|NCT03797079|Bupivacaine|bupivacaine|mesh-list
65527553|NCT03797079|Anesthetics, Local|anesthetics, local|mesh-ancestor
65527554|NCT03797079|Anesthetics|anesthetics|mesh-ancestor
65527555|NCT03797079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65527556|NCT03797079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527557|NCT03797079|Sensory System Agents|sensory system agents|mesh-ancestor
65527558|NCT03797079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527559|NCT02049268|Ethanol|ethanol|mesh-list
65527560|NCT02049268|Nicotine|nicotine|mesh-list
65527561|NCT02049268|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65527562|NCT02049268|Autonomic Agents|autonomic agents|mesh-ancestor
65527563|NCT02049268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527564|NCT02049268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527565|NCT02049268|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65527566|NCT02049268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65527567|NCT02049268|Cholinergic Agents|cholinergic agents|mesh-ancestor
65527568|NCT02049268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65527569|NCT02049268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527570|NCT02049268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65527571|NCT02049268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65527572|NCT02049268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65527573|NCT02049346|Epoetin Alfa|epoetin alfa|mesh-list
65527574|NCT02049346|Darbepoetin alfa|darbepoetin alfa|mesh-list
65527575|NCT02049346|Hematinics|hematinics|mesh-ancestor
65527576|NCT03564873|Azacitidine|azacitidine|mesh-list
65527577|NCT03564873|Homoharringtonine|homoharringtonine|mesh-list
65527578|NCT03564873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65527579|NCT03564873|Antimetabolites|antimetabolites|mesh-ancestor
65527580|NCT03564873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527581|NCT03564873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527582|NCT03564873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527583|NCT03564873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65527584|NCT03564873|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65527585|NCT02806024|Tranexamic Acid|tranexamic acid|mesh-list
65527586|NCT02806024|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65527587|NCT02806024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65527588|NCT02806024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527589|NCT02806024|Hemostatics|hemostatics|mesh-ancestor
65527590|NCT02806024|Coagulants|coagulants|mesh-ancestor
65527591|NCT03811197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65527592|NCT03811197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65527593|NCT03811197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527594|NCT02049580|Cyclophosphamide|cyclophosphamide|mesh-list
65527596|NCT02049580|Fludarabine|fludarabine|mesh-list
65527597|NCT02049580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65527598|NCT02049580|Immunologic Factors|immunologic factors|mesh-ancestor
65527599|NCT02049580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527600|NCT02049580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65527601|NCT02049580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65527602|NCT02049580|Alkylating Agents|alkylating agents|mesh-ancestor
65527603|NCT02049580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527604|NCT02049580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527605|NCT02049580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65527606|NCT01302951|Moxifloxacin|moxifloxacin|mesh-list
65527607|NCT01302951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65527608|NCT01302951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65527609|NCT01302951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65527610|NCT01302951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65527611|NCT01302951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527612|NCT01302951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527613|NCT01302951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527614|NCT03796533|Posaconazole|posaconazole|mesh-list
65527615|NCT03796533|Antifungal Agents|antifungal agents|mesh-ancestor
65527616|NCT03796533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65527617|NCT03796533|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65527618|NCT03796533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65527619|NCT03796533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65527620|NCT03796533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65527621|NCT03796533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65527622|NCT03796533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527623|NCT03796533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527624|NCT03796533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65527625|NCT03796533|Hormone Antagonists|hormone antagonists|mesh-ancestor
65527626|NCT03796533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65527627|NCT03796533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527628|NCT03796377|Rivaroxaban|rivaroxaban|mesh-list
65527629|NCT03796377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65527630|NCT03796377|Antithrombins|antithrombins|mesh-ancestor
65527631|NCT03796377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65527632|NCT03796377|Protease Inhibitors|protease inhibitors|mesh-ancestor
65527633|NCT03796377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527634|NCT03796377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527635|NCT03796377|Anticoagulants|anticoagulants|mesh-ancestor
65527636|NCT02049736|Telbivudine|telbivudine|mesh-list
65527637|NCT02049736|Antiviral Agents|antiviral agents|mesh-ancestor
65527638|NCT02049736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65527639|NCT02049736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65527640|NCT02049736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527641|NCT02049736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527642|NCT01303029|Gemcitabine|gemcitabine|mesh-list
65527643|NCT01303029|Capecitabine|capecitabine|mesh-list
65527644|NCT01303029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65527645|NCT01303029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65527646|NCT01303029|Antimetabolites|antimetabolites|mesh-ancestor
65527647|NCT01303029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527648|NCT01303029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527649|NCT01303029|Antiviral Agents|antiviral agents|mesh-ancestor
65527650|NCT01303029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65527651|NCT01303029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527652|NCT01303029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65527653|NCT01303029|Immunologic Factors|immunologic factors|mesh-ancestor
65527654|NCT01303029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527655|NCT01303029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65527656|NCT02052388|Daptomycin|daptomycin|mesh-list
65527657|NCT02052388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65527658|NCT02052388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65527659|NCT01303107|Bupivacaine|bupivacaine|mesh-list
65527660|NCT01303107|Anesthetics, Local|anesthetics, local|mesh-ancestor
65527661|NCT01303107|Anesthetics|anesthetics|mesh-ancestor
65527662|NCT01303107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65527663|NCT01303107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527664|NCT01303107|Sensory System Agents|sensory system agents|mesh-ancestor
65527665|NCT01303107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527666|NCT03795909|Dexamethasone|dexamethasone|mesh-list
65527667|NCT03795909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65527668|NCT03795909|Antiemetics|antiemetics|mesh-ancestor
65527669|NCT03795909|Autonomic Agents|autonomic agents|mesh-ancestor
65527670|NCT03795909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527671|NCT03795909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527672|NCT03795909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65527673|NCT03795909|Glucocorticoids|glucocorticoids|mesh-ancestor
65527674|NCT03795909|Hormones|hormones|mesh-ancestor
65527675|NCT03795909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65527676|NCT03795909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65527677|NCT03795909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527678|NCT03795597|Melphalan|melphalan|mesh-list
65527679|NCT03795597|Busulfan|busulfan|mesh-list
65527680|NCT03795597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65527681|NCT03795597|Alkylating Agents|alkylating agents|mesh-ancestor
65527682|NCT03795597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527683|NCT03795597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527684|NCT03795597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65527685|NCT03795597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65527686|NCT03795597|Immunologic Factors|immunologic factors|mesh-ancestor
65527687|NCT03795597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527688|NCT02802592|Epoetin Alfa|epoetin alfa|mesh-list
65527689|NCT02802592|Hematinics|hematinics|mesh-ancestor
65527690|NCT03637972|Nicotine|nicotine|mesh-list
65527691|NCT03637972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65527692|NCT03637972|Autonomic Agents|autonomic agents|mesh-ancestor
65527693|NCT03637972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527694|NCT03637972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527695|NCT03637972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65527696|NCT03637972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65527697|NCT03637972|Cholinergic Agents|cholinergic agents|mesh-ancestor
65527698|NCT03637972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65527699|NCT03637972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527700|NCT03383679|Capecitabine|capecitabine|mesh-list
65527701|NCT03383679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65527702|NCT03383679|Antimetabolites|antimetabolites|mesh-ancestor
65527703|NCT03383679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527704|NCT03383679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527705|NCT02037958|Chlorhexidine|chlorhexidine|mesh-list
65527706|NCT02037958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65527707|NCT02037958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65527708|NCT02037958|Disinfectants|disinfectants|mesh-ancestor
65527709|NCT02053402|Vitamin D|vitamin d|mesh-list
65527710|NCT02053402|Cholecalciferol|cholecalciferol|mesh-list
65527711|NCT02053402|Vitamins|vitamins|mesh-ancestor
65527712|NCT02053402|Micronutrients|micronutrients|mesh-ancestor
65527713|NCT02053402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527714|NCT02053402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65527715|NCT02053402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65527716|NCT04639011|Norepinephrine|norepinephrine|mesh-list
65527717|NCT04639011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65527718|NCT04639011|Serotonin|serotonin|mesh-list
65527719|NCT04639011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65527720|NCT04639011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65527721|NCT04639011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65527722|NCT04639011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527724|NCT04639011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527725|NCT04639011|Analgesics|analgesics|mesh-ancestor
65527726|NCT04639011|Sensory System Agents|sensory system agents|mesh-ancestor
65527727|NCT04639011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527728|NCT04639011|Antidepressive Agents|antidepressive agents|mesh-ancestor
65527729|NCT04639011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65527730|NCT04639011|Dopamine Agents|dopamine agents|mesh-ancestor
65527731|NCT04639011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65527732|NCT04639011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65527733|NCT04639011|Adrenergic Agents|adrenergic agents|mesh-ancestor
65527734|NCT04639011|Sympathomimetics|sympathomimetics|mesh-ancestor
65527735|NCT04639011|Autonomic Agents|autonomic agents|mesh-ancestor
65527736|NCT04639011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65527737|NCT04639011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65527738|NCT04639011|Serotonin Agents|serotonin agents|mesh-ancestor
65527739|NCT02053558|Lidocaine|lidocaine|mesh-list
65527740|NCT02053558|Ropivacaine|ropivacaine|mesh-list
65527741|NCT02053558|Anesthetics, Local|anesthetics, local|mesh-ancestor
65527742|NCT02053558|Anesthetics|anesthetics|mesh-ancestor
65527743|NCT02053558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65527744|NCT02053558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527745|NCT02053558|Sensory System Agents|sensory system agents|mesh-ancestor
65527746|NCT02053558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527747|NCT02053558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65527748|NCT02053558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65527749|NCT02053558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65527750|NCT02053558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65527751|NCT02053558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527752|NCT03809949|Fentanyl|fentanyl|mesh-list
65527753|NCT03809949|Anesthetics|anesthetics|mesh-list
65527754|NCT03809949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65527755|NCT03809949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527756|NCT03809949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65527757|NCT03809949|Narcotics|narcotics|mesh-ancestor
65527758|NCT03809949|Analgesics|analgesics|mesh-ancestor
65527759|NCT03809949|Sensory System Agents|sensory system agents|mesh-ancestor
65527760|NCT03809949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527761|NCT03809949|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65527762|NCT03809949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65527763|NCT03809949|Anesthetics, General|anesthetics, general|mesh-ancestor
65527764|NCT02052934|Vaccines|vaccines|mesh-list
65527765|NCT02052934|Immunologic Factors|immunologic factors|mesh-ancestor
65527766|NCT02052934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527767|NCT03810261|Vitamin D|vitamin d|mesh-list
65527768|NCT03810261|Ergocalciferols|ergocalciferols|mesh-list
65527769|NCT03810261|Cholecalciferol|cholecalciferol|mesh-list
65527770|NCT03810261|Vitamins|vitamins|mesh-list
65527771|NCT03810261|Micronutrients|micronutrients|mesh-ancestor
65527772|NCT03810261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527773|NCT03810261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65527774|NCT03810261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65527775|NCT02037724|Iron|iron|mesh-list
65527776|NCT02037724|Trace Elements|trace elements|mesh-ancestor
65527777|NCT02037724|Micronutrients|micronutrients|mesh-ancestor
65527778|NCT02037724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527779|NCT03327675|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65527780|NCT03327675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65527781|NCT03327675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527782|NCT01569633|Erythromycin|erythromycin|mesh-list
65527783|NCT01569633|Erythromycin Estolate|erythromycin estolate|mesh-list
65527784|NCT01569633|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65527785|NCT01569633|Erythromycin stearate|erythromycin stearate|mesh-list
65527786|NCT01569633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65527787|NCT01569633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65527788|NCT01569633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65527789|NCT01569633|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65527790|NCT01569633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527791|NCT01569633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527792|NCT02054182|Vitamin D|vitamin d|mesh-list
65527793|NCT02054182|Cholecalciferol|cholecalciferol|mesh-list
65527794|NCT02054182|Vitamins|vitamins|mesh-ancestor
65527795|NCT02054182|Micronutrients|micronutrients|mesh-ancestor
65527796|NCT02054182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527797|NCT02054182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65527798|NCT02054182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65527800|NCT03323151|Glycine|glycine|mesh-list
65527801|NCT03323151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527802|NCT03323151|Protease Inhibitors|protease inhibitors|mesh-ancestor
65527803|NCT03323151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527804|NCT03323151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527805|NCT03323151|Glycine Agents|glycine agents|mesh-ancestor
65527806|NCT03323151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65527807|NCT03323151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527808|NCT02803138|Ritonavir|ritonavir|mesh-list
65527809|NCT02803138|Ribavirin|ribavirin|mesh-list
65527810|NCT02803138|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65527811|NCT02803138|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65527812|NCT02803138|Protease Inhibitors|protease inhibitors|mesh-ancestor
65527813|NCT02803138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527814|NCT02803138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527815|NCT02803138|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65527816|NCT02803138|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65527817|NCT02803138|Antiviral Agents|antiviral agents|mesh-ancestor
65527818|NCT02803138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65527819|NCT02803138|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65527820|NCT02803138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65527821|NCT02803138|Antimetabolites|antimetabolites|mesh-ancestor
65527822|NCT03795207|Durvalumab|durvalumab|mesh-list
65527823|NCT03795207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65527824|NCT03795207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527825|NCT02056210|Plerixafor|plerixafor|mesh-list
65527826|NCT02056210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65527827|NCT02056210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65527828|NCT02056210|Antiviral Agents|antiviral agents|mesh-ancestor
65527829|NCT02056210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65527830|NCT00131235|Azithromycin|azithromycin|mesh-list
65527831|NCT00131235|Pyrimethamine|pyrimethamine|mesh-list
65527832|NCT00131235|Sulfadoxine|sulfadoxine|mesh-list
65527833|NCT00131235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65527834|NCT00131235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65527835|NCT00131235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65527836|NCT00131235|Antimalarials|antimalarials|mesh-ancestor
65527837|NCT00131235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65527838|NCT00131235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65527839|NCT00131235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65527840|NCT00131235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527841|NCT00131235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527842|NCT00131235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65527843|NCT00131235|Renal Agents|renal agents|mesh-ancestor
65527844|NCT03794505|Methylprednisolone|methylprednisolone|mesh-list
65527845|NCT03794505|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65527846|NCT03794505|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65527847|NCT03794505|Prednisolone|prednisolone|mesh-list
65527848|NCT03794505|Prednisolone acetate|prednisolone acetate|mesh-list
65527849|NCT03794505|Lidocaine|lidocaine|mesh-list
65527850|NCT03794505|Ropivacaine|ropivacaine|mesh-list
65527851|NCT03794505|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65527852|NCT03794505|Prednisolone phosphate|prednisolone phosphate|mesh-list
65527853|NCT03794505|Anesthetics, Local|anesthetics, local|mesh-ancestor
65527854|NCT03794505|Anesthetics|anesthetics|mesh-ancestor
65527855|NCT03794505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65527856|NCT03794505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527857|NCT03794505|Sensory System Agents|sensory system agents|mesh-ancestor
65527858|NCT03794505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527859|NCT03794505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65527860|NCT03794505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65527861|NCT03794505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65527862|NCT03794505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65527863|NCT03794505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527864|NCT03794505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65527865|NCT03794505|Antiemetics|antiemetics|mesh-ancestor
65527866|NCT03794505|Autonomic Agents|autonomic agents|mesh-ancestor
65527867|NCT03794505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65527868|NCT03794505|Glucocorticoids|glucocorticoids|mesh-ancestor
65527869|NCT03794505|Hormones|hormones|mesh-ancestor
65527870|NCT03794505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65325360|NCT02604797|Serotonin Agents|serotonin agents|mesh-ancestor
65527871|NCT03794505|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65527872|NCT03794505|Protective Agents|protective agents|mesh-ancestor
65527873|NCT03794505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65527874|NCT03794505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527875|NCT05625243|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
65527876|NCT05625243|Vasodilator Agents|vasodilator agents|mesh-ancestor
65527877|NCT05625243|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65527878|NCT05625243|Protective Agents|protective agents|mesh-ancestor
65527879|NCT05625243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527880|NCT03023007|Anesthetics|anesthetics|mesh-list
65527881|NCT03023007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65527882|NCT03023007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527883|NCT01304901|Montelukast|montelukast|mesh-list
65527884|NCT01304901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65527885|NCT01304901|Respiratory System Agents|respiratory system agents|mesh-ancestor
65527886|NCT01304901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65527887|NCT01304901|Hormone Antagonists|hormone antagonists|mesh-ancestor
65527888|NCT01304901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65527889|NCT01304901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527890|NCT01304901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65527891|NCT01304901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65527892|NCT01304901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527893|NCT05624853|Pregabalin|pregabalin|mesh-list
65527894|NCT05624853|Analgesics|analgesics|mesh-ancestor
65527895|NCT05624853|Sensory System Agents|sensory system agents|mesh-ancestor
65527896|NCT05624853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527897|NCT05624853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527898|NCT05624853|Anticonvulsants|anticonvulsants|mesh-ancestor
65527899|NCT05624853|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65527900|NCT05624853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65527901|NCT05624853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527902|NCT05624853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65527903|NCT05624853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65527904|NCT05624853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65527905|NCT05624853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65527906|NCT05624853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65527907|NCT03794271|Anesthetics|anesthetics|mesh-list
65527908|NCT03794271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65527909|NCT03794271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527910|NCT02798523|Methylprednisolone|methylprednisolone|mesh-list
65527911|NCT02798523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65527912|NCT02798523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65527913|NCT02798523|Prednisolone|prednisolone|mesh-list
65527914|NCT02798523|Prednisolone acetate|prednisolone acetate|mesh-list
65527915|NCT02798523|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
65527916|NCT02798523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65527917|NCT02798523|Prednisolone phosphate|prednisolone phosphate|mesh-list
65527918|NCT02798523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65527919|NCT02798523|Antiemetics|antiemetics|mesh-ancestor
65527920|NCT02798523|Autonomic Agents|autonomic agents|mesh-ancestor
65527921|NCT02798523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527922|NCT02798523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527923|NCT02798523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65527924|NCT02798523|Glucocorticoids|glucocorticoids|mesh-ancestor
65527925|NCT02798523|Hormones|hormones|mesh-ancestor
65527926|NCT02798523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65527927|NCT02798523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65527928|NCT02798523|Protective Agents|protective agents|mesh-ancestor
65527929|NCT02798523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65527930|NCT02798523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527931|NCT03792321|Methyltestosterone|methyltestosterone|mesh-list
65527932|NCT03792321|Testosterone|testosterone|mesh-list
65527933|NCT03792321|Testosterone undecanoate|testosterone undecanoate|mesh-list
65527934|NCT03792321|Testosterone enanthate|testosterone enanthate|mesh-list
65527935|NCT03792321|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65527936|NCT03792321|Androgens|androgens|mesh-ancestor
65527937|NCT03792321|Hormones|hormones|mesh-ancestor
65527938|NCT03792321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65527939|NCT03792321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527940|NCT03792321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65527941|NCT03792321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527942|NCT03792321|Anabolic Agents|anabolic agents|mesh-ancestor
65527943|NCT01305057|Pyridoxine|pyridoxine|mesh-list
65527944|NCT01305057|Vitamin B Complex|vitamin b complex|mesh-ancestor
65527945|NCT01305057|Vitamins|vitamins|mesh-ancestor
65527946|NCT01305057|Micronutrients|micronutrients|mesh-ancestor
65527947|NCT01305057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527948|NCT03792009|Bupivacaine|bupivacaine|mesh-list
65527949|NCT03792009|Anesthetics, Local|anesthetics, local|mesh-ancestor
65527950|NCT03792009|Anesthetics|anesthetics|mesh-ancestor
65527951|NCT03792009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65527952|NCT03792009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527953|NCT03792009|Sensory System Agents|sensory system agents|mesh-ancestor
65527954|NCT03792009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527955|NCT01305135|Azacitidine|azacitidine|mesh-list
65527956|NCT01305135|Idarubicin|idarubicin|mesh-list
65527957|NCT01305135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65527958|NCT01305135|Antimetabolites|antimetabolites|mesh-ancestor
65527959|NCT01305135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527960|NCT01305135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527961|NCT01305135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527962|NCT01305135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65527963|NCT01305135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65527964|NCT01305135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65527965|NCT01305603|Bupivacaine|bupivacaine|mesh-list
65527966|NCT01305603|Anesthetics, Local|anesthetics, local|mesh-list
65527967|NCT01305603|Anesthetics|anesthetics|mesh-list
65527968|NCT01305603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65527969|NCT01305603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527970|NCT01305603|Sensory System Agents|sensory system agents|mesh-ancestor
65527971|NCT01305603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65527972|NCT02058706|Leuprolide|leuprolide|mesh-list
65527973|NCT02058706|Goserelin|goserelin|mesh-list
65527974|NCT02058706|Bicalutamide|bicalutamide|mesh-list
65527975|NCT02058706|Androgens|androgens|mesh-list
65527976|NCT02058706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65527977|NCT02058706|Fertility Agents|fertility agents|mesh-ancestor
65527978|NCT02058706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65527979|NCT02058706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527980|NCT02058706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65527981|NCT02058706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527982|NCT02058706|Hormones|hormones|mesh-ancestor
65527983|NCT02058706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65527984|NCT02058706|Androgen Antagonists|androgen antagonists|mesh-ancestor
65527985|NCT02058706|Hormone Antagonists|hormone antagonists|mesh-ancestor
65527986|NCT03793725|Apatinib|apatinib|mesh-list
65527987|NCT03793725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65527988|NCT03793725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65527989|NCT03793725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65527990|NCT03793725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527991|NCT01305369|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65527992|NCT01305369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65527993|NCT02056366|Thioctic Acid|thioctic acid|mesh-list
65527994|NCT02056366|Antioxidants|antioxidants|mesh-ancestor
65527995|NCT02056366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65527996|NCT02056366|Protective Agents|protective agents|mesh-ancestor
65527997|NCT02056366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65527998|NCT02056366|Vitamin B Complex|vitamin b complex|mesh-ancestor
65527999|NCT02056366|Vitamins|vitamins|mesh-ancestor
65528000|NCT02056366|Micronutrients|micronutrients|mesh-ancestor
65528001|NCT02056444|Tranexamic Acid|tranexamic acid|mesh-list
65528002|NCT02056444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65528003|NCT02056444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65528004|NCT02056444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528005|NCT02056444|Hemostatics|hemostatics|mesh-ancestor
65528006|NCT02056444|Coagulants|coagulants|mesh-ancestor
65528007|NCT02665234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65528008|NCT02665234|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65528009|NCT05624229|Esomeprazole|esomeprazole|mesh-list
65528010|NCT05624229|Omeprazole|omeprazole|mesh-list
65528011|NCT05624229|Rabeprazole|rabeprazole|mesh-list
65528012|NCT05624229|Pantoprazole|pantoprazole|mesh-list
65528013|NCT05624229|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65528014|NCT05624229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65325508|NCT00721578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528015|NCT05624229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65528016|NCT05624229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528017|NCT05624229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528018|NCT05622370|Brivaracetam|brivaracetam|mesh-list
65528019|NCT05622370|Anticonvulsants|anticonvulsants|mesh-ancestor
65528020|NCT03791775|Polidocanol|polidocanol|mesh-list
65528021|NCT03791775|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65528022|NCT03791775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65528023|NCT01730937|Sorafenib|sorafenib|mesh-list
65528024|NCT01730937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528025|NCT01730937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65528026|NCT01730937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528027|NCT01730937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528028|NCT03789123|Dienogest|dienogest|mesh-list
65528029|NCT03789123|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65528030|NCT03789123|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65528031|NCT03789123|Estradiol|estradiol|mesh-list
65528032|NCT03789123|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65528033|NCT03789123|Nandrolone|nandrolone|mesh-list
65528034|NCT03789123|Estrogens|estrogens|mesh-ancestor
65528035|NCT03789123|Hormones|hormones|mesh-ancestor
65528036|NCT03789123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65528037|NCT03789123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528038|NCT03789123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65528039|NCT03789123|Contraceptive Agents|contraceptive agents|mesh-ancestor
65528040|NCT03789123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65528041|NCT03789123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65528042|NCT03789123|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65528043|NCT03789123|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65528044|NCT03789123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65528045|NCT03789123|Hormone Antagonists|hormone antagonists|mesh-ancestor
65528046|NCT03789123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65528047|NCT03789123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528048|NCT03789123|Androgens|androgens|mesh-ancestor
65528049|NCT03789123|Anabolic Agents|anabolic agents|mesh-ancestor
65528050|NCT05471817|Dabigatran|dabigatran|mesh-list
65528051|NCT05471817|Antithrombins|antithrombins|mesh-ancestor
65528052|NCT05471817|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65528053|NCT05471817|Protease Inhibitors|protease inhibitors|mesh-ancestor
65528054|NCT05471817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528055|NCT05471817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528056|NCT05471817|Anticoagulants|anticoagulants|mesh-ancestor
65528057|NCT03788889|Ketamine|ketamine|mesh-list
65528058|NCT03788889|Lorazepam|lorazepam|mesh-list
65528059|NCT03788889|Phenobarbital|phenobarbital|mesh-list
65528060|NCT03788889|Analgesics|analgesics|mesh-ancestor
65528061|NCT03788889|Sensory System Agents|sensory system agents|mesh-ancestor
65528062|NCT03788889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65528063|NCT03788889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528064|NCT03788889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65528065|NCT03788889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65528066|NCT03788889|Anesthetics, General|anesthetics, general|mesh-ancestor
65528067|NCT03788889|Anesthetics|anesthetics|mesh-ancestor
65528068|NCT03788889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65528069|NCT03788889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65528070|NCT03788889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65528071|NCT03788889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65528072|NCT03788889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528073|NCT03788889|Anticonvulsants|anticonvulsants|mesh-ancestor
65528074|NCT03788889|Antiemetics|antiemetics|mesh-ancestor
65528075|NCT03788889|Autonomic Agents|autonomic agents|mesh-ancestor
65528076|NCT03788889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65528077|NCT03788889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65528078|NCT03788889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65528079|NCT03788889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65528080|NCT03788889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65528081|NCT03788889|GABA Modulators|gaba modulators|mesh-ancestor
65528082|NCT03788889|GABA Agents|gaba agents|mesh-ancestor
65528083|NCT03788889|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65528084|NCT03788889|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65528085|NCT03788889|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65528086|NCT05669079|Decitabine|decitabine|mesh-list
65528087|NCT05669079|Epoetin Alfa|epoetin alfa|mesh-list
65528088|NCT05669079|Lenograstim|lenograstim|mesh-list
65528089|NCT05669079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65528090|NCT05669079|Antimetabolites|antimetabolites|mesh-ancestor
65528091|NCT05669079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528092|NCT05669079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528093|NCT05669079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528094|NCT05669079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65528095|NCT05669079|Immunologic Factors|immunologic factors|mesh-ancestor
65528096|NCT05669079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325583|NCT05073237|Estrogens|estrogens|mesh-list
65528097|NCT05669079|Hematinics|hematinics|mesh-ancestor
65528098|NCT03788733|Melatonin|melatonin|mesh-list
65528099|NCT03788733|Antioxidants|antioxidants|mesh-ancestor
65528100|NCT03788733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528101|NCT03788733|Protective Agents|protective agents|mesh-ancestor
65528102|NCT03788733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528103|NCT03788733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65528104|NCT03791463|Salvianolic acid A|salvianolic acid a|mesh-list
65528105|NCT03791463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528106|NCT03791463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528107|NCT03791463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528108|NCT03791463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65528109|NCT04753515|Midazolam|midazolam|mesh-list
65528110|NCT04753515|Dexmedetomidine|dexmedetomidine|mesh-list
65528111|NCT04753515|Remifentanil|remifentanil|mesh-list
65528112|NCT04753515|Propofol|propofol|mesh-list
65528113|NCT04753515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65528114|NCT04753515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65528115|NCT04753515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528116|NCT04753515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65528117|NCT04753515|Anesthetics, General|anesthetics, general|mesh-ancestor
65528118|NCT04753515|Anesthetics|anesthetics|mesh-ancestor
65528119|NCT04753515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65528120|NCT04753515|Analgesics|analgesics|mesh-ancestor
65528121|NCT04753515|Sensory System Agents|sensory system agents|mesh-ancestor
65528122|NCT04753515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65528123|NCT04753515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65528124|NCT04753515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65528125|NCT04753515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65528126|NCT04753515|Adrenergic Agents|adrenergic agents|mesh-ancestor
65528127|NCT04753515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65528128|NCT04753515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528129|NCT04753515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65528130|NCT04753515|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65528131|NCT04753515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65528132|NCT04753515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65528133|NCT04753515|GABA Modulators|gaba modulators|mesh-ancestor
65528134|NCT04753515|GABA Agents|gaba agents|mesh-ancestor
65528135|NCT04753515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65528136|NCT04753515|Narcotics|narcotics|mesh-ancestor
65528137|NCT01306461|Timolol|timolol|mesh-list
65528138|NCT01306461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65528139|NCT01306461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65528140|NCT01306461|Adrenergic Agents|adrenergic agents|mesh-ancestor
65528141|NCT01306461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65528142|NCT01306461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528143|NCT01306461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528144|NCT01306461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65528145|NCT01306461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65528146|NCT01305837|Methylprednisolone|methylprednisolone|mesh-list
65528147|NCT01305837|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65528148|NCT01305837|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65528149|NCT01305837|Prednisolone|prednisolone|mesh-list
65528150|NCT01305837|Prednisolone acetate|prednisolone acetate|mesh-list
65528151|NCT01305837|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65528152|NCT01305837|Prednisolone phosphate|prednisolone phosphate|mesh-list
65528153|NCT01305837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65528154|NCT01305837|Antiemetics|antiemetics|mesh-ancestor
65528155|NCT01305837|Autonomic Agents|autonomic agents|mesh-ancestor
65528156|NCT01305837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65528157|NCT01305837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528158|NCT01305837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65528159|NCT01305837|Glucocorticoids|glucocorticoids|mesh-ancestor
65528160|NCT01305837|Hormones|hormones|mesh-ancestor
65528161|NCT01305837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65528162|NCT01305837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65528163|NCT01305837|Protective Agents|protective agents|mesh-ancestor
65528164|NCT01305837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65528165|NCT01305837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528166|NCT01306773|Oseltamivir|oseltamivir|mesh-list
65528167|NCT01306773|Antiviral Agents|antiviral agents|mesh-ancestor
65528168|NCT01306773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65528169|NCT01306773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528170|NCT01306773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528171|NCT03790605|Curcumin|curcumin|mesh-list
65528172|NCT03790605|Iproplatin|iproplatin|mesh-list
65528173|NCT03790605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65528174|NCT03790605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65528175|NCT03790605|Analgesics|analgesics|mesh-ancestor
65528176|NCT03790605|Sensory System Agents|sensory system agents|mesh-ancestor
65528177|NCT03790605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65528178|NCT03790605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528179|NCT03790605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65528180|NCT03790605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65528181|NCT03790605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528182|NCT03790605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528183|NCT03790605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528184|NCT03787953|Antibodies|antibodies|mesh-list
65528185|NCT03787953|Immunologic Factors|immunologic factors|mesh-ancestor
65528186|NCT03787953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528187|NCT05590689|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65528188|NCT05590689|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65528189|NCT05590689|Dermatologic Agents|dermatologic agents|mesh-ancestor
65528190|NCT01306851|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65528191|NCT01306851|Hemostatics|hemostatics|mesh-ancestor
65528192|NCT01306851|Coagulants|coagulants|mesh-ancestor
65528193|NCT03790215|Dydrogesterone|dydrogesterone|mesh-list
65528194|NCT03790215|Progestins|progestins|mesh-ancestor
65528195|NCT03790215|Hormones|hormones|mesh-ancestor
65528196|NCT03790215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65528197|NCT03790215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528198|NCT03790371|Misoprostol|misoprostol|mesh-list
65528199|NCT03790371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65528200|NCT03790371|Abortifacient Agents|abortifacient agents|mesh-ancestor
65528201|NCT03790371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65528202|NCT03790371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528203|NCT03790371|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65528204|NCT03790371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65528205|NCT03790371|Oxytocics|oxytocics|mesh-ancestor
65528206|NCT01307475|Adenosine|adenosine|mesh-list
65528207|NCT01307475|Analgesics|analgesics|mesh-ancestor
65528208|NCT01307475|Sensory System Agents|sensory system agents|mesh-ancestor
65528209|NCT01307475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65528210|NCT01307475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528211|NCT01307475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65528212|NCT01307475|Vasodilator Agents|vasodilator agents|mesh-ancestor
65528213|NCT01307475|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65528214|NCT01307475|Purinergic Agonists|purinergic agonists|mesh-ancestor
65528215|NCT01307475|Purinergic Agents|purinergic agents|mesh-ancestor
65528216|NCT01307475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65528217|NCT01307475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528218|NCT03787641|Protamines|protamines|mesh-list
65528219|NCT03787641|Heparin Antagonists|heparin antagonists|mesh-ancestor
65528220|NCT03787641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528221|NCT03787641|Coagulants|coagulants|mesh-ancestor
65528222|NCT03790293|Rituximab|rituximab|mesh-list
65528223|NCT03790293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65528224|NCT03790293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528225|NCT03790293|Immunologic Factors|immunologic factors|mesh-ancestor
65528226|NCT03790293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528227|NCT03790293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65528228|NCT03245450|Irinotecan|irinotecan|mesh-list
65528229|NCT03245450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65528230|NCT03245450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65528231|NCT03245450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528232|NCT03245450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528233|NCT03245450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528234|NCT05694585|Esmolol|esmolol|mesh-list
65528235|NCT05694585|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65528236|NCT05694585|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65528237|NCT05694585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65528238|NCT05694585|Adrenergic Agents|adrenergic agents|mesh-ancestor
65528239|NCT05694585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65528240|NCT05694585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528241|NCT05694585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528242|NCT03712917|Topiramate|topiramate|mesh-list
65528243|NCT03712917|Flunarizine|flunarizine|mesh-list
65528244|NCT03712917|Anticonvulsants|anticonvulsants|mesh-ancestor
65528245|NCT03712917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65528246|NCT03712917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528247|NCT03712917|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65528248|NCT03712917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65528249|NCT03712917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528250|NCT03712917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65528252|NCT03712917|Histamine Antagonists|histamine antagonists|mesh-ancestor
65528253|NCT03712917|Histamine Agents|histamine agents|mesh-ancestor
65528254|NCT03712917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65528255|NCT03712917|Vasodilator Agents|vasodilator agents|mesh-ancestor
65528256|NCT03787017|Metformin|metformin|mesh-list
65528257|NCT03787017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65528258|NCT03787017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528259|NCT01307865|Mannitol|mannitol|mesh-list
65528260|NCT01307865|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65528261|NCT01307865|Diuretics|diuretics|mesh-ancestor
65528262|NCT01307865|Natriuretic Agents|natriuretic agents|mesh-ancestor
65528263|NCT01307865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528264|NCT01308177|Ecabet|ecabet|mesh-list
65528265|NCT01308177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65528266|NCT01308177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65528267|NCT01308177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65528268|NCT01308177|Protease Inhibitors|protease inhibitors|mesh-ancestor
65528269|NCT01308177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528270|NCT01308177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528271|NCT01308177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65528272|NCT01308177|Protective Agents|protective agents|mesh-ancestor
65528273|NCT01308177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528274|NCT01308177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528275|NCT01308255|Vitamins|vitamins|mesh-list
65528276|NCT01308255|Folic Acid|folic acid|mesh-list
65528277|NCT01308255|Methylprednisolone|methylprednisolone|mesh-list
65528278|NCT01308255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65528279|NCT01308255|Methotrexate|methotrexate|mesh-list
65528280|NCT01308255|Infliximab|infliximab|mesh-list
65528281|NCT01308255|Micronutrients|micronutrients|mesh-ancestor
65528282|NCT01308255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528283|NCT01308255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65528284|NCT01308255|Abortifacient Agents|abortifacient agents|mesh-ancestor
65528285|NCT01308255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65528286|NCT01308255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65528287|NCT01308255|Antimetabolites|antimetabolites|mesh-ancestor
65528288|NCT01308255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528289|NCT01308255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528290|NCT01308255|Dermatologic Agents|dermatologic agents|mesh-ancestor
65528291|NCT01308255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528292|NCT01308255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65528293|NCT01308255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65528294|NCT01308255|Immunologic Factors|immunologic factors|mesh-ancestor
65528295|NCT01308255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65528296|NCT01308255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65528297|NCT01308255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65528298|NCT01308255|Antiemetics|antiemetics|mesh-ancestor
65528299|NCT01308255|Autonomic Agents|autonomic agents|mesh-ancestor
65528300|NCT01308255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65528301|NCT01308255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65528302|NCT01308255|Glucocorticoids|glucocorticoids|mesh-ancestor
65528303|NCT01308255|Hormones|hormones|mesh-ancestor
65528304|NCT01308255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65528305|NCT01308255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65528306|NCT01308255|Protective Agents|protective agents|mesh-ancestor
65528307|NCT01308255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65528308|NCT01308255|Hematinics|hematinics|mesh-ancestor
65528309|NCT01308255|Vitamin B Complex|vitamin b complex|mesh-ancestor
65528310|NCT03782025|Vitamin K 1|vitamin k 1|mesh-list
65528311|NCT03782025|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65528312|NCT03782025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65528313|NCT03782025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528314|NCT03782025|Hemostatics|hemostatics|mesh-ancestor
65528315|NCT03782025|Coagulants|coagulants|mesh-ancestor
65528316|NCT03782025|Vitamins|vitamins|mesh-ancestor
65528317|NCT03782025|Micronutrients|micronutrients|mesh-ancestor
65528318|NCT03782025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528319|NCT03781947|Antarelix|antarelix|mesh-list
65528320|NCT03781947|Hormone Antagonists|hormone antagonists|mesh-ancestor
65528321|NCT03781947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65528322|NCT03781947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528323|NCT03781869|Cisplatin|cisplatin|mesh-list
65528324|NCT03781869|Etoposide|etoposide|mesh-list
65528325|NCT03781869|Etoposide phosphate|etoposide phosphate|mesh-list
65528326|NCT03781869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528327|NCT03781869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65528328|NCT03781869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65528329|NCT03781869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65528330|NCT03781869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528331|NCT03781869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528332|NCT01311765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65528333|NCT01311765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65528334|NCT03781635|Ketamine|ketamine|mesh-list
65528335|NCT03781635|Analgesics|analgesics|mesh-ancestor
65528336|NCT03781635|Sensory System Agents|sensory system agents|mesh-ancestor
65528337|NCT03781635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65528338|NCT03781635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528339|NCT03781635|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65528340|NCT03781635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65528341|NCT03781635|Anesthetics, General|anesthetics, general|mesh-ancestor
65528342|NCT03781635|Anesthetics|anesthetics|mesh-ancestor
65528343|NCT03781635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65528344|NCT03781635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65528345|NCT03781635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65528346|NCT03781635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65528347|NCT03781635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528348|NCT03781713|Anti-Infective Agents|anti-infective agents|mesh-list
65528349|NCT03781713|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65528350|NCT03781011|Choline|choline|mesh-list
65528351|NCT03781011|Lipotropic Agents|lipotropic agents|mesh-ancestor
65528352|NCT03781011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65528353|NCT03781011|Antimetabolites|antimetabolites|mesh-ancestor
65528354|NCT03781011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528355|NCT03781011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65528356|NCT03781011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65528357|NCT03781011|Nootropic Agents|nootropic agents|mesh-ancestor
65528358|NCT03785613|Buprenorphine|buprenorphine|mesh-list
65528359|NCT03785613|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65528360|NCT03785613|Narcotics|narcotics|mesh-ancestor
65528361|NCT03785613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65528362|NCT03785613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528363|NCT03785613|Analgesics|analgesics|mesh-ancestor
65528364|NCT03785613|Sensory System Agents|sensory system agents|mesh-ancestor
65528365|NCT03785613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65528366|NCT03785613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65528367|NCT03785223|Methylphenidate|methylphenidate|mesh-list
65528368|NCT03785223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65528369|NCT03785223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528370|NCT03785223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65528371|NCT03785223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65528372|NCT03785223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65528373|NCT03785223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528374|NCT03785223|Dopamine Agents|dopamine agents|mesh-ancestor
65528375|NCT03785223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65528376|NCT01308723|Sorafenib|sorafenib|mesh-list
65528377|NCT01308723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65528378|NCT01308723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528379|NCT01308723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65528380|NCT01308723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528381|NCT01308723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528382|NCT01308723|Immunologic Factors|immunologic factors|mesh-ancestor
65528383|NCT01308723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528384|NCT01561131|Calcium|calcium|mesh-list
65528385|NCT01561131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65528386|NCT01561131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528387|NCT01313403|Antidepressive Agents|antidepressive agents|mesh-list
65528388|NCT01313403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65528389|NCT03780621|Andrographolide|andrographolide|mesh-list
65528390|NCT03780621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65528391|NCT03780621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65528392|NCT03780621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65528393|NCT03780621|Analgesics|analgesics|mesh-ancestor
65528394|NCT03780621|Sensory System Agents|sensory system agents|mesh-ancestor
65528395|NCT03780621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65528396|NCT03780621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528397|NCT03780621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65528398|NCT03780621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65528399|NCT03780621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65528400|NCT03780621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65528401|NCT03780621|Antiviral Agents|antiviral agents|mesh-ancestor
65528402|NCT03780621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65528403|NCT03785067|Amlodipine|amlodipine|mesh-list
65528404|NCT03785067|Telmisartan|telmisartan|mesh-list
65528405|NCT03785067|Indapamide|indapamide|mesh-list
65528406|NCT03785067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65528407|NCT03785067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65528408|NCT03785067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65528409|NCT03785067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528410|NCT03785067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65528411|NCT03785067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528412|NCT03785067|Vasodilator Agents|vasodilator agents|mesh-ancestor
65528413|NCT03785067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65528414|NCT03785067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65528415|NCT03785067|Diuretics|diuretics|mesh-ancestor
65528416|NCT03785067|Natriuretic Agents|natriuretic agents|mesh-ancestor
65528417|NCT03785067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65528418|NCT05688111|Tranexamic Acid|tranexamic acid|mesh-list
65528419|NCT05688111|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65528420|NCT05688111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65528421|NCT05688111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528422|NCT05688111|Hemostatics|hemostatics|mesh-ancestor
65528423|NCT05688111|Coagulants|coagulants|mesh-ancestor
65528424|NCT02059018|Diclofenac|diclofenac|mesh-list
65528425|NCT02059018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
65528426|NCT02059018|Nitroglycerin|nitroglycerin|mesh-list
65528427|NCT02059018|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65528428|NCT02059018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65528429|NCT02059018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65528430|NCT02059018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65528431|NCT02059018|Analgesics|analgesics|mesh-ancestor
65528432|NCT02059018|Sensory System Agents|sensory system agents|mesh-ancestor
65528433|NCT02059018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65528434|NCT02059018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528435|NCT02059018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65528436|NCT02059018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65528437|NCT02059018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528438|NCT02059018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528439|NCT02059018|Vasodilator Agents|vasodilator agents|mesh-ancestor
65528440|NCT01561209|Amitriptyline|amitriptyline|mesh-list
65528441|NCT01561209|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65528442|NCT01561209|Antidepressive Agents|antidepressive agents|mesh-ancestor
65528443|NCT01561209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65528444|NCT01561209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65528445|NCT01561209|Analgesics|analgesics|mesh-ancestor
65528446|NCT01561209|Sensory System Agents|sensory system agents|mesh-ancestor
65528447|NCT01561209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65528448|NCT01561209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528449|NCT01561209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65528450|NCT01561209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65528451|NCT01561209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65528452|NCT01561209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528453|NCT01561209|Adrenergic Agents|adrenergic agents|mesh-ancestor
65528454|NCT01561209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65528455|NCT02800642|Aflibercept|aflibercept|mesh-list
65528456|NCT02800642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65528457|NCT02800642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65528458|NCT02800642|Growth Substances|growth substances|mesh-ancestor
65528459|NCT02800642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528460|NCT02800642|Growth Inhibitors|growth inhibitors|mesh-ancestor
65528461|NCT02800642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528462|NCT02056600|Metformin|metformin|mesh-list
65528463|NCT02056600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65528464|NCT02056600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528465|NCT02056678|Acetaminophen|acetaminophen|mesh-list
65528466|NCT02056678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65528467|NCT02056678|Analgesics|analgesics|mesh-ancestor
65528468|NCT02056678|Sensory System Agents|sensory system agents|mesh-ancestor
65528469|NCT02056678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65528470|NCT02056678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528471|NCT02056678|Antipyretics|antipyretics|mesh-ancestor
65528472|NCT04662567|Acetaminophen|acetaminophen|mesh-list
65528473|NCT04662567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65528474|NCT04662567|Analgesics|analgesics|mesh-ancestor
65528475|NCT04662567|Sensory System Agents|sensory system agents|mesh-ancestor
65528476|NCT04662567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65528477|NCT04662567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528478|NCT04662567|Antipyretics|antipyretics|mesh-ancestor
65528479|NCT02799784|Albuterol|albuterol|mesh-list
65528480|NCT02799784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65528481|NCT02799784|Autonomic Agents|autonomic agents|mesh-ancestor
65528482|NCT02799784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65528483|NCT02799784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528484|NCT02799784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65528485|NCT02799784|Respiratory System Agents|respiratory system agents|mesh-ancestor
65528486|NCT02799784|Tocolytic Agents|tocolytic agents|mesh-ancestor
65528487|NCT02799784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65528488|NCT02799784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65528489|NCT02799784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65528490|NCT02799784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65528491|NCT02799784|Adrenergic Agents|adrenergic agents|mesh-ancestor
65528492|NCT02799784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65528493|NCT02799784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528494|NCT03779685|Anesthetics|anesthetics|mesh-list
65528495|NCT03779685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65528496|NCT03779685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528497|NCT03779451|Progesterone|progesterone|mesh-list
65528498|NCT03779451|Progestins|progestins|mesh-ancestor
65528499|NCT03779451|Hormones|hormones|mesh-ancestor
65528500|NCT03779451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65528501|NCT03779451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528502|NCT02059330|Palbociclib|palbociclib|mesh-list
65528503|NCT02059330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528504|NCT02059330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65528505|NCT02059330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528506|NCT02059330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528507|NCT03784443|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
65528508|NCT03784443|Ranibizumab|ranibizumab|mesh-list
65528509|NCT03784443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65528510|NCT03784443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65528511|NCT03784443|Growth Substances|growth substances|mesh-ancestor
65528512|NCT03784443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528513|NCT03784443|Growth Inhibitors|growth inhibitors|mesh-ancestor
65528514|NCT03784443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528515|NCT03784443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65528516|NCT03784443|Glucocorticoids|glucocorticoids|mesh-ancestor
65528517|NCT03784443|Hormones|hormones|mesh-ancestor
65528518|NCT03784443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65528519|NCT02054806|Pembrolizumab|pembrolizumab|mesh-list
65528520|NCT02054806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65528521|NCT02054806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528522|NCT02054884|Paclitaxel|paclitaxel|mesh-list
65528523|NCT02054884|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65528524|NCT02054884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65528525|NCT02054884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528526|NCT02054884|Tubulin Modulators|tubulin modulators|mesh-ancestor
65528527|NCT02054884|Antimitotic Agents|antimitotic agents|mesh-ancestor
65528528|NCT02054884|Mitosis Modulators|mitosis modulators|mesh-ancestor
65528529|NCT02054884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528530|NCT01333072|Risperidone|risperidone|mesh-list
65528531|NCT01333072|Aripiprazole|aripiprazole|mesh-list
65528532|NCT01333072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65528533|NCT01333072|Serotonin Agents|serotonin agents|mesh-ancestor
65528534|NCT01333072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65528535|NCT01333072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528536|NCT01333072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528537|NCT01333072|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65528538|NCT01333072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65528539|NCT01333072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65528540|NCT01333072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65528541|NCT01333072|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65528542|NCT01333072|Dopamine Agents|dopamine agents|mesh-ancestor
65528543|NCT01333072|Antidepressive Agents|antidepressive agents|mesh-ancestor
65528544|NCT01333072|Dopamine Agonists|dopamine agonists|mesh-ancestor
65528545|NCT01333072|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65528546|NCT01333072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65528547|NCT01333072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65528548|NCT01333072|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65528549|NCT01560663|Carboplatin|carboplatin|mesh-list
65528551|NCT01560663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528552|NCT01560663|Tubulin Modulators|tubulin modulators|mesh-ancestor
65528553|NCT01560663|Antimitotic Agents|antimitotic agents|mesh-ancestor
65528554|NCT01560663|Mitosis Modulators|mitosis modulators|mesh-ancestor
65528555|NCT01560663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528556|NCT02059564|Liraglutide|liraglutide|mesh-list
65528557|NCT02059564|Exenatide|exenatide|mesh-list
65528558|NCT02059564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65528559|NCT02059564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528560|NCT02059564|Incretins|incretins|mesh-ancestor
65528561|NCT02059564|Hormones|hormones|mesh-ancestor
65528562|NCT02059564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65528563|NCT02059564|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65528564|NCT05622058|Cyclophosphamide|cyclophosphamide|mesh-list
65528565|NCT05622058|Docetaxel|docetaxel|mesh-list
65528566|NCT05622058|Doxorubicin|doxorubicin|mesh-list
65528567|NCT05622058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65528568|NCT05622058|Immunologic Factors|immunologic factors|mesh-ancestor
65528569|NCT05622058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528570|NCT05622058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65528571|NCT05622058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65528572|NCT05622058|Alkylating Agents|alkylating agents|mesh-ancestor
65528573|NCT05622058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528574|NCT05622058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528575|NCT05622058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65528576|NCT05622058|Tubulin Modulators|tubulin modulators|mesh-ancestor
65528577|NCT05622058|Antimitotic Agents|antimitotic agents|mesh-ancestor
65528578|NCT05622058|Mitosis Modulators|mitosis modulators|mesh-ancestor
65528579|NCT05622058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65528580|NCT05622058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65528581|NCT05622058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65528582|NCT05622058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528583|NCT02055196|Irinotecan|irinotecan|mesh-list
65528584|NCT02055196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65528585|NCT02055196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65528586|NCT02055196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528587|NCT02055196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528588|NCT02055196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528589|NCT02055274|Rotigotine|rotigotine|mesh-list
65528590|NCT02055274|Dopamine Agonists|dopamine agonists|mesh-ancestor
65528591|NCT02055274|Dopamine Agents|dopamine agents|mesh-ancestor
65528592|NCT02055274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65528593|NCT02055274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528594|NCT02055274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528595|NCT03783897|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65528596|NCT03783897|Norgestimate|norgestimate|mesh-list
65528597|NCT03783897|Contraceptive Agents|contraceptive agents|mesh-list
65528598|NCT03783897|Contraceptives, Oral|contraceptives, oral|mesh-list
65528599|NCT03783897|Estradiol|estradiol|mesh-list
65528600|NCT03783897|Estrogens|estrogens|mesh-ancestor
65528601|NCT03783897|Hormones|hormones|mesh-ancestor
65528602|NCT03783897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65528603|NCT03783897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528604|NCT03783897|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65528605|NCT03783897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65528606|NCT03783897|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65528607|NCT03783897|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65528608|NCT03783897|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65528609|NCT03779061|Propofol|propofol|mesh-list
65528610|NCT03779061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65528611|NCT03779061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65528612|NCT03779061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528613|NCT03779061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65528614|NCT03779061|Anesthetics, General|anesthetics, general|mesh-ancestor
65528615|NCT03779061|Anesthetics|anesthetics|mesh-ancestor
65528616|NCT01316445|Midazolam|midazolam|mesh-list
65528617|NCT01316445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65528618|NCT01316445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65528619|NCT01316445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65528620|NCT01316445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528621|NCT01316445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65528622|NCT01316445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65528623|NCT01316445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65528624|NCT01316445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65326113|NCT01021579|Metformin|metformin|mesh-list
65528625|NCT01316445|Anesthetics, General|anesthetics, general|mesh-ancestor
65528627|NCT01316445|GABA Modulators|gaba modulators|mesh-ancestor
65528628|NCT01316445|GABA Agents|gaba agents|mesh-ancestor
65528629|NCT01316445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65528630|NCT01316445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528631|NCT03712449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65528632|NCT03712449|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65528633|NCT03712449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65528634|NCT03712449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65528635|NCT03712449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528636|NCT03712449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65528637|NCT03712449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65528638|NCT03712449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528639|NCT03712449|Cholinergic Agents|cholinergic agents|mesh-ancestor
65528640|NCT03712449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65528641|NCT03517540|Cenicriviroc|cenicriviroc|mesh-list
65528642|NCT03517540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65528643|NCT03517540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528644|NCT03517540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65528645|NCT03517540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65528646|NCT03517540|Antiviral Agents|antiviral agents|mesh-ancestor
65528647|NCT03517540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65528648|NCT03778359|Leuprolide|leuprolide|mesh-list
65528649|NCT03778359|Dienogest|dienogest|mesh-list
65528650|NCT03778359|Levonorgestrel|levonorgestrel|mesh-list
65528651|NCT03778359|Progestins|progestins|mesh-list
65528652|NCT03778359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65528653|NCT03778359|Contraceptive Agents|contraceptive agents|mesh-ancestor
65528654|NCT03778359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65528655|NCT03778359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528656|NCT03778359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65528657|NCT03778359|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65528658|NCT03778359|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65528659|NCT03778359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65528660|NCT03778359|Fertility Agents|fertility agents|mesh-ancestor
65528661|NCT03778359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65528662|NCT03778359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528663|NCT03778359|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65528664|NCT03778359|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65528665|NCT03778359|Hormone Antagonists|hormone antagonists|mesh-ancestor
65528666|NCT03778359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65528667|NCT03778359|Hormones|hormones|mesh-ancestor
65528668|NCT03560908|Dasatinib|dasatinib|mesh-list
65528669|NCT03560908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528670|NCT03560908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65528671|NCT03560908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528672|NCT03560908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528673|NCT05623059|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65528674|NCT05623059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65528675|NCT05623059|Immunologic Factors|immunologic factors|mesh-ancestor
65528676|NCT05623059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528677|NCT02057770|Cyclophosphamide|cyclophosphamide|mesh-list
65528678|NCT02057770|Busulfan|busulfan|mesh-list
65528679|NCT02057770|Fludarabine|fludarabine|mesh-list
65528680|NCT02057770|Fludarabine phosphate|fludarabine phosphate|mesh-list
65528681|NCT02057770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65528682|NCT02057770|Immunologic Factors|immunologic factors|mesh-ancestor
65528683|NCT02057770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528684|NCT02057770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65528685|NCT02057770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65528686|NCT02057770|Alkylating Agents|alkylating agents|mesh-ancestor
65528687|NCT02057770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528688|NCT02057770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528689|NCT02057770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65528690|NCT02057770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65528691|NCT02057770|Antimetabolites|antimetabolites|mesh-ancestor
65528692|NCT05615025|Propofol|propofol|mesh-list
65528693|NCT05615025|Sevoflurane|sevoflurane|mesh-list
65528694|NCT05615025|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65528695|NCT05615025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65528696|NCT05615025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528697|NCT05615025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65528698|NCT05615025|Anesthetics, General|anesthetics, general|mesh-ancestor
65528699|NCT05615025|Anesthetics|anesthetics|mesh-ancestor
65528700|NCT05615025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65528701|NCT05615025|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65528702|NCT03778281|Baclofen|baclofen|mesh-list
65528703|NCT03778281|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65528704|NCT03778281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528705|NCT03778281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65528706|NCT03778281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65528707|NCT03778281|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65528708|NCT03778281|GABA Agonists|gaba agonists|mesh-ancestor
65528709|NCT03778281|GABA Agents|gaba agents|mesh-ancestor
65528710|NCT03778281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65528711|NCT03778281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528712|NCT02055586|Alovudine|alovudine|mesh-list
65528713|NCT02055586|Fluorides|fluorides|mesh-list
65528714|NCT02055586|Cariostatic Agents|cariostatic agents|mesh-ancestor
65528715|NCT02055586|Protective Agents|protective agents|mesh-ancestor
65528716|NCT02055586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528717|NCT02055586|Antiviral Agents|antiviral agents|mesh-ancestor
65528718|NCT02055586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65528719|NCT03778593|Leucovorin|leucovorin|mesh-list
65528720|NCT03778593|Fluorouracil|fluorouracil|mesh-list
65528721|NCT03778593|Oxaliplatin|oxaliplatin|mesh-list
65528722|NCT03778593|Irinotecan|irinotecan|mesh-list
65528723|NCT03778593|Antimetabolites|antimetabolites|mesh-ancestor
65528724|NCT03778593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528725|NCT03778593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65528726|NCT03778593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528727|NCT03778593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65528728|NCT03778593|Immunologic Factors|immunologic factors|mesh-ancestor
65528729|NCT03778593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528730|NCT03778593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65528731|NCT03778593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65528732|NCT03778593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528733|NCT03778593|Antidotes|antidotes|mesh-ancestor
65528734|NCT03778593|Protective Agents|protective agents|mesh-ancestor
65528735|NCT03778593|Vitamin B Complex|vitamin b complex|mesh-ancestor
65528736|NCT03778593|Vitamins|vitamins|mesh-ancestor
65528737|NCT03778593|Micronutrients|micronutrients|mesh-ancestor
65528738|NCT02055664|Ropivacaine|ropivacaine|mesh-list
65528739|NCT02055664|Anesthetics, Local|anesthetics, local|mesh-ancestor
65528740|NCT02055664|Anesthetics|anesthetics|mesh-ancestor
65528741|NCT02055664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65528742|NCT02055664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528743|NCT02055664|Sensory System Agents|sensory system agents|mesh-ancestor
65528744|NCT02055664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65528745|NCT01309425|Tapentadol|tapentadol|mesh-list
65528746|NCT01309425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65528747|NCT01309425|Narcotics|narcotics|mesh-ancestor
65528748|NCT01309425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65528749|NCT01309425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528750|NCT01309425|Analgesics|analgesics|mesh-ancestor
65528751|NCT01309425|Sensory System Agents|sensory system agents|mesh-ancestor
65528752|NCT01309425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65528753|NCT01309425|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65528754|NCT01309425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65528755|NCT01309425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65528756|NCT01309425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528757|NCT01309425|Adrenergic Agents|adrenergic agents|mesh-ancestor
65528758|NCT01309425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65528759|NCT03561298|Zanubrutinib|zanubrutinib|mesh-list
65528760|NCT03561298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528761|NCT03561298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65528762|NCT03561298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528763|NCT03561298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528764|NCT05648422|Nitazoxanide|nitazoxanide|mesh-list
65528765|NCT05648422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65528766|NCT05648422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65528767|NCT02057926|Tetracycline|tetracycline|mesh-list
65528768|NCT02057926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65528769|NCT02057926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65528770|NCT02057926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65528771|NCT02057926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528772|NCT02057926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528773|NCT03777579|Paclitaxel|paclitaxel|mesh-list
65528774|NCT03777579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65528775|NCT03777579|Antibodies|antibodies|mesh-list
65326262|NCT04100330|Cytarabine|cytarabine|mesh-list
65528776|NCT03777579|Immunoglobulins|immunoglobulins|mesh-list
65528777|NCT03777579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65528778|NCT03777579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528779|NCT03777579|Tubulin Modulators|tubulin modulators|mesh-ancestor
65528780|NCT03777579|Antimitotic Agents|antimitotic agents|mesh-ancestor
65528781|NCT03777579|Mitosis Modulators|mitosis modulators|mesh-ancestor
65528782|NCT03777579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528783|NCT03777579|Immunologic Factors|immunologic factors|mesh-ancestor
65528784|NCT03777579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528785|NCT02059876|Paclitaxel|paclitaxel|mesh-list
65528786|NCT02059876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65528787|NCT02059876|Carboplatin|carboplatin|mesh-list
65528788|NCT02059876|Trastuzumab|trastuzumab|mesh-list
65528789|NCT02059876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65528790|NCT02059876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528791|NCT02059876|Tubulin Modulators|tubulin modulators|mesh-ancestor
65528792|NCT02059876|Antimitotic Agents|antimitotic agents|mesh-ancestor
65528793|NCT02059876|Mitosis Modulators|mitosis modulators|mesh-ancestor
65528794|NCT02059876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528795|NCT02059876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65528797|NCT03777423|Chromium|chromium|mesh-list
65528798|NCT03777423|Trace Elements|trace elements|mesh-ancestor
65528799|NCT03777423|Micronutrients|micronutrients|mesh-ancestor
65528800|NCT03777423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528801|NCT05654662|Listerine|listerine|mesh-list
65528802|NCT05654662|Chlorhexidine|chlorhexidine|mesh-list
65528803|NCT05654662|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65528804|NCT05654662|Sodium Fluoride|sodium fluoride|mesh-list
65528805|NCT05654662|Cariostatic Agents|cariostatic agents|mesh-ancestor
65528806|NCT05654662|Protective Agents|protective agents|mesh-ancestor
65528807|NCT05654662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528808|NCT05654662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65528809|NCT05654662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65528810|NCT05654662|Disinfectants|disinfectants|mesh-ancestor
65528811|NCT05654662|Dermatologic Agents|dermatologic agents|mesh-ancestor
65528812|NCT03777033|Alfacalcidol|alfacalcidol|mesh-list
65528813|NCT03777033|Calcium|calcium|mesh-list
65528814|NCT03777033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65528815|NCT03777033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528816|NCT03777033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65528817|NCT03783429|Digoxin|digoxin|mesh-list
65528818|NCT03783429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65528819|NCT03783429|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65528820|NCT03783429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528821|NCT03783429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528822|NCT03783429|Protective Agents|protective agents|mesh-ancestor
65528823|NCT03783429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528824|NCT02060032|Atorvastatin|atorvastatin|mesh-list
65528825|NCT02060032|Simvastatin|simvastatin|mesh-list
65528826|NCT02060032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65528827|NCT02060032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65528828|NCT02060032|Antimetabolites|antimetabolites|mesh-ancestor
65528829|NCT02060032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528830|NCT02060032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65528831|NCT02060032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65528832|NCT02060032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528833|NCT03783273|Vitamin D|vitamin d|mesh-list
65528834|NCT03783273|Cholecalciferol|cholecalciferol|mesh-list
65528835|NCT03783273|Vitamins|vitamins|mesh-ancestor
65528836|NCT03783273|Micronutrients|micronutrients|mesh-ancestor
65528837|NCT03783273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528838|NCT03783273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65528839|NCT03783273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65528840|NCT03777345|Cobalt|cobalt|mesh-list
65528841|NCT03777345|Chromium|chromium|mesh-list
65528842|NCT03777345|Trace Elements|trace elements|mesh-ancestor
65528843|NCT03777345|Micronutrients|micronutrients|mesh-ancestor
65528844|NCT03777345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528845|NCT01318005|Contraceptive Agents|contraceptive agents|mesh-list
65528846|NCT01318005|Norinyl|norinyl|mesh-list
65528847|NCT01318005|Contraceptives, Oral|contraceptives, oral|mesh-list
65528848|NCT01318005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65528849|NCT01318005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528850|NCT01318005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65528851|NCT01318005|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65528852|NCT01318005|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65528853|NCT01318005|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65528854|NCT02799082|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65528855|NCT02799082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65528856|NCT02799082|Dermatologic Agents|dermatologic agents|mesh-ancestor
65528858|NCT03710889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65528859|NCT03710889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528860|NCT02061124|Sevelamer|sevelamer|mesh-list
65528861|NCT02061124|Chelating Agents|chelating agents|mesh-ancestor
65528862|NCT02061124|Sequestering Agents|sequestering agents|mesh-ancestor
65528863|NCT02061124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528864|NCT01318941|Ranibizumab|ranibizumab|mesh-list
65528865|NCT01318941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65528866|NCT01318941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65528867|NCT01318941|Growth Substances|growth substances|mesh-ancestor
65528868|NCT01318941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528869|NCT01318941|Growth Inhibitors|growth inhibitors|mesh-ancestor
65528870|NCT01318941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528871|NCT03560440|Vancomycin|vancomycin|mesh-list
65528872|NCT03560440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65528873|NCT03560440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65528874|NCT03776955|Carvedilol|carvedilol|mesh-list
65528875|NCT03776955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65528876|NCT03776955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65528877|NCT03776955|Adrenergic Agents|adrenergic agents|mesh-ancestor
65528878|NCT03776955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65528879|NCT03776955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528880|NCT03776955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528881|NCT03776955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65528882|NCT03776955|Antioxidants|antioxidants|mesh-ancestor
65528883|NCT03776955|Protective Agents|protective agents|mesh-ancestor
65528884|NCT03776955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65528885|NCT03776955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65528886|NCT03776955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65528887|NCT03776955|Vasodilator Agents|vasodilator agents|mesh-ancestor
65528888|NCT03776955|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65528889|NCT03776955|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65528890|NCT05102721|Avelumab|avelumab|mesh-list
65528891|NCT05102721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65528892|NCT05102721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528893|NCT03308942|Pembrolizumab|pembrolizumab|mesh-list
65528894|NCT03308942|Niraparib|niraparib|mesh-list
65528895|NCT03308942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65528896|NCT03308942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528897|NCT03308942|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65528898|NCT03308942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528899|NCT03308942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528900|NCT01319019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65528901|NCT01319019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65528902|NCT01319019|Autonomic Agents|autonomic agents|mesh-ancestor
65528903|NCT01319019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65528904|NCT01319019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528905|NCT01319019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65528906|NCT01319019|Respiratory System Agents|respiratory system agents|mesh-ancestor
65528907|NCT01319019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65528908|NCT01319019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65528909|NCT01319019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65528910|NCT01319019|Adrenergic Agents|adrenergic agents|mesh-ancestor
65528911|NCT01319019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65528912|NCT01319019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528913|NCT03308786|Aldesleukin|aldesleukin|mesh-list
65528914|NCT03308786|Interleukin-2|interleukin-2|mesh-list
65528915|NCT03308786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528916|NCT03308786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65528917|NCT03308786|Analgesics|analgesics|mesh-ancestor
65528918|NCT03308786|Sensory System Agents|sensory system agents|mesh-ancestor
65528919|NCT03308786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65528920|NCT03308786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528921|NCT03308786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65528922|NCT03308786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65528923|NCT03308786|Antiviral Agents|antiviral agents|mesh-ancestor
65528924|NCT03308786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65528925|NCT03776409|Vancomycin|vancomycin|mesh-list
65528926|NCT03776409|Tazobactam|tazobactam|mesh-list
65528927|NCT03776409|Piperacillin|piperacillin|mesh-list
65528928|NCT03776409|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65528930|NCT03776409|beta-Lactams|beta-lactams|mesh-list
65528931|NCT03776409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65528932|NCT03776409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65528933|NCT03776409|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65528934|NCT03776409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528935|NCT03776409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528936|NCT05045703|Vitamin A|vitamin a|mesh-list
65528937|NCT05045703|Retinol palmitate|retinol palmitate|mesh-list
65528938|NCT05045703|Vitamins|vitamins|mesh-ancestor
65528939|NCT05045703|Micronutrients|micronutrients|mesh-ancestor
65528940|NCT05045703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528941|NCT05045703|Antioxidants|antioxidants|mesh-ancestor
65528942|NCT05045703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528943|NCT05045703|Protective Agents|protective agents|mesh-ancestor
65528944|NCT05045703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65528945|NCT05045703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528946|NCT03782805|Cholecalciferol|cholecalciferol|mesh-list
65528947|NCT03782805|Vitamin D|vitamin d|mesh-list
65528948|NCT03782805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65528949|NCT03782805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528950|NCT03782805|Vitamins|vitamins|mesh-ancestor
65528951|NCT03782805|Micronutrients|micronutrients|mesh-ancestor
65528952|NCT03782805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65528953|NCT03775863|Liver Extracts|liver extracts|mesh-list
65528954|NCT03775863|Hematinics|hematinics|mesh-ancestor
65528955|NCT03274076|Tofacitinib|tofacitinib|mesh-list
65528956|NCT03274076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65528957|NCT03274076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528958|NCT03274076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528959|NCT03775707|Lenvatinib|lenvatinib|mesh-list
65528960|NCT03775707|Antibodies|antibodies|mesh-list
65528961|NCT03775707|Immunologic Factors|immunologic factors|mesh-ancestor
65528962|NCT03775707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528963|NCT03775707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528964|NCT03775707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65528965|NCT03775707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528966|NCT03775707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528967|NCT01320501|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65528968|NCT01320501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528969|NCT01320501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65528970|NCT01320501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528971|NCT01320501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528972|NCT02764268|Apatinib|apatinib|mesh-list
65528973|NCT02764268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528974|NCT02764268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65528975|NCT02764268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528976|NCT02764268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528977|NCT01320111|Paclitaxel|paclitaxel|mesh-list
65528978|NCT01320111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65528979|NCT01320111|Sorafenib|sorafenib|mesh-list
65528980|NCT01320111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65528981|NCT01320111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65528982|NCT01320111|Tubulin Modulators|tubulin modulators|mesh-ancestor
65528983|NCT01320111|Antimitotic Agents|antimitotic agents|mesh-ancestor
65528984|NCT01320111|Mitosis Modulators|mitosis modulators|mesh-ancestor
65528985|NCT01320111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528986|NCT01320111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65528987|NCT01320111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528988|NCT01320579|Tacrolimus|tacrolimus|mesh-list
65528989|NCT01320579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65528990|NCT01320579|Immunologic Factors|immunologic factors|mesh-ancestor
65528991|NCT01320579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65528992|NCT01320579|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65528993|NCT01320579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65528994|NCT01320579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65528995|NCT05669001|Mycophenolic Acid|mycophenolic acid|mesh-list
65528996|NCT05669001|Abatacept|abatacept|mesh-list
65528997|NCT05669001|Tacrolimus|tacrolimus|mesh-list
65528998|NCT05669001|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65528999|NCT05669001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65529000|NCT05669001|Immunologic Factors|immunologic factors|mesh-ancestor
65529001|NCT05669001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529002|NCT05669001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65529003|NCT05669001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529004|NCT05669001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529006|NCT05669001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65529007|NCT05669001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65529008|NCT05669001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65529009|NCT05669001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65529010|NCT05669001|Antitubercular Agents|antitubercular agents|mesh-ancestor
65529011|NCT05669001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65529012|NCT05669001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65529013|NCT03775395|Sorafenib|sorafenib|mesh-list
65529014|NCT03775395|Lenvatinib|lenvatinib|mesh-list
65529015|NCT03775395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65529016|NCT03775395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65529017|NCT03775395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529018|NCT03775395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529019|NCT02797522|Acetaminophen|acetaminophen|mesh-list
65529020|NCT02797522|Tenofovir|tenofovir|mesh-list
65529021|NCT02797522|Entecavir|entecavir|mesh-list
65529022|NCT02797522|Histamine Antagonists|histamine antagonists|mesh-list
65529023|NCT02797522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
65529024|NCT02797522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65529025|NCT02797522|Analgesics|analgesics|mesh-ancestor
65529026|NCT02797522|Sensory System Agents|sensory system agents|mesh-ancestor
65529027|NCT02797522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529028|NCT02797522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529029|NCT02797522|Antipyretics|antipyretics|mesh-ancestor
65529030|NCT02797522|Antiviral Agents|antiviral agents|mesh-ancestor
65529031|NCT02797522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65529032|NCT02797522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65529033|NCT02797522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65529034|NCT02797522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529035|NCT02797522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529036|NCT02797522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65529037|NCT02797522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65529038|NCT02797522|Histamine Agents|histamine agents|mesh-ancestor
65529039|NCT02797522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65529040|NCT03773367|Fluorouracil|fluorouracil|mesh-list
65529041|NCT03773367|Oxaliplatin|oxaliplatin|mesh-list
65529042|NCT03773367|Irinotecan|irinotecan|mesh-list
65529043|NCT03773367|Antimetabolites|antimetabolites|mesh-ancestor
65529044|NCT03773367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529045|NCT03773367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65529046|NCT03773367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65529047|NCT03773367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65529048|NCT03773367|Immunologic Factors|immunologic factors|mesh-ancestor
65529049|NCT03773367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529050|NCT03773367|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65529051|NCT03773367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65529052|NCT03773367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529053|NCT02060656|Gemcitabine|gemcitabine|mesh-list
65529054|NCT02060656|Methylprednisolone|methylprednisolone|mesh-list
65529055|NCT02060656|Rituximab|rituximab|mesh-list
65529056|NCT02060656|Lenalidomide|lenalidomide|mesh-list
65529057|NCT02060656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65529058|NCT02060656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65529059|NCT02060656|Immunologic Factors|immunologic factors|mesh-ancestor
65529060|NCT02060656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529061|NCT02060656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65529062|NCT02060656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65529063|NCT02060656|Antimetabolites|antimetabolites|mesh-ancestor
65529064|NCT02060656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529065|NCT02060656|Antiviral Agents|antiviral agents|mesh-ancestor
65529066|NCT02060656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65529067|NCT02060656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529068|NCT02060656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65529069|NCT02060656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65529070|NCT02060656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65529071|NCT02060656|Growth Substances|growth substances|mesh-ancestor
65529072|NCT02060656|Growth Inhibitors|growth inhibitors|mesh-ancestor
65529073|NCT02060656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65529074|NCT02060656|Antiemetics|antiemetics|mesh-ancestor
65529075|NCT02060656|Autonomic Agents|autonomic agents|mesh-ancestor
65529076|NCT02060656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529077|NCT02060656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65529078|NCT02060656|Glucocorticoids|glucocorticoids|mesh-ancestor
65529079|NCT02060656|Hormones|hormones|mesh-ancestor
65529080|NCT02060656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65529081|NCT02060656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65529082|NCT02060656|Protective Agents|protective agents|mesh-ancestor
65529083|NCT03774771|Cinacalcet|cinacalcet|mesh-list
65529084|NCT03774771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65529085|NCT03774771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529086|NCT03774771|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65529087|NCT03774771|Hormone Antagonists|hormone antagonists|mesh-ancestor
65529088|NCT03774771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65529089|NCT03774693|Fentanyl|fentanyl|mesh-list
65529090|NCT03774693|Anesthetics|anesthetics|mesh-ancestor
65529091|NCT03774693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65529092|NCT03774693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529093|NCT03774693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65529094|NCT03774693|Narcotics|narcotics|mesh-ancestor
65529095|NCT03774693|Analgesics|analgesics|mesh-ancestor
65529096|NCT03774693|Sensory System Agents|sensory system agents|mesh-ancestor
65529097|NCT03774693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529098|NCT03774693|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65529099|NCT03774693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65529100|NCT03774693|Anesthetics, General|anesthetics, general|mesh-ancestor
65529101|NCT03774615|Ferric maltol|ferric maltol|mesh-list
65529102|NCT03774615|Hematinics|hematinics|mesh-ancestor
65529103|NCT01321047|Propofol|propofol|mesh-list
65529104|NCT01321047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65529105|NCT01321047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65529106|NCT01321047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529107|NCT01321047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65529108|NCT01321047|Anesthetics, General|anesthetics, general|mesh-ancestor
65529109|NCT01321047|Anesthetics|anesthetics|mesh-ancestor
65529110|NCT01321125|Chlorhexidine|chlorhexidine|mesh-list
65529111|NCT01321125|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65529112|NCT01321125|Povidone-Iodine|povidone-iodine|mesh-list
65529113|NCT01321125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
65529114|NCT01321125|Povidone|povidone|mesh-list
65529115|NCT01321125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65529116|NCT01321125|Disinfectants|disinfectants|mesh-ancestor
65529117|NCT01321125|Dermatologic Agents|dermatologic agents|mesh-ancestor
65529118|NCT01321125|Plasma Substitutes|plasma substitutes|mesh-ancestor
65529119|NCT01321125|Blood Substitutes|blood substitutes|mesh-ancestor
65529120|NCT03773991|Nitric Oxide|nitric oxide|mesh-list
65529121|NCT03773991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65529122|NCT03773991|Autonomic Agents|autonomic agents|mesh-ancestor
65529123|NCT03773991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529124|NCT03773991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529125|NCT03773991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65529126|NCT03773991|Respiratory System Agents|respiratory system agents|mesh-ancestor
65529127|NCT03773991|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65529128|NCT03773991|Antioxidants|antioxidants|mesh-ancestor
65529129|NCT03773991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529130|NCT03773991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65529131|NCT03773991|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65529132|NCT03773991|Vasodilator Agents|vasodilator agents|mesh-ancestor
65529133|NCT03773991|Gasotransmitters|gasotransmitters|mesh-ancestor
65529134|NCT03773991|Protective Agents|protective agents|mesh-ancestor
65529135|NCT05435313|Oxaliplatin|oxaliplatin|mesh-list
65529136|NCT05435313|Irinotecan|irinotecan|mesh-list
65529137|NCT05435313|Raltitrexed|raltitrexed|mesh-list
65529138|NCT05435313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65529139|NCT05435313|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65529140|NCT05435313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65529141|NCT05435313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529142|NCT05435313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529143|NCT05435313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65529144|NCT05435313|Antimetabolites|antimetabolites|mesh-ancestor
65529145|NCT05435313|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65529146|NCT05472675|Bupivacaine|bupivacaine|mesh-list
65529147|NCT05472675|Botulinum Toxins|botulinum toxins|mesh-list
65529148|NCT05472675|Anesthetics, Local|anesthetics, local|mesh-ancestor
65529149|NCT05472675|Anesthetics|anesthetics|mesh-ancestor
65529150|NCT05472675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65529151|NCT05472675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529152|NCT05472675|Sensory System Agents|sensory system agents|mesh-ancestor
65529153|NCT05472675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529154|NCT05472675|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65529155|NCT05472675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65529156|NCT05472675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529157|NCT05472675|Cholinergic Agents|cholinergic agents|mesh-ancestor
65529158|NCT05472675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65529159|NCT01321905|Vitamin D|vitamin d|mesh-list
65529160|NCT01321905|Ergocalciferols|ergocalciferols|mesh-list
65529161|NCT01321905|Vitamins|vitamins|mesh-ancestor
65529162|NCT01321905|Micronutrients|micronutrients|mesh-ancestor
65529163|NCT01321905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529164|NCT01321905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65529165|NCT01321905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65529166|NCT04570670|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65529167|NCT04570670|Dermatologic Agents|dermatologic agents|mesh-ancestor
65529168|NCT04570670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65529169|NCT04570670|Immunologic Factors|immunologic factors|mesh-ancestor
65529170|NCT04570670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529171|NCT03763227|Ranibizumab|ranibizumab|mesh-list
65529172|NCT03763227|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-list
65529173|NCT03763227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65529174|NCT03763227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65529175|NCT03763227|Growth Substances|growth substances|mesh-ancestor
65529176|NCT03763227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529177|NCT03763227|Growth Inhibitors|growth inhibitors|mesh-ancestor
65529178|NCT03763227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65529179|NCT03763227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529180|NCT03763227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529181|NCT04929548|Maleic acid|maleic acid|mesh-list
65529182|NCT04929548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529183|NCT04929548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529184|NCT04150029|Azacitidine|azacitidine|mesh-list
65529185|NCT04150029|Venetoclax|venetoclax|mesh-list
65529186|NCT04150029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65529187|NCT04150029|Antimetabolites|antimetabolites|mesh-ancestor
65529188|NCT04150029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529189|NCT04150029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65529190|NCT04150029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529191|NCT02060734|Lidocaine|lidocaine|mesh-list
65529192|NCT02060734|Anesthetics, Local|anesthetics, local|mesh-ancestor
65529193|NCT02060734|Anesthetics|anesthetics|mesh-ancestor
65529194|NCT02060734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65529195|NCT02060734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529196|NCT02060734|Sensory System Agents|sensory system agents|mesh-ancestor
65529197|NCT02060734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529198|NCT02060734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65529199|NCT02060734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65529200|NCT02060734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65529201|NCT02060734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65529202|NCT02060734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529203|NCT03270644|Propranolol|propranolol|mesh-list
65529204|NCT03270644|Lasmiditan|lasmiditan|mesh-list
65529205|NCT03270644|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65529206|NCT03270644|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65529207|NCT03270644|Adrenergic Agents|adrenergic agents|mesh-ancestor
65529208|NCT03270644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65529209|NCT03270644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529210|NCT03270644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529211|NCT03270644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65529212|NCT03270644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65529213|NCT03270644|Vasodilator Agents|vasodilator agents|mesh-ancestor
65529214|NCT03270644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65529215|NCT03270644|Serotonin Agents|serotonin agents|mesh-ancestor
65529216|NCT04529720|Vaccines|vaccines|mesh-list
65529217|NCT04529720|Immunologic Factors|immunologic factors|mesh-ancestor
65529218|NCT04529720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529219|NCT03768609|Cyclosporine|cyclosporine|mesh-list
65529220|NCT03768609|Cyclosporins|cyclosporins|mesh-list
65529221|NCT03768609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529222|NCT03768609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529223|NCT03768609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65529224|NCT03768609|Immunologic Factors|immunologic factors|mesh-ancestor
65529225|NCT03768609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529226|NCT03768609|Antifungal Agents|antifungal agents|mesh-ancestor
65529227|NCT03768609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65529228|NCT03768609|Dermatologic Agents|dermatologic agents|mesh-ancestor
65529229|NCT03768609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65529230|NCT03768609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65529231|NCT03269552|Rituximab|rituximab|mesh-list
65529232|NCT03269552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65529233|NCT03269552|Antibodies|antibodies|mesh-list
65529234|NCT03269552|Immunoglobulins|immunoglobulins|mesh-list
65529235|NCT03269552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65529236|NCT03269552|Immunologic Factors|immunologic factors|mesh-ancestor
65529237|NCT03269552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529238|NCT03269552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65529239|NCT03269552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65529240|NCT03771729|Valsartan|valsartan|mesh-list
65529241|NCT03771729|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65529242|NCT03771729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65529243|NCT03771729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65529244|NCT03771729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65529245|NCT03771729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529246|NCT03560362|Epinephrine|epinephrine|mesh-list
65529247|NCT03560362|Bupivacaine|bupivacaine|mesh-list
65529248|NCT03560362|Anesthetics, Local|anesthetics, local|mesh-ancestor
65529249|NCT03560362|Anesthetics|anesthetics|mesh-ancestor
65529250|NCT03560362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65529251|NCT03560362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529252|NCT03560362|Sensory System Agents|sensory system agents|mesh-ancestor
65529253|NCT03560362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529254|NCT03560362|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65529255|NCT03560362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65529256|NCT03560362|Adrenergic Agents|adrenergic agents|mesh-ancestor
65529257|NCT03560362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65529258|NCT03560362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529259|NCT03560362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65529260|NCT03560362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65529261|NCT03560362|Autonomic Agents|autonomic agents|mesh-ancestor
65529262|NCT03560362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65529263|NCT03560362|Respiratory System Agents|respiratory system agents|mesh-ancestor
65529264|NCT03560362|Mydriatics|mydriatics|mesh-ancestor
65529265|NCT03560362|Sympathomimetics|sympathomimetics|mesh-ancestor
65529266|NCT03560362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65529267|NCT03768531|Nivolumab|nivolumab|mesh-list
65529268|NCT03768531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65529269|NCT03768531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65529270|NCT03768531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65529271|NCT03768531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529272|NCT01322061|Ascorbic Acid|ascorbic acid|mesh-list
65529273|NCT01322061|Vitamins|vitamins|mesh-ancestor
65529274|NCT01322061|Micronutrients|micronutrients|mesh-ancestor
65529275|NCT01322061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529276|NCT01322061|Antioxidants|antioxidants|mesh-ancestor
65529277|NCT01322061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529278|NCT01322061|Protective Agents|protective agents|mesh-ancestor
65529279|NCT02062996|Phenylephrine|phenylephrine|mesh-list
65529280|NCT02062996|Oxymetazoline|oxymetazoline|mesh-list
65529281|NCT02062996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65529282|NCT02062996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65529283|NCT02062996|Adrenergic Agents|adrenergic agents|mesh-ancestor
65529284|NCT02062996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65529285|NCT02062996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529286|NCT02062996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529287|NCT02062996|Sympathomimetics|sympathomimetics|mesh-ancestor
65529288|NCT02062996|Autonomic Agents|autonomic agents|mesh-ancestor
65529289|NCT02062996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529290|NCT02062996|Nasal Decongestants|nasal decongestants|mesh-ancestor
65529291|NCT02062996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65529292|NCT02062996|Respiratory System Agents|respiratory system agents|mesh-ancestor
65529293|NCT02062996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65529294|NCT02062996|Mydriatics|mydriatics|mesh-ancestor
65529295|NCT02062996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65529296|NCT02062996|Protective Agents|protective agents|mesh-ancestor
65529297|NCT03762369|Latanoprost|latanoprost|mesh-list
65529298|NCT03762369|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65529299|NCT03762369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65529300|NCT01321515|Famciclovir|famciclovir|mesh-list
65529301|NCT01321515|Antiviral Agents|antiviral agents|mesh-ancestor
65529302|NCT01321515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65529303|NCT01321515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65529304|NCT01321515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529305|NCT01321515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529306|NCT02065414|Chlorhexidine|chlorhexidine|mesh-list
65529307|NCT02065414|Listerine|listerine|mesh-list
65529308|NCT02065414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65529309|NCT02065414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65529310|NCT02065414|Disinfectants|disinfectants|mesh-ancestor
65529311|NCT04233879|Tenofovir|tenofovir|mesh-list
65529312|NCT04233879|Emtricitabine|emtricitabine|mesh-list
65529313|NCT04233879|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65529314|NCT04233879|Islatravir|islatravir|mesh-list
65529315|NCT04233879|Antiviral Agents|antiviral agents|mesh-ancestor
65529316|NCT04233879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65529317|NCT04233879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65529318|NCT04233879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65529319|NCT04233879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529320|NCT04233879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529321|NCT04233879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65529322|NCT04233879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65529323|NCT01370356|Varenicline|varenicline|mesh-list
65529324|NCT01370356|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65529325|NCT01370356|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65529326|NCT01370356|Cholinergic Agents|cholinergic agents|mesh-ancestor
65529327|NCT01370356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65529328|NCT01370356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529329|NCT01370356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529330|NCT03792334|Anesthetics|anesthetics|mesh-list
65529331|NCT03792334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65529332|NCT03792334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529333|NCT04545411|Dapagliflozin|dapagliflozin|mesh-list
65529334|NCT04545411|Volagidemab|volagidemab|mesh-list
65529335|NCT04545411|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65529336|NCT04545411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529337|NCT04545411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65529338|NCT04545411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529339|NCT02065492|Amlodipine|amlodipine|mesh-list
65529340|NCT02065492|Calcium Channel Blockers|calcium channel blockers|mesh-list
65529341|NCT02065492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65529342|NCT02065492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529343|NCT02065492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65529344|NCT02065492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65529345|NCT02065492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529346|NCT02065492|Vasodilator Agents|vasodilator agents|mesh-ancestor
65529347|NCT02063620|Ketamine|ketamine|mesh-list
65529348|NCT02063620|Analgesics|analgesics|mesh-ancestor
65529349|NCT02063620|Sensory System Agents|sensory system agents|mesh-ancestor
65529350|NCT02063620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529351|NCT02063620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529352|NCT02063620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65529353|NCT02063620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65529354|NCT02063620|Anesthetics, General|anesthetics, general|mesh-ancestor
65529355|NCT02063620|Anesthetics|anesthetics|mesh-ancestor
65529356|NCT02063620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65529357|NCT02063620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65529358|NCT02063620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65529359|NCT02063620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65529360|NCT02063620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529361|NCT03767439|Nivolumab|nivolumab|mesh-list
65529362|NCT03767439|Ipilimumab|ipilimumab|mesh-list
65529363|NCT03767439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65529364|NCT03767439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65529365|NCT03767439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65529366|NCT03767439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529367|NCT04539405|Sevoflurane|sevoflurane|mesh-list
65529368|NCT04539405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65529369|NCT04539405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65529370|NCT04539405|Anesthetics, General|anesthetics, general|mesh-ancestor
65529371|NCT04539405|Anesthetics|anesthetics|mesh-ancestor
65529372|NCT04539405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65529373|NCT04539405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529374|NCT02065804|Bupivacaine|bupivacaine|mesh-list
65529375|NCT02065804|Anesthetics, Local|anesthetics, local|mesh-ancestor
65529376|NCT02065804|Anesthetics|anesthetics|mesh-ancestor
65529377|NCT02065804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65529378|NCT02065804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326866|NCT04756401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65529379|NCT02065804|Sensory System Agents|sensory system agents|mesh-ancestor
65529380|NCT02065804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529381|NCT02064010|Calcium, Dietary|calcium, dietary|mesh-list
65529382|NCT02064010|Acamprosate|acamprosate|mesh-list
65529383|NCT02064010|Calcium|calcium|mesh-list
65529384|NCT02064010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65529385|NCT02064010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529386|NCT02064010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65529387|NCT02064010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65529388|NCT02064088|Levobupivacaine|levobupivacaine|mesh-list
65529389|NCT02064088|Anesthetics, Local|anesthetics, local|mesh-ancestor
65529390|NCT02064088|Anesthetics|anesthetics|mesh-ancestor
65529391|NCT02064088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65529392|NCT02064088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529393|NCT02064088|Sensory System Agents|sensory system agents|mesh-ancestor
65529394|NCT02064088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529395|NCT02066038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65529396|NCT02066038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65529397|NCT02066038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65529398|NCT02066038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529399|NCT02066038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529400|NCT03766893|Naltrexone|naltrexone|mesh-list
65529401|NCT03766893|Buprenorphine|buprenorphine|mesh-list
65529402|NCT03766893|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65529403|NCT03766893|Naloxone|naloxone|mesh-list
65529404|NCT03766893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65529405|NCT03766893|Narcotics|narcotics|mesh-ancestor
65529406|NCT03766893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65529407|NCT03766893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529408|NCT03766893|Analgesics|analgesics|mesh-ancestor
65529409|NCT03766893|Sensory System Agents|sensory system agents|mesh-ancestor
65529410|NCT03766893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529411|NCT03766893|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65529412|NCT03766893|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65529413|NCT03760809|Dexmedetomidine|dexmedetomidine|mesh-list
65529414|NCT03760809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65529415|NCT03760809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65529416|NCT03760809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529417|NCT03760809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65529418|NCT03760809|Analgesics|analgesics|mesh-ancestor
65529419|NCT03760809|Sensory System Agents|sensory system agents|mesh-ancestor
65529420|NCT03760809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529421|NCT03760809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65529422|NCT03760809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65529423|NCT03760809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65529424|NCT03760809|Adrenergic Agents|adrenergic agents|mesh-ancestor
65529425|NCT03760809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65529426|NCT03760809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529427|NCT01370590|Atorvastatin|atorvastatin|mesh-list
65529428|NCT01370590|Ezetimibe|ezetimibe|mesh-list
65529429|NCT01370590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65529430|NCT01370590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65529431|NCT01370590|Antimetabolites|antimetabolites|mesh-ancestor
65529432|NCT01370590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529433|NCT01370590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65529434|NCT01370590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65529435|NCT01370590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529436|NCT01567683|Imiquimod|imiquimod|mesh-list
65529437|NCT01567683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65529438|NCT01567683|Immunologic Factors|immunologic factors|mesh-ancestor
65529439|NCT01567683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529440|NCT01567683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65529441|NCT01567683|Interferon Inducers|interferon inducers|mesh-ancestor
65529442|NCT03766425|Aflibercept|aflibercept|mesh-list
65529443|NCT03766425|Mitomycins|mitomycins|mesh-list
65529444|NCT03766425|Mitomycin|mitomycin|mesh-list
65529445|NCT03766425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65529446|NCT03766425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65529447|NCT03766425|Growth Substances|growth substances|mesh-ancestor
65529448|NCT03766425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529449|NCT03766425|Growth Inhibitors|growth inhibitors|mesh-ancestor
65529450|NCT03766425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65529451|NCT03766425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65529452|NCT03766425|Alkylating Agents|alkylating agents|mesh-ancestor
65529453|NCT03766425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529454|NCT03766425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65529455|NCT03766425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529457|NCT01561911|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65529458|NCT01561911|Immunologic Factors|immunologic factors|mesh-ancestor
65529459|NCT01561911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529460|NCT03770637|Glucagon|glucagon|mesh-list
65529461|NCT03770637|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65529462|NCT03770637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65529463|NCT03770637|Hormones|hormones|mesh-ancestor
65529464|NCT03770637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65529465|NCT03770637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529466|NCT03770637|Incretins|incretins|mesh-ancestor
65529467|NCT03766269|Dronabinol|dronabinol|mesh-list
65529468|NCT03766269|Hallucinogens|hallucinogens|mesh-ancestor
65529469|NCT03766269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529470|NCT03766269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65529471|NCT03766269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65529472|NCT03766269|Analgesics|analgesics|mesh-ancestor
65529473|NCT03766269|Sensory System Agents|sensory system agents|mesh-ancestor
65529474|NCT03766269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529475|NCT03766269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65529476|NCT03766269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65529477|NCT03766269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65529478|NCT03766269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529479|NCT03766269|Hormones|hormones|mesh-ancestor
65529480|NCT03766269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65529481|NCT03894891|Docetaxel|docetaxel|mesh-list
65529482|NCT03894891|Nivolumab|nivolumab|mesh-list
65529483|NCT03894891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65529484|NCT03894891|Tubulin Modulators|tubulin modulators|mesh-ancestor
65529485|NCT03894891|Antimitotic Agents|antimitotic agents|mesh-ancestor
65529486|NCT03894891|Mitosis Modulators|mitosis modulators|mesh-ancestor
65529487|NCT03894891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529488|NCT03894891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65529489|NCT03894891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65529490|NCT03878979|Nivolumab|nivolumab|mesh-list
65529491|NCT03878979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65529492|NCT03878979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65529493|NCT03878979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65529494|NCT03878979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529495|NCT03765645|Tazobactam|tazobactam|mesh-list
65529496|NCT03765645|Piperacillin|piperacillin|mesh-list
65529497|NCT03765645|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65529498|NCT03765645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65529499|NCT03765645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65529500|NCT03765645|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65529501|NCT03765645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529502|NCT03765645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529503|NCT01321671|Pregabalin|pregabalin|mesh-list
65529504|NCT01321671|Analgesics|analgesics|mesh-ancestor
65529505|NCT01321671|Sensory System Agents|sensory system agents|mesh-ancestor
65529506|NCT01321671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529507|NCT01321671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529508|NCT01321671|Anticonvulsants|anticonvulsants|mesh-ancestor
65529509|NCT01321671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65529510|NCT01321671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65529511|NCT01321671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529512|NCT01321671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65529513|NCT01321671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65529514|NCT01321671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65529515|NCT01321671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65529516|NCT01321671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65529517|NCT03770013|Clonidine|clonidine|mesh-list
65529518|NCT03770013|Dexmedetomidine|dexmedetomidine|mesh-list
65529519|NCT03770013|Bupivacaine|bupivacaine|mesh-list
65529520|NCT03770013|Anesthetics, Local|anesthetics, local|mesh-ancestor
65529521|NCT03770013|Anesthetics|anesthetics|mesh-ancestor
65529522|NCT03770013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65529523|NCT03770013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529524|NCT03770013|Sensory System Agents|sensory system agents|mesh-ancestor
65529525|NCT03770013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529526|NCT03770013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65327021|NCT00719472|Hormones|hormones|mesh-ancestor
65529527|NCT03770013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65529528|NCT03770013|Analgesics|analgesics|mesh-ancestor
65529529|NCT03770013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65529530|NCT03770013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65529531|NCT03770013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65529532|NCT03770013|Adrenergic Agents|adrenergic agents|mesh-ancestor
65529533|NCT03770013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65529534|NCT03770013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529535|NCT03770013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65529536|NCT03770013|Sympatholytics|sympatholytics|mesh-ancestor
65529537|NCT03770013|Autonomic Agents|autonomic agents|mesh-ancestor
65529538|NCT03769935|Etoposide|etoposide|mesh-list
65529539|NCT03769935|Cisplatin|cisplatin|mesh-list
65529540|NCT03769935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65529541|NCT03769935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65529542|NCT03769935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65529543|NCT03769935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65529544|NCT03769935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529545|NCT03769935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529546|NCT03765021|Tranexamic Acid|tranexamic acid|mesh-list
65529547|NCT03765021|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65529548|NCT03765021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65529549|NCT03765021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529550|NCT03765021|Hemostatics|hemostatics|mesh-ancestor
65529551|NCT03765021|Coagulants|coagulants|mesh-ancestor
65529552|NCT05418699|Insulin|insulin|mesh-list
65529553|NCT05418699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65529554|NCT05418699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529555|NCT03758859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65529556|NCT03758859|Hyaluronic Acid|hyaluronic acid|mesh-list
65529557|NCT03758859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65529558|NCT03758859|Immunologic Factors|immunologic factors|mesh-ancestor
65529559|NCT03758859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529560|NCT03758859|Viscosupplements|viscosupplements|mesh-ancestor
65529561|NCT03758859|Protective Agents|protective agents|mesh-ancestor
65529562|NCT03758859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65529563|NCT03759093|Thalidomide|thalidomide|mesh-list
65529564|NCT03759093|Dexamethasone|dexamethasone|mesh-list
65529565|NCT03759093|Dexamethasone acetate|dexamethasone acetate|mesh-list
65529566|NCT03759093|Cyclophosphamide|cyclophosphamide|mesh-list
65529567|NCT03759093|Bortezomib|bortezomib|mesh-list
65529568|NCT03759093|BB 1101|bb 1101|mesh-list
65529569|NCT03759093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65529570|NCT03759093|Immunologic Factors|immunologic factors|mesh-ancestor
65529571|NCT03759093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529572|NCT03759093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65529573|NCT03759093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65529574|NCT03759093|Alkylating Agents|alkylating agents|mesh-ancestor
65529575|NCT03759093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529576|NCT03759093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65529577|NCT03759093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65529578|NCT03759093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65529579|NCT03759093|Antiemetics|antiemetics|mesh-ancestor
65529580|NCT03759093|Autonomic Agents|autonomic agents|mesh-ancestor
65529581|NCT03759093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529582|NCT03759093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65529583|NCT03759093|Glucocorticoids|glucocorticoids|mesh-ancestor
65529584|NCT03759093|Hormones|hormones|mesh-ancestor
65529585|NCT03759093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65529586|NCT03759093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65529587|NCT03759093|Protease Inhibitors|protease inhibitors|mesh-ancestor
65529588|NCT03759093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529589|NCT03759093|Leprostatic Agents|leprostatic agents|mesh-ancestor
65529590|NCT03759093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65529591|NCT03759093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65529592|NCT03759093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65529593|NCT03759093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65529594|NCT03759093|Growth Substances|growth substances|mesh-ancestor
65529595|NCT03759093|Growth Inhibitors|growth inhibitors|mesh-ancestor
65529596|NCT03764241|Vitamin K|vitamin k|mesh-list
65529597|NCT03764241|Rivaroxaban|rivaroxaban|mesh-list
65529598|NCT03764241|Vitamins|vitamins|mesh-ancestor
65529599|NCT03764241|Micronutrients|micronutrients|mesh-ancestor
65529600|NCT03764241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529601|NCT03764241|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65529602|NCT03764241|Antithrombins|antithrombins|mesh-ancestor
65529603|NCT03764241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65529604|NCT03764241|Protease Inhibitors|protease inhibitors|mesh-ancestor
65529606|NCT03764241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529607|NCT03764241|Anticoagulants|anticoagulants|mesh-ancestor
65529608|NCT03764241|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65529609|NCT03764241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65529610|NCT03764241|Hemostatics|hemostatics|mesh-ancestor
65529611|NCT03764241|Coagulants|coagulants|mesh-ancestor
65529612|NCT03764163|Xenon|xenon|mesh-list
65529613|NCT03764163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65529614|NCT03764163|Anesthetics, General|anesthetics, general|mesh-ancestor
65529615|NCT03764163|Anesthetics|anesthetics|mesh-ancestor
65529616|NCT03764163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65529617|NCT03764163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529618|NCT02556099|Hydroxyurea|hydroxyurea|mesh-list
65529619|NCT02556099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65529620|NCT02556099|Antisickling Agents|antisickling agents|mesh-ancestor
65529621|NCT02556099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529622|NCT02556099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529623|NCT02556099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65529624|NCT01321827|Itraconazole|itraconazole|mesh-list
65529625|NCT01321827|Prednisolone|prednisolone|mesh-list
65529626|NCT01321827|Glucocorticoids|glucocorticoids|mesh-list
65529627|NCT01321827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65529628|NCT01321827|Hormones|hormones|mesh-ancestor
65529629|NCT01321827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65529630|NCT01321827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529631|NCT01321827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65529632|NCT01321827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65529633|NCT01321827|Antifungal Agents|antifungal agents|mesh-ancestor
65529634|NCT01321827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65529635|NCT01321827|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65529636|NCT01321827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65529637|NCT01321827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529638|NCT01321827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529639|NCT01321827|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65529640|NCT01321827|Hormone Antagonists|hormone antagonists|mesh-ancestor
65529641|NCT01321827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65529642|NCT03753477|Amlodipine|amlodipine|mesh-list
65529643|NCT03753477|Olmesartan|olmesartan|mesh-list
65529644|NCT03753477|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65529645|NCT03753477|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
65529646|NCT03753477|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65529647|NCT03753477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65529648|NCT03753477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65529649|NCT03753477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65529650|NCT03753477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529651|NCT03753477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65529652|NCT03753477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529653|NCT03753477|Vasodilator Agents|vasodilator agents|mesh-ancestor
65529654|NCT03753477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65529655|NCT03753477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65529656|NCT03753477|Antimetabolites|antimetabolites|mesh-ancestor
65529657|NCT03753477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65529658|NCT03753477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65529659|NCT03753477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529660|NCT03753477|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65529661|NCT03753477|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65529662|NCT05236647|Morphine|morphine|mesh-list
65529663|NCT05236647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65529664|NCT05236647|Narcotics|narcotics|mesh-ancestor
65529665|NCT05236647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65529666|NCT05236647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529667|NCT05236647|Analgesics|analgesics|mesh-ancestor
65529668|NCT05236647|Sensory System Agents|sensory system agents|mesh-ancestor
65529669|NCT05236647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529670|NCT03758469|Rifampin|rifampin|mesh-list
65529671|NCT03758469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65529672|NCT03758469|Antitubercular Agents|antitubercular agents|mesh-ancestor
65529673|NCT03758469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65529674|NCT03758469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65529675|NCT03758469|Leprostatic Agents|leprostatic agents|mesh-ancestor
65529676|NCT03758469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65529677|NCT03758469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529678|NCT03758469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529679|NCT03758469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65529680|NCT03758469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65529681|NCT03758469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65529682|NCT03758469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65529683|NCT03758469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65529684|NCT03758469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65529686|NCT04646109|Hydroxychloroquine|hydroxychloroquine|mesh-list
65529687|NCT04646109|Ivermectin|ivermectin|mesh-list
65529688|NCT04646109|Favipiravir|favipiravir|mesh-list
65529689|NCT04646109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65529690|NCT04646109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65529691|NCT04646109|Antimalarials|antimalarials|mesh-ancestor
65529692|NCT04646109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65529693|NCT04646109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65529694|NCT04646109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529695|NCT04646109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529696|NCT04646109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65529697|NCT04646109|Antiviral Agents|antiviral agents|mesh-ancestor
65529698|NCT05320107|Ketamine|ketamine|mesh-list
65529699|NCT05320107|Analgesics|analgesics|mesh-ancestor
65529700|NCT05320107|Sensory System Agents|sensory system agents|mesh-ancestor
65529701|NCT05320107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529702|NCT05320107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529703|NCT05320107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65529704|NCT05320107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65529705|NCT05320107|Anesthetics, General|anesthetics, general|mesh-ancestor
65529706|NCT05320107|Anesthetics|anesthetics|mesh-ancestor
65529707|NCT05320107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65529708|NCT05320107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65529709|NCT05320107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65529710|NCT05320107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65529711|NCT05320107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529712|NCT03752931|Celiprolol|celiprolol|mesh-list
65529713|NCT03752931|Diltiazem|diltiazem|mesh-list
65529714|NCT03752931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65529715|NCT03752931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65529716|NCT03752931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65529717|NCT03752931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529718|NCT03752931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65529719|NCT03752931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529720|NCT03752931|Vasodilator Agents|vasodilator agents|mesh-ancestor
65529721|NCT03752931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65529722|NCT03752931|Sympathomimetics|sympathomimetics|mesh-ancestor
65529723|NCT03752931|Autonomic Agents|autonomic agents|mesh-ancestor
65529724|NCT03752931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529725|NCT03752931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65529726|NCT03752931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65529727|NCT03752931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65529728|NCT03752931|Adrenergic Agents|adrenergic agents|mesh-ancestor
65529729|NCT03752931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65529730|NCT05274633|Ravulizumab|ravulizumab|mesh-list
65529731|NCT05274633|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65529732|NCT05274633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65529733|NCT05274633|Immunologic Factors|immunologic factors|mesh-ancestor
65529734|NCT05274633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529735|NCT03758235|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65529736|NCT03758235|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65529737|NCT03758235|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65529738|NCT03758235|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65529739|NCT03758235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529740|NCT03758235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529741|NCT03758235|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65529742|NCT03758235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65529743|NCT03758235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529744|NCT03758235|Cholinergic Agents|cholinergic agents|mesh-ancestor
65529745|NCT03758235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65529746|NCT02066350|Pancrelipase|pancrelipase|mesh-list
65529747|NCT02066350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65529748|NCT05081583|Midazolam|midazolam|mesh-list
65529749|NCT05081583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65529750|NCT05081583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65529751|NCT05081583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65529752|NCT05081583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529753|NCT05081583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65529754|NCT05081583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65529755|NCT05081583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65529756|NCT05081583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65529757|NCT05081583|Anesthetics, General|anesthetics, general|mesh-ancestor
65529758|NCT05081583|Anesthetics|anesthetics|mesh-ancestor
65529759|NCT05081583|GABA Modulators|gaba modulators|mesh-ancestor
65529760|NCT05081583|GABA Agents|gaba agents|mesh-ancestor
65529761|NCT05081583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65529762|NCT05081583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529763|NCT02064946|Vitamin D|vitamin d|mesh-list
65529764|NCT02064946|Vitamins|vitamins|mesh-ancestor
65529765|NCT02064946|Micronutrients|micronutrients|mesh-ancestor
65529766|NCT02064946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529767|NCT02064946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65529768|NCT02064556|Amlodipine|amlodipine|mesh-list
65529769|NCT02064556|Candesartan|candesartan|mesh-list
65529770|NCT02064556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65529771|NCT02064556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65529772|NCT02064556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65529773|NCT02064556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529774|NCT02064556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65529775|NCT02064556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529776|NCT02064556|Vasodilator Agents|vasodilator agents|mesh-ancestor
65529777|NCT02064556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65529778|NCT02064556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65529779|NCT04578015|Metronidazole|metronidazole|mesh-list
65529780|NCT04578015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65529781|NCT04578015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65529782|NCT04578015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65529783|NCT04578015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65529784|NCT05041647|Dronabinol|dronabinol|mesh-list
65529785|NCT05041647|Hallucinogens|hallucinogens|mesh-ancestor
65529786|NCT05041647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529787|NCT05041647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65529788|NCT05041647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65529789|NCT05041647|Analgesics|analgesics|mesh-ancestor
65529790|NCT05041647|Sensory System Agents|sensory system agents|mesh-ancestor
65529791|NCT05041647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529792|NCT05041647|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65529793|NCT05041647|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65529794|NCT05041647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65529795|NCT05041647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529796|NCT05041647|Hormones|hormones|mesh-ancestor
65529797|NCT05041647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65529798|NCT03752229|Diazepam|diazepam|mesh-list
65529799|NCT03752229|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65529800|NCT03752229|Anticonvulsants|anticonvulsants|mesh-ancestor
65529801|NCT03752229|Antiemetics|antiemetics|mesh-ancestor
65529802|NCT03752229|Autonomic Agents|autonomic agents|mesh-ancestor
65529803|NCT03752229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529804|NCT03752229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529805|NCT03752229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65529806|NCT03752229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65529807|NCT03752229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65529808|NCT03752229|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65529809|NCT03752229|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65529810|NCT03752229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65529811|NCT03752229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65529812|NCT03752229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65529813|NCT03752229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65529814|NCT03752229|Anesthetics, General|anesthetics, general|mesh-ancestor
65529815|NCT03752229|Anesthetics|anesthetics|mesh-ancestor
65529816|NCT03752229|GABA Modulators|gaba modulators|mesh-ancestor
65529817|NCT03752229|GABA Agents|gaba agents|mesh-ancestor
65529818|NCT03752229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65529819|NCT03752229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529820|NCT05359731|Dexamethasone|dexamethasone|mesh-list
65529821|NCT05359731|Bupivacaine|bupivacaine|mesh-list
65529822|NCT05359731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65529823|NCT05359731|Antiemetics|antiemetics|mesh-ancestor
65529824|NCT05359731|Autonomic Agents|autonomic agents|mesh-ancestor
65529825|NCT05359731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529826|NCT05359731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529827|NCT05359731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65529828|NCT05359731|Glucocorticoids|glucocorticoids|mesh-ancestor
65529830|NCT05359731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65529831|NCT05359731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65529832|NCT05359731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65529833|NCT05359731|Anesthetics, Local|anesthetics, local|mesh-ancestor
65529834|NCT05359731|Anesthetics|anesthetics|mesh-ancestor
65529835|NCT05359731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65529836|NCT05359731|Sensory System Agents|sensory system agents|mesh-ancestor
65529837|NCT03695367|Acetaminophen|acetaminophen|mesh-list
65529838|NCT03695367|Ibuprofen|ibuprofen|mesh-list
65529839|NCT03695367|Ketorolac|ketorolac|mesh-list
65529840|NCT03695367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65529841|NCT03695367|Analgesics|analgesics|mesh-ancestor
65529842|NCT03695367|Sensory System Agents|sensory system agents|mesh-ancestor
65529843|NCT03695367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529844|NCT03695367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529845|NCT03695367|Antipyretics|antipyretics|mesh-ancestor
65529846|NCT03695367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65529847|NCT03695367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65529848|NCT03695367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65529849|NCT03695367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65529850|NCT03695367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529851|NCT03695367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529852|NCT04982445|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
65529853|NCT04982445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65529854|NCT04982445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65529855|NCT04982445|Antiviral Agents|antiviral agents|mesh-ancestor
65529856|NCT04982445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65529857|NCT03755427|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65529858|NCT03755427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65529859|NCT03755427|Immunologic Factors|immunologic factors|mesh-ancestor
65529860|NCT03755427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529861|NCT03755427|Antacids|antacids|mesh-ancestor
65529862|NCT03755427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529863|NCT03755427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65529864|NCT03758079|Gabapentin|gabapentin|mesh-list
65529865|NCT03758079|Doxepin|doxepin|mesh-list
65529866|NCT03758079|Analgesics|analgesics|mesh-ancestor
65529867|NCT03758079|Sensory System Agents|sensory system agents|mesh-ancestor
65529868|NCT03758079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529869|NCT03758079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529870|NCT03758079|Anticonvulsants|anticonvulsants|mesh-ancestor
65529871|NCT03758079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65529872|NCT03758079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65529873|NCT03758079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65529874|NCT03758079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65529875|NCT03758079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65529876|NCT03758079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65529877|NCT03758079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65529878|NCT03758079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529879|NCT03758079|Antimanic Agents|antimanic agents|mesh-ancestor
65529880|NCT03758079|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65529881|NCT03758079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65529882|NCT03758079|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65529883|NCT03758079|Antidepressive Agents|antidepressive agents|mesh-ancestor
65529884|NCT03758079|Histamine Antagonists|histamine antagonists|mesh-ancestor
65529885|NCT03758079|Histamine Agents|histamine agents|mesh-ancestor
65529886|NCT02067910|Abatacept|abatacept|mesh-list
65529887|NCT02067910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65529888|NCT02067910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529889|NCT02067910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65529890|NCT02067910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65529891|NCT02067910|Immunologic Factors|immunologic factors|mesh-ancestor
65529892|NCT02067910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529893|NCT02067910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65529894|NCT02066662|Rivaroxaban|rivaroxaban|mesh-list
65529895|NCT02066662|Phenprocoumon|phenprocoumon|mesh-list
65529896|NCT02066662|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65529897|NCT02066662|Antithrombins|antithrombins|mesh-ancestor
65529898|NCT02066662|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65529899|NCT02066662|Protease Inhibitors|protease inhibitors|mesh-ancestor
65529900|NCT02066662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529901|NCT02066662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529903|NCT05280873|Methylprednisolone|methylprednisolone|mesh-list
65529904|NCT05280873|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65529905|NCT05280873|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65529906|NCT05280873|Prednisolone|prednisolone|mesh-list
65529907|NCT05280873|Prednisolone acetate|prednisolone acetate|mesh-list
65529908|NCT05280873|Pirfenidone|pirfenidone|mesh-list
65529909|NCT05280873|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65529910|NCT05280873|Prednisolone phosphate|prednisolone phosphate|mesh-list
65529911|NCT05280873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65529912|NCT05280873|Antiemetics|antiemetics|mesh-ancestor
65529913|NCT05280873|Autonomic Agents|autonomic agents|mesh-ancestor
65529914|NCT05280873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529915|NCT05280873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529916|NCT05280873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65529917|NCT05280873|Glucocorticoids|glucocorticoids|mesh-ancestor
65529918|NCT05280873|Hormones|hormones|mesh-ancestor
65529919|NCT05280873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65529920|NCT05280873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65529921|NCT05280873|Protective Agents|protective agents|mesh-ancestor
65529922|NCT05280873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65529923|NCT05280873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65529924|NCT05280873|Analgesics|analgesics|mesh-ancestor
65529925|NCT05280873|Sensory System Agents|sensory system agents|mesh-ancestor
65529926|NCT05280873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65529927|NCT05280873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65529928|NCT05280873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65529929|NCT02066818|Lidocaine|lidocaine|mesh-list
65529930|NCT02066818|Tetracaine|tetracaine|mesh-list
65529931|NCT02066818|Anesthetics, Local|anesthetics, local|mesh-ancestor
65529932|NCT02066818|Anesthetics|anesthetics|mesh-ancestor
65529933|NCT02066818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65529934|NCT02066818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529935|NCT02066818|Sensory System Agents|sensory system agents|mesh-ancestor
65529936|NCT02066818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65529937|NCT02066818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65529938|NCT02066818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65529939|NCT02066818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65529940|NCT02066818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65529941|NCT02066818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529942|NCT04558125|Heparin|heparin|mesh-list
65529943|NCT04558125|Calcium heparin|calcium heparin|mesh-list
65529944|NCT04558125|Enoxaparin|enoxaparin|mesh-list
65529945|NCT04558125|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65529946|NCT04558125|Tinzaparin|tinzaparin|mesh-list
65529947|NCT04558125|Dalteparin|dalteparin|mesh-list
65529948|NCT04558125|Tenecteplase|tenecteplase|mesh-list
65529949|NCT04558125|Enoxaparin sodium|enoxaparin sodium|mesh-list
65529950|NCT04558125|Anticoagulants|anticoagulants|mesh-ancestor
65529951|NCT04558125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65529952|NCT04558125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65529953|NCT04558125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529954|NCT05460195|Immunologic Factors|immunologic factors|mesh-list
65529955|NCT05460195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529956|NCT02793622|Pyrimethamine|pyrimethamine|mesh-list
65529957|NCT02793622|Piperaquine|piperaquine|mesh-list
65529958|NCT02793622|Sulfadoxine|sulfadoxine|mesh-list
65529959|NCT02793622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65529960|NCT02793622|Artenimol|artenimol|mesh-list
65529961|NCT02793622|Antimalarials|antimalarials|mesh-ancestor
65529962|NCT02793622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65529963|NCT02793622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65529964|NCT02793622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65529965|NCT02793622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65529966|NCT02793622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529967|NCT02793622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529968|NCT02793622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65529969|NCT02793622|Renal Agents|renal agents|mesh-ancestor
65529970|NCT04493931|Rifampin|rifampin|mesh-list
65529971|NCT04493931|Digoxin|digoxin|mesh-list
65529972|NCT04493931|Midazolam|midazolam|mesh-list
65529973|NCT04493931|Cimetidine|cimetidine|mesh-list
65529974|NCT04493931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65529975|NCT04493931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65529976|NCT04493931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65529977|NCT04493931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65529978|NCT04493931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65327473|NCT00579345|Vaccines|vaccines|mesh-list
65529979|NCT04493931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65529980|NCT04493931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65529981|NCT04493931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65529982|NCT04493931|Anesthetics, General|anesthetics, general|mesh-ancestor
65529983|NCT04493931|Anesthetics|anesthetics|mesh-ancestor
65529984|NCT04493931|GABA Modulators|gaba modulators|mesh-ancestor
65529985|NCT04493931|GABA Agents|gaba agents|mesh-ancestor
65529986|NCT04493931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65529987|NCT04493931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65529988|NCT04493931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65529989|NCT04493931|Antitubercular Agents|antitubercular agents|mesh-ancestor
65529990|NCT04493931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65529991|NCT04493931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65529992|NCT04493931|Leprostatic Agents|leprostatic agents|mesh-ancestor
65529993|NCT04493931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65529994|NCT04493931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65529995|NCT04493931|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65529996|NCT04493931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65529997|NCT04493931|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65529998|NCT04493931|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65529999|NCT04493931|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65530000|NCT04493931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65530001|NCT04493931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65530002|NCT04493931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65530003|NCT04493931|Protective Agents|protective agents|mesh-ancestor
65530004|NCT04493931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65530005|NCT04493931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65530006|NCT04493931|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65530007|NCT04493931|Histamine Antagonists|histamine antagonists|mesh-ancestor
65530008|NCT04493931|Histamine Agents|histamine agents|mesh-ancestor
65530009|NCT04493931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65530010|NCT04493931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65530011|NCT02260336|Celecoxib|celecoxib|mesh-list
65530012|NCT02260336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65530013|NCT02260336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65530014|NCT02260336|Analgesics|analgesics|mesh-ancestor
65530015|NCT02260336|Sensory System Agents|sensory system agents|mesh-ancestor
65530016|NCT02260336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65530017|NCT02260336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530018|NCT02260336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65530019|NCT02260336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65530020|NCT02260336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65530021|NCT02260336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65530022|NCT02260336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530023|NCT02260336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530024|NCT04948203|Sirolimus|sirolimus|mesh-list
65530025|NCT04948203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65530026|NCT04948203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65530027|NCT04948203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65530028|NCT04948203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530029|NCT04948203|Antifungal Agents|antifungal agents|mesh-ancestor
65530030|NCT04948203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65530031|NCT04948203|Immunologic Factors|immunologic factors|mesh-ancestor
65530032|NCT04948203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530033|NCT03755193|Diphosphonates|diphosphonates|mesh-list
65530034|NCT03755193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65530035|NCT03755193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530036|NCT03755115|Epirubicin|epirubicin|mesh-list
65530037|NCT03755115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65530038|NCT03755115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530039|NCT03755115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65530040|NCT03755115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65530041|NCT03755115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530042|NCT03755115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530043|NCT03755037|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65530044|NCT03755037|Estradiol|estradiol|mesh-list
65530045|NCT03755037|Estrogens|estrogens|mesh-ancestor
65530046|NCT03755037|Hormones|hormones|mesh-ancestor
65530047|NCT03755037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65530048|NCT03755037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530049|NCT03755037|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65530050|NCT03755037|Contraceptive Agents|contraceptive agents|mesh-ancestor
65530051|NCT03755037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65530052|NCT03755037|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65530053|NCT03755037|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65530054|NCT03755037|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65530055|NCT03751917|Arsenic Trioxide|arsenic trioxide|mesh-list
65530056|NCT03751917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530057|NCT04490499|Vaccines|vaccines|mesh-list
65530058|NCT04490499|Immunologic Factors|immunologic factors|mesh-ancestor
65530059|NCT04490499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530060|NCT01332994|Rituximab|rituximab|mesh-list
65530061|NCT01332994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65530062|NCT01332994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530063|NCT01332994|Immunologic Factors|immunologic factors|mesh-ancestor
65530064|NCT01332994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530065|NCT01332994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65530066|NCT03754959|Midazolam|midazolam|mesh-list
65530067|NCT03754959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65530068|NCT03754959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65530069|NCT03754959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65530070|NCT03754959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530071|NCT03754959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65530072|NCT03754959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65530073|NCT03754959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65530074|NCT03754959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65530075|NCT03754959|Anesthetics, General|anesthetics, general|mesh-ancestor
65530076|NCT03754959|Anesthetics|anesthetics|mesh-ancestor
65530077|NCT03754959|GABA Modulators|gaba modulators|mesh-ancestor
65530078|NCT03754959|GABA Agents|gaba agents|mesh-ancestor
65530079|NCT03754959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65530080|NCT03754959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530081|NCT02068690|BI 425809|bi 425809|mesh-list
65530082|NCT02068690|Nootropic Agents|nootropic agents|mesh-ancestor
65530083|NCT02067442|Acetaminophen|acetaminophen|mesh-list
65530084|NCT02067442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65530085|NCT02067442|Analgesics|analgesics|mesh-ancestor
65530086|NCT02067442|Sensory System Agents|sensory system agents|mesh-ancestor
65530087|NCT02067442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65530088|NCT02067442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530089|NCT02067442|Antipyretics|antipyretics|mesh-ancestor
65530090|NCT02067520|Hydromorphone|hydromorphone|mesh-list
65530091|NCT02067520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65530092|NCT02067520|Narcotics|narcotics|mesh-ancestor
65530093|NCT02067520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65530094|NCT02067520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530095|NCT02067520|Analgesics|analgesics|mesh-ancestor
65530096|NCT02067520|Sensory System Agents|sensory system agents|mesh-ancestor
65530097|NCT02067520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65530098|NCT03757923|Metformin|metformin|mesh-list
65530099|NCT03757923|Pioglitazone|pioglitazone|mesh-list
65530100|NCT03757923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65530101|NCT03757923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530102|NCT02071888|Dexamethasone|dexamethasone|mesh-list
65530103|NCT02071888|Dexamethasone acetate|dexamethasone acetate|mesh-list
65530104|NCT02071888|Pomalidomide|pomalidomide|mesh-list
65530105|NCT02071888|BB 1101|bb 1101|mesh-list
65530106|NCT02071888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65530107|NCT02071888|Antiemetics|antiemetics|mesh-ancestor
65530108|NCT02071888|Autonomic Agents|autonomic agents|mesh-ancestor
65530109|NCT02071888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65530110|NCT02071888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530111|NCT02071888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65530112|NCT02071888|Glucocorticoids|glucocorticoids|mesh-ancestor
65530113|NCT02071888|Hormones|hormones|mesh-ancestor
65530114|NCT02071888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65530115|NCT02071888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65530116|NCT02071888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530117|NCT02071888|Protease Inhibitors|protease inhibitors|mesh-ancestor
65530118|NCT02071888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530119|NCT02071888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530120|NCT02071888|Immunologic Factors|immunologic factors|mesh-ancestor
65530121|NCT02071888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65530122|NCT02071888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65530123|NCT02071888|Growth Substances|growth substances|mesh-ancestor
65530124|NCT02071888|Growth Inhibitors|growth inhibitors|mesh-ancestor
65530125|NCT02071966|Clopidogrel|clopidogrel|mesh-list
65530126|NCT02071966|Ticagrelor|ticagrelor|mesh-list
65530127|NCT02071966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65530128|NCT02071966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65530129|NCT02071966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65530130|NCT02071966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65530132|NCT02071966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65530133|NCT02071966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530134|NCT02071966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530135|NCT02072278|Vortioxetine|vortioxetine|mesh-list
65530136|NCT02072278|Citalopram|citalopram|mesh-list
65530137|NCT02072278|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65530138|NCT02072278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65530139|NCT02072278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65530140|NCT02072278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530141|NCT02072278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65530142|NCT02072278|Serotonin Agents|serotonin agents|mesh-ancestor
65530143|NCT02072278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530144|NCT02072278|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65530145|NCT02072278|Antidepressive Agents|antidepressive agents|mesh-ancestor
65530146|NCT02072278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65530147|NCT02072278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65530148|NCT02072278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65530149|NCT02072278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65530150|NCT02072278|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65530151|NCT02072278|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65530152|NCT02072278|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65530153|NCT02072278|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65530154|NCT02072512|Fulvestrant|fulvestrant|mesh-list
65530155|NCT02072512|Anastrozole|anastrozole|mesh-list
65530156|NCT02072512|Goserelin|goserelin|mesh-list
65530157|NCT02072512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65530158|NCT02072512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530159|NCT02072512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65530160|NCT02072512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65530161|NCT02072512|Hormone Antagonists|hormone antagonists|mesh-ancestor
65530162|NCT02072512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65530163|NCT02072512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530164|NCT02072512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65530165|NCT02072512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65530166|NCT02072512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530167|NCT02072512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530168|NCT04534491|Oxybutynin|oxybutynin|mesh-list
65530169|NCT04534491|Parasympatholytics|parasympatholytics|mesh-ancestor
65530170|NCT04534491|Autonomic Agents|autonomic agents|mesh-ancestor
65530171|NCT04534491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65530172|NCT04534491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530173|NCT04534491|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65530174|NCT04534491|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65530175|NCT04534491|Cholinergic Agents|cholinergic agents|mesh-ancestor
65530176|NCT04534491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65530177|NCT04534491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530178|NCT04534491|Urological Agents|urological agents|mesh-ancestor
65530179|NCT02069080|Plerixafor|plerixafor|mesh-list
65530180|NCT02069080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65530181|NCT02069080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65530182|NCT02069080|Antiviral Agents|antiviral agents|mesh-ancestor
65530183|NCT02069080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65530184|NCT02077348|Hormones|hormones|mesh-list
65530185|NCT02077348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530186|NCT02077348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65530187|NCT03694821|Methylprednisolone|methylprednisolone|mesh-list
65530188|NCT03694821|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65530189|NCT03694821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65530190|NCT03694821|Prednisolone|prednisolone|mesh-list
65530191|NCT03694821|Prednisolone acetate|prednisolone acetate|mesh-list
65530192|NCT03694821|Ketorolac|ketorolac|mesh-list
65530193|NCT03694821|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65530194|NCT03694821|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65530195|NCT03694821|Prednisolone phosphate|prednisolone phosphate|mesh-list
65530196|NCT03694821|Hylan|hylan|mesh-list
65530197|NCT03694821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65530198|NCT03694821|Antiemetics|antiemetics|mesh-ancestor
65530199|NCT03694821|Autonomic Agents|autonomic agents|mesh-ancestor
65530200|NCT03694821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65530201|NCT03694821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530202|NCT03694821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65530203|NCT03694821|Glucocorticoids|glucocorticoids|mesh-ancestor
65530204|NCT03694821|Hormones|hormones|mesh-ancestor
65530205|NCT03694821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65530206|NCT03694821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65530207|NCT03694821|Protective Agents|protective agents|mesh-ancestor
65530208|NCT03694821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65530209|NCT03694821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530210|NCT03694821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65530211|NCT03694821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65530212|NCT03694821|Analgesics|analgesics|mesh-ancestor
65530213|NCT03694821|Sensory System Agents|sensory system agents|mesh-ancestor
65530214|NCT03694821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65530215|NCT03694821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65530216|NCT03694821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530217|NCT03694821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530218|NCT03694821|Viscosupplements|viscosupplements|mesh-ancestor
65530219|NCT02069158|Paclitaxel|paclitaxel|mesh-list
65530220|NCT02069158|Carboplatin|carboplatin|mesh-list
65530221|NCT02069158|Gedatolisib|gedatolisib|mesh-list
65530222|NCT02069158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65530223|NCT02069158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530224|NCT02069158|Tubulin Modulators|tubulin modulators|mesh-ancestor
65530225|NCT02069158|Antimitotic Agents|antimitotic agents|mesh-ancestor
65530226|NCT02069158|Mitosis Modulators|mitosis modulators|mesh-ancestor
65530227|NCT02069158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530228|NCT02069158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65530229|NCT02069158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530230|NCT04531527|Butenafine|butenafine|mesh-list
65530231|NCT04531527|Antifungal Agents|antifungal agents|mesh-ancestor
65530232|NCT04531527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65530233|NCT03165994|Paclitaxel|paclitaxel|mesh-list
65530234|NCT03165994|Carboplatin|carboplatin|mesh-list
65530235|NCT03165994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65530236|NCT03165994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530237|NCT03165994|Tubulin Modulators|tubulin modulators|mesh-ancestor
65530238|NCT03165994|Antimitotic Agents|antimitotic agents|mesh-ancestor
65530239|NCT03165994|Mitosis Modulators|mitosis modulators|mesh-ancestor
65530240|NCT03165994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530241|NCT02078440|Bromocriptine|bromocriptine|mesh-list
65530242|NCT02078440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65530243|NCT02078440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65530244|NCT02078440|Hormone Antagonists|hormone antagonists|mesh-ancestor
65530245|NCT02078440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65530246|NCT02078440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530247|NCT02078440|Dopamine Agonists|dopamine agonists|mesh-ancestor
65530248|NCT02078440|Dopamine Agents|dopamine agents|mesh-ancestor
65530249|NCT02078440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65530250|NCT02078440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530251|NCT02070406|Aldesleukin|aldesleukin|mesh-list
65530252|NCT02070406|Cyclophosphamide|cyclophosphamide|mesh-list
65530253|NCT02070406|Fludarabine|fludarabine|mesh-list
65530254|NCT02070406|Fludarabine phosphate|fludarabine phosphate|mesh-list
65530255|NCT02070406|Interleukin-2|interleukin-2|mesh-list
65530256|NCT02070406|Vaccines|vaccines|mesh-list
65530257|NCT02070406|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65530258|NCT02070406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65530259|NCT02070406|Immunologic Factors|immunologic factors|mesh-ancestor
65530260|NCT02070406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530261|NCT02070406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65530262|NCT02070406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65530263|NCT02070406|Alkylating Agents|alkylating agents|mesh-ancestor
65530264|NCT02070406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530265|NCT02070406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530266|NCT02070406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65530267|NCT02070406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65530268|NCT02070406|Antimetabolites|antimetabolites|mesh-ancestor
65530269|NCT02070406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65530270|NCT02070406|Analgesics|analgesics|mesh-ancestor
65530271|NCT02070406|Sensory System Agents|sensory system agents|mesh-ancestor
65530272|NCT02070406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65530273|NCT02070406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65530274|NCT02070406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65530275|NCT02070406|Antiviral Agents|antiviral agents|mesh-ancestor
65530276|NCT02070406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65530277|NCT02070406|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65530278|NCT04842045|Midazolam|midazolam|mesh-list
65530279|NCT04842045|Psilocybin|psilocybin|mesh-list
65530280|NCT04842045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65530281|NCT04842045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65530282|NCT04842045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65530283|NCT04842045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530284|NCT04842045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65530285|NCT04842045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65530286|NCT04842045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65530287|NCT04842045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65530288|NCT04842045|Anesthetics, General|anesthetics, general|mesh-ancestor
65530290|NCT04842045|GABA Modulators|gaba modulators|mesh-ancestor
65530291|NCT04842045|GABA Agents|gaba agents|mesh-ancestor
65530292|NCT04842045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65530293|NCT04842045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530294|NCT04842045|Hallucinogens|hallucinogens|mesh-ancestor
65530295|NCT02078596|Valproic Acid|valproic acid|mesh-list
65530296|NCT02078596|Anticonvulsants|anticonvulsants|mesh-ancestor
65530297|NCT02078596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530298|NCT02078596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530299|NCT02078596|GABA Agents|gaba agents|mesh-ancestor
65530300|NCT02078596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65530301|NCT02078596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530302|NCT02078596|Antimanic Agents|antimanic agents|mesh-ancestor
65530303|NCT02078596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65530304|NCT02078596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65530305|NCT02078596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65530306|NCT02070718|Pentazocine|pentazocine|mesh-list
65530307|NCT02070718|Naloxone|naloxone|mesh-list
65530308|NCT02070718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65530309|NCT02070718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530310|NCT02070718|Sensory System Agents|sensory system agents|mesh-ancestor
65530311|NCT02070718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65530312|NCT02070718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65530313|NCT02070718|Narcotics|narcotics|mesh-ancestor
65530314|NCT02070718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65530315|NCT02070718|Analgesics|analgesics|mesh-ancestor
65530316|NCT02070718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65530317|NCT02070796|Rotigotine|rotigotine|mesh-list
65530318|NCT02070796|Dopamine Agonists|dopamine agonists|mesh-ancestor
65530319|NCT02070796|Dopamine Agents|dopamine agents|mesh-ancestor
65530320|NCT02070796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65530321|NCT02070796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530322|NCT02070796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530323|NCT02079064|Propofol|propofol|mesh-list
65530324|NCT02079064|Desflurane|desflurane|mesh-list
65530325|NCT02079064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65530326|NCT02079064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65530327|NCT02079064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530328|NCT02079064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65530329|NCT02079064|Anesthetics, General|anesthetics, general|mesh-ancestor
65530330|NCT02079064|Anesthetics|anesthetics|mesh-ancestor
65530331|NCT02079064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65530332|NCT02079220|Capecitabine|capecitabine|mesh-list
65530333|NCT02079220|Oxaliplatin|oxaliplatin|mesh-list
65530334|NCT02079220|Aflibercept|aflibercept|mesh-list
65530335|NCT02079220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65530336|NCT02079220|Antimetabolites|antimetabolites|mesh-ancestor
65530337|NCT02079220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530338|NCT02079220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530339|NCT02079220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65530340|NCT02079220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65530341|NCT02079220|Growth Substances|growth substances|mesh-ancestor
65530342|NCT02079220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530343|NCT02079220|Growth Inhibitors|growth inhibitors|mesh-ancestor
65530344|NCT02079298|Fluconazole|fluconazole|mesh-list
65530345|NCT02079298|Ibuprofen|ibuprofen|mesh-list
65530346|NCT02079298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65530347|NCT02079298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65530348|NCT02079298|Analgesics|analgesics|mesh-ancestor
65530349|NCT02079298|Sensory System Agents|sensory system agents|mesh-ancestor
65530350|NCT02079298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65530351|NCT02079298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530352|NCT02079298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65530353|NCT02079298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65530354|NCT02079298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65530355|NCT02079298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530356|NCT02079298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530357|NCT02079298|Antifungal Agents|antifungal agents|mesh-ancestor
65530358|NCT02079298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65530359|NCT02079298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65530360|NCT02079298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65530361|NCT02079298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65530362|NCT02079298|Hormone Antagonists|hormone antagonists|mesh-ancestor
65530363|NCT02079298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65530364|NCT02079298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65530365|NCT02079298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65530367|NCT02071342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530368|NCT02071342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65530369|NCT02071342|Immunologic Factors|immunologic factors|mesh-ancestor
65530370|NCT02071342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530371|NCT02080078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65530372|NCT02080078|Theophylline|theophylline|mesh-list
65530373|NCT02080078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530374|NCT02080078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65530375|NCT02080078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530376|NCT02080078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530377|NCT02080078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65530378|NCT02080078|Autonomic Agents|autonomic agents|mesh-ancestor
65530379|NCT02080078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65530380|NCT02080078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530381|NCT02080078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65530382|NCT02080078|Respiratory System Agents|respiratory system agents|mesh-ancestor
65530383|NCT02080078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65530384|NCT02080078|Vasodilator Agents|vasodilator agents|mesh-ancestor
65530385|NCT02080078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65530386|NCT02080078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65530387|NCT02080078|Purinergic Agents|purinergic agents|mesh-ancestor
65530388|NCT02080078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65530389|NCT02083276|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
65530390|NCT02083276|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65530391|NCT02083276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65530392|NCT02083276|Renal Agents|renal agents|mesh-ancestor
65530393|NCT02083276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65530394|NCT03559504|Sevoflurane|sevoflurane|mesh-list
65530395|NCT03559504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65530396|NCT03559504|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65530397|NCT03559504|Anesthetics, General|anesthetics, general|mesh-ancestor
65530398|NCT03559504|Anesthetics|anesthetics|mesh-ancestor
65530399|NCT03559504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65530400|NCT03559504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530401|NCT02080234|Gemcitabine|gemcitabine|mesh-list
65530402|NCT02080234|Oxaliplatin|oxaliplatin|mesh-list
65530403|NCT02080234|Asparaginase|asparaginase|mesh-list
65530404|NCT02080234|Pegaspargase|pegaspargase|mesh-list
65530405|NCT02080234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65530406|NCT02080234|Antimetabolites|antimetabolites|mesh-ancestor
65530407|NCT02080234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530408|NCT02080234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530409|NCT02080234|Antiviral Agents|antiviral agents|mesh-ancestor
65530410|NCT02080234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65530411|NCT02080234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530412|NCT02080234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65530413|NCT02080234|Immunologic Factors|immunologic factors|mesh-ancestor
65530414|NCT02080234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530415|NCT05070039|Antibodies|antibodies|mesh-list
65530416|NCT05070039|Immunologic Factors|immunologic factors|mesh-ancestor
65530417|NCT05070039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530418|NCT05459649|Cyclosporine|cyclosporine|mesh-list
65530419|NCT05459649|Prednisone|prednisone|mesh-list
65530420|NCT05459649|Cyclosporins|cyclosporins|mesh-list
65530421|NCT05459649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65530422|NCT05459649|Glucocorticoids|glucocorticoids|mesh-ancestor
65530423|NCT05459649|Hormones|hormones|mesh-ancestor
65530424|NCT05459649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65530425|NCT05459649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530426|NCT05459649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65530427|NCT05459649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530428|NCT05459649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530429|NCT05459649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530430|NCT05459649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65530431|NCT05459649|Immunologic Factors|immunologic factors|mesh-ancestor
65530432|NCT05459649|Antifungal Agents|antifungal agents|mesh-ancestor
65530433|NCT05459649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65530434|NCT05459649|Dermatologic Agents|dermatologic agents|mesh-ancestor
65530435|NCT05459649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65530436|NCT05459649|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65530437|NCT05050305|Dexamethasone|dexamethasone|mesh-list
65530438|NCT05050305|Pomalidomide|pomalidomide|mesh-list
65530439|NCT05050305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65530440|NCT05050305|Antiemetics|antiemetics|mesh-ancestor
65530441|NCT05050305|Autonomic Agents|autonomic agents|mesh-ancestor
65530442|NCT05050305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65530443|NCT05050305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530444|NCT05050305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65530445|NCT05050305|Glucocorticoids|glucocorticoids|mesh-ancestor
65530446|NCT05050305|Hormones|hormones|mesh-ancestor
65530447|NCT05050305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65530448|NCT05050305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65530449|NCT05050305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530450|NCT05050305|Immunologic Factors|immunologic factors|mesh-ancestor
65530451|NCT05050305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65530452|NCT05050305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65530453|NCT05050305|Growth Substances|growth substances|mesh-ancestor
65530454|NCT05050305|Growth Inhibitors|growth inhibitors|mesh-ancestor
65530455|NCT04461795|Erenumab|erenumab|mesh-list
65530456|NCT04461795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65530457|NCT04461795|Immunologic Factors|immunologic factors|mesh-ancestor
65530458|NCT04461795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530459|NCT04461795|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65530460|NCT04461795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530461|NCT04461795|Analgesics|analgesics|mesh-ancestor
65530462|NCT04461795|Sensory System Agents|sensory system agents|mesh-ancestor
65530463|NCT04461795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65530464|NCT04461015|Insulin|insulin|mesh-list
65530465|NCT04461015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65530466|NCT04461015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65530467|NCT04461015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530468|NCT03754179|Hydroxychloroquine|hydroxychloroquine|mesh-list
65530469|NCT03754179|Trametinib|trametinib|mesh-list
65530470|NCT03754179|Dabrafenib|dabrafenib|mesh-list
65530471|NCT03754179|Antimalarials|antimalarials|mesh-ancestor
65530472|NCT03754179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65530473|NCT03754179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65530474|NCT03754179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65530475|NCT03754179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530476|NCT03754179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530477|NCT03754179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65530478|NCT03754179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530479|NCT03754179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65530480|NCT03753867|Acitretin|acitretin|mesh-list
65530481|NCT03753867|Keratolytic Agents|keratolytic agents|mesh-ancestor
65530482|NCT03753867|Dermatologic Agents|dermatologic agents|mesh-ancestor
65530483|NCT04439253|Crizotinib|crizotinib|mesh-list
65530484|NCT04439253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530485|NCT04439253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65530486|NCT04439253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530487|NCT04439253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530488|NCT03750669|Folic Acid|folic acid|mesh-list
65530489|NCT03750669|Gemcitabine|gemcitabine|mesh-list
65530490|NCT03750669|Paclitaxel|paclitaxel|mesh-list
65530491|NCT03750669|Fluorouracil|fluorouracil|mesh-list
65530492|NCT03750669|Oxaliplatin|oxaliplatin|mesh-list
65530493|NCT03750669|Irinotecan|irinotecan|mesh-list
65530494|NCT03750669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65530495|NCT03750669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530496|NCT03750669|Tubulin Modulators|tubulin modulators|mesh-ancestor
65530497|NCT03750669|Antimitotic Agents|antimitotic agents|mesh-ancestor
65530498|NCT03750669|Mitosis Modulators|mitosis modulators|mesh-ancestor
65530499|NCT03750669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530500|NCT03750669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65530501|NCT03750669|Antimetabolites|antimetabolites|mesh-ancestor
65530502|NCT03750669|Antiviral Agents|antiviral agents|mesh-ancestor
65530503|NCT03750669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65530504|NCT03750669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530505|NCT03750669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65530506|NCT03750669|Immunologic Factors|immunologic factors|mesh-ancestor
65530507|NCT03750669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530508|NCT03750669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65530509|NCT03750669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65530510|NCT03750669|Hematinics|hematinics|mesh-ancestor
65530511|NCT03750669|Vitamin B Complex|vitamin b complex|mesh-ancestor
65530512|NCT03750669|Vitamins|vitamins|mesh-ancestor
65530513|NCT03750669|Micronutrients|micronutrients|mesh-ancestor
65530514|NCT03757221|Daratumumab|daratumumab|mesh-list
65530515|NCT03757221|Ixazomib|ixazomib|mesh-list
65530516|NCT03757221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530517|NCT03757221|Protease Inhibitors|protease inhibitors|mesh-ancestor
65530518|NCT03757221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530519|NCT03757221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530520|NCT03757143|Ethanol|ethanol|mesh-list
65530521|NCT03757143|Chlorhexidine|chlorhexidine|mesh-list
65530522|NCT03757143|Povidone-Iodine|povidone-iodine|mesh-list
65530523|NCT03757143|Povidone|povidone|mesh-list
65530524|NCT03757143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65530525|NCT03757143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65530526|NCT03757143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65530527|NCT03757143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530528|NCT03757143|Disinfectants|disinfectants|mesh-ancestor
65530529|NCT03757143|Plasma Substitutes|plasma substitutes|mesh-ancestor
65530530|NCT03757143|Blood Substitutes|blood substitutes|mesh-ancestor
65530531|NCT04428411|Etanercept|etanercept|mesh-list
65530532|NCT04428411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65530533|NCT04428411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65530534|NCT04428411|Analgesics|analgesics|mesh-ancestor
65530535|NCT04428411|Sensory System Agents|sensory system agents|mesh-ancestor
65530536|NCT04428411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65530537|NCT04428411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530538|NCT04428411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65530539|NCT04428411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65530540|NCT04428411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65530541|NCT04428411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65530542|NCT04428411|Immunologic Factors|immunologic factors|mesh-ancestor
65530543|NCT03751059|Dexamethasone|dexamethasone|mesh-list
65530544|NCT03751059|Bromfenac|bromfenac|mesh-list
65530545|NCT03751059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65530546|NCT03751059|Antiemetics|antiemetics|mesh-ancestor
65530547|NCT03751059|Autonomic Agents|autonomic agents|mesh-ancestor
65530548|NCT03751059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65530549|NCT03751059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530550|NCT03751059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65530551|NCT03751059|Glucocorticoids|glucocorticoids|mesh-ancestor
65530552|NCT03751059|Hormones|hormones|mesh-ancestor
65530553|NCT03751059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65530554|NCT03751059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65530555|NCT03751059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530556|NCT03751059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65530557|NCT03751059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65530558|NCT03751059|Analgesics|analgesics|mesh-ancestor
65530559|NCT03751059|Sensory System Agents|sensory system agents|mesh-ancestor
65530560|NCT03751059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65530561|NCT04422561|Ivermectin|ivermectin|mesh-list
65530562|NCT04422561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65530563|NCT04422561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65530564|NCT03756987|Ropivacaine|ropivacaine|mesh-list
65530565|NCT03756987|Anesthetics, Local|anesthetics, local|mesh-ancestor
65530566|NCT03756987|Anesthetics|anesthetics|mesh-ancestor
65530567|NCT03756987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65530568|NCT03756987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530569|NCT03756987|Sensory System Agents|sensory system agents|mesh-ancestor
65530570|NCT03756987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65530571|NCT02072746|Zinc|zinc|mesh-list
65530572|NCT02072746|Zinc Sulfate|zinc sulfate|mesh-list
65530573|NCT02072746|Trace Elements|trace elements|mesh-ancestor
65530574|NCT02072746|Micronutrients|micronutrients|mesh-ancestor
65530575|NCT02072746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530576|NCT02072746|Astringents|astringents|mesh-ancestor
65530577|NCT02072746|Dermatologic Agents|dermatologic agents|mesh-ancestor
65530578|NCT04940338|Dexamethasone|dexamethasone|mesh-list
65530579|NCT04940338|Dexamethasone acetate|dexamethasone acetate|mesh-list
65530580|NCT04940338|Bromfenac|bromfenac|mesh-list
65530581|NCT04940338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65530582|NCT04940338|BB 1101|bb 1101|mesh-list
65530583|NCT04940338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65530584|NCT04940338|Antiemetics|antiemetics|mesh-ancestor
65530585|NCT04940338|Autonomic Agents|autonomic agents|mesh-ancestor
65530586|NCT04940338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65530587|NCT04940338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530588|NCT04940338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65530590|NCT04940338|Hormones|hormones|mesh-ancestor
65530591|NCT04940338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65530592|NCT04940338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65530593|NCT04940338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530594|NCT04940338|Protease Inhibitors|protease inhibitors|mesh-ancestor
65530595|NCT04940338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530596|NCT04940338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530597|NCT04940338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65530598|NCT04940338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65530599|NCT04940338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65530600|NCT04940338|Analgesics|analgesics|mesh-ancestor
65530601|NCT04940338|Sensory System Agents|sensory system agents|mesh-ancestor
65530602|NCT04940338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65530603|NCT02083510|Colchicine|colchicine|mesh-list
65530604|NCT02083510|Gout Suppressants|gout suppressants|mesh-ancestor
65530605|NCT02083510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65530606|NCT02083510|Tubulin Modulators|tubulin modulators|mesh-ancestor
65530607|NCT02083510|Antimitotic Agents|antimitotic agents|mesh-ancestor
65530608|NCT02083510|Mitosis Modulators|mitosis modulators|mesh-ancestor
65530609|NCT02083510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530610|NCT02083510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530611|NCT04407507|Ivermectin|ivermectin|mesh-list
65530612|NCT04407507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65530613|NCT04407507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65530614|NCT02080624|Sirolimus|sirolimus|mesh-list
65530615|NCT02080624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65530616|NCT02080624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65530617|NCT02080624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65530618|NCT02080624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530619|NCT02080624|Antifungal Agents|antifungal agents|mesh-ancestor
65530620|NCT02080624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65530621|NCT02080624|Immunologic Factors|immunologic factors|mesh-ancestor
65530622|NCT02080624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530623|NCT02080858|Apixaban|apixaban|mesh-list
65530624|NCT02080858|Ticagrelor|ticagrelor|mesh-list
65530625|NCT02080858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65530626|NCT02080858|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65530627|NCT02080858|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65530628|NCT02080858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65530629|NCT02080858|Purinergic Agents|purinergic agents|mesh-ancestor
65530630|NCT02080858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65530631|NCT02080858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530632|NCT02080858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530633|NCT02080858|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65530634|NCT02080858|Antithrombins|antithrombins|mesh-ancestor
65530635|NCT02080858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65530636|NCT02080858|Protease Inhibitors|protease inhibitors|mesh-ancestor
65530637|NCT02080858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530638|NCT02080858|Anticoagulants|anticoagulants|mesh-ancestor
65530639|NCT02073526|Adalimumab|adalimumab|mesh-list
65530640|NCT02073526|Infliximab|infliximab|mesh-list
65530641|NCT02073526|Certolizumab Pegol|certolizumab pegol|mesh-list
65530642|NCT02073526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65530643|NCT02073526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65530644|NCT02073526|Dermatologic Agents|dermatologic agents|mesh-ancestor
65530645|NCT02073526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65530646|NCT02073526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65530647|NCT02073526|Immunologic Factors|immunologic factors|mesh-ancestor
65530648|NCT02073526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530649|NCT03936933|Goserelin|goserelin|mesh-list
65530650|NCT03936933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65530651|NCT03936933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530652|NCT02073916|Paclitaxel|paclitaxel|mesh-list
65530653|NCT02073916|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65530654|NCT02073916|Trastuzumab|trastuzumab|mesh-list
65530655|NCT02073916|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65530656|NCT02073916|Lapatinib|lapatinib|mesh-list
65530657|NCT02073916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65530658|NCT02073916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530659|NCT02073916|Tubulin Modulators|tubulin modulators|mesh-ancestor
65530660|NCT02073916|Antimitotic Agents|antimitotic agents|mesh-ancestor
65530661|NCT02073916|Mitosis Modulators|mitosis modulators|mesh-ancestor
65530662|NCT02073916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530663|NCT02073916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65328153|NCT05683782|Chelating Agents|chelating agents|mesh-ancestor
65530664|NCT02073916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65530665|NCT02073916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530666|NCT02084368|Bupivacaine|bupivacaine|mesh-list
65530667|NCT02084368|Ropivacaine|ropivacaine|mesh-list
65530668|NCT02084368|Anesthetics, Local|anesthetics, local|mesh-ancestor
65530669|NCT02084368|Anesthetics|anesthetics|mesh-ancestor
65530670|NCT02084368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65530671|NCT02084368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530672|NCT02084368|Sensory System Agents|sensory system agents|mesh-ancestor
65530673|NCT02084368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65530674|NCT02084446|Mycophenolic Acid|mycophenolic acid|mesh-list
65530675|NCT02084446|Prednisone|prednisone|mesh-list
65530676|NCT02084446|Methylprednisolone|methylprednisolone|mesh-list
65530677|NCT02084446|Everolimus|everolimus|mesh-list
65530678|NCT02084446|Tacrolimus|tacrolimus|mesh-list
65530679|NCT02084446|Thymoglobulin|thymoglobulin|mesh-list
65530680|NCT02084446|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65530681|NCT02084446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65530682|NCT02084446|Glucocorticoids|glucocorticoids|mesh-ancestor
65530683|NCT02084446|Hormones|hormones|mesh-ancestor
65530684|NCT02084446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65530685|NCT02084446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530686|NCT02084446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65530687|NCT02084446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530688|NCT02084446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65530689|NCT02084446|Immunologic Factors|immunologic factors|mesh-ancestor
65530690|NCT02084446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65530691|NCT02084446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530692|NCT02084446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530693|NCT02084446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65530694|NCT02084446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65530695|NCT02084446|Antitubercular Agents|antitubercular agents|mesh-ancestor
65530696|NCT02084446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65530697|NCT02084446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65530698|NCT02084446|Antiemetics|antiemetics|mesh-ancestor
65530699|NCT02084446|Autonomic Agents|autonomic agents|mesh-ancestor
65530700|NCT02084446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65530701|NCT02084446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65530702|NCT02084446|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65530703|NCT02084446|Protective Agents|protective agents|mesh-ancestor
65530704|NCT02801656|Vancomycin|vancomycin|mesh-list
65530705|NCT02801656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65530706|NCT02801656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65530707|NCT02081482|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65530708|NCT02081482|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65530709|NCT02081482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530710|NCT02084602|Artesunate|artesunate|mesh-list
65530711|NCT02084602|Mefloquine|mefloquine|mesh-list
65530712|NCT02084602|Antimalarials|antimalarials|mesh-ancestor
65530713|NCT02084602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65530714|NCT02084602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65530715|NCT02084602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65530716|NCT02084602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530717|NCT02084602|Antiviral Agents|antiviral agents|mesh-ancestor
65530718|NCT02084602|Schistosomicides|schistosomicides|mesh-ancestor
65530719|NCT02084602|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65530720|NCT02084602|Anthelmintics|anthelmintics|mesh-ancestor
65530721|NCT02081560|Colistin|colistin|mesh-list
65530722|NCT02081560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65530723|NCT02081560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65530724|NCT02074150|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65530725|NCT02074150|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65530726|NCT02074150|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65530727|NCT02074150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65530728|NCT02074150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530729|NCT02074150|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65530730|NCT02074150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65530731|NCT02074150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530732|NCT02074150|Cholinergic Agents|cholinergic agents|mesh-ancestor
65530733|NCT02074150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65530734|NCT02074228|Methylphenidate|methylphenidate|mesh-list
65530735|NCT02074228|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65530736|NCT02074228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530737|NCT02074228|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65530738|NCT02074228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65328231|NCT02603159|Capecitabine|capecitabine|mesh-list
65530739|NCT02074228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65530740|NCT02074228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530741|NCT02074228|Dopamine Agents|dopamine agents|mesh-ancestor
65530742|NCT02074228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65530743|NCT04346199|Acalabrutinib|acalabrutinib|mesh-list
65530744|NCT04346199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530745|NCT04345653|Hydroxychloroquine|hydroxychloroquine|mesh-list
65530746|NCT04345653|Antimalarials|antimalarials|mesh-ancestor
65530747|NCT04345653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65530748|NCT04345653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65530749|NCT04345653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65530750|NCT04345653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530751|NCT04345653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530752|NCT04345653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65530753|NCT02085304|Temozolomide|temozolomide|mesh-list
65530754|NCT02085304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65530755|NCT02085304|Alkylating Agents|alkylating agents|mesh-ancestor
65530756|NCT02085304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530757|NCT02085304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530758|NCT02260414|Tinzaparin|tinzaparin|mesh-list
65530759|NCT02260414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65530760|NCT02260414|Dalteparin|dalteparin|mesh-list
65530761|NCT02260414|Anticoagulants|anticoagulants|mesh-ancestor
65530762|NCT02260414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65530763|NCT02260414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65530764|NCT02260414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530765|NCT02085538|Palbociclib|palbociclib|mesh-list
65530766|NCT02085538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530767|NCT02085538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65530768|NCT02085538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530769|NCT02085538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530770|NCT04169061|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65530771|NCT04169061|Hormones|hormones|mesh-ancestor
65530772|NCT04169061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65530773|NCT04169061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530774|NCT01562691|Petrolatum|petrolatum|mesh-list
65530775|NCT01562691|Emollients|emollients|mesh-ancestor
65530776|NCT01562691|Dermatologic Agents|dermatologic agents|mesh-ancestor
65530777|NCT04681677|Bevacizumab|bevacizumab|mesh-list
65530778|NCT04681677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65530779|NCT04681677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530780|NCT04681677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65530781|NCT04681677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65530782|NCT04681677|Growth Substances|growth substances|mesh-ancestor
65530783|NCT04681677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530784|NCT04681677|Growth Inhibitors|growth inhibitors|mesh-ancestor
65530785|NCT02792218|Teriflunomide|teriflunomide|mesh-list
65530786|NCT02792218|Ofatumumab|ofatumumab|mesh-list
65530787|NCT02792218|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65530788|NCT02792218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530789|NCT02792218|Immunologic Factors|immunologic factors|mesh-ancestor
65530790|NCT02792218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530791|NCT02792218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65530792|NCT02792218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65530793|NCT02792218|Analgesics|analgesics|mesh-ancestor
65530794|NCT02792218|Sensory System Agents|sensory system agents|mesh-ancestor
65530795|NCT02792218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65530796|NCT02792218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65530797|NCT02792218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65530798|NCT02792218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65530799|NCT02075086|Bevacizumab|bevacizumab|mesh-list
65530800|NCT02075086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65530801|NCT02075086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530802|NCT02075086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65530803|NCT02075086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65530804|NCT02075086|Growth Substances|growth substances|mesh-ancestor
65530805|NCT02075086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530806|NCT02075086|Growth Inhibitors|growth inhibitors|mesh-ancestor
65530807|NCT02082418|Caseins|caseins|mesh-list
65530808|NCT02082418|Chelating Agents|chelating agents|mesh-ancestor
65530809|NCT02082418|Sequestering Agents|sequestering agents|mesh-ancestor
65530810|NCT02082418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530811|NCT02082496|Liraglutide|liraglutide|mesh-list
65530812|NCT02082496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65530813|NCT02082496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328322|NCT00722475|Immunoglobulins|immunoglobulins|mesh-list
65530814|NCT02082496|Incretins|incretins|mesh-ancestor
65530815|NCT02082496|Hormones|hormones|mesh-ancestor
65530816|NCT02082496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65530817|NCT02075242|Mycophenolic Acid|mycophenolic acid|mesh-list
65530818|NCT02075242|Tacrolimus|tacrolimus|mesh-list
65530819|NCT02075242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65530820|NCT02075242|Immunologic Factors|immunologic factors|mesh-ancestor
65530821|NCT02075242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530822|NCT02075242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65530823|NCT02075242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530824|NCT02075242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530825|NCT02075242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65530826|NCT02075242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530827|NCT02075242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65530828|NCT02075242|Antitubercular Agents|antitubercular agents|mesh-ancestor
65530829|NCT02075242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65530830|NCT02075242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65530831|NCT02082652|Etonogestrel|etonogestrel|mesh-list
65530832|NCT02082652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65530833|NCT02082652|Contraceptive Agents|contraceptive agents|mesh-ancestor
65530834|NCT02082652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65530835|NCT02082652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530836|NCT02082652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65530837|NCT00153101|Telmisartan|telmisartan|mesh-list
65530838|NCT00153101|Ramipril|ramipril|mesh-list
65530839|NCT00153101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65530840|NCT00153101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65530841|NCT00153101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65530842|NCT00153101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530843|NCT00153101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65530844|NCT00153101|Protease Inhibitors|protease inhibitors|mesh-ancestor
65530845|NCT00153101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530846|NCT03558412|Decitabine|decitabine|mesh-list
65530847|NCT03558412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65530848|NCT03558412|Antimetabolites|antimetabolites|mesh-ancestor
65530849|NCT03558412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530850|NCT03558412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530851|NCT03558412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530852|NCT04401579|Remdesivir|remdesivir|mesh-list
65530853|NCT04401579|Antimetabolites|antimetabolites|mesh-ancestor
65530854|NCT04401579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530855|NCT04401579|Antiviral Agents|antiviral agents|mesh-ancestor
65530856|NCT04401579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65530857|NCT03558880|Anesthetics|anesthetics|mesh-list
65530858|NCT03558880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65530859|NCT03558880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530860|NCT04401423|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
65530861|NCT04401423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65530862|NCT04401423|Vasodilator Agents|vasodilator agents|mesh-ancestor
65530863|NCT03749733|Megestrol|megestrol|mesh-list
65530864|NCT03749733|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65530865|NCT03749733|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65530866|NCT03749733|Estradiol|estradiol|mesh-list
65530867|NCT03749733|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65530868|NCT03749733|Estrogens|estrogens|mesh-ancestor
65530869|NCT03749733|Hormones|hormones|mesh-ancestor
65530870|NCT03749733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65530871|NCT03749733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530872|NCT03749733|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65530873|NCT03749733|Contraceptive Agents|contraceptive agents|mesh-ancestor
65530874|NCT03749733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65530875|NCT03749733|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65530876|NCT03749733|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65530877|NCT03749733|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65530878|NCT03749733|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65530879|NCT03749733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65530880|NCT03749733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530881|NCT04399161|Chlorhexidine|chlorhexidine|mesh-list
65530882|NCT04399161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65530883|NCT04399161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65530884|NCT04399161|Disinfectants|disinfectants|mesh-ancestor
65530886|NCT04160091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65530887|NCT04160091|Glucocorticoids|glucocorticoids|mesh-ancestor
65530888|NCT04160091|Hormones|hormones|mesh-ancestor
65328384|NCT04107779|Menthol|menthol|mesh-list
65530889|NCT04160091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65530890|NCT04160091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530891|NCT04160091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65530892|NCT04160091|Immunologic Factors|immunologic factors|mesh-ancestor
65530893|NCT01582607|Fentanyl|fentanyl|mesh-list
65530894|NCT01582607|Bupivacaine|bupivacaine|mesh-list
65530895|NCT01582607|Ropivacaine|ropivacaine|mesh-list
65530896|NCT01582607|Levobupivacaine|levobupivacaine|mesh-list
65530897|NCT01582607|Anesthetics, Local|anesthetics, local|mesh-ancestor
65530898|NCT01582607|Anesthetics|anesthetics|mesh-ancestor
65530899|NCT01582607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65530900|NCT01582607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530901|NCT01582607|Sensory System Agents|sensory system agents|mesh-ancestor
65530902|NCT01582607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65530903|NCT01582607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65530904|NCT01582607|Narcotics|narcotics|mesh-ancestor
65530905|NCT01582607|Analgesics|analgesics|mesh-ancestor
65530906|NCT01582607|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65530907|NCT01582607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65530908|NCT01582607|Anesthetics, General|anesthetics, general|mesh-ancestor
65530909|NCT00149825|Dexetimide|dexetimide|mesh-list
65530910|NCT00149825|Citalopram|citalopram|mesh-list
65530911|NCT00149825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65530912|NCT00149825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65530913|NCT00149825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65530914|NCT00149825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530915|NCT00149825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65530916|NCT00149825|Serotonin Agents|serotonin agents|mesh-ancestor
65530917|NCT00149825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530918|NCT00149825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65530919|NCT00149825|Antidepressive Agents|antidepressive agents|mesh-ancestor
65530920|NCT00149825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65530921|NCT00149825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65530922|NCT00149825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65530923|NCT00149825|Parasympatholytics|parasympatholytics|mesh-ancestor
65530924|NCT00149825|Autonomic Agents|autonomic agents|mesh-ancestor
65530925|NCT00149825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65530926|NCT00149825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65530927|NCT00149825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65530928|NCT00149825|Cholinergic Agents|cholinergic agents|mesh-ancestor
65530929|NCT02792062|Relugolix|relugolix|mesh-list
65530930|NCT02792062|Androgen Antagonists|androgen antagonists|mesh-ancestor
65530931|NCT02792062|Hormone Antagonists|hormone antagonists|mesh-ancestor
65530932|NCT02792062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65530933|NCT02792062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530934|NCT05027295|Riboflavin|riboflavin|mesh-list
65530935|NCT05027295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65530936|NCT05027295|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65530937|NCT05027295|Vitamin B Complex|vitamin b complex|mesh-ancestor
65530938|NCT05027295|Vitamins|vitamins|mesh-ancestor
65530939|NCT05027295|Micronutrients|micronutrients|mesh-ancestor
65530940|NCT05027295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530941|NCT05027295|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65530942|NCT05027295|Dermatologic Agents|dermatologic agents|mesh-ancestor
65530943|NCT02090920|Nifedipine|nifedipine|mesh-list
65530944|NCT02090920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65530945|NCT02090920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65530946|NCT02090920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530947|NCT02090920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65530948|NCT02090920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530949|NCT02090920|Vasodilator Agents|vasodilator agents|mesh-ancestor
65530950|NCT02090920|Tocolytic Agents|tocolytic agents|mesh-ancestor
65530951|NCT02090920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65530952|NCT02086474|Bupivacaine|bupivacaine|mesh-list
65530953|NCT02086474|Hyaluronic Acid|hyaluronic acid|mesh-list
65530954|NCT02086474|Anesthetics, Local|anesthetics, local|mesh-ancestor
65530955|NCT02086474|Anesthetics|anesthetics|mesh-ancestor
65530956|NCT02086474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65530957|NCT02086474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530958|NCT02086474|Sensory System Agents|sensory system agents|mesh-ancestor
65530959|NCT02086474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65530960|NCT02086474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65530961|NCT02086474|Immunologic Factors|immunologic factors|mesh-ancestor
65530962|NCT02086474|Viscosupplements|viscosupplements|mesh-ancestor
65530963|NCT02086474|Protective Agents|protective agents|mesh-ancestor
65530964|NCT02091310|Moxifloxacin|moxifloxacin|mesh-list
65530965|NCT02091310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65530966|NCT02091310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65530967|NCT02091310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65530968|NCT02091310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65530969|NCT02091310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65530970|NCT02091310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530971|NCT02091310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530972|NCT02621398|Paclitaxel|paclitaxel|mesh-list
65530973|NCT02621398|Carboplatin|carboplatin|mesh-list
65530974|NCT02621398|Pembrolizumab|pembrolizumab|mesh-list
65530975|NCT02621398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65530976|NCT02621398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65530977|NCT02621398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65530978|NCT02621398|Tubulin Modulators|tubulin modulators|mesh-ancestor
65530979|NCT02621398|Antimitotic Agents|antimitotic agents|mesh-ancestor
65530980|NCT02621398|Mitosis Modulators|mitosis modulators|mesh-ancestor
65530981|NCT02621398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530982|NCT02621398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65530983|NCT04397445|Ranitidine|ranitidine|mesh-list
65530984|NCT04397445|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65530985|NCT04397445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65530986|NCT04397445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65530987|NCT04397445|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65530988|NCT04397445|Histamine Antagonists|histamine antagonists|mesh-ancestor
65530989|NCT04397445|Histamine Agents|histamine agents|mesh-ancestor
65530990|NCT04397445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65530991|NCT04397445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530992|NCT04397445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530993|NCT02091388|Risperidone|risperidone|mesh-list
65530994|NCT02091388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65530995|NCT02091388|Serotonin Agents|serotonin agents|mesh-ancestor
65530996|NCT02091388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65530997|NCT02091388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65530998|NCT02091388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65530999|NCT02091388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65531000|NCT02091388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65531001|NCT02091388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65531002|NCT02091388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65531003|NCT02091388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65531004|NCT02091388|Dopamine Agents|dopamine agents|mesh-ancestor
65531005|NCT02086942|Dexamethasone|dexamethasone|mesh-list
65531006|NCT02086942|Cyclophosphamide|cyclophosphamide|mesh-list
65531007|NCT02086942|Bortezomib|bortezomib|mesh-list
65531008|NCT02086942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65531009|NCT02086942|Immunologic Factors|immunologic factors|mesh-ancestor
65531010|NCT02086942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531011|NCT02086942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65531012|NCT02086942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65531013|NCT02086942|Alkylating Agents|alkylating agents|mesh-ancestor
65531014|NCT02086942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531015|NCT02086942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531016|NCT02086942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65531017|NCT02086942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65531018|NCT02086942|Antiemetics|antiemetics|mesh-ancestor
65531019|NCT02086942|Autonomic Agents|autonomic agents|mesh-ancestor
65531020|NCT02086942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65531021|NCT02086942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65531022|NCT02086942|Glucocorticoids|glucocorticoids|mesh-ancestor
65531023|NCT02086942|Hormones|hormones|mesh-ancestor
65531024|NCT02086942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65531025|NCT02086942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65531026|NCT02088424|Insulin|insulin|mesh-list
65531027|NCT02088424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65531028|NCT02088424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531029|NCT00191945|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65531030|NCT00191945|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65531031|NCT00191945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65531032|NCT00191945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65531033|NCT00191945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531034|NCT00191945|Adrenergic Agents|adrenergic agents|mesh-ancestor
65531035|NCT00191945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65531036|NCT00191945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531037|NCT02087020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65531038|NCT02087020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531040|NCT02088502|Theophylline|theophylline|mesh-list
65531041|NCT02088502|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65531042|NCT02088502|Antiviral Agents|antiviral agents|mesh-ancestor
65531043|NCT02088502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531044|NCT02088502|Expectorants|expectorants|mesh-ancestor
65531045|NCT02088502|Respiratory System Agents|respiratory system agents|mesh-ancestor
65531046|NCT02088502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65531047|NCT02088502|Antioxidants|antioxidants|mesh-ancestor
65531048|NCT02088502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531049|NCT02088502|Protective Agents|protective agents|mesh-ancestor
65531050|NCT02088502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531051|NCT02088502|Antidotes|antidotes|mesh-ancestor
65531052|NCT02088502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65531053|NCT02088502|Autonomic Agents|autonomic agents|mesh-ancestor
65531054|NCT02088502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65531055|NCT02088502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65531056|NCT02088502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65531057|NCT02088502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65531058|NCT02088502|Vasodilator Agents|vasodilator agents|mesh-ancestor
65531059|NCT02088502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65531060|NCT02088502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65531061|NCT02088502|Purinergic Agents|purinergic agents|mesh-ancestor
65531062|NCT02088502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65531063|NCT02087098|Solifenacin Succinate|solifenacin succinate|mesh-list
65531064|NCT02087098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65531065|NCT02087098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65531066|NCT02087098|Cholinergic Agents|cholinergic agents|mesh-ancestor
65531067|NCT02087098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65531068|NCT02087098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531069|NCT02087098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531070|NCT02087098|Urological Agents|urological agents|mesh-ancestor
65531071|NCT01369342|Ustekinumab|ustekinumab|mesh-list
65531072|NCT01369342|Dermatologic Agents|dermatologic agents|mesh-ancestor
65531073|NCT00191477|Gemcitabine|gemcitabine|mesh-list
65531074|NCT00191477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65531075|NCT00191477|Antimetabolites|antimetabolites|mesh-ancestor
65531076|NCT00191477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531077|NCT00191477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531078|NCT00191477|Antiviral Agents|antiviral agents|mesh-ancestor
65531079|NCT00191477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531080|NCT00191477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65531081|NCT00191477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65531082|NCT00191477|Immunologic Factors|immunologic factors|mesh-ancestor
65531083|NCT00191477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531084|NCT02087332|Torsemide|torsemide|mesh-list
65531085|NCT02087332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65531086|NCT02087332|Diuretics|diuretics|mesh-ancestor
65531087|NCT02087332|Natriuretic Agents|natriuretic agents|mesh-ancestor
65531088|NCT02087332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531089|NCT02087332|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65531090|NCT02087332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65531091|NCT02087332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531092|NCT02092012|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65531093|NCT02092012|Dexmedetomidine|dexmedetomidine|mesh-list
65531094|NCT02092012|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65531095|NCT02092012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65531096|NCT02092012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531097|NCT02092012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65531098|NCT02092012|Analgesics|analgesics|mesh-ancestor
65531099|NCT02092012|Sensory System Agents|sensory system agents|mesh-ancestor
65531100|NCT02092012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65531101|NCT02092012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65531102|NCT02092012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65531103|NCT02092012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65531104|NCT02092012|Adrenergic Agents|adrenergic agents|mesh-ancestor
65531105|NCT02092012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65531106|NCT02092012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531107|NCT02092012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65531108|NCT02092012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65531109|NCT02092012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65531110|NCT00187889|Eplerenone|eplerenone|mesh-list
65531111|NCT00187889|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65328605|NCT03907605|Hormones|hormones|mesh-list
65531112|NCT00187889|Hormone Antagonists|hormone antagonists|mesh-ancestor
65531113|NCT00187889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65531114|NCT00187889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531115|NCT00187889|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65531117|NCT00187889|Natriuretic Agents|natriuretic agents|mesh-ancestor
65531118|NCT00187889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65531119|NCT02087488|Eszopiclone|eszopiclone|mesh-list
65531120|NCT02087488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65531121|NCT02087488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65531122|NCT02087488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531123|NCT02087566|Linezolid|linezolid|mesh-list
65531124|NCT02087566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65531125|NCT02087566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531126|NCT02087566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65531127|NCT02087566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65531128|NCT02087566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531129|NCT00148109|Cetuximab|cetuximab|mesh-list
65531130|NCT00148109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65531131|NCT00148109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531132|NCT03746223|Rituximab|rituximab|mesh-list
65531133|NCT03746223|Methotrexate|methotrexate|mesh-list
65531134|NCT03746223|Lenalidomide|lenalidomide|mesh-list
65531135|NCT03746223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65531136|NCT03746223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531137|NCT03746223|Immunologic Factors|immunologic factors|mesh-ancestor
65531138|NCT03746223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531139|NCT03746223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65531140|NCT03746223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65531141|NCT03746223|Abortifacient Agents|abortifacient agents|mesh-ancestor
65531142|NCT03746223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65531143|NCT03746223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65531144|NCT03746223|Antimetabolites|antimetabolites|mesh-ancestor
65531145|NCT03746223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531146|NCT03746223|Dermatologic Agents|dermatologic agents|mesh-ancestor
65531147|NCT03746223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65531148|NCT03746223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65531149|NCT03746223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65531150|NCT03746223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65531151|NCT03746223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65531152|NCT03746223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65531153|NCT03746223|Growth Substances|growth substances|mesh-ancestor
65531154|NCT03746223|Growth Inhibitors|growth inhibitors|mesh-ancestor
65531155|NCT03969017|Interferons|interferons|mesh-list
65531156|NCT03969017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531157|NCT03969017|Antiviral Agents|antiviral agents|mesh-ancestor
65531158|NCT03969017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531159|NCT04596033|Cyclophosphamide|cyclophosphamide|mesh-list
65531160|NCT04596033|Fludarabine|fludarabine|mesh-list
65531161|NCT04596033|Interleukin-2|interleukin-2|mesh-list
65531162|NCT04596033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65531163|NCT04596033|Immunologic Factors|immunologic factors|mesh-ancestor
65531164|NCT04596033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531165|NCT04596033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65531166|NCT04596033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65531167|NCT04596033|Alkylating Agents|alkylating agents|mesh-ancestor
65531168|NCT04596033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531169|NCT04596033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531170|NCT04596033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65531171|NCT04596033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65531172|NCT04596033|Analgesics|analgesics|mesh-ancestor
65531173|NCT04596033|Sensory System Agents|sensory system agents|mesh-ancestor
65531174|NCT04596033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65531175|NCT02092558|Nitrofurantoin|nitrofurantoin|mesh-list
65531176|NCT02092558|Cephalosporins|cephalosporins|mesh-list
65531177|NCT02092558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65531178|NCT02092558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531179|NCT02092558|Renal Agents|renal agents|mesh-ancestor
65531180|NCT02092558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65531181|NCT01074359|Tocopherylquinone|tocopherylquinone|mesh-list
65531182|NCT01074359|Anticoagulants|anticoagulants|mesh-ancestor
65531183|NCT01074359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65531184|NCT01074359|Antioxidants|antioxidants|mesh-ancestor
65531185|NCT01074359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531186|NCT01074359|Protective Agents|protective agents|mesh-ancestor
65531187|NCT01074359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531189|NCT02087722|Antioxidants|antioxidants|mesh-ancestor
65531190|NCT02087722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531191|NCT02087722|Protective Agents|protective agents|mesh-ancestor
65531192|NCT02087722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531193|NCT02087722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65531194|NCT01326221|Tenofovir|tenofovir|mesh-list
65531195|NCT01326221|Emtricitabine|emtricitabine|mesh-list
65531196|NCT01326221|Antiviral Agents|antiviral agents|mesh-ancestor
65531197|NCT01326221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531198|NCT01326221|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65531199|NCT01326221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65531200|NCT01326221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65531201|NCT01326221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531202|NCT01326221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65531203|NCT01326221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65531204|NCT04311177|Losartan|losartan|mesh-list
65531205|NCT04311177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65531206|NCT04311177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65531207|NCT04311177|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65531208|NCT04311177|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65531209|NCT04311177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531210|NCT02088892|BCG Vaccine|bcg vaccine|mesh-list
65531211|NCT02088892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65531212|NCT02088892|Immunologic Factors|immunologic factors|mesh-ancestor
65531213|NCT02088892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531214|NCT01074593|Interferons|interferons|mesh-list
65531215|NCT01074593|Interferon-beta|interferon-beta|mesh-list
65531216|NCT01074593|Interferon beta-1a|interferon beta-1a|mesh-list
65531217|NCT01074593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531218|NCT01074593|Antiviral Agents|antiviral agents|mesh-ancestor
65531219|NCT01074593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531220|NCT01074593|Immunologic Factors|immunologic factors|mesh-ancestor
65531221|NCT01074593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531222|NCT01074593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65531223|NCT02088970|Riboflavin|riboflavin|mesh-list
65531224|NCT02088970|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65531225|NCT02088970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531226|NCT02088970|Vitamin B Complex|vitamin b complex|mesh-ancestor
65531227|NCT02088970|Vitamins|vitamins|mesh-ancestor
65531228|NCT02088970|Micronutrients|micronutrients|mesh-ancestor
65531229|NCT02088970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531230|NCT02088970|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65531231|NCT02088970|Dermatologic Agents|dermatologic agents|mesh-ancestor
65531232|NCT03968861|Xenon|xenon|mesh-list
65531233|NCT03968861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65531234|NCT03968861|Anesthetics, General|anesthetics, general|mesh-ancestor
65531235|NCT03968861|Anesthetics|anesthetics|mesh-ancestor
65531236|NCT03968861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65531237|NCT03968861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531238|NCT04292535|Insulin|insulin|mesh-list
65531239|NCT04292535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65531240|NCT04292535|Insulin Aspart|insulin aspart|mesh-list
65531241|NCT04292535|Insulin, Long-Acting|insulin, long-acting|mesh-list
65531242|NCT04292535|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65531243|NCT04292535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65531244|NCT04292535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531245|NCT03747081|Warfarin|warfarin|mesh-list
65531246|NCT03747081|Rivaroxaban|rivaroxaban|mesh-list
65531247|NCT03747081|Anticoagulants|anticoagulants|mesh-ancestor
65531248|NCT03747081|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65531249|NCT03747081|Antithrombins|antithrombins|mesh-ancestor
65531250|NCT03747081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65531251|NCT03747081|Protease Inhibitors|protease inhibitors|mesh-ancestor
65531252|NCT03747081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65531253|NCT03747081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531254|NCT01075841|Cetuximab|cetuximab|mesh-list
65531255|NCT01075841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65531256|NCT01075841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531257|NCT01313390|Docetaxel|docetaxel|mesh-list
65531258|NCT01313390|Everolimus|everolimus|mesh-list
65531259|NCT01313390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531260|NCT01313390|Tubulin Modulators|tubulin modulators|mesh-ancestor
65531261|NCT01313390|Antimitotic Agents|antimitotic agents|mesh-ancestor
65531262|NCT01313390|Mitosis Modulators|mitosis modulators|mesh-ancestor
65531263|NCT01313390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531264|NCT01313390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65531265|NCT01313390|Immunologic Factors|immunologic factors|mesh-ancestor
65531266|NCT01313390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531268|NCT05571332|Cyclosporins|cyclosporins|mesh-list
65531269|NCT05571332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65531270|NCT05571332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531271|NCT05571332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65531272|NCT05571332|Immunologic Factors|immunologic factors|mesh-ancestor
65531273|NCT05571332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531274|NCT05571332|Antifungal Agents|antifungal agents|mesh-ancestor
65531275|NCT05571332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531276|NCT05571332|Dermatologic Agents|dermatologic agents|mesh-ancestor
65531277|NCT05571332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65531278|NCT05571332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65531279|NCT02791438|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65531280|NCT02791438|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65531281|NCT02791438|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65531282|NCT02791438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531283|NCT02089048|Auranofin|auranofin|mesh-list
65531284|NCT02089048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65531285|NCT02089126|Glimepiride|glimepiride|mesh-list
65531286|NCT02089126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65531287|NCT02089126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65531288|NCT02089126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531289|NCT02089126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65531290|NCT02089126|Immunologic Factors|immunologic factors|mesh-ancestor
65531291|NCT05571176|Ketamine|ketamine|mesh-list
65531292|NCT05571176|Esketamine|esketamine|mesh-list
65531293|NCT05571176|Analgesics|analgesics|mesh-ancestor
65531294|NCT05571176|Sensory System Agents|sensory system agents|mesh-ancestor
65531295|NCT05571176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65531296|NCT05571176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531297|NCT05571176|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65531298|NCT05571176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65531299|NCT05571176|Anesthetics, General|anesthetics, general|mesh-ancestor
65531300|NCT05571176|Anesthetics|anesthetics|mesh-ancestor
65531301|NCT05571176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65531302|NCT05571176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65531303|NCT05571176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65531304|NCT05571176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65531305|NCT05571176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531306|NCT05571176|Antidepressive Agents|antidepressive agents|mesh-ancestor
65531307|NCT05571176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65531308|NCT03689582|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65531309|NCT03689582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65531310|NCT03689582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531311|NCT02095834|Dexamethasone|dexamethasone|mesh-list
65531312|NCT02095834|Dexamethasone acetate|dexamethasone acetate|mesh-list
65531313|NCT02095834|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65531314|NCT02095834|Ichthammol|ichthammol|mesh-list
65531315|NCT02095834|BB 1101|bb 1101|mesh-list
65531316|NCT02095834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65531317|NCT02095834|Antiemetics|antiemetics|mesh-ancestor
65531318|NCT02095834|Autonomic Agents|autonomic agents|mesh-ancestor
65531319|NCT02095834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65531320|NCT02095834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531321|NCT02095834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65531322|NCT02095834|Glucocorticoids|glucocorticoids|mesh-ancestor
65531323|NCT02095834|Hormones|hormones|mesh-ancestor
65531324|NCT02095834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65531325|NCT02095834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65531326|NCT02095834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531327|NCT02095834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65531328|NCT02095834|Alkylating Agents|alkylating agents|mesh-ancestor
65531329|NCT02095834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531330|NCT02095834|Protease Inhibitors|protease inhibitors|mesh-ancestor
65531331|NCT02095834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260312|NCT05211804|Ranibizumab|ranibizumab|mesh-list
65531332|NCT02095834|Dermatologic Agents|dermatologic agents|mesh-ancestor
65531333|NCT03125642|Cytarabine|cytarabine|mesh-list
65531334|NCT03125642|Cyclophosphamide|cyclophosphamide|mesh-list
65531335|NCT03125642|Melphalan|melphalan|mesh-list
65531336|NCT03125642|Carmustine|carmustine|mesh-list
65531337|NCT03125642|Etoposide|etoposide|mesh-list
65531338|NCT03125642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65531339|NCT03125642|Immunologic Factors|immunologic factors|mesh-ancestor
65531340|NCT03125642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531341|NCT03125642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65531342|NCT03125642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65531343|NCT03125642|Alkylating Agents|alkylating agents|mesh-ancestor
65531344|NCT03125642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531345|NCT03125642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531346|NCT03125642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65531347|NCT03125642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65531348|NCT03125642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65531349|NCT03125642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65531350|NCT03125642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65531351|NCT03125642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65531352|NCT03125642|Antimetabolites|antimetabolites|mesh-ancestor
65531353|NCT03125642|Antiviral Agents|antiviral agents|mesh-ancestor
65531354|NCT03125642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531355|NCT03556852|Misoprostol|misoprostol|mesh-list
65531356|NCT03556852|Carbetocin|carbetocin|mesh-list
65531357|NCT03556852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65531358|NCT03556852|Abortifacient Agents|abortifacient agents|mesh-ancestor
65531359|NCT03556852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65531360|NCT03556852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531361|NCT03556852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65531362|NCT03556852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65531363|NCT03556852|Oxytocics|oxytocics|mesh-ancestor
65531364|NCT02808572|Mitogens|mitogens|mesh-list
65531365|NCT02808572|Mitosis Modulators|mitosis modulators|mesh-ancestor
65531366|NCT02808572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531367|NCT02093728|Itraconazole|itraconazole|mesh-list
65531368|NCT02093728|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
65531369|NCT02093728|Fluconazole|fluconazole|mesh-list
65531370|NCT02093728|Antifungal Agents|antifungal agents|mesh-ancestor
65531371|NCT02093728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531372|NCT02093728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65531373|NCT02093728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65531374|NCT02093728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65531375|NCT02093728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531376|NCT02093728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65531377|NCT02093728|Hormone Antagonists|hormone antagonists|mesh-ancestor
65531378|NCT02093728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65531379|NCT02093728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531380|NCT02093728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65531381|NCT02093728|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65531382|NCT02093728|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65531383|NCT03692871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65531384|NCT03692871|Immunologic Factors|immunologic factors|mesh-ancestor
65531385|NCT03692871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531386|NCT02089204|Deoxyglucose|deoxyglucose|mesh-list
65531387|NCT02089204|Fluorides|fluorides|mesh-list
65531388|NCT02089204|Cariostatic Agents|cariostatic agents|mesh-ancestor
65531389|NCT02089204|Protective Agents|protective agents|mesh-ancestor
65531390|NCT02089204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531391|NCT02089204|Antimetabolites|antimetabolites|mesh-ancestor
65531392|NCT02089204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531393|NCT02089204|Antiviral Agents|antiviral agents|mesh-ancestor
65531394|NCT02089204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531395|NCT02095990|Hydroquinone|hydroquinone|mesh-list
65531396|NCT02095990|Antioxidants|antioxidants|mesh-ancestor
65531397|NCT02095990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531398|NCT02095990|Protective Agents|protective agents|mesh-ancestor
65531399|NCT02095990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531400|NCT02095990|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65531401|NCT02096068|Dexmedetomidine|dexmedetomidine|mesh-list
65531402|NCT02096068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65531403|NCT02096068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65531404|NCT02096068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531405|NCT02096068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65531406|NCT02096068|Analgesics|analgesics|mesh-ancestor
65531407|NCT02096068|Sensory System Agents|sensory system agents|mesh-ancestor
65531408|NCT02096068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65531409|NCT02096068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65531410|NCT02096068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65531411|NCT02096068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65531412|NCT02096068|Adrenergic Agents|adrenergic agents|mesh-ancestor
65531413|NCT02096068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65531414|NCT02096068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531416|NCT02089438|Vildagliptin|vildagliptin|mesh-list
65531417|NCT02089438|Saxagliptin|saxagliptin|mesh-list
65531418|NCT02089438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65531419|NCT02089438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531420|NCT02089438|Incretins|incretins|mesh-ancestor
65531421|NCT02089438|Hormones|hormones|mesh-ancestor
65531422|NCT02089438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65531423|NCT02089438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65531424|NCT02089438|Protease Inhibitors|protease inhibitors|mesh-ancestor
65531425|NCT02089438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65531426|NCT02089438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531427|NCT05471674|Nivolumab|nivolumab|mesh-list
65531428|NCT05471674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65531429|NCT05471674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531430|NCT05471674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65531431|NCT05471674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531432|NCT02096224|Sevoflurane|sevoflurane|mesh-list
65531433|NCT02096224|Desflurane|desflurane|mesh-list
65531434|NCT02096224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65531435|NCT02096224|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65531436|NCT02096224|Anesthetics, General|anesthetics, general|mesh-ancestor
65531437|NCT02096224|Anesthetics|anesthetics|mesh-ancestor
65531438|NCT02096224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65531439|NCT02096224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531440|NCT02096380|Cisplatin|cisplatin|mesh-list
65531441|NCT02096380|Docetaxel|docetaxel|mesh-list
65531442|NCT02096380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531443|NCT02096380|Tubulin Modulators|tubulin modulators|mesh-ancestor
65531444|NCT02096380|Antimitotic Agents|antimitotic agents|mesh-ancestor
65531445|NCT02096380|Mitosis Modulators|mitosis modulators|mesh-ancestor
65531446|NCT02096380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531447|NCT04384107|Vaccines|vaccines|mesh-list
65531448|NCT04384107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65531449|NCT04384107|Immunologic Factors|immunologic factors|mesh-ancestor
65531450|NCT04384107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531451|NCT02250118|Bevacizumab|bevacizumab|mesh-list
65531452|NCT02250118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65531453|NCT02250118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531454|NCT02250118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65531455|NCT02250118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65531456|NCT02250118|Growth Substances|growth substances|mesh-ancestor
65531457|NCT02250118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531458|NCT02250118|Growth Inhibitors|growth inhibitors|mesh-ancestor
65531459|NCT03060772|Pioglitazone|pioglitazone|mesh-list
65531460|NCT03060772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65531461|NCT03060772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531462|NCT02096536|Vancomycin|vancomycin|mesh-list
65531463|NCT02096536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65531464|NCT02096536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531465|NCT02096614|Cyclophosphamide|cyclophosphamide|mesh-list
65531466|NCT02096614|Fludarabine|fludarabine|mesh-list
65531467|NCT02096614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65531468|NCT02096614|Immunologic Factors|immunologic factors|mesh-ancestor
65531469|NCT02096614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531470|NCT02096614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65531471|NCT02096614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65531472|NCT02096614|Alkylating Agents|alkylating agents|mesh-ancestor
65531473|NCT02096614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531474|NCT02096614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531475|NCT02096614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65531476|NCT02094196|Ethanol|ethanol|mesh-list
65531477|NCT02094196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65531478|NCT02094196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531479|NCT02094196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65531480|NCT02094196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531481|NCT02094274|Fluticasone|fluticasone|mesh-list
65531482|NCT02094274|Xhance|xhance|mesh-list
65531483|NCT02094274|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65531484|NCT02094274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65531485|NCT02094274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65531486|NCT02094274|Autonomic Agents|autonomic agents|mesh-ancestor
65328975|NCT04250883|Trace Elements|trace elements|mesh-ancestor
65531487|NCT02094274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65531488|NCT02094274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531490|NCT02094274|Respiratory System Agents|respiratory system agents|mesh-ancestor
65531491|NCT02094274|Dermatologic Agents|dermatologic agents|mesh-ancestor
65531492|NCT02094274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65531493|NCT02094274|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65531494|NCT02094274|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65531495|NCT02094274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65531496|NCT02094274|Adrenergic Agents|adrenergic agents|mesh-ancestor
65531497|NCT02094274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65531498|NCT02094274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531499|NCT02096926|Ibuprofen|ibuprofen|mesh-list
65531500|NCT02096926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65531501|NCT02096926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65531502|NCT02096926|Analgesics|analgesics|mesh-ancestor
65531503|NCT02096926|Sensory System Agents|sensory system agents|mesh-ancestor
65531504|NCT02096926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65531505|NCT02096926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531506|NCT02096926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65531507|NCT02096926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65531508|NCT02096926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65531509|NCT02096926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65531510|NCT02096926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531511|NCT02097004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65531512|NCT02097004|Entecavir|entecavir|mesh-list
65531513|NCT02097004|Antiviral Agents|antiviral agents|mesh-ancestor
65531514|NCT02097004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531515|NCT05453968|Berotralstat|berotralstat|mesh-list
65531516|NCT05453968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65531517|NCT05453968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531518|NCT02090296|Hydroxyurea|hydroxyurea|mesh-list
65531519|NCT02090296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531520|NCT02090296|Antisickling Agents|antisickling agents|mesh-ancestor
65531521|NCT02090296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65531522|NCT02090296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531523|NCT02090296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65531524|NCT03691779|Ivacaftor|ivacaftor|mesh-list
65531525|NCT03691779|Elexacaftor|elexacaftor|mesh-list
65531526|NCT03691779|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65531527|NCT03691779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65531528|NCT03691779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531529|NCT02095054|Cetuximab|cetuximab|mesh-list
65531530|NCT02095054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65531531|NCT02095054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531532|NCT03555994|Liraglutide|liraglutide|mesh-list
65531533|NCT03555994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65531534|NCT03555994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531535|NCT03555994|Incretins|incretins|mesh-ancestor
65531536|NCT03555994|Hormones|hormones|mesh-ancestor
65531537|NCT03555994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65531538|NCT02095366|Sufentanil|sufentanil|mesh-list
65531539|NCT02095366|Morphine|morphine|mesh-list
65531540|NCT02095366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65531541|NCT02095366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65531542|NCT02095366|Narcotics|narcotics|mesh-ancestor
65531543|NCT02095366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65531544|NCT02095366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531545|NCT02095366|Analgesics|analgesics|mesh-ancestor
65531546|NCT02095366|Sensory System Agents|sensory system agents|mesh-ancestor
65531547|NCT02095366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65531548|NCT02095366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65531549|NCT02095366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65531550|NCT02095366|Anesthetics, General|anesthetics, general|mesh-ancestor
65531551|NCT02095366|Anesthetics|anesthetics|mesh-ancestor
65531552|NCT02097082|Paclitaxel|paclitaxel|mesh-list
65531553|NCT02097082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65531554|NCT02097082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531555|NCT02097082|Tubulin Modulators|tubulin modulators|mesh-ancestor
65531556|NCT02097082|Antimitotic Agents|antimitotic agents|mesh-ancestor
65531557|NCT02097082|Mitosis Modulators|mitosis modulators|mesh-ancestor
65531558|NCT02097082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531559|NCT02097160|Vitamin D|vitamin d|mesh-list
65531560|NCT02097160|Vitamins|vitamins|mesh-ancestor
65531561|NCT02097160|Micronutrients|micronutrients|mesh-ancestor
65531562|NCT02097160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531563|NCT02097160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65531564|NCT01562223|Motexafin gadolinium|motexafin gadolinium|mesh-list
65531565|NCT01562223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531566|NCT01562223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65531567|NCT01562223|Dermatologic Agents|dermatologic agents|mesh-ancestor
65531568|NCT02097316|Insulin|insulin|mesh-list
65531569|NCT02097316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65531570|NCT02097316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531571|NCT02095522|Colchicine|colchicine|mesh-list
65531572|NCT02095522|Gout Suppressants|gout suppressants|mesh-ancestor
65531573|NCT02095522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65531574|NCT02095522|Tubulin Modulators|tubulin modulators|mesh-ancestor
65531575|NCT02095522|Antimitotic Agents|antimitotic agents|mesh-ancestor
65531576|NCT02095522|Mitosis Modulators|mitosis modulators|mesh-ancestor
65531577|NCT02095522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531578|NCT02095522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531579|NCT02097394|Pancreatin|pancreatin|mesh-list
65531580|NCT02097394|Pancrelipase|pancrelipase|mesh-list
65531581|NCT02097394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65531582|NCT04123665|Fluorides|fluorides|mesh-list
65531583|NCT04123665|Tin Fluorides|tin fluorides|mesh-list
65531584|NCT04123665|Fluorophosphate|fluorophosphate|mesh-list
65531585|NCT04123665|Cariostatic Agents|cariostatic agents|mesh-ancestor
65531586|NCT04123665|Protective Agents|protective agents|mesh-ancestor
65531587|NCT04123665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531588|NCT02250508|Factor VIII|factor viii|mesh-list
65531589|NCT02250508|Coagulants|coagulants|mesh-ancestor
65531590|NCT03555526|Amoxicillin|amoxicillin|mesh-list
65531591|NCT03555526|Metronidazole|metronidazole|mesh-list
65531592|NCT03555526|Clarithromycin|clarithromycin|mesh-list
65531593|NCT03555526|Levofloxacin|levofloxacin|mesh-list
65531594|NCT03555526|Ofloxacin|ofloxacin|mesh-list
65531595|NCT03555526|Tetracycline|tetracycline|mesh-list
65531596|NCT03555526|Esomeprazole|esomeprazole|mesh-list
65531597|NCT03555526|Bismuth|bismuth|mesh-list
65531598|NCT03555526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65531599|NCT03555526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531600|NCT03555526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65531601|NCT03555526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65531602|NCT03555526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65531603|NCT03555526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65531604|NCT03555526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65531605|NCT03555526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65531606|NCT03555526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531607|NCT03555526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65531608|NCT03555526|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65531609|NCT03555526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65531610|NCT03555526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65531611|NCT03555526|Renal Agents|renal agents|mesh-ancestor
65531612|NCT03555526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65531613|NCT03555526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65531614|NCT03555526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531615|NCT03555526|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65531616|NCT03555526|Antacids|antacids|mesh-ancestor
65531617|NCT02102620|Lidocaine|lidocaine|mesh-list
65531618|NCT02102620|Anesthetics, Local|anesthetics, local|mesh-ancestor
65531619|NCT02102620|Anesthetics|anesthetics|mesh-ancestor
65531620|NCT02102620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65531621|NCT02102620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531622|NCT02102620|Sensory System Agents|sensory system agents|mesh-ancestor
65531623|NCT02102620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65531624|NCT02102620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65531625|NCT02102620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65531626|NCT02102620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65531627|NCT02102620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65531628|NCT02102620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531629|NCT02102698|Ecopipam|ecopipam|mesh-list
65531630|NCT02102698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65531631|NCT02102698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65531632|NCT02102698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65531633|NCT02102698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531634|NCT02102698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65531635|NCT02102698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65531636|NCT02102698|Dopamine Agents|dopamine agents|mesh-ancestor
65531637|NCT02102698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65531638|NCT02102698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531639|NCT03981614|Trifluridine|trifluridine|mesh-list
65531640|NCT03981614|Palbociclib|palbociclib|mesh-list
65531641|NCT03981614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531642|NCT03981614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65531643|NCT03981614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65531644|NCT03981614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531645|NCT03981614|Antimetabolites|antimetabolites|mesh-ancestor
65531646|NCT03981614|Antiviral Agents|antiviral agents|mesh-ancestor
65531647|NCT03981614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531648|NCT02102776|Mitomycins|mitomycins|mesh-list
65531649|NCT02102776|Mitomycin|mitomycin|mesh-list
65531650|NCT02102776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65531651|NCT02102776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531652|NCT02102776|Alkylating Agents|alkylating agents|mesh-ancestor
65531653|NCT02102776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531654|NCT02102776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65531655|NCT02102776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65531656|NCT02102854|Thymoglobulin|thymoglobulin|mesh-list
65531657|NCT02102854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65531658|NCT02102854|Immunologic Factors|immunologic factors|mesh-ancestor
65531659|NCT02102854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531660|NCT02102854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65531661|NCT02670044|Venetoclax|venetoclax|mesh-list
65531662|NCT02670044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531663|NCT02307656|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65531664|NCT02307656|Cobicistat|cobicistat|mesh-list
65531665|NCT02307656|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65531666|NCT02307656|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65531667|NCT02307656|Protease Inhibitors|protease inhibitors|mesh-ancestor
65531668|NCT02307656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65531669|NCT02307656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531670|NCT02307656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65531671|NCT02307656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65531672|NCT02307656|Antiviral Agents|antiviral agents|mesh-ancestor
65531673|NCT02307656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531674|NCT02307656|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65531675|NCT02307656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65531676|NCT04232943|Vaccines|vaccines|mesh-list
65531677|NCT04232943|Immunologic Factors|immunologic factors|mesh-ancestor
65531678|NCT04232943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531679|NCT02098330|Methylprednisolone|methylprednisolone|mesh-list
65531680|NCT02098330|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65531681|NCT02098330|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65531682|NCT02098330|Prednisolone|prednisolone|mesh-list
65531683|NCT02098330|Prednisolone acetate|prednisolone acetate|mesh-list
65531684|NCT02098330|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65531685|NCT02098330|Prednisolone phosphate|prednisolone phosphate|mesh-list
65531686|NCT02098330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65531687|NCT02098330|Antiemetics|antiemetics|mesh-ancestor
65531688|NCT02098330|Autonomic Agents|autonomic agents|mesh-ancestor
65531689|NCT02098330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65531690|NCT02098330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531691|NCT02098330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65531692|NCT02098330|Glucocorticoids|glucocorticoids|mesh-ancestor
65531693|NCT02098330|Hormones|hormones|mesh-ancestor
65531694|NCT02098330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65531695|NCT02098330|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65531696|NCT02098330|Protective Agents|protective agents|mesh-ancestor
65531697|NCT02098330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65531698|NCT02098330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531699|NCT02103166|Scopolamine|scopolamine|mesh-list
65531700|NCT02103166|Bromides|bromides|mesh-list
65531701|NCT02103166|Anticonvulsants|anticonvulsants|mesh-ancestor
65531702|NCT02103166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65531703|NCT02103166|Antiemetics|antiemetics|mesh-ancestor
65531704|NCT02103166|Autonomic Agents|autonomic agents|mesh-ancestor
65531705|NCT02103166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65531706|NCT02103166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531707|NCT02103166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65531708|NCT02103166|Mydriatics|mydriatics|mesh-ancestor
65531709|NCT02103166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65531710|NCT02103166|Cholinergic Agents|cholinergic agents|mesh-ancestor
65531711|NCT02103166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65531712|NCT02103166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531713|NCT02103166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65531714|NCT02103244|Carboplatin|carboplatin|mesh-list
65531715|NCT02103244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531716|NCT02098486|Moxifloxacin|moxifloxacin|mesh-list
65531717|NCT02098486|Ceftriaxone|ceftriaxone|mesh-list
65531718|NCT02098486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65531719|NCT02098486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531720|NCT02098486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65531721|NCT02098486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65531722|NCT02098486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65531723|NCT02098486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531724|NCT02098486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531725|NCT02099890|Curcumin|curcumin|mesh-list
65531726|NCT02099890|Antioxidants|antioxidants|mesh-list
65531727|NCT02099890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65531728|NCT02099890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65531729|NCT02099890|Analgesics|analgesics|mesh-ancestor
65531730|NCT02099890|Sensory System Agents|sensory system agents|mesh-ancestor
65531731|NCT02099890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65531732|NCT02099890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531733|NCT02099890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65531734|NCT02099890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65531735|NCT02099890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531736|NCT02099890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65531737|NCT02099890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531738|NCT02099890|Protective Agents|protective agents|mesh-ancestor
65531739|NCT02250820|Pentobarbital|pentobarbital|mesh-list
65531740|NCT02250820|Dexmedetomidine|dexmedetomidine|mesh-list
65531741|NCT02250820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65531742|NCT02250820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65531743|NCT02250820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531744|NCT02250820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65531745|NCT02250820|Analgesics|analgesics|mesh-ancestor
65531746|NCT02250820|Sensory System Agents|sensory system agents|mesh-ancestor
65531747|NCT02250820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65531748|NCT02250820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65531749|NCT02250820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65531750|NCT02250820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65531751|NCT02250820|Adrenergic Agents|adrenergic agents|mesh-ancestor
65531752|NCT02250820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65531753|NCT02250820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531754|NCT02250820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65531755|NCT02250820|GABA Modulators|gaba modulators|mesh-ancestor
65531756|NCT02250820|GABA Agents|gaba agents|mesh-ancestor
65531757|NCT04292457|Propofol|propofol|mesh-list
65531758|NCT04292457|Sevoflurane|sevoflurane|mesh-list
65531759|NCT04292457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65531760|NCT04292457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65531761|NCT04292457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531762|NCT04292457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65531763|NCT04292457|Anesthetics, General|anesthetics, general|mesh-ancestor
65531764|NCT04292457|Anesthetics|anesthetics|mesh-ancestor
65531765|NCT04292457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65531766|NCT04292457|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65531767|NCT02100046|Ethosuximide|ethosuximide|mesh-list
65531768|NCT02100046|Anticonvulsants|anticonvulsants|mesh-ancestor
65531769|NCT02100202|Turmeric extract|turmeric extract|mesh-list
65531770|NCT02100202|Antioxidants|antioxidants|mesh-ancestor
65531771|NCT02100202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531772|NCT02100202|Protective Agents|protective agents|mesh-ancestor
65260760|NCT04391764|Sensory System Agents|sensory system agents|mesh-ancestor
65531773|NCT02100202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531774|NCT05423392|Lidocaine|lidocaine|mesh-list
65531775|NCT05423392|Carticaine|carticaine|mesh-list
65531776|NCT05423392|Anesthetics|anesthetics|mesh-list
65531777|NCT05423392|Anesthetics, Local|anesthetics, local|mesh-ancestor
65531778|NCT05423392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65531779|NCT05423392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531780|NCT05423392|Sensory System Agents|sensory system agents|mesh-ancestor
65531781|NCT05423392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65531782|NCT05423392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65531783|NCT05423392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65531784|NCT05423392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65531785|NCT05423392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65531786|NCT05423392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531787|NCT02103556|Mineral Oil|mineral oil|mesh-list
65531788|NCT02103556|Emollients|emollients|mesh-ancestor
65531789|NCT02103556|Dermatologic Agents|dermatologic agents|mesh-ancestor
65531790|NCT03555136|Vortioxetine|vortioxetine|mesh-list
65531791|NCT03555136|Antidepressive Agents|antidepressive agents|mesh-ancestor
65531792|NCT03555136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65531793|NCT03555136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65531794|NCT03555136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65531795|NCT03555136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65531796|NCT03555136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531797|NCT03555136|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65531798|NCT03555136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65531799|NCT03555136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65531800|NCT03555136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531801|NCT03555136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65531802|NCT03555136|Serotonin Agents|serotonin agents|mesh-ancestor
65531803|NCT03555136|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65531804|NCT03555136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65531805|NCT03555136|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65531806|NCT03555136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65531807|NCT03554980|Listerine|listerine|mesh-list
65531808|NCT03554980|Fluorides|fluorides|mesh-list
65531809|NCT03554980|Sodium Fluoride|sodium fluoride|mesh-list
65531810|NCT03554980|Fluorides, Topical|fluorides, topical|mesh-list
65531811|NCT03554980|Cariostatic Agents|cariostatic agents|mesh-ancestor
65531812|NCT03554980|Protective Agents|protective agents|mesh-ancestor
65531813|NCT03554980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531814|NCT03554980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65531815|NCT03554980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531816|NCT04230213|Adalimumab|adalimumab|mesh-list
65531817|NCT04230213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65531818|NCT04230213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65531819|NCT03746691|Citalopram|citalopram|mesh-list
65531820|NCT03746691|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65531821|NCT03746691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65531822|NCT03746691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65531823|NCT03746691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531824|NCT03746691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65531825|NCT03746691|Serotonin Agents|serotonin agents|mesh-ancestor
65531826|NCT03746691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531827|NCT03746691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65531828|NCT03746691|Antidepressive Agents|antidepressive agents|mesh-ancestor
65531829|NCT03746691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65531830|NCT04222725|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65531831|NCT04222725|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65531832|NCT03745911|Paclitaxel|paclitaxel|mesh-list
65531833|NCT03745911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65531834|NCT03745911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531835|NCT03745911|Tubulin Modulators|tubulin modulators|mesh-ancestor
65531836|NCT03745911|Antimitotic Agents|antimitotic agents|mesh-ancestor
65531837|NCT03745911|Mitosis Modulators|mitosis modulators|mesh-ancestor
65531838|NCT03745911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531839|NCT03242252|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65531840|NCT03242252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65531841|NCT03242252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531842|NCT03242252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65531843|NCT03242252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531844|NCT03554590|Insulin|insulin|mesh-list
65531845|NCT03554590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65531846|NCT03554590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531847|NCT02106286|Bisoprolol|bisoprolol|mesh-list
65531848|NCT02106286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65531849|NCT02106286|Sympatholytics|sympatholytics|mesh-ancestor
65531850|NCT02106286|Autonomic Agents|autonomic agents|mesh-ancestor
65531851|NCT02106286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65531852|NCT02106286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531853|NCT02106286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65531854|NCT02106286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65531855|NCT02106286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65531856|NCT02106286|Adrenergic Agents|adrenergic agents|mesh-ancestor
65531857|NCT02106286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65531858|NCT02106286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531859|NCT04109391|Trastuzumab|trastuzumab|mesh-list
65531860|NCT04109391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65531861|NCT04109391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531862|NCT02106364|Insulin|insulin|mesh-list
65531863|NCT02106364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65531864|NCT02106364|Insulin Glargine|insulin glargine|mesh-list
65531865|NCT02106364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65531866|NCT02106364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531867|NCT04077866|Temozolomide|temozolomide|mesh-list
65531868|NCT04077866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65531869|NCT04077866|Alkylating Agents|alkylating agents|mesh-ancestor
65531870|NCT04077866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531871|NCT04077866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531872|NCT02101138|Pramipexole|pramipexole|mesh-list
65531873|NCT02101138|Antioxidants|antioxidants|mesh-ancestor
65531874|NCT02101138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531875|NCT02101138|Protective Agents|protective agents|mesh-ancestor
65531876|NCT02101138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531877|NCT02101138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65531878|NCT02101138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65531879|NCT02101138|Dopamine Agonists|dopamine agonists|mesh-ancestor
65531880|NCT02101138|Dopamine Agents|dopamine agents|mesh-ancestor
65531881|NCT02101138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65531882|NCT04064294|Levodopa|levodopa|mesh-list
65531883|NCT04064294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65531884|NCT04064294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65531885|NCT04064294|Dopamine Agents|dopamine agents|mesh-ancestor
65531886|NCT04064294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65531887|NCT04064294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531888|NCT04064294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531889|NCT02106520|Bevacizumab|bevacizumab|mesh-list
65531890|NCT02106520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65531891|NCT02106520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531892|NCT02106520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65531893|NCT02106520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65531894|NCT02106520|Growth Substances|growth substances|mesh-ancestor
65531895|NCT02106520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531896|NCT02106520|Growth Inhibitors|growth inhibitors|mesh-ancestor
65531897|NCT02101216|Abacavir|abacavir|mesh-list
65531898|NCT02101216|Dideoxynucleosides|dideoxynucleosides|mesh-list
65531899|NCT02101216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65531900|NCT02101216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65531901|NCT02101216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65531902|NCT02101216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531903|NCT02101216|Antiviral Agents|antiviral agents|mesh-ancestor
65531904|NCT02101216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531905|NCT02101216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65531906|NCT02101216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65531907|NCT02101216|Antimetabolites|antimetabolites|mesh-ancestor
65531908|NCT04097925|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65531909|NCT04097925|Antiviral Agents|antiviral agents|mesh-ancestor
65531910|NCT04097925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531911|NCT04097925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65531912|NCT04097925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65531913|NCT04097925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65531914|NCT04097925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531915|NCT04097925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65531916|NCT04097925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65531917|NCT02104648|Moxifloxacin|moxifloxacin|mesh-list
65531918|NCT02104648|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65531919|NCT02104648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65531920|NCT02104648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531921|NCT02104648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65531922|NCT02104648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65531923|NCT02104648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65531924|NCT02104648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531925|NCT02104648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531926|NCT02104648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65531927|NCT02104648|Contraceptive Agents|contraceptive agents|mesh-ancestor
65531928|NCT02104648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65531929|NCT02104648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531930|NCT02104648|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65531931|NCT02104648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65531932|NCT02104648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65531933|NCT01562301|Carboplatin|carboplatin|mesh-list
65531934|NCT01562301|Docetaxel|docetaxel|mesh-list
65531935|NCT01562301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531936|NCT01562301|Tubulin Modulators|tubulin modulators|mesh-ancestor
65531937|NCT01562301|Antimitotic Agents|antimitotic agents|mesh-ancestor
65531938|NCT01562301|Mitosis Modulators|mitosis modulators|mesh-ancestor
65531939|NCT01562301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531940|NCT02104960|Dermatologic Agents|dermatologic agents|mesh-list
65531941|NCT03260894|Pembrolizumab|pembrolizumab|mesh-list
65531942|NCT03260894|Sunitinib|sunitinib|mesh-list
65531943|NCT03260894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65531944|NCT03260894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531945|NCT03260894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65531946|NCT03260894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65531947|NCT03260894|Growth Substances|growth substances|mesh-ancestor
65531948|NCT03260894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531949|NCT03260894|Growth Inhibitors|growth inhibitors|mesh-ancestor
65531950|NCT03260894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65531951|NCT03260894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65531952|NCT03260894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531953|NCT04094883|Vaccines|vaccines|mesh-list
65531954|NCT04094883|Immunologic Factors|immunologic factors|mesh-ancestor
65531955|NCT04094883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531956|NCT02101606|Tenecteplase|tenecteplase|mesh-list
65531957|NCT02101606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65531958|NCT02101606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65531959|NCT02101606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531960|NCT02101840|Oxycodone|oxycodone|mesh-list
65531961|NCT02101840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65531962|NCT02101840|Narcotics|narcotics|mesh-ancestor
65531963|NCT02101840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65531964|NCT02101840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531965|NCT02101840|Analgesics|analgesics|mesh-ancestor
65531966|NCT02101840|Sensory System Agents|sensory system agents|mesh-ancestor
65531967|NCT02101840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65531968|NCT02107144|Trimetazidine|trimetazidine|mesh-list
65531969|NCT02107144|Vasodilator Agents|vasodilator agents|mesh-ancestor
65531970|NCT02107378|Paclitaxel|paclitaxel|mesh-list
65531971|NCT02107378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65531972|NCT02107378|Doxorubicin|doxorubicin|mesh-list
65531973|NCT02107378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65531974|NCT02107378|Topotecan|topotecan|mesh-list
65531975|NCT02107378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65531976|NCT02107378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531977|NCT02107378|Tubulin Modulators|tubulin modulators|mesh-ancestor
65531978|NCT02107378|Antimitotic Agents|antimitotic agents|mesh-ancestor
65531979|NCT02107378|Mitosis Modulators|mitosis modulators|mesh-ancestor
65531980|NCT02107378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531981|NCT02107378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65531982|NCT02107378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65531983|NCT02107378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65531984|NCT02107378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260985|NCT03785925|Nivolumab|nivolumab|mesh-list
65531985|NCT02107378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65531986|NCT02105350|Gemcitabine|gemcitabine|mesh-list
65531987|NCT02105350|Oxaliplatin|oxaliplatin|mesh-list
65531988|NCT02105350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65531989|NCT02105350|Antimetabolites|antimetabolites|mesh-ancestor
65531990|NCT02105350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65531991|NCT02105350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65531992|NCT02105350|Antiviral Agents|antiviral agents|mesh-ancestor
65531993|NCT02105350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65531994|NCT02105350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65531995|NCT02105350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65531996|NCT02105350|Immunologic Factors|immunologic factors|mesh-ancestor
65531997|NCT02105350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65531998|NCT02102152|Tobramycin|tobramycin|mesh-list
65531999|NCT02102152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65532000|NCT02102152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65532001|NCT01368562|Methylnaltrexone|methylnaltrexone|mesh-list
65532002|NCT01368562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65532003|NCT01368562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532004|NCT01368562|Sensory System Agents|sensory system agents|mesh-ancestor
65532005|NCT01368562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65532006|NCT03242018|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65532007|NCT03242018|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65532008|NCT03242018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532009|NCT03242018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65532010|NCT03242018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532011|NCT02107690|Lidocaine|lidocaine|mesh-list
65532012|NCT02107690|Anesthetics, Local|anesthetics, local|mesh-ancestor
65532013|NCT02107690|Anesthetics|anesthetics|mesh-ancestor
65532014|NCT02107690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65532015|NCT02107690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532016|NCT02107690|Sensory System Agents|sensory system agents|mesh-ancestor
65532017|NCT02107690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65532018|NCT02107690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65532019|NCT02107690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65532020|NCT02107690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65532021|NCT02107690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65532022|NCT02107690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532023|NCT05568836|Vitamin D|vitamin d|mesh-list
65532024|NCT05568836|Vitamins|vitamins|mesh-ancestor
65532025|NCT05568836|Micronutrients|micronutrients|mesh-ancestor
65532026|NCT05568836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532027|NCT05568836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65532028|NCT03259490|Metformin|metformin|mesh-list
65532029|NCT03259490|Empagliflozin|empagliflozin|mesh-list
65532030|NCT03259490|Linagliptin|linagliptin|mesh-list
65532031|NCT03259490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65532032|NCT03259490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532033|NCT03259490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65532034|NCT03259490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532035|NCT03259490|Incretins|incretins|mesh-ancestor
65532036|NCT03259490|Hormones|hormones|mesh-ancestor
65532037|NCT03259490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65532038|NCT03259490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65532039|NCT03259490|Protease Inhibitors|protease inhibitors|mesh-ancestor
65532040|NCT03259490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532041|NCT02106130|Rebamipide|rebamipide|mesh-list
65532042|NCT02106130|Mosapride|mosapride|mesh-list
65532043|NCT02106130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532044|NCT02106130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65532045|NCT02106130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65532046|NCT02106130|Antioxidants|antioxidants|mesh-ancestor
65532047|NCT02106130|Protective Agents|protective agents|mesh-ancestor
65532048|NCT02106130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532049|NCT02106130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532050|NCT02106130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65532051|NCT02106130|Serotonin Agents|serotonin agents|mesh-ancestor
65532052|NCT02106130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65532053|NCT02251132|Ritonavir|ritonavir|mesh-list
65532054|NCT02251132|Erythromycin|erythromycin|mesh-list
65532055|NCT02251132|Erythromycin Estolate|erythromycin estolate|mesh-list
65532056|NCT02251132|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65532057|NCT02251132|Erythromycin stearate|erythromycin stearate|mesh-list
65532058|NCT02251132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65532059|NCT02251132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65532060|NCT02251132|Protease Inhibitors|protease inhibitors|mesh-ancestor
65532061|NCT02251132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532062|NCT02251132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532063|NCT02251132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65532064|NCT02251132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65532065|NCT02251132|Antiviral Agents|antiviral agents|mesh-ancestor
65532066|NCT02251132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65532067|NCT02251132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65532068|NCT02251132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65532069|NCT02251132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65532070|NCT02251132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65532071|NCT02251132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65532072|NCT01331824|Amrubicin|amrubicin|mesh-list
65532073|NCT01331824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532074|NCT02113774|Anti-Infective Agents|anti-infective agents|mesh-list
65532075|NCT02113774|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65532076|NCT05571722|Vancomycin|vancomycin|mesh-list
65532077|NCT05571722|Linezolid|linezolid|mesh-list
65532078|NCT05571722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65532079|NCT05571722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65532080|NCT05571722|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65532081|NCT05571722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532082|NCT05571722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532083|NCT02110654|Mometasone Furoate|mometasone furoate|mesh-list
65532084|NCT02110654|Montelukast|montelukast|mesh-list
65532085|NCT02110654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65532086|NCT02110654|Respiratory System Agents|respiratory system agents|mesh-ancestor
65532087|NCT02110654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65532088|NCT02110654|Hormone Antagonists|hormone antagonists|mesh-ancestor
65532089|NCT02110654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65532090|NCT02110654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532091|NCT02110654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65532092|NCT02110654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65532093|NCT02110654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532094|NCT02110654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65532095|NCT02110654|Dermatologic Agents|dermatologic agents|mesh-ancestor
65532096|NCT02110654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65532098|NCT03258710|Antiviral Agents|antiviral agents|mesh-ancestor
65532099|NCT03258710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65532100|NCT03258710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65532101|NCT03258710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65532102|NCT03258710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532103|NCT03258710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532104|NCT03258710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65532105|NCT03258710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65532106|NCT02110810|Indomethacin|indomethacin|mesh-list
65532107|NCT02110810|Glycerol|glycerol|mesh-list
65532108|NCT02110810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65532109|NCT02110810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65532110|NCT02110810|Analgesics|analgesics|mesh-ancestor
65532111|NCT02110810|Sensory System Agents|sensory system agents|mesh-ancestor
65532112|NCT02110810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65532113|NCT02110810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532114|NCT02110810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65532115|NCT02110810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65532116|NCT02110810|Gout Suppressants|gout suppressants|mesh-ancestor
65532117|NCT02110810|Tocolytic Agents|tocolytic agents|mesh-ancestor
65532118|NCT02110810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65532119|NCT02110810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65532120|NCT02110810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532121|NCT02110810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532122|NCT02110810|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65532123|NCT02110810|Protective Agents|protective agents|mesh-ancestor
65532124|NCT02107924|Vancomycin|vancomycin|mesh-list
65532125|NCT02107924|Tobramycin|tobramycin|mesh-list
65532126|NCT02107924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65532127|NCT02107924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65532128|NCT02108002|Vorinostat|vorinostat|mesh-list
65532129|NCT02108002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532130|NCT02108002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65532131|NCT02108002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532132|NCT02108002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532133|NCT02114476|Progestins|progestins|mesh-list
65532134|NCT02114476|Hormones|hormones|mesh-ancestor
65532135|NCT02114476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65532136|NCT02114476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532137|NCT02110966|Tramadol|tramadol|mesh-list
65532138|NCT02110966|Mepivacaine|mepivacaine|mesh-list
65532139|NCT02110966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65532140|NCT02110966|Narcotics|narcotics|mesh-ancestor
65532141|NCT02110966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65532142|NCT02110966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532143|NCT02110966|Analgesics|analgesics|mesh-ancestor
65532144|NCT02110966|Sensory System Agents|sensory system agents|mesh-ancestor
65532145|NCT02110966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65532146|NCT02110966|Anesthetics, Local|anesthetics, local|mesh-ancestor
65532147|NCT02110966|Anesthetics|anesthetics|mesh-ancestor
65532148|NCT02937740|Methyltestosterone|methyltestosterone|mesh-list
65532149|NCT02937740|Testosterone|testosterone|mesh-list
65532150|NCT02937740|Testosterone undecanoate|testosterone undecanoate|mesh-list
65532151|NCT02937740|Testosterone enanthate|testosterone enanthate|mesh-list
65532152|NCT02937740|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65532153|NCT02937740|Androgens|androgens|mesh-ancestor
65532154|NCT02937740|Hormones|hormones|mesh-ancestor
65532155|NCT02937740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65532156|NCT02937740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532157|NCT02937740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65532158|NCT02937740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532159|NCT02937740|Anabolic Agents|anabolic agents|mesh-ancestor
65532160|NCT02111044|Octreotide|octreotide|mesh-list
65532161|NCT02111044|Somatostatin|somatostatin|mesh-list
65532162|NCT02111044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65532163|NCT02111044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65532164|NCT02111044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532165|NCT02111044|Hormones|hormones|mesh-ancestor
65532166|NCT02111044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65532167|NCT02111044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532168|NCT02114710|Hydrocortisone|hydrocortisone|mesh-list
65532169|NCT02114710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65532170|NCT02108548|Naproxen|naproxen|mesh-list
65532171|NCT02108548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65532172|NCT02108548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65532173|NCT02108548|Analgesics|analgesics|mesh-ancestor
65532174|NCT02108548|Sensory System Agents|sensory system agents|mesh-ancestor
65532175|NCT02108548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65532176|NCT02108548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532177|NCT02108548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65532178|NCT02108548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65532179|NCT02108548|Gout Suppressants|gout suppressants|mesh-ancestor
65532180|NCT02108548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65532181|NCT02108548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532182|NCT02108548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532183|NCT02111122|Sodium Oxybate|sodium oxybate|mesh-list
65532184|NCT02111122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65532185|NCT02111122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65532186|NCT02111122|Anesthetics, General|anesthetics, general|mesh-ancestor
65532187|NCT02111122|Anesthetics|anesthetics|mesh-ancestor
65532188|NCT02111122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65532189|NCT02111122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532190|NCT02108626|Nicotine|nicotine|mesh-list
65532191|NCT02108626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65532192|NCT02108626|Autonomic Agents|autonomic agents|mesh-ancestor
65532193|NCT02108626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65532194|NCT02108626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532195|NCT02108626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65532196|NCT02108626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65532197|NCT02108626|Cholinergic Agents|cholinergic agents|mesh-ancestor
65532198|NCT02108626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65532199|NCT02108626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532200|NCT05431322|Dexmedetomidine|dexmedetomidine|mesh-list
65532201|NCT05431322|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65532202|NCT05431322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65532203|NCT05431322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532204|NCT05431322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65532205|NCT05431322|Analgesics|analgesics|mesh-ancestor
65532206|NCT05431322|Sensory System Agents|sensory system agents|mesh-ancestor
65532207|NCT05431322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65532208|NCT05431322|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65532209|NCT05431322|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65532210|NCT05431322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65532211|NCT05431322|Adrenergic Agents|adrenergic agents|mesh-ancestor
65532212|NCT05431322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65532213|NCT05431322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532214|NCT03745599|Diclofenac|diclofenac|mesh-list
65532215|NCT03745599|Flurbiprofen|flurbiprofen|mesh-list
65532216|NCT03745599|Benzydamine|benzydamine|mesh-list
65532217|NCT03745599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65532218|NCT03745599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65532219|NCT03745599|Analgesics|analgesics|mesh-ancestor
65532220|NCT03745599|Sensory System Agents|sensory system agents|mesh-ancestor
65532221|NCT03745599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65532222|NCT03745599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532223|NCT03745599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65532224|NCT03745599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65532225|NCT03745599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65532226|NCT03745599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532227|NCT03745599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532228|NCT02111434|Testosterone|testosterone|mesh-list
65532229|NCT02111434|Androgens|androgens|mesh-ancestor
65532230|NCT02111434|Hormones|hormones|mesh-ancestor
65532231|NCT02111434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65532232|NCT02111434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532233|NCT03230864|Olanzapine|olanzapine|mesh-list
65532234|NCT03230864|Risperidone|risperidone|mesh-list
65532235|NCT03230864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65532236|NCT03230864|Serotonin Agents|serotonin agents|mesh-ancestor
65532237|NCT03230864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65329773|NCT00710385|Heroin|heroin|mesh-list
65532238|NCT03230864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532239|NCT03230864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532240|NCT03230864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65532241|NCT03230864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65532242|NCT03230864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65532243|NCT03230864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65532244|NCT03230864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65532245|NCT03230864|Dopamine Agents|dopamine agents|mesh-ancestor
65532246|NCT03230864|Antiemetics|antiemetics|mesh-ancestor
65532247|NCT03230864|Autonomic Agents|autonomic agents|mesh-ancestor
65532248|NCT03230864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65532249|NCT03230864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65532250|NCT03230864|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65532251|NCT03230864|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65532252|NCT03230864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65532253|NCT02111590|Immunoglobulins|immunoglobulins|mesh-list
65532254|NCT02111590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65532255|NCT02111590|Antibodies|antibodies|mesh-list
65532256|NCT02111590|Immunologic Factors|immunologic factors|mesh-ancestor
65532257|NCT02111590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532258|NCT02937350|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65532259|NCT02937350|Calcifediol|calcifediol|mesh-list
65532260|NCT02937350|Vitamins|vitamins|mesh-ancestor
65532261|NCT02937350|Micronutrients|micronutrients|mesh-ancestor
65532262|NCT02937350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532263|NCT02937350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65532264|NCT02109328|Paclitaxel|paclitaxel|mesh-list
65532265|NCT02109328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65532266|NCT02109328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532267|NCT02109328|Tubulin Modulators|tubulin modulators|mesh-ancestor
65532268|NCT02109328|Antimitotic Agents|antimitotic agents|mesh-ancestor
65532269|NCT02109328|Mitosis Modulators|mitosis modulators|mesh-ancestor
65532270|NCT02109328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532271|NCT02115490|Diphosphonates|diphosphonates|mesh-list
65532272|NCT02115490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65532273|NCT02115490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532274|NCT02251288|Vaccines|vaccines|mesh-list
65532275|NCT02251288|Immunologic Factors|immunologic factors|mesh-ancestor
65532276|NCT02251288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532277|NCT02109718|Sulfadiazine|sulfadiazine|mesh-list
65532278|NCT02109718|Silver Sulfadiazine|silver sulfadiazine|mesh-list
65532279|NCT02109718|Petrolatum|petrolatum|mesh-list
65532280|NCT02109718|Emollients|emollients|mesh-ancestor
65532281|NCT02109718|Dermatologic Agents|dermatologic agents|mesh-ancestor
65532282|NCT02109718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65532283|NCT02109718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65532284|NCT02109718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65532285|NCT02109718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65532286|NCT02109718|Coccidiostats|coccidiostats|mesh-ancestor
65532287|NCT02109718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65532288|NCT03744897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65532289|NCT03744897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65532290|NCT03744897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532291|NCT02112214|Bismuth|bismuth|mesh-list
65532292|NCT02112214|Antacids|antacids|mesh-ancestor
65532293|NCT02112214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532294|NCT02112214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65532295|NCT04014075|Trastuzumab|trastuzumab|mesh-list
65532296|NCT04014075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65532297|NCT04014075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532298|NCT02112292|Dronabinol|dronabinol|mesh-list
65532299|NCT02112292|Cannabidiol|cannabidiol|mesh-list
65532300|NCT02112292|Anticonvulsants|anticonvulsants|mesh-ancestor
65532301|NCT02112292|Hallucinogens|hallucinogens|mesh-ancestor
65532302|NCT02112292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532303|NCT02112292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65532304|NCT02112292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65532305|NCT02112292|Analgesics|analgesics|mesh-ancestor
65532306|NCT02112292|Sensory System Agents|sensory system agents|mesh-ancestor
65532307|NCT02112292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65532308|NCT02112292|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65532309|NCT02112292|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65532310|NCT02112292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65532311|NCT02112292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532312|NCT02112292|Hormones|hormones|mesh-ancestor
65532313|NCT02112292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65532314|NCT02116036|Rivaroxaban|rivaroxaban|mesh-list
65532315|NCT02116036|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65532316|NCT02116036|Antithrombins|antithrombins|mesh-ancestor
65532317|NCT02116036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65532318|NCT02116036|Protease Inhibitors|protease inhibitors|mesh-ancestor
65532319|NCT02116036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532320|NCT02116036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532321|NCT02116036|Anticoagulants|anticoagulants|mesh-ancestor
65532322|NCT04011735|Tiotropium Bromide|tiotropium bromide|mesh-list
65532323|NCT04011735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65532324|NCT04011735|Autonomic Agents|autonomic agents|mesh-ancestor
65532325|NCT04011735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65532326|NCT04011735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532327|NCT04011735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65532328|NCT04011735|Respiratory System Agents|respiratory system agents|mesh-ancestor
65532329|NCT04011735|Parasympatholytics|parasympatholytics|mesh-ancestor
65532330|NCT04011735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65532331|NCT04011735|Cholinergic Agents|cholinergic agents|mesh-ancestor
65532332|NCT04011735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65532333|NCT04011735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532334|NCT02118844|Rocuronium|rocuronium|mesh-list
65532335|NCT02118844|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65532336|NCT02118844|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65532337|NCT02118844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65532338|NCT02118844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65532339|NCT02118844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532340|NCT02116348|Cerebrolysin|cerebrolysin|mesh-list
65532341|NCT02116348|Mitogens|mitogens|mesh-list
65532342|NCT02116348|Mitosis Modulators|mitosis modulators|mesh-ancestor
65532343|NCT02116348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532344|NCT02116348|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65532345|NCT02116348|Protective Agents|protective agents|mesh-ancestor
65532346|NCT02116348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532347|NCT02116348|Nootropic Agents|nootropic agents|mesh-ancestor
65532348|NCT02119000|Bisacodyl|bisacodyl|mesh-list
65532349|NCT02119000|Cathartics|cathartics|mesh-ancestor
65532350|NCT02119000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65532351|NCT02119000|Laxatives|laxatives|mesh-ancestor
65532352|NCT02119234|Beclomethasone|beclomethasone|mesh-list
65532353|NCT02119234|Glycopyrrolate|glycopyrrolate|mesh-list
65532354|NCT02119234|Formoterol Fumarate|formoterol fumarate|mesh-list
65532355|NCT02119234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65532356|NCT02119234|Autonomic Agents|autonomic agents|mesh-ancestor
65532357|NCT02119234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65532358|NCT02119234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532359|NCT02119234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65532360|NCT02119234|Respiratory System Agents|respiratory system agents|mesh-ancestor
65532361|NCT02119234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65532362|NCT02119234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65532363|NCT02119234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65532364|NCT02119234|Adrenergic Agents|adrenergic agents|mesh-ancestor
65532365|NCT02119234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65532366|NCT02119234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532367|NCT02119234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65532368|NCT02119234|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65532369|NCT02119234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65532370|NCT02119234|Cholinergic Agents|cholinergic agents|mesh-ancestor
65532371|NCT02119234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65532372|NCT02119234|Glucocorticoids|glucocorticoids|mesh-ancestor
65532373|NCT02119234|Hormones|hormones|mesh-ancestor
65532374|NCT02119234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65532375|NCT02112604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65532376|NCT02112604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65532377|NCT02112604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532378|NCT04480424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65532379|NCT04480424|Immunologic Factors|immunologic factors|mesh-ancestor
65532380|NCT04480424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532381|NCT04473716|Paclitaxel|paclitaxel|mesh-list
65532382|NCT04473716|Cisplatin|cisplatin|mesh-list
65532383|NCT04473716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65532384|NCT04473716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532385|NCT04473716|Tubulin Modulators|tubulin modulators|mesh-ancestor
65532386|NCT04473716|Antimitotic Agents|antimitotic agents|mesh-ancestor
65532387|NCT04473716|Mitosis Modulators|mitosis modulators|mesh-ancestor
65532388|NCT04473716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532389|NCT04000815|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
65532390|NCT04000815|Natriuretic Agents|natriuretic agents|mesh-ancestor
65532391|NCT04000815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532392|NCT03919617|Volagidemab|volagidemab|mesh-list
65532393|NCT03919617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65532394|NCT03919617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532395|NCT03748173|Calfactant|calfactant|mesh-list
65532396|NCT03748173|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
65532397|NCT03748173|Respiratory System Agents|respiratory system agents|mesh-ancestor
65532398|NCT03848403|Ixekizumab|ixekizumab|mesh-list
65532399|NCT03848403|Dermatologic Agents|dermatologic agents|mesh-ancestor
65532400|NCT03995355|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65532401|NCT03995355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65532402|NCT04054011|Deoxycholic Acid|deoxycholic acid|mesh-list
65532403|NCT04054011|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65532404|NCT04054011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65532405|NCT03743883|Aspirin|aspirin|mesh-list
65532406|NCT03743883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65532407|NCT03743883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65532408|NCT03743883|Analgesics|analgesics|mesh-ancestor
65532409|NCT03743883|Sensory System Agents|sensory system agents|mesh-ancestor
65532410|NCT03743883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65532411|NCT03743883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532412|NCT03743883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65532413|NCT03743883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65532414|NCT03743883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65532415|NCT03743883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65532416|NCT03743883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532417|NCT03743883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65532418|NCT03743883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65532419|NCT03743883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532420|NCT03743883|Antipyretics|antipyretics|mesh-ancestor
65532421|NCT03988803|Memantine|memantine|mesh-list
65532422|NCT03988803|BI 425809|bi 425809|mesh-list
65532423|NCT03988803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65532424|NCT03988803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65532425|NCT03988803|Dopamine Agents|dopamine agents|mesh-ancestor
65532426|NCT03988803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65532427|NCT03988803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532428|NCT03988803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532429|NCT03988803|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65532430|NCT03988803|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65532431|NCT03988803|Nootropic Agents|nootropic agents|mesh-ancestor
65532432|NCT00181883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65532433|NCT00181883|Antidepressive Agents|antidepressive agents|mesh-ancestor
65532434|NCT00181883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65532435|NCT00181883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65532436|NCT00181883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65532437|NCT00181883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65532438|NCT00181883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532439|NCT00180713|Simvastatin|simvastatin|mesh-list
65532440|NCT00180713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65532441|NCT00180713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65532442|NCT00180713|Antimetabolites|antimetabolites|mesh-ancestor
65532443|NCT00180713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532444|NCT00180713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65532445|NCT00180713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65532446|NCT00180713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532447|NCT02531477|Propofol|propofol|mesh-list
65532448|NCT02531477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65532449|NCT02531477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65532450|NCT02531477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532451|NCT02531477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65532452|NCT02531477|Anesthetics, General|anesthetics, general|mesh-ancestor
65532453|NCT02531477|Anesthetics|anesthetics|mesh-ancestor
65532454|NCT04052139|Naltrexone|naltrexone|mesh-list
65532455|NCT04052139|Gabapentin|gabapentin|mesh-list
65532456|NCT04052139|Analgesics|analgesics|mesh-ancestor
65532457|NCT04052139|Sensory System Agents|sensory system agents|mesh-ancestor
65532458|NCT04052139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65532459|NCT04052139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532460|NCT04052139|Anticonvulsants|anticonvulsants|mesh-ancestor
65532461|NCT04052139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65532462|NCT04052139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65532463|NCT04052139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65532464|NCT04052139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65532465|NCT04052139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65532466|NCT04052139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65532467|NCT04052139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65532468|NCT04052139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532469|NCT04052139|Antimanic Agents|antimanic agents|mesh-ancestor
65532470|NCT04052139|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65532471|NCT04052139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65532472|NCT03743805|Naloxone|naloxone|mesh-list
65532473|NCT03743805|Flumazenil|flumazenil|mesh-list
65532474|NCT03743805|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65532475|NCT03743805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532476|NCT03743805|Sensory System Agents|sensory system agents|mesh-ancestor
65532477|NCT03743805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65532478|NCT03743805|Antidotes|antidotes|mesh-ancestor
65532479|NCT03743805|Protective Agents|protective agents|mesh-ancestor
65532480|NCT03743805|GABA Modulators|gaba modulators|mesh-ancestor
65532481|NCT03743805|GABA Agents|gaba agents|mesh-ancestor
65532482|NCT03743805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65532483|NCT03743805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532484|NCT03743727|Sofosbuvir|sofosbuvir|mesh-list
65532485|NCT03743727|Ledipasvir|ledipasvir|mesh-list
65532486|NCT03743727|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
65532487|NCT03743727|Antiviral Agents|antiviral agents|mesh-ancestor
65532488|NCT03743727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65532489|NCT03981861|Metformin|metformin|mesh-list
65532490|NCT03981861|Spironolactone|spironolactone|mesh-list
65532491|NCT03981861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65532492|NCT03981861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532493|NCT03981861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65532494|NCT03981861|Hormone Antagonists|hormone antagonists|mesh-ancestor
65532495|NCT03981861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65532496|NCT03981861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65532497|NCT03981861|Diuretics|diuretics|mesh-ancestor
65532498|NCT03981861|Natriuretic Agents|natriuretic agents|mesh-ancestor
65532499|NCT03743649|Lorazepam|lorazepam|mesh-list
65532500|NCT03743649|Haloperidol|haloperidol|mesh-list
65532501|NCT03743649|Haloperidol decanoate|haloperidol decanoate|mesh-list
65532502|NCT03743649|Antiemetics|antiemetics|mesh-ancestor
65532503|NCT03743649|Autonomic Agents|autonomic agents|mesh-ancestor
65532504|NCT03743649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65532505|NCT03743649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532506|NCT03743649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65532507|NCT03743649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65532508|NCT03743649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65532509|NCT03743649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65532510|NCT03743649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65532511|NCT03743649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65532512|NCT03743649|Dopamine Agents|dopamine agents|mesh-ancestor
65532513|NCT03743649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65532514|NCT03743649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532515|NCT03743649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65532516|NCT03743649|Anticonvulsants|anticonvulsants|mesh-ancestor
65532517|NCT03743649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65532518|NCT03743649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65532519|NCT03743649|GABA Modulators|gaba modulators|mesh-ancestor
65532520|NCT03743649|GABA Agents|gaba agents|mesh-ancestor
65532521|NCT01332266|Cetuximab|cetuximab|mesh-list
65532522|NCT01332266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65532523|NCT01332266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532524|NCT03255824|Fentanyl|fentanyl|mesh-list
65532525|NCT03255824|Midazolam|midazolam|mesh-list
65532526|NCT03255824|Dexmedetomidine|dexmedetomidine|mesh-list
65532527|NCT03255824|Propofol|propofol|mesh-list
65532528|NCT03255824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65532529|NCT03255824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65532530|NCT03255824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532531|NCT03255824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65532532|NCT03255824|Anesthetics, General|anesthetics, general|mesh-ancestor
65532533|NCT03255824|Anesthetics|anesthetics|mesh-ancestor
65532534|NCT03255824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65532535|NCT03255824|Analgesics|analgesics|mesh-ancestor
65532536|NCT03255824|Sensory System Agents|sensory system agents|mesh-ancestor
65532537|NCT03255824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65532538|NCT03255824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65532539|NCT03255824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65532540|NCT03255824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65532541|NCT03255824|Adrenergic Agents|adrenergic agents|mesh-ancestor
65532542|NCT03255824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65532543|NCT03255824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532544|NCT03255824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65532545|NCT03255824|Narcotics|narcotics|mesh-ancestor
65532546|NCT03255824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65532547|NCT03255824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65532548|NCT03255824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65532549|NCT03255824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65532550|NCT03255824|GABA Modulators|gaba modulators|mesh-ancestor
65532551|NCT03255824|GABA Agents|gaba agents|mesh-ancestor
65532552|NCT03238352|Listerine|listerine|mesh-list
65532553|NCT03238352|Fluorides|fluorides|mesh-list
65532554|NCT03238352|Sodium Fluoride|sodium fluoride|mesh-list
65532555|NCT03238352|Cariostatic Agents|cariostatic agents|mesh-ancestor
65532556|NCT03238352|Protective Agents|protective agents|mesh-ancestor
65532557|NCT03238352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532558|NCT03238352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65532559|NCT03238352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65532560|NCT01222754|Lenalidomide|lenalidomide|mesh-list
65532561|NCT01222754|Immunologic Factors|immunologic factors|mesh-ancestor
65532562|NCT01222754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532563|NCT01222754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65532564|NCT01222754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65532565|NCT01222754|Growth Substances|growth substances|mesh-ancestor
65532566|NCT01222754|Growth Inhibitors|growth inhibitors|mesh-ancestor
65532567|NCT01222754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532568|NCT03850418|Azacitidine|azacitidine|mesh-list
65532569|NCT03850418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65532570|NCT03850418|Antimetabolites|antimetabolites|mesh-ancestor
65532571|NCT03850418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532572|NCT03850418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532573|NCT03850418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532574|NCT05256914|Chlorhexidine|chlorhexidine|mesh-list
65532575|NCT05256914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65532576|NCT05256914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65532577|NCT05256914|Disinfectants|disinfectants|mesh-ancestor
65532578|NCT00180479|Paclitaxel|paclitaxel|mesh-list
65532579|NCT00180479|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65532580|NCT00180479|Everolimus|everolimus|mesh-list
65532581|NCT00180479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65532582|NCT00180479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532583|NCT00180479|Tubulin Modulators|tubulin modulators|mesh-ancestor
65532584|NCT00180479|Antimitotic Agents|antimitotic agents|mesh-ancestor
65532585|NCT00180479|Mitosis Modulators|mitosis modulators|mesh-ancestor
65532586|NCT00180479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532587|NCT00180479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65532588|NCT00180479|Immunologic Factors|immunologic factors|mesh-ancestor
65532589|NCT00180479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532590|NCT03999710|Durvalumab|durvalumab|mesh-list
65532591|NCT03999710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65532592|NCT03999710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532593|NCT05169944|Magrolimab|magrolimab|mesh-list
65532594|NCT05169944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65532595|NCT05169944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532596|NCT02955069|Spartalizumab|spartalizumab|mesh-list
65532597|NCT02955069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65532598|NCT02955069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532599|NCT02955069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532600|NCT03254108|Tolvaptan|tolvaptan|mesh-list
65532601|NCT03254108|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65532602|NCT03254108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532603|NCT03254108|Natriuretic Agents|natriuretic agents|mesh-ancestor
65532604|NCT03254108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532605|NCT02585895|Evolocumab|evolocumab|mesh-list
65532606|NCT02585895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65532607|NCT02585895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65532608|NCT02585895|Antimetabolites|antimetabolites|mesh-ancestor
65532609|NCT02585895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532610|NCT02585895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65532611|NCT03736161|Methotrexate|methotrexate|mesh-list
65532612|NCT03736161|Tofacitinib|tofacitinib|mesh-list
65532613|NCT03736161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65532614|NCT03736161|Abortifacient Agents|abortifacient agents|mesh-ancestor
65532615|NCT03736161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65532616|NCT03736161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532617|NCT03736161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65532618|NCT03736161|Antimetabolites|antimetabolites|mesh-ancestor
65532619|NCT03736161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532620|NCT03736161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532621|NCT03736161|Dermatologic Agents|dermatologic agents|mesh-ancestor
65532622|NCT03736161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532623|NCT03736161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65532624|NCT03736161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65532625|NCT03736161|Immunologic Factors|immunologic factors|mesh-ancestor
65532626|NCT03736161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65532627|NCT03736161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65532628|NCT03736161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65532630|NCT03253796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65532631|NCT03253796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65532632|NCT03253796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65532633|NCT03253796|Immunologic Factors|immunologic factors|mesh-ancestor
65532634|NCT03253796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532635|NCT02956005|Tacrolimus|tacrolimus|mesh-list
65532636|NCT02956005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65532637|NCT02956005|Immunologic Factors|immunologic factors|mesh-ancestor
65532638|NCT02956005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532639|NCT02956005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65532640|NCT02956005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532641|NCT02956005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532642|NCT02579499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65532643|NCT02579499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65532644|NCT02579499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65532645|NCT02579499|Antimetabolites|antimetabolites|mesh-ancestor
65532646|NCT02579499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532647|NCT02579499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532648|NCT02579499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65532649|NCT03253094|Fluconazole|fluconazole|mesh-list
65532650|NCT03253094|Ibrexafungerp|ibrexafungerp|mesh-list
65532651|NCT03253094|Antifungal Agents|antifungal agents|mesh-ancestor
65532652|NCT03253094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65532653|NCT03253094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65532654|NCT03253094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65532655|NCT03253094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532656|NCT03253094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532657|NCT03253094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65532658|NCT03253094|Hormone Antagonists|hormone antagonists|mesh-ancestor
65532659|NCT03253094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65532660|NCT03253094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532661|NCT03253094|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65532662|NCT03253094|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65532663|NCT05179070|Carvedilol|carvedilol|mesh-list
65532664|NCT05179070|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65532665|NCT05179070|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65532666|NCT05179070|Adrenergic Agents|adrenergic agents|mesh-ancestor
65532667|NCT05179070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65532668|NCT05179070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532669|NCT05179070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532670|NCT05179070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65532671|NCT05179070|Antioxidants|antioxidants|mesh-ancestor
65532672|NCT05179070|Protective Agents|protective agents|mesh-ancestor
65532673|NCT05179070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65532674|NCT05179070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65532675|NCT05179070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65532676|NCT05179070|Vasodilator Agents|vasodilator agents|mesh-ancestor
65532677|NCT05179070|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65532678|NCT05179070|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65532679|NCT03477500|Cyclophosphamide|cyclophosphamide|mesh-list
65532680|NCT03477500|Alemtuzumab|alemtuzumab|mesh-list
65532681|NCT03477500|Cladribine|cladribine|mesh-list
65532682|NCT03477500|Ocrelizumab|ocrelizumab|mesh-list
65532683|NCT03477500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65532684|NCT03477500|Immunologic Factors|immunologic factors|mesh-ancestor
65532685|NCT03477500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532686|NCT03477500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65532687|NCT03477500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65532688|NCT03477500|Alkylating Agents|alkylating agents|mesh-ancestor
65532689|NCT03477500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532690|NCT03477500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532691|NCT03477500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65532692|NCT03477500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65532693|NCT00179621|Lenalidomide|lenalidomide|mesh-list
65532694|NCT00179621|Immunologic Factors|immunologic factors|mesh-ancestor
65532695|NCT00179621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532696|NCT00179621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65532697|NCT00179621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65532698|NCT00179621|Growth Substances|growth substances|mesh-ancestor
65532699|NCT00179621|Growth Inhibitors|growth inhibitors|mesh-ancestor
65532700|NCT00179621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532701|NCT04862780|Osimertinib|osimertinib|mesh-list
65532702|NCT04862780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532703|NCT04862780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65532704|NCT04862780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532705|NCT04862780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532706|NCT00179309|Docetaxel|docetaxel|mesh-list
65532707|NCT00179309|Sargramostim|sargramostim|mesh-list
65532708|NCT00179309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532709|NCT00179309|Tubulin Modulators|tubulin modulators|mesh-ancestor
65532710|NCT00179309|Antimitotic Agents|antimitotic agents|mesh-ancestor
65532711|NCT00179309|Mitosis Modulators|mitosis modulators|mesh-ancestor
65532712|NCT00179309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532713|NCT00179309|Immunologic Factors|immunologic factors|mesh-ancestor
65532714|NCT00179309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532715|NCT03142568|Sildenafil Citrate|sildenafil citrate|mesh-list
65532716|NCT03142568|Vasodilator Agents|vasodilator agents|mesh-ancestor
65532717|NCT03142568|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65532718|NCT03142568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65532719|NCT03142568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532720|NCT03142568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532721|NCT03142568|Urological Agents|urological agents|mesh-ancestor
65532722|NCT00177671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65532723|NCT00177671|Donepezil|donepezil|mesh-list
65532724|NCT00177671|Citalopram|citalopram|mesh-list
65532725|NCT00177671|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65532726|NCT00177671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65532727|NCT00177671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65532728|NCT00177671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65532729|NCT00177671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532730|NCT00177671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65532731|NCT00177671|Serotonin Agents|serotonin agents|mesh-ancestor
65532732|NCT00177671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532733|NCT00177671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65532734|NCT00177671|Antidepressive Agents|antidepressive agents|mesh-ancestor
65532735|NCT00177671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65532736|NCT00177671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65532737|NCT00177671|Cholinergic Agents|cholinergic agents|mesh-ancestor
65532738|NCT00177671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65532739|NCT00177671|Analgesics|analgesics|mesh-ancestor
65532740|NCT00177671|Sensory System Agents|sensory system agents|mesh-ancestor
65532741|NCT00177671|Dopamine Agents|dopamine agents|mesh-ancestor
65532742|NCT00177671|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65532743|NCT00177671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532744|NCT00177671|Nootropic Agents|nootropic agents|mesh-ancestor
65532745|NCT03636932|Acetylcysteine|acetylcysteine|mesh-list
65532746|NCT03636932|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65532747|NCT03636932|Antiviral Agents|antiviral agents|mesh-ancestor
65532748|NCT03636932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65532749|NCT03636932|Expectorants|expectorants|mesh-ancestor
65532750|NCT03636932|Respiratory System Agents|respiratory system agents|mesh-ancestor
65532751|NCT03636932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65532752|NCT03636932|Antioxidants|antioxidants|mesh-ancestor
65532753|NCT03636932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532754|NCT03636932|Protective Agents|protective agents|mesh-ancestor
65532755|NCT03636932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532756|NCT03636932|Antidotes|antidotes|mesh-ancestor
65532757|NCT04781972|Methylphenidate|methylphenidate|mesh-list
65532758|NCT04781972|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65532759|NCT04781972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532760|NCT04781972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65532761|NCT04781972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65532762|NCT04781972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65532763|NCT04781972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532764|NCT04781972|Dopamine Agents|dopamine agents|mesh-ancestor
65532765|NCT04781972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65532766|NCT03235154|Sofosbuvir|sofosbuvir|mesh-list
65532767|NCT03235154|Velpatasvir|velpatasvir|mesh-list
65532768|NCT03235154|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65532769|NCT03235154|Antiviral Agents|antiviral agents|mesh-ancestor
65532770|NCT03235154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65532771|NCT04977908|Insulin|insulin|mesh-list
65532772|NCT04977908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65532773|NCT04977908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532774|NCT03233438|Dalbavancin|dalbavancin|mesh-list
65532775|NCT03233438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65532776|NCT03233438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65532777|NCT02251600|Deflazacort|deflazacort|mesh-list
65532778|NCT02251600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65532779|NCT02251600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65532780|NCT02251600|Immunologic Factors|immunologic factors|mesh-ancestor
65532781|NCT02251600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532782|NCT02113072|Beclomethasone|beclomethasone|mesh-list
65532783|NCT02113072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65532784|NCT02113072|Glucocorticoids|glucocorticoids|mesh-ancestor
65532785|NCT02113072|Hormones|hormones|mesh-ancestor
65532786|NCT02113072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65532787|NCT02113072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532788|NCT02113072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65532789|NCT02113072|Respiratory System Agents|respiratory system agents|mesh-ancestor
65532790|NCT02113150|Ketamine|ketamine|mesh-list
65532791|NCT02113150|Remifentanil|remifentanil|mesh-list
65532792|NCT02113150|Analgesics|analgesics|mesh-ancestor
65532793|NCT02113150|Sensory System Agents|sensory system agents|mesh-ancestor
65532794|NCT02113150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65532795|NCT02113150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532796|NCT02113150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65532797|NCT02113150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65532798|NCT02113150|Anesthetics, General|anesthetics, general|mesh-ancestor
65532799|NCT02113150|Anesthetics|anesthetics|mesh-ancestor
65532800|NCT02113150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65532801|NCT02113150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65532802|NCT02113150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65532803|NCT02113150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65532804|NCT02113150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532805|NCT02113150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65532806|NCT02113150|Narcotics|narcotics|mesh-ancestor
65532807|NCT04647500|Methylphenidate|methylphenidate|mesh-list
65532808|NCT04647500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65532809|NCT04647500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532810|NCT04647500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65532811|NCT04647500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65532812|NCT04647500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65532813|NCT04647500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532814|NCT04647500|Dopamine Agents|dopamine agents|mesh-ancestor
65532815|NCT04647500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65532816|NCT03553108|Olaparib|olaparib|mesh-list
65532817|NCT03553108|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65532818|NCT03553108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532819|NCT03553108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532820|NCT03553108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532821|NCT02119858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65532822|NCT02117128|Tranexamic Acid|tranexamic acid|mesh-list
65532823|NCT02117128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65532824|NCT02117128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65532825|NCT02117128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532826|NCT02117128|Hemostatics|hemostatics|mesh-ancestor
65532827|NCT02117128|Coagulants|coagulants|mesh-ancestor
65532828|NCT00175877|Certolizumab Pegol|certolizumab pegol|mesh-list
65532829|NCT00175877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65532830|NCT00175877|Immunologic Factors|immunologic factors|mesh-ancestor
65532831|NCT00175877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532832|NCT00175877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65532833|NCT02117362|Ipilimumab|ipilimumab|mesh-list
65532834|NCT02117362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65532835|NCT02117362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532836|NCT02117362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65532837|NCT02117362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532838|NCT02113540|Atorvastatin|atorvastatin|mesh-list
65330345|NCT00741117|Bilirubin|bilirubin|mesh-list
65532839|NCT02113540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65532840|NCT02113540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65532841|NCT02113540|Antimetabolites|antimetabolites|mesh-ancestor
65532842|NCT02113540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532843|NCT02113540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65532844|NCT02113540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65532845|NCT02113540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532846|NCT02123056|Metoprolol|metoprolol|mesh-list
65532847|NCT02123056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65532848|NCT02123056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65532849|NCT02123056|Sympatholytics|sympatholytics|mesh-ancestor
65532850|NCT02123056|Autonomic Agents|autonomic agents|mesh-ancestor
65532851|NCT02123056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65532852|NCT02123056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532853|NCT02123056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65532854|NCT02123056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65532855|NCT02123056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65532856|NCT02123056|Adrenergic Agents|adrenergic agents|mesh-ancestor
65532857|NCT02123056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65532858|NCT02123056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532859|NCT02120092|Clopidogrel|clopidogrel|mesh-list
65532860|NCT02120092|Ticagrelor|ticagrelor|mesh-list
65532861|NCT02120092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65532862|NCT02120092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65532863|NCT02120092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65532864|NCT02120092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65532865|NCT02120092|Purinergic Agents|purinergic agents|mesh-ancestor
65532866|NCT02120092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65532867|NCT02120092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532868|NCT02120092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532869|NCT02117596|Sirolimus|sirolimus|mesh-list
65532870|NCT02117596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65532871|NCT02117596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65532872|NCT02117596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65532873|NCT02117596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532874|NCT02117596|Antifungal Agents|antifungal agents|mesh-ancestor
65532875|NCT02117596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65532876|NCT02117596|Immunologic Factors|immunologic factors|mesh-ancestor
65532877|NCT02117596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532878|NCT02117752|Dapsone|dapsone|mesh-list
65532879|NCT02117752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65532880|NCT02117752|Antimalarials|antimalarials|mesh-ancestor
65532881|NCT02117752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65532882|NCT02117752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65532883|NCT02117752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65532884|NCT02117752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532885|NCT02117752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532886|NCT02117752|Leprostatic Agents|leprostatic agents|mesh-ancestor
65532887|NCT02117752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65532888|NCT02117830|Moxifloxacin|moxifloxacin|mesh-list
65532889|NCT02117830|Enclomiphene|enclomiphene|mesh-list
65532890|NCT02117830|Clomiphene|clomiphene|mesh-list
65532891|NCT02117830|Zuclomiphene|zuclomiphene|mesh-list
65532892|NCT02117830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65532893|NCT02117830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65532894|NCT02117830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65532895|NCT02117830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65532896|NCT02117830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532897|NCT02117830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532898|NCT02117830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532899|NCT02117830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65532900|NCT02117830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532901|NCT02117830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65532902|NCT02117830|Hormone Antagonists|hormone antagonists|mesh-ancestor
65532903|NCT02117830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65532904|NCT02117830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65532905|NCT02117830|Fertility Agents|fertility agents|mesh-ancestor
65532906|NCT02117830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65532907|NCT02117830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65532908|NCT02120638|Pyrazinamide|pyrazinamide|mesh-list
65532909|NCT02120638|Antitubercular Agents|antitubercular agents|mesh-ancestor
65532910|NCT02120638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65532911|NCT02120638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65532912|NCT03552406|Cetuximab|cetuximab|mesh-list
65532914|NCT03552406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532915|NCT02123368|Hyaluronic Acid|hyaluronic acid|mesh-list
65532916|NCT02123368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65532917|NCT02123368|Immunologic Factors|immunologic factors|mesh-ancestor
65532918|NCT02123368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532919|NCT02123368|Viscosupplements|viscosupplements|mesh-ancestor
65532920|NCT02123368|Protective Agents|protective agents|mesh-ancestor
65532921|NCT02123524|Rivaroxaban|rivaroxaban|mesh-list
65532922|NCT02123524|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65532923|NCT02123524|Antithrombins|antithrombins|mesh-ancestor
65532924|NCT02123524|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65532925|NCT02123524|Protease Inhibitors|protease inhibitors|mesh-ancestor
65532926|NCT02123524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532927|NCT02123524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532928|NCT02123524|Anticoagulants|anticoagulants|mesh-ancestor
65532929|NCT02117986|Colistin|colistin|mesh-list
65532930|NCT02117986|Polymyxins|polymyxins|mesh-list
65532931|NCT02117986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65532932|NCT02117986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65532933|NCT02118064|Irinotecan|irinotecan|mesh-list
65532934|NCT02118064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65532935|NCT02118064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65532936|NCT02118064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532937|NCT02118064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532938|NCT02118064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532939|NCT02120872|Simvastatin|simvastatin|mesh-list
65532940|NCT02120872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65532941|NCT02120872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65532942|NCT02120872|Antimetabolites|antimetabolites|mesh-ancestor
65532943|NCT02120872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532944|NCT02120872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65532945|NCT02120872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65532946|NCT02120872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532947|NCT03552016|Riboflavin|riboflavin|mesh-list
65532948|NCT03552016|Vitamins|vitamins|mesh-ancestor
65532949|NCT03552016|Micronutrients|micronutrients|mesh-ancestor
65532950|NCT03552016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532951|NCT03552016|Vitamin B Complex|vitamin b complex|mesh-ancestor
65532952|NCT03552016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65532953|NCT03552016|Dermatologic Agents|dermatologic agents|mesh-ancestor
65532954|NCT02788474|Nintedanib|nintedanib|mesh-list
65532955|NCT02788474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532956|NCT02788474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65532957|NCT02788474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65532958|NCT02788474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532959|NCT02118142|Betaine|betaine|mesh-list
65532960|NCT02118142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65532961|NCT02118142|Lipotropic Agents|lipotropic agents|mesh-ancestor
65532962|NCT02118142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65532963|NCT02118142|Antimetabolites|antimetabolites|mesh-ancestor
65532964|NCT02118142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532965|NCT02118142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65532966|NCT02118376|Exenatide|exenatide|mesh-list
65532967|NCT02118376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65532968|NCT02118376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532969|NCT02118376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65532970|NCT02118376|Incretins|incretins|mesh-ancestor
65532971|NCT02118376|Hormones|hormones|mesh-ancestor
65532972|NCT02118376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65532973|NCT02124070|Hormones|hormones|mesh-list
65532974|NCT02124070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65532975|NCT02124070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532976|NCT02118532|Paclitaxel|paclitaxel|mesh-list
65532977|NCT02118532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65532978|NCT02118532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65532979|NCT02118532|Tubulin Modulators|tubulin modulators|mesh-ancestor
65532980|NCT02118532|Antimitotic Agents|antimitotic agents|mesh-ancestor
65532981|NCT02118532|Mitosis Modulators|mitosis modulators|mesh-ancestor
65532982|NCT02118532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532983|NCT02118688|Risperidone|risperidone|mesh-list
65532984|NCT02118688|Trazodone|trazodone|mesh-list
65532985|NCT02118688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65532986|NCT02118688|Serotonin Agents|serotonin agents|mesh-ancestor
65532987|NCT02118688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65330497|NCT04077684|Interleukin-2|interleukin-2|mesh-list
65532988|NCT02118688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65532989|NCT02118688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65532990|NCT02118688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65532991|NCT02118688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65532992|NCT02118688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65532993|NCT02118688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65532994|NCT02118688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65532995|NCT02118688|Dopamine Agents|dopamine agents|mesh-ancestor
65532996|NCT02118688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65532997|NCT02118688|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65532998|NCT02118688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65532999|NCT02118688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65533000|NCT02118688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65533001|NCT02118688|Antidepressive Agents|antidepressive agents|mesh-ancestor
65533002|NCT02126956|Ponesimod|ponesimod|mesh-list
65533003|NCT02126956|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65533004|NCT02126956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533005|NCT02126956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65533006|NCT02126956|Immunologic Factors|immunologic factors|mesh-ancestor
65533007|NCT02126956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533008|NCT02124148|Leucovorin|leucovorin|mesh-list
65533009|NCT02124148|Fluorouracil|fluorouracil|mesh-list
65533010|NCT02124148|Pemetrexed|pemetrexed|mesh-list
65533011|NCT02124148|Cetuximab|cetuximab|mesh-list
65533012|NCT02124148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533013|NCT02124148|Antimetabolites|antimetabolites|mesh-ancestor
65533014|NCT02124148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533015|NCT02124148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65533016|NCT02124148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65533017|NCT02124148|Immunologic Factors|immunologic factors|mesh-ancestor
65533018|NCT02124148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533019|NCT02124148|Antidotes|antidotes|mesh-ancestor
65533020|NCT02124148|Protective Agents|protective agents|mesh-ancestor
65533021|NCT02124148|Vitamin B Complex|vitamin b complex|mesh-ancestor
65533022|NCT02124148|Vitamins|vitamins|mesh-ancestor
65533023|NCT02124148|Micronutrients|micronutrients|mesh-ancestor
65533024|NCT02124148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533025|NCT02124148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65533026|NCT02124148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65533027|NCT02124148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65533028|NCT02124226|Methotrexate|methotrexate|mesh-list
65533029|NCT02124226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65533030|NCT02124226|Abortifacient Agents|abortifacient agents|mesh-ancestor
65533031|NCT02124226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65533032|NCT02124226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533033|NCT02124226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65533034|NCT02124226|Antimetabolites|antimetabolites|mesh-ancestor
65533035|NCT02124226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533036|NCT02124226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533037|NCT02124226|Dermatologic Agents|dermatologic agents|mesh-ancestor
65533038|NCT02124226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533039|NCT02124226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65533040|NCT02124226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65533041|NCT02124226|Immunologic Factors|immunologic factors|mesh-ancestor
65533042|NCT02124226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65533043|NCT02124226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65533044|NCT02127034|Digoxin|digoxin|mesh-list
65533045|NCT02127034|Solifenacin Succinate|solifenacin succinate|mesh-list
65533046|NCT02127034|Mirabegron|mirabegron|mesh-list
65533047|NCT02127034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65533048|NCT02127034|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65533049|NCT02127034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533050|NCT02127034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533051|NCT02127034|Protective Agents|protective agents|mesh-ancestor
65533052|NCT02127034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533053|NCT02127034|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65533054|NCT02127034|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65533055|NCT02127034|Cholinergic Agents|cholinergic agents|mesh-ancestor
65533056|NCT02127034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65533057|NCT02127034|Urological Agents|urological agents|mesh-ancestor
65533058|NCT02127034|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65533059|NCT02127034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65533060|NCT02127034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65533061|NCT02127034|Adrenergic Agents|adrenergic agents|mesh-ancestor
65533062|NCT02787304|Volixibat|volixibat|mesh-list
65533063|NCT02787304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65533064|NCT00574496|Gemcitabine|gemcitabine|mesh-list
65533065|NCT00574496|Cyclosporine|cyclosporine|mesh-list
65533066|NCT00574496|Mycophenolic Acid|mycophenolic acid|mesh-list
65533068|NCT00574496|Cyclophosphamide|cyclophosphamide|mesh-list
65533069|NCT00574496|Melphalan|melphalan|mesh-list
65533070|NCT00574496|Ifosfamide|ifosfamide|mesh-list
65533071|NCT00574496|Mechlorethamine|mechlorethamine|mesh-list
65533072|NCT00574496|Methotrexate|methotrexate|mesh-list
65533073|NCT00574496|Fludarabine|fludarabine|mesh-list
65533074|NCT00574496|Fludarabine phosphate|fludarabine phosphate|mesh-list
65533075|NCT00574496|Vincristine|vincristine|mesh-list
65533076|NCT00574496|Vinorelbine|vinorelbine|mesh-list
65533077|NCT00574496|Procarbazine|procarbazine|mesh-list
65533078|NCT00574496|Cyclosporins|cyclosporins|mesh-list
65533079|NCT00574496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65533080|NCT00574496|Immunologic Factors|immunologic factors|mesh-ancestor
65533081|NCT00574496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533082|NCT00574496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65533083|NCT00574496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65533084|NCT00574496|Alkylating Agents|alkylating agents|mesh-ancestor
65533085|NCT00574496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533086|NCT00574496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533087|NCT00574496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65533088|NCT00574496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65533089|NCT00574496|Antimetabolites|antimetabolites|mesh-ancestor
65533090|NCT00574496|Antiviral Agents|antiviral agents|mesh-ancestor
65533091|NCT00574496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65533092|NCT00574496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533093|NCT00574496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65533094|NCT00574496|Glucocorticoids|glucocorticoids|mesh-ancestor
65533095|NCT00574496|Hormones|hormones|mesh-ancestor
65533096|NCT00574496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65533097|NCT00574496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65533098|NCT00574496|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65533099|NCT00574496|Abortifacient Agents|abortifacient agents|mesh-ancestor
65533100|NCT00574496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65533101|NCT00574496|Dermatologic Agents|dermatologic agents|mesh-ancestor
65533102|NCT00574496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65533103|NCT00574496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65533104|NCT00574496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65533105|NCT00574496|Tubulin Modulators|tubulin modulators|mesh-ancestor
65533106|NCT00574496|Antimitotic Agents|antimitotic agents|mesh-ancestor
65533107|NCT00574496|Mitosis Modulators|mitosis modulators|mesh-ancestor
65533108|NCT00574496|Antifungal Agents|antifungal agents|mesh-ancestor
65533109|NCT00574496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65533110|NCT00574496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65533111|NCT00574496|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65533112|NCT00574496|Antitubercular Agents|antitubercular agents|mesh-ancestor
65533113|NCT00574496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65533114|NCT02127190|CXA-10|cxa-10|mesh-list
65533115|NCT02127190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65533116|NCT02932904|Vortioxetine|vortioxetine|mesh-list
65533117|NCT02932904|Paroxetine|paroxetine|mesh-list
65533118|NCT02932904|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65533119|NCT02932904|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65533120|NCT02932904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65533121|NCT02932904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533122|NCT02932904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65533123|NCT02932904|Serotonin Agents|serotonin agents|mesh-ancestor
65533124|NCT02932904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533125|NCT02932904|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65533126|NCT02932904|Antidepressive Agents|antidepressive agents|mesh-ancestor
65533127|NCT02932904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65533128|NCT02932904|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65533129|NCT02932904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65533130|NCT02932904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65533131|NCT02932904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65533132|NCT02932904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65533133|NCT02932904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65533134|NCT02932904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65533135|NCT02932904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65533136|NCT02932904|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65533137|NCT02932904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65533138|NCT02127736|Amitriptyline|amitriptyline|mesh-list
65533139|NCT02127736|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65533140|NCT02127736|Antidepressive Agents|antidepressive agents|mesh-ancestor
65533141|NCT02127736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65533142|NCT02127736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65533144|NCT02127736|Sensory System Agents|sensory system agents|mesh-ancestor
65533145|NCT02127736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65533146|NCT02127736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533147|NCT02127736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65533148|NCT02127736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65533149|NCT02127736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65533150|NCT02127736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533151|NCT02127736|Adrenergic Agents|adrenergic agents|mesh-ancestor
65533152|NCT02127736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65533153|NCT02124850|Nivolumab|nivolumab|mesh-list
65533154|NCT02124850|Cetuximab|cetuximab|mesh-list
65533155|NCT02124850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65533156|NCT02124850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533157|NCT02124850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65533158|NCT02124850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533159|NCT02125084|Everolimus|everolimus|mesh-list
65533160|NCT02125084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65533161|NCT02125084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65533162|NCT02125084|Immunologic Factors|immunologic factors|mesh-ancestor
65533163|NCT02125084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533164|NCT02122510|Dexmedetomidine|dexmedetomidine|mesh-list
65533165|NCT02122510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65533166|NCT02122510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65533167|NCT02122510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65533168|NCT02122510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65533169|NCT02122510|Analgesics|analgesics|mesh-ancestor
65533170|NCT02122510|Sensory System Agents|sensory system agents|mesh-ancestor
65533171|NCT02122510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65533172|NCT02122510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65533173|NCT02122510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65533174|NCT02122510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65533175|NCT02122510|Adrenergic Agents|adrenergic agents|mesh-ancestor
65533176|NCT02122510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65533177|NCT02122510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65533178|NCT02125318|Anagrelide|anagrelide|mesh-list
65533179|NCT02125318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65533180|NCT02125318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65397919|NCT00093145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65397920|NCT00965406|Insulin|insulin|mesh-list
65397921|NCT00965406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65397922|NCT00965406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397923|NCT00513357|Melatonin|melatonin|mesh-list
65397924|NCT00513357|Antioxidants|antioxidants|mesh-ancestor
65397925|NCT00513357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397926|NCT00513357|Protective Agents|protective agents|mesh-ancestor
65397927|NCT00513357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397928|NCT00513357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65397929|NCT05181735|Luspatercept|luspatercept|mesh-list
65397962|NCT00961038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65397963|NCT00961038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65397964|NCT00961038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65397965|NCT00961038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397966|NCT00961038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397967|NCT00961038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397968|NCT00961038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65397969|NCT00961038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65398004|NCT00415636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398005|NCT00415636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65398006|NCT00415636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65398007|NCT00965874|Magnesium Sulfate|magnesium sulfate|mesh-list
65398008|NCT00965874|Analgesics|analgesics|mesh-ancestor
65398018|NCT00965874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398019|NCT00965874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65398020|NCT00965874|Tocolytic Agents|tocolytic agents|mesh-ancestor
65398021|NCT00965874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65398022|NCT00972426|Timolol|timolol|mesh-list
65398023|NCT00972426|Carteolol|carteolol|mesh-list
65398024|NCT00972426|Latanoprost|latanoprost|mesh-list
65398025|NCT00972426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65398026|NCT00972426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65398027|NCT00972426|Adrenergic Agents|adrenergic agents|mesh-ancestor
65398028|NCT00972426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65398029|NCT00972426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398030|NCT00972426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398031|NCT00972426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65398032|NCT00972426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65398033|NCT00972426|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65398034|NCT00972426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65398035|NCT00972426|Sympatholytics|sympatholytics|mesh-ancestor
65398036|NCT00972426|Autonomic Agents|autonomic agents|mesh-ancestor
65398037|NCT00972426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65398038|NCT00972660|Cyclosporine|cyclosporine|mesh-list
65398039|NCT00972660|Mycophenolic Acid|mycophenolic acid|mesh-list
65398040|NCT00972660|Prednisone|prednisone|mesh-list
65398041|NCT00972660|Cyclosporins|cyclosporins|mesh-list
64324453|NCT01435369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65398053|NCT00972660|Immunologic Factors|immunologic factors|mesh-ancestor
65398054|NCT00972660|Antifungal Agents|antifungal agents|mesh-ancestor
65398055|NCT00972660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65398056|NCT00972660|Dermatologic Agents|dermatologic agents|mesh-ancestor
65398057|NCT00972660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65398058|NCT00972660|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65398059|NCT00972660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65398060|NCT00972660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65398061|NCT00972660|Antitubercular Agents|antitubercular agents|mesh-ancestor
65398062|NCT00972660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65398063|NCT04008966|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65398064|NCT04008966|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65398066|NCT04008966|Progesterone|progesterone|mesh-list
65398067|NCT04008966|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65398068|NCT04008966|Progestins|progestins|mesh-ancestor
65398069|NCT04008966|Hormones|hormones|mesh-ancestor
65398070|NCT04008966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65398071|NCT04008966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398072|NCT04008966|Luteolytic Agents|luteolytic agents|mesh-ancestor
65398073|NCT04008966|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65398074|NCT04008966|Contraceptive Agents|contraceptive agents|mesh-ancestor
64324463|NCT03980509|Analgesics|analgesics|mesh-ancestor
65398123|NCT00966576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65398138|NCT00425308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65398139|NCT00425308|Dermatologic Agents|dermatologic agents|mesh-ancestor
65398140|NCT00425308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65398141|NCT00425308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65398142|NCT00425308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398143|NCT00425308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65398144|NCT00425308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65398145|NCT00425308|Antitubercular Agents|antitubercular agents|mesh-ancestor
65398146|NCT00425308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65398148|NCT04008888|Dexamethasone acetate|dexamethasone acetate|mesh-list
65398149|NCT04008888|Fludarabine|fludarabine|mesh-list
65398150|NCT04008888|Melphalan|melphalan|mesh-list
65398151|NCT04008888|BB 1101|bb 1101|mesh-list
65398152|NCT04008888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65398153|NCT04008888|Antiemetics|antiemetics|mesh-ancestor
65398154|NCT04008888|Autonomic Agents|autonomic agents|mesh-ancestor
65398155|NCT04008888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65398156|NCT04008888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398157|NCT04008888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65398158|NCT04008888|Glucocorticoids|glucocorticoids|mesh-ancestor
65398159|NCT04008888|Hormones|hormones|mesh-ancestor
64395955|NCT03103685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64395959|NCT03103685|Purinergic Agents|purinergic agents|mesh-ancestor
65398169|NCT04008888|Alkylating Agents|alkylating agents|mesh-ancestor
65398170|NCT04008888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65398171|NCT02672098|Carboplatin|carboplatin|mesh-list
65398172|NCT02672098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398173|NCT01033084|Sertraline|sertraline|mesh-list
65398174|NCT01033084|Antidepressive Agents|antidepressive agents|mesh-ancestor
65398175|NCT01033084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65398176|NCT01033084|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65398177|NCT01033084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65398178|NCT01033084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65398179|NCT01033084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398180|NCT01033084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65398181|NCT01033084|Serotonin Agents|serotonin agents|mesh-ancestor
65398182|NCT01033084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398183|NCT00979758|Atorvastatin|atorvastatin|mesh-list
65398184|NCT00979758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65398185|NCT00979758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65398186|NCT00979758|Antimetabolites|antimetabolites|mesh-ancestor
65398187|NCT00979758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398188|NCT00979758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65398189|NCT00979758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65398190|NCT00979758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398191|NCT00545064|Timolol|timolol|mesh-list
65398194|NCT00545064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398195|NCT00545064|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65398196|NCT00545064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65398197|NCT00545064|Adrenergic Agents|adrenergic agents|mesh-ancestor
65398198|NCT00545064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65398199|NCT00545064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398200|NCT00545064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65398201|NCT00545064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65398202|NCT00545064|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65398203|NCT00979836|Calcium Dobesilate|calcium dobesilate|mesh-list
65398204|NCT00979836|Calcium|calcium|mesh-list
65398205|NCT00979836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65398206|NCT00979836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398207|NCT00979836|Hemostatics|hemostatics|mesh-ancestor
65398208|NCT00979836|Coagulants|coagulants|mesh-ancestor
65398209|NCT01588912|Tenofovir|tenofovir|mesh-list
65398210|NCT01588912|Entecavir|entecavir|mesh-list
65398211|NCT01588912|Telbivudine|telbivudine|mesh-list
65398212|NCT01588912|Antiviral Agents|antiviral agents|mesh-ancestor
65398213|NCT01588912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65398214|NCT01588912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65398215|NCT01588912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65398216|NCT01588912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398217|NCT01588912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398218|NCT01588912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65398219|NCT01588912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65398220|NCT01589068|Nicotine|nicotine|mesh-list
65398221|NCT01589068|Progesterone|progesterone|mesh-list
65398222|NCT01589068|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65398223|NCT01589068|Autonomic Agents|autonomic agents|mesh-ancestor
65398224|NCT01589068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65398225|NCT01589068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398226|NCT01589068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65398227|NCT01589068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65398228|NCT01589068|Cholinergic Agents|cholinergic agents|mesh-ancestor
65398229|NCT01589068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65398230|NCT01589068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398232|NCT01589068|Hormones|hormones|mesh-ancestor
65398233|NCT01589068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65398234|NCT00432562|Vinorelbine|vinorelbine|mesh-list
65398235|NCT00432562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65398236|NCT00432562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398237|NCT00432562|Tubulin Modulators|tubulin modulators|mesh-ancestor
65398238|NCT00432562|Antimitotic Agents|antimitotic agents|mesh-ancestor
65398239|NCT00432562|Mitosis Modulators|mitosis modulators|mesh-ancestor
65398240|NCT00432562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398241|NCT00966966|Gemfibrozil|gemfibrozil|mesh-list
65398242|NCT00966966|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65398243|NCT00966966|Antimetabolites|antimetabolites|mesh-ancestor
65398244|NCT00966966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398245|NCT00966966|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65398246|NCT00966966|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65398247|NCT00966966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65398248|NCT00966966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398249|NCT00974532|Calcium, Dietary|calcium, dietary|mesh-list
65398250|NCT00974532|Calcium|calcium|mesh-list
65398251|NCT00974532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65398252|NCT00974532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398253|NCT00974532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65398254|NCT00432172|Cyclophosphamide|cyclophosphamide|mesh-list
65398255|NCT00432172|Carboplatin|carboplatin|mesh-list
65398256|NCT00432172|Docetaxel|docetaxel|mesh-list
65398257|NCT00432172|Epirubicin|epirubicin|mesh-list
65398258|NCT00432172|Exemestane|exemestane|mesh-list
65398259|NCT00432172|Goserelin|goserelin|mesh-list
65398260|NCT00432172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65398261|NCT00432172|Immunologic Factors|immunologic factors|mesh-ancestor
65398262|NCT00432172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398263|NCT00432172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65147836|NCT04304014|Sulfalene|sulfalene|mesh-list
65398264|NCT00432172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65398265|NCT00432172|Alkylating Agents|alkylating agents|mesh-ancestor
65398266|NCT00432172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398267|NCT00432172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398268|NCT00432172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65398269|NCT00432172|Tubulin Modulators|tubulin modulators|mesh-ancestor
65398273|NCT00432172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65398274|NCT00432172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65398275|NCT00432172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398276|NCT00432172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65398277|NCT00432172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65398278|NCT00432172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65398279|NCT00432172|Hormone Antagonists|hormone antagonists|mesh-ancestor
65398280|NCT00432172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65398281|NCT00432172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65398283|NCT01034410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65398284|NCT01034410|Antimetabolites|antimetabolites|mesh-ancestor
65398285|NCT01034410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398286|NCT01034410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398287|NCT01034410|Antiviral Agents|antiviral agents|mesh-ancestor
65398288|NCT01034410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65398289|NCT01034410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65398290|NCT01034410|Immunologic Factors|immunologic factors|mesh-ancestor
65398291|NCT01034410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398292|NCT00415168|Pemetrexed|pemetrexed|mesh-list
65398293|NCT00415168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398294|NCT00415168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398295|NCT00415168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398296|NCT00415168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65398297|NCT00415168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65398298|NCT00424762|Rosiglitazone|rosiglitazone|mesh-list
65398299|NCT00424762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65398300|NCT00424762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398301|NCT00980304|Rituximab|rituximab|mesh-list
65398302|NCT00980304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65398303|NCT00980304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398304|NCT00980304|Immunologic Factors|immunologic factors|mesh-ancestor
65398305|NCT00980304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224281|NCT04101136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65147911|NCT02890238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398338|NCT00967434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398339|NCT00967434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65398340|NCT00967434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65398341|NCT00967434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398342|NCT00967512|Cytarabine|cytarabine|mesh-list
65398343|NCT00967512|Idarubicin|idarubicin|mesh-list
65398344|NCT00967512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65398345|NCT00967512|Antimetabolites|antimetabolites|mesh-ancestor
65398346|NCT00967512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398347|NCT00967512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398348|NCT00967512|Antiviral Agents|antiviral agents|mesh-ancestor
65398349|NCT00967512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65398350|NCT00967512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65398351|NCT00967512|Immunologic Factors|immunologic factors|mesh-ancestor
65398352|NCT00967512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398353|NCT00967512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65398354|NCT00967512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65398355|NCT00967512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65398356|NCT00967512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398357|NCT04082910|Etanercept|etanercept|mesh-list
65398358|NCT04082910|Infliximab|infliximab|mesh-list
65398359|NCT04082910|Metoprolol|metoprolol|mesh-list
65398360|NCT04082910|Dermatologic Agents|dermatologic agents|mesh-ancestor
65398361|NCT04082910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65398362|NCT04082910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65398363|NCT04082910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65398364|NCT04082910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65398365|NCT04082910|Analgesics|analgesics|mesh-ancestor
65398383|NCT00975078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65398384|NCT00975078|Glucocorticoids|glucocorticoids|mesh-ancestor
65398385|NCT00975078|Hormones|hormones|mesh-ancestor
65398386|NCT00975078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65398387|NCT00975078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398388|NCT00975078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65398389|NCT00975078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398390|NCT00980616|Ropivacaine|ropivacaine|mesh-list
65398391|NCT00980616|Anesthetics, Local|anesthetics, local|mesh-ancestor
65398392|NCT00980616|Anesthetics|anesthetics|mesh-ancestor
65398393|NCT00980616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65398394|NCT00980616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398395|NCT00980616|Sensory System Agents|sensory system agents|mesh-ancestor
65398396|NCT00980616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65398397|NCT00980850|Vaccines|vaccines|mesh-list
64784746|NCT01683864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784747|NCT01608906|Heparin|heparin|mesh-list
65398430|NCT00975312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398431|NCT00975312|Keratolytic Agents|keratolytic agents|mesh-ancestor
65398432|NCT00975312|Dermatologic Agents|dermatologic agents|mesh-ancestor
65398434|NCT04974996|Cyclophosphamide|cyclophosphamide|mesh-list
65398435|NCT04974996|Rituximab|rituximab|mesh-list
65398436|NCT04974996|Doxorubicin|doxorubicin|mesh-list
65398437|NCT04974996|Vincristine|vincristine|mesh-list
65398438|NCT04974996|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
65398439|NCT04974996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65398440|NCT04974996|Immunologic Factors|immunologic factors|mesh-ancestor
64784753|NCT01602198|Rivastigmine|rivastigmine|mesh-list
65398475|NCT00981318|Ritonavir|ritonavir|mesh-list
65398476|NCT00981318|Lopinavir|lopinavir|mesh-list
65398477|NCT00981318|Maraviroc|maraviroc|mesh-list
65398478|NCT00981318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65398479|NCT00981318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65398480|NCT00981318|Protease Inhibitors|protease inhibitors|mesh-ancestor
65398481|NCT00981318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398482|NCT00981318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398483|NCT00981318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65398484|NCT00981318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65398485|NCT00981318|Antiviral Agents|antiviral agents|mesh-ancestor
65398486|NCT00981318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65148055|NCT01260948|Donepezil|donepezil|mesh-list
65398487|NCT00981318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65398488|NCT00981318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65398489|NCT00981318|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65398490|NCT00981318|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65398491|NCT00981318|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65398492|NCT00984984|Methylprednisolone|methylprednisolone|mesh-list
65224360|NCT00767806|Analgesics|analgesics|mesh-ancestor
65398493|NCT00984984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65398494|NCT00984984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65398495|NCT00984984|Prednisolone|prednisolone|mesh-list
65398496|NCT00984984|Prednisolone acetate|prednisolone acetate|mesh-list
65398504|NCT00984984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65398505|NCT00984984|Glucocorticoids|glucocorticoids|mesh-ancestor
65398506|NCT00984984|Hormones|hormones|mesh-ancestor
65398507|NCT00984984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65398508|NCT00984984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65398509|NCT00984984|Protective Agents|protective agents|mesh-ancestor
65398510|NCT00984984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65398511|NCT00984984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398512|NCT00545532|Oseltamivir|oseltamivir|mesh-list
65398513|NCT00545532|Antiviral Agents|antiviral agents|mesh-ancestor
65398514|NCT00545532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65398515|NCT00545532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398516|NCT00545532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398517|NCT00544440|Prednisone|prednisone|mesh-list
65398518|NCT00544440|Abiraterone Acetate|abiraterone acetate|mesh-list
65398519|NCT00544440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65398520|NCT00544440|Glucocorticoids|glucocorticoids|mesh-ancestor
65398521|NCT00544440|Hormones|hormones|mesh-ancestor
65398522|NCT00544440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65398523|NCT00544440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398524|NCT00544440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65398525|NCT00544440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398526|NCT00544440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65398527|NCT00544440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398528|NCT00544440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398529|NCT00544440|Hormone Antagonists|hormone antagonists|mesh-ancestor
65398530|NCT00544440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65398531|NCT00981708|Dexamethasone|dexamethasone|mesh-list
65398532|NCT00981708|Dexamethasone acetate|dexamethasone acetate|mesh-list
65398533|NCT00981708|Cyclophosphamide|cyclophosphamide|mesh-list
65398534|NCT00981708|Lenalidomide|lenalidomide|mesh-list
65398535|NCT00981708|BB 1101|bb 1101|mesh-list
65398536|NCT00981708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65398606|NCT00976092|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65398607|NCT00976092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65398608|NCT00976092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65398611|NCT00976092|Purinergic Agents|purinergic agents|mesh-ancestor
65398612|NCT00976092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65398613|NCT00976092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398614|NCT00976092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398615|NCT00976092|Anticoagulants|anticoagulants|mesh-ancestor
65398616|NCT00976092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65398617|NCT00976092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65398618|NCT00976092|Antithrombins|antithrombins|mesh-ancestor
65398619|NCT00976092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65398620|NCT00976092|Protease Inhibitors|protease inhibitors|mesh-ancestor
65398621|NCT00976092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398622|NCT00985530|Arsenic Trioxide|arsenic trioxide|mesh-list
65398623|NCT00985530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398624|NCT04006470|Fluorides|fluorides|mesh-list
65398625|NCT04006470|Tin Fluorides|tin fluorides|mesh-list
65398626|NCT04006470|Cariostatic Agents|cariostatic agents|mesh-ancestor
65398627|NCT04006470|Protective Agents|protective agents|mesh-ancestor
65398628|NCT04006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398629|NCT01323712|Vitamin D|vitamin d|mesh-list
65398630|NCT01323712|Cholecalciferol|cholecalciferol|mesh-list
65398631|NCT01323712|Vitamins|vitamins|mesh-ancestor
65398632|NCT01323712|Micronutrients|micronutrients|mesh-ancestor
65398633|NCT01323712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398634|NCT01323712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65398635|NCT01323712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65398636|NCT00981942|Imatinib Mesylate|imatinib mesylate|mesh-list
65398637|NCT00981942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398638|NCT00981942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65398639|NCT00981942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398640|NCT00981942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398641|NCT03927144|Erenumab|erenumab|mesh-list
65398642|NCT03927144|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65398643|NCT03927144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398644|NCT03927144|Analgesics|analgesics|mesh-ancestor
65224431|NCT03277729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65398645|NCT03927144|Sensory System Agents|sensory system agents|mesh-ancestor
65398646|NCT03927144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65398647|NCT03927144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396109|NCT02642159|Ezetimibe|ezetimibe|mesh-list
64396110|NCT02642159|Fenofibrate|fenofibrate|mesh-list
64396111|NCT02642159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65398670|NCT00982332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398671|NCT00982332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65398672|NCT00982332|Respiratory System Agents|respiratory system agents|mesh-ancestor
65398673|NCT04007328|Methylprednisolone|methylprednisolone|mesh-list
65398674|NCT04007328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65398675|NCT04007328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65398676|NCT04007328|Prednisolone|prednisolone|mesh-list
65398677|NCT04007328|Prednisolone acetate|prednisolone acetate|mesh-list
65398678|NCT04007328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65398679|NCT04007328|Prednisolone phosphate|prednisolone phosphate|mesh-list
65398680|NCT04007328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65398681|NCT04007328|Antiemetics|antiemetics|mesh-ancestor
65398682|NCT04007328|Autonomic Agents|autonomic agents|mesh-ancestor
65398683|NCT04007328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65398684|NCT04007328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398685|NCT04007328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65398686|NCT04007328|Glucocorticoids|glucocorticoids|mesh-ancestor
65398688|NCT04007328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65398689|NCT04007328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65398690|NCT04007328|Protective Agents|protective agents|mesh-ancestor
64784865|NCT01166724|Sirolimus|sirolimus|mesh-list
65398694|NCT00985920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65398695|NCT00985920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65398696|NCT00985920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398697|NCT00985920|Hemostatics|hemostatics|mesh-ancestor
65398698|NCT00985920|Coagulants|coagulants|mesh-ancestor
65398699|NCT00976794|Carbamazepine|carbamazepine|mesh-list
65398700|NCT00976794|Valproic Acid|valproic acid|mesh-list
65398701|NCT00976794|Lithium Carbonate|lithium carbonate|mesh-list
65398702|NCT00976794|Antidepressive Agents|antidepressive agents|mesh-ancestor
65398703|NCT00976794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65398704|NCT00976794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398705|NCT00976794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398706|NCT00976794|Antimanic Agents|antimanic agents|mesh-ancestor
65398707|NCT00976794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65398708|NCT00976794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65148288|NCT01598298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65398709|NCT00976794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398710|NCT00976794|Anticonvulsants|anticonvulsants|mesh-ancestor
65398711|NCT00976794|GABA Agents|gaba agents|mesh-ancestor
65398712|NCT00976794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65398713|NCT00976794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65398714|NCT00976794|Analgesics|analgesics|mesh-ancestor
65398715|NCT00976794|Sensory System Agents|sensory system agents|mesh-ancestor
65398716|NCT00976794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65398717|NCT00976794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65398718|NCT00976794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65398719|NCT00976794|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65398720|NCT00976794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65398721|NCT00985998|Nimotuzumab|nimotuzumab|mesh-list
65398722|NCT00985998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65398723|NCT00985998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398724|NCT04008186|Metformin|metformin|mesh-list
65398725|NCT04008186|Repaglinide|repaglinide|mesh-list
65398726|NCT04008186|Itraconazole|itraconazole|mesh-list
65398730|NCT04008186|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65398731|NCT04008186|Gemfibrozil|gemfibrozil|mesh-list
65398732|NCT04008186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65398733|NCT04008186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398734|NCT04008186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65398735|NCT04008186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65398736|NCT04008186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65398737|NCT04008186|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65398738|NCT04008186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65398739|NCT04008186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65398740|NCT04008186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65398741|NCT04008186|Anesthetics, General|anesthetics, general|mesh-ancestor
65398742|NCT04008186|Anesthetics|anesthetics|mesh-ancestor
65398743|NCT04008186|GABA Modulators|gaba modulators|mesh-ancestor
65224507|NCT02688985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398744|NCT04008186|GABA Agents|gaba agents|mesh-ancestor
65398745|NCT04008186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65398746|NCT04008186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398747|NCT04008186|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65398748|NCT04008186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65398749|NCT04008186|Antimetabolites|antimetabolites|mesh-ancestor
65398750|NCT04008186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65398751|NCT04008186|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65398752|NCT04008186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398753|NCT04008186|Antifungal Agents|antifungal agents|mesh-ancestor
65398754|NCT04008186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65398755|NCT04008186|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65398756|NCT04008186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65398757|NCT04008186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65398758|NCT04008186|Hormone Antagonists|hormone antagonists|mesh-ancestor
65398759|NCT04008186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65398760|NCT04008186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65398761|NCT04008186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65398762|NCT04008186|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65398763|NCT04008186|Protective Agents|protective agents|mesh-ancestor
65398764|NCT04008186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65398765|NCT04008186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65398766|NCT04008186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65398802|NCT00982722|Calcium|calcium|mesh-list
65398803|NCT00982722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65398804|NCT00982722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398805|NCT00982722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65398806|NCT00982722|Vitamins|vitamins|mesh-ancestor
65398807|NCT00982722|Micronutrients|micronutrients|mesh-ancestor
65398808|NCT00982722|Antacids|antacids|mesh-ancestor
65398809|NCT00982722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398850|NCT00986466|Vitamin D|vitamin d|mesh-list
65398851|NCT00986466|Ergocalciferols|ergocalciferols|mesh-list
65398852|NCT00986466|Cholecalciferol|cholecalciferol|mesh-list
65398853|NCT00986466|Vitamins|vitamins|mesh-list
65398854|NCT00986466|Micronutrients|micronutrients|mesh-ancestor
65398855|NCT00986466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398856|NCT00986466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65398857|NCT00986466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65398858|NCT00545298|Nitric Oxide|nitric oxide|mesh-list
65398859|NCT00545298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65398860|NCT00545298|Autonomic Agents|autonomic agents|mesh-ancestor
65398861|NCT00545298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65398862|NCT00545298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398863|NCT00545298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65398864|NCT00545298|Respiratory System Agents|respiratory system agents|mesh-ancestor
65398865|NCT00545298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65398867|NCT00545298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398868|NCT00545298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65398869|NCT00545298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65398870|NCT00545298|Vasodilator Agents|vasodilator agents|mesh-ancestor
65398871|NCT00545298|Gasotransmitters|gasotransmitters|mesh-ancestor
65398872|NCT00545298|Protective Agents|protective agents|mesh-ancestor
65398873|NCT00983268|Capecitabine|capecitabine|mesh-list
65398874|NCT00983268|Vorinostat|vorinostat|mesh-list
65398875|NCT00983268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65398876|NCT00983268|Antimetabolites|antimetabolites|mesh-ancestor
65398877|NCT00983268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398878|NCT00983268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398879|NCT00983268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65398880|NCT00983268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398881|NCT00977964|Caseins|caseins|mesh-list
65398882|NCT00977964|Chelating Agents|chelating agents|mesh-ancestor
65398883|NCT00977964|Sequestering Agents|sequestering agents|mesh-ancestor
64396187|NCT03491059|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65398917|NCT00986778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398918|NCT00986778|Antiviral Agents|antiviral agents|mesh-ancestor
65398919|NCT00986778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65398920|NCT00986778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65398921|NCT00986778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65398922|NCT00429364|Losartan|losartan|mesh-list
65398923|NCT00429364|Atenolol|atenolol|mesh-list
65398924|NCT00429364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65398925|NCT00429364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65398926|NCT00429364|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65398927|NCT00429364|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65398928|NCT00429364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398929|NCT00429364|Sympatholytics|sympatholytics|mesh-ancestor
65398930|NCT00429364|Autonomic Agents|autonomic agents|mesh-ancestor
65398931|NCT00429364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65398932|NCT00429364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398933|NCT00429364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65398934|NCT00429364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65398935|NCT00429364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65148507|NCT01231581|Antiviral Agents|antiviral agents|mesh-ancestor
65398936|NCT00429364|Adrenergic Agents|adrenergic agents|mesh-ancestor
65398937|NCT00429364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65398938|NCT00978354|Furosemide|furosemide|mesh-list
65398939|NCT00978354|Diuretics|diuretics|mesh-ancestor
65398940|NCT00978354|Natriuretic Agents|natriuretic agents|mesh-ancestor
65398941|NCT00978354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398942|NCT00978354|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65398943|NCT00978354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65398944|NCT00978354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398945|NCT00984360|Naltrexone|naltrexone|mesh-list
65398946|NCT00984360|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65398947|NCT00984360|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65398948|NCT00984360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398949|NCT00984360|Sensory System Agents|sensory system agents|mesh-ancestor
65398950|NCT00984360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65398951|NCT00414388|Sorafenib|sorafenib|mesh-list
65398982|NCT00424372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65398983|NCT00424372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398984|NCT00424372|Anticonvulsants|anticonvulsants|mesh-ancestor
65398985|NCT00424372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65398986|NCT00424372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65398987|NCT00424372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398988|NCT00424372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65398989|NCT00424372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65398990|NCT00424372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65398991|NCT00424372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65398992|NCT00424372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65398993|NCT00987168|Octreotide|octreotide|mesh-list
65398994|NCT00987168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64784979|NCT00749658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399007|NCT00978978|Narcotics|narcotics|mesh-ancestor
65399008|NCT00978978|Analgesics|analgesics|mesh-ancestor
65399009|NCT00978978|Sensory System Agents|sensory system agents|mesh-ancestor
65399010|NCT00978978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65399011|NCT00978978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65399012|NCT00978978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65399013|NCT00978978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65399014|NCT00978978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65399015|NCT00978978|GABA Modulators|gaba modulators|mesh-ancestor
65399016|NCT00978978|GABA Agents|gaba agents|mesh-ancestor
65399017|NCT00978978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65399018|NCT00978978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399019|NCT00414310|Decitabine|decitabine|mesh-list
65399020|NCT00414310|Valproic Acid|valproic acid|mesh-list
65399021|NCT00414310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65399022|NCT00414310|Antimetabolites|antimetabolites|mesh-ancestor
65399023|NCT00414310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399024|NCT00414310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399025|NCT00414310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399026|NCT00414310|Anticonvulsants|anticonvulsants|mesh-ancestor
65399027|NCT00414310|GABA Agents|gaba agents|mesh-ancestor
65399028|NCT00414310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65399029|NCT00414310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399030|NCT00414310|Antimanic Agents|antimanic agents|mesh-ancestor
65399031|NCT00414310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65399032|NCT00414310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65399033|NCT00414310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65399034|NCT00542880|Fluticasone|fluticasone|mesh-list
65399035|NCT00542880|Budesonide|budesonide|mesh-list
65399036|NCT00542880|Formoterol Fumarate|formoterol fumarate|mesh-list
64785011|NCT00704496|Sympathomimetics|sympathomimetics|mesh-ancestor
65399046|NCT00542880|Respiratory System Agents|respiratory system agents|mesh-ancestor
65399047|NCT00542880|Dermatologic Agents|dermatologic agents|mesh-ancestor
65399048|NCT00542880|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65399049|NCT00542880|Glucocorticoids|glucocorticoids|mesh-ancestor
65399050|NCT00542880|Hormones|hormones|mesh-ancestor
65399051|NCT00542880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65399052|NCT00542880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65399053|NCT00542880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65399054|NCT00542880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65399055|NCT00542880|Adrenergic Agents|adrenergic agents|mesh-ancestor
65399056|NCT00542880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65399057|NCT00542880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399058|NCT00542880|Sympathomimetics|sympathomimetics|mesh-ancestor
65399059|NCT00414076|Letrozole|letrozole|mesh-list
65399060|NCT00414076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399061|NCT00414076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65399062|NCT00414076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65399063|NCT00414076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399064|NCT00414076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399065|NCT00414076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65399066|NCT00414076|Hormone Antagonists|hormone antagonists|mesh-ancestor
65399067|NCT00414076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65399068|NCT00414076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399069|NCT01033318|Losartan|losartan|mesh-list
65399102|NCT00542178|Fenofibrate|fenofibrate|mesh-list
65399103|NCT00542178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65399104|NCT00542178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65399105|NCT00542178|Antimetabolites|antimetabolites|mesh-ancestor
65399106|NCT00542178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399107|NCT00542178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65399108|NCT00542178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65399109|NCT00542178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399110|NCT00542178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399111|NCT00987636|Zoledronic Acid|zoledronic acid|mesh-list
65399145|NCT00424294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65399146|NCT00424294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65399147|NCT00424294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65399148|NCT00424294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65399149|NCT05587998|Morphine|morphine|mesh-list
65399150|NCT05587998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65399151|NCT05587998|Narcotics|narcotics|mesh-ancestor
64785055|NCT00656916|Dermatologic Agents|dermatologic agents|mesh-ancestor
65399186|NCT04005768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65399187|NCT04005768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399188|NCT04005768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399189|NCT04005768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65399190|NCT00987792|Moxifloxacin|moxifloxacin|mesh-list
65399222|NCT05578170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399224|NCT00989274|Immunologic Factors|immunologic factors|mesh-ancestor
65399225|NCT00989274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399226|NCT03310944|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65399227|NCT03310944|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65399228|NCT03310944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399229|NCT03310944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65399230|NCT03310944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399291|NCT01326871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399293|NCT01326871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65399294|NCT01326871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399295|NCT01326871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65399296|NCT01326871|Immunologic Factors|immunologic factors|mesh-ancestor
65399297|NCT01326871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399298|NCT01081561|Riboflavin|riboflavin|mesh-list
65399299|NCT01081561|Vitamin B Complex|vitamin b complex|mesh-ancestor
65399300|NCT01081561|Vitamins|vitamins|mesh-ancestor
65399344|NCT04005222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399345|NCT04005222|Protective Agents|protective agents|mesh-ancestor
65399346|NCT04005222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399347|NCT04005222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65399348|NCT04005222|Trace Elements|trace elements|mesh-ancestor
65399349|NCT04005222|Micronutrients|micronutrients|mesh-ancestor
65399350|NCT05314374|Bile Acids and Salts|bile acids and salts|mesh-list
65399351|NCT05314374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65399353|NCT00098839|Cytarabine|cytarabine|mesh-list
65399354|NCT00098839|Prednisone|prednisone|mesh-list
65399355|NCT00098839|Hydrocortisone|hydrocortisone|mesh-list
65399356|NCT00098839|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65399357|NCT00098839|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65399358|NCT00098839|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65399359|NCT00098839|Cyclophosphamide|cyclophosphamide|mesh-list
65399378|NCT00098839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399380|NCT00098839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65399381|NCT00098839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65399382|NCT00098839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65399383|NCT00098839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65399384|NCT00098839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399385|NCT00098839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65399386|NCT00098839|Glucocorticoids|glucocorticoids|mesh-ancestor
65399387|NCT00098839|Hormones|hormones|mesh-ancestor
65399388|NCT00098839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65399389|NCT00098839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65399390|NCT00098839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65399391|NCT00098839|Abortifacient Agents|abortifacient agents|mesh-ancestor
65399392|NCT00098839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64396441|NCT02389231|Analgesics|analgesics|mesh-ancestor
65399399|NCT00098839|Antiviral Agents|antiviral agents|mesh-ancestor
65399400|NCT00098839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65399402|NCT00098839|Protective Agents|protective agents|mesh-ancestor
65399403|NCT00098839|Vitamin B Complex|vitamin b complex|mesh-ancestor
65399404|NCT00098839|Vitamins|vitamins|mesh-ancestor
65399405|NCT00098839|Micronutrients|micronutrients|mesh-ancestor
65399406|NCT00098839|Tubulin Modulators|tubulin modulators|mesh-ancestor
65399407|NCT00098839|Antimitotic Agents|antimitotic agents|mesh-ancestor
65399408|NCT00098839|Mitosis Modulators|mitosis modulators|mesh-ancestor
65399409|NCT00098839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65399410|NCT00098839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65399411|NCT05268744|Micronutrients|micronutrients|mesh-list
65399412|NCT05268744|Trace Elements|trace elements|mesh-list
65399413|NCT05268744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399414|NCT02531191|Peficitinib|peficitinib|mesh-list
65399415|NCT02531191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399416|NCT02531191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399417|NCT02531191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65399418|NCT02531191|Immunologic Factors|immunologic factors|mesh-ancestor
65399419|NCT02531191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399420|NCT01081639|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65399421|NCT01081639|Hormones|hormones|mesh-ancestor
65399422|NCT01081639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65399423|NCT01081639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399424|NCT01081717|Golimumab|golimumab|mesh-list
65399425|NCT01081717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65399426|NCT01081717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65399427|NCT01081717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65399428|NCT01081717|Immunologic Factors|immunologic factors|mesh-ancestor
65399429|NCT01081717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399430|NCT01085383|Aripiprazole|aripiprazole|mesh-list
64396448|NCT02383771|Ticagrelor|ticagrelor|mesh-list
64396449|NCT02383771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65399462|NCT00485589|Immunologic Factors|immunologic factors|mesh-ancestor
65399463|NCT00485589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65399464|NCT00485589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65399465|NCT00490971|Olanzapine|olanzapine|mesh-list
65399466|NCT00490971|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65399467|NCT00490971|Antiemetics|antiemetics|mesh-ancestor
65399468|NCT00490971|Autonomic Agents|autonomic agents|mesh-ancestor
65399469|NCT00490971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65399470|NCT00490971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399471|NCT00490971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65399472|NCT00490971|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65399473|NCT00490971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65399474|NCT00490971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65399475|NCT00490971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65399476|NCT00490971|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65399477|NCT00490971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65399478|NCT00490971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65399479|NCT00490971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399480|NCT00490971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65399481|NCT00490971|Serotonin Agents|serotonin agents|mesh-ancestor
65399482|NCT00490971|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65224806|NCT00628550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65399483|NCT00490971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65399484|NCT00490971|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65399485|NCT00490971|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65399486|NCT00490971|Dopamine Agents|dopamine agents|mesh-ancestor
65399487|NCT04286295|Nicotine|nicotine|mesh-list
65399488|NCT04286295|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65399489|NCT04286295|Autonomic Agents|autonomic agents|mesh-ancestor
65399490|NCT04286295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65399491|NCT04286295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399492|NCT04286295|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65399493|NCT04286295|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65399518|NCT00745589|Chelating Agents|chelating agents|mesh-ancestor
65399519|NCT00745589|Sequestering Agents|sequestering agents|mesh-ancestor
65399541|NCT00685763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399542|NCT00685763|Antiviral Agents|antiviral agents|mesh-ancestor
65399543|NCT00685763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65399544|NCT00685763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399545|NCT00685763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65399546|NCT00685763|Immunologic Factors|immunologic factors|mesh-ancestor
65399547|NCT00685763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399548|NCT00098293|Lamivudine|lamivudine|mesh-list
65399549|NCT00098293|Zidovudine|zidovudine|mesh-list
65399564|NCT00098293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65399565|NCT00098293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65399566|NCT00098293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65399567|NCT00098293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65399568|NCT00098293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65399569|NCT00098293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65399570|NCT00923741|Talactoferrin alfa|talactoferrin alfa|mesh-list
65399571|NCT00923741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399572|NCT00685685|Lovastatin|lovastatin|mesh-list
65399573|NCT00685685|L 647318|l 647318|mesh-list
65399574|NCT00685685|Dihydromevinolin|dihydromevinolin|mesh-list
65399575|NCT00685685|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65399576|NCT00685685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65399577|NCT00685685|Antimetabolites|antimetabolites|mesh-ancestor
65399578|NCT00685685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399579|NCT00685685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65399580|NCT00685685|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65399581|NCT00685685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399582|NCT01087567|Insulin|insulin|mesh-list
65399665|NCT01016223|Beclomethasone|beclomethasone|mesh-list
65399666|NCT01016223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65399667|NCT01016223|Glucocorticoids|glucocorticoids|mesh-ancestor
65399668|NCT01016223|Hormones|hormones|mesh-ancestor
65399669|NCT01016223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65399670|NCT01016223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399671|NCT01016223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65399672|NCT01016223|Respiratory System Agents|respiratory system agents|mesh-ancestor
65399673|NCT04151017|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65399674|NCT04151017|Hemostatics|hemostatics|mesh-ancestor
65399675|NCT04151017|Coagulants|coagulants|mesh-ancestor
65399676|NCT01019265|Buprenorphine|buprenorphine|mesh-list
65399677|NCT01019265|Tramadol|tramadol|mesh-list
65399678|NCT01019265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65399679|NCT01019265|Narcotics|narcotics|mesh-ancestor
65399680|NCT01019265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65399681|NCT01019265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399682|NCT01019265|Analgesics|analgesics|mesh-ancestor
65399683|NCT01019265|Sensory System Agents|sensory system agents|mesh-ancestor
65399684|NCT01019265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65399685|NCT01019265|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65149259|NCT01013740|Antimetabolites|antimetabolites|mesh-ancestor
65399686|NCT01085617|Cytarabine|cytarabine|mesh-list
65399687|NCT01085617|Cyclophosphamide|cyclophosphamide|mesh-list
65399688|NCT01085617|Melphalan|melphalan|mesh-list
65399689|NCT01085617|Rituximab|rituximab|mesh-list
65399690|NCT01085617|Methotrexate|methotrexate|mesh-list
65399691|NCT01085617|Fludarabine|fludarabine|mesh-list
65399692|NCT01085617|Fludarabine phosphate|fludarabine phosphate|mesh-list
65399693|NCT01085617|Etoposide|etoposide|mesh-list
65399694|NCT01085617|Vincristine|vincristine|mesh-list
65399695|NCT01085617|Imatinib Mesylate|imatinib mesylate|mesh-list
65399696|NCT01085617|Daunorubicin|daunorubicin|mesh-list
65399697|NCT01085617|Mercaptopurine|mercaptopurine|mesh-list
65399698|NCT01085617|Pegaspargase|pegaspargase|mesh-list
65399699|NCT01085617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65399700|NCT01085617|Immunologic Factors|immunologic factors|mesh-ancestor
65399701|NCT01085617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399702|NCT01085617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65399703|NCT01085617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65399732|NCT00499083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65399733|NCT00499083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65399734|NCT00499083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65399735|NCT00499083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399736|NCT00499083|Tubulin Modulators|tubulin modulators|mesh-ancestor
65399737|NCT00499083|Antimitotic Agents|antimitotic agents|mesh-ancestor
65399738|NCT00499083|Mitosis Modulators|mitosis modulators|mesh-ancestor
65399739|NCT00499083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399740|NCT00499083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65399741|NCT00499083|Immunologic Factors|immunologic factors|mesh-ancestor
65399742|NCT00499083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399743|NCT00499083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65399744|NCT00499083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65399745|NCT00499083|Alkylating Agents|alkylating agents|mesh-ancestor
65399746|NCT00499083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65399747|NCT00499083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65399748|NCT00499083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65399749|NCT00499083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65399750|NCT00499083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399751|NCT00499083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65399752|NCT00499083|Hormone Antagonists|hormone antagonists|mesh-ancestor
65399753|NCT00499083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65399754|NCT00499083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65399755|NCT00499083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65399756|NCT00499083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65399757|NCT00499083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65399758|NCT00499083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65399785|NCT01085695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399787|NCT01088035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399788|NCT01085851|Chlorpheniramine|chlorpheniramine|mesh-list
65399789|NCT01085851|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
65399790|NCT01085851|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65399791|NCT01085851|Histamine Antagonists|histamine antagonists|mesh-ancestor
65399792|NCT01085851|Histamine Agents|histamine agents|mesh-ancestor
65399793|NCT01085851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65399794|NCT01085851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399795|NCT01085851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399796|NCT01085851|Antipruritics|antipruritics|mesh-ancestor
65399797|NCT01085851|Dermatologic Agents|dermatologic agents|mesh-ancestor
65399798|NCT01085851|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65399799|NCT00751127|Timolol|timolol|mesh-list
65399800|NCT00751127|Latanoprost|latanoprost|mesh-list
65399801|NCT00751127|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65399802|NCT00751127|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65399803|NCT00751127|Adrenergic Agents|adrenergic agents|mesh-ancestor
65399804|NCT00751127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65399805|NCT00751127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399806|NCT00751127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399807|NCT00751127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65399808|NCT00751127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65399809|NCT00751127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65399810|NCT00751127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65399811|NCT00751205|Acetylcarnitine|acetylcarnitine|mesh-list
65399812|NCT00751205|Prednisone|prednisone|mesh-list
65399813|NCT00751205|Prednisolone|prednisolone|mesh-list
65399814|NCT00751205|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65399815|NCT00751205|Methylprednisolone|methylprednisolone|mesh-list
65399816|NCT00751205|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65399817|NCT00751205|Prednisolone acetate|prednisolone acetate|mesh-list
65399818|NCT00751205|Sagopilone|sagopilone|mesh-list
65399819|NCT00751205|Epothilones|epothilones|mesh-list
65399820|NCT00751205|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65399821|NCT00751205|Prednisolone phosphate|prednisolone phosphate|mesh-list
65399870|NCT00752375|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64785403|NCT00000138|Hormones|hormones|mesh-ancestor
64785457|NCT00000210|Sensory System Agents|sensory system agents|mesh-ancestor
64396656|NCT01946152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396657|NCT01946152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396658|NCT01946152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65399970|NCT01019655|Nadroparin|nadroparin|mesh-list
65399971|NCT01019655|Calcium|calcium|mesh-list
65399972|NCT01019655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65399973|NCT01019655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399974|NCT01019655|Anticoagulants|anticoagulants|mesh-ancestor
65399975|NCT01019655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65399976|NCT01019655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65399977|NCT01019655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399978|NCT00483717|Ketorolac|ketorolac|mesh-list
65399979|NCT00483717|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65399980|NCT00483717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65399981|NCT00483717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65399982|NCT00483717|Analgesics|analgesics|mesh-ancestor
65399983|NCT00483717|Sensory System Agents|sensory system agents|mesh-ancestor
65399984|NCT00483717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65399985|NCT00483717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399986|NCT00483717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65399987|NCT00483717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65399988|NCT00483717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65399989|NCT00483717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493984|NCT03897439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65399990|NCT00483717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399991|NCT00406354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65399992|NCT00406354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65399993|NCT00406354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65399994|NCT00406354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65399995|NCT00406354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399996|NCT00406354|Adrenergic Agents|adrenergic agents|mesh-ancestor
65399997|NCT00406354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64396659|NCT01946152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64396663|NCT01971346|Etanercept|etanercept|mesh-list
65400023|NCT00483327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65400024|NCT00684203|Aspirin|aspirin|mesh-list
65400025|NCT00684203|Clopidogrel|clopidogrel|mesh-list
65400026|NCT00684203|Vorapaxar|vorapaxar|mesh-list
65400027|NCT00684203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65400028|NCT00684203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65400029|NCT00684203|Analgesics|analgesics|mesh-ancestor
65400030|NCT00684203|Sensory System Agents|sensory system agents|mesh-ancestor
64785466|NCT00000222|Sensory System Agents|sensory system agents|mesh-ancestor
65400059|NCT00751829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65400060|NCT00751829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65400073|NCT00751907|Antimetabolites|antimetabolites|mesh-ancestor
65400074|NCT00751907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400075|NCT00751907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65400076|NCT00751907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65400077|NCT00751907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400078|NCT00752843|Mifepristone|mifepristone|mesh-list
65400079|NCT00752843|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65400080|NCT00752843|Abortifacient Agents|abortifacient agents|mesh-ancestor
65400081|NCT00752843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65400082|NCT00752843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400083|NCT00752843|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65400084|NCT00752843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65400085|NCT00752843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65400086|NCT00752843|Contraceptive Agents|contraceptive agents|mesh-ancestor
65400087|NCT00752843|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65400088|NCT00752843|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65400089|NCT00752843|Hormone Antagonists|hormone antagonists|mesh-ancestor
65400090|NCT00752843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65400091|NCT00752843|Luteolytic Agents|luteolytic agents|mesh-ancestor
65400092|NCT00752843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65400093|NCT00752843|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65400094|NCT00752921|Etoricoxib|etoricoxib|mesh-list
65400146|NCT00753389|Anesthetics|anesthetics|mesh-list
65400147|NCT00753389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64785521|NCT00000270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400245|NCT00496587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65400246|NCT00496587|Antimetabolites|antimetabolites|mesh-ancestor
64785563|NCT00000294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65400274|NCT00405652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65400275|NCT00405652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400276|NCT00405652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65400277|NCT00405652|Antitubercular Agents|antitubercular agents|mesh-ancestor
65225036|NCT04209699|BMS-986165|bms-986165|mesh-list
65400278|NCT00405652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65400279|NCT00405652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65400280|NCT00405652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400281|NCT00405652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400282|NCT01324180|Metformin|metformin|mesh-list
65400283|NCT01324180|Dexamethasone|dexamethasone|mesh-list
65400284|NCT01324180|Doxorubicin|doxorubicin|mesh-list
65400285|NCT01324180|Vincristine|vincristine|mesh-list
65400286|NCT01324180|Asparaginase|asparaginase|mesh-list
65400287|NCT01324180|Pegaspargase|pegaspargase|mesh-list
65400288|NCT01324180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65400289|NCT01324180|Antiemetics|antiemetics|mesh-ancestor
65400290|NCT01324180|Autonomic Agents|autonomic agents|mesh-ancestor
65400291|NCT01324180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400292|NCT01324180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400293|NCT01324180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65400294|NCT01324180|Glucocorticoids|glucocorticoids|mesh-ancestor
65400295|NCT01324180|Hormones|hormones|mesh-ancestor
65400296|NCT01324180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65400297|NCT01324180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65400298|NCT01324180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400299|NCT01324180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65400300|NCT01324180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65400301|NCT01324180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65400302|NCT01324180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65400303|NCT01324180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400304|NCT01324180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400305|NCT01324180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65400306|NCT01324180|Tubulin Modulators|tubulin modulators|mesh-ancestor
65400307|NCT01324180|Antimitotic Agents|antimitotic agents|mesh-ancestor
65400308|NCT01324180|Mitosis Modulators|mitosis modulators|mesh-ancestor
65400309|NCT02560649|Tenofovir|tenofovir|mesh-list
65400310|NCT02560649|Lamivudine|lamivudine|mesh-list
65400336|NCT02561039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65400337|NCT02561039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400339|NCT00422734|Vasodilator Agents|vasodilator agents|mesh-ancestor
65400340|NCT00422734|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65400341|NCT00422734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65400342|NCT00422734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400343|NCT00422734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400344|NCT00422734|Urological Agents|urological agents|mesh-ancestor
65400345|NCT00422422|Brivaracetam|brivaracetam|mesh-list
65400346|NCT00422422|Anticonvulsants|anticonvulsants|mesh-ancestor
65400347|NCT00413374|Enoxaparin|enoxaparin|mesh-list
65400348|NCT00413374|Anticoagulants|anticoagulants|mesh-ancestor
65400349|NCT00413374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65400350|NCT00413374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65400351|NCT00413374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400352|NCT00682643|Fluticasone|fluticasone|mesh-list
65400353|NCT00682643|Xhance|xhance|mesh-list
65400354|NCT00682643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65400355|NCT00682643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65400356|NCT00682643|Autonomic Agents|autonomic agents|mesh-ancestor
65400357|NCT00682643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400358|NCT00682643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400359|NCT00682643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65400360|NCT00682643|Respiratory System Agents|respiratory system agents|mesh-ancestor
65400361|NCT00682643|Dermatologic Agents|dermatologic agents|mesh-ancestor
65400362|NCT00682643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65400363|NCT00758381|Sorafenib|sorafenib|mesh-list
65400364|NCT00758381|Cisplatin|cisplatin|mesh-list
65400365|NCT00758381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400366|NCT00758381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65400367|NCT00758381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400368|NCT00758381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400369|NCT00754871|Dienogest|dienogest|mesh-list
65400370|NCT00754871|Nandrolone|nandrolone|mesh-list
65400371|NCT00754871|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65400372|NCT00754871|Contraceptive Agents|contraceptive agents|mesh-ancestor
65400397|NCT05435729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65400398|NCT05435729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400399|NCT05435729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400400|NCT01038388|Dexamethasone|dexamethasone|mesh-list
65400401|NCT01038388|Lenalidomide|lenalidomide|mesh-list
65400402|NCT01038388|Bortezomib|bortezomib|mesh-list
65400403|NCT01038388|Vorinostat|vorinostat|mesh-list
65400404|NCT01038388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65400405|NCT01038388|Antiemetics|antiemetics|mesh-ancestor
65400406|NCT01038388|Autonomic Agents|autonomic agents|mesh-ancestor
65400407|NCT01038388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400408|NCT01038388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400409|NCT01038388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65400410|NCT01038388|Glucocorticoids|glucocorticoids|mesh-ancestor
65400411|NCT01038388|Hormones|hormones|mesh-ancestor
65400412|NCT01038388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65400413|NCT01038388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65400414|NCT01038388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400415|NCT01038388|Immunologic Factors|immunologic factors|mesh-ancestor
65400416|NCT01038388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65400417|NCT01038388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65400418|NCT01038388|Growth Substances|growth substances|mesh-ancestor
65400419|NCT01038388|Growth Inhibitors|growth inhibitors|mesh-ancestor
65400420|NCT01038388|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65400421|NCT01038388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400422|NCT01038388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400423|NCT04050059|Lidocaine|lidocaine|mesh-list
65400424|NCT04050059|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65400425|NCT04050059|Anesthetics, Local|anesthetics, local|mesh-ancestor
65400426|NCT04050059|Anesthetics|anesthetics|mesh-ancestor
65400427|NCT04050059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65400428|NCT04050059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400429|NCT04050059|Sensory System Agents|sensory system agents|mesh-ancestor
65400430|NCT04050059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400431|NCT04050059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64396822|NCT00834119|Mometasone Furoate|mometasone furoate|mesh-list
64396823|NCT00834119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65400444|NCT00482001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65400445|NCT00482001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400446|NCT00482001|Nootropic Agents|nootropic agents|mesh-ancestor
65400447|NCT00490035|Brivaracetam|brivaracetam|mesh-list
65400448|NCT00490035|Anticonvulsants|anticonvulsants|mesh-ancestor
65400449|NCT00421174|Methylprednisolone|methylprednisolone|mesh-list
65400450|NCT00421174|Etanercept|etanercept|mesh-list
65400451|NCT00421174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65400452|NCT00421174|Antiemetics|antiemetics|mesh-ancestor
65400453|NCT00421174|Autonomic Agents|autonomic agents|mesh-ancestor
65400454|NCT00421174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400455|NCT00421174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400456|NCT00421174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65400457|NCT00421174|Glucocorticoids|glucocorticoids|mesh-ancestor
65400458|NCT00421174|Hormones|hormones|mesh-ancestor
65400459|NCT00421174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65400460|NCT00421174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65400461|NCT00421174|Protective Agents|protective agents|mesh-ancestor
65400462|NCT00421174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65400463|NCT00421174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65400464|NCT00421174|Analgesics|analgesics|mesh-ancestor
65400465|NCT00421174|Sensory System Agents|sensory system agents|mesh-ancestor
64396831|NCT02643251|Clonidine|clonidine|mesh-list
65400469|NCT00496197|Fluconazole|fluconazole|mesh-list
65400470|NCT00496197|Voriconazole|voriconazole|mesh-list
65400471|NCT00496197|Anidulafungin|anidulafungin|mesh-list
65400472|NCT00496197|Antifungal Agents|antifungal agents|mesh-ancestor
65400473|NCT00496197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65400474|NCT00496197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65400475|NCT00496197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65400476|NCT00496197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400477|NCT00496197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400478|NCT00496197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65400479|NCT00496197|Hormone Antagonists|hormone antagonists|mesh-ancestor
65400480|NCT00496197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65400481|NCT00496197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400482|NCT00496197|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65400483|NCT00496197|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65400484|NCT00496197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65400485|NCT03996993|Bicalutamide|bicalutamide|mesh-list
65400486|NCT03996993|Androgen Antagonists|androgen antagonists|mesh-ancestor
65400487|NCT03996993|Hormone Antagonists|hormone antagonists|mesh-ancestor
65400488|NCT03996993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65400489|NCT03996993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400490|NCT03996993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400491|NCT01015053|Ropivacaine|ropivacaine|mesh-list
65400492|NCT01015053|Anesthetics, Local|anesthetics, local|mesh-ancestor
65400493|NCT01015053|Anesthetics|anesthetics|mesh-ancestor
65400494|NCT01015053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65400495|NCT01015053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400496|NCT01015053|Sensory System Agents|sensory system agents|mesh-ancestor
65400497|NCT01015053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400498|NCT00404092|Caspofungin|caspofungin|mesh-list
65400499|NCT00404092|Antifungal Agents|antifungal agents|mesh-ancestor
65400500|NCT00404092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65400501|NCT00404092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400502|NCT00404092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400503|NCT00481767|Vaccines|vaccines|mesh-list
64396850|NCT02375191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400505|NCT00481767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400506|NCT00489489|Interferons|interferons|mesh-list
65400507|NCT00489489|Interferon-beta|interferon-beta|mesh-list
65400508|NCT00489489|Teriflunomide|teriflunomide|mesh-list
65400509|NCT00489489|Interferon beta-1b|interferon beta-1b|mesh-list
65400510|NCT00489489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400511|NCT00489489|Antiviral Agents|antiviral agents|mesh-ancestor
65400512|NCT00489489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65400513|NCT00489489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65400514|NCT00489489|Immunologic Factors|immunologic factors|mesh-ancestor
65400515|NCT00489489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400516|NCT00489489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65400517|NCT00489489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65400518|NCT00489489|Analgesics|analgesics|mesh-ancestor
65400519|NCT00489489|Sensory System Agents|sensory system agents|mesh-ancestor
65400520|NCT00489489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400521|NCT00489489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65400522|NCT00489489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65400523|NCT00489489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65400524|NCT00489411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65400525|NCT00489411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65400526|NCT00489411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65400527|NCT00489411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65400528|NCT00489411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400529|NCT00489411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65400530|NCT00489411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400531|NCT00489411|Analgesics|analgesics|mesh-ancestor
65400532|NCT00489411|Sensory System Agents|sensory system agents|mesh-ancestor
65400533|NCT00489411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400534|NCT00489411|Antidepressive Agents|antidepressive agents|mesh-ancestor
65400535|NCT00489411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65400536|NCT00489411|Dopamine Agents|dopamine agents|mesh-ancestor
65400537|NCT00420784|Interferons|interferons|mesh-list
65400538|NCT00420784|Ribavirin|ribavirin|mesh-list
65400539|NCT00420784|Interferon-alpha|interferon-alpha|mesh-list
65400540|NCT00420784|Interferon alpha-2|interferon alpha-2|mesh-list
65400541|NCT00420784|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65400542|NCT00420784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400543|NCT00420784|Antiviral Agents|antiviral agents|mesh-ancestor
65400549|NCT00420628|Loteprednol Etabonate|loteprednol etabonate|mesh-list
65400550|NCT00420628|Tobramycin|tobramycin|mesh-list
65400551|NCT00420628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65400552|NCT00420628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65400553|NCT00420628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65400554|NCT00413218|Voriconazole|voriconazole|mesh-list
65400555|NCT00413218|Caspofungin|caspofungin|mesh-list
65400556|NCT00413218|Isavuconazole|isavuconazole|mesh-list
65400557|NCT00413218|Antifungal Agents|antifungal agents|mesh-ancestor
65400558|NCT00413218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65400559|NCT00413218|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65400560|NCT00413218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65400561|NCT00413218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400562|NCT00413218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400563|NCT00413218|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65400564|NCT00413218|Hormone Antagonists|hormone antagonists|mesh-ancestor
65400565|NCT00413218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65400566|NCT00413218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400567|NCT00413218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65400568|NCT00494871|Warfarin|warfarin|mesh-list
65400569|NCT00494871|Rivaroxaban|rivaroxaban|mesh-list
65400570|NCT00494871|Anticoagulants|anticoagulants|mesh-ancestor
65400571|NCT00494871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65400572|NCT00494871|Antithrombins|antithrombins|mesh-ancestor
65400573|NCT00494871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65400574|NCT00494871|Protease Inhibitors|protease inhibitors|mesh-ancestor
65400575|NCT00494871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400576|NCT00494871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400577|NCT00420238|Etanercept|etanercept|mesh-list
65400582|NCT00420238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400583|NCT00420238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400584|NCT00420238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65400585|NCT00420238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65400586|NCT00420238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65400587|NCT00420238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65400588|NCT00420238|Immunologic Factors|immunologic factors|mesh-ancestor
65400589|NCT04081545|Analgesics, Opioid|analgesics, opioid|mesh-list
65400591|NCT04081545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
65400592|NCT04081545|Anesthetics|anesthetics|mesh-list
65400593|NCT04081545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65400594|NCT04081545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400595|NCT04081545|Narcotics|narcotics|mesh-ancestor
65400596|NCT04081545|Sensory System Agents|sensory system agents|mesh-ancestor
65400597|NCT04081545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400598|NCT00420004|Citalopram|citalopram|mesh-list
65400599|NCT00420004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65400600|NCT00420004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65400601|NCT00420004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65400602|NCT00420004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400603|NCT00420004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65400604|NCT00420004|Serotonin Agents|serotonin agents|mesh-ancestor
65400605|NCT00420004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400606|NCT00420004|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65400607|NCT00420004|Antidepressive Agents|antidepressive agents|mesh-ancestor
65400608|NCT00420004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65400609|NCT00494481|Docetaxel|docetaxel|mesh-list
65400610|NCT00494481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400611|NCT00494481|Tubulin Modulators|tubulin modulators|mesh-ancestor
65400612|NCT00494481|Antimitotic Agents|antimitotic agents|mesh-ancestor
65400613|NCT00494481|Mitosis Modulators|mitosis modulators|mesh-ancestor
65400614|NCT00494481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400615|NCT00097591|Clopidogrel|clopidogrel|mesh-list
64396864|NCT02375191|Narcotics|narcotics|mesh-ancestor
65400619|NCT00097591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65400620|NCT00097591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65400621|NCT00097591|Purinergic Agents|purinergic agents|mesh-ancestor
65400622|NCT00097591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65400623|NCT00097591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400624|NCT00097591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400625|NCT01082029|Lansoprazole|lansoprazole|mesh-list
65400626|NCT01082029|Dexlansoprazole|dexlansoprazole|mesh-list
65400627|NCT01082029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65400628|NCT01082029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65400629|NCT01082029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65400630|NCT01082029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400631|NCT01082029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400632|NCT00419926|Cyclosporine|cyclosporine|mesh-list
65400633|NCT00419926|Mycophenolic Acid|mycophenolic acid|mesh-list
65400634|NCT00419926|Prednisone|prednisone|mesh-list
65400635|NCT00419926|Cyclosporins|cyclosporins|mesh-list
65400636|NCT00419926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65400637|NCT00419926|Glucocorticoids|glucocorticoids|mesh-ancestor
65400638|NCT00419926|Hormones|hormones|mesh-ancestor
65400639|NCT00419926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65400640|NCT00419926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400641|NCT00419926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65400642|NCT00419926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400643|NCT00419926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400644|NCT00419926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400645|NCT00419926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65400646|NCT00419926|Immunologic Factors|immunologic factors|mesh-ancestor
65400647|NCT00419926|Antifungal Agents|antifungal agents|mesh-ancestor
65400648|NCT00419926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65400649|NCT00419926|Dermatologic Agents|dermatologic agents|mesh-ancestor
65400650|NCT00419926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65400651|NCT00419926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65400680|NCT00080119|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65400682|NCT00080119|Antimalarials|antimalarials|mesh-ancestor
65400683|NCT00080119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65400684|NCT00080119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65400685|NCT00080119|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65400686|NCT00080119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400687|NCT00080119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65400688|NCT00080119|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65400689|NCT00080119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65400690|NCT02294032|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65400691|NCT02294032|Immunologic Factors|immunologic factors|mesh-ancestor
65400692|NCT02294032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400693|NCT01034878|Sunitinib|sunitinib|mesh-list
65400694|NCT01034878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400695|NCT01034878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64785687|NCT00000444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65400716|NCT01082263|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65400717|NCT01082263|Serotonin Agents|serotonin agents|mesh-ancestor
65400718|NCT01082263|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65400719|NCT01082263|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65400720|NCT01082263|Dopamine Agents|dopamine agents|mesh-ancestor
65400721|NCT02208544|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65400722|NCT02208544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65400723|NCT02208544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400724|NCT00494091|Sirolimus|sirolimus|mesh-list
65400725|NCT00494091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65400726|NCT00494091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65400727|NCT00494091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65400742|NCT00494013|Heparin Antagonists|heparin antagonists|mesh-ancestor
65400743|NCT00494013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400745|NCT00079339|Tipifarnib|tipifarnib|mesh-list
65400746|NCT00079339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400747|NCT01088191|Hyaluronic Acid|hyaluronic acid|mesh-list
65400748|NCT01088191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65400749|NCT01088191|Immunologic Factors|immunologic factors|mesh-ancestor
65400750|NCT01088191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400751|NCT01088191|Viscosupplements|viscosupplements|mesh-ancestor
65400752|NCT01088191|Protective Agents|protective agents|mesh-ancestor
65400753|NCT01082341|Vaccines|vaccines|mesh-list
65400754|NCT01082341|Immunologic Factors|immunologic factors|mesh-ancestor
65400755|NCT01082341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400756|NCT00541866|Cytarabine|cytarabine|mesh-list
65400757|NCT00541866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65400758|NCT00541866|Antimetabolites|antimetabolites|mesh-ancestor
64396900|NCT00794495|Histamine Antagonists|histamine antagonists|mesh-ancestor
65400765|NCT00541866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400766|NCT00493467|Rituximab|rituximab|mesh-list
65400767|NCT00493467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65400768|NCT00493467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400769|NCT00493467|Immunologic Factors|immunologic factors|mesh-ancestor
65400770|NCT00493467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400771|NCT00493467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65400772|NCT01088347|Mapatumumab|mapatumumab|mesh-list
65400773|NCT01088347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400774|NCT05257824|Aspirin|aspirin|mesh-list
65400775|NCT05257824|Clopidogrel|clopidogrel|mesh-list
65400776|NCT05257824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65400777|NCT05257824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65400778|NCT05257824|Analgesics|analgesics|mesh-ancestor
65400779|NCT05257824|Sensory System Agents|sensory system agents|mesh-ancestor
65400780|NCT05257824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400781|NCT05257824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400782|NCT05257824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65400783|NCT05257824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65400784|NCT05257824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65400785|NCT05257824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65400786|NCT05257824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400787|NCT05257824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65400788|NCT05257824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65400789|NCT05257824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400790|NCT05257824|Antipyretics|antipyretics|mesh-ancestor
65400791|NCT05257824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65400792|NCT05257824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65400793|NCT05257824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65400794|NCT05257824|Purinergic Agents|purinergic agents|mesh-ancestor
65400795|NCT05257824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65225410|NCT00627653|Fenofibrate|fenofibrate|mesh-list
65225411|NCT00627653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65225412|NCT00627653|Antimetabolites|antimetabolites|mesh-ancestor
65225413|NCT00627653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225414|NCT00627653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65225415|NCT02347917|Pemetrexed|pemetrexed|mesh-list
65400796|NCT04221828|Paclitaxel|paclitaxel|mesh-list
65400797|NCT04221828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65400798|NCT04221828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64396906|NCT00794495|Cholinergic Agents|cholinergic agents|mesh-ancestor
64396907|NCT04157075|Bupivacaine|bupivacaine|mesh-list
65400807|NCT04221438|Alovudine|alovudine|mesh-list
65400808|NCT04221438|Antiviral Agents|antiviral agents|mesh-ancestor
65400810|NCT04198428|Analgesics, Opioid|analgesics, opioid|mesh-list
65400811|NCT04198428|Narcotics|narcotics|mesh-ancestor
65400812|NCT04198428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65400813|NCT04198428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400814|NCT04198428|Analgesics|analgesics|mesh-ancestor
65400815|NCT04198428|Sensory System Agents|sensory system agents|mesh-ancestor
65400816|NCT04198428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400817|NCT04113018|Dexamethasone|dexamethasone|mesh-list
65400818|NCT04113018|Lenalidomide|lenalidomide|mesh-list
65400819|NCT04113018|Daratumumab|daratumumab|mesh-list
65400820|NCT04113018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65400821|NCT04113018|Antiemetics|antiemetics|mesh-ancestor
65400822|NCT04113018|Autonomic Agents|autonomic agents|mesh-ancestor
65400823|NCT04113018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400824|NCT04113018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400825|NCT04113018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65400826|NCT04113018|Glucocorticoids|glucocorticoids|mesh-ancestor
65400827|NCT04113018|Hormones|hormones|mesh-ancestor
65400828|NCT04113018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65400829|NCT04113018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65400830|NCT04113018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400831|NCT04113018|Immunologic Factors|immunologic factors|mesh-ancestor
65400832|NCT04113018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65400833|NCT04113018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65400834|NCT04113018|Growth Substances|growth substances|mesh-ancestor
65400835|NCT04113018|Growth Inhibitors|growth inhibitors|mesh-ancestor
65400836|NCT00481065|MF59 oil emulsion|mf59 oil emulsion|mesh-list
65400869|NCT00571649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400870|NCT00571649|Anticoagulants|anticoagulants|mesh-ancestor
65400871|NCT00571649|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65400872|NCT00571649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65400873|NCT00546572|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65400874|NCT00546572|Immunologic Factors|immunologic factors|mesh-ancestor
65400875|NCT00546572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400876|NCT03917472|Aflibercept|aflibercept|mesh-list
65400877|NCT03917472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65400878|NCT03917472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65400879|NCT03917472|Growth Substances|growth substances|mesh-ancestor
65400880|NCT03917472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400881|NCT03917472|Growth Inhibitors|growth inhibitors|mesh-ancestor
65400882|NCT03917472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400883|NCT00681863|Pramipexole|pramipexole|mesh-list
65400884|NCT00681863|Antioxidants|antioxidants|mesh-ancestor
65400885|NCT00681863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400887|NCT00681863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400888|NCT00681863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65400889|NCT00681863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65400890|NCT00681863|Dopamine Agonists|dopamine agonists|mesh-ancestor
65400891|NCT00681863|Dopamine Agents|dopamine agents|mesh-ancestor
65400892|NCT00681863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65400893|NCT02559791|Reslizumab|reslizumab|mesh-list
65400894|NCT02559791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65400895|NCT02559791|Respiratory System Agents|respiratory system agents|mesh-ancestor
65400896|NCT05677620|Propofol|propofol|mesh-list
65400897|NCT05677620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65400898|NCT05677620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65400950|NCT00969566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65400951|NCT00969566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65400952|NCT00969566|Protease Inhibitors|protease inhibitors|mesh-ancestor
65400953|NCT00969566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400954|NCT00969566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400956|NCT00755495|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65400957|NCT00755495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65400958|NCT00755495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65400959|NCT00755495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400960|NCT00755495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65400961|NCT00755495|Antidepressive Agents|antidepressive agents|mesh-ancestor
65400962|NCT00755495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65400963|NCT00755495|Histamine Antagonists|histamine antagonists|mesh-ancestor
65400964|NCT00755495|Histamine Agents|histamine agents|mesh-ancestor
65400965|NCT00755495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65400966|NCT00755495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400967|NCT00964184|Metformin|metformin|mesh-list
65400968|NCT00964184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65400969|NCT00964184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400970|NCT00969800|Chlorine dioxide|chlorine dioxide|mesh-list
65400971|NCT00969800|Dental Disinfectants|dental disinfectants|mesh-ancestor
65400972|NCT00969800|Disinfectants|disinfectants|mesh-ancestor
65400973|NCT00969800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65400974|NCT00964262|Exenatide|exenatide|mesh-list
64785787|NCT00000714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65401560|NCT02897076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65401561|NCT02897076|Glucocorticoids|glucocorticoids|mesh-ancestor
65401562|NCT02897076|Hormones|hormones|mesh-ancestor
65493986|NCT03897439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65401563|NCT02897076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65401564|NCT02897076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401565|NCT02897076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65401566|NCT02897076|Respiratory System Agents|respiratory system agents|mesh-ancestor
65401568|NCT02797548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65401569|NCT02797548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65401570|NCT02797548|Analgesics|analgesics|mesh-ancestor
65401571|NCT02797548|Sensory System Agents|sensory system agents|mesh-ancestor
65401572|NCT02797548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65401573|NCT02797548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401574|NCT02797548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65401575|NCT02797548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65401576|NCT02797548|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65401577|NCT02797548|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65401578|NCT02797548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401579|NCT02797548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65401580|NCT02797548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65401602|NCT00538590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401603|NCT00990834|Simvastatin|simvastatin|mesh-list
65401604|NCT00990834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65401605|NCT00990834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65401606|NCT00990834|Antimetabolites|antimetabolites|mesh-ancestor
65401607|NCT00990834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401608|NCT00990834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65401609|NCT00990834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65401610|NCT00990834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401611|NCT00990990|Linezolid|linezolid|mesh-list
65401612|NCT00990990|Oxazolidinones|oxazolidinones|mesh-list
65401613|NCT00990990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65401614|NCT00990990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65401615|NCT00990990|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65401616|NCT00990990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401617|NCT00990990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401618|NCT05589402|Lidocaine|lidocaine|mesh-list
65401619|NCT05589402|Anesthetics, Local|anesthetics, local|mesh-ancestor
65401620|NCT05589402|Anesthetics|anesthetics|mesh-ancestor
65401621|NCT05589402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65401622|NCT05589402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401623|NCT05589402|Sensory System Agents|sensory system agents|mesh-ancestor
65401624|NCT05589402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65401625|NCT05589402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65401626|NCT05589402|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65401627|NCT05589402|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65401628|NCT05589402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65401629|NCT05589402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401630|NCT00466947|Vaccines|vaccines|mesh-list
65401631|NCT00466947|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65401632|NCT00466947|Immunologic Factors|immunologic factors|mesh-ancestor
65401633|NCT00466947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401655|NCT00848328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65401656|NCT00848328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401657|NCT00848328|Immunologic Factors|immunologic factors|mesh-ancestor
65401658|NCT00848328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401659|NCT00848328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65401660|NCT00848328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65401661|NCT00848328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65401662|NCT00848328|Growth Substances|growth substances|mesh-ancestor
65401663|NCT00848328|Growth Inhibitors|growth inhibitors|mesh-ancestor
65401664|NCT05408988|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65401665|NCT05408988|Natriuretic Agents|natriuretic agents|mesh-ancestor
65401666|NCT05408988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401667|NCT00989352|Rituximab|rituximab|mesh-list
65401668|NCT00989352|Methotrexate|methotrexate|mesh-list
65401669|NCT00989352|Lomustine|lomustine|mesh-list
65401670|NCT00989352|Procarbazine|procarbazine|mesh-list
65401671|NCT00989352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65401672|NCT00989352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401673|NCT00989352|Immunologic Factors|immunologic factors|mesh-ancestor
65401674|NCT00989352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401675|NCT00989352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65401676|NCT00989352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65401677|NCT00989352|Abortifacient Agents|abortifacient agents|mesh-ancestor
65401678|NCT00989352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65401679|NCT00989352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65401680|NCT00989352|Antimetabolites|antimetabolites|mesh-ancestor
65401681|NCT00989352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401682|NCT00989352|Dermatologic Agents|dermatologic agents|mesh-ancestor
65401683|NCT00989352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401684|NCT00989352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65401685|NCT00989352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65401686|NCT00989352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65401687|NCT00989352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65401688|NCT00989352|Alkylating Agents|alkylating agents|mesh-ancestor
65401705|NCT00989508|Vasodilator Agents|vasodilator agents|mesh-ancestor
65401706|NCT05360394|Paclitaxel|paclitaxel|mesh-list
65401707|NCT05360394|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65401708|NCT05360394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65401709|NCT05360394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401710|NCT05360394|Tubulin Modulators|tubulin modulators|mesh-ancestor
65401711|NCT05360394|Antimitotic Agents|antimitotic agents|mesh-ancestor
65401712|NCT05360394|Mitosis Modulators|mitosis modulators|mesh-ancestor
65401713|NCT05360394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401715|NCT00090259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65401716|NCT00090259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65401717|NCT00090259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65401718|NCT00090259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65401719|NCT00090259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401720|NCT00079183|Sirolimus|sirolimus|mesh-list
65401721|NCT00079183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65401722|NCT00079183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65401723|NCT00079183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65401724|NCT00079183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401725|NCT00079183|Antifungal Agents|antifungal agents|mesh-ancestor
65401726|NCT00079183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65401727|NCT00079183|Immunologic Factors|immunologic factors|mesh-ancestor
65401728|NCT00079183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401729|NCT01086085|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65401730|NCT01086085|Interferon-alpha|interferon-alpha|mesh-list
65401731|NCT01086085|Adefovir|adefovir|mesh-list
65401732|NCT01086085|Antiviral Agents|antiviral agents|mesh-ancestor
65401733|NCT01086085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65401734|NCT01086085|Immunologic Factors|immunologic factors|mesh-ancestor
65401735|NCT01086085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401736|NCT01086085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65401737|NCT01086085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65401738|NCT01086085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401739|NCT01086085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401740|NCT01589419|Capecitabine|capecitabine|mesh-list
65269864|NCT02727608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65401741|NCT01589419|Veliparib|veliparib|mesh-list
65401742|NCT01589419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65401743|NCT01589419|Antimetabolites|antimetabolites|mesh-ancestor
65401744|NCT01589419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401745|NCT01589419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401755|NCT00676403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65401756|NCT00676403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401757|NCT00676403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65401758|NCT00676403|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65401759|NCT00676403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65401760|NCT00676403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65401761|NCT00676403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65401762|NCT00078949|Gemcitabine|gemcitabine|mesh-list
65401764|NCT00078949|Dexamethasone|dexamethasone|mesh-list
65401765|NCT00078949|Rituximab|rituximab|mesh-list
65401766|NCT00078949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65401767|NCT00078949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401768|NCT00078949|Immunologic Factors|immunologic factors|mesh-ancestor
65401769|NCT00078949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401770|NCT00078949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65401771|NCT00078949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65401772|NCT00078949|Antiemetics|antiemetics|mesh-ancestor
65401773|NCT00078949|Autonomic Agents|autonomic agents|mesh-ancestor
65401774|NCT00078949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65401775|NCT00078949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65401776|NCT00078949|Glucocorticoids|glucocorticoids|mesh-ancestor
65401777|NCT00078949|Hormones|hormones|mesh-ancestor
65401778|NCT00078949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65401779|NCT00078949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65401780|NCT00078949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65401781|NCT00078949|Antimetabolites|antimetabolites|mesh-ancestor
65401782|NCT00078949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401783|NCT00078949|Antiviral Agents|antiviral agents|mesh-ancestor
65151352|NCT01294553|Metformin|metformin|mesh-list
65401784|NCT00078949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65401785|NCT00078949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401786|NCT00078949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65401787|NCT00078325|Modafinil|modafinil|mesh-list
65401788|NCT00078325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65401789|NCT00078325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401790|NCT00078325|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65401791|NCT00078325|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65401792|NCT00078325|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65401793|NCT00078325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401794|NCT03963193|Cisplatin|cisplatin|mesh-list
65401795|NCT03963193|Irinotecan|irinotecan|mesh-list
65401796|NCT03963193|Etoposide|etoposide|mesh-list
65401797|NCT03963193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401798|NCT03963193|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65401799|NCT03963193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65401800|NCT03963193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401801|NCT03963193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401802|NCT03963193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65401803|NCT03963193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65401804|NCT03961867|Docetaxel|docetaxel|mesh-list
65401805|NCT03961867|Oxaliplatin|oxaliplatin|mesh-list
65401806|NCT03961867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401807|NCT03961867|Tubulin Modulators|tubulin modulators|mesh-ancestor
65401808|NCT03961867|Antimitotic Agents|antimitotic agents|mesh-ancestor
65401809|NCT03961867|Mitosis Modulators|mitosis modulators|mesh-ancestor
64786553|NCT00002154|Thioctic Acid|thioctic acid|mesh-list
65401825|NCT00545402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401826|NCT00545402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65401827|NCT00545402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401828|NCT00545402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401829|NCT00545402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65401830|NCT00545402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401831|NCT00545402|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65401832|NCT00545402|Antitubercular Agents|antitubercular agents|mesh-ancestor
65401833|NCT00545402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65401834|NCT00545402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65401835|NCT00545402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65269865|NCT02727608|Immunologic Factors|immunologic factors|mesh-ancestor
65401836|NCT00545402|Glucocorticoids|glucocorticoids|mesh-ancestor
65401837|NCT00545402|Hormones|hormones|mesh-ancestor
65401838|NCT00545402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65401839|NCT00545402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65401840|NCT00545402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65401841|NCT00545402|Protective Agents|protective agents|mesh-ancestor
65401842|NCT03963115|Epinephrine|epinephrine|mesh-list
65401843|NCT03963115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65401844|NCT03963115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65401845|NCT03963115|Adrenergic Agents|adrenergic agents|mesh-ancestor
65401846|NCT03963115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65401847|NCT03963115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401848|NCT03963115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401849|NCT03963115|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65401850|NCT03963115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65401851|NCT03963115|Autonomic Agents|autonomic agents|mesh-ancestor
65401852|NCT03963115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65401853|NCT03963115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65401854|NCT03963115|Respiratory System Agents|respiratory system agents|mesh-ancestor
65401855|NCT03963115|Mydriatics|mydriatics|mesh-ancestor
65401856|NCT03963115|Sympathomimetics|sympathomimetics|mesh-ancestor
65401857|NCT03963115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65401858|NCT01583023|Bupropion|bupropion|mesh-list
65401859|NCT01583023|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65401860|NCT01583023|Antidepressive Agents|antidepressive agents|mesh-ancestor
65401861|NCT01583023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65401862|NCT01583023|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65401863|NCT01583023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65401864|NCT01583023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65401865|NCT01583023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401866|NCT01583023|Dopamine Agents|dopamine agents|mesh-ancestor
65401867|NCT01583023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64786630|NCT00002190|Lamivudine|lamivudine|mesh-list
65401880|NCT00976976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65401881|NCT00976976|Antimetabolites|antimetabolites|mesh-ancestor
65401882|NCT00977054|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65401883|NCT00977054|Interferon-alpha|interferon-alpha|mesh-list
65401884|NCT00977054|Ribavirin|ribavirin|mesh-list
65401885|NCT00977054|Interferon alpha-2|interferon alpha-2|mesh-list
65401886|NCT00977054|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65401887|NCT00977054|Antiviral Agents|antiviral agents|mesh-ancestor
65401888|NCT00977054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65401889|NCT00977054|Immunologic Factors|immunologic factors|mesh-ancestor
65401890|NCT00977054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401891|NCT00977054|Antimetabolites|antimetabolites|mesh-ancestor
65401892|NCT00977054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401893|NCT00977054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401894|NCT00977132|Lenalidomide|lenalidomide|mesh-list
65401895|NCT00977132|Immunologic Factors|immunologic factors|mesh-ancestor
65401896|NCT00977132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401897|NCT00977132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65401898|NCT00977132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65401899|NCT00977132|Growth Substances|growth substances|mesh-ancestor
65401900|NCT00977132|Growth Inhibitors|growth inhibitors|mesh-ancestor
65401901|NCT00977132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401902|NCT00545792|Bevacizumab|bevacizumab|mesh-list
65401903|NCT00545792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65401904|NCT00545792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401905|NCT00545792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65401906|NCT00545792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65401907|NCT00545792|Growth Substances|growth substances|mesh-ancestor
65401908|NCT00545792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401909|NCT00545792|Growth Inhibitors|growth inhibitors|mesh-ancestor
65401910|NCT00977288|Atorvastatin|atorvastatin|mesh-list
65401911|NCT00977288|Anacetrapib|anacetrapib|mesh-list
65401912|NCT00977288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65401913|NCT00977288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65401914|NCT00977288|Antimetabolites|antimetabolites|mesh-ancestor
65401915|NCT00977288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401916|NCT00977288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65401917|NCT00977288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65401918|NCT00977288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401919|NCT00966602|Ivacaftor|ivacaftor|mesh-list
65401920|NCT00966602|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65401921|NCT00966602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65401922|NCT00966602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401923|NCT00966680|Anesthetics|anesthetics|mesh-list
65401924|NCT00966680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65401925|NCT00966680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401926|NCT00977444|Prednisolone|prednisolone|mesh-list
65401927|NCT00977444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65401928|NCT00977444|Methylprednisolone|methylprednisolone|mesh-list
65401929|NCT00977444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65401930|NCT00977444|Prednisolone acetate|prednisolone acetate|mesh-list
65401934|NCT00977444|Glucocorticoids|glucocorticoids|mesh-ancestor
65401935|NCT00977444|Hormones|hormones|mesh-ancestor
65401936|NCT00977444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65401937|NCT00977444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401938|NCT00977444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65401939|NCT00977444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401940|NCT00977444|Antiemetics|antiemetics|mesh-ancestor
65401941|NCT00977444|Autonomic Agents|autonomic agents|mesh-ancestor
65401942|NCT00977444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65401943|NCT00977444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65401944|NCT00977444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65401945|NCT00977444|Protective Agents|protective agents|mesh-ancestor
65401946|NCT00977600|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
65401947|NCT00977600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401948|NCT00966836|Mycophenolic Acid|mycophenolic acid|mesh-list
65401949|NCT00966836|Valganciclovir|valganciclovir|mesh-list
65401950|NCT00966836|Everolimus|everolimus|mesh-list
65401951|NCT00966836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401952|NCT00966836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65401953|NCT00966836|Immunologic Factors|immunologic factors|mesh-ancestor
65401954|NCT00966836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401955|NCT00966836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65401956|NCT00966836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65401957|NCT00966836|Antitubercular Agents|antitubercular agents|mesh-ancestor
65401958|NCT00966836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65401959|NCT00966836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65401960|NCT00966836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401961|NCT00966836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401962|NCT00966836|Antiviral Agents|antiviral agents|mesh-ancestor
65401963|NCT00967070|Nicotine|nicotine|mesh-list
65401964|NCT00967070|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65401965|NCT00967070|Autonomic Agents|autonomic agents|mesh-ancestor
65401966|NCT00967070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65401967|NCT00967070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401968|NCT00967070|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65401969|NCT00967070|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65401970|NCT00967070|Cholinergic Agents|cholinergic agents|mesh-ancestor
65401971|NCT00967070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65401972|NCT00967070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401973|NCT00977756|Ritonavir|ritonavir|mesh-list
65401974|NCT00977756|Lopinavir|lopinavir|mesh-list
65401975|NCT00977756|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65401976|NCT00977756|Darunavir|darunavir|mesh-list
65401977|NCT00977756|Tenofovir|tenofovir|mesh-list
65401978|NCT00977756|Raltegravir Potassium|raltegravir potassium|mesh-list
65401979|NCT00977756|Maraviroc|maraviroc|mesh-list
65401980|NCT00977756|Etravirine|etravirine|mesh-list
65401981|NCT00977756|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65401982|NCT00977756|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65401983|NCT00977756|Protease Inhibitors|protease inhibitors|mesh-ancestor
65401984|NCT00977756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401985|NCT00977756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401986|NCT00977756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65401987|NCT00977756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65401988|NCT00977756|Antiviral Agents|antiviral agents|mesh-ancestor
65401989|NCT00977756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65401990|NCT00977756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65401991|NCT00977756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65401992|NCT00977756|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65401993|NCT00977756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65401994|NCT00977756|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65401995|NCT00977756|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65401996|NCT00977756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65401997|NCT00977756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65401998|NCT00977756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65269866|NCT02727608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401999|NCT00967148|Tinzaparin|tinzaparin|mesh-list
65402000|NCT00967148|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65402001|NCT00967148|Dalteparin|dalteparin|mesh-list
65402002|NCT00967148|Anticoagulants|anticoagulants|mesh-ancestor
65402003|NCT00967148|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64786738|NCT00002256|Antimetabolites|antimetabolites|mesh-ancestor
65402022|NCT00981968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402023|NCT00982046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65402024|NCT00967382|Dalteparin|dalteparin|mesh-list
65402025|NCT00967382|Tinzaparin|tinzaparin|mesh-list
65402026|NCT00967382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65402027|NCT00967382|Anticoagulants|anticoagulants|mesh-ancestor
65402028|NCT00967382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65402029|NCT00967382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65402030|NCT00967382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402031|NCT00982124|Zoledronic Acid|zoledronic acid|mesh-list
65402032|NCT00982124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65402033|NCT00982124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402034|NCT00982202|Pioglitazone|pioglitazone|mesh-list
65402035|NCT00982202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65402036|NCT00982202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402037|NCT00967538|Etanercept|etanercept|mesh-list
65402038|NCT00967538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65402039|NCT00967538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65402040|NCT00967538|Analgesics|analgesics|mesh-ancestor
65402041|NCT00967538|Sensory System Agents|sensory system agents|mesh-ancestor
65402042|NCT00967538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65402043|NCT00967538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402044|NCT00967538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65402045|NCT00967538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65402046|NCT00967538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65402047|NCT00967538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65402048|NCT00967538|Immunologic Factors|immunologic factors|mesh-ancestor
65402049|NCT00982358|Valsartan|valsartan|mesh-list
65402050|NCT00982358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65402051|NCT00982358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65402052|NCT00982358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65402053|NCT00982358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402054|NCT00982436|Carboplatin|carboplatin|mesh-list
65402055|NCT00982436|Docetaxel|docetaxel|mesh-list
65402056|NCT00982436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402057|NCT00982436|Tubulin Modulators|tubulin modulators|mesh-ancestor
65402058|NCT00982436|Antimitotic Agents|antimitotic agents|mesh-ancestor
64786811|NCT00002322|Zidovudine|zidovudine|mesh-list
65402067|NCT00984932|Antimetabolites|antimetabolites|mesh-ancestor
65402068|NCT00984932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402069|NCT00984932|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65402070|NCT00984932|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65402071|NCT00984932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402072|NCT00983138|Asparaginase|asparaginase|mesh-list
65402073|NCT00983138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402074|NCT00544544|Riluzole|riluzole|mesh-list
65402075|NCT00544544|Anticonvulsants|anticonvulsants|mesh-ancestor
65402076|NCT00544544|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65402077|NCT00544544|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65402078|NCT00544544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65402079|NCT00544544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402080|NCT00544544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402081|NCT00544544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65402082|NCT00544544|Protective Agents|protective agents|mesh-ancestor
65402083|NCT00979160|Dasatinib|dasatinib|mesh-list
65402084|NCT00979160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402085|NCT00979160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65402087|NCT00979160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402088|NCT00979316|Moxifloxacin|moxifloxacin|mesh-list
65402089|NCT00979316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65402090|NCT00979316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65402091|NCT00979316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65402092|NCT00979316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65402093|NCT00979316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402094|NCT00979316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402095|NCT00979316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402096|NCT00983450|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65402097|NCT00983450|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
65402098|NCT00983450|beta-Endorphin|beta-endorphin|mesh-list
65402099|NCT00983450|Hormones|hormones|mesh-ancestor
65402100|NCT00983450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65402101|NCT00983450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402102|NCT00983450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65402103|NCT00983450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402104|NCT00983996|Alendronate|alendronate|mesh-list
65402105|NCT00983996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65402106|NCT00983996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402107|NCT00985244|Azithromycin|azithromycin|mesh-list
65402108|NCT00985244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65402109|NCT00985244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65402110|NCT00979472|Solifenacin Succinate|solifenacin succinate|mesh-list
65402111|NCT00979472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65402112|NCT00979472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65402113|NCT00979472|Cholinergic Agents|cholinergic agents|mesh-ancestor
65402114|NCT00979472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65402115|NCT00979472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402116|NCT00979472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402117|NCT00979472|Urological Agents|urological agents|mesh-ancestor
65402118|NCT00984152|Efavirenz|efavirenz|mesh-list
65402119|NCT00984152|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65402120|NCT00984152|Raltegravir Potassium|raltegravir potassium|mesh-list
65402121|NCT00984152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65402122|NCT00984152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65402131|NCT00984152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65402132|NCT00984152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65402133|NCT00984152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65402134|NCT00984152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65402135|NCT00984152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65402136|NCT00984152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65402137|NCT00985322|Ramipril|ramipril|mesh-list
65402138|NCT00985322|Antihypertensive Agents|antihypertensive agents|mesh-list
65402139|NCT00985322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65402140|NCT00985322|Protease Inhibitors|protease inhibitors|mesh-ancestor
65402141|NCT00985322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402142|NCT00985322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402143|NCT00984230|Lactoferrin|lactoferrin|mesh-list
65402144|NCT00984230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65402145|NCT00984386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65402146|NCT00984386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65402147|NCT00984386|Estradiol|estradiol|mesh-list
65402148|NCT00984386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65402149|NCT00984386|Estrogens|estrogens|mesh-ancestor
65402150|NCT00984386|Hormones|hormones|mesh-ancestor
65402151|NCT00984386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65402152|NCT00984386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402153|NCT00984386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65402154|NCT00984386|Contraceptive Agents|contraceptive agents|mesh-ancestor
65151720|NCT01287221|Vitamins|vitamins|mesh-ancestor
65402156|NCT00984386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65402157|NCT00984464|Paclitaxel|paclitaxel|mesh-list
65402158|NCT00984464|Carboplatin|carboplatin|mesh-list
65402159|NCT00984464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65402160|NCT00984464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402161|NCT00984464|Tubulin Modulators|tubulin modulators|mesh-ancestor
65402162|NCT00984464|Antimitotic Agents|antimitotic agents|mesh-ancestor
65402163|NCT00984464|Mitosis Modulators|mitosis modulators|mesh-ancestor
65402164|NCT00984464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402165|NCT00985556|Capecitabine|capecitabine|mesh-list
65402166|NCT00985556|Tegafur|tegafur|mesh-list
65402167|NCT00985556|Oxaliplatin|oxaliplatin|mesh-list
65402168|NCT00985556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65402169|NCT00985556|Antimetabolites|antimetabolites|mesh-ancestor
65402170|NCT00985556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402171|NCT00985556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402172|NCT05537402|Bevacizumab|bevacizumab|mesh-list
65402173|NCT05537402|Atezolizumab|atezolizumab|mesh-list
65402174|NCT05537402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65402175|NCT05537402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402176|NCT05537402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65402177|NCT05537402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65402178|NCT05537402|Growth Substances|growth substances|mesh-ancestor
65402179|NCT05537402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402180|NCT05537402|Growth Inhibitors|growth inhibitors|mesh-ancestor
65402181|NCT04445246|Iloprost|iloprost|mesh-list
65402182|NCT04445246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65402183|NCT04445246|Vasodilator Agents|vasodilator agents|mesh-ancestor
65402184|NCT00541346|Methylphenidate|methylphenidate|mesh-list
65402185|NCT00541346|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65402186|NCT00541346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402187|NCT00541346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65402198|NCT00988520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65402199|NCT00988520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402200|NCT00988520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65402201|NCT00988520|Anesthetics, General|anesthetics, general|mesh-ancestor
65402202|NCT00988520|Anesthetics|anesthetics|mesh-ancestor
65402203|NCT00988520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65402204|NCT00988520|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65402205|NCT00988520|Anticonvulsants|anticonvulsants|mesh-ancestor
65402206|NCT00988520|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65402207|NCT00988520|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65402208|NCT00988520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65402209|NCT00988520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65402210|NCT05498090|Fenofibrate|fenofibrate|mesh-list
65402211|NCT05498090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65402212|NCT05498090|Antimetabolites|antimetabolites|mesh-ancestor
65402213|NCT05498090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402214|NCT05498090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65402215|NCT00077623|Epoetin Alfa|epoetin alfa|mesh-list
65402216|NCT00077623|Hematinics|hematinics|mesh-ancestor
65402217|NCT00541034|Cyclophosphamide|cyclophosphamide|mesh-list
65402218|NCT00541034|Rituximab|rituximab|mesh-list
65402219|NCT00541034|Pentostatin|pentostatin|mesh-list
65402220|NCT00541034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65402221|NCT00541034|Immunologic Factors|immunologic factors|mesh-ancestor
65402222|NCT00541034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402223|NCT00541034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65402224|NCT00541034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65402225|NCT00541034|Alkylating Agents|alkylating agents|mesh-ancestor
65402226|NCT00541034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402227|NCT00541034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402228|NCT00541034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65402229|NCT00541034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65402230|NCT00541034|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65402231|NCT00541034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402232|NCT00540644|Prednisone|prednisone|mesh-list
65402233|NCT00540644|Cyclophosphamide|cyclophosphamide|mesh-list
65402234|NCT00540644|Lenalidomide|lenalidomide|mesh-list
65402235|NCT00540644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65402236|NCT00540644|Immunologic Factors|immunologic factors|mesh-ancestor
65402237|NCT00540644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402238|NCT00540644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65402239|NCT00540644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65402240|NCT00540644|Alkylating Agents|alkylating agents|mesh-ancestor
65402241|NCT00540644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402242|NCT00540644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402243|NCT00540644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65402244|NCT00540644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65402245|NCT00540644|Glucocorticoids|glucocorticoids|mesh-ancestor
65402246|NCT00540644|Hormones|hormones|mesh-ancestor
65402247|NCT00540644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65402248|NCT00540644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65402249|NCT00540644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65402250|NCT00540644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65402251|NCT00540644|Growth Substances|growth substances|mesh-ancestor
65402252|NCT00540644|Growth Inhibitors|growth inhibitors|mesh-ancestor
65402253|NCT05470400|Vaccines|vaccines|mesh-list
65402271|NCT00986336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65402272|NCT00986336|Serotonin Agents|serotonin agents|mesh-ancestor
65402273|NCT00986336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65402274|NCT00986336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402275|NCT00986336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402276|NCT00986336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65402277|NCT00986336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65402278|NCT00986336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65402279|NCT00986336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65269867|NCT02727296|Propofol|propofol|mesh-list
65269868|NCT02727296|Sevoflurane|sevoflurane|mesh-list
65402280|NCT00986336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65402281|NCT00986336|Dopamine Agents|dopamine agents|mesh-ancestor
65402282|NCT00986336|Anticonvulsants|anticonvulsants|mesh-ancestor
65402283|NCT00986336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65402284|NCT00989300|Omeprazole|omeprazole|mesh-list
65402285|NCT00989300|Rabeprazole|rabeprazole|mesh-list
65402286|NCT00989300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65402287|NCT00989300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65402288|NCT00989300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65402289|NCT00989300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402290|NCT00989300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402291|NCT01563614|Cytarabine|cytarabine|mesh-list
65402292|NCT01563614|Lomustine|lomustine|mesh-list
65402293|NCT01563614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65402294|NCT01563614|Antimetabolites|antimetabolites|mesh-ancestor
65402295|NCT01563614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402296|NCT01563614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402297|NCT01563614|Antiviral Agents|antiviral agents|mesh-ancestor
65402298|NCT01563614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65402299|NCT01563614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65402300|NCT01563614|Immunologic Factors|immunologic factors|mesh-ancestor
65402301|NCT01563614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402302|NCT01563614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65402303|NCT01563614|Alkylating Agents|alkylating agents|mesh-ancestor
65402304|NCT00543296|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
65151872|NCT00960193|Colchicine|colchicine|mesh-list
65402305|NCT00543296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65402306|NCT00543296|Glucocorticoids|glucocorticoids|mesh-ancestor
65402307|NCT00543296|Hormones|hormones|mesh-ancestor
65402308|NCT00543296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65402309|NCT00543296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402310|NCT00543062|Moxifloxacin|moxifloxacin|mesh-list
65402311|NCT00543062|Prochlorperazine|prochlorperazine|mesh-list
65402312|NCT00543062|Loxapine|loxapine|mesh-list
65402313|NCT00543062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65402322|NCT00543062|Autonomic Agents|autonomic agents|mesh-ancestor
65402323|NCT00543062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65402324|NCT00543062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65402325|NCT00543062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65402326|NCT00543062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65402327|NCT00543062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65402328|NCT00543062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65402329|NCT00543062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65402330|NCT00543062|Dopamine Agents|dopamine agents|mesh-ancestor
65402331|NCT00543062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65402332|NCT05221580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65402333|NCT05221580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65402334|NCT05221580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402335|NCT00986804|Decitabine|decitabine|mesh-list
65402336|NCT00986804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65402337|NCT00986804|Antimetabolites|antimetabolites|mesh-ancestor
65402338|NCT00986804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402339|NCT00986804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402340|NCT00986804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402341|NCT00676091|Vaccines|vaccines|mesh-list
65402342|NCT00676091|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65402343|NCT00676091|Immunologic Factors|immunologic factors|mesh-ancestor
65402344|NCT00676091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402345|NCT02558933|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65402346|NCT02558933|Antioxidants|antioxidants|mesh-ancestor
65402347|NCT02558933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402348|NCT02558933|Protective Agents|protective agents|mesh-ancestor
65402349|NCT02558933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402350|NCT02558933|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65402351|NCT02558933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65402352|NCT02558933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402353|NCT02558933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65402354|NCT00678041|Nitrofurantoin|nitrofurantoin|mesh-list
65402355|NCT00678041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65402356|NCT00678041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65402357|NCT00678041|Renal Agents|renal agents|mesh-ancestor
65402358|NCT00678041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65402359|NCT03903822|PF-06700841|pf-06700841|mesh-list
65402360|NCT03903822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65402361|NCT03903822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402362|NCT03903822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402363|NCT04249427|Erenumab|erenumab|mesh-list
65402364|NCT04249427|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65402365|NCT04249427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402366|NCT04249427|Analgesics|analgesics|mesh-ancestor
65402367|NCT04249427|Sensory System Agents|sensory system agents|mesh-ancestor
65402368|NCT04249427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65402369|NCT04249427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402370|NCT04003350|Acetaminophen|acetaminophen|mesh-list
65402371|NCT04003350|Meloxicam|meloxicam|mesh-list
65402372|NCT04003350|Oxycodone|oxycodone|mesh-list
65402373|NCT04003350|Tramadol|tramadol|mesh-list
65402374|NCT04003350|Gabapentin|gabapentin|mesh-list
65402375|NCT04003350|Esomeprazole|esomeprazole|mesh-list
65402376|NCT04003350|Metaxalone|metaxalone|mesh-list
65402377|NCT04003350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65402378|NCT04003350|Narcotics|narcotics|mesh-ancestor
65402379|NCT04003350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64787124|NCT00002490|Mitomycins|mitomycins|mesh-list
65402397|NCT04003350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65402398|NCT04003350|Antipyretics|antipyretics|mesh-ancestor
65402399|NCT04003350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65402400|NCT04003350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65402401|NCT04003350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65402402|NCT04003350|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65402403|NCT04003350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65402404|NCT04003350|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65402405|NCT00748007|Rivastigmine|rivastigmine|mesh-list
65402406|NCT00748007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
65402407|NCT00748007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402408|NCT00748007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402409|NCT00748007|Cholinergic Agents|cholinergic agents|mesh-ancestor
65402410|NCT00748007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65402411|NCT00748007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402412|NCT00748007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65402413|NCT00748007|Protective Agents|protective agents|mesh-ancestor
65402415|NCT00748163|Sunitinib|sunitinib|mesh-list
65402416|NCT00748163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65402417|NCT00748163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65402418|NCT00748163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402419|NCT00748163|Tubulin Modulators|tubulin modulators|mesh-ancestor
65402420|NCT00748163|Antimitotic Agents|antimitotic agents|mesh-ancestor
65402421|NCT00748163|Mitosis Modulators|mitosis modulators|mesh-ancestor
65402422|NCT00748163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402423|NCT00748163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65402424|NCT00748163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65402425|NCT00748163|Growth Substances|growth substances|mesh-ancestor
65402426|NCT00748163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402427|NCT00748163|Growth Inhibitors|growth inhibitors|mesh-ancestor
65402428|NCT00748163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65402429|NCT00748163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402430|NCT00687401|Infliximab|infliximab|mesh-list
65402431|NCT00687401|Dermatologic Agents|dermatologic agents|mesh-ancestor
65402432|NCT00687401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65402433|NCT00687401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65402434|NCT00485693|Epinephrine|epinephrine|mesh-list
65402435|NCT00485693|Bupivacaine|bupivacaine|mesh-list
65402436|NCT00485693|Anesthetics, Local|anesthetics, local|mesh-ancestor
65402437|NCT00485693|Anesthetics|anesthetics|mesh-ancestor
65402444|NCT00485693|Adrenergic Agents|adrenergic agents|mesh-ancestor
65402445|NCT00485693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65402446|NCT00485693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402447|NCT00485693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65402448|NCT00485693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65402449|NCT00485693|Autonomic Agents|autonomic agents|mesh-ancestor
65402450|NCT00485693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65402451|NCT00485693|Respiratory System Agents|respiratory system agents|mesh-ancestor
65402452|NCT00485693|Mydriatics|mydriatics|mesh-ancestor
65402453|NCT00485693|Sympathomimetics|sympathomimetics|mesh-ancestor
65402454|NCT00485693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65402455|NCT00538902|Adalimumab|adalimumab|mesh-list
65402456|NCT00538902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65152020|NCT00630643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65402457|NCT00538902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65402458|NCT00541970|Vaccines|vaccines|mesh-list
65402459|NCT00541970|Immunologic Factors|immunologic factors|mesh-ancestor
65402460|NCT00541970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402461|NCT00687323|Temozolomide|temozolomide|mesh-list
65402462|NCT00687323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65402463|NCT00687323|Alkylating Agents|alkylating agents|mesh-ancestor
65402464|NCT00687323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402465|NCT00687323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402466|NCT00989742|Doxycycline|doxycycline|mesh-list
65402467|NCT00989742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65402468|NCT00989742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65402469|NCT00989742|Antimalarials|antimalarials|mesh-ancestor
65402470|NCT00989742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65402471|NCT00989742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65402472|NCT05408208|Triamcinolone|triamcinolone|mesh-list
65402473|NCT05408208|Methotrexate|methotrexate|mesh-list
65402474|NCT05408208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65402475|NCT05408208|Abortifacient Agents|abortifacient agents|mesh-ancestor
65402476|NCT05408208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65402477|NCT05408208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402478|NCT05408208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65402479|NCT05408208|Antimetabolites|antimetabolites|mesh-ancestor
65402480|NCT05408208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402481|NCT05408208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402482|NCT05408208|Dermatologic Agents|dermatologic agents|mesh-ancestor
65402483|NCT05408208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402484|NCT05408208|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65402485|NCT05408208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65402486|NCT05408208|Immunologic Factors|immunologic factors|mesh-ancestor
65402487|NCT05408208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65402488|NCT05408208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65402489|NCT05408208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65402490|NCT05408208|Glucocorticoids|glucocorticoids|mesh-ancestor
65402491|NCT05408208|Hormones|hormones|mesh-ancestor
65402492|NCT05408208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65402493|NCT00758693|Rituximab|rituximab|mesh-list
65402494|NCT00758693|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65402495|NCT00758693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65402496|NCT00758693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402497|NCT00758693|Immunologic Factors|immunologic factors|mesh-ancestor
65402498|NCT00758693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402499|NCT00758693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65402500|NCT00758693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65402501|NCT00758693|Alkylating Agents|alkylating agents|mesh-ancestor
65402502|NCT00758693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402503|NCT00989820|Coal Tar|coal tar|mesh-list
65402504|NCT00989820|Keratolytic Agents|keratolytic agents|mesh-ancestor
65402515|NCT05357820|Hormone Antagonists|hormone antagonists|mesh-ancestor
65402516|NCT05357820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65402517|NCT05357820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402518|NCT05357820|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65402519|NCT05357820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65402520|NCT05357820|Antitubercular Agents|antitubercular agents|mesh-ancestor
65402521|NCT05357820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65402522|NCT05357820|Leprostatic Agents|leprostatic agents|mesh-ancestor
65402523|NCT05357820|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65402524|NCT05357820|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65402525|NCT05357820|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65402526|NCT05357820|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65402527|NCT05357820|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65402528|NCT05357820|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65402529|NCT05357820|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65402531|NCT00748787|Calcium polycarbophil|calcium polycarbophil|mesh-list
65402533|NCT00748787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65402534|NCT00748787|Antidiarrheals|antidiarrheals|mesh-ancestor
65402535|NCT05712044|Folic Acid|folic acid|mesh-list
65402536|NCT05712044|Vitamin B Complex|vitamin b complex|mesh-list
65402537|NCT05712044|Hematinics|hematinics|mesh-ancestor
65402538|NCT05712044|Vitamins|vitamins|mesh-ancestor
65402539|NCT05712044|Micronutrients|micronutrients|mesh-ancestor
65402540|NCT05712044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402541|NCT00986960|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65402542|NCT00986960|Hormones|hormones|mesh-ancestor
65402543|NCT00986960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65402544|NCT00986960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402545|NCT05711966|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65402546|NCT05711966|Respiratory System Agents|respiratory system agents|mesh-ancestor
65402547|NCT00759005|Hydrocortisone|hydrocortisone|mesh-list
65402548|NCT00759005|Propranolol|propranolol|mesh-list
65402549|NCT00759005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65402550|NCT00759005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65402551|NCT00759005|Adrenergic Agents|adrenergic agents|mesh-ancestor
65402552|NCT00759005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65402553|NCT00759005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402554|NCT00759005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402555|NCT00759005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65402556|NCT00759005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65402557|NCT00759005|Vasodilator Agents|vasodilator agents|mesh-ancestor
65402558|NCT00759005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65402559|NCT04360070|Ketamine|ketamine|mesh-list
65402560|NCT04360070|Analgesics|analgesics|mesh-ancestor
65402561|NCT04360070|Sensory System Agents|sensory system agents|mesh-ancestor
65402562|NCT04360070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65402563|NCT04360070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402564|NCT04360070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65402565|NCT04360070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65402566|NCT04360070|Anesthetics, General|anesthetics, general|mesh-ancestor
65402567|NCT04360070|Anesthetics|anesthetics|mesh-ancestor
65402568|NCT04360070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65402572|NCT04360070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402573|NCT00748943|Chlorine dioxide|chlorine dioxide|mesh-list
65402574|NCT00748943|Dental Disinfectants|dental disinfectants|mesh-ancestor
65402575|NCT00748943|Disinfectants|disinfectants|mesh-ancestor
65402576|NCT00748943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65402577|NCT00749021|Ranibizumab|ranibizumab|mesh-list
65402578|NCT00749021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65402579|NCT00749021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65402580|NCT00749021|Growth Substances|growth substances|mesh-ancestor
65402581|NCT00749021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402582|NCT00749021|Growth Inhibitors|growth inhibitors|mesh-ancestor
65402583|NCT00749021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402584|NCT04048889|Ropivacaine|ropivacaine|mesh-list
65402585|NCT04048889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65402586|NCT04048889|Anesthetics, Local|anesthetics, local|mesh-ancestor
65402587|NCT04048889|Anesthetics|anesthetics|mesh-ancestor
65402588|NCT04048889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65402589|NCT04048889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402590|NCT04048889|Sensory System Agents|sensory system agents|mesh-ancestor
65402591|NCT04048889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65402592|NCT00987038|Midazolam|midazolam|mesh-list
65402593|NCT00987038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65402594|NCT00987038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65402595|NCT00987038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65402596|NCT00987038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402597|NCT00987038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65402598|NCT00987038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65402599|NCT00987038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65402600|NCT00987038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65402601|NCT00987038|Anesthetics, General|anesthetics, general|mesh-ancestor
65402602|NCT00987038|Anesthetics|anesthetics|mesh-ancestor
65402603|NCT00987038|GABA Modulators|gaba modulators|mesh-ancestor
65402604|NCT00987038|GABA Agents|gaba agents|mesh-ancestor
65402605|NCT00987038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65152182|NCT02857465|Dsuvia|dsuvia|mesh-list
65402606|NCT00987038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402607|NCT05711810|Ubiquinone|ubiquinone|mesh-list
65402608|NCT05711810|Coenzyme Q10|coenzyme q10|mesh-list
65402609|NCT05711810|Tocopherols|tocopherols|mesh-list
65402610|NCT05711810|Vitamin E|vitamin e|mesh-list
65402611|NCT05711810|alpha-Tocopherol|alpha-tocopherol|mesh-list
65402612|NCT05711810|Metoprolol|metoprolol|mesh-list
65402613|NCT05711810|Enalapril|enalapril|mesh-list
65402614|NCT05711810|Enalaprilat|enalaprilat|mesh-list
65402615|NCT05711810|Nifedipine|nifedipine|mesh-list
65402616|NCT05711810|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65402617|NCT05711810|Lansoprazole|lansoprazole|mesh-list
65402618|NCT05711810|Superoxide Dismutase|superoxide dismutase|mesh-list
65402619|NCT05711810|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65402620|NCT05711810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65402621|NCT05711810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65402622|NCT05711810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402623|NCT05711810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65226388|NCT00715039|Antidepressive Agents|antidepressive agents|mesh-ancestor
65402624|NCT05711810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402625|NCT05711810|Analgesics|analgesics|mesh-ancestor
65402626|NCT05711810|Sensory System Agents|sensory system agents|mesh-ancestor
65402627|NCT05711810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65402628|NCT05711810|Antidepressive Agents|antidepressive agents|mesh-ancestor
65402629|NCT05711810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65402630|NCT05711810|Dopamine Agents|dopamine agents|mesh-ancestor
65402631|NCT05711810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402632|NCT05711810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65402633|NCT05711810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65402634|NCT05711810|Sympatholytics|sympatholytics|mesh-ancestor
65402635|NCT05711810|Autonomic Agents|autonomic agents|mesh-ancestor
65402636|NCT05711810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65402637|NCT05711810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65402638|NCT05711810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65402639|NCT05711810|Adrenergic Agents|adrenergic agents|mesh-ancestor
65402640|NCT05711810|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65402641|NCT05711810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65402648|NCT05711810|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65402649|NCT05711810|Protease Inhibitors|protease inhibitors|mesh-ancestor
65402650|NCT05711810|Micronutrients|micronutrients|mesh-ancestor
65402651|NCT05711810|Vitamins|vitamins|mesh-ancestor
65402652|NCT05711810|Antioxidants|antioxidants|mesh-ancestor
65402653|NCT05711810|Protective Agents|protective agents|mesh-ancestor
65402654|NCT05711810|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65402655|NCT00759083|Bivalirudin|bivalirudin|mesh-list
65402656|NCT00759083|Antithrombins|antithrombins|mesh-ancestor
65402657|NCT00759083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65402658|NCT00759083|Protease Inhibitors|protease inhibitors|mesh-ancestor
65402659|NCT00759083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402660|NCT00759083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402661|NCT00759083|Anticoagulants|anticoagulants|mesh-ancestor
65402662|NCT00759239|Timolol|timolol|mesh-list
65402663|NCT00759239|Travoprost|travoprost|mesh-list
65402664|NCT00759239|Maleic acid|maleic acid|mesh-list
65402665|NCT00759239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402666|NCT00759239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402667|NCT00759239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65402668|NCT00759239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65402669|NCT00759239|Adrenergic Agents|adrenergic agents|mesh-ancestor
65402670|NCT00759239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65402671|NCT00759239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402672|NCT00759239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65402673|NCT00759239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65402674|NCT03742908|Clindamycin|clindamycin|mesh-list
65402675|NCT03742908|Clindamycin palmitate|clindamycin palmitate|mesh-list
65402676|NCT03742908|Clindamycin phosphate|clindamycin phosphate|mesh-list
65402677|NCT03742908|Cefazolin|cefazolin|mesh-list
65402678|NCT03742908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65402679|NCT03742908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65402680|NCT03742908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65402681|NCT03742908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402682|NCT03742908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402683|NCT05357196|Gemcitabine|gemcitabine|mesh-list
65402684|NCT05357196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65402685|NCT05357196|Antimetabolites|antimetabolites|mesh-ancestor
65402686|NCT05357196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402687|NCT05357196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402688|NCT05357196|Antiviral Agents|antiviral agents|mesh-ancestor
65402689|NCT05357196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65402690|NCT05357196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402691|NCT05357196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65402692|NCT05357196|Immunologic Factors|immunologic factors|mesh-ancestor
65402693|NCT05357196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402694|NCT05232630|Fenfluramine|fenfluramine|mesh-list
65402695|NCT05232630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65402696|NCT05232630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65402697|NCT05232630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65402698|NCT05232630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402699|NCT05232630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65402700|NCT05232630|Serotonin Agents|serotonin agents|mesh-ancestor
65402701|NCT05232630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402702|NCT03902574|Brexpiprazole|brexpiprazole|mesh-list
65402703|NCT03902574|Serotonin Agents|serotonin agents|mesh-ancestor
65402704|NCT03902574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65402705|NCT03902574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402706|NCT03902574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402707|NCT03902574|Dopamine Agonists|dopamine agonists|mesh-ancestor
65402708|NCT03902574|Dopamine Agents|dopamine agents|mesh-ancestor
65402709|NCT01004874|Bevacizumab|bevacizumab|mesh-list
65402710|NCT01004874|Temozolomide|temozolomide|mesh-list
64787457|NCT00002598|Antimetabolites|antimetabolites|mesh-ancestor
65402717|NCT01004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402718|NCT01004874|Growth Inhibitors|growth inhibitors|mesh-ancestor
65402719|NCT01004874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65402720|NCT01004874|Alkylating Agents|alkylating agents|mesh-ancestor
65402721|NCT01004874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402722|NCT01004874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65402723|NCT01004874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65402724|NCT01004874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402725|NCT00987116|Prednisone|prednisone|mesh-list
65402726|NCT00987116|Azathioprine|azathioprine|mesh-list
65402727|NCT00987116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65402728|NCT00987116|Glucocorticoids|glucocorticoids|mesh-ancestor
65402729|NCT00987116|Hormones|hormones|mesh-ancestor
65402730|NCT00987116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65402731|NCT00987116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402732|NCT00987116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65402733|NCT00987116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402734|NCT00987116|Antimetabolites|antimetabolites|mesh-ancestor
65402735|NCT00987116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402736|NCT00987116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65402737|NCT00987116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65402738|NCT00987116|Immunologic Factors|immunologic factors|mesh-ancestor
65402739|NCT00987116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65402740|NCT05711732|Busulfan|busulfan|mesh-list
65402741|NCT05711732|Alkylating Agents|alkylating agents|mesh-ancestor
65402742|NCT05711732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402743|NCT05711732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65402744|NCT05711732|Immunologic Factors|immunologic factors|mesh-ancestor
65402745|NCT05711732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402746|NCT05711732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65402747|NCT05711732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402748|NCT05711732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65402749|NCT04004702|Levetiracetam|levetiracetam|mesh-list
65402750|NCT04004702|Anticonvulsants|anticonvulsants|mesh-ancestor
65402751|NCT04004702|Nootropic Agents|nootropic agents|mesh-ancestor
65402752|NCT00542828|Immunoglobulins|immunoglobulins|mesh-list
65402753|NCT00542828|Thymoglobulin|thymoglobulin|mesh-list
65402754|NCT00542828|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65402755|NCT00542828|Immunologic Factors|immunologic factors|mesh-ancestor
65402756|NCT00542828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152322|NCT01235442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65402757|NCT00542828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65402758|NCT04731974|Melatonin|melatonin|mesh-list
65402759|NCT04731974|Antioxidants|antioxidants|mesh-ancestor
65402760|NCT04731974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402761|NCT04731974|Protective Agents|protective agents|mesh-ancestor
65402762|NCT04731974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402763|NCT04731974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65402764|NCT00987662|Amlodipine|amlodipine|mesh-list
65402765|NCT00987662|Irbesartan|irbesartan|mesh-list
65402766|NCT00987662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65402767|NCT00987662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65402768|NCT00987662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65402769|NCT00987662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402770|NCT00987662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65402771|NCT00987662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402772|NCT00987662|Vasodilator Agents|vasodilator agents|mesh-ancestor
65402773|NCT00987662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65402774|NCT00987662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65402775|NCT04430426|Glycolic acid|glycolic acid|mesh-list
65402776|NCT04430426|Keratolytic Agents|keratolytic agents|mesh-ancestor
65402777|NCT04430426|Dermatologic Agents|dermatologic agents|mesh-ancestor
65402778|NCT00090103|Tamsulosin|tamsulosin|mesh-list
64787540|NCT00002634|Cobalt|cobalt|mesh-list
65402784|NCT00090103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65402785|NCT00090103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402786|NCT00090103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402787|NCT00090103|Urological Agents|urological agents|mesh-ancestor
65402788|NCT00090103|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65402789|NCT00090103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65402790|NCT00090103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402791|NCT00090103|Hormone Antagonists|hormone antagonists|mesh-ancestor
65402792|NCT00090103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65402793|NCT01088659|Tenofovir|tenofovir|mesh-list
65402794|NCT01088659|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65402795|NCT01088659|Antiviral Agents|antiviral agents|mesh-ancestor
65402796|NCT01088659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65402797|NCT01088659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65402798|NCT01088659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65402799|NCT01088659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402800|NCT01088659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402801|NCT01088659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65402802|NCT01088659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65402803|NCT00087607|Ribavirin|ribavirin|mesh-list
65402804|NCT00087607|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65402805|NCT00087607|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65402806|NCT00087607|Antimetabolites|antimetabolites|mesh-ancestor
65402807|NCT00087607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402808|NCT00087607|Antiviral Agents|antiviral agents|mesh-ancestor
65402809|NCT00087607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65402810|NCT01088737|Imiquimod|imiquimod|mesh-list
65402811|NCT01088737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65402812|NCT01088737|Immunologic Factors|immunologic factors|mesh-ancestor
65402813|NCT01088737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402814|NCT01088737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402815|NCT01088737|Interferon Inducers|interferon inducers|mesh-ancestor
65402816|NCT00069823|Esomeprazole|esomeprazole|mesh-list
65402817|NCT00069823|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65402818|NCT00069823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65402819|NCT00069823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65402820|NCT00069823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402821|NCT00069823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402822|NCT01088815|Gemcitabine|gemcitabine|mesh-list
65402823|NCT01088815|Paclitaxel|paclitaxel|mesh-list
65402824|NCT01088815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65402825|NCT01088815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402826|NCT01088815|Tubulin Modulators|tubulin modulators|mesh-ancestor
65402827|NCT01088815|Antimitotic Agents|antimitotic agents|mesh-ancestor
65402828|NCT01088815|Mitosis Modulators|mitosis modulators|mesh-ancestor
65402829|NCT01088815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402830|NCT01088815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65402832|NCT01088815|Antiviral Agents|antiviral agents|mesh-ancestor
65402833|NCT01088815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65402834|NCT01088815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402835|NCT01088815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65402836|NCT01088815|Immunologic Factors|immunologic factors|mesh-ancestor
65402837|NCT01088815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402838|NCT00086515|Metformin|metformin|mesh-list
65402839|NCT00086515|Pioglitazone|pioglitazone|mesh-list
65402840|NCT00086515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65402841|NCT00086515|Glipizide|glipizide|mesh-list
65402842|NCT00086515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65402843|NCT00086515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402844|NCT00086515|Incretins|incretins|mesh-ancestor
65402845|NCT00086515|Hormones|hormones|mesh-ancestor
65402846|NCT00086515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65402847|NCT00086515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65402848|NCT00086515|Protease Inhibitors|protease inhibitors|mesh-ancestor
65402849|NCT00086515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402855|NCT00541658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402856|NCT00541658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65402857|NCT00541658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402858|NCT00541658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65402859|NCT04378868|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65402860|NCT04378868|Metronidazole|metronidazole|mesh-list
65402861|NCT04378868|Cefuroxime|cefuroxime|mesh-list
65402862|NCT04378868|Cefuroxime axetil|cefuroxime axetil|mesh-list
65402863|NCT04378868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65402864|NCT04378868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65402865|NCT04378868|Antitubercular Agents|antitubercular agents|mesh-ancestor
65402866|NCT04378868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65402867|NCT04378868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65269869|NCT02727296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65402868|NCT04334174|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65402869|NCT04334174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65402870|NCT04334174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402871|NCT04333706|Capecitabine|capecitabine|mesh-list
65402872|NCT04333706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65402873|NCT04333706|Antimetabolites|antimetabolites|mesh-ancestor
65402874|NCT04333706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402875|NCT04333706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402876|NCT00987974|Atorvastatin|atorvastatin|mesh-list
65402877|NCT00987974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65402878|NCT00987974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65402879|NCT00987974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65402880|NCT00987974|Antimetabolites|antimetabolites|mesh-ancestor
65402881|NCT00987974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402882|NCT00987974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65402883|NCT00987974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65402884|NCT00987974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402885|NCT03519074|Cisplatin|cisplatin|mesh-list
65402886|NCT03519074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402887|NCT03767582|Nivolumab|nivolumab|mesh-list
65402888|NCT03767582|Vaccines|vaccines|mesh-list
65402889|NCT03767582|Immunologic Factors|immunologic factors|mesh-ancestor
65402890|NCT03767582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402891|NCT03767582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65402892|NCT03767582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402893|NCT03767582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65402894|NCT03767582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402895|NCT03905642|Amikacin|amikacin|mesh-list
65402896|NCT03905642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65402897|NCT03905642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65402898|NCT04126538|Pirfenidone|pirfenidone|mesh-list
65402899|NCT04126538|Analgesics|analgesics|mesh-ancestor
65402900|NCT04126538|Sensory System Agents|sensory system agents|mesh-ancestor
65402901|NCT04126538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65402902|NCT04126538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402903|NCT04126538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65402904|NCT04126538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65152487|NCT01155531|Sertraline|sertraline|mesh-list
65402905|NCT04126538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65402906|NCT04126538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65402907|NCT04126538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402909|NCT04004234|Gemcitabine|gemcitabine|mesh-list
65402910|NCT04004234|Paclitaxel|paclitaxel|mesh-list
65402911|NCT04004234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65402912|NCT04004234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65402913|NCT04004234|Antibodies|antibodies|mesh-list
65402914|NCT04004234|Immunoglobulins|immunoglobulins|mesh-list
65402915|NCT04004234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65402916|NCT04004234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402917|NCT04004234|Tubulin Modulators|tubulin modulators|mesh-ancestor
65402918|NCT04004234|Antimitotic Agents|antimitotic agents|mesh-ancestor
64787676|NCT00002682|Amoxicillin|amoxicillin|mesh-list
65402930|NCT04004234|Micronutrients|micronutrients|mesh-ancestor
65402931|NCT00990158|Vitamin K|vitamin k|mesh-list
65402932|NCT00990158|Vitamin K 1|vitamin k 1|mesh-list
65402933|NCT00990158|Vitamins|vitamins|mesh-ancestor
65402934|NCT00990158|Micronutrients|micronutrients|mesh-ancestor
65402935|NCT00990158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402936|NCT00990158|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65402937|NCT00990158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65402938|NCT00990158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402939|NCT00990158|Hemostatics|hemostatics|mesh-ancestor
65402940|NCT00990158|Coagulants|coagulants|mesh-ancestor
65402941|NCT00412984|Warfarin|warfarin|mesh-list
65402942|NCT00412984|Apixaban|apixaban|mesh-list
65402943|NCT00412984|Anticoagulants|anticoagulants|mesh-ancestor
65402944|NCT00412984|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65402945|NCT00412984|Antithrombins|antithrombins|mesh-ancestor
65402946|NCT00412984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65402947|NCT00412984|Protease Inhibitors|protease inhibitors|mesh-ancestor
65402948|NCT00412984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402949|NCT00412984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402950|NCT03471182|Cocaine|cocaine|mesh-list
65402951|NCT03471182|Anesthetics, Local|anesthetics, local|mesh-ancestor
65402952|NCT03471182|Anesthetics|anesthetics|mesh-ancestor
65402953|NCT03471182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65402954|NCT03471182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402955|NCT03471182|Sensory System Agents|sensory system agents|mesh-ancestor
65402956|NCT03471182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65402957|NCT03471182|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65402958|NCT03471182|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65402959|NCT03471182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65402960|NCT03471182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65402961|NCT03471182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402962|NCT03471182|Dopamine Agents|dopamine agents|mesh-ancestor
65402963|NCT03471182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65402964|NCT00539864|Hemagglutinins|hemagglutinins|mesh-list
65402965|NCT00539864|Agglutinins|agglutinins|mesh-ancestor
65402966|NCT00539864|Immunologic Factors|immunologic factors|mesh-ancestor
65402967|NCT00539864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402968|NCT04003376|Vitamin D|vitamin d|mesh-list
65402969|NCT04003376|Triamcinolone|triamcinolone|mesh-list
65402970|NCT04003376|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65402971|NCT04003376|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65402972|NCT04003376|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65402973|NCT04003376|Vitamins|vitamins|mesh-ancestor
65402974|NCT04003376|Micronutrients|micronutrients|mesh-ancestor
65402975|NCT04003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402976|NCT04003376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65402977|NCT04003376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65402978|NCT04003376|Glucocorticoids|glucocorticoids|mesh-ancestor
65402979|NCT04003376|Hormones|hormones|mesh-ancestor
65402980|NCT04003376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65402981|NCT04003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65152555|NCT02884713|Doxycycline|doxycycline|mesh-list
65402982|NCT04003376|Immunologic Factors|immunologic factors|mesh-ancestor
65402983|NCT04003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402991|NCT05404490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65402992|NCT05404490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402994|NCT05404490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65402995|NCT05359874|Bevacizumab|bevacizumab|mesh-list
65402996|NCT05359874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65402997|NCT05359874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402998|NCT05359874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65402999|NCT05359874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65403000|NCT05359874|Growth Substances|growth substances|mesh-ancestor
65403001|NCT05359874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403002|NCT05359874|Growth Inhibitors|growth inhibitors|mesh-ancestor
65403003|NCT03391466|Cyclophosphamide|cyclophosphamide|mesh-list
65403004|NCT03391466|Fludarabine|fludarabine|mesh-list
65403005|NCT03391466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65403006|NCT03391466|Immunologic Factors|immunologic factors|mesh-ancestor
65403007|NCT03391466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403008|NCT03391466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65403009|NCT03391466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65403010|NCT03391466|Alkylating Agents|alkylating agents|mesh-ancestor
65403011|NCT03391466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403012|NCT03391466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403013|NCT03391466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65403014|NCT00990392|Polymyxins|polymyxins|mesh-list
65403015|NCT00990392|Bacitracin|bacitracin|mesh-list
65403016|NCT00990392|Polymyxin B|polymyxin b|mesh-list
65403017|NCT00990392|Gramicidin|gramicidin|mesh-list
65403018|NCT00990392|Petrolatum|petrolatum|mesh-list
65403019|NCT00990392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65403020|NCT00990392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65403021|NCT00990392|Emollients|emollients|mesh-ancestor
65403022|NCT00990392|Dermatologic Agents|dermatologic agents|mesh-ancestor
65403023|NCT00990392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65403024|NCT03367754|Pembrolizumab|pembrolizumab|mesh-list
65403025|NCT03367754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65403026|NCT03367754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403027|NCT03335072|Azithromycin|azithromycin|mesh-list
65403028|NCT03335072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65403029|NCT03335072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65403030|NCT01034956|Calcium|calcium|mesh-list
65403031|NCT01034956|Hyaluronic Acid|hyaluronic acid|mesh-list
65403032|NCT01034956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65403033|NCT01034956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403034|NCT01034956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65403035|NCT01034956|Immunologic Factors|immunologic factors|mesh-ancestor
65403036|NCT01034956|Viscosupplements|viscosupplements|mesh-ancestor
65403037|NCT01034956|Protective Agents|protective agents|mesh-ancestor
65403038|NCT01580878|Butenafine|butenafine|mesh-list
65403039|NCT01580878|Clotrimazole|clotrimazole|mesh-list
65403040|NCT01580878|Antifungal Agents|antifungal agents|mesh-ancestor
65403041|NCT01580878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65403042|NCT01580878|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65403043|NCT01580878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65403044|NCT01580878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65403045|NCT01580878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403046|NCT01580878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403047|NCT01580878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65403048|NCT01580878|Hormone Antagonists|hormone antagonists|mesh-ancestor
65403049|NCT01580878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65403050|NCT01580878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403051|NCT05589974|Verteporfin|verteporfin|mesh-list
65403052|NCT05589974|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65403059|NCT05589896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65403061|NCT05589896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403062|NCT05589896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65403063|NCT05589896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65403064|NCT05589896|Alkylating Agents|alkylating agents|mesh-ancestor
65403065|NCT05589896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403066|NCT05589896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403067|NCT05589896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65403068|NCT05589896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65403069|NCT05589896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403070|NCT05589896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65403071|NCT05589896|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65403072|NCT05589896|Antitubercular Agents|antitubercular agents|mesh-ancestor
65403073|NCT05589896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65403074|NCT05589896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65403075|NCT00673049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65403076|NCT00673049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403077|NCT00673049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65403078|NCT00673049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403079|NCT00673049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403080|NCT04003844|Aspirin|aspirin|mesh-list
65403081|NCT04003844|Immunoglobulins|immunoglobulins|mesh-list
65403082|NCT04003844|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65403083|NCT04003844|Antibodies|antibodies|mesh-list
65403084|NCT04003844|Immunoglobulin G|immunoglobulin g|mesh-list
65403085|NCT04003844|Immunologic Factors|immunologic factors|mesh-ancestor
65403086|NCT04003844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403087|NCT04003844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65403088|NCT04003844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65403089|NCT04003844|Analgesics|analgesics|mesh-ancestor
65403090|NCT04003844|Sensory System Agents|sensory system agents|mesh-ancestor
65403091|NCT04003844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65403092|NCT04003844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65403093|NCT04003844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65403094|NCT04003844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65403095|NCT04003844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65403096|NCT04003844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403097|NCT04003844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65403098|NCT04003844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65403099|NCT04003844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403100|NCT04003844|Antipyretics|antipyretics|mesh-ancestor
65403101|NCT05589584|Acetylcysteine|acetylcysteine|mesh-list
65403102|NCT05589584|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65403103|NCT05589584|Antiviral Agents|antiviral agents|mesh-ancestor
65403104|NCT05589584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65403105|NCT05589584|Expectorants|expectorants|mesh-ancestor
65403106|NCT05589584|Respiratory System Agents|respiratory system agents|mesh-ancestor
65403107|NCT05589584|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65403108|NCT05589584|Antioxidants|antioxidants|mesh-ancestor
65403109|NCT05589584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403110|NCT05589584|Protective Agents|protective agents|mesh-ancestor
65403111|NCT05589584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403112|NCT05589584|Antidotes|antidotes|mesh-ancestor
65403113|NCT00412750|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65403114|NCT00412750|Telbivudine|telbivudine|mesh-list
65403115|NCT00412750|Antiviral Agents|antiviral agents|mesh-ancestor
65403116|NCT00412750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65403117|NCT00412750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65403118|NCT00412750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65269870|NCT02727296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65403119|NCT00412750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403120|NCT05361278|Chlorhexidine|chlorhexidine|mesh-list
65403121|NCT05361278|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65403131|NCT00764855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65403132|NCT00764855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403134|NCT00764855|Anesthetics, General|anesthetics, general|mesh-ancestor
65403135|NCT00764855|Anesthetics|anesthetics|mesh-ancestor
65403136|NCT00759317|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65403137|NCT00759317|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65403138|NCT00759317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65403139|NCT00759317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65403140|NCT00759317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403141|NCT00759317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65403142|NCT00759317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403143|NCT00759317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65403144|NCT00759317|Antidepressive Agents|antidepressive agents|mesh-ancestor
65403145|NCT00759317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65403146|NCT02148796|Broncho-Vaxom|broncho-vaxom|mesh-list
65403147|NCT02148796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65403148|NCT02148796|Immunologic Factors|immunologic factors|mesh-ancestor
65403149|NCT02148796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403150|NCT00076999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65403151|NCT01041040|Gemtuzumab|gemtuzumab|mesh-list
65403152|NCT01041040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65403153|NCT01041040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403154|NCT00765011|Cetuximab|cetuximab|mesh-list
65403155|NCT00765011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65403156|NCT00765011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403157|NCT00765167|Chlorhexidine|chlorhexidine|mesh-list
65403158|NCT00765167|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65403159|NCT00765167|Triclosan|triclosan|mesh-list
65403160|NCT00765167|Fluorides|fluorides|mesh-list
65403161|NCT00765167|Cariostatic Agents|cariostatic agents|mesh-ancestor
65403162|NCT00765167|Protective Agents|protective agents|mesh-ancestor
65403163|NCT00765167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403164|NCT00765167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65403165|NCT00765167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65403166|NCT00765167|Disinfectants|disinfectants|mesh-ancestor
65403167|NCT00765167|Dermatologic Agents|dermatologic agents|mesh-ancestor
65403168|NCT00765167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65403169|NCT00765167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65403170|NCT00765167|Antimetabolites|antimetabolites|mesh-ancestor
65403171|NCT00765167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403172|NCT00765167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65403173|NCT00759551|Olmesartan|olmesartan|mesh-list
65403174|NCT00759551|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65403175|NCT00759551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65403176|NCT00759551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65403177|NCT00759551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65403178|NCT00759551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403179|NCT03905096|Donepezil|donepezil|mesh-list
65403180|NCT03905096|BI 425809|bi 425809|mesh-list
65403181|NCT03905096|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65403182|NCT03905096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403183|NCT03905096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403184|NCT03905096|Cholinergic Agents|cholinergic agents|mesh-ancestor
65403185|NCT03905096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65403186|NCT03905096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403187|NCT03905096|Nootropic Agents|nootropic agents|mesh-ancestor
65403201|NCT00412360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65403202|NCT00412360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403203|NCT00412360|Antifungal Agents|antifungal agents|mesh-ancestor
65403204|NCT00412360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65403205|NCT00412360|Dermatologic Agents|dermatologic agents|mesh-ancestor
65403206|NCT00412360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65403207|NCT00412360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65152766|NCT01735825|Everolimus|everolimus|mesh-list
65403208|NCT00412360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65403209|NCT00412360|Antitubercular Agents|antitubercular agents|mesh-ancestor
65403210|NCT00412360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65403211|NCT00761501|Naproxen|naproxen|mesh-list
65403212|NCT00761501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65403213|NCT00761501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65403214|NCT00761501|Analgesics|analgesics|mesh-ancestor
65403215|NCT00761501|Sensory System Agents|sensory system agents|mesh-ancestor
65403216|NCT00761501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65403217|NCT00761501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403218|NCT00761501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65403219|NCT00761501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65403220|NCT00761501|Gout Suppressants|gout suppressants|mesh-ancestor
65403221|NCT00761501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65403222|NCT00761501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403223|NCT00761501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403224|NCT01088893|Everolimus|everolimus|mesh-list
65403225|NCT01088893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403226|NCT01088893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65403227|NCT01088893|Immunologic Factors|immunologic factors|mesh-ancestor
65403228|NCT01088893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403229|NCT03026036|Raclopride|raclopride|mesh-list
65403230|NCT03026036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65403231|NCT03026036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65403232|NCT03026036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65403233|NCT03026036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403234|NCT03026036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65403235|NCT03026036|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65403236|NCT03026036|Dopamine Agents|dopamine agents|mesh-ancestor
65403237|NCT03026036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65403238|NCT03026036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403239|NCT00990860|Doxorubicin|doxorubicin|mesh-list
65403240|NCT00990860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65403241|NCT00990860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403242|NCT00990860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65403243|NCT00990860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65403244|NCT00990860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403245|NCT00990860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403246|NCT01035190|Budesonide|budesonide|mesh-list
65403247|NCT01035190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65403248|NCT01035190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64788020|NCT05748990|Insulin|insulin|mesh-list
65403254|NCT01035190|Glucocorticoids|glucocorticoids|mesh-ancestor
65403256|NCT01035190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65403257|NCT00571103|Acamprosate|acamprosate|mesh-list
65403258|NCT00571103|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65403259|NCT00084799|Antibodies|antibodies|mesh-list
65403260|NCT00084799|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65403261|NCT00084799|Immunologic Factors|immunologic factors|mesh-ancestor
65403262|NCT00084799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403263|NCT00765557|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65403264|NCT00765557|Laxatives|laxatives|mesh-ancestor
65403265|NCT00765557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65403266|NCT01086553|Budesonide|budesonide|mesh-list
65403267|NCT01086553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65403268|NCT01086553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65403269|NCT01086553|Autonomic Agents|autonomic agents|mesh-ancestor
65403270|NCT01086553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65403271|NCT01086553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403272|NCT01086553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65403273|NCT01086553|Respiratory System Agents|respiratory system agents|mesh-ancestor
65403274|NCT01086553|Glucocorticoids|glucocorticoids|mesh-ancestor
65403275|NCT01086553|Hormones|hormones|mesh-ancestor
65403276|NCT01086553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65403277|NCT04049513|Cyclophosphamide|cyclophosphamide|mesh-list
65403278|NCT04049513|Fludarabine|fludarabine|mesh-list
65403279|NCT04049513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65403280|NCT04049513|Immunologic Factors|immunologic factors|mesh-ancestor
65403281|NCT04049513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403282|NCT04049513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65403283|NCT04049513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65403284|NCT04049513|Alkylating Agents|alkylating agents|mesh-ancestor
65403285|NCT04049513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403286|NCT04049513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403287|NCT04049513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65403288|NCT01041508|Cyclosporine|cyclosporine|mesh-list
65403289|NCT01041508|Mycophenolic Acid|mycophenolic acid|mesh-list
65403290|NCT01041508|Clofarabine|clofarabine|mesh-list
65403291|NCT01041508|Cyclosporins|cyclosporins|mesh-list
65403292|NCT01041508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403293|NCT01041508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269871|NCT02727296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403294|NCT01041508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65403295|NCT01041508|Immunologic Factors|immunologic factors|mesh-ancestor
65403296|NCT01041508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403297|NCT01041508|Antifungal Agents|antifungal agents|mesh-ancestor
65403298|NCT01041508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65403299|NCT01041508|Dermatologic Agents|dermatologic agents|mesh-ancestor
65403300|NCT01041508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65403301|NCT01041508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65403302|NCT01041508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65403303|NCT01041508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403304|NCT01041508|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65403305|NCT01041508|Antitubercular Agents|antitubercular agents|mesh-ancestor
65403306|NCT01041508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65403307|NCT01041508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65403308|NCT01041508|Antimetabolites|antimetabolites|mesh-ancestor
65403309|NCT00766025|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65403310|NCT00766025|Calcium|calcium|mesh-list
65403311|NCT00766025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65403312|NCT00766025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403313|NCT00766025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65403314|NCT00766025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65403315|NCT00766025|Antimetabolites|antimetabolites|mesh-ancestor
65403316|NCT00766025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403317|NCT00766025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64788083|NCT05497674|Renal Agents|renal agents|mesh-ancestor
65403326|NCT00766181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65403327|NCT00766181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65403328|NCT00766181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65403329|NCT00766181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65403330|NCT00766181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65403331|NCT00766181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403332|NCT04048577|Natalizumab|natalizumab|mesh-list
65403333|NCT04048577|Immunologic Factors|immunologic factors|mesh-ancestor
65403334|NCT04048577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403335|NCT00991250|Temozolomide|temozolomide|mesh-list
65403336|NCT00991250|Dacarbazine|dacarbazine|mesh-list
65403337|NCT00991250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65403338|NCT00991250|Alkylating Agents|alkylating agents|mesh-ancestor
65403339|NCT00991250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403340|NCT00991250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403341|NCT00418522|Insulin|insulin|mesh-list
65403342|NCT00418522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65403343|NCT00418522|Insulin Glargine|insulin glargine|mesh-list
65403344|NCT00418522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65403345|NCT00418522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403346|NCT00760175|Vaccines|vaccines|mesh-list
65403347|NCT00760175|Immunologic Factors|immunologic factors|mesh-ancestor
65403348|NCT00760175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403349|NCT00766337|Sirolimus|sirolimus|mesh-list
65403350|NCT00766337|Ranibizumab|ranibizumab|mesh-list
65403351|NCT00766337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65403352|NCT00766337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65403353|NCT00766337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65403354|NCT00766337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403355|NCT00766337|Antifungal Agents|antifungal agents|mesh-ancestor
65403356|NCT00766337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65403357|NCT00766337|Immunologic Factors|immunologic factors|mesh-ancestor
65152918|NCT01147497|Oxytocics|oxytocics|mesh-ancestor
65403358|NCT00766337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403359|NCT00766337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65403360|NCT00766337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65403361|NCT00766337|Growth Substances|growth substances|mesh-ancestor
65403362|NCT00766337|Growth Inhibitors|growth inhibitors|mesh-ancestor
65403363|NCT00991562|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
65403364|NCT00991562|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65403365|NCT00991562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65403366|NCT00991562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403367|NCT00991562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65403368|NCT00991562|Tubulin Modulators|tubulin modulators|mesh-ancestor
65403369|NCT00991562|Antimitotic Agents|antimitotic agents|mesh-ancestor
65403370|NCT00991562|Mitosis Modulators|mitosis modulators|mesh-ancestor
65403371|NCT00991562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403372|NCT00762671|Ebselen|ebselen|mesh-list
65227067|NCT04096768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65403373|NCT00762671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65403374|NCT00762671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65403375|NCT00762671|Analgesics|analgesics|mesh-ancestor
65403376|NCT00762671|Sensory System Agents|sensory system agents|mesh-ancestor
65403377|NCT00762671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65403378|NCT00762671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403379|NCT00762671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65403380|NCT00762671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65403381|NCT00762671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65403382|NCT00762671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65403395|NCT00766805|Isosorbide|isosorbide|mesh-list
65403396|NCT00766805|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65403397|NCT00766805|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65403398|NCT00766805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65403399|NCT00766805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65403400|NCT00766805|Adrenergic Agents|adrenergic agents|mesh-ancestor
65403401|NCT00766805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65403402|NCT00766805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403403|NCT00766805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403404|NCT00766805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65403405|NCT00766805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65403406|NCT00766805|Vasodilator Agents|vasodilator agents|mesh-ancestor
65403407|NCT00766805|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65403408|NCT00766805|Diuretics|diuretics|mesh-ancestor
65403409|NCT00766805|Natriuretic Agents|natriuretic agents|mesh-ancestor
65403410|NCT00766805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65403411|NCT00762749|Diphenhydramine|diphenhydramine|mesh-list
65403412|NCT00762749|Promethazine|promethazine|mesh-list
65403413|NCT00762749|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65403414|NCT00762749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65403415|NCT00762749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65403416|NCT00762749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403417|NCT00762749|Anesthetics, Local|anesthetics, local|mesh-ancestor
65403418|NCT00762749|Anesthetics|anesthetics|mesh-ancestor
65403419|NCT00762749|Sensory System Agents|sensory system agents|mesh-ancestor
65403420|NCT00762749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65403421|NCT00762749|Antiemetics|antiemetics|mesh-ancestor
65403422|NCT00762749|Autonomic Agents|autonomic agents|mesh-ancestor
65403423|NCT00762749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65403424|NCT00762749|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65403425|NCT00762749|Histamine Antagonists|histamine antagonists|mesh-ancestor
65403426|NCT00762749|Histamine Agents|histamine agents|mesh-ancestor
65403427|NCT00762749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65403428|NCT00762749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403429|NCT00762749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65403430|NCT00762749|Antipruritics|antipruritics|mesh-ancestor
65403431|NCT00762749|Dermatologic Agents|dermatologic agents|mesh-ancestor
65403432|NCT00403546|Ziprasidone|ziprasidone|mesh-list
65403433|NCT00403546|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65403434|NCT00403546|Serotonin Agents|serotonin agents|mesh-ancestor
65403435|NCT00403546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65403436|NCT00403546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403437|NCT00403546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403438|NCT00403546|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65403439|NCT00403546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65403440|NCT00403546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65403441|NCT00403546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65403442|NCT00403546|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65403443|NCT00403546|Dopamine Agents|dopamine agents|mesh-ancestor
65403445|NCT00767117|Lopinavir|lopinavir|mesh-list
65403446|NCT00767117|Etravirine|etravirine|mesh-list
65403447|NCT00767117|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65403459|NCT00767117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65403461|NCT00762983|Antipruritics|antipruritics|mesh-ancestor
65403462|NCT00762983|Dermatologic Agents|dermatologic agents|mesh-ancestor
65403463|NCT00762983|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65403464|NCT00762983|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65403465|NCT00762983|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65403466|NCT00762983|Histamine Antagonists|histamine antagonists|mesh-ancestor
65403467|NCT00762983|Histamine Agents|histamine agents|mesh-ancestor
65403468|NCT00762983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65403469|NCT00762983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403470|NCT00762983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403471|NCT00403234|Buprenorphine|buprenorphine|mesh-list
65403472|NCT00403234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65403473|NCT00403234|Narcotics|narcotics|mesh-ancestor
65403474|NCT00403234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65403475|NCT00403234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403476|NCT00403234|Analgesics|analgesics|mesh-ancestor
65403477|NCT00403234|Sensory System Agents|sensory system agents|mesh-ancestor
65403478|NCT00403234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65403479|NCT00403234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65403480|NCT01039090|Dopamine|dopamine|mesh-list
65403481|NCT01039090|Apomorphine|apomorphine|mesh-list
65403482|NCT01039090|Dopamine Agonists|dopamine agonists|mesh-list
65403483|NCT01039090|Emetics|emetics|mesh-ancestor
65403484|NCT01039090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403485|NCT01039090|Autonomic Agents|autonomic agents|mesh-ancestor
65403486|NCT01039090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65403487|NCT01039090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65403488|NCT01039090|Dopamine Agents|dopamine agents|mesh-ancestor
65403489|NCT01039090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65403490|NCT01039090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403491|NCT01039090|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65403492|NCT01039090|Sympathomimetics|sympathomimetics|mesh-ancestor
65403493|NCT01039090|Protective Agents|protective agents|mesh-ancestor
65403494|NCT04049201|Midazolam|midazolam|mesh-list
65403495|NCT04049201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65403496|NCT04049201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65403497|NCT04049201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65403498|NCT04049201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403499|NCT04049201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65403500|NCT04049201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65403501|NCT04049201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65403502|NCT04049201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65403503|NCT04049201|Anesthetics, General|anesthetics, general|mesh-ancestor
65403504|NCT04049201|Anesthetics|anesthetics|mesh-ancestor
65403505|NCT04049201|GABA Modulators|gaba modulators|mesh-ancestor
65403506|NCT04049201|GABA Agents|gaba agents|mesh-ancestor
65403507|NCT04049201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65403508|NCT04049201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403509|NCT00767663|Dipyridamole|dipyridamole|mesh-list
65403510|NCT00767663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65403517|NCT00402688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65403518|NCT00402688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65403519|NCT00402688|Renal Agents|renal agents|mesh-ancestor
65403520|NCT00402688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65403521|NCT00402688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65403522|NCT00402688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65403523|NCT00402688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403524|NCT00402688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403525|NCT00402688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403526|NCT00402688|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65403527|NCT00402688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65403528|NCT04049045|Empagliflozin|empagliflozin|mesh-list
65403529|NCT04049045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65403530|NCT04049045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403531|NCT04049045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65403532|NCT04049045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403533|NCT00763373|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65403534|NCT00763373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65403535|NCT00763373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65403536|NCT00763373|Antitubercular Agents|antitubercular agents|mesh-ancestor
65403537|NCT01035580|Curcumin|curcumin|mesh-list
65403538|NCT01035580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65403539|NCT01035580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65403540|NCT01035580|Analgesics|analgesics|mesh-ancestor
65403541|NCT01035580|Sensory System Agents|sensory system agents|mesh-ancestor
65403542|NCT01035580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65403543|NCT01035580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403544|NCT01035580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65403545|NCT01035580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65403546|NCT01035580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403547|NCT01035580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403548|NCT01035580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403549|NCT00671879|Carisoprodol|carisoprodol|mesh-list
65403550|NCT00671879|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65403551|NCT00671879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403552|NCT00671879|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65227228|NCT00719797|Vitamins|vitamins|mesh-ancestor
65403553|NCT00671879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65403554|NCT00402298|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65403555|NCT00402298|Hallucinogens|hallucinogens|mesh-ancestor
65403556|NCT00402298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403557|NCT00402298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65403558|NCT00402298|Serotonin Agents|serotonin agents|mesh-ancestor
65403559|NCT00402298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65403560|NCT00402298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403561|NCT00402298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65403562|NCT00402298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65403563|NCT00402298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65403564|NCT00402298|Adrenergic Agents|adrenergic agents|mesh-ancestor
65403565|NCT00767975|Rifampin|rifampin|mesh-list
65403566|NCT00767975|Isoniazid|isoniazid|mesh-list
65403567|NCT00767975|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65403568|NCT00767975|Antitubercular Agents|antitubercular agents|mesh-ancestor
65403569|NCT00767975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65403570|NCT00767975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65403571|NCT00767975|Leprostatic Agents|leprostatic agents|mesh-ancestor
65403572|NCT00767975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65403573|NCT00767975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403574|NCT00767975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403575|NCT00767975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65403576|NCT00767975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65403582|NCT00767975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65403583|NCT00767975|Antimetabolites|antimetabolites|mesh-ancestor
65403584|NCT00767975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65403585|NCT00768131|Paclitaxel|paclitaxel|mesh-list
65403586|NCT00768131|Carboplatin|carboplatin|mesh-list
65403587|NCT00768131|Cetuximab|cetuximab|mesh-list
65403588|NCT00768131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65403589|NCT00768131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403590|NCT00768131|Tubulin Modulators|tubulin modulators|mesh-ancestor
65403591|NCT00768131|Antimitotic Agents|antimitotic agents|mesh-ancestor
65403592|NCT00768131|Mitosis Modulators|mitosis modulators|mesh-ancestor
65403593|NCT00768131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403594|NCT00768131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65403595|NCT00401830|Lacosamide|lacosamide|mesh-list
65403596|NCT00401830|Anticonvulsants|anticonvulsants|mesh-ancestor
65403597|NCT00401830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65403598|NCT00401830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65403599|NCT00401830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65403600|NCT00401830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403601|NCT00768209|Topiramate|topiramate|mesh-list
65403602|NCT00768209|Phentermine|phentermine|mesh-list
65403603|NCT00768209|Anticonvulsants|anticonvulsants|mesh-ancestor
65403604|NCT00768209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65403605|NCT00768209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403606|NCT00768209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65403607|NCT00768209|Appetite Depressants|appetite depressants|mesh-ancestor
65403608|NCT00768209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65403609|NCT00768209|Sympathomimetics|sympathomimetics|mesh-ancestor
65403610|NCT00768209|Autonomic Agents|autonomic agents|mesh-ancestor
65403611|NCT00768209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65403612|NCT00768209|Adrenergic Agents|adrenergic agents|mesh-ancestor
65403613|NCT00768209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65403614|NCT00768209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403615|NCT02471144|Etanercept|etanercept|mesh-list
65403616|NCT02471144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65403617|NCT02471144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65403618|NCT02471144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65403619|NCT02471144|Analgesics|analgesics|mesh-ancestor
65403620|NCT02471144|Sensory System Agents|sensory system agents|mesh-ancestor
65403621|NCT02471144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65403622|NCT02471144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403623|NCT02471144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65403624|NCT02471144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65403625|NCT02471144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65403626|NCT02471144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65403627|NCT02471144|Immunologic Factors|immunologic factors|mesh-ancestor
65403628|NCT00401752|Esomeprazole|esomeprazole|mesh-list
65403629|NCT00401752|Ranitidine|ranitidine|mesh-list
65403630|NCT00401752|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65227298|NCT00752986|Fulvestrant|fulvestrant|mesh-list
65403631|NCT00401752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65403632|NCT00401752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65403633|NCT00401752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65403634|NCT00401752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403635|NCT00401752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403636|NCT00401752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65403637|NCT00401752|Histamine Antagonists|histamine antagonists|mesh-ancestor
65403638|NCT00401752|Histamine Agents|histamine agents|mesh-ancestor
65403639|NCT00401752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65403640|NCT00401752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403641|NCT00770471|Temozolomide|temozolomide|mesh-list
65403642|NCT00770471|Veliparib|veliparib|mesh-list
65403643|NCT00770471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65403644|NCT00770471|Alkylating Agents|alkylating agents|mesh-ancestor
65403645|NCT00770471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403657|NCT00539240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403658|NCT00539240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65403659|NCT00539240|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65403660|NCT00539240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65403661|NCT00539240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65403662|NCT00539240|Adrenergic Agents|adrenergic agents|mesh-ancestor
65403663|NCT00539240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65403664|NCT00539240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403665|NCT00417976|Gemcitabine|gemcitabine|mesh-list
65403666|NCT00417976|Bevacizumab|bevacizumab|mesh-list
65403667|NCT00417976|Fluorouracil|fluorouracil|mesh-list
65403668|NCT00417976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65403669|NCT00417976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403670|NCT00417976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65403671|NCT00417976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65403672|NCT00417976|Growth Substances|growth substances|mesh-ancestor
65403673|NCT00417976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403674|NCT00417976|Growth Inhibitors|growth inhibitors|mesh-ancestor
65403675|NCT00417976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65403676|NCT00417976|Antimetabolites|antimetabolites|mesh-ancestor
65403677|NCT00417976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403678|NCT00417976|Antiviral Agents|antiviral agents|mesh-ancestor
65403679|NCT00417976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65403680|NCT00417976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403681|NCT00417976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65403682|NCT00417976|Immunologic Factors|immunologic factors|mesh-ancestor
65403683|NCT00770705|Phenoxybenzamine|phenoxybenzamine|mesh-list
65403684|NCT00770705|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65403685|NCT00770705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65403686|NCT00770705|Adrenergic Agents|adrenergic agents|mesh-ancestor
65403687|NCT00770705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65403688|NCT00770705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403689|NCT00770705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403690|NCT00770705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65403691|NCT00770705|Vasodilator Agents|vasodilator agents|mesh-ancestor
65403692|NCT00991796|Paclitaxel|paclitaxel|mesh-list
65403693|NCT00991796|Carboplatin|carboplatin|mesh-list
65403694|NCT00991796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65403695|NCT00991796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403696|NCT00991796|Tubulin Modulators|tubulin modulators|mesh-ancestor
65403697|NCT00991796|Antimitotic Agents|antimitotic agents|mesh-ancestor
65403698|NCT00991796|Mitosis Modulators|mitosis modulators|mesh-ancestor
65403699|NCT00991796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403700|NCT00673673|Bevacizumab|bevacizumab|mesh-list
65403701|NCT00673673|Fluorouracil|fluorouracil|mesh-list
65403702|NCT00673673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65403703|NCT00673673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403704|NCT00673673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65403705|NCT00673673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65403706|NCT00673673|Growth Substances|growth substances|mesh-ancestor
65403707|NCT00673673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403708|NCT00673673|Growth Inhibitors|growth inhibitors|mesh-ancestor
64788470|NCT02782104|Esketamine|esketamine|mesh-list
65403723|NCT00763685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403724|NCT00763685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65403725|NCT00763685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65403726|NCT00763685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65403727|NCT00763685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65403728|NCT00763685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403729|NCT00763685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403730|NCT04048655|Neostigmine|neostigmine|mesh-list
65153282|NCT00938431|Lacosamide|lacosamide|mesh-list
65403731|NCT04048655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65403732|NCT04048655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403733|NCT04048655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403734|NCT04048655|Cholinergic Agents|cholinergic agents|mesh-ancestor
65403735|NCT04048655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65403736|NCT04048655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403737|NCT04048655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65403738|NCT04048655|Autonomic Agents|autonomic agents|mesh-ancestor
65403739|NCT04048655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65403740|NCT00768677|Topiramate|topiramate|mesh-list
65403741|NCT00768677|Anticonvulsants|anticonvulsants|mesh-ancestor
65403742|NCT00768677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65403743|NCT00768677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403744|NCT02557451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
65403745|NCT02557451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65403746|NCT02557451|Growth Substances|growth substances|mesh-ancestor
65403747|NCT02557451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403748|NCT02557451|Growth Inhibitors|growth inhibitors|mesh-ancestor
65403749|NCT02557451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403750|NCT05408936|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65403751|NCT05408936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403752|NCT05408936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65403753|NCT05408936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403754|NCT02558153|Paclitaxel|paclitaxel|mesh-list
65403755|NCT02558153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65403756|NCT02558153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403757|NCT02558153|Tubulin Modulators|tubulin modulators|mesh-ancestor
65403758|NCT02558153|Antimitotic Agents|antimitotic agents|mesh-ancestor
65403759|NCT02558153|Mitosis Modulators|mitosis modulators|mesh-ancestor
65403760|NCT02558153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403761|NCT00763763|Interferons|interferons|mesh-list
65403762|NCT00763763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65403763|NCT00763763|Interferon-alpha|interferon-alpha|mesh-list
65403764|NCT00763763|Dexamethasone|dexamethasone|mesh-list
65403765|NCT00763763|Vincristine|vincristine|mesh-list
65403766|NCT00763763|Imatinib Mesylate|imatinib mesylate|mesh-list
65403767|NCT00763763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65403768|NCT00763763|Antiemetics|antiemetics|mesh-ancestor
65403774|NCT00763763|Hormones|hormones|mesh-ancestor
65403775|NCT00763763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65403776|NCT00763763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65403777|NCT00763763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403778|NCT00763763|Antiviral Agents|antiviral agents|mesh-ancestor
65403779|NCT00763763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65403780|NCT00763763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65403781|NCT00763763|Tubulin Modulators|tubulin modulators|mesh-ancestor
65403782|NCT00763763|Antimitotic Agents|antimitotic agents|mesh-ancestor
65403783|NCT00763763|Mitosis Modulators|mitosis modulators|mesh-ancestor
65403784|NCT00763763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403785|NCT00763763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65403786|NCT00763763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403787|NCT00763763|Immunologic Factors|immunologic factors|mesh-ancestor
65403788|NCT01037140|Vitamin D|vitamin d|mesh-list
65403789|NCT01037140|Cholecalciferol|cholecalciferol|mesh-list
65403790|NCT01037140|Vitamins|vitamins|mesh-ancestor
65403791|NCT01037140|Micronutrients|micronutrients|mesh-ancestor
65403792|NCT01037140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403793|NCT01037140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65403794|NCT01037140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65403795|NCT05357456|Epinephrine|epinephrine|mesh-list
65403796|NCT05357456|Racepinephrine|racepinephrine|mesh-list
65403797|NCT05357456|Epinephryl borate|epinephryl borate|mesh-list
65403798|NCT05357456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65403799|NCT05357456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65403800|NCT05357456|Adrenergic Agents|adrenergic agents|mesh-ancestor
65403801|NCT05357456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65403802|NCT05357456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403803|NCT05357456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403804|NCT05357456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65403805|NCT05357456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65227443|NCT02684019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65403806|NCT05357456|Autonomic Agents|autonomic agents|mesh-ancestor
65153355|NCT02691156|Carbon Monoxide|carbon monoxide|mesh-list
65403807|NCT05357456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65403808|NCT05357456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65403809|NCT05357456|Respiratory System Agents|respiratory system agents|mesh-ancestor
65403810|NCT05357456|Mydriatics|mydriatics|mesh-ancestor
65403811|NCT05357456|Sympathomimetics|sympathomimetics|mesh-ancestor
65403812|NCT05357456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65403814|NCT00069121|Fluorouracil|fluorouracil|mesh-list
65403815|NCT00069121|Capecitabine|capecitabine|mesh-list
65403816|NCT00069121|Oxaliplatin|oxaliplatin|mesh-list
65403817|NCT00069121|Antimetabolites|antimetabolites|mesh-ancestor
65403818|NCT00069121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403819|NCT00069121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65403820|NCT00069121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403821|NCT00069121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65403822|NCT00069121|Immunologic Factors|immunologic factors|mesh-ancestor
65403823|NCT00069121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403824|NCT00069121|Antidotes|antidotes|mesh-ancestor
65403825|NCT00069121|Protective Agents|protective agents|mesh-ancestor
65403826|NCT00069121|Vitamin B Complex|vitamin b complex|mesh-ancestor
65403827|NCT00069121|Vitamins|vitamins|mesh-ancestor
65403828|NCT00069121|Micronutrients|micronutrients|mesh-ancestor
65403829|NCT00768911|Temozolomide|temozolomide|mesh-list
65403830|NCT00768911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65403831|NCT00768911|Alkylating Agents|alkylating agents|mesh-ancestor
65403832|NCT00768911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403833|NCT00768911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403834|NCT00771017|Leuprolide|leuprolide|mesh-list
65403835|NCT00771017|Goserelin|goserelin|mesh-list
65403836|NCT00771017|Bicalutamide|bicalutamide|mesh-list
65403837|NCT00771017|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65403838|NCT00771017|Fertility Agents|fertility agents|mesh-ancestor
65403839|NCT00771017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64788598|NCT00002802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65403859|NCT00763997|Analgesics|analgesics|mesh-ancestor
65403860|NCT00763997|Sensory System Agents|sensory system agents|mesh-ancestor
65403861|NCT00763997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65403862|NCT00763997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403863|NCT00763997|Antipyretics|antipyretics|mesh-ancestor
65403864|NCT00763997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65403865|NCT00763997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65403866|NCT00763997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65403867|NCT00763997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65403868|NCT00763997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403869|NCT00763997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403870|NCT00763997|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65403871|NCT00771251|Golimumab|golimumab|mesh-list
65403872|NCT00771251|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65403873|NCT00771251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65403874|NCT00771251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65403875|NCT00771251|Immunologic Factors|immunologic factors|mesh-ancestor
65403876|NCT00771251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403877|NCT01420250|Bicalutamide|bicalutamide|mesh-list
65403878|NCT01420250|Hormones|hormones|mesh-list
65403879|NCT01420250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65403880|NCT01420250|Androgens|androgens|mesh-list
65403881|NCT01420250|Androgen Antagonists|androgen antagonists|mesh-list
65403882|NCT01420250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65403883|NCT01420250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403884|NCT01420250|Hormone Antagonists|hormone antagonists|mesh-ancestor
65403885|NCT01420250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403886|NCT00399568|Acetaminophen|acetaminophen|mesh-list
65403887|NCT00399568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65403888|NCT00399568|Analgesics|analgesics|mesh-ancestor
65403889|NCT00399568|Sensory System Agents|sensory system agents|mesh-ancestor
65403890|NCT00399568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65403891|NCT00399568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403892|NCT00399568|Antipyretics|antipyretics|mesh-ancestor
65403893|NCT05088356|Plerixafor|plerixafor|mesh-list
65403894|NCT05088356|Cyclophosphamide|cyclophosphamide|mesh-list
65403895|NCT05088356|Melphalan|melphalan|mesh-list
65403896|NCT05088356|Fludarabine|fludarabine|mesh-list
65403897|NCT05088356|Fludarabine phosphate|fludarabine phosphate|mesh-list
65403906|NCT05088356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227518|NCT02570581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403908|NCT05088356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65403909|NCT05088356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65403910|NCT05088356|Antimetabolites|antimetabolites|mesh-ancestor
65403911|NCT05088356|Antiviral Agents|antiviral agents|mesh-ancestor
65403912|NCT05088356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65403913|NCT05088356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65403914|NCT05088356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65403915|NCT05088356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403916|NCT05088356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65403917|NCT05088356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65403918|NCT01039558|Ecabet|ecabet|mesh-list
65403919|NCT01039558|Lansoprazole|lansoprazole|mesh-list
65403920|NCT01039558|Dexlansoprazole|dexlansoprazole|mesh-list
65403921|NCT01039558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65403922|NCT01039558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65403923|NCT01039558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65403924|NCT01039558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403925|NCT01039558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403926|NCT01039558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65403927|NCT01039558|Protease Inhibitors|protease inhibitors|mesh-ancestor
65403928|NCT01039558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65403929|NCT01039558|Protective Agents|protective agents|mesh-ancestor
65403930|NCT01039558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403931|NCT01039558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403932|NCT01324258|Gemcitabine|gemcitabine|mesh-list
65403933|NCT01324258|Trametinib|trametinib|mesh-list
65403934|NCT01324258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65403935|NCT01324258|Antimetabolites|antimetabolites|mesh-ancestor
65403936|NCT01324258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403937|NCT01324258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403938|NCT01324258|Antiviral Agents|antiviral agents|mesh-ancestor
65403939|NCT01324258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65403940|NCT01324258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403941|NCT01324258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65403942|NCT01324258|Immunologic Factors|immunologic factors|mesh-ancestor
65403943|NCT01324258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403944|NCT01324258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65403945|NCT01415882|Dexamethasone|dexamethasone|mesh-list
65403946|NCT01415882|Dexamethasone acetate|dexamethasone acetate|mesh-list
65403947|NCT01415882|Cyclophosphamide|cyclophosphamide|mesh-list
65403948|NCT01415882|Daratumumab|daratumumab|mesh-list
65403949|NCT01415882|Ixazomib|ixazomib|mesh-list
65403950|NCT01415882|Ichthammol|ichthammol|mesh-list
65403951|NCT01415882|BB 1101|bb 1101|mesh-list
65403952|NCT01415882|Glycine|glycine|mesh-list
65403953|NCT01415882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65403954|NCT01415882|Immunologic Factors|immunologic factors|mesh-ancestor
65403955|NCT01415882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403956|NCT01415882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65403957|NCT01415882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65403958|NCT01415882|Alkylating Agents|alkylating agents|mesh-ancestor
65403959|NCT01415882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403960|NCT01415882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403961|NCT01415882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65403962|NCT01415882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65403963|NCT01415882|Antiemetics|antiemetics|mesh-ancestor
65403964|NCT01415882|Autonomic Agents|autonomic agents|mesh-ancestor
65403965|NCT01415882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65403966|NCT01415882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65403969|NCT01415882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65403970|NCT01415882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65403971|NCT01415882|Protease Inhibitors|protease inhibitors|mesh-ancestor
65403972|NCT01415882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403973|NCT01415882|Dermatologic Agents|dermatologic agents|mesh-ancestor
65403974|NCT01415882|Glycine Agents|glycine agents|mesh-ancestor
65403975|NCT01415882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65403976|NCT00068419|Tamoxifen|tamoxifen|mesh-list
65403977|NCT00068419|Sulindac|sulindac|mesh-list
65403978|NCT00068419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403979|NCT00068419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65403980|NCT00068419|Hormone Antagonists|hormone antagonists|mesh-ancestor
65403981|NCT00068419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65403982|NCT00068419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403983|NCT00068419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65403984|NCT00068419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403985|NCT00068419|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65403986|NCT00068419|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65403987|NCT00068419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65403988|NCT00068419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65403989|NCT00068419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65403990|NCT00068419|Analgesics|analgesics|mesh-ancestor
65403991|NCT00068419|Sensory System Agents|sensory system agents|mesh-ancestor
65403992|NCT00068419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65403993|NCT00068419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65403994|NCT00068419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65403995|NCT00068419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65403996|NCT00068419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403997|NCT02557373|Vitamins|vitamins|mesh-list
65403998|NCT02557373|Vitamin A|vitamin a|mesh-list
65403999|NCT02557373|Retinol palmitate|retinol palmitate|mesh-list
65404000|NCT02557373|Micronutrients|micronutrients|mesh-ancestor
65404001|NCT02557373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404002|NCT02557373|Antioxidants|antioxidants|mesh-ancestor
65404003|NCT02557373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404004|NCT02557373|Protective Agents|protective agents|mesh-ancestor
65404005|NCT02557373|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65404006|NCT02557373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404007|NCT01757626|Molgramostim|molgramostim|mesh-list
65404008|NCT01757626|Sargramostim|sargramostim|mesh-list
65404009|NCT01757626|Immunologic Factors|immunologic factors|mesh-ancestor
65404010|NCT01757626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404011|NCT01757626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404012|NCT04048811|Propofol|propofol|mesh-list
65404013|NCT04048811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65404014|NCT04048811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65404015|NCT04048811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404016|NCT04048811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65404017|NCT04048811|Anesthetics, General|anesthetics, general|mesh-ancestor
65404018|NCT04048811|Anesthetics|anesthetics|mesh-ancestor
65404019|NCT01086631|Rituximab|rituximab|mesh-list
65404020|NCT01086631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65404021|NCT01086631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404022|NCT01086631|Immunologic Factors|immunologic factors|mesh-ancestor
65404023|NCT01086631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404024|NCT01086631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65404025|NCT00399490|Tanezumab|tanezumab|mesh-list
65404026|NCT00399490|Analgesics|analgesics|mesh-ancestor
65404027|NCT00399490|Sensory System Agents|sensory system agents|mesh-ancestor
65404028|NCT00399490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65404029|NCT00399490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404030|NCT00398866|Triamcinolone|triamcinolone|mesh-list
65404031|NCT00398866|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65404032|NCT00398866|Bupivacaine|bupivacaine|mesh-list
65404033|NCT00398866|Hyaluronic Acid|hyaluronic acid|mesh-list
65404034|NCT00398866|Hylan|hylan|mesh-list
65404035|NCT00398866|Anesthetics, Local|anesthetics, local|mesh-ancestor
65404036|NCT00398866|Anesthetics|anesthetics|mesh-ancestor
65404037|NCT00398866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65404038|NCT00398866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404039|NCT00398866|Sensory System Agents|sensory system agents|mesh-ancestor
65404040|NCT00398866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65404041|NCT00398866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65404046|NCT00398866|Immunologic Factors|immunologic factors|mesh-ancestor
65404047|NCT00398866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65404048|NCT00398866|Viscosupplements|viscosupplements|mesh-ancestor
65404049|NCT00398866|Protective Agents|protective agents|mesh-ancestor
65404050|NCT00771563|Cisplatin|cisplatin|mesh-list
65404051|NCT00771563|Docetaxel|docetaxel|mesh-list
65404052|NCT00771563|Enoxaparin|enoxaparin|mesh-list
65404053|NCT00771563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404054|NCT00771563|Tubulin Modulators|tubulin modulators|mesh-ancestor
65404055|NCT00771563|Antimitotic Agents|antimitotic agents|mesh-ancestor
65404056|NCT00771563|Mitosis Modulators|mitosis modulators|mesh-ancestor
65404057|NCT00771563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404058|NCT00771563|Anticoagulants|anticoagulants|mesh-ancestor
65404059|NCT00771563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65404060|NCT00771563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65404061|NCT00775073|Bevacizumab|bevacizumab|mesh-list
65404062|NCT00775073|Everolimus|everolimus|mesh-list
65404063|NCT00775073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65404064|NCT00775073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404065|NCT00775073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65227667|NCT05373277|Ticagrelor|ticagrelor|mesh-list
65404066|NCT00775073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65404067|NCT00775073|Growth Substances|growth substances|mesh-ancestor
65404068|NCT00775073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404069|NCT00775073|Growth Inhibitors|growth inhibitors|mesh-ancestor
65404070|NCT00775073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65404071|NCT00775073|Immunologic Factors|immunologic factors|mesh-ancestor
65404072|NCT00398632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65404073|NCT00398632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65404074|NCT00398632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65404075|NCT00398632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65404076|NCT00398632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404077|NCT00398632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65404078|NCT00398632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404079|NCT00398632|Analgesics|analgesics|mesh-ancestor
65404080|NCT00398632|Sensory System Agents|sensory system agents|mesh-ancestor
65404081|NCT00398632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65404082|NCT00398632|Antidepressive Agents|antidepressive agents|mesh-ancestor
65404083|NCT00398632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65404084|NCT00398632|Dopamine Agents|dopamine agents|mesh-ancestor
65404085|NCT01589146|Heparin|heparin|mesh-list
65404086|NCT01589146|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65404087|NCT01589146|Tinzaparin|tinzaparin|mesh-list
65404088|NCT01589146|Dalteparin|dalteparin|mesh-list
65404089|NCT01589146|Anticoagulants|anticoagulants|mesh-ancestor
65404090|NCT01589146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65404091|NCT01589146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65404092|NCT01589146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404093|NCT00775151|Amlodipine|amlodipine|mesh-list
65404094|NCT00775151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65404095|NCT00775151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65404096|NCT00775151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65404097|NCT00775151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404098|NCT00775151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65404099|NCT00775151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404100|NCT00775151|Vasodilator Agents|vasodilator agents|mesh-ancestor
65404101|NCT04694300|Acetaminophen|acetaminophen|mesh-list
65404102|NCT04694300|Naproxen|naproxen|mesh-list
65404103|NCT04694300|Tramadol|tramadol|mesh-list
65404104|NCT04694300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65404105|NCT04694300|Analgesics|analgesics|mesh-ancestor
65404106|NCT04694300|Sensory System Agents|sensory system agents|mesh-ancestor
65404107|NCT04694300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65404108|NCT04694300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404109|NCT04694300|Antipyretics|antipyretics|mesh-ancestor
65404110|NCT04694300|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65404111|NCT04694300|Narcotics|narcotics|mesh-ancestor
65404112|NCT04694300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65404113|NCT04694300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65404120|NCT04642820|Methamphetamine|methamphetamine|mesh-list
65404121|NCT04642820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65404122|NCT04642820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404123|NCT04642820|Sympathomimetics|sympathomimetics|mesh-ancestor
65404124|NCT04642820|Autonomic Agents|autonomic agents|mesh-ancestor
65404125|NCT04642820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65404126|NCT04642820|Dopamine Agents|dopamine agents|mesh-ancestor
65404127|NCT04642820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65404128|NCT04642820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404129|NCT04642820|Adrenergic Agents|adrenergic agents|mesh-ancestor
65404130|NCT04642820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65404131|NCT04642820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65404132|NCT04642820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65404133|NCT04642820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65404134|NCT00771641|Cobalt|cobalt|mesh-list
65404135|NCT00771641|Trace Elements|trace elements|mesh-ancestor
65404136|NCT00771641|Micronutrients|micronutrients|mesh-ancestor
65404137|NCT00771641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404138|NCT05408000|Propofol|propofol|mesh-list
65404139|NCT05408000|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65404140|NCT05408000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65404141|NCT05408000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404142|NCT05408000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65404143|NCT05408000|Anesthetics, General|anesthetics, general|mesh-ancestor
65404144|NCT05408000|Anesthetics|anesthetics|mesh-ancestor
65227749|NCT00577993|Antiviral Agents|antiviral agents|mesh-ancestor
65404145|NCT00771719|Ceftobiprole|ceftobiprole|mesh-list
65404146|NCT00771719|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
65404147|NCT00771719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65404148|NCT00771719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65404149|NCT00673361|Temozolomide|temozolomide|mesh-list
65404150|NCT00673361|Sorafenib|sorafenib|mesh-list
65404151|NCT00673361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65404152|NCT00673361|Alkylating Agents|alkylating agents|mesh-ancestor
65404153|NCT00673361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404154|NCT00673361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404155|NCT00673361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65404156|NCT00673361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65404157|NCT00393718|Liraglutide|liraglutide|mesh-list
65404158|NCT00393718|Glyburide|glyburide|mesh-list
65404159|NCT00393718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65404160|NCT00393718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404161|NCT00393718|Incretins|incretins|mesh-ancestor
65404162|NCT00393718|Hormones|hormones|mesh-ancestor
65404163|NCT00393718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65404164|NCT00669071|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
65404165|NCT00669071|Tretinoin|tretinoin|mesh-list
65404166|NCT00669071|Hydroquinone|hydroquinone|mesh-list
65404167|NCT00669071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404168|NCT00669071|Keratolytic Agents|keratolytic agents|mesh-ancestor
65404169|NCT00669071|Dermatologic Agents|dermatologic agents|mesh-ancestor
65404170|NCT00669071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65404171|NCT00669071|Glucocorticoids|glucocorticoids|mesh-ancestor
65404172|NCT00669071|Hormones|hormones|mesh-ancestor
65404173|NCT00669071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65404174|NCT00669071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404175|NCT00669071|Antioxidants|antioxidants|mesh-ancestor
65404176|NCT00669071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404177|NCT00669071|Protective Agents|protective agents|mesh-ancestor
65404178|NCT00669071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65404179|NCT00398320|Bevacizumab|bevacizumab|mesh-list
65404180|NCT00398320|Capecitabine|capecitabine|mesh-list
65404181|NCT00398320|Oxaliplatin|oxaliplatin|mesh-list
65404182|NCT00398320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65404183|NCT00398320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404191|NCT00398320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404193|NCT00670007|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65404194|NCT00670007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65404195|NCT00670007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404196|NCT00670007|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65404197|NCT00670007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65404198|NCT04003688|Magnesium Sulfate|magnesium sulfate|mesh-list
65404199|NCT04003688|Analgesics|analgesics|mesh-ancestor
65404200|NCT04003688|Sensory System Agents|sensory system agents|mesh-ancestor
65404201|NCT04003688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65404202|NCT04003688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404203|NCT04003688|Anesthetics|anesthetics|mesh-ancestor
65404204|NCT04003688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65404205|NCT04003688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65404206|NCT04003688|Anticonvulsants|anticonvulsants|mesh-ancestor
65404207|NCT04003688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65404208|NCT04003688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65404209|NCT04003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404210|NCT04003688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65404211|NCT04003688|Tocolytic Agents|tocolytic agents|mesh-ancestor
65404212|NCT04003688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65404213|NCT00779129|Cyclophosphamide|cyclophosphamide|mesh-list
65404214|NCT00779129|Doxorubicin|doxorubicin|mesh-list
65404215|NCT00779129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65404216|NCT00779129|Immunologic Factors|immunologic factors|mesh-ancestor
65404217|NCT00779129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404218|NCT00779129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65404219|NCT00779129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65404220|NCT00779129|Alkylating Agents|alkylating agents|mesh-ancestor
65404221|NCT00779129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404222|NCT00779129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404223|NCT00779129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65404224|NCT00779129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65404225|NCT00779129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65269872|NCT02727296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65404226|NCT00779129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65404227|NCT00779129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65404228|NCT00772187|Fentanyl|fentanyl|mesh-list
65404229|NCT00772187|Morphine|morphine|mesh-list
65404230|NCT00772187|Anesthetics|anesthetics|mesh-ancestor
65404231|NCT00772187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65404232|NCT00772187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404233|NCT00772187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65404234|NCT00772187|Narcotics|narcotics|mesh-ancestor
65404235|NCT00772187|Analgesics|analgesics|mesh-ancestor
65404236|NCT00772187|Sensory System Agents|sensory system agents|mesh-ancestor
65404237|NCT00772187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65404238|NCT00772187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65404239|NCT00772187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65404240|NCT00772187|Anesthetics, General|anesthetics, general|mesh-ancestor
65404241|NCT00772265|Insulin|insulin|mesh-list
65404242|NCT00772265|Isophane Insulin, Human|isophane insulin, human|mesh-list
65404243|NCT00772265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65404244|NCT00772265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404245|NCT00779441|Zolpidem|zolpidem|mesh-list
65404246|NCT00779441|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65404247|NCT00779441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65404259|NCT02556437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404260|NCT04946006|Oxytocin|oxytocin|mesh-list
65404261|NCT04946006|Oxytocics|oxytocics|mesh-ancestor
65404262|NCT04946006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65404263|NCT04946006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404264|NCT00775619|Carvedilol|carvedilol|mesh-list
65404265|NCT00775619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65153829|NCT05025397|Propofol|propofol|mesh-list
65404266|NCT00775619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65404267|NCT00775619|Adrenergic Agents|adrenergic agents|mesh-ancestor
65404268|NCT00775619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65404269|NCT00775619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404270|NCT00775619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404271|NCT00775619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65404272|NCT00775619|Antioxidants|antioxidants|mesh-ancestor
65404273|NCT00775619|Protective Agents|protective agents|mesh-ancestor
65404274|NCT00775619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65404275|NCT00775619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65404276|NCT00775619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65404277|NCT00775619|Vasodilator Agents|vasodilator agents|mesh-ancestor
65404278|NCT00775619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65404279|NCT00775619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65404280|NCT00775697|Montelukast|montelukast|mesh-list
65404281|NCT00775697|Leukotriene Antagonists|leukotriene antagonists|mesh-list
65404282|NCT00775697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65404283|NCT00775697|Respiratory System Agents|respiratory system agents|mesh-ancestor
65404284|NCT00775697|Hormone Antagonists|hormone antagonists|mesh-ancestor
65404285|NCT00775697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65404286|NCT00775697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404287|NCT00775697|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65404288|NCT00775697|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65404289|NCT00775697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404290|NCT05357066|Nitrous Oxide|nitrous oxide|mesh-list
65404291|NCT05357066|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65404292|NCT05357066|Anesthetics, General|anesthetics, general|mesh-ancestor
65404293|NCT05357066|Anesthetics|anesthetics|mesh-ancestor
65404294|NCT05357066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65404295|NCT05357066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404296|NCT05357066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65404297|NCT05357066|Analgesics|analgesics|mesh-ancestor
65404298|NCT05357066|Sensory System Agents|sensory system agents|mesh-ancestor
65404299|NCT05357066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65404300|NCT02556905|Dexamethasone|dexamethasone|mesh-list
65404301|NCT02556905|Lenalidomide|lenalidomide|mesh-list
65404302|NCT02556905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65404303|NCT02556905|Antiemetics|antiemetics|mesh-ancestor
65404304|NCT02556905|Autonomic Agents|autonomic agents|mesh-ancestor
65404305|NCT02556905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65404306|NCT02556905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404307|NCT02556905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65404308|NCT02556905|Glucocorticoids|glucocorticoids|mesh-ancestor
65404309|NCT02556905|Hormones|hormones|mesh-ancestor
64789075|NCT00003150|Prednisone|prednisone|mesh-list
65404324|NCT00539006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404325|NCT00539006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65404326|NCT00539006|Respiratory System Agents|respiratory system agents|mesh-ancestor
65404327|NCT00539006|Dermatologic Agents|dermatologic agents|mesh-ancestor
65404328|NCT00539006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65404330|NCT04047329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65404331|NCT04047329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404332|NCT00779753|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
65404333|NCT00779753|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65404334|NCT00779753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65404335|NCT00537056|Sunitinib|sunitinib|mesh-list
65404336|NCT00537056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65404337|NCT00537056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404338|NCT00537056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65153885|NCT00929695|Prednisone|prednisone|mesh-list
65404339|NCT00537056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65404340|NCT00537056|Growth Substances|growth substances|mesh-ancestor
65404341|NCT00537056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404342|NCT00537056|Growth Inhibitors|growth inhibitors|mesh-ancestor
65404343|NCT00537056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65404344|NCT00537056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65404345|NCT00537056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404346|NCT00537056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65404347|NCT00779831|Pseudoephedrine|pseudoephedrine|mesh-list
65404348|NCT00779831|Ephedrine|ephedrine|mesh-list
65404349|NCT00779831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65404350|NCT00779831|Autonomic Agents|autonomic agents|mesh-ancestor
65404351|NCT00779831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65404352|NCT00779831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404353|NCT00779831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65404354|NCT00779831|Respiratory System Agents|respiratory system agents|mesh-ancestor
65404355|NCT00779831|Nasal Decongestants|nasal decongestants|mesh-ancestor
65404356|NCT00779831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65404357|NCT00779831|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65404358|NCT00779831|Sympathomimetics|sympathomimetics|mesh-ancestor
65404359|NCT00779831|Adrenergic Agents|adrenergic agents|mesh-ancestor
65404360|NCT00779831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65404361|NCT00779831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404362|NCT04857398|Insulin|insulin|mesh-list
65404363|NCT04857398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65404364|NCT04857398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404365|NCT00535262|Selegiline|selegiline|mesh-list
65404366|NCT00535262|Antidepressive Agents|antidepressive agents|mesh-ancestor
65404367|NCT00535262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65404368|NCT00535262|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65404384|NCT00772499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65404385|NCT00772499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404386|NCT00772499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65404387|NCT00772499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404388|NCT00772499|Vasodilator Agents|vasodilator agents|mesh-ancestor
65404389|NCT00772499|Diuretics|diuretics|mesh-ancestor
65404390|NCT00772499|Natriuretic Agents|natriuretic agents|mesh-ancestor
65404391|NCT00772499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65404392|NCT00772499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65404393|NCT00772499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65404394|NCT00772499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65404395|NCT00772499|Sympatholytics|sympatholytics|mesh-ancestor
65404396|NCT00772499|Autonomic Agents|autonomic agents|mesh-ancestor
65404397|NCT00772499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65404398|NCT00772499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65404399|NCT00772499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65404400|NCT00772499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65404401|NCT00772499|Adrenergic Agents|adrenergic agents|mesh-ancestor
65404402|NCT00772499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65404404|NCT00989690|Pemetrexed|pemetrexed|mesh-list
65404405|NCT00989690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65404406|NCT00989690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404407|NCT00989690|Tubulin Modulators|tubulin modulators|mesh-ancestor
65404408|NCT00989690|Antimitotic Agents|antimitotic agents|mesh-ancestor
65404409|NCT00989690|Mitosis Modulators|mitosis modulators|mesh-ancestor
65153956|NCT05052541|Hallucinogens|hallucinogens|mesh-ancestor
65404410|NCT00989690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404411|NCT00989690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65404412|NCT00989690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65404413|NCT00989690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65404414|NCT00989690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65404415|NCT00074581|Ritonavir|ritonavir|mesh-list
65404416|NCT00074581|Lopinavir|lopinavir|mesh-list
65404417|NCT00074581|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65404418|NCT00074581|Tenofovir|tenofovir|mesh-list
65404419|NCT00074581|Lamivudine|lamivudine|mesh-list
65404420|NCT00074581|Zidovudine|zidovudine|mesh-list
65404421|NCT00074581|Emtricitabine|emtricitabine|mesh-list
65404422|NCT00074581|Nevirapine|nevirapine|mesh-list
65404423|NCT00074581|Didanosine|didanosine|mesh-list
65404424|NCT00074581|Stavudine|stavudine|mesh-list
65404425|NCT00074581|Efavirenz|efavirenz|mesh-list
65404426|NCT00074581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65404427|NCT00074581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65404428|NCT00074581|Protease Inhibitors|protease inhibitors|mesh-ancestor
65404429|NCT00074581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789202|NCT00003264|Gemcitabine|gemcitabine|mesh-list
65404443|NCT00074581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65404444|NCT00074581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65404446|NCT00776477|Clopidogrel|clopidogrel|mesh-list
65404447|NCT00776477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65404448|NCT00776477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65404449|NCT00776477|Analgesics|analgesics|mesh-ancestor
65404450|NCT00776477|Sensory System Agents|sensory system agents|mesh-ancestor
65404451|NCT00776477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65404452|NCT00776477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404453|NCT00776477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65404454|NCT00776477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65404455|NCT00776477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65404456|NCT00776477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65404457|NCT00776477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404458|NCT00776477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65404459|NCT00776477|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65404460|NCT00776477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65404461|NCT00776477|Antipyretics|antipyretics|mesh-ancestor
65404462|NCT00776477|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65404463|NCT00776477|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65404464|NCT00776477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65404465|NCT00776477|Purinergic Agents|purinergic agents|mesh-ancestor
65404466|NCT00776477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65404467|NCT00772655|Rituximab|rituximab|mesh-list
65404468|NCT00772655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65404469|NCT00772655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404470|NCT00772655|Immunologic Factors|immunologic factors|mesh-ancestor
65404471|NCT00772655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404472|NCT00772655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65404473|NCT04272086|Bupivacaine|bupivacaine|mesh-list
65404474|NCT04272086|Anesthetics, Local|anesthetics, local|mesh-ancestor
65404475|NCT04272086|Anesthetics|anesthetics|mesh-ancestor
65404476|NCT04272086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65404477|NCT04272086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404478|NCT04272086|Sensory System Agents|sensory system agents|mesh-ancestor
65404479|NCT04272086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65404480|NCT00776633|Aspirin|aspirin|mesh-list
65404481|NCT00776633|Clopidogrel|clopidogrel|mesh-list
65404482|NCT00776633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65404483|NCT00776633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65404484|NCT00776633|Analgesics|analgesics|mesh-ancestor
65404485|NCT00776633|Sensory System Agents|sensory system agents|mesh-ancestor
65404486|NCT00776633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64789261|NCT00003336|Alkylating Agents|alkylating agents|mesh-ancestor
65404504|NCT01093963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404505|NCT01093963|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65404506|NCT01093963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65404507|NCT01093963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65404508|NCT01093963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404509|NCT01093963|Dopamine Agents|dopamine agents|mesh-ancestor
65404510|NCT01093963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65404511|NCT04256018|Mogamulizumab|mogamulizumab|mesh-list
65404512|NCT04256018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404513|NCT03961087|Ubiquinone|ubiquinone|mesh-list
65404514|NCT03961087|Coenzyme Q10|coenzyme q10|mesh-list
65404515|NCT03961087|Meclofenoxate|meclofenoxate|mesh-list
65404516|NCT03961087|Micronutrients|micronutrients|mesh-ancestor
65404517|NCT03961087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404518|NCT03961087|Vitamins|vitamins|mesh-ancestor
65228052|NCT02683005|Sofosbuvir|sofosbuvir|mesh-list
65404519|NCT03961087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65404520|NCT03961087|Protective Agents|protective agents|mesh-ancestor
65404521|NCT03961087|Nootropic Agents|nootropic agents|mesh-ancestor
65404522|NCT03960775|Dexmedetomidine|dexmedetomidine|mesh-list
65404523|NCT03960775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65404524|NCT03960775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65404525|NCT03960775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404526|NCT03960775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65404527|NCT03960775|Analgesics|analgesics|mesh-ancestor
65404528|NCT03960775|Sensory System Agents|sensory system agents|mesh-ancestor
65404529|NCT03960775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65404530|NCT03960775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65404531|NCT03960775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65404532|NCT03960775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65404533|NCT03960775|Adrenergic Agents|adrenergic agents|mesh-ancestor
65404534|NCT03960775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65404535|NCT03960775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404536|NCT00536978|Cytarabine|cytarabine|mesh-list
65404537|NCT00536978|Cyclophosphamide|cyclophosphamide|mesh-list
65404538|NCT00536978|Melphalan|melphalan|mesh-list
65404539|NCT00536978|Carmustine|carmustine|mesh-list
65404540|NCT00536978|Rituximab|rituximab|mesh-list
65404541|NCT00536978|Methotrexate|methotrexate|mesh-list
65404542|NCT00536978|Fludarabine|fludarabine|mesh-list
65404543|NCT00536978|Fludarabine phosphate|fludarabine phosphate|mesh-list
65154104|NCT01217190|Autonomic Agents|autonomic agents|mesh-ancestor
65404561|NCT00536978|Antimetabolites|antimetabolites|mesh-ancestor
65404562|NCT00536978|Dermatologic Agents|dermatologic agents|mesh-ancestor
65404563|NCT00536978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65404564|NCT00536978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65404565|NCT00536978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65404566|NCT00536978|Antiviral Agents|antiviral agents|mesh-ancestor
65404567|NCT00536978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65404568|NCT00536978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65404569|NCT00536978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65404570|NCT00536978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65404571|NCT00536978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65404572|NCT03809611|Choline|choline|mesh-list
65404573|NCT03809611|Lipotropic Agents|lipotropic agents|mesh-ancestor
65404574|NCT03809611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65404575|NCT03809611|Antimetabolites|antimetabolites|mesh-ancestor
65404576|NCT03809611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404577|NCT03809611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65404578|NCT03809611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65404579|NCT03809611|Nootropic Agents|nootropic agents|mesh-ancestor
65404580|NCT05360342|Vitamins|vitamins|mesh-list
65404581|NCT05360342|Vitamin K|vitamin k|mesh-list
65404582|NCT05360342|Vitamin K 1|vitamin k 1|mesh-list
65404583|NCT05360342|Micronutrients|micronutrients|mesh-ancestor
65404584|NCT05360342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404585|NCT05360342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65404586|NCT05360342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65404587|NCT05360342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404588|NCT05360342|Hemostatics|hemostatics|mesh-ancestor
65404589|NCT05360342|Coagulants|coagulants|mesh-ancestor
65404590|NCT05290220|Lenvatinib|lenvatinib|mesh-list
65404591|NCT05290220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404592|NCT05290220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65404593|NCT05290220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65404594|NCT05290220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404595|NCT04026230|Atorvastatin|atorvastatin|mesh-list
65404596|NCT04026230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65404597|NCT04026230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65404598|NCT04026230|Antimetabolites|antimetabolites|mesh-ancestor
65404599|NCT04026230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789379|NCT00003408|Interferons|interferons|mesh-list
65404611|NCT00536510|Micronutrients|micronutrients|mesh-ancestor
65404612|NCT00536510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404613|NCT04424264|Tenofovir|tenofovir|mesh-list
65404614|NCT04424264|Lamivudine|lamivudine|mesh-list
65404615|NCT04424264|Emtricitabine|emtricitabine|mesh-list
65404616|NCT04424264|Efavirenz|efavirenz|mesh-list
65404617|NCT04424264|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65404618|NCT04424264|Rifampin|rifampin|mesh-list
65404619|NCT04424264|Isoniazid|isoniazid|mesh-list
65404620|NCT04424264|Antiviral Agents|antiviral agents|mesh-ancestor
65404621|NCT04424264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65269873|NCT02727296|Anesthetics, General|anesthetics, general|mesh-ancestor
65404622|NCT04424264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65404623|NCT04424264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65404624|NCT04424264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65404625|NCT04424264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404626|NCT04424264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65404627|NCT04424264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65404628|NCT04424264|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65404629|NCT04424264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65404630|NCT04424264|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65404631|NCT04424264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65404632|NCT04424264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65404633|NCT04424264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65404634|NCT04424264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65404635|NCT04424264|Antitubercular Agents|antitubercular agents|mesh-ancestor
65404636|NCT04424264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65404637|NCT04424264|Leprostatic Agents|leprostatic agents|mesh-ancestor
65154178|NCT00922441|Valsartan|valsartan|mesh-list
65493988|NCT03897439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65404638|NCT04424264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65404639|NCT04424264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65404640|NCT04424264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65404641|NCT04424264|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65404642|NCT04424264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65404643|NCT04424264|Antimetabolites|antimetabolites|mesh-ancestor
65404644|NCT04424264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65404645|NCT03790670|Sargramostim|sargramostim|mesh-list
65404646|NCT03790670|Immunologic Factors|immunologic factors|mesh-ancestor
65404647|NCT03790670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404648|NCT00398086|Gemcitabine|gemcitabine|mesh-list
65404649|NCT00398086|Paclitaxel|paclitaxel|mesh-list
65404650|NCT00398086|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65404651|NCT00398086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65404652|NCT00398086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404653|NCT00398086|Tubulin Modulators|tubulin modulators|mesh-ancestor
65404654|NCT00398086|Antimitotic Agents|antimitotic agents|mesh-ancestor
65404655|NCT00398086|Mitosis Modulators|mitosis modulators|mesh-ancestor
65404656|NCT00398086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404657|NCT00398086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65404658|NCT00398086|Antimetabolites|antimetabolites|mesh-ancestor
65404659|NCT00398086|Antiviral Agents|antiviral agents|mesh-ancestor
65404660|NCT00398086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65404661|NCT00398086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65404679|NCT00536198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404680|NCT00393484|Lamivudine|lamivudine|mesh-list
65404681|NCT00393484|Entecavir|entecavir|mesh-list
65404682|NCT00393484|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65404683|NCT00393484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65404684|NCT00393484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65404685|NCT00393484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404686|NCT00393484|Antiviral Agents|antiviral agents|mesh-ancestor
65404687|NCT00393484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65404688|NCT00393484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65404689|NCT00393484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65404690|NCT00667823|Macitentan|macitentan|mesh-list
65404691|NCT00667823|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65404692|NCT00667823|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65404693|NCT00667823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404694|NCT00667823|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65404695|NCT00536120|Natalizumab|natalizumab|mesh-list
65404696|NCT00536120|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
65404697|NCT00536120|Immunologic Factors|immunologic factors|mesh-ancestor
65404698|NCT00536120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404699|NCT00536120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65404700|NCT00057811|Leucovorin|leucovorin|mesh-list
65404701|NCT00057811|Cytarabine|cytarabine|mesh-list
65404702|NCT00057811|Prednisone|prednisone|mesh-list
65404703|NCT00057811|Methylprednisolone|methylprednisolone|mesh-list
65404704|NCT00057811|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65404705|NCT00057811|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65404706|NCT00057811|Prednisolone|prednisolone|mesh-list
65404707|NCT00057811|Prednisolone acetate|prednisolone acetate|mesh-list
65404708|NCT00057811|Hydrocortisone|hydrocortisone|mesh-list
65404709|NCT00057811|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65404710|NCT00057811|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65404711|NCT00057811|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65404712|NCT00057811|Cyclophosphamide|cyclophosphamide|mesh-list
65404713|NCT00057811|Rituximab|rituximab|mesh-list
65404715|NCT00057811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65404716|NCT00057811|Methotrexate|methotrexate|mesh-list
65404717|NCT00057811|Etoposide|etoposide|mesh-list
65404718|NCT00057811|Vincristine|vincristine|mesh-list
65404719|NCT00057811|Etoposide phosphate|etoposide phosphate|mesh-list
65404720|NCT00057811|Rasburicase|rasburicase|mesh-list
64789504|NCT00003558|Antidotes|antidotes|mesh-ancestor
65404739|NCT00057811|Glucocorticoids|glucocorticoids|mesh-ancestor
65404741|NCT00057811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65404742|NCT00057811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65404743|NCT00057811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65404744|NCT00057811|Abortifacient Agents|abortifacient agents|mesh-ancestor
65404745|NCT00057811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65404746|NCT00057811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65404747|NCT00057811|Antimetabolites|antimetabolites|mesh-ancestor
65404748|NCT00057811|Dermatologic Agents|dermatologic agents|mesh-ancestor
65404749|NCT00057811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65404750|NCT00057811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65404751|NCT00057811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65404752|NCT00057811|Antiviral Agents|antiviral agents|mesh-ancestor
65404753|NCT00057811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65404754|NCT00057811|Antidotes|antidotes|mesh-ancestor
65404755|NCT00057811|Protective Agents|protective agents|mesh-ancestor
65404756|NCT00057811|Vitamin B Complex|vitamin b complex|mesh-ancestor
65404757|NCT00057811|Vitamins|vitamins|mesh-ancestor
65404758|NCT00057811|Micronutrients|micronutrients|mesh-ancestor
65404759|NCT00057811|Tubulin Modulators|tubulin modulators|mesh-ancestor
65404760|NCT00057811|Antimitotic Agents|antimitotic agents|mesh-ancestor
65404761|NCT00057811|Mitosis Modulators|mitosis modulators|mesh-ancestor
65404762|NCT00057811|Antiemetics|antiemetics|mesh-ancestor
65404763|NCT00057811|Autonomic Agents|autonomic agents|mesh-ancestor
65404764|NCT00057811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65404765|NCT00057811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65404766|NCT00057811|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65404767|NCT00057811|Gout Suppressants|gout suppressants|mesh-ancestor
65404768|NCT03502148|Cisplatin|cisplatin|mesh-list
65404769|NCT03502148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404770|NCT02530801|Bevacizumab|bevacizumab|mesh-list
65404771|NCT02530801|Fluorouracil|fluorouracil|mesh-list
65404772|NCT02530801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65404773|NCT02530801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404774|NCT02530801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65404775|NCT02530801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64789561|NCT00003606|Cyclophosphamide|cyclophosphamide|mesh-list
65404781|NCT02530801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65404782|NCT02530801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65404783|NCT02530801|Immunologic Factors|immunologic factors|mesh-ancestor
65404784|NCT01091077|Naringenin|naringenin|mesh-list
65404785|NCT01091077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65404786|NCT01091077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65404787|NCT01091077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65404788|NCT01091077|Hormone Antagonists|hormone antagonists|mesh-ancestor
65404789|NCT01091077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65404790|NCT01091077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404791|NCT01094275|Omeprazole|omeprazole|mesh-list
65404792|NCT01094275|Clopidogrel|clopidogrel|mesh-list
65404793|NCT01094275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65404794|NCT01094275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65404795|NCT01094275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65404796|NCT01094275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65404797|NCT01094275|Purinergic Agents|purinergic agents|mesh-ancestor
65404798|NCT01094275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65404799|NCT01094275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404800|NCT01094275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404801|NCT01094275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65404802|NCT01094275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65404803|NCT01094275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65404804|NCT01094275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65404805|NCT01089205|Metformin|metformin|mesh-list
65404806|NCT01089205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65404807|NCT01089205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404808|NCT02866682|Tacrolimus|tacrolimus|mesh-list
65404809|NCT02866682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65404810|NCT02866682|Immunologic Factors|immunologic factors|mesh-ancestor
65404811|NCT02866682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404812|NCT02866682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65404813|NCT02866682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65404814|NCT02866682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404815|NCT01089439|Nitric Oxide|nitric oxide|mesh-list
65404816|NCT01089439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65404817|NCT01089439|Autonomic Agents|autonomic agents|mesh-ancestor
65404818|NCT01089439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65404819|NCT01089439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404820|NCT01089439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65404821|NCT01089439|Respiratory System Agents|respiratory system agents|mesh-ancestor
65404822|NCT01089439|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65404823|NCT01089439|Antioxidants|antioxidants|mesh-ancestor
65404824|NCT01089439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404825|NCT01089439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65404826|NCT01089439|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65404827|NCT01089439|Vasodilator Agents|vasodilator agents|mesh-ancestor
65404828|NCT01089439|Gasotransmitters|gasotransmitters|mesh-ancestor
65404829|NCT01089439|Protective Agents|protective agents|mesh-ancestor
65404830|NCT00992030|Rituximab|rituximab|mesh-list
65404831|NCT00992030|Doxorubicin|doxorubicin|mesh-list
65404832|NCT00992030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65404833|NCT00992030|Dacarbazine|dacarbazine|mesh-list
65404834|NCT00992030|Bleomycin|bleomycin|mesh-list
65404835|NCT00992030|Vinblastine|vinblastine|mesh-list
65404836|NCT00992030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65404837|NCT00992030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404838|NCT00992030|Immunologic Factors|immunologic factors|mesh-ancestor
65404839|NCT00992030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404840|NCT00992030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65404841|NCT00992030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65404842|NCT00992030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65404843|NCT00992030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65404844|NCT00992030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789616|NCT00003666|Alkylating Agents|alkylating agents|mesh-ancestor
65404849|NCT00992030|Tubulin Modulators|tubulin modulators|mesh-ancestor
65404850|NCT00992030|Antimitotic Agents|antimitotic agents|mesh-ancestor
65404851|NCT00992030|Mitosis Modulators|mitosis modulators|mesh-ancestor
65404852|NCT01976390|Sirolimus|sirolimus|mesh-list
65404853|NCT01976390|Everolimus|everolimus|mesh-list
65404854|NCT01976390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404855|NCT01976390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65404856|NCT01976390|Immunologic Factors|immunologic factors|mesh-ancestor
65404857|NCT01976390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404858|NCT01976390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65404859|NCT01976390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65404860|NCT01976390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65404861|NCT01976390|Antifungal Agents|antifungal agents|mesh-ancestor
65404862|NCT00570713|Gemcitabine|gemcitabine|mesh-list
65404863|NCT00570713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65404864|NCT00570713|Antimetabolites|antimetabolites|mesh-ancestor
65493989|NCT03897439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65404865|NCT00570713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404866|NCT00570713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404867|NCT00570713|Antiviral Agents|antiviral agents|mesh-ancestor
65404868|NCT00570713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65404869|NCT00570713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65404870|NCT00570713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65404871|NCT00570713|Immunologic Factors|immunologic factors|mesh-ancestor
65404872|NCT00570713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404873|NCT04002440|Candesartan cilexetil|candesartan cilexetil|mesh-list
65404874|NCT04002440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65404875|NCT04002440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65404876|NCT04002440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65404877|NCT04002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404878|NCT00780377|Bradykinin|bradykinin|mesh-list
65404879|NCT00780377|Kininogens|kininogens|mesh-list
65404880|NCT00780377|Vasodilator Agents|vasodilator agents|mesh-ancestor
65404881|NCT00780377|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65404882|NCT00780377|Protease Inhibitors|protease inhibitors|mesh-ancestor
65404883|NCT00780377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65404884|NCT00780377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404885|NCT05219942|Insulin|insulin|mesh-list
65404886|NCT05219942|Insulin Glargine|insulin glargine|mesh-list
65228348|NCT00730249|Methylphenidate|methylphenidate|mesh-list
65404887|NCT05219942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65404888|NCT05219942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404889|NCT00669617|Fluticasone|fluticasone|mesh-list
65404890|NCT00669617|Xhance|xhance|mesh-list
65404891|NCT00669617|Albuterol|albuterol|mesh-list
65404892|NCT00669617|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65404893|NCT00669617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65404894|NCT00669617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65404895|NCT00669617|Autonomic Agents|autonomic agents|mesh-ancestor
65404896|NCT00669617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65404897|NCT00669617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404898|NCT00669617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65404899|NCT00669617|Respiratory System Agents|respiratory system agents|mesh-ancestor
65404900|NCT00669617|Dermatologic Agents|dermatologic agents|mesh-ancestor
65404901|NCT00669617|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65404902|NCT00669617|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65404903|NCT00669617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65404904|NCT00669617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65404905|NCT00669617|Adrenergic Agents|adrenergic agents|mesh-ancestor
65404906|NCT00669617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65404907|NCT00669617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404908|NCT00669617|Tocolytic Agents|tocolytic agents|mesh-ancestor
65404909|NCT00669617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65404910|NCT03979352|Empagliflozin|empagliflozin|mesh-list
65404911|NCT03979352|Pancrelipase|pancrelipase|mesh-list
65404912|NCT03979352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65404913|NCT03979352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404919|NCT00773201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65404920|NCT00773201|Adrenergic Agents|adrenergic agents|mesh-ancestor
65404921|NCT00773201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65404922|NCT00773201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404923|NCT00773201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404924|NCT00773201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65404925|NCT00773201|Sympatholytics|sympatholytics|mesh-ancestor
65404926|NCT00773201|Autonomic Agents|autonomic agents|mesh-ancestor
65404927|NCT00773201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65404928|NCT00777413|Minocycline|minocycline|mesh-list
65404929|NCT00777413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65404930|NCT00777413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65404931|NCT05162690|Dapagliflozin|dapagliflozin|mesh-list
65404932|NCT05162690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65404933|NCT05162690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404934|NCT05162690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65404935|NCT05162690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404936|NCT00992576|Hydromorphone|hydromorphone|mesh-list
65404937|NCT00992576|Naloxone|naloxone|mesh-list
65404938|NCT00992576|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65404939|NCT00992576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404940|NCT00992576|Sensory System Agents|sensory system agents|mesh-ancestor
65404941|NCT00992576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65404942|NCT00992576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65404943|NCT00992576|Narcotics|narcotics|mesh-ancestor
65404944|NCT00992576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65404945|NCT00992576|Analgesics|analgesics|mesh-ancestor
65404946|NCT00777569|Nicotine|nicotine|mesh-list
65404947|NCT00777569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65404948|NCT00777569|Autonomic Agents|autonomic agents|mesh-ancestor
65404949|NCT00777569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65404950|NCT00777569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404951|NCT00777569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65404952|NCT00777569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65404953|NCT00777569|Cholinergic Agents|cholinergic agents|mesh-ancestor
65404954|NCT00777569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65404955|NCT00777569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404956|NCT02556593|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65404957|NCT02556593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404958|NCT02556593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65404959|NCT02556593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65404960|NCT02556593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404961|NCT00535730|Vaccines|vaccines|mesh-list
65404962|NCT00535730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65404963|NCT00535730|Immunologic Factors|immunologic factors|mesh-ancestor
65404964|NCT00535730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404965|NCT00992654|Maraviroc|maraviroc|mesh-list
65404966|NCT00992654|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65404967|NCT00992654|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65404968|NCT00992654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404969|NCT00992654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65404970|NCT00992654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65404971|NCT00992654|Antiviral Agents|antiviral agents|mesh-ancestor
65404972|NCT00992654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65404973|NCT00992654|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65404974|NCT00773591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65404975|NCT00773591|Botulinum Toxins|botulinum toxins|mesh-list
65404976|NCT00773591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65404977|NCT00773591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65404978|NCT00773591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65404979|NCT00773591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404980|NCT00773591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65404981|NCT00773591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65404982|NCT00773591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404994|NCT00666965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65404995|NCT00666965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404996|NCT00666965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404997|NCT00781157|Phenylephrine|phenylephrine|mesh-list
65404998|NCT00781157|Oxymetazoline|oxymetazoline|mesh-list
65404999|NCT00781157|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65405000|NCT00781157|Mydriatics|mydriatics|mesh-ancestor
65405001|NCT00781157|Autonomic Agents|autonomic agents|mesh-ancestor
65405002|NCT00781157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65405003|NCT00781157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405004|NCT00781157|Sympathomimetics|sympathomimetics|mesh-ancestor
65405005|NCT00781157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65405006|NCT00781157|Nasal Decongestants|nasal decongestants|mesh-ancestor
65405007|NCT00781157|Respiratory System Agents|respiratory system agents|mesh-ancestor
65405008|NCT00781157|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65405009|NCT00781157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65405010|NCT00781157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65405011|NCT00781157|Adrenergic Agents|adrenergic agents|mesh-ancestor
65405012|NCT00781157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65154551|NCT04251871|Immunologic Factors|immunologic factors|mesh-ancestor
65493990|NCT03897439|Cholinergic Agents|cholinergic agents|mesh-ancestor
65405013|NCT00781157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405014|NCT00781157|Protective Agents|protective agents|mesh-ancestor
65405015|NCT00777959|Sirolimus|sirolimus|mesh-list
65405016|NCT00777959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65405017|NCT00777959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65405018|NCT00777959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65405019|NCT00777959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405020|NCT00777959|Antifungal Agents|antifungal agents|mesh-ancestor
65405021|NCT00777959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65405022|NCT00777959|Immunologic Factors|immunologic factors|mesh-ancestor
65405023|NCT00777959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405024|NCT00778037|Cyclobenzaprine|cyclobenzaprine|mesh-list
65405025|NCT00778037|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65405026|NCT00778037|Antidepressive Agents|antidepressive agents|mesh-ancestor
65405027|NCT00778037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65405028|NCT00778037|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65405029|NCT00778037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405030|NCT00778037|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65405031|NCT00778037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65405032|NCT00778037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65405033|NCT00778037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65405034|NCT00778115|Simethicone|simethicone|mesh-list
65405035|NCT00778115|Loperamide|loperamide|mesh-list
65405036|NCT00778115|Antidiarrheals|antidiarrheals|mesh-list
65405037|NCT00778115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65405038|NCT00778115|Antifoaming Agents|antifoaming agents|mesh-ancestor
65405039|NCT00778115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405040|NCT00778115|Emollients|emollients|mesh-ancestor
65405041|NCT00778115|Dermatologic Agents|dermatologic agents|mesh-ancestor
65405042|NCT00993122|Ribavirin|ribavirin|mesh-list
65405043|NCT00993122|Antimetabolites|antimetabolites|mesh-ancestor
65405044|NCT00993122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405045|NCT00993122|Antiviral Agents|antiviral agents|mesh-ancestor
65405046|NCT00993122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65405060|NCT00778193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65269874|NCT02727296|Anesthetics|anesthetics|mesh-ancestor
65405061|NCT00778193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405062|NCT00778193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65405063|NCT00778193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65405064|NCT00778193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405066|NCT00778193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65405067|NCT00778193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65405068|NCT00778193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65405069|NCT00778193|Purinergic Agents|purinergic agents|mesh-ancestor
65405070|NCT00778193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65405071|NCT00778193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65405072|NCT00778193|Gout Suppressants|gout suppressants|mesh-ancestor
65405073|NCT00778271|Gabapentin|gabapentin|mesh-list
65405074|NCT00778271|Analgesics|analgesics|mesh-ancestor
65405075|NCT00778271|Sensory System Agents|sensory system agents|mesh-ancestor
65405076|NCT00778271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65405077|NCT00778271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405078|NCT00778271|Anticonvulsants|anticonvulsants|mesh-ancestor
65405079|NCT00778271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65405080|NCT00778271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65405081|NCT00778271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65405082|NCT00778271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65405083|NCT00778271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65405084|NCT00778271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65405085|NCT00778271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65154626|NCT01127607|Dopamine Agents|dopamine agents|mesh-ancestor
65405086|NCT00778271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405087|NCT00778271|Antimanic Agents|antimanic agents|mesh-ancestor
65405088|NCT00778349|Metformin|metformin|mesh-list
65405089|NCT00778349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65405090|NCT00778349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405091|NCT00995618|Tranilast|tranilast|mesh-list
65405092|NCT00995618|Febuxostat|febuxostat|mesh-list
65405093|NCT00995618|Gout Suppressants|gout suppressants|mesh-ancestor
65405094|NCT00995618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65405095|NCT00995618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65405096|NCT00995618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65405097|NCT00995618|Analgesics|analgesics|mesh-ancestor
65405098|NCT00995618|Sensory System Agents|sensory system agents|mesh-ancestor
65405099|NCT00995618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65405100|NCT00995618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405101|NCT00995618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65405102|NCT00995618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65405103|NCT00995618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65405104|NCT00995618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405105|NCT00995618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65405106|NCT00995618|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65405107|NCT00995618|Histamine Antagonists|histamine antagonists|mesh-ancestor
65405115|NCT03889886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65405116|NCT03889886|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65405117|NCT00667355|Adalimumab|adalimumab|mesh-list
65405118|NCT00667355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65405119|NCT00667355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65405120|NCT00778505|Remifentanil|remifentanil|mesh-list
65405121|NCT00778505|Propofol|propofol|mesh-list
65405122|NCT00778505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65405123|NCT00778505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65405124|NCT00778505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405125|NCT00778505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65405126|NCT00778505|Anesthetics, General|anesthetics, general|mesh-ancestor
65405127|NCT00778505|Anesthetics|anesthetics|mesh-ancestor
65405128|NCT00778505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65405129|NCT00778505|Narcotics|narcotics|mesh-ancestor
65405130|NCT00778505|Analgesics|analgesics|mesh-ancestor
65405131|NCT00778505|Sensory System Agents|sensory system agents|mesh-ancestor
65405132|NCT00778505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65405133|NCT00532844|Vitamins|vitamins|mesh-list
65405134|NCT00532844|Ascorbic Acid|ascorbic acid|mesh-list
65405135|NCT00532844|Verapamil|verapamil|mesh-list
65405136|NCT00532844|Micronutrients|micronutrients|mesh-ancestor
65405137|NCT00532844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405138|NCT00532844|Antioxidants|antioxidants|mesh-ancestor
65405139|NCT00532844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405140|NCT00532844|Protective Agents|protective agents|mesh-ancestor
65405141|NCT00532844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65405142|NCT00532844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65405143|NCT00532844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65405144|NCT00532844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65405145|NCT00532844|Vasodilator Agents|vasodilator agents|mesh-ancestor
65405146|NCT00778583|Nitrofurantoin|nitrofurantoin|mesh-list
65405147|NCT00778583|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65405148|NCT00778583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65405149|NCT00778583|Renal Agents|renal agents|mesh-ancestor
65405150|NCT00778583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65405151|NCT00778661|Amoxicillin|amoxicillin|mesh-list
65405152|NCT00778661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65405153|NCT00778661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65405154|NCT00993356|Lanreotide|lanreotide|mesh-list
65405155|NCT00993356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405156|NCT00781547|Hormones|hormones|mesh-list
65405157|NCT00781547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65405158|NCT00781547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405159|NCT00778739|Cefprozil|cefprozil|mesh-list
65405160|NCT00778739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65405161|NCT00778739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65405162|NCT00781625|Methenamine hippurate|methenamine hippurate|mesh-list
65405163|NCT00781625|Methenamine|methenamine|mesh-list
65405164|NCT00781625|Methenamine mandelate|methenamine mandelate|mesh-list
65405165|NCT00781625|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65405166|NCT00781625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65405167|NCT00781625|Renal Agents|renal agents|mesh-ancestor
65405168|NCT00781625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65405169|NCT00781781|Alemtuzumab|alemtuzumab|mesh-list
65405170|NCT00781781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65405171|NCT00781781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405172|NCT00666263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65405173|NCT00666263|Immunoglobulins|immunoglobulins|mesh-list
65405174|NCT00666263|Antibodies|antibodies|mesh-list
65405175|NCT00666263|gamma-Globulins|gamma-globulins|mesh-list
65405176|NCT00666263|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65405177|NCT00666263|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65405178|NCT00666263|Immunologic Factors|immunologic factors|mesh-ancestor
65405179|NCT00666263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405183|NCT00667277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65405184|NCT00667277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65405185|NCT00667277|Growth Substances|growth substances|mesh-ancestor
65405186|NCT00667277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405187|NCT00667277|Growth Inhibitors|growth inhibitors|mesh-ancestor
65405189|NCT00774527|Fludarabine|fludarabine|mesh-list
65405190|NCT00774527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65405191|NCT00774527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65405192|NCT00774527|Immunologic Factors|immunologic factors|mesh-ancestor
65405193|NCT00774527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405194|NCT00774527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65405195|NCT00774527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65405196|NCT00774527|Alkylating Agents|alkylating agents|mesh-ancestor
65405197|NCT00774527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405198|NCT00774527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405199|NCT00774527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65405200|NCT00778973|Sertraline|sertraline|mesh-list
65405201|NCT00778973|Antidepressive Agents|antidepressive agents|mesh-ancestor
65405202|NCT00778973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65405203|NCT00778973|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65405204|NCT00778973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65405205|NCT00778973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65405206|NCT00778973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405207|NCT00778973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65405208|NCT00778973|Serotonin Agents|serotonin agents|mesh-ancestor
65405209|NCT00778973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405210|NCT00774605|Varenicline|varenicline|mesh-list
65405211|NCT00774605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65405212|NCT00774605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65405213|NCT00774605|Cholinergic Agents|cholinergic agents|mesh-ancestor
65405214|NCT00774605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65405215|NCT00774605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405216|NCT00774605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405217|NCT00779051|Zolpidem|zolpidem|mesh-list
65405218|NCT00779051|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65405219|NCT00779051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65405220|NCT00779051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65228649|NCT00734773|Antimetabolites|antimetabolites|mesh-ancestor
65405221|NCT00779051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405222|NCT00779051|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65405223|NCT00779051|GABA Agonists|gaba agonists|mesh-ancestor
65405224|NCT00779051|GABA Agents|gaba agents|mesh-ancestor
65405225|NCT00779051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65405226|NCT00779051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405227|NCT00774683|Raltegravir Potassium|raltegravir potassium|mesh-list
65405228|NCT00774683|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65405229|NCT00774683|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65405230|NCT00774683|Antiviral Agents|antiviral agents|mesh-ancestor
65405231|NCT00774683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65405232|NCT00774683|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65405233|NCT00774683|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65405234|NCT00774683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405235|NCT00774683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405236|NCT00782093|Volociximab|volociximab|mesh-list
65405237|NCT00782093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65405238|NCT00782093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65405239|NCT00782093|Growth Substances|growth substances|mesh-ancestor
65405240|NCT00782093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405241|NCT00782093|Growth Inhibitors|growth inhibitors|mesh-ancestor
65405242|NCT00782093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405243|NCT00784511|Vitamin D|vitamin d|mesh-list
65405244|NCT00784511|Ergocalciferols|ergocalciferols|mesh-list
65405245|NCT00784511|Cholecalciferol|cholecalciferol|mesh-list
65405246|NCT00784511|Vitamins|vitamins|mesh-list
65405247|NCT00784511|Micronutrients|micronutrients|mesh-ancestor
65405248|NCT00784511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405249|NCT00784511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65405250|NCT00784511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65405257|NCT00784667|Cetuximab|cetuximab|mesh-list
65405258|NCT00784667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65405259|NCT00784667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65405260|NCT00784667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405261|NCT00784667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65405262|NCT00784667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405263|NCT00784667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405264|NCT00784745|Dexamethasone|dexamethasone|mesh-list
65405265|NCT00784745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65405266|NCT00784745|Antiemetics|antiemetics|mesh-ancestor
65405267|NCT00784745|Autonomic Agents|autonomic agents|mesh-ancestor
65405268|NCT00784745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65405269|NCT00784745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405270|NCT00784745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65405271|NCT00784745|Glucocorticoids|glucocorticoids|mesh-ancestor
65405272|NCT00784745|Hormones|hormones|mesh-ancestor
65405273|NCT00784745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65405274|NCT00784745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65405275|NCT00784745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405276|NCT00993512|Bleomycin|bleomycin|mesh-list
65405277|NCT00993512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65405278|NCT00993512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405279|NCT00662129|Gemcitabine|gemcitabine|mesh-list
65405280|NCT00662129|Paclitaxel|paclitaxel|mesh-list
65405281|NCT00662129|Bevacizumab|bevacizumab|mesh-list
65405282|NCT00662129|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65405283|NCT00662129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65405284|NCT00662129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405285|NCT00662129|Tubulin Modulators|tubulin modulators|mesh-ancestor
65405286|NCT00662129|Antimitotic Agents|antimitotic agents|mesh-ancestor
65405287|NCT00662129|Mitosis Modulators|mitosis modulators|mesh-ancestor
65405288|NCT00662129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405289|NCT00662129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65405290|NCT00662129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65405291|NCT00662129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65405292|NCT00662129|Growth Substances|growth substances|mesh-ancestor
65405293|NCT00662129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405294|NCT00662129|Growth Inhibitors|growth inhibitors|mesh-ancestor
65405295|NCT00662129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65405296|NCT00662129|Antimetabolites|antimetabolites|mesh-ancestor
65405297|NCT00662129|Antiviral Agents|antiviral agents|mesh-ancestor
65405298|NCT00662129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65405299|NCT00662129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405300|NCT00662129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65405301|NCT00662129|Immunologic Factors|immunologic factors|mesh-ancestor
65405302|NCT05346224|Pertuzumab|pertuzumab|mesh-list
65405303|NCT05346224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65405304|NCT05346224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405305|NCT00993746|Lidocaine|lidocaine|mesh-list
65405306|NCT00993746|Bupivacaine|bupivacaine|mesh-list
65405307|NCT00993746|Anesthetics, Local|anesthetics, local|mesh-ancestor
65405308|NCT00993746|Anesthetics|anesthetics|mesh-ancestor
65405309|NCT00993746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65405310|NCT00993746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405311|NCT00993746|Sensory System Agents|sensory system agents|mesh-ancestor
65405312|NCT00993746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65405313|NCT00993746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65405314|NCT00993746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65405315|NCT00993746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65405316|NCT00993746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65405317|NCT00993746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405318|NCT00789971|Triamcinolone|triamcinolone|mesh-list
65405319|NCT00789971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65405329|NCT00789971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405330|NCT00789971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405331|NCT05345522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65405332|NCT05345522|Antibodies|antibodies|mesh-list
65405333|NCT05345522|Immunoglobulins|immunoglobulins|mesh-list
65405334|NCT05345522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65405335|NCT05345522|Immunologic Factors|immunologic factors|mesh-ancestor
65405336|NCT05345522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405337|NCT05345522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405338|NCT00782405|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65405339|NCT00782405|Mirtazapine|mirtazapine|mesh-list
65405340|NCT00782405|Antidepressive Agents|antidepressive agents|mesh-ancestor
65405341|NCT00782405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65405342|NCT00782405|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65405343|NCT00782405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65405344|NCT00782405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65405345|NCT00782405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405346|NCT00782405|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65405347|NCT00782405|Histamine Antagonists|histamine antagonists|mesh-ancestor
65405348|NCT00782405|Histamine Agents|histamine agents|mesh-ancestor
65405349|NCT00782405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65405350|NCT00782405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405351|NCT00782405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65405352|NCT00782405|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65405353|NCT00782405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65405354|NCT00782405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65405355|NCT00782405|Adrenergic Agents|adrenergic agents|mesh-ancestor
65405356|NCT00782405|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65405357|NCT00782405|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65405358|NCT00782405|Serotonin Agents|serotonin agents|mesh-ancestor
65405359|NCT00782405|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65405360|NCT05343260|Propofol|propofol|mesh-list
65405361|NCT05343260|Sevoflurane|sevoflurane|mesh-list
65405362|NCT05343260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65405363|NCT05343260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65405364|NCT05343260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405365|NCT05343260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65405366|NCT05343260|Anesthetics, General|anesthetics, general|mesh-ancestor
65405367|NCT05343260|Anesthetics|anesthetics|mesh-ancestor
65405368|NCT05343260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65405369|NCT05343260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65405370|NCT00664859|Atorvastatin|atorvastatin|mesh-list
65405371|NCT00664859|Fenofibrate|fenofibrate|mesh-list
65405372|NCT00664859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65405373|NCT00664859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65405374|NCT00664859|Antimetabolites|antimetabolites|mesh-ancestor
65405375|NCT00664859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405376|NCT00664859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65405377|NCT00664859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65405378|NCT00664859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405379|NCT00996788|Rebamipide|rebamipide|mesh-list
65405380|NCT00996788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65405381|NCT00996788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65405382|NCT00996788|Antioxidants|antioxidants|mesh-ancestor
65405383|NCT00996788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405384|NCT00996788|Protective Agents|protective agents|mesh-ancestor
65405402|NCT00790439|Calcium heparin|calcium heparin|mesh-list
65405403|NCT00790439|Dextrans|dextrans|mesh-list
65405404|NCT00790439|Tacrolimus|tacrolimus|mesh-list
65405405|NCT00790439|Cyclosporins|cyclosporins|mesh-list
65405406|NCT00790439|Basiliximab|basiliximab|mesh-list
65405407|NCT00790439|Daclizumab|daclizumab|mesh-list
65405408|NCT00790439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65405409|NCT00790439|Immunologic Factors|immunologic factors|mesh-ancestor
65405410|NCT00790439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405411|NCT00790439|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65405412|NCT00790439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405413|NCT00790439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405414|NCT00790439|Antifungal Agents|antifungal agents|mesh-ancestor
65405415|NCT00790439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65405416|NCT00790439|Dermatologic Agents|dermatologic agents|mesh-ancestor
65405417|NCT00790439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65405418|NCT00790439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65405419|NCT00790439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405420|NCT00790439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65405421|NCT00790439|Antitubercular Agents|antitubercular agents|mesh-ancestor
65405422|NCT00790439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65405423|NCT00790439|Anticoagulants|anticoagulants|mesh-ancestor
65405424|NCT00790439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65405425|NCT00790439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65405426|NCT00790439|Plasma Substitutes|plasma substitutes|mesh-ancestor
65405427|NCT00790439|Blood Substitutes|blood substitutes|mesh-ancestor
65405428|NCT00785603|Tramadol|tramadol|mesh-list
65405429|NCT00785603|Paroxetine|paroxetine|mesh-list
65405430|NCT00785603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65405431|NCT00785603|Narcotics|narcotics|mesh-ancestor
65405432|NCT00785603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65405433|NCT00785603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405434|NCT00785603|Analgesics|analgesics|mesh-ancestor
65405435|NCT00785603|Sensory System Agents|sensory system agents|mesh-ancestor
65405436|NCT00785603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65405437|NCT00785603|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65405438|NCT00785603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65405439|NCT00785603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65405440|NCT00785603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405441|NCT00785603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65405442|NCT00785603|Serotonin Agents|serotonin agents|mesh-ancestor
65405443|NCT00785603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65405444|NCT00785603|Antidepressive Agents|antidepressive agents|mesh-ancestor
65405445|NCT00785603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64790237|NCT00004158|Melphalan|melphalan|mesh-list
65405450|NCT00570401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405451|NCT00570401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65405452|NCT00570401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405453|NCT00570401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405454|NCT00532298|Vaccines|vaccines|mesh-list
65405455|NCT00532298|Immunologic Factors|immunologic factors|mesh-ancestor
65405456|NCT00532298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405457|NCT04047017|Apatinib|apatinib|mesh-list
65405458|NCT04047017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405459|NCT04047017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65405460|NCT04047017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405461|NCT04047017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405462|NCT00997022|Sorafenib|sorafenib|mesh-list
65405463|NCT00997022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405464|NCT00997022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65405465|NCT00997022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405466|NCT00997022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405467|NCT00786149|Varenicline|varenicline|mesh-list
65405468|NCT00786149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65405469|NCT00786149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65405470|NCT00786149|Cholinergic Agents|cholinergic agents|mesh-ancestor
65405471|NCT00786149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65405472|NCT00786149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405473|NCT00786149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405474|NCT00410410|Abatacept|abatacept|mesh-list
65405475|NCT00410410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65405476|NCT00410410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405477|NCT00410410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405478|NCT00410410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65405479|NCT00410410|Immunologic Factors|immunologic factors|mesh-ancestor
65405480|NCT00410410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405481|NCT00410410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65405482|NCT00782951|Morphine|morphine|mesh-list
65405483|NCT00782951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65405484|NCT00782951|Narcotics|narcotics|mesh-ancestor
65405485|NCT00782951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65405486|NCT00782951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405487|NCT00782951|Analgesics|analgesics|mesh-ancestor
65405488|NCT00782951|Sensory System Agents|sensory system agents|mesh-ancestor
65405489|NCT00782951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65405490|NCT02555813|Gemcitabine|gemcitabine|mesh-list
65405491|NCT02555813|Paclitaxel|paclitaxel|mesh-list
65405492|NCT02555813|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65405493|NCT02555813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65405494|NCT02555813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405495|NCT02555813|Tubulin Modulators|tubulin modulators|mesh-ancestor
65405496|NCT02555813|Antimitotic Agents|antimitotic agents|mesh-ancestor
65405497|NCT02555813|Mitosis Modulators|mitosis modulators|mesh-ancestor
65405498|NCT02555813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405499|NCT02555813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65405500|NCT02555813|Antimetabolites|antimetabolites|mesh-ancestor
65405501|NCT02555813|Antiviral Agents|antiviral agents|mesh-ancestor
65405502|NCT02555813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65405503|NCT02555813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405504|NCT02555813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65405505|NCT02555813|Immunologic Factors|immunologic factors|mesh-ancestor
65405506|NCT02555813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405507|NCT00997412|Mycophenolic Acid|mycophenolic acid|mesh-list
65405508|NCT00997412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65405509|NCT00997412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405510|NCT00997412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65405511|NCT00997412|Antitubercular Agents|antitubercular agents|mesh-ancestor
65405512|NCT00997412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65405513|NCT00997412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65405514|NCT00997412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405515|NCT00997412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405519|NCT00783107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405521|NCT00783107|Immunologic Factors|immunologic factors|mesh-ancestor
65405522|NCT00783107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405523|NCT00783107|Antifungal Agents|antifungal agents|mesh-ancestor
65405524|NCT00783107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65405525|NCT00783107|Dermatologic Agents|dermatologic agents|mesh-ancestor
65405526|NCT00783107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65405527|NCT00783107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65405528|NCT00534404|Nicotine|nicotine|mesh-list
65405529|NCT00534404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65405530|NCT00534404|Autonomic Agents|autonomic agents|mesh-ancestor
65405531|NCT00534404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65405532|NCT00534404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405533|NCT00534404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65405534|NCT00534404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65405535|NCT00534404|Cholinergic Agents|cholinergic agents|mesh-ancestor
65405536|NCT00534404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65405537|NCT00534404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405538|NCT00393094|Bevacizumab|bevacizumab|mesh-list
65405539|NCT00393094|Irinotecan|irinotecan|mesh-list
65405540|NCT00393094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65405541|NCT00393094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405542|NCT00393094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65155076|NCT01269125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405543|NCT00393094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65405544|NCT00393094|Growth Substances|growth substances|mesh-ancestor
65405545|NCT00393094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405546|NCT00393094|Growth Inhibitors|growth inhibitors|mesh-ancestor
65405547|NCT00393094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65405548|NCT00393094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65405549|NCT00393094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405550|NCT00393094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405552|NCT00783653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405553|NCT00783653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65405554|NCT00783653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65405555|NCT00783653|Growth Substances|growth substances|mesh-ancestor
65405556|NCT00783653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405557|NCT00783653|Growth Inhibitors|growth inhibitors|mesh-ancestor
65405558|NCT00783653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65405559|NCT00783653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405560|NCT00783653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405561|NCT00786305|Amikacin|amikacin|mesh-list
65405562|NCT00786305|Ceftazidime|ceftazidime|mesh-list
65405563|NCT00786305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65405564|NCT00786305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65405565|NCT01044004|Modafinil|modafinil|mesh-list
65405566|NCT01044004|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65405567|NCT01044004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405568|NCT01044004|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65405569|NCT01044004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65405570|NCT01044004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65405571|NCT01044004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405572|NCT00786383|Ramucirumab|ramucirumab|mesh-list
65405573|NCT00786383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405574|NCT00790595|Sunitinib|sunitinib|mesh-list
65405575|NCT00790595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405576|NCT00790595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65405577|NCT00790595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65405578|NCT00790595|Growth Substances|growth substances|mesh-ancestor
65405579|NCT00790595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405580|NCT00790595|Growth Inhibitors|growth inhibitors|mesh-ancestor
65405581|NCT00790595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65405582|NCT00790595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405583|NCT00790595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405584|NCT00783731|Midazolam|midazolam|mesh-list
65405585|NCT00783731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65405586|NCT00783731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65405591|NCT00783731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65405592|NCT00783731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65405593|NCT00783731|Anesthetics, General|anesthetics, general|mesh-ancestor
65405594|NCT00783731|Anesthetics|anesthetics|mesh-ancestor
65405595|NCT00783731|GABA Modulators|gaba modulators|mesh-ancestor
65405596|NCT00783731|GABA Agents|gaba agents|mesh-ancestor
65405597|NCT00783731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65405598|NCT00783731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405599|NCT00409708|Methylphenidate|methylphenidate|mesh-list
65405600|NCT00409708|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65405601|NCT00409708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405602|NCT00409708|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65405603|NCT00409708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65405604|NCT00409708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65405605|NCT00409708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405606|NCT00409708|Dopamine Agents|dopamine agents|mesh-ancestor
65405607|NCT00409708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65405608|NCT00790985|Naproxen|naproxen|mesh-list
65405609|NCT00790985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65405610|NCT00790985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65405611|NCT00790985|Analgesics|analgesics|mesh-ancestor
65405612|NCT00790985|Sensory System Agents|sensory system agents|mesh-ancestor
65405613|NCT00790985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65405614|NCT00790985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155153|NCT01265615|Vitamins|vitamins|mesh-ancestor
65405615|NCT00790985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65405616|NCT00790985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65405617|NCT00790985|Gout Suppressants|gout suppressants|mesh-ancestor
65405618|NCT00790985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65405619|NCT00790985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405620|NCT00790985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405621|NCT01324336|Mercaptopurine|mercaptopurine|mesh-list
65405622|NCT01324336|Antimetabolites|antimetabolites|mesh-ancestor
65405623|NCT01324336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405624|NCT01324336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65405625|NCT01324336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405626|NCT01324336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65405627|NCT01324336|Immunologic Factors|immunologic factors|mesh-ancestor
65405628|NCT01324336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405629|NCT01324336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65405630|NCT01324336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405631|NCT01324492|Everolimus|everolimus|mesh-list
65405632|NCT01324492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405633|NCT01324492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65405634|NCT01324492|Immunologic Factors|immunologic factors|mesh-ancestor
65229030|NCT00644085|Antipyretics|antipyretics|mesh-ancestor
65405635|NCT01324492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405636|NCT01039948|Gefitinib|gefitinib|mesh-list
65405637|NCT01039948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405638|NCT01039948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65405639|NCT01039948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405640|NCT01039948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405641|NCT00391846|Metoprolol|metoprolol|mesh-list
65405642|NCT00391846|Valsartan|valsartan|mesh-list
65405643|NCT00391846|Carvedilol|carvedilol|mesh-list
65405644|NCT00391846|Candesartan|candesartan|mesh-list
65405645|NCT00391846|Ramipril|ramipril|mesh-list
65405646|NCT00391846|Enalapril|enalapril|mesh-list
65405647|NCT00391846|Lisinopril|lisinopril|mesh-list
65405648|NCT00391846|Eplerenone|eplerenone|mesh-list
65405649|NCT00391846|Bisoprolol|bisoprolol|mesh-list
65405650|NCT00391846|Captopril|captopril|mesh-list
65405651|NCT00391846|Trandolapril|trandolapril|mesh-list
65405652|NCT00391846|Spironolactone|spironolactone|mesh-list
65405653|NCT00391846|Diuretics|diuretics|mesh-list
65405654|NCT00391846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65405655|NCT00391846|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65405656|NCT00391846|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65405657|NCT00391846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405675|NCT00391846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65405676|NCT00391846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65405677|NCT00391846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65405678|NCT00391846|Vasodilator Agents|vasodilator agents|mesh-ancestor
65405679|NCT00391846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65405680|NCT00391846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65405681|NCT00391846|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65405682|NCT00391846|Protease Inhibitors|protease inhibitors|mesh-ancestor
65405683|NCT00391846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405684|NCT00391846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65405685|NCT00391768|Oseltamivir|oseltamivir|mesh-list
65405686|NCT00391768|Antiviral Agents|antiviral agents|mesh-ancestor
65405687|NCT00391768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65405688|NCT00391768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405689|NCT00391768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405690|NCT00391222|Olanzapine|olanzapine|mesh-list
65405691|NCT00391222|Risperidone|risperidone|mesh-list
65405692|NCT00391222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65405693|NCT00391222|Serotonin Agents|serotonin agents|mesh-ancestor
65405694|NCT00391222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65405695|NCT00391222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405696|NCT00391222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405697|NCT00391222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65405698|NCT00391222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65405699|NCT00391222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65405700|NCT00391222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65405701|NCT00391222|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65405702|NCT00391222|Dopamine Agents|dopamine agents|mesh-ancestor
65405703|NCT00391222|Antiemetics|antiemetics|mesh-ancestor
65405704|NCT00391222|Autonomic Agents|autonomic agents|mesh-ancestor
65405705|NCT00391222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65405706|NCT00391222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65405707|NCT00391222|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65405708|NCT00391222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65405709|NCT00391222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65405710|NCT00409006|Pemetrexed|pemetrexed|mesh-list
65405711|NCT00409006|Gefitinib|gefitinib|mesh-list
65405712|NCT00409006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790522|NCT00004404|Miconazole|miconazole|mesh-list
65405729|NCT00997880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65405731|NCT00408928|Bortezomib|bortezomib|mesh-list
65405732|NCT00408928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405733|NCT00997958|Mycophenolic Acid|mycophenolic acid|mesh-list
65405734|NCT00997958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65405735|NCT00997958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405736|NCT00997958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65405737|NCT00997958|Antitubercular Agents|antitubercular agents|mesh-ancestor
65405738|NCT00997958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65405739|NCT00997958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65405740|NCT00997958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405741|NCT00997958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405742|NCT00998036|Sirolimus|sirolimus|mesh-list
65405743|NCT00998036|Cisplatin|cisplatin|mesh-list
65229108|NCT05273775|Vitamin K|vitamin k|mesh-list
65405744|NCT00998036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65405745|NCT00998036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405746|NCT00998036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65405747|NCT00998036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405748|NCT00998036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405749|NCT00998036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65405750|NCT00998036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65405751|NCT00998036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65405752|NCT00998036|Antifungal Agents|antifungal agents|mesh-ancestor
65405753|NCT00998036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65405754|NCT00998036|Immunologic Factors|immunologic factors|mesh-ancestor
65405755|NCT00998036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405756|NCT05254808|Fosfomycin|fosfomycin|mesh-list
65405757|NCT05254808|Nitrofurantoin|nitrofurantoin|mesh-list
65405758|NCT05254808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65405759|NCT05254808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65405760|NCT05254808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65405761|NCT05254808|Renal Agents|renal agents|mesh-ancestor
65405762|NCT02275286|Trabectedin|trabectedin|mesh-list
65405763|NCT02275286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65405764|NCT02275286|Alkylating Agents|alkylating agents|mesh-ancestor
65493991|NCT03897439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65405765|NCT02275286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405766|NCT02275286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405767|NCT00998192|Paclitaxel|paclitaxel|mesh-list
65405785|NCT00998504|Antioxidants|antioxidants|mesh-ancestor
65405786|NCT00998504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405787|NCT00998504|Protective Agents|protective agents|mesh-ancestor
65405788|NCT00998504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405789|NCT00998504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405790|NCT00998504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65405791|NCT00788684|Rituximab|rituximab|mesh-list
65405792|NCT00788684|Navitoclax|navitoclax|mesh-list
65405793|NCT00788684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65405794|NCT00788684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405795|NCT00788684|Immunologic Factors|immunologic factors|mesh-ancestor
65405796|NCT00788684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405797|NCT00788684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65405798|NCT00998972|Acetylcysteine|acetylcysteine|mesh-list
65405799|NCT00998972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65405800|NCT00998972|Antiviral Agents|antiviral agents|mesh-ancestor
65405801|NCT00998972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65405802|NCT00998972|Expectorants|expectorants|mesh-ancestor
65405803|NCT00998972|Respiratory System Agents|respiratory system agents|mesh-ancestor
65405804|NCT00998972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65405805|NCT00998972|Antioxidants|antioxidants|mesh-ancestor
65405806|NCT00998972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405807|NCT00998972|Protective Agents|protective agents|mesh-ancestor
65405808|NCT00998972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405809|NCT00998972|Antidotes|antidotes|mesh-ancestor
65405810|NCT00390910|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65405811|NCT00390910|Immunologic Factors|immunologic factors|mesh-ancestor
65405812|NCT00390910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405813|NCT00998816|Pregabalin|pregabalin|mesh-list
65405814|NCT00998816|Analgesics|analgesics|mesh-ancestor
65405815|NCT00998816|Sensory System Agents|sensory system agents|mesh-ancestor
65405816|NCT00998816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65405817|NCT00998816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405818|NCT00998816|Anticonvulsants|anticonvulsants|mesh-ancestor
65405819|NCT00998816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65405820|NCT00998816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65405821|NCT00998816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405822|NCT00998816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65405823|NCT00998816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65405824|NCT00998816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65405825|NCT00998816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65405833|NCT00533702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405834|NCT00533702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405835|NCT00533702|Immunologic Factors|immunologic factors|mesh-ancestor
65405836|NCT00533702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405837|NCT00533702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405838|NCT00408694|Bevacizumab|bevacizumab|mesh-list
65405839|NCT00408694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65405840|NCT00408694|Cisplatin|cisplatin|mesh-list
65405841|NCT00408694|Fluorouracil|fluorouracil|mesh-list
65405842|NCT00408694|Endothelial Growth Factors|endothelial growth factors|mesh-list
65405843|NCT00408694|Antibodies|antibodies|mesh-list
65405844|NCT00408694|Immunoglobulins|immunoglobulins|mesh-list
65405845|NCT00408694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65405846|NCT00408694|Immunoglobulin G|immunoglobulin g|mesh-list
65405847|NCT00408694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405848|NCT00408694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65405849|NCT00408694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65405850|NCT00408694|Growth Substances|growth substances|mesh-ancestor
65405851|NCT00408694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405852|NCT00408694|Growth Inhibitors|growth inhibitors|mesh-ancestor
65405853|NCT00408694|Immunologic Factors|immunologic factors|mesh-ancestor
65405854|NCT00408694|Antimetabolites|antimetabolites|mesh-ancestor
65405855|NCT00408694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405856|NCT00408694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65405857|NCT00408694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65405858|NCT00999128|Rabeprazole|rabeprazole|mesh-list
65405859|NCT00999128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65405860|NCT00999128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65405861|NCT00999128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65405862|NCT00999128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405863|NCT00999128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405864|NCT00999206|Vaccines|vaccines|mesh-list
65405865|NCT00999206|Immunologic Factors|immunologic factors|mesh-ancestor
65405866|NCT00999206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405867|NCT01043224|Clobetasol|clobetasol|mesh-list
65405868|NCT01043224|Calcipotriene|calcipotriene|mesh-list
65405869|NCT01043224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65405870|NCT01043224|Glucocorticoids|glucocorticoids|mesh-ancestor
65405871|NCT01043224|Hormones|hormones|mesh-ancestor
65405872|NCT01043224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65405873|NCT01043224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405874|NCT01043224|Dermatologic Agents|dermatologic agents|mesh-ancestor
65405875|NCT01044238|Methylphenidate|methylphenidate|mesh-list
65405876|NCT01044238|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65405877|NCT01044238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405878|NCT01044238|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65405879|NCT01044238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65405880|NCT01044238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65405881|NCT01044238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405882|NCT01044238|Dopamine Agents|dopamine agents|mesh-ancestor
65405883|NCT01044238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65405884|NCT01043380|Atorvastatin|atorvastatin|mesh-list
65405885|NCT01043380|Ezetimibe|ezetimibe|mesh-list
65405886|NCT01043380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65405887|NCT01043380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65405888|NCT01043380|Antimetabolites|antimetabolites|mesh-ancestor
65405889|NCT01043380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405890|NCT01043380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65405891|NCT01043380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65405892|NCT01043380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405893|NCT01044394|Bisacodyl|bisacodyl|mesh-list
65405894|NCT01044394|Cathartics|cathartics|mesh-ancestor
65405895|NCT01044394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65405906|NCT01043536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405907|NCT01004198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65405909|NCT00056407|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65405910|NCT00056407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65155453|NCT01126359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65405911|NCT00056407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405912|NCT00056407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405913|NCT00056407|Hormone Antagonists|hormone antagonists|mesh-ancestor
65405914|NCT00056407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65405915|NCT00056407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405916|NCT00110110|Cyclosporine|cyclosporine|mesh-list
65405917|NCT00110110|Carboplatin|carboplatin|mesh-list
65405918|NCT00110110|Etoposide|etoposide|mesh-list
65405919|NCT00110110|Vincristine|vincristine|mesh-list
65405920|NCT00110110|Cyclosporins|cyclosporins|mesh-list
65405921|NCT00110110|Lenograstim|lenograstim|mesh-list
65405922|NCT00110110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405923|NCT00110110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65405924|NCT00110110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65405925|NCT00110110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65229255|NCT00738829|Fludarabine|fludarabine|mesh-list
65405926|NCT00110110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405927|NCT00110110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405928|NCT00110110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65405929|NCT00110110|Immunologic Factors|immunologic factors|mesh-ancestor
65405930|NCT00110110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405931|NCT00110110|Tubulin Modulators|tubulin modulators|mesh-ancestor
65405932|NCT00110110|Antimitotic Agents|antimitotic agents|mesh-ancestor
65405933|NCT00110110|Mitosis Modulators|mitosis modulators|mesh-ancestor
65405934|NCT00110110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65405935|NCT00110110|Antifungal Agents|antifungal agents|mesh-ancestor
65405936|NCT00110110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65405937|NCT00110110|Dermatologic Agents|dermatologic agents|mesh-ancestor
65405938|NCT00110110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65405939|NCT00110110|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65405940|NCT00387790|Motexafin gadolinium|motexafin gadolinium|mesh-list
65405941|NCT00387790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405942|NCT00387790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65405943|NCT00387790|Dermatologic Agents|dermatologic agents|mesh-ancestor
65405944|NCT00073021|Mesalamine|mesalamine|mesh-list
65405945|NCT00073021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65405946|NCT00073021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65405947|NCT00073021|Analgesics|analgesics|mesh-ancestor
65405948|NCT00073021|Sensory System Agents|sensory system agents|mesh-ancestor
65405949|NCT00073021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65405950|NCT00073021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405951|NCT00073021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65405952|NCT00073021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65405953|NCT01584115|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
65405954|NCT01584115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65405955|NCT01584115|Immunologic Factors|immunologic factors|mesh-ancestor
65405956|NCT01584115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405957|NCT00395746|Liraglutide|liraglutide|mesh-list
65405958|NCT00395746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65405959|NCT00395746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405964|NCT01004900|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65405966|NCT01004900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65405967|NCT01004900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65405968|NCT01004900|Adrenergic Agents|adrenergic agents|mesh-ancestor
65405969|NCT01004900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65405970|NCT01004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405971|NCT01004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405972|NCT01004900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65405973|NCT01004900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65405974|NCT01004900|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65405975|NCT01004900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65405976|NCT01004900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65405977|NCT04001348|Diazepam|diazepam|mesh-list
65405978|NCT04001348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65405979|NCT04001348|Anticonvulsants|anticonvulsants|mesh-ancestor
65405980|NCT04001348|Antiemetics|antiemetics|mesh-ancestor
65405981|NCT04001348|Autonomic Agents|autonomic agents|mesh-ancestor
65405982|NCT04001348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65405983|NCT04001348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405984|NCT04001348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65405985|NCT04001348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65405986|NCT04001348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65405987|NCT04001348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65155526|NCT02869672|Vaccines|vaccines|mesh-list
65405988|NCT04001348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65405989|NCT04001348|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65405990|NCT04001348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65405991|NCT04001348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65405992|NCT04001348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65405993|NCT04001348|Anesthetics, General|anesthetics, general|mesh-ancestor
65405994|NCT04001348|Anesthetics|anesthetics|mesh-ancestor
65405995|NCT04001348|GABA Modulators|gaba modulators|mesh-ancestor
65405996|NCT04001348|GABA Agents|gaba agents|mesh-ancestor
65405997|NCT04001348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65405998|NCT04001348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405999|NCT00395512|Pioglitazone|pioglitazone|mesh-list
65406000|NCT00395512|Alogliptin|alogliptin|mesh-list
65406001|NCT00395512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65406002|NCT00395512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406003|NCT00395512|Incretins|incretins|mesh-ancestor
65406004|NCT00395512|Hormones|hormones|mesh-ancestor
65269875|NCT02727296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65406005|NCT00395512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65406006|NCT00395512|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65406007|NCT00395512|Protease Inhibitors|protease inhibitors|mesh-ancestor
65406008|NCT00395512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406009|NCT00395512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406010|NCT03956017|Ubiquinone|ubiquinone|mesh-list
65406011|NCT03956017|Coenzyme Q10|coenzyme q10|mesh-list
65406012|NCT03956017|Micronutrients|micronutrients|mesh-ancestor
65406013|NCT03956017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406014|NCT03956017|Vitamins|vitamins|mesh-ancestor
65406015|NCT00994916|Amifampridine|amifampridine|mesh-list
65406016|NCT00994916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65406017|NCT00994916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65406018|NCT00994916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406019|NCT00994916|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65406020|NCT00994916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65406021|NCT00994916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406022|NCT00999440|Methadone|methadone|mesh-list
65406023|NCT00999440|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65406024|NCT00999440|Narcotics|narcotics|mesh-ancestor
65406025|NCT00999440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65406026|NCT00999440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406027|NCT00999440|Analgesics|analgesics|mesh-ancestor
65406028|NCT00999440|Sensory System Agents|sensory system agents|mesh-ancestor
65406029|NCT00999440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65406030|NCT00999440|Antitussive Agents|antitussive agents|mesh-ancestor
65406039|NCT02530879|Lansoprazole|lansoprazole|mesh-list
65406040|NCT02530879|Dexlansoprazole|dexlansoprazole|mesh-list
65406041|NCT02530879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65406042|NCT02530879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65406043|NCT02530879|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65406044|NCT02530879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406045|NCT02530879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406046|NCT03957499|Dexamethasone|dexamethasone|mesh-list
65406047|NCT03957499|Magnesium Sulfate|magnesium sulfate|mesh-list
65406048|NCT03957499|Bupivacaine|bupivacaine|mesh-list
65406049|NCT03957499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65406050|NCT03957499|Antiemetics|antiemetics|mesh-ancestor
65406051|NCT03957499|Autonomic Agents|autonomic agents|mesh-ancestor
65406052|NCT03957499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65406053|NCT03957499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406054|NCT03957499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65406055|NCT03957499|Glucocorticoids|glucocorticoids|mesh-ancestor
65406056|NCT03957499|Hormones|hormones|mesh-ancestor
65406057|NCT03957499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65406058|NCT03957499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65406059|NCT03957499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406060|NCT03957499|Anesthetics, Local|anesthetics, local|mesh-ancestor
65406061|NCT03957499|Anesthetics|anesthetics|mesh-ancestor
65406062|NCT03957499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65406063|NCT03957499|Sensory System Agents|sensory system agents|mesh-ancestor
65406064|NCT03957499|Analgesics|analgesics|mesh-ancestor
65406065|NCT03957499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65406066|NCT03957499|Anticonvulsants|anticonvulsants|mesh-ancestor
65406067|NCT03957499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65406068|NCT03957499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65406069|NCT03957499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406070|NCT03957499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65406071|NCT03957499|Tocolytic Agents|tocolytic agents|mesh-ancestor
65406072|NCT03957499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65406073|NCT01040338|Nicotine|nicotine|mesh-list
65406074|NCT01040338|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65406075|NCT01040338|Autonomic Agents|autonomic agents|mesh-ancestor
65406076|NCT01040338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65406077|NCT01040338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406078|NCT01040338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65406079|NCT01040338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65406080|NCT01040338|Cholinergic Agents|cholinergic agents|mesh-ancestor
65406081|NCT01040338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65406082|NCT01040338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406083|NCT00066703|Tamoxifen|tamoxifen|mesh-list
65406084|NCT00066703|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65406085|NCT00066703|Exemestane|exemestane|mesh-list
65406086|NCT00066703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65406087|NCT00066703|Hormone Antagonists|hormone antagonists|mesh-ancestor
65406088|NCT00066703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65406089|NCT00066703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406090|NCT00066703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65406091|NCT00066703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406092|NCT00066703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65406093|NCT00066703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65406094|NCT00066703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65406095|NCT00066703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65406096|NCT00066703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65406097|NCT00066703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406102|NCT00066703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65406103|NCT00066703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65406104|NCT03955939|Midazolam|midazolam|mesh-list
65406105|NCT03955939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65406106|NCT03955939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65406107|NCT03955939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65406108|NCT03955939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406109|NCT03955939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65406110|NCT03955939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65406111|NCT03955939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65406112|NCT03955939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65406113|NCT03955939|Anesthetics, General|anesthetics, general|mesh-ancestor
65406114|NCT03955939|Anesthetics|anesthetics|mesh-ancestor
65406115|NCT03955939|GABA Modulators|gaba modulators|mesh-ancestor
65406116|NCT03955939|GABA Agents|gaba agents|mesh-ancestor
65406117|NCT03955939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65406118|NCT03955939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406119|NCT01094821|ATI 7505|ati 7505|mesh-list
65406120|NCT01094821|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65406121|NCT01094821|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65406122|NCT01094821|Serotonin Agents|serotonin agents|mesh-ancestor
65406123|NCT01094821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65406124|NCT01094821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406125|NCT01094821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406126|NCT00072475|Vatalanib|vatalanib|mesh-list
65406127|NCT00072475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65406128|NCT00072475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406129|NCT00072475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406130|NCT01091701|Plasma-lyte 148|plasma-lyte 148|mesh-list
65406131|NCT01091701|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65406132|NCT01091701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65406133|NCT00066469|Prednisone|prednisone|mesh-list
65406134|NCT00066469|Methylprednisolone|methylprednisolone|mesh-list
65406135|NCT00066469|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65406136|NCT00066469|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65406137|NCT00066469|Prednisolone|prednisolone|mesh-list
65406138|NCT00066469|Prednisolone acetate|prednisolone acetate|mesh-list
65406139|NCT00066469|Cyclophosphamide|cyclophosphamide|mesh-list
65406140|NCT00066469|Rituximab|rituximab|mesh-list
65406141|NCT00066469|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65406142|NCT00066469|Prednisolone phosphate|prednisolone phosphate|mesh-list
65406143|NCT00066469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65406144|NCT00066469|Immunologic Factors|immunologic factors|mesh-ancestor
65406145|NCT00066469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406146|NCT00066469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65406147|NCT00066469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65406148|NCT00066469|Alkylating Agents|alkylating agents|mesh-ancestor
65406149|NCT00066469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406150|NCT00066469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406151|NCT00066469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65406152|NCT00066469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65406153|NCT00066469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65406154|NCT00066469|Glucocorticoids|glucocorticoids|mesh-ancestor
65406156|NCT00066469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65406157|NCT00066469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65406158|NCT00066469|Antiemetics|antiemetics|mesh-ancestor
65406159|NCT00066469|Autonomic Agents|autonomic agents|mesh-ancestor
65406160|NCT00066469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65406161|NCT00066469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65406162|NCT00066469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65406163|NCT00066469|Protective Agents|protective agents|mesh-ancestor
65406164|NCT01094977|Tranexamic Acid|tranexamic acid|mesh-list
65406165|NCT01094977|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65406166|NCT01094977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65406167|NCT01094977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406168|NCT01094977|Hemostatics|hemostatics|mesh-ancestor
65406177|NCT01095133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406178|NCT01095133|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65406179|NCT01095133|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65406181|NCT00387088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65406182|NCT00387088|Autonomic Agents|autonomic agents|mesh-ancestor
65406183|NCT00387088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65406184|NCT00387088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406185|NCT00387088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65406186|NCT00387088|Respiratory System Agents|respiratory system agents|mesh-ancestor
65406187|NCT00387088|Parasympatholytics|parasympatholytics|mesh-ancestor
65406188|NCT00387088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65406189|NCT00387088|Cholinergic Agents|cholinergic agents|mesh-ancestor
65406190|NCT00387088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65406191|NCT00387088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406192|NCT00070291|Cyclosporine|cyclosporine|mesh-list
65406193|NCT00070291|Cyclosporins|cyclosporins|mesh-list
65406194|NCT00070291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406195|NCT00070291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406196|NCT00070291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65406197|NCT00070291|Immunologic Factors|immunologic factors|mesh-ancestor
65406198|NCT00070291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406199|NCT00070291|Antifungal Agents|antifungal agents|mesh-ancestor
65406200|NCT00070291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65406201|NCT00070291|Dermatologic Agents|dermatologic agents|mesh-ancestor
65406202|NCT00070291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65406203|NCT00070291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65406204|NCT01095211|Vitamin B Complex|vitamin b complex|mesh-list
65406205|NCT01095211|Vitamins|vitamins|mesh-ancestor
65406206|NCT01095211|Micronutrients|micronutrients|mesh-ancestor
65406207|NCT01095211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406208|NCT01089985|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65406209|NCT01089985|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65406210|NCT00053365|Irofulven|irofulven|mesh-list
65406211|NCT00053365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65406212|NCT00053365|Alkylating Agents|alkylating agents|mesh-ancestor
65406213|NCT00053365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406214|NCT00053365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406215|NCT00387010|Fentanyl|fentanyl|mesh-list
65406216|NCT00387010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65406217|NCT00387010|Narcotics|narcotics|mesh-ancestor
65406218|NCT00387010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65406219|NCT00387010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406220|NCT00387010|Analgesics|analgesics|mesh-ancestor
65406221|NCT00387010|Sensory System Agents|sensory system agents|mesh-ancestor
65406222|NCT00387010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65406223|NCT00387010|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65406224|NCT00387010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65406225|NCT00387010|Anesthetics, General|anesthetics, general|mesh-ancestor
65406226|NCT00387010|Anesthetics|anesthetics|mesh-ancestor
65406227|NCT01092091|BCT-100|bct-100|mesh-list
65406228|NCT01092091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406229|NCT00065065|Rosiglitazone|rosiglitazone|mesh-list
65406230|NCT00065065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65406231|NCT00065065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406232|NCT00386308|Tranexamic Acid|tranexamic acid|mesh-list
65406233|NCT00386308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65406234|NCT00386308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65406235|NCT00386308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406241|NCT00064987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406243|NCT00374140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406244|NCT00374140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65406245|NCT00374140|Immunologic Factors|immunologic factors|mesh-ancestor
65406246|NCT00374140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406247|NCT00665561|Maraviroc|maraviroc|mesh-list
65406248|NCT00665561|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65406249|NCT00665561|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65406250|NCT00665561|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65406251|NCT00665561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406252|NCT00665561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65406253|NCT00665561|Antiviral Agents|antiviral agents|mesh-ancestor
65406254|NCT00665561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65229553|NCT02666001|Fostemsavir|fostemsavir|mesh-list
65406255|NCT00665561|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65406256|NCT03955705|Nefopam|nefopam|mesh-list
65406257|NCT03955705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65406258|NCT03955705|Analgesics|analgesics|mesh-ancestor
65406259|NCT03955705|Sensory System Agents|sensory system agents|mesh-ancestor
65406260|NCT03955705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65406261|NCT03955705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406262|NCT00786461|Silver Nitrate|silver nitrate|mesh-list
65406263|NCT00786461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65406264|NCT00786461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65406265|NCT00786695|Esomeprazole|esomeprazole|mesh-list
65406266|NCT00786695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65406267|NCT00786695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65406268|NCT00786695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65406269|NCT00786695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406270|NCT00786695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406271|NCT00786851|Lenalidomide|lenalidomide|mesh-list
65406272|NCT00786851|Immunologic Factors|immunologic factors|mesh-ancestor
65406273|NCT00786851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406274|NCT00786851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65406275|NCT00786851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65406276|NCT00786851|Growth Substances|growth substances|mesh-ancestor
65406277|NCT00786851|Growth Inhibitors|growth inhibitors|mesh-ancestor
65406278|NCT00786851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406279|NCT00787007|Equol|equol|mesh-list
65406280|NCT00787007|Phytoestrogens|phytoestrogens|mesh-ancestor
65406281|NCT00787007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65406282|NCT00787007|Estrogens|estrogens|mesh-ancestor
65406283|NCT00787007|Hormones|hormones|mesh-ancestor
65406284|NCT00787007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65406285|NCT00787007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406286|NCT00791141|Cetuximab|cetuximab|mesh-list
65406287|NCT00791141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65406288|NCT00791141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406289|NCT00386152|Epoetin Alfa|epoetin alfa|mesh-list
65406290|NCT00386152|Darbepoetin alfa|darbepoetin alfa|mesh-list
65406291|NCT00386152|Hematinics|hematinics|mesh-ancestor
65406292|NCT00787553|Cefazolin|cefazolin|mesh-list
65406293|NCT00787553|Tinidazole|tinidazole|mesh-list
65406295|NCT00787553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65406296|NCT00787553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65406297|NCT00787553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406298|NCT00787553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406299|NCT00787553|Alkylating Agents|alkylating agents|mesh-ancestor
65406300|NCT00787553|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65406301|NCT00787553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65406302|NCT00787553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65406303|NCT00795353|Alefacept|alefacept|mesh-list
65406304|NCT00795353|Dermatologic Agents|dermatologic agents|mesh-ancestor
65406305|NCT00795353|Immunologic Factors|immunologic factors|mesh-ancestor
65406306|NCT00795353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406307|NCT00791297|Ulipristal acetate|ulipristal acetate|mesh-list
65406308|NCT00791297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65406323|NCT01045876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65406324|NCT01045876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406326|NCT00385762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65406327|NCT00385762|Serotonin|serotonin|mesh-list
65406328|NCT00385762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65406329|NCT00385762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65406330|NCT00385762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406331|NCT00385762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65406332|NCT00385762|Serotonin Agents|serotonin agents|mesh-ancestor
65406333|NCT00385762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406334|NCT00385762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65406335|NCT00385762|Antidepressive Agents|antidepressive agents|mesh-ancestor
65406336|NCT00385762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65406337|NCT00385762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65406338|NCT00385762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65406339|NCT00385762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406340|NCT00385762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65406341|NCT00385684|Acetaminophen|acetaminophen|mesh-list
65406342|NCT00385684|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65406343|NCT00385684|Hydrocodone|hydrocodone|mesh-list
65406344|NCT00385684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65406345|NCT00385684|Narcotics|narcotics|mesh-ancestor
65229627|NCT04173039|Antibodies|antibodies|mesh-list
65406346|NCT00385684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65406347|NCT00385684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406348|NCT00385684|Analgesics|analgesics|mesh-ancestor
65406349|NCT00385684|Sensory System Agents|sensory system agents|mesh-ancestor
65406350|NCT00385684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65406351|NCT00385684|Antitussive Agents|antitussive agents|mesh-ancestor
65406352|NCT00385684|Respiratory System Agents|respiratory system agents|mesh-ancestor
65406353|NCT00385684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65406354|NCT00385684|Antipyretics|antipyretics|mesh-ancestor
65406355|NCT00385684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65406356|NCT00385684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65406357|NCT00385684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65406358|NCT00661661|Tofacitinib|tofacitinib|mesh-list
65406359|NCT00661661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65406360|NCT00661661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406361|NCT00661661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406362|NCT00038467|Tamoxifen|tamoxifen|mesh-list
65406363|NCT00038467|Exemestane|exemestane|mesh-list
65406364|NCT00038467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65406365|NCT00038467|Hormone Antagonists|hormone antagonists|mesh-ancestor
65406366|NCT00038467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65406367|NCT00038467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406376|NCT00038467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406377|NCT01095445|Ribavirin|ribavirin|mesh-list
65406378|NCT01095445|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65406379|NCT01095445|Antimetabolites|antimetabolites|mesh-ancestor
65406380|NCT01095445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406381|NCT01095445|Antiviral Agents|antiviral agents|mesh-ancestor
65406382|NCT01095445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65406383|NCT00660179|Macitentan|macitentan|mesh-list
65406384|NCT00660179|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65406385|NCT00660179|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65406386|NCT00660179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406387|NCT00660179|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65406388|NCT00050167|Paclitaxel|paclitaxel|mesh-list
65406389|NCT00050167|Docetaxel|docetaxel|mesh-list
65406390|NCT00050167|Capecitabine|capecitabine|mesh-list
65406391|NCT00050167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65406392|NCT00050167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406393|NCT00050167|Tubulin Modulators|tubulin modulators|mesh-ancestor
65406394|NCT00050167|Antimitotic Agents|antimitotic agents|mesh-ancestor
65406395|NCT00050167|Mitosis Modulators|mitosis modulators|mesh-ancestor
65406396|NCT00050167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406397|NCT00050167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65406398|NCT00050167|Antimetabolites|antimetabolites|mesh-ancestor
65406399|NCT01096927|Amoxicillin|amoxicillin|mesh-list
65406400|NCT01096927|Clavulanic Acids|clavulanic acids|mesh-list
65406401|NCT01096927|Clavulanic Acid|clavulanic acid|mesh-list
65406402|NCT01096927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65406403|NCT01096927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65406404|NCT01096927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406405|NCT01096927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406406|NCT01096927|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65406407|NCT00660023|Epoetin Alfa|epoetin alfa|mesh-list
65406408|NCT00660023|Hematinics|hematinics|mesh-ancestor
65406409|NCT02554955|Mycophenolic Acid|mycophenolic acid|mesh-list
65406410|NCT02554955|Daclizumab|daclizumab|mesh-list
65406411|NCT02554955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65406412|NCT02554955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406413|NCT02554955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65406414|NCT02554955|Antitubercular Agents|antitubercular agents|mesh-ancestor
65406415|NCT02554955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65406416|NCT02554955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65406417|NCT02554955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406418|NCT02554955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406419|NCT02554955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65406420|NCT02554955|Immunologic Factors|immunologic factors|mesh-ancestor
65406421|NCT02554955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406422|NCT00062647|Vancomycin|vancomycin|mesh-list
65406423|NCT00062647|Cloxacillin|cloxacillin|mesh-list
65406424|NCT00062647|Oxacillin|oxacillin|mesh-list
65406425|NCT00062647|Telavancin|telavancin|mesh-list
65406426|NCT00062647|Nafcillin|nafcillin|mesh-list
65406427|NCT00062647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65406428|NCT00062647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65406429|NCT00570323|Fulvestrant|fulvestrant|mesh-list
65406430|NCT00570323|Anastrozole|anastrozole|mesh-list
65406431|NCT00570323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65406432|NCT00570323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406433|NCT00570323|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65406434|NCT00570323|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65406439|NCT00570323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65406440|NCT00570323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406441|NCT00570323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406443|NCT00791531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65406444|NCT00791531|Abortifacient Agents|abortifacient agents|mesh-ancestor
65406445|NCT00791531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65406446|NCT00791531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406447|NCT00791531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65406448|NCT00791531|Antimetabolites|antimetabolites|mesh-ancestor
65406449|NCT00791531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406450|NCT00791531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406451|NCT00791531|Dermatologic Agents|dermatologic agents|mesh-ancestor
65406452|NCT00791531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406453|NCT00791531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65406454|NCT00791531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65406455|NCT00791531|Immunologic Factors|immunologic factors|mesh-ancestor
65406456|NCT00791531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65406457|NCT00791531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65406458|NCT00788099|Gemcitabine|gemcitabine|mesh-list
65406459|NCT00788099|Sorafenib|sorafenib|mesh-list
65406460|NCT00788099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65406461|NCT00788099|Antimetabolites|antimetabolites|mesh-ancestor
65406462|NCT00788099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406463|NCT00788099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406464|NCT00788099|Antiviral Agents|antiviral agents|mesh-ancestor
65406465|NCT00788099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65406466|NCT00788099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406467|NCT00788099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65406468|NCT00788099|Immunologic Factors|immunologic factors|mesh-ancestor
65406469|NCT00788099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406470|NCT00788099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65406471|NCT00795587|Mannitol|mannitol|mesh-list
65406472|NCT00795587|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65406473|NCT00795587|Diuretics|diuretics|mesh-ancestor
65406474|NCT00795587|Natriuretic Agents|natriuretic agents|mesh-ancestor
65406475|NCT00795587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406476|NCT00661505|Epoetin Alfa|epoetin alfa|mesh-list
65406477|NCT00661505|Hematinics|hematinics|mesh-ancestor
65406478|NCT00788333|Trastuzumab|trastuzumab|mesh-list
65406479|NCT00788333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65406480|NCT00788333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406481|NCT00795899|Paclitaxel|paclitaxel|mesh-list
65406482|NCT00795899|Cyclophosphamide|cyclophosphamide|mesh-list
65406483|NCT00795899|Trastuzumab|trastuzumab|mesh-list
65406484|NCT00795899|Epirubicin|epirubicin|mesh-list
65406485|NCT00795899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65406486|NCT00795899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406487|NCT00795899|Tubulin Modulators|tubulin modulators|mesh-ancestor
65406488|NCT00795899|Antimitotic Agents|antimitotic agents|mesh-ancestor
65406489|NCT00795899|Mitosis Modulators|mitosis modulators|mesh-ancestor
65406490|NCT00795899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406491|NCT00795899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65406492|NCT00795899|Immunologic Factors|immunologic factors|mesh-ancestor
65406493|NCT00795899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406494|NCT00795899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65406495|NCT00795899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65406496|NCT00795899|Alkylating Agents|alkylating agents|mesh-ancestor
65406497|NCT00795899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65406498|NCT00795899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65406499|NCT00795899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65406500|NCT00795899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65406501|NCT00795899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65406502|NCT00795899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406503|NCT00795977|Picibanil|picibanil|mesh-list
65406504|NCT00795977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406517|NCT00796211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406518|NCT00788567|Mycophenolic Acid|mycophenolic acid|mesh-list
65406519|NCT00788567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65406520|NCT00788567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229777|NCT02656095|Anticoagulants|anticoagulants|mesh-ancestor
65406521|NCT00788567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65406522|NCT00788567|Antitubercular Agents|antitubercular agents|mesh-ancestor
65406523|NCT00788567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65406524|NCT00788567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65406525|NCT00788567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406526|NCT00788567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406527|NCT00662909|Mirabegron|mirabegron|mesh-list
65406528|NCT00662909|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65406529|NCT00662909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65406530|NCT00662909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65406531|NCT00662909|Adrenergic Agents|adrenergic agents|mesh-ancestor
65406532|NCT00662909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65406533|NCT00662909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406534|NCT00662909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406535|NCT00662909|Urological Agents|urological agents|mesh-ancestor
65406536|NCT00050011|Zoledronic Acid|zoledronic acid|mesh-list
65406537|NCT00050011|Letrozole|letrozole|mesh-list
65406538|NCT00050011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406539|NCT00050011|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65406540|NCT00050011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65406541|NCT00050011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406542|NCT00050011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406543|NCT00050011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65406544|NCT00050011|Hormone Antagonists|hormone antagonists|mesh-ancestor
65406545|NCT00050011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65406546|NCT00050011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406547|NCT00050011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65406548|NCT00661427|Cetuximab|cetuximab|mesh-list
65406549|NCT00661427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65406550|NCT00661427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406551|NCT00049543|Gefitinib|gefitinib|mesh-list
65406552|NCT00049543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406553|NCT00049543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65406554|NCT00049543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406555|NCT00049543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406556|NCT03955393|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
65406557|NCT03955393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65406558|NCT03955393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406559|NCT04080427|Dronabinol|dronabinol|mesh-list
65406560|NCT04080427|Hallucinogens|hallucinogens|mesh-ancestor
65406561|NCT04080427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406562|NCT04080427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65406563|NCT04080427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65406564|NCT04080427|Analgesics|analgesics|mesh-ancestor
64791355|NCT00356928|Alkylating Agents|alkylating agents|mesh-ancestor
65406572|NCT04080427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65406573|NCT01092481|Oxaliplatin|oxaliplatin|mesh-list
65406574|NCT01092481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406575|NCT00035815|Mitogens|mitogens|mesh-list
65406576|NCT00035815|Mitosis Modulators|mitosis modulators|mesh-ancestor
65406577|NCT00035815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406578|NCT00662831|Dalteparin|dalteparin|mesh-list
65406579|NCT00662831|Tinzaparin|tinzaparin|mesh-list
65406580|NCT00662831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65406581|NCT00662831|Anticoagulants|anticoagulants|mesh-ancestor
65406582|NCT00662831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65406583|NCT00662831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65406584|NCT00662831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406585|NCT02555423|Anesthetics|anesthetics|mesh-list
65406586|NCT02555423|Levobupivacaine|levobupivacaine|mesh-list
65406587|NCT02555423|Anesthetics, Local|anesthetics, local|mesh-list
65406588|NCT02555423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65406589|NCT02555423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406590|NCT02555423|Sensory System Agents|sensory system agents|mesh-ancestor
65406591|NCT02555423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65406592|NCT00792779|Propofol|propofol|mesh-list
65406593|NCT00792779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65406594|NCT00792779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65406595|NCT00792779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406596|NCT00792779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65406597|NCT00792779|Anesthetics, General|anesthetics, general|mesh-ancestor
65406598|NCT00792779|Anesthetics|anesthetics|mesh-ancestor
65406599|NCT00662363|Lubiprostone|lubiprostone|mesh-list
65229853|NCT00732745|Docetaxel|docetaxel|mesh-list
65406600|NCT00662363|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65406601|NCT00662363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65406602|NCT00662363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406603|NCT00796835|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65406604|NCT00796835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65406605|NCT00796835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65406606|NCT00796835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65406607|NCT00796835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406608|NCT00796835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65406609|NCT00796835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65406610|NCT00796835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65406611|NCT00796835|Serotonin Agents|serotonin agents|mesh-ancestor
65406612|NCT00796835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65406613|NCT00796835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406614|NCT00796835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65406615|NCT00796835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65406616|NCT00796835|Dopamine Agents|dopamine agents|mesh-ancestor
65406617|NCT00792857|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
65406618|NCT00792857|Vitamins|vitamins|mesh-ancestor
65406619|NCT00792857|Micronutrients|micronutrients|mesh-ancestor
65406620|NCT00792857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406621|NCT00792857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65406622|NCT02554175|Propofol|propofol|mesh-list
65406623|NCT02554175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65406624|NCT02554175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65406625|NCT02554175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406626|NCT02554175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65406627|NCT02554175|Anesthetics, General|anesthetics, general|mesh-ancestor
65406628|NCT02554175|Anesthetics|anesthetics|mesh-ancestor
65406629|NCT00793091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65406630|NCT00793091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65406642|NCT00797303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65406643|NCT00797303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65406644|NCT00797303|Growth Substances|growth substances|mesh-ancestor
65406645|NCT00797303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406646|NCT00797303|Growth Inhibitors|growth inhibitors|mesh-ancestor
65406647|NCT00661193|Paclitaxel|paclitaxel|mesh-list
65406648|NCT00661193|Carboplatin|carboplatin|mesh-list
65406649|NCT00661193|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65406650|NCT00661193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65406651|NCT00661193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406652|NCT00661193|Tubulin Modulators|tubulin modulators|mesh-ancestor
65406653|NCT00661193|Antimitotic Agents|antimitotic agents|mesh-ancestor
65406654|NCT00661193|Mitosis Modulators|mitosis modulators|mesh-ancestor
65406655|NCT00661193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406656|NCT00661193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65406657|NCT00661193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406658|NCT00801047|Remifentanil|remifentanil|mesh-list
65406659|NCT00801047|Bupivacaine|bupivacaine|mesh-list
65406660|NCT00801047|Anesthetics, Local|anesthetics, local|mesh-ancestor
65406661|NCT00801047|Anesthetics|anesthetics|mesh-ancestor
65406662|NCT00801047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65406663|NCT00801047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406664|NCT00801047|Sensory System Agents|sensory system agents|mesh-ancestor
65406665|NCT00801047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65406666|NCT00801047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65406667|NCT00801047|Narcotics|narcotics|mesh-ancestor
65406668|NCT00801047|Analgesics|analgesics|mesh-ancestor
65406669|NCT00801125|Natalizumab|natalizumab|mesh-list
65406670|NCT00801125|Immunologic Factors|immunologic factors|mesh-ancestor
65406671|NCT00801125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406672|NCT00801281|Prednisone|prednisone|mesh-list
65406673|NCT00801281|Cyclophosphamide|cyclophosphamide|mesh-list
65406674|NCT00801281|Rituximab|rituximab|mesh-list
65406675|NCT00801281|Doxorubicin|doxorubicin|mesh-list
65406676|NCT00801281|Vincristine|vincristine|mesh-list
65406677|NCT00801281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65406678|NCT00801281|Immunologic Factors|immunologic factors|mesh-ancestor
65406679|NCT00801281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406680|NCT00801281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65406681|NCT00801281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65406682|NCT00801281|Alkylating Agents|alkylating agents|mesh-ancestor
65406683|NCT00801281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406684|NCT00801281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229927|NCT02653833|Tadalafil|tadalafil|mesh-list
65406685|NCT00801281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65406686|NCT00801281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65406687|NCT00801281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65406688|NCT00801281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65406689|NCT00801281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65406690|NCT00801281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406691|NCT00801281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65406692|NCT00801281|Glucocorticoids|glucocorticoids|mesh-ancestor
65406693|NCT00801281|Hormones|hormones|mesh-ancestor
65406694|NCT00801281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65406695|NCT00801281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65406696|NCT00801281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65406730|NCT00797927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406731|NCT00798083|Lidocaine|lidocaine|mesh-list
65406732|NCT00798083|Ketamine|ketamine|mesh-list
65406733|NCT00798083|Amitriptyline|amitriptyline|mesh-list
65406734|NCT00798083|Anesthetics, Local|anesthetics, local|mesh-ancestor
65406735|NCT00798083|Anesthetics|anesthetics|mesh-ancestor
65406736|NCT00798083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65406737|NCT00798083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406738|NCT00798083|Sensory System Agents|sensory system agents|mesh-ancestor
64791549|NCT00359658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65406761|NCT00798395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65406762|NCT00798395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65406763|NCT00798395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406764|NCT00798395|Antidepressive Agents|antidepressive agents|mesh-ancestor
65406765|NCT00798395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65406766|NCT00798395|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65406767|NCT00798395|Histamine Antagonists|histamine antagonists|mesh-ancestor
65406768|NCT00798395|Histamine Agents|histamine agents|mesh-ancestor
65406769|NCT00798395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65406770|NCT00798395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406771|NCT00798395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65406772|NCT00798395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65406773|NCT00798395|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65406774|NCT00798395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65406775|NCT00798395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65406776|NCT00798395|Adrenergic Agents|adrenergic agents|mesh-ancestor
65406777|NCT00798395|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65406778|NCT00798395|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65406779|NCT00798395|Serotonin Agents|serotonin agents|mesh-ancestor
65406780|NCT00798395|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65406781|NCT00801905|Nepafenac|nepafenac|mesh-list
65406782|NCT00801905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65406783|NCT00801905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65406784|NCT00801905|Analgesics|analgesics|mesh-ancestor
65406785|NCT00801905|Sensory System Agents|sensory system agents|mesh-ancestor
65406786|NCT00801905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65406787|NCT00801905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406788|NCT00801905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65406789|NCT00801905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65406802|NCT00048061|Calcium|calcium|mesh-list
65406803|NCT00048061|Vitamins|vitamins|mesh-ancestor
65406804|NCT00048061|Micronutrients|micronutrients|mesh-ancestor
65406805|NCT00048061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406806|NCT00048061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65406807|NCT00048061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65406808|NCT00802139|Iron|iron|mesh-list
65406809|NCT00802139|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65406810|NCT00802139|Trace Elements|trace elements|mesh-ancestor
65406811|NCT00802139|Micronutrients|micronutrients|mesh-ancestor
65406812|NCT00802139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406813|NCT00802139|Hematinics|hematinics|mesh-ancestor
65406814|NCT00802217|Capsaicin|capsaicin|mesh-list
65406815|NCT00802217|Antipruritics|antipruritics|mesh-ancestor
65406816|NCT00802217|Dermatologic Agents|dermatologic agents|mesh-ancestor
65406817|NCT00802217|Sensory System Agents|sensory system agents|mesh-ancestor
65156356|NCT04187144|Nitrofurantoin|nitrofurantoin|mesh-list
65406818|NCT00802217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65406819|NCT00802217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406820|NCT00802373|Solifenacin Succinate|solifenacin succinate|mesh-list
65406821|NCT00802373|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65406822|NCT00802373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65406823|NCT00802373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65230002|NCT00733525|Fluoxetine|fluoxetine|mesh-list
65406824|NCT00802373|Cholinergic Agents|cholinergic agents|mesh-ancestor
65406825|NCT00802373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65406826|NCT00802373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406827|NCT00802373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406828|NCT00802373|Urological Agents|urological agents|mesh-ancestor
65406829|NCT03957109|Anesthetics|anesthetics|mesh-list
65406830|NCT03957109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65406831|NCT03957109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406832|NCT00802451|Mesalamine|mesalamine|mesh-list
65406833|NCT00802451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65406834|NCT00802451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65406835|NCT00802451|Analgesics|analgesics|mesh-ancestor
65406836|NCT00802451|Sensory System Agents|sensory system agents|mesh-ancestor
65406837|NCT00802451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65406838|NCT00802451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406839|NCT00802451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65406840|NCT00802451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65406841|NCT03956953|BMS-986165|bms-986165|mesh-list
65406842|NCT03956953|Dermatologic Agents|dermatologic agents|mesh-ancestor
65406843|NCT03956953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65406844|NCT03956953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406845|NCT03956953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406846|NCT00798473|Zoledronic Acid|zoledronic acid|mesh-list
65406847|NCT00798473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65406848|NCT00798473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406849|NCT04045769|Moxifloxacin|moxifloxacin|mesh-list
65406850|NCT04045769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65406851|NCT04045769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65406852|NCT04045769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65406861|NCT01097317|Tubulin Modulators|tubulin modulators|mesh-ancestor
65406862|NCT01097317|Antimitotic Agents|antimitotic agents|mesh-ancestor
65406863|NCT01097317|Mitosis Modulators|mitosis modulators|mesh-ancestor
65406864|NCT01097317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406866|NCT01095679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65406867|NCT01095679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406868|NCT01095679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65406869|NCT01095679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65406870|NCT01095679|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65406871|NCT01095679|GABA Agonists|gaba agonists|mesh-ancestor
65406872|NCT01095679|GABA Agents|gaba agents|mesh-ancestor
65406873|NCT01095679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65406874|NCT01095679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406875|NCT00794261|Lenograstim|lenograstim|mesh-list
65406876|NCT00794261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65406877|NCT00794261|Immunologic Factors|immunologic factors|mesh-ancestor
65406878|NCT00794261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406879|NCT03953287|Acetaminophen|acetaminophen|mesh-list
65406880|NCT03953287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65406881|NCT03953287|Analgesics|analgesics|mesh-ancestor
65406882|NCT03953287|Sensory System Agents|sensory system agents|mesh-ancestor
65406883|NCT03953287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65406884|NCT03953287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406885|NCT03953287|Antipyretics|antipyretics|mesh-ancestor
65406886|NCT01097551|Phenylephrine|phenylephrine|mesh-list
65406887|NCT01097551|Acetylcholine|acetylcholine|mesh-list
65406888|NCT01097551|Nitroglycerin|nitroglycerin|mesh-list
65406889|NCT01097551|Vasodilator Agents|vasodilator agents|mesh-ancestor
65406890|NCT01097551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65406891|NCT01097551|Cholinergic Agents|cholinergic agents|mesh-ancestor
65406892|NCT01097551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65156436|NCT00625677|Vaccines|vaccines|mesh-list
65406893|NCT01097551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406894|NCT01097551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406895|NCT01097551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65406896|NCT01097551|Mydriatics|mydriatics|mesh-ancestor
65406897|NCT01097551|Autonomic Agents|autonomic agents|mesh-ancestor
65406898|NCT01097551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65406899|NCT01097551|Sympathomimetics|sympathomimetics|mesh-ancestor
65406900|NCT01097551|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65406901|NCT01097551|Nasal Decongestants|nasal decongestants|mesh-ancestor
65406902|NCT01097551|Respiratory System Agents|respiratory system agents|mesh-ancestor
65406903|NCT01097551|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65406904|NCT01097551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65406905|NCT01097551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65230087|NCT05742295|Vitamin K|vitamin k|mesh-list
65406906|NCT01097551|Adrenergic Agents|adrenergic agents|mesh-ancestor
65406907|NCT01097551|Protective Agents|protective agents|mesh-ancestor
65406908|NCT00803309|Interferons|interferons|mesh-list
65406909|NCT00803309|Ribavirin|ribavirin|mesh-list
65406910|NCT00803309|Interferon-alpha|interferon-alpha|mesh-list
65406911|NCT00803309|Interferon alpha-2|interferon alpha-2|mesh-list
65406912|NCT00803309|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65406913|NCT00803309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406914|NCT00803309|Antiviral Agents|antiviral agents|mesh-ancestor
65406915|NCT00803309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65406916|NCT00803309|Antimetabolites|antimetabolites|mesh-ancestor
65406917|NCT00803309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406918|NCT00803309|Immunologic Factors|immunologic factors|mesh-ancestor
65406919|NCT00803309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406942|NCT00803465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65406943|NCT00803465|Autonomic Agents|autonomic agents|mesh-ancestor
65406944|NCT00803465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65406945|NCT00803465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406946|NCT00803465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65406947|NCT00803465|Respiratory System Agents|respiratory system agents|mesh-ancestor
65406948|NCT00803465|Dermatologic Agents|dermatologic agents|mesh-ancestor
65406949|NCT00803465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65406950|NCT00803699|Selenium|selenium|mesh-list
65406951|NCT00803699|Antioxidants|antioxidants|mesh-ancestor
65406952|NCT00803699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406953|NCT00803699|Protective Agents|protective agents|mesh-ancestor
65406954|NCT00803699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406955|NCT00803699|Trace Elements|trace elements|mesh-ancestor
65406956|NCT00803699|Micronutrients|micronutrients|mesh-ancestor
65406957|NCT00798785|Rituximab|rituximab|mesh-list
65406958|NCT00798785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65406959|NCT00798785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406960|NCT00798785|Immunologic Factors|immunologic factors|mesh-ancestor
65406961|NCT00798785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406962|NCT00798785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65406963|NCT01095991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65406964|NCT01095991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65406965|NCT01095991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406966|NCT01095991|Incretins|incretins|mesh-ancestor
65406967|NCT01095991|Hormones|hormones|mesh-ancestor
65406968|NCT01095991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65406969|NCT01095991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65406970|NCT01095991|Protease Inhibitors|protease inhibitors|mesh-ancestor
65406971|NCT01095991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406972|NCT01095991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406973|NCT00794807|Alefacept|alefacept|mesh-list
65406974|NCT00794807|Dermatologic Agents|dermatologic agents|mesh-ancestor
65406975|NCT00794807|Immunologic Factors|immunologic factors|mesh-ancestor
64791777|NCT00365586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406988|NCT00794885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65406989|NCT00794885|Protease Inhibitors|protease inhibitors|mesh-ancestor
65406990|NCT00794885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65406991|NCT00803933|Pentamidine|pentamidine|mesh-list
65406992|NCT00803933|Pafuramidine|pafuramidine|mesh-list
65406993|NCT00803933|Antifungal Agents|antifungal agents|mesh-ancestor
65406994|NCT00803933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65406995|NCT00803933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65406996|NCT00803933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65406997|NCT00803933|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65406998|NCT02553707|Ibandronic Acid|ibandronic acid|mesh-list
65406999|NCT02553707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65407000|NCT02553707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407001|NCT00656669|Paclitaxel|paclitaxel|mesh-list
65407002|NCT00656669|Cyclophosphamide|cyclophosphamide|mesh-list
65407003|NCT00656669|Doxorubicin|doxorubicin|mesh-list
65407004|NCT00656669|Sunitinib|sunitinib|mesh-list
65407005|NCT00656669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65407006|NCT00656669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407007|NCT00656669|Tubulin Modulators|tubulin modulators|mesh-ancestor
65407008|NCT00656669|Antimitotic Agents|antimitotic agents|mesh-ancestor
65407009|NCT00656669|Mitosis Modulators|mitosis modulators|mesh-ancestor
65407010|NCT00656669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407011|NCT00656669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65407012|NCT00656669|Immunologic Factors|immunologic factors|mesh-ancestor
65407013|NCT00656669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407014|NCT00656669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65407015|NCT00656669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65407016|NCT00656669|Alkylating Agents|alkylating agents|mesh-ancestor
65407017|NCT00656669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65407018|NCT00656669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65407019|NCT00656669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65407020|NCT00656669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65407021|NCT00656669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407022|NCT00656669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65407023|NCT00656669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65407024|NCT00656669|Growth Substances|growth substances|mesh-ancestor
65407025|NCT00656669|Growth Inhibitors|growth inhibitors|mesh-ancestor
65407026|NCT00656669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65407027|NCT00799175|Ketorolac|ketorolac|mesh-list
65407028|NCT00799175|Epinephrine|epinephrine|mesh-list
65407029|NCT00799175|Ropivacaine|ropivacaine|mesh-list
65407030|NCT00799175|Anesthetics, Local|anesthetics, local|mesh-ancestor
65407031|NCT00799175|Anesthetics|anesthetics|mesh-ancestor
65407032|NCT00799175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65407033|NCT00799175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407034|NCT00799175|Sensory System Agents|sensory system agents|mesh-ancestor
65407035|NCT00799175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65407036|NCT00799175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65407037|NCT00799175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65407038|NCT00799175|Adrenergic Agents|adrenergic agents|mesh-ancestor
65407039|NCT00799175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65407040|NCT00799175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407041|NCT00799175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65407058|NCT00656513|Autonomic Agents|autonomic agents|mesh-ancestor
65407059|NCT00656513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65407060|NCT00656513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407061|NCT00656513|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65407062|NCT00656513|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65407063|NCT00656513|Cholinergic Agents|cholinergic agents|mesh-ancestor
65407064|NCT00656513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65407065|NCT00656513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407066|NCT04017221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65407067|NCT04017221|Protease Inhibitors|protease inhibitors|mesh-ancestor
65407068|NCT04017221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407069|NCT04017221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407070|NCT04017221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65407071|NCT04017221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407072|NCT00804245|Choline|choline|mesh-list
65407073|NCT00804245|Lipotropic Agents|lipotropic agents|mesh-ancestor
65407074|NCT00804245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65407075|NCT00804245|Antimetabolites|antimetabolites|mesh-ancestor
65407076|NCT00804245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407077|NCT00804245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65407078|NCT00804245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65407079|NCT00804245|Nootropic Agents|nootropic agents|mesh-ancestor
65407080|NCT00804401|Naproxen|naproxen|mesh-list
65407081|NCT00804401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65407082|NCT00804401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65407083|NCT00804401|Analgesics|analgesics|mesh-ancestor
65407084|NCT00804401|Sensory System Agents|sensory system agents|mesh-ancestor
65407085|NCT00804401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65407086|NCT00804401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407087|NCT00804401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65407088|NCT00804401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65407089|NCT00804401|Gout Suppressants|gout suppressants|mesh-ancestor
65407090|NCT00804401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65407091|NCT00804401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407092|NCT00804401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407093|NCT00804791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65407094|NCT00804791|Lubricant Eye Drops|lubricant eye drops|mesh-list
65407095|NCT00804791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65407096|NCT02553083|Amoxicillin|amoxicillin|mesh-list
65407097|NCT02553083|Doxycycline|doxycycline|mesh-list
65407098|NCT02553083|Esomeprazole|esomeprazole|mesh-list
65407099|NCT02553083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65407100|NCT02553083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65407101|NCT02553083|Antimalarials|antimalarials|mesh-ancestor
65407102|NCT02553083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65407113|NCT00804947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407114|NCT00804947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407115|NCT00804947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65407116|NCT00804947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65407117|NCT00804947|Immunologic Factors|immunologic factors|mesh-ancestor
65407118|NCT00804947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407119|NCT00806663|Sunitinib|sunitinib|mesh-list
65407120|NCT00806663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407121|NCT00806663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65407122|NCT00806663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65156662|NCT01204710|Prednisone|prednisone|mesh-list
65407123|NCT00806663|Growth Substances|growth substances|mesh-ancestor
65407124|NCT00806663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407125|NCT00806663|Growth Inhibitors|growth inhibitors|mesh-ancestor
65407126|NCT00806663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65407127|NCT00806663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407128|NCT00806663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407130|NCT00806741|Oxymetazoline|oxymetazoline|mesh-list
65407131|NCT00806741|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
65407132|NCT00806741|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65407133|NCT00806741|Mydriatics|mydriatics|mesh-ancestor
65407134|NCT00806741|Autonomic Agents|autonomic agents|mesh-ancestor
65407135|NCT00806741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65407136|NCT00806741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407137|NCT00806741|Sympathomimetics|sympathomimetics|mesh-ancestor
65407138|NCT00806741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65407139|NCT00806741|Nasal Decongestants|nasal decongestants|mesh-ancestor
65407140|NCT00806741|Respiratory System Agents|respiratory system agents|mesh-ancestor
65407141|NCT00806741|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65407142|NCT00806741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65407143|NCT00806741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65407144|NCT00806741|Adrenergic Agents|adrenergic agents|mesh-ancestor
65407145|NCT00806741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65407146|NCT00806741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407147|NCT00806741|Protective Agents|protective agents|mesh-ancestor
65407148|NCT00806741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407149|NCT00806897|Insulin Detemir|insulin detemir|mesh-list
65407150|NCT00806897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65407151|NCT00806897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407152|NCT00805649|Dexamethasone|dexamethasone|mesh-list
65407153|NCT00805649|Bevacizumab|bevacizumab|mesh-list
65407154|NCT00805649|Temazepam|temazepam|mesh-list
65407155|NCT00805649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65407156|NCT00805649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407157|NCT00805649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65407158|NCT00805649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65407159|NCT00805649|Growth Substances|growth substances|mesh-ancestor
65407160|NCT00805649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407161|NCT00805649|Growth Inhibitors|growth inhibitors|mesh-ancestor
65407162|NCT00805649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65407163|NCT00805649|Antiemetics|antiemetics|mesh-ancestor
65407164|NCT00805649|Autonomic Agents|autonomic agents|mesh-ancestor
65407165|NCT00805649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65407166|NCT00805649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65407167|NCT00805649|Glucocorticoids|glucocorticoids|mesh-ancestor
65407168|NCT00805649|Hormones|hormones|mesh-ancestor
65407180|NCT00807053|Ciclesonide|ciclesonide|mesh-list
65407181|NCT00807053|Glucocorticoids|glucocorticoids|mesh-ancestor
65407182|NCT00807053|Hormones|hormones|mesh-ancestor
65407183|NCT00807053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65407184|NCT00807053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407185|NCT00807053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65407186|NCT00809393|Tranexamic Acid|tranexamic acid|mesh-list
65407187|NCT00809393|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65407188|NCT00809393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65407189|NCT00809393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407190|NCT00809393|Hemostatics|hemostatics|mesh-ancestor
65407191|NCT00809393|Coagulants|coagulants|mesh-ancestor
65407192|NCT00658775|Esomeprazole|esomeprazole|mesh-list
65407193|NCT00658775|Rabeprazole|rabeprazole|mesh-list
65407194|NCT00658775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65407195|NCT00658775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65407196|NCT00658775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65407197|NCT00658775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156731|NCT01256294|Tacrolimus|tacrolimus|mesh-list
65407198|NCT00658775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407199|NCT00488631|Golimumab|golimumab|mesh-list
65407200|NCT00488631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65407201|NCT00488631|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65407202|NCT00488631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65230301|NCT02646657|Vedolizumab|vedolizumab|mesh-list
65407203|NCT00488631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65407204|NCT00488631|Immunologic Factors|immunologic factors|mesh-ancestor
65407205|NCT00488631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407206|NCT00809549|Lenograstim|lenograstim|mesh-list
65407207|NCT00809549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65407208|NCT00809549|Immunologic Factors|immunologic factors|mesh-ancestor
65407209|NCT00809549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407210|NCT00809627|Caffeine|caffeine|mesh-list
65407211|NCT00809627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65407212|NCT00809627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407213|NCT00809627|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65407214|NCT00809627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407215|NCT00809627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407216|NCT00809627|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65407217|NCT00809627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65407218|NCT00809627|Purinergic Agents|purinergic agents|mesh-ancestor
65407219|NCT00809627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65407220|NCT00809705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65407221|NCT00809705|Incretins|incretins|mesh-ancestor
65407222|NCT00809705|Hormones|hormones|mesh-ancestor
65407223|NCT00809705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65407224|NCT00809705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407225|NCT00655499|Irinotecan|irinotecan|mesh-list
65407226|NCT00655499|Panitumumab|panitumumab|mesh-list
65407227|NCT00655499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65407228|NCT00655499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65407229|NCT00655499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792020|NCT00370734|Botulinum Toxins|botulinum toxins|mesh-list
65407244|NCT00800267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65407245|NCT00809939|Progesterone|progesterone|mesh-list
65407246|NCT00809939|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
65407247|NCT00809939|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
65407248|NCT00809939|Progestins|progestins|mesh-ancestor
65407249|NCT00809939|Hormones|hormones|mesh-ancestor
65407250|NCT00809939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65407251|NCT00809939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407252|NCT00809939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65407253|NCT00809939|Hormone Antagonists|hormone antagonists|mesh-ancestor
65407254|NCT00807443|Raltegravir Potassium|raltegravir potassium|mesh-list
65407255|NCT00807443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65407256|NCT00807443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65407257|NCT00807443|Antiviral Agents|antiviral agents|mesh-ancestor
65407258|NCT00807443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65407259|NCT00807443|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65407260|NCT00807443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65407261|NCT00807443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407262|NCT00807443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407263|NCT00807521|Dexamethasone|dexamethasone|mesh-list
65407264|NCT00807521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65407265|NCT00807521|Antiemetics|antiemetics|mesh-ancestor
65407266|NCT00807521|Autonomic Agents|autonomic agents|mesh-ancestor
65407267|NCT00807521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65407268|NCT00807521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407269|NCT00807521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65156802|NCT01203072|Protease Inhibitors|protease inhibitors|mesh-ancestor
65407270|NCT00807521|Glucocorticoids|glucocorticoids|mesh-ancestor
65407271|NCT00807521|Hormones|hormones|mesh-ancestor
65407272|NCT00807521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65407273|NCT00807521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65407274|NCT00807521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407276|NCT00800423|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65407277|NCT00800423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407278|NCT00800423|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65407279|NCT00800423|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65407280|NCT00800423|Adrenergic Agents|adrenergic agents|mesh-ancestor
65407281|NCT00800423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65407282|NCT00800423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407283|NCT00800423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65407284|NCT00800423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65407285|NCT00800423|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65407286|NCT00800423|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65407287|NCT00800423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65407288|NCT00651755|Prednisone|prednisone|mesh-list
65269876|NCT02727296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65269877|NCT02732132|Fentanyl|fentanyl|mesh-list
65269878|NCT02732132|Midazolam|midazolam|mesh-list
65269879|NCT02732132|Ketamine|ketamine|mesh-list
65269880|NCT02732132|Propofol|propofol|mesh-list
65269881|NCT02732132|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65269882|NCT02732132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65269883|NCT02732132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269884|NCT02732132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65269885|NCT02732132|Anesthetics, General|anesthetics, general|mesh-ancestor
65269886|NCT02732132|Anesthetics|anesthetics|mesh-ancestor
65269887|NCT02732132|Analgesics|analgesics|mesh-ancestor
65269888|NCT02732132|Sensory System Agents|sensory system agents|mesh-ancestor
65230385|NCT02645565|Methylprednisolone|methylprednisolone|mesh-list
65407298|NCT00651755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407299|NCT00651755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65407300|NCT00651755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65407301|NCT00651755|Alkylating Agents|alkylating agents|mesh-ancestor
65407302|NCT00651755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407303|NCT00651755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407304|NCT00651755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65407305|NCT00651755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65407306|NCT00651755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65407307|NCT00651755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65407308|NCT00651755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65407309|NCT00651755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407310|NCT00651755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65407311|NCT00651755|Glucocorticoids|glucocorticoids|mesh-ancestor
65407312|NCT00651755|Hormones|hormones|mesh-ancestor
65407313|NCT00651755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65407314|NCT00651755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65407315|NCT00651755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65407316|NCT00651755|Tubulin Modulators|tubulin modulators|mesh-ancestor
65407317|NCT00651755|Antimitotic Agents|antimitotic agents|mesh-ancestor
65407318|NCT00651755|Mitosis Modulators|mitosis modulators|mesh-ancestor
65407319|NCT00651755|Antiemetics|antiemetics|mesh-ancestor
65407320|NCT00651755|Autonomic Agents|autonomic agents|mesh-ancestor
65407321|NCT00651755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65407322|NCT00651755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65407323|NCT00651755|Antipruritics|antipruritics|mesh-ancestor
65407324|NCT00651755|Dermatologic Agents|dermatologic agents|mesh-ancestor
65407325|NCT00651755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65407326|NCT00651755|Serotonin Agents|serotonin agents|mesh-ancestor
65407327|NCT00651755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65407328|NCT00651755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65407329|NCT00651755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65407330|NCT00651755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65407331|NCT00651755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65407332|NCT00651755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65407333|NCT00651755|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65407334|NCT00807755|Carboplatin|carboplatin|mesh-list
65407335|NCT00807755|Etoposide|etoposide|mesh-list
65407336|NCT00807755|Everolimus|everolimus|mesh-list
65407337|NCT00807755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407338|NCT00807755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65407339|NCT00807755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65407340|NCT00807755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65407341|NCT00807755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407342|NCT00807755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407343|NCT00807755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65407344|NCT00807755|Immunologic Factors|immunologic factors|mesh-ancestor
65407345|NCT00807755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407346|NCT00813527|Fenofibrate|fenofibrate|mesh-list
65230447|NCT03159897|Doxorubicin|doxorubicin|mesh-list
65407347|NCT00813527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65407348|NCT00813527|Antimetabolites|antimetabolites|mesh-ancestor
65407349|NCT00813527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407350|NCT00813527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65407352|NCT00810563|Anesthetics, Local|anesthetics, local|mesh-ancestor
65407353|NCT00810563|Anesthetics|anesthetics|mesh-ancestor
65407354|NCT00810563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65407355|NCT00810563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407356|NCT00810563|Sensory System Agents|sensory system agents|mesh-ancestor
65407357|NCT00810563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65407364|NCT00808145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407365|NCT00808145|Antiviral Agents|antiviral agents|mesh-ancestor
65407366|NCT00808145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65407367|NCT00808145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407368|NCT00808145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65407369|NCT00808145|Immunologic Factors|immunologic factors|mesh-ancestor
65407370|NCT00808145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407371|NCT00808145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65407372|NCT02552459|Sufentanil|sufentanil|mesh-list
65407373|NCT02552459|Dexmedetomidine|dexmedetomidine|mesh-list
65407374|NCT02552459|Dsuvia|dsuvia|mesh-list
65407375|NCT02552459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65407376|NCT02552459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65407377|NCT02552459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407378|NCT02552459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65407379|NCT02552459|Analgesics|analgesics|mesh-ancestor
65407380|NCT02552459|Sensory System Agents|sensory system agents|mesh-ancestor
65407381|NCT02552459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65407382|NCT02552459|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65407383|NCT02552459|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65407384|NCT02552459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65407385|NCT02552459|Adrenergic Agents|adrenergic agents|mesh-ancestor
65407386|NCT02552459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65407387|NCT02552459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407388|NCT02552459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65407389|NCT02552459|Narcotics|narcotics|mesh-ancestor
65407390|NCT02552459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65407391|NCT02552459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65407392|NCT02552459|Anesthetics, General|anesthetics, general|mesh-ancestor
65407393|NCT02552459|Anesthetics|anesthetics|mesh-ancestor
65407394|NCT00810953|Pentamidine|pentamidine|mesh-list
65407395|NCT00810953|Antifungal Agents|antifungal agents|mesh-ancestor
65407396|NCT00810953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65407397|NCT00810953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65407398|NCT00810953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65407399|NCT00810953|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65407400|NCT00811031|Prednisone|prednisone|mesh-list
65407401|NCT00811031|Docetaxel|docetaxel|mesh-list
65407402|NCT00811031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407403|NCT00811031|Tubulin Modulators|tubulin modulators|mesh-ancestor
65407404|NCT00811031|Antimitotic Agents|antimitotic agents|mesh-ancestor
65407405|NCT00811031|Mitosis Modulators|mitosis modulators|mesh-ancestor
65407406|NCT00811031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407407|NCT00811031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65407408|NCT00811031|Glucocorticoids|glucocorticoids|mesh-ancestor
65407409|NCT00811031|Hormones|hormones|mesh-ancestor
65407410|NCT00811031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65407411|NCT00811031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407412|NCT00811031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65407413|NCT02552537|Mannitol|mannitol|mesh-list
65407414|NCT02552537|Omeprazole|omeprazole|mesh-list
65407415|NCT02552537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65407416|NCT02552537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65407417|NCT02552537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65407418|NCT02552537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156955|NCT01109979|Estradiol|estradiol|mesh-list
65407419|NCT02552537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407420|NCT02552537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65407421|NCT02552537|Diuretics|diuretics|mesh-ancestor
65407422|NCT02552537|Natriuretic Agents|natriuretic agents|mesh-ancestor
65407423|NCT02552537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407424|NCT00808223|Alefacept|alefacept|mesh-list
65407425|NCT00808223|Dermatologic Agents|dermatologic agents|mesh-ancestor
65407426|NCT00808223|Immunologic Factors|immunologic factors|mesh-ancestor
65407427|NCT00808223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230523|NCT04288700|Timolol|timolol|mesh-list
65407428|NCT00811421|Pyrimethamine|pyrimethamine|mesh-list
65407429|NCT00811421|Sulfadoxine|sulfadoxine|mesh-list
65407462|NCT00811967|Interferon-alpha|interferon-alpha|mesh-list
65407463|NCT00811967|Antimetabolites|antimetabolites|mesh-ancestor
65407464|NCT00811967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407465|NCT00811967|Antiviral Agents|antiviral agents|mesh-ancestor
65407466|NCT00811967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65407467|NCT00811967|Immunologic Factors|immunologic factors|mesh-ancestor
65407468|NCT00811967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407470|NCT04046159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65407471|NCT04046159|Hormone Antagonists|hormone antagonists|mesh-ancestor
64792286|NCT00378456|Vitamins|vitamins|mesh-list
65407486|NCT00653939|Tubulin Modulators|tubulin modulators|mesh-ancestor
65407487|NCT00653939|Antimitotic Agents|antimitotic agents|mesh-ancestor
65407488|NCT00653939|Mitosis Modulators|mitosis modulators|mesh-ancestor
65407489|NCT00653939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407490|NCT00653939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65407491|NCT00653939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65407492|NCT00653939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65407493|NCT00653939|Growth Substances|growth substances|mesh-ancestor
65407494|NCT00653939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407495|NCT00653939|Growth Inhibitors|growth inhibitors|mesh-ancestor
65407496|NCT00812123|Cyclosporine|cyclosporine|mesh-list
65407497|NCT00812123|Sirolimus|sirolimus|mesh-list
65407498|NCT00812123|Mycophenolic Acid|mycophenolic acid|mesh-list
65407500|NCT00812123|Cyclosporins|cyclosporins|mesh-list
65407501|NCT00812123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65407502|NCT00812123|Glucocorticoids|glucocorticoids|mesh-ancestor
65407503|NCT00812123|Hormones|hormones|mesh-ancestor
65407504|NCT00812123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65407505|NCT00812123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407506|NCT00812123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65407507|NCT00812123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407508|NCT00812123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407509|NCT00812123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407510|NCT00812123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65407511|NCT00812123|Immunologic Factors|immunologic factors|mesh-ancestor
65407512|NCT00812123|Antifungal Agents|antifungal agents|mesh-ancestor
65407513|NCT00812123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65407514|NCT00812123|Dermatologic Agents|dermatologic agents|mesh-ancestor
65407515|NCT00812123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65407516|NCT00812123|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65407517|NCT00812123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65407518|NCT00812123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65407519|NCT00812123|Antitubercular Agents|antitubercular agents|mesh-ancestor
65407520|NCT00812123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65407521|NCT00646451|Pregabalin|pregabalin|mesh-list
65407522|NCT00646451|Analgesics|analgesics|mesh-ancestor
65407523|NCT00646451|Sensory System Agents|sensory system agents|mesh-ancestor
65407524|NCT00646451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65407525|NCT00646451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407526|NCT00646451|Anticonvulsants|anticonvulsants|mesh-ancestor
65407527|NCT00646451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65407528|NCT00646451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65407529|NCT00646451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407530|NCT00646451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65407531|NCT00646451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65407542|NCT00809237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407543|NCT00809237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65407544|NCT00809237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407545|NCT00809237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65407546|NCT00817583|Docetaxel|docetaxel|mesh-list
65407547|NCT00817583|Fluorouracil|fluorouracil|mesh-list
65407548|NCT00817583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407549|NCT00817583|Tubulin Modulators|tubulin modulators|mesh-ancestor
65407550|NCT00817583|Antimitotic Agents|antimitotic agents|mesh-ancestor
65407551|NCT00817583|Mitosis Modulators|mitosis modulators|mesh-ancestor
65407552|NCT00817583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407553|NCT00817583|Antimetabolites|antimetabolites|mesh-ancestor
65407554|NCT00817583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65407555|NCT00817583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65407556|NCT00817583|Immunologic Factors|immunologic factors|mesh-ancestor
65407557|NCT00817583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407558|NCT00817661|Vitamin A|vitamin a|mesh-list
65407559|NCT00817661|Vitamins|vitamins|mesh-ancestor
65407560|NCT00817661|Micronutrients|micronutrients|mesh-ancestor
65407561|NCT00817661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407562|NCT00642707|Leronlimab|leronlimab|mesh-list
65407563|NCT00642707|Antibodies|antibodies|mesh-list
65407564|NCT00642707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65407565|NCT00642707|Immunologic Factors|immunologic factors|mesh-ancestor
65407566|NCT00642707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407567|NCT00642707|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65407568|NCT00642707|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65407569|NCT00642707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407570|NCT00642707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65407571|NCT00642707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65407572|NCT00642707|Antiviral Agents|antiviral agents|mesh-ancestor
65407573|NCT00642707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65157092|NCT04309929|Analgesics|analgesics|mesh-list
65407574|NCT02551523|Dolutegravir|dolutegravir|mesh-list
65407575|NCT02551523|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65407576|NCT02551523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65407577|NCT02551523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65407578|NCT02551523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407579|NCT02551523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407580|NCT02551523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65407581|NCT02551523|Antiviral Agents|antiviral agents|mesh-ancestor
65407582|NCT02551523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65407583|NCT00817739|Leuprolide|leuprolide|mesh-list
65407584|NCT00817739|Flutamide|flutamide|mesh-list
65407585|NCT00817739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65407586|NCT00817739|Fertility Agents|fertility agents|mesh-ancestor
65407587|NCT00817739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65407588|NCT00817739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407589|NCT00817739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65407590|NCT00817739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407591|NCT00817739|Androgen Antagonists|androgen antagonists|mesh-ancestor
65407592|NCT00817739|Hormone Antagonists|hormone antagonists|mesh-ancestor
65407593|NCT00817739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65407594|NCT00817895|Cisplatin|cisplatin|mesh-list
65407595|NCT00817895|Fluorouracil|fluorouracil|mesh-list
65407596|NCT00817895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407597|NCT00817895|Antimetabolites|antimetabolites|mesh-ancestor
65407598|NCT00817895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407610|NCT00568685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65407611|NCT00568685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65407612|NCT00568685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407613|NCT00568685|Adrenergic Agents|adrenergic agents|mesh-ancestor
65407614|NCT00568685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65407615|NCT00568685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407616|NCT00061945|Leucovorin|leucovorin|mesh-list
65407617|NCT00061945|Cytarabine|cytarabine|mesh-list
65407618|NCT00061945|Acyclovir|acyclovir|mesh-list
65407619|NCT00061945|Trimethoprim|trimethoprim|mesh-list
65407620|NCT00061945|Sulfamethoxazole|sulfamethoxazole|mesh-list
65407621|NCT00061945|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65407622|NCT00061945|Dexamethasone|dexamethasone|mesh-list
65407623|NCT00061945|Cyclophosphamide|cyclophosphamide|mesh-list
65407624|NCT00061945|Methotrexate|methotrexate|mesh-list
65407625|NCT00061945|Vincristine|vincristine|mesh-list
65407626|NCT00061945|Imatinib Mesylate|imatinib mesylate|mesh-list
65407627|NCT00061945|Daunorubicin|daunorubicin|mesh-list
65407628|NCT00061945|Asparaginase|asparaginase|mesh-list
65407629|NCT00061945|Mercaptopurine|mercaptopurine|mesh-list
65407630|NCT00061945|Alemtuzumab|alemtuzumab|mesh-list
65407631|NCT00061945|Allopurinol|allopurinol|mesh-list
65407632|NCT00061945|Levoleucovorin|levoleucovorin|mesh-list
65407633|NCT00061945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65407634|NCT00061945|Immunologic Factors|immunologic factors|mesh-ancestor
65407635|NCT00061945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407636|NCT00061945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65407637|NCT00061945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65407638|NCT00061945|Alkylating Agents|alkylating agents|mesh-ancestor
65407639|NCT00061945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407640|NCT00061945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407641|NCT00061945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65407642|NCT00061945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65407643|NCT00061945|Antiemetics|antiemetics|mesh-ancestor
65407644|NCT00061945|Autonomic Agents|autonomic agents|mesh-ancestor
65407645|NCT00061945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65407646|NCT00061945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65157182|NCT01251614|Adalimumab|adalimumab|mesh-list
65269889|NCT02732132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65407647|NCT00061945|Glucocorticoids|glucocorticoids|mesh-ancestor
65407648|NCT00061945|Hormones|hormones|mesh-ancestor
65407649|NCT00061945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65407650|NCT00061945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65407651|NCT00061945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65407652|NCT00061945|Abortifacient Agents|abortifacient agents|mesh-ancestor
65407653|NCT00061945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65407654|NCT00061945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65407655|NCT00061945|Antimetabolites|antimetabolites|mesh-ancestor
65407656|NCT00061945|Dermatologic Agents|dermatologic agents|mesh-ancestor
65407657|NCT00061945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407658|NCT00061945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65407659|NCT00061945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65407660|NCT00061945|Antiviral Agents|antiviral agents|mesh-ancestor
65407661|NCT00061945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65407662|NCT00061945|Antidotes|antidotes|mesh-ancestor
64792445|NCT00383370|Aflibercept|aflibercept|mesh-list
65407671|NCT00061945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65407672|NCT00061945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65407673|NCT00061945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65407674|NCT00061945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65407675|NCT00061945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65407676|NCT00061945|Gout Suppressants|gout suppressants|mesh-ancestor
65407677|NCT00061945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65407678|NCT00061945|Antioxidants|antioxidants|mesh-ancestor
65407679|NCT00061945|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65407680|NCT00061945|Renal Agents|renal agents|mesh-ancestor
65407681|NCT00061945|Antimalarials|antimalarials|mesh-ancestor
65407682|NCT00061945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65407683|NCT00061945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65407684|NCT00061945|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65407685|NCT00061945|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65407686|NCT00061945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65407687|NCT00061945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65407688|NCT00817973|Caseins|caseins|mesh-list
65407689|NCT00817973|Chelating Agents|chelating agents|mesh-ancestor
65407690|NCT00817973|Sequestering Agents|sequestering agents|mesh-ancestor
65407691|NCT00817973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407692|NCT01097941|Vaccines|vaccines|mesh-list
65407693|NCT01097941|Immunologic Factors|immunologic factors|mesh-ancestor
65407694|NCT01097941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407695|NCT00642473|Metronidazole|metronidazole|mesh-list
65407696|NCT00642473|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65407697|NCT00642473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407698|NCT00642473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65407699|NCT00642473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407700|NCT00642473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407701|NCT00642473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65407702|NCT00642473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65407703|NCT00642473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65407704|NCT00642473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65407705|NCT00645671|Loteprednol Etabonate|loteprednol etabonate|mesh-list
65407706|NCT00645671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65407707|NCT00366340|Vaccines|vaccines|mesh-list
65407708|NCT00366340|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65407709|NCT00366340|Immunologic Factors|immunologic factors|mesh-ancestor
65407710|NCT00366340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407711|NCT03992326|Cyclophosphamide|cyclophosphamide|mesh-list
65407712|NCT03992326|Fludarabine|fludarabine|mesh-list
65407713|NCT03992326|Interleukin-2|interleukin-2|mesh-list
65407714|NCT03992326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65407715|NCT03992326|Immunologic Factors|immunologic factors|mesh-ancestor
65407716|NCT03992326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407717|NCT03992326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65407718|NCT03992326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65407719|NCT03992326|Alkylating Agents|alkylating agents|mesh-ancestor
65407720|NCT03992326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407721|NCT03992326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407722|NCT03992326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65407723|NCT03992326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65407724|NCT03992326|Analgesics|analgesics|mesh-ancestor
65407725|NCT03992326|Sensory System Agents|sensory system agents|mesh-ancestor
65407726|NCT03992326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65269890|NCT02732132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65407728|NCT01045954|Insulin Glargine|insulin glargine|mesh-list
65407729|NCT01045954|Insulin Lispro|insulin lispro|mesh-list
65407730|NCT01045954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65407731|NCT01045954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407732|NCT01046032|Metformin|metformin|mesh-list
65407743|NCT00645593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65407744|NCT00645593|Antimetabolites|antimetabolites|mesh-ancestor
65407745|NCT00645593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407746|NCT00645593|Antiviral Agents|antiviral agents|mesh-ancestor
65407747|NCT00645593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65407748|NCT00645593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407749|NCT00645593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65407750|NCT00645593|Immunologic Factors|immunologic factors|mesh-ancestor
65407751|NCT00645593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407752|NCT00645593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65407753|NCT01093261|Hydrocortisone|hydrocortisone|mesh-list
65407754|NCT01093261|Fludrocortisone|fludrocortisone|mesh-list
65407755|NCT01093261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65407756|NCT02550977|Gestodene|gestodene|mesh-list
65407757|NCT02550977|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65407758|NCT02550977|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65407759|NCT02550977|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65407760|NCT02550977|Contraceptive Agents|contraceptive agents|mesh-ancestor
65407761|NCT02550977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65407762|NCT02550977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407763|NCT02550977|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65407764|NCT02550977|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65407765|NCT02550977|Progestins|progestins|mesh-ancestor
65407766|NCT02550977|Hormones|hormones|mesh-ancestor
65407767|NCT02550977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65407768|NCT01045018|Mesalamine|mesalamine|mesh-list
65407769|NCT01045018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65407770|NCT01045018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65407771|NCT01045018|Analgesics|analgesics|mesh-ancestor
65407772|NCT01045018|Sensory System Agents|sensory system agents|mesh-ancestor
65407773|NCT01045018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65407774|NCT01045018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407775|NCT01045018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65407776|NCT01045018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65407777|NCT01049464|Magnesium Sulfate|magnesium sulfate|mesh-list
65407778|NCT01049464|Analgesics|analgesics|mesh-ancestor
65407779|NCT01049464|Sensory System Agents|sensory system agents|mesh-ancestor
65407780|NCT01049464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65407781|NCT01049464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407782|NCT01049464|Anesthetics|anesthetics|mesh-ancestor
65407783|NCT01049464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65407784|NCT01049464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65407785|NCT01049464|Anticonvulsants|anticonvulsants|mesh-ancestor
65407786|NCT01049464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65407787|NCT01049464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65407788|NCT01049464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407789|NCT01049464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65407790|NCT01049464|Tocolytic Agents|tocolytic agents|mesh-ancestor
65407791|NCT01049464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65407792|NCT01046266|Cetuximab|cetuximab|mesh-list
65407793|NCT01046266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65407794|NCT01046266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407795|NCT00365794|Testosterone|testosterone|mesh-list
65407796|NCT00365794|Androgens|androgens|mesh-ancestor
65407797|NCT00365794|Hormones|hormones|mesh-ancestor
65407798|NCT00365794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64792581|NCT00421980|Etanercept|etanercept|mesh-list
65407809|NCT01098019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65407810|NCT01098019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65407811|NCT00365716|Vaccines|vaccines|mesh-list
65407812|NCT00365716|Immunologic Factors|immunologic factors|mesh-ancestor
65407813|NCT00365716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407814|NCT01049542|Astressin|astressin|mesh-list
65407815|NCT01049542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65407816|NCT01049542|Protective Agents|protective agents|mesh-ancestor
65407817|NCT01049542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407818|NCT01049620|Capecitabine|capecitabine|mesh-list
65407819|NCT01049620|Oxaliplatin|oxaliplatin|mesh-list
65407820|NCT01049620|Everolimus|everolimus|mesh-list
65407821|NCT01049620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65407822|NCT01049620|Antimetabolites|antimetabolites|mesh-ancestor
65407823|NCT01049620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407824|NCT01049620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407825|NCT01049620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65407826|NCT01049620|Immunologic Factors|immunologic factors|mesh-ancestor
65407827|NCT01049620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407828|NCT00059839|Prednisone|prednisone|mesh-list
65407829|NCT00059839|Doxorubicin|doxorubicin|mesh-list
65407830|NCT00059839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65407831|NCT00059839|Methotrexate|methotrexate|mesh-list
65407832|NCT00059839|Vincristine|vincristine|mesh-list
65407833|NCT00059839|Mercaptopurine|mercaptopurine|mesh-list
65407834|NCT00059839|Vinblastine|vinblastine|mesh-list
65407835|NCT00059839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65407836|NCT00059839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407837|NCT00059839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65407838|NCT00059839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65407839|NCT00059839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407840|NCT00059839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407841|NCT00059839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65407842|NCT00059839|Glucocorticoids|glucocorticoids|mesh-ancestor
65407843|NCT00059839|Hormones|hormones|mesh-ancestor
65407844|NCT00059839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65407845|NCT00059839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407846|NCT00059839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65407847|NCT00059839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65407848|NCT00059839|Abortifacient Agents|abortifacient agents|mesh-ancestor
65407849|NCT00059839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65407850|NCT00059839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65407851|NCT00059839|Antimetabolites|antimetabolites|mesh-ancestor
65407852|NCT00059839|Dermatologic Agents|dermatologic agents|mesh-ancestor
65407853|NCT00059839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65407854|NCT00059839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65407855|NCT00059839|Immunologic Factors|immunologic factors|mesh-ancestor
65407856|NCT00059839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65407857|NCT00059839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65407858|NCT00059839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65407859|NCT00059839|Tubulin Modulators|tubulin modulators|mesh-ancestor
65407860|NCT00059839|Antimitotic Agents|antimitotic agents|mesh-ancestor
65407861|NCT00059839|Mitosis Modulators|mitosis modulators|mesh-ancestor
65407862|NCT00059215|Clopidogrel|clopidogrel|mesh-list
65407863|NCT00059215|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65407864|NCT00059215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65407872|NCT00058825|Cyclosporine|cyclosporine|mesh-list
65407873|NCT00058825|Fludarabine|fludarabine|mesh-list
65407874|NCT00058825|Alemtuzumab|alemtuzumab|mesh-list
65407875|NCT00058825|Tacrolimus|tacrolimus|mesh-list
65407876|NCT00058825|Cyclosporins|cyclosporins|mesh-list
65407877|NCT00058825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407878|NCT00058825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407879|NCT00058825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65407880|NCT00058825|Immunologic Factors|immunologic factors|mesh-ancestor
65407881|NCT00058825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407882|NCT00058825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65407883|NCT00058825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407884|NCT00058825|Antifungal Agents|antifungal agents|mesh-ancestor
65407885|NCT00058825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65407886|NCT00058825|Dermatologic Agents|dermatologic agents|mesh-ancestor
65407887|NCT00058825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65407888|NCT00058825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65407889|NCT02535052|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65407890|NCT02535052|Immunologic Factors|immunologic factors|mesh-ancestor
65407891|NCT02535052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407892|NCT03953989|Ranolazine|ranolazine|mesh-list
65407893|NCT03953989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65407894|NCT03953989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65407895|NCT03953989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407896|NCT01096225|Vaccines|vaccines|mesh-list
65407897|NCT01096225|Immunologic Factors|immunologic factors|mesh-ancestor
65407898|NCT01096225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407899|NCT02535130|Amikacin|amikacin|mesh-list
65407900|NCT02535130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65407901|NCT02535130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65407902|NCT01046500|Inositol|inositol|mesh-list
65407903|NCT01046500|Metformin|metformin|mesh-list
65230907|NCT03588884|Vitamin D|vitamin d|mesh-list
65407904|NCT01046500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65407905|NCT01046500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407906|NCT01046500|Vitamin B Complex|vitamin b complex|mesh-ancestor
65407907|NCT01046500|Vitamins|vitamins|mesh-ancestor
65407908|NCT01046500|Micronutrients|micronutrients|mesh-ancestor
65407909|NCT01046578|Letrozole|letrozole|mesh-list
65407910|NCT01046578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407911|NCT01046578|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65407912|NCT01046578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65407913|NCT01046578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407914|NCT01046578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407915|NCT01046578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65407916|NCT01046578|Hormone Antagonists|hormone antagonists|mesh-ancestor
65407917|NCT01046578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65407918|NCT01046578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407919|NCT00372424|Docetaxel|docetaxel|mesh-list
65407920|NCT00372424|Trastuzumab|trastuzumab|mesh-list
65407921|NCT00372424|Sunitinib|sunitinib|mesh-list
65407922|NCT00372424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407923|NCT00372424|Tubulin Modulators|tubulin modulators|mesh-ancestor
65407924|NCT00372424|Antimitotic Agents|antimitotic agents|mesh-ancestor
65407925|NCT00372424|Mitosis Modulators|mitosis modulators|mesh-ancestor
65407926|NCT00372424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407927|NCT00372424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65407928|NCT00372424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65407929|NCT00372424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65407930|NCT00372424|Growth Substances|growth substances|mesh-ancestor
65407931|NCT00372424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407937|NCT02530411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407938|NCT02530411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65407939|NCT02530411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65407940|NCT02530411|Hormone Antagonists|hormone antagonists|mesh-ancestor
65407941|NCT02530411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65407942|NCT02530411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407943|NCT01327027|Vasopressins|vasopressins|mesh-list
65407944|NCT01327027|Arginine Vasopressin|arginine vasopressin|mesh-list
65407945|NCT01327027|Hemostatics|hemostatics|mesh-ancestor
65407946|NCT01327027|Coagulants|coagulants|mesh-ancestor
65407947|NCT01327027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65407948|NCT01327027|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65407949|NCT01327027|Natriuretic Agents|natriuretic agents|mesh-ancestor
65407950|NCT01327027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407951|NCT01093807|Enalapril|enalapril|mesh-list
65407952|NCT01093807|Enalaprilat|enalaprilat|mesh-list
65157469|NCT00977938|Aspirin|aspirin|mesh-list
65407954|NCT01093807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65407955|NCT01093807|Protease Inhibitors|protease inhibitors|mesh-ancestor
65407956|NCT01093807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407957|NCT01093807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407958|NCT01093807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65407959|NCT01093807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65407960|NCT01093807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65407961|NCT01093807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65407962|NCT01093807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407963|NCT00044083|Tolcapone|tolcapone|mesh-list
65407964|NCT00044083|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65407965|NCT00044083|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65407966|NCT00044083|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65407967|NCT00044083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407968|NCT00044083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407969|NCT00058123|Poly ICLC|poly iclc|mesh-list
65407970|NCT00058123|Interferon Inducers|interferon inducers|mesh-ancestor
65407971|NCT00058123|Immunologic Factors|immunologic factors|mesh-ancestor
65407972|NCT00058123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407973|NCT00022633|Gemcitabine|gemcitabine|mesh-list
65407974|NCT00022633|Paclitaxel|paclitaxel|mesh-list
65407975|NCT00022633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65407976|NCT00022633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407977|NCT00022633|Tubulin Modulators|tubulin modulators|mesh-ancestor
65407978|NCT00022633|Antimitotic Agents|antimitotic agents|mesh-ancestor
65407979|NCT00022633|Mitosis Modulators|mitosis modulators|mesh-ancestor
65407980|NCT00022633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407981|NCT00022633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65407982|NCT00022633|Antimetabolites|antimetabolites|mesh-ancestor
65407983|NCT00022633|Antiviral Agents|antiviral agents|mesh-ancestor
65407984|NCT00022633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65407985|NCT00022633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407986|NCT00022633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65407987|NCT00022633|Immunologic Factors|immunologic factors|mesh-ancestor
65407988|NCT00022633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407989|NCT00021541|Tipifarnib|tipifarnib|mesh-list
65407990|NCT00021541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407991|NCT00021229|Imatinib Mesylate|imatinib mesylate|mesh-list
65407992|NCT00021229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407993|NCT00021229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65407994|NCT00021229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407995|NCT00021229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407996|NCT02688790|Dalbavancin|dalbavancin|mesh-list
65407997|NCT02688790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65407998|NCT02688790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65407999|NCT00488475|Etanercept|etanercept|mesh-list
65408000|NCT00488475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65408001|NCT00488475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65408002|NCT00488475|Analgesics|analgesics|mesh-ancestor
65408014|NCT01020279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65408015|NCT01020279|Analgesics|analgesics|mesh-ancestor
65408016|NCT01020279|Sensory System Agents|sensory system agents|mesh-ancestor
65408017|NCT01020279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65408018|NCT01020279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408019|NCT01020279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65408020|NCT01020279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65408021|NCT01020279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65408022|NCT01020279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65408023|NCT01020279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408024|NCT01020279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408025|NCT01020357|Caffeine|caffeine|mesh-list
65408026|NCT01020357|Caffeine citrate|caffeine citrate|mesh-list
65408027|NCT01020357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408028|NCT01020357|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65408029|NCT01020357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408030|NCT01020357|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65408032|NCT01020357|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65408033|NCT01020357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65408034|NCT01020357|Purinergic Agents|purinergic agents|mesh-ancestor
65408035|NCT01020357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65408036|NCT00042991|Gefitinib|gefitinib|mesh-list
65408037|NCT00042991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408038|NCT00042991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65408039|NCT00042991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408040|NCT00042991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408041|NCT00466167|Pramipexole|pramipexole|mesh-list
65408042|NCT00466167|Antioxidants|antioxidants|mesh-ancestor
65408043|NCT00466167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408044|NCT00466167|Protective Agents|protective agents|mesh-ancestor
65408045|NCT00466167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408046|NCT00466167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65408047|NCT00466167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65408048|NCT00466167|Dopamine Agonists|dopamine agonists|mesh-ancestor
65408049|NCT00466167|Dopamine Agents|dopamine agents|mesh-ancestor
65408050|NCT00466167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65408051|NCT01017939|Prednisone|prednisone|mesh-list
65408052|NCT01017939|Abiraterone Acetate|abiraterone acetate|mesh-list
65408053|NCT01017939|Theophylline|theophylline|mesh-list
65408054|NCT01017939|Dextromethorphan|dextromethorphan|mesh-list
65408055|NCT01017939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65408056|NCT01017939|Glucocorticoids|glucocorticoids|mesh-ancestor
65408057|NCT01017939|Hormones|hormones|mesh-ancestor
65408058|NCT01017939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65408059|NCT01017939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408060|NCT01017939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65408061|NCT01017939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408062|NCT01017939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65408063|NCT01017939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408064|NCT01017939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408065|NCT01017939|Hormone Antagonists|hormone antagonists|mesh-ancestor
65408066|NCT01017939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65408079|NCT01017939|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65408080|NCT01017939|Purinergic Agents|purinergic agents|mesh-ancestor
65408081|NCT00480441|Dronabinol|dronabinol|mesh-list
65408082|NCT00480441|Hallucinogens|hallucinogens|mesh-ancestor
65408083|NCT00480441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408084|NCT00480441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65408085|NCT00480441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65408086|NCT00480441|Analgesics|analgesics|mesh-ancestor
65408087|NCT00480441|Sensory System Agents|sensory system agents|mesh-ancestor
65408088|NCT00480441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65408089|NCT00480441|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65408090|NCT00480441|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65408091|NCT00480441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65408092|NCT00480441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408093|NCT00480441|Hormones|hormones|mesh-ancestor
65408094|NCT00480441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65408095|NCT01022463|Atenolol|atenolol|mesh-list
65408096|NCT01022463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65408097|NCT01022463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65408098|NCT01022463|Sympatholytics|sympatholytics|mesh-ancestor
65408099|NCT01022463|Autonomic Agents|autonomic agents|mesh-ancestor
65408100|NCT01022463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65408101|NCT01022463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408102|NCT01022463|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65408103|NCT01022463|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65408104|NCT01022463|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65408105|NCT01022463|Adrenergic Agents|adrenergic agents|mesh-ancestor
65408106|NCT01022463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65408107|NCT01022463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408108|NCT00488319|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65408109|NCT00488319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65408110|NCT00488319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65408111|NCT00488319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65408112|NCT00488319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408113|NCT00488319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65408114|NCT00488319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65408115|NCT00488319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65408116|NCT00488319|Serotonin Agents|serotonin agents|mesh-ancestor
65408117|NCT00488319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65408118|NCT00488319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408119|NCT00488319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65408120|NCT00488319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65408121|NCT00488319|Dopamine Agents|dopamine agents|mesh-ancestor
65408122|NCT01018251|Alovudine|alovudine|mesh-list
65408123|NCT01018251|Antiviral Agents|antiviral agents|mesh-ancestor
65408124|NCT01018251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65408125|NCT00463047|Fentanyl|fentanyl|mesh-list
65408126|NCT00463047|Oxycodone|oxycodone|mesh-list
65408127|NCT00463047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65408128|NCT00463047|Narcotics|narcotics|mesh-ancestor
65408136|NCT00463047|Anesthetics, General|anesthetics, general|mesh-ancestor
65408137|NCT00463047|Anesthetics|anesthetics|mesh-ancestor
65408138|NCT00487539|Golimumab|golimumab|mesh-list
65408139|NCT00487539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65408140|NCT00487539|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65408141|NCT00487539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65408142|NCT00487539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65408143|NCT00487539|Immunologic Factors|immunologic factors|mesh-ancestor
65408144|NCT00487539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408145|NCT00486837|Protease Inhibitors|protease inhibitors|mesh-list
65408146|NCT00486837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65408147|NCT00486837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408148|NCT00486837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408149|NCT00486837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65408150|NCT00486837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65408151|NCT00486759|Bevacizumab|bevacizumab|mesh-list
65408152|NCT00486759|Rituximab|rituximab|mesh-list
65408153|NCT00486759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65408154|NCT00486759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408155|NCT00486759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65408156|NCT00486759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65408157|NCT00486759|Growth Substances|growth substances|mesh-ancestor
65408158|NCT00486759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408159|NCT00486759|Growth Inhibitors|growth inhibitors|mesh-ancestor
65408160|NCT00486759|Immunologic Factors|immunologic factors|mesh-ancestor
65408161|NCT00486759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65408162|NCT00486603|Hydroxychloroquine|hydroxychloroquine|mesh-list
65408163|NCT00486603|Temozolomide|temozolomide|mesh-list
65408164|NCT00486603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65408165|NCT00486603|Alkylating Agents|alkylating agents|mesh-ancestor
65408166|NCT00486603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408167|NCT00486603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408168|NCT00486603|Antimalarials|antimalarials|mesh-ancestor
65408169|NCT00486603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65408170|NCT00486603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65408171|NCT00486603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65408172|NCT00486603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157700|NCT01087203|Tanezumab|tanezumab|mesh-list
65408173|NCT00486603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65408174|NCT00474045|Insulin|insulin|mesh-list
65408175|NCT00474045|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65408176|NCT00474045|Insulin Aspart|insulin aspart|mesh-list
65408177|NCT00474045|Insulin Detemir|insulin detemir|mesh-list
65408178|NCT00474045|Insulin, Isophane|insulin, isophane|mesh-list
65408179|NCT00474045|Isophane Insulin, Human|isophane insulin, human|mesh-list
65408180|NCT00474045|Isophane insulin, beef|isophane insulin, beef|mesh-list
65408181|NCT00474045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65408182|NCT00474045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408183|NCT01020825|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65408184|NCT01020825|Hemostatics|hemostatics|mesh-ancestor
65408185|NCT01020825|Coagulants|coagulants|mesh-ancestor
65408186|NCT01018485|Botulinum Toxins|botulinum toxins|mesh-list
65408187|NCT01018485|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65408188|NCT01018485|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65408189|NCT01018485|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65408190|NCT01018485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65408191|NCT01018485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408192|NCT01018485|Cholinergic Agents|cholinergic agents|mesh-ancestor
65408193|NCT01018485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65408194|NCT01018485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408195|NCT01018485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65408196|NCT01018485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65408210|NCT00462501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65408212|NCT00462501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408213|NCT00462501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65408214|NCT00462501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65408215|NCT00462501|Immunologic Factors|immunologic factors|mesh-ancestor
65408216|NCT00462501|Antidotes|antidotes|mesh-ancestor
65408217|NCT00462501|Protective Agents|protective agents|mesh-ancestor
65408218|NCT00462501|Vitamin B Complex|vitamin b complex|mesh-ancestor
65408219|NCT00462501|Vitamins|vitamins|mesh-ancestor
65408220|NCT00462501|Micronutrients|micronutrients|mesh-ancestor
65408221|NCT03996603|Estrogens|estrogens|mesh-list
65408222|NCT03996603|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65408223|NCT03996603|Hormones|hormones|mesh-ancestor
65408224|NCT03996603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65408225|NCT03996603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408226|NCT00462345|Rituximab|rituximab|mesh-list
65408227|NCT00462345|Methotrexate|methotrexate|mesh-list
65408228|NCT00462345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65408229|NCT00462345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408230|NCT00462345|Immunologic Factors|immunologic factors|mesh-ancestor
65408231|NCT00462345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408232|NCT00462345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65408233|NCT00462345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65408234|NCT00462345|Abortifacient Agents|abortifacient agents|mesh-ancestor
65408235|NCT00462345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65408236|NCT00462345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65408237|NCT00462345|Antimetabolites|antimetabolites|mesh-ancestor
65408238|NCT00462345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408239|NCT00462345|Dermatologic Agents|dermatologic agents|mesh-ancestor
65408240|NCT00462345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408241|NCT00462345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65408242|NCT00462345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65408243|NCT00462345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65408244|NCT01022541|Bevacizumab|bevacizumab|mesh-list
65408245|NCT01022541|Capecitabine|capecitabine|mesh-list
65408246|NCT01022541|Oxaliplatin|oxaliplatin|mesh-list
65408247|NCT01022541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65408248|NCT01022541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408249|NCT01022541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65408250|NCT01022541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65408251|NCT01022541|Growth Substances|growth substances|mesh-ancestor
65408252|NCT01022541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231200|NCT04091074|Ticagrelor|ticagrelor|mesh-list
65408253|NCT01022541|Growth Inhibitors|growth inhibitors|mesh-ancestor
65408254|NCT01022541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65408255|NCT01022541|Antimetabolites|antimetabolites|mesh-ancestor
65408256|NCT01022541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408257|NCT01047202|Vaccines|vaccines|mesh-list
65408258|NCT01047202|Immunologic Factors|immunologic factors|mesh-ancestor
65408259|NCT01047202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408271|NCT01049854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65408272|NCT01049854|Alkylating Agents|alkylating agents|mesh-ancestor
65408273|NCT01049854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408274|NCT01049854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408275|NCT01049854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65408276|NCT01049854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65408277|NCT01049854|Antimetabolites|antimetabolites|mesh-ancestor
65408278|NCT01049854|Antiviral Agents|antiviral agents|mesh-ancestor
65408279|NCT01049854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65408280|NCT00453999|Oseltamivir|oseltamivir|mesh-list
65408281|NCT00453999|Peramivir|peramivir|mesh-list
65408282|NCT00453999|Antiviral Agents|antiviral agents|mesh-ancestor
65408283|NCT00453999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65408284|NCT00453999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408285|NCT00453999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408286|NCT00453921|Methylphenidate|methylphenidate|mesh-list
65408287|NCT00453921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65408288|NCT00453921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408289|NCT00453921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65408290|NCT00453921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65408291|NCT00453921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65408292|NCT00453921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408293|NCT00453921|Dopamine Agents|dopamine agents|mesh-ancestor
65408294|NCT00453921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65408295|NCT00382720|Docetaxel|docetaxel|mesh-list
65408296|NCT00382720|Capecitabine|capecitabine|mesh-list
65408297|NCT00382720|Oxaliplatin|oxaliplatin|mesh-list
65408298|NCT00382720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408299|NCT00382720|Tubulin Modulators|tubulin modulators|mesh-ancestor
65408300|NCT00382720|Antimitotic Agents|antimitotic agents|mesh-ancestor
65408301|NCT00382720|Mitosis Modulators|mitosis modulators|mesh-ancestor
65408302|NCT00382720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408303|NCT00382720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65408304|NCT00382720|Antimetabolites|antimetabolites|mesh-ancestor
65408305|NCT01025349|Bevacizumab|bevacizumab|mesh-list
65408306|NCT01025349|Docetaxel|docetaxel|mesh-list
65408307|NCT01025349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65408308|NCT01025349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408309|NCT01025349|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65408310|NCT01025349|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65408311|NCT01025349|Growth Substances|growth substances|mesh-ancestor
65408312|NCT01025349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408313|NCT01025349|Growth Inhibitors|growth inhibitors|mesh-ancestor
65408314|NCT01025349|Tubulin Modulators|tubulin modulators|mesh-ancestor
65408315|NCT01025349|Antimitotic Agents|antimitotic agents|mesh-ancestor
65408316|NCT01025349|Mitosis Modulators|mitosis modulators|mesh-ancestor
65408317|NCT01025349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408318|NCT02473276|Morphine|morphine|mesh-list
65408319|NCT02473276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65408320|NCT02473276|Narcotics|narcotics|mesh-ancestor
65408321|NCT02473276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65408322|NCT02473276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408323|NCT02473276|Analgesics|analgesics|mesh-ancestor
65408324|NCT02473276|Sensory System Agents|sensory system agents|mesh-ancestor
65408325|NCT02473276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65408332|NCT00371566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65408333|NCT00371566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408334|NCT00371566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408335|NCT00371254|Dasatinib|dasatinib|mesh-list
65408336|NCT00371254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408337|NCT00371254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65408338|NCT00371254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408339|NCT00371254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408340|NCT00452673|Capecitabine|capecitabine|mesh-list
65408341|NCT00452673|Dasatinib|dasatinib|mesh-list
65408342|NCT00452673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65231273|NCT02596984|Caspofungin|caspofungin|mesh-list
65231274|NCT02596984|Antifungal Agents|antifungal agents|mesh-ancestor
65231275|NCT02596984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65231276|NCT02596984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408343|NCT00452673|Antimetabolites|antimetabolites|mesh-ancestor
65408344|NCT00452673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408345|NCT00452673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408346|NCT00452673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65408347|NCT00452673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408348|NCT00461253|Copper|copper|mesh-list
65408349|NCT00461253|Levonorgestrel|levonorgestrel|mesh-list
65408350|NCT00461253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65408351|NCT00461253|Contraceptive Agents|contraceptive agents|mesh-ancestor
65408352|NCT00461253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65408353|NCT00461253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408354|NCT00461253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65408355|NCT00461253|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65408356|NCT00461253|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65408357|NCT00461253|Trace Elements|trace elements|mesh-ancestor
65408358|NCT00461253|Micronutrients|micronutrients|mesh-ancestor
65408359|NCT00469833|Insulin|insulin|mesh-list
65408360|NCT00469833|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65408361|NCT00469833|Insulin Glargine|insulin glargine|mesh-list
65408362|NCT00469833|Insulin, Long-Acting|insulin, long-acting|mesh-list
65408363|NCT00469833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65408364|NCT00469833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408365|NCT00641537|Cladribine|cladribine|mesh-list
65408366|NCT00641537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408367|NCT00641537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65408368|NCT00641537|Immunologic Factors|immunologic factors|mesh-ancestor
65408369|NCT00641537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408370|NCT01025583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65408371|NCT00814541|Dexamethasone|dexamethasone|mesh-list
65408372|NCT00814541|Doxorubicin|doxorubicin|mesh-list
65408373|NCT00814541|Bortezomib|bortezomib|mesh-list
65408374|NCT00814541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65408375|NCT00814541|Antiemetics|antiemetics|mesh-ancestor
65408376|NCT00814541|Autonomic Agents|autonomic agents|mesh-ancestor
65408377|NCT00814541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65408378|NCT00814541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408379|NCT00814541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65408380|NCT00814541|Glucocorticoids|glucocorticoids|mesh-ancestor
65408381|NCT00814541|Hormones|hormones|mesh-ancestor
65408382|NCT00814541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65408383|NCT00814541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65408384|NCT00814541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408385|NCT00814541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65408386|NCT00814541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65408387|NCT00814541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65408388|NCT00814541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408389|NCT00814541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408390|NCT00814619|Capecitabine|capecitabine|mesh-list
65408391|NCT00814619|Panitumumab|panitumumab|mesh-list
65408392|NCT00814619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65408393|NCT00814619|Antimetabolites|antimetabolites|mesh-ancestor
65408394|NCT00814619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408395|NCT00814619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793164|NCT01275144|Lorazepam|lorazepam|mesh-list
65408401|NCT00641147|Sensory System Agents|sensory system agents|mesh-ancestor
65408402|NCT00641147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65408403|NCT00641147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408404|NCT00641147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65408405|NCT00641147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65408406|NCT00641147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408407|NCT00641147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408408|NCT00641147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408409|NCT00460239|Morphine|morphine|mesh-list
65408410|NCT00460239|Buprenorphine|buprenorphine|mesh-list
65408411|NCT00460239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65408412|NCT00460239|Narcotics|narcotics|mesh-ancestor
65408413|NCT00460239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65408414|NCT00460239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408415|NCT00460239|Analgesics|analgesics|mesh-ancestor
65408416|NCT00460239|Sensory System Agents|sensory system agents|mesh-ancestor
65408417|NCT00460239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65408418|NCT00460239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65408419|NCT00640835|Buprenorphine|buprenorphine|mesh-list
65408420|NCT00640835|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65408421|NCT00640835|Naloxone|naloxone|mesh-list
65408422|NCT00640835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65408423|NCT00640835|Narcotics|narcotics|mesh-ancestor
65408424|NCT00640835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65408425|NCT00640835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408426|NCT00640835|Analgesics|analgesics|mesh-ancestor
65408427|NCT00640835|Sensory System Agents|sensory system agents|mesh-ancestor
65408428|NCT00640835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65408429|NCT00640835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65408430|NCT03839355|Warfarin|warfarin|mesh-list
65408431|NCT03839355|Apixaban|apixaban|mesh-list
65408432|NCT03839355|Anticoagulants|anticoagulants|mesh-ancestor
65408433|NCT03839355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65408434|NCT03839355|Antithrombins|antithrombins|mesh-ancestor
65408435|NCT03839355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65408436|NCT03839355|Protease Inhibitors|protease inhibitors|mesh-ancestor
65408437|NCT03839355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408438|NCT03839355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408439|NCT00640601|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65408440|NCT00640601|Antidepressive Agents|antidepressive agents|mesh-ancestor
65408441|NCT00640601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65408442|NCT00640601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65408443|NCT00640601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65408444|NCT00640601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65408445|NCT00640601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408446|NCT02551133|Dexamethasone|dexamethasone|mesh-list
65408447|NCT02551133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65408448|NCT02551133|Antiemetics|antiemetics|mesh-ancestor
65408449|NCT02551133|Autonomic Agents|autonomic agents|mesh-ancestor
65408450|NCT02551133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65408451|NCT02551133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408452|NCT02551133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65408453|NCT02551133|Glucocorticoids|glucocorticoids|mesh-ancestor
65408454|NCT02551133|Hormones|hormones|mesh-ancestor
65408455|NCT02551133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65408456|NCT02551133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65408457|NCT02551133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408458|NCT00818285|Psychotropic Drugs|psychotropic drugs|mesh-list
65408459|NCT00452439|Vitamin D|vitamin d|mesh-list
65408460|NCT00452439|Risedronic Acid|risedronic acid|mesh-list
65408461|NCT00452439|Etidronic Acid|etidronic acid|mesh-list
65408462|NCT00452439|Calcium|calcium|mesh-list
65408463|NCT00452439|Vitamins|vitamins|mesh-ancestor
65408464|NCT00452439|Micronutrients|micronutrients|mesh-ancestor
65408465|NCT00452439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408466|NCT00452439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64793232|NCT01274988|Methadone|methadone|mesh-list
65408471|NCT01023087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65408472|NCT01023087|Colistin|colistin|mesh-list
65408473|NCT01023087|Polymyxins|polymyxins|mesh-list
65408474|NCT01023087|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65408475|NCT01023087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65408476|NCT01023087|Antitubercular Agents|antitubercular agents|mesh-ancestor
65408477|NCT00381940|Bortezomib|bortezomib|mesh-list
65408478|NCT00381940|Vinorelbine|vinorelbine|mesh-list
65408479|NCT00381940|Ifosfamide|ifosfamide|mesh-list
65408480|NCT00381940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408481|NCT00381940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65408482|NCT00381940|Tubulin Modulators|tubulin modulators|mesh-ancestor
65408483|NCT00381940|Antimitotic Agents|antimitotic agents|mesh-ancestor
65408484|NCT00381940|Mitosis Modulators|mitosis modulators|mesh-ancestor
65408485|NCT00381940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408486|NCT00381940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65408487|NCT00381940|Alkylating Agents|alkylating agents|mesh-ancestor
65408488|NCT00818675|Sirolimus|sirolimus|mesh-list
65408489|NCT00818675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65408490|NCT00818675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65408491|NCT00818675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65408492|NCT00818675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408493|NCT00818675|Antifungal Agents|antifungal agents|mesh-ancestor
65408494|NCT00818675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65408495|NCT00818675|Immunologic Factors|immunologic factors|mesh-ancestor
65408496|NCT00818675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408497|NCT00364156|Nicotine|nicotine|mesh-list
65231425|NCT00740116|Hemostatics|hemostatics|mesh-ancestor
65408498|NCT00364156|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65408499|NCT00364156|Autonomic Agents|autonomic agents|mesh-ancestor
65408500|NCT00364156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65408501|NCT00364156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408502|NCT00364156|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65408503|NCT00364156|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65408504|NCT00364156|Cholinergic Agents|cholinergic agents|mesh-ancestor
65408505|NCT00364156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65408506|NCT00364156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408507|NCT00452361|Cyclosporine|cyclosporine|mesh-list
65408508|NCT00452361|Sirolimus|sirolimus|mesh-list
65408509|NCT00452361|Tacrolimus|tacrolimus|mesh-list
65408510|NCT00452361|Cyclosporins|cyclosporins|mesh-list
65408511|NCT00452361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
65408512|NCT00452361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65408513|NCT00452361|Immunologic Factors|immunologic factors|mesh-ancestor
65408514|NCT00452361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408515|NCT00452361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408516|NCT00452361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408517|NCT00452361|Antifungal Agents|antifungal agents|mesh-ancestor
65408518|NCT00452361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65408519|NCT00452361|Dermatologic Agents|dermatologic agents|mesh-ancestor
65408520|NCT00452361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65408521|NCT00452361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65408522|NCT00452361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65408523|NCT00452361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408524|NCT03334318|Allopurinol|allopurinol|mesh-list
65408525|NCT03334318|Antimetabolites|antimetabolites|mesh-ancestor
65408526|NCT03334318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408527|NCT03334318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408528|NCT03334318|Gout Suppressants|gout suppressants|mesh-ancestor
65408529|NCT03334318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65408530|NCT03334318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65408531|NCT03334318|Antioxidants|antioxidants|mesh-ancestor
65408532|NCT03334318|Protective Agents|protective agents|mesh-ancestor
65408533|NCT03334318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408534|NCT00640289|Fibrinolysin|fibrinolysin|mesh-list
65408535|NCT00640289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65408536|NCT00640289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65408537|NCT00640289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408538|NCT03877809|Sirolimus|sirolimus|mesh-list
65408552|NCT01049932|Antiviral Agents|antiviral agents|mesh-ancestor
65408553|NCT01049932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65408554|NCT01049932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65408555|NCT01049932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65408556|NCT01047670|Hydrocortisone|hydrocortisone|mesh-list
65408557|NCT01047670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65408559|NCT00819065|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65408560|NCT00819065|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65408561|NCT00819065|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65408562|NCT00819065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65408563|NCT00819065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408564|NCT00819065|Cholinergic Agents|cholinergic agents|mesh-ancestor
65408565|NCT00819065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65408566|NCT00819065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408567|NCT00819065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65408568|NCT00819065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65408569|NCT01047748|Digoxin|digoxin|mesh-list
65408570|NCT01047748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65408571|NCT01047748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65408572|NCT01047748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408573|NCT01047748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408574|NCT01047748|Protective Agents|protective agents|mesh-ancestor
65408575|NCT01047748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408576|NCT00568451|Paclitaxel|paclitaxel|mesh-list
65408577|NCT00568451|Carboplatin|carboplatin|mesh-list
65408578|NCT00568451|Temozolomide|temozolomide|mesh-list
65408579|NCT00568451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65408580|NCT00568451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408581|NCT00568451|Tubulin Modulators|tubulin modulators|mesh-ancestor
65408582|NCT00568451|Antimitotic Agents|antimitotic agents|mesh-ancestor
65408583|NCT00568451|Mitosis Modulators|mitosis modulators|mesh-ancestor
65408584|NCT00568451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408585|NCT00568451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65231500|NCT04063189|Growth Inhibitors|growth inhibitors|mesh-ancestor
65408586|NCT00568451|Alkylating Agents|alkylating agents|mesh-ancestor
65408587|NCT00459537|Terbinafine|terbinafine|mesh-list
65408588|NCT00459537|Amorolfine|amorolfine|mesh-list
65408589|NCT00459537|Antifungal Agents|antifungal agents|mesh-ancestor
65408590|NCT00459537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65408591|NCT00459537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408592|NCT00459537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408593|NCT03866421|Liver Extracts|liver extracts|mesh-list
65408594|NCT03866421|Hematinics|hematinics|mesh-ancestor
65408595|NCT00819377|Milrinone|milrinone|mesh-list
65408596|NCT00819377|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65408597|NCT00819377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65408598|NCT00819377|Vasodilator Agents|vasodilator agents|mesh-ancestor
65408599|NCT00819377|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65408600|NCT00819377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65408610|NCT01023243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65408611|NCT01023243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65408612|NCT01023243|Analgesics|analgesics|mesh-ancestor
65408613|NCT01023243|Sensory System Agents|sensory system agents|mesh-ancestor
65408614|NCT01023243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65408615|NCT01023243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408616|NCT01023243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65408617|NCT01023243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65408618|NCT01023243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65408619|NCT01023243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65408620|NCT01023243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408621|NCT01023243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65408622|NCT01023243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65408623|NCT01023243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408624|NCT01023243|Antipyretics|antipyretics|mesh-ancestor
65408625|NCT03762915|Minocycline|minocycline|mesh-list
65408626|NCT03762915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65408627|NCT03762915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65408628|NCT00469209|Ascorbic Acid|ascorbic acid|mesh-list
65408629|NCT00469209|Bortezomib|bortezomib|mesh-list
65408630|NCT00469209|Melphalan|melphalan|mesh-list
65408631|NCT00469209|Arsenic Trioxide|arsenic trioxide|mesh-list
65408632|NCT00469209|Vitamins|vitamins|mesh-ancestor
65408633|NCT00469209|Micronutrients|micronutrients|mesh-ancestor
65408634|NCT00469209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408635|NCT00469209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408636|NCT00469209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65408638|NCT00469209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408639|NCT00469209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65408640|NCT00469209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65408641|NCT00469209|Immunologic Factors|immunologic factors|mesh-ancestor
65408642|NCT00469209|Antioxidants|antioxidants|mesh-ancestor
65408643|NCT00469209|Protective Agents|protective agents|mesh-ancestor
65408644|NCT00635219|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65408645|NCT00635219|Vortioxetine|vortioxetine|mesh-list
65408646|NCT00635219|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65408647|NCT00635219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65408648|NCT00635219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65408649|NCT00635219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408650|NCT00635219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65408651|NCT00635219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408652|NCT00635219|Analgesics|analgesics|mesh-ancestor
65408653|NCT00635219|Sensory System Agents|sensory system agents|mesh-ancestor
65408654|NCT00635219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65408655|NCT00635219|Antidepressive Agents|antidepressive agents|mesh-ancestor
65408656|NCT00635219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65408657|NCT00635219|Dopamine Agents|dopamine agents|mesh-ancestor
65408658|NCT00635219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65408659|NCT00635219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65408660|NCT00635219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65408661|NCT00635219|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65408662|NCT00635219|Serotonin Agents|serotonin agents|mesh-ancestor
65408663|NCT00635219|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65408664|NCT00635219|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65408665|NCT00635219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65408666|NCT00635219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65408667|NCT01026129|Lidocaine|lidocaine|mesh-list
65408682|NCT01026129|Analgesics|analgesics|mesh-ancestor
65408683|NCT01026285|Risperidone|risperidone|mesh-list
65231574|NCT02859584|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65408684|NCT01026285|Antipsychotic Agents|antipsychotic agents|mesh-list
65408685|NCT01026285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65408686|NCT01026285|Serotonin Agents|serotonin agents|mesh-ancestor
65408687|NCT01026285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65408688|NCT01026285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408689|NCT01026285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408690|NCT01026285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65408691|NCT01026285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65408692|NCT01026285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65408693|NCT01026285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65408694|NCT01026285|Dopamine Agents|dopamine agents|mesh-ancestor
65408695|NCT01026363|Vitamin D|vitamin d|mesh-list
65408696|NCT01026363|Ergocalciferols|ergocalciferols|mesh-list
65408697|NCT01026363|Cholecalciferol|cholecalciferol|mesh-list
65408698|NCT01026363|Calcitriol|calcitriol|mesh-list
65408699|NCT01026363|Vitamins|vitamins|mesh-list
65408700|NCT01026363|Micronutrients|micronutrients|mesh-ancestor
65408701|NCT01026363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408702|NCT01026363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65408703|NCT01026363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65408704|NCT01026363|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65408705|NCT01026363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65408706|NCT01026363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408707|NCT01026363|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65408708|NCT01023399|Artesunate|artesunate|mesh-list
65408709|NCT01023399|Amodiaquine|amodiaquine|mesh-list
65408710|NCT01023399|Antimalarials|antimalarials|mesh-ancestor
65408711|NCT01023399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65408712|NCT01023399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65408713|NCT01023399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65408714|NCT01023399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408715|NCT01023399|Antiviral Agents|antiviral agents|mesh-ancestor
65408716|NCT01023399|Schistosomicides|schistosomicides|mesh-ancestor
65408717|NCT01023399|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65408718|NCT01023399|Anthelmintics|anthelmintics|mesh-ancestor
65408719|NCT00451191|Botulinum Toxins|botulinum toxins|mesh-list
65408720|NCT00451191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65408721|NCT00451191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65408722|NCT00451191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65408723|NCT00451191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65408724|NCT00451191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408725|NCT00451191|Cholinergic Agents|cholinergic agents|mesh-ancestor
65408726|NCT00451191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65408727|NCT00451191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408728|NCT00451191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65408734|NCT00451035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408735|NCT00468585|Bevacizumab|bevacizumab|mesh-list
65408736|NCT00468585|Capecitabine|capecitabine|mesh-list
65408737|NCT00468585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65408738|NCT00468585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408739|NCT00468585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65408740|NCT00468585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65408741|NCT00468585|Growth Substances|growth substances|mesh-ancestor
65408742|NCT00468585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408743|NCT00468585|Growth Inhibitors|growth inhibitors|mesh-ancestor
65408744|NCT00468585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65408745|NCT00468585|Antimetabolites|antimetabolites|mesh-ancestor
65408746|NCT00468585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408747|NCT00450801|Leucovorin|leucovorin|mesh-list
65408748|NCT00450801|Cytarabine|cytarabine|mesh-list
65408749|NCT00450801|Thalidomide|thalidomide|mesh-list
65408750|NCT00450801|Cyclophosphamide|cyclophosphamide|mesh-list
65408751|NCT00450801|Ifosfamide|ifosfamide|mesh-list
65408752|NCT00450801|Rituximab|rituximab|mesh-list
65408753|NCT00450801|Doxorubicin|doxorubicin|mesh-list
65408754|NCT00450801|Methotrexate|methotrexate|mesh-list
65408755|NCT00450801|Etoposide|etoposide|mesh-list
65408756|NCT00450801|Vincristine|vincristine|mesh-list
65408757|NCT00450801|Granisetron|granisetron|mesh-list
65408758|NCT00450801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65408759|NCT00450801|Immunologic Factors|immunologic factors|mesh-ancestor
65408760|NCT00450801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408761|NCT00450801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65408762|NCT00450801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65408763|NCT00450801|Alkylating Agents|alkylating agents|mesh-ancestor
65269891|NCT02732132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65408764|NCT00450801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408765|NCT00450801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408766|NCT00450801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65408767|NCT00450801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65408768|NCT00450801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65408769|NCT00450801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65408770|NCT00450801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65408771|NCT00450801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408772|NCT00450801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65408773|NCT00450801|Abortifacient Agents|abortifacient agents|mesh-ancestor
65408774|NCT00450801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65408775|NCT00450801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65408776|NCT00450801|Antimetabolites|antimetabolites|mesh-ancestor
65408777|NCT00450801|Dermatologic Agents|dermatologic agents|mesh-ancestor
65408778|NCT00450801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65408779|NCT00450801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65408780|NCT00450801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65408781|NCT00450801|Antiviral Agents|antiviral agents|mesh-ancestor
65408782|NCT00450801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65408783|NCT00450801|Antidotes|antidotes|mesh-ancestor
65408785|NCT00450801|Vitamin B Complex|vitamin b complex|mesh-ancestor
65408786|NCT00450801|Vitamins|vitamins|mesh-ancestor
65408787|NCT00450801|Micronutrients|micronutrients|mesh-ancestor
65408788|NCT00450801|Tubulin Modulators|tubulin modulators|mesh-ancestor
65408789|NCT00450801|Antimitotic Agents|antimitotic agents|mesh-ancestor
65408790|NCT00450801|Mitosis Modulators|mitosis modulators|mesh-ancestor
65408791|NCT00450801|Antiemetics|antiemetics|mesh-ancestor
65408792|NCT00450801|Autonomic Agents|autonomic agents|mesh-ancestor
65408793|NCT00450801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65408794|NCT00450801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65408795|NCT00450801|Leprostatic Agents|leprostatic agents|mesh-ancestor
65408796|NCT00450801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65408797|NCT00450801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65408798|NCT00450801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65408799|NCT00450801|Growth Substances|growth substances|mesh-ancestor
65408800|NCT00450801|Growth Inhibitors|growth inhibitors|mesh-ancestor
64793560|NCT02017704|Antimetabolites|antimetabolites|mesh-ancestor
65408821|NCT00457821|Ivacaftor|ivacaftor|mesh-list
65408822|NCT00457821|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65408823|NCT00457821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65408824|NCT00457821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408825|NCT00633893|Apixaban|apixaban|mesh-list
65408826|NCT00633893|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65408827|NCT00633893|Antithrombins|antithrombins|mesh-ancestor
65408828|NCT00633893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65408829|NCT00633893|Protease Inhibitors|protease inhibitors|mesh-ancestor
65408830|NCT00633893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408831|NCT00633893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408832|NCT00633893|Anticoagulants|anticoagulants|mesh-ancestor
65408833|NCT02550665|Donepezil|donepezil|mesh-list
65408834|NCT02550665|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65408835|NCT02550665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408836|NCT02550665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408837|NCT02550665|Cholinergic Agents|cholinergic agents|mesh-ancestor
65408838|NCT02550665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65408839|NCT02550665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408840|NCT02550665|Nootropic Agents|nootropic agents|mesh-ancestor
65408841|NCT00819845|Carvedilol|carvedilol|mesh-list
65408842|NCT00819845|Ramipril|ramipril|mesh-list
65408843|NCT00819845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65408844|NCT00819845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65408845|NCT00819845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65408846|NCT00819845|Adrenergic Agents|adrenergic agents|mesh-ancestor
65408847|NCT00819845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65408848|NCT00819845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408849|NCT00819845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408850|NCT00819845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65408851|NCT00819845|Antioxidants|antioxidants|mesh-ancestor
65408852|NCT00819845|Protective Agents|protective agents|mesh-ancestor
65408853|NCT00819845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64793633|NCT03215940|Hormones|hormones|mesh-ancestor
65408864|NCT00457743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65408866|NCT00457743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408867|NCT00457743|Growth Inhibitors|growth inhibitors|mesh-ancestor
65408868|NCT00457743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65408869|NCT00457743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408870|NCT00457743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408871|NCT03705585|Vaccines|vaccines|mesh-list
65408872|NCT03705585|Immunologic Factors|immunologic factors|mesh-ancestor
65408873|NCT03705585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408874|NCT01023867|Donepezil|donepezil|mesh-list
65408875|NCT01023867|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65408876|NCT01023867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408877|NCT01023867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408878|NCT01023867|Cholinergic Agents|cholinergic agents|mesh-ancestor
65408879|NCT01023867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65408880|NCT01023867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408881|NCT01023867|Nootropic Agents|nootropic agents|mesh-ancestor
65408882|NCT00820469|Rituximab|rituximab|mesh-list
65408883|NCT00820469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65408884|NCT00820469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408885|NCT00820469|Immunologic Factors|immunologic factors|mesh-ancestor
65408886|NCT00820469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408887|NCT00820469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65408888|NCT00815399|Metformin|metformin|mesh-list
65408889|NCT00815399|Pioglitazone|pioglitazone|mesh-list
65408890|NCT00815399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65408891|NCT00815399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408892|NCT00644969|Varenicline|varenicline|mesh-list
65408893|NCT00644969|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65408894|NCT00644969|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65408895|NCT00644969|Cholinergic Agents|cholinergic agents|mesh-ancestor
65408896|NCT00644969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65408897|NCT00644969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408898|NCT00644969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408899|NCT00812435|Eptifibatide|eptifibatide|mesh-list
65408900|NCT00812435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65408901|NCT00812513|Becaplermin|becaplermin|mesh-list
65408902|NCT00812513|Anticoagulants|anticoagulants|mesh-ancestor
65408903|NCT00812513|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
65408904|NCT00812513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65408905|NCT00812513|Growth Substances|growth substances|mesh-ancestor
65408906|NCT00812513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408907|NCT00820547|Cyclophosphamide|cyclophosphamide|mesh-list
65408908|NCT00820547|Bevacizumab|bevacizumab|mesh-list
65408909|NCT00820547|Docetaxel|docetaxel|mesh-list
65408910|NCT00820547|Fluorouracil|fluorouracil|mesh-list
65408911|NCT00820547|Epirubicin|epirubicin|mesh-list
65408912|NCT00820547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65408913|NCT00820547|Immunologic Factors|immunologic factors|mesh-ancestor
65408914|NCT00820547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408915|NCT00820547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65408916|NCT00820547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65408924|NCT00820547|Growth Substances|growth substances|mesh-ancestor
65408925|NCT00820547|Growth Inhibitors|growth inhibitors|mesh-ancestor
65408926|NCT00820547|Tubulin Modulators|tubulin modulators|mesh-ancestor
65408927|NCT00820547|Antimitotic Agents|antimitotic agents|mesh-ancestor
65408928|NCT00820547|Mitosis Modulators|mitosis modulators|mesh-ancestor
65408929|NCT00820547|Antimetabolites|antimetabolites|mesh-ancestor
65408930|NCT00820547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65408931|NCT00820547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65408932|NCT00820547|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65408933|NCT00820547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65408934|NCT00820547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408935|NCT00815867|Epoetin Alfa|epoetin alfa|mesh-list
65408936|NCT00815867|Hematinics|hematinics|mesh-ancestor
65408937|NCT00815945|Carboplatin|carboplatin|mesh-list
65408938|NCT00815945|Doxorubicin|doxorubicin|mesh-list
65408939|NCT00815945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408940|NCT00815945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65408941|NCT00815945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65408942|NCT00815945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65408943|NCT00815945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408944|NCT00815945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408945|NCT00812825|Prednisolone|prednisolone|mesh-list
65408946|NCT00812825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65408947|NCT00812825|Glucocorticoids|glucocorticoids|mesh-ancestor
65408948|NCT00812825|Hormones|hormones|mesh-ancestor
65408949|NCT00812825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65408950|NCT00812825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231796|NCT04061473|Incretins|incretins|mesh-ancestor
65408951|NCT00812825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65408952|NCT00812825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408953|NCT00628355|Lidocaine|lidocaine|mesh-list
65408954|NCT00628355|Anesthetics, Local|anesthetics, local|mesh-ancestor
65408955|NCT00628355|Anesthetics|anesthetics|mesh-ancestor
65408956|NCT00628355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65408957|NCT00628355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408958|NCT00628355|Sensory System Agents|sensory system agents|mesh-ancestor
65408959|NCT00628355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65408960|NCT00628355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65408961|NCT00628355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65408962|NCT00628355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65408963|NCT00628355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65408964|NCT00628355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408965|NCT00647699|Riboflavin|riboflavin|mesh-list
65408966|NCT00647699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65408967|NCT00647699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65408968|NCT00647699|Vitamin B Complex|vitamin b complex|mesh-ancestor
65408969|NCT00647699|Vitamins|vitamins|mesh-ancestor
65408970|NCT00647699|Micronutrients|micronutrients|mesh-ancestor
65408971|NCT00647699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408972|NCT00647699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65408973|NCT00647699|Dermatologic Agents|dermatologic agents|mesh-ancestor
65408974|NCT00813059|Bevacizumab|bevacizumab|mesh-list
65408975|NCT00813059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65408976|NCT00813059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408977|NCT00813059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65408978|NCT00813059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65408979|NCT00813059|Growth Substances|growth substances|mesh-ancestor
65408980|NCT00813059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408981|NCT00813059|Growth Inhibitors|growth inhibitors|mesh-ancestor
65408982|NCT00467649|Insulin|insulin|mesh-list
65408983|NCT00467649|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65408989|NCT00467649|Pramlintide|pramlintide|mesh-list
65408990|NCT00467649|Insulin, Short-Acting|insulin, short-acting|mesh-list
65408991|NCT00467649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65408992|NCT00467649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408993|NCT01023945|Ipragliflozin|ipragliflozin|mesh-list
65408994|NCT01023945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65408995|NCT01023945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408996|NCT01023945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65408997|NCT01023945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408998|NCT00450333|Epoetin Alfa|epoetin alfa|mesh-list
65408999|NCT00450333|Hematinics|hematinics|mesh-ancestor
65409000|NCT00643565|Bevacizumab|bevacizumab|mesh-list
65409001|NCT00643565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65409002|NCT00643565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409003|NCT00643565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65409004|NCT00643565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65409005|NCT00643565|Growth Substances|growth substances|mesh-ancestor
65409006|NCT00643565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409007|NCT00643565|Growth Inhibitors|growth inhibitors|mesh-ancestor
65409008|NCT00450255|Aflibercept|aflibercept|mesh-list
65409009|NCT00450255|Endothelial Growth Factors|endothelial growth factors|mesh-list
65409010|NCT00450255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65409011|NCT00450255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65409012|NCT00450255|Growth Substances|growth substances|mesh-ancestor
65409013|NCT00450255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409014|NCT00450255|Growth Inhibitors|growth inhibitors|mesh-ancestor
65409015|NCT00450255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409016|NCT00816335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65409017|NCT00816335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65409018|NCT00816335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409019|NCT00816413|Cyclosporine|cyclosporine|mesh-list
65409020|NCT00816413|Mycophenolic Acid|mycophenolic acid|mesh-list
65409021|NCT00816413|Pentostatin|pentostatin|mesh-list
65409022|NCT00816413|Cyclosporins|cyclosporins|mesh-list
65409023|NCT00816413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409024|NCT00816413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409025|NCT00816413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65409026|NCT00816413|Immunologic Factors|immunologic factors|mesh-ancestor
65409027|NCT00816413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409028|NCT00816413|Antifungal Agents|antifungal agents|mesh-ancestor
65409029|NCT00816413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65231873|NCT03221257|Analgesics|analgesics|mesh-ancestor
65409030|NCT00816413|Dermatologic Agents|dermatologic agents|mesh-ancestor
65409031|NCT00816413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65409032|NCT00816413|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65409033|NCT00816413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65409034|NCT00816413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409035|NCT00816413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65409036|NCT00816413|Antitubercular Agents|antitubercular agents|mesh-ancestor
65409037|NCT00816413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65409038|NCT00816413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65409039|NCT00813137|Endostar protein|endostar protein|mesh-list
65409040|NCT00813137|Endostatins|endostatins|mesh-list
65409041|NCT00813137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65409042|NCT00813137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65409043|NCT00813137|Growth Substances|growth substances|mesh-ancestor
65409044|NCT00813137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409045|NCT00813137|Growth Inhibitors|growth inhibitors|mesh-ancestor
65409046|NCT00813137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409048|NCT01024179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65409049|NCT01024179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65409050|NCT01024179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65409051|NCT01024179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409052|NCT01024179|Antifungal Agents|antifungal agents|mesh-ancestor
65409053|NCT01024179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65409054|NCT01024179|Immunologic Factors|immunologic factors|mesh-ancestor
65409055|NCT01024179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409065|NCT02551367|Zuclomiphene|zuclomiphene|mesh-list
65409066|NCT02551367|Hormones|hormones|mesh-list
65409067|NCT02551367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409068|NCT02551367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65409069|NCT02551367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409070|NCT02551367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409071|NCT02551367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65409072|NCT02551367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65409073|NCT02551367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409074|NCT02551367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65409075|NCT02551367|Hormone Antagonists|hormone antagonists|mesh-ancestor
65409076|NCT02551367|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65409077|NCT02551367|Fertility Agents|fertility agents|mesh-ancestor
65409078|NCT02551367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65409079|NCT02551367|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65409080|NCT02551367|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65409081|NCT00813449|Dacarbazine|dacarbazine|mesh-list
65409082|NCT00813449|Endostar protein|endostar protein|mesh-list
65409083|NCT00813449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65409084|NCT00813449|Alkylating Agents|alkylating agents|mesh-ancestor
65409085|NCT00813449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409086|NCT00813449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409087|NCT00813449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65409088|NCT00813449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65409089|NCT00813449|Growth Substances|growth substances|mesh-ancestor
65409090|NCT00813449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409091|NCT00813449|Growth Inhibitors|growth inhibitors|mesh-ancestor
65409092|NCT00822029|Alendronate|alendronate|mesh-list
65409093|NCT00822029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65409094|NCT00822029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409095|NCT00467259|Testosterone|testosterone|mesh-list
65409096|NCT00467259|Androgens|androgens|mesh-ancestor
65409097|NCT00467259|Hormones|hormones|mesh-ancestor
65409098|NCT00467259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65409099|NCT00467259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409100|NCT01022151|Aminophylline|aminophylline|mesh-list
65409101|NCT01022151|Doxapram|doxapram|mesh-list
65409102|NCT01022151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65409103|NCT01022151|Autonomic Agents|autonomic agents|mesh-ancestor
65409104|NCT01022151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65409105|NCT01022151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409106|NCT01022151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65409107|NCT01022151|Respiratory System Agents|respiratory system agents|mesh-ancestor
65409108|NCT01022151|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65409109|NCT01022151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65409110|NCT01022151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409111|NCT01022151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409112|NCT01022151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65409113|NCT01022151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65409114|NCT01022151|Purinergic Agents|purinergic agents|mesh-ancestor
65409115|NCT01022151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65409116|NCT01022151|Protective Agents|protective agents|mesh-ancestor
65409117|NCT01022151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65409118|NCT01022229|Vitamins|vitamins|mesh-list
65409119|NCT01022229|Vitamin B 6|vitamin b 6|mesh-list
65409120|NCT01022229|Micronutrients|micronutrients|mesh-ancestor
64793876|NCT01834014|Oxaliplatin|oxaliplatin|mesh-list
65409126|NCT00449787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65409127|NCT00449787|Analgesics|analgesics|mesh-ancestor
65409128|NCT00449787|Sensory System Agents|sensory system agents|mesh-ancestor
65409129|NCT00449787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65409130|NCT00449787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409131|NCT00449787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65409132|NCT00449787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65409133|NCT00449787|Gout Suppressants|gout suppressants|mesh-ancestor
65409134|NCT00449787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65409135|NCT00449787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409136|NCT00449787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409137|NCT00449787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65409138|NCT00449787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65409139|NCT00449787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65409140|NCT00449787|Serotonin Agents|serotonin agents|mesh-ancestor
65409141|NCT00449787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65409142|NCT01566201|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65409143|NCT01566201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65409144|NCT01566279|Everolimus|everolimus|mesh-list
65409145|NCT01566279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409146|NCT01566279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65409147|NCT01566279|Immunologic Factors|immunologic factors|mesh-ancestor
65409148|NCT01566279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409149|NCT00449163|Leucovorin|leucovorin|mesh-list
65409150|NCT00449163|Bevacizumab|bevacizumab|mesh-list
65409151|NCT00449163|Irinotecan|irinotecan|mesh-list
65409152|NCT00449163|Floxuridine|floxuridine|mesh-list
65409153|NCT00449163|Levoleucovorin|levoleucovorin|mesh-list
65409154|NCT00449163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65409155|NCT00449163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409156|NCT00449163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65409157|NCT00449163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65409158|NCT00449163|Growth Substances|growth substances|mesh-ancestor
65409159|NCT00449163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409160|NCT00449163|Growth Inhibitors|growth inhibitors|mesh-ancestor
65409161|NCT00449163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65409163|NCT00449163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409164|NCT00449163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409165|NCT00449163|Antidotes|antidotes|mesh-ancestor
65409166|NCT00449163|Protective Agents|protective agents|mesh-ancestor
65409167|NCT00449163|Vitamin B Complex|vitamin b complex|mesh-ancestor
65409168|NCT00449163|Vitamins|vitamins|mesh-ancestor
65409169|NCT00449163|Micronutrients|micronutrients|mesh-ancestor
65409170|NCT00449163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65409171|NCT00449163|Antimetabolites|antimetabolites|mesh-ancestor
65409172|NCT01026987|Plerixafor|plerixafor|mesh-list
65409173|NCT01026987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65409174|NCT01026987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65409175|NCT01026987|Antiviral Agents|antiviral agents|mesh-ancestor
65409176|NCT01026987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65409177|NCT00448539|Rufinamide|rufinamide|mesh-list
65409178|NCT00448539|Anticonvulsants|anticonvulsants|mesh-ancestor
65409179|NCT00448539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65409180|NCT00448539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65409181|NCT00448539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65409182|NCT00448539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409183|NCT00457665|Efavirenz|efavirenz|mesh-list
65409184|NCT00457665|Nelfinavir|nelfinavir|mesh-list
65409185|NCT00457665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65409186|NCT00457665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65409187|NCT00457665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409188|NCT00457665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409189|NCT00457665|Antiviral Agents|antiviral agents|mesh-ancestor
65409190|NCT00457665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65409191|NCT00457665|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65409192|NCT00457665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65232024|NCT01006265|Ponesimod|ponesimod|mesh-list
65409199|NCT00457665|Protease Inhibitors|protease inhibitors|mesh-ancestor
65409200|NCT00457665|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65409201|NCT00457665|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65409202|NCT00447603|Losartan|losartan|mesh-list
65409203|NCT00447603|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65409204|NCT00447603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65409205|NCT00447603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65409206|NCT00447603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65409207|NCT00447603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65409208|NCT00447603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409209|NCT00447603|Diuretics|diuretics|mesh-ancestor
65409210|NCT00447603|Natriuretic Agents|natriuretic agents|mesh-ancestor
65409211|NCT00447603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409212|NCT00447603|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65409213|NCT00447603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65409214|NCT00447057|Pemetrexed|pemetrexed|mesh-list
65409215|NCT00447057|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65409216|NCT00447057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409217|NCT00447057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409218|NCT00447057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409219|NCT00447057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65409220|NCT00447057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65409221|NCT00447057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65409222|NCT01027611|Lidocaine|lidocaine|mesh-list
65409223|NCT01027611|Proxymetacaine|proxymetacaine|mesh-list
65409224|NCT01027611|Propoxycaine|propoxycaine|mesh-list
65409225|NCT01027611|Anesthetics, Local|anesthetics, local|mesh-ancestor
65409226|NCT01027611|Anesthetics|anesthetics|mesh-ancestor
65409227|NCT01027611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65409228|NCT01027611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409229|NCT01027611|Sensory System Agents|sensory system agents|mesh-ancestor
65409230|NCT01027611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65409231|NCT01027611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65409232|NCT01027611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65409233|NCT01027611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65409234|NCT01027611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65409235|NCT01027611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409236|NCT01024413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65409238|NCT01024413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409239|NCT01024413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65409240|NCT01024413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409241|NCT01024413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409242|NCT00446511|Valsartan|valsartan|mesh-list
65409243|NCT00446511|Enalapril|enalapril|mesh-list
65409244|NCT00446511|Enalaprilat|enalaprilat|mesh-list
65409245|NCT00446511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65409246|NCT00446511|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65409247|NCT00446511|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65409248|NCT00446511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409249|NCT00446511|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65409250|NCT00446511|Protease Inhibitors|protease inhibitors|mesh-ancestor
65409251|NCT00446511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409252|NCT01024491|Paroxetine|paroxetine|mesh-list
65409253|NCT01024491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65409254|NCT01024491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65409255|NCT01024491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65409256|NCT01024491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409257|NCT01024491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65409258|NCT01024491|Serotonin Agents|serotonin agents|mesh-ancestor
65409268|NCT00446199|Estrogens|estrogens|mesh-ancestor
65409269|NCT00446199|Hormones|hormones|mesh-ancestor
65409270|NCT00446199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65409271|NCT00446199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409272|NCT00446199|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65409273|NCT00446199|Hormone Antagonists|hormone antagonists|mesh-ancestor
65409274|NCT00446199|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65409275|NCT00446199|Diuretics|diuretics|mesh-ancestor
65409276|NCT00446199|Natriuretic Agents|natriuretic agents|mesh-ancestor
65409277|NCT01027689|Alprazolam|alprazolam|mesh-list
65409278|NCT01027689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65409279|NCT01027689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65232097|NCT02871323|Durvalumab|durvalumab|mesh-list
65409280|NCT01027689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409281|NCT01027689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65409282|NCT01027689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65409283|NCT01027689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65409284|NCT01027689|GABA Modulators|gaba modulators|mesh-ancestor
65409285|NCT01027689|GABA Agents|gaba agents|mesh-ancestor
65409286|NCT01027689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65409287|NCT01027689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409288|NCT01024647|Certolizumab Pegol|certolizumab pegol|mesh-list
65409289|NCT01024647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65409290|NCT01024647|Immunologic Factors|immunologic factors|mesh-ancestor
65409291|NCT01024647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409292|NCT01024647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65409293|NCT01027923|Cytarabine|cytarabine|mesh-list
65409294|NCT01027923|Plerixafor|plerixafor|mesh-list
65409295|NCT01027923|Etoposide|etoposide|mesh-list
65409296|NCT01027923|Mitoxantrone|mitoxantrone|mesh-list
65409297|NCT01027923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65409298|NCT01027923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409299|NCT01027923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65409300|NCT01027923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65409301|NCT01027923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409302|NCT01027923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409303|NCT01027923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65409304|NCT01027923|Antimetabolites|antimetabolites|mesh-ancestor
65409305|NCT01027923|Antiviral Agents|antiviral agents|mesh-ancestor
65409306|NCT01027923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65409307|NCT01027923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65409308|NCT01027923|Immunologic Factors|immunologic factors|mesh-ancestor
65409309|NCT01027923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409310|NCT01027923|Analgesics|analgesics|mesh-ancestor
65409311|NCT01027923|Sensory System Agents|sensory system agents|mesh-ancestor
65409312|NCT01027923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65409313|NCT01027923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65409314|NCT01027923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65409315|NCT01565733|Insulin Aspart|insulin aspart|mesh-list
65409316|NCT01565733|Biphasic Insulins|biphasic insulins|mesh-list
65409317|NCT01565733|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65409318|NCT01565733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65409319|NCT01565733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409320|NCT01027065|Tenofovir|tenofovir|mesh-list
65409321|NCT01027065|Entecavir|entecavir|mesh-list
65409322|NCT01027065|Antiviral Agents|antiviral agents|mesh-ancestor
65409323|NCT01027065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65409324|NCT01027065|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64794089|NCT01720212|Mirabegron|mirabegron|mesh-list
65409333|NCT00456495|Growth Substances|growth substances|mesh-ancestor
65409334|NCT00456495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409335|NCT00456495|Growth Inhibitors|growth inhibitors|mesh-ancestor
65409336|NCT00456495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409337|NCT00445341|Alvocidib|alvocidib|mesh-list
65409338|NCT00445341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409339|NCT00445341|Growth Inhibitors|growth inhibitors|mesh-ancestor
65409340|NCT00445341|Growth Substances|growth substances|mesh-ancestor
65409341|NCT00445341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409342|NCT00445341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65409343|NCT00445341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409344|NCT00445341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409345|NCT03846453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65409346|NCT03846453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65409347|NCT00444951|Vaccines|vaccines|mesh-list
65409348|NCT00444951|Immunologic Factors|immunologic factors|mesh-ancestor
65409349|NCT00444951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409350|NCT00444795|Sunitinib|sunitinib|mesh-list
65409351|NCT00444795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409352|NCT00444795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65409353|NCT00444795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65409354|NCT00444795|Growth Substances|growth substances|mesh-ancestor
65409355|NCT00444795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409356|NCT00444795|Growth Inhibitors|growth inhibitors|mesh-ancestor
65409357|NCT00444795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65409358|NCT00444795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409359|NCT00444795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409360|NCT03846219|Calcium, Dietary|calcium, dietary|mesh-list
65409361|NCT03846219|Calcium|calcium|mesh-list
65409362|NCT03846219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65409363|NCT03846219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409364|NCT03846219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65409365|NCT00455325|Chloroquine|chloroquine|mesh-list
65409366|NCT00455325|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65409367|NCT00455325|Amebicides|amebicides|mesh-ancestor
65409368|NCT00455325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65409369|NCT00455325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65409370|NCT00455325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65409371|NCT00455325|Antimalarials|antimalarials|mesh-ancestor
65409372|NCT00455325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65409373|NCT00455325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65409374|NCT00455325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65409375|NCT00455325|Analgesics|analgesics|mesh-ancestor
65409376|NCT00455325|Sensory System Agents|sensory system agents|mesh-ancestor
65409377|NCT00455325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65409378|NCT00455325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409379|NCT00455325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65409380|NCT00455325|Filaricides|filaricides|mesh-ancestor
65409381|NCT00455325|Antinematodal Agents|antinematodal agents|mesh-ancestor
65409382|NCT00455325|Anthelmintics|anthelmintics|mesh-ancestor
65409383|NCT01028079|Aspirin|aspirin|mesh-list
65409384|NCT01028079|Ibuprofen|ibuprofen|mesh-list
65409385|NCT01028079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65409386|NCT01028079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65409387|NCT01028079|Analgesics|analgesics|mesh-ancestor
65409388|NCT01028079|Sensory System Agents|sensory system agents|mesh-ancestor
65409389|NCT01028079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65409390|NCT01028079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409391|NCT01028079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65409398|NCT01028079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409399|NCT01028079|Antipyretics|antipyretics|mesh-ancestor
65409400|NCT00443781|Anesthetics|anesthetics|mesh-list
65409401|NCT00443781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65409402|NCT00443781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409404|NCT00443703|Lopinavir|lopinavir|mesh-list
65409405|NCT00443703|Raltegravir Potassium|raltegravir potassium|mesh-list
65409406|NCT00443703|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65409407|NCT00443703|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65409408|NCT00443703|Protease Inhibitors|protease inhibitors|mesh-ancestor
65409409|NCT00443703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409410|NCT00443703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409411|NCT00443703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65409412|NCT00443703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65409413|NCT00443703|Antiviral Agents|antiviral agents|mesh-ancestor
65409414|NCT00443703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65409415|NCT00443703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65409416|NCT00443703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65409417|NCT00443703|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65409418|NCT00443703|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65409419|NCT00381706|Leucovorin|leucovorin|mesh-list
65409420|NCT00381706|Cisplatin|cisplatin|mesh-list
65409421|NCT00381706|Fluorouracil|fluorouracil|mesh-list
65409422|NCT00381706|Oxaliplatin|oxaliplatin|mesh-list
65409423|NCT00381706|Irinotecan|irinotecan|mesh-list
65409424|NCT00381706|Cetuximab|cetuximab|mesh-list
65409425|NCT00381706|Epirubicin|epirubicin|mesh-list
65409426|NCT00381706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409427|NCT00381706|Antimetabolites|antimetabolites|mesh-ancestor
65409428|NCT00381706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409429|NCT00381706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65409430|NCT00381706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65409431|NCT00381706|Immunologic Factors|immunologic factors|mesh-ancestor
65409432|NCT00381706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409433|NCT00381706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65409434|NCT00381706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65409435|NCT00381706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409436|NCT00381706|Antidotes|antidotes|mesh-ancestor
65409437|NCT00381706|Protective Agents|protective agents|mesh-ancestor
65409438|NCT00381706|Vitamin B Complex|vitamin b complex|mesh-ancestor
65409439|NCT00381706|Vitamins|vitamins|mesh-ancestor
65409440|NCT00381706|Micronutrients|micronutrients|mesh-ancestor
65409441|NCT00381706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65409442|NCT00381706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65409443|NCT00381706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65409444|NCT01045642|Omeprazole|omeprazole|mesh-list
65409445|NCT01045642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65409446|NCT01045642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65409447|NCT01045642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65409448|NCT01045642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409449|NCT01045642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409450|NCT05357430|Propofol|propofol|mesh-list
65409451|NCT05357430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65409452|NCT05357430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65409453|NCT05357430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409454|NCT05357430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65409455|NCT05357430|Anesthetics, General|anesthetics, general|mesh-ancestor
65409456|NCT05357430|Anesthetics|anesthetics|mesh-ancestor
65409457|NCT00370552|Paclitaxel|paclitaxel|mesh-list
65409458|NCT00370552|Epothilones|epothilones|mesh-list
65409459|NCT00370552|Bevacizumab|bevacizumab|mesh-list
65409460|NCT00370552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65409461|NCT00370552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409462|NCT00370552|Tubulin Modulators|tubulin modulators|mesh-ancestor
65409463|NCT00370552|Antimitotic Agents|antimitotic agents|mesh-ancestor
65409471|NCT00370552|Growth Inhibitors|growth inhibitors|mesh-ancestor
65409472|NCT00537030|Asparaginase|asparaginase|mesh-list
65409473|NCT00537030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409474|NCT00381238|Rosiglitazone|rosiglitazone|mesh-list
65409475|NCT00381238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65409476|NCT00381238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409478|NCT04400994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65409479|NCT04400994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409480|NCT04400994|Immunologic Factors|immunologic factors|mesh-ancestor
65409481|NCT04400994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409482|NCT04400994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65409483|NCT04928820|Edetic Acid|edetic acid|mesh-list
65409484|NCT04928820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65409485|NCT04928820|Chelating Agents|chelating agents|mesh-ancestor
65409486|NCT04928820|Sequestering Agents|sequestering agents|mesh-ancestor
65409487|NCT04928820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409488|NCT04928820|Anticoagulants|anticoagulants|mesh-ancestor
65409489|NCT04928820|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65409490|NCT04928820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65409492|NCT04429152|Lamivudine|lamivudine|mesh-list
65409493|NCT04429152|Antiviral Agents|antiviral agents|mesh-ancestor
65409494|NCT04429152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65409495|NCT04429152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65409496|NCT04429152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65409497|NCT04429152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409498|NCT04429152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409499|NCT04429152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65409500|NCT04429152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65409501|NCT04262154|Prednisone|prednisone|mesh-list
65409502|NCT04262154|Atezolizumab|atezolizumab|mesh-list
65409503|NCT04262154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65409504|NCT04262154|Glucocorticoids|glucocorticoids|mesh-ancestor
65409505|NCT04262154|Hormones|hormones|mesh-ancestor
65409506|NCT04262154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65409507|NCT04262154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409508|NCT04262154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65409509|NCT04262154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409510|NCT04001400|Rabeprazole|rabeprazole|mesh-list
65409511|NCT04001400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65409512|NCT04001400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65409513|NCT04001400|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65409514|NCT04001400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409515|NCT04001400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409516|NCT00380692|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65409517|NCT00380692|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65409518|NCT00380692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65409519|NCT00380692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65409520|NCT00380692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409521|NCT00380692|Adrenergic Agents|adrenergic agents|mesh-ancestor
65409522|NCT00380692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65409523|NCT00380692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409524|NCT04285866|Durvalumab|durvalumab|mesh-list
65409525|NCT04285866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65409526|NCT04285866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409527|NCT01047982|Folic Acid|folic acid|mesh-list
65409528|NCT01047982|Inositol|inositol|mesh-list
65409529|NCT01047982|Hematinics|hematinics|mesh-ancestor
65409530|NCT01047982|Vitamin B Complex|vitamin b complex|mesh-ancestor
65409531|NCT01047982|Vitamins|vitamins|mesh-ancestor
65409540|NCT00536874|Antiviral Agents|antiviral agents|mesh-ancestor
65232325|NCT02857712|Axitinib|axitinib|mesh-list
65409541|NCT00536874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65409542|NCT00536874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409543|NCT00536874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65409544|NCT00536874|Immunologic Factors|immunologic factors|mesh-ancestor
65409545|NCT00536874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409546|NCT00991848|Lidocaine|lidocaine|mesh-list
65409547|NCT00991848|Anesthetics, Local|anesthetics, local|mesh-ancestor
65409548|NCT00991848|Anesthetics|anesthetics|mesh-ancestor
65409549|NCT00991848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65409550|NCT00991848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409551|NCT00991848|Sensory System Agents|sensory system agents|mesh-ancestor
65409552|NCT00991848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65409553|NCT00991848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65409554|NCT00991848|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65409555|NCT00991848|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65409556|NCT00991848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65409557|NCT00991848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409558|NCT05281068|Danazol|danazol|mesh-list
65409559|NCT05281068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65409560|NCT05281068|Hormone Antagonists|hormone antagonists|mesh-ancestor
65409561|NCT05281068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65409562|NCT05281068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409563|NCT00380068|Ambrisentan|ambrisentan|mesh-list
65409564|NCT00380068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65409565|NCT00991926|Orlistat|orlistat|mesh-list
65409566|NCT00991926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409567|NCT00991926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409568|NCT00991926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65409569|NCT00991926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65409570|NCT04230954|Pembrolizumab|pembrolizumab|mesh-list
65409571|NCT04230954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65409572|NCT04230954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409573|NCT00536484|Fesoterodine|fesoterodine|mesh-list
65409574|NCT00536484|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65409575|NCT00536484|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65409576|NCT00536484|Cholinergic Agents|cholinergic agents|mesh-ancestor
65409577|NCT00536484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65409578|NCT00536484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409579|NCT00536484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409580|NCT00536484|Urological Agents|urological agents|mesh-ancestor
65409581|NCT00370396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65409582|NCT00370396|Immunologic Factors|immunologic factors|mesh-ancestor
65409583|NCT00370396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409584|NCT00992004|Turmeric extract|turmeric extract|mesh-list
65409585|NCT00992004|Antioxidants|antioxidants|mesh-ancestor
65409586|NCT00992004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409587|NCT00992004|Protective Agents|protective agents|mesh-ancestor
65409588|NCT00992004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409589|NCT03862716|Insulin|insulin|mesh-list
65409590|NCT03862716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65409591|NCT03862716|Metformin|metformin|mesh-list
65409592|NCT03862716|Liraglutide|liraglutide|mesh-list
65409593|NCT03862716|Insulin, Long-Acting|insulin, long-acting|mesh-list
65409594|NCT03862716|Xultophy|xultophy|mesh-list
65409595|NCT03862716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64794351|NCT01720836|Immunologic Factors|immunologic factors|mesh-ancestor
65409606|NCT00992082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65409608|NCT00992082|Analgesics|analgesics|mesh-ancestor
65409609|NCT00992082|Sensory System Agents|sensory system agents|mesh-ancestor
65409610|NCT00992082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65409611|NCT00992082|Anesthetics, Local|anesthetics, local|mesh-ancestor
65409612|NCT00992082|Anesthetics|anesthetics|mesh-ancestor
65409614|NCT00992082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65409615|NCT00992082|Adrenergic Agents|adrenergic agents|mesh-ancestor
65409616|NCT00992082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65409617|NCT00992082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409618|NCT00992082|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65409619|NCT00992082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65409620|NCT00992082|Autonomic Agents|autonomic agents|mesh-ancestor
65409621|NCT00992082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65409622|NCT00992082|Respiratory System Agents|respiratory system agents|mesh-ancestor
65409623|NCT00992082|Mydriatics|mydriatics|mesh-ancestor
65409624|NCT00992082|Sympathomimetics|sympathomimetics|mesh-ancestor
65409625|NCT00992082|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65232397|NCT04281680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409626|NCT00992082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65409627|NCT00992082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65409628|NCT00992082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65409629|NCT00992082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65409630|NCT00992082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65409631|NCT00992082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409632|NCT00455013|Mycophenolic Acid|mycophenolic acid|mesh-list
65409633|NCT00455013|Sirolimus|sirolimus|mesh-list
65409634|NCT00455013|Abatacept|abatacept|mesh-list
65409635|NCT00455013|Tacrolimus|tacrolimus|mesh-list
65409636|NCT00455013|Thymoglobulin|thymoglobulin|mesh-list
65409637|NCT00455013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65409638|NCT00455013|Immunologic Factors|immunologic factors|mesh-ancestor
65409639|NCT00455013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409640|NCT00455013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65409641|NCT00455013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409642|NCT00455013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409643|NCT00455013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65409644|NCT00455013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409645|NCT00455013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65409646|NCT00455013|Antitubercular Agents|antitubercular agents|mesh-ancestor
65409647|NCT00455013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65409648|NCT00455013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65409649|NCT00455013|Antifungal Agents|antifungal agents|mesh-ancestor
65409650|NCT00455013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65409651|NCT00455013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65409652|NCT00363298|Caffeine|caffeine|mesh-list
65409653|NCT00363298|Amphetamine|amphetamine|mesh-list
65409654|NCT00363298|Dextroamphetamine|dextroamphetamine|mesh-list
65409655|NCT00363298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65409656|NCT00363298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409657|NCT00363298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65409658|NCT00363298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409659|NCT00363298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409660|NCT00363298|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65409661|NCT00363298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65409662|NCT00363298|Purinergic Agents|purinergic agents|mesh-ancestor
64794426|NCT01044498|Norinyl|norinyl|mesh-list
65409669|NCT00363298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65409670|NCT00363298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65409671|NCT00363298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65409672|NCT00363298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65409673|NCT05254548|Flurbiprofen|flurbiprofen|mesh-list
65409674|NCT05254548|Midazolam|midazolam|mesh-list
65409675|NCT05254548|Omeprazole|omeprazole|mesh-list
65409676|NCT05254548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65409677|NCT05254548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65409678|NCT05254548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65409679|NCT05254548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409680|NCT05254548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65409681|NCT05254548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65409682|NCT05254548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65409683|NCT05254548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65409684|NCT05254548|Anesthetics, General|anesthetics, general|mesh-ancestor
65409685|NCT05254548|Anesthetics|anesthetics|mesh-ancestor
65409686|NCT05254548|GABA Modulators|gaba modulators|mesh-ancestor
65409687|NCT05254548|GABA Agents|gaba agents|mesh-ancestor
65409688|NCT05254548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65409689|NCT05254548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409690|NCT05254548|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65409691|NCT05254548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65409692|NCT05254548|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65409693|NCT05254548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409694|NCT05254548|Analgesics|analgesics|mesh-ancestor
65409695|NCT05254548|Sensory System Agents|sensory system agents|mesh-ancestor
65409696|NCT05254548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65409697|NCT05254548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65409698|NCT05254548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65409699|NCT05254548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65409700|NCT05254548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65409701|NCT05254548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65409702|NCT00363142|Ritonavir|ritonavir|mesh-list
65409703|NCT00363142|Fosamprenavir|fosamprenavir|mesh-list
65409704|NCT00363142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65232469|NCT00948506|Cidofovir|cidofovir|mesh-list
65409705|NCT00363142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65409706|NCT00363142|Protease Inhibitors|protease inhibitors|mesh-ancestor
65409707|NCT00363142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409708|NCT00363142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409709|NCT00363142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65409710|NCT00363142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65409711|NCT00363142|Antiviral Agents|antiviral agents|mesh-ancestor
65409712|NCT00363142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65409713|NCT00363142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65409714|NCT00363142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65409715|NCT05246982|Capecitabine|capecitabine|mesh-list
65409716|NCT05246982|Oxaliplatin|oxaliplatin|mesh-list
65409717|NCT05246982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65409718|NCT05246982|Antimetabolites|antimetabolites|mesh-ancestor
65409719|NCT05246982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409720|NCT05246982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409721|NCT04002024|Salicylic Acid|salicylic acid|mesh-list
65409722|NCT04002024|Salicylates|salicylates|mesh-list
65409723|NCT04002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65409724|NCT04002024|Antifungal Agents|antifungal agents|mesh-ancestor
65409725|NCT04002024|Keratolytic Agents|keratolytic agents|mesh-ancestor
65409726|NCT04002024|Dermatologic Agents|dermatologic agents|mesh-ancestor
65409727|NCT04002024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65409728|NCT04002024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65409729|NCT04002024|Analgesics|analgesics|mesh-ancestor
65409730|NCT04002024|Sensory System Agents|sensory system agents|mesh-ancestor
65409731|NCT04002024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65409732|NCT04002024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794479|NCT03407196|Dapagliflozin|dapagliflozin|mesh-list
65409737|NCT04002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409739|NCT01028313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65409740|NCT01028313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65409741|NCT01028313|Prednisolone|prednisolone|mesh-list
65409742|NCT01028313|Prednisolone acetate|prednisolone acetate|mesh-list
65409743|NCT01028313|Panobinostat|panobinostat|mesh-list
65409744|NCT01028313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65409745|NCT01028313|Prednisolone phosphate|prednisolone phosphate|mesh-list
65409746|NCT01028313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65409747|NCT01028313|Antiemetics|antiemetics|mesh-ancestor
65409748|NCT01028313|Autonomic Agents|autonomic agents|mesh-ancestor
65409749|NCT01028313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65409750|NCT01028313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409751|NCT01028313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65409752|NCT01028313|Glucocorticoids|glucocorticoids|mesh-ancestor
65409753|NCT01028313|Hormones|hormones|mesh-ancestor
65409754|NCT01028313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65409755|NCT01028313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65409756|NCT01028313|Protective Agents|protective agents|mesh-ancestor
65409757|NCT01028313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65409758|NCT01028313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409759|NCT01028313|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65409760|NCT01028313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409761|NCT01028313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409762|NCT04001712|Caffeine|caffeine|mesh-list
65409763|NCT04001712|Caffeine citrate|caffeine citrate|mesh-list
65409764|NCT04001712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409766|NCT04001712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409767|NCT04001712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65409768|NCT04001712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409769|NCT04001712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65409770|NCT04001712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65409771|NCT04001712|Purinergic Agents|purinergic agents|mesh-ancestor
65409772|NCT04001712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65409773|NCT01027377|Factor VIII|factor viii|mesh-list
65409774|NCT01027377|Coagulants|coagulants|mesh-ancestor
65409775|NCT00992160|Vestipitant|vestipitant|mesh-list
65409776|NCT00992160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65409777|NCT00992160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65409778|NCT00992160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409779|NCT00992160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409780|NCT00379912|Azacitidine|azacitidine|mesh-list
65409781|NCT00379912|Epoetin Alfa|epoetin alfa|mesh-list
65409782|NCT00379912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65232545|NCT00948194|Nitric Oxide|nitric oxide|mesh-list
65409783|NCT00379912|Antimetabolites|antimetabolites|mesh-ancestor
65409784|NCT00379912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409785|NCT00379912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409786|NCT00379912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409787|NCT00379912|Hematinics|hematinics|mesh-ancestor
65409788|NCT00992238|Flavoxate|flavoxate|mesh-list
65409789|NCT00992238|Parasympatholytics|parasympatholytics|mesh-ancestor
65409790|NCT00992238|Autonomic Agents|autonomic agents|mesh-ancestor
65409791|NCT00992238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65409792|NCT00992238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409793|NCT00992238|Urological Agents|urological agents|mesh-ancestor
65409794|NCT00379834|Timolol|timolol|mesh-list
65409795|NCT00379834|Dorzolamide|dorzolamide|mesh-list
65409796|NCT00379834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65409797|NCT00379834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65409798|NCT00379834|Adrenergic Agents|adrenergic agents|mesh-ancestor
65409799|NCT00379834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65409800|NCT00379834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409801|NCT00379834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409802|NCT00379834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64794545|NCT03402204|Immunologic Factors|immunologic factors|mesh-ancestor
65409809|NCT00992472|Prochlorperazine|prochlorperazine|mesh-list
65409810|NCT00992472|Antiemetics|antiemetics|mesh-ancestor
65409811|NCT00992472|Autonomic Agents|autonomic agents|mesh-ancestor
65409812|NCT00992472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65409813|NCT00992472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409814|NCT00992472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65409815|NCT00992472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65409816|NCT00992472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65409817|NCT00992472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65409818|NCT00992472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65409819|NCT00992472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65409820|NCT00992472|Dopamine Agents|dopamine agents|mesh-ancestor
65409821|NCT00992472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65409822|NCT00992472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409823|NCT03453840|Lumefantrine|lumefantrine|mesh-list
65409824|NCT03453840|Artemether|artemether|mesh-list
65409825|NCT03453840|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65409826|NCT03453840|Antimalarials|antimalarials|mesh-ancestor
65409827|NCT03453840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65409828|NCT03453840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65409829|NCT03453840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65409830|NCT03439254|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
65409831|NCT03439254|Cathartics|cathartics|mesh-ancestor
65409832|NCT03439254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65409833|NCT03405792|Pembrolizumab|pembrolizumab|mesh-list
65409834|NCT03405792|Temozolomide|temozolomide|mesh-list
65409835|NCT03405792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65409836|NCT03405792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409837|NCT03405792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65409838|NCT03405792|Alkylating Agents|alkylating agents|mesh-ancestor
65409839|NCT03405792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409840|NCT03709446|Leflunomide|leflunomide|mesh-list
65409841|NCT03709446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409842|NCT03709446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409843|NCT03709446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65409844|NCT03709446|Immunologic Factors|immunologic factors|mesh-ancestor
65409845|NCT03709446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409846|NCT05354700|Carboplatin|carboplatin|mesh-list
65409847|NCT05354700|Etoposide|etoposide|mesh-list
65409848|NCT05354700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409849|NCT05354700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65409850|NCT05354700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65409851|NCT05354700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65409852|NCT05354700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409853|NCT05354700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409854|NCT03339258|Doxazosin|doxazosin|mesh-list
65409855|NCT03339258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65409856|NCT03339258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65409857|NCT03339258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65409858|NCT03339258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65409859|NCT03339258|Adrenergic Agents|adrenergic agents|mesh-ancestor
65409860|NCT03339258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65409861|NCT03339258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269892|NCT02732132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65232624|NCT00631124|Estradiol|estradiol|mesh-list
65409862|NCT03339258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409863|NCT00992706|Doxorubicin|doxorubicin|mesh-list
65409864|NCT00992706|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65409865|NCT00992706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65409866|NCT00992706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409867|NCT00992706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65409868|NCT00992706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65409869|NCT00992706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409870|NCT00992706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409871|NCT00454779|Cisplatin|cisplatin|mesh-list
65409878|NCT00454779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409879|NCT00454779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65409881|NCT00992862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65409882|NCT00992862|Protease Inhibitors|protease inhibitors|mesh-ancestor
65409883|NCT00992862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409884|NCT00992862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409885|NCT00992862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65409886|NCT00993096|Insulin|insulin|mesh-list
65409887|NCT00993096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65409888|NCT00993096|Insulin Aspart|insulin aspart|mesh-list
65409889|NCT00993096|Insulin, Long-Acting|insulin, long-acting|mesh-list
65409890|NCT00993096|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65409891|NCT00993096|Biphasic Insulins|biphasic insulins|mesh-list
65409892|NCT00993096|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65409893|NCT00993096|Insulin, Isophane|insulin, isophane|mesh-list
65409894|NCT00993096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65409895|NCT00993096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409896|NCT00439569|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
65409897|NCT00439569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409898|NCT03185208|Lithium Carbonate|lithium carbonate|mesh-list
65409899|NCT03185208|Antidepressive Agents|antidepressive agents|mesh-ancestor
65409900|NCT03185208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65409901|NCT03185208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409902|NCT03185208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409903|NCT03185208|Antimanic Agents|antimanic agents|mesh-ancestor
65409904|NCT03185208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65409905|NCT03185208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65409906|NCT03185208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409907|NCT01567800|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
65409908|NCT01567800|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65409909|NCT01567800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409910|NCT00993408|Selexipag|selexipag|mesh-list
65409911|NCT00993408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65409913|NCT03994107|Doxorubicin|doxorubicin|mesh-list
65409914|NCT03994107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65409915|NCT03994107|Trastuzumab|trastuzumab|mesh-list
65409916|NCT03994107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65409917|NCT03994107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65409918|NCT03994107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409919|NCT03994107|Tubulin Modulators|tubulin modulators|mesh-ancestor
65409920|NCT03994107|Antimitotic Agents|antimitotic agents|mesh-ancestor
65409921|NCT03994107|Mitosis Modulators|mitosis modulators|mesh-ancestor
65409922|NCT03994107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409923|NCT03994107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65409924|NCT03994107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65409925|NCT03994107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65409926|NCT03994107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409927|NCT03994107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65409928|NCT03469713|Nivolumab|nivolumab|mesh-list
65409929|NCT03469713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65409930|NCT03469713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409931|NCT03469713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65409932|NCT03469713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409933|NCT00427635|Esomeprazole|esomeprazole|mesh-list
65409934|NCT00427635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65409935|NCT00427635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65409936|NCT00427635|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65409937|NCT00427635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409938|NCT00427635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232698|NCT00694369|Narcotics|narcotics|mesh-ancestor
65409939|NCT00993642|Panobinostat|panobinostat|mesh-list
65409940|NCT00993642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409951|NCT01028547|Glucocorticoids|glucocorticoids|mesh-ancestor
65409952|NCT01028547|Hormones|hormones|mesh-ancestor
65409953|NCT01028547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65409954|NCT01028547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65409955|NCT01028547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409956|NCT01031355|Calcium, Dietary|calcium, dietary|mesh-list
65409957|NCT01031355|Tetrahydrofolates|tetrahydrofolates|mesh-list
65409958|NCT01031355|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65409959|NCT01031355|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65409960|NCT01031355|Calcium|calcium|mesh-list
65409961|NCT01031355|Estradiol|estradiol|mesh-list
65409962|NCT01031355|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65409963|NCT01031355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65409964|NCT01031355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409965|NCT01031355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65409966|NCT01031355|Estrogens|estrogens|mesh-ancestor
65409967|NCT01031355|Hormones|hormones|mesh-ancestor
65409968|NCT01031355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65409969|NCT01031355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65409970|NCT01031355|Contraceptive Agents|contraceptive agents|mesh-ancestor
65409971|NCT01031355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65409972|NCT01031355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65409973|NCT01031355|Vitamin B Complex|vitamin b complex|mesh-ancestor
65409974|NCT01031355|Vitamins|vitamins|mesh-ancestor
65409975|NCT01031355|Micronutrients|micronutrients|mesh-ancestor
65409976|NCT00993720|Liraglutide|liraglutide|mesh-list
65409977|NCT00993720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65409978|NCT00993720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409979|NCT00993720|Incretins|incretins|mesh-ancestor
65409980|NCT00993720|Hormones|hormones|mesh-ancestor
65409981|NCT00993720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65409982|NCT03891264|Cannabidiol|cannabidiol|mesh-list
65409983|NCT03891264|Anticonvulsants|anticonvulsants|mesh-ancestor
65409984|NCT00425607|Lonafarnib|lonafarnib|mesh-list
65409985|NCT00425607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159488|NCT00633373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65409986|NCT00425607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409987|NCT00437073|Capecitabine|capecitabine|mesh-list
65409988|NCT00437073|Topotecan|topotecan|mesh-list
65409989|NCT00437073|Lapatinib|lapatinib|mesh-list
65409990|NCT00437073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65409991|NCT00437073|Antimetabolites|antimetabolites|mesh-ancestor
65409992|NCT00437073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409993|NCT00437073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409994|NCT00437073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65409995|NCT00437073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65409996|NCT00437073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409997|NCT00437073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65409998|NCT00425373|Amlodipine|amlodipine|mesh-list
65409999|NCT00425373|Valsartan|valsartan|mesh-list
65410000|NCT00425373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65410001|NCT00425373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65410002|NCT00425373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65410003|NCT00425373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794753|NCT02243436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65410010|NCT01031589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65410011|NCT01031589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65410013|NCT01031589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410014|NCT01031589|Antiviral Agents|antiviral agents|mesh-ancestor
65410015|NCT01031589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65410016|NCT01031589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65410017|NCT01031589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65410018|NCT03894540|Paclitaxel|paclitaxel|mesh-list
65410019|NCT03894540|Pembrolizumab|pembrolizumab|mesh-list
65410020|NCT03894540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65410021|NCT03894540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410022|NCT03894540|Tubulin Modulators|tubulin modulators|mesh-ancestor
65410023|NCT03894540|Antimitotic Agents|antimitotic agents|mesh-ancestor
65410024|NCT03894540|Mitosis Modulators|mitosis modulators|mesh-ancestor
65410025|NCT03894540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410026|NCT03894540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65410027|NCT00993876|Citalopram|citalopram|mesh-list
65232770|NCT00954512|Antidotes|antidotes|mesh-ancestor
65410028|NCT00993876|Reboxetine|reboxetine|mesh-list
65410029|NCT00993876|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65410030|NCT00993876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65410031|NCT00993876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65410032|NCT00993876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410033|NCT00993876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65410034|NCT00993876|Serotonin Agents|serotonin agents|mesh-ancestor
65410035|NCT00993876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410036|NCT00993876|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65410037|NCT00993876|Antidepressive Agents|antidepressive agents|mesh-ancestor
65410038|NCT00993876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65410039|NCT00993876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65410040|NCT00993876|Adrenergic Agents|adrenergic agents|mesh-ancestor
65410041|NCT05129358|Furosemide|furosemide|mesh-list
65410042|NCT05129358|Diuretics|diuretics|mesh-ancestor
65410043|NCT05129358|Natriuretic Agents|natriuretic agents|mesh-ancestor
65410044|NCT05129358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410045|NCT05129358|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65410046|NCT05129358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65410047|NCT05129358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410048|NCT01646814|Aspirin|aspirin|mesh-list
65410049|NCT01646814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65410050|NCT01646814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65410051|NCT01646814|Analgesics|analgesics|mesh-ancestor
65410052|NCT01646814|Sensory System Agents|sensory system agents|mesh-ancestor
65410053|NCT01646814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65410054|NCT01646814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410055|NCT01646814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65410056|NCT01646814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65410057|NCT01646814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65410058|NCT01646814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65410059|NCT01646814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410060|NCT01646814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65410061|NCT01646814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65410062|NCT01646814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410063|NCT01646814|Antipyretics|antipyretics|mesh-ancestor
65410064|NCT00994344|Ritonavir|ritonavir|mesh-list
65410065|NCT00994344|Lopinavir|lopinavir|mesh-list
65410066|NCT00994344|Darunavir|darunavir|mesh-list
65410067|NCT00994344|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65410068|NCT00994344|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65410069|NCT00994344|Protease Inhibitors|protease inhibitors|mesh-ancestor
65410077|NCT00994344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65410079|NCT00994500|Vorinostat|vorinostat|mesh-list
65410080|NCT00994500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410081|NCT00994500|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65410082|NCT00994500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410083|NCT00994500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410084|NCT01416636|Treprostinil|treprostinil|mesh-list
65410085|NCT01416636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65410086|NCT00999180|Botulinum Toxins|botulinum toxins|mesh-list
65410087|NCT00999180|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65410088|NCT00999180|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65410089|NCT00999180|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65410090|NCT00999180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65410091|NCT00999180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410092|NCT00999180|Cholinergic Agents|cholinergic agents|mesh-ancestor
65410093|NCT00999180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65410094|NCT00999180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410095|NCT00999180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65410096|NCT00999180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65410097|NCT05280132|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65410098|NCT05280132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65410099|NCT05280132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65410100|NCT05280132|Antitubercular Agents|antitubercular agents|mesh-ancestor
65410101|NCT00999258|Sirolimus|sirolimus|mesh-list
65410102|NCT00999258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65410103|NCT00999258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65410104|NCT00999258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65410105|NCT00999258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410106|NCT00999258|Antifungal Agents|antifungal agents|mesh-ancestor
65410107|NCT00999258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65410108|NCT00999258|Immunologic Factors|immunologic factors|mesh-ancestor
65410109|NCT00999258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410110|NCT00994734|Mifepristone|mifepristone|mesh-list
65410111|NCT00994734|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65410112|NCT00994734|Abortifacient Agents|abortifacient agents|mesh-ancestor
65410113|NCT00994734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65410114|NCT00994734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410115|NCT00994734|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65410116|NCT00994734|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65410117|NCT00994734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65410118|NCT00994734|Contraceptive Agents|contraceptive agents|mesh-ancestor
65410119|NCT00994734|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65410120|NCT00994734|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65410121|NCT00994734|Hormone Antagonists|hormone antagonists|mesh-ancestor
65410122|NCT00994734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65410123|NCT00994734|Luteolytic Agents|luteolytic agents|mesh-ancestor
65410124|NCT00994734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65410125|NCT00994734|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65410126|NCT00999336|Betrixaban|betrixaban|mesh-list
65410127|NCT00999336|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65410128|NCT00999336|Antithrombins|antithrombins|mesh-ancestor
65410129|NCT00999336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65410130|NCT00999336|Protease Inhibitors|protease inhibitors|mesh-ancestor
65410131|NCT00999336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410132|NCT00999336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410133|NCT00999336|Anticoagulants|anticoagulants|mesh-ancestor
65410134|NCT00995826|Laninamivir|laninamivir|mesh-list
65410135|NCT00995826|Antiviral Agents|antiviral agents|mesh-ancestor
65410143|NCT00994968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65410145|NCT00994968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65410146|NCT00994968|Immunologic Factors|immunologic factors|mesh-ancestor
65410147|NCT00994968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410148|NCT00994968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65410149|NCT00994968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65410150|NCT00994968|Alkylating Agents|alkylating agents|mesh-ancestor
65410151|NCT00994968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410152|NCT00994968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410153|NCT00994968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65410154|NCT00994968|Tubulin Modulators|tubulin modulators|mesh-ancestor
65410155|NCT00994968|Antimitotic Agents|antimitotic agents|mesh-ancestor
65410156|NCT00994968|Mitosis Modulators|mitosis modulators|mesh-ancestor
65410157|NCT00994968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65410158|NCT00994968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65410159|NCT00994968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65410160|NCT00994968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410161|NCT00994968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65410162|NCT00994968|Antimetabolites|antimetabolites|mesh-ancestor
65410163|NCT03887442|Paclitaxel|paclitaxel|mesh-list
65410164|NCT03887442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65410165|NCT03887442|Cetuximab|cetuximab|mesh-list
65410166|NCT03887442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65410167|NCT03887442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410168|NCT03887442|Tubulin Modulators|tubulin modulators|mesh-ancestor
65410169|NCT03887442|Antimitotic Agents|antimitotic agents|mesh-ancestor
65410170|NCT03887442|Mitosis Modulators|mitosis modulators|mesh-ancestor
65410171|NCT03887442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410172|NCT03887442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65410173|NCT00996060|Hydralazine|hydralazine|mesh-list
65410174|NCT00996060|Valproic Acid|valproic acid|mesh-list
65410175|NCT00996060|Anticonvulsants|anticonvulsants|mesh-ancestor
65410176|NCT00996060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410177|NCT00996060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410178|NCT00996060|GABA Agents|gaba agents|mesh-ancestor
65410179|NCT00996060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65410180|NCT00996060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410181|NCT00996060|Antimanic Agents|antimanic agents|mesh-ancestor
65410182|NCT00996060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65410183|NCT00996060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65410184|NCT00996060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65410185|NCT00996060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65410186|NCT00996060|Vasodilator Agents|vasodilator agents|mesh-ancestor
65410187|NCT00995046|Factor VIII|factor viii|mesh-list
65410188|NCT00995046|Coagulants|coagulants|mesh-ancestor
65410189|NCT00995124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65232919|NCT00949910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410190|NCT04000932|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
65410191|NCT04000932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65410192|NCT04000932|Glucocorticoids|glucocorticoids|mesh-ancestor
65410193|NCT04000932|Hormones|hormones|mesh-ancestor
65410194|NCT04000932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65410195|NCT04000932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410196|NCT05170230|Terlipressin|terlipressin|mesh-list
65410197|NCT05170230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65410198|NCT05170230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65410199|NCT01000116|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65410200|NCT01000116|Hemostatics|hemostatics|mesh-ancestor
65410201|NCT01000116|Coagulants|coagulants|mesh-ancestor
65410202|NCT00996684|Plasminogen|plasminogen|mesh-list
65410203|NCT00996684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65410204|NCT00996684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64794951|NCT02249130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65410214|NCT05162196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410215|NCT05162196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410216|NCT00997074|Ibuprofen|ibuprofen|mesh-list
65410217|NCT00997074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65410218|NCT00997074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65410219|NCT00997074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65410220|NCT00997074|Analgesics|analgesics|mesh-ancestor
65410221|NCT00997074|Sensory System Agents|sensory system agents|mesh-ancestor
65410222|NCT00997074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65410223|NCT00997074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410224|NCT00997074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65410225|NCT00997074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65410226|NCT00997074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410227|NCT00997074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410228|NCT05249712|Androgens|androgens|mesh-list
65410229|NCT05249712|Hormones|hormones|mesh-ancestor
65410230|NCT05249712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65410231|NCT05249712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410232|NCT01000896|Paclitaxel|paclitaxel|mesh-list
65410233|NCT01000896|Carboplatin|carboplatin|mesh-list
65410234|NCT01000896|Saracatinib|saracatinib|mesh-list
65410235|NCT01000896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65410236|NCT01000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410237|NCT01000896|Tubulin Modulators|tubulin modulators|mesh-ancestor
65410238|NCT01000896|Antimitotic Agents|antimitotic agents|mesh-ancestor
65410239|NCT01000896|Mitosis Modulators|mitosis modulators|mesh-ancestor
65410240|NCT01000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410241|NCT01000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410242|NCT00997542|Allopurinol|allopurinol|mesh-list
65410243|NCT00997542|Antimetabolites|antimetabolites|mesh-ancestor
65410244|NCT00997542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410245|NCT00997542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410246|NCT00997542|Gout Suppressants|gout suppressants|mesh-ancestor
65410247|NCT00997542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65410248|NCT00997542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65410249|NCT00997542|Antioxidants|antioxidants|mesh-ancestor
65410250|NCT00997542|Protective Agents|protective agents|mesh-ancestor
65410251|NCT00997542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410252|NCT01001130|Fluticasone|fluticasone|mesh-list
65410253|NCT01001130|Xhance|xhance|mesh-list
65410254|NCT01001130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65410255|NCT01001130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65410256|NCT01001130|Autonomic Agents|autonomic agents|mesh-ancestor
65410257|NCT01001130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65410258|NCT01001130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410259|NCT01001130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65410260|NCT01001130|Respiratory System Agents|respiratory system agents|mesh-ancestor
65410261|NCT01001130|Dermatologic Agents|dermatologic agents|mesh-ancestor
65410262|NCT01001130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65410263|NCT00424827|Gemcitabine|gemcitabine|mesh-list
65410264|NCT00424827|Fluorouracil|fluorouracil|mesh-list
65410265|NCT00424827|Cetuximab|cetuximab|mesh-list
65410266|NCT00424827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65410267|NCT00424827|Antimetabolites|antimetabolites|mesh-ancestor
65410268|NCT00424827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410269|NCT00424827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410270|NCT00424827|Antiviral Agents|antiviral agents|mesh-ancestor
64795018|NCT02245308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65410279|NCT01001364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65410280|NCT01001364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65410282|NCT01001364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65410283|NCT01001364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410284|NCT01001364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65410285|NCT01001364|Respiratory System Agents|respiratory system agents|mesh-ancestor
65410286|NCT01001364|Glucocorticoids|glucocorticoids|mesh-ancestor
65410288|NCT01001364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65410289|NCT01001364|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65410290|NCT01001364|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65410291|NCT01001364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65410292|NCT01001364|Adrenergic Agents|adrenergic agents|mesh-ancestor
65410293|NCT01001364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65410294|NCT01001364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410295|NCT01031667|Cilostazol|cilostazol|mesh-list
65410296|NCT01031667|Probucol|probucol|mesh-list
65410297|NCT01031667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65410298|NCT01031667|Autonomic Agents|autonomic agents|mesh-ancestor
65410299|NCT01031667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65410300|NCT01031667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410301|NCT01031667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65410302|NCT01031667|Respiratory System Agents|respiratory system agents|mesh-ancestor
65410303|NCT01031667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65410304|NCT01031667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65410305|NCT01031667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410306|NCT01031667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65410307|NCT01031667|Vasodilator Agents|vasodilator agents|mesh-ancestor
65410308|NCT01031667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65410309|NCT01031667|Protective Agents|protective agents|mesh-ancestor
65410310|NCT01031667|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65410311|NCT01031667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65410312|NCT01031667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410313|NCT01031667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65410314|NCT01031667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65410315|NCT01031667|Antimetabolites|antimetabolites|mesh-ancestor
65410316|NCT01031667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65410317|NCT01031667|Antioxidants|antioxidants|mesh-ancestor
65410318|NCT03995277|Biotin|biotin|mesh-list
65410319|NCT03995277|Vitamin B Complex|vitamin b complex|mesh-ancestor
65410320|NCT03995277|Vitamins|vitamins|mesh-ancestor
65410321|NCT03995277|Micronutrients|micronutrients|mesh-ancestor
65410322|NCT03995277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410323|NCT04000386|Zinc Oxide|zinc oxide|mesh-list
65410324|NCT04000386|Dermatologic Agents|dermatologic agents|mesh-ancestor
65410325|NCT04000386|Sunscreening Agents|sunscreening agents|mesh-ancestor
65410326|NCT04000386|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65410327|NCT04000386|Protective Agents|protective agents|mesh-ancestor
65410328|NCT04000386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410329|NCT02919969|Pembrolizumab|pembrolizumab|mesh-list
65410330|NCT02919969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65410331|NCT02919969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410332|NCT00998088|Epoetin Alfa|epoetin alfa|mesh-list
65410333|NCT00998088|Hematinics|hematinics|mesh-ancestor
65410334|NCT00377962|Mycophenolic Acid|mycophenolic acid|mesh-list
65410335|NCT00377962|Everolimus|everolimus|mesh-list
65410336|NCT00377962|Azathioprine|azathioprine|mesh-list
65410337|NCT00377962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
65410338|NCT00377962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410339|NCT00377962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65410346|NCT00377962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65410347|NCT00377962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65410348|NCT00377962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65410349|NCT00377962|Antitubercular Agents|antitubercular agents|mesh-ancestor
65410350|NCT00377962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65410351|NCT00377962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65410352|NCT00424749|Prednisone|prednisone|mesh-list
65410353|NCT00424749|Rituximab|rituximab|mesh-list
65410354|NCT00424749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65410355|NCT00424749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410356|NCT00424749|Immunologic Factors|immunologic factors|mesh-ancestor
65410357|NCT00424749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410358|NCT00424749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65410359|NCT00424749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65410360|NCT00424749|Glucocorticoids|glucocorticoids|mesh-ancestor
65410361|NCT00424749|Hormones|hormones|mesh-ancestor
65410362|NCT00424749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65410363|NCT00424749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65410364|NCT00424593|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65410365|NCT00424593|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65410366|NCT00424593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65410367|NCT00424593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65410368|NCT00424593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410369|NCT00424593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65410370|NCT00424593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410372|NCT00424593|Sensory System Agents|sensory system agents|mesh-ancestor
65410373|NCT00424593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65410374|NCT00424593|Antidepressive Agents|antidepressive agents|mesh-ancestor
65410375|NCT00424593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65410376|NCT00424593|Dopamine Agents|dopamine agents|mesh-ancestor
65410377|NCT00369382|Cyclosporine|cyclosporine|mesh-list
65410378|NCT00369382|Sirolimus|sirolimus|mesh-list
65410379|NCT00369382|Tacrolimus|tacrolimus|mesh-list
65410380|NCT00369382|Cyclosporins|cyclosporins|mesh-list
65410381|NCT00369382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65410382|NCT00369382|Immunologic Factors|immunologic factors|mesh-ancestor
65410383|NCT00369382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410384|NCT00369382|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65410385|NCT00369382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410386|NCT00369382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410387|NCT00369382|Antifungal Agents|antifungal agents|mesh-ancestor
65410388|NCT00369382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65410389|NCT00369382|Dermatologic Agents|dermatologic agents|mesh-ancestor
65410390|NCT00369382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65410391|NCT00369382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65410392|NCT00369382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65410393|NCT00369382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410394|NCT00424515|Imatinib Mesylate|imatinib mesylate|mesh-list
65410395|NCT00424515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410396|NCT00424515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65410397|NCT00424515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410398|NCT00424515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410399|NCT05131204|Eculizumab|eculizumab|mesh-list
65410400|NCT05131204|Ravulizumab|ravulizumab|mesh-list
65410401|NCT05131204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65410402|NCT05131204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65410403|NCT05131204|Immunologic Factors|immunologic factors|mesh-ancestor
65410404|NCT05131204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410405|NCT00377260|Amoxicillin|amoxicillin|mesh-list
65410406|NCT00377260|Clavulanic Acid|clavulanic acid|mesh-list
65410407|NCT00377260|Clavulanic Acids|clavulanic acids|mesh-list
65410408|NCT00377260|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65410414|NCT00441441|Fluticasone|fluticasone|mesh-list
65410415|NCT00441441|Xhance|xhance|mesh-list
65410416|NCT00441441|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65410417|NCT00441441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65410418|NCT00441441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65410419|NCT00441441|Autonomic Agents|autonomic agents|mesh-ancestor
65410420|NCT00441441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65410421|NCT00441441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410422|NCT00441441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65410423|NCT00441441|Respiratory System Agents|respiratory system agents|mesh-ancestor
65410424|NCT00441441|Dermatologic Agents|dermatologic agents|mesh-ancestor
65410425|NCT00441441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65410426|NCT00441441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65410427|NCT00441441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65410428|NCT00441441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65410429|NCT00441441|Adrenergic Agents|adrenergic agents|mesh-ancestor
65410430|NCT00441441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65410431|NCT00441441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410432|NCT00436917|Zoledronic Acid|zoledronic acid|mesh-list
65410433|NCT00436917|Letrozole|letrozole|mesh-list
65410434|NCT00436917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410435|NCT00436917|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65410436|NCT00436917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65410437|NCT00436917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410438|NCT00436917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410439|NCT00436917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65410440|NCT00436917|Hormone Antagonists|hormone antagonists|mesh-ancestor
65410441|NCT00436917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65410442|NCT00436917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233141|NCT00736450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410443|NCT00436917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65410444|NCT00436605|Dasatinib|dasatinib|mesh-list
65410445|NCT00436605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410446|NCT00436605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65410447|NCT00436605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410448|NCT00436605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410449|NCT01034787|Tremelimumab|tremelimumab|mesh-list
65410450|NCT01034787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410451|NCT01028781|Thalidomide|thalidomide|mesh-list
65410452|NCT01028781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65410453|NCT01028781|Immunologic Factors|immunologic factors|mesh-ancestor
65410454|NCT01028781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410455|NCT01028781|Leprostatic Agents|leprostatic agents|mesh-ancestor
65410456|NCT01028781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65410457|NCT01028781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65410458|NCT01028781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65410459|NCT01028781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65410460|NCT01028781|Growth Substances|growth substances|mesh-ancestor
65410461|NCT01028781|Growth Inhibitors|growth inhibitors|mesh-ancestor
65410462|NCT01028781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410463|NCT01031901|Sirolimus|sirolimus|mesh-list
65410464|NCT01031901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65410465|NCT01031901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65410466|NCT01031901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65410467|NCT01031901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410468|NCT01031901|Antifungal Agents|antifungal agents|mesh-ancestor
65410469|NCT01031901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65410470|NCT01031901|Immunologic Factors|immunologic factors|mesh-ancestor
65410471|NCT01031901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410472|NCT00368992|Paclitaxel|paclitaxel|mesh-list
65410473|NCT00368992|Bevacizumab|bevacizumab|mesh-list
65410474|NCT00368992|Cetuximab|cetuximab|mesh-list
65410475|NCT00368992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65410476|NCT00368992|Antibodies|antibodies|mesh-list
65410477|NCT00368992|Immunoglobulins|immunoglobulins|mesh-list
65410478|NCT00368992|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65410494|NCT00376246|Antimetabolites|antimetabolites|mesh-ancestor
65410495|NCT00376246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410496|NCT00376246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65410497|NCT01050088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65410498|NCT00375934|Diclofenac|diclofenac|mesh-list
65410499|NCT00375934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65410500|NCT00375934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65410501|NCT00375934|Analgesics|analgesics|mesh-ancestor
65410502|NCT00375934|Sensory System Agents|sensory system agents|mesh-ancestor
65410503|NCT00375934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65410504|NCT00375934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410505|NCT00375934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65410506|NCT00375934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65410507|NCT00375934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65410508|NCT00375934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410509|NCT00375934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410510|NCT01052584|Chloroquine|chloroquine|mesh-list
65410511|NCT01052584|Lumefantrine|lumefantrine|mesh-list
65410512|NCT01052584|Artemether|artemether|mesh-list
65410513|NCT01052584|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65410514|NCT01052584|Amebicides|amebicides|mesh-ancestor
65410515|NCT01052584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65410516|NCT01052584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65410517|NCT01052584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65410518|NCT01052584|Antimalarials|antimalarials|mesh-ancestor
65410519|NCT01052584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65410520|NCT02534506|Nivolumab|nivolumab|mesh-list
65410521|NCT02534506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65410522|NCT02534506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410523|NCT02534506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65410524|NCT02534506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410525|NCT01050322|Gemcitabine|gemcitabine|mesh-list
65410526|NCT01050322|Capecitabine|capecitabine|mesh-list
65410527|NCT01050322|Vinorelbine|vinorelbine|mesh-list
65410528|NCT01050322|Lapatinib|lapatinib|mesh-list
65410529|NCT01050322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65410530|NCT01050322|Antimetabolites|antimetabolites|mesh-ancestor
65410531|NCT01050322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410532|NCT01050322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410533|NCT01050322|Antiviral Agents|antiviral agents|mesh-ancestor
65410534|NCT01050322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65410535|NCT01050322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410536|NCT01050322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65410537|NCT01050322|Immunologic Factors|immunologic factors|mesh-ancestor
65410538|NCT01050322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410548|NCT00531960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65410549|NCT00531960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65410550|NCT00531960|Growth Substances|growth substances|mesh-ancestor
65410551|NCT00531960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410552|NCT00531960|Growth Inhibitors|growth inhibitors|mesh-ancestor
65410553|NCT00531960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65410554|NCT00531960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410555|NCT00531960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410556|NCT01001676|Paclitaxel|paclitaxel|mesh-list
65410557|NCT01001676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65410558|NCT01001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410559|NCT01001676|Tubulin Modulators|tubulin modulators|mesh-ancestor
65410560|NCT01001676|Antimitotic Agents|antimitotic agents|mesh-ancestor
65410561|NCT01001676|Mitosis Modulators|mitosis modulators|mesh-ancestor
65410562|NCT01001676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410563|NCT00816959|Bleomycin|bleomycin|mesh-list
65410564|NCT00816959|Dacarbazine|dacarbazine|mesh-list
65410565|NCT00816959|Vinblastine|vinblastine|mesh-list
65410566|NCT00816959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65410567|NCT00816959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410568|NCT00816959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410569|NCT00816959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65410570|NCT00816959|Alkylating Agents|alkylating agents|mesh-ancestor
65410571|NCT00816959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65410572|NCT00816959|Tubulin Modulators|tubulin modulators|mesh-ancestor
65410573|NCT00816959|Antimitotic Agents|antimitotic agents|mesh-ancestor
65410574|NCT00816959|Mitosis Modulators|mitosis modulators|mesh-ancestor
65410575|NCT01001754|Ribavirin|ribavirin|mesh-list
65410576|NCT01001754|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65410577|NCT01001754|Antimetabolites|antimetabolites|mesh-ancestor
65410578|NCT01001754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410579|NCT01001754|Antiviral Agents|antiviral agents|mesh-ancestor
65410580|NCT01001754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65410581|NCT00825851|Nicotine|nicotine|mesh-list
65410582|NCT00825851|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65410583|NCT00825851|Autonomic Agents|autonomic agents|mesh-ancestor
65410584|NCT00825851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65410585|NCT00825851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410586|NCT00825851|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65410587|NCT00825851|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65410588|NCT00825851|Cholinergic Agents|cholinergic agents|mesh-ancestor
65410589|NCT00825851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65410590|NCT00825851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410591|NCT00361504|Oxycodone|oxycodone|mesh-list
65410592|NCT00361504|Tapentadol|tapentadol|mesh-list
65410593|NCT00361504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65410594|NCT00361504|Narcotics|narcotics|mesh-ancestor
65410595|NCT00361504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65410596|NCT00361504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410597|NCT00361504|Analgesics|analgesics|mesh-ancestor
65410598|NCT00361504|Sensory System Agents|sensory system agents|mesh-ancestor
65410599|NCT00361504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65410600|NCT00361504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65410601|NCT00361504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65410602|NCT00361504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65410603|NCT00361504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410610|NCT00361270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410611|NCT00826163|Budesonide|budesonide|mesh-list
65410612|NCT00826163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65410613|NCT00826163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65410614|NCT00826163|Autonomic Agents|autonomic agents|mesh-ancestor
65410615|NCT00826163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65410616|NCT00826163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410617|NCT00826163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65410618|NCT00826163|Respiratory System Agents|respiratory system agents|mesh-ancestor
65410619|NCT00826163|Glucocorticoids|glucocorticoids|mesh-ancestor
65410620|NCT00826163|Hormones|hormones|mesh-ancestor
65410621|NCT00826163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65233303|NCT02563327|Pyridoxine|pyridoxine|mesh-list
65410622|NCT00998166|Bevacizumab|bevacizumab|mesh-list
65410623|NCT00998166|Pemetrexed|pemetrexed|mesh-list
65410624|NCT00998166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65410625|NCT00998166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410626|NCT00998166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65410627|NCT00998166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65410628|NCT00998166|Growth Substances|growth substances|mesh-ancestor
65410629|NCT00998166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410630|NCT00998166|Growth Inhibitors|growth inhibitors|mesh-ancestor
65410631|NCT00998166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410632|NCT00998166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410633|NCT00998166|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65410634|NCT00998166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65410635|NCT03990922|Morphine|morphine|mesh-list
65410636|NCT03990922|Ropivacaine|ropivacaine|mesh-list
65410637|NCT03990922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65410638|NCT03990922|Narcotics|narcotics|mesh-ancestor
65410639|NCT03990922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65410640|NCT03990922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410641|NCT03990922|Analgesics|analgesics|mesh-ancestor
65410642|NCT03990922|Sensory System Agents|sensory system agents|mesh-ancestor
65410643|NCT03990922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65410644|NCT03990922|Anesthetics, Local|anesthetics, local|mesh-ancestor
65410645|NCT03990922|Anesthetics|anesthetics|mesh-ancestor
65410646|NCT00822263|Acetylcysteine|acetylcysteine|mesh-list
65410647|NCT00822263|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65410648|NCT00822263|Antiviral Agents|antiviral agents|mesh-ancestor
65410649|NCT00822263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65410650|NCT00822263|Expectorants|expectorants|mesh-ancestor
65410651|NCT00822263|Respiratory System Agents|respiratory system agents|mesh-ancestor
65410652|NCT00822263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65410653|NCT00822263|Antioxidants|antioxidants|mesh-ancestor
65410654|NCT00822263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410655|NCT00822263|Protective Agents|protective agents|mesh-ancestor
65410656|NCT00822263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410657|NCT00822263|Antidotes|antidotes|mesh-ancestor
65410658|NCT03992170|Daratumumab|daratumumab|mesh-list
65410659|NCT03992170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410660|NCT00817037|Nifedipine|nifedipine|mesh-list
65410661|NCT00817037|Sitaxsentan|sitaxsentan|mesh-list
65410662|NCT00817037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65410663|NCT00817037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65410664|NCT00817037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410665|NCT00817037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65410666|NCT00817037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410667|NCT00817037|Vasodilator Agents|vasodilator agents|mesh-ancestor
65410668|NCT00817037|Tocolytic Agents|tocolytic agents|mesh-ancestor
65410669|NCT00817037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65410670|NCT00817037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65410671|NCT00998322|Gemcitabine|gemcitabine|mesh-list
65410672|NCT00998322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65410673|NCT00998322|Antimetabolites|antimetabolites|mesh-ancestor
65410678|NCT00998322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410679|NCT00998322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65410680|NCT00998322|Immunologic Factors|immunologic factors|mesh-ancestor
65410681|NCT00998322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410683|NCT00367744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65410684|NCT00367744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410685|NCT01002300|Oxytocin|oxytocin|mesh-list
65410686|NCT01002300|Oxytocics|oxytocics|mesh-ancestor
65410687|NCT01002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65410688|NCT01002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410689|NCT00822419|Lidocaine|lidocaine|mesh-list
65410690|NCT00822419|Ketamine|ketamine|mesh-list
65410691|NCT00822419|Anesthetics, Local|anesthetics, local|mesh-ancestor
65410692|NCT00822419|Anesthetics|anesthetics|mesh-ancestor
65410693|NCT00822419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65410694|NCT00822419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410695|NCT00822419|Sensory System Agents|sensory system agents|mesh-ancestor
65410696|NCT00822419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65410697|NCT00822419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65410698|NCT00822419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65410699|NCT00822419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65410700|NCT00822419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65233370|NCT00742339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65410701|NCT00822419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410702|NCT00822419|Analgesics|analgesics|mesh-ancestor
65410703|NCT00822419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65410704|NCT00822419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65410705|NCT00822419|Anesthetics, General|anesthetics, general|mesh-ancestor
65410706|NCT00822419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65410707|NCT00822419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65410708|NCT00822419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65410709|NCT01002534|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65410710|NCT01002534|Vasodilator Agents|vasodilator agents|mesh-ancestor
65410711|NCT01002534|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65410712|NCT01002534|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65410713|NCT01002534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410714|NCT01002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410715|NCT01002534|Urological Agents|urological agents|mesh-ancestor
65410716|NCT00817271|Glucagon|glucagon|mesh-list
65410717|NCT00817271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65410718|NCT00817271|Hormones|hormones|mesh-ancestor
65410719|NCT00817271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65410720|NCT00817271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410721|NCT01052896|Gabapentin|gabapentin|mesh-list
65410722|NCT01052896|Analgesics|analgesics|mesh-ancestor
65410723|NCT01052896|Sensory System Agents|sensory system agents|mesh-ancestor
65410724|NCT01052896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65410725|NCT01052896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410726|NCT01052896|Anticonvulsants|anticonvulsants|mesh-ancestor
65410727|NCT01052896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65410728|NCT01052896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65410729|NCT01052896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65410730|NCT01052896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65410731|NCT01052896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65410732|NCT01052896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65410733|NCT01052896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65410734|NCT01052896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160262|NCT00892099|Vitamin D|vitamin d|mesh-list
65410735|NCT01052896|Antimanic Agents|antimanic agents|mesh-ancestor
65410737|NCT01002690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65410738|NCT01002690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65410739|NCT01002690|Analgesics|analgesics|mesh-ancestor
65410740|NCT01002690|Sensory System Agents|sensory system agents|mesh-ancestor
65410741|NCT01002690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65410742|NCT01002690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410748|NCT01002690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410750|NCT01048684|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65410751|NCT01048684|Diuretics|diuretics|mesh-ancestor
65410752|NCT01048684|Natriuretic Agents|natriuretic agents|mesh-ancestor
65410753|NCT01048684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410754|NCT01002768|Insulin|insulin|mesh-list
65410755|NCT01002768|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65410756|NCT01002768|Insulin Glargine|insulin glargine|mesh-list
65410757|NCT01002768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65410758|NCT01002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410759|NCT01050478|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65410760|NCT01050478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65410761|NCT01050478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65410762|NCT01050478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65410763|NCT01050478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410764|NCT01050478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65410765|NCT01050478|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65410766|NCT01050478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65410767|NCT01050478|Serotonin Agents|serotonin agents|mesh-ancestor
65410768|NCT01050478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65410769|NCT01050478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410770|NCT01050478|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65410771|NCT01050478|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65410772|NCT01050478|Dopamine Agents|dopamine agents|mesh-ancestor
65410773|NCT00998556|Bromocriptine|bromocriptine|mesh-list
65410774|NCT00998556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65410775|NCT00998556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65410776|NCT00998556|Hormone Antagonists|hormone antagonists|mesh-ancestor
65410777|NCT00998556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65233446|NCT05411497|Alkylating Agents|alkylating agents|mesh-ancestor
65410778|NCT00998556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410779|NCT00998556|Dopamine Agonists|dopamine agonists|mesh-ancestor
65410780|NCT00998556|Dopamine Agents|dopamine agents|mesh-ancestor
65410781|NCT00998556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65410782|NCT00998556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410783|NCT01052974|Ropivacaine|ropivacaine|mesh-list
65410784|NCT01052974|Anesthetics, Local|anesthetics, local|mesh-ancestor
65410785|NCT01052974|Anesthetics|anesthetics|mesh-ancestor
65410786|NCT01052974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65410787|NCT01052974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410788|NCT01052974|Sensory System Agents|sensory system agents|mesh-ancestor
65410789|NCT01052974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65410790|NCT00998634|Lithium Carbonate|lithium carbonate|mesh-list
65410791|NCT00998634|Antidepressive Agents|antidepressive agents|mesh-ancestor
65410792|NCT00998634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65410793|NCT00998634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410794|NCT00998634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410795|NCT00998634|Antimanic Agents|antimanic agents|mesh-ancestor
65410796|NCT00998634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65410797|NCT00998634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65410798|NCT00998634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410799|NCT01003002|Levodopa|levodopa|mesh-list
65410800|NCT01003002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65410801|NCT01003002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65410802|NCT01003002|Dopamine Agents|dopamine agents|mesh-ancestor
65410803|NCT01003002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65410804|NCT01003002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410805|NCT01003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410806|NCT01003158|Paclitaxel|paclitaxel|mesh-list
65410807|NCT01003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65160320|NCT02832973|Sympatholytics|sympatholytics|mesh-ancestor
65410808|NCT01003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410809|NCT01003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
65410810|NCT01003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
65410816|NCT03883386|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65410817|NCT03883386|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65410818|NCT03883386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65410819|NCT03883386|Histamine Antagonists|histamine antagonists|mesh-ancestor
65410820|NCT03883386|Histamine Agents|histamine agents|mesh-ancestor
65410821|NCT03883386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65410822|NCT03883386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410823|NCT03883386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410824|NCT00530946|Amlodipine|amlodipine|mesh-list
65410825|NCT00530946|Atorvastatin|atorvastatin|mesh-list
65410826|NCT00530946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65410827|NCT00530946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65410828|NCT00530946|Antimetabolites|antimetabolites|mesh-ancestor
65410829|NCT00530946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410830|NCT00530946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65410831|NCT00530946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65410832|NCT00530946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410833|NCT00530946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65410834|NCT00530946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65410835|NCT00530946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65410836|NCT00530946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65410837|NCT00530946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410838|NCT00530946|Vasodilator Agents|vasodilator agents|mesh-ancestor
65410839|NCT00424047|Dexamethasone|dexamethasone|mesh-list
65410840|NCT00424047|Dexamethasone acetate|dexamethasone acetate|mesh-list
65410841|NCT00424047|Lenalidomide|lenalidomide|mesh-list
65410842|NCT00424047|BB 1101|bb 1101|mesh-list
65410843|NCT00424047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65410844|NCT00424047|Antiemetics|antiemetics|mesh-ancestor
65410845|NCT00424047|Autonomic Agents|autonomic agents|mesh-ancestor
65410846|NCT00424047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65410847|NCT00424047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410848|NCT00424047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65410849|NCT00424047|Glucocorticoids|glucocorticoids|mesh-ancestor
65410850|NCT00424047|Hormones|hormones|mesh-ancestor
65410851|NCT00424047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65410852|NCT00424047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65410853|NCT00424047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233522|NCT00687973|Vasodilator Agents|vasodilator agents|mesh-ancestor
65410854|NCT00424047|Protease Inhibitors|protease inhibitors|mesh-ancestor
65410855|NCT00424047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410856|NCT00424047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410857|NCT00424047|Immunologic Factors|immunologic factors|mesh-ancestor
65410858|NCT00424047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65410859|NCT00424047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65410860|NCT00424047|Growth Substances|growth substances|mesh-ancestor
65410861|NCT00424047|Growth Inhibitors|growth inhibitors|mesh-ancestor
65410862|NCT00530790|Ropinirole|ropinirole|mesh-list
65410863|NCT00530790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65410864|NCT00530790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65410865|NCT00530790|Dopamine Agonists|dopamine agonists|mesh-ancestor
65410866|NCT00530790|Dopamine Agents|dopamine agents|mesh-ancestor
65410867|NCT00530790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65410868|NCT00530790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410869|NCT00530790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410870|NCT01032057|Gemcitabine|gemcitabine|mesh-list
65410871|NCT01032057|Capecitabine|capecitabine|mesh-list
65410872|NCT01032057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65410873|NCT01032057|Antimetabolites|antimetabolites|mesh-ancestor
65410874|NCT01032057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410875|NCT01032057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410876|NCT01032057|Antiviral Agents|antiviral agents|mesh-ancestor
65410877|NCT01032057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65410878|NCT01032057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410879|NCT01032057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64564200|NCT03292861|Sirolimus|sirolimus|mesh-list
65410899|NCT01006668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65410900|NCT00360568|Levodopa|levodopa|mesh-list
65410901|NCT00360568|Carbidopa|carbidopa|mesh-list
65410902|NCT00360568|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65410903|NCT00360568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65410904|NCT00360568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65410905|NCT00360568|Dopamine Agents|dopamine agents|mesh-ancestor
65410906|NCT00360568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65410907|NCT00360568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410908|NCT00360568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410909|NCT00360568|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65410910|NCT00360568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410911|NCT00360568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65410912|NCT00360568|Immunologic Factors|immunologic factors|mesh-ancestor
65410913|NCT00360568|Dopamine Agonists|dopamine agonists|mesh-ancestor
65410914|NCT00436215|Bevacizumab|bevacizumab|mesh-list
65410915|NCT00436215|Sorafenib|sorafenib|mesh-list
65410916|NCT00436215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65410917|NCT00436215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410918|NCT00436215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65410919|NCT00436215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65410920|NCT00436215|Growth Substances|growth substances|mesh-ancestor
65410921|NCT00436215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410922|NCT00436215|Growth Inhibitors|growth inhibitors|mesh-ancestor
65410923|NCT00436215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65410924|NCT00436215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410925|NCT00436215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410926|NCT05734248|Hyaluronic Acid|hyaluronic acid|mesh-list
65410927|NCT05734248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65410928|NCT05734248|Immunologic Factors|immunologic factors|mesh-ancestor
65410929|NCT05734248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410930|NCT05734248|Viscosupplements|viscosupplements|mesh-ancestor
65410931|NCT05734248|Protective Agents|protective agents|mesh-ancestor
65410932|NCT00441363|Bromocriptine|bromocriptine|mesh-list
65410933|NCT00441363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65410934|NCT00441363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65410935|NCT00441363|Hormone Antagonists|hormone antagonists|mesh-ancestor
65410944|NCT00626795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65410945|NCT00626795|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65410946|NCT00626795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410947|NCT00626795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410948|NCT00826553|Midazolam|midazolam|mesh-list
65410949|NCT00826553|Dexmedetomidine|dexmedetomidine|mesh-list
65410950|NCT00826553|Lorazepam|lorazepam|mesh-list
65410951|NCT00826553|Propofol|propofol|mesh-list
65410952|NCT00826553|GABA Agonists|gaba agonists|mesh-list
65410953|NCT00826553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65269893|NCT02732132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65410954|NCT00826553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65410955|NCT00826553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160476|NCT00887809|Antimetabolites|antimetabolites|mesh-ancestor
65410956|NCT00826553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65410957|NCT00826553|Anesthetics, General|anesthetics, general|mesh-ancestor
65410958|NCT00826553|Anesthetics|anesthetics|mesh-ancestor
65410959|NCT00826553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65410960|NCT00826553|Analgesics|analgesics|mesh-ancestor
65410961|NCT00826553|Sensory System Agents|sensory system agents|mesh-ancestor
65410962|NCT00826553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65410963|NCT00826553|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65410964|NCT00826553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65410965|NCT00826553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65410966|NCT00826553|Adrenergic Agents|adrenergic agents|mesh-ancestor
65410967|NCT00826553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65410968|NCT00826553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410969|NCT00826553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65410970|NCT00826553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65410971|NCT00826553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65410972|NCT00826553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65410973|NCT00826553|GABA Modulators|gaba modulators|mesh-ancestor
65410974|NCT00826553|GABA Agents|gaba agents|mesh-ancestor
65410975|NCT00826553|Anticonvulsants|anticonvulsants|mesh-ancestor
65410976|NCT00826553|Antiemetics|antiemetics|mesh-ancestor
65410977|NCT00826553|Autonomic Agents|autonomic agents|mesh-ancestor
65410978|NCT00826553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65410979|NCT00626639|Cisplatin|cisplatin|mesh-list
65410980|NCT00626639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410981|NCT00626561|Paclitaxel|paclitaxel|mesh-list
65410982|NCT00626561|Bevacizumab|bevacizumab|mesh-list
65410983|NCT00626561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65410984|NCT00626561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410985|NCT00626561|Tubulin Modulators|tubulin modulators|mesh-ancestor
65410986|NCT00626561|Antimitotic Agents|antimitotic agents|mesh-ancestor
65410987|NCT00626561|Mitosis Modulators|mitosis modulators|mesh-ancestor
65410988|NCT00626561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410989|NCT00626561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65410990|NCT00626561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65410991|NCT00626561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65410992|NCT00626561|Growth Substances|growth substances|mesh-ancestor
65410993|NCT00626561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410994|NCT00626561|Growth Inhibitors|growth inhibitors|mesh-ancestor
65410995|NCT03880266|Glycopyrrolate|glycopyrrolate|mesh-list
65410996|NCT03880266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65410997|NCT03880266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65410998|NCT03880266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65410999|NCT03880266|Cholinergic Agents|cholinergic agents|mesh-ancestor
65411000|NCT03880266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65411001|NCT03880266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411015|NCT00822809|Prednisolone|prednisolone|mesh-list
65411016|NCT00822809|Catumaxomab|catumaxomab|mesh-list
65411017|NCT00822809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65411018|NCT00822809|Glucocorticoids|glucocorticoids|mesh-ancestor
65411019|NCT00822809|Hormones|hormones|mesh-ancestor
65411020|NCT00822809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65411021|NCT00822809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411022|NCT00822809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65411023|NCT00822809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411024|NCT00822809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65411025|NCT05518032|Pembrolizumab|pembrolizumab|mesh-list
65411026|NCT05518032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65411027|NCT05518032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411028|NCT02549651|Durvalumab|durvalumab|mesh-list
65411029|NCT02549651|Tremelimumab|tremelimumab|mesh-list
65411030|NCT02549651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65411031|NCT02549651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411032|NCT03999372|Hyaluronic Acid|hyaluronic acid|mesh-list
65411033|NCT03999372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65411034|NCT03999372|Immunologic Factors|immunologic factors|mesh-ancestor
65411035|NCT03999372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411036|NCT03999372|Viscosupplements|viscosupplements|mesh-ancestor
65411037|NCT03999372|Protective Agents|protective agents|mesh-ancestor
65411038|NCT05733468|Calcium, Dietary|calcium, dietary|mesh-list
65411039|NCT05733468|Calcium|calcium|mesh-list
65233666|NCT00943124|Niacin|niacin|mesh-list
65411040|NCT05733468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65411041|NCT05733468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411042|NCT05733468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65411043|NCT00830843|Propofol|propofol|mesh-list
65411044|NCT00830843|Isoflurane|isoflurane|mesh-list
65411045|NCT00830843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65411046|NCT00830843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65411047|NCT00830843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411048|NCT00830843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65411049|NCT00830843|Anesthetics, General|anesthetics, general|mesh-ancestor
65411050|NCT00830843|Anesthetics|anesthetics|mesh-ancestor
65411051|NCT00830843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65411052|NCT00826787|Levetiracetam|levetiracetam|mesh-list
65411053|NCT00826787|Anticonvulsants|anticonvulsants|mesh-ancestor
65411054|NCT00826787|Nootropic Agents|nootropic agents|mesh-ancestor
65411055|NCT00823121|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65411056|NCT00823121|Buserelin|buserelin|mesh-list
65411057|NCT00823121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65411058|NCT00823121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411059|NCT00823121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65411060|NCT00823121|Fertility Agents|fertility agents|mesh-ancestor
65411061|NCT03687372|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65411062|NCT03687372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65411063|NCT03687372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65411064|NCT00626405|Paclitaxel|paclitaxel|mesh-list
65411065|NCT00626405|Bevacizumab|bevacizumab|mesh-list
65411066|NCT00626405|Carboplatin|carboplatin|mesh-list
65411067|NCT00626405|Temozolomide|temozolomide|mesh-list
65411075|NCT00626405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65411076|NCT00626405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65411077|NCT00626405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65411078|NCT00626405|Growth Substances|growth substances|mesh-ancestor
65411079|NCT00626405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411080|NCT00626405|Growth Inhibitors|growth inhibitors|mesh-ancestor
65411081|NCT00626405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65411082|NCT00626405|Alkylating Agents|alkylating agents|mesh-ancestor
65411083|NCT00826865|Levetiracetam|levetiracetam|mesh-list
65411084|NCT00826865|Anticonvulsants|anticonvulsants|mesh-ancestor
65411085|NCT00826865|Nootropic Agents|nootropic agents|mesh-ancestor
65411086|NCT00358150|Eliglustat|eliglustat|mesh-list
65411087|NCT00358150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65411088|NCT00358150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411089|NCT05427630|Dronabinol|dronabinol|mesh-list
65411090|NCT05427630|Hallucinogens|hallucinogens|mesh-ancestor
65411091|NCT05427630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411092|NCT05427630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65411093|NCT05427630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65411094|NCT05427630|Analgesics|analgesics|mesh-ancestor
65411095|NCT05427630|Sensory System Agents|sensory system agents|mesh-ancestor
65411096|NCT05427630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65411097|NCT05427630|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65411098|NCT05427630|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65411099|NCT05427630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65411100|NCT05427630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411101|NCT05427630|Hormones|hormones|mesh-ancestor
65411102|NCT05427630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65411103|NCT01050556|Folic Acid|folic acid|mesh-list
65411104|NCT01050556|Vitamin B Complex|vitamin b complex|mesh-list
65411105|NCT01050556|Hematinics|hematinics|mesh-ancestor
65411106|NCT01050556|Vitamins|vitamins|mesh-ancestor
65411107|NCT01050556|Micronutrients|micronutrients|mesh-ancestor
65411108|NCT01050556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411109|NCT00423735|Dasatinib|dasatinib|mesh-list
65411110|NCT00423735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411111|NCT00423735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65411113|NCT00423735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411114|NCT01032213|Magnesium Sulfate|magnesium sulfate|mesh-list
65411115|NCT01032213|Analgesics|analgesics|mesh-ancestor
65411116|NCT01032213|Sensory System Agents|sensory system agents|mesh-ancestor
65411117|NCT01032213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65411118|NCT01032213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411119|NCT01032213|Anesthetics|anesthetics|mesh-ancestor
65411120|NCT01032213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65411121|NCT01032213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65411122|NCT01032213|Anticonvulsants|anticonvulsants|mesh-ancestor
65411123|NCT01032213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65233745|NCT00685945|Sildenafil Citrate|sildenafil citrate|mesh-list
65411124|NCT01032213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65411125|NCT01032213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411126|NCT01032213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65411127|NCT01032213|Tocolytic Agents|tocolytic agents|mesh-ancestor
65411128|NCT01032213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65411129|NCT00357994|Levodopa|levodopa|mesh-list
65411130|NCT00357994|Carbidopa|carbidopa|mesh-list
65411131|NCT00357994|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65411132|NCT00357994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65411133|NCT00357994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65411134|NCT00357994|Dopamine Agents|dopamine agents|mesh-ancestor
65411135|NCT00357994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65411150|NCT00423657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65411151|NCT00423657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65411153|NCT00831155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65411154|NCT00831155|Autonomic Agents|autonomic agents|mesh-ancestor
65411155|NCT00831155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65411156|NCT00831155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411157|NCT00831155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65411158|NCT00831155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65411159|NCT00831155|Cholinergic Agents|cholinergic agents|mesh-ancestor
65411160|NCT00831155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65411161|NCT00831155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411162|NCT00827021|Epoetin Alfa|epoetin alfa|mesh-list
65411163|NCT00827021|Hematinics|hematinics|mesh-list
65411164|NCT04491617|Analgesics, Opioid|analgesics, opioid|mesh-list
65411165|NCT04491617|Narcotics|narcotics|mesh-ancestor
65411166|NCT04491617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65411167|NCT04491617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411168|NCT04491617|Analgesics|analgesics|mesh-ancestor
65411169|NCT04491617|Sensory System Agents|sensory system agents|mesh-ancestor
65411170|NCT04491617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65411171|NCT01050712|Carbon Monoxide|carbon monoxide|mesh-list
65411172|NCT01050712|Antimetabolites|antimetabolites|mesh-ancestor
65411173|NCT01050712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411174|NCT01050712|Gasotransmitters|gasotransmitters|mesh-ancestor
65411175|NCT01050712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65411176|NCT01050712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411177|NCT02407509|Everolimus|everolimus|mesh-list
65411178|NCT02407509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411179|NCT02407509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65411180|NCT02407509|Immunologic Factors|immunologic factors|mesh-ancestor
65411181|NCT02407509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411182|NCT02550119|Dexamethasone|dexamethasone|mesh-list
65411183|NCT02550119|Dexamethasone acetate|dexamethasone acetate|mesh-list
65411184|NCT02550119|Aprepitant|aprepitant|mesh-list
65411185|NCT02550119|Dolasetron|dolasetron|mesh-list
65160693|NCT02825719|Hemostatics|hemostatics|mesh-ancestor
65411186|NCT02550119|Ichthammol|ichthammol|mesh-list
65411187|NCT02550119|BB 1101|bb 1101|mesh-list
65411188|NCT02550119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65411189|NCT02550119|Antiemetics|antiemetics|mesh-ancestor
65411190|NCT02550119|Autonomic Agents|autonomic agents|mesh-ancestor
65411191|NCT02550119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65411192|NCT02550119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411193|NCT02550119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65411194|NCT02550119|Glucocorticoids|glucocorticoids|mesh-ancestor
65411195|NCT02550119|Hormones|hormones|mesh-ancestor
65411196|NCT02550119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65411197|NCT02550119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65411207|NCT02548403|Simethicone|simethicone|mesh-list
65411208|NCT02548403|Antifoaming Agents|antifoaming agents|mesh-ancestor
65411209|NCT02548403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411210|NCT02548403|Emollients|emollients|mesh-ancestor
65411211|NCT02548403|Dermatologic Agents|dermatologic agents|mesh-ancestor
65411212|NCT00367432|Levetiracetam|levetiracetam|mesh-list
65411213|NCT00367432|Anticonvulsants|anticonvulsants|mesh-ancestor
65411214|NCT00367432|Nootropic Agents|nootropic agents|mesh-ancestor
65411215|NCT00623363|Piclozotan|piclozotan|mesh-list
65411216|NCT00623363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65411217|NCT00623363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65411218|NCT00623363|Serotonin Agents|serotonin agents|mesh-ancestor
65411219|NCT00623363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65411220|NCT00623363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411221|NCT00623363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233820|NCT01006889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411222|NCT00827177|Sorafenib|sorafenib|mesh-list
65411223|NCT00827177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411224|NCT00827177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65411225|NCT00827177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65411226|NCT00827177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411227|NCT00423267|Fluconazole|fluconazole|mesh-list
65411228|NCT00423267|Posaconazole|posaconazole|mesh-list
65411229|NCT00423267|Antifungal Agents|antifungal agents|mesh-ancestor
65411230|NCT00423267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65411231|NCT00423267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65411232|NCT00423267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65411233|NCT00423267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65411234|NCT00423267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411235|NCT00423267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65411236|NCT00423267|Hormone Antagonists|hormone antagonists|mesh-ancestor
65411237|NCT00423267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65411238|NCT00423267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411239|NCT00423267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65411240|NCT00423267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65411241|NCT00423267|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65411242|NCT00423267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65411243|NCT00423267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65411244|NCT02549261|Etoposide|etoposide|mesh-list
65411245|NCT02549261|Nimotuzumab|nimotuzumab|mesh-list
65411246|NCT02549261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411247|NCT02549261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65411248|NCT02549261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65411249|NCT02549261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65411250|NCT02549261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65411251|NCT02549261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411252|NCT02549261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65411253|NCT00357760|Aflibercept|aflibercept|mesh-list
65411254|NCT00357760|Endothelial Growth Factors|endothelial growth factors|mesh-list
65411255|NCT00357760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65411256|NCT00357760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65411257|NCT00357760|Growth Substances|growth substances|mesh-ancestor
65411258|NCT00357760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411259|NCT00357760|Growth Inhibitors|growth inhibitors|mesh-ancestor
65411260|NCT00357760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411261|NCT04396535|Docetaxel|docetaxel|mesh-list
65411271|NCT00622739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411272|NCT00622739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411273|NCT00622739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65411274|NCT00622739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65411275|NCT00622739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65411276|NCT00622739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65411277|NCT00622739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65411278|NCT00622739|Dopamine Agents|dopamine agents|mesh-ancestor
65411280|NCT03742336|Abrocitinib|abrocitinib|mesh-list
65411281|NCT03742336|Antithrombins|antithrombins|mesh-ancestor
65411282|NCT03742336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65411283|NCT03742336|Protease Inhibitors|protease inhibitors|mesh-ancestor
65411284|NCT03742336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65411285|NCT03742336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411286|NCT03742336|Anticoagulants|anticoagulants|mesh-ancestor
65411287|NCT03742336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65411288|NCT00435825|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65411289|NCT00435825|Antiviral Agents|antiviral agents|mesh-ancestor
65411290|NCT00435825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65411292|NCT00824057|Caffeine|caffeine|mesh-list
65411293|NCT00824057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65411294|NCT00824057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65411295|NCT00824057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65411296|NCT00824057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411297|NCT00824057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65411298|NCT00824057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65411299|NCT00824057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65411300|NCT00824057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65411301|NCT00824057|Anesthetics, General|anesthetics, general|mesh-ancestor
65411302|NCT00824057|Anesthetics|anesthetics|mesh-ancestor
65411303|NCT00824057|GABA Modulators|gaba modulators|mesh-ancestor
65411304|NCT00824057|GABA Agents|gaba agents|mesh-ancestor
65233894|NCT00684307|Vitamin K|vitamin k|mesh-list
65411305|NCT00824057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65411306|NCT00824057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411307|NCT00824057|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65411308|NCT00824057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65411309|NCT00824057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65411310|NCT00824057|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65411311|NCT00824057|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65411312|NCT00824057|Purinergic Agents|purinergic agents|mesh-ancestor
65411313|NCT01053208|Diphenhydramine|diphenhydramine|mesh-list
65411314|NCT01053208|Promethazine|promethazine|mesh-list
65411315|NCT01053208|Ibuprofen|ibuprofen|mesh-list
65411316|NCT01053208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411317|NCT01053208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65411318|NCT01053208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65411319|NCT01053208|Analgesics|analgesics|mesh-ancestor
65411320|NCT01053208|Sensory System Agents|sensory system agents|mesh-ancestor
65411321|NCT01053208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65411322|NCT01053208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411323|NCT01053208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65411324|NCT01053208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65411325|NCT01053208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65411326|NCT01053208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65411327|NCT01053208|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64796074|NCT05156710|Immunologic Factors|immunologic factors|mesh-ancestor
65411344|NCT00423189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65411345|NCT00423189|Growth Substances|growth substances|mesh-ancestor
65411346|NCT00423189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411347|NCT00423189|Growth Inhibitors|growth inhibitors|mesh-ancestor
65411348|NCT00423189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411349|NCT00831545|Temozolomide|temozolomide|mesh-list
65411350|NCT00831545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65411351|NCT00831545|Alkylating Agents|alkylating agents|mesh-ancestor
65411352|NCT00831545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411353|NCT00831545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411354|NCT00824135|Mycophenolic Acid|mycophenolic acid|mesh-list
65411355|NCT00824135|Rituximab|rituximab|mesh-list
65411356|NCT00824135|Melphalan|melphalan|mesh-list
65411357|NCT00824135|Thiotepa|thiotepa|mesh-list
65411358|NCT00824135|Clofarabine|clofarabine|mesh-list
65411359|NCT00824135|Muromonab-CD3|muromonab-cd3|mesh-list
65411360|NCT00824135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65411361|NCT00824135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411362|NCT00824135|Immunologic Factors|immunologic factors|mesh-ancestor
65411363|NCT00824135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411364|NCT00824135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65411365|NCT00824135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65411366|NCT00824135|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65411367|NCT00824135|Antitubercular Agents|antitubercular agents|mesh-ancestor
65411368|NCT00824135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65411369|NCT00824135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65411370|NCT00824135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65411371|NCT00824135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411372|NCT00824135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65411373|NCT00824135|Alkylating Agents|alkylating agents|mesh-ancestor
65411374|NCT00824135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65411375|NCT00824135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65411376|NCT00824135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65411377|NCT00824135|Antimetabolites|antimetabolites|mesh-ancestor
65411378|NCT00422799|Rituximab|rituximab|mesh-list
65411379|NCT00422799|Bortezomib|bortezomib|mesh-list
65411380|NCT00422799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65411381|NCT00422799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411382|NCT00422799|Immunologic Factors|immunologic factors|mesh-ancestor
65411383|NCT00422799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411384|NCT00422799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65411385|NCT00827411|Aspirin|aspirin|mesh-list
65411386|NCT00827411|Clopidogrel|clopidogrel|mesh-list
65411387|NCT00827411|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65411388|NCT00827411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65411389|NCT00827411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65411398|NCT00827411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411399|NCT00827411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65411400|NCT00827411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65411401|NCT00827411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65411402|NCT00827411|Antipyretics|antipyretics|mesh-ancestor
65411403|NCT00827411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65411404|NCT00827411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65411405|NCT00827411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65411406|NCT00827411|Purinergic Agents|purinergic agents|mesh-ancestor
65411407|NCT00827411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65411408|NCT00435045|Atorvastatin|atorvastatin|mesh-list
65411409|NCT00435045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65411410|NCT00435045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65411411|NCT00435045|Antimetabolites|antimetabolites|mesh-ancestor
65411412|NCT00435045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411413|NCT00435045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65411414|NCT00435045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65411415|NCT00435045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65411416|NCT00441129|Insulin|insulin|mesh-list
65411417|NCT00441129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65411418|NCT00441129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411419|NCT00622505|Zoledronic Acid|zoledronic acid|mesh-list
65411420|NCT00622505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65411421|NCT00622505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411422|NCT00831857|Bevacizumab|bevacizumab|mesh-list
65411423|NCT00831857|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
65411424|NCT00831857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65411425|NCT00831857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411426|NCT00831857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65411427|NCT00831857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65411428|NCT00831857|Growth Substances|growth substances|mesh-ancestor
65411429|NCT00831857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411430|NCT00831857|Growth Inhibitors|growth inhibitors|mesh-ancestor
65411431|NCT00831857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65411432|NCT00831857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411433|NCT00832013|Propofol|propofol|mesh-list
65411434|NCT00832013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65411435|NCT00832013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65411436|NCT00832013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411437|NCT00832013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65411438|NCT00832013|Anesthetics, General|anesthetics, general|mesh-ancestor
65411439|NCT00832013|Anesthetics|anesthetics|mesh-ancestor
65411440|NCT00832481|Metformin|metformin|mesh-list
65411441|NCT00832481|Repaglinide|repaglinide|mesh-list
65411442|NCT00832481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65411443|NCT00832481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411444|NCT00350272|Tenofovir|tenofovir|mesh-list
65411445|NCT00350272|Lamivudine|lamivudine|mesh-list
65411446|NCT00350272|Efavirenz|efavirenz|mesh-list
65411447|NCT00350272|Dexelvucitabine|dexelvucitabine|mesh-list
65411448|NCT00350272|Antiviral Agents|antiviral agents|mesh-ancestor
65411449|NCT00350272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65411450|NCT00350272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65411451|NCT00350272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65411452|NCT00350272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65411453|NCT00350272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411454|NCT00350272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65411455|NCT00350272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64796200|NCT04907253|Antioxidants|antioxidants|mesh-ancestor
65411459|NCT00350272|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65411460|NCT00350272|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65411461|NCT00350272|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65411462|NCT04044287|Misoprostol|misoprostol|mesh-list
65411463|NCT04044287|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65411464|NCT04044287|Abortifacient Agents|abortifacient agents|mesh-ancestor
65411465|NCT04044287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65411466|NCT04044287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411467|NCT04044287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65411468|NCT04044287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65411469|NCT04044287|Oxytocics|oxytocics|mesh-ancestor
65411470|NCT00357370|Dapagliflozin|dapagliflozin|mesh-list
65411471|NCT00357370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65411472|NCT00357370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411473|NCT00357370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65411474|NCT00357370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411475|NCT00825071|Dexamethasone|dexamethasone|mesh-list
65411476|NCT00825071|Ondansetron|ondansetron|mesh-list
65411477|NCT00825071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65411478|NCT00825071|Antiemetics|antiemetics|mesh-ancestor
65234045|NCT00748423|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65411479|NCT00825071|Autonomic Agents|autonomic agents|mesh-ancestor
65411480|NCT00825071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65411481|NCT00825071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411482|NCT00825071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65411483|NCT00825071|Glucocorticoids|glucocorticoids|mesh-ancestor
65411484|NCT00825071|Hormones|hormones|mesh-ancestor
65411485|NCT00825071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65411486|NCT00825071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65411487|NCT00825071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411488|NCT00825071|Antipruritics|antipruritics|mesh-ancestor
65411489|NCT00825071|Dermatologic Agents|dermatologic agents|mesh-ancestor
65411490|NCT00825071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65411491|NCT00825071|Serotonin Agents|serotonin agents|mesh-ancestor
65411492|NCT00825071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65411493|NCT00825071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411494|NCT00825071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65411495|NCT00825071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65411496|NCT00825071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65411497|NCT00825071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65411498|NCT00825071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65411499|NCT00574847|Citalopram|citalopram|mesh-list
65411500|NCT00574847|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65411501|NCT00574847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65411502|NCT00574847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65411503|NCT00574847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411504|NCT00574847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65411505|NCT00574847|Serotonin Agents|serotonin agents|mesh-ancestor
65411506|NCT00574847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411507|NCT00574847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65411508|NCT00574847|Antidepressive Agents|antidepressive agents|mesh-ancestor
65411509|NCT00574847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65411510|NCT00348790|Vatalanib|vatalanib|mesh-list
65411511|NCT00348790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65411512|NCT00348790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65411513|NCT00348790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411514|NCT00825149|Prednisone|prednisone|mesh-list
65411515|NCT00825149|Cyclophosphamide|cyclophosphamide|mesh-list
65411516|NCT00825149|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65411517|NCT00825149|Doxorubicin|doxorubicin|mesh-list
65411518|NCT00825149|Fludarabine|fludarabine|mesh-list
65411519|NCT00825149|Vincristine|vincristine|mesh-list
65411520|NCT00825149|Obinutuzumab|obinutuzumab|mesh-list
65411521|NCT00825149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65411522|NCT00825149|Immunologic Factors|immunologic factors|mesh-ancestor
65411523|NCT00825149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411524|NCT00825149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65411525|NCT00825149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65411533|NCT00825149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65411534|NCT00825149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65411535|NCT00825149|Glucocorticoids|glucocorticoids|mesh-ancestor
65411537|NCT00825149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65411538|NCT00825149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65411539|NCT00825149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65411540|NCT00825149|Tubulin Modulators|tubulin modulators|mesh-ancestor
65411541|NCT00825149|Antimitotic Agents|antimitotic agents|mesh-ancestor
65411542|NCT00825149|Mitosis Modulators|mitosis modulators|mesh-ancestor
65411543|NCT00825149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65411544|NCT00360490|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65411545|NCT00360490|Levonorgestrel|levonorgestrel|mesh-list
65411546|NCT00360490|Medroxyprogesterone|medroxyprogesterone|mesh-list
65411547|NCT00360490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65411548|NCT00360490|Contraceptive Agents|contraceptive agents|mesh-ancestor
65411549|NCT00360490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65411550|NCT00360490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411551|NCT00360490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65411552|NCT00360490|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65411553|NCT00360490|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65411554|NCT00360490|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65411555|NCT00360490|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65411556|NCT00360490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65411557|NCT00360490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411558|NCT02549105|Lidocaine|lidocaine|mesh-list
65411559|NCT02549105|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65411560|NCT02549105|Anesthetics, Local|anesthetics, local|mesh-ancestor
65411561|NCT02549105|Anesthetics|anesthetics|mesh-ancestor
65411562|NCT02549105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65411563|NCT02549105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411564|NCT02549105|Sensory System Agents|sensory system agents|mesh-ancestor
65411565|NCT02549105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65411566|NCT02549105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65411567|NCT02549105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65411568|NCT02549105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65411569|NCT02549105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65411570|NCT02549105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411571|NCT02549105|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65411572|NCT00624377|Tiotropium Bromide|tiotropium bromide|mesh-list
65411573|NCT00624377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65411574|NCT00624377|Autonomic Agents|autonomic agents|mesh-ancestor
65411575|NCT00624377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65411576|NCT00624377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411577|NCT00624377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65411578|NCT00624377|Respiratory System Agents|respiratory system agents|mesh-ancestor
65411579|NCT00624377|Parasympatholytics|parasympatholytics|mesh-ancestor
65411580|NCT00624377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65411581|NCT00624377|Cholinergic Agents|cholinergic agents|mesh-ancestor
65411582|NCT00624377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65411583|NCT00624377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411584|NCT02549963|Rivaroxaban|rivaroxaban|mesh-list
65411585|NCT02549963|Anticoagulants|anticoagulants|mesh-list
65411586|NCT02549963|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65411587|NCT02549963|Antithrombins|antithrombins|mesh-ancestor
65411588|NCT02549963|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65411589|NCT02549963|Protease Inhibitors|protease inhibitors|mesh-ancestor
64796340|NCT04570293|Anesthetics|anesthetics|mesh-ancestor
65411614|NCT00833339|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65411615|NCT00833339|Abortifacient Agents|abortifacient agents|mesh-ancestor
65411616|NCT00833339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65411617|NCT00833339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411618|NCT00833339|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65411619|NCT00833339|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65411620|NCT00833339|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65411621|NCT00833339|Contraceptive Agents|contraceptive agents|mesh-ancestor
65411622|NCT00833339|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65411623|NCT00833339|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65411624|NCT00833339|Hormone Antagonists|hormone antagonists|mesh-ancestor
65411625|NCT00833339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65411626|NCT00833339|Luteolytic Agents|luteolytic agents|mesh-ancestor
65411627|NCT00833339|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65411628|NCT00833339|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65411630|NCT00825617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65411631|NCT00825617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411632|NCT00360334|Insulin Glargine|insulin glargine|mesh-list
65411633|NCT00360334|Exenatide|exenatide|mesh-list
65161141|NCT04238221|Autonomic Agents|autonomic agents|mesh-ancestor
65411635|NCT00360334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411636|NCT00360334|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65411637|NCT00360334|Incretins|incretins|mesh-ancestor
65411638|NCT00360334|Hormones|hormones|mesh-ancestor
65411650|NCT00422097|Histamine Antagonists|histamine antagonists|mesh-ancestor
65411651|NCT00422097|Histamine Agents|histamine agents|mesh-ancestor
65411652|NCT00422097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65411653|NCT00422097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411654|NCT01051102|Insulin|insulin|mesh-list
65411655|NCT01051102|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65411656|NCT01051102|Insulin Aspart|insulin aspart|mesh-list
65411657|NCT01051102|Insulin, Long-Acting|insulin, long-acting|mesh-list
65411658|NCT01051102|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65411659|NCT01051102|Biphasic Insulins|biphasic insulins|mesh-list
65411660|NCT01051102|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65411661|NCT01051102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65411662|NCT01051102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411663|NCT00348556|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65411664|NCT00348556|Natriuretic Agents|natriuretic agents|mesh-ancestor
65411665|NCT00348556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411666|NCT00434967|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65411667|NCT00434967|Candesartan|candesartan|mesh-list
65411668|NCT00434967|Candesartan cilexetil|candesartan cilexetil|mesh-list
65411669|NCT00434967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65411670|NCT00434967|Diuretics|diuretics|mesh-ancestor
65411671|NCT00434967|Natriuretic Agents|natriuretic agents|mesh-ancestor
65411672|NCT00434967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411673|NCT00434967|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65411674|NCT00434967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65411675|NCT00434967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411676|NCT00434967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65411677|NCT00434967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65411678|NCT00833729|Etanercept|etanercept|mesh-list
65411679|NCT00833729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65411680|NCT00833729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65411681|NCT00833729|Analgesics|analgesics|mesh-ancestor
65411682|NCT00833729|Sensory System Agents|sensory system agents|mesh-ancestor
65411683|NCT00833729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65411684|NCT00833729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411685|NCT00833729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65411686|NCT00833729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65411687|NCT00833729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65411688|NCT00833729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65411689|NCT00833729|Immunologic Factors|immunologic factors|mesh-ancestor
65411690|NCT00837239|Gemcitabine|gemcitabine|mesh-list
65411691|NCT00837239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65411692|NCT00837239|Antimetabolites|antimetabolites|mesh-ancestor
65411693|NCT00837239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411694|NCT00837239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411695|NCT00837239|Antiviral Agents|antiviral agents|mesh-ancestor
65411696|NCT00837239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65411697|NCT00837239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65411698|NCT00837239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65411699|NCT00837239|Immunologic Factors|immunologic factors|mesh-ancestor
65411700|NCT00837239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411713|NCT00833963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65411714|NCT00833963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411715|NCT00833963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65411716|NCT00833963|Tubulin Modulators|tubulin modulators|mesh-ancestor
65411717|NCT00833963|Antimitotic Agents|antimitotic agents|mesh-ancestor
65411718|NCT00833963|Mitosis Modulators|mitosis modulators|mesh-ancestor
65411719|NCT00833963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411720|NCT00837317|Phenol|phenol|mesh-list
65411721|NCT00837317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65411722|NCT00837317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65411723|NCT00837317|Disinfectants|disinfectants|mesh-ancestor
65411724|NCT00837317|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65411725|NCT00837317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65411726|NCT04043897|Rifaximin|rifaximin|mesh-list
65411727|NCT04043897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65411728|NCT04043897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65411729|NCT04043897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65411730|NCT00356590|Etanercept|etanercept|mesh-list
65411731|NCT00356590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65411732|NCT00356590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65411733|NCT00356590|Analgesics|analgesics|mesh-ancestor
65411734|NCT00356590|Sensory System Agents|sensory system agents|mesh-ancestor
65411735|NCT00356590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65411736|NCT00356590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411737|NCT00356590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65411738|NCT00356590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65411739|NCT00356590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65411740|NCT00356590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65411741|NCT00356590|Immunologic Factors|immunologic factors|mesh-ancestor
65411742|NCT00828503|Valganciclovir|valganciclovir|mesh-list
65411743|NCT00828503|Everolimus|everolimus|mesh-list
65411744|NCT00828503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411745|NCT00828503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65411746|NCT00828503|Immunologic Factors|immunologic factors|mesh-ancestor
65411747|NCT00828503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411748|NCT00828503|Antiviral Agents|antiviral agents|mesh-ancestor
65411749|NCT00828503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65411750|NCT00834665|Molgramostim|molgramostim|mesh-list
65411751|NCT00834665|Sargramostim|sargramostim|mesh-list
65411752|NCT00834665|Immunologic Factors|immunologic factors|mesh-ancestor
65411753|NCT00834665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411754|NCT00834665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234271|NCT02592226|Anesthetics|anesthetics|mesh-list
65411755|NCT00837707|Aripiprazole|aripiprazole|mesh-list
65411756|NCT00837707|Antidepressive Agents|antidepressive agents|mesh-ancestor
65411757|NCT00837707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65411758|NCT00837707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65411759|NCT00837707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65411760|NCT00837707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65411761|NCT00837707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411762|NCT00837707|Dopamine Agonists|dopamine agonists|mesh-ancestor
65411763|NCT00837707|Dopamine Agents|dopamine agents|mesh-ancestor
65411764|NCT00837707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65411765|NCT00837707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411766|NCT00837707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64796526|NCT04288427|Finasteride|finasteride|mesh-list
65411770|NCT00837707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65411771|NCT00837707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65411772|NCT00837707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65411774|NCT01055938|Anticonvulsants|anticonvulsants|mesh-ancestor
65411775|NCT01055938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65411776|NCT01055938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411777|NCT01055938|GABA Agents|gaba agents|mesh-ancestor
65411778|NCT01055938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65411779|NCT01055938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411780|NCT01055938|Antimanic Agents|antimanic agents|mesh-ancestor
65411781|NCT01055938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65411782|NCT01055938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65411783|NCT01055938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65411784|NCT00837785|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65411785|NCT00837785|Dermatologic Agents|dermatologic agents|mesh-ancestor
65411786|NCT00837785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65411787|NCT00837785|Immunologic Factors|immunologic factors|mesh-ancestor
65411788|NCT00837785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411789|NCT00356278|Cycloserine|cycloserine|mesh-list
65411790|NCT00356278|Alprazolam|alprazolam|mesh-list
65411791|NCT00356278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65411792|NCT00356278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65411793|NCT00356278|Renal Agents|renal agents|mesh-ancestor
65411794|NCT00356278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65411795|NCT00356278|Antitubercular Agents|antitubercular agents|mesh-ancestor
65411796|NCT00356278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65411797|NCT00356278|Antimetabolites|antimetabolites|mesh-ancestor
65411798|NCT00356278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411799|NCT00356278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65411800|NCT00356278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65411801|NCT00356278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411802|NCT00356278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65411803|NCT00356278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65411804|NCT00356278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65411805|NCT00356278|GABA Modulators|gaba modulators|mesh-ancestor
65411806|NCT00356278|GABA Agents|gaba agents|mesh-ancestor
65411807|NCT00356278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65411808|NCT00837941|Diphenhydramine|diphenhydramine|mesh-list
65411809|NCT00837941|Promethazine|promethazine|mesh-list
65411810|NCT00837941|Pregabalin|pregabalin|mesh-list
65411811|NCT00837941|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65411812|NCT00837941|Analgesics|analgesics|mesh-ancestor
65411813|NCT00837941|Sensory System Agents|sensory system agents|mesh-ancestor
65411814|NCT00837941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65411815|NCT00837941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411816|NCT00837941|Anticonvulsants|anticonvulsants|mesh-ancestor
65411817|NCT00837941|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65411818|NCT00837941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65411819|NCT00837941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411820|NCT00837941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65411821|NCT00837941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65411822|NCT00837941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65411823|NCT00837941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65411824|NCT00837941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65411825|NCT00837941|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65411826|NCT00837941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65411827|NCT00837941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65411828|NCT00837941|Antidepressive Agents|antidepressive agents|mesh-ancestor
65411829|NCT00837941|Dopamine Agents|dopamine agents|mesh-ancestor
65411830|NCT00837941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65234345|NCT04051567|Aspirin|aspirin|mesh-list
65411831|NCT00837941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65411832|NCT00837941|Anesthetics, Local|anesthetics, local|mesh-ancestor
65411833|NCT00837941|Anesthetics|anesthetics|mesh-ancestor
65411834|NCT00837941|Antiemetics|antiemetics|mesh-ancestor
65411835|NCT00837941|Autonomic Agents|autonomic agents|mesh-ancestor
65411836|NCT00837941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65411837|NCT00837941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65411838|NCT00837941|Histamine Antagonists|histamine antagonists|mesh-ancestor
65411844|NCT01053442|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65411846|NCT01053442|Sequestering Agents|sequestering agents|mesh-ancestor
65411847|NCT01053442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411848|NCT00356200|Fluphenazine|fluphenazine|mesh-list
65411849|NCT00356200|Fluphenazine depot|fluphenazine depot|mesh-list
65411850|NCT00356200|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
65411851|NCT00356200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65411852|NCT00356200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65411853|NCT00356200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65411854|NCT00356200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411855|NCT00356200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65411856|NCT00356200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65411857|NCT00356200|Dopamine Agents|dopamine agents|mesh-ancestor
65411858|NCT00356200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65411859|NCT00356200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411860|NCT00356122|Bevacizumab|bevacizumab|mesh-list
65411861|NCT00356122|Docetaxel|docetaxel|mesh-list
65411862|NCT00356122|Oxaliplatin|oxaliplatin|mesh-list
65411863|NCT00356122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65411864|NCT00356122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411865|NCT00356122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65411866|NCT00356122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65411867|NCT00356122|Growth Substances|growth substances|mesh-ancestor
65411868|NCT00356122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411869|NCT00356122|Growth Inhibitors|growth inhibitors|mesh-ancestor
65411870|NCT00356122|Tubulin Modulators|tubulin modulators|mesh-ancestor
65411871|NCT00356122|Antimitotic Agents|antimitotic agents|mesh-ancestor
65411872|NCT00356122|Mitosis Modulators|mitosis modulators|mesh-ancestor
65411873|NCT00356122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411874|NCT00828815|Etravirine|etravirine|mesh-list
65411875|NCT00828815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65411876|NCT00828815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65411877|NCT00828815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65411878|NCT00828815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411879|NCT00828815|Antiviral Agents|antiviral agents|mesh-ancestor
65411880|NCT00828815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65411881|NCT01053520|Navitoclax|navitoclax|mesh-list
65411882|NCT01053520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411883|NCT00347932|Besifloxacin|besifloxacin|mesh-list
65411884|NCT00347932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65411885|NCT00347932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65411886|NCT00347932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65411887|NCT00347932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65411888|NCT00347932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65411889|NCT00347932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411890|NCT00347932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411891|NCT00828971|Amoxicillin|amoxicillin|mesh-list
65411892|NCT00828971|Moxifloxacin|moxifloxacin|mesh-list
65411893|NCT00828971|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65411894|NCT00828971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65411895|NCT00828971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65411896|NCT00828971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65411897|NCT00828971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65411898|NCT00828971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65411899|NCT00828971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411900|NCT00828971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411901|NCT00828971|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65411902|NCT00828971|Contraceptive Agents|contraceptive agents|mesh-ancestor
65411903|NCT00828971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65411904|NCT00828971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411905|NCT00828971|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65411906|NCT00828971|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65411907|NCT00828971|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65411908|NCT00528996|Bromides|bromides|mesh-list
65411914|NCT00528996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65234431|NCT00725608|Naloxone|naloxone|mesh-list
65411915|NCT00528996|Respiratory System Agents|respiratory system agents|mesh-ancestor
65411916|NCT00528996|Parasympatholytics|parasympatholytics|mesh-ancestor
65411917|NCT00528996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65411918|NCT00528996|Cholinergic Agents|cholinergic agents|mesh-ancestor
65411919|NCT00528996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65411920|NCT00528996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411921|NCT00528996|Anticonvulsants|anticonvulsants|mesh-ancestor
65411923|NCT00359788|Tiotropium Bromide|tiotropium bromide|mesh-list
65411924|NCT00359788|Ipratropium|ipratropium|mesh-list
65411925|NCT00359788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65411926|NCT00359788|Autonomic Agents|autonomic agents|mesh-ancestor
65411927|NCT00359788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65411928|NCT00359788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411929|NCT00359788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65411930|NCT00359788|Respiratory System Agents|respiratory system agents|mesh-ancestor
65411931|NCT00359788|Parasympatholytics|parasympatholytics|mesh-ancestor
65411932|NCT00359788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65411933|NCT00359788|Cholinergic Agents|cholinergic agents|mesh-ancestor
65411934|NCT00359788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65411935|NCT00359788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411936|NCT00359788|Tocolytic Agents|tocolytic agents|mesh-ancestor
65411937|NCT00359788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65411938|NCT00359788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65411939|NCT00359788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65411940|NCT00359788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65411941|NCT00359788|Adrenergic Agents|adrenergic agents|mesh-ancestor
65411943|NCT05416476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65411944|NCT05416476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65411945|NCT05416476|Analgesics|analgesics|mesh-ancestor
65411946|NCT05416476|Sensory System Agents|sensory system agents|mesh-ancestor
65411947|NCT05416476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65411948|NCT05416476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411949|NCT05416476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65411950|NCT05416476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65411951|NCT05416476|Parasympatholytics|parasympatholytics|mesh-ancestor
65411952|NCT05416476|Autonomic Agents|autonomic agents|mesh-ancestor
65411953|NCT00623597|Ritonavir|ritonavir|mesh-list
65411954|NCT00623597|Saquinavir|saquinavir|mesh-list
65411955|NCT00623597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65411956|NCT00623597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65411957|NCT00623597|Protease Inhibitors|protease inhibitors|mesh-ancestor
65411958|NCT00623597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65411959|NCT00623597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411960|NCT00623597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65411961|NCT00623597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65411962|NCT00623597|Antiviral Agents|antiviral agents|mesh-ancestor
65411963|NCT00623597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65411964|NCT00623597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65411965|NCT00623597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65411966|NCT01056172|Ribavirin|ribavirin|mesh-list
65411967|NCT01056172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65411968|NCT01056172|Interferon-alpha|interferon-alpha|mesh-list
65411969|NCT01056172|Antimetabolites|antimetabolites|mesh-ancestor
65411970|NCT01056172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411971|NCT01056172|Antiviral Agents|antiviral agents|mesh-ancestor
65411972|NCT01056172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65411973|NCT01056172|Immunologic Factors|immunologic factors|mesh-ancestor
65411974|NCT01056172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411975|NCT00838955|Sirolimus|sirolimus|mesh-list
65411976|NCT00838955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65411977|NCT00838955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65411978|NCT00838955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65411979|NCT00838955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411990|NCT00347776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411992|NCT04452136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65411993|NCT04452136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411994|NCT00829205|Rituximab|rituximab|mesh-list
65411995|NCT00829205|Carboplatin|carboplatin|mesh-list
65411996|NCT00829205|Etoposide|etoposide|mesh-list
65411997|NCT00829205|Ifosfamide|ifosfamide|mesh-list
65411998|NCT00829205|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
65411999|NCT00829205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65412000|NCT00829205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412001|NCT00829205|Immunologic Factors|immunologic factors|mesh-ancestor
65234496|NCT02590900|Acetaminophen|acetaminophen|mesh-list
65412002|NCT00829205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412003|NCT00829205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65412004|NCT00829205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65412005|NCT00829205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65412006|NCT00829205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65412007|NCT00829205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412008|NCT00829205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412009|NCT00829205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65412010|NCT00829205|Alkylating Agents|alkylating agents|mesh-ancestor
65412011|NCT00829205|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65412012|NCT00829205|Protective Agents|protective agents|mesh-ancestor
65412013|NCT04944888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65412014|NCT04944888|Eliglustat|eliglustat|mesh-list
65412015|NCT04944888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412016|NCT04944888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412017|NCT04944888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412018|NCT00839111|Irinotecan|irinotecan|mesh-list
65412019|NCT00839111|Sorafenib|sorafenib|mesh-list
65412020|NCT00839111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65412021|NCT00839111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65412022|NCT00839111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412023|NCT00839111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412024|NCT00839111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412025|NCT00839111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65412026|NCT00836381|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65412027|NCT00836381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65412028|NCT00836381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65412029|NCT00836381|Cholinergic Agents|cholinergic agents|mesh-ancestor
65412030|NCT00836381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65412031|NCT00836381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412032|NCT00836381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412033|NCT00836381|Urological Agents|urological agents|mesh-ancestor
65412034|NCT02533336|Abamectin|abamectin|mesh-list
65412035|NCT02533336|Anthelmintics|anthelmintics|mesh-ancestor
65412036|NCT02533336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65412037|NCT02533336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65412038|NCT00836537|Benazepril|benazepril|mesh-list
65412039|NCT00836537|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65412040|NCT00836537|Protease Inhibitors|protease inhibitors|mesh-ancestor
65412041|NCT00836537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412042|NCT00836537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412043|NCT00836537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65412051|NCT00829595|Immunologic Factors|immunologic factors|mesh-ancestor
65412052|NCT00829595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412053|NCT01008384|Vitamin D|vitamin d|mesh-list
65412054|NCT01008384|Cholecalciferol|cholecalciferol|mesh-list
65412055|NCT01008384|Vitamins|vitamins|mesh-ancestor
65412056|NCT01008384|Micronutrients|micronutrients|mesh-ancestor
65412057|NCT01008384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412058|NCT01008384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65412059|NCT01008384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65412060|NCT02547155|Anesthetics|anesthetics|mesh-list
65412061|NCT02547155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65412062|NCT02547155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412063|NCT00836849|Sertraline|sertraline|mesh-list
65412064|NCT00836849|Antidepressive Agents|antidepressive agents|mesh-ancestor
65412065|NCT00836849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65412066|NCT00836849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65412067|NCT00836849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65412068|NCT00836849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65412069|NCT00836849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412070|NCT00836849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65412071|NCT00836849|Serotonin Agents|serotonin agents|mesh-ancestor
65412072|NCT00836849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412073|NCT00839345|Clopidogrel|clopidogrel|mesh-list
65412074|NCT00839345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65412075|NCT00839345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65412076|NCT00839345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65412077|NCT00839345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65412078|NCT00839345|Purinergic Agents|purinergic agents|mesh-ancestor
65412079|NCT00839345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65412080|NCT00839345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412081|NCT00839345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412082|NCT00839501|Acetazolamide|acetazolamide|mesh-list
65412083|NCT00839501|Anticonvulsants|anticonvulsants|mesh-ancestor
65412084|NCT00839501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65412086|NCT00839501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412087|NCT00839501|Diuretics|diuretics|mesh-ancestor
65412088|NCT00839501|Natriuretic Agents|natriuretic agents|mesh-ancestor
65412089|NCT00839501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412090|NCT00529542|Atorvastatin|atorvastatin|mesh-list
65412091|NCT00529542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65412092|NCT00529542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65412093|NCT00529542|Antimetabolites|antimetabolites|mesh-ancestor
65412094|NCT00529542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412095|NCT00529542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65412096|NCT00529542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65412097|NCT00529542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412098|NCT04043741|Sulfamethazine|sulfamethazine|mesh-list
65412099|NCT04043741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65412100|NCT00621959|Levocetirizine|levocetirizine|mesh-list
65412101|NCT00621959|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65412102|NCT00621959|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65412103|NCT00621959|Histamine Antagonists|histamine antagonists|mesh-ancestor
65412104|NCT00621959|Histamine Agents|histamine agents|mesh-ancestor
65412105|NCT00621959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65412106|NCT00621959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412107|NCT00621959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412108|NCT00839657|Warfarin|warfarin|mesh-list
65412109|NCT00839657|Anticoagulants|anticoagulants|mesh-ancestor
65412130|NCT03877224|Dapagliflozin|dapagliflozin|mesh-list
65412131|NCT03877224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65412132|NCT03877224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412133|NCT03877224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65412134|NCT03877224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412135|NCT00840125|Docetaxel|docetaxel|mesh-list
65412136|NCT00840125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65412137|NCT00840125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412138|NCT00840125|Tubulin Modulators|tubulin modulators|mesh-ancestor
65412139|NCT00840125|Antimitotic Agents|antimitotic agents|mesh-ancestor
65412140|NCT00840125|Mitosis Modulators|mitosis modulators|mesh-ancestor
65412141|NCT00840125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412142|NCT00840125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65412143|NCT00840125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412144|NCT00830531|Bumetanide|bumetanide|mesh-list
65412145|NCT00830531|Diuretics|diuretics|mesh-ancestor
65412146|NCT00830531|Natriuretic Agents|natriuretic agents|mesh-ancestor
65412147|NCT00830531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412148|NCT00830531|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65412149|NCT00830531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65412150|NCT00830531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412151|NCT05014542|Analgesics|analgesics|mesh-list
65412152|NCT05014542|Sensory System Agents|sensory system agents|mesh-ancestor
65412153|NCT05014542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412154|NCT05014542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412155|NCT04926324|Niraparib|niraparib|mesh-list
65412156|NCT04926324|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65412157|NCT04926324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412158|NCT04926324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412159|NCT04926324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412160|NCT00621257|Vitamin D|vitamin d|mesh-list
65412161|NCT00621257|Ergocalciferols|ergocalciferols|mesh-list
65412162|NCT00621257|Cholecalciferol|cholecalciferol|mesh-list
65412163|NCT00621257|Vitamins|vitamins|mesh-list
65412164|NCT00621257|Micronutrients|micronutrients|mesh-ancestor
65412165|NCT00621257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412196|NCT04043195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412197|NCT04043195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65412198|NCT04043195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65412199|NCT04043195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412200|NCT00841061|Ferrous fumarate|ferrous fumarate|mesh-list
65412201|NCT00841061|Trace Elements|trace elements|mesh-ancestor
65412202|NCT00841061|Micronutrients|micronutrients|mesh-ancestor
65412203|NCT00841061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412204|NCT04042805|Lenvatinib|lenvatinib|mesh-list
65412205|NCT04042805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412206|NCT04042805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65412207|NCT04042805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412208|NCT04042805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412209|NCT05643846|Bupivacaine|bupivacaine|mesh-list
64797012|NCT02811133|Inositol|inositol|mesh-list
65412236|NCT00841373|Growth Inhibitors|growth inhibitors|mesh-ancestor
65412237|NCT00841373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412239|NCT00851513|Anesthetics, Local|anesthetics, local|mesh-ancestor
65412240|NCT00851513|Anesthetics|anesthetics|mesh-ancestor
65412241|NCT00851513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65412242|NCT00851513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412243|NCT00851513|Sensory System Agents|sensory system agents|mesh-ancestor
65412244|NCT00851513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412245|NCT00851513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65412246|NCT00851513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65412247|NCT00851513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65412248|NCT00851513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65412249|NCT00851513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412250|NCT00841841|Acetaminophen|acetaminophen|mesh-list
65412251|NCT00841841|Dipyrone|dipyrone|mesh-list
65412252|NCT00841841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65412253|NCT00841841|Analgesics|analgesics|mesh-ancestor
65412254|NCT00841841|Sensory System Agents|sensory system agents|mesh-ancestor
65412265|NCT00841919|Insulin|insulin|mesh-list
65412266|NCT00841919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65412267|NCT00841919|Insulin Glargine|insulin glargine|mesh-list
65412268|NCT00841919|Insulin, Isophane|insulin, isophane|mesh-list
65412269|NCT00841919|Isophane Insulin, Human|isophane insulin, human|mesh-list
65412270|NCT00841919|Isophane insulin, beef|isophane insulin, beef|mesh-list
65412271|NCT00841919|Insulin Lispro|insulin lispro|mesh-list
65412272|NCT00841919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65412273|NCT00841919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412274|NCT00852059|Methylphenidate|methylphenidate|mesh-list
65412275|NCT00852059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65412276|NCT00852059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412277|NCT00852059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65412278|NCT00852059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65412279|NCT00852059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65412280|NCT00852059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412281|NCT00852059|Dopamine Agents|dopamine agents|mesh-ancestor
65412282|NCT00852059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65412283|NCT00844727|Rofecoxib|rofecoxib|mesh-list
65412284|NCT00844727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65412285|NCT00844727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65412286|NCT00844727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412287|NCT00844727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412288|NCT00844727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65412289|NCT00844727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65412290|NCT00844727|Analgesics|analgesics|mesh-ancestor
65412291|NCT00844727|Sensory System Agents|sensory system agents|mesh-ancestor
65412292|NCT00844727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412293|NCT00844727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412294|NCT00844727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65412295|NCT00844727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65412296|NCT00528528|Ribavirin|ribavirin|mesh-list
65412297|NCT00528528|Interferon-alpha|interferon-alpha|mesh-list
65412298|NCT00528528|Interferon alpha-2|interferon alpha-2|mesh-list
65412299|NCT00528528|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65412300|NCT00528528|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65412301|NCT00528528|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65412302|NCT00528528|Antimetabolites|antimetabolites|mesh-ancestor
65412303|NCT00528528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412304|NCT00528528|Antiviral Agents|antiviral agents|mesh-ancestor
65412305|NCT00528528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65412306|NCT00528528|Immunologic Factors|immunologic factors|mesh-ancestor
65412307|NCT00528528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412308|NCT00528528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412309|NCT00620555|Gabapentin|gabapentin|mesh-list
65412310|NCT00620555|Analgesics|analgesics|mesh-ancestor
65412311|NCT00620555|Sensory System Agents|sensory system agents|mesh-ancestor
65412312|NCT00620555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412313|NCT00620555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412314|NCT00620555|Anticonvulsants|anticonvulsants|mesh-ancestor
65412315|NCT00620555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65412316|NCT00620555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65412317|NCT00620555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65412318|NCT00620555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65412319|NCT00620555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65412329|NCT02546141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412330|NCT00845819|Iodine|iodine|mesh-list
65412331|NCT00845819|Chlorhexidine|chlorhexidine|mesh-list
65412332|NCT00845819|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65412333|NCT00845819|Cadexomer iodine|cadexomer iodine|mesh-list
65412334|NCT00845819|Povidone-Iodine|povidone-iodine|mesh-list
65412335|NCT00845819|Nystatin|nystatin|mesh-list
65412336|NCT00845819|Povidone|povidone|mesh-list
65412337|NCT00845819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65412338|NCT00845819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65412339|NCT00845819|Disinfectants|disinfectants|mesh-ancestor
65412340|NCT00845819|Dermatologic Agents|dermatologic agents|mesh-ancestor
65412341|NCT00845819|Trace Elements|trace elements|mesh-ancestor
65412342|NCT00845819|Micronutrients|micronutrients|mesh-ancestor
65412343|NCT00845819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412344|NCT00845819|Plasma Substitutes|plasma substitutes|mesh-ancestor
65412345|NCT00845819|Blood Substitutes|blood substitutes|mesh-ancestor
65412346|NCT00845819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65412347|NCT00845819|Antifungal Agents|antifungal agents|mesh-ancestor
65412348|NCT00845819|Ionophores|ionophores|mesh-ancestor
65412349|NCT00845819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65412350|NCT00845819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412351|NCT02546843|Rocuronium|rocuronium|mesh-list
65412352|NCT02546843|Atracurium|atracurium|mesh-list
65412353|NCT02546843|Cisatracurium|cisatracurium|mesh-list
65412354|NCT02546843|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65412355|NCT02546843|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65412356|NCT02546843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65412357|NCT02546843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412358|NCT02546843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412359|NCT02546843|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65412360|NCT02546843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65412361|NCT02546843|Cholinergic Agents|cholinergic agents|mesh-ancestor
65412362|NCT02546843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65412363|NCT02546843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412364|NCT03998982|Dexamethasone|dexamethasone|mesh-list
65412365|NCT03998982|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
65412366|NCT03998982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65412367|NCT03998982|Antiemetics|antiemetics|mesh-ancestor
65412368|NCT03998982|Autonomic Agents|autonomic agents|mesh-ancestor
65412369|NCT03998982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412370|NCT03998982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412371|NCT03998982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65412372|NCT03998982|Glucocorticoids|glucocorticoids|mesh-ancestor
65412373|NCT03998982|Hormones|hormones|mesh-ancestor
65412374|NCT03998982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65412375|NCT03998982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65412376|NCT03998982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412377|NCT04782180|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65412378|NCT04782180|Antiviral Agents|antiviral agents|mesh-ancestor
65412379|NCT04782180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65412380|NCT04782180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65412381|NCT04782180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65412382|NCT04782180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412383|NCT04782180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412384|NCT04782180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65412385|NCT04782180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65412386|NCT00620321|Cytarabine|cytarabine|mesh-list
65412387|NCT00620321|Idarubicin|idarubicin|mesh-list
65412405|NCT00621023|Antimetabolites|antimetabolites|mesh-ancestor
65412406|NCT00621023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412407|NCT00621023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412408|NCT00621023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412409|NCT00621023|Antioxidants|antioxidants|mesh-ancestor
65412410|NCT00621023|Protective Agents|protective agents|mesh-ancestor
65412411|NCT00621023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412412|NCT00621023|Vitamins|vitamins|mesh-ancestor
65412413|NCT00621023|Micronutrients|micronutrients|mesh-ancestor
65412414|NCT00848861|Midazolam|midazolam|mesh-list
65412415|NCT00848861|Meperidine|meperidine|mesh-list
65412416|NCT00848861|Propofol|propofol|mesh-list
65412417|NCT00848861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65412418|NCT00848861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65412419|NCT00848861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412420|NCT00848861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65412421|NCT00848861|Anesthetics, General|anesthetics, general|mesh-ancestor
65412422|NCT00848861|Anesthetics|anesthetics|mesh-ancestor
65412423|NCT00848861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65412424|NCT00848861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65412425|NCT00848861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65412426|NCT00848861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65412427|NCT00848861|GABA Modulators|gaba modulators|mesh-ancestor
65412428|NCT00848861|GABA Agents|gaba agents|mesh-ancestor
65412429|NCT00848861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65412430|NCT00848861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412431|NCT00848861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65412432|NCT00848861|Narcotics|narcotics|mesh-ancestor
65412433|NCT00848861|Analgesics|analgesics|mesh-ancestor
65412434|NCT00848861|Sensory System Agents|sensory system agents|mesh-ancestor
65412435|NCT00848861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412436|NCT00852371|Pyrimethamine|pyrimethamine|mesh-list
65412437|NCT00852371|Piperaquine|piperaquine|mesh-list
65412438|NCT00852371|Sulfadoxine|sulfadoxine|mesh-list
65412439|NCT00852371|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65412440|NCT00852371|Amodiaquine|amodiaquine|mesh-list
65412441|NCT00852371|Artenimol|artenimol|mesh-list
65412442|NCT00852371|Antimalarials|antimalarials|mesh-ancestor
65412443|NCT00852371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65412444|NCT00852371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65412445|NCT00852371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65412446|NCT00852371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65412447|NCT00852371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797212|NCT01969578|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65412459|NCT01564680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65412461|NCT01564680|Sensory System Agents|sensory system agents|mesh-ancestor
65412462|NCT01564680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412464|NCT01564680|Antipyretics|antipyretics|mesh-ancestor
65412465|NCT01564680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65412466|NCT01564680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65412467|NCT01564680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65412468|NCT01564836|Imatinib Mesylate|imatinib mesylate|mesh-list
65412469|NCT01564836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412470|NCT01564836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65412471|NCT01564836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412472|NCT01564836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412473|NCT00527982|Celecoxib|celecoxib|mesh-list
65412474|NCT00527982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65412475|NCT00527982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65412476|NCT00527982|Analgesics|analgesics|mesh-ancestor
65412477|NCT00527982|Sensory System Agents|sensory system agents|mesh-ancestor
65412478|NCT00527982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412479|NCT00527982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412480|NCT00527982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65412481|NCT00527982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65412482|NCT00527982|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65412483|NCT00527982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65412484|NCT00527982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412485|NCT00527982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412486|NCT00527904|Naproxen|naproxen|mesh-list
65412487|NCT00527904|Esomeprazole|esomeprazole|mesh-list
65412488|NCT00527904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65412489|NCT00527904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65412490|NCT00527904|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65412491|NCT00527904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412492|NCT00527904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412493|NCT00527904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65412494|NCT00527904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65412495|NCT00527904|Analgesics|analgesics|mesh-ancestor
65412496|NCT00527904|Sensory System Agents|sensory system agents|mesh-ancestor
65412497|NCT00527904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412498|NCT00527904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412499|NCT00527904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65412500|NCT00527904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65412501|NCT00527904|Gout Suppressants|gout suppressants|mesh-ancestor
65412502|NCT00527904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65412503|NCT00619619|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65412504|NCT00619619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65412505|NCT00619619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65412506|NCT00619619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65234869|NCT00755521|Sensory System Agents|sensory system agents|mesh-ancestor
65234870|NCT00755521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65234872|NCT00755521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65412507|NCT00619619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412508|NCT00619619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64797275|NCT01681264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65412522|NCT00842933|Hormones|hormones|mesh-ancestor
65412523|NCT00842933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65412524|NCT00842933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412525|NCT00842933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65412526|NCT00842933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412527|NCT00842933|Antiemetics|antiemetics|mesh-ancestor
65412528|NCT00842933|Autonomic Agents|autonomic agents|mesh-ancestor
65412529|NCT00842933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412530|NCT00842933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65412531|NCT00842933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65412532|NCT00842933|Protective Agents|protective agents|mesh-ancestor
65412533|NCT00849095|Budesonide|budesonide|mesh-list
65412534|NCT00849095|Terbutaline|terbutaline|mesh-list
65412535|NCT00849095|Formoterol Fumarate|formoterol fumarate|mesh-list
65412536|NCT00849095|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65412537|NCT00849095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65412538|NCT00849095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65412539|NCT00849095|Autonomic Agents|autonomic agents|mesh-ancestor
65412540|NCT00849095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412541|NCT00849095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412542|NCT00849095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65412543|NCT00849095|Respiratory System Agents|respiratory system agents|mesh-ancestor
65412544|NCT00849095|Glucocorticoids|glucocorticoids|mesh-ancestor
65412546|NCT00849095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65412547|NCT00849095|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65412548|NCT00849095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65412549|NCT00849095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65412550|NCT00849095|Adrenergic Agents|adrenergic agents|mesh-ancestor
65412551|NCT00849095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65412552|NCT00849095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412553|NCT00849095|Sympathomimetics|sympathomimetics|mesh-ancestor
65412554|NCT00849095|Tocolytic Agents|tocolytic agents|mesh-ancestor
65412555|NCT00849095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65412556|NCT00527826|Fluticasone|fluticasone|mesh-list
65412557|NCT00527826|Xhance|xhance|mesh-list
65412558|NCT00527826|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65412559|NCT00527826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65412560|NCT00527826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65412561|NCT00527826|Autonomic Agents|autonomic agents|mesh-ancestor
65412562|NCT00527826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412563|NCT00527826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412564|NCT00527826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65412565|NCT00527826|Respiratory System Agents|respiratory system agents|mesh-ancestor
65412566|NCT00527826|Dermatologic Agents|dermatologic agents|mesh-ancestor
65412567|NCT00527826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65412568|NCT00527826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65412569|NCT00527826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65412570|NCT00527826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65412571|NCT00527826|Adrenergic Agents|adrenergic agents|mesh-ancestor
64797335|NCT00295893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412584|NCT03998670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65412585|NCT03998670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412587|NCT03998670|Autonomic Agents|autonomic agents|mesh-ancestor
65412588|NCT03998670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412589|NCT03998670|Dopamine Agents|dopamine agents|mesh-ancestor
65412590|NCT03998670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65412591|NCT03998670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412592|NCT03998670|Adrenergic Agents|adrenergic agents|mesh-ancestor
65412593|NCT03998670|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65412594|NCT03998670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65412595|NCT03998670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65412596|NCT03998670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65412597|NCT00843323|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65412598|NCT00843323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65234943|NCT05190094|Letrozole|letrozole|mesh-list
65412599|NCT00843323|Dermatologic Agents|dermatologic agents|mesh-ancestor
65412600|NCT00852683|Pregabalin|pregabalin|mesh-list
65412601|NCT00852683|Analgesics|analgesics|mesh-ancestor
65412602|NCT00852683|Sensory System Agents|sensory system agents|mesh-ancestor
65412603|NCT00852683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412604|NCT00852683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412605|NCT00852683|Anticonvulsants|anticonvulsants|mesh-ancestor
65412606|NCT00852683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65412607|NCT00852683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65412608|NCT00852683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412609|NCT00852683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65412610|NCT00852683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65412611|NCT00852683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65412612|NCT00852683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65412613|NCT00852683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65412614|NCT00619307|Interferon beta-1a|interferon beta-1a|mesh-list
65412615|NCT00619307|Ibuprofen|ibuprofen|mesh-list
65412616|NCT00619307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65412617|NCT00619307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65412618|NCT00619307|Analgesics|analgesics|mesh-ancestor
65412619|NCT00619307|Sensory System Agents|sensory system agents|mesh-ancestor
65412620|NCT00619307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412621|NCT00619307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412622|NCT00619307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65412623|NCT00619307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65412624|NCT00619307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65412625|NCT00619307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412626|NCT00619307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412627|NCT00619307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64797397|NCT01384448|Sympathomimetics|sympathomimetics|mesh-ancestor
65412659|NCT02546297|Adrenergic Agents|adrenergic agents|mesh-ancestor
65412660|NCT02546297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65412661|NCT02546297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412662|NCT02546297|Parasympatholytics|parasympatholytics|mesh-ancestor
65412663|NCT02546297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65412664|NCT02546297|Cholinergic Agents|cholinergic agents|mesh-ancestor
65412665|NCT02546297|Anticonvulsants|anticonvulsants|mesh-ancestor
65412667|NCT00618995|Niacinamide|niacinamide|mesh-list
65412668|NCT00618995|Nicotinic Acids|nicotinic acids|mesh-list
65412669|NCT00618995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65412670|NCT00618995|Antimetabolites|antimetabolites|mesh-ancestor
64797454|NCT01384864|Proflavine|proflavine|mesh-list
65412693|NCT00856037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412694|NCT00856037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65412695|NCT02615184|Dexlansoprazole|dexlansoprazole|mesh-list
65412696|NCT02615184|Lansoprazole|lansoprazole|mesh-list
65412697|NCT02615184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65412698|NCT02615184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65412699|NCT02615184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65412700|NCT02615184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412701|NCT02615184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412702|NCT00856271|Losartan|losartan|mesh-list
65412703|NCT00856271|Olmesartan|olmesartan|mesh-list
65412704|NCT00856271|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65412705|NCT00856271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65412706|NCT00856271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65412707|NCT00856271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65412708|NCT00856271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65412709|NCT00856271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412710|NCT00856505|Mycophenolic Acid|mycophenolic acid|mesh-list
65412711|NCT00856505|Everolimus|everolimus|mesh-list
65412712|NCT00856505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412713|NCT00856505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65412714|NCT00856505|Immunologic Factors|immunologic factors|mesh-ancestor
65412715|NCT00856505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412716|NCT00856505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65412717|NCT00856505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65412718|NCT00856505|Antitubercular Agents|antitubercular agents|mesh-ancestor
65412719|NCT00856505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65412720|NCT00856505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65412721|NCT00856505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412722|NCT00856505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412723|NCT02544893|Dexmedetomidine|dexmedetomidine|mesh-list
65235015|NCT04989946|Nivolumab|nivolumab|mesh-list
65412724|NCT02544893|Bupivacaine|bupivacaine|mesh-list
65412725|NCT02544893|Anesthetics, Local|anesthetics, local|mesh-ancestor
65412736|NCT02544893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65412737|NCT02544893|Adrenergic Agents|adrenergic agents|mesh-ancestor
65412738|NCT02544893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65412739|NCT02544893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412740|NCT00520572|Etanercept|etanercept|mesh-list
65412741|NCT00520572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65412742|NCT00520572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65412743|NCT00520572|Analgesics|analgesics|mesh-ancestor
65412744|NCT00520572|Sensory System Agents|sensory system agents|mesh-ancestor
65412745|NCT00520572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412746|NCT00520572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412747|NCT00520572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65412748|NCT00520572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65412749|NCT00520572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65412750|NCT00520572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65412751|NCT00520572|Immunologic Factors|immunologic factors|mesh-ancestor
65412752|NCT00853697|Methyltestosterone|methyltestosterone|mesh-list
65412753|NCT00853697|Testosterone|testosterone|mesh-list
65412754|NCT00853697|Testosterone undecanoate|testosterone undecanoate|mesh-list
65412755|NCT00853697|Testosterone enanthate|testosterone enanthate|mesh-list
65412756|NCT00853697|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65412757|NCT00853697|Dutasteride|dutasteride|mesh-list
65412758|NCT00853697|Androgens|androgens|mesh-ancestor
65412759|NCT00853697|Hormones|hormones|mesh-ancestor
65412760|NCT00853697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65412761|NCT00853697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412762|NCT00853697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65412763|NCT00853697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412764|NCT00853697|Anabolic Agents|anabolic agents|mesh-ancestor
65412765|NCT00853697|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65412766|NCT00853697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65412767|NCT00853697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412768|NCT00853697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412769|NCT00853697|Hormone Antagonists|hormone antagonists|mesh-ancestor
65412770|NCT00861419|Niacinamide|niacinamide|mesh-list
65412771|NCT00861419|Bevacizumab|bevacizumab|mesh-list
65412772|NCT00861419|Sunitinib|sunitinib|mesh-list
65412773|NCT00861419|Trebananib|trebananib|mesh-list
65412774|NCT00861419|Sorafenib|sorafenib|mesh-list
65412775|NCT00861419|Motesanib diphosphate|motesanib diphosphate|mesh-list
65412776|NCT00861419|Imetelstat|imetelstat|mesh-list
65412777|NCT00861419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65412778|NCT00861419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412779|NCT00861419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65412780|NCT00861419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65412781|NCT00861419|Growth Substances|growth substances|mesh-ancestor
65412782|NCT00861419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412783|NCT00861419|Growth Inhibitors|growth inhibitors|mesh-ancestor
65412784|NCT00861419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65412785|NCT00861419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412786|NCT00861419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412787|NCT00861419|Vitamin B Complex|vitamin b complex|mesh-ancestor
65412788|NCT00861419|Vitamins|vitamins|mesh-ancestor
65412789|NCT00861419|Micronutrients|micronutrients|mesh-ancestor
65412790|NCT00527514|Amlodipine|amlodipine|mesh-list
65412791|NCT00527514|Olmesartan|olmesartan|mesh-list
65412798|NCT00527514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412799|NCT00527514|Vasodilator Agents|vasodilator agents|mesh-ancestor
65412800|NCT00527514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65412801|NCT00527514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65412803|NCT03998826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65412804|NCT03998826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65412805|NCT03998826|Analgesics|analgesics|mesh-ancestor
65412806|NCT03998826|Sensory System Agents|sensory system agents|mesh-ancestor
65412807|NCT03998826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412808|NCT03998826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412809|NCT03998826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65412810|NCT03998826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65412811|NCT03998826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65412812|NCT03998826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412813|NCT03998826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412814|NCT04035486|Carboplatin|carboplatin|mesh-list
65412815|NCT04035486|Pemetrexed|pemetrexed|mesh-list
65235090|NCT02588404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65412816|NCT04035486|Osimertinib|osimertinib|mesh-list
65412817|NCT04035486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412818|NCT04035486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412819|NCT04035486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412820|NCT04035486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65412821|NCT04035486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65412822|NCT04035486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65412823|NCT00853931|Panitumumab|panitumumab|mesh-list
65412824|NCT00853931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65412825|NCT00853931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412826|NCT00854009|BLI-489|bli-489|mesh-list
65412827|NCT00854009|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65412828|NCT00854009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412829|NCT00854009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412830|NCT00854009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65412831|NCT00854009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65412832|NCT03998592|Vaccines|vaccines|mesh-list
65412833|NCT03998592|Immunologic Factors|immunologic factors|mesh-ancestor
65162347|NCT02797717|Vincristine|vincristine|mesh-list
65412834|NCT03998592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412835|NCT00861731|Simvastatin|simvastatin|mesh-list
65412836|NCT00861731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65412837|NCT00861731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65412838|NCT00861731|Antimetabolites|antimetabolites|mesh-ancestor
65412839|NCT00861731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412840|NCT00861731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65412841|NCT00861731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65412842|NCT00861731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412843|NCT02544659|Pamidronate|pamidronate|mesh-list
65412844|NCT02544659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65412845|NCT02544659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412846|NCT00861887|Vancomycin|vancomycin|mesh-list
65412847|NCT00861887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65412848|NCT00861887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65412849|NCT00857519|Carboplatin|carboplatin|mesh-list
65412850|NCT00857519|Melphalan|melphalan|mesh-list
65412851|NCT00857519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412852|NCT00857519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65412853|NCT00857519|Alkylating Agents|alkylating agents|mesh-ancestor
65412854|NCT00857519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412855|NCT00857519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65412856|NCT00857519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65412874|NCT00857753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65412875|NCT00857753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412876|NCT00857753|Analgesics|analgesics|mesh-ancestor
65412877|NCT00857753|Sensory System Agents|sensory system agents|mesh-ancestor
65412878|NCT00857753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412879|NCT00857753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65412880|NCT00857753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65412881|NCT00857753|Anesthetics, General|anesthetics, general|mesh-ancestor
65412882|NCT00857753|Anesthetics|anesthetics|mesh-ancestor
65412883|NCT00854321|Rituximab|rituximab|mesh-list
65412884|NCT00854321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65412885|NCT00854321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412886|NCT00854321|Immunologic Factors|immunologic factors|mesh-ancestor
65412887|NCT00854321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412888|NCT00854321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65412889|NCT03684642|Metformin|metformin|mesh-list
65412890|NCT03684642|Dulaglutide|dulaglutide|mesh-list
65412891|NCT03684642|Efpeglenatide|efpeglenatide|mesh-list
65412892|NCT03684642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65412893|NCT03684642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412894|NCT00857831|Vitamin D|vitamin d|mesh-list
65412895|NCT00857831|Calcium|calcium|mesh-list
65412896|NCT00857831|Vitamins|vitamins|mesh-ancestor
65412897|NCT00857831|Micronutrients|micronutrients|mesh-ancestor
65412898|NCT00857831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412899|NCT00857831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65412900|NCT00857831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65412901|NCT00862043|Sildenafil Citrate|sildenafil citrate|mesh-list
65412902|NCT00862043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412903|NCT00862043|Vasodilator Agents|vasodilator agents|mesh-ancestor
65412904|NCT00862043|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65235200|NCT04082962|Hormones|hormones|mesh-ancestor
65412905|NCT00862043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65412906|NCT00862043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412907|NCT00862043|Urological Agents|urological agents|mesh-ancestor
65412908|NCT00519636|Fluticasone|fluticasone|mesh-list
65412909|NCT00519636|Xhance|xhance|mesh-list
65412910|NCT00519636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65412911|NCT00519636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65412912|NCT00519636|Autonomic Agents|autonomic agents|mesh-ancestor
65412913|NCT00519636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412914|NCT00519636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412915|NCT00519636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65412916|NCT00519636|Respiratory System Agents|respiratory system agents|mesh-ancestor
65412917|NCT00519636|Dermatologic Agents|dermatologic agents|mesh-ancestor
64797685|NCT01386567|Citric Acid|citric acid|mesh-list
65412928|NCT00857909|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65412929|NCT00857909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65412930|NCT00857909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65412931|NCT00857909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412932|NCT00857909|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65412934|NCT00857987|Respiratory System Agents|respiratory system agents|mesh-ancestor
65412935|NCT00854477|Capecitabine|capecitabine|mesh-list
65412936|NCT00854477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65412937|NCT00854477|Antimetabolites|antimetabolites|mesh-ancestor
65412938|NCT00854477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412939|NCT00854477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412940|NCT00854633|Lactoferrin|lactoferrin|mesh-list
65412941|NCT00854633|Talactoferrin alfa|talactoferrin alfa|mesh-list
65412942|NCT00854633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65412943|NCT00854633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412944|NCT00618371|Raltegravir Potassium|raltegravir potassium|mesh-list
65412945|NCT00618371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65412946|NCT00618371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65412947|NCT00618371|Antiviral Agents|antiviral agents|mesh-ancestor
65412948|NCT00618371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65412949|NCT00618371|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65412950|NCT00618371|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65412951|NCT00618371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412952|NCT00618371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412953|NCT00858299|Valsartan|valsartan|mesh-list
65412954|NCT00858299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65412955|NCT00858299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65412956|NCT00858299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65412957|NCT00858299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412958|NCT00526890|Selenium|selenium|mesh-list
65412959|NCT00526890|Paclitaxel|paclitaxel|mesh-list
65412960|NCT00526890|Carboplatin|carboplatin|mesh-list
65412961|NCT00526890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65412962|NCT00526890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412963|NCT00526890|Tubulin Modulators|tubulin modulators|mesh-ancestor
65412964|NCT00526890|Antimitotic Agents|antimitotic agents|mesh-ancestor
65412965|NCT00526890|Mitosis Modulators|mitosis modulators|mesh-ancestor
65412966|NCT00526890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412967|NCT00526890|Antioxidants|antioxidants|mesh-ancestor
65412968|NCT00526890|Protective Agents|protective agents|mesh-ancestor
65412969|NCT00526890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412970|NCT00526890|Trace Elements|trace elements|mesh-ancestor
65412971|NCT00526890|Micronutrients|micronutrients|mesh-ancestor
65412972|NCT04041167|Thioctic Acid|thioctic acid|mesh-list
65412973|NCT04041167|Antioxidants|antioxidants|mesh-ancestor
65412974|NCT04041167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412975|NCT04041167|Protective Agents|protective agents|mesh-ancestor
65412976|NCT04041167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412977|NCT04041167|Vitamin B Complex|vitamin b complex|mesh-ancestor
65412978|NCT04041167|Vitamins|vitamins|mesh-ancestor
65412979|NCT04041167|Micronutrients|micronutrients|mesh-ancestor
65412980|NCT00858377|Complement Factor H|complement factor h|mesh-list
65412981|NCT00858377|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65413002|NCT00858455|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65413003|NCT00858455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413004|NCT00858455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413005|NCT00858455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65413006|NCT00858455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65413007|NCT00858455|Antiviral Agents|antiviral agents|mesh-ancestor
65413008|NCT00858455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65235241|NCT02312245|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65413010|NCT02544737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413011|NCT02544737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65413012|NCT02544737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413013|NCT02544737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413014|NCT00526656|Sunitinib|sunitinib|mesh-list
65413015|NCT00526656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413016|NCT00526656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65413017|NCT00526656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65413018|NCT00526656|Growth Substances|growth substances|mesh-ancestor
65413019|NCT00526656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413020|NCT00526656|Growth Inhibitors|growth inhibitors|mesh-ancestor
65413021|NCT00526656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65413022|NCT00526656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413023|NCT00526656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413024|NCT00858767|Vitamin K 2|vitamin k 2|mesh-list
65413025|NCT00858767|Vitamin K|vitamin k|mesh-list
65413026|NCT00858767|Vitamin MK 7|vitamin mk 7|mesh-list
65413027|NCT00858767|Caseins|caseins|mesh-list
65413028|NCT00858767|Chelating Agents|chelating agents|mesh-ancestor
65413029|NCT00858767|Sequestering Agents|sequestering agents|mesh-ancestor
65413030|NCT00858767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413031|NCT00858767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65413032|NCT00858767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65413033|NCT00858767|Hemostatics|hemostatics|mesh-ancestor
65413034|NCT00858767|Coagulants|coagulants|mesh-ancestor
65413035|NCT00858767|Vitamins|vitamins|mesh-ancestor
65413036|NCT00858767|Micronutrients|micronutrients|mesh-ancestor
65413037|NCT00858767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413038|NCT00617903|Azelaic acid|azelaic acid|mesh-list
65413053|NCT00526110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413054|NCT04565730|Anesthetics|anesthetics|mesh-list
65413055|NCT04565730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65413056|NCT04565730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413057|NCT00859079|Insulin|insulin|mesh-list
65413058|NCT00859079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65413059|NCT00859079|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65413060|NCT00859079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65413061|NCT00859079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413062|NCT00859079|Incretins|incretins|mesh-ancestor
65413063|NCT00859079|Hormones|hormones|mesh-ancestor
65413064|NCT00859079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65413065|NCT02544425|Dexamethasone|dexamethasone|mesh-list
65413066|NCT02544425|Etoposide|etoposide|mesh-list
65413067|NCT02544425|Melphalan|melphalan|mesh-list
65413068|NCT02544425|Busulfan|busulfan|mesh-list
65413069|NCT02544425|Asparaginase|asparaginase|mesh-list
65413070|NCT02544425|Ifosfamide|ifosfamide|mesh-list
65413071|NCT02544425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65413072|NCT02544425|Antiemetics|antiemetics|mesh-ancestor
65413073|NCT02544425|Autonomic Agents|autonomic agents|mesh-ancestor
65413074|NCT02544425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65413075|NCT02544425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413076|NCT02544425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65413077|NCT02544425|Glucocorticoids|glucocorticoids|mesh-ancestor
65413078|NCT02544425|Hormones|hormones|mesh-ancestor
65413079|NCT02544425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65413080|NCT02544425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65413081|NCT02544425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413082|NCT02544425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65413083|NCT02544425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65413084|NCT02544425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65413085|NCT02544425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413086|NCT02544425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413087|NCT02544425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65413088|NCT02544425|Alkylating Agents|alkylating agents|mesh-ancestor
65413089|NCT02544425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65413090|NCT02544425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65413091|NCT02544425|Immunologic Factors|immunologic factors|mesh-ancestor
65413092|NCT00859235|Chlorhexidine|chlorhexidine|mesh-list
65413093|NCT00859235|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65413094|NCT00859235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65413095|NCT00859235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65413096|NCT00859235|Disinfectants|disinfectants|mesh-ancestor
65413097|NCT00859235|Dermatologic Agents|dermatologic agents|mesh-ancestor
65413098|NCT04523688|Temozolomide|temozolomide|mesh-list
65235317|NCT04767061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65413099|NCT04523688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65413100|NCT04523688|Alkylating Agents|alkylating agents|mesh-ancestor
64797857|NCT01387295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65413111|NCT00859703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65413112|NCT00859703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413113|NCT00859703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65413114|NCT00859703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413115|NCT00859703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65413117|NCT03998436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65413118|NCT03998436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65413119|NCT03998436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65413120|NCT03998436|Adrenergic Agents|adrenergic agents|mesh-ancestor
65413121|NCT03998436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413122|NCT03998436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413123|NCT03998436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413124|NCT00855101|Voriconazole|voriconazole|mesh-list
65413125|NCT00855101|Antifungal Agents|antifungal agents|mesh-ancestor
65413126|NCT00855101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65413127|NCT00855101|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65413128|NCT00855101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65413129|NCT00855101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413130|NCT00855101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413131|NCT00855101|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65413132|NCT00855101|Hormone Antagonists|hormone antagonists|mesh-ancestor
65413133|NCT00855101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65413134|NCT00855101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413135|NCT00855101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65162654|NCT02785393|Doxazosin|doxazosin|mesh-list
65413136|NCT00573755|Sorafenib|sorafenib|mesh-list
65413137|NCT00573755|Letrozole|letrozole|mesh-list
65413138|NCT00573755|Anastrozole|anastrozole|mesh-list
65413139|NCT00573755|Exemestane|exemestane|mesh-list
65413140|NCT00573755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413141|NCT00573755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65413142|NCT00573755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413143|NCT00573755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413144|NCT00573755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65413145|NCT00573755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65413146|NCT00573755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65413147|NCT00573755|Hormone Antagonists|hormone antagonists|mesh-ancestor
65413148|NCT00573755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65413149|NCT00573755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413150|NCT00573755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65413151|NCT02544191|Goserelin|goserelin|mesh-list
65413152|NCT02544191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65413153|NCT02544191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413154|NCT00524316|Doxorubicin|doxorubicin|mesh-list
65413155|NCT00524316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65413156|NCT00524316|Sunitinib|sunitinib|mesh-list
65413157|NCT00524316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65413158|NCT00524316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413159|NCT00524316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65413160|NCT00524316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64797920|NCT01388049|Antibodies|antibodies|mesh-list
65413168|NCT00524316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65413170|NCT03861936|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65413171|NCT03861936|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65413172|NCT03861936|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65413173|NCT03861936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65413174|NCT03861936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413175|NCT03861936|Cholinergic Agents|cholinergic agents|mesh-ancestor
65413176|NCT03861936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413177|NCT03861936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413178|NCT03861936|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65413179|NCT03861936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65413180|NCT02544269|Bupivacaine|bupivacaine|mesh-list
65413181|NCT02544269|Ropivacaine|ropivacaine|mesh-list
65413182|NCT02544269|Anesthetics, Local|anesthetics, local|mesh-ancestor
65413183|NCT02544269|Anesthetics|anesthetics|mesh-ancestor
65413184|NCT02544269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65413185|NCT02544269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413186|NCT02544269|Sensory System Agents|sensory system agents|mesh-ancestor
65413187|NCT02544269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65413188|NCT00434577|Vaccines|vaccines|mesh-list
65413189|NCT00434577|Immunologic Factors|immunologic factors|mesh-ancestor
65413190|NCT00434577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413191|NCT00865085|Dexetimide|dexetimide|mesh-list
65413192|NCT00865085|Citalopram|citalopram|mesh-list
65413193|NCT00865085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65413194|NCT00865085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65413195|NCT00865085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65413196|NCT00865085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413197|NCT00865085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413198|NCT00865085|Serotonin Agents|serotonin agents|mesh-ancestor
65413199|NCT00865085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413200|NCT00865085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65413201|NCT00865085|Antidepressive Agents|antidepressive agents|mesh-ancestor
65413202|NCT00865085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65413203|NCT00865085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65413204|NCT00865085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65413205|NCT00865085|Parasympatholytics|parasympatholytics|mesh-ancestor
65413206|NCT00865085|Autonomic Agents|autonomic agents|mesh-ancestor
65413207|NCT00865085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65413208|NCT00865085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65413209|NCT00865085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65162722|NCT02268175|Glucocorticoids|glucocorticoids|mesh-ancestor
65413210|NCT00865085|Cholinergic Agents|cholinergic agents|mesh-ancestor
65413211|NCT00796068|Cyclosporine|cyclosporine|mesh-list
65413212|NCT00796068|Mycophenolic Acid|mycophenolic acid|mesh-list
65413213|NCT00796068|Fludarabine|fludarabine|mesh-list
65413214|NCT00796068|Fludarabine phosphate|fludarabine phosphate|mesh-list
65413215|NCT00796068|Treosulfan|treosulfan|mesh-list
65413216|NCT00796068|Busulfan|busulfan|mesh-list
65413217|NCT00796068|Cyclosporins|cyclosporins|mesh-list
65413218|NCT00796068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413219|NCT00796068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65413220|NCT00796068|Antimetabolites|antimetabolites|mesh-ancestor
65413221|NCT00796068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413222|NCT00796068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65413223|NCT00796068|Immunologic Factors|immunologic factors|mesh-ancestor
65413224|NCT00796068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413225|NCT00796068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413226|NCT00796068|Antifungal Agents|antifungal agents|mesh-ancestor
65413241|NCT04732182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413242|NCT04732182|Cholinergic Agents|cholinergic agents|mesh-ancestor
65413243|NCT04732182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413244|NCT04732182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413245|NCT04732182|Nootropic Agents|nootropic agents|mesh-ancestor
65413246|NCT03783078|Pembrolizumab|pembrolizumab|mesh-list
65413247|NCT03783078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65413248|NCT03783078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413249|NCT01009476|Nicergoline|nicergoline|mesh-list
65413250|NCT01009476|Piracetam|piracetam|mesh-list
65413251|NCT01009476|Galantamine|galantamine|mesh-list
65413252|NCT01009476|Nootropic Agents|nootropic agents|mesh-list
65413253|NCT01009476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65413254|NCT01009476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413255|NCT01009476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413256|NCT01009476|Cholinergic Agents|cholinergic agents|mesh-ancestor
65413257|NCT01009476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413258|NCT01009476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413259|NCT01009476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65413260|NCT01009476|Autonomic Agents|autonomic agents|mesh-ancestor
65413261|NCT01009476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65413262|NCT01009476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65413263|NCT01009476|Protective Agents|protective agents|mesh-ancestor
65413264|NCT01009476|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65413265|NCT01009476|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65413266|NCT01009476|Adrenergic Agents|adrenergic agents|mesh-ancestor
65413267|NCT01009476|Vasodilator Agents|vasodilator agents|mesh-ancestor
65413268|NCT00517296|Adalimumab|adalimumab|mesh-list
65413269|NCT00517296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65413270|NCT00517296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65413271|NCT00516906|Chlorhexidine|chlorhexidine|mesh-list
65413272|NCT00516906|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65413273|NCT00516906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65413274|NCT00516906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65413275|NCT00516906|Disinfectants|disinfectants|mesh-ancestor
65413276|NCT00516906|Dermatologic Agents|dermatologic agents|mesh-ancestor
65413277|NCT00523848|Thalidomide|thalidomide|mesh-list
65413278|NCT00523848|Doxorubicin|doxorubicin|mesh-list
65413279|NCT00523848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65413280|NCT00523848|Bortezomib|bortezomib|mesh-list
65413281|NCT00523848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65413282|NCT00523848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413283|NCT00523848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65413284|NCT00523848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65413285|NCT00523848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413286|NCT00523848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413287|NCT00523848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65413289|NCT00523848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413297|NCT04414722|Amoxicillin|amoxicillin|mesh-list
65413298|NCT04414722|Clavulanic Acid|clavulanic acid|mesh-list
65413299|NCT04414722|Clavulanic Acids|clavulanic acids|mesh-list
65413300|NCT04414722|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65413301|NCT04414722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65413302|NCT04414722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65413303|NCT04414722|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65413304|NCT04414722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413305|NCT04414722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413306|NCT00617669|Docetaxel|docetaxel|mesh-list
65413307|NCT00617669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413308|NCT00617669|Tubulin Modulators|tubulin modulators|mesh-ancestor
65413309|NCT00617669|Antimitotic Agents|antimitotic agents|mesh-ancestor
65413310|NCT00617669|Mitosis Modulators|mitosis modulators|mesh-ancestor
65413311|NCT00617669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413312|NCT04018157|Dexmedetomidine|dexmedetomidine|mesh-list
65413313|NCT04018157|Ketamine|ketamine|mesh-list
65413314|NCT04018157|Propofol|propofol|mesh-list
65413315|NCT04018157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65413316|NCT04018157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65413317|NCT04018157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413318|NCT04018157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65413319|NCT04018157|Anesthetics, General|anesthetics, general|mesh-ancestor
65413320|NCT04018157|Anesthetics|anesthetics|mesh-ancestor
65413321|NCT04018157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65413322|NCT04018157|Analgesics|analgesics|mesh-ancestor
65413323|NCT04018157|Sensory System Agents|sensory system agents|mesh-ancestor
65413324|NCT04018157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65413325|NCT04018157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65413326|NCT04018157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65413327|NCT04018157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65413328|NCT04018157|Adrenergic Agents|adrenergic agents|mesh-ancestor
65413329|NCT04018157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413330|NCT04018157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413331|NCT04018157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65413332|NCT04018157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65413333|NCT04018157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65413334|NCT00865241|Metformin|metformin|mesh-list
65413335|NCT00865241|Glyburide|glyburide|mesh-list
65413336|NCT00865241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65413337|NCT00865241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413338|NCT00863213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
65413339|NCT00860639|Gemtuzumab|gemtuzumab|mesh-list
65413340|NCT00860639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65413341|NCT00860639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413342|NCT00863291|Buprenorphine|buprenorphine|mesh-list
65413343|NCT00863291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65413344|NCT00863291|Narcotics|narcotics|mesh-ancestor
65413345|NCT00863291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65413346|NCT00863291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413347|NCT00863291|Analgesics|analgesics|mesh-ancestor
65413348|NCT00863291|Sensory System Agents|sensory system agents|mesh-ancestor
65413349|NCT00863291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65413350|NCT00863291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65413351|NCT00865319|Deoxyglucose|deoxyglucose|mesh-list
65413352|NCT00865319|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65413353|NCT00865319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65413354|NCT00865319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413355|NCT00865319|Antimetabolites|antimetabolites|mesh-ancestor
65413356|NCT00865319|Antiviral Agents|antiviral agents|mesh-ancestor
65413357|NCT00865319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65413358|NCT03639714|Nivolumab|nivolumab|mesh-list
65413370|NCT00861029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235546|NCT00942968|Anticoagulants|anticoagulants|mesh-ancestor
65413371|NCT00861029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413372|NCT00861029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413373|NCT00861029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65413374|NCT00861029|Contraceptive Agents|contraceptive agents|mesh-ancestor
65413375|NCT00861029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65413376|NCT00861029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413377|NCT00861029|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65413378|NCT00861029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65413379|NCT00861029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65413380|NCT00865397|Insulin Detemir|insulin detemir|mesh-list
65413381|NCT00865397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65413382|NCT00865397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413383|NCT00861107|Vaccines|vaccines|mesh-list
65413384|NCT00861107|Immunologic Factors|immunologic factors|mesh-ancestor
65413385|NCT00861107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413386|NCT00510510|Glycopyrrolate|glycopyrrolate|mesh-list
65413387|NCT00510510|Bromides|bromides|mesh-list
65413388|NCT00510510|Anticonvulsants|anticonvulsants|mesh-ancestor
65413389|NCT00510510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65413390|NCT00510510|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65413391|NCT00510510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65413392|NCT00510510|Cholinergic Agents|cholinergic agents|mesh-ancestor
65413393|NCT00510510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413394|NCT00510510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413395|NCT00510510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413396|NCT04685694|Misoprostol|misoprostol|mesh-list
65413397|NCT04685694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65413398|NCT04685694|Abortifacient Agents|abortifacient agents|mesh-ancestor
65413399|NCT04685694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65413400|NCT04685694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413401|NCT04685694|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65413402|NCT04685694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65413403|NCT04685694|Oxytocics|oxytocics|mesh-ancestor
65413404|NCT00870311|Lithium Carbonate|lithium carbonate|mesh-list
65413405|NCT00870311|Antidepressive Agents|antidepressive agents|mesh-ancestor
65413406|NCT00870311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65413407|NCT00870311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413408|NCT00870311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413409|NCT00870311|Antimanic Agents|antimanic agents|mesh-ancestor
65413410|NCT00870311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65413411|NCT00870311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65413412|NCT00870311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413413|NCT00865631|Gabapentin|gabapentin|mesh-list
65413414|NCT00865631|Analgesics|analgesics|mesh-ancestor
65413415|NCT00865631|Sensory System Agents|sensory system agents|mesh-ancestor
65413416|NCT00865631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65413417|NCT00865631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413418|NCT00865631|Anticonvulsants|anticonvulsants|mesh-ancestor
65413419|NCT00865631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65413423|NCT00865631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65413424|NCT00865631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65413425|NCT00865631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413426|NCT00865631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413427|NCT00865631|Antimanic Agents|antimanic agents|mesh-ancestor
65413428|NCT00863837|Terlipressin|terlipressin|mesh-list
65413429|NCT00863837|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65413430|NCT00863837|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65413431|NCT00863837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413432|NCT00863837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413433|NCT00863837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65413434|NCT00863915|Ramipril|ramipril|mesh-list
65413435|NCT00863915|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65413436|NCT00863915|Protease Inhibitors|protease inhibitors|mesh-ancestor
65413437|NCT00863915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413438|NCT00863915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413439|NCT00863915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65413441|NCT01009944|Lisinopril|lisinopril|mesh-list
65413442|NCT01009944|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65413443|NCT01009944|Protease Inhibitors|protease inhibitors|mesh-ancestor
65413444|NCT01009944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413445|NCT01009944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413446|NCT01009944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65269894|NCT02732132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413447|NCT01009944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65413448|NCT01009944|Protective Agents|protective agents|mesh-ancestor
65413449|NCT01009944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413450|NCT01009944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65413451|NCT01009944|Sympatholytics|sympatholytics|mesh-ancestor
65413452|NCT01009944|Autonomic Agents|autonomic agents|mesh-ancestor
65413453|NCT01009944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65413454|NCT01009944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65413455|NCT01009944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65413456|NCT01009944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65413457|NCT01009944|Adrenergic Agents|adrenergic agents|mesh-ancestor
65413458|NCT01009944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413459|NCT01010022|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65413460|NCT01010022|Plasma Substitutes|plasma substitutes|mesh-ancestor
65413461|NCT01010022|Blood Substitutes|blood substitutes|mesh-ancestor
65413462|NCT00864071|Griseofulvin|griseofulvin|mesh-list
65413463|NCT00864071|Antifungal Agents|antifungal agents|mesh-ancestor
65413464|NCT00864071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65413465|NCT04264026|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65413466|NCT04264026|Hallucinogens|hallucinogens|mesh-ancestor
65413467|NCT04264026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413468|NCT04264026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65413469|NCT04264026|Serotonin Agents|serotonin agents|mesh-ancestor
65413470|NCT04264026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413471|NCT04264026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413472|NCT04264026|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65413473|NCT04264026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65413474|NCT04264026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65413475|NCT04264026|Adrenergic Agents|adrenergic agents|mesh-ancestor
65413476|NCT00864149|Carvedilol|carvedilol|mesh-list
65413477|NCT00864149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65413478|NCT00864149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65413479|NCT00864149|Adrenergic Agents|adrenergic agents|mesh-ancestor
65413480|NCT00864149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413481|NCT00864149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413482|NCT00864149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413483|NCT00864149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65413484|NCT00864149|Antioxidants|antioxidants|mesh-ancestor
65413485|NCT00864149|Protective Agents|protective agents|mesh-ancestor
65413486|NCT00864149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65413487|NCT00864149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65413488|NCT00864149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65413489|NCT00864149|Vasodilator Agents|vasodilator agents|mesh-ancestor
64798229|NCT01389544|Ritonavir|ritonavir|mesh-list
65413503|NCT01010178|Autonomic Agents|autonomic agents|mesh-ancestor
65413504|NCT01010178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65413505|NCT01010178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413506|NCT01010178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65413507|NCT01010178|Respiratory System Agents|respiratory system agents|mesh-ancestor
65413508|NCT01010178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65413509|NCT01010178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413510|NCT01010178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413511|NCT01010178|Vasodilator Agents|vasodilator agents|mesh-ancestor
65413512|NCT01010178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65413513|NCT01010178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65413514|NCT01010178|Purinergic Agents|purinergic agents|mesh-ancestor
65413515|NCT01010178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413516|NCT00617591|Dexamethasone|dexamethasone|mesh-list
65413517|NCT00617591|Doxorubicin|doxorubicin|mesh-list
65413518|NCT00617591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65413519|NCT00617591|Lenalidomide|lenalidomide|mesh-list
65413520|NCT00617591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65413521|NCT00617591|Antiemetics|antiemetics|mesh-ancestor
65413522|NCT00617591|Autonomic Agents|autonomic agents|mesh-ancestor
65413523|NCT00617591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65413524|NCT00617591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413525|NCT00617591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65413526|NCT00617591|Glucocorticoids|glucocorticoids|mesh-ancestor
65413527|NCT00617591|Hormones|hormones|mesh-ancestor
65413528|NCT00617591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65413529|NCT00617591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65269895|NCT02732132|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65413530|NCT00617591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413531|NCT00617591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65413532|NCT00617591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65413533|NCT00617591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65413534|NCT00617591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413535|NCT00617591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413536|NCT00617591|Immunologic Factors|immunologic factors|mesh-ancestor
65413537|NCT00617591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65413538|NCT00617591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65413539|NCT00617591|Growth Substances|growth substances|mesh-ancestor
65413540|NCT00617591|Growth Inhibitors|growth inhibitors|mesh-ancestor
65413541|NCT00864305|Gabapentin|gabapentin|mesh-list
65413542|NCT00864305|Analgesics|analgesics|mesh-ancestor
65413543|NCT00864305|Sensory System Agents|sensory system agents|mesh-ancestor
65413544|NCT00864305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65413545|NCT00864305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413546|NCT00864305|Anticonvulsants|anticonvulsants|mesh-ancestor
65413547|NCT00864305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65413548|NCT00864305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65413549|NCT00864305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64798303|NCT01389791|Tocolytic Agents|tocolytic agents|mesh-ancestor
65413558|NCT00510276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65413559|NCT00510276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65413560|NCT00510276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413561|NCT00510276|Adrenergic Agents|adrenergic agents|mesh-ancestor
65413562|NCT00510276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413563|NCT00510276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413564|NCT04018313|Omalizumab|omalizumab|mesh-list
65413565|NCT04018313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65413566|NCT04018313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65413567|NCT04018313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65413568|NCT04018313|Respiratory System Agents|respiratory system agents|mesh-ancestor
65413569|NCT04018313|Immunologic Factors|immunologic factors|mesh-ancestor
65413570|NCT04018313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413571|NCT00864617|Nifedipine|nifedipine|mesh-list
65413572|NCT00864617|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65413573|NCT00864617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65413574|NCT00864617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413575|NCT00864617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65413576|NCT00864617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413577|NCT00864617|Vasodilator Agents|vasodilator agents|mesh-ancestor
65413578|NCT00864617|Tocolytic Agents|tocolytic agents|mesh-ancestor
65413579|NCT00864617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65413580|NCT00865943|Dexetimide|dexetimide|mesh-list
65413581|NCT00865943|Citalopram|citalopram|mesh-list
65413582|NCT00865943|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65413583|NCT00865943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65413584|NCT00865943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65413585|NCT00865943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413586|NCT00865943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413587|NCT00865943|Serotonin Agents|serotonin agents|mesh-ancestor
65413588|NCT00865943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413589|NCT00865943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65413590|NCT00865943|Antidepressive Agents|antidepressive agents|mesh-ancestor
65413591|NCT00865943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65413592|NCT00865943|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65413593|NCT00865943|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65413594|NCT00865943|Parasympatholytics|parasympatholytics|mesh-ancestor
65413595|NCT00865943|Autonomic Agents|autonomic agents|mesh-ancestor
65413596|NCT00865943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65413597|NCT00865943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65413598|NCT00865943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65413599|NCT00865943|Cholinergic Agents|cholinergic agents|mesh-ancestor
65413600|NCT00866021|Ritonavir|ritonavir|mesh-list
65413601|NCT00866021|Lopinavir|lopinavir|mesh-list
65413602|NCT00866021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65413603|NCT00866021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65413604|NCT00866021|Protease Inhibitors|protease inhibitors|mesh-ancestor
65413605|NCT00866021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413606|NCT00866021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413607|NCT00866021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65413608|NCT00866021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65235772|NCT04080622|Trace Elements|trace elements|mesh-ancestor
65413609|NCT00866021|Antiviral Agents|antiviral agents|mesh-ancestor
65413610|NCT00866021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65413611|NCT00866021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65413612|NCT00866021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65413613|NCT04545762|Cyclophosphamide|cyclophosphamide|mesh-list
65413614|NCT04545762|Fludarabine|fludarabine|mesh-list
65413630|NCT00871247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413631|NCT00871247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413632|NCT00871247|Hormone Antagonists|hormone antagonists|mesh-ancestor
65413633|NCT00871247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65413634|NCT00871247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413635|NCT00871247|Urological Agents|urological agents|mesh-ancestor
65413636|NCT02543879|Azacitidine|azacitidine|mesh-list
65413637|NCT02543879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65413638|NCT02543879|Antimetabolites|antimetabolites|mesh-ancestor
65413639|NCT02543879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413640|NCT02543879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413641|NCT02543879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413642|NCT04137120|Aflibercept|aflibercept|mesh-list
65413643|NCT04137120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65413644|NCT04137120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65413645|NCT04137120|Growth Substances|growth substances|mesh-ancestor
65413646|NCT04137120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413647|NCT04137120|Growth Inhibitors|growth inhibitors|mesh-ancestor
65413648|NCT04137120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413649|NCT00616655|Eszopiclone|eszopiclone|mesh-list
65413650|NCT00616655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65413651|NCT00616655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65413652|NCT00616655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413653|NCT00864773|Endothelial Growth Factors|endothelial growth factors|mesh-list
65413654|NCT00864773|Growth Substances|growth substances|mesh-ancestor
65413655|NCT00864773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413656|NCT01010490|Dipivefrin|dipivefrin|mesh-list
65163169|NCT02777671|Gliclazide|gliclazide|mesh-list
65413657|NCT01010490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65413658|NCT01010490|Adrenergic Agents|adrenergic agents|mesh-ancestor
65413659|NCT01010490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413660|NCT01010490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413661|NCT01010490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413662|NCT00516048|Exenatide|exenatide|mesh-list
65413663|NCT00516048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65413664|NCT00516048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413665|NCT00516048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65413666|NCT00516048|Incretins|incretins|mesh-ancestor
65413667|NCT00516048|Hormones|hormones|mesh-ancestor
65413668|NCT00516048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65413669|NCT00871949|Oxazolidinones|oxazolidinones|mesh-list
65413670|NCT00871949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65413671|NCT00871949|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65413687|NCT00872417|Lamivudine|lamivudine|mesh-list
65413688|NCT00872417|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65413689|NCT00872417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65413690|NCT00872417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413691|NCT00872417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413692|NCT00872417|Antiviral Agents|antiviral agents|mesh-ancestor
65413693|NCT00872417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65413694|NCT00872417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65413695|NCT00872417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65413696|NCT00876317|Etoricoxib|etoricoxib|mesh-list
65413697|NCT00876317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65413698|NCT00876317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65413699|NCT00876317|Analgesics|analgesics|mesh-ancestor
65413700|NCT00876317|Sensory System Agents|sensory system agents|mesh-ancestor
65413701|NCT00876317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65413702|NCT00876317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413703|NCT00876317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65413704|NCT00876317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65413705|NCT00876317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65413706|NCT00876317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65413707|NCT00876317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413708|NCT00876317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413709|NCT00866645|Haloperidol|haloperidol|mesh-list
65269896|NCT02732132|Narcotics|narcotics|mesh-ancestor
65413710|NCT00866645|Haloperidol decanoate|haloperidol decanoate|mesh-list
65413711|NCT00866645|Sulpiride|sulpiride|mesh-list
65413712|NCT00866645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65413713|NCT00866645|Antiemetics|antiemetics|mesh-ancestor
65413714|NCT00866645|Autonomic Agents|autonomic agents|mesh-ancestor
65413715|NCT00866645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65413716|NCT00866645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413717|NCT00866645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65413718|NCT00866645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65413719|NCT00866645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65413720|NCT00866645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65413721|NCT00866645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65413722|NCT00866645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65413723|NCT00866645|Dopamine Agents|dopamine agents|mesh-ancestor
65413724|NCT00866645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413725|NCT00866645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413726|NCT00866645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65413727|NCT00866645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65413728|NCT00866645|Antidepressive Agents|antidepressive agents|mesh-ancestor
65413729|NCT00872651|Timolol|timolol|mesh-list
65413730|NCT00872651|Travoprost|travoprost|mesh-list
65413741|NCT00872651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65413742|NCT00872963|Vaccines|vaccines|mesh-list
65413743|NCT00872963|Immunologic Factors|immunologic factors|mesh-ancestor
65413744|NCT00872963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413745|NCT00873197|Granisetron|granisetron|mesh-list
65413746|NCT00873197|Antiemetics|antiemetics|mesh-ancestor
65413747|NCT00873197|Autonomic Agents|autonomic agents|mesh-ancestor
65413748|NCT00873197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65413749|NCT00873197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413750|NCT00873197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65413751|NCT00873197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65413752|NCT00873197|Serotonin Agents|serotonin agents|mesh-ancestor
65413753|NCT00873197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413754|NCT00873197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413755|NCT00873353|Capecitabine|capecitabine|mesh-list
65413756|NCT00873353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65413757|NCT00873353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65413758|NCT00873353|Antimetabolites|antimetabolites|mesh-ancestor
65413759|NCT00873353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413760|NCT00873353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413761|NCT00873353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65413762|NCT00873353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413763|NCT00877097|Clodronic Acid|clodronic acid|mesh-list
65413764|NCT00877097|Trisequens|trisequens|mesh-list
65413765|NCT00877097|Norethindrone|norethindrone|mesh-list
65413766|NCT00877097|Estradiol|estradiol|mesh-list
65413767|NCT00877097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65413768|NCT00877097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413769|NCT00877097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65413770|NCT00877097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65413771|NCT00877097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65413772|NCT00877097|Contraceptive Agents|contraceptive agents|mesh-ancestor
65413773|NCT00877097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65413774|NCT00877097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65413775|NCT00877097|Estrogens|estrogens|mesh-ancestor
65413776|NCT00877097|Hormones|hormones|mesh-ancestor
65413777|NCT00877097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65413778|NCT00877097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65413779|NCT00877175|Phenylephrine|phenylephrine|mesh-list
65413780|NCT00877175|Oxymetazoline|oxymetazoline|mesh-list
65413781|NCT00877175|Tropicamide|tropicamide|mesh-list
65413782|NCT00877175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65413783|NCT00877175|Mydriatics|mydriatics|mesh-ancestor
65413784|NCT00877175|Autonomic Agents|autonomic agents|mesh-ancestor
65413785|NCT00877175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65413786|NCT00877175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413787|NCT00877175|Sympathomimetics|sympathomimetics|mesh-ancestor
65413788|NCT00877175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65413789|NCT00877175|Nasal Decongestants|nasal decongestants|mesh-ancestor
65413790|NCT00877175|Respiratory System Agents|respiratory system agents|mesh-ancestor
65413791|NCT00877175|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65413792|NCT00877175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65413793|NCT00877175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65413794|NCT00877175|Adrenergic Agents|adrenergic agents|mesh-ancestor
65413795|NCT00877175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413796|NCT00877175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413797|NCT00877175|Protective Agents|protective agents|mesh-ancestor
65413806|NCT00420927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413807|NCT00420927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65413808|NCT00420927|Antimetabolites|antimetabolites|mesh-ancestor
65413809|NCT00420927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413810|NCT00420927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413811|NCT00420927|Dermatologic Agents|dermatologic agents|mesh-ancestor
65413812|NCT00420927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413813|NCT00420927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65413814|NCT00420927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65413815|NCT00420927|Immunologic Factors|immunologic factors|mesh-ancestor
65413816|NCT00420927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65413817|NCT00420927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65413818|NCT00420927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65413820|NCT00573443|Quinidine gluconate|quinidine gluconate|mesh-list
65413821|NCT00573443|Dextromethorphan|dextromethorphan|mesh-list
65413822|NCT00573443|Antitussive Agents|antitussive agents|mesh-ancestor
65413823|NCT00573443|Respiratory System Agents|respiratory system agents|mesh-ancestor
65413824|NCT00573443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65413825|NCT00573443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65413826|NCT00573443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413827|NCT00573443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413828|NCT00573443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413829|NCT00573443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65413830|NCT00573443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65413831|NCT00573443|Adrenergic Agents|adrenergic agents|mesh-ancestor
65413832|NCT00573443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65413833|NCT00573443|Antimalarials|antimalarials|mesh-ancestor
65413834|NCT00573443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65413835|NCT00573443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65413836|NCT00573443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65413837|NCT00573443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413838|NCT00573443|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65413839|NCT00573443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65413840|NCT00573443|Cholinergic Agents|cholinergic agents|mesh-ancestor
65413841|NCT00573443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65413842|NCT00573443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65413843|NCT00573443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65413844|NCT00573443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65413845|NCT00573443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65413846|NCT05225831|Cyclophosphamide|cyclophosphamide|mesh-list
65413847|NCT05225831|Fludarabine|fludarabine|mesh-list
65413848|NCT05225831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65413849|NCT05225831|Immunologic Factors|immunologic factors|mesh-ancestor
65413850|NCT05225831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413851|NCT05225831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65413852|NCT05225831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65413853|NCT05225831|Alkylating Agents|alkylating agents|mesh-ancestor
65413854|NCT05225831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413855|NCT05225831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413856|NCT05225831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65413857|NCT00873509|Buspirone|buspirone|mesh-list
65413858|NCT00873509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65413859|NCT00873509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65413860|NCT00873509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65413861|NCT00873509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413862|NCT00873509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64798611|NCT01392014|Primaquine|primaquine|mesh-list
65413878|NCT00877409|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65413879|NCT00877409|Dermatologic Agents|dermatologic agents|mesh-ancestor
65413881|NCT00874133|Antiemetics|antiemetics|mesh-ancestor
65413882|NCT00874133|Autonomic Agents|autonomic agents|mesh-ancestor
65413883|NCT00874133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65413884|NCT00874133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413885|NCT00874133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65413886|NCT00874133|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65413887|NCT00874133|Dopamine Agents|dopamine agents|mesh-ancestor
65413888|NCT00874133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413889|NCT00874133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413890|NCT00867737|Fluticasone|fluticasone|mesh-list
65413891|NCT00867737|Budesonide|budesonide|mesh-list
65413892|NCT00867737|Formoterol Fumarate|formoterol fumarate|mesh-list
65413893|NCT00867737|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65413894|NCT00867737|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65413895|NCT00867737|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65413896|NCT00867737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65413897|NCT00867737|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65413898|NCT00867737|Autonomic Agents|autonomic agents|mesh-ancestor
65413899|NCT00867737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65413900|NCT00867737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413901|NCT00867737|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65413902|NCT00867737|Respiratory System Agents|respiratory system agents|mesh-ancestor
65413903|NCT00867737|Dermatologic Agents|dermatologic agents|mesh-ancestor
65413904|NCT00867737|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65413905|NCT00867737|Glucocorticoids|glucocorticoids|mesh-ancestor
65413906|NCT00867737|Hormones|hormones|mesh-ancestor
65413907|NCT00867737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65413908|NCT00867737|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65413909|NCT00867737|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65413910|NCT00867737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65413911|NCT00867737|Adrenergic Agents|adrenergic agents|mesh-ancestor
65413912|NCT00867737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413913|NCT00867737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413914|NCT00867737|Sympathomimetics|sympathomimetics|mesh-ancestor
65413915|NCT04551677|Vaccines|vaccines|mesh-list
65413916|NCT04551677|Immunologic Factors|immunologic factors|mesh-ancestor
65413917|NCT04551677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413918|NCT04040465|Aspirin|aspirin|mesh-list
65413919|NCT04040465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65413920|NCT04040465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65413921|NCT04040465|Analgesics|analgesics|mesh-ancestor
65413939|NCT00420849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65413940|NCT00420849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413942|NCT00420849|Glucocorticoids|glucocorticoids|mesh-ancestor
65413943|NCT00420849|Hormones|hormones|mesh-ancestor
65413944|NCT00420849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65413945|NCT00420849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65413946|NCT00420849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413947|NCT00420849|Immunologic Factors|immunologic factors|mesh-ancestor
65413948|NCT00420849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65413949|NCT00420849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65413950|NCT00420849|Growth Substances|growth substances|mesh-ancestor
65413951|NCT00420849|Growth Inhibitors|growth inhibitors|mesh-ancestor
65413952|NCT00874523|Raltegravir Potassium|raltegravir potassium|mesh-list
65413953|NCT00874523|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65413954|NCT00874523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65413955|NCT00874523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65413957|NCT00874523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65413958|NCT00874523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65413959|NCT00874523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65413960|NCT00874523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413961|NCT00874523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413962|NCT00874523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65413963|NCT00874523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65413964|NCT00874523|Protease Inhibitors|protease inhibitors|mesh-ancestor
65413965|NCT00874601|Valsartan|valsartan|mesh-list
65413966|NCT00874601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65413967|NCT00874601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65413968|NCT00874601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65413969|NCT00874601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413970|NCT00874679|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65413971|NCT00874679|Vasodilator Agents|vasodilator agents|mesh-ancestor
65413972|NCT00874679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65413973|NCT00874679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65413974|NCT00874679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413975|NCT00874679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413976|NCT00874679|Urological Agents|urological agents|mesh-ancestor
65413977|NCT00617201|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64798738|NCT01392755|Histamine Agents|histamine agents|mesh-ancestor
65413986|NCT00420303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65413987|NCT00420303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65413989|NCT00420303|Sensory System Agents|sensory system agents|mesh-ancestor
65413990|NCT00420303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65413991|NCT00420303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269897|NCT02732132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65413992|NCT00420303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65413993|NCT00420303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65413994|NCT00420303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65413995|NCT00420303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65413996|NCT00420303|Immunologic Factors|immunologic factors|mesh-ancestor
65413997|NCT00617123|Vorapaxar|vorapaxar|mesh-list
65413998|NCT00617123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65413999|NCT00877955|Alprazolam|alprazolam|mesh-list
65414000|NCT00877955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65414001|NCT00877955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65414002|NCT00877955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414003|NCT00877955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65414004|NCT00877955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65414005|NCT00877955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65414006|NCT00877955|GABA Modulators|gaba modulators|mesh-ancestor
65414007|NCT00877955|GABA Agents|gaba agents|mesh-ancestor
65414008|NCT00877955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65414009|NCT00877955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414010|NCT00419757|Budesonide|budesonide|mesh-list
65414011|NCT00419757|Formoterol Fumarate|formoterol fumarate|mesh-list
65414012|NCT00419757|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65414013|NCT00419757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65414014|NCT00419757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65414015|NCT00419757|Autonomic Agents|autonomic agents|mesh-ancestor
65414016|NCT00419757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414017|NCT00419757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414018|NCT00419757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65414019|NCT00419757|Respiratory System Agents|respiratory system agents|mesh-ancestor
65414020|NCT00419757|Glucocorticoids|glucocorticoids|mesh-ancestor
65414021|NCT00419757|Hormones|hormones|mesh-ancestor
65414022|NCT00419757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65414023|NCT00419757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65414024|NCT00419757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65414025|NCT00419757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65414026|NCT00419757|Adrenergic Agents|adrenergic agents|mesh-ancestor
65414027|NCT00419757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65414028|NCT00419757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414029|NCT00434109|Sunitinib|sunitinib|mesh-list
65414030|NCT00434109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414031|NCT00434109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65414032|NCT00434109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65414033|NCT00434109|Growth Substances|growth substances|mesh-ancestor
65414034|NCT00434109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414035|NCT00434109|Growth Inhibitors|growth inhibitors|mesh-ancestor
65414036|NCT00434109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65414037|NCT00434109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414038|NCT00434109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414039|NCT00875069|Ethanol|ethanol|mesh-list
65414040|NCT00875069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65414041|NCT00875069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65414053|NCT00875147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65414054|NCT00875147|Growth Substances|growth substances|mesh-ancestor
65414055|NCT00875147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414056|NCT00875147|Growth Inhibitors|growth inhibitors|mesh-ancestor
65414057|NCT00433329|Bosentan|bosentan|mesh-list
65414058|NCT00433329|Sildenafil Citrate|sildenafil citrate|mesh-list
65414059|NCT00433329|Vasodilator Agents|vasodilator agents|mesh-ancestor
65414060|NCT00433329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65414061|NCT00433329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65414062|NCT00433329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414063|NCT00433329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414064|NCT00433329|Urological Agents|urological agents|mesh-ancestor
65414065|NCT00433329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65414066|NCT00433329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65414067|NCT01035021|Rocuronium|rocuronium|mesh-list
65414068|NCT01035021|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65414069|NCT01035021|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65414070|NCT01035021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65414071|NCT01035021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414072|NCT01035021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414073|NCT00878345|Pentobarbital|pentobarbital|mesh-list
65414074|NCT00878345|Dexmedetomidine|dexmedetomidine|mesh-list
65414075|NCT00878345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65414076|NCT00878345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65414077|NCT00878345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414078|NCT00878345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65414079|NCT00878345|Analgesics|analgesics|mesh-ancestor
65414080|NCT00878345|Sensory System Agents|sensory system agents|mesh-ancestor
65414081|NCT00878345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414082|NCT00878345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65414083|NCT00878345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65414084|NCT00878345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65414085|NCT00878345|Adrenergic Agents|adrenergic agents|mesh-ancestor
65414086|NCT00878345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65414087|NCT00878345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414088|NCT00878345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65414089|NCT00878345|GABA Modulators|gaba modulators|mesh-ancestor
65414090|NCT00878345|GABA Agents|gaba agents|mesh-ancestor
65414091|NCT00433017|Ranibizumab|ranibizumab|mesh-list
65414092|NCT00433017|Verteporfin|verteporfin|mesh-list
65414093|NCT00433017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65414094|NCT00433017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65414095|NCT00433017|Growth Substances|growth substances|mesh-ancestor
65414096|NCT00433017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414097|NCT00433017|Growth Inhibitors|growth inhibitors|mesh-ancestor
65414098|NCT00433017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414099|NCT00433017|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65414100|NCT00433017|Dermatologic Agents|dermatologic agents|mesh-ancestor
65414101|NCT03726671|Choline|choline|mesh-list
65414102|NCT03726671|Lipotropic Agents|lipotropic agents|mesh-ancestor
65414103|NCT03726671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65414104|NCT03726671|Antimetabolites|antimetabolites|mesh-ancestor
65414105|NCT03726671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414126|NCT00875537|Sensory System Agents|sensory system agents|mesh-ancestor
65414127|NCT00875537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414128|NCT00875537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414129|NCT00875771|Bevacizumab|bevacizumab|mesh-list
65414130|NCT00875771|Capecitabine|capecitabine|mesh-list
65414131|NCT00875771|Irinotecan|irinotecan|mesh-list
65414132|NCT00875771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65414133|NCT00875771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414134|NCT00875771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65414135|NCT00875771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65414136|NCT00875771|Growth Substances|growth substances|mesh-ancestor
65414137|NCT00875771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414138|NCT00875771|Growth Inhibitors|growth inhibitors|mesh-ancestor
65414139|NCT00875771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65414140|NCT00875771|Antimetabolites|antimetabolites|mesh-ancestor
65414141|NCT00875771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414142|NCT00875771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65414143|NCT00875771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65414144|NCT00875771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414145|NCT00875849|Cetuximab|cetuximab|mesh-list
65414146|NCT00875849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414147|NCT00875849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65414149|NCT00875927|Propolis|propolis|mesh-list
65414150|NCT00875927|Trace Elements|trace elements|mesh-ancestor
65414151|NCT00875927|Micronutrients|micronutrients|mesh-ancestor
65414152|NCT00875927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414153|NCT00875927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65414154|NCT00878657|Gemcitabine|gemcitabine|mesh-list
65414155|NCT00878657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65414156|NCT00878657|Antimetabolites|antimetabolites|mesh-ancestor
65414157|NCT00878657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414158|NCT00878657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414159|NCT00878657|Antiviral Agents|antiviral agents|mesh-ancestor
65414160|NCT00878657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65414161|NCT00878657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414162|NCT00878657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65414176|NCT00868829|Micronutrients|micronutrients|mesh-ancestor
65414177|NCT00868907|Risedronic Acid|risedronic acid|mesh-list
65414178|NCT00868907|Etidronic Acid|etidronic acid|mesh-list
65414179|NCT00868907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65414180|NCT00868907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65414181|NCT00868907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414182|NCT00868907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65414183|NCT00868907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414184|NCT00868907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65414185|NCT00868985|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65414186|NCT00868985|Laxatives|laxatives|mesh-ancestor
65414187|NCT00868985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65414188|NCT00869063|Diclofenac|diclofenac|mesh-list
65414189|NCT00869063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65414190|NCT00869063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65414191|NCT00869063|Analgesics|analgesics|mesh-ancestor
65414192|NCT00869063|Sensory System Agents|sensory system agents|mesh-ancestor
65414193|NCT00869063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414194|NCT00869063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414195|NCT00869063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65414196|NCT00869063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65414197|NCT00869063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65414198|NCT00869063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414199|NCT00869063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414200|NCT00869219|Nepafenac|nepafenac|mesh-list
65414201|NCT00869219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65414202|NCT00869219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65414203|NCT00869219|Analgesics|analgesics|mesh-ancestor
65414204|NCT00869219|Sensory System Agents|sensory system agents|mesh-ancestor
65414205|NCT00869219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414206|NCT00869219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414207|NCT00869219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65414208|NCT00869219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65414209|NCT03994965|Pimavanserin|pimavanserin|mesh-list
65414210|NCT03994965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65414211|NCT03994965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65414212|NCT03994965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65414213|NCT03994965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65414214|NCT03994965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65414215|NCT03994965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414216|NCT03994965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65414217|NCT03994965|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65414218|NCT03994965|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65414219|NCT03994965|Serotonin Agents|serotonin agents|mesh-ancestor
65414220|NCT03994965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65414221|NCT03994965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414222|NCT00531284|Dexamethasone|dexamethasone|mesh-list
65414223|NCT00531284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65414224|NCT00531284|Antiemetics|antiemetics|mesh-ancestor
65414232|NCT00531284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65414233|NCT00531284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414234|NCT00531206|Ritonavir|ritonavir|mesh-list
65414235|NCT00531206|Tipranavir|tipranavir|mesh-list
65414236|NCT00531206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65414237|NCT00531206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65414238|NCT00531206|Protease Inhibitors|protease inhibitors|mesh-ancestor
65414239|NCT00531206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414240|NCT00531206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414241|NCT00531206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65414242|NCT00531206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65414243|NCT00531206|Antiviral Agents|antiviral agents|mesh-ancestor
65414244|NCT00531206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65414245|NCT00531206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65414246|NCT00531206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65414247|NCT00994994|Tranylcypromine|tranylcypromine|mesh-list
65414248|NCT00994994|Tranexamic Acid|tranexamic acid|mesh-list
65414249|NCT00994994|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
65414250|NCT00994994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65414251|NCT00994994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414252|NCT00994994|Hemostatics|hemostatics|mesh-ancestor
65414253|NCT00994994|Coagulants|coagulants|mesh-ancestor
65414254|NCT00994994|Antidepressive Agents|antidepressive agents|mesh-ancestor
65414255|NCT00994994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65414256|NCT00994994|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65414257|NCT00994994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414258|NCT00994994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65414259|NCT00994994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65414260|NCT00994994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65414261|NCT00994994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414262|NCT00999752|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65414263|NCT00999752|Nebivolol|nebivolol|mesh-list
65414264|NCT00999752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65414265|NCT00999752|Diuretics|diuretics|mesh-ancestor
65414266|NCT00999752|Natriuretic Agents|natriuretic agents|mesh-ancestor
65236312|NCT04378426|Midazolam|midazolam|mesh-list
65414267|NCT00999752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414268|NCT00999752|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65414269|NCT00999752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65414270|NCT00999752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414271|NCT00999752|Vasodilator Agents|vasodilator agents|mesh-ancestor
65414272|NCT00999752|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65414273|NCT00999752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65414274|NCT00999752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65414275|NCT00999752|Adrenergic Agents|adrenergic agents|mesh-ancestor
65414276|NCT00999752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65414277|NCT01005758|Cytarabine|cytarabine|mesh-list
65414278|NCT01005758|Dexamethasone|dexamethasone|mesh-list
65414279|NCT01005758|Prednisone|prednisone|mesh-list
65414280|NCT01005758|Methylprednisolone|methylprednisolone|mesh-list
65414281|NCT01005758|Prednisolone|prednisolone|mesh-list
65414282|NCT01005758|Hydrocortisone|hydrocortisone|mesh-list
65414283|NCT01005758|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65414284|NCT01005758|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65414285|NCT01005758|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65414286|NCT01005758|Cyclophosphamide|cyclophosphamide|mesh-list
65414287|NCT01005758|Doxorubicin|doxorubicin|mesh-list
65414288|NCT01005758|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65414289|NCT01005758|Methotrexate|methotrexate|mesh-list
65414290|NCT01005758|Etoposide|etoposide|mesh-list
65414291|NCT01005758|Vincristine|vincristine|mesh-list
65414292|NCT01005758|Imatinib Mesylate|imatinib mesylate|mesh-list
65414293|NCT01005758|Mercaptopurine|mercaptopurine|mesh-list
65414294|NCT01005758|Pegaspargase|pegaspargase|mesh-list
65414302|NCT01005758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414304|NCT01005758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65414305|NCT01005758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65414306|NCT01005758|Antiemetics|antiemetics|mesh-ancestor
65414307|NCT01005758|Autonomic Agents|autonomic agents|mesh-ancestor
65414308|NCT01005758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414309|NCT01005758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65414310|NCT01005758|Glucocorticoids|glucocorticoids|mesh-ancestor
65414311|NCT01005758|Hormones|hormones|mesh-ancestor
65414312|NCT01005758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65414313|NCT01005758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65414314|NCT01005758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65414315|NCT01005758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65414316|NCT01005758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65414317|NCT01005758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414318|NCT01005758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65414319|NCT01005758|Abortifacient Agents|abortifacient agents|mesh-ancestor
65414320|NCT01005758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65414321|NCT01005758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65414322|NCT01005758|Antimetabolites|antimetabolites|mesh-ancestor
65414323|NCT01005758|Dermatologic Agents|dermatologic agents|mesh-ancestor
65414324|NCT01005758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65414325|NCT01005758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65414326|NCT01005758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65414327|NCT01005758|Antiviral Agents|antiviral agents|mesh-ancestor
65414328|NCT01005758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65414329|NCT01005758|Tubulin Modulators|tubulin modulators|mesh-ancestor
65414330|NCT01005758|Antimitotic Agents|antimitotic agents|mesh-ancestor
65414331|NCT01005758|Mitosis Modulators|mitosis modulators|mesh-ancestor
65414332|NCT01005758|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65414333|NCT01005758|Protective Agents|protective agents|mesh-ancestor
65414334|NCT01005758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65414335|NCT05152472|Atezolizumab|atezolizumab|mesh-list
65414336|NCT05152472|Imatinib Mesylate|imatinib mesylate|mesh-list
65414337|NCT05152472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414338|NCT05152472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65414339|NCT05152472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414340|NCT05152472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414341|NCT00879047|Ethanol|ethanol|mesh-list
65414342|NCT00879047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65414343|NCT00879047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65414344|NCT00879047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65414345|NCT00879047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414346|NCT00999986|Cyclophosphamide|cyclophosphamide|mesh-list
65414347|NCT00999986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65414348|NCT00999986|Immunologic Factors|immunologic factors|mesh-ancestor
65414349|NCT00999986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414350|NCT00999986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65414351|NCT00999986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65414352|NCT00999986|Alkylating Agents|alkylating agents|mesh-ancestor
65414353|NCT00999986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414354|NCT00999986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414355|NCT00999986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65414356|NCT01000220|Omeprazole|omeprazole|mesh-list
65414357|NCT01000220|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65414358|NCT01000220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65414359|NCT01000220|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65414360|NCT01000220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414382|NCT00614939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414383|NCT00614939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414384|NCT00614939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65414385|NCT01009190|Carboplatin|carboplatin|mesh-list
65414386|NCT01009190|Rucaparib|rucaparib|mesh-list
65414387|NCT01009190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414388|NCT01009190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65414389|NCT01009190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414390|NCT01009190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414391|NCT05176964|Capecitabine|capecitabine|mesh-list
65414392|NCT05176964|Oxaliplatin|oxaliplatin|mesh-list
65414393|NCT05176964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65414394|NCT05176964|Antimetabolites|antimetabolites|mesh-ancestor
65414395|NCT05176964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414396|NCT05176964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414397|NCT00879827|PENTA|penta|mesh-list
65414398|NCT00879827|Anticoagulants|anticoagulants|mesh-ancestor
65414399|NCT00879827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65414400|NCT00879827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65414401|NCT00879827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414402|NCT01007084|Propranolol|propranolol|mesh-list
65414403|NCT01007084|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65414404|NCT01007084|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65414405|NCT01007084|Adrenergic Agents|adrenergic agents|mesh-ancestor
65414406|NCT01007084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65414407|NCT01007084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414408|NCT01007084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414409|NCT01007084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65414410|NCT01007084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65414411|NCT01007084|Vasodilator Agents|vasodilator agents|mesh-ancestor
65414412|NCT04040309|Lidocaine|lidocaine|mesh-list
65414413|NCT04040309|Anesthetics, Local|anesthetics, local|mesh-ancestor
65414423|NCT04040309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414424|NCT01000688|Vildagliptin|vildagliptin|mesh-list
65414425|NCT01000688|Acarbose|acarbose|mesh-list
65414426|NCT01000688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65414427|NCT01000688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414428|NCT01000688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65414429|NCT01000688|Protease Inhibitors|protease inhibitors|mesh-ancestor
65414430|NCT01000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414431|NCT01000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414432|NCT01000688|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65414433|NCT00879983|Azithromycin|azithromycin|mesh-list
65414434|NCT00879983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65414435|NCT00879983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65414436|NCT00869765|Cycloserine|cycloserine|mesh-list
65414437|NCT00869765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65414438|NCT00869765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65414439|NCT00869765|Renal Agents|renal agents|mesh-ancestor
65414440|NCT00869765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65414441|NCT00869765|Antitubercular Agents|antitubercular agents|mesh-ancestor
65414442|NCT00869765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65414443|NCT00869765|Antimetabolites|antimetabolites|mesh-ancestor
65414444|NCT00869765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414445|NCT05076110|Acetaminophen|acetaminophen|mesh-list
65414446|NCT05076110|Ibuprofen|ibuprofen|mesh-list
65414447|NCT05076110|Oxycodone|oxycodone|mesh-list
65414448|NCT05076110|Gabapentin|gabapentin|mesh-list
65414449|NCT05076110|Methocarbamol|methocarbamol|mesh-list
65414450|NCT05076110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65414451|NCT05076110|Analgesics|analgesics|mesh-ancestor
65414452|NCT05076110|Sensory System Agents|sensory system agents|mesh-ancestor
65414453|NCT05076110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414454|NCT05076110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414455|NCT05076110|Antipyretics|antipyretics|mesh-ancestor
65236453|NCT02557867|Analgesics|analgesics|mesh-ancestor
65414456|NCT05076110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65414457|NCT05076110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65414458|NCT05076110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65414459|NCT05076110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65414460|NCT05076110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414461|NCT05076110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414462|NCT05076110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65414463|NCT05076110|Narcotics|narcotics|mesh-ancestor
65414464|NCT05076110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65414465|NCT05076110|Anticonvulsants|anticonvulsants|mesh-ancestor
65414466|NCT05076110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65414467|NCT05076110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65414468|NCT05076110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65414469|NCT05076110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65414470|NCT05076110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65414471|NCT05076110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65414472|NCT05076110|Antimanic Agents|antimanic agents|mesh-ancestor
65414473|NCT05076110|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65414474|NCT05076110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65414475|NCT00880373|Ibuprofen|ibuprofen|mesh-list
65414476|NCT00880373|Morphine|morphine|mesh-list
65414478|NCT00880373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65414479|NCT00880373|Narcotics|narcotics|mesh-ancestor
65414490|NCT00880373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414491|NCT00880373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414492|NCT01007630|Rasagiline|rasagiline|mesh-list
65414493|NCT01007630|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65414494|NCT01007630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414495|NCT01007630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414496|NCT01007630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65414497|NCT01007630|Protective Agents|protective agents|mesh-ancestor
65414498|NCT01007630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414499|NCT00885443|Propofol|propofol|mesh-list
65414500|NCT00885443|Sevoflurane|sevoflurane|mesh-list
65414501|NCT00885443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65414502|NCT00885443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65414503|NCT00885443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414504|NCT00885443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65414505|NCT00885443|Anesthetics, General|anesthetics, general|mesh-ancestor
65414506|NCT00885443|Anesthetics|anesthetics|mesh-ancestor
65414507|NCT00885443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65414508|NCT00885443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65414509|NCT00882869|Sorafenib|sorafenib|mesh-list
65414510|NCT00882869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414511|NCT00882869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65414512|NCT00882869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414513|NCT00882869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414514|NCT00882947|Iloprost|iloprost|mesh-list
65414515|NCT00882947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65414516|NCT00882947|Vasodilator Agents|vasodilator agents|mesh-ancestor
65414517|NCT00531050|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65414518|NCT00531050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65414519|NCT00531050|Autonomic Agents|autonomic agents|mesh-ancestor
65414520|NCT00531050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414521|NCT00531050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414522|NCT00531050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65414523|NCT00531050|Respiratory System Agents|respiratory system agents|mesh-ancestor
65414524|NCT00531050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65414525|NCT00531050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65414526|NCT00531050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65414527|NCT00531050|Adrenergic Agents|adrenergic agents|mesh-ancestor
65414528|NCT00531050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65414529|NCT00531050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414530|NCT00530348|Interferons|interferons|mesh-list
65414531|NCT00530348|Interferon-beta|interferon-beta|mesh-list
65414532|NCT00530348|Interferon beta-1a|interferon beta-1a|mesh-list
65414533|NCT00530348|Alemtuzumab|alemtuzumab|mesh-list
65414534|NCT00530348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414535|NCT00530348|Antiviral Agents|antiviral agents|mesh-ancestor
65414536|NCT00530348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65414537|NCT00530348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65414538|NCT00530348|Immunologic Factors|immunologic factors|mesh-ancestor
65414539|NCT00530348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414540|NCT00530348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65414541|NCT01007864|Pramipexole|pramipexole|mesh-list
65414542|NCT01007864|Ropinirole|ropinirole|mesh-list
65414543|NCT01007864|Piribedil|piribedil|mesh-list
65414544|NCT01007864|Antioxidants|antioxidants|mesh-ancestor
64799282|NCT01395485|Brodalumab|brodalumab|mesh-list
65414553|NCT01008020|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65414555|NCT01008020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414556|NCT01008020|Protective Agents|protective agents|mesh-ancestor
65414557|NCT01008020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414558|NCT01008020|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65414559|NCT01008020|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65414560|NCT01008020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414561|NCT01008020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65414562|NCT01008098|Citalopram|citalopram|mesh-list
65414563|NCT01008098|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65414564|NCT01008098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65414565|NCT01008098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65414566|NCT01008098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414567|NCT01008098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65414568|NCT01008098|Serotonin Agents|serotonin agents|mesh-ancestor
65414569|NCT01008098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414570|NCT01008098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65414571|NCT01008098|Antidepressive Agents|antidepressive agents|mesh-ancestor
65414572|NCT01008098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65414573|NCT00530270|Dexamethasone|dexamethasone|mesh-list
65414574|NCT00530270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65414575|NCT00530270|Antiemetics|antiemetics|mesh-ancestor
65414576|NCT00530270|Autonomic Agents|autonomic agents|mesh-ancestor
65414577|NCT00530270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414578|NCT00530270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414579|NCT00530270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65414580|NCT00530270|Glucocorticoids|glucocorticoids|mesh-ancestor
65414581|NCT00530270|Hormones|hormones|mesh-ancestor
65414582|NCT00530270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65414583|NCT00530270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65414584|NCT00530270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414585|NCT01008488|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65414586|NCT01008488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65414587|NCT01001624|Hydroquinone|hydroquinone|mesh-list
65414588|NCT01001624|Antioxidants|antioxidants|mesh-ancestor
65414589|NCT01001624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414590|NCT01001624|Protective Agents|protective agents|mesh-ancestor
65414591|NCT01001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414592|NCT01001624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65414593|NCT01001780|Cyclophosphamide|cyclophosphamide|mesh-list
65414594|NCT01001780|Rituximab|rituximab|mesh-list
65414595|NCT01001780|Pentostatin|pentostatin|mesh-list
65414596|NCT01001780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65414597|NCT01001780|Immunologic Factors|immunologic factors|mesh-ancestor
65414598|NCT01001780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414599|NCT01001780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65414600|NCT01001780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65414601|NCT01001780|Alkylating Agents|alkylating agents|mesh-ancestor
65414602|NCT01001780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414603|NCT01001780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414604|NCT01001780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65414605|NCT01001780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65414606|NCT01001780|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65414607|NCT01001780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414608|NCT01008566|Sorafenib|sorafenib|mesh-list
65414609|NCT01008566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65414617|NCT03885596|Celecoxib|celecoxib|mesh-list
65414618|NCT03885596|Ketorolac|ketorolac|mesh-list
65414619|NCT03885596|Lidocaine|lidocaine|mesh-list
65414620|NCT03885596|Fentanyl|fentanyl|mesh-list
65414621|NCT03885596|Bupivacaine|bupivacaine|mesh-list
65414622|NCT03885596|Anesthetics, Local|anesthetics, local|mesh-ancestor
65414623|NCT03885596|Anesthetics|anesthetics|mesh-ancestor
65414624|NCT03885596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65414625|NCT03885596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414626|NCT03885596|Sensory System Agents|sensory system agents|mesh-ancestor
65414627|NCT03885596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414628|NCT03885596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65414629|NCT03885596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65414630|NCT03885596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65414631|NCT03885596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65236598|NCT00767221|Budesonide|budesonide|mesh-list
65414632|NCT03885596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414633|NCT03885596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65414634|NCT03885596|Narcotics|narcotics|mesh-ancestor
65414635|NCT03885596|Analgesics|analgesics|mesh-ancestor
65414636|NCT03885596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65414637|NCT03885596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65414638|NCT03885596|Anesthetics, General|anesthetics, general|mesh-ancestor
65414639|NCT03885596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65414640|NCT03885596|Antipyretics|antipyretics|mesh-ancestor
65414641|NCT03885596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65414642|NCT03885596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65414643|NCT03885596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65414644|NCT03885596|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65414645|NCT03885596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65414646|NCT03885596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414647|NCT01002092|Endostar protein|endostar protein|mesh-list
65414648|NCT01002092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65414649|NCT01002092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65414650|NCT01002092|Growth Substances|growth substances|mesh-ancestor
65414651|NCT01002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414652|NCT01002092|Growth Inhibitors|growth inhibitors|mesh-ancestor
65414653|NCT01002092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414654|NCT03999866|Pyrithione zinc|pyrithione zinc|mesh-list
65414655|NCT03999866|Keratolytic Agents|keratolytic agents|mesh-ancestor
65414656|NCT03999866|Dermatologic Agents|dermatologic agents|mesh-ancestor
65414657|NCT05547386|Edetic Acid|edetic acid|mesh-list
65414658|NCT05547386|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65414659|NCT05547386|Chelating Agents|chelating agents|mesh-ancestor
65414660|NCT05547386|Sequestering Agents|sequestering agents|mesh-ancestor
65414661|NCT05547386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414662|NCT05547386|Anticoagulants|anticoagulants|mesh-ancestor
65414663|NCT05547386|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65414664|NCT05547386|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65414665|NCT00529100|Cisplatin|cisplatin|mesh-list
65414666|NCT00529100|Pemetrexed|pemetrexed|mesh-list
65414667|NCT00529100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414668|NCT00529100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414669|NCT00529100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414670|NCT00529100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65414671|NCT00529100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65414672|NCT05732948|Cyclophosphamide|cyclophosphamide|mesh-list
65414673|NCT05732948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65414674|NCT05732948|Immunologic Factors|immunologic factors|mesh-ancestor
65414675|NCT05732948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414676|NCT05732948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65414677|NCT05732948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65414678|NCT05732948|Alkylating Agents|alkylating agents|mesh-ancestor
65414689|NCT05021900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414690|NCT05021900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414691|NCT00528866|Docetaxel|docetaxel|mesh-list
65414692|NCT00528866|Bicalutamide|bicalutamide|mesh-list
65414693|NCT00528866|Flutamide|flutamide|mesh-list
65414694|NCT00528866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414695|NCT00528866|Tubulin Modulators|tubulin modulators|mesh-ancestor
65414696|NCT00528866|Antimitotic Agents|antimitotic agents|mesh-ancestor
65414697|NCT00528866|Mitosis Modulators|mitosis modulators|mesh-ancestor
65414698|NCT00528866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414699|NCT00528866|Androgen Antagonists|androgen antagonists|mesh-ancestor
65414700|NCT00528866|Hormone Antagonists|hormone antagonists|mesh-ancestor
65414701|NCT00528866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65414702|NCT00528866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414703|NCT00528866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65414704|NCT05730920|Methadone|methadone|mesh-list
65414705|NCT05730920|Bupivacaine|bupivacaine|mesh-list
65414706|NCT05730920|Anesthetics, Local|anesthetics, local|mesh-ancestor
65164230|NCT02855866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414707|NCT05730920|Anesthetics|anesthetics|mesh-ancestor
65414708|NCT05730920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65414709|NCT05730920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414710|NCT05730920|Sensory System Agents|sensory system agents|mesh-ancestor
65414711|NCT05730920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414712|NCT05730920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65414713|NCT05730920|Narcotics|narcotics|mesh-ancestor
65414714|NCT05730920|Analgesics|analgesics|mesh-ancestor
65414715|NCT05730920|Antitussive Agents|antitussive agents|mesh-ancestor
65269898|NCT02732132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65414716|NCT05730920|Respiratory System Agents|respiratory system agents|mesh-ancestor
65414717|NCT03999008|Budesonide|budesonide|mesh-list
65414718|NCT03999008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65414719|NCT03999008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65414720|NCT03999008|Autonomic Agents|autonomic agents|mesh-ancestor
65414721|NCT03999008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414722|NCT03999008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414723|NCT03999008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65414724|NCT03999008|Respiratory System Agents|respiratory system agents|mesh-ancestor
65414725|NCT03999008|Glucocorticoids|glucocorticoids|mesh-ancestor
65414726|NCT03999008|Hormones|hormones|mesh-ancestor
65414727|NCT03999008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65414728|NCT05140148|Amantadine|amantadine|mesh-list
65414729|NCT05140148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65414730|NCT05140148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65414731|NCT05140148|Antiviral Agents|antiviral agents|mesh-ancestor
65414732|NCT05140148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65414733|NCT05140148|Dopamine Agents|dopamine agents|mesh-ancestor
65414734|NCT05140148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65414735|NCT05140148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414736|NCT05140148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414737|NCT05140148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65414738|NCT05140148|Analgesics|analgesics|mesh-ancestor
65414739|NCT05140148|Sensory System Agents|sensory system agents|mesh-ancestor
65414740|NCT05140148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414741|NCT04932746|Dexmedetomidine|dexmedetomidine|mesh-list
65414742|NCT04932746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65414754|NCT04932746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414756|NCT00614393|Cetuximab|cetuximab|mesh-list
65414757|NCT00614393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65414758|NCT00614393|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65414759|NCT00614393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65414760|NCT00614393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414761|NCT00614393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414762|NCT00614393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414763|NCT00614393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65414764|NCT00614393|Immunologic Factors|immunologic factors|mesh-ancestor
65414765|NCT00614393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414766|NCT00880529|Morphine|morphine|mesh-list
65414767|NCT00880529|Bupivacaine|bupivacaine|mesh-list
65414768|NCT00880529|Anesthetics, Local|anesthetics, local|mesh-ancestor
65414769|NCT00880529|Anesthetics|anesthetics|mesh-ancestor
65414770|NCT00880529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65414771|NCT00880529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414772|NCT00880529|Sensory System Agents|sensory system agents|mesh-ancestor
65414773|NCT00880529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414774|NCT00880529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65414775|NCT00880529|Narcotics|narcotics|mesh-ancestor
65414776|NCT00880529|Analgesics|analgesics|mesh-ancestor
65414777|NCT04731779|Cannabidiol|cannabidiol|mesh-list
65414778|NCT04731779|Anticonvulsants|anticonvulsants|mesh-ancestor
65414779|NCT00880841|Buprenorphine|buprenorphine|mesh-list
65414780|NCT00880841|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65414781|NCT00880841|Naloxone|naloxone|mesh-list
65414782|NCT00880841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65414783|NCT00880841|Narcotics|narcotics|mesh-ancestor
65414784|NCT00880841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65414785|NCT00880841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414786|NCT00880841|Analgesics|analgesics|mesh-ancestor
65414787|NCT00880841|Sensory System Agents|sensory system agents|mesh-ancestor
65414788|NCT00880841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414789|NCT00880841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65414790|NCT00883259|Metformin|metformin|mesh-list
65414791|NCT00883259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65414792|NCT00883259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414793|NCT00885599|Listerine|listerine|mesh-list
65414794|NCT00885599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
65414795|NCT00885599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65414796|NCT04366115|Dexamethasone|dexamethasone|mesh-list
65414797|NCT04366115|Dexamethasone acetate|dexamethasone acetate|mesh-list
65414798|NCT04366115|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65414799|NCT04366115|BB 1101|bb 1101|mesh-list
65414800|NCT04366115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65414801|NCT04366115|Antiemetics|antiemetics|mesh-ancestor
65414802|NCT04366115|Autonomic Agents|autonomic agents|mesh-ancestor
65236750|NCT00776347|Nootropic Agents|nootropic agents|mesh-ancestor
65414803|NCT04366115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414804|NCT04366115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414805|NCT04366115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65414806|NCT04366115|Glucocorticoids|glucocorticoids|mesh-ancestor
65414807|NCT04366115|Hormones|hormones|mesh-ancestor
65414815|NCT04038125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65414816|NCT04038125|Antiemetics|antiemetics|mesh-ancestor
65414817|NCT04038125|Autonomic Agents|autonomic agents|mesh-ancestor
65414818|NCT04038125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414819|NCT04038125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414820|NCT04038125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65414821|NCT04038125|Glucocorticoids|glucocorticoids|mesh-ancestor
65414822|NCT04038125|Hormones|hormones|mesh-ancestor
65414823|NCT04038125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65414824|NCT04038125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65414825|NCT04038125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414826|NCT00881153|Cefprozil|cefprozil|mesh-list
65414827|NCT00881153|Cephalosporins|cephalosporins|mesh-list
65414828|NCT00881153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65414829|NCT00881153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65414830|NCT00885833|Fludarabine|fludarabine|mesh-list
65414831|NCT00885833|Busulfan|busulfan|mesh-list
65414832|NCT00885833|Thymoglobulin|thymoglobulin|mesh-list
65414833|NCT00885833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414834|NCT00885833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414835|NCT00885833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65414836|NCT00885833|Immunologic Factors|immunologic factors|mesh-ancestor
65414837|NCT00885833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414838|NCT00885833|Alkylating Agents|alkylating agents|mesh-ancestor
65414839|NCT00885833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65414840|NCT00885833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65414841|NCT00612677|Oxaliplatin|oxaliplatin|mesh-list
65414842|NCT00612677|Pemetrexed|pemetrexed|mesh-list
65414843|NCT00612677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414844|NCT00612677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414845|NCT00612677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414846|NCT00612677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65414847|NCT00612677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65414848|NCT04038749|Cabergoline|cabergoline|mesh-list
65414849|NCT04038749|Bromocriptine|bromocriptine|mesh-list
65414850|NCT04038749|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65414851|NCT04038749|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65414852|NCT04038749|Dopamine Agonists|dopamine agonists|mesh-ancestor
65414853|NCT04038749|Dopamine Agents|dopamine agents|mesh-ancestor
65414854|NCT04038749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65414855|NCT04038749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414856|NCT04038749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414857|NCT04038749|Hormone Antagonists|hormone antagonists|mesh-ancestor
65414858|NCT04038749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65414859|NCT00881231|Cilostazol|cilostazol|mesh-list
65414860|NCT00881231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65414861|NCT00881231|Autonomic Agents|autonomic agents|mesh-ancestor
65414862|NCT00881231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414863|NCT00881231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414864|NCT00881231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65414865|NCT00881231|Respiratory System Agents|respiratory system agents|mesh-ancestor
65414866|NCT00881231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65414867|NCT00881231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65414868|NCT00881231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414869|NCT00881231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65414870|NCT00881231|Vasodilator Agents|vasodilator agents|mesh-ancestor
65414871|NCT00881231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65414872|NCT00881231|Protective Agents|protective agents|mesh-ancestor
64799610|NCT05268835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65414893|NCT00881387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65414894|NCT00881387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65414895|NCT00881387|Tubulin Modulators|tubulin modulators|mesh-ancestor
65414896|NCT00881387|Antimitotic Agents|antimitotic agents|mesh-ancestor
65414897|NCT00881387|Mitosis Modulators|mitosis modulators|mesh-ancestor
65414898|NCT00883883|Cefdinir|cefdinir|mesh-list
65414899|NCT00883883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65414900|NCT00883883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65414901|NCT00881543|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65414902|NCT00881543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65414903|NCT00881543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65414904|NCT00881543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414905|NCT00881543|Incretins|incretins|mesh-ancestor
65414906|NCT00881543|Hormones|hormones|mesh-ancestor
65414907|NCT00881543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65414908|NCT00881543|Protease Inhibitors|protease inhibitors|mesh-ancestor
65414909|NCT00881543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414910|NCT00881543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414911|NCT00881855|Cefprozil|cefprozil|mesh-list
65414912|NCT00881855|Cephalosporins|cephalosporins|mesh-list
65414913|NCT00881855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65414914|NCT00881855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65414915|NCT04015115|Analgesics, Opioid|analgesics, opioid|mesh-list
65414916|NCT04015115|Narcotics|narcotics|mesh-ancestor
65414917|NCT04015115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65414918|NCT04015115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414919|NCT04015115|Analgesics|analgesics|mesh-ancestor
65414920|NCT04015115|Sensory System Agents|sensory system agents|mesh-ancestor
65414921|NCT04015115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414922|NCT02543645|Atezolizumab|atezolizumab|mesh-list
65414923|NCT02543645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414924|NCT02543411|Lidocaine|lidocaine|mesh-list
65414925|NCT02543411|Anesthetics, Local|anesthetics, local|mesh-ancestor
65414926|NCT02543411|Anesthetics|anesthetics|mesh-ancestor
65414927|NCT02543411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65414928|NCT02543411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414935|NCT02543411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414937|NCT00882323|Fludarabine|fludarabine|mesh-list
65414938|NCT00882323|Thymoglobulin|thymoglobulin|mesh-list
65414939|NCT00882323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65414940|NCT00882323|Immunologic Factors|immunologic factors|mesh-ancestor
65414941|NCT00882323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414942|NCT00882323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65414943|NCT00882323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65414944|NCT00882323|Alkylating Agents|alkylating agents|mesh-ancestor
65414945|NCT00882323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414946|NCT00882323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414947|NCT00882323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65414948|NCT00882401|Vitamin D|vitamin d|mesh-list
65414949|NCT00882401|Ergocalciferols|ergocalciferols|mesh-list
65414950|NCT00882401|Vitamins|vitamins|mesh-ancestor
65414951|NCT00882401|Micronutrients|micronutrients|mesh-ancestor
65414952|NCT00882401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414953|NCT00882401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65414954|NCT00882401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65414955|NCT00886457|Interferons|interferons|mesh-list
65414956|NCT00886457|Interferon-alpha|interferon-alpha|mesh-list
65414957|NCT00886457|Interferon alpha-2|interferon alpha-2|mesh-list
65414958|NCT00886457|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65414959|NCT00886457|Decitabine|decitabine|mesh-list
65414960|NCT00886457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414961|NCT00886457|Antiviral Agents|antiviral agents|mesh-ancestor
65414962|NCT00886457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65414963|NCT00886457|Immunologic Factors|immunologic factors|mesh-ancestor
65414964|NCT00886457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414965|NCT00886457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65414966|NCT00886457|Antimetabolites|antimetabolites|mesh-ancestor
65414967|NCT00886457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414968|NCT00886457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414969|NCT04038671|Anti-Infective Agents|anti-infective agents|mesh-list
65414970|NCT04038671|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65414971|NCT04038671|Charcoal|charcoal|mesh-list
65414972|NCT04038671|Antidotes|antidotes|mesh-ancestor
65414973|NCT04038671|Protective Agents|protective agents|mesh-ancestor
65414974|NCT04038671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414975|NCT02543099|Policosanol|policosanol|mesh-list
65414976|NCT02543099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65414977|NCT02543099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65414978|NCT02543099|Antimetabolites|antimetabolites|mesh-ancestor
65414979|NCT02543099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414980|NCT02543099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65414981|NCT02543099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65414982|NCT00882635|Heparin|heparin|mesh-list
65414983|NCT00882635|Enoxaparin|enoxaparin|mesh-list
65414984|NCT00882635|Calcium heparin|calcium heparin|mesh-list
65414985|NCT00882635|Anticoagulants|anticoagulants|mesh-ancestor
65414986|NCT00882635|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65414987|NCT00882635|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65414988|NCT00882635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414989|NCT00609869|Rituximab|rituximab|mesh-list
65414990|NCT00609869|Lenalidomide|lenalidomide|mesh-list
65414991|NCT00609869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65414992|NCT00609869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414993|NCT00609869|Immunologic Factors|immunologic factors|mesh-ancestor
65414994|NCT00609869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414995|NCT00609869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65415010|NCT00888797|Vasodilator Agents|vasodilator agents|mesh-ancestor
65415011|NCT00888797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65415012|NCT00888797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65415014|NCT00888797|Sensory System Agents|sensory system agents|mesh-ancestor
65415015|NCT00888797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65415016|NCT00888797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65415017|NCT00888797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65415018|NCT00888797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65415019|NCT00888797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65415020|NCT00888797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415021|NCT00884663|Propranolol|propranolol|mesh-list
65415022|NCT00884663|Candesartan|candesartan|mesh-list
65415023|NCT00884663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65415024|NCT00884663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65415025|NCT00884663|Adrenergic Agents|adrenergic agents|mesh-ancestor
65415026|NCT00884663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65415027|NCT00884663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415028|NCT00884663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415029|NCT00884663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65415030|NCT00884663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65415031|NCT00884663|Vasodilator Agents|vasodilator agents|mesh-ancestor
65415032|NCT00884663|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65415033|NCT00884663|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65415034|NCT00887003|Methylprednisolone|methylprednisolone|mesh-list
65415035|NCT00887003|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65415036|NCT00887003|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65415037|NCT00887003|Prednisolone|prednisolone|mesh-list
65415038|NCT00887003|Prednisolone acetate|prednisolone acetate|mesh-list
65415039|NCT00887003|Bupivacaine|bupivacaine|mesh-list
65415040|NCT00887003|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65415041|NCT00887003|Prednisolone phosphate|prednisolone phosphate|mesh-list
65415042|NCT00887003|Anesthetics, Local|anesthetics, local|mesh-ancestor
65415043|NCT00887003|Anesthetics|anesthetics|mesh-ancestor
65415044|NCT00887003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65415045|NCT00887003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415046|NCT00887003|Sensory System Agents|sensory system agents|mesh-ancestor
65415047|NCT00887003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65415048|NCT00887003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65415049|NCT00887003|Antiemetics|antiemetics|mesh-ancestor
65415050|NCT00887003|Autonomic Agents|autonomic agents|mesh-ancestor
65415051|NCT00887003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65415052|NCT00887003|Glucocorticoids|glucocorticoids|mesh-ancestor
65415054|NCT00887003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65415055|NCT00887003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65415056|NCT00887003|Protective Agents|protective agents|mesh-ancestor
65415068|NCT00887081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65415069|NCT00887081|Immunologic Factors|immunologic factors|mesh-ancestor
65415070|NCT00887081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415071|NCT00887081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415072|NCT03998696|Cisplatin|cisplatin|mesh-list
65415073|NCT03998696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415074|NCT00611975|Bupropion|bupropion|mesh-list
65415075|NCT00611975|Fluoxetine|fluoxetine|mesh-list
65415076|NCT00611975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65415077|NCT00611975|Antidepressive Agents|antidepressive agents|mesh-ancestor
65415078|NCT00611975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65415079|NCT00611975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65415080|NCT00611975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65415081|NCT00611975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65415082|NCT00611975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415083|NCT00611975|Dopamine Agents|dopamine agents|mesh-ancestor
65415084|NCT00611975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65415085|NCT00611975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415086|NCT00611975|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65415087|NCT00611975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65415089|NCT00611975|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65415090|NCT00611975|Serotonin Agents|serotonin agents|mesh-ancestor
65415091|NCT05695352|Meloxicam|meloxicam|mesh-list
65415092|NCT05695352|Levonorgestrel|levonorgestrel|mesh-list
65415093|NCT05695352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65415094|NCT05695352|Contraceptive Agents|contraceptive agents|mesh-ancestor
65415095|NCT05695352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65415096|NCT05695352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415097|NCT05695352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65415098|NCT05695352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65415099|NCT05695352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65415100|NCT05695352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65415101|NCT05695352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65415102|NCT05695352|Analgesics|analgesics|mesh-ancestor
65415103|NCT05695352|Sensory System Agents|sensory system agents|mesh-ancestor
65415104|NCT05695352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65415105|NCT05695352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65415106|NCT05695352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65415107|NCT05695352|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65415108|NCT05695352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65415109|NCT05695352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415110|NCT05695352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415111|NCT04895306|Methyltestosterone|methyltestosterone|mesh-list
65415112|NCT04895306|Testosterone|testosterone|mesh-list
65415113|NCT04895306|Testosterone undecanoate|testosterone undecanoate|mesh-list
65415114|NCT04895306|Testosterone enanthate|testosterone enanthate|mesh-list
65415115|NCT04895306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65415116|NCT04895306|Androgens|androgens|mesh-ancestor
65415117|NCT04895306|Hormones|hormones|mesh-ancestor
65415118|NCT04895306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65415119|NCT04895306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415120|NCT04895306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65415121|NCT04895306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415140|NCT00889343|Protective Agents|protective agents|mesh-ancestor
65415141|NCT00889343|Vitamin B Complex|vitamin b complex|mesh-ancestor
65415142|NCT00889343|Vitamins|vitamins|mesh-ancestor
65415143|NCT00889343|Micronutrients|micronutrients|mesh-ancestor
65415144|NCT00889343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65415145|NCT00884819|Fenofibrate|fenofibrate|mesh-list
65415146|NCT00884819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65415147|NCT00884819|Antimetabolites|antimetabolites|mesh-ancestor
65415148|NCT00884819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415149|NCT00884819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65415150|NCT04974398|Gemcitabine|gemcitabine|mesh-list
65415151|NCT04974398|Cisplatin|cisplatin|mesh-list
65415152|NCT04974398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415153|NCT04974398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65415154|NCT04974398|Antimetabolites|antimetabolites|mesh-ancestor
65415155|NCT04974398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415156|NCT04974398|Antiviral Agents|antiviral agents|mesh-ancestor
65415157|NCT04974398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65415158|NCT04974398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415159|NCT04974398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65164684|NCT01409200|Ascorbic Acid|ascorbic acid|mesh-list
65415160|NCT04974398|Immunologic Factors|immunologic factors|mesh-ancestor
65415161|NCT04974398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415162|NCT00573131|Paclitaxel|paclitaxel|mesh-list
65415163|NCT00573131|Cisplatin|cisplatin|mesh-list
65415164|NCT00573131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65415165|NCT00573131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415166|NCT00573131|Tubulin Modulators|tubulin modulators|mesh-ancestor
65415167|NCT00573131|Antimitotic Agents|antimitotic agents|mesh-ancestor
65415168|NCT00573131|Mitosis Modulators|mitosis modulators|mesh-ancestor
65415169|NCT00573131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415170|NCT01565018|Rotigotine|rotigotine|mesh-list
65415171|NCT01565018|Dopamine Agonists|dopamine agonists|mesh-ancestor
65415172|NCT01565018|Dopamine Agents|dopamine agents|mesh-ancestor
65415173|NCT01565018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65415174|NCT01565018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415175|NCT01565018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415176|NCT01565096|Metformin|metformin|mesh-list
65415177|NCT01565096|Glimepiride|glimepiride|mesh-list
65415178|NCT01565096|Vildagliptin|vildagliptin|mesh-list
65415179|NCT01565096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65415180|NCT01565096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269899|NCT02732132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65269900|NCT02732132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64799921|NCT05273944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415194|NCT00889499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65415195|NCT00889499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65415196|NCT00889499|Serotonin Agents|serotonin agents|mesh-ancestor
65415197|NCT00889499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65415198|NCT00889499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415199|NCT00889655|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65415200|NCT00889655|Laxatives|laxatives|mesh-ancestor
65415201|NCT00889655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65415202|NCT05002946|Naltrexone|naltrexone|mesh-list
65415203|NCT05002946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65415204|NCT05002946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65415205|NCT05002946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415206|NCT05002946|Sensory System Agents|sensory system agents|mesh-ancestor
65415207|NCT05002946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65415208|NCT04641338|Dipyrone|dipyrone|mesh-list
65415209|NCT04641338|Codeine|codeine|mesh-list
65415210|NCT04641338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65415211|NCT04641338|Narcotics|narcotics|mesh-ancestor
65415212|NCT04641338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65415213|NCT04641338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415214|NCT04641338|Analgesics|analgesics|mesh-ancestor
65415215|NCT04641338|Sensory System Agents|sensory system agents|mesh-ancestor
65415216|NCT04641338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65415217|NCT04641338|Antitussive Agents|antitussive agents|mesh-ancestor
65415218|NCT04641338|Respiratory System Agents|respiratory system agents|mesh-ancestor
65415219|NCT04641338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65415220|NCT04641338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65415221|NCT04641338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65415222|NCT04641338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65415223|NCT04641338|Antipyretics|antipyretics|mesh-ancestor
65415224|NCT04635098|Dexmedetomidine|dexmedetomidine|mesh-list
65415225|NCT04635098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65415226|NCT04635098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65415227|NCT04635098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415228|NCT04635098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65415229|NCT04635098|Analgesics|analgesics|mesh-ancestor
65415230|NCT04635098|Sensory System Agents|sensory system agents|mesh-ancestor
65415231|NCT04635098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65415232|NCT04635098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65415233|NCT04635098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65415234|NCT04635098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65415235|NCT04635098|Adrenergic Agents|adrenergic agents|mesh-ancestor
65415236|NCT04635098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65415237|NCT04635098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415238|NCT00521144|Topotecan|topotecan|mesh-list
65415239|NCT00521144|Obatoclax|obatoclax|mesh-list
65415240|NCT00521144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65415241|NCT00521144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65415242|NCT00521144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415259|NCT00887627|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65415260|NCT00887627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415262|NCT00887627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415263|NCT00885287|Lumefantrine|lumefantrine|mesh-list
65415264|NCT00885287|Artemether|artemether|mesh-list
65415265|NCT00885287|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65415266|NCT00885287|Antimalarials|antimalarials|mesh-ancestor
65415267|NCT00885287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65415268|NCT00885287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65415269|NCT00885287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65415270|NCT02542007|Sirolimus|sirolimus|mesh-list
65415271|NCT02542007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65415272|NCT02542007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65415273|NCT02542007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65415274|NCT02542007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415275|NCT02542007|Antifungal Agents|antifungal agents|mesh-ancestor
65415276|NCT02542007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65415277|NCT02542007|Immunologic Factors|immunologic factors|mesh-ancestor
65415278|NCT02542007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415279|NCT00892541|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65415280|NCT00892541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65415281|NCT00892541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65415282|NCT00892541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65415283|NCT00892541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415284|NCT00892541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65415285|NCT00892541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65415286|NCT00892541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65415287|NCT00892541|Serotonin Agents|serotonin agents|mesh-ancestor
65415288|NCT00892541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65415289|NCT00892541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415290|NCT00892541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65415291|NCT00892541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65415292|NCT00892541|Dopamine Agents|dopamine agents|mesh-ancestor
65415293|NCT00890279|Imidapril|imidapril|mesh-list
65415294|NCT00890279|Cilnidipine|cilnidipine|mesh-list
65415295|NCT00890279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65415296|NCT00890279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65415297|NCT00890279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415298|NCT00890279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65415299|NCT00890279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800041|NCT05271058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415307|NCT00608543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65415308|NCT00608543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65415309|NCT00608543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65415310|NCT00608543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415311|NCT00608543|Dopamine Agonists|dopamine agonists|mesh-ancestor
65415312|NCT00608543|Dopamine Agents|dopamine agents|mesh-ancestor
65415313|NCT00608543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65415314|NCT00608543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415315|NCT00608543|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65415316|NCT00608543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65415317|NCT00608543|Serotonin Agents|serotonin agents|mesh-ancestor
65415318|NCT00608543|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65415319|NCT00608543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65415320|NCT00608543|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65415321|NCT00608543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65415322|NCT02541383|Thalidomide|thalidomide|mesh-list
65415323|NCT02541383|Dexamethasone|dexamethasone|mesh-list
65415324|NCT02541383|Dexamethasone acetate|dexamethasone acetate|mesh-list
65415326|NCT02541383|Daratumumab|daratumumab|mesh-list
65415327|NCT02541383|BB 1101|bb 1101|mesh-list
65415328|NCT02541383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65415329|NCT02541383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65415330|NCT02541383|Antiemetics|antiemetics|mesh-ancestor
65415331|NCT02541383|Autonomic Agents|autonomic agents|mesh-ancestor
65415332|NCT02541383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65415333|NCT02541383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415334|NCT02541383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65415335|NCT02541383|Glucocorticoids|glucocorticoids|mesh-ancestor
65415336|NCT02541383|Hormones|hormones|mesh-ancestor
65415337|NCT02541383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65415338|NCT02541383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65415339|NCT02541383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415340|NCT02541383|Protease Inhibitors|protease inhibitors|mesh-ancestor
65415341|NCT02541383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415342|NCT02541383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415343|NCT02541383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65415344|NCT02541383|Immunologic Factors|immunologic factors|mesh-ancestor
65415345|NCT02541383|Leprostatic Agents|leprostatic agents|mesh-ancestor
65415346|NCT02541383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65415347|NCT02541383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65415348|NCT02541383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65415349|NCT02541383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65415350|NCT02541383|Growth Substances|growth substances|mesh-ancestor
65415351|NCT02541383|Growth Inhibitors|growth inhibitors|mesh-ancestor
65415352|NCT04036487|Propofol|propofol|mesh-list
65415353|NCT04036487|Desflurane|desflurane|mesh-list
65415354|NCT04036487|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65415355|NCT04036487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65415356|NCT04036487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415357|NCT04036487|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65415358|NCT04036487|Anesthetics, General|anesthetics, general|mesh-ancestor
65415359|NCT04036487|Anesthetics|anesthetics|mesh-ancestor
65415360|NCT04036487|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65415361|NCT05278793|Ferrous fumarate|ferrous fumarate|mesh-list
65415362|NCT05278793|Trace Elements|trace elements|mesh-ancestor
65415363|NCT05278793|Micronutrients|micronutrients|mesh-ancestor
65415364|NCT05278793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415365|NCT04037657|Propofol|propofol|mesh-list
65415366|NCT04037657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65415367|NCT04037657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65415368|NCT04037657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415369|NCT04037657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65415381|NCT00893009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415382|NCT00893009|Vasodilator Agents|vasodilator agents|mesh-ancestor
65415383|NCT00893009|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65415384|NCT00893009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65415385|NCT00893009|Purinergic Agents|purinergic agents|mesh-ancestor
65415386|NCT00893009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65415387|NCT00890747|Sunitinib|sunitinib|mesh-list
65415388|NCT00890747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415389|NCT00890747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65415390|NCT00890747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65415391|NCT00890747|Growth Substances|growth substances|mesh-ancestor
65415392|NCT00890747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415393|NCT00890747|Growth Inhibitors|growth inhibitors|mesh-ancestor
65415394|NCT00890747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65415395|NCT00890747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415396|NCT00890747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415397|NCT04017845|Tribenoside|tribenoside|mesh-list
65415398|NCT04017845|Lidocaine|lidocaine|mesh-list
65415399|NCT04017845|Diltiazem|diltiazem|mesh-list
65415400|NCT04017845|Calcium Channel Blockers|calcium channel blockers|mesh-list
65415401|NCT04017845|Nitroglycerin|nitroglycerin|mesh-list
65415402|NCT04017845|Bisacodyl|bisacodyl|mesh-list
65415403|NCT04017845|Anesthetics, Local|anesthetics, local|mesh-ancestor
65415404|NCT04017845|Anesthetics|anesthetics|mesh-ancestor
65415405|NCT04017845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65415406|NCT04017845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415407|NCT04017845|Sensory System Agents|sensory system agents|mesh-ancestor
65415408|NCT04017845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65415409|NCT04017845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65415410|NCT04017845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65415411|NCT04017845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65415412|NCT04017845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65415413|NCT04017845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415414|NCT04017845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65415415|NCT04017845|Vasodilator Agents|vasodilator agents|mesh-ancestor
65415416|NCT04017845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65415417|NCT04017845|Cathartics|cathartics|mesh-ancestor
65415418|NCT04017845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65415419|NCT04017845|Laxatives|laxatives|mesh-ancestor
65415420|NCT04017845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65415421|NCT04017845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65415422|NCT04017845|Analgesics|analgesics|mesh-ancestor
65415423|NCT04017845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65415424|NCT04017845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65415425|NCT00520130|Cytarabine|cytarabine|mesh-list
65415426|NCT00520130|Cyclosporine|cyclosporine|mesh-list
65415427|NCT00520130|Rituximab|rituximab|mesh-list
65415428|NCT00520130|Alemtuzumab|alemtuzumab|mesh-list
65415429|NCT00520130|Fludarabine|fludarabine|mesh-list
65415430|NCT00520130|Cyclosporins|cyclosporins|mesh-list
65415431|NCT00520130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65415432|NCT00520130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415433|NCT00520130|Immunologic Factors|immunologic factors|mesh-ancestor
65415434|NCT00520130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415444|NCT00520130|Dermatologic Agents|dermatologic agents|mesh-ancestor
65415445|NCT00520130|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65415446|NCT00519896|Sunitinib|sunitinib|mesh-list
65415447|NCT00519896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415448|NCT00519896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65415449|NCT00519896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65415450|NCT00519896|Growth Substances|growth substances|mesh-ancestor
65415451|NCT00519896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415452|NCT00519896|Growth Inhibitors|growth inhibitors|mesh-ancestor
65415453|NCT00519896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65415454|NCT00519896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415455|NCT00519896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415456|NCT00527618|Valacyclovir|valacyclovir|mesh-list
65415457|NCT00527618|Acyclovir|acyclovir|mesh-list
65415458|NCT00527618|Antiviral Agents|antiviral agents|mesh-ancestor
65415459|NCT00527618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65415460|NCT00527072|Infliximab|infliximab|mesh-list
65415461|NCT00527072|Dermatologic Agents|dermatologic agents|mesh-ancestor
65415462|NCT00527072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65415463|NCT00527072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65415464|NCT00519428|Dexetimide|dexetimide|mesh-list
65415465|NCT00519428|Citalopram|citalopram|mesh-list
65415466|NCT00519428|Bupropion|bupropion|mesh-list
65415467|NCT00519428|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65415468|NCT00519428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65415469|NCT00519428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65415470|NCT00519428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415471|NCT00519428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65415472|NCT00519428|Serotonin Agents|serotonin agents|mesh-ancestor
65415473|NCT00519428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415474|NCT00519428|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65415475|NCT00519428|Antidepressive Agents|antidepressive agents|mesh-ancestor
65415476|NCT00519428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65415477|NCT00519428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65415478|NCT00519428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65415479|NCT00519428|Parasympatholytics|parasympatholytics|mesh-ancestor
65415480|NCT00519428|Autonomic Agents|autonomic agents|mesh-ancestor
65415481|NCT00519428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65415482|NCT00519428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65415483|NCT00519428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65415484|NCT00519428|Cholinergic Agents|cholinergic agents|mesh-ancestor
65415485|NCT00519428|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65415486|NCT00519428|Dopamine Agents|dopamine agents|mesh-ancestor
65415487|NCT00519428|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65415488|NCT00519428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65415489|NCT00519428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415490|NCT00431847|Anesthetics|anesthetics|mesh-list
65415491|NCT00431847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65415492|NCT00431847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415493|NCT00431067|Afatinib|afatinib|mesh-list
65415494|NCT00431067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415495|NCT00431067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65415496|NCT00431067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415497|NCT00431067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415498|NCT00430989|Nitrous Oxide|nitrous oxide|mesh-list
65415499|NCT00430989|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65415500|NCT00430989|Anesthetics, General|anesthetics, general|mesh-ancestor
65415516|NCT00518180|Lactitol|lactitol|mesh-list
65415517|NCT00518180|Vaccines|vaccines|mesh-list
65415518|NCT00518180|Immunologic Factors|immunologic factors|mesh-ancestor
65415519|NCT00518180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415520|NCT00518180|Cathartics|cathartics|mesh-ancestor
65415521|NCT00518180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65415522|NCT00525902|Adalimumab|adalimumab|mesh-list
65415523|NCT00525902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65415524|NCT00525902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65415525|NCT00525824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65415526|NCT00525824|Simvastatin|simvastatin|mesh-list
65415527|NCT00525824|Ezetimibe|ezetimibe|mesh-list
65415528|NCT00525824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65415529|NCT00525824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65415530|NCT00525824|Antimetabolites|antimetabolites|mesh-ancestor
65415531|NCT00525824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415532|NCT00525824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65415533|NCT00525824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65415534|NCT00525824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415535|NCT00525590|Carmustine|carmustine|mesh-list
65415536|NCT00525590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65415537|NCT00525590|Alkylating Agents|alkylating agents|mesh-ancestor
65415538|NCT00525590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415539|NCT00525590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415540|NCT00430677|Mycophenolic Acid|mycophenolic acid|mesh-list
65165070|NCT02753647|Prednisone|prednisone|mesh-list
65415541|NCT00430677|Prednisone|prednisone|mesh-list
65415542|NCT00430677|Prednisolone|prednisolone|mesh-list
65415543|NCT00430677|Abatacept|abatacept|mesh-list
65415544|NCT00430677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65415545|NCT00430677|Glucocorticoids|glucocorticoids|mesh-ancestor
65415546|NCT00430677|Hormones|hormones|mesh-ancestor
65415547|NCT00430677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65415548|NCT00430677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415549|NCT00430677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65415550|NCT00430677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415551|NCT00430677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65415552|NCT00430677|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65415553|NCT00430677|Antitubercular Agents|antitubercular agents|mesh-ancestor
65415554|NCT00430677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65415555|NCT00430677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65415556|NCT00430677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415557|NCT00430677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415558|NCT00430677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65415559|NCT00430677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65415560|NCT00430677|Immunologic Factors|immunologic factors|mesh-ancestor
64800316|NCT05064137|Listerine|listerine|mesh-list
65415571|NCT00525512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65415572|NCT00525512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415573|NCT00525512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65415574|NCT00525512|Respiratory System Agents|respiratory system agents|mesh-ancestor
65415575|NCT00525512|Parasympatholytics|parasympatholytics|mesh-ancestor
65415576|NCT00525512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65415577|NCT00525512|Cholinergic Agents|cholinergic agents|mesh-ancestor
65415578|NCT00525512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65415579|NCT00525512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415581|NCT05199662|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65415582|NCT05199662|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65415583|NCT05199662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415584|NCT04501406|Pioglitazone|pioglitazone|mesh-list
65415585|NCT04501406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65415586|NCT04501406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415587|NCT03656666|Thalidomide|thalidomide|mesh-list
65415588|NCT03656666|Apremilast|apremilast|mesh-list
65415589|NCT03656666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65415590|NCT03656666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65415591|NCT03656666|Analgesics|analgesics|mesh-ancestor
65415592|NCT03656666|Sensory System Agents|sensory system agents|mesh-ancestor
65415593|NCT03656666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65415594|NCT03656666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415595|NCT03656666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65415596|NCT03656666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65415597|NCT03656666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65415598|NCT03656666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65415599|NCT03656666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415600|NCT03656666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415601|NCT03656666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65415602|NCT03656666|Immunologic Factors|immunologic factors|mesh-ancestor
65415603|NCT03656666|Leprostatic Agents|leprostatic agents|mesh-ancestor
65415604|NCT03656666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65415605|NCT03656666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65415606|NCT03656666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65415607|NCT03656666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65415608|NCT03656666|Growth Substances|growth substances|mesh-ancestor
65415609|NCT03656666|Growth Inhibitors|growth inhibitors|mesh-ancestor
65415610|NCT03656666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415611|NCT00430521|Vaccines|vaccines|mesh-list
65415612|NCT00430521|Immunologic Factors|immunologic factors|mesh-ancestor
65415613|NCT00430521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415614|NCT01036035|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65415615|NCT01036035|Pilocarpine|pilocarpine|mesh-list
65415616|NCT01036035|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65415617|NCT01036035|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65415618|NCT01036035|Cholinergic Agents|cholinergic agents|mesh-ancestor
65415619|NCT01036035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65415620|NCT01036035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415621|NCT01036035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415622|NCT01036035|Urological Agents|urological agents|mesh-ancestor
65415623|NCT01036035|Miotics|miotics|mesh-ancestor
65415624|NCT01036035|Autonomic Agents|autonomic agents|mesh-ancestor
65415625|NCT01036035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65415626|NCT01036035|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65415633|NCT01036659|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65415634|NCT01036659|Protease Inhibitors|protease inhibitors|mesh-ancestor
65415635|NCT01036659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415636|NCT01036659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415637|NCT01036659|Analgesics|analgesics|mesh-ancestor
65415638|NCT01036659|Sensory System Agents|sensory system agents|mesh-ancestor
65415639|NCT01036659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65415640|NCT01036659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269901|NCT02732132|GABA Modulators|gaba modulators|mesh-ancestor
65415641|NCT01036659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65415642|NCT01036659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65415643|NCT01036659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65415644|NCT01036659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65415645|NCT01036659|Coagulants|coagulants|mesh-ancestor
65415646|NCT01036659|Fertility Agents, Male|fertility agents, male|mesh-ancestor
65415647|NCT01036659|Fertility Agents|fertility agents|mesh-ancestor
65415648|NCT01036659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65415649|NCT01033149|Acetylcysteine|acetylcysteine|mesh-list
65415650|NCT01033149|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65415651|NCT01033149|Antiviral Agents|antiviral agents|mesh-ancestor
65415652|NCT01033149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65415653|NCT01033149|Expectorants|expectorants|mesh-ancestor
65415654|NCT01033149|Respiratory System Agents|respiratory system agents|mesh-ancestor
65415655|NCT01033149|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65415656|NCT01033149|Antioxidants|antioxidants|mesh-ancestor
65415657|NCT01033149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415658|NCT01033149|Protective Agents|protective agents|mesh-ancestor
65415659|NCT01033149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415660|NCT01033149|Antidotes|antidotes|mesh-ancestor
65415661|NCT00440271|Ritonavir|ritonavir|mesh-list
65415662|NCT00440271|Raltegravir Potassium|raltegravir potassium|mesh-list
65415663|NCT00440271|Maraviroc|maraviroc|mesh-list
65415664|NCT00440271|Tipranavir|tipranavir|mesh-list
65415665|NCT00440271|Enfuvirtide|enfuvirtide|mesh-list
65415666|NCT00440271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
65415667|NCT00440271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65415668|NCT00440271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65415669|NCT00440271|Protease Inhibitors|protease inhibitors|mesh-ancestor
65415670|NCT00440271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415671|NCT00440271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415672|NCT00440271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65415673|NCT00440271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65415674|NCT00440271|Antiviral Agents|antiviral agents|mesh-ancestor
65415675|NCT00440271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65415676|NCT00440271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65415677|NCT00440271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65415678|NCT00440271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65415679|NCT00440271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65415680|NCT00440271|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65415681|NCT00440271|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65415682|NCT00440271|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65415683|NCT00440271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65415684|NCT00346216|Ibuprofen|ibuprofen|mesh-list
65415685|NCT00346216|Celecoxib|celecoxib|mesh-list
65415686|NCT00346216|Naproxen|naproxen|mesh-list
65415687|NCT00346216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65415688|NCT00346216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65415689|NCT00346216|Analgesics|analgesics|mesh-ancestor
65415690|NCT00346216|Sensory System Agents|sensory system agents|mesh-ancestor
65415691|NCT00346216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65415692|NCT00346216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415693|NCT00346216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65415694|NCT00346216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65415695|NCT00346216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65415696|NCT00346216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415697|NCT00346216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800433|NCT04801641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65415714|NCT00429273|Methylphenidate|methylphenidate|mesh-list
65415715|NCT00429273|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
65415716|NCT00429273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65415717|NCT00429273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415718|NCT00429273|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65415719|NCT00429273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65415720|NCT00429273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65415721|NCT00429273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415722|NCT00429273|Dopamine Agents|dopamine agents|mesh-ancestor
65415723|NCT00429273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65415724|NCT00429273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65415725|NCT00429273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65415726|NCT00429273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65415727|NCT00429273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65415728|NCT00429273|Adrenergic Agents|adrenergic agents|mesh-ancestor
65237503|NCT00780169|Sorafenib|sorafenib|mesh-list
65415729|NCT00359632|Linezolid|linezolid|mesh-list
65415730|NCT00359632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65415731|NCT00359632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65415732|NCT00359632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65415733|NCT00359632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415734|NCT00359632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415735|NCT01324960|Aldesleukin|aldesleukin|mesh-list
65415736|NCT01324960|Azacitidine|azacitidine|mesh-list
65415737|NCT01324960|Histamine|histamine|mesh-list
65415738|NCT01324960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65415739|NCT01324960|Antimetabolites|antimetabolites|mesh-ancestor
65415740|NCT01324960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415741|NCT01324960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415742|NCT01324960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415743|NCT01324960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415744|NCT01324960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65415745|NCT01324960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65415746|NCT01324960|Antiviral Agents|antiviral agents|mesh-ancestor
65415747|NCT01324960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65415748|NCT01324960|Histamine Agonists|histamine agonists|mesh-ancestor
65415749|NCT01324960|Histamine Agents|histamine agents|mesh-ancestor
65415750|NCT01324960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65415751|NCT00417885|Sunitinib|sunitinib|mesh-list
65415752|NCT00417885|Exemestane|exemestane|mesh-list
65415753|NCT00417885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415754|NCT00417885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65415755|NCT00417885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65415774|NCT01036893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415776|NCT00525044|Ambroxol|ambroxol|mesh-list
65415777|NCT00525044|Expectorants|expectorants|mesh-ancestor
65415778|NCT00525044|Respiratory System Agents|respiratory system agents|mesh-ancestor
65415779|NCT00355342|Fluticasone|fluticasone|mesh-list
65415780|NCT00355342|Xhance|xhance|mesh-list
65415781|NCT00355342|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65415782|NCT00355342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65415783|NCT00355342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65415784|NCT00355342|Autonomic Agents|autonomic agents|mesh-ancestor
65415785|NCT00355342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65415786|NCT00355342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415787|NCT00355342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65415788|NCT00355342|Respiratory System Agents|respiratory system agents|mesh-ancestor
65415789|NCT00355342|Dermatologic Agents|dermatologic agents|mesh-ancestor
65415790|NCT00355342|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65415791|NCT00355342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65415792|NCT00355342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65415793|NCT00355342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65415794|NCT00355342|Adrenergic Agents|adrenergic agents|mesh-ancestor
65415795|NCT00355342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65415796|NCT00355342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415797|NCT01051804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65415798|NCT01051804|Lubricant Eye Drops|lubricant eye drops|mesh-list
65415799|NCT01051804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65415800|NCT01573754|Hydroxychloroquine|hydroxychloroquine|mesh-list
65415801|NCT01573754|Antimalarials|antimalarials|mesh-ancestor
65415802|NCT01573754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65415803|NCT01573754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65415804|NCT01573754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65415805|NCT01573754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415806|NCT01573754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415807|NCT01573754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65415808|NCT03989830|Endostatins|endostatins|mesh-list
65415809|NCT03989830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64800562|NCT04324021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65415815|NCT02533648|Allopurinol|allopurinol|mesh-list
65415816|NCT02533648|Antimetabolites|antimetabolites|mesh-ancestor
65415817|NCT02533648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415818|NCT02533648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415819|NCT02533648|Gout Suppressants|gout suppressants|mesh-ancestor
65415820|NCT02533648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65415821|NCT02533648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65415822|NCT02533648|Antioxidants|antioxidants|mesh-ancestor
65415823|NCT02533648|Protective Agents|protective agents|mesh-ancestor
65415824|NCT02533648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415826|NCT02533492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65415827|NCT02533492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65415828|NCT02533492|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65415829|NCT02533492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65415830|NCT02533492|Antimetabolites|antimetabolites|mesh-ancestor
65415831|NCT02533492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415832|NCT02533492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65415833|NCT01056874|Maraviroc|maraviroc|mesh-list
65415834|NCT01056874|Digoxin|digoxin|mesh-list
65415835|NCT01056874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65415836|NCT01056874|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65415837|NCT01056874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415838|NCT01056874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415839|NCT01056874|Protective Agents|protective agents|mesh-ancestor
65415840|NCT01056874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415841|NCT01056874|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65415842|NCT01056874|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65165358|NCT04116775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415844|NCT01056874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65415845|NCT01056874|Antiviral Agents|antiviral agents|mesh-ancestor
65415846|NCT01056874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65415847|NCT01056874|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65415848|NCT00355030|Leuprolide|leuprolide|mesh-list
65415849|NCT00355030|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65415850|NCT00355030|Fertility Agents|fertility agents|mesh-ancestor
65415851|NCT00355030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65415852|NCT00355030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415853|NCT00355030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65415854|NCT00355030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415855|NCT01057186|Alfacalcidol|alfacalcidol|mesh-list
65415856|NCT01057186|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65415857|NCT01057186|Sevelamer|sevelamer|mesh-list
65415858|NCT01057186|Chelating Agents|chelating agents|mesh-ancestor
65415859|NCT01057186|Sequestering Agents|sequestering agents|mesh-ancestor
65415860|NCT01057186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415861|NCT01057186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65415862|NCT01057186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415863|NCT01057186|Vitamins|vitamins|mesh-ancestor
65415864|NCT01057186|Micronutrients|micronutrients|mesh-ancestor
65415865|NCT01057264|Gemcitabine|gemcitabine|mesh-list
65415866|NCT01057264|Paclitaxel|paclitaxel|mesh-list
65415867|NCT01057264|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65415868|NCT01057264|Bevacizumab|bevacizumab|mesh-list
65415869|NCT01057264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65415870|NCT01057264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415871|NCT01057264|Tubulin Modulators|tubulin modulators|mesh-ancestor
65415872|NCT01057264|Antimitotic Agents|antimitotic agents|mesh-ancestor
65415873|NCT01057264|Mitosis Modulators|mitosis modulators|mesh-ancestor
65415874|NCT01057264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415875|NCT01057264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65415876|NCT01057264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65415877|NCT01057264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65415878|NCT01057264|Growth Substances|growth substances|mesh-ancestor
65415879|NCT01057264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415902|NCT03991312|Antitubercular Agents|antitubercular agents|mesh-ancestor
65415903|NCT03991312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65415904|NCT03991312|Leprostatic Agents|leprostatic agents|mesh-ancestor
65415905|NCT03991312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65415906|NCT03991312|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65415907|NCT03991312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65415908|NCT03991312|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65415909|NCT03991312|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65415910|NCT03991312|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65415911|NCT03991312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65415912|NCT01057342|Paclitaxel|paclitaxel|mesh-list
65415913|NCT01057342|Carboplatin|carboplatin|mesh-list
65415914|NCT01057342|Vadimezan|vadimezan|mesh-list
65415915|NCT01057342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65415916|NCT01057342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415917|NCT01057342|Tubulin Modulators|tubulin modulators|mesh-ancestor
65415918|NCT01057342|Antimitotic Agents|antimitotic agents|mesh-ancestor
65415919|NCT01057342|Mitosis Modulators|mitosis modulators|mesh-ancestor
65415920|NCT01057342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415921|NCT01057498|RNS60|rns60|mesh-list
65415922|NCT01057498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65415923|NCT01057498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65415924|NCT01057498|Analgesics|analgesics|mesh-ancestor
65415925|NCT01057498|Sensory System Agents|sensory system agents|mesh-ancestor
65415926|NCT01057498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65415927|NCT01057498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415928|NCT01057498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65415929|NCT01057498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65415948|NCT03742258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415949|NCT03742258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415950|NCT03742258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65415951|NCT03742258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65415952|NCT03742258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65415953|NCT03742258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65415954|NCT03742258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415955|NCT03742258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65415956|NCT03742258|Glucocorticoids|glucocorticoids|mesh-ancestor
65415957|NCT03742258|Hormones|hormones|mesh-ancestor
65415958|NCT03742258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65415959|NCT03742258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65415960|NCT03742258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65415961|NCT03742258|Tubulin Modulators|tubulin modulators|mesh-ancestor
65415962|NCT03742258|Antimitotic Agents|antimitotic agents|mesh-ancestor
65415963|NCT03742258|Mitosis Modulators|mitosis modulators|mesh-ancestor
65415964|NCT00354172|Cyclosporine|cyclosporine|mesh-list
65415965|NCT00354172|Mycophenolic Acid|mycophenolic acid|mesh-list
65415966|NCT00354172|Aldesleukin|aldesleukin|mesh-list
65415967|NCT00354172|Methylprednisolone|methylprednisolone|mesh-list
65415968|NCT00354172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65415969|NCT00354172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65415970|NCT00354172|Prednisolone|prednisolone|mesh-list
65415971|NCT00354172|Prednisolone acetate|prednisolone acetate|mesh-list
65415972|NCT00354172|Cyclophosphamide|cyclophosphamide|mesh-list
65415973|NCT00354172|Fludarabine|fludarabine|mesh-list
65415974|NCT00354172|Fludarabine phosphate|fludarabine phosphate|mesh-list
65415975|NCT00354172|Interleukin-2|interleukin-2|mesh-list
65415976|NCT00354172|Cyclosporins|cyclosporins|mesh-list
65415977|NCT00354172|Lenograstim|lenograstim|mesh-list
65415978|NCT00354172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65415979|NCT00354172|Prednisolone phosphate|prednisolone phosphate|mesh-list
65415980|NCT00354172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65415981|NCT00354172|Immunologic Factors|immunologic factors|mesh-ancestor
65415982|NCT00354172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415983|NCT00354172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65415984|NCT00354172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65415985|NCT00354172|Alkylating Agents|alkylating agents|mesh-ancestor
65415986|NCT00354172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415987|NCT00354172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415988|NCT00354172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65415989|NCT00354172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65415990|NCT00354172|Antimetabolites|antimetabolites|mesh-ancestor
65415997|NCT00354172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65415998|NCT00354172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65415999|NCT00354172|Antitubercular Agents|antitubercular agents|mesh-ancestor
65416000|NCT00354172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65416001|NCT00354172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65416002|NCT00354172|Antiemetics|antiemetics|mesh-ancestor
65416003|NCT00354172|Autonomic Agents|autonomic agents|mesh-ancestor
65416004|NCT00354172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65416005|NCT00354172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65416006|NCT00354172|Glucocorticoids|glucocorticoids|mesh-ancestor
65416007|NCT00354172|Hormones|hormones|mesh-ancestor
65416008|NCT00354172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65416009|NCT00354172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65416010|NCT00354172|Protective Agents|protective agents|mesh-ancestor
65416011|NCT00354172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65416012|NCT00354172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65416013|NCT00354172|Analgesics|analgesics|mesh-ancestor
65416014|NCT00354172|Sensory System Agents|sensory system agents|mesh-ancestor
65416015|NCT00354172|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65416016|NCT00354172|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65416017|NCT00354172|Antiviral Agents|antiviral agents|mesh-ancestor
65416018|NCT00353704|Pregabalin|pregabalin|mesh-list
65416019|NCT00353704|Morphine|morphine|mesh-list
65416020|NCT00353704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65416021|NCT00353704|Narcotics|narcotics|mesh-ancestor
65416022|NCT00353704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65416023|NCT00353704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416024|NCT00353704|Analgesics|analgesics|mesh-ancestor
65416025|NCT00353704|Sensory System Agents|sensory system agents|mesh-ancestor
65416026|NCT00353704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65237725|NCT02631603|Prednisolone|prednisolone|mesh-list
65416027|NCT00353704|Anticonvulsants|anticonvulsants|mesh-ancestor
65416028|NCT00353704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65416029|NCT00353704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65416030|NCT00353704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416031|NCT00353704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65416032|NCT00353704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65416033|NCT00353704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65416034|NCT00353704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65416035|NCT03742180|Ketorolac|ketorolac|mesh-list
65416036|NCT03742180|Dexmedetomidine|dexmedetomidine|mesh-list
65416037|NCT03742180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65416038|NCT03742180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65416039|NCT03742180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416040|NCT03742180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65416041|NCT03742180|Analgesics|analgesics|mesh-ancestor
65416042|NCT03742180|Sensory System Agents|sensory system agents|mesh-ancestor
65416043|NCT03742180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65416044|NCT03742180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65416045|NCT03742180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65416046|NCT03742180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65416047|NCT03742180|Adrenergic Agents|adrenergic agents|mesh-ancestor
65416048|NCT03742180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65416049|NCT03742180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416050|NCT03742180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65416051|NCT03742180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65416052|NCT03742180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65416053|NCT03742180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65416054|NCT03742180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416055|NCT00512252|Cytarabine|cytarabine|mesh-list
65416056|NCT00512252|Plerixafor|plerixafor|mesh-list
65416057|NCT00512252|Etoposide|etoposide|mesh-list
65416058|NCT00512252|Mitoxantrone|mitoxantrone|mesh-list
65416059|NCT00512252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65416060|NCT00512252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416066|NCT00512252|Antimetabolites|antimetabolites|mesh-ancestor
65416067|NCT00512252|Antiviral Agents|antiviral agents|mesh-ancestor
65416068|NCT00512252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65416069|NCT00512252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65416070|NCT00512252|Immunologic Factors|immunologic factors|mesh-ancestor
65416071|NCT00512252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416072|NCT00512252|Analgesics|analgesics|mesh-ancestor
65416073|NCT00512252|Sensory System Agents|sensory system agents|mesh-ancestor
65416074|NCT00512252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65416075|NCT00512252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65416076|NCT00512252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65416078|NCT00516386|Growth Substances|growth substances|mesh-ancestor
65416079|NCT00516386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416080|NCT00512096|Paclitaxel|paclitaxel|mesh-list
65416081|NCT00512096|Cisplatin|cisplatin|mesh-list
65416082|NCT00512096|Ifosfamide|ifosfamide|mesh-list
65416083|NCT00512096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65416084|NCT00512096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416085|NCT00512096|Tubulin Modulators|tubulin modulators|mesh-ancestor
65416086|NCT00512096|Antimitotic Agents|antimitotic agents|mesh-ancestor
65416087|NCT00512096|Mitosis Modulators|mitosis modulators|mesh-ancestor
65416088|NCT00512096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416089|NCT00512096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65416090|NCT00512096|Alkylating Agents|alkylating agents|mesh-ancestor
65416091|NCT04462796|Magnesium citrate|magnesium citrate|mesh-list
65416092|NCT04462796|Cathartics|cathartics|mesh-ancestor
65416093|NCT04462796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65416094|NCT00524030|Pregabalin|pregabalin|mesh-list
65416095|NCT00524030|Analgesics|analgesics|mesh-ancestor
65416096|NCT00524030|Sensory System Agents|sensory system agents|mesh-ancestor
65416097|NCT00524030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65416098|NCT00524030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416099|NCT00524030|Anticonvulsants|anticonvulsants|mesh-ancestor
65416100|NCT00524030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65416101|NCT00524030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65416102|NCT00524030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416103|NCT00524030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65416104|NCT00524030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65416105|NCT00524030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65416106|NCT00524030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65416107|NCT00524030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65416108|NCT00523718|Riluzole|riluzole|mesh-list
65416109|NCT00523718|Anticonvulsants|anticonvulsants|mesh-ancestor
65416110|NCT00523718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65416111|NCT00523718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65416112|NCT00523718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65416113|NCT00523718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416114|NCT00523718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416115|NCT00523718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65416116|NCT00523718|Protective Agents|protective agents|mesh-ancestor
65416117|NCT00523640|Gemcitabine|gemcitabine|mesh-list
65416118|NCT00523640|Bevacizumab|bevacizumab|mesh-list
65416119|NCT00523640|Capecitabine|capecitabine|mesh-list
65416120|NCT00523640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65416121|NCT00523640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416122|NCT00523640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65416123|NCT00523640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65416124|NCT00523640|Growth Substances|growth substances|mesh-ancestor
65416125|NCT00523640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416126|NCT00523640|Growth Inhibitors|growth inhibitors|mesh-ancestor
65416127|NCT00523640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65416128|NCT00523640|Antimetabolites|antimetabolites|mesh-ancestor
65416129|NCT00523640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416130|NCT00523640|Antiviral Agents|antiviral agents|mesh-ancestor
65416142|NCT03457142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65416143|NCT03457142|Antiemetics|antiemetics|mesh-ancestor
65416144|NCT03457142|Autonomic Agents|autonomic agents|mesh-ancestor
65416145|NCT03457142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65416146|NCT03457142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416147|NCT03457142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65416148|NCT03457142|Glucocorticoids|glucocorticoids|mesh-ancestor
65416149|NCT03457142|Hormones|hormones|mesh-ancestor
65416150|NCT03457142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65416151|NCT03457142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65416152|NCT03457142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416153|NCT03457142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416154|NCT03457142|Protease Inhibitors|protease inhibitors|mesh-ancestor
65416155|NCT03457142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416156|NCT03457142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65416157|NCT03457142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65416158|NCT03457142|Immunologic Factors|immunologic factors|mesh-ancestor
65416159|NCT03457142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65416160|NCT03457142|Dermatologic Agents|dermatologic agents|mesh-ancestor
65416161|NCT03457142|Glycine Agents|glycine agents|mesh-ancestor
65416162|NCT03457142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65416163|NCT00345358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65416164|NCT00345358|Immunologic Factors|immunologic factors|mesh-ancestor
65416165|NCT00345358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416166|NCT00516074|Exenatide|exenatide|mesh-list
65416167|NCT00516074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65416168|NCT00516074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416169|NCT00516074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65416170|NCT00516074|Incretins|incretins|mesh-ancestor
65416171|NCT00516074|Hormones|hormones|mesh-ancestor
65416172|NCT00516074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65416173|NCT01057654|Pravastatin|pravastatin|mesh-list
65416174|NCT01057654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65416175|NCT01057654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65416176|NCT01057654|Antimetabolites|antimetabolites|mesh-ancestor
65416177|NCT01057654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416178|NCT01057654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65416179|NCT01057654|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65416180|NCT01057654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416181|NCT00515294|Caffeine|caffeine|mesh-list
65416182|NCT00515294|Methamphetamine|methamphetamine|mesh-list
65416183|NCT00515294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65416184|NCT00515294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416185|NCT00515294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65416186|NCT00515294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416187|NCT00515294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416188|NCT00515294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65416189|NCT00515294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65416190|NCT00515294|Purinergic Agents|purinergic agents|mesh-ancestor
65416191|NCT00515294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65237887|NCT00790777|Serotonin Agents|serotonin agents|mesh-ancestor
65416192|NCT00515294|Sympathomimetics|sympathomimetics|mesh-ancestor
65416193|NCT00515294|Autonomic Agents|autonomic agents|mesh-ancestor
65416194|NCT00515294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65416195|NCT00515294|Dopamine Agents|dopamine agents|mesh-ancestor
65416196|NCT00515294|Adrenergic Agents|adrenergic agents|mesh-ancestor
64800943|NCT03254394|Lidocaine|lidocaine|mesh-list
65416201|NCT00345046|Prednisolone|prednisolone|mesh-list
65416202|NCT00345046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65416203|NCT00345046|Methylprednisolone|methylprednisolone|mesh-list
65416204|NCT00345046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65416205|NCT00345046|Prednisolone acetate|prednisolone acetate|mesh-list
65416206|NCT00345046|Prednisone|prednisone|mesh-list
65416207|NCT00345046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65416208|NCT00345046|Prednisolone phosphate|prednisolone phosphate|mesh-list
65416209|NCT00345046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65416210|NCT00345046|Glucocorticoids|glucocorticoids|mesh-ancestor
65416211|NCT00345046|Hormones|hormones|mesh-ancestor
65416212|NCT00345046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65416213|NCT00345046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416214|NCT00345046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65416215|NCT00345046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416216|NCT00345046|Antiemetics|antiemetics|mesh-ancestor
65416217|NCT00345046|Autonomic Agents|autonomic agents|mesh-ancestor
65416218|NCT00345046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65416219|NCT00345046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65416220|NCT00345046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65165739|NCT02737813|Bupivacaine|bupivacaine|mesh-list
65416221|NCT00345046|Protective Agents|protective agents|mesh-ancestor
65416222|NCT00515216|Leucovorin|leucovorin|mesh-list
65416223|NCT00515216|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
65416224|NCT00515216|Tetrahydrofolates|tetrahydrofolates|mesh-list
65416225|NCT00515216|Fluorouracil|fluorouracil|mesh-list
65416226|NCT00515216|Oxaliplatin|oxaliplatin|mesh-list
65416227|NCT00515216|Levoleucovorin|levoleucovorin|mesh-list
65416228|NCT00515216|Antimetabolites|antimetabolites|mesh-ancestor
65416229|NCT00515216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416230|NCT00515216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65416231|NCT00515216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416232|NCT00515216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65416233|NCT00515216|Immunologic Factors|immunologic factors|mesh-ancestor
65416234|NCT00515216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416235|NCT00515216|Antidotes|antidotes|mesh-ancestor
65416236|NCT00515216|Protective Agents|protective agents|mesh-ancestor
65416237|NCT00515216|Vitamin B Complex|vitamin b complex|mesh-ancestor
65416238|NCT00515216|Vitamins|vitamins|mesh-ancestor
65416239|NCT00515216|Micronutrients|micronutrients|mesh-ancestor
65416240|NCT01004978|Cisplatin|cisplatin|mesh-list
65416241|NCT01004978|Doxorubicin|doxorubicin|mesh-list
65416242|NCT01004978|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65416243|NCT01004978|Sorafenib|sorafenib|mesh-list
65416244|NCT01004978|Mitomycins|mitomycins|mesh-list
65416245|NCT01004978|Mitomycin|mitomycin|mesh-list
65416246|NCT01004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416247|NCT01004978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65416248|NCT01004978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65416249|NCT01004978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65416250|NCT01004978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416251|NCT01004978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416252|NCT01004978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65416253|NCT01004978|Alkylating Agents|alkylating agents|mesh-ancestor
65416254|NCT01004978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65416255|NCT00440193|Enoxaparin|enoxaparin|mesh-list
65416256|NCT00440193|Rivaroxaban|rivaroxaban|mesh-list
65416257|NCT00440193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65416258|NCT00440193|Antithrombins|antithrombins|mesh-ancestor
65416259|NCT00440193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65416260|NCT00440193|Protease Inhibitors|protease inhibitors|mesh-ancestor
65416261|NCT00440193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416262|NCT00440193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416263|NCT00440193|Anticoagulants|anticoagulants|mesh-ancestor
65416264|NCT00440193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65416265|NCT00440193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65416266|NCT00511472|Insulin Glargine|insulin glargine|mesh-list
65416267|NCT00511472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65416268|NCT00511472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416269|NCT01033305|Cyclosporine|cyclosporine|mesh-list
65416282|NCT00514904|Immunologic Factors|immunologic factors|mesh-ancestor
65416283|NCT00514904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416285|NCT00440115|Nicotine|nicotine|mesh-list
65416286|NCT00440115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65416287|NCT00440115|Autonomic Agents|autonomic agents|mesh-ancestor
65416288|NCT00440115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65416289|NCT00440115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416290|NCT00440115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65416291|NCT00440115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65416292|NCT00440115|Cholinergic Agents|cholinergic agents|mesh-ancestor
65416293|NCT00440115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65416294|NCT00440115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416295|NCT00440115|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65165826|NCT03326791|Antipyretics|antipyretics|mesh-ancestor
65416296|NCT00440115|Antidepressive Agents|antidepressive agents|mesh-ancestor
65416297|NCT00440115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65416298|NCT00440115|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65416299|NCT00440115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65416300|NCT00440115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65416301|NCT00440115|Dopamine Agents|dopamine agents|mesh-ancestor
65416302|NCT00440115|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65416303|NCT00440115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65416304|NCT00440115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416305|NCT01033461|Calcium|calcium|mesh-list
65416306|NCT01033461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65416307|NCT01033461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416308|NCT01030731|Ceftobiprole|ceftobiprole|mesh-list
65416309|NCT01030731|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
65416310|NCT01030731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65416311|NCT01030731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65416312|NCT00416715|Calcium, Dietary|calcium, dietary|mesh-list
65416313|NCT00416715|Vitamin D|vitamin d|mesh-list
65416314|NCT00416715|Cholecalciferol|cholecalciferol|mesh-list
65416315|NCT00416715|Letrozole|letrozole|mesh-list
65416316|NCT00416715|Calcium Carbonate|calcium carbonate|mesh-list
65416317|NCT00416715|Citric Acid|citric acid|mesh-list
65416318|NCT00416715|Sodium Citrate|sodium citrate|mesh-list
65416319|NCT00416715|Calcium|calcium|mesh-list
65416320|NCT00416715|Vitamins|vitamins|mesh-ancestor
65416321|NCT00416715|Micronutrients|micronutrients|mesh-ancestor
65416322|NCT00416715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416323|NCT00416715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65416324|NCT00416715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65416325|NCT00416715|Anticoagulants|anticoagulants|mesh-ancestor
65416326|NCT00416715|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65416327|NCT00416715|Chelating Agents|chelating agents|mesh-ancestor
65416328|NCT00416715|Sequestering Agents|sequestering agents|mesh-ancestor
65416329|NCT00416715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416330|NCT00416715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416331|NCT00416715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65416332|NCT00416715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65416344|NCT00406029|Levodopa|levodopa|mesh-list
65416345|NCT00406029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65416346|NCT00406029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65416347|NCT00406029|Dopamine Agents|dopamine agents|mesh-ancestor
65416348|NCT00406029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65416349|NCT00406029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416350|NCT00406029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416351|NCT00514514|Cyclosporine|cyclosporine|mesh-list
65416352|NCT00514514|Mycophenolic Acid|mycophenolic acid|mesh-list
65416353|NCT00514514|Everolimus|everolimus|mesh-list
65416354|NCT00514514|Cyclosporins|cyclosporins|mesh-list
65416355|NCT00514514|Basiliximab|basiliximab|mesh-list
65416356|NCT00514514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416357|NCT00514514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416358|NCT00514514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65416359|NCT00514514|Immunologic Factors|immunologic factors|mesh-ancestor
65416360|NCT00514514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416361|NCT00514514|Antifungal Agents|antifungal agents|mesh-ancestor
65416362|NCT00514514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65416363|NCT00514514|Dermatologic Agents|dermatologic agents|mesh-ancestor
65416364|NCT00514514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65416365|NCT00514514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65416366|NCT00514514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416367|NCT00514514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65416368|NCT00514514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65416369|NCT00514514|Antitubercular Agents|antitubercular agents|mesh-ancestor
65416370|NCT00514514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65416371|NCT00405639|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65416372|NCT00405639|Natriuretic Agents|natriuretic agents|mesh-ancestor
65416373|NCT00405639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416374|NCT00439725|Rivaroxaban|rivaroxaban|mesh-list
65416375|NCT00439725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65416376|NCT00439725|Antithrombins|antithrombins|mesh-ancestor
65416377|NCT00439725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65416378|NCT00439725|Protease Inhibitors|protease inhibitors|mesh-ancestor
65416379|NCT00439725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416380|NCT00439725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416381|NCT00439725|Anticoagulants|anticoagulants|mesh-ancestor
65416382|NCT00521586|Vaccines|vaccines|mesh-list
65416383|NCT00521586|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65416384|NCT00521586|Immunologic Factors|immunologic factors|mesh-ancestor
65416385|NCT00521586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416386|NCT00515502|Tiotropium Bromide|tiotropium bromide|mesh-list
65416387|NCT00515502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65416388|NCT00515502|Autonomic Agents|autonomic agents|mesh-ancestor
65416389|NCT00515502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65416390|NCT00515502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416391|NCT00515502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65416392|NCT00515502|Respiratory System Agents|respiratory system agents|mesh-ancestor
65416393|NCT00515502|Parasympatholytics|parasympatholytics|mesh-ancestor
65416394|NCT00515502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65416395|NCT00515502|Cholinergic Agents|cholinergic agents|mesh-ancestor
65416396|NCT00515502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65416397|NCT00515502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416398|NCT03336216|Leucovorin|leucovorin|mesh-list
65416419|NCT03336216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65416420|NCT03336216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65416421|NCT03336216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65416422|NCT03336216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65416423|NCT03336216|Antidotes|antidotes|mesh-ancestor
65416424|NCT03336216|Protective Agents|protective agents|mesh-ancestor
65416425|NCT03336216|Vitamin B Complex|vitamin b complex|mesh-ancestor
65416426|NCT03336216|Vitamins|vitamins|mesh-ancestor
65416427|NCT03336216|Micronutrients|micronutrients|mesh-ancestor
65416428|NCT01010646|Ribavirin|ribavirin|mesh-list
65416429|NCT01010646|Interferon-alpha|interferon-alpha|mesh-list
65416430|NCT01010646|Interferon alpha-2|interferon alpha-2|mesh-list
65416431|NCT01010646|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65416432|NCT01010646|Antimetabolites|antimetabolites|mesh-ancestor
65416433|NCT01010646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416434|NCT01010646|Antiviral Agents|antiviral agents|mesh-ancestor
65416435|NCT01010646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65416436|NCT01010646|Immunologic Factors|immunologic factors|mesh-ancestor
65416437|NCT01010646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416438|NCT01010646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416439|NCT00439647|Zoledronic Acid|zoledronic acid|mesh-list
65416440|NCT00439647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65416441|NCT00439647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416442|NCT00515112|Testosterone|testosterone|mesh-list
65416443|NCT00515112|Androgens|androgens|mesh-ancestor
65416444|NCT00515112|Hormones|hormones|mesh-ancestor
65416445|NCT00515112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65416446|NCT00515112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416447|NCT03742557|Ketamine|ketamine|mesh-list
65416448|NCT03742557|Analgesics|analgesics|mesh-ancestor
65416449|NCT03742557|Sensory System Agents|sensory system agents|mesh-ancestor
65416450|NCT03742557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65416451|NCT03742557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416452|NCT03742557|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65416453|NCT03742557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65416454|NCT03742557|Anesthetics, General|anesthetics, general|mesh-ancestor
65416455|NCT03742557|Anesthetics|anesthetics|mesh-ancestor
65416456|NCT03742557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65416465|NCT01324089|Protective Agents|protective agents|mesh-ancestor
65416466|NCT01324089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416467|NCT01324089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416468|NCT01324089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65416469|NCT01324089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65416470|NCT00404547|Ciclesonide|ciclesonide|mesh-list
65416471|NCT00404547|Glucocorticoids|glucocorticoids|mesh-ancestor
65416472|NCT00404547|Hormones|hormones|mesh-ancestor
65416473|NCT00404547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65416474|NCT00404547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416475|NCT00404547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65416476|NCT00515034|Imipenem|imipenem|mesh-list
65416477|NCT00515034|Doripenem|doripenem|mesh-list
65416478|NCT00515034|Cilastatin|cilastatin|mesh-list
65416479|NCT00515034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65416480|NCT00515034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65416481|NCT00515034|Protease Inhibitors|protease inhibitors|mesh-ancestor
65416482|NCT00515034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416483|NCT00515034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416484|NCT04635774|Insulin|insulin|mesh-list
65416485|NCT04635774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65416486|NCT04635774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416487|NCT00404235|Paclitaxel|paclitaxel|mesh-list
65416488|NCT00404235|Carboplatin|carboplatin|mesh-list
65416489|NCT00404235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65416490|NCT00404235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65416491|NCT00404235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416492|NCT00404235|Tubulin Modulators|tubulin modulators|mesh-ancestor
65416493|NCT00404235|Antimitotic Agents|antimitotic agents|mesh-ancestor
65416494|NCT00404235|Mitosis Modulators|mitosis modulators|mesh-ancestor
65416495|NCT00404235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416496|NCT00509262|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65416497|NCT00509262|Glipizide|glipizide|mesh-list
65416498|NCT00509262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65416499|NCT00509262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416500|NCT00509262|Incretins|incretins|mesh-ancestor
65416501|NCT00509262|Hormones|hormones|mesh-ancestor
65416502|NCT00509262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65416503|NCT00509262|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65416504|NCT00509262|Protease Inhibitors|protease inhibitors|mesh-ancestor
65416505|NCT00509262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416506|NCT00509262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416507|NCT00509106|Ceftriaxone|ceftriaxone|mesh-list
65416508|NCT00509106|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
65416509|NCT00509106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65416510|NCT00509106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65416511|NCT00607919|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65416512|NCT00607919|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65416513|NCT00607919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65416514|NCT00607919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65416515|NCT00607919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416516|NCT00607919|Adrenergic Agents|adrenergic agents|mesh-ancestor
65416517|NCT00607919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65416518|NCT00607919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416519|NCT00344968|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
65416520|NCT00344968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65416521|NCT00344968|Glucocorticoids|glucocorticoids|mesh-ancestor
65416522|NCT00344968|Hormones|hormones|mesh-ancestor
65416533|NCT00509028|Glucocorticoids|glucocorticoids|mesh-ancestor
65416534|NCT00509028|Hormones|hormones|mesh-ancestor
65416535|NCT00509028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65416536|NCT00352846|Vitamin D|vitamin d|mesh-list
65416537|NCT00352846|Zoledronic Acid|zoledronic acid|mesh-list
65416538|NCT00352846|Calcium Carbonate|calcium carbonate|mesh-list
65416539|NCT00352846|Calcium|calcium|mesh-list
65416540|NCT00352846|Vitamins|vitamins|mesh-ancestor
65416541|NCT00352846|Micronutrients|micronutrients|mesh-ancestor
65416542|NCT00352846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416543|NCT00352846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65416544|NCT00352846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65416545|NCT00352846|Antacids|antacids|mesh-ancestor
65416546|NCT00352846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416547|NCT00352846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65416548|NCT00508872|Leucovorin|leucovorin|mesh-list
65416549|NCT00508872|Bevacizumab|bevacizumab|mesh-list
65416550|NCT00508872|Fluorouracil|fluorouracil|mesh-list
65416551|NCT00508872|Oxaliplatin|oxaliplatin|mesh-list
65416552|NCT00508872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65416553|NCT00508872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416554|NCT00508872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65416555|NCT00508872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65416556|NCT00508872|Growth Substances|growth substances|mesh-ancestor
65416557|NCT00508872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416558|NCT00508872|Growth Inhibitors|growth inhibitors|mesh-ancestor
65416559|NCT00508872|Antimetabolites|antimetabolites|mesh-ancestor
65416560|NCT00508872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416561|NCT00508872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65269902|NCT02732132|GABA Agents|gaba agents|mesh-ancestor
65269903|NCT02737202|Saracatinib|saracatinib|mesh-list
65416562|NCT00508872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65416563|NCT00508872|Immunologic Factors|immunologic factors|mesh-ancestor
65416564|NCT00508872|Antidotes|antidotes|mesh-ancestor
65416565|NCT00508872|Protective Agents|protective agents|mesh-ancestor
65416566|NCT00508872|Vitamin B Complex|vitamin b complex|mesh-ancestor
65416567|NCT00508872|Vitamins|vitamins|mesh-ancestor
65416568|NCT00508872|Micronutrients|micronutrients|mesh-ancestor
65416569|NCT00508482|Lactulose|lactulose|mesh-list
65416570|NCT00508482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65416571|NCT00344032|Vaccines|vaccines|mesh-list
65416572|NCT00344032|Immunologic Factors|immunologic factors|mesh-ancestor
65416573|NCT00344032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416574|NCT00607373|Mipomersen|mipomersen|mesh-list
65416575|NCT00607373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65416576|NCT00607373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65416577|NCT00607373|Antimetabolites|antimetabolites|mesh-ancestor
65416578|NCT00607373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416579|NCT00607373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65416580|NCT00508404|Panitumumab|panitumumab|mesh-list
65416581|NCT00508404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65416582|NCT00508404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416583|NCT00352690|Paclitaxel|paclitaxel|mesh-list
65416584|NCT00352690|Carboplatin|carboplatin|mesh-list
65416585|NCT00352690|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
65416586|NCT00352690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64801339|NCT02619552|Prednisone|prednisone|mesh-list
65416591|NCT00352690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416593|NCT00895505|Phenprocoumon|phenprocoumon|mesh-list
65416594|NCT00895505|Anticoagulants|anticoagulants|mesh-ancestor
65416595|NCT03502577|Cyclophosphamide|cyclophosphamide|mesh-list
65416596|NCT03502577|Fludarabine|fludarabine|mesh-list
65416597|NCT03502577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65416598|NCT03502577|Immunologic Factors|immunologic factors|mesh-ancestor
65416599|NCT03502577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416600|NCT03502577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65416601|NCT03502577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65416602|NCT03502577|Alkylating Agents|alkylating agents|mesh-ancestor
65416603|NCT03502577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416604|NCT03502577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416605|NCT03502577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65416606|NCT03249012|Calcium, Dietary|calcium, dietary|mesh-list
65416607|NCT03249012|Calcitriol|calcitriol|mesh-list
65416608|NCT03249012|Calcium Carbonate|calcium carbonate|mesh-list
65416609|NCT03249012|Calcium|calcium|mesh-list
65416610|NCT03249012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65416611|NCT03249012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416612|NCT03249012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65416613|NCT03249012|Antacids|antacids|mesh-ancestor
65416614|NCT03249012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416615|NCT03249012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65416616|NCT03249012|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65416617|NCT03249012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65416618|NCT03249012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65416619|NCT03249012|Vitamins|vitamins|mesh-ancestor
65416620|NCT03249012|Micronutrients|micronutrients|mesh-ancestor
65416621|NCT03477539|Lenalidomide|lenalidomide|mesh-list
65416622|NCT03477539|Daratumumab|daratumumab|mesh-list
65416623|NCT03477539|Immunologic Factors|immunologic factors|mesh-ancestor
65416624|NCT03477539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416625|NCT03477539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65416626|NCT03477539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65416627|NCT03477539|Growth Substances|growth substances|mesh-ancestor
65416628|NCT03477539|Growth Inhibitors|growth inhibitors|mesh-ancestor
65416629|NCT03477539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416630|NCT03233724|Pembrolizumab|pembrolizumab|mesh-list
65416631|NCT03233724|Decitabine|decitabine|mesh-list
65416632|NCT03233724|Tetrahydrouridine|tetrahydrouridine|mesh-list
65416633|NCT03233724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65416634|NCT03233724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416635|NCT03233724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65416636|NCT03233724|Antimetabolites|antimetabolites|mesh-ancestor
65416637|NCT03233724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416638|NCT03233724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416639|NCT00893477|Rituximab|rituximab|mesh-list
65416640|NCT00893477|Sargramostim|sargramostim|mesh-list
65238245|NCT00791713|Dopamine Agents|dopamine agents|mesh-ancestor
65416641|NCT00893477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65416642|NCT00893477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416643|NCT00893477|Immunologic Factors|immunologic factors|mesh-ancestor
65416644|NCT00893477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416645|NCT00893477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65416646|NCT00609245|Valproic Acid|valproic acid|mesh-list
65416647|NCT00609245|Anticonvulsants|anticonvulsants|mesh-ancestor
65416648|NCT00609245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416649|NCT00609245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416650|NCT00609245|GABA Agents|gaba agents|mesh-ancestor
65416651|NCT00609245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65416652|NCT00609245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416653|NCT00609245|Antimanic Agents|antimanic agents|mesh-ancestor
65416654|NCT00609245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65416655|NCT00609245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65416656|NCT00609245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65416657|NCT01010802|Epoetin Alfa|epoetin alfa|mesh-list
65416658|NCT01010802|Hematinics|hematinics|mesh-ancestor
65416659|NCT04036253|Epoetin Alfa|epoetin alfa|mesh-list
65416668|NCT00893555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65416669|NCT00893555|Hormone Antagonists|hormone antagonists|mesh-ancestor
65416670|NCT00893555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65416671|NCT00893555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416672|NCT00893555|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65416673|NCT02541071|Clonidine|clonidine|mesh-list
65416674|NCT02541071|Yohimbine|yohimbine|mesh-list
65416675|NCT02541071|Analgesics|analgesics|mesh-ancestor
65416676|NCT02541071|Sensory System Agents|sensory system agents|mesh-ancestor
65416677|NCT02541071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65416678|NCT02541071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416679|NCT02541071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65416680|NCT02541071|Sympatholytics|sympatholytics|mesh-ancestor
65416681|NCT02541071|Autonomic Agents|autonomic agents|mesh-ancestor
65416682|NCT02541071|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65416683|NCT02541071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65416684|NCT02541071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65416685|NCT02541071|Adrenergic Agents|adrenergic agents|mesh-ancestor
65416686|NCT02541071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65416687|NCT02541071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416688|NCT02541071|Mydriatics|mydriatics|mesh-ancestor
65416689|NCT02541071|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65416690|NCT02541071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65416691|NCT02541071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65416692|NCT02541071|Urological Agents|urological agents|mesh-ancestor
65416693|NCT01058824|Lincomycin|lincomycin|mesh-list
65416694|NCT01058824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65416695|NCT01058824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65416696|NCT01058824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65416697|NCT01058824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416698|NCT01058824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416699|NCT00895739|Cyclosporine|cyclosporine|mesh-list
65416700|NCT00895739|Alemtuzumab|alemtuzumab|mesh-list
65416701|NCT00895739|Cyclosporins|cyclosporins|mesh-list
65416702|NCT00895739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416703|NCT00895739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416704|NCT00895739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65416705|NCT00895739|Immunologic Factors|immunologic factors|mesh-ancestor
65416706|NCT00895739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416707|NCT00895739|Antifungal Agents|antifungal agents|mesh-ancestor
65416708|NCT00895739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65416709|NCT00895739|Dermatologic Agents|dermatologic agents|mesh-ancestor
65416710|NCT00895739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65416711|NCT00895739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65416712|NCT00895739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65416713|NCT00895739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416714|NCT01058902|Aspirin|aspirin|mesh-list
65416715|NCT01058902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65416716|NCT01058902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65416717|NCT01058902|Analgesics|analgesics|mesh-ancestor
65416718|NCT01058902|Sensory System Agents|sensory system agents|mesh-ancestor
65416719|NCT01058902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65416720|NCT01058902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416721|NCT01058902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65416722|NCT01058902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65416723|NCT01058902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65416724|NCT01058902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64801470|NCT02293109|Methotrexate|methotrexate|mesh-list
65416731|NCT00609167|Cyclophosphamide|cyclophosphamide|mesh-list
65416732|NCT00609167|Bortezomib|bortezomib|mesh-list
65416733|NCT00609167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65416734|NCT00609167|Immunologic Factors|immunologic factors|mesh-ancestor
65416735|NCT00609167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416736|NCT00609167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65416737|NCT00609167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65416738|NCT00609167|Alkylating Agents|alkylating agents|mesh-ancestor
65416739|NCT00609167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416740|NCT00609167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416741|NCT00609167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65416742|NCT00609167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65416743|NCT00609167|Antiemetics|antiemetics|mesh-ancestor
65416744|NCT00609167|Autonomic Agents|autonomic agents|mesh-ancestor
65416745|NCT00609167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65416746|NCT00609167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65416747|NCT00609167|Glucocorticoids|glucocorticoids|mesh-ancestor
65416748|NCT00609167|Hormones|hormones|mesh-ancestor
65416749|NCT00609167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65416750|NCT00609167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65416751|NCT01055236|Hydroxyzine|hydroxyzine|mesh-list
65416752|NCT01055236|Antipruritics|antipruritics|mesh-ancestor
65416753|NCT01055236|Dermatologic Agents|dermatologic agents|mesh-ancestor
65416754|NCT01055236|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65416755|NCT01055236|Histamine Antagonists|histamine antagonists|mesh-ancestor
65416756|NCT01055236|Histamine Agents|histamine agents|mesh-ancestor
65416757|NCT01055236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65416758|NCT01055236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416759|NCT01055236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416760|NCT00606281|Aripiprazole|aripiprazole|mesh-list
65416761|NCT00606281|Antidepressive Agents|antidepressive agents|mesh-ancestor
65416762|NCT00606281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65416763|NCT00606281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65416764|NCT00606281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65416765|NCT00606281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65416766|NCT00606281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416767|NCT00606281|Dopamine Agonists|dopamine agonists|mesh-ancestor
65416768|NCT00606281|Dopamine Agents|dopamine agents|mesh-ancestor
65416769|NCT00606281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65416770|NCT00606281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416771|NCT00606281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65416772|NCT00606281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65416773|NCT00606281|Serotonin Agents|serotonin agents|mesh-ancestor
65416774|NCT00606281|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65416775|NCT00606281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65416776|NCT00606281|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65416777|NCT00606281|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65416778|NCT00506142|Vincristine|vincristine|mesh-list
65416779|NCT00506142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65416780|NCT00506142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416781|NCT00506142|Tubulin Modulators|tubulin modulators|mesh-ancestor
65416782|NCT00506142|Antimitotic Agents|antimitotic agents|mesh-ancestor
65416783|NCT00506142|Mitosis Modulators|mitosis modulators|mesh-ancestor
65416784|NCT00506142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416785|NCT00891605|Paclitaxel|paclitaxel|mesh-list
65416786|NCT00891605|Navitoclax|navitoclax|mesh-list
65416787|NCT00891605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65416788|NCT00891605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416789|NCT00891605|Tubulin Modulators|tubulin modulators|mesh-ancestor
65416790|NCT00891605|Antimitotic Agents|antimitotic agents|mesh-ancestor
65416791|NCT00891605|Mitosis Modulators|mitosis modulators|mesh-ancestor
64801537|NCT01982448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416808|NCT00514020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416809|NCT00514020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65416810|NCT00514020|Immunologic Factors|immunologic factors|mesh-ancestor
65416811|NCT00514020|Antidotes|antidotes|mesh-ancestor
65416812|NCT00514020|Protective Agents|protective agents|mesh-ancestor
65416813|NCT00514020|Vitamin B Complex|vitamin b complex|mesh-ancestor
65416815|NCT00514020|Micronutrients|micronutrients|mesh-ancestor
65416816|NCT03570827|Ascorbic Acid|ascorbic acid|mesh-list
65416817|NCT03570827|Methyltestosterone|methyltestosterone|mesh-list
65416818|NCT03570827|Androgens|androgens|mesh-list
65238400|NCT00782041|Antidotes|antidotes|mesh-ancestor
65416819|NCT03570827|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65416820|NCT03570827|Hormones|hormones|mesh-ancestor
65416821|NCT03570827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65416822|NCT03570827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416823|NCT03570827|Antioxidants|antioxidants|mesh-ancestor
65416824|NCT03570827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416825|NCT03570827|Protective Agents|protective agents|mesh-ancestor
65416826|NCT03570827|Vitamins|vitamins|mesh-ancestor
65416827|NCT03570827|Micronutrients|micronutrients|mesh-ancestor
65416828|NCT03570827|Estrogens|estrogens|mesh-ancestor
65416829|NCT03570827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65416830|NCT03570827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416831|NCT03570827|Anabolic Agents|anabolic agents|mesh-ancestor
65416832|NCT03560531|Palbociclib|palbociclib|mesh-list
65416833|NCT03560531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166349|NCT01015131|Alovudine|alovudine|mesh-list
65416835|NCT03560531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416836|NCT03560531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416837|NCT03075696|Obinutuzumab|obinutuzumab|mesh-list
65416838|NCT03075696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65416839|NCT03075696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416840|NCT00896285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65416841|NCT00896285|Analgesics|analgesics|mesh-list
65416842|NCT00896285|Opiate Alkaloids|opiate alkaloids|mesh-list
65416843|NCT00896285|Sensory System Agents|sensory system agents|mesh-ancestor
65416844|NCT00896285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65416845|NCT00896285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416846|NCT00896285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65416847|NCT00896285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65416848|NCT00896285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65416849|NCT00896285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65416850|NCT00896285|Narcotics|narcotics|mesh-ancestor
65416851|NCT00896285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64801607|NCT01595620|Analgesics|analgesics|mesh-ancestor
65416864|NCT00891761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416865|NCT00891761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65416867|NCT00891761|Hormones|hormones|mesh-ancestor
65416868|NCT00891761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65416869|NCT00891761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65416870|NCT00891761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416871|NCT00891761|Protease Inhibitors|protease inhibitors|mesh-ancestor
65416872|NCT00891761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416873|NCT00891761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416874|NCT00891761|Antipruritics|antipruritics|mesh-ancestor
65416875|NCT00891761|Dermatologic Agents|dermatologic agents|mesh-ancestor
65416876|NCT00891761|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65416877|NCT00891761|Serotonin Agents|serotonin agents|mesh-ancestor
65416878|NCT00891761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65416879|NCT00891761|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65416880|NCT00891761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65416881|NCT00891761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65416882|NCT00891761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65416883|NCT00891761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65416884|NCT00891761|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65416885|NCT01012830|Huperzine A|huperzine a|mesh-list
65416886|NCT01012830|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65416887|NCT01012830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416888|NCT01012830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416889|NCT01012830|Cholinergic Agents|cholinergic agents|mesh-ancestor
65416890|NCT01012830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65416891|NCT01012830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416892|NCT01012830|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65416893|NCT01012830|Protective Agents|protective agents|mesh-ancestor
65416894|NCT00513474|Cyclosporine|cyclosporine|mesh-list
65416895|NCT00513474|Sirolimus|sirolimus|mesh-list
65416896|NCT00513474|Cyclophosphamide|cyclophosphamide|mesh-list
65416897|NCT00513474|Busulfan|busulfan|mesh-list
65416898|NCT00513474|Methotrexate|methotrexate|mesh-list
65416899|NCT00513474|Fludarabine|fludarabine|mesh-list
65416900|NCT00513474|Etoposide|etoposide|mesh-list
65416901|NCT00513474|Allopurinol|allopurinol|mesh-list
65416902|NCT00513474|Rasburicase|rasburicase|mesh-list
65416903|NCT00513474|Tacrolimus|tacrolimus|mesh-list
65416904|NCT00513474|Cyclosporins|cyclosporins|mesh-list
65416905|NCT00513474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65416906|NCT00513474|Immunologic Factors|immunologic factors|mesh-ancestor
65416907|NCT00513474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416908|NCT00513474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65416909|NCT00513474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65416910|NCT00513474|Alkylating Agents|alkylating agents|mesh-ancestor
65416911|NCT00513474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416912|NCT00513474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416913|NCT00513474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65416914|NCT00513474|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65416915|NCT00513474|Abortifacient Agents|abortifacient agents|mesh-ancestor
65416916|NCT00513474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64801670|NCT01354977|Resveratrol|resveratrol|mesh-list
65416922|NCT00513474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65416923|NCT00513474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65416925|NCT00513474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65416926|NCT00513474|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65416927|NCT00513474|Antifungal Agents|antifungal agents|mesh-ancestor
65416928|NCT00513474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65416929|NCT00513474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65416930|NCT00513474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65416931|NCT00513474|Gout Suppressants|gout suppressants|mesh-ancestor
65416932|NCT00513474|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65416933|NCT00513474|Antioxidants|antioxidants|mesh-ancestor
65416934|NCT00513474|Protective Agents|protective agents|mesh-ancestor
65416935|NCT01010958|Valproic Acid|valproic acid|mesh-list
65416936|NCT01010958|Anticonvulsants|anticonvulsants|mesh-ancestor
65416937|NCT01010958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416938|NCT01010958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416939|NCT01010958|GABA Agents|gaba agents|mesh-ancestor
65416940|NCT01010958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65416941|NCT01010958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416942|NCT01010958|Antimanic Agents|antimanic agents|mesh-ancestor
65416943|NCT01010958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65416944|NCT01010958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65416945|NCT01010958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65416947|NCT00896519|Cyclophosphamide|cyclophosphamide|mesh-list
65416948|NCT00896519|Rituximab|rituximab|mesh-list
65416949|NCT00896519|Doxorubicin|doxorubicin|mesh-list
65416950|NCT00896519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65416951|NCT00896519|Vincristine|vincristine|mesh-list
65416952|NCT00896519|Sargramostim|sargramostim|mesh-list
65416953|NCT00896519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65416954|NCT00896519|Immunologic Factors|immunologic factors|mesh-ancestor
65416955|NCT00896519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416956|NCT00896519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65416957|NCT00896519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65416958|NCT00896519|Alkylating Agents|alkylating agents|mesh-ancestor
65416959|NCT00896519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416960|NCT00896519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416961|NCT00896519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65416962|NCT00896519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65416963|NCT00896519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65416964|NCT00896519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65416965|NCT00896519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65416966|NCT00896519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416967|NCT00896519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65416968|NCT00896519|Glucocorticoids|glucocorticoids|mesh-ancestor
65416969|NCT00896519|Hormones|hormones|mesh-ancestor
65416970|NCT00896519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65416971|NCT00896519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65416972|NCT00896519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65416973|NCT00896519|Tubulin Modulators|tubulin modulators|mesh-ancestor
65416974|NCT00896519|Antimitotic Agents|antimitotic agents|mesh-ancestor
65416975|NCT00896519|Mitosis Modulators|mitosis modulators|mesh-ancestor
65416976|NCT00505752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65416977|NCT00505752|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65416978|NCT00505752|Hormones|hormones|mesh-ancestor
65416979|NCT00505752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65416980|NCT00505752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416981|NCT00505752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65416982|NCT01011036|Clonazepam|clonazepam|mesh-list
65416983|NCT01011036|Clobazam|clobazam|mesh-list
65416984|NCT01011036|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65166494|NCT03982537|Acetylcysteine|acetylcysteine|mesh-list
65416985|NCT01011036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65416986|NCT01011036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65238554|NCT00927758|Hormones|hormones|mesh-ancestor
65416994|NCT01011036|GABA Agents|gaba agents|mesh-ancestor
65416995|NCT01011036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65416996|NCT01011036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65416997|NCT01011036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65416998|NCT01011036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65416999|NCT01011036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65417000|NCT01011036|GABA Agonists|gaba agonists|mesh-ancestor
65417001|NCT03601637|Ivacaftor|ivacaftor|mesh-list
65417002|NCT03601637|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65417003|NCT03601637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65417004|NCT03601637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417005|NCT00894023|Abciximab|abciximab|mesh-list
65417006|NCT00894023|Anticoagulants|anticoagulants|mesh-ancestor
65417007|NCT00894023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65417008|NCT00892073|Metformin|metformin|mesh-list
65417009|NCT00892073|Diazoxide|diazoxide|mesh-list
65417010|NCT00892073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65417011|NCT00892073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417012|NCT00892073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65417013|NCT00892073|Vasodilator Agents|vasodilator agents|mesh-ancestor
65417014|NCT00896831|N-Methylaspartate|n-methylaspartate|mesh-list
65417015|NCT00896831|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
65417016|NCT00896831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65417017|NCT00896831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65417018|NCT00896831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417019|NCT00896831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417020|NCT02541227|Cerebrolysin|cerebrolysin|mesh-list
65417021|NCT02541227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65417022|NCT02541227|Protective Agents|protective agents|mesh-ancestor
65417023|NCT02541227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417024|NCT02541227|Nootropic Agents|nootropic agents|mesh-ancestor
65417025|NCT00896987|Lamotrigine|lamotrigine|mesh-list
65417026|NCT00896987|Carbamazepine|carbamazepine|mesh-list
65417027|NCT00896987|Anticonvulsants|anticonvulsants|mesh-ancestor
65417028|NCT00896987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65417029|NCT00896987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65417030|NCT00896987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417031|NCT00896987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65417032|NCT00896987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417033|NCT00896987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65417034|NCT00896987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65417035|NCT00896987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65417036|NCT00896987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65417037|NCT00896987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65417038|NCT00896987|Antimanic Agents|antimanic agents|mesh-ancestor
65417039|NCT00896987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65417040|NCT00896987|Analgesics|analgesics|mesh-ancestor
65417041|NCT00896987|Sensory System Agents|sensory system agents|mesh-ancestor
65417042|NCT00896987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417043|NCT00896987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65417044|NCT00896987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65417045|NCT00897065|Antibodies|antibodies|mesh-list
65417046|NCT00897065|Immunologic Factors|immunologic factors|mesh-ancestor
65417047|NCT00897065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417048|NCT00343252|Teriparatide|teriparatide|mesh-list
65417049|NCT00343252|Risedronic Acid|risedronic acid|mesh-list
65417050|NCT00343252|Etidronic Acid|etidronic acid|mesh-list
65417051|NCT00343252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65417052|NCT00343252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417053|NCT00343252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65417054|NCT00343252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65417064|NCT00892229|Oxytocics|oxytocics|mesh-ancestor
65417065|NCT00897221|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65417066|NCT00897221|Deferiprone|deferiprone|mesh-list
65417067|NCT00897221|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65417068|NCT00897221|Chelating Agents|chelating agents|mesh-ancestor
65417069|NCT00897221|Sequestering Agents|sequestering agents|mesh-ancestor
65417070|NCT00897221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417072|NCT00892307|Analgesics|analgesics|mesh-ancestor
65417073|NCT00892307|Sensory System Agents|sensory system agents|mesh-ancestor
65417074|NCT00892307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417075|NCT00892307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417076|NCT00892307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65417077|NCT00892307|Vasodilator Agents|vasodilator agents|mesh-ancestor
65238624|NCT00608816|Mydriatics|mydriatics|mesh-ancestor
65417078|NCT00892307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65417079|NCT00892307|Purinergic Agonists|purinergic agonists|mesh-ancestor
65417080|NCT00892307|Purinergic Agents|purinergic agents|mesh-ancestor
65417081|NCT00892307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65417082|NCT00892307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417083|NCT00342628|Vaccines|vaccines|mesh-list
65417084|NCT00342628|Immunologic Factors|immunologic factors|mesh-ancestor
65417085|NCT00342628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417086|NCT00897377|Temozolomide|temozolomide|mesh-list
65417087|NCT00897377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65417088|NCT00897377|Alkylating Agents|alkylating agents|mesh-ancestor
65417089|NCT00897377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417090|NCT00897377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417091|NCT00894569|Paclitaxel|paclitaxel|mesh-list
65417092|NCT00894569|Carboplatin|carboplatin|mesh-list
65417093|NCT00894569|Cetuximab|cetuximab|mesh-list
65417094|NCT00894569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65417095|NCT00894569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417096|NCT00894569|Tubulin Modulators|tubulin modulators|mesh-ancestor
65417097|NCT00894569|Antimitotic Agents|antimitotic agents|mesh-ancestor
65417098|NCT00894569|Mitosis Modulators|mitosis modulators|mesh-ancestor
65417099|NCT00894569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417100|NCT00894569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65417101|NCT00337168|Cytarabine|cytarabine|mesh-list
65417102|NCT00337168|Clofarabine|clofarabine|mesh-list
65417103|NCT00337168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65417104|NCT00337168|Antimetabolites|antimetabolites|mesh-ancestor
65417105|NCT00337168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417106|NCT00337168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417107|NCT00337168|Antiviral Agents|antiviral agents|mesh-ancestor
65417108|NCT00337168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65417109|NCT00337168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65417110|NCT00337168|Immunologic Factors|immunologic factors|mesh-ancestor
65417111|NCT00337168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417112|NCT00892385|Temozolomide|temozolomide|mesh-list
65417113|NCT00892385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65417114|NCT00892385|Alkylating Agents|alkylating agents|mesh-ancestor
65417115|NCT00892385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417116|NCT00892385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417117|NCT00892463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65417118|NCT00892463|Antidepressive Agents|antidepressive agents|mesh-ancestor
65417127|NCT01011114|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65417128|NCT01011114|Hormone Antagonists|hormone antagonists|mesh-ancestor
65417129|NCT01011114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65417130|NCT00606905|Immunoglobulins|immunoglobulins|mesh-list
65417131|NCT00606905|gamma-Globulins|gamma-globulins|mesh-list
65417132|NCT00606905|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65417133|NCT00606905|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65417134|NCT00606905|Immunologic Factors|immunologic factors|mesh-ancestor
65417135|NCT00606905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417136|NCT01055392|Lithium Carbonate|lithium carbonate|mesh-list
65417137|NCT01055392|Antidepressive Agents|antidepressive agents|mesh-ancestor
65417138|NCT01055392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65417139|NCT01055392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417140|NCT01055392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417141|NCT01055392|Antimanic Agents|antimanic agents|mesh-ancestor
65417142|NCT01055392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65417143|NCT01055392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65417144|NCT01055392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417145|NCT03063762|Bevacizumab|bevacizumab|mesh-list
65417146|NCT03063762|Atezolizumab|atezolizumab|mesh-list
65417147|NCT03063762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65417148|NCT03063762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417149|NCT03063762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65417150|NCT03063762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65417151|NCT03063762|Growth Substances|growth substances|mesh-ancestor
65417152|NCT03063762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417153|NCT03063762|Growth Inhibitors|growth inhibitors|mesh-ancestor
65417154|NCT05278637|Aspirin|aspirin|mesh-list
65417155|NCT05278637|Ticagrelor|ticagrelor|mesh-list
65417156|NCT05278637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65417157|NCT05278637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65417158|NCT05278637|Analgesics|analgesics|mesh-ancestor
65238693|NCT00788749|Xhance|xhance|mesh-list
65417159|NCT05278637|Sensory System Agents|sensory system agents|mesh-ancestor
65417160|NCT05278637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417161|NCT05278637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417162|NCT05278637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65417163|NCT05278637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65417164|NCT05278637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65417165|NCT05278637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65417166|NCT05278637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417167|NCT05278637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65417168|NCT05278637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65417169|NCT05278637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417170|NCT05278637|Antipyretics|antipyretics|mesh-ancestor
65417171|NCT05278637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65417172|NCT05278637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65417173|NCT05278637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65417174|NCT05278637|Purinergic Agents|purinergic agents|mesh-ancestor
65417175|NCT05278637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65417176|NCT04017377|Paclitaxel|paclitaxel|mesh-list
65417177|NCT04017377|Cisplatin|cisplatin|mesh-list
65417178|NCT04017377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65417179|NCT04017377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417180|NCT04017377|Tubulin Modulators|tubulin modulators|mesh-ancestor
65417181|NCT04017377|Antimitotic Agents|antimitotic agents|mesh-ancestor
65417182|NCT04017377|Mitosis Modulators|mitosis modulators|mesh-ancestor
65417183|NCT04017377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417184|NCT04035785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65417191|NCT02539745|Vitamin D|vitamin d|mesh-list
65417192|NCT02539745|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
65417193|NCT02539745|Vitamins|vitamins|mesh-ancestor
65417194|NCT02539745|Micronutrients|micronutrients|mesh-ancestor
65417195|NCT02539745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417196|NCT02539745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65417197|NCT00901511|Molgramostim|molgramostim|mesh-list
65417198|NCT00901511|Sargramostim|sargramostim|mesh-list
65417199|NCT00901511|Immunologic Factors|immunologic factors|mesh-ancestor
65417200|NCT00901511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417201|NCT00901511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417202|NCT00894959|Heparin|heparin|mesh-list
65417203|NCT00894959|Calcium heparin|calcium heparin|mesh-list
65417204|NCT00894959|Anticoagulants|anticoagulants|mesh-ancestor
65417205|NCT00894959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65417206|NCT00894959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65417207|NCT00894959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417208|NCT03516617|Obinutuzumab|obinutuzumab|mesh-list
65417209|NCT03516617|Acalabrutinib|acalabrutinib|mesh-list
65166721|NCT02850718|Urological Agents|urological agents|mesh-ancestor
65417210|NCT03516617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65417211|NCT03516617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417213|NCT00895115|Vitamins|vitamins|mesh-ancestor
65417214|NCT00895115|Micronutrients|micronutrients|mesh-ancestor
65417215|NCT00895115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417216|NCT00895115|Antioxidants|antioxidants|mesh-ancestor
65417217|NCT00895115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417218|NCT00895115|Protective Agents|protective agents|mesh-ancestor
65417219|NCT00901745|Norepinephrine|norepinephrine|mesh-list
65417220|NCT00901745|Angiotensin II|angiotensin ii|mesh-list
65417221|NCT00901745|Giapreza|giapreza|mesh-list
65417222|NCT00901745|Angiotensinogen|angiotensinogen|mesh-list
65417223|NCT00901745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65417224|NCT00901745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65417225|NCT00901745|Adrenergic Agents|adrenergic agents|mesh-ancestor
65417226|NCT00901745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65417227|NCT00901745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417228|NCT00901745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417229|NCT00901745|Sympathomimetics|sympathomimetics|mesh-ancestor
65417230|NCT00901745|Autonomic Agents|autonomic agents|mesh-ancestor
65417231|NCT00901745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417232|NCT00901745|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65417233|NCT00901745|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65417234|NCT00901745|Protease Inhibitors|protease inhibitors|mesh-ancestor
65417235|NCT00901745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417236|NCT02540837|Bupivacaine|bupivacaine|mesh-list
65417237|NCT02540837|Anesthetics, Local|anesthetics, local|mesh-ancestor
65417238|NCT02540837|Anesthetics|anesthetics|mesh-ancestor
65417239|NCT02540837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65269904|NCT02737202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269905|NCT02737202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417240|NCT02540837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417241|NCT02540837|Sensory System Agents|sensory system agents|mesh-ancestor
65417242|NCT02540837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417243|NCT00901823|Diazoxide|diazoxide|mesh-list
65417244|NCT00901823|Choline|choline|mesh-list
65417245|NCT00901823|Lipotropic Agents|lipotropic agents|mesh-ancestor
65417246|NCT00901823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65417247|NCT00901823|Antimetabolites|antimetabolites|mesh-ancestor
65417248|NCT00901823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417249|NCT00901823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65417250|NCT00901823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65417251|NCT00901823|Nootropic Agents|nootropic agents|mesh-ancestor
65417252|NCT00901823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65417253|NCT00901823|Vasodilator Agents|vasodilator agents|mesh-ancestor
65417254|NCT00902057|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65417255|NCT00902057|Hemostatics|hemostatics|mesh-ancestor
65417264|NCT00902135|Antiviral Agents|antiviral agents|mesh-ancestor
65417265|NCT00902135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65417266|NCT00902135|Immunologic Factors|immunologic factors|mesh-ancestor
65417267|NCT00902135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417268|NCT00902135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65417269|NCT02540369|Aflibercept|aflibercept|mesh-list
65417270|NCT02540369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65417271|NCT02540369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65417272|NCT02540369|Growth Substances|growth substances|mesh-ancestor
65417273|NCT02540369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417274|NCT02540369|Growth Inhibitors|growth inhibitors|mesh-ancestor
65417275|NCT02540369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417276|NCT00605267|Tamoxifen|tamoxifen|mesh-list
65417277|NCT00605267|Goserelin|goserelin|mesh-list
65417278|NCT00605267|Anastrozole|anastrozole|mesh-list
65417279|NCT00605267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65417280|NCT00605267|Hormone Antagonists|hormone antagonists|mesh-ancestor
65417281|NCT00605267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65417282|NCT00605267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417283|NCT00605267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65417284|NCT00605267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417285|NCT00605267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65417286|NCT00605267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65417287|NCT00605267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65417288|NCT00605267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65417289|NCT00605267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65417290|NCT00605267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417291|NCT00605267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417292|NCT00902525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65417293|NCT00902525|Immunologic Factors|immunologic factors|mesh-ancestor
65417294|NCT00902525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417295|NCT00902603|Iloprost|iloprost|mesh-list
65417296|NCT00902603|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65417297|NCT00902603|Vasodilator Agents|vasodilator agents|mesh-ancestor
65417298|NCT00902681|Fesoterodine|fesoterodine|mesh-list
65417299|NCT00902681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65417300|NCT00902681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65417301|NCT00902681|Cholinergic Agents|cholinergic agents|mesh-ancestor
65417302|NCT00902681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65417303|NCT00902681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417304|NCT00902681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417305|NCT00902681|Urological Agents|urological agents|mesh-ancestor
65417306|NCT00906113|Melphalan|melphalan|mesh-list
65417307|NCT00906113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65417308|NCT00906113|Alkylating Agents|alkylating agents|mesh-ancestor
65417309|NCT00906113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417310|NCT00906113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417311|NCT00906113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65417312|NCT00906113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65417313|NCT00906113|Immunologic Factors|immunologic factors|mesh-ancestor
65417314|NCT00906113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417315|NCT00902837|Oxycodone|oxycodone|mesh-list
65417316|NCT00902837|Naloxone|naloxone|mesh-list
65417317|NCT00902837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65417318|NCT00902837|Narcotics|narcotics|mesh-ancestor
65417319|NCT00902837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65417320|NCT00902837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417321|NCT00902837|Analgesics|analgesics|mesh-ancestor
65417322|NCT00902837|Sensory System Agents|sensory system agents|mesh-ancestor
65417323|NCT00902837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417329|NCT00605813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65417330|NCT00605813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65417331|NCT00605813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417332|NCT00605813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65417333|NCT00605813|Serotonin Agents|serotonin agents|mesh-ancestor
65417334|NCT00605813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417335|NCT00906269|Sildenafil Citrate|sildenafil citrate|mesh-list
65417336|NCT00906269|Vasodilator Agents|vasodilator agents|mesh-ancestor
65417337|NCT00906269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65417338|NCT00906269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65417339|NCT00906269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417340|NCT00906269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417341|NCT00906269|Urological Agents|urological agents|mesh-ancestor
65417342|NCT00902915|Dexamethasone|dexamethasone|mesh-list
65417343|NCT00902915|Lenalidomide|lenalidomide|mesh-list
65417344|NCT00902915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65417345|NCT00902915|Antiemetics|antiemetics|mesh-ancestor
65417346|NCT00902915|Autonomic Agents|autonomic agents|mesh-ancestor
65417347|NCT00902915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417348|NCT00902915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417349|NCT00902915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65417350|NCT00902915|Glucocorticoids|glucocorticoids|mesh-ancestor
65417351|NCT00902915|Hormones|hormones|mesh-ancestor
65417352|NCT00902915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65417353|NCT00902915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65417354|NCT00902915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417355|NCT00902915|Immunologic Factors|immunologic factors|mesh-ancestor
65417356|NCT00902915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65417357|NCT00902915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65417358|NCT00902915|Growth Substances|growth substances|mesh-ancestor
65417359|NCT00902915|Growth Inhibitors|growth inhibitors|mesh-ancestor
65417360|NCT04034771|Propofol|propofol|mesh-list
65417361|NCT04034771|Melatonin|melatonin|mesh-list
65417362|NCT04034771|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65417363|NCT04034771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65417364|NCT04034771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417365|NCT04034771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65417366|NCT04034771|Anesthetics, General|anesthetics, general|mesh-ancestor
65417367|NCT04034771|Anesthetics|anesthetics|mesh-ancestor
65417368|NCT04034771|Antioxidants|antioxidants|mesh-ancestor
65417369|NCT04034771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417370|NCT04034771|Protective Agents|protective agents|mesh-ancestor
65417371|NCT00899483|Insulin|insulin|mesh-list
65417372|NCT00899483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65417373|NCT00899483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417374|NCT02539199|Misoprostol|misoprostol|mesh-list
65417375|NCT02539199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65417376|NCT02539199|Abortifacient Agents|abortifacient agents|mesh-ancestor
65417377|NCT02539199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65417378|NCT02539199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417379|NCT02539199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65417380|NCT02539199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65417381|NCT02539199|Oxytocics|oxytocics|mesh-ancestor
65417382|NCT00903227|Fluticasone|fluticasone|mesh-list
65417383|NCT00903227|Xhance|xhance|mesh-list
65417384|NCT00903227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65417385|NCT00903227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65417386|NCT00903227|Autonomic Agents|autonomic agents|mesh-ancestor
65417387|NCT00903227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417388|NCT00903227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417389|NCT00903227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65417390|NCT00903227|Respiratory System Agents|respiratory system agents|mesh-ancestor
65417391|NCT00903227|Dermatologic Agents|dermatologic agents|mesh-ancestor
65417392|NCT00903227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65417393|NCT00605657|Valproic Acid|valproic acid|mesh-list
65417394|NCT00605657|Anticonvulsants|anticonvulsants|mesh-ancestor
64802132|NCT01400100|Octreotide|octreotide|mesh-list
65417407|NCT00899951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65417408|NCT00899951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417409|NCT00899951|Analgesics|analgesics|mesh-ancestor
65417410|NCT00899951|Sensory System Agents|sensory system agents|mesh-ancestor
65238916|NCT00795613|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65417411|NCT00899951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417412|NCT00899951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65417413|NCT00899951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65417414|NCT00899951|Anesthetics, General|anesthetics, general|mesh-ancestor
65417415|NCT00899951|Anesthetics|anesthetics|mesh-ancestor
65417416|NCT02539979|Acetaminophen|acetaminophen|mesh-list
65417417|NCT02539979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65417418|NCT02539979|Analgesics|analgesics|mesh-ancestor
65417419|NCT02539979|Sensory System Agents|sensory system agents|mesh-ancestor
65417420|NCT02539979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417421|NCT02539979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417422|NCT02539979|Antipyretics|antipyretics|mesh-ancestor
65417423|NCT05277701|Lazertinib|lazertinib|mesh-list
65417424|NCT05277701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65417425|NCT05277701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417426|NCT05277701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417427|NCT00605345|Darbepoetin alfa|darbepoetin alfa|mesh-list
65417428|NCT00605345|Hematinics|hematinics|mesh-ancestor
65417429|NCT00903851|Lidocaine|lidocaine|mesh-list
65417430|NCT00903851|Anesthetics, Local|anesthetics, local|mesh-ancestor
65417431|NCT00903851|Anesthetics|anesthetics|mesh-ancestor
65417432|NCT00903851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65417433|NCT00903851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417434|NCT00903851|Sensory System Agents|sensory system agents|mesh-ancestor
65417435|NCT00903851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417436|NCT00903851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65417437|NCT00903851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65417438|NCT00903851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65417440|NCT00903851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417441|NCT00900887|Ketorolac|ketorolac|mesh-list
65417442|NCT00900887|Nepafenac|nepafenac|mesh-list
65417443|NCT00900887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65417444|NCT00900887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65417445|NCT00900887|Analgesics|analgesics|mesh-ancestor
65417446|NCT00900887|Sensory System Agents|sensory system agents|mesh-ancestor
65417447|NCT00900887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417448|NCT00900887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417449|NCT00900887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65417450|NCT00900887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65417451|NCT00900887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65417452|NCT00900887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417453|NCT00900887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417454|NCT00904085|Oxymorphone|oxymorphone|mesh-list
65417455|NCT00904085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65417456|NCT00904085|Narcotics|narcotics|mesh-ancestor
65417457|NCT00904085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65417458|NCT00904085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802202|NCT01400633|Decitabine|decitabine|mesh-list
65417475|NCT00908531|Hormone Antagonists|hormone antagonists|mesh-ancestor
65417476|NCT00908531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65417477|NCT00908531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417478|NCT00904397|Celecoxib|celecoxib|mesh-list
65417479|NCT00904397|Lidocaine|lidocaine|mesh-list
65417480|NCT00904397|Anesthetics, Local|anesthetics, local|mesh-ancestor
65417481|NCT00904397|Anesthetics|anesthetics|mesh-ancestor
65417482|NCT00904397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65417483|NCT00904397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417484|NCT00904397|Sensory System Agents|sensory system agents|mesh-ancestor
65417485|NCT00904397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417486|NCT00904397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65417487|NCT00904397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65417488|NCT00904397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65417489|NCT00904397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65417490|NCT00904397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417491|NCT00904397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65417492|NCT00904397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65417493|NCT00904397|Analgesics|analgesics|mesh-ancestor
65417494|NCT00904397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65417495|NCT00904397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65417496|NCT00904397|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65417497|NCT00904397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65417498|NCT00904397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417499|NCT00904475|Lidocaine|lidocaine|mesh-list
65417500|NCT00904475|Anesthetics, Local|anesthetics, local|mesh-ancestor
65417501|NCT00904475|Anesthetics|anesthetics|mesh-ancestor
65417502|NCT00904475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65417503|NCT00904475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417504|NCT00904475|Sensory System Agents|sensory system agents|mesh-ancestor
65417505|NCT00904475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417506|NCT00904475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65417507|NCT00904475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65417508|NCT00904475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65417509|NCT00904475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65167021|NCT00611689|Vatalanib|vatalanib|mesh-list
65417510|NCT00904475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417511|NCT00908921|Glimepiride|glimepiride|mesh-list
65417512|NCT00908921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65417513|NCT00908921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64802270|NCT01400789|Insulin Lispro|insulin lispro|mesh-list
65417528|NCT00904631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417529|NCT00904631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65417530|NCT00904631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65417531|NCT00904631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65417532|NCT00904631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417533|NCT00904631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417534|NCT00909077|Dexamethasone|dexamethasone|mesh-list
65417535|NCT00909077|Dexamethasone acetate|dexamethasone acetate|mesh-list
65417536|NCT00909077|Rituximab|rituximab|mesh-list
65417537|NCT00909077|BB 1101|bb 1101|mesh-list
65417538|NCT00909077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65417539|NCT00909077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417540|NCT00909077|Immunologic Factors|immunologic factors|mesh-ancestor
65417541|NCT00909077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417542|NCT00909077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65417543|NCT00909077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65417544|NCT00909077|Antiemetics|antiemetics|mesh-ancestor
65417545|NCT00909077|Autonomic Agents|autonomic agents|mesh-ancestor
65417546|NCT00909077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417547|NCT00909077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65417548|NCT00909077|Glucocorticoids|glucocorticoids|mesh-ancestor
65417549|NCT00909077|Hormones|hormones|mesh-ancestor
65417550|NCT00909077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65417551|NCT00909077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65417552|NCT00909077|Protease Inhibitors|protease inhibitors|mesh-ancestor
65417553|NCT00909077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417554|NCT00909077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417555|NCT00904709|Tranexamic Acid|tranexamic acid|mesh-list
65417556|NCT00904709|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65417557|NCT00904709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65417558|NCT00904709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417559|NCT00904709|Hemostatics|hemostatics|mesh-ancestor
65417560|NCT00904709|Coagulants|coagulants|mesh-ancestor
65417561|NCT00340834|Interferons|interferons|mesh-list
65417562|NCT00340834|Interferon-beta|interferon-beta|mesh-list
65417563|NCT00340834|Interferon beta-1a|interferon beta-1a|mesh-list
65417564|NCT00340834|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65417565|NCT00340834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417566|NCT00340834|Antiviral Agents|antiviral agents|mesh-ancestor
65417567|NCT00340834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65417568|NCT00340834|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65417569|NCT00340834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417570|NCT00340834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65417571|NCT00340834|Immunologic Factors|immunologic factors|mesh-ancestor
65417572|NCT00340834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417573|NCT00340834|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65417574|NCT01057966|Vitamins|vitamins|mesh-list
65417575|NCT01057966|Micronutrients|micronutrients|mesh-ancestor
65417597|NCT01055470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417598|NCT01055470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417599|NCT01055470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65417600|NCT01055470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65417601|NCT01055470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65417602|NCT01055470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417603|NCT01055470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417604|NCT03986008|Liraglutide|liraglutide|mesh-list
65417605|NCT03986008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65417606|NCT03986008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417607|NCT03986008|Incretins|incretins|mesh-ancestor
65417608|NCT03986008|Hormones|hormones|mesh-ancestor
65417609|NCT03986008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65417610|NCT00909233|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65417611|NCT00909233|Vasodilator Agents|vasodilator agents|mesh-ancestor
65417612|NCT00909233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65417613|NCT00909233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65417614|NCT00909233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417615|NCT00909233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417616|NCT00909233|Urological Agents|urological agents|mesh-ancestor
65417617|NCT00909311|Ritonavir|ritonavir|mesh-list
65417618|NCT00909311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65417619|NCT00909311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65417620|NCT00909311|Protease Inhibitors|protease inhibitors|mesh-ancestor
65417621|NCT00909311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417622|NCT00909311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417623|NCT00909311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65417624|NCT00909311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65417625|NCT00909311|Antiviral Agents|antiviral agents|mesh-ancestor
65417626|NCT00909311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65417642|NCT00336856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65417643|NCT00905333|Felodipine|felodipine|mesh-list
65417644|NCT00905333|Candesartan|candesartan|mesh-list
65417645|NCT00905333|Candesartan cilexetil|candesartan cilexetil|mesh-list
65417646|NCT00905333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65417647|NCT00905333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65417648|NCT00905333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65417649|NCT00905333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417650|NCT00905333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65417651|NCT00905333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65417652|NCT00905333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65417653|NCT00905333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65417654|NCT00905333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417655|NCT00905333|Vasodilator Agents|vasodilator agents|mesh-ancestor
65417656|NCT00907829|Lidocaine|lidocaine|mesh-list
65167172|NCT00935818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65417657|NCT00907829|Anesthetics, Local|anesthetics, local|mesh-ancestor
65417658|NCT00907829|Anesthetics|anesthetics|mesh-ancestor
65417659|NCT00907829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65417660|NCT00907829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417661|NCT00907829|Sensory System Agents|sensory system agents|mesh-ancestor
65417662|NCT00907829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417663|NCT00907829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65417664|NCT00907829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65417665|NCT00907829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65417666|NCT00907829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65417667|NCT00907829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417668|NCT00336544|Clarithromycin|clarithromycin|mesh-list
65417669|NCT00336544|Cethromycin|cethromycin|mesh-list
65417670|NCT00336544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65417671|NCT00336544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65417672|NCT00336544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65417673|NCT00336544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417674|NCT00336544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417675|NCT00336544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65417676|NCT00336544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65417677|NCT01059058|Fluorides|fluorides|mesh-list
65417678|NCT01059058|Fluorides, Topical|fluorides, topical|mesh-list
65417679|NCT01059058|Cariostatic Agents|cariostatic agents|mesh-ancestor
65417680|NCT01059058|Protective Agents|protective agents|mesh-ancestor
65417681|NCT01059058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417682|NCT00605033|Buprenorphine|buprenorphine|mesh-list
64802443|NCT01402089|Anesthetics|anesthetics|mesh-ancestor
65417705|NCT00905723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417707|NCT00907985|Vofopitant|vofopitant|mesh-list
65417708|NCT00907985|Anticonvulsants|anticonvulsants|mesh-ancestor
65417709|NCT00907985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65417710|NCT00907985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65417711|NCT00907985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417712|NCT00907985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65417713|NCT00907985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417714|NCT00907985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65417715|NCT00907985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65417716|NCT00907985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65417717|NCT00907985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65417718|NCT00907985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65417719|NCT00907985|Antiemetics|antiemetics|mesh-ancestor
65417720|NCT00907985|Autonomic Agents|autonomic agents|mesh-ancestor
65417721|NCT00907985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417722|NCT00907985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65417723|NCT00907985|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65417724|NCT00907985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65417725|NCT01325194|Cytarabine|cytarabine|mesh-list
65417726|NCT01325194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65417727|NCT01325194|Antimetabolites|antimetabolites|mesh-ancestor
65417728|NCT01325194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417729|NCT01325194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417730|NCT01325194|Antiviral Agents|antiviral agents|mesh-ancestor
65417731|NCT01325194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64802505|NCT01402336|Fertility Agents|fertility agents|mesh-ancestor
65417737|NCT00908219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417738|NCT00908219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65417739|NCT00908219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65417740|NCT00908219|Growth Substances|growth substances|mesh-ancestor
65417741|NCT00908219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417742|NCT00908219|Growth Inhibitors|growth inhibitors|mesh-ancestor
65417744|NCT00908297|Coenzyme Q10|coenzyme q10|mesh-list
65417745|NCT00908297|Micronutrients|micronutrients|mesh-ancestor
65417746|NCT00908297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417747|NCT00908297|Vitamins|vitamins|mesh-ancestor
65417748|NCT00927407|Malathion|malathion|mesh-list
65417749|NCT00927407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65417750|NCT00927407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417751|NCT00927407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417752|NCT00927407|Cholinergic Agents|cholinergic agents|mesh-ancestor
65417753|NCT00927407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65417754|NCT00927407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417755|NCT00931697|Mefloquine|mefloquine|mesh-list
65417756|NCT00931697|Antimalarials|antimalarials|mesh-ancestor
65417757|NCT00931697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65417758|NCT00931697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65417759|NCT00931697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65417760|NCT00927797|Cyclophosphamide|cyclophosphamide|mesh-list
65417761|NCT00927797|Rituximab|rituximab|mesh-list
65417762|NCT00927797|Pentostatin|pentostatin|mesh-list
65417763|NCT00927797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65417764|NCT00927797|Immunologic Factors|immunologic factors|mesh-ancestor
65417765|NCT00927797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417766|NCT00927797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65417767|NCT00927797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65417768|NCT00927797|Alkylating Agents|alkylating agents|mesh-ancestor
65417769|NCT00927797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417770|NCT00927797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417771|NCT00927797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65417772|NCT00927797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65417773|NCT00927797|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65417774|NCT00927797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417775|NCT00338962|Naltrexone|naltrexone|mesh-list
65417776|NCT00338962|Paroxetine|paroxetine|mesh-list
65417777|NCT00338962|Desipramine|desipramine|mesh-list
65417778|NCT00338962|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65417779|NCT00338962|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65417780|NCT00338962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417781|NCT00338962|Sensory System Agents|sensory system agents|mesh-ancestor
65417782|NCT00338962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417783|NCT00338962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65417784|NCT00338962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65417785|NCT00338962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65417786|NCT00338962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417787|NCT00338962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65417788|NCT00338962|Serotonin Agents|serotonin agents|mesh-ancestor
65417789|NCT00338962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65417790|NCT00338962|Antidepressive Agents|antidepressive agents|mesh-ancestor
65417791|NCT00338962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65417792|NCT00338962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65417793|NCT00338962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65417794|NCT00338962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417795|NCT00338962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65239216|NCT00793429|Serotonin Agents|serotonin agents|mesh-ancestor
65417796|NCT00338962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65417797|NCT00338962|Adrenergic Agents|adrenergic agents|mesh-ancestor
65417798|NCT00931775|Pindolol|pindolol|mesh-list
65417799|NCT00931775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65417800|NCT00931775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64571198|NCT00984659|Xhance|xhance|mesh-list
65417806|NCT00931775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65417807|NCT00931775|Serotonin Agents|serotonin agents|mesh-ancestor
65417808|NCT00931775|Vasodilator Agents|vasodilator agents|mesh-ancestor
65417809|NCT00927875|Carboplatin|carboplatin|mesh-list
65417810|NCT00927875|Etoposide|etoposide|mesh-list
65417811|NCT00927875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417812|NCT00927875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65417813|NCT00927875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65417814|NCT00927875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65417815|NCT00927875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417816|NCT00927875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417817|NCT00568061|Nitric Oxide|nitric oxide|mesh-list
65417818|NCT00568061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65417819|NCT00568061|Autonomic Agents|autonomic agents|mesh-ancestor
65417820|NCT00568061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417821|NCT00568061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417822|NCT00568061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65417823|NCT00568061|Respiratory System Agents|respiratory system agents|mesh-ancestor
65417824|NCT00568061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65417825|NCT00568061|Antioxidants|antioxidants|mesh-ancestor
65417826|NCT00568061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417827|NCT00568061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65417828|NCT00568061|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65417829|NCT00568061|Vasodilator Agents|vasodilator agents|mesh-ancestor
65417830|NCT00568061|Gasotransmitters|gasotransmitters|mesh-ancestor
65417831|NCT00568061|Protective Agents|protective agents|mesh-ancestor
65417832|NCT03547427|Acetaminophen|acetaminophen|mesh-list
65417833|NCT03547427|Insulin|insulin|mesh-list
65417834|NCT03547427|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65417835|NCT03547427|Pramlintide|pramlintide|mesh-list
65417836|NCT03547427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65417837|NCT03547427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417838|NCT03547427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65417839|NCT03547427|Analgesics|analgesics|mesh-ancestor
65417840|NCT03547427|Sensory System Agents|sensory system agents|mesh-ancestor
65417841|NCT03547427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417842|NCT03547427|Antipyretics|antipyretics|mesh-ancestor
65417843|NCT00338884|Sunitinib|sunitinib|mesh-list
65417844|NCT00338884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417845|NCT00338884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65417846|NCT00338884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65417847|NCT00338884|Growth Substances|growth substances|mesh-ancestor
65417848|NCT00338884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417849|NCT00338884|Growth Inhibitors|growth inhibitors|mesh-ancestor
65417850|NCT00338884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65417851|NCT00338884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417852|NCT00338884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417853|NCT03038100|Paclitaxel|paclitaxel|mesh-list
65417854|NCT03038100|Bevacizumab|bevacizumab|mesh-list
65417855|NCT03038100|Carboplatin|carboplatin|mesh-list
65417856|NCT03038100|Atezolizumab|atezolizumab|mesh-list
65417857|NCT03038100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65417858|NCT03038100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65417859|NCT03038100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417860|NCT03038100|Tubulin Modulators|tubulin modulators|mesh-ancestor
65417861|NCT03038100|Antimitotic Agents|antimitotic agents|mesh-ancestor
65417862|NCT03038100|Mitosis Modulators|mitosis modulators|mesh-ancestor
65417863|NCT03038100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417864|NCT03038100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65417865|NCT03038100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65417866|NCT03038100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65417867|NCT03038100|Growth Substances|growth substances|mesh-ancestor
65417868|NCT03038100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417869|NCT03038100|Growth Inhibitors|growth inhibitors|mesh-ancestor
65417870|NCT03038100|Immunologic Factors|immunologic factors|mesh-ancestor
65417881|NCT00338728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417883|NCT01059136|Spironolactone|spironolactone|mesh-list
65417884|NCT01059136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65417885|NCT01059136|Hormone Antagonists|hormone antagonists|mesh-ancestor
65417886|NCT01059136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65417887|NCT01059136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417888|NCT01059136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65417889|NCT01059136|Diuretics|diuretics|mesh-ancestor
65417890|NCT01059136|Natriuretic Agents|natriuretic agents|mesh-ancestor
65417891|NCT00566501|Donepezil|donepezil|mesh-list
65417892|NCT00566501|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65417893|NCT00566501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417894|NCT00566501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417895|NCT00566501|Cholinergic Agents|cholinergic agents|mesh-ancestor
65417896|NCT00566501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65417897|NCT00566501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417898|NCT00566501|Nootropic Agents|nootropic agents|mesh-ancestor
65417899|NCT00504894|Thiopental|thiopental|mesh-list
65417900|NCT00504894|Propofol|propofol|mesh-list
65417901|NCT00504894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65417902|NCT00504894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65417903|NCT00504894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417904|NCT00504894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65417905|NCT00504894|Anesthetics, General|anesthetics, general|mesh-ancestor
65417906|NCT00504894|Anesthetics|anesthetics|mesh-ancestor
65417907|NCT00504894|Anticonvulsants|anticonvulsants|mesh-ancestor
65417908|NCT00504894|GABA Modulators|gaba modulators|mesh-ancestor
65417909|NCT00504894|GABA Agents|gaba agents|mesh-ancestor
65417910|NCT00504894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65417911|NCT00504894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417912|NCT00924755|Caffeine|caffeine|mesh-list
65417913|NCT00924755|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65417914|NCT00924755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417915|NCT00924755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65417916|NCT00924755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417917|NCT00924755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417918|NCT00924755|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65417919|NCT00924755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65417920|NCT00924755|Purinergic Agents|purinergic agents|mesh-ancestor
65417921|NCT00924755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65417922|NCT01011348|Ubiquinone|ubiquinone|mesh-list
65417923|NCT01011348|Coenzyme Q10|coenzyme q10|mesh-list
65417924|NCT01011348|Micronutrients|micronutrients|mesh-ancestor
65417925|NCT01011348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417926|NCT01011348|Vitamins|vitamins|mesh-ancestor
65417927|NCT00928655|Acetazolamide|acetazolamide|mesh-list
65417928|NCT00928655|Anticonvulsants|anticonvulsants|mesh-ancestor
65417929|NCT00928655|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65417930|NCT00928655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417931|NCT00928655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417932|NCT00928655|Diuretics|diuretics|mesh-ancestor
65417933|NCT00928655|Natriuretic Agents|natriuretic agents|mesh-ancestor
65417934|NCT00928655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802697|NCT01403662|Minocycline|minocycline|mesh-list
65417942|NCT00932555|Factor VIII|factor viii|mesh-list
65417943|NCT00932555|Coagulants|coagulants|mesh-ancestor
65417944|NCT04722575|Atezolizumab|atezolizumab|mesh-list
65417945|NCT04722575|Vemurafenib|vemurafenib|mesh-list
65417946|NCT04722575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417947|NCT04722575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65417948|NCT04722575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417949|NCT04722575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417950|NCT00513240|Epoetin Alfa|epoetin alfa|mesh-list
65417951|NCT00513240|Hematinics|hematinics|mesh-ancestor
65417952|NCT00928811|Basiliximab|basiliximab|mesh-list
65417953|NCT00928811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65417954|NCT00928811|Immunologic Factors|immunologic factors|mesh-ancestor
65417955|NCT00928811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417956|NCT00932867|Telmisartan|telmisartan|mesh-list
65417957|NCT00932867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65417958|NCT00932867|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65417959|NCT00932867|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65417960|NCT00932867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417961|NCT00928967|Interferons|interferons|mesh-list
65417962|NCT00928967|Interferon-beta|interferon-beta|mesh-list
65417963|NCT00928967|Interferon beta-1b|interferon beta-1b|mesh-list
65417964|NCT00928967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417965|NCT00928967|Antiviral Agents|antiviral agents|mesh-ancestor
65417966|NCT00928967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65417967|NCT00928967|Immunologic Factors|immunologic factors|mesh-ancestor
65239386|NCT02868827|Vitamin D|vitamin d|mesh-list
65417968|NCT00928967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417969|NCT00928967|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65417970|NCT00933023|Hydrocortisone|hydrocortisone|mesh-list
65417971|NCT00933023|Betamethasone|betamethasone|mesh-list
65417972|NCT00933023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65417973|NCT00933023|Glucocorticoids|glucocorticoids|mesh-ancestor
65417974|NCT00933023|Hormones|hormones|mesh-ancestor
65417975|NCT00933023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65417976|NCT00933023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417977|NCT00933023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65417978|NCT00933023|Respiratory System Agents|respiratory system agents|mesh-ancestor
65417979|NCT00933179|Levonorgestrel|levonorgestrel|mesh-list
65417980|NCT00933179|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65417981|NCT00933179|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
65417982|NCT00933179|Gestodene|gestodene|mesh-list
65417983|NCT00933179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65417984|NCT00933179|Contraceptive Agents|contraceptive agents|mesh-ancestor
65417985|NCT00933179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65417986|NCT00933179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417987|NCT00933179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65417988|NCT00933179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65417989|NCT00933179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65417990|NCT00933179|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65417991|NCT00933179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65417992|NCT00933179|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
65417993|NCT00933179|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65417994|NCT00933179|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65417995|NCT00933179|Progestins|progestins|mesh-ancestor
65417996|NCT00933179|Hormones|hormones|mesh-ancestor
65417997|NCT00933179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65417998|NCT00504348|Tacrolimus|tacrolimus|mesh-list
65417999|NCT00504348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65418000|NCT00504348|Immunologic Factors|immunologic factors|mesh-ancestor
65418001|NCT00504348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418002|NCT00504348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65418003|NCT00504348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418004|NCT00504348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418013|NCT00925457|Autonomic Agents|autonomic agents|mesh-ancestor
65418014|NCT00925457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65418015|NCT00925457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418016|NCT00925457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65418017|NCT00925457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65418018|NCT00925457|Dopamine Agents|dopamine agents|mesh-ancestor
65418019|NCT00925457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65418020|NCT00929279|Abciximab|abciximab|mesh-list
65418021|NCT00929279|Anticoagulants|anticoagulants|mesh-ancestor
65418022|NCT00929279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65418023|NCT00567593|Rosiglitazone|rosiglitazone|mesh-list
65418024|NCT00567593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65418025|NCT00567593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418026|NCT00335764|Sirolimus|sirolimus|mesh-list
65418027|NCT00335764|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65418028|NCT00335764|Sorafenib|sorafenib|mesh-list
65418029|NCT00335764|Tipifarnib|tipifarnib|mesh-list
65418030|NCT00335764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418031|NCT00335764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65418032|NCT00335764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418033|NCT00335764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418034|NCT00335764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65418035|NCT00335764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65418036|NCT00335764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65418037|NCT00335764|Antifungal Agents|antifungal agents|mesh-ancestor
65418038|NCT00335764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65418039|NCT00335764|Immunologic Factors|immunologic factors|mesh-ancestor
65418040|NCT00335764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418041|NCT03743285|Insulin Lispro|insulin lispro|mesh-list
65418042|NCT03743285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65418043|NCT03743285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418044|NCT03981484|Thrombin|thrombin|mesh-list
65418045|NCT03981484|Hemostatics|hemostatics|mesh-ancestor
65418046|NCT03981484|Coagulants|coagulants|mesh-ancestor
65418047|NCT00567359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65418048|NCT00567359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418049|NCT00567359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65418050|NCT00567359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418051|NCT00567359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418052|NCT01063660|Treosulfan|treosulfan|mesh-list
65418053|NCT01063660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65418054|NCT01063660|Alkylating Agents|alkylating agents|mesh-ancestor
65418055|NCT01063660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418056|NCT01063660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418057|NCT00925847|Lithium Carbonate|lithium carbonate|mesh-list
65418058|NCT00925847|Antidepressive Agents|antidepressive agents|mesh-ancestor
65418059|NCT00925847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65418060|NCT00925847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418061|NCT00925847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418062|NCT00925847|Antimanic Agents|antimanic agents|mesh-ancestor
65418063|NCT00925847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65418064|NCT00925847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65418065|NCT00925847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418066|NCT00492726|Moxifloxacin|moxifloxacin|mesh-list
65418067|NCT00492726|Ertapenem|ertapenem|mesh-list
65418068|NCT00492726|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65418069|NCT00492726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65418070|NCT00492726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65418071|NCT00492726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65418080|NCT00492726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65418082|NCT00492726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65418083|NCT00309946|Cediranib|cediranib|mesh-list
65418084|NCT00309946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418085|NCT00309946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418086|NCT00309946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418087|NCT00309946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65418088|NCT00929591|Tamoxifen|tamoxifen|mesh-list
65418089|NCT00929591|Cyclophosphamide|cyclophosphamide|mesh-list
65418090|NCT00929591|Doxorubicin|doxorubicin|mesh-list
65418091|NCT00929591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65418092|NCT00929591|Fluorouracil|fluorouracil|mesh-list
65418093|NCT00929591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65418094|NCT00929591|Immunologic Factors|immunologic factors|mesh-ancestor
65418095|NCT00929591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418096|NCT00929591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65418097|NCT00929591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65418098|NCT00929591|Alkylating Agents|alkylating agents|mesh-ancestor
65418099|NCT00929591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418100|NCT00929591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418101|NCT00929591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65418102|NCT00929591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65418103|NCT00929591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65418104|NCT00929591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65167626|NCT03586687|Glucocorticoids|glucocorticoids|mesh-ancestor
65418105|NCT00929591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418106|NCT00929591|Antimetabolites|antimetabolites|mesh-ancestor
65418107|NCT00929591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65418108|NCT00929591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65418109|NCT00929591|Hormone Antagonists|hormone antagonists|mesh-ancestor
65418110|NCT00929591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65418111|NCT00929591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65418112|NCT00929591|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65418113|NCT00929591|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65418114|NCT00929591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65418115|NCT03997500|Norepinephrine|norepinephrine|mesh-list
65418116|NCT03997500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65418117|NCT03997500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65418118|NCT03997500|Adrenergic Agents|adrenergic agents|mesh-ancestor
65418119|NCT03997500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65418120|NCT03997500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418121|NCT03997500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418122|NCT03997500|Sympathomimetics|sympathomimetics|mesh-ancestor
65418123|NCT03997500|Autonomic Agents|autonomic agents|mesh-ancestor
65418124|NCT03997500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65418125|NCT03997500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65418126|NCT01011660|Amlodipine|amlodipine|mesh-list
65418127|NCT01011660|Telmisartan|telmisartan|mesh-list
65418128|NCT01011660|Amiloride|amiloride|mesh-list
65418129|NCT01011660|Simvastatin|simvastatin|mesh-list
65418130|NCT01011660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65418131|NCT01011660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65239512|NCT02868749|Viscosupplements|viscosupplements|mesh-ancestor
65418132|NCT01011660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65418133|NCT01011660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418134|NCT01011660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65418147|NCT01011660|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65418148|NCT01011660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65418149|NCT01011660|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65418150|NCT01011660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65418151|NCT01015248|Rituximab|rituximab|mesh-list
65418152|NCT01015248|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65418153|NCT01015248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65418154|NCT01015248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418155|NCT01015248|Immunologic Factors|immunologic factors|mesh-ancestor
65418156|NCT01015248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418157|NCT01015248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65418158|NCT01015248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65418159|NCT01015248|Alkylating Agents|alkylating agents|mesh-ancestor
65418160|NCT01015248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418161|NCT00506922|Methotrexate|methotrexate|mesh-list
65418162|NCT00506922|Pentostatin|pentostatin|mesh-list
65418163|NCT00506922|Tacrolimus|tacrolimus|mesh-list
65418164|NCT00506922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65418165|NCT00506922|Abortifacient Agents|abortifacient agents|mesh-ancestor
65418166|NCT00506922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65418167|NCT00506922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418168|NCT00506922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65418169|NCT00506922|Antimetabolites|antimetabolites|mesh-ancestor
65418170|NCT00506922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418171|NCT00506922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418172|NCT00506922|Dermatologic Agents|dermatologic agents|mesh-ancestor
65418173|NCT00506922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418174|NCT00506922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65418175|NCT00506922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65418176|NCT00506922|Immunologic Factors|immunologic factors|mesh-ancestor
65418177|NCT00506922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65418178|NCT00506922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65418179|NCT00506922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65418180|NCT00506922|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65418182|NCT00934193|Analgesics|analgesics|mesh-ancestor
65418183|NCT00934193|Sensory System Agents|sensory system agents|mesh-ancestor
65418184|NCT00934193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65418185|NCT00934193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418186|NCT00934193|Anticonvulsants|anticonvulsants|mesh-ancestor
65418187|NCT00934193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65418188|NCT00934193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65418189|NCT00934193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65418190|NCT00934193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65418191|NCT00934193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65418192|NCT00934193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65418193|NCT00934193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65418194|NCT00934193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418195|NCT00934193|Antimanic Agents|antimanic agents|mesh-ancestor
65418199|NCT00492024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65418200|NCT00492024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65418201|NCT00492024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65418202|NCT00492024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418203|NCT00492024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418204|NCT00492024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418205|NCT00492024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65418206|NCT00492024|Contraceptive Agents|contraceptive agents|mesh-ancestor
65418207|NCT00492024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65418208|NCT00492024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418209|NCT00492024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65418210|NCT00492024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65418211|NCT00492024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65418212|NCT00934427|Nitroglycerin|nitroglycerin|mesh-list
65418213|NCT00934427|Vasodilator Agents|vasodilator agents|mesh-ancestor
65418214|NCT00926315|Calcitriol|calcitriol|mesh-list
65418215|NCT00926315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65418216|NCT00926315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418217|NCT00926315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65239586|NCT00679653|Antidepressive Agents|antidepressive agents|mesh-ancestor
65418218|NCT00926315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65418219|NCT00926315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418220|NCT00926315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65418221|NCT00926315|Vitamins|vitamins|mesh-ancestor
65418222|NCT00926315|Micronutrients|micronutrients|mesh-ancestor
65418223|NCT00926315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65418224|NCT01013454|Varenicline|varenicline|mesh-list
65418225|NCT01013454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65418226|NCT01013454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65418227|NCT01013454|Cholinergic Agents|cholinergic agents|mesh-ancestor
65418228|NCT01013454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65418229|NCT01013454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418230|NCT01013454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418231|NCT00491556|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65418232|NCT00491556|Antiviral Agents|antiviral agents|mesh-ancestor
65418233|NCT00491556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65418234|NCT00926627|Bosentan|bosentan|mesh-list
65418235|NCT00926627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65418236|NCT00926627|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65418237|NCT00926627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418238|NCT00934739|Thalidomide|thalidomide|mesh-list
65418239|NCT00934739|Dexamethasone|dexamethasone|mesh-list
65418240|NCT00934739|Celecoxib|celecoxib|mesh-list
65418241|NCT00934739|Cyclophosphamide|cyclophosphamide|mesh-list
65418242|NCT00934739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65418243|NCT00934739|Immunologic Factors|immunologic factors|mesh-ancestor
65418244|NCT00934739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418245|NCT00934739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65418246|NCT00934739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65418247|NCT00934739|Alkylating Agents|alkylating agents|mesh-ancestor
65418248|NCT00934739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418249|NCT00934739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418250|NCT00934739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65418251|NCT00934739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65418252|NCT00934739|Antiemetics|antiemetics|mesh-ancestor
65418253|NCT00934739|Autonomic Agents|autonomic agents|mesh-ancestor
65418254|NCT00934739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65418255|NCT00934739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65418256|NCT00934739|Glucocorticoids|glucocorticoids|mesh-ancestor
65418257|NCT00934739|Hormones|hormones|mesh-ancestor
65418258|NCT00934739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65418259|NCT00934739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65418260|NCT00934739|Leprostatic Agents|leprostatic agents|mesh-ancestor
65418261|NCT00934739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65418262|NCT00934739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65418263|NCT00934739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65418264|NCT00934739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65418265|NCT00934739|Growth Substances|growth substances|mesh-ancestor
65418266|NCT00934739|Growth Inhibitors|growth inhibitors|mesh-ancestor
65418275|NCT01015482|Remifentanil|remifentanil|mesh-list
65418276|NCT01015482|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65418277|NCT01015482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65418278|NCT01015482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65418279|NCT01015482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418280|NCT01015482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65418281|NCT01015482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65418282|NCT01015482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65418283|NCT01015482|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65418284|NCT01015482|Anesthetics, General|anesthetics, general|mesh-ancestor
65418285|NCT01015482|Anesthetics|anesthetics|mesh-ancestor
65418286|NCT01015482|GABA Modulators|gaba modulators|mesh-ancestor
65418287|NCT01015482|GABA Agents|gaba agents|mesh-ancestor
65418288|NCT01015482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65418289|NCT01015482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418290|NCT01015482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65418291|NCT01015482|Narcotics|narcotics|mesh-ancestor
65418292|NCT01015482|Analgesics|analgesics|mesh-ancestor
65418293|NCT01015482|Sensory System Agents|sensory system agents|mesh-ancestor
65418294|NCT01015482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65418295|NCT03760679|Chlorhexidine|chlorhexidine|mesh-list
65418296|NCT03760679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65418297|NCT03760679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65418298|NCT03760679|Disinfectants|disinfectants|mesh-ancestor
65418299|NCT00934817|Metformin|metformin|mesh-list
65239682|NCT00875433|Afatinib|afatinib|mesh-list
65418300|NCT00934817|Glimepiride|glimepiride|mesh-list
65418301|NCT00934817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65418302|NCT00934817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418303|NCT00934817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65418304|NCT00934817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65418305|NCT00934817|Immunologic Factors|immunologic factors|mesh-ancestor
65418306|NCT01013532|Aspirin|aspirin|mesh-list
65418307|NCT01013532|Cilostazol|cilostazol|mesh-list
65418308|NCT01013532|Probucol|probucol|mesh-list
65418309|NCT01013532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65418310|NCT01013532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65418311|NCT01013532|Analgesics|analgesics|mesh-ancestor
65418312|NCT01013532|Sensory System Agents|sensory system agents|mesh-ancestor
65418313|NCT01013532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65418314|NCT01013532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418315|NCT01013532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65418316|NCT01013532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65418317|NCT01013532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65418318|NCT01013532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65418319|NCT01013532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418320|NCT01013532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65418321|NCT01013532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65418322|NCT01013532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418323|NCT01013532|Antipyretics|antipyretics|mesh-ancestor
65418324|NCT01013532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65418325|NCT01013532|Autonomic Agents|autonomic agents|mesh-ancestor
65418326|NCT01013532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65418327|NCT01013532|Respiratory System Agents|respiratory system agents|mesh-ancestor
65418328|NCT01013532|Vasodilator Agents|vasodilator agents|mesh-ancestor
65418329|NCT01013532|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65418330|NCT01013532|Protective Agents|protective agents|mesh-ancestor
65418331|NCT01013532|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65418332|NCT01013532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65418333|NCT01013532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65418334|NCT01013532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65418335|NCT01013532|Antimetabolites|antimetabolites|mesh-ancestor
65418351|NCT00926705|Dexmedetomidine|dexmedetomidine|mesh-list
65418352|NCT00926705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65418353|NCT00926705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65418354|NCT00926705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418355|NCT00926705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65418356|NCT00926705|Analgesics|analgesics|mesh-ancestor
65418357|NCT00926705|Sensory System Agents|sensory system agents|mesh-ancestor
65418358|NCT00926705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65418359|NCT00926705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65418360|NCT00926705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65418361|NCT00926705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65418362|NCT00926705|Adrenergic Agents|adrenergic agents|mesh-ancestor
65418363|NCT00926705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65418364|NCT00926705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418365|NCT00926705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65418366|NCT00926705|Narcotics|narcotics|mesh-ancestor
65418367|NCT00926705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65418368|NCT00926705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65418369|NCT00926705|Anesthetics, General|anesthetics, general|mesh-ancestor
65418370|NCT00926705|Anesthetics|anesthetics|mesh-ancestor
65418371|NCT01012284|Bedaquiline|bedaquiline|mesh-list
65418372|NCT01012284|Antitubercular Agents|antitubercular agents|mesh-ancestor
65418373|NCT01012284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65418374|NCT01012284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65418376|NCT00934973|Alverine|alverine|mesh-list
65418377|NCT00934973|Anticonvulsants|anticonvulsants|mesh-ancestor
65418378|NCT00934973|Parasympatholytics|parasympatholytics|mesh-ancestor
65418379|NCT00934973|Autonomic Agents|autonomic agents|mesh-ancestor
65418380|NCT00934973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65418381|NCT00934973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418382|NCT00485472|Lacosamide|lacosamide|mesh-list
65418383|NCT00485472|Anticonvulsants|anticonvulsants|mesh-ancestor
65418384|NCT00485472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65418385|NCT00485472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65418386|NCT00485472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65418387|NCT00485472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418388|NCT00930605|Alemtuzumab|alemtuzumab|mesh-list
65418389|NCT00930605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65239740|NCT00685425|Albuterol|albuterol|mesh-list
65418390|NCT00930605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418391|NCT01018836|Riluzole|riluzole|mesh-list
65418392|NCT01018836|Anticonvulsants|anticonvulsants|mesh-ancestor
65418393|NCT01018836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65418394|NCT01018836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65418395|NCT01018836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64803157|NCT01405482|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65418402|NCT04015661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65418404|NCT04015661|Tubulin Modulators|tubulin modulators|mesh-ancestor
65418405|NCT04015661|Antimitotic Agents|antimitotic agents|mesh-ancestor
65418406|NCT04015661|Mitosis Modulators|mitosis modulators|mesh-ancestor
65418407|NCT04015661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418408|NCT00491400|Atorvastatin|atorvastatin|mesh-list
65418409|NCT00491400|Fenofibrate|fenofibrate|mesh-list
65418410|NCT00491400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65418411|NCT00491400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65418412|NCT00491400|Antimetabolites|antimetabolites|mesh-ancestor
65418413|NCT00491400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418414|NCT00491400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65418415|NCT00491400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65418416|NCT00491400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418417|NCT00491322|Ergocalciferols|ergocalciferols|mesh-list
65418418|NCT00491322|Vitamin D|vitamin d|mesh-list
65418419|NCT00491322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65418420|NCT00491322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418421|NCT00491322|Vitamins|vitamins|mesh-ancestor
65418422|NCT00491322|Micronutrients|micronutrients|mesh-ancestor
65418423|NCT00491322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65418424|NCT00930683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65418425|NCT00930683|Immunologic Factors|immunologic factors|mesh-ancestor
65418426|NCT00930683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418427|NCT04314570|Ropivacaine|ropivacaine|mesh-list
65418428|NCT04314570|Anesthetics, Local|anesthetics, local|mesh-ancestor
65418429|NCT04314570|Anesthetics|anesthetics|mesh-ancestor
65418430|NCT04314570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65418431|NCT04314570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418432|NCT04314570|Sensory System Agents|sensory system agents|mesh-ancestor
65418433|NCT04314570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65418434|NCT04297332|Nicotine|nicotine|mesh-list
65418435|NCT04297332|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65418436|NCT04297332|Autonomic Agents|autonomic agents|mesh-ancestor
65418437|NCT04297332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65418438|NCT04297332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418439|NCT04297332|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65418440|NCT04297332|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65418441|NCT04297332|Cholinergic Agents|cholinergic agents|mesh-ancestor
65418442|NCT04297332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65418443|NCT04297332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418444|NCT00930839|Aspirin|aspirin|mesh-list
65418445|NCT00930839|Niacin|niacin|mesh-list
65418446|NCT00930839|Nicotinic Acids|nicotinic acids|mesh-list
65418447|NCT00930839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65418448|NCT00930839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65418449|NCT00930839|Analgesics|analgesics|mesh-ancestor
65418450|NCT00930839|Sensory System Agents|sensory system agents|mesh-ancestor
65418451|NCT00930839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65418452|NCT00930839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418453|NCT00930839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65418454|NCT00930839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65418455|NCT00930839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65418456|NCT00930839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65418457|NCT00930839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418458|NCT00930839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65418459|NCT00930839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65418460|NCT00930839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418461|NCT00930839|Antipyretics|antipyretics|mesh-ancestor
65418462|NCT00930839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65418463|NCT00930839|Antimetabolites|antimetabolites|mesh-ancestor
65418476|NCT01015794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65418478|NCT01015794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65418479|NCT01015794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418480|NCT01015794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65418481|NCT01015794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65418482|NCT01015794|Respiratory System Agents|respiratory system agents|mesh-ancestor
65418483|NCT01015794|Nasal Decongestants|nasal decongestants|mesh-ancestor
65418484|NCT00935363|Glyburide|glyburide|mesh-list
65418485|NCT00935363|Rifampin|rifampin|mesh-list
65418486|NCT00935363|Fluconazole|fluconazole|mesh-list
65418487|NCT00935363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65418488|NCT00935363|Antitubercular Agents|antitubercular agents|mesh-ancestor
65418489|NCT00935363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65418490|NCT00935363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65418491|NCT00935363|Leprostatic Agents|leprostatic agents|mesh-ancestor
65418492|NCT00935363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65418493|NCT00935363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418494|NCT00935363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418495|NCT00935363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65418496|NCT00935363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65418497|NCT00935363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65418498|NCT00935363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65418499|NCT00935363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65418500|NCT00935363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65418501|NCT00935363|Antifungal Agents|antifungal agents|mesh-ancestor
65418502|NCT00935363|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65418503|NCT00935363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65418504|NCT00935363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65418505|NCT00935363|Hormone Antagonists|hormone antagonists|mesh-ancestor
65418506|NCT00935363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65418507|NCT00935363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418508|NCT00935363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65418509|NCT00935363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65418510|NCT00935363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65418511|NCT00930995|Candesartan|candesartan|mesh-list
65418512|NCT00930995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65418513|NCT00930995|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65418514|NCT00930995|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65418515|NCT00930995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418516|NCT00931073|Ketoconazole|ketoconazole|mesh-list
65418517|NCT00931073|Omeprazole|omeprazole|mesh-list
65418518|NCT00931073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65418519|NCT00931073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65418520|NCT00931073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65418521|NCT00931073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418522|NCT00931073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418523|NCT00931073|Antifungal Agents|antifungal agents|mesh-ancestor
65418524|NCT00931073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65418529|NCT00931073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65418531|NCT00931073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65418532|NCT04179864|Prednisone|prednisone|mesh-list
65418533|NCT04179864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65418534|NCT04179864|Glucocorticoids|glucocorticoids|mesh-ancestor
65418535|NCT04179864|Hormones|hormones|mesh-ancestor
65418536|NCT04179864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65418537|NCT04179864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418538|NCT04179864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65418539|NCT04179864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418540|NCT00936689|Doxorubicin|doxorubicin|mesh-list
65418541|NCT00936689|Chlorotrianisene|chlorotrianisene|mesh-list
65418542|NCT00936689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65418543|NCT00936689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418544|NCT00936689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65418545|NCT00936689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65418546|NCT00936689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418547|NCT00936689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418548|NCT00936689|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65418549|NCT00936689|Estrogens|estrogens|mesh-ancestor
65418550|NCT00936689|Hormones|hormones|mesh-ancestor
65168079|NCT02703571|Trametinib|trametinib|mesh-list
65418551|NCT00936689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65418552|NCT00936689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418553|NCT00936689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65418555|NCT01018914|Tacrolimus|tacrolimus|mesh-list
65418556|NCT01018914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65418557|NCT01018914|Immunologic Factors|immunologic factors|mesh-ancestor
65418558|NCT01018914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418559|NCT01018914|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65418560|NCT01018914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418561|NCT01018914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418562|NCT01018914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65418563|NCT01018914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418564|NCT01018914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65418565|NCT01018914|Antitubercular Agents|antitubercular agents|mesh-ancestor
65418566|NCT01018914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65418567|NCT01018914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65418568|NCT01019070|Asunaprevir|asunaprevir|mesh-list
65418569|NCT01019070|Protease Inhibitors|protease inhibitors|mesh-ancestor
65418570|NCT01019070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418571|NCT01019070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418572|NCT00936767|Artesunate|artesunate|mesh-list
65418573|NCT00936767|Mefloquine|mefloquine|mesh-list
65418574|NCT00936767|Antimalarials|antimalarials|mesh-ancestor
65418575|NCT00936767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65418576|NCT00936767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65418577|NCT00936767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65418578|NCT00936767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418579|NCT00936767|Antiviral Agents|antiviral agents|mesh-ancestor
65418580|NCT00936767|Schistosomicides|schistosomicides|mesh-ancestor
65418581|NCT00936767|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65418582|NCT00936767|Anthelmintics|anthelmintics|mesh-ancestor
65418583|NCT00931229|Entecavir|entecavir|mesh-list
65418584|NCT00931229|Antiviral Agents|antiviral agents|mesh-ancestor
65418585|NCT00931229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65418586|NCT00936923|Furosemide|furosemide|mesh-list
65418587|NCT00936923|Diuretics|diuretics|mesh-list
65418588|NCT00936923|Natriuretic Agents|natriuretic agents|mesh-ancestor
65418589|NCT00936923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418590|NCT00936923|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65418591|NCT00936923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65418592|NCT00936923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418593|NCT01019382|Gemcitabine|gemcitabine|mesh-list
65418603|NCT01019382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418604|NCT00935675|Citalopram|citalopram|mesh-list
65418605|NCT00935675|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65418606|NCT00935675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65418607|NCT00935675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65418608|NCT00935675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418609|NCT00935675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65418610|NCT00935675|Serotonin Agents|serotonin agents|mesh-ancestor
65418611|NCT00935675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418612|NCT00935675|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65418613|NCT00935675|Antidepressive Agents|antidepressive agents|mesh-ancestor
65418614|NCT00935675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65418615|NCT01016184|Vitamin D|vitamin d|mesh-list
65418616|NCT01016184|Vitamins|vitamins|mesh-ancestor
65418617|NCT01016184|Micronutrients|micronutrients|mesh-ancestor
65418618|NCT01016184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418619|NCT01016184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65418620|NCT02567825|Amoxicillin|amoxicillin|mesh-list
65418621|NCT02567825|Ceftriaxone|ceftriaxone|mesh-list
65418622|NCT02567825|Clavulanic Acid|clavulanic acid|mesh-list
65418623|NCT02567825|Clavulanic Acids|clavulanic acids|mesh-list
65418624|NCT02567825|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65418625|NCT02567825|Ofloxacin|ofloxacin|mesh-list
65418626|NCT02567825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65418627|NCT02567825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65418628|NCT02567825|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65418629|NCT02567825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418630|NCT02567825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418631|NCT02567825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65418633|NCT02567825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65418634|NCT02567825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65418635|NCT02567825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418636|NCT02567825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65418637|NCT02567825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65418638|NCT00490776|Panobinostat|panobinostat|mesh-list
65418639|NCT00490776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418640|NCT00490776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65418641|NCT00490776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418642|NCT00490776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418643|NCT00566735|Galantamine|galantamine|mesh-list
65418644|NCT00566735|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65418645|NCT00566735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418646|NCT00566735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418647|NCT00566735|Cholinergic Agents|cholinergic agents|mesh-ancestor
65418648|NCT00566735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65418649|NCT00566735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418650|NCT00566735|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65418651|NCT00566735|Autonomic Agents|autonomic agents|mesh-ancestor
65418652|NCT00566735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65418653|NCT00566735|Nootropic Agents|nootropic agents|mesh-ancestor
65418654|NCT00936143|Infliximab|infliximab|mesh-list
65418655|NCT00936143|Dermatologic Agents|dermatologic agents|mesh-ancestor
65418656|NCT00936143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65418657|NCT00936143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65418658|NCT00937079|Exenatide|exenatide|mesh-list
65418659|NCT00937079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65418671|NCT00937625|Interleukin-2|interleukin-2|mesh-list
65418672|NCT00937625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65418673|NCT00937625|Immunologic Factors|immunologic factors|mesh-ancestor
65418674|NCT00937625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418675|NCT00937625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65418676|NCT00937625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65418677|NCT00937625|Alkylating Agents|alkylating agents|mesh-ancestor
65418678|NCT00937625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418679|NCT00937625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418680|NCT00937625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65418681|NCT00937625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65418682|NCT00937625|Antimetabolites|antimetabolites|mesh-ancestor
65418683|NCT00937625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65418684|NCT00937625|Analgesics|analgesics|mesh-ancestor
65418685|NCT00937625|Sensory System Agents|sensory system agents|mesh-ancestor
65418686|NCT00937625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65418687|NCT04014101|Apatinib|apatinib|mesh-list
65418688|NCT04014101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418689|NCT04014101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65418690|NCT04014101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418691|NCT04014101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418692|NCT00936533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65418693|NCT00936533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65418694|NCT00936533|Botulinum Toxins|botulinum toxins|mesh-list
65418695|NCT00936533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65418696|NCT00936533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65418697|NCT00936533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418698|NCT00936533|Cholinergic Agents|cholinergic agents|mesh-ancestor
65418699|NCT00936533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65418700|NCT00936533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418702|NCT00936533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65418703|NCT00564629|Acetaminophen|acetaminophen|mesh-list
65418704|NCT00564629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65418705|NCT00564629|Analgesics|analgesics|mesh-ancestor
65418706|NCT00564629|Sensory System Agents|sensory system agents|mesh-ancestor
65418707|NCT00564629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65418708|NCT00564629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418709|NCT00564629|Antipyretics|antipyretics|mesh-ancestor
65418710|NCT00564395|Insulin|insulin|mesh-list
65418711|NCT00564395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65418712|NCT00564395|Insulin Detemir|insulin detemir|mesh-list
65418713|NCT00564395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65418714|NCT00564395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418715|NCT04013243|Magnesium Sulfate|magnesium sulfate|mesh-list
65418716|NCT04013243|Analgesics|analgesics|mesh-ancestor
65418717|NCT04013243|Sensory System Agents|sensory system agents|mesh-ancestor
65418718|NCT04013243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65418719|NCT04013243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418720|NCT04013243|Anesthetics|anesthetics|mesh-ancestor
65418721|NCT04013243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65418722|NCT04013243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65418723|NCT04013243|Anticonvulsants|anticonvulsants|mesh-ancestor
65418724|NCT04013243|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64803488|NCT01407887|Artesunate|artesunate|mesh-list
65418729|NCT04013243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65418731|NCT00938171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65418732|NCT00938171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418733|NCT05280275|Dexamethasone|dexamethasone|mesh-list
65418734|NCT05280275|Lenalidomide|lenalidomide|mesh-list
65418735|NCT05280275|Daratumumab|daratumumab|mesh-list
65418736|NCT05280275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65418737|NCT05280275|Antiemetics|antiemetics|mesh-ancestor
65418738|NCT05280275|Autonomic Agents|autonomic agents|mesh-ancestor
65418739|NCT05280275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65418740|NCT05280275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418741|NCT05280275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65418742|NCT05280275|Glucocorticoids|glucocorticoids|mesh-ancestor
65418743|NCT05280275|Hormones|hormones|mesh-ancestor
65418744|NCT05280275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65418745|NCT05280275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65418746|NCT05280275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418747|NCT05280275|Immunologic Factors|immunologic factors|mesh-ancestor
65418748|NCT05280275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65418749|NCT05280275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65418750|NCT05280275|Growth Substances|growth substances|mesh-ancestor
65418751|NCT05280275|Growth Inhibitors|growth inhibitors|mesh-ancestor
65418752|NCT00939497|Risperidone|risperidone|mesh-list
65418753|NCT00939497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65418754|NCT00939497|Serotonin Agents|serotonin agents|mesh-ancestor
65418755|NCT00939497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65418756|NCT00939497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418757|NCT00939497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418758|NCT00939497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65418759|NCT00939497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65418760|NCT00939497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65418761|NCT00939497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65418762|NCT00939497|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65418763|NCT00939497|Dopamine Agents|dopamine agents|mesh-ancestor
65418764|NCT00502242|Ramipril|ramipril|mesh-list
65418765|NCT00502242|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65418766|NCT00502242|Protease Inhibitors|protease inhibitors|mesh-ancestor
65418767|NCT00502242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418768|NCT00502242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418769|NCT00502242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65418770|NCT00938405|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65418771|NCT00938405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65418772|NCT00938405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65418773|NCT00938405|Antimetabolites|antimetabolites|mesh-ancestor
65168301|NCT04214821|Moxifloxacin|moxifloxacin|mesh-list
65418774|NCT00938405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418775|NCT00938405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65418776|NCT03045653|Tamoxifen|tamoxifen|mesh-list
65418777|NCT03045653|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65418778|NCT03045653|Hormone Antagonists|hormone antagonists|mesh-ancestor
65418779|NCT03045653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65418780|NCT03045653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418781|NCT03045653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65418782|NCT03045653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418783|NCT03045653|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65418784|NCT03045653|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65418785|NCT03045653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65418786|NCT02991365|Insulin|insulin|mesh-list
65418787|NCT02991365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65418788|NCT02991365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418789|NCT03972137|Nicotine|nicotine|mesh-list
65418790|NCT03972137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65418791|NCT03972137|Autonomic Agents|autonomic agents|mesh-ancestor
64803552|NCT01408186|Rabeprazole|rabeprazole|mesh-list
65418800|NCT00490698|Atorvastatin|atorvastatin|mesh-list
65418801|NCT00490698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65418802|NCT00490698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65418803|NCT00490698|Antimetabolites|antimetabolites|mesh-ancestor
65418804|NCT00490698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418805|NCT00490698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65418806|NCT00490698|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65418807|NCT00490698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418808|NCT00490698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65418809|NCT00490698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418810|NCT04492254|Enoxaparin|enoxaparin|mesh-list
65418811|NCT04492254|Anticoagulants|anticoagulants|mesh-ancestor
65418812|NCT04492254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65418813|NCT04492254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65418814|NCT04492254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418815|NCT03855228|Mometasone Furoate|mometasone furoate|mesh-list
65418816|NCT03855228|Loratadine|loratadine|mesh-list
65418817|NCT03855228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65418818|NCT03855228|Dermatologic Agents|dermatologic agents|mesh-ancestor
65418819|NCT03855228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65418820|NCT03855228|Antipruritics|antipruritics|mesh-ancestor
65418821|NCT03855228|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65418822|NCT03855228|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65418823|NCT03855228|Histamine Antagonists|histamine antagonists|mesh-ancestor
65418824|NCT03855228|Histamine Agents|histamine agents|mesh-ancestor
65418825|NCT03855228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65418826|NCT03855228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418827|NCT03855228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418828|NCT04013477|Donepezil|donepezil|mesh-list
65418829|NCT04013477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65418830|NCT04013477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418831|NCT04013477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418832|NCT04013477|Cholinergic Agents|cholinergic agents|mesh-ancestor
65418833|NCT04013477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65418834|NCT04013477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418835|NCT04013477|Nootropic Agents|nootropic agents|mesh-ancestor
65418836|NCT00940667|Losartan|losartan|mesh-list
65418837|NCT00940667|Amlodipine|amlodipine|mesh-list
65418838|NCT00940667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65418839|NCT00940667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65418840|NCT00940667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65418841|NCT00940667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418842|NCT00940667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65418843|NCT00940667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418844|NCT00940667|Vasodilator Agents|vasodilator agents|mesh-ancestor
65418845|NCT00940667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65418846|NCT00940667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65418847|NCT00940667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65418849|NCT01019772|Immunologic Factors|immunologic factors|mesh-ancestor
65418850|NCT01019772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418851|NCT00513500|Amoxicillin|amoxicillin|mesh-list
65418852|NCT00513500|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65418853|NCT00513500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65418854|NCT00513500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65418855|NCT00513500|Antimalarials|antimalarials|mesh-ancestor
65418856|NCT00513500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65418857|NCT00513500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65418872|NCT00511004|Antinematodal Agents|antinematodal agents|mesh-ancestor
65418873|NCT00511004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65418874|NCT00511004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418875|NCT02550197|Vaccines|vaccines|mesh-list
65418876|NCT02550197|Immunologic Factors|immunologic factors|mesh-ancestor
65418877|NCT02550197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418878|NCT00939965|Isotretinoin|isotretinoin|mesh-list
65418879|NCT00939965|Dermatologic Agents|dermatologic agents|mesh-ancestor
65418880|NCT04012541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65418881|NCT02877134|Ustekinumab|ustekinumab|mesh-list
65418882|NCT02877134|Dermatologic Agents|dermatologic agents|mesh-ancestor
65418883|NCT00563381|Bromides|bromides|mesh-list
65418884|NCT00563381|Tiotropium Bromide|tiotropium bromide|mesh-list
65418885|NCT00563381|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65418886|NCT00563381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65418887|NCT00563381|Autonomic Agents|autonomic agents|mesh-ancestor
65418888|NCT00563381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65418889|NCT00563381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418890|NCT00563381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65418891|NCT00563381|Respiratory System Agents|respiratory system agents|mesh-ancestor
65418892|NCT00563381|Parasympatholytics|parasympatholytics|mesh-ancestor
65418893|NCT00563381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65418894|NCT00563381|Cholinergic Agents|cholinergic agents|mesh-ancestor
65418895|NCT00563381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65418896|NCT00563381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418897|NCT00563381|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65418898|NCT00563381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65418899|NCT00563381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65418900|NCT00563381|Adrenergic Agents|adrenergic agents|mesh-ancestor
65418901|NCT00563381|Anticonvulsants|anticonvulsants|mesh-ancestor
65418902|NCT00512798|Temozolomide|temozolomide|mesh-list
65418903|NCT00512798|Bortezomib|bortezomib|mesh-list
65418904|NCT00512798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65418905|NCT00512798|Alkylating Agents|alkylating agents|mesh-ancestor
65418906|NCT00512798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418907|NCT00512798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418908|NCT00940121|Mirabegron|mirabegron|mesh-list
65418909|NCT00940121|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65418910|NCT00940121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65418911|NCT00940121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65418912|NCT00940121|Adrenergic Agents|adrenergic agents|mesh-ancestor
65418913|NCT00940121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65418914|NCT00940121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418915|NCT00940121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418916|NCT00940121|Urological Agents|urological agents|mesh-ancestor
65418917|NCT04012619|Cisplatin|cisplatin|mesh-list
65418918|NCT04012619|Carboplatin|carboplatin|mesh-list
65168455|NCT02700685|Pycnogenols|pycnogenols|mesh-list
65418919|NCT04012619|Pemetrexed|pemetrexed|mesh-list
64803689|NCT01408979|Anesthetics|anesthetics|mesh-ancestor
65418928|NCT00941057|Calcium|calcium|mesh-list
65418929|NCT00941057|Nandrolone|nandrolone|mesh-list
65418930|NCT00941057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65418931|NCT00941057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418932|NCT00941057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65418933|NCT00941057|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65418934|NCT00941057|Contraceptive Agents|contraceptive agents|mesh-ancestor
65418935|NCT00941057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65418936|NCT00941057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65418937|NCT00941057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65418938|NCT00941057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65418939|NCT00941057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65418940|NCT00941057|Hormone Antagonists|hormone antagonists|mesh-ancestor
65418941|NCT00941057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65418942|NCT00941057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65418943|NCT00941057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418944|NCT00941057|Androgens|androgens|mesh-ancestor
65418945|NCT00941057|Hormones|hormones|mesh-ancestor
65418946|NCT00941057|Anabolic Agents|anabolic agents|mesh-ancestor
65418947|NCT00941057|Vitamin B Complex|vitamin b complex|mesh-ancestor
65418948|NCT00941057|Vitamins|vitamins|mesh-ancestor
65418949|NCT00941057|Micronutrients|micronutrients|mesh-ancestor
65418950|NCT00561821|Mirtazapine|mirtazapine|mesh-list
65418951|NCT00561821|Antidepressive Agents|antidepressive agents|mesh-ancestor
65418952|NCT00561821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65418953|NCT00561821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65418954|NCT00561821|Histamine Antagonists|histamine antagonists|mesh-ancestor
65418955|NCT00561821|Histamine Agents|histamine agents|mesh-ancestor
65418956|NCT00561821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65418957|NCT00561821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418958|NCT00561821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418959|NCT00561821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65418960|NCT00561821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65418961|NCT00561821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65418962|NCT00561821|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65418963|NCT00561821|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65418964|NCT00561821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65418965|NCT00561821|Adrenergic Agents|adrenergic agents|mesh-ancestor
65418966|NCT00561821|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65418967|NCT00561821|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65418968|NCT00561821|Serotonin Agents|serotonin agents|mesh-ancestor
65418969|NCT00561821|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65418970|NCT03684044|Baloxavir|baloxavir|mesh-list
65418971|NCT03684044|Antiviral Agents|antiviral agents|mesh-ancestor
65418972|NCT03684044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65418973|NCT03684044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418974|NCT03684044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418975|NCT01009502|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
65418976|NCT01009502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65418977|NCT01009502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65418978|NCT01009502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65418979|NCT01009502|Schistosomicides|schistosomicides|mesh-ancestor
65418980|NCT01009502|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65418981|NCT01009502|Anthelmintics|anthelmintics|mesh-ancestor
65418982|NCT00335452|Clopidogrel|clopidogrel|mesh-list
65418983|NCT00335452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65418984|NCT00335452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65418985|NCT00335452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65418986|NCT00335452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65269906|NCT02737202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269907|NCT02721368|Lidocaine|lidocaine|mesh-list
65269908|NCT02721368|Anesthetics, Local|anesthetics, local|mesh-ancestor
65269909|NCT02721368|Anesthetics|anesthetics|mesh-ancestor
65269910|NCT02721368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65269911|NCT02721368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269912|NCT02721368|Sensory System Agents|sensory system agents|mesh-ancestor
65269913|NCT02721368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65269914|NCT02721368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65240263|NCT02866409|Analgesics|analgesics|mesh-ancestor
65240264|NCT02866409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65240265|NCT02866409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65240266|NCT02866409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65240267|NCT02866409|Adrenergic Agents|adrenergic agents|mesh-ancestor
65240268|NCT02866409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65240269|NCT02866409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240270|NCT05834023|Lidocaine|lidocaine|mesh-list
65240271|NCT05834023|Bupivacaine|bupivacaine|mesh-list
65240272|NCT05834023|Anesthetics, Local|anesthetics, local|mesh-ancestor
65240273|NCT05834023|Anesthetics|anesthetics|mesh-ancestor
65240274|NCT05834023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65240275|NCT05834023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240276|NCT05834023|Sensory System Agents|sensory system agents|mesh-ancestor
65240277|NCT05834023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65240278|NCT05834023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65240279|NCT05834023|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65240280|NCT05834023|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65240281|NCT05834023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65240282|NCT05834023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240296|NCT05833919|Capecitabine|capecitabine|mesh-list
65240297|NCT05833919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65240298|NCT05833919|Antimetabolites|antimetabolites|mesh-ancestor
65240299|NCT05833919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240300|NCT05833919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240301|NCT05833815|Everolimus|everolimus|mesh-list
65418987|NCT00335452|Purinergic Agents|purinergic agents|mesh-ancestor
65418994|NCT00522548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65240329|NCT05833529|Sensory System Agents|sensory system agents|mesh-ancestor
65418996|NCT00522548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65418997|NCT00522548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65418998|NCT00522548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418999|NCT00522548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419000|NCT00522392|Dexamethasone|dexamethasone|mesh-list
65419001|NCT00522392|Lenalidomide|lenalidomide|mesh-list
65419002|NCT00522392|Bortezomib|bortezomib|mesh-list
65419003|NCT00522392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65419004|NCT00522392|Antiemetics|antiemetics|mesh-ancestor
65419005|NCT00522392|Autonomic Agents|autonomic agents|mesh-ancestor
65419006|NCT00522392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65419007|NCT00522392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419008|NCT00522392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65419009|NCT00522392|Glucocorticoids|glucocorticoids|mesh-ancestor
65419010|NCT00522392|Hormones|hormones|mesh-ancestor
65419011|NCT00522392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65419012|NCT00522392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65419013|NCT00522392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419014|NCT00522392|Immunologic Factors|immunologic factors|mesh-ancestor
65419015|NCT00522392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65419016|NCT00522392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65419017|NCT00522392|Growth Substances|growth substances|mesh-ancestor
65419018|NCT00522392|Growth Inhibitors|growth inhibitors|mesh-ancestor
65419019|NCT00335140|Leucovorin|leucovorin|mesh-list
65419020|NCT00335140|Cytarabine|cytarabine|mesh-list
65419021|NCT00335140|Dexamethasone|dexamethasone|mesh-list
65419022|NCT00335140|Dexamethasone acetate|dexamethasone acetate|mesh-list
65419023|NCT00335140|Rituximab|rituximab|mesh-list
65419024|NCT00335140|Methotrexate|methotrexate|mesh-list
65419025|NCT00335140|Vincristine|vincristine|mesh-list
65419026|NCT00335140|Procarbazine|procarbazine|mesh-list
65419027|NCT00335140|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65419028|NCT00335140|BB 1101|bb 1101|mesh-list
65419029|NCT00335140|Levoleucovorin|levoleucovorin|mesh-list
65419030|NCT00335140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65419031|NCT00335140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419032|NCT00335140|Immunologic Factors|immunologic factors|mesh-ancestor
65419033|NCT00335140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419034|NCT00335140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65419035|NCT00335140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65419036|NCT00335140|Antiemetics|antiemetics|mesh-ancestor
65419037|NCT00335140|Autonomic Agents|autonomic agents|mesh-ancestor
65419038|NCT00335140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65419039|NCT00335140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65419040|NCT00335140|Glucocorticoids|glucocorticoids|mesh-ancestor
65419041|NCT00335140|Hormones|hormones|mesh-ancestor
65419042|NCT00335140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65419043|NCT00335140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65419044|NCT00335140|Protease Inhibitors|protease inhibitors|mesh-ancestor
65419045|NCT00335140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419046|NCT00335140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419047|NCT00335140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65419048|NCT00335140|Abortifacient Agents|abortifacient agents|mesh-ancestor
65419049|NCT00335140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65419050|NCT00335140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65419051|NCT00335140|Antimetabolites|antimetabolites|mesh-ancestor
65419052|NCT00335140|Dermatologic Agents|dermatologic agents|mesh-ancestor
65419053|NCT00335140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65419054|NCT00335140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65419055|NCT00335140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65419056|NCT00335140|Antiviral Agents|antiviral agents|mesh-ancestor
65419068|NCT01061320|Vitamin E|vitamin e|mesh-list
65419069|NCT01061320|Tocotrienols|tocotrienols|mesh-list
65419070|NCT01061320|alpha-Tocopherol|alpha-tocopherol|mesh-list
65419071|NCT01061320|Vitamins|vitamins|mesh-ancestor
65419072|NCT01061320|Micronutrients|micronutrients|mesh-ancestor
65419073|NCT01061320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419074|NCT01061320|Antioxidants|antioxidants|mesh-ancestor
65419075|NCT01061320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419076|NCT01061320|Protective Agents|protective agents|mesh-ancestor
65419078|NCT01012544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65419079|NCT01012544|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65419080|NCT01012544|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65419081|NCT01012544|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65419082|NCT01012544|Purinergic Agents|purinergic agents|mesh-ancestor
65240402|NCT05833126|Bevacizumab|bevacizumab|mesh-list
65419083|NCT01012544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65419084|NCT01012544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419085|NCT01012544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419086|NCT01012700|Poly ICLC|poly iclc|mesh-list
65419087|NCT01012700|Interferon Inducers|interferon inducers|mesh-ancestor
65419088|NCT01012700|Immunologic Factors|immunologic factors|mesh-ancestor
65419089|NCT01012700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419090|NCT01565720|Moxifloxacin|moxifloxacin|mesh-list
65419091|NCT01565720|Isavuconazole|isavuconazole|mesh-list
65419092|NCT01565720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65419093|NCT01565720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65419094|NCT01565720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65419095|NCT01565720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65419096|NCT01565720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419097|NCT01565720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419098|NCT01565720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419099|NCT01565720|Antifungal Agents|antifungal agents|mesh-ancestor
65419100|NCT00309244|Insulin|insulin|mesh-list
65419101|NCT00309244|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65419102|NCT00309244|Insulin Aspart|insulin aspart|mesh-list
65419103|NCT00309244|Protamines|protamines|mesh-list
65419104|NCT00309244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65419105|NCT00309244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419106|NCT00309244|Heparin Antagonists|heparin antagonists|mesh-ancestor
65419107|NCT00309244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419108|NCT00309244|Coagulants|coagulants|mesh-ancestor
65419109|NCT00483756|Cyclosporine|cyclosporine|mesh-list
65419110|NCT00483756|Cyclosporins|cyclosporins|mesh-list
65419111|NCT00483756|Tofacitinib|tofacitinib|mesh-list
65419112|NCT00483756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419113|NCT00483756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419114|NCT00483756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65419115|NCT00483756|Immunologic Factors|immunologic factors|mesh-ancestor
65419116|NCT00483756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419117|NCT00483756|Antifungal Agents|antifungal agents|mesh-ancestor
65419118|NCT00483756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65419119|NCT00483756|Dermatologic Agents|dermatologic agents|mesh-ancestor
65419120|NCT00483756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65419121|NCT00483756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65419122|NCT00483756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65419123|NCT00309166|Vaccines|vaccines|mesh-list
65419124|NCT00309166|Immunologic Factors|immunologic factors|mesh-ancestor
64803890|NCT01410162|Tacrolimus|tacrolimus|mesh-list
65419147|NCT00501852|Respiratory System Agents|respiratory system agents|mesh-ancestor
65419148|NCT00501852|Parasympatholytics|parasympatholytics|mesh-ancestor
65419149|NCT00501852|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65419150|NCT00501852|Cholinergic Agents|cholinergic agents|mesh-ancestor
65419151|NCT00501852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65419152|NCT00501852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419153|NCT00501852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65419154|NCT00501852|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65419156|NCT00482274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419157|NCT00482274|Tubulin Modulators|tubulin modulators|mesh-ancestor
65419158|NCT00482274|Antimitotic Agents|antimitotic agents|mesh-ancestor
65419159|NCT00482274|Mitosis Modulators|mitosis modulators|mesh-ancestor
65419160|NCT00482274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419161|NCT00490542|Ziprasidone|ziprasidone|mesh-list
65419162|NCT00490542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65419163|NCT00490542|Serotonin Agents|serotonin agents|mesh-ancestor
65419164|NCT00490542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65419165|NCT00490542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419166|NCT00490542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419167|NCT00490542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65419168|NCT00490542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65419169|NCT00490542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65419170|NCT00490542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65419171|NCT00490542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65419172|NCT00490542|Dopamine Agents|dopamine agents|mesh-ancestor
65419173|NCT01059604|Naproxen|naproxen|mesh-list
65419174|NCT01059604|Sumatriptan|sumatriptan|mesh-list
65419175|NCT01059604|Naratriptan|naratriptan|mesh-list
65419176|NCT01059604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65419177|NCT01059604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65419178|NCT01059604|Analgesics|analgesics|mesh-ancestor
65419202|NCT02532634|Autonomic Agents|autonomic agents|mesh-ancestor
65269915|NCT02721368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65269916|NCT02721368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65269917|NCT02721368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65269918|NCT02721368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269919|NCT02737124|Acetaminophen|acetaminophen|mesh-list
65269920|NCT02737124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65269921|NCT02737124|Analgesics|analgesics|mesh-ancestor
65019921|NCT05782894|Propofol|propofol|mesh-list
65269923|NCT02737124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65269924|NCT02737124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269925|NCT02737124|Antipyretics|antipyretics|mesh-ancestor
65269926|NCT02721290|Ropivacaine|ropivacaine|mesh-list
65269927|NCT02721290|Anesthetics, Local|anesthetics, local|mesh-ancestor
65269928|NCT02721290|Anesthetics|anesthetics|mesh-ancestor
65419203|NCT02532634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65419204|NCT02532634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419205|NCT02532634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65419206|NCT02532634|Glucocorticoids|glucocorticoids|mesh-ancestor
65419207|NCT02532634|Hormones|hormones|mesh-ancestor
65419208|NCT02532634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65419209|NCT02532634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65419210|NCT02532634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419211|NCT02532634|Protease Inhibitors|protease inhibitors|mesh-ancestor
65419212|NCT02532634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419213|NCT02532634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419214|NCT02532634|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65419215|NCT02532634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65419216|NCT02532634|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65419217|NCT02532634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65419218|NCT02532634|Serotonin Agents|serotonin agents|mesh-ancestor
65419219|NCT00501540|Lithium Carbonate|lithium carbonate|mesh-list
65419220|NCT00501540|Antidepressive Agents|antidepressive agents|mesh-ancestor
65419221|NCT00501540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65419222|NCT00501540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419223|NCT00501540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419224|NCT00501540|Antimanic Agents|antimanic agents|mesh-ancestor
65419225|NCT00501540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65419226|NCT00501540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65419227|NCT00501540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419228|NCT01014156|Epoprostenol|epoprostenol|mesh-list
65419229|NCT01014156|Tezosentan|tezosentan|mesh-list
65419230|NCT01014156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64804005|NCT01411124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65419236|NCT01014234|Cyclosporine|cyclosporine|mesh-list
65419238|NCT01014234|Cyclosporins|cyclosporins|mesh-list
65419239|NCT01014234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419240|NCT01014234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419241|NCT01014234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65419242|NCT01014234|Immunologic Factors|immunologic factors|mesh-ancestor
65419243|NCT01014234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419244|NCT01014234|Antifungal Agents|antifungal agents|mesh-ancestor
65419245|NCT01014234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65419246|NCT01014234|Dermatologic Agents|dermatologic agents|mesh-ancestor
65419247|NCT01014234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65419248|NCT01014234|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65419249|NCT01014234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65419250|NCT01014234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65419251|NCT01014234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419252|NCT00501228|Lenograstim|lenograstim|mesh-list
65419253|NCT00501228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65419254|NCT00501228|Immunologic Factors|immunologic factors|mesh-ancestor
65269929|NCT02721290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65269930|NCT02721290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419255|NCT00501228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419256|NCT00308620|Chloroquine|chloroquine|mesh-list
65419257|NCT00308620|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65419258|NCT00308620|Amebicides|amebicides|mesh-ancestor
65419259|NCT00308620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65419260|NCT00308620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65419261|NCT00308620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65419262|NCT00308620|Antimalarials|antimalarials|mesh-ancestor
65419263|NCT00308620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65419264|NCT00308620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65419265|NCT00308620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65419266|NCT00308620|Analgesics|analgesics|mesh-ancestor
65419267|NCT00308620|Sensory System Agents|sensory system agents|mesh-ancestor
65419268|NCT00308620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65419269|NCT00308620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419270|NCT00308620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65419271|NCT00308620|Filaricides|filaricides|mesh-ancestor
65419272|NCT00308620|Antinematodal Agents|antinematodal agents|mesh-ancestor
65419273|NCT00308620|Anthelmintics|anthelmintics|mesh-ancestor
65419274|NCT00492752|Sorafenib|sorafenib|mesh-list
65419275|NCT00492752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419276|NCT00492752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65419277|NCT00492752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419278|NCT00492752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419279|NCT00308308|Insulin|insulin|mesh-list
65419280|NCT00308308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65419281|NCT00308308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419282|NCT00505934|Levetiracetam|levetiracetam|mesh-list
65419283|NCT00505934|Anticonvulsants|anticonvulsants|mesh-ancestor
65419284|NCT00505934|Nootropic Agents|nootropic agents|mesh-ancestor
65419285|NCT02532790|Prednisone|prednisone|mesh-list
65419286|NCT02532790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65419287|NCT02532790|Glucocorticoids|glucocorticoids|mesh-ancestor
65419288|NCT02532790|Hormones|hormones|mesh-ancestor
65419289|NCT02532790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65419290|NCT02532790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419291|NCT02532790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65419292|NCT02532790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419293|NCT00505778|Mesalamine|mesalamine|mesh-list
65419294|NCT00505778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65419295|NCT00505778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65419296|NCT00505778|Analgesics|analgesics|mesh-ancestor
65419297|NCT00505778|Sensory System Agents|sensory system agents|mesh-ancestor
65419298|NCT00505778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65419299|NCT00505778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419300|NCT00505778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65419301|NCT00505778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65419302|NCT00308074|Aripiprazole|aripiprazole|mesh-list
65419321|NCT03997058|Anticonvulsants|anticonvulsants|mesh-ancestor
65419322|NCT03997058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65419323|NCT03997058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65419324|NCT03997058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65419325|NCT03997058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419326|NCT03997058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65419327|NCT03997058|GABA Modulators|gaba modulators|mesh-ancestor
65419328|NCT03997058|GABA Agents|gaba agents|mesh-ancestor
65419329|NCT03997058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65419330|NCT03997058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419331|NCT00500760|Panitumumab|panitumumab|mesh-list
65419332|NCT00500760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419333|NCT00500760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65419334|NCT01016730|Bortezomib|bortezomib|mesh-list
65419335|NCT01016730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419336|NCT01012934|Alendronate|alendronate|mesh-list
65419337|NCT01012934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65419338|NCT01012934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419339|NCT04334330|Trastuzumab|trastuzumab|mesh-list
65419340|NCT04334330|Fulvestrant|fulvestrant|mesh-list
65419341|NCT04334330|Palbociclib|palbociclib|mesh-list
65419342|NCT04334330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65419343|NCT04334330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419344|NCT04334330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65240612|NCT05807399|Moxifloxacin|moxifloxacin|mesh-list
65240613|NCT05807399|Rifampin|rifampin|mesh-list
65240614|NCT05807399|Isoniazid|isoniazid|mesh-list
65240615|NCT05807399|Pyrazinamide|pyrazinamide|mesh-list
65240616|NCT05807399|Bedaquiline|bedaquiline|mesh-list
65240617|NCT05807399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65240618|NCT05807399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65240619|NCT05807399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65240620|NCT05807399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65240621|NCT05807399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419345|NCT04334330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65419346|NCT04334330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65419347|NCT04334330|Hormone Antagonists|hormone antagonists|mesh-ancestor
65419348|NCT04334330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65419349|NCT04334330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419350|NCT04334330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65419351|NCT04334330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419352|NCT04334330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419353|NCT01015196|Daunorubicin|daunorubicin|mesh-list
65419354|NCT01015196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65419355|NCT01015196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419356|NCT01015196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64804127|NCT01411969|Autonomic Agents|autonomic agents|mesh-ancestor
65419364|NCT01009892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419365|NCT01009892|Analgesics|analgesics|mesh-ancestor
65419366|NCT01009892|Sensory System Agents|sensory system agents|mesh-ancestor
65419367|NCT01009892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65419368|NCT01009892|Antitussive Agents|antitussive agents|mesh-ancestor
65419369|NCT01009892|Respiratory System Agents|respiratory system agents|mesh-ancestor
65419370|NCT00307684|Methylphenidate|methylphenidate|mesh-list
65419371|NCT00307684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65419372|NCT00307684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419373|NCT00307684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65419374|NCT00307684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65419375|NCT00307684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65419376|NCT00307684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419377|NCT00307684|Dopamine Agents|dopamine agents|mesh-ancestor
65419379|NCT00489918|Teriparatide|teriparatide|mesh-list
65419380|NCT00489918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65419381|NCT00489918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419382|NCT00489918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65419384|NCT01061788|Panitumumab|panitumumab|mesh-list
65419385|NCT01061788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419386|NCT01061788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65419387|NCT01061788|Immunologic Factors|immunologic factors|mesh-ancestor
65419388|NCT01061788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419389|NCT01061788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65419390|NCT00307294|Thalidomide|thalidomide|mesh-list
65419391|NCT00307294|Doxorubicin|doxorubicin|mesh-list
65419392|NCT00307294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65419393|NCT00307294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419394|NCT00307294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65419395|NCT00307294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65419396|NCT00307294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419397|NCT00307294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419398|NCT00307294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65419399|NCT00307294|Immunologic Factors|immunologic factors|mesh-ancestor
65419400|NCT00307294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419401|NCT00307294|Leprostatic Agents|leprostatic agents|mesh-ancestor
65419402|NCT00307294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65419403|NCT00307294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65419404|NCT00307294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65419405|NCT00307294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65419406|NCT00307294|Growth Substances|growth substances|mesh-ancestor
65419407|NCT00307294|Growth Inhibitors|growth inhibitors|mesh-ancestor
65240690|NCT05796401|Leucovorin|leucovorin|mesh-list
65240691|NCT05796401|Folic Acid|folic acid|mesh-list
65240692|NCT05796401|Vitamin B 12|vitamin b 12|mesh-list
65240693|NCT05796401|Levoleucovorin|levoleucovorin|mesh-list
65240694|NCT05796401|Vitamins|vitamins|mesh-ancestor
65240695|NCT05796401|Micronutrients|micronutrients|mesh-ancestor
65240696|NCT05796401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240697|NCT05796401|Antidotes|antidotes|mesh-ancestor
65240698|NCT05796401|Protective Agents|protective agents|mesh-ancestor
65240699|NCT05796401|Vitamin B Complex|vitamin b complex|mesh-ancestor
65240700|NCT05796401|Hematinics|hematinics|mesh-ancestor
65240708|NCT05771402|Antibodies|antibodies|mesh-list
65240711|NCT05769816|Antibodies|antibodies|mesh-list
65419408|NCT03981094|Pirfenidone|pirfenidone|mesh-list
65419409|NCT03981094|Analgesics|analgesics|mesh-ancestor
65419410|NCT03981094|Sensory System Agents|sensory system agents|mesh-ancestor
65419411|NCT03981094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65419412|NCT03981094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419413|NCT03981094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65419414|NCT03981094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65419415|NCT03981094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65419416|NCT03981094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65419417|NCT03981094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419418|NCT03963401|PF-06700841|pf-06700841|mesh-list
65419419|NCT03963401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65419420|NCT03963401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419421|NCT03963401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419422|NCT04410965|Teriflunomide|teriflunomide|mesh-list
65419423|NCT04410965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65419434|NCT04012775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65419435|NCT04012775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65419436|NCT04012775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419437|NCT00944723|Vitamins|vitamins|mesh-list
65419438|NCT00944723|Zinc|zinc|mesh-list
65419439|NCT00944723|Vitamin B Complex|vitamin b complex|mesh-list
65419440|NCT00944723|Zinc Sulfate|zinc sulfate|mesh-list
65419441|NCT00944723|Micronutrients|micronutrients|mesh-ancestor
65419442|NCT00944723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419443|NCT00944723|Trace Elements|trace elements|mesh-ancestor
65419444|NCT00944723|Astringents|astringents|mesh-ancestor
65419445|NCT00944723|Dermatologic Agents|dermatologic agents|mesh-ancestor
65419446|NCT00944801|Doxorubicin|doxorubicin|mesh-list
65419447|NCT00944801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65419448|NCT00944801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65066888|NCT00307944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65419449|NCT00944801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419450|NCT00944801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65419451|NCT00944801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65419452|NCT00944801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419453|NCT00944801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419454|NCT01060228|Valproic Acid|valproic acid|mesh-list
65419455|NCT01060228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65419456|NCT01060228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65419457|NCT01060228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65419458|NCT01060228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65419459|NCT01060228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419460|NCT01060228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65419461|NCT01060228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65419462|NCT01060228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65419463|NCT01060228|Serotonin Agents|serotonin agents|mesh-ancestor
65419464|NCT01060228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65419465|NCT01060228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419466|NCT01060228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65419467|NCT01060228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65419468|NCT01060228|Dopamine Agents|dopamine agents|mesh-ancestor
65419469|NCT01060228|Anticonvulsants|anticonvulsants|mesh-ancestor
65419470|NCT01060228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419471|NCT01060228|GABA Agents|gaba agents|mesh-ancestor
65240771|NCT05709483|Aspirin|aspirin|mesh-list
65240772|NCT05709483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65240773|NCT05709483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65240774|NCT05709483|Analgesics|analgesics|mesh-ancestor
65240775|NCT05709483|Sensory System Agents|sensory system agents|mesh-ancestor
65240776|NCT05709483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65240777|NCT05709483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419472|NCT01060228|Antimanic Agents|antimanic agents|mesh-ancestor
65419473|NCT00306670|Prednisone|prednisone|mesh-list
65419474|NCT00306670|Rituximab|rituximab|mesh-list
65419475|NCT00306670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65419476|NCT00306670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419477|NCT00306670|Immunologic Factors|immunologic factors|mesh-ancestor
65419478|NCT00306670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419479|NCT00306670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65419480|NCT00306670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65419481|NCT00306670|Glucocorticoids|glucocorticoids|mesh-ancestor
65419482|NCT00306670|Hormones|hormones|mesh-ancestor
65419483|NCT00306670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65419484|NCT00306670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65419485|NCT00306592|Natalizumab|natalizumab|mesh-list
65419486|NCT00306592|Immunologic Factors|immunologic factors|mesh-ancestor
65419487|NCT00306592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419488|NCT00321646|Bevacizumab|bevacizumab|mesh-list
65419489|NCT00321646|Docetaxel|docetaxel|mesh-list
65419490|NCT00321646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65419523|NCT00492284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419524|NCT00492284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65419525|NCT00492284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65419526|NCT00492284|Growth Substances|growth substances|mesh-ancestor
65419527|NCT00492284|Growth Inhibitors|growth inhibitors|mesh-ancestor
65419528|NCT00492284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65419530|NCT01013012|Dexamethasone|dexamethasone|mesh-list
65419531|NCT01013012|Ramosetron|ramosetron|mesh-list
65419532|NCT01013012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65419533|NCT01013012|Antiemetics|antiemetics|mesh-ancestor
65419534|NCT01013012|Autonomic Agents|autonomic agents|mesh-ancestor
65419535|NCT01013012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65419553|NCT01009970|Immunologic Factors|immunologic factors|mesh-ancestor
65419554|NCT01009970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419555|NCT01009970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65419556|NCT01009970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65419557|NCT01009970|Alkylating Agents|alkylating agents|mesh-ancestor
65419558|NCT01009970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419559|NCT01009970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419560|NCT01009970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65419561|NCT01009970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65419562|NCT01009970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65419563|NCT01009970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65419564|NCT01009970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65419565|NCT01009970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419566|NCT01009970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65419567|NCT01009970|Glucocorticoids|glucocorticoids|mesh-ancestor
65419568|NCT01009970|Hormones|hormones|mesh-ancestor
65419569|NCT01009970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65419570|NCT01009970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65419571|NCT01009970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65419572|NCT01009970|Tubulin Modulators|tubulin modulators|mesh-ancestor
65419573|NCT01009970|Antimitotic Agents|antimitotic agents|mesh-ancestor
65419574|NCT01009970|Mitosis Modulators|mitosis modulators|mesh-ancestor
65419575|NCT01015352|Azacitidine|azacitidine|mesh-list
65419576|NCT01015352|Epoetin Alfa|epoetin alfa|mesh-list
65419577|NCT01015352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65419578|NCT01015352|Antimetabolites|antimetabolites|mesh-ancestor
65419579|NCT01015352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419580|NCT01015352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419581|NCT01015352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419582|NCT01015352|Hematinics|hematinics|mesh-ancestor
65419583|NCT05102162|Meropenem|meropenem|mesh-list
65240839|NCT05647889|Sensory System Agents|sensory system agents|mesh-ancestor
65240840|NCT05647889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65240841|NCT05647889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65240846|NCT05647057|Polygeline|polygeline|mesh-list
65419584|NCT05102162|Tazobactam|tazobactam|mesh-list
65419585|NCT05102162|Piperacillin|piperacillin|mesh-list
65419586|NCT05102162|Cefepime|cefepime|mesh-list
65419587|NCT05102162|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65419588|NCT05102162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65419589|NCT05102162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65419590|NCT05102162|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65419591|NCT05102162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419592|NCT05102162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419593|NCT03563157|Leucovorin|leucovorin|mesh-list
65419594|NCT03563157|Paclitaxel|paclitaxel|mesh-list
65419612|NCT03563157|Alkylating Agents|alkylating agents|mesh-ancestor
65419613|NCT03563157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65419614|NCT03563157|Antimetabolites|antimetabolites|mesh-ancestor
65419615|NCT03563157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65419616|NCT03563157|Antidotes|antidotes|mesh-ancestor
65419617|NCT03563157|Protective Agents|protective agents|mesh-ancestor
65419618|NCT03563157|Vitamin B Complex|vitamin b complex|mesh-ancestor
65419620|NCT03563157|Micronutrients|micronutrients|mesh-ancestor
65419621|NCT03563157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65419622|NCT01010048|Nifedipine|nifedipine|mesh-list
65419623|NCT01010048|Bromides|bromides|mesh-list
65419624|NCT01010048|Propantheline|propantheline|mesh-list
65419625|NCT01010048|Tamsulosin|tamsulosin|mesh-list
65419626|NCT01010048|Progesterone|progesterone|mesh-list
65419627|NCT01010048|Progestins|progestins|mesh-ancestor
65419628|NCT01010048|Hormones|hormones|mesh-ancestor
65419629|NCT01010048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65419630|NCT01010048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419631|NCT01010048|Anticonvulsants|anticonvulsants|mesh-ancestor
65419632|NCT01010048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65419633|NCT01010048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65419634|NCT01010048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65419635|NCT01010048|Adrenergic Agents|adrenergic agents|mesh-ancestor
65419636|NCT01010048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65419637|NCT01010048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419638|NCT01010048|Urological Agents|urological agents|mesh-ancestor
65419639|NCT01010048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65419640|NCT01010048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65419641|NCT01010048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65419642|NCT01010048|Vasodilator Agents|vasodilator agents|mesh-ancestor
65419643|NCT01010048|Tocolytic Agents|tocolytic agents|mesh-ancestor
65419644|NCT01010048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65419645|NCT01010048|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65419646|NCT01010048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65419647|NCT01010048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65419648|NCT01010048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65419649|NCT01010048|Cholinergic Agents|cholinergic agents|mesh-ancestor
65419650|NCT01589055|Nicotine|nicotine|mesh-list
65419651|NCT01589055|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65419652|NCT01589055|Autonomic Agents|autonomic agents|mesh-ancestor
65419653|NCT01589055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65419654|NCT01589055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419669|NCT03997292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419671|NCT01013402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65419672|NCT01013402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65419673|NCT01013402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419675|NCT01013480|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65419676|NCT01013480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419677|NCT01013480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65419678|NCT01013480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65419679|NCT01013480|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65419680|NCT01013480|GABA Agonists|gaba agonists|mesh-ancestor
65169190|NCT00622141|Saquinavir|saquinavir|mesh-list
65419681|NCT01013480|GABA Agents|gaba agents|mesh-ancestor
65419682|NCT01013480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65419683|NCT01013480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419684|NCT00500370|Exenatide|exenatide|mesh-list
65419685|NCT00500370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65240915|NCT05612490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240916|NCT05612490|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65240917|NCT05612490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65240918|NCT05612490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240919|NCT05605964|Leuprolide|leuprolide|mesh-list
65240920|NCT05605964|Relugolix|relugolix|mesh-list
65419686|NCT00500370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419687|NCT00500370|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65419688|NCT00500370|Incretins|incretins|mesh-ancestor
65419689|NCT00500370|Hormones|hormones|mesh-ancestor
65419690|NCT00500370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65419691|NCT00320788|Aflibercept|aflibercept|mesh-list
65419692|NCT00320788|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65419693|NCT00320788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65419694|NCT00320788|Growth Substances|growth substances|mesh-ancestor
65419695|NCT00320788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419696|NCT00320788|Growth Inhibitors|growth inhibitors|mesh-ancestor
65419697|NCT00320788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419698|NCT03996486|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
65419699|NCT03996486|Immunoglobulins|immunoglobulins|mesh-list
65419700|NCT03996486|Immunoglobulin G|immunoglobulin g|mesh-list
65419701|NCT03996486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65419702|NCT03996486|Myeloma Proteins|myeloma proteins|mesh-list
65419703|NCT03996486|Paraproteins|paraproteins|mesh-list
65419704|NCT03996486|Immunologic Factors|immunologic factors|mesh-ancestor
65419705|NCT03996486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419706|NCT03996486|Anticoagulants|anticoagulants|mesh-ancestor
65419707|NCT03996486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65419708|NCT03996486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65419709|NCT03996486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419710|NCT03996486|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65419711|NCT03996486|Protease Inhibitors|protease inhibitors|mesh-ancestor
65419712|NCT03996486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419713|NCT03996486|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65419714|NCT03996486|Antithrombins|antithrombins|mesh-ancestor
65419722|NCT01014468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419723|NCT01014468|Growth Inhibitors|growth inhibitors|mesh-ancestor
65419724|NCT00503984|Prednisone|prednisone|mesh-list
65419725|NCT00503984|Docetaxel|docetaxel|mesh-list
65419726|NCT00503984|Azacitidine|azacitidine|mesh-list
65419727|NCT00503984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419728|NCT00503984|Tubulin Modulators|tubulin modulators|mesh-ancestor
65419729|NCT00503984|Antimitotic Agents|antimitotic agents|mesh-ancestor
65419730|NCT00503984|Mitosis Modulators|mitosis modulators|mesh-ancestor
65419731|NCT00503984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419732|NCT00503984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65419733|NCT00503984|Glucocorticoids|glucocorticoids|mesh-ancestor
65419734|NCT00503984|Hormones|hormones|mesh-ancestor
65419735|NCT00503984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65419736|NCT00503984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419737|NCT00503984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65419738|NCT00503984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65419739|NCT00503984|Antimetabolites|antimetabolites|mesh-ancestor
65419740|NCT00503984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419741|NCT03996564|Acetaminophen|acetaminophen|mesh-list
65419742|NCT03996564|Diclofenac|diclofenac|mesh-list
65419743|NCT03996564|Ketorolac|ketorolac|mesh-list
65419744|NCT03996564|Diazepam|diazepam|mesh-list
65419745|NCT03996564|Hydrocodone|hydrocodone|mesh-list
65419746|NCT03996564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65419747|NCT03996564|Analgesics|analgesics|mesh-ancestor
65419748|NCT03996564|Sensory System Agents|sensory system agents|mesh-ancestor
65419749|NCT03996564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65419750|NCT03996564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419751|NCT03996564|Antipyretics|antipyretics|mesh-ancestor
65419752|NCT03996564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65419753|NCT03996564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65419754|NCT03996564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65419755|NCT03996564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65269931|NCT02721290|Sensory System Agents|sensory system agents|mesh-ancestor
65269932|NCT02721290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65269933|NCT02720978|Oxytocin|oxytocin|mesh-list
65269934|NCT02720978|Oxytocics|oxytocics|mesh-ancestor
65269935|NCT02720978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65269936|NCT02720978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269937|NCT02726984|Listerine|listerine|mesh-list
65269938|NCT02726984|Fluorides|fluorides|mesh-list
65269939|NCT02726984|Sodium Fluoride|sodium fluoride|mesh-list
65269940|NCT02726984|Cariostatic Agents|cariostatic agents|mesh-ancestor
65269941|NCT02726984|Protective Agents|protective agents|mesh-ancestor
65269942|NCT02726984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269943|NCT02726984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65269944|NCT02726984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65269945|NCT02726828|Ketamine|ketamine|mesh-list
65269946|NCT02726828|Morphine|morphine|mesh-list
65269947|NCT02726828|Analgesics|analgesics|mesh-ancestor
65269948|NCT02726828|Sensory System Agents|sensory system agents|mesh-ancestor
65269949|NCT02726828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65269950|NCT02726828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269951|NCT02726828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65269952|NCT02726828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65269953|NCT02726828|Anesthetics, General|anesthetics, general|mesh-ancestor
65269954|NCT02726828|Anesthetics|anesthetics|mesh-ancestor
65269955|NCT02726828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65269956|NCT02726828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65269957|NCT02726828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65269958|NCT02726828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65269959|NCT02726828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269960|NCT02726828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65269961|NCT02726828|Narcotics|narcotics|mesh-ancestor
65269962|NCT02799134|Dexamethasone|dexamethasone|mesh-list
65419756|NCT03996564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419757|NCT03996564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419758|NCT03996564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65419759|NCT03996564|Narcotics|narcotics|mesh-ancestor
65419760|NCT03996564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65419761|NCT03996564|Antitussive Agents|antitussive agents|mesh-ancestor
65419762|NCT03996564|Respiratory System Agents|respiratory system agents|mesh-ancestor
65419763|NCT03996564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65419764|NCT03996564|Anticonvulsants|anticonvulsants|mesh-ancestor
65419765|NCT03996564|Antiemetics|antiemetics|mesh-ancestor
65419766|NCT03996564|Autonomic Agents|autonomic agents|mesh-ancestor
65419767|NCT03996564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65241064|NCT05502237|Mitosis Modulators|mitosis modulators|mesh-ancestor
65241065|NCT05502237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241066|NCT05502237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65241067|NCT05502237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241068|NCT05502237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65241069|NCT05502237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65241070|NCT05485519|Midazolam|midazolam|mesh-list
65241071|NCT05485519|Dexmedetomidine|dexmedetomidine|mesh-list
65241072|NCT05485519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65241073|NCT05485519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65241074|NCT05485519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241075|NCT05485519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65241076|NCT05485519|Analgesics|analgesics|mesh-ancestor
65241077|NCT05485519|Sensory System Agents|sensory system agents|mesh-ancestor
65241078|NCT05485519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65241079|NCT05485519|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64883853|NCT01941888|Midazolam|midazolam|mesh-list
65241080|NCT05485519|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65241081|NCT05485519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65241082|NCT05485519|Adrenergic Agents|adrenergic agents|mesh-ancestor
65241083|NCT05485519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65241091|NCT05485519|Anesthetics|anesthetics|mesh-ancestor
65419768|NCT03996564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65419769|NCT03996564|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65419770|NCT03996564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65419771|NCT03996564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65419772|NCT03996564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65419773|NCT03996564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65419774|NCT03996564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65419775|NCT03996564|Anesthetics, General|anesthetics, general|mesh-ancestor
65419776|NCT03996564|Anesthetics|anesthetics|mesh-ancestor
65419777|NCT03996564|GABA Modulators|gaba modulators|mesh-ancestor
65419778|NCT03996564|GABA Agents|gaba agents|mesh-ancestor
65419779|NCT03996564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65419780|NCT00565409|Etanercept|etanercept|mesh-list
65419781|NCT00565409|Methotrexate|methotrexate|mesh-list
65419782|NCT00565409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65419783|NCT00565409|Abortifacient Agents|abortifacient agents|mesh-ancestor
65419784|NCT00565409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65419785|NCT00565409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419789|NCT00565409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419791|NCT00565409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419792|NCT00565409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65419793|NCT00565409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65419794|NCT00565409|Immunologic Factors|immunologic factors|mesh-ancestor
65419795|NCT00565409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65419796|NCT00565409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65419797|NCT00565409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65419798|NCT00565409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65419799|NCT00565409|Analgesics|analgesics|mesh-ancestor
65419800|NCT00565409|Sensory System Agents|sensory system agents|mesh-ancestor
65419801|NCT00565409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65419802|NCT00565409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65241138|NCT05436418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241139|NCT05436418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241140|NCT05436418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65241141|NCT05436418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65241142|NCT05436418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65241143|NCT05436418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65241144|NCT05436418|Antifungal Agents|antifungal agents|mesh-ancestor
65241145|NCT05411744|Vitamin B 6|vitamin b 6|mesh-list
65241146|NCT05411744|Pyridoxal|pyridoxal|mesh-list
65241147|NCT05411744|Pyridoxine|pyridoxine|mesh-list
65241148|NCT05411744|Isoniazid|isoniazid|mesh-list
65241149|NCT05411744|Rifapentine|rifapentine|mesh-list
65241150|NCT05411744|Vitamins|vitamins|mesh-ancestor
65241151|NCT05411744|Micronutrients|micronutrients|mesh-ancestor
65241152|NCT05411744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241153|NCT05411744|Vitamin B Complex|vitamin b complex|mesh-ancestor
65241154|NCT05411744|Antitubercular Agents|antitubercular agents|mesh-ancestor
65241155|NCT05411744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65241156|NCT05411744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65241157|NCT05411744|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65241158|NCT05411744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65241159|NCT05411744|Antimetabolites|antimetabolites|mesh-ancestor
65241160|NCT05411744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241161|NCT05411744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65241162|NCT05411744|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65241163|NCT05411744|Leprostatic Agents|leprostatic agents|mesh-ancestor
65241169|NCT05400603|Zoledronic Acid|zoledronic acid|mesh-list
65241170|NCT05400603|Irinotecan|irinotecan|mesh-list
65241171|NCT05400603|Temozolomide|temozolomide|mesh-list
65241172|NCT05400603|Dinutuximab|dinutuximab|mesh-list
65241173|NCT05400603|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65241174|NCT05400603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65241175|NCT05400603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241176|NCT05400603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241177|NCT05400603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241178|NCT05400603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65241179|NCT05400603|Alkylating Agents|alkylating agents|mesh-ancestor
65419803|NCT00565409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65419804|NCT00394251|Paclitaxel|paclitaxel|mesh-list
65419805|NCT00394251|Cyclophosphamide|cyclophosphamide|mesh-list
65241216|NCT05378113|Lidocaine|lidocaine|mesh-list
65419806|NCT00394251|Bevacizumab|bevacizumab|mesh-list
65419807|NCT00394251|Doxorubicin|doxorubicin|mesh-list
65419808|NCT00394251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65419809|NCT00394251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65419810|NCT00394251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65419811|NCT00394251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419812|NCT00394251|Tubulin Modulators|tubulin modulators|mesh-ancestor
65419813|NCT00394251|Antimitotic Agents|antimitotic agents|mesh-ancestor
65419814|NCT00394251|Mitosis Modulators|mitosis modulators|mesh-ancestor
65419815|NCT00394251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419816|NCT00394251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65419817|NCT00394251|Immunologic Factors|immunologic factors|mesh-ancestor
65419818|NCT00394251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419819|NCT00394251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65419820|NCT00394251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65419821|NCT00394251|Alkylating Agents|alkylating agents|mesh-ancestor
65419822|NCT00394251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65419823|NCT00394251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65419824|NCT00394251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65419825|NCT00394251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65419826|NCT00394251|Growth Substances|growth substances|mesh-ancestor
65419827|NCT00394251|Growth Inhibitors|growth inhibitors|mesh-ancestor
65419828|NCT00394251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65419829|NCT00394251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65419830|NCT00394251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65419831|NCT00394251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419832|NCT02532400|Goserelin|goserelin|mesh-list
65419833|NCT02532400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65419834|NCT02532400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419835|NCT00394095|Topiramate|topiramate|mesh-list
65419836|NCT00394095|Anticonvulsants|anticonvulsants|mesh-ancestor
65419837|NCT00394095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65419838|NCT00394095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419839|NCT00503906|Gemcitabine|gemcitabine|mesh-list
65419840|NCT00503906|Paclitaxel|paclitaxel|mesh-list
65419841|NCT00503906|Bevacizumab|bevacizumab|mesh-list
65419842|NCT00503906|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65419843|NCT00503906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65419844|NCT00503906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419845|NCT00503906|Tubulin Modulators|tubulin modulators|mesh-ancestor
65419846|NCT00503906|Antimitotic Agents|antimitotic agents|mesh-ancestor
65419847|NCT00503906|Mitosis Modulators|mitosis modulators|mesh-ancestor
65419848|NCT00503906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419849|NCT00503906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65419850|NCT00503906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65419851|NCT00503906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65419852|NCT00503906|Growth Substances|growth substances|mesh-ancestor
65419853|NCT00503906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419854|NCT00503906|Growth Inhibitors|growth inhibitors|mesh-ancestor
65419855|NCT00503906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65419856|NCT00503906|Antimetabolites|antimetabolites|mesh-ancestor
65419865|NCT00305110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65419866|NCT00305110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419867|NCT00305110|Analgesics|analgesics|mesh-ancestor
65419868|NCT00305110|Sensory System Agents|sensory system agents|mesh-ancestor
65419869|NCT00305110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65419870|NCT03984760|Sevelamer|sevelamer|mesh-list
65419871|NCT03984760|Chelating Agents|chelating agents|mesh-ancestor
65419872|NCT03984760|Sequestering Agents|sequestering agents|mesh-ancestor
65419873|NCT03984760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419874|NCT00491894|Glycopyrrolate|glycopyrrolate|mesh-list
65419875|NCT00491894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65419876|NCT00491894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65419877|NCT00491894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65419878|NCT00491894|Cholinergic Agents|cholinergic agents|mesh-ancestor
65419879|NCT00491894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65419880|NCT00491894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419881|NCT00491894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419882|NCT01060618|Maraviroc|maraviroc|mesh-list
65419883|NCT01060618|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65419884|NCT01060618|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65419885|NCT01060618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419886|NCT01060618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65269963|NCT02799134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269964|NCT02799134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65269965|NCT02799134|Antiemetics|antiemetics|mesh-ancestor
65269966|NCT02799134|Autonomic Agents|autonomic agents|mesh-ancestor
65269967|NCT02799134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65269968|NCT02799134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65269969|NCT02799134|Glucocorticoids|glucocorticoids|mesh-ancestor
65269970|NCT02799134|Hormones|hormones|mesh-ancestor
65241292|NCT05364944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241293|NCT05359627|Polymyxins|polymyxins|mesh-list
65241294|NCT05359627|Polymyxin B|polymyxin b|mesh-list
65241295|NCT05359627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65241296|NCT05359627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65241304|NCT05319730|Paclitaxel|paclitaxel|mesh-list
65241305|NCT05319730|Pembrolizumab|pembrolizumab|mesh-list
65419887|NCT01060618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65419888|NCT01060618|Antiviral Agents|antiviral agents|mesh-ancestor
65419889|NCT01060618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65419890|NCT01060618|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65419891|NCT00491504|Mometasone Furoate|mometasone furoate|mesh-list
65419892|NCT00491504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65419893|NCT00491504|Dermatologic Agents|dermatologic agents|mesh-ancestor
65419894|NCT00491504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65419895|NCT00500292|Leucovorin|leucovorin|mesh-list
65419896|NCT00500292|Folic Acid|folic acid|mesh-list
65419897|NCT00500292|Fluorouracil|fluorouracil|mesh-list
65419898|NCT00500292|Oxaliplatin|oxaliplatin|mesh-list
65419899|NCT00500292|Levoleucovorin|levoleucovorin|mesh-list
65419900|NCT00500292|Antimetabolites|antimetabolites|mesh-ancestor
65419901|NCT00500292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419902|NCT00500292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65419903|NCT00500292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419904|NCT00500292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65419905|NCT00500292|Immunologic Factors|immunologic factors|mesh-ancestor
65419906|NCT00500292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419907|NCT00500292|Antidotes|antidotes|mesh-ancestor
65419908|NCT00500292|Protective Agents|protective agents|mesh-ancestor
65419909|NCT00500292|Vitamin B Complex|vitamin b complex|mesh-ancestor
65419910|NCT00500292|Vitamins|vitamins|mesh-ancestor
65419911|NCT00500292|Micronutrients|micronutrients|mesh-ancestor
65419912|NCT00500292|Hematinics|hematinics|mesh-ancestor
65419913|NCT01013558|Remifentanil|remifentanil|mesh-list
65419914|NCT01013558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65419915|NCT01013558|Narcotics|narcotics|mesh-ancestor
65419916|NCT01013558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65419917|NCT01013558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419918|NCT01013558|Analgesics|analgesics|mesh-ancestor
65419919|NCT01013558|Sensory System Agents|sensory system agents|mesh-ancestor
65419920|NCT01013558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65419921|NCT00499746|Tramadol|tramadol|mesh-list
65419922|NCT00499746|Hydromorphone|hydromorphone|mesh-list
65419923|NCT00499746|Methylphenidate|methylphenidate|mesh-list
65419924|NCT00499746|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65419925|NCT00499746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419926|NCT00499746|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64804676|NCT01416220|Lithium Carbonate|lithium carbonate|mesh-list
65419935|NCT00499746|Analgesics|analgesics|mesh-ancestor
65419936|NCT00499746|Sensory System Agents|sensory system agents|mesh-ancestor
65419937|NCT00499746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65419938|NCT01010516|Niacin|niacin|mesh-list
65419939|NCT01010516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65419940|NCT01010516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65419941|NCT01010516|Fenofibrate|fenofibrate|mesh-list
65419942|NCT01010516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65419943|NCT01010516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65419944|NCT01010516|Antimetabolites|antimetabolites|mesh-ancestor
65419945|NCT01010516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419946|NCT01010516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65419947|NCT01010516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419948|NCT01010516|Vasodilator Agents|vasodilator agents|mesh-ancestor
65419949|NCT01010516|Vitamin B Complex|vitamin b complex|mesh-ancestor
65419950|NCT01010516|Vitamins|vitamins|mesh-ancestor
65419951|NCT01010516|Micronutrients|micronutrients|mesh-ancestor
65419952|NCT01010516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419953|NCT01020162|Gabapentin|gabapentin|mesh-list
65419954|NCT01020162|Amitriptyline|amitriptyline|mesh-list
65419955|NCT01020162|Analgesics|analgesics|mesh-ancestor
65419956|NCT01020162|Sensory System Agents|sensory system agents|mesh-ancestor
65419957|NCT01020162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65419958|NCT01020162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419959|NCT01020162|Anticonvulsants|anticonvulsants|mesh-ancestor
65419960|NCT01020162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65419961|NCT01020162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65419962|NCT01020162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65419963|NCT01020162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65419964|NCT01020162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65419965|NCT01020162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65419966|NCT01020162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65419967|NCT01020162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419968|NCT01020162|Antimanic Agents|antimanic agents|mesh-ancestor
65419969|NCT01020162|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65419970|NCT01020162|Antidepressive Agents|antidepressive agents|mesh-ancestor
65419971|NCT01020162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65419972|NCT01020162|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65419973|NCT01020162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65419974|NCT01020162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65419975|NCT01020162|Adrenergic Agents|adrenergic agents|mesh-ancestor
65419976|NCT01016886|Bisoprolol|bisoprolol|mesh-list
65419977|NCT01016886|Perindopril|perindopril|mesh-list
65419978|NCT01016886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65419979|NCT01016886|Sympatholytics|sympatholytics|mesh-ancestor
65419980|NCT01016886|Autonomic Agents|autonomic agents|mesh-ancestor
65419981|NCT01016886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65419982|NCT01016886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419983|NCT01016886|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65419984|NCT01016886|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65419985|NCT01016886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65419986|NCT01016886|Adrenergic Agents|adrenergic agents|mesh-ancestor
65419987|NCT01016886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65419988|NCT01016886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419989|NCT01016886|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65419990|NCT01016886|Protease Inhibitors|protease inhibitors|mesh-ancestor
65419991|NCT01016886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419992|NCT00499590|Ranibizumab|ranibizumab|mesh-list
65420002|NCT00510146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65420003|NCT00510146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420004|NCT00510146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65420005|NCT00510146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65420006|NCT00510146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65420007|NCT00510146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65420008|NCT00510146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65420009|NCT00510146|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65420010|NCT00510146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65420011|NCT00510146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65420012|NCT00510146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420013|NCT00510146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65420014|NCT00510146|Serotonin Agents|serotonin agents|mesh-ancestor
65420016|NCT04250064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65420017|NCT04250064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420018|NCT04250064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65420019|NCT04250064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65420020|NCT04250064|Growth Substances|growth substances|mesh-ancestor
65420021|NCT04250064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420022|NCT04250064|Growth Inhibitors|growth inhibitors|mesh-ancestor
65420023|NCT00480636|Dalteparin|dalteparin|mesh-list
65420024|NCT00480636|Tinzaparin|tinzaparin|mesh-list
65420025|NCT00480636|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65420026|NCT00480636|Anticoagulants|anticoagulants|mesh-ancestor
65420027|NCT00480636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65420028|NCT00480636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65274216|NCT01773083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420029|NCT00480636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420030|NCT01017198|Antacids|antacids|mesh-list
65420031|NCT01017198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420032|NCT01017198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65420033|NCT00499122|Cyclophosphamide|cyclophosphamide|mesh-list
65420034|NCT00499122|Docetaxel|docetaxel|mesh-list
65420035|NCT00499122|Doxorubicin|doxorubicin|mesh-list
65420036|NCT00499122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65420037|NCT00499122|Immunologic Factors|immunologic factors|mesh-ancestor
65420038|NCT00499122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420039|NCT00499122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65420040|NCT00499122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65420041|NCT00499122|Alkylating Agents|alkylating agents|mesh-ancestor
65420042|NCT00499122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420043|NCT00499122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420044|NCT00499122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65420045|NCT00499122|Tubulin Modulators|tubulin modulators|mesh-ancestor
65420046|NCT00499122|Antimitotic Agents|antimitotic agents|mesh-ancestor
65420047|NCT00499122|Mitosis Modulators|mitosis modulators|mesh-ancestor
65420048|NCT00499122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65420049|NCT00499122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65420050|NCT00499122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65420051|NCT00499122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420052|NCT00393939|Docetaxel|docetaxel|mesh-list
65420053|NCT00393939|Sunitinib|sunitinib|mesh-list
65420054|NCT00393939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420055|NCT00393939|Tubulin Modulators|tubulin modulators|mesh-ancestor
65420056|NCT00393939|Antimitotic Agents|antimitotic agents|mesh-ancestor
65420057|NCT00393939|Mitosis Modulators|mitosis modulators|mesh-ancestor
65420058|NCT00393939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420107|NCT00488592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420108|NCT00488592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65420110|NCT00488514|Sumatriptan|sumatriptan|mesh-list
65420111|NCT00488514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65420112|NCT00488514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65420113|NCT00488514|Analgesics|analgesics|mesh-ancestor
65420114|NCT00488514|Sensory System Agents|sensory system agents|mesh-ancestor
65420115|NCT00488514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65420116|NCT00488514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420117|NCT00488514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65420118|NCT00488514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65420119|NCT00488514|Gout Suppressants|gout suppressants|mesh-ancestor
65420120|NCT00488514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65420121|NCT00488514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420122|NCT00488514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420123|NCT00488514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65420124|NCT00488514|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65420125|NCT00488514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65420126|NCT00488514|Serotonin Agents|serotonin agents|mesh-ancestor
65420127|NCT00488514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65420128|NCT00320710|Zoledronic Acid|zoledronic acid|mesh-list
65420129|NCT00320710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65420130|NCT00320710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420131|NCT00320398|PENTA|penta|mesh-list
65420132|NCT00320398|Fondaparinux|fondaparinux|mesh-list
65420133|NCT00320398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65420134|NCT00320398|Antithrombins|antithrombins|mesh-ancestor
65420135|NCT00320398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65420136|NCT00320398|Protease Inhibitors|protease inhibitors|mesh-ancestor
65420137|NCT00320398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420138|NCT00320398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420139|NCT00320398|Anticoagulants|anticoagulants|mesh-ancestor
65420140|NCT00320398|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65420141|NCT00320398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65420142|NCT00498186|Rotigotine|rotigotine|mesh-list
65420143|NCT00498186|Dopamine Agonists|dopamine agonists|mesh-ancestor
65420144|NCT00498186|Dopamine Agents|dopamine agents|mesh-ancestor
65420145|NCT00498186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65420146|NCT00498186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420147|NCT00498186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420148|NCT03984526|Atropine|atropine|mesh-list
65420149|NCT03984526|Ephedrine|ephedrine|mesh-list
65420150|NCT03984526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65241516|NCT05051527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241517|NCT05051527|Protective Agents|protective agents|mesh-ancestor
65241518|NCT05051527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241519|NCT05041062|Nivolumab|nivolumab|mesh-list
65241520|NCT05041062|Ipilimumab|ipilimumab|mesh-list
65241521|NCT05041062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65241522|NCT05041062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241523|NCT05041062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65241524|NCT05041062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241525|NCT05013229|Insulin|insulin|mesh-list
65241526|NCT05013229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65241527|NCT05013229|Insulin Glargine|insulin glargine|mesh-list
65241528|NCT05013229|Insulin Aspart|insulin aspart|mesh-list
65241529|NCT05013229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65420151|NCT03984526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65420152|NCT03984526|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65420153|NCT03984526|Autonomic Agents|autonomic agents|mesh-ancestor
65420154|NCT03984526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65420155|NCT03984526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420156|NCT03984526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65420157|NCT03984526|Respiratory System Agents|respiratory system agents|mesh-ancestor
65420158|NCT03984526|Mydriatics|mydriatics|mesh-ancestor
65420159|NCT03984526|Parasympatholytics|parasympatholytics|mesh-ancestor
65420160|NCT03984526|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65420171|NCT01017666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65420172|NCT01017666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65420173|NCT01017666|Purinergic Agents|purinergic agents|mesh-ancestor
65420174|NCT01017666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65420175|NCT01017666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420176|NCT01017666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420177|NCT01017744|Anesthetics|anesthetics|mesh-list
65420178|NCT01017744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65420179|NCT01017744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420180|NCT00477594|Mipomersen|mipomersen|mesh-list
65420181|NCT00477594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65420182|NCT00477594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65420183|NCT00477594|Antimetabolites|antimetabolites|mesh-ancestor
65420184|NCT00477594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420185|NCT00477594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65420186|NCT00304954|Sirolimus|sirolimus|mesh-list
65420187|NCT00304954|Infliximab|infliximab|mesh-list
65420188|NCT00304954|Daclizumab|daclizumab|mesh-list
65420189|NCT00304954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65420190|NCT00304954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65420191|NCT00304954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65420192|NCT00304954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420193|NCT00304954|Antifungal Agents|antifungal agents|mesh-ancestor
65420194|NCT00304954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65420195|NCT00304954|Immunologic Factors|immunologic factors|mesh-ancestor
65420196|NCT00304954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420197|NCT00304954|Dermatologic Agents|dermatologic agents|mesh-ancestor
65420198|NCT00304954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65420199|NCT00304954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65420200|NCT00475176|Ribavirin|ribavirin|mesh-list
65420201|NCT00475176|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65420202|NCT00475176|Antimetabolites|antimetabolites|mesh-ancestor
65420203|NCT00475176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420204|NCT00475176|Antiviral Agents|antiviral agents|mesh-ancestor
65420205|NCT00475176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65420206|NCT00393705|Insulin|insulin|mesh-list
65420207|NCT00393705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65420208|NCT00393705|Insulin Lispro|insulin lispro|mesh-list
65241591|NCT04908956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241592|NCT04908956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241593|NCT04907721|Glucagon|glucagon|mesh-list
65241594|NCT04907721|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65241595|NCT04907721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65241596|NCT04907721|Hormones|hormones|mesh-ancestor
65241597|NCT04907721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65241598|NCT04907721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241599|NCT04907721|Incretins|incretins|mesh-ancestor
65241600|NCT04902885|Carboplatin|carboplatin|mesh-list
65420209|NCT00393705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65420210|NCT00393705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420211|NCT00303628|Leucovorin|leucovorin|mesh-list
65420212|NCT00303628|Bevacizumab|bevacizumab|mesh-list
65420213|NCT00303628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65420214|NCT00303628|Fluorouracil|fluorouracil|mesh-list
65169714|NCT05392127|Midazolam|midazolam|mesh-list
65420215|NCT00303628|Oxaliplatin|oxaliplatin|mesh-list
65420216|NCT00303628|Antibodies|antibodies|mesh-list
65420217|NCT00303628|Immunoglobulins|immunoglobulins|mesh-list
65420218|NCT00303628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65420219|NCT00303628|Levoleucovorin|levoleucovorin|mesh-list
65420220|NCT00303628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420221|NCT00303628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65420222|NCT00303628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64804980|NCT01418131|Tacrolimus|tacrolimus|mesh-list
65420230|NCT00303628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65420231|NCT00303628|Antidotes|antidotes|mesh-ancestor
65420232|NCT00303628|Protective Agents|protective agents|mesh-ancestor
65420233|NCT00303628|Vitamin B Complex|vitamin b complex|mesh-ancestor
65420234|NCT00303628|Vitamins|vitamins|mesh-ancestor
65420235|NCT00303628|Micronutrients|micronutrients|mesh-ancestor
65420236|NCT00414453|Lidocaine|lidocaine|mesh-list
65420237|NCT00414453|Oxycodone|oxycodone|mesh-list
65420238|NCT00414453|Anesthetics, Local|anesthetics, local|mesh-ancestor
65420239|NCT00414453|Anesthetics|anesthetics|mesh-ancestor
65420240|NCT00414453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65420241|NCT00414453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420242|NCT00414453|Sensory System Agents|sensory system agents|mesh-ancestor
65420243|NCT00414453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65420244|NCT00414453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65420245|NCT00414453|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65420246|NCT00414453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65420247|NCT00414453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65420248|NCT00414453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420249|NCT00414453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65420250|NCT00414453|Narcotics|narcotics|mesh-ancestor
65420251|NCT00414453|Analgesics|analgesics|mesh-ancestor
65420252|NCT01037595|Turmeric extract|turmeric extract|mesh-list
65420253|NCT01037595|Antioxidants|antioxidants|mesh-ancestor
65420254|NCT01037595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420255|NCT01037595|Protective Agents|protective agents|mesh-ancestor
65420256|NCT01037595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420257|NCT01041027|Paclitaxel|paclitaxel|mesh-list
65420258|NCT01041027|Carboplatin|carboplatin|mesh-list
65420259|NCT01041027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65420260|NCT01041027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420261|NCT01041027|Tubulin Modulators|tubulin modulators|mesh-ancestor
65420262|NCT01041027|Antimitotic Agents|antimitotic agents|mesh-ancestor
65420263|NCT01041027|Mitosis Modulators|mitosis modulators|mesh-ancestor
65420264|NCT01041027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420265|NCT00332488|Insulin|insulin|mesh-list
65420266|NCT00332488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65420267|NCT00332488|Metformin|metformin|mesh-list
65420268|NCT00332488|Secretagogues|secretagogues|mesh-list
65420269|NCT00332488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65420270|NCT00332488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420271|NCT00332332|Etanercept|etanercept|mesh-list
65420272|NCT00332332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65420273|NCT00332332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65420274|NCT00332332|Analgesics|analgesics|mesh-ancestor
65420275|NCT00332332|Sensory System Agents|sensory system agents|mesh-ancestor
65420276|NCT00332332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65420277|NCT00332332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420278|NCT00332332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65420279|NCT00332332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65420280|NCT00332332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65420281|NCT00332332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65420282|NCT00332332|Immunologic Factors|immunologic factors|mesh-ancestor
65420283|NCT00392925|Pramlintide|pramlintide|mesh-list
65420284|NCT00392925|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
65420285|NCT00392925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65420286|NCT00392925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420287|NCT00392925|Appetite Depressants|appetite depressants|mesh-ancestor
65420288|NCT00392925|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65420289|NCT00392925|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
65066889|NCT00307944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420290|NCT00392925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420311|NCT01041183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420312|NCT01041183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65420313|NCT01041183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65420314|NCT01041183|Serotonin Agents|serotonin agents|mesh-ancestor
65420315|NCT01041183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65420316|NCT01041183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420318|NCT00319696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65420319|NCT00319696|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65420320|NCT00319696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420321|NCT00474630|Naltrexone|naltrexone|mesh-list
65420322|NCT00474630|Bupropion|bupropion|mesh-list
65420323|NCT00474630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65420324|NCT00474630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65420325|NCT00474630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420326|NCT00474630|Sensory System Agents|sensory system agents|mesh-ancestor
65420327|NCT00474630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65420328|NCT00474630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65420329|NCT00474630|Antidepressive Agents|antidepressive agents|mesh-ancestor
65420330|NCT00474630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65420331|NCT00474630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65420332|NCT00474630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65420333|NCT00474630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65420334|NCT00474630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420335|NCT00474630|Dopamine Agents|dopamine agents|mesh-ancestor
65420336|NCT00474630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65420337|NCT00474630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65420338|NCT00474630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65420339|NCT00474630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420340|NCT01064752|Minocycline|minocycline|mesh-list
65420341|NCT01064752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65420342|NCT01064752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65420343|NCT00392379|Nicotine|nicotine|mesh-list
65420344|NCT00392379|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65420345|NCT00392379|Autonomic Agents|autonomic agents|mesh-ancestor
65420346|NCT00392379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65420355|NCT01038063|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65420356|NCT01038063|Antimalarials|antimalarials|mesh-ancestor
65420357|NCT01038063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65420358|NCT01038063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65420359|NCT01038063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65420360|NCT01043991|Darbepoetin alfa|darbepoetin alfa|mesh-list
65420361|NCT01043991|Hematinics|hematinics|mesh-ancestor
65420362|NCT01020630|Sunitinib|sunitinib|mesh-list
65420363|NCT01020630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420364|NCT01020630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65420365|NCT01020630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65420366|NCT01020630|Growth Substances|growth substances|mesh-ancestor
65420367|NCT01020630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420368|NCT01020630|Growth Inhibitors|growth inhibitors|mesh-ancestor
65420369|NCT01020630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65420370|NCT01020630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420371|NCT01020630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420373|NCT00403455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65241744|NCT04796194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65241745|NCT04796194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241746|NCT04777357|Cariprazine|cariprazine|mesh-list
65241747|NCT04777357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65241748|NCT04777357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65241749|NCT04777357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65241750|NCT04777357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241752|NCT04763759|Antibodies|antibodies|mesh-list
65420374|NCT00403455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65420375|NCT00403455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65420376|NCT00403455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420377|NCT00403455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65420378|NCT00403455|Serotonin Agents|serotonin agents|mesh-ancestor
65420379|NCT00403455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420380|NCT00403455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65420381|NCT00403455|Antidepressive Agents|antidepressive agents|mesh-ancestor
65420382|NCT00403455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65420383|NCT00403455|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65420384|NCT00403455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65420385|NCT00403455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420386|NCT00318370|Farletuzumab|farletuzumab|mesh-list
65420387|NCT00318370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420388|NCT00510068|Everolimus|everolimus|mesh-list
65420389|NCT00510068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420390|NCT00510068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65420391|NCT00510068|Immunologic Factors|immunologic factors|mesh-ancestor
65420392|NCT00510068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420393|NCT00509600|Etanercept|etanercept|mesh-list
65420394|NCT00509600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65420395|NCT00509600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65420396|NCT00509600|Analgesics|analgesics|mesh-ancestor
65420397|NCT00509600|Sensory System Agents|sensory system agents|mesh-ancestor
65420398|NCT00509600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65420399|NCT00509600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420400|NCT00509600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65420401|NCT00509600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65420402|NCT00509600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65420403|NCT00509600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65420404|NCT00509600|Immunologic Factors|immunologic factors|mesh-ancestor
65420405|NCT01014104|Methylprednisolone|methylprednisolone|mesh-list
65420406|NCT01014104|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65420407|NCT01014104|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65420408|NCT01014104|Prednisolone|prednisolone|mesh-list
65420409|NCT01014104|Prednisolone acetate|prednisolone acetate|mesh-list
65420410|NCT01014104|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65420411|NCT01014104|Prednisolone phosphate|prednisolone phosphate|mesh-list
65420412|NCT01014104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65420413|NCT01014104|Antiemetics|antiemetics|mesh-ancestor
65420414|NCT01014104|Autonomic Agents|autonomic agents|mesh-ancestor
65420422|NCT01014104|Protective Agents|protective agents|mesh-ancestor
65420423|NCT01014104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65420424|NCT01014104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420425|NCT00402987|Celecoxib|celecoxib|mesh-list
65420426|NCT00402987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65420427|NCT00402987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65420428|NCT00402987|Analgesics|analgesics|mesh-ancestor
65420429|NCT00402987|Sensory System Agents|sensory system agents|mesh-ancestor
65420430|NCT00402987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65420431|NCT00402987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420432|NCT00402987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65420433|NCT00402987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65420434|NCT00402987|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65420435|NCT00402987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65420436|NCT00402987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420437|NCT00402987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420438|NCT01015664|Sirolimus|sirolimus|mesh-list
65420439|NCT01015664|Cetuximab|cetuximab|mesh-list
65274217|NCT02354898|Sorafenib|sorafenib|mesh-list
65420440|NCT01015664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420441|NCT01015664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65420442|NCT01015664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65420443|NCT01015664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65420444|NCT01015664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65420445|NCT01015664|Antifungal Agents|antifungal agents|mesh-ancestor
65420446|NCT01015664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65420447|NCT01015664|Immunologic Factors|immunologic factors|mesh-ancestor
65420448|NCT01015664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420449|NCT00501644|Interferons|interferons|mesh-list
65420450|NCT00501644|Interferon-gamma|interferon-gamma|mesh-list
65420451|NCT00501644|Carboplatin|carboplatin|mesh-list
65420452|NCT00501644|Molgramostim|molgramostim|mesh-list
65420453|NCT00501644|Sargramostim|sargramostim|mesh-list
65420454|NCT00501644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420455|NCT00501644|Antiviral Agents|antiviral agents|mesh-ancestor
65420456|NCT00501644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65420457|NCT00501644|Immunologic Factors|immunologic factors|mesh-ancestor
65420458|NCT00501644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420459|NCT01014260|Doxycycline|doxycycline|mesh-list
65420460|NCT01014260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65420461|NCT01014260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65420462|NCT01014260|Antimalarials|antimalarials|mesh-ancestor
65420463|NCT01014260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65420464|NCT01014260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65420465|NCT01010672|Sirolimus|sirolimus|mesh-list
65420466|NCT01010672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65420467|NCT01010672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65420468|NCT01010672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65420469|NCT01010672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420470|NCT01010672|Antifungal Agents|antifungal agents|mesh-ancestor
65420471|NCT01010672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65420472|NCT01010672|Immunologic Factors|immunologic factors|mesh-ancestor
65420473|NCT01010672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420474|NCT01014338|Fosinopril|fosinopril|mesh-list
65420475|NCT01014338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65420476|NCT01014338|Protease Inhibitors|protease inhibitors|mesh-ancestor
65420477|NCT01014338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420478|NCT01014338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420479|NCT01014338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65420480|NCT01014416|Tolvaptan|tolvaptan|mesh-list
65420481|NCT01014416|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64805226|NCT01419405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65420488|NCT00497796|Antiviral Agents|antiviral agents|mesh-ancestor
65420489|NCT00497796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65420490|NCT00497796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65420491|NCT00497796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420492|NCT00497796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420493|NCT01017822|Gemcitabine|gemcitabine|mesh-list
65420494|NCT01017822|Capecitabine|capecitabine|mesh-list
65420495|NCT01017822|Conatumumab|conatumumab|mesh-list
65420496|NCT01017822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65420497|NCT01017822|Antimetabolites|antimetabolites|mesh-ancestor
65420498|NCT01017822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420499|NCT01017822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420500|NCT01017822|Antiviral Agents|antiviral agents|mesh-ancestor
65420501|NCT01017822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65420502|NCT01017822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420503|NCT01017822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65420504|NCT01017822|Immunologic Factors|immunologic factors|mesh-ancestor
65420505|NCT01017822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420506|NCT01017822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65420507|NCT00496782|Maraviroc|maraviroc|mesh-list
65420508|NCT00496782|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65420509|NCT00496782|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65420510|NCT00496782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420511|NCT00496782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65420512|NCT00496782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65420513|NCT00496782|Antiviral Agents|antiviral agents|mesh-ancestor
65420514|NCT00496782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65420515|NCT00496782|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65420516|NCT01020708|Acetylcysteine|acetylcysteine|mesh-list
65420517|NCT01020708|Aminosalicylic Acid|aminosalicylic acid|mesh-list
65420519|NCT01020708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65420520|NCT01020708|Antiviral Agents|antiviral agents|mesh-ancestor
65269971|NCT02799134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65269972|NCT02799134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65269973|NCT02799134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269974|NCT02720822|Morphine|morphine|mesh-list
65420521|NCT01020708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65420522|NCT01020708|Expectorants|expectorants|mesh-ancestor
65420523|NCT01020708|Respiratory System Agents|respiratory system agents|mesh-ancestor
65420524|NCT01020708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65420525|NCT01020708|Antioxidants|antioxidants|mesh-ancestor
65420526|NCT01020708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420527|NCT01020708|Protective Agents|protective agents|mesh-ancestor
65420528|NCT01020708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420529|NCT01020708|Antidotes|antidotes|mesh-ancestor
65420530|NCT01020708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65420531|NCT01020708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65420532|NCT01020708|Analgesics|analgesics|mesh-ancestor
65420533|NCT01020708|Sensory System Agents|sensory system agents|mesh-ancestor
65420534|NCT01020708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65420535|NCT01020708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65420536|NCT01020708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65420537|NCT01020708|Antitubercular Agents|antitubercular agents|mesh-ancestor
65420538|NCT01020708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65420539|NCT01020864|Carboplatin|carboplatin|mesh-list
65420540|NCT01020864|Cetuximab|cetuximab|mesh-list
65420541|NCT01020864|Vinorelbine|vinorelbine|mesh-list
65420542|NCT01020864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420543|NCT01020864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65420544|NCT01020864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65420545|NCT01020864|Tubulin Modulators|tubulin modulators|mesh-ancestor
65420546|NCT01020864|Antimitotic Agents|antimitotic agents|mesh-ancestor
65420547|NCT01020864|Mitosis Modulators|mitosis modulators|mesh-ancestor
65420548|NCT01020864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420549|NCT04428372|Mannitol|mannitol|mesh-list
65420550|NCT04428372|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65420551|NCT04428372|Diuretics|diuretics|mesh-ancestor
64805298|NCT01420302|Insulin|insulin|mesh-list
65420570|NCT00471276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65420572|NCT00471276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420573|NCT00471276|Growth Inhibitors|growth inhibitors|mesh-ancestor
65420574|NCT00471276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65420575|NCT00471276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420576|NCT00471276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420577|NCT00470262|Pioglitazone|pioglitazone|mesh-list
65420578|NCT00470262|Fenofibrate|fenofibrate|mesh-list
65420579|NCT00470262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65420580|NCT00470262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420581|NCT00470262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65420582|NCT00470262|Antimetabolites|antimetabolites|mesh-ancestor
65420583|NCT00470262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420584|NCT00470262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65420585|NCT04034862|Lamivudine|lamivudine|mesh-list
65420586|NCT04034862|Dolutegravir|dolutegravir|mesh-list
65420587|NCT04034862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65420588|NCT04034862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65420589|NCT04034862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170103|NCT00640159|Selegiline|selegiline|mesh-list
65420590|NCT04034862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420591|NCT04034862|Antiviral Agents|antiviral agents|mesh-ancestor
65420592|NCT04034862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65420593|NCT04034862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65420594|NCT04034862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65420595|NCT04034862|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65420596|NCT04034862|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65420598|NCT00496470|Bromides|bromides|mesh-list
65420599|NCT00496470|Formoterol Fumarate|formoterol fumarate|mesh-list
65420600|NCT00496470|Tiotropium Bromide|tiotropium bromide|mesh-list
65420601|NCT00496470|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65420602|NCT00496470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65420603|NCT00496470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65420604|NCT00496470|Autonomic Agents|autonomic agents|mesh-ancestor
65420605|NCT00496470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65241965|NCT04423718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65241966|NCT04423718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65241967|NCT04423718|Growth Substances|growth substances|mesh-ancestor
65241968|NCT04423718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241969|NCT04423718|Growth Inhibitors|growth inhibitors|mesh-ancestor
65241970|NCT04423718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241971|NCT04394546|Anticoagulants|anticoagulants|mesh-list
65241986|NCT04368559|Fluconazole|fluconazole|mesh-list
64884747|NCT04030429|Crizotinib|crizotinib|mesh-list
65241987|NCT04368559|Posaconazole|posaconazole|mesh-list
65241988|NCT04368559|Rezafungin|rezafungin|mesh-list
65241989|NCT04368559|Trimethoprim|trimethoprim|mesh-list
65241990|NCT04368559|Sulfamethoxazole|sulfamethoxazole|mesh-list
65241991|NCT04368559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65241992|NCT04368559|Antifungal Agents|antifungal agents|mesh-ancestor
65420606|NCT00496470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420607|NCT00496470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65420625|NCT01021176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65420626|NCT01021176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420627|NCT01021176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65420628|NCT01021176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420629|NCT01021176|Vasodilator Agents|vasodilator agents|mesh-ancestor
65420630|NCT01018368|Rifampin|rifampin|mesh-list
65420631|NCT01018368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65420632|NCT01018368|Antitubercular Agents|antitubercular agents|mesh-ancestor
65420633|NCT01018368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65420634|NCT01018368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65420635|NCT01018368|Leprostatic Agents|leprostatic agents|mesh-ancestor
65420636|NCT01018368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65420637|NCT01018368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420638|NCT01018368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420639|NCT01018368|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65420640|NCT01018368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65420641|NCT01018368|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65420642|NCT01018368|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65420643|NCT01018368|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65420644|NCT01018368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65420645|NCT00487578|Naratriptan|naratriptan|mesh-list
65420646|NCT00487578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65420647|NCT00487578|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65420648|NCT00487578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65420649|NCT00487578|Serotonin Agents|serotonin agents|mesh-ancestor
65420650|NCT00487578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65420651|NCT00487578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420652|NCT00487578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420653|NCT00495612|Omalizumab|omalizumab|mesh-list
65420654|NCT00495612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65420655|NCT00495612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65420656|NCT00495612|Respiratory System Agents|respiratory system agents|mesh-ancestor
65420657|NCT01021488|Enoxaparin|enoxaparin|mesh-list
65420658|NCT01021488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65420659|NCT01021488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65420660|NCT01021488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65420661|NCT01021488|Antimetabolites|antimetabolites|mesh-ancestor
64805418|NCT01420913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65420680|NCT00509366|Pemetrexed|pemetrexed|mesh-list
65420681|NCT00509366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420682|NCT00509366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65420683|NCT00509366|Antimetabolites|antimetabolites|mesh-ancestor
65242040|NCT04310007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65242041|NCT04310007|Antibodies|antibodies|mesh-list
65242042|NCT04310007|Immunoglobulins|immunoglobulins|mesh-list
65242043|NCT04310007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65242044|NCT04310007|Lexatumumab|lexatumumab|mesh-list
65242045|NCT04310007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65242046|NCT04310007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242047|NCT04310007|Tubulin Modulators|tubulin modulators|mesh-ancestor
65242048|NCT04310007|Antimitotic Agents|antimitotic agents|mesh-ancestor
65242049|NCT04310007|Mitosis Modulators|mitosis modulators|mesh-ancestor
65242050|NCT04310007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242051|NCT04310007|Immunologic Factors|immunologic factors|mesh-ancestor
65242052|NCT04310007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242053|NCT04310007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65242054|NCT04310007|Antimetabolites|antimetabolites|mesh-ancestor
65242055|NCT04310007|Antiviral Agents|antiviral agents|mesh-ancestor
65242056|NCT04310007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65242057|NCT04310007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65242058|NCT04310007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65242059|NCT04310007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65242060|NCT04270409|Dexamethasone|dexamethasone|mesh-list
65242061|NCT04270409|Lenalidomide|lenalidomide|mesh-list
65242062|NCT04270409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65420684|NCT00509366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420685|NCT00509366|Antiviral Agents|antiviral agents|mesh-ancestor
65420686|NCT00509366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65420687|NCT00509366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420688|NCT00509366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65420689|NCT00509366|Immunologic Factors|immunologic factors|mesh-ancestor
65420690|NCT00509366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420691|NCT00509366|Tubulin Modulators|tubulin modulators|mesh-ancestor
65420692|NCT00509366|Antimitotic Agents|antimitotic agents|mesh-ancestor
65420693|NCT00509366|Mitosis Modulators|mitosis modulators|mesh-ancestor
65420694|NCT00509366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65420695|NCT00509366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65420696|NCT01016054|Gemcitabine|gemcitabine|mesh-list
65420697|NCT01016054|Carboplatin|carboplatin|mesh-list
65420698|NCT01016054|Doxorubicin|doxorubicin|mesh-list
65420699|NCT01016054|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65420700|NCT01016054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420701|NCT01016054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65420702|NCT01016054|Antimetabolites|antimetabolites|mesh-ancestor
65420703|NCT01016054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420704|NCT01016054|Antiviral Agents|antiviral agents|mesh-ancestor
65420705|NCT01016054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65420706|NCT01016054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420707|NCT01016054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65420708|NCT01016054|Immunologic Factors|immunologic factors|mesh-ancestor
65420709|NCT01016054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420710|NCT01016054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65420711|NCT01016054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65420712|NCT01016054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65420713|NCT00500318|Bromides|bromides|mesh-list
65269975|NCT02720822|Laxatives|laxatives|mesh-list
65269976|NCT02720822|Cathartics|cathartics|mesh-list
65269977|NCT02720822|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65269978|NCT02720822|Narcotics|narcotics|mesh-ancestor
65269979|NCT02720822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65269980|NCT02720822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269981|NCT02720822|Analgesics|analgesics|mesh-ancestor
65269982|NCT02720822|Sensory System Agents|sensory system agents|mesh-ancestor
65269983|NCT02720822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65269984|NCT02720822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65269985|NCT02757872|Vitamin D|vitamin d|mesh-list
65269986|NCT02757872|Ergocalciferols|ergocalciferols|mesh-list
65269987|NCT02757872|Cholecalciferol|cholecalciferol|mesh-list
65269988|NCT02757872|Vitamins|vitamins|mesh-list
65269989|NCT02757872|Micronutrients|micronutrients|mesh-ancestor
65269990|NCT02757872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269991|NCT02757872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65269992|NCT02757872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65269993|NCT02746796|Capecitabine|capecitabine|mesh-list
65242117|NCT04233164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65242118|NCT04233164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65242119|NCT04233164|Protective Agents|protective agents|mesh-ancestor
65242120|NCT04233164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65242121|NCT04233164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420714|NCT00500318|Anticonvulsants|anticonvulsants|mesh-ancestor
65420715|NCT00499694|Bevacizumab|bevacizumab|mesh-list
65420716|NCT00499694|Satraplatin|satraplatin|mesh-list
65420717|NCT00499694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65420718|NCT00499694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420719|NCT00499694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65420744|NCT00494676|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65420745|NCT00494676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65420746|NCT00494676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65420747|NCT00494676|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65420748|NCT00486720|Vorinostat|vorinostat|mesh-list
65420749|NCT00486720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420750|NCT00486720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65420751|NCT00486720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420752|NCT00486720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420753|NCT00486330|Ritonavir|ritonavir|mesh-list
65420754|NCT00486330|Tipranavir|tipranavir|mesh-list
65420755|NCT00486330|Buprenorphine|buprenorphine|mesh-list
65420756|NCT00486330|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65420757|NCT00486330|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65420758|NCT00486330|Protease Inhibitors|protease inhibitors|mesh-ancestor
65420759|NCT00486330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420760|NCT00486330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420761|NCT00486330|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65420762|NCT00486330|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65420763|NCT00486330|Antiviral Agents|antiviral agents|mesh-ancestor
65420764|NCT00486330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65242202|NCT04101357|Carboplatin|carboplatin|mesh-list
65242203|NCT04101357|Etoposide|etoposide|mesh-list
65242204|NCT04101357|Atezolizumab|atezolizumab|mesh-list
65242205|NCT04101357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242206|NCT04101357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65242207|NCT04101357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65242208|NCT04101357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65242209|NCT04101357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65242210|NCT04101357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420765|NCT00486330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65420766|NCT00486330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65420767|NCT00486330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65420768|NCT00486330|Narcotics|narcotics|mesh-ancestor
64805541|NCT01421901|Ertapenem|ertapenem|mesh-list
65420778|NCT01021566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65420779|NCT01021566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420780|NCT01021566|Analgesics|analgesics|mesh-ancestor
65420781|NCT01021566|Sensory System Agents|sensory system agents|mesh-ancestor
65420782|NCT01021566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65420783|NCT01021566|Antitussive Agents|antitussive agents|mesh-ancestor
65420784|NCT01021566|Respiratory System Agents|respiratory system agents|mesh-ancestor
65420785|NCT00494442|Olaparib|olaparib|mesh-list
65420786|NCT00494442|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65420787|NCT00494442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420788|NCT00494442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420789|NCT00494442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420790|NCT00493974|Zileuton|zileuton|mesh-list
65420791|NCT00493974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65420792|NCT00493974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65420793|NCT00493974|Analgesics|analgesics|mesh-ancestor
65420794|NCT00493974|Sensory System Agents|sensory system agents|mesh-ancestor
65420795|NCT00493974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65420796|NCT00493974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420797|NCT00493974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65420798|NCT00493974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65420799|NCT00493974|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65420800|NCT00493974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420801|NCT00493974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420802|NCT00493974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65420803|NCT00493974|Hormone Antagonists|hormone antagonists|mesh-ancestor
65420804|NCT00493974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65420805|NCT01018446|Busulfan|busulfan|mesh-list
65420806|NCT01018446|Alkylating Agents|alkylating agents|mesh-ancestor
65420807|NCT01018446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420808|NCT01018446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65420809|NCT01018446|Immunologic Factors|immunologic factors|mesh-ancestor
65420810|NCT01018446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420811|NCT01018446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65420812|NCT01018446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420813|NCT01018446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65420814|NCT01018602|Vildagliptin|vildagliptin|mesh-list
65420815|NCT01018602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65420816|NCT01018602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420817|NCT01018602|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65420818|NCT01018602|Protease Inhibitors|protease inhibitors|mesh-ancestor
65420819|NCT01018602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420820|NCT01018602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420821|NCT01018758|Palonosetron|palonosetron|mesh-list
65420822|NCT01018758|Antiemetics|antiemetics|mesh-ancestor
65420823|NCT01018758|Autonomic Agents|autonomic agents|mesh-ancestor
65420824|NCT01018758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65420825|NCT01018758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420826|NCT01018758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65420827|NCT01018758|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65420828|NCT01018758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65420829|NCT01018758|Serotonin Agents|serotonin agents|mesh-ancestor
65420830|NCT01018758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65420831|NCT01018758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420832|NCT00469092|Insulin|insulin|mesh-list
65420833|NCT00469092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65420845|NCT00499616|Carboplatin|carboplatin|mesh-list
65420846|NCT00499616|Doxorubicin|doxorubicin|mesh-list
65420847|NCT00499616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65420848|NCT00499616|Etoposide|etoposide|mesh-list
65420849|NCT00499616|Topotecan|topotecan|mesh-list
65420850|NCT00499616|Isotretinoin|isotretinoin|mesh-list
65420851|NCT00499616|Lenograstim|lenograstim|mesh-list
65420852|NCT00499616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65420853|NCT00499616|Immunologic Factors|immunologic factors|mesh-ancestor
65420854|NCT00499616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420855|NCT00499616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65420856|NCT00499616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65420857|NCT00499616|Alkylating Agents|alkylating agents|mesh-ancestor
65420858|NCT00499616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420859|NCT00499616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420860|NCT00499616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65420861|NCT00499616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65420862|NCT00499616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65420863|NCT00499616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65420864|NCT00499616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420865|NCT00499616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65420866|NCT00499616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65420867|NCT00499616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65420868|NCT00499616|Dermatologic Agents|dermatologic agents|mesh-ancestor
65420869|NCT00402597|Rivaroxaban|rivaroxaban|mesh-list
65420870|NCT00402597|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65420871|NCT00402597|Antithrombins|antithrombins|mesh-ancestor
65420872|NCT00402597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65420873|NCT00402597|Protease Inhibitors|protease inhibitors|mesh-ancestor
65420874|NCT00402597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420875|NCT00402597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420876|NCT00402597|Anticoagulants|anticoagulants|mesh-ancestor
65420877|NCT00469014|Fludarabine|fludarabine|mesh-list
65420878|NCT00469014|Fludarabine phosphate|fludarabine phosphate|mesh-list
65420879|NCT00469014|Busulfan|busulfan|mesh-list
65420880|NCT00469014|Clofarabine|clofarabine|mesh-list
65420881|NCT00469014|Thymoglobulin|thymoglobulin|mesh-list
65420882|NCT00469014|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65420883|NCT00469014|Lenograstim|lenograstim|mesh-list
65420884|NCT00469014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420885|NCT00469014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65170394|NCT01196741|Saracatinib|saracatinib|mesh-list
65420886|NCT00469014|Antimetabolites|antimetabolites|mesh-ancestor
65420887|NCT00469014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420888|NCT00469014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65420889|NCT00469014|Immunologic Factors|immunologic factors|mesh-ancestor
65420890|NCT00469014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420891|NCT00469014|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65420892|NCT00469014|Alkylating Agents|alkylating agents|mesh-ancestor
65420893|NCT00469014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65420894|NCT00469014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65420895|NCT00493038|Amoxicillin|amoxicillin|mesh-list
65420896|NCT00493038|Moxifloxacin|moxifloxacin|mesh-list
65420897|NCT00493038|Clavulanic Acid|clavulanic acid|mesh-list
65420898|NCT00493038|Clavulanic Acids|clavulanic acids|mesh-list
65420899|NCT00493038|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65420900|NCT00493038|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65420932|NCT03747159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420934|NCT00413283|Carboplatin|carboplatin|mesh-list
65420935|NCT00413283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420936|NCT00413283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65420937|NCT00413283|Antimetabolites|antimetabolites|mesh-ancestor
65420938|NCT00413283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420939|NCT00413283|Antiviral Agents|antiviral agents|mesh-ancestor
65420940|NCT00413283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65420941|NCT00413283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420942|NCT00413283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65420969|NCT00401973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420970|NCT00401973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65420971|NCT00401973|Serotonin Agents|serotonin agents|mesh-ancestor
65420972|NCT00401973|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65420973|NCT00401973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65420974|NCT00401973|Antiviral Agents|antiviral agents|mesh-ancestor
65420975|NCT00401973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65420976|NCT00401973|Dopamine Agents|dopamine agents|mesh-ancestor
65420977|NCT00401973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65420978|NCT00401973|Analgesics|analgesics|mesh-ancestor
65420979|NCT00401973|Sensory System Agents|sensory system agents|mesh-ancestor
65420980|NCT00401973|Anticonvulsants|anticonvulsants|mesh-ancestor
65420981|NCT00401973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65420982|NCT00401973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65420983|NCT01038453|Vitamin D|vitamin d|mesh-list
65420984|NCT01038453|Cholecalciferol|cholecalciferol|mesh-list
65420985|NCT01038453|Vitamins|vitamins|mesh-ancestor
65420986|NCT01038453|Micronutrients|micronutrients|mesh-ancestor
65420987|NCT01038453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420988|NCT01038453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65420989|NCT01038453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65420990|NCT00401193|Tranexamic Acid|tranexamic acid|mesh-list
65420991|NCT00401193|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65420992|NCT00401193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64805760|NCT01422954|Mefloquine|mefloquine|mesh-list
65421021|NCT03732495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421022|NCT03732495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421023|NCT03732495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65421024|NCT03732495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421025|NCT01041729|Atorvastatin|atorvastatin|mesh-list
65421026|NCT01041729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65421027|NCT01041729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65421028|NCT01041729|Antimetabolites|antimetabolites|mesh-ancestor
65421029|NCT01041729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421030|NCT01041729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65421031|NCT01041729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65421032|NCT01041729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421033|NCT01324245|Fenoldopam|fenoldopam|mesh-list
65421034|NCT01324245|Enalaprilat|enalaprilat|mesh-list
65421035|NCT01324245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65421036|NCT01324245|Vasodilator Agents|vasodilator agents|mesh-ancestor
65421037|NCT01324245|Dopamine Agonists|dopamine agonists|mesh-ancestor
65421093|NCT00468312|Mometasone Furoate|mometasone furoate|mesh-list
65421094|NCT00468312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65421095|NCT00468312|Dermatologic Agents|dermatologic agents|mesh-ancestor
65421096|NCT00468312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65421097|NCT03980002|Thalidomide|thalidomide|mesh-list
65421098|NCT03980002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65421099|NCT03980002|Immunologic Factors|immunologic factors|mesh-ancestor
65421100|NCT03980002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421101|NCT03980002|Leprostatic Agents|leprostatic agents|mesh-ancestor
64805874|NCT01423500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421131|NCT00331552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65421132|NCT00331552|Antibodies|antibodies|mesh-list
65421133|NCT00331552|Immunoglobulins|immunoglobulins|mesh-list
65421134|NCT00331552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65421135|NCT00331552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65421136|NCT00331552|Immunologic Factors|immunologic factors|mesh-ancestor
65421137|NCT00331552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421138|NCT00331552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65421139|NCT00331552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65421140|NCT00331552|Alkylating Agents|alkylating agents|mesh-ancestor
65421141|NCT00331552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421142|NCT00331552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421143|NCT00331552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65421144|NCT00331552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65421145|NCT00331552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65421146|NCT00331552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65421164|NCT00302458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65421165|NCT00391053|Vaccines|vaccines|mesh-list
65421166|NCT00391053|Immunologic Factors|immunologic factors|mesh-ancestor
65421167|NCT00391053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421168|NCT00317044|Esomeprazole|esomeprazole|mesh-list
65421169|NCT00317044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65421170|NCT00317044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65421171|NCT00317044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65421172|NCT00317044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421173|NCT00317044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421174|NCT00301834|Cyclosporine|cyclosporine|mesh-list
65421175|NCT00301834|Methylprednisolone|methylprednisolone|mesh-list
65421176|NCT00301834|Methotrexate|methotrexate|mesh-list
65242431|NCT03834493|Pembrolizumab|pembrolizumab|mesh-list
65421177|NCT00301834|Fludarabine phosphate|fludarabine phosphate|mesh-list
65421178|NCT00301834|Fludarabine|fludarabine|mesh-list
65421179|NCT00301834|Busulfan|busulfan|mesh-list
65421180|NCT00301834|Alemtuzumab|alemtuzumab|mesh-list
65421181|NCT00301834|Cyclosporins|cyclosporins|mesh-list
65421182|NCT00301834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65421183|NCT00301834|Abortifacient Agents|abortifacient agents|mesh-ancestor
65421184|NCT00301834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65421185|NCT00301834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421186|NCT00301834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65421187|NCT00301834|Antimetabolites|antimetabolites|mesh-ancestor
65421188|NCT00301834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421189|NCT00301834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421190|NCT00301834|Dermatologic Agents|dermatologic agents|mesh-ancestor
65421191|NCT00301834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421192|NCT00301834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65421193|NCT00301834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65421194|NCT00301834|Immunologic Factors|immunologic factors|mesh-ancestor
65421195|NCT00301834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65421196|NCT00301834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65421197|NCT00301834|Antifungal Agents|antifungal agents|mesh-ancestor
65421198|NCT00301834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65421199|NCT00301834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65421200|NCT00301834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65421201|NCT00301834|Antiemetics|antiemetics|mesh-ancestor
65421202|NCT00301834|Autonomic Agents|autonomic agents|mesh-ancestor
65421203|NCT00301834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65421229|NCT00466440|Hormones|hormones|mesh-ancestor
65421230|NCT00466440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65421231|NCT00466440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421232|NCT00466440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65421233|NCT00465972|Doxepin|doxepin|mesh-list
65421234|NCT00465972|Temazepam|temazepam|mesh-list
65421235|NCT00465972|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65421236|NCT00465972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65421237|NCT00465972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65421238|NCT00465972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421239|NCT00465972|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65421240|NCT00465972|Antidepressive Agents|antidepressive agents|mesh-ancestor
65421241|NCT00465972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65421242|NCT00465972|Histamine Antagonists|histamine antagonists|mesh-ancestor
65421243|NCT00465972|Histamine Agents|histamine agents|mesh-ancestor
65421244|NCT00465972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65421245|NCT00465972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421246|NCT00465972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65421247|NCT00465972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65421248|NCT00465972|GABA Modulators|gaba modulators|mesh-ancestor
65421249|NCT00465972|GABA Agents|gaba agents|mesh-ancestor
65421250|NCT03926754|Mirabegron|mirabegron|mesh-list
65421251|NCT03926754|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64806013|NCT01424332|Aspirin|aspirin|mesh-list
65421263|NCT00465894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65421264|NCT00465894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421265|NCT00465894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65421266|NCT00465894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65421267|NCT00465894|Cholinergic Agents|cholinergic agents|mesh-ancestor
65421268|NCT00465894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65421269|NCT00465894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421270|NCT00465894|Urological Agents|urological agents|mesh-ancestor
65421272|NCT00330460|Alendronate|alendronate|mesh-list
65421273|NCT00330460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65421274|NCT00330460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421275|NCT01062490|Treosulfan|treosulfan|mesh-list
65421276|NCT01062490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65421277|NCT01062490|Alkylating Agents|alkylating agents|mesh-ancestor
65421278|NCT01062490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421279|NCT01062490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421280|NCT00465738|Botulinum Toxins|botulinum toxins|mesh-list
65421281|NCT00465738|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65421282|NCT00465738|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65421283|NCT00465738|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65421284|NCT00465738|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65421285|NCT00465738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65242497|NCT03789240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242498|NCT03789240|Immunologic Factors|immunologic factors|mesh-ancestor
65242499|NCT03789240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242500|NCT03789240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65242501|NCT03779191|Bevacizumab|bevacizumab|mesh-list
65242502|NCT03779191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65242503|NCT03779191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242504|NCT03779191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65421286|NCT00465738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421287|NCT00465738|Cholinergic Agents|cholinergic agents|mesh-ancestor
65421288|NCT00465738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65421289|NCT00465738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421290|NCT00465738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65421291|NCT00465738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65421292|NCT00400179|Cisplatin|cisplatin|mesh-list
65421293|NCT00400179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421294|NCT00464568|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
65421295|NCT00464568|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65421296|NCT00464568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65421297|NCT00464568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421298|NCT00464568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421299|NCT00464490|Dexmedetomidine|dexmedetomidine|mesh-list
65421300|NCT00464490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65421301|NCT00464490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65421302|NCT00464490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421303|NCT00464490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65421304|NCT00464490|Analgesics|analgesics|mesh-ancestor
65421305|NCT00464490|Sensory System Agents|sensory system agents|mesh-ancestor
65421306|NCT00464490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65421307|NCT00464490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65421308|NCT00464490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65421309|NCT00464490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65421310|NCT00464490|Adrenergic Agents|adrenergic agents|mesh-ancestor
65421311|NCT00464490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65421312|NCT00464490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421313|NCT00412893|Voriconazole|voriconazole|mesh-list
65421336|NCT01041963|Enalapril|enalapril|mesh-list
65170869|NCT01147848|Xhance|xhance|mesh-list
65421337|NCT01041963|Enalaprilat|enalaprilat|mesh-list
65421338|NCT01041963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65421339|NCT01041963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65421340|NCT01041963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65421341|NCT01041963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65421342|NCT01041963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421343|NCT01041963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65421344|NCT01041963|Protease Inhibitors|protease inhibitors|mesh-ancestor
65421345|NCT01041963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421346|NCT01044225|Cetuximab|cetuximab|mesh-list
65421347|NCT01044225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65421348|NCT01044225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421349|NCT00508274|Capecitabine|capecitabine|mesh-list
65421350|NCT00508274|Lapatinib|lapatinib|mesh-list
65421351|NCT00508274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65421352|NCT00508274|Antimetabolites|antimetabolites|mesh-ancestor
65421353|NCT00508274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421354|NCT00508274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421355|NCT00508274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65421356|NCT00508274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421357|NCT01042041|Doxorubicin|doxorubicin|mesh-list
65421358|NCT01042041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65421359|NCT01042041|Sorafenib|sorafenib|mesh-list
65421360|NCT01042041|Mitomycins|mitomycins|mesh-list
65421361|NCT01042041|Mitomycin|mitomycin|mesh-list
65421362|NCT01042041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421363|NCT01042041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65421395|NCT00412113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65421396|NCT00412113|Vasodilator Agents|vasodilator agents|mesh-ancestor
65421397|NCT04466150|Ocrelizumab|ocrelizumab|mesh-list
65421398|NCT04466150|Immunologic Factors|immunologic factors|mesh-ancestor
65421399|NCT04466150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421400|NCT01014650|Glycine|glycine|mesh-list
65421401|NCT01014650|Glycine Agents|glycine agents|mesh-ancestor
65421402|NCT01014650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65421403|NCT01014650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421404|NCT01014650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421405|NCT00411645|Maribavir|maribavir|mesh-list
65421431|NCT00490646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421432|NCT00490646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65421433|NCT03992937|Levonorgestrel|levonorgestrel|mesh-list
65421434|NCT03992937|Progesterone|progesterone|mesh-list
65421435|NCT03992937|Progestins|progestins|mesh-ancestor
65421436|NCT03992937|Hormones|hormones|mesh-ancestor
65421437|NCT03992937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65421438|NCT03992937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421439|NCT03992937|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65421440|NCT03992937|Contraceptive Agents|contraceptive agents|mesh-ancestor
65421441|NCT03992937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65421442|NCT03992937|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65421443|NCT03992937|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65421444|NCT03992937|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65421445|NCT01039545|Norfloxacin|norfloxacin|mesh-list
65421446|NCT01039545|Diclofenac|diclofenac|mesh-list
65421447|NCT01039545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65421448|NCT01039545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65421449|NCT01039545|Analgesics|analgesics|mesh-ancestor
65421450|NCT01039545|Sensory System Agents|sensory system agents|mesh-ancestor
65421451|NCT01039545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65421452|NCT01039545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421453|NCT01039545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65421454|NCT01039545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65421455|NCT01039545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65421456|NCT01039545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806217|NCT01425320|Sensory System Agents|sensory system agents|mesh-ancestor
65421487|NCT00859781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65421488|NCT00859781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421489|NCT00859781|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65421490|NCT00944957|Efavirenz|efavirenz|mesh-list
65421491|NCT00944957|Raltegravir Potassium|raltegravir potassium|mesh-list
65421492|NCT00944957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65421493|NCT00944957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65421494|NCT00944957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421495|NCT00944957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421496|NCT00944957|Antiviral Agents|antiviral agents|mesh-ancestor
65421497|NCT00944957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64806266|NCT01425476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65421504|NCT00944957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65421505|NCT00944957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65421506|NCT00944957|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65421507|NCT00944957|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65421508|NCT00945347|Miglustat|miglustat|mesh-list
65421509|NCT00945347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421510|NCT00945347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421511|NCT00945347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65421512|NCT00945347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65421513|NCT00945347|Antiviral Agents|antiviral agents|mesh-ancestor
65421514|NCT00945347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65421515|NCT00945347|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65421516|NCT00945347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65421517|NCT00945347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421518|NCT00941135|Docetaxel|docetaxel|mesh-list
65421519|NCT00941135|Cetuximab|cetuximab|mesh-list
65421520|NCT00941135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421521|NCT00941135|Tubulin Modulators|tubulin modulators|mesh-ancestor
65421522|NCT00941135|Antimitotic Agents|antimitotic agents|mesh-ancestor
65421523|NCT00941135|Mitosis Modulators|mitosis modulators|mesh-ancestor
65421524|NCT00941135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421525|NCT00941135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65421526|NCT00556439|Abatacept|abatacept|mesh-list
65421527|NCT00556439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65421528|NCT00556439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421529|NCT00556439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421530|NCT00556439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65421531|NCT00556439|Immunologic Factors|immunologic factors|mesh-ancestor
65421532|NCT00556439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421533|NCT00556439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65421534|NCT04012307|Candesartan|candesartan|mesh-list
65421535|NCT04012307|Candesartan cilexetil|candesartan cilexetil|mesh-list
65421536|NCT04012307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65421537|NCT04012307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65421538|NCT04012307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65421539|NCT04012307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421540|NCT00387465|Azacitidine|azacitidine|mesh-list
65421541|NCT00387465|Entinostat|entinostat|mesh-list
65421542|NCT00387465|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65421543|NCT00387465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65421544|NCT00387465|Antimetabolites|antimetabolites|mesh-ancestor
65421545|NCT00387465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421546|NCT00387465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421547|NCT00387465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421548|NCT01042665|Latanoprost|latanoprost|mesh-list
65421549|NCT01042665|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65421550|NCT01042665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65421551|NCT00949949|Gemcitabine|gemcitabine|mesh-list
65421552|NCT00949949|Everolimus|everolimus|mesh-list
65421553|NCT00949949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421554|NCT00949949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65421555|NCT00949949|Antimetabolites|antimetabolites|mesh-ancestor
65421556|NCT00949949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421557|NCT00949949|Antiviral Agents|antiviral agents|mesh-ancestor
65421558|NCT00949949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65421559|NCT00949949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421560|NCT00949949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65421561|NCT00949949|Immunologic Factors|immunologic factors|mesh-ancestor
65421562|NCT00949949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421564|NCT00941369|Insulin Glargine|insulin glargine|mesh-list
64806311|NCT01425658|Anesthetics|anesthetics|mesh-ancestor
65421589|NCT00456261|Growth Inhibitors|growth inhibitors|mesh-ancestor
65421590|NCT00456261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65421591|NCT00456261|Antimetabolites|antimetabolites|mesh-ancestor
65421592|NCT00456261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421593|NCT00456261|Antiviral Agents|antiviral agents|mesh-ancestor
65421594|NCT00456261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65421595|NCT00456261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421596|NCT00456261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65421597|NCT00456261|Immunologic Factors|immunologic factors|mesh-ancestor
65421598|NCT00456261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65421599|NCT00456261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65421600|NCT00386607|Valsartan|valsartan|mesh-list
65421601|NCT00386607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65421602|NCT00386607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65421603|NCT00386607|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65421604|NCT00386607|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65421605|NCT00386607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421606|NCT00386607|Diuretics|diuretics|mesh-ancestor
65421607|NCT00386607|Natriuretic Agents|natriuretic agents|mesh-ancestor
65421608|NCT00386607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421609|NCT00386607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65421610|NCT00386607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65421611|NCT00410163|Cyclophosphamide|cyclophosphamide|mesh-list
65421612|NCT00410163|Fludarabine|fludarabine|mesh-list
65421613|NCT00410163|Ofatumumab|ofatumumab|mesh-list
65421614|NCT00410163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65421615|NCT00410163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65421616|NCT00410163|Immunologic Factors|immunologic factors|mesh-ancestor
64806380|NCT05386160|Ranibizumab|ranibizumab|mesh-list
65421634|NCT00300274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421635|NCT00300274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421636|NCT00300274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65421637|NCT00300274|Immunologic Factors|immunologic factors|mesh-ancestor
65421638|NCT00300274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421639|NCT00300274|Antifungal Agents|antifungal agents|mesh-ancestor
65421640|NCT00300274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65421641|NCT00300274|Dermatologic Agents|dermatologic agents|mesh-ancestor
65421642|NCT00300274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65269994|NCT02746796|Tegafur|tegafur|mesh-list
65269995|NCT02746796|Oxaliplatin|oxaliplatin|mesh-list
65020009|NCT05757869|Apixaban|apixaban|mesh-list
65269996|NCT02746796|Nivolumab|nivolumab|mesh-list
65269997|NCT02746796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65269998|NCT02746796|Antimetabolites|antimetabolites|mesh-ancestor
65269999|NCT02746796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270000|NCT02746796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270001|NCT02746796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65242741|NCT03110107|Nivolumab|nivolumab|mesh-list
65421643|NCT00300274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65421644|NCT00300274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421645|NCT00300274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65421646|NCT00300274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65421647|NCT00300274|Antitubercular Agents|antitubercular agents|mesh-ancestor
65421648|NCT00300274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65421650|NCT01043211|Epinephrine|epinephrine|mesh-list
65421651|NCT01043211|Anesthetics, Local|anesthetics, local|mesh-ancestor
65421652|NCT01043211|Anesthetics|anesthetics|mesh-ancestor
65421653|NCT01043211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65421654|NCT01043211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421655|NCT01043211|Sensory System Agents|sensory system agents|mesh-ancestor
65421656|NCT01043211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65421657|NCT01043211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65421658|NCT01043211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65421659|NCT01043211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65421660|NCT01043211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65421661|NCT01043211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421662|NCT01043211|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65421663|NCT01043211|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65421664|NCT01043211|Adrenergic Agents|adrenergic agents|mesh-ancestor
65421665|NCT01043211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65421666|NCT01043211|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65421667|NCT01043211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65421668|NCT01043211|Autonomic Agents|autonomic agents|mesh-ancestor
65421669|NCT01043211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65421670|NCT01043211|Respiratory System Agents|respiratory system agents|mesh-ancestor
65421671|NCT01043211|Mydriatics|mydriatics|mesh-ancestor
65421672|NCT01043211|Sympathomimetics|sympathomimetics|mesh-ancestor
65421673|NCT01043211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65421674|NCT01043445|Glycerol|glycerol|mesh-list
64806436|NCT05385185|Endostatins|endostatins|mesh-list
65421700|NCT00385827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65421701|NCT00385827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65421702|NCT00385827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65421703|NCT00385827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421704|NCT00385827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421705|NCT00498602|Saponin QA-21V1|saponin qa-21v1|mesh-list
65421706|NCT00498602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65421707|NCT00498602|Immunologic Factors|immunologic factors|mesh-ancestor
65421708|NCT00498602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421709|NCT00507728|Bupropion|bupropion|mesh-list
65421710|NCT00507728|Varenicline|varenicline|mesh-list
65421711|NCT00507728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65421712|NCT00507728|Antidepressive Agents|antidepressive agents|mesh-ancestor
65421714|NCT00507728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65421715|NCT00507728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65421716|NCT00507728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65421717|NCT00507728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421718|NCT00507728|Dopamine Agents|dopamine agents|mesh-ancestor
65421719|NCT00507728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65421720|NCT00507728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421721|NCT00507728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65421722|NCT00507728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65421723|NCT00507728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270002|NCT02746796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65270003|NCT04167176|Lidocaine|lidocaine|mesh-list
65270004|NCT04167176|Bupivacaine|bupivacaine|mesh-list
65270005|NCT04167176|Anesthetics, Local|anesthetics, local|mesh-ancestor
65270006|NCT04167176|Anesthetics|anesthetics|mesh-ancestor
65270007|NCT04167176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65270008|NCT04167176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270009|NCT04167176|Sensory System Agents|sensory system agents|mesh-ancestor
65270010|NCT04167176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65270011|NCT04167176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65270012|NCT04167176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65270013|NCT04167176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65270014|NCT04167176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65270015|NCT04167176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270016|NCT02720120|Ocrelizumab|ocrelizumab|mesh-list
65270017|NCT02720120|Immunologic Factors|immunologic factors|mesh-ancestor
65270018|NCT02720120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270019|NCT04189250|Carbon Monoxide|carbon monoxide|mesh-list
65421724|NCT00507728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65421725|NCT00507728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65421751|NCT00385671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65421752|NCT00385671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421753|NCT00385671|Anticonvulsants|anticonvulsants|mesh-ancestor
65421754|NCT00385671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65421755|NCT00385671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65421756|NCT00385671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421757|NCT00385671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65421758|NCT00385671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65421759|NCT00385671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65421760|NCT00385671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65421761|NCT00385671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65421762|NCT00385671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65421763|NCT00385671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65421764|NCT00385671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65421765|NCT00385671|Antimanic Agents|antimanic agents|mesh-ancestor
65421766|NCT00385671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65421767|NCT00385671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65421768|NCT00385671|Antidepressive Agents|antidepressive agents|mesh-ancestor
65421769|NCT00385671|Dopamine Agents|dopamine agents|mesh-ancestor
65421770|NCT00497198|Bile Acids and Salts|bile acids and salts|mesh-list
65421771|NCT00497198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65421772|NCT00496964|Botulinum Toxins|botulinum toxins|mesh-list
65421773|NCT00496964|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65421774|NCT00496964|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65421775|NCT00496964|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65421795|NCT00490490|Micronutrients|micronutrients|mesh-ancestor
65421796|NCT00490490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421797|NCT00490490|Hemostatics|hemostatics|mesh-ancestor
65421798|NCT00490490|Coagulants|coagulants|mesh-ancestor
65421799|NCT05049980|Mifepristone|mifepristone|mesh-list
65421800|NCT05049980|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65421801|NCT05049980|Abortifacient Agents|abortifacient agents|mesh-ancestor
65421802|NCT05049980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65421803|NCT05049980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421804|NCT05049980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65421805|NCT05049980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65421806|NCT05049980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65421807|NCT05049980|Contraceptive Agents|contraceptive agents|mesh-ancestor
65421808|NCT05049980|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65421809|NCT05049980|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65421810|NCT05049980|Hormone Antagonists|hormone antagonists|mesh-ancestor
65421811|NCT05049980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65421812|NCT05049980|Luteolytic Agents|luteolytic agents|mesh-ancestor
65421813|NCT05049980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65421814|NCT05049980|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65421816|NCT05176418|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65421817|NCT05176418|Autonomic Agents|autonomic agents|mesh-ancestor
65421818|NCT05176418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65421819|NCT05176418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421820|NCT05176418|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65421821|NCT05176418|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65421822|NCT05176418|Cholinergic Agents|cholinergic agents|mesh-ancestor
65421823|NCT05176418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65421824|NCT05176418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421825|NCT00385593|Budesonide|budesonide|mesh-list
65421826|NCT00385593|Formoterol Fumarate|formoterol fumarate|mesh-list
65421827|NCT00385593|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65421828|NCT00385593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65421829|NCT00385593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65421850|NCT01015040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421851|NCT01015040|Urological Agents|urological agents|mesh-ancestor
65421853|NCT00495170|Carboplatin|carboplatin|mesh-list
65421854|NCT00495170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65421855|NCT00495170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421856|NCT00495170|Tubulin Modulators|tubulin modulators|mesh-ancestor
65421857|NCT00495170|Antimitotic Agents|antimitotic agents|mesh-ancestor
65421858|NCT00495170|Mitosis Modulators|mitosis modulators|mesh-ancestor
65421859|NCT00495170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421860|NCT01011374|Ranibizumab|ranibizumab|mesh-list
65421861|NCT01011374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65421862|NCT01011374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65421863|NCT01011374|Growth Substances|growth substances|mesh-ancestor
65421864|NCT01011374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421865|NCT01011374|Growth Inhibitors|growth inhibitors|mesh-ancestor
65421866|NCT01011374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421867|NCT00385203|Cediranib|cediranib|mesh-list
65421868|NCT00385203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421869|NCT00385203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65421870|NCT00385203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421871|NCT00385203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421872|NCT01043601|Formoterol Fumarate|formoterol fumarate|mesh-list
65421873|NCT01043601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65421874|NCT01043601|Autonomic Agents|autonomic agents|mesh-ancestor
65421875|NCT01043601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65421876|NCT01043601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421877|NCT01043601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65421878|NCT01043601|Respiratory System Agents|respiratory system agents|mesh-ancestor
65421879|NCT01043601|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65421880|NCT01043601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65421906|NCT00395967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65421907|NCT00395967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65421908|NCT00395967|Antiviral Agents|antiviral agents|mesh-ancestor
65421909|NCT00395967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65421910|NCT00395343|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65421911|NCT00395343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65421912|NCT00395343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421913|NCT00395343|Incretins|incretins|mesh-ancestor
65421914|NCT00395343|Hormones|hormones|mesh-ancestor
65421915|NCT00395343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65421916|NCT00395343|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65421917|NCT00395343|Protease Inhibitors|protease inhibitors|mesh-ancestor
65421918|NCT00395343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421919|NCT00395343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421920|NCT00560573|Gemcitabine|gemcitabine|mesh-list
65421921|NCT00560573|Pemetrexed|pemetrexed|mesh-list
65421922|NCT00560573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421923|NCT00560573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65421924|NCT00560573|Antimetabolites|antimetabolites|mesh-ancestor
65242956|NCT02616640|Hormones|hormones|mesh-ancestor
65421925|NCT00560573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421926|NCT00560573|Antiviral Agents|antiviral agents|mesh-ancestor
65421927|NCT00560573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65421981|NCT00494780|Ofatumumab|ofatumumab|mesh-list
65421982|NCT00494780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65421983|NCT00494780|Immunologic Factors|immunologic factors|mesh-ancestor
65421984|NCT00494780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421985|NCT00494780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65421986|NCT00494780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65421987|NCT00494780|Alkylating Agents|alkylating agents|mesh-ancestor
65421988|NCT00494780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421989|NCT00494780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421990|NCT00494780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65421991|NCT00494780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65421992|NCT00494780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65421993|NCT00494780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65421994|NCT00494780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421995|NCT00494780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65421996|NCT00494780|Glucocorticoids|glucocorticoids|mesh-ancestor
65421997|NCT00494780|Hormones|hormones|mesh-ancestor
65421998|NCT00494780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65421999|NCT00494780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65422000|NCT00494780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65422001|NCT00494780|Tubulin Modulators|tubulin modulators|mesh-ancestor
65422002|NCT00494780|Antimitotic Agents|antimitotic agents|mesh-ancestor
65422003|NCT00494780|Mitosis Modulators|mitosis modulators|mesh-ancestor
65422004|NCT01011452|Montelukast|montelukast|mesh-list
65171531|NCT00931528|Tadalafil|tadalafil|mesh-list
65422005|NCT01011452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65422006|NCT01011452|Respiratory System Agents|respiratory system agents|mesh-ancestor
65422007|NCT01011452|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65422008|NCT01011452|Hormone Antagonists|hormone antagonists|mesh-ancestor
65422009|NCT01011452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65422010|NCT01011452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422011|NCT01011452|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65422012|NCT01011452|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64806777|NCT03771612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65422033|NCT00950339|Pantoprazole|pantoprazole|mesh-list
65422034|NCT00950339|Famotidine|famotidine|mesh-list
65422035|NCT00950339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65422036|NCT00950339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65422037|NCT00950339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65422038|NCT00950339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422039|NCT00950339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422040|NCT00950339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65422041|NCT00950339|Histamine Antagonists|histamine antagonists|mesh-ancestor
65422042|NCT00950339|Histamine Agents|histamine agents|mesh-ancestor
65422043|NCT00950339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65422044|NCT00950339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422045|NCT00950417|Nimotuzumab|nimotuzumab|mesh-list
65422046|NCT00950417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65422047|NCT00950417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422048|NCT00946673|Vorinostat|vorinostat|mesh-list
65422049|NCT00946673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422050|NCT00946673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65422051|NCT00946673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422052|NCT00946673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422053|NCT00394953|Darbepoetin alfa|darbepoetin alfa|mesh-list
65422054|NCT00394953|Hematinics|hematinics|mesh-ancestor
65422055|NCT00946751|Levetiracetam|levetiracetam|mesh-list
65422056|NCT00946751|Anticonvulsants|anticonvulsants|mesh-ancestor
65422057|NCT00946751|Nootropic Agents|nootropic agents|mesh-ancestor
65422058|NCT00485732|Vaccines|vaccines|mesh-list
65422059|NCT00485732|Immunologic Factors|immunologic factors|mesh-ancestor
65422060|NCT00485732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422061|NCT00946829|Telmisartan|telmisartan|mesh-list
65422062|NCT00946829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65422063|NCT00946829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65422064|NCT00946829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65422065|NCT00946829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422066|NCT00489554|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65422067|NCT00489554|Immunologic Factors|immunologic factors|mesh-ancestor
65422083|NCT00560417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65243029|NCT02393794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65243030|NCT02393794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243031|NCT02356159|Rituximab|rituximab|mesh-list
65243032|NCT02356159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65243033|NCT02356159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243034|NCT02356159|Immunologic Factors|immunologic factors|mesh-ancestor
65243035|NCT02356159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243036|NCT02356159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65243037|NCT02319837|Leuprolide|leuprolide|mesh-list
65243038|NCT02319837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65243039|NCT02319837|Fertility Agents|fertility agents|mesh-ancestor
65243040|NCT02319837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65243041|NCT02319837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243042|NCT02319837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65243043|NCT02319837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243072|NCT02159950|Vaccines|vaccines|mesh-list
65243073|NCT02159950|Immunologic Factors|immunologic factors|mesh-ancestor
65243074|NCT02159950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243075|NCT02152137|Paclitaxel|paclitaxel|mesh-list
65243076|NCT02152137|Efatutazone|efatutazone|mesh-list
65243077|NCT02152137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65243078|NCT02152137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243079|NCT02152137|Tubulin Modulators|tubulin modulators|mesh-ancestor
65243080|NCT02152137|Antimitotic Agents|antimitotic agents|mesh-ancestor
65243081|NCT02152137|Mitosis Modulators|mitosis modulators|mesh-ancestor
65243082|NCT02152137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422084|NCT00560417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422085|NCT00560417|Heparin Antagonists|heparin antagonists|mesh-ancestor
65422086|NCT00560417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422087|NCT00560417|Coagulants|coagulants|mesh-ancestor
65422088|NCT01040091|Tenofovir|tenofovir|mesh-list
65422089|NCT01040091|Emtricitabine|emtricitabine|mesh-list
65422090|NCT01040091|Efavirenz|efavirenz|mesh-list
65422091|NCT01040091|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65422092|NCT01040091|Antiviral Agents|antiviral agents|mesh-ancestor
65422093|NCT01040091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65422094|NCT01040091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65422095|NCT01040091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65422096|NCT01040091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422097|NCT01040091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422098|NCT01040091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65422099|NCT01040091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65422100|NCT01040091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65422101|NCT01040091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65422102|NCT01040091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65422103|NCT01040091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65422104|NCT01040091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65243114|NCT01971489|Gemcitabine|gemcitabine|mesh-list
65422105|NCT01040091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65422106|NCT00946907|Aspirin|aspirin|mesh-list
65422107|NCT00946907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65422108|NCT00946907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65422109|NCT00946907|Analgesics|analgesics|mesh-ancestor
65422110|NCT00946907|Sensory System Agents|sensory system agents|mesh-ancestor
65422111|NCT00946907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65422112|NCT00946907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422113|NCT00946907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65422114|NCT00946907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65422115|NCT00946907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65422116|NCT00946907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65422117|NCT00946907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422118|NCT00946907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65422119|NCT00946907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65422120|NCT00946907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422121|NCT00946907|Antipyretics|antipyretics|mesh-ancestor
65422122|NCT00942539|Midazolam|midazolam|mesh-list
65422123|NCT00942539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65422124|NCT00942539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65422125|NCT00942539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65422139|NCT00947063|Antipruritics|antipruritics|mesh-ancestor
65422140|NCT00947063|Dermatologic Agents|dermatologic agents|mesh-ancestor
65422141|NCT00947063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65422142|NCT00947063|Histamine Antagonists|histamine antagonists|mesh-ancestor
65422143|NCT00947063|Histamine Agents|histamine agents|mesh-ancestor
65422144|NCT00947063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65422145|NCT00947063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422146|NCT00947063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422147|NCT00947063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65422148|NCT00947063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65422149|NCT00947063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65422150|NCT00947063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65422151|NCT00947063|Anesthetics, Local|anesthetics, local|mesh-ancestor
65422152|NCT00947063|Anesthetics|anesthetics|mesh-ancestor
65422153|NCT00947063|Sensory System Agents|sensory system agents|mesh-ancestor
65422154|NCT00947063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65422155|NCT00947063|Antiemetics|antiemetics|mesh-ancestor
65422156|NCT00947063|Autonomic Agents|autonomic agents|mesh-ancestor
65422157|NCT00947063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65422158|NCT00942617|Aspirin|aspirin|mesh-list
65422159|NCT00942617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65422160|NCT00942617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65422161|NCT00942617|Analgesics|analgesics|mesh-ancestor
65422162|NCT00942617|Sensory System Agents|sensory system agents|mesh-ancestor
65422163|NCT00942617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65422164|NCT00942617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422165|NCT00942617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65422166|NCT00942617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65422167|NCT00942617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65422168|NCT00942617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65422169|NCT00942617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422170|NCT00942617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65422171|NCT00942617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65422172|NCT00942617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422173|NCT00942617|Antipyretics|antipyretics|mesh-ancestor
65422174|NCT00345345|Alemtuzumab|alemtuzumab|mesh-list
65422175|NCT00345345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65422176|NCT00345345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422177|NCT03968159|Pimavanserin|pimavanserin|mesh-list
65422178|NCT03968159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65422179|NCT03968159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65422180|NCT03968159|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65422181|NCT03968159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65422182|NCT03968159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65422183|NCT03968159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422184|NCT03968159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65422185|NCT03968159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65422186|NCT03968159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65422187|NCT03968159|Serotonin Agents|serotonin agents|mesh-ancestor
65422188|NCT03968159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65422211|NCT03966365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65422212|NCT03966365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65270020|NCT04189250|Antimetabolites|antimetabolites|mesh-ancestor
65422213|NCT03966365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65422215|NCT03966365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65422216|NCT03966365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422217|NCT00375219|Homoharringtonine|homoharringtonine|mesh-list
65422218|NCT00375219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65422219|NCT00375219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422220|NCT00375219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65422221|NCT00375219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422222|NCT00375219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422223|NCT03965351|Probenecid|probenecid|mesh-list
65422224|NCT03965351|Uricosuric Agents|uricosuric agents|mesh-ancestor
65422225|NCT03965351|Gout Suppressants|gout suppressants|mesh-ancestor
65422226|NCT03965351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65422227|NCT03965351|Renal Agents|renal agents|mesh-ancestor
65422228|NCT00947375|Lamotrigine|lamotrigine|mesh-list
65422229|NCT00947375|Haloperidol|haloperidol|mesh-list
65422230|NCT00947375|Haloperidol decanoate|haloperidol decanoate|mesh-list
65422231|NCT00947375|Antiemetics|antiemetics|mesh-ancestor
65422232|NCT00947375|Autonomic Agents|autonomic agents|mesh-ancestor
65422233|NCT00947375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65422234|NCT00947375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422235|NCT00947375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65422236|NCT00947375|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65422237|NCT00947375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65422238|NCT00947375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65422239|NCT00947375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65422240|NCT00947375|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65422261|NCT00942773|Antifungal Agents|antifungal agents|mesh-ancestor
65422262|NCT00942773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65422263|NCT00942773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65422264|NCT00942773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65422265|NCT00942773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422266|NCT00942773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422267|NCT00942773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65422268|NCT00942773|Hormone Antagonists|hormone antagonists|mesh-ancestor
65422269|NCT00942773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65422270|NCT00942773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422271|NCT00942773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65422272|NCT04364555|Clobetasol|clobetasol|mesh-list
65422273|NCT04364555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65422274|NCT04364555|Glucocorticoids|glucocorticoids|mesh-ancestor
65422275|NCT04364555|Hormones|hormones|mesh-ancestor
65422276|NCT04364555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65422277|NCT04364555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422278|NCT00374907|Metformin|metformin|mesh-list
65422279|NCT00374907|Saxagliptin|saxagliptin|mesh-list
65422280|NCT00374907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65422281|NCT00374907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422282|NCT00374907|Incretins|incretins|mesh-ancestor
65422283|NCT00374907|Hormones|hormones|mesh-ancestor
65422284|NCT00374907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65422285|NCT00374907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65422286|NCT00374907|Protease Inhibitors|protease inhibitors|mesh-ancestor
65422287|NCT00374907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422288|NCT00374907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422289|NCT01045083|Methylphenidate|methylphenidate|mesh-list
65422290|NCT01045083|Citalopram|citalopram|mesh-list
65422316|NCT00947843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65422317|NCT00947843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65422318|NCT00947843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65422319|NCT00947843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422320|NCT00947843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65422321|NCT00947843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65422322|NCT00947843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422323|NCT00947843|Antipyretics|antipyretics|mesh-ancestor
65422324|NCT00947843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65422325|NCT00947843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65422326|NCT00947843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65422327|NCT00947843|Purinergic Agents|purinergic agents|mesh-ancestor
65422328|NCT00947843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65422329|NCT00948077|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
65422330|NCT00948077|Antitubercular Agents|antitubercular agents|mesh-ancestor
65243268|NCT00359684|Cysteamine|cysteamine|mesh-list
65422331|NCT00948077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65422332|NCT00948077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65422333|NCT00407745|Pregabalin|pregabalin|mesh-list
65422334|NCT00407745|Analgesics|analgesics|mesh-ancestor
65422335|NCT00407745|Sensory System Agents|sensory system agents|mesh-ancestor
65422352|NCT00951431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422354|NCT00299494|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65422355|NCT00299494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65422356|NCT00299494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422357|NCT00299494|Immunologic Factors|immunologic factors|mesh-ancestor
65422358|NCT00299494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422359|NCT00299494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65422360|NCT00299494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65422361|NCT00943553|Decitabine|decitabine|mesh-list
65422362|NCT00943553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65422363|NCT00943553|Antimetabolites|antimetabolites|mesh-ancestor
65422364|NCT00943553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422365|NCT00943553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422366|NCT00943553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422367|NCT00453180|Acetylcysteine|acetylcysteine|mesh-list
65422368|NCT00453180|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65422369|NCT00453180|Antiviral Agents|antiviral agents|mesh-ancestor
65422370|NCT00453180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65422371|NCT00453180|Expectorants|expectorants|mesh-ancestor
65422372|NCT00453180|Respiratory System Agents|respiratory system agents|mesh-ancestor
65171902|NCT00976989|Docetaxel|docetaxel|mesh-list
65422373|NCT00453180|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65422374|NCT00453180|Antioxidants|antioxidants|mesh-ancestor
65422375|NCT00453180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422376|NCT00453180|Protective Agents|protective agents|mesh-ancestor
65422377|NCT00453180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422378|NCT00453180|Antidotes|antidotes|mesh-ancestor
65422379|NCT00943709|Insulin|insulin|mesh-list
65422380|NCT00943709|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65422381|NCT00943709|Insulin Glargine|insulin glargine|mesh-list
65422382|NCT00943709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65422383|NCT00943709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422384|NCT00464178|Bortezomib|bortezomib|mesh-list
65422385|NCT00464178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422386|NCT00316186|Carboplatin|carboplatin|mesh-list
65422387|NCT00316186|Topotecan|topotecan|mesh-list
65422388|NCT00316186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422389|NCT00316186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65422390|NCT00316186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65422391|NCT00316186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422392|NCT00316186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422414|NCT01065220|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65422416|NCT01065220|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65422417|NCT01065220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65422418|NCT00943943|Plerixafor|plerixafor|mesh-list
65422419|NCT00943943|Sorafenib|sorafenib|mesh-list
65422420|NCT00943943|Lenograstim|lenograstim|mesh-list
65422421|NCT00943943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422422|NCT00943943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65422423|NCT00943943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422424|NCT00943943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422425|NCT00943943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65422426|NCT00943943|Immunologic Factors|immunologic factors|mesh-ancestor
65422427|NCT00943943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422428|NCT00943943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65422429|NCT00943943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65422430|NCT00943943|Antiviral Agents|antiviral agents|mesh-ancestor
65422431|NCT00943943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65422432|NCT00948779|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65422433|NCT00948779|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65422434|NCT00948779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65422435|NCT00948779|Antitubercular Agents|antitubercular agents|mesh-ancestor
65422436|NCT00453102|Rituximab|rituximab|mesh-list
65422437|NCT00453102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65422438|NCT00453102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422439|NCT00453102|Immunologic Factors|immunologic factors|mesh-ancestor
65422440|NCT00453102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422441|NCT00453102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65422442|NCT00299182|Cytarabine|cytarabine|mesh-list
65422443|NCT00299182|Dexamethasone|dexamethasone|mesh-list
65422444|NCT00299182|Cyclophosphamide|cyclophosphamide|mesh-list
65422445|NCT00299182|Rituximab|rituximab|mesh-list
65422446|NCT00299182|Doxorubicin|doxorubicin|mesh-list
65422447|NCT00299182|Methotrexate|methotrexate|mesh-list
65422456|NCT00299182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422457|NCT00299182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65422458|NCT00299182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65422459|NCT00299182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65422460|NCT00299182|Antiemetics|antiemetics|mesh-ancestor
65422461|NCT00299182|Autonomic Agents|autonomic agents|mesh-ancestor
65422462|NCT00299182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65422463|NCT00299182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65422464|NCT00299182|Glucocorticoids|glucocorticoids|mesh-ancestor
65422465|NCT00299182|Hormones|hormones|mesh-ancestor
65422466|NCT00299182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65422467|NCT00299182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65422468|NCT00299182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65422469|NCT00299182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65422470|NCT00299182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65422471|NCT00299182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422472|NCT00299182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65422473|NCT00299182|Abortifacient Agents|abortifacient agents|mesh-ancestor
65422474|NCT00299182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65422475|NCT00299182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65422476|NCT00299182|Antimetabolites|antimetabolites|mesh-ancestor
65422477|NCT00299182|Dermatologic Agents|dermatologic agents|mesh-ancestor
65422478|NCT00299182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65422479|NCT00299182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65422480|NCT00299182|Antiviral Agents|antiviral agents|mesh-ancestor
65422481|NCT00299182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65422482|NCT00299182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65422483|NCT00299182|Tubulin Modulators|tubulin modulators|mesh-ancestor
65422484|NCT00299182|Antimitotic Agents|antimitotic agents|mesh-ancestor
65422485|NCT00299182|Mitosis Modulators|mitosis modulators|mesh-ancestor
65422486|NCT00467142|Leucovorin|leucovorin|mesh-list
65422487|NCT00467142|Bevacizumab|bevacizumab|mesh-list
65422488|NCT00467142|Fluorouracil|fluorouracil|mesh-list
65422489|NCT00467142|Irinotecan|irinotecan|mesh-list
65422490|NCT00467142|Calcium|calcium|mesh-list
65422491|NCT00467142|Levoleucovorin|levoleucovorin|mesh-list
65422492|NCT00467142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65422493|NCT00467142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422494|NCT00467142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65422495|NCT00467142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65422496|NCT00467142|Growth Substances|growth substances|mesh-ancestor
65422497|NCT00467142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422498|NCT00467142|Growth Inhibitors|growth inhibitors|mesh-ancestor
65422499|NCT00467142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65422500|NCT00467142|Antimetabolites|antimetabolites|mesh-ancestor
65422501|NCT00467142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422502|NCT00467142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65422503|NCT00467142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65422504|NCT00467142|Immunologic Factors|immunologic factors|mesh-ancestor
65422505|NCT00467142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65422506|NCT00467142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65422507|NCT00467142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422508|NCT00467142|Antidotes|antidotes|mesh-ancestor
65422509|NCT00467142|Protective Agents|protective agents|mesh-ancestor
65422510|NCT00467142|Vitamin B Complex|vitamin b complex|mesh-ancestor
65422511|NCT00467142|Vitamins|vitamins|mesh-ancestor
65422512|NCT00467142|Micronutrients|micronutrients|mesh-ancestor
65422513|NCT01065376|Cabergoline|cabergoline|mesh-list
65422514|NCT01065376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65422543|NCT00329602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65422544|NCT00329602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422545|NCT00329602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422546|NCT01060696|Mefenamic Acid|mefenamic acid|mesh-list
65422547|NCT01060696|Scopolamine|scopolamine|mesh-list
65422548|NCT01060696|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65422549|NCT01060696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65422550|NCT01060696|Antiemetics|antiemetics|mesh-ancestor
65422551|NCT01060696|Autonomic Agents|autonomic agents|mesh-ancestor
65422552|NCT01060696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65422553|NCT01060696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422554|NCT01060696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65422555|NCT01060696|Mydriatics|mydriatics|mesh-ancestor
65422556|NCT01060696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65422557|NCT01060696|Cholinergic Agents|cholinergic agents|mesh-ancestor
65243414|NCT00001521|Letrozole|letrozole|mesh-list
65422558|NCT01060696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65422559|NCT01060696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422560|NCT01060696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65422585|NCT00463866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65422587|NCT00463866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65422588|NCT00463866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65422589|NCT00463866|Adrenergic Agents|adrenergic agents|mesh-ancestor
65422590|NCT00463866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65422591|NCT00463866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422592|NCT00313846|Buprenorphine|buprenorphine|mesh-list
65422593|NCT00313846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65422594|NCT00313846|Narcotics|narcotics|mesh-ancestor
65422595|NCT00313846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65422596|NCT00313846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422597|NCT00313846|Analgesics|analgesics|mesh-ancestor
65422598|NCT00313846|Sensory System Agents|sensory system agents|mesh-ancestor
65422599|NCT00313846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65422600|NCT00313846|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65422601|NCT00949247|Bevacizumab|bevacizumab|mesh-list
65422603|NCT00949247|Carboplatin|carboplatin|mesh-list
65422604|NCT00949247|Docetaxel|docetaxel|mesh-list
65422605|NCT00949247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65422606|NCT00949247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422607|NCT00949247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65422608|NCT00949247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65422609|NCT00949247|Growth Substances|growth substances|mesh-ancestor
65422610|NCT00949247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422611|NCT00949247|Growth Inhibitors|growth inhibitors|mesh-ancestor
65422612|NCT00949247|Tubulin Modulators|tubulin modulators|mesh-ancestor
65422643|NCT00299104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422644|NCT00299104|Immunologic Factors|immunologic factors|mesh-ancestor
65422645|NCT00299104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422646|NCT00299104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65422647|NCT00299104|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65422648|NCT00299104|Abortifacient Agents|abortifacient agents|mesh-ancestor
65422649|NCT00299104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65422650|NCT00299104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65422651|NCT00299104|Antimetabolites|antimetabolites|mesh-ancestor
65422652|NCT00299104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422653|NCT00299104|Dermatologic Agents|dermatologic agents|mesh-ancestor
65422665|NCT00299104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65422666|NCT00299104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65422667|NCT00299104|Protective Agents|protective agents|mesh-ancestor
65422669|NCT03979456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65422670|NCT03979456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422671|NCT03979456|Immunologic Factors|immunologic factors|mesh-ancestor
65422672|NCT03979456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422673|NCT03979456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65422674|NCT00313612|Oxaliplatin|oxaliplatin|mesh-list
65422675|NCT00313612|Topotecan|topotecan|mesh-list
65422676|NCT00313612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422677|NCT00313612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65422678|NCT00313612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65422679|NCT00313612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422680|NCT00313612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422681|NCT00507416|Thalidomide|thalidomide|mesh-list
65422682|NCT00507416|Dexamethasone|dexamethasone|mesh-list
65422683|NCT00507416|Prednisone|prednisone|mesh-list
65422684|NCT00507416|Bortezomib|bortezomib|mesh-list
65422685|NCT00507416|Melphalan|melphalan|mesh-list
65422686|NCT00507416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65422687|NCT00507416|Antiemetics|antiemetics|mesh-ancestor
65422688|NCT00507416|Autonomic Agents|autonomic agents|mesh-ancestor
65422689|NCT00507416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65422690|NCT00507416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422691|NCT00507416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65422692|NCT00507416|Glucocorticoids|glucocorticoids|mesh-ancestor
65422693|NCT00507416|Hormones|hormones|mesh-ancestor
65422694|NCT00507416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65422695|NCT00507416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65422696|NCT00507416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422697|NCT00507416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65422698|NCT00507416|Alkylating Agents|alkylating agents|mesh-ancestor
65274218|NCT02354898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422699|NCT00507416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422700|NCT00507416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65422701|NCT00507416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65422702|NCT00507416|Immunologic Factors|immunologic factors|mesh-ancestor
65422703|NCT00507416|Leprostatic Agents|leprostatic agents|mesh-ancestor
65422704|NCT00507416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65422705|NCT00507416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65422706|NCT00507416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65422707|NCT00507416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65422708|NCT00507416|Growth Substances|growth substances|mesh-ancestor
65422709|NCT00507416|Growth Inhibitors|growth inhibitors|mesh-ancestor
65422710|NCT00489476|Loxapine|loxapine|mesh-list
65422711|NCT00489476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65422712|NCT00489476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65422713|NCT00489476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65422714|NCT00489476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422715|NCT00489476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65422716|NCT00489476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65422717|NCT00489476|Dopamine Agents|dopamine agents|mesh-ancestor
65422718|NCT00489476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65422754|NCT00952913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65422755|NCT00952913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807536|NCT01428531|Protease Inhibitors|protease inhibitors|mesh-ancestor
65422783|NCT00953303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65422784|NCT00953303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422785|NCT00953303|Protease Inhibitors|protease inhibitors|mesh-ancestor
65422786|NCT00953303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422787|NCT00953303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422788|NCT00953303|Diuretics|diuretics|mesh-ancestor
65422789|NCT00953303|Natriuretic Agents|natriuretic agents|mesh-ancestor
65422790|NCT00953303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65422791|NCT00953303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65422792|NCT00953303|Vasodilator Agents|vasodilator agents|mesh-ancestor
65422793|NCT00953303|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65422794|NCT00953303|Sympathomimetics|sympathomimetics|mesh-ancestor
65422795|NCT00953303|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65422796|NCT00953303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65422797|NCT00953303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65422798|NCT00953303|Adrenergic Agents|adrenergic agents|mesh-ancestor
65422799|NCT00953303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65422800|NCT00953303|Protective Agents|protective agents|mesh-ancestor
65422801|NCT00953303|Dopamine Agents|dopamine agents|mesh-ancestor
65422802|NCT00953303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65422803|NCT05300555|Warfarin|warfarin|mesh-list
65422804|NCT05300555|Rivaroxaban|rivaroxaban|mesh-list
65422805|NCT05300555|Anticoagulants|anticoagulants|mesh-ancestor
65422806|NCT05300555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65422807|NCT05300555|Antithrombins|antithrombins|mesh-ancestor
65422875|NCT01025466|Protective Agents|protective agents|mesh-ancestor
65422876|NCT01025544|Vaccines|vaccines|mesh-list
65422877|NCT01025544|Immunologic Factors|immunologic factors|mesh-ancestor
65422878|NCT01025544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422879|NCT03839940|Dexamethasone|dexamethasone|mesh-list
65422880|NCT03839940|Everolimus|everolimus|mesh-list
65422881|NCT03839940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65422882|NCT03839940|Antiemetics|antiemetics|mesh-ancestor
65422883|NCT03839940|Autonomic Agents|autonomic agents|mesh-ancestor
65422884|NCT03839940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807659|NCT01429545|Vasodilator Agents|vasodilator agents|mesh-ancestor
65422914|NCT01027494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65422916|NCT01027494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422917|NCT01027494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65422918|NCT01027494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65422919|NCT01027494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65422920|NCT01027494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65422921|NCT01027494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422922|NCT01027494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422923|NCT01027494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65422924|NCT01027494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65422925|NCT01025700|Nabilone|nabilone|mesh-list
65422926|NCT01025700|Antiemetics|antiemetics|mesh-ancestor
65422927|NCT01025700|Autonomic Agents|autonomic agents|mesh-ancestor
64807700|NCT01429701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65422945|NCT00452400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64939055|NCT01784159|Antipyretics|antipyretics|mesh-ancestor
65422946|NCT00452400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422947|NCT00452400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65422948|NCT00452400|Respiratory System Agents|respiratory system agents|mesh-ancestor
65422949|NCT03576690|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
65422950|NCT03576690|Atoltivimab|atoltivimab|mesh-list
65422951|NCT03576690|Odesivimab|odesivimab|mesh-list
65422952|NCT03576690|Maftivimab|maftivimab|mesh-list
65422953|NCT03576690|Antiviral Agents|antiviral agents|mesh-ancestor
65422954|NCT03576690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65422955|NCT01566474|Melatonin|melatonin|mesh-list
65422956|NCT01566474|Omeprazole|omeprazole|mesh-list
65422957|NCT01566474|Antioxidants|antioxidants|mesh-ancestor
65422958|NCT01566474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422959|NCT01566474|Protective Agents|protective agents|mesh-ancestor
65422960|NCT01566474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422961|NCT01566474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65422962|NCT01566474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65422963|NCT01566474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65422964|NCT01566474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65422965|NCT01566474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422966|NCT01025778|Cyclophosphamide|cyclophosphamide|mesh-list
65422967|NCT01025778|Thiotepa|thiotepa|mesh-list
65422968|NCT01025778|Etoposide|etoposide|mesh-list
65422969|NCT01025778|Clofarabine|clofarabine|mesh-list
65422970|NCT01025778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65422971|NCT01025778|Immunologic Factors|immunologic factors|mesh-ancestor
65422972|NCT01025778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422973|NCT01025778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65422974|NCT01025778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65422975|NCT01025778|Alkylating Agents|alkylating agents|mesh-ancestor
65422976|NCT01025778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422977|NCT01025778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422978|NCT01025778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65422979|NCT01025778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65422980|NCT01025778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65422981|NCT01025778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65422982|NCT01025778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422983|NCT01025778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65422985|NCT00443430|Prednisone|prednisone|mesh-list
65422986|NCT00443430|Prednisolone|prednisolone|mesh-list
65422987|NCT00443430|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65422994|NCT00443430|Prednisolone phosphate|prednisolone phosphate|mesh-list
65422995|NCT00443430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65422996|NCT00443430|Glucocorticoids|glucocorticoids|mesh-ancestor
65422997|NCT00443430|Hormones|hormones|mesh-ancestor
65422998|NCT00443430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65422999|NCT00443430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423000|NCT00443430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65423001|NCT00443430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423002|NCT00443430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65423003|NCT00443430|Abortifacient Agents|abortifacient agents|mesh-ancestor
65423004|NCT00443430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65423005|NCT00443430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65423006|NCT00443430|Antimetabolites|antimetabolites|mesh-ancestor
65423007|NCT00443430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423008|NCT00443430|Dermatologic Agents|dermatologic agents|mesh-ancestor
65423009|NCT00443430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423010|NCT00443430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65423011|NCT00443430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65423012|NCT00443430|Immunologic Factors|immunologic factors|mesh-ancestor
65423013|NCT00443430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65423014|NCT00443430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65423015|NCT00443430|Antiemetics|antiemetics|mesh-ancestor
65423016|NCT00443430|Autonomic Agents|autonomic agents|mesh-ancestor
65423017|NCT00443430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65423018|NCT00443430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65423019|NCT00443430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65423020|NCT00443430|Protective Agents|protective agents|mesh-ancestor
65423021|NCT00443430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65423022|NCT00443430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65423023|NCT00443430|Analgesics|analgesics|mesh-ancestor
65423024|NCT00443430|Sensory System Agents|sensory system agents|mesh-ancestor
65423025|NCT03540420|Atezolizumab|atezolizumab|mesh-list
65423026|NCT03540420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423027|NCT03898986|Vaccines|vaccines|mesh-list
65423028|NCT03898986|Immunologic Factors|immunologic factors|mesh-ancestor
65423029|NCT03898986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423030|NCT01022658|Insulin|insulin|mesh-list
65423031|NCT01022658|Insulin Detemir|insulin detemir|mesh-list
65423032|NCT01022658|Insulin Aspart|insulin aspart|mesh-list
65423033|NCT01022658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65423034|NCT01022658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423035|NCT01022736|Gabapentin|gabapentin|mesh-list
65423036|NCT01022736|Analgesics|analgesics|mesh-ancestor
65423037|NCT01022736|Sensory System Agents|sensory system agents|mesh-ancestor
65423038|NCT01022736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65423039|NCT01022736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423040|NCT01022736|Anticonvulsants|anticonvulsants|mesh-ancestor
65423041|NCT01022736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65423042|NCT01022736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65423043|NCT01022736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65423044|NCT01022736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65423045|NCT01022736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65423046|NCT01022736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65423047|NCT01022736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65423048|NCT01022736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423049|NCT01022736|Antimanic Agents|antimanic agents|mesh-ancestor
65423050|NCT01025934|Bevacizumab|bevacizumab|mesh-list
65423051|NCT01025934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65423052|NCT01025934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423053|NCT01025934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65172588|NCT00645073|Levofloxacin|levofloxacin|mesh-list
65423054|NCT01025934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65423055|NCT01025934|Growth Substances|growth substances|mesh-ancestor
65423056|NCT01025934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423070|NCT00460746|Antiviral Agents|antiviral agents|mesh-ancestor
65423071|NCT00460746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65423072|NCT00460746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65423073|NCT00460746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65423074|NCT00460746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65423075|NCT00460746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65423076|NCT01026558|Ceftobiprole|ceftobiprole|mesh-list
65423077|NCT01026558|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
65423078|NCT01026558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65423079|NCT01026558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65423080|NCT00373425|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65423081|NCT00373425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423082|NCT00373425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65423083|NCT00373425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423084|NCT00373425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423086|NCT00459342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423087|NCT00459342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65423088|NCT00459342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423089|NCT00459342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423090|NCT00442962|Tenofovir|tenofovir|mesh-list
65423091|NCT00442962|Emtricitabine|emtricitabine|mesh-list
65423092|NCT00442962|Efavirenz|efavirenz|mesh-list
65423093|NCT00442962|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65423094|NCT00442962|Antiviral Agents|antiviral agents|mesh-ancestor
65423095|NCT00442962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65423096|NCT00442962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65423097|NCT00442962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65423098|NCT00442962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423099|NCT00442962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423100|NCT00442962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65423101|NCT00442962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65423102|NCT00442962|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65423103|NCT00442962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65423104|NCT00442962|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65423105|NCT00442962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65423106|NCT00442962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65423107|NCT00442962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65423108|NCT01028508|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65423109|NCT01028508|Antidepressive Agents|antidepressive agents|mesh-ancestor
65423110|NCT01028508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65423111|NCT01028508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423112|NCT01028508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993924|NCT00333112|Urological Agents|urological agents|mesh-ancestor
65423113|NCT01028508|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65423114|NCT01028508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65423115|NCT01028508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64807875|NCT01431053|Aspirin|aspirin|mesh-list
65423137|NCT00459186|Mitosis Modulators|mitosis modulators|mesh-ancestor
65423138|NCT00459186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423139|NCT00459186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65423140|NCT00459186|Glucocorticoids|glucocorticoids|mesh-ancestor
65423141|NCT00459186|Hormones|hormones|mesh-ancestor
65423142|NCT00459186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65423143|NCT00459186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423144|NCT00459186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65423145|NCT00459186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65423146|NCT00459186|Immunologic Factors|immunologic factors|mesh-ancestor
65423147|NCT01026714|Fluconazole|fluconazole|mesh-list
65423148|NCT01026714|Rifampin|rifampin|mesh-list
65423149|NCT01026714|Flurbiprofen|flurbiprofen|mesh-list
65423150|NCT01026714|Antifungal Agents|antifungal agents|mesh-ancestor
65423151|NCT01026714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65423152|NCT01026714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65423153|NCT01026714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65423154|NCT01026714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423155|NCT01026714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423156|NCT01026714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65423157|NCT01026714|Hormone Antagonists|hormone antagonists|mesh-ancestor
65423158|NCT01026714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65423159|NCT01026714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423160|NCT01026714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65423161|NCT01026714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65423162|NCT01026714|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65423163|NCT01026714|Antitubercular Agents|antitubercular agents|mesh-ancestor
65423164|NCT01026714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65423165|NCT01026714|Leprostatic Agents|leprostatic agents|mesh-ancestor
65423166|NCT01026714|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65423167|NCT01026714|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65423168|NCT01026714|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65423169|NCT01026714|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65423200|NCT00313144|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65423201|NCT00313144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423202|NCT00313144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423203|NCT00313144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65423204|NCT00313144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65423205|NCT00459108|Dasatinib|dasatinib|mesh-list
65423206|NCT00459108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423207|NCT00459108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65423208|NCT00459108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423209|NCT00459108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423210|NCT00328198|Alemtuzumab|alemtuzumab|mesh-list
65423211|NCT00328198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64807995|NCT01431326|Vasodilator Agents|vasodilator agents|mesh-ancestor
65423223|NCT03440892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65423224|NCT03440892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423225|NCT03440892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65423227|NCT03440892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423228|NCT03440892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423229|NCT03440892|Dermatologic Agents|dermatologic agents|mesh-ancestor
65423230|NCT03440892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423231|NCT03440892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65423232|NCT03440892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65423233|NCT03440892|Immunologic Factors|immunologic factors|mesh-ancestor
65423234|NCT03440892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65423235|NCT03440892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65423236|NCT03440892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65423237|NCT03440892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65423238|NCT03440892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65423239|NCT03440892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65423240|NCT03440892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65423241|NCT03440892|Analgesics|analgesics|mesh-ancestor
65423242|NCT03440892|Sensory System Agents|sensory system agents|mesh-ancestor
65423243|NCT03440892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65423244|NCT03440892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65423245|NCT03440892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65423246|NCT00442572|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65423247|NCT00442572|Antiviral Agents|antiviral agents|mesh-ancestor
65423248|NCT00442572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65423249|NCT01023360|Esomeprazole|esomeprazole|mesh-list
65423250|NCT01023360|Rabeprazole|rabeprazole|mesh-list
65423251|NCT01023360|Pantoprazole|pantoprazole|mesh-list
65423252|NCT01023360|Clopidogrel|clopidogrel|mesh-list
65423253|NCT01023360|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65423254|NCT01023360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65423255|NCT01023360|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65423256|NCT01023360|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65423257|NCT01023360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65423258|NCT01023360|Purinergic Agents|purinergic agents|mesh-ancestor
65423259|NCT01023360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65423260|NCT01023360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423261|NCT01023360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423262|NCT01023360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65423263|NCT01023360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65423264|NCT01023360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423265|NCT03685890|Nivolumab|nivolumab|mesh-list
65423266|NCT03685890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65423267|NCT03685890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423268|NCT03685890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65423269|NCT03685890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423270|NCT00442416|Epoetin Alfa|epoetin alfa|mesh-list
65423271|NCT00442416|Hematinics|hematinics|mesh-ancestor
65423272|NCT03674424|Avelumab|avelumab|mesh-list
65423273|NCT03674424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65423274|NCT03674424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172809|NCT00968253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423275|NCT00441792|Midazolam|midazolam|mesh-list
65423303|NCT00312208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65423305|NCT00312208|Antimitotic Agents|antimitotic agents|mesh-ancestor
65423306|NCT00312208|Mitosis Modulators|mitosis modulators|mesh-ancestor
65423307|NCT00312208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65423308|NCT00312208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65423309|NCT00312208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65423310|NCT00312208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423311|NCT00297778|Pramipexole|pramipexole|mesh-list
65423312|NCT00297778|Antioxidants|antioxidants|mesh-ancestor
65423313|NCT00297778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423314|NCT00297778|Protective Agents|protective agents|mesh-ancestor
65423315|NCT00297778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423316|NCT00297778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65423317|NCT00297778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65423318|NCT00297778|Dopamine Agonists|dopamine agonists|mesh-ancestor
65423319|NCT00297778|Dopamine Agents|dopamine agents|mesh-ancestor
65423320|NCT00297778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65423321|NCT03848832|Cannabidiol|cannabidiol|mesh-list
65423322|NCT03848832|Anticonvulsants|anticonvulsants|mesh-ancestor
65423323|NCT00327340|Docetaxel|docetaxel|mesh-list
65423324|NCT00327340|Mitoxantrone|mitoxantrone|mesh-list
65423356|NCT00450216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65423357|NCT00450216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65423358|NCT00450216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65423359|NCT00450216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423360|NCT00450216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423361|NCT00450216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65423362|NCT00450216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65423363|NCT00450216|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65423364|NCT00450216|Histamine Antagonists|histamine antagonists|mesh-ancestor
65423365|NCT00450216|Histamine Agents|histamine agents|mesh-ancestor
64808151|NCT01431924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65423390|NCT05352191|Beclomethasone|beclomethasone|mesh-list
65423391|NCT05352191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65423392|NCT05352191|Glucocorticoids|glucocorticoids|mesh-ancestor
65423393|NCT05352191|Hormones|hormones|mesh-ancestor
65423394|NCT05352191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65423395|NCT05352191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423396|NCT05352191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65423397|NCT05352191|Respiratory System Agents|respiratory system agents|mesh-ancestor
65423398|NCT00954005|Gemcitabine|gemcitabine|mesh-list
65423399|NCT00954005|Rituximab|rituximab|mesh-list
65423400|NCT00954005|Oxaliplatin|oxaliplatin|mesh-list
65423401|NCT00954005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65423402|NCT00954005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423403|NCT00954005|Immunologic Factors|immunologic factors|mesh-ancestor
65423404|NCT00954005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423405|NCT00954005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65423406|NCT00954005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65423407|NCT00954005|Antimetabolites|antimetabolites|mesh-ancestor
65423408|NCT00954005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423409|NCT00954005|Antiviral Agents|antiviral agents|mesh-ancestor
65423410|NCT00954005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65423411|NCT00954005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423412|NCT00954005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65423413|NCT01023750|Fenofibrate|fenofibrate|mesh-list
65423414|NCT01023750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65423415|NCT01023750|Antimetabolites|antimetabolites|mesh-ancestor
65423434|NCT05352113|Antidepressive Agents|antidepressive agents|mesh-list
65423435|NCT05352113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65423436|NCT00547703|Nortriptyline|nortriptyline|mesh-list
65423437|NCT00547703|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65423438|NCT00547703|Antidepressive Agents|antidepressive agents|mesh-ancestor
65423439|NCT00547703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65423440|NCT00547703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65423441|NCT00547703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65423442|NCT00547703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65423443|NCT00547703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423444|NCT00547703|Adrenergic Agents|adrenergic agents|mesh-ancestor
65423445|NCT00547703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65423446|NCT00547703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423447|NCT00297232|Natalizumab|natalizumab|mesh-list
65423448|NCT00297232|Immunologic Factors|immunologic factors|mesh-ancestor
65423449|NCT00297232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423450|NCT01062802|Atorvastatin|atorvastatin|mesh-list
65423451|NCT01062802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65423452|NCT01062802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65423453|NCT01062802|Antimetabolites|antimetabolites|mesh-ancestor
65423454|NCT01062802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423455|NCT01062802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65423456|NCT01062802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65423457|NCT01062802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423458|NCT03867383|Calcium, Dietary|calcium, dietary|mesh-list
65423459|NCT03867383|Calcium|calcium|mesh-list
65423460|NCT03867383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65423461|NCT03867383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423462|NCT03867383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65423463|NCT03824561|Vedolizumab|vedolizumab|mesh-list
65423464|NCT03824561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65423465|NCT00954395|Fibrin Fibrinogen Degradation Products|fibrin fibrinogen degradation products|mesh-list
65423466|NCT00954395|Fibrin fragment D|fibrin fragment d|mesh-list
65423467|NCT00954395|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65423468|NCT00954395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64808241|NCT01432249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65423517|NCT00954785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65423518|NCT00954785|Analgesics|analgesics|mesh-ancestor
65423519|NCT00954785|Sensory System Agents|sensory system agents|mesh-ancestor
65423520|NCT00954785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65423521|NCT00954785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423522|NCT00954785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65423523|NCT00954785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65423524|NCT00954785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65423525|NCT00954785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423526|NCT00954785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423527|NCT00954785|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65423528|NCT00548717|Mycophenolic Acid|mycophenolic acid|mesh-list
65423529|NCT00548717|Sirolimus|sirolimus|mesh-list
65423530|NCT00548717|Bortezomib|bortezomib|mesh-list
65423531|NCT00548717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65423532|NCT00548717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423533|NCT00548717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65423534|NCT00548717|Antitubercular Agents|antitubercular agents|mesh-ancestor
65423535|NCT00548717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65423536|NCT00548717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65423537|NCT00548717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423538|NCT00548717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423539|NCT00548717|Antifungal Agents|antifungal agents|mesh-ancestor
65423540|NCT00548717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65423541|NCT00548717|Immunologic Factors|immunologic factors|mesh-ancestor
65423542|NCT00548717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423543|NCT00441168|Dexamethasone|dexamethasone|mesh-list
65423544|NCT00441168|Vincristine|vincristine|mesh-list
65423545|NCT00441168|Doxorubicin|doxorubicin|mesh-list
65423546|NCT00441168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65423547|NCT00441168|Bortezomib|bortezomib|mesh-list
65423548|NCT00441168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65423549|NCT00441168|Antiemetics|antiemetics|mesh-ancestor
65423550|NCT00441168|Autonomic Agents|autonomic agents|mesh-ancestor
65423551|NCT00441168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65423552|NCT00441168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423553|NCT00441168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65423554|NCT00441168|Glucocorticoids|glucocorticoids|mesh-ancestor
65423555|NCT00441168|Hormones|hormones|mesh-ancestor
65423556|NCT00441168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65423557|NCT00441168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65423558|NCT00441168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423559|NCT00441168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65423560|NCT00441168|Tubulin Modulators|tubulin modulators|mesh-ancestor
65423561|NCT00441168|Antimitotic Agents|antimitotic agents|mesh-ancestor
65423562|NCT00441168|Mitosis Modulators|mitosis modulators|mesh-ancestor
65423563|NCT00441168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423564|NCT00441168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65423565|NCT00441168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65423566|NCT00441168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65423567|NCT00441168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423568|NCT01062958|Vitamins|vitamins|mesh-list
65423569|NCT01062958|Folic Acid|folic acid|mesh-list
65423570|NCT01062958|Vitamin B 12|vitamin b 12|mesh-list
65423597|NCT00457626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65423598|NCT00457626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423600|NCT02748707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65423601|NCT02748707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423602|NCT02748707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65423603|NCT02748707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423604|NCT02748707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423605|NCT02748707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65423606|NCT02748707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65423607|NCT02748707|Analgesics|analgesics|mesh-ancestor
65423608|NCT02748707|Sensory System Agents|sensory system agents|mesh-ancestor
65423609|NCT02748707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65423610|NCT02748707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423611|NCT02748707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65423612|NCT02748707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65423613|NCT02748707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65423614|NCT02748707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65423615|NCT05014061|Adenosine|adenosine|mesh-list
65423616|NCT05014061|Analgesics|analgesics|mesh-ancestor
65423617|NCT05014061|Sensory System Agents|sensory system agents|mesh-ancestor
65423632|NCT00373113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423633|NCT00373113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65423634|NCT00373113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65423636|NCT00373113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423637|NCT00373113|Growth Inhibitors|growth inhibitors|mesh-ancestor
65423638|NCT00373113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65423639|NCT00373113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423640|NCT01045941|Gemcitabine|gemcitabine|mesh-list
65423641|NCT01045941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65423642|NCT01045941|Antimetabolites|antimetabolites|mesh-ancestor
65423643|NCT01045941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423644|NCT01045941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423645|NCT01045941|Antiviral Agents|antiviral agents|mesh-ancestor
65423646|NCT01045941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65423647|NCT01045941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423648|NCT01045941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65423649|NCT01045941|Immunologic Factors|immunologic factors|mesh-ancestor
65423650|NCT01045941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423652|NCT00407511|Analgesics|analgesics|mesh-ancestor
65423653|NCT00407511|Sensory System Agents|sensory system agents|mesh-ancestor
65423654|NCT00407511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65423655|NCT00407511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423656|NCT00407511|Anticonvulsants|anticonvulsants|mesh-ancestor
65423657|NCT00407511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64994237|NCT00089453|Hormones|hormones|mesh-ancestor
65423658|NCT00407511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65423659|NCT00407511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423660|NCT00407511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65423661|NCT00407511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65423662|NCT00407511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65423663|NCT00407511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65423664|NCT00407511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65423665|NCT00384189|Ciclesonide|ciclesonide|mesh-list
65423666|NCT00384189|Albuterol|albuterol|mesh-list
65423667|NCT00384189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65423668|NCT00384189|Autonomic Agents|autonomic agents|mesh-ancestor
65423669|NCT00384189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65423670|NCT00384189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423671|NCT00384189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65423672|NCT00384189|Respiratory System Agents|respiratory system agents|mesh-ancestor
65423673|NCT00384189|Tocolytic Agents|tocolytic agents|mesh-ancestor
65423674|NCT00384189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65423675|NCT00384189|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65423676|NCT00384189|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65423688|NCT00326716|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65423689|NCT00326716|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65423690|NCT00326716|Protease Inhibitors|protease inhibitors|mesh-ancestor
65423691|NCT00326716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423692|NCT00326716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423693|NCT00326716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65423694|NCT00326716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65423695|NCT00326716|Antiviral Agents|antiviral agents|mesh-ancestor
65423696|NCT00326716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65423697|NCT00326716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65423698|NCT00326716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65423699|NCT00326716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65423700|NCT00326716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65423702|NCT01063192|Gemcitabine|gemcitabine|mesh-list
65423703|NCT01063192|Fluorouracil|fluorouracil|mesh-list
65423704|NCT01063192|Oxaliplatin|oxaliplatin|mesh-list
65423705|NCT01063192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65423706|NCT01063192|Antimetabolites|antimetabolites|mesh-ancestor
65423707|NCT01063192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423708|NCT01063192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423709|NCT01063192|Antiviral Agents|antiviral agents|mesh-ancestor
65423710|NCT01063192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65423711|NCT01063192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423712|NCT01063192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65423713|NCT01063192|Immunologic Factors|immunologic factors|mesh-ancestor
65423714|NCT01063192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423715|NCT01063192|Antidotes|antidotes|mesh-ancestor
65423716|NCT01063192|Protective Agents|protective agents|mesh-ancestor
65423717|NCT01063192|Vitamin B Complex|vitamin b complex|mesh-ancestor
65423718|NCT01063192|Vitamins|vitamins|mesh-ancestor
65423719|NCT01063192|Micronutrients|micronutrients|mesh-ancestor
65423720|NCT03978988|Aspirin|aspirin|mesh-list
65423721|NCT03978988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65423722|NCT03978988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65423723|NCT03978988|Analgesics|analgesics|mesh-ancestor
65423724|NCT03978988|Sensory System Agents|sensory system agents|mesh-ancestor
65423725|NCT03978988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65423726|NCT03978988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423727|NCT03978988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65423728|NCT03978988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65423729|NCT03978988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65423730|NCT03978988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65423731|NCT03978988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423732|NCT03978988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65423733|NCT03978988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65423734|NCT03978988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423735|NCT03978988|Antipyretics|antipyretics|mesh-ancestor
65423736|NCT01063426|Enoxaparin|enoxaparin|mesh-list
65423737|NCT01063426|Enoxaparin sodium|enoxaparin sodium|mesh-list
65423738|NCT01063426|Atorvastatin|atorvastatin|mesh-list
65423739|NCT01063426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65423740|NCT01063426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65423778|NCT00959075|Micronutrients|micronutrients|mesh-ancestor
65423779|NCT00959075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423780|NCT00959075|Vitamin B Complex|vitamin b complex|mesh-ancestor
65274219|NCT02354898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65423781|NCT00295750|Leuprolide|leuprolide|mesh-list
65423782|NCT00295750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65423807|NCT00959231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65423808|NCT00959231|Dermatologic Agents|dermatologic agents|mesh-ancestor
65423809|NCT00959231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65423810|NCT00959231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65423811|NCT00959231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65423812|NCT00959231|Antitubercular Agents|antitubercular agents|mesh-ancestor
65423813|NCT00959231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65423814|NCT03948581|Vedolizumab|vedolizumab|mesh-list
65423815|NCT03948581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65423816|NCT00548327|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65423817|NCT00548327|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65423818|NCT00548327|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65423819|NCT00548327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65423820|NCT00548327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423821|NCT00548327|Adrenergic Agents|adrenergic agents|mesh-ancestor
65423822|NCT00548327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65423823|NCT00548327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423825|NCT04720547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65423826|NCT04720547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65423827|NCT04720547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65423828|NCT04720547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423829|NCT04720547|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65423830|NCT04720547|GABA Agonists|gaba agonists|mesh-ancestor
65423831|NCT04720547|GABA Agents|gaba agents|mesh-ancestor
65423832|NCT04720547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65423833|NCT04720547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423859|NCT00959621|Sensory System Agents|sensory system agents|mesh-ancestor
65423860|NCT00959621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65423861|NCT00959621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423862|NCT00959621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65423864|NCT00959621|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65423865|NCT00959621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65423866|NCT00959621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423867|NCT00959621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65423868|NCT00959621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65423869|NCT00959621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423870|NCT00959621|Antipyretics|antipyretics|mesh-ancestor
65423871|NCT00959777|Lenograstim|lenograstim|mesh-list
65423872|NCT00959777|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65423873|NCT00959777|Immunologic Factors|immunologic factors|mesh-ancestor
65423874|NCT00959777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423875|NCT00959933|Ribavirin|ribavirin|mesh-list
65423876|NCT00959933|Antimetabolites|antimetabolites|mesh-ancestor
65173421|NCT01221350|Vitamins|vitamins|mesh-ancestor
65423877|NCT00959933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423878|NCT00959933|Antiviral Agents|antiviral agents|mesh-ancestor
65423879|NCT00959933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65423880|NCT00960245|Nadolol|nadolol|mesh-list
65423905|NCT00960479|Antimetabolites|antimetabolites|mesh-ancestor
65423906|NCT00960479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423907|NCT00960479|Antiviral Agents|antiviral agents|mesh-ancestor
65423908|NCT00960479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65423909|NCT00960557|Combretastatin|combretastatin|mesh-list
65423910|NCT00960557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65423911|NCT00960557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423912|NCT00960557|Tubulin Modulators|tubulin modulators|mesh-ancestor
65423913|NCT00960557|Antimitotic Agents|antimitotic agents|mesh-ancestor
65423914|NCT00960557|Mitosis Modulators|mitosis modulators|mesh-ancestor
65423915|NCT00960557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423916|NCT00960635|Vitamin D|vitamin d|mesh-list
65423917|NCT00960635|Cholecalciferol|cholecalciferol|mesh-list
65423918|NCT00960635|Calcitriol|calcitriol|mesh-list
65423919|NCT00960635|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
65423920|NCT00960635|Vitamins|vitamins|mesh-ancestor
65423921|NCT00960635|Micronutrients|micronutrients|mesh-ancestor
65423922|NCT00960635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423923|NCT00960635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65423924|NCT00960635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65423925|NCT00960635|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65423926|NCT00960635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64994382|NCT00335179|Imiquimod|imiquimod|mesh-list
65423927|NCT00960635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423928|NCT00960635|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65423929|NCT00960713|Rituximab|rituximab|mesh-list
64808708|NCT01435252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423947|NCT00962507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423948|NCT00384033|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65423949|NCT00384033|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65423950|NCT00384033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65423951|NCT00384033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65423952|NCT00384033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65423953|NCT00384033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423954|NCT00384033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65423955|NCT00384033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423956|NCT00384033|Analgesics|analgesics|mesh-ancestor
65423957|NCT00384033|Sensory System Agents|sensory system agents|mesh-ancestor
65423958|NCT00384033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65423959|NCT00384033|Antidepressive Agents|antidepressive agents|mesh-ancestor
65423960|NCT00384033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65423961|NCT00384033|Dopamine Agents|dopamine agents|mesh-ancestor
65423962|NCT00962663|Ibuprofen|ibuprofen|mesh-list
65423963|NCT00962663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65423964|NCT00962663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65423965|NCT00962663|Analgesics|analgesics|mesh-ancestor
65423966|NCT00962663|Sensory System Agents|sensory system agents|mesh-ancestor
65423967|NCT00962663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65423968|NCT00962663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423969|NCT00962663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65423970|NCT00962663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65423971|NCT00962663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65423972|NCT00962663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423973|NCT00962663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423974|NCT00962975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65423975|NCT00962975|Antiviral Agents|antiviral agents|mesh-ancestor
65423976|NCT00962975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65423977|NCT00075387|Sodium thiosulfate|sodium thiosulfate|mesh-list
65423978|NCT00075387|Cyclophosphamide|cyclophosphamide|mesh-list
65423979|NCT00075387|Carboplatin|carboplatin|mesh-list
65423980|NCT00075387|Etoposide|etoposide|mesh-list
65423981|NCT00075387|Etoposide phosphate|etoposide phosphate|mesh-list
65423982|NCT00075387|Antidotes|antidotes|mesh-list
65423983|NCT00075387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65423984|NCT00075387|Immunologic Factors|immunologic factors|mesh-ancestor
65423985|NCT00075387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423986|NCT00075387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65424001|NCT00075387|Chelating Agents|chelating agents|mesh-ancestor
65424002|NCT00075387|Sequestering Agents|sequestering agents|mesh-ancestor
65424003|NCT00963131|Antioxidants|antioxidants|mesh-list
65424004|NCT00963131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424005|NCT00963131|Protective Agents|protective agents|mesh-ancestor
65424006|NCT00963131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424007|NCT00963209|Tamoxifen|tamoxifen|mesh-list
65424008|NCT00963209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65424009|NCT00963209|Hormone Antagonists|hormone antagonists|mesh-ancestor
65424010|NCT00963209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65424011|NCT00963209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424012|NCT00963209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65424013|NCT00963209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424014|NCT00963209|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65424015|NCT00963209|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65424016|NCT00963209|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65424017|NCT00963443|Aspirin|aspirin|mesh-list
65424018|NCT00963443|Pseudoephedrine|pseudoephedrine|mesh-list
65424019|NCT00963443|Ephedrine|ephedrine|mesh-list
65424020|NCT00963443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65424021|NCT00963443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65424022|NCT00963443|Analgesics|analgesics|mesh-ancestor
65424023|NCT00963443|Sensory System Agents|sensory system agents|mesh-ancestor
65424024|NCT00963443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65173560|NCT01217060|Dexamethasone|dexamethasone|mesh-list
65424025|NCT00963443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424026|NCT00963443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65424027|NCT00963443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65424028|NCT00963443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65424029|NCT00963443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65424030|NCT00963443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424031|NCT00963443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65424032|NCT00963443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65424033|NCT00963443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424034|NCT00963443|Antipyretics|antipyretics|mesh-ancestor
65424035|NCT00963443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65424036|NCT00963443|Autonomic Agents|autonomic agents|mesh-ancestor
65424037|NCT00963443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65424038|NCT00963443|Respiratory System Agents|respiratory system agents|mesh-ancestor
65424039|NCT00963443|Nasal Decongestants|nasal decongestants|mesh-ancestor
65424040|NCT00963443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65424041|NCT00963443|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65424042|NCT00963443|Sympathomimetics|sympathomimetics|mesh-ancestor
65424043|NCT00963443|Adrenergic Agents|adrenergic agents|mesh-ancestor
65424044|NCT00963443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65424077|NCT00546377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424078|NCT00546377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65424079|NCT00546377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65424080|NCT00546377|Analgesics|analgesics|mesh-ancestor
65424081|NCT00546377|Sensory System Agents|sensory system agents|mesh-ancestor
65424082|NCT00546377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65424083|NCT00546377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65424084|NCT00546377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65424085|NCT00546377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424086|NCT00546377|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65424087|NCT00967967|Mometasone Furoate|mometasone furoate|mesh-list
65424088|NCT00967967|Desloratadine|desloratadine|mesh-list
65424089|NCT00967967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65424103|NCT00964457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424104|NCT00964535|Budesonide|budesonide|mesh-list
65424105|NCT00964535|Formoterol Fumarate|formoterol fumarate|mesh-list
65424106|NCT00964535|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65424107|NCT00964535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65424108|NCT00964535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65424109|NCT00964535|Autonomic Agents|autonomic agents|mesh-ancestor
65424110|NCT00964535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65424111|NCT00964535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424112|NCT00964535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65424113|NCT00964535|Respiratory System Agents|respiratory system agents|mesh-ancestor
65424114|NCT00964535|Glucocorticoids|glucocorticoids|mesh-ancestor
65424115|NCT00964535|Hormones|hormones|mesh-ancestor
65424116|NCT00964535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65424117|NCT00964535|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65424118|NCT00964535|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65424119|NCT00964535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65424120|NCT00964535|Adrenergic Agents|adrenergic agents|mesh-ancestor
65424121|NCT00964535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65424122|NCT00964535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424123|NCT00964691|Chloroquine|chloroquine|mesh-list
65424124|NCT00964691|Pyrimethamine|pyrimethamine|mesh-list
65424125|NCT00964691|Sulfadoxine|sulfadoxine|mesh-list
65424126|NCT00964691|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65424127|NCT00964691|Amebicides|amebicides|mesh-ancestor
65424128|NCT00964691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65424129|NCT00964691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65424130|NCT00964691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65424131|NCT00964691|Antimalarials|antimalarials|mesh-ancestor
65424132|NCT00964691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65424133|NCT00964691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65424134|NCT00964691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424135|NCT00964691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424136|NCT00964691|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65424137|NCT00964691|Renal Agents|renal agents|mesh-ancestor
65424138|NCT00964769|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65424139|NCT00964769|Immunologic Factors|immunologic factors|mesh-ancestor
65424140|NCT00964769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424141|NCT00968435|Bevacizumab|bevacizumab|mesh-list
65424142|NCT00968435|Cetuximab|cetuximab|mesh-list
65424143|NCT00968435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65424144|NCT00968435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424145|NCT00968435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65424146|NCT00968435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65424147|NCT00968435|Growth Substances|growth substances|mesh-ancestor
65424148|NCT00968435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424149|NCT00968435|Growth Inhibitors|growth inhibitors|mesh-ancestor
65424185|NCT00969137|Cholinergic Agents|cholinergic agents|mesh-ancestor
65424186|NCT00969137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65424187|NCT00969137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424188|NCT00965315|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65424220|NCT00965393|Kininogens|kininogens|mesh-list
65424221|NCT00965393|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
65424222|NCT00965393|Vasodilator Agents|vasodilator agents|mesh-ancestor
65424223|NCT00965393|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65424224|NCT00965393|Protease Inhibitors|protease inhibitors|mesh-ancestor
65424225|NCT00965393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424226|NCT00965393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424227|NCT00965549|Insulin|insulin|mesh-list
65424228|NCT00965549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65424229|NCT00965549|Insulin Glargine|insulin glargine|mesh-list
65424230|NCT00965549|Insulin Aspart|insulin aspart|mesh-list
64809027|NCT01437592|Insulin|insulin|mesh-list
65424266|NCT00967109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424267|NCT00967109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65424268|NCT00967109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65424269|NCT00545753|Permethrin|permethrin|mesh-list
64809061|NCT01437748|Bromides|bromides|mesh-list
65424316|NCT00971165|Natriuretic Agents|natriuretic agents|mesh-ancestor
65424317|NCT00971165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424318|NCT00971165|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65424319|NCT00971165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65424320|NCT00971165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65424321|NCT00971165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65424322|NCT00971165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65173861|NCT00648817|Tenofovir|tenofovir|mesh-list
65424324|NCT00971399|Ondansetron|ondansetron|mesh-list
65424325|NCT00971399|Ramosetron|ramosetron|mesh-list
65424326|NCT00971399|Antiemetics|antiemetics|mesh-ancestor
65424327|NCT00971399|Autonomic Agents|autonomic agents|mesh-ancestor
65424328|NCT00971399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65424329|NCT00971399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424330|NCT00971399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65424331|NCT00971399|Antipruritics|antipruritics|mesh-ancestor
65424332|NCT00971399|Dermatologic Agents|dermatologic agents|mesh-ancestor
65424333|NCT00971399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65424334|NCT00971399|Serotonin Agents|serotonin agents|mesh-ancestor
65424335|NCT00971399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65424336|NCT00971399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424337|NCT00971399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65424338|NCT00971399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65424339|NCT00971399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65424340|NCT00971399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65424341|NCT00971399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65424342|NCT00973505|Anastrozole|anastrozole|mesh-list
65424343|NCT00973505|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65424344|NCT00973505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424345|NCT00973505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65424346|NCT00973505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424347|NCT00973505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424348|NCT00973505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65424349|NCT00973505|Hormone Antagonists|hormone antagonists|mesh-ancestor
65424350|NCT00973505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65424351|NCT00973505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424352|NCT00973505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65424353|NCT00973583|Vitamin D|vitamin d|mesh-list
65424354|NCT00973583|Vitamins|vitamins|mesh-ancestor
65424355|NCT00973583|Micronutrients|micronutrients|mesh-ancestor
65424356|NCT00973583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424357|NCT00973583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65424358|NCT00972101|Mycophenolic Acid|mycophenolic acid|mesh-list
65424359|NCT00972101|Rituximab|rituximab|mesh-list
65424360|NCT00972101|Fludarabine|fludarabine|mesh-list
65424361|NCT00972101|Fludarabine phosphate|fludarabine phosphate|mesh-list
65424362|NCT00972101|Etoposide|etoposide|mesh-list
65424363|NCT00972101|Melphalan|melphalan|mesh-list
65424364|NCT00972101|Thiotepa|thiotepa|mesh-list
65424365|NCT00972101|Tacrolimus|tacrolimus|mesh-list
65424366|NCT00972101|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65424367|NCT00972101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65424380|NCT00972101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424381|NCT00972101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65424382|NCT00972101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65424383|NCT00972101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65424384|NCT00972101|Antitubercular Agents|antitubercular agents|mesh-ancestor
65424385|NCT00972101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65424386|NCT00972101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65424387|NCT00972101|Alkylating Agents|alkylating agents|mesh-ancestor
65424388|NCT00972101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65424389|NCT00325468|Denosumab|denosumab|mesh-list
65424390|NCT00325468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65424391|NCT00325468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424392|NCT00972257|Timolol|timolol|mesh-list
65424393|NCT00972257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65424394|NCT00972257|Dorzolamide|dorzolamide|mesh-list
65424395|NCT00972257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65424396|NCT00972257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65424397|NCT00972257|Adrenergic Agents|adrenergic agents|mesh-ancestor
65424398|NCT00972257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65424399|NCT00972257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424400|NCT00972257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424401|NCT00972257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65424402|NCT00972257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65424403|NCT00972257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65424404|NCT00972257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65424405|NCT00972257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65424406|NCT00972257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65424407|NCT00972257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424408|NCT00311584|Irinotecan|irinotecan|mesh-list
65424409|NCT00311584|Temozolomide|temozolomide|mesh-list
65424410|NCT00311584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65424411|NCT00311584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65424412|NCT00311584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424413|NCT00311584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424414|NCT00311584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424415|NCT00311584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65424416|NCT00311584|Alkylating Agents|alkylating agents|mesh-ancestor
65424417|NCT00383331|Gemcitabine|gemcitabine|mesh-list
65424418|NCT00383331|Pemetrexed|pemetrexed|mesh-list
65424419|NCT00383331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65424420|NCT00383331|Antimetabolites|antimetabolites|mesh-ancestor
65424421|NCT00383331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424422|NCT00383331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424423|NCT00383331|Antiviral Agents|antiviral agents|mesh-ancestor
65424424|NCT00383331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65424425|NCT00383331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424426|NCT00383331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65424427|NCT00383331|Immunologic Factors|immunologic factors|mesh-ancestor
65424428|NCT00383331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424451|NCT00325234|Tubulin Modulators|tubulin modulators|mesh-ancestor
65424452|NCT00325234|Antimitotic Agents|antimitotic agents|mesh-ancestor
65424453|NCT00325234|Mitosis Modulators|mitosis modulators|mesh-ancestor
65424454|NCT01063504|Teriparatide|teriparatide|mesh-list
65424455|NCT01063504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65424456|NCT01063504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424457|NCT01063504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65424458|NCT00366249|Ertapenem|ertapenem|mesh-list
65424459|NCT00366249|Tigecycline|tigecycline|mesh-list
65424460|NCT00366249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65424461|NCT00366249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65424462|NCT00366249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65424463|NCT00366249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424464|NCT00366249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424465|NCT03927911|Bupivacaine|bupivacaine|mesh-list
65424466|NCT03927911|Anesthetics, Local|anesthetics, local|mesh-ancestor
65424467|NCT03927911|Anesthetics|anesthetics|mesh-ancestor
65424468|NCT03927911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65424469|NCT03927911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424470|NCT03927911|Sensory System Agents|sensory system agents|mesh-ancestor
65424471|NCT03927911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65424472|NCT00383019|Latanoprost|latanoprost|mesh-list
65424473|NCT00383019|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65424474|NCT00383019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65424476|NCT00310804|Immunologic Factors|immunologic factors|mesh-ancestor
65424477|NCT00310804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424478|NCT00590187|Sapacitabine|sapacitabine|mesh-list
65424479|NCT00590187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270021|NCT04189250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424480|NCT03978364|Azacitidine|azacitidine|mesh-list
65424481|NCT03978364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65424482|NCT03978364|Antimetabolites|antimetabolites|mesh-ancestor
64420402|NCT05489185|Coagulants|coagulants|mesh-ancestor
65424512|NCT03978286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65424513|NCT03978286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65424514|NCT03978286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65424515|NCT03978286|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65424516|NCT03978286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65424517|NCT03933449|Paclitaxel|paclitaxel|mesh-list
65424518|NCT03933449|Docetaxel|docetaxel|mesh-list
65424519|NCT03933449|Pembrolizumab|pembrolizumab|mesh-list
65424520|NCT03933449|Irinotecan|irinotecan|mesh-list
65424521|NCT03933449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65424522|NCT03933449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424523|NCT03933449|Tubulin Modulators|tubulin modulators|mesh-ancestor
65424524|NCT03933449|Antimitotic Agents|antimitotic agents|mesh-ancestor
65424525|NCT03933449|Mitosis Modulators|mitosis modulators|mesh-ancestor
64809306|NCT05164146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65424537|NCT00974441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424539|NCT00974441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65424540|NCT00974441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65424541|NCT00974441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65424542|NCT01049451|Methylprednisolone|methylprednisolone|mesh-list
65424543|NCT01049451|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65424544|NCT01049451|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65424545|NCT01049451|Prednisolone|prednisolone|mesh-list
65424546|NCT01049451|Prednisolone acetate|prednisolone acetate|mesh-list
65424547|NCT01049451|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65424548|NCT01049451|Prednisolone phosphate|prednisolone phosphate|mesh-list
65424549|NCT01049451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65424550|NCT01049451|Antiemetics|antiemetics|mesh-ancestor
65424551|NCT01049451|Autonomic Agents|autonomic agents|mesh-ancestor
65424552|NCT01049451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65424553|NCT01049451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424554|NCT01049451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65424555|NCT01049451|Glucocorticoids|glucocorticoids|mesh-ancestor
65424556|NCT01049451|Hormones|hormones|mesh-ancestor
65424557|NCT01049451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65424558|NCT01049451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65424559|NCT01049451|Protective Agents|protective agents|mesh-ancestor
65424560|NCT01049451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65424561|NCT01049451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424562|NCT00972569|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65424563|NCT00972569|Natriuretic Agents|natriuretic agents|mesh-ancestor
65424564|NCT00972569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424565|NCT00974753|Ketorolac|ketorolac|mesh-list
65424566|NCT00974753|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65424567|NCT00974753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65424568|NCT00974753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65424569|NCT00974753|Analgesics|analgesics|mesh-ancestor
65424570|NCT00974753|Sensory System Agents|sensory system agents|mesh-ancestor
65424571|NCT00974753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65424572|NCT00974753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424573|NCT00974753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65424574|NCT00974753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65424575|NCT00974753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65424576|NCT00974753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424577|NCT00974753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424578|NCT00972803|Chlorhexidine|chlorhexidine|mesh-list
65424579|NCT00972803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65424580|NCT00972803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65424581|NCT00972803|Disinfectants|disinfectants|mesh-ancestor
65424582|NCT02908269|Vaccines|vaccines|mesh-list
65424583|NCT02908269|Immunologic Factors|immunologic factors|mesh-ancestor
65424584|NCT02908269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424585|NCT00974987|Temozolomide|temozolomide|mesh-list
65424586|NCT00974987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65424587|NCT00974987|Alkylating Agents|alkylating agents|mesh-ancestor
64809353|NCT04955470|Midazolam|midazolam|mesh-list
65424615|NCT00290758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424616|NCT00290758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424617|NCT00290758|Phytoestrogens|phytoestrogens|mesh-ancestor
65424618|NCT00290758|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65424619|NCT00290758|Estrogens|estrogens|mesh-ancestor
65424621|NCT00290758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65424622|NCT00975299|Bombesin|bombesin|mesh-list
65424623|NCT00975299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65424624|NCT00975299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424625|NCT00975299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424626|NCT01060930|Epinephrine|epinephrine|mesh-list
65424627|NCT01060930|Norepinephrine|norepinephrine|mesh-list
65424628|NCT01060930|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
65424629|NCT01060930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65424630|NCT01060930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65424631|NCT01060930|Adrenergic Agents|adrenergic agents|mesh-ancestor
65424632|NCT01060930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65424633|NCT01060930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424644|NCT01060930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424645|NCT00973037|Tamoxifen|tamoxifen|mesh-list
65424646|NCT00973037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65424647|NCT00973037|Hormone Antagonists|hormone antagonists|mesh-ancestor
65424648|NCT00973037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65424649|NCT00973037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424650|NCT00973037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65424651|NCT00973037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424652|NCT00973037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65424653|NCT00973037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65424654|NCT00973037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65424655|NCT00973115|Simvastatin|simvastatin|mesh-list
65424656|NCT00973115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65424657|NCT00973115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65424658|NCT00973115|Antimetabolites|antimetabolites|mesh-ancestor
65424659|NCT00973115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424660|NCT00973115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65424661|NCT00973115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65424662|NCT00973115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424663|NCT00973193|Panitumumab|panitumumab|mesh-list
65424664|NCT00973193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65424665|NCT00973193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424666|NCT00975533|Insulin|insulin|mesh-list
65424667|NCT00975533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65424668|NCT00975533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424669|NCT00372567|Sunitinib|sunitinib|mesh-list
65424670|NCT00372567|Imatinib Mesylate|imatinib mesylate|mesh-list
65424671|NCT00372567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424672|NCT00372567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65424673|NCT00372567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65424674|NCT00372567|Growth Substances|growth substances|mesh-ancestor
65424675|NCT00372567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424676|NCT00372567|Growth Inhibitors|growth inhibitors|mesh-ancestor
65424677|NCT00372567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65424678|NCT00372567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424679|NCT00372567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424680|NCT00973271|Atorvastatin|atorvastatin|mesh-list
65424681|NCT00973271|Fenofibric acid|fenofibric acid|mesh-list
65424682|NCT00973271|Fenofibrate|fenofibrate|mesh-list
65424683|NCT00973271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65424684|NCT00973271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65424685|NCT00973271|Antimetabolites|antimetabolites|mesh-ancestor
65424686|NCT00973271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424687|NCT00973271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65424688|NCT00973271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65424689|NCT00973271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424690|NCT00975767|Docetaxel|docetaxel|mesh-list
65424691|NCT00975767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65424692|NCT00975767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424693|NCT00975767|Tubulin Modulators|tubulin modulators|mesh-ancestor
65424694|NCT00975767|Antimitotic Agents|antimitotic agents|mesh-ancestor
65424695|NCT00975767|Mitosis Modulators|mitosis modulators|mesh-ancestor
65424696|NCT00975767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809463|NCT04800692|Vasodilator Agents|vasodilator agents|mesh-ancestor
65424722|NCT00979589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65424723|NCT00979589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65424724|NCT00979589|Analgesics|analgesics|mesh-ancestor
65424725|NCT00979589|Sensory System Agents|sensory system agents|mesh-ancestor
64994828|NCT00345163|Irinotecan|irinotecan|mesh-list
65424726|NCT00979589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65424727|NCT00979589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65424728|NCT00979589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65424729|NCT00979589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65424730|NCT00979589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65424731|NCT00979589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65424732|NCT00979589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424733|NCT00979589|Antipyretics|antipyretics|mesh-ancestor
65424735|NCT00294658|Prednisolone|prednisolone|mesh-list
65424736|NCT00294658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65424737|NCT00294658|Glucocorticoids|glucocorticoids|mesh-ancestor
65424738|NCT00294658|Hormones|hormones|mesh-ancestor
65424739|NCT00294658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65424740|NCT00294658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424741|NCT00294658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65424742|NCT00294658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424743|NCT00979667|Oseltamivir|oseltamivir|mesh-list
65424744|NCT00979667|Zanamivir|zanamivir|mesh-list
65424752|NCT03978052|Protective Agents|protective agents|mesh-ancestor
65424753|NCT03978052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424754|NCT03978052|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65424755|NCT03978052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65424756|NCT03978052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424757|NCT03978052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65424758|NCT03923933|Chlorthalidone|chlorthalidone|mesh-list
65424759|NCT03923933|Bumetanide|bumetanide|mesh-list
65424760|NCT03923933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65424761|NCT03923933|Diuretics|diuretics|mesh-ancestor
65424762|NCT03923933|Natriuretic Agents|natriuretic agents|mesh-ancestor
65424763|NCT03923933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424764|NCT03923933|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65424765|NCT03923933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65424766|NCT03923933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424767|NCT03923933|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65424768|NCT01066468|Imatinib Mesylate|imatinib mesylate|mesh-list
65424769|NCT01066468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424770|NCT01066468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65424771|NCT01066468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424772|NCT01066468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424773|NCT00980135|Hydrocortisone|hydrocortisone|mesh-list
65424774|NCT00980135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65424775|NCT00980213|Sunitinib|sunitinib|mesh-list
65424776|NCT00980213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424777|NCT00980213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65424778|NCT00980213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65424779|NCT00980213|Growth Substances|growth substances|mesh-ancestor
65424780|NCT00980213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424781|NCT00980213|Growth Inhibitors|growth inhibitors|mesh-ancestor
65424782|NCT00980213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65424783|NCT00980213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424784|NCT00980213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424785|NCT00976469|Vaccines|vaccines|mesh-list
65424786|NCT00976469|Immunologic Factors|immunologic factors|mesh-ancestor
65424787|NCT00976469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424788|NCT00980603|Docetaxel|docetaxel|mesh-list
65424789|NCT00980603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424790|NCT00980603|Tubulin Modulators|tubulin modulators|mesh-ancestor
65424791|NCT00980603|Antimitotic Agents|antimitotic agents|mesh-ancestor
65424792|NCT00980603|Mitosis Modulators|mitosis modulators|mesh-ancestor
65424793|NCT00980603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424794|NCT00274456|Paclitaxel|paclitaxel|mesh-list
65424795|NCT00274456|Docetaxel|docetaxel|mesh-list
65424796|NCT00274456|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65424797|NCT00274456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65424798|NCT00274456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424799|NCT00274456|Tubulin Modulators|tubulin modulators|mesh-ancestor
65424800|NCT00274456|Antimitotic Agents|antimitotic agents|mesh-ancestor
65424801|NCT00274456|Mitosis Modulators|mitosis modulators|mesh-ancestor
65424802|NCT00274456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424803|NCT00977093|Pentetic Acid|pentetic acid|mesh-list
65424804|NCT00977093|Antidotes|antidotes|mesh-ancestor
65424805|NCT00977093|Protective Agents|protective agents|mesh-ancestor
65424806|NCT00977093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424807|NCT00977093|Chelating Agents|chelating agents|mesh-ancestor
65424808|NCT00977093|Sequestering Agents|sequestering agents|mesh-ancestor
65424809|NCT00977093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424810|NCT00977093|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65424811|NCT00977249|Varenicline|varenicline|mesh-list
65424859|NCT00273052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65424860|NCT00273052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65424861|NCT01046721|Exenatide|exenatide|mesh-list
65424862|NCT01046721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65424863|NCT01046721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424864|NCT01046721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65424865|NCT01046721|Incretins|incretins|mesh-ancestor
65424866|NCT01046721|Hormones|hormones|mesh-ancestor
65424867|NCT01046721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65424868|NCT01046799|Entecavir|entecavir|mesh-list
65424869|NCT01046799|Antiviral Agents|antiviral agents|mesh-ancestor
65424870|NCT01046799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65424871|NCT00290290|Chlorhexidine|chlorhexidine|mesh-list
65424872|NCT00290290|Povidone-Iodine|povidone-iodine|mesh-list
65424873|NCT00290290|Povidone|povidone|mesh-list
65424874|NCT00290290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65424875|NCT00290290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65424876|NCT00290290|Disinfectants|disinfectants|mesh-ancestor
65424877|NCT00290290|Plasma Substitutes|plasma substitutes|mesh-ancestor
65424878|NCT00290290|Blood Substitutes|blood substitutes|mesh-ancestor
65424879|NCT01049685|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65424880|NCT01049685|Antiviral Agents|antiviral agents|mesh-ancestor
65424881|NCT01049685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65424882|NCT01580943|Chlorhexidine|chlorhexidine|mesh-list
65424883|NCT01580943|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65424884|NCT01580943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65424885|NCT01580943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65424886|NCT01580943|Disinfectants|disinfectants|mesh-ancestor
65424887|NCT01580943|Dermatologic Agents|dermatologic agents|mesh-ancestor
65424888|NCT02534961|Cefazolin|cefazolin|mesh-list
65424889|NCT02534961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65424890|NCT02534961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65424891|NCT01046955|Alemtuzumab|alemtuzumab|mesh-list
65424892|NCT01046955|Thymoglobulin|thymoglobulin|mesh-list
65424893|NCT01046955|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65424894|NCT01046955|Daclizumab|daclizumab|mesh-list
65424895|NCT01046955|Immunologic Factors|immunologic factors|mesh-ancestor
65424896|NCT01046955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424897|NCT01046955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65424898|NCT01046955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65424899|NCT01046955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424900|NCT00272038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65424901|NCT00272038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424902|NCT00272038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65424916|NCT00381693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424917|NCT00545363|Ibandronic Acid|ibandronic acid|mesh-list
65424918|NCT00545363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65174461|NCT00650455|Naproxen|naproxen|mesh-list
65424919|NCT00545363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424920|NCT00977405|Gentamicins|gentamicins|mesh-list
65424921|NCT00977405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65424922|NCT00977405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65424923|NCT00977405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65424924|NCT00977405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424925|NCT00977405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424926|NCT00977795|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65424927|NCT00977795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65424928|NCT00977795|Dermatologic Agents|dermatologic agents|mesh-ancestor
65424929|NCT00977873|Cholecalciferol|cholecalciferol|mesh-list
65424930|NCT00977873|Vitamin D|vitamin d|mesh-list
65424931|NCT00977873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65424932|NCT00977873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424933|NCT00977873|Vitamins|vitamins|mesh-ancestor
65424934|NCT00977873|Micronutrients|micronutrients|mesh-ancestor
65424935|NCT00977873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65424936|NCT00457392|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65424937|NCT00457392|Sunitinib|sunitinib|mesh-list
65424938|NCT00457392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424939|NCT00457392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65424940|NCT00457392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424941|NCT00457392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424942|NCT00457392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65424943|NCT00457392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65424944|NCT00457392|Growth Substances|growth substances|mesh-ancestor
65424945|NCT00457392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424946|NCT00457392|Growth Inhibitors|growth inhibitors|mesh-ancestor
65424947|NCT00545051|Ibandronic Acid|ibandronic acid|mesh-list
65424948|NCT00545051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65424949|NCT00545051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424950|NCT00381615|Vaccines|vaccines|mesh-list
65424951|NCT00381615|Immunologic Factors|immunologic factors|mesh-ancestor
65424952|NCT00381615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424953|NCT00978107|Flucytosine|flucytosine|mesh-list
65424954|NCT00978107|Antifungal Agents|antifungal agents|mesh-ancestor
65424955|NCT00978107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65424956|NCT00978107|Antimetabolites|antimetabolites|mesh-ancestor
65424957|NCT00978107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424958|NCT01029132|Galantamine|galantamine|mesh-list
65424959|NCT01029132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65424960|NCT01029132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424961|NCT01029132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424962|NCT01029132|Cholinergic Agents|cholinergic agents|mesh-ancestor
65424991|NCT01049841|Antifungal Agents|antifungal agents|mesh-ancestor
65424992|NCT01049841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65424993|NCT01049841|Immunologic Factors|immunologic factors|mesh-ancestor
65424994|NCT01049841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424995|NCT00978263|Metformin|metformin|mesh-list
65424996|NCT00978263|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65424997|NCT00978263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424999|NCT00981851|Tiotropium Bromide|tiotropium bromide|mesh-list
65425000|NCT00981851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65425001|NCT00981851|Autonomic Agents|autonomic agents|mesh-ancestor
65425002|NCT00981851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65425003|NCT00981851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425004|NCT00981851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65425005|NCT00981851|Respiratory System Agents|respiratory system agents|mesh-ancestor
65425006|NCT00981851|Parasympatholytics|parasympatholytics|mesh-ancestor
65425007|NCT00981851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65425008|NCT00981851|Cholinergic Agents|cholinergic agents|mesh-ancestor
65425009|NCT00981851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64809790|NCT03227731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65425019|NCT00981929|Caffeine|caffeine|mesh-list
65425020|NCT00981929|Omeprazole|omeprazole|mesh-list
65425021|NCT00981929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65425022|NCT00981929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65425023|NCT00981929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65425024|NCT00981929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65425025|NCT00981929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425026|NCT00981929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65425027|NCT00981929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425028|NCT00981929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65425029|NCT00981929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425030|NCT00981929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65425031|NCT00981929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65425032|NCT00981929|Purinergic Agents|purinergic agents|mesh-ancestor
65425033|NCT00981929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65425034|NCT00981929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65425035|NCT00981929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65425036|NCT00981929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65425037|NCT00981929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65425038|NCT00981929|Narcotics|narcotics|mesh-ancestor
65425039|NCT00981929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65425040|NCT00981929|Analgesics|analgesics|mesh-ancestor
65425041|NCT00981929|Sensory System Agents|sensory system agents|mesh-ancestor
65425042|NCT00981929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65425043|NCT00364845|Darbepoetin alfa|darbepoetin alfa|mesh-list
65425044|NCT00364845|Hematinics|hematinics|mesh-ancestor
65425045|NCT00978653|Allopurinol|allopurinol|mesh-list
65425046|NCT00978653|Antimetabolites|antimetabolites|mesh-ancestor
65425047|NCT00978653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425048|NCT00978653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425049|NCT00978653|Gout Suppressants|gout suppressants|mesh-ancestor
65425050|NCT00978653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65425051|NCT00978653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65425052|NCT00978653|Antioxidants|antioxidants|mesh-ancestor
65425053|NCT00978653|Protective Agents|protective agents|mesh-ancestor
65425054|NCT00978653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425055|NCT00293722|Etanercept|etanercept|mesh-list
65425056|NCT00293722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65425057|NCT00293722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65425058|NCT00293722|Analgesics|analgesics|mesh-ancestor
65425059|NCT00293722|Sensory System Agents|sensory system agents|mesh-ancestor
65425060|NCT00293722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65425061|NCT00293722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425062|NCT00293722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65425063|NCT00293722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65425064|NCT00293722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65425065|NCT00293722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65425066|NCT00293722|Immunologic Factors|immunologic factors|mesh-ancestor
65425067|NCT00381303|Ritonavir|ritonavir|mesh-list
65425068|NCT00381303|Darunavir|darunavir|mesh-list
65425069|NCT00381303|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65425070|NCT00381303|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65425071|NCT00381303|Protease Inhibitors|protease inhibitors|mesh-ancestor
65174605|NCT02653261|Hemostatics|hemostatics|mesh-ancestor
65425072|NCT00381303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425073|NCT00381303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425074|NCT00381303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65425075|NCT00381303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65425105|NCT00364611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65425106|NCT00364611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425107|NCT00364611|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65425108|NCT00364611|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65425109|NCT00364611|Growth Substances|growth substances|mesh-ancestor
65425110|NCT00364611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425111|NCT00364611|Growth Inhibitors|growth inhibitors|mesh-ancestor
65425112|NCT00364611|Tubulin Modulators|tubulin modulators|mesh-ancestor
65425113|NCT00364611|Antimitotic Agents|antimitotic agents|mesh-ancestor
65425114|NCT00364611|Mitosis Modulators|mitosis modulators|mesh-ancestor
65425115|NCT00364611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425117|NCT00956189|Amisulpride|amisulpride|mesh-list
65425118|NCT00956189|Antidepressive Agents|antidepressive agents|mesh-ancestor
65425119|NCT00956189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65425120|NCT00956189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65425121|NCT00956189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65425122|NCT00956189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65425123|NCT00956189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425128|NCT00956189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65425129|NCT00956189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65425130|NCT00956189|Serotonin Agents|serotonin agents|mesh-ancestor
65425131|NCT00956189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65425132|NCT00956189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65425133|NCT00956189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65425134|NCT00956189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65425135|NCT00956189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65425136|NCT00956267|Letrozole|letrozole|mesh-list
65425137|NCT00956267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425138|NCT00956267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65425139|NCT00956267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65425140|NCT00956267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425141|NCT00956267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425142|NCT00956267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65425143|NCT00956267|Hormone Antagonists|hormone antagonists|mesh-ancestor
65425144|NCT00956267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65425145|NCT00956267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425146|NCT04007003|Insulin|insulin|mesh-list
65174676|NCT02650609|Prednisolone|prednisolone|mesh-list
65425147|NCT04007003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65425148|NCT04007003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425150|NCT00364533|Tapentadol|tapentadol|mesh-list
65425151|NCT00364533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65425152|NCT00364533|Narcotics|narcotics|mesh-ancestor
65425153|NCT00364533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65425154|NCT00364533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425155|NCT00364533|Analgesics|analgesics|mesh-ancestor
65425156|NCT00364533|Sensory System Agents|sensory system agents|mesh-ancestor
65425157|NCT00364533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65425158|NCT00364533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65425159|NCT00364533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65425160|NCT00364533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65425161|NCT00364533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425162|NCT00364533|Adrenergic Agents|adrenergic agents|mesh-ancestor
65425163|NCT00364533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65425164|NCT01047423|Simvastatin|simvastatin|mesh-list
65270022|NCT04189250|Gasotransmitters|gasotransmitters|mesh-ancestor
65425165|NCT01047423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65425166|NCT01047423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65425167|NCT01047423|Antimetabolites|antimetabolites|mesh-ancestor
65425168|NCT01047423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425169|NCT01047423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65425170|NCT01047423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65425171|NCT01047423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425172|NCT00984737|Insulin|insulin|mesh-list
65425173|NCT00984737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65425174|NCT00984737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425175|NCT01047579|Rivastigmine|rivastigmine|mesh-list
65425176|NCT01047579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65425177|NCT01047579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425178|NCT01047579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425179|NCT01047579|Cholinergic Agents|cholinergic agents|mesh-ancestor
65425180|NCT01047579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65425181|NCT01047579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425182|NCT01047579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65425183|NCT01047579|Protective Agents|protective agents|mesh-ancestor
65425184|NCT04006847|Dasatinib|dasatinib|mesh-list
65425185|NCT04006847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425186|NCT04006847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65425187|NCT04006847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425188|NCT04006847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425189|NCT00984893|Zoledronic Acid|zoledronic acid|mesh-list
65425190|NCT00984893|Diphosphonates|diphosphonates|mesh-list
65425191|NCT00984893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65425192|NCT00984893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425216|NCT00544817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425217|NCT00544817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425218|NCT00544817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65425219|NCT00544817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425220|NCT00289978|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65174752|NCT00649675|Meloxicam|meloxicam|mesh-list
65425221|NCT00289978|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65425222|NCT00289978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425223|NCT00289978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65425224|NCT00289978|Immunologic Factors|immunologic factors|mesh-ancestor
65425225|NCT00289978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425226|NCT00983177|Colchicine|colchicine|mesh-list
65425227|NCT00983177|Gout Suppressants|gout suppressants|mesh-ancestor
65425228|NCT00983177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65425229|NCT00983177|Tubulin Modulators|tubulin modulators|mesh-ancestor
65425230|NCT00983177|Antimitotic Agents|antimitotic agents|mesh-ancestor
65425231|NCT00983177|Mitosis Modulators|mitosis modulators|mesh-ancestor
65425232|NCT00983177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425233|NCT00983177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425234|NCT00983255|Tedizolid phosphate|tedizolid phosphate|mesh-list
65425235|NCT00983255|Tedizolid|tedizolid|mesh-list
65425236|NCT00983255|Oxazolidinones|oxazolidinones|mesh-list
65425237|NCT00983255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65425238|NCT00983255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65425239|NCT00983255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65425240|NCT00983255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425241|NCT00983255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425242|NCT00988403|Levan|levan|mesh-list
65425243|NCT00988403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425244|NCT00988481|Topiramate|topiramate|mesh-list
65425245|NCT00988481|Anticonvulsants|anticonvulsants|mesh-ancestor
65425261|NCT00543725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425262|NCT00543725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425263|NCT00543725|Antiviral Agents|antiviral agents|mesh-ancestor
65425264|NCT00543725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65425265|NCT00543725|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65425266|NCT00543725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65425267|NCT00543725|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65425268|NCT00543725|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65425269|NCT00543725|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65425270|NCT00543725|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65425271|NCT00543725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65425272|NCT00543725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65425273|NCT00985361|Vitamin D|vitamin d|mesh-list
65270023|NCT04189250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65425274|NCT00985361|Cholecalciferol|cholecalciferol|mesh-list
65425275|NCT00985361|Vitamins|vitamins|mesh-list
65425276|NCT00985361|Micronutrients|micronutrients|mesh-ancestor
65425277|NCT00985361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425278|NCT00985361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65425279|NCT00985361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65425280|NCT00269152|Carboplatin|carboplatin|mesh-list
65425281|NCT00269152|Pemetrexed|pemetrexed|mesh-list
65425282|NCT00269152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425283|NCT00269152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425284|NCT00269152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425285|NCT00269152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65425286|NCT00269152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65425287|NCT00988715|Cyclosporine|cyclosporine|mesh-list
65425288|NCT00988715|Mycophenolic Acid|mycophenolic acid|mesh-list
65425289|NCT00988715|Fludarabine|fludarabine|mesh-list
65425290|NCT00988715|Fludarabine phosphate|fludarabine phosphate|mesh-list
65425291|NCT00988715|Cyclosporins|cyclosporins|mesh-list
65425292|NCT00988715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425293|NCT00988715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65425294|NCT00988715|Antimetabolites|antimetabolites|mesh-ancestor
65425295|NCT00988715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425296|NCT00988715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65425297|NCT00988715|Immunologic Factors|immunologic factors|mesh-ancestor
65425298|NCT00988715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425299|NCT00988715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425300|NCT00988715|Antifungal Agents|antifungal agents|mesh-ancestor
65425301|NCT00988715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65425302|NCT00988715|Dermatologic Agents|dermatologic agents|mesh-ancestor
65425303|NCT00988715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65425304|NCT00988715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65425317|NCT03975166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425318|NCT03975166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65425319|NCT03975166|Respiratory System Agents|respiratory system agents|mesh-ancestor
65425320|NCT03975166|Dermatologic Agents|dermatologic agents|mesh-ancestor
65425321|NCT03975166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65425322|NCT03975166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65425323|NCT03975166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65425324|NCT03975166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65425325|NCT03975166|Adrenergic Agents|adrenergic agents|mesh-ancestor
65425326|NCT03975166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65425327|NCT03975166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425328|NCT03975166|Glucocorticoids|glucocorticoids|mesh-ancestor
65425329|NCT03975166|Hormones|hormones|mesh-ancestor
65425330|NCT03975166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65425331|NCT03975166|Sympathomimetics|sympathomimetics|mesh-ancestor
65425332|NCT01325818|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65425333|NCT01325818|Pravastatin|pravastatin|mesh-list
65425334|NCT01325818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65425335|NCT01325818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65425336|NCT01325818|Antimetabolites|antimetabolites|mesh-ancestor
65425337|NCT01325818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425338|NCT01325818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65425339|NCT01325818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65425340|NCT01325818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425341|NCT00379899|Vitamin D|vitamin d|mesh-list
65425342|NCT00379899|Cinacalcet|cinacalcet|mesh-list
65425343|NCT00379899|Vitamins|vitamins|mesh-ancestor
65425344|NCT00379899|Micronutrients|micronutrients|mesh-ancestor
65425345|NCT00379899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425346|NCT00379899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65425347|NCT00379899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65425348|NCT00379899|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65425349|NCT00379899|Hormone Antagonists|hormone antagonists|mesh-ancestor
65425350|NCT00379899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65425351|NCT02535039|Methylprednisolone|methylprednisolone|mesh-list
65425352|NCT02535039|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65425353|NCT02535039|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65425354|NCT02535039|Prednisolone|prednisolone|mesh-list
65425355|NCT02535039|Prednisolone acetate|prednisolone acetate|mesh-list
65425356|NCT02535039|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65425357|NCT02535039|Prednisolone phosphate|prednisolone phosphate|mesh-list
65425358|NCT02535039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65425359|NCT02535039|Antiemetics|antiemetics|mesh-ancestor
65425360|NCT02535039|Autonomic Agents|autonomic agents|mesh-ancestor
65425361|NCT02535039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65425362|NCT02535039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425363|NCT02535039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65425364|NCT02535039|Glucocorticoids|glucocorticoids|mesh-ancestor
65425365|NCT02535039|Hormones|hormones|mesh-ancestor
65425366|NCT02535039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65425367|NCT02535039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65425381|NCT00379587|Immunologic Factors|immunologic factors|mesh-ancestor
65425382|NCT00379587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425383|NCT00379587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65425384|NCT00363051|Everolimus|everolimus|mesh-list
65425385|NCT00363051|Octreotide|octreotide|mesh-list
65425386|NCT00363051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425387|NCT00363051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65425388|NCT00363051|Immunologic Factors|immunologic factors|mesh-ancestor
65425389|NCT00363051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425390|NCT00363051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65425391|NCT00363051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65425392|NCT00379353|Thalidomide|thalidomide|mesh-list
65425393|NCT00379353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65425394|NCT00379353|Immunologic Factors|immunologic factors|mesh-ancestor
65425395|NCT00379353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425396|NCT00379353|Leprostatic Agents|leprostatic agents|mesh-ancestor
65425397|NCT00379353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65425398|NCT00379353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65425399|NCT00379353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65425400|NCT00379353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65425401|NCT00379353|Growth Substances|growth substances|mesh-ancestor
65425402|NCT00379353|Growth Inhibitors|growth inhibitors|mesh-ancestor
65425403|NCT00379353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425404|NCT01047657|Orlistat|orlistat|mesh-list
65425405|NCT01047657|Sibutramine|sibutramine|mesh-list
65425406|NCT01047657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425407|NCT01047657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425408|NCT01047657|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65425409|NCT01047657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65425410|NCT01047657|Antidepressive Agents|antidepressive agents|mesh-ancestor
65425411|NCT01047657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65425412|NCT01047657|Appetite Depressants|appetite depressants|mesh-ancestor
65425413|NCT00378573|Gemcitabine|gemcitabine|mesh-list
65425414|NCT00378573|Bevacizumab|bevacizumab|mesh-list
65425415|NCT00378573|Docetaxel|docetaxel|mesh-list
65425416|NCT00378573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65425417|NCT00378573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425418|NCT00378573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65425419|NCT00378573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65425420|NCT00378573|Growth Substances|growth substances|mesh-ancestor
65425421|NCT00378573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425422|NCT00378573|Growth Inhibitors|growth inhibitors|mesh-ancestor
65425423|NCT00378573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65425424|NCT00378573|Antimetabolites|antimetabolites|mesh-ancestor
65425425|NCT00378573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425426|NCT00378573|Antiviral Agents|antiviral agents|mesh-ancestor
65425427|NCT00378573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65425428|NCT00378573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425429|NCT00378573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65425430|NCT00378573|Immunologic Factors|immunologic factors|mesh-ancestor
65425431|NCT00378573|Tubulin Modulators|tubulin modulators|mesh-ancestor
65425440|NCT01047891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425442|NCT02534571|Hemostatics|hemostatics|mesh-list
65425443|NCT02534571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65425444|NCT02534571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65425445|NCT02534571|Adrenergic Agents|adrenergic agents|mesh-ancestor
65425446|NCT02534571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65425447|NCT02534571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425448|NCT02534571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425449|NCT02534571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65425450|NCT02534571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65425451|NCT02534571|Autonomic Agents|autonomic agents|mesh-ancestor
65425452|NCT02534571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65425453|NCT02534571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65425454|NCT02534571|Respiratory System Agents|respiratory system agents|mesh-ancestor
65425455|NCT02534571|Mydriatics|mydriatics|mesh-ancestor
65425456|NCT02534571|Sympathomimetics|sympathomimetics|mesh-ancestor
65425457|NCT02534571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65425458|NCT02534571|Coagulants|coagulants|mesh-ancestor
65425459|NCT00457002|Enoxaparin|enoxaparin|mesh-list
65425460|NCT00457002|Apixaban|apixaban|mesh-list
65425461|NCT00457002|Anticoagulants|anticoagulants|mesh-ancestor
65425462|NCT00457002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65425463|NCT00457002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65425464|NCT00457002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425465|NCT00457002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65425466|NCT00457002|Antithrombins|antithrombins|mesh-ancestor
65425467|NCT00457002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65425468|NCT00457002|Protease Inhibitors|protease inhibitors|mesh-ancestor
65425469|NCT00457002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425470|NCT00362115|Olmesartan|olmesartan|mesh-list
65425471|NCT00362115|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65425472|NCT00362115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65425473|NCT00362115|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65425474|NCT00362115|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65425475|NCT00362115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425476|NCT00485264|Raltegravir Potassium|raltegravir potassium|mesh-list
65425477|NCT00485264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65425478|NCT00485264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65425479|NCT00485264|Antiviral Agents|antiviral agents|mesh-ancestor
65425480|NCT00485264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65425481|NCT00485264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65425482|NCT00485264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65425483|NCT00485264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425484|NCT00485264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425485|NCT00293254|Raltegravir Potassium|raltegravir potassium|mesh-list
65425486|NCT00293254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65425487|NCT00293254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65425488|NCT00293254|Antiviral Agents|antiviral agents|mesh-ancestor
65425489|NCT00293254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65425490|NCT00293254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65425491|NCT00293254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65425492|NCT00293254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425493|NCT00293254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425494|NCT03975010|Naltrexone|naltrexone|mesh-list
65425495|NCT03975010|Buprenorphine|buprenorphine|mesh-list
65425496|NCT03975010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65425497|NCT03975010|Narcotics|narcotics|mesh-ancestor
65425498|NCT03975010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65425499|NCT03975010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425523|NCT01048047|Vasodilator Agents|vasodilator agents|mesh-ancestor
65425524|NCT01324635|Panobinostat|panobinostat|mesh-list
65425525|NCT01324635|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65425526|NCT01324635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425527|NCT01324635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425528|NCT01324635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425529|NCT00456846|Paclitaxel|paclitaxel|mesh-list
65425530|NCT00456846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65425531|NCT00456846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65425532|NCT00456846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425533|NCT00456846|Tubulin Modulators|tubulin modulators|mesh-ancestor
65425534|NCT00456846|Antimitotic Agents|antimitotic agents|mesh-ancestor
65425535|NCT00456846|Mitosis Modulators|mitosis modulators|mesh-ancestor
65425536|NCT00456846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425537|NCT03324282|Avelumab|avelumab|mesh-list
65425538|NCT03324282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65425539|NCT03324282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425540|NCT00484094|Sirolimus|sirolimus|mesh-list
65425541|NCT00484094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65425542|NCT00484094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65425543|NCT00484094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65425544|NCT00484094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425545|NCT00484094|Antifungal Agents|antifungal agents|mesh-ancestor
65425546|NCT00484094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65425547|NCT00484094|Immunologic Factors|immunologic factors|mesh-ancestor
65425548|NCT00484094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425581|NCT03654066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425582|NCT03654066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65425583|NCT03654066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65425585|NCT01565772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425586|NCT01565772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65425587|NCT01565772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65425616|NCT01067638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65425617|NCT01067638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425619|NCT01067638|Coagulants|coagulants|mesh-ancestor
65425620|NCT00267046|Doxorubicin|doxorubicin|mesh-list
65425621|NCT00267046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65425622|NCT00267046|Vincristine|vincristine|mesh-list
65425623|NCT00267046|Ifosfamide|ifosfamide|mesh-list
65425624|NCT00267046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425625|NCT00267046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65425626|NCT00267046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65425627|NCT00267046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65425628|NCT00267046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425629|NCT00267046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425630|NCT00267046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65425631|NCT00267046|Tubulin Modulators|tubulin modulators|mesh-ancestor
65425666|NCT00507026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425667|NCT01019174|Cyclophosphamide|cyclophosphamide|mesh-list
65425668|NCT01019174|Lenalidomide|lenalidomide|mesh-list
65425669|NCT01019174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65425670|NCT01019174|Immunologic Factors|immunologic factors|mesh-ancestor
64810455|NCT01441505|GABA Modulators|gaba modulators|mesh-ancestor
65425674|NCT01019174|Alkylating Agents|alkylating agents|mesh-ancestor
65425675|NCT01019174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425676|NCT01019174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425677|NCT01019174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65425678|NCT01019174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65425679|NCT01019174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65425680|NCT01019174|Growth Substances|growth substances|mesh-ancestor
65425681|NCT01019174|Growth Inhibitors|growth inhibitors|mesh-ancestor
65425682|NCT01017224|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
65425683|NCT01017224|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65425684|NCT01017224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425687|NCT01011920|Methotrexate|methotrexate|mesh-list
65425688|NCT01011920|Thiotepa|thiotepa|mesh-list
65425689|NCT01011920|Carmustine|carmustine|mesh-list
65425690|NCT01011920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65425691|NCT01011920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425692|NCT01011920|Immunologic Factors|immunologic factors|mesh-ancestor
65425693|NCT01011920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425694|NCT01011920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65425695|NCT01011920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65425696|NCT01011920|Abortifacient Agents|abortifacient agents|mesh-ancestor
65425697|NCT01011920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65425698|NCT01011920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65425699|NCT01011920|Antimetabolites|antimetabolites|mesh-ancestor
65425700|NCT01011920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425701|NCT01011920|Dermatologic Agents|dermatologic agents|mesh-ancestor
65425702|NCT01011920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425703|NCT01011920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65425704|NCT01011920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65425705|NCT01011920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65425706|NCT01011920|Antiviral Agents|antiviral agents|mesh-ancestor
65425707|NCT01011920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65425708|NCT01011920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65425709|NCT01011920|Alkylating Agents|alkylating agents|mesh-ancestor
65425710|NCT01011920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65425711|NCT03976102|Rituximab|rituximab|mesh-list
65425712|NCT03976102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65425713|NCT03976102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425714|NCT03976102|Immunologic Factors|immunologic factors|mesh-ancestor
65425715|NCT03976102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425716|NCT03976102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65425717|NCT00506948|Mycophenolic Acid|mycophenolic acid|mesh-list
65425718|NCT00506948|Sirolimus|sirolimus|mesh-list
65425719|NCT00506948|Thymoglobulin|thymoglobulin|mesh-list
65425720|NCT00506948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65425721|NCT00506948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65425722|NCT00506948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425723|NCT00506948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65425724|NCT00506948|Antitubercular Agents|antitubercular agents|mesh-ancestor
65425725|NCT00506948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65425726|NCT00506948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65425727|NCT00506948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425728|NCT00506948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425729|NCT00506948|Antifungal Agents|antifungal agents|mesh-ancestor
65425730|NCT00506948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64995513|NCT00091598|Ambrisentan|ambrisentan|mesh-list
65425731|NCT00506948|Immunologic Factors|immunologic factors|mesh-ancestor
65425732|NCT00506948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425733|NCT00286234|Niacin|niacin|mesh-list
65425734|NCT00286234|Nicotinic Acids|nicotinic acids|mesh-list
65425735|NCT00286234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65425736|NCT00286234|Antimetabolites|antimetabolites|mesh-ancestor
65425737|NCT00286234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425738|NCT00286234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65425739|NCT00286234|Vasodilator Agents|vasodilator agents|mesh-ancestor
65425740|NCT00286234|Vitamin B Complex|vitamin b complex|mesh-ancestor
65425741|NCT00286234|Vitamins|vitamins|mesh-ancestor
65425742|NCT00286234|Micronutrients|micronutrients|mesh-ancestor
64810495|NCT01441869|Incretins|incretins|mesh-ancestor
65425762|NCT00445848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65425763|NCT00445848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425764|NCT00445848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425765|NCT00286156|Sirolimus|sirolimus|mesh-list
65425766|NCT00286156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65425767|NCT00286156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65425768|NCT00286156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65425769|NCT00286156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425770|NCT00286156|Antifungal Agents|antifungal agents|mesh-ancestor
65425771|NCT00286156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65425772|NCT00286156|Immunologic Factors|immunologic factors|mesh-ancestor
65425773|NCT00286156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425774|NCT00455520|Tapentadol|tapentadol|mesh-list
65425775|NCT00455520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65425776|NCT00455520|Narcotics|narcotics|mesh-ancestor
65425777|NCT00455520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65425778|NCT00455520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425779|NCT00455520|Analgesics|analgesics|mesh-ancestor
65425780|NCT00455520|Sensory System Agents|sensory system agents|mesh-ancestor
65425781|NCT00455520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65425782|NCT00455520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65425783|NCT00455520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65425784|NCT00455520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65425785|NCT00455520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425786|NCT00455520|Adrenergic Agents|adrenergic agents|mesh-ancestor
65425787|NCT00455520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65425788|NCT00284050|Ranibizumab|ranibizumab|mesh-list
65425789|NCT00284050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65425790|NCT00284050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65425791|NCT00284050|Growth Substances|growth substances|mesh-ancestor
65425792|NCT00284050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425793|NCT00284050|Growth Inhibitors|growth inhibitors|mesh-ancestor
65425794|NCT00284050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425795|NCT00293020|Fentanyl|fentanyl|mesh-list
65425796|NCT00293020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65425797|NCT00293020|Narcotics|narcotics|mesh-ancestor
65425798|NCT00293020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65425799|NCT00293020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425825|NCT00377637|Antimetabolites|antimetabolites|mesh-ancestor
65425826|NCT00377637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65425827|NCT00377403|Acetaminophen|acetaminophen|mesh-list
65425828|NCT00377403|Amoxicillin|amoxicillin|mesh-list
65425829|NCT00377403|Phenylpropanolamine|phenylpropanolamine|mesh-list
65425830|NCT00377403|Pseudoephedrine|pseudoephedrine|mesh-list
65425831|NCT00377403|Ephedrine|ephedrine|mesh-list
65425832|NCT00377403|Dextromethorphan|dextromethorphan|mesh-list
65425833|NCT00377403|Guaifenesin|guaifenesin|mesh-list
65425834|NCT00377403|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
65425835|NCT00377403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65425836|NCT00377403|Analgesics|analgesics|mesh-ancestor
65425837|NCT00377403|Sensory System Agents|sensory system agents|mesh-ancestor
65425838|NCT00377403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65425839|NCT00377403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425840|NCT00377403|Antipyretics|antipyretics|mesh-ancestor
65425841|NCT00377403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65425842|NCT00377403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65425843|NCT00377403|Antitussive Agents|antitussive agents|mesh-ancestor
65425844|NCT00377403|Respiratory System Agents|respiratory system agents|mesh-ancestor
65425845|NCT00377403|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65425846|NCT00377403|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65425847|NCT00377403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65270024|NCT04189250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425848|NCT00377403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425849|NCT00377403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65425864|NCT00292942|Artesunate|artesunate|mesh-list
65425865|NCT00292942|Mannitol|mannitol|mesh-list
65425866|NCT00292942|Antimalarials|antimalarials|mesh-ancestor
65425867|NCT00292942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65425868|NCT00292942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65425869|NCT00292942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65425870|NCT00292942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425871|NCT00292942|Antiviral Agents|antiviral agents|mesh-ancestor
65425872|NCT00292942|Schistosomicides|schistosomicides|mesh-ancestor
65425873|NCT00292942|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65425874|NCT00292942|Anthelmintics|anthelmintics|mesh-ancestor
65425875|NCT00292942|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65425876|NCT00292942|Diuretics|diuretics|mesh-ancestor
65425877|NCT00292942|Natriuretic Agents|natriuretic agents|mesh-ancestor
65425878|NCT00292942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425879|NCT00483938|Interferons|interferons|mesh-list
65425880|NCT00483938|Ribavirin|ribavirin|mesh-list
65425881|NCT00483938|Interferon-alpha|interferon-alpha|mesh-list
65425882|NCT00483938|Interferon alpha-2|interferon alpha-2|mesh-list
65425883|NCT00483938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65425884|NCT00483938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425885|NCT00483938|Antiviral Agents|antiviral agents|mesh-ancestor
65425886|NCT00483938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65425887|NCT00483938|Antimetabolites|antimetabolites|mesh-ancestor
65425888|NCT00483938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425889|NCT00483938|Immunologic Factors|immunologic factors|mesh-ancestor
65425890|NCT00483938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425891|NCT00370071|Interferons|interferons|mesh-list
65425892|NCT00370071|Interferon-beta|interferon-beta|mesh-list
65425893|NCT00370071|Interferon beta-1b|interferon beta-1b|mesh-list
65425894|NCT00370071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425895|NCT00370071|Antiviral Agents|antiviral agents|mesh-ancestor
65425896|NCT00370071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65425897|NCT00370071|Immunologic Factors|immunologic factors|mesh-ancestor
65425898|NCT00370071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425899|NCT00370071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65425900|NCT00369915|Scopolamine|scopolamine|mesh-list
65425901|NCT00369915|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65425902|NCT00369915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65425903|NCT00369915|Antiemetics|antiemetics|mesh-ancestor
65425904|NCT00369915|Autonomic Agents|autonomic agents|mesh-ancestor
65425905|NCT00369915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65425906|NCT00369915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425907|NCT00369915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65425908|NCT00369915|Mydriatics|mydriatics|mesh-ancestor
65425909|NCT00369915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65425910|NCT00369915|Cholinergic Agents|cholinergic agents|mesh-ancestor
65425911|NCT00369915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65425912|NCT00369915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425913|NCT00369915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65425914|NCT00369915|Parasympatholytics|parasympatholytics|mesh-ancestor
65425945|NCT00369681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425946|NCT00369681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65425947|NCT00369681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65425948|NCT00369681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65425949|NCT00369681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65425950|NCT00369681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425951|NCT00369681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425952|NCT00369681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65425953|NCT00369681|Alkylating Agents|alkylating agents|mesh-ancestor
65425954|NCT00369681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65425955|NCT00369681|Tubulin Modulators|tubulin modulators|mesh-ancestor
65425956|NCT00369681|Antimitotic Agents|antimitotic agents|mesh-ancestor
65425957|NCT00369681|Mitosis Modulators|mitosis modulators|mesh-ancestor
65425958|NCT00266812|Temozolomide|temozolomide|mesh-list
65425968|NCT04249544|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65425969|NCT04249544|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65425970|NCT04249544|Dopamine Agonists|dopamine agonists|mesh-ancestor
65425971|NCT04249544|Dopamine Agents|dopamine agents|mesh-ancestor
65425972|NCT04249544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65425973|NCT00488774|Golimumab|golimumab|mesh-list
65425974|NCT00488774|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65425975|NCT00488774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65425977|NCT00488774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65425978|NCT00488774|Immunologic Factors|immunologic factors|mesh-ancestor
65425979|NCT00488774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425980|NCT00361569|Estrogens|estrogens|mesh-list
65425981|NCT00361569|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65425982|NCT00361569|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
65425983|NCT00361569|Hormones|hormones|mesh-ancestor
65425984|NCT00361569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65425985|NCT00361569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425986|NCT01011998|Imatinib Mesylate|imatinib mesylate|mesh-list
65425987|NCT01011998|Valproic Acid|valproic acid|mesh-list
65425988|NCT01011998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425989|NCT01011998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65425990|NCT01011998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425991|NCT01011998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425992|NCT01011998|Anticonvulsants|anticonvulsants|mesh-ancestor
65425993|NCT01011998|GABA Agents|gaba agents|mesh-ancestor
65425994|NCT01011998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65425995|NCT01011998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425996|NCT01011998|Antimanic Agents|antimanic agents|mesh-ancestor
65425997|NCT01011998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65425998|NCT01011998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65425999|NCT01011998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65426000|NCT01017458|Methyltestosterone|methyltestosterone|mesh-list
65426001|NCT01017458|Testosterone|testosterone|mesh-list
65426002|NCT01017458|Testosterone undecanoate|testosterone undecanoate|mesh-list
65426003|NCT01017458|Testosterone enanthate|testosterone enanthate|mesh-list
65426004|NCT01017458|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65426005|NCT01017458|Androgens|androgens|mesh-ancestor
65426006|NCT01017458|Hormones|hormones|mesh-ancestor
65426007|NCT01017458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65426008|NCT01017458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426009|NCT01017458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65426010|NCT01017458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426011|NCT01017458|Anabolic Agents|anabolic agents|mesh-ancestor
65426012|NCT02534415|Hyaluronic Acid|hyaluronic acid|mesh-list
65426013|NCT02534415|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65426014|NCT02534415|Immunologic Factors|immunologic factors|mesh-ancestor
65426015|NCT02534415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426016|NCT02534415|Viscosupplements|viscosupplements|mesh-ancestor
65426017|NCT02534415|Protective Agents|protective agents|mesh-ancestor
65426018|NCT00488618|Cariprazine|cariprazine|mesh-list
65426019|NCT00488618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65426020|NCT00488618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65426021|NCT00488618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65426022|NCT00488618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426023|NCT00488618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65426024|NCT01019642|Cholecalciferol|cholecalciferol|mesh-list
65426025|NCT01019642|Vitamin D|vitamin d|mesh-list
65426051|NCT00445770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426052|NCT00445770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65426053|NCT00445770|Antimetabolites|antimetabolites|mesh-ancestor
65426054|NCT00445770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426055|NCT00445770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426056|NCT00445770|Dermatologic Agents|dermatologic agents|mesh-ancestor
65426057|NCT00445770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426058|NCT00445770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65426059|NCT00445770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65426060|NCT00445770|Immunologic Factors|immunologic factors|mesh-ancestor
65426061|NCT00445770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65426062|NCT00445770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65426063|NCT00445770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65426064|NCT00445770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65426066|NCT00445770|Sensory System Agents|sensory system agents|mesh-ancestor
65426067|NCT00445770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65426068|NCT00445770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65426069|NCT00445770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65426070|NCT00266032|Drospirenone|drospirenone|mesh-list
65426071|NCT00266032|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65426072|NCT00266032|Hormone Antagonists|hormone antagonists|mesh-ancestor
65426073|NCT00266032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65426074|NCT00266032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426102|NCT00482612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65426103|NCT00482612|Histamine Antagonists|histamine antagonists|mesh-ancestor
65270025|NCT02726126|Fentanyl|fentanyl|mesh-list
65270026|NCT02726126|Melatonin|melatonin|mesh-list
65426104|NCT00482612|Histamine Agents|histamine agents|mesh-ancestor
65426105|NCT00482612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65426106|NCT00482612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426107|NCT00482612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426108|NCT00482612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65426109|NCT00482612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65426110|NCT00482612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65426111|NCT00482612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65426112|NCT00482612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65426113|NCT00482612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65426114|NCT00482612|Adrenergic Agents|adrenergic agents|mesh-ancestor
65426115|NCT00482612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65426116|NCT00482612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65426117|NCT00482612|Serotonin Agents|serotonin agents|mesh-ancestor
65426118|NCT00482612|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65426119|NCT00282568|Tacrolimus|tacrolimus|mesh-list
65426120|NCT00282568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65426121|NCT00282568|Immunologic Factors|immunologic factors|mesh-ancestor
65175662|NCT00654043|Torsemide|torsemide|mesh-list
65426143|NCT00445692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426144|NCT00445692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65426145|NCT00445692|Glucocorticoids|glucocorticoids|mesh-ancestor
65426146|NCT00445692|Hormones|hormones|mesh-ancestor
65426147|NCT00445692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65426148|NCT00445692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65426149|NCT00445692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426150|NCT00445692|Immunologic Factors|immunologic factors|mesh-ancestor
65426151|NCT00445692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65426152|NCT00445692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65426153|NCT00445692|Growth Substances|growth substances|mesh-ancestor
65426154|NCT00445692|Growth Inhibitors|growth inhibitors|mesh-ancestor
65426155|NCT00445692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65426156|NCT00445692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65426157|NCT00445692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65426158|NCT00445692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426159|NCT00445692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426160|NCT00445692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65426161|NCT00445692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65426162|NCT00445692|Protease Inhibitors|protease inhibitors|mesh-ancestor
65426163|NCT00445692|Dermatologic Agents|dermatologic agents|mesh-ancestor
65426164|NCT00282412|Cyclosporine|cyclosporine|mesh-list
65426165|NCT00282412|Mycophenolic Acid|mycophenolic acid|mesh-list
65426166|NCT00282412|Cyclophosphamide|cyclophosphamide|mesh-list
65426167|NCT00282412|Fludarabine|fludarabine|mesh-list
65426168|NCT00282412|Alemtuzumab|alemtuzumab|mesh-list
65426169|NCT00282412|Cyclosporins|cyclosporins|mesh-list
65426170|NCT00282412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65426171|NCT00282412|Immunologic Factors|immunologic factors|mesh-ancestor
65426172|NCT00282412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426173|NCT00282412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65426174|NCT00282412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65426175|NCT00282412|Alkylating Agents|alkylating agents|mesh-ancestor
65426176|NCT00282412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426177|NCT00282412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426189|NCT03974932|Acetaminophen|acetaminophen|mesh-list
65426190|NCT03974932|Ibuprofen|ibuprofen|mesh-list
65426191|NCT03974932|Celecoxib|celecoxib|mesh-list
65426192|NCT03974932|Bupivacaine|bupivacaine|mesh-list
65426193|NCT03974932|Anesthetics, Local|anesthetics, local|mesh-ancestor
65426194|NCT03974932|Anesthetics|anesthetics|mesh-ancestor
65426195|NCT03974932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65426196|NCT03974932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426197|NCT03974932|Sensory System Agents|sensory system agents|mesh-ancestor
65426198|NCT03974932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65426199|NCT03974932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65426200|NCT03974932|Analgesics|analgesics|mesh-ancestor
65426201|NCT03974932|Antipyretics|antipyretics|mesh-ancestor
65426202|NCT03974932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65426203|NCT03974932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65426204|NCT03974932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65426205|NCT03974932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65426206|NCT03974932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995805|NCT05561049|Autonomic Agents|autonomic agents|mesh-ancestor
65426207|NCT03974932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426208|NCT03974932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65426209|NCT00282256|Tacrolimus|tacrolimus|mesh-list
65426210|NCT00282256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65426211|NCT00282256|Immunologic Factors|immunologic factors|mesh-ancestor
65426212|NCT00282256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426213|NCT00282256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65426214|NCT00282256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426215|NCT00282256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426216|NCT00265330|Ziprasidone|ziprasidone|mesh-list
65426217|NCT00265330|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65426218|NCT00265330|Serotonin Agents|serotonin agents|mesh-ancestor
65426219|NCT00265330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65426220|NCT00265330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426221|NCT00265330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426222|NCT00265330|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65426223|NCT00265330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65426224|NCT00265330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65426225|NCT00265330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65426226|NCT00265330|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65426227|NCT00265330|Dopamine Agents|dopamine agents|mesh-ancestor
65426228|NCT00543569|Mycophenolic Acid|mycophenolic acid|mesh-list
65426229|NCT00543569|Alefacept|alefacept|mesh-list
65426230|NCT00543569|Tacrolimus|tacrolimus|mesh-list
65426231|NCT00543569|Basiliximab|basiliximab|mesh-list
65426232|NCT00543569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65426233|NCT00543569|Immunologic Factors|immunologic factors|mesh-ancestor
65426234|NCT00543569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426235|NCT00543569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65426236|NCT00543569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426237|NCT00543569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426238|NCT00543569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65426239|NCT00543569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426240|NCT00543569|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65426241|NCT00543569|Antitubercular Agents|antitubercular agents|mesh-ancestor
65426247|NCT00984347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65426248|NCT00984347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426249|NCT00984425|Sorafenib|sorafenib|mesh-list
65426250|NCT00984425|Lapatinib|lapatinib|mesh-list
65426251|NCT00984425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426252|NCT00984425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65426253|NCT00984425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426254|NCT00984425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426255|NCT05596955|Naltrexone|naltrexone|mesh-list
65426256|NCT05596955|Buprenorphine|buprenorphine|mesh-list
65426257|NCT05596955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65426258|NCT05596955|Narcotics|narcotics|mesh-ancestor
65426259|NCT05596955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65426260|NCT05596955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426261|NCT05596955|Analgesics|analgesics|mesh-ancestor
65426262|NCT05596955|Sensory System Agents|sensory system agents|mesh-ancestor
65426263|NCT05596955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65426264|NCT05596955|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65426265|NCT05596955|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65426266|NCT00445458|Paclitaxel|paclitaxel|mesh-list
65426267|NCT00445458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65426268|NCT00445458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426269|NCT00445458|Tubulin Modulators|tubulin modulators|mesh-ancestor
65426270|NCT00445458|Antimitotic Agents|antimitotic agents|mesh-ancestor
65426271|NCT00445458|Mitosis Modulators|mitosis modulators|mesh-ancestor
65426272|NCT00445458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175803|NCT01165307|Levonorgestrel|levonorgestrel|mesh-list
65426273|NCT03914417|Imiquimod|imiquimod|mesh-list
65426274|NCT03914417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65426275|NCT03914417|Immunologic Factors|immunologic factors|mesh-ancestor
65426276|NCT03914417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426277|NCT03914417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426278|NCT03914417|Interferon Inducers|interferon inducers|mesh-ancestor
65426279|NCT05586113|Bismuth|bismuth|mesh-list
65426280|NCT05586113|Antacids|antacids|mesh-ancestor
65426281|NCT05586113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426282|NCT05586113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65426283|NCT00541385|Artesunate|artesunate|mesh-list
65426284|NCT00541385|Lumefantrine|lumefantrine|mesh-list
65426285|NCT00541385|Pyronaridine|pyronaridine|mesh-list
64995884|NCT05549895|Anesthetics|anesthetics|mesh-ancestor
65426286|NCT00541385|Antimalarials|antimalarials|mesh-ancestor
65426287|NCT00541385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65426288|NCT00541385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65426289|NCT00541385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65426290|NCT00541385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426291|NCT00541385|Antiviral Agents|antiviral agents|mesh-ancestor
65426292|NCT00541385|Schistosomicides|schistosomicides|mesh-ancestor
65426293|NCT00541385|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65426294|NCT00541385|Anthelmintics|anthelmintics|mesh-ancestor
65426295|NCT00988949|Spiradoline|spiradoline|mesh-list
65426296|NCT00988949|Analgesics|analgesics|mesh-ancestor
65426297|NCT00988949|Sensory System Agents|sensory system agents|mesh-ancestor
65426298|NCT00988949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65426299|NCT00988949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426300|NCT00988949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65426301|NCT00988949|Diuretics|diuretics|mesh-ancestor
65426302|NCT00988949|Natriuretic Agents|natriuretic agents|mesh-ancestor
65426303|NCT00989027|Oxytocin|oxytocin|mesh-list
65426304|NCT00989027|Carboprost|carboprost|mesh-list
65426305|NCT00989027|Carboprost tromethamine|carboprost tromethamine|mesh-list
65426306|NCT00989027|Ergonovine|ergonovine|mesh-list
65426307|NCT00989027|Oxytocics|oxytocics|mesh-ancestor
65426308|NCT00989027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65426309|NCT00989027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426310|NCT00989027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65426311|NCT00989027|Abortifacient Agents|abortifacient agents|mesh-ancestor
65426312|NCT00265096|Golimumab|golimumab|mesh-list
65426313|NCT00265096|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65426314|NCT00265096|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65426315|NCT00265096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65426336|NCT00986609|Interferon Inducers|interferon inducers|mesh-ancestor
65426337|NCT00986609|Laxatives|laxatives|mesh-ancestor
65426338|NCT00986609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65426339|NCT00986609|Antiviral Agents|antiviral agents|mesh-ancestor
65426340|NCT00986609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65426341|NCT00281320|Asenapine|asenapine|mesh-list
65426342|NCT00281320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65426343|NCT00281320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65426344|NCT00281320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65426345|NCT00281320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426346|NCT00281320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65426347|NCT00541307|Heparin|heparin|mesh-list
65426348|NCT00541307|Anticoagulants|anticoagulants|mesh-ancestor
65426349|NCT00541307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65426350|NCT00541307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65426351|NCT00541307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426352|NCT05003258|Dexamethasone|dexamethasone|mesh-list
65426353|NCT05003258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65426354|NCT05003258|Antiemetics|antiemetics|mesh-ancestor
65426356|NCT05003258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65426357|NCT05003258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426358|NCT05003258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65426359|NCT05003258|Glucocorticoids|glucocorticoids|mesh-ancestor
65426360|NCT05003258|Hormones|hormones|mesh-ancestor
65426361|NCT05003258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65426362|NCT05003258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65426363|NCT05003258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426364|NCT05499689|Bupivacaine|bupivacaine|mesh-list
65426365|NCT05499689|Anesthetics, Local|anesthetics, local|mesh-ancestor
65426366|NCT05499689|Anesthetics|anesthetics|mesh-ancestor
65426367|NCT05499689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65426368|NCT05499689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426369|NCT05499689|Sensory System Agents|sensory system agents|mesh-ancestor
65426370|NCT05499689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65426371|NCT01012232|Ropivacaine|ropivacaine|mesh-list
65426372|NCT01012232|Anesthetics, Local|anesthetics, local|mesh-ancestor
65426373|NCT01012232|Anesthetics|anesthetics|mesh-ancestor
65426391|NCT04006691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426392|NCT04006691|Alkylating Agents|alkylating agents|mesh-ancestor
65426393|NCT04006691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426394|NCT04006691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65426395|NCT04006691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426396|NCT00986765|Aspirin|aspirin|mesh-list
65426397|NCT00986765|Enoxaparin|enoxaparin|mesh-list
65426398|NCT00986765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65426399|NCT00986765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65426400|NCT00986765|Analgesics|analgesics|mesh-ancestor
65270027|NCT02726126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65426401|NCT00986765|Sensory System Agents|sensory system agents|mesh-ancestor
65426402|NCT00986765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65426403|NCT00986765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426404|NCT00986765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65426405|NCT00986765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65426406|NCT00986765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65426407|NCT00986765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65426408|NCT00986765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426409|NCT00986765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65426410|NCT00986765|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65426411|NCT00986765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426412|NCT00986765|Antipyretics|antipyretics|mesh-ancestor
65426413|NCT00986765|Anticoagulants|anticoagulants|mesh-ancestor
65426414|NCT00986843|Irinotecan|irinotecan|mesh-list
65426415|NCT00986843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65426416|NCT00986843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65426417|NCT00986843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426418|NCT00986843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426419|NCT00986843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426420|NCT01019876|Cyclophosphamide|cyclophosphamide|mesh-list
65426421|NCT01019876|Fludarabine|fludarabine|mesh-list
65426422|NCT01019876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65426423|NCT01019876|Immunologic Factors|immunologic factors|mesh-ancestor
65426424|NCT01019876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426425|NCT01019876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65426426|NCT01019876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65426427|NCT01019876|Alkylating Agents|alkylating agents|mesh-ancestor
65175974|NCT02638909|Ceritinib|ceritinib|mesh-list
65426428|NCT01019876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426441|NCT01017770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65426442|NCT01017770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65426443|NCT01017770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426444|NCT01017770|Antiviral Agents|antiviral agents|mesh-ancestor
65426445|NCT01017770|Schistosomicides|schistosomicides|mesh-ancestor
65426446|NCT01017770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65426447|NCT01017770|Anthelmintics|anthelmintics|mesh-ancestor
65426448|NCT05712707|Lofexidine|lofexidine|mesh-list
65426449|NCT05712707|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65426450|NCT05712707|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65426451|NCT05712707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426452|NCT05712707|Sensory System Agents|sensory system agents|mesh-ancestor
65426453|NCT05712707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65426454|NCT05712707|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65426455|NCT05712707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65426456|NCT05712707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65426457|NCT05712707|Adrenergic Agents|adrenergic agents|mesh-ancestor
65426458|NCT05712707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65426459|NCT05712707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426460|NCT01017926|Triazolam|triazolam|mesh-list
65426461|NCT01017926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65426462|NCT01017926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65426463|NCT01017926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65426464|NCT01017926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65426465|NCT01017926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426466|NCT01017926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65426467|NCT01017926|GABA Modulators|gaba modulators|mesh-ancestor
65426468|NCT01017926|GABA Agents|gaba agents|mesh-ancestor
65426469|NCT01017926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65426470|NCT01017926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426471|NCT00481832|Cyclosporine|cyclosporine|mesh-list
65426472|NCT00481832|Mycophenolic Acid|mycophenolic acid|mesh-list
65426473|NCT00481832|Methylprednisolone|methylprednisolone|mesh-list
65426474|NCT00481832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65426475|NCT00481832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65426476|NCT00481832|Prednisolone|prednisolone|mesh-list
65426477|NCT00481832|Prednisolone acetate|prednisolone acetate|mesh-list
65426478|NCT00481832|Cyclophosphamide|cyclophosphamide|mesh-list
65426479|NCT00481832|Carmustine|carmustine|mesh-list
65426480|NCT00481832|Rituximab|rituximab|mesh-list
65426481|NCT00481832|Etoposide|etoposide|mesh-list
65426482|NCT00481832|Cyclosporins|cyclosporins|mesh-list
65426483|NCT00481832|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65426484|NCT00481832|Lenograstim|lenograstim|mesh-list
65426485|NCT00481832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65426486|NCT00481832|Prednisolone phosphate|prednisolone phosphate|mesh-list
65426487|NCT00481832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65426488|NCT00481832|Immunologic Factors|immunologic factors|mesh-ancestor
65426489|NCT00481832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426490|NCT00481832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65426491|NCT00481832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65426492|NCT00481832|Alkylating Agents|alkylating agents|mesh-ancestor
65426493|NCT00481832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426494|NCT00481832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426495|NCT00481832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65426506|NCT00481832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65426507|NCT00481832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65426508|NCT00481832|Antitubercular Agents|antitubercular agents|mesh-ancestor
65426509|NCT00481832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65426510|NCT00481832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65426511|NCT00481832|Antiemetics|antiemetics|mesh-ancestor
65426512|NCT00481832|Autonomic Agents|autonomic agents|mesh-ancestor
65426513|NCT00481832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65426514|NCT00481832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65426515|NCT00481832|Glucocorticoids|glucocorticoids|mesh-ancestor
65426516|NCT00481832|Hormones|hormones|mesh-ancestor
65426517|NCT00481832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65426518|NCT00481832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65426519|NCT00481832|Protective Agents|protective agents|mesh-ancestor
65426520|NCT00481832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65426521|NCT00481676|Omalizumab|omalizumab|mesh-list
65426522|NCT00481676|Loratadine|loratadine|mesh-list
65426523|NCT00481676|Clemastine|clemastine|mesh-list
65426524|NCT00481676|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65426525|NCT00481676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65426526|NCT00481676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65426527|NCT00481676|Respiratory System Agents|respiratory system agents|mesh-ancestor
65426528|NCT00481676|Immunologic Factors|immunologic factors|mesh-ancestor
65426529|NCT00481676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426530|NCT00481676|Antipruritics|antipruritics|mesh-ancestor
65426531|NCT00481676|Dermatologic Agents|dermatologic agents|mesh-ancestor
65426532|NCT00481676|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65426533|NCT00481676|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65426534|NCT00481676|Histamine Antagonists|histamine antagonists|mesh-ancestor
65426535|NCT00481676|Histamine Agents|histamine agents|mesh-ancestor
65426536|NCT00481676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65426537|NCT00481676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426538|NCT00987233|Triamcinolone|triamcinolone|mesh-list
65426539|NCT00987233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65426540|NCT00987233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65426541|NCT00987233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65426542|NCT00987233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65426543|NCT00987233|Glucocorticoids|glucocorticoids|mesh-ancestor
65426544|NCT00987233|Hormones|hormones|mesh-ancestor
65426545|NCT00987233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65426546|NCT00987233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426547|NCT00987233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65426548|NCT00987233|Immunologic Factors|immunologic factors|mesh-ancestor
65426549|NCT00987233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426550|NCT00987233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426551|NCT04377503|Methylprednisolone|methylprednisolone|mesh-list
65426552|NCT04377503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65426553|NCT04377503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65426554|NCT04377503|Prednisolone|prednisolone|mesh-list
65426555|NCT04377503|Prednisolone acetate|prednisolone acetate|mesh-list
65426556|NCT04377503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65426557|NCT04377503|Prednisolone phosphate|prednisolone phosphate|mesh-list
64811313|NCT01446328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65426580|NCT03996434|Cetrorelix|cetrorelix|mesh-list
65426581|NCT03996434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65426582|NCT03996434|Fertility Agents|fertility agents|mesh-ancestor
65426583|NCT03996434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65426584|NCT03996434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426585|NCT03996434|Hormone Antagonists|hormone antagonists|mesh-ancestor
65426586|NCT03996434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65426587|NCT00987779|Gabapentin|gabapentin|mesh-list
65426588|NCT00987779|Analgesics|analgesics|mesh-ancestor
65426589|NCT00987779|Sensory System Agents|sensory system agents|mesh-ancestor
65426590|NCT00987779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65426591|NCT00987779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426592|NCT00987779|Anticonvulsants|anticonvulsants|mesh-ancestor
65270028|NCT02726126|Narcotics|narcotics|mesh-ancestor
65426593|NCT00987779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65426594|NCT00987779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65426595|NCT00987779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65426596|NCT00987779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65426597|NCT00987779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65426598|NCT00987779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65426599|NCT00987779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65426600|NCT00987779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426601|NCT00987779|Antimanic Agents|antimanic agents|mesh-ancestor
65426602|NCT01018160|Rabeprazole|rabeprazole|mesh-list
65426603|NCT01018160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65426604|NCT01018160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65426605|NCT01018160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65426606|NCT01018160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426607|NCT01018160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426608|NCT00473876|Metformin|metformin|mesh-list
65426609|NCT00473876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65426620|NCT01020734|Fludarabine phosphate|fludarabine phosphate|mesh-list
65426621|NCT01020734|Cyclosporins|cyclosporins|mesh-list
65426622|NCT01020734|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65426623|NCT01020734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65426624|NCT01020734|Immunologic Factors|immunologic factors|mesh-ancestor
65426625|NCT01020734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426626|NCT01020734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65426627|NCT01020734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65426628|NCT01020734|Alkylating Agents|alkylating agents|mesh-ancestor
65426629|NCT01020734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426630|NCT01020734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426631|NCT01020734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65426632|NCT01020734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65426633|NCT01020734|Abortifacient Agents|abortifacient agents|mesh-ancestor
65426634|NCT01020734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65426635|NCT01020734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65426636|NCT01020734|Antimetabolites|antimetabolites|mesh-ancestor
65426637|NCT01020734|Dermatologic Agents|dermatologic agents|mesh-ancestor
65426638|NCT01020734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426639|NCT01020734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65426640|NCT01020734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65426641|NCT01020734|Antifungal Agents|antifungal agents|mesh-ancestor
65426642|NCT01020734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65426643|NCT01020734|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65426644|NCT00540449|Efavirenz|efavirenz|mesh-list
65426645|NCT00540449|Rilpivirine|rilpivirine|mesh-list
65426646|NCT00540449|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65426647|NCT00540449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65426648|NCT00540449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426649|NCT00540449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426650|NCT00540449|Antiviral Agents|antiviral agents|mesh-ancestor
65426651|NCT00540449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65426652|NCT00540449|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65426653|NCT00540449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65426654|NCT00540449|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65426655|NCT00540449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65426656|NCT00540449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65426657|NCT00540449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65426658|NCT00540449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65426659|NCT00540449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65426660|NCT04891289|Gemcitabine|gemcitabine|mesh-list
65426661|NCT04891289|Dexamethasone|dexamethasone|mesh-list
65426662|NCT04891289|Oxaliplatin|oxaliplatin|mesh-list
65426663|NCT04891289|Floxuridine|floxuridine|mesh-list
65426664|NCT04891289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65426665|NCT04891289|Antiemetics|antiemetics|mesh-ancestor
65426666|NCT04891289|Autonomic Agents|autonomic agents|mesh-ancestor
65426667|NCT04891289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65426668|NCT04891289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426669|NCT04891289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65426670|NCT04891289|Glucocorticoids|glucocorticoids|mesh-ancestor
65426671|NCT04891289|Hormones|hormones|mesh-ancestor
65426672|NCT04891289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65426673|NCT04891289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65426674|NCT04891289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426675|NCT04891289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65426676|NCT04891289|Antimetabolites|antimetabolites|mesh-ancestor
65426695|NCT00361335|Antimetabolites|antimetabolites|mesh-ancestor
65426696|NCT00361335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426697|NCT00361335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426698|NCT00361335|Dermatologic Agents|dermatologic agents|mesh-ancestor
65426699|NCT00361335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426700|NCT00361335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65426701|NCT00361335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65426702|NCT00361335|Immunologic Factors|immunologic factors|mesh-ancestor
65426703|NCT00361335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65426704|NCT00361335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65426705|NCT00361335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65426706|NCT00361335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65426707|NCT00264550|Golimumab|golimumab|mesh-list
65426708|NCT00264550|Methotrexate|methotrexate|mesh-list
65426709|NCT00264550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65426710|NCT00264550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65426711|NCT00264550|Abortifacient Agents|abortifacient agents|mesh-ancestor
65426712|NCT00264550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65426713|NCT00264550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426714|NCT00264550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65426715|NCT00264550|Antimetabolites|antimetabolites|mesh-ancestor
65426716|NCT00264550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426717|NCT00264550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426718|NCT00264550|Dermatologic Agents|dermatologic agents|mesh-ancestor
65426719|NCT00264550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426720|NCT00264550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65426721|NCT00264550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65426722|NCT00264550|Immunologic Factors|immunologic factors|mesh-ancestor
65426723|NCT00264550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65426724|NCT00264550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65426725|NCT00264550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65426726|NCT00264550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65426727|NCT04004507|Phentolamine|phentolamine|mesh-list
65426728|NCT04004507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65426729|NCT04004507|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65426730|NCT04004507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65426731|NCT04004507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65426732|NCT04004507|Adrenergic Agents|adrenergic agents|mesh-ancestor
64811503|NCT01447654|Losartan|losartan|mesh-list
65426742|NCT01070290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426744|NCT01070290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65426745|NCT01070290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65426746|NCT01070290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426747|NCT01070446|Choline|choline|mesh-list
65426748|NCT01070446|Lipotropic Agents|lipotropic agents|mesh-ancestor
65426749|NCT01070446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65426750|NCT01070446|Antimetabolites|antimetabolites|mesh-ancestor
65426751|NCT01070446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426752|NCT01070446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65426753|NCT01070446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65426754|NCT01070446|Nootropic Agents|nootropic agents|mesh-ancestor
65426755|NCT01050387|Vitamin D|vitamin d|mesh-list
65426756|NCT01050387|Vitamins|vitamins|mesh-ancestor
65426757|NCT01050387|Micronutrients|micronutrients|mesh-ancestor
65426758|NCT01050387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426759|NCT01050387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65426760|NCT01070524|Budesonide|budesonide|mesh-list
65426761|NCT01070524|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65426762|NCT01070524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65426763|NCT01070524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65426764|NCT01070524|Autonomic Agents|autonomic agents|mesh-ancestor
65426765|NCT01070524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65426766|NCT01070524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426767|NCT01070524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65426768|NCT01070524|Respiratory System Agents|respiratory system agents|mesh-ancestor
65426769|NCT01070524|Glucocorticoids|glucocorticoids|mesh-ancestor
65426770|NCT01070524|Hormones|hormones|mesh-ancestor
65426771|NCT01070524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65426772|NCT01070524|Sympathomimetics|sympathomimetics|mesh-ancestor
65426773|NCT01071304|Midazolam|midazolam|mesh-list
65426774|NCT01071304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65426775|NCT01071304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65426776|NCT01071304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64996260|NCT00429559|Gemcitabine|gemcitabine|mesh-list
65426777|NCT01071304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426778|NCT01071304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65426779|NCT01071304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65426780|NCT01071304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65426781|NCT01071304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65426782|NCT01071304|Anesthetics, General|anesthetics, general|mesh-ancestor
65426783|NCT01071304|Anesthetics|anesthetics|mesh-ancestor
65426784|NCT01071304|GABA Modulators|gaba modulators|mesh-ancestor
65426785|NCT01071304|GABA Agents|gaba agents|mesh-ancestor
65426786|NCT01071304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65426787|NCT01071304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426788|NCT01069042|Enalapril|enalapril|mesh-list
65426789|NCT01069042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65426790|NCT01069042|Protease Inhibitors|protease inhibitors|mesh-ancestor
65426791|NCT01069042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426792|NCT01069042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426793|NCT01069042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65426794|NCT00368979|Dutasteride|dutasteride|mesh-list
65426795|NCT00368979|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65426796|NCT00368979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65426797|NCT00368979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811551|NCT01448096|Rituximab|rituximab|mesh-list
65426809|NCT00264238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65426810|NCT00264238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65426811|NCT00540293|Atorvastatin|atorvastatin|mesh-list
65426812|NCT00540293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65426813|NCT00540293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65426814|NCT00540293|Antimetabolites|antimetabolites|mesh-ancestor
65426815|NCT00540293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426816|NCT00540293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65426817|NCT00540293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65426818|NCT00540293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426819|NCT00375609|Enoxaparin|enoxaparin|mesh-list
65426820|NCT00375609|Betrixaban|betrixaban|mesh-list
65426821|NCT00375609|Anticoagulants|anticoagulants|mesh-ancestor
65426822|NCT00375609|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65426823|NCT00375609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65426824|NCT00375609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426825|NCT00375609|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65426826|NCT00375609|Antithrombins|antithrombins|mesh-ancestor
65426827|NCT00375609|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65426828|NCT00375609|Protease Inhibitors|protease inhibitors|mesh-ancestor
65426829|NCT00375609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426830|NCT01050621|Ascorbic Acid|ascorbic acid|mesh-list
65426831|NCT01050621|Vitamins|vitamins|mesh-ancestor
65426832|NCT01050621|Micronutrients|micronutrients|mesh-ancestor
65426833|NCT01050621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426834|NCT01050621|Antioxidants|antioxidants|mesh-ancestor
65426835|NCT01050621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426836|NCT01050621|Protective Agents|protective agents|mesh-ancestor
65426837|NCT00359073|Montelukast|montelukast|mesh-list
65426838|NCT00359073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65426839|NCT00359073|Respiratory System Agents|respiratory system agents|mesh-ancestor
65426840|NCT00359073|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65426841|NCT00359073|Hormone Antagonists|hormone antagonists|mesh-ancestor
65426842|NCT00359073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65426843|NCT00359073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426844|NCT00359073|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65426845|NCT00359073|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65426846|NCT00359073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426847|NCT00368745|Pregabalin|pregabalin|mesh-list
65426848|NCT00368745|Analgesics|analgesics|mesh-ancestor
65426849|NCT00368745|Sensory System Agents|sensory system agents|mesh-ancestor
65426850|NCT00368745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65426851|NCT00368745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426852|NCT00368745|Anticonvulsants|anticonvulsants|mesh-ancestor
65426853|NCT00368745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65426854|NCT00368745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65426855|NCT00368745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426856|NCT00368745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64811620|NCT01448499|Clozapine|clozapine|mesh-list
65426891|NCT01050699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65426892|NCT01050699|Anesthetics, General|anesthetics, general|mesh-ancestor
65270029|NCT02726126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65426894|NCT01050699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65426895|NCT01050699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65426896|NCT01050699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64811680|NCT01448772|Dronabinol|dronabinol|mesh-list
65426927|NCT05711615|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65426928|NCT05711615|Peposertib|peposertib|mesh-list
65426929|NCT05711615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65426930|NCT05711615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426931|NCT05711615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65426932|NCT05711615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65426933|NCT05711615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426934|NCT05711615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426935|NCT05711615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65426936|NCT01027182|Raltegravir Potassium|raltegravir potassium|mesh-list
65426937|NCT01027182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65426938|NCT01027182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65426939|NCT01027182|Antiviral Agents|antiviral agents|mesh-ancestor
65426940|NCT01027182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65427046|NCT00368277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65427047|NCT00368277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65427048|NCT00368277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427049|NCT00368277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65427050|NCT00368277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427051|NCT00368277|Vasodilator Agents|vasodilator agents|mesh-ancestor
65427053|NCT00368277|Natriuretic Agents|natriuretic agents|mesh-ancestor
65427054|NCT00368277|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65427055|NCT00368277|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65427056|NCT00368277|Protease Inhibitors|protease inhibitors|mesh-ancestor
65427057|NCT00368277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427058|NCT00280150|Paclitaxel|paclitaxel|mesh-list
65427059|NCT00280150|Bevacizumab|bevacizumab|mesh-list
65427060|NCT00280150|Carboplatin|carboplatin|mesh-list
65427061|NCT00280150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65427062|NCT00280150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65427063|NCT00280150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427064|NCT00280150|Tubulin Modulators|tubulin modulators|mesh-ancestor
65427065|NCT00280150|Antimitotic Agents|antimitotic agents|mesh-ancestor
65427066|NCT00280150|Mitosis Modulators|mitosis modulators|mesh-ancestor
65427067|NCT00280150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427068|NCT00280150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65427069|NCT00280150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65427070|NCT00280150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65427071|NCT00280150|Growth Substances|growth substances|mesh-ancestor
65427072|NCT00280150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427073|NCT00280150|Growth Inhibitors|growth inhibitors|mesh-ancestor
65427074|NCT00280150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65427075|NCT00280150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427076|NCT00279916|Triamcinolone|triamcinolone|mesh-list
65427077|NCT00279916|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65427078|NCT00279916|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65427079|NCT00279916|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65427080|NCT00279916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65427081|NCT00279916|Glucocorticoids|glucocorticoids|mesh-ancestor
65427082|NCT00279916|Hormones|hormones|mesh-ancestor
65427083|NCT00279916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65427084|NCT00279916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427085|NCT00279916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65427086|NCT00279916|Immunologic Factors|immunologic factors|mesh-ancestor
65427087|NCT00279916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427088|NCT00279916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427089|NCT02534337|Leucovorin|leucovorin|mesh-list
65427090|NCT02534337|Gemcitabine|gemcitabine|mesh-list
65427091|NCT02534337|Fluorouracil|fluorouracil|mesh-list
65427092|NCT02534337|Oxaliplatin|oxaliplatin|mesh-list
65427093|NCT02534337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65427094|NCT02534337|Antimetabolites|antimetabolites|mesh-ancestor
64811856|NCT01449617|Aspirin|aspirin|mesh-list
65427099|NCT02534337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427100|NCT02534337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65427101|NCT02534337|Immunologic Factors|immunologic factors|mesh-ancestor
65427102|NCT02534337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427103|NCT02534337|Antidotes|antidotes|mesh-ancestor
65427104|NCT02534337|Protective Agents|protective agents|mesh-ancestor
65274220|NCT02354898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427105|NCT02534337|Vitamin B Complex|vitamin b complex|mesh-ancestor
65427106|NCT02534337|Vitamins|vitamins|mesh-ancestor
65427107|NCT02534337|Micronutrients|micronutrients|mesh-ancestor
65427108|NCT01325896|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65427109|NCT01325896|Antiviral Agents|antiviral agents|mesh-ancestor
65427110|NCT01325896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65427111|NCT01050933|Carbon Monoxide|carbon monoxide|mesh-list
65427112|NCT01050933|Antimetabolites|antimetabolites|mesh-ancestor
65427113|NCT01050933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427114|NCT01050933|Gasotransmitters|gasotransmitters|mesh-ancestor
65427115|NCT01050933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65427116|NCT01050933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427117|NCT00358527|Mometasone Furoate|mometasone furoate|mesh-list
65427118|NCT00358527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65427119|NCT00358527|Dermatologic Agents|dermatologic agents|mesh-ancestor
65427120|NCT00358527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65427121|NCT00251758|Dexlansoprazole|dexlansoprazole|mesh-list
65427122|NCT00251758|Lansoprazole|lansoprazole|mesh-list
65427123|NCT00251758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65427124|NCT00251758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65427125|NCT00251758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65427126|NCT00251758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427127|NCT00251758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427128|NCT00279214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
65427129|NCT00279214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65427130|NCT00262834|Vorinostat|vorinostat|mesh-list
65427131|NCT00262834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427132|NCT00262834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65427133|NCT00262834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427134|NCT00262834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427135|NCT04417361|Erenumab|erenumab|mesh-list
65427136|NCT04417361|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65427137|NCT04417361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427138|NCT04417361|Analgesics|analgesics|mesh-ancestor
65427139|NCT04417361|Sensory System Agents|sensory system agents|mesh-ancestor
65427140|NCT04417361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65427141|NCT04417361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427142|NCT03396575|Cyclophosphamide|cyclophosphamide|mesh-list
65427143|NCT03396575|Fludarabine|fludarabine|mesh-list
65427144|NCT03396575|Vaccines|vaccines|mesh-list
65427145|NCT03396575|Immunologic Factors|immunologic factors|mesh-ancestor
65427146|NCT03396575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427147|NCT03396575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65427148|NCT03396575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65427149|NCT03396575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65427150|NCT03396575|Alkylating Agents|alkylating agents|mesh-ancestor
65427151|NCT03396575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427152|NCT03396575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427153|NCT03396575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65427154|NCT00541775|Metformin|metformin|mesh-list
65427155|NCT00541775|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65427156|NCT00541775|Rosiglitazone|rosiglitazone|mesh-list
65427157|NCT00541775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65427158|NCT00541775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427159|NCT00541775|Incretins|incretins|mesh-ancestor
65427160|NCT00541775|Hormones|hormones|mesh-ancestor
65427161|NCT00541775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65427162|NCT00541775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65427163|NCT00541775|Protease Inhibitors|protease inhibitors|mesh-ancestor
65427164|NCT00541775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427165|NCT00541775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427184|NCT00539513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65427185|NCT00539513|Antioxidants|antioxidants|mesh-ancestor
65427186|NCT00539513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427187|NCT00539513|Protective Agents|protective agents|mesh-ancestor
65427188|NCT00539513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427189|NCT00539513|Antidotes|antidotes|mesh-ancestor
65427190|NCT02997761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65427191|NCT02997761|Blinatumomab|blinatumomab|mesh-list
65427192|NCT02997761|Antibodies|antibodies|mesh-list
65427193|NCT02997761|Immunoglobulins|immunoglobulins|mesh-list
65427194|NCT02997761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65427195|NCT02997761|Muromonab-CD3|muromonab-cd3|mesh-list
65427196|NCT02997761|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65427197|NCT02997761|Immunologic Factors|immunologic factors|mesh-ancestor
65427198|NCT02997761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427199|NCT02997761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427200|NCT02997761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65427201|NCT00454584|Etanercept|etanercept|mesh-list
65427202|NCT00454584|Ustekinumab|ustekinumab|mesh-list
65427203|NCT00454584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65427204|NCT00454584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65427205|NCT00454584|Analgesics|analgesics|mesh-ancestor
65427206|NCT00454584|Sensory System Agents|sensory system agents|mesh-ancestor
65427207|NCT00454584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65427208|NCT00454584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427209|NCT00454584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65427210|NCT00454584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65427211|NCT00454584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65427212|NCT00454584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65427213|NCT00454584|Immunologic Factors|immunologic factors|mesh-ancestor
65427214|NCT00454584|Dermatologic Agents|dermatologic agents|mesh-ancestor
65427215|NCT02583893|Cytarabine|cytarabine|mesh-list
65427216|NCT02583893|Sirolimus|sirolimus|mesh-list
65427217|NCT02583893|Etoposide|etoposide|mesh-list
65427218|NCT02583893|Mitoxantrone|mitoxantrone|mesh-list
65427219|NCT02583893|Etoposide phosphate|etoposide phosphate|mesh-list
65427220|NCT02583893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65427221|NCT02583893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427222|NCT02583893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65427223|NCT02583893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65427224|NCT02583893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427225|NCT02583893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811993|NCT01452256|Anesthetics|anesthetics|mesh-ancestor
65427244|NCT04204343|Bupivacaine|bupivacaine|mesh-list
65427245|NCT04204343|Anesthetics, Local|anesthetics, local|mesh-ancestor
65427246|NCT04204343|Anesthetics|anesthetics|mesh-ancestor
65427247|NCT04204343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65427248|NCT04204343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427249|NCT04204343|Sensory System Agents|sensory system agents|mesh-ancestor
65427250|NCT04204343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65427251|NCT02845271|Acetaminophen|acetaminophen|mesh-list
65427252|NCT02845271|Tramadol|tramadol|mesh-list
65427253|NCT02845271|Codeine|codeine|mesh-list
65427254|NCT02845271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65427255|NCT02845271|Analgesics|analgesics|mesh-ancestor
65427256|NCT02845271|Sensory System Agents|sensory system agents|mesh-ancestor
65427257|NCT02845271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65427258|NCT02845271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427259|NCT02845271|Antipyretics|antipyretics|mesh-ancestor
65427260|NCT02845271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65427261|NCT02845271|Narcotics|narcotics|mesh-ancestor
65427262|NCT02845271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65427263|NCT02845271|Antitussive Agents|antitussive agents|mesh-ancestor
65427264|NCT02845271|Respiratory System Agents|respiratory system agents|mesh-ancestor
65427265|NCT00445068|Panobinostat|panobinostat|mesh-list
65427266|NCT00445068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427267|NCT00445068|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65427268|NCT00445068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427269|NCT00445068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427270|NCT02404337|Betaine|betaine|mesh-list
65427271|NCT02404337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65427272|NCT02404337|Lipotropic Agents|lipotropic agents|mesh-ancestor
65427273|NCT02404337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65427274|NCT02404337|Antimetabolites|antimetabolites|mesh-ancestor
65427275|NCT02404337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427276|NCT02404337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65427277|NCT05360147|Metformin|metformin|mesh-list
65427278|NCT05360147|Liraglutide|liraglutide|mesh-list
65427279|NCT05360147|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65427280|NCT05360147|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
65427281|NCT05360147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427282|NCT05360147|Incretins|incretins|mesh-ancestor
65427283|NCT05360147|Hormones|hormones|mesh-ancestor
64812047|NCT01455636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427301|NCT00538733|Lenalidomide|lenalidomide|mesh-list
65427302|NCT00538733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65427303|NCT00538733|Antiemetics|antiemetics|mesh-ancestor
65427304|NCT00538733|Autonomic Agents|autonomic agents|mesh-ancestor
65427305|NCT00538733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65427306|NCT00538733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427307|NCT00538733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65427308|NCT00538733|Glucocorticoids|glucocorticoids|mesh-ancestor
65427309|NCT00538733|Hormones|hormones|mesh-ancestor
65427310|NCT00538733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65427311|NCT00538733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65427312|NCT00538733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427313|NCT00538733|Immunologic Factors|immunologic factors|mesh-ancestor
65427314|NCT00538733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65427315|NCT00538733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65427316|NCT00538733|Growth Substances|growth substances|mesh-ancestor
65427317|NCT00538733|Growth Inhibitors|growth inhibitors|mesh-ancestor
65427318|NCT00538733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65427319|NCT00538733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65427320|NCT00538733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65427321|NCT00538733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427322|NCT00538733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427323|NCT00538733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65427324|NCT00538733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65427325|NCT00538733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65427326|NCT00538733|Leprostatic Agents|leprostatic agents|mesh-ancestor
65427327|NCT00444678|Capecitabine|capecitabine|mesh-list
65427328|NCT00444678|Oxaliplatin|oxaliplatin|mesh-list
65427329|NCT00444678|Cetuximab|cetuximab|mesh-list
65427330|NCT00444678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65427331|NCT00444678|Antimetabolites|antimetabolites|mesh-ancestor
65176861|NCT02848612|Heparin|heparin|mesh-list
65427332|NCT00444678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427333|NCT00444678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427334|NCT00444678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65427335|NCT00539981|Hemagglutinins|hemagglutinins|mesh-list
65427336|NCT00539981|Immunologic Factors|immunologic factors|mesh-ancestor
65427337|NCT00539981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427338|NCT00539981|Agglutinins|agglutinins|mesh-ancestor
65427339|NCT00990197|Nicotine|nicotine|mesh-list
65427340|NCT00990197|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65427341|NCT00990197|Autonomic Agents|autonomic agents|mesh-ancestor
64812105|NCT01458808|Dialysis Solutions|dialysis solutions|mesh-list
65427349|NCT01051011|Metformin|metformin|mesh-list
65427350|NCT01051011|Insulin Glargine|insulin glargine|mesh-list
65427351|NCT01051011|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65427352|NCT01051011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65427353|NCT01051011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427354|NCT01051011|Incretins|incretins|mesh-ancestor
65427355|NCT01051011|Hormones|hormones|mesh-ancestor
65427356|NCT01051011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65427357|NCT01048827|Busulfan|busulfan|mesh-list
65427358|NCT01048827|Alkylating Agents|alkylating agents|mesh-ancestor
65427359|NCT01048827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427360|NCT01048827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65427361|NCT01048827|Immunologic Factors|immunologic factors|mesh-ancestor
65427362|NCT01048827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427363|NCT01048827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65427364|NCT01048827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427365|NCT01048827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65427366|NCT02023463|Leuprolide|leuprolide|mesh-list
65427367|NCT02023463|Goserelin|goserelin|mesh-list
65427368|NCT02023463|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65427369|NCT02023463|Fertility Agents|fertility agents|mesh-ancestor
65427370|NCT02023463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65427371|NCT02023463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427372|NCT02023463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65427373|NCT02023463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427374|NCT01302327|Exenatide|exenatide|mesh-list
65427375|NCT01302327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65427376|NCT01302327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427377|NCT01302327|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65427378|NCT01302327|Incretins|incretins|mesh-ancestor
65427379|NCT01302327|Hormones|hormones|mesh-ancestor
65427380|NCT01302327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65427381|NCT01048983|Minocycline|minocycline|mesh-list
65427382|NCT01048983|Curcumin|curcumin|mesh-list
65427383|NCT01048983|Modafinil|modafinil|mesh-list
65427384|NCT01048983|Bupropion|bupropion|mesh-list
65427385|NCT01048983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65427386|NCT01048983|Antidepressive Agents|antidepressive agents|mesh-ancestor
65427387|NCT01048983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65427388|NCT01048983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65427389|NCT01048983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64996637|NCT00096863|Haloperidol decanoate|haloperidol decanoate|mesh-list
65427390|NCT01048983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65427391|NCT01048983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427392|NCT01048983|Dopamine Agents|dopamine agents|mesh-ancestor
65427393|NCT01048983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65427394|NCT01048983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427395|NCT01048983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65427396|NCT01048983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65427397|NCT01048983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427398|NCT01048983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65427399|NCT01048983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65427400|NCT01048983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65427401|NCT01048983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65427402|NCT01048983|Analgesics|analgesics|mesh-ancestor
65427403|NCT01048983|Sensory System Agents|sensory system agents|mesh-ancestor
65427404|NCT01048983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65427405|NCT01048983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65427406|NCT01048983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65427407|NCT01048983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812164|NCT01460355|Botulinum Toxins|botulinum toxins|mesh-list
65427428|NCT00367341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65427429|NCT00367341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427430|NCT00367341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65427431|NCT00367341|Serotonin Agents|serotonin agents|mesh-ancestor
65427432|NCT00367341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427433|NCT00367341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65427434|NCT00367341|Antidepressive Agents|antidepressive agents|mesh-ancestor
65427435|NCT00367341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65427436|NCT01052961|Oseltamivir|oseltamivir|mesh-list
65427437|NCT01052961|Antiviral Agents|antiviral agents|mesh-ancestor
65427438|NCT01052961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65427439|NCT01052961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427440|NCT01052961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427441|NCT00440466|Epoetin Alfa|epoetin alfa|mesh-list
65427442|NCT00440466|Hematinics|hematinics|mesh-ancestor
65427443|NCT01051167|Cetuximab|cetuximab|mesh-list
65427444|NCT01051167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65427445|NCT01051167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427446|NCT01325441|Paclitaxel|paclitaxel|mesh-list
65427447|NCT01325441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65427448|NCT01325441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427449|NCT01325441|Tubulin Modulators|tubulin modulators|mesh-ancestor
65427450|NCT01325441|Antimitotic Agents|antimitotic agents|mesh-ancestor
65427451|NCT01325441|Mitosis Modulators|mitosis modulators|mesh-ancestor
65427452|NCT01325441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427453|NCT00616967|Paclitaxel|paclitaxel|mesh-list
65427454|NCT00616967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65427455|NCT00616967|Carboplatin|carboplatin|mesh-list
65427456|NCT00616967|Vorinostat|vorinostat|mesh-list
65427457|NCT00616967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65427458|NCT00616967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427459|NCT00616967|Tubulin Modulators|tubulin modulators|mesh-ancestor
65427460|NCT00616967|Antimitotic Agents|antimitotic agents|mesh-ancestor
65427468|NCT05360537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427469|NCT05360537|Incretins|incretins|mesh-ancestor
65427470|NCT05360537|Hormones|hormones|mesh-ancestor
65427471|NCT05360537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65427472|NCT05590637|Pimavanserin|pimavanserin|mesh-list
65427473|NCT05590637|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65427474|NCT05590637|Antidepressive Agents|antidepressive agents|mesh-ancestor
65427475|NCT05590637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65427476|NCT05590637|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65427477|NCT05590637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65427478|NCT05590637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65427479|NCT05590637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427480|NCT05590637|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65427481|NCT05590637|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65427482|NCT05590637|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65427483|NCT05590637|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65427484|NCT05590637|Serotonin Agents|serotonin agents|mesh-ancestor
65427485|NCT05590637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65427486|NCT05590637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427487|NCT00989651|Paclitaxel|paclitaxel|mesh-list
65427488|NCT00989651|Bevacizumab|bevacizumab|mesh-list
65427489|NCT00989651|Cisplatin|cisplatin|mesh-list
65427490|NCT00989651|Carboplatin|carboplatin|mesh-list
65427491|NCT00989651|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65427492|NCT00989651|Veliparib|veliparib|mesh-list
65427493|NCT00989651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65427494|NCT00989651|Endothelial Growth Factors|endothelial growth factors|mesh-list
65427495|NCT00989651|Antibodies|antibodies|mesh-list
65427496|NCT00989651|Immunoglobulins|immunoglobulins|mesh-list
65427497|NCT00989651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65427498|NCT00989651|Immunoglobulin G|immunoglobulin g|mesh-list
65427499|NCT00989651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65427500|NCT00989651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427501|NCT00989651|Tubulin Modulators|tubulin modulators|mesh-ancestor
65427502|NCT00989651|Antimitotic Agents|antimitotic agents|mesh-ancestor
65427503|NCT00989651|Mitosis Modulators|mitosis modulators|mesh-ancestor
65427504|NCT00989651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427505|NCT00989651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65427506|NCT00989651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65427507|NCT00989651|Growth Substances|growth substances|mesh-ancestor
65427508|NCT00989651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427509|NCT00989651|Growth Inhibitors|growth inhibitors|mesh-ancestor
65427510|NCT00989651|Immunologic Factors|immunologic factors|mesh-ancestor
65427511|NCT00989651|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65427512|NCT00989651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427513|NCT05590559|Morphine|morphine|mesh-list
65427514|NCT05590559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65427515|NCT05590559|Narcotics|narcotics|mesh-ancestor
65427516|NCT05590559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65427517|NCT05590559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427518|NCT05590559|Analgesics|analgesics|mesh-ancestor
65427519|NCT05590559|Sensory System Agents|sensory system agents|mesh-ancestor
65427520|NCT05590559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65427521|NCT05590325|Dolutegravir|dolutegravir|mesh-list
65427522|NCT05590325|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65427523|NCT05590325|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65427524|NCT05590325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427525|NCT05590325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427526|NCT05590325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65427527|NCT05590325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65427528|NCT05590325|Antiviral Agents|antiviral agents|mesh-ancestor
65427529|NCT05590325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65427547|NCT00989729|Protective Agents|protective agents|mesh-ancestor
65427548|NCT00989729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65427549|NCT00989729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427550|NCT00989807|Aztreonam|aztreonam|mesh-list
65427551|NCT00989807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65427552|NCT00989807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65427553|NCT00990587|Ciclopirox|ciclopirox|mesh-list
65427554|NCT00990587|Antifungal Agents|antifungal agents|mesh-ancestor
65427555|NCT00990587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65427556|NCT00537329|Anidulafungin|anidulafungin|mesh-list
65427557|NCT00537329|Antifungal Agents|antifungal agents|mesh-ancestor
65427558|NCT00537329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65427559|NCT03905135|Avelumab|avelumab|mesh-list
65427560|NCT03905135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65427561|NCT03905135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427562|NCT00991055|Pioglitazone|pioglitazone|mesh-list
65427563|NCT00991055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65427564|NCT00991055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427565|NCT00991133|Clofarabine|clofarabine|mesh-list
65427566|NCT00991133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427567|NCT00991133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427568|NCT00991133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65427569|NCT00991133|Antimetabolites|antimetabolites|mesh-ancestor
65427570|NCT00991211|Cyclophosphamide|cyclophosphamide|mesh-list
65427571|NCT00991211|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65427572|NCT00991211|Doxorubicin|doxorubicin|mesh-list
65427573|NCT00991211|Vincristine|vincristine|mesh-list
65427574|NCT00991211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65427575|NCT00991211|Immunologic Factors|immunologic factors|mesh-ancestor
65427576|NCT00991211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427577|NCT00991211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65427578|NCT00991211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65427579|NCT00991211|Alkylating Agents|alkylating agents|mesh-ancestor
65427580|NCT00991211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427581|NCT00991211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427582|NCT00991211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65427583|NCT00991211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65427584|NCT00991211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65427585|NCT00991211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65427586|NCT00991211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427587|NCT00991211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65427588|NCT00991211|Tubulin Modulators|tubulin modulators|mesh-ancestor
65427599|NCT00357903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65427600|NCT00357903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65427601|NCT00357903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65427602|NCT00357903|Immunologic Factors|immunologic factors|mesh-ancestor
65427603|NCT01053039|Morphine|morphine|mesh-list
65427604|NCT01053039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65427605|NCT01053039|Narcotics|narcotics|mesh-ancestor
65427606|NCT01053039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65427607|NCT01053039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427608|NCT01053039|Analgesics|analgesics|mesh-ancestor
65427609|NCT01053039|Sensory System Agents|sensory system agents|mesh-ancestor
65427610|NCT01053039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65427611|NCT01051401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65427612|NCT01051401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65427613|NCT01051401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65427614|NCT01051401|Antimetabolites|antimetabolites|mesh-ancestor
65427615|NCT01051401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427616|NCT01051401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65427617|NCT01051401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65427618|NCT01051401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427619|NCT00348933|Vitamin B 12|vitamin b 12|mesh-list
65427620|NCT00348933|Hydroxocobalamin|hydroxocobalamin|mesh-list
65427621|NCT00348933|Betaine|betaine|mesh-list
65427622|NCT00348933|Vitamins|vitamins|mesh-ancestor
65427623|NCT00348933|Micronutrients|micronutrients|mesh-ancestor
65427624|NCT00348933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427625|NCT00348933|Vitamin B Complex|vitamin b complex|mesh-ancestor
65427626|NCT00348933|Hematinics|hematinics|mesh-ancestor
65427627|NCT00348933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65427628|NCT00348933|Lipotropic Agents|lipotropic agents|mesh-ancestor
65427629|NCT00348933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65427630|NCT00348933|Antimetabolites|antimetabolites|mesh-ancestor
65427631|NCT00348933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427632|NCT00348933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65427633|NCT01051479|Choline|choline|mesh-list
65427634|NCT01051479|Lipotropic Agents|lipotropic agents|mesh-ancestor
65427635|NCT01051479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65427636|NCT01051479|Antimetabolites|antimetabolites|mesh-ancestor
65427637|NCT01051479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427638|NCT01051479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65427639|NCT01051479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65427640|NCT01051479|Nootropic Agents|nootropic agents|mesh-ancestor
65427642|NCT01055691|Dapagliflozin|dapagliflozin|mesh-list
65427643|NCT01055691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65427644|NCT01055691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427645|NCT01055691|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65427646|NCT01055691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427647|NCT03896477|Vaccines|vaccines|mesh-list
65427648|NCT03896477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65427649|NCT03896477|Immunologic Factors|immunologic factors|mesh-ancestor
65427650|NCT03896477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427651|NCT00444600|Triamcinolone|triamcinolone|mesh-list
65427652|NCT00444600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65427653|NCT00444600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65427654|NCT00444600|Ranibizumab|ranibizumab|mesh-list
65427655|NCT00444600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65427668|NCT00444600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427669|NCT00444600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427670|NCT05357027|Cyclophosphamide|cyclophosphamide|mesh-list
65427671|NCT05357027|Fludarabine|fludarabine|mesh-list
65427672|NCT05357027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65427673|NCT05357027|Immunologic Factors|immunologic factors|mesh-ancestor
65427674|NCT05357027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427675|NCT05357027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65427676|NCT05357027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65427677|NCT05357027|Alkylating Agents|alkylating agents|mesh-ancestor
65427678|NCT05357027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427679|NCT05357027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427680|NCT05357027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65427681|NCT00443898|Terbinafine|terbinafine|mesh-list
65270030|NCT02726126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427682|NCT00443898|Antifungal Agents|antifungal agents|mesh-ancestor
65427683|NCT00443898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65427684|NCT00443898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427685|NCT00443898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427686|NCT00537017|Levodopa|levodopa|mesh-list
65427687|NCT00537017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65427688|NCT00537017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65427689|NCT00537017|Dopamine Agents|dopamine agents|mesh-ancestor
65427690|NCT00537017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65427691|NCT00537017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427692|NCT00537017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427693|NCT00348309|Rosiglitazone|rosiglitazone|mesh-list
65427694|NCT00348309|Donepezil|donepezil|mesh-list
65427695|NCT00348309|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65427696|NCT00348309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427697|NCT00348309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427698|NCT00348309|Cholinergic Agents|cholinergic agents|mesh-ancestor
65427699|NCT00348309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65427700|NCT00348309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427701|NCT00348309|Nootropic Agents|nootropic agents|mesh-ancestor
65427702|NCT00348309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65427703|NCT04451837|Dapagliflozin|dapagliflozin|mesh-list
65427704|NCT04451837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65427705|NCT04451837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427706|NCT04451837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65427707|NCT04451837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427708|NCT04403165|Norepinephrine|norepinephrine|mesh-list
65427709|NCT04403165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65427710|NCT04403165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65427711|NCT04403165|Adrenergic Agents|adrenergic agents|mesh-ancestor
65427712|NCT04403165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65427713|NCT04403165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427714|NCT04403165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427716|NCT04403165|Autonomic Agents|autonomic agents|mesh-ancestor
65427717|NCT04403165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65427729|NCT02533791|Vaccines|vaccines|mesh-list
65427730|NCT02533791|Immunologic Factors|immunologic factors|mesh-ancestor
65427731|NCT02533791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427732|NCT05426681|Glyburide|glyburide|mesh-list
65427733|NCT05426681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65427734|NCT05426681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427735|NCT01055925|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65427736|NCT01055925|Laxatives|laxatives|mesh-ancestor
65427737|NCT01055925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65427738|NCT00440232|Frovatriptan|frovatriptan|mesh-list
65427739|NCT00440232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65427740|NCT00440232|Serotonin Agents|serotonin agents|mesh-ancestor
65427741|NCT00440232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65427742|NCT00440232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427743|NCT00440232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427744|NCT01564199|Fluticasone|fluticasone|mesh-list
65427745|NCT01564199|Xhance|xhance|mesh-list
65427746|NCT01564199|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65427747|NCT01564199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65427748|NCT01564199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65427749|NCT01564199|Autonomic Agents|autonomic agents|mesh-ancestor
65427750|NCT01564199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65427751|NCT01564199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427752|NCT01564199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65427753|NCT01564199|Respiratory System Agents|respiratory system agents|mesh-ancestor
65427754|NCT01564199|Dermatologic Agents|dermatologic agents|mesh-ancestor
65427755|NCT01564199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65427756|NCT01564199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65427757|NCT01564199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65427758|NCT01564199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65427759|NCT01564199|Adrenergic Agents|adrenergic agents|mesh-ancestor
65427760|NCT01564199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65427761|NCT01564199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427762|NCT02533323|Gemcitabine|gemcitabine|mesh-list
65427763|NCT02533323|Oxaliplatin|oxaliplatin|mesh-list
65427764|NCT02533323|Pegaspargase|pegaspargase|mesh-list
65427765|NCT02533323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65427766|NCT02533323|Antimetabolites|antimetabolites|mesh-ancestor
65427767|NCT02533323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427768|NCT02533323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427769|NCT02533323|Antiviral Agents|antiviral agents|mesh-ancestor
65427770|NCT02533323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65427771|NCT02533323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427772|NCT02533323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65427773|NCT02533323|Immunologic Factors|immunologic factors|mesh-ancestor
65427774|NCT02533323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427775|NCT05379959|Methamphetamine|methamphetamine|mesh-list
65427776|NCT05379959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65427777|NCT05379959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427778|NCT05379959|Sympathomimetics|sympathomimetics|mesh-ancestor
65427779|NCT05379959|Autonomic Agents|autonomic agents|mesh-ancestor
65427780|NCT05379959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65427781|NCT05379959|Dopamine Agents|dopamine agents|mesh-ancestor
65427782|NCT05379959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64812546|NCT01464099|Insulin|insulin|mesh-list
65427803|NCT05357885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427804|NCT04003181|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65427805|NCT04003181|Bile Acids and Salts|bile acids and salts|mesh-list
65427806|NCT04003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65427807|NCT04003181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65427808|NCT00356889|Bevacizumab|bevacizumab|mesh-list
65427809|NCT00356889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65427810|NCT00356889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65427811|NCT00356889|Antibodies|antibodies|mesh-list
65427812|NCT00356889|Immunoglobulins|immunoglobulins|mesh-list
65427813|NCT00356889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65427814|NCT00356889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427815|NCT00356889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65427816|NCT00356889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65427817|NCT00356889|Growth Substances|growth substances|mesh-ancestor
65427818|NCT00356889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427819|NCT00356889|Growth Inhibitors|growth inhibitors|mesh-ancestor
65427820|NCT00356889|Immunologic Factors|immunologic factors|mesh-ancestor
65427821|NCT00356889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65427822|NCT00356889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427823|NCT00356889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427824|NCT05186363|Pyrimethamine|pyrimethamine|mesh-list
65427825|NCT05186363|Sulfadoxine|sulfadoxine|mesh-list
65427826|NCT05186363|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65427827|NCT05186363|Amodiaquine|amodiaquine|mesh-list
65427828|NCT05186363|Antimalarials|antimalarials|mesh-ancestor
65427829|NCT05186363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65427830|NCT05186363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65427831|NCT05186363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65427832|NCT05186363|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65427833|NCT05186363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427834|NCT05186363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812612|NCT01464489|Atropine|atropine|mesh-list
65427850|NCT00356811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65427851|NCT00356811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427852|NCT00356811|Tubulin Modulators|tubulin modulators|mesh-ancestor
65427853|NCT00356811|Antimitotic Agents|antimitotic agents|mesh-ancestor
65427854|NCT00356811|Mitosis Modulators|mitosis modulators|mesh-ancestor
65427855|NCT00356811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427856|NCT00356811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65427857|NCT00356811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427858|NCT00439218|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
65177391|NCT00655837|Rituximab|rituximab|mesh-list
65427859|NCT00439218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427860|NCT01030614|Dexamethasone|dexamethasone|mesh-list
65427861|NCT01030614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65427862|NCT01030614|Antiemetics|antiemetics|mesh-ancestor
65427863|NCT01030614|Autonomic Agents|autonomic agents|mesh-ancestor
65427864|NCT01030614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65427865|NCT01030614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427866|NCT01030614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65427867|NCT01030614|Glucocorticoids|glucocorticoids|mesh-ancestor
65427868|NCT01030614|Hormones|hormones|mesh-ancestor
65427869|NCT01030614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65427870|NCT01030614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65427871|NCT01030614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427872|NCT01030692|Rivastigmine|rivastigmine|mesh-list
65427873|NCT01030692|Huperzine A|huperzine a|mesh-list
65427874|NCT01030692|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65270031|NCT02726126|Analgesics|analgesics|mesh-ancestor
65427875|NCT01030692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427876|NCT01030692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427877|NCT01030692|Cholinergic Agents|cholinergic agents|mesh-ancestor
65427878|NCT01030692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65427879|NCT01030692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427880|NCT01030692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65427881|NCT01030692|Protective Agents|protective agents|mesh-ancestor
65427882|NCT03138252|Oxytocin|oxytocin|mesh-list
65427883|NCT03138252|Oxytocics|oxytocics|mesh-ancestor
65427884|NCT03138252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65427885|NCT03138252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427886|NCT04994561|Niacinamide|niacinamide|mesh-list
65427887|NCT04994561|Metformin|metformin|mesh-list
65427888|NCT04994561|Dasatinib|dasatinib|mesh-list
65427889|NCT04994561|Resveratrol|resveratrol|mesh-list
65427890|NCT04994561|Quercetin|quercetin|mesh-list
65427891|NCT04994561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65427892|NCT04994561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427893|NCT04994561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427894|NCT04994561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65427895|NCT04994561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812661|NCT01466829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427906|NCT01030770|Growth Substances|growth substances|mesh-ancestor
65427907|NCT01030770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427908|NCT01030770|Growth Inhibitors|growth inhibitors|mesh-ancestor
65427909|NCT01030770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427910|NCT04941443|Ibuprofen|ibuprofen|mesh-list
65427911|NCT04941443|Methadone|methadone|mesh-list
65427912|NCT04941443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65427913|NCT04941443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65427914|NCT04941443|Analgesics|analgesics|mesh-ancestor
65427915|NCT04941443|Sensory System Agents|sensory system agents|mesh-ancestor
65427916|NCT04941443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65427917|NCT04941443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427918|NCT04941443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65427919|NCT04941443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65427920|NCT04941443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65427921|NCT04941443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427922|NCT04941443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427923|NCT04941443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65427924|NCT04941443|Narcotics|narcotics|mesh-ancestor
65427925|NCT04941443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65427926|NCT04941443|Antitussive Agents|antitussive agents|mesh-ancestor
65427927|NCT04941443|Respiratory System Agents|respiratory system agents|mesh-ancestor
65427928|NCT03994692|Ether|ether|mesh-list
65427929|NCT03994692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65427930|NCT03994692|Anesthetics, General|anesthetics, general|mesh-ancestor
65427931|NCT03994692|Anesthetics|anesthetics|mesh-ancestor
65427932|NCT03994692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65427933|NCT03994692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427934|NCT01030926|Insulin|insulin|mesh-list
65427935|NCT01030926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65427936|NCT01030926|Insulin Glargine|insulin glargine|mesh-list
65427937|NCT01030926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65427938|NCT01030926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427939|NCT04198805|Vitamins|vitamins|mesh-list
65177454|NCT00882583|Cisplatin|cisplatin|mesh-list
65427940|NCT04198805|Vitamin E|vitamin e|mesh-list
65427941|NCT04198805|Tocopherols|tocopherols|mesh-list
65427942|NCT04198805|Tocotrienols|tocotrienols|mesh-list
65427943|NCT04198805|alpha-Tocopherol|alpha-tocopherol|mesh-list
65427944|NCT04198805|Micronutrients|micronutrients|mesh-ancestor
65427945|NCT04198805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427946|NCT04198805|Antioxidants|antioxidants|mesh-ancestor
65427947|NCT04198805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427948|NCT04198805|Protective Agents|protective agents|mesh-ancestor
65427949|NCT00536939|Paclitaxel|paclitaxel|mesh-list
65427950|NCT00536939|Bevacizumab|bevacizumab|mesh-list
65427951|NCT00536939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65427952|NCT00536939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427953|NCT00536939|Tubulin Modulators|tubulin modulators|mesh-ancestor
65427954|NCT00536939|Antimitotic Agents|antimitotic agents|mesh-ancestor
65427955|NCT00536939|Mitosis Modulators|mitosis modulators|mesh-ancestor
65427956|NCT00536939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427957|NCT00536939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65427958|NCT00536939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64997090|NCT00098111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427959|NCT00536939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65427960|NCT00536939|Growth Substances|growth substances|mesh-ancestor
65427961|NCT00536939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427970|NCT00347919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427972|NCT00439140|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65427973|NCT00439140|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65427974|NCT00439140|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65427975|NCT00439140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65427976|NCT00439140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427977|NCT00439140|Cholinergic Agents|cholinergic agents|mesh-ancestor
65427978|NCT00439140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65427979|NCT00439140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427980|NCT00439140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65427981|NCT00439140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65427982|NCT00356421|Insulin|insulin|mesh-list
65427983|NCT00356421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65427984|NCT00356421|Insulin Lispro|insulin lispro|mesh-list
65427985|NCT00356421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65427986|NCT00356421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427987|NCT03990129|Dipyrone|dipyrone|mesh-list
65427988|NCT03990129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65427989|NCT03990129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65427990|NCT03990129|Analgesics|analgesics|mesh-ancestor
65427991|NCT03990129|Sensory System Agents|sensory system agents|mesh-ancestor
65427992|NCT03990129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65427993|NCT03990129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427994|NCT03990129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65427995|NCT03990129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65427996|NCT03990129|Antipyretics|antipyretics|mesh-ancestor
65427997|NCT01051947|Metoprolol|metoprolol|mesh-list
65427998|NCT01051947|Nebivolol|nebivolol|mesh-list
65427999|NCT01051947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65428000|NCT01051947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65428001|NCT01051947|Sympatholytics|sympatholytics|mesh-ancestor
65428002|NCT01051947|Autonomic Agents|autonomic agents|mesh-ancestor
65428003|NCT01051947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65428004|NCT01051947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428005|NCT01051947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65428006|NCT01051947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65428007|NCT01051947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65428008|NCT01051947|Adrenergic Agents|adrenergic agents|mesh-ancestor
65428009|NCT01051947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65428010|NCT01051947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428011|NCT01051947|Vasodilator Agents|vasodilator agents|mesh-ancestor
65428012|NCT01051947|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65428013|NCT01051947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65428014|NCT01051947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65428015|NCT01052025|Curcumin|curcumin|mesh-list
65428016|NCT01052025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65428017|NCT01052025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65428018|NCT01052025|Analgesics|analgesics|mesh-ancestor
65428019|NCT01052025|Sensory System Agents|sensory system agents|mesh-ancestor
65428020|NCT01052025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65428021|NCT01052025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428022|NCT01052025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65428023|NCT01052025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65428024|NCT01052025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428025|NCT01052025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428026|NCT01052025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428027|NCT00443820|Terbinafine|terbinafine|mesh-list
65428028|NCT00443820|Antifungal Agents|antifungal agents|mesh-ancestor
65428034|NCT00438672|Antiemetics|antiemetics|mesh-ancestor
65428035|NCT00438672|Autonomic Agents|autonomic agents|mesh-ancestor
65428036|NCT00438672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65428037|NCT00438672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428038|NCT00438672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65428039|NCT00438672|Glucocorticoids|glucocorticoids|mesh-ancestor
65428040|NCT00438672|Hormones|hormones|mesh-ancestor
65428041|NCT00438672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65428042|NCT00438672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65428043|NCT00438672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428044|NCT00438360|Cyclosporine|cyclosporine|mesh-list
65428045|NCT00438360|Cyclosporins|cyclosporins|mesh-list
65428046|NCT00438360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428047|NCT00438360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428048|NCT00438360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65428049|NCT00438360|Immunologic Factors|immunologic factors|mesh-ancestor
65428050|NCT00438360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428051|NCT00438360|Antifungal Agents|antifungal agents|mesh-ancestor
65428052|NCT00438360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65428053|NCT00438360|Dermatologic Agents|dermatologic agents|mesh-ancestor
65428054|NCT00438360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65428055|NCT00438360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65428056|NCT00536471|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65428057|NCT00536471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65428058|NCT00536471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65428059|NCT00536471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65428060|NCT00536471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428061|NCT00536471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65428062|NCT00536471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428063|NCT00536471|Analgesics|analgesics|mesh-ancestor
65428064|NCT00536471|Sensory System Agents|sensory system agents|mesh-ancestor
65428065|NCT00536471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65428066|NCT00536471|Antidepressive Agents|antidepressive agents|mesh-ancestor
65428067|NCT00536471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65428068|NCT00536471|Dopamine Agents|dopamine agents|mesh-ancestor
65428069|NCT00437658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65428070|NCT00437658|Medroxyprogesterone|medroxyprogesterone|mesh-list
65428071|NCT00437658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65428072|NCT00437658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65428073|NCT00437658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65428074|NCT00437658|Contraceptive Agents|contraceptive agents|mesh-ancestor
65428075|NCT00437658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65428076|NCT00437658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428077|NCT00437658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65428078|NCT00437658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65428079|NCT00437658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65428080|NCT00437658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65428081|NCT00437658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428082|NCT04002635|Letrozole|letrozole|mesh-list
65428083|NCT04002635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65428084|NCT04002635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65428085|NCT04002635|Estradiol|estradiol|mesh-list
65428086|NCT04002635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65428087|NCT04002635|Progesterone|progesterone|mesh-list
65428088|NCT04002635|Estrogens|estrogens|mesh-ancestor
65428089|NCT04002635|Hormones|hormones|mesh-ancestor
65428090|NCT04002635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65428091|NCT04002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428092|NCT04002635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65428093|NCT04002635|Contraceptive Agents|contraceptive agents|mesh-ancestor
65428094|NCT04002635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65428095|NCT04002635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65428096|NCT04002635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428102|NCT04002635|Hormone Antagonists|hormone antagonists|mesh-ancestor
65428103|NCT04002635|Progestins|progestins|mesh-ancestor
65428104|NCT01052181|Cholecalciferol|cholecalciferol|mesh-list
65428105|NCT01052181|Vitamin D|vitamin d|mesh-list
65428106|NCT01052181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65428107|NCT01052181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428108|NCT01052181|Vitamins|vitamins|mesh-ancestor
65428109|NCT01052181|Micronutrients|micronutrients|mesh-ancestor
65428110|NCT01052181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65428111|NCT01056237|Mycophenolic Acid|mycophenolic acid|mesh-list
65428112|NCT01056237|Azathioprine|azathioprine|mesh-list
65428113|NCT01056237|Tacrolimus|tacrolimus|mesh-list
65428114|NCT01056237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65428115|NCT01056237|Immunologic Factors|immunologic factors|mesh-ancestor
65428116|NCT01056237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428117|NCT01056237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65428118|NCT01056237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428119|NCT01056237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428120|NCT01056237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65428121|NCT01056237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428122|NCT01056237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65428123|NCT01056237|Antitubercular Agents|antitubercular agents|mesh-ancestor
65428124|NCT01056237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65428125|NCT01056237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65428126|NCT01056237|Antimetabolites|antimetabolites|mesh-ancestor
65428127|NCT01056237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65428128|NCT01056237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65428129|NCT02533557|Lidocaine|lidocaine|mesh-list
65428130|NCT02533557|Epinephrine|epinephrine|mesh-list
65428131|NCT02533557|Racepinephrine|racepinephrine|mesh-list
65428132|NCT02533557|Epinephryl borate|epinephryl borate|mesh-list
65428133|NCT02533557|Anesthetics, Local|anesthetics, local|mesh-ancestor
65428134|NCT02533557|Anesthetics|anesthetics|mesh-ancestor
65428135|NCT02533557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65428136|NCT02533557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428137|NCT02533557|Sensory System Agents|sensory system agents|mesh-ancestor
65428138|NCT02533557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65428139|NCT02533557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65428140|NCT02533557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65428141|NCT02533557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65428142|NCT02533557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65428143|NCT02533557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428144|NCT02533557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65428145|NCT02533557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65428146|NCT02533557|Adrenergic Agents|adrenergic agents|mesh-ancestor
65428147|NCT02533557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65428148|NCT02533557|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65428149|NCT02533557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65428150|NCT02533557|Autonomic Agents|autonomic agents|mesh-ancestor
65428151|NCT02533557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65428152|NCT02533557|Respiratory System Agents|respiratory system agents|mesh-ancestor
65428153|NCT02533557|Mydriatics|mydriatics|mesh-ancestor
65428154|NCT02533557|Sympathomimetics|sympathomimetics|mesh-ancestor
65428155|NCT02533557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65428156|NCT00356265|Phenylephrine|phenylephrine|mesh-list
65428157|NCT00356265|Oxymetazoline|oxymetazoline|mesh-list
65428158|NCT00356265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65428159|NCT00356265|Mydriatics|mydriatics|mesh-ancestor
65428160|NCT00356265|Autonomic Agents|autonomic agents|mesh-ancestor
65428161|NCT00356265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65428162|NCT00356265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428163|NCT00356265|Sympathomimetics|sympathomimetics|mesh-ancestor
65428164|NCT00356265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65428165|NCT00356265|Nasal Decongestants|nasal decongestants|mesh-ancestor
65428166|NCT00356265|Respiratory System Agents|respiratory system agents|mesh-ancestor
64812926|NCT01468272|Adrenergic Agents|adrenergic agents|mesh-ancestor
65428179|NCT01052259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65428180|NCT01052259|Immunologic Factors|immunologic factors|mesh-ancestor
65428181|NCT01052259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65428182|NCT01052259|Protective Agents|protective agents|mesh-ancestor
65428184|NCT01056549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65428185|NCT01056549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428186|NCT01056549|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65428187|NCT01056549|Incretins|incretins|mesh-ancestor
65428188|NCT01056549|Hormones|hormones|mesh-ancestor
65428189|NCT01056549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65428190|NCT01052337|Anesthetics|anesthetics|mesh-list
65428191|NCT01052337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65428192|NCT01052337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428193|NCT00535145|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65428194|NCT00535145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65428195|NCT00535145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65428196|NCT00535145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65428197|NCT00535145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428198|NCT00535145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65428199|NCT00535145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65428200|NCT00535145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65428201|NCT00535145|Serotonin Agents|serotonin agents|mesh-ancestor
65428202|NCT00535145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65428203|NCT00535145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428204|NCT00535145|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65428205|NCT00535145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65428206|NCT00535145|Dopamine Agents|dopamine agents|mesh-ancestor
65428207|NCT01056627|Valproic Acid|valproic acid|mesh-list
65428208|NCT01056627|Anticonvulsants|anticonvulsants|mesh-ancestor
65428209|NCT01056627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428210|NCT01056627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428211|NCT01056627|GABA Agents|gaba agents|mesh-ancestor
64944312|NCT00845936|Metformin|metformin|mesh-list
65428212|NCT01056627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65428213|NCT01056627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428214|NCT01056627|Antimanic Agents|antimanic agents|mesh-ancestor
65428215|NCT01056627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65428216|NCT01056627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65428217|NCT01056627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65428218|NCT04273061|Atezolizumab|atezolizumab|mesh-list
65428219|NCT04273061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428220|NCT01053585|Baclofen|baclofen|mesh-list
65428221|NCT01053585|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65428222|NCT01053585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428223|NCT01053585|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65428224|NCT01053585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65428225|NCT01053585|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65428226|NCT01053585|GABA Agonists|gaba agonists|mesh-ancestor
65428227|NCT01053585|GABA Agents|gaba agents|mesh-ancestor
65428228|NCT01053585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65428229|NCT01053585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428257|NCT01056861|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65428258|NCT01056861|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65428259|NCT01056861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65428260|NCT01056861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65428261|NCT01056861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428262|NCT01056861|Cholinergic Agents|cholinergic agents|mesh-ancestor
65428263|NCT01056861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65428264|NCT01056861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428265|NCT01056861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65428266|NCT01056861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65428267|NCT05355467|Tenofovir|tenofovir|mesh-list
65428268|NCT05355467|Antiviral Agents|antiviral agents|mesh-ancestor
65428269|NCT05355467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65428270|NCT05355467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65428271|NCT05355467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65428272|NCT05355467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428273|NCT05355467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428274|NCT05355467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65428275|NCT05355467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65428276|NCT04139525|Heparin|heparin|mesh-list
65428329|NCT01057329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65428330|NCT01057329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65428331|NCT01057329|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65428332|NCT01057329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65428333|NCT01057329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65428334|NCT01057329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428335|NCT01057329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65428336|NCT01057329|Serotonin Agents|serotonin agents|mesh-ancestor
65428337|NCT01057329|Antidepressive Agents|antidepressive agents|mesh-ancestor
65428338|NCT01057329|Dopamine Agonists|dopamine agonists|mesh-ancestor
65428339|NCT01057329|Dopamine Agents|dopamine agents|mesh-ancestor
65428340|NCT01057329|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65428341|NCT01057329|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65428342|NCT01057329|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65428343|NCT01057329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65428344|NCT01057329|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65428345|NCT01057329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65428346|NCT01057329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65428348|NCT01057329|Sensory System Agents|sensory system agents|mesh-ancestor
65428349|NCT01057329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65428350|NCT01057329|Adrenergic Agents|adrenergic agents|mesh-ancestor
65428351|NCT01057407|Sevelamer|sevelamer|mesh-list
65428352|NCT01057407|Chelating Agents|chelating agents|mesh-ancestor
65428353|NCT01057407|Sequestering Agents|sequestering agents|mesh-ancestor
65428364|NCT00345579|Anticoagulants|anticoagulants|mesh-ancestor
65428365|NCT00345579|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65428366|NCT00345579|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65428367|NCT00345579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428369|NCT04002323|Dolutegravir|dolutegravir|mesh-list
65428370|NCT04002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65428371|NCT04002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65428372|NCT04002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428373|NCT04002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428374|NCT04002323|Antiviral Agents|antiviral agents|mesh-ancestor
65428375|NCT04002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65428376|NCT04002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65428377|NCT04002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65428378|NCT04002323|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65428379|NCT04002323|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65428380|NCT04001855|Acetic Acid|acetic acid|mesh-list
65428381|NCT04001855|Retinol acetate|retinol acetate|mesh-list
65428382|NCT04001855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65428383|NCT04001855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65428384|NCT04001855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65428385|NCT04001855|Immunologic Factors|immunologic factors|mesh-ancestor
65428386|NCT04001855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428387|NCT04001855|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65428388|NCT04001855|Protective Agents|protective agents|mesh-ancestor
65428389|NCT04001855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428390|NCT00335829|Bevacizumab|bevacizumab|mesh-list
65428391|NCT00335829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65428392|NCT00335829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428393|NCT00335829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65428394|NCT00335829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65428395|NCT00335829|Growth Substances|growth substances|mesh-ancestor
65428396|NCT00335829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428397|NCT00335829|Growth Inhibitors|growth inhibitors|mesh-ancestor
65428399|NCT02533011|Anticoagulants|anticoagulants|mesh-ancestor
65428400|NCT02533011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65428401|NCT02533011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65428402|NCT02533011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428403|NCT05262257|Metformin|metformin|mesh-list
65428404|NCT05262257|Dapagliflozin|dapagliflozin|mesh-list
65428405|NCT05262257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65428406|NCT05262257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428407|NCT05262257|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65428408|NCT05262257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428409|NCT03989817|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
65428410|NCT03989817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65428411|NCT03989817|Vasodilator Agents|vasodilator agents|mesh-ancestor
65428412|NCT03989817|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65428413|NCT03989817|Protective Agents|protective agents|mesh-ancestor
65428414|NCT03989817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428415|NCT01059123|Amoxicillin|amoxicillin|mesh-list
65428416|NCT01059123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65428417|NCT01059123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65428418|NCT03986385|Capecitabine|capecitabine|mesh-list
65428442|NCT00535847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65428443|NCT00535847|Antimetabolites|antimetabolites|mesh-ancestor
65428444|NCT00535847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428445|NCT00535847|Immunologic Factors|immunologic factors|mesh-ancestor
65428446|NCT00535847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428447|NCT03606785|Tranexamic Acid|tranexamic acid|mesh-list
65428448|NCT03606785|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65428449|NCT03606785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65428450|NCT03606785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428451|NCT03606785|Hemostatics|hemostatics|mesh-ancestor
65428452|NCT03606785|Coagulants|coagulants|mesh-ancestor
65428453|NCT05356169|Venetoclax|venetoclax|mesh-list
65428454|NCT05356169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428455|NCT05072093|Tenofovir|tenofovir|mesh-list
65428456|NCT05072093|Emtricitabine|emtricitabine|mesh-list
65428457|NCT05072093|Cabotegravir|cabotegravir|mesh-list
65428458|NCT05072093|Doxycycline|doxycycline|mesh-list
65428459|NCT05072093|Antiviral Agents|antiviral agents|mesh-ancestor
65428460|NCT05072093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65428461|NCT05072093|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65428462|NCT05072093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65428463|NCT05072093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428464|NCT05072093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428465|NCT05072093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65428466|NCT05072093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65428467|NCT05072093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65428468|NCT05072093|Antimalarials|antimalarials|mesh-ancestor
65428469|NCT05072093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65428470|NCT05072093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65428471|NCT05072093|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65428472|NCT05072093|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65428481|NCT01057875|Purinergic Agents|purinergic agents|mesh-ancestor
65428482|NCT01057875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64997486|NCT00099164|Hormones|hormones|mesh-ancestor
65428483|NCT04001387|Anesthetics|anesthetics|mesh-list
65428484|NCT04001387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65428485|NCT04001387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428486|NCT00334737|Epoetin Alfa|epoetin alfa|mesh-list
65428487|NCT00334737|Darbepoetin alfa|darbepoetin alfa|mesh-list
65428488|NCT00334737|Hematinics|hematinics|mesh-ancestor
65428489|NCT03986073|Linagliptin|linagliptin|mesh-list
65428490|NCT03986073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65428491|NCT03986073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428492|NCT03986073|Incretins|incretins|mesh-ancestor
65428493|NCT03986073|Hormones|hormones|mesh-ancestor
65428494|NCT03986073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65428495|NCT03986073|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65428496|NCT03986073|Protease Inhibitors|protease inhibitors|mesh-ancestor
65428497|NCT03986073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428498|NCT03986073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428499|NCT05347199|Amisulpride|amisulpride|mesh-list
65428500|NCT05347199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65428501|NCT05347199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65428502|NCT05347199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65428503|NCT05347199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428504|NCT05347199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65428505|NCT05347199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65428506|NCT05347199|Dopamine Agents|dopamine agents|mesh-ancestor
65428507|NCT05347199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65428508|NCT05347199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428509|NCT05347199|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65428510|NCT05347199|Antidepressive Agents|antidepressive agents|mesh-ancestor
65428511|NCT01060137|Fentanyl|fentanyl|mesh-list
65428512|NCT01060137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65428513|NCT01060137|Narcotics|narcotics|mesh-ancestor
65428514|NCT01060137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65428515|NCT01060137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428516|NCT01060137|Analgesics|analgesics|mesh-ancestor
65428517|NCT01060137|Sensory System Agents|sensory system agents|mesh-ancestor
65428518|NCT01060137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65428519|NCT01060137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65428520|NCT01060137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65428521|NCT01060137|Anesthetics, General|anesthetics, general|mesh-ancestor
65428522|NCT01060137|Anesthetics|anesthetics|mesh-ancestor
65428523|NCT03989271|Quercetin|quercetin|mesh-list
65428524|NCT03989271|Antioxidants|antioxidants|mesh-ancestor
65428525|NCT03989271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428526|NCT03989271|Protective Agents|protective agents|mesh-ancestor
65428527|NCT03989271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428528|NCT01058109|Calcium, Dietary|calcium, dietary|mesh-list
65428529|NCT01058109|Calcium|calcium|mesh-list
65428530|NCT01058109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65428531|NCT01058109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428532|NCT01058109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65428533|NCT00992069|Efavirenz|efavirenz|mesh-list
65428534|NCT00992069|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65428535|NCT00992069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65428536|NCT00992069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428537|NCT00992069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428538|NCT00992069|Antiviral Agents|antiviral agents|mesh-ancestor
64813294|NCT01470456|Rituximab|rituximab|mesh-list
65428557|NCT01060293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65428558|NCT01060293|Dopamine Agents|dopamine agents|mesh-ancestor
65428559|NCT01060293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65428560|NCT01060293|Protective Agents|protective agents|mesh-ancestor
65428562|NCT05343767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65428563|NCT05343767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428564|NCT01054677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65428565|NCT01054677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65428566|NCT03989037|Carboplatin|carboplatin|mesh-list
65428567|NCT03989037|Docetaxel|docetaxel|mesh-list
65428568|NCT03989037|Trastuzumab|trastuzumab|mesh-list
65428569|NCT03989037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428570|NCT03989037|Tubulin Modulators|tubulin modulators|mesh-ancestor
65428571|NCT03989037|Antimitotic Agents|antimitotic agents|mesh-ancestor
65428572|NCT03989037|Mitosis Modulators|mitosis modulators|mesh-ancestor
65428573|NCT03989037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428574|NCT03989037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64997534|NCT00403728|Cyclosporine|cyclosporine|mesh-list
65428575|NCT00416598|Cytarabine|cytarabine|mesh-list
65428576|NCT00416598|Etoposide|etoposide|mesh-list
65428577|NCT00416598|Podophyllotoxin|podophyllotoxin|mesh-list
65428578|NCT00416598|Daunorubicin|daunorubicin|mesh-list
65428579|NCT00416598|Etoposide phosphate|etoposide phosphate|mesh-list
65428580|NCT00416598|Busulfan|busulfan|mesh-list
65428581|NCT00416598|Decitabine|decitabine|mesh-list
65428582|NCT00416598|Lenograstim|lenograstim|mesh-list
65428583|NCT00416598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65428584|NCT00416598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428585|NCT00416598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65428586|NCT00416598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65428587|NCT00416598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428588|NCT00416598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428589|NCT00416598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65428590|NCT00416598|Antimetabolites|antimetabolites|mesh-ancestor
65428591|NCT00416598|Antiviral Agents|antiviral agents|mesh-ancestor
65428592|NCT00416598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65428593|NCT00416598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65428594|NCT00416598|Immunologic Factors|immunologic factors|mesh-ancestor
65428606|NCT00534599|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65428607|NCT00534599|Antidepressive Agents|antidepressive agents|mesh-ancestor
65428608|NCT00534599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65428609|NCT00534599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65428610|NCT00534599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65428611|NCT00534599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65428612|NCT00534599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428613|NCT04001465|Methacholine Chloride|methacholine chloride|mesh-list
65428615|NCT04001465|Autonomic Agents|autonomic agents|mesh-ancestor
65428616|NCT04001465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65428617|NCT04001465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428618|NCT04001465|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65428619|NCT04001465|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
65428620|NCT04001465|Respiratory System Agents|respiratory system agents|mesh-ancestor
65428621|NCT04001465|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65428622|NCT04001465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65428623|NCT04001465|Cholinergic Agents|cholinergic agents|mesh-ancestor
65428624|NCT04001465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65428625|NCT04001465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428627|NCT00992381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65428628|NCT00992381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65428629|NCT00992381|Analgesics|analgesics|mesh-ancestor
65428630|NCT00992381|Sensory System Agents|sensory system agents|mesh-ancestor
65428631|NCT00992381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65428632|NCT00992381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428633|NCT00992381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65428634|NCT00992381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65428635|NCT00992381|Gout Suppressants|gout suppressants|mesh-ancestor
65428636|NCT00992381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65428637|NCT00992381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428638|NCT00992381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428639|NCT00992537|Insulin|insulin|mesh-list
65428640|NCT00992537|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65428641|NCT00992537|Insulin Aspart|insulin aspart|mesh-list
65428642|NCT00992537|Insulin, Long-Acting|insulin, long-acting|mesh-list
65428643|NCT00992537|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65428644|NCT00992537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65428645|NCT00992537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428646|NCT00992693|Ribavirin|ribavirin|mesh-list
65428647|NCT00992693|Antimetabolites|antimetabolites|mesh-ancestor
65428648|NCT00992693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428649|NCT00992693|Antiviral Agents|antiviral agents|mesh-ancestor
65428650|NCT00992693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65428651|NCT00992771|Varenicline|varenicline|mesh-list
65428652|NCT00992771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65428653|NCT00992771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65428654|NCT00992771|Cholinergic Agents|cholinergic agents|mesh-ancestor
65428655|NCT00992771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65428656|NCT00992771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428657|NCT00992771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428658|NCT00992849|Bevacizumab|bevacizumab|mesh-list
65428670|NCT04001231|Incretins|incretins|mesh-ancestor
65428672|NCT04001231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65428673|NCT03892889|Aripiprazole|aripiprazole|mesh-list
65428674|NCT03892889|Antidepressive Agents|antidepressive agents|mesh-ancestor
65428675|NCT03892889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65428676|NCT03892889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65428677|NCT03892889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65428678|NCT03892889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65428679|NCT03892889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428680|NCT03892889|Dopamine Agonists|dopamine agonists|mesh-ancestor
65428681|NCT03892889|Dopamine Agents|dopamine agents|mesh-ancestor
65428682|NCT03892889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65428683|NCT03892889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428684|NCT03892889|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65428685|NCT03892889|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65428686|NCT03892889|Serotonin Agents|serotonin agents|mesh-ancestor
65428687|NCT03892889|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65428688|NCT03892889|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65428689|NCT03892889|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65428690|NCT03892889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65428691|NCT00993707|Hyaluronic Acid|hyaluronic acid|mesh-list
65428692|NCT00993707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65428693|NCT00993707|Immunologic Factors|immunologic factors|mesh-ancestor
65428694|NCT00993707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428696|NCT00993707|Protective Agents|protective agents|mesh-ancestor
65428697|NCT00473330|Ranibizumab|ranibizumab|mesh-list
65428698|NCT00473330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65428699|NCT00473330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65428700|NCT00473330|Growth Substances|growth substances|mesh-ancestor
65428701|NCT00473330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428702|NCT00473330|Growth Inhibitors|growth inhibitors|mesh-ancestor
65428703|NCT00473330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428704|NCT00416520|Sevelamer|sevelamer|mesh-list
65428705|NCT00416520|Chelating Agents|chelating agents|mesh-ancestor
65428706|NCT00416520|Sequestering Agents|sequestering agents|mesh-ancestor
65428707|NCT00416520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428708|NCT00533429|Bevacizumab|bevacizumab|mesh-list
65428709|NCT00533429|Carboplatin|carboplatin|mesh-list
65428710|NCT00533429|Pemetrexed|pemetrexed|mesh-list
65428711|NCT00533429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65428712|NCT00533429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428713|NCT00533429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65428714|NCT00533429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65428715|NCT00533429|Growth Substances|growth substances|mesh-ancestor
65428716|NCT00533429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428717|NCT00533429|Growth Inhibitors|growth inhibitors|mesh-ancestor
65428718|NCT00533429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428719|NCT00533429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428720|NCT00533429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65428721|NCT00533429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65428722|NCT01034124|Vitamin K|vitamin k|mesh-list
65428737|NCT01034124|GABA Modulators|gaba modulators|mesh-ancestor
65428738|NCT01034124|GABA Agents|gaba agents|mesh-ancestor
65428739|NCT01034124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65428740|NCT01034124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428741|NCT01034124|Anticoagulants|anticoagulants|mesh-ancestor
65428742|NCT01034124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65428743|NCT01034124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65428744|NCT01034124|Hemostatics|hemostatics|mesh-ancestor
65428745|NCT01034124|Coagulants|coagulants|mesh-ancestor
65428746|NCT00339183|Panitumumab|panitumumab|mesh-list
65428747|NCT00339183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65428748|NCT00339183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428749|NCT01060605|Sirolimus|sirolimus|mesh-list
65428750|NCT01060605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65428751|NCT01060605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65428752|NCT01060605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65428753|NCT01060605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428754|NCT01060605|Antifungal Agents|antifungal agents|mesh-ancestor
65428755|NCT01060605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65428756|NCT01060605|Immunologic Factors|immunologic factors|mesh-ancestor
65428757|NCT01060605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428758|NCT00532883|Hydroxyurea|hydroxyurea|mesh-list
65428759|NCT00532883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428760|NCT00532883|Antisickling Agents|antisickling agents|mesh-ancestor
65428761|NCT00532883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428762|NCT00532883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428763|NCT00532883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65428764|NCT00993863|Ibuprofen|ibuprofen|mesh-list
65428765|NCT00993863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65428766|NCT00993863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65428767|NCT00993863|Analgesics|analgesics|mesh-ancestor
65428768|NCT00993863|Sensory System Agents|sensory system agents|mesh-ancestor
65428769|NCT00993863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65428770|NCT00993863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428771|NCT00993863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65428772|NCT00993863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65428773|NCT00993863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65428774|NCT00993863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428775|NCT00993863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428776|NCT00995423|Paclitaxel|paclitaxel|mesh-list
65428777|NCT00995423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65428778|NCT00995423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428779|NCT00995423|Tubulin Modulators|tubulin modulators|mesh-ancestor
65428780|NCT00995423|Antimitotic Agents|antimitotic agents|mesh-ancestor
65428781|NCT00995423|Mitosis Modulators|mitosis modulators|mesh-ancestor
65428782|NCT00995423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428783|NCT00995657|Fluticasone|fluticasone|mesh-list
65428784|NCT00995657|Xhance|xhance|mesh-list
65428785|NCT00995657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64813544|NCT01472029|Leucovorin|leucovorin|mesh-list
65428803|NCT00994097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65428805|NCT00994097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428806|NCT00994097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65428807|NCT00994097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65428808|NCT04000919|Carbidopa|carbidopa|mesh-list
65428809|NCT04000919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65428810|NCT04000919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65428811|NCT04000919|Dopamine Agents|dopamine agents|mesh-ancestor
65428812|NCT04000919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65428813|NCT04000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428814|NCT04000919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428815|NCT04000919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65428816|NCT04000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428817|NCT00994253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65428818|NCT00994253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65428819|NCT00994253|Diuretics|diuretics|mesh-ancestor
65428820|NCT00994253|Natriuretic Agents|natriuretic agents|mesh-ancestor
65428821|NCT00994253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428822|NCT00994253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65428823|NCT00994253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65428824|NCT00994253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428825|NCT00338949|Olanzapine|olanzapine|mesh-list
65428826|NCT00338949|Risperidone|risperidone|mesh-list
65428827|NCT00338949|Ziprasidone|ziprasidone|mesh-list
65428828|NCT00338949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65428829|NCT00338949|Serotonin Agents|serotonin agents|mesh-ancestor
65428830|NCT00338949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65428831|NCT00338949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428832|NCT00338949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428833|NCT00338949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65428834|NCT00338949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65428835|NCT00338949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65428836|NCT00338949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65428837|NCT00338949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65428838|NCT00338949|Dopamine Agents|dopamine agents|mesh-ancestor
65428839|NCT00338949|Antiemetics|antiemetics|mesh-ancestor
65428840|NCT00338949|Autonomic Agents|autonomic agents|mesh-ancestor
65428841|NCT00338949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64813606|NCT01472640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65428848|NCT01325259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428850|NCT00332709|Letrozole|letrozole|mesh-list
65428851|NCT00332709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428852|NCT00332709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65428853|NCT00332709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65428854|NCT00332709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428855|NCT00332709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428856|NCT00332709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65428857|NCT00332709|Hormone Antagonists|hormone antagonists|mesh-ancestor
65428858|NCT00332709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65428859|NCT00332709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428860|NCT00332709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64997757|NCT04728581|Antidepressive Agents|antidepressive agents|mesh-ancestor
65428861|NCT03988725|Vitamin E|vitamin e|mesh-list
65428862|NCT03988725|Vitamins|vitamins|mesh-ancestor
65428863|NCT03988725|Micronutrients|micronutrients|mesh-ancestor
65428864|NCT03988725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428865|NCT03988725|Antioxidants|antioxidants|mesh-ancestor
65428866|NCT03988725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428867|NCT03988725|Protective Agents|protective agents|mesh-ancestor
65428868|NCT00332241|Aripiprazole|aripiprazole|mesh-list
65428869|NCT00332241|Antidepressive Agents|antidepressive agents|mesh-ancestor
65428870|NCT00332241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65428871|NCT00332241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65428872|NCT00332241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65428873|NCT00332241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65428874|NCT00332241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428875|NCT00332241|Dopamine Agonists|dopamine agonists|mesh-ancestor
65428876|NCT00332241|Dopamine Agents|dopamine agents|mesh-ancestor
65428877|NCT00332241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65428878|NCT00332241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428879|NCT00332241|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65428880|NCT00332241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65428881|NCT00332241|Serotonin Agents|serotonin agents|mesh-ancestor
65428882|NCT00332241|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65428883|NCT00332241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65428884|NCT00332241|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65428885|NCT00332241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65428886|NCT01058577|Somatostatin|somatostatin|mesh-list
65428887|NCT01058577|Hormones|hormones|mesh-ancestor
65428888|NCT01058577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65428889|NCT01058577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428890|NCT03983889|Fentanyl|fentanyl|mesh-list
65428891|NCT03983889|Midazolam|midazolam|mesh-list
65428892|NCT03983889|Dexmedetomidine|dexmedetomidine|mesh-list
65428893|NCT03983889|Remifentanil|remifentanil|mesh-list
65428894|NCT03983889|Propofol|propofol|mesh-list
65428895|NCT03983889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65428896|NCT03983889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65428897|NCT03983889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428898|NCT03983889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65428899|NCT03983889|Anesthetics, General|anesthetics, general|mesh-ancestor
65428900|NCT03983889|Anesthetics|anesthetics|mesh-ancestor
65428901|NCT03983889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65428902|NCT03983889|Analgesics|analgesics|mesh-ancestor
65428903|NCT03983889|Sensory System Agents|sensory system agents|mesh-ancestor
65428904|NCT03983889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65428905|NCT03983889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65428906|NCT03983889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65428907|NCT03983889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65428908|NCT03983889|Adrenergic Agents|adrenergic agents|mesh-ancestor
65428921|NCT00337779|Glatiramer Acetate|glatiramer acetate|mesh-list
65428922|NCT00337779|(T,G)-A-L|(t,g)-a-l|mesh-list
65428923|NCT00337779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65428924|NCT00337779|Immunologic Factors|immunologic factors|mesh-ancestor
65428925|NCT00337779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428926|NCT00337779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65428927|NCT00337779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65428928|NCT00352755|Leucovorin|leucovorin|mesh-list
65428929|NCT00352755|Fluorouracil|fluorouracil|mesh-list
65428930|NCT00352755|Oxaliplatin|oxaliplatin|mesh-list
65428931|NCT00352755|Antimetabolites|antimetabolites|mesh-ancestor
65428932|NCT00352755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428933|NCT00352755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65428934|NCT00352755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428935|NCT00352755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65428936|NCT00352755|Immunologic Factors|immunologic factors|mesh-ancestor
65428937|NCT00352755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428938|NCT00352755|Antidotes|antidotes|mesh-ancestor
65428939|NCT00352755|Protective Agents|protective agents|mesh-ancestor
65428940|NCT00352755|Vitamin B Complex|vitamin b complex|mesh-ancestor
65428941|NCT00352755|Vitamins|vitamins|mesh-ancestor
65428942|NCT00352755|Micronutrients|micronutrients|mesh-ancestor
65428943|NCT00533897|Abatacept|abatacept|mesh-list
65428944|NCT00533897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65428945|NCT00533897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428946|NCT00533897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428947|NCT00533897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65428948|NCT00533897|Immunologic Factors|immunologic factors|mesh-ancestor
65428949|NCT00533897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428950|NCT00533897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65428951|NCT00426660|Maraviroc|maraviroc|mesh-list
65428952|NCT00426660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65428953|NCT00426660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65428954|NCT00426660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428955|NCT00426660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65428956|NCT00426660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65428957|NCT00426660|Antiviral Agents|antiviral agents|mesh-ancestor
65428958|NCT00426660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65428959|NCT00426660|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65428960|NCT00426270|Immunoglobulins|immunoglobulins|mesh-list
65428961|NCT00426270|Immunologic Factors|immunologic factors|mesh-ancestor
65428962|NCT00426270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428963|NCT00330681|Edaravone|edaravone|mesh-list
65428964|NCT00330681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65428965|NCT00330681|Antioxidants|antioxidants|mesh-ancestor
65428966|NCT00330681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428967|NCT00330681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65428968|NCT00330681|Protective Agents|protective agents|mesh-ancestor
65428969|NCT00330681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428970|NCT00329901|Vaccines|vaccines|mesh-list
65428971|NCT00329901|Immunologic Factors|immunologic factors|mesh-ancestor
65428972|NCT00329901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428973|NCT00436956|Prednisone|prednisone|mesh-list
65428974|NCT00436956|Cediranib|cediranib|mesh-list
65428975|NCT00436956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65428986|NCT00436644|Lapatinib|lapatinib|mesh-list
65428987|NCT00436644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65428988|NCT00436644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65428989|NCT00436644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428990|NCT00436644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428991|NCT00436644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428992|NCT00436644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65428993|NCT00324987|Bevacizumab|bevacizumab|mesh-list
65428994|NCT00324987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65178506|NCT02835664|Niacinamide|niacinamide|mesh-list
65428995|NCT00324987|Imatinib Mesylate|imatinib mesylate|mesh-list
65428996|NCT00324987|Endothelial Growth Factors|endothelial growth factors|mesh-list
65428997|NCT00324987|Antibodies|antibodies|mesh-list
65428998|NCT00324987|Immunoglobulins|immunoglobulins|mesh-list
65428999|NCT00324987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65429000|NCT00324987|Immunoglobulin G|immunoglobulin g|mesh-list
65429001|NCT00324987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429002|NCT00324987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65429003|NCT00324987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65429004|NCT00324987|Growth Substances|growth substances|mesh-ancestor
65429005|NCT00324987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429006|NCT00324987|Growth Inhibitors|growth inhibitors|mesh-ancestor
65429007|NCT00324987|Immunologic Factors|immunologic factors|mesh-ancestor
65429008|NCT00324987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65429009|NCT00324987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429010|NCT00324987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429011|NCT00324675|Rosiglitazone|rosiglitazone|mesh-list
65429012|NCT00324675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65429013|NCT00324675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429014|NCT01055145|Moxifloxacin|moxifloxacin|mesh-list
65429015|NCT01055145|Levofloxacin|levofloxacin|mesh-list
65429016|NCT01055145|Ofloxacin|ofloxacin|mesh-list
65429017|NCT01055145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65429018|NCT01055145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65429019|NCT01055145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65429020|NCT01055145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65429021|NCT01055145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429022|NCT01055145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429023|NCT01055145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429024|NCT01055145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65429025|NCT01055145|Renal Agents|renal agents|mesh-ancestor
65429026|NCT01055145|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65429027|NCT01055145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65429028|NCT00436566|Paclitaxel|paclitaxel|mesh-list
65429029|NCT00436566|Cyclophosphamide|cyclophosphamide|mesh-list
65429030|NCT00436566|Doxorubicin|doxorubicin|mesh-list
65429031|NCT00436566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65429032|NCT00436566|Trastuzumab|trastuzumab|mesh-list
65429033|NCT00436566|Lapatinib|lapatinib|mesh-list
64997908|NCT00101153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65429034|NCT00436566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65429035|NCT00436566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429036|NCT00436566|Tubulin Modulators|tubulin modulators|mesh-ancestor
65429037|NCT00436566|Antimitotic Agents|antimitotic agents|mesh-ancestor
65429038|NCT00436566|Mitosis Modulators|mitosis modulators|mesh-ancestor
65429039|NCT00436566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429054|NCT01060683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65429056|NCT01060683|Analgesics|analgesics|mesh-ancestor
65429057|NCT01060683|Sensory System Agents|sensory system agents|mesh-ancestor
65429058|NCT01060683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65429059|NCT01060683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429060|NCT01060683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65429061|NCT01060683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65429062|NCT01055301|Thalidomide|thalidomide|mesh-list
65429063|NCT01055301|Dexamethasone|dexamethasone|mesh-list
65429064|NCT01055301|Cyclophosphamide|cyclophosphamide|mesh-list
65429065|NCT01055301|Melphalan|melphalan|mesh-list
65429066|NCT01055301|Doxorubicin|doxorubicin|mesh-list
65429067|NCT01055301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65429068|NCT01055301|Etoposide|etoposide|mesh-list
65429069|NCT01055301|Lenalidomide|lenalidomide|mesh-list
65429070|NCT01055301|Bortezomib|bortezomib|mesh-list
65429071|NCT01055301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65429072|NCT01055301|Immunologic Factors|immunologic factors|mesh-ancestor
65429073|NCT01055301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429074|NCT01055301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65429075|NCT01055301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65429076|NCT01055301|Alkylating Agents|alkylating agents|mesh-ancestor
65429077|NCT01055301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429078|NCT01055301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429079|NCT01055301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65429080|NCT01055301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65429081|NCT01055301|Antiemetics|antiemetics|mesh-ancestor
65429082|NCT01055301|Autonomic Agents|autonomic agents|mesh-ancestor
65429083|NCT01055301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65429084|NCT01055301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65429085|NCT01055301|Glucocorticoids|glucocorticoids|mesh-ancestor
65429086|NCT01055301|Hormones|hormones|mesh-ancestor
65429087|NCT01055301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65429088|NCT01055301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65429089|NCT01055301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65429090|NCT01055301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65429091|NCT01055301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65429092|NCT01055301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429093|NCT01055301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65429094|NCT01055301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65429095|NCT01055301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65429096|NCT01055301|Growth Substances|growth substances|mesh-ancestor
65429097|NCT01055301|Growth Inhibitors|growth inhibitors|mesh-ancestor
65429098|NCT01055301|Leprostatic Agents|leprostatic agents|mesh-ancestor
65429099|NCT01055301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65429104|NCT01055379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429106|NCT01055379|Protective Agents|protective agents|mesh-ancestor
65429107|NCT01055379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429108|NCT03988101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65429109|NCT03988101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65429110|NCT03988101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65429111|NCT03988101|Antimetabolites|antimetabolites|mesh-ancestor
65429112|NCT03988101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429113|NCT03988101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65429114|NCT03988101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65429115|NCT03988101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429116|NCT00352365|Lenalidomide|lenalidomide|mesh-list
65429117|NCT00352365|Immunologic Factors|immunologic factors|mesh-ancestor
65429118|NCT00352365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429119|NCT00352365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65429120|NCT00352365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65429121|NCT00352365|Growth Substances|growth substances|mesh-ancestor
65429122|NCT00352365|Growth Inhibitors|growth inhibitors|mesh-ancestor
65429123|NCT00352365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429124|NCT01055535|Plasminogen|plasminogen|mesh-list
65429125|NCT01055535|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65429126|NCT01055535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65429127|NCT01055535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429128|NCT03987867|Paclitaxel|paclitaxel|mesh-list
65429129|NCT03987867|Carboplatin|carboplatin|mesh-list
65429130|NCT03987867|Pemetrexed|pemetrexed|mesh-list
65429131|NCT03987867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65429132|NCT03987867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65429133|NCT03987867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429134|NCT03987867|Tubulin Modulators|tubulin modulators|mesh-ancestor
65429135|NCT03987867|Antimitotic Agents|antimitotic agents|mesh-ancestor
65429136|NCT03987867|Mitosis Modulators|mitosis modulators|mesh-ancestor
65429137|NCT03987867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429138|NCT03987867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429139|NCT03987867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65429140|NCT03987867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65429141|NCT00532493|Prazosin|prazosin|mesh-list
65429142|NCT00532493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65429143|NCT00532493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65429144|NCT00532493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65429145|NCT00532493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65429146|NCT00532493|Adrenergic Agents|adrenergic agents|mesh-ancestor
65429147|NCT00532493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65429148|NCT00532493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429149|NCT00532493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429150|NCT00996515|Azacitidine|azacitidine|mesh-list
65429151|NCT00996515|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65429152|NCT00996515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65429153|NCT00996515|Antimetabolites|antimetabolites|mesh-ancestor
65429154|NCT00996515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429155|NCT00996515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429156|NCT00996515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429157|NCT00996515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65429158|NCT00994799|Ranibizumab|ranibizumab|mesh-list
65429159|NCT00994799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65429160|NCT00994799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65429161|NCT00994799|Growth Substances|growth substances|mesh-ancestor
65429162|NCT00994799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429163|NCT00994799|Growth Inhibitors|growth inhibitors|mesh-ancestor
65429164|NCT00994799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429165|NCT00533507|Vaccines|vaccines|mesh-list
65429166|NCT00533507|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65429167|NCT00533507|Immunologic Factors|immunologic factors|mesh-ancestor
65429168|NCT00533507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429186|NCT00997061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65429187|NCT00997061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65429188|NCT00997061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429189|NCT00997061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429190|NCT00997061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429191|NCT00351819|Testosterone|testosterone|mesh-list
65429192|NCT00351819|Androgens|androgens|mesh-ancestor
65429193|NCT00351819|Hormones|hormones|mesh-ancestor
65429194|NCT00351819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65429195|NCT00351819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429196|NCT00998933|Testosterone|testosterone|mesh-list
65429197|NCT00998933|Androgens|androgens|mesh-ancestor
65429198|NCT00998933|Hormones|hormones|mesh-ancestor
65429199|NCT00998933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65429200|NCT00998933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429201|NCT00323115|Temozolomide|temozolomide|mesh-list
65429202|NCT00323115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65429203|NCT00323115|Alkylating Agents|alkylating agents|mesh-ancestor
65429204|NCT00323115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429205|NCT00323115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429206|NCT00322881|Paclitaxel|paclitaxel|mesh-list
65429207|NCT00322881|Carboplatin|carboplatin|mesh-list
65429208|NCT00322881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65429209|NCT00322881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429210|NCT00322881|Tubulin Modulators|tubulin modulators|mesh-ancestor
65429211|NCT00322881|Antimitotic Agents|antimitotic agents|mesh-ancestor
65429212|NCT00322881|Mitosis Modulators|mitosis modulators|mesh-ancestor
65429213|NCT00322881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429214|NCT00415194|Pemetrexed|pemetrexed|mesh-list
65429215|NCT00415194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429216|NCT00415194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429217|NCT00415194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429218|NCT00415194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65429219|NCT00415194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65429220|NCT00436332|Bevacizumab|bevacizumab|mesh-list
65429221|NCT00436332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65429222|NCT00436332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65429223|NCT00436332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429224|NCT00436332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64813991|NCT01475877|Bromfenac|bromfenac|mesh-list
65429231|NCT00436332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429233|NCT00532259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65429234|NCT00532259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429235|NCT00322491|Plerixafor|plerixafor|mesh-list
65429236|NCT00322491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65429237|NCT00322491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65429238|NCT00322491|Antiviral Agents|antiviral agents|mesh-ancestor
65429239|NCT00322491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65429240|NCT01034514|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
65429241|NCT01034514|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65429242|NCT01034514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429243|NCT00997607|Vaccines|vaccines|mesh-list
65429244|NCT00997607|Immunologic Factors|immunologic factors|mesh-ancestor
65429245|NCT00997607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429246|NCT00997685|Capecitabine|capecitabine|mesh-list
65429247|NCT00997685|Oxaliplatin|oxaliplatin|mesh-list
65429248|NCT00997685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65429249|NCT00997685|Antimetabolites|antimetabolites|mesh-ancestor
65429250|NCT00997685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429251|NCT00997685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429252|NCT00997919|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65429253|NCT00997919|Immunologic Factors|immunologic factors|mesh-ancestor
65429254|NCT00997919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429255|NCT00997997|Moxifloxacin|moxifloxacin|mesh-list
65429256|NCT00997997|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65429257|NCT00997997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65429258|NCT00997997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65429259|NCT00997997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65429260|NCT00997997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65429261|NCT00997997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429262|NCT00997997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429263|NCT00997997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429264|NCT00997997|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65429265|NCT00997997|Contraceptive Agents|contraceptive agents|mesh-ancestor
65429266|NCT00997997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65429267|NCT00997997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429268|NCT00997997|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65429269|NCT00997997|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65429270|NCT00997997|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65429271|NCT00998075|Esomeprazole|esomeprazole|mesh-list
65429272|NCT00998075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429273|NCT00998075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429274|NCT00998075|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65429275|NCT00998075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65429276|NCT00998075|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65429277|NCT00531947|Selegiline|selegiline|mesh-list
65429278|NCT00531947|Antidepressive Agents|antidepressive agents|mesh-ancestor
65429279|NCT00531947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65429280|NCT00531947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65429281|NCT00531947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65429282|NCT00531947|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65429283|NCT00531947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429284|NCT00531947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429285|NCT00531947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65429286|NCT00531947|Protective Agents|protective agents|mesh-ancestor
65429287|NCT00531947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429288|NCT01003847|Fenofibrate|fenofibrate|mesh-list
65429289|NCT01003847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65429290|NCT01003847|Antimetabolites|antimetabolites|mesh-ancestor
64814051|NCT01476280|Autonomic Agents|autonomic agents|mesh-ancestor
65429304|NCT01004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429306|NCT01004237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65429307|NCT01004237|Antimetabolites|antimetabolites|mesh-ancestor
65429308|NCT01004237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65429309|NCT01004237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65429310|NCT01004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429311|NCT01004315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65429312|NCT01004315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65429313|NCT01004315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65429314|NCT01004315|Cholinergic Agents|cholinergic agents|mesh-ancestor
65429315|NCT01004315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65429316|NCT01004315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429317|NCT01004315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429318|NCT01004315|Urological Agents|urological agents|mesh-ancestor
65429319|NCT05239637|Heparin|heparin|mesh-list
65429320|NCT05239637|Calcium heparin|calcium heparin|mesh-list
65429321|NCT05239637|Anticoagulants|anticoagulants|mesh-ancestor
65429322|NCT05239637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65429323|NCT05239637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65429324|NCT05239637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429325|NCT01005095|Vitamin D|vitamin d|mesh-list
65429326|NCT01005095|Ergocalciferols|ergocalciferols|mesh-list
65429327|NCT01005095|Cholecalciferol|cholecalciferol|mesh-list
65429328|NCT01005095|Vitamins|vitamins|mesh-list
65429329|NCT01005095|Micronutrients|micronutrients|mesh-ancestor
65429330|NCT01005095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429331|NCT01005095|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65429332|NCT01005095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65429333|NCT05223335|Clopidogrel|clopidogrel|mesh-list
65429334|NCT05223335|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65429335|NCT05223335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65429336|NCT05223335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65429337|NCT05223335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65429338|NCT05223335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65429339|NCT05223335|Purinergic Agents|purinergic agents|mesh-ancestor
65429340|NCT05223335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65429341|NCT05223335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429342|NCT05223335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429343|NCT01005641|Lapatinib|lapatinib|mesh-list
65429344|NCT01005641|Exemestane|exemestane|mesh-list
65429345|NCT01005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429346|NCT01005641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65429347|NCT01005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429368|NCT01006031|Antiviral Agents|antiviral agents|mesh-ancestor
65429369|NCT01006031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65429370|NCT01006031|Antimetabolites|antimetabolites|mesh-ancestor
65429371|NCT01006031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429372|NCT01006031|Immunologic Factors|immunologic factors|mesh-ancestor
65429373|NCT01006031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429375|NCT01006187|Anesthetics, Local|anesthetics, local|mesh-ancestor
65429377|NCT01006187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65429378|NCT01006187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429379|NCT01006187|Sensory System Agents|sensory system agents|mesh-ancestor
65429380|NCT01006187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65429381|NCT01006187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65429382|NCT01006187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65429383|NCT01006187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65429384|NCT01006187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65429385|NCT01006187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429386|NCT00530777|Valacyclovir|valacyclovir|mesh-list
65429387|NCT00530777|Antiviral Agents|antiviral agents|mesh-ancestor
65429388|NCT00530777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65429389|NCT01006499|Pentoxifylline|pentoxifylline|mesh-list
65429390|NCT01006499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65429391|NCT01006499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429392|NCT01006499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429393|NCT01006499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65429394|NCT01006499|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65429395|NCT01006499|Protective Agents|protective agents|mesh-ancestor
65429396|NCT01006499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429397|NCT01006499|Vasodilator Agents|vasodilator agents|mesh-ancestor
65429398|NCT01006499|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65429399|NCT01006499|Antioxidants|antioxidants|mesh-ancestor
65429400|NCT03882047|Fluticasone|fluticasone|mesh-list
65429401|NCT03882047|Xhance|xhance|mesh-list
65429408|NCT03882047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65429409|NCT03882047|Respiratory System Agents|respiratory system agents|mesh-ancestor
65429411|NCT03882047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64998205|NCT00135954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65429412|NCT01007279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65429413|NCT01007279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65429414|NCT01007279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65429415|NCT01007279|Antimetabolites|antimetabolites|mesh-ancestor
65429416|NCT01007279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429417|NCT01007279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65429418|NCT01007279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65429419|NCT01007279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429420|NCT00530621|Pemetrexed|pemetrexed|mesh-list
65429421|NCT00530621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429422|NCT00530621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429423|NCT00530621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429424|NCT00530621|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65429425|NCT00530621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65429426|NCT00531479|Voriconazole|voriconazole|mesh-list
65429427|NCT00531479|Anidulafungin|anidulafungin|mesh-list
65429428|NCT00531479|Antifungal Agents|antifungal agents|mesh-ancestor
65429429|NCT00531479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65429430|NCT00531479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65429431|NCT00531479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65429432|NCT00531479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429433|NCT00531479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429434|NCT00531479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65429435|NCT00531479|Hormone Antagonists|hormone antagonists|mesh-ancestor
65429436|NCT00531479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65429437|NCT00531479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429438|NCT00531479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65429439|NCT00999479|Ferrous fumarate|ferrous fumarate|mesh-list
65429440|NCT00999479|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65429441|NCT00999479|Norethindrone|norethindrone|mesh-list
65429442|NCT00999479|Norethindrone Acetate|norethindrone acetate|mesh-list
65429443|NCT00999479|Estradiol|estradiol|mesh-list
65429444|NCT00999479|Estrogens|estrogens|mesh-ancestor
65429445|NCT00999479|Hormones|hormones|mesh-ancestor
65429446|NCT00999479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65429447|NCT00999479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429448|NCT00999479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65429449|NCT00999479|Contraceptive Agents|contraceptive agents|mesh-ancestor
65429450|NCT00999479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65429451|NCT00999479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65429452|NCT00999479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65429453|NCT00999479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65429454|NCT00999479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65429455|NCT00999479|Trace Elements|trace elements|mesh-ancestor
65429456|NCT00999479|Micronutrients|micronutrients|mesh-ancestor
65429457|NCT00999557|Bimatoprost|bimatoprost|mesh-list
65429458|NCT00999557|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65429459|NCT00999557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65429460|NCT00999557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65429461|NCT01008137|Vaccines|vaccines|mesh-list
65429462|NCT01008137|Immunologic Factors|immunologic factors|mesh-ancestor
65429463|NCT01008137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429464|NCT00999791|Diclofenac|diclofenac|mesh-list
65429465|NCT00999791|Bevacizumab|bevacizumab|mesh-list
65429466|NCT00999791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65429467|NCT00999791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429468|NCT00999791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64814231|NCT01477242|Antiemetics|antiemetics|mesh-ancestor
65429479|NCT00999791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65429480|NCT00999791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65429481|NCT00999791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429482|NCT00999791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429483|NCT00999869|Triamcinolone|triamcinolone|mesh-list
65429484|NCT00999869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65429485|NCT00999869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65429486|NCT00999869|Botulinum Toxins|botulinum toxins|mesh-list
65429487|NCT00999869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65429488|NCT00999869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65429489|NCT00999869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65429490|NCT00999869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65429491|NCT00999869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65429492|NCT00999869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429493|NCT00999869|Cholinergic Agents|cholinergic agents|mesh-ancestor
65429494|NCT00999869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65429495|NCT00999869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429496|NCT00999869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65429497|NCT00999869|Glucocorticoids|glucocorticoids|mesh-ancestor
65429498|NCT00999869|Hormones|hormones|mesh-ancestor
65429499|NCT00999869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65429500|NCT00999869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65429501|NCT00999869|Immunologic Factors|immunologic factors|mesh-ancestor
65429502|NCT00999869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429503|NCT00999869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65429504|NCT00999869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65429505|NCT01008293|Lactulose|lactulose|mesh-list
65429506|NCT01008293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65429507|NCT01008527|Poly ICLC|poly iclc|mesh-list
65429508|NCT01008527|Interferon Inducers|interferon inducers|mesh-ancestor
65429509|NCT01008527|Immunologic Factors|immunologic factors|mesh-ancestor
65429510|NCT01008527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429511|NCT01000415|Cisplatin|cisplatin|mesh-list
65429512|NCT01000415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429513|NCT01008761|Azithromycin|azithromycin|mesh-list
65429514|NCT01008761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65429515|NCT01008761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65429516|NCT01008917|Sirolimus|sirolimus|mesh-list
65429517|NCT01008917|Sorafenib|sorafenib|mesh-list
65429518|NCT01008917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429519|NCT01008917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65429520|NCT01008917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429521|NCT01008917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429522|NCT01008917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65429523|NCT01008917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65429524|NCT01008917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65429525|NCT01008917|Antifungal Agents|antifungal agents|mesh-ancestor
65429526|NCT01008917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65429527|NCT01008917|Immunologic Factors|immunologic factors|mesh-ancestor
65429528|NCT01008917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429529|NCT01009073|Irinotecan|irinotecan|mesh-list
65429530|NCT01009073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65429531|NCT01009073|Navitoclax|navitoclax|mesh-list
65429532|NCT01009073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65429533|NCT01009073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65429552|NCT01001585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65429553|NCT01001585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429554|NCT01001897|Misoprostol|misoprostol|mesh-list
65429555|NCT01001897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65429556|NCT01001897|Abortifacient Agents|abortifacient agents|mesh-ancestor
65429557|NCT01001897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65429558|NCT01001897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429559|NCT01001897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65429560|NCT01001897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65429561|NCT01001897|Oxytocics|oxytocics|mesh-ancestor
65429562|NCT05734001|Hemostatics|hemostatics|mesh-list
65429563|NCT05734001|Coagulants|coagulants|mesh-ancestor
65429564|NCT01002911|Cefazolin|cefazolin|mesh-list
65429565|NCT01002911|Cephalexin|cephalexin|mesh-list
65429566|NCT01002911|Bacitracin|bacitracin|mesh-list
65429567|NCT01002911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65429568|NCT01002911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65429569|NCT01002911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65429570|NCT05059535|Acetaminophen|acetaminophen|mesh-list
65429571|NCT05059535|Analgesics|analgesics|mesh-list
65429572|NCT05059535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65429573|NCT05059535|Sensory System Agents|sensory system agents|mesh-ancestor
65429574|NCT05059535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65429575|NCT05059535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429576|NCT05059535|Antipyretics|antipyretics|mesh-ancestor
65429577|NCT00531011|Paclitaxel|paclitaxel|mesh-list
65429578|NCT00531011|Everolimus|everolimus|mesh-list
65429579|NCT00531011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65429580|NCT00531011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429581|NCT00531011|Tubulin Modulators|tubulin modulators|mesh-ancestor
65429582|NCT00531011|Antimitotic Agents|antimitotic agents|mesh-ancestor
65429583|NCT00531011|Mitosis Modulators|mitosis modulators|mesh-ancestor
65429584|NCT00531011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429585|NCT00531011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65429586|NCT00531011|Immunologic Factors|immunologic factors|mesh-ancestor
65429587|NCT00531011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429588|NCT04000295|Paclitaxel|paclitaxel|mesh-list
65429589|NCT04000295|Etoposide|etoposide|mesh-list
65429590|NCT04000295|Apatinib|apatinib|mesh-list
65429591|NCT04000295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65429592|NCT04000295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429607|NCT01003613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65429608|NCT01003613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429609|NCT01003613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65429610|NCT01003613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65429611|NCT01003613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65429612|NCT01003613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65429613|NCT01003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429614|NCT01003613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65429615|NCT01003613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65429616|NCT01003613|Histamine Antagonists|histamine antagonists|mesh-ancestor
65429617|NCT01003613|Histamine Agents|histamine agents|mesh-ancestor
65429618|NCT01003613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65429619|NCT01003613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65429620|NCT01003613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65429621|NCT01003613|Hemostatics|hemostatics|mesh-ancestor
65429622|NCT01003613|Coagulants|coagulants|mesh-ancestor
65429623|NCT00471146|Gemcitabine|gemcitabine|mesh-list
65429624|NCT00471146|Axitinib|axitinib|mesh-list
65429625|NCT00471146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65429626|NCT00471146|Antimetabolites|antimetabolites|mesh-ancestor
65429627|NCT00471146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429628|NCT00471146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429629|NCT00471146|Antiviral Agents|antiviral agents|mesh-ancestor
65429630|NCT00471146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65429631|NCT00471146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429632|NCT00471146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65429633|NCT00471146|Immunologic Factors|immunologic factors|mesh-ancestor
65429634|NCT00471146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429635|NCT00471146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65429636|NCT01021358|Ketoconazole|ketoconazole|mesh-list
65429637|NCT01021358|Navitoclax|navitoclax|mesh-list
65429638|NCT01021358|Antifungal Agents|antifungal agents|mesh-ancestor
65429639|NCT01021358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65429640|NCT01021358|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65429641|NCT01021358|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65429642|NCT01021358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429643|NCT01021358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429644|NCT01021358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65429645|NCT01021358|Hormone Antagonists|hormone antagonists|mesh-ancestor
65429646|NCT01021358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65429647|NCT01021358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429648|NCT01021358|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65429649|NCT01021358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429650|NCT00469898|Carboplatin|carboplatin|mesh-list
65429651|NCT00469898|Irinotecan|irinotecan|mesh-list
65429652|NCT00469898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429653|NCT00469898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65429663|NCT00529763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429664|NCT00529763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429665|NCT00486902|Ketamine|ketamine|mesh-list
65429666|NCT00486902|N-Methylaspartate|n-methylaspartate|mesh-list
65429667|NCT00486902|Analgesics|analgesics|mesh-ancestor
65179181|NCT02832778|Antimetabolites|antimetabolites|mesh-ancestor
65429668|NCT00486902|Sensory System Agents|sensory system agents|mesh-ancestor
65429669|NCT00486902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65429670|NCT00486902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429671|NCT00486902|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65429672|NCT00486902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65429673|NCT00486902|Anesthetics, General|anesthetics, general|mesh-ancestor
65429674|NCT00486902|Anesthetics|anesthetics|mesh-ancestor
65429675|NCT00486902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65429676|NCT00486902|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65429677|NCT00486902|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65429678|NCT00486902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65429679|NCT00486902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429680|NCT00486902|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
65429681|NCT05538767|Albendazole|albendazole|mesh-list
65429683|NCT05538767|Anthelmintics|anthelmintics|mesh-ancestor
65429684|NCT05538767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65429685|NCT05538767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65429686|NCT05538767|Anticestodal Agents|anticestodal agents|mesh-ancestor
64998441|NCT00103298|Leucovorin|leucovorin|mesh-list
65429687|NCT05538767|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65429688|NCT05538767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65429689|NCT05538767|Tubulin Modulators|tubulin modulators|mesh-ancestor
65429690|NCT05538767|Antimitotic Agents|antimitotic agents|mesh-ancestor
65429691|NCT05538767|Mitosis Modulators|mitosis modulators|mesh-ancestor
65429692|NCT05538767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429693|NCT05538767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429694|NCT03687827|Insulin|insulin|mesh-list
65429695|NCT03687827|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65429696|NCT03687827|Insulin Glargine|insulin glargine|mesh-list
65429697|NCT03687827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65429698|NCT03687827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429699|NCT00529529|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65429700|NCT00529529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65429701|NCT00529529|Autonomic Agents|autonomic agents|mesh-ancestor
65429702|NCT00529529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65429703|NCT00529529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429704|NCT00529529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65429705|NCT00529529|Respiratory System Agents|respiratory system agents|mesh-ancestor
65429706|NCT00529529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65429707|NCT00529529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65429708|NCT00529529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65429709|NCT00529529|Adrenergic Agents|adrenergic agents|mesh-ancestor
65429710|NCT00529529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65429711|NCT00529529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429712|NCT05685953|Vaccines|vaccines|mesh-list
65429713|NCT05685953|Immunologic Factors|immunologic factors|mesh-ancestor
65429714|NCT05685953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429715|NCT00486434|Calcitonin|calcitonin|mesh-list
65429716|NCT00486434|Salmon calcitonin|salmon calcitonin|mesh-list
65429717|NCT00486434|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
65429718|NCT00486434|Katacalcin|katacalcin|mesh-list
65429719|NCT00486434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65429740|NCT05405387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429741|NCT05405387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65429742|NCT05405387|Respiratory System Agents|respiratory system agents|mesh-ancestor
65429745|NCT05405387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65429746|NCT03999437|Terbinafine|terbinafine|mesh-list
65429747|NCT03999437|Butenafine|butenafine|mesh-list
65429748|NCT03999437|Antifungal Agents|antifungal agents|mesh-ancestor
65429749|NCT03999437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65429750|NCT03999437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429751|NCT03999437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429752|NCT05638217|Listerine|listerine|mesh-list
65429753|NCT05638217|Fluorides|fluorides|mesh-list
65429754|NCT05638217|Sodium Fluoride|sodium fluoride|mesh-list
65429755|NCT05638217|Fluorides, Topical|fluorides, topical|mesh-list
65429756|NCT05638217|Cariostatic Agents|cariostatic agents|mesh-ancestor
65429757|NCT05638217|Protective Agents|protective agents|mesh-ancestor
65429758|NCT05638217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429759|NCT05638217|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65429760|NCT05638217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65429761|NCT05637281|Indomethacin|indomethacin|mesh-list
65429762|NCT05637281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65429763|NCT05637281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65429764|NCT05637281|Analgesics|analgesics|mesh-ancestor
65429765|NCT05637281|Sensory System Agents|sensory system agents|mesh-ancestor
65429766|NCT05637281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65429767|NCT05637281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429768|NCT05637281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65429769|NCT05637281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65429770|NCT05637281|Gout Suppressants|gout suppressants|mesh-ancestor
65429771|NCT05637281|Tocolytic Agents|tocolytic agents|mesh-ancestor
65429772|NCT05637281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65429773|NCT05637281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64814548|NCT01478724|Caseins|caseins|mesh-list
65429783|NCT00486044|Simvastatin|simvastatin|mesh-list
65429784|NCT00486044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65429785|NCT00486044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65429786|NCT00486044|Antimetabolites|antimetabolites|mesh-ancestor
65429787|NCT00486044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429788|NCT00486044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65429789|NCT00486044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65429790|NCT00486044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429791|NCT00351273|Azithromycin|azithromycin|mesh-list
65429792|NCT00351273|Doxycycline|doxycycline|mesh-list
65429793|NCT00351273|Rifampin|rifampin|mesh-list
65429794|NCT00351273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65429795|NCT00351273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65429796|NCT00351273|Antimalarials|antimalarials|mesh-ancestor
65429797|NCT00351273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65429798|NCT00351273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65429799|NCT00351273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65429800|NCT00351273|Antitubercular Agents|antitubercular agents|mesh-ancestor
65429801|NCT00351273|Leprostatic Agents|leprostatic agents|mesh-ancestor
65429802|NCT00351273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65429803|NCT00351273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429804|NCT00351273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429805|NCT00351273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65429806|NCT00351273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65429807|NCT00351273|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65429808|NCT00351273|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65429809|NCT00351273|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65429810|NCT00351273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65429811|NCT00327717|Zonisamide|zonisamide|mesh-list
65429812|NCT00327717|Anticonvulsants|anticonvulsants|mesh-ancestor
65429813|NCT00327717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65429814|NCT00327717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65429815|NCT00327717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429816|NCT00327717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65429817|NCT00327717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429818|NCT00463346|Acamprosate|acamprosate|mesh-list
65429819|NCT00463346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65429820|NCT01022528|Dexamethasone|dexamethasone|mesh-list
65429821|NCT01022528|Dexamethasone acetate|dexamethasone acetate|mesh-list
65429822|NCT01022528|BB 1101|bb 1101|mesh-list
65429823|NCT01022528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65429824|NCT01022528|Antiemetics|antiemetics|mesh-ancestor
65429825|NCT01022528|Autonomic Agents|autonomic agents|mesh-ancestor
65429826|NCT01022528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65429827|NCT01022528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429828|NCT01022528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65429829|NCT01022528|Glucocorticoids|glucocorticoids|mesh-ancestor
65429830|NCT01022528|Hormones|hormones|mesh-ancestor
65429831|NCT01022528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65429832|NCT01022528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65429833|NCT01022528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429834|NCT01022528|Protease Inhibitors|protease inhibitors|mesh-ancestor
65429835|NCT01022528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429836|NCT01022528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429837|NCT01025102|Sufentanil|sufentanil|mesh-list
65429838|NCT01025102|Ropivacaine|ropivacaine|mesh-list
65429859|NCT01037634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429861|NCT01037712|Antiviral Agents|antiviral agents|mesh-ancestor
65429862|NCT01037712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65429863|NCT00453362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65429864|NCT00453362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429865|NCT00453362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65429866|NCT00453362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429867|NCT00453362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429868|NCT00424398|Bepotastine besilate|bepotastine besilate|mesh-list
65429869|NCT00424398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65429870|NCT00461786|Pemetrexed|pemetrexed|mesh-list
65429871|NCT00461786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429872|NCT00461786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429873|NCT00461786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429874|NCT00461786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65429875|NCT00461786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65429876|NCT01021592|Bortezomib|bortezomib|mesh-list
65429877|NCT01021592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429878|NCT00435162|Valsartan|valsartan|mesh-list
65429879|NCT00435162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65429880|NCT00435162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65429881|NCT00435162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65429882|NCT00435162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429883|NCT03836664|Timolol|timolol|mesh-list
65429884|NCT03836664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65429885|NCT03836664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65429886|NCT03836664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65429887|NCT03836664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65429888|NCT03836664|Adrenergic Agents|adrenergic agents|mesh-ancestor
65429889|NCT03836664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65429890|NCT03836664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429891|NCT03836664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429892|NCT03836664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64814670|NCT01479634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429908|NCT01061697|Sensory System Agents|sensory system agents|mesh-ancestor
65429909|NCT01061697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65429910|NCT01061697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429911|NCT01061697|Anticonvulsants|anticonvulsants|mesh-ancestor
65429912|NCT01061697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65429913|NCT01061697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65429914|NCT01061697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429915|NCT01061697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65429916|NCT01061697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65429917|NCT01061697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65429918|NCT01061697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65429919|NCT01061697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65429921|NCT00434304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65429922|NCT00434304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65429923|NCT00434304|Dopamine Agonists|dopamine agonists|mesh-ancestor
65429924|NCT00434304|Dopamine Agents|dopamine agents|mesh-ancestor
65429925|NCT00434304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65429926|NCT00434304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429927|NCT00434304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429928|NCT00424008|Fluticasone|fluticasone|mesh-list
65429929|NCT00424008|Xhance|xhance|mesh-list
65429930|NCT00424008|Mometasone Furoate|mometasone furoate|mesh-list
65429931|NCT00424008|Formoterol Fumarate|formoterol fumarate|mesh-list
65429932|NCT00424008|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65429933|NCT00424008|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65429934|NCT00424008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65429935|NCT00424008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65429936|NCT00424008|Autonomic Agents|autonomic agents|mesh-ancestor
65429937|NCT00424008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65429938|NCT00424008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429939|NCT00424008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65429940|NCT00424008|Respiratory System Agents|respiratory system agents|mesh-ancestor
65429941|NCT00424008|Dermatologic Agents|dermatologic agents|mesh-ancestor
65429942|NCT00424008|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65429943|NCT00424008|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65429944|NCT00424008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65429945|NCT00424008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65429946|NCT00424008|Adrenergic Agents|adrenergic agents|mesh-ancestor
65429947|NCT00424008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65429948|NCT00424008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429949|NCT00424008|Glucocorticoids|glucocorticoids|mesh-ancestor
65429950|NCT00424008|Hormones|hormones|mesh-ancestor
64814723|NCT01479920|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65430003|NCT00461630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430004|NCT00461630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65430005|NCT00461630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65430006|NCT00461630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430007|NCT00461630|Vasodilator Agents|vasodilator agents|mesh-ancestor
65430008|NCT00461630|Vitamin B Complex|vitamin b complex|mesh-ancestor
65430009|NCT00461630|Vitamins|vitamins|mesh-ancestor
65430010|NCT00461630|Micronutrients|micronutrients|mesh-ancestor
65430011|NCT00461630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430012|NCT01061853|Sirolimus|sirolimus|mesh-list
65430013|NCT01061853|Betamethasone|betamethasone|mesh-list
65430014|NCT01061853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65430015|NCT01061853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65430016|NCT01061853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65430017|NCT01061853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430018|NCT01061853|Antifungal Agents|antifungal agents|mesh-ancestor
65430019|NCT01061853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65430020|NCT01061853|Immunologic Factors|immunologic factors|mesh-ancestor
65430021|NCT01061853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430022|NCT01061853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65430023|NCT01061853|Glucocorticoids|glucocorticoids|mesh-ancestor
65430024|NCT01061853|Hormones|hormones|mesh-ancestor
65430025|NCT01061853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65430026|NCT01061853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65430027|NCT01061853|Respiratory System Agents|respiratory system agents|mesh-ancestor
65430028|NCT01325415|Moxifloxacin|moxifloxacin|mesh-list
65430029|NCT01325415|Naloxegol|naloxegol|mesh-list
65430030|NCT01325415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65430031|NCT01325415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65430032|NCT01325415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65430033|NCT01325415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65430034|NCT01325415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430035|NCT01325415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430049|NCT01022840|Anesthetics, General|anesthetics, general|mesh-ancestor
65430050|NCT01022840|Anesthetics|anesthetics|mesh-ancestor
65430051|NCT01022840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65430052|NCT01022840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65430053|NCT01022840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65430054|NCT01022840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65430055|NCT01022840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430056|NCT01022840|Antidepressive Agents|antidepressive agents|mesh-ancestor
65430057|NCT01022840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65430058|NCT01025570|Gemcitabine|gemcitabine|mesh-list
65430059|NCT01025570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65430060|NCT01025570|Antimetabolites|antimetabolites|mesh-ancestor
65430061|NCT01025570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430062|NCT01025570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430063|NCT01025570|Antiviral Agents|antiviral agents|mesh-ancestor
65430064|NCT01025570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65430065|NCT01025570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430066|NCT01025570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65430067|NCT01025570|Immunologic Factors|immunologic factors|mesh-ancestor
65430068|NCT01025570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430069|NCT03983876|Adalimumab|adalimumab|mesh-list
65430070|NCT03983876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65430071|NCT03983876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65430072|NCT00327015|Metformin|metformin|mesh-list
65430073|NCT00327015|Pioglitazone|pioglitazone|mesh-list
65430074|NCT00327015|Saxagliptin|saxagliptin|mesh-list
65430075|NCT00327015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65430076|NCT00327015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430077|NCT00327015|Incretins|incretins|mesh-ancestor
65430078|NCT00327015|Hormones|hormones|mesh-ancestor
65430079|NCT00327015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65430080|NCT00327015|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65430081|NCT00327015|Protease Inhibitors|protease inhibitors|mesh-ancestor
65430082|NCT00327015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430083|NCT00327015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430084|NCT00434148|Pasireotide|pasireotide|mesh-list
65430085|NCT00434148|Hormones|hormones|mesh-ancestor
65430086|NCT00434148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65430087|NCT00434148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430088|NCT01063569|Hydrocortisone|hydrocortisone|mesh-list
65430089|NCT01063569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65430090|NCT01063569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65430091|NCT01063569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65430092|NCT01063569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65430093|NCT01063647|Treosulfan|treosulfan|mesh-list
65430094|NCT01063647|Busulfan|busulfan|mesh-list
65430095|NCT01063647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65430096|NCT01063647|Alkylating Agents|alkylating agents|mesh-ancestor
65430097|NCT01063647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430104|NCT00468728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65430105|NCT00468728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65430106|NCT00433914|Vaccines|vaccines|mesh-list
65430107|NCT00433914|Immunologic Factors|immunologic factors|mesh-ancestor
65430108|NCT00433914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430109|NCT00321555|Immunotoxins|immunotoxins|mesh-list
65430110|NCT00321555|Immunologic Factors|immunologic factors|mesh-ancestor
65430111|NCT00321555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430112|NCT00468650|Sildenafil Citrate|sildenafil citrate|mesh-list
65430113|NCT00468650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430114|NCT00468650|Vasodilator Agents|vasodilator agents|mesh-ancestor
65430115|NCT00468650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65430116|NCT00468650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65179632|NCT00946647|Azacitidine|azacitidine|mesh-list
65430117|NCT00468650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430118|NCT00468650|Urological Agents|urological agents|mesh-ancestor
65430119|NCT00423150|Temozolomide|temozolomide|mesh-list
65430120|NCT00423150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65430121|NCT00423150|Alkylating Agents|alkylating agents|mesh-ancestor
65430122|NCT00423150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430123|NCT00423150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430124|NCT00433836|Valsartan|valsartan|mesh-list
65430125|NCT00433836|Enalapril|enalapril|mesh-list
65430126|NCT00433836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65430127|NCT00433836|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65430128|NCT00433836|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65430129|NCT00433836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430130|NCT00433836|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65430131|NCT00433836|Protease Inhibitors|protease inhibitors|mesh-ancestor
65430132|NCT00433836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430133|NCT01022918|Bevacizumab|bevacizumab|mesh-list
65430134|NCT01022918|Temozolomide|temozolomide|mesh-list
65430135|NCT01022918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65430136|NCT01022918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430137|NCT01022918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65430138|NCT01022918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65430139|NCT01022918|Growth Substances|growth substances|mesh-ancestor
65430140|NCT01022918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430141|NCT01022918|Growth Inhibitors|growth inhibitors|mesh-ancestor
65430142|NCT01022918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65430143|NCT01022918|Alkylating Agents|alkylating agents|mesh-ancestor
65430144|NCT01022918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430145|NCT03996044|Anti-Infective Agents|anti-infective agents|mesh-list
65430146|NCT03996044|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65430147|NCT00433446|Siltuximab|siltuximab|mesh-list
65430148|NCT00433446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430149|NCT00468104|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65430150|NCT00468104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65430151|NCT00468104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65430152|NCT00468104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430153|NCT00326625|Glatiramer Acetate|glatiramer acetate|mesh-list
65430154|NCT00326625|(T,G)-A-L|(t,g)-a-l|mesh-list
65430155|NCT00326625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65430156|NCT00326625|Immunologic Factors|immunologic factors|mesh-ancestor
65430157|NCT00326625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430158|NCT00326625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65430159|NCT00326625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65430160|NCT00433290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65430161|NCT00433290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65430162|NCT00433290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65430163|NCT00433290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64814922|NCT01481194|Glucocorticoids|glucocorticoids|mesh-ancestor
65430169|NCT00433290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65430170|NCT00433290|Antidepressive Agents|antidepressive agents|mesh-ancestor
65430171|NCT00433290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65430172|NCT00433290|Dopamine Agents|dopamine agents|mesh-ancestor
65430173|NCT00467870|Methyltestosterone|methyltestosterone|mesh-list
65430174|NCT00467870|Testosterone|testosterone|mesh-list
65430175|NCT00467870|Testosterone undecanoate|testosterone undecanoate|mesh-list
65430176|NCT00467870|Testosterone enanthate|testosterone enanthate|mesh-list
65430177|NCT00467870|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65430178|NCT00467870|Androgens|androgens|mesh-ancestor
65430179|NCT00467870|Hormones|hormones|mesh-ancestor
65430180|NCT00467870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65430181|NCT00467870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430182|NCT00467870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65430183|NCT00467870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430184|NCT00467870|Anabolic Agents|anabolic agents|mesh-ancestor
65430185|NCT00467558|Naltrexone|naltrexone|mesh-list
65430186|NCT00467558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65430187|NCT00467558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65430188|NCT00467558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430189|NCT00467558|Sensory System Agents|sensory system agents|mesh-ancestor
65430190|NCT00467558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65430191|NCT00422292|Vaccines|vaccines|mesh-list
65430192|NCT00422292|Immunologic Factors|immunologic factors|mesh-ancestor
65430193|NCT00422292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430194|NCT00452348|Fluticasone|fluticasone|mesh-list
65430196|NCT00452348|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65430197|NCT00452348|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65430198|NCT00452348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65430199|NCT00452348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65430200|NCT00452348|Autonomic Agents|autonomic agents|mesh-ancestor
65430201|NCT00452348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65430202|NCT00452348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430203|NCT00452348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65430204|NCT00452348|Respiratory System Agents|respiratory system agents|mesh-ancestor
65430205|NCT00452348|Dermatologic Agents|dermatologic agents|mesh-ancestor
65430206|NCT00452348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65430207|NCT00452348|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65430208|NCT00452348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65430209|NCT00452348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65430210|NCT00452348|Adrenergic Agents|adrenergic agents|mesh-ancestor
65430211|NCT00452348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65430212|NCT00452348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430213|NCT00452348|Glucocorticoids|glucocorticoids|mesh-ancestor
65430214|NCT00452348|Hormones|hormones|mesh-ancestor
65430215|NCT00452348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65430216|NCT00452348|Sympathomimetics|sympathomimetics|mesh-ancestor
65430217|NCT01323062|Bavituximab|bavituximab|mesh-list
65430218|NCT01323062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65430219|NCT01323062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430220|NCT00320541|Gemcitabine|gemcitabine|mesh-list
65430221|NCT00320541|Paclitaxel|paclitaxel|mesh-list
65430222|NCT00320541|Bevacizumab|bevacizumab|mesh-list
65430223|NCT00320541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65430224|NCT00320541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430225|NCT00320541|Tubulin Modulators|tubulin modulators|mesh-ancestor
65430226|NCT00320541|Antimitotic Agents|antimitotic agents|mesh-ancestor
65430227|NCT00320541|Mitosis Modulators|mitosis modulators|mesh-ancestor
65430228|NCT00320541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430229|NCT00320541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65430230|NCT00320541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65430231|NCT00320541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65430232|NCT00320541|Growth Substances|growth substances|mesh-ancestor
65430233|NCT00320541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430248|NCT00320385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430250|NCT00309777|Pitavastatin|pitavastatin|mesh-list
65430251|NCT00309777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65430252|NCT00309777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65430253|NCT00309777|Antimetabolites|antimetabolites|mesh-ancestor
65430254|NCT00309777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430255|NCT00309777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65430256|NCT00309777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65430257|NCT00309777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430258|NCT00325143|Edetic Acid|edetic acid|mesh-list
65430259|NCT00325143|Pentetic Acid|pentetic acid|mesh-list
65430260|NCT00325143|Antidotes|antidotes|mesh-ancestor
65430261|NCT00325143|Protective Agents|protective agents|mesh-ancestor
65430262|NCT00325143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430263|NCT00325143|Chelating Agents|chelating agents|mesh-ancestor
65430264|NCT00325143|Sequestering Agents|sequestering agents|mesh-ancestor
65430265|NCT00325143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430266|NCT00325143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65430267|NCT00325143|Anticoagulants|anticoagulants|mesh-ancestor
65430268|NCT00325143|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65430269|NCT00319839|Paclitaxel|paclitaxel|mesh-list
65430270|NCT00319839|Cetuximab|cetuximab|mesh-list
65430271|NCT00319839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65430272|NCT00319839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65430273|NCT00319839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430274|NCT00319839|Tubulin Modulators|tubulin modulators|mesh-ancestor
65430275|NCT00319839|Antimitotic Agents|antimitotic agents|mesh-ancestor
65430276|NCT00319839|Mitosis Modulators|mitosis modulators|mesh-ancestor
65430277|NCT00319839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430278|NCT00319839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65430279|NCT01062087|Lidocaine|lidocaine|mesh-list
65430280|NCT01062087|Bupivacaine|bupivacaine|mesh-list
65430281|NCT01062087|Anesthetics, Local|anesthetics, local|mesh-ancestor
65430282|NCT01062087|Anesthetics|anesthetics|mesh-ancestor
65430283|NCT01062087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65430284|NCT01062087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430285|NCT01062087|Sensory System Agents|sensory system agents|mesh-ancestor
65430286|NCT01062087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64998884|NCT00105209|Aspirin|aspirin|mesh-list
65430287|NCT01062087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65430288|NCT01062087|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65430289|NCT01062087|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65430290|NCT01062087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65430291|NCT01062087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430292|NCT00319449|Atorvastatin|atorvastatin|mesh-list
65430293|NCT00319449|Ezetimibe|ezetimibe|mesh-list
65430294|NCT00319449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65430303|NCT00308685|Autonomic Agents|autonomic agents|mesh-ancestor
65430304|NCT00308685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65430305|NCT00308685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430306|NCT00308685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65430307|NCT00308685|Respiratory System Agents|respiratory system agents|mesh-ancestor
65430308|NCT00308685|Tocolytic Agents|tocolytic agents|mesh-ancestor
65430309|NCT00308685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65430310|NCT00308685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65430311|NCT00308685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65430312|NCT00308685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65430313|NCT00308685|Adrenergic Agents|adrenergic agents|mesh-ancestor
65430314|NCT00308685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65430315|NCT00308685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430316|NCT01060917|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65430317|NCT01060917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430318|NCT03981081|Prednisone|prednisone|mesh-list
65430319|NCT03981081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65430320|NCT03981081|Glucocorticoids|glucocorticoids|mesh-ancestor
65430321|NCT03981081|Hormones|hormones|mesh-ancestor
65430322|NCT03981081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65430323|NCT03981081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430324|NCT03981081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65430325|NCT03981081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430326|NCT03979209|Mometasone Furoate|mometasone furoate|mesh-list
65430327|NCT03979209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65430328|NCT03979209|Dermatologic Agents|dermatologic agents|mesh-ancestor
65430329|NCT03979209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65430330|NCT00316719|Lamivudine|lamivudine|mesh-list
65430331|NCT00316719|Adefovir|adefovir|mesh-list
65430332|NCT00316719|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65430333|NCT00316719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65430334|NCT00316719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65430335|NCT00316719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430336|NCT00316719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430337|NCT00316719|Antiviral Agents|antiviral agents|mesh-ancestor
65430338|NCT00316719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65430339|NCT00316719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65430340|NCT00316719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65430341|NCT01065987|Tizanidine|tizanidine|mesh-list
65430342|NCT01065987|Analgesics|analgesics|mesh-ancestor
65430343|NCT01065987|Sensory System Agents|sensory system agents|mesh-ancestor
65430344|NCT01065987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65430345|NCT01065987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430346|NCT01065987|Anticonvulsants|anticonvulsants|mesh-ancestor
65430347|NCT01065987|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65430348|NCT01065987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65430349|NCT01065987|Parasympatholytics|parasympatholytics|mesh-ancestor
65430350|NCT01065987|Autonomic Agents|autonomic agents|mesh-ancestor
65430351|NCT01065987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65430352|NCT01065987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65430353|NCT01065987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65430354|NCT01065987|Adrenergic Agents|adrenergic agents|mesh-ancestor
65430355|NCT01065987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65430356|NCT01065987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430357|NCT01064115|Cetirizine|cetirizine|mesh-list
65430358|NCT01064115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65430359|NCT01064115|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65430360|NCT01064115|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65430374|NCT00422058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430375|NCT00422058|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65430376|NCT00422058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65430377|NCT01032798|Mepivacaine|mepivacaine|mesh-list
65430378|NCT01032798|Anesthetics, Local|anesthetics, local|mesh-ancestor
65430379|NCT01032798|Anesthetics|anesthetics|mesh-ancestor
65430380|NCT01032798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65430381|NCT01032798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430382|NCT01032798|Sensory System Agents|sensory system agents|mesh-ancestor
65430383|NCT01032798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65430384|NCT00413244|Testosterone|testosterone|mesh-list
65430385|NCT00413244|Androgens|androgens|mesh-ancestor
65430386|NCT00413244|Hormones|hormones|mesh-ancestor
65430387|NCT00413244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65430388|NCT00413244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430389|NCT01033032|Amrubicin|amrubicin|mesh-list
65430390|NCT01033032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430391|NCT01038570|Oxytocin|oxytocin|mesh-list
65430392|NCT01038570|Oxytocics|oxytocics|mesh-ancestor
65430393|NCT01038570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65430394|NCT01038570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430395|NCT00420342|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65430396|NCT00420342|Drospirenone|drospirenone|mesh-list
65430397|NCT00420342|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65430398|NCT00420342|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65430399|NCT00420342|Medroxyprogesterone|medroxyprogesterone|mesh-list
65430400|NCT00420342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65430401|NCT00420342|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65430402|NCT00420342|Estradiol|estradiol|mesh-list
65430403|NCT00420342|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65430404|NCT00420342|Estrogens|estrogens|mesh-ancestor
65430405|NCT00420342|Hormones|hormones|mesh-ancestor
65430406|NCT00420342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65430407|NCT00420342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430408|NCT00420342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65430409|NCT00420342|Contraceptive Agents|contraceptive agents|mesh-ancestor
65430410|NCT00420342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65430411|NCT00420342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65430412|NCT00420342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65430413|NCT00420342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65430414|NCT00420342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65430415|NCT00420342|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65430416|NCT00420342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65430417|NCT00420342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430418|NCT00420342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65430419|NCT00420342|Hormone Antagonists|hormone antagonists|mesh-ancestor
65430420|NCT00420342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65430422|NCT00420342|Natriuretic Agents|natriuretic agents|mesh-ancestor
65430446|NCT00451958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430447|NCT00451958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65430448|NCT00451958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430449|NCT01025882|Gemcitabine|gemcitabine|mesh-list
65430450|NCT01025882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65430451|NCT01025882|Antimetabolites|antimetabolites|mesh-ancestor
65430452|NCT01025882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430453|NCT01025882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430454|NCT01025882|Antiviral Agents|antiviral agents|mesh-ancestor
65430455|NCT01025882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65430456|NCT01025882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430457|NCT01025882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65430458|NCT01025882|Immunologic Factors|immunologic factors|mesh-ancestor
65430459|NCT01025882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430460|NCT01026116|Paclitaxel|paclitaxel|mesh-list
65430461|NCT01026116|Cyclophosphamide|cyclophosphamide|mesh-list
65430462|NCT01026116|Epirubicin|epirubicin|mesh-list
65430463|NCT01026116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65430464|NCT01026116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430465|NCT01026116|Tubulin Modulators|tubulin modulators|mesh-ancestor
65430466|NCT01026116|Antimitotic Agents|antimitotic agents|mesh-ancestor
65430467|NCT01026116|Mitosis Modulators|mitosis modulators|mesh-ancestor
65430468|NCT01026116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430469|NCT01026116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65430470|NCT01026116|Immunologic Factors|immunologic factors|mesh-ancestor
65430471|NCT01026116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430479|NCT01026116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430480|NCT00432276|Metformin|metformin|mesh-list
65430481|NCT00432276|Pioglitazone|pioglitazone|mesh-list
65430482|NCT00432276|Alogliptin|alogliptin|mesh-list
65430483|NCT00432276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65430484|NCT00432276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430485|NCT00432276|Incretins|incretins|mesh-ancestor
65430486|NCT00432276|Hormones|hormones|mesh-ancestor
65430487|NCT00432276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65430488|NCT00432276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65430489|NCT00432276|Protease Inhibitors|protease inhibitors|mesh-ancestor
65430490|NCT00432276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430491|NCT00432276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430493|NCT01027520|Antifungal Agents|antifungal agents|mesh-ancestor
65430494|NCT01027520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65430495|NCT01027520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65430496|NCT01027520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65430497|NCT01027520|Coccidiostats|coccidiostats|mesh-ancestor
65430498|NCT01027520|Proton Ionophores|proton ionophores|mesh-ancestor
65430499|NCT01027520|Uncoupling Agents|uncoupling agents|mesh-ancestor
65430500|NCT01027520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430501|NCT01027520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430502|NCT01027520|Ionophores|ionophores|mesh-ancestor
65430503|NCT01027520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65430504|NCT01027520|Sodium Ionophores|sodium ionophores|mesh-ancestor
65430505|NCT01023230|Entecavir|entecavir|mesh-list
65430506|NCT01023230|Antiviral Agents|antiviral agents|mesh-ancestor
65430507|NCT01023230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65430508|NCT01027832|Tazobactam|tazobactam|mesh-list
65430509|NCT01027832|Piperacillin|piperacillin|mesh-list
65430510|NCT01027832|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65430511|NCT01027832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65430512|NCT01027832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65430513|NCT01027832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65430514|NCT01027832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430515|NCT01027832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430516|NCT00413010|Pregabalin|pregabalin|mesh-list
65430517|NCT00413010|Analgesics|analgesics|mesh-ancestor
65430518|NCT00413010|Sensory System Agents|sensory system agents|mesh-ancestor
65430519|NCT00413010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65430520|NCT00413010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430521|NCT00413010|Anticonvulsants|anticonvulsants|mesh-ancestor
65430522|NCT00413010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65430523|NCT00413010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65430524|NCT00413010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430525|NCT00413010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65430526|NCT00413010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65430527|NCT00413010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65430528|NCT00413010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65430529|NCT00413010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65430530|NCT00459290|Mifepristone|mifepristone|mesh-list
65430531|NCT00459290|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65430532|NCT00459290|Abortifacient Agents|abortifacient agents|mesh-ancestor
65430533|NCT00459290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65430534|NCT00459290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430535|NCT00459290|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65430536|NCT00459290|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65430537|NCT00459290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65430538|NCT00459290|Contraceptive Agents|contraceptive agents|mesh-ancestor
65430539|NCT00459290|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65430548|NCT00443534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65430549|NCT00443534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65430550|NCT00443534|Growth Substances|growth substances|mesh-ancestor
65430551|NCT00443534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430552|NCT00443534|Growth Inhibitors|growth inhibitors|mesh-ancestor
65430553|NCT00443534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65430554|NCT00443534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430555|NCT00443534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430557|NCT00419952|Formoterol Fumarate|formoterol fumarate|mesh-list
65430558|NCT00419952|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65430559|NCT00419952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65430560|NCT00419952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65430561|NCT00419952|Autonomic Agents|autonomic agents|mesh-ancestor
65430562|NCT00419952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65430563|NCT00419952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430564|NCT00419952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65430565|NCT00419952|Respiratory System Agents|respiratory system agents|mesh-ancestor
65430566|NCT00419952|Glucocorticoids|glucocorticoids|mesh-ancestor
65430567|NCT00419952|Hormones|hormones|mesh-ancestor
65430568|NCT00419952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65430569|NCT00419952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65430570|NCT00419952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65430571|NCT00419952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65430572|NCT00419952|Adrenergic Agents|adrenergic agents|mesh-ancestor
65430573|NCT00419952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65430574|NCT00419952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430575|NCT00443456|Amlodipine|amlodipine|mesh-list
65430576|NCT00443456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65430577|NCT00443456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65430578|NCT00443456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65430579|NCT00443456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430580|NCT00443456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65430581|NCT00443456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430582|NCT00443456|Vasodilator Agents|vasodilator agents|mesh-ancestor
65430583|NCT00419562|Insulin|insulin|mesh-list
65430584|NCT00419562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65430585|NCT00419562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430586|NCT03557294|Varenicline|varenicline|mesh-list
65430587|NCT03557294|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65430588|NCT03557294|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65430589|NCT03557294|Cholinergic Agents|cholinergic agents|mesh-ancestor
65430590|NCT03557294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65430591|NCT03557294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430592|NCT03557294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430593|NCT01026350|Antibodies|antibodies|mesh-list
65430594|NCT01026350|Immunologic Factors|immunologic factors|mesh-ancestor
65430595|NCT01026350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430596|NCT01026428|Levodopa|levodopa|mesh-list
65430597|NCT01026428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65430598|NCT01026428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65430599|NCT01026428|Dopamine Agents|dopamine agents|mesh-ancestor
65430600|NCT01026428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65430601|NCT01026428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430602|NCT01026428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430603|NCT00308139|Exenatide|exenatide|mesh-list
65430625|NCT00459056|Protective Agents|protective agents|mesh-ancestor
65430626|NCT00459056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65430627|NCT00459056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65430628|NCT00459056|Vasodilator Agents|vasodilator agents|mesh-ancestor
65430629|NCT00459056|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65430630|NCT00459056|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65430631|NCT00459056|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65430632|NCT00459056|Protease Inhibitors|protease inhibitors|mesh-ancestor
65430633|NCT00459056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430634|NCT00459056|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65430635|NCT01062477|Vaccines|vaccines|mesh-list
65430636|NCT01062477|Immunologic Factors|immunologic factors|mesh-ancestor
65180160|NCT00912145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65430637|NCT01062477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430639|NCT01323374|Droxidopa|droxidopa|mesh-list
65430640|NCT01323374|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65430641|NCT01323374|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65430642|NCT01323374|Dopamine Agents|dopamine agents|mesh-ancestor
65430643|NCT01323374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65430644|NCT01323374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430645|NCT01323374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430646|NCT01323374|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65430647|NCT01323374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430648|NCT00431964|Azithromycin|azithromycin|mesh-list
65430649|NCT00431964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65430650|NCT00431964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65430651|NCT00431496|Cinacalcet|cinacalcet|mesh-list
65430652|NCT00431496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65430653|NCT00431496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430654|NCT00431496|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65430655|NCT00431496|Hormone Antagonists|hormone antagonists|mesh-ancestor
64815431|NCT01485185|Sensory System Agents|sensory system agents|mesh-ancestor
65430714|NCT00450866|Epothilone B|epothilone b|mesh-list
65430715|NCT00450866|Tubulin Modulators|tubulin modulators|mesh-ancestor
65430716|NCT00450866|Antimitotic Agents|antimitotic agents|mesh-ancestor
65430717|NCT00450866|Mitosis Modulators|mitosis modulators|mesh-ancestor
65430718|NCT00450866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430719|NCT00450866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430720|NCT01026584|Aripiprazole|aripiprazole|mesh-list
64999190|NCT00435331|Vasodilator Agents|vasodilator agents|mesh-ancestor
65430721|NCT01026584|Antidepressive Agents|antidepressive agents|mesh-ancestor
65430722|NCT01026584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65430723|NCT01026584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65430724|NCT01026584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65430725|NCT01026584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65430726|NCT01026584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430727|NCT01026584|Dopamine Agonists|dopamine agonists|mesh-ancestor
65430728|NCT01026584|Dopamine Agents|dopamine agents|mesh-ancestor
65430729|NCT01026584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65430730|NCT01026584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430731|NCT01026584|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65430732|NCT01026584|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65430733|NCT01026584|Serotonin Agents|serotonin agents|mesh-ancestor
65430734|NCT01026584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65430735|NCT01026584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65430744|NCT01023542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65430746|NCT01023542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430747|NCT01026740|Ceftobiprole|ceftobiprole|mesh-list
65430748|NCT01026740|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
65430749|NCT01026740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65430750|NCT01026740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65430751|NCT01028534|Olmesartan|olmesartan|mesh-list
65430752|NCT01028534|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65430753|NCT01028534|Calcium Channel Blockers|calcium channel blockers|mesh-list
65430754|NCT01028534|Angiotensin II|angiotensin ii|mesh-list
65430755|NCT01028534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65430756|NCT01028534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65430757|NCT01028534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430758|NCT01028534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65430759|NCT01028534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65430760|NCT01028534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430761|NCT01028534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65430762|NCT01028534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65430763|NCT00441974|Adefovir|adefovir|mesh-list
65430764|NCT00441974|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65430765|NCT00441974|Antiviral Agents|antiviral agents|mesh-ancestor
65430766|NCT00441974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65430767|NCT00441974|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65430768|NCT00441974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65430769|NCT00441974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430770|NCT00441974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430771|NCT00441584|Ribavirin|ribavirin|mesh-list
65430772|NCT00441584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65430773|NCT00441584|Interferon-alpha|interferon-alpha|mesh-list
65430774|NCT00441584|Antimetabolites|antimetabolites|mesh-ancestor
65430775|NCT00441584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430776|NCT00441584|Antiviral Agents|antiviral agents|mesh-ancestor
65430777|NCT00441584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65430778|NCT00441584|Immunologic Factors|immunologic factors|mesh-ancestor
65430779|NCT00441584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430780|NCT00430716|Sildenafil Citrate|sildenafil citrate|mesh-list
65430781|NCT00430716|Citric Acid|citric acid|mesh-list
65430782|NCT00430716|Sodium Citrate|sodium citrate|mesh-list
65430783|NCT00430716|Anticoagulants|anticoagulants|mesh-ancestor
65430784|NCT00430716|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65430785|NCT00430716|Chelating Agents|chelating agents|mesh-ancestor
65430786|NCT00430716|Sequestering Agents|sequestering agents|mesh-ancestor
65430787|NCT00430716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430788|NCT00430716|Vasodilator Agents|vasodilator agents|mesh-ancestor
65430789|NCT00430716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65430790|NCT00430716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65430791|NCT00430716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430792|NCT00430716|Urological Agents|urological agents|mesh-ancestor
65430793|NCT01028768|Teduglutide|teduglutide|mesh-list
65430794|NCT01028768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65430795|NCT01028768|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65430796|NCT01028768|Protective Agents|protective agents|mesh-ancestor
65430797|NCT01028768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430798|NCT00441272|Pioglitazone|pioglitazone|mesh-list
65430799|NCT00441272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65430800|NCT00441272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430801|NCT01566552|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65430802|NCT01566552|Antifungal Agents|antifungal agents|mesh-ancestor
65270032|NCT02726126|Sensory System Agents|sensory system agents|mesh-ancestor
65430803|NCT01566552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65430813|NCT01029002|Micronutrients|micronutrients|mesh-ancestor
65430814|NCT01029002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430815|NCT01029002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65430816|NCT00430638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65430817|NCT00430638|Olmesartan|olmesartan|mesh-list
65430818|NCT00430638|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65430819|NCT00430638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65430820|NCT00430638|Diuretics|diuretics|mesh-ancestor
65430821|NCT00430638|Natriuretic Agents|natriuretic agents|mesh-ancestor
65430822|NCT00430638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430823|NCT00430638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65430824|NCT00430638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65430825|NCT00430638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430826|NCT00430638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65430827|NCT00430638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65430828|NCT03671330|Letrozole|letrozole|mesh-list
65430829|NCT03671330|Goserelin|goserelin|mesh-list
65430830|NCT03671330|Anastrozole|anastrozole|mesh-list
65430831|NCT03671330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430832|NCT03671330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65430833|NCT03671330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65430834|NCT03671330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430835|NCT03671330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430836|NCT03671330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65430837|NCT03671330|Hormone Antagonists|hormone antagonists|mesh-ancestor
65430838|NCT03671330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65430839|NCT03671330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430840|NCT03671330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65430841|NCT01038882|Midazolam|midazolam|mesh-list
65430842|NCT01038882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65430843|NCT01038882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65430844|NCT01038882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65430845|NCT01038882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430846|NCT01038882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65430847|NCT01038882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65430848|NCT01038882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65430849|NCT01038882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65430850|NCT01038882|Anesthetics, General|anesthetics, general|mesh-ancestor
65430851|NCT01038882|Anesthetics|anesthetics|mesh-ancestor
65430852|NCT01038882|GABA Modulators|gaba modulators|mesh-ancestor
65430853|NCT01038882|GABA Agents|gaba agents|mesh-ancestor
65430854|NCT01038882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65430855|NCT01038882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430856|NCT00449930|Metformin|metformin|mesh-list
65430857|NCT00449930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65430858|NCT00449930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65430859|NCT00449930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430860|NCT00449930|Incretins|incretins|mesh-ancestor
65430861|NCT00449930|Hormones|hormones|mesh-ancestor
65430862|NCT00449930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65430863|NCT00449930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65430864|NCT00449930|Protease Inhibitors|protease inhibitors|mesh-ancestor
65430865|NCT00449930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430866|NCT00449930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430867|NCT00441116|Dutasteride|dutasteride|mesh-list
65430868|NCT00441116|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65430869|NCT00441116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65430870|NCT00441116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430904|NCT03320642|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
65430905|NCT03320642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430906|NCT03320642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430907|NCT01566266|Amoxicillin|amoxicillin|mesh-list
65430908|NCT01566266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65430909|NCT01566266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65430916|NCT00430248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65430917|NCT00430248|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65430918|NCT00430248|Antioxidants|antioxidants|mesh-ancestor
65430919|NCT00430248|Protective Agents|protective agents|mesh-ancestor
65430920|NCT00430248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430921|NCT00411762|Capecitabine|capecitabine|mesh-list
65430922|NCT00411762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65430923|NCT00411762|Antimetabolites|antimetabolites|mesh-ancestor
64999342|NCT00138099|Dalteparin|dalteparin|mesh-list
65430924|NCT00411762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430925|NCT00411762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430926|NCT00429858|Gemcitabine|gemcitabine|mesh-list
65430927|NCT00429858|Tegafur|tegafur|mesh-list
65430928|NCT00429858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65430929|NCT00429858|Antimetabolites|antimetabolites|mesh-ancestor
65430930|NCT00429858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430931|NCT00429858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430932|NCT00429858|Antiviral Agents|antiviral agents|mesh-ancestor
65430933|NCT00429858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65430934|NCT00429858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430935|NCT00429858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65430936|NCT00429858|Immunologic Factors|immunologic factors|mesh-ancestor
65430937|NCT00429858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430938|NCT01035216|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
65430939|NCT01035216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65430940|NCT01035216|Immunologic Factors|immunologic factors|mesh-ancestor
65430941|NCT01035216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430942|NCT00449150|Cetrorelix|cetrorelix|mesh-list
65430943|NCT00449150|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65430944|NCT00449150|Fertility Agents|fertility agents|mesh-ancestor
65430945|NCT00449150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65430946|NCT00449150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430947|NCT00449150|Hormone Antagonists|hormone antagonists|mesh-ancestor
65430948|NCT00449150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65430949|NCT00428844|Vancomycin|vancomycin|mesh-list
65430950|NCT00428844|Daptomycin|daptomycin|mesh-list
65430951|NCT00428844|Teicoplanin|teicoplanin|mesh-list
65430952|NCT00428844|Floxacillin|floxacillin|mesh-list
65430953|NCT00428844|Oxacillin|oxacillin|mesh-list
65430954|NCT00428844|Nafcillin|nafcillin|mesh-list
65430955|NCT00428844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65430956|NCT00428844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65430957|NCT00457418|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65430958|NCT00457418|Antiviral Agents|antiviral agents|mesh-ancestor
65430959|NCT00457418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65430960|NCT01039194|Galantamine|galantamine|mesh-list
65430961|NCT01039194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65430962|NCT01039194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430963|NCT01039194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430964|NCT01039194|Cholinergic Agents|cholinergic agents|mesh-ancestor
65430965|NCT01039194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65430966|NCT01039194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430967|NCT01039194|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65430968|NCT01039194|Autonomic Agents|autonomic agents|mesh-ancestor
65430969|NCT01039194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65430970|NCT01039194|Nootropic Agents|nootropic agents|mesh-ancestor
65430971|NCT00449072|Loratadine|loratadine|mesh-list
65430972|NCT00449072|Antipruritics|antipruritics|mesh-ancestor
65430973|NCT00449072|Dermatologic Agents|dermatologic agents|mesh-ancestor
65430974|NCT00449072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65430975|NCT00449072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65430976|NCT00449072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65430977|NCT00449072|Histamine Antagonists|histamine antagonists|mesh-ancestor
65430978|NCT00449072|Histamine Agents|histamine agents|mesh-ancestor
65430979|NCT00449072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65430980|NCT00449072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815743|NCT01486511|Hematinics|hematinics|mesh-ancestor
65430997|NCT00448916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65430998|NCT00448916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65431000|NCT00418938|Bevacizumab|bevacizumab|mesh-list
65431001|NCT00418938|Panitumumab|panitumumab|mesh-list
65431002|NCT00418938|Fluorouracil|fluorouracil|mesh-list
65431003|NCT00418938|Irinotecan|irinotecan|mesh-list
65431004|NCT00418938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65431005|NCT00418938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431006|NCT00418938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65431007|NCT00418938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65431008|NCT00418938|Growth Substances|growth substances|mesh-ancestor
65431009|NCT00418938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431010|NCT00418938|Growth Inhibitors|growth inhibitors|mesh-ancestor
65431011|NCT00418938|Antimetabolites|antimetabolites|mesh-ancestor
65431012|NCT00418938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431013|NCT00418938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65431014|NCT00418938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65270033|NCT02726126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65431015|NCT00418938|Immunologic Factors|immunologic factors|mesh-ancestor
65431016|NCT00418938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65431017|NCT00418938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65431018|NCT00418938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431019|NCT00418938|Antidotes|antidotes|mesh-ancestor
65431020|NCT00418938|Protective Agents|protective agents|mesh-ancestor
65431021|NCT00418938|Vitamin B Complex|vitamin b complex|mesh-ancestor
65431023|NCT00418938|Micronutrients|micronutrients|mesh-ancestor
65431024|NCT00448760|Leucovorin|leucovorin|mesh-list
65431025|NCT00448760|Docetaxel|docetaxel|mesh-list
65431026|NCT00448760|Oxaliplatin|oxaliplatin|mesh-list
65431027|NCT00448760|Floxuridine|floxuridine|mesh-list
65431028|NCT00448760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431029|NCT00448760|Tubulin Modulators|tubulin modulators|mesh-ancestor
65431030|NCT00448760|Antimitotic Agents|antimitotic agents|mesh-ancestor
65431031|NCT00448760|Mitosis Modulators|mitosis modulators|mesh-ancestor
65431032|NCT00448760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431033|NCT00448760|Antidotes|antidotes|mesh-ancestor
65431034|NCT00448760|Protective Agents|protective agents|mesh-ancestor
65431035|NCT00448760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431036|NCT00448760|Vitamin B Complex|vitamin b complex|mesh-ancestor
65431037|NCT00448760|Vitamins|vitamins|mesh-ancestor
65431038|NCT00448760|Micronutrients|micronutrients|mesh-ancestor
65431039|NCT00448760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65431040|NCT00448760|Antimetabolites|antimetabolites|mesh-ancestor
65431041|NCT01039350|Darbepoetin alfa|darbepoetin alfa|mesh-list
64815818|NCT01486953|Desflurane|desflurane|mesh-list
65431057|NCT01035450|Sirolimus|sirolimus|mesh-list
65431058|NCT01035450|Everolimus|everolimus|mesh-list
65431059|NCT01035450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431060|NCT01035450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65431061|NCT01035450|Immunologic Factors|immunologic factors|mesh-ancestor
65431062|NCT01035450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431063|NCT01035450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65431064|NCT01035450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65431065|NCT01035450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65431066|NCT01035450|Antifungal Agents|antifungal agents|mesh-ancestor
65431067|NCT01035528|Metformin|metformin|mesh-list
65431068|NCT01035528|Insulin Glargine|insulin glargine|mesh-list
65431069|NCT01035528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65431070|NCT01035528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431071|NCT01033656|Methotrexate|methotrexate|mesh-list
65431072|NCT01033656|Azathioprine|azathioprine|mesh-list
65431073|NCT01033656|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65431074|NCT01033656|Leflunomide|leflunomide|mesh-list
65431075|NCT01033656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65431076|NCT01033656|Abortifacient Agents|abortifacient agents|mesh-ancestor
65431077|NCT01033656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65431078|NCT01033656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431079|NCT01033656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65431080|NCT01033656|Antimetabolites|antimetabolites|mesh-ancestor
65431081|NCT01033656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431082|NCT01033656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431083|NCT01033656|Dermatologic Agents|dermatologic agents|mesh-ancestor
65431084|NCT01033656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431085|NCT01033656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65431086|NCT01033656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65431087|NCT01033656|Immunologic Factors|immunologic factors|mesh-ancestor
65431088|NCT01033656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65431089|NCT01033656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65431090|NCT01039740|Mirtazapine|mirtazapine|mesh-list
65431091|NCT01039740|Antidepressive Agents|antidepressive agents|mesh-ancestor
65431092|NCT01039740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65431093|NCT01039740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65431095|NCT01039740|Histamine Agents|histamine agents|mesh-ancestor
65431096|NCT01039740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65431097|NCT01039740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431098|NCT01039740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431099|NCT01039740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65431100|NCT01039740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65431101|NCT01039740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64815872|NCT01487278|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65431115|NCT00448136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65431116|NCT00448136|Growth Substances|growth substances|mesh-ancestor
65431117|NCT00448136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431118|NCT00448136|Growth Inhibitors|growth inhibitors|mesh-ancestor
65431119|NCT00448136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65431120|NCT00447902|Ritonavir|ritonavir|mesh-list
65431121|NCT00447902|Tipranavir|tipranavir|mesh-list
65431122|NCT00447902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65431123|NCT00447902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65431124|NCT00447902|Protease Inhibitors|protease inhibitors|mesh-ancestor
65431125|NCT00447902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431126|NCT00447902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431127|NCT00447902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65431128|NCT00447902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65431129|NCT00447902|Antiviral Agents|antiviral agents|mesh-ancestor
65431130|NCT00447902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65431131|NCT00447902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65431132|NCT00447902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65431133|NCT00307437|Ustekinumab|ustekinumab|mesh-list
65431134|NCT00307437|Dermatologic Agents|dermatologic agents|mesh-ancestor
65431135|NCT00440726|Cytarabine|cytarabine|mesh-list
65431136|NCT00440726|Dexamethasone|dexamethasone|mesh-list
65431137|NCT00440726|Doxorubicin|doxorubicin|mesh-list
65431138|NCT00440726|Methotrexate|methotrexate|mesh-list
65431139|NCT00440726|Vincristine|vincristine|mesh-list
65431140|NCT00440726|Bortezomib|bortezomib|mesh-list
65431141|NCT00440726|Asparaginase|asparaginase|mesh-list
65431142|NCT00440726|Pegaspargase|pegaspargase|mesh-list
65431143|NCT00440726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65431144|NCT00440726|Antiemetics|antiemetics|mesh-ancestor
65431145|NCT00440726|Autonomic Agents|autonomic agents|mesh-ancestor
65431146|NCT00440726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65431147|NCT00440726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431148|NCT00440726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65431149|NCT00440726|Glucocorticoids|glucocorticoids|mesh-ancestor
65431150|NCT00440726|Hormones|hormones|mesh-ancestor
65431151|NCT00440726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65431152|NCT00440726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65431153|NCT00440726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431154|NCT00440726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65431155|NCT00440726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65431156|NCT00440726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65431157|NCT00440726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431158|NCT00440726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431159|NCT00440726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65431160|NCT00440726|Abortifacient Agents|abortifacient agents|mesh-ancestor
65431161|NCT00440726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65431162|NCT00440726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65431163|NCT00440726|Antimetabolites|antimetabolites|mesh-ancestor
65431182|NCT01030016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431183|NCT01030016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65431184|NCT01030016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65431185|NCT01030016|Sympatholytics|sympatholytics|mesh-ancestor
65431186|NCT01030016|Autonomic Agents|autonomic agents|mesh-ancestor
65431187|NCT01030016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65431188|NCT01030016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65431189|NCT03996278|Thymoglobulin|thymoglobulin|mesh-list
65431190|NCT03996278|Immunologic Factors|immunologic factors|mesh-ancestor
65431191|NCT03996278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431192|NCT03996278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65431193|NCT00447278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65431194|NCT00447278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65431195|NCT00447278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65431196|NCT00447278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65431197|NCT00447278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431198|NCT00447278|Adrenergic Agents|adrenergic agents|mesh-ancestor
65431199|NCT00447278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65431200|NCT00447278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431201|NCT01030094|Topiramate|topiramate|mesh-list
65431202|NCT01030094|Carbamazepine|carbamazepine|mesh-list
65431203|NCT01030094|Valproic Acid|valproic acid|mesh-list
65431204|NCT01030094|Anticonvulsants|anticonvulsants|mesh-ancestor
65431205|NCT01030094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65431206|NCT01030094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431207|NCT01030094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431208|NCT01030094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431209|NCT01030094|GABA Agents|gaba agents|mesh-ancestor
65431210|NCT01030094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65431211|NCT01030094|Antimanic Agents|antimanic agents|mesh-ancestor
65431212|NCT01030094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65431213|NCT01030094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65431214|NCT01030094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65431215|NCT01030094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65431216|NCT01030094|Analgesics|analgesics|mesh-ancestor
65431217|NCT01030094|Sensory System Agents|sensory system agents|mesh-ancestor
65431218|NCT01030094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65431219|NCT01030094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65431232|NCT00405756|Aspirin|aspirin|mesh-list
65431233|NCT00405756|Prednisone|prednisone|mesh-list
65431234|NCT00405756|Lenalidomide|lenalidomide|mesh-list
65431235|NCT00405756|Melphalan|melphalan|mesh-list
65431236|NCT00405756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65431237|NCT00405756|Glucocorticoids|glucocorticoids|mesh-ancestor
65431238|NCT00405756|Hormones|hormones|mesh-ancestor
65431239|NCT00405756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65431240|NCT00405756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431241|NCT00405756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65431242|NCT00405756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431243|NCT00405756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65431244|NCT00405756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65431245|NCT00405756|Analgesics|analgesics|mesh-ancestor
65431246|NCT00405756|Sensory System Agents|sensory system agents|mesh-ancestor
65431247|NCT00405756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65431248|NCT00405756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65431249|NCT00405756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65431250|NCT00405756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65431251|NCT00405756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431252|NCT00405756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65431253|NCT00405756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65431254|NCT00405756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431255|NCT00405756|Antipyretics|antipyretics|mesh-ancestor
65431256|NCT00405756|Immunologic Factors|immunologic factors|mesh-ancestor
65431257|NCT00405756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65431258|NCT00405756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65431259|NCT00405756|Growth Substances|growth substances|mesh-ancestor
65431260|NCT00405756|Growth Inhibitors|growth inhibitors|mesh-ancestor
65431261|NCT00405756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65431262|NCT00405756|Alkylating Agents|alkylating agents|mesh-ancestor
65431263|NCT00405756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65431264|NCT00405756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65431265|NCT00456092|Apremilast|apremilast|mesh-list
65431266|NCT00456092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65431267|NCT00456092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65431268|NCT00456092|Analgesics|analgesics|mesh-ancestor
65431269|NCT00456092|Sensory System Agents|sensory system agents|mesh-ancestor
65431270|NCT00456092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65431271|NCT00456092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431272|NCT00456092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65431273|NCT00456092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65431274|NCT00456092|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65431275|NCT00456092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65431276|NCT00456092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431277|NCT00456092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431278|NCT01030640|Tanezumab|tanezumab|mesh-list
65431279|NCT01030640|Analgesics|analgesics|mesh-ancestor
65431280|NCT01030640|Sensory System Agents|sensory system agents|mesh-ancestor
65431281|NCT01030640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65431282|NCT01030640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431309|NCT00446030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65431310|NCT00446030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65431311|NCT00446030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65431312|NCT00446030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65431313|NCT00446030|Growth Substances|growth substances|mesh-ancestor
65431314|NCT00446030|Growth Inhibitors|growth inhibitors|mesh-ancestor
65431315|NCT00446030|Tubulin Modulators|tubulin modulators|mesh-ancestor
65431316|NCT00446030|Antimitotic Agents|antimitotic agents|mesh-ancestor
65431317|NCT00446030|Mitosis Modulators|mitosis modulators|mesh-ancestor
65431318|NCT00446030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65431319|NCT00446030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65431320|NCT00446030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65431321|NCT00446030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431322|NCT00410514|Mirabegron|mirabegron|mesh-list
65431323|NCT00410514|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65431324|NCT00410514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65431325|NCT00410514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65431326|NCT00410514|Adrenergic Agents|adrenergic agents|mesh-ancestor
65431327|NCT00410514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65431328|NCT00410514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431329|NCT00410514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431330|NCT00410514|Urological Agents|urological agents|mesh-ancestor
65431331|NCT03847610|Penicillins|penicillins|mesh-list
65431332|NCT03847610|Penicillin V|penicillin v|mesh-list
65431333|NCT03847610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65431334|NCT03847610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65431365|NCT00439556|Cytarabine|cytarabine|mesh-list
65431366|NCT00439556|Rituximab|rituximab|mesh-list
65431367|NCT00439556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65431368|NCT00439556|Methotrexate|methotrexate|mesh-list
65431369|NCT00439556|Etoposide|etoposide|mesh-list
65431370|NCT00439556|Etoposide phosphate|etoposide phosphate|mesh-list
65431371|NCT00439556|Bortezomib|bortezomib|mesh-list
65431372|NCT00439556|Melphalan|melphalan|mesh-list
65431373|NCT00439556|Mechlorethamine|mechlorethamine|mesh-list
65431374|NCT00439556|Carmustine|carmustine|mesh-list
65431375|NCT00439556|Podophyllotoxin|podophyllotoxin|mesh-list
65431376|NCT00439556|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65431377|NCT00439556|Antibodies|antibodies|mesh-list
65431378|NCT00439556|Immunoglobulins|immunoglobulins|mesh-list
65431379|NCT00439556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65431380|NCT00439556|Lenograstim|lenograstim|mesh-list
65431381|NCT00439556|Tacrolimus|tacrolimus|mesh-list
65431394|NCT00439556|Dermatologic Agents|dermatologic agents|mesh-ancestor
65431395|NCT00439556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431396|NCT00439556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65431397|NCT00439556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65431398|NCT00439556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65431399|NCT00439556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65431400|NCT00439556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65431401|NCT00439556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65431402|NCT00439556|Antiviral Agents|antiviral agents|mesh-ancestor
65431403|NCT00439556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65431404|NCT00439556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65431405|NCT00439556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65431406|NCT00439556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65431407|NCT00439556|Alkylating Agents|alkylating agents|mesh-ancestor
65431408|NCT00439556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65431409|NCT00439556|Keratolytic Agents|keratolytic agents|mesh-ancestor
65431410|NCT00439556|Tubulin Modulators|tubulin modulators|mesh-ancestor
65431411|NCT00439556|Antimitotic Agents|antimitotic agents|mesh-ancestor
65431412|NCT00439556|Mitosis Modulators|mitosis modulators|mesh-ancestor
65431413|NCT00410202|Tenofovir|tenofovir|mesh-list
65431414|NCT00410202|Lamivudine|lamivudine|mesh-list
65431415|NCT00410202|Entecavir|entecavir|mesh-list
65431416|NCT00410202|Adefovir|adefovir|mesh-list
65431417|NCT00410202|Antiviral Agents|antiviral agents|mesh-ancestor
65431418|NCT00410202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65431419|NCT00410202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65431420|NCT00410202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65431421|NCT00410202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431422|NCT00410202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431423|NCT00410202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65431424|NCT00410202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65431425|NCT03011684|Tamoxifen|tamoxifen|mesh-list
65431426|NCT03011684|Letrozole|letrozole|mesh-list
65431427|NCT03011684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431428|NCT03011684|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65431429|NCT03011684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65431430|NCT03011684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431431|NCT03011684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431432|NCT03011684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65431433|NCT03011684|Hormone Antagonists|hormone antagonists|mesh-ancestor
65431434|NCT03011684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65431435|NCT03011684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431436|NCT03011684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65431437|NCT03011684|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65431438|NCT03011684|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65431439|NCT03011684|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65431440|NCT03802058|Paclitaxel|paclitaxel|mesh-list
65431441|NCT03802058|Carboplatin|carboplatin|mesh-list
65431442|NCT03802058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65431443|NCT03802058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431469|NCT00455312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431471|NCT00455312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65270034|NCT02726126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65431472|NCT00455312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65431473|NCT00455312|Antiemetics|antiemetics|mesh-ancestor
65431474|NCT00455312|Autonomic Agents|autonomic agents|mesh-ancestor
65431475|NCT00455312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65431476|NCT00455312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65431477|NCT00455312|Glucocorticoids|glucocorticoids|mesh-ancestor
65431479|NCT00455312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65431480|NCT00455312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65431481|NCT00455312|Protective Agents|protective agents|mesh-ancestor
65431482|NCT00455312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65431483|NCT01031030|Cyclophosphamide|cyclophosphamide|mesh-list
65431484|NCT01031030|Fluorouracil|fluorouracil|mesh-list
65431485|NCT01031030|Methotrexate|methotrexate|mesh-list
65431486|NCT01031030|Epirubicin|epirubicin|mesh-list
65431487|NCT01031030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65431488|NCT01031030|Immunologic Factors|immunologic factors|mesh-ancestor
65431489|NCT01031030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431490|NCT01031030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65431491|NCT01031030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65431492|NCT01031030|Alkylating Agents|alkylating agents|mesh-ancestor
65431493|NCT01031030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431494|NCT01031030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816276|NCT01489631|Ropivacaine|ropivacaine|mesh-list
65431521|NCT01323452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65431522|NCT00444626|Lidocaine|lidocaine|mesh-list
65431523|NCT00444626|Prilocaine|prilocaine|mesh-list
65431524|NCT00444626|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65431525|NCT00444626|Hyaluronic Acid|hyaluronic acid|mesh-list
65431526|NCT00444626|Anesthetics, Local|anesthetics, local|mesh-ancestor
65431527|NCT00444626|Anesthetics|anesthetics|mesh-ancestor
65431528|NCT00444626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65431529|NCT00444626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431530|NCT00444626|Sensory System Agents|sensory system agents|mesh-ancestor
65431531|NCT00444626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65431532|NCT00444626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65431533|NCT00444626|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65431534|NCT00444626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65431535|NCT00444626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65431536|NCT00444626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431537|NCT00444626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65431538|NCT00444626|Immunologic Factors|immunologic factors|mesh-ancestor
65431539|NCT00444626|Viscosupplements|viscosupplements|mesh-ancestor
65431540|NCT00444626|Protective Agents|protective agents|mesh-ancestor
65431541|NCT00444626|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65431542|NCT01024868|Ropivacaine|ropivacaine|mesh-list
65431543|NCT01024868|Anesthetics, Local|anesthetics, local|mesh-ancestor
65431567|NCT00439244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65431568|NCT00439244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431569|NCT00439244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65431571|NCT04844762|Antipruritics|antipruritics|mesh-ancestor
65431572|NCT04844762|Dermatologic Agents|dermatologic agents|mesh-ancestor
65431573|NCT01323218|Vitamin D|vitamin d|mesh-list
65431574|NCT01323218|Vitamins|vitamins|mesh-ancestor
65431575|NCT01323218|Micronutrients|micronutrients|mesh-ancestor
65431576|NCT01323218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431577|NCT01323218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65431578|NCT01323296|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65431579|NCT01323296|Hematinics|hematinics|mesh-ancestor
65431580|NCT01323296|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65431581|NCT01323296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65431582|NCT00438464|Finasteride|finasteride|mesh-list
65431583|NCT00438464|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65431584|NCT00438464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65431585|NCT00438464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431586|NCT00438464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431587|NCT00438464|Hormone Antagonists|hormone antagonists|mesh-ancestor
65431588|NCT00438464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65431589|NCT00438464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431590|NCT00438464|Urological Agents|urological agents|mesh-ancestor
65431591|NCT00437294|Capecitabine|capecitabine|mesh-list
65431592|NCT00437294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65431593|NCT00437294|Antimetabolites|antimetabolites|mesh-ancestor
65431594|NCT00437294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431595|NCT00437294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431604|NCT01033760|Protease Inhibitors|protease inhibitors|mesh-ancestor
65431605|NCT01033760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431606|NCT01033760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431607|NCT01033760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65431608|NCT01033760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65431609|NCT01033760|Antiviral Agents|antiviral agents|mesh-ancestor
65431610|NCT01033760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65431611|NCT01033760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65431612|NCT01033760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65431613|NCT01033760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65431614|NCT01033760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65431615|NCT01033760|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65431616|NCT01033760|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65431617|NCT01033760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65431618|NCT01033760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65431619|NCT01033760|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65431620|NCT01031732|Tacrine|tacrine|mesh-list
65431621|NCT01031732|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65431622|NCT01031732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181135|NCT02811484|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65431623|NCT01031732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431624|NCT01031732|Cholinergic Agents|cholinergic agents|mesh-ancestor
65431625|NCT01031732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65431626|NCT01031732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431627|NCT01031732|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65431628|NCT01031732|Autonomic Agents|autonomic agents|mesh-ancestor
65431629|NCT01031732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65431630|NCT01031732|Nootropic Agents|nootropic agents|mesh-ancestor
65431631|NCT01033994|Mitogens|mitogens|mesh-list
65431632|NCT01033994|Mitosis Modulators|mitosis modulators|mesh-ancestor
65431633|NCT01033994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431634|NCT01031888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65431635|NCT01031888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65431636|NCT00436826|Interferons|interferons|mesh-list
65431637|NCT00436826|Interferon-beta|interferon-beta|mesh-list
65431638|NCT00436826|Cladribine|cladribine|mesh-list
65431639|NCT00436826|Interferon beta-1b|interferon beta-1b|mesh-list
65431640|NCT00436826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431641|NCT00436826|Antiviral Agents|antiviral agents|mesh-ancestor
65431642|NCT00436826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65431643|NCT00436826|Immunologic Factors|immunologic factors|mesh-ancestor
65431644|NCT00436826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431645|NCT00436826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65431646|NCT00436826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65431647|NCT00410124|Everolimus|everolimus|mesh-list
65431648|NCT00410124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431649|NCT00410124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65431650|NCT00410124|Immunologic Factors|immunologic factors|mesh-ancestor
65431651|NCT00410124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431652|NCT01036932|Lenograstim|lenograstim|mesh-list
65431653|NCT01036932|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65431654|NCT01036932|Immunologic Factors|immunologic factors|mesh-ancestor
65431655|NCT01036932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431656|NCT00410046|Etanercept|etanercept|mesh-list
65431657|NCT00410046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65431658|NCT00410046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65431659|NCT00410046|Analgesics|analgesics|mesh-ancestor
65431660|NCT00410046|Sensory System Agents|sensory system agents|mesh-ancestor
65431661|NCT00410046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65431662|NCT00410046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431663|NCT00410046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65431664|NCT00410046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65431692|NCT01037322|Cannabidiol|cannabidiol|mesh-list
65431693|NCT01037322|Anticonvulsants|anticonvulsants|mesh-ancestor
65431694|NCT01070758|Lanreotide|lanreotide|mesh-list
65431695|NCT01070758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431696|NCT00428090|Rosiglitazone|rosiglitazone|mesh-list
65431697|NCT00428090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65431698|NCT00428090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431699|NCT01031966|Thymalfasin|thymalfasin|mesh-list
65431700|NCT01031966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65431701|NCT01031966|Immunologic Factors|immunologic factors|mesh-ancestor
65431702|NCT01031966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431703|NCT00436436|Temozolomide|temozolomide|mesh-list
64999873|NCT00142779|Fluoxetine|fluoxetine|mesh-list
65431704|NCT00436436|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
65431705|NCT00436436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65431706|NCT00436436|Alkylating Agents|alkylating agents|mesh-ancestor
65431707|NCT00436436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431708|NCT00436436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431709|NCT00436436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431710|NCT00262522|Ritonavir|ritonavir|mesh-list
65431711|NCT00262522|Lopinavir|lopinavir|mesh-list
65431712|NCT00262522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
65431713|NCT00262522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65431714|NCT00262522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65431724|NCT00262522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65431725|NCT00436280|Gemcitabine|gemcitabine|mesh-list
65431726|NCT00436280|Rituximab|rituximab|mesh-list
65431727|NCT00436280|Oxaliplatin|oxaliplatin|mesh-list
65431728|NCT00436280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65431729|NCT00436280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431730|NCT00436280|Immunologic Factors|immunologic factors|mesh-ancestor
65431731|NCT00436280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431732|NCT00436280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65431733|NCT00436280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65431734|NCT00436280|Antimetabolites|antimetabolites|mesh-ancestor
65431735|NCT00436280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431736|NCT00436280|Antiviral Agents|antiviral agents|mesh-ancestor
65431737|NCT00436280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65431738|NCT00436280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431739|NCT00436280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65431740|NCT00394836|Ofatumumab|ofatumumab|mesh-list
65431741|NCT00394836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65431742|NCT00394836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431743|NCT00394836|Immunologic Factors|immunologic factors|mesh-ancestor
65431744|NCT00394836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431745|NCT01040598|Omalizumab|omalizumab|mesh-list
65431746|NCT01040598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65431747|NCT01040598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65431748|NCT01040598|Respiratory System Agents|respiratory system agents|mesh-ancestor
65431749|NCT01039974|Ketoconazole|ketoconazole|mesh-list
65431750|NCT01039974|Antifungal Agents|antifungal agents|mesh-ancestor
65431751|NCT01039974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65431752|NCT01039974|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65431753|NCT01039974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65431754|NCT01039974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431755|NCT01039974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431756|NCT01039974|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65431757|NCT01039974|Hormone Antagonists|hormone antagonists|mesh-ancestor
65431758|NCT01039974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65431759|NCT01039974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431760|NCT01039974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65431761|NCT01032122|Rituximab|rituximab|mesh-list
65431762|NCT01032122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65431763|NCT01032122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431764|NCT01032122|Immunologic Factors|immunologic factors|mesh-ancestor
65431765|NCT01032122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431766|NCT01032122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65431767|NCT03819660|Amifampridine|amifampridine|mesh-list
65431768|NCT03819660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65431769|NCT03819660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65431770|NCT03819660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431771|NCT03819660|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65431772|NCT03819660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65431773|NCT03819660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431774|NCT00394524|Insulin|insulin|mesh-list
65431775|NCT00394524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65431776|NCT00394524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431777|NCT00409344|Dexmedetomidine|dexmedetomidine|mesh-list
64816540|NCT01490567|Donepezil|donepezil|mesh-list
65431796|NCT00415610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65431797|NCT00415610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431798|NCT00415610|Vasodilator Agents|vasodilator agents|mesh-ancestor
65431799|NCT01722812|Cromolyn Sodium|cromolyn sodium|mesh-list
65431800|NCT01722812|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
65431801|NCT01722812|Immunologic Factors|immunologic factors|mesh-ancestor
65431802|NCT01722812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431803|NCT01722812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65431804|NCT01722812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65431805|NCT01722812|Respiratory System Agents|respiratory system agents|mesh-ancestor
65431806|NCT00250432|Caspofungin|caspofungin|mesh-list
65431807|NCT00250432|Antifungal Agents|antifungal agents|mesh-ancestor
65431808|NCT00250432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65431809|NCT00250432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431810|NCT00250432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431811|NCT03741478|Insulin|insulin|mesh-list
65431812|NCT03741478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65431813|NCT03741478|Insulin Lispro|insulin lispro|mesh-list
65431814|NCT03741478|Olanzapine|olanzapine|mesh-list
65431815|NCT03741478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65431816|NCT03741478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431817|NCT03741478|Antiemetics|antiemetics|mesh-ancestor
65431818|NCT03741478|Autonomic Agents|autonomic agents|mesh-ancestor
65431819|NCT03741478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65431820|NCT03741478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65431821|NCT03741478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65431822|NCT03741478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65431823|NCT03741478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65431824|NCT03741478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65431825|NCT03741478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65431826|NCT03741478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65431827|NCT03741478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65431828|NCT03741478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431829|NCT03741478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65431830|NCT03741478|Serotonin Agents|serotonin agents|mesh-ancestor
65431831|NCT00249808|Antibodies|antibodies|mesh-list
65431853|NCT01072240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65431854|NCT01072240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431855|NCT01072240|Immunologic Factors|immunologic factors|mesh-ancestor
65431856|NCT01072240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431857|NCT01072240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65431858|NCT00427934|Maraviroc|maraviroc|mesh-list
65431859|NCT00427934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65431860|NCT00427934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65431861|NCT00427934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431862|NCT00427934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65431863|NCT00427934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65431864|NCT00427934|Antiviral Agents|antiviral agents|mesh-ancestor
65431865|NCT00427934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65431866|NCT00427934|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65431867|NCT00427700|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65431868|NCT00427700|Clomiphene|clomiphene|mesh-list
65431869|NCT00427700|Enclomiphene|enclomiphene|mesh-list
65431870|NCT00427700|Zuclomiphene|zuclomiphene|mesh-list
65431871|NCT00427700|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65431872|NCT00427700|Hormone Antagonists|hormone antagonists|mesh-ancestor
65431873|NCT00427700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65431874|NCT00427700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431875|NCT00427700|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65431876|NCT00427700|Fertility Agents|fertility agents|mesh-ancestor
65431877|NCT00427700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65431878|NCT00427700|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65431879|NCT00427700|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65431880|NCT00427700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65431881|NCT01324076|Doxorubicin|doxorubicin|mesh-list
65431882|NCT01324076|Sorafenib|sorafenib|mesh-list
65431883|NCT01324076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65431884|NCT01324076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431885|NCT01324076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65431886|NCT01324076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65431916|NCT00276484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431917|NCT00426842|Midodrine|midodrine|mesh-list
65431918|NCT00426842|Sympathomimetics|sympathomimetics|mesh-ancestor
65431919|NCT00426842|Autonomic Agents|autonomic agents|mesh-ancestor
65431920|NCT00426842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65431921|NCT00426842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431922|NCT00426842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65431923|NCT00426842|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65431924|NCT00426842|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65431925|NCT00426842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65431926|NCT00426842|Adrenergic Agents|adrenergic agents|mesh-ancestor
65431927|NCT00426842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65431928|NCT00426842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431929|NCT00434876|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65431930|NCT00434876|Antidepressive Agents|antidepressive agents|mesh-ancestor
65431943|NCT01072318|Hormone Antagonists|hormone antagonists|mesh-ancestor
65431944|NCT01072318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65431945|NCT01072318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431946|NCT00276094|Tamoxifen|tamoxifen|mesh-list
65431947|NCT00276094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65431948|NCT00276094|Hormone Antagonists|hormone antagonists|mesh-ancestor
65431949|NCT00276094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65431950|NCT00276094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431951|NCT00276094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65431952|NCT00276094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431953|NCT00276094|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65431954|NCT00276094|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65431955|NCT00276094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65431956|NCT03975088|Ranibizumab|ranibizumab|mesh-list
65431957|NCT03975088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65431958|NCT03975088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65431959|NCT03975088|Growth Substances|growth substances|mesh-ancestor
65431960|NCT03975088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431961|NCT03975088|Growth Inhibitors|growth inhibitors|mesh-ancestor
65431962|NCT03975088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431963|NCT00276016|Phenylephrine|phenylephrine|mesh-list
65431964|NCT00276016|Oxymetazoline|oxymetazoline|mesh-list
65431965|NCT00276016|Pseudoephedrine|pseudoephedrine|mesh-list
65431966|NCT00276016|Ephedrine|ephedrine|mesh-list
65431967|NCT00276016|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65431968|NCT00276016|Mydriatics|mydriatics|mesh-ancestor
65431969|NCT00276016|Autonomic Agents|autonomic agents|mesh-ancestor
65431970|NCT00276016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65431971|NCT00276016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431972|NCT00276016|Sympathomimetics|sympathomimetics|mesh-ancestor
65431973|NCT00276016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65431974|NCT00276016|Nasal Decongestants|nasal decongestants|mesh-ancestor
65431975|NCT00276016|Respiratory System Agents|respiratory system agents|mesh-ancestor
65431976|NCT00276016|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65431977|NCT00276016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65431978|NCT00276016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65431979|NCT00276016|Adrenergic Agents|adrenergic agents|mesh-ancestor
65431980|NCT00276016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65431981|NCT00276016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431982|NCT00276016|Protective Agents|protective agents|mesh-ancestor
65431983|NCT00276016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65431984|NCT00276016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65431985|NCT00276016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65431986|NCT00434642|Gemcitabine|gemcitabine|mesh-list
65431987|NCT00434642|Bevacizumab|bevacizumab|mesh-list
65431988|NCT00434642|Carboplatin|carboplatin|mesh-list
65431989|NCT00434642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65431990|NCT00434642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431991|NCT00434642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64816759|NCT01492153|Insulin|insulin|mesh-list
65431996|NCT00434642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65431998|NCT00434642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431999|NCT00434642|Antiviral Agents|antiviral agents|mesh-ancestor
65432000|NCT00434642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65432001|NCT00434642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432002|NCT00434642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65432003|NCT00434642|Immunologic Factors|immunologic factors|mesh-ancestor
65432005|NCT01032434|Antidepressive Agents|antidepressive agents|mesh-ancestor
65432006|NCT01032434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65432007|NCT01032434|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65432008|NCT01032434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65432009|NCT01032434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65432010|NCT01032434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432011|NCT01032434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65432012|NCT01032434|Serotonin Agents|serotonin agents|mesh-ancestor
65432013|NCT01032434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432014|NCT00426764|Romidepsin|romidepsin|mesh-list
65432015|NCT00426764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65432016|NCT00426764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432017|NCT01032668|Clopidogrel|clopidogrel|mesh-list
65432018|NCT01032668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65432019|NCT01032668|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65432020|NCT01032668|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65432021|NCT01032668|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65432022|NCT01032668|Purinergic Agents|purinergic agents|mesh-ancestor
65432023|NCT01032668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65432024|NCT01032668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432025|NCT01032668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432026|NCT00434252|Paclitaxel|paclitaxel|mesh-list
65432027|NCT00434252|Bevacizumab|bevacizumab|mesh-list
65432028|NCT00434252|Carboplatin|carboplatin|mesh-list
65432029|NCT00434252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65432030|NCT00434252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432031|NCT00434252|Tubulin Modulators|tubulin modulators|mesh-ancestor
65432032|NCT00434252|Antimitotic Agents|antimitotic agents|mesh-ancestor
65432033|NCT00434252|Mitosis Modulators|mitosis modulators|mesh-ancestor
65432034|NCT00434252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432035|NCT00434252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65432036|NCT00434252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65432037|NCT00434252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65432038|NCT00434252|Growth Substances|growth substances|mesh-ancestor
65432039|NCT00434252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432040|NCT00434252|Growth Inhibitors|growth inhibitors|mesh-ancestor
65432041|NCT00425750|Docetaxel|docetaxel|mesh-list
65432042|NCT00425750|Bortezomib|bortezomib|mesh-list
65432043|NCT00425750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432044|NCT00425750|Tubulin Modulators|tubulin modulators|mesh-ancestor
65432045|NCT00425750|Antimitotic Agents|antimitotic agents|mesh-ancestor
65432046|NCT00425750|Mitosis Modulators|mitosis modulators|mesh-ancestor
65432047|NCT00425750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432048|NCT00414908|Pancrelipase|pancrelipase|mesh-list
65432049|NCT00414908|Pancreatin|pancreatin|mesh-list
65432050|NCT00414908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65432051|NCT00242710|Bazedoxifene|bazedoxifene|mesh-list
65432052|NCT00242710|Estrogens|estrogens|mesh-list
65432053|NCT00242710|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65432054|NCT00242710|Hormones|hormones|mesh-ancestor
65432055|NCT00242710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65432056|NCT00242710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432057|NCT00242710|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65432058|NCT00242710|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65432059|NCT00242710|Hormone Antagonists|hormone antagonists|mesh-ancestor
65432060|NCT00242710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64557467|NCT02943057|Ganciclovir|ganciclovir|mesh-list
65432064|NCT00408876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65432065|NCT00408876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432066|NCT00408876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65432067|NCT00408876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432068|NCT00408876|Analgesics|analgesics|mesh-ancestor
65432069|NCT00408876|Sensory System Agents|sensory system agents|mesh-ancestor
65432070|NCT00408876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65432071|NCT00408876|Antidepressive Agents|antidepressive agents|mesh-ancestor
65432072|NCT00408876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65432073|NCT00408876|Dopamine Agents|dopamine agents|mesh-ancestor
65432074|NCT00240994|Mycophenolic Acid|mycophenolic acid|mesh-list
65432075|NCT00240994|Sirolimus|sirolimus|mesh-list
65432076|NCT00240994|Alemtuzumab|alemtuzumab|mesh-list
65432077|NCT00240994|Tacrolimus|tacrolimus|mesh-list
65432078|NCT00240994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65432079|NCT00240994|Immunologic Factors|immunologic factors|mesh-ancestor
65432080|NCT00240994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432081|NCT00240994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65432082|NCT00240994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432083|NCT00240994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432084|NCT00240994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65432085|NCT00240994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432086|NCT00240994|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65432087|NCT00240994|Antitubercular Agents|antitubercular agents|mesh-ancestor
65432088|NCT00240994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65432089|NCT00240994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65432090|NCT00240994|Antifungal Agents|antifungal agents|mesh-ancestor
65432091|NCT00240994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65432092|NCT01070836|Natalizumab|natalizumab|mesh-list
65432093|NCT01070836|Immunologic Factors|immunologic factors|mesh-ancestor
65432094|NCT01070836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432095|NCT00239590|Methyltestosterone|methyltestosterone|mesh-list
65432096|NCT00239590|Testosterone|testosterone|mesh-list
65432097|NCT00239590|Testosterone undecanoate|testosterone undecanoate|mesh-list
65432098|NCT00239590|Testosterone enanthate|testosterone enanthate|mesh-list
65432099|NCT00239590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65432100|NCT00239590|Androgens|androgens|mesh-ancestor
65432101|NCT00239590|Hormones|hormones|mesh-ancestor
65432102|NCT00239590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65432103|NCT00239590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432104|NCT00239590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65432105|NCT00239590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432106|NCT00239590|Anabolic Agents|anabolic agents|mesh-ancestor
65432107|NCT00433160|Teriparatide|teriparatide|mesh-list
65432108|NCT00433160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65432109|NCT00433160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432110|NCT00433160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65432111|NCT00239356|Aripiprazole|aripiprazole|mesh-list
65432112|NCT00239356|Antidepressive Agents|antidepressive agents|mesh-ancestor
65432113|NCT00239356|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65432114|NCT00239356|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65432115|NCT00239356|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65432116|NCT00239356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65432117|NCT00239356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432118|NCT00239356|Dopamine Agonists|dopamine agonists|mesh-ancestor
65432119|NCT00239356|Dopamine Agents|dopamine agents|mesh-ancestor
65432120|NCT00239356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65432121|NCT00239356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432122|NCT00239356|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65432123|NCT00239356|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65432124|NCT00239356|Serotonin Agents|serotonin agents|mesh-ancestor
65432125|NCT00239356|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65432126|NCT00239356|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65432127|NCT00239356|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65432128|NCT00239356|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65432129|NCT00425438|Mycophenolic Acid|mycophenolic acid|mesh-list
65432130|NCT00425438|Prednisolone|prednisolone|mesh-list
65432147|NCT00425438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432148|NCT00425438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65432149|NCT00425438|Glucocorticoids|glucocorticoids|mesh-ancestor
65432151|NCT00425438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65432152|NCT00425438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65432153|NCT00425438|Antimetabolites|antimetabolites|mesh-ancestor
65432154|NCT00425438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65432155|NCT01041066|Labetalol|labetalol|mesh-list
65432156|NCT01041066|Nicardipine|nicardipine|mesh-list
65432157|NCT01041066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65432158|NCT01041066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65432159|NCT01041066|Adrenergic Agents|adrenergic agents|mesh-ancestor
65432160|NCT01041066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65432161|NCT01041066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432162|NCT01041066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432163|NCT01041066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65432164|NCT01041066|Sympathomimetics|sympathomimetics|mesh-ancestor
65432165|NCT01041066|Autonomic Agents|autonomic agents|mesh-ancestor
65432166|NCT01041066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65432167|NCT01041066|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65432168|NCT01041066|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65432169|NCT01041066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65432170|NCT01041066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65432171|NCT01041066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65432172|NCT01041066|Vasodilator Agents|vasodilator agents|mesh-ancestor
65432173|NCT01323608|Vitamin D|vitamin d|mesh-list
65432174|NCT01323608|Cholecalciferol|cholecalciferol|mesh-list
65432175|NCT01323608|Vitamins|vitamins|mesh-ancestor
65432176|NCT01323608|Micronutrients|micronutrients|mesh-ancestor
65432177|NCT01323608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432178|NCT01323608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65432179|NCT01323608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65432180|NCT00275002|Temozolomide|temozolomide|mesh-list
65432181|NCT00275002|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
65432182|NCT00275002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65432183|NCT00275002|Alkylating Agents|alkylating agents|mesh-ancestor
65432184|NCT00275002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432185|NCT00275002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432186|NCT00275002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270035|NCT02726126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65432187|NCT00433004|Levonorgestrel|levonorgestrel|mesh-list
65432203|NCT00393042|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
65432204|NCT00393042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65432205|NCT00393042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432206|NCT00393042|Sympathomimetics|sympathomimetics|mesh-ancestor
65432207|NCT00393042|Autonomic Agents|autonomic agents|mesh-ancestor
65432208|NCT00393042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65432209|NCT00393042|Dopamine Agents|dopamine agents|mesh-ancestor
65432210|NCT00393042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65432211|NCT00393042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432212|NCT00393042|Adrenergic Agents|adrenergic agents|mesh-ancestor
65432213|NCT00393042|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65432214|NCT00393042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65432215|NCT00393042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65432216|NCT00393042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65432217|NCT01040286|Chlorhexidine|chlorhexidine|mesh-list
65432218|NCT01040286|Flurbiprofen|flurbiprofen|mesh-list
65432219|NCT01040286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65432220|NCT01040286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65432221|NCT01040286|Disinfectants|disinfectants|mesh-ancestor
65432222|NCT01040286|Analgesics|analgesics|mesh-ancestor
65432223|NCT01040286|Sensory System Agents|sensory system agents|mesh-ancestor
65432224|NCT01040286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65432225|NCT01040286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432226|NCT01040286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65432227|NCT01040286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65432228|NCT01040286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65432229|NCT01040286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65432230|NCT01040286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65432231|NCT01040286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432232|NCT01040286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432233|NCT01041378|Dexamethasone|dexamethasone|mesh-list
65432234|NCT01041378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65432235|NCT01041378|Antiemetics|antiemetics|mesh-ancestor
65432236|NCT01041378|Autonomic Agents|autonomic agents|mesh-ancestor
65432237|NCT01041378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65432238|NCT01041378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432239|NCT01041378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65432240|NCT01041378|Glucocorticoids|glucocorticoids|mesh-ancestor
65432242|NCT01041378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65432243|NCT01041378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65432244|NCT01041378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432245|NCT03546192|Vaccines|vaccines|mesh-list
65432246|NCT03546192|Immunologic Factors|immunologic factors|mesh-ancestor
65432269|NCT00274924|Vincristine|vincristine|mesh-list
65432270|NCT00274924|Podophyllotoxin|podophyllotoxin|mesh-list
65432271|NCT00274924|Lenograstim|lenograstim|mesh-list
65432272|NCT00274924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65432273|NCT00274924|Immunologic Factors|immunologic factors|mesh-ancestor
65432274|NCT00274924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432275|NCT00274924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65432276|NCT00274924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65432277|NCT00274924|Alkylating Agents|alkylating agents|mesh-ancestor
65432278|NCT00274924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432279|NCT00274924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432280|NCT00274924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65432281|NCT00274924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65432282|NCT00274924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65432283|NCT00274924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65432284|NCT00274924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65432285|NCT00274924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432286|NCT00274924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65432287|NCT00274924|Glucocorticoids|glucocorticoids|mesh-ancestor
65432288|NCT00274924|Hormones|hormones|mesh-ancestor
65432289|NCT00274924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65432290|NCT00274924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65432291|NCT00274924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65432292|NCT00274924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65432293|NCT00274924|Tubulin Modulators|tubulin modulators|mesh-ancestor
65432294|NCT00274924|Antimitotic Agents|antimitotic agents|mesh-ancestor
65432295|NCT00274924|Mitosis Modulators|mitosis modulators|mesh-ancestor
65181818|NCT02804386|Sofosbuvir|sofosbuvir|mesh-list
65270036|NCT02726126|Anesthetics, General|anesthetics, general|mesh-ancestor
65432296|NCT00274924|Keratolytic Agents|keratolytic agents|mesh-ancestor
65432297|NCT00274924|Dermatologic Agents|dermatologic agents|mesh-ancestor
65432298|NCT00274846|Aldesleukin|aldesleukin|mesh-list
65432299|NCT00274846|Cyclophosphamide|cyclophosphamide|mesh-list
65432300|NCT00274846|Fludarabine|fludarabine|mesh-list
65432301|NCT00274846|Fludarabine phosphate|fludarabine phosphate|mesh-list
65432302|NCT00274846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65432303|NCT00274846|Immunologic Factors|immunologic factors|mesh-ancestor
65432312|NCT00274846|Antimetabolites|antimetabolites|mesh-ancestor
65432313|NCT00274846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65432314|NCT00274846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65432315|NCT00274846|Antiviral Agents|antiviral agents|mesh-ancestor
65432316|NCT00274846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65432317|NCT01072786|Vaccines|vaccines|mesh-list
65432318|NCT01072786|Immunologic Factors|immunologic factors|mesh-ancestor
65432319|NCT01072786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432320|NCT03970798|Midazolam|midazolam|mesh-list
65432321|NCT03970798|Caffeine|caffeine|mesh-list
65432322|NCT03970798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65432323|NCT03970798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65432324|NCT03970798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65432325|NCT03970798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65432326|NCT03970798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432327|NCT03970798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65432328|NCT03970798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65432329|NCT03970798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65432330|NCT03970798|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65432331|NCT03970798|Anesthetics, General|anesthetics, general|mesh-ancestor
65432332|NCT03970798|Anesthetics|anesthetics|mesh-ancestor
65432333|NCT03970798|GABA Modulators|gaba modulators|mesh-ancestor
65432334|NCT03970798|GABA Agents|gaba agents|mesh-ancestor
65432335|NCT03970798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65432336|NCT03970798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432337|NCT03970798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65432338|NCT03970798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65432339|NCT03970798|Antimetabolites|antimetabolites|mesh-ancestor
65432340|NCT03970798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65432341|NCT03970798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65432342|NCT03970798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432343|NCT03970798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65432344|NCT03970798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65432345|NCT03970798|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65432346|NCT03970798|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65432347|NCT03970798|Purinergic Agents|purinergic agents|mesh-ancestor
65432348|NCT00414440|Everolimus|everolimus|mesh-list
65432349|NCT00414440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432350|NCT00414440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65432351|NCT00414440|Immunologic Factors|immunologic factors|mesh-ancestor
65432352|NCT00414440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432353|NCT00209560|Fospropofol|fospropofol|mesh-list
65432354|NCT00209560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65432355|NCT00209560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65432356|NCT00209560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432357|NCT01073800|Atorvastatin|atorvastatin|mesh-list
65432358|NCT01073800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65432359|NCT01073800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65432360|NCT01073800|Antimetabolites|antimetabolites|mesh-ancestor
65432361|NCT01073800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432362|NCT01073800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65432363|NCT01073800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65432364|NCT01073800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432365|NCT01037660|Metformin|metformin|mesh-list
65432366|NCT01037660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65432367|NCT01037660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432368|NCT00236080|Modafinil|modafinil|mesh-list
65432369|NCT00236080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65432374|NCT00236080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432375|NCT01033058|Atorvastatin|atorvastatin|mesh-list
65432376|NCT01033058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65432377|NCT01033058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65432378|NCT01033058|Antimetabolites|antimetabolites|mesh-ancestor
65432379|NCT01033058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432380|NCT01033058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65432381|NCT01033058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65432382|NCT01033058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432383|NCT03973138|Ranibizumab|ranibizumab|mesh-list
65432384|NCT03973138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65432385|NCT03973138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65432386|NCT03973138|Growth Substances|growth substances|mesh-ancestor
65432387|NCT03973138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432388|NCT03973138|Growth Inhibitors|growth inhibitors|mesh-ancestor
65432389|NCT03973138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432390|NCT01072942|Ciprofloxacin|ciprofloxacin|mesh-list
65432391|NCT01072942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65432392|NCT01072942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65432393|NCT01072942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65432394|NCT01072942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65432395|NCT01072942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432396|NCT01072942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432397|NCT01072942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432398|NCT01072942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65432399|NCT01072942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65432400|NCT00234052|Bevacizumab|bevacizumab|mesh-list
65432401|NCT00234052|Carboplatin|carboplatin|mesh-list
65432402|NCT00234052|Pemetrexed|pemetrexed|mesh-list
65432403|NCT00234052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65432404|NCT00234052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432405|NCT00234052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65432406|NCT00234052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65432407|NCT00234052|Growth Substances|growth substances|mesh-ancestor
65432408|NCT00234052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432409|NCT00234052|Growth Inhibitors|growth inhibitors|mesh-ancestor
65432410|NCT00234052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432411|NCT00234052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432412|NCT00234052|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65432413|NCT00234052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65432414|NCT00408408|Gemcitabine|gemcitabine|mesh-list
65432415|NCT00408408|Cyclophosphamide|cyclophosphamide|mesh-list
65432416|NCT00408408|Bevacizumab|bevacizumab|mesh-list
65432417|NCT00408408|Docetaxel|docetaxel|mesh-list
65432418|NCT00408408|Doxorubicin|doxorubicin|mesh-list
65432419|NCT00408408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65432420|NCT00408408|Capecitabine|capecitabine|mesh-list
65432421|NCT00408408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65432422|NCT00408408|Immunologic Factors|immunologic factors|mesh-ancestor
65432423|NCT00408408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432424|NCT00408408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65432425|NCT00408408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65432426|NCT00408408|Alkylating Agents|alkylating agents|mesh-ancestor
65432427|NCT00408408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432428|NCT00408408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432429|NCT00408408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65432430|NCT00408408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65432431|NCT00408408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65432432|NCT00408408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65432433|NCT00408408|Growth Substances|growth substances|mesh-ancestor
65432434|NCT00408408|Growth Inhibitors|growth inhibitors|mesh-ancestor
65432435|NCT00408408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65432436|NCT00408408|Antimetabolites|antimetabolites|mesh-ancestor
65432437|NCT00408408|Antiviral Agents|antiviral agents|mesh-ancestor
65432438|NCT00408408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65432451|NCT03973840|Testosterone undecanoate|testosterone undecanoate|mesh-list
65432452|NCT03973840|Testosterone enanthate|testosterone enanthate|mesh-list
65432453|NCT03973840|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65432455|NCT03973840|Hormones|hormones|mesh-ancestor
65432456|NCT03973840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65432457|NCT03973840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432458|NCT03973840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65432459|NCT03973840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432460|NCT03973840|Anabolic Agents|anabolic agents|mesh-ancestor
65432461|NCT01370330|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65432462|NCT01370330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432463|NCT01370330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432464|NCT01370330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432465|NCT01370330|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65432466|NCT00413972|Simvastatin|simvastatin|mesh-list
65432467|NCT00413972|Ezetimibe|ezetimibe|mesh-list
65432468|NCT00413972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65432469|NCT00413972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65000456|NCT00444223|Fluorides|fluorides|mesh-list
65432470|NCT00413972|Antimetabolites|antimetabolites|mesh-ancestor
65432471|NCT00413972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432472|NCT00413972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65432473|NCT00413972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65432474|NCT00413972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432475|NCT00259012|Pantoprazole|pantoprazole|mesh-list
65432476|NCT00259012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65432477|NCT00259012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65432478|NCT00259012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65432479|NCT00259012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432480|NCT00259012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432481|NCT01044186|Deferasirox|deferasirox|mesh-list
65432482|NCT01044186|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65432483|NCT01044186|Chelating Agents|chelating agents|mesh-ancestor
65432484|NCT01044186|Sequestering Agents|sequestering agents|mesh-ancestor
65432485|NCT01044186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432486|NCT00209170|Citalopram|citalopram|mesh-list
65432487|NCT00209170|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65432488|NCT00209170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65432489|NCT00209170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65432490|NCT00209170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432491|NCT00209170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65432492|NCT00209170|Serotonin Agents|serotonin agents|mesh-ancestor
65432493|NCT00209170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432494|NCT00209170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65432495|NCT00209170|Antidepressive Agents|antidepressive agents|mesh-ancestor
65432496|NCT00209170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65432497|NCT01071694|Interferons|interferons|mesh-list
65432498|NCT01071694|Interferon-beta|interferon-beta|mesh-list
65432499|NCT01071694|Interferon beta-1b|interferon beta-1b|mesh-list
65432534|NCT00407550|Gemcitabine|gemcitabine|mesh-list
65432535|NCT00407550|Pemetrexed|pemetrexed|mesh-list
65432536|NCT00407550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65432537|NCT00407550|Antimetabolites|antimetabolites|mesh-ancestor
65432545|NCT00407550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432546|NCT00407550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65432547|NCT00407550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65432548|NCT00209092|Docetaxel|docetaxel|mesh-list
65432549|NCT00209092|Capecitabine|capecitabine|mesh-list
65432550|NCT00209092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432551|NCT00209092|Tubulin Modulators|tubulin modulators|mesh-ancestor
65432552|NCT00209092|Antimitotic Agents|antimitotic agents|mesh-ancestor
65432553|NCT00209092|Mitosis Modulators|mitosis modulators|mesh-ancestor
65432554|NCT00209092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432555|NCT00209092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65432556|NCT00209092|Antimetabolites|antimetabolites|mesh-ancestor
65432557|NCT03972982|Insulin|insulin|mesh-list
65432558|NCT03972982|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65432559|NCT03972982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65432560|NCT03972982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432561|NCT00403494|Verapamil|verapamil|mesh-list
65432562|NCT00403494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65432563|NCT00403494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65432564|NCT00403494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65432565|NCT00403494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432566|NCT00403494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65432567|NCT00403494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432568|NCT00403494|Vasodilator Agents|vasodilator agents|mesh-ancestor
65432569|NCT00403260|Artesunate|artesunate|mesh-list
65432570|NCT00403260|Mefloquine|mefloquine|mesh-list
65432571|NCT00403260|Pyronaridine|pyronaridine|mesh-list
65432572|NCT00403260|Antimalarials|antimalarials|mesh-ancestor
65432573|NCT00403260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65432574|NCT00403260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65432575|NCT00403260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65432576|NCT00403260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432577|NCT00403260|Antiviral Agents|antiviral agents|mesh-ancestor
65432578|NCT00403260|Schistosomicides|schistosomicides|mesh-ancestor
65432579|NCT00403260|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65432580|NCT00403260|Anthelmintics|anthelmintics|mesh-ancestor
65432581|NCT00406848|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65432582|NCT00406848|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65432583|NCT00406848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65432584|NCT00406848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65432585|NCT00406848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432586|NCT00406848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65432587|NCT00406848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432588|NCT00406848|Analgesics|analgesics|mesh-ancestor
65432589|NCT00406848|Sensory System Agents|sensory system agents|mesh-ancestor
65432590|NCT00406848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65432591|NCT00406848|Antidepressive Agents|antidepressive agents|mesh-ancestor
65432592|NCT00406848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65432593|NCT00406848|Dopamine Agents|dopamine agents|mesh-ancestor
65432594|NCT00406692|Zonisamide|zonisamide|mesh-list
65432595|NCT00406692|Anticonvulsants|anticonvulsants|mesh-ancestor
65432596|NCT00406692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65432597|NCT00406692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65432598|NCT00406692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432599|NCT00406692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65432600|NCT00406692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432601|NCT00004494|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
65432602|NCT00004494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65432603|NCT00004494|Vasodilator Agents|vasodilator agents|mesh-ancestor
65432604|NCT00004494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65432617|NCT00315705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432618|NCT00315705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65432619|NCT00315705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65432620|NCT00315705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65432621|NCT00315705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65432622|NCT00315705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432623|NCT00315705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65432624|NCT00315705|Antimetabolites|antimetabolites|mesh-ancestor
65432625|NCT03982173|Durvalumab|durvalumab|mesh-list
65432626|NCT03982173|Tremelimumab|tremelimumab|mesh-list
65432627|NCT03982173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65432628|NCT03982173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432629|NCT01062633|Erythritol|erythritol|mesh-list
65432630|NCT01062633|Sorbitol|sorbitol|mesh-list
65432631|NCT01062633|Vasodilator Agents|vasodilator agents|mesh-ancestor
65432632|NCT01062633|Cathartics|cathartics|mesh-ancestor
65432633|NCT01062633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65432634|NCT00307125|Rituximab|rituximab|mesh-list
65432635|NCT00307125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65432636|NCT00307125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432637|NCT00307125|Immunologic Factors|immunologic factors|mesh-ancestor
65432638|NCT00307125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432639|NCT00307125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65432640|NCT01066299|Oxytocin|oxytocin|mesh-list
65432641|NCT01066299|Oxytocics|oxytocics|mesh-ancestor
65432642|NCT01066299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65432643|NCT01066299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432644|NCT00307047|Paclitaxel|paclitaxel|mesh-list
65432645|NCT00307047|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65432646|NCT00307047|Everolimus|everolimus|mesh-list
65432647|NCT00307047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65432648|NCT00307047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432649|NCT00307047|Tubulin Modulators|tubulin modulators|mesh-ancestor
65432650|NCT00307047|Antimitotic Agents|antimitotic agents|mesh-ancestor
65432651|NCT00307047|Mitosis Modulators|mitosis modulators|mesh-ancestor
65432652|NCT00307047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432653|NCT00307047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65432654|NCT00307047|Immunologic Factors|immunologic factors|mesh-ancestor
65432655|NCT00307047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432656|NCT01066377|Sulfalene|sulfalene|mesh-list
65432657|NCT01066377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65432658|NCT01066377|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65432659|NCT01066377|Renal Agents|renal agents|mesh-ancestor
65432660|NCT01066377|Antimalarials|antimalarials|mesh-ancestor
65432661|NCT01066377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65432662|NCT01066377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65432663|NCT00306891|Cediranib|cediranib|mesh-list
65432664|NCT00306891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432665|NCT00306891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65432666|NCT00306891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432667|NCT00306891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432668|NCT03980847|Alendronate|alendronate|mesh-list
65432669|NCT03980847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65432678|NCT00391872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65432679|NCT00391872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432680|NCT00391872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432681|NCT00391170|Dexamethasone|dexamethasone|mesh-list
65432682|NCT00391170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65432683|NCT00391170|Antiemetics|antiemetics|mesh-ancestor
65432684|NCT00391170|Autonomic Agents|autonomic agents|mesh-ancestor
65432685|NCT00391170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65432686|NCT00391170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432687|NCT00391170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65432688|NCT00391170|Glucocorticoids|glucocorticoids|mesh-ancestor
65432689|NCT00391170|Hormones|hormones|mesh-ancestor
65432690|NCT00391170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65432691|NCT00391170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65432692|NCT00391170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432693|NCT00402324|Valproic Acid|valproic acid|mesh-list
65432694|NCT00402324|Olanzapine|olanzapine|mesh-list
65432695|NCT00402324|Antiemetics|antiemetics|mesh-ancestor
65432696|NCT00402324|Autonomic Agents|autonomic agents|mesh-ancestor
65432697|NCT00402324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65432698|NCT00402324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432699|NCT00402324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65432700|NCT00402324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65432701|NCT00402324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65432702|NCT00402324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65432703|NCT00402324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65432704|NCT00402324|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65432705|NCT00402324|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65432706|NCT00402324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65432707|NCT00402324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432708|NCT00402324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65432709|NCT00402324|Serotonin Agents|serotonin agents|mesh-ancestor
65432710|NCT00402324|Anticonvulsants|anticonvulsants|mesh-ancestor
65432711|NCT00402324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432712|NCT00402324|GABA Agents|gaba agents|mesh-ancestor
65432713|NCT00402324|Antimanic Agents|antimanic agents|mesh-ancestor
65432714|NCT00294723|Liraglutide|liraglutide|mesh-list
65432715|NCT00294723|Glimepiride|glimepiride|mesh-list
65432716|NCT00294723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65432717|NCT00294723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432718|NCT00294723|Incretins|incretins|mesh-ancestor
65432719|NCT00294723|Hormones|hormones|mesh-ancestor
65432720|NCT00294723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65432721|NCT00294723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65432722|NCT00294723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65432723|NCT00294723|Immunologic Factors|immunologic factors|mesh-ancestor
65432724|NCT00375492|Exenatide|exenatide|mesh-list
65432725|NCT00375492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65432726|NCT00375492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432727|NCT00375492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65432728|NCT00375492|Incretins|incretins|mesh-ancestor
65432729|NCT00375492|Hormones|hormones|mesh-ancestor
65432730|NCT00375492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65432731|NCT00306189|Denosumab|denosumab|mesh-list
65432732|NCT00306189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65432733|NCT00306189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432734|NCT00305877|Gemcitabine|gemcitabine|mesh-list
65432735|NCT00305877|Bevacizumab|bevacizumab|mesh-list
65432746|NCT00305877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432747|NCT00305877|Growth Inhibitors|growth inhibitors|mesh-ancestor
65432748|NCT00305877|Immunologic Factors|immunologic factors|mesh-ancestor
65432749|NCT00305877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65432750|NCT00305877|Antimetabolites|antimetabolites|mesh-ancestor
65432751|NCT00305877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432752|NCT00305877|Antiviral Agents|antiviral agents|mesh-ancestor
65432753|NCT00305877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65432754|NCT00305877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432755|NCT00305877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65432756|NCT00312195|Buprenorphine|buprenorphine|mesh-list
65432757|NCT00312195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65432758|NCT00312195|Narcotics|narcotics|mesh-ancestor
65432759|NCT00312195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65432760|NCT00312195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432761|NCT00312195|Analgesics|analgesics|mesh-ancestor
65432762|NCT00312195|Sensory System Agents|sensory system agents|mesh-ancestor
65432763|NCT00312195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65432764|NCT00312195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65432765|NCT02532777|Mycophenolic Acid|mycophenolic acid|mesh-list
65432767|NCT02532777|Methylprednisolone|methylprednisolone|mesh-list
65432768|NCT02532777|Cyclophosphamide|cyclophosphamide|mesh-list
65432769|NCT02532777|Leflunomide|leflunomide|mesh-list
65432770|NCT02532777|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65432771|NCT02532777|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65432772|NCT02532777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65432773|NCT02532777|Immunologic Factors|immunologic factors|mesh-ancestor
65432774|NCT02532777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432775|NCT02532777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65432776|NCT02532777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65432777|NCT02532777|Alkylating Agents|alkylating agents|mesh-ancestor
65432778|NCT02532777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432779|NCT02532777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432780|NCT02532777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65432781|NCT02532777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65432782|NCT02532777|Glucocorticoids|glucocorticoids|mesh-ancestor
65432783|NCT02532777|Hormones|hormones|mesh-ancestor
65432784|NCT02532777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65432785|NCT02532777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65432786|NCT02532777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65432787|NCT02532777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65432788|NCT02532777|Antitubercular Agents|antitubercular agents|mesh-ancestor
65432789|NCT02532777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65432790|NCT02532777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65432791|NCT02532777|Antiemetics|antiemetics|mesh-ancestor
65432792|NCT02532777|Autonomic Agents|autonomic agents|mesh-ancestor
65432793|NCT02532777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65432794|NCT02532777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65432795|NCT02532777|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65432796|NCT02532777|Protective Agents|protective agents|mesh-ancestor
65432797|NCT02532777|Protease Inhibitors|protease inhibitors|mesh-ancestor
65432798|NCT01062945|Doxazosin|doxazosin|mesh-list
65432799|NCT01062945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65432800|NCT01062945|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65432801|NCT01062945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65432820|NCT01063023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65432821|NCT01063023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65432822|NCT01063023|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65432823|NCT01063023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65432824|NCT01063023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432826|NCT01063101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65432827|NCT01063101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65432828|NCT01063101|Anticoagulants|anticoagulants|mesh-ancestor
65432829|NCT01063101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432830|NCT01066689|Rituximab|rituximab|mesh-list
65432831|NCT01066689|Citric Acid|citric acid|mesh-list
65432832|NCT01066689|Sodium Citrate|sodium citrate|mesh-list
65432833|NCT01066689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65432834|NCT01066689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432835|NCT01066689|Immunologic Factors|immunologic factors|mesh-ancestor
65432836|NCT01066689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432837|NCT01066689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65432838|NCT01066689|Anticoagulants|anticoagulants|mesh-ancestor
65432839|NCT01066689|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65432840|NCT01066689|Chelating Agents|chelating agents|mesh-ancestor
65432841|NCT01066689|Sequestering Agents|sequestering agents|mesh-ancestor
65432842|NCT01066689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432843|NCT01063179|Thalidomide|thalidomide|mesh-list
65432844|NCT01063179|Prednisone|prednisone|mesh-list
65432845|NCT01063179|Bortezomib|bortezomib|mesh-list
65432846|NCT01063179|Melphalan|melphalan|mesh-list
65432847|NCT01063179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65432848|NCT01063179|Glucocorticoids|glucocorticoids|mesh-ancestor
65432849|NCT01063179|Hormones|hormones|mesh-ancestor
65432850|NCT01063179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65432851|NCT01063179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432852|NCT01063179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65432853|NCT01063179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432854|NCT01063179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65432855|NCT01063179|Alkylating Agents|alkylating agents|mesh-ancestor
64817573|NCT01497002|Cytarabine|cytarabine|mesh-list
65432879|NCT01063257|Clofarabine|clofarabine|mesh-list
65432880|NCT01063257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65432881|NCT01063257|Antimetabolites|antimetabolites|mesh-ancestor
65432882|NCT01063257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432883|NCT01063257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432884|NCT03977649|Erenumab|erenumab|mesh-list
65432885|NCT03977649|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65432886|NCT03977649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432887|NCT03977649|Analgesics|analgesics|mesh-ancestor
65432888|NCT03977649|Sensory System Agents|sensory system agents|mesh-ancestor
65432889|NCT03977649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65432890|NCT03977649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432891|NCT01066767|Fexofenadine|fexofenadine|mesh-list
65432892|NCT01066767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65432893|NCT01066767|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65432894|NCT01066767|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65432896|NCT01066767|Histamine Agents|histamine agents|mesh-ancestor
65432897|NCT01066767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65432898|NCT01066767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432899|NCT01066767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432900|NCT03980379|Rituximab|rituximab|mesh-list
65432901|NCT03980379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65432902|NCT03980379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432903|NCT03980379|Immunologic Factors|immunologic factors|mesh-ancestor
65432904|NCT03980379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432905|NCT03980379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65432906|NCT01064271|Risperidone|risperidone|mesh-list
65432916|NCT01064271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65432917|NCT01064271|Dopamine Agents|dopamine agents|mesh-ancestor
65432918|NCT01066845|Tadalafil|tadalafil|mesh-list
65432919|NCT01066845|Vasodilator Agents|vasodilator agents|mesh-ancestor
65432920|NCT01066845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65432921|NCT01066845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65432922|NCT01066845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432923|NCT01066845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432924|NCT01066845|Urological Agents|urological agents|mesh-ancestor
65432925|NCT01064349|Trastuzumab|trastuzumab|mesh-list
65432926|NCT01064349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65432927|NCT01064349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432928|NCT00293397|Doxorubicin|doxorubicin|mesh-list
65432929|NCT00293397|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65432930|NCT00293397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65432931|NCT00293397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432932|NCT00293397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65432933|NCT00293397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65432934|NCT00293397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432935|NCT00293397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432936|NCT03981627|Insulin Aspart|insulin aspart|mesh-list
65432937|NCT03981627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65432938|NCT03981627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432939|NCT01069263|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
65432940|NCT01069263|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65432941|NCT01069263|Protective Agents|protective agents|mesh-ancestor
65432942|NCT01069263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432943|NCT01069263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65432944|NCT01069263|Antioxidants|antioxidants|mesh-ancestor
65432945|NCT01069263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432946|NCT01067235|Modafinil|modafinil|mesh-list
65432947|NCT01067235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65432948|NCT01067235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432949|NCT01067235|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65432950|NCT01067235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65432951|NCT01067235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65432952|NCT01067235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432953|NCT00290745|Tamoxifen|tamoxifen|mesh-list
65432954|NCT00290745|Letrozole|letrozole|mesh-list
65432955|NCT00290745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432956|NCT00290745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432957|NCT00290745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65432958|NCT00290745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65432959|NCT00290745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432960|NCT00290745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65432961|NCT00290745|Hormone Antagonists|hormone antagonists|mesh-ancestor
65432962|NCT00290745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65432963|NCT00290745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432964|NCT00290745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65432965|NCT00290745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65432966|NCT00290745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65432968|NCT03980223|Doxycycline|doxycycline|mesh-list
65432969|NCT03980223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65432970|NCT03980223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65432980|NCT01067391|Urological Agents|urological agents|mesh-ancestor
65432981|NCT00402168|Cyclosporine|cyclosporine|mesh-list
65432983|NCT00402168|Tacrolimus|tacrolimus|mesh-list
65432984|NCT00402168|Cyclosporins|cyclosporins|mesh-list
65432985|NCT00402168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65432986|NCT00402168|Immunologic Factors|immunologic factors|mesh-ancestor
65432987|NCT00402168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432988|NCT00402168|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65432989|NCT00402168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432990|NCT00402168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432991|NCT00402168|Antifungal Agents|antifungal agents|mesh-ancestor
65432992|NCT00402168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65432993|NCT00402168|Dermatologic Agents|dermatologic agents|mesh-ancestor
65432994|NCT00402168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65432995|NCT00402168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65432996|NCT00402168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432997|NCT00290589|Methylprednisolone|methylprednisolone|mesh-list
65432998|NCT00290589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65432999|NCT00290589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65433000|NCT00290589|Prednisolone|prednisolone|mesh-list
65433001|NCT00290589|Prednisolone acetate|prednisolone acetate|mesh-list
65433002|NCT00290589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65433003|NCT00290589|Prednisolone phosphate|prednisolone phosphate|mesh-list
65433004|NCT00290589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65433005|NCT00290589|Antiemetics|antiemetics|mesh-ancestor
65433006|NCT00290589|Autonomic Agents|autonomic agents|mesh-ancestor
65433007|NCT00290589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65433008|NCT00290589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433009|NCT00290589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65433010|NCT00290589|Glucocorticoids|glucocorticoids|mesh-ancestor
65433011|NCT00290589|Hormones|hormones|mesh-ancestor
65433012|NCT00290589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65433013|NCT00290589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65433014|NCT00290589|Protective Agents|protective agents|mesh-ancestor
65433015|NCT00290589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65433016|NCT00290589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433017|NCT01067547|Iron|iron|mesh-list
65433018|NCT01067547|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65433019|NCT01067547|Trace Elements|trace elements|mesh-ancestor
65433020|NCT01067547|Micronutrients|micronutrients|mesh-ancestor
65433021|NCT01067547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433022|NCT01067547|Hematinics|hematinics|mesh-ancestor
65433023|NCT00290511|Dexamethasone|dexamethasone|mesh-list
65433024|NCT00290511|Rituximab|rituximab|mesh-list
65433025|NCT00290511|Fludarabine|fludarabine|mesh-list
65433026|NCT00290511|Fludarabine phosphate|fludarabine phosphate|mesh-list
65433027|NCT00290511|Mitoxantrone|mitoxantrone|mesh-list
65433028|NCT00290511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65433029|NCT00290511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433030|NCT00290511|Immunologic Factors|immunologic factors|mesh-ancestor
65433031|NCT00290511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433032|NCT00290511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65433033|NCT00290511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65433034|NCT00290511|Antiemetics|antiemetics|mesh-ancestor
65433035|NCT00290511|Autonomic Agents|autonomic agents|mesh-ancestor
65433036|NCT00290511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65433037|NCT00290511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65433038|NCT00290511|Glucocorticoids|glucocorticoids|mesh-ancestor
65433039|NCT00290511|Hormones|hormones|mesh-ancestor
65433055|NCT00290433|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65433056|NCT00290433|Methotrexate|methotrexate|mesh-list
65433057|NCT00290433|Vincristine|vincristine|mesh-list
65433058|NCT00290433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65433059|NCT00290433|Immunologic Factors|immunologic factors|mesh-ancestor
65433060|NCT00290433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433061|NCT00290433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65433062|NCT00290433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65433063|NCT00290433|Alkylating Agents|alkylating agents|mesh-ancestor
65433064|NCT00290433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433065|NCT00290433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433066|NCT00290433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65433067|NCT00290433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65433068|NCT00290433|Antiemetics|antiemetics|mesh-ancestor
65433069|NCT00290433|Autonomic Agents|autonomic agents|mesh-ancestor
65433070|NCT00290433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65433071|NCT00290433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65433072|NCT00290433|Glucocorticoids|glucocorticoids|mesh-ancestor
65433073|NCT00290433|Hormones|hormones|mesh-ancestor
65433074|NCT00290433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65433075|NCT00290433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65433076|NCT00290433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65433077|NCT00290433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65433078|NCT00290433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65433079|NCT00290433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433080|NCT00290433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65433081|NCT00290433|Abortifacient Agents|abortifacient agents|mesh-ancestor
65433082|NCT00290433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65433083|NCT00290433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65433084|NCT00290433|Antimetabolites|antimetabolites|mesh-ancestor
65433085|NCT00290433|Dermatologic Agents|dermatologic agents|mesh-ancestor
65433086|NCT00290433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65433087|NCT00290433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65433088|NCT00290433|Antiviral Agents|antiviral agents|mesh-ancestor
65433089|NCT00290433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65433090|NCT00290433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65433091|NCT00290433|Tubulin Modulators|tubulin modulators|mesh-ancestor
65433092|NCT00290433|Antimitotic Agents|antimitotic agents|mesh-ancestor
65433093|NCT00290433|Mitosis Modulators|mitosis modulators|mesh-ancestor
65433094|NCT00304083|Doxorubicin|doxorubicin|mesh-list
65433095|NCT00304083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65433096|NCT00304083|Etoposide|etoposide|mesh-list
65433097|NCT00304083|Ifosfamide|ifosfamide|mesh-list
65433098|NCT00304083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64817806|NCT01498406|Vitamin D|vitamin d|mesh-list
65433107|NCT01069965|BGP 15|bgp 15|mesh-list
65433108|NCT01069965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433109|NCT01069965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433110|NCT00391092|Bevacizumab|bevacizumab|mesh-list
65433111|NCT00391092|Trastuzumab|trastuzumab|mesh-list
65433112|NCT00391092|Docetaxel|docetaxel|mesh-list
65433113|NCT00391092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65433114|NCT00391092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433115|NCT00391092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65433116|NCT00391092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65433117|NCT00391092|Growth Substances|growth substances|mesh-ancestor
65433118|NCT00391092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433119|NCT00391092|Growth Inhibitors|growth inhibitors|mesh-ancestor
65433120|NCT00391092|Tubulin Modulators|tubulin modulators|mesh-ancestor
65433121|NCT00391092|Antimitotic Agents|antimitotic agents|mesh-ancestor
65433122|NCT00391092|Mitosis Modulators|mitosis modulators|mesh-ancestor
65433123|NCT00391092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433124|NCT00374868|Pemetrexed|pemetrexed|mesh-list
65433125|NCT00374868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433126|NCT00374868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433127|NCT00374868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433128|NCT00374868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65433129|NCT00374868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65433130|NCT01044342|Donepezil|donepezil|mesh-list
65433131|NCT01044342|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65433132|NCT01044342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433133|NCT01044342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433134|NCT01044342|Cholinergic Agents|cholinergic agents|mesh-ancestor
65433135|NCT01044342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65433136|NCT01044342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433137|NCT01044342|Nootropic Agents|nootropic agents|mesh-ancestor
65433138|NCT00374556|Eszopiclone|eszopiclone|mesh-list
65433139|NCT00374556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65433140|NCT00374556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65433141|NCT00374556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433142|NCT01064973|Baclofen|baclofen|mesh-list
65433143|NCT01064973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65433144|NCT01064973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433145|NCT01064973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65433146|NCT01064973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65433147|NCT01064973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65433148|NCT01064973|GABA Agonists|gaba agonists|mesh-ancestor
65433149|NCT01064973|GABA Agents|gaba agents|mesh-ancestor
65433150|NCT01064973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65433151|NCT01064973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433152|NCT00374322|Lapatinib|lapatinib|mesh-list
65433153|NCT00374322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270037|NCT02726126|Anesthetics|anesthetics|mesh-ancestor
65433154|NCT00374322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65433155|NCT00374322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433156|NCT00374322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433157|NCT00303459|Bosentan|bosentan|mesh-list
65433158|NCT00303459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65433159|NCT00303459|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65433160|NCT00303459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433161|NCT00289887|Losartan|losartan|mesh-list
65433162|NCT00289887|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65433163|NCT00289887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65433171|NCT01068093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433173|NCT00401544|Dextrans|dextrans|mesh-list
65433174|NCT00401544|Darbepoetin alfa|darbepoetin alfa|mesh-list
65433175|NCT00401544|Iron-Dextran Complex|iron-dextran complex|mesh-list
65433176|NCT00401544|Hematinics|hematinics|mesh-ancestor
65433177|NCT00401544|Anticoagulants|anticoagulants|mesh-ancestor
65433178|NCT00401544|Plasma Substitutes|plasma substitutes|mesh-ancestor
65433179|NCT00401544|Blood Substitutes|blood substitutes|mesh-ancestor
65433180|NCT00292461|Lamotrigine|lamotrigine|mesh-list
65433181|NCT00292461|Zonisamide|zonisamide|mesh-list
65433182|NCT00292461|Anticonvulsants|anticonvulsants|mesh-ancestor
65433183|NCT00292461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65433184|NCT00292461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65433185|NCT00292461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433186|NCT00292461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65433187|NCT00292461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433188|NCT00292461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65433189|NCT00292461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65433190|NCT00292461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65433191|NCT00292461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65433192|NCT00292461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65433193|NCT00288639|Pregabalin|pregabalin|mesh-list
65433194|NCT00288639|Analgesics|analgesics|mesh-ancestor
65433195|NCT00288639|Sensory System Agents|sensory system agents|mesh-ancestor
65433196|NCT00288639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65433197|NCT00288639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433199|NCT00288639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65433200|NCT00288639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65433201|NCT00288639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433202|NCT00288639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65433203|NCT00288639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65433204|NCT00288639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65433205|NCT00288639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65433206|NCT00288639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65433207|NCT00390858|Deferasirox|deferasirox|mesh-list
65433208|NCT00390858|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65433209|NCT00390858|Chelating Agents|chelating agents|mesh-ancestor
65433210|NCT00390858|Sequestering Agents|sequestering agents|mesh-ancestor
65433211|NCT00390858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433212|NCT00390780|Clotrimazole|clotrimazole|mesh-list
65433213|NCT00390780|Miconazole|miconazole|mesh-list
65433214|NCT00390780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65433215|NCT00390780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65433216|NCT00390780|Antifungal Agents|antifungal agents|mesh-ancestor
65433217|NCT00390780|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65433218|NCT00390780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65433219|NCT00390780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433220|NCT00390780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433221|NCT00390780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65433222|NCT00390780|Hormone Antagonists|hormone antagonists|mesh-ancestor
65433223|NCT00390780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65433224|NCT00390780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433225|NCT00390780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65433226|NCT00390780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65433227|NCT00390546|Propranolol|propranolol|mesh-list
65433228|NCT00390546|Digoxin|digoxin|mesh-list
64817924|NCT01499108|Hormones|hormones|mesh-ancestor
65433260|NCT01045902|Ampicillin|ampicillin|mesh-list
65433261|NCT01045902|Sulbactam|sulbactam|mesh-list
65433262|NCT01045902|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65433263|NCT01045902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65433264|NCT01045902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65433265|NCT01045902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65433266|NCT01045902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65433267|NCT01045902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433269|NCT01045902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433270|NCT01045902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65433271|NCT01045902|Contraceptive Agents|contraceptive agents|mesh-ancestor
65433272|NCT01045902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65433283|NCT01041690|Growth Substances|growth substances|mesh-ancestor
65433284|NCT01041690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433285|NCT01041690|Growth Inhibitors|growth inhibitors|mesh-ancestor
65433286|NCT00288015|Bevacizumab|bevacizumab|mesh-list
65433287|NCT00288015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65433288|NCT00288015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433289|NCT00288015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65433290|NCT00288015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65433291|NCT00288015|Growth Substances|growth substances|mesh-ancestor
65433292|NCT00288015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433293|NCT00288015|Growth Inhibitors|growth inhibitors|mesh-ancestor
65433294|NCT00389064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65433295|NCT00389064|Antidepressive Agents|antidepressive agents|mesh-ancestor
65433296|NCT00389064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65433297|NCT00389064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65433298|NCT00389064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65433299|NCT00389064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65433300|NCT00389064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433301|NCT01068327|Leucovorin|leucovorin|mesh-list
65433302|NCT01068327|Gemcitabine|gemcitabine|mesh-list
65433303|NCT01068327|Nelfinavir|nelfinavir|mesh-list
65433304|NCT01068327|Fluorouracil|fluorouracil|mesh-list
65433305|NCT01068327|Calcium|calcium|mesh-list
65433306|NCT01068327|Levoleucovorin|levoleucovorin|mesh-list
65433307|NCT01068327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65433308|NCT01068327|Antimetabolites|antimetabolites|mesh-ancestor
65433309|NCT01068327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433310|NCT01068327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433311|NCT01068327|Antiviral Agents|antiviral agents|mesh-ancestor
65433312|NCT01068327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65433313|NCT01068327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433314|NCT01068327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65433315|NCT01068327|Immunologic Factors|immunologic factors|mesh-ancestor
65433316|NCT01068327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433317|NCT01068327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65433318|NCT01068327|Antidotes|antidotes|mesh-ancestor
65433319|NCT01068327|Protective Agents|protective agents|mesh-ancestor
65433320|NCT01068327|Vitamin B Complex|vitamin b complex|mesh-ancestor
65433321|NCT01068327|Vitamins|vitamins|mesh-ancestor
65433322|NCT01068327|Micronutrients|micronutrients|mesh-ancestor
65433323|NCT01068327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65433324|NCT01068327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65433325|NCT01068327|Protease Inhibitors|protease inhibitors|mesh-ancestor
65433326|NCT01068327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65433327|NCT01068327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65433328|NCT01045980|Vitamin D|vitamin d|mesh-list
65433329|NCT01045980|Ergocalciferols|ergocalciferols|mesh-list
65433330|NCT01045980|Cholecalciferol|cholecalciferol|mesh-list
65433331|NCT01045980|Vitamins|vitamins|mesh-list
65433332|NCT01045980|Micronutrients|micronutrients|mesh-ancestor
65433333|NCT01045980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433334|NCT01045980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65433335|NCT01045980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65433336|NCT00388674|Entecavir|entecavir|mesh-list
65433337|NCT00388674|Antiviral Agents|antiviral agents|mesh-ancestor
65433338|NCT00388674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65433339|NCT00388362|Sirolimus|sirolimus|mesh-list
65433358|NCT01046058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433359|NCT01046058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433360|NCT01046214|Bupropion|bupropion|mesh-list
65433361|NCT01046214|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65433362|NCT01046214|Antidepressive Agents|antidepressive agents|mesh-ancestor
65433363|NCT01046214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65433364|NCT01046214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65433365|NCT01046214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65433366|NCT01046214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65433367|NCT01046214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433368|NCT01046214|Dopamine Agents|dopamine agents|mesh-ancestor
65433369|NCT01046214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65433370|NCT01046214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433371|NCT01046214|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65433372|NCT01046214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65433373|NCT01046214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433374|NCT01324284|Lubiprostone|lubiprostone|mesh-list
65433375|NCT01324284|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65433376|NCT01324284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65433377|NCT01324284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433378|NCT00387894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65433379|NCT00387894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433380|NCT00387894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65433381|NCT00387894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433382|NCT00387894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433383|NCT00387426|Sunitinib|sunitinib|mesh-list
65433384|NCT00387426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433385|NCT00387426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65433386|NCT00387426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65433387|NCT00387426|Growth Substances|growth substances|mesh-ancestor
65433388|NCT00387426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433389|NCT00387426|Growth Inhibitors|growth inhibitors|mesh-ancestor
65433390|NCT00387426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65433391|NCT00387426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433392|NCT00387426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433413|NCT03992820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65433414|NCT03992820|Anesthetics, Local|anesthetics, local|mesh-ancestor
65433416|NCT03992820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65433417|NCT03992820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433418|NCT03992820|Sensory System Agents|sensory system agents|mesh-ancestor
65433419|NCT03992820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65433420|NCT03992820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65433421|NCT00413660|Tofacitinib|tofacitinib|mesh-list
65433422|NCT00413660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65433423|NCT00413660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433424|NCT00413660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433425|NCT01234532|Anastrozole|anastrozole|mesh-list
65433426|NCT01234532|Entinostat|entinostat|mesh-list
65433427|NCT01234532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65433428|NCT01234532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433429|NCT01234532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65433430|NCT01234532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65433431|NCT01234532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433432|NCT01234532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433433|NCT01234532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65433434|NCT01234532|Hormone Antagonists|hormone antagonists|mesh-ancestor
65433435|NCT01234532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65433436|NCT01234532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433437|NCT01234532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65433438|NCT00431444|Zoledronic Acid|zoledronic acid|mesh-list
65433439|NCT00431444|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65433440|NCT00431444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65433441|NCT00431444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433442|NCT00431444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65433443|NCT00431444|Hormone Antagonists|hormone antagonists|mesh-ancestor
64818149|NCT01500590|Protease Inhibitors|protease inhibitors|mesh-ancestor
65433451|NCT02594384|Immunologic Factors|immunologic factors|mesh-ancestor
65433452|NCT02594384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433453|NCT02594384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65433454|NCT00430352|Rituximab|rituximab|mesh-list
65433455|NCT00430352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65433456|NCT00430352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433457|NCT00430352|Immunologic Factors|immunologic factors|mesh-ancestor
65433458|NCT00430352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433459|NCT00430352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65433460|NCT01068405|Methotrexate|methotrexate|mesh-list
65433461|NCT01068405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65433462|NCT01068405|Abortifacient Agents|abortifacient agents|mesh-ancestor
65433463|NCT01068405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65433464|NCT01068405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433465|NCT01068405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65433466|NCT01068405|Antimetabolites|antimetabolites|mesh-ancestor
65433467|NCT01068405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433468|NCT01068405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433469|NCT01068405|Dermatologic Agents|dermatologic agents|mesh-ancestor
65001220|NCT00456313|Hormones|hormones|mesh-ancestor
65433470|NCT01068405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433471|NCT01068405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65433472|NCT01068405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65433473|NCT01068405|Immunologic Factors|immunologic factors|mesh-ancestor
65433474|NCT01068405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65433475|NCT01068405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65433476|NCT00429572|Fludarabine|fludarabine|mesh-list
65433477|NCT00429572|Melphalan|melphalan|mesh-list
65433478|NCT00429572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433479|NCT00429572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433480|NCT00429572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65433481|NCT00429572|Immunologic Factors|immunologic factors|mesh-ancestor
65433482|NCT00429572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433483|NCT00429572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65433484|NCT00429572|Alkylating Agents|alkylating agents|mesh-ancestor
65433485|NCT00429572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65433486|NCT00429494|Leuprolide|leuprolide|mesh-list
65433487|NCT00429494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65433488|NCT00429494|Fertility Agents|fertility agents|mesh-ancestor
65433489|NCT00429494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65433490|NCT00429494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433491|NCT00429494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65433492|NCT00429494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433493|NCT00429416|Cytarabine|cytarabine|mesh-list
65433494|NCT00429416|Cyclophosphamide|cyclophosphamide|mesh-list
65433495|NCT00429416|Fludarabine|fludarabine|mesh-list
65433496|NCT00429416|Fludarabine phosphate|fludarabine phosphate|mesh-list
65433497|NCT00429416|Molgramostim|molgramostim|mesh-list
65433498|NCT00429416|Tacrolimus|tacrolimus|mesh-list
65433499|NCT00429416|Sargramostim|sargramostim|mesh-list
65433501|NCT00429416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65433502|NCT00429416|Immunologic Factors|immunologic factors|mesh-ancestor
65433503|NCT00429416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433504|NCT00429416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65433505|NCT00429416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65433506|NCT00429416|Alkylating Agents|alkylating agents|mesh-ancestor
65433507|NCT00429416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433508|NCT00429416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433509|NCT00429416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65433510|NCT00429416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65433511|NCT00429416|Antimetabolites|antimetabolites|mesh-ancestor
65433526|NCT00429182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433527|NCT00429182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433528|NCT00429182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65433529|NCT00429104|Trastuzumab|trastuzumab|mesh-list
65433530|NCT00429104|Sargramostim|sargramostim|mesh-list
65433531|NCT00429104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65433532|NCT00429104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433533|NCT00429104|Immunologic Factors|immunologic factors|mesh-ancestor
65433534|NCT00429104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433535|NCT00429026|Cyclophosphamide|cyclophosphamide|mesh-list
65433536|NCT00429026|Melphalan|melphalan|mesh-list
65433537|NCT00429026|Fludarabine|fludarabine|mesh-list
65433538|NCT00429026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65433539|NCT00429026|Immunologic Factors|immunologic factors|mesh-ancestor
65433540|NCT00429026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433541|NCT00429026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65433542|NCT00429026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65433543|NCT00429026|Alkylating Agents|alkylating agents|mesh-ancestor
65433544|NCT00429026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433545|NCT00429026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433546|NCT00429026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65433547|NCT00301821|Prednisone|prednisone|mesh-list
65433548|NCT00301821|Cyclophosphamide|cyclophosphamide|mesh-list
65433549|NCT00301821|Rituximab|rituximab|mesh-list
65433550|NCT00301821|Doxorubicin|doxorubicin|mesh-list
65433551|NCT00301821|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65433552|NCT00301821|Vincristine|vincristine|mesh-list
65433553|NCT00301821|Epratuzumab|epratuzumab|mesh-list
65433554|NCT00301821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65433555|NCT00301821|Immunologic Factors|immunologic factors|mesh-ancestor
65433556|NCT00301821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433557|NCT00301821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65433558|NCT00301821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65433559|NCT00301821|Alkylating Agents|alkylating agents|mesh-ancestor
65270038|NCT02726126|Antioxidants|antioxidants|mesh-ancestor
65433560|NCT00301821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433561|NCT00301821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433562|NCT00301821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65433563|NCT00301821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65433564|NCT00301821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65433565|NCT00301821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65433566|NCT00301821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65433567|NCT00301821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433568|NCT00301821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65433569|NCT00301821|Glucocorticoids|glucocorticoids|mesh-ancestor
65433571|NCT00301821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65433572|NCT00301821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65433573|NCT00301821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65433574|NCT00301821|Tubulin Modulators|tubulin modulators|mesh-ancestor
65433603|NCT00372996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433605|NCT00399360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65433606|NCT00399360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433607|NCT00428948|Tolvaptan|tolvaptan|mesh-list
65433608|NCT00428948|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65433609|NCT00428948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433610|NCT00428948|Natriuretic Agents|natriuretic agents|mesh-ancestor
65433611|NCT00428948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433612|NCT00428792|Methylphenidate|methylphenidate|mesh-list
65433613|NCT00428792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65433614|NCT00428792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433615|NCT00428792|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65433616|NCT00428792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65433617|NCT00428792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64818334|NCT01501149|Antiemetics|antiemetics|mesh-ancestor
65433632|NCT00300885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433634|NCT00386334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65433635|NCT00386334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65433636|NCT00386334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433637|NCT01143116|Silver Nitrate|silver nitrate|mesh-list
65433638|NCT01143116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65433639|NCT01143116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65433640|NCT00292227|Moxifloxacin|moxifloxacin|mesh-list
65433641|NCT00292227|Rotigotine|rotigotine|mesh-list
65433642|NCT00292227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65433643|NCT00292227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65433644|NCT00292227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65433645|NCT00292227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65433646|NCT00292227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433647|NCT00292227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433648|NCT00292227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433649|NCT00292227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433650|NCT00292227|Dopamine Agonists|dopamine agonists|mesh-ancestor
65433651|NCT00292227|Dopamine Agents|dopamine agents|mesh-ancestor
65433652|NCT00292227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65433653|NCT00386100|Metformin|metformin|mesh-list
65433654|NCT00386100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65433655|NCT00386100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433656|NCT00300495|Amiodarone|amiodarone|mesh-list
65433657|NCT00300495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65433658|NCT00300495|Vasodilator Agents|vasodilator agents|mesh-ancestor
65433659|NCT00300495|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65433660|NCT00300495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65433661|NCT00300495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433662|NCT00300495|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65433663|NCT00300495|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65433664|NCT00300495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65433665|NCT00300495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433666|NCT00300495|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65433667|NCT00300495|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65433668|NCT00300495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65433669|NCT03979989|Tapentadol|tapentadol|mesh-list
65433670|NCT03979989|Omeprazole|omeprazole|mesh-list
65433671|NCT03979989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65433672|NCT03979989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65433673|NCT03979989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65433674|NCT03979989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433675|NCT03979989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433676|NCT03979989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65433677|NCT03979989|Narcotics|narcotics|mesh-ancestor
65433706|NCT01068795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433707|NCT00286455|Alogliptin|alogliptin|mesh-list
65433708|NCT00286455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65433709|NCT00286455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433710|NCT00286455|Incretins|incretins|mesh-ancestor
65433711|NCT00286455|Hormones|hormones|mesh-ancestor
65183235|NCT00868231|Bromides|bromides|mesh-list
65433712|NCT00286455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65433713|NCT00286455|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65433715|NCT00286455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433716|NCT00286455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433717|NCT00385944|Clopidogrel|clopidogrel|mesh-list
65433718|NCT00385944|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65433719|NCT00385944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65433720|NCT00385944|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65433742|NCT00398112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65433743|NCT00398112|Growth Substances|growth substances|mesh-ancestor
65433744|NCT00398112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433745|NCT00398112|Growth Inhibitors|growth inhibitors|mesh-ancestor
65433746|NCT00398112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65433747|NCT00398112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433748|NCT00398112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433749|NCT01065129|Plerixafor|plerixafor|mesh-list
65433750|NCT01065129|Azacitidine|azacitidine|mesh-list
65433751|NCT01065129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65433752|NCT01065129|Antimetabolites|antimetabolites|mesh-ancestor
65433753|NCT01065129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433754|NCT01065129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433755|NCT01065129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433756|NCT01065129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65433757|NCT01065129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65433758|NCT01065129|Antiviral Agents|antiviral agents|mesh-ancestor
65433759|NCT01065129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65433760|NCT01042314|Donepezil|donepezil|mesh-list
65433761|NCT01042314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65433762|NCT01042314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433763|NCT01042314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433764|NCT01042314|Cholinergic Agents|cholinergic agents|mesh-ancestor
65433765|NCT01042314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65433766|NCT01042314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433767|NCT01042314|Nootropic Agents|nootropic agents|mesh-ancestor
65433768|NCT00372528|Pregabalin|pregabalin|mesh-list
65433769|NCT00372528|Analgesics|analgesics|mesh-ancestor
65433770|NCT00372528|Sensory System Agents|sensory system agents|mesh-ancestor
65433771|NCT00372528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65433772|NCT00372528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433773|NCT00372528|Anticonvulsants|anticonvulsants|mesh-ancestor
64818490|NCT01501669|Irinotecan|irinotecan|mesh-list
65433784|NCT00283803|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65433785|NCT00283803|Androgen Antagonists|androgen antagonists|mesh-list
65433786|NCT00283803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65433787|NCT00283803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433788|NCT00283803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433789|NCT00283803|Hormone Antagonists|hormone antagonists|mesh-ancestor
65433790|NCT00283803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65433791|NCT00283803|Protective Agents|protective agents|mesh-ancestor
65433792|NCT00283803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65433793|NCT00283803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433794|NCT00283803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433795|NCT00283803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65433796|NCT00283803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65433797|NCT00283803|Analgesics|analgesics|mesh-ancestor
65433798|NCT00283803|Sensory System Agents|sensory system agents|mesh-ancestor
65433799|NCT00283803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65433800|NCT00283803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65433801|NCT00283803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65433802|NCT01044810|Efavirenz|efavirenz|mesh-list
65433803|NCT01044810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65433804|NCT01044810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65433805|NCT01044810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433806|NCT01044810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433807|NCT01044810|Antiviral Agents|antiviral agents|mesh-ancestor
65433808|NCT01044810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65433809|NCT01044810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65433810|NCT01044810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65433811|NCT01044810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65433812|NCT01044810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65433813|NCT01044810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65433814|NCT01044810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65433815|NCT01033370|Clevidipine|clevidipine|mesh-list
65433816|NCT01033370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65433817|NCT01033370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65433818|NCT01033370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433819|NCT01033370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65433820|NCT01033370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433821|NCT01044888|Heparin|heparin|mesh-list
65433822|NCT01044888|Anticoagulants|anticoagulants|mesh-ancestor
65433823|NCT01044888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65433824|NCT01044888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65433825|NCT01044888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433826|NCT03742466|Methylprednisolone|methylprednisolone|mesh-list
65433827|NCT03742466|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65433828|NCT03742466|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65433829|NCT03742466|Prednisolone|prednisolone|mesh-list
65433830|NCT03742466|Prednisolone acetate|prednisolone acetate|mesh-list
65433831|NCT03742466|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64818541|NCT01501747|Antipyretics|antipyretics|mesh-ancestor
65433865|NCT00397488|Sunitinib|sunitinib|mesh-list
65433866|NCT00397488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433867|NCT00397488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65433868|NCT00397488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65433869|NCT00397488|Growth Substances|growth substances|mesh-ancestor
65433870|NCT00397488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433871|NCT00397488|Growth Inhibitors|growth inhibitors|mesh-ancestor
64818601|NCT01501916|Vitamin D|vitamin d|mesh-list
65433890|NCT01324596|Methylprednisolone|methylprednisolone|mesh-list
65433891|NCT01324596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65433892|NCT01324596|Prednisolone acetate|prednisolone acetate|mesh-list
65433893|NCT01324596|Cyclophosphamide|cyclophosphamide|mesh-list
65433894|NCT01324596|Rituximab|rituximab|mesh-list
65433895|NCT01324596|Doxorubicin|doxorubicin|mesh-list
65433896|NCT01324596|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65433897|NCT01324596|Vincristine|vincristine|mesh-list
65433898|NCT01324596|Bortezomib|bortezomib|mesh-list
65433899|NCT01324596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65433900|NCT01324596|Prednisolone phosphate|prednisolone phosphate|mesh-list
65433901|NCT01324596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65433902|NCT01324596|Immunologic Factors|immunologic factors|mesh-ancestor
65433903|NCT01324596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433904|NCT01324596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65433905|NCT01324596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65433906|NCT01324596|Alkylating Agents|alkylating agents|mesh-ancestor
65433907|NCT01324596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433908|NCT01324596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433909|NCT01324596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65433910|NCT01324596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65433911|NCT01324596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65433912|NCT01324596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65433913|NCT01324596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65433914|NCT01324596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433915|NCT01324596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65433916|NCT01324596|Tubulin Modulators|tubulin modulators|mesh-ancestor
65433917|NCT01324596|Antimitotic Agents|antimitotic agents|mesh-ancestor
65433918|NCT01324596|Mitosis Modulators|mitosis modulators|mesh-ancestor
65433919|NCT01324596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65433920|NCT01324596|Glucocorticoids|glucocorticoids|mesh-ancestor
65433921|NCT01324596|Hormones|hormones|mesh-ancestor
65433922|NCT01324596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65433923|NCT01324596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65433924|NCT01324596|Antiemetics|antiemetics|mesh-ancestor
65433925|NCT01324596|Autonomic Agents|autonomic agents|mesh-ancestor
65433926|NCT01324596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65433927|NCT01324596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65433928|NCT01324596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65433948|NCT01045278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433950|NCT01045278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65433951|NCT01045278|Antimetabolites|antimetabolites|mesh-ancestor
65433952|NCT01045278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433953|NCT01045278|Immunologic Factors|immunologic factors|mesh-ancestor
65433954|NCT01045278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433955|NCT00423800|Interferons|interferons|mesh-list
65433956|NCT00423800|Ribavirin|ribavirin|mesh-list
65433957|NCT00423800|Interferon-alpha|interferon-alpha|mesh-list
65433958|NCT00423800|Interferon alpha-2|interferon alpha-2|mesh-list
65433959|NCT00423800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65433960|NCT00423800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433961|NCT00423800|Antiviral Agents|antiviral agents|mesh-ancestor
65433962|NCT00423800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65433963|NCT00423800|Antimetabolites|antimetabolites|mesh-ancestor
65433964|NCT00423800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433965|NCT00423800|Immunologic Factors|immunologic factors|mesh-ancestor
65433966|NCT00423800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433967|NCT00405548|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65433968|NCT00405548|Natriuretic Agents|natriuretic agents|mesh-ancestor
65433969|NCT00405548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433970|NCT00405392|Ibandronic Acid|ibandronic acid|mesh-list
65433971|NCT00405392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65433972|NCT00405392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433973|NCT00282243|Tacrolimus|tacrolimus|mesh-list
65433974|NCT00282243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65433975|NCT00282243|Immunologic Factors|immunologic factors|mesh-ancestor
65433976|NCT00282243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433977|NCT00282243|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65433978|NCT00282243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433979|NCT00282243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433980|NCT00272961|N-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|n-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|mesh-list
65433981|NCT00272961|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65433982|NCT00272961|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64818695|NCT01502774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65433993|NCT00282087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433994|NCT00282087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65433995|NCT00282087|Immunologic Factors|immunologic factors|mesh-ancestor
65433996|NCT00282087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433997|NCT00282087|Tubulin Modulators|tubulin modulators|mesh-ancestor
65433998|NCT00282087|Antimitotic Agents|antimitotic agents|mesh-ancestor
65433999|NCT00282087|Mitosis Modulators|mitosis modulators|mesh-ancestor
65434000|NCT00282087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65434001|NCT00282087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65434002|NCT00282087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65434003|NCT00281697|Bevacizumab|bevacizumab|mesh-list
65434004|NCT00281697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65434005|NCT00281697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434006|NCT00281697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65434007|NCT00281697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65434008|NCT00281697|Growth Substances|growth substances|mesh-ancestor
65434009|NCT00281697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434010|NCT00281697|Growth Inhibitors|growth inhibitors|mesh-ancestor
65434011|NCT00232180|Eplerenone|eplerenone|mesh-list
65434012|NCT00232180|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65434013|NCT00232180|Hormone Antagonists|hormone antagonists|mesh-ancestor
65434014|NCT00232180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65434015|NCT00232180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434016|NCT00232180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65434017|NCT00232180|Diuretics|diuretics|mesh-ancestor
65434018|NCT00232180|Natriuretic Agents|natriuretic agents|mesh-ancestor
65434019|NCT00232180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65434020|NCT01070277|Albendazole|albendazole|mesh-list
65434021|NCT01070277|Tinidazole|tinidazole|mesh-list
65434022|NCT01070277|Anthelmintics|anthelmintics|mesh-ancestor
65434023|NCT01070277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65434024|NCT01070277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65434025|NCT01070277|Anticestodal Agents|anticestodal agents|mesh-ancestor
65434026|NCT01070277|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65434027|NCT01070277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65434028|NCT01070277|Tubulin Modulators|tubulin modulators|mesh-ancestor
65434029|NCT01070277|Antimitotic Agents|antimitotic agents|mesh-ancestor
65434030|NCT01070277|Mitosis Modulators|mitosis modulators|mesh-ancestor
64456687|NCT01777269|Urological Agents|urological agents|mesh-ancestor
65434031|NCT01070277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434032|NCT01070277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434033|NCT01070277|Alkylating Agents|alkylating agents|mesh-ancestor
65434034|NCT01070277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65434035|NCT01070277|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65434036|NCT00270231|Naltrexone|naltrexone|mesh-list
65434037|NCT00270231|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65434038|NCT00270231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65434039|NCT00270231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434040|NCT00270231|Sensory System Agents|sensory system agents|mesh-ancestor
65434041|NCT00270231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65434042|NCT02532309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65434043|NCT02532309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65434044|NCT02532309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65434045|NCT02532309|Antimetabolites|antimetabolites|mesh-ancestor
65434046|NCT02532309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434047|NCT02532309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65434058|NCT00269919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434059|NCT00269919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65434060|NCT00269919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65434061|NCT00269919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65434062|NCT00269919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65434063|NCT00269919|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65434064|NCT00269919|Dopamine Agents|dopamine agents|mesh-ancestor
65434065|NCT00257920|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
65434066|NCT00257920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434068|NCT00257920|Micronutrients|micronutrients|mesh-ancestor
65434069|NCT00257920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65434070|NCT00268983|Iodine|iodine|mesh-list
65434071|NCT00268983|Rituximab|rituximab|mesh-list
65434072|NCT00268983|Tositumomab I-131|tositumomab i-131|mesh-list
65434073|NCT00268983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65434074|NCT00268983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65434075|NCT00268983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434076|NCT00268983|Immunologic Factors|immunologic factors|mesh-ancestor
65434077|NCT00268983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434078|NCT00268983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65434079|NCT00268983|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65434080|NCT00268983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65434081|NCT00268983|Trace Elements|trace elements|mesh-ancestor
65434082|NCT00268983|Micronutrients|micronutrients|mesh-ancestor
65434083|NCT01070511|Tadalafil|tadalafil|mesh-list
65434084|NCT01070511|Vasodilator Agents|vasodilator agents|mesh-ancestor
65434085|NCT01070511|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65434086|NCT01070511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65434087|NCT01070511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434088|NCT01070511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434089|NCT01070511|Urological Agents|urological agents|mesh-ancestor
65434090|NCT01070667|Dronedarone|dronedarone|mesh-list
65434091|NCT01070667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65434092|NCT00257608|Bevacizumab|bevacizumab|mesh-list
65434093|NCT00257608|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65434094|NCT00257608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65434095|NCT00257608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434096|NCT00257608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65434097|NCT00257608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65434098|NCT00257608|Growth Substances|growth substances|mesh-ancestor
65434099|NCT00257608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434100|NCT00257608|Growth Inhibitors|growth inhibitors|mesh-ancestor
65434101|NCT00257608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65434102|NCT00257608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434103|NCT00257608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434104|NCT00231478|Granisetron|granisetron|mesh-list
65434105|NCT00231478|Antiemetics|antiemetics|mesh-ancestor
65434106|NCT00231478|Autonomic Agents|autonomic agents|mesh-ancestor
65434107|NCT00231478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65434108|NCT00231478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434109|NCT00231478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65434110|NCT00231478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65434111|NCT00231478|Serotonin Agents|serotonin agents|mesh-ancestor
65434112|NCT00231478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65434131|NCT00206518|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65434132|NCT00206518|Cyclophosphamide|cyclophosphamide|mesh-list
65434133|NCT00206518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001654|NCT00111215|Hemostatics|hemostatics|mesh-ancestor
65434134|NCT00206518|Tubulin Modulators|tubulin modulators|mesh-ancestor
65434135|NCT00206518|Antimitotic Agents|antimitotic agents|mesh-ancestor
65434136|NCT00206518|Mitosis Modulators|mitosis modulators|mesh-ancestor
65434137|NCT00206518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434138|NCT00206518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65434139|NCT00206518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65434140|NCT00206518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65434141|NCT00206518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434142|NCT00206518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65434143|NCT00206518|Immunologic Factors|immunologic factors|mesh-ancestor
65434144|NCT00206518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434145|NCT00206518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65434146|NCT00206518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65434147|NCT00206518|Alkylating Agents|alkylating agents|mesh-ancestor
65434148|NCT00206518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65434149|NCT00206440|Esomeprazole|esomeprazole|mesh-list
65434150|NCT00206440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65434151|NCT00206440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65434152|NCT00206440|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65434153|NCT00206440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434154|NCT00206440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434155|NCT00268437|Carboplatin|carboplatin|mesh-list
65434156|NCT00268437|Pemetrexed|pemetrexed|mesh-list
65434157|NCT00268437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434158|NCT00268437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434159|NCT00268437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434160|NCT00268437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65434161|NCT00268437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65434162|NCT00423488|Simvastatin|simvastatin|mesh-list
65434163|NCT00423488|Ezetimibe|ezetimibe|mesh-list
65434164|NCT00423488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65434165|NCT00423488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65434166|NCT00423488|Antimetabolites|antimetabolites|mesh-ancestor
65434167|NCT00423488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434168|NCT00423488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64818885|NCT01503502|HH-GV-678|hh-gv-678|mesh-list
65434181|NCT00404066|Cyclophosphamide|cyclophosphamide|mesh-list
65434183|NCT00404066|Doxorubicin|doxorubicin|mesh-list
65434184|NCT00404066|Trastuzumab|trastuzumab|mesh-list
65434185|NCT00404066|Lapatinib|lapatinib|mesh-list
65434186|NCT00404066|Lenograstim|lenograstim|mesh-list
65434187|NCT00404066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65434188|NCT00404066|Immunologic Factors|immunologic factors|mesh-ancestor
65434189|NCT00404066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434190|NCT00404066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65434191|NCT00404066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65434192|NCT00404066|Alkylating Agents|alkylating agents|mesh-ancestor
65434193|NCT00404066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434194|NCT00404066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434195|NCT00404066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65434196|NCT00404066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65434197|NCT00404066|Antiemetics|antiemetics|mesh-ancestor
65434198|NCT00404066|Autonomic Agents|autonomic agents|mesh-ancestor
65434199|NCT00404066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65434200|NCT00404066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65434201|NCT00404066|Glucocorticoids|glucocorticoids|mesh-ancestor
65434202|NCT00404066|Hormones|hormones|mesh-ancestor
65434203|NCT00404066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65434204|NCT00404066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65434205|NCT00404066|Tubulin Modulators|tubulin modulators|mesh-ancestor
65434206|NCT00404066|Antimitotic Agents|antimitotic agents|mesh-ancestor
65434207|NCT00404066|Mitosis Modulators|mitosis modulators|mesh-ancestor
65434208|NCT00404066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65434209|NCT00404066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65434210|NCT00404066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65434211|NCT00404066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434212|NCT00404066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65434213|NCT00404066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65434214|NCT00404066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65434215|NCT00423332|Cediranib|cediranib|mesh-list
65434216|NCT00423332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434217|NCT00423332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65434218|NCT00423332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434219|NCT00423332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001727|NCT00348400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434220|NCT00413036|Lenalidomide|lenalidomide|mesh-list
65434221|NCT00413036|Immunologic Factors|immunologic factors|mesh-ancestor
65434222|NCT00413036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434223|NCT00413036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65434224|NCT00413036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65434225|NCT00413036|Growth Substances|growth substances|mesh-ancestor
65434226|NCT00413036|Growth Inhibitors|growth inhibitors|mesh-ancestor
65434227|NCT00413036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434228|NCT00412958|Plasminogen|plasminogen|mesh-list
65434229|NCT00412958|Fibrinolysin|fibrinolysin|mesh-list
65434230|NCT00412958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65434231|NCT00412958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64818941|NCT01503788|Midazolam|midazolam|mesh-list
65434239|NCT01040702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434240|NCT01040702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65434241|NCT01040702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65434242|NCT01040702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65434243|NCT01040702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434244|NCT01040702|Dopamine Agents|dopamine agents|mesh-ancestor
65434245|NCT01040702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65434246|NCT00268203|Tositumomab I-131|tositumomab i-131|mesh-list
65434247|NCT00268203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434248|NCT00384930|Tadalafil|tadalafil|mesh-list
65434249|NCT00384930|Vasodilator Agents|vasodilator agents|mesh-ancestor
65434250|NCT00384930|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65434251|NCT00384930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65434252|NCT00384930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434253|NCT00384930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434254|NCT00384930|Urological Agents|urological agents|mesh-ancestor
65434255|NCT00423098|Mycophenolic Acid|mycophenolic acid|mesh-list
65434256|NCT00423098|Prednisone|prednisone|mesh-list
65434257|NCT00423098|Methylprednisolone|methylprednisolone|mesh-list
65434258|NCT00423098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65434259|NCT00423098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65434260|NCT00423098|Prednisolone|prednisolone|mesh-list
65434261|NCT00423098|Prednisolone acetate|prednisolone acetate|mesh-list
65434262|NCT00423098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65434263|NCT00423098|Prednisolone phosphate|prednisolone phosphate|mesh-list
65434264|NCT00423098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65434265|NCT00423098|Glucocorticoids|glucocorticoids|mesh-ancestor
65434266|NCT00423098|Hormones|hormones|mesh-ancestor
65434267|NCT00423098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65434268|NCT00423098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434269|NCT00423098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65434270|NCT00423098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434271|NCT00423098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65434272|NCT00423098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65434273|NCT00423098|Antitubercular Agents|antitubercular agents|mesh-ancestor
65434274|NCT00423098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65434275|NCT00423098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65434276|NCT00423098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434277|NCT00423098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434278|NCT00423098|Antiemetics|antiemetics|mesh-ancestor
65434279|NCT00423098|Autonomic Agents|autonomic agents|mesh-ancestor
65434280|NCT00423098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65434281|NCT00423098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65434282|NCT00423098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65434283|NCT00423098|Protective Agents|protective agents|mesh-ancestor
65434284|NCT01042704|Aspirin|aspirin|mesh-list
65434285|NCT01042704|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65434286|NCT01042704|Dexamethasone|dexamethasone|mesh-list
65434287|NCT01042704|Lenalidomide|lenalidomide|mesh-list
65434288|NCT01042704|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65434289|NCT01042704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65434290|NCT01042704|Antiemetics|antiemetics|mesh-ancestor
65434291|NCT01042704|Autonomic Agents|autonomic agents|mesh-ancestor
65434292|NCT01042704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65434293|NCT01042704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434294|NCT01042704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65434295|NCT01042704|Glucocorticoids|glucocorticoids|mesh-ancestor
65434296|NCT01042704|Hormones|hormones|mesh-ancestor
65434297|NCT01042704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65434298|NCT01042704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65434299|NCT01042704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001806|NCT00421369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64819000|NCT01503918|Valacyclovir|valacyclovir|mesh-list
65434316|NCT01042704|Growth Inhibitors|growth inhibitors|mesh-ancestor
65434317|NCT01042704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65434318|NCT01042704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65434319|NCT01042704|Alkylating Agents|alkylating agents|mesh-ancestor
65434320|NCT00750698|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65434321|NCT00750698|Entinostat|entinostat|mesh-list
65434322|NCT00750698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434323|NCT00750698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65434324|NCT00750698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434325|NCT00750698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434326|NCT00750698|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65434327|NCT01046838|Sildenafil Citrate|sildenafil citrate|mesh-list
65434328|NCT01046838|Vasodilator Agents|vasodilator agents|mesh-ancestor
65434329|NCT01046838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65434330|NCT01046838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65434331|NCT01046838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434332|NCT01046838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434333|NCT01046838|Urological Agents|urological agents|mesh-ancestor
65434334|NCT01042782|Everolimus|everolimus|mesh-list
65434335|NCT01042782|Mitomycin|mitomycin|mesh-list
65434336|NCT01042782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434337|NCT01042782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65434338|NCT01042782|Immunologic Factors|immunologic factors|mesh-ancestor
65434339|NCT01042782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434340|NCT01042782|Alkylating Agents|alkylating agents|mesh-ancestor
65434341|NCT01042782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434342|NCT01042782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65434343|NCT01042782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65434344|NCT01042782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434345|NCT00411788|Sirolimus|sirolimus|mesh-list
65434346|NCT00411788|Trastuzumab|trastuzumab|mesh-list
65434347|NCT00411788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65434348|NCT00411788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434349|NCT00411788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65434350|NCT00411788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65434351|NCT00411788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65434352|NCT00411788|Antifungal Agents|antifungal agents|mesh-ancestor
65434353|NCT00411788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65434354|NCT00411788|Immunologic Factors|immunologic factors|mesh-ancestor
65434355|NCT00411788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434356|NCT01046994|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64819072|NCT01504178|Emetics|emetics|mesh-ancestor
65434377|NCT01041170|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65434378|NCT01041170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65434379|NCT01041170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183904|NCT00869557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434380|NCT01041170|Hormones|hormones|mesh-ancestor
65434381|NCT01041170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65434382|NCT01041170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434383|NCT01041482|Sorafenib|sorafenib|mesh-list
65434384|NCT01041482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434385|NCT01041482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65434386|NCT01041482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434387|NCT01041482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434388|NCT00422942|Rituximab|rituximab|mesh-list
65434389|NCT00422942|Methotrexate|methotrexate|mesh-list
65434390|NCT00422942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65434391|NCT00422942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434392|NCT00422942|Immunologic Factors|immunologic factors|mesh-ancestor
65434393|NCT00422942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434394|NCT00422942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65434395|NCT00422942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65434396|NCT00422942|Abortifacient Agents|abortifacient agents|mesh-ancestor
65434397|NCT00422942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65434398|NCT00422942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65434399|NCT00422942|Antimetabolites|antimetabolites|mesh-ancestor
65434400|NCT00422942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434401|NCT00422942|Dermatologic Agents|dermatologic agents|mesh-ancestor
65434402|NCT00422942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434403|NCT00422942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65434404|NCT00422942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65434405|NCT00422942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65434411|NCT00422162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65434412|NCT00422162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65434413|NCT00422162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434414|NCT00422162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65434415|NCT00422162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434416|NCT00422162|Analgesics|analgesics|mesh-ancestor
65434417|NCT00422162|Sensory System Agents|sensory system agents|mesh-ancestor
65434418|NCT00422162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65434419|NCT00422162|Antidepressive Agents|antidepressive agents|mesh-ancestor
65434420|NCT00422162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65434421|NCT00422162|Dopamine Agents|dopamine agents|mesh-ancestor
65434422|NCT00411632|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65434423|NCT00411632|Bexarotene|bexarotene|mesh-list
65434424|NCT00411632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434425|NCT00411632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65434426|NCT00411632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434427|NCT00411632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434428|NCT00422084|Artesunate|artesunate|mesh-list
65434429|NCT00422084|Lumefantrine|lumefantrine|mesh-list
65434430|NCT00422084|Artemether|artemether|mesh-list
65434431|NCT00422084|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65434432|NCT00422084|Pyronaridine|pyronaridine|mesh-list
65434433|NCT00422084|Antimalarials|antimalarials|mesh-ancestor
65434434|NCT00422084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65434435|NCT00422084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65434436|NCT00422084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65434437|NCT00422084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434438|NCT00422084|Antiviral Agents|antiviral agents|mesh-ancestor
65434439|NCT00422084|Schistosomicides|schistosomicides|mesh-ancestor
65434440|NCT00422084|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65434441|NCT00422084|Anthelmintics|anthelmintics|mesh-ancestor
65434442|NCT00421928|Oxycodone|oxycodone|mesh-list
65434443|NCT00421928|Tapentadol|tapentadol|mesh-list
65434444|NCT00421928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65434445|NCT00421928|Narcotics|narcotics|mesh-ancestor
65434446|NCT00421928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65434447|NCT00421928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434448|NCT00421928|Analgesics|analgesics|mesh-ancestor
65434449|NCT00421928|Sensory System Agents|sensory system agents|mesh-ancestor
65434450|NCT00421928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65434451|NCT00421928|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65183992|NCT01092780|Modafinil|modafinil|mesh-list
65434452|NCT00421928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65434453|NCT00421928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65434454|NCT00421928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434455|NCT00421928|Adrenergic Agents|adrenergic agents|mesh-ancestor
65434456|NCT00421928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65434457|NCT01047072|Mycophenolic Acid|mycophenolic acid|mesh-list
65434458|NCT01047072|Cyclophosphamide|cyclophosphamide|mesh-list
65434459|NCT01047072|Rituximab|rituximab|mesh-list
65434460|NCT01047072|Fludarabine|fludarabine|mesh-list
65434461|NCT01047072|Fludarabine phosphate|fludarabine phosphate|mesh-list
65434462|NCT01047072|Tacrolimus|tacrolimus|mesh-list
65434463|NCT01047072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65434464|NCT01047072|Immunologic Factors|immunologic factors|mesh-ancestor
65434465|NCT01047072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434466|NCT01047072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65434467|NCT01047072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65434468|NCT01047072|Alkylating Agents|alkylating agents|mesh-ancestor
65434469|NCT01047072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434470|NCT01047072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434471|NCT01047072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65434472|NCT01047072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65434473|NCT01047072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65434474|NCT01047072|Antimetabolites|antimetabolites|mesh-ancestor
65434475|NCT01047072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65434486|NCT00372060|Incretins|incretins|mesh-ancestor
65434488|NCT00372060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65434489|NCT00372060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65434490|NCT00372060|Protease Inhibitors|protease inhibitors|mesh-ancestor
65434491|NCT00372060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434492|NCT00372060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434493|NCT01043172|Gemcitabine|gemcitabine|mesh-list
65434494|NCT01043172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65001959|NCT00404781|Aspirin|aspirin|mesh-list
65434495|NCT01043172|Antimetabolites|antimetabolites|mesh-ancestor
65434496|NCT01043172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434497|NCT01043172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434498|NCT01043172|Antiviral Agents|antiviral agents|mesh-ancestor
65434499|NCT01043172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65434500|NCT01043172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434501|NCT01043172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65434502|NCT01043172|Immunologic Factors|immunologic factors|mesh-ancestor
65434503|NCT01043172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434504|NCT01045434|Omeprazole|omeprazole|mesh-list
65434505|NCT01045434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65434506|NCT01045434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65434507|NCT01045434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65434508|NCT01045434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434509|NCT01045434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434510|NCT01043484|Bevacizumab|bevacizumab|mesh-list
65434511|NCT01043484|Capecitabine|capecitabine|mesh-list
65434512|NCT01043484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65434513|NCT01043484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434514|NCT01043484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65434515|NCT01043484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65434516|NCT01043484|Growth Substances|growth substances|mesh-ancestor
65434517|NCT01043484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434518|NCT01043484|Growth Inhibitors|growth inhibitors|mesh-ancestor
65434519|NCT01043484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65434520|NCT01043484|Antimetabolites|antimetabolites|mesh-ancestor
65434521|NCT01043484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434522|NCT00396318|Tenecteplase|tenecteplase|mesh-list
65434523|NCT00396318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65434524|NCT00396318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65434525|NCT00396318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434526|NCT00381888|PENTA|penta|mesh-list
65434527|NCT00381888|Fondaparinux|fondaparinux|mesh-list
65434528|NCT00381888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65434529|NCT00381888|Antithrombins|antithrombins|mesh-ancestor
65434530|NCT00381888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65434531|NCT00381888|Protease Inhibitors|protease inhibitors|mesh-ancestor
65434532|NCT00381888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434533|NCT00381888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434534|NCT00381888|Anticoagulants|anticoagulants|mesh-ancestor
65434535|NCT00381888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65434536|NCT00381888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65434537|NCT00267969|Ustekinumab|ustekinumab|mesh-list
65434538|NCT00267969|Dermatologic Agents|dermatologic agents|mesh-ancestor
65434539|NCT00280293|Lamotrigine|lamotrigine|mesh-list
65434540|NCT00280293|Anticonvulsants|anticonvulsants|mesh-ancestor
65434548|NCT00280293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65434549|NCT00280293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65434550|NCT00280293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65434552|NCT00421148|Rocuronium|rocuronium|mesh-list
65434553|NCT00421148|Anticonvulsants|anticonvulsants|mesh-ancestor
65434554|NCT00421148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65434555|NCT00421148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65434556|NCT00421148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65434557|NCT00421148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65434558|NCT00421148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434559|NCT00403754|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65434560|NCT00403754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65434561|NCT00403754|Autonomic Agents|autonomic agents|mesh-ancestor
65434562|NCT00403754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65434563|NCT00403754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434564|NCT00403754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65434565|NCT00403754|Respiratory System Agents|respiratory system agents|mesh-ancestor
65434566|NCT00403754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65434567|NCT00403754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65434568|NCT00403754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65434569|NCT00403754|Adrenergic Agents|adrenergic agents|mesh-ancestor
65434570|NCT00403754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65434571|NCT00403754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434572|NCT00280059|Pregabalin|pregabalin|mesh-list
65434573|NCT00280059|Lamotrigine|lamotrigine|mesh-list
65434574|NCT00280059|Analgesics|analgesics|mesh-ancestor
65434575|NCT00280059|Sensory System Agents|sensory system agents|mesh-ancestor
65434576|NCT00280059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65002030|NCT00350467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65434577|NCT00280059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434578|NCT00280059|Anticonvulsants|anticonvulsants|mesh-ancestor
65434579|NCT00280059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65434580|NCT00280059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65434581|NCT00280059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434582|NCT00280059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65434583|NCT00280059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65434584|NCT00280059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65434585|NCT00280059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65434586|NCT00280059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65434587|NCT00280059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65434588|NCT00280059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65434589|NCT00403130|Gemcitabine|gemcitabine|mesh-list
65434590|NCT00403130|Paclitaxel|paclitaxel|mesh-list
65434591|NCT00403130|Bevacizumab|bevacizumab|mesh-list
65434592|NCT00403130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65434593|NCT00403130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434594|NCT00403130|Tubulin Modulators|tubulin modulators|mesh-ancestor
65434595|NCT00403130|Antimitotic Agents|antimitotic agents|mesh-ancestor
65434596|NCT00403130|Mitosis Modulators|mitosis modulators|mesh-ancestor
65434597|NCT00403130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434598|NCT00403130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65434599|NCT00403130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65434600|NCT00403130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65434601|NCT00403130|Growth Substances|growth substances|mesh-ancestor
65184131|NCT04227652|Ibuprofen|ibuprofen|mesh-list
65434602|NCT00403130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434603|NCT00403130|Growth Inhibitors|growth inhibitors|mesh-ancestor
65434604|NCT00403130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65434605|NCT00403130|Antimetabolites|antimetabolites|mesh-ancestor
65434621|NCT00420290|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65434622|NCT00420290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65434623|NCT00267189|Cyclosporine|cyclosporine|mesh-list
65434624|NCT00267189|Everolimus|everolimus|mesh-list
65434625|NCT00267189|Azathioprine|azathioprine|mesh-list
65434626|NCT00267189|Tacrolimus|tacrolimus|mesh-list
65434627|NCT00267189|Cyclosporins|cyclosporins|mesh-list
65434628|NCT00267189|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
65434629|NCT00267189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434630|NCT00267189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65434631|NCT00267189|Immunologic Factors|immunologic factors|mesh-ancestor
65434632|NCT00267189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434633|NCT00267189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65434634|NCT00267189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434635|NCT00267189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434636|NCT00267189|Antimetabolites|antimetabolites|mesh-ancestor
65434637|NCT00267189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65434638|NCT00267189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65434639|NCT00267189|Antifungal Agents|antifungal agents|mesh-ancestor
65434640|NCT00267189|Dermatologic Agents|dermatologic agents|mesh-ancestor
65434641|NCT00402116|Temozolomide|temozolomide|mesh-list
65434642|NCT00402116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65434643|NCT00402116|Alkylating Agents|alkylating agents|mesh-ancestor
65434644|NCT00402116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434645|NCT00402116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434646|NCT00401960|Daptomycin|daptomycin|mesh-list
65434647|NCT00401960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65434648|NCT00401960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65434649|NCT00401726|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65434650|NCT00401726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65434651|NCT00401726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65434652|NCT00401726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65434653|NCT00401726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434654|NCT00401726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65434655|NCT00401726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434656|NCT00401726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65434657|NCT00401726|Antidepressive Agents|antidepressive agents|mesh-ancestor
65434658|NCT00401726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65434659|NCT00371826|Cyclosporine|cyclosporine|mesh-list
65434660|NCT00371826|Mycophenolic Acid|mycophenolic acid|mesh-list
65434661|NCT00371826|Prednisone|prednisone|mesh-list
65434662|NCT00371826|Everolimus|everolimus|mesh-list
65002102|NCT00351052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65434663|NCT00371826|Cyclosporins|cyclosporins|mesh-list
65434664|NCT00371826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
65434665|NCT00371826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65434666|NCT00371826|Glucocorticoids|glucocorticoids|mesh-ancestor
65434681|NCT00371826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65434682|NCT00371826|Antitubercular Agents|antitubercular agents|mesh-ancestor
65434683|NCT00371826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65434684|NCT03993366|Pramlintide|pramlintide|mesh-list
65434685|NCT03993366|Insulin Aspart|insulin aspart|mesh-list
65434686|NCT03993366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65434687|NCT03993366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434689|NCT02457702|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65434690|NCT02457702|Protective Agents|protective agents|mesh-ancestor
65434691|NCT02457702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434692|NCT00396084|Moxifloxacin|moxifloxacin|mesh-list
65434693|NCT00396084|Levofloxacin|levofloxacin|mesh-list
65434694|NCT00396084|Ofloxacin|ofloxacin|mesh-list
65434695|NCT00396084|Isoniazid|isoniazid|mesh-list
65434696|NCT00396084|Linezolid|linezolid|mesh-list
65434697|NCT00396084|Gatifloxacin|gatifloxacin|mesh-list
65434698|NCT00396084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65434699|NCT00396084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65434700|NCT00396084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65434701|NCT00396084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65434702|NCT00396084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434703|NCT00396084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434704|NCT00396084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434705|NCT00396084|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65434706|NCT00396084|Renal Agents|renal agents|mesh-ancestor
65434707|NCT00396084|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65434708|NCT00396084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65434709|NCT00396084|Antitubercular Agents|antitubercular agents|mesh-ancestor
65434710|NCT00396084|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65434711|NCT00396084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65434712|NCT00396084|Antimetabolites|antimetabolites|mesh-ancestor
65434713|NCT00396084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65434714|NCT00396084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65434715|NCT00396084|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65434716|NCT00396084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65434717|NCT00395850|Disulfiram|disulfiram|mesh-list
65434718|NCT00395850|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65434719|NCT00395850|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65434720|NCT00395850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434721|NCT00395850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434722|NCT00420212|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65434723|NCT00420212|Dermatologic Agents|dermatologic agents|mesh-ancestor
65434724|NCT00420212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65434725|NCT00420212|Immunologic Factors|immunologic factors|mesh-ancestor
65434726|NCT00420212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434731|NCT00401258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434732|NCT00401258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65434733|NCT00401258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434734|NCT00401258|Analgesics|analgesics|mesh-ancestor
65434735|NCT00401258|Sensory System Agents|sensory system agents|mesh-ancestor
65434736|NCT00401258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65434737|NCT00401258|Antidepressive Agents|antidepressive agents|mesh-ancestor
65434738|NCT00401258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65434739|NCT00401258|Dopamine Agents|dopamine agents|mesh-ancestor
65434740|NCT00380874|Pregabalin|pregabalin|mesh-list
65434741|NCT00380874|Analgesics|analgesics|mesh-ancestor
65434742|NCT00380874|Sensory System Agents|sensory system agents|mesh-ancestor
65434743|NCT00380874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65434744|NCT00380874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434745|NCT00380874|Anticonvulsants|anticonvulsants|mesh-ancestor
65434746|NCT00380874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65434747|NCT00380874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65434748|NCT00380874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434749|NCT00380874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65434750|NCT00380874|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65434751|NCT00380874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65434753|NCT00380874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65434754|NCT00420056|Palbociclib|palbociclib|mesh-list
65434755|NCT00420056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434756|NCT00420056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65002174|NCT00112034|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65434757|NCT00420056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434758|NCT00420056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434759|NCT00411554|Inositol|inositol|mesh-list
65434760|NCT00411554|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65434761|NCT00411554|Voglibose|voglibose|mesh-list
65434762|NCT00411554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65434763|NCT00411554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434764|NCT00411554|Incretins|incretins|mesh-ancestor
65434765|NCT00411554|Hormones|hormones|mesh-ancestor
65434766|NCT00411554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65434767|NCT00411554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65434768|NCT00411554|Protease Inhibitors|protease inhibitors|mesh-ancestor
65434769|NCT00411554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434770|NCT00411554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434771|NCT00411554|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65434772|NCT00411554|Vitamin B Complex|vitamin b complex|mesh-ancestor
65434773|NCT00411554|Vitamins|vitamins|mesh-ancestor
65434774|NCT00411554|Micronutrients|micronutrients|mesh-ancestor
65434775|NCT00380718|Pemetrexed|pemetrexed|mesh-list
65434776|NCT00380718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434777|NCT00380718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434778|NCT00380718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434779|NCT00380718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65434780|NCT00380718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65434781|NCT00380250|Lubiprostone|lubiprostone|mesh-list
65434782|NCT00380250|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65434783|NCT00380250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65434784|NCT00380250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434785|NCT00400400|Mycophenolic Acid|mycophenolic acid|mesh-list
65434786|NCT00400400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65434787|NCT00400400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434788|NCT00400400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65434789|NCT00400400|Antitubercular Agents|antitubercular agents|mesh-ancestor
65434790|NCT00400400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65434791|NCT00400400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65434792|NCT00400400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434793|NCT00400400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434794|NCT00395694|Lamotrigine|lamotrigine|mesh-list
65434795|NCT00395694|Anticonvulsants|anticonvulsants|mesh-ancestor
65434810|NCT00419744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65434811|NCT00419744|Autonomic Agents|autonomic agents|mesh-ancestor
65434812|NCT00419744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65434813|NCT00419744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434814|NCT00419744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65434815|NCT00419744|Respiratory System Agents|respiratory system agents|mesh-ancestor
65434816|NCT00419744|Glucocorticoids|glucocorticoids|mesh-ancestor
65434817|NCT00419744|Hormones|hormones|mesh-ancestor
65434818|NCT00419744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65434819|NCT00419744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65434820|NCT00419744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65434821|NCT00419744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65434822|NCT00419744|Adrenergic Agents|adrenergic agents|mesh-ancestor
65434823|NCT00419744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65434824|NCT00419744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434825|NCT01047774|Caseins|caseins|mesh-list
65434826|NCT01047774|Chelating Agents|chelating agents|mesh-ancestor
65434827|NCT01047774|Sequestering Agents|sequestering agents|mesh-ancestor
65434828|NCT01047774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434829|NCT00395304|Fluticasone|fluticasone|mesh-list
65434830|NCT00395304|Xhance|xhance|mesh-list
65434831|NCT00395304|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65434832|NCT00395304|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65434833|NCT00395304|Montelukast|montelukast|mesh-list
65434834|NCT00395304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65434835|NCT00395304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65434836|NCT00395304|Autonomic Agents|autonomic agents|mesh-ancestor
65434837|NCT00395304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65434838|NCT00395304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434839|NCT00395304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65434840|NCT00395304|Respiratory System Agents|respiratory system agents|mesh-ancestor
65434841|NCT00395304|Dermatologic Agents|dermatologic agents|mesh-ancestor
65434842|NCT00395304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65002249|NCT00351715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65434843|NCT00395304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65434844|NCT00395304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65434845|NCT00395304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65434846|NCT00395304|Adrenergic Agents|adrenergic agents|mesh-ancestor
65434847|NCT00395304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65434848|NCT00395304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434849|NCT00395304|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65434850|NCT00395304|Hormone Antagonists|hormone antagonists|mesh-ancestor
65434851|NCT00395304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64819566|NCT01506505|Protective Agents|protective agents|mesh-ancestor
65434871|NCT00366444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65434872|NCT00366444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65434873|NCT00366444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65434874|NCT00366444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434875|NCT00366444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434876|NCT00365976|Eszopiclone|eszopiclone|mesh-list
65434877|NCT00365976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65434878|NCT00365976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65434879|NCT00365976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434880|NCT00378534|Cyclosporine|cyclosporine|mesh-list
65434881|NCT00378534|Cyclophosphamide|cyclophosphamide|mesh-list
65434882|NCT00378534|Fludarabine|fludarabine|mesh-list
65434883|NCT00378534|Cyclosporins|cyclosporins|mesh-list
65434884|NCT00378534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65434885|NCT00378534|Immunologic Factors|immunologic factors|mesh-ancestor
65434886|NCT00378534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434887|NCT00378534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65434888|NCT00378534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65434889|NCT00378534|Alkylating Agents|alkylating agents|mesh-ancestor
65434890|NCT00378534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434891|NCT00378534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434892|NCT00378534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65434893|NCT00378534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434894|NCT00378534|Antifungal Agents|antifungal agents|mesh-ancestor
65434895|NCT00378534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65434896|NCT00378534|Dermatologic Agents|dermatologic agents|mesh-ancestor
65434897|NCT00378534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65434898|NCT00377676|Bromocriptine|bromocriptine|mesh-list
65434899|NCT00377676|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65434901|NCT00377676|Hormone Antagonists|hormone antagonists|mesh-ancestor
65434902|NCT00377676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65434903|NCT00377676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434904|NCT00377676|Dopamine Agonists|dopamine agonists|mesh-ancestor
65434905|NCT00377676|Dopamine Agents|dopamine agents|mesh-ancestor
65434906|NCT00377676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65434907|NCT00377676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434908|NCT00377520|Pemetrexed|pemetrexed|mesh-list
65434909|NCT00377520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434937|NCT00365352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65434938|NCT00365352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65434939|NCT00365352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65434940|NCT00365352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65434941|NCT00365352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65434942|NCT00365352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65434943|NCT00365352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65434944|NCT00365352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434945|NCT00365352|Antimanic Agents|antimanic agents|mesh-ancestor
65434946|NCT00410384|Belimumab|belimumab|mesh-list
65434947|NCT00410384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65434948|NCT00410384|Immunologic Factors|immunologic factors|mesh-ancestor
65434949|NCT00410384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434950|NCT00370032|Alosetron|alosetron|mesh-list
65434951|NCT00370032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65434952|NCT00370032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65434953|NCT00370032|Serotonin Agents|serotonin agents|mesh-ancestor
65434954|NCT00370032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65434955|NCT00370032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434956|NCT00370032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434973|NCT00409838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65434974|NCT00409838|Antimetabolites|antimetabolites|mesh-ancestor
65002323|NCT00352183|Fenofibrate|fenofibrate|mesh-list
65002331|NCT00112619|Topotecan|topotecan|mesh-list
65434975|NCT00409838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434976|NCT00409838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434977|NCT00409838|Dermatologic Agents|dermatologic agents|mesh-ancestor
65434978|NCT00409838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434979|NCT00409838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65434980|NCT00409838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65434981|NCT00409838|Immunologic Factors|immunologic factors|mesh-ancestor
65434982|NCT00409838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65434983|NCT00409838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65434984|NCT00409838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65434985|NCT01041872|Lidocaine|lidocaine|mesh-list
65434986|NCT01041872|Propofol|propofol|mesh-list
65434987|NCT01041872|Anesthetics, Local|anesthetics, local|mesh-ancestor
65434988|NCT01041872|Anesthetics|anesthetics|mesh-ancestor
65434989|NCT01041872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65434990|NCT01041872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434991|NCT01041872|Sensory System Agents|sensory system agents|mesh-ancestor
65434992|NCT01041872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65434993|NCT01041872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65434994|NCT01041872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65434995|NCT01041872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65434996|NCT01041872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65434997|NCT01041872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434998|NCT01041872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65434999|NCT01041872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65435000|NCT01041872|Anesthetics, General|anesthetics, general|mesh-ancestor
65435001|NCT00399542|Lubiprostone|lubiprostone|mesh-list
65435002|NCT00399542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65435003|NCT00399542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65435004|NCT00399542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435005|NCT01039766|Oxytocin|oxytocin|mesh-list
65435006|NCT01039766|Oxytocics|oxytocics|mesh-ancestor
65435007|NCT01039766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65435008|NCT01039766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435009|NCT00409682|Adalimumab|adalimumab|mesh-list
65435010|NCT00409682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65435011|NCT00409682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65435012|NCT01039844|Paclitaxel|paclitaxel|mesh-list
65435013|NCT01039844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65435027|NCT01042028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435028|NCT01042028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65435029|NCT01042028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65435031|NCT01042028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65435032|NCT01042028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65435033|NCT01042028|Immunologic Factors|immunologic factors|mesh-ancestor
65435034|NCT01042028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435035|NCT03993626|Nivolumab|nivolumab|mesh-list
65435036|NCT03993626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65435037|NCT03993626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435038|NCT03993626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65435039|NCT03993626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435040|NCT00398216|Edoxaban|edoxaban|mesh-list
65435041|NCT00398216|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
65435042|NCT00398216|Antithrombins|antithrombins|mesh-ancestor
65435043|NCT00398216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65435044|NCT00398216|Protease Inhibitors|protease inhibitors|mesh-ancestor
65435045|NCT00398216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435046|NCT00398216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184579|NCT04134637|Anesthetics|anesthetics|mesh-ancestor
65435047|NCT00398216|Anticoagulants|anticoagulants|mesh-ancestor
65435048|NCT00398138|Sargramostim|sargramostim|mesh-list
65435049|NCT00398138|Freund's Adjuvant|freund's adjuvant|mesh-list
65435050|NCT00398138|Immunologic Factors|immunologic factors|mesh-ancestor
65435051|NCT00398138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435052|NCT00398138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65435053|NCT04566380|Bevacizumab|bevacizumab|mesh-list
65435054|NCT04566380|Nivolumab|nivolumab|mesh-list
65435055|NCT04566380|Capecitabine|capecitabine|mesh-list
65435056|NCT04566380|Oxaliplatin|oxaliplatin|mesh-list
65435057|NCT04566380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65435058|NCT04566380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435059|NCT04566380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65002399|NCT00352378|Capecitabine|capecitabine|mesh-list
65435060|NCT04566380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65435061|NCT04566380|Growth Substances|growth substances|mesh-ancestor
65435062|NCT04566380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435063|NCT04566380|Growth Inhibitors|growth inhibitors|mesh-ancestor
65435064|NCT04566380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65435065|NCT04566380|Antimetabolites|antimetabolites|mesh-ancestor
65435066|NCT04566380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435067|NCT04566380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65435068|NCT02095184|Letrozole|letrozole|mesh-list
65435069|NCT02095184|Anastrozole|anastrozole|mesh-list
65435070|NCT02095184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435071|NCT02095184|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65435072|NCT02095184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65435073|NCT02095184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435074|NCT02095184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819786|NCT01507428|Misonidazole|misonidazole|mesh-list
65435099|NCT00397982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65435100|NCT03715166|Bumetanide|bumetanide|mesh-list
65435101|NCT03715166|Diuretics|diuretics|mesh-ancestor
65435102|NCT03715166|Natriuretic Agents|natriuretic agents|mesh-ancestor
65435103|NCT03715166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435104|NCT03715166|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65435105|NCT03715166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65435106|NCT03715166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435107|NCT01042574|Clevidipine|clevidipine|mesh-list
65435108|NCT01042574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65435109|NCT01042574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65435110|NCT01042574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435111|NCT01042574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65435112|NCT01042574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435113|NCT01042652|Raltegravir Potassium|raltegravir potassium|mesh-list
65435114|NCT01042652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65435115|NCT01042652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65435116|NCT01042652|Antiviral Agents|antiviral agents|mesh-ancestor
65435117|NCT01042652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65435118|NCT01042652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65435119|NCT01042652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65435120|NCT01042652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435121|NCT01042652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435122|NCT01040078|Vaccines|vaccines|mesh-list
65435123|NCT01040078|Immunologic Factors|immunologic factors|mesh-ancestor
65435124|NCT01040078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435133|NCT01035320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435135|NCT01042730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65435136|NCT01042730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65435137|NCT01042730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65435138|NCT01042730|Antimetabolites|antimetabolites|mesh-ancestor
65435139|NCT01042730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435140|NCT01042730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435141|NCT01042730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65435142|NCT00396812|Rituximab|rituximab|mesh-list
65435143|NCT00396812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65435144|NCT00396812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435145|NCT00396812|Immunologic Factors|immunologic factors|mesh-ancestor
65435146|NCT00396812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435147|NCT00396812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65435148|NCT01566578|Mitogens|mitogens|mesh-list
65435149|NCT01566578|Mitosis Modulators|mitosis modulators|mesh-ancestor
65435150|NCT01566578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435151|NCT01040234|Bupivacaine|bupivacaine|mesh-list
65435152|NCT01040234|Anesthetics, Local|anesthetics, local|mesh-ancestor
65435153|NCT01040234|Anesthetics|anesthetics|mesh-ancestor
65435154|NCT01040234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65435155|NCT01040234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435156|NCT01040234|Sensory System Agents|sensory system agents|mesh-ancestor
65435157|NCT01040234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65435158|NCT00396656|Atenolol|atenolol|mesh-list
65435159|NCT00396656|Valsartan|valsartan|mesh-list
65435160|NCT00396656|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65435161|NCT00396656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65435162|NCT00396656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65435163|NCT00396656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65435164|NCT00396656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435165|NCT00396656|Diuretics|diuretics|mesh-ancestor
65435166|NCT00396656|Natriuretic Agents|natriuretic agents|mesh-ancestor
65435167|NCT00396656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435168|NCT00396656|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65435169|NCT00396656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65435170|NCT00396656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65435171|NCT00396656|Sympatholytics|sympatholytics|mesh-ancestor
65435172|NCT00396656|Autonomic Agents|autonomic agents|mesh-ancestor
65435173|NCT00396656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65435174|NCT00396656|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65435175|NCT00396656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65435176|NCT00396656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65435177|NCT00396656|Adrenergic Agents|adrenergic agents|mesh-ancestor
65435178|NCT00396656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65435179|NCT00408434|Efatutazone|efatutazone|mesh-list
65435180|NCT00408434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435181|NCT00418886|Pemetrexed|pemetrexed|mesh-list
65435182|NCT00418886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435183|NCT00418886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435184|NCT00418886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435185|NCT00418886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65435186|NCT00418886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65435187|NCT01040312|Cisplatin|cisplatin|mesh-list
65435188|NCT01040312|Carboplatin|carboplatin|mesh-list
65435189|NCT01040312|Nedaplatin|nedaplatin|mesh-list
65435190|NCT01040312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435198|NCT00407030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435200|NCT00407030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65435201|NCT00406640|Citalopram|citalopram|mesh-list
65435202|NCT00406640|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65435203|NCT00406640|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65435204|NCT00406640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65435205|NCT00406640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65435206|NCT00406640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435207|NCT00406640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65435208|NCT00406640|Serotonin Agents|serotonin agents|mesh-ancestor
65435209|NCT00406640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435210|NCT00406640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65435211|NCT00406640|Antidepressive Agents|antidepressive agents|mesh-ancestor
65435212|NCT00406640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65435213|NCT00406640|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65435214|NCT01043510|Insulin|insulin|mesh-list
65435215|NCT01043510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65435216|NCT01043510|Insulin Detemir|insulin detemir|mesh-list
65435217|NCT01043510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65435218|NCT01043510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435219|NCT01043666|Mirabegron|mirabegron|mesh-list
65435220|NCT01043666|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65435221|NCT01043666|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65435222|NCT01043666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65435223|NCT01043666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65435224|NCT01043666|Adrenergic Agents|adrenergic agents|mesh-ancestor
65435225|NCT01043666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65435226|NCT01043666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435227|NCT01043666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435228|NCT01043666|Urological Agents|urological agents|mesh-ancestor
65435229|NCT01043666|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65435230|NCT01043666|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65435231|NCT01043666|Cholinergic Agents|cholinergic agents|mesh-ancestor
65435232|NCT00394472|Lesogaberan|lesogaberan|mesh-list
65435233|NCT00394472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65435234|NCT00394472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65435235|NCT00394472|GABA Agonists|gaba agonists|mesh-ancestor
65435236|NCT00394472|GABA Agents|gaba agents|mesh-ancestor
65435237|NCT00394472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65435238|NCT00394472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435239|NCT00394472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435240|NCT00395486|Atorvastatin|atorvastatin|mesh-list
65435241|NCT00395486|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65435242|NCT00395486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65435243|NCT00395486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65435244|NCT00395486|Antimetabolites|antimetabolites|mesh-ancestor
65435245|NCT00395486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270039|NCT02726126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435246|NCT00395486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65435247|NCT00395486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65435248|NCT00395486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435249|NCT01043744|Lumefantrine|lumefantrine|mesh-list
65435250|NCT01043744|Artemether|artemether|mesh-list
65435251|NCT01043744|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65435252|NCT01043744|Antimalarials|antimalarials|mesh-ancestor
65435253|NCT01043744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64819968|NCT01508182|Canagliflozin|canagliflozin|mesh-list
65435264|NCT01036412|Dermatologic Agents|dermatologic agents|mesh-ancestor
65435265|NCT00375518|Atorvastatin|atorvastatin|mesh-list
65435266|NCT00375518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65435267|NCT00375518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65435268|NCT00375518|Antimetabolites|antimetabolites|mesh-ancestor
65435269|NCT00375518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435270|NCT00375518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65435271|NCT00375518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65435272|NCT00375518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435274|NCT01045772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65435275|NCT01045928|Rituximab|rituximab|mesh-list
65435276|NCT01045928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65435277|NCT01045928|Lenalidomide|lenalidomide|mesh-list
65435278|NCT01045928|Antibodies|antibodies|mesh-list
65435279|NCT01045928|Immunoglobulins|immunoglobulins|mesh-list
65435280|NCT01045928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65435281|NCT01045928|Immunologic Factors|immunologic factors|mesh-ancestor
65435282|NCT01045928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435283|NCT01045928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435284|NCT01045928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65435285|NCT01045928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65435286|NCT01045928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65435287|NCT01045928|Growth Substances|growth substances|mesh-ancestor
65435288|NCT01045928|Growth Inhibitors|growth inhibitors|mesh-ancestor
65435289|NCT00256750|Cyclosporine|cyclosporine|mesh-list
65435290|NCT00256750|Abatacept|abatacept|mesh-list
65435291|NCT00256750|Cyclosporins|cyclosporins|mesh-list
65435292|NCT00256750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435293|NCT00256750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435294|NCT00256750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65435295|NCT00256750|Immunologic Factors|immunologic factors|mesh-ancestor
65435296|NCT00256750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435297|NCT00256750|Antifungal Agents|antifungal agents|mesh-ancestor
65435298|NCT00256750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65435299|NCT00256750|Dermatologic Agents|dermatologic agents|mesh-ancestor
65435300|NCT00256750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65435301|NCT00256750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65435302|NCT00256750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65435303|NCT00256750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435304|NCT00279201|Insulin Glargine|insulin glargine|mesh-list
65435305|NCT00279201|Insulin Lispro|insulin lispro|mesh-list
65435306|NCT00279201|Insulin, Isophane|insulin, isophane|mesh-list
65435307|NCT00279201|Biphasic Insulins|biphasic insulins|mesh-list
65435308|NCT00279201|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
65435309|NCT00279201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65435310|NCT00279201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435311|NCT00203476|Niacin|niacin|mesh-list
65435312|NCT00203476|Ezetimibe|ezetimibe|mesh-list
65435313|NCT00203476|Colestipol|colestipol|mesh-list
65435314|NCT00203476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65435315|NCT00203476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65435316|NCT00203476|Antimetabolites|antimetabolites|mesh-ancestor
65435317|NCT00203476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435318|NCT00203476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65435319|NCT00203476|Vasodilator Agents|vasodilator agents|mesh-ancestor
65435320|NCT00203476|Vitamin B Complex|vitamin b complex|mesh-ancestor
65435321|NCT00203476|Vitamins|vitamins|mesh-ancestor
65435322|NCT00203476|Micronutrients|micronutrients|mesh-ancestor
65435323|NCT00203476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435351|NCT00227266|Valproic Acid|valproic acid|mesh-list
65435352|NCT00227266|Anticonvulsants|anticonvulsants|mesh-ancestor
65435353|NCT00227266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435354|NCT00227266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435355|NCT00227266|GABA Agents|gaba agents|mesh-ancestor
65435356|NCT00227266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65435357|NCT00227266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435358|NCT00227266|Antimanic Agents|antimanic agents|mesh-ancestor
65435359|NCT00227266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65435360|NCT00227266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65435361|NCT00227266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65435362|NCT00256282|Docetaxel|docetaxel|mesh-list
65435363|NCT00256282|Vinorelbine|vinorelbine|mesh-list
65435364|NCT00256282|Sargramostim|sargramostim|mesh-list
65435365|NCT00256282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435366|NCT00256282|Tubulin Modulators|tubulin modulators|mesh-ancestor
65435367|NCT00256282|Antimitotic Agents|antimitotic agents|mesh-ancestor
65435368|NCT00256282|Mitosis Modulators|mitosis modulators|mesh-ancestor
65435369|NCT00256282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435370|NCT00256282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65435371|NCT00256282|Immunologic Factors|immunologic factors|mesh-ancestor
65435372|NCT00256282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435373|NCT00256204|Rasagiline|rasagiline|mesh-list
65435384|NCT03972358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65435385|NCT03972358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435386|NCT03972358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65435387|NCT03972358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65435388|NCT03972358|Oxytocics|oxytocics|mesh-ancestor
65435389|NCT03972358|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65435390|NCT03972358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65435391|NCT03972358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65435392|NCT03972358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65435393|NCT03972358|Contraceptive Agents|contraceptive agents|mesh-ancestor
65435394|NCT03972358|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65435395|NCT03972358|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65435396|NCT03972358|Hormone Antagonists|hormone antagonists|mesh-ancestor
65435397|NCT03972358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65435398|NCT03972358|Luteolytic Agents|luteolytic agents|mesh-ancestor
65435399|NCT03972358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65435400|NCT03972358|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65435401|NCT01073332|Antioxidants|antioxidants|mesh-list
65435402|NCT01073332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435403|NCT01073332|Protective Agents|protective agents|mesh-ancestor
65435404|NCT01073332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435405|NCT03972046|Trametinib|trametinib|mesh-list
65435406|NCT03972046|Dabrafenib|dabrafenib|mesh-list
65435407|NCT03972046|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
65435408|NCT03972046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435409|NCT03972046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65435410|NCT03972046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435411|NCT03972046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435412|NCT03972046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65435413|NCT01071772|Insulin|insulin|mesh-list
65435414|NCT01071772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65435415|NCT01071772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435416|NCT01074346|Interferons|interferons|mesh-list
65435417|NCT01074346|Interferon-beta|interferon-beta|mesh-list
65435418|NCT01074346|Interferon beta-1a|interferon beta-1a|mesh-list
65435419|NCT01074346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435420|NCT01074346|Antiviral Agents|antiviral agents|mesh-ancestor
65435421|NCT01074346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65435422|NCT01074346|Immunologic Factors|immunologic factors|mesh-ancestor
65435423|NCT01074346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435424|NCT01074346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65435426|NCT00278889|Bevacizumab|bevacizumab|mesh-list
65435427|NCT00278889|Fluorouracil|fluorouracil|mesh-list
65435428|NCT00278889|Oxaliplatin|oxaliplatin|mesh-list
65435429|NCT00278889|Cediranib|cediranib|mesh-list
65435430|NCT00278889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65435431|NCT00278889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435432|NCT00278889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65435433|NCT00278889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65435434|NCT00278889|Growth Substances|growth substances|mesh-ancestor
65435435|NCT00278889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435436|NCT00278889|Growth Inhibitors|growth inhibitors|mesh-ancestor
65435437|NCT00278889|Antimetabolites|antimetabolites|mesh-ancestor
65435438|NCT00278889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435450|NCT01070745|Indomethacin|indomethacin|mesh-list
65435451|NCT01070745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65435452|NCT01070745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65435453|NCT01070745|Analgesics|analgesics|mesh-ancestor
65435454|NCT01070745|Sensory System Agents|sensory system agents|mesh-ancestor
65435455|NCT01070745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65435456|NCT01070745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435457|NCT01070745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65435458|NCT01070745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65435459|NCT01070745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65435460|NCT01070745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435461|NCT01070745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435462|NCT01070745|Gout Suppressants|gout suppressants|mesh-ancestor
65435463|NCT01070745|Tocolytic Agents|tocolytic agents|mesh-ancestor
65435464|NCT01070745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65435465|NCT01071057|Morphine|morphine|mesh-list
65435466|NCT01071057|Naloxone|naloxone|mesh-list
65435467|NCT01071057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65435468|NCT01071057|Narcotics|narcotics|mesh-ancestor
65435469|NCT01071057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65435470|NCT01071057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435471|NCT01071057|Analgesics|analgesics|mesh-ancestor
65435472|NCT01071057|Sensory System Agents|sensory system agents|mesh-ancestor
65435473|NCT01071057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65435474|NCT01071057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65435475|NCT00278109|Cyclophosphamide|cyclophosphamide|mesh-list
65435476|NCT00278109|Doxorubicin|doxorubicin|mesh-list
65435477|NCT00278109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65435478|NCT00278109|Immunologic Factors|immunologic factors|mesh-ancestor
65435479|NCT00278109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435480|NCT00278109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65435481|NCT00278109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65435482|NCT00278109|Alkylating Agents|alkylating agents|mesh-ancestor
65435483|NCT00278109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435484|NCT00278109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435485|NCT00278109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65435486|NCT00278109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65435487|NCT00278109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65435488|NCT00278109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65435489|NCT00278109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435490|NCT00296517|Bupropion|bupropion|mesh-list
65435491|NCT00296517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65435492|NCT00296517|Antidepressive Agents|antidepressive agents|mesh-ancestor
65435493|NCT00296517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65435494|NCT00296517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65435495|NCT00296517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65435496|NCT00296517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65435497|NCT00296517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435498|NCT00296517|Dopamine Agents|dopamine agents|mesh-ancestor
65185029|NCT02768116|Sirolimus|sirolimus|mesh-list
65435499|NCT00296517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65435500|NCT00296517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435501|NCT00296517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65435502|NCT00296517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65435516|NCT00266409|GABA Agents|gaba agents|mesh-ancestor
65435517|NCT00266409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65435518|NCT00266409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435519|NCT00265785|Pemetrexed|pemetrexed|mesh-list
65435520|NCT00265785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435521|NCT00265785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435522|NCT00265785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435523|NCT00265785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65435524|NCT00265785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65435525|NCT02532153|Ketamine|ketamine|mesh-list
65435526|NCT02532153|Analgesics|analgesics|mesh-ancestor
65435527|NCT02532153|Sensory System Agents|sensory system agents|mesh-ancestor
65435528|NCT02532153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65435529|NCT02532153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435530|NCT02532153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65435531|NCT02532153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65435532|NCT02532153|Anesthetics, General|anesthetics, general|mesh-ancestor
65435533|NCT02532153|Anesthetics|anesthetics|mesh-ancestor
65435534|NCT02532153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65435535|NCT02532153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65435536|NCT02532153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65435537|NCT02532153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65435538|NCT02532153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435539|NCT00265395|Interferons|interferons|mesh-list
65435540|NCT00265395|Ribavirin|ribavirin|mesh-list
65270040|NCT02726126|Protective Agents|protective agents|mesh-ancestor
65270041|NCT02694458|Vancomycin|vancomycin|mesh-list
65435541|NCT00265395|Interferon-alpha|interferon-alpha|mesh-list
65435542|NCT00265395|Interferon alpha-2|interferon alpha-2|mesh-list
65435543|NCT00265395|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65435544|NCT00265395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435545|NCT00265395|Antiviral Agents|antiviral agents|mesh-ancestor
65435546|NCT00265395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65435547|NCT00265395|Antimetabolites|antimetabolites|mesh-ancestor
65435548|NCT00265395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435549|NCT00265395|Immunologic Factors|immunologic factors|mesh-ancestor
65435550|NCT00265395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435551|NCT01582113|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
65435552|NCT01582113|Nootropic Agents|nootropic agents|mesh-ancestor
65435553|NCT00195442|Factor VIII|factor viii|mesh-list
65435554|NCT00195442|Coagulants|coagulants|mesh-ancestor
65435555|NCT01070823|Natalizumab|natalizumab|mesh-list
65435556|NCT01070823|Immunologic Factors|immunologic factors|mesh-ancestor
65435557|NCT01070823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435558|NCT01071135|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65435559|NCT01071135|Antidepressive Agents|antidepressive agents|mesh-ancestor
65435560|NCT01071135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65435561|NCT01071135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65435562|NCT01071135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65435563|NCT01071135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64820281|NCT01509976|Triclosan|triclosan|mesh-list
65435571|NCT00275301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65435572|NCT00275301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65435573|NCT00275301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65435574|NCT00275301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65435575|NCT00275301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65435576|NCT00275301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65435577|NCT00275301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65435578|NCT00275301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435579|NCT00275301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65435580|NCT00275301|Serotonin Agents|serotonin agents|mesh-ancestor
65435581|NCT02531997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65435582|NCT02531997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65435583|NCT02531997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435584|NCT00251745|Dexlansoprazole|dexlansoprazole|mesh-list
65435586|NCT00251745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65435587|NCT00251745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65435588|NCT00251745|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65435589|NCT00251745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435590|NCT00251745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435591|NCT00255190|Dexlansoprazole|dexlansoprazole|mesh-list
65435592|NCT00255190|Lansoprazole|lansoprazole|mesh-list
65435593|NCT00255190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65435594|NCT00255190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65435595|NCT00255190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65435596|NCT00255190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435597|NCT00255190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435598|NCT00359424|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65435599|NCT00359424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65435600|NCT00359424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65435601|NCT00359424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435602|NCT01049646|Angiotensin II|angiotensin ii|mesh-list
65435603|NCT01049646|Giapreza|giapreza|mesh-list
65435604|NCT01049646|Angiotensinogen|angiotensinogen|mesh-list
65435605|NCT01049646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65435606|NCT01049646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65435607|NCT01049646|Protease Inhibitors|protease inhibitors|mesh-ancestor
65435608|NCT01049646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435609|NCT01049646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435610|NCT02286414|Vitamins|vitamins|mesh-list
65435611|NCT02286414|Vitamin K|vitamin k|mesh-list
65435612|NCT02286414|Warfarin|warfarin|mesh-list
65435613|NCT02286414|Rivaroxaban|rivaroxaban|mesh-list
65435614|NCT02286414|Dabigatran|dabigatran|mesh-list
65435615|NCT02286414|Apixaban|apixaban|mesh-list
65435616|NCT02286414|Acenocoumarol|acenocoumarol|mesh-list
65435617|NCT02286414|Fluindione|fluindione|mesh-list
65435618|NCT02286414|Micronutrients|micronutrients|mesh-ancestor
65435619|NCT02286414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435620|NCT02286414|Anticoagulants|anticoagulants|mesh-ancestor
65435621|NCT02286414|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65002838|NCT00444886|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65435622|NCT02286414|Antithrombins|antithrombins|mesh-ancestor
65435623|NCT02286414|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65435624|NCT02286414|Protease Inhibitors|protease inhibitors|mesh-ancestor
65435625|NCT02286414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435626|NCT02286414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435627|NCT02286414|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65435628|NCT02286414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65435629|NCT02286414|Hemostatics|hemostatics|mesh-ancestor
65435630|NCT02286414|Coagulants|coagulants|mesh-ancestor
65435631|NCT00255034|Ribavirin|ribavirin|mesh-list
65435632|NCT00255034|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65435633|NCT00255034|Interferon-alpha|interferon-alpha|mesh-list
65435642|NCT00254566|Azithromycin|azithromycin|mesh-list
65435643|NCT00254566|Moxifloxacin|moxifloxacin|mesh-list
65435644|NCT00254566|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65435645|NCT00254566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65435646|NCT00254566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65435647|NCT00254566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65435648|NCT00254566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65435649|NCT00254566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435650|NCT00254566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435651|NCT00254566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435652|NCT00254566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65435653|NCT00254566|Contraceptive Agents|contraceptive agents|mesh-ancestor
65435654|NCT00254566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65435655|NCT00254566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435656|NCT00254566|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65435657|NCT00254566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65435658|NCT00254566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65435659|NCT02531854|Pemetrexed|pemetrexed|mesh-list
65435660|NCT02531854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435661|NCT02531854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435662|NCT02531854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435663|NCT02531854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65435664|NCT02531854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65435665|NCT01048086|Tretinoin|tretinoin|mesh-list
65435666|NCT01048086|Isotretinoin|isotretinoin|mesh-list
65435667|NCT01048086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435668|NCT01048086|Keratolytic Agents|keratolytic agents|mesh-ancestor
65435669|NCT01048086|Dermatologic Agents|dermatologic agents|mesh-ancestor
65435670|NCT03830892|Nicotine|nicotine|mesh-list
65435671|NCT03830892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65435672|NCT03830892|Autonomic Agents|autonomic agents|mesh-ancestor
65435673|NCT03830892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65435674|NCT03830892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435675|NCT03830892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65435676|NCT03830892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65435677|NCT03830892|Cholinergic Agents|cholinergic agents|mesh-ancestor
65435678|NCT03830892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65435679|NCT03830892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435680|NCT01049880|Ascorbic Acid|ascorbic acid|mesh-list
65435681|NCT01049880|Gemcitabine|gemcitabine|mesh-list
65435682|NCT01049880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65435683|NCT01049880|Antimetabolites|antimetabolites|mesh-ancestor
65435684|NCT01049880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435685|NCT01049880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435686|NCT01049880|Antiviral Agents|antiviral agents|mesh-ancestor
65435687|NCT01049880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65435688|NCT01049880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435689|NCT01049880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65435690|NCT01049880|Immunologic Factors|immunologic factors|mesh-ancestor
65435691|NCT01049880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435692|NCT01049880|Antioxidants|antioxidants|mesh-ancestor
65435693|NCT01049880|Protective Agents|protective agents|mesh-ancestor
65435694|NCT01049880|Vitamins|vitamins|mesh-ancestor
65435695|NCT01049880|Micronutrients|micronutrients|mesh-ancestor
65435696|NCT00253630|Vorinostat|vorinostat|mesh-list
65435697|NCT00253630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435698|NCT00253630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65435699|NCT00253630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435700|NCT00253630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435721|NCT03990480|Amlodipine|amlodipine|mesh-list
65435722|NCT03990480|Valsartan|valsartan|mesh-list
65435723|NCT03990480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65435724|NCT03990480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65435725|NCT03990480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65435726|NCT03990480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435727|NCT03990480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65435728|NCT03990480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435729|NCT03990480|Vasodilator Agents|vasodilator agents|mesh-ancestor
65435730|NCT03990480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65435731|NCT03990480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65435732|NCT00369486|Triamcinolone|triamcinolone|mesh-list
65435733|NCT00369486|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65435734|NCT00369486|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65435735|NCT00369486|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65435736|NCT00369486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65435737|NCT00369486|Glucocorticoids|glucocorticoids|mesh-ancestor
65435738|NCT00369486|Hormones|hormones|mesh-ancestor
65435739|NCT00369486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65435740|NCT00369486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435741|NCT00369486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65435742|NCT00369486|Immunologic Factors|immunologic factors|mesh-ancestor
65435743|NCT00369486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435744|NCT00369486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435745|NCT00363480|Fluticasone|fluticasone|mesh-list
65435746|NCT00363480|Albuterol|albuterol|mesh-list
65435747|NCT00363480|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65435748|NCT00363480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65435749|NCT00363480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65435750|NCT00363480|Autonomic Agents|autonomic agents|mesh-ancestor
65435751|NCT00363480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65435752|NCT00363480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435753|NCT00363480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65435754|NCT00363480|Respiratory System Agents|respiratory system agents|mesh-ancestor
65435781|NCT01073644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65435782|NCT01073644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65435783|NCT01073644|Growth Substances|growth substances|mesh-ancestor
65435784|NCT01073644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435785|NCT01073644|Growth Inhibitors|growth inhibitors|mesh-ancestor
65435786|NCT01073644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65435787|NCT01073644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435788|NCT01073644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435789|NCT03992586|Methamphetamine|methamphetamine|mesh-list
65435790|NCT03992586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65435791|NCT03992586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435792|NCT03992586|Sympathomimetics|sympathomimetics|mesh-ancestor
65435793|NCT03992586|Autonomic Agents|autonomic agents|mesh-ancestor
65435794|NCT03992586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65435795|NCT03992586|Dopamine Agents|dopamine agents|mesh-ancestor
65435796|NCT03992586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65435797|NCT03992586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435798|NCT03992586|Adrenergic Agents|adrenergic agents|mesh-ancestor
65435799|NCT03992586|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65435800|NCT03992586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65435801|NCT03992586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65435802|NCT03992586|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65435803|NCT00221104|Pravastatin|pravastatin|mesh-list
65435820|NCT01071928|Docetaxel|docetaxel|mesh-list
65435821|NCT01071928|Vadimezan|vadimezan|mesh-list
65435822|NCT01071928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435823|NCT01071928|Tubulin Modulators|tubulin modulators|mesh-ancestor
65435824|NCT01071928|Antimitotic Agents|antimitotic agents|mesh-ancestor
65435825|NCT01071928|Mitosis Modulators|mitosis modulators|mesh-ancestor
65435826|NCT01071928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435827|NCT00187486|Temozolomide|temozolomide|mesh-list
65435828|NCT00187486|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65435829|NCT00187486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65435830|NCT00187486|Alkylating Agents|alkylating agents|mesh-ancestor
65435831|NCT00187486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435832|NCT00187486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435833|NCT00187486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65435834|NCT00187486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435835|NCT00220636|Aripiprazole|aripiprazole|mesh-list
65435836|NCT00220636|Antidepressive Agents|antidepressive agents|mesh-ancestor
65435837|NCT00220636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65435838|NCT00220636|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65435839|NCT00220636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65002985|NCT00446017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65435840|NCT00220636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65435841|NCT00220636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435842|NCT00220636|Dopamine Agonists|dopamine agonists|mesh-ancestor
65435843|NCT00220636|Dopamine Agents|dopamine agents|mesh-ancestor
65435844|NCT00220636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65435845|NCT00220636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435846|NCT00220636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65435847|NCT00220636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65435848|NCT00220636|Serotonin Agents|serotonin agents|mesh-ancestor
65435849|NCT00220636|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65435850|NCT00220636|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65435851|NCT00220636|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65435852|NCT00220636|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65435853|NCT00362232|Enoxaparin|enoxaparin|mesh-list
65435854|NCT00362232|Rivaroxaban|rivaroxaban|mesh-list
65435855|NCT00362232|Enoxaparin sodium|enoxaparin sodium|mesh-list
65435856|NCT00362232|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65435857|NCT00362232|Antithrombins|antithrombins|mesh-ancestor
65435858|NCT00362232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65435859|NCT00362232|Protease Inhibitors|protease inhibitors|mesh-ancestor
65435860|NCT00362232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435861|NCT00362232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435879|NCT00219544|Sensory System Agents|sensory system agents|mesh-ancestor
65435880|NCT00219544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65435881|NCT00219544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435882|NCT00219544|Anticonvulsants|anticonvulsants|mesh-ancestor
65435883|NCT00219544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65435884|NCT00219544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65435885|NCT00219544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435886|NCT00219544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65435887|NCT00219544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65435888|NCT00219544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65435889|NCT00219544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65435890|NCT00219544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65435892|NCT00357552|Lopinavir|lopinavir|mesh-list
65435893|NCT00357552|Tenofovir|tenofovir|mesh-list
65435894|NCT00357552|Emtricitabine|emtricitabine|mesh-list
65435895|NCT00357552|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65435896|NCT00357552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65435897|NCT00357552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65435898|NCT00357552|Protease Inhibitors|protease inhibitors|mesh-ancestor
65435899|NCT00357552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435900|NCT00357552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435901|NCT00357552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65435902|NCT00357552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65435903|NCT00357552|Antiviral Agents|antiviral agents|mesh-ancestor
65435904|NCT00357552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65435905|NCT00357552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65435906|NCT00357552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65435907|NCT00357552|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65435908|NCT00357552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65435909|NCT00187096|Cyclophosphamide|cyclophosphamide|mesh-list
65435910|NCT00187096|Fludarabine|fludarabine|mesh-list
65435911|NCT00187096|Etoposide|etoposide|mesh-list
65435912|NCT00187096|Interleukin-2|interleukin-2|mesh-list
65435913|NCT00187096|Clofarabine|clofarabine|mesh-list
65435914|NCT00187096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65435915|NCT00187096|Immunologic Factors|immunologic factors|mesh-ancestor
65435916|NCT00187096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435917|NCT00187096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65435918|NCT00187096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65435938|NCT00357396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435940|NCT00357396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65435941|NCT00357396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65435942|NCT00357396|Immunologic Factors|immunologic factors|mesh-ancestor
65435943|NCT00357396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435944|NCT00186628|Acetaminophen|acetaminophen|mesh-list
65435945|NCT00186628|Diphenhydramine|diphenhydramine|mesh-list
65435946|NCT00186628|Promethazine|promethazine|mesh-list
65435947|NCT00186628|Cyclosporine|cyclosporine|mesh-list
65435948|NCT00186628|Hydrocortisone|hydrocortisone|mesh-list
65185483|NCT05362292|Urological Agents|urological agents|mesh-ancestor
65003064|NCT00114179|Antibodies|antibodies|mesh-list
65435949|NCT00186628|Methylprednisolone|methylprednisolone|mesh-list
65435950|NCT00186628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65435951|NCT00186628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65435952|NCT00186628|Prednisolone|prednisolone|mesh-list
65435953|NCT00186628|Prednisolone acetate|prednisolone acetate|mesh-list
65435954|NCT00186628|Rituximab|rituximab|mesh-list
65435955|NCT00186628|Granisetron|granisetron|mesh-list
65435956|NCT00186628|Lenograstim|lenograstim|mesh-list
65435957|NCT00186628|Cyclosporins|cyclosporins|mesh-list
65435958|NCT00186628|Thymoglobulin|thymoglobulin|mesh-list
65435959|NCT00186628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65435960|NCT00186628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65435961|NCT00186628|Prednisolone phosphate|prednisolone phosphate|mesh-list
65435962|NCT00186628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65435963|NCT00186628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435964|NCT00186628|Immunologic Factors|immunologic factors|mesh-ancestor
65435965|NCT00186628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435966|NCT00186628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65435967|NCT00186628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65435968|NCT00186628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435969|NCT00186628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435970|NCT00186628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65435971|NCT00186628|Antifungal Agents|antifungal agents|mesh-ancestor
65435972|NCT00186628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65435973|NCT00186628|Dermatologic Agents|dermatologic agents|mesh-ancestor
65435974|NCT00186628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65435994|NCT00186628|Anesthetics|anesthetics|mesh-ancestor
65435995|NCT00186628|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65435996|NCT00186628|Histamine Antagonists|histamine antagonists|mesh-ancestor
65435997|NCT00186628|Histamine Agents|histamine agents|mesh-ancestor
65435998|NCT00186628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65435999|NCT00186628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65436000|NCT00186628|Antipruritics|antipruritics|mesh-ancestor
65436001|NCT00186628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65436002|NCT00186628|Serotonin Agents|serotonin agents|mesh-ancestor
65436003|NCT00368550|Sertraline|sertraline|mesh-list
65436004|NCT00368550|Antidepressive Agents|antidepressive agents|mesh-ancestor
65436005|NCT00368550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65436006|NCT00368550|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65436007|NCT00368550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65436008|NCT00368550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65436009|NCT00368550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436010|NCT00368550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65436011|NCT00368550|Serotonin Agents|serotonin agents|mesh-ancestor
65436012|NCT00368550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436013|NCT01050036|Busulfan|busulfan|mesh-list
65436014|NCT01050036|Alkylating Agents|alkylating agents|mesh-ancestor
65436015|NCT01050036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436016|NCT01050036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65436017|NCT01050036|Immunologic Factors|immunologic factors|mesh-ancestor
65436018|NCT01050036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436019|NCT01050036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65436020|NCT01050036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436021|NCT01050036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65436022|NCT00357006|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65436023|NCT00357006|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65436024|NCT00357006|Estradiol|estradiol|mesh-list
65436025|NCT00357006|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65436026|NCT00357006|Estrogens|estrogens|mesh-ancestor
65436027|NCT00357006|Hormones|hormones|mesh-ancestor
65436028|NCT00357006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65436029|NCT00357006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820755|NCT01512004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65436060|NCT00165646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436061|NCT01050270|Acetylcysteine|acetylcysteine|mesh-list
65436062|NCT01050270|Ondansetron|ondansetron|mesh-list
65436063|NCT01050270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65436064|NCT01050270|Antiemetics|antiemetics|mesh-ancestor
65436065|NCT01050270|Autonomic Agents|autonomic agents|mesh-ancestor
65436066|NCT01050270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65436067|NCT01050270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436068|NCT01050270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65436069|NCT01050270|Antipruritics|antipruritics|mesh-ancestor
65436070|NCT01050270|Dermatologic Agents|dermatologic agents|mesh-ancestor
65436071|NCT01050270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65003145|NCT00447031|Hormones|hormones|mesh-ancestor
65436072|NCT01050270|Serotonin Agents|serotonin agents|mesh-ancestor
65436073|NCT01050270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65436074|NCT01050270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436075|NCT01050270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65436085|NCT01050270|Antioxidants|antioxidants|mesh-ancestor
65436086|NCT01050270|Protective Agents|protective agents|mesh-ancestor
65436087|NCT01050270|Antidotes|antidotes|mesh-ancestor
65436088|NCT00367770|Bosentan|bosentan|mesh-list
65436089|NCT00367770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65436090|NCT00367770|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65436091|NCT00367770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436092|NCT00185614|Cyclosporine|cyclosporine|mesh-list
65436093|NCT00185614|Mycophenolic Acid|mycophenolic acid|mesh-list
65436094|NCT00185614|Cyclophosphamide|cyclophosphamide|mesh-list
65436095|NCT00185614|Melphalan|melphalan|mesh-list
65436096|NCT00185614|Cyclosporins|cyclosporins|mesh-list
65436097|NCT00185614|Lenograstim|lenograstim|mesh-list
65436098|NCT00185614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65436099|NCT00185614|Immunologic Factors|immunologic factors|mesh-ancestor
65436100|NCT00185614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436101|NCT00185614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65185645|NCT01186328|Cytarabine|cytarabine|mesh-list
65436102|NCT00185614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65436103|NCT00185614|Alkylating Agents|alkylating agents|mesh-ancestor
65436104|NCT00185614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436105|NCT00185614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436106|NCT00185614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65436107|NCT00185614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65436108|NCT00185614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436109|NCT00185614|Antifungal Agents|antifungal agents|mesh-ancestor
65436110|NCT00185614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65436111|NCT00185614|Dermatologic Agents|dermatologic agents|mesh-ancestor
65436112|NCT00185614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65436113|NCT00185614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65436114|NCT00185614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65436115|NCT00185614|Antitubercular Agents|antitubercular agents|mesh-ancestor
65436116|NCT00185614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65436118|NCT01075438|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65436119|NCT01075438|Immunologic Factors|immunologic factors|mesh-ancestor
65436120|NCT01075438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436121|NCT00361842|Irinotecan|irinotecan|mesh-list
65436122|NCT00361842|Floxuridine|floxuridine|mesh-list
65436123|NCT00361842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65436124|NCT00361842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65436125|NCT00361842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436126|NCT00361842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436127|NCT00361842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436128|NCT00361842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65436129|NCT00361842|Antimetabolites|antimetabolites|mesh-ancestor
65436130|NCT01324752|Losartan|losartan|mesh-list
65436131|NCT01324752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65436132|NCT01324752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65436133|NCT01324752|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65436134|NCT01324752|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65436135|NCT01324752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436136|NCT01050348|Atorvastatin|atorvastatin|mesh-list
65436137|NCT01050348|Calcium|calcium|mesh-list
65436138|NCT01050348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65436139|NCT01050348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436140|NCT01050348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65436141|NCT01050348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65436142|NCT01050348|Antimetabolites|antimetabolites|mesh-ancestor
65436165|NCT01053390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65436166|NCT01053390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436168|NCT01053390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65436169|NCT00356148|Ampicillin|ampicillin|mesh-list
65436170|NCT00356148|Sulbactam|sulbactam|mesh-list
65436171|NCT00356148|Sultamicillin|sultamicillin|mesh-list
65436172|NCT00356148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65436173|NCT00356148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65436174|NCT00356148|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65436175|NCT00356148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436176|NCT00356148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436177|NCT00361218|Citalopram|citalopram|mesh-list
65436178|NCT00361218|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65436179|NCT00361218|Serotonin|serotonin|mesh-list
65436180|NCT00361218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65436181|NCT00361218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65436182|NCT00361218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436183|NCT00361218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65436184|NCT00361218|Serotonin Agents|serotonin agents|mesh-ancestor
65436185|NCT00361218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436186|NCT00361218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65436187|NCT00361218|Antidepressive Agents|antidepressive agents|mesh-ancestor
65436188|NCT00361218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65436189|NCT00361218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65436190|NCT01049022|Moxifloxacin|moxifloxacin|mesh-list
65436191|NCT01049022|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65436192|NCT01049022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65436193|NCT01049022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65436194|NCT01049022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65436216|NCT02534610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65436217|NCT02534610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436218|NCT02534610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436219|NCT01050426|Leucovorin|leucovorin|mesh-list
65436220|NCT01050426|Cetuximab|cetuximab|mesh-list
65436221|NCT01050426|Levoleucovorin|levoleucovorin|mesh-list
65436222|NCT01050426|Antidotes|antidotes|mesh-ancestor
65436223|NCT01050426|Protective Agents|protective agents|mesh-ancestor
65436224|NCT01050426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436225|NCT01050426|Vitamin B Complex|vitamin b complex|mesh-ancestor
65436226|NCT01050426|Vitamins|vitamins|mesh-ancestor
65436227|NCT01050426|Micronutrients|micronutrients|mesh-ancestor
65436228|NCT01050426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65436229|NCT01050426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436230|NCT00367458|Atorvastatin|atorvastatin|mesh-list
65436231|NCT00367458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65436232|NCT00367458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65436233|NCT00367458|Antimetabolites|antimetabolites|mesh-ancestor
65436234|NCT00367458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436235|NCT00367458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65436236|NCT00367458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65436237|NCT00367458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436238|NCT00252694|Candesartan|candesartan|mesh-list
65436239|NCT00252694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65436240|NCT00252694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65436241|NCT00252694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65436242|NCT00252694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436243|NCT00185380|Levonorgestrel|levonorgestrel|mesh-list
65436244|NCT00185380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65436245|NCT00185380|Contraceptive Agents|contraceptive agents|mesh-ancestor
64820968|NCT01513174|Olaparib|olaparib|mesh-list
65436268|NCT00366678|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65436269|NCT00366678|Immunologic Factors|immunologic factors|mesh-ancestor
65436270|NCT00366678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436271|NCT01049178|Silymarin|silymarin|mesh-list
65436272|NCT01049178|Antioxidants|antioxidants|mesh-ancestor
65436273|NCT01049178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436274|NCT01049178|Protective Agents|protective agents|mesh-ancestor
65436275|NCT01049178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436276|NCT02534454|Nicotine|nicotine|mesh-list
65436277|NCT02534454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65436278|NCT02534454|Autonomic Agents|autonomic agents|mesh-ancestor
65436279|NCT02534454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65436280|NCT02534454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436281|NCT02534454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65436282|NCT02534454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65436283|NCT02534454|Cholinergic Agents|cholinergic agents|mesh-ancestor
65436284|NCT02534454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65436285|NCT02534454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436286|NCT00355368|Rocuronium|rocuronium|mesh-list
65436287|NCT00355368|Succinylcholine|succinylcholine|mesh-list
65436288|NCT00355368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65436289|NCT00355368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65436290|NCT00355368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65436291|NCT00355368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65436292|NCT00355368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003288|NCT00114686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65436293|NCT00355368|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
65436294|NCT01054092|Ipragliflozin|ipragliflozin|mesh-list
65436295|NCT01054092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65436296|NCT01054092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436297|NCT01054092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65436327|NCT00373880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65436328|NCT00373880|Anesthetics, Local|anesthetics, local|mesh-ancestor
65436329|NCT00373880|Anesthetics|anesthetics|mesh-ancestor
65436330|NCT00373880|Sensory System Agents|sensory system agents|mesh-ancestor
65436331|NCT00373880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65436332|NCT00373880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65436333|NCT00373880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65436334|NCT00373880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65436335|NCT00373880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65436336|NCT00184600|Insulin|insulin|mesh-list
65436337|NCT00184600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65436338|NCT00184600|Insulin Aspart|insulin aspart|mesh-list
65436339|NCT00184600|Insulin, Long-Acting|insulin, long-acting|mesh-list
65436340|NCT00184600|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65436372|NCT00265239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65436373|NCT00265239|Protective Agents|protective agents|mesh-ancestor
65436374|NCT00265239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436376|NCT00159874|Citric Acid|citric acid|mesh-list
65436377|NCT00159874|Sodium Citrate|sodium citrate|mesh-list
65436378|NCT00159874|Anticoagulants|anticoagulants|mesh-ancestor
65436379|NCT00159874|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65436380|NCT00159874|Chelating Agents|chelating agents|mesh-ancestor
65436381|NCT00159874|Sequestering Agents|sequestering agents|mesh-ancestor
65436382|NCT00159874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436414|NCT00183430|Prazosin|prazosin|mesh-list
65436415|NCT00183430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65436416|NCT00183430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65436417|NCT00183430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65436418|NCT00183430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65436419|NCT00183430|Adrenergic Agents|adrenergic agents|mesh-ancestor
65436420|NCT00183430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65436421|NCT00183430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436422|NCT00183430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436423|NCT00183274|Norepinephrine|norepinephrine|mesh-list
65436424|NCT00183274|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65436425|NCT00183274|Serotonin|serotonin|mesh-list
65436426|NCT00183274|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
65436427|NCT00183274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65436428|NCT00183274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65436444|NCT00183196|Naltrexone|naltrexone|mesh-list
65436445|NCT00183196|Gabapentin|gabapentin|mesh-list
65436446|NCT00183196|Analgesics|analgesics|mesh-ancestor
65436447|NCT00183196|Sensory System Agents|sensory system agents|mesh-ancestor
65436448|NCT00183196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65436449|NCT00183196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436450|NCT00183196|Anticonvulsants|anticonvulsants|mesh-ancestor
65436451|NCT00183196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65436452|NCT00183196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65436453|NCT00183196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65436454|NCT00183196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65436455|NCT00183196|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65436456|NCT00183196|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65436457|NCT00183196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65436458|NCT00183196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436459|NCT00183196|Antimanic Agents|antimanic agents|mesh-ancestor
65436460|NCT00183196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65436461|NCT00183196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65436462|NCT00349752|Certolizumab Pegol|certolizumab pegol|mesh-list
65436463|NCT00349752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65436464|NCT00349752|Immunologic Factors|immunologic factors|mesh-ancestor
65436465|NCT00349752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436466|NCT00349752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65436467|NCT01055652|Dapagliflozin|dapagliflozin|mesh-list
65436468|NCT01055652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65436469|NCT01055652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436470|NCT01055652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65436471|NCT01055652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003371|NCT03276325|Hormones|hormones|mesh-ancestor
65436472|NCT00348816|Prednisone|prednisone|mesh-list
65436473|NCT00348816|Docetaxel|docetaxel|mesh-list
65436474|NCT00348816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436475|NCT00348816|Tubulin Modulators|tubulin modulators|mesh-ancestor
65436476|NCT00348816|Antimitotic Agents|antimitotic agents|mesh-ancestor
65436477|NCT00348816|Mitosis Modulators|mitosis modulators|mesh-ancestor
65436478|NCT00348816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436479|NCT00348816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65436480|NCT00348816|Glucocorticoids|glucocorticoids|mesh-ancestor
65436481|NCT00348816|Hormones|hormones|mesh-ancestor
65436482|NCT00348816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65436483|NCT00348816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436484|NCT00348816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65436485|NCT03989310|Manganese|manganese|mesh-list
65436486|NCT03989310|Gemcitabine|gemcitabine|mesh-list
65436516|NCT03966898|Hormone Antagonists|hormone antagonists|mesh-ancestor
65436517|NCT03966898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65436518|NCT03966898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436519|NCT03966898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65436520|NCT03989700|Thiamine|thiamine|mesh-list
65436521|NCT03989700|Vitamins|vitamins|mesh-ancestor
65436522|NCT03989700|Micronutrients|micronutrients|mesh-ancestor
65436523|NCT03989700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436524|NCT03989700|Vitamin B Complex|vitamin b complex|mesh-ancestor
65436525|NCT01051284|Gemcitabine|gemcitabine|mesh-list
65436526|NCT01051284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65436527|NCT01051284|Antimetabolites|antimetabolites|mesh-ancestor
65436528|NCT01051284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436529|NCT01051284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436530|NCT01051284|Antiviral Agents|antiviral agents|mesh-ancestor
65436531|NCT01051284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65436532|NCT01051284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436533|NCT01051284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65436566|NCT00211809|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65436568|NCT00211809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65436569|NCT01071291|Niacin|niacin|mesh-list
65436570|NCT01071291|Nicotinic Acids|nicotinic acids|mesh-list
65436571|NCT01071291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65436572|NCT01071291|Antimetabolites|antimetabolites|mesh-ancestor
65436573|NCT01071291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436574|NCT01071291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65436601|NCT00149890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65436602|NCT00149890|Dermatologic Agents|dermatologic agents|mesh-ancestor
65436603|NCT00149890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65436604|NCT00149890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65436605|NCT00174382|Donepezil|donepezil|mesh-list
65436606|NCT00174382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65436607|NCT00174382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436608|NCT00174382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436609|NCT00174382|Cholinergic Agents|cholinergic agents|mesh-ancestor
65436610|NCT00174382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65436611|NCT00174382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436612|NCT00174382|Nootropic Agents|nootropic agents|mesh-ancestor
65436613|NCT00355134|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65436614|NCT00355134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65436615|NCT00355134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436616|NCT00355134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65436617|NCT00355134|Immunologic Factors|immunologic factors|mesh-ancestor
65436618|NCT00355134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436619|NCT00171730|Pasireotide|pasireotide|mesh-list
65436620|NCT00171730|Hormones|hormones|mesh-ancestor
65436621|NCT00171730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65436622|NCT00171730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436623|NCT00348348|Moxifloxacin|moxifloxacin|mesh-list
65436667|NCT01055964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65436668|NCT01055964|Immunologic Factors|immunologic factors|mesh-ancestor
65436669|NCT01055964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436670|NCT01055964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65436671|NCT01055964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436672|NCT01055964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436673|NCT01056042|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65436674|NCT01056042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65436675|NCT01056042|Medroxyprogesterone|medroxyprogesterone|mesh-list
65270042|NCT02694458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65003473|NCT00115154|Imiquimod|imiquimod|mesh-list
65436676|NCT01056042|Gestodene|gestodene|mesh-list
65436677|NCT01056042|Estradiol|estradiol|mesh-list
65436678|NCT01056042|Estrogens|estrogens|mesh-ancestor
65436679|NCT01056042|Hormones|hormones|mesh-ancestor
65436680|NCT01056042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65436681|NCT01056042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436682|NCT01056042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65436683|NCT01056042|Contraceptive Agents|contraceptive agents|mesh-ancestor
65436684|NCT01056042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65436685|NCT01056042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65436686|NCT01056042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65436687|NCT01056042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65436688|NCT01056042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65436689|NCT01056042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65436690|NCT01056042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65436691|NCT01056042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436692|NCT01056042|Progestins|progestins|mesh-ancestor
65436693|NCT00373256|Paclitaxel|paclitaxel|mesh-list
65436694|NCT00373256|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65436695|NCT00373256|Bevacizumab|bevacizumab|mesh-list
65436696|NCT00373256|Sunitinib|sunitinib|mesh-list
65436697|NCT00373256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65436698|NCT00373256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436699|NCT00373256|Tubulin Modulators|tubulin modulators|mesh-ancestor
65436700|NCT00373256|Antimitotic Agents|antimitotic agents|mesh-ancestor
65436701|NCT00373256|Mitosis Modulators|mitosis modulators|mesh-ancestor
65436702|NCT00373256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436704|NCT00373256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65436705|NCT00373256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65436706|NCT00373256|Growth Substances|growth substances|mesh-ancestor
65436707|NCT00373256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436708|NCT00373256|Growth Inhibitors|growth inhibitors|mesh-ancestor
65436709|NCT00373256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65436710|NCT00373256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436711|NCT01324544|Buprenorphine|buprenorphine|mesh-list
65436712|NCT01324544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65436713|NCT01324544|Narcotics|narcotics|mesh-ancestor
65436714|NCT01324544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65436715|NCT01324544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436716|NCT01324544|Analgesics|analgesics|mesh-ancestor
65436736|NCT00393848|Antifungal Agents|antifungal agents|mesh-ancestor
65436737|NCT00393848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65436738|NCT00393848|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65436739|NCT00393848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65436740|NCT00393848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436741|NCT00393848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436742|NCT00393848|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65436743|NCT00393848|Hormone Antagonists|hormone antagonists|mesh-ancestor
65436744|NCT00393848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65436745|NCT00393848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436746|NCT00393848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65436747|NCT00393458|Formoterol Fumarate|formoterol fumarate|mesh-list
65436748|NCT00393458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65436750|NCT00393458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65436751|NCT00393458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436752|NCT00393458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65436753|NCT00393458|Respiratory System Agents|respiratory system agents|mesh-ancestor
65436754|NCT00393458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65436755|NCT00393458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65436756|NCT00393458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65436757|NCT00393458|Adrenergic Agents|adrenergic agents|mesh-ancestor
65436758|NCT00393458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65436759|NCT00393458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436760|NCT00392990|Cytarabine|cytarabine|mesh-list
65436761|NCT00392990|Cyclophosphamide|cyclophosphamide|mesh-list
65436762|NCT00392990|Ifosfamide|ifosfamide|mesh-list
65436763|NCT00392990|Rituximab|rituximab|mesh-list
65436764|NCT00392990|Doxorubicin|doxorubicin|mesh-list
65436765|NCT00392990|Methotrexate|methotrexate|mesh-list
65436766|NCT00392990|Etoposide|etoposide|mesh-list
65436767|NCT00392990|Vincristine|vincristine|mesh-list
65436768|NCT00392990|Etoposide phosphate|etoposide phosphate|mesh-list
65436769|NCT00392990|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65436770|NCT00392990|Podophyllotoxin|podophyllotoxin|mesh-list
64821488|NCT01516255|Incretins|incretins|mesh-ancestor
65436792|NCT00392990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65436793|NCT00392990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65436794|NCT00392990|Antiviral Agents|antiviral agents|mesh-ancestor
65436795|NCT00392990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65436796|NCT00392990|Tubulin Modulators|tubulin modulators|mesh-ancestor
65436797|NCT00392990|Antimitotic Agents|antimitotic agents|mesh-ancestor
65436798|NCT00392990|Mitosis Modulators|mitosis modulators|mesh-ancestor
65436799|NCT00392990|Keratolytic Agents|keratolytic agents|mesh-ancestor
65436801|NCT01046006|Rituximab|rituximab|mesh-list
65436802|NCT01046006|Bortezomib|bortezomib|mesh-list
65436803|NCT01046006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65436804|NCT01046006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436805|NCT01046006|Immunologic Factors|immunologic factors|mesh-ancestor
65436806|NCT01046006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436807|NCT01046006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65436808|NCT01046006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65436809|NCT01046006|Antiemetics|antiemetics|mesh-ancestor
65436810|NCT01046006|Autonomic Agents|autonomic agents|mesh-ancestor
65436811|NCT01046006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65436812|NCT01046006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65436813|NCT01046006|Glucocorticoids|glucocorticoids|mesh-ancestor
65436814|NCT01046006|Hormones|hormones|mesh-ancestor
65436815|NCT01046006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65436816|NCT01046006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65436817|NCT01046162|Alprazolam|alprazolam|mesh-list
65436818|NCT01046162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65436819|NCT01046162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65436820|NCT01046162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436821|NCT01046162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65436822|NCT01046162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65436823|NCT01046162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65436834|NCT00417482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65436835|NCT00417482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65436836|NCT00417482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65436837|NCT00417482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65436838|NCT00417482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65436839|NCT00417482|Dopamine Agents|dopamine agents|mesh-ancestor
65436840|NCT00417248|Etoposide|etoposide|mesh-list
65436841|NCT00417248|Sorafenib|sorafenib|mesh-list
65436842|NCT00417248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436843|NCT00417248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65436844|NCT00417248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65436845|NCT00417248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65436846|NCT00417248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436847|NCT00417248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436848|NCT00417248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65436849|NCT01046240|Palonosetron|palonosetron|mesh-list
65436850|NCT01046240|Antiemetics|antiemetics|mesh-ancestor
65436851|NCT01046240|Autonomic Agents|autonomic agents|mesh-ancestor
65436852|NCT01046240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65436853|NCT01046240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436854|NCT01046240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65436855|NCT01046240|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65436856|NCT01046240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65436857|NCT01046240|Serotonin Agents|serotonin agents|mesh-ancestor
65436858|NCT01046240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65436859|NCT01046240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436860|NCT00392288|Ciclesonide|ciclesonide|mesh-list
65436861|NCT00392288|Glucocorticoids|glucocorticoids|mesh-ancestor
65436862|NCT00392288|Hormones|hormones|mesh-ancestor
65436863|NCT00392288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65436864|NCT00392288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436865|NCT00392288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65436866|NCT00417170|Amlodipine|amlodipine|mesh-list
65436867|NCT00417170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65436868|NCT00417170|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65436869|NCT00417170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65436870|NCT00417170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436871|NCT00417170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65436872|NCT00417170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436873|NCT00417170|Vasodilator Agents|vasodilator agents|mesh-ancestor
65436874|NCT01840592|Doxorubicin|doxorubicin|mesh-list
65436875|NCT01840592|Sorafenib|sorafenib|mesh-list
65003593|NCT00450892|Docetaxel|docetaxel|mesh-list
65436876|NCT01840592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65436877|NCT01840592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436878|NCT01840592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65436879|NCT01840592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65436880|NCT01840592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436881|NCT01840592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436882|NCT01840592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65436883|NCT00249873|Clopidogrel|clopidogrel|mesh-list
65436884|NCT00249873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65436885|NCT00249873|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64821594|NCT01516723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65436893|NCT01037348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65436894|NCT01037348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65436895|NCT01037348|Growth Substances|growth substances|mesh-ancestor
65436896|NCT01037348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436897|NCT01037348|Growth Inhibitors|growth inhibitors|mesh-ancestor
65436898|NCT01037348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436900|NCT03490292|Carboplatin|carboplatin|mesh-list
65436901|NCT03490292|Avelumab|avelumab|mesh-list
65436902|NCT03490292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65436903|NCT03490292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436904|NCT03490292|Tubulin Modulators|tubulin modulators|mesh-ancestor
65436905|NCT03490292|Antimitotic Agents|antimitotic agents|mesh-ancestor
65436906|NCT03490292|Mitosis Modulators|mitosis modulators|mesh-ancestor
65436907|NCT03490292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436908|NCT03490292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65436909|NCT01046630|Ketamine|ketamine|mesh-list
65436910|NCT01046630|Analgesics|analgesics|mesh-ancestor
65436911|NCT01046630|Sensory System Agents|sensory system agents|mesh-ancestor
65436912|NCT01046630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65436913|NCT01046630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436914|NCT01046630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65436915|NCT01046630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65436916|NCT01046630|Anesthetics, General|anesthetics, general|mesh-ancestor
65436917|NCT01046630|Anesthetics|anesthetics|mesh-ancestor
65436918|NCT01046630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65436919|NCT01046630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65436920|NCT01046630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65436921|NCT01046630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65436922|NCT01046630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436923|NCT01046708|Progesterone|progesterone|mesh-list
65186456|NCT04799626|Meropenem|meropenem|mesh-list
65436925|NCT01046708|Hormones|hormones|mesh-ancestor
65436926|NCT01046708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65436927|NCT01046708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436928|NCT01046786|Methylprednisolone|methylprednisolone|mesh-list
65436929|NCT01046786|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65436930|NCT01046786|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65436931|NCT01046786|Prednisolone|prednisolone|mesh-list
65436932|NCT01046786|Prednisolone acetate|prednisolone acetate|mesh-list
65436933|NCT01046786|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65436934|NCT01046786|Prednisolone phosphate|prednisolone phosphate|mesh-list
65436935|NCT01046786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65436936|NCT01046786|Antiemetics|antiemetics|mesh-ancestor
65436937|NCT01046786|Autonomic Agents|autonomic agents|mesh-ancestor
65436938|NCT01046786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65436939|NCT01046786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436940|NCT01046786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65436941|NCT01046786|Glucocorticoids|glucocorticoids|mesh-ancestor
65436942|NCT01046786|Hormones|hormones|mesh-ancestor
65436943|NCT01046786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65436944|NCT01046786|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65436945|NCT01046786|Protective Agents|protective agents|mesh-ancestor
65436946|NCT01046786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65436947|NCT01046786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436948|NCT00391976|Tobramycin|tobramycin|mesh-list
65436949|NCT00391976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65436950|NCT00391976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65436951|NCT00762554|Fentanyl|fentanyl|mesh-list
64821667|NCT01517165|Pioglitazone|pioglitazone|mesh-list
65436980|NCT01046864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65436981|NCT01046864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436982|NCT01046864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65436983|NCT01046864|Immunologic Factors|immunologic factors|mesh-ancestor
65436984|NCT01046864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436985|NCT01046864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65436986|NCT01046864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65436987|NCT01046864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436989|NCT01046864|Protective Agents|protective agents|mesh-ancestor
65436990|NCT01046864|Vitamin B Complex|vitamin b complex|mesh-ancestor
65436991|NCT01046864|Vitamins|vitamins|mesh-ancestor
65436992|NCT01046864|Micronutrients|micronutrients|mesh-ancestor
65436993|NCT01046942|Aspirin|aspirin|mesh-list
65436994|NCT01046942|Clopidogrel|clopidogrel|mesh-list
65436995|NCT01046942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65436996|NCT01046942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65436997|NCT01046942|Analgesics|analgesics|mesh-ancestor
65436998|NCT01046942|Sensory System Agents|sensory system agents|mesh-ancestor
65436999|NCT01046942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65437019|NCT01049438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65437021|NCT01049438|Sulfamethoxazole|sulfamethoxazole|mesh-list
65437022|NCT01049438|Hexachlorophene|hexachlorophene|mesh-list
65437023|NCT01049438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65437024|NCT01049438|Antimalarials|antimalarials|mesh-ancestor
65437025|NCT01049438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65437026|NCT01049438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65437027|NCT01049438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65437028|NCT01049438|Renal Agents|renal agents|mesh-ancestor
65437029|NCT01049438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65437030|NCT01049438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437031|NCT01049438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437032|NCT01049438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65437033|NCT01049438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65437034|NCT01049438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65437035|NCT01049438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65437036|NCT01049438|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65437037|NCT01047098|Iron|iron|mesh-list
65437038|NCT01047098|Trace Elements|trace elements|mesh-ancestor
65437039|NCT01047098|Micronutrients|micronutrients|mesh-ancestor
65437040|NCT01047098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437041|NCT00391586|Gemcitabine|gemcitabine|mesh-list
65437042|NCT00391586|Paclitaxel|paclitaxel|mesh-list
65437043|NCT00391586|Etoposide|etoposide|mesh-list
65437044|NCT00391586|Vinorelbine|vinorelbine|mesh-list
65437045|NCT00391586|Docetaxel|docetaxel|mesh-list
65437046|NCT00391586|Irinotecan|irinotecan|mesh-list
65437047|NCT00391586|Pemetrexed|pemetrexed|mesh-list
65437048|NCT00391586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65437049|NCT00391586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65437050|NCT00391586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437051|NCT00391586|Tubulin Modulators|tubulin modulators|mesh-ancestor
65437052|NCT00391586|Antimitotic Agents|antimitotic agents|mesh-ancestor
65437053|NCT00391586|Mitosis Modulators|mitosis modulators|mesh-ancestor
65437054|NCT00391586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437072|NCT00391430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65437073|NCT00391430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65437074|NCT00391430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65437075|NCT00391430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437076|NCT00391430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65437077|NCT00391430|Serotonin Agents|serotonin agents|mesh-ancestor
65437078|NCT00391430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437080|NCT00391274|Pemetrexed|pemetrexed|mesh-list
65437081|NCT00391274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437082|NCT00391274|Tubulin Modulators|tubulin modulators|mesh-ancestor
65437083|NCT00391274|Antimitotic Agents|antimitotic agents|mesh-ancestor
65437084|NCT00391274|Mitosis Modulators|mitosis modulators|mesh-ancestor
65437085|NCT00391274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437086|NCT00391274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437087|NCT00391274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65437088|NCT00391274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65437089|NCT00391118|Paclitaxel|paclitaxel|mesh-list
65437090|NCT00391118|Carboplatin|carboplatin|mesh-list
65437091|NCT00391118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65437092|NCT00391118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437093|NCT00391118|Tubulin Modulators|tubulin modulators|mesh-ancestor
65437094|NCT00391118|Antimitotic Agents|antimitotic agents|mesh-ancestor
65437095|NCT00391118|Mitosis Modulators|mitosis modulators|mesh-ancestor
65437096|NCT00391118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437097|NCT00390884|Vaccines|vaccines|mesh-list
65437098|NCT00390884|Immunologic Factors|immunologic factors|mesh-ancestor
65437099|NCT00390884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437100|NCT01047488|Pregabalin|pregabalin|mesh-list
65437101|NCT01047488|Imipramine|imipramine|mesh-list
65437102|NCT01047488|Analgesics|analgesics|mesh-ancestor
65437103|NCT01047488|Sensory System Agents|sensory system agents|mesh-ancestor
65437104|NCT01047488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65437105|NCT01047488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437106|NCT01047488|Anticonvulsants|anticonvulsants|mesh-ancestor
65437107|NCT01047488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65437108|NCT01047488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65437109|NCT01047488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437110|NCT01047488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64821837|NCT01518062|Estrogens|estrogens|mesh-list
65437134|NCT01047566|Adrenergic Agents|adrenergic agents|mesh-ancestor
65437135|NCT01047566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65437136|NCT01047566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65437137|NCT00365846|Alemtuzumab|alemtuzumab|mesh-list
65437138|NCT00365846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65437139|NCT00365846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437140|NCT00264537|Golimumab|golimumab|mesh-list
65437141|NCT00264537|Methotrexate|methotrexate|mesh-list
65437142|NCT00264537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65437143|NCT00264537|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65437144|NCT00264537|Abortifacient Agents|abortifacient agents|mesh-ancestor
65437145|NCT00264537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65437146|NCT00264537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437147|NCT00264537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65437148|NCT00264537|Antimetabolites|antimetabolites|mesh-ancestor
65437149|NCT00264537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437150|NCT00264537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437151|NCT00264537|Dermatologic Agents|dermatologic agents|mesh-ancestor
65437152|NCT00264537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437153|NCT00264537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65437154|NCT00264537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65437155|NCT00264537|Immunologic Factors|immunologic factors|mesh-ancestor
65437156|NCT00264537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65437157|NCT00264537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65437158|NCT00264537|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65437159|NCT00264537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65437161|NCT00371150|Antiviral Agents|antiviral agents|mesh-ancestor
64821896|NCT01518231|Antipyretics|antipyretics|mesh-ancestor
65437183|NCT01071369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437184|NCT01071369|Sensory System Agents|sensory system agents|mesh-ancestor
65437185|NCT01071369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65437186|NCT01071369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65437187|NCT01071369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65437188|NCT01071369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65437189|NCT01071369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65437190|NCT01071369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437191|NCT01071369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65437192|NCT01071369|Glucocorticoids|glucocorticoids|mesh-ancestor
65437193|NCT01071369|Hormones|hormones|mesh-ancestor
65437194|NCT01071369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65437195|NCT01071369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65437196|NCT01071369|Respiratory System Agents|respiratory system agents|mesh-ancestor
65437197|NCT00370682|Vaccines|vaccines|mesh-list
65437198|NCT00370682|Immunologic Factors|immunologic factors|mesh-ancestor
65437199|NCT00370682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437200|NCT00264147|Diclofenac|diclofenac|mesh-list
65437201|NCT00264147|Etoricoxib|etoricoxib|mesh-list
65437202|NCT00264147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65437203|NCT00264147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65437204|NCT00264147|Analgesics|analgesics|mesh-ancestor
65437205|NCT00264147|Sensory System Agents|sensory system agents|mesh-ancestor
65437206|NCT00264147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65437207|NCT00264147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437208|NCT00264147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65437209|NCT00264147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65437210|NCT00264147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65437211|NCT00264147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437212|NCT00264147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437213|NCT00264147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64821946|NCT01518595|Bosentan|bosentan|mesh-list
65437225|NCT03971019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65003817|NCT00460447|Gemtuzumab|gemtuzumab|mesh-list
65437226|NCT03971019|Antimetabolites|antimetabolites|mesh-ancestor
65437227|NCT03971019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437228|NCT03971019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65437229|NCT03971019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65437230|NCT03971019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437231|NCT03974685|Niacinamide|niacinamide|mesh-list
65437232|NCT03974685|Niacin|niacin|mesh-list
65437233|NCT03974685|Nicotinic Acids|nicotinic acids|mesh-list
65437234|NCT03974685|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
65437235|NCT03974685|Vitamin B Complex|vitamin b complex|mesh-ancestor
65437236|NCT03974685|Vitamins|vitamins|mesh-ancestor
65437237|NCT03974685|Micronutrients|micronutrients|mesh-ancestor
65437238|NCT03974685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437239|NCT03974685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65437240|NCT03974685|Antimetabolites|antimetabolites|mesh-ancestor
65437241|NCT03974685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437242|NCT03974685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65437243|NCT03974685|Vasodilator Agents|vasodilator agents|mesh-ancestor
65437244|NCT03974685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437245|NCT00263211|Aspirin|aspirin|mesh-list
65437246|NCT00263211|Clopidogrel|clopidogrel|mesh-list
65437247|NCT00263211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65437248|NCT00263211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65437249|NCT00263211|Analgesics|analgesics|mesh-ancestor
65437250|NCT00263211|Sensory System Agents|sensory system agents|mesh-ancestor
65437251|NCT00263211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65437252|NCT00263211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437253|NCT00263211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65437254|NCT00263211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65437255|NCT00263211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65437256|NCT00263211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65437257|NCT00263211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437258|NCT00263211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65437259|NCT00263211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65437260|NCT00263211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437261|NCT00263211|Antipyretics|antipyretics|mesh-ancestor
65437262|NCT00263211|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65437263|NCT00263211|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65437264|NCT00263211|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65437265|NCT00263211|Purinergic Agents|purinergic agents|mesh-ancestor
65437266|NCT00263211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65437267|NCT00248625|Acetylcysteine|acetylcysteine|mesh-list
65437268|NCT00248625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65437269|NCT00248625|Antiviral Agents|antiviral agents|mesh-ancestor
65437270|NCT00248625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65437271|NCT00248625|Expectorants|expectorants|mesh-ancestor
65437272|NCT00248625|Respiratory System Agents|respiratory system agents|mesh-ancestor
65437273|NCT00248625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65437274|NCT00248625|Antioxidants|antioxidants|mesh-ancestor
65437275|NCT00248625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437276|NCT00248625|Protective Agents|protective agents|mesh-ancestor
65437277|NCT00248625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437278|NCT00248625|Antidotes|antidotes|mesh-ancestor
65437279|NCT00262821|Tirapazamine|tirapazamine|mesh-list
65437307|NCT00170950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65437309|NCT00170950|Vasodilator Agents|vasodilator agents|mesh-ancestor
65437310|NCT00170950|Diuretics|diuretics|mesh-ancestor
65437311|NCT00170950|Natriuretic Agents|natriuretic agents|mesh-ancestor
65437312|NCT00170950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65437313|NCT00170950|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65437314|NCT00170950|Protease Inhibitors|protease inhibitors|mesh-ancestor
65437315|NCT00170950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437316|NCT00262041|Vaccines|vaccines|mesh-list
65437317|NCT00262041|Immunologic Factors|immunologic factors|mesh-ancestor
65437318|NCT00262041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437319|NCT00208767|Valsartan|valsartan|mesh-list
65437320|NCT00208767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65437321|NCT00208767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65437322|NCT00208767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65437323|NCT00208767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437324|NCT02531529|Fentanyl|fentanyl|mesh-list
65437325|NCT02531529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65437326|NCT02531529|Narcotics|narcotics|mesh-ancestor
65437340|NCT01071525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65270043|NCT02694458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65437341|NCT01071525|Vasodilator Agents|vasodilator agents|mesh-ancestor
65437342|NCT01071525|Vitamin B Complex|vitamin b complex|mesh-ancestor
65437343|NCT01071525|Vitamins|vitamins|mesh-ancestor
65437344|NCT01071525|Micronutrients|micronutrients|mesh-ancestor
65437345|NCT01071525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437346|NCT01072695|Ribavirin|ribavirin|mesh-list
65437347|NCT01072695|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65437348|NCT01072695|Antimetabolites|antimetabolites|mesh-ancestor
65437349|NCT01072695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437350|NCT01072695|Antiviral Agents|antiviral agents|mesh-ancestor
65437351|NCT01072695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65437352|NCT00390806|Topotecan|topotecan|mesh-list
65437353|NCT00390806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65437354|NCT00390806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65437355|NCT00390806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437356|NCT00390806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437357|NCT00390806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437358|NCT00135200|Tositumomab I-131|tositumomab i-131|mesh-list
65437359|NCT00135200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437360|NCT01047722|Aspirin|aspirin|mesh-list
65437361|NCT01047722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65437362|NCT01047722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65437363|NCT01047722|Analgesics|analgesics|mesh-ancestor
65437364|NCT01047722|Sensory System Agents|sensory system agents|mesh-ancestor
65437365|NCT01047722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65437366|NCT01047722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437367|NCT01047722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65437368|NCT01047722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65437369|NCT01047722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65437370|NCT01047722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65437371|NCT01047722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437372|NCT01047722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65437373|NCT01047722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65437374|NCT01047722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437375|NCT01047722|Antipyretics|antipyretics|mesh-ancestor
65437376|NCT00390416|Leucovorin|leucovorin|mesh-list
65437377|NCT00390416|Bevacizumab|bevacizumab|mesh-list
65186912|NCT02742142|Fluorides|fluorides|mesh-list
65437378|NCT00390416|Docetaxel|docetaxel|mesh-list
65437379|NCT00390416|Fluorouracil|fluorouracil|mesh-list
65437380|NCT00390416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65437381|NCT00390416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437382|NCT00390416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65437383|NCT00390416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65437384|NCT00390416|Growth Substances|growth substances|mesh-ancestor
65437385|NCT00390416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437386|NCT00390416|Growth Inhibitors|growth inhibitors|mesh-ancestor
65437387|NCT00390416|Tubulin Modulators|tubulin modulators|mesh-ancestor
65437388|NCT00390416|Antimitotic Agents|antimitotic agents|mesh-ancestor
65437389|NCT00390416|Mitosis Modulators|mitosis modulators|mesh-ancestor
65437423|NCT00365456|Parathyroid Hormone|parathyroid hormone|mesh-list
65437424|NCT00365456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65437425|NCT00365456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437426|NCT00365456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65437427|NCT00365456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65437428|NCT00365456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437429|NCT00365456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65437430|NCT00365456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65437431|NCT01047956|Methadone|methadone|mesh-list
65437454|NCT00389324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65437455|NCT00389324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65437456|NCT00389324|Immunoglobulin G|immunoglobulin g|mesh-list
65437457|NCT00389324|Immunologic Factors|immunologic factors|mesh-ancestor
65437458|NCT00389324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437459|NCT00365300|Pantoprazole|pantoprazole|mesh-list
65437460|NCT00365300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65437461|NCT00365300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65437462|NCT00365300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65437463|NCT00365300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437464|NCT00365300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437465|NCT01048034|Azacitidine|azacitidine|mesh-list
65437466|NCT01048034|Epoetin Alfa|epoetin alfa|mesh-list
65437467|NCT01048034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65437468|NCT01048034|Antimetabolites|antimetabolites|mesh-ancestor
65003964|NCT04697992|Coagulants|coagulants|mesh-ancestor
65437469|NCT01048034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437470|NCT01048034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437471|NCT01048034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437472|NCT01048034|Hematinics|hematinics|mesh-ancestor
65437473|NCT00370292|Pemetrexed|pemetrexed|mesh-list
65437474|NCT00370292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437475|NCT00370292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437476|NCT00370292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437477|NCT00370292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65437478|NCT00370292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65437479|NCT01049672|Alfentanil|alfentanil|mesh-list
65437480|NCT01049672|Heroin|heroin|mesh-list
65437481|NCT01049672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65437482|NCT01049672|Narcotics|narcotics|mesh-ancestor
65437483|NCT01049672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65437484|NCT01049672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437504|NCT03993236|Antimetabolites|antimetabolites|mesh-ancestor
65437505|NCT03993236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437506|NCT03993236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65437507|NCT03993236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65437508|NCT03993236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437509|NCT00388154|Gemcitabine|gemcitabine|mesh-list
65437510|NCT00388154|Cisplatin|cisplatin|mesh-list
65437511|NCT00388154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437512|NCT00388154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65437513|NCT00388154|Antimetabolites|antimetabolites|mesh-ancestor
65437514|NCT00388154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437515|NCT00388154|Antiviral Agents|antiviral agents|mesh-ancestor
65437516|NCT00388154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65437517|NCT00388154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437518|NCT00388154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65437519|NCT00388154|Immunologic Factors|immunologic factors|mesh-ancestor
65437520|NCT00388154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437521|NCT02535104|Ranpirnase|ranpirnase|mesh-list
65437522|NCT02535104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437523|NCT02535104|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65437524|NCT02535104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437525|NCT02535104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437526|NCT00386360|Risedronic Acid|risedronic acid|mesh-list
65437527|NCT00386360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65437528|NCT00386360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65437529|NCT00386360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437530|NCT00386360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65437531|NCT00386360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437532|NCT00386360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65437533|NCT00369278|Mycophenolic Acid|mycophenolic acid|mesh-list
65437534|NCT00369278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65437535|NCT00369278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437536|NCT00369278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65437537|NCT00369278|Antitubercular Agents|antitubercular agents|mesh-ancestor
65437538|NCT00369278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65437539|NCT00369278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64822263|NCT01520415|Bupivacaine|bupivacaine|mesh-list
65437543|NCT00529373|Vitamin D|vitamin d|mesh-list
65437544|NCT00529373|Cholecalciferol|cholecalciferol|mesh-list
65437545|NCT00529373|Calcium Carbonate|calcium carbonate|mesh-list
65437546|NCT00529373|Calcium|calcium|mesh-list
65437547|NCT00529373|Vitamins|vitamins|mesh-ancestor
65437548|NCT00529373|Micronutrients|micronutrients|mesh-ancestor
65437549|NCT00529373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437550|NCT00529373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65437551|NCT00529373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65437552|NCT00529373|Antacids|antacids|mesh-ancestor
65437553|NCT00529373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437554|NCT00529373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65437555|NCT00369122|Bevacizumab|bevacizumab|mesh-list
65437556|NCT00369122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65437557|NCT00369122|Cisplatin|cisplatin|mesh-list
65437558|NCT00369122|Endothelial Growth Factors|endothelial growth factors|mesh-list
65437559|NCT00369122|Antibodies|antibodies|mesh-list
65437560|NCT00369122|Immunoglobulins|immunoglobulins|mesh-list
65437561|NCT00369122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65437562|NCT00369122|Immunoglobulin G|immunoglobulin g|mesh-list
65437563|NCT00369122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65004042|NCT00462358|Filanesib|filanesib|mesh-list
65437564|NCT00369122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65437565|NCT00369122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65437566|NCT00369122|Growth Substances|growth substances|mesh-ancestor
65437567|NCT00369122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437568|NCT00369122|Growth Inhibitors|growth inhibitors|mesh-ancestor
65437569|NCT00369122|Immunologic Factors|immunologic factors|mesh-ancestor
65437570|NCT03999203|Nitric Oxide|nitric oxide|mesh-list
65437571|NCT03999203|Citric Acid|citric acid|mesh-list
65437572|NCT03999203|Sodium Citrate|sodium citrate|mesh-list
65437573|NCT03999203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65437574|NCT03999203|Autonomic Agents|autonomic agents|mesh-ancestor
65437575|NCT03999203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65437576|NCT03999203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437577|NCT03999203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65437578|NCT03999203|Respiratory System Agents|respiratory system agents|mesh-ancestor
65437579|NCT03999203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65437580|NCT03999203|Antioxidants|antioxidants|mesh-ancestor
65437581|NCT03999203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437582|NCT03999203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65437583|NCT03999203|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65437584|NCT03999203|Vasodilator Agents|vasodilator agents|mesh-ancestor
65437585|NCT03999203|Gasotransmitters|gasotransmitters|mesh-ancestor
65437586|NCT03999203|Protective Agents|protective agents|mesh-ancestor
65437587|NCT03999203|Anticoagulants|anticoagulants|mesh-ancestor
65437588|NCT03999203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65437589|NCT03999203|Chelating Agents|chelating agents|mesh-ancestor
65437590|NCT03999203|Sequestering Agents|sequestering agents|mesh-ancestor
65437591|NCT04854395|Bupivacaine|bupivacaine|mesh-list
65437592|NCT04854395|Anesthetics, Local|anesthetics, local|mesh-ancestor
65437593|NCT04854395|Anesthetics|anesthetics|mesh-ancestor
65437594|NCT04854395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65437595|NCT04854395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437596|NCT04854395|Sensory System Agents|sensory system agents|mesh-ancestor
65437597|NCT04854395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65437598|NCT05173493|Amoxicillin|amoxicillin|mesh-list
65437599|NCT05173493|Levofloxacin|levofloxacin|mesh-list
65437600|NCT05173493|Ofloxacin|ofloxacin|mesh-list
65437601|NCT05173493|Tetracycline|tetracycline|mesh-list
65437602|NCT05173493|Furazolidone|furazolidone|mesh-list
65437603|NCT05173493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65437604|NCT05173493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65437605|NCT05173493|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65437606|NCT05173493|Renal Agents|renal agents|mesh-ancestor
65437607|NCT05173493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65437608|NCT05173493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65437609|NCT05173493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437610|NCT05173493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437611|NCT05173493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437612|NCT05173493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65437613|NCT05173493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65437648|NCT03999125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65437649|NCT03999125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65437651|NCT03999125|Protease Inhibitors|protease inhibitors|mesh-ancestor
65437652|NCT03999125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437653|NCT03999125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437654|NCT03999125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65437669|NCT00166114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437670|NCT00166114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65437672|NCT00166114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437673|NCT00166114|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65437674|NCT00166114|Antidepressive Agents|antidepressive agents|mesh-ancestor
65437675|NCT00166114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65437676|NCT00166114|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65437677|NCT00166114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437678|NCT00166114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65437679|NCT00166114|Adrenergic Agents|adrenergic agents|mesh-ancestor
65437680|NCT05032781|Minocycline|minocycline|mesh-list
65437681|NCT05032781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65437682|NCT05032781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65437683|NCT00129376|Cyclophosphamide|cyclophosphamide|mesh-list
65437684|NCT00129376|Docetaxel|docetaxel|mesh-list
65437685|NCT00129376|Doxorubicin|doxorubicin|mesh-list
65437686|NCT00129376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65437687|NCT00129376|Immunologic Factors|immunologic factors|mesh-ancestor
65437688|NCT00129376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437689|NCT00129376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65437690|NCT00129376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65437691|NCT00129376|Alkylating Agents|alkylating agents|mesh-ancestor
65437692|NCT00129376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437693|NCT00129376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437694|NCT00129376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65437695|NCT00129376|Tubulin Modulators|tubulin modulators|mesh-ancestor
65437696|NCT00129376|Antimitotic Agents|antimitotic agents|mesh-ancestor
65437697|NCT00129376|Mitosis Modulators|mitosis modulators|mesh-ancestor
65437698|NCT00129376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65437699|NCT00129376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65437700|NCT00129376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65437701|NCT00129376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437702|NCT04878107|Docetaxel|docetaxel|mesh-list
65437703|NCT04878107|Apatinib|apatinib|mesh-list
65437704|NCT04878107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437705|NCT04878107|Tubulin Modulators|tubulin modulators|mesh-ancestor
65437706|NCT04878107|Antimitotic Agents|antimitotic agents|mesh-ancestor
65437707|NCT04878107|Mitosis Modulators|mitosis modulators|mesh-ancestor
65437708|NCT04878107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437709|NCT04878107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65437710|NCT04878107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437711|NCT03998969|Pantoprazole|pantoprazole|mesh-list
65437712|NCT03998969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65437713|NCT03998969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64822431|NCT01521624|Metformin|metformin|mesh-list
65437731|NCT00129220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65437732|NCT00129220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437733|NCT00129220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65437734|NCT00129220|Serotonin Agents|serotonin agents|mesh-ancestor
65437735|NCT00129220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65437736|NCT00129220|Dopamine Agents|dopamine agents|mesh-ancestor
65437737|NCT00129220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65437738|NCT03686813|Sildenafil Citrate|sildenafil citrate|mesh-list
65437739|NCT03686813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437740|NCT03686813|Vasodilator Agents|vasodilator agents|mesh-ancestor
65437741|NCT03686813|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65437742|NCT03686813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65437743|NCT03686813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437744|NCT03686813|Urological Agents|urological agents|mesh-ancestor
65437745|NCT04754945|Dexamethasone|dexamethasone|mesh-list
65437746|NCT04754945|Dexamethasone acetate|dexamethasone acetate|mesh-list
65437747|NCT04754945|Cyclophosphamide|cyclophosphamide|mesh-list
65437748|NCT04754945|Bortezomib|bortezomib|mesh-list
65437749|NCT04754945|Ichthammol|ichthammol|mesh-list
65437750|NCT04754945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65437751|NCT04754945|BB 1101|bb 1101|mesh-list
65437752|NCT04754945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65437753|NCT04754945|Immunologic Factors|immunologic factors|mesh-ancestor
65437754|NCT04754945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437755|NCT04754945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65437756|NCT04754945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65437757|NCT04754945|Alkylating Agents|alkylating agents|mesh-ancestor
65437758|NCT04754945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437759|NCT04754945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437760|NCT04754945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65437761|NCT04754945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65437762|NCT04754945|Antiemetics|antiemetics|mesh-ancestor
65437763|NCT04754945|Autonomic Agents|autonomic agents|mesh-ancestor
65437764|NCT04754945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65437765|NCT04754945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65437766|NCT04754945|Glucocorticoids|glucocorticoids|mesh-ancestor
65437767|NCT04754945|Hormones|hormones|mesh-ancestor
65437768|NCT04754945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65437769|NCT04754945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65437770|NCT04754945|Protease Inhibitors|protease inhibitors|mesh-ancestor
65437771|NCT04754945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437790|NCT01074892|Medroxyprogesterone|medroxyprogesterone|mesh-list
65437791|NCT01074892|Progestins|progestins|mesh-list
65437792|NCT01074892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65437793|NCT01074892|Contraceptive Agents|contraceptive agents|mesh-ancestor
65437794|NCT01074892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65437795|NCT01074892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437796|NCT01074892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65437797|NCT01074892|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65270044|NCT02719808|Tenofovir|tenofovir|mesh-list
65437798|NCT01074892|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65437799|NCT01074892|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65437800|NCT01074892|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65437801|NCT01074892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65437802|NCT01074892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437803|NCT01074892|Hormones|hormones|mesh-ancestor
65437804|NCT01074892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65437805|NCT00128206|Rifampin|rifampin|mesh-list
65437806|NCT00128206|Isoniazid|isoniazid|mesh-list
65437807|NCT00128206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65437808|NCT00128206|Antitubercular Agents|antitubercular agents|mesh-ancestor
65437809|NCT00128206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65437810|NCT00128206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65437811|NCT00128206|Leprostatic Agents|leprostatic agents|mesh-ancestor
65437812|NCT00128206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65437813|NCT00128206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437814|NCT00128206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437815|NCT00128206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65437816|NCT00128206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65437817|NCT00128206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65437818|NCT00128206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65437819|NCT00128206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65437820|NCT00128206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65437821|NCT00128206|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65437822|NCT00128206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65437823|NCT00128206|Antimetabolites|antimetabolites|mesh-ancestor
65437824|NCT00128206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65437825|NCT01075828|Cetuximab|cetuximab|mesh-list
65437826|NCT01075828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65437839|NCT03968146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65437840|NCT03968146|Narcotics|narcotics|mesh-ancestor
65437841|NCT03968146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65437842|NCT03968146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437843|NCT03968146|Analgesics|analgesics|mesh-ancestor
65437844|NCT03968146|Sensory System Agents|sensory system agents|mesh-ancestor
65437845|NCT03968146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65437846|NCT03968146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65437847|NCT03968146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65437848|NCT03968146|Anesthetics, General|anesthetics, general|mesh-ancestor
65437849|NCT03968146|Anesthetics|anesthetics|mesh-ancestor
65437850|NCT03968146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65437851|NCT03968146|Antipyretics|antipyretics|mesh-ancestor
65437852|NCT03968146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65437853|NCT03968146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65437854|NCT03968146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65437855|NCT03968146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65437856|NCT03968146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437857|NCT03968146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437858|NCT03966118|Paclitaxel|paclitaxel|mesh-list
65437859|NCT03966118|Avelumab|avelumab|mesh-list
65437860|NCT03966118|Ramucirumab|ramucirumab|mesh-list
65437861|NCT03966118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65437862|NCT03966118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437863|NCT03966118|Tubulin Modulators|tubulin modulators|mesh-ancestor
65437864|NCT03966118|Antimitotic Agents|antimitotic agents|mesh-ancestor
65437865|NCT03966118|Mitosis Modulators|mitosis modulators|mesh-ancestor
65437866|NCT03966118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437867|NCT03966118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65437868|NCT03968224|Metformin|metformin|mesh-list
65437869|NCT03968224|Dapagliflozin|dapagliflozin|mesh-list
65437870|NCT03968224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65437871|NCT03968224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437872|NCT03968224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65437873|NCT03968224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437874|NCT01075126|Valproic Acid|valproic acid|mesh-list
65437875|NCT01075126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65437876|NCT01075126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437877|NCT01075126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437878|NCT01075126|Antimanic Agents|antimanic agents|mesh-ancestor
65437879|NCT01075126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65437880|NCT01075126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65437881|NCT01075126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270045|NCT02719808|Antiviral Agents|antiviral agents|mesh-ancestor
65437882|NCT01075126|Anticonvulsants|anticonvulsants|mesh-ancestor
65437883|NCT01075126|GABA Agents|gaba agents|mesh-ancestor
65437884|NCT01075126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65437885|NCT03823378|Upadacitinib|upadacitinib|mesh-list
65437886|NCT03823378|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65437887|NCT03823378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65437888|NCT03823378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437889|NCT03823378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437890|NCT03823378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65437891|NCT00141778|Ramipril|ramipril|mesh-list
65437892|NCT00141778|Spironolactone|spironolactone|mesh-list
65437908|NCT01079884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65437909|NCT01079884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65437910|NCT01079884|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65437911|NCT01079884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437912|NCT01079884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437913|NCT01075906|Colchicine|colchicine|mesh-list
65437914|NCT01075906|Gout Suppressants|gout suppressants|mesh-ancestor
65437915|NCT01075906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65437916|NCT01075906|Tubulin Modulators|tubulin modulators|mesh-ancestor
65437917|NCT01075906|Antimitotic Agents|antimitotic agents|mesh-ancestor
65437918|NCT01075906|Mitosis Modulators|mitosis modulators|mesh-ancestor
65437919|NCT01075906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437920|NCT01075906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437921|NCT01076062|Misoprostol|misoprostol|mesh-list
65437922|NCT01076062|Oxytocin|oxytocin|mesh-list
65437923|NCT01076062|Oxytocics|oxytocics|mesh-ancestor
65437924|NCT01076062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65437925|NCT01076062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437926|NCT01076062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65437927|NCT01076062|Abortifacient Agents|abortifacient agents|mesh-ancestor
65437928|NCT01076062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65437929|NCT01076062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65437930|NCT00115336|Ibuprofen|ibuprofen|mesh-list
65437931|NCT00115336|Ketorolac|ketorolac|mesh-list
65437932|NCT00115336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65437933|NCT00115336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65437934|NCT00115336|Analgesics|analgesics|mesh-ancestor
65437935|NCT00115336|Sensory System Agents|sensory system agents|mesh-ancestor
65437936|NCT00115336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65437937|NCT00115336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437938|NCT00115336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65437939|NCT00115336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65437940|NCT00115336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65437941|NCT00115336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437942|NCT00115336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437943|NCT01076140|Lisinopril|lisinopril|mesh-list
65437944|NCT01076140|Nebivolol|nebivolol|mesh-list
65437945|NCT01076140|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65437946|NCT01076140|Protease Inhibitors|protease inhibitors|mesh-ancestor
65437947|NCT01076140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437948|NCT01076140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437949|NCT01076140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65437971|NCT00127192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437972|NCT00127192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437973|NCT00127036|Bevacizumab|bevacizumab|mesh-list
65437974|NCT00127036|Capecitabine|capecitabine|mesh-list
65437975|NCT00127036|Oxaliplatin|oxaliplatin|mesh-list
65437976|NCT00127036|Irinotecan|irinotecan|mesh-list
65437977|NCT00127036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65437978|NCT00127036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437979|NCT00127036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65437980|NCT00127036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65437982|NCT00127036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437983|NCT00127036|Growth Inhibitors|growth inhibitors|mesh-ancestor
65437984|NCT00127036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65437985|NCT00127036|Antimetabolites|antimetabolites|mesh-ancestor
65437986|NCT00127036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437987|NCT00127036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65437988|NCT00127036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65437989|NCT00127036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437990|NCT00259857|Alendronate|alendronate|mesh-list
65437991|NCT00259857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65437992|NCT00259857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437993|NCT01071681|Telmisartan|telmisartan|mesh-list
65437994|NCT01071681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65437995|NCT01071681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65437996|NCT01071681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65437997|NCT01071681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437998|NCT00203307|Olanzapine|olanzapine|mesh-list
65437999|NCT00203307|Antiemetics|antiemetics|mesh-ancestor
65438000|NCT00203307|Autonomic Agents|autonomic agents|mesh-ancestor
65438001|NCT00203307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65438002|NCT00203307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438016|NCT00126568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65438017|NCT00126568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438018|NCT00126568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438019|NCT00202839|Ribavirin|ribavirin|mesh-list
65438020|NCT00202839|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65438021|NCT00202839|Interferon-alpha|interferon-alpha|mesh-list
65438022|NCT00202839|Antimetabolites|antimetabolites|mesh-ancestor
65438023|NCT00202839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438024|NCT00202839|Antiviral Agents|antiviral agents|mesh-ancestor
65438025|NCT00202839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65438026|NCT00202839|Immunologic Factors|immunologic factors|mesh-ancestor
65438027|NCT00202839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438028|NCT00126490|Aldesleukin|aldesleukin|mesh-list
65438029|NCT00126490|Bevacizumab|bevacizumab|mesh-list
65438030|NCT00126490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65438031|NCT00126490|Interleukin-2|interleukin-2|mesh-list
65438032|NCT00126490|Endothelial Growth Factors|endothelial growth factors|mesh-list
65438033|NCT00126490|Antibodies|antibodies|mesh-list
65438034|NCT00126490|Immunoglobulins|immunoglobulins|mesh-list
65438035|NCT00126490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65438036|NCT00126490|Immunoglobulin G|immunoglobulin g|mesh-list
65438037|NCT00126490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438038|NCT00126490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65438039|NCT00126490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65438040|NCT00126490|Growth Substances|growth substances|mesh-ancestor
65438041|NCT00126490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438042|NCT00126490|Growth Inhibitors|growth inhibitors|mesh-ancestor
65438043|NCT00126490|Immunologic Factors|immunologic factors|mesh-ancestor
65438044|NCT00126490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65438045|NCT00126490|Analgesics|analgesics|mesh-ancestor
65438046|NCT00126490|Sensory System Agents|sensory system agents|mesh-ancestor
65438047|NCT00126490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65438048|NCT00126490|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65438049|NCT00126490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65438050|NCT00126490|Antiviral Agents|antiviral agents|mesh-ancestor
65438051|NCT00126490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65438052|NCT00200967|Beclomethasone|beclomethasone|mesh-list
65438053|NCT00200967|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65438054|NCT00200967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65438055|NCT00200967|Autonomic Agents|autonomic agents|mesh-ancestor
65438056|NCT00200967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65438057|NCT00200967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438058|NCT00200967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65438059|NCT00200967|Respiratory System Agents|respiratory system agents|mesh-ancestor
65438060|NCT00200967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65438061|NCT00200967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65438062|NCT00200967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65438063|NCT00200967|Adrenergic Agents|adrenergic agents|mesh-ancestor
65438064|NCT00200967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65438092|NCT00140140|Trastuzumab|trastuzumab|mesh-list
65438093|NCT00140140|Lenograstim|lenograstim|mesh-list
65438094|NCT00140140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65438095|NCT00140140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438096|NCT00140140|Tubulin Modulators|tubulin modulators|mesh-ancestor
65438097|NCT00140140|Antimitotic Agents|antimitotic agents|mesh-ancestor
65438098|NCT00140140|Mitosis Modulators|mitosis modulators|mesh-ancestor
65438099|NCT00140140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438100|NCT00140140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65438101|NCT00140140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65438102|NCT00140140|Immunologic Factors|immunologic factors|mesh-ancestor
65438103|NCT00140140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438104|NCT00346164|Doxorubicin|doxorubicin|mesh-list
65438105|NCT00346164|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65438106|NCT00346164|Ifosfamide|ifosfamide|mesh-list
65438107|NCT00346164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65438108|NCT00346164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822860|NCT01523639|Metformin|metformin|mesh-list
65438123|NCT01052298|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65438124|NCT01052298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65438125|NCT00114244|Gemcitabine|gemcitabine|mesh-list
65438126|NCT00114244|Sorafenib|sorafenib|mesh-list
65438127|NCT00114244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65438128|NCT00114244|Antimetabolites|antimetabolites|mesh-ancestor
65438129|NCT00114244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438130|NCT00114244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438131|NCT00114244|Antiviral Agents|antiviral agents|mesh-ancestor
65438132|NCT00114244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65438133|NCT00114244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438134|NCT00114244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65438135|NCT00114244|Immunologic Factors|immunologic factors|mesh-ancestor
65438136|NCT00114244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438137|NCT00114244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65438138|NCT01054872|Vaccines|vaccines|mesh-list
65438139|NCT01054872|Immunologic Factors|immunologic factors|mesh-ancestor
65438140|NCT01054872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438141|NCT00337662|Olanzapine|olanzapine|mesh-list
65438142|NCT00337662|Risperidone|risperidone|mesh-list
65438143|NCT00337662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65438144|NCT00337662|Serotonin Agents|serotonin agents|mesh-ancestor
65438145|NCT00337662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65438146|NCT00337662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438147|NCT00337662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438148|NCT00337662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65438149|NCT00337662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65438150|NCT00337662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65438151|NCT00337662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65438152|NCT00337662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65438153|NCT00337662|Dopamine Agents|dopamine agents|mesh-ancestor
65438154|NCT00337662|Antiemetics|antiemetics|mesh-ancestor
65438155|NCT00337662|Autonomic Agents|autonomic agents|mesh-ancestor
65438156|NCT00337662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65438157|NCT00337662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65438158|NCT00337662|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65438159|NCT00337662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65438160|NCT00337662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65438161|NCT00138424|Cidofovir|cidofovir|mesh-list
65438162|NCT00138424|Antiviral Agents|antiviral agents|mesh-ancestor
65438163|NCT00138424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65438164|NCT00138424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438165|NCT00138424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438166|NCT00368966|Vaccines|vaccines|mesh-list
65438167|NCT00368966|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65438176|NCT00337428|Vaccines|vaccines|mesh-list
65438177|NCT00337428|Immunologic Factors|immunologic factors|mesh-ancestor
65438178|NCT00337428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438179|NCT00235989|Interferons|interferons|mesh-list
65438180|NCT00235989|Interferon-beta|interferon-beta|mesh-list
65438181|NCT00235989|Interferon beta-1b|interferon beta-1b|mesh-list
65438182|NCT00235989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438183|NCT00235989|Antiviral Agents|antiviral agents|mesh-ancestor
65438184|NCT00235989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65438185|NCT00235989|Immunologic Factors|immunologic factors|mesh-ancestor
65438186|NCT00235989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438187|NCT00235989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65438188|NCT00113386|Docetaxel|docetaxel|mesh-list
65438189|NCT00113386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438190|NCT00113386|Tubulin Modulators|tubulin modulators|mesh-ancestor
65438191|NCT00113386|Antimitotic Agents|antimitotic agents|mesh-ancestor
65438192|NCT00113386|Mitosis Modulators|mitosis modulators|mesh-ancestor
65438193|NCT00113386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438194|NCT00353262|Capecitabine|capecitabine|mesh-list
65438195|NCT00353262|Oxaliplatin|oxaliplatin|mesh-list
65438196|NCT00353262|Bevacizumab|bevacizumab|mesh-list
65438197|NCT00353262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65438198|NCT00353262|Antimetabolites|antimetabolites|mesh-ancestor
65438199|NCT00353262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438200|NCT00353262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438201|NCT00353262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65438202|NCT00353262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65187760|NCT01042392|Ramipril|ramipril|mesh-list
65438203|NCT00353262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65438204|NCT00353262|Growth Substances|growth substances|mesh-ancestor
65438205|NCT00353262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438206|NCT00353262|Growth Inhibitors|growth inhibitors|mesh-ancestor
65438207|NCT00125164|Mecasermin|mecasermin|mesh-list
65438208|NCT00125164|Growth Substances|growth substances|mesh-ancestor
65438209|NCT00125164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438210|NCT03985410|Moxifloxacin|moxifloxacin|mesh-list
65438211|NCT03985410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65438212|NCT03985410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65438213|NCT03985410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65438214|NCT03985410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65438215|NCT03985410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438216|NCT03985410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438217|NCT03985410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438218|NCT03988530|Scopolamine|scopolamine|mesh-list
65438219|NCT03988530|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65438220|NCT03988530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65438221|NCT03988530|Antiemetics|antiemetics|mesh-ancestor
65438222|NCT03988530|Autonomic Agents|autonomic agents|mesh-ancestor
65438223|NCT03988530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65438224|NCT03988530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438225|NCT03988530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65438226|NCT03988530|Mydriatics|mydriatics|mesh-ancestor
65438227|NCT03988530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65438228|NCT03988530|Cholinergic Agents|cholinergic agents|mesh-ancestor
65438229|NCT03988530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65438230|NCT03988530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438231|NCT03988530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65438232|NCT03988530|Parasympatholytics|parasympatholytics|mesh-ancestor
65438233|NCT00136318|Ribavirin|ribavirin|mesh-list
65438234|NCT00136318|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65438247|NCT00136318|Antidepressive Agents|antidepressive agents|mesh-ancestor
65438248|NCT00136318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65438249|NCT01058850|Rindopepimut|rindopepimut|mesh-list
65438250|NCT01058850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65438251|NCT01058850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438252|NCT00136084|Cytarabine|cytarabine|mesh-list
65438253|NCT00136084|Dexamethasone|dexamethasone|mesh-list
65438254|NCT00136084|Prednisone|prednisone|mesh-list
65438255|NCT00136084|Cyclophosphamide|cyclophosphamide|mesh-list
65438256|NCT00136084|Methotrexate|methotrexate|mesh-list
65438257|NCT00136084|Etoposide|etoposide|mesh-list
65438258|NCT00136084|Vincristine|vincristine|mesh-list
65438259|NCT00136084|Daunorubicin|daunorubicin|mesh-list
65438260|NCT00136084|Asparaginase|asparaginase|mesh-list
65438261|NCT00136084|Mitoxantrone|mitoxantrone|mesh-list
65438262|NCT00136084|Mercaptopurine|mercaptopurine|mesh-list
65438263|NCT00136084|Cladribine|cladribine|mesh-list
65438264|NCT00136084|Gemtuzumab|gemtuzumab|mesh-list
65438265|NCT00136084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65438266|NCT00136084|Immunologic Factors|immunologic factors|mesh-ancestor
65438267|NCT00136084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438268|NCT00136084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65438269|NCT00136084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65438270|NCT00136084|Alkylating Agents|alkylating agents|mesh-ancestor
65438271|NCT00136084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438272|NCT00136084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438273|NCT00136084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65438274|NCT00136084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65438275|NCT00136084|Antiemetics|antiemetics|mesh-ancestor
65438276|NCT00136084|Autonomic Agents|autonomic agents|mesh-ancestor
65438277|NCT00136084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65438278|NCT00136084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65438279|NCT00136084|Glucocorticoids|glucocorticoids|mesh-ancestor
65438280|NCT00136084|Hormones|hormones|mesh-ancestor
65438281|NCT00136084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65438282|NCT00136084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65438283|NCT00136084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65438284|NCT00136084|Abortifacient Agents|abortifacient agents|mesh-ancestor
65438285|NCT00136084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65438286|NCT00136084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65438287|NCT00136084|Antimetabolites|antimetabolites|mesh-ancestor
65438288|NCT00136084|Dermatologic Agents|dermatologic agents|mesh-ancestor
65438289|NCT00136084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438290|NCT00136084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65438291|NCT00136084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65438292|NCT00136084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65438293|NCT00136084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65438294|NCT00136084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65438295|NCT00136084|Antiviral Agents|antiviral agents|mesh-ancestor
65004569|NCT00116961|Dexamethasone|dexamethasone|mesh-list
65438296|NCT00136084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65438297|NCT00136084|Tubulin Modulators|tubulin modulators|mesh-ancestor
64823009|NCT01524575|Oxaliplatin|oxaliplatin|mesh-list
65438304|NCT00364832|Epoetin Alfa|epoetin alfa|mesh-list
65438305|NCT00364832|Hematinics|hematinics|mesh-ancestor
65438306|NCT00235755|Ezogabine|ezogabine|mesh-list
65438307|NCT00235755|Anticonvulsants|anticonvulsants|mesh-ancestor
65438308|NCT00235755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65438309|NCT00235755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438310|NCT01581879|Ziprasidone|ziprasidone|mesh-list
65438311|NCT01581879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65438312|NCT01581879|Serotonin Agents|serotonin agents|mesh-ancestor
65438313|NCT01581879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65438314|NCT01581879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438315|NCT01581879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438316|NCT01581879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65438317|NCT01581879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65438318|NCT01581879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65438319|NCT01581879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65438320|NCT01581879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65438321|NCT01581879|Dopamine Agents|dopamine agents|mesh-ancestor
65438322|NCT00337194|Gemcitabine|gemcitabine|mesh-list
65438323|NCT00337194|Doxorubicin|doxorubicin|mesh-list
65438324|NCT00337194|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65438325|NCT00337194|Vinorelbine|vinorelbine|mesh-list
65438326|NCT00337194|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65438327|NCT00337194|Antibodies|antibodies|mesh-list
65438328|NCT00337194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65438329|NCT00337194|Immunologic Factors|immunologic factors|mesh-ancestor
65438330|NCT00337194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438331|NCT00337194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65438332|NCT00337194|Antimetabolites|antimetabolites|mesh-ancestor
65438333|NCT00337194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438334|NCT00337194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438335|NCT00337194|Antiviral Agents|antiviral agents|mesh-ancestor
65438336|NCT00337194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65438337|NCT00337194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438338|NCT00337194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65438339|NCT00337194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65438340|NCT00337194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65438341|NCT00337194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65438342|NCT00337194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65438343|NCT00337194|Tubulin Modulators|tubulin modulators|mesh-ancestor
65438344|NCT00337194|Antimitotic Agents|antimitotic agents|mesh-ancestor
65438345|NCT00337194|Mitosis Modulators|mitosis modulators|mesh-ancestor
65438346|NCT00337194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65438347|NCT01074021|Nimotuzumab|nimotuzumab|mesh-list
65438348|NCT01074021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65438349|NCT01074021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438350|NCT01074333|Cetuximab|cetuximab|mesh-list
65438351|NCT01074333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65438352|NCT01074333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438353|NCT00385736|Adalimumab|adalimumab|mesh-list
65438354|NCT00385736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65438355|NCT00385736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65438356|NCT01057212|Bevacizumab|bevacizumab|mesh-list
65438357|NCT01057212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65438358|NCT01057212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438359|NCT01057212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65438360|NCT01057212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65438361|NCT01057212|Growth Substances|growth substances|mesh-ancestor
65438362|NCT01057212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438363|NCT01057212|Growth Inhibitors|growth inhibitors|mesh-ancestor
65438364|NCT03988452|Ritonavir|ritonavir|mesh-list
65438365|NCT03988452|Darunavir|darunavir|mesh-list
65438366|NCT03988452|Tenofovir|tenofovir|mesh-list
65438367|NCT03988452|Lamivudine|lamivudine|mesh-list
65438368|NCT03988452|Zidovudine|zidovudine|mesh-list
65438369|NCT03988452|Dolutegravir|dolutegravir|mesh-list
65438375|NCT03988452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65438376|NCT03988452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65438377|NCT03988452|Antiviral Agents|antiviral agents|mesh-ancestor
65438378|NCT03988452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65438379|NCT03988452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65438380|NCT03988452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65438381|NCT03988452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65270046|NCT02719808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65438382|NCT03988452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65438383|NCT03988452|Antimetabolites|antimetabolites|mesh-ancestor
65438384|NCT03988452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65438385|NCT03988452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65438386|NCT01048580|Capecitabine|capecitabine|mesh-list
65438387|NCT01048580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65438388|NCT01048580|Antimetabolites|antimetabolites|mesh-ancestor
65438389|NCT01048580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438390|NCT01048580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438391|NCT00195819|Adalimumab|adalimumab|mesh-list
65438392|NCT00195819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65438393|NCT00195819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65438394|NCT00527735|Paclitaxel|paclitaxel|mesh-list
65438395|NCT00527735|Carboplatin|carboplatin|mesh-list
65438396|NCT00527735|Ipilimumab|ipilimumab|mesh-list
65438397|NCT00527735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65438398|NCT00527735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438399|NCT00527735|Tubulin Modulators|tubulin modulators|mesh-ancestor
65438400|NCT00527735|Antimitotic Agents|antimitotic agents|mesh-ancestor
65438401|NCT00527735|Mitosis Modulators|mitosis modulators|mesh-ancestor
65438402|NCT00527735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438403|NCT00527735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65438404|NCT00527735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65438405|NCT00336492|Infliximab|infliximab|mesh-list
65438406|NCT00336492|Dermatologic Agents|dermatologic agents|mesh-ancestor
65438407|NCT00336492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65438408|NCT00336492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65438409|NCT00194025|Valproic Acid|valproic acid|mesh-list
65438410|NCT00194025|Anticonvulsants|anticonvulsants|mesh-ancestor
65438411|NCT00194025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438412|NCT00194025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438413|NCT00194025|GABA Agents|gaba agents|mesh-ancestor
65438414|NCT00194025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65438415|NCT00194025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438416|NCT00194025|Antimanic Agents|antimanic agents|mesh-ancestor
65438417|NCT00194025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65438418|NCT00194025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65438419|NCT00194025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65438420|NCT00521339|Apremilast|apremilast|mesh-list
65438421|NCT00521339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65438422|NCT00521339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65438423|NCT00521339|Analgesics|analgesics|mesh-ancestor
65438424|NCT00521339|Sensory System Agents|sensory system agents|mesh-ancestor
65438425|NCT00521339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65438426|NCT00521339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438427|NCT00521339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65438428|NCT00521339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65438429|NCT00521339|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65438430|NCT00521339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65438431|NCT00521339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438432|NCT00521339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438433|NCT00363896|Bromides|bromides|mesh-list
65438434|NCT00363896|Anticonvulsants|anticonvulsants|mesh-ancestor
65438435|NCT00527423|Aflibercept|aflibercept|mesh-list
65438436|NCT00527423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65438437|NCT00527423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65438438|NCT00527423|Growth Substances|growth substances|mesh-ancestor
65438439|NCT00527423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438458|NCT00336024|Vincristine|vincristine|mesh-list
65438459|NCT00336024|Etoposide phosphate|etoposide phosphate|mesh-list
65438460|NCT00336024|Levoleucovorin|levoleucovorin|mesh-list
65438461|NCT00336024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65438462|NCT00336024|Immunologic Factors|immunologic factors|mesh-ancestor
65438463|NCT00336024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438464|NCT00336024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65438465|NCT00336024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65438466|NCT00336024|Alkylating Agents|alkylating agents|mesh-ancestor
65438467|NCT00336024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438468|NCT00336024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438469|NCT00336024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65438470|NCT00336024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65438471|NCT00336024|Abortifacient Agents|abortifacient agents|mesh-ancestor
65438472|NCT00336024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65438473|NCT00336024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65438474|NCT00336024|Antimetabolites|antimetabolites|mesh-ancestor
65438475|NCT00336024|Dermatologic Agents|dermatologic agents|mesh-ancestor
65438476|NCT00336024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438477|NCT00336024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65438478|NCT00336024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65438479|NCT00336024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65438480|NCT00336024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65438481|NCT00336024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65438482|NCT00336024|Antidotes|antidotes|mesh-ancestor
65438483|NCT00336024|Protective Agents|protective agents|mesh-ancestor
65438484|NCT00336024|Vitamin B Complex|vitamin b complex|mesh-ancestor
65438485|NCT00336024|Vitamins|vitamins|mesh-ancestor
65438486|NCT00336024|Micronutrients|micronutrients|mesh-ancestor
65438487|NCT00336024|Tubulin Modulators|tubulin modulators|mesh-ancestor
65438488|NCT00336024|Antimitotic Agents|antimitotic agents|mesh-ancestor
65438489|NCT00336024|Mitosis Modulators|mitosis modulators|mesh-ancestor
65438490|NCT00384956|Azacitidine|azacitidine|mesh-list
65438491|NCT00384956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65438492|NCT00384956|Antimetabolites|antimetabolites|mesh-ancestor
65438493|NCT00384956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438494|NCT00384956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438495|NCT00384956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438496|NCT04090697|Oxandrolone|oxandrolone|mesh-list
65438497|NCT04090697|Androgens|androgens|mesh-ancestor
65438498|NCT04090697|Hormones|hormones|mesh-ancestor
65438499|NCT04090697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65438534|NCT03992144|Amoxicillin|amoxicillin|mesh-list
65438535|NCT03992144|Metronidazole|metronidazole|mesh-list
65438536|NCT03992144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65438537|NCT03992144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65438538|NCT03992144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65438539|NCT03992144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65438540|NCT02534870|Ritonavir|ritonavir|mesh-list
65438541|NCT02534870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65438542|NCT02534870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65438566|NCT01048892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65438567|NCT01048892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65438568|NCT01048892|Alkylating Agents|alkylating agents|mesh-ancestor
65438569|NCT01048892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438570|NCT01048892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438571|NCT01048892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65438572|NCT01259648|Remifentanil|remifentanil|mesh-list
65438573|NCT01259648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65438574|NCT01259648|Narcotics|narcotics|mesh-ancestor
65438575|NCT01259648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65438576|NCT01259648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438577|NCT01259648|Analgesics|analgesics|mesh-ancestor
65438578|NCT01259648|Sensory System Agents|sensory system agents|mesh-ancestor
65438579|NCT01259648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65438580|NCT01049048|Vitamin D|vitamin d|mesh-list
65438581|NCT01049048|Cholecalciferol|cholecalciferol|mesh-list
65438582|NCT01049048|Vitamins|vitamins|mesh-ancestor
65438583|NCT01049048|Micronutrients|micronutrients|mesh-ancestor
65438584|NCT01049048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438585|NCT01049048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65438586|NCT01049048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65188108|NCT02882477|Hormones|hormones|mesh-ancestor
65438587|NCT00520481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65438588|NCT00520481|Immunologic Factors|immunologic factors|mesh-ancestor
65438589|NCT00520481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438591|NCT01044992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65438592|NCT01044992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65438593|NCT01044992|Dopamine Agents|dopamine agents|mesh-ancestor
65438594|NCT01044992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64823311|NCT01526278|Alendronate|alendronate|mesh-list
65438604|NCT00520403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65438605|NCT00520403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65438606|NCT00520403|Growth Substances|growth substances|mesh-ancestor
65438607|NCT00520403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438608|NCT00520403|Growth Inhibitors|growth inhibitors|mesh-ancestor
65438609|NCT00520403|Antiviral Agents|antiviral agents|mesh-ancestor
65438610|NCT00520403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65438611|NCT00520403|Immunologic Factors|immunologic factors|mesh-ancestor
65438612|NCT00520403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65438613|NCT00520403|Tubulin Modulators|tubulin modulators|mesh-ancestor
65438614|NCT00520403|Antimitotic Agents|antimitotic agents|mesh-ancestor
65438615|NCT00520403|Mitosis Modulators|mitosis modulators|mesh-ancestor
65438616|NCT00520403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438618|NCT00520013|Bevacizumab|bevacizumab|mesh-list
65438619|NCT00520013|Carboplatin|carboplatin|mesh-list
65438620|NCT00520013|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65438621|NCT00520013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65438622|NCT00520013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438623|NCT00520013|Tubulin Modulators|tubulin modulators|mesh-ancestor
65438624|NCT00520013|Antimitotic Agents|antimitotic agents|mesh-ancestor
65438625|NCT00520013|Mitosis Modulators|mitosis modulators|mesh-ancestor
65438626|NCT00520013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438627|NCT00520013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65438628|NCT00520013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65438629|NCT00520013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65438630|NCT00520013|Growth Substances|growth substances|mesh-ancestor
65438631|NCT00520013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438632|NCT00520013|Growth Inhibitors|growth inhibitors|mesh-ancestor
65438633|NCT00520013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65438634|NCT00520013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438635|NCT00526097|Bisacodyl|bisacodyl|mesh-list
65438636|NCT00526097|Cathartics|cathartics|mesh-ancestor
65438637|NCT00526097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65438638|NCT00526097|Laxatives|laxatives|mesh-ancestor
65438639|NCT00525785|Leucovorin|leucovorin|mesh-list
65438640|NCT00525785|Folic Acid|folic acid|mesh-list
65438641|NCT00525785|Fluorouracil|fluorouracil|mesh-list
65438642|NCT00525785|Oxaliplatin|oxaliplatin|mesh-list
65438643|NCT00525785|Levoleucovorin|levoleucovorin|mesh-list
65438644|NCT00525785|Antimetabolites|antimetabolites|mesh-ancestor
65438645|NCT00525785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438646|NCT00525785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65438647|NCT00525785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438648|NCT00525785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65438649|NCT00525785|Immunologic Factors|immunologic factors|mesh-ancestor
65438650|NCT00525785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438651|NCT00525785|Antidotes|antidotes|mesh-ancestor
65438652|NCT00525785|Protective Agents|protective agents|mesh-ancestor
65438653|NCT00525785|Vitamin B Complex|vitamin b complex|mesh-ancestor
65438654|NCT00525785|Vitamins|vitamins|mesh-ancestor
65438655|NCT00525785|Micronutrients|micronutrients|mesh-ancestor
65438656|NCT00525785|Hematinics|hematinics|mesh-ancestor
65438657|NCT00525161|Sorafenib|sorafenib|mesh-list
65438658|NCT00525161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438659|NCT00525161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65438660|NCT00525161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438661|NCT00525161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438662|NCT00135694|Prednisone|prednisone|mesh-list
65438696|NCT00519077|Gefitinib|gefitinib|mesh-list
65438697|NCT00519077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438698|NCT00519077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65438699|NCT00519077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438700|NCT00519077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438701|NCT00124618|Cetuximab|cetuximab|mesh-list
64823426|NCT01526694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65438713|NCT00124072|Antimetabolites|antimetabolites|mesh-ancestor
65438714|NCT00124072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438715|NCT00124072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65438716|NCT00124072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65438717|NCT00124072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438719|NCT00124072|Vitamin B Complex|vitamin b complex|mesh-ancestor
65438720|NCT01080352|Ascorbic Acid|ascorbic acid|mesh-list
65438721|NCT01080352|Vitamins|vitamins|mesh-ancestor
65438722|NCT01080352|Micronutrients|micronutrients|mesh-ancestor
65438723|NCT01080352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438724|NCT01080352|Antioxidants|antioxidants|mesh-ancestor
65438725|NCT01080352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438726|NCT01080352|Protective Agents|protective agents|mesh-ancestor
65438727|NCT00524303|Paclitaxel|paclitaxel|mesh-list
65438728|NCT00524303|Trastuzumab|trastuzumab|mesh-list
65438729|NCT00524303|Lapatinib|lapatinib|mesh-list
65438730|NCT00524303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65438731|NCT00524303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438732|NCT00524303|Tubulin Modulators|tubulin modulators|mesh-ancestor
65438733|NCT00524303|Antimitotic Agents|antimitotic agents|mesh-ancestor
65438734|NCT00524303|Mitosis Modulators|mitosis modulators|mesh-ancestor
65438735|NCT00524303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438736|NCT00524303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65270047|NCT02719808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65438737|NCT00524303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65438738|NCT00524303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438739|NCT04461041|Empagliflozin|empagliflozin|mesh-list
65438740|NCT04461041|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65438741|NCT04461041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438742|NCT04461041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65438743|NCT04461041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438744|NCT00335556|Dactinomycin|dactinomycin|mesh-list
65438745|NCT00335556|Cyclophosphamide|cyclophosphamide|mesh-list
65438746|NCT00335556|Carboplatin|carboplatin|mesh-list
65438747|NCT00335556|Doxorubicin|doxorubicin|mesh-list
65438748|NCT00335556|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65438749|NCT00335556|Irinotecan|irinotecan|mesh-list
65438750|NCT00335556|Etoposide|etoposide|mesh-list
65438751|NCT00335556|Vincristine|vincristine|mesh-list
65438752|NCT00335556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65438753|NCT00335556|Immunologic Factors|immunologic factors|mesh-ancestor
65438754|NCT00335556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438755|NCT00335556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65438756|NCT00335556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65438757|NCT00335556|Alkylating Agents|alkylating agents|mesh-ancestor
65438758|NCT00335556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438759|NCT00335556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438760|NCT00335556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65438761|NCT00335556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65438762|NCT00335556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65438763|NCT00335556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65438764|NCT00335556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438765|NCT00335556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65438766|NCT00335556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65438767|NCT00335556|Tubulin Modulators|tubulin modulators|mesh-ancestor
65438782|NCT00134056|Antimitotic Agents|antimitotic agents|mesh-ancestor
65438783|NCT00134056|Mitosis Modulators|mitosis modulators|mesh-ancestor
65438784|NCT00134056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438785|NCT00134056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65438786|NCT00134056|Glucocorticoids|glucocorticoids|mesh-ancestor
65438787|NCT00134056|Hormones|hormones|mesh-ancestor
65438788|NCT00134056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65438789|NCT00134056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438790|NCT00134056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65438791|NCT00134056|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65438792|NCT00134056|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65438793|NCT00518531|Denosumab|denosumab|mesh-list
65438794|NCT00518531|Alendronate|alendronate|mesh-list
65438795|NCT00518531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65438796|NCT00518531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438797|NCT01326442|Vitamin D|vitamin d|mesh-list
65438798|NCT01326442|Vitamins|vitamins|mesh-ancestor
65438799|NCT01326442|Micronutrients|micronutrients|mesh-ancestor
65438800|NCT01326442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438801|NCT01326442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65438802|NCT00523991|Tiotropium Bromide|tiotropium bromide|mesh-list
65438803|NCT00523991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65438804|NCT00523991|Autonomic Agents|autonomic agents|mesh-ancestor
65438805|NCT00523991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65438806|NCT00523991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438807|NCT00523991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65438808|NCT00523991|Respiratory System Agents|respiratory system agents|mesh-ancestor
65438809|NCT00523991|Parasympatholytics|parasympatholytics|mesh-ancestor
65438810|NCT00523991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65438811|NCT00523991|Cholinergic Agents|cholinergic agents|mesh-ancestor
65438812|NCT00523991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65438813|NCT00523991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438814|NCT00350844|Hydroxyurea|hydroxyurea|mesh-list
65438815|NCT00350844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188339|NCT02712502|Ofloxacin|ofloxacin|mesh-list
65438816|NCT00350844|Antisickling Agents|antisickling agents|mesh-ancestor
65438817|NCT00350844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438818|NCT00350844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438819|NCT00350844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65438821|NCT00345540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438822|NCT00335322|Ritonavir|ritonavir|mesh-list
65438823|NCT00335322|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65438824|NCT00335322|Tenofovir|tenofovir|mesh-list
65438825|NCT00335322|Zidovudine|zidovudine|mesh-list
65438826|NCT00335322|Emtricitabine|emtricitabine|mesh-list
65438827|NCT00335322|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65438828|NCT00335322|Abacavir|abacavir|mesh-list
65438829|NCT00335322|Efavirenz|efavirenz|mesh-list
65438830|NCT00335322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65438848|NCT00335322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65438849|NCT01059396|Propranolol|propranolol|mesh-list
65438850|NCT01059396|Carvedilol|carvedilol|mesh-list
65438851|NCT01059396|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65438852|NCT01059396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65438853|NCT01059396|Adrenergic Agents|adrenergic agents|mesh-ancestor
65438854|NCT01059396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65438855|NCT01059396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438856|NCT01059396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438857|NCT01059396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65438858|NCT01059396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65438859|NCT01059396|Vasodilator Agents|vasodilator agents|mesh-ancestor
65438860|NCT01059396|Antioxidants|antioxidants|mesh-ancestor
65438861|NCT01059396|Protective Agents|protective agents|mesh-ancestor
65438862|NCT01059396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65438863|NCT01059396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65438864|NCT01059396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65438865|NCT01059396|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65438866|NCT01059396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65438867|NCT01059552|Vorinostat|vorinostat|mesh-list
65438868|NCT01059552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438869|NCT01059552|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65438870|NCT01059552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438871|NCT01059552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438872|NCT03741894|Chlorhexidine|chlorhexidine|mesh-list
65438873|NCT03741894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65438874|NCT03741894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65438875|NCT03741894|Disinfectants|disinfectants|mesh-ancestor
65438876|NCT03755765|Amoxicillin|amoxicillin|mesh-list
65438877|NCT03755765|Clavulanic Acid|clavulanic acid|mesh-list
65438878|NCT03755765|Clavulanic Acids|clavulanic acids|mesh-list
65438879|NCT03755765|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65438880|NCT03755765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65438881|NCT03755765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65438882|NCT03755765|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65438883|NCT03755765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64823592|NCT01527422|Tubulin Modulators|tubulin modulators|mesh-ancestor
65438892|NCT01061112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65438893|NCT01061112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438894|NCT01061112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438895|NCT01061112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65438896|NCT01061112|Hormone Antagonists|hormone antagonists|mesh-ancestor
65438897|NCT01061112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65438898|NCT01061112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438899|NCT01061112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65438900|NCT01061112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65438901|NCT01061112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65438902|NCT01061112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65438903|NCT01061112|Analgesics|analgesics|mesh-ancestor
65438904|NCT01061112|Sensory System Agents|sensory system agents|mesh-ancestor
65438905|NCT01061112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65438906|NCT01061112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65438907|NCT01061112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65438908|NCT01061112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65438909|NCT01061112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65438910|NCT01061190|Propranolol|propranolol|mesh-list
65438911|NCT01061190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65438912|NCT01061190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65438913|NCT01061190|Adrenergic Agents|adrenergic agents|mesh-ancestor
65438914|NCT01061190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65438915|NCT01061190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438916|NCT01061190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438917|NCT01061190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65438918|NCT01061190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65438919|NCT01061190|Vasodilator Agents|vasodilator agents|mesh-ancestor
65438920|NCT00324168|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65005026|NCT00476983|Ritonavir|ritonavir|mesh-list
65438921|NCT00324168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65438922|NCT00517829|Docetaxel|docetaxel|mesh-list
65438923|NCT00517829|Oxaliplatin|oxaliplatin|mesh-list
65438924|NCT00517829|Cetuximab|cetuximab|mesh-list
65438925|NCT00517829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438926|NCT00517829|Tubulin Modulators|tubulin modulators|mesh-ancestor
65438927|NCT00517829|Antimitotic Agents|antimitotic agents|mesh-ancestor
65438928|NCT00517829|Mitosis Modulators|mitosis modulators|mesh-ancestor
65438929|NCT00517829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438930|NCT00517829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65438931|NCT00343512|Docetaxel|docetaxel|mesh-list
65438932|NCT00343512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438933|NCT00343512|Tubulin Modulators|tubulin modulators|mesh-ancestor
65438934|NCT00343512|Antimitotic Agents|antimitotic agents|mesh-ancestor
65438935|NCT00343512|Mitosis Modulators|mitosis modulators|mesh-ancestor
65438936|NCT00343512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438937|NCT00334542|Simvastatin|simvastatin|mesh-list
65438938|NCT00334542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65438939|NCT00334542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65438940|NCT00334542|Antimetabolites|antimetabolites|mesh-ancestor
65438941|NCT00334542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438942|NCT00334542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65438943|NCT00334542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65438944|NCT00334542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438945|NCT00112294|Paclitaxel|paclitaxel|mesh-list
65438946|NCT00112294|Docetaxel|docetaxel|mesh-list
65438947|NCT00112294|Carboplatin|carboplatin|mesh-list
65438948|NCT00112294|Cetuximab|cetuximab|mesh-list
65438949|NCT00112294|Taxane|taxane|mesh-list
65438950|NCT00112294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65438955|NCT00112294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438956|NCT00112294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65438957|NCT00235443|Lacosamide|lacosamide|mesh-list
65438958|NCT00235443|Anticonvulsants|anticonvulsants|mesh-ancestor
65438959|NCT00235443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65438960|NCT00235443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65438961|NCT00235443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65438962|NCT00235443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438963|NCT00234039|Gemcitabine|gemcitabine|mesh-list
65438964|NCT00234039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65438965|NCT00234039|Antimetabolites|antimetabolites|mesh-ancestor
65438966|NCT00234039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438967|NCT00234039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438968|NCT00234039|Antiviral Agents|antiviral agents|mesh-ancestor
65438969|NCT00234039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65438970|NCT00234039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438971|NCT00234039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65438972|NCT00234039|Immunologic Factors|immunologic factors|mesh-ancestor
65438973|NCT00234039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438975|NCT02531451|Ibuprofen|ibuprofen|mesh-list
65438976|NCT02531451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65438977|NCT02531451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65438978|NCT02531451|Analgesics|analgesics|mesh-ancestor
65438979|NCT02531451|Sensory System Agents|sensory system agents|mesh-ancestor
65438980|NCT02531451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65438981|NCT02531451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438982|NCT02531451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65438983|NCT02531451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65438984|NCT02531451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65438985|NCT02531451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438986|NCT02531451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438987|NCT02531451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65438988|NCT02531451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65438989|NCT02531451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65438990|NCT02531451|Antipyretics|antipyretics|mesh-ancestor
65438991|NCT03973203|Niacin|niacin|mesh-list
65438992|NCT03973203|Nicotinic Acids|nicotinic acids|mesh-list
65438993|NCT03973203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65438994|NCT03973203|Antimetabolites|antimetabolites|mesh-ancestor
65438995|NCT03973203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438996|NCT03973203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65438997|NCT03973203|Vasodilator Agents|vasodilator agents|mesh-ancestor
65438998|NCT03973203|Vitamin B Complex|vitamin b complex|mesh-ancestor
65438999|NCT03973203|Vitamins|vitamins|mesh-ancestor
65005095|NCT00478075|Bortezomib|bortezomib|mesh-list
65439000|NCT03973203|Micronutrients|micronutrients|mesh-ancestor
65439001|NCT03973203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439002|NCT01073007|Simvastatin|simvastatin|mesh-list
65439003|NCT01073007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65439004|NCT01073007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65439005|NCT01073007|Antimetabolites|antimetabolites|mesh-ancestor
65439006|NCT01073007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439007|NCT01073007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65439008|NCT01073007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65439009|NCT01073007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439010|NCT03741621|Psyllium|psyllium|mesh-list
65439011|NCT03741621|Cathartics|cathartics|mesh-ancestor
65439012|NCT03741621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65439013|NCT00323622|Pyrimethamine|pyrimethamine|mesh-list
65439014|NCT00323622|Sulfadoxine|sulfadoxine|mesh-list
65439015|NCT00323622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65439016|NCT00323622|Amodiaquine|amodiaquine|mesh-list
65439017|NCT00323622|Vaccines|vaccines|mesh-list
65439018|NCT00323622|Immunologic Factors|immunologic factors|mesh-ancestor
65439019|NCT00323622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439020|NCT00323622|Antimalarials|antimalarials|mesh-ancestor
65439021|NCT00323622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65439022|NCT00323622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65439023|NCT00323622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65439032|NCT01326039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65439033|NCT01326039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439034|NCT01326039|Sensory System Agents|sensory system agents|mesh-ancestor
65439035|NCT01326039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65439037|NCT01057758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65439038|NCT01057758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65439039|NCT01057758|Antimetabolites|antimetabolites|mesh-ancestor
65439040|NCT01057758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439041|NCT01057758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65439042|NCT01057758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65439043|NCT01057758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439044|NCT00186537|Rosiglitazone|rosiglitazone|mesh-list
65439045|NCT00186537|Fenofibrate|fenofibrate|mesh-list
65439046|NCT00186537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65439047|NCT00186537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439048|NCT00186537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65439049|NCT00186537|Antimetabolites|antimetabolites|mesh-ancestor
65439050|NCT00186537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439051|NCT00186537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65439052|NCT03968835|Bacitracin|bacitracin|mesh-list
65439053|NCT03968835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65439054|NCT03968835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65439055|NCT03968835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65439056|NCT00322842|Plerixafor|plerixafor|mesh-list
65439057|NCT00322842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65439058|NCT00322842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65439059|NCT00322842|Antiviral Agents|antiviral agents|mesh-ancestor
65439060|NCT00322842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65439061|NCT04726085|Ibuprofen|ibuprofen|mesh-list
65439062|NCT04726085|Indomethacin|indomethacin|mesh-list
65439063|NCT04726085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65439064|NCT04726085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65439065|NCT04726085|Analgesics|analgesics|mesh-ancestor
65439066|NCT04726085|Sensory System Agents|sensory system agents|mesh-ancestor
65439067|NCT04726085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65439068|NCT04726085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439069|NCT04726085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65439070|NCT04726085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65439071|NCT04726085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65439072|NCT04726085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439073|NCT04726085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439074|NCT04726085|Gout Suppressants|gout suppressants|mesh-ancestor
65439075|NCT04726085|Tocolytic Agents|tocolytic agents|mesh-ancestor
65439076|NCT04726085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65439077|NCT00255723|Carboplatin|carboplatin|mesh-list
65439078|NCT00255723|Etoposide|etoposide|mesh-list
65439079|NCT00255723|Ifosfamide|ifosfamide|mesh-list
65439080|NCT00255723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439081|NCT00255723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65439082|NCT00255723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65439083|NCT00255723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65439084|NCT00255723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439085|NCT00255723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439086|NCT00255723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65439087|NCT00255723|Alkylating Agents|alkylating agents|mesh-ancestor
65439088|NCT01060176|Tranexamic Acid|tranexamic acid|mesh-list
65439089|NCT01060176|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65439090|NCT01060176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65439105|NCT00517361|Bevacizumab|bevacizumab|mesh-list
65439106|NCT00517361|Carboplatin|carboplatin|mesh-list
65439107|NCT00517361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65439108|NCT00517361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439109|NCT00517361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65439110|NCT00517361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65439111|NCT00517361|Growth Substances|growth substances|mesh-ancestor
65439112|NCT00517361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439113|NCT00517361|Growth Inhibitors|growth inhibitors|mesh-ancestor
65439114|NCT00516893|Natalizumab|natalizumab|mesh-list
65439115|NCT00516893|Immunologic Factors|immunologic factors|mesh-ancestor
65439116|NCT00516893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439117|NCT03677141|Prednisone|prednisone|mesh-list
65439118|NCT03677141|Cyclophosphamide|cyclophosphamide|mesh-list
65439120|NCT03677141|Vincristine|vincristine|mesh-list
65439121|NCT03677141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65439122|NCT03677141|Immunologic Factors|immunologic factors|mesh-ancestor
65439123|NCT03677141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439124|NCT03677141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65439125|NCT03677141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65439126|NCT03677141|Alkylating Agents|alkylating agents|mesh-ancestor
65439127|NCT03677141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439128|NCT03677141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439129|NCT03677141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65439130|NCT03677141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65439131|NCT03677141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65439132|NCT03677141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65439133|NCT03677141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439134|NCT03677141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65439135|NCT03677141|Glucocorticoids|glucocorticoids|mesh-ancestor
65439136|NCT03677141|Hormones|hormones|mesh-ancestor
65439137|NCT03677141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65439138|NCT03677141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65439139|NCT03677141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65439140|NCT03677141|Tubulin Modulators|tubulin modulators|mesh-ancestor
65439141|NCT03677141|Antimitotic Agents|antimitotic agents|mesh-ancestor
65439142|NCT03677141|Mitosis Modulators|mitosis modulators|mesh-ancestor
65439143|NCT03657641|Pembrolizumab|pembrolizumab|mesh-list
65439144|NCT03657641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65439145|NCT03657641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439146|NCT03649841|Ascorbic Acid|ascorbic acid|mesh-list
65439147|NCT03649841|Prednisone|prednisone|mesh-list
65439148|NCT03649841|Cortisone|cortisone|mesh-list
65439149|NCT03649841|Methyltestosterone|methyltestosterone|mesh-list
65439150|NCT03649841|Abiraterone Acetate|abiraterone acetate|mesh-list
65439151|NCT03649841|Hormones|hormones|mesh-list
65439152|NCT03649841|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65439153|NCT03649841|Androgens|androgens|mesh-list
65439154|NCT03649841|Androgen Antagonists|androgen antagonists|mesh-list
65439176|NCT00522431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439177|NCT00185211|Interferons|interferons|mesh-list
65439178|NCT00185211|Interferon-beta|interferon-beta|mesh-list
65439179|NCT00185211|Interferon beta-1b|interferon beta-1b|mesh-list
65439180|NCT00185211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439181|NCT00185211|Antiviral Agents|antiviral agents|mesh-ancestor
65439182|NCT00185211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65439183|NCT00185211|Immunologic Factors|immunologic factors|mesh-ancestor
65439184|NCT00185211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439185|NCT00185211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65439186|NCT00516737|Rizatriptan|rizatriptan|mesh-list
65439187|NCT00516737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65439188|NCT00516737|Serotonin Agents|serotonin agents|mesh-ancestor
65439189|NCT00516737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65439190|NCT00516737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439191|NCT00516737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439192|NCT03540485|Melatonin|melatonin|mesh-list
65439193|NCT03540485|Antioxidants|antioxidants|mesh-ancestor
65439194|NCT03540485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439195|NCT03540485|Protective Agents|protective agents|mesh-ancestor
65439196|NCT03540485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439197|NCT03540485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65439198|NCT00132730|MK 0873|mk 0873|mesh-list
65439199|NCT00132730|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65439200|NCT00132730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65439201|NCT00132730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439202|NCT00132730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439203|NCT02531841|Dexamethasone acetate|dexamethasone acetate|mesh-list
65439204|NCT02531841|Dexamethasone|dexamethasone|mesh-list
65439205|NCT02531841|Etoposide phosphate|etoposide phosphate|mesh-list
65439206|NCT02531841|Etoposide|etoposide|mesh-list
65439207|NCT02531841|Ifosfamide|ifosfamide|mesh-list
65439208|NCT02531841|Isophosphamide mustard|isophosphamide mustard|mesh-list
65439223|NCT02531841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439224|NCT02531841|Protease Inhibitors|protease inhibitors|mesh-ancestor
65439225|NCT02531841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439226|NCT02531841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439227|NCT02531841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65439228|NCT02531841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65439229|NCT02531841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65439230|NCT02531841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65439231|NCT02531841|Alkylating Agents|alkylating agents|mesh-ancestor
65439232|NCT02531841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65439233|NCT02531841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65439234|NCT02531841|Immunologic Factors|immunologic factors|mesh-ancestor
65439235|NCT01074411|Carboplatin|carboplatin|mesh-list
65439236|NCT01074411|Bortezomib|bortezomib|mesh-list
65439237|NCT01074411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439238|NCT03973047|Ondansetron|ondansetron|mesh-list
65439239|NCT03973047|Antiemetics|antiemetics|mesh-ancestor
65439240|NCT03973047|Autonomic Agents|autonomic agents|mesh-ancestor
65439241|NCT03973047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65439242|NCT03973047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439243|NCT03973047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65439244|NCT03973047|Antipruritics|antipruritics|mesh-ancestor
65439245|NCT03973047|Dermatologic Agents|dermatologic agents|mesh-ancestor
65439246|NCT03973047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65439247|NCT03973047|Serotonin Agents|serotonin agents|mesh-ancestor
65439248|NCT03973047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65439249|NCT03973047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439250|NCT03973047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65439251|NCT03973047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65439252|NCT03973047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65439253|NCT03973047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65439254|NCT03973047|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65439255|NCT00522275|Lacosamide|lacosamide|mesh-list
65439256|NCT00522275|Anticonvulsants|anticonvulsants|mesh-ancestor
65439257|NCT00522275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65439258|NCT00522275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65439259|NCT00522275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65439260|NCT00522275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439261|NCT01074567|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
65439262|NCT01074567|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65439263|NCT01074567|Protective Agents|protective agents|mesh-ancestor
65439264|NCT01074567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439265|NCT01074567|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65439266|NCT01074567|Antioxidants|antioxidants|mesh-ancestor
65439267|NCT01074567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439268|NCT00522041|Nitroglycerin|nitroglycerin|mesh-list
65439269|NCT00522041|Vasodilator Agents|vasodilator agents|mesh-ancestor
65439270|NCT03519971|Paclitaxel|paclitaxel|mesh-list
65439271|NCT03519971|Etoposide|etoposide|mesh-list
65439278|NCT03519971|Tubulin Modulators|tubulin modulators|mesh-ancestor
65439279|NCT03519971|Antimitotic Agents|antimitotic agents|mesh-ancestor
65439280|NCT03519971|Mitosis Modulators|mitosis modulators|mesh-ancestor
65439281|NCT03519971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439282|NCT03519971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65439283|NCT03519971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65439284|NCT03519971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439285|NCT03519971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65439286|NCT03519971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65439287|NCT03519971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65439288|NCT00122980|Hydroxyurea|hydroxyurea|mesh-list
65439289|NCT00122980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439290|NCT00122980|Antisickling Agents|antisickling agents|mesh-ancestor
65439291|NCT00122980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439292|NCT00122980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439293|NCT00122980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65439294|NCT00340704|Tamsulosin|tamsulosin|mesh-list
65439295|NCT00340704|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65439296|NCT00340704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65439297|NCT00340704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65439298|NCT00340704|Adrenergic Agents|adrenergic agents|mesh-ancestor
65439299|NCT00340704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65439300|NCT00340704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439301|NCT00340704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439302|NCT00340704|Urological Agents|urological agents|mesh-ancestor
65439303|NCT00132496|Rabeprazole|rabeprazole|mesh-list
65439304|NCT00132496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65439305|NCT00132496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65439306|NCT00132496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65439307|NCT00132496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439308|NCT00132496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439309|NCT01080586|Cyclosporine|cyclosporine|mesh-list
65439310|NCT01080586|Cyclosporins|cyclosporins|mesh-list
65439311|NCT01080586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439312|NCT01080586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439313|NCT01080586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65439314|NCT01080586|Immunologic Factors|immunologic factors|mesh-ancestor
65439315|NCT01080586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439316|NCT01080586|Antifungal Agents|antifungal agents|mesh-ancestor
65439317|NCT01080586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65439318|NCT01080586|Dermatologic Agents|dermatologic agents|mesh-ancestor
65439319|NCT01080586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65439320|NCT01080586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65439321|NCT00231777|Ondansetron|ondansetron|mesh-list
65439322|NCT00231777|Aprepitant|aprepitant|mesh-list
65439323|NCT00231777|Antiemetics|antiemetics|mesh-ancestor
65439324|NCT00231777|Autonomic Agents|autonomic agents|mesh-ancestor
65439325|NCT00231777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65439326|NCT00231777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439327|NCT00231777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65439328|NCT00231777|Antipruritics|antipruritics|mesh-ancestor
65439329|NCT00231777|Dermatologic Agents|dermatologic agents|mesh-ancestor
65439330|NCT00231777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65439331|NCT00231777|Serotonin Agents|serotonin agents|mesh-ancestor
65439332|NCT00231777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65439333|NCT00231777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439334|NCT00231777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65439335|NCT00231777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65439336|NCT00231777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65439337|NCT00231777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65439338|NCT00231777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65439339|NCT00231777|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65439340|NCT01076842|Insulin|insulin|mesh-list
65439341|NCT01076842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65439366|NCT00231465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439367|NCT00231465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65439368|NCT00231465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439369|NCT00254397|Leuprolide|leuprolide|mesh-list
65439370|NCT00254397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65439371|NCT00254397|Fertility Agents|fertility agents|mesh-ancestor
65439372|NCT00254397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65439373|NCT00254397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439374|NCT00254397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65439375|NCT00254397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439376|NCT00254163|Cyclophosphamide|cyclophosphamide|mesh-list
65439377|NCT00254163|Rituximab|rituximab|mesh-list
65439378|NCT00254163|Fludarabine|fludarabine|mesh-list
65439379|NCT00254163|Pentostatin|pentostatin|mesh-list
65439380|NCT00254163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65439381|NCT00254163|Immunologic Factors|immunologic factors|mesh-ancestor
65439382|NCT00254163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439383|NCT00254163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65439384|NCT00254163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65439385|NCT00254163|Alkylating Agents|alkylating agents|mesh-ancestor
65439386|NCT00254163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439387|NCT00254163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439388|NCT00254163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65439389|NCT00254163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65439390|NCT00254163|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65439391|NCT00254163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439407|NCT00122278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65439408|NCT00122278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439409|NCT00122278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65439410|NCT00122278|Glucocorticoids|glucocorticoids|mesh-ancestor
65439411|NCT00122278|Hormones|hormones|mesh-ancestor
65439412|NCT00122278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65439413|NCT00122278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65439414|NCT00122278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439415|NCT00182091|Hormones|hormones|mesh-list
65439416|NCT00182091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65439417|NCT00182091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439418|NCT03398135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65439419|NCT03398135|Immunologic Factors|immunologic factors|mesh-ancestor
65188938|NCT02723578|Pemetrexed|pemetrexed|mesh-list
65439420|NCT03398135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439421|NCT01072071|Furosemide|furosemide|mesh-list
65439422|NCT01072071|Diuretics|diuretics|mesh-ancestor
65439423|NCT01072071|Natriuretic Agents|natriuretic agents|mesh-ancestor
65439424|NCT01072071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439425|NCT01072071|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65439426|NCT01072071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65439427|NCT01072071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439428|NCT00181155|Allopurinol|allopurinol|mesh-list
65439429|NCT00181155|Antimetabolites|antimetabolites|mesh-ancestor
65439430|NCT00181155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439431|NCT00181155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439432|NCT00181155|Gout Suppressants|gout suppressants|mesh-ancestor
65439433|NCT00181155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65439434|NCT00181155|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65439435|NCT00181155|Antioxidants|antioxidants|mesh-ancestor
65439436|NCT00181155|Protective Agents|protective agents|mesh-ancestor
65439437|NCT00181155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439438|NCT00322452|Paclitaxel|paclitaxel|mesh-list
65439439|NCT00322452|Carboplatin|carboplatin|mesh-list
65439440|NCT00322452|Gefitinib|gefitinib|mesh-list
65439441|NCT00322452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65439442|NCT00322452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439443|NCT00322452|Tubulin Modulators|tubulin modulators|mesh-ancestor
65439444|NCT00322452|Antimitotic Agents|antimitotic agents|mesh-ancestor
65439445|NCT00322452|Mitosis Modulators|mitosis modulators|mesh-ancestor
65439446|NCT00322452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439447|NCT00322452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65439448|NCT00322452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439449|NCT00110812|Aldesleukin|aldesleukin|mesh-list
65439450|NCT00110812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439460|NCT00516269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65439461|NCT00516269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439463|NCT00516269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65439464|NCT04639037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65439465|NCT03367871|Paclitaxel|paclitaxel|mesh-list
65439466|NCT03367871|Bevacizumab|bevacizumab|mesh-list
65439467|NCT03367871|Carboplatin|carboplatin|mesh-list
65439468|NCT03367871|Pembrolizumab|pembrolizumab|mesh-list
65439469|NCT03367871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65439470|NCT03367871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439471|NCT03367871|Tubulin Modulators|tubulin modulators|mesh-ancestor
65439472|NCT03367871|Antimitotic Agents|antimitotic agents|mesh-ancestor
65439473|NCT03367871|Mitosis Modulators|mitosis modulators|mesh-ancestor
65439474|NCT03367871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439475|NCT03367871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65439476|NCT03367871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65439477|NCT03367871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65439478|NCT03367871|Growth Substances|growth substances|mesh-ancestor
65439479|NCT03367871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439480|NCT03367871|Growth Inhibitors|growth inhibitors|mesh-ancestor
65439481|NCT00228813|Lenograstim|lenograstim|mesh-list
65439482|NCT00228813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65439483|NCT00228813|Immunologic Factors|immunologic factors|mesh-ancestor
65439484|NCT00228813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439485|NCT00322374|Epirubicin|epirubicin|mesh-list
65439486|NCT00322374|Epothilones|epothilones|mesh-list
65439487|NCT00322374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65439488|NCT00322374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439489|NCT00322374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65439490|NCT00322374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65439491|NCT00322374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188998|NCT00607035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65439492|NCT00322374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439493|NCT00322374|Tubulin Modulators|tubulin modulators|mesh-ancestor
65439494|NCT00322374|Antimitotic Agents|antimitotic agents|mesh-ancestor
65439495|NCT00322374|Mitosis Modulators|mitosis modulators|mesh-ancestor
65439496|NCT00174447|Ziprasidone|ziprasidone|mesh-list
65439497|NCT00174447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65439498|NCT00174447|Serotonin Agents|serotonin agents|mesh-ancestor
65439499|NCT00174447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65439500|NCT00174447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439501|NCT00174447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439502|NCT00174447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65439503|NCT00174447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65439504|NCT00174447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65439505|NCT00174447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65439506|NCT00174447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65439507|NCT00174447|Dopamine Agents|dopamine agents|mesh-ancestor
65439508|NCT00321984|Dexlansoprazole|dexlansoprazole|mesh-list
65439509|NCT00321984|Lansoprazole|lansoprazole|mesh-list
65439510|NCT00321984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65439511|NCT00321984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65439512|NCT00321984|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65439513|NCT00321984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439514|NCT00321984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439526|NCT02533284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65439527|NCT02533284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439528|NCT02533284|Anesthetics|anesthetics|mesh-ancestor
65439529|NCT02533284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65439530|NCT02533284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65439531|NCT02533284|Anticonvulsants|anticonvulsants|mesh-ancestor
65439532|NCT02533284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65439533|NCT02533284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65439534|NCT02533284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439535|NCT02533284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65439536|NCT02533284|Tocolytic Agents|tocolytic agents|mesh-ancestor
65439537|NCT02533284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65439538|NCT00515099|Thymoglobulin|thymoglobulin|mesh-list
65439539|NCT00515099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65439540|NCT00515099|Immunologic Factors|immunologic factors|mesh-ancestor
65439541|NCT00515099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439542|NCT00515099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65439543|NCT00110266|Deferasirox|deferasirox|mesh-list
65439544|NCT00110266|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65439545|NCT00110266|Chelating Agents|chelating agents|mesh-ancestor
65439546|NCT00110266|Sequestering Agents|sequestering agents|mesh-ancestor
65439547|NCT00110266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439548|NCT00366548|Vaccines|vaccines|mesh-list
65439549|NCT00366548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65439550|NCT00366548|Immunologic Factors|immunologic factors|mesh-ancestor
65439551|NCT00366548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439552|NCT01074645|Tenofovir|tenofovir|mesh-list
65439553|NCT01074645|Antiviral Agents|antiviral agents|mesh-ancestor
65439554|NCT01074645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65439555|NCT01074645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65439556|NCT01074645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65439557|NCT01074645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439558|NCT01074645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439559|NCT01074645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65439560|NCT01074645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65439561|NCT00132028|Vorinostat|vorinostat|mesh-list
65439562|NCT00132028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439563|NCT00132028|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65439564|NCT00132028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439565|NCT00132028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439566|NCT01045304|Gemcitabine|gemcitabine|mesh-list
65439567|NCT01045304|Carboplatin|carboplatin|mesh-list
65439568|NCT01045304|Iniparib|iniparib|mesh-list
65439570|NCT01045304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65439571|NCT01045304|Antimetabolites|antimetabolites|mesh-ancestor
65439572|NCT01045304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439573|NCT01045304|Antiviral Agents|antiviral agents|mesh-ancestor
65005543|NCT01240408|Lenvatinib|lenvatinib|mesh-list
65439574|NCT01045304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65439575|NCT01045304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439576|NCT01045304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65439577|NCT01045304|Immunologic Factors|immunologic factors|mesh-ancestor
65439578|NCT01045304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439587|NCT01080742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65439588|NCT01080742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439590|NCT01080742|Autonomic Agents|autonomic agents|mesh-ancestor
65439591|NCT01080742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65439592|NCT01080742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65439593|NCT01080742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65439594|NCT01080742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65439595|NCT01080742|Adrenergic Agents|adrenergic agents|mesh-ancestor
65439596|NCT01080742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65439597|NCT00131248|Metoclopramide|metoclopramide|mesh-list
65439598|NCT00131248|Ranitidine|ranitidine|mesh-list
65439599|NCT00131248|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65439600|NCT00131248|Antiemetics|antiemetics|mesh-ancestor
65439601|NCT00131248|Autonomic Agents|autonomic agents|mesh-ancestor
65439602|NCT00131248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65439603|NCT00131248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439604|NCT00131248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65439605|NCT00131248|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65439606|NCT00131248|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65439607|NCT00131248|Dopamine Agents|dopamine agents|mesh-ancestor
65439608|NCT00131248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65439609|NCT00131248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439610|NCT00131248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65439611|NCT00131248|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65439612|NCT00131248|Histamine Antagonists|histamine antagonists|mesh-ancestor
65439613|NCT00131248|Histamine Agents|histamine agents|mesh-ancestor
65439614|NCT00362414|Mitogens|mitogens|mesh-list
65439615|NCT00362414|Mitosis Modulators|mitosis modulators|mesh-ancestor
65439616|NCT00362414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439617|NCT01080820|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
65439618|NCT01080820|Antiviral Agents|antiviral agents|mesh-ancestor
65439619|NCT01080820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65439620|NCT01080820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65439621|NCT01080820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65439622|NCT01049204|Maraviroc|maraviroc|mesh-list
65439623|NCT01049204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65439624|NCT01049204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65439625|NCT01049204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439626|NCT01049204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65439627|NCT01049204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65439628|NCT01049204|Antiviral Agents|antiviral agents|mesh-ancestor
65439629|NCT01049204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65439630|NCT01049204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65439631|NCT00096382|Aldesleukin|aldesleukin|mesh-list
65439632|NCT00096382|Cyclophosphamide|cyclophosphamide|mesh-list
65439633|NCT00096382|Fludarabine|fludarabine|mesh-list
65439634|NCT00096382|Fludarabine phosphate|fludarabine phosphate|mesh-list
65439635|NCT00096382|Interleukin-2|interleukin-2|mesh-list
65439636|NCT00096382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65439637|NCT00096382|Immunologic Factors|immunologic factors|mesh-ancestor
65439638|NCT00096382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439639|NCT00096382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65439640|NCT00096382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65439641|NCT00096382|Alkylating Agents|alkylating agents|mesh-ancestor
65189145|NCT00612898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439642|NCT00096382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439643|NCT00096382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439657|NCT00384332|Autonomic Agents|autonomic agents|mesh-ancestor
65439658|NCT00384332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65439659|NCT00384332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439660|NCT00384332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65439661|NCT00384332|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65439662|NCT00384332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65439663|NCT00384332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65439664|NCT00384332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65439665|NCT00384332|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65439666|NCT00384332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65439667|NCT00384332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65005620|NCT00481819|Immunologic Factors|immunologic factors|mesh-ancestor
65439668|NCT00384332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439669|NCT00384332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65439670|NCT00384332|Serotonin Agents|serotonin agents|mesh-ancestor
65439672|NCT00096226|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65439673|NCT00096226|Carboplatin|carboplatin|mesh-list
65439674|NCT00096226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65439675|NCT00096226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439676|NCT00096226|Tubulin Modulators|tubulin modulators|mesh-ancestor
65439677|NCT00096226|Antimitotic Agents|antimitotic agents|mesh-ancestor
65439678|NCT00096226|Mitosis Modulators|mitosis modulators|mesh-ancestor
65439679|NCT00096226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439680|NCT01078714|Bumetanide|bumetanide|mesh-list
65439681|NCT01078714|Diuretics|diuretics|mesh-ancestor
65439682|NCT01078714|Natriuretic Agents|natriuretic agents|mesh-ancestor
65439683|NCT01078714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439684|NCT01078714|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65439685|NCT01078714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65439686|NCT01078714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439687|NCT03964324|Nitric Oxide|nitric oxide|mesh-list
65439688|NCT03964324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65439689|NCT03964324|Autonomic Agents|autonomic agents|mesh-ancestor
65439690|NCT03964324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65439691|NCT03964324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439692|NCT03964324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65439693|NCT03964324|Respiratory System Agents|respiratory system agents|mesh-ancestor
65439694|NCT03964324|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65439695|NCT03964324|Antioxidants|antioxidants|mesh-ancestor
65439696|NCT03964324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439697|NCT03964324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65439698|NCT03964324|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65439699|NCT03964324|Vasodilator Agents|vasodilator agents|mesh-ancestor
65439700|NCT03964324|Gasotransmitters|gasotransmitters|mesh-ancestor
65439701|NCT03964324|Protective Agents|protective agents|mesh-ancestor
65439702|NCT01082848|Aripiprazole|aripiprazole|mesh-list
65439703|NCT01082848|Antidepressive Agents|antidepressive agents|mesh-ancestor
65439704|NCT01082848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65439705|NCT01082848|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65439711|NCT01082848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65439712|NCT01082848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439713|NCT01082848|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65439714|NCT01082848|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65439715|NCT01082848|Serotonin Agents|serotonin agents|mesh-ancestor
65439716|NCT01082848|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65439717|NCT01082848|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65439718|NCT01082848|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65439719|NCT01082848|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65439721|NCT01082926|Interleukin-2|interleukin-2|mesh-list
65439722|NCT01082926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439723|NCT01082926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65439724|NCT01082926|Analgesics|analgesics|mesh-ancestor
65439725|NCT01082926|Sensory System Agents|sensory system agents|mesh-ancestor
65439726|NCT01082926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65439727|NCT01082926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439728|NCT01082926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65439729|NCT01082926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65439730|NCT01082926|Antiviral Agents|antiviral agents|mesh-ancestor
65439731|NCT01082926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65439732|NCT03962920|Tigecycline|tigecycline|mesh-list
65439733|NCT03962920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65439734|NCT03962920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65439735|NCT03962920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65439736|NCT03962920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439737|NCT03962920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439738|NCT01078870|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65439739|NCT01078870|Citalopram|citalopram|mesh-list
65439740|NCT01078870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65439741|NCT01078870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65439742|NCT01078870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65439743|NCT01078870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439744|NCT01078870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65439745|NCT01078870|Serotonin Agents|serotonin agents|mesh-ancestor
65439746|NCT01078870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439747|NCT01078870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65439748|NCT01078870|Antidepressive Agents|antidepressive agents|mesh-ancestor
65439749|NCT01078870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65439750|NCT01078870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65439751|NCT01078870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65439752|NCT01078870|Analgesics|analgesics|mesh-ancestor
65439753|NCT01078870|Sensory System Agents|sensory system agents|mesh-ancestor
65439754|NCT01078870|Dopamine Agents|dopamine agents|mesh-ancestor
65439755|NCT00105196|Aripiprazole|aripiprazole|mesh-list
65439756|NCT00105196|Antidepressive Agents|antidepressive agents|mesh-ancestor
65439757|NCT00105196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65439758|NCT00105196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65439759|NCT00105196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65439760|NCT00105196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65439761|NCT00105196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439762|NCT00105196|Dopamine Agonists|dopamine agonists|mesh-ancestor
65439763|NCT00105196|Dopamine Agents|dopamine agents|mesh-ancestor
65439764|NCT00105196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65439765|NCT00105196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439766|NCT00105196|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65439767|NCT00105196|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65439768|NCT00105196|Serotonin Agents|serotonin agents|mesh-ancestor
65439769|NCT00105196|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65439770|NCT00105196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65439771|NCT00105196|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65439772|NCT00105196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65439773|NCT00104572|Vitamin D|vitamin d|mesh-list
65439774|NCT00104572|Anastrozole|anastrozole|mesh-list
65439797|NCT00514943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65439798|NCT00514943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439799|NCT00514943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439801|NCT00103402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65439802|NCT00103402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65439803|NCT00103402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65439804|NCT00103402|Adrenergic Agents|adrenergic agents|mesh-ancestor
65439805|NCT00103402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65439806|NCT00103402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439807|NCT00103402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439808|NCT00103402|Urological Agents|urological agents|mesh-ancestor
65439809|NCT00095836|Gefitinib|gefitinib|mesh-list
65439810|NCT00095836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439811|NCT00095836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65439812|NCT00095836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439813|NCT00095836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439814|NCT00168831|Tiotropium Bromide|tiotropium bromide|mesh-list
65439815|NCT00168831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65439816|NCT00168831|Autonomic Agents|autonomic agents|mesh-ancestor
65439817|NCT00168831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65439818|NCT00168831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439819|NCT00168831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65439820|NCT00168831|Respiratory System Agents|respiratory system agents|mesh-ancestor
65439821|NCT00168831|Parasympatholytics|parasympatholytics|mesh-ancestor
65439822|NCT00168831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65439823|NCT00168831|Cholinergic Agents|cholinergic agents|mesh-ancestor
65439824|NCT00168831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65439825|NCT00168831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439826|NCT03330821|Cytarabine|cytarabine|mesh-list
65439827|NCT03330821|Idarubicin|idarubicin|mesh-list
65439836|NCT03330821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65439837|NCT03330821|Immunologic Factors|immunologic factors|mesh-ancestor
65439838|NCT03330821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439839|NCT03330821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65439840|NCT03330821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65439841|NCT03330821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65439842|NCT00512135|Botulinum Toxins|botulinum toxins|mesh-list
65439843|NCT00512135|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65439844|NCT00512135|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65439845|NCT00512135|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65439846|NCT00512135|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65439847|NCT00512135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65439848|NCT00512135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439849|NCT00512135|Cholinergic Agents|cholinergic agents|mesh-ancestor
65005782|NCT05176470|Pembrolizumab|pembrolizumab|mesh-list
65439850|NCT00512135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65439851|NCT00512135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439852|NCT00512135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65439853|NCT00512135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65439854|NCT03235505|Nicotine|nicotine|mesh-list
65439855|NCT03235505|Varenicline|varenicline|mesh-list
65439856|NCT03235505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65439857|NCT03235505|Autonomic Agents|autonomic agents|mesh-ancestor
65439858|NCT03235505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65439859|NCT03235505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439860|NCT03235505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65439861|NCT03235505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65439862|NCT03235505|Cholinergic Agents|cholinergic agents|mesh-ancestor
65439863|NCT03235505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65439864|NCT03235505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439865|NCT00251979|Esomeprazole|esomeprazole|mesh-list
65439866|NCT00251979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65439867|NCT00251979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65439868|NCT00251979|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65439869|NCT00251979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439870|NCT00251979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439871|NCT00511901|Epoetin Alfa|epoetin alfa|mesh-list
65439872|NCT00511901|Hematinics|hematinics|mesh-ancestor
65439873|NCT04580147|Aflibercept|aflibercept|mesh-list
65439874|NCT04580147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65439875|NCT04580147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65439876|NCT04580147|Growth Substances|growth substances|mesh-ancestor
65439877|NCT04580147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439878|NCT04580147|Growth Inhibitors|growth inhibitors|mesh-ancestor
65439879|NCT04580147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439880|NCT03147287|Fulvestrant|fulvestrant|mesh-list
65439881|NCT03147287|Palbociclib|palbociclib|mesh-list
65439882|NCT03147287|Avelumab|avelumab|mesh-list
65439883|NCT03147287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65439884|NCT03147287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439885|NCT03147287|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65439886|NCT03147287|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65439887|NCT03147287|Hormone Antagonists|hormone antagonists|mesh-ancestor
65439888|NCT03147287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65439889|NCT03147287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439890|NCT03147287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65439891|NCT03147287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439892|NCT03147287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439893|NCT03147287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65439914|NCT00513695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65439915|NCT00513695|Immunologic Factors|immunologic factors|mesh-ancestor
65439916|NCT00513695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439917|NCT00513695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65439918|NCT00513695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65439919|NCT00513695|Alkylating Agents|alkylating agents|mesh-ancestor
65439920|NCT00513695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65439921|NCT00513695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65439922|NCT00513695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65439923|NCT00513695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65439924|NCT00513695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439925|NCT00513695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65439926|NCT00513695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65439927|NCT00513695|Growth Substances|growth substances|mesh-ancestor
65439928|NCT00513695|Growth Inhibitors|growth inhibitors|mesh-ancestor
65439929|NCT00513695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65439930|NCT00162981|Clobazam|clobazam|mesh-list
65439931|NCT00162981|Anticonvulsants|anticonvulsants|mesh-ancestor
65439932|NCT00162981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65439933|NCT00162981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65439934|NCT00162981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65439935|NCT00162981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439936|NCT00162981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65439937|NCT00162981|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65439938|NCT00162981|GABA Agonists|gaba agonists|mesh-ancestor
65439939|NCT00162981|GABA Agents|gaba agents|mesh-ancestor
65439940|NCT00162981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65439941|NCT00162981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439942|NCT00099268|Levodopa|levodopa|mesh-list
65439943|NCT00099268|Carbidopa|carbidopa|mesh-list
65005842|NCT00120536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65439944|NCT00099268|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65439945|NCT00099268|Entacapone|entacapone|mesh-list
65439946|NCT00099268|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65439947|NCT00099268|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65439948|NCT00099268|Dopamine Agents|dopamine agents|mesh-ancestor
65439960|NCT00511355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65439961|NCT00511355|Estradiol|estradiol|mesh-list
65439962|NCT00511355|Estrogens|estrogens|mesh-ancestor
65439963|NCT00511355|Hormones|hormones|mesh-ancestor
65439964|NCT00511355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65439965|NCT00511355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439966|NCT00511355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65439967|NCT00511355|Contraceptive Agents|contraceptive agents|mesh-ancestor
65439968|NCT00511355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65439969|NCT00511355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65439970|NCT00511355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65439971|NCT00511355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65439972|NCT00511355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65439973|NCT00511355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65439974|NCT01083784|Valproic Acid|valproic acid|mesh-list
65439975|NCT01083784|Clonazepam|clonazepam|mesh-list
65439976|NCT01083784|Anticonvulsants|anticonvulsants|mesh-list
65439977|NCT01083784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439978|NCT01083784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439979|NCT01083784|GABA Agents|gaba agents|mesh-ancestor
65439980|NCT01083784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65439981|NCT01083784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439982|NCT01083784|Antimanic Agents|antimanic agents|mesh-ancestor
65439983|NCT01083784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65439984|NCT01083784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65439985|NCT01083784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65439986|NCT01083784|GABA Modulators|gaba modulators|mesh-ancestor
65439987|NCT00095212|Testosterone|testosterone|mesh-list
65439988|NCT00095212|Androgens|androgens|mesh-ancestor
65439989|NCT00095212|Hormones|hormones|mesh-ancestor
65439990|NCT00095212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65439991|NCT00095212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439992|NCT02834975|Paclitaxel|paclitaxel|mesh-list
65439993|NCT02834975|Carboplatin|carboplatin|mesh-list
65439994|NCT02834975|Pembrolizumab|pembrolizumab|mesh-list
65439995|NCT02834975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65439996|NCT02834975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439997|NCT02834975|Tubulin Modulators|tubulin modulators|mesh-ancestor
65439998|NCT02834975|Antimitotic Agents|antimitotic agents|mesh-ancestor
65439999|NCT02834975|Mitosis Modulators|mitosis modulators|mesh-ancestor
65440000|NCT02834975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440001|NCT02834975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65440002|NCT00120874|Memantine|memantine|mesh-list
65440003|NCT00120874|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65440004|NCT00120874|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65440005|NCT00120874|Dopamine Agents|dopamine agents|mesh-ancestor
65440006|NCT00120874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65440007|NCT00120874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440008|NCT00120874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440009|NCT00120874|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65440010|NCT00120874|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65440027|NCT01079338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65440028|NCT00384176|Leucovorin|leucovorin|mesh-list
65440029|NCT00384176|Bevacizumab|bevacizumab|mesh-list
65440030|NCT00384176|Fluorouracil|fluorouracil|mesh-list
65440031|NCT00384176|Oxaliplatin|oxaliplatin|mesh-list
65440032|NCT00384176|Cediranib|cediranib|mesh-list
65440033|NCT00384176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65440034|NCT00384176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440035|NCT00384176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65440036|NCT00384176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65440037|NCT00384176|Growth Substances|growth substances|mesh-ancestor
65440038|NCT00384176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440039|NCT00384176|Growth Inhibitors|growth inhibitors|mesh-ancestor
65440040|NCT00384176|Antimetabolites|antimetabolites|mesh-ancestor
65440041|NCT00384176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440042|NCT00384176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65440043|NCT00384176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65440044|NCT00384176|Immunologic Factors|immunologic factors|mesh-ancestor
65440045|NCT00384176|Antidotes|antidotes|mesh-ancestor
65440046|NCT00384176|Protective Agents|protective agents|mesh-ancestor
65440047|NCT00384176|Vitamin B Complex|vitamin b complex|mesh-ancestor
65440048|NCT00384176|Vitamins|vitamins|mesh-ancestor
65440049|NCT00384176|Micronutrients|micronutrients|mesh-ancestor
65440050|NCT00384176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65440051|NCT00384176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440052|NCT00513305|Cytarabine|cytarabine|mesh-list
65440053|NCT00513305|Arsenic Trioxide|arsenic trioxide|mesh-list
65440054|NCT00513305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65440055|NCT00513305|Antimetabolites|antimetabolites|mesh-ancestor
65440056|NCT00513305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440057|NCT00513305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440058|NCT00513305|Antiviral Agents|antiviral agents|mesh-ancestor
65440059|NCT00513305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65440060|NCT00513305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65440061|NCT00513305|Immunologic Factors|immunologic factors|mesh-ancestor
65440062|NCT00513305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440063|NCT00513071|Saracatinib|saracatinib|mesh-list
65440064|NCT00513071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440065|NCT00513071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440066|NCT00513071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440067|NCT00510887|Dexamethasone|dexamethasone|mesh-list
65440068|NCT00510887|Rituximab|rituximab|mesh-list
65440069|NCT00510887|Fludarabine|fludarabine|mesh-list
65440095|NCT01012349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65440096|NCT01012349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65440098|NCT01012349|Sensory System Agents|sensory system agents|mesh-ancestor
65440099|NCT01012349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65440100|NCT01012349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440101|NCT01012349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65440102|NCT01012349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65440103|NCT01012349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65440104|NCT01012349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65440105|NCT01012349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440106|NCT01012349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65440107|NCT01012349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65440108|NCT01012349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440109|NCT01012349|Antipyretics|antipyretics|mesh-ancestor
65440110|NCT01012349|Anticoagulants|anticoagulants|mesh-ancestor
65440111|NCT01012349|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65440112|NCT01012349|Chelating Agents|chelating agents|mesh-ancestor
65440113|NCT01012349|Sequestering Agents|sequestering agents|mesh-ancestor
65440114|NCT00358826|Atreleuton|atreleuton|mesh-list
65440115|NCT00358826|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65440116|NCT00358826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440117|NCT00358826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440118|NCT01009541|Pregabalin|pregabalin|mesh-list
65440119|NCT01009541|Analgesics|analgesics|mesh-ancestor
65440120|NCT01009541|Sensory System Agents|sensory system agents|mesh-ancestor
65440121|NCT01009541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824840|NCT01534026|Aspirin|aspirin|mesh-list
65440151|NCT01009853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440152|NCT01009853|Analgesics|analgesics|mesh-ancestor
65440153|NCT01009853|Sensory System Agents|sensory system agents|mesh-ancestor
65440154|NCT01009853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65440155|NCT01009853|Antitussive Agents|antitussive agents|mesh-ancestor
65440156|NCT01009853|Respiratory System Agents|respiratory system agents|mesh-ancestor
65440157|NCT00506285|Methylphenidate|methylphenidate|mesh-list
65440158|NCT00506285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65440159|NCT00506285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440160|NCT00506285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65440161|NCT00506285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65440162|NCT00506285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65440163|NCT00506285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436097|NCT01639729|Dsuvia|dsuvia|mesh-list
65440176|NCT00506129|Immunologic Factors|immunologic factors|mesh-ancestor
65440177|NCT00506129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440178|NCT00506129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65440179|NCT00506129|Alkylating Agents|alkylating agents|mesh-ancestor
65440180|NCT00506129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65440181|NCT00358670|Infliximab|infliximab|mesh-list
65440182|NCT00358670|Dermatologic Agents|dermatologic agents|mesh-ancestor
65440183|NCT00358670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65440184|NCT00358670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65440185|NCT01010087|Oseltamivir|oseltamivir|mesh-list
65440186|NCT01010087|Antiviral Agents|antiviral agents|mesh-ancestor
65440187|NCT01010087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65440188|NCT01010087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440189|NCT01010087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440190|NCT00505661|Letrozole|letrozole|mesh-list
65440191|NCT00505661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440192|NCT00505661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65440193|NCT00505661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65440194|NCT00505661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440195|NCT00505661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440196|NCT00505661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65440197|NCT00505661|Hormone Antagonists|hormone antagonists|mesh-ancestor
65440198|NCT00505661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65440199|NCT00505661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440200|NCT00383786|Vofopitant|vofopitant|mesh-list
65440201|NCT00383786|Antiemetics|antiemetics|mesh-ancestor
65440202|NCT00383786|Autonomic Agents|autonomic agents|mesh-ancestor
65440203|NCT00383786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65440204|NCT00383786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440205|NCT00383786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65440206|NCT00383786|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65440207|NCT00383786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65440208|NCT00383786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440209|NCT05358977|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65440210|NCT05358977|Hemostatics|hemostatics|mesh-ancestor
65440211|NCT05358977|Coagulants|coagulants|mesh-ancestor
65440212|NCT01010243|Pioglitazone|pioglitazone|mesh-list
65440213|NCT01010243|Dexamethasone|dexamethasone|mesh-list
65440214|NCT01010243|Lenalidomide|lenalidomide|mesh-list
65440215|NCT01010243|Treosulfan|treosulfan|mesh-list
65440216|NCT01010243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65440217|NCT01010243|Antiemetics|antiemetics|mesh-ancestor
65440218|NCT01010243|Autonomic Agents|autonomic agents|mesh-ancestor
65440219|NCT01010243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65440220|NCT01010243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440221|NCT01010243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65440222|NCT01010243|Glucocorticoids|glucocorticoids|mesh-ancestor
65440223|NCT01010243|Hormones|hormones|mesh-ancestor
65440224|NCT01010243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65440225|NCT01010243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65440226|NCT01010243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440227|NCT01010243|Immunologic Factors|immunologic factors|mesh-ancestor
65440228|NCT01010243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65440243|NCT00504725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65440244|NCT00504725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440245|NCT00504725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65440246|NCT00504725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65440247|NCT00504725|Anesthetics, General|anesthetics, general|mesh-ancestor
65440249|NCT00504725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65440250|NCT00504725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65440251|NCT00504725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65440252|NCT00504725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65440253|NCT00504725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440254|NCT00383240|Mometasone Furoate|mometasone furoate|mesh-list
65440255|NCT00383240|Formoterol Fumarate|formoterol fumarate|mesh-list
65440256|NCT00383240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65440257|NCT00383240|Autonomic Agents|autonomic agents|mesh-ancestor
65440258|NCT00383240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65440259|NCT00383240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440260|NCT00383240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65440261|NCT00383240|Respiratory System Agents|respiratory system agents|mesh-ancestor
65440262|NCT00383240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65440263|NCT00383240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65440264|NCT00383240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65440265|NCT00383240|Adrenergic Agents|adrenergic agents|mesh-ancestor
65440266|NCT00383240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65440267|NCT00383240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440268|NCT00383240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65440269|NCT00383240|Dermatologic Agents|dermatologic agents|mesh-ancestor
65440270|NCT00383240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65440271|NCT05130788|Nicotine|nicotine|mesh-list
65440272|NCT05130788|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65440273|NCT05130788|Autonomic Agents|autonomic agents|mesh-ancestor
65006068|NCT01241383|Bosentan|bosentan|mesh-list
65440274|NCT05130788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65440275|NCT05130788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440276|NCT05130788|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65440277|NCT05130788|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65440278|NCT05130788|Cholinergic Agents|cholinergic agents|mesh-ancestor
65440279|NCT05130788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65440280|NCT05130788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440281|NCT00362180|Mipomersen|mipomersen|mesh-list
65440282|NCT00362180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65440283|NCT00362180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65440284|NCT00362180|Antimetabolites|antimetabolites|mesh-ancestor
65440285|NCT00362180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440286|NCT00362180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65440287|NCT00383162|Naproxen|naproxen|mesh-list
65440288|NCT00383162|Sumatriptan|sumatriptan|mesh-list
64825008|NCT01535092|Silybin|silybin|mesh-list
65440308|NCT01052792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65440309|NCT01052792|Analgesics|analgesics|mesh-ancestor
65440310|NCT01052792|Sensory System Agents|sensory system agents|mesh-ancestor
65440311|NCT01052792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65189813|NCT01055496|Mitosis Modulators|mitosis modulators|mesh-ancestor
65440313|NCT01052792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65440314|NCT01052792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65440315|NCT01052792|Gout Suppressants|gout suppressants|mesh-ancestor
65440316|NCT01052792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65440317|NCT01052792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440318|NCT01052792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440319|NCT01052870|Finasteride|finasteride|mesh-list
65440320|NCT01052870|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65440321|NCT01052870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65440322|NCT01052870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440323|NCT01052870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440324|NCT01052870|Hormone Antagonists|hormone antagonists|mesh-ancestor
65440325|NCT01052870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65440326|NCT01052870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440327|NCT01052870|Urological Agents|urological agents|mesh-ancestor
65440328|NCT00358436|Bromides|bromides|mesh-list
65440329|NCT00358436|Anticonvulsants|anticonvulsants|mesh-ancestor
65440330|NCT01053026|Olmesartan|olmesartan|mesh-list
65440331|NCT01053026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65440332|NCT01053026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65440333|NCT01053026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65440334|NCT01053026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440335|NCT01045538|Capecitabine|capecitabine|mesh-list
65440336|NCT01045538|Vorinostat|vorinostat|mesh-list
65440337|NCT01045538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440338|NCT01045538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65440339|NCT01045538|Antimetabolites|antimetabolites|mesh-ancestor
65440340|NCT01045538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440341|NCT01045538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65440348|NCT00361634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65440349|NCT00361634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440350|NCT00361634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65440351|NCT00361634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65440352|NCT00361634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65440353|NCT00361634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65440354|NCT00361634|Immunologic Factors|immunologic factors|mesh-ancestor
65440355|NCT00357968|Clopidogrel|clopidogrel|mesh-list
65440356|NCT00357968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65440357|NCT00357968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65440358|NCT00357968|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65440359|NCT00357968|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65440360|NCT00357968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65440361|NCT00357968|Purinergic Agents|purinergic agents|mesh-ancestor
65440362|NCT00357968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65440363|NCT00357968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440364|NCT00357968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440365|NCT00357656|Factor VIII|factor viii|mesh-list
65440366|NCT00357656|Coagulants|coagulants|mesh-ancestor
65440367|NCT00357500|Thalidomide|thalidomide|mesh-list
65440368|NCT00357500|Celecoxib|celecoxib|mesh-list
65440369|NCT00357500|Cyclophosphamide|cyclophosphamide|mesh-list
65440370|NCT00357500|Etoposide|etoposide|mesh-list
65440371|NCT00357500|Fenofibrate|fenofibrate|mesh-list
65440372|NCT00357500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65440373|NCT00357500|Immunologic Factors|immunologic factors|mesh-ancestor
65440374|NCT00357500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440375|NCT00357500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65440376|NCT00357500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65440377|NCT00357500|Alkylating Agents|alkylating agents|mesh-ancestor
65440378|NCT00357500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440379|NCT00357500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440380|NCT00357500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65440381|NCT00357500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65440382|NCT00357500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65440383|NCT00357500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65440384|NCT00357500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440385|NCT00357500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65440386|NCT00357500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65440387|NCT00357500|Analgesics|analgesics|mesh-ancestor
65440388|NCT00357500|Sensory System Agents|sensory system agents|mesh-ancestor
65440389|NCT00357500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65440390|NCT00357500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65440391|NCT00357500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65440392|NCT00357500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65440393|NCT00357500|Leprostatic Agents|leprostatic agents|mesh-ancestor
65440394|NCT00357500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65440395|NCT00357500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65440396|NCT00357500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65440397|NCT00357500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65440398|NCT00357500|Growth Substances|growth substances|mesh-ancestor
65440399|NCT00357500|Growth Inhibitors|growth inhibitors|mesh-ancestor
65440400|NCT00357500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65440401|NCT00357500|Antimetabolites|antimetabolites|mesh-ancestor
65440402|NCT00357500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65440403|NCT00357110|Fulvestrant|fulvestrant|mesh-list
65440404|NCT00357110|Anastrozole|anastrozole|mesh-list
65440405|NCT00357110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65440406|NCT00357110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440407|NCT00357110|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65440408|NCT00357110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65440409|NCT00357110|Hormone Antagonists|hormone antagonists|mesh-ancestor
65440410|NCT00357110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65440424|NCT03337646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65440425|NCT00098722|Maraviroc|maraviroc|mesh-list
65440426|NCT00098722|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65440427|NCT00098722|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65440428|NCT00098722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440429|NCT00098722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65440430|NCT00098722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65440431|NCT00098722|Antiviral Agents|antiviral agents|mesh-ancestor
65440432|NCT00098722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65440433|NCT00098722|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65440434|NCT02531152|Latanoprost|latanoprost|mesh-list
65440435|NCT02531152|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65440436|NCT02531152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65440437|NCT01084408|Paclitaxel|paclitaxel|mesh-list
65440438|NCT01084408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65440439|NCT01084408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65440440|NCT01084408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440441|NCT01084408|Tubulin Modulators|tubulin modulators|mesh-ancestor
65440442|NCT01084408|Antimitotic Agents|antimitotic agents|mesh-ancestor
65440443|NCT01084408|Mitosis Modulators|mitosis modulators|mesh-ancestor
65440444|NCT01084408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440445|NCT00098254|Sorafenib|sorafenib|mesh-list
65440446|NCT00098254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440447|NCT00098254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65440448|NCT00098254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440449|NCT00098254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440450|NCT00095056|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65440451|NCT00095056|Glipizide|glipizide|mesh-list
65440452|NCT00095056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65440453|NCT00095056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440454|NCT00095056|Incretins|incretins|mesh-ancestor
65440455|NCT00095056|Hormones|hormones|mesh-ancestor
65440456|NCT00095056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65440457|NCT00095056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65440458|NCT00095056|Protease Inhibitors|protease inhibitors|mesh-ancestor
65440459|NCT00095056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440460|NCT00095056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440462|NCT00098020|Dermatologic Agents|dermatologic agents|mesh-ancestor
65440463|NCT00381680|Leucovorin|leucovorin|mesh-list
65440464|NCT00381680|Cytarabine|cytarabine|mesh-list
65440465|NCT00381680|Dexamethasone|dexamethasone|mesh-list
65440466|NCT00381680|Prednisone|prednisone|mesh-list
65440467|NCT00381680|Cyclophosphamide|cyclophosphamide|mesh-list
65440468|NCT00381680|Doxorubicin|doxorubicin|mesh-list
65440469|NCT00381680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65440470|NCT00381680|Methotrexate|methotrexate|mesh-list
65440471|NCT00381680|Etoposide|etoposide|mesh-list
65440497|NCT00381680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65440498|NCT00381680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65440499|NCT00381680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440500|NCT00381680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65440501|NCT00381680|Abortifacient Agents|abortifacient agents|mesh-ancestor
65440502|NCT00381680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65440503|NCT00381680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65440504|NCT00381680|Antimetabolites|antimetabolites|mesh-ancestor
65440505|NCT00381680|Dermatologic Agents|dermatologic agents|mesh-ancestor
65440506|NCT00381680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65440507|NCT00381680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65440508|NCT00381680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65440509|NCT00381680|Antiviral Agents|antiviral agents|mesh-ancestor
65440510|NCT00381680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65440511|NCT00381680|Antidotes|antidotes|mesh-ancestor
65440512|NCT00381680|Protective Agents|protective agents|mesh-ancestor
65440513|NCT00381680|Vitamin B Complex|vitamin b complex|mesh-ancestor
65440514|NCT00381680|Vitamins|vitamins|mesh-ancestor
65440515|NCT00381680|Micronutrients|micronutrients|mesh-ancestor
65440516|NCT00381680|Tubulin Modulators|tubulin modulators|mesh-ancestor
65440517|NCT00381680|Antimitotic Agents|antimitotic agents|mesh-ancestor
65440518|NCT00381680|Mitosis Modulators|mitosis modulators|mesh-ancestor
65440519|NCT03292250|Durvalumab|durvalumab|mesh-list
65440520|NCT03292250|Tremelimumab|tremelimumab|mesh-list
65440521|NCT03292250|Nintedanib|nintedanib|mesh-list
65440522|NCT03292250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64825243|NCT01536431|Insulin|insulin|mesh-list
65440559|NCT01050374|Piperazine|piperazine|mesh-list
65440560|NCT01050374|Piperazine citrate|piperazine citrate|mesh-list
65440561|NCT01050374|DMP 777|dmp 777|mesh-list
65440562|NCT01050374|Anthelmintics|anthelmintics|mesh-ancestor
65440563|NCT01050374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65440579|NCT00360698|Glimepiride|glimepiride|mesh-list
65440580|NCT00360698|Insulin glulisine|insulin glulisine|mesh-list
65440581|NCT00360698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65440582|NCT00360698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440583|NCT00360698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65440584|NCT00360698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65440585|NCT00360698|Immunologic Factors|immunologic factors|mesh-ancestor
65440586|NCT03990194|Leuprolide|leuprolide|mesh-list
65440587|NCT03990194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65440588|NCT03990194|Fertility Agents|fertility agents|mesh-ancestor
65440589|NCT03990194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65440590|NCT03990194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440591|NCT03990194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65440592|NCT03990194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440593|NCT00380978|Narcotics|narcotics|mesh-list
65440594|NCT00380978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65440595|NCT00380978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440596|NCT00380978|Analgesics|analgesics|mesh-ancestor
65440597|NCT00380978|Sensory System Agents|sensory system agents|mesh-ancestor
65440598|NCT00380978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65440599|NCT00162123|Ipilimumab|ipilimumab|mesh-list
65440600|NCT00162123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65440601|NCT00162123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440602|NCT00162123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65440603|NCT00162123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440604|NCT00227721|Gemcitabine|gemcitabine|mesh-list
65440605|NCT00227721|Docetaxel|docetaxel|mesh-list
65440606|NCT00227721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65440607|NCT00227721|Antimetabolites|antimetabolites|mesh-ancestor
65440608|NCT00227721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440609|NCT00227721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440610|NCT00227721|Antiviral Agents|antiviral agents|mesh-ancestor
65440611|NCT00227721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65440612|NCT00227721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440613|NCT00227721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65440614|NCT00227721|Immunologic Factors|immunologic factors|mesh-ancestor
65440615|NCT00227721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440617|NCT00227721|Antimitotic Agents|antimitotic agents|mesh-ancestor
65440618|NCT00227721|Mitosis Modulators|mitosis modulators|mesh-ancestor
65440619|NCT01074723|Carotenoids|carotenoids|mesh-list
65440620|NCT01074723|Antioxidants|antioxidants|mesh-ancestor
65440621|NCT01074723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440622|NCT01074723|Protective Agents|protective agents|mesh-ancestor
65440623|NCT01074723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440624|NCT01074801|Insulin|insulin|mesh-list
65440625|NCT01074801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64825329|NCT01536873|Antiviral Agents|antiviral agents|mesh-ancestor
65440653|NCT00226941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65440654|NCT00226941|Histamine Antagonists|histamine antagonists|mesh-ancestor
65440655|NCT00226941|Histamine Agents|histamine agents|mesh-ancestor
65440656|NCT00226941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65440657|NCT00226941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65440658|NCT00226941|Antipruritics|antipruritics|mesh-ancestor
65440659|NCT00226941|Dermatologic Agents|dermatologic agents|mesh-ancestor
65440660|NCT01075503|Ropivacaine|ropivacaine|mesh-list
65440661|NCT01075503|Anesthetics, Local|anesthetics, local|mesh-ancestor
65440662|NCT01075503|Anesthetics|anesthetics|mesh-ancestor
65440663|NCT01075503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65440664|NCT01075503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440665|NCT01075503|Sensory System Agents|sensory system agents|mesh-ancestor
65440666|NCT01075503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65440667|NCT01075581|Epinephrine|epinephrine|mesh-list
65440668|NCT01075581|Racepinephrine|racepinephrine|mesh-list
65440669|NCT01075581|Epinephryl borate|epinephryl borate|mesh-list
65440670|NCT01075581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65440671|NCT01075581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65440672|NCT01075581|Adrenergic Agents|adrenergic agents|mesh-ancestor
65440673|NCT01075581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65440674|NCT01075581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440705|NCT00504257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440707|NCT00504257|Tubulin Modulators|tubulin modulators|mesh-ancestor
65440708|NCT00504257|Antimitotic Agents|antimitotic agents|mesh-ancestor
65440709|NCT00504257|Mitosis Modulators|mitosis modulators|mesh-ancestor
65440710|NCT00504257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440711|NCT00509093|Imatinib Mesylate|imatinib mesylate|mesh-list
65440712|NCT00509093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440713|NCT00509093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65440714|NCT00509093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440715|NCT00509093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440716|NCT05358509|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65440717|NCT05358509|Ferric Compounds|ferric compounds|mesh-list
65440718|NCT05358509|Hematinics|hematinics|mesh-ancestor
65440719|NCT00160641|Certolizumab Pegol|certolizumab pegol|mesh-list
65440730|NCT00493025|Tubulin Modulators|tubulin modulators|mesh-ancestor
65440731|NCT00493025|Antimitotic Agents|antimitotic agents|mesh-ancestor
65440732|NCT00493025|Mitosis Modulators|mitosis modulators|mesh-ancestor
65440733|NCT00493025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440734|NCT00493025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65440735|NCT00493025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440736|NCT01075113|Sorafenib|sorafenib|mesh-list
65440737|NCT01075113|Vorinostat|vorinostat|mesh-list
65440738|NCT01075113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440739|NCT01075113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65440740|NCT01075113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440741|NCT01075113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440742|NCT01075113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65440743|NCT01073319|Rivastigmine|rivastigmine|mesh-list
65440744|NCT01073319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65440745|NCT01073319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440746|NCT01073319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440747|NCT01073319|Cholinergic Agents|cholinergic agents|mesh-ancestor
65440748|NCT01073319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65440749|NCT01073319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440750|NCT01073319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65440751|NCT01073319|Protective Agents|protective agents|mesh-ancestor
65440752|NCT00160563|Levocetirizine|levocetirizine|mesh-list
65440753|NCT00160563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65440754|NCT00160563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65440755|NCT00160563|Histamine Antagonists|histamine antagonists|mesh-ancestor
65440756|NCT00160563|Histamine Agents|histamine agents|mesh-ancestor
65440757|NCT00160563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65006360|NCT01242202|Miglitol|miglitol|mesh-list
65440758|NCT00160563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440759|NCT00160563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440760|NCT01050452|Ivermectin|ivermectin|mesh-list
65440761|NCT01050452|Albendazole|albendazole|mesh-list
65440762|NCT01050452|Mebendazole|mebendazole|mesh-list
65440763|NCT01050452|Piperazine|piperazine|mesh-list
65440764|NCT01050452|Piperazine citrate|piperazine citrate|mesh-list
65440765|NCT01050452|DMP 777|dmp 777|mesh-list
65440766|NCT01050452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65440767|NCT01050452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65440768|NCT01050452|Anthelmintics|anthelmintics|mesh-ancestor
65440769|NCT01050452|Anticestodal Agents|anticestodal agents|mesh-ancestor
65440770|NCT01050452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65440771|NCT01050452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65440772|NCT01050452|Tubulin Modulators|tubulin modulators|mesh-ancestor
65440773|NCT01050452|Antimitotic Agents|antimitotic agents|mesh-ancestor
65440774|NCT01050452|Mitosis Modulators|mitosis modulators|mesh-ancestor
65440775|NCT01050452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440776|NCT01050452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440777|NCT01050452|Antinematodal Agents|antinematodal agents|mesh-ancestor
65440778|NCT01050452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440779|NCT00380588|Gemcitabine|gemcitabine|mesh-list
65440780|NCT00380588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440781|NCT00380588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65440782|NCT00380588|Antimetabolites|antimetabolites|mesh-ancestor
65440783|NCT00380588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440784|NCT00380588|Antiviral Agents|antiviral agents|mesh-ancestor
65440785|NCT00380588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64825482|NCT01538095|Trebananib|trebananib|mesh-list
65440797|NCT00379808|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65440798|NCT00379808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65440799|NCT00379808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440800|NCT03990038|Ropivacaine|ropivacaine|mesh-list
65440801|NCT03990038|Anesthetics, Local|anesthetics, local|mesh-ancestor
65440802|NCT03990038|Anesthetics|anesthetics|mesh-ancestor
65440803|NCT03990038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65440804|NCT03990038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440805|NCT03990038|Sensory System Agents|sensory system agents|mesh-ancestor
65440806|NCT03990038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65440808|NCT00355784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65440809|NCT00355784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440810|NCT02534636|Interferons|interferons|mesh-list
65440811|NCT02534636|Interferon-alpha|interferon-alpha|mesh-list
65440812|NCT02534636|Interferon alpha-2|interferon alpha-2|mesh-list
65440813|NCT02534636|BMS-986165|bms-986165|mesh-list
65440814|NCT02534636|Famotidine|famotidine|mesh-list
65440815|NCT02534636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440816|NCT02534636|Antiviral Agents|antiviral agents|mesh-ancestor
65440817|NCT02534636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65440818|NCT02534636|Immunologic Factors|immunologic factors|mesh-ancestor
65440819|NCT02534636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440820|NCT02534636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65440821|NCT02534636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65440822|NCT02534636|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65440823|NCT02534636|Histamine Antagonists|histamine antagonists|mesh-ancestor
65440824|NCT02534636|Histamine Agents|histamine agents|mesh-ancestor
65440825|NCT02534636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65440826|NCT02534636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440827|NCT02534636|Dermatologic Agents|dermatologic agents|mesh-ancestor
65440828|NCT02534636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65440829|NCT02534636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440830|NCT01053650|Acetaminophen|acetaminophen|mesh-list
65440831|NCT01053650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65440832|NCT01053650|Analgesics|analgesics|mesh-ancestor
65440833|NCT01053650|Sensory System Agents|sensory system agents|mesh-ancestor
65440834|NCT01053650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65440835|NCT01053650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440836|NCT01053650|Antipyretics|antipyretics|mesh-ancestor
65440837|NCT01053728|Insulin Glargine|insulin glargine|mesh-list
65440838|NCT01053728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65440839|NCT01053728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440840|NCT01050608|Ethanol|ethanol|mesh-list
65440841|NCT01050608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65440842|NCT01050608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65440843|NCT01050608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65006438|NCT00488176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65440844|NCT01050608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440845|NCT01053806|Lenalidomide|lenalidomide|mesh-list
65440846|NCT01053806|Azacitidine|azacitidine|mesh-list
65440847|NCT01053806|Immunologic Factors|immunologic factors|mesh-ancestor
65440848|NCT01053806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440866|NCT01010789|Modafinil|modafinil|mesh-list
65440867|NCT01010789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65440868|NCT01010789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440869|NCT01010789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65440870|NCT01010789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65440871|NCT01010789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65440872|NCT01010789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440873|NCT01015235|Ketorolac|ketorolac|mesh-list
65440874|NCT01015235|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65440875|NCT01015235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65440876|NCT01015235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65440877|NCT01015235|Analgesics|analgesics|mesh-ancestor
65440878|NCT01015235|Sensory System Agents|sensory system agents|mesh-ancestor
65440879|NCT01015235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65440880|NCT01015235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440881|NCT01015235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65440882|NCT01015235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65440883|NCT01015235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65440884|NCT01015235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440885|NCT01015235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440886|NCT00508157|Olanzapine|olanzapine|mesh-list
65440887|NCT00508157|Risperidone|risperidone|mesh-list
65440888|NCT00508157|Aripiprazole|aripiprazole|mesh-list
65440889|NCT00508157|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65440890|NCT00508157|Antipsychotic Agents|antipsychotic agents|mesh-list
65440891|NCT00508157|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65440892|NCT00508157|Serotonin Agents|serotonin agents|mesh-ancestor
65440893|NCT00508157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65440894|NCT00508157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440895|NCT00508157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440896|NCT00508157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65440897|NCT00508157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65440898|NCT00508157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65440899|NCT00508157|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65440900|NCT00508157|Dopamine Agents|dopamine agents|mesh-ancestor
65440901|NCT00508157|Antiemetics|antiemetics|mesh-ancestor
65440902|NCT00508157|Autonomic Agents|autonomic agents|mesh-ancestor
65440903|NCT00508157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65440904|NCT00508157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65440905|NCT00508157|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65440910|NCT00508157|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65440911|NCT00508157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65440912|NCT00508157|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65440913|NCT00508157|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65440914|NCT04331717|Leuprolide|leuprolide|mesh-list
65440915|NCT04331717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65440916|NCT04331717|Fertility Agents|fertility agents|mesh-ancestor
65440917|NCT04331717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65440918|NCT04331717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440919|NCT04331717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65440920|NCT04331717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440922|NCT01015391|Antimetabolites|antimetabolites|mesh-ancestor
65440923|NCT01015391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440924|NCT01015391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65440925|NCT01015391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440926|NCT01015391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65440927|NCT01015391|Immunologic Factors|immunologic factors|mesh-ancestor
65440928|NCT01015391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440929|NCT01015391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65440930|NCT01010945|Gemcitabine|gemcitabine|mesh-list
65440931|NCT01010945|Paclitaxel|paclitaxel|mesh-list
65440932|NCT01010945|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65440933|NCT01010945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65440934|NCT01010945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440935|NCT01010945|Tubulin Modulators|tubulin modulators|mesh-ancestor
65440936|NCT01010945|Antimitotic Agents|antimitotic agents|mesh-ancestor
65440937|NCT01010945|Mitosis Modulators|mitosis modulators|mesh-ancestor
65270048|NCT02719808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65440938|NCT01010945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440939|NCT01010945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65440940|NCT01010945|Antimetabolites|antimetabolites|mesh-ancestor
65440941|NCT01010945|Antiviral Agents|antiviral agents|mesh-ancestor
65440942|NCT01010945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65440943|NCT01010945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440944|NCT01010945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65440945|NCT01010945|Immunologic Factors|immunologic factors|mesh-ancestor
65440946|NCT01010945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440947|NCT01010945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65440948|NCT00507689|Immunoglobulins|immunoglobulins|mesh-list
65440949|NCT00507689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65440950|NCT00507689|Antibodies|antibodies|mesh-list
65440951|NCT00507689|Immunologic Factors|immunologic factors|mesh-ancestor
65440952|NCT00507689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440953|NCT00491387|Metoprolol|metoprolol|mesh-list
65440954|NCT00491387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65440955|NCT00491387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65440956|NCT00491387|Sympatholytics|sympatholytics|mesh-ancestor
65440957|NCT00491387|Autonomic Agents|autonomic agents|mesh-ancestor
65440958|NCT00491387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65440959|NCT00491387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440960|NCT00491387|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65440961|NCT00491387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65440962|NCT00491387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65440963|NCT00491387|Adrenergic Agents|adrenergic agents|mesh-ancestor
65440964|NCT00491387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65440965|NCT00491387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440966|NCT01011257|Clopidogrel|clopidogrel|mesh-list
65440967|NCT01011257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65440968|NCT01011257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65440969|NCT01011257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65440970|NCT01011257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65440971|NCT01011257|Purinergic Agents|purinergic agents|mesh-ancestor
65440972|NCT01011257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65440973|NCT01011257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440974|NCT01011257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440975|NCT01015547|Sulfasalazine|sulfasalazine|mesh-list
65441002|NCT01015547|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65441003|NCT01015547|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65441004|NCT00491075|Gemcitabine|gemcitabine|mesh-list
65441005|NCT00491075|Pemetrexed|pemetrexed|mesh-list
65441006|NCT00491075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65441007|NCT00491075|Antimetabolites|antimetabolites|mesh-ancestor
65441008|NCT00491075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441009|NCT00491075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441010|NCT00491075|Antiviral Agents|antiviral agents|mesh-ancestor
65441011|NCT00491075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65441012|NCT00491075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441013|NCT00491075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65441014|NCT00491075|Immunologic Factors|immunologic factors|mesh-ancestor
65441015|NCT00491075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441016|NCT00491075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65441017|NCT00491075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65441018|NCT00507455|Tamsulosin|tamsulosin|mesh-list
65441019|NCT00507455|Solifenacin Succinate|solifenacin succinate|mesh-list
65441020|NCT00507455|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65441021|NCT00507455|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65441022|NCT00507455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65441023|NCT00507455|Adrenergic Agents|adrenergic agents|mesh-ancestor
64825746|NCT01539174|Prednisone|prednisone|mesh-list
65441040|NCT00490919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65441042|NCT00490919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65441043|NCT00490919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441044|NCT00490919|Analgesics|analgesics|mesh-ancestor
65441045|NCT00490919|Sensory System Agents|sensory system agents|mesh-ancestor
65441046|NCT00490919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65441047|NCT00490919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65441048|NCT01015937|Losartan|losartan|mesh-list
65441049|NCT01015937|Enalapril|enalapril|mesh-list
65441050|NCT01015937|Angiotensin II|angiotensin ii|mesh-list
65441051|NCT01015937|Giapreza|giapreza|mesh-list
65441052|NCT01015937|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65441053|NCT01015937|Angiotensinogen|angiotensinogen|mesh-list
65441054|NCT01015937|Turmeric extract|turmeric extract|mesh-list
65441055|NCT01015937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65441056|NCT01015937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65441057|NCT01015937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65441058|NCT01015937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65441059|NCT01015937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441060|NCT01015937|Protease Inhibitors|protease inhibitors|mesh-ancestor
65441061|NCT01015937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441062|NCT01015937|Antioxidants|antioxidants|mesh-ancestor
65441063|NCT01015937|Protective Agents|protective agents|mesh-ancestor
65441064|NCT01015937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441065|NCT01015937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65441066|NCT01015937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65441067|NCT04266353|Resveratrol|resveratrol|mesh-list
65441068|NCT04266353|Antioxidants|antioxidants|mesh-ancestor
65441069|NCT04266353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441070|NCT04266353|Protective Agents|protective agents|mesh-ancestor
65441071|NCT04266353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441072|NCT04266353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441073|NCT04266353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65441074|NCT01012193|Cilostazol|cilostazol|mesh-list
65441075|NCT01012193|Clopidogrel|clopidogrel|mesh-list
65441076|NCT01012193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65441077|NCT01012193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65441078|NCT01012193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65441079|NCT01012193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65441080|NCT01012193|Purinergic Agents|purinergic agents|mesh-ancestor
65441081|NCT01012193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65441089|NCT01012193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65441090|NCT01012193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65441091|NCT01012193|Vasodilator Agents|vasodilator agents|mesh-ancestor
65441092|NCT01012193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65441093|NCT01012193|Protective Agents|protective agents|mesh-ancestor
65441094|NCT01012193|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65441095|NCT01012193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65441096|NCT01012193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441097|NCT00503399|Teriparatide|teriparatide|mesh-list
65441098|NCT00503399|Risedronic Acid|risedronic acid|mesh-list
65441099|NCT00503399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65441100|NCT00503399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441101|NCT00503399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65441102|NCT00503399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65441103|NCT00503399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65441104|NCT00503399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441105|NCT00506519|Antithrombins|antithrombins|mesh-list
65441106|NCT00506519|Antithrombin III|antithrombin iii|mesh-list
65441107|NCT00506519|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65441108|NCT00506519|Protease Inhibitors|protease inhibitors|mesh-ancestor
65441109|NCT00506519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441110|NCT00506519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441111|NCT00506519|Anticoagulants|anticoagulants|mesh-ancestor
65441112|NCT00503009|Fluticasone|fluticasone|mesh-list
65441113|NCT00503009|Xhance|xhance|mesh-list
65441114|NCT00503009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65441115|NCT00503009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65441116|NCT00503009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65441117|NCT00503009|Autonomic Agents|autonomic agents|mesh-ancestor
65441118|NCT00503009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65441119|NCT00503009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441120|NCT00503009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65441121|NCT00503009|Respiratory System Agents|respiratory system agents|mesh-ancestor
65441122|NCT00503009|Dermatologic Agents|dermatologic agents|mesh-ancestor
65441123|NCT00503009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65441124|NCT00503009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65441125|NCT00503009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65441126|NCT00503009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65441127|NCT00503009|Adrenergic Agents|adrenergic agents|mesh-ancestor
65441128|NCT00503009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65441129|NCT00503009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441130|NCT01016093|Zoledronic Acid|zoledronic acid|mesh-list
65441131|NCT01016093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65441132|NCT01016093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441133|NCT00160251|Ribavirin|ribavirin|mesh-list
65270049|NCT02719808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441134|NCT00160251|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65441135|NCT00160251|Antimetabolites|antimetabolites|mesh-ancestor
65441136|NCT00160251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441137|NCT00160251|Antiviral Agents|antiviral agents|mesh-ancestor
65441138|NCT00160251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65441139|NCT01075425|Bortezomib|bortezomib|mesh-list
65441140|NCT01075425|Belinostat|belinostat|mesh-list
65441141|NCT01075425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441142|NCT01075425|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65441143|NCT01075425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441144|NCT01075425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441145|NCT00378014|Everolimus|everolimus|mesh-list
65441146|NCT00378014|Basiliximab|basiliximab|mesh-list
65441147|NCT00378014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441148|NCT00378014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65441177|NCT01016249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441178|NCT01016249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441179|NCT01016249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65441180|NCT01016249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65441181|NCT01016249|Autonomic Agents|autonomic agents|mesh-ancestor
65441182|NCT01016249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65441183|NCT01016249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65441184|NCT01016249|Respiratory System Agents|respiratory system agents|mesh-ancestor
65441185|NCT01016249|Mydriatics|mydriatics|mesh-ancestor
65441186|NCT01016249|Sympathomimetics|sympathomimetics|mesh-ancestor
65441187|NCT01016249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65441188|NCT00377858|Insulin|insulin|mesh-list
65441189|NCT00377858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65441190|NCT00377858|Insulin Glargine|insulin glargine|mesh-list
65441191|NCT00377858|Insulin Lispro|insulin lispro|mesh-list
65441192|NCT00377858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65441193|NCT00377858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441206|NCT00502775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65441207|NCT00502775|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65441208|NCT00502775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65441209|NCT00502775|Histamine Antagonists|histamine antagonists|mesh-ancestor
65441210|NCT00502775|Histamine Agents|histamine agents|mesh-ancestor
65441211|NCT00502775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65441212|NCT00502775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441213|NCT01013675|Vaccines|vaccines|mesh-list
65441214|NCT01013675|Immunologic Factors|immunologic factors|mesh-ancestor
65441215|NCT01013675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441216|NCT01054118|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65441217|NCT01054118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65441218|NCT01054118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441220|NCT01054118|Hormones|hormones|mesh-ancestor
65441221|NCT01054118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65441222|NCT01054118|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65441223|NCT01054118|Protease Inhibitors|protease inhibitors|mesh-ancestor
65441224|NCT01054118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441225|NCT01054118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441226|NCT01050842|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65441227|NCT01050842|Bicalutamide|bicalutamide|mesh-list
65441228|NCT01050842|Androgen Antagonists|androgen antagonists|mesh-ancestor
65441229|NCT01050842|Hormone Antagonists|hormone antagonists|mesh-ancestor
65441230|NCT01050842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65441231|NCT01050842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441232|NCT01050842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441233|NCT01050842|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65441234|NCT01050842|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65441235|NCT01050842|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65441236|NCT01050842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65441237|NCT00485069|Levodopa|levodopa|mesh-list
65441238|NCT00485069|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65441239|NCT00485069|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65441240|NCT00485069|Dopamine Agents|dopamine agents|mesh-ancestor
65441241|NCT00485069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65441242|NCT00485069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441243|NCT00485069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441244|NCT03989336|Manganese|manganese|mesh-list
65441245|NCT03989336|Paclitaxel|paclitaxel|mesh-list
65441246|NCT03989336|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65441247|NCT03989336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65441248|NCT03989336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65441249|NCT03989336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441250|NCT03989336|Tubulin Modulators|tubulin modulators|mesh-ancestor
65441251|NCT03989336|Antimitotic Agents|antimitotic agents|mesh-ancestor
65441252|NCT03989336|Mitosis Modulators|mitosis modulators|mesh-ancestor
65441253|NCT03989336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441254|NCT03989336|Trace Elements|trace elements|mesh-ancestor
65441255|NCT03989336|Micronutrients|micronutrients|mesh-ancestor
65441256|NCT03989336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441257|NCT00355082|Lamotrigine|lamotrigine|mesh-list
65441262|NCT00355082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65441264|NCT00355082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65441265|NCT00355082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65441266|NCT00355082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65441267|NCT00355082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65441268|NCT00355082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65441269|NCT00484679|Triamcinolone|triamcinolone|mesh-list
65441270|NCT00484679|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65441271|NCT00484679|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65441272|NCT00484679|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65441273|NCT00484679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65441274|NCT00484679|Glucocorticoids|glucocorticoids|mesh-ancestor
65441275|NCT00484679|Hormones|hormones|mesh-ancestor
65441276|NCT00484679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65441277|NCT00484679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441278|NCT00484679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65441279|NCT00484679|Immunologic Factors|immunologic factors|mesh-ancestor
65441280|NCT00484679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441281|NCT00484679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441282|NCT00377312|Hormones|hormones|mesh-list
65441283|NCT00377312|Parathyroid Hormone|parathyroid hormone|mesh-list
65441284|NCT00377312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65441285|NCT00377312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441286|NCT00377312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65441287|NCT00377234|Risedronic Acid|risedronic acid|mesh-list
65441288|NCT00377234|Ibandronic Acid|ibandronic acid|mesh-list
65441289|NCT00377234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65441290|NCT00377234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65441291|NCT00377234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441292|NCT00377234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65441293|NCT00377234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441294|NCT00377234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65441296|NCT00376688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65441297|NCT00376688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65441298|NCT00376688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65441299|NCT00376688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441300|NCT00376688|Antifungal Agents|antifungal agents|mesh-ancestor
65441301|NCT00376688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65441302|NCT00376688|Immunologic Factors|immunologic factors|mesh-ancestor
65441303|NCT00376688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441304|NCT00376220|Riluzole|riluzole|mesh-list
65441305|NCT00376220|Anticonvulsants|anticonvulsants|mesh-ancestor
65441306|NCT00376220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65441307|NCT00376220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65441308|NCT00376220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65441309|NCT00376220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441310|NCT00376220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441311|NCT00376220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65441312|NCT00376220|Protective Agents|protective agents|mesh-ancestor
65441313|NCT00375752|Letrozole|letrozole|mesh-list
65441314|NCT00375752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441315|NCT00375752|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65441316|NCT00375752|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65441317|NCT00375752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441318|NCT00375752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441319|NCT00375752|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65441320|NCT00375752|Hormone Antagonists|hormone antagonists|mesh-ancestor
65441321|NCT00375752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65441322|NCT00375752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441323|NCT00484289|Abatacept|abatacept|mesh-list
65441324|NCT00484289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65441333|NCT01013831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65270050|NCT02719808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441334|NCT01013831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441335|NCT01013831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441336|NCT01013909|Terbinafine|terbinafine|mesh-list
65441338|NCT01013909|Antifungal Agents|antifungal agents|mesh-ancestor
65441339|NCT01013909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65441340|NCT01013909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441341|NCT01013909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441342|NCT01013987|Ritonavir|ritonavir|mesh-list
65441343|NCT01013987|Darunavir|darunavir|mesh-list
65441344|NCT01013987|Raltegravir Potassium|raltegravir potassium|mesh-list
65441345|NCT01013987|Maraviroc|maraviroc|mesh-list
65441346|NCT01013987|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65441347|NCT01013987|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65441348|NCT01013987|Protease Inhibitors|protease inhibitors|mesh-ancestor
65441349|NCT01013987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441350|NCT01013987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441351|NCT01013987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65441352|NCT01013987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65441353|NCT01013987|Antiviral Agents|antiviral agents|mesh-ancestor
65441354|NCT01013987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65441355|NCT01013987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65441356|NCT01013987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65441357|NCT01013987|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65441358|NCT01013987|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65441359|NCT01013987|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65441360|NCT01013987|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65441361|NCT01013987|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65441362|NCT01019291|Formaldehyde|formaldehyde|mesh-list
65441363|NCT01019291|Disinfectants|disinfectants|mesh-ancestor
65441364|NCT01019291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65441365|NCT01019447|Anti-Infective Agents|anti-infective agents|mesh-list
65441366|NCT01019447|Triclosan|triclosan|mesh-list
65441367|NCT01019447|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65441368|NCT01019447|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65441369|NCT01019447|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65441370|NCT01019447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65441371|NCT01019447|Antimetabolites|antimetabolites|mesh-ancestor
65441372|NCT01019447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441373|NCT01019447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65441374|NCT00490529|Cyclophosphamide|cyclophosphamide|mesh-list
65441375|NCT00490529|Rituximab|rituximab|mesh-list
65441376|NCT00490529|Vaccines|vaccines|mesh-list
65441377|NCT00490529|Immunologic Factors|immunologic factors|mesh-ancestor
65441378|NCT00490529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441379|NCT00490529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65441380|NCT00490529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65441381|NCT00490529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65441382|NCT00490529|Alkylating Agents|alkylating agents|mesh-ancestor
65441383|NCT00490529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441384|NCT00490529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441385|NCT00490529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65441386|NCT00490529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65441387|NCT00333840|Interferons|interferons|mesh-list
65441388|NCT00333840|Cytarabine|cytarabine|mesh-list
65441389|NCT00333840|Interferon-alpha|interferon-alpha|mesh-list
65441390|NCT00333840|Interferon alpha-2|interferon alpha-2|mesh-list
65441391|NCT00333840|Imatinib Mesylate|imatinib mesylate|mesh-list
65441404|NCT01019603|Tazarotene|tazarotene|mesh-list
65441405|NCT01019603|Dermatologic Agents|dermatologic agents|mesh-ancestor
65441406|NCT01019603|Keratolytic Agents|keratolytic agents|mesh-ancestor
65441407|NCT01019603|Vitamin B Complex|vitamin b complex|mesh-ancestor
65441408|NCT01019603|Vitamins|vitamins|mesh-ancestor
65441409|NCT01019603|Micronutrients|micronutrients|mesh-ancestor
65441410|NCT01019603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441411|NCT00321906|Sirolimus|sirolimus|mesh-list
65441412|NCT00321906|Azathioprine|azathioprine|mesh-list
65441413|NCT00321906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65441414|NCT00321906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65441415|NCT00321906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65441416|NCT00321906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441417|NCT00321906|Antifungal Agents|antifungal agents|mesh-ancestor
65441418|NCT00321906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65441419|NCT00321906|Immunologic Factors|immunologic factors|mesh-ancestor
65441420|NCT00321906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441421|NCT00321906|Antimetabolites|antimetabolites|mesh-ancestor
65270051|NCT02719808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65441422|NCT00321906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441423|NCT00321906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65441424|NCT00321906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65441425|NCT00339144|Dasatinib|dasatinib|mesh-list
65441426|NCT00339144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441427|NCT00339144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65441428|NCT00339144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441429|NCT00339144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441430|NCT00321828|Leucovorin|leucovorin|mesh-list
65441431|NCT00321828|Bevacizumab|bevacizumab|mesh-list
65441432|NCT00321828|Fluorouracil|fluorouracil|mesh-list
65441433|NCT00321828|Oxaliplatin|oxaliplatin|mesh-list
65441434|NCT00321828|Levoleucovorin|levoleucovorin|mesh-list
65441435|NCT00321828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65441436|NCT00321828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441437|NCT00321828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65441438|NCT00321828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65441439|NCT00321828|Growth Substances|growth substances|mesh-ancestor
65441440|NCT00321828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441441|NCT00321828|Growth Inhibitors|growth inhibitors|mesh-ancestor
65441442|NCT00321828|Antimetabolites|antimetabolites|mesh-ancestor
65441443|NCT00321828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441444|NCT00321828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65441445|NCT00321828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65441446|NCT00321828|Immunologic Factors|immunologic factors|mesh-ancestor
65441447|NCT00321828|Antidotes|antidotes|mesh-ancestor
65441448|NCT00321828|Protective Agents|protective agents|mesh-ancestor
65441449|NCT00321828|Vitamin B Complex|vitamin b complex|mesh-ancestor
65441450|NCT00321828|Vitamins|vitamins|mesh-ancestor
65441451|NCT00321828|Micronutrients|micronutrients|mesh-ancestor
65441452|NCT00333138|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65441453|NCT00333138|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65441454|NCT00333138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826155|NCT01541267|Telmisartan|telmisartan|mesh-list
65441469|NCT01061814|Antimetabolites|antimetabolites|mesh-ancestor
65441470|NCT01061814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441471|NCT01061814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65441472|NCT00331422|Paclitaxel|paclitaxel|mesh-list
65441473|NCT00331422|Carboplatin|carboplatin|mesh-list
65441474|NCT00331422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65441475|NCT00331422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441476|NCT00331422|Tubulin Modulators|tubulin modulators|mesh-ancestor
65441477|NCT00331422|Antimitotic Agents|antimitotic agents|mesh-ancestor
65441478|NCT00331422|Mitosis Modulators|mitosis modulators|mesh-ancestor
65441479|NCT00331422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441480|NCT00331344|Prednisone|prednisone|mesh-list
65441481|NCT00331344|Mitoxantrone|mitoxantrone|mesh-list
65441482|NCT00331344|Epothilone B|epothilone b|mesh-list
65441483|NCT00331344|Epothilones|epothilones|mesh-list
65441484|NCT00331344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65441485|NCT00331344|Glucocorticoids|glucocorticoids|mesh-ancestor
65441486|NCT00331344|Hormones|hormones|mesh-ancestor
65441487|NCT00331344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65441488|NCT00331344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441489|NCT00331344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65441490|NCT00331344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441491|NCT00331344|Analgesics|analgesics|mesh-ancestor
65441492|NCT00331344|Sensory System Agents|sensory system agents|mesh-ancestor
65441493|NCT00331344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65441494|NCT00331344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65441495|NCT00331344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65441496|NCT00331344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441497|NCT00331344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441498|NCT00331344|Tubulin Modulators|tubulin modulators|mesh-ancestor
65441499|NCT00331344|Antimitotic Agents|antimitotic agents|mesh-ancestor
65441500|NCT00331344|Mitosis Modulators|mitosis modulators|mesh-ancestor
65441501|NCT00321672|Capsaicin|capsaicin|mesh-list
65441502|NCT00321672|Antipruritics|antipruritics|mesh-ancestor
65441503|NCT00321672|Dermatologic Agents|dermatologic agents|mesh-ancestor
65441504|NCT00321672|Sensory System Agents|sensory system agents|mesh-ancestor
65441505|NCT00321672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65441506|NCT00321672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441507|NCT00330174|Acamprosate|acamprosate|mesh-list
65441508|NCT00330174|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65006939|NCT00492388|Anesthetics, General|anesthetics, general|mesh-ancestor
65441509|NCT00320424|PENTA|penta|mesh-list
65441510|NCT00320424|Fondaparinux|fondaparinux|mesh-list
65441511|NCT00320424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65441512|NCT00320424|Antithrombins|antithrombins|mesh-ancestor
65441513|NCT00320424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65441514|NCT00320424|Protease Inhibitors|protease inhibitors|mesh-ancestor
65441515|NCT00320424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441516|NCT00320424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441517|NCT00320424|Anticoagulants|anticoagulants|mesh-ancestor
65441539|NCT03991910|Protease Inhibitors|protease inhibitors|mesh-ancestor
65441540|NCT03991910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441541|NCT03991910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441542|NCT03991910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65441543|NCT00320190|Imatinib Mesylate|imatinib mesylate|mesh-list
65441544|NCT00320190|Dasatinib|dasatinib|mesh-list
65441545|NCT00320190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441546|NCT00320190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65441547|NCT00320190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441548|NCT00320190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441549|NCT02534402|Prednisone|prednisone|mesh-list
65441550|NCT02534402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65441551|NCT02534402|Glucocorticoids|glucocorticoids|mesh-ancestor
65441552|NCT02534402|Hormones|hormones|mesh-ancestor
65441553|NCT02534402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65441554|NCT02534402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441555|NCT02534402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65441556|NCT02534402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441557|NCT00319956|Azithromycin|azithromycin|mesh-list
65441558|NCT00319956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65441559|NCT00319956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65441560|NCT01062048|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65441561|NCT01062048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65441562|NCT01062048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441563|NCT01062048|Incretins|incretins|mesh-ancestor
65441564|NCT01062048|Hormones|hormones|mesh-ancestor
65441565|NCT01062048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65441566|NCT01062048|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65441567|NCT01062048|Protease Inhibitors|protease inhibitors|mesh-ancestor
65441568|NCT01062048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441569|NCT01062048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441570|NCT00349622|Ceftriaxone|ceftriaxone|mesh-list
64826276|NCT01541956|Metformin|metformin|mesh-list
65441591|NCT00348686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65441592|NCT00348686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65441593|NCT00348686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65441594|NCT00348686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441595|NCT00348686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65441596|NCT00348686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65441597|NCT00348686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65441598|NCT00348686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65441599|NCT00348686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441600|NCT00348686|Vasodilator Agents|vasodilator agents|mesh-ancestor
65441601|NCT03742310|Vitamin D|vitamin d|mesh-list
65441602|NCT03742310|Calcitriol|calcitriol|mesh-list
65441603|NCT03742310|Vitamins|vitamins|mesh-ancestor
65441604|NCT03742310|Micronutrients|micronutrients|mesh-ancestor
65441605|NCT03742310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441606|NCT03742310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65441607|NCT03742310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65441608|NCT03742310|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65441609|NCT03742310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65441610|NCT03742310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441611|NCT03742310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65441612|NCT00360230|Vaccines|vaccines|mesh-list
65441613|NCT00360230|Immunologic Factors|immunologic factors|mesh-ancestor
65441614|NCT00360230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441615|NCT03989024|Clomiphene|clomiphene|mesh-list
65441616|NCT03989024|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65441617|NCT03989024|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65441618|NCT03989024|Hormone Antagonists|hormone antagonists|mesh-ancestor
65441619|NCT03989024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65441620|NCT03989024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007016|NCT02274454|Oxytocin|oxytocin|mesh-list
65441621|NCT03989024|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65441622|NCT03989024|Fertility Agents|fertility agents|mesh-ancestor
65441623|NCT03989024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64826330|NCT01542242|Hormones|hormones|mesh-ancestor
65441640|NCT00352664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441641|NCT00352664|Cholinergic Agents|cholinergic agents|mesh-ancestor
65441642|NCT00352664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65441643|NCT00352664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441644|NCT00352664|Nootropic Agents|nootropic agents|mesh-ancestor
65441645|NCT03991442|Amlodipine|amlodipine|mesh-list
65441646|NCT03991442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65441647|NCT03991442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65441648|NCT03991442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65441649|NCT03991442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441650|NCT03991442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65441651|NCT03991442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441652|NCT03991442|Vasodilator Agents|vasodilator agents|mesh-ancestor
65441653|NCT00490139|Trastuzumab|trastuzumab|mesh-list
65441654|NCT00490139|Lapatinib|lapatinib|mesh-list
65441655|NCT00490139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65441656|NCT00490139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441657|NCT00490139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65441658|NCT00490139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441659|NCT00490139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441660|NCT00348140|Rosiglitazone|rosiglitazone|mesh-list
65441661|NCT00348140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65441662|NCT00348140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441663|NCT01051388|Rabeprazole|rabeprazole|mesh-list
65441664|NCT01051388|Gefarnate|gefarnate|mesh-list
65441665|NCT01051388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65441666|NCT01051388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65441667|NCT01051388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65441668|NCT01051388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441669|NCT01051388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441671|NCT00490061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441672|NCT00490061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65441673|NCT00490061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441674|NCT00490061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441675|NCT00483119|Cyclophosphamide|cyclophosphamide|mesh-list
65441676|NCT00483119|Immunoglobulins|immunoglobulins|mesh-list
65441677|NCT00483119|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65441678|NCT00483119|Antibodies|antibodies|mesh-list
65441679|NCT00483119|gamma-Globulins|gamma-globulins|mesh-list
65441680|NCT00483119|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65441681|NCT00483119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65441682|NCT00483119|Immunologic Factors|immunologic factors|mesh-ancestor
65441683|NCT00483119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826394|NCT01542710|Bimatoprost|bimatoprost|mesh-list
65441706|NCT01014221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65441707|NCT01014221|Glucocorticoids|glucocorticoids|mesh-ancestor
65441708|NCT01014221|Hormones|hormones|mesh-ancestor
65441709|NCT01014221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65441710|NCT01014221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441711|NCT01014221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65441712|NCT01014221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441713|NCT00482729|Metformin|metformin|mesh-list
65441714|NCT00482729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65441715|NCT00482729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65441716|NCT00482729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441717|NCT00482729|Incretins|incretins|mesh-ancestor
65441718|NCT00482729|Hormones|hormones|mesh-ancestor
65441719|NCT00482729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65441720|NCT00482729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65441721|NCT00482729|Protease Inhibitors|protease inhibitors|mesh-ancestor
65441722|NCT00482729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441723|NCT00482729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441724|NCT00359762|Exenatide|exenatide|mesh-list
65441725|NCT00359762|Glimepiride|glimepiride|mesh-list
65441726|NCT00359762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65441727|NCT00359762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441728|NCT00359762|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65441729|NCT00359762|Incretins|incretins|mesh-ancestor
65441730|NCT00359762|Hormones|hormones|mesh-ancestor
65248406|NCT00202904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007088|NCT00493363|Artesunate|artesunate|mesh-list
65441731|NCT00359762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65441732|NCT00359762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64826449|NCT01543139|GABA Agents|gaba agents|mesh-ancestor
65441751|NCT01055522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65441753|NCT01055522|Sensory System Agents|sensory system agents|mesh-ancestor
65441754|NCT01055522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65441755|NCT01055522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441756|NCT01055522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65441757|NCT01055522|Alkylating Agents|alkylating agents|mesh-ancestor
65441758|NCT01055522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441759|NCT03987152|Sirolimus|sirolimus|mesh-list
65441760|NCT03987152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65441761|NCT03987152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65441762|NCT03987152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65441763|NCT03987152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441764|NCT03987152|Antifungal Agents|antifungal agents|mesh-ancestor
65441765|NCT03987152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65441766|NCT03987152|Immunologic Factors|immunologic factors|mesh-ancestor
65441767|NCT03987152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441768|NCT00347438|Capecitabine|capecitabine|mesh-list
65441769|NCT00347438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65441770|NCT00347438|Antimetabolites|antimetabolites|mesh-ancestor
65441771|NCT00347438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441772|NCT00347438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441773|NCT00329238|Warfarin|warfarin|mesh-list
65441774|NCT00329238|Dabigatran|dabigatran|mesh-list
65441775|NCT00329238|Anticoagulants|anticoagulants|mesh-ancestor
65441776|NCT00329238|Antithrombins|antithrombins|mesh-ancestor
65441777|NCT00329238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65441778|NCT00329238|Protease Inhibitors|protease inhibitors|mesh-ancestor
65441779|NCT00329238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441780|NCT00329238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441781|NCT00329160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65441782|NCT00329160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65441783|NCT00329160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65441784|NCT00329160|Antimetabolites|antimetabolites|mesh-ancestor
65441785|NCT00329160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441786|NCT00329160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65441787|NCT00329160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65441788|NCT00329160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441789|NCT00328926|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65441803|NCT00347360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65441805|NCT00347360|Protective Agents|protective agents|mesh-ancestor
65441806|NCT00347360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65441807|NCT00347360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65441808|NCT00347360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65441809|NCT00347360|Vasodilator Agents|vasodilator agents|mesh-ancestor
65441810|NCT00347360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65441811|NCT00347360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65191310|NCT00833053|Methotrexate|methotrexate|mesh-list
65441812|NCT00347360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65441813|NCT00347360|Protease Inhibitors|protease inhibitors|mesh-ancestor
65441814|NCT00347360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441815|NCT00347360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65441817|NCT00319020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65441818|NCT00319020|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65441819|NCT00319020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441820|NCT01056224|Remifentanil|remifentanil|mesh-list
65441821|NCT01056224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65441822|NCT01056224|Narcotics|narcotics|mesh-ancestor
65441823|NCT01056224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65441824|NCT01056224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441825|NCT01056224|Analgesics|analgesics|mesh-ancestor
65441826|NCT01056224|Sensory System Agents|sensory system agents|mesh-ancestor
65441827|NCT01056224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65441828|NCT03982680|Gemcitabine|gemcitabine|mesh-list
65441829|NCT03982680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65441830|NCT03982680|Antimetabolites|antimetabolites|mesh-ancestor
65441831|NCT03982680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441832|NCT03982680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441833|NCT03982680|Antiviral Agents|antiviral agents|mesh-ancestor
65441834|NCT03982680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65441835|NCT03982680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441836|NCT03982680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65441837|NCT03982680|Immunologic Factors|immunologic factors|mesh-ancestor
65441838|NCT03982680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441839|NCT00352118|Docetaxel|docetaxel|mesh-list
65441840|NCT00352118|Fluorouracil|fluorouracil|mesh-list
65441841|NCT00352118|Lenograstim|lenograstim|mesh-list
65441842|NCT00352118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441843|NCT00352118|Tubulin Modulators|tubulin modulators|mesh-ancestor
65441844|NCT00352118|Antimitotic Agents|antimitotic agents|mesh-ancestor
65441845|NCT00352118|Mitosis Modulators|mitosis modulators|mesh-ancestor
65441846|NCT00352118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441847|NCT00352118|Antimetabolites|antimetabolites|mesh-ancestor
65441848|NCT00352118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64437761|NCT04915612|Cytarabine|cytarabine|mesh-list
65441865|NCT00350870|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65441866|NCT00350870|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65441867|NCT00350870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441868|NCT00350870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441870|NCT00350792|Pemetrexed|pemetrexed|mesh-list
65441871|NCT00350792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441872|NCT00350792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441873|NCT00350792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441874|NCT00350792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65441875|NCT00350792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65441876|NCT00317772|Topotecan|topotecan|mesh-list
65441877|NCT00317772|Gefitinib|gefitinib|mesh-list
65441878|NCT00317772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65441879|NCT00317772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65441880|NCT00317772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441881|NCT00317772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441882|NCT00317772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441883|NCT00317772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65441884|NCT01325298|Riboflavin|riboflavin|mesh-list
65441885|NCT01325298|Vitamin B Complex|vitamin b complex|mesh-ancestor
65441886|NCT01325298|Vitamins|vitamins|mesh-ancestor
65441888|NCT01325298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441889|NCT01325298|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65441890|NCT01325298|Dermatologic Agents|dermatologic agents|mesh-ancestor
65441891|NCT00350636|Mandelic Acids|mandelic acids|mesh-list
65441892|NCT00350636|Oxybutynin|oxybutynin|mesh-list
65441893|NCT00350636|Parasympatholytics|parasympatholytics|mesh-ancestor
65441894|NCT00350636|Autonomic Agents|autonomic agents|mesh-ancestor
65441895|NCT00350636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65441896|NCT00350636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441897|NCT00350636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65441898|NCT00350636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65441899|NCT00350636|Cholinergic Agents|cholinergic agents|mesh-ancestor
65441900|NCT00350636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65441901|NCT00350636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441902|NCT00350636|Urological Agents|urological agents|mesh-ancestor
65441903|NCT00350636|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65441904|NCT00350636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65441905|NCT00350636|Renal Agents|renal agents|mesh-ancestor
65441906|NCT01051544|Factor VIII|factor viii|mesh-list
65441907|NCT01051544|Coagulants|coagulants|mesh-ancestor
65441922|NCT00346268|Sensory System Agents|sensory system agents|mesh-ancestor
65441923|NCT00346268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65441924|NCT00346268|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65441925|NCT00346268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65441926|NCT00346268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441927|NCT00346268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441928|NCT00346268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65441929|NCT00346268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65441930|NCT00346268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65441931|NCT00346268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65441932|NCT00327444|Aflibercept|aflibercept|mesh-list
65441933|NCT00327444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65441934|NCT00327444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65441935|NCT00327444|Growth Substances|growth substances|mesh-ancestor
65441936|NCT00327444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441937|NCT00327444|Growth Inhibitors|growth inhibitors|mesh-ancestor
65441938|NCT00327444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441939|NCT01051622|Technetium Tc 99m Exametazime|technetium tc 99m exametazime|mesh-list
65441940|NCT01051622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65270052|NCT02719808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65441941|NCT01051622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441942|NCT03982134|Panobinostat|panobinostat|mesh-list
65441943|NCT03982134|Spartalizumab|spartalizumab|mesh-list
65441944|NCT03982134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441945|NCT03982134|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65441946|NCT03982134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441947|NCT03982134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441948|NCT03982134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65441949|NCT00337610|Metformin|metformin|mesh-list
65441950|NCT00337610|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65441951|NCT00337610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65441952|NCT00337610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441953|NCT00337610|Incretins|incretins|mesh-ancestor
65441954|NCT00337610|Hormones|hormones|mesh-ancestor
65441955|NCT00337610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65441956|NCT00337610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65441957|NCT00337610|Protease Inhibitors|protease inhibitors|mesh-ancestor
65441958|NCT00337610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441959|NCT00337610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441960|NCT01062204|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65441961|NCT01062204|Laxatives|laxatives|mesh-ancestor
65441962|NCT01062204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65441963|NCT01062282|Iloprost|iloprost|mesh-list
65441964|NCT01062282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65441965|NCT01062282|Vasodilator Agents|vasodilator agents|mesh-ancestor
65441966|NCT03985280|Anesthetics|anesthetics|mesh-list
65441967|NCT03985280|Anesthetics, Local|anesthetics, local|mesh-list
65441968|NCT03985280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65441969|NCT03985280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441981|NCT01058876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441982|NCT03986762|Clavulanic Acids|clavulanic acids|mesh-list
65441983|NCT03986762|Clavulanic Acid|clavulanic acid|mesh-list
65441984|NCT03986762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65441985|NCT03986762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65441986|NCT03986762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441987|NCT03986762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441988|NCT03986762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65441989|NCT01051934|Paclitaxel|paclitaxel|mesh-list
65441990|NCT01051934|Bevacizumab|bevacizumab|mesh-list
65441991|NCT01051934|Carboplatin|carboplatin|mesh-list
65441992|NCT01051934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65441993|NCT01051934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441994|NCT01051934|Tubulin Modulators|tubulin modulators|mesh-ancestor
65441995|NCT01051934|Antimitotic Agents|antimitotic agents|mesh-ancestor
65441996|NCT01051934|Mitosis Modulators|mitosis modulators|mesh-ancestor
65441997|NCT01051934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441998|NCT01051934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65441999|NCT01051934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65442000|NCT01051934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65442001|NCT01051934|Growth Substances|growth substances|mesh-ancestor
65442002|NCT01051934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442003|NCT01051934|Growth Inhibitors|growth inhibitors|mesh-ancestor
65442004|NCT01325168|Oxytocin|oxytocin|mesh-list
65442005|NCT01325168|Oxytocics|oxytocics|mesh-ancestor
65442006|NCT01325168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65442007|NCT01325168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442008|NCT00316914|Magnesium Sulfate|magnesium sulfate|mesh-list
65442009|NCT00316914|Calcium|calcium|mesh-list
65442010|NCT00316914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65442011|NCT00316914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442012|NCT00316914|Analgesics|analgesics|mesh-ancestor
65442013|NCT00316914|Sensory System Agents|sensory system agents|mesh-ancestor
65442014|NCT00316914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442015|NCT00316914|Anesthetics|anesthetics|mesh-ancestor
65442016|NCT00316914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65442017|NCT00316914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65442018|NCT00316914|Anticonvulsants|anticonvulsants|mesh-ancestor
65442019|NCT00316914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65442020|NCT00316914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65442021|NCT00316914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442022|NCT00316914|Tocolytic Agents|tocolytic agents|mesh-ancestor
65442023|NCT00316914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65270053|NCT02719418|Tinzaparin|tinzaparin|mesh-list
65442024|NCT00335972|Dexmedetomidine|dexmedetomidine|mesh-list
65442025|NCT00335972|Remifentanil|remifentanil|mesh-list
65442026|NCT00335972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65442027|NCT00335972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65442028|NCT00335972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442029|NCT00335972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65442030|NCT00335972|Analgesics|analgesics|mesh-ancestor
65442031|NCT00335972|Sensory System Agents|sensory system agents|mesh-ancestor
65442032|NCT00335972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826732|NCT01544751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65442047|NCT03983460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65442048|NCT03983460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442050|NCT03983460|Respiratory System Agents|respiratory system agents|mesh-ancestor
65442051|NCT01056614|Methotrexate|methotrexate|mesh-list
65442052|NCT01056614|Fludarabine phosphate|fludarabine phosphate|mesh-list
65442053|NCT01056614|Fludarabine|fludarabine|mesh-list
65442054|NCT01056614|Busulfan|busulfan|mesh-list
65442055|NCT01056614|Tacrolimus|tacrolimus|mesh-list
65442056|NCT01056614|Thymoglobulin|thymoglobulin|mesh-list
65442057|NCT01056614|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65442058|NCT01056614|Immunoglobulins|immunoglobulins|mesh-list
65442059|NCT01056614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65442060|NCT01056614|Abortifacient Agents|abortifacient agents|mesh-ancestor
65442061|NCT01056614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65442062|NCT01056614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442063|NCT01056614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65442064|NCT01056614|Antimetabolites|antimetabolites|mesh-ancestor
65442065|NCT01056614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442066|NCT01056614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442067|NCT01056614|Dermatologic Agents|dermatologic agents|mesh-ancestor
65442068|NCT01056614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442069|NCT01056614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65442070|NCT01056614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65442071|NCT01056614|Immunologic Factors|immunologic factors|mesh-ancestor
65442072|NCT01056614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65442073|NCT01056614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65442074|NCT01056614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65442075|NCT01056614|Alkylating Agents|alkylating agents|mesh-ancestor
65442076|NCT01056614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65442077|NCT01056614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65442078|NCT00346034|Pregabalin|pregabalin|mesh-list
65442079|NCT00346034|Analgesics|analgesics|mesh-ancestor
65442080|NCT00346034|Sensory System Agents|sensory system agents|mesh-ancestor
65442081|NCT00346034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442082|NCT00346034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442083|NCT00346034|Anticonvulsants|anticonvulsants|mesh-ancestor
65442084|NCT00346034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65442085|NCT00346034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65442086|NCT00346034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442087|NCT00346034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65442088|NCT00346034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65442089|NCT00346034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65442090|NCT00346034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65442091|NCT00346034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65442092|NCT00345878|Vaccines|vaccines|mesh-list
65442106|NCT01059110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65442107|NCT01059110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65442108|NCT01059110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65442109|NCT01059110|Analgesics|analgesics|mesh-ancestor
65191612|NCT02879981|Guaifenesin|guaifenesin|mesh-list
65442110|NCT01059110|Sensory System Agents|sensory system agents|mesh-ancestor
65442111|NCT01059110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442112|NCT01059110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65442114|NCT01059110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65442115|NCT01059110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442116|NCT03991364|Methamphetamine|methamphetamine|mesh-list
65442117|NCT03991364|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65442118|NCT03991364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442119|NCT03991364|Sympathomimetics|sympathomimetics|mesh-ancestor
65442120|NCT03991364|Autonomic Agents|autonomic agents|mesh-ancestor
65442121|NCT03991364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442122|NCT03991364|Dopamine Agents|dopamine agents|mesh-ancestor
65442123|NCT03991364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65007389|NCT00495781|Iron|iron|mesh-list
65442124|NCT03991364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442125|NCT03991364|Adrenergic Agents|adrenergic agents|mesh-ancestor
65442126|NCT03991364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65442127|NCT03991364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65442128|NCT03991364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65442129|NCT03991364|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65442130|NCT00335738|Carboplatin|carboplatin|mesh-list
65442131|NCT00335738|Etoposide|etoposide|mesh-list
65442132|NCT00335738|Vincristine|vincristine|mesh-list
65442133|NCT00335738|Etoposide phosphate|etoposide phosphate|mesh-list
65442134|NCT00335738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442135|NCT00335738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65442136|NCT00335738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65442137|NCT00335738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65442138|NCT00335738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442139|NCT00335738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442140|NCT00335738|Tubulin Modulators|tubulin modulators|mesh-ancestor
65442141|NCT00335738|Antimitotic Agents|antimitotic agents|mesh-ancestor
65442142|NCT00335738|Mitosis Modulators|mitosis modulators|mesh-ancestor
65442143|NCT02533076|Capsaicin|capsaicin|mesh-list
65442144|NCT02533076|Antipruritics|antipruritics|mesh-ancestor
65442145|NCT02533076|Dermatologic Agents|dermatologic agents|mesh-ancestor
65442146|NCT02533076|Sensory System Agents|sensory system agents|mesh-ancestor
65442147|NCT02533076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442148|NCT02533076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442149|NCT03991520|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65442150|NCT03991520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65442151|NCT01056926|Nicotine|nicotine|mesh-list
65442152|NCT01056926|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65442153|NCT01056926|Autonomic Agents|autonomic agents|mesh-ancestor
65442154|NCT01056926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442162|NCT01059422|Abacavir|abacavir|mesh-list
65442163|NCT01059422|Raltegravir Potassium|raltegravir potassium|mesh-list
65442164|NCT01059422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65442165|NCT01059422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65442166|NCT01059422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442167|NCT01059422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442168|NCT01059422|Antiviral Agents|antiviral agents|mesh-ancestor
65442169|NCT01059422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65442170|NCT01059422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65442171|NCT01059422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65442172|NCT01059422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65442173|NCT01059422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65442174|NCT01052246|Clindamycin|clindamycin|mesh-list
65442175|NCT01052246|Clindamycin palmitate|clindamycin palmitate|mesh-list
65442176|NCT01052246|Clindamycin phosphate|clindamycin phosphate|mesh-list
65442177|NCT01052246|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65442178|NCT01052246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65442179|NCT01052246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65442180|NCT01052246|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65442181|NCT01052246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442182|NCT01052246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442183|NCT01052246|Dermatologic Agents|dermatologic agents|mesh-ancestor
65442184|NCT00334958|Rufinamide|rufinamide|mesh-list
65442185|NCT00334958|Anticonvulsants|anticonvulsants|mesh-ancestor
65442186|NCT00334958|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65442187|NCT00334958|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65442188|NCT00334958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65442189|NCT00334958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442190|NCT00326898|Sorafenib|sorafenib|mesh-list
65442191|NCT00326898|Sunitinib|sunitinib|mesh-list
65442192|NCT00326898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442193|NCT00326898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65442194|NCT00326898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442195|NCT00326898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442196|NCT00326898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65442197|NCT00326898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65442198|NCT00326898|Growth Substances|growth substances|mesh-ancestor
65442199|NCT00326898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442200|NCT00326898|Growth Inhibitors|growth inhibitors|mesh-ancestor
65442201|NCT01062360|Aspirin|aspirin|mesh-list
65442202|NCT01062360|Pseudoephedrine|pseudoephedrine|mesh-list
65442203|NCT01062360|Ephedrine|ephedrine|mesh-list
65442204|NCT01062360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65270054|NCT02719418|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65442205|NCT01062360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65442206|NCT01062360|Analgesics|analgesics|mesh-ancestor
65442207|NCT01062360|Sensory System Agents|sensory system agents|mesh-ancestor
65442208|NCT01062360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442209|NCT01062360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442210|NCT01062360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65442211|NCT01062360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65442212|NCT01062360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65442213|NCT01062360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65442214|NCT01062360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442215|NCT01062360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65442216|NCT01062360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65442217|NCT01062360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442218|NCT01062360|Antipyretics|antipyretics|mesh-ancestor
65442219|NCT01062360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65442220|NCT01062360|Autonomic Agents|autonomic agents|mesh-ancestor
65442221|NCT01062360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65442222|NCT01062360|Respiratory System Agents|respiratory system agents|mesh-ancestor
65442242|NCT01063920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65442244|NCT01063920|Sensory System Agents|sensory system agents|mesh-ancestor
65442245|NCT01063920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442246|NCT01063920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442247|NCT01063920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65442248|NCT01063920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65442249|NCT01063920|Gout Suppressants|gout suppressants|mesh-ancestor
65442250|NCT01063920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65442251|NCT01063920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442252|NCT01063920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442253|NCT01062516|Esomeprazole|esomeprazole|mesh-list
65442254|NCT01062516|Famotidine|famotidine|mesh-list
65442255|NCT01062516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65442256|NCT01062516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65442257|NCT01062516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65442258|NCT01062516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442259|NCT01062516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442260|NCT01062516|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65442261|NCT01062516|Histamine Antagonists|histamine antagonists|mesh-ancestor
65442262|NCT01062516|Histamine Agents|histamine agents|mesh-ancestor
65442263|NCT01062516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65442264|NCT01062516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442265|NCT00334802|Gemcitabine|gemcitabine|mesh-list
65442266|NCT00334802|Paclitaxel|paclitaxel|mesh-list
65442267|NCT00334802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65442268|NCT00334802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442269|NCT00334802|Tubulin Modulators|tubulin modulators|mesh-ancestor
65442270|NCT00334802|Antimitotic Agents|antimitotic agents|mesh-ancestor
65442271|NCT00334802|Mitosis Modulators|mitosis modulators|mesh-ancestor
65442272|NCT00334802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442273|NCT00334802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65442274|NCT00334802|Antimetabolites|antimetabolites|mesh-ancestor
65442275|NCT00334802|Antiviral Agents|antiviral agents|mesh-ancestor
65442276|NCT00334802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65442277|NCT00334802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442278|NCT00334802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64826989|NCT01546896|Serotonin Agents|serotonin agents|mesh-ancestor
65442312|NCT01057160|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65442313|NCT01057160|Serotonin Agents|serotonin agents|mesh-ancestor
65442314|NCT01057160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65442315|NCT01057160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442316|NCT01057160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442317|NCT03990974|Anti-Infective Agents|anti-infective agents|mesh-list
65442318|NCT03990974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65442319|NCT00307086|Bortezomib|bortezomib|mesh-list
65442320|NCT00307086|Melphalan|melphalan|mesh-list
65442321|NCT00307086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442347|NCT00325416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442349|NCT00325416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65442350|NCT00325416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65442351|NCT00325416|Immunologic Factors|immunologic factors|mesh-ancestor
65442352|NCT00325416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442353|NCT00325416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65442354|NCT00325416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65442355|NCT00325416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007539|NCT01244932|Anesthetics|anesthetics|mesh-ancestor
65442356|NCT00314808|Dronabinol|dronabinol|mesh-list
65442357|NCT00314808|Hallucinogens|hallucinogens|mesh-ancestor
65442358|NCT00314808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442359|NCT00314808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65442360|NCT00314808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65442361|NCT00314808|Analgesics|analgesics|mesh-ancestor
65442362|NCT00314808|Sensory System Agents|sensory system agents|mesh-ancestor
65442363|NCT00314808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442364|NCT00314808|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65442365|NCT00314808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65442366|NCT00314808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65442367|NCT00314808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442368|NCT00314808|Hormones|hormones|mesh-ancestor
65442369|NCT00314808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65442370|NCT01060514|Vinorelbine|vinorelbine|mesh-list
65442383|NCT00314574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65442384|NCT00314574|Respiratory System Agents|respiratory system agents|mesh-ancestor
65442386|NCT01064154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65442387|NCT01064154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65442388|NCT01064154|Adrenergic Agents|adrenergic agents|mesh-ancestor
65442389|NCT01064154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65442390|NCT01064154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442391|NCT01064154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442392|NCT01064154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65442393|NCT01064154|Antioxidants|antioxidants|mesh-ancestor
65442394|NCT01064154|Protective Agents|protective agents|mesh-ancestor
65442395|NCT01064154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65442396|NCT01064154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65442397|NCT01064154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65442398|NCT01064154|Vasodilator Agents|vasodilator agents|mesh-ancestor
65442399|NCT01064154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65442400|NCT01064154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65442401|NCT00314340|Acetaminophen|acetaminophen|mesh-list
65442402|NCT00314340|Morphine|morphine|mesh-list
65442403|NCT00314340|Hydrocodone|hydrocodone|mesh-list
65442404|NCT00314340|Phenobarbital|phenobarbital|mesh-list
65442405|NCT00314340|Amphetamine|amphetamine|mesh-list
65442406|NCT00314340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65442407|NCT00314340|Narcotics|narcotics|mesh-ancestor
65442408|NCT00314340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65442409|NCT00314340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442410|NCT00314340|Analgesics|analgesics|mesh-ancestor
65442411|NCT00314340|Sensory System Agents|sensory system agents|mesh-ancestor
65442412|NCT00314340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442413|NCT00314340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65442414|NCT00314340|Antipyretics|antipyretics|mesh-ancestor
65442415|NCT00314340|Antitussive Agents|antitussive agents|mesh-ancestor
65442416|NCT00314340|Respiratory System Agents|respiratory system agents|mesh-ancestor
65442417|NCT00314340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65442418|NCT00314340|Sympathomimetics|sympathomimetics|mesh-ancestor
65442419|NCT00314340|Autonomic Agents|autonomic agents|mesh-ancestor
65442420|NCT00314340|Dopamine Agents|dopamine agents|mesh-ancestor
65442421|NCT00314340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65442422|NCT00314340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442423|NCT00314340|Adrenergic Agents|adrenergic agents|mesh-ancestor
65442424|NCT00314340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65442425|NCT00314340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65442426|NCT00314340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65442427|NCT00314340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65442428|NCT00314340|Anticonvulsants|anticonvulsants|mesh-ancestor
65442429|NCT00314340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65442430|NCT00314340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65442431|NCT00314340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65442432|NCT00314340|GABA Modulators|gaba modulators|mesh-ancestor
65442433|NCT00314340|GABA Agents|gaba agents|mesh-ancestor
65442444|NCT00306852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442445|NCT00314262|Celecoxib|celecoxib|mesh-list
65442446|NCT00314262|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65442447|NCT00314262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442448|NCT00314262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65442449|NCT00314262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442450|NCT00314262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442451|NCT00314262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65270055|NCT02719418|Dalteparin|dalteparin|mesh-list
65442452|NCT00314262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65442453|NCT00314262|Analgesics|analgesics|mesh-ancestor
65442454|NCT00314262|Sensory System Agents|sensory system agents|mesh-ancestor
65442455|NCT00314262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442456|NCT00314262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442457|NCT00314262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65442458|NCT00314262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65442459|NCT00314262|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65442460|NCT00314262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65442461|NCT00333866|Pregabalin|pregabalin|mesh-list
65442462|NCT00333866|Analgesics|analgesics|mesh-ancestor
65442463|NCT00333866|Sensory System Agents|sensory system agents|mesh-ancestor
65442464|NCT00333866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442465|NCT00333866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442466|NCT00333866|Anticonvulsants|anticonvulsants|mesh-ancestor
65442467|NCT00333866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65442468|NCT00333866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65442469|NCT00333866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442470|NCT00333866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65442471|NCT00333866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65442472|NCT00333866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65442473|NCT00333866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65442474|NCT00333866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65442475|NCT00324740|Vorinostat|vorinostat|mesh-list
65442476|NCT00324740|Isotretinoin|isotretinoin|mesh-list
65442477|NCT00324740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442478|NCT00324740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65442479|NCT00324740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442480|NCT00324740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442481|NCT00324740|Dermatologic Agents|dermatologic agents|mesh-ancestor
65442482|NCT00333788|Certolizumab Pegol|certolizumab pegol|mesh-list
65442483|NCT00333788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65442484|NCT00333788|Immunologic Factors|immunologic factors|mesh-ancestor
65191984|NCT02739412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65442485|NCT00333788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442486|NCT00333788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65442487|NCT00332696|Methylprednisolone|methylprednisolone|mesh-list
65442488|NCT00332696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65442489|NCT00332696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65442490|NCT00332696|Prednisolone|prednisolone|mesh-list
65442491|NCT00332696|Prednisolone acetate|prednisolone acetate|mesh-list
65442492|NCT00332696|Octreotide|octreotide|mesh-list
65442493|NCT00332696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65442494|NCT00332696|Prednisolone phosphate|prednisolone phosphate|mesh-list
65442495|NCT00332696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65442496|NCT00332696|Antiemetics|antiemetics|mesh-ancestor
65442500|NCT00332696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65442502|NCT00332696|Hormones|hormones|mesh-ancestor
65442503|NCT00332696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65442504|NCT00332696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65442505|NCT00332696|Protective Agents|protective agents|mesh-ancestor
65442506|NCT00332696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65442507|NCT00332696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442508|NCT00313716|Epoetin Alfa|epoetin alfa|mesh-list
65442509|NCT00313716|Hematinics|hematinics|mesh-ancestor
65442510|NCT00313170|Fulvestrant|fulvestrant|mesh-list
65442511|NCT00313170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65442512|NCT00313170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442513|NCT00313170|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65442514|NCT00313170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65442515|NCT00313170|Hormone Antagonists|hormone antagonists|mesh-ancestor
65442516|NCT00313170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65442517|NCT00313170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442518|NCT00332462|Cyclosporine|cyclosporine|mesh-list
65442519|NCT00332462|Cyclosporins|cyclosporins|mesh-list
65442520|NCT00332462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442521|NCT00332462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442522|NCT00332462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65442523|NCT00332462|Immunologic Factors|immunologic factors|mesh-ancestor
65442524|NCT00332462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442525|NCT00332462|Antifungal Agents|antifungal agents|mesh-ancestor
65442526|NCT00332462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65442527|NCT00332462|Dermatologic Agents|dermatologic agents|mesh-ancestor
65442528|NCT00332462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65270056|NCT02719418|Anticoagulants|anticoagulants|mesh-ancestor
65442529|NCT00332462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65442530|NCT00324038|Acetaminophen|acetaminophen|mesh-list
65442531|NCT00324038|Buprenorphine|buprenorphine|mesh-list
65442532|NCT00324038|Codeine|codeine|mesh-list
65442533|NCT00324038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65442534|NCT00324038|Analgesics|analgesics|mesh-ancestor
65442535|NCT00324038|Sensory System Agents|sensory system agents|mesh-ancestor
65442536|NCT00324038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442537|NCT00324038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442538|NCT00324038|Antipyretics|antipyretics|mesh-ancestor
65442539|NCT00324038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65442540|NCT00324038|Narcotics|narcotics|mesh-ancestor
65442541|NCT00324038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65442542|NCT00324038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65442543|NCT00324038|Antitussive Agents|antitussive agents|mesh-ancestor
65442544|NCT00324038|Respiratory System Agents|respiratory system agents|mesh-ancestor
65442545|NCT03984110|Dexamethasone|dexamethasone|mesh-list
65442546|NCT03984110|Aflibercept|aflibercept|mesh-list
65442547|NCT03984110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65442548|NCT03984110|Antiemetics|antiemetics|mesh-ancestor
65442549|NCT03984110|Autonomic Agents|autonomic agents|mesh-ancestor
65442550|NCT03984110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442551|NCT03984110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442552|NCT03984110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65442553|NCT03984110|Glucocorticoids|glucocorticoids|mesh-ancestor
65442554|NCT03984110|Hormones|hormones|mesh-ancestor
65442555|NCT03984110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65442556|NCT03984110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65442557|NCT03984110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442558|NCT03984110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65442559|NCT03984110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65442560|NCT03984110|Growth Substances|growth substances|mesh-ancestor
65442561|NCT03984110|Growth Inhibitors|growth inhibitors|mesh-ancestor
65442563|NCT00159861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442564|NCT00159861|Vasodilator Agents|vasodilator agents|mesh-ancestor
65442565|NCT00159861|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65442566|NCT00159861|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65442567|NCT00159861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442568|NCT00159861|Urological Agents|urological agents|mesh-ancestor
65442569|NCT01057628|Ipragliflozin|ipragliflozin|mesh-list
65442585|NCT00313014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65442586|NCT00313014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442587|NCT00313014|Analgesics|analgesics|mesh-ancestor
65442588|NCT00313014|Sensory System Agents|sensory system agents|mesh-ancestor
65442589|NCT00313014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442590|NCT00313014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65442591|NCT01075659|Nicotine|nicotine|mesh-list
65442592|NCT01075659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65442593|NCT01075659|Autonomic Agents|autonomic agents|mesh-ancestor
65442594|NCT01075659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442595|NCT01075659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442596|NCT01075659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65442597|NCT01075659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65442598|NCT01075659|Cholinergic Agents|cholinergic agents|mesh-ancestor
65442599|NCT01075659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65442600|NCT01075659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442601|NCT01077453|Letrozole|letrozole|mesh-list
65442602|NCT01077453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442603|NCT01077453|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65442604|NCT01077453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65442605|NCT01077453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442606|NCT01077453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442607|NCT01077453|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65442608|NCT01077453|Hormone Antagonists|hormone antagonists|mesh-ancestor
65442609|NCT01077453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65442610|NCT01077453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442611|NCT00157209|Cyclophosphamide|cyclophosphamide|mesh-list
65442612|NCT00157209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65442613|NCT00157209|Immunologic Factors|immunologic factors|mesh-ancestor
65442614|NCT00157209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442615|NCT00157209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65442616|NCT00157209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65442617|NCT00157209|Alkylating Agents|alkylating agents|mesh-ancestor
65442618|NCT00157209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442619|NCT00157209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442620|NCT00157209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65442621|NCT00312858|Vaccines|vaccines|mesh-list
65442622|NCT00312858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65442623|NCT00312858|Immunologic Factors|immunologic factors|mesh-ancestor
65442624|NCT00312858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442625|NCT00156819|Fluticasone|fluticasone|mesh-list
65442626|NCT00156819|Xhance|xhance|mesh-list
65442627|NCT00156819|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65442628|NCT00156819|Montelukast|montelukast|mesh-list
65442646|NCT00156819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65442647|NCT00156819|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65442648|NCT00156819|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65442649|NCT00224133|Silodosin|silodosin|mesh-list
65442650|NCT00224133|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65442651|NCT00224133|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65442652|NCT00224133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65442653|NCT00224133|Adrenergic Agents|adrenergic agents|mesh-ancestor
65442654|NCT00224133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65442655|NCT00224133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442656|NCT00224133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442657|NCT00224133|Urological Agents|urological agents|mesh-ancestor
65442658|NCT00224055|Ferric gluconate|ferric gluconate|mesh-list
65442659|NCT00224055|Hematinics|hematinics|mesh-ancestor
65442660|NCT00150969|Vitamin K|vitamin k|mesh-list
65442661|NCT00150969|Vitamin K 1|vitamin k 1|mesh-list
65442662|NCT00150969|Vitamins|vitamins|mesh-ancestor
65442663|NCT00150969|Micronutrients|micronutrients|mesh-ancestor
65442664|NCT00150969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442665|NCT00150969|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65442666|NCT00150969|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65442667|NCT00150969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442668|NCT00150969|Hemostatics|hemostatics|mesh-ancestor
65442669|NCT00150969|Coagulants|coagulants|mesh-ancestor
65442670|NCT00150345|Voriconazole|voriconazole|mesh-list
65442671|NCT00150345|Antifungal Agents|antifungal agents|mesh-ancestor
65442672|NCT00150345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65442673|NCT00150345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65442674|NCT00150345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65442675|NCT00150345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442676|NCT00150345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442677|NCT00150345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65442678|NCT00150345|Hormone Antagonists|hormone antagonists|mesh-ancestor
65442679|NCT00150345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65442680|NCT00150345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442681|NCT00150345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64827391|NCT01549418|Aspirin|aspirin|mesh-list
65442699|NCT01077609|Dermatologic Agents|dermatologic agents|mesh-ancestor
65442700|NCT01077609|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65442701|NCT00223977|Ferric gluconate|ferric gluconate|mesh-list
65442702|NCT00223977|Ferric Compounds|ferric compounds|mesh-list
65442704|NCT00148941|Vaccines|vaccines|mesh-list
65442705|NCT00148941|Immunologic Factors|immunologic factors|mesh-ancestor
65442706|NCT00148941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442707|NCT01073553|Cephalexin|cephalexin|mesh-list
65442708|NCT01073553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65442709|NCT01073553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65442710|NCT00148317|Dexamethasone|dexamethasone|mesh-list
65442711|NCT00148317|Doxorubicin|doxorubicin|mesh-list
65442712|NCT00148317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65442713|NCT00148317|Bortezomib|bortezomib|mesh-list
65442714|NCT00148317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65442715|NCT00148317|Antiemetics|antiemetics|mesh-ancestor
65442716|NCT00148317|Autonomic Agents|autonomic agents|mesh-ancestor
65442717|NCT00148317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442718|NCT00148317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442719|NCT00148317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65442720|NCT00148317|Glucocorticoids|glucocorticoids|mesh-ancestor
65442721|NCT00148317|Hormones|hormones|mesh-ancestor
65442722|NCT00148317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65442723|NCT00148317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65442724|NCT00148317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442725|NCT00148317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65442726|NCT00148317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65442727|NCT00148317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65442728|NCT00148317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442729|NCT00148317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442730|NCT00323882|Ipilimumab|ipilimumab|mesh-list
65442731|NCT00323882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65442732|NCT00323882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442733|NCT00323882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65442734|NCT00323882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442735|NCT00331682|Docetaxel|docetaxel|mesh-list
65442736|NCT00331682|Alvocidib|alvocidib|mesh-list
65442737|NCT00331682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442738|NCT00331682|Tubulin Modulators|tubulin modulators|mesh-ancestor
65442739|NCT00331682|Antimitotic Agents|antimitotic agents|mesh-ancestor
65442740|NCT00331682|Mitosis Modulators|mitosis modulators|mesh-ancestor
64827435|NCT01549548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442746|NCT00331682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442747|NCT00323492|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65442748|NCT00323492|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65442749|NCT00323492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65442750|NCT00323492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442751|NCT00323492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442752|NCT00323492|Antiviral Agents|antiviral agents|mesh-ancestor
65442753|NCT00323492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65442754|NCT00323492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65442755|NCT00323492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65442756|NCT00331136|Artesunate|artesunate|mesh-list
65442757|NCT00331136|Pyronaridine|pyronaridine|mesh-list
65442758|NCT00331136|Antimalarials|antimalarials|mesh-ancestor
65442759|NCT00331136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65442760|NCT00331136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65442761|NCT00331136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65442762|NCT00331136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442763|NCT00331136|Antiviral Agents|antiviral agents|mesh-ancestor
65442764|NCT00331136|Schistosomicides|schistosomicides|mesh-ancestor
65442765|NCT00331136|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65442766|NCT00331136|Anthelmintics|anthelmintics|mesh-ancestor
65442767|NCT00330668|Mecasermin|mecasermin|mesh-list
65442768|NCT00330668|Growth Substances|growth substances|mesh-ancestor
65442769|NCT00330668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442770|NCT00306384|Alogliptin|alogliptin|mesh-list
65442771|NCT00306384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65442772|NCT00306384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442773|NCT00306384|Incretins|incretins|mesh-ancestor
65442774|NCT00306384|Hormones|hormones|mesh-ancestor
65442775|NCT00306384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65442776|NCT00306384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65442777|NCT00306384|Protease Inhibitors|protease inhibitors|mesh-ancestor
65442778|NCT00306384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442779|NCT00306384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442780|NCT01062906|Lidocaine|lidocaine|mesh-list
65442781|NCT01062906|Fentanyl|fentanyl|mesh-list
65442782|NCT01062906|Anesthetics, Local|anesthetics, local|mesh-ancestor
65442783|NCT01062906|Anesthetics|anesthetics|mesh-ancestor
65442784|NCT01062906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65442785|NCT01062906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442786|NCT01062906|Sensory System Agents|sensory system agents|mesh-ancestor
65442787|NCT01062906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442788|NCT01062906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65442789|NCT01062906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65442790|NCT01062906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65442791|NCT01062906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65442792|NCT01062906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442793|NCT01062906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65442794|NCT01062906|Narcotics|narcotics|mesh-ancestor
65442795|NCT01062906|Analgesics|analgesics|mesh-ancestor
65442796|NCT01062906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65442797|NCT01062906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65442798|NCT01062906|Anesthetics, General|anesthetics, general|mesh-ancestor
65442799|NCT00305604|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65442800|NCT00305604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65442801|NCT00305604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442802|NCT00305604|Incretins|incretins|mesh-ancestor
65442804|NCT00305604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65442805|NCT00305604|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65442806|NCT00305604|Protease Inhibitors|protease inhibitors|mesh-ancestor
65442807|NCT00305604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442808|NCT00305604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442809|NCT01064232|Risperidone|risperidone|mesh-list
64827493|NCT01549847|Piracetam|piracetam|mesh-list
65442845|NCT01016717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65442846|NCT01016717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65442847|NCT01016717|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65442848|NCT01016717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192361|NCT00621400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65442859|NCT00343382|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65442860|NCT00343382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65442861|NCT00343382|Cholinergic Agents|cholinergic agents|mesh-ancestor
65442862|NCT00343382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65442863|NCT00343382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442864|NCT00481871|Vitamins|vitamins|mesh-list
65442865|NCT00481871|Folic Acid|folic acid|mesh-list
65442866|NCT00481871|Vitamin B 12|vitamin b 12|mesh-list
65442867|NCT00481871|Vitamin B Complex|vitamin b complex|mesh-list
65442868|NCT00481871|Gemcitabine|gemcitabine|mesh-list
65442869|NCT00481871|10-deazaaminopterin|10-deazaaminopterin|mesh-list
65442870|NCT00481871|Aminopterin|aminopterin|mesh-list
65442871|NCT00481871|Micronutrients|micronutrients|mesh-ancestor
65442872|NCT00481871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442873|NCT00481871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65442874|NCT00481871|Antimetabolites|antimetabolites|mesh-ancestor
65442875|NCT00481871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442876|NCT00481871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442877|NCT00481871|Antiviral Agents|antiviral agents|mesh-ancestor
65442878|NCT00481871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65442879|NCT00481871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442880|NCT00481871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65442881|NCT00481871|Immunologic Factors|immunologic factors|mesh-ancestor
65442882|NCT00481871|Hematinics|hematinics|mesh-ancestor
65442883|NCT00481871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65442884|NCT00329420|Certolizumab Pegol|certolizumab pegol|mesh-list
65442885|NCT00329420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65442886|NCT00329420|Immunologic Factors|immunologic factors|mesh-ancestor
65442887|NCT00329420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442888|NCT00329420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65442889|NCT00329108|Olanzapine|olanzapine|mesh-list
65442890|NCT00329108|Ziprasidone|ziprasidone|mesh-list
65442891|NCT00329108|Antiemetics|antiemetics|mesh-ancestor
65442892|NCT00329108|Autonomic Agents|autonomic agents|mesh-ancestor
65442893|NCT00329108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442894|NCT00329108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442895|NCT00329108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65442896|NCT00329108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65442897|NCT00329108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65442898|NCT00329108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65442899|NCT00329108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65442900|NCT00329108|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65442901|NCT00329108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65442902|NCT00329108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65442903|NCT00329108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442904|NCT00329108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65442905|NCT00329108|Serotonin Agents|serotonin agents|mesh-ancestor
65442906|NCT00329108|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65442907|NCT00329108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65442908|NCT00329108|Dopamine Agents|dopamine agents|mesh-ancestor
65442909|NCT00329030|Rituximab|rituximab|mesh-list
65442910|NCT00329030|Tositumomab I-131|tositumomab i-131|mesh-list
65442911|NCT00329030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65442912|NCT00329030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442913|NCT00329030|Immunologic Factors|immunologic factors|mesh-ancestor
65442914|NCT00329030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442929|NCT00328172|Protease Inhibitors|protease inhibitors|mesh-ancestor
65442930|NCT00328172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442931|NCT00328172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442933|NCT01061372|Analgesics|analgesics|mesh-ancestor
65442934|NCT01061372|Sensory System Agents|sensory system agents|mesh-ancestor
65442935|NCT01061372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442936|NCT01061372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442937|NCT01061372|Anticonvulsants|anticonvulsants|mesh-ancestor
65442938|NCT01061372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65442939|NCT01061372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65442940|NCT01061372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442941|NCT01061372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65007989|NCT01245556|Ipilimumab|ipilimumab|mesh-list
65442942|NCT01061372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65442943|NCT01061372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65442944|NCT01061372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65442945|NCT01061372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65442946|NCT00328094|Insulin|insulin|mesh-list
65442947|NCT00328094|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65442948|NCT00328094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65442949|NCT00328094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442950|NCT00295932|Prednisone|prednisone|mesh-list
65442951|NCT00295932|Cyclophosphamide|cyclophosphamide|mesh-list
65442952|NCT00295932|Rituximab|rituximab|mesh-list
65442953|NCT00295932|Bortezomib|bortezomib|mesh-list
65442954|NCT00295932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65442955|NCT00295932|Immunologic Factors|immunologic factors|mesh-ancestor
65442956|NCT00295932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442957|NCT00295932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65442958|NCT00295932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65442959|NCT00295932|Alkylating Agents|alkylating agents|mesh-ancestor
65442960|NCT00295932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442961|NCT00295932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442962|NCT00295932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65442963|NCT00295932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65442964|NCT00295932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65442965|NCT00295932|Glucocorticoids|glucocorticoids|mesh-ancestor
65442966|NCT00295932|Hormones|hormones|mesh-ancestor
65442967|NCT00295932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65442968|NCT00295932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65442969|NCT01063140|Vaccines|vaccines|mesh-list
65442970|NCT01063140|Immunologic Factors|immunologic factors|mesh-ancestor
65442971|NCT01063140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442972|NCT00305448|Fulvestrant|fulvestrant|mesh-list
65442973|NCT00305448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65442974|NCT00305448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443006|NCT00322556|Immunoglobulins|immunoglobulins|mesh-list
65443007|NCT00322556|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65443008|NCT00322556|Antibodies|antibodies|mesh-list
65443009|NCT00322556|Immunologic Factors|immunologic factors|mesh-ancestor
65443010|NCT00322556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443011|NCT00321932|Calcium, Dietary|calcium, dietary|mesh-list
65443012|NCT00321932|Cholecalciferol|cholecalciferol|mesh-list
65443013|NCT00321932|Zoledronic Acid|zoledronic acid|mesh-list
65443014|NCT00321932|Calcium Carbonate|calcium carbonate|mesh-list
65443015|NCT00321932|Calcium|calcium|mesh-list
65443016|NCT00321932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65443017|NCT00321932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443018|NCT00321932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65443019|NCT00321932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443028|NCT00326612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65443029|NCT00326612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443031|NCT00326612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65443032|NCT00326612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65443033|NCT00326612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65443034|NCT00326612|Anesthetics, General|anesthetics, general|mesh-ancestor
65443035|NCT00326612|Anesthetics|anesthetics|mesh-ancestor
65443036|NCT00326612|GABA Modulators|gaba modulators|mesh-ancestor
65443037|NCT00326612|GABA Agents|gaba agents|mesh-ancestor
65443038|NCT00326612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65443039|NCT00326612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443040|NCT00326612|Anticonvulsants|anticonvulsants|mesh-ancestor
65443041|NCT00326612|Antiemetics|antiemetics|mesh-ancestor
65443042|NCT00326612|Autonomic Agents|autonomic agents|mesh-ancestor
65443043|NCT00326612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65443044|NCT00326612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65443045|NCT00326612|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65443046|NCT00326612|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65443047|NCT01060826|Somatostatin|somatostatin|mesh-list
65443048|NCT01060826|Hormones|hormones|mesh-ancestor
65443049|NCT01060826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65443050|NCT01060826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443051|NCT00321854|Pramipexole|pramipexole|mesh-list
65443052|NCT00321854|Antioxidants|antioxidants|mesh-ancestor
65443053|NCT00321854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443054|NCT00321854|Protective Agents|protective agents|mesh-ancestor
65443055|NCT00321854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443056|NCT00321854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65008080|NCT01245868|Lidocaine|lidocaine|mesh-list
65443057|NCT00321854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65443058|NCT00321854|Dopamine Agonists|dopamine agonists|mesh-ancestor
65443059|NCT00321854|Dopamine Agents|dopamine agents|mesh-ancestor
65443060|NCT00321854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65443061|NCT03982862|Triamcinolone|triamcinolone|mesh-list
65443062|NCT03982862|Lidocaine|lidocaine|mesh-list
65443063|NCT03982862|Botulinum Toxins|botulinum toxins|mesh-list
65443064|NCT03982862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65443065|NCT03982862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65443066|NCT03982862|Anesthetics, Local|anesthetics, local|mesh-ancestor
65443067|NCT03982862|Anesthetics|anesthetics|mesh-ancestor
65443068|NCT03982862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65443069|NCT03982862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443070|NCT03982862|Sensory System Agents|sensory system agents|mesh-ancestor
65443071|NCT03982862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65443072|NCT03982862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65443073|NCT03982862|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65443074|NCT03982862|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65443075|NCT03982862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65443076|NCT03982862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443077|NCT03982862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65443078|NCT03982862|Cholinergic Agents|cholinergic agents|mesh-ancestor
65443079|NCT03982862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65443080|NCT03982862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65443081|NCT03982862|Glucocorticoids|glucocorticoids|mesh-ancestor
65443082|NCT03982862|Hormones|hormones|mesh-ancestor
65443083|NCT03982862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65443084|NCT03982862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65443085|NCT01060904|Doxorubicin|doxorubicin|mesh-list
65443086|NCT01060904|Bleomycin|bleomycin|mesh-list
65443087|NCT01060904|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65443088|NCT01060904|Dacarbazine|dacarbazine|mesh-list
65443089|NCT01060904|Vinblastine|vinblastine|mesh-list
65443096|NCT01060904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443097|NCT01060904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65443098|NCT01060904|Immunologic Factors|immunologic factors|mesh-ancestor
65443099|NCT01060904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443100|NCT01060904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65443101|NCT01060904|Alkylating Agents|alkylating agents|mesh-ancestor
65443102|NCT01060904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65443103|NCT01060904|Tubulin Modulators|tubulin modulators|mesh-ancestor
65443104|NCT01060904|Antimitotic Agents|antimitotic agents|mesh-ancestor
65443105|NCT01060904|Mitosis Modulators|mitosis modulators|mesh-ancestor
65443106|NCT01058174|Fluconazole|fluconazole|mesh-list
65443107|NCT01058174|Amphotericin B|amphotericin b|mesh-list
65443108|NCT01058174|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65443109|NCT01058174|Caspofungin|caspofungin|mesh-list
65443110|NCT01058174|Micafungin|micafungin|mesh-list
65443111|NCT01058174|Antifungal Agents|antifungal agents|mesh-ancestor
65443112|NCT01058174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65443113|NCT01058174|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65443114|NCT01058174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65443115|NCT01058174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443116|NCT01058174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443117|NCT01058174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65443118|NCT01058174|Hormone Antagonists|hormone antagonists|mesh-ancestor
65443119|NCT01058174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65443120|NCT01058174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443121|NCT01058174|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65443122|NCT01058174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65443123|NCT01058174|Amebicides|amebicides|mesh-ancestor
65443124|NCT01058174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65443125|NCT01058174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65443126|NCT01058174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65443127|NCT01058252|Indomethacin|indomethacin|mesh-list
65443128|NCT01058252|Letrozole|letrozole|mesh-list
65443129|NCT01058252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443130|NCT01058252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65443131|NCT01058252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65443132|NCT01058252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443133|NCT01058252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443134|NCT01058252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65443135|NCT01058252|Hormone Antagonists|hormone antagonists|mesh-ancestor
65443136|NCT01058252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65443137|NCT01058252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443138|NCT01058252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65443139|NCT01058252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65443140|NCT01058252|Analgesics|analgesics|mesh-ancestor
65443141|NCT01058252|Sensory System Agents|sensory system agents|mesh-ancestor
65443142|NCT01058252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65443143|NCT01058252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65443144|NCT01058252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65443145|NCT01058252|Gout Suppressants|gout suppressants|mesh-ancestor
65443146|NCT01058252|Tocolytic Agents|tocolytic agents|mesh-ancestor
65443147|NCT01058252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65443148|NCT01058252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65443149|NCT01058408|Cisplatin|cisplatin|mesh-list
65443150|NCT01058408|Everolimus|everolimus|mesh-list
65443151|NCT01058408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443152|NCT01058408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65443153|NCT01058408|Immunologic Factors|immunologic factors|mesh-ancestor
65443154|NCT01058408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443155|NCT01061060|Epoprostenol|epoprostenol|mesh-list
65443156|NCT01061060|Beraprost|beraprost|mesh-list
65443157|NCT01061060|Tezosentan|tezosentan|mesh-list
64827841|NCT01552122|Antacids|antacids|mesh-ancestor
65443172|NCT01063556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65443173|NCT01063556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443174|NCT01063556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443175|NCT01063556|Cholinergic Agents|cholinergic agents|mesh-ancestor
65443176|NCT01063556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65443177|NCT01063556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443178|NCT01063556|Nootropic Agents|nootropic agents|mesh-ancestor
65443179|NCT03981458|Hyaluronic Acid|hyaluronic acid|mesh-list
65443180|NCT03981458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65443181|NCT03981458|Immunologic Factors|immunologic factors|mesh-ancestor
65443182|NCT03981458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443183|NCT03981458|Viscosupplements|viscosupplements|mesh-ancestor
65443184|NCT03981458|Protective Agents|protective agents|mesh-ancestor
65443185|NCT00309842|Cyclosporine|cyclosporine|mesh-list
65443186|NCT00309842|Mycophenolic Acid|mycophenolic acid|mesh-list
65443187|NCT00309842|Cyclophosphamide|cyclophosphamide|mesh-list
65443188|NCT00309842|Fludarabine|fludarabine|mesh-list
65443189|NCT00309842|Fludarabine phosphate|fludarabine phosphate|mesh-list
65443190|NCT00309842|Cyclosporins|cyclosporins|mesh-list
65443191|NCT00309842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65443192|NCT00309842|Immunologic Factors|immunologic factors|mesh-ancestor
65443193|NCT00309842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443194|NCT00309842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65443195|NCT00309842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65443196|NCT00309842|Alkylating Agents|alkylating agents|mesh-ancestor
65443197|NCT00309842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443198|NCT00309842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443199|NCT00309842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65443200|NCT00309842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65443201|NCT00309842|Antimetabolites|antimetabolites|mesh-ancestor
65443202|NCT00309842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443203|NCT00309842|Antifungal Agents|antifungal agents|mesh-ancestor
65443204|NCT00309842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65443205|NCT00309842|Dermatologic Agents|dermatologic agents|mesh-ancestor
65443206|NCT00309842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65443207|NCT00309842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65443208|NCT00309842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65443209|NCT00309842|Antitubercular Agents|antitubercular agents|mesh-ancestor
65443210|NCT00309842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65443211|NCT03985982|Botulinum Toxins|botulinum toxins|mesh-list
65443212|NCT03985982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65443213|NCT03985982|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65443214|NCT03985982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65443215|NCT03985982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65443216|NCT03985982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443217|NCT03985982|Cholinergic Agents|cholinergic agents|mesh-ancestor
65443218|NCT03985982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65443239|NCT00499889|Dermatologic Agents|dermatologic agents|mesh-ancestor
65443240|NCT00499889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443241|NCT00499889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65443242|NCT00499889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65443243|NCT00499889|Immunologic Factors|immunologic factors|mesh-ancestor
65443244|NCT00499889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65270057|NCT02719418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65443245|NCT00499889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65443246|NCT00499889|Antiviral Agents|antiviral agents|mesh-ancestor
65443247|NCT00499889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65443248|NCT00499889|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65443249|NCT00499889|Alkylating Agents|alkylating agents|mesh-ancestor
65443250|NCT00499889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65443251|NCT00499889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65443252|NCT00499889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65443253|NCT00309608|Glimepiride|glimepiride|mesh-list
65443254|NCT00309608|Linagliptin|linagliptin|mesh-list
65443255|NCT00309608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65443256|NCT00309608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65443257|NCT00309608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443258|NCT00309608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65443259|NCT00309608|Immunologic Factors|immunologic factors|mesh-ancestor
65443260|NCT00309608|Incretins|incretins|mesh-ancestor
65443261|NCT00309608|Hormones|hormones|mesh-ancestor
65443262|NCT00309608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65443263|NCT00309608|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65443264|NCT00309608|Protease Inhibitors|protease inhibitors|mesh-ancestor
65443265|NCT00309608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443266|NCT00309608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443267|NCT00308750|Carboplatin|carboplatin|mesh-list
65443268|NCT00308750|Docetaxel|docetaxel|mesh-list
65443269|NCT00308750|Pemetrexed|pemetrexed|mesh-list
65443270|NCT00308750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443271|NCT00308750|Tubulin Modulators|tubulin modulators|mesh-ancestor
65443272|NCT00308750|Antimitotic Agents|antimitotic agents|mesh-ancestor
65443273|NCT00308750|Mitosis Modulators|mitosis modulators|mesh-ancestor
65443274|NCT00308750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443275|NCT00308750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443303|NCT01017107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65443305|NCT03997019|Narcotics|narcotics|mesh-ancestor
65443306|NCT03997019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65443307|NCT03997019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443308|NCT03997019|Analgesics|analgesics|mesh-ancestor
65443309|NCT03997019|Sensory System Agents|sensory system agents|mesh-ancestor
65443310|NCT03997019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65443311|NCT00480857|Docetaxel|docetaxel|mesh-list
65443312|NCT00480857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443313|NCT00480857|Tubulin Modulators|tubulin modulators|mesh-ancestor
65443314|NCT00480857|Antimitotic Agents|antimitotic agents|mesh-ancestor
65192812|NCT00618358|Thrombin|thrombin|mesh-list
65443315|NCT00480857|Mitosis Modulators|mitosis modulators|mesh-ancestor
65443316|NCT00480857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443317|NCT00499031|Cetuximab|cetuximab|mesh-list
65443318|NCT00499031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65443319|NCT00499031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443320|NCT00498797|Prednisolone|prednisolone|mesh-list
65443321|NCT00498797|Docetaxel|docetaxel|mesh-list
65443322|NCT00498797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443323|NCT00498797|Tubulin Modulators|tubulin modulators|mesh-ancestor
65443339|NCT00498485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443340|NCT00498173|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65443341|NCT00498173|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65443342|NCT00498173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65443343|NCT00498173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65443344|NCT00498173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443345|NCT00498173|Adrenergic Agents|adrenergic agents|mesh-ancestor
65443346|NCT00498173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65443347|NCT00498173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443348|NCT00295620|Anastrozole|anastrozole|mesh-list
65443349|NCT00295620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65443350|NCT00295620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443351|NCT00295620|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65443352|NCT00295620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65443353|NCT00295620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443354|NCT00295620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443355|NCT00295620|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65443356|NCT00295620|Hormone Antagonists|hormone antagonists|mesh-ancestor
65443357|NCT00295620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65443358|NCT00295620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443359|NCT03980496|Omeprazole|omeprazole|mesh-list
65443360|NCT03980496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65443361|NCT03980496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65443362|NCT03980496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65443363|NCT03980496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443364|NCT03980496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443365|NCT01063530|Fluorides|fluorides|mesh-list
65443366|NCT01063530|Cariostatic Agents|cariostatic agents|mesh-ancestor
65443367|NCT01063530|Protective Agents|protective agents|mesh-ancestor
65443368|NCT01063530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443369|NCT00304356|Nitazoxanide|nitazoxanide|mesh-list
65443370|NCT00304356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65443371|NCT00304356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65443372|NCT01069302|Clopidogrel|clopidogrel|mesh-list
65443373|NCT01069302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65443374|NCT01069302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65443375|NCT01069302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65443376|NCT01069302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65443377|NCT01069302|Purinergic Agents|purinergic agents|mesh-ancestor
65443378|NCT01069302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65443379|NCT01069302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828082|NCT01554631|Acarbose|acarbose|mesh-list
65443393|NCT03981068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443394|NCT03981068|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65443395|NCT03981068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65443396|NCT03981068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65443397|NCT03981068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65443399|NCT01064102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65443400|NCT01064102|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65443401|NCT01064102|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65443402|NCT01064102|Histamine Antagonists|histamine antagonists|mesh-ancestor
65443403|NCT01064102|Histamine Agents|histamine agents|mesh-ancestor
65443404|NCT01064102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65443405|NCT01064102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443406|NCT01064102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443407|NCT02532114|Niclosamide|niclosamide|mesh-list
65443408|NCT02532114|Anticestodal Agents|anticestodal agents|mesh-ancestor
65443409|NCT02532114|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65443410|NCT02532114|Anthelmintics|anthelmintics|mesh-ancestor
65443411|NCT02532114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65443412|NCT02532114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65443413|NCT02532114|Antinematodal Agents|antinematodal agents|mesh-ancestor
65443414|NCT00307736|Bevacizumab|bevacizumab|mesh-list
65443415|NCT00307736|Fluorouracil|fluorouracil|mesh-list
65443416|NCT00307736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65443417|NCT00307736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65443418|NCT00307736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443419|NCT00307736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65443420|NCT00307736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65443421|NCT00307736|Growth Substances|growth substances|mesh-ancestor
65443422|NCT00307736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443423|NCT00307736|Growth Inhibitors|growth inhibitors|mesh-ancestor
65443424|NCT00307736|Antimetabolites|antimetabolites|mesh-ancestor
65443425|NCT00307736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443426|NCT00307736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65443427|NCT00307736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65443428|NCT00307736|Immunologic Factors|immunologic factors|mesh-ancestor
65443429|NCT00307736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65443430|NCT00307736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443431|NCT00320528|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65443432|NCT00320528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65443433|NCT00320528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65443434|NCT00320528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65443435|NCT00320528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443436|NCT00320528|Adrenergic Agents|adrenergic agents|mesh-ancestor
65443437|NCT00320528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65443438|NCT00320528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443439|NCT03979586|Hyaluronic Acid|hyaluronic acid|mesh-list
65443440|NCT03979586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65443441|NCT03979586|Immunologic Factors|immunologic factors|mesh-ancestor
64828135|NCT01554930|Methylprednisolone|methylprednisolone|mesh-list
65443454|NCT00294762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65443455|NCT00294762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443456|NCT00294684|Methylprednisolone|methylprednisolone|mesh-list
65443457|NCT00294684|Prednisolone|prednisolone|mesh-list
65008361|NCT00503386|Granisetron|granisetron|mesh-list
65443458|NCT00294684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65443459|NCT00294684|Antiemetics|antiemetics|mesh-ancestor
65443460|NCT00294684|Autonomic Agents|autonomic agents|mesh-ancestor
65443461|NCT00294684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192965|NCT02870478|Parasympatholytics|parasympatholytics|mesh-ancestor
65443462|NCT00294684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443463|NCT00294684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65443464|NCT00294684|Glucocorticoids|glucocorticoids|mesh-ancestor
65443465|NCT00294684|Hormones|hormones|mesh-ancestor
65443466|NCT00294684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65443467|NCT00294684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65443468|NCT00294684|Protective Agents|protective agents|mesh-ancestor
65443469|NCT00294684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65443470|NCT00294684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443471|NCT00307034|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65443472|NCT00307034|Immunologic Factors|immunologic factors|mesh-ancestor
65443473|NCT00307034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443474|NCT01061996|Basiliximab|basiliximab|mesh-list
65443475|NCT01061996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65443476|NCT01061996|Immunologic Factors|immunologic factors|mesh-ancestor
65443477|NCT01061996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443478|NCT01064180|Carvedilol|carvedilol|mesh-list
65443479|NCT01064180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65443480|NCT01064180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65443481|NCT01064180|Adrenergic Agents|adrenergic agents|mesh-ancestor
65443482|NCT01064180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65443483|NCT01064180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443484|NCT01064180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443485|NCT01064180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65443486|NCT01064180|Antioxidants|antioxidants|mesh-ancestor
65443487|NCT01064180|Protective Agents|protective agents|mesh-ancestor
65443488|NCT01064180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65443489|NCT01064180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65443490|NCT01064180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65443491|NCT01064180|Vasodilator Agents|vasodilator agents|mesh-ancestor
65443492|NCT01064180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65443493|NCT01064180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65443494|NCT01069536|Metoclopramide|metoclopramide|mesh-list
65443495|NCT01069536|Antiemetics|antiemetics|mesh-ancestor
65443496|NCT01069536|Autonomic Agents|autonomic agents|mesh-ancestor
65443497|NCT01069536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65443498|NCT01069536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443499|NCT01069536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65443500|NCT01069536|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65443501|NCT01069536|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65443502|NCT01069536|Dopamine Agents|dopamine agents|mesh-ancestor
65443503|NCT01069536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65443508|NCT00290706|Bortezomib|bortezomib|mesh-list
65443509|NCT00290706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65443510|NCT00290706|Antimetabolites|antimetabolites|mesh-ancestor
65443511|NCT00290706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443512|NCT00290706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443513|NCT00290706|Antiviral Agents|antiviral agents|mesh-ancestor
65443514|NCT00290706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65443515|NCT00290706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443516|NCT00290706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65443517|NCT00290706|Immunologic Factors|immunologic factors|mesh-ancestor
65443518|NCT00290706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443519|NCT03978156|Dronabinol|dronabinol|mesh-list
65443520|NCT03978156|Hallucinogens|hallucinogens|mesh-ancestor
65443521|NCT03978156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443522|NCT03978156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65443523|NCT03978156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65443524|NCT03978156|Analgesics|analgesics|mesh-ancestor
65443525|NCT03978156|Sensory System Agents|sensory system agents|mesh-ancestor
65443526|NCT03978156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65443527|NCT03978156|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65443528|NCT03978156|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65443529|NCT03978156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65443530|NCT03978156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443531|NCT03978156|Hormones|hormones|mesh-ancestor
65443532|NCT03978156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65008435|NCT00147654|Adrenergic Agents|adrenergic agents|mesh-ancestor
65443533|NCT03978234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65443534|NCT03978234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65443535|NCT03978234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65443536|NCT03978234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65443537|NCT03978234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443539|NCT03978234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65443540|NCT03978234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443541|NCT03978234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65443542|NCT03978234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65443543|NCT01066494|Cytarabine|cytarabine|mesh-list
65443544|NCT01066494|Amonafide|amonafide|mesh-list
65443545|NCT01066494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65443546|NCT01066494|Antimetabolites|antimetabolites|mesh-ancestor
65443547|NCT01066494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443548|NCT01066494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443549|NCT01066494|Antiviral Agents|antiviral agents|mesh-ancestor
65443550|NCT01066494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65443551|NCT01066494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65443552|NCT01066494|Immunologic Factors|immunologic factors|mesh-ancestor
65443553|NCT01066494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443554|NCT01066494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443555|NCT01069770|Sunitinib|sunitinib|mesh-list
65443556|NCT01069770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443557|NCT01069770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65443558|NCT01069770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65443559|NCT01069770|Growth Substances|growth substances|mesh-ancestor
65443560|NCT01069770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443561|NCT01069770|Growth Inhibitors|growth inhibitors|mesh-ancestor
65443562|NCT01069770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65443563|NCT01069770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443564|NCT01069770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443565|NCT00303108|Carboplatin|carboplatin|mesh-list
65443566|NCT00303108|Doxorubicin|doxorubicin|mesh-list
65443567|NCT00303108|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65443568|NCT00303108|Trastuzumab|trastuzumab|mesh-list
65443569|NCT00303108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443570|NCT00303108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65443571|NCT00303108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65443572|NCT00303108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65443573|NCT00303108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443574|NCT00303108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443592|NCT01066572|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65443593|NCT01066572|Protective Agents|protective agents|mesh-ancestor
65443594|NCT01066572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443595|NCT01066650|Everolimus|everolimus|mesh-list
65443596|NCT01066650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443597|NCT01066650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65443598|NCT01066650|Immunologic Factors|immunologic factors|mesh-ancestor
65443599|NCT01066650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443600|NCT01066728|Theophylline|theophylline|mesh-list
65443601|NCT01066728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65443602|NCT01066728|Autonomic Agents|autonomic agents|mesh-ancestor
65443603|NCT01066728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65443604|NCT01066728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443605|NCT01066728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65443606|NCT01066728|Respiratory System Agents|respiratory system agents|mesh-ancestor
65443607|NCT01066728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65443608|NCT01066728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193120|NCT01176032|Diuretics|diuretics|mesh-ancestor
65443609|NCT01066728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443610|NCT01066728|Vasodilator Agents|vasodilator agents|mesh-ancestor
65443611|NCT01066728|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65443612|NCT01066728|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65443613|NCT01066728|Purinergic Agents|purinergic agents|mesh-ancestor
65443614|NCT01066728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65443615|NCT01325610|Cholecalciferol|cholecalciferol|mesh-list
65443616|NCT01325610|Vitamin D|vitamin d|mesh-list
65443617|NCT01325610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65443618|NCT01325610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443619|NCT01325610|Vitamins|vitamins|mesh-ancestor
65443620|NCT01325610|Micronutrients|micronutrients|mesh-ancestor
65443621|NCT01325610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65443622|NCT00301080|Cycloserine|cycloserine|mesh-list
65008508|NCT01247077|Selenium|selenium|mesh-list
65443623|NCT00301080|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65443624|NCT00301080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65443625|NCT00301080|Renal Agents|renal agents|mesh-ancestor
65443626|NCT00301080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65443627|NCT00301080|Antitubercular Agents|antitubercular agents|mesh-ancestor
65443628|NCT00301080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65443629|NCT00301080|Antimetabolites|antimetabolites|mesh-ancestor
65443630|NCT00301080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443648|NCT02532270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443649|NCT02532270|Sympathomimetics|sympathomimetics|mesh-ancestor
65443650|NCT02532270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65443651|NCT02532270|Nasal Decongestants|nasal decongestants|mesh-ancestor
65443652|NCT02532270|Respiratory System Agents|respiratory system agents|mesh-ancestor
65443653|NCT02532270|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65443654|NCT02532270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65443655|NCT02532270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65443656|NCT02532270|Adrenergic Agents|adrenergic agents|mesh-ancestor
65443657|NCT02532270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65443658|NCT02532270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443659|NCT02532270|Protective Agents|protective agents|mesh-ancestor
65443660|NCT01581450|Nitrous Oxide|nitrous oxide|mesh-list
65443661|NCT01581450|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65443662|NCT01581450|Anesthetics, General|anesthetics, general|mesh-ancestor
65443663|NCT01581450|Anesthetics|anesthetics|mesh-ancestor
65443664|NCT01581450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65443665|NCT01581450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443666|NCT01581450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65443667|NCT01581450|Analgesics|analgesics|mesh-ancestor
65443668|NCT01581450|Sensory System Agents|sensory system agents|mesh-ancestor
65443669|NCT01581450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65443670|NCT00289848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65443671|NCT00289848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65443672|NCT00289848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443673|NCT00289848|Incretins|incretins|mesh-ancestor
65443675|NCT00289848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65443676|NCT00289848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65443677|NCT00289848|Protease Inhibitors|protease inhibitors|mesh-ancestor
65443678|NCT00289848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443679|NCT00289848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443680|NCT00289536|Factor VIII|factor viii|mesh-list
65443681|NCT00289536|Coagulants|coagulants|mesh-ancestor
65443682|NCT01066962|Ritonavir|ritonavir|mesh-list
65193196|NCT01193842|Tubulin Modulators|tubulin modulators|mesh-ancestor
65443683|NCT01066962|Darunavir|darunavir|mesh-list
65443684|NCT01066962|Tenofovir|tenofovir|mesh-list
65443685|NCT01066962|Emtricitabine|emtricitabine|mesh-list
65443686|NCT01066962|Raltegravir Potassium|raltegravir potassium|mesh-list
64828389|NCT01556698|Autonomic Agents|autonomic agents|mesh-ancestor
65443695|NCT01066962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65443696|NCT01066962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65443697|NCT01066962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65443698|NCT01066962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65443699|NCT01066962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65443700|NCT01066962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65443701|NCT01066962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65443702|NCT01067118|Insulin|insulin|mesh-list
65443703|NCT01067118|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65443704|NCT01067118|Insulin Lispro|insulin lispro|mesh-list
65443705|NCT01067118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65443706|NCT01067118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443707|NCT01067274|Cytarabine|cytarabine|mesh-list
65443708|NCT01067274|Azacitidine|azacitidine|mesh-list
65443709|NCT01067274|Tretinoin|tretinoin|mesh-list
65443710|NCT01067274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65443711|NCT01067274|Antimetabolites|antimetabolites|mesh-ancestor
65443712|NCT01067274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443713|NCT01067274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443714|NCT01067274|Antiviral Agents|antiviral agents|mesh-ancestor
65443715|NCT01067274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65443716|NCT01067274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65443717|NCT01067274|Immunologic Factors|immunologic factors|mesh-ancestor
65443718|NCT01067274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443719|NCT01067274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443720|NCT01067274|Keratolytic Agents|keratolytic agents|mesh-ancestor
65443721|NCT01067274|Dermatologic Agents|dermatologic agents|mesh-ancestor
65008582|NCT02275039|Immunologic Factors|immunologic factors|mesh-ancestor
65443722|NCT01065246|Catumaxomab|catumaxomab|mesh-list
65443723|NCT01065246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65443724|NCT01325844|Anesthetics|anesthetics|mesh-list
65443725|NCT01325844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65443726|NCT01325844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443727|NCT01067430|Diclofenac|diclofenac|mesh-list
65443728|NCT01067430|Etoricoxib|etoricoxib|mesh-list
65443729|NCT01067430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65443730|NCT01067430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65443731|NCT01067430|Analgesics|analgesics|mesh-ancestor
65443732|NCT01067430|Sensory System Agents|sensory system agents|mesh-ancestor
65443733|NCT01067430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65443734|NCT01067430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443735|NCT01067430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65443736|NCT01067430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65443737|NCT01067430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65443738|NCT01067430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443739|NCT01067430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443740|NCT01067430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65443741|NCT00305864|Temozolomide|temozolomide|mesh-list
65443742|NCT00305864|Motexafin gadolinium|motexafin gadolinium|mesh-list
65443743|NCT00305864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65443744|NCT00305864|Alkylating Agents|alkylating agents|mesh-ancestor
65443745|NCT00305864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443746|NCT00305864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443747|NCT00305864|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65443748|NCT00305864|Dermatologic Agents|dermatologic agents|mesh-ancestor
65443749|NCT03982784|Morphine|morphine|mesh-list
65443750|NCT03982784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65443751|NCT03982784|Narcotics|narcotics|mesh-ancestor
65443752|NCT03982784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65443753|NCT03982784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443761|NCT03978884|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65443762|NCT03978884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65443763|NCT03978884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443764|NCT03978884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65443765|NCT03978884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443766|NCT03978884|Vasodilator Agents|vasodilator agents|mesh-ancestor
65443767|NCT03978884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65443768|NCT03978884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65443769|NCT03978884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65443770|NCT03978884|Diuretics|diuretics|mesh-ancestor
65443771|NCT03978884|Natriuretic Agents|natriuretic agents|mesh-ancestor
65443772|NCT03978884|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65443773|NCT00319982|Diltiazem|diltiazem|mesh-list
65443774|NCT00319982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65443775|NCT00319982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65443776|NCT00319982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65443777|NCT00319982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443778|NCT00319982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65443779|NCT00319982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443780|NCT00319982|Vasodilator Agents|vasodilator agents|mesh-ancestor
65443781|NCT00319592|Vaccines|vaccines|mesh-list
65443782|NCT00319592|Immunologic Factors|immunologic factors|mesh-ancestor
65443783|NCT00319592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443784|NCT03980990|Metformin|metformin|mesh-list
65443785|NCT03980990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65443786|NCT03980990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443787|NCT03980756|Esomeprazole|esomeprazole|mesh-list
65443788|NCT03980756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65443789|NCT03980756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65443790|NCT03980756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65443791|NCT03980756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443792|NCT03980756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443793|NCT03978494|Tacrolimus|tacrolimus|mesh-list
65443794|NCT03978494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65443795|NCT03978494|Immunologic Factors|immunologic factors|mesh-ancestor
65443796|NCT03978494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443797|NCT03978494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65443798|NCT03978494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443799|NCT03978494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443800|NCT01064570|Tretinoin|tretinoin|mesh-list
65270058|NCT02719418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65443801|NCT01064570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443802|NCT01064570|Keratolytic Agents|keratolytic agents|mesh-ancestor
65443803|NCT01064570|Dermatologic Agents|dermatologic agents|mesh-ancestor
65443804|NCT01581164|Vaccines|vaccines|mesh-list
65443805|NCT01581164|Immunologic Factors|immunologic factors|mesh-ancestor
65443806|NCT01581164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443807|NCT00319046|Miglustat|miglustat|mesh-list
65443808|NCT00319046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443809|NCT00319046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443810|NCT00319046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65443811|NCT00319046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65443812|NCT00319046|Antiviral Agents|antiviral agents|mesh-ancestor
65443813|NCT00319046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65443814|NCT00319046|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65443815|NCT00319046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65443816|NCT00319046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443817|NCT00303602|Olanzapine|olanzapine|mesh-list
65443818|NCT00303602|Antiemetics|antiemetics|mesh-ancestor
65443819|NCT00303602|Autonomic Agents|autonomic agents|mesh-ancestor
65443820|NCT00303602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65443821|NCT00303602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443822|NCT00303602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65443829|NCT00303602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65443830|NCT00303602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443831|NCT00303602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65193349|NCT04314674|Mannitol|mannitol|mesh-list
65443834|NCT03979976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65443835|NCT03979976|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65443836|NCT03979976|Protease Inhibitors|protease inhibitors|mesh-ancestor
65443837|NCT03979976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443838|NCT03979976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65443839|NCT00299130|Methylprednisolone|methylprednisolone|mesh-list
65443840|NCT00299130|Rituximab|rituximab|mesh-list
65443841|NCT00299130|Methotrexate|methotrexate|mesh-list
65443842|NCT00299130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65443843|NCT00299130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443844|NCT00299130|Immunologic Factors|immunologic factors|mesh-ancestor
65443845|NCT00299130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443846|NCT00299130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65443847|NCT00299130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65443848|NCT00299130|Abortifacient Agents|abortifacient agents|mesh-ancestor
65443849|NCT00299130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65443850|NCT00299130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65443851|NCT00299130|Antimetabolites|antimetabolites|mesh-ancestor
65443852|NCT00299130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443853|NCT00299130|Dermatologic Agents|dermatologic agents|mesh-ancestor
65443854|NCT00299130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443855|NCT00299130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65443856|NCT00299130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65443857|NCT00299130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65443858|NCT00299130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65443859|NCT00299130|Antiemetics|antiemetics|mesh-ancestor
65443860|NCT00299130|Autonomic Agents|autonomic agents|mesh-ancestor
65443861|NCT00299130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65443862|NCT00299130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65443863|NCT00299130|Glucocorticoids|glucocorticoids|mesh-ancestor
65443864|NCT00299130|Hormones|hormones|mesh-ancestor
65443865|NCT00299130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65443866|NCT00299130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65443867|NCT00299130|Protective Agents|protective agents|mesh-ancestor
65443868|NCT00288054|Docetaxel|docetaxel|mesh-list
65443869|NCT00288054|Cetuximab|cetuximab|mesh-list
65443870|NCT00288054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443871|NCT00288054|Tubulin Modulators|tubulin modulators|mesh-ancestor
65443872|NCT00288054|Antimitotic Agents|antimitotic agents|mesh-ancestor
65443873|NCT00288054|Mitosis Modulators|mitosis modulators|mesh-ancestor
65443874|NCT00288054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443875|NCT00288054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65443876|NCT00287586|Testosterone|testosterone|mesh-list
65443877|NCT00287586|Androgens|androgens|mesh-ancestor
65443878|NCT00287586|Hormones|hormones|mesh-ancestor
65443879|NCT00287586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65443880|NCT00287586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008736|NCT00504283|Morphine|morphine|mesh-list
65443881|NCT01070160|Metformin|metformin|mesh-list
65443882|NCT01070160|Progesterone|progesterone|mesh-list
65443883|NCT01070160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65443884|NCT01070160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443885|NCT01070160|Progestins|progestins|mesh-ancestor
65443886|NCT01070160|Hormones|hormones|mesh-ancestor
65443887|NCT01070160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65443888|NCT03977298|Chlorhexidine|chlorhexidine|mesh-list
65443889|NCT03977298|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64828576|NCT01557764|Antibodies|antibodies|mesh-list
65443901|NCT00293202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65443903|NCT00293202|Sensory System Agents|sensory system agents|mesh-ancestor
65443904|NCT00293202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65443905|NCT00293202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443906|NCT00293202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65443907|NCT00293202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65443908|NCT00293202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65443909|NCT00293202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65443910|NCT00293202|Immunologic Factors|immunologic factors|mesh-ancestor
65443911|NCT00286494|Pioglitazone|pioglitazone|mesh-list
65443912|NCT00286494|Alogliptin|alogliptin|mesh-list
65443913|NCT00286494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65443914|NCT00286494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443915|NCT00286494|Incretins|incretins|mesh-ancestor
65443916|NCT00286494|Hormones|hormones|mesh-ancestor
65443917|NCT00286494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65443918|NCT00286494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65443919|NCT00286494|Protease Inhibitors|protease inhibitors|mesh-ancestor
65443920|NCT00286494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443921|NCT00286494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443922|NCT00298740|Insulin|insulin|mesh-list
65443923|NCT00298740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65443924|NCT00298740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443925|NCT01067898|Vitamin D|vitamin d|mesh-list
65443926|NCT01067898|Ergocalciferols|ergocalciferols|mesh-list
65443927|NCT01067898|Cholecalciferol|cholecalciferol|mesh-list
65443928|NCT01067898|Vitamins|vitamins|mesh-list
65443929|NCT01067898|Calcium Carbonate|calcium carbonate|mesh-list
65443930|NCT01067898|Micronutrients|micronutrients|mesh-ancestor
65443931|NCT01067898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443932|NCT01067898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65443933|NCT01067898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65443934|NCT01067898|Antacids|antacids|mesh-ancestor
65443935|NCT01067898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443936|NCT01067898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65443937|NCT03979248|BMS-986165|bms-986165|mesh-list
65443938|NCT03979248|Rabeprazole|rabeprazole|mesh-list
65443939|NCT03979248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65443940|NCT03979248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65443941|NCT03979248|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65443942|NCT03979248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443943|NCT03979248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443944|NCT03979248|Dermatologic Agents|dermatologic agents|mesh-ancestor
65443945|NCT03979248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65443946|NCT00285012|Varenicline|varenicline|mesh-list
65443947|NCT00285012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65443948|NCT00285012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65443949|NCT00285012|Cholinergic Agents|cholinergic agents|mesh-ancestor
65443950|NCT00285012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65443951|NCT00285012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443952|NCT00285012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443953|NCT00284934|Mycophenolic Acid|mycophenolic acid|mesh-list
65443964|NCT00284934|Immunologic Factors|immunologic factors|mesh-ancestor
65443965|NCT00284934|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65443966|NCT00284934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443967|NCT00284934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443968|NCT00284934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65443969|NCT00284934|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65443970|NCT00284934|Antitubercular Agents|antitubercular agents|mesh-ancestor
65443971|NCT00284934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65443972|NCT00284934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65443973|NCT00284856|Fluticasone|fluticasone|mesh-list
65443974|NCT00284856|Montelukast|montelukast|mesh-list
65443975|NCT00284856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65443976|NCT00284856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65008804|NCT00403325|Ranibizumab|ranibizumab|mesh-list
65443977|NCT00284856|Autonomic Agents|autonomic agents|mesh-ancestor
65443978|NCT00284856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65443979|NCT00284856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443980|NCT00284856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65443981|NCT00284856|Respiratory System Agents|respiratory system agents|mesh-ancestor
65443982|NCT00284856|Dermatologic Agents|dermatologic agents|mesh-ancestor
65443983|NCT00284856|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65443984|NCT00284856|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65443985|NCT00284856|Hormone Antagonists|hormone antagonists|mesh-ancestor
65443986|NCT00284856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65443987|NCT00284856|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65443988|NCT00284856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65443989|NCT00284856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443990|NCT00298272|Methylprednisolone|methylprednisolone|mesh-list
65443992|NCT00298272|Etanercept|etanercept|mesh-list
65443993|NCT00298272|Rituximab|rituximab|mesh-list
65443994|NCT00298272|Methotrexate|methotrexate|mesh-list
65443995|NCT00298272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65443996|NCT00298272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443997|NCT00298272|Immunologic Factors|immunologic factors|mesh-ancestor
65443998|NCT00298272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443999|NCT00298272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65444000|NCT00298272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65444001|NCT00298272|Abortifacient Agents|abortifacient agents|mesh-ancestor
65444002|NCT00298272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65444003|NCT00298272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65444004|NCT00298272|Antimetabolites|antimetabolites|mesh-ancestor
65444005|NCT00298272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444006|NCT00298272|Dermatologic Agents|dermatologic agents|mesh-ancestor
65444007|NCT00298272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444008|NCT00298272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65444009|NCT00298272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65444010|NCT00298272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65444011|NCT00298272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65444012|NCT00298272|Antiemetics|antiemetics|mesh-ancestor
65444013|NCT00298272|Autonomic Agents|autonomic agents|mesh-ancestor
65444014|NCT00298272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65444015|NCT00298272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65444016|NCT00298272|Glucocorticoids|glucocorticoids|mesh-ancestor
65444017|NCT00298272|Hormones|hormones|mesh-ancestor
65444018|NCT00298272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65444025|NCT01068054|Cyclosporine|cyclosporine|mesh-list
65444026|NCT01068054|Tacrolimus|tacrolimus|mesh-list
65444027|NCT01068054|Cyclosporins|cyclosporins|mesh-list
65444028|NCT01068054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65444029|NCT01068054|Immunologic Factors|immunologic factors|mesh-ancestor
65444030|NCT01068054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444031|NCT01068054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65444032|NCT01068054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444033|NCT01068054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444034|NCT01068054|Antifungal Agents|antifungal agents|mesh-ancestor
65444035|NCT01068054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65444036|NCT01068054|Dermatologic Agents|dermatologic agents|mesh-ancestor
65444037|NCT01068054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65444038|NCT00298038|Rifaximin|rifaximin|mesh-list
65444039|NCT00298038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65444040|NCT00298038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65444041|NCT00298038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65444042|NCT00283686|Telmisartan|telmisartan|mesh-list
65444043|NCT00283686|Lisinopril|lisinopril|mesh-list
65444044|NCT00283686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65444045|NCT00283686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65444046|NCT00283686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65444047|NCT00283686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65444048|NCT00283686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444049|NCT00283686|Protease Inhibitors|protease inhibitors|mesh-ancestor
65444050|NCT00283686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444051|NCT00283686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65444052|NCT00283686|Protective Agents|protective agents|mesh-ancestor
65444053|NCT00283686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444054|NCT00297882|Artesunate|artesunate|mesh-list
65444055|NCT00297882|Lumefantrine|lumefantrine|mesh-list
65444056|NCT00297882|Artemether|artemether|mesh-list
65444057|NCT00297882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65444058|NCT00297882|Amodiaquine|amodiaquine|mesh-list
65444059|NCT00297882|Antimalarials|antimalarials|mesh-ancestor
65444060|NCT00297882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65444061|NCT00297882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65444062|NCT00297882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65444063|NCT00297882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444064|NCT00297882|Antiviral Agents|antiviral agents|mesh-ancestor
65444065|NCT00297882|Schistosomicides|schistosomicides|mesh-ancestor
65444066|NCT00297882|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65444067|NCT00297882|Anthelmintics|anthelmintics|mesh-ancestor
65444068|NCT01065870|Gemcitabine|gemcitabine|mesh-list
65444069|NCT01065870|Capecitabine|capecitabine|mesh-list
65444070|NCT01065870|Docetaxel|docetaxel|mesh-list
65444071|NCT01065870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65444072|NCT01065870|Antimetabolites|antimetabolites|mesh-ancestor
65444073|NCT01065870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444074|NCT01065870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444075|NCT01065870|Antiviral Agents|antiviral agents|mesh-ancestor
65444076|NCT01065870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65444077|NCT01065870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444078|NCT01065870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65444079|NCT01065870|Immunologic Factors|immunologic factors|mesh-ancestor
65444080|NCT01065870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444081|NCT01065870|Tubulin Modulators|tubulin modulators|mesh-ancestor
65444082|NCT01065870|Antimitotic Agents|antimitotic agents|mesh-ancestor
65444083|NCT01065870|Mitosis Modulators|mitosis modulators|mesh-ancestor
65444084|NCT00297648|Certolizumab Pegol|certolizumab pegol|mesh-list
65444085|NCT00297648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65444086|NCT00297648|Immunologic Factors|immunologic factors|mesh-ancestor
65444087|NCT00297648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444088|NCT00297648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65444089|NCT01068132|Cetuximab|cetuximab|mesh-list
65444090|NCT01068132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65444122|NCT00496769|Protease Inhibitors|protease inhibitors|mesh-ancestor
65444123|NCT00496769|Anticoagulants|anticoagulants|mesh-ancestor
65444124|NCT01014845|Vaccines|vaccines|mesh-list
65444125|NCT01014845|Immunologic Factors|immunologic factors|mesh-ancestor
65444126|NCT01014845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444127|NCT00488345|Tigecycline|tigecycline|mesh-list
65444128|NCT00488345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65444129|NCT00488345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65444130|NCT00488345|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65444131|NCT00488345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444132|NCT00488345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444133|NCT00283062|Docetaxel|docetaxel|mesh-list
65444134|NCT00283062|Leuprolide|leuprolide|mesh-list
65444170|NCT00296244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65444171|NCT00296244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444172|NCT00296244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65444173|NCT00296244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444187|NCT00296244|Antitubercular Agents|antitubercular agents|mesh-ancestor
65444188|NCT00296244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65444189|NCT00296244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65444190|NCT01068444|Pioglitazone|pioglitazone|mesh-list
65444191|NCT01068444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65444192|NCT01068444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444193|NCT00282048|Axitinib|axitinib|mesh-list
65444194|NCT00282048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444195|NCT00282048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65444196|NCT00282048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444197|NCT00282048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444198|NCT00474539|Vaccines|vaccines|mesh-list
65444199|NCT00474539|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65444200|NCT00474539|Immunologic Factors|immunologic factors|mesh-ancestor
65444201|NCT00474539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444202|NCT01017809|Aprepitant|aprepitant|mesh-list
65444203|NCT01017809|Antiemetics|antiemetics|mesh-ancestor
65444204|NCT01017809|Autonomic Agents|autonomic agents|mesh-ancestor
65444205|NCT01017809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65444206|NCT01017809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444207|NCT01017809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65444208|NCT01017809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65444209|NCT01017809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65444210|NCT01017809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444211|NCT01020539|Fludarabine|fludarabine|mesh-list
65444212|NCT01020539|Busulfan|busulfan|mesh-list
65008970|NCT02086175|Rituximab|rituximab|mesh-list
65444213|NCT01020539|Gemtuzumab|gemtuzumab|mesh-list
65444214|NCT01020539|Isotretinoin|isotretinoin|mesh-list
65444215|NCT01020539|Thymoglobulin|thymoglobulin|mesh-list
65444216|NCT01020539|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65444217|NCT01020539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444218|NCT01020539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444219|NCT01020539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65444220|NCT01020539|Immunologic Factors|immunologic factors|mesh-ancestor
65444221|NCT01020539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444222|NCT01020539|Alkylating Agents|alkylating agents|mesh-ancestor
65444223|NCT01020539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65444224|NCT01020539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65444225|NCT01020539|Dermatologic Agents|dermatologic agents|mesh-ancestor
65444226|NCT01020539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65444227|NCT00281580|Amlodipine|amlodipine|mesh-list
65444228|NCT00281580|Telmisartan|telmisartan|mesh-list
65444229|NCT00281580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65444230|NCT00281580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65444231|NCT00281580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65444232|NCT00281580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444233|NCT00281580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64828925|NCT05570409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65444237|NCT00281580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65444239|NCT00495755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65444240|NCT00495755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444241|NCT01070862|Thalidomide|thalidomide|mesh-list
65444242|NCT01070862|Dexamethasone|dexamethasone|mesh-list
65444243|NCT01070862|Dexamethasone acetate|dexamethasone acetate|mesh-list
65444244|NCT01070862|Doxorubicin|doxorubicin|mesh-list
65444245|NCT01070862|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65444246|NCT01070862|Melphalan|melphalan|mesh-list
65444247|NCT01070862|Cyclophosphamide|cyclophosphamide|mesh-list
65444248|NCT01070862|Vincristine|vincristine|mesh-list
65444249|NCT01070862|BB 1101|bb 1101|mesh-list
65444250|NCT01070862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65444251|NCT01070862|Antiemetics|antiemetics|mesh-ancestor
65444252|NCT01070862|Autonomic Agents|autonomic agents|mesh-ancestor
65444253|NCT01070862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65444254|NCT01070862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444255|NCT01070862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65444256|NCT01070862|Glucocorticoids|glucocorticoids|mesh-ancestor
65444257|NCT01070862|Hormones|hormones|mesh-ancestor
65444258|NCT01070862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65444259|NCT01070862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65444260|NCT01070862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444261|NCT01070862|Protease Inhibitors|protease inhibitors|mesh-ancestor
65444262|NCT01070862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444263|NCT01070862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444264|NCT01070862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65444265|NCT01070862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65444266|NCT01070862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65444267|NCT01070862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65444268|NCT01070862|Alkylating Agents|alkylating agents|mesh-ancestor
65444269|NCT01070862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65444270|NCT01070862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65444271|NCT01070862|Immunologic Factors|immunologic factors|mesh-ancestor
65444272|NCT01070862|Leprostatic Agents|leprostatic agents|mesh-ancestor
65444273|NCT01070862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65444274|NCT01070862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65444275|NCT01070862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65444276|NCT01070862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65444277|NCT01070862|Growth Substances|growth substances|mesh-ancestor
65444278|NCT01070862|Growth Inhibitors|growth inhibitors|mesh-ancestor
65444279|NCT01070862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65444280|NCT01070862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65444281|NCT01070862|Tubulin Modulators|tubulin modulators|mesh-ancestor
65444282|NCT01070862|Antimitotic Agents|antimitotic agents|mesh-ancestor
65444283|NCT01070862|Mitosis Modulators|mitosis modulators|mesh-ancestor
65444284|NCT00495677|PF 232798|pf 232798|mesh-list
65193801|NCT02680132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65444285|NCT00495677|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65444286|NCT00495677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444287|NCT00495677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65444288|NCT00495677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65444289|NCT00495677|Antiviral Agents|antiviral agents|mesh-ancestor
65444290|NCT00495677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65444291|NCT00495521|Aminosalicylic Acid|aminosalicylic acid|mesh-list
65444292|NCT00495521|Antitubercular Agents|antitubercular agents|mesh-ancestor
65444293|NCT00495521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65444294|NCT00495521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65444295|NCT00494507|Dichlorphenamide|dichlorphenamide|mesh-list
65444296|NCT00494507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65444297|NCT00494507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444298|NCT00494507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444299|NCT00292188|Pregabalin|pregabalin|mesh-list
65444300|NCT00292188|Analgesics|analgesics|mesh-ancestor
65444301|NCT00292188|Sensory System Agents|sensory system agents|mesh-ancestor
65444302|NCT00292188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65444303|NCT00292188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444304|NCT00292188|Anticonvulsants|anticonvulsants|mesh-ancestor
65444321|NCT00271596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65444322|NCT00271596|Antidepressive Agents|antidepressive agents|mesh-ancestor
65444323|NCT00271596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65444324|NCT01068756|Dapagliflozin|dapagliflozin|mesh-list
65444325|NCT01068756|Rifampin|rifampin|mesh-list
65444326|NCT01068756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65444327|NCT01068756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444328|NCT01068756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65444329|NCT01068756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444330|NCT01068756|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65444331|NCT01068756|Antitubercular Agents|antitubercular agents|mesh-ancestor
65444332|NCT01068756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65444333|NCT01068756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65444334|NCT01068756|Leprostatic Agents|leprostatic agents|mesh-ancestor
65444335|NCT01068756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65444336|NCT01068756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444337|NCT01068756|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65444338|NCT01068756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65444339|NCT01068756|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65444340|NCT01068756|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65444341|NCT01068756|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65444342|NCT01068756|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65444343|NCT00291642|Cetirizine|cetirizine|mesh-list
65444344|NCT00291642|Levocetirizine|levocetirizine|mesh-list
65444345|NCT00291642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65444346|NCT00291642|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65444347|NCT00291642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65444348|NCT00291642|Histamine Antagonists|histamine antagonists|mesh-ancestor
65444349|NCT00291642|Histamine Agents|histamine agents|mesh-ancestor
65444350|NCT00291642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65444351|NCT00291642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444352|NCT00291642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444353|NCT01070472|Misoprostol|misoprostol|mesh-list
65444354|NCT01070472|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65444355|NCT01070472|Abortifacient Agents|abortifacient agents|mesh-ancestor
65444356|NCT01070472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65444357|NCT01070472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444358|NCT01070472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65444365|NCT00280566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444366|NCT00280566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444367|NCT00280566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65444368|NCT00280566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65444369|NCT00280566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65444370|NCT00280566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65444371|NCT00280566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65444372|NCT00280566|Dopamine Agents|dopamine agents|mesh-ancestor
65444373|NCT00270894|Cyclophosphamide|cyclophosphamide|mesh-list
65444374|NCT00270894|Docetaxel|docetaxel|mesh-list
65444375|NCT00270894|Trastuzumab|trastuzumab|mesh-list
65444376|NCT00270894|Epirubicin|epirubicin|mesh-list
65444377|NCT00270894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65444378|NCT00270894|Immunologic Factors|immunologic factors|mesh-ancestor
65444379|NCT00270894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444380|NCT00270894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65444381|NCT00270894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65444382|NCT00270894|Alkylating Agents|alkylating agents|mesh-ancestor
65444383|NCT00270894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444384|NCT00270894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444385|NCT00270894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65444386|NCT00270894|Tubulin Modulators|tubulin modulators|mesh-ancestor
65444387|NCT00270894|Antimitotic Agents|antimitotic agents|mesh-ancestor
65444388|NCT00270894|Mitosis Modulators|mitosis modulators|mesh-ancestor
65444389|NCT00270894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65444390|NCT00270894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65444391|NCT00270894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65444392|NCT00270894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65444393|NCT00270894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444394|NCT01070628|Levodopa|levodopa|mesh-list
65444395|NCT01070628|Carbidopa|carbidopa|mesh-list
65444396|NCT01070628|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65444397|NCT01070628|Entacapone|entacapone|mesh-list
65444398|NCT01070628|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65444399|NCT01070628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65444400|NCT01070628|Dopamine Agents|dopamine agents|mesh-ancestor
65444401|NCT01070628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65444402|NCT01070628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444403|NCT01070628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444404|NCT01070628|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65444405|NCT01070628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444406|NCT01070628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65444407|NCT01070628|Immunologic Factors|immunologic factors|mesh-ancestor
65444408|NCT01070628|Dopamine Agonists|dopamine agonists|mesh-ancestor
65444409|NCT01070628|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65444410|NCT01070940|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
65444411|NCT01070940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444412|NCT01070940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444413|NCT00317642|Cytarabine|cytarabine|mesh-list
65444414|NCT00317642|Clofarabine|clofarabine|mesh-list
65444415|NCT00317642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65444416|NCT00317642|Antimetabolites|antimetabolites|mesh-ancestor
65444417|NCT00317642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444418|NCT00317642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444419|NCT00317642|Antiviral Agents|antiviral agents|mesh-ancestor
65444420|NCT00317642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65444421|NCT00317642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65444422|NCT00317642|Immunologic Factors|immunologic factors|mesh-ancestor
65444423|NCT00317642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444424|NCT01064726|Fluticasone|fluticasone|mesh-list
65444425|NCT01064726|Xhance|xhance|mesh-list
65444426|NCT01064726|Ibuprofen|ibuprofen|mesh-list
65444427|NCT01064726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65444428|NCT01064726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65444429|NCT01064726|Autonomic Agents|autonomic agents|mesh-ancestor
65444437|NCT01064726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65444438|NCT01064726|Analgesics|analgesics|mesh-ancestor
65444439|NCT01064726|Sensory System Agents|sensory system agents|mesh-ancestor
65444440|NCT01064726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65444441|NCT01064726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65444442|NCT01064726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444443|NCT01064726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444444|NCT00295022|Montelukast|montelukast|mesh-list
65444445|NCT00295022|Levocetirizine|levocetirizine|mesh-list
65444446|NCT00295022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65444447|NCT00295022|Respiratory System Agents|respiratory system agents|mesh-ancestor
65444448|NCT00295022|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65444449|NCT00295022|Hormone Antagonists|hormone antagonists|mesh-ancestor
65444450|NCT00295022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65444451|NCT00295022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444452|NCT00295022|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65444453|NCT00295022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65444454|NCT00295022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444455|NCT00295022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65444456|NCT00295022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65444457|NCT00295022|Histamine Antagonists|histamine antagonists|mesh-ancestor
65444458|NCT00295022|Histamine Agents|histamine agents|mesh-ancestor
65444459|NCT00295022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65444460|NCT01062152|Lenalidomide|lenalidomide|mesh-list
65444461|NCT01062152|Immunologic Factors|immunologic factors|mesh-ancestor
65444462|NCT01062152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444463|NCT01062152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65444464|NCT01062152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65444465|NCT01062152|Growth Substances|growth substances|mesh-ancestor
65444466|NCT01062152|Growth Inhibitors|growth inhibitors|mesh-ancestor
65009181|NCT00139815|Anticoagulants|anticoagulants|mesh-ancestor
65444467|NCT01062152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444468|NCT00303446|Dutasteride|dutasteride|mesh-list
65444469|NCT00303446|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65444470|NCT00303446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65444471|NCT00303446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444472|NCT00303446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444473|NCT00303446|Hormone Antagonists|hormone antagonists|mesh-ancestor
65444474|NCT00303446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65444475|NCT00303446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444476|NCT01065038|Hydroxyurea|hydroxyurea|mesh-list
65444477|NCT01065038|Anagrelide|anagrelide|mesh-list
65444478|NCT01065038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444479|NCT01065038|Antisickling Agents|antisickling agents|mesh-ancestor
65444480|NCT01065038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444481|NCT01065038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444482|NCT01065038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65444483|NCT01065038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65444484|NCT01065038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65444485|NCT01065038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65444486|NCT00291486|Capecitabine|capecitabine|mesh-list
65444487|NCT00291486|Antibodies|antibodies|mesh-list
65444488|NCT00291486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65444489|NCT00291486|Immunologic Factors|immunologic factors|mesh-ancestor
65444490|NCT00291486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444491|NCT00291486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65444492|NCT00291486|Antimetabolites|antimetabolites|mesh-ancestor
65444493|NCT00291486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444494|NCT00291486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444512|NCT00301808|Mitosis Modulators|mitosis modulators|mesh-ancestor
65444513|NCT00301808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444514|NCT00301808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444515|NCT00301808|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65444516|NCT00301808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65444517|NCT01070706|Gemcitabine|gemcitabine|mesh-list
65444518|NCT01070706|Paclitaxel|paclitaxel|mesh-list
65444519|NCT01070706|Sunitinib|sunitinib|mesh-list
65444520|NCT01070706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65444521|NCT01070706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444522|NCT01070706|Tubulin Modulators|tubulin modulators|mesh-ancestor
65444523|NCT01070706|Antimitotic Agents|antimitotic agents|mesh-ancestor
65444524|NCT01070706|Mitosis Modulators|mitosis modulators|mesh-ancestor
65444525|NCT01070706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444526|NCT01070706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65444527|NCT01070706|Antimetabolites|antimetabolites|mesh-ancestor
65444528|NCT01070706|Antiviral Agents|antiviral agents|mesh-ancestor
65444529|NCT01070706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65444530|NCT01070706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444531|NCT01070706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65444532|NCT01070706|Immunologic Factors|immunologic factors|mesh-ancestor
65444533|NCT01070706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444534|NCT01070706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65444535|NCT01070706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65444536|NCT01070706|Growth Substances|growth substances|mesh-ancestor
65444537|NCT01070706|Growth Inhibitors|growth inhibitors|mesh-ancestor
65444538|NCT01070706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65444539|NCT00268242|Gemcitabine|gemcitabine|mesh-list
65444540|NCT00268242|Mitoxantrone|mitoxantrone|mesh-list
65444541|NCT00268242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65444542|NCT00268242|Antimetabolites|antimetabolites|mesh-ancestor
65444543|NCT00268242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444544|NCT00268242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444545|NCT00268242|Antiviral Agents|antiviral agents|mesh-ancestor
65444546|NCT00268242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65444547|NCT00268242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444548|NCT00268242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65444549|NCT00268242|Immunologic Factors|immunologic factors|mesh-ancestor
65444550|NCT00268242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444551|NCT00268242|Analgesics|analgesics|mesh-ancestor
65444552|NCT00268242|Sensory System Agents|sensory system agents|mesh-ancestor
65444553|NCT00268242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65444554|NCT00268242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65444575|NCT00294398|Dermatologic Agents|dermatologic agents|mesh-ancestor
65444576|NCT00294398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65444577|NCT00294398|Glucocorticoids|glucocorticoids|mesh-ancestor
65444578|NCT00294398|Hormones|hormones|mesh-ancestor
65444579|NCT00294398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65444580|NCT00279708|Atorvastatin|atorvastatin|mesh-list
65444581|NCT00279708|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65444582|NCT00279708|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65194103|NCT02678728|Analgesics|analgesics|mesh-ancestor
65444583|NCT00279708|Antimetabolites|antimetabolites|mesh-ancestor
65444584|NCT00279708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444585|NCT00279708|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65444586|NCT00279708|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65444587|NCT00279708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444588|NCT03976518|Atezolizumab|atezolizumab|mesh-list
65444589|NCT03976518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444590|NCT00299702|Aripiprazole|aripiprazole|mesh-list
65444591|NCT00299702|Risperidone|risperidone|mesh-list
65444592|NCT00299702|Antidepressive Agents|antidepressive agents|mesh-ancestor
65444593|NCT00299702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65444594|NCT00299702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65444595|NCT00299702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65444596|NCT00299702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65444597|NCT00299702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444598|NCT00299702|Dopamine Agonists|dopamine agonists|mesh-ancestor
65444599|NCT00299702|Dopamine Agents|dopamine agents|mesh-ancestor
65444600|NCT00299702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65444601|NCT00299702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444602|NCT00299702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65444603|NCT00299702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65444604|NCT00299702|Serotonin Agents|serotonin agents|mesh-ancestor
65444605|NCT00299702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65444606|NCT00299702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65444607|NCT00299702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65444608|NCT00299702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65444619|NCT03975036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444620|NCT00267150|Mycophenolic Acid|mycophenolic acid|mesh-list
65444621|NCT00267150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65444622|NCT00267150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444623|NCT00267150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65444624|NCT00267150|Antitubercular Agents|antitubercular agents|mesh-ancestor
65444625|NCT00267150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65444626|NCT00267150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65444627|NCT00267150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444628|NCT00267150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444630|NCT01582230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65444631|NCT01582230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444632|NCT01582230|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65444633|NCT01582230|Protease Inhibitors|protease inhibitors|mesh-ancestor
65444634|NCT01582230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444635|NCT01582230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444636|NCT00278148|Paclitaxel|paclitaxel|mesh-list
65444637|NCT00278148|Carboplatin|carboplatin|mesh-list
65444638|NCT00278148|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65444639|NCT00278148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65444640|NCT00278148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444641|NCT00278148|Tubulin Modulators|tubulin modulators|mesh-ancestor
65444642|NCT00278148|Antimitotic Agents|antimitotic agents|mesh-ancestor
65444643|NCT00278148|Mitosis Modulators|mitosis modulators|mesh-ancestor
65444644|NCT00278148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444645|NCT00278148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65444646|NCT00278148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444647|NCT00299546|Golimumab|golimumab|mesh-list
65444648|NCT00299546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65444649|NCT00299546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65444650|NCT00299546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65444651|NCT00299546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65444652|NCT00299546|Immunologic Factors|immunologic factors|mesh-ancestor
65444653|NCT00299546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444654|NCT03975270|Paclitaxel|paclitaxel|mesh-list
65444655|NCT03975270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65444656|NCT03975270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444657|NCT03975270|Tubulin Modulators|tubulin modulators|mesh-ancestor
65444658|NCT03975270|Antimitotic Agents|antimitotic agents|mesh-ancestor
65444659|NCT03975270|Mitosis Modulators|mitosis modulators|mesh-ancestor
65444660|NCT03975270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444661|NCT01065116|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65444662|NCT01065116|Antimalarials|antimalarials|mesh-ancestor
65444663|NCT01065116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65444664|NCT01065116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65444665|NCT01065116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65444666|NCT03977792|Docosanol|docosanol|mesh-list
65444667|NCT03977792|Antiviral Agents|antiviral agents|mesh-ancestor
65444668|NCT03977792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65444669|NCT01066598|Rituximab|rituximab|mesh-list
65444670|NCT01066598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65444671|NCT01066598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444672|NCT01066598|Immunologic Factors|immunologic factors|mesh-ancestor
65444673|NCT01066598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444674|NCT01066598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65444682|NCT01066676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65444683|NCT01066676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65444684|NCT01066676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65444685|NCT01066676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444686|NCT01066676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444687|NCT01065194|Simendan|simendan|mesh-list
65444688|NCT01065194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65444689|NCT01065194|Vasodilator Agents|vasodilator agents|mesh-ancestor
65444690|NCT01065194|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65444691|NCT01065194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65444692|NCT01065194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444693|NCT01065194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444694|NCT01065194|Protective Agents|protective agents|mesh-ancestor
65444695|NCT01065194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444696|NCT01065272|Dexamethasone|dexamethasone|mesh-list
65444697|NCT01065272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65444698|NCT01065272|Antiemetics|antiemetics|mesh-ancestor
65444699|NCT01065272|Autonomic Agents|autonomic agents|mesh-ancestor
65444700|NCT01065272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65444701|NCT01065272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444702|NCT01065272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65444703|NCT01065272|Glucocorticoids|glucocorticoids|mesh-ancestor
65444704|NCT01065272|Hormones|hormones|mesh-ancestor
65444705|NCT01065272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65444706|NCT01065272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65444707|NCT01065272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444708|NCT00299156|Clofarabine|clofarabine|mesh-list
65444709|NCT00299156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65444710|NCT00299156|Antimetabolites|antimetabolites|mesh-ancestor
65444711|NCT00299156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444712|NCT00299156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444713|NCT00277212|Lamotrigine|lamotrigine|mesh-list
65444714|NCT00277212|Anticonvulsants|anticonvulsants|mesh-list
65444715|NCT00277212|Aripiprazole|aripiprazole|mesh-list
65444716|NCT00277212|Antidepressive Agents|antidepressive agents|mesh-ancestor
65444717|NCT00277212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65444718|NCT00277212|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65444719|NCT00277212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65444720|NCT00277212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65444721|NCT00277212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444722|NCT00277212|Dopamine Agonists|dopamine agonists|mesh-ancestor
65444723|NCT00277212|Dopamine Agents|dopamine agents|mesh-ancestor
65444724|NCT00277212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65444725|NCT00277212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444726|NCT00277212|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65444727|NCT00277212|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65444728|NCT00277212|Serotonin Agents|serotonin agents|mesh-ancestor
65444729|NCT00277212|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65444730|NCT00277212|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65444731|NCT00277212|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65444732|NCT00277212|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65444733|NCT00277212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65444734|NCT00277212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65444735|NCT00277212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65444736|NCT00277212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65444737|NCT01066754|Fexofenadine|fexofenadine|mesh-list
65444738|NCT01066754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65444739|NCT01066754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65444740|NCT01066754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64829426|NCT03471507|Diclofenac|diclofenac|mesh-list
65270059|NCT02719418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444745|NCT01066754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444746|NCT00276744|Gemcitabine|gemcitabine|mesh-list
65444747|NCT00276744|Sirolimus|sirolimus|mesh-list
65444748|NCT00276744|Capecitabine|capecitabine|mesh-list
65444749|NCT00276744|Docetaxel|docetaxel|mesh-list
65444750|NCT00276744|Irinotecan|irinotecan|mesh-list
65444751|NCT00276744|Cetuximab|cetuximab|mesh-list
65444752|NCT00276744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65444753|NCT00276744|Mitomycins|mitomycins|mesh-list
65444754|NCT00276744|Mitomycin|mitomycin|mesh-list
65444755|NCT00276744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65444756|NCT00276744|Antimetabolites|antimetabolites|mesh-ancestor
65444757|NCT00276744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444758|NCT00276744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444759|NCT00276744|Antiviral Agents|antiviral agents|mesh-ancestor
65444760|NCT00276744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65444761|NCT00276744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444762|NCT00276744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65444763|NCT00276744|Immunologic Factors|immunologic factors|mesh-ancestor
65444764|NCT00276744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444765|NCT00276744|Tubulin Modulators|tubulin modulators|mesh-ancestor
65444766|NCT00276744|Antimitotic Agents|antimitotic agents|mesh-ancestor
65444767|NCT00276744|Mitosis Modulators|mitosis modulators|mesh-ancestor
65444768|NCT00276744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65444769|NCT00276744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65444770|NCT00276744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65444771|NCT00276744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65444772|NCT00276744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65444773|NCT00276744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65444774|NCT00276744|Antifungal Agents|antifungal agents|mesh-ancestor
65444775|NCT00276744|Alkylating Agents|alkylating agents|mesh-ancestor
65444776|NCT00276744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65444777|NCT00251316|Lithium Carbonate|lithium carbonate|mesh-list
65444778|NCT00251316|Antidepressive Agents|antidepressive agents|mesh-ancestor
65444779|NCT00251316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65444780|NCT00251316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444781|NCT00251316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444782|NCT00251316|Antimanic Agents|antimanic agents|mesh-ancestor
65444783|NCT00251316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65444784|NCT00251316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65444785|NCT00251316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444786|NCT02532192|Cytarabine|cytarabine|mesh-list
65444787|NCT02532192|Ciprofloxacin|ciprofloxacin|mesh-list
65444788|NCT02532192|Fluconazole|fluconazole|mesh-list
65444789|NCT02532192|Dexamethasone|dexamethasone|mesh-list
65444790|NCT02532192|Rituximab|rituximab|mesh-list
65444791|NCT02532192|Cisplatin|cisplatin|mesh-list
65444792|NCT02532192|Belinostat|belinostat|mesh-list
65444793|NCT02532192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65444794|NCT02532192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444795|NCT02532192|Immunologic Factors|immunologic factors|mesh-ancestor
65444796|NCT02532192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444797|NCT02532192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65444798|NCT02532192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65444799|NCT02532192|Antiemetics|antiemetics|mesh-ancestor
65444800|NCT02532192|Autonomic Agents|autonomic agents|mesh-ancestor
65444801|NCT02532192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65444802|NCT02532192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65444803|NCT02532192|Glucocorticoids|glucocorticoids|mesh-ancestor
65444804|NCT02532192|Hormones|hormones|mesh-ancestor
65444805|NCT02532192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65444806|NCT02532192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65444807|NCT02532192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65444808|NCT02532192|Antimetabolites|antimetabolites|mesh-ancestor
65444809|NCT02532192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444810|NCT02532192|Antiviral Agents|antiviral agents|mesh-ancestor
65444811|NCT02532192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65444812|NCT02532192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65444813|NCT02532192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65444831|NCT00316082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65444832|NCT00316082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444833|NCT00316082|Incretins|incretins|mesh-ancestor
65444834|NCT00316082|Hormones|hormones|mesh-ancestor
65444835|NCT00316082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65444836|NCT00316082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65444837|NCT00316082|Protease Inhibitors|protease inhibitors|mesh-ancestor
65444838|NCT00316082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444839|NCT00316082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444840|NCT00316004|Dextrans|dextrans|mesh-list
65444841|NCT00316004|Anticoagulants|anticoagulants|mesh-ancestor
65444842|NCT00316004|Plasma Substitutes|plasma substitutes|mesh-ancestor
65444843|NCT00316004|Blood Substitutes|blood substitutes|mesh-ancestor
65444844|NCT01066832|Paclitaxel|paclitaxel|mesh-list
65444845|NCT01066832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65444846|NCT01066832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444847|NCT01066832|Tubulin Modulators|tubulin modulators|mesh-ancestor
65444848|NCT01066832|Antimitotic Agents|antimitotic agents|mesh-ancestor
65444849|NCT01066832|Mitosis Modulators|mitosis modulators|mesh-ancestor
65444850|NCT01066832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444851|NCT00298766|Bortezomib|bortezomib|mesh-list
65444852|NCT00298766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444853|NCT03979664|Dexamethasone|dexamethasone|mesh-list
65444854|NCT03979664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65444855|NCT03979664|Antiemetics|antiemetics|mesh-ancestor
65444856|NCT03979664|Autonomic Agents|autonomic agents|mesh-ancestor
65444857|NCT03979664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65444858|NCT03979664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444859|NCT03979664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65444860|NCT03979664|Glucocorticoids|glucocorticoids|mesh-ancestor
65444861|NCT03979664|Hormones|hormones|mesh-ancestor
65444862|NCT03979664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65444863|NCT03979664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65444864|NCT03979664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444865|NCT01325558|Gemcitabine|gemcitabine|mesh-list
65444866|NCT01325558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65444867|NCT01325558|Antimetabolites|antimetabolites|mesh-ancestor
65444868|NCT01325558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444869|NCT01325558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444870|NCT01325558|Antiviral Agents|antiviral agents|mesh-ancestor
65444888|NCT01065662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65444889|NCT01065662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65444890|NCT01065662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444891|NCT01065662|Antifungal Agents|antifungal agents|mesh-ancestor
65444892|NCT01065662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65444893|NCT01065662|Immunologic Factors|immunologic factors|mesh-ancestor
65444894|NCT01065662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444895|NCT01065662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65444896|NCT01065662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444897|NCT01065662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444898|NCT01581242|Adefovir|adefovir|mesh-list
65444899|NCT01581242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65444900|NCT01581242|Clevudine|clevudine|mesh-list
65444901|NCT01581242|Antiviral Agents|antiviral agents|mesh-ancestor
65444902|NCT01581242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65444903|NCT01581242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65444904|NCT01581242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65444905|NCT01581242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444906|NCT01581242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444907|NCT03982238|Metformin|metformin|mesh-list
65444908|NCT03982238|Dapagliflozin|dapagliflozin|mesh-list
65444909|NCT03982238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65444910|NCT03982238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444911|NCT03982238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65444912|NCT03982238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444913|NCT00293384|Dexamethasone|dexamethasone|mesh-list
65444914|NCT00293384|Dexamethasone acetate|dexamethasone acetate|mesh-list
65444915|NCT00293384|Cyclophosphamide|cyclophosphamide|mesh-list
65444916|NCT00293384|Aprepitant|aprepitant|mesh-list
65444917|NCT00293384|Granisetron|granisetron|mesh-list
65444918|NCT00293384|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65444919|NCT00293384|BB 1101|bb 1101|mesh-list
65444920|NCT00293384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65444921|NCT00293384|Immunologic Factors|immunologic factors|mesh-ancestor
65444922|NCT00293384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444923|NCT00293384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65444924|NCT00293384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65444925|NCT00293384|Alkylating Agents|alkylating agents|mesh-ancestor
65444926|NCT00293384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444927|NCT00293384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444928|NCT00293384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65444929|NCT00293384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65444930|NCT00293384|Antiemetics|antiemetics|mesh-ancestor
65444946|NCT00297830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65444947|NCT00297830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444949|NCT00296816|Docetaxel|docetaxel|mesh-list
65444950|NCT00296816|Oxaliplatin|oxaliplatin|mesh-list
65444951|NCT00296816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65444952|NCT00296816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444953|NCT00296816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65444954|NCT00296816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65444955|NCT00296816|Growth Substances|growth substances|mesh-ancestor
65444956|NCT00296816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444957|NCT00296816|Growth Inhibitors|growth inhibitors|mesh-ancestor
65444958|NCT00296816|Tubulin Modulators|tubulin modulators|mesh-ancestor
65444959|NCT00296816|Antimitotic Agents|antimitotic agents|mesh-ancestor
65444960|NCT00296816|Mitosis Modulators|mitosis modulators|mesh-ancestor
65194484|NCT00643240|Antibodies|antibodies|mesh-list
65444961|NCT00296816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444963|NCT01066988|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65444964|NCT01066988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65444965|NCT01066988|Dermatologic Agents|dermatologic agents|mesh-ancestor
65444966|NCT00097786|Nateglinide|nateglinide|mesh-list
65444967|NCT00097786|Valsartan|valsartan|mesh-list
65444968|NCT00097786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65444969|NCT00097786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65444970|NCT00097786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65444971|NCT00097786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444972|NCT00097786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65444973|NCT00097786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444974|NCT01081756|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65444975|NCT01081756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65444976|NCT01081756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444977|NCT01081990|Cyclobenzaprine|cyclobenzaprine|mesh-list
65444978|NCT01081990|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65444979|NCT01081990|Antidepressive Agents|antidepressive agents|mesh-ancestor
65444980|NCT01081990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65444981|NCT01081990|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65444982|NCT01081990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444983|NCT01081990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65444984|NCT01081990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65444985|NCT01081990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65444986|NCT01081990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65444987|NCT01084486|Metformin|metformin|mesh-list
65444988|NCT01084486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65444989|NCT01084486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444995|NCT01082146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65444996|NCT01082146|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65444997|NCT01082146|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65444998|NCT01082146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65444999|NCT01082146|Adrenergic Agents|adrenergic agents|mesh-ancestor
65445000|NCT01082146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65445001|NCT01082146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445002|NCT01082146|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65445003|NCT01082146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65445004|NCT01082146|Serotonin Agents|serotonin agents|mesh-ancestor
65445005|NCT01082146|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65445006|NCT01082146|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65445007|NCT01082146|Dopamine Agents|dopamine agents|mesh-ancestor
65445008|NCT01084720|V0034CR|v0034cr|mesh-list
65445009|NCT01084720|Emollients|emollients|mesh-ancestor
65445010|NCT01084720|Dermatologic Agents|dermatologic agents|mesh-ancestor
65445011|NCT03963466|Tranexamic Acid|tranexamic acid|mesh-list
65445012|NCT03963466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65445013|NCT03963466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65445014|NCT03963466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445015|NCT03963466|Hemostatics|hemostatics|mesh-ancestor
65445016|NCT03963466|Coagulants|coagulants|mesh-ancestor
65445017|NCT01082224|Motexafin gadolinium|motexafin gadolinium|mesh-list
65445018|NCT01082224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445019|NCT01082224|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65445020|NCT01082224|Dermatologic Agents|dermatologic agents|mesh-ancestor
65445021|NCT01084876|Paclitaxel|paclitaxel|mesh-list
65445022|NCT01084876|Trastuzumab|trastuzumab|mesh-list
65445023|NCT01084876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65009637|NCT00132821|Bupropion|bupropion|mesh-list
65445024|NCT01084876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445025|NCT01084876|Tubulin Modulators|tubulin modulators|mesh-ancestor
65445026|NCT01084876|Antimitotic Agents|antimitotic agents|mesh-ancestor
65445027|NCT01084876|Mitosis Modulators|mitosis modulators|mesh-ancestor
65445028|NCT01084876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445029|NCT01084876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65445030|NCT00117676|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65445031|NCT00117676|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65445032|NCT00117676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65445033|NCT00117676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65445034|NCT00117676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445035|NCT00117676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445037|NCT00117676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65445038|NCT00117676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65445039|NCT00117676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65445040|NCT00251004|Cyclosporine|cyclosporine|mesh-list
65445041|NCT00251004|Mycophenolic Acid|mycophenolic acid|mesh-list
65445042|NCT00251004|Everolimus|everolimus|mesh-list
65445043|NCT00251004|Cyclosporins|cyclosporins|mesh-list
65445044|NCT00251004|Basiliximab|basiliximab|mesh-list
65445045|NCT00251004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445046|NCT00251004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445047|NCT00251004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65445048|NCT00251004|Immunologic Factors|immunologic factors|mesh-ancestor
65445049|NCT00251004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445050|NCT00251004|Antifungal Agents|antifungal agents|mesh-ancestor
65445051|NCT00251004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65445052|NCT00251004|Dermatologic Agents|dermatologic agents|mesh-ancestor
65445053|NCT00251004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65445054|NCT00251004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65445055|NCT00251004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445056|NCT00251004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65445057|NCT00251004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65445058|NCT00251004|Antitubercular Agents|antitubercular agents|mesh-ancestor
65445059|NCT00251004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65445069|NCT00275028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445070|NCT00275028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445071|NCT00275028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65445073|NCT00471497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445074|NCT00471497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65445075|NCT00471497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445076|NCT00471497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445077|NCT04357457|Almitrine|almitrine|mesh-list
65445078|NCT04357457|Respiratory System Agents|respiratory system agents|mesh-ancestor
65445079|NCT00493649|Cyclophosphamide|cyclophosphamide|mesh-list
65445080|NCT00493649|Docetaxel|docetaxel|mesh-list
65445081|NCT00493649|Trastuzumab|trastuzumab|mesh-list
65445082|NCT00493649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65445083|NCT00493649|Immunologic Factors|immunologic factors|mesh-ancestor
65445084|NCT00493649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445085|NCT00493649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65445086|NCT00493649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65445087|NCT00493649|Alkylating Agents|alkylating agents|mesh-ancestor
65445088|NCT00493649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445089|NCT00493649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445090|NCT00493649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65445091|NCT00493649|Tubulin Modulators|tubulin modulators|mesh-ancestor
65445092|NCT00493649|Antimitotic Agents|antimitotic agents|mesh-ancestor
65445093|NCT00493649|Mitosis Modulators|mitosis modulators|mesh-ancestor
65445094|NCT00493649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65445095|NCT01021163|Acetylcysteine|acetylcysteine|mesh-list
65445096|NCT01021163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65445097|NCT01021163|Antiviral Agents|antiviral agents|mesh-ancestor
65445098|NCT01021163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65445099|NCT01021163|Expectorants|expectorants|mesh-ancestor
65445100|NCT01021163|Respiratory System Agents|respiratory system agents|mesh-ancestor
65445101|NCT01021163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65445102|NCT01021163|Antioxidants|antioxidants|mesh-ancestor
65445103|NCT01021163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445104|NCT01021163|Protective Agents|protective agents|mesh-ancestor
65445105|NCT01021163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445106|NCT01021163|Antidotes|antidotes|mesh-ancestor
65445107|NCT01022333|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
65445108|NCT01022333|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65445109|NCT01022333|Protective Agents|protective agents|mesh-ancestor
65445110|NCT01022333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445111|NCT01022333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445112|NCT00117598|Sirolimus|sirolimus|mesh-list
65445113|NCT00117598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65445114|NCT00117598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65445115|NCT00117598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65445116|NCT00117598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445117|NCT00117598|Antifungal Agents|antifungal agents|mesh-ancestor
65445118|NCT00117598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65445119|NCT00117598|Immunologic Factors|immunologic factors|mesh-ancestor
65445120|NCT00117598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445121|NCT01082458|Lidocaine|lidocaine|mesh-list
65445122|NCT01082458|Remifentanil|remifentanil|mesh-list
65445123|NCT01082458|Anesthetics, Local|anesthetics, local|mesh-ancestor
65445124|NCT01082458|Anesthetics|anesthetics|mesh-ancestor
65445125|NCT01082458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65445126|NCT01082458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445149|NCT00469859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65445150|NCT00469859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65445151|NCT00469859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445152|NCT01021475|Domperidone|domperidone|mesh-list
65445153|NCT01021475|Antiemetics|antiemetics|mesh-ancestor
65445154|NCT01021475|Autonomic Agents|autonomic agents|mesh-ancestor
65445155|NCT01021475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65445156|NCT01021475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445157|NCT01021475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65445158|NCT01021475|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65445159|NCT01021475|Dopamine Agents|dopamine agents|mesh-ancestor
65445160|NCT01021475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65445161|NCT01021475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445162|NCT01085032|Nicotine|nicotine|mesh-list
65445163|NCT01085032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65445164|NCT01085032|Autonomic Agents|autonomic agents|mesh-ancestor
65445165|NCT01085032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65445166|NCT01085032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445167|NCT01085032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65445168|NCT01085032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65445169|NCT01085032|Cholinergic Agents|cholinergic agents|mesh-ancestor
65445170|NCT01085032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65445171|NCT01085032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445172|NCT01021787|Titanium dioxide|titanium dioxide|mesh-list
65445173|NCT01021787|Sunscreening Agents|sunscreening agents|mesh-ancestor
65445174|NCT01021787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65445175|NCT01021787|Protective Agents|protective agents|mesh-ancestor
65445176|NCT01021787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445177|NCT01021787|Dermatologic Agents|dermatologic agents|mesh-ancestor
64829867|NCT01570569|Purinergic Agents|purinergic agents|mesh-ancestor
65445199|NCT00469079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65445200|NCT00469079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445201|NCT01326754|Artesunate|artesunate|mesh-list
65445202|NCT01326754|Lumefantrine|lumefantrine|mesh-list
65445203|NCT01326754|Artemether|artemether|mesh-list
65445204|NCT01326754|Piperaquine|piperaquine|mesh-list
65445205|NCT01326754|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65445206|NCT01326754|Amodiaquine|amodiaquine|mesh-list
65445207|NCT01326754|Artenimol|artenimol|mesh-list
65445208|NCT01326754|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
65445209|NCT01326754|Antimalarials|antimalarials|mesh-ancestor
65445210|NCT01326754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65445211|NCT01326754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65445212|NCT01326754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65445213|NCT01326754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445214|NCT01326754|Antiviral Agents|antiviral agents|mesh-ancestor
65445215|NCT01326754|Schistosomicides|schistosomicides|mesh-ancestor
65445216|NCT01326754|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65445217|NCT01326754|Anthelmintics|anthelmintics|mesh-ancestor
65445218|NCT00093496|Gemcitabine|gemcitabine|mesh-list
65445219|NCT00093496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65445220|NCT00093496|Antimetabolites|antimetabolites|mesh-ancestor
65445221|NCT00093496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445222|NCT00093496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445223|NCT00093496|Antiviral Agents|antiviral agents|mesh-ancestor
65445224|NCT00093496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65445225|NCT00093496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445226|NCT00093496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65445227|NCT00093496|Immunologic Factors|immunologic factors|mesh-ancestor
65445228|NCT00093496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445229|NCT00265122|Ustekinumab|ustekinumab|mesh-list
65445230|NCT00265122|Dermatologic Agents|dermatologic agents|mesh-ancestor
65445231|NCT00096538|Valganciclovir|valganciclovir|mesh-list
65445232|NCT00096538|Antiviral Agents|antiviral agents|mesh-ancestor
65445233|NCT00096538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65445245|NCT00468845|Pregabalin|pregabalin|mesh-list
65445246|NCT00468845|Analgesics|analgesics|mesh-ancestor
65445247|NCT00468845|Sensory System Agents|sensory system agents|mesh-ancestor
65445248|NCT00468845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65445249|NCT00468845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445250|NCT00468845|Anticonvulsants|anticonvulsants|mesh-ancestor
65445251|NCT00468845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65445252|NCT00468845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65445253|NCT00468845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445254|NCT00468845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65445255|NCT00468845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65445256|NCT00468845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65445257|NCT00468845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65445258|NCT00468845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65445259|NCT00468299|Misoprostol|misoprostol|mesh-list
65445260|NCT00468299|Mifepristone|mifepristone|mesh-list
65445261|NCT00468299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65445262|NCT00468299|Abortifacient Agents|abortifacient agents|mesh-ancestor
65445263|NCT00468299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65445264|NCT00468299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445265|NCT00468299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65445266|NCT00468299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65445267|NCT00468299|Oxytocics|oxytocics|mesh-ancestor
65445268|NCT00468299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65445269|NCT00468299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65445270|NCT00468299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65445271|NCT00468299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65445272|NCT00468299|Contraceptive Agents|contraceptive agents|mesh-ancestor
65445273|NCT00468299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65445274|NCT00468299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65445275|NCT00468299|Hormone Antagonists|hormone antagonists|mesh-ancestor
65445276|NCT00468299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65445277|NCT00468299|Luteolytic Agents|luteolytic agents|mesh-ancestor
65445278|NCT00468299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65445279|NCT00468299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65445280|NCT01021865|Glucagon|glucagon|mesh-list
65445281|NCT01021865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65445282|NCT01021865|Regadenoson|regadenoson|mesh-list
65445283|NCT01021865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65445284|NCT01021865|Hormones|hormones|mesh-ancestor
65445285|NCT01021865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65445286|NCT01021865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445287|NCT01021865|Incretins|incretins|mesh-ancestor
65445288|NCT01021865|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65445289|NCT01021865|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65445290|NCT01021865|Purinergic Agonists|purinergic agonists|mesh-ancestor
65445291|NCT01021865|Purinergic Agents|purinergic agents|mesh-ancestor
65445292|NCT01021865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65445293|NCT01021865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445294|NCT00468143|Adderall|adderall|mesh-list
65445295|NCT00468143|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65445306|NCT00467831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65445307|NCT00467831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65445308|NCT00467831|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65445309|NCT00467831|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65445310|NCT00467831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445312|NCT00467831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65445313|NCT00467831|Expectorants|expectorants|mesh-ancestor
65445314|NCT00467831|Respiratory System Agents|respiratory system agents|mesh-ancestor
65445315|NCT00467831|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65445316|NCT00467831|Antioxidants|antioxidants|mesh-ancestor
65445317|NCT00467831|Protective Agents|protective agents|mesh-ancestor
65445318|NCT00467831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445319|NCT00467831|Antidotes|antidotes|mesh-ancestor
65445320|NCT00467831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65445321|NCT00467831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65445322|NCT00467831|Antimetabolites|antimetabolites|mesh-ancestor
65445323|NCT00467831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65445324|NCT00467831|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65445325|NCT00467831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445326|NCT00467831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65445327|NCT00467831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65445328|NCT00467831|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65445329|NCT00467831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65445330|NCT00467831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65445331|NCT00467831|Analgesics|analgesics|mesh-ancestor
65445332|NCT00467831|Sensory System Agents|sensory system agents|mesh-ancestor
65445333|NCT00467831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65445334|NCT00467831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65445335|NCT00467831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65194863|NCT00910390|Ethylene|ethylene|mesh-list
65445336|NCT00467831|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65445337|NCT00467831|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65445338|NCT00467831|Hormone Antagonists|hormone antagonists|mesh-ancestor
65445339|NCT00467831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65445340|NCT00467753|Oxcarbazepine|oxcarbazepine|mesh-list
65445341|NCT00467753|Anticonvulsants|anticonvulsants|mesh-ancestor
65445342|NCT00467753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65445343|NCT00467753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65445344|NCT00467753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65445345|NCT00467753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445346|NCT00467753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65445347|NCT00467753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65445348|NCT01021943|Spironolactone|spironolactone|mesh-list
65445349|NCT01021943|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65445350|NCT01021943|Hormone Antagonists|hormone antagonists|mesh-ancestor
65445351|NCT01021943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65445352|NCT01021943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445353|NCT01021943|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65445354|NCT01021943|Diuretics|diuretics|mesh-ancestor
65445355|NCT01021943|Natriuretic Agents|natriuretic agents|mesh-ancestor
65445356|NCT00116272|Etanercept|etanercept|mesh-list
65445357|NCT00116272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65445358|NCT00116272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65445359|NCT00116272|Analgesics|analgesics|mesh-ancestor
65445373|NCT01022021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445375|NCT01022021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65445376|NCT01022021|Alkylating Agents|alkylating agents|mesh-ancestor
65445377|NCT01022021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445378|NCT00467597|Levodopa|levodopa|mesh-list
65445379|NCT00467597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65445380|NCT00467597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65445381|NCT00467597|Dopamine Agents|dopamine agents|mesh-ancestor
65445382|NCT00467597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65445383|NCT00467597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445384|NCT00467597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445385|NCT00115804|Fluoxetine|fluoxetine|mesh-list
65445386|NCT00115804|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65445387|NCT00115804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65445388|NCT00115804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65445389|NCT00115804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445390|NCT00115804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65445391|NCT00115804|Serotonin Agents|serotonin agents|mesh-ancestor
65445392|NCT00115804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445393|NCT00115804|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65445394|NCT00115804|Antidepressive Agents|antidepressive agents|mesh-ancestor
65445395|NCT00115804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65445396|NCT00115804|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65445397|NCT00115804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65445398|NCT00115804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445399|NCT00467363|Aspirin|aspirin|mesh-list
65445400|NCT00467363|Folic Acid|folic acid|mesh-list
65445401|NCT00467363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65445402|NCT00467363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65445403|NCT00467363|Analgesics|analgesics|mesh-ancestor
65445404|NCT00467363|Sensory System Agents|sensory system agents|mesh-ancestor
65445405|NCT00467363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65445406|NCT00467363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270060|NCT02129348|Lithium Carbonate|lithium carbonate|mesh-list
65270061|NCT02129348|Antidepressive Agents|antidepressive agents|mesh-ancestor
65445407|NCT00467363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65194937|NCT04064476|Serotonin Agents|serotonin agents|mesh-ancestor
65445408|NCT00467363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65445409|NCT00467363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65445410|NCT00467363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65445411|NCT00467363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445412|NCT00467363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65445413|NCT00467363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65445414|NCT00467363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445415|NCT00467363|Antipyretics|antipyretics|mesh-ancestor
65445416|NCT00467363|Hematinics|hematinics|mesh-ancestor
65445417|NCT00467363|Vitamin B Complex|vitamin b complex|mesh-ancestor
65445418|NCT00467363|Vitamins|vitamins|mesh-ancestor
65445428|NCT00466505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445429|NCT00466505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65445430|NCT00466505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65445431|NCT00466505|Analgesics|analgesics|mesh-ancestor
65445432|NCT00466505|Sensory System Agents|sensory system agents|mesh-ancestor
65445433|NCT00466505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65445434|NCT00466505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445435|NCT00466505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65445436|NCT00466505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65445437|NCT00466505|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65445438|NCT00466505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65445439|NCT00466505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445440|NCT00466505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445441|NCT02531568|Warfarin|warfarin|mesh-list
65445442|NCT02531568|Anticoagulants|anticoagulants|mesh-ancestor
65445443|NCT00467051|Paclitaxel|paclitaxel|mesh-list
65445444|NCT00467051|Carboplatin|carboplatin|mesh-list
65445445|NCT00467051|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65445446|NCT00467051|Ifosfamide|ifosfamide|mesh-list
65445447|NCT00467051|Isophosphamide mustard|isophosphamide mustard|mesh-list
65445448|NCT00467051|Lenograstim|lenograstim|mesh-list
65445449|NCT00467051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65445450|NCT00467051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445451|NCT00467051|Tubulin Modulators|tubulin modulators|mesh-ancestor
65445452|NCT00467051|Antimitotic Agents|antimitotic agents|mesh-ancestor
65445453|NCT00467051|Mitosis Modulators|mitosis modulators|mesh-ancestor
65445454|NCT00467051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445455|NCT00467051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65445456|NCT00467051|Immunologic Factors|immunologic factors|mesh-ancestor
65445457|NCT00467051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445458|NCT00467051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65445459|NCT00467051|Alkylating Agents|alkylating agents|mesh-ancestor
65445460|NCT00264498|Gemcitabine|gemcitabine|mesh-list
65445461|NCT00264498|Carboplatin|carboplatin|mesh-list
65445462|NCT00264498|Gefitinib|gefitinib|mesh-list
65445463|NCT00264498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445464|NCT00264498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65445465|NCT00264498|Antimetabolites|antimetabolites|mesh-ancestor
65445466|NCT00264498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445467|NCT00264498|Antiviral Agents|antiviral agents|mesh-ancestor
65445468|NCT00264498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65445469|NCT00264498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445470|NCT00264498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65445471|NCT00264498|Immunologic Factors|immunologic factors|mesh-ancestor
65445472|NCT00264498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445473|NCT00264498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65445474|NCT00466193|Zolpidem|zolpidem|mesh-list
65445475|NCT00466193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65445476|NCT00466193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65445477|NCT00466193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65445478|NCT00466193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445479|NCT00466193|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65445480|NCT00466193|GABA Agonists|gaba agonists|mesh-ancestor
65445481|NCT00466193|GABA Agents|gaba agents|mesh-ancestor
65445482|NCT00466193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65445483|NCT00466193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445484|NCT01072578|Dapagliflozin|dapagliflozin|mesh-list
65445485|NCT01072578|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65445486|NCT01072578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270062|NCT02129348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65445497|NCT03970668|Incretins|incretins|mesh-ancestor
65445498|NCT03970668|Hormones|hormones|mesh-ancestor
65445499|NCT03970668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65445500|NCT03970668|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65445501|NCT03970668|Protease Inhibitors|protease inhibitors|mesh-ancestor
65445502|NCT03970668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445503|NCT03970668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445504|NCT00454181|Interferons|interferons|mesh-list
65445505|NCT00454181|Interferon-alpha|interferon-alpha|mesh-list
65445506|NCT00454181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445507|NCT00454181|Antiviral Agents|antiviral agents|mesh-ancestor
65445508|NCT00454181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65445509|NCT00454181|Immunologic Factors|immunologic factors|mesh-ancestor
65445510|NCT00454181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445511|NCT01073826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65445512|NCT01073826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65445513|NCT01073826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445514|NCT01073826|Incretins|incretins|mesh-ancestor
65445515|NCT01073826|Hormones|hormones|mesh-ancestor
65445516|NCT01073826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65445517|NCT01073826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65445518|NCT01073826|Protease Inhibitors|protease inhibitors|mesh-ancestor
65445519|NCT01073826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445520|NCT01073826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445521|NCT01072812|Phenserine|phenserine|mesh-list
65445522|NCT01072812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65445523|NCT01072812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445524|NCT01072812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445525|NCT01072812|Cholinergic Agents|cholinergic agents|mesh-ancestor
65445526|NCT01072812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65445527|NCT01072812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445528|NCT00237042|Levonorgestrel|levonorgestrel|mesh-list
65445529|NCT00237042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65445530|NCT00237042|Estradiol|estradiol|mesh-list
65445531|NCT00237042|Estrogens|estrogens|mesh-ancestor
65445532|NCT00237042|Hormones|hormones|mesh-ancestor
65445533|NCT00237042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65445534|NCT00237042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445535|NCT00237042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65445536|NCT00237042|Contraceptive Agents|contraceptive agents|mesh-ancestor
65445537|NCT00237042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65445538|NCT00237042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65445539|NCT00237042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65445540|NCT00237042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65445541|NCT00237042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65445542|NCT00465647|Hydromorphone|hydromorphone|mesh-list
65445543|NCT00465647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65445544|NCT00465647|Narcotics|narcotics|mesh-ancestor
65445545|NCT00465647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65445546|NCT00465647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445547|NCT00465647|Analgesics|analgesics|mesh-ancestor
65445548|NCT00465647|Sensory System Agents|sensory system agents|mesh-ancestor
65445549|NCT00465647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65445550|NCT00090766|Valganciclovir|valganciclovir|mesh-list
65445551|NCT00090766|Antiviral Agents|antiviral agents|mesh-ancestor
65445552|NCT00090766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65445553|NCT03961828|Sofosbuvir|sofosbuvir|mesh-list
64830232|NCT01572285|Glucocorticoids|glucocorticoids|mesh-ancestor
65445560|NCT00465179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65445561|NCT00465179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65445562|NCT00465179|Growth Substances|growth substances|mesh-ancestor
65445563|NCT00465179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445564|NCT00465179|Growth Inhibitors|growth inhibitors|mesh-ancestor
65445565|NCT00465179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65445566|NCT00465179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445567|NCT00465179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445569|NCT00084136|Lamivudine|lamivudine|mesh-list
65445570|NCT00084136|Zidovudine|zidovudine|mesh-list
65445571|NCT00084136|Emtricitabine|emtricitabine|mesh-list
65445572|NCT00084136|Efavirenz|efavirenz|mesh-list
65445573|NCT00084136|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65445574|NCT00084136|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65445575|NCT00084136|Didanosine|didanosine|mesh-list
65445576|NCT00084136|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
65445577|NCT00084136|Antiviral Agents|antiviral agents|mesh-ancestor
65445578|NCT00084136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65445579|NCT00084136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65445580|NCT00084136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65445581|NCT00084136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445582|NCT00084136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445583|NCT00084136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65445584|NCT00084136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65445585|NCT00084136|Antimetabolites|antimetabolites|mesh-ancestor
65445586|NCT00084136|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65445587|NCT00084136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65445588|NCT00084136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65445589|NCT00084136|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65445590|NCT00084136|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65445591|NCT00084136|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65445592|NCT00084136|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65445593|NCT00084136|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65445594|NCT00084136|Protease Inhibitors|protease inhibitors|mesh-ancestor
65445595|NCT03812380|Magnesium citrate|magnesium citrate|mesh-list
65445596|NCT03812380|Cathartics|cathartics|mesh-ancestor
65445597|NCT03812380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65445598|NCT01085422|Temozolomide|temozolomide|mesh-list
65445599|NCT01085422|Veliparib|veliparib|mesh-list
65445600|NCT01085422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65445601|NCT01085422|Alkylating Agents|alkylating agents|mesh-ancestor
65445602|NCT01085422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445603|NCT01085422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445604|NCT01085422|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65445605|NCT01085422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445606|NCT01085656|Combretastatin|combretastatin|mesh-list
65445607|NCT01085656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65445608|NCT01085656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445609|NCT01085656|Tubulin Modulators|tubulin modulators|mesh-ancestor
65445610|NCT01085656|Antimitotic Agents|antimitotic agents|mesh-ancestor
65445611|NCT01085656|Mitosis Modulators|mitosis modulators|mesh-ancestor
65445612|NCT01085656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445613|NCT01087138|Calcium|calcium|mesh-list
65445614|NCT01087138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65445615|NCT01087138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445616|NCT00464945|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65445617|NCT00464945|Immunologic Factors|immunologic factors|mesh-ancestor
65445618|NCT00464945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445619|NCT00464087|Heparin|heparin|mesh-list
65445620|NCT00464087|Calcium heparin|calcium heparin|mesh-list
65445621|NCT00464087|PENTA|penta|mesh-list
65445622|NCT00464087|Bivalirudin|bivalirudin|mesh-list
65445623|NCT00464087|Fondaparinux|fondaparinux|mesh-list
65445648|NCT00452699|Adrenergic Agents|adrenergic agents|mesh-ancestor
65445649|NCT00452699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65445650|NCT00452699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445651|NCT00069784|Insulin|insulin|mesh-list
65445652|NCT00069784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65445653|NCT00069784|Insulin Glargine|insulin glargine|mesh-list
65445654|NCT00069784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65445655|NCT00069784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445656|NCT00090610|Carboplatin|carboplatin|mesh-list
65445657|NCT00090610|Docetaxel|docetaxel|mesh-list
65445658|NCT00090610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445659|NCT00090610|Tubulin Modulators|tubulin modulators|mesh-ancestor
65445660|NCT00090610|Antimitotic Agents|antimitotic agents|mesh-ancestor
65445661|NCT00090610|Mitosis Modulators|mitosis modulators|mesh-ancestor
65445662|NCT00090610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445663|NCT01326988|Anesthetics|anesthetics|mesh-list
65445664|NCT01326988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65445665|NCT01326988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445666|NCT03962296|Calcium Dobesilate|calcium dobesilate|mesh-list
65445667|NCT03962296|Calcium|calcium|mesh-list
65445668|NCT03962296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65445669|NCT03962296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445670|NCT03962296|Hemostatics|hemostatics|mesh-ancestor
65445671|NCT03962296|Coagulants|coagulants|mesh-ancestor
65445672|NCT01086046|Heparin|heparin|mesh-list
65445673|NCT01086046|Enoxaparin|enoxaparin|mesh-list
65445674|NCT01086046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65445675|NCT01086046|Tinzaparin|tinzaparin|mesh-list
65270063|NCT02129348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445676|NCT01086046|Dalteparin|dalteparin|mesh-list
65445692|NCT03741244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445694|NCT03741244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65445695|NCT03741244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445696|NCT00463385|Thalidomide|thalidomide|mesh-list
65445697|NCT00463385|Prednisone|prednisone|mesh-list
65445698|NCT00463385|Pomalidomide|pomalidomide|mesh-list
65445699|NCT00463385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65445700|NCT00463385|Glucocorticoids|glucocorticoids|mesh-ancestor
65445701|NCT00463385|Hormones|hormones|mesh-ancestor
65445702|NCT00463385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65445703|NCT00463385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445704|NCT00463385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65445705|NCT00463385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445706|NCT00463385|Immunologic Factors|immunologic factors|mesh-ancestor
65445707|NCT00463385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65445708|NCT00463385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65445709|NCT00463385|Growth Substances|growth substances|mesh-ancestor
65445710|NCT00463385|Growth Inhibitors|growth inhibitors|mesh-ancestor
65445711|NCT00463385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65445712|NCT00463385|Leprostatic Agents|leprostatic agents|mesh-ancestor
65445713|NCT00463385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65445714|NCT00463385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65445715|NCT03839693|Botulinum Toxins|botulinum toxins|mesh-list
65445716|NCT03839693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65445717|NCT03839693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65445718|NCT03839693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65445719|NCT03839693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65445720|NCT03839693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445721|NCT03839693|Cholinergic Agents|cholinergic agents|mesh-ancestor
65445722|NCT03839693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65445723|NCT03839693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445724|NCT03839693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65445725|NCT03839693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65445726|NCT00068692|Leucovorin|leucovorin|mesh-list
65445727|NCT00068692|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
65445728|NCT00068692|Tetrahydrofolates|tetrahydrofolates|mesh-list
65445729|NCT00068692|Fluorouracil|fluorouracil|mesh-list
65445730|NCT00068692|Oxaliplatin|oxaliplatin|mesh-list
65445731|NCT00068692|Irinotecan|irinotecan|mesh-list
65445732|NCT00068692|Camptothecin|camptothecin|mesh-list
65445733|NCT00068692|Levoleucovorin|levoleucovorin|mesh-list
65445734|NCT00068692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445735|NCT00068692|Antimetabolites|antimetabolites|mesh-ancestor
64830424|NCT01573377|Metformin|metformin|mesh-list
65445739|NCT00068692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65445740|NCT00068692|Immunologic Factors|immunologic factors|mesh-ancestor
65445741|NCT00068692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65445742|NCT00068692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65445743|NCT00068692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445744|NCT00068692|Antidotes|antidotes|mesh-ancestor
65445745|NCT00068692|Protective Agents|protective agents|mesh-ancestor
65445746|NCT00068692|Vitamin B Complex|vitamin b complex|mesh-ancestor
65445747|NCT00068692|Vitamins|vitamins|mesh-ancestor
65445748|NCT00068692|Micronutrients|micronutrients|mesh-ancestor
65445749|NCT00068692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65445750|NCT00463151|Rebamipide|rebamipide|mesh-list
65445751|NCT00463151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65445752|NCT00463151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65445753|NCT00463151|Antioxidants|antioxidants|mesh-ancestor
65445754|NCT00463151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445755|NCT00463151|Protective Agents|protective agents|mesh-ancestor
65445756|NCT00463151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445757|NCT00463151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445758|NCT00068380|Imatinib Mesylate|imatinib mesylate|mesh-list
65445759|NCT00068380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445760|NCT00068380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65445761|NCT00068380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445762|NCT00068380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445763|NCT00067990|Losartan|losartan|mesh-list
65445764|NCT00067990|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65445765|NCT00067990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65445766|NCT00067990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65445767|NCT00067990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65445768|NCT00067990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010240|NCT00152490|Certolizumab Pegol|certolizumab pegol|mesh-list
65445769|NCT00263328|Tacrolimus|tacrolimus|mesh-list
65445770|NCT00263328|Tofacitinib|tofacitinib|mesh-list
65445771|NCT00263328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65445772|NCT00263328|Immunologic Factors|immunologic factors|mesh-ancestor
65445773|NCT00263328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445774|NCT00263328|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65445775|NCT00263328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445776|NCT00263328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445777|NCT00263328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65445778|NCT03741660|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
65445779|NCT03741660|Cathartics|cathartics|mesh-ancestor
65445780|NCT03741660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65445781|NCT00262860|Gemcitabine|gemcitabine|mesh-list
65445782|NCT00262860|Bortezomib|bortezomib|mesh-list
65445783|NCT00262860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65445784|NCT00262860|Antimetabolites|antimetabolites|mesh-ancestor
65445785|NCT00262860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445786|NCT00262860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65195304|NCT02662894|Valsartan|valsartan|mesh-list
65445787|NCT00262860|Antiviral Agents|antiviral agents|mesh-ancestor
65445788|NCT00262860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65445789|NCT00262860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445790|NCT00262860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65445791|NCT00262860|Immunologic Factors|immunologic factors|mesh-ancestor
65445792|NCT00262860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445793|NCT00236184|Rabeprazole|rabeprazole|mesh-list
65445794|NCT00236184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65445795|NCT00236184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65445796|NCT00236184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65445797|NCT00236184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445798|NCT00236184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445799|NCT00296504|Ritonavir|ritonavir|mesh-list
65445800|NCT00296504|Fosamprenavir|fosamprenavir|mesh-list
65445801|NCT00296504|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65445802|NCT00296504|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65445803|NCT00296504|Protease Inhibitors|protease inhibitors|mesh-ancestor
65445804|NCT00296504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445805|NCT00296504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445806|NCT00296504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65445824|NCT00313820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65445825|NCT00313820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65445826|NCT00235872|Adalimumab|adalimumab|mesh-list
65445827|NCT00235872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65445828|NCT00235872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65445829|NCT00461981|Vaccines|vaccines|mesh-list
65445830|NCT00461981|Immunologic Factors|immunologic factors|mesh-ancestor
65445831|NCT00461981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445832|NCT00296036|Pyridoxine|pyridoxine|mesh-list
65445833|NCT00296036|Vitamin B 6|vitamin b 6|mesh-list
65445834|NCT00296036|Vitamin B Complex|vitamin b complex|mesh-ancestor
65445835|NCT00296036|Vitamins|vitamins|mesh-ancestor
65445836|NCT00296036|Micronutrients|micronutrients|mesh-ancestor
65445837|NCT00296036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445838|NCT01072890|Sirolimus|sirolimus|mesh-list
65445839|NCT01072890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65445840|NCT01072890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65445841|NCT01072890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65445842|NCT01072890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445843|NCT01072890|Antifungal Agents|antifungal agents|mesh-ancestor
65445844|NCT01072890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65445845|NCT01072890|Immunologic Factors|immunologic factors|mesh-ancestor
65445846|NCT01072890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445847|NCT00089674|Denosumab|denosumab|mesh-list
65445848|NCT00089674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65445849|NCT00089674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445850|NCT01090882|Bupivacaine|bupivacaine|mesh-list
65445851|NCT01090882|Anesthetics, Local|anesthetics, local|mesh-ancestor
65445852|NCT01090882|Anesthetics|anesthetics|mesh-ancestor
65445853|NCT01090882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65445854|NCT01090882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445855|NCT01090882|Sensory System Agents|sensory system agents|mesh-ancestor
65445856|NCT01090882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65445857|NCT01067066|Temozolomide|temozolomide|mesh-list
65445858|NCT01067066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65445859|NCT01067066|Alkylating Agents|alkylating agents|mesh-ancestor
65445860|NCT01067066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010310|NCT00135122|Autonomic Agents|autonomic agents|mesh-ancestor
65445861|NCT01067066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445862|NCT00313586|Azacitidine|azacitidine|mesh-list
65445863|NCT00313586|Entinostat|entinostat|mesh-list
64830546|NCT01574313|alpha-Tocopherol|alpha-tocopherol|mesh-list
65445890|NCT01067222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445891|NCT01067222|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65445892|NCT01067222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65445893|NCT01067222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65445894|NCT01067222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445896|NCT00312572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65445897|NCT00312572|Narcotics|narcotics|mesh-ancestor
65445898|NCT00312572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65445899|NCT00312572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445900|NCT00312572|Analgesics|analgesics|mesh-ancestor
65445901|NCT00312572|Sensory System Agents|sensory system agents|mesh-ancestor
65445902|NCT00312572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65445903|NCT00312572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65445904|NCT00290732|Doxorubicin|doxorubicin|mesh-list
65445905|NCT00290732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65445906|NCT00290732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65445907|NCT00290732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445908|NCT00290732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65445909|NCT00290732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65445910|NCT00290732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445933|NCT00312338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65445934|NCT00312338|Contraceptive Agents|contraceptive agents|mesh-ancestor
65445935|NCT00312338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65445936|NCT00312338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445937|NCT00312338|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65445938|NCT00312338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65445939|NCT00312338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65445940|NCT00290498|Cytarabine|cytarabine|mesh-list
65445941|NCT00290498|Dexamethasone|dexamethasone|mesh-list
65445942|NCT00290498|Prednisone|prednisone|mesh-list
65445943|NCT00290498|Cyclophosphamide|cyclophosphamide|mesh-list
65445944|NCT00290498|Rituximab|rituximab|mesh-list
65445945|NCT00290498|Doxorubicin|doxorubicin|mesh-list
65445946|NCT00290498|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65445947|NCT00290498|Methotrexate|methotrexate|mesh-list
65445948|NCT00290498|Vincristine|vincristine|mesh-list
65445949|NCT00290498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65445950|NCT00290498|Immunologic Factors|immunologic factors|mesh-ancestor
65445951|NCT00290498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445952|NCT00290498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65445953|NCT00290498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65445954|NCT00290498|Alkylating Agents|alkylating agents|mesh-ancestor
65445955|NCT00290498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445956|NCT00290498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445957|NCT00290498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65445958|NCT00290498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65445959|NCT00290498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65445960|NCT00290498|Antiemetics|antiemetics|mesh-ancestor
65445961|NCT00290498|Autonomic Agents|autonomic agents|mesh-ancestor
65445974|NCT00290498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65445975|NCT00290498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65445977|NCT00290498|Dermatologic Agents|dermatologic agents|mesh-ancestor
65445978|NCT00290498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65445979|NCT00290498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65445980|NCT00290498|Antiviral Agents|antiviral agents|mesh-ancestor
65445981|NCT00290498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65445982|NCT00290498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65445983|NCT00290498|Tubulin Modulators|tubulin modulators|mesh-ancestor
65445984|NCT00290498|Antimitotic Agents|antimitotic agents|mesh-ancestor
65445985|NCT00290498|Mitosis Modulators|mitosis modulators|mesh-ancestor
65445986|NCT01069796|Paclitaxel|paclitaxel|mesh-list
65445987|NCT01069796|Bevacizumab|bevacizumab|mesh-list
65445988|NCT01069796|Capecitabine|capecitabine|mesh-list
65445989|NCT01069796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65445990|NCT01069796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445991|NCT01069796|Tubulin Modulators|tubulin modulators|mesh-ancestor
65445992|NCT01069796|Antimitotic Agents|antimitotic agents|mesh-ancestor
65445993|NCT01069796|Mitosis Modulators|mitosis modulators|mesh-ancestor
65445994|NCT01069796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445995|NCT01069796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65445996|NCT01069796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65445997|NCT01069796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65445998|NCT01069796|Growth Substances|growth substances|mesh-ancestor
65445999|NCT01069796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446000|NCT01069796|Growth Inhibitors|growth inhibitors|mesh-ancestor
65446001|NCT01069796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65446002|NCT01069796|Antimetabolites|antimetabolites|mesh-ancestor
65446003|NCT01067534|Albuterol|albuterol|mesh-list
65446004|NCT01067534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65446005|NCT01067534|Autonomic Agents|autonomic agents|mesh-ancestor
65446006|NCT01067534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65446007|NCT01067534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195529|NCT00648154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446008|NCT01067534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65446009|NCT01067534|Respiratory System Agents|respiratory system agents|mesh-ancestor
65446010|NCT01067534|Tocolytic Agents|tocolytic agents|mesh-ancestor
65446011|NCT01067534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65446012|NCT01067534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65446013|NCT01067534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65446014|NCT01067534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65446015|NCT01067534|Adrenergic Agents|adrenergic agents|mesh-ancestor
65446016|NCT01067534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65446017|NCT01067534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446018|NCT00451451|Glatiramer Acetate|glatiramer acetate|mesh-list
65446019|NCT00451451|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65446020|NCT00451451|(T,G)-A-L|(t,g)-a-l|mesh-list
65446021|NCT00451451|Dermatologic Agents|dermatologic agents|mesh-ancestor
65446038|NCT01069874|Micronutrients|micronutrients|mesh-ancestor
65446039|NCT01069874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446040|NCT01069874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65446041|NCT01069874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65446043|NCT01022645|Levonorgestrel|levonorgestrel|mesh-list
65446044|NCT01022645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65446045|NCT01022645|Contraceptive Agents|contraceptive agents|mesh-ancestor
65446046|NCT01022645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65446047|NCT01022645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446048|NCT01022645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65446049|NCT01022645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65446050|NCT01022645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65446051|NCT01022645|Trace Elements|trace elements|mesh-ancestor
65446052|NCT01022645|Micronutrients|micronutrients|mesh-ancestor
65446053|NCT01025765|Metformin|metformin|mesh-list
65446054|NCT01025765|Pioglitazone|pioglitazone|mesh-list
65446055|NCT01025765|Acarbose|acarbose|mesh-list
65446056|NCT01025765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65446057|NCT01025765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446058|NCT01025765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65446059|NCT01025765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446060|NCT01025765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446061|NCT03824912|Ketoconazole|ketoconazole|mesh-list
65446062|NCT03824912|Antifungal Agents|antifungal agents|mesh-ancestor
65446063|NCT03824912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65446064|NCT03824912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65446065|NCT03824912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65446066|NCT03824912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446067|NCT03824912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446068|NCT03824912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65446069|NCT03824912|Hormone Antagonists|hormone antagonists|mesh-ancestor
65446070|NCT03824912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65446071|NCT03824912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446072|NCT03824912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65446073|NCT01062776|Furosemide|furosemide|mesh-list
65446074|NCT01062776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65446075|NCT01062776|Diuretics|diuretics|mesh-ancestor
65446076|NCT01062776|Natriuretic Agents|natriuretic agents|mesh-ancestor
65446077|NCT01062776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446078|NCT01062776|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65446079|NCT01062776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65446086|NCT01070030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65446087|NCT01070030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65446088|NCT01070030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65446089|NCT01070030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446090|NCT01070030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65010466|NCT00152841|Vitamin E|vitamin e|mesh-list
65446091|NCT01070030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446094|NCT01070030|Natriuretic Agents|natriuretic agents|mesh-ancestor
65446095|NCT01070030|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65446096|NCT00461123|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65446097|NCT00461123|Vasodilator Agents|vasodilator agents|mesh-ancestor
65446098|NCT00461123|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65446099|NCT00461123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65446100|NCT00461123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446101|NCT00461123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446102|NCT00461123|Urological Agents|urological agents|mesh-ancestor
65446103|NCT00290342|Edetic Acid|edetic acid|mesh-list
65446104|NCT00290342|Pentetic Acid|pentetic acid|mesh-list
65446105|NCT00290342|Antidotes|antidotes|mesh-ancestor
65446106|NCT00290342|Protective Agents|protective agents|mesh-ancestor
65446107|NCT00290342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446108|NCT00290342|Chelating Agents|chelating agents|mesh-ancestor
65446109|NCT00290342|Sequestering Agents|sequestering agents|mesh-ancestor
65446110|NCT00290342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446111|NCT00290342|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65446112|NCT00290342|Anticoagulants|anticoagulants|mesh-ancestor
65446113|NCT00290342|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65446114|NCT00460811|Linaclotide|linaclotide|mesh-list
65446115|NCT00460811|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65446116|NCT00460811|Enzyme Activators|enzyme activators|mesh-ancestor
65446117|NCT00460811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446118|NCT00460811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65446119|NCT01070108|Ketamine|ketamine|mesh-list
65446120|NCT01070108|Analgesics|analgesics|mesh-ancestor
65446121|NCT01070108|Sensory System Agents|sensory system agents|mesh-ancestor
65446122|NCT01070108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65446123|NCT01070108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446124|NCT01070108|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65446125|NCT01070108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65446126|NCT01070108|Anesthetics, General|anesthetics, general|mesh-ancestor
65446127|NCT01070108|Anesthetics|anesthetics|mesh-ancestor
65446128|NCT01070108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65446129|NCT01070108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65446130|NCT01070108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65446131|NCT01070108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65446132|NCT01070108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446133|NCT01067690|Indinavir|indinavir|mesh-list
65446134|NCT01067690|Bleomycin|bleomycin|mesh-list
65446135|NCT01067690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65446136|NCT01067690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65446137|NCT01067690|Protease Inhibitors|protease inhibitors|mesh-ancestor
65446138|NCT01067690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446139|NCT01067690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446140|NCT01067690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65446141|NCT01067690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65446142|NCT01067690|Antiviral Agents|antiviral agents|mesh-ancestor
65446143|NCT01067690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65446144|NCT01067690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65446145|NCT01067690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446146|NCT03982004|Pembrolizumab|pembrolizumab|mesh-list
65446147|NCT03982004|Imiquimod|imiquimod|mesh-list
65446148|NCT03982004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65446172|NCT01063010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65446173|NCT01063010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446174|NCT01063010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65446175|NCT01063010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65446176|NCT01063010|Growth Substances|growth substances|mesh-ancestor
65446177|NCT01063010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446178|NCT01063010|Growth Inhibitors|growth inhibitors|mesh-ancestor
65446179|NCT00460577|Bromides|bromides|mesh-list
65446180|NCT00460577|Fenoterol|fenoterol|mesh-list
65446181|NCT00460577|Formoterol Fumarate|formoterol fumarate|mesh-list
65446182|NCT00460577|Ipratropium|ipratropium|mesh-list
65446183|NCT00460577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65446184|NCT00460577|Autonomic Agents|autonomic agents|mesh-ancestor
65446185|NCT00460577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65446186|NCT00460577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446187|NCT00460577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65446188|NCT00460577|Respiratory System Agents|respiratory system agents|mesh-ancestor
65446189|NCT00460577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65446190|NCT00460577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65446191|NCT00460577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65446192|NCT00460577|Adrenergic Agents|adrenergic agents|mesh-ancestor
65446193|NCT00460577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65446194|NCT00460577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446195|NCT00460577|Anticonvulsants|anticonvulsants|mesh-ancestor
65446196|NCT00460577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65446197|NCT00460577|Cholinergic Agents|cholinergic agents|mesh-ancestor
65446198|NCT00460577|Sympathomimetics|sympathomimetics|mesh-ancestor
65446199|NCT00460577|Tocolytic Agents|tocolytic agents|mesh-ancestor
65446200|NCT00460577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65446201|NCT01581320|Vitamin D|vitamin d|mesh-list
65446202|NCT01581320|Cholecalciferol|cholecalciferol|mesh-list
65446203|NCT01581320|Ibandronic Acid|ibandronic acid|mesh-list
65446204|NCT01581320|Vitamins|vitamins|mesh-ancestor
65446233|NCT00288626|Antimetabolites|antimetabolites|mesh-ancestor
65446234|NCT00288626|Antiviral Agents|antiviral agents|mesh-ancestor
65446235|NCT00288626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65446236|NCT00288626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65446237|NCT00288626|Immunologic Factors|immunologic factors|mesh-ancestor
65446238|NCT00288626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65446239|NCT00288626|Alkylating Agents|alkylating agents|mesh-ancestor
65446240|NCT00288626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65446241|NCT00288626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65446242|NCT00087490|Vancomycin|vancomycin|mesh-list
65446243|NCT00087490|Linezolid|linezolid|mesh-list
65446244|NCT00087490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65446245|NCT00087490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65446246|NCT00087490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65446247|NCT00087490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446248|NCT00087490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446249|NCT00087178|Cyclophosphamide|cyclophosphamide|mesh-list
65446250|NCT00087178|Doxorubicin|doxorubicin|mesh-list
65446251|NCT00087178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65446263|NCT00087178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65446264|NCT00087178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65446265|NCT00087178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65446266|NCT00087178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446267|NCT00087178|Antimetabolites|antimetabolites|mesh-ancestor
65446268|NCT00087178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65446269|NCT00288080|Dexamethasone|dexamethasone|mesh-list
65446271|NCT00288080|Docetaxel|docetaxel|mesh-list
65446272|NCT00288080|Androgen Antagonists|androgen antagonists|mesh-list
65446273|NCT00288080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65446274|NCT00288080|Antiemetics|antiemetics|mesh-ancestor
65446275|NCT00288080|Autonomic Agents|autonomic agents|mesh-ancestor
65446276|NCT00288080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65446277|NCT00288080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446278|NCT00288080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65446279|NCT00288080|Glucocorticoids|glucocorticoids|mesh-ancestor
65446280|NCT00288080|Hormones|hormones|mesh-ancestor
65446281|NCT00288080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65446282|NCT00288080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65446283|NCT00288080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446284|NCT00288080|Tubulin Modulators|tubulin modulators|mesh-ancestor
65446285|NCT00288080|Antimitotic Agents|antimitotic agents|mesh-ancestor
65446286|NCT00288080|Mitosis Modulators|mitosis modulators|mesh-ancestor
65446287|NCT00288080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446288|NCT00288080|Hormone Antagonists|hormone antagonists|mesh-ancestor
65446289|NCT01068392|Prednisolone|prednisolone|mesh-list
65446290|NCT01068392|Oxaliplatin|oxaliplatin|mesh-list
65446291|NCT01068392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446292|NCT01068392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65446293|NCT01068392|Glucocorticoids|glucocorticoids|mesh-ancestor
65446294|NCT01068392|Hormones|hormones|mesh-ancestor
65446295|NCT01068392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65446296|NCT01068392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446297|NCT01068392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65446298|NCT01086826|Cisplatin|cisplatin|mesh-list
65446299|NCT01086826|Docetaxel|docetaxel|mesh-list
65446300|NCT01086826|Fluorouracil|fluorouracil|mesh-list
65446301|NCT01086826|Cetuximab|cetuximab|mesh-list
65446302|NCT01086826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446303|NCT01086826|Tubulin Modulators|tubulin modulators|mesh-ancestor
65446304|NCT01086826|Antimitotic Agents|antimitotic agents|mesh-ancestor
65446305|NCT01086826|Mitosis Modulators|mitosis modulators|mesh-ancestor
65446306|NCT01086826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446307|NCT01086826|Antimetabolites|antimetabolites|mesh-ancestor
65010614|NCT00159471|Docetaxel|docetaxel|mesh-list
65446308|NCT01086826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65446309|NCT01086826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65446310|NCT01086826|Immunologic Factors|immunologic factors|mesh-ancestor
65446311|NCT01086826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446312|NCT01086826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65446313|NCT00287690|Genistein|genistein|mesh-list
65446314|NCT00287690|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65446315|NCT00287690|Protective Agents|protective agents|mesh-ancestor
64830990|NCT01578057|Ethanol|ethanol|mesh-list
65446321|NCT00287690|Phytoestrogens|phytoestrogens|mesh-ancestor
65446322|NCT00287690|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65446323|NCT00287690|Estrogens|estrogens|mesh-ancestor
65446324|NCT00287690|Hormones|hormones|mesh-ancestor
65446325|NCT00287690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65446326|NCT01070186|Sunitinib|sunitinib|mesh-list
65446327|NCT01070186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446328|NCT01070186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65446329|NCT01070186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65446330|NCT01070186|Growth Substances|growth substances|mesh-ancestor
65446331|NCT01070186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446332|NCT01070186|Growth Inhibitors|growth inhibitors|mesh-ancestor
65446333|NCT01070186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65446334|NCT01070186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446335|NCT01070186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446336|NCT00066742|Etoposide|etoposide|mesh-list
65446337|NCT00066742|Etoposide phosphate|etoposide phosphate|mesh-list
65446338|NCT00066742|Tirapazamine|tirapazamine|mesh-list
65446339|NCT00066742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446340|NCT00066742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65446341|NCT00066742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65446342|NCT00066742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65446343|NCT00066742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446344|NCT00066742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446345|NCT01026467|Carboplatin|carboplatin|mesh-list
65446346|NCT01026467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446347|NCT01094158|Cholic Acids|cholic acids|mesh-list
65446348|NCT01094158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65446349|NCT00460109|Rituximab|rituximab|mesh-list
65446350|NCT00460109|Denileukin diftitox|denileukin diftitox|mesh-list
65446351|NCT00460109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65446352|NCT00460109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446353|NCT00460109|Immunologic Factors|immunologic factors|mesh-ancestor
65446354|NCT00460109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446355|NCT00460109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65446356|NCT03956212|Doxycycline|doxycycline|mesh-list
65446357|NCT03956212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65446358|NCT03956212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65446359|NCT03956212|Antimalarials|antimalarials|mesh-ancestor
65446360|NCT03956212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65446361|NCT03956212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65446362|NCT01091818|Midazolam|midazolam|mesh-list
65446363|NCT01091818|Dexmedetomidine|dexmedetomidine|mesh-list
65446364|NCT01091818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65446365|NCT01091818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65446366|NCT01091818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446367|NCT01091818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65446368|NCT01091818|Analgesics|analgesics|mesh-ancestor
65446369|NCT01091818|Sensory System Agents|sensory system agents|mesh-ancestor
65446370|NCT01091818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65446371|NCT01091818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65446372|NCT01091818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65446373|NCT01091818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65446374|NCT01091818|Adrenergic Agents|adrenergic agents|mesh-ancestor
65446375|NCT01091818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65446376|NCT01091818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446377|NCT01091818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65446378|NCT01091818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65446379|NCT01091818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65446380|NCT01091818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65446381|NCT01091818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65446382|NCT01091818|Anesthetics, General|anesthetics, general|mesh-ancestor
65446383|NCT01091818|Anesthetics|anesthetics|mesh-ancestor
65446384|NCT01091818|GABA Modulators|gaba modulators|mesh-ancestor
65446385|NCT01091818|GABA Agents|gaba agents|mesh-ancestor
65446403|NCT00065260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446404|NCT00065260|Antifungal Agents|antifungal agents|mesh-ancestor
65446405|NCT00065260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65446406|NCT00065260|Dermatologic Agents|dermatologic agents|mesh-ancestor
65446407|NCT00065260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65446408|NCT00065260|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65446409|NCT00065260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65446410|NCT00065260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446411|NCT01327066|Moxifloxacin|moxifloxacin|mesh-list
65446412|NCT01327066|Droxidopa|droxidopa|mesh-list
65446413|NCT01327066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65446414|NCT01327066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65446415|NCT01327066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65446416|NCT01327066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65446417|NCT01327066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446418|NCT01327066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446419|NCT01327066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446420|NCT01327066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65446421|NCT01327066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65446422|NCT01094626|Secretin|secretin|mesh-list
65446423|NCT01094626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65446424|NCT01094626|Hormones|hormones|mesh-ancestor
65446425|NCT01094626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65446426|NCT01094626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446427|NCT03956134|Tapentadol|tapentadol|mesh-list
65446428|NCT03956134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65446429|NCT03956134|Narcotics|narcotics|mesh-ancestor
65446430|NCT03956134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65446431|NCT03956134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446432|NCT03956134|Analgesics|analgesics|mesh-ancestor
65446433|NCT03956134|Sensory System Agents|sensory system agents|mesh-ancestor
65446434|NCT03956134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65446435|NCT03956134|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65446436|NCT03956134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65446437|NCT03956134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65446438|NCT03956134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446439|NCT03956134|Adrenergic Agents|adrenergic agents|mesh-ancestor
65446440|NCT03956134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65446441|NCT00460031|Ketoconazole|ketoconazole|mesh-list
65446442|NCT00460031|Hydrocortisone|hydrocortisone|mesh-list
65446443|NCT00460031|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65446460|NCT00460031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446462|NCT00460031|Hormone Antagonists|hormone antagonists|mesh-ancestor
65446463|NCT00460031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65446464|NCT00460031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65446465|NCT00451217|Glycopyrrolate|glycopyrrolate|mesh-list
65446466|NCT00451217|Neostigmine|neostigmine|mesh-list
65446467|NCT00451217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65446468|NCT00451217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446469|NCT00451217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446470|NCT00451217|Cholinergic Agents|cholinergic agents|mesh-ancestor
65446471|NCT00451217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65446472|NCT00451217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446473|NCT00451217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65446474|NCT00451217|Autonomic Agents|autonomic agents|mesh-ancestor
65446475|NCT00451217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65446476|NCT00451217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65446477|NCT00451217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65446478|NCT00451217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65446480|NCT00459953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65446481|NCT00459953|Autonomic Agents|autonomic agents|mesh-ancestor
65446482|NCT00459953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65446483|NCT00459953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446484|NCT00459953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65446485|NCT00459953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65446486|NCT00459953|Cholinergic Agents|cholinergic agents|mesh-ancestor
65446487|NCT00459953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65446488|NCT00459953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446489|NCT00459875|Sunitinib|sunitinib|mesh-list
65446490|NCT00459875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446491|NCT00459875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65446492|NCT00459875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65446493|NCT00459875|Growth Substances|growth substances|mesh-ancestor
65446494|NCT00459875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446495|NCT00459875|Growth Inhibitors|growth inhibitors|mesh-ancestor
65446496|NCT00459875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65446497|NCT00459875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446498|NCT00459875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446499|NCT00311402|Aspirin|aspirin|mesh-list
64831180|NCT01578629|Aspirin|aspirin|mesh-list
65446514|NCT00311402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446515|NCT00311402|Antipyretics|antipyretics|mesh-ancestor
65446516|NCT03724175|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65446517|NCT03724175|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65446518|NCT03724175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65446519|NCT00450749|Lycopene|lycopene|mesh-list
65446520|NCT00450749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65446521|NCT00450749|Antioxidants|antioxidants|mesh-ancestor
65446522|NCT00450749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446523|NCT00450749|Protective Agents|protective agents|mesh-ancestor
65446524|NCT00450749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446525|NCT00450749|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65446526|NCT00450749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65446527|NCT00450749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446528|NCT00292370|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65446529|NCT00292370|Paroxetine|paroxetine|mesh-list
65446530|NCT00292370|Antidepressive Agents|antidepressive agents|mesh-ancestor
65446531|NCT00292370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65446532|NCT00292370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65446533|NCT00292370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65446534|NCT00292370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65446535|NCT00292370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446536|NCT00292370|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65446537|NCT00292370|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65196069|NCT04169464|Sofosbuvir|sofosbuvir|mesh-list
65446538|NCT00292370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65446539|NCT00292370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446540|NCT00292370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65446541|NCT00292370|Serotonin Agents|serotonin agents|mesh-ancestor
65446542|NCT00292370|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65446543|NCT00292370|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65446544|NCT00292370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65446545|NCT00292370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446547|NCT00065182|Topotecan|topotecan|mesh-list
65446548|NCT00065182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446549|NCT00065182|Tubulin Modulators|tubulin modulators|mesh-ancestor
65446550|NCT00065182|Antimitotic Agents|antimitotic agents|mesh-ancestor
65446551|NCT00065182|Mitosis Modulators|mitosis modulators|mesh-ancestor
65446552|NCT00065182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446553|NCT00065182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65446554|NCT00065182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65446555|NCT00065182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446556|NCT01026701|Bortezomib|bortezomib|mesh-list
65446557|NCT01026701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446572|NCT01095016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65446574|NCT01095016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65446575|NCT01095016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446576|NCT01095016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65446577|NCT01095016|Respiratory System Agents|respiratory system agents|mesh-ancestor
65446578|NCT01095016|Sympathomimetics|sympathomimetics|mesh-ancestor
65446579|NCT01095016|Tocolytic Agents|tocolytic agents|mesh-ancestor
65446580|NCT01095016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65446581|NCT01095016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65446582|NCT01095016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65446583|NCT01095016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65446584|NCT01095016|Adrenergic Agents|adrenergic agents|mesh-ancestor
65446585|NCT01095016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65446586|NCT01095016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446587|NCT01095172|Prednisolone|prednisolone|mesh-list
65446588|NCT01095172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65446589|NCT01095172|Methylprednisolone|methylprednisolone|mesh-list
65446590|NCT01095172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65446591|NCT01095172|Prednisolone acetate|prednisolone acetate|mesh-list
65446592|NCT01095172|Hydrocortisone|hydrocortisone|mesh-list
65446593|NCT01095172|Rituximab|rituximab|mesh-list
65446594|NCT01095172|Tacrolimus|tacrolimus|mesh-list
65446595|NCT01095172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65446596|NCT01095172|Prednisolone phosphate|prednisolone phosphate|mesh-list
65446597|NCT01095172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65446598|NCT01095172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446599|NCT01095172|Immunologic Factors|immunologic factors|mesh-ancestor
65446600|NCT01095172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446601|NCT01095172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65446602|NCT01095172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65446603|NCT01095172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65446604|NCT01095172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446605|NCT01095172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446606|NCT01095172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65446607|NCT01095172|Glucocorticoids|glucocorticoids|mesh-ancestor
65446608|NCT01095172|Hormones|hormones|mesh-ancestor
65446609|NCT01095172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65446610|NCT01095172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65446611|NCT01095172|Antiemetics|antiemetics|mesh-ancestor
65446612|NCT01095172|Autonomic Agents|autonomic agents|mesh-ancestor
65446613|NCT01095172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65446614|NCT01095172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65446615|NCT01095172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65446616|NCT01095172|Protective Agents|protective agents|mesh-ancestor
65446617|NCT00286442|Metformin|metformin|mesh-list
65446618|NCT00286442|Alogliptin|alogliptin|mesh-list
64831306|NCT01579227|Vitamins|vitamins|mesh-ancestor
65446636|NCT00063934|Mitosis Modulators|mitosis modulators|mesh-ancestor
65446637|NCT00063934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446638|NCT00063934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65446639|NCT00063934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65446640|NCT00063934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65446641|NCT00063934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446642|NCT00063934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65446643|NCT00063934|Immunologic Factors|immunologic factors|mesh-ancestor
65446644|NCT00063934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446645|NCT00063154|Pertuzumab|pertuzumab|mesh-list
65446646|NCT00063154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65446647|NCT00063154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446648|NCT01092520|Gabapentin|gabapentin|mesh-list
65446649|NCT01092520|Analgesics|analgesics|mesh-ancestor
65446650|NCT01092520|Sensory System Agents|sensory system agents|mesh-ancestor
65446651|NCT01092520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65446652|NCT01092520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446653|NCT01092520|Anticonvulsants|anticonvulsants|mesh-ancestor
65446654|NCT01092520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65446655|NCT01092520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65446656|NCT01092520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65446657|NCT01092520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65446658|NCT01092520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65446659|NCT01092520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65446660|NCT01092520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65446661|NCT01092520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446662|NCT01092520|Antimanic Agents|antimanic agents|mesh-ancestor
65446663|NCT00458705|Thalidomide|thalidomide|mesh-list
65446664|NCT00458705|Dexamethasone|dexamethasone|mesh-list
65446665|NCT00458705|Doxorubicin|doxorubicin|mesh-list
65446666|NCT00458705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65446667|NCT00458705|Bortezomib|bortezomib|mesh-list
65446668|NCT00458705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65446669|NCT00458705|Antiemetics|antiemetics|mesh-ancestor
65446670|NCT00458705|Autonomic Agents|autonomic agents|mesh-ancestor
65446671|NCT00458705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65446672|NCT00458705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446673|NCT00458705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65446674|NCT00458705|Glucocorticoids|glucocorticoids|mesh-ancestor
65446675|NCT00458705|Hormones|hormones|mesh-ancestor
65446676|NCT00458705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64831359|NCT01579539|Prednisolone phosphate|prednisolone phosphate|mesh-list
65446687|NCT00458705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65446688|NCT00458705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65446689|NCT00458705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65446690|NCT00458705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65446691|NCT00458705|Growth Substances|growth substances|mesh-ancestor
65446692|NCT00458705|Growth Inhibitors|growth inhibitors|mesh-ancestor
65446693|NCT00062374|Deoxyglucose|deoxyglucose|mesh-list
65446695|NCT00062374|Cisplatin|cisplatin|mesh-list
65446696|NCT00062374|Irinotecan|irinotecan|mesh-list
65446697|NCT00062374|Camptothecin|camptothecin|mesh-list
65446698|NCT00062374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65446699|NCT00062374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446700|NCT00062374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65446701|NCT00062374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65446702|NCT00062374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446703|NCT00062374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446704|NCT00062374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65446705|NCT00062374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65446706|NCT00062374|Antimetabolites|antimetabolites|mesh-ancestor
65446707|NCT00062374|Antiviral Agents|antiviral agents|mesh-ancestor
65446708|NCT00062374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65446709|NCT00285818|Mifepristone|mifepristone|mesh-list
65446710|NCT00285818|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65446711|NCT00285818|Abortifacient Agents|abortifacient agents|mesh-ancestor
65446712|NCT00285818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65446713|NCT00285818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446714|NCT00285818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65446715|NCT00285818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65446716|NCT00285818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65446717|NCT00285818|Contraceptive Agents|contraceptive agents|mesh-ancestor
65446718|NCT00285818|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65446719|NCT00285818|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65446720|NCT00285818|Hormone Antagonists|hormone antagonists|mesh-ancestor
65446721|NCT00285818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65446722|NCT00285818|Luteolytic Agents|luteolytic agents|mesh-ancestor
65446723|NCT00285818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65446724|NCT00285818|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65446725|NCT01023347|Paclitaxel|paclitaxel|mesh-list
65446726|NCT01023347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65446727|NCT01023347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65446728|NCT01023347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446729|NCT01023347|Tubulin Modulators|tubulin modulators|mesh-ancestor
65446730|NCT01023347|Antimitotic Agents|antimitotic agents|mesh-ancestor
65446731|NCT01023347|Mitosis Modulators|mitosis modulators|mesh-ancestor
65446732|NCT01023347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446733|NCT01023425|Donepezil|donepezil|mesh-list
65446734|NCT01023425|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65446735|NCT01023425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446736|NCT01023425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446737|NCT01023425|Cholinergic Agents|cholinergic agents|mesh-ancestor
65446738|NCT01023425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65446739|NCT01023425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446764|NCT00291668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65446765|NCT00458393|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65446766|NCT00458393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65446767|NCT00458393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65446768|NCT00458393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446769|NCT00458393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446770|NCT00458393|Antiviral Agents|antiviral agents|mesh-ancestor
65446771|NCT00458393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65446772|NCT00458393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65446773|NCT00458393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65446774|NCT03955354|Apatinib|apatinib|mesh-list
65446775|NCT03955354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446776|NCT03955354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65446777|NCT03955354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446778|NCT03955354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446779|NCT01095484|Rotigotine|rotigotine|mesh-list
65446780|NCT01095484|Dopamine Agonists|dopamine agonists|mesh-ancestor
65446781|NCT01095484|Dopamine Agents|dopamine agents|mesh-ancestor
65446782|NCT01095484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65446783|NCT01095484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446784|NCT01095484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446785|NCT01063478|Everolimus|everolimus|mesh-list
64831492|NCT01582711|Isoniazid|isoniazid|mesh-list
65446793|NCT01327144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65446794|NCT01327144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65446795|NCT01327144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446796|NCT01327144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446797|NCT01323101|Doxycycline|doxycycline|mesh-list
65446798|NCT01323101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65446799|NCT01323101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65446800|NCT01323101|Antimalarials|antimalarials|mesh-ancestor
65446801|NCT01323101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65446802|NCT01323101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65446803|NCT00310856|Vaccines|vaccines|mesh-list
65446804|NCT00310856|Immunologic Factors|immunologic factors|mesh-ancestor
65446805|NCT00310856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446806|NCT03670355|Tenofovir|tenofovir|mesh-list
65446807|NCT03670355|Antiviral Agents|antiviral agents|mesh-ancestor
65446808|NCT03670355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65446809|NCT03670355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65446810|NCT03670355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65446811|NCT03670355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446812|NCT03670355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446813|NCT03670355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65446814|NCT03670355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65446815|NCT02532062|Vitamin D|vitamin d|mesh-list
65446816|NCT02532062|Cholecalciferol|cholecalciferol|mesh-list
65446817|NCT02532062|Vitamins|vitamins|mesh-ancestor
65446818|NCT02532062|Micronutrients|micronutrients|mesh-ancestor
65446819|NCT02532062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446820|NCT02532062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65446821|NCT02532062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65446822|NCT00283712|Infliximab|infliximab|mesh-list
65446823|NCT00283712|Dermatologic Agents|dermatologic agents|mesh-ancestor
65446824|NCT00283712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65446825|NCT00283712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65446826|NCT00048724|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65446827|NCT00048724|Antiviral Agents|antiviral agents|mesh-ancestor
65446828|NCT00048724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65446829|NCT00449033|Gemcitabine|gemcitabine|mesh-list
65446830|NCT00449033|Sorafenib|sorafenib|mesh-list
65446831|NCT00449033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446832|NCT00449033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65446833|NCT00449033|Antimetabolites|antimetabolites|mesh-ancestor
65446834|NCT00449033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446835|NCT00449033|Antiviral Agents|antiviral agents|mesh-ancestor
65446836|NCT00449033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65446837|NCT00449033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446838|NCT00449033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65446839|NCT00449033|Immunologic Factors|immunologic factors|mesh-ancestor
65446840|NCT00449033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446841|NCT00449033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65446842|NCT01024205|Sunitinib|sunitinib|mesh-list
65446843|NCT01024205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446844|NCT01024205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65446845|NCT01024205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65446846|NCT01024205|Growth Substances|growth substances|mesh-ancestor
65446847|NCT01024205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446848|NCT01024205|Growth Inhibitors|growth inhibitors|mesh-ancestor
65446849|NCT01024205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65446850|NCT01024205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446851|NCT01024205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446852|NCT00448019|Cyclophosphamide|cyclophosphamide|mesh-list
65446853|NCT00448019|Bevacizumab|bevacizumab|mesh-list
65446854|NCT00448019|Rituximab|rituximab|mesh-list
65446855|NCT00448019|Fludarabine|fludarabine|mesh-list
65446856|NCT00448019|Fludarabine phosphate|fludarabine phosphate|mesh-list
65446878|NCT00457691|Antimetabolites|antimetabolites|mesh-ancestor
65446879|NCT00457691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446880|NCT00457691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65446881|NCT00457691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446882|NCT00457691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65446883|NCT00457691|Immunologic Factors|immunologic factors|mesh-ancestor
65446884|NCT00457691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446885|NCT00457691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65446886|NCT00457691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65446887|NCT00457691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446889|NCT00457691|Protective Agents|protective agents|mesh-ancestor
65446890|NCT00457691|Vitamin B Complex|vitamin b complex|mesh-ancestor
65446891|NCT00457691|Vitamins|vitamins|mesh-ancestor
65446892|NCT00457691|Micronutrients|micronutrients|mesh-ancestor
65446893|NCT00457691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65446894|NCT00457691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65446895|NCT00457691|Growth Substances|growth substances|mesh-ancestor
65446896|NCT00457691|Growth Inhibitors|growth inhibitors|mesh-ancestor
65446897|NCT00457691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65446898|NCT00447005|Axitinib|axitinib|mesh-list
65446899|NCT00447005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446900|NCT00447005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65446901|NCT00447005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446902|NCT00447005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446903|NCT01565759|Lithium Carbonate|lithium carbonate|mesh-list
65446904|NCT01565759|Antidepressive Agents|antidepressive agents|mesh-ancestor
65446905|NCT01565759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65446906|NCT01565759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446907|NCT01565759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446908|NCT01565759|Antimanic Agents|antimanic agents|mesh-ancestor
65446909|NCT01565759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65446910|NCT01565759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65446935|NCT00456599|Gemcitabine|gemcitabine|mesh-list
65446936|NCT00456599|Oxaliplatin|oxaliplatin|mesh-list
65446937|NCT00456599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65446938|NCT00456599|Antimetabolites|antimetabolites|mesh-ancestor
65446939|NCT00456599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446940|NCT00456599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446941|NCT00456599|Antiviral Agents|antiviral agents|mesh-ancestor
65446942|NCT00456599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65446943|NCT00456599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446944|NCT00456599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65446945|NCT00456599|Immunologic Factors|immunologic factors|mesh-ancestor
65446946|NCT00456599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446947|NCT00456521|Naltrexone|naltrexone|mesh-list
65446948|NCT00456521|Bupropion|bupropion|mesh-list
65446949|NCT00456521|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65446950|NCT00456521|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65446951|NCT00456521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446952|NCT00456521|Sensory System Agents|sensory system agents|mesh-ancestor
65446953|NCT00456521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65446954|NCT00456521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65446955|NCT00456521|Antidepressive Agents|antidepressive agents|mesh-ancestor
65446956|NCT00456521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65446957|NCT00456521|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65446958|NCT00456521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65446959|NCT00456521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64831652|NCT01589861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446973|NCT00456365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446974|NCT03843047|Nicotine|nicotine|mesh-list
65446975|NCT03843047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65446976|NCT03843047|Autonomic Agents|autonomic agents|mesh-ancestor
65446977|NCT03843047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65446978|NCT03843047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446979|NCT03843047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65446980|NCT03843047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65446981|NCT03843047|Cholinergic Agents|cholinergic agents|mesh-ancestor
65446982|NCT03843047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65446983|NCT03843047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446984|NCT00455741|Estradiol|estradiol|mesh-list
65446985|NCT00455741|Progesterone|progesterone|mesh-list
65446986|NCT00455741|Estrogens|estrogens|mesh-ancestor
65446987|NCT00455741|Hormones|hormones|mesh-ancestor
65196505|NCT04166578|Anesthetics|anesthetics|mesh-ancestor
65446988|NCT00455741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65446989|NCT00455741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446990|NCT00455741|Progestins|progestins|mesh-ancestor
65446991|NCT00445679|Paroxetine|paroxetine|mesh-list
65446992|NCT00445679|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65446993|NCT00445679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65446994|NCT00445679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65446995|NCT00445679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446996|NCT00445679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65446997|NCT00445679|Serotonin Agents|serotonin agents|mesh-ancestor
65446998|NCT00445679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446999|NCT00445679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65447000|NCT00445679|Antidepressive Agents|antidepressive agents|mesh-ancestor
65447001|NCT00445679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65447002|NCT00445679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65447003|NCT00445679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65447004|NCT00445679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447005|NCT00445601|Gemcitabine|gemcitabine|mesh-list
65447006|NCT00445601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65447007|NCT00445601|Antimetabolites|antimetabolites|mesh-ancestor
65447008|NCT00445601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447009|NCT00445601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447010|NCT00445601|Antiviral Agents|antiviral agents|mesh-ancestor
65447011|NCT00445601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65447012|NCT00445601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447013|NCT00445601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65447014|NCT00445601|Immunologic Factors|immunologic factors|mesh-ancestor
65447015|NCT00445601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447016|NCT00444587|Trastuzumab|trastuzumab|mesh-list
65447017|NCT00444587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65447029|NCT00235716|Memantine|memantine|mesh-list
65447030|NCT00235716|Micronutrients|micronutrients|mesh-ancestor
65447031|NCT00235716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447032|NCT00235716|Antioxidants|antioxidants|mesh-ancestor
65447033|NCT00235716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447034|NCT00235716|Protective Agents|protective agents|mesh-ancestor
65447035|NCT00235716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65447036|NCT00235716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65447037|NCT00235716|Dopamine Agents|dopamine agents|mesh-ancestor
65447038|NCT00235716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65447039|NCT00235716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65447040|NCT00235716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65447041|NCT00274742|Blinatumomab|blinatumomab|mesh-list
65447042|NCT00274742|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65447043|NCT00274742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447044|NCT00274742|Immunologic Factors|immunologic factors|mesh-ancestor
65447045|NCT00274742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447046|NCT03970044|Dapagliflozin|dapagliflozin|mesh-list
65447047|NCT03970044|Exenatide|exenatide|mesh-list
65447048|NCT03970044|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65447049|NCT03970044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447050|NCT03970044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65447051|NCT03970044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447052|NCT03970044|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65447053|NCT03970044|Incretins|incretins|mesh-ancestor
65447054|NCT03970044|Hormones|hormones|mesh-ancestor
65447055|NCT03970044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65447056|NCT00444275|Esomeprazole|esomeprazole|mesh-list
65447057|NCT00444275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65447058|NCT00444275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65447059|NCT00444275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65447060|NCT00444275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447061|NCT00444275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447062|NCT00454805|Fulvestrant|fulvestrant|mesh-list
65447063|NCT00454805|Cediranib|cediranib|mesh-list
65447064|NCT00454805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65447065|NCT00454805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447066|NCT00454805|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65447067|NCT00454805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65447068|NCT00454805|Hormone Antagonists|hormone antagonists|mesh-ancestor
65447069|NCT00454805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65447070|NCT00454805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447071|NCT00454805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65447072|NCT00454805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447073|NCT00454805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447074|NCT00283244|Gemcitabine|gemcitabine|mesh-list
65447075|NCT00283244|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65447076|NCT00283244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65447077|NCT00283244|Antimetabolites|antimetabolites|mesh-ancestor
65447078|NCT00283244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447079|NCT00283244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447080|NCT00283244|Antiviral Agents|antiviral agents|mesh-ancestor
65447081|NCT00283244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65447094|NCT00282464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65447095|NCT00282464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65447096|NCT00282464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65447097|NCT00282464|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65447098|NCT00282464|Dopamine Agents|dopamine agents|mesh-ancestor
65447099|NCT00262080|Ecallantide|ecallantide|mesh-list
65447100|NCT00262080|Analgesics|analgesics|mesh-ancestor
65447101|NCT00262080|Sensory System Agents|sensory system agents|mesh-ancestor
65447102|NCT00262080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65447103|NCT00262080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447104|NCT00262080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65447105|NCT00262080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65447106|NCT00262080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65447107|NCT00262080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65447108|NCT01073904|Levonorgestrel|levonorgestrel|mesh-list
65447109|NCT01073904|Norgestrel|norgestrel|mesh-list
65447110|NCT01073904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65011212|NCT00161070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65447111|NCT01073904|Contraceptive Agents|contraceptive agents|mesh-ancestor
65447112|NCT01073904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65447113|NCT01073904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447114|NCT01073904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65447115|NCT01073904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65447116|NCT01073904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65447117|NCT01073904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65447118|NCT00282308|Rituximab|rituximab|mesh-list
65447119|NCT00282308|Methotrexate|methotrexate|mesh-list
65447120|NCT00282308|Vaccines|vaccines|mesh-list
65447121|NCT00282308|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65447122|NCT00282308|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
65447123|NCT00282308|Immunologic Factors|immunologic factors|mesh-ancestor
65447124|NCT00282308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447125|NCT00282308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65447126|NCT00282308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447127|NCT00282308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65447128|NCT00282308|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65447129|NCT00282308|Abortifacient Agents|abortifacient agents|mesh-ancestor
65447130|NCT00282308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65447131|NCT00282308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65447132|NCT00282308|Antimetabolites|antimetabolites|mesh-ancestor
65196667|NCT02535988|Thymalfasin|thymalfasin|mesh-list
65447133|NCT00282308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447134|NCT00282308|Dermatologic Agents|dermatologic agents|mesh-ancestor
65447135|NCT00282308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447136|NCT00282308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65447137|NCT00282308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65447138|NCT00282308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65447139|NCT00282308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65447140|NCT00281840|Bevacizumab|bevacizumab|mesh-list
65447141|NCT00281840|Docetaxel|docetaxel|mesh-list
65447142|NCT00281840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65447159|NCT00272792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447160|NCT00272792|Vasodilator Agents|vasodilator agents|mesh-ancestor
65447161|NCT01069094|Leuprolide|leuprolide|mesh-list
65447162|NCT01069094|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65447163|NCT01069094|Fertility Agents|fertility agents|mesh-ancestor
65447164|NCT01069094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65447165|NCT01069094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447166|NCT01069094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65447167|NCT01069094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447168|NCT00048568|Methotrexate|methotrexate|mesh-list
65447169|NCT00048568|Abatacept|abatacept|mesh-list
65447170|NCT00048568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65447171|NCT00048568|Abortifacient Agents|abortifacient agents|mesh-ancestor
65447172|NCT00048568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65447173|NCT00048568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447174|NCT00048568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65447175|NCT00048568|Antimetabolites|antimetabolites|mesh-ancestor
65447176|NCT00048568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447177|NCT00048568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447178|NCT00048568|Dermatologic Agents|dermatologic agents|mesh-ancestor
65447179|NCT00048568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447180|NCT00048568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65447181|NCT00048568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65447182|NCT00048568|Immunologic Factors|immunologic factors|mesh-ancestor
65447183|NCT00048568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65447184|NCT00048568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65447185|NCT00048568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65447186|NCT00262002|Vaccines|vaccines|mesh-list
65447187|NCT00262002|Immunologic Factors|immunologic factors|mesh-ancestor
65447188|NCT00262002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447189|NCT01584076|Donepezil|donepezil|mesh-list
65447190|NCT01584076|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65447191|NCT01584076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447192|NCT01584076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447193|NCT01584076|Cholinergic Agents|cholinergic agents|mesh-ancestor
65447194|NCT01584076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65447195|NCT01584076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447196|NCT01584076|Nootropic Agents|nootropic agents|mesh-ancestor
65447197|NCT03954964|Analgesics, Opioid|analgesics, opioid|mesh-list
65447198|NCT03954964|Narcotics|narcotics|mesh-ancestor
65447199|NCT03954964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65447203|NCT03954964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65447204|NCT00281528|Paclitaxel|paclitaxel|mesh-list
65447205|NCT00281528|Bevacizumab|bevacizumab|mesh-list
65447206|NCT00281528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65447207|NCT00281528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65447208|NCT00281528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447209|NCT00281528|Tubulin Modulators|tubulin modulators|mesh-ancestor
65447210|NCT00281528|Antimitotic Agents|antimitotic agents|mesh-ancestor
65447211|NCT00281528|Mitosis Modulators|mitosis modulators|mesh-ancestor
65447212|NCT00281528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447213|NCT00281528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65447214|NCT00281528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65447215|NCT00281528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65447216|NCT00281528|Growth Substances|growth substances|mesh-ancestor
65447217|NCT00281528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447218|NCT00281528|Growth Inhibitors|growth inhibitors|mesh-ancestor
65447220|NCT01095640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65447221|NCT01095640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65447222|NCT01095640|Analgesics|analgesics|mesh-ancestor
65447223|NCT01095640|Sensory System Agents|sensory system agents|mesh-ancestor
65447224|NCT01095640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65447225|NCT01095640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447226|NCT01095640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65447227|NCT01095640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65447228|NCT01095640|Dermatologic Agents|dermatologic agents|mesh-ancestor
65447229|NCT00280748|Pemetrexed|pemetrexed|mesh-list
65447230|NCT00280748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447231|NCT00280748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447232|NCT00280748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447233|NCT00280748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65447234|NCT00280748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65447235|NCT03975374|Tobramycin|tobramycin|mesh-list
65447236|NCT03975374|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
65447237|NCT03975374|Dexamethasone|dexamethasone|mesh-list
65447238|NCT03975374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65447239|NCT03975374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65447240|NCT03975374|Antiemetics|antiemetics|mesh-ancestor
65447241|NCT03975374|Autonomic Agents|autonomic agents|mesh-ancestor
65447242|NCT03975374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65447243|NCT03975374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447244|NCT03975374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65447245|NCT03975374|Glucocorticoids|glucocorticoids|mesh-ancestor
65447246|NCT03975374|Hormones|hormones|mesh-ancestor
65447247|NCT03975374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65447248|NCT03975374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65447249|NCT03975374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447250|NCT03975374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65447251|NCT03975374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65447252|NCT03975374|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65447253|NCT00061048|Alemtuzumab|alemtuzumab|mesh-list
65447254|NCT00061048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65447255|NCT00061048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447256|NCT01581398|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65447257|NCT01581398|Interferon-alpha|interferon-alpha|mesh-list
65447258|NCT01581398|Antiviral Agents|antiviral agents|mesh-ancestor
65447259|NCT01581398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65447260|NCT01581398|Immunologic Factors|immunologic factors|mesh-ancestor
65447261|NCT01581398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447262|NCT03976544|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65447263|NCT03976544|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65447264|NCT03976544|Estradiol|estradiol|mesh-list
65447265|NCT03976544|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65447266|NCT03976544|Progesterone|progesterone|mesh-list
65447267|NCT03976544|Estrogens|estrogens|mesh-ancestor
65447268|NCT03976544|Hormones|hormones|mesh-ancestor
65447269|NCT03976544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65447270|NCT03976544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447271|NCT03976544|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65447272|NCT03976544|Contraceptive Agents|contraceptive agents|mesh-ancestor
65447282|NCT00279812|Protective Agents|protective agents|mesh-ancestor
65447283|NCT00279812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447284|NCT00279812|Trace Elements|trace elements|mesh-ancestor
65447285|NCT00279812|Micronutrients|micronutrients|mesh-ancestor
65447286|NCT01070732|Acetaminophen|acetaminophen|mesh-list
65011364|NCT00139568|Tegaserod|tegaserod|mesh-list
65447287|NCT01070732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65447288|NCT01070732|Analgesics|analgesics|mesh-ancestor
65447289|NCT01070732|Sensory System Agents|sensory system agents|mesh-ancestor
65447290|NCT01070732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65447291|NCT01070732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447292|NCT01070732|Antipyretics|antipyretics|mesh-ancestor
65447293|NCT00207714|Golimumab|golimumab|mesh-list
65447294|NCT00207714|Infliximab|infliximab|mesh-list
65447295|NCT00207714|Dermatologic Agents|dermatologic agents|mesh-ancestor
65447296|NCT00207714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65447297|NCT00207714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65447298|NCT00207714|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65447299|NCT00207714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65447300|NCT00207714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65447301|NCT00207714|Immunologic Factors|immunologic factors|mesh-ancestor
65447302|NCT00207714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447303|NCT00207090|Rifampin|rifampin|mesh-list
65447304|NCT00207090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65447305|NCT00207090|Antitubercular Agents|antitubercular agents|mesh-ancestor
65447306|NCT00207090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65447307|NCT00207090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65447308|NCT00207090|Leprostatic Agents|leprostatic agents|mesh-ancestor
65447309|NCT00207090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65447310|NCT00207090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447311|NCT00207090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447312|NCT00207090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65447313|NCT00207090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65447314|NCT00207090|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65447315|NCT00207090|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65447316|NCT00207090|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65447317|NCT00207090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65447318|NCT00059332|Magnesium Sulfate|magnesium sulfate|mesh-list
65447319|NCT00059332|Analgesics|analgesics|mesh-ancestor
65447320|NCT00059332|Sensory System Agents|sensory system agents|mesh-ancestor
65447321|NCT00059332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65447322|NCT00059332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447323|NCT00059332|Anesthetics|anesthetics|mesh-ancestor
65447324|NCT00059332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65447325|NCT00059332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65447326|NCT00059332|Anticonvulsants|anticonvulsants|mesh-ancestor
65447327|NCT00059332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65447328|NCT00059332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65447329|NCT00059332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447330|NCT00059332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65447331|NCT00059332|Tocolytic Agents|tocolytic agents|mesh-ancestor
65447332|NCT00059332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65447333|NCT00233454|Midostaurin|midostaurin|mesh-list
65447334|NCT00233454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447335|NCT00233454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65447336|NCT00233454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447337|NCT00233454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447338|NCT00047320|Carboplatin|carboplatin|mesh-list
65447343|NCT00047320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447344|NCT00047320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65447345|NCT00047320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65447346|NCT00047320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65447347|NCT00047320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447348|NCT00047320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447349|NCT00047320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65447350|NCT00047320|Alkylating Agents|alkylating agents|mesh-ancestor
65447351|NCT00047320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65447352|NCT00047320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65447353|NCT00047320|Immunologic Factors|immunologic factors|mesh-ancestor
65447354|NCT00047320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447355|NCT00233064|Palivizumab|palivizumab|mesh-list
65447356|NCT00233064|Antiviral Agents|antiviral agents|mesh-ancestor
65447357|NCT00233064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65447358|NCT03973086|Cardiac Glycosides|cardiac glycosides|mesh-list
65447359|NCT03973086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65447360|NCT03973086|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65447361|NCT03973086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447362|NCT03973086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270064|NCT02129348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447363|NCT03973086|Protective Agents|protective agents|mesh-ancestor
65447364|NCT03973086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447365|NCT00206076|Mycophenolic Acid|mycophenolic acid|mesh-list
65447366|NCT00206076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65447367|NCT00206076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447368|NCT00206076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65447369|NCT00206076|Antitubercular Agents|antitubercular agents|mesh-ancestor
65447370|NCT00206076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65447371|NCT00206076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65447372|NCT00206076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447373|NCT00206076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447374|NCT00278954|Immunoglobulins|immunoglobulins|mesh-list
65447375|NCT00278954|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65447376|NCT00278954|Antibodies|antibodies|mesh-list
65447377|NCT00278954|gamma-Globulins|gamma-globulins|mesh-list
65447378|NCT00278954|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65447379|NCT00278954|Immunologic Factors|immunologic factors|mesh-ancestor
65447380|NCT00278954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447381|NCT00278564|Methylprednisolone|methylprednisolone|mesh-list
65447382|NCT00278564|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65447383|NCT00278564|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65447384|NCT00278564|Prednisolone|prednisolone|mesh-list
65447385|NCT00278564|Prednisolone acetate|prednisolone acetate|mesh-list
65447386|NCT00278564|Cyclophosphamide|cyclophosphamide|mesh-list
65447387|NCT00278564|Rituximab|rituximab|mesh-list
65447388|NCT00278564|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65447389|NCT00278564|Prednisolone phosphate|prednisolone phosphate|mesh-list
65447390|NCT00278564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65447391|NCT00278564|Immunologic Factors|immunologic factors|mesh-ancestor
65447392|NCT00278564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447393|NCT00278564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65447394|NCT00278564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65447395|NCT00278564|Alkylating Agents|alkylating agents|mesh-ancestor
65447396|NCT00278564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447397|NCT00278564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447398|NCT00278564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65447399|NCT00278564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65447400|NCT00278564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65447401|NCT00278564|Antiemetics|antiemetics|mesh-ancestor
65447402|NCT00278564|Autonomic Agents|autonomic agents|mesh-ancestor
65447403|NCT00278564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65447404|NCT00278564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65447405|NCT00278564|Glucocorticoids|glucocorticoids|mesh-ancestor
65447406|NCT00278564|Hormones|hormones|mesh-ancestor
65447407|NCT00278564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65447408|NCT00278564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65447409|NCT00278564|Protective Agents|protective agents|mesh-ancestor
65447410|NCT00278564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65447411|NCT01071564|R04929097|r04929097|mesh-list
65447437|NCT00250718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65447438|NCT00250718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65447439|NCT00250718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65447441|NCT00250718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65447442|NCT00250718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447443|NCT00250718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447444|NCT00250718|Tubulin Modulators|tubulin modulators|mesh-ancestor
65447445|NCT00250718|Antimitotic Agents|antimitotic agents|mesh-ancestor
65447446|NCT00250718|Mitosis Modulators|mitosis modulators|mesh-ancestor
65447447|NCT00250718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65447448|NCT00250718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65447449|NCT00250718|Renal Agents|renal agents|mesh-ancestor
65447450|NCT00250718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65447451|NCT00250718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65447452|NCT00250718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65447453|NCT00276614|Bortezomib|bortezomib|mesh-list
65447454|NCT00276614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447455|NCT00276458|Atorvastatin|atorvastatin|mesh-list
65447456|NCT00276458|Ezetimibe|ezetimibe|mesh-list
65447457|NCT00276458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65447458|NCT00276458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65447459|NCT00276458|Antimetabolites|antimetabolites|mesh-ancestor
65447460|NCT00276458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270065|NCT02129348|Antimanic Agents|antimanic agents|mesh-ancestor
65447461|NCT00276458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64832160|NCT01593293|Pemetrexed|pemetrexed|mesh-list
65447487|NCT00267488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65447488|NCT00267488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447489|NCT00267488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447490|NCT00267488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447491|NCT01073696|Granisetron|granisetron|mesh-list
65447492|NCT01073696|Antiemetics|antiemetics|mesh-ancestor
65447493|NCT01073696|Autonomic Agents|autonomic agents|mesh-ancestor
65447494|NCT01073696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65447495|NCT01073696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447496|NCT01073696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65447497|NCT01073696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65447498|NCT01073696|Serotonin Agents|serotonin agents|mesh-ancestor
65447499|NCT01073696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65447500|NCT01073696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447501|NCT00046930|Cytarabine|cytarabine|mesh-list
65447502|NCT00046930|Daunorubicin|daunorubicin|mesh-list
65447503|NCT00046930|Molgramostim|molgramostim|mesh-list
65447504|NCT00046930|Lenograstim|lenograstim|mesh-list
65447505|NCT00046930|Sargramostim|sargramostim|mesh-list
65447506|NCT00046930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65447507|NCT00046930|Antimetabolites|antimetabolites|mesh-ancestor
65447508|NCT00046930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447509|NCT00046930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197039|NCT00707785|Vitamin A|vitamin a|mesh-list
64832214|NCT01593410|Hormones|hormones|mesh-ancestor
65447537|NCT00044512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447538|NCT00044512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447539|NCT03805438|Chloroprocaine|chloroprocaine|mesh-list
65447540|NCT03805438|Anesthetics, Local|anesthetics, local|mesh-ancestor
65447541|NCT03805438|Anesthetics|anesthetics|mesh-ancestor
65447542|NCT03805438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65447543|NCT03805438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447544|NCT03805438|Sensory System Agents|sensory system agents|mesh-ancestor
65447545|NCT03805438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65447546|NCT01096420|Topiramate|topiramate|mesh-list
65447547|NCT01096420|Anticonvulsants|anticonvulsants|mesh-ancestor
65447548|NCT01096420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65447549|NCT01096420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447550|NCT03953716|Desogestrel|desogestrel|mesh-list
65447551|NCT03953716|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65447552|NCT03953716|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65447553|NCT03953716|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65447554|NCT03953716|Contraceptive Agents|contraceptive agents|mesh-ancestor
65447555|NCT03953716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65447556|NCT03953716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447557|NCT03953716|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65447558|NCT03953716|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65447559|NCT03953716|Progestins|progestins|mesh-ancestor
65447580|NCT00147537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447582|NCT00147537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447583|NCT00147537|Immunologic Factors|immunologic factors|mesh-ancestor
65447584|NCT00147537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447585|NCT00222729|Bevacizumab|bevacizumab|mesh-list
65447586|NCT00222729|Pemetrexed|pemetrexed|mesh-list
65447587|NCT00222729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65447588|NCT00222729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447589|NCT00222729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65447590|NCT00222729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65447591|NCT00222729|Growth Substances|growth substances|mesh-ancestor
65447592|NCT00222729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447593|NCT00222729|Growth Inhibitors|growth inhibitors|mesh-ancestor
65447594|NCT00222729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447595|NCT00222729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447596|NCT00222729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65447597|NCT00222729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65447598|NCT00147225|Carboplatin|carboplatin|mesh-list
65447599|NCT00147225|Doxorubicin|doxorubicin|mesh-list
65447600|NCT00147225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65447601|NCT00147225|Ifosfamide|ifosfamide|mesh-list
65447602|NCT00147225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447603|NCT00147225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65447604|NCT00147225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65270066|NCT02129348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65447605|NCT00147225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65447606|NCT00147225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447607|NCT00147225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447608|NCT00147225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65447609|NCT00147225|Alkylating Agents|alkylating agents|mesh-ancestor
65447610|NCT00222105|Thalidomide|thalidomide|mesh-list
65447611|NCT00222105|Dexamethasone|dexamethasone|mesh-list
65447612|NCT00222105|Doxorubicin|doxorubicin|mesh-list
64832310|NCT01594047|Ketamine|ketamine|mesh-list
65447645|NCT00247676|Growth Inhibitors|growth inhibitors|mesh-ancestor
65447646|NCT00247676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65447647|NCT00247676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447648|NCT00247676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447650|NCT00267020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65447651|NCT00267020|Antimetabolites|antimetabolites|mesh-ancestor
65447652|NCT00267020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447671|NCT03970772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447672|NCT00242216|Ritonavir|ritonavir|mesh-list
65447673|NCT00242216|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65447674|NCT00242216|Fosamprenavir|fosamprenavir|mesh-list
65447675|NCT00242216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65447676|NCT00242216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65447677|NCT00242216|Protease Inhibitors|protease inhibitors|mesh-ancestor
65447678|NCT00242216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447679|NCT00242216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447680|NCT00242216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65447681|NCT00242216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65447682|NCT00242216|Antiviral Agents|antiviral agents|mesh-ancestor
65447683|NCT00242216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65447684|NCT00242216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65447685|NCT00242216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65447686|NCT00240110|Valproic Acid|valproic acid|mesh-list
65447687|NCT00240110|Lithium Carbonate|lithium carbonate|mesh-list
65447688|NCT00240110|Antidepressive Agents|antidepressive agents|mesh-ancestor
65447689|NCT00240110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65447690|NCT00240110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447691|NCT00240110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447692|NCT00240110|Antimanic Agents|antimanic agents|mesh-ancestor
65447693|NCT00240110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65447694|NCT00240110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65447695|NCT00240110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447696|NCT00240110|Anticonvulsants|anticonvulsants|mesh-ancestor
65447697|NCT00240110|GABA Agents|gaba agents|mesh-ancestor
65447698|NCT00240110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65447699|NCT00239720|Muromonab-CD3|muromonab-cd3|mesh-list
65447700|NCT00239720|Immunologic Factors|immunologic factors|mesh-ancestor
65447701|NCT00239720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447702|NCT00239720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65447703|NCT02532140|Cefepime|cefepime|mesh-list
65447704|NCT02532140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65447705|NCT02532140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65447706|NCT00266864|Methyltestosterone|methyltestosterone|mesh-list
65447707|NCT00266864|Testosterone|testosterone|mesh-list
65447708|NCT00266864|Testosterone undecanoate|testosterone undecanoate|mesh-list
65447709|NCT00266864|Testosterone enanthate|testosterone enanthate|mesh-list
65447710|NCT00266864|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65447711|NCT00266864|Androgens|androgens|mesh-ancestor
65447725|NCT00266708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447726|NCT00266708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65447727|NCT00266630|Carbamazepine|carbamazepine|mesh-list
65447728|NCT00266630|Valproic Acid|valproic acid|mesh-list
65447729|NCT00266630|Olanzapine|olanzapine|mesh-list
65447730|NCT00266630|Antiemetics|antiemetics|mesh-ancestor
65447731|NCT00266630|Autonomic Agents|autonomic agents|mesh-ancestor
65447732|NCT00266630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65447733|NCT00266630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447734|NCT00266630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65447735|NCT00266630|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65447736|NCT00266630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65447737|NCT00266630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65447738|NCT00266630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65447739|NCT00266630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65447740|NCT00266630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65447741|NCT00266630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65447742|NCT00266630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447743|NCT00266630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65447744|NCT00266630|Serotonin Agents|serotonin agents|mesh-ancestor
65447745|NCT00266630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447746|NCT00266630|Antimanic Agents|antimanic agents|mesh-ancestor
65447747|NCT00266630|Anticonvulsants|anticonvulsants|mesh-ancestor
65447748|NCT00266630|GABA Agents|gaba agents|mesh-ancestor
65447749|NCT00266630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65447750|NCT00266630|Analgesics|analgesics|mesh-ancestor
65447751|NCT00266630|Sensory System Agents|sensory system agents|mesh-ancestor
65447752|NCT00266630|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65447753|NCT00266630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65447754|NCT00266630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65447755|NCT02531672|Choline|choline|mesh-list
65447756|NCT02531672|Lipotropic Agents|lipotropic agents|mesh-ancestor
65447757|NCT02531672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65447758|NCT02531672|Antimetabolites|antimetabolites|mesh-ancestor
65447759|NCT02531672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447760|NCT02531672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65447761|NCT02531672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65447762|NCT02531672|Nootropic Agents|nootropic agents|mesh-ancestor
65447763|NCT00129129|Vaccines|vaccines|mesh-list
65447764|NCT00129129|Immunologic Factors|immunologic factors|mesh-ancestor
65447765|NCT00129129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447766|NCT00221403|Valproic Acid|valproic acid|mesh-list
65447767|NCT00221403|Risperidone|risperidone|mesh-list
65447768|NCT00221403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65447769|NCT00221403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65447770|NCT00221403|Serotonin Agents|serotonin agents|mesh-ancestor
65447771|NCT00221403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65447772|NCT00221403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447797|NCT00238238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447798|NCT00238238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65447799|NCT00238238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65447800|NCT00238238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65447801|NCT00238238|Growth Substances|growth substances|mesh-ancestor
65447802|NCT00238238|Growth Inhibitors|growth inhibitors|mesh-ancestor
65447803|NCT01073852|Hydroxychloroquine|hydroxychloroquine|mesh-list
65447804|NCT01073852|Antimalarials|antimalarials|mesh-ancestor
65447805|NCT01073852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65447806|NCT01073852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65447807|NCT01073852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65447808|NCT01073852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447809|NCT01073852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447810|NCT01073852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65447811|NCT01071122|Valsartan|valsartan|mesh-list
65447812|NCT01071122|Nifedipine|nifedipine|mesh-list
65447813|NCT01071122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65447814|NCT01071122|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65447815|NCT01071122|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65447816|NCT01071122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447817|NCT01071122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65447818|NCT01071122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65447819|NCT01071122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65447820|NCT01071122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447821|NCT01071122|Vasodilator Agents|vasodilator agents|mesh-ancestor
65447822|NCT01071122|Tocolytic Agents|tocolytic agents|mesh-ancestor
65447823|NCT01071122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65447825|NCT01072604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64832520|NCT01595152|Fesoterodine|fesoterodine|mesh-list
65447839|NCT01072604|Antipyretics|antipyretics|mesh-ancestor
65447840|NCT00128661|Vaccines|vaccines|mesh-list
65447841|NCT00128661|Immunologic Factors|immunologic factors|mesh-ancestor
65447842|NCT00128661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447843|NCT00145509|Asenapine|asenapine|mesh-list
65447844|NCT00145509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65447845|NCT00145509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65447846|NCT00145509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65447847|NCT00145509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447848|NCT00145509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65447849|NCT03965871|Esketamine|esketamine|mesh-list
65447850|NCT03965871|Antidepressive Agents|antidepressive agents|mesh-ancestor
65447851|NCT03965871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65447852|NCT03965949|Hormones|hormones|mesh-list
65447853|NCT03965949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65447854|NCT03965949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011733|NCT00140894|Analgesics|analgesics|mesh-ancestor
65447855|NCT00220779|Immunoglobulins|immunoglobulins|mesh-list
65447856|NCT00220779|Antibodies|antibodies|mesh-list
65447857|NCT00220779|gamma-Globulins|gamma-globulins|mesh-list
65447858|NCT00220779|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65447859|NCT00220779|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65447860|NCT00220779|Immunoglobulin G|immunoglobulin g|mesh-list
65447861|NCT00220779|Immunologic Factors|immunologic factors|mesh-ancestor
65447862|NCT00220779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447863|NCT00207740|Golimumab|golimumab|mesh-list
65447864|NCT00207740|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65447865|NCT00207740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65447866|NCT00207740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65447867|NCT00207740|Immunologic Factors|immunologic factors|mesh-ancestor
65447868|NCT00207740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447869|NCT00265382|Ziprasidone|ziprasidone|mesh-list
65447870|NCT00265382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65447871|NCT00265382|Serotonin Agents|serotonin agents|mesh-ancestor
65447872|NCT00265382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65447873|NCT00265382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447874|NCT00265382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447875|NCT00265382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65447876|NCT00265382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65447877|NCT00265382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65447878|NCT00265382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65447879|NCT00265382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65447880|NCT00265382|Dopamine Agents|dopamine agents|mesh-ancestor
65447881|NCT03974984|Anesthetics|anesthetics|mesh-list
65447882|NCT03974984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65447883|NCT03974984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447884|NCT00206726|Fludarabine|fludarabine|mesh-list
65447885|NCT00206726|Alemtuzumab|alemtuzumab|mesh-list
65447886|NCT00206726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447887|NCT00206726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65447893|NCT00237458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447895|NCT01581788|Anticonvulsants|anticonvulsants|mesh-ancestor
65447896|NCT01581788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447897|NCT01581788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447898|NCT01581788|GABA Agents|gaba agents|mesh-ancestor
65447899|NCT01581788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65447900|NCT01581788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447901|NCT01581788|Antimanic Agents|antimanic agents|mesh-ancestor
65447902|NCT01581788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65447903|NCT01581788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65447904|NCT01581788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65447905|NCT00265148|Rosiglitazone|rosiglitazone|mesh-list
65447906|NCT00265148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65447907|NCT00265148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447908|NCT00043186|Denosumab|denosumab|mesh-list
65447909|NCT00043186|Alendronate|alendronate|mesh-list
65447910|NCT00043186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65447911|NCT00043186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447912|NCT00041470|Paclitaxel|paclitaxel|mesh-list
65447913|NCT00041470|Vinorelbine|vinorelbine|mesh-list
65447914|NCT00041470|Trastuzumab|trastuzumab|mesh-list
65447915|NCT00041470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65447916|NCT00041470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447917|NCT00041470|Tubulin Modulators|tubulin modulators|mesh-ancestor
65447918|NCT00041470|Antimitotic Agents|antimitotic agents|mesh-ancestor
65447919|NCT00041470|Mitosis Modulators|mitosis modulators|mesh-ancestor
65447920|NCT00041470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447921|NCT00041470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65447922|NCT03953950|Losartan|losartan|mesh-list
65447923|NCT03953950|Spironolactone|spironolactone|mesh-list
65447924|NCT03953950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65447925|NCT03953950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65447926|NCT03953950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65447927|NCT03953950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65447928|NCT03953950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447929|NCT03953950|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65447930|NCT03953950|Hormone Antagonists|hormone antagonists|mesh-ancestor
65447931|NCT03953950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65447932|NCT03953950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447933|NCT03953950|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65447934|NCT03953950|Diuretics|diuretics|mesh-ancestor
65447935|NCT03953950|Natriuretic Agents|natriuretic agents|mesh-ancestor
65447936|NCT00206102|Risperidone|risperidone|mesh-list
65447937|NCT00206102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65447938|NCT00206102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65447939|NCT00206102|Serotonin Agents|serotonin agents|mesh-ancestor
65447940|NCT00206102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65447941|NCT00206102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447942|NCT00206102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447943|NCT00206102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65447944|NCT00206102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65447945|NCT00206102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65447946|NCT00206102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65447947|NCT00206102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65447948|NCT00206102|Dopamine Agents|dopamine agents|mesh-ancestor
65447949|NCT00206102|Antidepressive Agents|antidepressive agents|mesh-ancestor
65447950|NCT03954262|Propofol|propofol|mesh-list
65447951|NCT03954262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65447952|NCT03954262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65447953|NCT03954262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447954|NCT03954262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65447955|NCT03954262|Anesthetics, General|anesthetics, general|mesh-ancestor
65447956|NCT03954262|Anesthetics|anesthetics|mesh-ancestor
65447957|NCT00041080|Tamoxifen|tamoxifen|mesh-list
65447958|NCT00041080|Thalidomide|thalidomide|mesh-list
65447962|NCT00041080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447963|NCT00041080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65447964|NCT00041080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447965|NCT00041080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65447966|NCT00041080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65447967|NCT00041080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65447968|NCT00041080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65447969|NCT00041080|Immunologic Factors|immunologic factors|mesh-ancestor
65447970|NCT00041080|Leprostatic Agents|leprostatic agents|mesh-ancestor
65447971|NCT00041080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65447972|NCT00041080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65447973|NCT00041080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65447974|NCT00041080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65447975|NCT00041080|Growth Substances|growth substances|mesh-ancestor
65447976|NCT00041080|Growth Inhibitors|growth inhibitors|mesh-ancestor
65447977|NCT00205712|Dexmedetomidine|dexmedetomidine|mesh-list
65447978|NCT00205712|Ketamine|ketamine|mesh-list
65447979|NCT00205712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65447980|NCT00205712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65447981|NCT00205712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447982|NCT00205712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65447983|NCT00205712|Analgesics|analgesics|mesh-ancestor
65447984|NCT00205712|Sensory System Agents|sensory system agents|mesh-ancestor
65447985|NCT00205712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65447986|NCT00205712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65447987|NCT00205712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65447988|NCT00205712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65447989|NCT00205712|Adrenergic Agents|adrenergic agents|mesh-ancestor
65447990|NCT00205712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65447991|NCT00205712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447992|NCT00205712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65447993|NCT00205712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65447994|NCT00205712|Anesthetics, General|anesthetics, general|mesh-ancestor
65447995|NCT00205712|Anesthetics|anesthetics|mesh-ancestor
65447996|NCT00205712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65447997|NCT00205712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65447998|NCT03969758|Metronidazole|metronidazole|mesh-list
65447999|NCT03969758|Ciprofloxacin|ciprofloxacin|mesh-list
65448000|NCT03969758|Cefixime|cefixime|mesh-list
65448001|NCT03969758|Liver Extracts|liver extracts|mesh-list
65448002|NCT03969758|Hematinics|hematinics|mesh-ancestor
65448003|NCT03969758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65448004|NCT03969758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65448005|NCT03969758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65448006|NCT03969758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65448007|NCT03969758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65448008|NCT03969758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65448009|NCT03969758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448010|NCT03969758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448011|NCT03969758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448012|NCT03969758|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65011880|NCT00141362|Pregabalin|pregabalin|mesh-list
65448013|NCT03969758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65448014|NCT00203294|Triamcinolone|triamcinolone|mesh-list
65448015|NCT00203294|Lidocaine|lidocaine|mesh-list
65448016|NCT00203294|Bupivacaine|bupivacaine|mesh-list
65448017|NCT00203294|Anesthetics, Local|anesthetics, local|mesh-ancestor
65448018|NCT00203294|Anesthetics|anesthetics|mesh-ancestor
65448019|NCT00203294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65448020|NCT00203294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448021|NCT00203294|Sensory System Agents|sensory system agents|mesh-ancestor
65448022|NCT00203294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65448023|NCT00203294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65448024|NCT00203294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65448025|NCT00203294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65448026|NCT00203294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65448027|NCT00203294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448042|NCT00234494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65448043|NCT00234494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448044|NCT00234494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65448045|NCT00234494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65448046|NCT00234494|Growth Substances|growth substances|mesh-ancestor
65448047|NCT00234494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448048|NCT00234494|Growth Inhibitors|growth inhibitors|mesh-ancestor
65448049|NCT00234494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65448050|NCT00234494|Antimetabolites|antimetabolites|mesh-ancestor
65448051|NCT00234494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448052|NCT00234494|Antiviral Agents|antiviral agents|mesh-ancestor
65448053|NCT00234494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65448054|NCT00234494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448055|NCT00234494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65448056|NCT00234494|Immunologic Factors|immunologic factors|mesh-ancestor
65448057|NCT00234104|Tolvaptan|tolvaptan|mesh-list
65448058|NCT00234104|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65448059|NCT00234104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448060|NCT00234104|Natriuretic Agents|natriuretic agents|mesh-ancestor
65448061|NCT00234104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448062|NCT01582568|Certolizumab Pegol|certolizumab pegol|mesh-list
65448063|NCT01582568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65448064|NCT01582568|Immunologic Factors|immunologic factors|mesh-ancestor
65448065|NCT01582568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448066|NCT01582568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65448067|NCT00195338|Etanercept|etanercept|mesh-list
65448068|NCT00195338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65448069|NCT00195338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65448070|NCT00195338|Analgesics|analgesics|mesh-ancestor
65448071|NCT00195338|Sensory System Agents|sensory system agents|mesh-ancestor
65448072|NCT00195338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65448073|NCT00195338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448074|NCT00195338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65448075|NCT00195338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65448076|NCT00195338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65448077|NCT00195338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65448078|NCT00195338|Immunologic Factors|immunologic factors|mesh-ancestor
65448079|NCT00039130|Leucovorin|leucovorin|mesh-list
65448080|NCT00039130|Cytarabine|cytarabine|mesh-list
65448081|NCT00039130|Dexamethasone|dexamethasone|mesh-list
65448082|NCT00039130|Prednisone|prednisone|mesh-list
65448083|NCT00039130|Cyclophosphamide|cyclophosphamide|mesh-list
65448084|NCT00039130|Ifosfamide|ifosfamide|mesh-list
65448085|NCT00039130|Rituximab|rituximab|mesh-list
65448086|NCT00039130|Doxorubicin|doxorubicin|mesh-list
65448087|NCT00039130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65448088|NCT00039130|Methotrexate|methotrexate|mesh-list
65448089|NCT00039130|Etoposide|etoposide|mesh-list
65448090|NCT00039130|Vincristine|vincristine|mesh-list
65448091|NCT00039130|Allopurinol|allopurinol|mesh-list
65448092|NCT00039130|Levoleucovorin|levoleucovorin|mesh-list
65448154|NCT01096654|Sympathomimetics|sympathomimetics|mesh-ancestor
65448155|NCT01096654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65448157|NCT00035932|Lopinavir|lopinavir|mesh-list
65448158|NCT00035932|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65448159|NCT00035932|Saquinavir|saquinavir|mesh-list
65448160|NCT00035932|Tenofovir|tenofovir|mesh-list
65448161|NCT00035932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65448162|NCT00035932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65448163|NCT00035932|Protease Inhibitors|protease inhibitors|mesh-ancestor
65448806|NCT01098448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448807|NCT01098526|Efavirenz|efavirenz|mesh-list
65448808|NCT01098526|Dolutegravir|dolutegravir|mesh-list
65448809|NCT01098526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65448810|NCT01098526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65448811|NCT01098526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448812|NCT01098526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448813|NCT01098526|Antiviral Agents|antiviral agents|mesh-ancestor
65448814|NCT01098526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65448815|NCT01098526|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65448816|NCT01098526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65448817|NCT01098526|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65448818|NCT01098526|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64835209|NCT02420821|Growth Substances|growth substances|mesh-ancestor
64835210|NCT02420821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835211|NCT02420821|Growth Inhibitors|growth inhibitors|mesh-ancestor
64835212|NCT02420821|Immunologic Factors|immunologic factors|mesh-ancestor
64835213|NCT02420821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64835214|NCT02420821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835215|NCT02420821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835216|NCT02398773|Estradiol|estradiol|mesh-list
64835217|NCT02398773|Estrogens|estrogens|mesh-ancestor
64835218|NCT02398773|Hormones|hormones|mesh-ancestor
64835219|NCT02398773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64835220|NCT02398773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450713|NCT01212250|Protective Agents|protective agents|mesh-ancestor
65450714|NCT01212250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65450715|NCT01212250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65450716|NCT01212250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65450717|NCT01212250|Vasodilator Agents|vasodilator agents|mesh-ancestor
65450718|NCT01212250|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65450719|NCT01212250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65450720|NCT01209988|Tamsulosin|tamsulosin|mesh-list
65450721|NCT01209988|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65450722|NCT01209988|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65450723|NCT01209988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65450724|NCT01209988|Adrenergic Agents|adrenergic agents|mesh-ancestor
65452061|NCT03927118|Dexamethasone acetate|dexamethasone acetate|mesh-list
65452062|NCT03927118|BB 1101|bb 1101|mesh-list
65452063|NCT03927118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65452064|NCT03927118|Antiemetics|antiemetics|mesh-ancestor
65452065|NCT03927118|Autonomic Agents|autonomic agents|mesh-ancestor
65453303|NCT00425945|Pycnogenols|pycnogenols|mesh-list
65453304|NCT00425945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65453305|NCT00425945|Immunologic Factors|immunologic factors|mesh-ancestor
65453306|NCT00425945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453307|NCT00425945|Antioxidants|antioxidants|mesh-ancestor
65453308|NCT00425945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837900|NCT01621451|Aspirin|aspirin|mesh-list
65453659|NCT00423449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838250|NCT01623817|Vancomycin|vancomycin|mesh-list
65453953|NCT00421343|Calcium Carbonate|calcium carbonate|mesh-list
65453954|NCT00421343|Calcium|calcium|mesh-list
65453955|NCT00421343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65453956|NCT00421343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453957|NCT00421343|Vitamins|vitamins|mesh-ancestor
65453958|NCT00421343|Micronutrients|micronutrients|mesh-ancestor
65453959|NCT00421343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65453960|NCT00421343|Antacids|antacids|mesh-ancestor
65453961|NCT00421343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453962|NCT00421343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65453963|NCT01147588|Esomeprazole|esomeprazole|mesh-list
65454236|NCT03914092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64839181|NCT01630278|Analgesics|analgesics|mesh-ancestor
65454837|NCT01153828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454838|NCT01151722|Bevacizumab|bevacizumab|mesh-list
65454839|NCT01151722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65454840|NCT01151722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454841|NCT01151722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65454842|NCT01151722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65454843|NCT01151722|Growth Substances|growth substances|mesh-ancestor
65454844|NCT01151722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454845|NCT01151722|Growth Inhibitors|growth inhibitors|mesh-ancestor
65454846|NCT01258192|Paclitaxel|paclitaxel|mesh-list
65454847|NCT01258192|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65454848|NCT01258192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65012024|NCT04518982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65454849|NCT01258192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454850|NCT01258192|Tubulin Modulators|tubulin modulators|mesh-ancestor
65455555|NCT01266694|Tubulin Modulators|tubulin modulators|mesh-ancestor
65455556|NCT01266694|Antimitotic Agents|antimitotic agents|mesh-ancestor
65455557|NCT01266694|Mitosis Modulators|mitosis modulators|mesh-ancestor
65455558|NCT01266694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840093|NCT01636128|Eflornithine|eflornithine|mesh-list
65455747|NCT01159132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65455748|NCT01159132|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65455749|NCT01159132|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65455750|NCT01159132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455751|NCT01159132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455752|NCT01161316|Cetuximab|cetuximab|mesh-list
65455753|NCT01161316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65455754|NCT01161316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455755|NCT01161550|Cytarabine|cytarabine|mesh-list
65455756|NCT01161550|Tretinoin|tretinoin|mesh-list
65455757|NCT01161550|Cladribine|cladribine|mesh-list
65455758|NCT01161550|Midostaurin|midostaurin|mesh-list
65455759|NCT01161550|Lenograstim|lenograstim|mesh-list
65455760|NCT01161550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65455761|NCT01161550|Antimetabolites|antimetabolites|mesh-ancestor
65455762|NCT01161550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455784|NCT03877120|Dexmedetomidine|dexmedetomidine|mesh-list
65455785|NCT03877120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65455786|NCT03877120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65455787|NCT03877120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455788|NCT03877120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65455789|NCT03877120|Analgesics|analgesics|mesh-ancestor
65455790|NCT03877120|Sensory System Agents|sensory system agents|mesh-ancestor
65455791|NCT03877120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455792|NCT03877120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65455793|NCT03877120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65455794|NCT03877120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65455795|NCT03877120|Adrenergic Agents|adrenergic agents|mesh-ancestor
65455796|NCT03877120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65455797|NCT03877120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455798|NCT03877120|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65455799|NCT03877120|Anticonvulsants|anticonvulsants|mesh-ancestor
65455800|NCT03877120|Antiemetics|antiemetics|mesh-ancestor
65455801|NCT03877120|Autonomic Agents|autonomic agents|mesh-ancestor
65455802|NCT03877120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65455803|NCT03877120|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65455804|NCT03877120|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65455805|NCT03877120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65455806|NCT03877120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65455807|NCT03877120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65455808|NCT03877120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65455809|NCT03877120|Anesthetics, General|anesthetics, general|mesh-ancestor
65455810|NCT03877120|Anesthetics|anesthetics|mesh-ancestor
65455811|NCT03877120|GABA Modulators|gaba modulators|mesh-ancestor
65455812|NCT03877120|GABA Agents|gaba agents|mesh-ancestor
65455813|NCT03879382|Cyclophosphamide|cyclophosphamide|mesh-list
65455814|NCT03879382|Fludarabine|fludarabine|mesh-list
65455815|NCT03879382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65455816|NCT03879382|Immunologic Factors|immunologic factors|mesh-ancestor
65455817|NCT03879382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455818|NCT03879382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65455819|NCT03879382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65455827|NCT01166932|Clavulanic Acid|clavulanic acid|mesh-list
65455829|NCT01166932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65455830|NCT01166932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65455831|NCT01166932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455832|NCT01166932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455833|NCT01166932|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65455834|NCT01167010|Budesonide|budesonide|mesh-list
65455835|NCT01167010|Formoterol Fumarate|formoterol fumarate|mesh-list
65455836|NCT01167010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65455837|NCT01167010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65455838|NCT01167010|Autonomic Agents|autonomic agents|mesh-ancestor
65455839|NCT01167010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455840|NCT01167010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455841|NCT01167010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65455842|NCT01167010|Respiratory System Agents|respiratory system agents|mesh-ancestor
65455843|NCT01167010|Glucocorticoids|glucocorticoids|mesh-ancestor
65455844|NCT01167010|Hormones|hormones|mesh-ancestor
65455845|NCT01167010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65455846|NCT01167010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65455847|NCT01167010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65455848|NCT01167010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65455849|NCT01167010|Adrenergic Agents|adrenergic agents|mesh-ancestor
65455850|NCT01167010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65455851|NCT01167010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455852|NCT01280188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65455853|NCT01280188|Hemostatics|hemostatics|mesh-ancestor
65455854|NCT01280188|Coagulants|coagulants|mesh-ancestor
65455855|NCT01280188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65455856|NCT01280188|Natriuretic Agents|natriuretic agents|mesh-ancestor
65455857|NCT01280188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455858|NCT03871972|Sirolimus|sirolimus|mesh-list
65455859|NCT03871972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65455860|NCT03871972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65455861|NCT03871972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65455862|NCT03871972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455863|NCT03871972|Antifungal Agents|antifungal agents|mesh-ancestor
65455864|NCT03871972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65455865|NCT03871972|Immunologic Factors|immunologic factors|mesh-ancestor
65455866|NCT03871972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455867|NCT01165060|Bezafibrate|bezafibrate|mesh-list
65455868|NCT01165060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65455869|NCT01165060|Antimetabolites|antimetabolites|mesh-ancestor
65455870|NCT01165060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455871|NCT01165060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65455872|NCT01165294|Ketamine|ketamine|mesh-list
65455873|NCT01165294|Analgesics|analgesics|mesh-ancestor
65455874|NCT01165294|Sensory System Agents|sensory system agents|mesh-ancestor
65455875|NCT01165294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455876|NCT01165294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455877|NCT01165294|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65455878|NCT01165294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65455879|NCT01165294|Anesthetics, General|anesthetics, general|mesh-ancestor
65455880|NCT01165294|Anesthetics|anesthetics|mesh-ancestor
65455881|NCT01165294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65455882|NCT01165294|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65455883|NCT01165294|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65455884|NCT01165294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65455885|NCT01165294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455886|NCT01165372|Artesunate|artesunate|mesh-list
65455887|NCT01165372|Piperaquine|piperaquine|mesh-list
65455888|NCT01165372|Artenimol|artenimol|mesh-list
65455889|NCT01165372|Antimalarials|antimalarials|mesh-ancestor
65455904|NCT01269970|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65455905|NCT01269970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65455906|NCT01269970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455907|NCT01587430|Cytarabine|cytarabine|mesh-list
65455908|NCT01587430|Daunorubicin|daunorubicin|mesh-list
65455909|NCT01587430|Mitoxantrone|mitoxantrone|mesh-list
65455910|NCT01587430|Idarubicin|idarubicin|mesh-list
65455911|NCT01587430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65455912|NCT01587430|Antimetabolites|antimetabolites|mesh-ancestor
65455913|NCT01587430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455914|NCT01587430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455915|NCT01587430|Antiviral Agents|antiviral agents|mesh-ancestor
65455916|NCT01587430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65455917|NCT01587430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65455918|NCT01587430|Immunologic Factors|immunologic factors|mesh-ancestor
65455919|NCT01587430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455920|NCT01587430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65455921|NCT01587430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65455922|NCT01587430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65455923|NCT01587430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455924|NCT01587430|Analgesics|analgesics|mesh-ancestor
65455925|NCT01587430|Sensory System Agents|sensory system agents|mesh-ancestor
65455926|NCT01587430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455927|NCT03874000|Metformin|metformin|mesh-list
65455928|NCT03874000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65455929|NCT03874000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455930|NCT03757234|Levofloxacin|levofloxacin|mesh-list
65455931|NCT03757234|Ofloxacin|ofloxacin|mesh-list
65455932|NCT03757234|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65455933|NCT03757234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65455934|NCT03757234|Renal Agents|renal agents|mesh-ancestor
65455935|NCT03757234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65455936|NCT03757234|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65455937|NCT03757234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65455938|NCT03757234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455939|NCT03757234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455940|NCT03757234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455941|NCT03757234|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65455942|NCT03757234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65455943|NCT03874156|Atorvastatin|atorvastatin|mesh-list
65455944|NCT03874156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65455945|NCT03874156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65455946|NCT03874156|Antimetabolites|antimetabolites|mesh-ancestor
65455947|NCT03874156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455948|NCT03874156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65455949|NCT03874156|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65455950|NCT03874156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455951|NCT01167478|Caffeine|caffeine|mesh-list
65456270|NCT01168804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65456271|NCT01168804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456272|NCT01168804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65456273|NCT01168804|Alkylating Agents|alkylating agents|mesh-ancestor
65456274|NCT01168804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456275|NCT03873532|Capecitabine|capecitabine|mesh-list
65456276|NCT03873532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65456277|NCT03873532|Antimetabolites|antimetabolites|mesh-ancestor
65456278|NCT03873532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456279|NCT03873532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456280|NCT01282528|Infliximab|infliximab|mesh-list
65456281|NCT01282528|Dermatologic Agents|dermatologic agents|mesh-ancestor
65456282|NCT01282528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65456283|NCT01282528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65456845|NCT03860662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456846|NCT01177696|Psychotropic Drugs|psychotropic drugs|mesh-list
65456848|NCT01177852|Promethazine|promethazine|mesh-list
65456849|NCT01177852|Brompheniramine|brompheniramine|mesh-list
65456850|NCT01177852|Pseudoephedrine|pseudoephedrine|mesh-list
65456851|NCT01177852|Brompheniramine, pseudoephedrine drug combination|brompheniramine, pseudoephedrine drug combination|mesh-list
65457038|NCT01178788|Progestins|progestins|mesh-ancestor
65457040|NCT01178788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65457041|NCT01178788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457462|NCT01289938|Anesthetics|anesthetics|mesh-ancestor
65457463|NCT01289938|Sensory System Agents|sensory system agents|mesh-ancestor
65457464|NCT01289938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457465|NCT01289938|Antiemetics|antiemetics|mesh-ancestor
65457466|NCT01289938|Autonomic Agents|autonomic agents|mesh-ancestor
65457467|NCT01289938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65457468|NCT01289938|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65457469|NCT01289938|Histamine Antagonists|histamine antagonists|mesh-ancestor
65457470|NCT01289938|Histamine Agents|histamine agents|mesh-ancestor
65457471|NCT01289938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842000|NCT01654575|Immunologic Factors|immunologic factors|mesh-ancestor
65457593|NCT01184638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65457594|NCT01184638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457595|NCT01184638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65457596|NCT01184638|Anesthetics, General|anesthetics, general|mesh-ancestor
65457598|NCT01184638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65457599|NCT01184638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65457600|NCT01290328|Epoetin Alfa|epoetin alfa|mesh-list
65457601|NCT01290328|Hematinics|hematinics|mesh-ancestor
65457602|NCT01184716|Vitamin D|vitamin d|mesh-list
65457603|NCT01184716|Vitamins|vitamins|mesh-ancestor
65457604|NCT01184716|Micronutrients|micronutrients|mesh-ancestor
65457605|NCT01184716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457606|NCT01184716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65457607|NCT01184794|Levobupivacaine|levobupivacaine|mesh-list
65457608|NCT01184794|Anesthetics, Local|anesthetics, local|mesh-ancestor
65457609|NCT01184794|Anesthetics|anesthetics|mesh-ancestor
65457610|NCT01184794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65457611|NCT01184794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457612|NCT01184794|Sensory System Agents|sensory system agents|mesh-ancestor
65457613|NCT01184794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457614|NCT01587508|Meloxicam|meloxicam|mesh-list
65457615|NCT01587508|Amitriptyline|amitriptyline|mesh-list
65457616|NCT01587508|Cyclobenzaprine|cyclobenzaprine|mesh-list
65457617|NCT01587508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65457618|NCT01587508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65457619|NCT01587508|Analgesics|analgesics|mesh-ancestor
65457620|NCT01587508|Sensory System Agents|sensory system agents|mesh-ancestor
65457621|NCT01587508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457622|NCT01587508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457623|NCT01587508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65457624|NCT01587508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65457625|NCT01587508|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65457626|NCT01587508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65457627|NCT01587508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457628|NCT01587508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458097|NCT02524210|Dabigatran|dabigatran|mesh-list
65458098|NCT02524210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65458099|NCT02524210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65458100|NCT02524210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65458101|NCT02524210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458102|NCT02524210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458103|NCT02524210|Antithrombins|antithrombins|mesh-ancestor
65458176|NCT03849196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65458177|NCT03849196|Laxatives|laxatives|mesh-ancestor
65458178|NCT01292668|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65458179|NCT01292668|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65458180|NCT01292668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65458181|NCT01292668|Dermatologic Agents|dermatologic agents|mesh-ancestor
65458182|NCT01296802|Fenfluramine|fenfluramine|mesh-list
65458183|NCT01296802|Dexfenfluramine|dexfenfluramine|mesh-list
65458184|NCT01296802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65458185|NCT01296802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65458186|NCT01296802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65458187|NCT01296802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458188|NCT01296802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65458189|NCT01296802|Serotonin Agents|serotonin agents|mesh-ancestor
65458190|NCT01296802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458191|NCT01296802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65458192|NCT01296958|Niclosamide|niclosamide|mesh-list
65458193|NCT01296958|Anticestodal Agents|anticestodal agents|mesh-ancestor
65458194|NCT01296958|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65458195|NCT01296958|Anthelmintics|anthelmintics|mesh-ancestor
65458196|NCT01296958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65458197|NCT01296958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65458198|NCT01296958|Antinematodal Agents|antinematodal agents|mesh-ancestor
65458199|NCT01295086|Docetaxel|docetaxel|mesh-list
65458200|NCT01295086|Capecitabine|capecitabine|mesh-list
65458201|NCT01295086|Oxaliplatin|oxaliplatin|mesh-list
65458202|NCT01295086|Trastuzumab|trastuzumab|mesh-list
65458203|NCT01295086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458204|NCT01295086|Tubulin Modulators|tubulin modulators|mesh-ancestor
65458205|NCT01295086|Antimitotic Agents|antimitotic agents|mesh-ancestor
65458206|NCT01295086|Mitosis Modulators|mitosis modulators|mesh-ancestor
65458207|NCT01295086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458208|NCT01295086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65458209|NCT01295086|Antimetabolites|antimetabolites|mesh-ancestor
65458210|NCT01295086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65458211|NCT01194700|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65458212|NCT01194700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65458213|NCT01194700|Autonomic Agents|autonomic agents|mesh-ancestor
65458214|NCT01194700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458215|NCT01194700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458216|NCT01194700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65458217|NCT01194700|Respiratory System Agents|respiratory system agents|mesh-ancestor
65458218|NCT01194700|Glucocorticoids|glucocorticoids|mesh-ancestor
65458398|NCT01197040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65458399|NCT01197040|Antitubercular Agents|antitubercular agents|mesh-ancestor
65458400|NCT01197040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65458401|NCT01197040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65458402|NCT01197040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458403|NCT01197040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458404|NCT05440864|Durvalumab|durvalumab|mesh-list
65458405|NCT05440864|Tremelimumab|tremelimumab|mesh-list
65458549|NCT01198054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458550|NCT01198054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65458551|NCT01198054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65458552|NCT01198054|Growth Substances|growth substances|mesh-ancestor
65458553|NCT01198054|Growth Inhibitors|growth inhibitors|mesh-ancestor
65458554|NCT01198054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458640|NCT01198210|Anesthetics|anesthetics|mesh-ancestor
65458641|NCT01198210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65458642|NCT01198210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65458643|NCT01198210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65458644|NCT01198210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65458645|NCT03843736|Drospirenone|drospirenone|mesh-list
65458646|NCT03843736|Contraceptive Agents|contraceptive agents|mesh-list
65458647|NCT03843736|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65458648|NCT03843736|Contraceptives, Oral|contraceptives, oral|mesh-list
65458649|NCT03843736|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65458650|NCT03843736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65458651|NCT03843736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458652|NCT03843736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65458653|NCT03843736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65458654|NCT03843736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65458655|NCT03843736|Estrogens|estrogens|mesh-ancestor
65458656|NCT03843736|Hormones|hormones|mesh-ancestor
65458657|NCT03843736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65458658|NCT03843736|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65458659|NCT03843736|Hormone Antagonists|hormone antagonists|mesh-ancestor
65458660|NCT03843736|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65458661|NCT03843736|Diuretics|diuretics|mesh-ancestor
65458662|NCT03843736|Natriuretic Agents|natriuretic agents|mesh-ancestor
65458663|NCT01200472|Apremilast|apremilast|mesh-list
65458740|NCT05132920|Glucocorticoids|glucocorticoids|mesh-ancestor
65458742|NCT05132920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65458743|NCT05132920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65458744|NCT05132920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458745|NCT03841474|Citalopram|citalopram|mesh-list
65458746|NCT03841474|Sertraline|sertraline|mesh-list
65458747|NCT03841474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65458748|NCT03841474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65458749|NCT03841474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65458750|NCT03841474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458751|NCT03841474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65458752|NCT03841474|Serotonin Agents|serotonin agents|mesh-ancestor
65458753|NCT03841474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843230|NCT01660620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65459136|NCT01204996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65459137|NCT01204996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65459138|NCT01297192|Solifenacin Succinate|solifenacin succinate|mesh-list
65459139|NCT01297192|Mirabegron|mirabegron|mesh-list
65459140|NCT01297192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65459141|NCT01297192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65459142|NCT01297192|Cholinergic Agents|cholinergic agents|mesh-ancestor
65459143|NCT01297192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65459144|NCT01297192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459145|NCT01297192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459146|NCT01297192|Urological Agents|urological agents|mesh-ancestor
65459147|NCT01297192|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65459148|NCT01297192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65459149|NCT01297192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65459150|NCT01297192|Adrenergic Agents|adrenergic agents|mesh-ancestor
65459151|NCT01205074|Ethanol|ethanol|mesh-list
65459152|NCT01205074|Propranolol|propranolol|mesh-list
65459153|NCT01205074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65459154|NCT01205074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65459155|NCT01205074|Adrenergic Agents|adrenergic agents|mesh-ancestor
65459156|NCT01205074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65459157|NCT01205074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459158|NCT01205074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459159|NCT01205074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65459160|NCT01205074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65459161|NCT01205074|Vasodilator Agents|vasodilator agents|mesh-ancestor
65459162|NCT01205074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65459163|NCT01205074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65459164|NCT01205074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65459165|NCT05667376|Curcumin|curcumin|mesh-list
65459166|NCT05667376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65459167|NCT05667376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65459168|NCT05667376|Analgesics|analgesics|mesh-ancestor
65459169|NCT05667376|Sensory System Agents|sensory system agents|mesh-ancestor
65270067|NCT02129348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65270068|NCT02129348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270069|NCT02725736|Nifedipine|nifedipine|mesh-list
65270070|NCT02725736|Atosiban|atosiban|mesh-list
65270071|NCT02725736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65270072|NCT02725736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65270073|NCT02725736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270074|NCT02725736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65270075|NCT02725736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270076|NCT02725736|Vasodilator Agents|vasodilator agents|mesh-ancestor
65270077|NCT02725736|Tocolytic Agents|tocolytic agents|mesh-ancestor
65270078|NCT02725736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65270079|NCT02725736|Hormone Antagonists|hormone antagonists|mesh-ancestor
65270080|NCT02725736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65270081|NCT02716142|Misoprostol|misoprostol|mesh-list
65012400|NCT00505804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65459170|NCT05667376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65459171|NCT05667376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459172|NCT05667376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65459173|NCT05667376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65459174|NCT05667376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459175|NCT05667376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459176|NCT05667376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843827|NCT01665235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459775|NCT04979806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65459776|NCT04979806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65459777|NCT00255164|Dexlansoprazole|dexlansoprazole|mesh-list
65459779|NCT00255164|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65459780|NCT00255164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65459781|NCT00255164|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65459782|NCT00255164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459783|NCT00255164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328018|NCT00492999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64328020|NCT00492999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64328021|NCT00492999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64328022|NCT00492999|Antimetabolites|antimetabolites|mesh-ancestor
64328351|NCT02403687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328352|NCT02403687|Analgesics|analgesics|mesh-ancestor
64328355|NCT02403687|Anesthetics, General|anesthetics, general|mesh-ancestor
64328356|NCT02403687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64328357|NCT02403687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64328358|NCT02403687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65460550|NCT01305850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65460551|NCT01305850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460552|NCT01305850|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65460553|NCT01305850|Protease Inhibitors|protease inhibitors|mesh-ancestor
64845263|NCT05057949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64845264|NCT05057949|Hormone Antagonists|hormone antagonists|mesh-ancestor
64845265|NCT05057949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65460738|NCT00139776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65460739|NCT00139776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65460740|NCT00139776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65460741|NCT00139776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270090|NCT03015974|Prednisone|prednisone|mesh-list
65270157|NCT02718482|Antimetabolites|antimetabolites|mesh-ancestor
65270302|NCT02694224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270450|NCT02650479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65270598|NCT00302744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65270599|NCT00302744|Vasodilator Agents|vasodilator agents|mesh-ancestor
65270747|NCT04002362|Triamcinolone|triamcinolone|mesh-list
65270748|NCT04002362|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65270820|NCT02709902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65270821|NCT02709902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65270971|NCT02637375|Paclitaxel|paclitaxel|mesh-list
65271204|NCT03781544|Narcotics|narcotics|mesh-ancestor
65271272|NCT03769766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65271345|NCT00884793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65271567|NCT02535351|Sunitinib|sunitinib|mesh-list
65271577|NCT00613964|Diuretics|diuretics|mesh-list
65271640|NCT02690480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271711|NCT00911313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271784|NCT00597519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65271860|NCT02630823|Tubulin Modulators|tubulin modulators|mesh-ancestor
65271947|NCT00667407|Albuterol|albuterol|mesh-list
65272013|NCT03481556|Hormones|hormones|mesh-ancestor
65272081|NCT04717700|Growth Inhibitors|growth inhibitors|mesh-ancestor
65272154|NCT00669591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65272303|NCT00613808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65272377|NCT03681158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272383|NCT05343806|Nifedipine|nifedipine|mesh-list
65272455|NCT02704520|Antimetabolites|antimetabolites|mesh-ancestor
65272532|NCT00615446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65272533|NCT00615446|Antimetabolites|antimetabolites|mesh-ancestor
65272534|NCT00615446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272535|NCT00615446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272536|NCT00615446|Antiviral Agents|antiviral agents|mesh-ancestor
65272537|NCT00615446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65272538|NCT00615446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272539|NCT00615446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65272540|NCT00615446|Immunologic Factors|immunologic factors|mesh-ancestor
65272541|NCT00615446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272542|NCT00615446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65272543|NCT00615446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65272597|NCT02402660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272598|NCT02402660|Protective Agents|protective agents|mesh-ancestor
65272669|NCT04215536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65272744|NCT02698514|Anesthetics|anesthetics|mesh-ancestor
65272823|NCT02698748|Filaricides|filaricides|mesh-ancestor
65272899|NCT02705768|Carbamazepine|carbamazepine|mesh-list
65272970|NCT04215614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65273043|NCT03059147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273044|NCT03356834|Tenofovir|tenofovir|mesh-list
65273045|NCT03356834|Antiviral Agents|antiviral agents|mesh-ancestor
65273046|NCT03356834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65273047|NCT03356834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65273048|NCT03356834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65273049|NCT03356834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273050|NCT03356834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273051|NCT03356834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65273052|NCT03356834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65273053|NCT02705066|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
65273054|NCT02705066|Nootropic Agents|nootropic agents|mesh-ancestor
65273055|NCT00615758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65273056|NCT00615758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273057|NCT00615758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65273058|NCT00615758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273059|NCT00615758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273060|NCT02704988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65273061|NCT02704754|Suvorexant|suvorexant|mesh-list
65273062|NCT02704754|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65273063|NCT02704754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65273064|NCT02704754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65273065|NCT02704754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273066|NCT02704754|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65273067|NCT02704754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65273068|NCT02704754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273069|NCT05182658|Empagliflozin|empagliflozin|mesh-list
65273070|NCT05182658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65273072|NCT05182658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65460742|NCT00139776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460743|NCT00413699|Tofacitinib|tofacitinib|mesh-list
65460744|NCT00413699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65460745|NCT00413699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460746|NCT00413699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460747|NCT03713320|Vorinostat|vorinostat|mesh-list
65460748|NCT03713320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460749|NCT03713320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65460750|NCT03713320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460751|NCT03713320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460752|NCT00420407|Vasopressins|vasopressins|mesh-list
65460753|NCT00420407|Arginine Vasopressin|arginine vasopressin|mesh-list
65460754|NCT00420407|Hemostatics|hemostatics|mesh-ancestor
65460755|NCT00420407|Coagulants|coagulants|mesh-ancestor
65460756|NCT00420407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65460757|NCT00420407|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65460758|NCT00420407|Natriuretic Agents|natriuretic agents|mesh-ancestor
65460759|NCT00420407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460760|NCT03789370|Propofol|propofol|mesh-list
64845317|NCT04810793|Ofloxacin|ofloxacin|mesh-list
64329566|NCT02296840|Antipyretics|antipyretics|mesh-ancestor
64329567|NCT02296840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64329568|NCT02296840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64329595|NCT02191709|Dextromethorphan|dextromethorphan|mesh-list
64329596|NCT02191709|Antitussive Agents|antitussive agents|mesh-ancestor
64329597|NCT02191709|Respiratory System Agents|respiratory system agents|mesh-ancestor
64329598|NCT02191709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64329599|NCT02191709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64329600|NCT02191709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64845418|NCT04432506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64845420|NCT04432506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845421|NCT04432506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64845422|NCT04432506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64845423|NCT04432506|Alkylating Agents|alkylating agents|mesh-ancestor
64845424|NCT04432506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845425|NCT04432506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845426|NCT04432506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64845427|NCT04281017|Anesthetics|anesthetics|mesh-list
64329717|NCT00317395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64329834|NCT04360941|Palbociclib|palbociclib|mesh-list
64329835|NCT04360941|Avelumab|avelumab|mesh-list
64329836|NCT04360941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329837|NCT04360941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64329838|NCT04360941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329839|NCT04360941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330194|NCT02378415|Anesthetics, General|anesthetics, general|mesh-ancestor
64330195|NCT02378415|Anesthetics|anesthetics|mesh-ancestor
64330196|NCT02378415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64330197|NCT02378415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64330198|NCT02378415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64330199|NCT02378415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64330200|NCT02378415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330201|NCT02197403|Dexmedetomidine|dexmedetomidine|mesh-list
64330202|NCT02197403|Propofol|propofol|mesh-list
64845533|NCT03894904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64845534|NCT03894904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845535|NCT03894904|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64845536|NCT03894904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845537|NCT03894904|Vasodilator Agents|vasodilator agents|mesh-ancestor
64845538|NCT03894904|Urological Agents|urological agents|mesh-ancestor
64330425|NCT00135421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330428|NCT00135421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330429|NCT00135421|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64845556|NCT03681652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64845557|NCT03681652|Antimetabolites|antimetabolites|mesh-ancestor
64845558|NCT03681652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845559|NCT03681652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64845560|NCT03681652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845561|NCT03681652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64845562|NCT03681652|Immunologic Factors|immunologic factors|mesh-ancestor
64845563|NCT03681652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845565|NCT03671525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64845566|NCT03671525|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65273085|NCT02909036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845567|NCT03671525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64845568|NCT03671525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845569|NCT03671525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65461158|NCT01561222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461160|NCT01561222|Vitamins|vitamins|mesh-ancestor
65461161|NCT01561222|Micronutrients|micronutrients|mesh-ancestor
65461162|NCT01561222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65210666|NCT05658861|Caseins|caseins|mesh-list
65461163|NCT01035515|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
65461164|NCT01035515|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
64845679|NCT03404193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461553|NCT03964350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65461554|NCT03964350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65461555|NCT03964350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461556|NCT01310452|Insulin|insulin|mesh-list
65461557|NCT01310452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65461558|NCT01310452|Insulin Detemir|insulin detemir|mesh-list
65461559|NCT01310452|Protamines|protamines|mesh-list
65461560|NCT01310452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65461561|NCT01310452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461562|NCT01310452|Heparin Antagonists|heparin antagonists|mesh-ancestor
65461563|NCT01310452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461564|NCT01310452|Coagulants|coagulants|mesh-ancestor
65461565|NCT01035671|Vitamin E|vitamin e|mesh-list
65461596|NCT03769402|Chelating Agents|chelating agents|mesh-ancestor
65461597|NCT03769402|Sequestering Agents|sequestering agents|mesh-ancestor
65461598|NCT03769402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461599|NCT00411671|Sorafenib|sorafenib|mesh-list
65461600|NCT00411671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461601|NCT00411671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65461602|NCT00411671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461603|NCT00411671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461604|NCT01035983|Frovatriptan|frovatriptan|mesh-list
65461605|NCT01035983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65461606|NCT01035983|Serotonin Agents|serotonin agents|mesh-ancestor
65461607|NCT01035983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65461608|NCT01035983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461609|NCT01035983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461610|NCT03770806|Acetaminophen|acetaminophen|mesh-list
65461611|NCT03770806|Celecoxib|celecoxib|mesh-list
65461794|NCT03762928|Efavirenz|efavirenz|mesh-list
65461795|NCT03762928|Midazolam|midazolam|mesh-list
65461796|NCT03762928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65461797|NCT03762928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65461798|NCT03762928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65461799|NCT03762928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461855|NCT03762382|Levonorgestrel|levonorgestrel|mesh-list
65461856|NCT03762382|Antiviral Agents|antiviral agents|mesh-ancestor
65461857|NCT03762382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65461858|NCT03762382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65461859|NCT03762382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65461860|NCT03762382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461861|NCT03762382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461862|NCT03762382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65461863|NCT03762382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65461864|NCT03762382|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65461865|NCT03762382|Contraceptive Agents|contraceptive agents|mesh-ancestor
65461866|NCT03762382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65461867|NCT03762382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461868|NCT03762382|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65461869|NCT03762382|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65461870|NCT03762382|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65461871|NCT04005352|Aflibercept|aflibercept|mesh-list
65461872|NCT04005352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65461873|NCT04005352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65461874|NCT04005352|Growth Substances|growth substances|mesh-ancestor
65461961|NCT03767296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65461962|NCT03767296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65461963|NCT03767296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65461964|NCT00410813|Dasatinib|dasatinib|mesh-list
65461965|NCT00410813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273086|NCT04213898|Paclitaxel|paclitaxel|mesh-list
65273087|NCT04213898|Epirubicin|epirubicin|mesh-list
65461966|NCT00410813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65461967|NCT00410813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461968|NCT00410813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461990|NCT03766984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65461991|NCT03766984|Analgesics|analgesics|mesh-ancestor
65461992|NCT03766984|Sensory System Agents|sensory system agents|mesh-ancestor
65461993|NCT03766984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65461994|NCT03766984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461995|NCT03766984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65461996|NCT03766984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65461997|NCT03766984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65461998|NCT03766984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461999|NCT03766984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462000|NCT03766984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65462001|NCT03766984|Narcotics|narcotics|mesh-ancestor
65462002|NCT03766984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65462003|NCT00405821|Acyclovir|acyclovir|mesh-list
65462004|NCT00405821|Antiviral Agents|antiviral agents|mesh-ancestor
65462005|NCT00405821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65462006|NCT03928600|Misoprostol|misoprostol|mesh-list
65462007|NCT03928600|Dinoprostone|dinoprostone|mesh-list
65462008|NCT03928600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65462009|NCT03928600|Abortifacient Agents|abortifacient agents|mesh-ancestor
65462010|NCT03928600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65462011|NCT03928600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462012|NCT03928600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65462013|NCT03928600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65462014|NCT03928600|Oxytocics|oxytocics|mesh-ancestor
65462015|NCT03924856|Gemcitabine|gemcitabine|mesh-list
65462016|NCT03924856|Pembrolizumab|pembrolizumab|mesh-list
65462017|NCT03924856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462018|NCT03924856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65462019|NCT03924856|Antimetabolites|antimetabolites|mesh-ancestor
64846470|NCT01691807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462074|NCT03760354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65462075|NCT03760354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462076|NCT03760354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65462077|NCT03760354|Glucocorticoids|glucocorticoids|mesh-ancestor
65462079|NCT03760354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65462080|NCT03760354|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65462081|NCT03760354|Protective Agents|protective agents|mesh-ancestor
65462082|NCT03760354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65462083|NCT03760354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462084|NCT03760276|Voriconazole|voriconazole|mesh-list
65462085|NCT03760276|Antifungal Agents|antifungal agents|mesh-ancestor
65462086|NCT03760276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65462087|NCT03760276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65462088|NCT03760276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65462089|NCT03760276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462090|NCT03760276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462091|NCT03760276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65462092|NCT03760276|Hormone Antagonists|hormone antagonists|mesh-ancestor
65462093|NCT03760276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65462094|NCT03760276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462095|NCT03760276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65462097|NCT03766594|Sildenafil Citrate|sildenafil citrate|mesh-list
65462098|NCT03766594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462099|NCT03766594|Vasodilator Agents|vasodilator agents|mesh-ancestor
65462100|NCT03766594|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65462101|NCT03766594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65462102|NCT03766594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462103|NCT03766594|Urological Agents|urological agents|mesh-ancestor
65462104|NCT03766594|Hematinics|hematinics|mesh-ancestor
65462105|NCT03766594|Vitamin B Complex|vitamin b complex|mesh-ancestor
65462106|NCT03766594|Vitamins|vitamins|mesh-ancestor
65462107|NCT03766594|Micronutrients|micronutrients|mesh-ancestor
65462108|NCT03766594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462109|NCT03923374|Buprenorphine|buprenorphine|mesh-list
65462110|NCT03923374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65462111|NCT03923374|Narcotics|narcotics|mesh-ancestor
64846556|NCT01692808|Vitamin D|vitamin d|mesh-list
65273088|NCT04213898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65462176|NCT03760198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462177|NCT03760198|Cholinergic Agents|cholinergic agents|mesh-ancestor
65462178|NCT03760198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65462179|NCT00106704|Pioglitazone|pioglitazone|mesh-list
65462180|NCT00106704|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65462181|NCT00106704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65462182|NCT00106704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462183|NCT00106704|Incretins|incretins|mesh-ancestor
65462184|NCT00106704|Hormones|hormones|mesh-ancestor
65462185|NCT00106704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65462186|NCT00106704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65462187|NCT00106704|Protease Inhibitors|protease inhibitors|mesh-ancestor
65462188|NCT00106704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846677|NCT01693432|Docetaxel|docetaxel|mesh-list
65462282|NCT01076478|Respiratory System Agents|respiratory system agents|mesh-ancestor
65462283|NCT01076478|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65462284|NCT01076478|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65211785|NCT05804734|Vitamin K|vitamin k|mesh-list
65462285|NCT01076478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462286|NCT01076478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65462287|NCT01076478|Vasodilator Agents|vasodilator agents|mesh-ancestor
65462288|NCT01076478|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65462289|NCT01076478|Protective Agents|protective agents|mesh-ancestor
65462290|NCT01076478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65462291|NCT01076478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65462292|NCT01076478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462293|NCT01076556|Cyclophosphamide|cyclophosphamide|mesh-list
65462294|NCT01076556|Rituximab|rituximab|mesh-list
65462328|NCT00134082|Alkylating Agents|alkylating agents|mesh-ancestor
65462329|NCT00134082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462330|NCT00134082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462331|NCT00134082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65462332|NCT00134082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65462333|NCT01326312|Leuprolide|leuprolide|mesh-list
65462334|NCT01326312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65462392|NCT01081548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65462393|NCT01081548|Antimetabolites|antimetabolites|mesh-ancestor
65462394|NCT01081548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462395|NCT01081548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65462396|NCT01081548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65462397|NCT01081548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462398|NCT00101400|Sorafenib|sorafenib|mesh-list
65462399|NCT00101400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462400|NCT00101400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65462401|NCT00101400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462402|NCT00101400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462403|NCT01076790|Dexmedetomidine|dexmedetomidine|mesh-list
65462404|NCT01076790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65462405|NCT01076790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65462406|NCT01076790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462407|NCT01076790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65462408|NCT01076790|Analgesics|analgesics|mesh-ancestor
65462409|NCT01076790|Sensory System Agents|sensory system agents|mesh-ancestor
65462410|NCT01076790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65462411|NCT01076790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65462466|NCT01075880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65462468|NCT00098748|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65462469|NCT00098748|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65462470|NCT00098748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462471|NCT00098748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65462472|NCT00098748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65462473|NCT00098748|Antiviral Agents|antiviral agents|mesh-ancestor
65462474|NCT00098748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65462475|NCT00098748|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65462476|NCT00130520|Bevacizumab|bevacizumab|mesh-list
65462477|NCT00130520|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65462478|NCT00130520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65462479|NCT00130520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462480|NCT00130520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65462481|NCT00130520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65462482|NCT00130520|Growth Substances|growth substances|mesh-ancestor
65273089|NCT04213898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65273090|NCT04213898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273091|NCT04213898|Tubulin Modulators|tubulin modulators|mesh-ancestor
65273092|NCT04213898|Antimitotic Agents|antimitotic agents|mesh-ancestor
65273093|NCT04213898|Mitosis Modulators|mitosis modulators|mesh-ancestor
65273094|NCT04213898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273095|NCT04213898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65273096|NCT04213898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65273097|NCT04213898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65273098|NCT04213898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273099|NCT03170882|Dexamethasone|dexamethasone|mesh-list
65273100|NCT03170882|Pomalidomide|pomalidomide|mesh-list
65273101|NCT03170882|Ixazomib|ixazomib|mesh-list
65273102|NCT03170882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65273103|NCT03170882|Antiemetics|antiemetics|mesh-ancestor
65273104|NCT03170882|Autonomic Agents|autonomic agents|mesh-ancestor
65273105|NCT03170882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65273106|NCT03170882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273107|NCT03170882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65273108|NCT03170882|Glucocorticoids|glucocorticoids|mesh-ancestor
65273109|NCT03170882|Hormones|hormones|mesh-ancestor
65273110|NCT03170882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65462483|NCT00130520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462484|NCT00130520|Growth Inhibitors|growth inhibitors|mesh-ancestor
65462485|NCT00130520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65462486|NCT00130520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462487|NCT00130520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462488|NCT00130442|Dacarbazine|dacarbazine|mesh-list
65462489|NCT00130442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64846945|NCT05290324|Anesthetics|anesthetics|mesh-ancestor
65462553|NCT01072058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65462554|NCT01072058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65462555|NCT01072058|Dermatologic Agents|dermatologic agents|mesh-ancestor
65462556|NCT01072058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65462557|NCT01072058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65462558|NCT01072058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65462559|NCT01072058|Analgesics|analgesics|mesh-ancestor
65462560|NCT01072058|Sensory System Agents|sensory system agents|mesh-ancestor
65462561|NCT01072058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65462562|NCT01072058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462563|NCT01072058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65462564|NCT01072058|Immunologic Factors|immunologic factors|mesh-ancestor
65462565|NCT00121134|Cyclophosphamide|cyclophosphamide|mesh-list
65462566|NCT00121134|Bevacizumab|bevacizumab|mesh-list
65462567|NCT00121134|Capecitabine|capecitabine|mesh-list
65462568|NCT00121134|Methotrexate|methotrexate|mesh-list
65462569|NCT00121134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65462570|NCT00121134|Immunologic Factors|immunologic factors|mesh-ancestor
65462571|NCT00121134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462572|NCT00121134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64847026|NCT05294887|Adrenergic Agents|adrenergic agents|mesh-ancestor
65462622|NCT00119262|Cyclophosphamide|cyclophosphamide|mesh-list
65462623|NCT00119262|Bevacizumab|bevacizumab|mesh-list
65462624|NCT00119262|Doxorubicin|doxorubicin|mesh-list
65462625|NCT00119262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65273111|NCT03170882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65273112|NCT03170882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273113|NCT03170882|Immunologic Factors|immunologic factors|mesh-ancestor
65273114|NCT03170882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65273115|NCT03170882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65273116|NCT03170882|Growth Substances|growth substances|mesh-ancestor
65462626|NCT00119262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65462627|NCT00119262|Antibodies|antibodies|mesh-list
65462628|NCT00119262|Immunoglobulins|immunoglobulins|mesh-list
65462629|NCT00119262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65462630|NCT00119262|Lenograstim|lenograstim|mesh-list
65462631|NCT00119262|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65462632|NCT00119262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462633|NCT00119262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462634|NCT00119262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65462635|NCT00119262|Immunologic Factors|immunologic factors|mesh-ancestor
65462636|NCT00119262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462637|NCT00119262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65462638|NCT00119262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65462639|NCT00119262|Alkylating Agents|alkylating agents|mesh-ancestor
65462640|NCT00119262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65462641|NCT00119262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64847095|NCT05294640|Respiratory System Agents|respiratory system agents|mesh-ancestor
65462804|NCT00135512|Bupropion|bupropion|mesh-list
65462805|NCT00135512|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65462806|NCT00135512|Antidepressive Agents|antidepressive agents|mesh-ancestor
65462807|NCT00135512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65462808|NCT00135512|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65462809|NCT00135512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65462810|NCT00135512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65462811|NCT00135512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462812|NCT00135512|Dopamine Agents|dopamine agents|mesh-ancestor
65462813|NCT00135512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65462814|NCT00135512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462815|NCT00135512|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65212306|NCT05627232|Palbociclib|palbociclib|mesh-list
65462816|NCT00135512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65462817|NCT00135512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462818|NCT00130728|Bevacizumab|bevacizumab|mesh-list
65462819|NCT00130728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65462820|NCT00130728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65462821|NCT00130728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847281|NCT05294900|Tubulin Modulators|tubulin modulators|mesh-ancestor
65462848|NCT03966326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462849|NCT03966326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65462850|NCT03966326|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65462851|NCT03966326|Anesthetics, General|anesthetics, general|mesh-ancestor
65462852|NCT03966326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65462853|NCT03966326|Narcotics|narcotics|mesh-ancestor
65462854|NCT03966326|Analgesics|analgesics|mesh-ancestor
65462855|NCT03966326|Sensory System Agents|sensory system agents|mesh-ancestor
65462856|NCT03966326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65462857|NCT03966326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65462858|NCT03966326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65462859|NCT00119106|Tenofovir|tenofovir|mesh-list
65462860|NCT00119106|Antiviral Agents|antiviral agents|mesh-ancestor
65462861|NCT00119106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65462862|NCT00119106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65462863|NCT00119106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65462864|NCT00119106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462865|NCT00119106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462866|NCT00119106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65462867|NCT00119106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65462868|NCT03758014|Lomustine|lomustine|mesh-list
65462869|NCT03758014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65462929|NCT01076582|Desogestrel|desogestrel|mesh-list
65462930|NCT01076582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65462931|NCT01076582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65273117|NCT03170882|Growth Inhibitors|growth inhibitors|mesh-ancestor
64468118|NCT00168298|BB 1101|bb 1101|mesh-list
65462932|NCT01076582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65462933|NCT01076582|Contraceptive Agents|contraceptive agents|mesh-ancestor
65462934|NCT01076582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65462935|NCT01076582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462936|NCT01076582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65462937|NCT01076582|Estrogens|estrogens|mesh-ancestor
64847414|NCT05238506|Lidocaine|lidocaine|mesh-list
65462994|NCT00129272|Dopamine Agents|dopamine agents|mesh-ancestor
65462995|NCT00129272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65462996|NCT00129272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462997|NCT00129272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65462998|NCT00129272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65462999|NCT00129272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463000|NCT01326338|Nitazoxanide|nitazoxanide|mesh-list
65463001|NCT01326338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65463002|NCT01326338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65463003|NCT03963648|Nitric Oxide|nitric oxide|mesh-list
65463004|NCT03963648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65463005|NCT03963648|Autonomic Agents|autonomic agents|mesh-ancestor
65463006|NCT03963648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65463007|NCT03963648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463008|NCT03963648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65463009|NCT03963648|Respiratory System Agents|respiratory system agents|mesh-ancestor
65463010|NCT03963648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65463011|NCT03963648|Antioxidants|antioxidants|mesh-ancestor
65463012|NCT03963648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463013|NCT03963648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64847483|NCT05192629|Anesthetics|anesthetics|mesh-ancestor
65463990|NCT04052620|Analgesics|analgesics|mesh-ancestor
65463991|NCT04052620|Sensory System Agents|sensory system agents|mesh-ancestor
65463992|NCT04052620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65463993|NCT04052620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463994|NCT04052620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65463995|NCT04052620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65464044|NCT03414034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65464046|NCT03414034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65464047|NCT03414034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464048|NCT03414034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65464049|NCT03414034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464050|NCT03414034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464051|NCT04489732|Interferons|interferons|mesh-list
65464052|NCT04489732|Interferon-gamma|interferon-gamma|mesh-list
65464053|NCT04489732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464054|NCT04489732|Antiviral Agents|antiviral agents|mesh-ancestor
65464055|NCT04489732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65464056|NCT03744988|Androgens|androgens|mesh-list
65464057|NCT03744988|Hormones|hormones|mesh-ancestor
65464058|NCT03744988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65464059|NCT03744988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464060|NCT03746782|Thrombin|thrombin|mesh-list
65464218|NCT04428502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464219|NCT04428502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464220|NCT04428502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65464221|NCT04428502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65464222|NCT04428502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65464223|NCT04428502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65464224|NCT04428502|Immunologic Factors|immunologic factors|mesh-ancestor
65464225|NCT03736330|Pembrolizumab|pembrolizumab|mesh-list
65464226|NCT03736330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65464227|NCT03736330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464228|NCT04428424|Etanercept|etanercept|mesh-list
65464229|NCT04428424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65464230|NCT04428424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65464231|NCT04428424|Analgesics|analgesics|mesh-ancestor
65464232|NCT04428424|Sensory System Agents|sensory system agents|mesh-ancestor
65464233|NCT04428424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464234|NCT04428424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464235|NCT04428424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65464236|NCT04428424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65464237|NCT04428424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65464238|NCT04428424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65273118|NCT03170882|Protease Inhibitors|protease inhibitors|mesh-ancestor
65273119|NCT03170882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464239|NCT04428424|Immunologic Factors|immunologic factors|mesh-ancestor
65464240|NCT00095238|Irbesartan|irbesartan|mesh-list
65464241|NCT00095238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65213736|NCT03078855|Cholecalciferol|cholecalciferol|mesh-list
65464242|NCT00095238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65464243|NCT00095238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65464244|NCT00095238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464245|NCT01087008|Zoledronic Acid|zoledronic acid|mesh-list
65464246|NCT01087008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65464247|NCT01087008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464248|NCT01084044|Urinastatin|urinastatin|mesh-list
65464400|NCT00404495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464401|NCT00404495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65464402|NCT00404495|Alkylating Agents|alkylating agents|mesh-ancestor
65464404|NCT00409331|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65464405|NCT00409331|Protective Agents|protective agents|mesh-ancestor
65464406|NCT00409331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464407|NCT00362219|Morphine|morphine|mesh-list
65464408|NCT00362219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65464409|NCT00362219|Narcotics|narcotics|mesh-ancestor
65464410|NCT00362219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65464411|NCT00362219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464412|NCT00362219|Analgesics|analgesics|mesh-ancestor
65464413|NCT00362219|Sensory System Agents|sensory system agents|mesh-ancestor
64848859|NCT05601154|Listerine|listerine|mesh-list
65464545|NCT01080560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464546|NCT01080560|Antifungal Agents|antifungal agents|mesh-ancestor
65464547|NCT01080560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65464548|NCT01080560|Dermatologic Agents|dermatologic agents|mesh-ancestor
65464549|NCT01080560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65464550|NCT01080560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65464551|NCT00094328|Anastrozole|anastrozole|mesh-list
65464552|NCT00094328|Bicalutamide|bicalutamide|mesh-list
65464553|NCT00094328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65464554|NCT00094328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464555|NCT00094328|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65464656|NCT01087554|Vorinostat|vorinostat|mesh-list
65464657|NCT01087554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464658|NCT01087554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65464659|NCT01087554|Immunologic Factors|immunologic factors|mesh-ancestor
65464660|NCT01087554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464661|NCT01087554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65464662|NCT01087554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65464663|NCT01087554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65464664|NCT01087554|Antifungal Agents|antifungal agents|mesh-ancestor
65464665|NCT01087554|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65464695|NCT00403559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65464696|NCT00403559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65464697|NCT00403559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464698|NCT00403559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464699|NCT00403559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65464700|NCT00403559|Hormone Antagonists|hormone antagonists|mesh-ancestor
65464701|NCT00403559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65464702|NCT00403559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464703|NCT00403559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65464704|NCT00403559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65464705|NCT00403559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65464707|NCT00403559|Sensory System Agents|sensory system agents|mesh-ancestor
65464708|NCT00403559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464883|NCT00091832|Denosumab|denosumab|mesh-list
65464884|NCT00091832|Diphosphonates|diphosphonates|mesh-list
65464885|NCT00091832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65464886|NCT00091832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464887|NCT00391391|Vaccines|vaccines|mesh-list
65464888|NCT00391391|Immunologic Factors|immunologic factors|mesh-ancestor
65464889|NCT00391391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464890|NCT01044251|Frovatriptan|frovatriptan|mesh-list
65464891|NCT01044251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65464892|NCT01044251|Serotonin Agents|serotonin agents|mesh-ancestor
65464893|NCT01044251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64468226|NCT00168454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65464894|NCT01044251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464895|NCT01044251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464896|NCT01044329|Triamcinolone|triamcinolone|mesh-list
65464897|NCT01044329|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65464898|NCT01044329|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65464899|NCT01044329|Bevacizumab|bevacizumab|mesh-list
65464900|NCT01044329|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65464901|NCT01044329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65464902|NCT01044329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464903|NCT01044329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65464904|NCT01044329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65464905|NCT01044329|Growth Substances|growth substances|mesh-ancestor
65464906|NCT01044329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464907|NCT01044329|Growth Inhibitors|growth inhibitors|mesh-ancestor
65464908|NCT01044329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65464909|NCT01044329|Glucocorticoids|glucocorticoids|mesh-ancestor
65464910|NCT01044329|Hormones|hormones|mesh-ancestor
65464911|NCT01044329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65464912|NCT01044329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65464913|NCT01044329|Immunologic Factors|immunologic factors|mesh-ancestor
65464914|NCT01044329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464915|NCT01044329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464916|NCT00091442|Docetaxel|docetaxel|mesh-list
64849358|NCT04892043|Nivolumab|nivolumab|mesh-list
65464973|NCT01079312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65464974|NCT01079312|Anesthetics, General|anesthetics, general|mesh-ancestor
65464975|NCT01079312|Anesthetics|anesthetics|mesh-ancestor
65464976|NCT01079312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65464977|NCT01079312|Narcotics|narcotics|mesh-ancestor
65464978|NCT01079312|Analgesics|analgesics|mesh-ancestor
65464979|NCT01079312|Sensory System Agents|sensory system agents|mesh-ancestor
65464980|NCT01079312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464981|NCT01079312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65464982|NCT01044485|Docetaxel|docetaxel|mesh-list
65464983|NCT01044485|Lapatinib|lapatinib|mesh-list
65464984|NCT01044485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464985|NCT01044485|Tubulin Modulators|tubulin modulators|mesh-ancestor
65464986|NCT01044485|Antimitotic Agents|antimitotic agents|mesh-ancestor
65464987|NCT01044485|Mitosis Modulators|mitosis modulators|mesh-ancestor
65464988|NCT01044485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464989|NCT01044485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65465066|NCT00118898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65465067|NCT00118898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64849525|NCT04632992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465193|NCT00118040|Estrogens|estrogens|mesh-ancestor
65465195|NCT00118040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65465196|NCT03961958|Propofol|propofol|mesh-list
65465724|NCT00099632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65465725|NCT00099632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65465726|NCT00099632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65465727|NCT00099632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65465728|NCT00099632|Antimetabolites|antimetabolites|mesh-ancestor
65465729|NCT00099632|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65465730|NCT00099632|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65465731|NCT01087190|Isoniazid|isoniazid|mesh-list
65465732|NCT01087190|Antitubercular Agents|antitubercular agents|mesh-ancestor
65465733|NCT01087190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65465734|NCT01087190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65465765|NCT04116398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65465766|NCT04116398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465767|NCT00098774|Leucovorin|leucovorin|mesh-list
65465768|NCT00098774|Cytarabine|cytarabine|mesh-list
65465769|NCT00098774|Rituximab|rituximab|mesh-list
65465770|NCT00098774|Methotrexate|methotrexate|mesh-list
65465771|NCT00098774|Etoposide|etoposide|mesh-list
65465772|NCT00098774|Temozolomide|temozolomide|mesh-list
65465773|NCT00098774|Calcium|calcium|mesh-list
65465774|NCT00098774|Levoleucovorin|levoleucovorin|mesh-list
65465775|NCT00098774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65465776|NCT00098774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465777|NCT00098774|Immunologic Factors|immunologic factors|mesh-ancestor
65465778|NCT00098774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465779|NCT00098774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65465780|NCT00098774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64468307|NCT01897012|Romidepsin|romidepsin|mesh-list
65465962|NCT01080417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466066|NCT00381797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466068|NCT00381797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65466156|NCT00112047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65466157|NCT03658876|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65466158|NCT03658876|Hematinics|hematinics|mesh-ancestor
65466159|NCT03618628|Carbon Fiber|carbon fiber|mesh-list
65466160|NCT03618628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65466161|NCT03618628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65466162|NCT03639922|Imatinib Mesylate|imatinib mesylate|mesh-list
65466163|NCT03639922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466164|NCT03639922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65466165|NCT03639922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466166|NCT03639922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466167|NCT03734614|Aspirin|aspirin|mesh-list
65466168|NCT03734614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65466169|NCT03734614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65466170|NCT03734614|Analgesics|analgesics|mesh-ancestor
65466171|NCT03734614|Sensory System Agents|sensory system agents|mesh-ancestor
65466172|NCT03734614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65466173|NCT03734614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466246|NCT03963752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466247|NCT03963752|Appetite Stimulants|appetite stimulants|mesh-ancestor
65466248|NCT03963752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65466280|NCT03734068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466281|NCT03575806|Chlorotrianisene|chlorotrianisene|mesh-list
65466282|NCT03575806|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65466283|NCT03575806|Estrogens|estrogens|mesh-ancestor
65466284|NCT03575806|Hormones|hormones|mesh-ancestor
65466285|NCT03575806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65466286|NCT03575806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466287|NCT03575806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65466288|NCT03575806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466289|NCT03606460|Ocrelizumab|ocrelizumab|mesh-list
65466290|NCT03606460|Immunologic Factors|immunologic factors|mesh-ancestor
64850659|NCT03426293|Heparin|heparin|mesh-list
65466320|NCT00118287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466322|NCT00118287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65466323|NCT00118287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65466324|NCT00118287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65466325|NCT00118287|Immunologic Factors|immunologic factors|mesh-ancestor
65466326|NCT03965247|Lithium Carbonate|lithium carbonate|mesh-list
65466327|NCT03965247|Antidepressive Agents|antidepressive agents|mesh-ancestor
65466328|NCT03965247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65466329|NCT03965247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466330|NCT03965247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466331|NCT03965247|Antimanic Agents|antimanic agents|mesh-ancestor
65466332|NCT03965247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65466333|NCT03965247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65466334|NCT03965247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466335|NCT01079715|Propranolol|propranolol|mesh-list
64850728|NCT05438108|Bevacizumab|bevacizumab|mesh-list
65466407|NCT03603496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65466408|NCT03603496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466410|NCT00096135|Cytarabine|cytarabine|mesh-list
65466411|NCT00096135|Dexamethasone|dexamethasone|mesh-list
65466412|NCT00096135|Hydrocortisone|hydrocortisone|mesh-list
64850763|NCT05437471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466446|NCT00096135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65466447|NCT00096135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65466448|NCT00096135|Antimetabolites|antimetabolites|mesh-ancestor
65466449|NCT00096135|Dermatologic Agents|dermatologic agents|mesh-ancestor
65466450|NCT00096135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466451|NCT00096135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65466452|NCT00096135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65466453|NCT00096135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65466454|NCT00096135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65466455|NCT00096135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65466490|NCT01080651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466491|NCT01080651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65466493|NCT01080651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64468398|NCT00185692|Hormones|hormones|mesh-ancestor
65466494|NCT01080651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466590|NCT01087359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466591|NCT01087359|Protective Agents|protective agents|mesh-ancestor
65466592|NCT01087359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466593|NCT01087359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65466595|NCT01087437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65466596|NCT01087437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466597|NCT01083537|Paclitaxel|paclitaxel|mesh-list
65466598|NCT01083537|Cisplatin|cisplatin|mesh-list
65466599|NCT01083537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65466600|NCT01083537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466601|NCT01083537|Tubulin Modulators|tubulin modulators|mesh-ancestor
65466602|NCT01083537|Antimitotic Agents|antimitotic agents|mesh-ancestor
65466603|NCT01083537|Mitosis Modulators|mitosis modulators|mesh-ancestor
65466604|NCT01083537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466689|NCT01087593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65466690|NCT01087593|Contraceptive Agents|contraceptive agents|mesh-ancestor
65466691|NCT01087593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65466692|NCT01087593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65466693|NCT00082173|Moxifloxacin|moxifloxacin|mesh-list
65466694|NCT00082173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65466695|NCT00082173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65466696|NCT00082173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65466697|NCT00082173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65466698|NCT00082173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466699|NCT00082173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466700|NCT00082173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466701|NCT01087749|Losartan|losartan|mesh-list
65466702|NCT01087749|Propranolol|propranolol|mesh-list
65466703|NCT01087749|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65466704|NCT01087749|Eprosartan|eprosartan|mesh-list
65466705|NCT01087749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65466706|NCT01087749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65466707|NCT01087749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64850972|NCT03424122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65466773|NCT01081964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466774|NCT01081964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466775|NCT01081964|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65466776|NCT01081964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65466777|NCT01081964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65466778|NCT00079040|Bevacizumab|bevacizumab|mesh-list
65466779|NCT00079040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65466780|NCT00079040|Etoposide|etoposide|mesh-list
65466781|NCT00079040|Etoposide phosphate|etoposide phosphate|mesh-list
65466782|NCT00079040|Antibodies|antibodies|mesh-list
65466783|NCT00079040|Immunoglobulins|immunoglobulins|mesh-list
65466784|NCT00079040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65466785|NCT00079040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466786|NCT00079040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65466787|NCT00079040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65466788|NCT00079040|Growth Substances|growth substances|mesh-ancestor
65466789|NCT00079040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466790|NCT00079040|Growth Inhibitors|growth inhibitors|mesh-ancestor
65466791|NCT00079040|Immunologic Factors|immunologic factors|mesh-ancestor
64851040|NCT02175030|Copper|copper|mesh-list
65467017|NCT03591874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65467018|NCT03591874|Adrenergic Agents|adrenergic agents|mesh-ancestor
64851281|NCT02943785|Anticoagulants|anticoagulants|mesh-ancestor
65467071|NCT01087983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467072|NCT00080301|Capecitabine|capecitabine|mesh-list
65467073|NCT00080301|Epothilones|epothilones|mesh-list
65467074|NCT00080301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65467075|NCT00080301|Antimetabolites|antimetabolites|mesh-ancestor
65467076|NCT00080301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467077|NCT00080301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467078|NCT00080301|Tubulin Modulators|tubulin modulators|mesh-ancestor
65467079|NCT00080301|Antimitotic Agents|antimitotic agents|mesh-ancestor
65467080|NCT00080301|Mitosis Modulators|mitosis modulators|mesh-ancestor
65467081|NCT03961503|Vancomycin|vancomycin|mesh-list
65467082|NCT03961503|Daptomycin|daptomycin|mesh-list
65467083|NCT03961503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65467084|NCT03961503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65467085|NCT00079677|Modafinil|modafinil|mesh-list
64851335|NCT02787551|Metformin|metformin|mesh-list
65273120|NCT03170882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467116|NCT00095121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65467117|NCT00095121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65467118|NCT00095121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65467119|NCT01081431|Lenalidomide|lenalidomide|mesh-list
65467120|NCT01081431|Immunologic Factors|immunologic factors|mesh-ancestor
65467121|NCT01081431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467122|NCT01081431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65467123|NCT01081431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65467124|NCT01081431|Growth Substances|growth substances|mesh-ancestor
65467125|NCT01081431|Growth Inhibitors|growth inhibitors|mesh-ancestor
65467161|NCT01088373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467198|NCT00104247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467199|NCT00104247|Vasodilator Agents|vasodilator agents|mesh-ancestor
65467200|NCT03565900|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65467201|NCT03565900|Immunologic Factors|immunologic factors|mesh-ancestor
65467202|NCT03565900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467237|NCT03730558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65467238|NCT03730558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65467240|NCT03730558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467241|NCT03730558|Growth Inhibitors|growth inhibitors|mesh-ancestor
65467242|NCT03730558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467243|NCT03588910|Acetaminophen|acetaminophen|mesh-list
65467244|NCT03588910|Ibuprofen|ibuprofen|mesh-list
65467275|NCT00103857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65467277|NCT00103857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467278|NCT00103857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467279|NCT03587584|Bupivacaine|bupivacaine|mesh-list
65467280|NCT03587584|Anesthetics, Local|anesthetics, local|mesh-ancestor
65467281|NCT03587584|Anesthetics|anesthetics|mesh-ancestor
65467282|NCT03587584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65467283|NCT03587584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467284|NCT03587584|Sensory System Agents|sensory system agents|mesh-ancestor
65467285|NCT03587584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467286|NCT03586726|Rifampin|rifampin|mesh-list
65467376|NCT05782608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467377|NCT05782608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467378|NCT05782608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65467379|NCT05782608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65467380|NCT05782608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65467381|NCT05782608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467382|NCT05782608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467383|NCT05782426|Paclitaxel|paclitaxel|mesh-list
65467384|NCT05782426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65467385|NCT05782426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467386|NCT05782426|Tubulin Modulators|tubulin modulators|mesh-ancestor
65467387|NCT05782426|Antimitotic Agents|antimitotic agents|mesh-ancestor
65467388|NCT05782426|Mitosis Modulators|mitosis modulators|mesh-ancestor
65467389|NCT05782426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467390|NCT05782348|Listerine|listerine|mesh-list
65467391|NCT05782348|Sodium Fluoride|sodium fluoride|mesh-list
65467392|NCT05782348|Cariostatic Agents|cariostatic agents|mesh-ancestor
65467393|NCT05782348|Protective Agents|protective agents|mesh-ancestor
64851567|NCT02325466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467426|NCT05781854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65467427|NCT05781854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65467428|NCT05781854|Analgesics|analgesics|mesh-ancestor
65467429|NCT05781854|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65467430|NCT05781854|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65467431|NCT05781854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65467432|NCT05781854|Adrenergic Agents|adrenergic agents|mesh-ancestor
65467502|NCT05780554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65467503|NCT05780554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65467504|NCT05780554|Alkylating Agents|alkylating agents|mesh-ancestor
65467505|NCT05780554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467506|NCT05780554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467507|NCT05780554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65467508|NCT05743946|Ivacaftor|ivacaftor|mesh-list
65467509|NCT05743946|Elexacaftor|elexacaftor|mesh-list
65467510|NCT05743946|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65467511|NCT05743946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65467545|NCT05687071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467546|NCT05681611|Rocuronium|rocuronium|mesh-list
65273121|NCT00616850|Lidocaine|lidocaine|mesh-list
65273122|NCT00616850|Anesthetics, Local|anesthetics, local|mesh-ancestor
65273123|NCT00616850|Anesthetics|anesthetics|mesh-ancestor
65467547|NCT05681611|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65467548|NCT05681611|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65467549|NCT05681611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65467550|NCT05681611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467674|NCT05532358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65467675|NCT05532358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65467676|NCT05532358|Purinergic Agents|purinergic agents|mesh-ancestor
65467677|NCT05532358|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64851767|NCT01913730|Dexamethasone|dexamethasone|mesh-list
65467857|NCT05251948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467858|NCT05250011|Dapagliflozin|dapagliflozin|mesh-list
65467859|NCT05250011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65467860|NCT05250011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468021|NCT04971473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65468022|NCT04971473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468023|NCT04945733|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
65468024|NCT04945733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65468025|NCT04945733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468026|NCT04943588|Antibodies|antibodies|mesh-list
65468188|NCT04710277|Analgesics|analgesics|mesh-ancestor
65468189|NCT04710277|Sensory System Agents|sensory system agents|mesh-ancestor
65468190|NCT04710277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64852286|NCT01695005|Prednisone|prednisone|mesh-list
65468221|NCT04652245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65468223|NCT04642287|Calcipotriene|calcipotriene|mesh-list
65468224|NCT04642287|Petrolatum|petrolatum|mesh-list
65468225|NCT04642287|Antimetabolites|antimetabolites|mesh-ancestor
65468226|NCT04642287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468227|NCT04642287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65468228|NCT04642287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468229|NCT04642287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65468231|NCT04642287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468232|NCT04642287|Dermatologic Agents|dermatologic agents|mesh-ancestor
65468233|NCT04642287|Emollients|emollients|mesh-ancestor
65468234|NCT04635735|Ipilimumab|ipilimumab|mesh-list
65468235|NCT04635735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65468236|NCT04635735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468237|NCT04635735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65468238|NCT04635735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468572|NCT03622788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64852660|NCT01697631|Insulin Aspart|insulin aspart|mesh-list
65468878|NCT01898117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65468879|NCT01898117|Cyclophosphamide|cyclophosphamide|mesh-list
65468880|NCT01898117|Carboplatin|carboplatin|mesh-list
65468881|NCT01898117|Atezolizumab|atezolizumab|mesh-list
65468882|NCT01898117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65468883|NCT01898117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65468884|NCT01898117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469123|NCT03478696|Tiotropium Bromide|tiotropium bromide|mesh-list
65469124|NCT03478696|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65469126|NCT03478696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65469127|NCT03478696|Autonomic Agents|autonomic agents|mesh-ancestor
65469128|NCT03478696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65469129|NCT03478696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469130|NCT03478696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65469131|NCT03478696|Respiratory System Agents|respiratory system agents|mesh-ancestor
65469316|NCT00098865|Immunologic Factors|immunologic factors|mesh-ancestor
65469317|NCT00098865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469318|NCT00098865|Leprostatic Agents|leprostatic agents|mesh-ancestor
65469319|NCT00098865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65469320|NCT00098865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65469321|NCT00098865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65469322|NCT00098865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65469323|NCT00098865|Growth Substances|growth substances|mesh-ancestor
65469324|NCT00098865|Growth Inhibitors|growth inhibitors|mesh-ancestor
65469325|NCT00098787|Leucovorin|leucovorin|mesh-list
65469326|NCT00098787|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
65469327|NCT00098787|Tetrahydrofolates|tetrahydrofolates|mesh-list
65469328|NCT00098787|Bevacizumab|bevacizumab|mesh-list
65469329|NCT00098787|Fluorouracil|fluorouracil|mesh-list
65469439|NCT01088763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469440|NCT01088763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469441|NCT01094600|Secretin|secretin|mesh-list
65469442|NCT01094600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65469443|NCT01094600|Hormones|hormones|mesh-ancestor
65469444|NCT01094600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65469656|NCT00053846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469658|NCT00053846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65469659|NCT00053846|Serotonin Agents|serotonin agents|mesh-ancestor
65469660|NCT00053846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65469661|NCT00053846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469662|NCT01089075|Hydrocortisone|hydrocortisone|mesh-list
65469663|NCT01089075|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65469664|NCT01089075|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65469665|NCT01089075|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65469666|NCT01089075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65469693|NCT03543358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469694|NCT03485950|Meropenem|meropenem|mesh-list
65469695|NCT03485950|Tazobactam|tazobactam|mesh-list
65469696|NCT03485950|Piperacillin|piperacillin|mesh-list
65469697|NCT03485950|Cefepime|cefepime|mesh-list
65469698|NCT03485950|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65469699|NCT03485950|Ceftolozane|ceftolozane|mesh-list
65469700|NCT03485950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65469701|NCT03485950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65469702|NCT03485950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65469703|NCT03485950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469704|NCT03485950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469705|NCT00060944|Dexamethasone|dexamethasone|mesh-list
65469706|NCT00060944|Dexamethasone acetate|dexamethasone acetate|mesh-list
65469707|NCT00060944|Trabectedin|trabectedin|mesh-list
65469708|NCT00060944|BB 1101|bb 1101|mesh-list
65469709|NCT00060944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65469710|NCT00060944|Antiemetics|antiemetics|mesh-ancestor
65469711|NCT00060944|Autonomic Agents|autonomic agents|mesh-ancestor
65469712|NCT00060944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65469713|NCT00060944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469714|NCT00060944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65469715|NCT00060944|Glucocorticoids|glucocorticoids|mesh-ancestor
65469716|NCT00060944|Hormones|hormones|mesh-ancestor
65469717|NCT00060944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65469773|NCT03457636|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65469774|NCT03457636|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65469775|NCT03457636|Dermatologic Agents|dermatologic agents|mesh-ancestor
65469776|NCT03457636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65469777|NCT03457636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65469778|NCT03457636|Analgesics|analgesics|mesh-ancestor
65469779|NCT03457636|Sensory System Agents|sensory system agents|mesh-ancestor
65469780|NCT03457636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65469781|NCT03457636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469782|NCT03457636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65469783|NCT03457636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65469784|NCT01099436|Zoledronic Acid|zoledronic acid|mesh-list
65469785|NCT01099436|Cyclophosphamide|cyclophosphamide|mesh-list
65469786|NCT01099436|Docetaxel|docetaxel|mesh-list
65469787|NCT01099436|Doxorubicin|doxorubicin|mesh-list
65469788|NCT01099436|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65469789|NCT01099436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65469790|NCT01099436|Immunologic Factors|immunologic factors|mesh-ancestor
65469791|NCT01099436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469792|NCT01099436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65469793|NCT01099436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65470206|NCT01085721|Adrenergic Agents|adrenergic agents|mesh-ancestor
65470207|NCT01085721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65470208|NCT01085721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470210|NCT01085721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65470211|NCT01085721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65470212|NCT01085721|Appetite Depressants|appetite depressants|mesh-ancestor
65470213|NCT01085721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65470214|NCT01085721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65470215|NCT01085721|Histamine Antagonists|histamine antagonists|mesh-ancestor
65470216|NCT01085721|Histamine Agents|histamine agents|mesh-ancestor
65470217|NCT01085721|Antipruritics|antipruritics|mesh-ancestor
65470218|NCT01085721|Dermatologic Agents|dermatologic agents|mesh-ancestor
65470219|NCT01085721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65470220|NCT01089465|Dermatologic Agents|dermatologic agents|mesh-list
65470221|NCT00006392|Vitamins|vitamins|mesh-list
65273124|NCT00616850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65470222|NCT00006392|Vitamin E|vitamin e|mesh-list
65470223|NCT00006392|Tocopherols|tocopherols|mesh-list
65470276|NCT00378599|Immunologic Factors|immunologic factors|mesh-ancestor
65470277|NCT00378599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470278|NCT00378599|Antimetabolites|antimetabolites|mesh-ancestor
65470428|NCT01049633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65470429|NCT01049633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65470430|NCT01049633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470431|NCT01049633|Antipyretics|antipyretics|mesh-ancestor
65470432|NCT01049633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65470765|NCT01096082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65470766|NCT01096082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470859|NCT03353740|Sequestering Agents|sequestering agents|mesh-ancestor
65470860|NCT03353740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470861|NCT03353740|Anticoagulants|anticoagulants|mesh-ancestor
65470862|NCT03353740|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65470863|NCT03353740|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65470864|NCT04814602|Proglumide|proglumide|mesh-list
65470865|NCT04814602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65470866|NCT04814602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65470893|NCT00399035|Vitamin B Complex|vitamin b complex|mesh-ancestor
65470894|NCT00399035|Vitamins|vitamins|mesh-ancestor
65470895|NCT00399035|Micronutrients|micronutrients|mesh-ancestor
65470896|NCT00399035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65470897|NCT00399035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470898|NCT00073749|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65470899|NCT00073749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65470900|NCT00073749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470901|NCT00073749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65470902|NCT03960801|Remifentanil|remifentanil|mesh-list
65470903|NCT03960801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65470904|NCT03960801|Narcotics|narcotics|mesh-ancestor
65470905|NCT03960801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65470906|NCT03960801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470907|NCT03960801|Analgesics|analgesics|mesh-ancestor
65470908|NCT03960801|Sensory System Agents|sensory system agents|mesh-ancestor
65470909|NCT03960801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65470910|NCT01583439|Ritonavir|ritonavir|mesh-list
65470911|NCT01583439|Lopinavir|lopinavir|mesh-list
65470912|NCT01583439|Tenofovir|tenofovir|mesh-list
65470913|NCT01583439|Lamivudine|lamivudine|mesh-list
65470914|NCT01583439|Zidovudine|zidovudine|mesh-list
65470915|NCT01583439|Emtricitabine|emtricitabine|mesh-list
65470949|NCT01082289|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65470950|NCT01082289|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65470951|NCT01082289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65470952|NCT01082289|Adrenergic Agents|adrenergic agents|mesh-ancestor
64855019|NCT01712126|Irbesartan|irbesartan|mesh-list
65470982|NCT00364793|Didanosine|didanosine|mesh-list
65470983|NCT00364793|Antiviral Agents|antiviral agents|mesh-ancestor
65470984|NCT00364793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65470985|NCT00364793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65470986|NCT00364793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65470987|NCT00364793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470988|NCT00364793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470989|NCT00364793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65470990|NCT00364793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65470991|NCT00364793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65470992|NCT00364793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65470993|NCT00364793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65470994|NCT00364793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65470995|NCT00364793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65471072|NCT01088724|Alkylating Agents|alkylating agents|mesh-ancestor
65471073|NCT01088724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471074|NCT01088724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471075|NCT01088724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65471076|NCT01088724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65471077|NCT01088724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65471134|NCT01042457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471136|NCT00362297|Acyclovir|acyclovir|mesh-list
65471137|NCT00362297|Antiviral Agents|antiviral agents|mesh-ancestor
65471138|NCT00362297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65471139|NCT01042691|Oxaliplatin|oxaliplatin|mesh-list
65471140|NCT01042691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273125|NCT00616850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273126|NCT00616850|Sensory System Agents|sensory system agents|mesh-ancestor
65273127|NCT00616850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65273128|NCT00616850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65273129|NCT00616850|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65273130|NCT00616850|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65273131|NCT00616850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65273132|NCT00616850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273133|NCT00618644|Ranibizumab|ranibizumab|mesh-list
65273134|NCT00618644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65023124|NCT02933905|Ranibizumab|ranibizumab|mesh-list
65273135|NCT00618644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65273136|NCT00618644|Growth Substances|growth substances|mesh-ancestor
65273137|NCT00618644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273138|NCT00618644|Growth Inhibitors|growth inhibitors|mesh-ancestor
65273139|NCT00618644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273140|NCT05324774|Aflibercept|aflibercept|mesh-list
65471141|NCT00090402|Thioctic Acid|thioctic acid|mesh-list
65471142|NCT00090402|Antioxidants|antioxidants|mesh-ancestor
64855209|NCT01713153|Misoprostol|misoprostol|mesh-list
65471241|NCT00394901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65471243|NCT03349060|Abrocitinib|abrocitinib|mesh-list
65471244|NCT03349060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65471245|NCT03349060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471246|NCT03349060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471247|NCT03348904|Gemcitabine|gemcitabine|mesh-list
65471248|NCT03348904|Paclitaxel|paclitaxel|mesh-list
65471249|NCT03348904|Carboplatin|carboplatin|mesh-list
65471250|NCT03348904|Nivolumab|nivolumab|mesh-list
65471251|NCT03348904|Pemetrexed|pemetrexed|mesh-list
65471252|NCT03348904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65471253|NCT03348904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471254|NCT03348904|Tubulin Modulators|tubulin modulators|mesh-ancestor
65471255|NCT03348904|Antimitotic Agents|antimitotic agents|mesh-ancestor
65471256|NCT03348904|Mitosis Modulators|mitosis modulators|mesh-ancestor
65471257|NCT03348904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471283|NCT00360269|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65471284|NCT00360269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65471285|NCT00360269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65471286|NCT00360269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471287|NCT00360269|Adrenergic Agents|adrenergic agents|mesh-ancestor
65471288|NCT00360269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65471289|NCT00360269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471291|NCT01052597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65471292|NCT01052597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65471293|NCT01052597|Analgesics|analgesics|mesh-ancestor
65471294|NCT01052597|Sensory System Agents|sensory system agents|mesh-ancestor
65471295|NCT01052597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65471296|NCT01052597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471297|NCT01052597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65471298|NCT01052597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65471299|NCT01052597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471300|NCT01052597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471301|NCT01052597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471302|NCT01051115|Dasatinib|dasatinib|mesh-list
65471303|NCT01051115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471340|NCT00076752|Anesthetics|anesthetics|mesh-ancestor
64468809|NCT00201838|Antiviral Agents|antiviral agents|mesh-ancestor
65471341|NCT00076752|Sensory System Agents|sensory system agents|mesh-ancestor
65471342|NCT00076752|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65471343|NCT00076752|Histamine Antagonists|histamine antagonists|mesh-ancestor
65471344|NCT00076752|Histamine Agents|histamine agents|mesh-ancestor
65471357|NCT00075582|Immunologic Factors|immunologic factors|mesh-ancestor
65471358|NCT00075582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471359|NCT00075582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65471360|NCT00075582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65471361|NCT00075582|Alkylating Agents|alkylating agents|mesh-ancestor
65471362|NCT00075582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471363|NCT00075582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471364|NCT00075582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65471365|NCT00075582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65471366|NCT00075582|Tubulin Modulators|tubulin modulators|mesh-ancestor
65471367|NCT00075582|Antimitotic Agents|antimitotic agents|mesh-ancestor
65471368|NCT00075582|Mitosis Modulators|mitosis modulators|mesh-ancestor
65471369|NCT00075582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65220868|NCT03492099|Buprenorphine|buprenorphine|mesh-list
65471370|NCT00075582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65471371|NCT00075582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65471372|NCT00075582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65471373|NCT00075582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471374|NCT00075582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65471375|NCT00063258|Paclitaxel|paclitaxel|mesh-list
65471376|NCT00063258|Carboplatin|carboplatin|mesh-list
65471377|NCT00063258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65471378|NCT00063258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65471379|NCT00063258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471380|NCT00063258|Tubulin Modulators|tubulin modulators|mesh-ancestor
65471381|NCT00063258|Antimitotic Agents|antimitotic agents|mesh-ancestor
65471382|NCT00063258|Mitosis Modulators|mitosis modulators|mesh-ancestor
65471383|NCT00063258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471384|NCT00063258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65471385|NCT00063258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471386|NCT00088530|Gemcitabine|gemcitabine|mesh-list
65471388|NCT00088530|Cyclophosphamide|cyclophosphamide|mesh-list
65471389|NCT00088530|Rituximab|rituximab|mesh-list
65471390|NCT00088530|Etoposide|etoposide|mesh-list
65471391|NCT00088530|Vincristine|vincristine|mesh-list
65471392|NCT00088530|Vinorelbine|vinorelbine|mesh-list
65471393|NCT00088530|Pixantrone|pixantrone|mesh-list
65471394|NCT00088530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65471395|NCT00088530|Immunologic Factors|immunologic factors|mesh-ancestor
65471396|NCT00088530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471397|NCT00088530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65471398|NCT00088530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65471399|NCT00088530|Alkylating Agents|alkylating agents|mesh-ancestor
65471400|NCT00088530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471401|NCT00088530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471402|NCT00088530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65471403|NCT00088530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65471404|NCT00088530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65471405|NCT00088530|Antimetabolites|antimetabolites|mesh-ancestor
65471406|NCT00088530|Antiviral Agents|antiviral agents|mesh-ancestor
65471407|NCT00088530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65471408|NCT00088530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471409|NCT00088530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65471410|NCT00088530|Glucocorticoids|glucocorticoids|mesh-ancestor
65471539|NCT00356603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471540|NCT01052051|Vitamin D|vitamin d|mesh-list
65471541|NCT01052051|Cholecalciferol|cholecalciferol|mesh-list
65471542|NCT01052051|Calcium Carbonate|calcium carbonate|mesh-list
65471543|NCT01052051|Calcium|calcium|mesh-list
65471544|NCT01052051|Vitamins|vitamins|mesh-ancestor
65471545|NCT01052051|Micronutrients|micronutrients|mesh-ancestor
65471546|NCT01052051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471547|NCT01052051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65471548|NCT01052051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65471549|NCT01052051|Antacids|antacids|mesh-ancestor
65471550|NCT01052051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471551|NCT01052051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65471552|NCT00002558|Paclitaxel|paclitaxel|mesh-list
65471553|NCT00002558|Etoposide|etoposide|mesh-list
65471554|NCT00002558|Carboplatin|carboplatin|mesh-list
65471555|NCT00002558|Ifosfamide|ifosfamide|mesh-list
65471556|NCT00002558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65273141|NCT05324774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65471557|NCT00002558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471558|NCT00002558|Tubulin Modulators|tubulin modulators|mesh-ancestor
65471559|NCT00002558|Antimitotic Agents|antimitotic agents|mesh-ancestor
65471560|NCT00002558|Mitosis Modulators|mitosis modulators|mesh-ancestor
65471561|NCT00002558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471562|NCT00002558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65471563|NCT00002558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65471564|NCT00002558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471565|NCT00002558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65471566|NCT00002558|Alkylating Agents|alkylating agents|mesh-ancestor
65471567|NCT00001880|Cyclosporine|cyclosporine|mesh-list
65471568|NCT00001880|Methotrexate|methotrexate|mesh-list
65471569|NCT00001880|Cyclosporins|cyclosporins|mesh-list
65471600|NCT05296772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471601|NCT03947528|Sarpogrelate|sarpogrelate|mesh-list
65471602|NCT03947528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65471603|NCT03947528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65471604|NCT03947528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471605|NCT03947528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65471607|NCT03947528|Serotonin Agents|serotonin agents|mesh-ancestor
65471608|NCT03947528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65471609|NCT03947528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471610|NCT01104896|Nicotine|nicotine|mesh-list
65471611|NCT01104896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65471612|NCT01104896|Autonomic Agents|autonomic agents|mesh-ancestor
65471613|NCT01104896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65471614|NCT01104896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471668|NCT00041132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471669|NCT00041132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471670|NCT00041132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65471671|NCT00041132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65471672|NCT00041132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65471673|NCT00041132|Antiemetics|antiemetics|mesh-ancestor
65471674|NCT00041132|Autonomic Agents|autonomic agents|mesh-ancestor
65471675|NCT00041132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65471676|NCT00041132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65471677|NCT00041132|Glucocorticoids|glucocorticoids|mesh-ancestor
65471678|NCT00041132|Hormones|hormones|mesh-ancestor
65471679|NCT00041132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65471680|NCT00041132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65471681|NCT00041132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65471682|NCT00041132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65471683|NCT00041132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65471684|NCT00041132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471685|NCT00041132|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65471686|NCT00041132|Abortifacient Agents|abortifacient agents|mesh-ancestor
65471687|NCT00041132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65471688|NCT00041132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65471689|NCT00041132|Antimetabolites|antimetabolites|mesh-ancestor
65471690|NCT00041132|Dermatologic Agents|dermatologic agents|mesh-ancestor
65471691|NCT00041132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65471692|NCT00041132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65471693|NCT00041132|Antiviral Agents|antiviral agents|mesh-ancestor
65471694|NCT00041132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65471695|NCT00041132|Antidotes|antidotes|mesh-ancestor
65471696|NCT00041132|Protective Agents|protective agents|mesh-ancestor
65471697|NCT00041132|Vitamin B Complex|vitamin b complex|mesh-ancestor
65471698|NCT00041132|Vitamins|vitamins|mesh-ancestor
65471699|NCT00041132|Micronutrients|micronutrients|mesh-ancestor
65471700|NCT00041132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65471701|NCT00041132|Tubulin Modulators|tubulin modulators|mesh-ancestor
65471702|NCT00041132|Antimitotic Agents|antimitotic agents|mesh-ancestor
65471703|NCT00041132|Mitosis Modulators|mitosis modulators|mesh-ancestor
65471704|NCT00040664|Ritonavir|ritonavir|mesh-list
65471705|NCT00040664|Fosamprenavir|fosamprenavir|mesh-list
65471706|NCT00040664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65471707|NCT00040664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65471708|NCT00040664|Protease Inhibitors|protease inhibitors|mesh-ancestor
65471709|NCT00040664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855743|NCT01715909|Oseltamivir|oseltamivir|mesh-list
65471763|NCT01096706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65471764|NCT01096706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65471765|NCT01096706|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65273142|NCT05324774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65471767|NCT01102478|Losartan|losartan|mesh-list
65471768|NCT01102478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65471769|NCT01102478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65471770|NCT01102478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65471771|NCT01102478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65471772|NCT01102478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65471773|NCT01102478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471774|NCT01102478|Diuretics|diuretics|mesh-ancestor
65471775|NCT01102478|Natriuretic Agents|natriuretic agents|mesh-ancestor
65471776|NCT01102478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471797|NCT03994172|Parathyroid Hormone|parathyroid hormone|mesh-list
65471798|NCT03994172|Cinacalcet|cinacalcet|mesh-list
65471799|NCT03994172|Hormones|hormones|mesh-list
65471800|NCT03994172|Vitamins|vitamins|mesh-ancestor
65471801|NCT03994172|Micronutrients|micronutrients|mesh-ancestor
65471802|NCT03994172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471803|NCT03994172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65471804|NCT03994172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65471805|NCT03994172|Anticoagulants|anticoagulants|mesh-ancestor
65471806|NCT03994172|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65471807|NCT03994172|Chelating Agents|chelating agents|mesh-ancestor
65471808|NCT03994172|Sequestering Agents|sequestering agents|mesh-ancestor
65471809|NCT03994172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471810|NCT03994172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65471811|NCT03994172|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65471812|NCT03994172|Hormone Antagonists|hormone antagonists|mesh-ancestor
65471813|NCT01105832|Teriparatide|teriparatide|mesh-list
65471814|NCT01105832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65471815|NCT01105832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471816|NCT01105832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65471817|NCT01105910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65471818|NCT01105910|Lubricant Eye Drops|lubricant eye drops|mesh-list
65471819|NCT01105910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65471820|NCT03856658|Floxuridine|floxuridine|mesh-list
65471821|NCT03856658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65471822|NCT03856658|Antimetabolites|antimetabolites|mesh-ancestor
65471823|NCT03856658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471824|NCT03856658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471825|NCT00356525|Gemcitabine|gemcitabine|mesh-list
65471826|NCT00356525|Carboplatin|carboplatin|mesh-list
65471827|NCT00356525|Pemetrexed|pemetrexed|mesh-list
65471828|NCT00356525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221322|NCT00627848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471829|NCT00356525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65471831|NCT00356525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471832|NCT00356525|Antiviral Agents|antiviral agents|mesh-ancestor
65471850|NCT01052129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65471851|NCT01052129|Gout Suppressants|gout suppressants|mesh-ancestor
65471852|NCT01052129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65471853|NCT01052129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471854|NCT01052129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471855|NCT01053377|Oseltamivir|oseltamivir|mesh-list
65471856|NCT01053377|Antiviral Agents|antiviral agents|mesh-ancestor
65471857|NCT01053377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65471858|NCT01053377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471859|NCT01053377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471860|NCT03991559|Manganese|manganese|mesh-list
65471861|NCT03991559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65471862|NCT03991559|Antibodies|antibodies|mesh-list
65471863|NCT03991559|Immunoglobulins|immunoglobulins|mesh-list
65471864|NCT03991559|Immunologic Factors|immunologic factors|mesh-ancestor
65471865|NCT03991559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471866|NCT03991559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471867|NCT03991559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471868|NCT03991559|Trace Elements|trace elements|mesh-ancestor
65471869|NCT03991559|Micronutrients|micronutrients|mesh-ancestor
65471870|NCT03949634|Paclitaxel|paclitaxel|mesh-list
65471871|NCT03949634|Docetaxel|docetaxel|mesh-list
65471872|NCT03949634|Doxorubicin|doxorubicin|mesh-list
65471873|NCT03949634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65471874|NCT03949634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471875|NCT03949634|Tubulin Modulators|tubulin modulators|mesh-ancestor
65471876|NCT03949634|Antimitotic Agents|antimitotic agents|mesh-ancestor
65273143|NCT05324774|Growth Substances|growth substances|mesh-ancestor
65273144|NCT05324774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469030|NCT00217438|Amifostine|amifostine|mesh-list
65471877|NCT03949634|Mitosis Modulators|mitosis modulators|mesh-ancestor
65471878|NCT03949634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471879|NCT03949634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65471880|NCT03949634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65471881|NCT03949634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65471882|NCT03949634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471883|NCT01108874|Metaraminol|metaraminol|mesh-list
65471884|NCT01108874|Sympathomimetics|sympathomimetics|mesh-ancestor
65471885|NCT01108874|Autonomic Agents|autonomic agents|mesh-ancestor
65471886|NCT01108874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65471887|NCT01108874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471888|NCT01108874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65471889|NCT01108874|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65471890|NCT01108874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65471976|NCT00350207|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65471977|NCT00350207|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65471978|NCT00350207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65471979|NCT00350207|Adrenergic Agents|adrenergic agents|mesh-ancestor
65471980|NCT00350207|Anticonvulsants|anticonvulsants|mesh-ancestor
65471981|NCT03946826|Halometasone|halometasone|mesh-list
65471982|NCT03946826|Petrolatum|petrolatum|mesh-list
65471983|NCT03946826|Emollients|emollients|mesh-ancestor
65471984|NCT03946826|Dermatologic Agents|dermatologic agents|mesh-ancestor
65471985|NCT03946826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65471986|NCT03946826|Glucocorticoids|glucocorticoids|mesh-ancestor
65471987|NCT03946826|Hormones|hormones|mesh-ancestor
65471988|NCT03946826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65471989|NCT03946826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472018|NCT01109030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65472019|NCT01109030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65472020|NCT01109030|GABA Modulators|gaba modulators|mesh-ancestor
65472021|NCT01109030|GABA Agents|gaba agents|mesh-ancestor
65472022|NCT04542824|Gemcitabine|gemcitabine|mesh-list
65472023|NCT04542824|Prednisone|prednisone|mesh-list
65472024|NCT04542824|Cyclophosphamide|cyclophosphamide|mesh-list
65472025|NCT04542824|Rituximab|rituximab|mesh-list
65472026|NCT04542824|Doxorubicin|doxorubicin|mesh-list
65472027|NCT04542824|Oxaliplatin|oxaliplatin|mesh-list
65472028|NCT04542824|Vincristine|vincristine|mesh-list
65472029|NCT04542824|Lenalidomide|lenalidomide|mesh-list
65472030|NCT04542824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65472031|NCT04542824|Immunologic Factors|immunologic factors|mesh-ancestor
65472032|NCT04542824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472033|NCT04542824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65472034|NCT04542824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65472035|NCT04542824|Alkylating Agents|alkylating agents|mesh-ancestor
65472036|NCT04542824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472037|NCT04542824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472038|NCT04542824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65472069|NCT00349973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65472070|NCT00349973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65472071|NCT00349973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65472072|NCT00349973|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65472073|NCT00349973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65472074|NCT00349973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65472075|NCT00349973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472076|NCT00349973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65472077|NCT00349973|Serotonin Agents|serotonin agents|mesh-ancestor
65472078|NCT00349973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65472079|NCT00349973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472080|NCT00349973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65472081|NCT00349973|Vasodilator Agents|vasodilator agents|mesh-ancestor
65472082|NCT01111682|Mannitol|mannitol|mesh-list
65472112|NCT01209026|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65472114|NCT01209026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65472115|NCT01209026|Autonomic Agents|autonomic agents|mesh-ancestor
65472116|NCT01209026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472117|NCT01209026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472118|NCT01209026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65472119|NCT01209026|Respiratory System Agents|respiratory system agents|mesh-ancestor
65273145|NCT05324774|Growth Inhibitors|growth inhibitors|mesh-ancestor
65273146|NCT05324774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273147|NCT05324618|Hydrocortisone|hydrocortisone|mesh-list
65273148|NCT05324618|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65273149|NCT05324618|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64469106|NCT05819892|Paclitaxel|paclitaxel|mesh-list
65472120|NCT01209026|Dermatologic Agents|dermatologic agents|mesh-ancestor
65472121|NCT01209026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65472122|NCT01209026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65472123|NCT01209026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65472124|NCT01209026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65472125|NCT01209026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65472126|NCT01209026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472127|NCT01209026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472128|NCT01209026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856167|NCT01718587|Antiviral Agents|antiviral agents|mesh-list
65472203|NCT01209416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472204|NCT01209416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65472205|NCT00349349|Ofatumumab|ofatumumab|mesh-list
65472206|NCT00349349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472207|NCT01112462|Acetaminophen|acetaminophen|mesh-list
65472208|NCT01112462|Phenylephrine|phenylephrine|mesh-list
65472209|NCT01112462|Oxymetazoline|oxymetazoline|mesh-list
65472210|NCT01112462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65472211|NCT01112462|Analgesics|analgesics|mesh-ancestor
65472212|NCT01112462|Sensory System Agents|sensory system agents|mesh-ancestor
65472213|NCT01112462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472214|NCT01112462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472215|NCT01112462|Antipyretics|antipyretics|mesh-ancestor
65472216|NCT01112462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65472217|NCT01112462|Mydriatics|mydriatics|mesh-ancestor
65472218|NCT01112462|Autonomic Agents|autonomic agents|mesh-ancestor
65472219|NCT01112462|Sympathomimetics|sympathomimetics|mesh-ancestor
65472220|NCT01112462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65472221|NCT01112462|Nasal Decongestants|nasal decongestants|mesh-ancestor
65472222|NCT01112462|Respiratory System Agents|respiratory system agents|mesh-ancestor
65472223|NCT01112462|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65472224|NCT01112462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65472225|NCT01112462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65472226|NCT01112462|Adrenergic Agents|adrenergic agents|mesh-ancestor
65472227|NCT01112462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65472228|NCT01112462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472229|NCT01112462|Protective Agents|protective agents|mesh-ancestor
65472286|NCT00347009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472288|NCT01209650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472289|NCT01209650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65472290|NCT01209650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856349|NCT01719601|Tapentadol|tapentadol|mesh-list
65472320|NCT01112540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472322|NCT01112540|Sensory System Agents|sensory system agents|mesh-ancestor
65472323|NCT01112540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472324|NCT03400852|Cosyntropin|cosyntropin|mesh-list
65472325|NCT03400852|Hormones|hormones|mesh-ancestor
65472326|NCT03400852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65472327|NCT03400852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472328|NCT01056419|Propylthiouracil|propylthiouracil|mesh-list
65472329|NCT01056419|Antimetabolites|antimetabolites|mesh-ancestor
65472330|NCT01056419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472331|NCT01056419|Antithyroid Agents|antithyroid agents|mesh-ancestor
65472332|NCT01056419|Hormone Antagonists|hormone antagonists|mesh-ancestor
64856379|NCT01719627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65472354|NCT00346151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65472355|NCT00346151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65221859|NCT02591095|Navitoclax|navitoclax|mesh-list
65472356|NCT00346151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472357|NCT00346151|Antifungal Agents|antifungal agents|mesh-ancestor
65472358|NCT00346151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65472359|NCT00346151|Immunologic Factors|immunologic factors|mesh-ancestor
65472360|NCT00346151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472361|NCT00346151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65273150|NCT05324618|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65273151|NCT05324618|Tacrolimus|tacrolimus|mesh-list
65273152|NCT05324618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65273153|NCT05324618|Immunologic Factors|immunologic factors|mesh-ancestor
65273154|NCT05324618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273155|NCT05324618|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65273156|NCT05324618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273157|NCT05324618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273158|NCT05324618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65273159|NCT05300594|Vitamins|vitamins|mesh-list
65472362|NCT00346151|Antiemetics|antiemetics|mesh-ancestor
65472363|NCT00346151|Autonomic Agents|autonomic agents|mesh-ancestor
65472364|NCT00346151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472365|NCT00346151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65472366|NCT00346151|Hormones|hormones|mesh-ancestor
65472367|NCT00346151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65472368|NCT00346151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65472369|NCT00346151|Protective Agents|protective agents|mesh-ancestor
65472370|NCT00346151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65472371|NCT00346151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472372|NCT00346151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65472373|NCT03940976|Afatinib|afatinib|mesh-list
65472374|NCT03940976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472375|NCT03940976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65472376|NCT03940976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472377|NCT03940976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472378|NCT01109498|Cyclosporine|cyclosporine|mesh-list
65472379|NCT01109498|Mycophenolic Acid|mycophenolic acid|mesh-list
65472380|NCT01109498|Cyclosporins|cyclosporins|mesh-list
65472381|NCT01109498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472382|NCT01109498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472383|NCT01109498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65472384|NCT01109498|Immunologic Factors|immunologic factors|mesh-ancestor
65472385|NCT01109498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472386|NCT01109498|Antifungal Agents|antifungal agents|mesh-ancestor
64856426|NCT01719835|Antimetabolites|antimetabolites|mesh-ancestor
65472416|NCT03374488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65472417|NCT03374488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472418|NCT01209728|Ethanol|ethanol|mesh-list
65472419|NCT01209728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65472420|NCT01209728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65472421|NCT01209728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65472422|NCT01209728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472423|NCT00076310|Cisplatin|cisplatin|mesh-list
65472424|NCT00076310|Docetaxel|docetaxel|mesh-list
65472425|NCT00076310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65472426|NCT00076310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472427|NCT00076310|Tubulin Modulators|tubulin modulators|mesh-ancestor
65221925|NCT05563168|Diltiazem|diltiazem|mesh-list
65472428|NCT00076310|Antimitotic Agents|antimitotic agents|mesh-ancestor
65472429|NCT00076310|Mitosis Modulators|mitosis modulators|mesh-ancestor
65472430|NCT00076310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472431|NCT00076310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64624979|NCT04331470|Glucocorticoids|glucocorticoids|mesh-ancestor
65472464|NCT01209806|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
65472466|NCT01209806|Antifoaming Agents|antifoaming agents|mesh-ancestor
65472467|NCT01209806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472468|NCT01209806|Emollients|emollients|mesh-ancestor
65472469|NCT01209806|Dermatologic Agents|dermatologic agents|mesh-ancestor
65472470|NCT01209806|Antacids|antacids|mesh-ancestor
65472471|NCT01209806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65472472|NCT01209806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65472473|NCT01209806|Immunologic Factors|immunologic factors|mesh-ancestor
65472613|NCT01115426|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65273160|NCT05300594|Micronutrients|micronutrients|mesh-ancestor
65472614|NCT01115426|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65472615|NCT01115426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472616|NCT01115426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65472618|NCT01115426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472619|NCT03942458|Clopidogrel|clopidogrel|mesh-list
65472620|NCT03942458|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65472621|NCT03942458|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65472622|NCT03942458|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65472623|NCT03942458|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65472624|NCT03942458|Purinergic Agents|purinergic agents|mesh-ancestor
65472625|NCT03942458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65472653|NCT01054547|Sensory System Agents|sensory system agents|mesh-ancestor
65472654|NCT01054547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472656|NCT01115894|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65472657|NCT01115894|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65472658|NCT01115894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472659|NCT01115894|Sensory System Agents|sensory system agents|mesh-ancestor
65472660|NCT01115894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472661|NCT01115972|Valsartan|valsartan|mesh-list
65472662|NCT01115972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65472663|NCT01115972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65472664|NCT01115972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65472665|NCT01115972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472666|NCT01116050|Misoprostol|misoprostol|mesh-list
65472667|NCT01116050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65472668|NCT01116050|Abortifacient Agents|abortifacient agents|mesh-ancestor
65472669|NCT01116050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65472670|NCT01116050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472671|NCT01116050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65472709|NCT03708718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472710|NCT00354107|Cytarabine|cytarabine|mesh-list
65472814|NCT01055249|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65472815|NCT01055249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65472816|NCT01055249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65472818|NCT01055249|Sensory System Agents|sensory system agents|mesh-ancestor
65472819|NCT01055249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472820|NCT01055249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472821|NCT01055249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65472822|NCT01055249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65472823|NCT01055249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65472824|NCT01055249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472825|NCT01055249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472860|NCT01113164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65472861|NCT01113164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65472862|NCT01113164|Antidepressive Agents|antidepressive agents|mesh-ancestor
65472863|NCT01113164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65472864|NCT01113164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65472897|NCT01116128|Immunologic Factors|immunologic factors|mesh-ancestor
65472898|NCT01116128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65472899|NCT01116128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472900|NCT03390166|Vaccines|vaccines|mesh-list
65472901|NCT03390166|Immunologic Factors|immunologic factors|mesh-ancestor
65472902|NCT03390166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472903|NCT01116206|Prucalopride|prucalopride|mesh-list
65472904|NCT01116206|Laxatives|laxatives|mesh-ancestor
65472905|NCT01116206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65472906|NCT01116206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65472907|NCT01116206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65472908|NCT01116206|Serotonin Agents|serotonin agents|mesh-ancestor
65472909|NCT01116206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65472968|NCT01055405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472970|NCT02949934|Tolcapone|tolcapone|mesh-list
65472971|NCT02949934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65472972|NCT02949934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65472973|NCT02949934|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65472974|NCT02949934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472975|NCT02949934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472976|NCT01055483|Panobinostat|panobinostat|mesh-list
65472977|NCT01055483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472978|NCT01055483|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65273161|NCT05300594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273162|NCT00907517|Cytarabine|cytarabine|mesh-list
65472979|NCT01055483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472980|NCT01055483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472981|NCT03370510|Oxytocin|oxytocin|mesh-list
65472982|NCT03370510|Oxytocics|oxytocics|mesh-ancestor
65472983|NCT03370510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65472984|NCT03370510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472985|NCT03985865|Quinine|quinine|mesh-list
65472986|NCT03985865|Denatonium|denatonium|mesh-list
65472987|NCT03985865|Antimalarials|antimalarials|mesh-ancestor
65472988|NCT03985865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65472989|NCT03985865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65472990|NCT03985865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65473069|NCT00337727|Antiemetics|antiemetics|mesh-ancestor
65473070|NCT00337727|Autonomic Agents|autonomic agents|mesh-ancestor
65473071|NCT00337727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65473072|NCT00337727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473073|NCT00337727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65473074|NCT00337727|Glucocorticoids|glucocorticoids|mesh-ancestor
65473075|NCT00337727|Hormones|hormones|mesh-ancestor
65473076|NCT00337727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65473077|NCT00337727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65473078|NCT00337727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473079|NCT00337727|Protease Inhibitors|protease inhibitors|mesh-ancestor
65473080|NCT00337727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473081|NCT00337727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473082|NCT00337727|Antipruritics|antipruritics|mesh-ancestor
65473083|NCT00337727|Dermatologic Agents|dermatologic agents|mesh-ancestor
65473084|NCT00337727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65473085|NCT00337727|Serotonin Agents|serotonin agents|mesh-ancestor
65473086|NCT00337727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64857143|NCT01733134|Tolvaptan|tolvaptan|mesh-list
65473117|NCT04774120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473118|NCT04774120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65473119|NCT04774120|Anesthetics, General|anesthetics, general|mesh-ancestor
65473120|NCT04774120|Anesthetics|anesthetics|mesh-ancestor
65473121|NCT01117220|Ziprasidone|ziprasidone|mesh-list
65473122|NCT01117220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65473123|NCT01117220|Serotonin Agents|serotonin agents|mesh-ancestor
65473124|NCT01117220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65473125|NCT01117220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473126|NCT01117220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473127|NCT01117220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65473128|NCT01117220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65473129|NCT01117220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64857193|NCT01733485|Antipyretics|antipyretics|mesh-ancestor
65473158|NCT01117298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65473159|NCT01117298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65473160|NCT01117298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473161|NCT01117298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473162|NCT01117298|Urological Agents|urological agents|mesh-ancestor
65473163|NCT01117376|Erythromycin|erythromycin|mesh-list
65473164|NCT01117376|Erythromycin Estolate|erythromycin estolate|mesh-list
65473165|NCT01117376|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65473166|NCT01117376|Erythromycin stearate|erythromycin stearate|mesh-list
65473167|NCT01117376|Methylnaltrexone|methylnaltrexone|mesh-list
65473168|NCT01117376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65473169|NCT01117376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65473170|NCT01117376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65473171|NCT01117376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65473172|NCT01117376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473173|NCT01117376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473174|NCT01117376|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65473201|NCT01110824|Protective Agents|protective agents|mesh-ancestor
65473202|NCT01110824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65473203|NCT01110824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65473204|NCT01110824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65473205|NCT01110824|Vasodilator Agents|vasodilator agents|mesh-ancestor
65473206|NCT01110824|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65473207|NCT01110824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65473208|NCT01110824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65473209|NCT01110824|Protease Inhibitors|protease inhibitors|mesh-ancestor
65273163|NCT00907517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65473210|NCT01110824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473212|NCT03936140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65473213|NCT03936140|Vasodilator Agents|vasodilator agents|mesh-ancestor
65473214|NCT01117610|Ropivacaine|ropivacaine|mesh-list
65473215|NCT01117610|Anesthetics, Local|anesthetics, local|mesh-ancestor
65473216|NCT01117610|Anesthetics|anesthetics|mesh-ancestor
65473217|NCT01117610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65473218|NCT01117610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473219|NCT01117610|Sensory System Agents|sensory system agents|mesh-ancestor
65473220|NCT01117610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65473221|NCT01215890|Risedronic Acid|risedronic acid|mesh-list
65473284|NCT03937544|Cyclophosphamide|cyclophosphamide|mesh-list
65473285|NCT03937544|Fludarabine|fludarabine|mesh-list
65473286|NCT03937544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65473287|NCT03937544|Immunologic Factors|immunologic factors|mesh-ancestor
65473308|NCT01219088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473309|NCT01219088|Sensory System Agents|sensory system agents|mesh-ancestor
65473310|NCT01219088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65473311|NCT01219088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65473312|NCT01219088|Narcotics|narcotics|mesh-ancestor
65473313|NCT01219088|Analgesics|analgesics|mesh-ancestor
65473314|NCT01122134|Artesunate|artesunate|mesh-list
65473315|NCT01122134|Antimalarials|antimalarials|mesh-ancestor
65473316|NCT01122134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65473317|NCT01122134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65473318|NCT01122134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65473319|NCT01122134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473320|NCT01122134|Antiviral Agents|antiviral agents|mesh-ancestor
65473321|NCT01122134|Schistosomicides|schistosomicides|mesh-ancestor
65473322|NCT01122134|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65473323|NCT01122134|Anthelmintics|anthelmintics|mesh-ancestor
65222817|NCT02699385|Domperidone|domperidone|mesh-list
65473324|NCT01118702|Methylphenidate|methylphenidate|mesh-list
65473325|NCT01118702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65473326|NCT01118702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473327|NCT01118702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65473328|NCT01118702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65473329|NCT01118702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65473330|NCT01118702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473331|NCT01118702|Dopamine Agents|dopamine agents|mesh-ancestor
65473332|NCT01118702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65473333|NCT01118936|Magnesium Hydroxide|magnesium hydroxide|mesh-list
65473334|NCT01118936|Antacids|antacids|mesh-ancestor
65473335|NCT01118936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473336|NCT01118936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65473337|NCT01119014|Aripiprazole|aripiprazole|mesh-list
65473338|NCT01119014|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65473339|NCT01119014|Antidepressive Agents|antidepressive agents|mesh-ancestor
65473340|NCT01119014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65473341|NCT01119014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65473342|NCT01119014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65473357|NCT01219244|Antioxidants|antioxidants|mesh-ancestor
65473358|NCT01219244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473359|NCT01219244|Protective Agents|protective agents|mesh-ancestor
65473360|NCT01219244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473361|NCT01219244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473362|NCT01219244|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65473363|NCT01119482|Vaccines|vaccines|mesh-list
65473364|NCT01119482|Immunologic Factors|immunologic factors|mesh-ancestor
65473365|NCT01119482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473366|NCT01119638|Risperidone|risperidone|mesh-list
65473367|NCT01119638|Citalopram|citalopram|mesh-list
65473368|NCT01119638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65473369|NCT01119638|Serotonin Agents|serotonin agents|mesh-ancestor
65473370|NCT01119638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65473371|NCT01119638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473372|NCT01119638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473373|NCT01119638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65473374|NCT01119638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65473375|NCT01119638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65473376|NCT01119638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65473377|NCT01119638|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65473378|NCT01119638|Dopamine Agents|dopamine agents|mesh-ancestor
65473379|NCT01119638|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65273164|NCT00907517|Antimetabolites|antimetabolites|mesh-ancestor
65273165|NCT00907517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273166|NCT00907517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273167|NCT00907517|Antiviral Agents|antiviral agents|mesh-ancestor
65273168|NCT00907517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65473380|NCT01119638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65473381|NCT01119638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65473382|NCT01119638|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65473383|NCT01119638|Antidepressive Agents|antidepressive agents|mesh-ancestor
65473384|NCT03338998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65473385|NCT03338998|Siponimod|siponimod|mesh-list
65473386|NCT03338998|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65473387|NCT03338998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473388|NCT03338998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65473389|NCT03338998|Immunologic Factors|immunologic factors|mesh-ancestor
65473390|NCT03338998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473391|NCT03935984|Calcitonin|calcitonin|mesh-list
65473392|NCT03935984|Salmon calcitonin|salmon calcitonin|mesh-list
65473393|NCT03935984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
65473394|NCT03935984|Katacalcin|katacalcin|mesh-list
65473395|NCT03935984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65473396|NCT03935984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473397|NCT03935984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65473398|NCT03935984|Vasodilator Agents|vasodilator agents|mesh-ancestor
65473400|NCT01219400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65473401|NCT01219400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473430|NCT01120106|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65473431|NCT01120106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65473432|NCT01120106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473433|NCT01120106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473434|NCT01120106|Protective Agents|protective agents|mesh-ancestor
65473435|NCT01120106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473436|NCT01122368|Micafungin|micafungin|mesh-list
65473437|NCT01122368|Antifungal Agents|antifungal agents|mesh-ancestor
65473438|NCT01122368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65473439|NCT03338062|Iminodiacetic acid|iminodiacetic acid|mesh-list
65473440|NCT03338062|Chelating Agents|chelating agents|mesh-ancestor
65473441|NCT03338062|Sequestering Agents|sequestering agents|mesh-ancestor
65473442|NCT03338062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473443|NCT01216826|Everolimus|everolimus|mesh-list
65473444|NCT01216826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473445|NCT01216826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65473446|NCT01216826|Immunologic Factors|immunologic factors|mesh-ancestor
65473447|NCT01216826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473448|NCT01120340|Mesalamine|mesalamine|mesh-list
65473449|NCT01120340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65473450|NCT01120340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65473466|NCT01214408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65473467|NCT01214408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65473468|NCT01214408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65473469|NCT01214408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473470|NCT01214408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473471|NCT01214486|Raltegravir Potassium|raltegravir potassium|mesh-list
65473472|NCT01214486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65473473|NCT01214486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65473474|NCT01214486|Antiviral Agents|antiviral agents|mesh-ancestor
65473475|NCT01214486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65473476|NCT01214486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65473477|NCT01214486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65473478|NCT01214486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473479|NCT01214486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473480|NCT01216904|Nicotine|nicotine|mesh-list
65473481|NCT01216904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65473482|NCT01216904|Autonomic Agents|autonomic agents|mesh-ancestor
65473483|NCT01216904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65473484|NCT01216904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473485|NCT01216904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65473486|NCT01216904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65473487|NCT01216904|Cholinergic Agents|cholinergic agents|mesh-ancestor
65273169|NCT00907517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65273170|NCT00907517|Immunologic Factors|immunologic factors|mesh-ancestor
65273171|NCT00907517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273172|NCT03043547|Leucovorin|leucovorin|mesh-list
65273173|NCT03043547|Antidotes|antidotes|mesh-ancestor
65273174|NCT03043547|Protective Agents|protective agents|mesh-ancestor
65473488|NCT01216904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65473489|NCT01216904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473490|NCT01125020|Gemcitabine|gemcitabine|mesh-list
65473491|NCT01125020|Doxorubicin|doxorubicin|mesh-list
65473492|NCT01125020|Oxaliplatin|oxaliplatin|mesh-list
65473493|NCT01125020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473494|NCT01125020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65473495|NCT01125020|Antimetabolites|antimetabolites|mesh-ancestor
65473496|NCT01125020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473497|NCT01125020|Antiviral Agents|antiviral agents|mesh-ancestor
65473498|NCT01125020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65473499|NCT01125020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473500|NCT01125020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65473501|NCT01125020|Immunologic Factors|immunologic factors|mesh-ancestor
65473502|NCT01125020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473503|NCT01125020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65473504|NCT01125020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65473505|NCT01125020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65473506|NCT01312012|Antiviral Agents|antiviral agents|mesh-list
65473507|NCT01312012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65473508|NCT01125254|Amlodipine|amlodipine|mesh-list
65473509|NCT01125254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65473510|NCT01125254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65473522|NCT03710434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473523|NCT03706924|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65473524|NCT03706924|Elsulfavirine|elsulfavirine|mesh-list
65473525|NCT03706924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65473526|NCT03706924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65473527|NCT03706924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473528|NCT03706924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473529|NCT03706924|Antiviral Agents|antiviral agents|mesh-ancestor
65473530|NCT03706924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65473531|NCT03706924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65473532|NCT03706924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65473533|NCT01217138|Epinephrine|epinephrine|mesh-list
65473534|NCT01217138|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65473535|NCT01217138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65473536|NCT01217138|Adrenergic Agents|adrenergic agents|mesh-ancestor
65473537|NCT01217138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65473538|NCT01217138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473539|NCT01217138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473540|NCT01217138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65473541|NCT01217138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65473542|NCT01217138|Autonomic Agents|autonomic agents|mesh-ancestor
65473543|NCT01217138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65473544|NCT01217138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65473545|NCT01217138|Respiratory System Agents|respiratory system agents|mesh-ancestor
65473546|NCT01217138|Mydriatics|mydriatics|mesh-ancestor
65473547|NCT01217138|Sympathomimetics|sympathomimetics|mesh-ancestor
65473548|NCT01217138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65473549|NCT03710356|Danazol|danazol|mesh-list
65473550|NCT03710356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65473551|NCT03710356|Hormone Antagonists|hormone antagonists|mesh-ancestor
65473552|NCT03710356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65473553|NCT03710356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473554|NCT01217294|Morphine|morphine|mesh-list
65473555|NCT01217294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65473556|NCT01217294|Narcotics|narcotics|mesh-ancestor
65473557|NCT01217294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65473558|NCT01217294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473559|NCT01217294|Analgesics|analgesics|mesh-ancestor
65473560|NCT01217294|Sensory System Agents|sensory system agents|mesh-ancestor
65473561|NCT01217294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65473562|NCT03361228|Pembrolizumab|pembrolizumab|mesh-list
65473563|NCT03361228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65473564|NCT03361228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473565|NCT01121042|Ondansetron|ondansetron|mesh-list
65473566|NCT01121042|Antiemetics|antiemetics|mesh-ancestor
65473567|NCT01121042|Autonomic Agents|autonomic agents|mesh-ancestor
65473568|NCT01121042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65473569|NCT01121042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473570|NCT01121042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65473571|NCT01121042|Antipruritics|antipruritics|mesh-ancestor
65473572|NCT01121042|Dermatologic Agents|dermatologic agents|mesh-ancestor
65473583|NCT01121120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65473584|NCT01121120|Vasodilator Agents|vasodilator agents|mesh-ancestor
65473585|NCT01217450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65473586|NCT01217450|Cetuximab|cetuximab|mesh-list
65473587|NCT01217450|Antibodies|antibodies|mesh-list
65473588|NCT01217450|Immunoglobulins|immunoglobulins|mesh-list
65473589|NCT01217450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65473590|NCT01217450|Immunologic Factors|immunologic factors|mesh-ancestor
65473591|NCT01217450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473592|NCT01217450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473593|NCT01219556|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65473594|NCT01219556|Olmesartan|olmesartan|mesh-list
65473595|NCT01219556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65473596|NCT01219556|Diuretics|diuretics|mesh-ancestor
65473597|NCT01219556|Natriuretic Agents|natriuretic agents|mesh-ancestor
65473598|NCT01219556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473599|NCT01219556|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65473600|NCT01219556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65473601|NCT01219556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473602|NCT01219556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65473603|NCT01219556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65473604|NCT01121198|Ipragliflozin|ipragliflozin|mesh-list
65473605|NCT01121198|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65473606|NCT01121198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473607|NCT01121198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65473608|NCT01121198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473609|NCT01121276|Insulin|insulin|mesh-list
65473610|NCT01121276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65473611|NCT01121276|Insulin Aspart|insulin aspart|mesh-list
65473612|NCT01121276|Insulin, Long-Acting|insulin, long-acting|mesh-list
65473613|NCT01121276|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65473614|NCT01121276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65473615|NCT01121276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473616|NCT05175508|Azacitidine|azacitidine|mesh-list
65473617|NCT05175508|Tretinoin|tretinoin|mesh-list
65473618|NCT05175508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65473619|NCT05175508|Antimetabolites|antimetabolites|mesh-ancestor
65473620|NCT05175508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473621|NCT05175508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473622|NCT05175508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473623|NCT05175508|Keratolytic Agents|keratolytic agents|mesh-ancestor
65473624|NCT05175508|Dermatologic Agents|dermatologic agents|mesh-ancestor
65473625|NCT01125410|Clindamycin|clindamycin|mesh-list
65473626|NCT01125410|Clindamycin palmitate|clindamycin palmitate|mesh-list
65473627|NCT01125410|Clindamycin phosphate|clindamycin phosphate|mesh-list
65473628|NCT01125410|Dequalinium|dequalinium|mesh-list
65473629|NCT01125410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65473630|NCT01125410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65473631|NCT01125410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65473632|NCT01125410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473633|NCT01125410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473634|NCT01125410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65473635|NCT01328834|Tacrolimus|tacrolimus|mesh-list
65473636|NCT01328834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65473637|NCT01328834|Immunologic Factors|immunologic factors|mesh-ancestor
65473652|NCT01122602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65473653|NCT01122602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65473654|NCT01122602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65473655|NCT01122602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65473656|NCT01122602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473657|NCT01122602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65473658|NCT01122602|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65473659|NCT01122602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473661|NCT03359590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65473662|NCT03359590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65273175|NCT03043547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273176|NCT03043547|Vitamin B Complex|vitamin b complex|mesh-ancestor
65473663|NCT03359590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473664|NCT03359590|Incretins|incretins|mesh-ancestor
65473665|NCT03359590|Hormones|hormones|mesh-ancestor
65473666|NCT03359590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65473667|NCT03359590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65473668|NCT03359590|Protease Inhibitors|protease inhibitors|mesh-ancestor
65473669|NCT03359590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473670|NCT03359590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473671|NCT01219712|Simendan|simendan|mesh-list
65473672|NCT01219712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65473673|NCT01219712|Vasodilator Agents|vasodilator agents|mesh-ancestor
65473674|NCT01219712|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65473675|NCT01219712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65473676|NCT01219712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473677|NCT01219712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473678|NCT01219712|Protective Agents|protective agents|mesh-ancestor
65473679|NCT01219712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473680|NCT03936062|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65473681|NCT03936062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65473682|NCT03936062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473683|NCT03936062|Incretins|incretins|mesh-ancestor
65473684|NCT03936062|Hormones|hormones|mesh-ancestor
65473685|NCT03936062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65473686|NCT03936062|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65473687|NCT03936062|Protease Inhibitors|protease inhibitors|mesh-ancestor
65473688|NCT03936062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473689|NCT03936062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473690|NCT01215266|Sorafenib|sorafenib|mesh-list
65473691|NCT01215266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473692|NCT01215266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65473693|NCT01215266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473694|NCT01215266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223193|NCT02585401|Growth Inhibitors|growth inhibitors|mesh-ancestor
65473701|NCT03936374|Omeprazole|omeprazole|mesh-list
65473702|NCT03936374|Linrodostat|linrodostat|mesh-list
65473703|NCT03936374|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65473704|NCT03936374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65473705|NCT03936374|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65473706|NCT03936374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473707|NCT03936374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473708|NCT01125488|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65473709|NCT01125488|Luteolytic Agents|luteolytic agents|mesh-ancestor
65473710|NCT01125488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65473711|NCT01125488|Contraceptive Agents|contraceptive agents|mesh-ancestor
65473712|NCT01125488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65473713|NCT01125488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473714|NCT01125488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65473715|NCT01125488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65473716|NCT01125488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473717|NCT05082610|Pembrolizumab|pembrolizumab|mesh-list
65473718|NCT05082610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65473719|NCT05082610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473720|NCT01215578|Sunitinib|sunitinib|mesh-list
65473721|NCT01215578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473722|NCT01215578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65473723|NCT01215578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65473724|NCT01215578|Growth Substances|growth substances|mesh-ancestor
65473725|NCT01215578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473726|NCT01215578|Growth Inhibitors|growth inhibitors|mesh-ancestor
65473727|NCT01215578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65473728|NCT01215578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473729|NCT01215578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473730|NCT05577988|Aspirin|aspirin|mesh-list
65473731|NCT05577988|Clopidogrel|clopidogrel|mesh-list
65473732|NCT05577988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65473733|NCT05577988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65473734|NCT05577988|Analgesics|analgesics|mesh-ancestor
65473735|NCT05577988|Sensory System Agents|sensory system agents|mesh-ancestor
65473736|NCT05577988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65273177|NCT03043547|Vitamins|vitamins|mesh-ancestor
65273178|NCT03043547|Micronutrients|micronutrients|mesh-ancestor
65273179|NCT00905255|Lixisenatide|lixisenatide|mesh-list
65473737|NCT05577988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473738|NCT05577988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65473739|NCT05577988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65473740|NCT05577988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65473741|NCT05577988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65473742|NCT05577988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473743|NCT05577988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65473744|NCT05577988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65473745|NCT05577988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473746|NCT05577988|Antipyretics|antipyretics|mesh-ancestor
65473747|NCT05577988|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65473748|NCT05577988|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65473749|NCT05577988|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65473750|NCT05577988|Purinergic Agents|purinergic agents|mesh-ancestor
65473751|NCT05577988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65473752|NCT01222052|Cyclophosphamide|cyclophosphamide|mesh-list
65473753|NCT01222052|Docetaxel|docetaxel|mesh-list
65473754|NCT01222052|Fluorouracil|fluorouracil|mesh-list
65473755|NCT01222052|Epirubicin|epirubicin|mesh-list
65473756|NCT01222052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65473757|NCT01222052|Immunologic Factors|immunologic factors|mesh-ancestor
65473758|NCT01222052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473759|NCT01222052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65473760|NCT01222052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65473761|NCT01222052|Alkylating Agents|alkylating agents|mesh-ancestor
65473762|NCT01222052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473763|NCT01222052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473771|NCT01222052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65473772|NCT01222052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65473773|NCT01222052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473774|NCT03710044|Cyclosporine|cyclosporine|mesh-list
65473775|NCT03710044|Cyclosporins|cyclosporins|mesh-list
65473776|NCT03710044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473777|NCT03710044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473778|NCT03710044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65473779|NCT03710044|Immunologic Factors|immunologic factors|mesh-ancestor
65473780|NCT03710044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473781|NCT03710044|Antifungal Agents|antifungal agents|mesh-ancestor
65473782|NCT03710044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65473783|NCT03710044|Dermatologic Agents|dermatologic agents|mesh-ancestor
65473784|NCT03710044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65473785|NCT03710044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65473786|NCT03706300|Phenylpropanolamine|phenylpropanolamine|mesh-list
65473787|NCT03706300|Pseudoephedrine|pseudoephedrine|mesh-list
65473789|NCT03706300|Guaifenesin|guaifenesin|mesh-list
65473790|NCT03706300|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
65473791|NCT03706300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65473792|NCT03706300|Autonomic Agents|autonomic agents|mesh-ancestor
65473793|NCT03706300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65473794|NCT03706300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473795|NCT03706300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65473796|NCT03706300|Respiratory System Agents|respiratory system agents|mesh-ancestor
65473797|NCT03706300|Nasal Decongestants|nasal decongestants|mesh-ancestor
65473798|NCT03706300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65473799|NCT03706300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65473800|NCT03706300|Sympathomimetics|sympathomimetics|mesh-ancestor
65473801|NCT03706300|Adrenergic Agents|adrenergic agents|mesh-ancestor
65473802|NCT03706300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65473803|NCT03706300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473804|NCT03706300|Expectorants|expectorants|mesh-ancestor
65473805|NCT03706300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65473806|NCT03706300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65473807|NCT03706300|Appetite Depressants|appetite depressants|mesh-ancestor
65473808|NCT03706300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65473809|NCT05155540|Plasminogen|plasminogen|mesh-list
65473810|NCT05155540|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65473811|NCT05155540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65473812|NCT05155540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65473813|NCT05155540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248407|NCT00202904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65273180|NCT00905255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65273181|NCT00905255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273182|NCT00905021|Sunitinib|sunitinib|mesh-list
65473814|NCT01122914|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65473815|NCT01122914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65473816|NCT01222442|Moxifloxacin|moxifloxacin|mesh-list
65473817|NCT01222442|AZD-3199|azd-3199|mesh-list
65473818|NCT01222442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65473819|NCT01222442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65473820|NCT01222442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65473821|NCT01222442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65473822|NCT01222442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473823|NCT01222442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473824|NCT01222442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473825|NCT01222442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473826|NCT01222442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65473827|NCT01222442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65473828|NCT01222442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65473829|NCT01222442|Adrenergic Agents|adrenergic agents|mesh-ancestor
65473830|NCT01222442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65473831|NCT03706222|Grazoprevir|grazoprevir|mesh-list
65473832|NCT03706222|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65473867|NCT05681728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65473868|NCT05681728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65473869|NCT05681728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65473871|NCT05681728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473872|NCT05535166|Cyclophosphamide|cyclophosphamide|mesh-list
65473873|NCT05535166|Carboplatin|carboplatin|mesh-list
65473881|NCT05535166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65473882|NCT05535166|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65473883|NCT05535166|Alkylating Agents|alkylating agents|mesh-ancestor
65473884|NCT05535166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473885|NCT05535166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473886|NCT05535166|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65473887|NCT05535166|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65473888|NCT05535166|Abortifacient Agents|abortifacient agents|mesh-ancestor
65473889|NCT05535166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65473890|NCT05535166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65473891|NCT05535166|Antimetabolites|antimetabolites|mesh-ancestor
65473892|NCT05535166|Dermatologic Agents|dermatologic agents|mesh-ancestor
65473893|NCT05535166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473894|NCT05535166|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65473895|NCT05535166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65473896|NCT05535166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65473897|NCT05535166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65473898|NCT05535166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65473899|NCT05535166|Tubulin Modulators|tubulin modulators|mesh-ancestor
65473900|NCT05535166|Antimitotic Agents|antimitotic agents|mesh-ancestor
65473901|NCT05535166|Mitosis Modulators|mitosis modulators|mesh-ancestor
65473902|NCT05535166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65473903|NCT03931928|Tamoxifen|tamoxifen|mesh-list
65473904|NCT03931928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65473905|NCT03931928|Hormone Antagonists|hormone antagonists|mesh-ancestor
65473906|NCT03931928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65473907|NCT03931928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473908|NCT03931928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65473909|NCT03931928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473910|NCT03931928|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65473911|NCT03931928|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65473912|NCT03931928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65473913|NCT01220102|Adapalene|adapalene|mesh-list
65473914|NCT01220102|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65473915|NCT01220102|Dermatologic Agents|dermatologic agents|mesh-ancestor
65473916|NCT01220102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65473917|NCT01220102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65473918|NCT01220102|Analgesics|analgesics|mesh-ancestor
65473919|NCT01220102|Sensory System Agents|sensory system agents|mesh-ancestor
65473921|NCT01220102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473922|NCT01220102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65473923|NCT01220102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65473924|NCT05133310|Simvastatin|simvastatin|mesh-list
65273183|NCT00905021|Exemestane|exemestane|mesh-list
65473925|NCT05133310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65473926|NCT05133310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65473927|NCT05133310|Antimetabolites|antimetabolites|mesh-ancestor
65473928|NCT05133310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473929|NCT05133310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65473930|NCT05133310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65473931|NCT05133310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473932|NCT04576000|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
65473933|NCT04576000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65473934|NCT04576000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473935|NCT04576000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473936|NCT01222910|Valacyclovir|valacyclovir|mesh-list
65473937|NCT01222910|Antiviral Agents|antiviral agents|mesh-ancestor
65473938|NCT01222910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65473939|NCT04533568|Ibuprofen|ibuprofen|mesh-list
65473940|NCT04533568|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65473941|NCT04533568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64857954|NCT01738815|Valproic Acid|valproic acid|mesh-list
65473949|NCT04533568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65473950|NCT04533568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473951|NCT04533568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473952|NCT03932864|Plerixafor|plerixafor|mesh-list
65473953|NCT03932864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65473954|NCT03932864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65473955|NCT03932864|Antiviral Agents|antiviral agents|mesh-ancestor
65473956|NCT03932864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65473957|NCT05268562|Ketamine|ketamine|mesh-list
65473958|NCT05268562|Propofol|propofol|mesh-list
65473959|NCT05268562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65473960|NCT05268562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65473961|NCT05268562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473962|NCT05268562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65473963|NCT05268562|Anesthetics, General|anesthetics, general|mesh-ancestor
65473964|NCT05268562|Anesthetics|anesthetics|mesh-ancestor
65473965|NCT05268562|Analgesics|analgesics|mesh-ancestor
65473966|NCT05268562|Sensory System Agents|sensory system agents|mesh-ancestor
65473967|NCT05268562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65473968|NCT05268562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65473969|NCT05268562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65473970|NCT05268562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65473971|NCT05268562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65473972|NCT05268562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473973|NCT05245552|Vaccines|vaccines|mesh-list
65473974|NCT05245552|Immunologic Factors|immunologic factors|mesh-ancestor
65473975|NCT05245552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473976|NCT01312324|Docetaxel|docetaxel|mesh-list
65473977|NCT01312324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473978|NCT01312324|Tubulin Modulators|tubulin modulators|mesh-ancestor
65473979|NCT01312324|Antimitotic Agents|antimitotic agents|mesh-ancestor
65473980|NCT01312324|Mitosis Modulators|mitosis modulators|mesh-ancestor
65473981|NCT01312324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473982|NCT05482516|Bevacizumab|bevacizumab|mesh-list
65473983|NCT05482516|Atezolizumab|atezolizumab|mesh-list
65473984|NCT05482516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65473985|NCT05482516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473986|NCT05482516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65473987|NCT05482516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65473988|NCT05482516|Growth Substances|growth substances|mesh-ancestor
65473989|NCT05482516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473990|NCT05482516|Growth Inhibitors|growth inhibitors|mesh-ancestor
65473991|NCT01127594|Temozolomide|temozolomide|mesh-list
65473992|NCT01127594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65473993|NCT01127594|Alkylating Agents|alkylating agents|mesh-ancestor
65473994|NCT01127594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473995|NCT01127594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473996|NCT01127672|Betamethasone|betamethasone|mesh-list
65473997|NCT01127672|Lidocaine|lidocaine|mesh-list
65473998|NCT01127672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65473999|NCT01127672|Glucocorticoids|glucocorticoids|mesh-ancestor
65474000|NCT01127672|Hormones|hormones|mesh-ancestor
65474001|NCT01127672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65474002|NCT01127672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474003|NCT01127672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65248408|NCT02690870|Tamoxifen|tamoxifen|mesh-list
64469996|NCT05603910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64469997|NCT05603910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469998|NCT05603910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64469999|NCT05603910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470000|NCT05603910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474004|NCT01127672|Respiratory System Agents|respiratory system agents|mesh-ancestor
65474005|NCT01127672|Anesthetics, Local|anesthetics, local|mesh-ancestor
65474006|NCT01127672|Anesthetics|anesthetics|mesh-ancestor
65474007|NCT01127672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65474008|NCT01127672|Sensory System Agents|sensory system agents|mesh-ancestor
64858022|NCT01739192|Antidepressive Agents|antidepressive agents|mesh-ancestor
65474014|NCT01127672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474015|NCT01220258|Azithromycin|azithromycin|mesh-list
65474016|NCT01220258|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65474017|NCT01220258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65474018|NCT01220258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65474019|NCT01220258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65474020|NCT01223534|Isoniazid|isoniazid|mesh-list
65474021|NCT01223534|Antitubercular Agents|antitubercular agents|mesh-ancestor
65474022|NCT01223534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65474023|NCT01223534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65474024|NCT01223534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65474025|NCT01223534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65474026|NCT01223534|Antimetabolites|antimetabolites|mesh-ancestor
65474027|NCT01223534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474028|NCT01223534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65474029|NCT01223612|Ranibizumab|ranibizumab|mesh-list
65474030|NCT01223612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65474031|NCT01223612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65474032|NCT01223612|Growth Substances|growth substances|mesh-ancestor
65474033|NCT01223612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474034|NCT01223612|Growth Inhibitors|growth inhibitors|mesh-ancestor
65474035|NCT01223612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474036|NCT01127750|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65474037|NCT01127750|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65474038|NCT01127750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474039|NCT01127750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65474040|NCT01127750|Immunologic Factors|immunologic factors|mesh-ancestor
65474041|NCT01127750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474042|NCT02946580|Naloxegol|naloxegol|mesh-list
65474043|NCT02946580|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65474044|NCT02946580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474045|NCT02946580|Sensory System Agents|sensory system agents|mesh-ancestor
65474046|NCT02946580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65474047|NCT01223690|Clarithromycin|clarithromycin|mesh-list
65474048|NCT01223690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65474049|NCT01223690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65474050|NCT01223690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65474051|NCT01223690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474052|NCT01223690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474053|NCT01223690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65474054|NCT01223690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65474055|NCT05381350|Vaccines|vaccines|mesh-list
65474056|NCT05381350|Immunologic Factors|immunologic factors|mesh-ancestor
65474057|NCT05381350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474058|NCT01223768|Acetylcarnitine|acetylcarnitine|mesh-list
65474059|NCT01223768|Vitamin B Complex|vitamin b complex|mesh-ancestor
65474060|NCT01223768|Vitamins|vitamins|mesh-ancestor
65474061|NCT01223768|Micronutrients|micronutrients|mesh-ancestor
65474062|NCT01223768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474063|NCT01223768|Nootropic Agents|nootropic agents|mesh-ancestor
65474064|NCT01126112|Panitumumab|panitumumab|mesh-list
65474065|NCT01126112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65474066|NCT01126112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474067|NCT05024032|Tirzepatide|tirzepatide|mesh-list
65474068|NCT05024032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65474069|NCT05024032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474070|NCT05024032|Incretins|incretins|mesh-ancestor
65273184|NCT00905021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273185|NCT00905021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65273186|NCT00905021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65273187|NCT00905021|Growth Substances|growth substances|mesh-ancestor
65273188|NCT00905021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273189|NCT00905021|Growth Inhibitors|growth inhibitors|mesh-ancestor
65273190|NCT00905021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65273191|NCT00905021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273192|NCT00905021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474072|NCT05024032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65474073|NCT04724668|Melatonin|melatonin|mesh-list
65474074|NCT04724668|Antioxidants|antioxidants|mesh-ancestor
65474075|NCT04724668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474076|NCT04724668|Protective Agents|protective agents|mesh-ancestor
64858086|NCT01739556|Purinergic Agents|purinergic agents|mesh-ancestor
65474079|NCT01123538|Chlormadinone Acetate|chlormadinone acetate|mesh-list
65474080|NCT01123538|Progesterone|progesterone|mesh-list
65474081|NCT01123538|Progestins|progestins|mesh-ancestor
65474082|NCT01123538|Hormones|hormones|mesh-ancestor
65474083|NCT01123538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65474084|NCT01123538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474085|NCT01123538|Androgen Antagonists|androgen antagonists|mesh-ancestor
65474086|NCT01123538|Hormone Antagonists|hormone antagonists|mesh-ancestor
65474087|NCT01123538|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65474088|NCT01123538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65474089|NCT01123538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65474090|NCT01123538|Contraceptive Agents|contraceptive agents|mesh-ancestor
65474091|NCT01123538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65474092|NCT01123538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65474093|NCT01123538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65474094|NCT03930992|Zoledronic Acid|zoledronic acid|mesh-list
65474095|NCT03930992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65474096|NCT03930992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474097|NCT04524910|Aflibercept|aflibercept|mesh-list
65474098|NCT04524910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65474099|NCT04524910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65474100|NCT04524910|Growth Substances|growth substances|mesh-ancestor
65474101|NCT04524910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474102|NCT04524910|Growth Inhibitors|growth inhibitors|mesh-ancestor
65474103|NCT04524910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474104|NCT01220570|Sirolimus|sirolimus|mesh-list
65474105|NCT01220570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65474106|NCT01220570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65474107|NCT01220570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65474108|NCT01220570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65474109|NCT01220570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474110|NCT01220570|Antifungal Agents|antifungal agents|mesh-ancestor
65474111|NCT01220570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65474112|NCT01220570|Immunologic Factors|immunologic factors|mesh-ancestor
65474113|NCT01220570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474114|NCT04682860|Scopolamine|scopolamine|mesh-list
65474115|NCT04682860|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65474116|NCT04682860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65474117|NCT04682860|Antiemetics|antiemetics|mesh-ancestor
65474118|NCT04682860|Autonomic Agents|autonomic agents|mesh-ancestor
65474119|NCT04682860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65474120|NCT04682860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474121|NCT04682860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65474122|NCT04682860|Mydriatics|mydriatics|mesh-ancestor
65474123|NCT04682860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65474124|NCT04682860|Cholinergic Agents|cholinergic agents|mesh-ancestor
65474125|NCT04682860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65474126|NCT04682860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474127|NCT04682860|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65273193|NCT00905021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65474128|NCT04682860|Parasympatholytics|parasympatholytics|mesh-ancestor
65474129|NCT01127906|Oxycodone|oxycodone|mesh-list
65474130|NCT01127906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65474131|NCT01127906|Narcotics|narcotics|mesh-ancestor
65474132|NCT01127906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65474133|NCT01127906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474134|NCT01127906|Analgesics|analgesics|mesh-ancestor
65474135|NCT01127906|Sensory System Agents|sensory system agents|mesh-ancestor
65474136|NCT01127906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65474137|NCT01127984|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65474138|NCT01127984|Hemostatics|hemostatics|mesh-ancestor
65474139|NCT01127984|Coagulants|coagulants|mesh-ancestor
65474140|NCT01220648|Interferons|interferons|mesh-list
65474141|NCT01220648|Interferon-alpha|interferon-alpha|mesh-list
65474142|NCT01220648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474143|NCT01220648|Antiviral Agents|antiviral agents|mesh-ancestor
65474144|NCT01220648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65474146|NCT01220648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474147|NCT01218386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65474148|NCT01218386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65474149|NCT01218386|Estradiol|estradiol|mesh-list
65474150|NCT01218386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65474151|NCT01218386|Estrogens|estrogens|mesh-ancestor
65474155|NCT01218386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65474156|NCT01218386|Contraceptive Agents|contraceptive agents|mesh-ancestor
65474157|NCT01218386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65474158|NCT01218386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65474160|NCT03933098|Immunologic Factors|immunologic factors|mesh-ancestor
65474161|NCT03933098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474162|NCT05111314|Edetic Acid|edetic acid|mesh-list
65474163|NCT05111314|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65474164|NCT05111314|Chelating Agents|chelating agents|mesh-ancestor
65474165|NCT05111314|Sequestering Agents|sequestering agents|mesh-ancestor
65474166|NCT05111314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474167|NCT05111314|Anticoagulants|anticoagulants|mesh-ancestor
65474168|NCT05111314|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65474169|NCT05111314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65474170|NCT01224314|Dialysis Solutions|dialysis solutions|mesh-list
65474171|NCT01224314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65474172|NCT01224392|Capecitabine|capecitabine|mesh-list
65474173|NCT01224392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65474174|NCT01224392|Antimetabolites|antimetabolites|mesh-ancestor
65474175|NCT01224392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474176|NCT01224392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474177|NCT01224470|Dexmedetomidine|dexmedetomidine|mesh-list
65474178|NCT01224470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65474179|NCT01224470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65474180|NCT01224470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474181|NCT01224470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65474182|NCT01224470|Analgesics|analgesics|mesh-ancestor
65474183|NCT01224470|Sensory System Agents|sensory system agents|mesh-ancestor
65474184|NCT01224470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65474185|NCT01224470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65474186|NCT01224470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65474187|NCT01224470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65474188|NCT01224470|Adrenergic Agents|adrenergic agents|mesh-ancestor
65474189|NCT01224470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65474190|NCT01224470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474191|NCT01128218|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65474192|NCT01128218|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65474193|NCT01128218|Dermatologic Agents|dermatologic agents|mesh-ancestor
65474194|NCT03740516|Apremilast|apremilast|mesh-list
65474195|NCT03740516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65474196|NCT03740516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65474197|NCT03740516|Analgesics|analgesics|mesh-ancestor
65474198|NCT03740516|Sensory System Agents|sensory system agents|mesh-ancestor
65474199|NCT03740516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65474200|NCT03740516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474201|NCT03740516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65474202|NCT03740516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65474203|NCT03740516|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65474204|NCT03740516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65474205|NCT03740516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474206|NCT03740516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470307|NCT05415215|Tubulin Modulators|tubulin modulators|mesh-ancestor
65474207|NCT03933956|Empagliflozin|empagliflozin|mesh-list
65474208|NCT03933956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65474209|NCT03933956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474210|NCT03933956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65474211|NCT03933956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474212|NCT01218620|Tolbutamide|tolbutamide|mesh-list
65474213|NCT01218620|Rifampin|rifampin|mesh-list
65474214|NCT01218620|Ketoconazole|ketoconazole|mesh-list
65474215|NCT01218620|Midazolam|midazolam|mesh-list
65474216|NCT01218620|Dextromethorphan|dextromethorphan|mesh-list
65474217|NCT01218620|Omeprazole|omeprazole|mesh-list
65474218|NCT01218620|R04929097|r04929097|mesh-list
65474219|NCT01218620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65474220|NCT01218620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65474221|NCT01218620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64858231|NCT01740947|Colistin|colistin|mesh-list
65474237|NCT01218620|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65474238|NCT01218620|Antitubercular Agents|antitubercular agents|mesh-ancestor
65474239|NCT01218620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65474240|NCT01218620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65474241|NCT01218620|Leprostatic Agents|leprostatic agents|mesh-ancestor
65474242|NCT01218620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65474243|NCT01218620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65474244|NCT01218620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65474245|NCT01218620|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65474246|NCT01218620|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65474247|NCT01218620|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65474248|NCT01218620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65474249|NCT01218620|Antifungal Agents|antifungal agents|mesh-ancestor
65474250|NCT01218620|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65474251|NCT01218620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65474252|NCT01218620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65474253|NCT01218620|Hormone Antagonists|hormone antagonists|mesh-ancestor
65474254|NCT01218620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65474255|NCT01218620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65474256|NCT01218620|Antitussive Agents|antitussive agents|mesh-ancestor
65474257|NCT01218620|Respiratory System Agents|respiratory system agents|mesh-ancestor
65474258|NCT01218620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65474259|NCT01218620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65474260|NCT01218620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65474261|NCT00323297|Bosentan|bosentan|mesh-list
65474262|NCT00323297|Sildenafil Citrate|sildenafil citrate|mesh-list
65474263|NCT00323297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474264|NCT00323297|Vasodilator Agents|vasodilator agents|mesh-ancestor
65474265|NCT00323297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65474266|NCT00323297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65474267|NCT00323297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474268|NCT00323297|Urological Agents|urological agents|mesh-ancestor
65474269|NCT00323297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65474270|NCT00323297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65474271|NCT01218698|Losartan|losartan|mesh-list
65474272|NCT01218698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65474273|NCT01218698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65474274|NCT01218698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65474275|NCT01218698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65474276|NCT01218698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474277|NCT01224860|Losartan|losartan|mesh-list
65474278|NCT01224860|Telmisartan|telmisartan|mesh-list
65474279|NCT01224860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65474308|NCT01328990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65474309|NCT01328990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65474310|NCT01328990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474311|NCT01328990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474312|NCT01328990|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65474313|NCT01328990|Renal Agents|renal agents|mesh-ancestor
65474314|NCT01225094|Curcumin|curcumin|mesh-list
65474315|NCT01225094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65474316|NCT01225094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65474317|NCT01225094|Analgesics|analgesics|mesh-ancestor
65474318|NCT01225094|Sensory System Agents|sensory system agents|mesh-ancestor
65474319|NCT01225094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65248409|NCT02690870|Clomiphene|clomiphene|mesh-list
64470382|NCT05382286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474320|NCT01225094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474321|NCT01225094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65474322|NCT01225094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65474323|NCT01225094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474324|NCT01225094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474325|NCT01225094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474326|NCT03930212|Progesterone|progesterone|mesh-list
65474327|NCT03930212|Progestins|progestins|mesh-ancestor
65474342|NCT01221116|Simendan|simendan|mesh-list
65474343|NCT01221116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65474344|NCT01221116|Vasodilator Agents|vasodilator agents|mesh-ancestor
65474345|NCT01221116|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65474346|NCT01221116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65474347|NCT01221116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474348|NCT01221116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474349|NCT01221116|Protective Agents|protective agents|mesh-ancestor
65474350|NCT01221116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474351|NCT03929744|Midazolam|midazolam|mesh-list
65474352|NCT03929744|Atorvastatin|atorvastatin|mesh-list
65474353|NCT03929744|Simvastatin|simvastatin|mesh-list
65474354|NCT03929744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65474355|NCT03929744|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65474356|NCT03929744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65474357|NCT03929744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474358|NCT03929744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65474359|NCT03929744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65474360|NCT03929744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65474361|NCT03929744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65474362|NCT03929744|Anesthetics, General|anesthetics, general|mesh-ancestor
65474363|NCT03929744|Anesthetics|anesthetics|mesh-ancestor
65474364|NCT03929744|GABA Modulators|gaba modulators|mesh-ancestor
65474365|NCT03929744|GABA Agents|gaba agents|mesh-ancestor
65474366|NCT03929744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65474367|NCT03929744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474368|NCT03929744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65474369|NCT03929744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65474370|NCT03929744|Antimetabolites|antimetabolites|mesh-ancestor
65474371|NCT03929744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65474372|NCT03929744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65474373|NCT03929744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474374|NCT01225406|Tenofovir|tenofovir|mesh-list
65474375|NCT01225406|Antiviral Agents|antiviral agents|mesh-ancestor
65474376|NCT01225406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65474377|NCT01225406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65474378|NCT01225406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65474379|NCT01225406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474380|NCT01225406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474381|NCT01225406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65474382|NCT01225406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65474383|NCT01126814|Imatinib Mesylate|imatinib mesylate|mesh-list
65474384|NCT01126814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474385|NCT01126814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65474386|NCT01126814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474387|NCT01126814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474388|NCT01225484|Ropivacaine|ropivacaine|mesh-list
65474393|NCT01225484|Sensory System Agents|sensory system agents|mesh-ancestor
65474394|NCT01225484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65474395|NCT03928496|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65474396|NCT03928496|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65474397|NCT03928496|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65474398|NCT03928496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65474399|NCT03928496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474400|NCT03928496|Cholinergic Agents|cholinergic agents|mesh-ancestor
65474401|NCT03928496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65474402|NCT03928496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474403|NCT03928496|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65474404|NCT03928496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65474405|NCT01128998|Sorafenib|sorafenib|mesh-list
65474406|NCT01128998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474407|NCT01128998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65474408|NCT01128998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474409|NCT01128998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474410|NCT00321893|Budesonide|budesonide|mesh-list
65273194|NCT00905021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65273195|NCT00905021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65273196|NCT00905021|Hormone Antagonists|hormone antagonists|mesh-ancestor
65273197|NCT00905021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65273198|NCT03537131|Dapagliflozin|dapagliflozin|mesh-list
65273199|NCT03537131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65273200|NCT03537131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273201|NCT03537131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65273202|NCT03537131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273203|NCT02685605|Temozolomide|temozolomide|mesh-list
65273204|NCT02685605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65474411|NCT00321893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65474412|NCT00321893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65474413|NCT00321893|Autonomic Agents|autonomic agents|mesh-ancestor
65474414|NCT00321893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65474415|NCT00321893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474416|NCT00321893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65474417|NCT00321893|Respiratory System Agents|respiratory system agents|mesh-ancestor
65474418|NCT00321893|Glucocorticoids|glucocorticoids|mesh-ancestor
65474419|NCT00321893|Hormones|hormones|mesh-ancestor
65474420|NCT00321893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65474421|NCT01225874|Cytarabine|cytarabine|mesh-list
65474422|NCT01225874|Dexamethasone|dexamethasone|mesh-list
65474423|NCT01225874|Prednisone|prednisone|mesh-list
65474424|NCT01225874|Methotrexate|methotrexate|mesh-list
65474425|NCT01225874|Vincristine|vincristine|mesh-list
65474426|NCT01225874|Daunorubicin|daunorubicin|mesh-list
65474427|NCT01225874|Asparaginase|asparaginase|mesh-list
65474428|NCT01225874|Pegaspargase|pegaspargase|mesh-list
65474429|NCT01225874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65474430|NCT01225874|Antiemetics|antiemetics|mesh-ancestor
65474431|NCT01225874|Autonomic Agents|autonomic agents|mesh-ancestor
65474432|NCT01225874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65474433|NCT01225874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474434|NCT01225874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65474435|NCT01225874|Glucocorticoids|glucocorticoids|mesh-ancestor
65474436|NCT01225874|Hormones|hormones|mesh-ancestor
65474437|NCT01225874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65474438|NCT01225874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65474439|NCT01225874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474440|NCT01225874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65474441|NCT01225874|Abortifacient Agents|abortifacient agents|mesh-ancestor
65474442|NCT01225874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65474443|NCT01225874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65474444|NCT01225874|Antimetabolites|antimetabolites|mesh-ancestor
65474445|NCT01225874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474446|NCT01225874|Dermatologic Agents|dermatologic agents|mesh-ancestor
65474447|NCT01225874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474448|NCT01225874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65474449|NCT01225874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65474450|NCT01225874|Immunologic Factors|immunologic factors|mesh-ancestor
65474451|NCT01225874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65474452|NCT01225874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65474453|NCT01225874|Antiviral Agents|antiviral agents|mesh-ancestor
65474454|NCT01225874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65474455|NCT01225874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65474456|NCT01225874|Tubulin Modulators|tubulin modulators|mesh-ancestor
65474457|NCT01225874|Antimitotic Agents|antimitotic agents|mesh-ancestor
65474458|NCT01225874|Mitosis Modulators|mitosis modulators|mesh-ancestor
65474459|NCT01225874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65474466|NCT00371345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474467|NCT00371345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65474468|NCT00371345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474469|NCT00371345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474470|NCT01226186|Morphine|morphine|mesh-list
65474471|NCT01226186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65474472|NCT01226186|Narcotics|narcotics|mesh-ancestor
65474473|NCT01226186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65474474|NCT01226186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474475|NCT01226186|Analgesics|analgesics|mesh-ancestor
65474476|NCT01226186|Sensory System Agents|sensory system agents|mesh-ancestor
65474477|NCT01226186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65474478|NCT01228214|Aspirin|aspirin|mesh-list
65474479|NCT01228214|Amiloride|amiloride|mesh-list
65474480|NCT01228214|Clopidogrel|clopidogrel|mesh-list
65474481|NCT01228214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65474482|NCT01228214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65474483|NCT01228214|Analgesics|analgesics|mesh-ancestor
65474484|NCT01228214|Sensory System Agents|sensory system agents|mesh-ancestor
65474485|NCT01228214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65474486|NCT01228214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474487|NCT01228214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65474488|NCT01228214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65474489|NCT01228214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65474490|NCT01228214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65474491|NCT01228214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474492|NCT01228214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65474493|NCT01228214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65474494|NCT01228214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474495|NCT01228214|Antipyretics|antipyretics|mesh-ancestor
65474496|NCT01228214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65474497|NCT01228214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65474498|NCT01228214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65474499|NCT01228214|Purinergic Agents|purinergic agents|mesh-ancestor
65474500|NCT01228214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65474501|NCT01228214|Diuretics|diuretics|mesh-ancestor
65474502|NCT01228214|Natriuretic Agents|natriuretic agents|mesh-ancestor
65474503|NCT01228214|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65474504|NCT01228214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65474505|NCT01228214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65474506|NCT01228214|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65474507|NCT01228214|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65474508|NCT00321737|Dexlansoprazole|dexlansoprazole|mesh-list
65474509|NCT00321737|Lansoprazole|lansoprazole|mesh-list
65474510|NCT00321737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65474511|NCT00321737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65474512|NCT00321737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65474513|NCT00321737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474514|NCT00321737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474515|NCT03928262|Benralizumab|benralizumab|mesh-list
65474516|NCT03928262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65474517|NCT03928262|Respiratory System Agents|respiratory system agents|mesh-ancestor
65474518|NCT03740438|Chrysarobin|chrysarobin|mesh-list
65474519|NCT03740438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65474520|NCT03740438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65474521|NCT03740438|Analgesics|analgesics|mesh-ancestor
65474522|NCT03740438|Sensory System Agents|sensory system agents|mesh-ancestor
65474523|NCT03740438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65474524|NCT03740438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474525|NCT03740438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65474526|NCT03740438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65474527|NCT01129154|Panitumumab|panitumumab|mesh-list
65474528|NCT01129154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64858551|NCT01742689|Hemostatics|hemostatics|mesh-ancestor
65474549|NCT01129310|Capecitabine|capecitabine|mesh-list
65474550|NCT01129310|Oxaliplatin|oxaliplatin|mesh-list
65474551|NCT01129310|Irinotecan|irinotecan|mesh-list
65474552|NCT01129310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65474553|NCT01129310|Antimetabolites|antimetabolites|mesh-ancestor
65474554|NCT01129310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474555|NCT01129310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474556|NCT01129310|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65474557|NCT01129310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65474558|NCT01129310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474559|NCT01129388|Omeprazole|omeprazole|mesh-list
65474560|NCT01129388|Clopidogrel|clopidogrel|mesh-list
65474561|NCT01129388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65474562|NCT01129388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65273205|NCT02685605|Alkylating Agents|alkylating agents|mesh-ancestor
64470648|NCT05090033|Ofatumumab|ofatumumab|mesh-list
65474563|NCT01129388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65474564|NCT01129388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65474565|NCT01129388|Purinergic Agents|purinergic agents|mesh-ancestor
65474566|NCT01129388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65474567|NCT01129388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474568|NCT01129388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474569|NCT01129388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65474570|NCT01129388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65474571|NCT01129388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65474572|NCT01129388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474573|NCT01228292|Heparin|heparin|mesh-list
65474574|NCT01228292|Calcium heparin|calcium heparin|mesh-list
65474575|NCT01228292|Anticoagulants|anticoagulants|mesh-ancestor
65474576|NCT01228292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65474577|NCT01228292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65474578|NCT01228292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474579|NCT03924596|Boswellic acid|boswellic acid|mesh-list
65474580|NCT03924596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65474581|NCT03924596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65474582|NCT03924596|Analgesics|analgesics|mesh-ancestor
65474583|NCT03924596|Sensory System Agents|sensory system agents|mesh-ancestor
65474584|NCT03924596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65474592|NCT00320801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474593|NCT00320801|Analgesics|analgesics|mesh-ancestor
65474594|NCT00320801|Sensory System Agents|sensory system agents|mesh-ancestor
65474595|NCT00320801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65474596|NCT00320801|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65474598|NCT01127204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65474599|NCT01127204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65474600|NCT01127204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474601|NCT01127204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474602|NCT01127204|Antiviral Agents|antiviral agents|mesh-ancestor
65474603|NCT01127204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65474604|NCT01127204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65474605|NCT01127204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65474606|NCT01228370|Silodosin|silodosin|mesh-list
65474607|NCT01228370|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65474608|NCT01228370|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65474609|NCT01228370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65474610|NCT01228370|Adrenergic Agents|adrenergic agents|mesh-ancestor
65474611|NCT01228370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65474612|NCT01228370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474613|NCT01228370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474614|NCT01228370|Urological Agents|urological agents|mesh-ancestor
65474615|NCT01221740|Milnacipran|milnacipran|mesh-list
65474616|NCT01221740|Levomilnacipran|levomilnacipran|mesh-list
65474617|NCT01221740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65474618|NCT01221740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65474619|NCT01221740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65474620|NCT01221740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474621|NCT01221740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65474622|NCT01221740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474623|NCT01221740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65474624|NCT01221740|Analgesics|analgesics|mesh-ancestor
65474625|NCT01221740|Sensory System Agents|sensory system agents|mesh-ancestor
65474626|NCT01221740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65474627|NCT01221740|Antidepressive Agents|antidepressive agents|mesh-ancestor
65474628|NCT01221740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65474629|NCT00320489|Olanzapine|olanzapine|mesh-list
65474630|NCT00320489|Antiemetics|antiemetics|mesh-ancestor
65474631|NCT00320489|Autonomic Agents|autonomic agents|mesh-ancestor
65474632|NCT00320489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65474633|NCT00320489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474634|NCT00320489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65474635|NCT00320489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65474636|NCT00320489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65474637|NCT00320489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65474638|NCT00320489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65474639|NCT00320489|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65474640|NCT00320489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65273206|NCT02685605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474641|NCT00320489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65474642|NCT00320489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474643|NCT00320489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65474644|NCT00320489|Serotonin Agents|serotonin agents|mesh-ancestor
65474645|NCT01127282|Vitamins|vitamins|mesh-list
65474646|NCT01127282|Vitamin A|vitamin a|mesh-list
65474647|NCT01127282|Micronutrients|micronutrients|mesh-ancestor
65474648|NCT01127282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474649|NCT01127360|Bevacizumab|bevacizumab|mesh-list
65474650|NCT01127360|Ranibizumab|ranibizumab|mesh-list
65474651|NCT01127360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65474654|NCT01127360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65474655|NCT01127360|Growth Substances|growth substances|mesh-ancestor
65474656|NCT01127360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474657|NCT01127360|Growth Inhibitors|growth inhibitors|mesh-ancestor
65474658|NCT01228604|Methylphenidate|methylphenidate|mesh-list
65474659|NCT01228604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65474660|NCT01228604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474661|NCT01228604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65474662|NCT01228604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65474663|NCT01228604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65474664|NCT01228604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474665|NCT01228604|Dopamine Agents|dopamine agents|mesh-ancestor
65474666|NCT01228604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65474667|NCT01228682|Tolvaptan|tolvaptan|mesh-list
65474668|NCT01228682|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65474669|NCT01228682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474670|NCT01228682|Natriuretic Agents|natriuretic agents|mesh-ancestor
65474671|NCT01228682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474672|NCT01221896|Choline|choline|mesh-list
65474673|NCT01221896|Lipotropic Agents|lipotropic agents|mesh-ancestor
65474674|NCT01221896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65474675|NCT01221896|Antimetabolites|antimetabolites|mesh-ancestor
65474676|NCT01221896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474677|NCT01221896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65474678|NCT01221896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65474679|NCT01221896|Nootropic Agents|nootropic agents|mesh-ancestor
65474680|NCT03923114|Exenatide|exenatide|mesh-list
65474681|NCT03923114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65474682|NCT03923114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474683|NCT03923114|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65474684|NCT03923114|Incretins|incretins|mesh-ancestor
65474685|NCT03923114|Hormones|hormones|mesh-ancestor
65474686|NCT03923114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65474687|NCT00320411|Lapatinib|lapatinib|mesh-list
65474688|NCT00320411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474689|NCT00320411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65474690|NCT00320411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474691|NCT00320411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474692|NCT01132040|Primidone|primidone|mesh-list
65474693|NCT01132040|Anticonvulsants|anticonvulsants|mesh-ancestor
65474694|NCT01132040|GABA Modulators|gaba modulators|mesh-ancestor
65474695|NCT01132040|GABA Agents|gaba agents|mesh-ancestor
65474696|NCT01132040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65474697|NCT01132040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474698|NCT01132040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474699|NCT01226966|Liraglutide|liraglutide|mesh-list
65474700|NCT01226966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65474701|NCT01226966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474702|NCT01226966|Incretins|incretins|mesh-ancestor
65474703|NCT01226966|Hormones|hormones|mesh-ancestor
65474704|NCT01226966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65474705|NCT03923036|Cetuximab|cetuximab|mesh-list
65474706|NCT03923036|Panitumumab|panitumumab|mesh-list
65474707|NCT03923036|Aflibercept|aflibercept|mesh-list
65474708|NCT03923036|Capecitabine|capecitabine|mesh-list
65474709|NCT03923036|Irinotecan|irinotecan|mesh-list
65474710|NCT03923036|Antineoplastic Agents|antineoplastic agents|mesh-list
65474711|NCT03923036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65474712|NCT03923036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65474713|NCT03923036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65474714|NCT03923036|Growth Substances|growth substances|mesh-ancestor
65248410|NCT02690870|Enclomiphene|enclomiphene|mesh-list
65273207|NCT02685605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273208|NCT02677805|Botulinum Toxins|botulinum toxins|mesh-list
65474715|NCT03923036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474716|NCT03923036|Growth Inhibitors|growth inhibitors|mesh-ancestor
65474717|NCT03923036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65474718|NCT03923036|Antimetabolites|antimetabolites|mesh-ancestor
65474719|NCT03923036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474720|NCT03923036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65474721|NCT03923036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65474722|NCT03923036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474723|NCT01129856|Dexamethasone|dexamethasone|mesh-list
65474724|NCT01129856|Citric Acid|citric acid|mesh-list
65474733|NCT01129856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474734|NCT01129856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65474735|NCT01129856|Glucocorticoids|glucocorticoids|mesh-ancestor
65474736|NCT01129856|Hormones|hormones|mesh-ancestor
65474737|NCT01129856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65474738|NCT01129856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65474739|NCT01129856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474740|NCT01129856|Anticoagulants|anticoagulants|mesh-ancestor
65474741|NCT01129856|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65474742|NCT01129856|Chelating Agents|chelating agents|mesh-ancestor
65474743|NCT01129856|Sequestering Agents|sequestering agents|mesh-ancestor
65474744|NCT01129856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474745|NCT01129934|Promethazine|promethazine|mesh-list
65474746|NCT01129934|Diphenhydramine|diphenhydramine|mesh-list
65474747|NCT01129934|Morphine|morphine|mesh-list
65474748|NCT01129934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65474749|NCT01129934|Narcotics|narcotics|mesh-ancestor
65474750|NCT01129934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65474751|NCT01129934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474752|NCT01129934|Analgesics|analgesics|mesh-ancestor
65474753|NCT01129934|Sensory System Agents|sensory system agents|mesh-ancestor
65474754|NCT01129934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65474755|NCT01129934|Antipruritics|antipruritics|mesh-ancestor
65474756|NCT01129934|Dermatologic Agents|dermatologic agents|mesh-ancestor
65474757|NCT01129934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65474758|NCT01129934|Histamine Antagonists|histamine antagonists|mesh-ancestor
65474759|NCT01129934|Histamine Agents|histamine agents|mesh-ancestor
65474760|NCT01129934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65474761|NCT01129934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474762|NCT01129934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65474763|NCT01129934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65474764|NCT01129934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65474765|NCT01129934|Anesthetics, Local|anesthetics, local|mesh-ancestor
65474766|NCT01129934|Anesthetics|anesthetics|mesh-ancestor
65474767|NCT01129934|Antiemetics|antiemetics|mesh-ancestor
65474768|NCT01129934|Autonomic Agents|autonomic agents|mesh-ancestor
65474769|NCT01129934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65474770|NCT01131572|Acetylcysteine|acetylcysteine|mesh-list
65474771|NCT01131572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65474772|NCT01131572|Antiviral Agents|antiviral agents|mesh-ancestor
65474773|NCT01131572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65474774|NCT01131572|Expectorants|expectorants|mesh-ancestor
65474775|NCT01131572|Respiratory System Agents|respiratory system agents|mesh-ancestor
65474776|NCT01131572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65474777|NCT01131572|Antioxidants|antioxidants|mesh-ancestor
65474778|NCT01131572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474779|NCT01131572|Protective Agents|protective agents|mesh-ancestor
65474780|NCT01131572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474781|NCT01131572|Antidotes|antidotes|mesh-ancestor
65474782|NCT01132196|Valproic Acid|valproic acid|mesh-list
65474783|NCT01132196|Anticonvulsants|anticonvulsants|mesh-ancestor
65474784|NCT01132196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474785|NCT01132196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474786|NCT01132196|GABA Agents|gaba agents|mesh-ancestor
65474787|NCT01132196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65474788|NCT01132196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474789|NCT01132196|Antimanic Agents|antimanic agents|mesh-ancestor
65474790|NCT01132196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65474791|NCT01132196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65474792|NCT01132196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65474793|NCT01228994|Baclofen|baclofen|mesh-list
65474794|NCT01228994|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65474798|NCT01228994|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65273209|NCT02677805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65273210|NCT02677805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65474799|NCT01228994|GABA Agonists|gaba agonists|mesh-ancestor
65474800|NCT01228994|GABA Agents|gaba agents|mesh-ancestor
65474801|NCT01228994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65474802|NCT01228994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474803|NCT03927170|Metformin|metformin|mesh-list
65474804|NCT03927170|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65474805|NCT03927170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65474806|NCT03927170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474807|NCT03927170|Incretins|incretins|mesh-ancestor
65474808|NCT03927170|Hormones|hormones|mesh-ancestor
65474809|NCT03927170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65474810|NCT03927170|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65474811|NCT03927170|Protease Inhibitors|protease inhibitors|mesh-ancestor
65474812|NCT03927170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474813|NCT03927170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474814|NCT01227200|Tramadol|tramadol|mesh-list
65474815|NCT01227200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65474816|NCT01227200|Narcotics|narcotics|mesh-ancestor
65474817|NCT01227200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65474818|NCT01227200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474819|NCT01227200|Analgesics|analgesics|mesh-ancestor
65474820|NCT01227200|Sensory System Agents|sensory system agents|mesh-ancestor
65474821|NCT01227200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65474822|NCT01227356|Interferons|interferons|mesh-list
65474823|NCT01227356|Imatinib Mesylate|imatinib mesylate|mesh-list
65474824|NCT01227356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474825|NCT01227356|Antiviral Agents|antiviral agents|mesh-ancestor
65474826|NCT01227356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65474827|NCT01227356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65474828|NCT01227356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474829|NCT01227356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474830|NCT01132352|Levetiracetam|levetiracetam|mesh-list
65474831|NCT01132352|Anticonvulsants|anticonvulsants|mesh-ancestor
65474832|NCT01132352|Nootropic Agents|nootropic agents|mesh-ancestor
65474833|NCT01131728|Naproxen|naproxen|mesh-list
65474834|NCT01131728|Pseudoephedrine|pseudoephedrine|mesh-list
65474835|NCT01131728|Ephedrine|ephedrine|mesh-list
65474836|NCT01131728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65474837|NCT01131728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65474838|NCT01131728|Analgesics|analgesics|mesh-ancestor
65474839|NCT01131728|Sensory System Agents|sensory system agents|mesh-ancestor
65474840|NCT01131728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65474841|NCT01131728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474842|NCT01131728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65474843|NCT01131728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65474844|NCT01131728|Gout Suppressants|gout suppressants|mesh-ancestor
65474845|NCT01131728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65474846|NCT01131728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474847|NCT01131728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474848|NCT01131728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65474849|NCT01131728|Autonomic Agents|autonomic agents|mesh-ancestor
65474850|NCT01131728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65474851|NCT01131728|Respiratory System Agents|respiratory system agents|mesh-ancestor
65474852|NCT01131728|Nasal Decongestants|nasal decongestants|mesh-ancestor
65474853|NCT01131728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65474854|NCT01131728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65474855|NCT01131728|Sympathomimetics|sympathomimetics|mesh-ancestor
65474856|NCT01131728|Adrenergic Agents|adrenergic agents|mesh-ancestor
65474857|NCT01131728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65474858|NCT01132586|Cytarabine|cytarabine|mesh-list
65474859|NCT01132586|Lenalidomide|lenalidomide|mesh-list
65474860|NCT01132586|Idarubicin|idarubicin|mesh-list
65474861|NCT01132586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65474862|NCT01132586|Antimetabolites|antimetabolites|mesh-ancestor
65474863|NCT01132586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474864|NCT01132586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474865|NCT01132586|Antiviral Agents|antiviral agents|mesh-ancestor
65474866|NCT01132586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65474867|NCT01132586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65474873|NCT01132586|Growth Inhibitors|growth inhibitors|mesh-ancestor
65474874|NCT01132586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65474875|NCT01132586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65474876|NCT01132586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64471000|NCT04873362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471001|NCT04854499|Carboplatin|carboplatin|mesh-list
64471002|NCT04854499|Docetaxel|docetaxel|mesh-list
64471003|NCT04854499|Pembrolizumab|pembrolizumab|mesh-list
64471004|NCT04854499|Magrolimab|magrolimab|mesh-list
65474877|NCT01132586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474878|NCT01130246|Varespladib methyl|varespladib methyl|mesh-list
65474879|NCT01130246|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
65474880|NCT01130246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474881|NCT01130246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474882|NCT03921086|Antihypertensive Agents|antihypertensive agents|mesh-list
65474883|NCT01227590|Ritonavir|ritonavir|mesh-list
65474884|NCT01227590|Lopinavir|lopinavir|mesh-list
65474885|NCT01227590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65474886|NCT01227590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65474887|NCT01227590|Protease Inhibitors|protease inhibitors|mesh-ancestor
65474888|NCT01227590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474889|NCT01227590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474890|NCT01227590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65474891|NCT01227590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65474892|NCT01227590|Antiviral Agents|antiviral agents|mesh-ancestor
65474893|NCT01227590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65474894|NCT01227590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65474895|NCT01227590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65474896|NCT03927248|Nivolumab|nivolumab|mesh-list
65474897|NCT03927248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65474898|NCT03927248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474899|NCT03927248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65474900|NCT03927248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474901|NCT03926780|Warfarin|warfarin|mesh-list
65474902|NCT03926780|Rivaroxaban|rivaroxaban|mesh-list
65474903|NCT03926780|Anticoagulants|anticoagulants|mesh-ancestor
65474904|NCT03926780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65474905|NCT03926780|Antithrombins|antithrombins|mesh-ancestor
65474906|NCT03926780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65474907|NCT03926780|Protease Inhibitors|protease inhibitors|mesh-ancestor
65474908|NCT03926780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474909|NCT03926780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474910|NCT03919448|Bevacizumab|bevacizumab|mesh-list
65474911|NCT03919448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65474912|NCT03919448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474913|NCT03919448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65474914|NCT03919448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65474915|NCT03919448|Growth Substances|growth substances|mesh-ancestor
65474916|NCT03919448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474917|NCT03919448|Growth Inhibitors|growth inhibitors|mesh-ancestor
65474918|NCT03926936|Fulvestrant|fulvestrant|mesh-list
65474919|NCT03926936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65474920|NCT03926936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474921|NCT03926936|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65474922|NCT03926936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65474923|NCT03926936|Hormone Antagonists|hormone antagonists|mesh-ancestor
65474924|NCT03926936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65474925|NCT03926936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474926|NCT03920618|Tenofovir|tenofovir|mesh-list
65474927|NCT03920618|Entecavir|entecavir|mesh-list
65474928|NCT03920618|Antiviral Agents|antiviral agents|mesh-ancestor
65474929|NCT03920618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65474930|NCT03920618|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65474931|NCT03920618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65474932|NCT03920618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474933|NCT03920618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474934|NCT03920618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65474935|NCT03920618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64858952|NCT01744873|Bisoprolol|bisoprolol|mesh-list
65474961|NCT01229930|Cediranib|cediranib|mesh-list
65474962|NCT01229930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65474963|NCT01229930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474964|NCT01229930|Tubulin Modulators|tubulin modulators|mesh-ancestor
65474965|NCT01229930|Antimitotic Agents|antimitotic agents|mesh-ancestor
65474966|NCT01229930|Mitosis Modulators|mitosis modulators|mesh-ancestor
64471208|NCT04696523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471209|NCT04688320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64471211|NCT04688320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64471212|NCT04688320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471213|NCT04669197|Gemcitabine|gemcitabine|mesh-list
64471214|NCT04669197|Hydroxychloroquine|hydroxychloroquine|mesh-list
64471215|NCT04669197|Paclitaxel|paclitaxel|mesh-list
65474967|NCT01229930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224482|NCT02713009|Cholecalciferol|cholecalciferol|mesh-list
65474968|NCT01229930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474969|NCT01229930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65474970|NCT03805100|Ranibizumab|ranibizumab|mesh-list
65474971|NCT03805100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65474972|NCT03805100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65474973|NCT03805100|Growth Substances|growth substances|mesh-ancestor
65474974|NCT03805100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474975|NCT03805100|Growth Inhibitors|growth inhibitors|mesh-ancestor
65474976|NCT03805100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474977|NCT03920150|Vitamin D|vitamin d|mesh-list
65474978|NCT03920150|Ergocalciferols|ergocalciferols|mesh-list
65474979|NCT03920150|Cholecalciferol|cholecalciferol|mesh-list
65474980|NCT03920150|Vitamins|vitamins|mesh-list
65474981|NCT03920150|Micronutrients|micronutrients|mesh-ancestor
65474982|NCT03920150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474983|NCT03920150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65474984|NCT03920150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64859024|NCT01745549|Insulin|insulin|mesh-list
65474993|NCT01229774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65474994|NCT01229774|Analgesics|analgesics|mesh-ancestor
65474995|NCT01229774|Sensory System Agents|sensory system agents|mesh-ancestor
65474996|NCT01229774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65474997|NCT01229774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474998|NCT01229774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65474999|NCT01229774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65475000|NCT01229774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65475001|NCT01229774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475002|NCT01229774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475003|NCT01229774|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65475005|NCT03918590|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65475006|NCT03918590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65475007|NCT03918590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65475008|NCT03918590|Analgesics|analgesics|mesh-ancestor
65475009|NCT03918590|Sensory System Agents|sensory system agents|mesh-ancestor
65475010|NCT03918590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65475011|NCT03918590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475012|NCT03918590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65475013|NCT03918590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65475014|NCT03918590|Laxatives|laxatives|mesh-ancestor
65475015|NCT03918590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65475016|NCT00320255|Apixaban|apixaban|mesh-list
65475017|NCT00320255|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65475018|NCT00320255|Antithrombins|antithrombins|mesh-ancestor
65475019|NCT00320255|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65475020|NCT00320255|Protease Inhibitors|protease inhibitors|mesh-ancestor
65475021|NCT00320255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475022|NCT00320255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475023|NCT00320255|Anticoagulants|anticoagulants|mesh-ancestor
65475024|NCT01231802|Leucovorin|leucovorin|mesh-list
65475025|NCT01231802|Fluorouracil|fluorouracil|mesh-list
65475026|NCT01231802|Capecitabine|capecitabine|mesh-list
65475027|NCT01231802|Eniluracil|eniluracil|mesh-list
65475028|NCT01231802|Antimetabolites|antimetabolites|mesh-ancestor
65475029|NCT01231802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475030|NCT01231802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65475031|NCT01231802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475032|NCT01231802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65273211|NCT02677805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65475033|NCT01231802|Immunologic Factors|immunologic factors|mesh-ancestor
65475034|NCT01231802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475035|NCT01231802|Antidotes|antidotes|mesh-ancestor
65475036|NCT01231802|Protective Agents|protective agents|mesh-ancestor
65475037|NCT01231802|Vitamin B Complex|vitamin b complex|mesh-ancestor
65475038|NCT01231802|Vitamins|vitamins|mesh-ancestor
65475039|NCT01231802|Micronutrients|micronutrients|mesh-ancestor
65475040|NCT01231802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475041|NCT01329614|Nicotine|nicotine|mesh-list
65475042|NCT01329614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65475043|NCT01329614|Autonomic Agents|autonomic agents|mesh-ancestor
65475044|NCT01329614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65475045|NCT01329614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475046|NCT01329614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65475047|NCT01329614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65475048|NCT01329614|Cholinergic Agents|cholinergic agents|mesh-ancestor
65475049|NCT01329614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65475050|NCT01329614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475051|NCT01231880|Piperaquine|piperaquine|mesh-list
65475052|NCT01231880|Artenimol|artenimol|mesh-list
65475053|NCT01231880|Antimalarials|antimalarials|mesh-ancestor
65475054|NCT01231880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65475066|NCT03926156|Rivaroxaban|rivaroxaban|mesh-list
65475067|NCT03926156|Anticoagulants|anticoagulants|mesh-ancestor
65475068|NCT03926156|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65475069|NCT03926156|Antithrombins|antithrombins|mesh-ancestor
65475070|NCT03926156|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65475071|NCT03926156|Protease Inhibitors|protease inhibitors|mesh-ancestor
65475072|NCT03926156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475073|NCT03926156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475074|NCT01134536|Tapentadol|tapentadol|mesh-list
65475075|NCT01134536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65475076|NCT01134536|Narcotics|narcotics|mesh-ancestor
65475077|NCT01134536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65475078|NCT01134536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475079|NCT01134536|Analgesics|analgesics|mesh-ancestor
65475080|NCT01134536|Sensory System Agents|sensory system agents|mesh-ancestor
65475081|NCT01134536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65475082|NCT01134536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65475083|NCT01134536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65475084|NCT01134536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65475085|NCT01134536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475086|NCT01134536|Adrenergic Agents|adrenergic agents|mesh-ancestor
65475087|NCT01134536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65475088|NCT01134692|Norfloxacin|norfloxacin|mesh-list
65475089|NCT01134692|Propranolol|propranolol|mesh-list
65475090|NCT01134692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65475091|NCT01134692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65475092|NCT01134692|Adrenergic Agents|adrenergic agents|mesh-ancestor
65475093|NCT01134692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65475094|NCT01134692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475095|NCT01134692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475096|NCT01134692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65475097|NCT01134692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65475098|NCT01134692|Vasodilator Agents|vasodilator agents|mesh-ancestor
65475099|NCT01134692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65475100|NCT01134692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65475101|NCT01134692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65475102|NCT01134692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65475103|NCT01134692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475104|NCT01134692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475105|NCT01134692|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65475106|NCT01134692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65475107|NCT01134848|Morphine|morphine|mesh-list
65475108|NCT01134848|Secretin|secretin|mesh-list
65475109|NCT01134848|Neostigmine|neostigmine|mesh-list
65475110|NCT01134848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65475111|NCT01134848|Narcotics|narcotics|mesh-ancestor
65475112|NCT01134848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65475113|NCT01134848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475114|NCT01134848|Analgesics|analgesics|mesh-ancestor
65475115|NCT01134848|Sensory System Agents|sensory system agents|mesh-ancestor
65475116|NCT01134848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65475117|NCT01134848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65273212|NCT02677805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65475118|NCT01134848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859138|NCT01745835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65475124|NCT01134848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65475126|NCT01134848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65475127|NCT03926000|Pregabalin|pregabalin|mesh-list
65475128|NCT03926000|Analgesics|analgesics|mesh-ancestor
65475129|NCT03926000|Sensory System Agents|sensory system agents|mesh-ancestor
65475130|NCT03926000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65475131|NCT03926000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475132|NCT03926000|Anticonvulsants|anticonvulsants|mesh-ancestor
65475133|NCT03926000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65475134|NCT03926000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65475135|NCT03926000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475136|NCT03926000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65475137|NCT03926000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65475138|NCT03926000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65475139|NCT03926000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65475140|NCT03926000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65475141|NCT01134926|Misoprostol|misoprostol|mesh-list
65475142|NCT01134926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65475143|NCT01134926|Abortifacient Agents|abortifacient agents|mesh-ancestor
65475144|NCT01134926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65475145|NCT01134926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475146|NCT01134926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65475147|NCT01134926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65475148|NCT01134926|Oxytocics|oxytocics|mesh-ancestor
65475149|NCT01228136|Tranexamic Acid|tranexamic acid|mesh-list
65475150|NCT01228136|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65475151|NCT01228136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65475152|NCT01228136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475153|NCT01228136|Hemostatics|hemostatics|mesh-ancestor
65475154|NCT01228136|Coagulants|coagulants|mesh-ancestor
65475155|NCT03140176|Sunitinib|sunitinib|mesh-list
65475156|NCT03140176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475157|NCT03140176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65475158|NCT03140176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65475159|NCT03140176|Growth Substances|growth substances|mesh-ancestor
65475160|NCT03140176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475161|NCT03140176|Growth Inhibitors|growth inhibitors|mesh-ancestor
65475162|NCT03140176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65475163|NCT03140176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475164|NCT03140176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475165|NCT04259164|Mometasone Furoate|mometasone furoate|mesh-list
65475166|NCT04259164|Glycopyrrolate|glycopyrrolate|mesh-list
65475167|NCT04259164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65475168|NCT04259164|Dermatologic Agents|dermatologic agents|mesh-ancestor
65475169|NCT04259164|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65475170|NCT04259164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65475171|NCT04259164|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65475172|NCT04259164|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65475173|NCT04259164|Cholinergic Agents|cholinergic agents|mesh-ancestor
65475174|NCT04259164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65475175|NCT04259164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475176|NCT04259164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475177|NCT01230476|Cetuximab|cetuximab|mesh-list
65475178|NCT01230476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65475179|NCT01230476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475180|NCT01135472|Esomeprazole|esomeprazole|mesh-list
65475181|NCT01135472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65475182|NCT01135472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65475183|NCT01135472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65475184|NCT01135472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475185|NCT01135472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475186|NCT01133210|Maraviroc|maraviroc|mesh-list
64859203|NCT01746680|Methotrexate|methotrexate|mesh-list
65475202|NCT01135550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475203|NCT01135550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65475204|NCT01135550|Glucocorticoids|glucocorticoids|mesh-ancestor
65475206|NCT01135550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65475207|NCT01135550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65475208|NCT01135550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475209|NCT01135550|Protease Inhibitors|protease inhibitors|mesh-ancestor
64471348|NCT04587427|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65475210|NCT01135550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475211|NCT01135550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475212|NCT05401370|Methylene Blue|methylene blue|mesh-list
65475213|NCT05401370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475214|NCT05401370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475215|NCT01131026|Amoxicillin|amoxicillin|mesh-list
65475216|NCT01131026|Levofloxacin|levofloxacin|mesh-list
65475217|NCT01131026|Ofloxacin|ofloxacin|mesh-list
65475218|NCT01131026|Lansoprazole|lansoprazole|mesh-list
65475219|NCT01131026|Dexlansoprazole|dexlansoprazole|mesh-list
65475220|NCT01131026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65475221|NCT01131026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65475222|NCT01131026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65475223|NCT01131026|Renal Agents|renal agents|mesh-ancestor
65475224|NCT01131026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65475225|NCT01131026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65475226|NCT01131026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475227|NCT01131026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475228|NCT01131026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475229|NCT01131026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65475230|NCT01131026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65475231|NCT01131026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65475232|NCT01131026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65475233|NCT01131026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65475234|NCT05401292|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65475235|NCT05401292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65475236|NCT05401292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65475237|NCT05401292|Dermatologic Agents|dermatologic agents|mesh-ancestor
65475238|NCT01135628|Nitazoxanide|nitazoxanide|mesh-list
65475239|NCT01135628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65475240|NCT01135628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65475241|NCT01133366|Warfarin|warfarin|mesh-list
65475242|NCT01133366|Mipomersen|mipomersen|mesh-list
65475243|NCT01133366|Anticoagulants|anticoagulants|mesh-ancestor
65475244|NCT01133366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64859288|NCT01746992|Glucocorticoids|glucocorticoids|mesh-ancestor
65475252|NCT01232270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475253|NCT01232270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65475254|NCT01232270|Anesthetics, General|anesthetics, general|mesh-ancestor
65475255|NCT01232270|Anesthetics|anesthetics|mesh-ancestor
65475256|NCT05400902|Apatinib|apatinib|mesh-list
65475257|NCT05400902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475258|NCT05400902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65475259|NCT05400902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475260|NCT05400902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475261|NCT01233206|Metformin|metformin|mesh-list
65475262|NCT01233206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65475263|NCT01233206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475264|NCT00369941|Tenofovir|tenofovir|mesh-list
65475265|NCT00369941|Emtricitabine|emtricitabine|mesh-list
65475266|NCT00369941|Efavirenz|efavirenz|mesh-list
65475267|NCT00369941|Raltegravir Potassium|raltegravir potassium|mesh-list
65475268|NCT00369941|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65475269|NCT00369941|Antiviral Agents|antiviral agents|mesh-ancestor
65475270|NCT00369941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65475271|NCT00369941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65475272|NCT00369941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65475273|NCT00369941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475274|NCT00369941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475275|NCT00369941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65475276|NCT00369941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65475277|NCT00369941|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65475278|NCT00369941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65475279|NCT00369941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65475280|NCT00369941|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65475281|NCT00369941|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65475282|NCT00369941|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65475283|NCT00369941|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65475284|NCT00369941|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65475285|NCT01133444|Finasteride|finasteride|mesh-list
65475286|NCT01133444|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65475287|NCT01133444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65475288|NCT01133444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475289|NCT01133444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475290|NCT01133444|Hormone Antagonists|hormone antagonists|mesh-ancestor
65475291|NCT01133444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65475292|NCT01133444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475293|NCT01133444|Urological Agents|urological agents|mesh-ancestor
65475294|NCT01137656|Acetylcholine|acetylcholine|mesh-list
65475295|NCT01137656|Vasodilator Agents|vasodilator agents|mesh-ancestor
65475296|NCT01137656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65475297|NCT01137656|Cholinergic Agents|cholinergic agents|mesh-ancestor
65475298|NCT01137656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65475299|NCT01137656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475300|NCT01137656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475301|NCT00369785|Donepezil|donepezil|mesh-list
65475302|NCT00369785|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65475303|NCT00369785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475304|NCT00369785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475305|NCT00369785|Cholinergic Agents|cholinergic agents|mesh-ancestor
65475306|NCT00369785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65475307|NCT00369785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475308|NCT00369785|Nootropic Agents|nootropic agents|mesh-ancestor
65475309|NCT01136252|Adalimumab|adalimumab|mesh-list
64859334|NCT01747174|Adenosine|adenosine|mesh-list
65475313|NCT05597462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65475314|NCT05597462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65475316|NCT00369707|Bortezomib|bortezomib|mesh-list
65475317|NCT00369707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65475318|NCT00369707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475319|NCT00369707|Immunologic Factors|immunologic factors|mesh-ancestor
65475320|NCT00369707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475321|NCT00369707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65475322|NCT04973254|Rilpivirine|rilpivirine|mesh-list
65475323|NCT04973254|Cabotegravir|cabotegravir|mesh-list
65475324|NCT04973254|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65475325|NCT04973254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65475326|NCT04973254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475327|NCT04973254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475328|NCT04973254|Antiviral Agents|antiviral agents|mesh-ancestor
65475329|NCT04973254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65475330|NCT04973254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65475331|NCT04973254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65475332|NCT04973254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65475333|NCT04973254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65475334|NCT01232660|Hydroxychloroquine|hydroxychloroquine|mesh-list
65475335|NCT01232660|Antimalarials|antimalarials|mesh-ancestor
65475336|NCT01232660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65475337|NCT01232660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65475338|NCT01232660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65475339|NCT01232660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475340|NCT01232660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475341|NCT01232660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65475342|NCT01233362|Vaccines|vaccines|mesh-list
65475343|NCT01233362|Immunologic Factors|immunologic factors|mesh-ancestor
65475344|NCT01233362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475345|NCT01136642|Nicotine|nicotine|mesh-list
65475346|NCT01136642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65475347|NCT01136642|Autonomic Agents|autonomic agents|mesh-ancestor
65224856|NCT04304144|Dexamethasone|dexamethasone|mesh-list
65475348|NCT01136642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65475349|NCT01136642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475350|NCT01136642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65475351|NCT01136642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65475352|NCT01136642|Cholinergic Agents|cholinergic agents|mesh-ancestor
65475353|NCT01136642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65475354|NCT01136642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475355|NCT00369629|Gemcitabine|gemcitabine|mesh-list
65475356|NCT00369629|Pemetrexed|pemetrexed|mesh-list
65475357|NCT00369629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65475358|NCT00369629|Antimetabolites|antimetabolites|mesh-ancestor
65475359|NCT00369629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475360|NCT00369629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475361|NCT00369629|Antiviral Agents|antiviral agents|mesh-ancestor
65475362|NCT00369629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65475363|NCT00369629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475364|NCT00369629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65475365|NCT00369629|Immunologic Factors|immunologic factors|mesh-ancestor
65248411|NCT02690870|Zuclomiphene|zuclomiphene|mesh-list
65475366|NCT00369629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475367|NCT00369629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65475368|NCT00369629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65475369|NCT05435222|Psychotropic Drugs|psychotropic drugs|mesh-list
65475370|NCT01133600|Vancomycin|vancomycin|mesh-list
65475371|NCT01133600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65475372|NCT01133600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65475373|NCT01133912|Gemcitabine|gemcitabine|mesh-list
65475374|NCT01133912|Paclitaxel|paclitaxel|mesh-list
65475375|NCT01133912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65475376|NCT01133912|Lapatinib|lapatinib|mesh-list
65475377|NCT01133912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65475378|NCT01133912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475379|NCT01133912|Tubulin Modulators|tubulin modulators|mesh-ancestor
65475380|NCT01133912|Antimitotic Agents|antimitotic agents|mesh-ancestor
65475381|NCT01133912|Mitosis Modulators|mitosis modulators|mesh-ancestor
65475382|NCT01133912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475407|NCT01140620|Ketamine|ketamine|mesh-list
65475408|NCT01140620|Risperidone|risperidone|mesh-list
65475409|NCT01140620|Analgesics|analgesics|mesh-ancestor
65475410|NCT01140620|Sensory System Agents|sensory system agents|mesh-ancestor
65475411|NCT01140620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65475412|NCT01140620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475413|NCT01140620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65475414|NCT01140620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65475415|NCT01140620|Anesthetics, General|anesthetics, general|mesh-ancestor
65475416|NCT01140620|Anesthetics|anesthetics|mesh-ancestor
65475417|NCT01140620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65475418|NCT01140620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65475419|NCT01140620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65475420|NCT01140620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65475421|NCT01140620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475422|NCT01140620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65475423|NCT01140620|Serotonin Agents|serotonin agents|mesh-ancestor
65475424|NCT01140620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65475425|NCT01140620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65475426|NCT01140620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65475427|NCT01140620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65475428|NCT01140620|Dopamine Agents|dopamine agents|mesh-ancestor
65475429|NCT03917186|Sevoflurane|sevoflurane|mesh-list
65475430|NCT03917186|Desflurane|desflurane|mesh-list
65475431|NCT03917186|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65475432|NCT03917186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65475433|NCT03917186|Anesthetics, General|anesthetics, general|mesh-ancestor
65475434|NCT03917186|Anesthetics|anesthetics|mesh-ancestor
65475435|NCT03917186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65475436|NCT03917186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475448|NCT04630730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65475449|NCT04630730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475450|NCT04630730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65475451|NCT04630730|Immunologic Factors|immunologic factors|mesh-ancestor
65475452|NCT04630730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475453|NCT04630730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65475454|NCT01140932|Prednisolone|prednisolone|mesh-list
65475455|NCT01140932|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65475456|NCT01140932|Methylprednisolone|methylprednisolone|mesh-list
65475457|NCT01140932|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65475458|NCT01140932|Prednisolone acetate|prednisolone acetate|mesh-list
65475459|NCT01140932|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65475460|NCT01140932|Prednisolone phosphate|prednisolone phosphate|mesh-list
65475461|NCT01140932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65475462|NCT01140932|Glucocorticoids|glucocorticoids|mesh-ancestor
65475463|NCT01140932|Hormones|hormones|mesh-ancestor
65475464|NCT01140932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65475465|NCT01140932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475466|NCT01140932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65475467|NCT01140932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475468|NCT01140932|Antiemetics|antiemetics|mesh-ancestor
65475469|NCT01140932|Autonomic Agents|autonomic agents|mesh-ancestor
65475470|NCT01140932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65475471|NCT01140932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65475472|NCT01140932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65475473|NCT01140932|Protective Agents|protective agents|mesh-ancestor
65475474|NCT01138904|Oxaliplatin|oxaliplatin|mesh-list
65475475|NCT01138904|Irinotecan|irinotecan|mesh-list
65475476|NCT01138904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273213|NCT02677805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475477|NCT01138904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65475478|NCT01138904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65475479|NCT01138904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475480|NCT01138904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475481|NCT04582448|Insulin|insulin|mesh-list
65475482|NCT04582448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65475483|NCT04582448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475484|NCT05280314|Pembrolizumab|pembrolizumab|mesh-list
65475485|NCT05280314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65475486|NCT05280314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475487|NCT01139138|Irinotecan|irinotecan|mesh-list
65475488|NCT01139138|Everolimus|everolimus|mesh-list
65475489|NCT01139138|Panitumumab|panitumumab|mesh-list
65475490|NCT01139138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65475491|NCT01139138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65475492|NCT01139138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475493|NCT01139138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475494|NCT01139138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475495|NCT01139138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65475496|NCT01139138|Immunologic Factors|immunologic factors|mesh-ancestor
65475497|NCT01139138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475498|NCT01139138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65475499|NCT01134224|Insulin|insulin|mesh-list
65475500|NCT01134224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65475501|NCT01134224|Insulin Aspart|insulin aspart|mesh-list
65475502|NCT01134224|Insulin, Long-Acting|insulin, long-acting|mesh-list
64859531|NCT01748318|Renal Agents|renal agents|mesh-ancestor
65475508|NCT01134224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475509|NCT05308888|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65475510|NCT05308888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65475511|NCT05308888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475512|NCT01231490|Naproxen|naproxen|mesh-list
65475513|NCT01231490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65475514|NCT01231490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65475515|NCT01231490|Analgesics|analgesics|mesh-ancestor
65475516|NCT01231490|Sensory System Agents|sensory system agents|mesh-ancestor
65475517|NCT01231490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65475518|NCT01231490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475519|NCT01231490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65475520|NCT01231490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65475521|NCT01231490|Gout Suppressants|gout suppressants|mesh-ancestor
65475522|NCT01231490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65475523|NCT01231490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475524|NCT01231490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475525|NCT01141244|Sirolimus|sirolimus|mesh-list
65475526|NCT01141244|Irinotecan|irinotecan|mesh-list
65475527|NCT01141244|Temozolomide|temozolomide|mesh-list
65475528|NCT01141244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65475529|NCT01141244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65475530|NCT01141244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475531|NCT01141244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475532|NCT01141244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475533|NCT01141244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65475534|NCT01141244|Alkylating Agents|alkylating agents|mesh-ancestor
65475535|NCT01141244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65475536|NCT01141244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65475537|NCT01141244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65475538|NCT01141244|Antifungal Agents|antifungal agents|mesh-ancestor
65475539|NCT01141244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65475540|NCT01141244|Immunologic Factors|immunologic factors|mesh-ancestor
65475541|NCT01141244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475542|NCT01141322|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65475543|NCT01141322|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65475544|NCT01141322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65475545|NCT04003636|Gemcitabine|gemcitabine|mesh-list
65475546|NCT04003636|Cisplatin|cisplatin|mesh-list
65475547|NCT04003636|Pembrolizumab|pembrolizumab|mesh-list
65475548|NCT04003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475549|NCT04003636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65475550|NCT04003636|Antimetabolites|antimetabolites|mesh-ancestor
65475551|NCT04003636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475552|NCT04003636|Antiviral Agents|antiviral agents|mesh-ancestor
65475553|NCT04003636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65475554|NCT04003636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475555|NCT04003636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65475556|NCT04003636|Immunologic Factors|immunologic factors|mesh-ancestor
65475557|NCT04003636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475558|NCT04003636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65475559|NCT01141556|Selenium|selenium|mesh-list
65475560|NCT01141556|Antioxidants|antioxidants|mesh-ancestor
65475561|NCT01141556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475562|NCT01141556|Protective Agents|protective agents|mesh-ancestor
65475563|NCT01141556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475564|NCT01141556|Trace Elements|trace elements|mesh-ancestor
65475565|NCT01141556|Micronutrients|micronutrients|mesh-ancestor
65475566|NCT01139372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65475567|NCT01139372|Lubricant Eye Drops|lubricant eye drops|mesh-list
65475568|NCT01139372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65475569|NCT03638440|Naloxegol|naloxegol|mesh-list
65475570|NCT03638440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65475571|NCT03638440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475574|NCT01719640|Insulin|insulin|mesh-list
65475575|NCT01719640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65475576|NCT01719640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225089|NCT04073719|Acetic Acid|acetic acid|mesh-list
65475577|NCT02439658|Sotalol|sotalol|mesh-list
65475578|NCT02439658|Dofetilide|dofetilide|mesh-list
65475579|NCT02439658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65475580|NCT02439658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65475581|NCT02439658|Adrenergic Agents|adrenergic agents|mesh-ancestor
65475582|NCT02439658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65475583|NCT02439658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475584|NCT02439658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475585|NCT02439658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65475586|NCT02439658|Sympatholytics|sympatholytics|mesh-ancestor
65475587|NCT02439658|Autonomic Agents|autonomic agents|mesh-ancestor
65475588|NCT02439658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65475589|NCT02439658|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65475590|NCT02439658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65475591|NCT05191394|Antibodies|antibodies|mesh-list
65475592|NCT05191394|Immunologic Factors|immunologic factors|mesh-ancestor
65475593|NCT05191394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475594|NCT04895098|Ezetimibe|ezetimibe|mesh-list
65475595|NCT04895098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65475596|NCT04895098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65475597|NCT04895098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65475598|NCT04895098|Antimetabolites|antimetabolites|mesh-ancestor
65475599|NCT04895098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475600|NCT04895098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65475601|NCT04895098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475602|NCT00318461|Metformin|metformin|mesh-list
65475603|NCT00318461|Liraglutide|liraglutide|mesh-list
65475604|NCT00318461|Glimepiride|glimepiride|mesh-list
65475605|NCT00318461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65475606|NCT00318461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475607|NCT00318461|Incretins|incretins|mesh-ancestor
65475608|NCT00318461|Hormones|hormones|mesh-ancestor
65475609|NCT00318461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65475610|NCT00318461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65475611|NCT00318461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65475612|NCT00318461|Immunologic Factors|immunologic factors|mesh-ancestor
65475613|NCT02243878|Ranibizumab|ranibizumab|mesh-list
65475614|NCT02243878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65475615|NCT02243878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65475616|NCT02243878|Growth Substances|growth substances|mesh-ancestor
65475617|NCT02243878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475618|NCT02243878|Growth Inhibitors|growth inhibitors|mesh-ancestor
65475619|NCT02243878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475620|NCT04734652|Tenofovir|tenofovir|mesh-list
65475621|NCT04734652|Lamivudine|lamivudine|mesh-list
65475622|NCT04734652|Dolutegravir|dolutegravir|mesh-list
65475623|NCT04734652|Antiviral Agents|antiviral agents|mesh-ancestor
65475624|NCT04734652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65475625|NCT04734652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65475626|NCT04734652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65475627|NCT04734652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475628|NCT04734652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475629|NCT04734652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65475630|NCT04734652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65475631|NCT04734652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65273214|NCT02677805|Cholinergic Agents|cholinergic agents|mesh-ancestor
65273215|NCT02677805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65475632|NCT04734652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65475633|NCT01142258|Trazodone|trazodone|mesh-list
65475634|NCT01142258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65475635|NCT01142258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65475636|NCT01142258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65475637|NCT01142258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475638|NCT01142258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65475639|NCT01142258|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65475640|NCT01142258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65475641|NCT01142258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65475642|NCT01142258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475643|NCT01142258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65475644|NCT01142258|Serotonin Agents|serotonin agents|mesh-ancestor
65475656|NCT01139840|Micronutrients|micronutrients|mesh-ancestor
65475657|NCT01139840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475658|NCT01139840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65475659|NCT01139840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65475660|NCT02945410|Vitamin D|vitamin d|mesh-list
65475661|NCT02945410|Calcium|calcium|mesh-list
65475662|NCT02945410|Vitamins|vitamins|mesh-ancestor
65475663|NCT02945410|Micronutrients|micronutrients|mesh-ancestor
65475664|NCT02945410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475665|NCT02945410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65475666|NCT02945410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65475667|NCT03727724|Cetuximab|cetuximab|mesh-list
65475668|NCT03727724|Afatinib|afatinib|mesh-list
65475669|NCT03727724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65475670|NCT03727724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475671|NCT03727724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65475672|NCT03727724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475673|NCT03727724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475674|NCT05032508|Lidocaine|lidocaine|mesh-list
65475675|NCT05032508|Anesthetics, Local|anesthetics, local|mesh-ancestor
65475676|NCT05032508|Anesthetics|anesthetics|mesh-ancestor
65475677|NCT05032508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65475678|NCT05032508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475679|NCT05032508|Sensory System Agents|sensory system agents|mesh-ancestor
65475680|NCT05032508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65475681|NCT05032508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65475682|NCT05032508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65475683|NCT05032508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65475684|NCT05032508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65475685|NCT05032508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475686|NCT01140074|Zinc Sulfate|zinc sulfate|mesh-list
65475687|NCT01140074|Astringents|astringents|mesh-ancestor
65475688|NCT01140074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475689|NCT01140074|Dermatologic Agents|dermatologic agents|mesh-ancestor
65475690|NCT03913442|Colchicine|colchicine|mesh-list
65475691|NCT03913442|Gout Suppressants|gout suppressants|mesh-ancestor
65475692|NCT03913442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65475693|NCT03913442|Tubulin Modulators|tubulin modulators|mesh-ancestor
65475694|NCT03913442|Antimitotic Agents|antimitotic agents|mesh-ancestor
65475695|NCT03913442|Mitosis Modulators|mitosis modulators|mesh-ancestor
65475696|NCT03913442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475697|NCT03913442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475698|NCT01142414|Fluorouracil|fluorouracil|mesh-list
65475699|NCT01142414|Panitumumab|panitumumab|mesh-list
65475700|NCT01142414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475701|NCT01142414|Antimetabolites|antimetabolites|mesh-ancestor
65475702|NCT01142414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475703|NCT01142414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65475704|NCT01142414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65475705|NCT01142414|Immunologic Factors|immunologic factors|mesh-ancestor
65475706|NCT01142414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475707|NCT01142414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65475708|NCT02267603|Pembrolizumab|pembrolizumab|mesh-list
64859730|NCT01749111|Abortifacient Agents|abortifacient agents|mesh-ancestor
65475722|NCT01142492|Immunologic Factors|immunologic factors|mesh-ancestor
65475723|NCT01142492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475724|NCT01142492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65475725|NCT03958474|Remifentanil|remifentanil|mesh-list
65273216|NCT02677805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475726|NCT03958474|Oxycodone|oxycodone|mesh-list
65475727|NCT03958474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65475728|NCT03958474|Narcotics|narcotics|mesh-ancestor
65475729|NCT03958474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65475730|NCT03958474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475731|NCT03958474|Analgesics|analgesics|mesh-ancestor
65475732|NCT03958474|Sensory System Agents|sensory system agents|mesh-ancestor
65475733|NCT03958474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65475734|NCT04956692|Paclitaxel|paclitaxel|mesh-list
65475735|NCT04956692|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65475736|NCT04956692|Carboplatin|carboplatin|mesh-list
65475737|NCT04956692|Pembrolizumab|pembrolizumab|mesh-list
65475738|NCT04956692|Pemetrexed|pemetrexed|mesh-list
65475739|NCT04956692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65475740|NCT04956692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475741|NCT04956692|Tubulin Modulators|tubulin modulators|mesh-ancestor
65475742|NCT04956692|Antimitotic Agents|antimitotic agents|mesh-ancestor
65475743|NCT04956692|Mitosis Modulators|mitosis modulators|mesh-ancestor
65475744|NCT04956692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475745|NCT04956692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65475746|NCT04956692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475747|NCT04956692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65475748|NCT04956692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65475749|NCT01234142|Varenicline|varenicline|mesh-list
65475750|NCT01234142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65475751|NCT01234142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65475752|NCT01234142|Cholinergic Agents|cholinergic agents|mesh-ancestor
65475753|NCT01234142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65475754|NCT01234142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475755|NCT01234142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475756|NCT01140308|Ubiquinone|ubiquinone|mesh-list
65475757|NCT01140308|Coenzyme Q10|coenzyme q10|mesh-list
65475758|NCT01140308|Micronutrients|micronutrients|mesh-ancestor
65475759|NCT01140308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475760|NCT01140308|Vitamins|vitamins|mesh-ancestor
65475761|NCT01142648|Glycopyrrolate|glycopyrrolate|mesh-list
65475762|NCT01142648|Neostigmine|neostigmine|mesh-list
65475763|NCT01142648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65475764|NCT01142648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475765|NCT01142648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475766|NCT01142648|Cholinergic Agents|cholinergic agents|mesh-ancestor
65475767|NCT01142648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65475768|NCT01142648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475769|NCT01142648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65475770|NCT01142648|Autonomic Agents|autonomic agents|mesh-ancestor
65475771|NCT01142648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65475772|NCT01142648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65475773|NCT01142648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65475778|NCT02143726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65475779|NCT02143726|Immunologic Factors|immunologic factors|mesh-ancestor
65475780|NCT02143726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475781|NCT02143726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65475782|NCT02143726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475783|NCT02143726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475784|NCT03503864|Arsenic Trioxide|arsenic trioxide|mesh-list
65475785|NCT03503864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475787|NCT02088112|Gefitinib|gefitinib|mesh-list
65475788|NCT02088112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65475789|NCT02088112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475790|NCT02088112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65475791|NCT02088112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475792|NCT02088112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475793|NCT04700176|Dexamethasone|dexamethasone|mesh-list
65475794|NCT04700176|Daratumumab|daratumumab|mesh-list
65475795|NCT04700176|Pomalidomide|pomalidomide|mesh-list
65475796|NCT04700176|Tretinoin|tretinoin|mesh-list
65475797|NCT04700176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65475798|NCT04700176|Antiemetics|antiemetics|mesh-ancestor
65475799|NCT04700176|Autonomic Agents|autonomic agents|mesh-ancestor
65475800|NCT04700176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65475801|NCT04700176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475802|NCT04700176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65475803|NCT04700176|Glucocorticoids|glucocorticoids|mesh-ancestor
65475804|NCT04700176|Hormones|hormones|mesh-ancestor
65248412|NCT02690870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65273217|NCT02677805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65475805|NCT04700176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65475806|NCT04700176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65475807|NCT04700176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475809|NCT04700176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65475810|NCT04700176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65475811|NCT04700176|Growth Substances|growth substances|mesh-ancestor
65475812|NCT04700176|Growth Inhibitors|growth inhibitors|mesh-ancestor
65475813|NCT04700176|Keratolytic Agents|keratolytic agents|mesh-ancestor
65475814|NCT04700176|Dermatologic Agents|dermatologic agents|mesh-ancestor
65475815|NCT01144910|Methacholine Chloride|methacholine chloride|mesh-list
65475816|NCT01144910|Miotics|miotics|mesh-ancestor
65475817|NCT01144910|Autonomic Agents|autonomic agents|mesh-ancestor
65475818|NCT01144910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65475819|NCT01144910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475820|NCT01144910|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65475821|NCT01144910|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
65475822|NCT01144910|Respiratory System Agents|respiratory system agents|mesh-ancestor
65475823|NCT01144910|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65475824|NCT01144910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65475825|NCT01144910|Cholinergic Agents|cholinergic agents|mesh-ancestor
65475826|NCT01144910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65475827|NCT01144910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475828|NCT01234298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65475829|NCT01234298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65475830|NCT01234298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475831|NCT01234298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65475832|NCT01234298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65475833|NCT01234298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65475834|NCT01234298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475835|NCT01234298|Dopamine Agents|dopamine agents|mesh-ancestor
65475836|NCT01234298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65475837|NCT05308342|Hormones|hormones|mesh-list
65475838|NCT05308342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65475839|NCT05308342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475840|NCT03332212|Empagliflozin|empagliflozin|mesh-list
65475841|NCT03332212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65475842|NCT03332212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475843|NCT03332212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65475844|NCT03332212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475849|NCT01144988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65475850|NCT01144988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65475851|NCT01144988|Growth Substances|growth substances|mesh-ancestor
65475852|NCT01144988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475853|NCT01144988|Growth Inhibitors|growth inhibitors|mesh-ancestor
65475854|NCT01144988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65475855|NCT01144988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65475856|NCT01144988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475857|NCT01144988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475858|NCT03331666|Evolocumab|evolocumab|mesh-list
65475859|NCT03331666|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65475860|NCT03331666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65475861|NCT03331666|Antimetabolites|antimetabolites|mesh-ancestor
65475862|NCT03331666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475863|NCT03331666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65475864|NCT04828538|Vitamin D|vitamin d|mesh-list
65475865|NCT04828538|Vitamins|vitamins|mesh-list
65475866|NCT04828538|Folic Acid|folic acid|mesh-list
65475867|NCT04828538|Vitamin B Complex|vitamin b complex|mesh-list
65475868|NCT04828538|Micronutrients|micronutrients|mesh-ancestor
65475869|NCT04828538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475870|NCT04828538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65475871|NCT04828538|Hematinics|hematinics|mesh-ancestor
65475872|NCT01145144|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65475873|NCT01145144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65475874|NCT01145144|Immunologic Factors|immunologic factors|mesh-ancestor
65475875|NCT01145144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475876|NCT00566488|Parathyroid Hormone|parathyroid hormone|mesh-list
65475877|NCT00566488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65225383|NCT04314219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65475879|NCT04943302|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65248413|NCT02690870|Hormone Antagonists|hormone antagonists|mesh-ancestor
64471352|NCT04585711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65475880|NCT04943302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65475881|NCT04943302|Alkylating Agents|alkylating agents|mesh-ancestor
65475882|NCT04943302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475883|NCT04943302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475884|NCT04786210|Triamcinolone|triamcinolone|mesh-list
65475885|NCT04786210|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65475886|NCT04786210|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65475887|NCT04786210|Fluorouracil|fluorouracil|mesh-list
65475888|NCT04786210|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65475889|NCT04786210|Antimetabolites|antimetabolites|mesh-ancestor
65475890|NCT04786210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475891|NCT04786210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65475892|NCT04786210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475893|NCT04786210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65475894|NCT04786210|Immunologic Factors|immunologic factors|mesh-ancestor
65475895|NCT04786210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475896|NCT04786210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65475897|NCT04786210|Glucocorticoids|glucocorticoids|mesh-ancestor
65475898|NCT04786210|Hormones|hormones|mesh-ancestor
65475899|NCT04786210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65475900|NCT04786210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475901|NCT01234454|Olanzapine|olanzapine|mesh-list
65475902|NCT01234454|Risperidone|risperidone|mesh-list
65475903|NCT01234454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65475904|NCT01234454|Serotonin Agents|serotonin agents|mesh-ancestor
65475905|NCT01234454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65475906|NCT01234454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475907|NCT01234454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475908|NCT01234454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65475909|NCT01234454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65475910|NCT01234454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65475911|NCT01234454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65475912|NCT01234454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65475913|NCT01234454|Dopamine Agents|dopamine agents|mesh-ancestor
65475914|NCT01234454|Antiemetics|antiemetics|mesh-ancestor
65475915|NCT01234454|Autonomic Agents|autonomic agents|mesh-ancestor
64859936|NCT01750359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65475922|NCT01145456|R04929097|r04929097|mesh-list
65475923|NCT01145456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65475924|NCT01145456|Antimetabolites|antimetabolites|mesh-ancestor
65475925|NCT01145456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475926|NCT01145456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475927|NCT01145456|Antiviral Agents|antiviral agents|mesh-ancestor
65475928|NCT01145456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65475929|NCT01145456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475930|NCT01145456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65475931|NCT01145456|Immunologic Factors|immunologic factors|mesh-ancestor
65475932|NCT01145456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475933|NCT04939636|Vitamin D|vitamin d|mesh-list
65475934|NCT04939636|Ergocalciferols|ergocalciferols|mesh-list
65475935|NCT04939636|Cholecalciferol|cholecalciferol|mesh-list
65475936|NCT04939636|Vitamins|vitamins|mesh-list
65475937|NCT04939636|Micronutrients|micronutrients|mesh-ancestor
65475938|NCT04939636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475939|NCT04939636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65475940|NCT04939636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65475941|NCT01238276|Cefazolin|cefazolin|mesh-list
65475942|NCT01238276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65475943|NCT01238276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65475944|NCT01145534|Glyburide|glyburide|mesh-list
65475945|NCT01145534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65475946|NCT01145534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475947|NCT01145612|Losartan|losartan|mesh-list
65475948|NCT01145612|Atenolol|atenolol|mesh-list
65475949|NCT01145612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65475950|NCT01145612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65475951|NCT01145612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65475952|NCT01145612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65475953|NCT01145612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475954|NCT01145612|Sympatholytics|sympatholytics|mesh-ancestor
65475955|NCT01145612|Autonomic Agents|autonomic agents|mesh-ancestor
65475956|NCT01145612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65475957|NCT01145612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923721|NCT00026260|Semaxinib|semaxinib|mesh-list
64471353|NCT04585711|Analgesics|analgesics|mesh-ancestor
65475958|NCT01145612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65475959|NCT01145612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65475960|NCT01145612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65475961|NCT01145612|Adrenergic Agents|adrenergic agents|mesh-ancestor
65475962|NCT01145612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65475963|NCT05293366|Dermatologic Agents|dermatologic agents|mesh-list
65475964|NCT03621670|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65475965|NCT03621670|Immunologic Factors|immunologic factors|mesh-ancestor
65475966|NCT03621670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475967|NCT01143584|Dopamine|dopamine|mesh-list
65475968|NCT01143584|Cabergoline|cabergoline|mesh-list
65475969|NCT01143584|Dopamine Agonists|dopamine agonists|mesh-list
65475970|NCT01143584|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65475971|NCT01143584|Sympathomimetics|sympathomimetics|mesh-ancestor
65475972|NCT01143584|Autonomic Agents|autonomic agents|mesh-ancestor
65475973|NCT01143584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65475974|NCT01143584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475975|NCT01143584|Dopamine Agents|dopamine agents|mesh-ancestor
65475976|NCT01143584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65475977|NCT01143584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475978|NCT01143584|Protective Agents|protective agents|mesh-ancestor
65475979|NCT01143584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65475980|NCT01143584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65475981|NCT01145846|Cytarabine|cytarabine|mesh-list
65475982|NCT01145846|Daunorubicin|daunorubicin|mesh-list
65475983|NCT01145846|Idarubicin|idarubicin|mesh-list
65475984|NCT01145846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65475985|NCT01145846|Antimetabolites|antimetabolites|mesh-ancestor
65475986|NCT01145846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475988|NCT01145846|Antiviral Agents|antiviral agents|mesh-ancestor
65475989|NCT01145846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65475990|NCT01145846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65475991|NCT01145846|Immunologic Factors|immunologic factors|mesh-ancestor
65475992|NCT01145846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475993|NCT01145846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65475994|NCT01145846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65475995|NCT01145846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65475996|NCT01145846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475997|NCT03134456|Pembrolizumab|pembrolizumab|mesh-list
65475998|NCT03134456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65475999|NCT03134456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476000|NCT01143662|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65476001|NCT01143662|Antiviral Agents|antiviral agents|mesh-ancestor
65476002|NCT01143662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65476003|NCT05173688|Propofol|propofol|mesh-list
65476004|NCT05173688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65476005|NCT05173688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65476006|NCT05173688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476007|NCT05173688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65476008|NCT05173688|Anesthetics, General|anesthetics, general|mesh-ancestor
65476009|NCT05173688|Anesthetics|anesthetics|mesh-ancestor
65476010|NCT01146548|Fluoxetine|fluoxetine|mesh-list
65476011|NCT01146548|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65476012|NCT01146548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65476013|NCT01146548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65476014|NCT01146548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476015|NCT01146548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65476016|NCT01146548|Serotonin Agents|serotonin agents|mesh-ancestor
65476017|NCT01146548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476018|NCT01146548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65476019|NCT01146548|Antidepressive Agents|antidepressive agents|mesh-ancestor
65476020|NCT01146548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65476021|NCT01146548|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65476022|NCT01146548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65476023|NCT01146548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476024|NCT03813836|Pembrolizumab|pembrolizumab|mesh-list
65476025|NCT03813836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65476026|NCT03813836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476027|NCT03478930|Omalizumab|omalizumab|mesh-list
65476028|NCT03478930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65476029|NCT03478930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65476030|NCT03478930|Respiratory System Agents|respiratory system agents|mesh-ancestor
65476031|NCT01312714|Vitamin D|vitamin d|mesh-list
65476032|NCT01312714|Cholecalciferol|cholecalciferol|mesh-list
65273218|NCT02677805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65273219|NCT04202861|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65476033|NCT01312714|Vitamins|vitamins|mesh-ancestor
65476034|NCT01312714|Micronutrients|micronutrients|mesh-ancestor
65476035|NCT01312714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476036|NCT01312714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65476037|NCT01312714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65476038|NCT04188028|Dextromethorphan|dextromethorphan|mesh-list
65476039|NCT04188028|Paroxetine|paroxetine|mesh-list
65476040|NCT04188028|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65476041|NCT04188028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65476042|NCT04188028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65476043|NCT04188028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476044|NCT04188028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65476045|NCT04188028|Serotonin Agents|serotonin agents|mesh-ancestor
65476046|NCT04188028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476047|NCT04188028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65476048|NCT04188028|Antidepressive Agents|antidepressive agents|mesh-ancestor
65476049|NCT04188028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65476050|NCT04188028|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65476051|NCT04188028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65476052|NCT04188028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476053|NCT04188028|Antitussive Agents|antitussive agents|mesh-ancestor
65476054|NCT04188028|Respiratory System Agents|respiratory system agents|mesh-ancestor
65476055|NCT04188028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65476056|NCT04188028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65476057|NCT01312792|Ampicillin|ampicillin|mesh-list
65476058|NCT01312792|Cephradine|cephradine|mesh-list
65476072|NCT03523000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65476073|NCT03523000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65476074|NCT03523000|Anesthetics, General|anesthetics, general|mesh-ancestor
65476076|NCT04705480|Gabapentin|gabapentin|mesh-list
65476077|NCT04705480|Analgesics|analgesics|mesh-ancestor
65476078|NCT04705480|Sensory System Agents|sensory system agents|mesh-ancestor
65476079|NCT04705480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65476080|NCT04705480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476081|NCT04705480|Anticonvulsants|anticonvulsants|mesh-ancestor
65476082|NCT04705480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65476083|NCT04705480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65476084|NCT04705480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476085|NCT04705480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65476086|NCT04705480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65476087|NCT04705480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65476088|NCT04705480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65476089|NCT04705480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65476090|NCT04705480|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65476091|NCT04705480|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65476092|NCT04705480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65476093|NCT04705480|Antimanic Agents|antimanic agents|mesh-ancestor
65476094|NCT01238978|Vildagliptin|vildagliptin|mesh-list
65476095|NCT01238978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65476096|NCT01238978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476097|NCT01238978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65476098|NCT01238978|Protease Inhibitors|protease inhibitors|mesh-ancestor
65476099|NCT01238978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476100|NCT01238978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476101|NCT00318149|Vaccines|vaccines|mesh-list
65225612|NCT01007552|Growth Substances|growth substances|mesh-ancestor
65476102|NCT00318149|Immunologic Factors|immunologic factors|mesh-ancestor
65476103|NCT00318149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476104|NCT05139914|Dapagliflozin|dapagliflozin|mesh-list
65476105|NCT05139914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65476106|NCT05139914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476107|NCT05139914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65476108|NCT05139914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476109|NCT04648696|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65476110|NCT04648696|Vancomycin|vancomycin|mesh-list
65476111|NCT04648696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65476112|NCT04648696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65476113|NCT04648696|Antitubercular Agents|antitubercular agents|mesh-ancestor
65476114|NCT01236716|Gemcitabine|gemcitabine|mesh-list
65476115|NCT01236716|Paclitaxel|paclitaxel|mesh-list
65476116|NCT01236716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65476117|NCT01236716|Carboplatin|carboplatin|mesh-list
65476118|NCT01236716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65476119|NCT01236716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476120|NCT01236716|Tubulin Modulators|tubulin modulators|mesh-ancestor
65476128|NCT01236716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476129|NCT01236716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65476130|NCT01236716|Immunologic Factors|immunologic factors|mesh-ancestor
65476131|NCT01236716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476133|NCT04154800|Diltiazem|diltiazem|mesh-list
65476134|NCT04154800|Antifungal Agents|antifungal agents|mesh-ancestor
65476135|NCT04154800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65476136|NCT04154800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65476137|NCT04154800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65476138|NCT04154800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476139|NCT04154800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476140|NCT04154800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65476141|NCT04154800|Hormone Antagonists|hormone antagonists|mesh-ancestor
65476142|NCT04154800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65476143|NCT04154800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476144|NCT04154800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65476145|NCT04154800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65476146|NCT04154800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65476147|NCT04154800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65476148|NCT04154800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65476149|NCT04154800|Vasodilator Agents|vasodilator agents|mesh-ancestor
65476150|NCT01048229|Pramipexole|pramipexole|mesh-list
65476151|NCT01048229|Rasagiline|rasagiline|mesh-list
65476152|NCT01048229|Antioxidants|antioxidants|mesh-ancestor
65476153|NCT01048229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476154|NCT01048229|Protective Agents|protective agents|mesh-ancestor
65476155|NCT01048229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476156|NCT01048229|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65476157|NCT01048229|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65476158|NCT01048229|Dopamine Agonists|dopamine agonists|mesh-ancestor
65476159|NCT01048229|Dopamine Agents|dopamine agents|mesh-ancestor
65476160|NCT01048229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65476161|NCT01048229|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65476162|NCT01048229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476163|NCT01048229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65476164|NCT01048307|Polihexanide|polihexanide|mesh-list
65476165|NCT01048307|Betaine|betaine|mesh-list
65476166|NCT01048307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65476167|NCT01048307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65476168|NCT01048307|Lipotropic Agents|lipotropic agents|mesh-ancestor
65476169|NCT01048307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65476170|NCT01048307|Antimetabolites|antimetabolites|mesh-ancestor
65476171|NCT01048307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476172|NCT01048307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65476173|NCT01048307|Disinfectants|disinfectants|mesh-ancestor
65476174|NCT01048307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65476175|NCT04017832|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65476176|NCT04017832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65476177|NCT04017832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476178|NCT04017832|Incretins|incretins|mesh-ancestor
65476179|NCT04017832|Hormones|hormones|mesh-ancestor
65476180|NCT04017832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65476181|NCT04017832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65476182|NCT04017832|Protease Inhibitors|protease inhibitors|mesh-ancestor
65476183|NCT04017832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476184|NCT04017832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476185|NCT02049905|Gemcitabine|gemcitabine|mesh-list
65476186|NCT02049905|Docetaxel|docetaxel|mesh-list
65476187|NCT02049905|Doxorubicin|doxorubicin|mesh-list
65476199|NCT02049905|Immunologic Factors|immunologic factors|mesh-ancestor
65476200|NCT02049905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476201|NCT02049905|Tubulin Modulators|tubulin modulators|mesh-ancestor
65476202|NCT02049905|Antimitotic Agents|antimitotic agents|mesh-ancestor
65476203|NCT02049905|Mitosis Modulators|mitosis modulators|mesh-ancestor
65476204|NCT02049905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65476205|NCT02049905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65476206|NCT02049905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65476207|NCT02049905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65273220|NCT04202861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65476208|NCT02049905|Alkylating Agents|alkylating agents|mesh-ancestor
65476209|NCT01062191|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65476210|NCT01062191|Laxatives|laxatives|mesh-ancestor
65476211|NCT01062191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65476212|NCT01058759|Enoxaparin|enoxaparin|mesh-list
65476213|NCT01058759|Enoxaparin sodium|enoxaparin sodium|mesh-list
65476214|NCT01058759|Anticoagulants|anticoagulants|mesh-ancestor
65476215|NCT01058759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65476216|NCT01058759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65476217|NCT01058759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476218|NCT01239368|Sirolimus|sirolimus|mesh-list
65476219|NCT01239368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65476220|NCT01239368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65476221|NCT01239368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65476222|NCT01239368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476223|NCT01239368|Antifungal Agents|antifungal agents|mesh-ancestor
65476224|NCT01239368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65476225|NCT01239368|Immunologic Factors|immunologic factors|mesh-ancestor
65476226|NCT01239368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476227|NCT01146002|Guanfacine|guanfacine|mesh-list
65476228|NCT01146002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65476229|NCT01146002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65476230|NCT01146002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65476231|NCT01146002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65476232|NCT01146002|Adrenergic Agents|adrenergic agents|mesh-ancestor
65476233|NCT01146002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65476234|NCT01146002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476235|NCT01146002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476236|NCT01146626|Vitamin D|vitamin d|mesh-list
65476237|NCT01146626|Ribavirin|ribavirin|mesh-list
65476238|NCT01146626|Vitamins|vitamins|mesh-ancestor
65476239|NCT01146626|Micronutrients|micronutrients|mesh-ancestor
65476240|NCT01146626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476241|NCT01146626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65476242|NCT01146626|Antimetabolites|antimetabolites|mesh-ancestor
65476243|NCT01146626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476244|NCT01146626|Antiviral Agents|antiviral agents|mesh-ancestor
65476245|NCT01146626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65476246|NCT02924324|Propofol|propofol|mesh-list
65476247|NCT02924324|Ropivacaine|ropivacaine|mesh-list
65476248|NCT02924324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65476249|NCT02924324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65476250|NCT02924324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476251|NCT02924324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65476252|NCT02924324|Anesthetics, General|anesthetics, general|mesh-ancestor
65476265|NCT03518606|Mitosis Modulators|mitosis modulators|mesh-ancestor
65476266|NCT03518606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476267|NCT05137574|Ketamine|ketamine|mesh-list
65476268|NCT05137574|Propofol|propofol|mesh-list
65476269|NCT05137574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65476270|NCT05137574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65476271|NCT05137574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476272|NCT05137574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65476273|NCT05137574|Anesthetics, General|anesthetics, general|mesh-ancestor
65476274|NCT05137574|Anesthetics|anesthetics|mesh-ancestor
65476275|NCT05137574|Analgesics|analgesics|mesh-ancestor
65476276|NCT05137574|Sensory System Agents|sensory system agents|mesh-ancestor
65476277|NCT05137574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65476278|NCT05137574|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65476279|NCT05137574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65476280|NCT05137574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65476281|NCT05137574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65476282|NCT05137574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476283|NCT02842424|Ramipril|ramipril|mesh-list
65476284|NCT02842424|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65476285|NCT02842424|Protease Inhibitors|protease inhibitors|mesh-ancestor
65476286|NCT02842424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476287|NCT02842424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476288|NCT02842424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65476289|NCT01236950|Listerine|listerine|mesh-list
65476290|NCT01236950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65476291|NCT01236950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65476292|NCT04971746|Pirfenidone|pirfenidone|mesh-list
65476293|NCT04971746|Nintedanib|nintedanib|mesh-list
65273221|NCT04202471|Chlorhexidine|chlorhexidine|mesh-list
65476294|NCT04971746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476295|NCT04971746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65476296|NCT04971746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476297|NCT04971746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476298|NCT04971746|Analgesics|analgesics|mesh-ancestor
65476299|NCT04971746|Sensory System Agents|sensory system agents|mesh-ancestor
65476300|NCT04971746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65476301|NCT04971746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476302|NCT04971746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65476303|NCT04971746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65476304|NCT04971746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65476305|NCT04971746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65476306|NCT00369161|Everolimus|everolimus|mesh-list
65476307|NCT00369161|Tacrolimus|tacrolimus|mesh-list
65476308|NCT00369161|Basiliximab|basiliximab|mesh-list
65476309|NCT00369161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65476310|NCT00369161|Immunologic Factors|immunologic factors|mesh-ancestor
65476311|NCT00369161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476312|NCT00369161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65476313|NCT00369161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476314|NCT00369161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476315|NCT00369161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476316|NCT01143974|Pemetrexed|pemetrexed|mesh-list
65476324|NCT00337571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65476325|NCT00337571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65476326|NCT00337571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65476327|NCT00337571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65476328|NCT00337571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476329|NCT00337571|Dopamine Agonists|dopamine agonists|mesh-ancestor
65476330|NCT00337571|Dopamine Agents|dopamine agents|mesh-ancestor
65476331|NCT00337571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65476332|NCT00337571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476333|NCT00337571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65476334|NCT00337571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65476335|NCT00337571|Serotonin Agents|serotonin agents|mesh-ancestor
65476336|NCT00337571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65476337|NCT00337571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65476338|NCT00337571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65476339|NCT00337571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65476340|NCT01247870|Metformin|metformin|mesh-list
65476341|NCT01247870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65476342|NCT01247870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476343|NCT02528396|Insulin Lispro|insulin lispro|mesh-list
65476344|NCT02528396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65476345|NCT02528396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476346|NCT03985319|Esomeprazole|esomeprazole|mesh-list
65476347|NCT03985319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65476348|NCT03985319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65476349|NCT03985319|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65476350|NCT03985319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476351|NCT03985319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476352|NCT01237028|Calcitriol|calcitriol|mesh-list
65476353|NCT01237028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65476354|NCT01237028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476355|NCT01237028|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65476356|NCT01237028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65476357|NCT01237028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476358|NCT01237028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65476359|NCT01237028|Vitamins|vitamins|mesh-ancestor
65476360|NCT01237028|Micronutrients|micronutrients|mesh-ancestor
65476361|NCT01237028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65476362|NCT01240850|Prednisone|prednisone|mesh-list
65476363|NCT01240850|Methotrexate|methotrexate|mesh-list
65476364|NCT01240850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65476365|NCT01240850|Glucocorticoids|glucocorticoids|mesh-ancestor
65476366|NCT01240850|Hormones|hormones|mesh-ancestor
65476367|NCT01240850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65476368|NCT01240850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476369|NCT01240850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65476370|NCT01240850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476371|NCT01240850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65476372|NCT01240850|Abortifacient Agents|abortifacient agents|mesh-ancestor
65273222|NCT04202471|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65476373|NCT01240850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65476374|NCT01240850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65476375|NCT01240850|Antimetabolites|antimetabolites|mesh-ancestor
65476376|NCT01240850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476377|NCT01240850|Dermatologic Agents|dermatologic agents|mesh-ancestor
65476378|NCT01240850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476379|NCT01240850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65476380|NCT01240850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65476381|NCT01240850|Immunologic Factors|immunologic factors|mesh-ancestor
65476382|NCT01240850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65476396|NCT04813016|Adrenergic Agents|adrenergic agents|mesh-ancestor
65476397|NCT04813016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65476398|NCT04813016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476399|NCT04813016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65476400|NCT04813016|Narcotics|narcotics|mesh-ancestor
65225958|NCT00769132|Niacin|niacin|mesh-list
65476401|NCT00368927|Sulindac|sulindac|mesh-list
65476402|NCT00368927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65476403|NCT00368927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65476404|NCT00368927|Analgesics|analgesics|mesh-ancestor
65476405|NCT00368927|Sensory System Agents|sensory system agents|mesh-ancestor
65476406|NCT00368927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65476407|NCT00368927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476408|NCT00368927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65476409|NCT00368927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65476410|NCT00368927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476411|NCT00368927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65476412|NCT00368927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476413|NCT00368927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476414|NCT01242410|Silicon|silicon|mesh-list
65476415|NCT01242410|Trace Elements|trace elements|mesh-ancestor
65476416|NCT01242410|Micronutrients|micronutrients|mesh-ancestor
65476417|NCT01242410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476418|NCT02655692|Ketamine|ketamine|mesh-list
65476419|NCT02655692|Analgesics|analgesics|mesh-ancestor
65476420|NCT02655692|Sensory System Agents|sensory system agents|mesh-ancestor
65476421|NCT02655692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65476422|NCT02655692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476423|NCT02655692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65476424|NCT02655692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65476425|NCT02655692|Anesthetics, General|anesthetics, general|mesh-ancestor
65476426|NCT02655692|Anesthetics|anesthetics|mesh-ancestor
65476427|NCT02655692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65476428|NCT02655692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65476429|NCT02655692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65476430|NCT02655692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65476431|NCT02655692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476432|NCT01237262|Adalimumab|adalimumab|mesh-list
65476433|NCT01237262|Etanercept|etanercept|mesh-list
65476434|NCT01237262|Infliximab|infliximab|mesh-list
65476435|NCT01237262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65476436|NCT01237262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65476437|NCT01237262|Dermatologic Agents|dermatologic agents|mesh-ancestor
65476438|NCT01237262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65476439|NCT01237262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65476440|NCT01237262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65476441|NCT01237262|Analgesics|analgesics|mesh-ancestor
65476442|NCT01237262|Sensory System Agents|sensory system agents|mesh-ancestor
65476443|NCT01237262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65476450|NCT01329770|Tocopherols|tocopherols|mesh-list
65476451|NCT01329770|alpha-Tocopherol|alpha-tocopherol|mesh-list
65476452|NCT01329770|Micronutrients|micronutrients|mesh-ancestor
65476453|NCT01329770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476454|NCT01329770|Antioxidants|antioxidants|mesh-ancestor
65476455|NCT01329770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476456|NCT01329770|Protective Agents|protective agents|mesh-ancestor
65476457|NCT01048385|Ubiquinone|ubiquinone|mesh-list
65476458|NCT01048385|Coenzyme Q10|coenzyme q10|mesh-list
65476459|NCT01048385|Micronutrients|micronutrients|mesh-ancestor
65476460|NCT01048385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476461|NCT01048385|Vitamins|vitamins|mesh-ancestor
65476462|NCT03916640|Insulin Lispro|insulin lispro|mesh-list
65476463|NCT03916640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65476464|NCT03916640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476465|NCT03916250|Petrolatum|petrolatum|mesh-list
65273223|NCT04202471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65476466|NCT03916250|PF-06700841|pf-06700841|mesh-list
65476467|NCT03916250|Emollients|emollients|mesh-ancestor
65476468|NCT03916250|Dermatologic Agents|dermatologic agents|mesh-ancestor
65476469|NCT03916250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65476470|NCT03916250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476471|NCT03916250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476472|NCT01062503|Zoledronic Acid|zoledronic acid|mesh-list
65476473|NCT01062503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65476474|NCT01062503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476475|NCT03916406|Midazolam|midazolam|mesh-list
65225990|NCT00779038|Fentanyl|fentanyl|mesh-list
65476476|NCT03916406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65476477|NCT03916406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65476478|NCT03916406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65476479|NCT03916406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476480|NCT03916406|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65476481|NCT03916406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65476482|NCT03916406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65476483|NCT03916406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65476484|NCT03916406|Anesthetics, General|anesthetics, general|mesh-ancestor
65476485|NCT03916406|Anesthetics|anesthetics|mesh-ancestor
65476486|NCT03916406|GABA Modulators|gaba modulators|mesh-ancestor
65476487|NCT03916406|GABA Agents|gaba agents|mesh-ancestor
65476488|NCT03916406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65476489|NCT03916406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476490|NCT00316277|Opiate Alkaloids|opiate alkaloids|mesh-list
65476491|NCT00316277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65476492|NCT00316277|Narcotics|narcotics|mesh-ancestor
65476493|NCT00316277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65476494|NCT00316277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476495|NCT00316277|Analgesics|analgesics|mesh-ancestor
65476496|NCT00316277|Sensory System Agents|sensory system agents|mesh-ancestor
65476497|NCT00316277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65476498|NCT01249352|Fluorouracil|fluorouracil|mesh-list
65476499|NCT01249352|Nimotuzumab|nimotuzumab|mesh-list
65476500|NCT01249352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476501|NCT01249352|Antimetabolites|antimetabolites|mesh-ancestor
65476502|NCT01249352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476503|NCT01249352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65476504|NCT01249352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65476505|NCT01249352|Immunologic Factors|immunologic factors|mesh-ancestor
65476506|NCT01249352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476507|NCT01249352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65476508|NCT03912974|Citalopram|citalopram|mesh-list
65476509|NCT03912974|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65476510|NCT03912974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65476511|NCT03912974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65476512|NCT03912974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476513|NCT03912974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65476514|NCT03912974|Serotonin Agents|serotonin agents|mesh-ancestor
65476516|NCT03912974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65476517|NCT03912974|Antidepressive Agents|antidepressive agents|mesh-ancestor
65476519|NCT00368849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65476520|NCT00368849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65476521|NCT00368849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65476522|NCT00368849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65476523|NCT00368849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476524|NCT00368849|Adrenergic Agents|adrenergic agents|mesh-ancestor
65476525|NCT00368849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65476526|NCT00368849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476527|NCT01144676|Dapivirine|dapivirine|mesh-list
65476528|NCT01144676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65476529|NCT01144676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65476530|NCT01144676|Antiviral Agents|antiviral agents|mesh-ancestor
65476531|NCT01144676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65476532|NCT00316199|Gemcitabine|gemcitabine|mesh-list
65476533|NCT00316199|Paclitaxel|paclitaxel|mesh-list
65476534|NCT00316199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65476535|NCT00316199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476536|NCT00316199|Tubulin Modulators|tubulin modulators|mesh-ancestor
65476537|NCT00316199|Antimitotic Agents|antimitotic agents|mesh-ancestor
65476538|NCT00316199|Mitosis Modulators|mitosis modulators|mesh-ancestor
65476539|NCT00316199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476540|NCT00316199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65476541|NCT00316199|Antimetabolites|antimetabolites|mesh-ancestor
65476542|NCT00316199|Antiviral Agents|antiviral agents|mesh-ancestor
65476543|NCT00316199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65476544|NCT00316199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476545|NCT00316199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65476546|NCT00316199|Immunologic Factors|immunologic factors|mesh-ancestor
65476547|NCT00316199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476548|NCT01147718|Digoxin|digoxin|mesh-list
65476549|NCT01147718|rGLP-1 protein|rglp-1 protein|mesh-list
65476550|NCT01147718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65476551|NCT01147718|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65476552|NCT01147718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476553|NCT01147718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476554|NCT01147718|Protective Agents|protective agents|mesh-ancestor
65476555|NCT01147718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476556|NCT01147718|Incretins|incretins|mesh-ancestor
65476557|NCT01147718|Hormones|hormones|mesh-ancestor
65476558|NCT01147718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65476559|NCT03913052|Viscosupplements|viscosupplements|mesh-list
65476560|NCT03913052|Protective Agents|protective agents|mesh-ancestor
65476561|NCT03913052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476562|NCT03915938|Ketamine|ketamine|mesh-list
65476563|NCT03915938|Analgesics|analgesics|mesh-ancestor
65476564|NCT03915938|Sensory System Agents|sensory system agents|mesh-ancestor
65476565|NCT03915938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65476566|NCT03915938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476567|NCT03915938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65476568|NCT03915938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65476569|NCT03915938|Anesthetics, General|anesthetics, general|mesh-ancestor
65476570|NCT03915938|Anesthetics|anesthetics|mesh-ancestor
65476571|NCT03915938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65476572|NCT03915938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65476573|NCT03915938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65476574|NCT03915938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65476575|NCT03915938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476576|NCT01237496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65476577|NCT01237496|Antiviral Agents|antiviral agents|mesh-ancestor
65476578|NCT01237496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65476579|NCT01251458|Sirolimus|sirolimus|mesh-list
65476580|NCT01251458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65476581|NCT01251458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65476582|NCT01251458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65476583|NCT01251458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476584|NCT01251458|Antifungal Agents|antifungal agents|mesh-ancestor
65476585|NCT01251458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65476586|NCT01251458|Immunologic Factors|immunologic factors|mesh-ancestor
65476587|NCT01251458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476598|NCT03912740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65476599|NCT03912740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65476600|NCT03912740|Adrenergic Agents|adrenergic agents|mesh-ancestor
65476601|NCT03912740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65476602|NCT03912740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476603|NCT03912740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65476605|NCT01058915|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65476606|NCT01058915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65476607|NCT01058915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65476608|NCT01058915|Antimetabolites|antimetabolites|mesh-ancestor
65476609|NCT01058915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476610|NCT01058915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65476611|NCT01058915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65476612|NCT01058915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476613|NCT01144754|Rituximab|rituximab|mesh-list
65476614|NCT01144754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65476615|NCT01144754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476616|NCT01144754|Immunologic Factors|immunologic factors|mesh-ancestor
65476617|NCT01144754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476618|NCT01144754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65476619|NCT01144832|Ebastine|ebastine|mesh-list
65476620|NCT01144832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65476621|NCT01144832|Histamine Antagonists|histamine antagonists|mesh-ancestor
65476622|NCT01144832|Histamine Agents|histamine agents|mesh-ancestor
65476623|NCT01144832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65273224|NCT04202471|Disinfectants|disinfectants|mesh-ancestor
65476624|NCT01144832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476625|NCT01144832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476626|NCT01251848|Ritonavir|ritonavir|mesh-list
65476627|NCT01251848|Sitaxsentan|sitaxsentan|mesh-list
65476628|NCT01251848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65476629|NCT01251848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65476630|NCT01251848|Protease Inhibitors|protease inhibitors|mesh-ancestor
65476631|NCT01251848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476632|NCT01251848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476633|NCT01251848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65476634|NCT01251848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65476635|NCT01251848|Antiviral Agents|antiviral agents|mesh-ancestor
65476636|NCT01251848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65476637|NCT01251848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65476638|NCT01251848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65476639|NCT01251848|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65476640|NCT01251926|Bevacizumab|bevacizumab|mesh-list
65476641|NCT01251926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65476642|NCT01251926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476643|NCT01251926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65476644|NCT01251926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65476645|NCT01251926|Growth Substances|growth substances|mesh-ancestor
65476646|NCT01251926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476647|NCT01251926|Growth Inhibitors|growth inhibitors|mesh-ancestor
65476648|NCT03911648|Lidocaine|lidocaine|mesh-list
65476649|NCT03911648|Bupivacaine|bupivacaine|mesh-list
65476650|NCT03911648|Anesthetics, Local|anesthetics, local|mesh-ancestor
65476651|NCT03911648|Anesthetics|anesthetics|mesh-ancestor
65476653|NCT03911648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476654|NCT03911648|Sensory System Agents|sensory system agents|mesh-ancestor
65476655|NCT03911648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65476656|NCT03911648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65476657|NCT03911648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65476658|NCT03911648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65476659|NCT03911648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65476660|NCT03911648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476661|NCT01237730|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65476662|NCT01237730|Cefuroxime|cefuroxime|mesh-list
65476663|NCT01237730|Cefuroxime axetil|cefuroxime axetil|mesh-list
65476664|NCT01237730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65476665|NCT01148030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
65476666|NCT01148030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65476667|NCT01252160|Capsaicin|capsaicin|mesh-list
65476668|NCT01252160|Antipruritics|antipruritics|mesh-ancestor
65476669|NCT01252160|Dermatologic Agents|dermatologic agents|mesh-ancestor
65476670|NCT01252160|Sensory System Agents|sensory system agents|mesh-ancestor
65476671|NCT01252160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65476672|NCT01252160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476673|NCT00337103|Capecitabine|capecitabine|mesh-list
65476674|NCT00337103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65476675|NCT00337103|Antimetabolites|antimetabolites|mesh-ancestor
65476676|NCT00337103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476677|NCT00337103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476678|NCT03911570|Acetaminophen|acetaminophen|mesh-list
65476679|NCT03911570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65476680|NCT03911570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65476681|NCT03911570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65476682|NCT03911570|Analgesics|analgesics|mesh-ancestor
65476683|NCT03911570|Sensory System Agents|sensory system agents|mesh-ancestor
65476684|NCT03911570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65476685|NCT03911570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476686|NCT03911570|Antipyretics|antipyretics|mesh-ancestor
65476687|NCT03911570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65476688|NCT01250366|Ribavirin|ribavirin|mesh-list
65476689|NCT01250366|Antimetabolites|antimetabolites|mesh-ancestor
65476690|NCT01250366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476691|NCT01250366|Antiviral Agents|antiviral agents|mesh-ancestor
65476692|NCT01250366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65476693|NCT00075504|Gemcitabine|gemcitabine|mesh-list
65476694|NCT00075504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65476695|NCT00075504|Antimetabolites|antimetabolites|mesh-ancestor
65476696|NCT00075504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476697|NCT00075504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476698|NCT00075504|Antiviral Agents|antiviral agents|mesh-ancestor
65476699|NCT00075504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65476700|NCT00075504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476701|NCT00075504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65476702|NCT00075504|Immunologic Factors|immunologic factors|mesh-ancestor
65476703|NCT00075504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476704|NCT01092624|Solifenacin Succinate|solifenacin succinate|mesh-list
65476705|NCT01092624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65476706|NCT01092624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65476707|NCT01092624|Cholinergic Agents|cholinergic agents|mesh-ancestor
65476708|NCT01092624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65476709|NCT01092624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476710|NCT01092624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476711|NCT01092624|Urological Agents|urological agents|mesh-ancestor
65476712|NCT00321464|Zoledronic Acid|zoledronic acid|mesh-list
65476713|NCT00321464|Denosumab|denosumab|mesh-list
65476714|NCT00321464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65476715|NCT00321464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476716|NCT02889796|Adalimumab|adalimumab|mesh-list
65476717|NCT02889796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65476718|NCT02889796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65476719|NCT01237808|Cytarabine|cytarabine|mesh-list
65476720|NCT01237808|Etoposide|etoposide|mesh-list
65476721|NCT01237808|Tretinoin|tretinoin|mesh-list
65476722|NCT01237808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65476723|NCT01237808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476724|NCT01237808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64629295|NCT03968393|Anticoagulants|anticoagulants|mesh-list
65476729|NCT01237808|Antimetabolites|antimetabolites|mesh-ancestor
65476730|NCT01237808|Antiviral Agents|antiviral agents|mesh-ancestor
65476731|NCT01237808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65476732|NCT01237808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65476733|NCT01237808|Immunologic Factors|immunologic factors|mesh-ancestor
65476734|NCT01237808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476735|NCT01237808|Keratolytic Agents|keratolytic agents|mesh-ancestor
65476736|NCT01237808|Dermatologic Agents|dermatologic agents|mesh-ancestor
65476738|NCT03910634|Fluorouracil|fluorouracil|mesh-list
65476739|NCT03910634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476740|NCT03910634|Antimetabolites|antimetabolites|mesh-ancestor
65476741|NCT03910634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476742|NCT03910634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65476743|NCT03910634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65476744|NCT03910634|Immunologic Factors|immunologic factors|mesh-ancestor
65476745|NCT03910634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476746|NCT03910712|Trastuzumab|trastuzumab|mesh-list
65476747|NCT03910712|Letrozole|letrozole|mesh-list
65476748|NCT03910712|Anastrozole|anastrozole|mesh-list
65476749|NCT03910712|Exemestane|exemestane|mesh-list
65476750|NCT03910712|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65476751|NCT03910712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65476752|NCT03910712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476753|NCT03910712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65476754|NCT03910712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476755|NCT03910712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476756|NCT03910712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65476757|NCT03910712|Hormone Antagonists|hormone antagonists|mesh-ancestor
65476758|NCT03910712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65476759|NCT03910712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476760|NCT03910712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65476761|NCT03910556|Propofol|propofol|mesh-list
65476762|NCT03910556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65476763|NCT03910556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65476764|NCT03910556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476765|NCT03910556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65476766|NCT03910556|Anesthetics, General|anesthetics, general|mesh-ancestor
65476767|NCT03910556|Anesthetics|anesthetics|mesh-ancestor
65476768|NCT03659578|Thymalfasin|thymalfasin|mesh-list
65476769|NCT03659578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65476770|NCT03659578|Immunologic Factors|immunologic factors|mesh-ancestor
65476771|NCT03659578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476772|NCT03877354|Anesthetics|anesthetics|mesh-list
65476773|NCT03877354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65476774|NCT03877354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476775|NCT02889562|Warfarin|warfarin|mesh-list
65476776|NCT02889562|Apixaban|apixaban|mesh-list
65226290|NCT01014689|Adapalene|adapalene|mesh-list
65476777|NCT02889562|Anticoagulants|anticoagulants|mesh-ancestor
65476778|NCT02889562|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65476779|NCT02889562|Antithrombins|antithrombins|mesh-ancestor
65476780|NCT02889562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65476781|NCT02889562|Protease Inhibitors|protease inhibitors|mesh-ancestor
65476782|NCT02889562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476783|NCT02889562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476785|NCT03323164|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65476786|NCT03323164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476787|NCT03323164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65476788|NCT03323164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65476789|NCT03323164|Adrenergic Agents|adrenergic agents|mesh-ancestor
65476790|NCT03323164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65476791|NCT03323164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476792|NCT03323164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65476793|NCT03323164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65476794|NCT03323164|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65476803|NCT03914534|GABA Agents|gaba agents|mesh-ancestor
65476804|NCT03914534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65476805|NCT03914534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476806|NCT03914534|Antimanic Agents|antimanic agents|mesh-ancestor
65476807|NCT03914534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65476808|NCT03914534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65476809|NCT03914534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65476810|NCT03910088|Acetaminophen|acetaminophen|mesh-list
65476811|NCT03910088|Hydrocortisone|hydrocortisone|mesh-list
65476812|NCT03910088|Diclofenac|diclofenac|mesh-list
65476813|NCT03910088|Pregabalin|pregabalin|mesh-list
65476814|NCT03910088|Caffeine|caffeine|mesh-list
65476815|NCT03910088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65476816|NCT03910088|Analgesics|analgesics|mesh-ancestor
65476817|NCT03910088|Sensory System Agents|sensory system agents|mesh-ancestor
65476818|NCT03910088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65476819|NCT03910088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476820|NCT03910088|Antipyretics|antipyretics|mesh-ancestor
65476821|NCT03910088|Anticonvulsants|anticonvulsants|mesh-ancestor
65476822|NCT03910088|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65476823|NCT03910088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65476824|NCT03910088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476825|NCT03910088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65476826|NCT03910088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65476827|NCT03910088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65476828|NCT03910088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65476829|NCT03910088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65476830|NCT03910088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65476831|NCT03910088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65476832|NCT03910088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65476833|NCT03910088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476834|NCT03910088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65476835|NCT03910088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65476836|NCT03910088|Purinergic Agents|purinergic agents|mesh-ancestor
65476837|NCT03910088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65476838|NCT03910088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65476839|NCT03910088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65476840|NCT03910088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65476841|NCT03610438|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65476842|NCT03610438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65476843|NCT03610438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476844|NCT03610438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65476845|NCT03908372|Docetaxel|docetaxel|mesh-list
65476846|NCT03908372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476847|NCT03908372|Tubulin Modulators|tubulin modulators|mesh-ancestor
65476848|NCT03908372|Antimitotic Agents|antimitotic agents|mesh-ancestor
65476849|NCT03908372|Mitosis Modulators|mitosis modulators|mesh-ancestor
65476850|NCT03908372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476851|NCT05617664|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65476852|NCT05617664|Mirabegron|mirabegron|mesh-list
65476853|NCT05617664|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65476854|NCT05617664|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65476855|NCT05617664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65476856|NCT05617664|Adrenergic Agents|adrenergic agents|mesh-ancestor
65476857|NCT05617664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65476858|NCT05617664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476859|NCT05617664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274221|NCT02354898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476860|NCT05617664|Urological Agents|urological agents|mesh-ancestor
65476861|NCT05617664|Hemostatics|hemostatics|mesh-ancestor
65476862|NCT05617664|Coagulants|coagulants|mesh-ancestor
65476867|NCT01148264|Olanzapine|olanzapine|mesh-list
65476868|NCT01148264|Metoclopramide|metoclopramide|mesh-list
65476869|NCT01148264|Antiemetics|antiemetics|mesh-ancestor
65476870|NCT01148264|Autonomic Agents|autonomic agents|mesh-ancestor
65476871|NCT01148264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65476872|NCT01148264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476873|NCT01148264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65476874|NCT01148264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65476875|NCT01148264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65476876|NCT01148264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65476877|NCT01148264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65476878|NCT01148264|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65476879|NCT01148264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65476880|NCT01148264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65476881|NCT01148264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476882|NCT01148264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65476883|NCT01148264|Serotonin Agents|serotonin agents|mesh-ancestor
65476884|NCT01148264|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65476885|NCT01148264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65476886|NCT01148264|Dopamine Agents|dopamine agents|mesh-ancestor
65476887|NCT01253252|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65476888|NCT01253252|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65476889|NCT01253252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476890|NCT00086580|Vidarabine|vidarabine|mesh-list
65476891|NCT00086580|Fludarabine|fludarabine|mesh-list
65476892|NCT00086580|Fludarabine phosphate|fludarabine phosphate|mesh-list
65476893|NCT00086580|Alemtuzumab|alemtuzumab|mesh-list
65476894|NCT00086580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476895|NCT00086580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65476896|NCT00086580|Antimetabolites|antimetabolites|mesh-ancestor
65476897|NCT00086580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476898|NCT00086580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65476899|NCT00086580|Immunologic Factors|immunologic factors|mesh-ancestor
65476900|NCT00086580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476901|NCT00086580|Antiviral Agents|antiviral agents|mesh-ancestor
65476902|NCT00086580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65476903|NCT00086580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65476904|NCT03321526|Norepinephrine|norepinephrine|mesh-list
65476905|NCT03321526|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65476906|NCT03321526|Serotonin|serotonin|mesh-list
65476907|NCT03321526|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65476908|NCT03321526|Antidepressive Agents|antidepressive agents|mesh-ancestor
65476909|NCT03321526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65476910|NCT03321526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65476911|NCT03321526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65476912|NCT03321526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65476913|NCT03321526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476914|NCT03321526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65476915|NCT03321526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65476916|NCT03321526|Adrenergic Agents|adrenergic agents|mesh-ancestor
65476917|NCT03321526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65476918|NCT03321526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476919|NCT03321526|Sympathomimetics|sympathomimetics|mesh-ancestor
65476920|NCT03321526|Autonomic Agents|autonomic agents|mesh-ancestor
65476921|NCT03321526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65476922|NCT03321526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65476923|NCT03321526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65476924|NCT03321526|Serotonin Agents|serotonin agents|mesh-ancestor
65476925|NCT03321526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65476926|NCT03321526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65476927|NCT03908528|Thioctic Acid|thioctic acid|mesh-list
65476928|NCT03908528|Cyclophosphamide|cyclophosphamide|mesh-list
65476929|NCT03908528|Doxorubicin|doxorubicin|mesh-list
65476930|NCT03908528|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65476931|NCT03908528|Paclitaxel|paclitaxel|mesh-list
65476932|NCT03908528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65476933|NCT03908528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65476934|NCT03908528|Immunologic Factors|immunologic factors|mesh-ancestor
65476935|NCT03908528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476964|NCT00086502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274222|NCT00110435|Atorvastatin|atorvastatin|mesh-list
65476966|NCT00086502|Hormones|hormones|mesh-ancestor
65476967|NCT00086502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65476968|NCT00086502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65476969|NCT00086502|Protease Inhibitors|protease inhibitors|mesh-ancestor
65476970|NCT00086502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476971|NCT00086502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476972|NCT03903302|Valproic Acid|valproic acid|mesh-list
65476973|NCT03903302|Anticonvulsants|anticonvulsants|mesh-ancestor
65476974|NCT03903302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476975|NCT03903302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476976|NCT03903302|GABA Agents|gaba agents|mesh-ancestor
65476977|NCT03903302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65476978|NCT03903302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476979|NCT03903302|Antimanic Agents|antimanic agents|mesh-ancestor
65476980|NCT03903302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65476981|NCT03903302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65476986|NCT03636542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65476987|NCT03636542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476989|NCT03636542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65476990|NCT00086190|Paroxetine|paroxetine|mesh-list
65476991|NCT00086190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65476992|NCT00086190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65476993|NCT00086190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65476994|NCT00086190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65476995|NCT00086190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476996|NCT00086190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65476997|NCT00086190|Serotonin Agents|serotonin agents|mesh-ancestor
65476998|NCT00086190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476999|NCT00086190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65477000|NCT00086190|Antidepressive Agents|antidepressive agents|mesh-ancestor
65477001|NCT00086190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65477002|NCT00086190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65226516|NCT00711919|Pitavastatin|pitavastatin|mesh-list
65477003|NCT00086190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65477005|NCT00086190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65477006|NCT03275350|Naltrexone|naltrexone|mesh-list
65477007|NCT03275350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65477008|NCT03275350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65477009|NCT03275350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477010|NCT03275350|Sensory System Agents|sensory system agents|mesh-ancestor
65477011|NCT03275350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65477012|NCT01148342|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65477013|NCT01148342|Hallucinogens|hallucinogens|mesh-ancestor
65477014|NCT01148342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477015|NCT01148342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65477016|NCT01148342|Serotonin Agents|serotonin agents|mesh-ancestor
65477017|NCT01148342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65477018|NCT01148342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477019|NCT01148342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65477020|NCT01148342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65477021|NCT01148342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65477022|NCT01148342|Adrenergic Agents|adrenergic agents|mesh-ancestor
65477023|NCT03557242|Aspirin|aspirin|mesh-list
65477024|NCT03557242|Warfarin|warfarin|mesh-list
65477025|NCT03557242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65477026|NCT03557242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65477027|NCT03557242|Analgesics|analgesics|mesh-ancestor
65477028|NCT03557242|Sensory System Agents|sensory system agents|mesh-ancestor
65477029|NCT03557242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65477030|NCT03557242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477031|NCT03557242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65477032|NCT03557242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65477033|NCT03557242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65477034|NCT03557242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65477035|NCT03557242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477036|NCT03557242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65477037|NCT03557242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65477038|NCT03557242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477039|NCT03557242|Antipyretics|antipyretics|mesh-ancestor
65477040|NCT03557242|Anticoagulants|anticoagulants|mesh-ancestor
65477041|NCT04774666|Antibodies|antibodies|mesh-list
65477042|NCT04774666|Immunologic Factors|immunologic factors|mesh-ancestor
65477043|NCT04774666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477044|NCT01150448|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65477045|NCT01150448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65477046|NCT01150448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65477047|NCT01150448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65477048|NCT01150448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477049|NCT01150448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65477050|NCT01150448|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65477055|NCT01150448|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65477056|NCT01150448|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65477057|NCT01150448|Dopamine Agents|dopamine agents|mesh-ancestor
65477058|NCT03898466|Fluticasone|fluticasone|mesh-list
65477059|NCT03898466|Xhance|xhance|mesh-list
65477060|NCT03898466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65477061|NCT03898466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65477062|NCT03898466|Autonomic Agents|autonomic agents|mesh-ancestor
65477063|NCT03898466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65477064|NCT03898466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477065|NCT03898466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65477066|NCT03898466|Respiratory System Agents|respiratory system agents|mesh-ancestor
65477067|NCT03898466|Dermatologic Agents|dermatologic agents|mesh-ancestor
65477068|NCT03898466|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65477069|NCT03907124|Psychotropic Drugs|psychotropic drugs|mesh-list
65477070|NCT02527772|Leucovorin|leucovorin|mesh-list
65477071|NCT02527772|Gemcitabine|gemcitabine|mesh-list
65477072|NCT02527772|Fluorouracil|fluorouracil|mesh-list
65477073|NCT02527772|Doxorubicin|doxorubicin|mesh-list
65477074|NCT02527772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65477075|NCT02527772|Oxaliplatin|oxaliplatin|mesh-list
65477076|NCT02527772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65477077|NCT02527772|Antimetabolites|antimetabolites|mesh-ancestor
65477078|NCT02527772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477079|NCT02527772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477080|NCT02527772|Antiviral Agents|antiviral agents|mesh-ancestor
65477081|NCT02527772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65477082|NCT02527772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477083|NCT02527772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65477084|NCT02527772|Immunologic Factors|immunologic factors|mesh-ancestor
65477085|NCT02527772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477086|NCT02527772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65477087|NCT02527772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65477088|NCT02527772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65477089|NCT02527772|Antidotes|antidotes|mesh-ancestor
65477090|NCT02527772|Protective Agents|protective agents|mesh-ancestor
65477091|NCT02527772|Vitamin B Complex|vitamin b complex|mesh-ancestor
65477092|NCT02527772|Vitamins|vitamins|mesh-ancestor
65477093|NCT02527772|Micronutrients|micronutrients|mesh-ancestor
65477094|NCT03273946|Fluticasone|fluticasone|mesh-list
65477095|NCT03273946|Xhance|xhance|mesh-list
65477096|NCT03273946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65477097|NCT03273946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65477098|NCT03273946|Autonomic Agents|autonomic agents|mesh-ancestor
65477099|NCT03273946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65477100|NCT03273946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477101|NCT03273946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65477102|NCT03273946|Respiratory System Agents|respiratory system agents|mesh-ancestor
65477103|NCT03273946|Dermatologic Agents|dermatologic agents|mesh-ancestor
65477104|NCT03273946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65477105|NCT00660218|Paclitaxel|paclitaxel|mesh-list
65477106|NCT00660218|Cetuximab|cetuximab|mesh-list
65477107|NCT00660218|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
65477108|NCT00660218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65477109|NCT00660218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477110|NCT00660218|Tubulin Modulators|tubulin modulators|mesh-ancestor
65477111|NCT00660218|Antimitotic Agents|antimitotic agents|mesh-ancestor
65477112|NCT00660218|Mitosis Modulators|mitosis modulators|mesh-ancestor
65477113|NCT00660218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477114|NCT00660218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65477115|NCT00314951|Vancomycin|vancomycin|mesh-list
65477116|NCT00314951|Fidaxomicin|fidaxomicin|mesh-list
65477117|NCT00314951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65477118|NCT00314951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65477119|NCT00085644|Adalimumab|adalimumab|mesh-list
65477120|NCT00085644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65477121|NCT00085644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65477122|NCT01257074|Acyclovir|acyclovir|mesh-list
65477123|NCT01257074|Penciclovir|penciclovir|mesh-list
65477124|NCT01257074|Antiviral Agents|antiviral agents|mesh-ancestor
65274223|NCT00110435|Simvastatin|simvastatin|mesh-list
65274224|NCT00110435|Ezetimibe|ezetimibe|mesh-list
65274225|NCT00110435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65477125|NCT01257074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65477133|NCT01086774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65477134|NCT01086774|Lubricant Eye Drops|lubricant eye drops|mesh-list
65477135|NCT01086774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65477137|NCT03902522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65477138|NCT03902522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65477139|NCT03902522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477140|NCT03902522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65477141|NCT03902522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65477142|NCT03902522|Antiviral Agents|antiviral agents|mesh-ancestor
65477143|NCT03902522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65477144|NCT01092858|Methyltestosterone|methyltestosterone|mesh-list
65477145|NCT01092858|Testosterone|testosterone|mesh-list
65477146|NCT01092858|Testosterone undecanoate|testosterone undecanoate|mesh-list
65477147|NCT01092858|Testosterone enanthate|testosterone enanthate|mesh-list
65477148|NCT01092858|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65477149|NCT01092858|Androgens|androgens|mesh-ancestor
65477150|NCT01092858|Hormones|hormones|mesh-ancestor
65477151|NCT01092858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65477152|NCT01092858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477153|NCT01092858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65477154|NCT01092858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477155|NCT01092858|Anabolic Agents|anabolic agents|mesh-ancestor
65477156|NCT00314327|Risperidone|risperidone|mesh-list
65477157|NCT00314327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65477158|NCT00314327|Serotonin Agents|serotonin agents|mesh-ancestor
65477159|NCT00314327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65477160|NCT00314327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477161|NCT00314327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477162|NCT00314327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65477163|NCT00314327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65477164|NCT00314327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65477165|NCT00314327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65477166|NCT00314327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65477167|NCT00314327|Dopamine Agents|dopamine agents|mesh-ancestor
65477168|NCT03897452|Fentanyl|fentanyl|mesh-list
65477169|NCT03897452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65477170|NCT03897452|Narcotics|narcotics|mesh-ancestor
65477171|NCT03897452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65477172|NCT03897452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477173|NCT03897452|Analgesics|analgesics|mesh-ancestor
65477174|NCT03897452|Sensory System Agents|sensory system agents|mesh-ancestor
65477175|NCT03897452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65477176|NCT03897452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65477177|NCT03897452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65477178|NCT03897452|Anesthetics, General|anesthetics, general|mesh-ancestor
65477179|NCT03897452|Anesthetics|anesthetics|mesh-ancestor
65477180|NCT01151072|Insulin|insulin|mesh-list
65477181|NCT01151072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65477182|NCT01151072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477183|NCT01257386|Mesalamine|mesalamine|mesh-list
65477184|NCT01257386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65477185|NCT01257386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65477186|NCT01257386|Analgesics|analgesics|mesh-ancestor
65477187|NCT01257386|Sensory System Agents|sensory system agents|mesh-ancestor
65477188|NCT01257386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65477189|NCT01257386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477190|NCT01257386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65477191|NCT01257386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65477192|NCT01257464|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65477193|NCT01257464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64861206|NCT01758471|Glipizide|glipizide|mesh-list
65477200|NCT01257464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477201|NCT01257464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477202|NCT01255046|Donepezil|donepezil|mesh-list
65477203|NCT01255046|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65477204|NCT01255046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477205|NCT01255046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477206|NCT01255046|Cholinergic Agents|cholinergic agents|mesh-ancestor
65477207|NCT01255046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65477208|NCT01255046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274226|NCT00110435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65477209|NCT01255046|Nootropic Agents|nootropic agents|mesh-ancestor
65477210|NCT01149356|Exemestane|exemestane|mesh-list
65477211|NCT01149356|Goserelin|goserelin|mesh-list
65477212|NCT01149356|R04929097|r04929097|mesh-list
65477213|NCT01149356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477214|NCT01149356|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65477215|NCT01149356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65477216|NCT01149356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477217|NCT01149356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477218|NCT01149356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65477219|NCT01149356|Hormone Antagonists|hormone antagonists|mesh-ancestor
65477220|NCT01149356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65477221|NCT01149356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477222|NCT01149356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65477223|NCT01148576|Vitamin E|vitamin e|mesh-list
65477224|NCT01148576|Entecavir|entecavir|mesh-list
65477225|NCT01148576|Essential 303 forte|essential 303 forte|mesh-list
65477226|NCT01148576|Vitamins|vitamins|mesh-ancestor
65477227|NCT01148576|Micronutrients|micronutrients|mesh-ancestor
65477228|NCT01148576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477229|NCT01148576|Antioxidants|antioxidants|mesh-ancestor
65477230|NCT01148576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477231|NCT01148576|Protective Agents|protective agents|mesh-ancestor
65477232|NCT01148576|Antiviral Agents|antiviral agents|mesh-ancestor
65477233|NCT01148576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65477234|NCT01148576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65477235|NCT01148576|Immunologic Factors|immunologic factors|mesh-ancestor
65477236|NCT01148576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65477237|NCT01148576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65477238|NCT01148576|Antimetabolites|antimetabolites|mesh-ancestor
65477239|NCT01148576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65477240|NCT01148576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65477241|NCT01148576|Antitubercular Agents|antitubercular agents|mesh-ancestor
65477242|NCT01148576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65477243|NCT01148576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65477245|NCT03905486|Analgesics|analgesics|mesh-ancestor
65477246|NCT03905486|Sensory System Agents|sensory system agents|mesh-ancestor
65477247|NCT03905486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65477248|NCT03905486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477249|NCT03905486|Anticonvulsants|anticonvulsants|mesh-ancestor
65477250|NCT03905486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65477251|NCT03905486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65477252|NCT03905486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477253|NCT03905486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65477254|NCT03905486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65477255|NCT03905486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65477256|NCT03905486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65477257|NCT03905486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65477258|NCT03901118|Paclitaxel|paclitaxel|mesh-list
65477259|NCT03901118|Etoposide|etoposide|mesh-list
65477260|NCT03901118|Chiauranib|chiauranib|mesh-list
65477261|NCT03901118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65477262|NCT03901118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477263|NCT03901118|Tubulin Modulators|tubulin modulators|mesh-ancestor
65477268|NCT03901118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65477269|NCT03901118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477270|NCT03901118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65477271|NCT03895892|Caffeine|caffeine|mesh-list
65477272|NCT03895892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65477273|NCT03895892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477274|NCT03895892|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65477275|NCT03895892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477276|NCT03895892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477277|NCT03895892|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65477278|NCT03895892|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65477279|NCT03895892|Purinergic Agents|purinergic agents|mesh-ancestor
65477280|NCT03895892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65477281|NCT01151306|Simvastatin|simvastatin|mesh-list
65477282|NCT01151306|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65477283|NCT01151306|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65477284|NCT01151306|Antimetabolites|antimetabolites|mesh-ancestor
65477285|NCT01151306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477286|NCT01151306|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65274227|NCT00110435|Antimetabolites|antimetabolites|mesh-ancestor
65477287|NCT01151306|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65477288|NCT01151306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477289|NCT05570786|Gestrinone|gestrinone|mesh-list
65477290|NCT05570786|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65477291|NCT05570786|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65477292|NCT05570786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65477293|NCT05570786|Contraceptive Agents|contraceptive agents|mesh-ancestor
65477294|NCT05570786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65477295|NCT05570786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477296|NCT05570786|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65477297|NCT05570786|Progestins|progestins|mesh-ancestor
65477298|NCT05570786|Hormones|hormones|mesh-ancestor
65477299|NCT05570786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65477300|NCT03895970|Pembrolizumab|pembrolizumab|mesh-list
65477301|NCT03895970|Lenvatinib|lenvatinib|mesh-list
65477302|NCT03895970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65477303|NCT03895970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477304|NCT03895970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65477305|NCT03895970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477306|NCT03895970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477307|NCT00336479|Interferons|interferons|mesh-list
65477308|NCT00336479|Ribavirin|ribavirin|mesh-list
65477309|NCT00336479|Interferon-alpha|interferon-alpha|mesh-list
65477310|NCT00336479|Interferon alpha-2|interferon alpha-2|mesh-list
65477311|NCT00336479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65477312|NCT00336479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477313|NCT00336479|Antiviral Agents|antiviral agents|mesh-ancestor
65477314|NCT00336479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65477315|NCT00336479|Antimetabolites|antimetabolites|mesh-ancestor
65477316|NCT00336479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477317|NCT00336479|Immunologic Factors|immunologic factors|mesh-ancestor
65477318|NCT00336479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477319|NCT03905564|Pyridoxine|pyridoxine|mesh-list
65477320|NCT03905564|Vitamin B 6|vitamin b 6|mesh-list
65477321|NCT03905564|Doxylamine|doxylamine|mesh-list
65477322|NCT03905564|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
65477323|NCT03905564|Doxylamine succinate|doxylamine succinate|mesh-list
65477324|NCT03905564|Vitamin B Complex|vitamin b complex|mesh-ancestor
65477325|NCT03905564|Vitamins|vitamins|mesh-ancestor
65477326|NCT03905564|Micronutrients|micronutrients|mesh-ancestor
65477327|NCT03905564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477328|NCT03905564|Antiemetics|antiemetics|mesh-ancestor
65477329|NCT03905564|Autonomic Agents|autonomic agents|mesh-ancestor
65477330|NCT03905564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65477331|NCT03905564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65477332|NCT03905564|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65477333|NCT03905564|Histamine Antagonists|histamine antagonists|mesh-ancestor
65477334|NCT03905564|Histamine Agents|histamine agents|mesh-ancestor
65477340|NCT01151384|Antimitotic Agents|antimitotic agents|mesh-ancestor
65477341|NCT01151384|Mitosis Modulators|mitosis modulators|mesh-ancestor
65477342|NCT01151384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477344|NCT01258010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65477345|NCT01258010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65477346|NCT01258010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477347|NCT01258010|Hemostatics|hemostatics|mesh-ancestor
65477348|NCT01258010|Coagulants|coagulants|mesh-ancestor
65477349|NCT00314249|Milnacipran|milnacipran|mesh-list
65477350|NCT00314249|Levomilnacipran|levomilnacipran|mesh-list
65477351|NCT00314249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65477352|NCT00314249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65477353|NCT00314249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65477354|NCT00314249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477355|NCT00314249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65477356|NCT00314249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477357|NCT00314249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65477358|NCT00314249|Analgesics|analgesics|mesh-ancestor
65477359|NCT00314249|Sensory System Agents|sensory system agents|mesh-ancestor
65477360|NCT00314249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65477361|NCT00314249|Antidepressive Agents|antidepressive agents|mesh-ancestor
65477362|NCT00314249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65477363|NCT03905018|Tadalafil|tadalafil|mesh-list
65477364|NCT03905018|Vasodilator Agents|vasodilator agents|mesh-ancestor
65477365|NCT03905018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64471360|NCT04585711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65477366|NCT03905018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65477367|NCT03905018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477368|NCT03905018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477369|NCT03905018|Urological Agents|urological agents|mesh-ancestor
65477370|NCT03894722|Povidone-Iodine|povidone-iodine|mesh-list
65477371|NCT03894722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65477372|NCT03894722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65477373|NCT03894800|Fentanyl|fentanyl|mesh-list
65477374|NCT03894800|Methoxyflurane|methoxyflurane|mesh-list
65477375|NCT03894800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65477376|NCT03894800|Narcotics|narcotics|mesh-ancestor
65477377|NCT03894800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65477378|NCT03894800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477379|NCT03894800|Analgesics|analgesics|mesh-ancestor
65477380|NCT03894800|Sensory System Agents|sensory system agents|mesh-ancestor
65477381|NCT03894800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65477382|NCT03894800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65477383|NCT03894800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65477384|NCT03894800|Anesthetics, General|anesthetics, general|mesh-ancestor
65477385|NCT03894800|Anesthetics|anesthetics|mesh-ancestor
65477386|NCT03894800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65477387|NCT03900026|Evolocumab|evolocumab|mesh-list
65477388|NCT03900026|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65477389|NCT03900026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65477390|NCT03900026|Antimetabolites|antimetabolites|mesh-ancestor
65477391|NCT03900026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477392|NCT03900026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65477393|NCT01149668|Abexinostat|abexinostat|mesh-list
65477394|NCT01149668|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65477395|NCT01149668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477396|NCT01149668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477397|NCT01149746|Tamsulosin|tamsulosin|mesh-list
65477398|NCT01149746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65477399|NCT01149746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65477400|NCT01149746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65477401|NCT01149746|Adrenergic Agents|adrenergic agents|mesh-ancestor
65477402|NCT01149746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64861424|NCT01759875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65477407|NCT01149824|Hallucinogens|hallucinogens|mesh-ancestor
65477408|NCT01149824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477409|NCT01149824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65477410|NCT01149902|Cyclophosphamide|cyclophosphamide|mesh-list
65477411|NCT01149902|Docetaxel|docetaxel|mesh-list
65477412|NCT01149902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65477413|NCT01149902|Immunologic Factors|immunologic factors|mesh-ancestor
65477414|NCT01149902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477415|NCT01149902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65477416|NCT01149902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65477417|NCT01149902|Alkylating Agents|alkylating agents|mesh-ancestor
65477418|NCT01149902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477419|NCT01149902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477420|NCT01149902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65477421|NCT01149902|Tubulin Modulators|tubulin modulators|mesh-ancestor
65477422|NCT01149902|Antimitotic Agents|antimitotic agents|mesh-ancestor
65477423|NCT01149902|Mitosis Modulators|mitosis modulators|mesh-ancestor
65477424|NCT01151696|Hydroxyzine|hydroxyzine|mesh-list
65477425|NCT01151696|Antipruritics|antipruritics|mesh-ancestor
65477426|NCT01151696|Dermatologic Agents|dermatologic agents|mesh-ancestor
65477427|NCT01151696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65477428|NCT01151696|Histamine Antagonists|histamine antagonists|mesh-ancestor
65477429|NCT01151696|Histamine Agents|histamine agents|mesh-ancestor
65477430|NCT01151696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65477431|NCT01151696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477432|NCT01151696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477433|NCT01149980|Dexetimide|dexetimide|mesh-list
65477434|NCT01149980|Citalopram|citalopram|mesh-list
65477435|NCT01149980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65477436|NCT01149980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65477437|NCT01149980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65477438|NCT01149980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477439|NCT01149980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65477440|NCT01149980|Serotonin Agents|serotonin agents|mesh-ancestor
65477441|NCT01149980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274228|NCT00110435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477442|NCT01149980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65477443|NCT01149980|Antidepressive Agents|antidepressive agents|mesh-ancestor
65477444|NCT01149980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65477445|NCT01149980|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65477446|NCT01149980|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65477447|NCT01149980|Parasympatholytics|parasympatholytics|mesh-ancestor
65477448|NCT01149980|Autonomic Agents|autonomic agents|mesh-ancestor
65477449|NCT01149980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65477450|NCT01149980|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65477451|NCT01149980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65477452|NCT01149980|Cholinergic Agents|cholinergic agents|mesh-ancestor
65477453|NCT01258322|Pioglitazone|pioglitazone|mesh-list
65477454|NCT01258322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65477455|NCT01258322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477456|NCT01255358|Dexamethasone|dexamethasone|mesh-list
65477457|NCT01255358|Dexamethasone acetate|dexamethasone acetate|mesh-list
65477458|NCT01255358|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65477459|NCT01255358|BB 1101|bb 1101|mesh-list
65477460|NCT01255358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65477461|NCT01255358|Antiemetics|antiemetics|mesh-ancestor
65477462|NCT01255358|Autonomic Agents|autonomic agents|mesh-ancestor
65477463|NCT01255358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65477464|NCT01255358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477465|NCT01255358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65477466|NCT01255358|Glucocorticoids|glucocorticoids|mesh-ancestor
65477467|NCT01255358|Hormones|hormones|mesh-ancestor
65477468|NCT01255358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65477469|NCT01255358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65477470|NCT01255358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477471|NCT01255358|Protease Inhibitors|protease inhibitors|mesh-ancestor
65477472|NCT01255358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861491|NCT01760161|Ropivacaine|ropivacaine|mesh-list
65477481|NCT03893864|Coenzyme Q10|coenzyme q10|mesh-list
65477482|NCT03893864|Antioxidants|antioxidants|mesh-list
65477483|NCT03893864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477484|NCT03893864|Protective Agents|protective agents|mesh-ancestor
65477485|NCT03893864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477486|NCT03893864|Micronutrients|micronutrients|mesh-ancestor
65477487|NCT03893864|Vitamins|vitamins|mesh-ancestor
65477488|NCT03899324|Bumetanide|bumetanide|mesh-list
65477489|NCT03899324|Diuretics|diuretics|mesh-ancestor
65477490|NCT03899324|Natriuretic Agents|natriuretic agents|mesh-ancestor
65477491|NCT03899324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477492|NCT03899324|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65477493|NCT03899324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65477494|NCT03899324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477495|NCT01148966|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65477496|NCT01148966|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65477497|NCT01148966|Dermatologic Agents|dermatologic agents|mesh-ancestor
65477498|NCT01258634|Leucovorin|leucovorin|mesh-list
65477499|NCT01258634|Doxorubicin|doxorubicin|mesh-list
65477500|NCT01258634|Etoposide|etoposide|mesh-list
65477501|NCT01258634|Ifosfamide|ifosfamide|mesh-list
65477502|NCT01258634|Dexrazoxane|dexrazoxane|mesh-list
65477503|NCT01258634|Razoxane|razoxane|mesh-list
65477504|NCT01258634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477505|NCT01258634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65477506|NCT01258634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65477507|NCT01258634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65477508|NCT01258634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477509|NCT01258634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477510|NCT01258634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65477511|NCT01258634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477512|NCT01258634|Antidotes|antidotes|mesh-ancestor
65477513|NCT01258634|Protective Agents|protective agents|mesh-ancestor
65477514|NCT01258634|Vitamin B Complex|vitamin b complex|mesh-ancestor
65477515|NCT01258634|Vitamins|vitamins|mesh-ancestor
65477516|NCT01258634|Micronutrients|micronutrients|mesh-ancestor
65477517|NCT01258634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65477518|NCT01258634|Alkylating Agents|alkylating agents|mesh-ancestor
65477519|NCT01258634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65477520|NCT01258634|Antimitotic Agents|antimitotic agents|mesh-ancestor
65477521|NCT01258634|Mitosis Modulators|mitosis modulators|mesh-ancestor
65477522|NCT01258712|Methotrexate|methotrexate|mesh-list
65477523|NCT01258712|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65477524|NCT01258712|Abortifacient Agents|abortifacient agents|mesh-ancestor
65477525|NCT01258712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65477526|NCT01258712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477527|NCT01258712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65477528|NCT01258712|Antimetabolites|antimetabolites|mesh-ancestor
65477529|NCT01258712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477530|NCT01258712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477531|NCT01258712|Dermatologic Agents|dermatologic agents|mesh-ancestor
65477532|NCT01258712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477533|NCT01258712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65477534|NCT01258712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65477535|NCT01258712|Immunologic Factors|immunologic factors|mesh-ancestor
65477536|NCT01258712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65477537|NCT01258712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65477538|NCT01258868|Celecoxib|celecoxib|mesh-list
65477539|NCT01258868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65477540|NCT01258868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65477545|NCT01258868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65477546|NCT01258868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65477547|NCT01258868|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65477548|NCT01258868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65477549|NCT01258868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477550|NCT01258868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477551|NCT01254578|Lenalidomide|lenalidomide|mesh-list
65477552|NCT01254578|Immunologic Factors|immunologic factors|mesh-ancestor
65477553|NCT01254578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477554|NCT01254578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65477555|NCT01254578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65477556|NCT01254578|Growth Substances|growth substances|mesh-ancestor
65477557|NCT01254578|Growth Inhibitors|growth inhibitors|mesh-ancestor
65477558|NCT01254578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477559|NCT03892928|Dexmedetomidine|dexmedetomidine|mesh-list
65477561|NCT03892928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65477562|NCT03892928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65477563|NCT03892928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477564|NCT03892928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65477565|NCT03892928|Anesthetics, General|anesthetics, general|mesh-ancestor
65477566|NCT03892928|Anesthetics|anesthetics|mesh-ancestor
65477567|NCT03892928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65477568|NCT03892928|Analgesics|analgesics|mesh-ancestor
65477569|NCT03892928|Sensory System Agents|sensory system agents|mesh-ancestor
65477570|NCT03892928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65477571|NCT03892928|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65477572|NCT03892928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65477573|NCT03892928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65477574|NCT03892928|Adrenergic Agents|adrenergic agents|mesh-ancestor
65477575|NCT03892928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65477576|NCT03892928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477577|NCT01152242|Insulin Glargine|insulin glargine|mesh-list
65477578|NCT01152242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65477579|NCT01152242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477580|NCT03341806|Avelumab|avelumab|mesh-list
65477581|NCT03341806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65477582|NCT03341806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477583|NCT03904004|Botulinum Toxins|botulinum toxins|mesh-list
65477584|NCT03904004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65477585|NCT03904004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65477586|NCT03904004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477587|NCT03904004|Cholinergic Agents|cholinergic agents|mesh-ancestor
65477588|NCT03904004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65477589|NCT03904004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477590|NCT01149122|Gemcitabine|gemcitabine|mesh-list
65477591|NCT01149122|Oxaliplatin|oxaliplatin|mesh-list
65477592|NCT01149122|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65477593|NCT01149122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65477594|NCT01149122|Antimetabolites|antimetabolites|mesh-ancestor
65477595|NCT01149122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477596|NCT01149122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477597|NCT01149122|Antiviral Agents|antiviral agents|mesh-ancestor
65477598|NCT01149122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65477599|NCT01149122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477600|NCT01149122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65477601|NCT01149122|Immunologic Factors|immunologic factors|mesh-ancestor
65477602|NCT01149122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477603|NCT01149122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65477604|NCT03892148|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65477605|NCT03892148|Furosemide|furosemide|mesh-list
65477606|NCT03892148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65477607|NCT03892148|Diuretics|diuretics|mesh-ancestor
65477608|NCT03892148|Natriuretic Agents|natriuretic agents|mesh-ancestor
65477609|NCT03892148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477610|NCT03892148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65477626|NCT03892070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477628|NCT01155440|Anesthetics, Local|anesthetics, local|mesh-ancestor
65477629|NCT01155440|Anesthetics|anesthetics|mesh-ancestor
65477630|NCT01155440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65477631|NCT01155440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477632|NCT01155440|Sensory System Agents|sensory system agents|mesh-ancestor
65477633|NCT01155440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65477634|NCT01155440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65477635|NCT01155440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65477636|NCT01155440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65477637|NCT01155440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65477638|NCT01155440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477639|NCT01259336|Itraconazole|itraconazole|mesh-list
65477640|NCT01259336|Antifungal Agents|antifungal agents|mesh-ancestor
65477641|NCT01259336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65477642|NCT01259336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65477643|NCT01259336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65477644|NCT01259336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477645|NCT01259336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477646|NCT01259336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65477647|NCT01259336|Hormone Antagonists|hormone antagonists|mesh-ancestor
65477648|NCT01259336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65477649|NCT01259336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477650|NCT01259336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65477651|NCT01259414|Ethiodized Oil|ethiodized oil|mesh-list
65477652|NCT01259414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477653|NCT03314662|Vaccines|vaccines|mesh-list
65477654|NCT03314662|MF59 oil emulsion|mf59 oil emulsion|mesh-list
65477655|NCT03314662|Immunologic Factors|immunologic factors|mesh-ancestor
65477656|NCT03314662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477657|NCT03314662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65477658|NCT01152710|Capecitabine|capecitabine|mesh-list
65477659|NCT01152710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65477660|NCT01152710|Antimetabolites|antimetabolites|mesh-ancestor
65477661|NCT01152710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477662|NCT01152710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477663|NCT03271528|Lacosamide|lacosamide|mesh-list
65477664|NCT03271528|Anticonvulsants|anticonvulsants|mesh-ancestor
65477665|NCT03271528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65477666|NCT03271528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65477667|NCT03271528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65477668|NCT03271528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477678|NCT04480372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65477679|NCT04480372|Immunologic Factors|immunologic factors|mesh-ancestor
65227194|NCT04096690|Antibodies|antibodies|mesh-list
65477680|NCT04480372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477682|NCT04462276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477683|NCT03890510|Anesthetics|anesthetics|mesh-list
65477684|NCT03890510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65477685|NCT03890510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477686|NCT01152866|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65477687|NCT01152866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65477688|NCT01152866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477689|NCT01153568|Vitamin D|vitamin d|mesh-list
65477690|NCT01153568|Cholecalciferol|cholecalciferol|mesh-list
65477691|NCT01153568|Vitamins|vitamins|mesh-ancestor
65477692|NCT01153568|Micronutrients|micronutrients|mesh-ancestor
65477693|NCT01153568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477694|NCT01153568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65477695|NCT01153568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65477696|NCT03889808|Antitoxins|antitoxins|mesh-list
65477697|NCT03889808|Immunologic Factors|immunologic factors|mesh-ancestor
65477698|NCT03889808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477699|NCT03890042|Dienogest|dienogest|mesh-list
65477700|NCT03890042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65477701|NCT03890042|Gestodene|gestodene|mesh-list
65477702|NCT03890042|Femovan|femovan|mesh-list
65477703|NCT03890042|Estradiol|estradiol|mesh-list
65477704|NCT03890042|Estrogens|estrogens|mesh-ancestor
65477705|NCT03890042|Hormones|hormones|mesh-ancestor
65477706|NCT03890042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65477707|NCT03890042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477708|NCT03890042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65477709|NCT03890042|Contraceptive Agents|contraceptive agents|mesh-ancestor
65477710|NCT03890042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65477711|NCT03890042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65477712|NCT03890042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65477713|NCT03890042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65477714|NCT03890042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65477715|NCT03890042|Hormone Antagonists|hormone antagonists|mesh-ancestor
65477716|NCT03890042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65477717|NCT03890042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477718|NCT03890042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65477719|NCT03890042|Progestins|progestins|mesh-ancestor
65477720|NCT03890042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65477721|NCT01153802|Dopamine|dopamine|mesh-list
65477722|NCT01153802|Norepinephrine|norepinephrine|mesh-list
65477723|NCT01153802|Serotonin|serotonin|mesh-list
65477724|NCT01153802|Neurotransmitter Agents|neurotransmitter agents|mesh-list
65477725|NCT01153802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65477726|NCT01153802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65477727|NCT01153802|Adrenergic Agents|adrenergic agents|mesh-ancestor
65477728|NCT01153802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477729|NCT01153802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477730|NCT01153802|Sympathomimetics|sympathomimetics|mesh-ancestor
65477731|NCT01153802|Autonomic Agents|autonomic agents|mesh-ancestor
65477732|NCT01153802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65477733|NCT01153802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65477734|NCT01153802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65477735|NCT01153802|Dopamine Agents|dopamine agents|mesh-ancestor
65477736|NCT01153802|Protective Agents|protective agents|mesh-ancestor
65477759|NCT01153334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65477760|NCT01153334|Antimetabolites|antimetabolites|mesh-ancestor
65477761|NCT01153334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477762|NCT01153334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65477763|NCT01153334|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65477764|NCT01153334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477765|NCT01153880|Mupirocin|mupirocin|mesh-list
65477766|NCT01153880|Retapamulin|retapamulin|mesh-list
65477767|NCT01153880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65477768|NCT01153880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65477769|NCT01153880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65477770|NCT01153880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477771|NCT01153880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477772|NCT01260506|Bevacizumab|bevacizumab|mesh-list
65477773|NCT01260506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65477774|NCT01260506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477775|NCT01260506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65477776|NCT01260506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65477777|NCT01260506|Growth Substances|growth substances|mesh-ancestor
65477778|NCT01260506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477779|NCT01260506|Growth Inhibitors|growth inhibitors|mesh-ancestor
65477780|NCT03884972|Venetoclax|venetoclax|mesh-list
65477781|NCT03884972|Trabectedin|trabectedin|mesh-list
65477782|NCT03884972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477783|NCT03884972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65477784|NCT03884972|Alkylating Agents|alkylating agents|mesh-ancestor
65477785|NCT03884972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477786|NCT01154114|Darapladib|darapladib|mesh-list
65477787|NCT01154114|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
65477796|NCT01157312|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65477797|NCT01157312|Chelating Agents|chelating agents|mesh-ancestor
65477798|NCT01157312|Sequestering Agents|sequestering agents|mesh-ancestor
65477799|NCT01157312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477800|NCT01157312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65477801|NCT01157312|Hormone Antagonists|hormone antagonists|mesh-ancestor
65477802|NCT01157312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65477803|NCT01157312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477804|NCT01157312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65477805|NCT01157312|Fertility Agents|fertility agents|mesh-ancestor
65274229|NCT00110435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65477806|NCT01157312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65477807|NCT01157312|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65477808|NCT01157312|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65477809|NCT01157546|Lidocaine|lidocaine|mesh-list
65477810|NCT01157546|Anesthetics, Local|anesthetics, local|mesh-ancestor
65477811|NCT01157546|Anesthetics|anesthetics|mesh-ancestor
65477812|NCT01157546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65477813|NCT01157546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477814|NCT01157546|Sensory System Agents|sensory system agents|mesh-ancestor
65477815|NCT01157546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65477816|NCT01157546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65477817|NCT01157546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65477818|NCT01157546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65477819|NCT01157546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65477820|NCT01157546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477821|NCT02527460|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65477822|NCT02527460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65477823|NCT01263860|Ribavirin|ribavirin|mesh-list
65477824|NCT01263860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65477825|NCT01263860|Interferon-alpha|interferon-alpha|mesh-list
65477826|NCT01263860|Antimetabolites|antimetabolites|mesh-ancestor
65477827|NCT01263860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477828|NCT01263860|Antiviral Agents|antiviral agents|mesh-ancestor
65477829|NCT01263860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65477830|NCT01263860|Immunologic Factors|immunologic factors|mesh-ancestor
65477831|NCT01263860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477832|NCT03881306|Oxaliplatin|oxaliplatin|mesh-list
65477833|NCT03881306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477834|NCT01154348|Metformin|metformin|mesh-list
65477835|NCT01154348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65477836|NCT01154348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477837|NCT00075270|Paclitaxel|paclitaxel|mesh-list
65477838|NCT00075270|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65477839|NCT00075270|Lapatinib|lapatinib|mesh-list
65477840|NCT00075270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65477841|NCT00075270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477842|NCT00075270|Tubulin Modulators|tubulin modulators|mesh-ancestor
65477843|NCT00075270|Antimitotic Agents|antimitotic agents|mesh-ancestor
65477844|NCT00075270|Mitosis Modulators|mitosis modulators|mesh-ancestor
65477845|NCT00075270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477846|NCT00075270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65477847|NCT00075270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477848|NCT01264094|Clevudine|clevudine|mesh-list
65477849|NCT01264094|Antiviral Agents|antiviral agents|mesh-ancestor
65477850|NCT01264094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65477851|NCT03884348|Amoxicillin|amoxicillin|mesh-list
65477852|NCT03884348|Metronidazole|metronidazole|mesh-list
65477853|NCT03884348|Clarithromycin|clarithromycin|mesh-list
65477854|NCT03884348|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65477855|NCT03884348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64861879|NCT01761994|Nafamostat|nafamostat|mesh-list
65477864|NCT01154426|Gemcitabine|gemcitabine|mesh-list
65477865|NCT01154426|Veliparib|veliparib|mesh-list
65477866|NCT01154426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65477867|NCT01154426|Antimetabolites|antimetabolites|mesh-ancestor
65477868|NCT01154426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477869|NCT01154426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477870|NCT01154426|Antiviral Agents|antiviral agents|mesh-ancestor
65477871|NCT01154426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65477872|NCT01154426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477873|NCT01154426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65477874|NCT01154426|Immunologic Factors|immunologic factors|mesh-ancestor
65477875|NCT01154426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477876|NCT01154426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65477877|NCT01589744|Hemostatics|hemostatics|mesh-list
65477878|NCT01589744|Coagulants|coagulants|mesh-ancestor
65477879|NCT01154504|Adrenomedullin|adrenomedullin|mesh-list
65477880|NCT01154504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65477881|NCT01154504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65477882|NCT01154504|Autonomic Agents|autonomic agents|mesh-ancestor
65477883|NCT01154504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65477884|NCT01154504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477885|NCT01154504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65477886|NCT01154504|Respiratory System Agents|respiratory system agents|mesh-ancestor
64475774|NCT00455650|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
65477887|NCT01154504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65477888|NCT01154504|Vasodilator Agents|vasodilator agents|mesh-ancestor
65477889|NCT01154504|Protective Agents|protective agents|mesh-ancestor
65477890|NCT03880916|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65477891|NCT03880916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65477892|NCT03880916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65477893|NCT03880916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65477894|NCT03880916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477895|NCT03880916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65477896|NCT03880916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477897|NCT03880916|Analgesics|analgesics|mesh-ancestor
65477898|NCT03880916|Sensory System Agents|sensory system agents|mesh-ancestor
65477899|NCT03880916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65477900|NCT03880916|Antidepressive Agents|antidepressive agents|mesh-ancestor
65477901|NCT03880916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65477902|NCT03880916|Dopamine Agents|dopamine agents|mesh-ancestor
65477903|NCT01155908|Amlodipine|amlodipine|mesh-list
65477904|NCT01155908|Benazepril|benazepril|mesh-list
65477905|NCT01155908|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65477906|NCT01155908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65477907|NCT01155908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65477908|NCT01155908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477909|NCT01155908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65477910|NCT01155908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477911|NCT01155908|Vasodilator Agents|vasodilator agents|mesh-ancestor
65477912|NCT01155908|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65477913|NCT01155908|Protease Inhibitors|protease inhibitors|mesh-ancestor
65477914|NCT01155908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477915|NCT03880448|Metronidazole|metronidazole|mesh-list
65477916|NCT03880448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65477917|NCT03880448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65477918|NCT03880448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65477919|NCT03880448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65477920|NCT03298984|Cytarabine|cytarabine|mesh-list
65477930|NCT03298984|Immunologic Factors|immunologic factors|mesh-ancestor
65477931|NCT03298984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477932|NCT03298984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65477933|NCT03298984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65477934|NCT03298984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65477935|NCT03298984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477936|NCT03298984|Growth Inhibitors|growth inhibitors|mesh-ancestor
65477937|NCT03298984|Growth Substances|growth substances|mesh-ancestor
65477938|NCT03298984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65477939|NCT03883880|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65477941|NCT03883880|Antipruritics|antipruritics|mesh-ancestor
65477942|NCT03883880|Dermatologic Agents|dermatologic agents|mesh-ancestor
65477943|NCT03883880|Sensory System Agents|sensory system agents|mesh-ancestor
65477944|NCT03883880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65477945|NCT03883880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477946|NCT03883880|Antioxidants|antioxidants|mesh-ancestor
65477947|NCT03883880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477948|NCT03883880|Protective Agents|protective agents|mesh-ancestor
65477949|NCT03883880|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65477950|NCT03883880|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65477951|NCT03883880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477952|NCT03883880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65477953|NCT03887858|Tamsulosin|tamsulosin|mesh-list
65477954|NCT03887858|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65477955|NCT03887858|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65477956|NCT03887858|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65477957|NCT03887858|Adrenergic Agents|adrenergic agents|mesh-ancestor
65477958|NCT03887858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65477959|NCT03887858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477960|NCT03887858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477961|NCT03887858|Urological Agents|urological agents|mesh-ancestor
65477962|NCT02940574|Oxytocin|oxytocin|mesh-list
65477963|NCT02940574|Oxytocics|oxytocics|mesh-ancestor
65477964|NCT02940574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65477965|NCT02940574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477966|NCT01264328|Paclitaxel|paclitaxel|mesh-list
65477967|NCT01264328|Panitumumab|panitumumab|mesh-list
65477968|NCT01264328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65274230|NCT00110435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65477969|NCT01264328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477970|NCT01264328|Tubulin Modulators|tubulin modulators|mesh-ancestor
65477971|NCT01264328|Antimitotic Agents|antimitotic agents|mesh-ancestor
65477972|NCT01264328|Mitosis Modulators|mitosis modulators|mesh-ancestor
65477973|NCT01264328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477974|NCT01264328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65477975|NCT01157858|Everolimus|everolimus|mesh-list
65477976|NCT01157858|Octreotide|octreotide|mesh-list
65477977|NCT01157858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477978|NCT01157858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65477979|NCT01157858|Immunologic Factors|immunologic factors|mesh-ancestor
65477980|NCT01157858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477981|NCT01157858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65477982|NCT01157858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65477983|NCT01157936|Allopurinol|allopurinol|mesh-list
65477984|NCT01157936|Antimetabolites|antimetabolites|mesh-ancestor
65477985|NCT01157936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477986|NCT01157936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477997|NCT01264484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477999|NCT01260818|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65478000|NCT01260818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65478001|NCT01260818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478002|NCT01260818|Hemostatics|hemostatics|mesh-ancestor
65478003|NCT01260818|Coagulants|coagulants|mesh-ancestor
65478004|NCT01262612|Cediranib|cediranib|mesh-list
65478005|NCT01262612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65478006|NCT01262612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65478007|NCT01262612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478008|NCT01262612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478009|NCT01158014|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65478010|NCT01158014|Hemostatics|hemostatics|mesh-ancestor
65478011|NCT01158014|Coagulants|coagulants|mesh-ancestor
65478012|NCT03884036|Vitamin D|vitamin d|mesh-list
65478013|NCT03884036|Vitamins|vitamins|mesh-ancestor
65478014|NCT03884036|Micronutrients|micronutrients|mesh-ancestor
65478015|NCT03884036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478016|NCT03884036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65478017|NCT01158170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65478018|NCT01158170|Gefitinib|gefitinib|mesh-list
65478019|NCT01158170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65478020|NCT01158170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65478021|NCT01158170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478022|NCT01158170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478023|NCT01260974|Caspofungin|caspofungin|mesh-list
65478024|NCT01260974|Antifungal Agents|antifungal agents|mesh-ancestor
65478025|NCT01260974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65478026|NCT01260974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478027|NCT01260974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478028|NCT01264640|Aspirin|aspirin|mesh-list
65478029|NCT01264640|Clopidogrel|clopidogrel|mesh-list
65478030|NCT01264640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65478031|NCT01264640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65478032|NCT01264640|Analgesics|analgesics|mesh-ancestor
65478033|NCT01264640|Sensory System Agents|sensory system agents|mesh-ancestor
65478034|NCT01264640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65478035|NCT01264640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478036|NCT01264640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65478037|NCT01264640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65478038|NCT01264640|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65478039|NCT01264640|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65478040|NCT01264640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478041|NCT01264640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65478042|NCT01264640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65478043|NCT01264640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478044|NCT01264640|Antipyretics|antipyretics|mesh-ancestor
65478045|NCT01264640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65478046|NCT01264640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65478047|NCT01264640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65478048|NCT01264640|Purinergic Agents|purinergic agents|mesh-ancestor
65478049|NCT01264640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65478050|NCT01155986|Lidocaine|lidocaine|mesh-list
65478051|NCT01155986|Anesthetics, Local|anesthetics, local|mesh-ancestor
65478057|NCT01155986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65478058|NCT01155986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65478059|NCT01155986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65478060|NCT01155986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65478061|NCT01155986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478062|NCT01261130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65478063|NCT01261130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65478064|NCT01261130|Immunologic Factors|immunologic factors|mesh-ancestor
65478065|NCT01261130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478066|NCT01261130|Antacids|antacids|mesh-ancestor
65478067|NCT01261130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478068|NCT01261130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65478069|NCT01158248|Panitumumab|panitumumab|mesh-list
65478070|NCT01158248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65478071|NCT01158248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65478072|NCT01264874|Vitamin D|vitamin d|mesh-list
65478073|NCT01264874|Cholecalciferol|cholecalciferol|mesh-list
65478074|NCT01264874|Vitamins|vitamins|mesh-ancestor
65478075|NCT01264874|Micronutrients|micronutrients|mesh-ancestor
65478076|NCT01264874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478077|NCT01264874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65478078|NCT01264874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65478079|NCT01262924|Vaccines|vaccines|mesh-list
65478080|NCT01262924|Immunologic Factors|immunologic factors|mesh-ancestor
65478081|NCT01262924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478082|NCT01158560|Vitamin D|vitamin d|mesh-list
65478083|NCT01158560|Cholecalciferol|cholecalciferol|mesh-list
65478084|NCT01158560|Vitamins|vitamins|mesh-ancestor
65478085|NCT01158560|Micronutrients|micronutrients|mesh-ancestor
65478086|NCT01158560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478087|NCT01158560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65478088|NCT01158560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65478089|NCT03879746|Paroxetine|paroxetine|mesh-list
65478090|NCT03879746|Tamsulosin|tamsulosin|mesh-list
65478091|NCT03879746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65478092|NCT03879746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65478093|NCT03879746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65478094|NCT03879746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478095|NCT03879746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65478096|NCT03879746|Serotonin Agents|serotonin agents|mesh-ancestor
65478097|NCT03879746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478098|NCT03879746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65478099|NCT03879746|Antidepressive Agents|antidepressive agents|mesh-ancestor
65478100|NCT03879746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65478101|NCT03879746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65478102|NCT03879746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65478103|NCT03879746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478104|NCT03879746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65478105|NCT03879746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65478106|NCT03879746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65478107|NCT03879746|Adrenergic Agents|adrenergic agents|mesh-ancestor
65478108|NCT03879746|Urological Agents|urological agents|mesh-ancestor
65478109|NCT03879590|Budesonide|budesonide|mesh-list
65478110|NCT03879590|Doxofylline|doxofylline|mesh-list
65478111|NCT03879590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65478112|NCT03879590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65478113|NCT03879590|Autonomic Agents|autonomic agents|mesh-ancestor
65478114|NCT03879590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65478115|NCT03879590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478116|NCT03879590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65478117|NCT03879590|Respiratory System Agents|respiratory system agents|mesh-ancestor
65478118|NCT03879590|Glucocorticoids|glucocorticoids|mesh-ancestor
65478120|NCT03879590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65478121|NCT03879590|Antitussive Agents|antitussive agents|mesh-ancestor
65478122|NCT03879590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65478123|NCT03879590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478124|NCT03879590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478125|NCT01265108|Iron|iron|mesh-list
65478126|NCT01265108|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65478127|NCT01265108|Trace Elements|trace elements|mesh-ancestor
65478128|NCT01265108|Micronutrients|micronutrients|mesh-ancestor
65478129|NCT01265108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478131|NCT01154738|Lidocaine|lidocaine|mesh-list
65274231|NCT00110435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478132|NCT01154738|Anesthetics, Local|anesthetics, local|mesh-ancestor
65478133|NCT01154738|Anesthetics|anesthetics|mesh-ancestor
65478134|NCT01154738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65478135|NCT01154738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478136|NCT01154738|Sensory System Agents|sensory system agents|mesh-ancestor
65478137|NCT01154738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65478138|NCT01154738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65478139|NCT01154738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65478140|NCT01154738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65478141|NCT01154738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65478142|NCT01154738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478143|NCT01263002|Adefovir|adefovir|mesh-list
65478144|NCT01263002|Clevudine|clevudine|mesh-list
65478145|NCT01263002|Antiviral Agents|antiviral agents|mesh-ancestor
65478146|NCT01263002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65478147|NCT01263002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65478148|NCT01263002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65478149|NCT01263002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478150|NCT01263002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478151|NCT01261286|Verapamil|verapamil|mesh-list
65478152|NCT01261286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65478153|NCT01261286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65478154|NCT01261286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65478155|NCT01261286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478156|NCT01261286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65478157|NCT01261286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478158|NCT01261286|Vasodilator Agents|vasodilator agents|mesh-ancestor
65478159|NCT01263080|Folic Acid|folic acid|mesh-list
65478160|NCT01263080|Vitamin B Complex|vitamin b complex|mesh-list
65478161|NCT01263080|Mirtazapine|mirtazapine|mesh-list
65478162|NCT01263080|Vitamins|vitamins|mesh-ancestor
65478163|NCT01263080|Micronutrients|micronutrients|mesh-ancestor
65478164|NCT01263080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478165|NCT01263080|Hematinics|hematinics|mesh-ancestor
65478166|NCT01263080|Antidepressive Agents|antidepressive agents|mesh-ancestor
65478167|NCT01263080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65478168|NCT01263080|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65478169|NCT01263080|Histamine Antagonists|histamine antagonists|mesh-ancestor
65478170|NCT01263080|Histamine Agents|histamine agents|mesh-ancestor
65478171|NCT01263080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65478172|NCT01263080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478173|NCT01263080|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65478174|NCT01263080|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65478175|NCT01263080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65478176|NCT01263080|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65478177|NCT01263080|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65478178|NCT01263080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65478179|NCT01263080|Adrenergic Agents|adrenergic agents|mesh-ancestor
65478180|NCT01263080|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65478181|NCT01263080|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65478182|NCT01263080|Serotonin Agents|serotonin agents|mesh-ancestor
65478183|NCT01263080|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65478184|NCT01263158|Oxytocin|oxytocin|mesh-list
65478185|NCT01263158|Oxytocics|oxytocics|mesh-ancestor
65478186|NCT01263158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65478187|NCT01263158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478188|NCT03879356|Acetylcysteine|acetylcysteine|mesh-list
65478189|NCT03879356|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65478190|NCT03879356|Antiviral Agents|antiviral agents|mesh-ancestor
65478191|NCT03879356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65478192|NCT03879356|Expectorants|expectorants|mesh-ancestor
65478193|NCT03879356|Respiratory System Agents|respiratory system agents|mesh-ancestor
65227723|NCT00577993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65478203|NCT01159418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65478204|NCT01159418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65478206|NCT01159418|Antimitotic Agents|antimitotic agents|mesh-ancestor
65478207|NCT01159418|Mitosis Modulators|mitosis modulators|mesh-ancestor
65478208|NCT01159418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478209|NCT01159418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65478210|NCT01159418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478211|NCT03886766|Efavirenz|efavirenz|mesh-list
65478212|NCT03886766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65478213|NCT03886766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65478214|NCT03886766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478215|NCT03886766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478216|NCT03886766|Antiviral Agents|antiviral agents|mesh-ancestor
65478217|NCT03886766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65478218|NCT03886766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65478219|NCT03886766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65478220|NCT03886766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65478221|NCT03886766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65478222|NCT03886766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65478223|NCT03886766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65478224|NCT01265342|Beclomethasone|beclomethasone|mesh-list
65478225|NCT01265342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65478226|NCT01265342|Glucocorticoids|glucocorticoids|mesh-ancestor
65478227|NCT01265342|Hormones|hormones|mesh-ancestor
65478228|NCT01265342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65478229|NCT01265342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478230|NCT01265342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65478231|NCT01265342|Respiratory System Agents|respiratory system agents|mesh-ancestor
65478232|NCT03883334|Inosine Pranobex|inosine pranobex|mesh-list
65478233|NCT03883334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65478234|NCT03883334|Immunologic Factors|immunologic factors|mesh-ancestor
65478235|NCT03883334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478236|NCT03883334|Antiviral Agents|antiviral agents|mesh-ancestor
65478237|NCT03883334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65478238|NCT01265576|Etodolac|etodolac|mesh-list
65478239|NCT01265576|Sorafenib|sorafenib|mesh-list
65478240|NCT01265576|Propranolol|propranolol|mesh-list
65478241|NCT01265576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65478242|NCT01265576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65478243|NCT01265576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478244|NCT01265576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478245|NCT01265576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65478246|NCT01265576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65478247|NCT01265576|Adrenergic Agents|adrenergic agents|mesh-ancestor
65478248|NCT01265576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65478249|NCT01265576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478250|NCT01265576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65478251|NCT01265576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65478252|NCT01265576|Vasodilator Agents|vasodilator agents|mesh-ancestor
65478253|NCT01265576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65478254|NCT01265576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65478255|NCT01265576|Analgesics|analgesics|mesh-ancestor
65478256|NCT01265576|Sensory System Agents|sensory system agents|mesh-ancestor
65478257|NCT01265576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65478267|NCT01159652|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65478268|NCT01159652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65478269|NCT01159652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65478270|NCT01159652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478271|NCT01159652|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65478272|NCT01159652|GABA Agonists|gaba agonists|mesh-ancestor
65478273|NCT01159652|GABA Agents|gaba agents|mesh-ancestor
65478274|NCT01159652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65478275|NCT01159652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478276|NCT01159652|Anticonvulsants|anticonvulsants|mesh-ancestor
65478277|NCT01159652|GABA Modulators|gaba modulators|mesh-ancestor
65478279|NCT01261832|Clopidogrel|clopidogrel|mesh-list
65478280|NCT01261832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65478281|NCT01261832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65478282|NCT01261832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65478283|NCT01261832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65478284|NCT01261832|Purinergic Agents|purinergic agents|mesh-ancestor
65478285|NCT01261832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65478286|NCT01261832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478287|NCT01261832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478288|NCT01261832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65478289|NCT01261832|Autonomic Agents|autonomic agents|mesh-ancestor
65478290|NCT01261832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65478291|NCT01261832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65478292|NCT01261832|Respiratory System Agents|respiratory system agents|mesh-ancestor
65478293|NCT01261832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65478294|NCT01261832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65478295|NCT01261832|Vasodilator Agents|vasodilator agents|mesh-ancestor
65478296|NCT01261832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65478297|NCT01261832|Protective Agents|protective agents|mesh-ancestor
65478298|NCT01261832|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65478299|NCT01261832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65478300|NCT01261832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478301|NCT01265810|Calcium|calcium|mesh-list
65478302|NCT01265810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65478303|NCT01265810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478304|NCT01265888|Nitric Oxide|nitric oxide|mesh-list
65478305|NCT01265888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65478306|NCT01265888|Autonomic Agents|autonomic agents|mesh-ancestor
65478307|NCT01265888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65478308|NCT01265888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478309|NCT01265888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65478310|NCT01265888|Respiratory System Agents|respiratory system agents|mesh-ancestor
65478311|NCT01265888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65478312|NCT01265888|Antioxidants|antioxidants|mesh-ancestor
65478313|NCT01265888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478314|NCT01265888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65478315|NCT01265888|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65478316|NCT01265888|Vasodilator Agents|vasodilator agents|mesh-ancestor
65478317|NCT01265888|Gasotransmitters|gasotransmitters|mesh-ancestor
65478318|NCT01265888|Protective Agents|protective agents|mesh-ancestor
65478319|NCT01155206|Glucagon|glucagon|mesh-list
65478320|NCT01155206|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65478321|NCT01155206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65478322|NCT01155206|Hormones|hormones|mesh-ancestor
65478323|NCT01155206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65478324|NCT01155206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478341|NCT03882710|Autonomic Agents|autonomic agents|mesh-ancestor
65478342|NCT03882710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65478343|NCT03882710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478344|NCT03882710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65478345|NCT03882710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65478346|NCT03882710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65478347|NCT03882710|Adrenergic Agents|adrenergic agents|mesh-ancestor
65478348|NCT03882710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65478349|NCT03882710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478350|NCT01161836|Iniparib|iniparib|mesh-list
65227878|NCT00603525|Ofatumumab|ofatumumab|mesh-list
65478351|NCT01161836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65478352|NCT01161836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478353|NCT01161836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478354|NCT01161836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65478355|NCT01266434|Simvastatin|simvastatin|mesh-list
65478356|NCT01266434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65478357|NCT01266434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65478358|NCT01266434|Antimetabolites|antimetabolites|mesh-ancestor
65478359|NCT01266434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478360|NCT01266434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65478361|NCT01266434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65478362|NCT01266434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478363|NCT01266512|Docetaxel|docetaxel|mesh-list
65478364|NCT01266512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65478365|NCT01266512|Tubulin Modulators|tubulin modulators|mesh-ancestor
65478366|NCT01266512|Antimitotic Agents|antimitotic agents|mesh-ancestor
65478367|NCT01266512|Mitosis Modulators|mitosis modulators|mesh-ancestor
65478368|NCT01266512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478369|NCT01160042|Metformin|metformin|mesh-list
65478370|NCT01160042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65478371|NCT01160042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478372|NCT03882788|Fentanyl|fentanyl|mesh-list
65478373|NCT03882788|Isoflurane|isoflurane|mesh-list
65478374|NCT03882788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65478375|NCT03882788|Narcotics|narcotics|mesh-ancestor
65478376|NCT03882788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65478377|NCT03882788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478378|NCT03882788|Analgesics|analgesics|mesh-ancestor
65478379|NCT03882788|Sensory System Agents|sensory system agents|mesh-ancestor
65478380|NCT03882788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65478381|NCT03882788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65478382|NCT03882788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65478383|NCT03882788|Anesthetics, General|anesthetics, general|mesh-ancestor
65478388|NCT01156688|Abortifacient Agents|abortifacient agents|mesh-ancestor
65274232|NCT00093899|Simvastatin|simvastatin|mesh-list
65478389|NCT01156688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65478390|NCT01156688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478391|NCT01156688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65478392|NCT01156688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65478393|NCT01156688|Oxytocics|oxytocics|mesh-ancestor
65478394|NCT03876704|Vitamins|vitamins|mesh-list
65478395|NCT03876704|Micronutrients|micronutrients|mesh-ancestor
65478396|NCT03876704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478397|NCT03878654|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
65478398|NCT03878654|Antiviral Agents|antiviral agents|mesh-ancestor
65478399|NCT03878654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65478400|NCT03878654|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65478401|NCT03878654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65478402|NCT03878264|Cortisone|cortisone|mesh-list
65478403|NCT03878264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65478404|NCT03882164|Tacrolimus|tacrolimus|mesh-list
65478405|NCT03882164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65478406|NCT03882164|Immunologic Factors|immunologic factors|mesh-ancestor
65478407|NCT03882164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478408|NCT03882164|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65478409|NCT03882164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478410|NCT03882164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478411|NCT01160276|Cyclosporine|cyclosporine|mesh-list
65478412|NCT01160276|Colchicine|colchicine|mesh-list
65478413|NCT01160276|Tacrolimus|tacrolimus|mesh-list
65478414|NCT01160276|Cyclosporins|cyclosporins|mesh-list
65478415|NCT01160276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65478416|NCT01160276|Immunologic Factors|immunologic factors|mesh-ancestor
65478417|NCT01160276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478418|NCT01160276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65478419|NCT01160276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478420|NCT01160276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478421|NCT01160276|Antifungal Agents|antifungal agents|mesh-ancestor
65478422|NCT01160276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65478423|NCT01160276|Dermatologic Agents|dermatologic agents|mesh-ancestor
65478424|NCT01160276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65478425|NCT01160276|Gout Suppressants|gout suppressants|mesh-ancestor
65478426|NCT01160276|Tubulin Modulators|tubulin modulators|mesh-ancestor
65478427|NCT01160276|Antimitotic Agents|antimitotic agents|mesh-ancestor
65478428|NCT01160276|Mitosis Modulators|mitosis modulators|mesh-ancestor
65478429|NCT01160276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65478430|NCT01263548|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65478431|NCT01263548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65478432|NCT01263548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478433|NCT01263548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65478434|NCT01263548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65478435|NCT01263548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65478436|NCT01263548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478437|NCT01263548|Dopamine Agents|dopamine agents|mesh-ancestor
65478438|NCT01263548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65478440|NCT01160432|Naloxone|naloxone|mesh-list
65478441|NCT01160432|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65478442|NCT01160432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478443|NCT01160432|Sensory System Agents|sensory system agents|mesh-ancestor
65478444|NCT01160432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65478445|NCT01160432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65478446|NCT01160432|Narcotics|narcotics|mesh-ancestor
65478447|NCT01160432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65478448|NCT01160432|Analgesics|analgesics|mesh-ancestor
65478449|NCT01160432|Antitussive Agents|antitussive agents|mesh-ancestor
65478450|NCT01160432|Respiratory System Agents|respiratory system agents|mesh-ancestor
65478451|NCT03877718|Promethazine|promethazine|mesh-list
65478452|NCT03877718|Diphenhydramine|diphenhydramine|mesh-list
65478453|NCT03877718|Sumatriptan|sumatriptan|mesh-list
65478454|NCT03877718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65478455|NCT03877718|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65478456|NCT03877718|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65478457|NCT03877718|Serotonin Agents|serotonin agents|mesh-ancestor
65478463|NCT03877718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65478464|NCT03877718|Histamine Antagonists|histamine antagonists|mesh-ancestor
65478465|NCT03877718|Histamine Agents|histamine agents|mesh-ancestor
65478466|NCT03877718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65478467|NCT03877718|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65478468|NCT03877718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65478469|NCT03877718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65274233|NCT00093899|Ezetimibe|ezetimibe|mesh-list
65274234|NCT00093899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65478470|NCT03877718|Anesthetics, Local|anesthetics, local|mesh-ancestor
65478471|NCT03877718|Anesthetics|anesthetics|mesh-ancestor
65478472|NCT03877718|Sensory System Agents|sensory system agents|mesh-ancestor
65478473|NCT03877718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65478474|NCT03877718|Antiemetics|antiemetics|mesh-ancestor
65478475|NCT03877718|Autonomic Agents|autonomic agents|mesh-ancestor
65478476|NCT03877718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65478477|NCT01267058|Vaccines|vaccines|mesh-list
65478478|NCT01267058|Immunologic Factors|immunologic factors|mesh-ancestor
65478479|NCT01267058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478480|NCT02526914|Vasopressins|vasopressins|mesh-list
65478481|NCT02526914|Arginine Vasopressin|arginine vasopressin|mesh-list
65478482|NCT02526914|Oxytocin|oxytocin|mesh-list
65478483|NCT02526914|Oxytocics|oxytocics|mesh-ancestor
65478484|NCT02526914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65478485|NCT02526914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478486|NCT02526914|Hemostatics|hemostatics|mesh-ancestor
65478487|NCT02526914|Coagulants|coagulants|mesh-ancestor
65478488|NCT02526914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65478489|NCT02526914|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65478490|NCT02526914|Natriuretic Agents|natriuretic agents|mesh-ancestor
65478491|NCT03876938|Olanzapine|olanzapine|mesh-list
65478492|NCT03876938|Aprepitant|aprepitant|mesh-list
65478493|NCT03876938|Antiemetics|antiemetics|mesh-ancestor
65478494|NCT03876938|Autonomic Agents|autonomic agents|mesh-ancestor
65478495|NCT03876938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65478496|NCT03876938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478497|NCT03876938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65478498|NCT03876938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65478499|NCT03876938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65478500|NCT03876938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65478501|NCT03876938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65478502|NCT03876938|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65228025|NCT00754624|Insulin|insulin|mesh-list
65478503|NCT03876938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65478504|NCT03876938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65478505|NCT03876938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478506|NCT03876938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65478508|NCT03876938|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65478509|NCT01162460|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
65478510|NCT01162460|Anticonvulsants|anticonvulsants|mesh-ancestor
65478511|NCT01162460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65478512|NCT01162460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65478513|NCT01162460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65478514|NCT01162460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478515|NCT03882008|Abatacept|abatacept|mesh-list
65478516|NCT03882008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65478517|NCT03882008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478518|NCT03882008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65478519|NCT03882008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65478520|NCT03882008|Immunologic Factors|immunologic factors|mesh-ancestor
65478521|NCT03882008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478522|NCT03882008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65478523|NCT01267214|Hyaluronic Acid|hyaluronic acid|mesh-list
65478524|NCT01267214|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65478525|NCT01267214|Immunologic Factors|immunologic factors|mesh-ancestor
65478526|NCT01267214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478527|NCT01267214|Viscosupplements|viscosupplements|mesh-ancestor
65478530|NCT01156922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65478531|NCT01156922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65478532|NCT01156922|Immunologic Factors|immunologic factors|mesh-ancestor
65478533|NCT01156922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478534|NCT01156922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65478535|NCT03877874|Terbutaline|terbutaline|mesh-list
65478536|NCT03877874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65478537|NCT03877874|Autonomic Agents|autonomic agents|mesh-ancestor
65478538|NCT03877874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65478539|NCT03877874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478540|NCT03877874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65478541|NCT03877874|Respiratory System Agents|respiratory system agents|mesh-ancestor
65478542|NCT03877874|Sympathomimetics|sympathomimetics|mesh-ancestor
65478543|NCT03877874|Tocolytic Agents|tocolytic agents|mesh-ancestor
65478544|NCT03877874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65274235|NCT00093899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65478545|NCT03877874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65478546|NCT03877874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65478547|NCT03877874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65478548|NCT03877874|Adrenergic Agents|adrenergic agents|mesh-ancestor
65478549|NCT03877874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65478550|NCT03877874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478551|NCT01160588|Sertraline|sertraline|mesh-list
65478552|NCT01160588|Antidepressive Agents|antidepressive agents|mesh-ancestor
65478553|NCT01160588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65478554|NCT01160588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65478555|NCT01160588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65478556|NCT01160588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65478557|NCT01160588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478558|NCT01160588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65478559|NCT01160588|Serotonin Agents|serotonin agents|mesh-ancestor
65478560|NCT01160588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478561|NCT03877562|Olanzapine|olanzapine|mesh-list
65478562|NCT03877562|Antiemetics|antiemetics|mesh-ancestor
65478563|NCT03877562|Autonomic Agents|autonomic agents|mesh-ancestor
65478564|NCT03877562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65478565|NCT03877562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478566|NCT03877562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65478567|NCT03877562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65478568|NCT03877562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65478569|NCT03877562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65478570|NCT03877562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65478571|NCT03877562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65478572|NCT03877562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65478573|NCT03877562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65478574|NCT03877562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228096|NCT02682693|Cyclophosphamide|cyclophosphamide|mesh-list
65478575|NCT03877562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65478576|NCT03877562|Serotonin Agents|serotonin agents|mesh-ancestor
65478577|NCT01160666|Belimumab|belimumab|mesh-list
65478578|NCT01160666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65478579|NCT01160666|Immunologic Factors|immunologic factors|mesh-ancestor
65478580|NCT01160666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478581|NCT03876548|Iodine|iodine|mesh-list
65478582|NCT03876548|Cadexomer iodine|cadexomer iodine|mesh-list
65478583|NCT03876548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65478584|NCT03876548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65478585|NCT03876548|Trace Elements|trace elements|mesh-ancestor
65478586|NCT03876548|Micronutrients|micronutrients|mesh-ancestor
65478587|NCT03876548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478588|NCT03760250|Imiquimod|imiquimod|mesh-list
65478589|NCT03760250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65478590|NCT03760250|Immunologic Factors|immunologic factors|mesh-ancestor
65478591|NCT03760250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478592|NCT03760250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65478593|NCT03760250|Interferon Inducers|interferon inducers|mesh-ancestor
65478594|NCT01157000|Canagliflozin|canagliflozin|mesh-list
65478595|NCT01157000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65478596|NCT01157000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478597|NCT01157000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65478598|NCT01157000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478599|NCT01160900|Bivalirudin|bivalirudin|mesh-list
64862618|NCT01765855|Betrixaban|betrixaban|mesh-list
65478613|NCT01160978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65478614|NCT01160978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65478615|NCT01160978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478617|NCT01161134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65478618|NCT01161134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65478619|NCT01161134|Analgesics|analgesics|mesh-ancestor
65478620|NCT01161134|Sensory System Agents|sensory system agents|mesh-ancestor
65478621|NCT01161134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65478622|NCT01161134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478623|NCT01161134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65478624|NCT01161134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65478625|NCT01161134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65478626|NCT01161134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65478627|NCT01161134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478628|NCT01161134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274236|NCT00093899|Antimetabolites|antimetabolites|mesh-ancestor
64471368|NCT04551495|Entrectinib|entrectinib|mesh-list
65478629|NCT01268384|Gemcitabine|gemcitabine|mesh-list
65478630|NCT01268384|Capecitabine|capecitabine|mesh-list
65478631|NCT01268384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65478632|NCT01268384|Antimetabolites|antimetabolites|mesh-ancestor
65478633|NCT01268384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478634|NCT01268384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65478635|NCT01268384|Antiviral Agents|antiviral agents|mesh-ancestor
65478636|NCT01268384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65478637|NCT01268384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478638|NCT01268384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65478639|NCT01268384|Immunologic Factors|immunologic factors|mesh-ancestor
65478640|NCT01268384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478641|NCT01267448|Metformin|metformin|mesh-list
65478642|NCT01267448|Saxagliptin|saxagliptin|mesh-list
65478643|NCT01267448|Glipizide|glipizide|mesh-list
65478644|NCT01267448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65478645|NCT01267448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478646|NCT01267448|Incretins|incretins|mesh-ancestor
65478647|NCT01267448|Hormones|hormones|mesh-ancestor
65478648|NCT01267448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65228180|NCT00754390|Calcium|calcium|mesh-list
65478649|NCT01267448|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65478650|NCT01267448|Protease Inhibitors|protease inhibitors|mesh-ancestor
65478651|NCT01267448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478652|NCT01267448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478653|NCT01269476|Fluorides|fluorides|mesh-list
65478654|NCT01269476|Methanesulfonyl fluoride|methanesulfonyl fluoride|mesh-list
65478655|NCT01269476|Cariostatic Agents|cariostatic agents|mesh-ancestor
65478656|NCT01269476|Protective Agents|protective agents|mesh-ancestor
65478657|NCT01269476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478658|NCT01269476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65478659|NCT01269476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478676|NCT01161368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65478677|NCT01161368|Tubulin Modulators|tubulin modulators|mesh-ancestor
65478678|NCT01161368|Antimitotic Agents|antimitotic agents|mesh-ancestor
65478679|NCT01161368|Mitosis Modulators|mitosis modulators|mesh-ancestor
65478680|NCT01161368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478681|NCT01161368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65478682|NCT01161368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478683|NCT01267760|Dialysis Solutions|dialysis solutions|mesh-list
65478684|NCT01267760|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65478685|NCT01280162|Piperaquine|piperaquine|mesh-list
65478686|NCT01280162|Artenimol|artenimol|mesh-list
65478687|NCT01280162|Antimalarials|antimalarials|mesh-ancestor
65478688|NCT01280162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65478689|NCT01280162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65478690|NCT01280162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65478691|NCT01167062|Tamsulosin|tamsulosin|mesh-list
65478692|NCT01167062|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65478693|NCT01167062|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65478694|NCT01167062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65478695|NCT01167062|Adrenergic Agents|adrenergic agents|mesh-ancestor
65478696|NCT01167062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65478697|NCT01167062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478698|NCT01167062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478699|NCT01167062|Urological Agents|urological agents|mesh-ancestor
65478700|NCT01280240|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65478701|NCT01280240|Hematinics|hematinics|mesh-ancestor
65478702|NCT01165268|Dapagliflozin|dapagliflozin|mesh-list
65478703|NCT01165268|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65478704|NCT01165268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478705|NCT01165268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65478706|NCT01165268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478707|NCT03874364|Lidocaine|lidocaine|mesh-list
65478708|NCT03874364|Anesthetics, Local|anesthetics, local|mesh-ancestor
65478709|NCT03874364|Anesthetics|anesthetics|mesh-ancestor
65478710|NCT03874364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65478711|NCT03874364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478712|NCT03874364|Sensory System Agents|sensory system agents|mesh-ancestor
65478713|NCT03874364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65478714|NCT03874364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65478715|NCT03874364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65274237|NCT00093899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476520|NCT01414257|Antimetabolites|antimetabolites|mesh-ancestor
65478716|NCT03874364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65478717|NCT03874364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64862749|NCT01766583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65478725|NCT01163396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65478726|NCT01163396|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65478727|NCT01163396|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65478728|NCT01163396|Growth Substances|growth substances|mesh-ancestor
65478729|NCT01163396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478730|NCT01163396|Growth Inhibitors|growth inhibitors|mesh-ancestor
65478731|NCT01163396|Antimetabolites|antimetabolites|mesh-ancestor
65478732|NCT01163396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478733|NCT01163396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65478734|NCT01163396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65478735|NCT01163396|Immunologic Factors|immunologic factors|mesh-ancestor
65478736|NCT01163396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65478737|NCT01163396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65478738|NCT01163396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478739|NCT01163396|Antidotes|antidotes|mesh-ancestor
65478740|NCT01163396|Protective Agents|protective agents|mesh-ancestor
65478741|NCT01163396|Vitamin B Complex|vitamin b complex|mesh-ancestor
65478742|NCT01163396|Vitamins|vitamins|mesh-ancestor
65478743|NCT01163396|Micronutrients|micronutrients|mesh-ancestor
65478744|NCT01269788|Fluoxetine|fluoxetine|mesh-list
65478745|NCT01269788|Omeprazole|omeprazole|mesh-list
65478746|NCT01269788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65478747|NCT01269788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65478748|NCT01269788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65478749|NCT01269788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478750|NCT01269788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478751|NCT01269788|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65478752|NCT01269788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65478753|NCT01269788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65478754|NCT01269788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65478755|NCT01269788|Serotonin Agents|serotonin agents|mesh-ancestor
65478756|NCT01269788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478757|NCT01269788|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65478758|NCT01269788|Antidepressive Agents|antidepressive agents|mesh-ancestor
65478759|NCT01269788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65478760|NCT01269788|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65478761|NCT01269788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65478762|NCT01163630|Esomeprazole|esomeprazole|mesh-list
65478763|NCT01163630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65478764|NCT01163630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65478765|NCT01163630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65478766|NCT01163630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478767|NCT01163630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478768|NCT03874130|Scopolamine|scopolamine|mesh-list
65478769|NCT03874130|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65478770|NCT03874130|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65478771|NCT03874130|Antiemetics|antiemetics|mesh-ancestor
65478772|NCT03874130|Autonomic Agents|autonomic agents|mesh-ancestor
65478773|NCT03874130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65478774|NCT03874130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478775|NCT03874130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65478776|NCT03874130|Mydriatics|mydriatics|mesh-ancestor
65478777|NCT03874130|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65478778|NCT03874130|Cholinergic Agents|cholinergic agents|mesh-ancestor
65478779|NCT03874130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65478780|NCT03874130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478781|NCT03874130|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65478782|NCT03874130|Parasympatholytics|parasympatholytics|mesh-ancestor
65478783|NCT01269866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64862807|NCT01767259|Natriuretic Agents|natriuretic agents|mesh-ancestor
65478790|NCT01269866|Analgesics|analgesics|mesh-ancestor
65478791|NCT01269866|Sensory System Agents|sensory system agents|mesh-ancestor
65478792|NCT01269866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65478793|NCT01269866|Antidepressive Agents|antidepressive agents|mesh-ancestor
65478794|NCT01269866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65478795|NCT01269866|Dopamine Agents|dopamine agents|mesh-ancestor
65478796|NCT05387642|Pramoxine|pramoxine|mesh-list
65478797|NCT05387642|Anesthetics, Local|anesthetics, local|mesh-ancestor
65274238|NCT00093899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65478798|NCT05387642|Anesthetics|anesthetics|mesh-ancestor
65478799|NCT05387642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65478800|NCT05387642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478801|NCT05387642|Sensory System Agents|sensory system agents|mesh-ancestor
65478802|NCT05387642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65478804|NCT03871322|Ergocalciferols|ergocalciferols|mesh-list
65478805|NCT03871322|Cholecalciferol|cholecalciferol|mesh-list
65478806|NCT03871322|Vitamins|vitamins|mesh-list
65478807|NCT03871322|Micronutrients|micronutrients|mesh-ancestor
65478808|NCT03871322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478809|NCT03871322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65478810|NCT03871322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65478811|NCT00313781|Prednisone|prednisone|mesh-list
65478812|NCT00313781|Docetaxel|docetaxel|mesh-list
65478813|NCT00313781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65478814|NCT00313781|Tubulin Modulators|tubulin modulators|mesh-ancestor
65478815|NCT00313781|Antimitotic Agents|antimitotic agents|mesh-ancestor
65478816|NCT00313781|Mitosis Modulators|mitosis modulators|mesh-ancestor
65478817|NCT00313781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478818|NCT00313781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65478819|NCT00313781|Glucocorticoids|glucocorticoids|mesh-ancestor
65478820|NCT00313781|Hormones|hormones|mesh-ancestor
65478821|NCT00313781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65478822|NCT00313781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478823|NCT00313781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65478824|NCT03871478|Lidocaine|lidocaine|mesh-list
65478825|NCT03871478|Bupivacaine|bupivacaine|mesh-list
65478826|NCT03871478|Anesthetics, Local|anesthetics, local|mesh-ancestor
65478827|NCT03871478|Anesthetics|anesthetics|mesh-ancestor
65478828|NCT03871478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65478829|NCT03871478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478830|NCT03871478|Sensory System Agents|sensory system agents|mesh-ancestor
65478831|NCT03871478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65478832|NCT03871478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65478833|NCT03871478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65478834|NCT03871478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65478835|NCT03871478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65478836|NCT03871478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478837|NCT01281566|Cisapride|cisapride|mesh-list
65478838|NCT01281566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65478839|NCT01281566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65478840|NCT01281566|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65478841|NCT01281566|Serotonin Agents|serotonin agents|mesh-ancestor
65478842|NCT01281566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65478843|NCT01281566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478844|NCT01281566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478845|NCT00368537|Ampicillin|ampicillin|mesh-list
65478846|NCT00368537|Tigecycline|tigecycline|mesh-list
65478847|NCT00368537|Sulbactam|sulbactam|mesh-list
65478848|NCT00368537|Sultamicillin|sultamicillin|mesh-list
65478849|NCT00368537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65478850|NCT00368537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65478851|NCT00368537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65478859|NCT01048619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65478860|NCT01048619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65478861|NCT01048619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478862|NCT01048619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478863|NCT01281800|Gemcitabine|gemcitabine|mesh-list
65478864|NCT01281800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65478865|NCT01281800|Antimetabolites|antimetabolites|mesh-ancestor
65478866|NCT01281800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478867|NCT01281800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65478868|NCT01281800|Antiviral Agents|antiviral agents|mesh-ancestor
65478869|NCT01281800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65478870|NCT01281800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478871|NCT01281800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65478872|NCT01281800|Immunologic Factors|immunologic factors|mesh-ancestor
65228395|NCT02682225|Ketamine|ketamine|mesh-list
65478873|NCT01281800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478874|NCT03982121|Nivolumab|nivolumab|mesh-list
65478875|NCT03982121|Ipilimumab|ipilimumab|mesh-list
65478876|NCT03982121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65478877|NCT03982121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65478878|NCT03982121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65478879|NCT03982121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478880|NCT01167530|Everolimus|everolimus|mesh-list
65478881|NCT01167530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65478882|NCT01167530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65478883|NCT01167530|Immunologic Factors|immunologic factors|mesh-ancestor
65478884|NCT01167530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478885|NCT01167764|Tranexamic Acid|tranexamic acid|mesh-list
65478886|NCT01167764|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65478887|NCT01167764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65478888|NCT01167764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478889|NCT01167764|Hemostatics|hemostatics|mesh-ancestor
65478890|NCT01167764|Coagulants|coagulants|mesh-ancestor
65478891|NCT01164176|Everolimus|everolimus|mesh-list
65478892|NCT01164176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65478893|NCT01164176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65478894|NCT01164176|Immunologic Factors|immunologic factors|mesh-ancestor
65478895|NCT01164176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478896|NCT00313313|Metformin|metformin|mesh-list
65478897|NCT00313313|Saxagliptin|saxagliptin|mesh-list
65478898|NCT00313313|Glyburide|glyburide|mesh-list
65478899|NCT00313313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65478900|NCT00313313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478901|NCT00313313|Incretins|incretins|mesh-ancestor
65478902|NCT00313313|Hormones|hormones|mesh-ancestor
65478903|NCT00313313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65478904|NCT00313313|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65478905|NCT00313313|Protease Inhibitors|protease inhibitors|mesh-ancestor
65478906|NCT00313313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478907|NCT00313313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478908|NCT01167920|Calcium Channel Blockers|calcium channel blockers|mesh-list
65478909|NCT01167920|Angiotensin II|angiotensin ii|mesh-list
65478910|NCT01167920|Diuretics|diuretics|mesh-list
65478911|NCT01167920|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65478912|NCT01167920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65478913|NCT01167920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478914|NCT01167920|Natriuretic Agents|natriuretic agents|mesh-ancestor
65478915|NCT01167920|Protease Inhibitors|protease inhibitors|mesh-ancestor
65478916|NCT01167920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478917|NCT01167920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478918|NCT01167920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65478930|NCT02526758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65478931|NCT02526758|Autonomic Agents|autonomic agents|mesh-ancestor
65478932|NCT02526758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65478933|NCT02526758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478934|NCT02526758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65478935|NCT02526758|Respiratory System Agents|respiratory system agents|mesh-ancestor
65478936|NCT02526758|Glucocorticoids|glucocorticoids|mesh-ancestor
65478937|NCT02526758|Hormones|hormones|mesh-ancestor
65478938|NCT02526758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65478939|NCT02526758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65478940|NCT02526758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65478941|NCT02526758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65478942|NCT02526758|Adrenergic Agents|adrenergic agents|mesh-ancestor
65478943|NCT02526758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65478944|NCT02526758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478945|NCT01281878|Vitamin B 6|vitamin b 6|mesh-list
65478946|NCT01281878|Pyridoxal|pyridoxal|mesh-list
65478947|NCT01281878|Pyridoxine|pyridoxine|mesh-list
65228488|NCT00727831|Vitamins|vitamins|mesh-ancestor
65478948|NCT01281878|Vitamins|vitamins|mesh-ancestor
65478949|NCT01281878|Micronutrients|micronutrients|mesh-ancestor
65478950|NCT01281878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478951|NCT01281878|Vitamin B Complex|vitamin b complex|mesh-ancestor
65478952|NCT01164488|Ritonavir|ritonavir|mesh-list
65478953|NCT01164488|Ketoconazole|ketoconazole|mesh-list
65478954|NCT01164488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65478955|NCT01164488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65478956|NCT01164488|Protease Inhibitors|protease inhibitors|mesh-ancestor
65478957|NCT01164488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478958|NCT01164488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478959|NCT01164488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65478960|NCT01164488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65478961|NCT01164488|Antiviral Agents|antiviral agents|mesh-ancestor
65478962|NCT01164488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64471371|NCT04551495|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65478963|NCT01164488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65478964|NCT01164488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65478965|NCT01164488|Antifungal Agents|antifungal agents|mesh-ancestor
65478966|NCT01164488|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65478967|NCT01164488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65478968|NCT01164488|Hormone Antagonists|hormone antagonists|mesh-ancestor
65478969|NCT01164488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65478970|NCT01164488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478971|NCT00312845|Rituximab|rituximab|mesh-list
65478972|NCT00312845|Bortezomib|bortezomib|mesh-list
65478973|NCT00312845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65478974|NCT00312845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65478975|NCT00312845|Immunologic Factors|immunologic factors|mesh-ancestor
65478976|NCT00312845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478977|NCT00312845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65478978|NCT01168544|Vitamin D|vitamin d|mesh-list
65478979|NCT01168544|Ergocalciferols|ergocalciferols|mesh-list
65478980|NCT01168544|Cholecalciferol|cholecalciferol|mesh-list
65478981|NCT01168544|Vitamins|vitamins|mesh-list
65478982|NCT01168544|Micronutrients|micronutrients|mesh-ancestor
65478983|NCT01168544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478984|NCT01168544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65479008|NCT00367835|Guanfacine|guanfacine|mesh-list
65479009|NCT00367835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65479010|NCT00367835|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65479011|NCT00367835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65479012|NCT00367835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65479013|NCT00367835|Adrenergic Agents|adrenergic agents|mesh-ancestor
65479014|NCT00367835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65479015|NCT00367835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479016|NCT00367835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479017|NCT03874832|Dihydroergotamine|dihydroergotamine|mesh-list
65479018|NCT03874832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65479019|NCT03874832|Dopamine Agonists|dopamine agonists|mesh-ancestor
65479020|NCT03874832|Dopamine Agents|dopamine agents|mesh-ancestor
65479021|NCT03874832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65479022|NCT03874832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479023|NCT03874832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479024|NCT03874832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65479025|NCT03874832|Analgesics|analgesics|mesh-ancestor
65479026|NCT03874832|Sensory System Agents|sensory system agents|mesh-ancestor
65479027|NCT03874832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65479028|NCT01164800|Trandolapril|trandolapril|mesh-list
65479029|NCT01164800|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65479030|NCT01164800|Protease Inhibitors|protease inhibitors|mesh-ancestor
65479031|NCT01164800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479032|NCT01164800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479033|NCT01164800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65479034|NCT01169012|Clofarabine|clofarabine|mesh-list
65479035|NCT01169012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65479036|NCT01169012|Antimetabolites|antimetabolites|mesh-ancestor
65479362|NCT02987530|Tenofovir|tenofovir|mesh-list
65479363|NCT02987530|Emtricitabine|emtricitabine|mesh-list
65479364|NCT02987530|Dolutegravir|dolutegravir|mesh-list
65479365|NCT02987530|Darunavir|darunavir|mesh-list
65479366|NCT02987530|Cobicistat|cobicistat|mesh-list
65479367|NCT02987530|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
65479368|NCT02987530|Antiviral Agents|antiviral agents|mesh-ancestor
65479369|NCT02987530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65479370|NCT02987530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65479371|NCT02987530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65479372|NCT02987530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479373|NCT02987530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479374|NCT02987530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65479375|NCT02987530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65479376|NCT02987530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65479377|NCT02987530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65479378|NCT02987530|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65479379|NCT02987530|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65479380|NCT02987530|Protease Inhibitors|protease inhibitors|mesh-ancestor
64863430|NCT01770106|Denosumab|denosumab|mesh-list
65479426|NCT01285466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65479427|NCT01285544|Atorvastatin|atorvastatin|mesh-list
65274239|NCT00093899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65479428|NCT01285544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65479429|NCT01285544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65479430|NCT01285544|Antimetabolites|antimetabolites|mesh-ancestor
65479431|NCT01285544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479432|NCT01285544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65479433|NCT01285544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65479434|NCT01285544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479435|NCT01174394|Fluoxetine|fluoxetine|mesh-list
65479436|NCT01174394|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65479437|NCT01174394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65479438|NCT01174394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65479439|NCT01174394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479440|NCT01174394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65479441|NCT01174394|Serotonin Agents|serotonin agents|mesh-ancestor
65479442|NCT01174394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479443|NCT01174394|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65479444|NCT01174394|Antidepressive Agents|antidepressive agents|mesh-ancestor
65479445|NCT01174394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65479446|NCT01174394|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65479447|NCT01174394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65479448|NCT01174394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479449|NCT01174472|Paclitaxel|paclitaxel|mesh-list
65479450|NCT01174472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65479451|NCT01174472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65479452|NCT01174472|Tubulin Modulators|tubulin modulators|mesh-ancestor
65479453|NCT01174472|Antimitotic Agents|antimitotic agents|mesh-ancestor
65479454|NCT01174472|Mitosis Modulators|mitosis modulators|mesh-ancestor
65479455|NCT01174472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479456|NCT00335153|Levodopa|levodopa|mesh-list
65479457|NCT00335153|Carbidopa|carbidopa|mesh-list
65479458|NCT00335153|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65479459|NCT00335153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65479460|NCT00335153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65479461|NCT00335153|Dopamine Agents|dopamine agents|mesh-ancestor
65479462|NCT00335153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65479463|NCT00335153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479464|NCT00335153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479465|NCT00335153|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65479466|NCT00335153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479467|NCT00335153|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65228999|NCT04179045|Antifungal Agents|antifungal agents|mesh-ancestor
65479468|NCT00335153|Immunologic Factors|immunologic factors|mesh-ancestor
65479469|NCT00335153|Dopamine Agonists|dopamine agonists|mesh-ancestor
65479470|NCT01170806|Orlistat|orlistat|mesh-list
65479471|NCT01170806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479472|NCT01170806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479473|NCT01170806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65479474|NCT01170806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65479475|NCT03868436|Methoxyflurane|methoxyflurane|mesh-list
65479476|NCT03868436|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65479477|NCT03868436|Anesthetics, General|anesthetics, general|mesh-ancestor
65479478|NCT03868436|Anesthetics|anesthetics|mesh-ancestor
65479515|NCT03865160|Cholinergic Agents|cholinergic agents|mesh-ancestor
65479599|NCT01063439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65479600|NCT01063439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479601|NCT01063439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479602|NCT01063439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65479604|NCT01063439|Antiviral Agents|antiviral agents|mesh-ancestor
65479605|NCT01063439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65479606|NCT01063439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65479607|NCT01063439|Immunologic Factors|immunologic factors|mesh-ancestor
65479608|NCT01063439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479609|NCT01063439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65479610|NCT01063439|Alkylating Agents|alkylating agents|mesh-ancestor
65479611|NCT01063439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65479612|NCT05275270|Oxytocin|oxytocin|mesh-list
65479613|NCT05275270|Oxytocics|oxytocics|mesh-ancestor
65479614|NCT05275270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65479615|NCT05275270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479616|NCT02884648|Bevacizumab|bevacizumab|mesh-list
65274240|NCT00093899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274241|NCT00092807|Ezetimibe|ezetimibe|mesh-list
65274242|NCT00092807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65479617|NCT02884648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65229150|NCT02671851|Fentanyl|fentanyl|mesh-list
65479618|NCT02884648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65479619|NCT02884648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65479620|NCT02884648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65479621|NCT02884648|Growth Substances|growth substances|mesh-ancestor
65479622|NCT02884648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479623|NCT02884648|Growth Inhibitors|growth inhibitors|mesh-ancestor
65479624|NCT03868124|Travoprost|travoprost|mesh-list
65479625|NCT03868124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65479626|NCT03868124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65479627|NCT03868124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65479628|NCT03868202|Estradiol|estradiol|mesh-list
65479629|NCT03868202|Progesterone|progesterone|mesh-list
65479630|NCT03868202|Estrogens|estrogens|mesh-ancestor
65479631|NCT03868202|Hormones|hormones|mesh-ancestor
65479632|NCT03868202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65479633|NCT03868202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479634|NCT03868202|Progestins|progestins|mesh-ancestor
65479635|NCT00311363|Gabapentin|gabapentin|mesh-list
65479636|NCT00311363|Analgesics|analgesics|mesh-ancestor
65479637|NCT00311363|Sensory System Agents|sensory system agents|mesh-ancestor
65479638|NCT00311363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65479639|NCT00311363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479640|NCT00311363|Anticonvulsants|anticonvulsants|mesh-ancestor
65479641|NCT00311363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65479642|NCT00311363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65479643|NCT00311363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65479644|NCT00311363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65479645|NCT00311363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65479646|NCT00311363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65479647|NCT00311363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65479648|NCT00311363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479649|NCT00311363|Antimanic Agents|antimanic agents|mesh-ancestor
65479650|NCT01175330|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65479651|NCT01175330|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65479652|NCT01175330|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65479653|NCT01175330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65479654|NCT03262012|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65479655|NCT03262012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65479656|NCT03262012|Respiratory System Agents|respiratory system agents|mesh-ancestor
65479657|NCT01286090|Cisapride|cisapride|mesh-list
65479658|NCT01286090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65479983|NCT03857672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479984|NCT03283696|Doxorubicin|doxorubicin|mesh-list
65479985|NCT03283696|Ifosfamide|ifosfamide|mesh-list
65479986|NCT03283696|Olaratumab|olaratumab|mesh-list
65479987|NCT03283696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65479988|NCT03283696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65479989|NCT03283696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65479990|NCT03283696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65479991|NCT03283696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479992|NCT03283696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479993|NCT03283696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65479994|NCT03283696|Alkylating Agents|alkylating agents|mesh-ancestor
65479995|NCT01176344|Vitamin D|vitamin d|mesh-list
65479996|NCT01176344|Vitamins|vitamins|mesh-ancestor
65479997|NCT01176344|Micronutrients|micronutrients|mesh-ancestor
65479998|NCT01176344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479999|NCT01176344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65480000|NCT02530788|Selenium|selenium|mesh-list
65480001|NCT02530788|Selenious Acid|selenious acid|mesh-list
65480002|NCT02530788|Sodium Selenite|sodium selenite|mesh-list
65480003|NCT02530788|Antioxidants|antioxidants|mesh-ancestor
65480161|NCT05200312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65480162|NCT05200312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65480164|NCT05200312|Antimitotic Agents|antimitotic agents|mesh-ancestor
65480165|NCT05200312|Mitosis Modulators|mitosis modulators|mesh-ancestor
65480166|NCT05200312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65480167|NCT05200312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65480168|NCT05200312|Growth Substances|growth substances|mesh-ancestor
65480169|NCT05200312|Growth Inhibitors|growth inhibitors|mesh-ancestor
65480170|NCT05200312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65480171|NCT01180166|Nimotuzumab|nimotuzumab|mesh-list
65480172|NCT01180166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65480173|NCT01180166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480174|NCT02940730|Dalbavancin|dalbavancin|mesh-list
65480175|NCT02940730|Teicoplanin|teicoplanin|mesh-list
65480176|NCT02940730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65480177|NCT02940730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65480178|NCT01587638|Metoprolol|metoprolol|mesh-list
65480179|NCT01587638|Atenolol|atenolol|mesh-list
65480180|NCT01587638|Carvedilol|carvedilol|mesh-list
65480181|NCT01587638|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
65480182|NCT01587638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65480183|NCT01587638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65480184|NCT01587638|Sympatholytics|sympatholytics|mesh-ancestor
65480185|NCT01587638|Autonomic Agents|autonomic agents|mesh-ancestor
65480186|NCT01587638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65480187|NCT01587638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480188|NCT01587638|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65480189|NCT01587638|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65480190|NCT01587638|Adrenergic Agents|adrenergic agents|mesh-ancestor
65480191|NCT01587638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65480192|NCT01587638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480193|NCT01587638|Antioxidants|antioxidants|mesh-ancestor
65480194|NCT01587638|Protective Agents|protective agents|mesh-ancestor
65480195|NCT01587638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65480196|NCT01587638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65480197|NCT01587638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65480198|NCT01587638|Vasodilator Agents|vasodilator agents|mesh-ancestor
65480199|NCT01587638|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65480200|NCT01587638|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65480201|NCT01287338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
65480202|NCT01287338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65480203|NCT01287338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65480204|NCT01287338|Analgesics|analgesics|mesh-ancestor
65480205|NCT01287338|Sensory System Agents|sensory system agents|mesh-ancestor
65480206|NCT01287338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65480207|NCT01287338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480208|NCT01287338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65480209|NCT01287338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65480210|NCT01287338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65480211|NCT01287338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65480212|NCT01287338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65480213|NCT01287338|Histamine Antagonists|histamine antagonists|mesh-ancestor
65480214|NCT01287338|Histamine Agents|histamine agents|mesh-ancestor
65480215|NCT01287338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65480248|NCT02524964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65480249|NCT02524964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65480250|NCT02524964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65480251|NCT02524964|Analgesics|analgesics|mesh-ancestor
65480252|NCT02524964|Sensory System Agents|sensory system agents|mesh-ancestor
65480253|NCT02524964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65480254|NCT02524964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480255|NCT02524964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65480256|NCT02524964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65480257|NCT02524964|Anticoagulants|anticoagulants|mesh-ancestor
65480327|NCT01181960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480328|NCT01181960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65480329|NCT01181960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65480330|NCT01181960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65480331|NCT01181960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65480333|NCT01181960|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65480334|NCT01181960|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65480335|NCT03858062|Insulin|insulin|mesh-list
65480336|NCT03858062|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65480337|NCT03858062|Pancrelipase|pancrelipase|mesh-list
65480338|NCT03858062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65480339|NCT03858062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480340|NCT03858062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65480341|NCT01290692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
65480342|NCT01290692|Immunologic Factors|immunologic factors|mesh-ancestor
65480343|NCT01290692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480344|NCT03307252|Metformin|metformin|mesh-list
65480345|NCT03307252|Rifampin|rifampin|mesh-list
64477031|NCT00512278|Infliximab|infliximab|mesh-list
65480346|NCT03307252|Probenecid|probenecid|mesh-list
65480347|NCT03307252|Digoxin|digoxin|mesh-list
65480348|NCT03307252|Verapamil|verapamil|mesh-list
65480349|NCT03307252|Furosemide|furosemide|mesh-list
65480350|NCT03307252|Cimetidine|cimetidine|mesh-list
65480351|NCT03307252|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65480352|NCT03307252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65480353|NCT03307252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480354|NCT03307252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65480355|NCT03307252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65480356|NCT03307252|Antimetabolites|antimetabolites|mesh-ancestor
65480357|NCT03307252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480358|NCT03307252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65480359|NCT03307252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65480360|NCT03307252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480361|NCT03307252|Diuretics|diuretics|mesh-ancestor
65480362|NCT03307252|Natriuretic Agents|natriuretic agents|mesh-ancestor
65480363|NCT03307252|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65480364|NCT03307252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65480365|NCT03307252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65480366|NCT03307252|Antitubercular Agents|antitubercular agents|mesh-ancestor
65480367|NCT03307252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65480368|NCT03307252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65480369|NCT03307252|Leprostatic Agents|leprostatic agents|mesh-ancestor
65480370|NCT03307252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65480371|NCT03307252|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65480372|NCT03307252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65480373|NCT03307252|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65480374|NCT03307252|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65480474|NCT00056160|Immunologic Factors|immunologic factors|mesh-ancestor
65480475|NCT00056160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65480476|NCT00056160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65480477|NCT00056160|Growth Substances|growth substances|mesh-ancestor
65480478|NCT00056160|Growth Inhibitors|growth inhibitors|mesh-ancestor
65480480|NCT01290146|Diuretics|diuretics|mesh-list
65480481|NCT01290146|Natriuretic Agents|natriuretic agents|mesh-ancestor
65480482|NCT01290146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480483|NCT01290146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65480484|NCT01290146|Vasodilator Agents|vasodilator agents|mesh-ancestor
64864513|NCT01779284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65480540|NCT01291316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65480541|NCT01291316|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65480543|NCT00060840|Nitric Oxide|nitric oxide|mesh-list
65480544|NCT00060840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65480545|NCT00060840|Autonomic Agents|autonomic agents|mesh-ancestor
65480546|NCT00060840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65480547|NCT00060840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480548|NCT00060840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65480549|NCT00060840|Respiratory System Agents|respiratory system agents|mesh-ancestor
65480550|NCT00060840|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65480551|NCT00060840|Antioxidants|antioxidants|mesh-ancestor
65480552|NCT00060840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480553|NCT00060840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65480554|NCT00060840|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65480555|NCT00060840|Vasodilator Agents|vasodilator agents|mesh-ancestor
65480556|NCT00060840|Gasotransmitters|gasotransmitters|mesh-ancestor
65480557|NCT00060840|Protective Agents|protective agents|mesh-ancestor
65480558|NCT01185860|Ritonavir|ritonavir|mesh-list
65480559|NCT01185860|Ribavirin|ribavirin|mesh-list
65480560|NCT01185860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65480561|NCT01185860|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65480562|NCT01185860|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65480563|NCT01185860|Protease Inhibitors|protease inhibitors|mesh-ancestor
65480564|NCT01185860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480565|NCT01185860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480566|NCT01185860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65480567|NCT01185860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65480568|NCT01185860|Antiviral Agents|antiviral agents|mesh-ancestor
65480569|NCT01185860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65480570|NCT01185860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65480571|NCT01185860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65480572|NCT01185860|Antimetabolites|antimetabolites|mesh-ancestor
65480573|NCT01290302|Azacitidine|azacitidine|mesh-list
65480574|NCT01290302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65274243|NCT00092807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65480575|NCT01290302|Antimetabolites|antimetabolites|mesh-ancestor
65480576|NCT01290302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480577|NCT01290302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480578|NCT01290302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480579|NCT01089660|Vaccines|vaccines|mesh-list
65480580|NCT01089660|Immunologic Factors|immunologic factors|mesh-ancestor
65480581|NCT01089660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480582|NCT01182662|Cyclosporine|cyclosporine|mesh-list
65480583|NCT01182662|Cyclosporins|cyclosporins|mesh-list
65480584|NCT01182662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480585|NCT01182662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480586|NCT01182662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65480587|NCT01182662|Immunologic Factors|immunologic factors|mesh-ancestor
65480588|NCT01182662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480589|NCT01182662|Antifungal Agents|antifungal agents|mesh-ancestor
65480590|NCT01182662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65480591|NCT01182662|Dermatologic Agents|dermatologic agents|mesh-ancestor
65480592|NCT01182662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65480626|NCT03278626|Tubulin Modulators|tubulin modulators|mesh-ancestor
65480627|NCT03278626|Antimitotic Agents|antimitotic agents|mesh-ancestor
65480628|NCT03278626|Mitosis Modulators|mitosis modulators|mesh-ancestor
65480629|NCT03278626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480630|NCT01186094|Sirolimus|sirolimus|mesh-list
65480692|NCT01182974|Sensory System Agents|sensory system agents|mesh-ancestor
65480693|NCT01182974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65480694|NCT01182974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480695|NCT01182974|Antipyretics|antipyretics|mesh-ancestor
65480696|NCT03856502|Dexamethasone|dexamethasone|mesh-list
64864732|NCT01780467|Sympathomimetics|sympathomimetics|mesh-ancestor
65480724|NCT01583478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480725|NCT01583478|Cholinergic Agents|cholinergic agents|mesh-ancestor
65480726|NCT01583478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65480727|NCT03854396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65480728|NCT03854396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65480729|NCT03854396|Immunologic Factors|immunologic factors|mesh-ancestor
65480730|NCT03854396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480731|NCT01093638|Insulin|insulin|mesh-list
65480732|NCT01093638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65480733|NCT01093638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480734|NCT01287962|Apatinib|apatinib|mesh-list
65480735|NCT01287962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480736|NCT01287962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65480737|NCT01287962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480738|NCT01287962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480739|NCT00058422|Prednisone|prednisone|mesh-list
65480740|NCT00058422|Cyclophosphamide|cyclophosphamide|mesh-list
65480741|NCT00058422|Rituximab|rituximab|mesh-list
65480742|NCT00058422|Doxorubicin|doxorubicin|mesh-list
65480743|NCT00058422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65480744|NCT00058422|Vincristine|vincristine|mesh-list
65480745|NCT00058422|Darbepoetin alfa|darbepoetin alfa|mesh-list
65480746|NCT00058422|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65480747|NCT00058422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65480748|NCT00058422|Immunologic Factors|immunologic factors|mesh-ancestor
65480749|NCT00058422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480750|NCT00058422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65480751|NCT00058422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65480752|NCT00058422|Alkylating Agents|alkylating agents|mesh-ancestor
65480753|NCT00058422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480754|NCT00058422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480755|NCT00058422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65480756|NCT00058422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65480757|NCT00058422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65480758|NCT00058422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65480759|NCT00058422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65480760|NCT00058422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480761|NCT00058422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65480762|NCT00058422|Glucocorticoids|glucocorticoids|mesh-ancestor
65480763|NCT00058422|Hormones|hormones|mesh-ancestor
65480764|NCT00058422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65480765|NCT00058422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65480766|NCT00058422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65480767|NCT00058422|Tubulin Modulators|tubulin modulators|mesh-ancestor
65480768|NCT00058422|Antimitotic Agents|antimitotic agents|mesh-ancestor
65274244|NCT00092807|Antimetabolites|antimetabolites|mesh-ancestor
64477179|NCT00559468|Anesthetics, General|anesthetics, general|mesh-ancestor
65480769|NCT00058422|Mitosis Modulators|mitosis modulators|mesh-ancestor
65480770|NCT00058422|Hematinics|hematinics|mesh-ancestor
65480771|NCT01094964|Interferons|interferons|mesh-list
65480772|NCT01094964|Interferon-alpha|interferon-alpha|mesh-list
65480773|NCT01094964|Epirubicin|epirubicin|mesh-list
65480774|NCT01094964|Mitomycins|mitomycins|mesh-list
65480775|NCT01094964|Mitomycin|mitomycin|mesh-list
65480776|NCT01094964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480777|NCT01094964|Antiviral Agents|antiviral agents|mesh-ancestor
65480778|NCT01094964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65480779|NCT01094964|Immunologic Factors|immunologic factors|mesh-ancestor
65480780|NCT01094964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480781|NCT01094964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65480782|NCT01094964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65480783|NCT01094964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65480784|NCT01094964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480785|NCT01094964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480786|NCT01094964|Alkylating Agents|alkylating agents|mesh-ancestor
65230344|NCT05740657|Narcotics|narcotics|mesh-ancestor
65480825|NCT00072384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480826|NCT00072384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480827|NCT00072384|Tubulin Modulators|tubulin modulators|mesh-ancestor
65480828|NCT00072384|Antimitotic Agents|antimitotic agents|mesh-ancestor
65480829|NCT00072384|Mitosis Modulators|mitosis modulators|mesh-ancestor
65480830|NCT01183442|Vitamin D|vitamin d|mesh-list
65480831|NCT01183442|Ergocalciferols|ergocalciferols|mesh-list
65480832|NCT01183442|Cholecalciferol|cholecalciferol|mesh-list
65480833|NCT01183442|Vitamins|vitamins|mesh-list
65480834|NCT01183442|Micronutrients|micronutrients|mesh-ancestor
65480835|NCT01183442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480836|NCT01183442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65480837|NCT01183442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65480838|NCT01187108|Acetylcysteine|acetylcysteine|mesh-list
65480839|NCT01187108|Acetazolamide|acetazolamide|mesh-list
65480840|NCT01187108|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65480841|NCT01187108|Antiviral Agents|antiviral agents|mesh-ancestor
65480842|NCT01187108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65480843|NCT01187108|Expectorants|expectorants|mesh-ancestor
65480844|NCT01187108|Respiratory System Agents|respiratory system agents|mesh-ancestor
65480845|NCT01187108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65480846|NCT01187108|Antioxidants|antioxidants|mesh-ancestor
65480847|NCT01187108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480848|NCT01187108|Protective Agents|protective agents|mesh-ancestor
65480849|NCT01187108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480850|NCT01187108|Antidotes|antidotes|mesh-ancestor
65480851|NCT01187108|Anticonvulsants|anticonvulsants|mesh-ancestor
65480852|NCT01187108|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65480853|NCT01187108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480854|NCT01187108|Diuretics|diuretics|mesh-ancestor
65480855|NCT01187108|Natriuretic Agents|natriuretic agents|mesh-ancestor
65480856|NCT01187888|Rasagiline|rasagiline|mesh-list
65480857|NCT01187888|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65480858|NCT01187888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480859|NCT01187888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480860|NCT01187888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65480861|NCT01187888|Protective Agents|protective agents|mesh-ancestor
64864882|NCT01781507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65480897|NCT01187264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65480898|NCT01187264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65480953|NCT00057954|Mycophenolic Acid|mycophenolic acid|mesh-list
65480954|NCT00057954|Methotrexate|methotrexate|mesh-list
65480955|NCT00057954|Pentostatin|pentostatin|mesh-list
65480956|NCT00057954|Cyclosporins|cyclosporins|mesh-list
65480957|NCT00057954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65480958|NCT00057954|Abortifacient Agents|abortifacient agents|mesh-ancestor
65480959|NCT00057954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65480960|NCT00057954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480961|NCT00057954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65481120|NCT02459392|Prednisolone phosphate|prednisolone phosphate|mesh-list
65481121|NCT02459392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65481122|NCT02459392|Immunologic Factors|immunologic factors|mesh-ancestor
65481123|NCT02459392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481124|NCT02459392|Viscosupplements|viscosupplements|mesh-ancestor
65481207|NCT03245398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65481208|NCT03245398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65274245|NCT00092807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477263|NCT00520468|Hematinics|hematinics|mesh-ancestor
65481209|NCT03245398|Tubulin Modulators|tubulin modulators|mesh-ancestor
65481210|NCT03245398|Antimitotic Agents|antimitotic agents|mesh-ancestor
65481211|NCT03245398|Mitosis Modulators|mitosis modulators|mesh-ancestor
65481212|NCT03245398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481213|NCT03245398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481214|NCT03245398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481215|NCT01291940|Petrolatum|petrolatum|mesh-list
65481216|NCT01291940|Emollients|emollients|mesh-ancestor
65481217|NCT01291940|Dermatologic Agents|dermatologic agents|mesh-ancestor
65481218|NCT03244618|Fluorides|fluorides|mesh-list
65481219|NCT03244618|Cariostatic Agents|cariostatic agents|mesh-ancestor
65481220|NCT03244618|Protective Agents|protective agents|mesh-ancestor
65481221|NCT03244618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481222|NCT05571046|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
65481223|NCT05571046|Glucocorticoids|glucocorticoids|mesh-list
65481224|NCT05571046|Hormones|hormones|mesh-ancestor
65481225|NCT05571046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65481258|NCT03847922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65481259|NCT03847922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481260|NCT03847922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65481261|NCT03847922|Anesthetics, General|anesthetics, general|mesh-ancestor
65481262|NCT03847922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65481264|NCT01194284|Mifamurtide|mifamurtide|mesh-list
65481265|NCT01194284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65481266|NCT01194284|Immunologic Factors|immunologic factors|mesh-ancestor
65481267|NCT01194284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481268|NCT03255382|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65481269|NCT03255382|Dermatologic Agents|dermatologic agents|mesh-ancestor
65481270|NCT03255382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65481271|NCT03255382|Immunologic Factors|immunologic factors|mesh-ancestor
65481272|NCT03255382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481273|NCT01191554|Tranexamic Acid|tranexamic acid|mesh-list
65481274|NCT01191554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65481275|NCT01191554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65481276|NCT01191554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481277|NCT01191554|Hemostatics|hemostatics|mesh-ancestor
65481278|NCT01191554|Coagulants|coagulants|mesh-ancestor
65481279|NCT01296464|Carbidopa|carbidopa|mesh-list
65230852|NCT04061863|Nivolumab|nivolumab|mesh-list
65481280|NCT01296464|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65481281|NCT01296464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65481282|NCT01296464|Dopamine Agents|dopamine agents|mesh-ancestor
65481283|NCT01296464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65481284|NCT01296464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481285|NCT01296464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481286|NCT01296464|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65481287|NCT01296464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481288|NCT00038142|Cyclophosphamide|cyclophosphamide|mesh-list
65481289|NCT00038142|Doxorubicin|doxorubicin|mesh-list
65481290|NCT00038142|Vincristine|vincristine|mesh-list
65481291|NCT00038142|Dexrazoxane|dexrazoxane|mesh-list
65481292|NCT00038142|Razoxane|razoxane|mesh-list
65481293|NCT00038142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65481294|NCT00038142|Immunologic Factors|immunologic factors|mesh-ancestor
65481295|NCT00038142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481296|NCT00038142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65481297|NCT00038142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65481298|NCT00038142|Alkylating Agents|alkylating agents|mesh-ancestor
65481299|NCT00038142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481300|NCT00038142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481301|NCT00038142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65481302|NCT00038142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65481303|NCT00038142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65481304|NCT00038142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65481305|NCT00038142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481306|NCT00038142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65481307|NCT00038142|Tubulin Modulators|tubulin modulators|mesh-ancestor
65481308|NCT00038142|Antimitotic Agents|antimitotic agents|mesh-ancestor
65481309|NCT00038142|Mitosis Modulators|mitosis modulators|mesh-ancestor
65481310|NCT00038142|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65481311|NCT00038142|Protective Agents|protective agents|mesh-ancestor
65481312|NCT00366899|Vaccines|vaccines|mesh-list
65481313|NCT00366899|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65481314|NCT00366899|Immunologic Factors|immunologic factors|mesh-ancestor
65481315|NCT00366899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481316|NCT03847376|Rilpivirine|rilpivirine|mesh-list
65481317|NCT03847376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65481318|NCT03847376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65481319|NCT03847376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865326|NCT01784978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481406|NCT01060631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65481407|NCT01060631|Anesthetics, General|anesthetics, general|mesh-ancestor
65481408|NCT01060631|Anesthetics|anesthetics|mesh-ancestor
65481409|NCT03254134|Warfarin|warfarin|mesh-list
65481410|NCT03254134|Dabigatran|dabigatran|mesh-list
65481411|NCT03254134|Anticoagulants|anticoagulants|mesh-ancestor
65481412|NCT03254134|Antithrombins|antithrombins|mesh-ancestor
65481413|NCT03254134|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65481414|NCT03254134|Protease Inhibitors|protease inhibitors|mesh-ancestor
65481415|NCT03254134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481416|NCT03254134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481417|NCT01295294|Mefenamic Acid|mefenamic acid|mesh-list
65481418|NCT01295294|Tranexamic Acid|tranexamic acid|mesh-list
65481419|NCT01295294|Levonorgestrel|levonorgestrel|mesh-list
65481420|NCT01295294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65481421|NCT01295294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65481422|NCT01295294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481423|NCT01295294|Hemostatics|hemostatics|mesh-ancestor
65481424|NCT01295294|Coagulants|coagulants|mesh-ancestor
65481425|NCT01295294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65481426|NCT01295294|Contraceptive Agents|contraceptive agents|mesh-ancestor
65481427|NCT01295294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65481428|NCT01295294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481429|NCT01295294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65481430|NCT01295294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65481518|NCT01192490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65481519|NCT01192490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65481520|NCT01192490|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65481521|NCT01192490|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65481522|NCT01192490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65481523|NCT01192490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481524|NCT01295606|Cefazolin|cefazolin|mesh-list
65481525|NCT01295606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64865561|NCT01786070|Hormones|hormones|mesh-ancestor
65481664|NCT01195298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65481665|NCT01195298|Growth Substances|growth substances|mesh-ancestor
65481666|NCT01195298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481667|NCT01195298|Growth Inhibitors|growth inhibitors|mesh-ancestor
65481668|NCT01195298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65481669|NCT01195298|Antimetabolites|antimetabolites|mesh-ancestor
65481670|NCT01195298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481671|NCT01296074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65481672|NCT01296074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65481721|NCT01197014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65481722|NCT01197014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65481724|NCT01195454|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65481725|NCT01195454|Insulin Glargine|insulin glargine|mesh-list
65481726|NCT01195454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65481727|NCT01195454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481728|NCT01197170|Bevacizumab|bevacizumab|mesh-list
65481729|NCT01197170|Everolimus|everolimus|mesh-list
65481730|NCT01197170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65481731|NCT01197170|Sorafenib|sorafenib|mesh-list
65481732|NCT01197170|Anastrozole|anastrozole|mesh-list
65481733|NCT01197170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65481734|NCT01197170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481735|NCT01197170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65482187|NCT01202084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482188|NCT01202084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65482657|NCT03902912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482658|NCT03902912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65482659|NCT03902912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482660|NCT01205360|Fentanyl|fentanyl|mesh-list
65482661|NCT01205360|Bupivacaine|bupivacaine|mesh-list
65482662|NCT01205360|Anesthetics, Local|anesthetics, local|mesh-ancestor
65482663|NCT01205360|Anesthetics|anesthetics|mesh-ancestor
65274246|NCT00092807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65482664|NCT01205360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65482665|NCT01205360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482666|NCT01205360|Sensory System Agents|sensory system agents|mesh-ancestor
65482667|NCT01205360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65482668|NCT01205360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65482669|NCT01205360|Narcotics|narcotics|mesh-ancestor
65483009|NCT00303719|Antitubercular Agents|antitubercular agents|mesh-ancestor
65483010|NCT00303719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65483012|NCT01207310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65483013|NCT01207310|Autonomic Agents|autonomic agents|mesh-ancestor
65483014|NCT01207310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65483015|NCT01207310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483016|NCT01207310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65483017|NCT01207310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65483018|NCT01207310|Cholinergic Agents|cholinergic agents|mesh-ancestor
65483019|NCT01207310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65483020|NCT01207310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483021|NCT00331409|Everolimus|everolimus|mesh-list
65483022|NCT00331409|Imatinib Mesylate|imatinib mesylate|mesh-list
65483023|NCT00331409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483299|NCT01302002|Metformin|metformin|mesh-list
65483300|NCT01302002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65483301|NCT01302002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483302|NCT01303250|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65483303|NCT01303250|Plasma Substitutes|plasma substitutes|mesh-ancestor
65483304|NCT01303250|Blood Substitutes|blood substitutes|mesh-ancestor
65483305|NCT03814616|Artesunate|artesunate|mesh-list
65483306|NCT03814616|Pyronaridine|pyronaridine|mesh-list
65483307|NCT03814616|Antimalarials|antimalarials|mesh-ancestor
65483308|NCT03814616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65483309|NCT03814616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65483310|NCT03814616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65483311|NCT03814616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483312|NCT03814616|Antiviral Agents|antiviral agents|mesh-ancestor
65483313|NCT03814616|Schistosomicides|schistosomicides|mesh-ancestor
65483411|NCT01097382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483467|NCT00033540|Immunologic Factors|immunologic factors|mesh-ancestor
65483468|NCT00033540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483469|NCT00300365|Aspirin|aspirin|mesh-list
65483470|NCT00300365|Niacin|niacin|mesh-list
65483471|NCT00300365|Pioglitazone|pioglitazone|mesh-list
65483472|NCT00300365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65483473|NCT00300365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65483474|NCT00300365|Analgesics|analgesics|mesh-ancestor
65483475|NCT00300365|Sensory System Agents|sensory system agents|mesh-ancestor
65483476|NCT00300365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65483477|NCT00300365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483478|NCT00300365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65483479|NCT00300365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65483480|NCT00300365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64867455|NCT01810848|Hylan|hylan|mesh-list
65483618|NCT03979469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483620|NCT03979469|Analgesics|analgesics|mesh-ancestor
65483621|NCT03979469|Sensory System Agents|sensory system agents|mesh-ancestor
65483622|NCT03979469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65483623|NCT03979469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65483624|NCT03979469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65483625|NCT03979469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65483700|NCT00290771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65483702|NCT00290693|Capecitabine|capecitabine|mesh-list
65483703|NCT00290693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483704|NCT00290693|Tubulin Modulators|tubulin modulators|mesh-ancestor
65483705|NCT00290693|Antimitotic Agents|antimitotic agents|mesh-ancestor
65483706|NCT00290693|Mitosis Modulators|mitosis modulators|mesh-ancestor
65483707|NCT00290693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483708|NCT00290693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65483750|NCT02379520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65483751|NCT02379520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65483752|NCT01973452|Dexmedetomidine|dexmedetomidine|mesh-list
65483753|NCT01973452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65483754|NCT01973452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65483755|NCT01973452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483756|NCT01973452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65483757|NCT01973452|Analgesics|analgesics|mesh-ancestor
65274247|NCT00092729|Naproxen|naproxen|mesh-list
65274248|NCT00092729|Etoricoxib|etoricoxib|mesh-list
65483758|NCT01973452|Sensory System Agents|sensory system agents|mesh-ancestor
65483759|NCT01973452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65483760|NCT01973452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65483761|NCT01973452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65483762|NCT01973452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65483763|NCT01973452|Adrenergic Agents|adrenergic agents|mesh-ancestor
65483764|NCT01973452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65483765|NCT01973452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483767|NCT04504942|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65483768|NCT04504942|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65483769|NCT04504942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483770|NCT04504942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64867741|NCT01812720|Dexamethasone|dexamethasone|mesh-list
65483804|NCT00272987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483805|NCT01069757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65483806|NCT01069757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483807|NCT01069757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65483808|NCT01069757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483809|NCT01069757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483810|NCT01070927|R04929097|r04929097|mesh-list
65483811|NCT01070927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483997|NCT00265889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483998|NCT00265889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483999|NCT00265889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65484000|NCT00265889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65484001|NCT00265889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65484002|NCT00265889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65484003|NCT00265889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484005|NCT02795182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484006|NCT02795182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65484007|NCT02795182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484008|NCT02795182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484009|NCT01333696|Pemetrexed|pemetrexed|mesh-list
65484010|NCT01333696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484011|NCT01333696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484012|NCT01333696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484013|NCT01333696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65484014|NCT01333696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65484015|NCT01333774|Acarbose|acarbose|mesh-list
65484016|NCT01333774|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65484017|NCT01333774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484018|NCT01333774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484019|NCT01333774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65484020|NCT01333774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484021|NCT01333852|Metformin|metformin|mesh-list
65484022|NCT01333852|Paclitaxel|paclitaxel|mesh-list
65484023|NCT01333852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65484024|NCT01333852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484025|NCT01333852|Tubulin Modulators|tubulin modulators|mesh-ancestor
65484026|NCT01333852|Antimitotic Agents|antimitotic agents|mesh-ancestor
65484027|NCT01333852|Mitosis Modulators|mitosis modulators|mesh-ancestor
65484028|NCT01333852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484029|NCT01333852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65484030|NCT01333852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484031|NCT03365362|Varenicline|varenicline|mesh-list
65484032|NCT03365362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65484033|NCT03365362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65484034|NCT03365362|Cholinergic Agents|cholinergic agents|mesh-ancestor
65484035|NCT03365362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65484036|NCT03365362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484037|NCT03365362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484038|NCT03206788|Losartan|losartan|mesh-list
65484039|NCT03206788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65484040|NCT03206788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64867995|NCT01814059|Antifungal Agents|antifungal agents|mesh-ancestor
65484158|NCT03093922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484160|NCT03093922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65484161|NCT03093922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484162|NCT03093922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64514722|NCT02395497|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65484163|NCT03093922|Immunologic Factors|immunologic factors|mesh-ancestor
65484164|NCT03093922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484165|NCT03175198|Dabigatran|dabigatran|mesh-list
65484297|NCT01331590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65484298|NCT01331590|Glucocorticoids|glucocorticoids|mesh-ancestor
65484300|NCT01331590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65484301|NCT01331590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65484302|NCT01331590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484303|NCT01331590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65484304|NCT01331590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65484305|NCT01331590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65484306|NCT01331590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484307|NCT01331590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484344|NCT04245748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65484345|NCT04245748|Analgesics|analgesics|mesh-ancestor
65484434|NCT02913664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484437|NCT02818582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484438|NCT02818582|Antiviral Agents|antiviral agents|mesh-ancestor
65484439|NCT02818582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65484440|NCT01337440|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65484441|NCT01337440|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65484442|NCT01337440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65484443|NCT01337440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484444|NCT01337440|Incretins|incretins|mesh-ancestor
65484445|NCT01337440|Hormones|hormones|mesh-ancestor
65484446|NCT01337440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65484447|NCT01337440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65484448|NCT01337440|Protease Inhibitors|protease inhibitors|mesh-ancestor
65484449|NCT01337440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484450|NCT01337440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484451|NCT01337440|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65484452|NCT01337440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65484453|NCT01337518|Androgens|androgens|mesh-list
65484454|NCT01337518|Hormones|hormones|mesh-ancestor
65484455|NCT01337518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65484456|NCT01337518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484457|NCT05186194|Vitamin D|vitamin d|mesh-list
65484458|NCT05186194|Calcium|calcium|mesh-list
65484459|NCT05186194|Vitamins|vitamins|mesh-ancestor
65484460|NCT05186194|Micronutrients|micronutrients|mesh-ancestor
65484461|NCT05186194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484462|NCT05186194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65484497|NCT01339468|Immunologic Factors|immunologic factors|mesh-ancestor
65484498|NCT01339468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484499|NCT01339468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65484500|NCT01339468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484501|NCT01339468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484503|NCT01339624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65484504|NCT01339624|Fentanyl|fentanyl|mesh-list
65484505|NCT01339624|Morphine|morphine|mesh-list
65484506|NCT01339624|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65484531|NCT01340248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65484533|NCT01340248|Protective Agents|protective agents|mesh-ancestor
65484534|NCT01340248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65484535|NCT01340248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65484536|NCT01340248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65484537|NCT01340248|Vasodilator Agents|vasodilator agents|mesh-ancestor
65484538|NCT01340248|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65484539|NCT01340248|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65484540|NCT01340326|Valsartan|valsartan|mesh-list
65484541|NCT01340326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65484542|NCT01340326|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65484543|NCT01340326|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65484544|NCT01340326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484545|NCT00286091|Denosumab|denosumab|mesh-list
65484546|NCT00286091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65484547|NCT00286091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484548|NCT01340950|Tenofovir|tenofovir|mesh-list
65484549|NCT01340950|Lamivudine|lamivudine|mesh-list
65484550|NCT01340950|Zidovudine|zidovudine|mesh-list
65484551|NCT01340950|Efavirenz|efavirenz|mesh-list
65484552|NCT01340950|Nevirapine|nevirapine|mesh-list
65274249|NCT00092729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65024251|NCT04883632|Lidocaine|lidocaine|mesh-list
64868478|NCT01816958|Anesthetics|anesthetics|mesh-ancestor
65484587|NCT01341184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65484607|NCT01341262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65484608|NCT01341262|Alkylating Agents|alkylating agents|mesh-ancestor
65484609|NCT01341262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484610|NCT01341262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484611|NCT01341262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65484612|NCT01341262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65484614|NCT01341262|Autonomic Agents|autonomic agents|mesh-ancestor
65484615|NCT01341262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65484616|NCT01341262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65484617|NCT01341262|Glucocorticoids|glucocorticoids|mesh-ancestor
65484618|NCT01341262|Hormones|hormones|mesh-ancestor
65484619|NCT01341262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65484620|NCT01341262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65484621|NCT01341262|Leprostatic Agents|leprostatic agents|mesh-ancestor
65484622|NCT01341262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65484623|NCT01341262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65484624|NCT01341262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65484625|NCT01341262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65484626|NCT01341262|Growth Substances|growth substances|mesh-ancestor
65484627|NCT01341262|Growth Inhibitors|growth inhibitors|mesh-ancestor
65484628|NCT01341262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65484629|NCT01341340|Everolimus|everolimus|mesh-list
65484630|NCT01341340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484631|NCT01341340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65484632|NCT01341340|Immunologic Factors|immunologic factors|mesh-ancestor
65484633|NCT01341340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484634|NCT01341496|Celecoxib|celecoxib|mesh-list
65484635|NCT01341496|Cyclophosphamide|cyclophosphamide|mesh-list
65484636|NCT01341496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65484637|NCT01341496|Immunologic Factors|immunologic factors|mesh-ancestor
65484638|NCT01341496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484639|NCT01341496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65484640|NCT01341496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65484641|NCT01341496|Alkylating Agents|alkylating agents|mesh-ancestor
65484642|NCT01341496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484643|NCT01341496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484644|NCT01341496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65484675|NCT01315990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65484676|NCT01315990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484678|NCT00265343|Asenapine|asenapine|mesh-list
65484679|NCT00265343|Antiemetics|antiemetics|mesh-ancestor
65484680|NCT00265343|Autonomic Agents|autonomic agents|mesh-ancestor
65484681|NCT00265343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65484682|NCT00265343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484683|NCT00265343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65484684|NCT00265343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65484685|NCT00265343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65484686|NCT00265343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65484687|NCT00265343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65484688|NCT00265343|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65484712|NCT01341964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484713|NCT01341964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65484714|NCT01341964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65484715|NCT01341964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484716|NCT01341964|Antipyretics|antipyretics|mesh-ancestor
65484717|NCT01341964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65484718|NCT01341964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65484719|NCT01341964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65484720|NCT01341964|Purinergic Agents|purinergic agents|mesh-ancestor
65484721|NCT01341964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65484722|NCT00265109|Levetiracetam|levetiracetam|mesh-list
65484723|NCT00265109|Anticonvulsants|anticonvulsants|mesh-ancestor
65484724|NCT00265109|Nootropic Agents|nootropic agents|mesh-ancestor
65484725|NCT01342198|Erythromycin|erythromycin|mesh-list
65484726|NCT01342198|Erythromycin Estolate|erythromycin estolate|mesh-list
65484727|NCT01342198|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65484728|NCT01342198|Erythromycin stearate|erythromycin stearate|mesh-list
65484729|NCT01342198|Pregabalin|pregabalin|mesh-list
65484730|NCT01342198|Analgesics|analgesics|mesh-ancestor
65274251|NCT00092729|Analgesics|analgesics|mesh-ancestor
65274252|NCT00092729|Sensory System Agents|sensory system agents|mesh-ancestor
65484731|NCT01342198|Sensory System Agents|sensory system agents|mesh-ancestor
65484732|NCT01342198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65484733|NCT01342198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484734|NCT01342198|Anticonvulsants|anticonvulsants|mesh-ancestor
65484735|NCT01342198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65484736|NCT01342198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65484737|NCT01342198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868657|NCT01817972|Immunologic Factors|immunologic factors|mesh-ancestor
65484862|NCT04786756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65484863|NCT04786756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484864|NCT04786756|Sensory System Agents|sensory system agents|mesh-ancestor
65484865|NCT04786756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65484867|NCT05073250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65484868|NCT05073250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484869|NCT05073250|Immunologic Factors|immunologic factors|mesh-ancestor
65484870|NCT05073250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484871|NCT05073250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65484872|NCT00546754|Losartan|losartan|mesh-list
65484902|NCT04471402|Analgesics|analgesics|mesh-ancestor
65484903|NCT04471402|Sensory System Agents|sensory system agents|mesh-ancestor
65484904|NCT04471402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65484905|NCT04471402|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65484906|NCT04471402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65484907|NCT04471402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65484908|NCT04471402|Adrenergic Agents|adrenergic agents|mesh-ancestor
65484909|NCT04471402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65484910|NCT04471402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484911|NCT00282347|Acetaminophen|acetaminophen|mesh-list
65484912|NCT00282347|Diphenhydramine|diphenhydramine|mesh-list
65484913|NCT00282347|Promethazine|promethazine|mesh-list
65485000|NCT00281957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65485001|NCT00281957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65485002|NCT00281957|Antifungal Agents|antifungal agents|mesh-ancestor
65485003|NCT00281957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65485004|NCT00281957|Immunologic Factors|immunologic factors|mesh-ancestor
65485005|NCT00281957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485006|NCT01071161|Azithromycin|azithromycin|mesh-list
65485007|NCT01071161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65485008|NCT01071161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65485009|NCT01070225|Hydrocortisone|hydrocortisone|mesh-list
65485010|NCT01070225|Propranolol|propranolol|mesh-list
65485011|NCT01070225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65485012|NCT01070225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65485013|NCT01070225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65485014|NCT01070225|Adrenergic Agents|adrenergic agents|mesh-ancestor
65485015|NCT01070225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65485031|NCT00262925|Dexamethasone|dexamethasone|mesh-list
65485032|NCT00262925|Methotrexate|methotrexate|mesh-list
65485033|NCT00262925|Vincristine|vincristine|mesh-list
65485034|NCT00262925|Asparaginase|asparaginase|mesh-list
65485035|NCT00262925|Mercaptopurine|mercaptopurine|mesh-list
65485036|NCT00262925|Alemtuzumab|alemtuzumab|mesh-list
65485037|NCT00262925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65485038|NCT00262925|Antibodies|antibodies|mesh-list
65485039|NCT00262925|Immunoglobulins|immunoglobulins|mesh-list
65485040|NCT00262925|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65485041|NCT00262925|Levoleucovorin|levoleucovorin|mesh-list
65485042|NCT00262925|Immunologic Factors|immunologic factors|mesh-ancestor
65485043|NCT00262925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485044|NCT00262925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65485045|NCT00262925|Antiemetics|antiemetics|mesh-ancestor
65485046|NCT00262925|Autonomic Agents|autonomic agents|mesh-ancestor
65485047|NCT00262925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65485048|NCT00262925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65485049|NCT00262925|Glucocorticoids|glucocorticoids|mesh-ancestor
65485050|NCT00262925|Hormones|hormones|mesh-ancestor
65485051|NCT00262925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65485052|NCT00262925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65485053|NCT00262925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485054|NCT00262925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65485055|NCT00262925|Abortifacient Agents|abortifacient agents|mesh-ancestor
65485056|NCT00262925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65274253|NCT00092729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64477762|NCT01863667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65485057|NCT00262925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65485058|NCT00262925|Antimetabolites|antimetabolites|mesh-ancestor
65485059|NCT00262925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485060|NCT00262925|Dermatologic Agents|dermatologic agents|mesh-ancestor
65485061|NCT00262925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485062|NCT00262925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65485063|NCT00262925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65485064|NCT00262925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65485065|NCT00262925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65485066|NCT00262925|Antidotes|antidotes|mesh-ancestor
65485067|NCT00262925|Protective Agents|protective agents|mesh-ancestor
65485068|NCT00262925|Vitamin B Complex|vitamin b complex|mesh-ancestor
65485069|NCT00262925|Vitamins|vitamins|mesh-ancestor
65485070|NCT00262925|Micronutrients|micronutrients|mesh-ancestor
65485071|NCT00262925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65485072|NCT00262925|Tubulin Modulators|tubulin modulators|mesh-ancestor
65485073|NCT00262925|Antimitotic Agents|antimitotic agents|mesh-ancestor
65485074|NCT00262925|Mitosis Modulators|mitosis modulators|mesh-ancestor
65485075|NCT01581515|Everolimus|everolimus|mesh-list
65485076|NCT01581515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485107|NCT05329532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65485109|NCT01303640|Everolimus|everolimus|mesh-list
65485110|NCT01303640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485111|NCT01303640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65485112|NCT01303640|Immunologic Factors|immunologic factors|mesh-ancestor
65485113|NCT01303640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485114|NCT03817268|Capecitabine|capecitabine|mesh-list
65485115|NCT03817268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65485116|NCT03817268|Antimetabolites|antimetabolites|mesh-ancestor
65485117|NCT03817268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485118|NCT03817268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485119|NCT00280397|Lenvatinib|lenvatinib|mesh-list
65485120|NCT00280397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869020|NCT01820858|Paclitaxel|paclitaxel|mesh-list
65485151|NCT03814148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485152|NCT03814148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65485153|NCT03814148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65485154|NCT03814148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485155|NCT00279305|Rituximab|rituximab|mesh-list
65485156|NCT00279305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65485157|NCT00279305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485158|NCT00279305|Immunologic Factors|immunologic factors|mesh-ancestor
65485159|NCT00279305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485160|NCT00279305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65485161|NCT04224272|Fulvestrant|fulvestrant|mesh-list
65485162|NCT04224272|Palbociclib|palbociclib|mesh-list
65485163|NCT04224272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65485188|NCT03974867|Glucocorticoids|glucocorticoids|mesh-ancestor
65485190|NCT03974867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65485191|NCT03974867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485192|NCT03974867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65485193|NCT03974867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485194|NCT03974867|Antiemetics|antiemetics|mesh-ancestor
65485195|NCT03974867|Autonomic Agents|autonomic agents|mesh-ancestor
65485196|NCT03974867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65485197|NCT03974867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65485198|NCT03974867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65485199|NCT03974867|Protective Agents|protective agents|mesh-ancestor
65485200|NCT03799406|Vitamin D|vitamin d|mesh-list
65485201|NCT03799406|Cholecalciferol|cholecalciferol|mesh-list
65485202|NCT03799406|Vitamins|vitamins|mesh-ancestor
65485203|NCT03799406|Micronutrients|micronutrients|mesh-ancestor
65485204|NCT03799406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485205|NCT03799406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65485206|NCT03799406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65485207|NCT03799172|Echinocandins|echinocandins|mesh-list
65485208|NCT03799172|Antifungal Agents|antifungal agents|mesh-ancestor
65485209|NCT03799172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65485210|NCT03799094|Ascorbic Acid|ascorbic acid|mesh-list
65485211|NCT03799094|Vitamins|vitamins|mesh-ancestor
65485212|NCT03799094|Micronutrients|micronutrients|mesh-ancestor
65485213|NCT03799094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274254|NCT00092729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274255|NCT00092729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65485214|NCT03799094|Antioxidants|antioxidants|mesh-ancestor
64869101|NCT01821170|Dopamine Agents|dopamine agents|mesh-ancestor
65485236|NCT00262223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65485237|NCT00262223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485239|NCT00262223|Serotonin Agents|serotonin agents|mesh-ancestor
65485240|NCT00262223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485241|NCT05575700|Ibuprofen|ibuprofen|mesh-list
65485242|NCT05575700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65485243|NCT05575700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65485244|NCT05575700|Analgesics|analgesics|mesh-ancestor
65485245|NCT05575700|Sensory System Agents|sensory system agents|mesh-ancestor
65485246|NCT05575700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65485247|NCT05575700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485248|NCT05575700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65485249|NCT05575700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65485250|NCT05575700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65485251|NCT05575700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485252|NCT05575700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485253|NCT00276419|Diclofenac|diclofenac|mesh-list
65485254|NCT00276419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65485255|NCT00276419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65485256|NCT00276419|Analgesics|analgesics|mesh-ancestor
65485257|NCT00276419|Sensory System Agents|sensory system agents|mesh-ancestor
65485258|NCT00276419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65485259|NCT00276419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485260|NCT00276419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65485261|NCT00276419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65485262|NCT00276419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65485263|NCT00276419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485264|NCT00276419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485265|NCT05216432|Fulvestrant|fulvestrant|mesh-list
64869154|NCT01821430|Pregabalin|pregabalin|mesh-list
65485297|NCT01303874|Etanercept|etanercept|mesh-list
65485298|NCT01303874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65485299|NCT01303874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65485300|NCT01303874|Analgesics|analgesics|mesh-ancestor
65485301|NCT01303874|Sensory System Agents|sensory system agents|mesh-ancestor
65485302|NCT01303874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65485303|NCT01303874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485304|NCT01303874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65485305|NCT01303874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65485306|NCT01303874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65485307|NCT01303874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64869202|NCT01821612|Vitamins|vitamins|mesh-ancestor
65485338|NCT04109924|Immunologic Factors|immunologic factors|mesh-ancestor
65234859|NCT05291221|Analgesics|analgesics|mesh-ancestor
65485339|NCT04109924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65485340|NCT04109924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65485341|NCT04109924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485342|NCT04109924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485343|NCT04109924|Antimetabolites|antimetabolites|mesh-ancestor
65485344|NCT04109924|Antiviral Agents|antiviral agents|mesh-ancestor
65485345|NCT04109924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65485346|NCT04109924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65485347|NCT04070768|Venetoclax|venetoclax|mesh-list
65485348|NCT04070768|Gemtuzumab|gemtuzumab|mesh-list
65485349|NCT04070768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485350|NCT04070768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65485351|NCT01301612|Cisplatin|cisplatin|mesh-list
65485352|NCT01301612|Nimotuzumab|nimotuzumab|mesh-list
64869249|NCT01822080|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65485385|NCT01302236|Eplerenone|eplerenone|mesh-list
65485386|NCT01302236|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65485387|NCT01302236|Hormone Antagonists|hormone antagonists|mesh-ancestor
65485388|NCT01302236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65485389|NCT01302236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485390|NCT01302236|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65485391|NCT01302236|Diuretics|diuretics|mesh-ancestor
65485392|NCT01302236|Natriuretic Agents|natriuretic agents|mesh-ancestor
65485444|NCT03796364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485445|NCT03795584|Hemostatics|hemostatics|mesh-list
65273225|NCT02395601|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
65485446|NCT03795584|Coagulants|coagulants|mesh-ancestor
65485447|NCT03792776|Lidocaine|lidocaine|mesh-list
65485448|NCT03792776|Anesthetics|anesthetics|mesh-list
65485449|NCT03792776|Anesthetics, Local|anesthetics, local|mesh-ancestor
65485450|NCT03792776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65485451|NCT03792776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485452|NCT03792776|Sensory System Agents|sensory system agents|mesh-ancestor
65485453|NCT03792776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65485454|NCT03792776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65485455|NCT03792776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65485456|NCT03792776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65485457|NCT03792776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65485458|NCT03792776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485459|NCT03795272|Rucaparib|rucaparib|mesh-list
65485460|NCT03795272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65485461|NCT03795272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485567|NCT05624996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485568|NCT05624996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65485569|NCT05624996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65485570|NCT05624996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485571|NCT05624996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65485572|NCT05624996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65485573|NCT05624996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65485574|NCT05624996|Immunologic Factors|immunologic factors|mesh-ancestor
65485575|NCT05624996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485576|NCT05624996|Keratolytic Agents|keratolytic agents|mesh-ancestor
65485577|NCT05624996|Dermatologic Agents|dermatologic agents|mesh-ancestor
65485578|NCT03792152|Warfarin|warfarin|mesh-list
65485579|NCT03792152|Rivaroxaban|rivaroxaban|mesh-list
65485580|NCT03792152|Anticoagulants|anticoagulants|mesh-ancestor
65485581|NCT03792152|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65485582|NCT03792152|Antithrombins|antithrombins|mesh-ancestor
65485583|NCT03792152|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65485584|NCT03792152|Protease Inhibitors|protease inhibitors|mesh-ancestor
65485585|NCT03792152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485586|NCT03792152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485587|NCT00262067|Bevacizumab|bevacizumab|mesh-list
65485588|NCT00262067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65485589|NCT00262067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485590|NCT00262067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65485591|NCT00262067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65485592|NCT00262067|Growth Substances|growth substances|mesh-ancestor
65485593|NCT00262067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485594|NCT00262067|Growth Inhibitors|growth inhibitors|mesh-ancestor
65485595|NCT00275561|Fluticasone|fluticasone|mesh-list
65485596|NCT00275561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65485597|NCT00275561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65485598|NCT00275561|Autonomic Agents|autonomic agents|mesh-ancestor
65485599|NCT00275561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64869472|NCT01823809|Vasodilator Agents|vasodilator agents|mesh-ancestor
65485638|NCT03792074|Mitosis Modulators|mitosis modulators|mesh-ancestor
65485908|NCT05694416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485909|NCT05694416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485911|NCT03789422|Tranexamic Acid|tranexamic acid|mesh-list
65485912|NCT03789422|Levocetirizine|levocetirizine|mesh-list
65485913|NCT03789422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65485914|NCT03789422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65485915|NCT03789422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485916|NCT03789422|Hemostatics|hemostatics|mesh-ancestor
65485917|NCT03789422|Coagulants|coagulants|mesh-ancestor
65485918|NCT03789422|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65485919|NCT03789422|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65485920|NCT03789422|Histamine Antagonists|histamine antagonists|mesh-ancestor
65485921|NCT03789422|Histamine Agents|histamine agents|mesh-ancestor
65485922|NCT03789422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65485923|NCT03789422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485924|NCT03789422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65273226|NCT02395601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477972|NCT01386645|Antidotes|antidotes|mesh-ancestor
65485925|NCT04751084|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65485926|NCT04751084|Parasympatholytics|parasympatholytics|mesh-ancestor
65485927|NCT04751084|Autonomic Agents|autonomic agents|mesh-ancestor
65485928|NCT04751084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65485929|NCT04751084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485930|NCT04751084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65485931|NCT04751084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65485932|NCT04751084|Cholinergic Agents|cholinergic agents|mesh-ancestor
65485933|NCT04751084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65485934|NCT04751084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485935|NCT05690048|Vancomycin|vancomycin|mesh-list
65485936|NCT05690048|Bevacizumab|bevacizumab|mesh-list
65485937|NCT05690048|Atezolizumab|atezolizumab|mesh-list
65485938|NCT05690048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65485939|NCT05690048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485940|NCT05690048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65485941|NCT05690048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65485942|NCT05690048|Growth Substances|growth substances|mesh-ancestor
65485979|NCT03777488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65485980|NCT03777488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65485981|NCT03777488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485982|NCT03777488|Hemostatics|hemostatics|mesh-ancestor
65485983|NCT03777488|Coagulants|coagulants|mesh-ancestor
65485984|NCT03777254|RC28-E protein|rc28-e protein|mesh-list
65485985|NCT03777254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65486011|NCT01309022|Tacrolimus|tacrolimus|mesh-list
65486012|NCT01309022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65486013|NCT01309022|Immunologic Factors|immunologic factors|mesh-ancestor
65486014|NCT01309022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486015|NCT01309022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65486016|NCT01309022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486017|NCT01309022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486018|NCT01309022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65486019|NCT01309022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486020|NCT01309022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65486021|NCT01309022|Antitubercular Agents|antitubercular agents|mesh-ancestor
65486022|NCT01309022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65486023|NCT01309022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65486024|NCT01309022|Antifungal Agents|antifungal agents|mesh-ancestor
65486025|NCT01560962|Azithromycin|azithromycin|mesh-list
65486026|NCT01560962|Tobramycin|tobramycin|mesh-list
65486027|NCT01560962|Povidone-Iodine|povidone-iodine|mesh-list
65486028|NCT01560962|Povidone|povidone|mesh-list
65486029|NCT01560962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65486030|NCT01560962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65486031|NCT01560962|Plasma Substitutes|plasma substitutes|mesh-ancestor
65486032|NCT01560962|Blood Substitutes|blood substitutes|mesh-ancestor
65486033|NCT01560962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65486034|NCT05401058|Droperidol|droperidol|mesh-list
65486035|NCT05401058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65486036|NCT05401058|Antiemetics|antiemetics|mesh-ancestor
65486037|NCT05401058|Autonomic Agents|autonomic agents|mesh-ancestor
65486064|NCT01309178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65486065|NCT01309178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65486066|NCT01309178|Analgesics|analgesics|mesh-ancestor
65486067|NCT01309178|Sensory System Agents|sensory system agents|mesh-ancestor
65486068|NCT01309178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65486069|NCT01309178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486070|NCT01309178|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65486071|NCT01309178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65486072|NCT01309178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65486073|NCT01309178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486074|NCT01309178|Adrenergic Agents|adrenergic agents|mesh-ancestor
65486075|NCT01309178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65486076|NCT01309178|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65486077|NCT01309178|Diuretics|diuretics|mesh-ancestor
65486078|NCT01309178|Natriuretic Agents|natriuretic agents|mesh-ancestor
65486079|NCT01335334|Metronidazole|metronidazole|mesh-list
65486080|NCT01335334|Tetracycline|tetracycline|mesh-list
65486081|NCT01335334|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
65486082|NCT01335334|Omeprazole|omeprazole|mesh-list
65486083|NCT01335334|Bismuth|bismuth|mesh-list
65486084|NCT01335334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65486085|NCT01335334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65273227|NCT02395601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486086|NCT01335334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65486174|NCT03780686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65486176|NCT03780686|Protective Agents|protective agents|mesh-ancestor
65486177|NCT00338260|Atenolol|atenolol|mesh-list
65486178|NCT00338260|Adrenergic Agents|adrenergic agents|mesh-ancestor
65486179|NCT00338260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65486180|NCT00338260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486181|NCT00338260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486182|NCT00338260|Autonomic Agents|autonomic agents|mesh-ancestor
65486183|NCT00338260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65486184|NCT00338260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65486185|NCT00338260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65486186|NCT00338260|Sympatholytics|sympatholytics|mesh-ancestor
65486187|NCT00338260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65486188|NCT00338260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65486189|NCT00338260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65486190|NCT03775928|Capecitabine|capecitabine|mesh-list
65486191|NCT03775928|Apatinib|apatinib|mesh-list
65486192|NCT03775928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65486193|NCT03775928|Antimetabolites|antimetabolites|mesh-ancestor
65486250|NCT01320254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486252|NCT01320254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65486253|NCT01320254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486254|NCT01320254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65486255|NCT01320254|Immunologic Factors|immunologic factors|mesh-ancestor
65486256|NCT01320254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486257|NCT01320254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65486259|NCT00092638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65486260|NCT00092638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65486261|NCT00092638|Antimetabolites|antimetabolites|mesh-ancestor
65486262|NCT00092638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486263|NCT00092638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65486264|NCT03775382|Ascorbic Acid|ascorbic acid|mesh-list
65486265|NCT03775382|Vitamins|vitamins|mesh-ancestor
65486266|NCT03775382|Micronutrients|micronutrients|mesh-ancestor
65486267|NCT03775382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486268|NCT03775382|Antioxidants|antioxidants|mesh-ancestor
65486269|NCT03775382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486270|NCT03775382|Protective Agents|protective agents|mesh-ancestor
65486271|NCT03783728|Pyridoxine|pyridoxine|mesh-list
65486272|NCT03783728|Vitamin B 6|vitamin b 6|mesh-list
65486273|NCT03783728|Isoniazid|isoniazid|mesh-list
65486274|NCT03783728|Rifapentine|rifapentine|mesh-list
65486275|NCT03783728|Vitamins|vitamins|mesh-ancestor
65486276|NCT03783728|Micronutrients|micronutrients|mesh-ancestor
65486277|NCT03783728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486278|NCT03783728|Vitamin B Complex|vitamin b complex|mesh-ancestor
65486279|NCT03783728|Antitubercular Agents|antitubercular agents|mesh-ancestor
65486455|NCT03779360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65486456|NCT03779360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65486457|NCT03779360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486458|NCT03779360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486460|NCT01320878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65486461|NCT01320878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65486462|NCT01320878|Vasodilator Agents|vasodilator agents|mesh-ancestor
65486463|NCT01321034|Niacin|niacin|mesh-list
65486464|NCT01321034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65486465|NCT01321034|Antimetabolites|antimetabolites|mesh-ancestor
65486466|NCT01321034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486467|NCT01321034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65486468|NCT01321034|Vasodilator Agents|vasodilator agents|mesh-ancestor
65486469|NCT01321034|Vitamin B Complex|vitamin b complex|mesh-ancestor
65486470|NCT01321034|Vitamins|vitamins|mesh-ancestor
65235985|NCT00606164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486472|NCT01321034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486473|NCT05254184|Nivolumab|nivolumab|mesh-list
65486530|NCT03772262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65486531|NCT03772262|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65486532|NCT03772262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486533|NCT03772262|Diuretics|diuretics|mesh-ancestor
65486534|NCT03772262|Natriuretic Agents|natriuretic agents|mesh-ancestor
65486535|NCT03772262|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65486536|NCT03772262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65273228|NCT00632645|Olanzapine|olanzapine|mesh-list
65486537|NCT03772106|Propofol|propofol|mesh-list
65486538|NCT03772106|Sevoflurane|sevoflurane|mesh-list
65486539|NCT03772106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65486540|NCT03772106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65486541|NCT03772106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486542|NCT03772106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65486543|NCT03772106|Anesthetics, General|anesthetics, general|mesh-ancestor
65486544|NCT03772106|Anesthetics|anesthetics|mesh-ancestor
65486545|NCT03772106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65486546|NCT03772106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65486547|NCT01345240|Vaccines|vaccines|mesh-list
65486548|NCT01345240|Immunologic Factors|immunologic factors|mesh-ancestor
65486549|NCT01345240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486550|NCT03771638|Tenofovir|tenofovir|mesh-list
65486614|NCT03768908|Amodiaquine|amodiaquine|mesh-list
65486615|NCT03768908|Antimalarials|antimalarials|mesh-ancestor
65486616|NCT03768908|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65486617|NCT03768908|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65486618|NCT03768908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65486619|NCT03768908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486620|NCT03768908|Antiviral Agents|antiviral agents|mesh-ancestor
65486621|NCT03768908|Schistosomicides|schistosomicides|mesh-ancestor
65486622|NCT03768908|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65486624|NCT03777878|Oxytocin|oxytocin|mesh-list
65486730|NCT01345708|Prednisone|prednisone|mesh-list
65486731|NCT01345708|Rituximab|rituximab|mesh-list
65486732|NCT01345708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65486768|NCT03948022|Dydrogesterone|dydrogesterone|mesh-list
65486769|NCT03948022|Progestins|progestins|mesh-ancestor
65486770|NCT03948022|Hormones|hormones|mesh-ancestor
65486771|NCT03948022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65486772|NCT03948022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486773|NCT03777644|Morphine|morphine|mesh-list
65486824|NCT04459234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65486825|NCT04459234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65486826|NCT04459234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65486827|NCT04459234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486828|NCT01336348|Tirofiban|tirofiban|mesh-list
65486829|NCT01336348|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65486830|NCT01336348|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65486831|NCT01336348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65486832|NCT01336348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65486833|NCT01336348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486834|NCT01346254|Pioglitazone|pioglitazone|mesh-list
65486835|NCT01346254|Vildagliptin|vildagliptin|mesh-list
65486836|NCT01346254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65486837|NCT01346254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486838|NCT01346254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65486839|NCT01346254|Protease Inhibitors|protease inhibitors|mesh-ancestor
65486840|NCT01346254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486841|NCT01346254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486842|NCT04592536|Alprazolam|alprazolam|mesh-list
65486843|NCT04592536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65486844|NCT04592536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65486910|NCT04276376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486911|NCT04276376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65486912|NCT04276376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486913|NCT04276376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486915|NCT04254692|Anesthetics, Local|anesthetics, local|mesh-ancestor
65486916|NCT04254692|Anesthetics|anesthetics|mesh-ancestor
65486917|NCT04254692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65486918|NCT04254692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486919|NCT04254692|Sensory System Agents|sensory system agents|mesh-ancestor
65486920|NCT04254692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65486921|NCT03770000|Romidepsin|romidepsin|mesh-list
65486922|NCT03770000|Tenalisib|tenalisib|mesh-list
65486993|NCT00654628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65486995|NCT00536380|Loratadine|loratadine|mesh-list
65486996|NCT00536380|Desloratadine|desloratadine|mesh-list
65486997|NCT00536380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65486998|NCT00536380|Cholinergic Agents|cholinergic agents|mesh-ancestor
65486999|NCT00536380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65487000|NCT00536380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487001|NCT00536380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487002|NCT00536380|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65487003|NCT00536380|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65487004|NCT00536380|Histamine Antagonists|histamine antagonists|mesh-ancestor
65487005|NCT00536380|Histamine Agents|histamine agents|mesh-ancestor
65487006|NCT00536380|Antipruritics|antipruritics|mesh-ancestor
65487007|NCT00536380|Dermatologic Agents|dermatologic agents|mesh-ancestor
65487008|NCT00536380|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65487009|NCT01337362|Insulin|insulin|mesh-list
65487010|NCT01337362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65487011|NCT01337362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65487012|NCT01337362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487013|NCT03762824|Vaccines|vaccines|mesh-list
65487014|NCT03762824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65487015|NCT03762824|Immunologic Factors|immunologic factors|mesh-ancestor
65487016|NCT03762824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487017|NCT00496834|Losartan|losartan|mesh-list
65487018|NCT00496834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65487019|NCT00496834|Carvedilol|carvedilol|mesh-list
65487020|NCT00496834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65487021|NCT00496834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65487022|NCT00496834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65487071|NCT01347814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487072|NCT04505098|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
65487073|NCT04505098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65487075|NCT01348126|Docetaxel|docetaxel|mesh-list
65487076|NCT01348126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487077|NCT01348126|Tubulin Modulators|tubulin modulators|mesh-ancestor
65487078|NCT01348126|Antimitotic Agents|antimitotic agents|mesh-ancestor
65487079|NCT01348126|Mitosis Modulators|mitosis modulators|mesh-ancestor
65487080|NCT01348126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487081|NCT01348204|Quercetin|quercetin|mesh-list
65487082|NCT01348204|Antioxidants|antioxidants|mesh-ancestor
65487083|NCT01348204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487084|NCT01348204|Protective Agents|protective agents|mesh-ancestor
65487085|NCT01348204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487086|NCT00166504|Atorvastatin|atorvastatin|mesh-list
65487087|NCT00166504|Simvastatin|simvastatin|mesh-list
65487088|NCT00166504|Ezetimibe|ezetimibe|mesh-list
65487089|NCT00166504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65487090|NCT00166504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65487091|NCT00166504|Antimetabolites|antimetabolites|mesh-ancestor
65487092|NCT00166504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487093|NCT00166504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65487094|NCT00166504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65487095|NCT00166504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487096|NCT01348282|Rivastigmine|rivastigmine|mesh-list
65487097|NCT01348282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487098|NCT01348282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870874|NCT01842373|Lidocaine|lidocaine|mesh-list
65487136|NCT01352572|Nortriptyline|nortriptyline|mesh-list
65487137|NCT01352572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65487138|NCT01352572|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65487218|NCT03761264|Zinc Oxide|zinc oxide|mesh-list
65487219|NCT03761264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487220|NCT03761264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65487221|NCT03761264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65487222|NCT03761264|Dermatologic Agents|dermatologic agents|mesh-ancestor
65487223|NCT03761264|Sunscreening Agents|sunscreening agents|mesh-ancestor
65487224|NCT03761264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65487225|NCT03761264|Protective Agents|protective agents|mesh-ancestor
65487227|NCT05096312|Adapalene|adapalene|mesh-list
65487228|NCT05096312|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
65487229|NCT05096312|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65487230|NCT05096312|Trace Elements|trace elements|mesh-ancestor
65487231|NCT05096312|Micronutrients|micronutrients|mesh-ancestor
65487232|NCT05096312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487233|NCT05096312|Dermatologic Agents|dermatologic agents|mesh-ancestor
65487234|NCT05096312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65487235|NCT05096312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65487236|NCT05096312|Analgesics|analgesics|mesh-ancestor
65487237|NCT05096312|Sensory System Agents|sensory system agents|mesh-ancestor
65487238|NCT05096312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65487239|NCT05096312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64871007|NCT01843296|Narcotics|narcotics|mesh-ancestor
65487296|NCT03110380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65487298|NCT03757910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65273229|NCT00632645|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
65273230|NCT00632645|Tetrabenazine|tetrabenazine|mesh-list
65273231|NCT00632645|Antiemetics|antiemetics|mesh-ancestor
65273232|NCT00632645|Autonomic Agents|autonomic agents|mesh-ancestor
65274256|NCT00092729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65487299|NCT01322204|Codeine|codeine|mesh-list
65487300|NCT01322204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65487301|NCT01322204|Narcotics|narcotics|mesh-ancestor
65487302|NCT01322204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65487303|NCT01322204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487304|NCT01322204|Analgesics|analgesics|mesh-ancestor
65487305|NCT01322204|Sensory System Agents|sensory system agents|mesh-ancestor
65487306|NCT01322204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65487307|NCT01322204|Antitussive Agents|antitussive agents|mesh-ancestor
65487308|NCT01322204|Respiratory System Agents|respiratory system agents|mesh-ancestor
65487309|NCT03766490|Gefitinib|gefitinib|mesh-list
64871079|NCT01843738|Vemurafenib|vemurafenib|mesh-list
65487408|NCT03757052|Amoxicillin|amoxicillin|mesh-list
65487409|NCT03757052|Penicillins|penicillins|mesh-list
65487410|NCT03757052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65487411|NCT03757052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64871273|NCT01844804|Infliximab|infliximab|mesh-list
65487654|NCT00031590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487655|NCT00031590|Tubulin Modulators|tubulin modulators|mesh-ancestor
65487656|NCT00031590|Antimitotic Agents|antimitotic agents|mesh-ancestor
65487657|NCT00031590|Mitosis Modulators|mitosis modulators|mesh-ancestor
65487658|NCT01318096|Tenofovir|tenofovir|mesh-list
65487659|NCT01318096|Lamivudine|lamivudine|mesh-list
65487660|NCT01318096|Efavirenz|efavirenz|mesh-list
65487661|NCT01318096|Raltegravir Potassium|raltegravir potassium|mesh-list
65487662|NCT01318096|Antiviral Agents|antiviral agents|mesh-ancestor
65487663|NCT01318096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65487664|NCT01318096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65487665|NCT01318096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65487666|NCT01318096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487667|NCT01318096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487668|NCT01318096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65487669|NCT01318096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65237191|NCT02557087|Meperidine|meperidine|mesh-list
65487670|NCT01318096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65487671|NCT01318096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65487672|NCT01318096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65487673|NCT01318096|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65487674|NCT01318096|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65487675|NCT01318096|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65487676|NCT01318096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65487677|NCT01318096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65487678|NCT02530320|Palbociclib|palbociclib|mesh-list
65487679|NCT02530320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487680|NCT02530320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65487681|NCT02530320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487682|NCT02530320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487683|NCT00239681|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65487684|NCT00239681|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65487685|NCT00239681|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65487712|NCT02532023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487713|NCT02532023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487714|NCT01354522|Cyclophosphamide|cyclophosphamide|mesh-list
65487716|NCT01354522|Doxorubicin|doxorubicin|mesh-list
65487717|NCT01354522|Capecitabine|capecitabine|mesh-list
65487718|NCT01354522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65487719|NCT01354522|Immunologic Factors|immunologic factors|mesh-ancestor
65487720|NCT01354522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487721|NCT01354522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65487722|NCT01354522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65487723|NCT01354522|Alkylating Agents|alkylating agents|mesh-ancestor
65487724|NCT01354522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487725|NCT01354522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487726|NCT01354522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65487727|NCT01354522|Tubulin Modulators|tubulin modulators|mesh-ancestor
65487728|NCT01354522|Antimitotic Agents|antimitotic agents|mesh-ancestor
65487729|NCT01354522|Mitosis Modulators|mitosis modulators|mesh-ancestor
65487730|NCT01354522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65273233|NCT00632645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65487731|NCT01354522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64871466|NCT01845701|Artesunate|artesunate|mesh-list
65487762|NCT01350622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65487763|NCT01350622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65487764|NCT01350622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487765|NCT01350622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487766|NCT01096212|Sevoflurane|sevoflurane|mesh-list
65487767|NCT01096212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65487768|NCT01096212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65487769|NCT01096212|Anesthetics, General|anesthetics, general|mesh-ancestor
65487770|NCT01096212|Anesthetics|anesthetics|mesh-ancestor
65487771|NCT01096212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65487772|NCT01096212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487773|NCT03139240|Oxycodone|oxycodone|mesh-list
65487774|NCT03139240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65487853|NCT00042432|Cinacalcet|cinacalcet|mesh-list
65487854|NCT00042432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65487855|NCT00042432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487856|NCT00042432|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65487857|NCT00042432|Hormone Antagonists|hormone antagonists|mesh-ancestor
65487858|NCT00042432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65487859|NCT01352338|Prednisone|prednisone|mesh-list
65487860|NCT01352338|Cyclophosphamide|cyclophosphamide|mesh-list
65487861|NCT01352338|Lenalidomide|lenalidomide|mesh-list
65487862|NCT01352338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65487863|NCT01352338|Immunologic Factors|immunologic factors|mesh-ancestor
65487864|NCT01352338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487865|NCT01352338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65487866|NCT01352338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65487867|NCT01352338|Alkylating Agents|alkylating agents|mesh-ancestor
65487868|NCT01352338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487869|NCT01352338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487870|NCT01352338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65487871|NCT01352338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65487872|NCT01352338|Glucocorticoids|glucocorticoids|mesh-ancestor
65487873|NCT01352338|Hormones|hormones|mesh-ancestor
65487874|NCT01352338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65487875|NCT01352338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65487876|NCT01352338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65487877|NCT01352338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65487878|NCT01352338|Growth Substances|growth substances|mesh-ancestor
65487879|NCT01352338|Growth Inhibitors|growth inhibitors|mesh-ancestor
65487880|NCT01542736|Carboplatin|carboplatin|mesh-list
65487915|NCT03950700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65487916|NCT03950700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487917|NCT03950700|Sensory System Agents|sensory system agents|mesh-ancestor
65487918|NCT03950700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64871663|NCT01847339|Anesthetics, Local|anesthetics, local|mesh-ancestor
65488003|NCT01362400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488004|NCT00003102|Antibodies|antibodies|mesh-list
65488005|NCT00003102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65488006|NCT00003102|Immunologic Factors|immunologic factors|mesh-ancestor
65488007|NCT00003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488008|NCT00002850|Ciprofloxacin|ciprofloxacin|mesh-list
65488009|NCT00002850|Ofloxacin|ofloxacin|mesh-list
65488010|NCT00002850|Trimethoprim|trimethoprim|mesh-list
65488011|NCT00002850|Sulfamethoxazole|sulfamethoxazole|mesh-list
65488012|NCT00002850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64871748|NCT01847872|Vaccines|vaccines|mesh-list
65488040|NCT04234906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65488041|NCT04234906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65488042|NCT04234906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65488043|NCT04234906|Adrenergic Agents|adrenergic agents|mesh-ancestor
65488044|NCT04234906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65488045|NCT04234906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488047|NCT04234906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65488048|NCT04234906|Anticonvulsants|anticonvulsants|mesh-ancestor
65488049|NCT04234906|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65488050|NCT04234906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65488051|NCT04234906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65488052|NCT04234906|Tocolytic Agents|tocolytic agents|mesh-ancestor
65488053|NCT04234906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65273234|NCT00632645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488054|NCT04234906|Vasodilator Agents|vasodilator agents|mesh-ancestor
65488055|NCT04234906|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65488056|NCT04234906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65488057|NCT04234906|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65488058|NCT04234906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65488059|NCT04234906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488060|NCT04234906|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65488061|NCT04234906|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65488062|NCT04234906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65488063|NCT04234906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65488064|NCT00002766|Cytarabine|cytarabine|mesh-list
65488065|NCT00002766|Dactinomycin|dactinomycin|mesh-list
65488066|NCT00002766|Prednisone|prednisone|mesh-list
65488067|NCT00002766|Cyclophosphamide|cyclophosphamide|mesh-list
65488068|NCT00002766|Carmustine|carmustine|mesh-list
65488069|NCT00002766|Doxorubicin|doxorubicin|mesh-list
65488070|NCT00002766|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65488071|NCT00002766|Methotrexate|methotrexate|mesh-list
65488072|NCT00002766|Etoposide|etoposide|mesh-list
65488073|NCT00002766|Vincristine|vincristine|mesh-list
65488074|NCT00002766|Daunorubicin|daunorubicin|mesh-list
65488075|NCT00002766|Mitoxantrone|mitoxantrone|mesh-list
65488076|NCT00002766|Mercaptopurine|mercaptopurine|mesh-list
65488077|NCT00002766|Pegaspargase|pegaspargase|mesh-list
65488078|NCT00002766|Sargramostim|sargramostim|mesh-list
65488079|NCT00002766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65488080|NCT00002766|Immunologic Factors|immunologic factors|mesh-ancestor
65488081|NCT00002766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488082|NCT00002766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65488083|NCT00002766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65488084|NCT00002766|Alkylating Agents|alkylating agents|mesh-ancestor
65488085|NCT00002766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488086|NCT00002766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488087|NCT00002766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65488088|NCT00002766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65488089|NCT00002766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65488090|NCT00002766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65488091|NCT00002766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488092|NCT00002766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65488093|NCT00002766|Glucocorticoids|glucocorticoids|mesh-ancestor
65488094|NCT00002766|Hormones|hormones|mesh-ancestor
65488095|NCT00002766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65488096|NCT00002766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65488097|NCT00002766|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65488098|NCT00002766|Abortifacient Agents|abortifacient agents|mesh-ancestor
65488099|NCT00002766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65488100|NCT00002766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65488101|NCT00002766|Antimetabolites|antimetabolites|mesh-ancestor
65488102|NCT00002766|Dermatologic Agents|dermatologic agents|mesh-ancestor
65488103|NCT00002766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65488104|NCT00002766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65488105|NCT00002766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65488106|NCT00002766|Antiviral Agents|antiviral agents|mesh-ancestor
65488107|NCT00002766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65488108|NCT00002766|Tubulin Modulators|tubulin modulators|mesh-ancestor
65488109|NCT00002766|Antimitotic Agents|antimitotic agents|mesh-ancestor
65488110|NCT00002766|Mitosis Modulators|mitosis modulators|mesh-ancestor
65488111|NCT00002766|Analgesics|analgesics|mesh-ancestor
65488112|NCT00002766|Sensory System Agents|sensory system agents|mesh-ancestor
65488175|NCT01103154|Autonomic Agents|autonomic agents|mesh-ancestor
65488176|NCT01103154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64871910|NCT01848873|Amlodipine|amlodipine|mesh-list
65488213|NCT00256997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488214|NCT00256997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488274|NCT03949062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65488275|NCT03949062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488276|NCT03949062|Immunologic Factors|immunologic factors|mesh-ancestor
65488277|NCT03949062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488278|NCT03949062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65488279|NCT03949062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65488280|NCT03949062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65488281|NCT03949062|Growth Substances|growth substances|mesh-ancestor
65488282|NCT03949062|Growth Inhibitors|growth inhibitors|mesh-ancestor
65488283|NCT00235391|Deferasirox|deferasirox|mesh-list
65274257|NCT00092729|Gout Suppressants|gout suppressants|mesh-ancestor
65488284|NCT00235391|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65488285|NCT00235391|Chelating Agents|chelating agents|mesh-ancestor
65488286|NCT00235391|Sequestering Agents|sequestering agents|mesh-ancestor
65488287|NCT00235391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488288|NCT01103622|Digoxin|digoxin|mesh-list
65488289|NCT01103622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65488290|NCT01103622|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65488291|NCT01103622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488292|NCT01103622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488293|NCT01103622|Protective Agents|protective agents|mesh-ancestor
65488294|NCT01103622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488295|NCT01072955|Heparin|heparin|mesh-list
65488296|NCT01072955|Calcium heparin|calcium heparin|mesh-list
65488297|NCT01072955|Anticoagulants|anticoagulants|mesh-ancestor
65488298|NCT01072955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65488299|NCT01072955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65488300|NCT01072955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488301|NCT00026208|Prednisone|prednisone|mesh-list
65488302|NCT00026208|Cyclophosphamide|cyclophosphamide|mesh-list
65488303|NCT00026208|Doxorubicin|doxorubicin|mesh-list
65488304|NCT00026208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65488305|NCT00026208|Etoposide|etoposide|mesh-list
65488306|NCT00026208|Etoposide phosphate|etoposide phosphate|mesh-list
65488307|NCT00026208|Vincristine|vincristine|mesh-list
65488308|NCT00026208|Bleomycin|bleomycin|mesh-list
65488309|NCT00026208|Vinblastine|vinblastine|mesh-list
65488310|NCT00026208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65488311|NCT00026208|Immunologic Factors|immunologic factors|mesh-ancestor
65488312|NCT00026208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488313|NCT00026208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65488314|NCT00026208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65488315|NCT00026208|Alkylating Agents|alkylating agents|mesh-ancestor
65488316|NCT00026208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488317|NCT00026208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488318|NCT00026208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65488319|NCT00026208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65488320|NCT00026208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65488321|NCT00026208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65488322|NCT00026208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488323|NCT00026208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65488324|NCT00026208|Glucocorticoids|glucocorticoids|mesh-ancestor
65488325|NCT00026208|Hormones|hormones|mesh-ancestor
65488326|NCT00026208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65488327|NCT00026208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65488328|NCT00026208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65488329|NCT00026208|Tubulin Modulators|tubulin modulators|mesh-ancestor
65488330|NCT00026208|Antimitotic Agents|antimitotic agents|mesh-ancestor
65488331|NCT00026208|Mitosis Modulators|mitosis modulators|mesh-ancestor
65488332|NCT02955290|Pembrolizumab|pembrolizumab|mesh-list
65488367|NCT02922764|Docetaxel|docetaxel|mesh-list
65488368|NCT02922764|Pembrolizumab|pembrolizumab|mesh-list
65488369|NCT02922764|Pemetrexed|pemetrexed|mesh-list
65488370|NCT02922764|Ipilimumab|ipilimumab|mesh-list
65488371|NCT02922764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488372|NCT02922764|Tubulin Modulators|tubulin modulators|mesh-ancestor
65488373|NCT02922764|Antimitotic Agents|antimitotic agents|mesh-ancestor
65488374|NCT02922764|Mitosis Modulators|mitosis modulators|mesh-ancestor
65488375|NCT02922764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488376|NCT02922764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65488377|NCT02922764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488439|NCT04640168|Antiviral Agents|antiviral agents|mesh-ancestor
65488440|NCT04640168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65488441|NCT00022698|Capecitabine|capecitabine|mesh-list
65488442|NCT00022698|Irinotecan|irinotecan|mesh-list
65488443|NCT00022698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65488444|NCT00022698|Antimetabolites|antimetabolites|mesh-ancestor
65488445|NCT00022698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488446|NCT00022698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488447|NCT00022698|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65488448|NCT00022698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65488449|NCT00022698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488450|NCT03951402|Moxifloxacin|moxifloxacin|mesh-list
65488451|NCT03951402|Tapentadol|tapentadol|mesh-list
65488452|NCT03951402|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65488453|NCT03951402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65273235|NCT00632645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65488454|NCT03951402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65488455|NCT03951402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65488456|NCT03951402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65488515|NCT03949842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65488516|NCT03949842|Autonomic Agents|autonomic agents|mesh-ancestor
65488517|NCT03949842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65488518|NCT03949842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488519|NCT03949842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65488520|NCT03949842|Respiratory System Agents|respiratory system agents|mesh-ancestor
65488521|NCT03949842|Dermatologic Agents|dermatologic agents|mesh-ancestor
65488522|NCT03949842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65488523|NCT03949842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64872230|NCT01851473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65488556|NCT05626140|Codeine|codeine|mesh-list
65488557|NCT05626140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65488558|NCT05626140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65488559|NCT05626140|Analgesics|analgesics|mesh-ancestor
65488560|NCT05626140|Sensory System Agents|sensory system agents|mesh-ancestor
65488561|NCT05626140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65488562|NCT05626140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488563|NCT05626140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65488564|NCT05626140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65488565|NCT05626140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64872278|NCT01851681|Amoxicillin|amoxicillin|mesh-list
65488608|NCT00234065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65488609|NCT00234065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65488610|NCT00234065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65488611|NCT00234065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488612|NCT00234065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65488613|NCT00234065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65488614|NCT00234065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488616|NCT00234065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65488617|NCT00234065|Autonomic Agents|autonomic agents|mesh-ancestor
65488618|NCT00234065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65488619|NCT00234065|Respiratory System Agents|respiratory system agents|mesh-ancestor
65488620|NCT00234065|Vasodilator Agents|vasodilator agents|mesh-ancestor
65488621|NCT00234065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65488622|NCT00234065|Protective Agents|protective agents|mesh-ancestor
65488623|NCT00234065|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65488624|NCT00234065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65488625|NCT01108848|Complement C1s|complement c1s|mesh-list
65488626|NCT01108848|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
65488627|NCT01108848|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
65488628|NCT01108848|Immunologic Factors|immunologic factors|mesh-ancestor
65488629|NCT01108848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488630|NCT01108848|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65488631|NCT01108848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65488632|NCT04660812|Bevacizumab|bevacizumab|mesh-list
65488745|NCT01363336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65488746|NCT01363336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488852|NCT05460416|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64872560|NCT01853956|Alprazolam|alprazolam|mesh-list
65488874|NCT03066622|Autonomic Agents|autonomic agents|mesh-ancestor
65488875|NCT03066622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65488876|NCT03066622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488877|NCT03066622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65488878|NCT03066622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65488879|NCT03066622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65488880|NCT03066622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65488881|NCT03066622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65488882|NCT03066622|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65488883|NCT03066622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65488884|NCT03066622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65488885|NCT03066622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488886|NCT03066622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65488887|NCT03066622|Serotonin Agents|serotonin agents|mesh-ancestor
65488888|NCT01364974|Peficitinib|peficitinib|mesh-list
65488889|NCT01364974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488890|NCT01364974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488891|NCT01364974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65488892|NCT01364974|Immunologic Factors|immunologic factors|mesh-ancestor
65273236|NCT00632645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64478639|NCT03599427|Anesthetics|anesthetics|mesh-ancestor
65488893|NCT01364974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488894|NCT05323214|Fentanyl|fentanyl|mesh-list
65488895|NCT05323214|Dexmedetomidine|dexmedetomidine|mesh-list
65488896|NCT05323214|Analgesics|analgesics|mesh-list
65488897|NCT05323214|Bupivacaine|bupivacaine|mesh-list
65488898|NCT05323214|Anesthetics, Local|anesthetics, local|mesh-ancestor
65488899|NCT05323214|Anesthetics|anesthetics|mesh-ancestor
65488900|NCT05323214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65488901|NCT05323214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488902|NCT05323214|Sensory System Agents|sensory system agents|mesh-ancestor
65488903|NCT05323214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65488904|NCT05323214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65488905|NCT05323214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65488994|NCT01365676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488995|NCT03754712|Vitamin D|vitamin d|mesh-list
65488996|NCT03754712|Cholecalciferol|cholecalciferol|mesh-list
65488997|NCT03754712|Vitamins|vitamins|mesh-ancestor
65488998|NCT03754712|Micronutrients|micronutrients|mesh-ancestor
65488999|NCT03754712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489000|NCT03754712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65489001|NCT03754712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65489002|NCT03754634|Diacetylrhein|diacetylrhein|mesh-list
65489003|NCT03754634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65489004|NCT00070018|Prednisone|prednisone|mesh-list
65489005|NCT00070018|Cyclophosphamide|cyclophosphamide|mesh-list
65489006|NCT00070018|Rituximab|rituximab|mesh-list
65489007|NCT00070018|Doxorubicin|doxorubicin|mesh-list
65489008|NCT00070018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65489040|NCT03991988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489041|NCT03991988|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65489042|NCT03991988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65489043|NCT03991988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489045|NCT01073189|Furosemide|furosemide|mesh-list
65489046|NCT01073189|Diuretics|diuretics|mesh-ancestor
65489047|NCT01073189|Natriuretic Agents|natriuretic agents|mesh-ancestor
64872745|NCT01855061|GABA Modulators|gaba modulators|mesh-ancestor
65489203|NCT03972683|Purinergic Agonists|purinergic agonists|mesh-ancestor
65489204|NCT03972683|Purinergic Agents|purinergic agents|mesh-ancestor
65489205|NCT03972683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65489206|NCT03972683|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65489207|NCT03972683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65489208|NCT04411628|Bamlanivimab|bamlanivimab|mesh-list
65489209|NCT04411628|Antiviral Agents|antiviral agents|mesh-ancestor
65489210|NCT04411628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65489211|NCT03754010|Hyaluronic Acid|hyaluronic acid|mesh-list
65489212|NCT03754010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65489213|NCT03754010|Immunologic Factors|immunologic factors|mesh-ancestor
65489214|NCT03754010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489215|NCT03754010|Viscosupplements|viscosupplements|mesh-ancestor
65489216|NCT03754010|Protective Agents|protective agents|mesh-ancestor
65489217|NCT00227591|Prednisone|prednisone|mesh-list
65489218|NCT00227591|Lenalidomide|lenalidomide|mesh-list
65489219|NCT00227591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65489291|NCT05261516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489292|NCT05261516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65489294|NCT05261516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65489295|NCT00226655|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
65489296|NCT00226655|Hormones|hormones|mesh-ancestor
65489297|NCT00226655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65489298|NCT00226655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489299|NCT03691376|Aldesleukin|aldesleukin|mesh-list
65489300|NCT03691376|Melphalan|melphalan|mesh-list
65489301|NCT03691376|Mechlorethamine|mechlorethamine|mesh-list
65489302|NCT03691376|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65489303|NCT03691376|Interleukin-2|interleukin-2|mesh-list
65489363|NCT05171166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489364|NCT05171166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65489365|NCT05171166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489366|NCT05171166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65489367|NCT05171166|Immunologic Factors|immunologic factors|mesh-ancestor
65489396|NCT03747536|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65489397|NCT03747536|Autonomic Agents|autonomic agents|mesh-ancestor
65489398|NCT03747536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65489399|NCT03747536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273237|NCT00632645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64713999|NCT03043105|Glucocorticoids|glucocorticoids|mesh-ancestor
65489400|NCT03747536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65489401|NCT03747536|Respiratory System Agents|respiratory system agents|mesh-ancestor
65489402|NCT03747536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65489403|NCT03747536|Cholinergic Agents|cholinergic agents|mesh-ancestor
65489404|NCT03747536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65489405|NCT03747536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489406|NCT04734080|Dronabinol|dronabinol|mesh-list
65489407|NCT04734080|Hallucinogens|hallucinogens|mesh-ancestor
65489408|NCT04734080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489409|NCT04734080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65489410|NCT04734080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65489411|NCT04734080|Analgesics|analgesics|mesh-ancestor
65489412|NCT04734080|Sensory System Agents|sensory system agents|mesh-ancestor
65489413|NCT04734080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65489414|NCT04734080|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65489580|NCT01111656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65489581|NCT01111656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65489582|NCT01111656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489583|NCT01111656|Immunologic Factors|immunologic factors|mesh-ancestor
65489584|NCT01111656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489585|NCT01111656|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65489586|NCT02819752|Pembrolizumab|pembrolizumab|mesh-list
65489592|NCT02567578|Serotonin Agents|serotonin agents|mesh-ancestor
65489593|NCT02567578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65489594|NCT02567578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489595|NCT02567578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489596|NCT02523274|Resveratrol|resveratrol|mesh-list
65489597|NCT02523274|Antioxidants|antioxidants|mesh-ancestor
65489598|NCT02523274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489599|NCT02523274|Protective Agents|protective agents|mesh-ancestor
65489600|NCT02523274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489601|NCT02523274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489602|NCT02523274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65489603|NCT02432560|Sirolimus|sirolimus|mesh-list
65489604|NCT02432560|Everolimus|everolimus|mesh-list
65489605|NCT02432560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489606|NCT02432560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65489607|NCT02432560|Immunologic Factors|immunologic factors|mesh-ancestor
65489608|NCT02432560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489609|NCT02432560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65489610|NCT02432560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65489611|NCT02432560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65489612|NCT02432560|Antifungal Agents|antifungal agents|mesh-ancestor
65489613|NCT01111734|Acetylcysteine|acetylcysteine|mesh-list
65489614|NCT01111734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65489615|NCT01111734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489616|NCT01111734|Antiviral Agents|antiviral agents|mesh-ancestor
65489617|NCT01111734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65489618|NCT01111734|Expectorants|expectorants|mesh-ancestor
65489619|NCT01111734|Respiratory System Agents|respiratory system agents|mesh-ancestor
65489620|NCT01111734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65489621|NCT01111734|Antioxidants|antioxidants|mesh-ancestor
65489622|NCT01111734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489623|NCT01111734|Protective Agents|protective agents|mesh-ancestor
65489624|NCT01111734|Antidotes|antidotes|mesh-ancestor
65489625|NCT01698138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65489626|NCT01698138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65489627|NCT01698138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65489628|NCT01698138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65489629|NCT01698138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489630|NCT01698138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65489631|NCT01698138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65489632|NCT01698138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489633|NCT01698138|Cholinergic Agents|cholinergic agents|mesh-ancestor
65489634|NCT01698138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65489635|NCT01111890|Timolol|timolol|mesh-list
65489636|NCT01111890|Dorzolamide|dorzolamide|mesh-list
65489637|NCT01111890|Brinzolamide|brinzolamide|mesh-list
65489638|NCT01111890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65489639|NCT01111890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65489640|NCT01111890|Adrenergic Agents|adrenergic agents|mesh-ancestor
65489641|NCT01111890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65273238|NCT00632645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65489642|NCT01111890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489643|NCT01111890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489644|NCT01111890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65489645|NCT01111890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65489646|NCT01111890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65489647|NCT01111890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489648|NCT00745134|Curcumin|curcumin|mesh-list
65489649|NCT00745134|Capecitabine|capecitabine|mesh-list
65489650|NCT00745134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65489651|NCT00745134|Antimetabolites|antimetabolites|mesh-ancestor
65489652|NCT00745134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489653|NCT00745134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489654|NCT00745134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65489655|NCT00745134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65489693|NCT01319188|Ranibizumab|ranibizumab|mesh-list
65489763|NCT01328340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65489764|NCT01328340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65489765|NCT01328340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65489766|NCT03796728|Lidocaine|lidocaine|mesh-list
65489796|NCT00352534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65489797|NCT01328106|Trametinib|trametinib|mesh-list
65489798|NCT01328106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489799|NCT01328106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65489800|NCT01328106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489801|NCT01328106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489802|NCT05010590|Denosumab|denosumab|mesh-list
65489803|NCT05010590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65489804|NCT05010590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489805|NCT03122548|Pembrolizumab|pembrolizumab|mesh-list
65489806|NCT03122548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65489807|NCT03122548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489808|NCT03749642|Gabapentin|gabapentin|mesh-list
65489809|NCT03749642|Trazodone|trazodone|mesh-list
64873437|NCT01858311|Vitamin E|vitamin e|mesh-list
65489835|NCT03751358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65489836|NCT04097028|Trifluridine|trifluridine|mesh-list
65489837|NCT04097028|Oxaliplatin|oxaliplatin|mesh-list
65489838|NCT04097028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489839|NCT04097028|Antimetabolites|antimetabolites|mesh-ancestor
65489840|NCT04097028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489841|NCT04097028|Antiviral Agents|antiviral agents|mesh-ancestor
65489842|NCT04097028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65489843|NCT05193292|Trastuzumab|trastuzumab|mesh-list
65489844|NCT05193292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65489845|NCT05193292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489846|NCT05193214|Antibodies|antibodies|mesh-list
65489847|NCT05193214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65489848|NCT05193214|Immunologic Factors|immunologic factors|mesh-ancestor
65489849|NCT05193214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489850|NCT02529774|Leucovorin|leucovorin|mesh-list
65489851|NCT02529774|Dexamethasone|dexamethasone|mesh-list
65489852|NCT02529774|Capecitabine|capecitabine|mesh-list
65489853|NCT02529774|Oxaliplatin|oxaliplatin|mesh-list
65489854|NCT02529774|Fluorouracil|fluorouracil|mesh-list
65489855|NCT02529774|Floxuridine|floxuridine|mesh-list
65489856|NCT02529774|Heparin|heparin|mesh-list
65489857|NCT02529774|Levoleucovorin|levoleucovorin|mesh-list
65489858|NCT02529774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65489859|NCT02529774|Antiemetics|antiemetics|mesh-ancestor
65489926|NCT01367548|Sensory System Agents|sensory system agents|mesh-ancestor
65489927|NCT01367548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65489929|NCT01367626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489930|NCT01367626|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65489931|NCT01367626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65489932|NCT01367626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489933|NCT01367626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489934|NCT01367626|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65489967|NCT01209858|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65489968|NCT01209858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65489969|NCT01209858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65490039|NCT03941886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65490040|NCT03941886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490070|NCT01368016|Autonomic Agents|autonomic agents|mesh-ancestor
65490071|NCT01368016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490072|NCT01368016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490073|NCT01368016|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65490074|NCT01368016|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65490075|NCT01368016|Cholinergic Agents|cholinergic agents|mesh-ancestor
65490076|NCT01368016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65490077|NCT01368016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490078|NCT03634852|Moxifloxacin|moxifloxacin|mesh-list
65490079|NCT03634852|Dexamethasone|dexamethasone|mesh-list
65490080|NCT03634852|Triamcinolone|triamcinolone|mesh-list
65490081|NCT03634852|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65490082|NCT03634852|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65490083|NCT03634852|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65490084|NCT03634852|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65490107|NCT03634852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65490108|NCT03634852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65490109|NCT03634852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65490110|NCT03634852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65490111|NCT03634852|Immunologic Factors|immunologic factors|mesh-ancestor
65490112|NCT01208454|Vitamin A|vitamin a|mesh-list
65490113|NCT01208454|Vorinostat|vorinostat|mesh-list
65490114|NCT01208454|Tretinoin|tretinoin|mesh-list
65490115|NCT01208454|Isotretinoin|isotretinoin|mesh-list
65490116|NCT01208454|Vitamins|vitamins|mesh-ancestor
65490117|NCT01208454|Micronutrients|micronutrients|mesh-ancestor
65490118|NCT01208454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490119|NCT01208454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490120|NCT01208454|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65490121|NCT01208454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490122|NCT01208454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490123|NCT01208454|Keratolytic Agents|keratolytic agents|mesh-ancestor
65490124|NCT01208454|Dermatologic Agents|dermatologic agents|mesh-ancestor
65490125|NCT01110486|Carboplatin|carboplatin|mesh-list
65490126|NCT01110486|Docetaxel|docetaxel|mesh-list
65490127|NCT01110486|Ilorasertib|ilorasertib|mesh-list
65490128|NCT01110486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490129|NCT01110486|Tubulin Modulators|tubulin modulators|mesh-ancestor
65490130|NCT01110486|Antimitotic Agents|antimitotic agents|mesh-ancestor
65490131|NCT01110486|Mitosis Modulators|mitosis modulators|mesh-ancestor
65490132|NCT01110486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490133|NCT01110486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65490134|NCT01110486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490135|NCT01372306|Galantamine|galantamine|mesh-list
65490136|NCT01372306|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65490173|NCT01110642|Lovastatin|lovastatin|mesh-list
65490174|NCT01110642|L 647318|l 647318|mesh-list
65490175|NCT01110642|Dihydromevinolin|dihydromevinolin|mesh-list
65490176|NCT01110642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65490177|NCT01110642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65490178|NCT01110642|Antimetabolites|antimetabolites|mesh-ancestor
65490208|NCT03792672|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65490210|NCT03792672|Anesthetics, General|anesthetics, general|mesh-ancestor
65490211|NCT03792672|Anesthetics|anesthetics|mesh-ancestor
65490212|NCT03792672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65490213|NCT03792672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65490214|NCT03792672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65490215|NCT03792672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65490216|NCT03792672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490217|NCT01372540|Filanesib|filanesib|mesh-list
65490218|NCT01372540|Antimitotic Agents|antimitotic agents|mesh-ancestor
64873769|NCT01860391|Fluorides|fluorides|mesh-list
65490251|NCT01210482|Sirolimus|sirolimus|mesh-list
65490252|NCT01210482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65490253|NCT01210482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65490254|NCT01210482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65490255|NCT01210482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490256|NCT01210482|Antifungal Agents|antifungal agents|mesh-ancestor
65490257|NCT01210482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65490258|NCT01210482|Immunologic Factors|immunologic factors|mesh-ancestor
65490259|NCT01210482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490260|NCT01360060|Magnesium Sulfate|magnesium sulfate|mesh-list
65490261|NCT01360060|Analgesics|analgesics|mesh-ancestor
65490296|NCT01111422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65490297|NCT01111422|Antioxidants|antioxidants|mesh-ancestor
65490298|NCT01111422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490299|NCT01111422|Protective Agents|protective agents|mesh-ancestor
65490300|NCT01111422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490301|NCT01111422|Antidotes|antidotes|mesh-ancestor
65490302|NCT01212432|Daptomycin|daptomycin|mesh-list
65490303|NCT01212432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65273239|NCT00632645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65273240|NCT00632645|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65273241|NCT00632645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65273242|NCT00632645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65273243|NCT00632645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273244|NCT00632645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65273245|NCT00632645|Serotonin Agents|serotonin agents|mesh-ancestor
65273246|NCT00632645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65273247|NCT00632645|Adrenergic Agents|adrenergic agents|mesh-ancestor
65273248|NCT00632645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65490304|NCT01212432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65490342|NCT01113372|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65490374|NCT01328652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490375|NCT01328652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65490376|NCT01328652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65490377|NCT01373008|Beclomethasone|beclomethasone|mesh-list
65490378|NCT01373008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65490379|NCT01373008|Glucocorticoids|glucocorticoids|mesh-ancestor
65490380|NCT01373008|Hormones|hormones|mesh-ancestor
65490381|NCT01373008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65490382|NCT01373008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490383|NCT01373008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65490384|NCT01373008|Respiratory System Agents|respiratory system agents|mesh-ancestor
65490385|NCT01116180|Candesartan|candesartan|mesh-list
65490386|NCT01116180|Angiotensin II|angiotensin ii|mesh-list
65490418|NCT01369576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65490419|NCT01369576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490421|NCT01113762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65490422|NCT01113762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65490423|NCT01113762|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65490424|NCT01113762|Histamine Antagonists|histamine antagonists|mesh-ancestor
65490425|NCT01113762|Histamine Agents|histamine agents|mesh-ancestor
65490426|NCT01113762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65490427|NCT01113762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490428|NCT01113762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490459|NCT01211496|Adrenergic Agents|adrenergic agents|mesh-ancestor
65490460|NCT01211496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65490461|NCT01211496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65490462|NCT01211496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65490463|NCT01211496|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65490464|NCT01118286|Nifedipine|nifedipine|mesh-list
65490465|NCT01118286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65490466|NCT01118286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65490467|NCT01118286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490468|NCT01118286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65490469|NCT01118286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490500|NCT01118598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65490501|NCT01118598|Vasodilator Agents|vasodilator agents|mesh-ancestor
65490503|NCT01216020|Cetuximab|cetuximab|mesh-list
65490504|NCT01216020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490505|NCT01216020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65490506|NCT01121796|Vitamin D|vitamin d|mesh-list
65490507|NCT01121796|Ergocalciferols|ergocalciferols|mesh-list
65490508|NCT01121796|Cholecalciferol|cholecalciferol|mesh-list
65490509|NCT01121796|Vitamins|vitamins|mesh-list
65490510|NCT01121796|Micronutrients|micronutrients|mesh-ancestor
65490511|NCT01121796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490512|NCT01121796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65490513|NCT01121796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65490514|NCT03939624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65490515|NCT03939624|Protease Inhibitors|protease inhibitors|mesh-ancestor
65490516|NCT03939624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490527|NCT01117038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65490528|NCT01117038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65490529|NCT01117038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65490530|NCT01117038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490531|NCT01117038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65490532|NCT01117038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490534|NCT01117038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65490535|NCT01117038|Protease Inhibitors|protease inhibitors|mesh-ancestor
65490536|NCT01117038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490537|NCT01119534|Camphor|camphor|mesh-list
65490538|NCT01119534|Eucalyptol|eucalyptol|mesh-list
65490539|NCT01119534|Phenylpropanolamine|phenylpropanolamine|mesh-list
65490540|NCT01119534|Menthol|menthol|mesh-list
65490541|NCT01119534|Guaifenesin|guaifenesin|mesh-list
65490542|NCT01119534|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
65490543|NCT01119534|Antipruritics|antipruritics|mesh-ancestor
65490544|NCT01119534|Dermatologic Agents|dermatologic agents|mesh-ancestor
65490545|NCT01119534|Expectorants|expectorants|mesh-ancestor
65490546|NCT01119534|Respiratory System Agents|respiratory system agents|mesh-ancestor
65490547|NCT01119534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65490548|NCT01119534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65490549|NCT01119534|Adrenergic Agents|adrenergic agents|mesh-ancestor
65490550|NCT01119534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65490551|NCT01119534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490552|NCT01119534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490553|NCT01119534|Appetite Depressants|appetite depressants|mesh-ancestor
65490554|NCT01119534|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65490555|NCT01119534|Sympathomimetics|sympathomimetics|mesh-ancestor
65490556|NCT01119534|Autonomic Agents|autonomic agents|mesh-ancestor
65490557|NCT01119534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490558|NCT01119534|Nasal Decongestants|nasal decongestants|mesh-ancestor
65490559|NCT01119534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65490560|NCT01119534|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65490561|NCT01119534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65490562|NCT01119534|Antitussive Agents|antitussive agents|mesh-ancestor
65490563|NCT01119534|Insect Repellents|insect repellents|mesh-ancestor
65490564|NCT01119534|Protective Agents|protective agents|mesh-ancestor
65490565|NCT01117116|Fluticasone|fluticasone|mesh-list
65490566|NCT01117116|Xhance|xhance|mesh-list
65490567|NCT01117116|Budesonide|budesonide|mesh-list
65490568|NCT01117116|Formoterol Fumarate|formoterol fumarate|mesh-list
65490569|NCT01117116|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65490570|NCT01117116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65490571|NCT01117116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65490572|NCT01117116|Autonomic Agents|autonomic agents|mesh-ancestor
65490573|NCT01117116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490574|NCT01117116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490575|NCT01117116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65490576|NCT01117116|Respiratory System Agents|respiratory system agents|mesh-ancestor
65490577|NCT01117116|Dermatologic Agents|dermatologic agents|mesh-ancestor
65490578|NCT01117116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65490579|NCT01117116|Glucocorticoids|glucocorticoids|mesh-ancestor
65490580|NCT01117116|Hormones|hormones|mesh-ancestor
65490603|NCT01122342|Testosterone enanthate|testosterone enanthate|mesh-list
65490604|NCT01122342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65490606|NCT01122342|Hormones|hormones|mesh-ancestor
65490607|NCT01122342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65490608|NCT01122342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490609|NCT01122342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65490610|NCT01122342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490611|NCT01122342|Anabolic Agents|anabolic agents|mesh-ancestor
65490612|NCT01213992|Iron|iron|mesh-list
65490613|NCT01213992|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65490614|NCT01213992|Ferric Compounds|ferric compounds|mesh-list
65490615|NCT01213992|Trace Elements|trace elements|mesh-ancestor
65490616|NCT01213992|Micronutrients|micronutrients|mesh-ancestor
65490617|NCT01213992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490618|NCT01213992|Hematinics|hematinics|mesh-ancestor
65490619|NCT03963414|Carboplatin|carboplatin|mesh-list
65490620|NCT03963414|Etoposide|etoposide|mesh-list
65490621|NCT03963414|Etoposide phosphate|etoposide phosphate|mesh-list
65490622|NCT03963414|Durvalumab|durvalumab|mesh-list
65490623|NCT03963414|Tremelimumab|tremelimumab|mesh-list
65490624|NCT03963414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65490625|NCT03963414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490626|NCT03963414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65490627|NCT03963414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65490628|NCT03963414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65273249|NCT00632645|Dopamine Agents|dopamine agents|mesh-ancestor
65490629|NCT03963414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490630|NCT03963414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490646|NCT01216644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65490647|NCT01216644|Immunologic Factors|immunologic factors|mesh-ancestor
65490648|NCT01216644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490649|NCT01216644|Antidotes|antidotes|mesh-ancestor
65490650|NCT01216644|Protective Agents|protective agents|mesh-ancestor
65490651|NCT01216644|Vitamin B Complex|vitamin b complex|mesh-ancestor
65490652|NCT01216644|Vitamins|vitamins|mesh-ancestor
65490653|NCT01216644|Micronutrients|micronutrients|mesh-ancestor
65490654|NCT01216644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65490655|NCT01216644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65490656|NCT01216644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65490657|NCT01216644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490658|NCT04816162|Dexmedetomidine|dexmedetomidine|mesh-list
65490659|NCT04816162|Ketamine|ketamine|mesh-list
65490660|NCT04816162|Propofol|propofol|mesh-list
65490661|NCT04816162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65490662|NCT04816162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65490663|NCT04816162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490664|NCT04816162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65490665|NCT04816162|Anesthetics, General|anesthetics, general|mesh-ancestor
65490666|NCT04816162|Anesthetics|anesthetics|mesh-ancestor
65490667|NCT04816162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65490668|NCT04816162|Analgesics|analgesics|mesh-ancestor
65490669|NCT04816162|Sensory System Agents|sensory system agents|mesh-ancestor
65490670|NCT04816162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490671|NCT04816162|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65490672|NCT04816162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65490673|NCT04816162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65490674|NCT04816162|Adrenergic Agents|adrenergic agents|mesh-ancestor
65490675|NCT04816162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65490676|NCT04816162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490677|NCT04816162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65490678|NCT04816162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65490679|NCT04816162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65490680|NCT04959760|Antibodies|antibodies|mesh-list
65490681|NCT04959760|Immunoglobulins|immunoglobulins|mesh-list
65490682|NCT04959760|Immunoglobulin G|immunoglobulin g|mesh-list
65490683|NCT04959760|Immunologic Factors|immunologic factors|mesh-ancestor
65490684|NCT04959760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490685|NCT01214226|Pentoxifylline|pentoxifylline|mesh-list
65490686|NCT01214226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65490687|NCT01214226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490688|NCT01214226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490689|NCT01214226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65490690|NCT01214226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65490691|NCT01214226|Protective Agents|protective agents|mesh-ancestor
65490692|NCT01214226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490702|NCT01219062|Bupivacaine|bupivacaine|mesh-list
65490703|NCT01219062|Anesthetics, Local|anesthetics, local|mesh-ancestor
65490704|NCT01219062|Anesthetics|anesthetics|mesh-ancestor
65490705|NCT01219062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65490706|NCT01219062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490707|NCT01219062|Sensory System Agents|sensory system agents|mesh-ancestor
65490708|NCT01219062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490709|NCT01219062|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65490710|NCT01219062|Narcotics|narcotics|mesh-ancestor
65490711|NCT01219062|Analgesics|analgesics|mesh-ancestor
65490712|NCT01120158|Paclitaxel|paclitaxel|mesh-list
65490713|NCT01120158|Bevacizumab|bevacizumab|mesh-list
65490714|NCT01120158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65490715|NCT01120158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490716|NCT01120158|Tubulin Modulators|tubulin modulators|mesh-ancestor
65490717|NCT01120158|Antimitotic Agents|antimitotic agents|mesh-ancestor
65490718|NCT01120158|Mitosis Modulators|mitosis modulators|mesh-ancestor
65490719|NCT01120158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490720|NCT01120158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65490721|NCT01120158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65490722|NCT01120158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65490723|NCT01120158|Growth Substances|growth substances|mesh-ancestor
65490724|NCT01120158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490725|NCT01120158|Growth Inhibitors|growth inhibitors|mesh-ancestor
65490726|NCT01373398|Apaziquone|apaziquone|mesh-list
65273250|NCT02849873|Tazarotene|tazarotene|mesh-list
65273251|NCT02849873|Dermatologic Agents|dermatologic agents|mesh-ancestor
65273252|NCT02849873|Keratolytic Agents|keratolytic agents|mesh-ancestor
65490727|NCT01373398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490728|NCT01124526|Cyclophosphamide|cyclophosphamide|mesh-list
65490729|NCT01124526|Rituximab|rituximab|mesh-list
65490730|NCT01124526|Fludarabine|fludarabine|mesh-list
65490731|NCT01124526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65490732|NCT01124526|Immunologic Factors|immunologic factors|mesh-ancestor
65490733|NCT01124526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490734|NCT01124526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65490735|NCT01124526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65490736|NCT01124526|Alkylating Agents|alkylating agents|mesh-ancestor
65490737|NCT01124526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490738|NCT01124526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490739|NCT01124526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65490740|NCT01124526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65490741|NCT01120314|Otamixaban|otamixaban|mesh-list
65490742|NCT01120314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65490743|NCT01120314|Antithrombins|antithrombins|mesh-ancestor
65490744|NCT01120314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65490745|NCT01120314|Protease Inhibitors|protease inhibitors|mesh-ancestor
65490746|NCT01120314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490747|NCT01120314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490749|NCT03633994|Heparin|heparin|mesh-list
65490750|NCT03633994|Anticoagulants|anticoagulants|mesh-ancestor
65490751|NCT03633994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65490752|NCT03633994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65490753|NCT03633994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490754|NCT01328886|Omalizumab|omalizumab|mesh-list
65490755|NCT01328886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65490756|NCT01328886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65490757|NCT01328886|Respiratory System Agents|respiratory system agents|mesh-ancestor
65490758|NCT01216878|Losartan|losartan|mesh-list
65490759|NCT01216878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65490760|NCT01216878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64874239|NCT01863589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65490780|NCT04624984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65490781|NCT04624984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65490782|NCT04624984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65490783|NCT04624984|Tubulin Modulators|tubulin modulators|mesh-ancestor
65490784|NCT04624984|Antimitotic Agents|antimitotic agents|mesh-ancestor
65490785|NCT04624984|Mitosis Modulators|mitosis modulators|mesh-ancestor
65490786|NCT01214382|Sertraline|sertraline|mesh-list
65490787|NCT01214382|Antidepressive Agents|antidepressive agents|mesh-ancestor
65490788|NCT01214382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65490789|NCT01214382|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65490790|NCT01214382|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65490791|NCT01214382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65490792|NCT01214382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490793|NCT01214382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65490794|NCT01214382|Serotonin Agents|serotonin agents|mesh-ancestor
65490795|NCT01214382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490796|NCT01216956|Nicotinic Acids|nicotinic acids|mesh-list
65490797|NCT01216956|Niacin|niacin|mesh-list
65490798|NCT01216956|Niacinamide|niacinamide|mesh-list
65490799|NCT01216956|Vitamin B Complex|vitamin b complex|mesh-ancestor
65490800|NCT01216956|Vitamins|vitamins|mesh-ancestor
65490801|NCT01216956|Micronutrients|micronutrients|mesh-ancestor
65490802|NCT01216956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490803|NCT01216956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65490804|NCT01216956|Antimetabolites|antimetabolites|mesh-ancestor
65490805|NCT01216956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490806|NCT01216956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65490807|NCT01216956|Vasodilator Agents|vasodilator agents|mesh-ancestor
65490808|NCT01217034|Sorafenib|sorafenib|mesh-list
65490809|NCT01217034|Chlorotrianisene|chlorotrianisene|mesh-list
65490810|NCT01217034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490811|NCT01217034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65490812|NCT01217034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490813|NCT01217034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490814|NCT01217034|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65490815|NCT01217034|Estrogens|estrogens|mesh-ancestor
65490832|NCT01373554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65273253|NCT02304809|Vemurafenib|vemurafenib|mesh-list
65490833|NCT01373554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490834|NCT01373554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490836|NCT01319344|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65490837|NCT01319344|Hormone Antagonists|hormone antagonists|mesh-ancestor
65490838|NCT01319344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65490839|NCT01319344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490840|NCT01319344|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65490841|NCT01319344|Diuretics|diuretics|mesh-ancestor
65490842|NCT01319344|Natriuretic Agents|natriuretic agents|mesh-ancestor
65490843|NCT01319344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65490845|NCT01373632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65490846|NCT01373632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65490847|NCT01373632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65490848|NCT01373632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490849|NCT01373632|Antifungal Agents|antifungal agents|mesh-ancestor
65490850|NCT01373632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65490851|NCT01373632|Immunologic Factors|immunologic factors|mesh-ancestor
65490852|NCT01373632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490853|NCT01124760|Ketoconazole|ketoconazole|mesh-list
65490854|NCT01124760|Diltiazem|diltiazem|mesh-list
65490855|NCT01124760|Antifungal Agents|antifungal agents|mesh-ancestor
65490856|NCT01124760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65490857|NCT01124760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65490858|NCT01124760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65490859|NCT01124760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490860|NCT01124760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490861|NCT01124760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65490862|NCT01124760|Hormone Antagonists|hormone antagonists|mesh-ancestor
65490863|NCT01124760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65490864|NCT01124760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490865|NCT01124760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65490866|NCT01124760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65490867|NCT01124760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65490868|NCT01124760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65490869|NCT01124760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65490870|NCT01124760|Vasodilator Agents|vasodilator agents|mesh-ancestor
65490871|NCT01214772|Heparin|heparin|mesh-list
65490872|NCT01214772|Anticoagulants|anticoagulants|mesh-ancestor
65490900|NCT03783702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490901|NCT03783702|Antipyretics|antipyretics|mesh-ancestor
65490902|NCT03783702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65490903|NCT03783702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65490904|NCT03783702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65490905|NCT03783702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65490906|NCT03783702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490907|NCT03783702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490908|NCT03783702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65490909|NCT03783702|Narcotics|narcotics|mesh-ancestor
65490910|NCT03783702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65490911|NCT01319734|Glyburide|glyburide|mesh-list
65490912|NCT01319734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490913|NCT01319734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65490914|NCT01121016|Montelukast|montelukast|mesh-list
65490915|NCT01121016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65490916|NCT01121016|Respiratory System Agents|respiratory system agents|mesh-ancestor
65490917|NCT01121016|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65490918|NCT01121016|Hormone Antagonists|hormone antagonists|mesh-ancestor
65490919|NCT01121016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65490920|NCT01121016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874418|NCT01864681|Metformin|metformin|mesh-list
65490931|NCT03575572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490932|NCT01214928|Vitamin D|vitamin d|mesh-list
65490933|NCT01214928|Cholecalciferol|cholecalciferol|mesh-list
65490934|NCT01214928|Vitamins|vitamins|mesh-ancestor
65490935|NCT01214928|Micronutrients|micronutrients|mesh-ancestor
65490936|NCT01214928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490937|NCT01214928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65490938|NCT01214928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65490939|NCT01122966|Bevacizumab|bevacizumab|mesh-list
65490940|NCT01122966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65490941|NCT01122966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490942|NCT01122966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65490943|NCT01122966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65490944|NCT01122966|Growth Substances|growth substances|mesh-ancestor
65490945|NCT01122966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490946|NCT01122966|Growth Inhibitors|growth inhibitors|mesh-ancestor
65490947|NCT01219686|Pindolol|pindolol|mesh-list
65490948|NCT01219686|Dexetimide|dexetimide|mesh-list
65490949|NCT01219686|Citalopram|citalopram|mesh-list
65490950|NCT01219686|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65490951|NCT01219686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65490952|NCT01219686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65490953|NCT01219686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490954|NCT01219686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65490955|NCT01219686|Serotonin Agents|serotonin agents|mesh-ancestor
65490956|NCT01219686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490957|NCT01219686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65490958|NCT01219686|Antidepressive Agents|antidepressive agents|mesh-ancestor
65490959|NCT01219686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65490960|NCT01219686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65490961|NCT01219686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65490962|NCT01219686|Parasympatholytics|parasympatholytics|mesh-ancestor
65490963|NCT01219686|Autonomic Agents|autonomic agents|mesh-ancestor
65490964|NCT01219686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490965|NCT01219686|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65490966|NCT01219686|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65490967|NCT01219686|Cholinergic Agents|cholinergic agents|mesh-ancestor
65490968|NCT01219686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65490969|NCT01219686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65490970|NCT01219686|Adrenergic Agents|adrenergic agents|mesh-ancestor
65490971|NCT01219686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65490972|NCT01219686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65490973|NCT01219686|Vasodilator Agents|vasodilator agents|mesh-ancestor
65490974|NCT01219764|Amoxicillin|amoxicillin|mesh-list
65490975|NCT01219764|Metronidazole|metronidazole|mesh-list
65490976|NCT01219764|Clarithromycin|clarithromycin|mesh-list
65490977|NCT01219764|Rabeprazole|rabeprazole|mesh-list
65490978|NCT01219764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65490979|NCT01219764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65490980|NCT01219764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65490981|NCT01219764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65490982|NCT01219764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65490983|NCT01219764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490984|NCT01219764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874466|NCT01865201|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65491003|NCT01217970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491005|NCT01217970|Vasodilator Agents|vasodilator agents|mesh-ancestor
65491006|NCT01215084|4-Aminopyridine|4-aminopyridine|mesh-list
65491007|NCT01215084|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65491008|NCT01215084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65491009|NCT01215084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491010|NCT01125696|Ritonavir|ritonavir|mesh-list
65491011|NCT01125696|Lopinavir|lopinavir|mesh-list
65491012|NCT01125696|Tenofovir|tenofovir|mesh-list
65491013|NCT01125696|Lamivudine|lamivudine|mesh-list
65491014|NCT01125696|Zidovudine|zidovudine|mesh-list
65491015|NCT01125696|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65491016|NCT01125696|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65491017|NCT01125696|Protease Inhibitors|protease inhibitors|mesh-ancestor
65491018|NCT01125696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491019|NCT01125696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491020|NCT01125696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65491021|NCT01125696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65491022|NCT01125696|Antiviral Agents|antiviral agents|mesh-ancestor
65491023|NCT01125696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65491024|NCT01125696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65491025|NCT01125696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65491026|NCT01125696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65491027|NCT01125696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65491028|NCT01125696|Antimetabolites|antimetabolites|mesh-ancestor
65491029|NCT03932916|Donepezil|donepezil|mesh-list
65491030|NCT03932916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65491031|NCT03932916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491032|NCT03932916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491033|NCT03932916|Cholinergic Agents|cholinergic agents|mesh-ancestor
65491034|NCT03932916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65273254|NCT02304809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273255|NCT02304809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64479355|NCT01847443|Autonomic Agents|autonomic agents|mesh-ancestor
65491035|NCT03932916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491036|NCT03932916|Nootropic Agents|nootropic agents|mesh-ancestor
65491037|NCT03116152|Paclitaxel|paclitaxel|mesh-list
65491038|NCT03116152|Irinotecan|irinotecan|mesh-list
65491039|NCT03116152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65491040|NCT03116152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491065|NCT01219920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491066|NCT01400776|Estradiol|estradiol|mesh-list
65491067|NCT01400776|Estrogens|estrogens|mesh-ancestor
65491068|NCT01400776|Hormones|hormones|mesh-ancestor
65491069|NCT01400776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65491070|NCT01400776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491071|NCT01220076|Tamoxifen|tamoxifen|mesh-list
65491072|NCT01220076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65491073|NCT01220076|Hormone Antagonists|hormone antagonists|mesh-ancestor
65491074|NCT01220076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65491075|NCT01220076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491076|NCT01220076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65491077|NCT01220076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491078|NCT01220076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65491079|NCT01220076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65491080|NCT01220076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65491081|NCT01220154|Paclitaxel|paclitaxel|mesh-list
65491082|NCT01220154|Bevacizumab|bevacizumab|mesh-list
65491083|NCT01220154|Carboplatin|carboplatin|mesh-list
65491084|NCT01220154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65491085|NCT01220154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491086|NCT01220154|Tubulin Modulators|tubulin modulators|mesh-ancestor
65491087|NCT01220154|Antimitotic Agents|antimitotic agents|mesh-ancestor
65491088|NCT01220154|Mitosis Modulators|mitosis modulators|mesh-ancestor
65491089|NCT01220154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491090|NCT01220154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65491091|NCT01220154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65491092|NCT01220154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65491127|NCT05169424|Olodaterol|olodaterol|mesh-list
65491128|NCT05169424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65491129|NCT05169424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65491130|NCT05169424|Autonomic Agents|autonomic agents|mesh-ancestor
65491131|NCT05169424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65491132|NCT05169424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491133|NCT05169424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65491134|NCT05169424|Respiratory System Agents|respiratory system agents|mesh-ancestor
65491135|NCT05169424|Dermatologic Agents|dermatologic agents|mesh-ancestor
65491136|NCT05169424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65491137|NCT05169424|Parasympatholytics|parasympatholytics|mesh-ancestor
65491138|NCT05169424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64874683|NCT01867255|Antidepressive Agents|antidepressive agents|mesh-ancestor
65491205|NCT01375972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491206|NCT01375972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65491207|NCT01375972|Immunologic Factors|immunologic factors|mesh-ancestor
65491208|NCT01375972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491209|NCT05129644|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65491210|NCT05129644|Antiviral Agents|antiviral agents|mesh-ancestor
65491211|NCT05129644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65491212|NCT01220622|Nimodipine|nimodipine|mesh-list
65491213|NCT01220622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65491214|NCT01220622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65491215|NCT01220622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65491216|NCT01220622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491217|NCT01220622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65491218|NCT01220622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491236|NCT05123170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65491237|NCT05123170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65491238|NCT05123170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65491239|NCT05123170|Adrenergic Agents|adrenergic agents|mesh-ancestor
65491240|NCT05123170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65491242|NCT01215708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65491243|NCT01215708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65273256|NCT02304809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273257|NCT02304809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491244|NCT01215708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65491245|NCT01215708|Adrenergic Agents|adrenergic agents|mesh-ancestor
65491246|NCT01215708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65491247|NCT01215708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491248|NCT01215708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491249|NCT01215708|Urological Agents|urological agents|mesh-ancestor
65491250|NCT01222026|Vitamin D|vitamin d|mesh-list
65491251|NCT01222026|Strontium ranelate|strontium ranelate|mesh-list
65491252|NCT01222026|Vitamins|vitamins|mesh-ancestor
65491253|NCT01222026|Micronutrients|micronutrients|mesh-ancestor
65491254|NCT01222026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491255|NCT01222026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65491256|NCT00225251|Bupropion|bupropion|mesh-list
65491257|NCT00225251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65491258|NCT00225251|Antidepressive Agents|antidepressive agents|mesh-ancestor
65491259|NCT00225251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65491260|NCT00225251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65491261|NCT00225251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65491262|NCT00225251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65491263|NCT00225251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491264|NCT00225251|Dopamine Agents|dopamine agents|mesh-ancestor
65491265|NCT00225251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65491266|NCT00225251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491267|NCT00225251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65491268|NCT00225251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65491269|NCT00225251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491270|NCT01376128|Paroxetine|paroxetine|mesh-list
65491271|NCT01376128|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65491272|NCT01376128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65491273|NCT01376128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65491298|NCT01073501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491299|NCT01073501|Anticonvulsants|anticonvulsants|mesh-ancestor
65491300|NCT01073501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65491301|NCT01073501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65491302|NCT01073501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491303|NCT01073501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65491304|NCT01073501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65491305|NCT01073501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65491306|NCT01073501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65491307|NCT01073501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65491309|NCT05005312|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65491310|NCT05005312|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65491311|NCT05005312|Protease Inhibitors|protease inhibitors|mesh-ancestor
65491312|NCT05005312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491313|NCT05005312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491314|NCT05005312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65491315|NCT05005312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65491316|NCT05005312|Antiviral Agents|antiviral agents|mesh-ancestor
65491317|NCT05005312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65491318|NCT05005312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65491319|NCT05005312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65491320|NCT01222182|Atorvastatin|atorvastatin|mesh-list
65491321|NCT01222182|Simvastatin|simvastatin|mesh-list
65491334|NCT01218750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65491336|NCT01218750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491337|NCT01218750|Growth Inhibitors|growth inhibitors|mesh-ancestor
65491338|NCT01376284|Dutasteride|dutasteride|mesh-list
65491339|NCT01376284|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65491340|NCT01376284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65240858|NCT05643794|Immunologic Factors|immunologic factors|mesh-ancestor
65491341|NCT01376284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491342|NCT01376284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491343|NCT01376284|Hormone Antagonists|hormone antagonists|mesh-ancestor
65491344|NCT01376284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65491345|NCT01376284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491346|NCT01376440|Sodium Hypochlorite|sodium hypochlorite|mesh-list
65491347|NCT01376440|Eusol|eusol|mesh-list
65491348|NCT01376440|Disinfectants|disinfectants|mesh-ancestor
65273258|NCT02849483|Ramosetron|ramosetron|mesh-list
65273259|NCT02849483|Antiemetics|antiemetics|mesh-ancestor
65273260|NCT02849483|Autonomic Agents|autonomic agents|mesh-ancestor
65491349|NCT01376440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65491350|NCT01329042|Citric Acid|citric acid|mesh-list
65491351|NCT01329042|Sodium Citrate|sodium citrate|mesh-list
65491352|NCT01329042|Anticoagulants|anticoagulants|mesh-ancestor
65491353|NCT01329042|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65491354|NCT01329042|Chelating Agents|chelating agents|mesh-ancestor
65491355|NCT01329042|Sequestering Agents|sequestering agents|mesh-ancestor
65491356|NCT01329042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491357|NCT00253643|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65491358|NCT00253643|Antioxidants|antioxidants|mesh-ancestor
65491359|NCT00253643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491360|NCT00253643|Protective Agents|protective agents|mesh-ancestor
65491361|NCT00253643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491362|NCT00253643|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65491363|NCT00253643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65491364|NCT00253643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491365|NCT00253643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65491366|NCT01222650|Silodosin|silodosin|mesh-list
65491367|NCT01222650|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65491368|NCT01222650|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65491369|NCT01222650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65491370|NCT01222650|Adrenergic Agents|adrenergic agents|mesh-ancestor
65491371|NCT01222650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65491372|NCT01222650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491373|NCT01222650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491374|NCT01222650|Urological Agents|urological agents|mesh-ancestor
65491375|NCT04856488|Lugol's solution|lugol's solution|mesh-list
65491376|NCT04856488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65491377|NCT04856488|Hemostatics|hemostatics|mesh-ancestor
65491378|NCT04856488|Coagulants|coagulants|mesh-ancestor
65491379|NCT01073579|Vigabatrin|vigabatrin|mesh-list
65491380|NCT01073579|Anticonvulsants|anticonvulsants|mesh-ancestor
65491381|NCT01073579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64874877|NCT01868581|Insulin|insulin|mesh-list
65491406|NCT00220727|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65491407|NCT00220727|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65491409|NCT00220727|Immunologic Factors|immunologic factors|mesh-ancestor
65491410|NCT00220727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491411|NCT01072097|Atorvastatin|atorvastatin|mesh-list
65491412|NCT01072097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65491413|NCT01072097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65491414|NCT01072097|Antimetabolites|antimetabolites|mesh-ancestor
65491415|NCT01072097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491416|NCT01072097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65491417|NCT01072097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65491418|NCT01072097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491420|NCT05760430|Apatinib|apatinib|mesh-list
65491421|NCT05760430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65491422|NCT05760430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491423|NCT05760430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65491424|NCT05760430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65491425|NCT05760430|Growth Substances|growth substances|mesh-ancestor
65491426|NCT05760430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491427|NCT05760430|Growth Inhibitors|growth inhibitors|mesh-ancestor
65491428|NCT05760430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65491429|NCT05760430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491430|NCT05760430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491431|NCT01221402|Niacin|niacin|mesh-list
65491432|NCT01221402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65491433|NCT01221402|Antimetabolites|antimetabolites|mesh-ancestor
65491434|NCT01221402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874933|NCT01868984|Heparin|heparin|mesh-list
65491456|NCT01127490|Sensory System Agents|sensory system agents|mesh-ancestor
65491457|NCT01127490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65491458|NCT01127490|Antidepressive Agents|antidepressive agents|mesh-ancestor
65491459|NCT01127490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65491460|NCT01127490|Dopamine Agents|dopamine agents|mesh-ancestor
65491461|NCT01223040|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65491462|NCT01223040|Lubricant Eye Drops|lubricant eye drops|mesh-list
65491463|NCT01223040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65491464|NCT01126866|Bevacizumab|bevacizumab|mesh-list
65491465|NCT01126866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65491466|NCT01126866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491467|NCT01126866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65491468|NCT01126866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65491469|NCT01126866|Growth Substances|growth substances|mesh-ancestor
65491470|NCT01126866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491471|NCT01126866|Growth Inhibitors|growth inhibitors|mesh-ancestor
65491472|NCT04103554|Valsartan|valsartan|mesh-list
65491473|NCT04103554|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65491474|NCT04103554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65491475|NCT04103554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65491476|NCT04103554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65491477|NCT04103554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491478|NCT03740568|Progesterone|progesterone|mesh-list
65491479|NCT03740568|Progestins|progestins|mesh-ancestor
65491480|NCT03740568|Hormones|hormones|mesh-ancestor
65491481|NCT03740568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65491482|NCT03740568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491483|NCT00252239|Plasminogen|plasminogen|mesh-list
65491484|NCT00252239|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65491485|NCT00252239|Tenecteplase|tenecteplase|mesh-list
65491486|NCT00252239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65491514|NCT05731804|Ritonavir|ritonavir|mesh-list
65491515|NCT05731804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65491516|NCT05731804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65491517|NCT05731804|Protease Inhibitors|protease inhibitors|mesh-ancestor
65491518|NCT05731804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491519|NCT05731804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491520|NCT05731804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65491521|NCT05731804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65491522|NCT05731804|Antiviral Agents|antiviral agents|mesh-ancestor
65491523|NCT05731804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65491524|NCT05731804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65491525|NCT05731804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65491526|NCT01127568|Propranolol|propranolol|mesh-list
65491527|NCT01127568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65491528|NCT01127568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65491529|NCT01127568|Adrenergic Agents|adrenergic agents|mesh-ancestor
65491530|NCT01127568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65491531|NCT01127568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491532|NCT01127568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491559|NCT01127100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491561|NCT01127178|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
65491562|NCT01127178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65491563|NCT01127178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491564|NCT01127178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491565|NCT01127178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491566|NCT01221792|Carvedilol|carvedilol|mesh-list
65491567|NCT01221792|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65491568|NCT01221792|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65491569|NCT01221792|Adrenergic Agents|adrenergic agents|mesh-ancestor
65491570|NCT01221792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65491571|NCT01221792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491572|NCT01221792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491573|NCT01221792|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65491574|NCT01221792|Antioxidants|antioxidants|mesh-ancestor
65491575|NCT01221792|Protective Agents|protective agents|mesh-ancestor
65491576|NCT01221792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65491577|NCT01221792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65491578|NCT01221792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64875084|NCT01870024|Fosphenytoin|fosphenytoin|mesh-list
65491608|NCT05675098|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65491609|NCT05675098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65491610|NCT05675098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65491611|NCT05675098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491612|NCT05675098|Dopamine Agents|dopamine agents|mesh-ancestor
65491613|NCT05675098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65491614|NCT05675098|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65491615|NCT05675098|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65491616|NCT05675098|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65273261|NCT02849483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65491617|NCT01223742|Acetylcarnitine|acetylcarnitine|mesh-list
65491618|NCT01223742|Vitamin B Complex|vitamin b complex|mesh-ancestor
65491619|NCT01223742|Vitamins|vitamins|mesh-ancestor
65491620|NCT01223742|Micronutrients|micronutrients|mesh-ancestor
65491621|NCT01223742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491622|NCT01223742|Nootropic Agents|nootropic agents|mesh-ancestor
65491623|NCT01129518|Vaccines|vaccines|mesh-list
65491624|NCT01129518|Immunologic Factors|immunologic factors|mesh-ancestor
65491625|NCT01129518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491656|NCT01228344|Lumefantrine|lumefantrine|mesh-list
65491657|NCT01228344|Artemether|artemether|mesh-list
65491658|NCT01228344|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65491659|NCT01228344|Antimalarials|antimalarials|mesh-ancestor
65491660|NCT01228344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65491661|NCT01228344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65491662|NCT01228344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65491663|NCT03927456|Fulvestrant|fulvestrant|mesh-list
65491664|NCT03927456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65491665|NCT03927456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491666|NCT03927456|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65491667|NCT03927456|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65491668|NCT03927456|Hormone Antagonists|hormone antagonists|mesh-ancestor
65491669|NCT03927456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65491670|NCT03927456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491699|NCT05615974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65491701|NCT05615974|Immunologic Factors|immunologic factors|mesh-ancestor
65491702|NCT05615974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491703|NCT05615974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65491704|NCT03924492|Pregnanolone|pregnanolone|mesh-list
65491705|NCT03924492|Brexanolone|brexanolone|mesh-list
65491706|NCT03924492|Neurosteroids|neurosteroids|mesh-ancestor
65491707|NCT03924492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65491708|NCT03924492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491709|NCT03924492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491710|NCT03924492|GABA Modulators|gaba modulators|mesh-ancestor
65491711|NCT03924492|GABA Agents|gaba agents|mesh-ancestor
65491712|NCT03924492|Anesthetics|anesthetics|mesh-ancestor
65491713|NCT03924492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65491714|NCT01329276|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65491715|NCT01329276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65491716|NCT01329276|Respiratory System Agents|respiratory system agents|mesh-ancestor
65491717|NCT01224366|Vildagliptin|vildagliptin|mesh-list
65491718|NCT01224366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65491747|NCT03774576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65491748|NCT03774576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65491749|NCT03774576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65491750|NCT03774576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491751|NCT03774576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491752|NCT03774576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65491753|NCT03774576|Hormone Antagonists|hormone antagonists|mesh-ancestor
65491754|NCT03774576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65491755|NCT03774576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491756|NCT03774576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65491757|NCT05415436|Propofol|propofol|mesh-list
65491758|NCT05415436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65491759|NCT05415436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65491760|NCT05415436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875278|NCT01870674|YH12852|yh12852|mesh-list
65491786|NCT01227408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491787|NCT01227408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65491788|NCT01227408|Antimetabolites|antimetabolites|mesh-ancestor
65491789|NCT01227408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65241322|NCT05318105|Diuretics|diuretics|mesh-list
65491790|NCT01227408|Abortifacient Agents|abortifacient agents|mesh-ancestor
65491791|NCT01227408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65491792|NCT01227408|Dermatologic Agents|dermatologic agents|mesh-ancestor
65491793|NCT01227408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65491794|NCT01227408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65491796|NCT03773796|Antiemetics|antiemetics|mesh-ancestor
65491797|NCT03773796|Autonomic Agents|autonomic agents|mesh-ancestor
65491798|NCT03773796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65491799|NCT03773796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273262|NCT02849483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491800|NCT03773796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65491801|NCT03773796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65491802|NCT03773796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65491803|NCT03773796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65491804|NCT03773796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65491805|NCT02927938|Cytarabine|cytarabine|mesh-list
65491806|NCT02927938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65491807|NCT02927938|Antimetabolites|antimetabolites|mesh-ancestor
65491808|NCT02927938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491809|NCT02927938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491810|NCT02927938|Antiviral Agents|antiviral agents|mesh-ancestor
64875316|NCT01871129|Dexmedetomidine|dexmedetomidine|mesh-list
65491833|NCT01224756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65491835|NCT03392428|177Lu-PSMA-617|177lu-psma-617|mesh-list
65491836|NCT03392428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65491837|NCT03392428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491838|NCT03222856|Pembrolizumab|pembrolizumab|mesh-list
65491839|NCT03222856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65491840|NCT03222856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491841|NCT01130298|Testosterone|testosterone|mesh-list
65491842|NCT01130298|Androgens|androgens|mesh-ancestor
65491843|NCT01130298|Hormones|hormones|mesh-ancestor
65491844|NCT01130298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65491845|NCT01130298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491846|NCT01227720|Nicotine|nicotine|mesh-list
65491847|NCT01227720|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65491848|NCT01227720|Autonomic Agents|autonomic agents|mesh-ancestor
65491849|NCT01227720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65491850|NCT01227720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491851|NCT01227720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65491852|NCT01227720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65491853|NCT01227720|Cholinergic Agents|cholinergic agents|mesh-ancestor
65491854|NCT01227720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65491855|NCT01227720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491856|NCT03175978|Methotrexate|methotrexate|mesh-list
65491857|NCT03175978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491858|NCT03175978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65491859|NCT03175978|Abortifacient Agents|abortifacient agents|mesh-ancestor
65491860|NCT03175978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65491861|NCT03175978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65491892|NCT01130376|Sargramostim|sargramostim|mesh-list
65491893|NCT01130376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65491894|NCT01130376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491895|NCT01130376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491896|NCT01130376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65491897|NCT01130376|Analgesics|analgesics|mesh-ancestor
65491898|NCT01130376|Sensory System Agents|sensory system agents|mesh-ancestor
65491899|NCT01130376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65491900|NCT01130376|Immunologic Factors|immunologic factors|mesh-ancestor
65491901|NCT01130376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65491902|NCT01130376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65491903|NCT01130376|Antiviral Agents|antiviral agents|mesh-ancestor
65491904|NCT01130376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65491905|NCT03740178|Donepezil|donepezil|mesh-list
64875415|NCT01871701|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65491933|NCT01131546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65491934|NCT01131546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65491935|NCT01131546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491936|NCT01131546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65491937|NCT01131546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491939|NCT01225302|Paclitaxel|paclitaxel|mesh-list
65491940|NCT01225302|Carboplatin|carboplatin|mesh-list
65491941|NCT01225302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65491942|NCT01225302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491943|NCT01225302|Tubulin Modulators|tubulin modulators|mesh-ancestor
65491944|NCT01225302|Antimitotic Agents|antimitotic agents|mesh-ancestor
65491945|NCT01225302|Mitosis Modulators|mitosis modulators|mesh-ancestor
65491946|NCT01225302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491947|NCT01229046|Clavulanic Acids|clavulanic acids|mesh-list
65491948|NCT01229046|Clavulanic Acid|clavulanic acid|mesh-list
65491949|NCT01229046|Ticarcillin|ticarcillin|mesh-list
65491950|NCT01229046|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
65273263|NCT02849483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65273264|NCT02849483|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65491951|NCT01229046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65491952|NCT01229046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65491953|NCT01229046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491977|NCT03929094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491978|NCT03929094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65491979|NCT03929094|Immunologic Factors|immunologic factors|mesh-ancestor
65491980|NCT03929094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491981|NCT01131702|Ranitidine|ranitidine|mesh-list
65491982|NCT01131702|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65491983|NCT01131702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65491984|NCT01131702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65491985|NCT01131702|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65491986|NCT01131702|Histamine Antagonists|histamine antagonists|mesh-ancestor
65491987|NCT01131702|Histamine Agents|histamine agents|mesh-ancestor
65491988|NCT01131702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65491989|NCT01131702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491990|NCT01131702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491991|NCT01228110|Hydrocortisone|hydrocortisone|mesh-list
65491992|NCT01228110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65491993|NCT03925818|Metronidazole|metronidazole|mesh-list
65491994|NCT03925818|Tetracycline|tetracycline|mesh-list
65491995|NCT03925818|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
65491996|NCT03925818|Pantoprazole|pantoprazole|mesh-list
65491997|NCT03925818|Bismuth|bismuth|mesh-list
65491998|NCT03925818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65491999|NCT03925818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65492000|NCT03925818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65492001|NCT03925818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65492002|NCT03925818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65492003|NCT03925818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65492004|NCT03925818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64875509|NCT01871922|Mydriatics|mydriatics|mesh-ancestor
65492038|NCT03925662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65492039|NCT03925662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65492040|NCT03925662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65492041|NCT03925662|Growth Substances|growth substances|mesh-ancestor
65492042|NCT03925662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492043|NCT03925662|Growth Inhibitors|growth inhibitors|mesh-ancestor
65492044|NCT03925662|Antinematodal Agents|antinematodal agents|mesh-ancestor
65492075|NCT01131780|Sensory System Agents|sensory system agents|mesh-ancestor
65492076|NCT01131780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65492077|NCT01131780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492078|NCT01131780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65492079|NCT01131780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65492080|NCT01131780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65492081|NCT01131780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492082|NCT01131780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492083|NCT01131780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65492084|NCT01131780|Autonomic Agents|autonomic agents|mesh-ancestor
65492085|NCT01131780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65492086|NCT01131780|Respiratory System Agents|respiratory system agents|mesh-ancestor
65492087|NCT01131780|Nasal Decongestants|nasal decongestants|mesh-ancestor
65241625|NCT04900220|Hormones|hormones|mesh-ancestor
64875596|NCT01872416|Doxorubicin|doxorubicin|mesh-list
65492117|NCT01131000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65492118|NCT01131000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65492119|NCT01131000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492120|NCT01131000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492122|NCT01132170|Anticonvulsants|anticonvulsants|mesh-ancestor
65492123|NCT01132170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492124|NCT01132170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492125|NCT01132170|GABA Agents|gaba agents|mesh-ancestor
65492126|NCT01132170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65492127|NCT01132170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492128|NCT01132170|Antimanic Agents|antimanic agents|mesh-ancestor
65492129|NCT01132170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65492151|NCT03919656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492153|NCT01132248|Antimalarials|antimalarials|mesh-ancestor
65492154|NCT01132248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65492155|NCT01132248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65492156|NCT01132248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492157|NCT01229592|Ethanol|ethanol|mesh-list
65492158|NCT01229592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65273265|NCT02849483|Serotonin Agents|serotonin agents|mesh-ancestor
65492159|NCT01229592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492160|NCT01229592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65241685|NCT04847063|Antioxidants|antioxidants|mesh-ancestor
65492161|NCT01229592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492163|NCT01131936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65492164|NCT01131936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65492165|NCT01131936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65492166|NCT01131936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492167|NCT01131936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65492168|NCT01131936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492169|NCT01131936|Vasodilator Agents|vasodilator agents|mesh-ancestor
65492170|NCT01132404|Leuprolide|leuprolide|mesh-list
65492171|NCT01132404|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65492172|NCT01132404|Fertility Agents|fertility agents|mesh-ancestor
65492173|NCT01132404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65492174|NCT01132404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492175|NCT01132404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65492176|NCT01132404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65492177|NCT01231854|Cyclosporine|cyclosporine|mesh-list
65492178|NCT01231854|Alitretinoin|alitretinoin|mesh-list
65492179|NCT01231854|Cyclosporins|cyclosporins|mesh-list
65492180|NCT01231854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875685|NCT01872845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65492209|NCT05402124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492210|NCT05402124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65492211|NCT05402124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65492212|NCT05402124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492213|NCT05402124|Antipyretics|antipyretics|mesh-ancestor
65492214|NCT01134432|Prednisolone|prednisolone|mesh-list
65492215|NCT01134432|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65492216|NCT01134432|Methylprednisolone|methylprednisolone|mesh-list
65492217|NCT01134432|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65492218|NCT01134432|Prednisolone acetate|prednisolone acetate|mesh-list
65492219|NCT01134432|Rituximab|rituximab|mesh-list
65492220|NCT01134432|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65492221|NCT01134432|Prednisolone phosphate|prednisolone phosphate|mesh-list
65492222|NCT01134432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65492223|NCT01134432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65492224|NCT01134432|Immunologic Factors|immunologic factors|mesh-ancestor
65492225|NCT01134432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492226|NCT01134432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65492239|NCT01232010|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65492240|NCT01232010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65492241|NCT01232010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492242|NCT01232010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492243|NCT01132716|Valacyclovir|valacyclovir|mesh-list
65492244|NCT01132716|Antiviral Agents|antiviral agents|mesh-ancestor
65492245|NCT01132716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492246|NCT05401812|Glucocorticoids|glucocorticoids|mesh-list
65492247|NCT05401812|Hormones|hormones|mesh-ancestor
65492248|NCT05401812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65492249|NCT05401812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492250|NCT01137708|Levonorgestrel|levonorgestrel|mesh-list
65492251|NCT01137708|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65492252|NCT01137708|Tofacitinib|tofacitinib|mesh-list
65492253|NCT01137708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65492254|NCT01137708|Contraceptive Agents|contraceptive agents|mesh-ancestor
65492255|NCT01137708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65492256|NCT01137708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492257|NCT01137708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65492258|NCT01137708|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65492259|NCT01137708|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65492260|NCT01137708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65492261|NCT01137708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492262|NCT01137708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492263|NCT01137708|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65492264|NCT01137708|Estrogens|estrogens|mesh-ancestor
65492265|NCT01137708|Hormones|hormones|mesh-ancestor
65492266|NCT01137708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65492267|NCT03765138|Pramipexole|pramipexole|mesh-list
65492268|NCT03765138|Antioxidants|antioxidants|mesh-ancestor
65492269|NCT03765138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492270|NCT03765138|Protective Agents|protective agents|mesh-ancestor
65492271|NCT03765138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492272|NCT03765138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65492273|NCT03765138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65492274|NCT03765138|Dopamine Agonists|dopamine agonists|mesh-ancestor
65492275|NCT03765138|Dopamine Agents|dopamine agents|mesh-ancestor
65492276|NCT03765138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65492277|NCT01134666|Cetuximab|cetuximab|mesh-list
65492278|NCT01134666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65492279|NCT01134666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65492280|NCT03739788|BMS-986165|bms-986165|mesh-list
65492281|NCT03739788|Dermatologic Agents|dermatologic agents|mesh-ancestor
65492282|NCT03739788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65492283|NCT03739788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492284|NCT03739788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492285|NCT01137942|Metronidazole|metronidazole|mesh-list
65492286|NCT01137942|Clarithromycin|clarithromycin|mesh-list
65492287|NCT01137942|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65492288|NCT01137942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492303|NCT01135056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65492304|NCT01135056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65492305|NCT01135056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492306|NCT01135056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492307|NCT01132794|Dexmedetomidine|dexmedetomidine|mesh-list
65492308|NCT01132794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65492309|NCT01132794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65492310|NCT01132794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492311|NCT01132794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65492312|NCT01132794|Analgesics|analgesics|mesh-ancestor
65492313|NCT01132794|Sensory System Agents|sensory system agents|mesh-ancestor
65492314|NCT01132794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65492315|NCT01132794|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65492316|NCT01132794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65492317|NCT01132794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65492318|NCT01132794|Adrenergic Agents|adrenergic agents|mesh-ancestor
65492319|NCT01132794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65492320|NCT01132794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492321|NCT01135212|Candesartan|candesartan|mesh-list
65492322|NCT01135212|Candesartan cilexetil|candesartan cilexetil|mesh-list
65492323|NCT01135212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65492324|NCT01135212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65492325|NCT01135212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65492326|NCT01135212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492328|NCT01233570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65492329|NCT01233570|Immunologic Factors|immunologic factors|mesh-ancestor
65492330|NCT01233570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492331|NCT01233570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65492332|NCT01233570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492333|NCT01233570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492334|NCT01135290|Petrolatum|petrolatum|mesh-list
65492335|NCT01135290|Emollients|emollients|mesh-ancestor
65492336|NCT01135290|Dermatologic Agents|dermatologic agents|mesh-ancestor
65492337|NCT01135446|Dapagliflozin|dapagliflozin|mesh-list
65492338|NCT01135446|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65492339|NCT01135446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492340|NCT01135446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65492341|NCT01135446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492342|NCT01135602|Topiramate|topiramate|mesh-list
65492343|NCT01135602|Anticonvulsants|anticonvulsants|mesh-ancestor
65492344|NCT01135602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65492345|NCT01135602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492346|NCT05308212|Vaccines|vaccines|mesh-list
65492347|NCT05308212|Immunologic Factors|immunologic factors|mesh-ancestor
65492348|NCT05308212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492377|NCT01135758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65492378|NCT01135758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492379|NCT05401032|Tamsulosin|tamsulosin|mesh-list
65492380|NCT05401032|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65492381|NCT05401032|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65492382|NCT05401032|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65492383|NCT05401032|Adrenergic Agents|adrenergic agents|mesh-ancestor
65492385|NCT05401032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492386|NCT05401032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492387|NCT05401032|Urological Agents|urological agents|mesh-ancestor
65492388|NCT03768726|Ziprasidone|ziprasidone|mesh-list
65492389|NCT03768726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65492390|NCT03768726|Serotonin Agents|serotonin agents|mesh-ancestor
65492391|NCT03768726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65492392|NCT03768726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492393|NCT03768726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492394|NCT03768726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65492395|NCT03768726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65492411|NCT01138956|Antidotes|antidotes|mesh-ancestor
65492412|NCT03917940|Glimepiride|glimepiride|mesh-list
65492413|NCT03917940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65492414|NCT03917940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65492415|NCT03917940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492416|NCT03917940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65492417|NCT03917940|Immunologic Factors|immunologic factors|mesh-ancestor
65492418|NCT05291598|Ketorolac|ketorolac|mesh-list
65492419|NCT05291598|Meloxicam|meloxicam|mesh-list
65492420|NCT05291598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65492421|NCT05291598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65492422|NCT05291598|Analgesics|analgesics|mesh-ancestor
65492423|NCT05291598|Sensory System Agents|sensory system agents|mesh-ancestor
65492424|NCT05291598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65492425|NCT05291598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492426|NCT05291598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65492427|NCT05291598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65492428|NCT05291598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65492429|NCT05291598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492430|NCT05291598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492431|NCT05291598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65492432|NCT05287542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65492433|NCT05287542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65492434|NCT05287542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492435|NCT01232244|Glucagon|glucagon|mesh-list
65492436|NCT01232244|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65492437|NCT01232244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65492438|NCT01232244|Hormones|hormones|mesh-ancestor
65492439|NCT01232244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65492440|NCT01232244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492441|NCT01232244|Incretins|incretins|mesh-ancestor
65492442|NCT03917784|Curcumin|curcumin|mesh-list
65492443|NCT03917784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65492444|NCT03917784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65492445|NCT03917784|Analgesics|analgesics|mesh-ancestor
65492446|NCT03917784|Sensory System Agents|sensory system agents|mesh-ancestor
65492447|NCT03917784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65492448|NCT03917784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492449|NCT03917784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65492450|NCT03917784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65492451|NCT03917784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65492452|NCT03917784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492453|NCT03917784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492454|NCT01133496|Alendronate|alendronate|mesh-list
65492455|NCT01133496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65492487|NCT05594472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65492488|NCT05594472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492489|NCT05594472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492490|NCT01136538|Valacyclovir|valacyclovir|mesh-list
65492491|NCT01136538|Antiviral Agents|antiviral agents|mesh-ancestor
65492492|NCT01136538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492493|NCT03917628|Adalimumab|adalimumab|mesh-list
65492494|NCT03917628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65492495|NCT03917628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65492496|NCT01329588|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65492497|NCT01329588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492498|NCT01136850|Azithromycin|azithromycin|mesh-list
65492529|NCT01234116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65492530|NCT01234116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65492531|NCT01234116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492532|NCT01234116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492533|NCT01234116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65492534|NCT01234116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65492536|NCT03917004|Vasodilator Agents|vasodilator agents|mesh-ancestor
65273266|NCT02849483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65492537|NCT03916926|Fluorides|fluorides|mesh-list
65492538|NCT03916926|Fluorides, Topical|fluorides, topical|mesh-list
65492539|NCT03916926|Cariostatic Agents|cariostatic agents|mesh-ancestor
65492540|NCT03916926|Protective Agents|protective agents|mesh-ancestor
65492541|NCT03916926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492542|NCT01230996|Cisplatin|cisplatin|mesh-list
65492543|NCT01230996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65492544|NCT01137084|Methylprednisolone|methylprednisolone|mesh-list
65492545|NCT01137084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64876057|NCT01874847|Melatonin|melatonin|mesh-list
65492577|NCT03917082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65492578|NCT03917082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65492579|NCT03917082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65492580|NCT03917082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65492581|NCT03917082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65492582|NCT03917082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65492583|NCT03917082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492584|NCT01140126|UB-421|ub-421|mesh-list
65492585|NCT01140126|Antibodies|antibodies|mesh-list
65492586|NCT01140126|Immunologic Factors|immunologic factors|mesh-ancestor
65492587|NCT01140126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492615|NCT01234194|Analgesics|analgesics|mesh-ancestor
65492616|NCT01234194|Sensory System Agents|sensory system agents|mesh-ancestor
65492617|NCT01234194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65492618|NCT04913922|Nivolumab|nivolumab|mesh-list
65492619|NCT04913922|Azacitidine|azacitidine|mesh-list
65492620|NCT04913922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65492621|NCT04913922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65492622|NCT04913922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65492623|NCT04913922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492624|NCT04913922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65492625|NCT04913922|Antimetabolites|antimetabolites|mesh-ancestor
65492626|NCT04913922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492627|NCT04910022|Lomustine|lomustine|mesh-list
65492628|NCT04910022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65492629|NCT04910022|Alkylating Agents|alkylating agents|mesh-ancestor
65492630|NCT04910022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492631|NCT04910022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65492632|NCT05485662|Listerine|listerine|mesh-list
65492633|NCT05485662|Fluorides|fluorides|mesh-list
65492634|NCT05485662|Sodium Fluoride|sodium fluoride|mesh-list
65492635|NCT05485662|Cariostatic Agents|cariostatic agents|mesh-ancestor
65492636|NCT05485662|Protective Agents|protective agents|mesh-ancestor
65492637|NCT05485662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492638|NCT05485662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65492661|NCT01140438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65492662|NCT01140438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65492663|NCT01140438|Protease Inhibitors|protease inhibitors|mesh-ancestor
65492664|NCT01140438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492665|NCT01140438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492666|NCT01234506|Vitamin D|vitamin d|mesh-list
65492667|NCT01234506|Secoisolariciresinol|secoisolariciresinol|mesh-list
65492668|NCT01234506|Vitamins|vitamins|mesh-ancestor
65492669|NCT01234506|Micronutrients|micronutrients|mesh-ancestor
65492670|NCT01234506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492671|NCT01234506|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65492672|NCT01234506|Phytoestrogens|phytoestrogens|mesh-ancestor
65492673|NCT01234506|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65492674|NCT01234506|Estrogens|estrogens|mesh-ancestor
65492675|NCT01234506|Hormones|hormones|mesh-ancestor
65492676|NCT01234506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65492677|NCT04751604|Niacinamide|niacinamide|mesh-list
65492678|NCT04751604|Niacin|niacin|mesh-list
65492679|NCT04751604|Nicotinic Acids|nicotinic acids|mesh-list
65492680|NCT04751604|Vitamin B Complex|vitamin b complex|mesh-ancestor
65492681|NCT04751604|Vitamins|vitamins|mesh-ancestor
65492682|NCT04751604|Micronutrients|micronutrients|mesh-ancestor
65492683|NCT04751604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492684|NCT04751604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65492685|NCT04751604|Antimetabolites|antimetabolites|mesh-ancestor
65492686|NCT04751604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492687|NCT04751604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65492688|NCT04751604|Vasodilator Agents|vasodilator agents|mesh-ancestor
65492689|NCT01231542|Rifampin|rifampin|mesh-list
65492690|NCT01231542|Rifabutin|rifabutin|mesh-list
65492691|NCT01231542|Dolutegravir|dolutegravir|mesh-list
65273267|NCT02849483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492692|NCT01231542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65492693|NCT01231542|Antitubercular Agents|antitubercular agents|mesh-ancestor
65492694|NCT01231542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65492695|NCT01231542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492696|NCT01231542|Leprostatic Agents|leprostatic agents|mesh-ancestor
65492723|NCT01142778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65492724|NCT01142778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65492725|NCT01142778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65492727|NCT01142778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492728|NCT01142778|Growth Inhibitors|growth inhibitors|mesh-ancestor
65492729|NCT01142778|Tubulin Modulators|tubulin modulators|mesh-ancestor
65492730|NCT01142778|Antimitotic Agents|antimitotic agents|mesh-ancestor
65492731|NCT01142778|Mitosis Modulators|mitosis modulators|mesh-ancestor
65492732|NCT01142778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492733|NCT03739710|Docetaxel|docetaxel|mesh-list
65492734|NCT03739710|Ipilimumab|ipilimumab|mesh-list
65492735|NCT03739710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65492736|NCT03739710|Tubulin Modulators|tubulin modulators|mesh-ancestor
65492737|NCT03739710|Antimitotic Agents|antimitotic agents|mesh-ancestor
65492738|NCT03739710|Mitosis Modulators|mitosis modulators|mesh-ancestor
65492739|NCT03739710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492740|NCT03739710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64876246|NCT01876290|Serotonin Agents|serotonin agents|mesh-ancestor
65492755|NCT04722978|Antimetabolites|antimetabolites|mesh-ancestor
65492756|NCT04722978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492757|NCT04722978|Antiviral Agents|antiviral agents|mesh-ancestor
65492758|NCT04722978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492759|NCT04722978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492760|NCT04722978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65492761|NCT04722978|Immunologic Factors|immunologic factors|mesh-ancestor
65492762|NCT04722978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242297|NCT03948035|Hormones|hormones|mesh-ancestor
65492764|NCT04722978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65492765|NCT04722978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65492766|NCT04722978|Contraceptive Agents|contraceptive agents|mesh-ancestor
65492767|NCT04722978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65492768|NCT04722978|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65492769|NCT04722978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65492770|NCT04722978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65492771|NCT01140828|Rabeprazole|rabeprazole|mesh-list
65492772|NCT01140828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65492773|NCT01140828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65492774|NCT01140828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65492775|NCT01140828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492776|NCT01140828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492777|NCT01234740|Bafetinib|bafetinib|mesh-list
65492778|NCT01234740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65492779|NCT01234740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492780|NCT01234740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492781|NCT01234818|Levonorgestrel|levonorgestrel|mesh-list
65492782|NCT01234818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65492783|NCT01234818|Contraceptive Agents|contraceptive agents|mesh-ancestor
65492784|NCT01234818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65492785|NCT01234818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492786|NCT01234818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65492787|NCT01234818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65492788|NCT01234818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65492789|NCT03720990|Cholic Acids|cholic acids|mesh-list
65492790|NCT03720990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65492791|NCT03714594|Dapagliflozin|dapagliflozin|mesh-list
65492792|NCT03714594|Saxagliptin|saxagliptin|mesh-list
65492793|NCT03714594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65492794|NCT03714594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492795|NCT03714594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65492796|NCT03714594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492797|NCT03714594|Incretins|incretins|mesh-ancestor
65492798|NCT03714594|Hormones|hormones|mesh-ancestor
65492799|NCT03714594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65492800|NCT03714594|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65492801|NCT03714594|Protease Inhibitors|protease inhibitors|mesh-ancestor
65492831|NCT01234896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65492832|NCT01234896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492834|NCT01238094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65492835|NCT01238094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65492836|NCT01238094|Antimetabolites|antimetabolites|mesh-ancestor
65492837|NCT01238094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492838|NCT01238094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65492839|NCT01238094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65492840|NCT01238094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492841|NCT01236612|Chloroquine|chloroquine|mesh-list
65492842|NCT01236612|Proguanil|proguanil|mesh-list
65492843|NCT01236612|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
65492844|NCT01236612|Amebicides|amebicides|mesh-ancestor
65492845|NCT01236612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65492846|NCT01236612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65492847|NCT01236612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492884|NCT01140984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876399|NCT01877746|Hormones|hormones|mesh-ancestor
65492916|NCT05796752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65492917|NCT05796752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492918|NCT05796752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492919|NCT05796752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65492920|NCT05796752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65492921|NCT05796635|Allantoin|allantoin|mesh-list
65492922|NCT05796635|Dermatologic Agents|dermatologic agents|mesh-ancestor
65492923|NCT05796388|Linaclotide|linaclotide|mesh-list
65492924|NCT05796388|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65492925|NCT05796388|Enzyme Activators|enzyme activators|mesh-ancestor
65492926|NCT05796388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492927|NCT05796388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65492928|NCT05796362|Azithromycin|azithromycin|mesh-list
64876436|NCT01878136|Plasminogen|plasminogen|mesh-list
65492993|NCT05795478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65492994|NCT05795478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65492995|NCT05795478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65492996|NCT05795478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65492997|NCT05795478|Narcotics|narcotics|mesh-ancestor
65492998|NCT05795413|Bupivacaine|bupivacaine|mesh-list
65492999|NCT05795413|Anesthetics, Local|anesthetics, local|mesh-ancestor
65493000|NCT05795413|Anesthetics|anesthetics|mesh-ancestor
65493001|NCT05795413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65493002|NCT05795413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493003|NCT05795413|Sensory System Agents|sensory system agents|mesh-ancestor
65493004|NCT05795413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65493005|NCT05795400|Dapagliflozin|dapagliflozin|mesh-list
65493006|NCT05795400|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65493007|NCT05795400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493008|NCT05795400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65493009|NCT05795400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493010|NCT05795309|Insulin|insulin|mesh-list
65493039|NCT05795101|Durvalumab|durvalumab|mesh-list
65493040|NCT05795101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65493041|NCT05795101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493042|NCT05795062|Warfarin|warfarin|mesh-list
65493043|NCT05795062|Apixaban|apixaban|mesh-list
65493044|NCT05795062|Anticoagulants|anticoagulants|mesh-ancestor
65493045|NCT05795062|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65493046|NCT05795062|Antithrombins|antithrombins|mesh-ancestor
65493047|NCT05795062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65493048|NCT05795062|Protease Inhibitors|protease inhibitors|mesh-ancestor
65493049|NCT05795062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493050|NCT05795062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493051|NCT05794997|Propranolol|propranolol|mesh-list
65493052|NCT05794997|Atenolol|atenolol|mesh-list
65493053|NCT05794997|Sotalol|sotalol|mesh-list
65493054|NCT05794997|Carvedilol|carvedilol|mesh-list
65493055|NCT05794997|Bisoprolol|bisoprolol|mesh-list
65493056|NCT05794997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65493057|NCT05794997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65493073|NCT05794997|Autonomic Agents|autonomic agents|mesh-ancestor
65493074|NCT05794997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65493075|NCT05794997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65493076|NCT05794971|Irinotecan|irinotecan|mesh-list
65493077|NCT05794971|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65493078|NCT05794971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65493079|NCT05794971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493080|NCT05794971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493081|NCT05794971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493082|NCT05794919|Calcium, Dietary|calcium, dietary|mesh-list
65493083|NCT05794919|Phenol|phenol|mesh-list
65493084|NCT05794919|Calcium|calcium|mesh-list
65493085|NCT05794919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65493086|NCT05794919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493087|NCT05794919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65493088|NCT05794919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65493089|NCT05794919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65493090|NCT05794919|Disinfectants|disinfectants|mesh-ancestor
65493091|NCT05794919|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65493092|NCT05794919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65493093|NCT05794828|Bupivacaine|bupivacaine|mesh-list
65493094|NCT05794828|Anesthetics, Local|anesthetics, local|mesh-ancestor
65493095|NCT05794828|Anesthetics|anesthetics|mesh-ancestor
65493096|NCT05794828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65493097|NCT05794828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493098|NCT05794828|Sensory System Agents|sensory system agents|mesh-ancestor
65493099|NCT05794828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65493100|NCT05794659|Paclitaxel|paclitaxel|mesh-list
65493101|NCT05794659|Carboplatin|carboplatin|mesh-list
65493102|NCT05794659|Molgramostim|molgramostim|mesh-list
65493103|NCT05794659|Sargramostim|sargramostim|mesh-list
65493104|NCT05794659|Immunologic Factors|immunologic factors|mesh-ancestor
65493105|NCT05794659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493106|NCT05794659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65493107|NCT05794659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493108|NCT05794659|Tubulin Modulators|tubulin modulators|mesh-ancestor
65493109|NCT05794659|Antimitotic Agents|antimitotic agents|mesh-ancestor
65493110|NCT05794659|Mitosis Modulators|mitosis modulators|mesh-ancestor
65493111|NCT05794659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493112|NCT05794581|Liraglutide|liraglutide|mesh-list
65493113|NCT05794581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65493114|NCT05794581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493115|NCT05794581|Incretins|incretins|mesh-ancestor
65493116|NCT05794581|Hormones|hormones|mesh-ancestor
65493122|NCT05794477|Pemetrexed|pemetrexed|mesh-list
65493123|NCT05794477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65493124|NCT05794477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493125|NCT05794477|Tubulin Modulators|tubulin modulators|mesh-ancestor
65493126|NCT05794477|Antimitotic Agents|antimitotic agents|mesh-ancestor
65493127|NCT05794477|Mitosis Modulators|mitosis modulators|mesh-ancestor
65493128|NCT05794477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493129|NCT05794477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493130|NCT05794477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65493131|NCT05794477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65493132|NCT05794425|Cyclosporine|cyclosporine|mesh-list
65493133|NCT05794425|Cyclosporins|cyclosporins|mesh-list
65493134|NCT05794425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493135|NCT05794425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493136|NCT05794425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65493137|NCT05794425|Immunologic Factors|immunologic factors|mesh-ancestor
65493138|NCT05794425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493139|NCT05794425|Antifungal Agents|antifungal agents|mesh-ancestor
65493140|NCT05794425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65493141|NCT05794425|Dermatologic Agents|dermatologic agents|mesh-ancestor
65493142|NCT05794425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65493143|NCT05794425|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65493144|NCT05783596|Obinutuzumab|obinutuzumab|mesh-list
65493145|NCT05783596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65493146|NCT05783596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493147|NCT05726097|Ascorbic Acid|ascorbic acid|mesh-list
65493148|NCT05726097|Prucalopride|prucalopride|mesh-list
65493149|NCT05726097|Picosulfate sodium|picosulfate sodium|mesh-list
65493150|NCT05726097|Antioxidants|antioxidants|mesh-ancestor
65493151|NCT05726097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493152|NCT05726097|Protective Agents|protective agents|mesh-ancestor
65493153|NCT05726097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493154|NCT05726097|Vitamins|vitamins|mesh-ancestor
65493155|NCT05726097|Micronutrients|micronutrients|mesh-ancestor
65493156|NCT05726097|Laxatives|laxatives|mesh-ancestor
65493157|NCT05726097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65493158|NCT05726097|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65493159|NCT05726097|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65493160|NCT05726097|Serotonin Agents|serotonin agents|mesh-ancestor
65493161|NCT05726097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65493162|NCT05726097|Cathartics|cathartics|mesh-ancestor
65493163|NCT05724329|Dasatinib|dasatinib|mesh-list
65273268|NCT02432274|Etoposide|etoposide|mesh-list
65273269|NCT02432274|Etoposide phosphate|etoposide phosphate|mesh-list
65493164|NCT05724329|Quercetin|quercetin|mesh-list
65493165|NCT05724329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493166|NCT05724329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65493167|NCT05724329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493168|NCT05724329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493169|NCT05724329|Antioxidants|antioxidants|mesh-ancestor
65493170|NCT05724329|Protective Agents|protective agents|mesh-ancestor
65493171|NCT05724329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493172|NCT05712343|Valacyclovir|valacyclovir|mesh-list
65493173|NCT05712343|Antiviral Agents|antiviral agents|mesh-ancestor
65493174|NCT05712343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65493175|NCT05703425|Sulfasalazine|sulfasalazine|mesh-list
65493176|NCT05703425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65493177|NCT05703425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65493178|NCT05703425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65493179|NCT05703425|Analgesics|analgesics|mesh-ancestor
65493180|NCT05703425|Sensory System Agents|sensory system agents|mesh-ancestor
65493181|NCT05703425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65493182|NCT05703425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493183|NCT05703425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65493184|NCT05703425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65493185|NCT05703425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65493186|NCT05702359|Vitamin D|vitamin d|mesh-list
65493187|NCT05702359|Ergocalciferols|ergocalciferols|mesh-list
65493188|NCT05702359|Cholecalciferol|cholecalciferol|mesh-list
65493189|NCT05702359|Vitamins|vitamins|mesh-list
65493210|NCT05690503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65493211|NCT05690503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65493212|NCT05690503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493213|NCT05667662|Itraconazole|itraconazole|mesh-list
65493214|NCT05667662|Antifungal Agents|antifungal agents|mesh-ancestor
65493215|NCT05667662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65493216|NCT05667662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65493217|NCT05667662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65493218|NCT05667662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493219|NCT05667662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493220|NCT05667662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65493221|NCT05667662|Hormone Antagonists|hormone antagonists|mesh-ancestor
65493222|NCT05667662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65493223|NCT05667662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493224|NCT05667662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65493225|NCT05667285|Sirolimus|sirolimus|mesh-list
65493226|NCT05667285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65493227|NCT05667285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65493228|NCT05667285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65493229|NCT05667285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493230|NCT05667285|Antifungal Agents|antifungal agents|mesh-ancestor
65493231|NCT05667285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65493232|NCT05667285|Immunologic Factors|immunologic factors|mesh-ancestor
65493233|NCT05667285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493234|NCT05663515|Insulin|insulin|mesh-list
65493235|NCT05663515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65493236|NCT05663515|Exenatide|exenatide|mesh-list
65493237|NCT05663515|Biguanides|biguanides|mesh-list
65493238|NCT05663515|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
65493239|NCT05663515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65493240|NCT05663515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493241|NCT05663515|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65493263|NCT05608070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65493264|NCT05608070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493265|NCT05600114|Cannabidiol|cannabidiol|mesh-list
65493266|NCT05600114|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65493267|NCT05600114|Anticonvulsants|anticonvulsants|mesh-ancestor
65493268|NCT05600062|Racecadotril|racecadotril|mesh-list
65493269|NCT05600062|Antidiarrheals|antidiarrheals|mesh-ancestor
65493270|NCT05600062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65493271|NCT05600062|Protease Inhibitors|protease inhibitors|mesh-ancestor
65493272|NCT05600062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493273|NCT05600062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493274|NCT05597085|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65493275|NCT05597085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65493276|NCT05597085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493277|NCT05597085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65493278|NCT05574101|Cemiplimab|cemiplimab|mesh-list
65493279|NCT05574101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65493280|NCT05574101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493281|NCT05571267|Bevacizumab|bevacizumab|mesh-list
65493282|NCT05571267|Ranibizumab|ranibizumab|mesh-list
65493283|NCT05571267|Aflibercept|aflibercept|mesh-list
65493284|NCT05571267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65493285|NCT05571267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493286|NCT05571267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65493287|NCT05571267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65493288|NCT05571267|Growth Substances|growth substances|mesh-ancestor
65493289|NCT05571267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493290|NCT05571267|Growth Inhibitors|growth inhibitors|mesh-ancestor
65493291|NCT05550194|Valacyclovir|valacyclovir|mesh-list
65493292|NCT05550194|Antiviral Agents|antiviral agents|mesh-ancestor
65493293|NCT05550194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65493294|NCT05477459|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
65493295|NCT05477459|Hallucinogens|hallucinogens|mesh-ancestor
65493296|NCT05477459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493297|NCT05477459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65493298|NCT05477459|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65493329|NCT05389852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65493330|NCT05389852|Adrenergic Agents|adrenergic agents|mesh-ancestor
65493331|NCT05389852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65493332|NCT05389852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493333|NCT05386914|Sirolimus|sirolimus|mesh-list
65493334|NCT05386914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65493335|NCT05386914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65493336|NCT05386914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65493337|NCT05386914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493338|NCT05386914|Antifungal Agents|antifungal agents|mesh-ancestor
65493339|NCT05386914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65493340|NCT05386914|Immunologic Factors|immunologic factors|mesh-ancestor
65493341|NCT05386914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493342|NCT05383495|Midazolam|midazolam|mesh-list
65493343|NCT05383495|Dexmedetomidine|dexmedetomidine|mesh-list
65493344|NCT05383495|Nitrous Oxide|nitrous oxide|mesh-list
65493345|NCT05383495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65493383|NCT05318248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65493384|NCT05318248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493416|NCT05287256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493417|NCT05287256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65493418|NCT05287256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65493419|NCT05287256|Analgesics|analgesics|mesh-ancestor
65493420|NCT05287256|Sensory System Agents|sensory system agents|mesh-ancestor
65493421|NCT05287256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65493422|NCT05287256|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65493423|NCT05287256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65493424|NCT05287256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64876927|NCT01882322|Tacrolimus|tacrolimus|mesh-list
65493456|NCT05195918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493457|NCT05195918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65493458|NCT05195918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65493459|NCT05195918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65493460|NCT05195918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65493461|NCT05195918|Antioxidants|antioxidants|mesh-ancestor
65493462|NCT05195918|Protective Agents|protective agents|mesh-ancestor
65493463|NCT05195918|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65493464|NCT05195918|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65493484|NCT05193318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493485|NCT05171777|Atezolizumab|atezolizumab|mesh-list
65493486|NCT05171777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493487|NCT05168566|Maleic acid|maleic acid|mesh-list
65493488|NCT05168566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493489|NCT05168566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493490|NCT05163041|Nivolumab|nivolumab|mesh-list
65493491|NCT05163041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65493492|NCT05163041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493493|NCT05163041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65493494|NCT05163041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493495|NCT05138575|Empagliflozin|empagliflozin|mesh-list
65493496|NCT05138575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65493497|NCT05138575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493498|NCT05138575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65273270|NCT02432274|Ifosfamide|ifosfamide|mesh-list
65493499|NCT05138575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493500|NCT05122559|Acetylcysteine|acetylcysteine|mesh-list
65493501|NCT05122559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65493502|NCT05122559|Antiviral Agents|antiviral agents|mesh-ancestor
65493503|NCT05122559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65493504|NCT05122559|Expectorants|expectorants|mesh-ancestor
65493505|NCT05122559|Respiratory System Agents|respiratory system agents|mesh-ancestor
65493506|NCT05122559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65493507|NCT05122559|Antioxidants|antioxidants|mesh-ancestor
65493508|NCT05122559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493509|NCT05122559|Protective Agents|protective agents|mesh-ancestor
65493510|NCT05122559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493511|NCT05122559|Antidotes|antidotes|mesh-ancestor
65493512|NCT05113251|Paclitaxel|paclitaxel|mesh-list
65493513|NCT05113251|Cyclophosphamide|cyclophosphamide|mesh-list
65493514|NCT05113251|Doxorubicin|doxorubicin|mesh-list
65493515|NCT05113251|Trastuzumab|trastuzumab|mesh-list
65493516|NCT05113251|Pertuzumab|pertuzumab|mesh-list
65493517|NCT05113251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65493518|NCT05113251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64877052|NCT01883505|Levodopa|levodopa|mesh-list
65493536|NCT05112666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65493537|NCT05112666|Antithrombins|antithrombins|mesh-ancestor
65493538|NCT05112666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65493539|NCT05112666|Protease Inhibitors|protease inhibitors|mesh-ancestor
65493540|NCT05112666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493541|NCT05112666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493542|NCT05112666|Anticoagulants|anticoagulants|mesh-ancestor
65493543|NCT05080764|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65493544|NCT05080764|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65493545|NCT05080764|Dermatologic Agents|dermatologic agents|mesh-ancestor
65493547|NCT05047211|Iron-Dextran Complex|iron-dextran complex|mesh-list
65493548|NCT05047211|Anticoagulants|anticoagulants|mesh-ancestor
65493549|NCT05047211|Plasma Substitutes|plasma substitutes|mesh-ancestor
65493550|NCT05047211|Blood Substitutes|blood substitutes|mesh-ancestor
65493551|NCT05047211|Hematinics|hematinics|mesh-ancestor
65493552|NCT05046522|Palmidrol|palmidrol|mesh-list
65493553|NCT05046522|Analgesics|analgesics|mesh-ancestor
65493554|NCT05046522|Sensory System Agents|sensory system agents|mesh-ancestor
65493555|NCT05046522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65493556|NCT05046522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493557|NCT05046522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65493558|NCT05046522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65493559|NCT05046522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65493560|NCT05046522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65493561|NCT05046522|Antiviral Agents|antiviral agents|mesh-ancestor
65493562|NCT05046522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65493563|NCT05046522|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65493564|NCT05046522|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65493565|NCT05046522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65493566|NCT05046522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493567|NCT05046522|Hormones|hormones|mesh-ancestor
65493568|NCT05046522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65493569|NCT05046132|Moxifloxacin|moxifloxacin|mesh-list
65493570|NCT05046132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65493571|NCT05046132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65493572|NCT05046132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65493573|NCT05046132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65493574|NCT05046132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877065|NCT01883531|Mannitol|mannitol|mesh-list
65493586|NCT05043090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65493588|NCT05043090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493589|NCT05011058|Valganciclovir|valganciclovir|mesh-list
65493590|NCT05011058|Antiviral Agents|antiviral agents|mesh-ancestor
65493591|NCT05011058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65493592|NCT04915482|Antibodies|antibodies|mesh-list
65493593|NCT04915482|Immunologic Factors|immunologic factors|mesh-ancestor
65493594|NCT04915482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493595|NCT04897971|Antibodies|antibodies|mesh-list
65493596|NCT04897971|Immunologic Factors|immunologic factors|mesh-ancestor
65493597|NCT04897971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493598|NCT04887857|Azacitidine|azacitidine|mesh-list
65493599|NCT04887857|Venetoclax|venetoclax|mesh-list
65493601|NCT04887857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65493602|NCT04887857|Antimetabolites|antimetabolites|mesh-ancestor
65493603|NCT04887857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273271|NCT02432274|Isophosphamide mustard|isophosphamide mustard|mesh-list
65273272|NCT02432274|Lenvatinib|lenvatinib|mesh-list
64480602|NCT00629122|Miconazole|miconazole|mesh-list
65493604|NCT04887857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493605|NCT04887857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493606|NCT04857827|Timolol|timolol|mesh-list
65493607|NCT04857827|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65493608|NCT04857827|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65493609|NCT04857827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493610|NCT04857827|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65493611|NCT04857827|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65493612|NCT04857827|Adrenergic Agents|adrenergic agents|mesh-ancestor
65493613|NCT04857827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65493614|NCT04857827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493615|NCT04857827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65493616|NCT04857827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65493617|NCT04796584|Antibodies|antibodies|mesh-list
65493618|NCT04796584|Immunologic Factors|immunologic factors|mesh-ancestor
65493619|NCT04796584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493620|NCT04725149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65493621|NCT04716075|Acalabrutinib|acalabrutinib|mesh-list
65493622|NCT04716075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493623|NCT04712539|Oseltamivir|oseltamivir|mesh-list
65493624|NCT04712539|Baloxavir|baloxavir|mesh-list
65493625|NCT04712539|Antiviral Agents|antiviral agents|mesh-ancestor
65493626|NCT04712539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65493627|NCT04712539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493628|NCT04712539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493629|NCT04688931|Mitomycins|mitomycins|mesh-list
65493630|NCT04688931|Mitomycin|mitomycin|mesh-list
65493631|NCT04688931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65493632|NCT04688931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493633|NCT04688931|Alkylating Agents|alkylating agents|mesh-ancestor
65493634|NCT04688931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493635|NCT04688931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65493636|NCT04688931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493637|NCT04630769|Interleukin-2|interleukin-2|mesh-list
65493638|NCT04630769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493639|NCT04630769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65493674|NCT04559139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493676|NCT04559139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65493677|NCT04559139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493678|NCT04559139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65493735|NCT04477512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65493736|NCT04477512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493737|NCT04477512|Hormone Antagonists|hormone antagonists|mesh-ancestor
65493738|NCT04477512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65493739|NCT04459273|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65493741|NCT04459273|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65493742|NCT04459273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493743|NCT04457258|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65493744|NCT04457258|FAPI-46|fapi-46|mesh-list
65493745|NCT04457258|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65493746|NCT04457258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493747|NCT04457232|FAPI-46|fapi-46|mesh-list
65493748|NCT04457232|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65493749|NCT04457232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493750|NCT04435600|Ustekinumab|ustekinumab|mesh-list
65493751|NCT04435600|Dermatologic Agents|dermatologic agents|mesh-ancestor
65493752|NCT04407247|Infliximab|infliximab|mesh-list
65493753|NCT04407247|Vedolizumab|vedolizumab|mesh-list
65493754|NCT04407247|Immunoglobulins|immunoglobulins|mesh-list
65493755|NCT04407247|Immunoglobulin G|immunoglobulin g|mesh-list
65493756|NCT04407247|Immunologic Factors|immunologic factors|mesh-ancestor
65493757|NCT04407247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493758|NCT04407247|Dermatologic Agents|dermatologic agents|mesh-ancestor
65493759|NCT04407247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65493760|NCT04407247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65493761|NCT04349124|Nifedipine|nifedipine|mesh-list
65493762|NCT04349124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65493763|NCT04349124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65493764|NCT04349124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493765|NCT04349124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65493766|NCT04349124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273273|NCT02432274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65493812|NCT04248452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65493814|NCT04248452|Antidotes|antidotes|mesh-ancestor
65493815|NCT04248452|Protective Agents|protective agents|mesh-ancestor
65493816|NCT04248452|Vitamin B Complex|vitamin b complex|mesh-ancestor
65066953|NCT00273026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493817|NCT04248452|Vitamins|vitamins|mesh-ancestor
65493818|NCT04248452|Micronutrients|micronutrients|mesh-ancestor
65493819|NCT04248452|Hematinics|hematinics|mesh-ancestor
65493820|NCT04233866|Calcium, Dietary|calcium, dietary|mesh-list
65012558|NCT00506272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65012559|NCT00506272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012560|NCT00506311|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65012561|NCT00506311|Hemostatics|hemostatics|mesh-ancestor
65012562|NCT00506311|Coagulants|coagulants|mesh-ancestor
65012563|NCT04519645|Lacosamide|lacosamide|mesh-list
65012564|NCT04519645|Anticonvulsants|anticonvulsants|mesh-ancestor
65012565|NCT04519645|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65012566|NCT04519645|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65012567|NCT04519645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65012568|NCT04519645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012569|NCT00406731|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
65012570|NCT00406731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012571|NCT00406731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012572|NCT00142844|Naltrexone|naltrexone|mesh-list
65012573|NCT00142844|Disulfiram|disulfiram|mesh-list
65012574|NCT00142844|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65012575|NCT00142844|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65012576|NCT00142844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012577|NCT00142844|Sensory System Agents|sensory system agents|mesh-ancestor
65012578|NCT00142844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65012579|NCT00142844|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65012580|NCT00142844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012581|NCT00142844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012582|NCT04510207|Vaccines|vaccines|mesh-list
65012583|NCT04510207|Immunologic Factors|immunologic factors|mesh-ancestor
64877333|NCT01885338|Expectorants|expectorants|mesh-ancestor
65012612|NCT04512430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65012613|NCT04512430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65012614|NCT04512430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65012615|NCT04512430|Growth Substances|growth substances|mesh-ancestor
65012616|NCT04512430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012617|NCT04512430|Growth Inhibitors|growth inhibitors|mesh-ancestor
65012618|NCT04512430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012619|NCT04512430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012620|NCT04512430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65012621|NCT04512430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65012623|NCT04517851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65012624|NCT04515238|Venetoclax|venetoclax|mesh-list
65012625|NCT04515238|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65012626|NCT04515238|Obinutuzumab|obinutuzumab|mesh-list
65012627|NCT04515238|Zanubrutinib|zanubrutinib|mesh-list
65012653|NCT04514029|Simvastatin|simvastatin|mesh-list
65012654|NCT04514029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65012655|NCT04514029|Antiemetics|antiemetics|mesh-ancestor
65012656|NCT04514029|Autonomic Agents|autonomic agents|mesh-ancestor
65012657|NCT04514029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65012658|NCT04514029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012659|NCT04514029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65012660|NCT04514029|Glucocorticoids|glucocorticoids|mesh-ancestor
65012661|NCT04514029|Hormones|hormones|mesh-ancestor
65012662|NCT04514029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65012663|NCT04514029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65012664|NCT04514029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65012665|NCT04514029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65012666|NCT04514029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65012667|NCT04514029|Antimetabolites|antimetabolites|mesh-ancestor
65012668|NCT04514029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012669|NCT04514029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65012670|NCT04514029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65012671|NCT04514029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012672|NCT04511650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65012673|NCT02590393|Nicotine|nicotine|mesh-list
65012674|NCT02590393|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65012709|NCT00143156|Pregabalin|pregabalin|mesh-list
65273274|NCT02432274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273275|NCT02432274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64877482|NCT01886209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877483|NCT01886209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64877486|NCT01886248|Antithrombins|antithrombins|mesh-list
65012721|NCT00143156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65012722|NCT00143156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65012724|NCT00163410|Glucocorticoids|glucocorticoids|mesh-ancestor
65012725|NCT00163410|Hormones|hormones|mesh-ancestor
65012726|NCT00163410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65012727|NCT00163410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012728|NCT00163410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65012729|NCT00143195|Amlodipine|amlodipine|mesh-list
65012730|NCT00143195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65012731|NCT00143195|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65012732|NCT00143195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65012733|NCT00143195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012734|NCT00143195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65012735|NCT00143195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012736|NCT00143195|Vasodilator Agents|vasodilator agents|mesh-ancestor
65012737|NCT00163449|Ciclesonide|ciclesonide|mesh-list
65012738|NCT00163449|Glucocorticoids|glucocorticoids|mesh-ancestor
65012739|NCT00163449|Hormones|hormones|mesh-ancestor
65012740|NCT00163449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65012741|NCT00163449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012742|NCT00163449|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65012743|NCT00143234|Amlodipine|amlodipine|mesh-list
65012744|NCT00143234|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
65012745|NCT00143234|Atorvastatin|atorvastatin|mesh-list
65012746|NCT00143234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65012747|NCT00143234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65012748|NCT00143234|Antimetabolites|antimetabolites|mesh-ancestor
65012749|NCT00143234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012750|NCT00143234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65012751|NCT00143234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65012752|NCT00143234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012753|NCT00143234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65012754|NCT00143234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65012755|NCT00143234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65012756|NCT00143234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65012757|NCT00143234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012758|NCT00143234|Vasodilator Agents|vasodilator agents|mesh-ancestor
65012759|NCT00163488|Ciclesonide|ciclesonide|mesh-list
65012760|NCT00163488|Glucocorticoids|glucocorticoids|mesh-ancestor
65012761|NCT00163488|Hormones|hormones|mesh-ancestor
65012762|NCT00163488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65012763|NCT00163488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012764|NCT00163488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65012765|NCT00143351|Ziprasidone|ziprasidone|mesh-list
65012766|NCT00143351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65012767|NCT00143351|Serotonin Agents|serotonin agents|mesh-ancestor
65012768|NCT00143351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65012769|NCT00143351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012795|NCT02598895|Tubulin Modulators|tubulin modulators|mesh-ancestor
65012796|NCT02598895|Antimitotic Agents|antimitotic agents|mesh-ancestor
65012797|NCT02598895|Mitosis Modulators|mitosis modulators|mesh-ancestor
65012798|NCT02598895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012799|NCT05147272|Gemcitabine|gemcitabine|mesh-list
65012800|NCT05147272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65012801|NCT05147272|Antimetabolites|antimetabolites|mesh-ancestor
65012802|NCT05147272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012803|NCT05147272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65012804|NCT05147272|Antiviral Agents|antiviral agents|mesh-ancestor
65012805|NCT05147272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65012806|NCT05147272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012807|NCT05147272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65012808|NCT05147272|Immunologic Factors|immunologic factors|mesh-ancestor
65012809|NCT05147272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012810|NCT00143546|Defibrotide|defibrotide|mesh-list
65012811|NCT00143546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65012812|NCT00143546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65273276|NCT02432274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65273277|NCT02432274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273278|NCT02432274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273279|NCT02432274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65012813|NCT00143546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012814|NCT00143546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65012815|NCT00155883|Leucovorin|leucovorin|mesh-list
65012816|NCT00155883|Fluorouracil|fluorouracil|mesh-list
65012817|NCT00155883|Antimetabolites|antimetabolites|mesh-ancestor
65012818|NCT00155883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012819|NCT00155883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65012820|NCT00155883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64877583|NCT01886664|Anesthetics|anesthetics|mesh-ancestor
65012845|NCT05142865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65012846|NCT05142865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65012847|NCT05142865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012848|NCT05142865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012849|NCT05142865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65012850|NCT00143702|Riboflavin|riboflavin|mesh-list
64453834|NCT02003365|FX006|fx006|mesh-list
65012851|NCT00143702|Thiamine|thiamine|mesh-list
65012852|NCT00143702|Abacavir|abacavir|mesh-list
65012853|NCT00143702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65012854|NCT00143702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65012855|NCT00143702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012856|NCT00143702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012858|NCT00143702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65012859|NCT00143702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65012860|NCT00143702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65012861|NCT00143702|Vitamin B Complex|vitamin b complex|mesh-ancestor
65012862|NCT00143702|Vitamins|vitamins|mesh-ancestor
65012863|NCT00143702|Micronutrients|micronutrients|mesh-ancestor
65012864|NCT00143702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012865|NCT00143702|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65012866|NCT00143702|Dermatologic Agents|dermatologic agents|mesh-ancestor
65012867|NCT00156078|Pregabalin|pregabalin|mesh-list
65012868|NCT00156078|Analgesics|analgesics|mesh-ancestor
65012869|NCT00156078|Sensory System Agents|sensory system agents|mesh-ancestor
65012870|NCT00156078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65012871|NCT00156078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012872|NCT00156078|Anticonvulsants|anticonvulsants|mesh-ancestor
64877634|NCT01887249|Metronidazole|metronidazole|mesh-list
65012903|NCT02276365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65012904|NCT02276365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012905|NCT02276365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65012906|NCT02276365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012907|NCT05145634|Anticoagulants|anticoagulants|mesh-list
65012908|NCT00143975|Cytarabine|cytarabine|mesh-list
65012909|NCT00143975|Mitoxantrone|mitoxantrone|mesh-list
65012910|NCT00143975|Gemtuzumab|gemtuzumab|mesh-list
65012911|NCT00143975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65012912|NCT00143975|Antimetabolites|antimetabolites|mesh-ancestor
65012913|NCT00143975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012914|NCT00143975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65012915|NCT00143975|Antiviral Agents|antiviral agents|mesh-ancestor
65012955|NCT00144053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65012956|NCT00144053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65012957|NCT00144053|Tubulin Modulators|tubulin modulators|mesh-ancestor
65012958|NCT00144053|Antimitotic Agents|antimitotic agents|mesh-ancestor
65012959|NCT00144053|Mitosis Modulators|mitosis modulators|mesh-ancestor
65012960|NCT00144053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012961|NCT00144053|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65012962|NCT00144053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65012963|NCT00144053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012964|NCT05147194|Trimetazidine|trimetazidine|mesh-list
65012965|NCT05147194|Vasodilator Agents|vasodilator agents|mesh-ancestor
65012966|NCT00144131|Darbepoetin alfa|darbepoetin alfa|mesh-list
65012967|NCT00144131|Hematinics|hematinics|mesh-ancestor
65012968|NCT00144209|Levodopa|levodopa|mesh-list
65012969|NCT00144209|Pramipexole|pramipexole|mesh-list
65012996|NCT00144248|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65273280|NCT02432274|Alkylating Agents|alkylating agents|mesh-ancestor
64480889|NCT00687076|Antipyretics|antipyretics|mesh-ancestor
65012997|NCT00144248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65012998|NCT00144248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012999|NCT00144248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013000|NCT00144248|Antiviral Agents|antiviral agents|mesh-ancestor
65013001|NCT00144248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013002|NCT00144248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65013003|NCT00144248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65013004|NCT00144248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65013005|NCT00144248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65013006|NCT00148005|Cholinergic Antagonists|cholinergic antagonists|mesh-list
65013007|NCT00148005|Cholinergic Agents|cholinergic agents|mesh-ancestor
65013008|NCT00148005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65013009|NCT00148005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013010|NCT00148005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013012|NCT00144287|Tipranavir|tipranavir|mesh-list
65013013|NCT00144287|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65013014|NCT00144287|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65013015|NCT00144287|Protease Inhibitors|protease inhibitors|mesh-ancestor
65013016|NCT00144287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013017|NCT00144287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013018|NCT00144287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65013019|NCT00144287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65013020|NCT00144287|Antiviral Agents|antiviral agents|mesh-ancestor
65013021|NCT00144287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013022|NCT00144287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65013023|NCT00144287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65013024|NCT00144326|Bromides|bromides|mesh-list
65013025|NCT00144326|Tiotropium Bromide|tiotropium bromide|mesh-list
65013026|NCT00144326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65013027|NCT00144326|Autonomic Agents|autonomic agents|mesh-ancestor
65013028|NCT00144326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65013029|NCT00144326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013030|NCT00144326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65013031|NCT00144326|Respiratory System Agents|respiratory system agents|mesh-ancestor
65013032|NCT00144326|Parasympatholytics|parasympatholytics|mesh-ancestor
65013033|NCT00144326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65013064|NCT00156546|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65013065|NCT00156546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013066|NCT00507052|Acetylcysteine|acetylcysteine|mesh-list
65013067|NCT00507052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65013068|NCT00507052|Antiviral Agents|antiviral agents|mesh-ancestor
65013069|NCT00507052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013070|NCT00507052|Expectorants|expectorants|mesh-ancestor
65013071|NCT00507052|Respiratory System Agents|respiratory system agents|mesh-ancestor
65013072|NCT00507052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65013073|NCT00507052|Antioxidants|antioxidants|mesh-ancestor
65013074|NCT00507052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013075|NCT00507052|Protective Agents|protective agents|mesh-ancestor
65013076|NCT00507052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013077|NCT00507052|Antidotes|antidotes|mesh-ancestor
65013079|NCT00507091|Fluorouracil|fluorouracil|mesh-list
65013108|NCT00148083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65013110|NCT00148083|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65013111|NCT00148083|Dopamine Agents|dopamine agents|mesh-ancestor
65013112|NCT05148442|Azacitidine|azacitidine|mesh-list
65013113|NCT05148442|Decitabine|decitabine|mesh-list
65013114|NCT05148442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65013115|NCT05148442|Antimetabolites|antimetabolites|mesh-ancestor
65013116|NCT05148442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013117|NCT05148442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013118|NCT05148442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013119|NCT05148403|Glyburide|glyburide|mesh-list
65013120|NCT05148403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65013121|NCT05148403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013122|NCT05148208|Dialysis Solutions|dialysis solutions|mesh-list
65013123|NCT05148208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65013124|NCT05148169|Sulforaphane|sulforaphane|mesh-list
65013125|NCT05148169|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65013126|NCT05148169|Protective Agents|protective agents|mesh-ancestor
65013127|NCT05148169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013152|NCT05141422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013153|NCT05141422|Antiviral Agents|antiviral agents|mesh-ancestor
65013154|NCT05141422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013155|NCT05141422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65013156|NCT05141422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65013157|NCT05141422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65013158|NCT05141422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65013159|NCT05141422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65013160|NCT05141422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65013162|NCT05148637|Fentanyl|fentanyl|mesh-list
65013163|NCT05148637|Anesthetics|anesthetics|mesh-list
65013164|NCT05148637|Sevoflurane|sevoflurane|mesh-list
65013165|NCT05148637|Desflurane|desflurane|mesh-list
65013166|NCT05148637|Anesthetics, Local|anesthetics, local|mesh-ancestor
65013167|NCT05148637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65013168|NCT05148637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013169|NCT05148637|Sensory System Agents|sensory system agents|mesh-ancestor
65013170|NCT05148637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65013171|NCT05148637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65013172|NCT05148637|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65013173|NCT05148637|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65013174|NCT05148637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65013175|NCT05148637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013176|NCT05148637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65013177|NCT05148637|Narcotics|narcotics|mesh-ancestor
65013178|NCT05148637|Analgesics|analgesics|mesh-ancestor
65013179|NCT05148637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65013180|NCT05148637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65013204|NCT00148278|Protective Agents|protective agents|mesh-ancestor
65013205|NCT05594849|Budesonide|budesonide|mesh-list
65013206|NCT05594849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65013207|NCT05594849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65013208|NCT05594849|Autonomic Agents|autonomic agents|mesh-ancestor
65013209|NCT05594849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65013210|NCT05594849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013211|NCT05594849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65013212|NCT05594849|Respiratory System Agents|respiratory system agents|mesh-ancestor
65013213|NCT05594849|Glucocorticoids|glucocorticoids|mesh-ancestor
65013214|NCT05594849|Hormones|hormones|mesh-ancestor
65013215|NCT05594849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65013216|NCT00507247|Daptomycin|daptomycin|mesh-list
65013217|NCT00507247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65013218|NCT00507247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013219|NCT00507286|Alprostadil|alprostadil|mesh-list
65013220|NCT00507286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65013221|NCT00507286|Vasodilator Agents|vasodilator agents|mesh-ancestor
65013222|NCT00507286|Urological Agents|urological agents|mesh-ancestor
65013223|NCT05143762|Acetaminophen|acetaminophen|mesh-list
65013224|NCT05143762|Dexamethasone|dexamethasone|mesh-list
65013225|NCT05143762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65013226|NCT05143762|Antiemetics|antiemetics|mesh-ancestor
65013227|NCT05143762|Autonomic Agents|autonomic agents|mesh-ancestor
65013228|NCT05143762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65013229|NCT05143762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013230|NCT05143762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65013231|NCT05143762|Glucocorticoids|glucocorticoids|mesh-ancestor
65013232|NCT05143762|Hormones|hormones|mesh-ancestor
65013233|NCT05143762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65013321|NCT00156858|Alkylating Agents|alkylating agents|mesh-ancestor
65013322|NCT00156858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013323|NCT00156858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65013324|NCT00156858|Immunologic Factors|immunologic factors|mesh-ancestor
65013325|NCT00156858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013326|NCT00156858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65013327|NCT00156858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013328|NCT00156858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65013330|NCT03451825|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65013331|NCT03451825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65013332|NCT03451825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878058|NCT01888978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64878059|NCT01888978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64878060|NCT01888978|Antidotes|antidotes|mesh-ancestor
64878061|NCT01888978|Protective Agents|protective agents|mesh-ancestor
65013393|NCT05594342|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65013394|NCT05594342|Sympathomimetics|sympathomimetics|mesh-ancestor
65013395|NCT05594342|Autonomic Agents|autonomic agents|mesh-ancestor
65013396|NCT05594342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65273281|NCT02432274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65013397|NCT05594342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013398|NCT05594342|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65013399|NCT05594342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65013400|NCT05594342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65013401|NCT05594342|Adrenergic Agents|adrenergic agents|mesh-ancestor
65013402|NCT05594342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65013403|NCT05594342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013404|NCT05594342|Protective Agents|protective agents|mesh-ancestor
65013405|NCT00157053|Factor VIII|factor viii|mesh-list
65013406|NCT00157053|Coagulants|coagulants|mesh-ancestor
65013407|NCT00507793|Cyclosporine|cyclosporine|mesh-list
65013408|NCT00507793|Sirolimus|sirolimus|mesh-list
65013409|NCT00507793|Cyclosporins|cyclosporins|mesh-list
65013410|NCT00507793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013411|NCT00507793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013412|NCT00507793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65013413|NCT00507793|Immunologic Factors|immunologic factors|mesh-ancestor
65013414|NCT00507793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013415|NCT00507793|Antifungal Agents|antifungal agents|mesh-ancestor
65013416|NCT00507793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013417|NCT00507793|Dermatologic Agents|dermatologic agents|mesh-ancestor
65013418|NCT00507793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65013452|NCT00507949|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65013453|NCT00507949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65013454|NCT00507949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013455|NCT00507949|Appetite Stimulants|appetite stimulants|mesh-ancestor
65013456|NCT00507949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65013457|NCT00148551|Triamcinolone|triamcinolone|mesh-list
65013458|NCT00148551|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65013481|NCT05594186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013482|NCT05594186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65013483|NCT05594186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65013484|NCT05594186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65013485|NCT00157092|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65013486|NCT00157092|Protein C Inhibitor|protein c inhibitor|mesh-list
65013487|NCT00157092|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65013488|NCT00157092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65013489|NCT00157092|Protease Inhibitors|protease inhibitors|mesh-ancestor
65013490|NCT00157092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013491|NCT00157092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013493|NCT00148590|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65013494|NCT00148590|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65013495|NCT00148590|Dopamine Agents|dopamine agents|mesh-ancestor
65013496|NCT00148590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65013497|NCT00148590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013498|NCT00148590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013499|NCT00148590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65013500|NCT00148590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65013501|NCT02954068|Oxytocin|oxytocin|mesh-list
65013502|NCT02954068|Oxytocics|oxytocics|mesh-ancestor
65013503|NCT02954068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65013504|NCT02954068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013505|NCT00157131|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65013506|NCT00157131|Hemostatics|hemostatics|mesh-ancestor
65013507|NCT00157131|Coagulants|coagulants|mesh-ancestor
65013508|NCT02954029|Hemostatics|hemostatics|mesh-list
65013509|NCT02954029|Coagulants|coagulants|mesh-ancestor
64878183|NCT01889810|Vitamins|vitamins|mesh-ancestor
65013544|NCT02953522|Vitamin B Complex|vitamin b complex|mesh-list
65013545|NCT02953522|Hematinics|hematinics|mesh-ancestor
65013546|NCT02953522|Vitamins|vitamins|mesh-ancestor
65013547|NCT02953522|Micronutrients|micronutrients|mesh-ancestor
65013548|NCT02953522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013549|NCT00148746|Cyclosporine|cyclosporine|mesh-list
65013550|NCT00148746|Prednisolone|prednisolone|mesh-list
65013571|NCT00148746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65013572|NCT00148746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65013573|NCT00148746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65013574|NCT00148746|Analgesics|analgesics|mesh-ancestor
65013575|NCT00148746|Sensory System Agents|sensory system agents|mesh-ancestor
65013576|NCT00148785|Ritonavir|ritonavir|mesh-list
65013577|NCT00148785|Indinavir|indinavir|mesh-list
65013578|NCT00148785|Fosamprenavir|fosamprenavir|mesh-list
65013579|NCT00148785|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65013580|NCT00148785|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65013581|NCT00148785|Protease Inhibitors|protease inhibitors|mesh-ancestor
65013582|NCT00148785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013583|NCT00148785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013584|NCT00148785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65013585|NCT00148785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65013586|NCT00148785|Antiviral Agents|antiviral agents|mesh-ancestor
65013587|NCT00148785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013588|NCT00148785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65013589|NCT00148785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65013590|NCT00148824|Vaccines|vaccines|mesh-list
65013591|NCT00148824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65013592|NCT00148824|Immunologic Factors|immunologic factors|mesh-ancestor
65013593|NCT00148824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013594|NCT00466570|Moxifloxacin|moxifloxacin|mesh-list
65013595|NCT00466570|Gatifloxacin|gatifloxacin|mesh-list
65013596|NCT00466570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65013597|NCT00466570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013598|NCT00466570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65013599|NCT00466570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65013600|NCT00466570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013601|NCT00466570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013602|NCT00466570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013603|NCT00466570|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65013604|NCT00466570|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65013605|NCT00466609|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65013606|NCT00466609|Fluoxetine|fluoxetine|mesh-list
65013628|NCT00157326|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65013629|NCT00157326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013630|NCT00157326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013631|NCT00157326|Urological Agents|urological agents|mesh-ancestor
65013632|NCT00466843|Prednisone|prednisone|mesh-list
65013633|NCT00466843|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65013634|NCT00466843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65013635|NCT00466843|Glucocorticoids|glucocorticoids|mesh-ancestor
65013636|NCT00466843|Hormones|hormones|mesh-ancestor
65013637|NCT00466843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65013638|NCT00466843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013639|NCT00466843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65013640|NCT00466843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013641|NCT00466843|Immunologic Factors|immunologic factors|mesh-ancestor
65013642|NCT00466843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65013643|NCT00148863|Interferons|interferons|mesh-list
65013644|NCT00148863|Ribavirin|ribavirin|mesh-list
65013645|NCT00148863|Interferon-alpha|interferon-alpha|mesh-list
65013646|NCT00148863|Interferon alpha-2|interferon alpha-2|mesh-list
65013647|NCT00148863|Interferon-gamma|interferon-gamma|mesh-list
65013648|NCT00148863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65013649|NCT00148863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013650|NCT00148863|Antiviral Agents|antiviral agents|mesh-ancestor
65013651|NCT00148863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013652|NCT00148863|Antimetabolites|antimetabolites|mesh-ancestor
65013653|NCT00148863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013654|NCT00148863|Immunologic Factors|immunologic factors|mesh-ancestor
65013655|NCT00148863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013656|NCT00466999|Misoprostol|misoprostol|mesh-list
65013657|NCT00466999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64878331|NCT01895049|Hormones|hormones|mesh-ancestor
65013684|NCT00157482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65013685|NCT00157482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013686|NCT00467194|Sirolimus|sirolimus|mesh-list
65013687|NCT00467194|Bevacizumab|bevacizumab|mesh-list
65013688|NCT00467194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65013689|NCT00467194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013690|NCT00467194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65013691|NCT00467194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65013692|NCT00467194|Growth Substances|growth substances|mesh-ancestor
65013693|NCT00467194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013694|NCT00467194|Growth Inhibitors|growth inhibitors|mesh-ancestor
65013695|NCT00467194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65013696|NCT00467194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013697|NCT00467194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65013698|NCT00467194|Antifungal Agents|antifungal agents|mesh-ancestor
65013699|NCT00467194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65013700|NCT00467194|Immunologic Factors|immunologic factors|mesh-ancestor
65013701|NCT00148902|Docetaxel|docetaxel|mesh-list
65013702|NCT00148902|Lapatinib|lapatinib|mesh-list
65273282|NCT04500665|Colchicine|colchicine|mesh-list
65013703|NCT00148902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013704|NCT00148902|Tubulin Modulators|tubulin modulators|mesh-ancestor
65013705|NCT00148902|Antimitotic Agents|antimitotic agents|mesh-ancestor
65013706|NCT00148902|Mitosis Modulators|mitosis modulators|mesh-ancestor
64878383|NCT01898065|Misonidazole|misonidazole|mesh-list
65013724|NCT03271918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65013725|NCT03271918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65013726|NCT03271918|Dopamine Agonists|dopamine agonists|mesh-ancestor
65013727|NCT03271918|Dopamine Agents|dopamine agents|mesh-ancestor
65013728|NCT03271918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65013729|NCT03271918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013730|NCT03271918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013731|NCT00467467|Alfuzosin|alfuzosin|mesh-list
65013732|NCT00467467|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65013733|NCT00467467|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65013734|NCT00467467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65013735|NCT00467467|Adrenergic Agents|adrenergic agents|mesh-ancestor
65013736|NCT00467467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65013737|NCT00467467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013738|NCT00467467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013739|NCT00467467|Urological Agents|urological agents|mesh-ancestor
65013740|NCT00406887|Difluprednate|difluprednate|mesh-list
65013741|NCT00406887|Glucocorticoids|glucocorticoids|mesh-ancestor
65013742|NCT00406887|Hormones|hormones|mesh-ancestor
65013743|NCT00406887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65013744|NCT00406887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013745|NCT00467506|Antibodies|antibodies|mesh-list
65013746|NCT00467506|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65013747|NCT00467506|Immunologic Factors|immunologic factors|mesh-ancestor
65013748|NCT00467506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013749|NCT00467545|Telbivudine|telbivudine|mesh-list
65013750|NCT00467545|Antiviral Agents|antiviral agents|mesh-ancestor
65013751|NCT00467545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013752|NCT00467545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65013753|NCT00467545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013754|NCT00467545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013755|NCT00467662|Acyclovir|acyclovir|mesh-list
65013756|NCT00467662|Docosanol|docosanol|mesh-list
65013757|NCT00467662|Antiviral Agents|antiviral agents|mesh-ancestor
65013758|NCT00467662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013759|NCT05497310|Tretinoin|tretinoin|mesh-list
65013760|NCT05497310|Arsenic Trioxide|arsenic trioxide|mesh-list
65013761|NCT05497310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013762|NCT05497310|Keratolytic Agents|keratolytic agents|mesh-ancestor
65013763|NCT05497310|Dermatologic Agents|dermatologic agents|mesh-ancestor
65013794|NCT00468364|Insulin, Isophane|insulin, isophane|mesh-list
65013795|NCT00468364|Isophane Insulin, Human|isophane insulin, human|mesh-list
65013796|NCT00468364|Isophane insulin, beef|isophane insulin, beef|mesh-list
65013797|NCT00468364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65013798|NCT00468364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013799|NCT00149058|Epoetin Alfa|epoetin alfa|mesh-list
65013800|NCT00149058|Hematinics|hematinics|mesh-ancestor
65013801|NCT00468520|Oxytocin|oxytocin|mesh-list
65013802|NCT00468520|Oxytocics|oxytocics|mesh-ancestor
65013803|NCT00468520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65013804|NCT00468520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013805|NCT03271450|Warfarin|warfarin|mesh-list
65013806|NCT03271450|Rivaroxaban|rivaroxaban|mesh-list
65013807|NCT03271450|Dabigatran|dabigatran|mesh-list
65013808|NCT03271450|Apixaban|apixaban|mesh-list
65013809|NCT03271450|Edoxaban|edoxaban|mesh-list
65013810|NCT03271450|Anticoagulants|anticoagulants|mesh-ancestor
65013811|NCT03271450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65013812|NCT03271450|Antithrombins|antithrombins|mesh-ancestor
65013846|NCT00469300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013847|NCT04697641|Amoxicillin|amoxicillin|mesh-list
65013848|NCT04697641|Clarithromycin|clarithromycin|mesh-list
65013849|NCT04697641|Pantoprazole|pantoprazole|mesh-list
65013851|NCT04697641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65013852|NCT04697641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013853|NCT04697641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65013854|NCT04697641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013855|NCT04697641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013882|NCT00149253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65013883|NCT00149253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65013884|NCT00149253|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65013885|NCT00149253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65013886|NCT00149253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013887|NCT00149253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013888|NCT00469690|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65013889|NCT00469690|Bromfenac|bromfenac|mesh-list
65013890|NCT00469690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65013891|NCT00469690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65013892|NCT00469690|Analgesics|analgesics|mesh-ancestor
65013893|NCT00469690|Sensory System Agents|sensory system agents|mesh-ancestor
65013894|NCT00469690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65013895|NCT00469690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013896|NCT00469690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65013897|NCT00469690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65013898|NCT00469690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65013899|NCT00469690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013900|NCT00469690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013901|NCT00469768|Dapivirine|dapivirine|mesh-list
65013902|NCT00469768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64878572|NCT01900639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65013927|NCT00157677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65013928|NCT00157677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65013929|NCT00157677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013930|NCT00157677|Hemostatics|hemostatics|mesh-ancestor
65013931|NCT00157677|Coagulants|coagulants|mesh-ancestor
65013932|NCT05425979|Bupivacaine|bupivacaine|mesh-list
65013933|NCT05425979|Mepivacaine|mepivacaine|mesh-list
65013934|NCT05425979|Anesthetics, Local|anesthetics, local|mesh-ancestor
65013935|NCT05425979|Anesthetics|anesthetics|mesh-ancestor
65013936|NCT05425979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65013937|NCT05425979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013938|NCT05425979|Sensory System Agents|sensory system agents|mesh-ancestor
65013939|NCT05425979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65013940|NCT00470041|Lamivudine|lamivudine|mesh-list
65013941|NCT00470041|Zidovudine|zidovudine|mesh-list
65013942|NCT00470041|Antiviral Agents|antiviral agents|mesh-list
65013943|NCT00470041|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65013944|NCT00470041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65013945|NCT00470041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013946|NCT00470041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013947|NCT00470041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013948|NCT00470041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65013949|NCT00470041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65013950|NCT00470041|Antimetabolites|antimetabolites|mesh-ancestor
65013951|NCT00157716|Pyridoxal|pyridoxal|mesh-list
65013981|NCT00470314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65013982|NCT00470314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013983|NCT00470314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013985|NCT00149292|Antiemetics|antiemetics|mesh-ancestor
65013986|NCT00149292|Autonomic Agents|autonomic agents|mesh-ancestor
65013987|NCT00149292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65013988|NCT00149292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013989|NCT00149292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65013990|NCT00149292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65013991|NCT00149292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65013992|NCT00149292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65013993|NCT00149292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65013994|NCT00149292|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65013995|NCT00149292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65013996|NCT00149292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64878671|NCT01901003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65014017|NCT05391893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65014018|NCT05391893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014020|NCT00470509|Adalimumab|adalimumab|mesh-list
65014021|NCT00470509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65014022|NCT00470509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65014023|NCT05378906|Darunavir|darunavir|mesh-list
65014024|NCT05378906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65014025|NCT05378906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65014026|NCT05378906|Protease Inhibitors|protease inhibitors|mesh-ancestor
65014027|NCT05378906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014028|NCT05378906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014029|NCT05378906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65014030|NCT05378906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65014031|NCT05378906|Antiviral Agents|antiviral agents|mesh-ancestor
65014032|NCT05378906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65014033|NCT00470665|Sirolimus|sirolimus|mesh-list
65273284|NCT04500665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65273285|NCT04500665|Tubulin Modulators|tubulin modulators|mesh-ancestor
65014034|NCT00470665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65014035|NCT00470665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65014036|NCT00470665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65014037|NCT00470665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014038|NCT00470665|Antifungal Agents|antifungal agents|mesh-ancestor
65014039|NCT00470665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65014040|NCT00470665|Immunologic Factors|immunologic factors|mesh-ancestor
65014041|NCT00470665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014042|NCT00470743|Ibuprofen|ibuprofen|mesh-list
65014043|NCT00470743|Indomethacin|indomethacin|mesh-list
65014044|NCT00470743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65014045|NCT00470743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65014046|NCT00470743|Analgesics|analgesics|mesh-ancestor
65014047|NCT00470743|Sensory System Agents|sensory system agents|mesh-ancestor
65014048|NCT00470743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65014049|NCT00470743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014050|NCT00470743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65014051|NCT00470743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65014052|NCT00470743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65014082|NCT00470977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014083|NCT00470977|Growth Inhibitors|growth inhibitors|mesh-ancestor
65014084|NCT00470977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014085|NCT05350592|Dobutamine|dobutamine|mesh-list
65014086|NCT05350592|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65014087|NCT05350592|Sympathomimetics|sympathomimetics|mesh-ancestor
65014088|NCT05350592|Autonomic Agents|autonomic agents|mesh-ancestor
65014089|NCT05350592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65014090|NCT05350592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014091|NCT05350592|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65014092|NCT05350592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65014093|NCT05350592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65014094|NCT05350592|Adrenergic Agents|adrenergic agents|mesh-ancestor
65014095|NCT05350592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65014096|NCT05350592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014097|NCT05350592|Protective Agents|protective agents|mesh-ancestor
65014098|NCT00471055|Capsaicin|capsaicin|mesh-list
65014099|NCT00471055|Antipruritics|antipruritics|mesh-ancestor
65014120|NCT00157872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65014121|NCT00157872|Gout Suppressants|gout suppressants|mesh-ancestor
65014122|NCT00157872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65014123|NCT00157872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014124|NCT00157872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014125|NCT00157872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65014126|NCT03271255|Bevacizumab|bevacizumab|mesh-list
65014127|NCT03271255|Apatinib|apatinib|mesh-list
65014128|NCT03271255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65014129|NCT03271255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014130|NCT03271255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65014131|NCT03271255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65014132|NCT03271255|Growth Substances|growth substances|mesh-ancestor
65014133|NCT03271255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014134|NCT03271255|Growth Inhibitors|growth inhibitors|mesh-ancestor
65014135|NCT03271255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65014136|NCT03271255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014137|NCT03271255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014138|NCT00471289|Paclitaxel|paclitaxel|mesh-list
65014139|NCT00471289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65014140|NCT00471289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014141|NCT00471289|Tubulin Modulators|tubulin modulators|mesh-ancestor
65014142|NCT00471289|Antimitotic Agents|antimitotic agents|mesh-ancestor
65014143|NCT00471289|Mitosis Modulators|mitosis modulators|mesh-ancestor
64455111|NCT01393600|Tetrabenazine|tetrabenazine|mesh-list
65014144|NCT00471289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014145|NCT00336154|Tetracycline|tetracycline|mesh-list
65014146|NCT00336154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65014147|NCT00336154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65014148|NCT00336154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65014149|NCT00336154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014150|NCT00336154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014151|NCT00158028|Risperidone|risperidone|mesh-list
65014152|NCT00158028|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65273286|NCT04500665|Antimitotic Agents|antimitotic agents|mesh-ancestor
65014204|NCT00471562|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
65014205|NCT00471562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65014206|NCT00471562|Vasodilator Agents|vasodilator agents|mesh-ancestor
65014208|NCT00471640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65014209|NCT00471640|Antiemetics|antiemetics|mesh-ancestor
65014210|NCT00471640|Autonomic Agents|autonomic agents|mesh-ancestor
65014211|NCT00471640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65014212|NCT00471640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014213|NCT00471640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65014214|NCT00471640|Glucocorticoids|glucocorticoids|mesh-ancestor
65014215|NCT00471640|Hormones|hormones|mesh-ancestor
65014216|NCT00471640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65014217|NCT00471640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64469413|NCT05815264|Immunologic Factors|immunologic factors|mesh-ancestor
65014218|NCT00471640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014219|NCT00471679|Ethanol|ethanol|mesh-list
65014220|NCT00471679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65014221|NCT00471679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65493823|NCT04233866|Gemcitabine|gemcitabine|mesh-list
65014222|NCT00471679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64878898|NCT01902498|Antipyretics|antipyretics|mesh-ancestor
65014253|NCT00471952|Purinergic Agents|purinergic agents|mesh-ancestor
65014254|NCT00471952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65014255|NCT00471952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65014256|NCT00471952|Serotonin Agents|serotonin agents|mesh-ancestor
65014257|NCT00471991|Dienogest|dienogest|mesh-list
65014258|NCT00471991|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65014259|NCT00471991|Estradiol|estradiol|mesh-list
65014260|NCT00471991|Estrogens|estrogens|mesh-ancestor
65014261|NCT00471991|Hormones|hormones|mesh-ancestor
65014262|NCT00471991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65014263|NCT00471991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014264|NCT00471991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65014292|NCT00472225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65014293|NCT00472225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014294|NCT00472225|Immunologic Factors|immunologic factors|mesh-ancestor
65014295|NCT00472225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014296|NCT00472225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65014297|NCT00336466|Epoetin Alfa|epoetin alfa|mesh-list
65014298|NCT00336466|Hematinics|hematinics|mesh-ancestor
65014299|NCT00472381|Insulin|insulin|mesh-list
65014300|NCT00472381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65014301|NCT00472381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014302|NCT00472459|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65014303|NCT00472459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65014304|NCT00472459|Dermatologic Agents|dermatologic agents|mesh-ancestor
65014305|NCT00336739|Cinacalcet|cinacalcet|mesh-list
65014306|NCT00336739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65014307|NCT00336739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014308|NCT00336739|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65014309|NCT00336739|Hormone Antagonists|hormone antagonists|mesh-ancestor
65014310|NCT00336739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65014311|NCT00424151|Rituximab|rituximab|mesh-list
65014329|NCT00337051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014331|NCT00337051|Anesthetics, General|anesthetics, general|mesh-ancestor
65014332|NCT00337051|Anesthetics|anesthetics|mesh-ancestor
65014333|NCT00337051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65014334|NCT00337051|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65014335|NCT00472927|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65014336|NCT00472927|Estrogens|estrogens|mesh-ancestor
65014337|NCT00472927|Hormones|hormones|mesh-ancestor
65014338|NCT00472927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65014339|NCT00472927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014340|NCT00337090|Mirabegron|mirabegron|mesh-list
65014341|NCT00337090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65014342|NCT00337090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65014343|NCT00337090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65014344|NCT00337090|Adrenergic Agents|adrenergic agents|mesh-ancestor
65014345|NCT00337090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65014346|NCT00337090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014347|NCT00337090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014348|NCT00337090|Urological Agents|urological agents|mesh-ancestor
65014349|NCT05262452|Folfirinox|folfirinox|mesh-list
65014350|NCT05262452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014351|NCT00337246|Cyclophosphamide|cyclophosphamide|mesh-list
65014352|NCT00337246|Rituximab|rituximab|mesh-list
65014353|NCT00337246|Fludarabine|fludarabine|mesh-list
65014354|NCT00337246|Fludarabine phosphate|fludarabine phosphate|mesh-list
65014355|NCT00337246|Mitoxantrone|mitoxantrone|mesh-list
65014356|NCT00337246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65014357|NCT00337246|Immunologic Factors|immunologic factors|mesh-ancestor
65014358|NCT00337246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014359|NCT00337246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65014360|NCT00337246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65014361|NCT00337246|Alkylating Agents|alkylating agents|mesh-ancestor
65014362|NCT00337246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469564|NCT05814640|Antimanic Agents|antimanic agents|mesh-ancestor
64469565|NCT05814640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64469566|NCT05814640|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65493824|NCT04233866|Paclitaxel|paclitaxel|mesh-list
64469567|NCT05814627|Adalimumab|adalimumab|mesh-list
64469568|NCT05814627|Upadacitinib|upadacitinib|mesh-list
64469569|NCT05814627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65014389|NCT00473005|Everolimus|everolimus|mesh-list
65014390|NCT00473005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65014391|NCT00473005|Antimetabolites|antimetabolites|mesh-ancestor
65014392|NCT00473005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014393|NCT00473005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014394|NCT00473005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65014395|NCT00473005|Immunologic Factors|immunologic factors|mesh-ancestor
65014396|NCT00473005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014397|NCT00149877|Tegaserod|tegaserod|mesh-list
65014398|NCT00149877|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65014399|NCT00149877|Serotonin Agents|serotonin agents|mesh-ancestor
65014400|NCT00149877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65014401|NCT00149877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014402|NCT00149877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014403|NCT00473239|Vitamin D|vitamin d|mesh-list
65014404|NCT00473239|Cholecalciferol|cholecalciferol|mesh-list
65014427|NCT00337558|Solifenacin Succinate|solifenacin succinate|mesh-list
65014428|NCT00337558|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65014429|NCT00337558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65014430|NCT00337558|Cholinergic Agents|cholinergic agents|mesh-ancestor
65014431|NCT00337558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65014432|NCT00337558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014433|NCT00337558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014434|NCT00337558|Urological Agents|urological agents|mesh-ancestor
65014435|NCT00508963|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
65014436|NCT00508963|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65014437|NCT00508963|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65014438|NCT00508963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65014439|NCT00508963|Schistosomicides|schistosomicides|mesh-ancestor
65014440|NCT00508963|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65014441|NCT00508963|Anthelmintics|anthelmintics|mesh-ancestor
65014442|NCT02964104|Insulin|insulin|mesh-list
65014443|NCT02964104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65014444|NCT02964104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65014445|NCT02964104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014446|NCT00158457|Tenofovir|tenofovir|mesh-list
65014447|NCT00158457|Emtricitabine|emtricitabine|mesh-list
65014448|NCT00158457|Efavirenz|efavirenz|mesh-list
65014449|NCT00158457|Antiviral Agents|antiviral agents|mesh-ancestor
65014450|NCT00158457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65014451|NCT00158457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65014452|NCT00158457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65014453|NCT00158457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014454|NCT00158457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014455|NCT00158457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65014456|NCT00158457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65014457|NCT00158457|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65014466|NCT00509158|Immunologic Factors|immunologic factors|mesh-ancestor
65014467|NCT00509158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014469|NCT00509158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014470|NCT00509158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65014471|NCT00405080|Rifampin|rifampin|mesh-list
65014472|NCT00405080|Casopitant|casopitant|mesh-list
65014473|NCT00405080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65014474|NCT00405080|Antitubercular Agents|antitubercular agents|mesh-ancestor
65014475|NCT00405080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65014476|NCT00405080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65014477|NCT00405080|Leprostatic Agents|leprostatic agents|mesh-ancestor
65273287|NCT04500665|Mitosis Modulators|mitosis modulators|mesh-ancestor
65014478|NCT00405080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65014479|NCT00405080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014480|NCT00405080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014481|NCT00405080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65014482|NCT00405080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65014483|NCT00405080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65014484|NCT00405080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65014485|NCT00405080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65014486|NCT00405080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65014487|NCT00405080|Antiemetics|antiemetics|mesh-ancestor
65014488|NCT00405080|Autonomic Agents|autonomic agents|mesh-ancestor
65014489|NCT00405080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65014490|NCT00405080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014491|NCT00405080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65014492|NCT00405080|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65014493|NCT00405080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65014494|NCT00158496|Interferons|interferons|mesh-list
65014495|NCT00158496|Ribavirin|ribavirin|mesh-list
65014496|NCT00158496|Interferon-alpha|interferon-alpha|mesh-list
65014497|NCT00158496|Interferon alpha-2|interferon alpha-2|mesh-list
65014498|NCT00158496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65014499|NCT00158496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014500|NCT00158496|Antiviral Agents|antiviral agents|mesh-ancestor
65014501|NCT00158496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65014502|NCT00158496|Antimetabolites|antimetabolites|mesh-ancestor
65014503|NCT00158496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014504|NCT00158496|Immunologic Factors|immunologic factors|mesh-ancestor
65014505|NCT00158496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014506|NCT00337792|Fentanyl|fentanyl|mesh-list
65014507|NCT00337792|Midazolam|midazolam|mesh-list
65014508|NCT00337792|Oxycodone|oxycodone|mesh-list
65014509|NCT00337792|Lorazepam|lorazepam|mesh-list
65014510|NCT00337792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65014511|NCT00337792|Narcotics|narcotics|mesh-ancestor
65014512|NCT00337792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65014513|NCT00337792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014514|NCT00337792|Analgesics|analgesics|mesh-ancestor
65014515|NCT00337792|Sensory System Agents|sensory system agents|mesh-ancestor
65014516|NCT00337792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65014517|NCT00337792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65014518|NCT00337792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65014519|NCT00337792|Anesthetics, General|anesthetics, general|mesh-ancestor
65014520|NCT00337792|Anesthetics|anesthetics|mesh-ancestor
65014521|NCT00337792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65014522|NCT00337792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65014523|NCT00337792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65014539|NCT00509353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014540|NCT00509353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014541|NCT00509353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65014542|NCT00509353|Tubulin Modulators|tubulin modulators|mesh-ancestor
65014543|NCT00509353|Antimitotic Agents|antimitotic agents|mesh-ancestor
65014544|NCT00509353|Mitosis Modulators|mitosis modulators|mesh-ancestor
65014545|NCT00509353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65014546|NCT00405119|Esomeprazole|esomeprazole|mesh-list
65014547|NCT00405119|Ranitidine|ranitidine|mesh-list
65014548|NCT00405119|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65014549|NCT00405119|Loxtidine|loxtidine|mesh-list
65014550|NCT00405119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65014551|NCT00405119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65014552|NCT00405119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65014553|NCT00405119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014554|NCT00405119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014555|NCT00405119|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65014556|NCT00405119|Histamine Antagonists|histamine antagonists|mesh-ancestor
65014557|NCT00405119|Histamine Agents|histamine agents|mesh-ancestor
65014558|NCT00405119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65014559|NCT00405119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014560|NCT04715737|Vasopressins|vasopressins|mesh-list
65014561|NCT04715737|Arginine Vasopressin|arginine vasopressin|mesh-list
65014562|NCT04715737|Oxytocin|oxytocin|mesh-list
65014563|NCT04715737|Oxytocics|oxytocics|mesh-ancestor
65014564|NCT04715737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65014565|NCT04715737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014566|NCT04715737|Hemostatics|hemostatics|mesh-ancestor
65014567|NCT04715737|Coagulants|coagulants|mesh-ancestor
65273288|NCT04500665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273289|NCT04500665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014568|NCT04715737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65014569|NCT04715737|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65014570|NCT04715737|Natriuretic Agents|natriuretic agents|mesh-ancestor
65014571|NCT00509431|Sirolimus|sirolimus|mesh-list
65014572|NCT00509431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65014573|NCT00509431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014574|NCT00509431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65014575|NCT00509431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014576|NCT00509431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014577|NCT00509431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65014578|NCT00509431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65014579|NCT00509431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65014580|NCT00509431|Antifungal Agents|antifungal agents|mesh-ancestor
65014581|NCT00509431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65014582|NCT00509431|Immunologic Factors|immunologic factors|mesh-ancestor
65014583|NCT00509431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014584|NCT00509470|Amlodipine|amlodipine|mesh-list
65014585|NCT00509470|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65014586|NCT00509470|Telmisartan|telmisartan|mesh-list
65014587|NCT00509470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65014680|NCT02953210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65014681|NCT02953210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65014682|NCT02953210|GABA Modulators|gaba modulators|mesh-ancestor
65014683|NCT02953210|GABA Agents|gaba agents|mesh-ancestor
65014684|NCT02953210|Antipruritics|antipruritics|mesh-ancestor
65014685|NCT02953210|Dermatologic Agents|dermatologic agents|mesh-ancestor
65014686|NCT02953210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65014687|NCT02953210|Serotonin Agents|serotonin agents|mesh-ancestor
65014688|NCT02953210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65014689|NCT02953210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65014690|NCT02953210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65014691|NCT02953210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65014692|NCT02953210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65014693|NCT02953210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014694|NCT02953210|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65014695|NCT02953210|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65014696|NCT02953210|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65014697|NCT02953210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65014698|NCT02953210|Sympatholytics|sympatholytics|mesh-ancestor
65014699|NCT02953210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65014700|NCT02953210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65014701|NCT02953210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65014702|NCT02953210|Adrenergic Agents|adrenergic agents|mesh-ancestor
65014703|NCT02953210|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65014704|NCT02953210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65014705|NCT02953210|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65014706|NCT02953210|Histamine Antagonists|histamine antagonists|mesh-ancestor
65014707|NCT02953210|Histamine Agents|histamine agents|mesh-ancestor
65014708|NCT00509743|Diclofenac|diclofenac|mesh-list
65014709|NCT00509743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65014710|NCT00509743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65014711|NCT00509743|Analgesics|analgesics|mesh-ancestor
65014712|NCT00509743|Sensory System Agents|sensory system agents|mesh-ancestor
65014713|NCT00509743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65014714|NCT00509743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014715|NCT00509743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65014716|NCT00509743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65014717|NCT00509743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65014718|NCT00509743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014719|NCT00509743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014720|NCT00509860|Irinotecan|irinotecan|mesh-list
64879387|NCT01905696|Antioxidants|antioxidants|mesh-ancestor
65014757|NCT00158574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65014758|NCT00158574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65014759|NCT00158574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65014760|NCT00158574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014761|NCT00158574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879448|NCT01906450|Azithromycin|azithromycin|mesh-list
65014783|NCT00510016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65014784|NCT00510016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65014785|NCT00510016|Adrenergic Agents|adrenergic agents|mesh-ancestor
65014786|NCT00510016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65273290|NCT05116007|Carboplatin|carboplatin|mesh-list
65273291|NCT05116007|Etoposide|etoposide|mesh-list
65014787|NCT00510016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014789|NCT00150228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65014790|NCT00150228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65014791|NCT00150228|Cholinergic Agents|cholinergic agents|mesh-ancestor
65014792|NCT00150228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65014793|NCT00150228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014794|NCT00150228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014795|NCT00338338|Amlodipine|amlodipine|mesh-list
65014796|NCT00338338|Lacidipine|lacidipine|mesh-list
65014797|NCT00338338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65014798|NCT00338338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65014799|NCT00338338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65014800|NCT00338338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014801|NCT00338338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65014802|NCT00338338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014803|NCT00338338|Vasodilator Agents|vasodilator agents|mesh-ancestor
65014804|NCT00338416|Epoetin Alfa|epoetin alfa|mesh-list
65014805|NCT00338416|Hematinics|hematinics|mesh-ancestor
65014806|NCT00338494|Clofarabine|clofarabine|mesh-list
65014807|NCT00338494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65014808|NCT00338494|Antimetabolites|antimetabolites|mesh-ancestor
64455774|NCT04624399|Atezolizumab|atezolizumab|mesh-list
65014809|NCT00338494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470022|NCT05586776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64470023|NCT05586776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470024|NCT05586776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470025|NCT05586360|Simvastatin|simvastatin|mesh-list
64470026|NCT05586360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65014821|NCT00158652|Carboplatin|carboplatin|mesh-list
65014822|NCT00158652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014823|NCT00338650|Adalimumab|adalimumab|mesh-list
65014824|NCT00338650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65014825|NCT00338650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65014826|NCT00158691|Amifostine|amifostine|mesh-list
65014827|NCT00158691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65014828|NCT00158691|Protective Agents|protective agents|mesh-ancestor
65014829|NCT00158691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014830|NCT00338767|Fluoxetine|fluoxetine|mesh-list
65014831|NCT00338767|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65014832|NCT00338767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65014833|NCT00338767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65014834|NCT00338767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014835|NCT00338767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65014836|NCT00338767|Serotonin Agents|serotonin agents|mesh-ancestor
65014837|NCT00338767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014838|NCT00338767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65014839|NCT00338767|Antidepressive Agents|antidepressive agents|mesh-ancestor
65014840|NCT00338767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65014841|NCT00338767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65014842|NCT00338767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65014843|NCT00338767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014844|NCT00339001|Epoetin Alfa|epoetin alfa|mesh-list
65014845|NCT00339001|Hematinics|hematinics|mesh-ancestor
65014846|NCT00150306|Sertraline|sertraline|mesh-list
65014847|NCT00150306|Antidepressive Agents|antidepressive agents|mesh-ancestor
65014848|NCT00150306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65014849|NCT00150306|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65014850|NCT00150306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65014851|NCT00150306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65014852|NCT00150306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014853|NCT00150306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65014854|NCT00150306|Serotonin Agents|serotonin agents|mesh-ancestor
65014855|NCT00150306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014856|NCT00510172|Epoprostenol|epoprostenol|mesh-list
65014857|NCT00510172|Tezosentan|tezosentan|mesh-list
65014858|NCT00510172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65014859|NCT00510172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65014860|NCT00510172|Vasodilator Agents|vasodilator agents|mesh-ancestor
65014861|NCT00420901|Sildenafil Citrate|sildenafil citrate|mesh-list
65014862|NCT00420901|Vasodilator Agents|vasodilator agents|mesh-ancestor
64648085|NCT00765128|Ketorolac|ketorolac|mesh-list
64470117|NCT05545670|Protective Agents|protective agents|mesh-ancestor
65273292|NCT05116007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273293|NCT05116007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65273294|NCT05116007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65273295|NCT05116007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65273296|NCT05116007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273297|NCT05116007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273298|NCT00618696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65273299|NCT00618696|Antibodies|antibodies|mesh-list
65273300|NCT00618696|Immunoglobulins|immunoglobulins|mesh-list
65273301|NCT00618696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65273302|NCT00618696|Immunologic Factors|immunologic factors|mesh-ancestor
65273303|NCT00618696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273304|NCT00618696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273305|NCT00618852|Furosemide|furosemide|mesh-list
65273306|NCT00618852|Diuretics|diuretics|mesh-ancestor
65273307|NCT00618852|Natriuretic Agents|natriuretic agents|mesh-ancestor
64470118|NCT05545670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014866|NCT00420901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014867|NCT00420901|Urological Agents|urological agents|mesh-ancestor
65014869|NCT00150384|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
65014870|NCT00150384|Atorvastatin|atorvastatin|mesh-list
65014871|NCT00150384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65014872|NCT00150384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65014873|NCT00150384|Antimetabolites|antimetabolites|mesh-ancestor
65014874|NCT00150384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014875|NCT00150384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65014876|NCT00150384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65014877|NCT00150384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014878|NCT00150384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65014879|NCT00150384|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65014880|NCT00150384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65014881|NCT00150384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65014882|NCT00150384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014883|NCT00150384|Vasodilator Agents|vasodilator agents|mesh-ancestor
65014884|NCT00425191|Gemcitabine|gemcitabine|mesh-list
65014885|NCT00425191|Docetaxel|docetaxel|mesh-list
65014886|NCT00425191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014887|NCT00425191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65014888|NCT00425191|Antimetabolites|antimetabolites|mesh-ancestor
65014889|NCT00425191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014890|NCT00425191|Antiviral Agents|antiviral agents|mesh-ancestor
65014891|NCT00425191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65014892|NCT00425191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014893|NCT00425191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65014894|NCT00425191|Immunologic Factors|immunologic factors|mesh-ancestor
65014895|NCT00425191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014896|NCT00425191|Tubulin Modulators|tubulin modulators|mesh-ancestor
65014897|NCT00425191|Antimitotic Agents|antimitotic agents|mesh-ancestor
65014898|NCT00425191|Mitosis Modulators|mitosis modulators|mesh-ancestor
65014899|NCT00339118|Doxorubicin|doxorubicin|mesh-list
65014917|NCT00339196|Tretinoin|tretinoin|mesh-list
65014918|NCT00339196|Valproic Acid|valproic acid|mesh-list
65014919|NCT00339196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65014920|NCT00339196|Antimetabolites|antimetabolites|mesh-ancestor
65014921|NCT00339196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014922|NCT00339196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014923|NCT00339196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273308|NCT00618852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273309|NCT00618852|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65273310|NCT00618852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65273311|NCT00618852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014924|NCT00339196|Keratolytic Agents|keratolytic agents|mesh-ancestor
65014925|NCT00339196|Dermatologic Agents|dermatologic agents|mesh-ancestor
65014926|NCT00339196|Anticonvulsants|anticonvulsants|mesh-ancestor
65014927|NCT00339196|GABA Agents|gaba agents|mesh-ancestor
65014928|NCT00339196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65014929|NCT00339196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014930|NCT00339196|Antimanic Agents|antimanic agents|mesh-ancestor
65014931|NCT00339196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65014932|NCT00339196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65014933|NCT00339196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65014934|NCT00158730|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65014935|NCT00158730|Antifungal Agents|antifungal agents|mesh-ancestor
65014936|NCT00158730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65014937|NCT00158730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65014938|NCT00158730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65014939|NCT00510211|Olanzapine|olanzapine|mesh-list
64470172|NCT05497778|Gemcitabine|gemcitabine|mesh-list
65014940|NCT00510211|Antiemetics|antiemetics|mesh-ancestor
65014941|NCT00510211|Autonomic Agents|autonomic agents|mesh-ancestor
65014942|NCT00510211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65014943|NCT00510211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014944|NCT00510211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65014945|NCT00510211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65014946|NCT00510211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65014947|NCT00510211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65014948|NCT00510211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65014949|NCT00510211|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65014950|NCT00510211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65014951|NCT00510211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65014952|NCT00510211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014953|NCT00510211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65014954|NCT00510211|Serotonin Agents|serotonin agents|mesh-ancestor
65014955|NCT00150423|Pregabalin|pregabalin|mesh-list
65014956|NCT00150423|Analgesics|analgesics|mesh-ancestor
65014989|NCT00510250|Sorafenib|sorafenib|mesh-list
65014990|NCT00510250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014991|NCT00510250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65014992|NCT00510250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014993|NCT00510250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014994|NCT04981067|Ropivacaine|ropivacaine|mesh-list
65014995|NCT04981067|Anesthetics, Local|anesthetics, local|mesh-ancestor
65014996|NCT04981067|Anesthetics|anesthetics|mesh-ancestor
65014997|NCT04981067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65015026|NCT00158847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65015093|NCT00510445|Motesanib diphosphate|motesanib diphosphate|mesh-list
65015094|NCT00510445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015095|NCT00510445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015096|NCT00510445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65015097|NCT00150657|Gemcitabine|gemcitabine|mesh-list
65015098|NCT00150657|Bevacizumab|bevacizumab|mesh-list
65015099|NCT00150657|Carboplatin|carboplatin|mesh-list
64879830|NCT01908556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015129|NCT00511849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65015130|NCT00511849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015131|NCT00511849|Tubulin Modulators|tubulin modulators|mesh-ancestor
65015132|NCT00511849|Antimitotic Agents|antimitotic agents|mesh-ancestor
65015133|NCT00511849|Mitosis Modulators|mitosis modulators|mesh-ancestor
65015134|NCT00511849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015135|NCT00511849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65015136|NCT00511849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65015137|NCT00511849|Growth Substances|growth substances|mesh-ancestor
65015138|NCT00511849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015139|NCT00511849|Growth Inhibitors|growth inhibitors|mesh-ancestor
65015140|NCT00511849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65015141|NCT00511849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273312|NCT02073474|Nabiximols|nabiximols|mesh-list
65273313|NCT02073474|Analgesics|analgesics|mesh-ancestor
65273314|NCT02073474|Sensory System Agents|sensory system agents|mesh-ancestor
65273315|NCT02073474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65273316|NCT02073474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015165|NCT00165633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015166|NCT00165633|Vitamins|vitamins|mesh-ancestor
65015167|NCT00165633|Micronutrients|micronutrients|mesh-ancestor
65015168|NCT00165633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015169|NCT02952469|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65015170|NCT02952469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015171|NCT02952469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65015172|NCT00510913|Tacrolimus|tacrolimus|mesh-list
65015173|NCT00510913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65015174|NCT00510913|Immunologic Factors|immunologic factors|mesh-ancestor
65015175|NCT00510913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015176|NCT00510913|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65015177|NCT00510913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015178|NCT00510913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015179|NCT00150735|Levetiracetam|levetiracetam|mesh-list
65015180|NCT00150735|Anticonvulsants|anticonvulsants|mesh-ancestor
65015181|NCT00150735|Nootropic Agents|nootropic agents|mesh-ancestor
65015182|NCT04695925|Carboplatin|carboplatin|mesh-list
65015183|NCT04695925|Pemetrexed|pemetrexed|mesh-list
65015184|NCT04695925|Osimertinib|osimertinib|mesh-list
65015185|NCT04695925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015186|NCT04695925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015187|NCT04695925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015188|NCT04695925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65015189|NCT04695925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65015190|NCT04695925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65015191|NCT00511069|Bortezomib|bortezomib|mesh-list
65015192|NCT00511069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015193|NCT00165750|Donepezil|donepezil|mesh-list
65015194|NCT00165750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65015227|NCT00511303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015228|NCT00511303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015230|NCT00165828|Anticonvulsants|anticonvulsants|mesh-ancestor
65015231|NCT00165828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65015232|NCT00165828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65015233|NCT00165828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015234|NCT00165828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65015235|NCT00165828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015236|NCT00511498|Sildenafil Citrate|sildenafil citrate|mesh-list
65015237|NCT00511498|Vasodilator Agents|vasodilator agents|mesh-ancestor
65015238|NCT00511498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65015271|NCT04799249|Antimetabolites|antimetabolites|mesh-ancestor
65015272|NCT04799249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015273|NCT04799249|Antiviral Agents|antiviral agents|mesh-ancestor
65015274|NCT04799249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65015275|NCT04799249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015276|NCT04799249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65015277|NCT04799249|Immunologic Factors|immunologic factors|mesh-ancestor
65015278|NCT04799249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015279|NCT00150852|Vancomycin|vancomycin|mesh-list
65015280|NCT00150852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65015281|NCT00150852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65015282|NCT02952235|Sunscreening Agents|sunscreening agents|mesh-list
64880023|NCT01910246|Metformin|metformin|mesh-list
64470574|NCT05180357|Benralizumab|benralizumab|mesh-list
65015293|NCT02951806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65015294|NCT02951806|Narcotics|narcotics|mesh-ancestor
65015295|NCT02951806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65015296|NCT02951806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015297|NCT02951806|Analgesics|analgesics|mesh-ancestor
65015298|NCT02951806|Sensory System Agents|sensory system agents|mesh-ancestor
65015299|NCT02951806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65015300|NCT02951806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65015301|NCT02951806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65015302|NCT02951806|Anesthetics, General|anesthetics, general|mesh-ancestor
65015303|NCT02951806|Anesthetics|anesthetics|mesh-ancestor
65273317|NCT00637104|Chromium|chromium|mesh-list
65273318|NCT00637104|Trace Elements|trace elements|mesh-ancestor
65273319|NCT00637104|Micronutrients|micronutrients|mesh-ancestor
65015304|NCT00512980|Gemcitabine|gemcitabine|mesh-list
65015306|NCT00512980|Doxorubicin|doxorubicin|mesh-list
65015307|NCT00512980|Vinblastine|vinblastine|mesh-list
65015308|NCT00512980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65015309|NCT00512980|Antimetabolites|antimetabolites|mesh-ancestor
65015310|NCT00512980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015311|NCT00512980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015312|NCT00512980|Antiviral Agents|antiviral agents|mesh-ancestor
65015313|NCT00512980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65015314|NCT00512980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015315|NCT00512980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65015316|NCT00512980|Immunologic Factors|immunologic factors|mesh-ancestor
65015317|NCT00512980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015318|NCT00512980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65015319|NCT00512980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65015320|NCT00512980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65015321|NCT00512980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65015322|NCT00512980|Glucocorticoids|glucocorticoids|mesh-ancestor
65015323|NCT00512980|Hormones|hormones|mesh-ancestor
65015324|NCT00512980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64880053|NCT01910285|Sufentanil|sufentanil|mesh-list
65015355|NCT00513058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015356|NCT00513058|Tubulin Modulators|tubulin modulators|mesh-ancestor
65015357|NCT00513058|Antimitotic Agents|antimitotic agents|mesh-ancestor
65015358|NCT00513058|Mitosis Modulators|mitosis modulators|mesh-ancestor
65015359|NCT00513058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015360|NCT00513058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65015361|NCT00513058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015362|NCT02951962|Amlodipine|amlodipine|mesh-list
65015363|NCT02951962|Telmisartan|telmisartan|mesh-list
65015364|NCT02951962|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
65015365|NCT02951962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64470640|NCT05117489|Cortisone|cortisone|mesh-list
65015366|NCT02951962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65015367|NCT02951962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65015368|NCT02951962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65015369|NCT02951962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015391|NCT00513487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65015392|NCT00513487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015393|NCT00513487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65015394|NCT00513487|Respiratory System Agents|respiratory system agents|mesh-ancestor
65015395|NCT00513487|Dermatologic Agents|dermatologic agents|mesh-ancestor
65015396|NCT00513487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65015397|NCT00513487|Miotics|miotics|mesh-ancestor
65015398|NCT00513487|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65015399|NCT00513487|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
65015400|NCT00513487|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65015401|NCT00513487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65015402|NCT00513487|Cholinergic Agents|cholinergic agents|mesh-ancestor
65015403|NCT00513487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65015404|NCT00513487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015405|NCT00405236|Tiotropium Bromide|tiotropium bromide|mesh-list
65015406|NCT00405236|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65015407|NCT00405236|Autonomic Agents|autonomic agents|mesh-ancestor
65015408|NCT00405236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65015409|NCT00405236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015410|NCT00405236|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65015411|NCT00405236|Respiratory System Agents|respiratory system agents|mesh-ancestor
65015412|NCT00405236|Parasympatholytics|parasympatholytics|mesh-ancestor
65015413|NCT00405236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65015414|NCT00405236|Cholinergic Agents|cholinergic agents|mesh-ancestor
65015415|NCT00405236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65015416|NCT00405236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015417|NCT00403949|Azelaic acid|azelaic acid|mesh-list
65015418|NCT00403949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015419|NCT00403949|Dermatologic Agents|dermatologic agents|mesh-ancestor
65015420|NCT00513643|Insulin|insulin|mesh-list
65015421|NCT00513643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65015422|NCT00513643|Insulin Aspart|insulin aspart|mesh-list
65015423|NCT00513643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65015497|NCT00151086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65273320|NCT00637104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015498|NCT00151086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015499|NCT00151086|Tubulin Modulators|tubulin modulators|mesh-ancestor
65015500|NCT00151086|Antimitotic Agents|antimitotic agents|mesh-ancestor
65015501|NCT00151086|Mitosis Modulators|mitosis modulators|mesh-ancestor
65015502|NCT00151086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015503|NCT00151086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65015504|NCT00151086|Alkylating Agents|alkylating agents|mesh-ancestor
65015505|NCT00151086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65015541|NCT02951299|Protective Agents|protective agents|mesh-ancestor
65015542|NCT02951299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015543|NCT02951299|Vasodilator Agents|vasodilator agents|mesh-ancestor
65015544|NCT02951299|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65015599|NCT00151203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65015600|NCT00151203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015601|NCT00151203|Immunologic Factors|immunologic factors|mesh-ancestor
65015602|NCT00151203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65015603|NCT00151203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65015604|NCT00151203|Growth Substances|growth substances|mesh-ancestor
65015605|NCT00151203|Growth Inhibitors|growth inhibitors|mesh-ancestor
65015606|NCT00151203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65015607|NCT00151203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65015608|NCT00151203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65015609|NCT00151203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880364|NCT01911949|Mydriatics|mydriatics|mesh-ancestor
65015638|NCT00515788|Alkylating Agents|alkylating agents|mesh-ancestor
65015640|NCT02950870|Ribavirin|ribavirin|mesh-list
65015641|NCT02950870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65015642|NCT02950870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65015643|NCT02950870|Protease Inhibitors|protease inhibitors|mesh-ancestor
65015644|NCT02950870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015645|NCT02950870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015646|NCT02950870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65015647|NCT02950870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65015648|NCT02950870|Antiviral Agents|antiviral agents|mesh-ancestor
65015649|NCT02950870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65015650|NCT02950870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65015651|NCT02950870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65015681|NCT00515944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015682|NCT00515944|Cholinergic Agents|cholinergic agents|mesh-ancestor
65015683|NCT00515944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65015684|NCT00515944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015685|NCT00515944|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65015686|NCT00515944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65015688|NCT00151242|Etoposide|etoposide|mesh-list
65015689|NCT00151242|Idarubicin|idarubicin|mesh-list
65015690|NCT00151242|Tretinoin|tretinoin|mesh-list
65015691|NCT00151242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65015692|NCT00151242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015693|NCT00151242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65015694|NCT00151242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65015695|NCT00151242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880441|NCT01912573|Naloxone|naloxone|mesh-list
64471094|NCT04763564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64471095|NCT04763564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471097|NCT04763564|Hormones|hormones|mesh-ancestor
64471098|NCT04763564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64471155|NCT04748588|Bamlanivimab|bamlanivimab|mesh-list
64471156|NCT04748588|Antiviral Agents|antiviral agents|mesh-ancestor
64471157|NCT04748588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64471158|NCT04741997|Nivolumab|nivolumab|mesh-list
64471159|NCT04741997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64471160|NCT04741997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471161|NCT04741997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64471162|NCT04741997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471163|NCT04735510|Cyclosporine|cyclosporine|mesh-list
64471164|NCT04735510|Cyclosporins|cyclosporins|mesh-list
64471165|NCT04735510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64471166|NCT04735510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471167|NCT04735510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65015711|NCT00516100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015712|NCT00516100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65015713|NCT00516100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65273321|NCT00617760|Vaccines|vaccines|mesh-list
65273322|NCT00617760|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65015715|NCT00166413|Lenalidomide|lenalidomide|mesh-list
65015716|NCT00166413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65015717|NCT00166413|Immunologic Factors|immunologic factors|mesh-ancestor
65015718|NCT00166413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015719|NCT00166413|Leprostatic Agents|leprostatic agents|mesh-ancestor
65015720|NCT00166413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65015721|NCT00166413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65015722|NCT00166413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65015723|NCT00166413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65015724|NCT00166413|Growth Substances|growth substances|mesh-ancestor
65015725|NCT00166413|Growth Inhibitors|growth inhibitors|mesh-ancestor
65015744|NCT02950168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65015745|NCT02950168|Antithrombins|antithrombins|mesh-ancestor
65015746|NCT02950168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65015747|NCT02950168|Protease Inhibitors|protease inhibitors|mesh-ancestor
65015748|NCT02950168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015749|NCT02950168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015750|NCT02950168|Anticoagulants|anticoagulants|mesh-ancestor
65015751|NCT04695223|Arsenic Trioxide|arsenic trioxide|mesh-list
65015752|NCT04695223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015753|NCT00166491|Insulin|insulin|mesh-list
65015754|NCT00166491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65015755|NCT00166491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015756|NCT04505189|Psilocybin|psilocybin|mesh-list
65015757|NCT04505189|Hallucinogens|hallucinogens|mesh-ancestor
65015758|NCT04505189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015759|NCT04505189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65015760|NCT00508885|Niacinamide|niacinamide|mesh-list
65015761|NCT00508885|Niacin|niacin|mesh-list
65015762|NCT00508885|Nicotinic Acids|nicotinic acids|mesh-list
65015763|NCT00508885|Vitamin B Complex|vitamin b complex|mesh-ancestor
65015764|NCT00508885|Vitamins|vitamins|mesh-ancestor
65015765|NCT00508885|Micronutrients|micronutrients|mesh-ancestor
65015766|NCT00508885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015767|NCT00508885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65015768|NCT00508885|Antimetabolites|antimetabolites|mesh-ancestor
65015769|NCT00508885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015770|NCT00508885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65015771|NCT00508885|Vasodilator Agents|vasodilator agents|mesh-ancestor
65015772|NCT02953405|Clopidogrel|clopidogrel|mesh-list
65015773|NCT02953405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65015774|NCT02953405|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65015775|NCT02953405|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65015776|NCT02953405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65015777|NCT02953405|Purinergic Agents|purinergic agents|mesh-ancestor
65015778|NCT02953405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65015779|NCT02953405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015780|NCT02953405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015781|NCT00516802|Olaparib|olaparib|mesh-list
65015782|NCT00516802|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65015783|NCT00516802|Dacarbazine|dacarbazine|mesh-list
65015784|NCT00516802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015785|NCT00516802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015786|NCT00516802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015787|NCT00516802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65015845|NCT00517270|Rabeprazole|rabeprazole|mesh-list
65015846|NCT00517270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65015847|NCT00517270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65015848|NCT00517270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65015849|NCT00517270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015850|NCT00517270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015851|NCT00517309|Vaccines|vaccines|mesh-list
65015852|NCT00517309|Immunologic Factors|immunologic factors|mesh-ancestor
65015853|NCT00517309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015854|NCT00517387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65015855|NCT00517387|Antidepressive Agents|antidepressive agents|mesh-ancestor
65015856|NCT00517387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65015857|NCT00517387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65015858|NCT00517387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65015859|NCT00517387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65015860|NCT00517387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015861|NCT00517426|Acetazolamide|acetazolamide|mesh-list
65273323|NCT00617760|Immunologic Factors|immunologic factors|mesh-ancestor
65273324|NCT00617760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273325|NCT00620490|Ropivacaine|ropivacaine|mesh-list
65273326|NCT00620490|Anesthetics, Local|anesthetics, local|mesh-ancestor
65273327|NCT00620490|Anesthetics|anesthetics|mesh-ancestor
65273328|NCT00620490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65273329|NCT00620490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482179|NCT04140591|Propranolol|propranolol|mesh-list
65015862|NCT00517426|Anticonvulsants|anticonvulsants|mesh-ancestor
65015863|NCT00517426|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65015864|NCT00517426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015865|NCT00517426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015866|NCT00517426|Diuretics|diuretics|mesh-ancestor
65015867|NCT00517426|Natriuretic Agents|natriuretic agents|mesh-ancestor
65015868|NCT00517426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015869|NCT00517504|Methylphenidate|methylphenidate|mesh-list
65015870|NCT00517504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65015871|NCT00517504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015872|NCT00517504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65015873|NCT00517504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65015874|NCT00517504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65015875|NCT00517504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015876|NCT00517504|Dopamine Agents|dopamine agents|mesh-ancestor
65015877|NCT00517504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64880628|NCT01913964|Nootropic Agents|nootropic agents|mesh-ancestor
65015897|NCT00517621|Antimitotic Agents|antimitotic agents|mesh-ancestor
65015898|NCT00517621|Mitosis Modulators|mitosis modulators|mesh-ancestor
65015899|NCT00517621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015900|NCT04480853|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65015901|NCT04480853|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65015902|NCT04480853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015903|NCT04480853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65015904|NCT04480853|Immunologic Factors|immunologic factors|mesh-ancestor
65015905|NCT04480853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015906|NCT00151515|Minoxidil|minoxidil|mesh-list
65015907|NCT00151515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65015908|NCT00151515|Vasodilator Agents|vasodilator agents|mesh-ancestor
65015909|NCT00166686|Clonidine|clonidine|mesh-list
65015910|NCT00166686|Analgesics|analgesics|mesh-ancestor
65015911|NCT00166686|Sensory System Agents|sensory system agents|mesh-ancestor
65015912|NCT00166686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65015913|NCT00166686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015914|NCT00166686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65015915|NCT00166686|Sympatholytics|sympatholytics|mesh-ancestor
65015916|NCT00166686|Autonomic Agents|autonomic agents|mesh-ancestor
65015917|NCT00166686|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65015918|NCT00166686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65015919|NCT00166686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65015920|NCT00166686|Adrenergic Agents|adrenergic agents|mesh-ancestor
65015921|NCT00166686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65015922|NCT00166686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015923|NCT02949778|Ropivacaine|ropivacaine|mesh-list
65015924|NCT02949778|Anesthetics, Local|anesthetics, local|mesh-ancestor
65015925|NCT02949778|Anesthetics|anesthetics|mesh-ancestor
65015926|NCT02949778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65015927|NCT02949778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015928|NCT02949778|Sensory System Agents|sensory system agents|mesh-ancestor
65015929|NCT02949778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65015930|NCT00518245|Enoxaparin|enoxaparin|mesh-list
65015931|NCT00518245|Anticoagulants|anticoagulants|mesh-ancestor
65015932|NCT00518245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65015962|NCT00518635|Insulin|insulin|mesh-list
65015963|NCT00518635|Hormones|hormones|mesh-list
65015964|NCT00518635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65015965|NCT00518635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015966|NCT00518635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65273330|NCT00620490|Sensory System Agents|sensory system agents|mesh-ancestor
65273331|NCT00620490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65273332|NCT04212078|Levofloxacin|levofloxacin|mesh-list
65273333|NCT04212078|Ofloxacin|ofloxacin|mesh-list
65273334|NCT04212078|Cefuroxime|cefuroxime|mesh-list
65273335|NCT04212078|Cefuroxime axetil|cefuroxime axetil|mesh-list
65273336|NCT04212078|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65273337|NCT04212078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65273338|NCT04212078|Renal Agents|renal agents|mesh-ancestor
65273339|NCT04212078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65273340|NCT04212078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65273341|NCT04212078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65273342|NCT04212078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273343|NCT04212078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273344|NCT04212078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273345|NCT04212078|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65273346|NCT04212078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65273347|NCT05059860|Insulin|insulin|mesh-list
65273348|NCT05059860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65273349|NCT05059860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273350|NCT01898520|Nabiximols|nabiximols|mesh-list
65273351|NCT01898520|Analgesics|analgesics|mesh-ancestor
65273352|NCT01898520|Sensory System Agents|sensory system agents|mesh-ancestor
65273353|NCT01898520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65015967|NCT00151632|Mycophenolic Acid|mycophenolic acid|mesh-list
65015968|NCT00151632|Tacrolimus|tacrolimus|mesh-list
65015969|NCT00151632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65015970|NCT00151632|Immunologic Factors|immunologic factors|mesh-ancestor
65015971|NCT00151632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015972|NCT00151632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65015973|NCT00151632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015974|NCT00151632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015975|NCT00151632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65015976|NCT00151632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015977|NCT00151632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65015978|NCT00151632|Antitubercular Agents|antitubercular agents|mesh-ancestor
64880752|NCT01914692|Hormones|hormones|mesh-ancestor
65016013|NCT02949466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65016014|NCT02949466|Glucocorticoids|glucocorticoids|mesh-ancestor
65016015|NCT02949466|Hormones|hormones|mesh-ancestor
65016016|NCT02949466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65016017|NCT02949466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016051|NCT02949349|Antitubercular Agents|antitubercular agents|mesh-ancestor
65016052|NCT02949349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65016053|NCT02949349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65016054|NCT02949349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016055|NCT02949349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471549|NCT04397484|Autonomic Agents|autonomic agents|mesh-ancestor
64471550|NCT04397484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64471551|NCT04397484|Respiratory System Agents|respiratory system agents|mesh-ancestor
64471552|NCT04397484|Mydriatics|mydriatics|mesh-ancestor
64471553|NCT04397484|Sympathomimetics|sympathomimetics|mesh-ancestor
65273354|NCT01898520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273355|NCT00903617|Niacin|niacin|mesh-list
65273356|NCT00903617|Nicotinic Acids|nicotinic acids|mesh-list
65273357|NCT00903617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65273358|NCT00903617|Antimetabolites|antimetabolites|mesh-ancestor
65273359|NCT00903617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273360|NCT00903617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65273361|NCT00903617|Vasodilator Agents|vasodilator agents|mesh-ancestor
65273362|NCT00903617|Vitamin B Complex|vitamin b complex|mesh-ancestor
65273363|NCT00903617|Vitamins|vitamins|mesh-ancestor
65273364|NCT00903617|Micronutrients|micronutrients|mesh-ancestor
64471554|NCT04397484|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65016070|NCT00166842|Cyclosporins|cyclosporins|mesh-list
65016071|NCT00166842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65016105|NCT00519298|Donepezil|donepezil|mesh-list
65016106|NCT00519298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65016107|NCT00519298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016108|NCT00519298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016109|NCT00519298|Cholinergic Agents|cholinergic agents|mesh-ancestor
65016110|NCT00519298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65016136|NCT02948998|Spironolactone|spironolactone|mesh-list
65016137|NCT02948998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65016138|NCT02948998|Hormone Antagonists|hormone antagonists|mesh-ancestor
65016139|NCT02948998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65016140|NCT02948998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016141|NCT02948998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65016142|NCT02948998|Diuretics|diuretics|mesh-ancestor
65016143|NCT02948998|Natriuretic Agents|natriuretic agents|mesh-ancestor
65016144|NCT00519688|Thalidomide|thalidomide|mesh-list
65016145|NCT00519688|Tegafur|tegafur|mesh-list
65016146|NCT00519688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65016147|NCT00519688|Immunologic Factors|immunologic factors|mesh-ancestor
65016148|NCT00519688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016149|NCT00519688|Leprostatic Agents|leprostatic agents|mesh-ancestor
65016150|NCT00519688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65016151|NCT00519688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65016152|NCT00519688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65016153|NCT00519688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65016154|NCT00519688|Growth Substances|growth substances|mesh-ancestor
65016155|NCT00519688|Growth Inhibitors|growth inhibitors|mesh-ancestor
65016156|NCT00519688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016157|NCT00519688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65016158|NCT00519688|Antimetabolites|antimetabolites|mesh-ancestor
64880941|NCT01915979|Glucocorticoids|glucocorticoids|mesh-ancestor
65016184|NCT00519805|Dalteparin|dalteparin|mesh-list
65016185|NCT00519805|Tinzaparin|tinzaparin|mesh-list
65016186|NCT00519805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65016187|NCT00519805|Anticoagulants|anticoagulants|mesh-ancestor
65016188|NCT00519805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65016189|NCT00519805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65016190|NCT00519805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016191|NCT02948881|Ibandronic Acid|ibandronic acid|mesh-list
64457273|NCT01874535|Esomeprazole|esomeprazole|mesh-list
64471703|NCT04233190|Respiratory System Agents|respiratory system agents|mesh-ancestor
64471704|NCT04233190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64471705|NCT04233190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64471706|NCT04233190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64471707|NCT04233190|Adrenergic Agents|adrenergic agents|mesh-ancestor
64471708|NCT04233190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64471709|NCT04233190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471710|NCT04233190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64471711|NCT04233190|Glucocorticoids|glucocorticoids|mesh-ancestor
64471712|NCT04233190|Hormones|hormones|mesh-ancestor
64471713|NCT04233190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65016192|NCT02948881|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65273365|NCT00903617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273366|NCT02848937|Citric Acid|citric acid|mesh-list
65273367|NCT02848937|Sodium Citrate|sodium citrate|mesh-list
65273368|NCT02848937|Anticoagulants|anticoagulants|mesh-ancestor
65273369|NCT02848937|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65273370|NCT02848937|Chelating Agents|chelating agents|mesh-ancestor
65016193|NCT02948881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016219|NCT00520000|Antimitotic Agents|antimitotic agents|mesh-ancestor
65016220|NCT00520000|Mitosis Modulators|mitosis modulators|mesh-ancestor
65016221|NCT00520000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016222|NCT00151944|Mesalamine|mesalamine|mesh-list
65016223|NCT00151944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65016224|NCT00151944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65016225|NCT00151944|Analgesics|analgesics|mesh-ancestor
65016226|NCT00151944|Sensory System Agents|sensory system agents|mesh-ancestor
65016227|NCT00151944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65016228|NCT00151944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016229|NCT00151944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65016230|NCT00151944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65016231|NCT00520507|Olanzapine|olanzapine|mesh-list
65016232|NCT00520507|Antiemetics|antiemetics|mesh-ancestor
65016233|NCT00520507|Autonomic Agents|autonomic agents|mesh-ancestor
65016234|NCT00520507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65016235|NCT00520507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016236|NCT00520507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65016237|NCT00520507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65016238|NCT00520507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64471780|NCT04117178|Memantine|memantine|mesh-list
64471781|NCT04117178|Donepezil|donepezil|mesh-list
64471782|NCT04117178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64471783|NCT04117178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64471784|NCT04117178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471785|NCT04117178|Cholinergic Agents|cholinergic agents|mesh-ancestor
64471786|NCT04117178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64471877|NCT04025216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64471878|NCT04020185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64471879|NCT04020185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471880|NCT04020185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016295|NCT00521092|Sunitinib|sunitinib|mesh-list
65016296|NCT00521092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016297|NCT00521092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65016298|NCT00521092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65016299|NCT00521092|Growth Substances|growth substances|mesh-ancestor
65016300|NCT00521092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016301|NCT00521092|Growth Inhibitors|growth inhibitors|mesh-ancestor
65016302|NCT00521092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65016327|NCT00521170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016329|NCT00521248|Morphine|morphine|mesh-list
65016330|NCT00521248|Buprenorphine|buprenorphine|mesh-list
65016331|NCT00521248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65016332|NCT00521248|Narcotics|narcotics|mesh-ancestor
65016333|NCT00521248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65016334|NCT00521248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016335|NCT00521248|Analgesics|analgesics|mesh-ancestor
65016336|NCT00521248|Sensory System Agents|sensory system agents|mesh-ancestor
65016337|NCT00521248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65016338|NCT00521248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65016339|NCT00167154|Risperidone|risperidone|mesh-list
65016340|NCT00167154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65016341|NCT00167154|Serotonin Agents|serotonin agents|mesh-ancestor
65016342|NCT00167154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65016343|NCT00167154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016344|NCT00167154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016345|NCT00167154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65016346|NCT00167154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65016347|NCT00167154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65016348|NCT00167154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65016349|NCT00167154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65016383|NCT00521950|Immunologic Factors|immunologic factors|mesh-ancestor
65016384|NCT00521950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016385|NCT00521950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65016386|NCT00521950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016387|NCT00521950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65016388|NCT00522184|Etanercept|etanercept|mesh-list
65016389|NCT00522184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65016390|NCT00522184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65016446|NCT00511966|Rabeprazole|rabeprazole|mesh-list
65016447|NCT00511966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65016448|NCT00511966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65016449|NCT00511966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65016450|NCT00511966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016451|NCT00511966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016452|NCT00152178|Tamoxifen|tamoxifen|mesh-list
65016453|NCT00152178|Cyclophosphamide|cyclophosphamide|mesh-list
65016454|NCT00152178|Fluorouracil|fluorouracil|mesh-list
65016455|NCT00152178|Methotrexate|methotrexate|mesh-list
65016456|NCT00152178|Tegafur|tegafur|mesh-list
65016457|NCT00152178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65016458|NCT00152178|Immunologic Factors|immunologic factors|mesh-ancestor
65016459|NCT00152178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016460|NCT00152178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65016461|NCT00152178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65016462|NCT00152178|Alkylating Agents|alkylating agents|mesh-ancestor
65016463|NCT00152178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472100|NCT03794999|Respiratory System Agents|respiratory system agents|mesh-ancestor
64472102|NCT03790111|Cisplatin|cisplatin|mesh-list
64472103|NCT03790111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472104|NCT03790111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64472105|NCT03790111|Antimetabolites|antimetabolites|mesh-ancestor
64472106|NCT03790111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472107|NCT03790111|Antiviral Agents|antiviral agents|mesh-ancestor
64472108|NCT03790111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64472109|NCT03790111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472110|NCT03790111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64472111|NCT03790111|Immunologic Factors|immunologic factors|mesh-ancestor
64472112|NCT03790111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472113|NCT03780543|Tenofovir|tenofovir|mesh-list
64472114|NCT03780543|Entecavir|entecavir|mesh-list
65016477|NCT00152178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65016478|NCT00152178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65016479|NCT00152178|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65016480|NCT00152178|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65016481|NCT00152178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65016483|NCT00523120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65016484|NCT00523120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65016485|NCT00523120|Analgesics|analgesics|mesh-ancestor
65016486|NCT00523120|Sensory System Agents|sensory system agents|mesh-ancestor
65016487|NCT00523120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65016488|NCT00523120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016518|NCT04726553|Methotrexate|methotrexate|mesh-list
65016519|NCT04726553|Azathioprine|azathioprine|mesh-list
65016520|NCT04726553|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65016521|NCT04726553|Abortifacient Agents|abortifacient agents|mesh-ancestor
65016522|NCT04726553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65016523|NCT04726553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016524|NCT04726553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65016525|NCT04726553|Antimetabolites|antimetabolites|mesh-ancestor
65016526|NCT04726553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016527|NCT04726553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016528|NCT04726553|Dermatologic Agents|dermatologic agents|mesh-ancestor
65016529|NCT04726553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016530|NCT04726553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65016531|NCT04726553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65016532|NCT04726553|Immunologic Factors|immunologic factors|mesh-ancestor
65016533|NCT04726553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65016534|NCT04726553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65016566|NCT02952157|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65016567|NCT02952157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65016568|NCT02952157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016569|NCT02951728|Prednisone|prednisone|mesh-list
65016570|NCT02951728|Cyclophosphamide|cyclophosphamide|mesh-list
65016571|NCT02951728|Rituximab|rituximab|mesh-list
65016572|NCT02951728|Doxorubicin|doxorubicin|mesh-list
65016573|NCT02951728|Vincristine|vincristine|mesh-list
65016574|NCT02951728|Decitabine|decitabine|mesh-list
65273371|NCT02848937|Sequestering Agents|sequestering agents|mesh-ancestor
65273372|NCT02848937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273373|NCT00343824|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65273374|NCT00343824|Laxatives|laxatives|mesh-ancestor
65273375|NCT00343824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65273376|NCT01428089|Progesterone|progesterone|mesh-list
65273377|NCT01428089|Progestins|progestins|mesh-ancestor
65273378|NCT01428089|Hormones|hormones|mesh-ancestor
65273379|NCT01428089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65273380|NCT01428089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273381|NCT04212000|Ketoconazole|ketoconazole|mesh-list
65273382|NCT04212000|Antifungal Agents|antifungal agents|mesh-ancestor
65016575|NCT02951728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65016576|NCT02951728|Immunologic Factors|immunologic factors|mesh-ancestor
65016577|NCT02951728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016578|NCT02951728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64472251|NCT03618641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64472252|NCT03618641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472253|NCT03618641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64472254|NCT03618641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472255|NCT03617718|Glycine|glycine|mesh-list
64472256|NCT03617718|Glycine Agents|glycine agents|mesh-ancestor
64472257|NCT03617718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65016610|NCT00523393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016611|NCT00523432|Sirolimus|sirolimus|mesh-list
65016612|NCT00523432|Topotecan|topotecan|mesh-list
65016613|NCT00523432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65016614|NCT00523432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65016615|NCT00523432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016616|NCT00523432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016617|NCT00523432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016618|NCT00523432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65016619|NCT00523432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65016620|NCT00523432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65016621|NCT00523432|Antifungal Agents|antifungal agents|mesh-ancestor
65016622|NCT00523432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65016623|NCT00523432|Immunologic Factors|immunologic factors|mesh-ancestor
65016624|NCT00523432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016625|NCT00512044|Anesthetics|anesthetics|mesh-list
65016626|NCT00512044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65016627|NCT00512044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016628|NCT04726007|Fibrinolytic Agents|fibrinolytic agents|mesh-list
65016629|NCT04726007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65016630|NCT04726007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016631|NCT00523666|Galantamine|galantamine|mesh-list
65016632|NCT00523666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65016633|NCT00523666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016634|NCT00523666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016635|NCT00523666|Cholinergic Agents|cholinergic agents|mesh-ancestor
65016636|NCT00523666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65016637|NCT00523666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016638|NCT00523666|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65016639|NCT00523666|Autonomic Agents|autonomic agents|mesh-ancestor
65016640|NCT00523666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65016641|NCT00523666|Nootropic Agents|nootropic agents|mesh-ancestor
65016642|NCT00167583|Interferons|interferons|mesh-list
65016643|NCT00167583|Interferon-alpha|interferon-alpha|mesh-list
65016644|NCT00167583|Interferon alpha-2|interferon alpha-2|mesh-list
65016645|NCT00167583|Cyclosporine|cyclosporine|mesh-list
65016682|NCT00512395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65016683|NCT00512395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016685|NCT00512395|Sensory System Agents|sensory system agents|mesh-ancestor
65016686|NCT00512395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65273383|NCT04212000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65273384|NCT04212000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65273385|NCT04212000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65273386|NCT04212000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273387|NCT04212000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273388|NCT04212000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65273389|NCT04212000|Hormone Antagonists|hormone antagonists|mesh-ancestor
65273390|NCT04212000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65273391|NCT04212000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273392|NCT04212000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65273393|NCT00619398|Tacrolimus|tacrolimus|mesh-list
65273394|NCT00619398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65273395|NCT00619398|Immunologic Factors|immunologic factors|mesh-ancestor
65273396|NCT00619398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273397|NCT00619398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65273398|NCT00619398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273399|NCT00619398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273400|NCT00620646|Aspirin|aspirin|mesh-list
65016719|NCT00512668|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65016720|NCT00512668|Fertility Agents|fertility agents|mesh-ancestor
65016721|NCT00512668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65016722|NCT00512668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016723|NCT00512668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65016724|NCT00512668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016725|NCT00512668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65016726|NCT00512668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65016727|NCT00512668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65016728|NCT00512668|Antifungal Agents|antifungal agents|mesh-ancestor
65016729|NCT00512668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65016730|NCT00512668|Immunologic Factors|immunologic factors|mesh-ancestor
65016731|NCT00512668|Androgen Antagonists|androgen antagonists|mesh-ancestor
65016732|NCT00512668|Hormone Antagonists|hormone antagonists|mesh-ancestor
64881641|NCT01919918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65016755|NCT00524251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65016756|NCT00524251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65016757|NCT00524251|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65016758|NCT00524251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016759|NCT00524251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016760|NCT00512824|Calcium Carbonate|calcium carbonate|mesh-list
65016761|NCT00512824|Calcium|calcium|mesh-list
65016762|NCT00512824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65016763|NCT00512824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016764|NCT00512824|Antacids|antacids|mesh-ancestor
65016765|NCT00512824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016766|NCT00512824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65016767|NCT00512863|Adalimumab|adalimumab|mesh-list
65016768|NCT00512863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65016769|NCT00512863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65016770|NCT00524407|Epoetin Alfa|epoetin alfa|mesh-list
65016771|NCT00524407|Hematinics|hematinics|mesh-ancestor
65016772|NCT00525889|Sirolimus|sirolimus|mesh-list
65016773|NCT00525889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64881692|NCT01921374|Hormones|hormones|mesh-list
64472473|NCT03245892|Paclitaxel|paclitaxel|mesh-list
64472474|NCT03245892|Carboplatin|carboplatin|mesh-list
64472475|NCT03245892|Nivolumab|nivolumab|mesh-list
65273401|NCT00620646|Cilostazol|cilostazol|mesh-list
65273402|NCT00620646|Clopidogrel|clopidogrel|mesh-list
65273403|NCT00620646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65273404|NCT00620646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65273405|NCT00620646|Analgesics|analgesics|mesh-ancestor
65273406|NCT00620646|Sensory System Agents|sensory system agents|mesh-ancestor
65273407|NCT00620646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65273408|NCT00620646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273409|NCT00620646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65273410|NCT00620646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65273411|NCT00620646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65273412|NCT00620646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65273413|NCT00620646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472476|NCT03245892|Ipilimumab|ipilimumab|mesh-list
64472477|NCT03245892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64472478|NCT03245892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472479|NCT03245892|Tubulin Modulators|tubulin modulators|mesh-ancestor
64472480|NCT03245892|Antimitotic Agents|antimitotic agents|mesh-ancestor
64472481|NCT03245892|Mitosis Modulators|mitosis modulators|mesh-ancestor
64472482|NCT03245892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472483|NCT03245892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64472485|NCT03204188|Pembrolizumab|pembrolizumab|mesh-list
65016800|NCT03879122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65016826|NCT00167817|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65016827|NCT02947711|Diltiazem|diltiazem|mesh-list
65016828|NCT02947711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65016829|NCT02947711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65016830|NCT02947711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65016831|NCT02947711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016832|NCT02947711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65016833|NCT02947711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016834|NCT02947711|Vasodilator Agents|vasodilator agents|mesh-ancestor
65016835|NCT03845348|Ketoconazole|ketoconazole|mesh-list
65016836|NCT03845348|Antifungal Agents|antifungal agents|mesh-ancestor
65016837|NCT03845348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65016838|NCT03845348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65016839|NCT03845348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65016840|NCT03845348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016841|NCT03845348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016842|NCT03845348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65016843|NCT03845348|Hormone Antagonists|hormone antagonists|mesh-ancestor
65016844|NCT03845348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65016845|NCT03845348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016846|NCT03845348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65016847|NCT04723563|Heparin|heparin|mesh-list
65016882|NCT03681275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64881826|NCT01928407|Darunavir|darunavir|mesh-list
64881827|NCT01928407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64881844|NCT01930019|Thiopental|thiopental|mesh-list
65016912|NCT00524914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65016913|NCT00524914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65016914|NCT00524914|Dopamine Agonists|dopamine agonists|mesh-ancestor
65016915|NCT00524914|Dopamine Agents|dopamine agents|mesh-ancestor
65016916|NCT00524914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65016917|NCT00524914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016919|NCT02957864|Abacavir|abacavir|mesh-list
65016920|NCT02957864|Antiviral Agents|antiviral agents|mesh-ancestor
65016921|NCT02957864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65016922|NCT02957864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64482629|NCT03584919|Cefuroxime axetil|cefuroxime axetil|mesh-list
65016923|NCT02957864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65016924|NCT02957864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64881863|NCT01930292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016957|NCT02947672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65016958|NCT02947672|Glucocorticoids|glucocorticoids|mesh-ancestor
65016959|NCT02947672|Hormones|hormones|mesh-ancestor
65016960|NCT02947672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65016961|NCT02947672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65016962|NCT02947672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016963|NCT03539627|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65016964|NCT03539627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65016965|NCT03539627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64881917|NCT01930552|Antidotes|antidotes|mesh-ancestor
65016997|NCT00526318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016998|NCT00526318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65016999|NCT00526318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65017000|NCT00526318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65017001|NCT00526318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65017002|NCT00526318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017003|NCT00526318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65017004|NCT00526318|Tubulin Modulators|tubulin modulators|mesh-ancestor
65017005|NCT00526318|Antimitotic Agents|antimitotic agents|mesh-ancestor
65017006|NCT00526318|Mitosis Modulators|mitosis modulators|mesh-ancestor
65017007|NCT00526318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65017008|NCT00526318|Dermatologic Agents|dermatologic agents|mesh-ancestor
65017009|NCT00526318|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65017010|NCT04693312|Methylprednisolone|methylprednisolone|mesh-list
65017011|NCT04693312|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65017012|NCT04693312|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65017013|NCT04693312|Prednisolone|prednisolone|mesh-list
65017035|NCT00525382|Histamine Antagonists|histamine antagonists|mesh-ancestor
65017037|NCT00525382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65017038|NCT00525382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017039|NCT00525382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017041|NCT00526513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65017042|NCT00526513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017043|NCT00168168|Lenograstim|lenograstim|mesh-list
65017044|NCT00168168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65017045|NCT00168168|Immunologic Factors|immunologic factors|mesh-ancestor
65017046|NCT00168168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017047|NCT03225755|Hormones|hormones|mesh-list
65017048|NCT03225755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65017049|NCT03225755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017050|NCT00525577|Probucol|probucol|mesh-list
65017051|NCT00525577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65017052|NCT00525577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65017084|NCT00525616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017085|NCT00525616|Immunologic Factors|immunologic factors|mesh-ancestor
64472776|NCT02790710|Vasodilator Agents|vasodilator agents|mesh-ancestor
64472777|NCT02779855|Paclitaxel|paclitaxel|mesh-list
64472778|NCT02779855|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
64472780|NCT02779855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017086|NCT00525616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017087|NCT00525616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65017088|NCT00525694|Cocaine|cocaine|mesh-list
65017089|NCT00525694|Anesthetics, Local|anesthetics, local|mesh-ancestor
65017090|NCT00525694|Anesthetics|anesthetics|mesh-ancestor
65017091|NCT00525694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65017116|NCT02946970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017117|NCT02946970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65017118|NCT02946970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65017119|NCT02946970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65017120|NCT02946970|Analgesics|analgesics|mesh-ancestor
65017121|NCT02946970|Sensory System Agents|sensory system agents|mesh-ancestor
65017122|NCT00527020|Nicotine|nicotine|mesh-list
65017123|NCT00527020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65017124|NCT00527020|Autonomic Agents|autonomic agents|mesh-ancestor
65017125|NCT00527020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65017126|NCT00527020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017127|NCT00527020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65017128|NCT00527020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65017129|NCT00527020|Cholinergic Agents|cholinergic agents|mesh-ancestor
65017130|NCT00527020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65273414|NCT00620646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65273415|NCT00620646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65273416|NCT00620646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273417|NCT00620646|Antipyretics|antipyretics|mesh-ancestor
65273418|NCT00620646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64471536|NCT04397484|Sensory System Agents|sensory system agents|mesh-ancestor
65017131|NCT00527020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017132|NCT00407277|Nicotine|nicotine|mesh-list
65017133|NCT00407277|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65017134|NCT00407277|Autonomic Agents|autonomic agents|mesh-ancestor
65017135|NCT00407277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65017136|NCT00407277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017137|NCT00407277|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65017138|NCT00407277|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65017139|NCT00407277|Cholinergic Agents|cholinergic agents|mesh-ancestor
65017140|NCT00407277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65017141|NCT00407277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017169|NCT03156452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65017170|NCT03156452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017171|NCT03156452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017172|NCT03156452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65017173|NCT03156452|Glucocorticoids|glucocorticoids|mesh-ancestor
65017174|NCT03156452|Hormones|hormones|mesh-ancestor
65017175|NCT03156452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65017176|NCT03156452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017177|NCT03156452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65017178|NCT00525772|Ciclesonide|ciclesonide|mesh-list
65017214|NCT00407433|Gemcitabine|gemcitabine|mesh-list
65017215|NCT00407433|Oxaliplatin|oxaliplatin|mesh-list
65017216|NCT00407433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65017217|NCT00407433|Antimetabolites|antimetabolites|mesh-ancestor
65017218|NCT00407433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017219|NCT00407433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017220|NCT00407433|Antiviral Agents|antiviral agents|mesh-ancestor
65017253|NCT00516607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017254|NCT00516607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017256|NCT00173667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65017257|NCT00173667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65017258|NCT00173667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017259|NCT00173667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65017260|NCT00173667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017322|NCT02460887|Cisplatin|cisplatin|mesh-list
65017323|NCT02460887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017324|NCT02460887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65017325|NCT02460887|Antimetabolites|antimetabolites|mesh-ancestor
65017326|NCT02460887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017327|NCT02460887|Antiviral Agents|antiviral agents|mesh-ancestor
65017328|NCT02460887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65017329|NCT02460887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017330|NCT02460887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65017331|NCT02460887|Immunologic Factors|immunologic factors|mesh-ancestor
65017332|NCT02460887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017333|NCT02945527|Dexamethasone|dexamethasone|mesh-list
65017334|NCT02945527|Acetazolamide|acetazolamide|mesh-list
65017335|NCT02945527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65017336|NCT02945527|Antiemetics|antiemetics|mesh-ancestor
65017337|NCT02945527|Autonomic Agents|autonomic agents|mesh-ancestor
65017338|NCT02945527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65017339|NCT02945527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017340|NCT02945527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65017341|NCT02945527|Glucocorticoids|glucocorticoids|mesh-ancestor
65017342|NCT02945527|Hormones|hormones|mesh-ancestor
65017343|NCT02945527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65017376|NCT00168402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65017377|NCT00529594|Etoricoxib|etoricoxib|mesh-list
65017378|NCT00529594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65017379|NCT00529594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65017380|NCT00529594|Analgesics|analgesics|mesh-ancestor
65017381|NCT00529594|Sensory System Agents|sensory system agents|mesh-ancestor
64882337|NCT01932580|Mitosis Modulators|mitosis modulators|mesh-ancestor
65017414|NCT00529750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017415|NCT00529750|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65017416|NCT00529750|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65017417|NCT00529750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65017418|NCT00529750|Adrenergic Agents|adrenergic agents|mesh-ancestor
65017419|NCT00529750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65017420|NCT00529867|Lumefantrine|lumefantrine|mesh-list
65017421|NCT00529867|Artemether|artemether|mesh-list
65017422|NCT00529867|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65017423|NCT00529867|Antimalarials|antimalarials|mesh-ancestor
65017441|NCT00168480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65017442|NCT00168480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65017443|NCT00168480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017444|NCT00168480|Cholinergic Agents|cholinergic agents|mesh-ancestor
65017445|NCT00168480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65017446|NCT00168480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017447|NCT00168480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65017448|NCT00168480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65017449|NCT00527449|Carboplatin|carboplatin|mesh-list
65017450|NCT00527449|Docetaxel|docetaxel|mesh-list
65017451|NCT00527449|Epirubicin|epirubicin|mesh-list
65017452|NCT00527449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017453|NCT00527449|Tubulin Modulators|tubulin modulators|mesh-ancestor
65017454|NCT00527449|Antimitotic Agents|antimitotic agents|mesh-ancestor
65017455|NCT00527449|Mitosis Modulators|mitosis modulators|mesh-ancestor
65017456|NCT00527449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017457|NCT00527449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65017458|NCT00527449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65017459|NCT00527449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65017460|NCT00527449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017461|NCT00168519|Nitroprusside|nitroprusside|mesh-list
65017462|NCT00168519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65017463|NCT00168519|Vasodilator Agents|vasodilator agents|mesh-ancestor
65017464|NCT00168519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65017465|NCT00168519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017466|NCT04692376|Cyclosporine|cyclosporine|mesh-list
65017467|NCT04692376|Cyclosporins|cyclosporins|mesh-list
65017468|NCT04692376|Glucocorticoids|glucocorticoids|mesh-list
65017469|NCT04692376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017470|NCT04692376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017471|NCT04692376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65017472|NCT04692376|Immunologic Factors|immunologic factors|mesh-ancestor
65017473|NCT04692376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017474|NCT04692376|Antifungal Agents|antifungal agents|mesh-ancestor
65017475|NCT04692376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65017476|NCT04692376|Dermatologic Agents|dermatologic agents|mesh-ancestor
65017477|NCT04692376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65017478|NCT04692376|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65017479|NCT04692376|Hormones|hormones|mesh-ancestor
65017480|NCT04692376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65017498|NCT00527761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017499|NCT00527761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65017500|NCT00527761|Alkylating Agents|alkylating agents|mesh-ancestor
65017501|NCT00527800|Lumefantrine|lumefantrine|mesh-list
65017502|NCT00527800|Artemether|artemether|mesh-list
65017503|NCT00527800|Piperaquine|piperaquine|mesh-list
65017504|NCT00527800|Trimethoprim|trimethoprim|mesh-list
65017505|NCT00527800|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65017506|NCT00527800|Artenimol|artenimol|mesh-list
65017507|NCT00527800|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65017508|NCT00527800|Sulfamethoxazole|sulfamethoxazole|mesh-list
65017509|NCT00527800|Antimalarials|antimalarials|mesh-ancestor
65017510|NCT00527800|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65017511|NCT00527800|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65017512|NCT00527800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65017513|NCT00527800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65017514|NCT00527800|Renal Agents|renal agents|mesh-ancestor
65017515|NCT00527800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65017516|NCT00527800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017517|NCT00527800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017518|NCT00527800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65273419|NCT00620646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65017519|NCT00527800|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65017520|NCT00527800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65017521|NCT00527800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65017522|NCT02945293|Oxycodone|oxycodone|mesh-list
65017523|NCT02945293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65017524|NCT02945293|Narcotics|narcotics|mesh-ancestor
65017525|NCT02945293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65017526|NCT02945293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017527|NCT02945293|Analgesics|analgesics|mesh-ancestor
64458773|NCT03944434|Leuprolide|leuprolide|mesh-list
65017528|NCT02945293|Sensory System Agents|sensory system agents|mesh-ancestor
65017529|NCT02945293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65017530|NCT04692415|Insulin Glargine|insulin glargine|mesh-list
65017531|NCT04692415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65017532|NCT04692415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017533|NCT02945215|Rituximab|rituximab|mesh-list
65017534|NCT02945215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65017535|NCT02945215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017536|NCT02945215|Immunologic Factors|immunologic factors|mesh-ancestor
65017537|NCT02945215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017538|NCT02945215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65017539|NCT00144677|Sirolimus|sirolimus|mesh-list
65017540|NCT00144677|Tacrolimus|tacrolimus|mesh-list
64882482|NCT01934088|Anesthetics|anesthetics|mesh-ancestor
65017565|NCT00144716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017566|NCT00531193|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
65017567|NCT00531193|SCH 442416|sch 442416|mesh-list
65017568|NCT00531193|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
65017569|NCT00531193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65017570|NCT00531193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65017571|NCT00531193|Purinergic Agents|purinergic agents|mesh-ancestor
65017572|NCT00531193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65017573|NCT00531193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017574|NCT00531193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017575|NCT00144755|Darbepoetin alfa|darbepoetin alfa|mesh-list
65017576|NCT00144755|Hematinics|hematinics|mesh-ancestor
65017577|NCT00531271|Docetaxel|docetaxel|mesh-list
65017578|NCT00531271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017579|NCT00531271|Tubulin Modulators|tubulin modulators|mesh-ancestor
65017580|NCT00531271|Antimitotic Agents|antimitotic agents|mesh-ancestor
65017581|NCT00531271|Mitosis Modulators|mitosis modulators|mesh-ancestor
65017582|NCT00531271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017583|NCT00531310|Fludarabine|fludarabine|mesh-list
65017584|NCT00531310|Busulfan|busulfan|mesh-list
65017585|NCT00531310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017586|NCT00531310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017587|NCT00531310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65017588|NCT00531310|Immunologic Factors|immunologic factors|mesh-ancestor
65017589|NCT00531310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017590|NCT00531310|Alkylating Agents|alkylating agents|mesh-ancestor
65017614|NCT00144833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017616|NCT00144833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65017617|NCT00144833|Antiviral Agents|antiviral agents|mesh-ancestor
65017618|NCT00144833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65017619|NCT00144833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65017620|NCT00144833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65017621|NCT02944942|Anesthetics|anesthetics|mesh-list
65017622|NCT02944942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65017623|NCT02944942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017624|NCT00144872|Lamotrigine|lamotrigine|mesh-list
65017625|NCT00144872|Anticonvulsants|anticonvulsants|mesh-ancestor
65017627|NCT00144872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65017628|NCT00144872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017629|NCT00144872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65017630|NCT00144872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017631|NCT00144872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65017632|NCT00144872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65017633|NCT00144872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65017634|NCT00144872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65017635|NCT00144872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65017636|NCT02945020|Simeprevir|simeprevir|mesh-list
65273420|NCT00620646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65273421|NCT00620646|Purinergic Agents|purinergic agents|mesh-ancestor
65273422|NCT00620646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65273423|NCT00620646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65273424|NCT00620646|Autonomic Agents|autonomic agents|mesh-ancestor
65273425|NCT00620646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65273426|NCT00620646|Respiratory System Agents|respiratory system agents|mesh-ancestor
65273427|NCT00620646|Vasodilator Agents|vasodilator agents|mesh-ancestor
65273428|NCT00620646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65273429|NCT00620646|Protective Agents|protective agents|mesh-ancestor
65273430|NCT00620646|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65273431|NCT00620646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65273432|NCT00810017|Trastuzumab|trastuzumab|mesh-list
65273433|NCT00810017|Etoposide|etoposide|mesh-list
64608256|NCT05516862|Camphor|camphor|mesh-list
65017637|NCT02945020|Odalasvir|odalasvir|mesh-list
65017638|NCT02945020|Dabigatran|dabigatran|mesh-list
65017639|NCT02945020|Antithrombins|antithrombins|mesh-ancestor
65017640|NCT02945020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65017641|NCT02945020|Protease Inhibitors|protease inhibitors|mesh-ancestor
65017642|NCT02945020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882595|NCT01934829|Sorafenib|sorafenib|mesh-list
65017676|NCT00144911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65017677|NCT00144911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65017678|NCT00144911|Adrenergic Agents|adrenergic agents|mesh-ancestor
65017679|NCT00144911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65017680|NCT00144911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017681|NCT00168597|Vitamin A|vitamin a|mesh-list
65017682|NCT00168597|Vitamins|vitamins|mesh-ancestor
65017683|NCT00168597|Micronutrients|micronutrients|mesh-ancestor
65017684|NCT00168597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017712|NCT00144989|Cisplatin|cisplatin|mesh-list
65017713|NCT00144989|Irinotecan|irinotecan|mesh-list
65017714|NCT00144989|Etoposide|etoposide|mesh-list
65017715|NCT00144989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017716|NCT00144989|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65017717|NCT00144989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65017718|NCT00144989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017719|NCT00144989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017720|NCT00144989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65017721|NCT00144989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65017722|NCT00528502|Lidocaine|lidocaine|mesh-list
65017723|NCT00528502|Anesthetics, Local|anesthetics, local|mesh-ancestor
65017724|NCT00528502|Anesthetics|anesthetics|mesh-ancestor
65017725|NCT00528502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65017726|NCT00528502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017727|NCT00528502|Sensory System Agents|sensory system agents|mesh-ancestor
65017728|NCT00528502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65017729|NCT00528502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65017730|NCT00528502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65017731|NCT00528502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65017732|NCT00528502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65017760|NCT00528658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65017762|NCT00528658|Sensory System Agents|sensory system agents|mesh-ancestor
65017763|NCT00528658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65017764|NCT00528658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017765|NCT00528658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65017766|NCT00528658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65017767|NCT00528658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65017768|NCT00528658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017769|NCT00528658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017770|NCT00528658|Antipyretics|antipyretics|mesh-ancestor
65017771|NCT00145028|Carboplatin|carboplatin|mesh-list
64609488|NCT03400111|Acetaminophen|acetaminophen|mesh-list
65017772|NCT00145028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017773|NCT00528814|Hand Sanitizers|hand sanitizers|mesh-list
65017774|NCT00528814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65017775|NCT00528814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65017776|NCT00528814|Disinfectants|disinfectants|mesh-ancestor
65017777|NCT00168753|Alefacept|alefacept|mesh-list
65017778|NCT00168753|Dermatologic Agents|dermatologic agents|mesh-ancestor
65017779|NCT00168753|Immunologic Factors|immunologic factors|mesh-ancestor
65017780|NCT00168753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017811|NCT00531544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65017812|NCT00531544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65017813|NCT00531544|Growth Substances|growth substances|mesh-ancestor
65017814|NCT00531544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017815|NCT00531544|Growth Inhibitors|growth inhibitors|mesh-ancestor
65017816|NCT00531544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65017817|NCT00531544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017818|NCT00531544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017819|NCT00145106|Minocycline|minocycline|mesh-list
65017820|NCT00145106|Tazarotene|tazarotene|mesh-list
65017821|NCT00145106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65017822|NCT00145106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65017823|NCT00145106|Dermatologic Agents|dermatologic agents|mesh-ancestor
65017824|NCT00145106|Keratolytic Agents|keratolytic agents|mesh-ancestor
65017825|NCT00145184|Vitamins|vitamins|mesh-list
65017826|NCT00145184|Vitamin B Complex|vitamin b complex|mesh-list
65017841|NCT02944357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017843|NCT02944396|Carboplatin|carboplatin|mesh-list
65017844|NCT02944396|Nivolumab|nivolumab|mesh-list
65017845|NCT02944396|Pemetrexed|pemetrexed|mesh-list
65017846|NCT02944396|Veliparib|veliparib|mesh-list
65017847|NCT02944396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65017848|NCT02944396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017849|NCT02944396|Tubulin Modulators|tubulin modulators|mesh-ancestor
65017850|NCT02944396|Antimitotic Agents|antimitotic agents|mesh-ancestor
65017851|NCT02944396|Mitosis Modulators|mitosis modulators|mesh-ancestor
65017852|NCT02944396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017853|NCT02944396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65017854|NCT02944396|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65017855|NCT02944396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017856|NCT02944396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65017857|NCT02944396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65017858|NCT02944396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65017859|NCT00174174|Modafinil|modafinil|mesh-list
65017860|NCT00174174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65017861|NCT00174174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017862|NCT00174174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65017863|NCT00174174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65017864|NCT00174174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65017865|NCT00174174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017866|NCT00530101|Doxorubicin|doxorubicin|mesh-list
65017867|NCT00530101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65017868|NCT00530101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017869|NCT00530101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65017870|NCT00530101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65017871|NCT00530101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017872|NCT00530101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017873|NCT00530140|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
65017874|NCT00530140|Immunologic Factors|immunologic factors|mesh-ancestor
65017875|NCT00530140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017876|NCT02944552|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
65017877|NCT02944552|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65017878|NCT02944552|Antimetabolites|antimetabolites|mesh-ancestor
65017879|NCT02944552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017880|NCT02944552|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65017881|NCT00145301|Lumiracoxib|lumiracoxib|mesh-list
65017882|NCT00145301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65017883|NCT00145301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65017884|NCT00145301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017885|NCT00145301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882826|NCT01935830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65017908|NCT02944201|Carvedilol|carvedilol|mesh-list
65017909|NCT02944201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65017910|NCT02944201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65273434|NCT00810017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65017911|NCT02944201|Adrenergic Agents|adrenergic agents|mesh-ancestor
65017912|NCT02944201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65017913|NCT02944201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017914|NCT02944201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017915|NCT02944201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65017916|NCT02944201|Antioxidants|antioxidants|mesh-ancestor
65017917|NCT02944201|Protective Agents|protective agents|mesh-ancestor
65017918|NCT02944201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65017919|NCT02944201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65017920|NCT02944201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65017921|NCT02944201|Vasodilator Agents|vasodilator agents|mesh-ancestor
65017922|NCT02944201|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65017923|NCT02944201|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65017924|NCT00145340|Pioglitazone|pioglitazone|mesh-list
65017925|NCT00145340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65017926|NCT00145340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017928|NCT00168909|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65017929|NCT00168909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65017930|NCT00168909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017931|NCT00168909|Vitamins|vitamins|mesh-ancestor
65017932|NCT00168909|Micronutrients|micronutrients|mesh-ancestor
65017933|NCT00145379|Metformin|metformin|mesh-list
65017934|NCT00145379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65017935|NCT00145379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017936|NCT00168948|Pyrimethamine|pyrimethamine|mesh-list
65017937|NCT00168948|Antimalarials|antimalarials|mesh-ancestor
65017938|NCT00168948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65017969|NCT00174330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65017970|NCT00174330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65017971|NCT00174330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017972|NCT00174330|Vasodilator Agents|vasodilator agents|mesh-ancestor
65017973|NCT00531856|Carbon Monoxide|carbon monoxide|mesh-list
65017974|NCT00531856|Antimetabolites|antimetabolites|mesh-ancestor
65017975|NCT00531856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017976|NCT00531856|Gasotransmitters|gasotransmitters|mesh-ancestor
65017977|NCT00531856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65017978|NCT00531856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017979|NCT00531895|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65018094|NCT02942680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65018095|NCT02942680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018096|NCT02942680|Antipyretics|antipyretics|mesh-ancestor
65018097|NCT00174564|Oxaliplatin|oxaliplatin|mesh-list
65018098|NCT00174564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018099|NCT02276911|Ibuprofen|ibuprofen|mesh-list
65018100|NCT02276911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65018101|NCT02276911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65018102|NCT02276911|Analgesics|analgesics|mesh-ancestor
65018103|NCT02276911|Sensory System Agents|sensory system agents|mesh-ancestor
65018104|NCT02276911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65018105|NCT02276911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018264|NCT02942602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65018265|NCT02942602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65018266|NCT02942602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018267|NCT02942329|Apatinib|apatinib|mesh-list
65018268|NCT02942329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018269|NCT02942329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65018270|NCT02942329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64883240|NCT01938144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65018413|NCT00174876|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65018414|NCT00174876|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65018415|NCT00146471|Levetiracetam|levetiracetam|mesh-list
65018416|NCT00146471|Anticonvulsants|anticonvulsants|mesh-ancestor
65018417|NCT00146471|Nootropic Agents|nootropic agents|mesh-ancestor
65018418|NCT00174993|Pioglitazone|pioglitazone|mesh-list
65018419|NCT00174993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65018420|NCT00174993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018421|NCT02940379|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65018422|NCT02940379|Metoprolol|metoprolol|mesh-list
65018423|NCT02940379|Midazolam|midazolam|mesh-list
65018424|NCT02940379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65018425|NCT02940379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65018426|NCT02940379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65273435|NCT00810017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273436|NCT00810017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65018427|NCT02940379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018456|NCT00146549|Antimitotic Agents|antimitotic agents|mesh-ancestor
65018457|NCT00146549|Mitosis Modulators|mitosis modulators|mesh-ancestor
65018458|NCT00146549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018459|NCT00146549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65018460|NCT02940535|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65018461|NCT02940535|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65018462|NCT02940535|Menotropins|menotropins|mesh-list
65018463|NCT02940535|Luteolytic Agents|luteolytic agents|mesh-ancestor
65018464|NCT02940535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65018465|NCT02940535|Contraceptive Agents|contraceptive agents|mesh-ancestor
65018466|NCT02940535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65018467|NCT02940535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018468|NCT02940535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65018469|NCT02940535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65018470|NCT02940535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018471|NCT02940535|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65018472|NCT02940535|Fertility Agents|fertility agents|mesh-ancestor
65018473|NCT00146588|Cyclophosphamide|cyclophosphamide|mesh-list
65018474|NCT00146588|Capecitabine|capecitabine|mesh-list
65018475|NCT00146588|Epirubicin|epirubicin|mesh-list
65018476|NCT00146588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65018477|NCT00146588|Immunologic Factors|immunologic factors|mesh-ancestor
65018580|NCT00169572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65018581|NCT00169572|Glucocorticoids|glucocorticoids|mesh-ancestor
65018583|NCT00169572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65018584|NCT00169572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65019457|NCT00170547|Vaccines|vaccines|mesh-list
65019458|NCT00170547|Immunologic Factors|immunologic factors|mesh-ancestor
65019459|NCT00170547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019460|NCT00149201|Fluorouracil|fluorouracil|mesh-list
65019461|NCT00149201|Antimetabolites|antimetabolites|mesh-ancestor
65019462|NCT00149201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019463|NCT00149201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65019464|NCT00149201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019465|NCT00149201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65019466|NCT00149201|Immunologic Factors|immunologic factors|mesh-ancestor
65019467|NCT00149201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019468|NCT02925559|Dapagliflozin|dapagliflozin|mesh-list
65019469|NCT02925559|Gliclazide|gliclazide|mesh-list
65019470|NCT02925559|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65019471|NCT02925559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019472|NCT02925559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65345398|NCT00873808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345399|NCT00873808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345400|NCT04064190|Durvalumab|durvalumab|mesh-list
65345401|NCT04064190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65345402|NCT04064190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65345403|NCT00873886|Oseltamivir|oseltamivir|mesh-list
65345404|NCT00873886|Antiviral Agents|antiviral agents|mesh-ancestor
65345405|NCT00873886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65345406|NCT00873886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345782|NCT00874744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345783|NCT00874744|Growth Inhibitors|growth inhibitors|mesh-ancestor
65345784|NCT00874744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65345785|NCT00874744|Glucocorticoids|glucocorticoids|mesh-ancestor
65345786|NCT00874744|Hormones|hormones|mesh-ancestor
65345787|NCT00874744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65345788|NCT00874744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65345789|NCT00874744|Immunologic Factors|immunologic factors|mesh-ancestor
65345790|NCT00874744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345791|NCT00874744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345792|NCT05736744|Magnesium Sulfate|magnesium sulfate|mesh-list
65345793|NCT05736744|Bromides|bromides|mesh-list
65345794|NCT05736744|Rocuronium|rocuronium|mesh-list
65345795|NCT05736744|Atracurium|atracurium|mesh-list
65345796|NCT05736744|Cisatracurium|cisatracurium|mesh-list
65345797|NCT05736744|Anticonvulsants|anticonvulsants|mesh-ancestor
65345798|NCT05736744|Analgesics|analgesics|mesh-ancestor
65345799|NCT05736744|Sensory System Agents|sensory system agents|mesh-ancestor
65345800|NCT05736744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64483158|NCT01278394|Tavaborole|tavaborole|mesh-list
65345801|NCT05736744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345802|NCT05736744|Anesthetics|anesthetics|mesh-ancestor
65345803|NCT05736744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65345804|NCT05736744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65345805|NCT05736744|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65345806|NCT05736744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65345807|NCT05736744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345808|NCT05736744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65345809|NCT05736744|Tocolytic Agents|tocolytic agents|mesh-ancestor
65345810|NCT05736744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65345887|NCT00874978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65345888|NCT00874978|Growth Substances|growth substances|mesh-ancestor
65345889|NCT00874978|Growth Inhibitors|growth inhibitors|mesh-ancestor
65345890|NCT00874978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65345891|NCT00737880|Pancrelipase|pancrelipase|mesh-list
65345892|NCT00737880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65345893|NCT05728632|Nebivolol|nebivolol|mesh-list
65345894|NCT05728632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65345895|NCT05728632|Vasodilator Agents|vasodilator agents|mesh-ancestor
65345896|NCT05728632|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65345897|NCT05728632|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65346228|NCT02542852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65346229|NCT02542852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65346230|NCT02542852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65346231|NCT02542852|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65346232|NCT02542852|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65346233|NCT00651261|Cytarabine|cytarabine|mesh-list
65346234|NCT00651261|Dexamethasone|dexamethasone|mesh-list
65346235|NCT00651261|Dexamethasone acetate|dexamethasone acetate|mesh-list
65346236|NCT00651261|Daunorubicin|daunorubicin|mesh-list
65346237|NCT00651261|Midostaurin|midostaurin|mesh-list
65346238|NCT00651261|BB 1101|bb 1101|mesh-list
65346239|NCT00651261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65346240|NCT00651261|Antiemetics|antiemetics|mesh-ancestor
65346241|NCT00651261|Autonomic Agents|autonomic agents|mesh-ancestor
65346242|NCT00651261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65346243|NCT00651261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346244|NCT00651261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65346245|NCT00651261|Glucocorticoids|glucocorticoids|mesh-ancestor
65346246|NCT00651261|Hormones|hormones|mesh-ancestor
65346247|NCT00651261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65346248|NCT00651261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65346249|NCT00651261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346250|NCT00651261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65346251|NCT00651261|Antimetabolites|antimetabolites|mesh-ancestor
65346252|NCT00651261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346253|NCT00651261|Antiviral Agents|antiviral agents|mesh-ancestor
65346254|NCT00651261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65346255|NCT00651261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65346256|NCT00651261|Immunologic Factors|immunologic factors|mesh-ancestor
65346257|NCT00651261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65346258|NCT00651261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65346259|NCT00651261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65346260|NCT00651261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65346261|NCT00651261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65346262|NCT00651261|Protease Inhibitors|protease inhibitors|mesh-ancestor
65346263|NCT00885820|Prednisone|prednisone|mesh-list
65346264|NCT00885820|Methylprednisolone|methylprednisolone|mesh-list
65346284|NCT02567838|Lidocaine|lidocaine|mesh-list
65346285|NCT02567838|Anesthetics, Local|anesthetics, local|mesh-ancestor
65346286|NCT02567838|Anesthetics|anesthetics|mesh-ancestor
65346287|NCT02567838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65346288|NCT02567838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346289|NCT02567838|Sensory System Agents|sensory system agents|mesh-ancestor
65346290|NCT02567838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65346291|NCT02567838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65346292|NCT02567838|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65346293|NCT02567838|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65346294|NCT02567838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65346295|NCT02567838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346297|NCT05093322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65346298|NCT05093322|Antimetabolites|antimetabolites|mesh-ancestor
65346299|NCT05093322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273437|NCT00810017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65346300|NCT05093322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346301|NCT05093322|Antiviral Agents|antiviral agents|mesh-ancestor
65346302|NCT05093322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65346303|NCT05093322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65346304|NCT05093322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65346305|NCT05093322|Immunologic Factors|immunologic factors|mesh-ancestor
65346306|NCT05093322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346307|NCT00651183|Pramipexole|pramipexole|mesh-list
65346308|NCT00651183|Antioxidants|antioxidants|mesh-ancestor
65346309|NCT00651183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346310|NCT00651183|Protective Agents|protective agents|mesh-ancestor
65346311|NCT00651183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346312|NCT00651183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65346313|NCT00651183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65346314|NCT00651183|Dopamine Agonists|dopamine agonists|mesh-ancestor
65346315|NCT00651183|Dopamine Agents|dopamine agents|mesh-ancestor
65346316|NCT00651183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65346317|NCT00810381|Nitroprusside|nitroprusside|mesh-list
65346318|NCT00810381|Isosorbide|isosorbide|mesh-list
65346319|NCT00810381|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65346320|NCT00810381|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65346350|NCT00810849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65346351|NCT00810849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346352|NCT00810849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65346353|NCT00810849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346355|NCT00811005|Methoxsalen|methoxsalen|mesh-list
65346356|NCT00811005|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65346357|NCT00811005|Dermatologic Agents|dermatologic agents|mesh-ancestor
65346358|NCT00811005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65346359|NCT00813735|Dexetimide|dexetimide|mesh-list
65346360|NCT00813735|Eszopiclone|eszopiclone|mesh-list
65346361|NCT00813735|Citalopram|citalopram|mesh-list
65346362|NCT00813735|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65346363|NCT00813735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65346364|NCT00813735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65346365|NCT00813735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346620|NCT00413959|Hormones|hormones|mesh-ancestor
65346621|NCT00413959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65346622|NCT00413959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65346623|NCT00814905|Clindamycin|clindamycin|mesh-list
65346624|NCT00814905|Clindamycin palmitate|clindamycin palmitate|mesh-list
65346625|NCT00814905|Clindamycin phosphate|clindamycin phosphate|mesh-list
65346626|NCT00814905|Gentamicins|gentamicins|mesh-list
65346627|NCT00814905|Ampicillin|ampicillin|mesh-list
65346628|NCT00814905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64738730|NCT02973581|Acetaminophen|acetaminophen|mesh-list
65346702|NCT00403585|Antiviral Agents|antiviral agents|mesh-ancestor
65346703|NCT00403585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65346704|NCT00403585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65346705|NCT00403585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65346706|NCT00403585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65346707|NCT00403585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346709|NCT00645411|Immunologic Factors|immunologic factors|mesh-ancestor
65346710|NCT00645411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346711|NCT00403273|Botulinum Toxins|botulinum toxins|mesh-list
65346712|NCT00403273|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65346713|NCT00403273|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65346714|NCT00403273|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65346715|NCT00403273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65346716|NCT00403273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346717|NCT00403273|Cholinergic Agents|cholinergic agents|mesh-ancestor
65346718|NCT00403273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65346719|NCT00403273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346720|NCT00403273|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65346721|NCT00403273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65346722|NCT00885274|Magnesium Oxide|magnesium oxide|mesh-list
65346723|NCT00885274|Citric Acid|citric acid|mesh-list
65346724|NCT00885274|Antacids|antacids|mesh-ancestor
65346725|NCT00885274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346726|NCT00885274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65346727|NCT00885274|Anticoagulants|anticoagulants|mesh-ancestor
65346728|NCT00885274|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65346729|NCT00885274|Chelating Agents|chelating agents|mesh-ancestor
64618912|NCT04323592|Glucocorticoids|glucocorticoids|mesh-ancestor
65346730|NCT00885274|Sequestering Agents|sequestering agents|mesh-ancestor
65346731|NCT00402727|Amoxicillin|amoxicillin|mesh-list
65346732|NCT00402727|Moxifloxacin|moxifloxacin|mesh-list
65346733|NCT00402727|Tazobactam|tazobactam|mesh-list
65346734|NCT00402727|Piperacillin|piperacillin|mesh-list
65346735|NCT00402727|Clavulanic Acids|clavulanic acids|mesh-list
65346736|NCT00402727|Clavulanic Acid|clavulanic acid|mesh-list
65346737|NCT00402727|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64738808|NCT00002471|Dexamethasone|dexamethasone|mesh-list
65346781|NCT00402337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346782|NCT00402337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65346783|NCT00888862|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65346784|NCT00888862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65346785|NCT00888862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65346786|NCT00888862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65346787|NCT00888862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346788|NCT00888862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65346789|NCT00888862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346790|NCT00888862|Antidepressive Agents|antidepressive agents|mesh-ancestor
65346792|NCT00886990|Ritonavir|ritonavir|mesh-list
65346793|NCT00886990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65346794|NCT00886990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65346795|NCT00886990|Protease Inhibitors|protease inhibitors|mesh-ancestor
65346796|NCT00886990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65346797|NCT00886990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346798|NCT00886990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65346799|NCT00886990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65346800|NCT00886990|Antiviral Agents|antiviral agents|mesh-ancestor
65346801|NCT00886990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65346802|NCT00886990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65346803|NCT00886990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65346804|NCT00650091|Acetylcysteine|acetylcysteine|mesh-list
65346924|NCT01038037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65346925|NCT01038037|Tubulin Modulators|tubulin modulators|mesh-ancestor
65346926|NCT01038037|Antimitotic Agents|antimitotic agents|mesh-ancestor
65346927|NCT01038037|Mitosis Modulators|mitosis modulators|mesh-ancestor
65346928|NCT01038037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347085|NCT00402103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65347086|NCT00402103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347087|NCT00402103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65347088|NCT00402103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347089|NCT00402103|Vasodilator Agents|vasodilator agents|mesh-ancestor
65347090|NCT00402103|Diuretics|diuretics|mesh-ancestor
65347091|NCT00402103|Natriuretic Agents|natriuretic agents|mesh-ancestor
65347092|NCT00402103|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65347093|NCT00812175|Sorafenib|sorafenib|mesh-list
65347094|NCT00812175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347095|NCT00812175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65347096|NCT00812175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347097|NCT00812175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347098|NCT00815373|Timolol|timolol|mesh-list
65347099|NCT00815373|Dorzolamide|dorzolamide|mesh-list
65347100|NCT00815373|Latanoprost|latanoprost|mesh-list
65347101|NCT00815373|Maleic acid|maleic acid|mesh-list
65347102|NCT00815373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347103|NCT00815373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347104|NCT00815373|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65347105|NCT00815373|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65347106|NCT00815373|Adrenergic Agents|adrenergic agents|mesh-ancestor
65347107|NCT00815373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65347108|NCT00815373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347109|NCT00815373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65096909|NCT01243242|Metadoxine|metadoxine|mesh-list
65347111|NCT00815373|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65347112|NCT00815373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65347113|NCT00815373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65347114|NCT00641667|Fentanyl|fentanyl|mesh-list
65347115|NCT00641667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65347116|NCT00641667|Narcotics|narcotics|mesh-ancestor
65347117|NCT00641667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65347118|NCT00641667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347258|NCT05388942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64471585|NCT04310995|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65347259|NCT05388942|Analgesics|analgesics|mesh-ancestor
65347260|NCT05388942|Sensory System Agents|sensory system agents|mesh-ancestor
65347261|NCT05388942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65347262|NCT04037566|Cyclophosphamide|cyclophosphamide|mesh-list
65347334|NCT00890500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65347335|NCT04061772|Prednisone|prednisone|mesh-list
65347336|NCT04061772|Cyclophosphamide|cyclophosphamide|mesh-list
65347337|NCT04061772|Etoposide|etoposide|mesh-list
65347338|NCT04061772|Bortezomib|bortezomib|mesh-list
65347339|NCT04061772|Epirubicin|epirubicin|mesh-list
65347340|NCT04061772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65347341|NCT04061772|Immunologic Factors|immunologic factors|mesh-ancestor
65347342|NCT04061772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347343|NCT04061772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65347344|NCT04061772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65347345|NCT04061772|Alkylating Agents|alkylating agents|mesh-ancestor
65347346|NCT04061772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347347|NCT04061772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347348|NCT04061772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65347349|NCT04061772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65347350|NCT04061772|Glucocorticoids|glucocorticoids|mesh-ancestor
65347351|NCT04061772|Hormones|hormones|mesh-ancestor
64739452|NCT00002657|Cytarabine|cytarabine|mesh-list
65347378|NCT00821301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65347379|NCT00821301|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65347380|NCT00821301|Dopamine Agents|dopamine agents|mesh-ancestor
65347381|NCT00821301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65347382|NCT00821301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347384|NCT00699348|Hematinics|hematinics|mesh-ancestor
65347385|NCT00643851|Metformin|metformin|mesh-list
65347386|NCT00643851|Dapagliflozin|dapagliflozin|mesh-list
65347387|NCT00643851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65347388|NCT00643851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347389|NCT00643851|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65347390|NCT00643851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347391|NCT00821457|Mitogens|mitogens|mesh-list
65347392|NCT00821457|Mitosis Modulators|mitosis modulators|mesh-ancestor
65347393|NCT00821457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347394|NCT03667690|Fluconazole|fluconazole|mesh-list
65347395|NCT03667690|Caspofungin|caspofungin|mesh-list
65347396|NCT03667690|Rezafungin|rezafungin|mesh-list
65347397|NCT03667690|Antifungal Agents|antifungal agents|mesh-ancestor
65347398|NCT03667690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65347399|NCT03667690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65347495|NCT00577122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65347497|NCT00577122|Dermatologic Agents|dermatologic agents|mesh-ancestor
65347498|NCT00577122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347499|NCT00577122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65347500|NCT00577122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65347501|NCT00577122|Progestins|progestins|mesh-ancestor
65347502|NCT00577122|Hormones|hormones|mesh-ancestor
65347503|NCT00577122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65347504|NCT00577122|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65347505|NCT00577122|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65347506|NCT00577122|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65347507|NCT00577122|Contraceptive Agents|contraceptive agents|mesh-ancestor
65347508|NCT00577122|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65347509|NCT00577122|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65347510|NCT00577122|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65347511|NCT00577122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65347512|NCT00822081|Timolol|timolol|mesh-list
65347513|NCT00822081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65347514|NCT00822081|Dorzolamide|dorzolamide|mesh-list
65347515|NCT00822081|Maleic acid|maleic acid|mesh-list
65347516|NCT00822081|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
65347517|NCT00822081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347518|NCT00822081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347519|NCT00822081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65347520|NCT00822081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65347521|NCT00822081|Adrenergic Agents|adrenergic agents|mesh-ancestor
65347522|NCT00822081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65347523|NCT00822081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347524|NCT00822081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65347525|NCT00822081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64483444|NCT00243412|Hormones|hormones|mesh-ancestor
65347526|NCT00822081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65347527|NCT00822081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65347528|NCT00822081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65347529|NCT00822081|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65347530|NCT00696774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65347531|NCT00696774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65347532|NCT00696774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65347533|NCT00696774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65347534|NCT00696774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739627|NCT00002735|Antimetabolites|antimetabolites|mesh-ancestor
65347584|NCT04625907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65347585|NCT04625907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65347586|NCT04625907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65347587|NCT04625907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65347588|NCT04625907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347589|NCT04625907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65347590|NCT04625907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65347591|NCT04625907|Tubulin Modulators|tubulin modulators|mesh-ancestor
65347592|NCT04625907|Antimitotic Agents|antimitotic agents|mesh-ancestor
65347593|NCT04625907|Mitosis Modulators|mitosis modulators|mesh-ancestor
65347594|NCT04625907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65347595|NCT04625907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65347596|NCT04625907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65347597|NCT04625907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65347599|NCT02565888|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65347600|NCT02565888|Cobicistat|cobicistat|mesh-list
65347601|NCT02565888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65347602|NCT02565888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65347603|NCT02565888|Protease Inhibitors|protease inhibitors|mesh-ancestor
65347604|NCT02565888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347605|NCT02565888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347606|NCT02565888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65347607|NCT02565888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65347608|NCT02565888|Antiviral Agents|antiviral agents|mesh-ancestor
65347609|NCT02565888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65347610|NCT02565888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65347611|NCT02565888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65347612|NCT00609466|Morphine|morphine|mesh-list
65347613|NCT00609466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65347614|NCT00609466|Narcotics|narcotics|mesh-ancestor
65347615|NCT00609466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65347616|NCT00609466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347617|NCT00609466|Analgesics|analgesics|mesh-ancestor
65347618|NCT00609466|Sensory System Agents|sensory system agents|mesh-ancestor
65347619|NCT00609466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65347620|NCT00822315|Efavirenz|efavirenz|mesh-list
65347621|NCT00822315|Raltegravir Potassium|raltegravir potassium|mesh-list
65347622|NCT00822315|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65347623|NCT00822315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65347682|NCT00892996|BB 1101|bb 1101|mesh-list
65347683|NCT00892996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65347684|NCT00892996|Antiemetics|antiemetics|mesh-ancestor
65347685|NCT00892996|Autonomic Agents|autonomic agents|mesh-ancestor
65347686|NCT00892996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64739797|NCT00382343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347879|NCT01034917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65347880|NCT01034917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347881|NCT01034917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347951|NCT00634647|Hormones|hormones|mesh-ancestor
65347952|NCT00634647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65347953|NCT00634647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347954|NCT00634647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65347955|NCT00634647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347956|NCT00576732|Risperidone|risperidone|mesh-list
65347957|NCT00576732|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65347958|NCT00576732|Serotonin Agents|serotonin agents|mesh-ancestor
65347959|NCT00576732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65347960|NCT00576732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347961|NCT00576732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347962|NCT00576732|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65347963|NCT00576732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65273438|NCT00810017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65347964|NCT00576732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65347965|NCT00576732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65347966|NCT00576732|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65347967|NCT00576732|Dopamine Agents|dopamine agents|mesh-ancestor
65347968|NCT00817011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65347969|NCT00817011|Mirtazapine|mirtazapine|mesh-list
65347970|NCT00817011|Trazodone|trazodone|mesh-list
65347971|NCT00817011|Bupropion|bupropion|mesh-list
65347972|NCT00817011|Fluoxetine|fluoxetine|mesh-list
65347973|NCT00817011|Paroxetine|paroxetine|mesh-list
65347974|NCT00817011|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65347975|NCT00817011|Citalopram|citalopram|mesh-list
65347976|NCT00817011|Sertraline|sertraline|mesh-list
65347977|NCT00817011|Nortriptyline|nortriptyline|mesh-list
65347978|NCT00817011|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65347979|NCT00817011|Antidepressive Agents|antidepressive agents|mesh-ancestor
65347980|NCT00817011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65347981|NCT00817011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65347982|NCT00817011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65347983|NCT00817011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65347984|NCT00817011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347985|NCT00817011|Dopamine Agents|dopamine agents|mesh-ancestor
65347986|NCT00817011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65347987|NCT00817011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347988|NCT00817011|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65347989|NCT00817011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65347990|NCT00817011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347991|NCT00817011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65347992|NCT00817011|Analgesics|analgesics|mesh-ancestor
65347993|NCT00817011|Sensory System Agents|sensory system agents|mesh-ancestor
64740092|NCT05007509|Vaccines|vaccines|mesh-list
65348016|NCT00697788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65348017|NCT00697788|Analgesics|analgesics|mesh-ancestor
65348018|NCT00697788|Sensory System Agents|sensory system agents|mesh-ancestor
65348019|NCT00697788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65348020|NCT00697788|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65348021|NCT00697788|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65348022|NCT00697788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65348023|NCT00697788|Adrenergic Agents|adrenergic agents|mesh-ancestor
65348024|NCT00697788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65348025|NCT00697788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348026|NCT00400153|Ipratropium|ipratropium|mesh-list
65348027|NCT00400153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65348028|NCT00400153|Autonomic Agents|autonomic agents|mesh-ancestor
65348029|NCT00400153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65348030|NCT00400153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348031|NCT00400153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65348032|NCT00400153|Respiratory System Agents|respiratory system agents|mesh-ancestor
65348033|NCT00400153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65348034|NCT00400153|Cholinergic Agents|cholinergic agents|mesh-ancestor
65348035|NCT00400153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65348036|NCT00400153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348037|NCT04062890|Vigabatrin|vigabatrin|mesh-list
65348038|NCT04062890|Anticonvulsants|anticonvulsants|mesh-ancestor
65348039|NCT04062890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348040|NCT04062890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348041|NCT04062890|GABA Agents|gaba agents|mesh-ancestor
65348042|NCT04062890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64740151|NCT04581395|Rocuronium|rocuronium|mesh-list
65348212|NCT00411151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65348214|NCT00411151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348215|NCT00411151|Growth Inhibitors|growth inhibitors|mesh-ancestor
65348216|NCT00411151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65348217|NCT00411151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348218|NCT00411151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348219|NCT00607048|Paclitaxel|paclitaxel|mesh-list
65348220|NCT00607048|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65348221|NCT00607048|Carboplatin|carboplatin|mesh-list
65348222|NCT00607048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65348223|NCT00607048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65348224|NCT00607048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348225|NCT00607048|Tubulin Modulators|tubulin modulators|mesh-ancestor
65348226|NCT00607048|Antimitotic Agents|antimitotic agents|mesh-ancestor
65348227|NCT00607048|Mitosis Modulators|mitosis modulators|mesh-ancestor
65348228|NCT00607048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348229|NCT00607048|Immunologic Factors|immunologic factors|mesh-ancestor
65348230|NCT00607048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348375|NCT02962050|Sensory System Agents|sensory system agents|mesh-ancestor
65348376|NCT02962050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65348377|NCT02962050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348450|NCT00631371|Bevacizumab|bevacizumab|mesh-list
65348451|NCT00631371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65348452|NCT00631371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348453|NCT00631371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65348454|NCT00631371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65348455|NCT00631371|Growth Substances|growth substances|mesh-ancestor
64352658|NCT03645603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65348485|NCT04016740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65348486|NCT04016740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65348487|NCT04016740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65348488|NCT04016740|Adrenergic Agents|adrenergic agents|mesh-ancestor
65348489|NCT04016740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65348490|NCT04016740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348491|NCT04016740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65348492|NCT04016740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65348493|NCT04016740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65348494|NCT04016740|Anesthetics, Local|anesthetics, local|mesh-ancestor
65348495|NCT04016740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65348496|NCT04016740|Narcotics|narcotics|mesh-ancestor
65348497|NCT04016740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65348498|NCT04016740|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65348499|NCT04016740|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65348500|NCT04016740|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65348501|NCT04016740|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65348502|NCT02540512|Acetaminophen|acetaminophen|mesh-list
65348503|NCT02540512|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65348504|NCT02540512|Hydrocodone|hydrocodone|mesh-list
65348528|NCT00894634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65348529|NCT00894634|Histamine Antagonists|histamine antagonists|mesh-ancestor
65348531|NCT00894634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65348532|NCT00894634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348533|NCT00894634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65348534|NCT00894712|Sulforaphane|sulforaphane|mesh-list
65348535|NCT00894712|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65348536|NCT00894712|Protective Agents|protective agents|mesh-ancestor
65348537|NCT00894712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348538|NCT00894712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348539|NCT00823641|Infliximab|infliximab|mesh-list
65348540|NCT00823641|Dermatologic Agents|dermatologic agents|mesh-ancestor
65348541|NCT00823641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65348542|NCT00823641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65348543|NCT00823875|Cilostazol|cilostazol|mesh-list
65348544|NCT00823875|Probucol|probucol|mesh-list
65348545|NCT00823875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65348546|NCT00823875|Autonomic Agents|autonomic agents|mesh-ancestor
65348547|NCT00823875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65348548|NCT00823875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348549|NCT00823875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65348550|NCT00823875|Respiratory System Agents|respiratory system agents|mesh-ancestor
65348551|NCT00823875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65348552|NCT00823875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65348553|NCT00823875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348554|NCT00823875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65348555|NCT00823875|Vasodilator Agents|vasodilator agents|mesh-ancestor
65348556|NCT00823875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65348557|NCT00823875|Protective Agents|protective agents|mesh-ancestor
65348586|NCT04044651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348587|NCT00606034|Insulin|insulin|mesh-list
65348588|NCT00606034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65348589|NCT00606034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348590|NCT00819975|Caseins|caseins|mesh-list
65348591|NCT00819975|Chelating Agents|chelating agents|mesh-ancestor
65348592|NCT00819975|Sequestering Agents|sequestering agents|mesh-ancestor
65348593|NCT00819975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348594|NCT04044417|Curcumin|curcumin|mesh-list
65348595|NCT04044417|Simvastatin|simvastatin|mesh-list
65348596|NCT04044417|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65348597|NCT04044417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65348598|NCT04044417|Antimetabolites|antimetabolites|mesh-ancestor
65348599|NCT04044417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348600|NCT04044417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65348601|NCT04044417|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65348602|NCT04044417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348603|NCT04044417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65348604|NCT04044417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64740727|NCT01545557|Lidocaine|lidocaine|mesh-list
65348633|NCT00820053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348634|NCT00572728|Alovudine|alovudine|mesh-list
65348635|NCT00572728|Dideoxynucleosides|dideoxynucleosides|mesh-list
65348636|NCT00572728|Antiviral Agents|antiviral agents|mesh-ancestor
65348637|NCT00572728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65348638|NCT00572728|Antimetabolites|antimetabolites|mesh-ancestor
65348639|NCT00572728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348640|NCT00572728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65348641|NCT00572728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65348642|NCT00572728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348643|NCT00699374|Sorafenib|sorafenib|mesh-list
65348644|NCT00699374|Sunitinib|sunitinib|mesh-list
65348645|NCT00699374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348646|NCT00699374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65348647|NCT00699374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348648|NCT00699374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348649|NCT00699374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65348650|NCT00699374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65348651|NCT00699374|Growth Substances|growth substances|mesh-ancestor
65348677|NCT04667078|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65348678|NCT04667078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65348679|NCT04667078|Purinergic Agents|purinergic agents|mesh-ancestor
65348680|NCT04667078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65348681|NCT04667078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348682|NCT04667078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348683|NCT00894946|Ethiodized Oil|ethiodized oil|mesh-list
65348684|NCT00894946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348685|NCT01042561|Vitamin D|vitamin d|mesh-list
65348686|NCT01042561|Ergocalciferols|ergocalciferols|mesh-list
65348687|NCT01042561|Cholecalciferol|cholecalciferol|mesh-list
65348688|NCT01042561|Vitamins|vitamins|mesh-list
65348689|NCT01042561|Micronutrients|micronutrients|mesh-ancestor
65348690|NCT01042561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348691|NCT01042561|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65348692|NCT01042561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65348693|NCT01035853|Colistin|colistin|mesh-list
65348694|NCT01035853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65348695|NCT01035853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65348696|NCT05268614|Cisplatin|cisplatin|mesh-list
65348697|NCT05268614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348698|NCT01042717|Plerixafor|plerixafor|mesh-list
65348699|NCT01042717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65348700|NCT01042717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65348701|NCT01042717|Antiviral Agents|antiviral agents|mesh-ancestor
65348725|NCT00826527|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65348726|NCT00826527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65348727|NCT00826527|Cholinergic Agents|cholinergic agents|mesh-ancestor
65348728|NCT00826527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65348729|NCT00826527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348730|NCT00826527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348731|NCT00826527|Urological Agents|urological agents|mesh-ancestor
65348732|NCT02550717|Aspirin|aspirin|mesh-list
65348733|NCT02550717|Anticoagulants|anticoagulants|mesh-list
65348734|NCT02550717|Clopidogrel|clopidogrel|mesh-list
65348735|NCT02550717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65348736|NCT02550717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65348737|NCT02550717|Analgesics|analgesics|mesh-ancestor
65348738|NCT02550717|Sensory System Agents|sensory system agents|mesh-ancestor
65348739|NCT02550717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65348740|NCT02550717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348741|NCT02550717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65348742|NCT02550717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65348743|NCT02550717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65348744|NCT02550717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65348745|NCT02550717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348746|NCT02550717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65348747|NCT02550717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65348748|NCT02550717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348749|NCT02550717|Antipyretics|antipyretics|mesh-ancestor
65348750|NCT02550717|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65348751|NCT02550717|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65348785|NCT00606580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65348786|NCT02550327|Gemcitabine|gemcitabine|mesh-list
65348787|NCT02550327|Paclitaxel|paclitaxel|mesh-list
65348788|NCT02550327|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65348789|NCT02550327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65348790|NCT02550327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348791|NCT02550327|Tubulin Modulators|tubulin modulators|mesh-ancestor
65348792|NCT02550327|Antimitotic Agents|antimitotic agents|mesh-ancestor
65348793|NCT02550327|Mitosis Modulators|mitosis modulators|mesh-ancestor
65348863|NCT00825123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348865|NCT00826839|Contraceptive Agents|contraceptive agents|mesh-list
65348866|NCT00826839|Contraceptives, Oral|contraceptives, oral|mesh-list
65348867|NCT00826839|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65348868|NCT00826839|Ganirelix|ganirelix|mesh-list
65348869|NCT00826839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64740989|NCT00003449|Immunologic Factors|immunologic factors|mesh-ancestor
65348928|NCT00882076|Sensory System Agents|sensory system agents|mesh-ancestor
65348929|NCT00882076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65348930|NCT00882076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348931|NCT00882076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65348932|NCT00882076|Antimetabolites|antimetabolites|mesh-ancestor
65348933|NCT00827151|Estrogens|estrogens|mesh-list
65348934|NCT00827151|Hormones|hormones|mesh-ancestor
65348935|NCT00827151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65348936|NCT00827151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348937|NCT00882154|Cefdinir|cefdinir|mesh-list
65348938|NCT00882154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65348939|NCT00882154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65348940|NCT00825591|Melatonin|melatonin|mesh-list
65348941|NCT00825591|Antioxidants|antioxidants|mesh-ancestor
65348942|NCT00825591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348943|NCT00825591|Protective Agents|protective agents|mesh-ancestor
65348944|NCT00825591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348945|NCT00825591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65348946|NCT00882232|Hyaluronic Acid|hyaluronic acid|mesh-list
65348947|NCT00882232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65348948|NCT00882232|Immunologic Factors|immunologic factors|mesh-ancestor
65348949|NCT00882232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348950|NCT00882232|Viscosupplements|viscosupplements|mesh-ancestor
65348951|NCT00882232|Protective Agents|protective agents|mesh-ancestor
65348952|NCT03417154|Cyclophosphamide|cyclophosphamide|mesh-list
65348953|NCT03417154|Nivolumab|nivolumab|mesh-list
65348954|NCT03417154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65348955|NCT03417154|Immunologic Factors|immunologic factors|mesh-ancestor
65348956|NCT03417154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348957|NCT03417154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65348988|NCT00605566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348989|NCT00605566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348990|NCT00605566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65348991|NCT00605566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65348992|NCT00605566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348993|NCT00882388|Aspirin|aspirin|mesh-list
65348994|NCT00882388|Celecoxib|celecoxib|mesh-list
65348995|NCT00882388|Clopidogrel|clopidogrel|mesh-list
65348996|NCT00882388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65348997|NCT00882388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65348998|NCT00882388|Analgesics|analgesics|mesh-ancestor
65348999|NCT00882388|Sensory System Agents|sensory system agents|mesh-ancestor
65349000|NCT00882388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349012|NCT00882388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65349013|NCT00882388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65349014|NCT00882388|Purinergic Agents|purinergic agents|mesh-ancestor
65349015|NCT00882388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65349016|NCT00882388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65349018|NCT00396877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65349019|NCT00396877|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65349020|NCT00396877|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65349021|NCT00396877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65349022|NCT00396877|Purinergic Agents|purinergic agents|mesh-ancestor
65349023|NCT00396877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65349024|NCT00396877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273439|NCT00810017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273440|NCT00810017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273441|NCT00620724|Nifedipine|nifedipine|mesh-list
65273442|NCT00620724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65273443|NCT00620724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65273444|NCT00620724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349025|NCT00396877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349026|NCT00124891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
65349027|NCT00882466|Epoetin Alfa|epoetin alfa|mesh-list
65349028|NCT00882466|Hematinics|hematinics|mesh-ancestor
65349029|NCT00628251|Doxorubicin|doxorubicin|mesh-list
65349030|NCT00628251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65349031|NCT00628251|Olaparib|olaparib|mesh-list
65349032|NCT00628251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65349033|NCT00628251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65349034|NCT00628251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65349035|NCT00628251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65349036|NCT00628251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349037|NCT00628251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349038|NCT00628251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65349039|NCT01036399|Lenalidomide|lenalidomide|mesh-list
65349040|NCT01036399|Immunologic Factors|immunologic factors|mesh-ancestor
65349041|NCT01036399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349042|NCT01036399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65349043|NCT01036399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65349044|NCT01036399|Growth Substances|growth substances|mesh-ancestor
65349045|NCT01036399|Growth Inhibitors|growth inhibitors|mesh-ancestor
65349046|NCT01036399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65349047|NCT00901654|Vaccines|vaccines|mesh-list
65349048|NCT00901654|Immunologic Factors|immunologic factors|mesh-ancestor
65349049|NCT00901654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349050|NCT00901732|Calcium|calcium|mesh-list
65349051|NCT00901732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65349052|NCT00901732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349053|NCT00882700|Cefdinir|cefdinir|mesh-list
65349054|NCT00882700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65349055|NCT00882700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65349056|NCT00408499|Cetuximab|cetuximab|mesh-list
65349057|NCT00408499|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65349058|NCT00408499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65349059|NCT00408499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65349060|NCT00408499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65349061|NCT00408499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741164|NCT00002855|Tubulin Modulators|tubulin modulators|mesh-ancestor
65349077|NCT00900874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65349078|NCT00900874|Respiratory System Agents|respiratory system agents|mesh-ancestor
65349079|NCT00900874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65349080|NCT00900874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65349081|NCT00900874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65349082|NCT00900874|Adrenergic Agents|adrenergic agents|mesh-ancestor
65349083|NCT00900874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65349084|NCT00900874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349086|NCT00900874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65349087|NCT02539810|Antihypertensive Agents|antihypertensive agents|mesh-list
65349088|NCT00901888|Nitroprusside|nitroprusside|mesh-list
65349089|NCT00901888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65349090|NCT00901888|Vasodilator Agents|vasodilator agents|mesh-ancestor
65349091|NCT00901888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65349092|NCT00901888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349093|NCT00908362|Fluticasone|fluticasone|mesh-list
65349094|NCT00908362|Xhance|xhance|mesh-list
65349095|NCT00908362|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65349096|NCT00908362|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65349097|NCT00908362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65349098|NCT00908362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65349099|NCT00908362|Autonomic Agents|autonomic agents|mesh-ancestor
65349100|NCT00908362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65274258|NCT00092729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65349101|NCT00908362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349102|NCT00908362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65349103|NCT00908362|Respiratory System Agents|respiratory system agents|mesh-ancestor
65349104|NCT00908362|Dermatologic Agents|dermatologic agents|mesh-ancestor
65349105|NCT00908362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65349106|NCT00908362|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65349107|NCT00908362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65349108|NCT00908362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65349109|NCT00908362|Adrenergic Agents|adrenergic agents|mesh-ancestor
65349110|NCT00908362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65349111|NCT00908362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349112|NCT00908362|Glucocorticoids|glucocorticoids|mesh-ancestor
65349113|NCT00908362|Hormones|hormones|mesh-ancestor
65349114|NCT00908362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65349115|NCT00908362|Sympathomimetics|sympathomimetics|mesh-ancestor
65349116|NCT02549469|Naproxen|naproxen|mesh-list
65349117|NCT02549469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64741224|NCT00003935|Vincristine|vincristine|mesh-list
65349244|NCT00837915|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65349245|NCT00837915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65349246|NCT00837915|Sympathomimetics|sympathomimetics|mesh-ancestor
65349247|NCT00837915|Adrenergic Agents|adrenergic agents|mesh-ancestor
65349364|NCT00407797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349365|NCT00407797|Anticonvulsants|anticonvulsants|mesh-ancestor
65349366|NCT00407797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65349367|NCT00407797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65349368|NCT00407797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349369|NCT00407797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65349370|NCT00407797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65349371|NCT00407797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65349372|NCT00407797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65349373|NCT00407797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65349374|NCT00903292|Pemetrexed|pemetrexed|mesh-list
64741514|NCT00003599|Vitamin E|vitamin e|mesh-list
65349443|NCT00407563|Antimitotic Agents|antimitotic agents|mesh-ancestor
65349444|NCT00407563|Mitosis Modulators|mitosis modulators|mesh-ancestor
65349445|NCT00407563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349446|NCT00407563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65349447|NCT00407563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65349448|NCT00407563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65349449|NCT00407563|Growth Substances|growth substances|mesh-ancestor
65349450|NCT00407563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349451|NCT00407563|Growth Inhibitors|growth inhibitors|mesh-ancestor
65349452|NCT00906724|Insulin|insulin|mesh-list
65349453|NCT00906724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65349454|NCT00906724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349455|NCT01037101|Cycloserine|cycloserine|mesh-list
65349456|NCT01037101|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65349457|NCT01037101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65349458|NCT01037101|Renal Agents|renal agents|mesh-ancestor
65349459|NCT01037101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65349460|NCT01037101|Antitubercular Agents|antitubercular agents|mesh-ancestor
65349461|NCT01037101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65349462|NCT01037101|Antimetabolites|antimetabolites|mesh-ancestor
65349463|NCT01037101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349464|NCT00904306|Chromium|chromium|mesh-list
65349465|NCT00904306|Picolinic acid|picolinic acid|mesh-list
65349466|NCT00904306|Trace Elements|trace elements|mesh-ancestor
65349467|NCT00904306|Micronutrients|micronutrients|mesh-ancestor
65349468|NCT00904306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349469|NCT00904306|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65349470|NCT00904306|Chelating Agents|chelating agents|mesh-ancestor
65349471|NCT00904306|Sequestering Agents|sequestering agents|mesh-ancestor
65349472|NCT00904306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349473|NCT00623103|Rivastigmine|rivastigmine|mesh-list
65349474|NCT00623103|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65349475|NCT00623103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349476|NCT00623103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349477|NCT00623103|Cholinergic Agents|cholinergic agents|mesh-ancestor
64741601|NCT00004055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349599|NCT03653832|Anesthetics|anesthetics|mesh-ancestor
65349600|NCT03653832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65273445|NCT00620724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65349601|NCT03653832|Analgesics|analgesics|mesh-ancestor
65349602|NCT03653832|Sensory System Agents|sensory system agents|mesh-ancestor
65349603|NCT03653832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349604|NCT03653832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65349605|NCT03653832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65349606|NCT03653832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65349607|NCT03653832|Adrenergic Agents|adrenergic agents|mesh-ancestor
65349608|NCT03653832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65349609|NCT03653832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349610|NCT03653832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65349611|NCT03653832|Sympatholytics|sympatholytics|mesh-ancestor
65349612|NCT03653832|Autonomic Agents|autonomic agents|mesh-ancestor
65349613|NCT04060836|Factor VIII|factor viii|mesh-list
65349614|NCT04060836|Coagulants|coagulants|mesh-ancestor
65349615|NCT00693420|Bimatoprost|bimatoprost|mesh-list
65349616|NCT00693420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65349617|NCT00693420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65349618|NCT04034524|Insulin|insulin|mesh-list
65349805|NCT00931840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349807|NCT00931840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65349808|NCT04034368|Tenofovir|tenofovir|mesh-list
65349809|NCT04034368|Antiviral Agents|antiviral agents|mesh-ancestor
65349810|NCT04034368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65349811|NCT04034368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65349812|NCT04034368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65349813|NCT04034368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349814|NCT04034368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349815|NCT04034368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65349816|NCT04034368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65349817|NCT00907270|Cholecalciferol|cholecalciferol|mesh-list
65349818|NCT00907270|Vitamin D|vitamin d|mesh-list
65349819|NCT00907270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65349820|NCT00907270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349821|NCT00907270|Vitamins|vitamins|mesh-ancestor
65349822|NCT00907270|Micronutrients|micronutrients|mesh-ancestor
65349823|NCT00907270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65349824|NCT00375505|Zoledronic Acid|zoledronic acid|mesh-list
65349825|NCT00375505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65349826|NCT00375505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349827|NCT00928876|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65349828|NCT00928876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65349829|NCT00907504|Gemcitabine|gemcitabine|mesh-list
65349830|NCT00907504|Cisplatin|cisplatin|mesh-list
65349831|NCT00907504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65349832|NCT00907504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65349833|NCT00907504|Antimetabolites|antimetabolites|mesh-ancestor
65349834|NCT00907504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349835|NCT00907504|Antiviral Agents|antiviral agents|mesh-ancestor
65349836|NCT00907504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65349837|NCT00907504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349838|NCT00907504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65349839|NCT00907504|Immunologic Factors|immunologic factors|mesh-ancestor
65349840|NCT00907504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349841|NCT00932386|Dexmedetomidine|dexmedetomidine|mesh-list
65349842|NCT00932386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65349843|NCT00932386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65349844|NCT00932386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349845|NCT00932386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65349846|NCT00932386|Analgesics|analgesics|mesh-ancestor
65349847|NCT00932386|Sensory System Agents|sensory system agents|mesh-ancestor
65349848|NCT00932386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349849|NCT00932386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65349850|NCT00932386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65349851|NCT00932386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65349852|NCT00932386|Adrenergic Agents|adrenergic agents|mesh-ancestor
65349853|NCT00932386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65349854|NCT00932386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349855|NCT00932542|Lidocaine|lidocaine|mesh-list
65349856|NCT00932542|Prilocaine|prilocaine|mesh-list
65349857|NCT00932542|Anesthetics, Local|anesthetics, local|mesh-ancestor
65349858|NCT00932542|Anesthetics|anesthetics|mesh-ancestor
65349859|NCT00932542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64741975|NCT00004217|Antiviral Agents|antiviral agents|mesh-ancestor
65274259|NCT00092729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349886|NCT04014634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65349888|NCT04014634|Protective Agents|protective agents|mesh-ancestor
65349889|NCT04014634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65349890|NCT04014634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65349891|NCT01043575|Rifampin|rifampin|mesh-list
65349892|NCT01043575|Rifapentine|rifapentine|mesh-list
65349893|NCT01043575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65349894|NCT01043575|Antitubercular Agents|antitubercular agents|mesh-ancestor
65349895|NCT01043575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65349896|NCT01043575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65349897|NCT01043575|Leprostatic Agents|leprostatic agents|mesh-ancestor
65349898|NCT01043575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65349899|NCT01043575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349900|NCT01043575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349901|NCT01043575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65349902|NCT01043575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65349903|NCT01043575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65349904|NCT01043575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65349938|NCT04014556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65349940|NCT04014556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349941|NCT04014556|Growth Inhibitors|growth inhibitors|mesh-ancestor
65349942|NCT04014556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65349943|NCT00929812|Glucagon|glucagon|mesh-list
65350030|NCT00393367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65350031|NCT00393367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65350032|NCT00393367|Respiratory System Agents|respiratory system agents|mesh-ancestor
65350033|NCT00393367|Anticonvulsants|anticonvulsants|mesh-ancestor
65350034|NCT00393367|Tocolytic Agents|tocolytic agents|mesh-ancestor
65350035|NCT00393367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65350036|NCT00393367|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65350037|NCT00393367|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65350038|NCT00393367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65350039|NCT00393367|Adrenergic Agents|adrenergic agents|mesh-ancestor
65350040|NCT00393367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65350041|NCT00393367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350042|NCT00393367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65350043|NCT00393367|Cholinergic Agents|cholinergic agents|mesh-ancestor
65350044|NCT00395629|Deferasirox|deferasirox|mesh-list
65350045|NCT00395629|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65350046|NCT00395629|Chelating Agents|chelating agents|mesh-ancestor
65350047|NCT00395629|Sequestering Agents|sequestering agents|mesh-ancestor
65350048|NCT00395629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350049|NCT00392665|Sulindac|sulindac|mesh-list
65350050|NCT00392665|Bevacizumab|bevacizumab|mesh-list
65350051|NCT00392665|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65350052|NCT00392665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65350053|NCT00392665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350054|NCT00392665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65350055|NCT00392665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65350056|NCT00392665|Growth Substances|growth substances|mesh-ancestor
65350057|NCT00392665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350058|NCT00392665|Growth Inhibitors|growth inhibitors|mesh-ancestor
65350120|NCT01049347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65350121|NCT01049347|Analgesics|analgesics|mesh-ancestor
65350122|NCT01049347|Sensory System Agents|sensory system agents|mesh-ancestor
65350123|NCT01049347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65350124|NCT01049347|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65350125|NCT01049347|Adrenergic Agents|adrenergic agents|mesh-ancestor
65350126|NCT01049425|Cyclophosphamide|cyclophosphamide|mesh-list
65350127|NCT01049425|Docetaxel|docetaxel|mesh-list
65350128|NCT01049425|Epirubicin|epirubicin|mesh-list
65350129|NCT01049425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65350130|NCT01049425|Immunologic Factors|immunologic factors|mesh-ancestor
65350131|NCT01049425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350132|NCT01049425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65350133|NCT01049425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65350134|NCT01049425|Alkylating Agents|alkylating agents|mesh-ancestor
65350135|NCT01049425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350136|NCT01049425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350137|NCT01049425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65350138|NCT01049425|Tubulin Modulators|tubulin modulators|mesh-ancestor
65350139|NCT01049425|Antimitotic Agents|antimitotic agents|mesh-ancestor
65273446|NCT00620724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273447|NCT00620724|Vasodilator Agents|vasodilator agents|mesh-ancestor
65350140|NCT01049425|Mitosis Modulators|mitosis modulators|mesh-ancestor
65350141|NCT01049425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65350142|NCT01049425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65350143|NCT01049425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65350144|NCT01049425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350145|NCT00838227|Modafinil|modafinil|mesh-list
65350146|NCT00838227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65350147|NCT00838227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350148|NCT00838227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65350149|NCT00838227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65350150|NCT00838227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65350151|NCT00838227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350152|NCT00366301|Metformin|metformin|mesh-list
65350153|NCT00366301|Insulin Glargine|insulin glargine|mesh-list
65350154|NCT00366301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65350155|NCT00366301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350156|NCT00838305|Citalopram|citalopram|mesh-list
65350157|NCT00838305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65350158|NCT00838305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65350159|NCT00838305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65350160|NCT00838305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350161|NCT00838305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65350162|NCT00838305|Serotonin Agents|serotonin agents|mesh-ancestor
65350195|NCT00392197|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65350196|NCT00392197|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65350197|NCT00391807|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65350198|NCT00391807|Norethindrone|norethindrone|mesh-list
65350199|NCT00391807|Norethindrone Acetate|norethindrone acetate|mesh-list
65350200|NCT00391807|Estradiol|estradiol|mesh-list
65350201|NCT00391807|Estrogens|estrogens|mesh-ancestor
65350202|NCT00391807|Hormones|hormones|mesh-ancestor
65350203|NCT00391807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65350307|NCT00621543|Contraceptive Agents|contraceptive agents|mesh-ancestor
65350308|NCT00621543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65350309|NCT00621543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350310|NCT00621543|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65350311|NCT00621543|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65350312|NCT00621543|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65350313|NCT00621543|Trace Elements|trace elements|mesh-ancestor
65350314|NCT00621543|Micronutrients|micronutrients|mesh-ancestor
65350315|NCT00623805|Bevacizumab|bevacizumab|mesh-list
65350316|NCT00623805|Capecitabine|capecitabine|mesh-list
65350317|NCT00623805|Oxaliplatin|oxaliplatin|mesh-list
65350318|NCT00623805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65350337|NCT02548923|Analgesics|analgesics|mesh-ancestor
65350338|NCT02548923|Sensory System Agents|sensory system agents|mesh-ancestor
65350339|NCT02548923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65350340|NCT02548923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65350341|NCT02548923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65350342|NCT02548923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65350343|NCT02548923|Adrenergic Agents|adrenergic agents|mesh-ancestor
65350344|NCT02548923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65350345|NCT02548923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350346|NCT00832221|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65350347|NCT00832221|Raclopride|raclopride|mesh-list
65350348|NCT00832221|Antidepressive Agents|antidepressive agents|mesh-ancestor
65350349|NCT00832221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65350350|NCT00832221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65350351|NCT00832221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65350352|NCT00832221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65350353|NCT00832221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350354|NCT00832221|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65350355|NCT00832221|Dopamine Agents|dopamine agents|mesh-ancestor
65350356|NCT00832221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65350357|NCT00832221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350358|NCT00839397|Paroxetine|paroxetine|mesh-list
65350359|NCT00839397|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65350360|NCT00839397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65350361|NCT00839397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65350362|NCT00839397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273448|NCT00620724|Tocolytic Agents|tocolytic agents|mesh-ancestor
65350363|NCT00839397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65350364|NCT00839397|Serotonin Agents|serotonin agents|mesh-ancestor
65350365|NCT00839397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350366|NCT00839397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65350367|NCT00839397|Antidepressive Agents|antidepressive agents|mesh-ancestor
65350368|NCT00839397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65350369|NCT00839397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65350370|NCT00839397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65350371|NCT00839397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350372|NCT00828477|Nepafenac|nepafenac|mesh-list
65350373|NCT00828477|Bromfenac|bromfenac|mesh-list
65350374|NCT00828477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65350398|NCT00621309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65350399|NCT00621309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65350400|NCT00621309|Protective Agents|protective agents|mesh-ancestor
65350401|NCT00621309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350402|NCT00621309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350403|NCT00839553|Minocycline|minocycline|mesh-list
65350404|NCT00839553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65350405|NCT00839553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65350406|NCT00832689|Gemcitabine|gemcitabine|mesh-list
65350407|NCT00832689|Irinotecan|irinotecan|mesh-list
65350408|NCT00832689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65350409|NCT00832689|Antimetabolites|antimetabolites|mesh-ancestor
65350410|NCT00832689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350411|NCT00832689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350412|NCT00832689|Antiviral Agents|antiviral agents|mesh-ancestor
65350413|NCT00832689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65350414|NCT00832689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350415|NCT00832689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65350416|NCT00832689|Immunologic Factors|immunologic factors|mesh-ancestor
65350417|NCT00832689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350418|NCT00832689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65350419|NCT00832689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65350420|NCT00567190|Docetaxel|docetaxel|mesh-list
65350421|NCT00567190|Trastuzumab|trastuzumab|mesh-list
65350422|NCT00567190|Pertuzumab|pertuzumab|mesh-list
65350423|NCT00567190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350424|NCT00567190|Tubulin Modulators|tubulin modulators|mesh-ancestor
65350438|NCT00691938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350439|NCT00691938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350440|NCT00691938|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65350441|NCT00365365|Cyclophosphamide|cyclophosphamide|mesh-list
65350442|NCT00365365|Bevacizumab|bevacizumab|mesh-list
65350443|NCT00365365|Carboplatin|carboplatin|mesh-list
65350444|NCT00365365|Docetaxel|docetaxel|mesh-list
65350445|NCT00365365|Doxorubicin|doxorubicin|mesh-list
65350446|NCT00365365|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65350447|NCT00365365|Trastuzumab|trastuzumab|mesh-list
65350448|NCT00365365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65350449|NCT00365365|Immunologic Factors|immunologic factors|mesh-ancestor
65350450|NCT00365365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350451|NCT00365365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65350452|NCT00365365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65350453|NCT00365365|Alkylating Agents|alkylating agents|mesh-ancestor
65350454|NCT00365365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350455|NCT00365365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350456|NCT00365365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65350457|NCT00365365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65350458|NCT00365365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65350459|NCT00365365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65350460|NCT00365365|Growth Substances|growth substances|mesh-ancestor
65350461|NCT00365365|Growth Inhibitors|growth inhibitors|mesh-ancestor
65350462|NCT00365365|Tubulin Modulators|tubulin modulators|mesh-ancestor
65350463|NCT00365365|Antimitotic Agents|antimitotic agents|mesh-ancestor
65350464|NCT00365365|Mitosis Modulators|mitosis modulators|mesh-ancestor
65350465|NCT00365365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65350466|NCT00365365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65350467|NCT00365365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65350468|NCT00365365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350469|NCT01046461|Dexamethasone|dexamethasone|mesh-list
65350470|NCT01046461|Aprepitant|aprepitant|mesh-list
65350471|NCT01046461|Ramosetron|ramosetron|mesh-list
65350472|NCT01046461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65350473|NCT01046461|Antiemetics|antiemetics|mesh-ancestor
65350474|NCT01046461|Autonomic Agents|autonomic agents|mesh-ancestor
65350475|NCT01046461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65350476|NCT01046461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350477|NCT01046461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65350478|NCT01046461|Glucocorticoids|glucocorticoids|mesh-ancestor
65350479|NCT01046461|Hormones|hormones|mesh-ancestor
65350480|NCT01046461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65350481|NCT01046461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65350482|NCT01046461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350483|NCT01046461|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65350484|NCT01046461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65350485|NCT01046461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350486|NCT01046461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65350510|NCT00828789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350511|NCT00828789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65350512|NCT00828789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65350513|NCT00828789|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65350514|NCT00828789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65350515|NCT00828789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65350516|NCT00828789|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65350517|NCT00828789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65350518|NCT00828789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65350519|NCT00930358|Anesthetics|anesthetics|mesh-list
65350520|NCT00930358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65350521|NCT00930358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350522|NCT00372775|Sunitinib|sunitinib|mesh-list
65350523|NCT00372775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350524|NCT00372775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65350525|NCT00372775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65350526|NCT00372775|Growth Substances|growth substances|mesh-ancestor
65350527|NCT00372775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350528|NCT00372775|Growth Inhibitors|growth inhibitors|mesh-ancestor
65350529|NCT00372775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65350530|NCT00372775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350531|NCT00372775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350532|NCT00936676|Rasagiline|rasagiline|mesh-list
65350533|NCT00936676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65350534|NCT00936676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350535|NCT00936676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350536|NCT00936676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65350537|NCT00936676|Protective Agents|protective agents|mesh-ancestor
65350538|NCT00936676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350539|NCT00839787|Morphine|morphine|mesh-list
65350609|NCT00937144|Vasodilator Agents|vasodilator agents|mesh-ancestor
65350610|NCT00937144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65350611|NCT00937144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65350612|NCT00937144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350613|NCT00937144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350614|NCT00937144|Urological Agents|urological agents|mesh-ancestor
65350615|NCT00566098|Melphalan|melphalan|mesh-list
65350616|NCT00566098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65350617|NCT00566098|Alkylating Agents|alkylating agents|mesh-ancestor
65350618|NCT00566098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350619|NCT00566098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350620|NCT00566098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65350621|NCT00566098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65350622|NCT00566098|Immunologic Factors|immunologic factors|mesh-ancestor
65350623|NCT00566098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350624|NCT00937300|Cyclophosphamide|cyclophosphamide|mesh-list
65350625|NCT00937300|Fludarabine|fludarabine|mesh-list
65350647|NCT02226276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65350648|NCT02226276|Immunoconjugates|immunoconjugates|mesh-list
65350649|NCT02226276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65350650|NCT02226276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350651|NCT02226276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350652|NCT02226276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65350653|NCT02226276|Trace Elements|trace elements|mesh-ancestor
65350654|NCT02226276|Micronutrients|micronutrients|mesh-ancestor
65350655|NCT02226276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350656|NCT02226276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65350657|NCT02226276|Tubulin Modulators|tubulin modulators|mesh-ancestor
65350658|NCT02226276|Antimitotic Agents|antimitotic agents|mesh-ancestor
65273449|NCT00620724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65350659|NCT02226276|Mitosis Modulators|mitosis modulators|mesh-ancestor
65350660|NCT02226276|Immunologic Factors|immunologic factors|mesh-ancestor
65350661|NCT00935116|Etoricoxib|etoricoxib|mesh-list
65350662|NCT00935116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65350663|NCT00935116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65350664|NCT00935116|Analgesics|analgesics|mesh-ancestor
65350665|NCT00935116|Sensory System Agents|sensory system agents|mesh-ancestor
65350666|NCT00935116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65350667|NCT00935116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350668|NCT00935116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65350669|NCT00935116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65350670|NCT00935116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65350671|NCT00935116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65350672|NCT00935116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350673|NCT00935116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350674|NCT00931138|Cytarabine|cytarabine|mesh-list
65350675|NCT00931138|Daunorubicin|daunorubicin|mesh-list
65350676|NCT00931138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65350677|NCT00931138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350678|NCT00931138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65350679|NCT00931138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64742819|NCT00005807|Epothilones|epothilones|mesh-list
65350699|NCT00690378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65350700|NCT00690378|Protease Inhibitors|protease inhibitors|mesh-ancestor
65350701|NCT00690378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350702|NCT00690378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350703|NCT00690378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65350704|NCT00574275|Gemcitabine|gemcitabine|mesh-list
65350705|NCT00574275|Aflibercept|aflibercept|mesh-list
65350706|NCT00574275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65350707|NCT00574275|Antimetabolites|antimetabolites|mesh-ancestor
65350708|NCT00574275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350709|NCT00574275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350710|NCT00574275|Antiviral Agents|antiviral agents|mesh-ancestor
65350711|NCT00574275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65350712|NCT00574275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350713|NCT00574275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65350714|NCT00574275|Immunologic Factors|immunologic factors|mesh-ancestor
65350715|NCT00574275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350716|NCT00574275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65350717|NCT00574275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65350718|NCT00574275|Growth Substances|growth substances|mesh-ancestor
65350719|NCT00574275|Growth Inhibitors|growth inhibitors|mesh-ancestor
65350720|NCT01742832|Citalopram|citalopram|mesh-list
65350721|NCT01742832|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
65350722|NCT01742832|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65350723|NCT01742832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65350724|NCT01742832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65350725|NCT01742832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350726|NCT01742832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65350727|NCT01742832|Serotonin Agents|serotonin agents|mesh-ancestor
65350728|NCT01742832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350729|NCT01742832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65350730|NCT01742832|Antidepressive Agents|antidepressive agents|mesh-ancestor
65350731|NCT01742832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65350732|NCT01742832|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65350733|NCT01742832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65350734|NCT00833079|Tacrolimus|tacrolimus|mesh-list
65350735|NCT00833079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65350778|NCT04285671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65350779|NCT04285671|Trastuzumab|trastuzumab|mesh-list
65350780|NCT04285671|Necitumumab|necitumumab|mesh-list
65350781|NCT04285671|Osimertinib|osimertinib|mesh-list
65350782|NCT04285671|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
65350783|NCT04285671|Antibodies|antibodies|mesh-list
65350784|NCT04285671|Immunoglobulins|immunoglobulins|mesh-list
65350785|NCT04285671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65350786|NCT04285671|Immunologic Factors|immunologic factors|mesh-ancestor
65350787|NCT04285671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350788|NCT04285671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350789|NCT04285671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350790|NCT04285671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65350791|NCT04285671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350792|NCT00931372|Lixisenatide|lixisenatide|mesh-list
65350793|NCT00931372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65350794|NCT00931372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350795|NCT00829257|Fluticasone|fluticasone|mesh-list
65350796|NCT00829257|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65350797|NCT00829257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64742960|NCT00003707|Gemcitabine|gemcitabine|mesh-list
65350831|NCT00840333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350832|NCT00840333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350833|NCT00840333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65350834|NCT00840333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65350835|NCT00840489|Ribavirin|ribavirin|mesh-list
65350836|NCT00840489|Colchicine|colchicine|mesh-list
65350837|NCT00840489|Antimetabolites|antimetabolites|mesh-ancestor
65350838|NCT00840489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350839|NCT00840489|Antiviral Agents|antiviral agents|mesh-ancestor
65350863|NCT00566722|Adalimumab|adalimumab|mesh-list
65350864|NCT00566722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65350865|NCT00566722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65350866|NCT00691704|Prednisone|prednisone|mesh-list
65350867|NCT00691704|Lenalidomide|lenalidomide|mesh-list
65350868|NCT00691704|Bortezomib|bortezomib|mesh-list
65350869|NCT00691704|Melphalan|melphalan|mesh-list
65350870|NCT00691704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65350871|NCT00691704|Glucocorticoids|glucocorticoids|mesh-ancestor
65350872|NCT00691704|Hormones|hormones|mesh-ancestor
65350873|NCT00691704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65350874|NCT00691704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350875|NCT00691704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65350876|NCT00691704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350877|NCT00691704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350878|NCT00691704|Immunologic Factors|immunologic factors|mesh-ancestor
65350879|NCT00691704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65350880|NCT00691704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65350881|NCT00691704|Growth Substances|growth substances|mesh-ancestor
65350882|NCT00691704|Growth Inhibitors|growth inhibitors|mesh-ancestor
65350883|NCT00691704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65350884|NCT00691704|Alkylating Agents|alkylating agents|mesh-ancestor
65350885|NCT00691704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65350886|NCT00691704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65350887|NCT00829647|Lenalidomide|lenalidomide|mesh-list
65350888|NCT00829647|Dasatinib|dasatinib|mesh-list
65350889|NCT00829647|Immunologic Factors|immunologic factors|mesh-ancestor
65350890|NCT00829647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350891|NCT00829647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65350892|NCT00829647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65350912|NCT00829881|Histamine Agents|histamine agents|mesh-ancestor
65350913|NCT00829881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65350914|NCT00829881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350915|NCT00829881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350917|NCT00840801|Immunologic Factors|immunologic factors|mesh-ancestor
65350918|NCT00840801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350919|NCT04014244|Triamcinolone|triamcinolone|mesh-list
65350920|NCT04014244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65350921|NCT04014244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65350922|NCT04014244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65350923|NCT04014244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65350924|NCT04014244|Glucocorticoids|glucocorticoids|mesh-ancestor
65350925|NCT04014244|Hormones|hormones|mesh-ancestor
65350926|NCT04014244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65350927|NCT04014244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350928|NCT04014244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65350929|NCT04014244|Immunologic Factors|immunologic factors|mesh-ancestor
65350930|NCT04014244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350931|NCT04014244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350932|NCT02548611|Clopidogrel|clopidogrel|mesh-list
65350933|NCT02548611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65350934|NCT02548611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65350935|NCT02548611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65350936|NCT02548611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65350937|NCT02548611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65350938|NCT02548611|Purinergic Agents|purinergic agents|mesh-ancestor
65350939|NCT02548611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65350940|NCT02548611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350941|NCT02548611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350942|NCT00937924|Diphenhydramine|diphenhydramine|mesh-list
65350943|NCT00937924|Promethazine|promethazine|mesh-list
65350944|NCT00937924|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65350945|NCT00937924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65350979|NCT00938158|Incretins|incretins|mesh-ancestor
65350980|NCT00938158|Hormones|hormones|mesh-ancestor
65350981|NCT00938158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65350982|NCT00938158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350983|NCT00840957|Infliximab|infliximab|mesh-list
65350984|NCT00840957|Dermatologic Agents|dermatologic agents|mesh-ancestor
65350985|NCT00840957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65350986|NCT00840957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65350987|NCT00743964|Capecitabine|capecitabine|mesh-list
65350989|NCT00743964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351023|NCT00830505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65351024|NCT00830505|Autonomic Agents|autonomic agents|mesh-ancestor
65351025|NCT00830505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65351026|NCT00830505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351027|NCT00830505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65351028|NCT00830505|Respiratory System Agents|respiratory system agents|mesh-ancestor
65351029|NCT00830505|Dermatologic Agents|dermatologic agents|mesh-ancestor
65351030|NCT00830505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65351057|NCT02563782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351058|NCT02563782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65351059|NCT02563782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351060|NCT02563782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351061|NCT02563782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65351062|NCT02563782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351063|NCT02563782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65351064|NCT02563782|Antitubercular Agents|antitubercular agents|mesh-ancestor
65351065|NCT02563782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65351066|NCT02563782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65351067|NCT00841191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65351068|NCT00841191|Siltuximab|siltuximab|mesh-list
65351069|NCT00841191|Antibodies|antibodies|mesh-list
65351070|NCT00841191|Immunoglobulins|immunoglobulins|mesh-list
65351071|NCT00841191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65351072|NCT00841191|Immunologic Factors|immunologic factors|mesh-ancestor
65351073|NCT00841191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351074|NCT00841191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351075|NCT00843453|Vitamin B 12|vitamin b 12|mesh-list
65351076|NCT00843453|Hydroxocobalamin|hydroxocobalamin|mesh-list
65351088|NCT00938236|Cyclosporine|cyclosporine|mesh-list
65351089|NCT00938236|Cyclosporins|cyclosporins|mesh-list
65351090|NCT00938236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351091|NCT00938236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351092|NCT00938236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65351093|NCT00938236|Immunologic Factors|immunologic factors|mesh-ancestor
65351094|NCT00938236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351095|NCT00938236|Antifungal Agents|antifungal agents|mesh-ancestor
65351096|NCT00938236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65351097|NCT00938236|Dermatologic Agents|dermatologic agents|mesh-ancestor
65351098|NCT00938236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65351099|NCT00938236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65351100|NCT00741780|Plerixafor|plerixafor|mesh-list
65351101|NCT00741780|Lenograstim|lenograstim|mesh-list
65351102|NCT00741780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65351103|NCT00741780|Immunologic Factors|immunologic factors|mesh-ancestor
65351104|NCT00741780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351105|NCT00741780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65351106|NCT00741780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65351107|NCT00741780|Antiviral Agents|antiviral agents|mesh-ancestor
65351108|NCT00741780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65351109|NCT00936442|Anastrozole|anastrozole|mesh-list
65351110|NCT00936442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65351111|NCT00936442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351112|NCT00936442|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65351113|NCT00936442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65351114|NCT00936442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351115|NCT00936442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351116|NCT00936442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65351117|NCT00936442|Hormone Antagonists|hormone antagonists|mesh-ancestor
65351118|NCT00936442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65351119|NCT00936442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273450|NCT04209426|Tacrine|tacrine|mesh-list
65273451|NCT04209426|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65273452|NCT04209426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273453|NCT04209426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273454|NCT04209426|Cholinergic Agents|cholinergic agents|mesh-ancestor
65273455|NCT04209426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65273456|NCT04209426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273457|NCT04209426|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65273458|NCT04209426|Autonomic Agents|autonomic agents|mesh-ancestor
65273459|NCT04209426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65273460|NCT04209426|Nootropic Agents|nootropic agents|mesh-ancestor
65273461|NCT00620802|Clopidogrel|clopidogrel|mesh-list
65273462|NCT00620802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65273463|NCT00620802|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65273464|NCT00620802|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64471621|NCT04309552|Alovudine|alovudine|mesh-list
65351120|NCT00744354|Doxorubicin|doxorubicin|mesh-list
65351121|NCT00744354|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65351122|NCT00744354|Bortezomib|bortezomib|mesh-list
65351123|NCT00744354|Vorinostat|vorinostat|mesh-list
65351124|NCT00744354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65351125|NCT00744354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351126|NCT00744354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65351127|NCT00744354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65351128|NCT00744354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351129|NCT00744354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351130|NCT00744354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65351131|NCT04043325|Antibodies|antibodies|mesh-list
65351132|NCT04043325|Immunologic Factors|immunologic factors|mesh-ancestor
65351133|NCT04043325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351134|NCT00936520|Lifitegrast|lifitegrast|mesh-list
65351135|NCT00936520|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65351136|NCT00936520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65351137|NCT00835029|Clotrimazole|clotrimazole|mesh-list
65351138|NCT00835029|Miconazole|miconazole|mesh-list
65351139|NCT00835029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65351140|NCT00835029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65351141|NCT00835029|Antifungal Agents|antifungal agents|mesh-ancestor
65351142|NCT00835029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65351143|NCT00835029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65351157|NCT00835107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351159|NCT00835107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65351160|NCT00835107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65351161|NCT00835107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65351162|NCT00835107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65351163|NCT00835107|Dopamine Agents|dopamine agents|mesh-ancestor
65351164|NCT00690612|Candesartan|candesartan|mesh-list
65351165|NCT00690612|Candesartan cilexetil|candesartan cilexetil|mesh-list
65351166|NCT00690612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65351167|NCT00690612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65351168|NCT00690612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65351169|NCT00690612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351170|NCT00742014|Sildenafil Citrate|sildenafil citrate|mesh-list
65351171|NCT00742014|Vasodilator Agents|vasodilator agents|mesh-ancestor
65351172|NCT00742014|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65351173|NCT00742014|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65351174|NCT00742014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351175|NCT00742014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351176|NCT00742014|Urological Agents|urological agents|mesh-ancestor
65273465|NCT00620802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65273466|NCT00620802|Purinergic Agents|purinergic agents|mesh-ancestor
65351177|NCT00742092|Miglustat|miglustat|mesh-list
65351178|NCT00742092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351179|NCT00742092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351180|NCT00742092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65351181|NCT00742092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65351182|NCT00742092|Antiviral Agents|antiviral agents|mesh-ancestor
65351183|NCT00742092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65351184|NCT00742092|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65351185|NCT00742092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65351186|NCT00742092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351187|NCT00841581|Ranibizumab|ranibizumab|mesh-list
65351188|NCT00841581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65351189|NCT00841581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65351190|NCT00841581|Growth Substances|growth substances|mesh-ancestor
65351191|NCT00841581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351192|NCT00841581|Growth Inhibitors|growth inhibitors|mesh-ancestor
65351193|NCT00841581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351194|NCT00742248|Formoterol Fumarate|formoterol fumarate|mesh-list
65351195|NCT00742248|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65351196|NCT00742248|Autonomic Agents|autonomic agents|mesh-ancestor
65351197|NCT00742248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65351198|NCT00742248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351199|NCT00742248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65351200|NCT00742248|Respiratory System Agents|respiratory system agents|mesh-ancestor
65351201|NCT00742248|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65351225|NCT00621153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351226|NCT00621153|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65351227|NCT00621153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65351228|NCT00621153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351229|NCT00621153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65351230|NCT00621153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65351232|NCT05447910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351233|NCT05447910|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65351234|NCT05447910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65351235|NCT05447910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351236|NCT05447910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351237|NCT05447910|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65351238|NCT05447910|Hormone Antagonists|hormone antagonists|mesh-ancestor
65351239|NCT05447910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65351240|NCT05447910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351241|NCT00574119|Spironolactone|spironolactone|mesh-list
65351242|NCT00574119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65351243|NCT00574119|Hormone Antagonists|hormone antagonists|mesh-ancestor
65351244|NCT00574119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65351245|NCT00574119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351246|NCT00574119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65351247|NCT00574119|Diuretics|diuretics|mesh-ancestor
65351248|NCT00574119|Natriuretic Agents|natriuretic agents|mesh-ancestor
65351249|NCT00705614|Infliximab|infliximab|mesh-list
65351250|NCT00705614|Dermatologic Agents|dermatologic agents|mesh-ancestor
64743386|NCT01618266|Dexamethasone|dexamethasone|mesh-list
65351304|NCT00842127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65351305|NCT00842127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351306|NCT00842127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65351307|NCT00842127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65351308|NCT00842127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65351309|NCT00842127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351310|NCT00842127|Dopamine Agents|dopamine agents|mesh-ancestor
65351311|NCT00842127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65351312|NCT00835965|Dexamethasone|dexamethasone|mesh-list
65351313|NCT00835965|Dexamethasone acetate|dexamethasone acetate|mesh-list
65351314|NCT00835965|Aprepitant|aprepitant|mesh-list
65351315|NCT00835965|Fosaprepitant|fosaprepitant|mesh-list
65351316|NCT00835965|BB 1101|bb 1101|mesh-list
65351317|NCT00835965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65351318|NCT00835965|Antiemetics|antiemetics|mesh-ancestor
65351319|NCT00835965|Autonomic Agents|autonomic agents|mesh-ancestor
65351320|NCT00835965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65273467|NCT00620802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65351321|NCT00835965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351322|NCT00835965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65351323|NCT00835965|Glucocorticoids|glucocorticoids|mesh-ancestor
65351324|NCT00835965|Hormones|hormones|mesh-ancestor
65351325|NCT00835965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65351326|NCT00835965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65351327|NCT00835965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351328|NCT00835965|Protease Inhibitors|protease inhibitors|mesh-ancestor
65351329|NCT00835965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351330|NCT00835965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351331|NCT00835965|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65351332|NCT00835965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65351333|NCT02567786|Plasma-lyte 148|plasma-lyte 148|mesh-list
65351334|NCT02567786|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65351335|NCT02567786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65351336|NCT05667740|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65351337|NCT05667740|Immunologic Factors|immunologic factors|mesh-ancestor
65351338|NCT05667740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351339|NCT00842205|Interferons|interferons|mesh-list
65351384|NCT05664542|Adrenergic Agents|adrenergic agents|mesh-ancestor
65351385|NCT05664542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65351386|NCT05664542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351387|NCT05664542|Anesthetics, Local|anesthetics, local|mesh-ancestor
65351388|NCT05664542|Anesthetics|anesthetics|mesh-ancestor
65351389|NCT04344795|Pembrolizumab|pembrolizumab|mesh-list
65351390|NCT04344795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65351391|NCT04344795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351392|NCT00562978|Cyclophosphamide|cyclophosphamide|mesh-list
65351393|NCT00562978|Etoposide|etoposide|mesh-list
65351394|NCT00562978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65351395|NCT00562978|Immunologic Factors|immunologic factors|mesh-ancestor
65351396|NCT00562978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351397|NCT00562978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65351398|NCT00562978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65351399|NCT00562978|Alkylating Agents|alkylating agents|mesh-ancestor
65351400|NCT00562978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351401|NCT00562978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351402|NCT00562978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65351403|NCT00562978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65351404|NCT00562978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65351405|NCT00562978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65351406|NCT00562978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351407|NCT05661188|Atezolizumab|atezolizumab|mesh-list
65351408|NCT05661188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351409|NCT00842595|Prednisone|prednisone|mesh-list
65351410|NCT00842595|Rituximab|rituximab|mesh-list
65351411|NCT00842595|Vinorelbine|vinorelbine|mesh-list
65351412|NCT00842595|Ifosfamide|ifosfamide|mesh-list
65351413|NCT00842595|Mitoxantrone|mitoxantrone|mesh-list
65351414|NCT00842595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65351415|NCT00842595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351416|NCT00842595|Immunologic Factors|immunologic factors|mesh-ancestor
65351417|NCT00842595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351418|NCT00842595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65351419|NCT00842595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65351420|NCT00842595|Glucocorticoids|glucocorticoids|mesh-ancestor
65351421|NCT00842595|Hormones|hormones|mesh-ancestor
64743545|NCT01911546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351440|NCT00938626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351441|NCT00836199|Vaccines|vaccines|mesh-list
65351442|NCT00836199|Immunologic Factors|immunologic factors|mesh-ancestor
65351443|NCT00836199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351444|NCT04013386|Dexamethasone|dexamethasone|mesh-list
65351445|NCT04013386|Dexamethasone acetate|dexamethasone acetate|mesh-list
65351446|NCT04013386|Aprepitant|aprepitant|mesh-list
65351447|NCT04013386|Mirtazapine|mirtazapine|mesh-list
65351448|NCT04013386|BB 1101|bb 1101|mesh-list
65351449|NCT04013386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65351450|NCT04013386|Antiemetics|antiemetics|mesh-ancestor
65351451|NCT04013386|Autonomic Agents|autonomic agents|mesh-ancestor
65351452|NCT04013386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65351453|NCT04013386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351454|NCT04013386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65351455|NCT04013386|Glucocorticoids|glucocorticoids|mesh-ancestor
65351456|NCT04013386|Hormones|hormones|mesh-ancestor
65351457|NCT04013386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65351458|NCT04013386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65351459|NCT04013386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351460|NCT04013386|Protease Inhibitors|protease inhibitors|mesh-ancestor
65351461|NCT04013386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351462|NCT04013386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351463|NCT04013386|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65351464|NCT04013386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65351465|NCT04013386|Antidepressive Agents|antidepressive agents|mesh-ancestor
65351466|NCT04013386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65351467|NCT04013386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65351468|NCT04013386|Histamine Antagonists|histamine antagonists|mesh-ancestor
65351469|NCT04013386|Histamine Agents|histamine agents|mesh-ancestor
65351470|NCT04013386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65351471|NCT04013386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65351472|NCT04013386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65351473|NCT04013386|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65351474|NCT04013386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65351475|NCT04013386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65351476|NCT04013386|Adrenergic Agents|adrenergic agents|mesh-ancestor
65351538|NCT04012918|Hormone Antagonists|hormone antagonists|mesh-ancestor
65351539|NCT04012918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65351540|NCT04012918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351541|NCT00939718|Vitamin B 12|vitamin b 12|mesh-list
65351542|NCT00939718|Hydroxocobalamin|hydroxocobalamin|mesh-list
65351543|NCT00939718|Vitamins|vitamins|mesh-ancestor
65351544|NCT00939718|Micronutrients|micronutrients|mesh-ancestor
65351545|NCT00939718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351546|NCT00939718|Vitamin B Complex|vitamin b complex|mesh-ancestor
65351547|NCT00939718|Hematinics|hematinics|mesh-ancestor
65351548|NCT00836667|Sertraline|sertraline|mesh-list
65351549|NCT00836667|Antidepressive Agents|antidepressive agents|mesh-ancestor
65351550|NCT00836667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65351551|NCT00836667|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65351552|NCT00836667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64743695|NCT01862328|Gemcitabine|gemcitabine|mesh-list
65351789|NCT00561574|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65351790|NCT00561574|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65351791|NCT00561574|Serotonin Agents|serotonin agents|mesh-ancestor
65351792|NCT00561574|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65351793|NCT00687804|Ranibizumab|ranibizumab|mesh-list
65351794|NCT00687804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65351795|NCT00687804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65351796|NCT00687804|Growth Substances|growth substances|mesh-ancestor
65351797|NCT00687804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351798|NCT00687804|Growth Inhibitors|growth inhibitors|mesh-ancestor
65351799|NCT00687804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351800|NCT02563704|Artesunate|artesunate|mesh-list
65351801|NCT02563704|Quinine|quinine|mesh-list
65351802|NCT02563704|Antimalarials|antimalarials|mesh-ancestor
65351803|NCT02563704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65351834|NCT00742404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65351835|NCT00742404|Antiemetics|antiemetics|mesh-ancestor
65351836|NCT00742404|Autonomic Agents|autonomic agents|mesh-ancestor
65351837|NCT00742404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65351838|NCT00742404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351839|NCT00742404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65351840|NCT00742404|Glucocorticoids|glucocorticoids|mesh-ancestor
65351841|NCT00742404|Hormones|hormones|mesh-ancestor
65351842|NCT00742404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65351843|NCT00742404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65351844|NCT00742404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351845|NCT00742404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65351846|NCT00742404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65351847|NCT00742404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65351848|NCT00742404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351849|NCT00742404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351885|NCT00749112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351886|NCT00749112|Immunologic Factors|immunologic factors|mesh-ancestor
65351887|NCT00749112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351888|NCT00749112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65351890|NCT00848679|Anesthetics, Local|anesthetics, local|mesh-ancestor
65351891|NCT00848679|Anesthetics|anesthetics|mesh-ancestor
65273468|NCT00620802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273469|NCT00620802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351892|NCT00848679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65351893|NCT00848679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351894|NCT00848679|Sensory System Agents|sensory system agents|mesh-ancestor
65351895|NCT00848679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65351896|NCT00848679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65351897|NCT00848679|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65351898|NCT00848679|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65351899|NCT00848679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65351900|NCT00848679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351901|NCT04012606|Carboplatin|carboplatin|mesh-list
65351902|NCT04012606|Etoposide|etoposide|mesh-list
65351903|NCT04012606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351904|NCT04012606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65351905|NCT04012606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65351906|NCT04012606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64744033|NCT01832766|Hormones|hormones|mesh-ancestor
65351929|NCT02545959|Prednisolone phosphate|prednisolone phosphate|mesh-list
65351930|NCT02545959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65351931|NCT02545959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351932|NCT02545959|Immunologic Factors|immunologic factors|mesh-ancestor
65351933|NCT02545959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351934|NCT02545959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65351935|NCT02545959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65351937|NCT02545959|Autonomic Agents|autonomic agents|mesh-ancestor
65351938|NCT02545959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65351939|NCT02545959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65351940|NCT02545959|Glucocorticoids|glucocorticoids|mesh-ancestor
65351941|NCT02545959|Hormones|hormones|mesh-ancestor
65351942|NCT02545959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65351943|NCT02545959|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65351944|NCT02545959|Protective Agents|protective agents|mesh-ancestor
65351945|NCT02545959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65351946|NCT00744900|Pemetrexed|pemetrexed|mesh-list
65351947|NCT00744900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351948|NCT00744900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351949|NCT00744900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351950|NCT00744900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65351951|NCT00744900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65351952|NCT00727090|Conivaptan|conivaptan|mesh-list
65351953|NCT00727090|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65351954|NCT00727090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351955|NCT00727090|Natriuretic Agents|natriuretic agents|mesh-ancestor
65351956|NCT00727090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352050|NCT00921284|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65352051|NCT00921284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65352052|NCT00921284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352053|NCT00921284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65352054|NCT00921284|Analgesics|analgesics|mesh-ancestor
65352055|NCT00921284|Sensory System Agents|sensory system agents|mesh-ancestor
65352056|NCT00921284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65352057|NCT00921284|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65352058|NCT00921284|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65352059|NCT00921284|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65352060|NCT00921284|Adrenergic Agents|adrenergic agents|mesh-ancestor
65352061|NCT00921284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65352062|NCT00921284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352063|NCT02565680|Prednisone|prednisone|mesh-list
65352064|NCT02565680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65352065|NCT02565680|Glucocorticoids|glucocorticoids|mesh-ancestor
65352066|NCT02565680|Hormones|hormones|mesh-ancestor
65352067|NCT02565680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65352068|NCT02565680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352069|NCT02565680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65352070|NCT02565680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352071|NCT00749502|Niraparib|niraparib|mesh-list
65352072|NCT00749502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65273470|NCT02848157|Dexmedetomidine|dexmedetomidine|mesh-list
65273471|NCT02848157|Ropivacaine|ropivacaine|mesh-list
65352073|NCT00749502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352074|NCT00749502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352075|NCT00749502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352076|NCT00560794|Blinatumomab|blinatumomab|mesh-list
65352077|NCT00560794|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65352078|NCT00560794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352079|NCT00560794|Immunologic Factors|immunologic factors|mesh-ancestor
65352080|NCT00560794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352081|NCT00749736|Cholecalciferol|cholecalciferol|mesh-list
65352082|NCT00749736|Vitamin D|vitamin d|mesh-list
65352083|NCT00749736|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
65352084|NCT00749736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65352085|NCT00749736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352086|NCT00749736|Vitamins|vitamins|mesh-ancestor
65352087|NCT00749736|Micronutrients|micronutrients|mesh-ancestor
65352088|NCT00749736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65352089|NCT00950404|Sildenafil Citrate|sildenafil citrate|mesh-list
65352113|NCT00619359|Autonomic Agents|autonomic agents|mesh-ancestor
65352114|NCT00619359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65352115|NCT00619359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352116|NCT00619359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65352117|NCT00619359|Glucocorticoids|glucocorticoids|mesh-ancestor
65352119|NCT00619359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65352120|NCT00619359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65352121|NCT00619359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352122|NCT00619359|Protease Inhibitors|protease inhibitors|mesh-ancestor
65352123|NCT00619359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352124|NCT00619359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352125|NCT00619359|Antipruritics|antipruritics|mesh-ancestor
65352126|NCT00619359|Dermatologic Agents|dermatologic agents|mesh-ancestor
65352127|NCT00619359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65352128|NCT00619359|Serotonin Agents|serotonin agents|mesh-ancestor
65352129|NCT00619359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65352130|NCT00619359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65352131|NCT00619359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65352132|NCT00619359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65352133|NCT00619359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65352134|NCT00619359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65352135|NCT00619359|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65352136|NCT00848991|Dexmedetomidine|dexmedetomidine|mesh-list
65352137|NCT00848991|Propofol|propofol|mesh-list
65352138|NCT00848991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65352139|NCT00848991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65352140|NCT00848991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352141|NCT00848991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65352235|NCT00849459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65352236|NCT00849459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65352237|NCT00849459|Growth Substances|growth substances|mesh-ancestor
65352238|NCT00849459|Growth Inhibitors|growth inhibitors|mesh-ancestor
65352239|NCT00849459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352240|NCT00852345|Clofazimine|clofazimine|mesh-list
65352241|NCT00852345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65352242|NCT00852345|Leprostatic Agents|leprostatic agents|mesh-ancestor
65352243|NCT00852345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65352244|NCT00852345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65352440|NCT00686634|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65352441|NCT00686634|Protease Inhibitors|protease inhibitors|mesh-ancestor
65352442|NCT00686634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352443|NCT00686634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352444|NCT00856401|Parathyroid Hormone|parathyroid hormone|mesh-list
65352445|NCT00856401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352446|NCT00856401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65352448|NCT00560404|Hematinics|hematinics|mesh-ancestor
65352449|NCT00942526|Nystatin|nystatin|mesh-list
65352450|NCT00942526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65352451|NCT00942526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65352452|NCT00942526|Antifungal Agents|antifungal agents|mesh-ancestor
65352453|NCT00942526|Ionophores|ionophores|mesh-ancestor
65352454|NCT00942526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65352455|NCT00942526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352456|NCT03967444|Hyaluronic Acid|hyaluronic acid|mesh-list
65352457|NCT03967444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65352458|NCT03967444|Immunologic Factors|immunologic factors|mesh-ancestor
65352459|NCT03967444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352460|NCT03967444|Viscosupplements|viscosupplements|mesh-ancestor
65352461|NCT03967444|Protective Agents|protective agents|mesh-ancestor
65352462|NCT05300854|Anesthetics|anesthetics|mesh-list
65352463|NCT05300854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65352464|NCT05300854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352465|NCT00946504|Glipizide|glipizide|mesh-list
65352466|NCT00946504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65352467|NCT00946504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352468|NCT00619983|Gabapentin|gabapentin|mesh-list
65352469|NCT00619983|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65352503|NCT04144023|Molgramostim|molgramostim|mesh-list
65352504|NCT04144023|Vaccines|vaccines|mesh-list
65352505|NCT04144023|Sargramostim|sargramostim|mesh-list
65352506|NCT04144023|Immunologic Factors|immunologic factors|mesh-ancestor
65352507|NCT04144023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744632|NCT01813422|Evolocumab|evolocumab|mesh-list
65352570|NCT00752154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352571|NCT00752154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65352572|NCT00752154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65352573|NCT00752154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352574|NCT00752154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352575|NCT00752154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352576|NCT00943228|Mycophenolic Acid|mycophenolic acid|mesh-list
65352577|NCT00943228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65352578|NCT00943228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352579|NCT00943228|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65352662|NCT00854529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352663|NCT00854529|Growth Inhibitors|growth inhibitors|mesh-ancestor
65352664|NCT00952432|Carbamazepine|carbamazepine|mesh-list
65352665|NCT00952432|Anticonvulsants|anticonvulsants|mesh-ancestor
65352666|NCT00952432|Antimanic Agents|antimanic agents|mesh-ancestor
65352667|NCT00952432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65352668|NCT00952432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65352669|NCT00952432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352670|NCT00952432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65352671|NCT00952432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65352672|NCT00952432|Analgesics|analgesics|mesh-ancestor
65352673|NCT00952432|Sensory System Agents|sensory system agents|mesh-ancestor
65352674|NCT00952432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65352675|NCT00952432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65352676|NCT00952432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65352677|NCT00952432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352678|NCT00952432|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65352679|NCT00952432|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65352680|NCT00861315|Amikacin|amikacin|mesh-list
65352681|NCT00861315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65352682|NCT00861315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65352683|NCT00943540|Lamivudine|lamivudine|mesh-list
65352684|NCT00943540|Emtricitabine|emtricitabine|mesh-list
65352685|NCT00943540|Raltegravir Potassium|raltegravir potassium|mesh-list
65352686|NCT00943540|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65352687|NCT00943540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65352688|NCT00943540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65352689|NCT00943540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352690|NCT00943540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352691|NCT00943540|Antiviral Agents|antiviral agents|mesh-ancestor
65352692|NCT00943540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65352693|NCT00943540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65352694|NCT00943540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65352695|NCT00943540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65352696|NCT00943540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65352697|NCT00943540|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65352732|NCT00943930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65352734|NCT00854763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65352735|NCT00854763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65352736|NCT00854763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65352737|NCT00854763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352738|NCT00854841|Imatinib Mesylate|imatinib mesylate|mesh-list
65352739|NCT00854841|Dasatinib|dasatinib|mesh-list
65352740|NCT00854841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352741|NCT00854841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65352742|NCT00854841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273472|NCT02848157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65273473|NCT02848157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65273474|NCT02848157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273475|NCT02848157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65273476|NCT02848157|Analgesics|analgesics|mesh-ancestor
65352743|NCT00854841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352744|NCT00854919|Antipsychotic Agents|antipsychotic agents|mesh-list
65352745|NCT00854919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65352746|NCT00854919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65352747|NCT00854919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352748|NCT00854919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65352749|NCT02807467|Dexmedetomidine|dexmedetomidine|mesh-list
65352750|NCT02807467|Propofol|propofol|mesh-list
65352751|NCT02807467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65352752|NCT02807467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65352753|NCT02807467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352754|NCT02807467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65352755|NCT02807467|Anesthetics, General|anesthetics, general|mesh-ancestor
65352756|NCT02807467|Anesthetics|anesthetics|mesh-ancestor
65352757|NCT02807467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65352758|NCT02807467|Analgesics|analgesics|mesh-ancestor
65352759|NCT02807467|Sensory System Agents|sensory system agents|mesh-ancestor
65352760|NCT02807467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65352761|NCT02807467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65352762|NCT02807467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64744878|NCT01780974|Vitamins|vitamins|mesh-ancestor
65353220|NCT00756990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353221|NCT00756990|Sensory System Agents|sensory system agents|mesh-ancestor
65353222|NCT00756990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65353224|NCT00957346|Mifepristone|mifepristone|mesh-list
65353225|NCT00957346|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65353226|NCT00957346|Abortifacient Agents|abortifacient agents|mesh-ancestor
65353227|NCT00957346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65353228|NCT00957346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353229|NCT00957346|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65353230|NCT00957346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65353231|NCT00957346|Oxytocics|oxytocics|mesh-ancestor
65353232|NCT00957346|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65353233|NCT00957346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65353234|NCT00957346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65353235|NCT00957346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65353236|NCT00957346|Contraceptive Agents|contraceptive agents|mesh-ancestor
65353237|NCT00957346|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65353238|NCT00957346|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65353239|NCT00957346|Hormone Antagonists|hormone antagonists|mesh-ancestor
65103065|NCT02937779|Tenofovir|tenofovir|mesh-list
65353240|NCT00957346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65353241|NCT00957346|Luteolytic Agents|luteolytic agents|mesh-ancestor
65353242|NCT00957346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65353243|NCT00957346|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65353245|NCT00752544|Antiviral Agents|antiviral agents|mesh-ancestor
65353246|NCT00752544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65353247|NCT00752544|Protease Inhibitors|protease inhibitors|mesh-ancestor
65353248|NCT00752544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353249|NCT00752544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353286|NCT00757380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65353287|NCT00757380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65353288|NCT00757380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65353289|NCT00757380|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65353407|NCT00695864|Serotonin Agents|serotonin agents|mesh-ancestor
65353408|NCT00695864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65353409|NCT00695864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353410|NCT00695864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65353411|NCT00695864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65353412|NCT00695864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65353413|NCT00695864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65353414|NCT00695864|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65353415|NCT00684996|Bevacizumab|bevacizumab|mesh-list
64514469|NCT02721537|Vitamins|vitamins|mesh-ancestor
65353416|NCT00684996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65353417|NCT00684996|Antibodies|antibodies|mesh-list
65353418|NCT00684996|Immunoglobulins|immunoglobulins|mesh-list
65353419|NCT00684996|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65353420|NCT00684996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353421|NCT00684996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65353422|NCT00684996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65353423|NCT00684996|Growth Substances|growth substances|mesh-ancestor
65353424|NCT00684996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353425|NCT00684996|Growth Inhibitors|growth inhibitors|mesh-ancestor
65353426|NCT00684996|Immunologic Factors|immunologic factors|mesh-ancestor
65353427|NCT05325008|Immunoglobulins|immunoglobulins|mesh-list
65353428|NCT05325008|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65353429|NCT05325008|Antibodies|antibodies|mesh-list
65353450|NCT00684762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353451|NCT00753246|Nimotuzumab|nimotuzumab|mesh-list
65353452|NCT00753246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65353453|NCT00753246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353455|NCT00695786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65353456|NCT00695786|Lenalidomide|lenalidomide|mesh-list
65353457|NCT00695786|Antibodies|antibodies|mesh-list
65353458|NCT00695786|Immunoglobulins|immunoglobulins|mesh-list
65353459|NCT00695786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65353460|NCT00695786|Immunologic Factors|immunologic factors|mesh-ancestor
65353461|NCT00695786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353462|NCT00695786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353463|NCT00695786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65353464|NCT00695786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65353465|NCT00695786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65353466|NCT00695786|Growth Substances|growth substances|mesh-ancestor
65353467|NCT00695786|Growth Inhibitors|growth inhibitors|mesh-ancestor
65353468|NCT00753324|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65353469|NCT00753324|Antiviral Agents|antiviral agents|mesh-ancestor
65353470|NCT00753324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65353471|NCT02561520|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65353472|NCT02561520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65353473|NCT00387127|Lapatinib|lapatinib|mesh-list
65353474|NCT00387127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353475|NCT00387127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65353476|NCT00387127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353477|NCT00387127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353478|NCT00683592|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
65353479|NCT00683592|Antidepressive Agents|antidepressive agents|mesh-ancestor
65353480|NCT00683592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65353481|NCT00683592|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65353482|NCT00683592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65353483|NCT00683592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65353593|NCT00553696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353594|NCT05430126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
65353595|NCT05430126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353596|NCT05430126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353598|NCT00958204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65353599|NCT00958204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65353600|NCT00958204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65353601|NCT00958204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353602|NCT00958204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65353603|NCT00958204|Serotonin Agents|serotonin agents|mesh-ancestor
65353604|NCT00958204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353605|NCT00958204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65353606|NCT00958204|Antidepressive Agents|antidepressive agents|mesh-ancestor
65353607|NCT00958204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64745715|NCT01712178|Adalimumab|adalimumab|mesh-list
65353977|NCT03387085|Antidotes|antidotes|mesh-ancestor
65353978|NCT03387085|Protective Agents|protective agents|mesh-ancestor
65353979|NCT03387085|Vitamin B Complex|vitamin b complex|mesh-ancestor
65353980|NCT03387085|Vitamins|vitamins|mesh-ancestor
65353981|NCT03387085|Micronutrients|micronutrients|mesh-ancestor
65353982|NCT00867867|Ferrous fumarate|ferrous fumarate|mesh-list
65353983|NCT00867867|Trace Elements|trace elements|mesh-ancestor
65353984|NCT00867867|Micronutrients|micronutrients|mesh-ancestor
65353985|NCT00867867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353986|NCT00955318|Apomorphine|apomorphine|mesh-list
65353987|NCT00955318|Emetics|emetics|mesh-ancestor
65353988|NCT00955318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353989|NCT00955318|Autonomic Agents|autonomic agents|mesh-ancestor
65273477|NCT02848157|Sensory System Agents|sensory system agents|mesh-ancestor
65273478|NCT02848157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65273479|NCT02848157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65273480|NCT02848157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65273481|NCT02848157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65353990|NCT00955318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65353991|NCT00955318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65353992|NCT00955318|Dopamine Agonists|dopamine agonists|mesh-ancestor
65353993|NCT00955318|Dopamine Agents|dopamine agents|mesh-ancestor
65353995|NCT00955318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353996|NCT00860223|Digoxin|digoxin|mesh-list
65353997|NCT00860223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65353998|NCT00860223|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65353999|NCT00860223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354000|NCT00860223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354129|NCT00755118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65354130|NCT00755118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354132|NCT00755118|Protective Agents|protective agents|mesh-ancestor
65354133|NCT00755118|Vitamin B Complex|vitamin b complex|mesh-ancestor
65354134|NCT00755118|Vitamins|vitamins|mesh-ancestor
65354135|NCT00755118|Micronutrients|micronutrients|mesh-ancestor
65354136|NCT00755352|Pravastatin|pravastatin|mesh-list
65354137|NCT00755352|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65354138|NCT00755352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65354139|NCT00755352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65354140|NCT00755352|Antimetabolites|antimetabolites|mesh-ancestor
65354141|NCT00755352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354142|NCT00755352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65354143|NCT00755352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65354144|NCT00755352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354145|NCT00549640|Methylphenidate|methylphenidate|mesh-list
65354146|NCT00549640|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65354147|NCT00549640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354148|NCT00549640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65354149|NCT00549640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65354150|NCT00549640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65354151|NCT00549640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354152|NCT00549640|Dopamine Agents|dopamine agents|mesh-ancestor
65354153|NCT00549640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354154|NCT03963960|Dialysis Solutions|dialysis solutions|mesh-list
65354155|NCT03963960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65354156|NCT04444804|Rivaroxaban|rivaroxaban|mesh-list
65354157|NCT04444804|Phenprocoumon|phenprocoumon|mesh-list
65354158|NCT04444804|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65354159|NCT04444804|Antithrombins|antithrombins|mesh-ancestor
65354160|NCT04444804|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65354161|NCT04444804|Protease Inhibitors|protease inhibitors|mesh-ancestor
65354162|NCT04444804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354163|NCT04444804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354164|NCT04444804|Anticoagulants|anticoagulants|mesh-ancestor
65354165|NCT05008146|Hydrocortisone|hydrocortisone|mesh-list
65354166|NCT05008146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65354167|NCT05008146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65354168|NCT05008146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65354169|NCT05008146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65354170|NCT00863577|Bemiparin|bemiparin|mesh-list
65354171|NCT00863577|Anticoagulants|anticoagulants|mesh-ancestor
65354172|NCT00868413|Cyclophosphamide|cyclophosphamide|mesh-list
65354173|NCT00868413|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65354174|NCT00868413|Rituximab|rituximab|mesh-list
65354175|NCT00868413|Fludarabine|fludarabine|mesh-list
65354176|NCT00868413|Navitoclax|navitoclax|mesh-list
65354229|NCT00868569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65354230|NCT00868569|Immunologic Factors|immunologic factors|mesh-ancestor
65354231|NCT00868569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354232|NCT00868569|Antidotes|antidotes|mesh-ancestor
65354233|NCT00868569|Protective Agents|protective agents|mesh-ancestor
65354234|NCT00868569|Vitamin B Complex|vitamin b complex|mesh-ancestor
65354235|NCT00868569|Vitamins|vitamins|mesh-ancestor
65354236|NCT00868569|Micronutrients|micronutrients|mesh-ancestor
65354237|NCT00863733|Acetic Acid|acetic acid|mesh-list
65273482|NCT02848157|Adrenergic Agents|adrenergic agents|mesh-ancestor
65273483|NCT02848157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354238|NCT00863733|Vadimezan|vadimezan|mesh-list
65354239|NCT00863733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65354240|NCT00863733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65354241|NCT00863733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65354242|NCT00549562|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65354243|NCT00549562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65354244|NCT00549562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65354245|NCT00549562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65354246|NCT00549562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354247|NCT00549562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65354248|NCT00549562|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65354249|NCT00549562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65354250|NCT00549562|Serotonin Agents|serotonin agents|mesh-ancestor
65354251|NCT00549562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354252|NCT00549562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746353|NCT01531998|Hormones|hormones|mesh-ancestor
65354322|NCT00677352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65354323|NCT00677352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354324|NCT00677352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354326|NCT00677352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354327|NCT00677352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65354328|NCT00677352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65354329|NCT00677352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65354330|NCT00677352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354331|NCT00864045|Olanzapine|olanzapine|mesh-list
65104207|NCT02921204|Vitamin D|vitamin d|mesh-list
65354366|NCT03680352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65354367|NCT03680352|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65354368|NCT03680352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354369|NCT03680352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354370|NCT00864201|Bosentan|bosentan|mesh-list
65354732|NCT00872625|Antimetabolites|antimetabolites|mesh-ancestor
65354733|NCT00872625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65354734|NCT00872625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65354735|NCT00872625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65354737|NCT00872625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354738|NCT00872781|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65354739|NCT00872781|Quinapril|quinapril|mesh-list
65354740|NCT00872781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65354741|NCT00872781|Diuretics|diuretics|mesh-ancestor
65354852|NCT00760968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65354853|NCT00369967|Contraceptive Agents|contraceptive agents|mesh-list
65354854|NCT00369967|NuvaRing|nuvaring|mesh-list
65354855|NCT00369967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65354856|NCT00369967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354857|NCT00369967|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65354858|NCT00878865|Alprazolam|alprazolam|mesh-list
65354859|NCT00878865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65354860|NCT00878865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65354861|NCT00878865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354862|NCT00878865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65354863|NCT00878865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65354864|NCT00878865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65354865|NCT00878865|GABA Modulators|gaba modulators|mesh-ancestor
65354866|NCT00878865|GABA Agents|gaba agents|mesh-ancestor
65354867|NCT00878865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354868|NCT00878865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354869|NCT00873483|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65354870|NCT00873483|Gestodene|gestodene|mesh-list
65354871|NCT00873483|Femovan|femovan|mesh-list
65354872|NCT00873483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65354873|NCT00873483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65354874|NCT00873483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65354875|NCT00873483|Contraceptive Agents|contraceptive agents|mesh-ancestor
65354876|NCT00873483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65354877|NCT00873483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354878|NCT00873483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65354908|NCT02534467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354910|NCT01050595|Bromides|bromides|mesh-list
65354911|NCT01050595|Methylnaltrexone|methylnaltrexone|mesh-list
65354912|NCT01050595|Anticonvulsants|anticonvulsants|mesh-ancestor
64514496|NCT02716311|Afatinib|afatinib|mesh-list
64514498|NCT02716311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65354913|NCT01050595|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65354914|NCT01050595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354915|NCT01050595|Sensory System Agents|sensory system agents|mesh-ancestor
65354916|NCT01050595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65354917|NCT01050595|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65354918|NCT00878943|Sildenafil Citrate|sildenafil citrate|mesh-list
65354919|NCT00878943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354920|NCT00878943|Vasodilator Agents|vasodilator agents|mesh-ancestor
65354921|NCT00878943|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64747017|NCT01458210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64747060|NCT01454934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65354993|NCT00676338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354994|NCT00676338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65354996|NCT02534623|Bupivacaine|bupivacaine|mesh-list
65354997|NCT02534623|Anesthetics|anesthetics|mesh-list
65355060|NCT00761358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65355061|NCT00761358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355062|NCT00761358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65355063|NCT00879723|Vitamins|vitamins|mesh-list
65355064|NCT00879723|Micronutrients|micronutrients|mesh-ancestor
65355065|NCT00879723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355066|NCT00874419|Gemcitabine|gemcitabine|mesh-list
65355067|NCT00874419|Carboplatin|carboplatin|mesh-list
65355068|NCT00874419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65355069|NCT00874419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355070|NCT00874419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65355128|NCT00874653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65355129|NCT00874653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65355130|NCT00369577|Loxapine|loxapine|mesh-list
65355131|NCT00369577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65355132|NCT00369577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65355133|NCT00369577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65355134|NCT00369577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355135|NCT00369577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65355136|NCT00369577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65355137|NCT00369577|Dopamine Agents|dopamine agents|mesh-ancestor
65355138|NCT00369577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65355139|NCT00369577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355140|NCT00879957|Heparin|heparin|mesh-list
65355141|NCT00879957|Calcium heparin|calcium heparin|mesh-list
65355142|NCT00879957|Anticoagulants|anticoagulants|mesh-ancestor
65355143|NCT00879957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65355144|NCT00879957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65355145|NCT00879957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355146|NCT00874809|Insulin|insulin|mesh-list
65355147|NCT00874809|Insulin, Short-Acting|insulin, short-acting|mesh-list
65355148|NCT00874809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65355182|NCT00880815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355183|NCT00880815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355185|NCT00880815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65355186|NCT00880815|Abortifacient Agents|abortifacient agents|mesh-ancestor
65355187|NCT00880815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65355188|NCT00880815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65355189|NCT00880815|Antimetabolites|antimetabolites|mesh-ancestor
65355190|NCT00880815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355191|NCT00880815|Dermatologic Agents|dermatologic agents|mesh-ancestor
65355192|NCT00880815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355220|NCT00881127|Histamine Antagonists|histamine antagonists|mesh-ancestor
65355221|NCT00881127|Histamine Agents|histamine agents|mesh-ancestor
65355222|NCT00881127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65355223|NCT00881127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355224|NCT00881127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355225|NCT00881127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65355226|NCT00881127|Autonomic Agents|autonomic agents|mesh-ancestor
65355227|NCT00881127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65355228|NCT00881127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65355229|NCT00881127|Respiratory System Agents|respiratory system agents|mesh-ancestor
65355230|NCT00881127|Nasal Decongestants|nasal decongestants|mesh-ancestor
65355231|NCT00881127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65355232|NCT00881127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65355233|NCT00881127|Sympathomimetics|sympathomimetics|mesh-ancestor
65355234|NCT00881127|Adrenergic Agents|adrenergic agents|mesh-ancestor
65355235|NCT00369265|Lansoprazole|lansoprazole|mesh-list
65355236|NCT00369265|Dexlansoprazole|dexlansoprazole|mesh-list
65355259|NCT00368875|Antimitotic Agents|antimitotic agents|mesh-ancestor
65355260|NCT00368875|Mitosis Modulators|mitosis modulators|mesh-ancestor
65355261|NCT00368875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355262|NCT00368875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65355263|NCT00368875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65355264|NCT00368875|Growth Substances|growth substances|mesh-ancestor
65355265|NCT00368875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355266|NCT00368875|Growth Inhibitors|growth inhibitors|mesh-ancestor
65355267|NCT00368875|Immunologic Factors|immunologic factors|mesh-ancestor
65355268|NCT00368875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65355269|NCT00368875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355271|NCT00614055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65355272|NCT00614055|Metformin|metformin|mesh-list
65355273|NCT00614055|Insulin Glargine|insulin glargine|mesh-list
65355274|NCT00614055|Insulin Aspart|insulin aspart|mesh-list
65355275|NCT00614055|Insulin, Long-Acting|insulin, long-acting|mesh-list
65355276|NCT00614055|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65355277|NCT00614055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65355278|NCT00614055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355279|NCT00613821|Lidocaine|lidocaine|mesh-list
65355280|NCT00613821|Anesthetics, Local|anesthetics, local|mesh-ancestor
65355281|NCT00613821|Anesthetics|anesthetics|mesh-ancestor
65355282|NCT00613821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65355283|NCT00613821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355284|NCT00613821|Sensory System Agents|sensory system agents|mesh-ancestor
65355285|NCT00613821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65355286|NCT00613821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65355287|NCT00613821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65355288|NCT00613821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65355289|NCT00613821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65355301|NCT00882765|Estrogens|estrogens|mesh-ancestor
65355302|NCT00882765|Hormones|hormones|mesh-ancestor
65355303|NCT00882765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65355304|NCT00548548|Bevacizumab|bevacizumab|mesh-list
65355305|NCT00548548|Fluorouracil|fluorouracil|mesh-list
65355306|NCT00548548|Capecitabine|capecitabine|mesh-list
65355307|NCT00548548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65355308|NCT00548548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355309|NCT00548548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65355310|NCT00548548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65355311|NCT00548548|Growth Substances|growth substances|mesh-ancestor
65355312|NCT00548548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355313|NCT00548548|Growth Inhibitors|growth inhibitors|mesh-ancestor
65355314|NCT00548548|Antimetabolites|antimetabolites|mesh-ancestor
65355315|NCT00548548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355316|NCT00548548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65355317|NCT00548548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65355318|NCT00548548|Immunologic Factors|immunologic factors|mesh-ancestor
65355319|NCT00613509|Interferons|interferons|mesh-list
65355320|NCT00613509|Interferon-alpha|interferon-alpha|mesh-list
65355321|NCT00613509|Vaccines|vaccines|mesh-list
65355322|NCT00613509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355323|NCT00613509|Antiviral Agents|antiviral agents|mesh-ancestor
65355324|NCT00613509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65355325|NCT00613509|Immunologic Factors|immunologic factors|mesh-ancestor
65355326|NCT00613509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355327|NCT00881517|Immunoglobulins|immunoglobulins|mesh-list
65355328|NCT00881517|Immunologic Factors|immunologic factors|mesh-ancestor
65355329|NCT00881517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355330|NCT00881595|Temozolomide|temozolomide|mesh-list
65355331|NCT00881595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65355332|NCT00881595|Alkylating Agents|alkylating agents|mesh-ancestor
65355333|NCT00881595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105174|NCT00534261|Antiviral Agents|antiviral agents|mesh-ancestor
65355334|NCT00881595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355336|NCT00883155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65355337|NCT00883155|Antidepressive Agents|antidepressive agents|mesh-ancestor
65355338|NCT00883155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65355339|NCT00883155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65355340|NCT00883155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65355341|NCT00883155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65273484|NCT02848157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273485|NCT02848157|Anesthetics, Local|anesthetics, local|mesh-ancestor
65273486|NCT02848157|Anesthetics|anesthetics|mesh-ancestor
65355342|NCT00883155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355343|NCT00883155|Dopamine Agents|dopamine agents|mesh-ancestor
65355344|NCT00883155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65355345|NCT00883155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355346|NCT00883155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65355347|NCT00883155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65355348|NCT00883155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355349|NCT00881673|Dexamethasone|dexamethasone|mesh-list
65355350|NCT00881673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64747420|NCT01445886|Calcitriol|calcitriol|mesh-list
65355420|NCT00958750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65355421|NCT00958750|Vasodilator Agents|vasodilator agents|mesh-ancestor
65355423|NCT00958906|Dermatologic Agents|dermatologic agents|mesh-ancestor
65355424|NCT00958906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65355425|NCT00958906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65355480|NCT00882453|Immunologic Factors|immunologic factors|mesh-ancestor
65355481|NCT00882453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355482|NCT00882453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65355484|NCT00882531|Dermatologic Agents|dermatologic agents|mesh-ancestor
65355485|NCT00963274|Bortezomib|bortezomib|mesh-list
65355486|NCT00963274|Romidepsin|romidepsin|mesh-list
65355487|NCT00963274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355488|NCT00963274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65355489|NCT00882609|Fluorides|fluorides|mesh-list
65355490|NCT00882609|Cariostatic Agents|cariostatic agents|mesh-ancestor
65355491|NCT00882609|Protective Agents|protective agents|mesh-ancestor
65355492|NCT00882609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355493|NCT00883623|Lenalidomide|lenalidomide|mesh-list
65355494|NCT00883623|Immunologic Factors|immunologic factors|mesh-ancestor
65355495|NCT00883623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355496|NCT00883623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65355497|NCT00883623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65355498|NCT00883623|Growth Substances|growth substances|mesh-ancestor
65355499|NCT00883623|Growth Inhibitors|growth inhibitors|mesh-ancestor
65355500|NCT00883623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355501|NCT00959218|Dronabinol|dronabinol|mesh-list
65355502|NCT00959218|Hallucinogens|hallucinogens|mesh-ancestor
65355503|NCT00959218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355504|NCT00959218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65355505|NCT00959218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65355506|NCT00959218|Analgesics|analgesics|mesh-ancestor
65355507|NCT00959218|Sensory System Agents|sensory system agents|mesh-ancestor
65355508|NCT00959218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65355509|NCT00959218|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65355510|NCT00959218|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65355511|NCT00959218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65355512|NCT00959218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355513|NCT00959218|Hormones|hormones|mesh-ancestor
65355514|NCT00959218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65355515|NCT00678210|Tofacitinib|tofacitinib|mesh-list
64516415|NCT04349410|Antimetabolites|antimetabolites|mesh-ancestor
65355575|NCT00963664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355577|NCT00611559|Anticoagulants|anticoagulants|mesh-ancestor
65355578|NCT00611559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65355579|NCT00611559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65355580|NCT00611559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355581|NCT00761904|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65355582|NCT00761904|Simvastatin|simvastatin|mesh-list
65355583|NCT00761904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65355584|NCT00761904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65355585|NCT00761904|Antimetabolites|antimetabolites|mesh-ancestor
65355586|NCT00761904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355587|NCT00761904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65355683|NCT00672984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65355684|NCT00672984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355685|NCT00672984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355686|NCT00672984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355687|NCT00672984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355688|NCT00672984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65273487|NCT04211844|Sofosbuvir|sofosbuvir|mesh-list
65273488|NCT04211844|Ledipasvir|ledipasvir|mesh-list
65355689|NCT00672984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65355690|NCT00672984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65355691|NCT00672984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65355692|NCT00672984|Adrenergic Agents|adrenergic agents|mesh-ancestor
65355693|NCT00672984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65355694|NCT02543697|Epinephrine|epinephrine|mesh-list
65355695|NCT02543697|Racepinephrine|racepinephrine|mesh-list
65355696|NCT02543697|Epinephryl borate|epinephryl borate|mesh-list
65355697|NCT02543697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65355698|NCT02543697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65355699|NCT02543697|Adrenergic Agents|adrenergic agents|mesh-ancestor
65355700|NCT02543697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65355701|NCT02543697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355702|NCT02543697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355703|NCT02543697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65355704|NCT02543697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65355705|NCT02543697|Autonomic Agents|autonomic agents|mesh-ancestor
65355706|NCT02543697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65355707|NCT02543697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65355708|NCT02543697|Respiratory System Agents|respiratory system agents|mesh-ancestor
65355710|NCT02543697|Sympathomimetics|sympathomimetics|mesh-ancestor
65355711|NCT02543697|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65355712|NCT00886275|Midazolam|midazolam|mesh-list
65355713|NCT00886275|Dexmedetomidine|dexmedetomidine|mesh-list
65355714|NCT00886275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65355715|NCT00886275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65355818|NCT00964756|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65355819|NCT00964756|Antiviral Agents|antiviral agents|mesh-ancestor
65355820|NCT00964756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65355821|NCT00964756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65355822|NCT00964756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355823|NCT00964756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355824|NCT00964834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65355825|NCT00964834|Doxycycline|doxycycline|mesh-list
65355826|NCT00964834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65355827|NCT00964834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65355828|NCT00964834|Antitubercular Agents|antitubercular agents|mesh-ancestor
65355829|NCT00964834|Antimalarials|antimalarials|mesh-ancestor
65355830|NCT00964834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65355831|NCT00964834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65355832|NCT00612105|Ezogabine|ezogabine|mesh-list
65355833|NCT00612105|Anticonvulsants|anticonvulsants|mesh-ancestor
65355834|NCT00612105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65355869|NCT00546052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65355870|NCT00546052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65355871|NCT00546052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65355872|NCT00546052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355900|NCT00887757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65355902|NCT00887757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65355903|NCT00887757|Immunologic Factors|immunologic factors|mesh-ancestor
65355904|NCT00887757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355905|NCT04392921|Amiodarone|amiodarone|mesh-list
65355906|NCT04392921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65355907|NCT04392921|Vasodilator Agents|vasodilator agents|mesh-ancestor
65355908|NCT04392921|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65355909|NCT04392921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65355910|NCT04392921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355911|NCT04392921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65355912|NCT04392921|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65355913|NCT04392921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65355914|NCT04392921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355915|NCT04392921|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65355916|NCT04392921|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65355946|NCT00379795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355947|NCT04588948|Aflibercept|aflibercept|mesh-list
65355948|NCT04588948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65355949|NCT04588948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65355950|NCT04588948|Growth Substances|growth substances|mesh-ancestor
65355951|NCT04588948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355952|NCT04588948|Growth Inhibitors|growth inhibitors|mesh-ancestor
65355953|NCT04588948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273489|NCT04211844|Antiviral Agents|antiviral agents|mesh-ancestor
65273490|NCT04211844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65355954|NCT00765024|Ivermectin|ivermectin|mesh-list
65355955|NCT00765024|Albendazole|albendazole|mesh-list
65355956|NCT00765024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65355957|NCT00765024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65355958|NCT00765024|Anthelmintics|anthelmintics|mesh-ancestor
65355959|NCT00765024|Anticestodal Agents|anticestodal agents|mesh-ancestor
65355960|NCT00765024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65355961|NCT00765024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65355962|NCT00765024|Tubulin Modulators|tubulin modulators|mesh-ancestor
65355992|NCT04577014|Mitosis Modulators|mitosis modulators|mesh-ancestor
65355993|NCT05282550|Trazodone|trazodone|mesh-list
65355994|NCT05282550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65355995|NCT05282550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65355996|NCT05282550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65355997|NCT05282550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355998|NCT05282550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65355999|NCT05282550|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65356000|NCT05282550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65356001|NCT05282550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65356002|NCT05282550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356003|NCT05282550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65356004|NCT05282550|Serotonin Agents|serotonin agents|mesh-ancestor
65356005|NCT05282550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65356006|NCT05282550|Antidepressive Agents|antidepressive agents|mesh-ancestor
65356007|NCT00960310|Bicalutamide|bicalutamide|mesh-list
65356008|NCT00960310|Androgen Antagonists|androgen antagonists|mesh-ancestor
65356081|NCT00379639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356082|NCT00379639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356083|NCT00379639|Antiviral Agents|antiviral agents|mesh-ancestor
65356084|NCT00379639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65356085|NCT00379639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356086|NCT00379639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65356087|NCT00379639|Immunologic Factors|immunologic factors|mesh-ancestor
65356088|NCT00379639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356089|NCT00379639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65356090|NCT00609765|Dexamethasone|dexamethasone|mesh-list
65356091|NCT00609765|Bevacizumab|bevacizumab|mesh-list
65356092|NCT00609765|Doxorubicin|doxorubicin|mesh-list
65356093|NCT00609765|Fluorouracil|fluorouracil|mesh-list
65356094|NCT00609765|Streptozocin|streptozocin|mesh-list
65356095|NCT00609765|Ondansetron|ondansetron|mesh-list
65356096|NCT00609765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65356097|NCT00609765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356098|NCT00609765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65356099|NCT00609765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65356100|NCT00609765|Growth Substances|growth substances|mesh-ancestor
65356101|NCT00609765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356102|NCT00609765|Growth Inhibitors|growth inhibitors|mesh-ancestor
65356103|NCT00609765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65356104|NCT00609765|Antiemetics|antiemetics|mesh-ancestor
65356105|NCT00609765|Autonomic Agents|autonomic agents|mesh-ancestor
65356106|NCT00609765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65356107|NCT00609765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65356108|NCT00609765|Glucocorticoids|glucocorticoids|mesh-ancestor
65356110|NCT00609765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65356111|NCT00609765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65356112|NCT00609765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65356113|NCT00609765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65356114|NCT00609765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65356115|NCT00609765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356116|NCT00609765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356117|NCT00609765|Antimetabolites|antimetabolites|mesh-ancestor
65356118|NCT00609765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65356119|NCT00609765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65356120|NCT00609765|Immunologic Factors|immunologic factors|mesh-ancestor
65356121|NCT00609765|Antipruritics|antipruritics|mesh-ancestor
65356122|NCT00609765|Dermatologic Agents|dermatologic agents|mesh-ancestor
65356123|NCT00609765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65356124|NCT00609765|Serotonin Agents|serotonin agents|mesh-ancestor
65356125|NCT00609765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65356126|NCT00609765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65356127|NCT00609765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64471657|NCT04267887|Ascorbic Acid|ascorbic acid|mesh-list
65356128|NCT00609765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65356129|NCT00609765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65356130|NCT00609765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65356131|NCT01051219|Losartan|losartan|mesh-list
65356132|NCT01051219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65356152|NCT00766350|Analgesics|analgesics|mesh-ancestor
65356153|NCT00766350|Sensory System Agents|sensory system agents|mesh-ancestor
65106008|NCT00535860|Teriparatide|teriparatide|mesh-list
65356154|NCT00766350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65356155|NCT00766350|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65356156|NCT00766350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65356157|NCT00766350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65356158|NCT00766350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356159|NCT00766350|Adrenergic Agents|adrenergic agents|mesh-ancestor
65356160|NCT00766350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65356162|NCT00889161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65356163|NCT00889161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65356164|NCT00889161|Analgesics|analgesics|mesh-ancestor
65356165|NCT00889161|Sensory System Agents|sensory system agents|mesh-ancestor
65356166|NCT00889161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65356167|NCT00889161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356168|NCT00889161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65356169|NCT00889161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65356170|NCT00889161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356171|NCT00889161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356172|NCT00889161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356173|NCT03992755|Treprostinil|treprostinil|mesh-list
65356174|NCT03992755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65356175|NCT01563328|Dolutegravir|dolutegravir|mesh-list
65356176|NCT01563328|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65356177|NCT01563328|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65356178|NCT01563328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356179|NCT01563328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356180|NCT01563328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65356181|NCT01563328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65356182|NCT01563328|Antiviral Agents|antiviral agents|mesh-ancestor
65356183|NCT01563328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65356184|NCT00760032|Ciprofloxacin|ciprofloxacin|mesh-list
65356185|NCT00760032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65356218|NCT00965926|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65356219|NCT00965926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65356220|NCT00965926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65356221|NCT00965926|Adrenergic Agents|adrenergic agents|mesh-ancestor
65356222|NCT00965926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65356223|NCT00965926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356224|NCT00965926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356225|NCT00965926|Urological Agents|urological agents|mesh-ancestor
65356253|NCT00889629|Vitamins|vitamins|mesh-ancestor
65356254|NCT00889629|Micronutrients|micronutrients|mesh-ancestor
65356255|NCT00889629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356256|NCT00889629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65356257|NCT00889629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65356258|NCT00966160|Ritonavir|ritonavir|mesh-list
65356259|NCT00966160|Lopinavir|lopinavir|mesh-list
65356260|NCT00966160|Lamivudine|lamivudine|mesh-list
65356261|NCT00966160|Zidovudine|zidovudine|mesh-list
65356262|NCT00966160|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
65356263|NCT00966160|Efavirenz|efavirenz|mesh-list
65356264|NCT00966160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65356265|NCT00966160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65356266|NCT00966160|Protease Inhibitors|protease inhibitors|mesh-ancestor
65356267|NCT00966160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356268|NCT00966160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356269|NCT00966160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65356270|NCT00966160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65356271|NCT00966160|Antiviral Agents|antiviral agents|mesh-ancestor
65356272|NCT00966160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65356273|NCT00966160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65356322|NCT00766896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65356323|NCT00766896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356324|NCT00766896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65356325|NCT00766896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65356326|NCT00766896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65273491|NCT00002981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65356327|NCT00766896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65356328|NCT00766896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356329|NCT00766896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65356330|NCT00766896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65356331|NCT00766896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356332|NCT00766896|Antipyretics|antipyretics|mesh-ancestor
65356333|NCT00763620|Dimercaprol|dimercaprol|mesh-list
65356334|NCT00763620|Chelating Agents|chelating agents|mesh-ancestor
65356335|NCT00763620|Sequestering Agents|sequestering agents|mesh-ancestor
65356336|NCT00763620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356337|NCT00973804|Sirolimus|sirolimus|mesh-list
65356338|NCT00973804|Tacrolimus|tacrolimus|mesh-list
65356339|NCT00973804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65356340|NCT00973804|Immunologic Factors|immunologic factors|mesh-ancestor
65356341|NCT00973804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356342|NCT00973804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65356343|NCT00973804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356344|NCT00973804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356345|NCT00973804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65356346|NCT00973804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65356347|NCT00973804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65356348|NCT00973804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356349|NCT00973804|Antifungal Agents|antifungal agents|mesh-ancestor
65356350|NCT04018131|Cimetidine|cimetidine|mesh-list
65356351|NCT04018131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65356352|NCT04018131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65356353|NCT04018131|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65356354|NCT04018131|Histamine Antagonists|histamine antagonists|mesh-ancestor
65356355|NCT04018131|Histamine Agents|histamine agents|mesh-ancestor
65356356|NCT04018131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65356357|NCT04018131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356358|NCT04018131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356359|NCT04018131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65356360|NCT04018131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65356361|NCT04018131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356362|NCT00973882|Carboplatin|carboplatin|mesh-list
65356363|NCT00973882|Etoposide|etoposide|mesh-list
65356364|NCT00973882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356365|NCT00973882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65356393|NCT05279482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65356394|NCT05279482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356395|NCT05279482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65356396|NCT05279482|Glucocorticoids|glucocorticoids|mesh-ancestor
65356397|NCT05279482|Hormones|hormones|mesh-ancestor
65356398|NCT05279482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65356399|NCT05279482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65356400|NCT05279482|Protective Agents|protective agents|mesh-ancestor
65356401|NCT05279482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65356402|NCT05279482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356403|NCT00890175|Loxapine|loxapine|mesh-list
65356404|NCT00890175|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65356405|NCT00890175|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65356406|NCT00890175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65356407|NCT00890175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356408|NCT00890175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65356409|NCT00890175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65356410|NCT00890175|Dopamine Agents|dopamine agents|mesh-ancestor
65356483|NCT00608517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356484|NCT00608517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356485|NCT00608517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65356513|NCT00966706|Antimitotic Agents|antimitotic agents|mesh-ancestor
65356514|NCT00966706|Mitosis Modulators|mitosis modulators|mesh-ancestor
65356515|NCT00966706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65356516|NCT00966706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65356517|NCT00966706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65356518|NCT00893061|Tamoxifen|tamoxifen|mesh-list
65356519|NCT00893061|Letrozole|letrozole|mesh-list
65356520|NCT00893061|Anastrozole|anastrozole|mesh-list
65106377|NCT00536861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356521|NCT00893061|Exemestane|exemestane|mesh-list
65356522|NCT00893061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356523|NCT00893061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356524|NCT00893061|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64471659|NCT04267887|Cortisone|cortisone|mesh-list
64711841|NCT05020899|Nicotine|nicotine|mesh-list
65356525|NCT00893061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65356526|NCT00893061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356527|NCT00893061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65356528|NCT00893061|Hormone Antagonists|hormone antagonists|mesh-ancestor
65356529|NCT00893061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65356530|NCT00893061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356531|NCT00893061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65356532|NCT00893061|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65356533|NCT00893061|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65356569|NCT00608205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65356570|NCT00608205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65356571|NCT00608205|Immunologic Factors|immunologic factors|mesh-ancestor
65356572|NCT00608205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356573|NCT00974740|Atorvastatin|atorvastatin|mesh-list
65356588|NCT05227300|Anesthetics|anesthetics|mesh-ancestor
65356589|NCT05227300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65356590|NCT05227300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356591|NCT05227300|Sensory System Agents|sensory system agents|mesh-ancestor
65356592|NCT05227300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65356593|NCT05227300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65356594|NCT05227300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65356595|NCT05227300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65356596|NCT05227300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65106451|NCT03457194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356597|NCT05227300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356598|NCT05227300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65356599|NCT05227300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65356600|NCT05227300|Adrenergic Agents|adrenergic agents|mesh-ancestor
65356601|NCT05227300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65356602|NCT05227300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65356603|NCT05227300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65356604|NCT05227300|Autonomic Agents|autonomic agents|mesh-ancestor
65356605|NCT05227300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65356606|NCT05227300|Respiratory System Agents|respiratory system agents|mesh-ancestor
65356607|NCT05227300|Mydriatics|mydriatics|mesh-ancestor
65356608|NCT05227300|Sympathomimetics|sympathomimetics|mesh-ancestor
65356609|NCT05227300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65356610|NCT00890487|Hyaluronic Acid|hyaluronic acid|mesh-list
65356611|NCT00890487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65356612|NCT00890487|Immunologic Factors|immunologic factors|mesh-ancestor
65356613|NCT00890487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356614|NCT00890487|Viscosupplements|viscosupplements|mesh-ancestor
65356615|NCT00890487|Protective Agents|protective agents|mesh-ancestor
65356616|NCT00890565|Granisetron|granisetron|mesh-list
65356617|NCT00890565|Antiemetics|antiemetics|mesh-ancestor
65356618|NCT00890565|Autonomic Agents|autonomic agents|mesh-ancestor
65356619|NCT00890565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65356620|NCT00890565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356621|NCT00890565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65356622|NCT00890565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65356623|NCT00890565|Serotonin Agents|serotonin agents|mesh-ancestor
65356624|NCT00890565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65356625|NCT00890565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356627|NCT00890643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65356628|NCT00890643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65356629|NCT00890643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65356630|NCT00890643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65356631|NCT00890643|Adrenergic Agents|adrenergic agents|mesh-ancestor
65356632|NCT00890643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65356633|NCT00890643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356662|NCT00764166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356664|NCT00764166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65356665|NCT00764166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356666|NCT00770406|Botulinum Toxins|botulinum toxins|mesh-list
65356667|NCT00770406|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65356668|NCT00770406|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65356669|NCT00770406|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65356670|NCT00770406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64712466|NCT04300647|Atezolizumab|atezolizumab|mesh-list
64712522|NCT04195633|Cyclosporine|cyclosporine|mesh-list
64712523|NCT04195633|Mycophenolic Acid|mycophenolic acid|mesh-list
64712524|NCT04195633|Cyclophosphamide|cyclophosphamide|mesh-list
65106528|NCT05226871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356671|NCT00770406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356672|NCT00770406|Cholinergic Agents|cholinergic agents|mesh-ancestor
65356673|NCT00770406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65356674|NCT00770406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356675|NCT00770406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65356676|NCT00770406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65356677|NCT02557542|Polidocanol|polidocanol|mesh-list
65356678|NCT02557542|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
65356696|NCT00764244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65356697|NCT00764244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65356698|NCT00764244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65356699|NCT00764244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65356700|NCT00764244|Glucocorticoids|glucocorticoids|mesh-ancestor
65356702|NCT00764244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65356703|NCT00764244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356704|NCT00764244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65356705|NCT00764244|Immunologic Factors|immunologic factors|mesh-ancestor
65356706|NCT00764244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356707|NCT00764244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356708|NCT00770640|Insulin|insulin|mesh-list
65356709|NCT00770640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65356710|NCT00770640|Pioglitazone|pioglitazone|mesh-list
65356711|NCT00770640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65356712|NCT00770640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356713|NCT00770718|Thrombin|thrombin|mesh-list
65356714|NCT00770718|Hemostatics|hemostatics|mesh-ancestor
65356715|NCT00770718|Coagulants|coagulants|mesh-ancestor
65356716|NCT00770796|Atorvastatin|atorvastatin|mesh-list
65356717|NCT00770796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65356718|NCT00770796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65356719|NCT00770796|Antimetabolites|antimetabolites|mesh-ancestor
65356720|NCT00770796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356721|NCT00770796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65356722|NCT00770796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65356723|NCT00770796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356724|NCT00545740|Mesalamine|mesalamine|mesh-list
65356725|NCT00545740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65356726|NCT00545740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65356727|NCT00545740|Analgesics|analgesics|mesh-ancestor
65356728|NCT00545740|Sensory System Agents|sensory system agents|mesh-ancestor
65356729|NCT00545740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65356730|NCT00545740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356731|NCT00545740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65356732|NCT00545740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65356733|NCT05208190|Clozapine|clozapine|mesh-list
65356734|NCT05208190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65356770|NCT00673452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65356792|NCT00967252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356794|NCT00967252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65356795|NCT00967252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356796|NCT00890955|Cyclophosphamide|cyclophosphamide|mesh-list
65356797|NCT00890955|Amrubicin|amrubicin|mesh-list
65356798|NCT00890955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65356799|NCT00890955|Immunologic Factors|immunologic factors|mesh-ancestor
65356800|NCT00890955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356801|NCT00890955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65356802|NCT00890955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65356803|NCT00890955|Alkylating Agents|alkylating agents|mesh-ancestor
65356804|NCT00890955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356805|NCT00890955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356806|NCT00890955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65356807|NCT00975052|Metformin|metformin|mesh-list
65356808|NCT00975052|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65356809|NCT00975052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65356810|NCT00975052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356811|NCT00975052|Incretins|incretins|mesh-ancestor
65356812|NCT00975052|Hormones|hormones|mesh-ancestor
65356813|NCT00975052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65356814|NCT00975052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65356815|NCT00975052|Protease Inhibitors|protease inhibitors|mesh-ancestor
65356816|NCT00975052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356817|NCT00975052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356818|NCT00891033|Bortezomib|bortezomib|mesh-list
65356819|NCT00891033|Panobinostat|panobinostat|mesh-list
65356820|NCT00891033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356821|NCT00891033|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65356822|NCT00891033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748914|NCT04196946|Fentanyl|fentanyl|mesh-list
65356843|NCT00968578|Autonomic Agents|autonomic agents|mesh-ancestor
65356844|NCT00968578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65356845|NCT00968578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356846|NCT00968578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65356847|NCT00968578|Glucocorticoids|glucocorticoids|mesh-ancestor
65356848|NCT00968578|Hormones|hormones|mesh-ancestor
65356849|NCT00968578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65356850|NCT00968578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65356851|NCT00968578|Protective Agents|protective agents|mesh-ancestor
65356852|NCT00968578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65356853|NCT00968578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356854|NCT00893373|Sorafenib|sorafenib|mesh-list
65356855|NCT00893373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356856|NCT00893373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65356857|NCT00893373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356858|NCT00893373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356859|NCT00891267|Amlodipine|amlodipine|mesh-list
65356860|NCT00891267|Olmesartan|olmesartan|mesh-list
65356861|NCT00891267|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65356862|NCT00891267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65356863|NCT00891267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65356864|NCT00891267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65356865|NCT00891267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356866|NCT00891267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65356867|NCT00891267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356868|NCT00891267|Vasodilator Agents|vasodilator agents|mesh-ancestor
65356869|NCT00891267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65356870|NCT00891267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65356871|NCT00545584|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65356872|NCT00545584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65356873|NCT00545584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356874|NCT00545584|Incretins|incretins|mesh-ancestor
65356875|NCT00545584|Hormones|hormones|mesh-ancestor
65356876|NCT00545584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65356877|NCT00545584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65356903|NCT00378703|Antifungal Agents|antifungal agents|mesh-ancestor
65356904|NCT00378703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65356905|NCT00893451|Vitamin D|vitamin d|mesh-list
65356906|NCT00893451|Cholecalciferol|cholecalciferol|mesh-list
65356907|NCT00893451|Vitamins|vitamins|mesh-ancestor
65356908|NCT00893451|Micronutrients|micronutrients|mesh-ancestor
65356909|NCT00893451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356910|NCT00893451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65356911|NCT00893451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65356912|NCT00967408|Citalopram|citalopram|mesh-list
65356913|NCT00967408|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65356914|NCT00967408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65356915|NCT00967408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65356916|NCT00967408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356917|NCT00967408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65356918|NCT00967408|Serotonin Agents|serotonin agents|mesh-ancestor
65356919|NCT00967408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356920|NCT00967408|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65356921|NCT00967408|Antidepressive Agents|antidepressive agents|mesh-ancestor
65356922|NCT00967408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65356923|NCT00891423|Meropenem|meropenem|mesh-list
65356924|NCT00891423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65356925|NCT00891423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65356926|NCT04035382|Misoprostol|misoprostol|mesh-list
65356927|NCT04035382|Oxytocin|oxytocin|mesh-list
64749012|NCT04195074|Tenofovir|tenofovir|mesh-list
65356959|NCT03620643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64953409|NCT00033644|Dacarbazine|dacarbazine|mesh-list
64953483|NCT00033722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954588|NCT00070083|Prednisone|prednisone|mesh-list
64504998|NCT03336840|Metformin|metformin|mesh-list
65356960|NCT03620643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356961|NCT03620643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65356962|NCT03620643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356963|NCT03620643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356964|NCT04008316|Colchicine|colchicine|mesh-list
65356965|NCT04008316|Gout Suppressants|gout suppressants|mesh-ancestor
65356966|NCT04008316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65356967|NCT04008316|Tubulin Modulators|tubulin modulators|mesh-ancestor
65106827|NCT04362527|Milrinone|milrinone|mesh-list
65356968|NCT04008316|Antimitotic Agents|antimitotic agents|mesh-ancestor
65356969|NCT04008316|Mitosis Modulators|mitosis modulators|mesh-ancestor
65356970|NCT04008316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356988|NCT00969046|Mitosis Modulators|mitosis modulators|mesh-ancestor
65356989|NCT00969046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356991|NCT05008354|Vitamin B Complex|vitamin b complex|mesh-ancestor
65356992|NCT05008354|Vitamins|vitamins|mesh-ancestor
65356993|NCT05008354|Micronutrients|micronutrients|mesh-ancestor
65356994|NCT05008354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356995|NCT00975754|Budesonide|budesonide|mesh-list
65356996|NCT00975754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65356997|NCT00975754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65356998|NCT00975754|Autonomic Agents|autonomic agents|mesh-ancestor
65356999|NCT00975754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65357000|NCT00975754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357001|NCT00975754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65357002|NCT00975754|Respiratory System Agents|respiratory system agents|mesh-ancestor
65357003|NCT00975754|Glucocorticoids|glucocorticoids|mesh-ancestor
65357004|NCT00975754|Hormones|hormones|mesh-ancestor
65357005|NCT00975754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65357006|NCT01045681|Dexamethasone|dexamethasone|mesh-list
65357007|NCT01045681|Dexamethasone acetate|dexamethasone acetate|mesh-list
65357008|NCT01045681|Bortezomib|bortezomib|mesh-list
65357009|NCT01045681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65357010|NCT01045681|BB 1101|bb 1101|mesh-list
65357011|NCT01045681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65357012|NCT01045681|Antiemetics|antiemetics|mesh-ancestor
65357013|NCT01045681|Autonomic Agents|autonomic agents|mesh-ancestor
65357014|NCT01045681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65357015|NCT01045681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357016|NCT01045681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65357017|NCT01045681|Glucocorticoids|glucocorticoids|mesh-ancestor
65357018|NCT01045681|Hormones|hormones|mesh-ancestor
65357019|NCT01045681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65357020|NCT01045681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65357021|NCT01045681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357022|NCT01045681|Protease Inhibitors|protease inhibitors|mesh-ancestor
65357023|NCT01045681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357024|NCT01045681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357025|NCT01045681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65357026|NCT01045681|Alkylating Agents|alkylating agents|mesh-ancestor
65357027|NCT00975910|Lidocaine|lidocaine|mesh-list
65357028|NCT00975910|Anesthetics, Local|anesthetics, local|mesh-ancestor
65357062|NCT00976066|Naltrexone|naltrexone|mesh-list
65357063|NCT00976066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65357064|NCT00976066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65357065|NCT00976066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357066|NCT00976066|Sensory System Agents|sensory system agents|mesh-ancestor
65357067|NCT00976066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65357068|NCT03557619|Venetoclax|venetoclax|mesh-list
65357085|NCT03557619|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65357087|NCT00969592|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65357088|NCT00969592|Insulin Aspart|insulin aspart|mesh-list
65357089|NCT00969592|Insulin, Long-Acting|insulin, long-acting|mesh-list
65357090|NCT00969592|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65357091|NCT00969592|Insulin glulisine|insulin glulisine|mesh-list
65357092|NCT00969592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65357093|NCT00969592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357094|NCT00368641|Icodextrin|icodextrin|mesh-list
65357095|NCT00368641|Dialysis Solutions|dialysis solutions|mesh-ancestor
65357096|NCT00368641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65273492|NCT00002981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65273493|NCT00002981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357097|NCT00976222|Ranibizumab|ranibizumab|mesh-list
65357098|NCT00976222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65357099|NCT00976222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65357100|NCT00976222|Growth Substances|growth substances|mesh-ancestor
65357101|NCT00976222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357102|NCT00976222|Growth Inhibitors|growth inhibitors|mesh-ancestor
65357103|NCT00976222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357104|NCT00976300|Cyclosporine|cyclosporine|mesh-list
65357105|NCT00976300|Cyclophosphamide|cyclophosphamide|mesh-list
65357106|NCT00976300|Cyclosporins|cyclosporins|mesh-list
65357107|NCT00976300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65357108|NCT00976300|Immunologic Factors|immunologic factors|mesh-ancestor
65357109|NCT00976300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357110|NCT00976300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65357111|NCT00976300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65357112|NCT00976300|Alkylating Agents|alkylating agents|mesh-ancestor
65357113|NCT00976300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357114|NCT00976300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357115|NCT00976300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65357116|NCT00976300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357117|NCT00976300|Antifungal Agents|antifungal agents|mesh-ancestor
65357118|NCT00976300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65357119|NCT00976300|Dermatologic Agents|dermatologic agents|mesh-ancestor
65357120|NCT00976300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65357122|NCT00979966|Sunitinib|sunitinib|mesh-list
65357123|NCT00979966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357124|NCT00979966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65357125|NCT00979966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65357126|NCT00979966|Growth Substances|growth substances|mesh-ancestor
65357127|NCT00979966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357153|NCT00976690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357154|NCT00976690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65357155|NCT00976690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357156|NCT00976690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65357158|NCT00976690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357159|NCT00976690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65357160|NCT00976690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65357161|NCT00976690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65357162|NCT00976690|Analgesics|analgesics|mesh-ancestor
65357163|NCT00976690|Sensory System Agents|sensory system agents|mesh-ancestor
65357164|NCT00976690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65357165|NCT00976690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65357166|NCT00976768|Fluorouracil|fluorouracil|mesh-list
65357167|NCT00976768|Oxaliplatin|oxaliplatin|mesh-list
65357168|NCT00976768|Antimetabolites|antimetabolites|mesh-ancestor
65357169|NCT00976768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357170|NCT00976768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65357171|NCT00976768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357172|NCT00976768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65357173|NCT00976768|Immunologic Factors|immunologic factors|mesh-ancestor
65357174|NCT00976768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357175|NCT00608985|Zolpidem|zolpidem|mesh-list
65357176|NCT00608985|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65357177|NCT00608985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65357193|NCT00969982|Oxytocics|oxytocics|mesh-ancestor
65357194|NCT00969982|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65357195|NCT00969982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65357196|NCT00969982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65357197|NCT00969982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65357198|NCT00969982|Contraceptive Agents|contraceptive agents|mesh-ancestor
65357199|NCT00969982|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65357200|NCT00969982|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65357201|NCT00969982|Hormone Antagonists|hormone antagonists|mesh-ancestor
65357202|NCT00969982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65357203|NCT00969982|Luteolytic Agents|luteolytic agents|mesh-ancestor
65357204|NCT00969982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65357205|NCT00969982|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65357206|NCT00970138|Apatinib|apatinib|mesh-list
65357207|NCT00970138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357208|NCT00970138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65357209|NCT00970138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357210|NCT00970138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357211|NCT00892125|Carbamazepine|carbamazepine|mesh-list
65357212|NCT00892125|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65357213|NCT00892125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65357214|NCT00892125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65357215|NCT00892125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65357216|NCT00892125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357217|NCT00892125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65357218|NCT00892125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65357219|NCT00892125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65357220|NCT00892125|Serotonin Agents|serotonin agents|mesh-ancestor
65357221|NCT00892125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65357222|NCT00892125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357223|NCT00892125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65357224|NCT00892125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65357225|NCT00892125|Dopamine Agents|dopamine agents|mesh-ancestor
65357226|NCT00892125|Anticonvulsants|anticonvulsants|mesh-ancestor
65357227|NCT00892125|Antimanic Agents|antimanic agents|mesh-ancestor
65357228|NCT00892125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65357229|NCT00892125|Analgesics|analgesics|mesh-ancestor
65357230|NCT00892125|Sensory System Agents|sensory system agents|mesh-ancestor
65357231|NCT00892125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65357232|NCT00892125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65357233|NCT00892125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65357234|NCT00892125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64749312|NCT03929640|Ibuprofen|ibuprofen|mesh-list
65357263|NCT00378079|Narcotics|narcotics|mesh-ancestor
65357264|NCT00378079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65357265|NCT00378079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357266|NCT00378079|Analgesics|analgesics|mesh-ancestor
65357267|NCT00378079|Sensory System Agents|sensory system agents|mesh-ancestor
65357268|NCT00378079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65107121|NCT03872180|Venetoclax|venetoclax|mesh-list
65357269|NCT00378079|Antitussive Agents|antitussive agents|mesh-ancestor
65357270|NCT00378079|Respiratory System Agents|respiratory system agents|mesh-ancestor
65357272|NCT00970450|Tropisetron|tropisetron|mesh-list
65357273|NCT00970450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65357274|NCT00970450|Analgesics|analgesics|mesh-ancestor
65357275|NCT00970450|Sensory System Agents|sensory system agents|mesh-ancestor
65357276|NCT00970450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65357277|NCT00970450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357278|NCT00970450|Antipyretics|antipyretics|mesh-ancestor
65357279|NCT00970450|Antiemetics|antiemetics|mesh-ancestor
65357280|NCT00970450|Autonomic Agents|autonomic agents|mesh-ancestor
65357281|NCT00970450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65357282|NCT00970450|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65357309|NCT00978172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65357310|NCT00978172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65357311|NCT00978172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65357312|NCT00978172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357314|NCT00978172|Schistosomicides|schistosomicides|mesh-ancestor
65357315|NCT00978172|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65357316|NCT00978172|Anthelmintics|anthelmintics|mesh-ancestor
65357317|NCT03923530|Eplerenone|eplerenone|mesh-list
65357318|NCT03923530|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65357319|NCT03923530|Hormone Antagonists|hormone antagonists|mesh-ancestor
65357320|NCT03923530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65357321|NCT03923530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357322|NCT03923530|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65357323|NCT03923530|Diuretics|diuretics|mesh-ancestor
65357324|NCT03923530|Natriuretic Agents|natriuretic agents|mesh-ancestor
65357325|NCT03923530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65357326|NCT00608907|Rifampin|rifampin|mesh-list
65357327|NCT00608907|Dexamethasone|dexamethasone|mesh-list
65357328|NCT00608907|Dexamethasone acetate|dexamethasone acetate|mesh-list
65357329|NCT00608907|Bortezomib|bortezomib|mesh-list
65357330|NCT00608907|BB 1101|bb 1101|mesh-list
65357331|NCT00608907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65357367|NCT00970996|Tubulin Modulators|tubulin modulators|mesh-ancestor
65357368|NCT00970996|Antimitotic Agents|antimitotic agents|mesh-ancestor
65357369|NCT00970996|Mitosis Modulators|mitosis modulators|mesh-ancestor
65357370|NCT00970996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357371|NCT00970996|Antiviral Agents|antiviral agents|mesh-ancestor
65357401|NCT00869271|Antidotes|antidotes|mesh-ancestor
65357402|NCT00869271|Protective Agents|protective agents|mesh-ancestor
65273494|NCT00619710|Meropenem|meropenem|mesh-list
65357403|NCT00869271|Vitamin B Complex|vitamin b complex|mesh-ancestor
65357404|NCT00869271|Vitamins|vitamins|mesh-ancestor
65357405|NCT00869271|Micronutrients|micronutrients|mesh-ancestor
65357406|NCT00971074|Hylan|hylan|mesh-list
65357407|NCT00971074|Viscosupplements|viscosupplements|mesh-ancestor
65357408|NCT00971074|Protective Agents|protective agents|mesh-ancestor
65357409|NCT00971074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357410|NCT00971152|Menotropins|menotropins|mesh-list
65357411|NCT00971152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65357412|NCT00971152|Fertility Agents|fertility agents|mesh-ancestor
65357413|NCT00971152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65357414|NCT00971152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357415|NCT00893919|Mycophenolic Acid|mycophenolic acid|mesh-list
65357416|NCT00893919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65357417|NCT00893919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357446|NCT01051531|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65357448|NCT01051531|Dopamine Agents|dopamine agents|mesh-ancestor
65357449|NCT03992911|Carboplatin|carboplatin|mesh-list
65357450|NCT03992911|Etoposide|etoposide|mesh-list
65357451|NCT03992911|Etoposide phosphate|etoposide phosphate|mesh-list
65357452|NCT03992911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357453|NCT03992911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65357454|NCT03992911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65357455|NCT03992911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65357456|NCT03992911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357457|NCT03992911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357458|NCT00545272|Formoterol Fumarate|formoterol fumarate|mesh-list
65357459|NCT00545272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65357460|NCT00545272|Autonomic Agents|autonomic agents|mesh-ancestor
65357483|NCT00869973|Aprepitant|aprepitant|mesh-list
65357484|NCT00869973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65357485|NCT00869973|Antiemetics|antiemetics|mesh-ancestor
65357486|NCT00869973|Autonomic Agents|autonomic agents|mesh-ancestor
65357487|NCT00869973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65357488|NCT00869973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357489|NCT00869973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65357490|NCT00869973|Glucocorticoids|glucocorticoids|mesh-ancestor
65357491|NCT00869973|Hormones|hormones|mesh-ancestor
65357492|NCT00869973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65357493|NCT00869973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65357494|NCT00869973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357495|NCT00869973|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65357496|NCT00869973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65357497|NCT00869973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357499|NCT04008784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65357500|NCT04008784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65357501|NCT04008784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65357502|NCT04008784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65357503|NCT04008784|Glucocorticoids|glucocorticoids|mesh-ancestor
65357504|NCT04008784|Hormones|hormones|mesh-ancestor
65357505|NCT04008784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65357506|NCT04008784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357507|NCT04008784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65357508|NCT04008784|Immunologic Factors|immunologic factors|mesh-ancestor
65357509|NCT04008784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019545|NCT02917018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357540|NCT01051765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357541|NCT01051765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357542|NCT00978796|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65357543|NCT00978796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65357544|NCT00978796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357546|NCT00978796|Hormones|hormones|mesh-ancestor
65357547|NCT00978796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65357548|NCT00978796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65357549|NCT00978796|Protease Inhibitors|protease inhibitors|mesh-ancestor
65357550|NCT00978796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357551|NCT00978796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357552|NCT00894231|Levocetirizine|levocetirizine|mesh-list
65357577|NCT00894621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357578|NCT00894621|Sympathomimetics|sympathomimetics|mesh-ancestor
65357579|NCT00894621|Autonomic Agents|autonomic agents|mesh-ancestor
65357580|NCT00894621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65357581|NCT00894621|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64715456|NCT00375661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715457|NCT00375661|Antiviral Agents|antiviral agents|mesh-ancestor
64715458|NCT00375661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64715459|NCT00375661|Antimetabolites|antimetabolites|mesh-ancestor
64715460|NCT00375661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715461|NCT00375661|Immunologic Factors|immunologic factors|mesh-ancestor
64715462|NCT00375661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715463|NCT04736186|Loperamide|loperamide|mesh-list
64715464|NCT04736186|Antidiarrheals|antidiarrheals|mesh-list
64715465|NCT04736186|Bentonite|bentonite|mesh-list
64715466|NCT04736186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64715467|NCT04736186|Antidotes|antidotes|mesh-ancestor
64327987|NCT00459745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64327990|NCT00459745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65357582|NCT00376675|Methylphenidate|methylphenidate|mesh-list
65357583|NCT00376675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65357584|NCT00376675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357585|NCT00376675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65357586|NCT00376675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65357587|NCT00376675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65357588|NCT00376675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357589|NCT00376675|Dopamine Agents|dopamine agents|mesh-ancestor
65357590|NCT00376675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65357591|NCT00979186|Hemostatics|hemostatics|mesh-list
65357592|NCT00979186|Coagulants|coagulants|mesh-ancestor
65357593|NCT05178628|Gemcitabine|gemcitabine|mesh-list
65357594|NCT05178628|Paclitaxel|paclitaxel|mesh-list
65357595|NCT05178628|Tinzaparin|tinzaparin|mesh-list
65357596|NCT05178628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65357597|NCT05178628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357598|NCT05178628|Tubulin Modulators|tubulin modulators|mesh-ancestor
65357599|NCT05178628|Antimitotic Agents|antimitotic agents|mesh-ancestor
65357600|NCT05178628|Mitosis Modulators|mitosis modulators|mesh-ancestor
65357601|NCT05178628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357620|NCT00896571|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65357622|NCT00896571|Hormones|hormones|mesh-ancestor
65357623|NCT00896571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65357624|NCT00896727|Antibodies|antibodies|mesh-list
65357625|NCT00896727|Immunologic Factors|immunologic factors|mesh-ancestor
65357626|NCT00896727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357627|NCT00981838|Rituximab|rituximab|mesh-list
65357628|NCT00981838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65357629|NCT00981838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357630|NCT00981838|Immunologic Factors|immunologic factors|mesh-ancestor
65357631|NCT00981838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357632|NCT00981838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65357633|NCT02533765|Olaparib|olaparib|mesh-list
65357634|NCT02533765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65357635|NCT02533765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357636|NCT02533765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357637|NCT02533765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357638|NCT04035993|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65357639|NCT04035993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357640|NCT00367237|Methotrexate|methotrexate|mesh-list
65357641|NCT00367237|Infliximab|infliximab|mesh-list
65357642|NCT00367237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65357644|NCT00367237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65357645|NCT00367237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357646|NCT00367237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65357647|NCT00367237|Antimetabolites|antimetabolites|mesh-ancestor
65357648|NCT00367237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273495|NCT00619710|Imipenem|imipenem|mesh-list
65273496|NCT00619710|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
65273497|NCT00619710|Cilastatin|cilastatin|mesh-list
65273498|NCT00619710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65273499|NCT00619710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65273500|NCT00619710|Protease Inhibitors|protease inhibitors|mesh-ancestor
65273501|NCT00619710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273502|NCT00619710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273503|NCT03929627|Hydrocortisone|hydrocortisone|mesh-list
65273504|NCT03929627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65023513|NCT02923687|Ketorolac|ketorolac|mesh-list
65273505|NCT04019015|Thrombin|thrombin|mesh-list
64328010|NCT00492999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64328011|NCT00492999|Antiemetics|antiemetics|mesh-ancestor
64328012|NCT00492999|Autonomic Agents|autonomic agents|mesh-ancestor
64328013|NCT00492999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64328014|NCT00492999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328015|NCT00492999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64328016|NCT00492999|Glucocorticoids|glucocorticoids|mesh-ancestor
64328017|NCT00492999|Hormones|hormones|mesh-ancestor
64328019|NCT00492999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64328105|NCT02741713|Analgesics|analgesics|mesh-ancestor
64328106|NCT02741713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64328107|NCT02741713|Sympatholytics|sympatholytics|mesh-ancestor
64328108|NCT02741713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64328109|NCT00459277|Fentanyl|fentanyl|mesh-list
64328110|NCT00459277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64328111|NCT00459277|Narcotics|narcotics|mesh-ancestor
64328161|NCT02182505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64328162|NCT02182505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357649|NCT00367237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357650|NCT00367237|Dermatologic Agents|dermatologic agents|mesh-ancestor
65357651|NCT00367237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357652|NCT00367237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65357653|NCT00367237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65357654|NCT00367237|Immunologic Factors|immunologic factors|mesh-ancestor
65357655|NCT00367237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65357656|NCT00367237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65357657|NCT00367237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65357658|NCT00901407|Lamotrigine|lamotrigine|mesh-list
65357687|NCT00984724|Cholinergic Agents|cholinergic agents|mesh-ancestor
65357688|NCT00984724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65357689|NCT00984724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357690|NCT00901719|Nitroprusside|nitroprusside|mesh-list
65357691|NCT00901719|Acetylcholine|acetylcholine|mesh-list
65357692|NCT00901719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65357693|NCT00901719|Vasodilator Agents|vasodilator agents|mesh-ancestor
64328486|NCT02183441|Protease Inhibitors|protease inhibitors|mesh-ancestor
64720594|NCT00002132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64720595|NCT00002132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64720597|NCT00002144|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
64720598|NCT00002144|Antiviral Agents|antiviral agents|mesh-ancestor
64720599|NCT00002144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720600|NCT00002144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64720604|NCT00000578|Beclomethasone|beclomethasone|mesh-list
65357694|NCT00901719|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65357695|NCT00901719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357696|NCT00901719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65357697|NCT00901719|Cholinergic Agents|cholinergic agents|mesh-ancestor
65357698|NCT00901719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65357699|NCT00901719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357700|NCT00972712|Bortezomib|bortezomib|mesh-list
65357701|NCT00972712|Tipifarnib|tipifarnib|mesh-list
65357702|NCT00972712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357703|NCT02539641|Hormones|hormones|mesh-list
65357728|NCT04035603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65357729|NCT04035603|Renal Agents|renal agents|mesh-ancestor
65357730|NCT04035603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65357731|NCT04035603|Antitubercular Agents|antitubercular agents|mesh-ancestor
65357732|NCT04035603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65357733|NCT04035603|Antimetabolites|antimetabolites|mesh-ancestor
65357734|NCT04035603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357735|NCT00606801|Galantamine|galantamine|mesh-list
65357736|NCT00606801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65357737|NCT00606801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357738|NCT00606801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357739|NCT00606801|Cholinergic Agents|cholinergic agents|mesh-ancestor
65357740|NCT00606801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65357741|NCT00606801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357742|NCT00606801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65357743|NCT00606801|Autonomic Agents|autonomic agents|mesh-ancestor
65357744|NCT00606801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65357745|NCT00606801|Nootropic Agents|nootropic agents|mesh-ancestor
65357746|NCT00972790|Bupivacaine|bupivacaine|mesh-list
65357747|NCT00972790|Anesthetics, Local|anesthetics, local|mesh-ancestor
65357748|NCT00972790|Anesthetics|anesthetics|mesh-ancestor
65357749|NCT00972790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65357750|NCT00972790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357751|NCT00972790|Sensory System Agents|sensory system agents|mesh-ancestor
65357752|NCT00972790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65357753|NCT00901875|Buprenorphine|buprenorphine|mesh-list
65357754|NCT00901875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65357775|NCT00606177|Dopamine Agonists|dopamine agonists|mesh-ancestor
65357776|NCT00606177|Dopamine Agents|dopamine agents|mesh-ancestor
65357777|NCT00606177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65357778|NCT00606177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357779|NCT00606177|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65357780|NCT00606177|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65357781|NCT00606177|Serotonin Agents|serotonin agents|mesh-ancestor
65357782|NCT00606177|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65357783|NCT00606177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65357784|NCT00606177|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65357785|NCT00606177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65357786|NCT00985270|Rifampin|rifampin|mesh-list
65357787|NCT00985270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65357788|NCT00985270|Antitubercular Agents|antitubercular agents|mesh-ancestor
65357789|NCT00985270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65357790|NCT00985270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65107638|NCT03851588|Dolutegravir|dolutegravir|mesh-list
65357792|NCT00985270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65357793|NCT00985270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357794|NCT00985270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357795|NCT00985270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65273506|NCT04019015|Hemostatics|hemostatics|mesh-ancestor
65273507|NCT04019015|Coagulants|coagulants|mesh-ancestor
65273508|NCT02846909|Progesterone|progesterone|mesh-list
65273509|NCT02846909|Progestins|progestins|mesh-ancestor
65273511|NCT02846909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65273512|NCT02846909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273513|NCT00632723|Gefitinib|gefitinib|mesh-list
65273514|NCT00632723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273515|NCT00632723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65273516|NCT00632723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273517|NCT00632723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273518|NCT02847143|Oxytocin|oxytocin|mesh-list
65357796|NCT00985270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65357797|NCT00985270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65357798|NCT00985270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65357799|NCT00985270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65357800|NCT00985270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65357801|NCT00359281|Niacin|niacin|mesh-list
65357802|NCT00359281|Dextromethorphan|dextromethorphan|mesh-list
65357803|NCT00359281|Atorvastatin|atorvastatin|mesh-list
65357804|NCT00359281|Simvastatin|simvastatin|mesh-list
65357805|NCT00359281|Ezetimibe|ezetimibe|mesh-list
65357806|NCT00359281|Fenofibrate|fenofibrate|mesh-list
65357807|NCT00359281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65357808|NCT00359281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65357809|NCT00359281|Antimetabolites|antimetabolites|mesh-ancestor
65357810|NCT00359281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357836|NCT03990961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357838|NCT00973336|Calcium|calcium|mesh-list
65357839|NCT00973336|Vitamins|vitamins|mesh-ancestor
65357840|NCT00973336|Micronutrients|micronutrients|mesh-ancestor
65357841|NCT00973336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357842|NCT00973336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65357843|NCT00973336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65357844|NCT00902187|Fesoterodine|fesoterodine|mesh-list
65357845|NCT00902187|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65357846|NCT00902187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65357847|NCT00902187|Cholinergic Agents|cholinergic agents|mesh-ancestor
65357848|NCT00902187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65357849|NCT00902187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357850|NCT00902187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357851|NCT00902187|Urological Agents|urological agents|mesh-ancestor
65357852|NCT01052311|Niacin|niacin|mesh-list
65357853|NCT01052311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65357854|NCT01052311|Antimetabolites|antimetabolites|mesh-ancestor
65357855|NCT01052311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357856|NCT01052311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65357857|NCT01052311|Vasodilator Agents|vasodilator agents|mesh-ancestor
65357858|NCT01052311|Vitamin B Complex|vitamin b complex|mesh-ancestor
65357859|NCT01052311|Vitamins|vitamins|mesh-ancestor
65357860|NCT01052311|Micronutrients|micronutrients|mesh-ancestor
65357861|NCT01052311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357862|NCT00988078|Metformin|metformin|mesh-list
65357863|NCT00988078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65357895|NCT00982540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357896|NCT00982540|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65357897|NCT00982540|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65357898|NCT04674358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65357899|NCT04674358|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65357900|NCT00366535|Neurotropin|neurotropin|mesh-list
65357901|NCT00366535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65357902|NCT00366535|Immunologic Factors|immunologic factors|mesh-ancestor
65357903|NCT00366535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750026|NCT05701488|Durvalumab|durvalumab|mesh-list
65357912|NCT00982618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65357913|NCT00982618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357915|NCT00982618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65357916|NCT00982618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65357917|NCT00982618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65357918|NCT00982618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65357919|NCT00982618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65357920|NCT00982618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357921|NCT00982618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65357922|NCT00982618|Narcotics|narcotics|mesh-ancestor
65357923|NCT00982618|Analgesics|analgesics|mesh-ancestor
65357924|NCT00895167|Curcumin|curcumin|mesh-list
65357925|NCT00895167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65357926|NCT00895167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65357927|NCT00895167|Analgesics|analgesics|mesh-ancestor
65357928|NCT00895167|Sensory System Agents|sensory system agents|mesh-ancestor
65357929|NCT00895167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65357930|NCT00895167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357931|NCT00895167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65357932|NCT00895167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65357933|NCT00895167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357934|NCT00895167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357935|NCT00895167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357936|NCT00902421|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65357937|NCT00902421|Serotonin|serotonin|mesh-list
65357938|NCT00902421|Muscarinic Antagonists|muscarinic antagonists|mesh-list
65357939|NCT00902421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65357940|NCT00902421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65357941|NCT00902421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357942|NCT00902421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65357943|NCT00902421|Serotonin Agents|serotonin agents|mesh-ancestor
65357944|NCT00902421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357945|NCT00902421|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65357946|NCT00902421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65357947|NCT00902421|Cholinergic Agents|cholinergic agents|mesh-ancestor
65357948|NCT00985660|Nisoldipine|nisoldipine|mesh-list
65357949|NCT00985660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65357950|NCT00985660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65357951|NCT00985660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65357952|NCT00985660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357953|NCT00985660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65357954|NCT00985660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357955|NCT00985660|Vasodilator Agents|vasodilator agents|mesh-ancestor
65357956|NCT00350545|Cyclosporine|cyclosporine|mesh-list
65357957|NCT00350545|Prednisone|prednisone|mesh-list
65357958|NCT00350545|Rituximab|rituximab|mesh-list
65357959|NCT00350545|Tacrolimus|tacrolimus|mesh-list
65357960|NCT00350545|Cyclosporins|cyclosporins|mesh-list
65357961|NCT00350545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65357962|NCT00350545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357963|NCT00350545|Immunologic Factors|immunologic factors|mesh-ancestor
65357964|NCT00350545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357965|NCT00350545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65357966|NCT00350545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65357967|NCT00350545|Glucocorticoids|glucocorticoids|mesh-ancestor
65357968|NCT00350545|Hormones|hormones|mesh-ancestor
65357969|NCT00350545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65357970|NCT00350545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65357990|NCT04006054|Adrenergic Agents|adrenergic agents|mesh-ancestor
65357991|NCT04006054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65357992|NCT04006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357993|NCT04006054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65357994|NCT04006054|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65357995|NCT04006054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65357996|NCT04006054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65357997|NCT04006054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65357998|NCT04006054|Anesthetics, General|anesthetics, general|mesh-ancestor
65358000|NCT04006054|GABA Modulators|gaba modulators|mesh-ancestor
65358001|NCT04006054|GABA Agents|gaba agents|mesh-ancestor
65358002|NCT00897975|Red yeast rice|red yeast rice|mesh-list
65358003|NCT00897975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65358004|NCT00897975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65358005|NCT00897975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65358006|NCT00897975|Antimetabolites|antimetabolites|mesh-ancestor
65273519|NCT02847143|Oxytocics|oxytocics|mesh-ancestor
65273520|NCT02847143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65273521|NCT02847143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273522|NCT02847455|Rabeprazole|rabeprazole|mesh-list
65273523|NCT02847455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65273524|NCT02847455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65273525|NCT02847455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65273526|NCT02847455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358007|NCT00897975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358008|NCT00897975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358009|NCT00897975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65358010|NCT01052389|Haloperidol|haloperidol|mesh-list
65358011|NCT01052389|Olanzapine|olanzapine|mesh-list
65358012|NCT01052389|Aripiprazole|aripiprazole|mesh-list
65358013|NCT01052389|Haloperidol decanoate|haloperidol decanoate|mesh-list
65358014|NCT01052389|Antiemetics|antiemetics|mesh-ancestor
65358015|NCT01052389|Autonomic Agents|autonomic agents|mesh-ancestor
65358016|NCT01052389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65358017|NCT01052389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358018|NCT01052389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65358019|NCT01052389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65358020|NCT01052389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65358021|NCT01052389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65358022|NCT01052389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65358023|NCT01052389|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65358024|NCT01052389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65358025|NCT01052389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65358048|NCT00349921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65358049|NCT00349921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358050|NCT00349921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65358051|NCT00349921|Sympatholytics|sympatholytics|mesh-ancestor
65358052|NCT00349921|Autonomic Agents|autonomic agents|mesh-ancestor
65358053|NCT00349921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65358054|NCT00349921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65358055|NCT00349921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65358056|NCT00349921|Adrenergic Agents|adrenergic agents|mesh-ancestor
65358057|NCT00349921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65358058|NCT00349921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358059|NCT00349921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65358060|NCT00349921|Vasodilator Agents|vasodilator agents|mesh-ancestor
65358061|NCT00349921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65358062|NCT00349921|Purinergic Agonists|purinergic agonists|mesh-ancestor
65358063|NCT00349921|Purinergic Agents|purinergic agents|mesh-ancestor
65358064|NCT00902655|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65358065|NCT00902655|Hemostatics|hemostatics|mesh-ancestor
65358066|NCT00902655|Coagulants|coagulants|mesh-ancestor
65358067|NCT00902655|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65358068|NCT00902655|Natriuretic Agents|natriuretic agents|mesh-ancestor
65358069|NCT00902655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358070|NCT01052623|Clonidine|clonidine|mesh-list
65358071|NCT01052623|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65358072|NCT01052623|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65358073|NCT01052623|Estradiol|estradiol|mesh-list
65358074|NCT01052623|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65358075|NCT01052623|Hormones|hormones|mesh-ancestor
65358076|NCT01052623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65358077|NCT01052623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358078|NCT01052623|Estrogens|estrogens|mesh-ancestor
65358079|NCT01052623|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65358080|NCT01052623|Contraceptive Agents|contraceptive agents|mesh-ancestor
65358115|NCT00898287|Immunologic Factors|immunologic factors|mesh-ancestor
65358116|NCT00898287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358117|NCT04034823|Docetaxel|docetaxel|mesh-list
65358118|NCT04034823|Trastuzumab|trastuzumab|mesh-list
65358119|NCT04034823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358120|NCT04034823|Tubulin Modulators|tubulin modulators|mesh-ancestor
65358121|NCT04034823|Antimitotic Agents|antimitotic agents|mesh-ancestor
65358122|NCT04034823|Mitosis Modulators|mitosis modulators|mesh-ancestor
64750228|NCT05033808|Epirubicin|epirubicin|mesh-list
65273527|NCT02847455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273528|NCT03897335|Aminophylline|aminophylline|mesh-list
65273529|NCT03897335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65273530|NCT03897335|Autonomic Agents|autonomic agents|mesh-ancestor
65273531|NCT03897335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65273532|NCT03897335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273533|NCT03897335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65273534|NCT03897335|Respiratory System Agents|respiratory system agents|mesh-ancestor
65273535|NCT03897335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65273536|NCT03897335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65273537|NCT03897335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64471664|NCT04267887|Androgens|androgens|mesh-list
64329076|NCT00528697|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64329077|NCT00528697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64329078|NCT00528697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64329080|NCT00528697|Adrenergic Agents|adrenergic agents|mesh-ancestor
65358146|NCT00902967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65358147|NCT00902967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65358148|NCT00902967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358149|NCT00903045|Propiverine|propiverine|mesh-list
65358150|NCT00903045|Parasympatholytics|parasympatholytics|mesh-ancestor
65358151|NCT00903045|Autonomic Agents|autonomic agents|mesh-ancestor
65358152|NCT00903045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65358153|NCT00903045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358154|NCT00903045|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65358155|NCT00903045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65358156|NCT00903045|Cholinergic Agents|cholinergic agents|mesh-ancestor
65358157|NCT00903045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65358158|NCT00903045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358159|NCT00903045|Urological Agents|urological agents|mesh-ancestor
65358160|NCT00337285|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65358161|NCT00337285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65358162|NCT00337285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358163|NCT00337285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65358164|NCT00337285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65358165|NCT00337285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65358166|NCT00337285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358167|NCT00337285|Dopamine Agents|dopamine agents|mesh-ancestor
65358195|NCT00905931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358197|NCT04035135|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65358198|NCT04035135|Antibodies|antibodies|mesh-list
65358199|NCT04035135|gamma-Globulins|gamma-globulins|mesh-list
65358200|NCT04035135|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65358201|NCT04035135|Immunologic Factors|immunologic factors|mesh-ancestor
65358202|NCT04035135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358203|NCT00903279|Retapamulin|retapamulin|mesh-list
65358204|NCT00903279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65358205|NCT00903279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65358206|NCT00605865|Sertraline|sertraline|mesh-list
65358207|NCT00605865|Antidepressive Agents|antidepressive agents|mesh-ancestor
65358208|NCT00605865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65358209|NCT00605865|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65358210|NCT00605865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65358211|NCT00605865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65358212|NCT00605865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358213|NCT00605865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65273538|NCT03897335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273539|NCT03897335|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65273540|NCT03897335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65273541|NCT03897335|Purinergic Agents|purinergic agents|mesh-ancestor
65273542|NCT03897335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65273543|NCT03897335|Protective Agents|protective agents|mesh-ancestor
65273544|NCT01617096|Dapivirine|dapivirine|mesh-list
65273545|NCT01617096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65273546|NCT01617096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64471665|NCT04267887|Androgen Antagonists|androgen antagonists|mesh-list
64471666|NCT04267887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64471667|NCT04267887|Glucocorticoids|glucocorticoids|mesh-ancestor
64721561|NCT03538015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721562|NCT03538015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721563|NCT03538015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64721564|NCT03538015|Antioxidants|antioxidants|mesh-ancestor
64721565|NCT03538015|Protective Agents|protective agents|mesh-ancestor
64721566|NCT03538015|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64721567|NCT03538015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64721568|NCT03538015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64721569|NCT03538015|Vasodilator Agents|vasodilator agents|mesh-ancestor
64721572|NCT03342157|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
65358222|NCT00922467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358223|NCT00922467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358224|NCT00903747|Moxifloxacin|moxifloxacin|mesh-list
65358225|NCT00903747|Prucalopride|prucalopride|mesh-list
65358226|NCT00903747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65358227|NCT00903747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65358228|NCT00903747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65358229|NCT00903747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65358230|NCT00903747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358231|NCT00903747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358232|NCT00903747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358233|NCT00903747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358234|NCT00903747|Laxatives|laxatives|mesh-ancestor
65358235|NCT00903747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65358236|NCT00903747|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65358237|NCT00903747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65358238|NCT00903747|Serotonin Agents|serotonin agents|mesh-ancestor
65358239|NCT00903747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65358240|NCT02538627|Trametinib|trametinib|mesh-list
65358241|NCT02538627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358242|NCT02538627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65358243|NCT02538627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358244|NCT02538627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358245|NCT00903825|Lidocaine|lidocaine|mesh-list
65358246|NCT00903825|Anesthetics, Local|anesthetics, local|mesh-list
65358247|NCT00903825|Anesthetics|anesthetics|mesh-list
65358248|NCT00903825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65358249|NCT00903825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329541|NCT02381145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329542|NCT02381145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721858|NCT00002516|Cobalt|cobalt|mesh-list
64329583|NCT02191319|Antiviral Agents|antiviral agents|mesh-ancestor
64329584|NCT02191319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64329585|NCT02191319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64329586|NCT02191319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64329587|NCT02191319|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64329588|NCT02191319|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64329589|NCT02191475|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65358250|NCT00903825|Sensory System Agents|sensory system agents|mesh-ancestor
65358251|NCT00903825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65358252|NCT00903825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65358253|NCT00903825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65358254|NCT00903825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65358255|NCT00903825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65358256|NCT00903825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358257|NCT00904059|Asunaprevir|asunaprevir|mesh-list
65358258|NCT00904059|Protease Inhibitors|protease inhibitors|mesh-ancestor
65358259|NCT00904059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358260|NCT00904059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358261|NCT00337207|Bevacizumab|bevacizumab|mesh-list
65358262|NCT00337207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65358263|NCT00337207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358264|NCT00337207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65358265|NCT00337207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65358266|NCT00337207|Growth Substances|growth substances|mesh-ancestor
65358267|NCT00337207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358268|NCT00337207|Growth Inhibitors|growth inhibitors|mesh-ancestor
65358269|NCT01055743|Fluorouracil|fluorouracil|mesh-list
65358270|NCT01055743|Antimetabolites|antimetabolites|mesh-ancestor
65358271|NCT01055743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358272|NCT01055743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65358273|NCT01055743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358274|NCT01055743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65358275|NCT01055743|Immunologic Factors|immunologic factors|mesh-ancestor
65358276|NCT01055743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358277|NCT00604695|Tenecteplase|tenecteplase|mesh-list
65358278|NCT00604695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65358305|NCT00348595|Growth Inhibitors|growth inhibitors|mesh-ancestor
65358306|NCT00348595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358308|NCT02538939|Antidotes|antidotes|mesh-ancestor
65358309|NCT02538939|Protective Agents|protective agents|mesh-ancestor
65358310|NCT02538939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358311|NCT02538939|Antioxidants|antioxidants|mesh-ancestor
65358312|NCT02538939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108167|NCT01263691|Vaccines|vaccines|mesh-list
65358313|NCT02538939|Antitubercular Agents|antitubercular agents|mesh-ancestor
65358314|NCT02538939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65358315|NCT02538939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65358316|NCT02538939|Chelating Agents|chelating agents|mesh-ancestor
65358317|NCT02538939|Sequestering Agents|sequestering agents|mesh-ancestor
65358318|NCT00904605|Celecoxib|celecoxib|mesh-list
65358319|NCT00904605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65358320|NCT00904605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65358321|NCT00904605|Analgesics|analgesics|mesh-ancestor
65358322|NCT00904605|Sensory System Agents|sensory system agents|mesh-ancestor
65358323|NCT00904605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65358324|NCT00904605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358325|NCT00904605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65358326|NCT00904605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64750430|NCT04747080|Glucocorticoids|glucocorticoids|mesh-ancestor
65358359|NCT00905229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358361|NCT00905229|Coagulants|coagulants|mesh-ancestor
65273547|NCT01617096|Antiviral Agents|antiviral agents|mesh-ancestor
65273548|NCT01617096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65273549|NCT00619944|Ritonavir|ritonavir|mesh-list
65273550|NCT00619944|Lopinavir|lopinavir|mesh-list
65273551|NCT00619944|Lumefantrine|lumefantrine|mesh-list
65273552|NCT00619944|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65273553|NCT00619944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65273554|NCT00619944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65273555|NCT00619944|Protease Inhibitors|protease inhibitors|mesh-ancestor
64329677|NCT02192723|Antipsychotic Agents|antipsychotic agents|mesh-list
64329678|NCT02192723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64329701|NCT00319969|Topotecan|topotecan|mesh-list
64329702|NCT00319969|Amrubicin|amrubicin|mesh-list
64329703|NCT00319969|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64329704|NCT00319969|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64329705|NCT00319969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358362|NCT00905541|Simvastatin|simvastatin|mesh-list
65358363|NCT00905541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65358364|NCT00905541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65358365|NCT00905541|Antimetabolites|antimetabolites|mesh-ancestor
65358366|NCT00905541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358367|NCT00905541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65019546|NCT02917018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65358429|NCT03987529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65358430|NCT03987529|Anesthetics, General|anesthetics, general|mesh-ancestor
65358431|NCT03987529|Anesthetics|anesthetics|mesh-ancestor
65358432|NCT03987529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65358433|NCT03987529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65358434|NCT00335959|Capecitabine|capecitabine|mesh-list
65358435|NCT00335959|Oxaliplatin|oxaliplatin|mesh-list
65358436|NCT00335959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65358437|NCT00335959|Antimetabolites|antimetabolites|mesh-ancestor
65358438|NCT00335959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358439|NCT00335959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358440|NCT01053169|Thrombin|thrombin|mesh-list
65358441|NCT01053169|Hemostatics|hemostatics|mesh-ancestor
65358442|NCT01053169|Coagulants|coagulants|mesh-ancestor
65358443|NCT01059331|Pregabalin|pregabalin|mesh-list
65358444|NCT01059331|Analgesics|analgesics|mesh-ancestor
65358445|NCT01059331|Sensory System Agents|sensory system agents|mesh-ancestor
65358446|NCT01059331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65358447|NCT01059331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358448|NCT01059331|Anticonvulsants|anticonvulsants|mesh-ancestor
65358449|NCT01059331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65358450|NCT01059331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65358451|NCT01059331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358452|NCT01059331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65358453|NCT01059331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65358454|NCT01059331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65358455|NCT01059331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65358456|NCT01059331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65358492|NCT01060267|Erythromycin stearate|erythromycin stearate|mesh-list
65358493|NCT01060267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65358494|NCT01060267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65358495|NCT01060267|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65358496|NCT01060267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358497|NCT01060267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358498|NCT01060423|Irinotecan|irinotecan|mesh-list
65358499|NCT01060423|Cetuximab|cetuximab|mesh-list
65358531|NCT00671658|Doxorubicin|doxorubicin|mesh-list
65358532|NCT00671658|Methotrexate|methotrexate|mesh-list
65358533|NCT00671658|Vincristine|vincristine|mesh-list
65273556|NCT00619944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273557|NCT00619944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273558|NCT00619944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65273559|NCT00619944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65273560|NCT00619944|Antiviral Agents|antiviral agents|mesh-ancestor
65273561|NCT00619944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65273562|NCT00619944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65273563|NCT00619944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64471668|NCT04267887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64329999|NCT00004231|Vincristine|vincristine|mesh-list
64330000|NCT00004231|Teniposide|teniposide|mesh-list
64330001|NCT00004231|Levoleucovorin|levoleucovorin|mesh-list
64330002|NCT00004231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64330003|NCT00004231|Immunologic Factors|immunologic factors|mesh-ancestor
64330004|NCT00004231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330005|NCT00004231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64330006|NCT00004231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64330033|NCT00004231|Vitamins|vitamins|mesh-ancestor
64330086|NCT00004093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330087|NCT02193269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64330108|NCT00002371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64330109|NCT00002371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64330110|NCT00002371|Antimetabolites|antimetabolites|mesh-ancestor
64330111|NCT00002371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64330112|NCT00002371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65358534|NCT00671658|Asparaginase|asparaginase|mesh-list
65358535|NCT00671658|Pegaspargase|pegaspargase|mesh-list
65358536|NCT00671658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65358537|NCT00671658|Prednisolone phosphate|prednisolone phosphate|mesh-list
65358538|NCT00671658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65358539|NCT00671658|Immunologic Factors|immunologic factors|mesh-ancestor
65358540|NCT00671658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358541|NCT00671658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65358542|NCT00671658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65358543|NCT00671658|Alkylating Agents|alkylating agents|mesh-ancestor
65358544|NCT00671658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358545|NCT00671658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358546|NCT00671658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65358547|NCT00671658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65358548|NCT00671658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65358549|NCT00671658|Antiemetics|antiemetics|mesh-ancestor
65358559|NCT00671658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65358560|NCT00671658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358561|NCT00671658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65358562|NCT00671658|Abortifacient Agents|abortifacient agents|mesh-ancestor
65358563|NCT00671658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65358564|NCT00671658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65358565|NCT00671658|Antimetabolites|antimetabolites|mesh-ancestor
65358566|NCT00671658|Dermatologic Agents|dermatologic agents|mesh-ancestor
65273564|NCT00619944|Antimalarials|antimalarials|mesh-ancestor
65273565|NCT00619944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65273566|NCT00619944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65273567|NCT00621036|Methotrexate|methotrexate|mesh-list
64722592|NCT00002744|Cobalt|cobalt|mesh-list
65358567|NCT00671658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65358568|NCT00671658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65358569|NCT00671658|Antiviral Agents|antiviral agents|mesh-ancestor
65358570|NCT00671658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65358571|NCT00671658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65358572|NCT00671658|Tubulin Modulators|tubulin modulators|mesh-ancestor
65358573|NCT00671658|Antimitotic Agents|antimitotic agents|mesh-ancestor
65358574|NCT00671658|Mitosis Modulators|mitosis modulators|mesh-ancestor
65358575|NCT00671658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65358576|NCT00671658|Protective Agents|protective agents|mesh-ancestor
65358577|NCT00764712|Insulin|insulin|mesh-list
65358578|NCT00764712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65358579|NCT00764712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358580|NCT00768456|Ropivacaine|ropivacaine|mesh-list
65358581|NCT00768456|Anesthetics, Local|anesthetics, local|mesh-ancestor
65358582|NCT00768456|Anesthetics|anesthetics|mesh-ancestor
65358583|NCT00768456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65358584|NCT00768456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358585|NCT00768456|Sensory System Agents|sensory system agents|mesh-ancestor
65358586|NCT00768456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65358587|NCT00768612|Risperidone|risperidone|mesh-list
65358588|NCT00768612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65358589|NCT00768612|Serotonin Agents|serotonin agents|mesh-ancestor
65358590|NCT00768612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65358591|NCT00768612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358592|NCT00768612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358593|NCT00768612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65358594|NCT00768612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65358595|NCT00768612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65358596|NCT00768612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65358597|NCT00768612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65358598|NCT00768612|Dopamine Agents|dopamine agents|mesh-ancestor
65358599|NCT00604383|Ruboxistaurin|ruboxistaurin|mesh-list
65358600|NCT00604383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358601|NCT00604383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358602|NCT04048200|Fentanyl|fentanyl|mesh-list
65358603|NCT04048200|Dexmedetomidine|dexmedetomidine|mesh-list
65358604|NCT04048200|Ketamine|ketamine|mesh-list
65358605|NCT04048200|Analgesics, Opioid|analgesics, opioid|mesh-list
65358606|NCT04048200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65358607|NCT04048200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65358608|NCT04048200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358609|NCT04048200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65358610|NCT04048200|Analgesics|analgesics|mesh-ancestor
65358611|NCT04048200|Sensory System Agents|sensory system agents|mesh-ancestor
65358612|NCT04048200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65358613|NCT04048200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65358614|NCT04048200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65358629|NCT04034589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358630|NCT04034589|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65358631|NCT04034589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65358632|NCT04034589|Hormone Antagonists|hormone antagonists|mesh-ancestor
65358633|NCT04034589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65358634|NCT04034589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358635|NCT00988312|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
65358636|NCT00988312|Immunologic Factors|immunologic factors|mesh-ancestor
65358637|NCT00988312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358638|NCT00906867|Methacholine Chloride|methacholine chloride|mesh-list
65358640|NCT00906867|Autonomic Agents|autonomic agents|mesh-ancestor
65358641|NCT00906867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65358642|NCT00906867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358643|NCT00906867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65358644|NCT00906867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
65358645|NCT00906867|Respiratory System Agents|respiratory system agents|mesh-ancestor
65358646|NCT00906867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65358647|NCT00906867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65273568|NCT00621036|Thiotepa|thiotepa|mesh-list
65273569|NCT00621036|Immunoglobulins|immunoglobulins|mesh-list
65273570|NCT00621036|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65273571|NCT00621036|Antibodies|antibodies|mesh-list
65273572|NCT00621036|Sargramostim|sargramostim|mesh-list
65273573|NCT00621036|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
65273574|NCT00621036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65273575|NCT00621036|Abortifacient Agents|abortifacient agents|mesh-ancestor
65273576|NCT00621036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64471670|NCT04267887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64330403|NCT04109885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64330404|NCT04109885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64330405|NCT04109885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64330406|NCT04109885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64330407|NCT04109885|Dopamine Agents|dopamine agents|mesh-ancestor
64330408|NCT02198261|Minoxidil|minoxidil|mesh-list
64330449|NCT02368743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64330451|NCT02368743|Analgesics|analgesics|mesh-ancestor
64330452|NCT02368743|Sensory System Agents|sensory system agents|mesh-ancestor
64330453|NCT02368743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330454|NCT02368743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330455|NCT02368743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64330456|NCT02368743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64330622|NCT02364765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64330624|NCT02364765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64330625|NCT02364765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330627|NCT02364765|Sensory System Agents|sensory system agents|mesh-ancestor
64330628|NCT02364765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330629|NCT03529201|Fentanyl|fentanyl|mesh-list
64330630|NCT03529201|Oxycodone|oxycodone|mesh-list
64330631|NCT03529201|Sevoflurane|sevoflurane|mesh-list
64330632|NCT03529201|Rocuronium|rocuronium|mesh-list
65358648|NCT00906867|Cholinergic Agents|cholinergic agents|mesh-ancestor
65358649|NCT00906867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65358650|NCT00906867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358651|NCT00768690|Ketoconazole|ketoconazole|mesh-list
65358652|NCT00768690|Antifungal Agents|antifungal agents|mesh-ancestor
65358653|NCT00768690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65358654|NCT00768690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65358655|NCT00768690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65358656|NCT00768690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358657|NCT00768690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358658|NCT00768690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65358659|NCT00768690|Hormone Antagonists|hormone antagonists|mesh-ancestor
65273577|NCT00621036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358660|NCT00768690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65358661|NCT00768690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358662|NCT00768690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65358663|NCT00768768|Terbinafine|terbinafine|mesh-list
65358664|NCT00768768|Antifungal Agents|antifungal agents|mesh-ancestor
65358665|NCT00768768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65358666|NCT00768768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358667|NCT00768768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358668|NCT00775086|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65358669|NCT00775086|Norelgestromin|norelgestromin|mesh-list
65358670|NCT00775086|Contraceptive Agents|contraceptive agents|mesh-list
65358671|NCT00775086|Estradiol|estradiol|mesh-list
65358688|NCT02557854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358690|NCT02557386|Anesthetics, Local|anesthetics, local|mesh-ancestor
65358691|NCT02557386|Anesthetics|anesthetics|mesh-ancestor
65358692|NCT02557386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65358693|NCT02557386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358694|NCT02557386|Sensory System Agents|sensory system agents|mesh-ancestor
65358695|NCT02557386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65358696|NCT00986050|Sirolimus|sirolimus|mesh-list
65358697|NCT00986050|Abciximab|abciximab|mesh-list
65358698|NCT00986050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65358699|NCT00986050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65358700|NCT00986050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65358701|NCT00986050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358702|NCT00986050|Antifungal Agents|antifungal agents|mesh-ancestor
65358703|NCT00986050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65358704|NCT00986050|Immunologic Factors|immunologic factors|mesh-ancestor
65358705|NCT00986050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358706|NCT00986050|Anticoagulants|anticoagulants|mesh-ancestor
65358707|NCT00986050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65358708|NCT00986128|Topiramate|topiramate|mesh-list
65358709|NCT00986128|Anticonvulsants|anticonvulsants|mesh-ancestor
65358710|NCT00986128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65358711|NCT00986128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358712|NCT00771342|Nitric Oxide|nitric oxide|mesh-list
65358713|NCT00771342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65358714|NCT00771342|Autonomic Agents|autonomic agents|mesh-ancestor
65358715|NCT00771342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65358716|NCT00771342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358717|NCT00771342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65358718|NCT00771342|Respiratory System Agents|respiratory system agents|mesh-ancestor
65358719|NCT00771342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65358720|NCT00771342|Antioxidants|antioxidants|mesh-ancestor
65358721|NCT00771342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358722|NCT00771342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65358723|NCT00771342|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65358724|NCT00771342|Vasodilator Agents|vasodilator agents|mesh-ancestor
65358725|NCT00771342|Gasotransmitters|gasotransmitters|mesh-ancestor
65358726|NCT00771342|Protective Agents|protective agents|mesh-ancestor
65358727|NCT00775164|Metformin|metformin|mesh-list
65358728|NCT00775164|Pioglitazone|pioglitazone|mesh-list
65358729|NCT00775164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65358749|NCT04767256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65358750|NCT04767256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65358751|NCT04767256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65358752|NCT04767256|Analgesics|analgesics|mesh-ancestor
65358753|NCT04767256|Sensory System Agents|sensory system agents|mesh-ancestor
65358754|NCT04767256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65358755|NCT04767256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65358756|NCT04767256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65358757|NCT04767256|Adrenergic Agents|adrenergic agents|mesh-ancestor
65358758|NCT04767256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65358759|NCT04767256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358760|NCT00771498|Lopinavir|lopinavir|mesh-list
65358761|NCT00771498|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65358762|NCT00771498|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65358763|NCT00771498|Protease Inhibitors|protease inhibitors|mesh-ancestor
65358764|NCT00771498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108620|NCT02907593|Budesonide|budesonide|mesh-list
65358765|NCT00771498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358766|NCT00771498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65358767|NCT00771498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65273578|NCT00621036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65358768|NCT00771498|Antiviral Agents|antiviral agents|mesh-ancestor
65358769|NCT00771498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65358770|NCT00771498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65358771|NCT00771498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65358773|NCT00986284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358774|NCT00986284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65358775|NCT00986284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358776|NCT00986284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358777|NCT00988780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65358778|NCT00988780|Efavirenz|efavirenz|mesh-list
65358779|NCT00988780|Maraviroc|maraviroc|mesh-list
65358780|NCT00988780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65358781|NCT00988780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65358782|NCT00988780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358783|NCT00988780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358784|NCT00988780|Antiviral Agents|antiviral agents|mesh-ancestor
65358807|NCT00775242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65358809|NCT00775242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65358810|NCT00775242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65358811|NCT00769158|Topiramate|topiramate|mesh-list
65358812|NCT00769158|Naltrexone|naltrexone|mesh-list
65358813|NCT00769158|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65358814|NCT00769158|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65358815|NCT00769158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358816|NCT00769158|Sensory System Agents|sensory system agents|mesh-ancestor
65358817|NCT00769158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65358818|NCT00769158|Anticonvulsants|anticonvulsants|mesh-ancestor
65358819|NCT00769158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65358820|NCT00983164|Antioxidants|antioxidants|mesh-list
65358821|NCT00983164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358822|NCT00983164|Protective Agents|protective agents|mesh-ancestor
65358823|NCT00983164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358824|NCT00333775|Bevacizumab|bevacizumab|mesh-list
65358825|NCT00333775|Docetaxel|docetaxel|mesh-list
65358826|NCT00333775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65358827|NCT00333775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358828|NCT00333775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65358829|NCT00333775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65358830|NCT00333775|Growth Substances|growth substances|mesh-ancestor
65358831|NCT00333775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358832|NCT00333775|Growth Inhibitors|growth inhibitors|mesh-ancestor
65358833|NCT00333775|Tubulin Modulators|tubulin modulators|mesh-ancestor
65358834|NCT00333775|Antimitotic Agents|antimitotic agents|mesh-ancestor
65358835|NCT00333775|Mitosis Modulators|mitosis modulators|mesh-ancestor
65358857|NCT00986596|Cholecalciferol|cholecalciferol|mesh-list
65358858|NCT00986596|Vitamins|vitamins|mesh-ancestor
65358859|NCT00986596|Micronutrients|micronutrients|mesh-ancestor
65358860|NCT00986596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358861|NCT00986596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65358862|NCT00986596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65358863|NCT00769470|Carboplatin|carboplatin|mesh-list
65358864|NCT00769470|Docetaxel|docetaxel|mesh-list
65358865|NCT00769470|Trastuzumab|trastuzumab|mesh-list
65358866|NCT00769470|Lapatinib|lapatinib|mesh-list
65358867|NCT00769470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358868|NCT00769470|Tubulin Modulators|tubulin modulators|mesh-ancestor
65358869|NCT00769470|Antimitotic Agents|antimitotic agents|mesh-ancestor
65358870|NCT00769470|Mitosis Modulators|mitosis modulators|mesh-ancestor
65358871|NCT00769470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358872|NCT00769470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65358873|NCT00769470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65358874|NCT00769470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358875|NCT00605319|Fesoterodine|fesoterodine|mesh-list
65358876|NCT00605319|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65358877|NCT00605319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65358878|NCT00605319|Cholinergic Agents|cholinergic agents|mesh-ancestor
65358879|NCT00605319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65358880|NCT00605319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358881|NCT00605319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358882|NCT00605319|Urological Agents|urological agents|mesh-ancestor
65358883|NCT00983320|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65358884|NCT00983320|Antidepressive Agents|antidepressive agents|mesh-ancestor
65273579|NCT00621036|Antimetabolites|antimetabolites|mesh-ancestor
64471672|NCT04267887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65358885|NCT00983320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65358886|NCT00983320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65358887|NCT00983320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65358888|NCT00983320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65358889|NCT00983320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358890|NCT00908661|Cellulose, Oxidized|cellulose, oxidized|mesh-list
65358923|NCT00769548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65358924|NCT00769548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358925|NCT00769548|Androgen Antagonists|androgen antagonists|mesh-ancestor
65358926|NCT00769548|Hormone Antagonists|hormone antagonists|mesh-ancestor
65358927|NCT00769548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65358928|NCT00769548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358929|NCT05277675|Bevacizumab|bevacizumab|mesh-list
65358930|NCT05277675|Lenvatinib|lenvatinib|mesh-list
65358931|NCT05277675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65358932|NCT05277675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358933|NCT05277675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65358934|NCT05277675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65358935|NCT05277675|Growth Substances|growth substances|mesh-ancestor
65358936|NCT05277675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358937|NCT05277675|Growth Inhibitors|growth inhibitors|mesh-ancestor
65358938|NCT05277675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65358952|NCT00983554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65358953|NCT00983554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358954|NCT00983554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65358955|NCT00983554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358956|NCT00983554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65358957|NCT00983554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65358959|NCT00983554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358960|NCT00983554|Hormone Antagonists|hormone antagonists|mesh-ancestor
65358961|NCT00983554|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65358962|NCT00983554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65358963|NCT05004987|Dexetimide|dexetimide|mesh-list
65358964|NCT05004987|Citalopram|citalopram|mesh-list
65358965|NCT05004987|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65358966|NCT05004987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65358967|NCT05004987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65358968|NCT05004987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358969|NCT05004987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65358970|NCT05004987|Serotonin Agents|serotonin agents|mesh-ancestor
65358971|NCT05004987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358972|NCT05004987|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65358973|NCT05004987|Antidepressive Agents|antidepressive agents|mesh-ancestor
65358974|NCT05004987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65358975|NCT05004987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65358976|NCT05004987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65358977|NCT05004987|Parasympatholytics|parasympatholytics|mesh-ancestor
65358978|NCT05004987|Autonomic Agents|autonomic agents|mesh-ancestor
65358979|NCT05004987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65358980|NCT05004987|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65358981|NCT05004987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65358982|NCT05004987|Cholinergic Agents|cholinergic agents|mesh-ancestor
65358983|NCT00908817|Chlorhexidine|chlorhexidine|mesh-list
65358984|NCT00908817|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65358985|NCT00908817|Triamcinolone|triamcinolone|mesh-list
65358986|NCT00908817|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65358987|NCT00908817|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65358988|NCT00908817|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65358989|NCT00908817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65358990|NCT00908817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65358991|NCT00908817|Disinfectants|disinfectants|mesh-ancestor
65358992|NCT00908817|Dermatologic Agents|dermatologic agents|mesh-ancestor
65358993|NCT00908817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65358994|NCT00908817|Glucocorticoids|glucocorticoids|mesh-ancestor
65358996|NCT00908817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65358997|NCT00908817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358998|NCT00908817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65358999|NCT00908817|Immunologic Factors|immunologic factors|mesh-ancestor
65359000|NCT00908817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359001|NCT00908817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359026|NCT05712616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65359027|NCT05712616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359028|NCT00927225|Ropivacaine|ropivacaine|mesh-list
65359029|NCT00927225|Anesthetics, Local|anesthetics, local|mesh-ancestor
65359030|NCT00927225|Anesthetics|anesthetics|mesh-ancestor
65359031|NCT00927225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65359032|NCT00927225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359033|NCT00927225|Sensory System Agents|sensory system agents|mesh-ancestor
65359034|NCT00927225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65359035|NCT00357097|Ropinirole|ropinirole|mesh-list
65359036|NCT00357097|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65359037|NCT00357097|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65359038|NCT00357097|Dopamine Agonists|dopamine agonists|mesh-ancestor
65359039|NCT00357097|Dopamine Agents|dopamine agents|mesh-ancestor
65359040|NCT00357097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65359041|NCT00357097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359042|NCT00357097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359043|NCT00983788|Bezafibrate|bezafibrate|mesh-list
65359044|NCT00983788|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65359045|NCT00983788|Antimetabolites|antimetabolites|mesh-ancestor
65359046|NCT00983788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359047|NCT00983788|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65359048|NCT00909051|Acarbose|acarbose|mesh-list
65359049|NCT00909051|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65359050|NCT00909051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359051|NCT00909051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359052|NCT00909051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65359053|NCT00909051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359087|NCT00927537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65359088|NCT00927537|Diuretics|diuretics|mesh-ancestor
65359089|NCT00927537|Natriuretic Agents|natriuretic agents|mesh-ancestor
65359090|NCT00927537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359091|NCT00927537|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65359092|NCT00927537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65359093|NCT00927537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359094|NCT00927537|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65359095|NCT00927537|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65359125|NCT01053403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65359127|NCT01053403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65359128|NCT01053403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359129|NCT01053403|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65359130|NCT01053403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65359131|NCT01053403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65359132|NCT01053403|Adrenergic Agents|adrenergic agents|mesh-ancestor
65359133|NCT00927615|Abciximab|abciximab|mesh-list
65359134|NCT00927615|Anticoagulants|anticoagulants|mesh-ancestor
65359135|NCT00927615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65359136|NCT03990103|Paclitaxel|paclitaxel|mesh-list
65359137|NCT03990103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65359138|NCT03990103|Bevacizumab|bevacizumab|mesh-list
65359139|NCT03990103|Oxaliplatin|oxaliplatin|mesh-list
65359140|NCT03990103|Tegafur|tegafur|mesh-list
65108990|NCT00535470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359174|NCT01581151|Glucocorticoids|glucocorticoids|mesh-ancestor
65359175|NCT01581151|Hormones|hormones|mesh-ancestor
65359176|NCT01581151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65359177|NCT01581151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65359178|NCT01581151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359179|NCT01581151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65359180|NCT01581151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65359181|NCT01581151|Growth Substances|growth substances|mesh-ancestor
65359203|NCT01053637|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65359205|NCT01053637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65359206|NCT01053637|Analgesics|analgesics|mesh-ancestor
65359207|NCT01053637|Sensory System Agents|sensory system agents|mesh-ancestor
65359208|NCT01053637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65359209|NCT01053637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359210|NCT01053637|Antipyretics|antipyretics|mesh-ancestor
65359211|NCT01053637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65359212|NCT01053637|Narcotics|narcotics|mesh-ancestor
65359213|NCT01053637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65359214|NCT01053637|Antitussive Agents|antitussive agents|mesh-ancestor
65359215|NCT01053637|Respiratory System Agents|respiratory system agents|mesh-ancestor
65359216|NCT01053637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65359217|NCT01053637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65359218|NCT01053637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65359219|NCT00928161|Dexlansoprazole|dexlansoprazole|mesh-list
65359220|NCT00928161|Lansoprazole|lansoprazole|mesh-list
65359221|NCT00928161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65359222|NCT00928161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65359223|NCT00928161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65359224|NCT00928161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359225|NCT00928161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359226|NCT00909519|Naproxen|naproxen|mesh-list
65359227|NCT00909519|Furosemide|furosemide|mesh-list
65359228|NCT00909519|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
65359229|NCT00909519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65359230|NCT00909519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65359231|NCT00909519|Analgesics|analgesics|mesh-ancestor
65359232|NCT00909519|Sensory System Agents|sensory system agents|mesh-ancestor
65359233|NCT00909519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65359234|NCT00909519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359235|NCT00909519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65359236|NCT00909519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65359242|NCT00909519|Natriuretic Agents|natriuretic agents|mesh-ancestor
65359243|NCT00909519|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65359244|NCT00909519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65359245|NCT00909519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65359246|NCT00355615|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65359247|NCT00355615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65359248|NCT00355615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65359249|NCT00355615|Antimetabolites|antimetabolites|mesh-ancestor
65359250|NCT00355615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359251|NCT00355615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65359252|NCT00355615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65359253|NCT00355615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359254|NCT00907179|Pemetrexed|pemetrexed|mesh-list
65359255|NCT00907179|Panobinostat|panobinostat|mesh-list
65359256|NCT00907179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359257|NCT00907179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359258|NCT00907179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359259|NCT00907179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65359260|NCT00907179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65359261|NCT00907179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65359262|NCT00347269|Psychotropic Drugs|psychotropic drugs|mesh-list
65359263|NCT00544648|Paclitaxel|paclitaxel|mesh-list
65359264|NCT00544648|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65359265|NCT00544648|Carboplatin|carboplatin|mesh-list
65359266|NCT00544648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65359267|NCT00544648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359268|NCT00544648|Tubulin Modulators|tubulin modulators|mesh-ancestor
65359269|NCT00544648|Antimitotic Agents|antimitotic agents|mesh-ancestor
65359270|NCT00544648|Mitosis Modulators|mitosis modulators|mesh-ancestor
65359271|NCT00544648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359272|NCT01053871|Fentanyl|fentanyl|mesh-list
65359273|NCT01053871|Midazolam|midazolam|mesh-list
65359274|NCT01053871|Propofol|propofol|mesh-list
65359275|NCT01053871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65359276|NCT01053871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65359277|NCT01053871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359278|NCT01053871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65359279|NCT01053871|Anesthetics, General|anesthetics, general|mesh-ancestor
65359280|NCT01053871|Anesthetics|anesthetics|mesh-ancestor
65359281|NCT01053871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65359282|NCT01053871|Narcotics|narcotics|mesh-ancestor
65359283|NCT01053871|Analgesics|analgesics|mesh-ancestor
65359284|NCT01053871|Sensory System Agents|sensory system agents|mesh-ancestor
65359285|NCT01053871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65359286|NCT01053871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65359287|NCT01053871|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65359288|NCT01053871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65359289|NCT01053871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65359290|NCT01053871|GABA Modulators|gaba modulators|mesh-ancestor
65359291|NCT01053871|GABA Agents|gaba agents|mesh-ancestor
65359292|NCT01053871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65359293|NCT01053871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359294|NCT01053949|Thalidomide|thalidomide|mesh-list
65359295|NCT01053949|Pomalidomide|pomalidomide|mesh-list
65359296|NCT01053949|Immunologic Factors|immunologic factors|mesh-ancestor
65359297|NCT01053949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359298|NCT01053949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65359299|NCT01053949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65359300|NCT01053949|Growth Substances|growth substances|mesh-ancestor
65359301|NCT01053949|Growth Inhibitors|growth inhibitors|mesh-ancestor
65359302|NCT01053949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359303|NCT01053949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65359304|NCT01053949|Leprostatic Agents|leprostatic agents|mesh-ancestor
65359305|NCT01053949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65359306|NCT01053949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65359307|NCT00987376|Choline|choline|mesh-list
65359315|NCT00987454|Epoetin Alfa|epoetin alfa|mesh-list
65359316|NCT00987454|Hematinics|hematinics|mesh-ancestor
65359317|NCT04005664|Phenylephrine|phenylephrine|mesh-list
65359318|NCT04005664|Oxymetazoline|oxymetazoline|mesh-list
65359319|NCT04005664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65359320|NCT04005664|Mydriatics|mydriatics|mesh-ancestor
65359321|NCT04005664|Autonomic Agents|autonomic agents|mesh-ancestor
65359322|NCT04005664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65359323|NCT04005664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359324|NCT04005664|Sympathomimetics|sympathomimetics|mesh-ancestor
65359325|NCT04005664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65359326|NCT04005664|Nasal Decongestants|nasal decongestants|mesh-ancestor
65359327|NCT04005664|Respiratory System Agents|respiratory system agents|mesh-ancestor
65359328|NCT04005664|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65359329|NCT04005664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65359330|NCT04005664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65359331|NCT04005664|Adrenergic Agents|adrenergic agents|mesh-ancestor
65359332|NCT04005664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65359333|NCT04005664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359334|NCT04005664|Protective Agents|protective agents|mesh-ancestor
65359335|NCT00330967|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65359336|NCT00330967|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65359337|NCT00330967|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65359338|NCT00330967|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65359339|NCT00924573|Metformin|metformin|mesh-list
65359340|NCT00924573|Glimepiride|glimepiride|mesh-list
65359341|NCT00924573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65359342|NCT00924573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359343|NCT00924573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65359344|NCT00924573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65359345|NCT00924573|Immunologic Factors|immunologic factors|mesh-ancestor
65359346|NCT01054027|Phenylephrine|phenylephrine|mesh-list
65359347|NCT01054027|Oxymetazoline|oxymetazoline|mesh-list
65359348|NCT01054027|Cyclopentolate|cyclopentolate|mesh-list
65359349|NCT01054027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65359350|NCT01054027|Mydriatics|mydriatics|mesh-ancestor
65359351|NCT01054027|Autonomic Agents|autonomic agents|mesh-ancestor
65359352|NCT01054027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65359353|NCT01054027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359354|NCT01054027|Sympathomimetics|sympathomimetics|mesh-ancestor
65359355|NCT01054027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65359356|NCT01054027|Nasal Decongestants|nasal decongestants|mesh-ancestor
65359357|NCT01054027|Respiratory System Agents|respiratory system agents|mesh-ancestor
65359358|NCT01054027|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65359359|NCT01054027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65359360|NCT01054027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65359361|NCT01054027|Adrenergic Agents|adrenergic agents|mesh-ancestor
65359362|NCT01054027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65359363|NCT01054027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359364|NCT01054027|Protective Agents|protective agents|mesh-ancestor
65359365|NCT01054027|Parasympatholytics|parasympatholytics|mesh-ancestor
65359366|NCT01054027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65359367|NCT01054027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65359368|NCT01054027|Cholinergic Agents|cholinergic agents|mesh-ancestor
65359369|NCT01054105|Iloprost|iloprost|mesh-list
65359370|NCT01054105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65359371|NCT01054105|Vasodilator Agents|vasodilator agents|mesh-ancestor
65359372|NCT00330343|Naloxone|naloxone|mesh-list
65359373|NCT00330343|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65359374|NCT00330343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359375|NCT00330343|Sensory System Agents|sensory system agents|mesh-ancestor
65359376|NCT00330343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64730129|NCT00386282|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65359377|NCT00987766|Gemcitabine|gemcitabine|mesh-list
65359389|NCT00987766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359390|NCT00987766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65359391|NCT04005430|Dexamethasone|dexamethasone|mesh-list
65359392|NCT04005430|Dexamethasone acetate|dexamethasone acetate|mesh-list
65359393|NCT04005430|BB 1101|bb 1101|mesh-list
65359394|NCT04005430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65359395|NCT04005430|Antiemetics|antiemetics|mesh-ancestor
65359396|NCT04005430|Autonomic Agents|autonomic agents|mesh-ancestor
65359397|NCT04005430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65359398|NCT04005430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359399|NCT04005430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65359400|NCT04005430|Glucocorticoids|glucocorticoids|mesh-ancestor
65359401|NCT04005430|Hormones|hormones|mesh-ancestor
65359402|NCT04005430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65359403|NCT04005430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65359404|NCT04005430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359405|NCT04005430|Protease Inhibitors|protease inhibitors|mesh-ancestor
65359406|NCT04005430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359407|NCT04005430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359408|NCT00330187|Bupropion|bupropion|mesh-list
65359409|NCT00330187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65359410|NCT00330187|Antidepressive Agents|antidepressive agents|mesh-ancestor
65359411|NCT00330187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65359412|NCT00330187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65359413|NCT00330187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65359414|NCT00330187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65359415|NCT00330187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359416|NCT00330187|Dopamine Agents|dopamine agents|mesh-ancestor
65359417|NCT00330187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65359418|NCT00330187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359419|NCT00330187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65359420|NCT00330187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65359421|NCT00330187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359422|NCT00987844|Prucalopride|prucalopride|mesh-list
65359423|NCT00987844|Laxatives|laxatives|mesh-ancestor
65359424|NCT00987844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65359425|NCT00987844|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65359426|NCT00987844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65359427|NCT00987844|Serotonin Agents|serotonin agents|mesh-ancestor
65359428|NCT00987844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65359429|NCT00987844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359430|NCT00987844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359431|NCT03986905|Scopolamine|scopolamine|mesh-list
65359432|NCT03986905|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65359433|NCT03986905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65359434|NCT03986905|Antiemetics|antiemetics|mesh-ancestor
65359435|NCT03986905|Autonomic Agents|autonomic agents|mesh-ancestor
65359436|NCT03986905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65359437|NCT03986905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359438|NCT03986905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65359439|NCT03986905|Mydriatics|mydriatics|mesh-ancestor
64751528|NCT00088452|Valproic Acid|valproic acid|mesh-list
65359460|NCT00329797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65359461|NCT00541450|Metformin|metformin|mesh-list
65359462|NCT00541450|Pioglitazone|pioglitazone|mesh-list
65359463|NCT00541450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65359464|NCT00541450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65359465|NCT00541450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359466|NCT00541450|Incretins|incretins|mesh-ancestor
65359467|NCT00541450|Hormones|hormones|mesh-ancestor
65359468|NCT00541450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65359469|NCT00541450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65359470|NCT00541450|Protease Inhibitors|protease inhibitors|mesh-ancestor
65359471|NCT00541450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359472|NCT00541450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359473|NCT01056679|Doxorubicin|doxorubicin|mesh-list
65359474|NCT01056679|Lenalidomide|lenalidomide|mesh-list
65359475|NCT01056679|Vinblastine|vinblastine|mesh-list
65359476|NCT01056679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65359477|NCT01056679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359478|NCT01056679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65359479|NCT01056679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64730745|NCT02461927|Anesthetics|anesthetics|mesh-ancestor
65359480|NCT01056679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359481|NCT01056679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359482|NCT01056679|Immunologic Factors|immunologic factors|mesh-ancestor
65359483|NCT01056679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359484|NCT01056679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65359485|NCT01056679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65359486|NCT01056679|Growth Substances|growth substances|mesh-ancestor
65359487|NCT01056679|Growth Inhibitors|growth inhibitors|mesh-ancestor
65359488|NCT01056679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65359489|NCT01056679|Tubulin Modulators|tubulin modulators|mesh-ancestor
65359490|NCT01056679|Antimitotic Agents|antimitotic agents|mesh-ancestor
65359491|NCT01056679|Mitosis Modulators|mitosis modulators|mesh-ancestor
65359492|NCT04769362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65359493|NCT04769362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65359494|NCT04769362|Adrenergic Agents|adrenergic agents|mesh-ancestor
65359495|NCT04769362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65359496|NCT04769362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359497|NCT04769362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751594|NCT01679574|Metformin|metformin|mesh-list
65359518|NCT05546242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359519|NCT05546242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65359520|NCT05546242|Antiviral Agents|antiviral agents|mesh-ancestor
65359521|NCT05546242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65359522|NCT05546242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65359523|NCT05546242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65359525|NCT04690504|Antioxidants|antioxidants|mesh-ancestor
65359526|NCT04690504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359527|NCT04690504|Protective Agents|protective agents|mesh-ancestor
65359528|NCT04690504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359529|NCT04690504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65359530|NCT00540124|Tadalafil|tadalafil|mesh-list
65359531|NCT00540124|Tamsulosin|tamsulosin|mesh-list
65359532|NCT00540124|Vasodilator Agents|vasodilator agents|mesh-ancestor
65359533|NCT00540124|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65359534|NCT00540124|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65359535|NCT00540124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359536|NCT00540124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359537|NCT00540124|Urological Agents|urological agents|mesh-ancestor
65359538|NCT00540124|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65359539|NCT00540124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65359540|NCT00540124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65359541|NCT00540124|Adrenergic Agents|adrenergic agents|mesh-ancestor
65359542|NCT00540124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65359543|NCT00540124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359544|NCT00540046|Copper|copper|mesh-list
65359545|NCT00540046|Trace Elements|trace elements|mesh-ancestor
65359546|NCT00540046|Micronutrients|micronutrients|mesh-ancestor
65359547|NCT00540046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359548|NCT05677126|Copper|copper|mesh-list
65359549|NCT05677126|Trace Elements|trace elements|mesh-list
65359550|NCT05677126|Selenious Acid|selenious acid|mesh-list
65359551|NCT05677126|Micronutrients|micronutrients|mesh-list
65359552|NCT05677126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359571|NCT00689936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65359573|NCT00689936|Autonomic Agents|autonomic agents|mesh-ancestor
65359574|NCT00689936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65359575|NCT00689936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359576|NCT00689936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65359577|NCT00689936|Glucocorticoids|glucocorticoids|mesh-ancestor
65359578|NCT00689936|Hormones|hormones|mesh-ancestor
65359579|NCT00689936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65359580|NCT00689936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65359581|NCT00689936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359582|NCT00689936|Protease Inhibitors|protease inhibitors|mesh-ancestor
65359583|NCT00689936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359584|NCT00689936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359585|NCT00689936|Immunologic Factors|immunologic factors|mesh-ancestor
65359586|NCT00689936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65359587|NCT00689936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65359588|NCT00689936|Growth Substances|growth substances|mesh-ancestor
65359589|NCT00689936|Growth Inhibitors|growth inhibitors|mesh-ancestor
65359590|NCT00689936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65359591|NCT00689936|Alkylating Agents|alkylating agents|mesh-ancestor
65359592|NCT00689936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65359593|NCT00689936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65359594|NCT00689936|Leprostatic Agents|leprostatic agents|mesh-ancestor
65359595|NCT00689936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65359596|NCT00689936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65359597|NCT05661682|Zinc|zinc|mesh-list
65359598|NCT05661682|Copper|copper|mesh-list
65359599|NCT05661682|Manganese|manganese|mesh-list
65359600|NCT05661682|Trace Elements|trace elements|mesh-list
65359601|NCT05661682|Selenious Acid|selenious acid|mesh-list
65359602|NCT05661682|Micronutrients|micronutrients|mesh-list
65359603|NCT05661682|Copper Sulfate|copper sulfate|mesh-list
65359604|NCT05661682|Zinc Sulfate|zinc sulfate|mesh-list
65359605|NCT05661682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359606|NCT05661682|Astringents|astringents|mesh-ancestor
65359607|NCT05661682|Dermatologic Agents|dermatologic agents|mesh-ancestor
65359608|NCT05661682|Antidotes|antidotes|mesh-ancestor
65359609|NCT05661682|Protective Agents|protective agents|mesh-ancestor
65359610|NCT05661682|Emetics|emetics|mesh-ancestor
65359611|NCT05661682|Autonomic Agents|autonomic agents|mesh-ancestor
65359612|NCT05661682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65359613|NCT05661682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65359614|NCT01563718|Naltrexone|naltrexone|mesh-list
65359615|NCT01563718|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65359616|NCT01563718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65359652|NCT00671034|2-Aminopurine|2-aminopurine|mesh-list
65359653|NCT00671034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65359654|NCT00671034|Immunologic Factors|immunologic factors|mesh-ancestor
65359655|NCT00671034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359656|NCT00671034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65359657|NCT00671034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65359658|NCT00671034|Alkylating Agents|alkylating agents|mesh-ancestor
65359659|NCT00671034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359660|NCT00671034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359661|NCT00671034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65359662|NCT00671034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65359685|NCT00671034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65359686|NCT00671034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65359687|NCT00671034|Tubulin Modulators|tubulin modulators|mesh-ancestor
65359688|NCT00671034|Antimitotic Agents|antimitotic agents|mesh-ancestor
65359689|NCT00671034|Mitosis Modulators|mitosis modulators|mesh-ancestor
65359690|NCT04622228|Carboplatin|carboplatin|mesh-list
65359691|NCT04622228|Etoposide|etoposide|mesh-list
65359692|NCT04622228|Atezolizumab|atezolizumab|mesh-list
65359693|NCT04622228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359694|NCT04622228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65359695|NCT04622228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65359696|NCT04622228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65359697|NCT04622228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359698|NCT04622228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359699|NCT04425070|Gemcitabine|gemcitabine|mesh-list
65359700|NCT04425070|Carboplatin|carboplatin|mesh-list
65359701|NCT04425070|Oxaliplatin|oxaliplatin|mesh-list
65359702|NCT04425070|Etoposide|etoposide|mesh-list
65359703|NCT04425070|Ifosfamide|ifosfamide|mesh-list
65359704|NCT04425070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359705|NCT04425070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65359706|NCT04425070|Antimetabolites|antimetabolites|mesh-ancestor
65359707|NCT04425070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359708|NCT04425070|Antiviral Agents|antiviral agents|mesh-ancestor
65359709|NCT04425070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65359710|NCT04425070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359711|NCT04425070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65359712|NCT04425070|Immunologic Factors|immunologic factors|mesh-ancestor
65359713|NCT04425070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751804|NCT05345808|Hormones|hormones|mesh-ancestor
65359747|NCT00775632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359748|NCT00775632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359749|NCT00775632|Dermatologic Agents|dermatologic agents|mesh-ancestor
65359750|NCT00775632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359751|NCT00775632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65359752|NCT00775632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65359753|NCT00775632|Immunologic Factors|immunologic factors|mesh-ancestor
65359754|NCT00775632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65359755|NCT00775632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65359787|NCT04394182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65359788|NCT04394182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65359790|NCT04394182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64733107|NCT00004339|Trientine|trientine|mesh-list
65359791|NCT04394182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65359792|NCT04394182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65359793|NCT04394182|Antimalarials|antimalarials|mesh-ancestor
65359794|NCT04394182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65359795|NCT04394182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65359796|NCT04394182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65359797|NCT04394182|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65359798|NCT05386576|Venetoclax|venetoclax|mesh-list
65359799|NCT05386576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359800|NCT04146922|Anti-Infective Agents|anti-infective agents|mesh-list
65359801|NCT04146922|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65359802|NCT05325580|Magnesium Sulfate|magnesium sulfate|mesh-list
65359803|NCT05325580|Analgesics|analgesics|mesh-ancestor
65359804|NCT05325580|Sensory System Agents|sensory system agents|mesh-ancestor
65359805|NCT05325580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65359827|NCT04050436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65359828|NCT04050436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359830|NCT01093976|Hallucinogens|hallucinogens|mesh-ancestor
65359831|NCT01093976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359832|NCT01093976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65359833|NCT01093976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65359834|NCT01093976|Analgesics|analgesics|mesh-ancestor
65359835|NCT01093976|Sensory System Agents|sensory system agents|mesh-ancestor
65359836|NCT01093976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65359837|NCT01093976|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65359838|NCT01093976|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65359839|NCT01093976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65359840|NCT01093976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359841|NCT01093976|Hormones|hormones|mesh-ancestor
65359842|NCT01093976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65359843|NCT00329719|Sirolimus|sirolimus|mesh-list
65359844|NCT00329719|Sorafenib|sorafenib|mesh-list
65359845|NCT00329719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359846|NCT00329719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65359847|NCT00329719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359848|NCT00329719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359849|NCT00329719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65359850|NCT00329719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65359851|NCT00329719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65359852|NCT00329719|Antifungal Agents|antifungal agents|mesh-ancestor
65359853|NCT00329719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65359854|NCT00329719|Immunologic Factors|immunologic factors|mesh-ancestor
65359855|NCT00329719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359856|NCT04008628|Nitrous Oxide|nitrous oxide|mesh-list
65359857|NCT04008628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65359887|NCT00743912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65359888|NCT04060472|Paclitaxel|paclitaxel|mesh-list
65359889|NCT04060472|Oxaliplatin|oxaliplatin|mesh-list
65359890|NCT04060472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65359891|NCT04060472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65359892|NCT04060472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359893|NCT04060472|Tubulin Modulators|tubulin modulators|mesh-ancestor
65359894|NCT04060472|Antimitotic Agents|antimitotic agents|mesh-ancestor
65359895|NCT04060472|Mitosis Modulators|mitosis modulators|mesh-ancestor
65359896|NCT04060472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359897|NCT00329641|Paclitaxel|paclitaxel|mesh-list
65359898|NCT00329641|Carboplatin|carboplatin|mesh-list
65359899|NCT00329641|Sorafenib|sorafenib|mesh-list
65359900|NCT00329641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65359933|NCT01056835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65359935|NCT03986515|Apatinib|apatinib|mesh-list
65359936|NCT03986515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359937|NCT03986515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65359938|NCT03986515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359939|NCT03986515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359940|NCT00567489|Icodextrin|icodextrin|mesh-list
65359941|NCT00567489|Dialysis Solutions|dialysis solutions|mesh-ancestor
65359942|NCT00567489|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65359943|NCT02538393|Sorafenib|sorafenib|mesh-list
65359944|NCT02538393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359945|NCT02538393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65359946|NCT02538393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019548|NCT02917018|Sensory System Agents|sensory system agents|mesh-ancestor
65359957|NCT00924963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65359958|NCT00924963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65273580|NCT00621036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733263|NCT00004933|Hydroxyurea|hydroxyurea|mesh-list
65359959|NCT00924963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359960|NCT00669864|Metformin|metformin|mesh-list
65359961|NCT00669864|Insulin Aspart|insulin aspart|mesh-list
65359962|NCT00669864|Biphasic Insulins|biphasic insulins|mesh-list
65359963|NCT00669864|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65359964|NCT00669864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65359965|NCT00669864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359966|NCT00770172|Lenograstim|lenograstim|mesh-list
65359967|NCT00770172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65359968|NCT00770172|Immunologic Factors|immunologic factors|mesh-ancestor
65359969|NCT00770172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359970|NCT00776022|Cetirizine|cetirizine|mesh-list
65359971|NCT00776022|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65359972|NCT00776022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65359973|NCT00776022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65359974|NCT00776022|Histamine Antagonists|histamine antagonists|mesh-ancestor
65359975|NCT00776022|Histamine Agents|histamine agents|mesh-ancestor
65359976|NCT00776022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65359977|NCT00776022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359978|NCT00776022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359979|NCT00772902|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65359980|NCT00772902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65359981|NCT00772902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65359982|NCT00772902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359983|NCT00772902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359984|NCT00772902|Antiviral Agents|antiviral agents|mesh-ancestor
65359985|NCT00772902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65359986|NCT00772902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65359987|NCT00772902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65359988|NCT00779220|Methotrexate|methotrexate|mesh-list
65359989|NCT00779220|Ocrelizumab|ocrelizumab|mesh-list
65359990|NCT00779220|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65359991|NCT00779220|Abortifacient Agents|abortifacient agents|mesh-ancestor
65359992|NCT00779220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65359993|NCT00779220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359994|NCT00779220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65359995|NCT00779220|Antimetabolites|antimetabolites|mesh-ancestor
65359996|NCT00779220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359997|NCT00779220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359998|NCT00779220|Dermatologic Agents|dermatologic agents|mesh-ancestor
65359999|NCT00779220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360000|NCT00779220|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65360001|NCT00779220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65360002|NCT00779220|Immunologic Factors|immunologic factors|mesh-ancestor
65360003|NCT00779220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65360004|NCT00779220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65360005|NCT00779376|Zidovudine|zidovudine|mesh-list
65360006|NCT00779376|Antimetabolites|antimetabolites|mesh-ancestor
65360007|NCT00779376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360026|NCT00779454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65360027|NCT00779454|Immunologic Factors|immunologic factors|mesh-ancestor
65360028|NCT00779454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360029|NCT00779454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65360031|NCT00773058|Glucocorticoids|glucocorticoids|mesh-list
65360032|NCT00773058|Hormones|hormones|mesh-ancestor
65360033|NCT00773058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65360034|NCT00773058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360035|NCT00773058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65360036|NCT00776334|Fosinopril|fosinopril|mesh-list
65360037|NCT00776334|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65360038|NCT00776334|Protease Inhibitors|protease inhibitors|mesh-ancestor
65360039|NCT00776334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360040|NCT00776334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360041|NCT00776334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65360042|NCT00668148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65360043|NCT00668148|Immunologic Factors|immunologic factors|mesh-ancestor
65360044|NCT00668148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360045|NCT00667992|Budesonide|budesonide|mesh-list
65360046|NCT00667992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65360047|NCT00667992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65360048|NCT00667992|Autonomic Agents|autonomic agents|mesh-ancestor
65360049|NCT00667992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65360050|NCT00667992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360051|NCT00667992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65360052|NCT00667992|Respiratory System Agents|respiratory system agents|mesh-ancestor
65360053|NCT00667992|Glucocorticoids|glucocorticoids|mesh-ancestor
65360054|NCT00667992|Hormones|hormones|mesh-ancestor
65360055|NCT00667992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65360056|NCT00776490|Glimepiride|glimepiride|mesh-list
65360057|NCT00776490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65360058|NCT00776490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65360059|NCT00776490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360060|NCT00776490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65360061|NCT00776490|Immunologic Factors|immunologic factors|mesh-ancestor
65360062|NCT05109702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65360063|NCT05109702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65360064|NCT00776568|Antihypertensive Agents|antihypertensive agents|mesh-list
65360096|NCT00776802|Autonomic Agents|autonomic agents|mesh-ancestor
65360097|NCT00776802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65360098|NCT00776802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360099|NCT00776802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65360100|NCT00776802|Glucocorticoids|glucocorticoids|mesh-ancestor
65360101|NCT00776802|Hormones|hormones|mesh-ancestor
65360102|NCT00776802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65360103|NCT00776802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65360104|NCT00776802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360105|NCT00776802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65360106|NCT00776802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65360107|NCT00776802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65360108|NCT00776802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752209|NCT03227562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65360140|NCT00780780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65360142|NCT00780858|Ganirelix|ganirelix|mesh-list
65360143|NCT00780858|Hormone Antagonists|hormone antagonists|mesh-ancestor
65360144|NCT00780858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65360145|NCT00780858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360146|NCT00777114|Bortezomib|bortezomib|mesh-list
65360147|NCT00777114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360148|NCT00669396|Copper|copper|mesh-list
65360170|NCT00669318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360171|NCT00669318|Immunologic Factors|immunologic factors|mesh-ancestor
65360172|NCT00669318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360173|NCT00669318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65360174|NCT00669318|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65360175|NCT00669318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360176|NCT00669318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360177|NCT00774540|Ketorolac|ketorolac|mesh-list
65360178|NCT00774540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65360179|NCT00774540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65360180|NCT00774540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65360181|NCT00774540|Analgesics|analgesics|mesh-ancestor
65360182|NCT00774540|Sensory System Agents|sensory system agents|mesh-ancestor
65360183|NCT00774540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65360184|NCT00774540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360185|NCT00774540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65360186|NCT00774540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65360187|NCT00774540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65360188|NCT00774540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360189|NCT00774540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360190|NCT00669240|Varenicline|varenicline|mesh-list
65360191|NCT00669240|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65360192|NCT00669240|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65360193|NCT00669240|Cholinergic Agents|cholinergic agents|mesh-ancestor
65360194|NCT00669240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65360195|NCT00669240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360196|NCT00669240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360197|NCT00669162|Docetaxel|docetaxel|mesh-list
65360198|NCT00669162|Leuprolide|leuprolide|mesh-list
65360199|NCT00669162|Goserelin|goserelin|mesh-list
65360200|NCT00669162|Bicalutamide|bicalutamide|mesh-list
65360201|NCT00669162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360202|NCT00669162|Tubulin Modulators|tubulin modulators|mesh-ancestor
65360203|NCT00669162|Antimitotic Agents|antimitotic agents|mesh-ancestor
65273581|NCT00621036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734007|NCT02127372|Cisplatin|cisplatin|mesh-list
65360204|NCT00669162|Mitosis Modulators|mitosis modulators|mesh-ancestor
65360227|NCT02556060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65360229|NCT02556060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65360230|NCT02556060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65360231|NCT02556060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65360232|NCT02556060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65360233|NCT02556060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65360234|NCT00400946|Leucovorin|leucovorin|mesh-list
65360235|NCT00400946|Cytarabine|cytarabine|mesh-list
65360236|NCT00400946|Dexamethasone|dexamethasone|mesh-list
65360237|NCT00400946|Methylprednisolone|methylprednisolone|mesh-list
65360238|NCT00400946|Prednisolone|prednisolone|mesh-list
65360239|NCT00400946|Hydrocortisone|hydrocortisone|mesh-list
65360240|NCT00400946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65360241|NCT00400946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65360242|NCT00400946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65360243|NCT00400946|Cyclophosphamide|cyclophosphamide|mesh-list
65360244|NCT00400946|Doxorubicin|doxorubicin|mesh-list
65360245|NCT00400946|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65360246|NCT00400946|Methotrexate|methotrexate|mesh-list
65360247|NCT00400946|Etoposide|etoposide|mesh-list
65360248|NCT00400946|Vincristine|vincristine|mesh-list
65360249|NCT00400946|Asparaginase|asparaginase|mesh-list
65360250|NCT00400946|Mercaptopurine|mercaptopurine|mesh-list
65360251|NCT00400946|Pegaspargase|pegaspargase|mesh-list
65360252|NCT00400946|Dexrazoxane|dexrazoxane|mesh-list
65360253|NCT00400946|Razoxane|razoxane|mesh-list
65360254|NCT00400946|Levoleucovorin|levoleucovorin|mesh-list
64752358|NCT03249558|Morphine|morphine|mesh-list
65360283|NCT00400946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65360284|NCT00400946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65360285|NCT00400946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65360286|NCT00400946|Antiviral Agents|antiviral agents|mesh-ancestor
65360287|NCT00400946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65360288|NCT00400946|Antidotes|antidotes|mesh-ancestor
65360289|NCT00400946|Protective Agents|protective agents|mesh-ancestor
65360290|NCT00400946|Vitamin B Complex|vitamin b complex|mesh-ancestor
65360292|NCT00400946|Micronutrients|micronutrients|mesh-ancestor
65360293|NCT00400946|Tubulin Modulators|tubulin modulators|mesh-ancestor
65360294|NCT00400946|Antimitotic Agents|antimitotic agents|mesh-ancestor
65360295|NCT00400946|Mitosis Modulators|mitosis modulators|mesh-ancestor
65360296|NCT00400946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65360297|NCT00400946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65360298|NCT00354770|Acetylcysteine|acetylcysteine|mesh-list
65360299|NCT00354770|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65360333|NCT00744224|Incretins|incretins|mesh-ancestor
65360334|NCT00744302|Dialysis Solutions|dialysis solutions|mesh-list
65360336|NCT00744302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65360337|NCT00744302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360338|NCT00744302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65360339|NCT00666588|Cytarabine|cytarabine|mesh-list
65360340|NCT00666588|Etoposide|etoposide|mesh-list
65360341|NCT00666588|Idarubicin|idarubicin|mesh-list
65360342|NCT00666588|Etoposide phosphate|etoposide phosphate|mesh-list
65360343|NCT00666588|Bortezomib|bortezomib|mesh-list
65360356|NCT00666588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360357|NCT00666588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65360358|NCT00689390|Ribavirin|ribavirin|mesh-list
65360359|NCT00689390|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65360360|NCT00689390|Antimetabolites|antimetabolites|mesh-ancestor
65360361|NCT00689390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360362|NCT00689390|Antiviral Agents|antiviral agents|mesh-ancestor
65360363|NCT00689390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65360364|NCT00567879|Trastuzumab|trastuzumab|mesh-list
65360365|NCT00567879|Panobinostat|panobinostat|mesh-list
65360366|NCT00567879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65360367|NCT00567879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360368|NCT00567879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65360369|NCT00567879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360370|NCT00567879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360371|NCT00781404|Adenosine|adenosine|mesh-list
65360372|NCT00781404|Analgesics|analgesics|mesh-ancestor
65360373|NCT00781404|Sensory System Agents|sensory system agents|mesh-ancestor
65360374|NCT00781404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65360375|NCT00781404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360376|NCT00781404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65360377|NCT00781404|Vasodilator Agents|vasodilator agents|mesh-ancestor
65360378|NCT00781404|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65360379|NCT00781404|Purinergic Agonists|purinergic agonists|mesh-ancestor
65360380|NCT00781404|Purinergic Agents|purinergic agents|mesh-ancestor
65360381|NCT00781404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65360382|NCT00781404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360383|NCT00777504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
65360384|NCT00777504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65360385|NCT00777504|Growth Substances|growth substances|mesh-ancestor
65360386|NCT00777504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360387|NCT00777504|Growth Inhibitors|growth inhibitors|mesh-ancestor
65360388|NCT00777504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360389|NCT00781482|Zolpidem|zolpidem|mesh-list
65360390|NCT00781482|Eszopiclone|eszopiclone|mesh-list
65360391|NCT00781482|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65360392|NCT00781482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65360393|NCT00781482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65360394|NCT00781482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360395|NCT00781482|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65360396|NCT00781482|GABA Agonists|gaba agonists|mesh-ancestor
65360397|NCT00781482|GABA Agents|gaba agents|mesh-ancestor
65360398|NCT00781482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65360399|NCT00781482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360400|NCT00603915|Gemcitabine|gemcitabine|mesh-list
65360401|NCT00603915|Carboplatin|carboplatin|mesh-list
65360402|NCT00603915|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65360403|NCT00603915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360404|NCT00603915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65360405|NCT00603915|Antimetabolites|antimetabolites|mesh-ancestor
65360432|NCT00926055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65360433|NCT00926055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110274|NCT03147612|Antimetabolites|antimetabolites|mesh-ancestor
65360434|NCT04034199|Zoledronic Acid|zoledronic acid|mesh-list
65360435|NCT04034199|Denosumab|denosumab|mesh-list
65360436|NCT04034199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65360437|NCT04034199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360438|NCT02538237|Ibuprofen|ibuprofen|mesh-list
65360439|NCT02538237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65360440|NCT02538237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65360441|NCT02538237|Analgesics|analgesics|mesh-ancestor
65360442|NCT02538237|Sensory System Agents|sensory system agents|mesh-ancestor
65360443|NCT02538237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65360444|NCT02538237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360445|NCT02538237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65360446|NCT02538237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65360447|NCT02538237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65360448|NCT02538237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360449|NCT02538237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360450|NCT00691028|Infliximab|infliximab|mesh-list
65360451|NCT00691028|Dermatologic Agents|dermatologic agents|mesh-ancestor
65360452|NCT00691028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65360453|NCT00691028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65360490|NCT00784446|Imatinib Mesylate|imatinib mesylate|mesh-list
65360491|NCT00784446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65360492|NCT00784446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360517|NCT00929799|Hormones|hormones|mesh-list
65360518|NCT00929799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65360519|NCT00929799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360520|NCT00777738|Bortezomib|bortezomib|mesh-list
65360521|NCT00777738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360522|NCT00744770|Rilpivirine|rilpivirine|mesh-list
65360523|NCT00744770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65360524|NCT00744770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65360525|NCT00744770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360526|NCT00744770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360527|NCT00744770|Antiviral Agents|antiviral agents|mesh-ancestor
65360528|NCT00744770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65360529|NCT00744770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65360530|NCT00744770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65360531|NCT00784680|Tamoxifen|tamoxifen|mesh-list
65360532|NCT00784680|Anastrozole|anastrozole|mesh-list
65360533|NCT00784680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65360534|NCT00784680|Hormone Antagonists|hormone antagonists|mesh-ancestor
65360535|NCT00784680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65360536|NCT00784680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360537|NCT00784680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65360538|NCT00784680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360539|NCT00784680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65360540|NCT00784680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65360568|NCT00741884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65360569|NCT00741884|Cholinergic Agents|cholinergic agents|mesh-ancestor
65360570|NCT00741884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65360571|NCT00741884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360572|NCT00741884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360574|NCT00931437|Vitamins|vitamins|mesh-ancestor
65360575|NCT00931437|Micronutrients|micronutrients|mesh-ancestor
65360576|NCT00931437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360577|NCT00931437|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65360578|NCT00931437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65360579|NCT00931437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360580|NCT00931437|Hemostatics|hemostatics|mesh-ancestor
65360581|NCT00931437|Coagulants|coagulants|mesh-ancestor
65360582|NCT00742040|Captopril|captopril|mesh-list
65360583|NCT00742040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65360584|NCT00742040|Protease Inhibitors|protease inhibitors|mesh-ancestor
65360585|NCT00742040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360602|NCT00929955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65360603|NCT00929955|Antimetabolites|antimetabolites|mesh-ancestor
65360604|NCT00929955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360605|NCT00929955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65360606|NCT00929955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65360607|NCT00929955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360608|NCT00929955|Antiemetics|antiemetics|mesh-ancestor
65360609|NCT00929955|Autonomic Agents|autonomic agents|mesh-ancestor
65360610|NCT00929955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65360611|NCT00929955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360612|NCT00929955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65360613|NCT00929955|Antipruritics|antipruritics|mesh-ancestor
65360614|NCT00929955|Dermatologic Agents|dermatologic agents|mesh-ancestor
65360615|NCT00929955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65360616|NCT00929955|Serotonin Agents|serotonin agents|mesh-ancestor
65360617|NCT00929955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65360618|NCT00929955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65360619|NCT00929955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65360620|NCT00929955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65360621|NCT00929955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65360622|NCT00929955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65360623|NCT00784914|Sirolimus|sirolimus|mesh-list
65360624|NCT00784914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65360625|NCT00784914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65360626|NCT00784914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65360627|NCT00784914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360628|NCT00784914|Antifungal Agents|antifungal agents|mesh-ancestor
65360629|NCT00784914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65360630|NCT00784914|Immunologic Factors|immunologic factors|mesh-ancestor
65360631|NCT00784914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360632|NCT00745004|Ondansetron|ondansetron|mesh-list
65360633|NCT00745004|Antiemetics|antiemetics|mesh-ancestor
65360634|NCT00745004|Autonomic Agents|autonomic agents|mesh-ancestor
65360635|NCT00745004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65360636|NCT00745004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360637|NCT00745004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65360638|NCT00745004|Antipruritics|antipruritics|mesh-ancestor
65360639|NCT00745004|Dermatologic Agents|dermatologic agents|mesh-ancestor
65360640|NCT00745004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65360641|NCT00745004|Serotonin Agents|serotonin agents|mesh-ancestor
65360642|NCT00745004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65360643|NCT00745004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360644|NCT00745004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65360645|NCT00745004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65360646|NCT00745004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65360647|NCT00745004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65360648|NCT00745004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65360671|NCT00667446|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65360672|NCT00667446|Fertility Agents|fertility agents|mesh-ancestor
65360673|NCT00667446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65360674|NCT00667446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360675|NCT00667446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65360676|NCT00667446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360677|NCT00777972|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65273582|NCT00621036|Dermatologic Agents|dermatologic agents|mesh-ancestor
65360678|NCT00777972|Fosinopril|fosinopril|mesh-list
65360679|NCT00777972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65360680|NCT00777972|Diuretics|diuretics|mesh-ancestor
65360681|NCT00777972|Natriuretic Agents|natriuretic agents|mesh-ancestor
65360682|NCT00777972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360683|NCT00777972|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65360684|NCT00777972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65360685|NCT00777972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360686|NCT00777972|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65360687|NCT00777972|Protease Inhibitors|protease inhibitors|mesh-ancestor
65360688|NCT00777972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360689|NCT00778050|Amoxicillin|amoxicillin|mesh-list
65360690|NCT00778050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65360691|NCT00778050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65360692|NCT00746486|Budesonide|budesonide|mesh-list
65360693|NCT00746486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65360694|NCT00746486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65360695|NCT00746486|Autonomic Agents|autonomic agents|mesh-ancestor
65360696|NCT00746486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65360697|NCT00746486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360698|NCT00746486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65360699|NCT00746486|Respiratory System Agents|respiratory system agents|mesh-ancestor
65360700|NCT00746486|Glucocorticoids|glucocorticoids|mesh-ancestor
65360701|NCT00746486|Hormones|hormones|mesh-ancestor
65360702|NCT00746486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65360703|NCT00778128|Gemcitabine|gemcitabine|mesh-list
65360723|NCT00749138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360724|NCT00749138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65360725|NCT00749138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65360726|NCT00749138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65360727|NCT02563340|Rituximab|rituximab|mesh-list
65360728|NCT02563340|Bortezomib|bortezomib|mesh-list
65360729|NCT02563340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65360730|NCT02563340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360731|NCT02563340|Immunologic Factors|immunologic factors|mesh-ancestor
65360732|NCT02563340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360733|NCT02563340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65360734|NCT00782652|Nitric Oxide|nitric oxide|mesh-list
65110553|NCT01962636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65360735|NCT00782652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65360736|NCT00782652|Autonomic Agents|autonomic agents|mesh-ancestor
65360737|NCT00782652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65360738|NCT00782652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360739|NCT00782652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65360740|NCT00782652|Respiratory System Agents|respiratory system agents|mesh-ancestor
65360741|NCT00782652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65360742|NCT00782652|Antioxidants|antioxidants|mesh-ancestor
65360743|NCT00782652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360744|NCT00782652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65360745|NCT00782652|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65360746|NCT00782652|Vasodilator Agents|vasodilator agents|mesh-ancestor
65360747|NCT00782652|Gasotransmitters|gasotransmitters|mesh-ancestor
65360748|NCT00782652|Protective Agents|protective agents|mesh-ancestor
65360749|NCT00785382|Pregabalin|pregabalin|mesh-list
65360750|NCT00785382|Analgesics|analgesics|mesh-ancestor
65360751|NCT00785382|Sensory System Agents|sensory system agents|mesh-ancestor
65360752|NCT00785382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65360753|NCT00785382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360754|NCT00785382|Anticonvulsants|anticonvulsants|mesh-ancestor
65360755|NCT00785382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65360756|NCT00785382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65360772|NCT00785460|Chelating Agents|chelating agents|mesh-ancestor
65360773|NCT00785460|Sequestering Agents|sequestering agents|mesh-ancestor
65360774|NCT00785460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360775|NCT00567567|Vitamin A|vitamin a|mesh-list
65360776|NCT00567567|Cyclophosphamide|cyclophosphamide|mesh-list
65360777|NCT00567567|Melphalan|melphalan|mesh-list
65360778|NCT00567567|Mechlorethamine|mechlorethamine|mesh-list
65360779|NCT00567567|Thiotepa|thiotepa|mesh-list
65360780|NCT00567567|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65360781|NCT00567567|Cisplatin|cisplatin|mesh-list
65360782|NCT00567567|Carboplatin|carboplatin|mesh-list
65360783|NCT00567567|Doxorubicin|doxorubicin|mesh-list
65360784|NCT00567567|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65360785|NCT00567567|Etoposide|etoposide|mesh-list
65273583|NCT00621036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360786|NCT00567567|Vincristine|vincristine|mesh-list
65360787|NCT00567567|Etoposide phosphate|etoposide phosphate|mesh-list
65360788|NCT00567567|Topotecan|topotecan|mesh-list
65360789|NCT00567567|Tretinoin|tretinoin|mesh-list
65360790|NCT00567567|Podophyllotoxin|podophyllotoxin|mesh-list
65360791|NCT00567567|Isotretinoin|isotretinoin|mesh-list
65360792|NCT00567567|Lenograstim|lenograstim|mesh-list
65360793|NCT00567567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65360794|NCT00567567|Immunologic Factors|immunologic factors|mesh-ancestor
65360795|NCT00567567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360796|NCT00567567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65360797|NCT00567567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65360798|NCT00567567|Alkylating Agents|alkylating agents|mesh-ancestor
65360799|NCT00567567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360800|NCT00567567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360801|NCT00567567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65360802|NCT00567567|Vitamins|vitamins|mesh-ancestor
65360803|NCT00567567|Micronutrients|micronutrients|mesh-ancestor
65360804|NCT00567567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65360805|NCT00567567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65360806|NCT00567567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65110633|NCT01209832|Anesthetics|anesthetics|mesh-ancestor
65360807|NCT00567567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360808|NCT00567567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65360809|NCT00567567|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65360810|NCT00567567|Tubulin Modulators|tubulin modulators|mesh-ancestor
65360811|NCT00567567|Antimitotic Agents|antimitotic agents|mesh-ancestor
65360812|NCT00567567|Mitosis Modulators|mitosis modulators|mesh-ancestor
65360813|NCT00567567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65360814|NCT00567567|Keratolytic Agents|keratolytic agents|mesh-ancestor
65360815|NCT00567567|Dermatologic Agents|dermatologic agents|mesh-ancestor
65360816|NCT00666198|Sildenafil Citrate|sildenafil citrate|mesh-list
65360817|NCT00666198|Vasodilator Agents|vasodilator agents|mesh-ancestor
65360818|NCT00666198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65360849|NCT00778752|Growth Inhibitors|growth inhibitors|mesh-ancestor
65360850|NCT00778752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360851|NCT00926835|Lamotrigine|lamotrigine|mesh-list
65360852|NCT00926835|Dexetimide|dexetimide|mesh-list
65360853|NCT00926835|Aripiprazole|aripiprazole|mesh-list
65360854|NCT00926835|Mirtazapine|mirtazapine|mesh-list
65360855|NCT00926835|Citalopram|citalopram|mesh-list
65360856|NCT00926835|Bupropion|bupropion|mesh-list
65360857|NCT00926835|Paroxetine|paroxetine|mesh-list
65360858|NCT00926835|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65360859|NCT00926835|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65360860|NCT00926835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65360861|NCT00926835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64752997|NCT00636792|Rituximab|rituximab|mesh-list
65360875|NCT00926835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65360876|NCT00926835|Cholinergic Agents|cholinergic agents|mesh-ancestor
65360877|NCT00926835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65360878|NCT00926835|Dopamine Agents|dopamine agents|mesh-ancestor
65360879|NCT00926835|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65360880|NCT00926835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65360881|NCT00926835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360882|NCT00926835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65360883|NCT00926835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65360884|NCT00926835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65360885|NCT00926835|Dopamine Agonists|dopamine agonists|mesh-ancestor
65360886|NCT00926835|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65360887|NCT00926835|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65360888|NCT00926835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65360889|NCT00926835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65360890|NCT00926835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65360891|NCT00926835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65360892|NCT00926835|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65360893|NCT00926835|Anticonvulsants|anticonvulsants|mesh-ancestor
65360894|NCT00926835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65360895|NCT00926835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65360896|NCT00926835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65360897|NCT00926835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65360898|NCT00926835|Histamine Antagonists|histamine antagonists|mesh-ancestor
65360899|NCT00926835|Histamine Agents|histamine agents|mesh-ancestor
65360900|NCT00926835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65360901|NCT00926835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65273584|NCT00621036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65360902|NCT00926835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65360903|NCT00926835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65360904|NCT00926835|Adrenergic Agents|adrenergic agents|mesh-ancestor
65360905|NCT00926835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65360906|NCT00930033|Sunitinib|sunitinib|mesh-list
65360907|NCT00930033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360908|NCT00930033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65360909|NCT00930033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65360910|NCT00930033|Growth Substances|growth substances|mesh-ancestor
65360911|NCT00930033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360912|NCT00930033|Growth Inhibitors|growth inhibitors|mesh-ancestor
65360913|NCT00930033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65360914|NCT00930033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360915|NCT00930033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360916|NCT00664560|Celecoxib|celecoxib|mesh-list
65360917|NCT00664560|Antacids|antacids|mesh-list
65360918|NCT00664560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65360919|NCT00664560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65360920|NCT00664560|Analgesics|analgesics|mesh-ancestor
65360937|NCT00783042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65360938|NCT00783042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360939|NCT00688688|Mirabegron|mirabegron|mesh-list
65360940|NCT00688688|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65360941|NCT00688688|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65360942|NCT00688688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65360943|NCT00688688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65360944|NCT00688688|Adrenergic Agents|adrenergic agents|mesh-ancestor
65360945|NCT00688688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65360946|NCT00688688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360947|NCT00688688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360948|NCT00688688|Urological Agents|urological agents|mesh-ancestor
65360949|NCT00688688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65360950|NCT00688688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65360951|NCT00688688|Cholinergic Agents|cholinergic agents|mesh-ancestor
65360952|NCT00930189|Triamcinolone|triamcinolone|mesh-list
65360953|NCT00930189|Ranibizumab|ranibizumab|mesh-list
65360954|NCT00930189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65360955|NCT00930189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65360956|NCT00930189|Growth Substances|growth substances|mesh-ancestor
65360957|NCT00930189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360958|NCT00930189|Growth Inhibitors|growth inhibitors|mesh-ancestor
65110780|NCT04766853|Dexamethasone|dexamethasone|mesh-list
65360959|NCT00930189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360960|NCT00930189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65360961|NCT00930189|Glucocorticoids|glucocorticoids|mesh-ancestor
65360962|NCT00930189|Hormones|hormones|mesh-ancestor
65360963|NCT00930189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65360964|NCT00936819|Plasma-lyte 148|plasma-lyte 148|mesh-list
65360965|NCT00936819|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65360966|NCT00936819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65360967|NCT00931827|Levonorgestrel|levonorgestrel|mesh-list
65360968|NCT00931827|Etonogestrel|etonogestrel|mesh-list
65360969|NCT00931827|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65360970|NCT00931827|Contraceptive Agents|contraceptive agents|mesh-ancestor
65360971|NCT00931827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65360972|NCT00931827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360973|NCT00931827|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65360974|NCT00931827|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65360975|NCT00931827|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65360976|NCT00937131|Rituximab|rituximab|mesh-list
65361002|NCT00930345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65361003|NCT00930345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65361004|NCT00930345|Growth Substances|growth substances|mesh-ancestor
65361005|NCT00930345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361006|NCT00930345|Growth Inhibitors|growth inhibitors|mesh-ancestor
65361007|NCT00930345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65361008|NCT00930345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361009|NCT00930345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361010|NCT02562326|Insulin Lispro|insulin lispro|mesh-list
65361011|NCT02562326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65361012|NCT02562326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361013|NCT00746720|Etoricoxib|etoricoxib|mesh-list
65361014|NCT00746720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65361015|NCT00746720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65361016|NCT00746720|Analgesics|analgesics|mesh-ancestor
65361017|NCT00746720|Sensory System Agents|sensory system agents|mesh-ancestor
65361018|NCT00746720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65361019|NCT00746720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361020|NCT00746720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65361021|NCT00746720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65361022|NCT00746720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65361023|NCT00746720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65361024|NCT00746720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361025|NCT00746720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361060|NCT04498923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65361061|NCT04498923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361062|NCT04498923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65361063|NCT04498923|Glucocorticoids|glucocorticoids|mesh-ancestor
65361065|NCT04498923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65361066|NCT04498923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65361067|NCT04498923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361068|NCT04498923|Anesthetics, Local|anesthetics, local|mesh-ancestor
65361069|NCT04498923|Anesthetics|anesthetics|mesh-ancestor
65361087|NCT00779064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65361089|NCT00779064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361090|NCT00779064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361091|NCT00779064|Anticoagulants|anticoagulants|mesh-ancestor
65361092|NCT04046874|Analgesics|analgesics|mesh-list
65361093|NCT04046874|Sensory System Agents|sensory system agents|mesh-ancestor
65361094|NCT04046874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65361095|NCT04046874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361096|NCT00932217|Lenograstim|lenograstim|mesh-list
65361097|NCT00932217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65361098|NCT00932217|Immunologic Factors|immunologic factors|mesh-ancestor
65361099|NCT00932217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361100|NCT00786318|Ziprasidone|ziprasidone|mesh-list
65361101|NCT00786318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65361102|NCT00786318|Serotonin Agents|serotonin agents|mesh-ancestor
65361103|NCT00786318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65361104|NCT00786318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361105|NCT00786318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361106|NCT00786318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65361107|NCT00786318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65361108|NCT00786318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65110927|NCT04663763|Antibodies|antibodies|mesh-list
65361109|NCT00786318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65361110|NCT00786318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65361111|NCT00786318|Dopamine Agents|dopamine agents|mesh-ancestor
65361112|NCT00566631|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65361113|NCT00566631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65361114|NCT00566631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65361115|NCT00566631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65361116|NCT00566631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361117|NCT00566631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65361118|NCT00566631|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65361119|NCT00566631|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65361120|NCT00566631|Serotonin Agents|serotonin agents|mesh-ancestor
65361121|NCT00566631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65361122|NCT00566631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361123|NCT00566631|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65361124|NCT00566631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64753249|NCT00989196|Factor VIII|factor viii|mesh-list
65361160|NCT00932529|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65361161|NCT00932529|Ziprasidone|ziprasidone|mesh-list
65361162|NCT00932529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65361163|NCT00932529|Serotonin Agents|serotonin agents|mesh-ancestor
65361164|NCT00932529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65019549|NCT02917018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65361198|NCT00932685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361199|NCT00932685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65361200|NCT00932685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65361201|NCT00932685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65361202|NCT00932685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65361203|NCT00932685|Anesthetics, General|anesthetics, general|mesh-ancestor
65361204|NCT00932685|Anesthetics|anesthetics|mesh-ancestor
65361205|NCT00932685|GABA Modulators|gaba modulators|mesh-ancestor
65361206|NCT00932685|GABA Agents|gaba agents|mesh-ancestor
65361207|NCT00932685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65273585|NCT00621036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65273586|NCT00621036|Immunologic Factors|immunologic factors|mesh-ancestor
65361208|NCT00932685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361233|NCT00783900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361234|NCT00783900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65361235|NCT00783900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65361236|NCT00783900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65361237|NCT00783900|Adrenergic Agents|adrenergic agents|mesh-ancestor
65361238|NCT00783900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65361239|NCT00783900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361241|NCT00938613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65361242|NCT00938613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65361243|NCT00938613|Autonomic Agents|autonomic agents|mesh-ancestor
65361244|NCT00938613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65361245|NCT00938613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361246|NCT00938613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65361247|NCT00938613|Respiratory System Agents|respiratory system agents|mesh-ancestor
65361248|NCT00938613|Glucocorticoids|glucocorticoids|mesh-ancestor
65361249|NCT00938613|Hormones|hormones|mesh-ancestor
65361250|NCT00938613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65361251|NCT00786552|Paclitaxel|paclitaxel|mesh-list
65361252|NCT00786552|Pemetrexed|pemetrexed|mesh-list
65361253|NCT00786552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65361254|NCT00786552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361255|NCT00786552|Tubulin Modulators|tubulin modulators|mesh-ancestor
65361256|NCT00786552|Antimitotic Agents|antimitotic agents|mesh-ancestor
65361257|NCT00786552|Mitosis Modulators|mitosis modulators|mesh-ancestor
64753388|NCT00982878|Maraviroc|maraviroc|mesh-list
65361269|NCT00931203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65361271|NCT00931203|Sensory System Agents|sensory system agents|mesh-ancestor
65361272|NCT00931203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65361273|NCT00931203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361274|NCT00931203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65361275|NCT00931203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65361276|NCT00931203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65361277|NCT00931203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65361278|NCT00931203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361279|NCT00931203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361280|NCT00565773|Sirolimus|sirolimus|mesh-list
65361281|NCT00565773|Alemtuzumab|alemtuzumab|mesh-list
65361282|NCT00565773|Abatacept|abatacept|mesh-list
65361283|NCT00565773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65361284|NCT00565773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65361285|NCT00565773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65361286|NCT00565773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361287|NCT00565773|Antifungal Agents|antifungal agents|mesh-ancestor
65361288|NCT00565773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65361289|NCT00565773|Immunologic Factors|immunologic factors|mesh-ancestor
65361290|NCT00565773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361291|NCT00565773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65361292|NCT00565773|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65361293|NCT00565773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361294|NCT00565773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65361295|NCT00570492|Fluticasone|fluticasone|mesh-list
65361296|NCT00570492|Xhance|xhance|mesh-list
65361297|NCT00570492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65361298|NCT00570492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65361299|NCT00570492|Autonomic Agents|autonomic agents|mesh-ancestor
65361300|NCT00570492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65361301|NCT00570492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361302|NCT00570492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65361303|NCT00570492|Respiratory System Agents|respiratory system agents|mesh-ancestor
65361304|NCT00570492|Dermatologic Agents|dermatologic agents|mesh-ancestor
65361305|NCT00570492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65361306|NCT00931281|Ritonavir|ritonavir|mesh-list
65361307|NCT00931281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65361308|NCT00931281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65361309|NCT00931281|Protease Inhibitors|protease inhibitors|mesh-ancestor
65361310|NCT00931281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361311|NCT00931281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361312|NCT00931281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65361313|NCT00931281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65361314|NCT00931281|Antiviral Agents|antiviral agents|mesh-ancestor
65273587|NCT00621036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65361315|NCT00931281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65361316|NCT00931281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64753442|NCT03118674|Sofosbuvir|sofosbuvir|mesh-list
65361339|NCT00933231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65361341|NCT00933231|Hormones|hormones|mesh-ancestor
65361342|NCT00933231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65361343|NCT00933231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361344|NCT00933231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65361345|NCT00933231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361346|NCT00933231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65361347|NCT00933231|Immunologic Factors|immunologic factors|mesh-ancestor
65361348|NCT00933231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65361349|NCT00933231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361350|NCT00933231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361351|NCT00933231|Antiemetics|antiemetics|mesh-ancestor
65361352|NCT00933231|Autonomic Agents|autonomic agents|mesh-ancestor
65361353|NCT00933231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65361354|NCT00933231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65361355|NCT00933231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65361356|NCT00933231|Protective Agents|protective agents|mesh-ancestor
65361357|NCT00933231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65361358|NCT00933231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65361359|NCT00933231|Antitubercular Agents|antitubercular agents|mesh-ancestor
65361360|NCT00933231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65361361|NCT00933231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65361362|NCT00933231|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65361363|NCT00933231|Protease Inhibitors|protease inhibitors|mesh-ancestor
65361364|NCT00933231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65361365|NCT00933231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65361366|NCT00933231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65361367|NCT03489525|Antibodies|antibodies|mesh-list
65361368|NCT03489525|Immunoglobulins|immunoglobulins|mesh-list
65361369|NCT03489525|Immunoconjugates|immunoconjugates|mesh-list
65361370|NCT03489525|Immunologic Factors|immunologic factors|mesh-ancestor
65361406|NCT00328627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361407|NCT00328627|Incretins|incretins|mesh-ancestor
65361409|NCT00328627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65361410|NCT00328627|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65361439|NCT03374956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361440|NCT03374956|Anticonvulsants|anticonvulsants|mesh-ancestor
65361441|NCT03374956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65361442|NCT03374956|Appetite Depressants|appetite depressants|mesh-ancestor
65361443|NCT03374956|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65361444|NCT03374956|Sympathomimetics|sympathomimetics|mesh-ancestor
65361445|NCT03374956|Autonomic Agents|autonomic agents|mesh-ancestor
65361446|NCT03374956|Adrenergic Agents|adrenergic agents|mesh-ancestor
65361447|NCT03977727|Insulin Aspart|insulin aspart|mesh-list
65361448|NCT03977727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65361449|NCT03977727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361450|NCT00663858|Cetrorelix|cetrorelix|mesh-list
65361451|NCT00663858|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65361452|NCT00663858|Fertility Agents|fertility agents|mesh-ancestor
65361453|NCT00663858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65361454|NCT00663858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361455|NCT00663858|Hormone Antagonists|hormone antagonists|mesh-ancestor
65019550|NCT02917018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65361485|NCT00749450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65361486|NCT00749450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361487|NCT00749450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65361488|NCT00749450|Immunologic Factors|immunologic factors|mesh-ancestor
65361489|NCT00749450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361490|NCT00795444|Maraviroc|maraviroc|mesh-list
65361491|NCT00795444|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65361492|NCT00795444|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65361493|NCT00795444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361494|NCT00795444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65361495|NCT00795444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65361496|NCT00795444|Antiviral Agents|antiviral agents|mesh-ancestor
65361497|NCT00795444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65361498|NCT00795444|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65361499|NCT02561936|Rilpivirine|rilpivirine|mesh-list
65361531|NCT02555358|Antimitotic Agents|antimitotic agents|mesh-ancestor
65361532|NCT02555358|Mitosis Modulators|mitosis modulators|mesh-ancestor
65273588|NCT00621036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65361533|NCT02555358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361534|NCT02555358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65361535|NCT02555358|Antimetabolites|antimetabolites|mesh-ancestor
65361536|NCT00683774|Diazoxide|diazoxide|mesh-list
65361537|NCT00683774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65361538|NCT00683774|Vasodilator Agents|vasodilator agents|mesh-ancestor
65361539|NCT00787410|Gefitinib|gefitinib|mesh-list
65361540|NCT00787410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361541|NCT00787410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65361542|NCT00787410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753669|NCT05605002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65361546|NCT03989557|Ticagrelor|ticagrelor|mesh-list
65361547|NCT03989557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65361548|NCT03989557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65361549|NCT03989557|Analgesics|analgesics|mesh-ancestor
65361550|NCT03989557|Sensory System Agents|sensory system agents|mesh-ancestor
65361551|NCT03989557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65361552|NCT03989557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361553|NCT03989557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65361554|NCT03989557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65361555|NCT03989557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65361556|NCT03989557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65361557|NCT03989557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361558|NCT03989557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65361559|NCT03989557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65361560|NCT03989557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111380|NCT00541086|Tamoxifen|tamoxifen|mesh-list
65361561|NCT03989557|Antipyretics|antipyretics|mesh-ancestor
65361562|NCT03989557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65361563|NCT03989557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65361564|NCT03989557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65361565|NCT03989557|Purinergic Agents|purinergic agents|mesh-ancestor
65361566|NCT03989557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65361567|NCT00790998|Ivermectin|ivermectin|mesh-list
65361568|NCT00790998|Moxidectin|moxidectin|mesh-list
65361569|NCT00790998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65361570|NCT00790998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65361571|NCT00790998|Anthelmintics|anthelmintics|mesh-ancestor
65361572|NCT00790998|Antinematodal Agents|antinematodal agents|mesh-ancestor
65361573|NCT02555046|Anesthetics|anesthetics|mesh-list
65361574|NCT02555046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65361575|NCT02555046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361576|NCT00354679|Bevacizumab|bevacizumab|mesh-list
65361577|NCT00354679|Irinotecan|irinotecan|mesh-list
65361578|NCT00354679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65361579|NCT00354679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361580|NCT00354679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65361581|NCT00354679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65361582|NCT00354679|Growth Substances|growth substances|mesh-ancestor
65361583|NCT00354679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361584|NCT00354679|Growth Inhibitors|growth inhibitors|mesh-ancestor
65361585|NCT00354679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65361586|NCT00354679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65361587|NCT00354679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361588|NCT00354679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361589|NCT00540514|Paclitaxel|paclitaxel|mesh-list
65361590|NCT00540514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65361591|NCT00540514|Carboplatin|carboplatin|mesh-list
65361592|NCT00540514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65361593|NCT00540514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361594|NCT00540514|Tubulin Modulators|tubulin modulators|mesh-ancestor
65361595|NCT00540514|Antimitotic Agents|antimitotic agents|mesh-ancestor
65361596|NCT00540514|Mitosis Modulators|mitosis modulators|mesh-ancestor
65361597|NCT00540514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361598|NCT00663702|Abatacept|abatacept|mesh-list
65361599|NCT00663702|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65361600|NCT00663702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361601|NCT00663702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753724|NCT04275024|Calcipotriene|calcipotriene|mesh-list
65361623|NCT00683618|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65361624|NCT00683618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65361625|NCT00683618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65361626|NCT00683618|Antimetabolites|antimetabolites|mesh-ancestor
65273589|NCT00621036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65361627|NCT00683618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361628|NCT00683618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65361629|NCT00683618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65361630|NCT00683618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361631|NCT03290794|Aflibercept|aflibercept|mesh-list
65361632|NCT03290794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65361633|NCT03290794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65361634|NCT03290794|Growth Substances|growth substances|mesh-ancestor
65361635|NCT03290794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361636|NCT03290794|Growth Inhibitors|growth inhibitors|mesh-ancestor
65361637|NCT03290794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361638|NCT03816358|Gemcitabine|gemcitabine|mesh-list
65361639|NCT03816358|Nivolumab|nivolumab|mesh-list
65361640|NCT03816358|Ipilimumab|ipilimumab|mesh-list
65361641|NCT03816358|Maytansine|maytansine|mesh-list
65361642|NCT03816358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65361643|NCT03816358|Antimetabolites|antimetabolites|mesh-ancestor
65361644|NCT03816358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361645|NCT03816358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361646|NCT03816358|Antiviral Agents|antiviral agents|mesh-ancestor
65361647|NCT03816358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65361648|NCT03816358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361649|NCT03816358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65361650|NCT03816358|Immunologic Factors|immunologic factors|mesh-ancestor
65361651|NCT03816358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361652|NCT03816358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65361653|NCT03816358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65361654|NCT03816358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65361655|NCT03816358|Tubulin Modulators|tubulin modulators|mesh-ancestor
65361656|NCT03816358|Antimitotic Agents|antimitotic agents|mesh-ancestor
65361688|NCT00795678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65361689|NCT00795678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65361690|NCT00795678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65361692|NCT00753038|Carboplatin|carboplatin|mesh-list
65361693|NCT00753038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65361694|NCT00753038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361695|NCT00753038|Tubulin Modulators|tubulin modulators|mesh-ancestor
65361696|NCT00753038|Antimitotic Agents|antimitotic agents|mesh-ancestor
65361697|NCT00753038|Mitosis Modulators|mitosis modulators|mesh-ancestor
65361698|NCT00753038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361699|NCT00795756|Cytarabine|cytarabine|mesh-list
65361700|NCT00795756|Methotrexate|methotrexate|mesh-list
65361701|NCT00795756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65361702|NCT00795756|Abortifacient Agents|abortifacient agents|mesh-ancestor
65361734|NCT00791232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361735|NCT00791232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65361736|NCT00791232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65361737|NCT00791232|Dopamine Agents|dopamine agents|mesh-ancestor
65361738|NCT01563952|Sirolimus|sirolimus|mesh-list
65361739|NCT01563952|Umirolimus|umirolimus|mesh-list
65361740|NCT01563952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65361741|NCT01563952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65361742|NCT01563952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65361743|NCT01563952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361744|NCT01563952|Antifungal Agents|antifungal agents|mesh-ancestor
65361768|NCT00788034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65361769|NCT00788034|Serotonin Agents|serotonin agents|mesh-ancestor
65361770|NCT00788034|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65361771|NCT00788034|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65361772|NCT00788034|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65361773|NCT00788034|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65361774|NCT04004884|Ulipristal acetate|ulipristal acetate|mesh-list
65361775|NCT04004884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65361776|NCT04004884|Contraceptive Agents|contraceptive agents|mesh-ancestor
65361777|NCT04004884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65361778|NCT04004884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361779|NCT04004884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65361780|NCT00688064|Doxycycline|doxycycline|mesh-list
65361781|NCT00688064|Adapalene|adapalene|mesh-list
65361782|NCT00688064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65361783|NCT00688064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65361784|NCT00688064|Antimalarials|antimalarials|mesh-ancestor
65273590|NCT00621036|Alkylating Agents|alkylating agents|mesh-ancestor
65361785|NCT00688064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65361786|NCT00688064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65361787|NCT00688064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65361819|NCT00791544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361820|NCT00791544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65361821|NCT00791544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361822|NCT00791544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361823|NCT05171686|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65361824|NCT05171686|Chlorthalidone|chlorthalidone|mesh-list
65361825|NCT05171686|Torsemide|torsemide|mesh-list
65361826|NCT05171686|Furosemide|furosemide|mesh-list
65361827|NCT05171686|Bumetanide|bumetanide|mesh-list
65361828|NCT05171686|Diuretics|diuretics|mesh-list
65361829|NCT05171686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65361830|NCT05171686|Natriuretic Agents|natriuretic agents|mesh-ancestor
65361831|NCT05171686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361832|NCT05171686|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65361833|NCT05171686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65361866|NCT00753740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361867|NCT00753740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65361868|NCT00753740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65361869|NCT00753740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361870|NCT00753740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361871|NCT00326911|Gemcitabine|gemcitabine|mesh-list
65361904|NCT00747110|Mesalamine|mesalamine|mesh-list
65361905|NCT00747110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65361906|NCT00747110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65361907|NCT00747110|Autonomic Agents|autonomic agents|mesh-ancestor
65361908|NCT00747110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65361909|NCT00747110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361910|NCT00747110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65361911|NCT00747110|Respiratory System Agents|respiratory system agents|mesh-ancestor
65361912|NCT00747110|Glucocorticoids|glucocorticoids|mesh-ancestor
65361913|NCT00747110|Hormones|hormones|mesh-ancestor
65361938|NCT01057615|Micronutrients|micronutrients|mesh-ancestor
65361939|NCT01057615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361940|NCT01057615|Antioxidants|antioxidants|mesh-ancestor
65361941|NCT01057615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361942|NCT01057615|Protective Agents|protective agents|mesh-ancestor
65361943|NCT00788424|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
65361944|NCT00788424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65361945|NCT00788424|Immunologic Factors|immunologic factors|mesh-ancestor
65361946|NCT00788424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361947|NCT00788424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361948|NCT00788424|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65361949|NCT00788424|Protective Agents|protective agents|mesh-ancestor
65361950|NCT00788424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65361951|NCT00788424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65361952|NCT00788424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361953|NCT00788424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361954|NCT00788424|Antiviral Agents|antiviral agents|mesh-ancestor
65361955|NCT00788424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65361956|NCT00791856|Methyltestosterone|methyltestosterone|mesh-list
65361957|NCT00791856|Testosterone|testosterone|mesh-list
65361958|NCT00791856|Testosterone undecanoate|testosterone undecanoate|mesh-list
65361959|NCT00791856|Testosterone enanthate|testosterone enanthate|mesh-list
65361960|NCT00791856|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65361961|NCT00791856|Androgens|androgens|mesh-ancestor
65361962|NCT00791856|Hormones|hormones|mesh-ancestor
65361987|NCT00792012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65361989|NCT00792012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361990|NCT00792012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361991|NCT00990418|Fentanyl|fentanyl|mesh-list
65361992|NCT00990418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65361993|NCT00990418|Narcotics|narcotics|mesh-ancestor
65361994|NCT00990418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65361995|NCT00990418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361996|NCT00990418|Analgesics|analgesics|mesh-ancestor
65361997|NCT00990418|Sensory System Agents|sensory system agents|mesh-ancestor
65361998|NCT00990418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65361999|NCT00990418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65362000|NCT00990418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65362001|NCT00990418|Anesthetics, General|anesthetics, general|mesh-ancestor
65362002|NCT00990418|Anesthetics|anesthetics|mesh-ancestor
65273591|NCT00621036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65362003|NCT02562950|Midazolam|midazolam|mesh-list
65362004|NCT02562950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65362005|NCT02562950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65362006|NCT02562950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65362007|NCT02562950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362008|NCT02562950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65362009|NCT02562950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65362010|NCT02562950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65362011|NCT02562950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65362012|NCT02562950|Anesthetics, General|anesthetics, general|mesh-ancestor
65362013|NCT02562950|Anesthetics|anesthetics|mesh-ancestor
65362040|NCT00687440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362041|NCT00687440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65362042|NCT02554734|Levodopa|levodopa|mesh-list
65362043|NCT02554734|Carbidopa|carbidopa|mesh-list
65362044|NCT02554734|Entacapone|entacapone|mesh-list
65362045|NCT02554734|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65362046|NCT02554734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65362047|NCT02554734|Dopamine Agents|dopamine agents|mesh-ancestor
65362048|NCT02554734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65362049|NCT02554734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362050|NCT02554734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362051|NCT02554734|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65362052|NCT02554734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362053|NCT02554734|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65362054|NCT00990496|Cyclophosphamide|cyclophosphamide|mesh-list
65362055|NCT00990496|Fludarabine|fludarabine|mesh-list
65362056|NCT00990496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65362057|NCT00990496|Immunologic Factors|immunologic factors|mesh-ancestor
65362058|NCT00990496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362059|NCT00990496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65362062|NCT00990496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362063|NCT00990496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362064|NCT00990496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65362065|NCT00754910|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
65362066|NCT00754910|Trioxsalen|trioxsalen|mesh-list
65362067|NCT00754910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362068|NCT00754910|Dermatologic Agents|dermatologic agents|mesh-ancestor
65362069|NCT00754910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65362070|NCT00755066|Fluticasone|fluticasone|mesh-list
65362071|NCT00755066|Xhance|xhance|mesh-list
65362072|NCT00755066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65362073|NCT00755066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65362074|NCT00755066|Autonomic Agents|autonomic agents|mesh-ancestor
65362075|NCT00755066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65362076|NCT00755066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362077|NCT00755066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65362078|NCT00755066|Respiratory System Agents|respiratory system agents|mesh-ancestor
65362079|NCT00755066|Dermatologic Agents|dermatologic agents|mesh-ancestor
65362080|NCT00755066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65362081|NCT00990574|Anesthetics|anesthetics|mesh-list
65362082|NCT00990574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65362083|NCT00990574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362084|NCT00659490|Naproxen|naproxen|mesh-list
65362085|NCT00659490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65111907|NCT02352558|Hormones|hormones|mesh-ancestor
65362086|NCT00659490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65362087|NCT00659490|Analgesics|analgesics|mesh-ancestor
65362088|NCT00659490|Sensory System Agents|sensory system agents|mesh-ancestor
65362089|NCT00659490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65362090|NCT00659490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362091|NCT00659490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65362092|NCT00659490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65362093|NCT00659490|Gout Suppressants|gout suppressants|mesh-ancestor
65362094|NCT00659490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65362095|NCT00659490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362096|NCT00659490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362097|NCT00792246|Voriconazole|voriconazole|mesh-list
65362098|NCT00792246|Antifungal Agents|antifungal agents|mesh-ancestor
65362099|NCT00792246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65362100|NCT00792246|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65362101|NCT00792246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65362102|NCT00792246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273593|NCT02846831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65362103|NCT00792246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362104|NCT00792246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65362105|NCT00792246|Hormone Antagonists|hormone antagonists|mesh-ancestor
65362106|NCT00792246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65362107|NCT00792246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362108|NCT00792246|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65362109|NCT00539500|Carboplatin|carboplatin|mesh-list
65362110|NCT00539500|Etoposide|etoposide|mesh-list
65362111|NCT00539500|Melphalan|melphalan|mesh-list
65362112|NCT00539500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362113|NCT00539500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65362114|NCT00539500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65362115|NCT00539500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65362116|NCT00539500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362117|NCT00539500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362118|NCT00539500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65362119|NCT00539500|Alkylating Agents|alkylating agents|mesh-ancestor
65362120|NCT00539500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65362121|NCT00539500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65362122|NCT00539500|Immunologic Factors|immunologic factors|mesh-ancestor
65362123|NCT00539500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362124|NCT00662532|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65362125|NCT00662532|Minocycline|minocycline|mesh-list
65362126|NCT00662532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65362127|NCT00792324|Efavirenz|efavirenz|mesh-list
65362128|NCT00792324|Etravirine|etravirine|mesh-list
65362129|NCT00792324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65362130|NCT00792324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65362151|NCT00797160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65362152|NCT00797160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65362153|NCT00797160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362154|NCT00797160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65362155|NCT00797160|Anesthetics, General|anesthetics, general|mesh-ancestor
65362156|NCT00797160|Anesthetics|anesthetics|mesh-ancestor
65362157|NCT00682448|Metformin|metformin|mesh-list
65362158|NCT00682448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65362159|NCT00682448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362160|NCT04003792|Bevacizumab|bevacizumab|mesh-list
65362161|NCT04003792|Oxaliplatin|oxaliplatin|mesh-list
65362162|NCT04003792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65362163|NCT04003792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362164|NCT04003792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65362165|NCT04003792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65362166|NCT04003792|Growth Substances|growth substances|mesh-ancestor
65362167|NCT04003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362168|NCT04003792|Growth Inhibitors|growth inhibitors|mesh-ancestor
65362169|NCT00990886|Oxybutynin|oxybutynin|mesh-list
65362170|NCT00990886|Parasympatholytics|parasympatholytics|mesh-ancestor
65362171|NCT00990886|Autonomic Agents|autonomic agents|mesh-ancestor
65362172|NCT00990886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65362173|NCT00990886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362174|NCT00990886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65362175|NCT00990886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65362176|NCT00990886|Cholinergic Agents|cholinergic agents|mesh-ancestor
65362177|NCT00990886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65362178|NCT00990886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362179|NCT00990886|Urological Agents|urological agents|mesh-ancestor
65362180|NCT00797394|Saw palmetto extract|saw palmetto extract|mesh-list
65362181|NCT00797394|Urological Agents|urological agents|mesh-ancestor
65362182|NCT00681824|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65362183|NCT00681824|Thrombin|thrombin|mesh-list
65362215|NCT00539188|Expectorants|expectorants|mesh-ancestor
65362216|NCT00539188|Respiratory System Agents|respiratory system agents|mesh-ancestor
65362217|NCT00539188|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65362218|NCT00539188|Antioxidants|antioxidants|mesh-ancestor
65362219|NCT00539188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362220|NCT00539188|Protective Agents|protective agents|mesh-ancestor
65362221|NCT00539188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362222|NCT00539188|Antidotes|antidotes|mesh-ancestor
65362223|NCT00681590|Vitamin D|vitamin d|mesh-list
65362224|NCT00681590|Ergocalciferols|ergocalciferols|mesh-list
65362225|NCT00681590|Cholecalciferol|cholecalciferol|mesh-list
65362226|NCT00681590|Vitamins|vitamins|mesh-list
65362227|NCT00681590|Micronutrients|micronutrients|mesh-ancestor
65362228|NCT00681590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754356|NCT01450176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65362243|NCT00755534|Irinotecan|irinotecan|mesh-list
65362244|NCT00755534|Cetuximab|cetuximab|mesh-list
65362245|NCT00755534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65362246|NCT00755534|Antimetabolites|antimetabolites|mesh-ancestor
65362247|NCT00755534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362248|NCT00755534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362249|NCT00755534|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65362250|NCT00755534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65362251|NCT00755534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362252|NCT00755534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65362253|NCT00326599|Gemcitabine|gemcitabine|mesh-list
65362254|NCT00326599|Carboplatin|carboplatin|mesh-list
65362255|NCT00326599|Cediranib|cediranib|mesh-list
65362256|NCT00326599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362257|NCT00326599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65362258|NCT00326599|Antimetabolites|antimetabolites|mesh-ancestor
65362259|NCT00326599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362260|NCT00326599|Antiviral Agents|antiviral agents|mesh-ancestor
65362261|NCT00326599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65362262|NCT00326599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362263|NCT00326599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65362264|NCT00326599|Immunologic Factors|immunologic factors|mesh-ancestor
65362265|NCT00326599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362266|NCT00326599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65362267|NCT05004688|BCG Vaccine|bcg vaccine|mesh-list
65362268|NCT05004688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65362269|NCT05004688|Immunologic Factors|immunologic factors|mesh-ancestor
65362270|NCT05004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362271|NCT00750386|Paclitaxel|paclitaxel|mesh-list
65362272|NCT00750386|Carboplatin|carboplatin|mesh-list
65362273|NCT00750386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65362274|NCT00750386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362275|NCT00750386|Tubulin Modulators|tubulin modulators|mesh-ancestor
65362276|NCT00750386|Antimitotic Agents|antimitotic agents|mesh-ancestor
65362277|NCT00750386|Mitosis Modulators|mitosis modulators|mesh-ancestor
65362278|NCT00750386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362279|NCT00539032|Vaccines|vaccines|mesh-list
65362280|NCT00539032|Immunologic Factors|immunologic factors|mesh-ancestor
65362281|NCT00539032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362282|NCT00685802|Cilostazol|cilostazol|mesh-list
65362283|NCT00685802|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65362284|NCT00685802|Autonomic Agents|autonomic agents|mesh-ancestor
65362285|NCT00685802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65362286|NCT00685802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362287|NCT00685802|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65362288|NCT00685802|Respiratory System Agents|respiratory system agents|mesh-ancestor
65362289|NCT00685802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65362290|NCT00685802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65362312|NCT01054651|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65362314|NCT01054651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362315|NCT01054651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65362316|NCT01054651|Renal Agents|renal agents|mesh-ancestor
65362317|NCT00792714|Mannitol|mannitol|mesh-list
65362318|NCT00792714|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65362319|NCT00792714|Diuretics|diuretics|mesh-ancestor
65362320|NCT00792714|Natriuretic Agents|natriuretic agents|mesh-ancestor
65362321|NCT00792714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362322|NCT04961554|Anesthetics|anesthetics|mesh-list
65362323|NCT04961554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65362324|NCT04961554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362325|NCT00354601|Docetaxel|docetaxel|mesh-list
65362326|NCT00354601|Capecitabine|capecitabine|mesh-list
65362327|NCT00354601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362328|NCT00354601|Tubulin Modulators|tubulin modulators|mesh-ancestor
65362329|NCT00354601|Antimitotic Agents|antimitotic agents|mesh-ancestor
65362330|NCT00354601|Mitosis Modulators|mitosis modulators|mesh-ancestor
65362331|NCT00354601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362332|NCT00354601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65362333|NCT00354601|Antimetabolites|antimetabolites|mesh-ancestor
65362334|NCT01563640|Permethrin|permethrin|mesh-list
65362335|NCT01563640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362336|NCT01563640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362337|NCT00750620|Mirabegron|mirabegron|mesh-list
65362338|NCT00750620|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64530767|NCT05233228|Nicotine|nicotine|mesh-list
65362339|NCT00750620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65362340|NCT00750620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65362341|NCT00750620|Adrenergic Agents|adrenergic agents|mesh-ancestor
65362342|NCT00750620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65362343|NCT00750620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362344|NCT00750620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362345|NCT00750620|Urological Agents|urological agents|mesh-ancestor
65362377|NCT00800592|Vasodilator Agents|vasodilator agents|mesh-ancestor
65362378|NCT00800592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65362379|NCT00800592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65362380|NCT00800592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362381|NCT00800592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362382|NCT00800592|Urological Agents|urological agents|mesh-ancestor
65362383|NCT00797784|Etanercept|etanercept|mesh-list
65362384|NCT00797784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65362385|NCT00797784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65362386|NCT00797784|Analgesics|analgesics|mesh-ancestor
65362387|NCT00797784|Sensory System Agents|sensory system agents|mesh-ancestor
65362388|NCT00797784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65362389|NCT00797784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362390|NCT00797784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65362391|NCT00797784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64754535|NCT01452828|Tedizolid|tedizolid|mesh-list
65362429|NCT00798252|Antimetabolites|antimetabolites|mesh-ancestor
65362460|NCT00661362|Metformin|metformin|mesh-list
65362461|NCT00661362|Saxagliptin|saxagliptin|mesh-list
65362462|NCT00661362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65362463|NCT00661362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362464|NCT00661362|Incretins|incretins|mesh-ancestor
65362465|NCT00661362|Hormones|hormones|mesh-ancestor
65362466|NCT00661362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65362467|NCT00661362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65362468|NCT00661362|Protease Inhibitors|protease inhibitors|mesh-ancestor
65362469|NCT00661362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362470|NCT00661362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362471|NCT00748202|Complement C1s|complement c1s|mesh-list
65362472|NCT00748202|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
65362506|NCT05406856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362508|NCT00344773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362509|NCT00344773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65362510|NCT00344773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019551|NCT02917018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65362530|NCT01055041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65362531|NCT01055041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362532|NCT01055041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65362533|NCT01055041|Respiratory System Agents|respiratory system agents|mesh-ancestor
65362534|NCT01055041|Glucocorticoids|glucocorticoids|mesh-ancestor
65362535|NCT01055041|Hormones|hormones|mesh-ancestor
65362536|NCT01055041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65362537|NCT01055041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65362538|NCT01055041|Hormone Antagonists|hormone antagonists|mesh-ancestor
65362539|NCT01055041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65112359|NCT01229371|Vaccines|vaccines|mesh-list
65362540|NCT01055041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65362541|NCT01055041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362542|NCT01055041|Antitussive Agents|antitussive agents|mesh-ancestor
65362543|NCT01055041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65362544|NCT01055041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362545|NCT00325819|Acetaminophen|acetaminophen|mesh-list
65362546|NCT00325819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65362547|NCT00325819|Analgesics|analgesics|mesh-ancestor
65362548|NCT00325819|Sensory System Agents|sensory system agents|mesh-ancestor
65362549|NCT00325819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65362550|NCT00325819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362551|NCT00325819|Antipyretics|antipyretics|mesh-ancestor
65362552|NCT00748358|Sunitinib|sunitinib|mesh-list
65362553|NCT00748358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362554|NCT00748358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65362555|NCT00748358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65362556|NCT00748358|Growth Substances|growth substances|mesh-ancestor
65362557|NCT00748358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362558|NCT00748358|Growth Inhibitors|growth inhibitors|mesh-ancestor
65362559|NCT00748358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65273594|NCT02846831|Hormones|hormones|mesh-list
65273595|NCT02846831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65362560|NCT00748358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362561|NCT00748358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362562|NCT00748436|Betahistine|betahistine|mesh-list
65362563|NCT00748436|Vasodilator Agents|vasodilator agents|mesh-ancestor
65362564|NCT00748436|Histamine Agonists|histamine agonists|mesh-ancestor
65362594|NCT00751478|Morphine|morphine|mesh-list
65362595|NCT00751478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65362596|NCT00751478|Narcotics|narcotics|mesh-ancestor
65362597|NCT00751478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65362598|NCT00751478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362599|NCT00751478|Analgesics|analgesics|mesh-ancestor
65362600|NCT00751478|Sensory System Agents|sensory system agents|mesh-ancestor
65362601|NCT00751478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65362602|NCT00751478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65362603|NCT00751478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65362604|NCT00751556|Naproxen|naproxen|mesh-list
65362605|NCT00751556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65362606|NCT00751556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65362607|NCT00751556|Analgesics|analgesics|mesh-ancestor
65362608|NCT00751556|Sensory System Agents|sensory system agents|mesh-ancestor
65362609|NCT00751556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65019552|NCT02917018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65362635|NCT00685334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65362636|NCT00685334|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65362637|NCT00685334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65362638|NCT00685334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65362639|NCT00685334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65362640|NCT00685334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65362641|NCT00685334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65362642|NCT00685334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65362643|NCT00685334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362644|NCT00685334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65362645|NCT00685334|Serotonin Agents|serotonin agents|mesh-ancestor
65362646|NCT00685334|Antidepressive Agents|antidepressive agents|mesh-ancestor
65362647|NCT00685334|Dopamine Agonists|dopamine agonists|mesh-ancestor
65362648|NCT00685334|Dopamine Agents|dopamine agents|mesh-ancestor
65362649|NCT00685334|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65362650|NCT00685334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65362651|NCT00685334|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65362652|NCT00685334|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65362653|NCT00685334|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65362654|NCT00685334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65362655|NCT00801294|Nintedanib|nintedanib|mesh-list
65362656|NCT00801294|Afatinib|afatinib|mesh-list
65362657|NCT00801294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362658|NCT00801294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64475276|NCT00398476|Xhance|xhance|mesh-list
65362692|NCT00537394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65362693|NCT00537394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362694|NCT00537394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362695|NCT00537394|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65362696|NCT00537394|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65362697|NCT00537394|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65362698|NCT00537394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65362699|NCT00537394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65362700|NCT00537394|Protease Inhibitors|protease inhibitors|mesh-ancestor
65362701|NCT00537394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65362702|NCT00537394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65362733|NCT00933387|Mitosis Modulators|mitosis modulators|mesh-ancestor
65362734|NCT00933387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362735|NCT00933387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65362736|NCT00660660|Esomeprazole|esomeprazole|mesh-list
65362737|NCT00660660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65362738|NCT00660660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65362739|NCT00660660|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65362740|NCT00660660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362741|NCT00660660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362742|NCT02560766|Gabapentin|gabapentin|mesh-list
65362743|NCT02560766|Analgesics|analgesics|mesh-ancestor
65362744|NCT02560766|Sensory System Agents|sensory system agents|mesh-ancestor
65362745|NCT02560766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65273596|NCT02846831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362781|NCT00933777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65362782|NCT00933777|Immunologic Factors|immunologic factors|mesh-ancestor
65362783|NCT00933777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362784|NCT00933777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65362812|NCT00801528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65362813|NCT00801528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65362814|NCT00801528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362815|NCT00801528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362816|NCT01060891|Colistin|colistin|mesh-list
65362817|NCT01060891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65362818|NCT01060891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65362819|NCT04003402|Ethanol|ethanol|mesh-list
65362820|NCT04003402|ASP8062|asp8062|mesh-list
65362821|NCT04003402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65362822|NCT04003402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65362823|NCT04003402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65362824|NCT04003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362825|NCT04003402|Analgesics|analgesics|mesh-ancestor
65362826|NCT04003402|Sensory System Agents|sensory system agents|mesh-ancestor
65362827|NCT04003402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65362828|NCT04003402|GABA Modulators|gaba modulators|mesh-ancestor
65362829|NCT04003402|GABA Agents|gaba agents|mesh-ancestor
65362830|NCT04003402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64754956|NCT02716974|Docetaxel|docetaxel|mesh-list
65362851|NCT00991744|Prednisolone acetate|prednisolone acetate|mesh-list
65362852|NCT00991744|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65362853|NCT00991744|Prednisolone phosphate|prednisolone phosphate|mesh-list
65362854|NCT00991744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65362855|NCT00991744|Antimetabolites|antimetabolites|mesh-ancestor
65362856|NCT00991744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362857|NCT00991744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362858|NCT00991744|Antiviral Agents|antiviral agents|mesh-ancestor
65362859|NCT00991744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65362860|NCT00991744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65362861|NCT00991744|Immunologic Factors|immunologic factors|mesh-ancestor
65362862|NCT00991744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362863|NCT00991744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65362864|NCT00991744|Glucocorticoids|glucocorticoids|mesh-ancestor
65362865|NCT00991744|Hormones|hormones|mesh-ancestor
65362866|NCT00991744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65362867|NCT00991744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65362868|NCT00991744|Antiemetics|antiemetics|mesh-ancestor
65362869|NCT00991744|Autonomic Agents|autonomic agents|mesh-ancestor
65362870|NCT00991744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65362871|NCT00991744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65362872|NCT00991744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65362873|NCT00991744|Protective Agents|protective agents|mesh-ancestor
65362874|NCT00798876|Vitamin E|vitamin e|mesh-list
65362875|NCT00798876|Vitamins|vitamins|mesh-ancestor
65362876|NCT00798876|Micronutrients|micronutrients|mesh-ancestor
65362877|NCT00798876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362878|NCT00798876|Antioxidants|antioxidants|mesh-ancestor
65362879|NCT00798876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362880|NCT00798876|Protective Agents|protective agents|mesh-ancestor
65362881|NCT00989404|Zanamivir|zanamivir|mesh-list
65362882|NCT00989404|Antiviral Agents|antiviral agents|mesh-ancestor
65362883|NCT00989404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65362884|NCT00989404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019553|NCT02917018|Adrenergic Agents|adrenergic agents|mesh-ancestor
65362907|NCT00991822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362908|NCT00991822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65362909|NCT00991822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65362910|NCT00991822|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65362911|NCT00991822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362913|NCT00798954|Paclitaxel|paclitaxel|mesh-list
65112739|NCT04642001|Listerine|listerine|mesh-list
65362914|NCT00798954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65362915|NCT00798954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362916|NCT00798954|Tubulin Modulators|tubulin modulators|mesh-ancestor
65362917|NCT00798954|Antimitotic Agents|antimitotic agents|mesh-ancestor
65362918|NCT00798954|Mitosis Modulators|mitosis modulators|mesh-ancestor
65362919|NCT00798954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362920|NCT00798954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65362921|NCT00798954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64471688|NCT04251533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362922|NCT00798954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65362923|NCT00798954|Antifungal Agents|antifungal agents|mesh-ancestor
65362924|NCT00798954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65362925|NCT00798954|Immunologic Factors|immunologic factors|mesh-ancestor
65362926|NCT00798954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362927|NCT00934011|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65362928|NCT00934011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65362929|NCT00934011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65362930|NCT00934011|Antitubercular Agents|antitubercular agents|mesh-ancestor
65362931|NCT00934167|Heparin|heparin|mesh-list
65362932|NCT00934167|Calcium heparin|calcium heparin|mesh-list
65362933|NCT00934167|Anticoagulants|anticoagulants|mesh-ancestor
65362934|NCT00934167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65362967|NCT00934323|Glimepiride|glimepiride|mesh-list
65362968|NCT00934323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65362969|NCT00934323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362970|NCT00934323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65362971|NCT00934323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65362972|NCT00934323|Immunologic Factors|immunologic factors|mesh-ancestor
65362973|NCT00575666|Insulin|insulin|mesh-list
65362974|NCT00575666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65362975|NCT00575666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362976|NCT00934479|Lubiprostone|lubiprostone|mesh-list
64755107|NCT04390854|Clotrimazole|clotrimazole|mesh-list
65363005|NCT00660348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65363006|NCT03734198|Daratumumab|daratumumab|mesh-list
65363007|NCT03734198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65363008|NCT03734198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363009|NCT03734198|Immunologic Factors|immunologic factors|mesh-ancestor
65363010|NCT03734198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363011|NCT01564108|Ranibizumab|ranibizumab|mesh-list
65363012|NCT01564108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65363013|NCT01564108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65363014|NCT01564108|Growth Substances|growth substances|mesh-ancestor
65363015|NCT01564108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363016|NCT01564108|Growth Inhibitors|growth inhibitors|mesh-ancestor
65363017|NCT01564108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363018|NCT00801918|Cyclophosphamide|cyclophosphamide|mesh-list
65363019|NCT00801918|Ifosfamide|ifosfamide|mesh-list
65363020|NCT00801918|Etoposide|etoposide|mesh-list
65363021|NCT00801918|Denileukin diftitox|denileukin diftitox|mesh-list
65363022|NCT00801918|Interleukin-2|interleukin-2|mesh-list
65363023|NCT00801918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64755152|NCT04757376|Denosumab|denosumab|mesh-list
65363048|NCT00571688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65363049|NCT00571688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363050|NCT00571688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363052|NCT00571688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65363053|NCT00571688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65363054|NCT00571688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65363055|NCT00571688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65363056|NCT00571688|Dopamine Agents|dopamine agents|mesh-ancestor
65363057|NCT00799656|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
65363058|NCT00799656|Enzyme Activators|enzyme activators|mesh-ancestor
65363059|NCT00799656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363060|NCT05408104|Tolvaptan|tolvaptan|mesh-list
65363061|NCT05408104|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65363062|NCT05408104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363063|NCT05408104|Natriuretic Agents|natriuretic agents|mesh-ancestor
65363064|NCT05408104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363065|NCT04837716|Bevacizumab|bevacizumab|mesh-list
65363066|NCT04837716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65363067|NCT04837716|Carboplatin|carboplatin|mesh-list
65363068|NCT04837716|Pemetrexed|pemetrexed|mesh-list
65363069|NCT04837716|Ensartinib|ensartinib|mesh-list
65363070|NCT04837716|Endothelial Growth Factors|endothelial growth factors|mesh-list
65363071|NCT04837716|Antibodies|antibodies|mesh-list
65363104|NCT05407870|Etomidate|etomidate|mesh-list
65363105|NCT05407870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65363106|NCT05407870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65363107|NCT05407870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363108|NCT05407870|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65363109|NCT05407870|Anesthetics, General|anesthetics, general|mesh-ancestor
65363110|NCT05407870|Anesthetics|anesthetics|mesh-ancestor
65363111|NCT03988231|Enoxaparin|enoxaparin|mesh-list
64471689|NCT04251533|Tubulin Modulators|tubulin modulators|mesh-ancestor
65363112|NCT03988231|Anticoagulants|anticoagulants|mesh-ancestor
65363113|NCT03988231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65363114|NCT03988231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65363134|NCT00658788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65363135|NCT00658788|Glucocorticoids|glucocorticoids|mesh-ancestor
65363136|NCT00658788|Hormones|hormones|mesh-ancestor
65363137|NCT00658788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65363138|NCT01060969|Acetazolamide|acetazolamide|mesh-list
65363139|NCT01060969|Tadalafil|tadalafil|mesh-list
65363140|NCT01060969|Vasodilator Agents|vasodilator agents|mesh-ancestor
65363141|NCT01060969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65363142|NCT01060969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65363144|NCT01060969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363145|NCT01060969|Urological Agents|urological agents|mesh-ancestor
65363146|NCT01060969|Anticonvulsants|anticonvulsants|mesh-ancestor
65363147|NCT01060969|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65363148|NCT01060969|Diuretics|diuretics|mesh-ancestor
65363149|NCT01060969|Natriuretic Agents|natriuretic agents|mesh-ancestor
65363150|NCT01060969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363151|NCT05407246|Hemay005|hemay005|mesh-list
65363152|NCT05407246|Dermatologic Agents|dermatologic agents|mesh-ancestor
65363153|NCT05407246|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65363154|NCT05407246|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65363155|NCT05407246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363156|NCT05407246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363157|NCT00799890|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65363158|NCT00799890|Antioxidants|antioxidants|mesh-ancestor
65363159|NCT00799890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363160|NCT00799890|Protective Agents|protective agents|mesh-ancestor
65363161|NCT00799890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363162|NCT00799890|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65363163|NCT00799890|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65363164|NCT00799890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363165|NCT00799890|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65363166|NCT00799968|Fibrinolytic Agents|fibrinolytic agents|mesh-list
65363167|NCT00799968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65363168|NCT00799968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755291|NCT02013648|Cytarabine|cytarabine|mesh-list
65363187|NCT00802230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363188|NCT00802308|Morphine|morphine|mesh-list
65363189|NCT00802308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65363190|NCT00802308|Narcotics|narcotics|mesh-ancestor
65363191|NCT00802308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65363192|NCT00802308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363193|NCT00802308|Analgesics|analgesics|mesh-ancestor
65363194|NCT00802308|Sensory System Agents|sensory system agents|mesh-ancestor
65363195|NCT00802308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65363196|NCT00562965|Dexamethasone|dexamethasone|mesh-list
65363197|NCT00562965|Prednisone|prednisone|mesh-list
65363198|NCT00562965|Prednisolone|prednisolone|mesh-list
65363199|NCT00562965|Cyclophosphamide|cyclophosphamide|mesh-list
65363200|NCT00562965|Rituximab|rituximab|mesh-list
65363201|NCT00562965|Fludarabine|fludarabine|mesh-list
65363202|NCT00562965|Vincristine|vincristine|mesh-list
65363203|NCT00562965|Mitoxantrone|mitoxantrone|mesh-list
65363204|NCT00562965|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65363205|NCT00562965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65363206|NCT00562965|Immunologic Factors|immunologic factors|mesh-ancestor
65363207|NCT00562965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363208|NCT00562965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65363209|NCT00562965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65363210|NCT00562965|Alkylating Agents|alkylating agents|mesh-ancestor
65363211|NCT00562965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363212|NCT00562965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363213|NCT00562965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65363214|NCT00562965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65363215|NCT00562965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65363216|NCT00562965|Antiemetics|antiemetics|mesh-ancestor
65363217|NCT00562965|Autonomic Agents|autonomic agents|mesh-ancestor
65363218|NCT00562965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65363219|NCT00562965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65363220|NCT00562965|Glucocorticoids|glucocorticoids|mesh-ancestor
65363222|NCT00562965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65363223|NCT00562965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65363224|NCT00562965|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65363225|NCT00562965|Tubulin Modulators|tubulin modulators|mesh-ancestor
65363226|NCT00562965|Antimitotic Agents|antimitotic agents|mesh-ancestor
65363254|NCT00800358|Calcitriol|calcitriol|mesh-list
65363255|NCT00800358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65363256|NCT00800358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363257|NCT00800358|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65363258|NCT00800358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65363259|NCT00800358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363260|NCT00800358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65363261|NCT00800358|Vitamins|vitamins|mesh-ancestor
65363262|NCT00800358|Micronutrients|micronutrients|mesh-ancestor
65363263|NCT00800358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65363264|NCT00934713|Montelukast|montelukast|mesh-list
65363265|NCT00934713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65363266|NCT00934713|Respiratory System Agents|respiratory system agents|mesh-ancestor
65363267|NCT00934713|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65363268|NCT00934713|Hormone Antagonists|hormone antagonists|mesh-ancestor
65363269|NCT00934713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65363270|NCT00934713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363271|NCT00934713|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65363272|NCT00934713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65363273|NCT00934713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363308|NCT00794976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363309|NCT00794976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65363310|NCT00794976|Glucocorticoids|glucocorticoids|mesh-ancestor
65363311|NCT00794976|Hormones|hormones|mesh-ancestor
65363312|NCT00794976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65363313|NCT00794976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64755449|NCT04390152|Antimalarials|antimalarials|mesh-ancestor
65363346|NCT00803166|Glucocorticoids|glucocorticoids|mesh-ancestor
65363347|NCT00803166|Hormones|hormones|mesh-ancestor
65363348|NCT00803166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65363349|NCT00803166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363350|NCT00324961|Adefovir|adefovir|mesh-list
65363351|NCT00324961|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65363352|NCT00324961|Antiviral Agents|antiviral agents|mesh-ancestor
65363353|NCT00324961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64755496|NCT02456532|Zolpidem|zolpidem|mesh-list
65363373|NCT00935415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363376|NCT00935571|Sevoflurane|sevoflurane|mesh-list
65363377|NCT00935571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65363378|NCT00935571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65363379|NCT00935571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363380|NCT00935571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65363381|NCT00935571|Anesthetics, General|anesthetics, general|mesh-ancestor
65363382|NCT00935571|Anesthetics|anesthetics|mesh-ancestor
65363383|NCT00935571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65363384|NCT00935571|Narcotics|narcotics|mesh-ancestor
65363385|NCT00935571|Analgesics|analgesics|mesh-ancestor
65363386|NCT00935571|Sensory System Agents|sensory system agents|mesh-ancestor
65363387|NCT00935571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65363388|NCT00935571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65363389|NCT00935571|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65363390|NCT00324649|Lamivudine|lamivudine|mesh-list
65363391|NCT00324649|Zidovudine|zidovudine|mesh-list
65363392|NCT00324649|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65363393|NCT00324649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65363394|NCT00324649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65363395|NCT00324649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363396|NCT00324649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363397|NCT00324649|Antiviral Agents|antiviral agents|mesh-ancestor
65363398|NCT00324649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65363399|NCT00324649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65363400|NCT00324649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65363401|NCT00324649|Antimetabolites|antimetabolites|mesh-ancestor
65363402|NCT03743259|Charcoal|charcoal|mesh-list
65363403|NCT03743259|Antidotes|antidotes|mesh-ancestor
65363404|NCT03743259|Protective Agents|protective agents|mesh-ancestor
65363405|NCT03743259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363406|NCT03983239|Efavirenz|efavirenz|mesh-list
65363441|NCT00935805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65363442|NCT00935805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64471690|NCT04251533|Antimitotic Agents|antimitotic agents|mesh-ancestor
65363443|NCT00935805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65363444|NCT00935805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363445|NCT00935805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65363447|NCT00935805|Natriuretic Agents|natriuretic agents|mesh-ancestor
65363478|NCT00803556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363479|NCT00803556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65363480|NCT00936195|Ritonavir|ritonavir|mesh-list
65363481|NCT00936195|Lopinavir|lopinavir|mesh-list
65363482|NCT00936195|Tenofovir|tenofovir|mesh-list
65363483|NCT00936195|Lamivudine|lamivudine|mesh-list
65363484|NCT00936195|Zidovudine|zidovudine|mesh-list
65363485|NCT00936195|Emtricitabine|emtricitabine|mesh-list
65363486|NCT00936195|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
65363487|NCT00936195|Efavirenz|efavirenz|mesh-list
65363488|NCT00936195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65363489|NCT00936195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65363490|NCT00936195|Protease Inhibitors|protease inhibitors|mesh-ancestor
65363491|NCT00936195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363492|NCT00936195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363493|NCT00936195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65363494|NCT00936195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65363523|NCT00656292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65363524|NCT00656292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65363525|NCT00656292|Antimetabolites|antimetabolites|mesh-ancestor
65363526|NCT00656292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363527|NCT00656292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65363528|NCT00656292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65363529|NCT00656292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363530|NCT00352417|Atreleuton|atreleuton|mesh-list
65363531|NCT00352417|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65363532|NCT00352417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363533|NCT00352417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363534|NCT00944541|Maraviroc|maraviroc|mesh-list
65363535|NCT00944541|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65363536|NCT00944541|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65363537|NCT00944541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755671|NCT02063022|Dactinomycin|dactinomycin|mesh-list
65363562|NCT00323869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65363563|NCT00323869|Immunologic Factors|immunologic factors|mesh-ancestor
65363565|NCT00323557|Sargramostim|sargramostim|mesh-list
65363566|NCT00323557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65363567|NCT00323557|Immunologic Factors|immunologic factors|mesh-ancestor
65363568|NCT00323557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363569|NCT00323557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363570|NCT00558363|Dutasteride|dutasteride|mesh-list
65363571|NCT00558363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65363572|NCT00558363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65363573|NCT00558363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363574|NCT00558363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363575|NCT00558363|Hormone Antagonists|hormone antagonists|mesh-ancestor
65363576|NCT00558363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65363577|NCT00558363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363578|NCT00323479|Anastrozole|anastrozole|mesh-list
65363579|NCT00323479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65363580|NCT00323479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363581|NCT00323479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65363582|NCT00323479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65363583|NCT00323479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363584|NCT00323479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363585|NCT00323479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65363586|NCT00323479|Hormone Antagonists|hormone antagonists|mesh-ancestor
65019554|NCT02917018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65363621|NCT03985891|Antibodies|antibodies|mesh-list
65363622|NCT03985891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65363623|NCT03985891|Immunologic Factors|immunologic factors|mesh-ancestor
65363624|NCT03985891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363625|NCT00350779|Metformin|metformin|mesh-list
65363626|NCT00350779|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65363627|NCT00350779|Rosiglitazone|rosiglitazone|mesh-list
65363628|NCT00350779|Glipizide|glipizide|mesh-list
65363660|NCT00322621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363661|NCT00322621|Analgesics|analgesics|mesh-ancestor
65363662|NCT00322621|Sensory System Agents|sensory system agents|mesh-ancestor
65273597|NCT02846831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65273598|NCT01497509|Epinephrine|epinephrine|mesh-list
65363663|NCT00322621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65363664|NCT00322621|Antidepressive Agents|antidepressive agents|mesh-ancestor
65363665|NCT00322621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65363666|NCT00322621|Dopamine Agents|dopamine agents|mesh-ancestor
65363668|NCT02558972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65363669|NCT02558972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65363701|NCT00575042|Antimetabolites|antimetabolites|mesh-ancestor
65363702|NCT00575042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363703|NCT00575042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65363704|NCT00656058|Montelukast|montelukast|mesh-list
65363705|NCT00656058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65363706|NCT00656058|Respiratory System Agents|respiratory system agents|mesh-ancestor
65363707|NCT00656058|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65363708|NCT00656058|Hormone Antagonists|hormone antagonists|mesh-ancestor
65363709|NCT00656058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65363710|NCT00656058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755844|NCT00262470|Sympatholytics|sympatholytics|mesh-ancestor
65363742|NCT00655980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65363743|NCT00655980|Anesthetics, General|anesthetics, general|mesh-ancestor
65363744|NCT00655980|Anesthetics|anesthetics|mesh-ancestor
65363745|NCT00655980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65363746|NCT00655980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65363747|NCT00655980|Analgesics|analgesics|mesh-ancestor
65363748|NCT00655980|Sensory System Agents|sensory system agents|mesh-ancestor
65363749|NCT00655980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65363750|NCT01063621|Apomorphine|apomorphine|mesh-list
65363751|NCT01063621|Emetics|emetics|mesh-ancestor
65363752|NCT01063621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363753|NCT01063621|Autonomic Agents|autonomic agents|mesh-ancestor
64755887|NCT01851642|Tocolytic Agents|tocolytic agents|mesh-ancestor
65363817|NCT00809874|Chelating Agents|chelating agents|mesh-ancestor
65363818|NCT00809874|Sequestering Agents|sequestering agents|mesh-ancestor
65363819|NCT00809874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363820|NCT05436002|Hyaluronic Acid|hyaluronic acid|mesh-list
65363821|NCT05436002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65363822|NCT05436002|Immunologic Factors|immunologic factors|mesh-ancestor
65363823|NCT05436002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363824|NCT05436002|Viscosupplements|viscosupplements|mesh-ancestor
65363825|NCT05436002|Protective Agents|protective agents|mesh-ancestor
65363827|NCT02560376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65363828|NCT02560376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363829|NCT02560376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65363830|NCT02560376|Incretins|incretins|mesh-ancestor
65363831|NCT02560376|Hormones|hormones|mesh-ancestor
65363832|NCT02560376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65363833|NCT00535288|Mirtazapine|mirtazapine|mesh-list
65363834|NCT00535288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363835|NCT00535288|Antidepressive Agents|antidepressive agents|mesh-ancestor
65363861|NCT00921830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65363862|NCT00921830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65363863|NCT00921830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363864|NCT00921830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363865|NCT02560220|Mitomycins|mitomycins|mesh-list
65363866|NCT02560220|Mitomycin|mitomycin|mesh-list
65363867|NCT02560220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65363868|NCT02560220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363869|NCT02560220|Alkylating Agents|alkylating agents|mesh-ancestor
65363870|NCT02560220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363871|NCT02560220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65363872|NCT02560220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363873|NCT05356078|Antidepressive Agents|antidepressive agents|mesh-list
65363874|NCT05356078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65363875|NCT04836832|Acalabrutinib|acalabrutinib|mesh-list
65363876|NCT04836832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363877|NCT05222438|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
65363878|NCT05222438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65363879|NCT05222438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363880|NCT02783300|Pembrolizumab|pembrolizumab|mesh-list
65363881|NCT02783300|GSK-3326595|gsk-3326595|mesh-list
65363882|NCT02783300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64539369|NCT00654069|Niacin|niacin|mesh-list
65363883|NCT02783300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363908|NCT03895840|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65363909|NCT03895840|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65363910|NCT03895840|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65363911|NCT03895840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65363912|NCT03895840|Glucocorticoids|glucocorticoids|mesh-ancestor
65363913|NCT03895840|Hormones|hormones|mesh-ancestor
65363914|NCT03895840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65363915|NCT03895840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363916|NCT03895840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65363917|NCT03895840|Immunologic Factors|immunologic factors|mesh-ancestor
65363918|NCT03895840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363919|NCT03895840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363920|NCT00310375|Ezogabine|ezogabine|mesh-list
65363921|NCT00310375|Anticonvulsants|anticonvulsants|mesh-ancestor
65363922|NCT00310375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65363923|NCT00310375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363924|NCT00309907|Methylprednisolone|methylprednisolone|mesh-list
65363925|NCT00309907|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65363926|NCT00309907|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65363927|NCT00309907|Prednisolone|prednisolone|mesh-list
65363928|NCT00309907|Prednisolone acetate|prednisolone acetate|mesh-list
65363929|NCT00309907|Etanercept|etanercept|mesh-list
65363930|NCT00309907|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65363931|NCT00309907|Prednisolone phosphate|prednisolone phosphate|mesh-list
65363932|NCT00309907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65363965|NCT03985969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65363966|NCT03985969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65363967|NCT03985969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363968|NCT03985969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363969|NCT01061437|Lansoprazole|lansoprazole|mesh-list
65363970|NCT01061437|Dexlansoprazole|dexlansoprazole|mesh-list
65363971|NCT01061437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65363972|NCT01061437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65363973|NCT01061437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65363974|NCT01061437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363975|NCT01061437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363976|NCT00575588|Metformin|metformin|mesh-list
65363977|NCT00575588|Saxagliptin|saxagliptin|mesh-list
65363995|NCT01058317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65363997|NCT00810030|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65363998|NCT00810030|Hematinics|hematinics|mesh-ancestor
65363999|NCT00675428|Natalizumab|natalizumab|mesh-list
65364000|NCT00675428|Immunologic Factors|immunologic factors|mesh-ancestor
65364001|NCT00675428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364002|NCT00760916|Treprostinil|treprostinil|mesh-list
65364003|NCT00760916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65364004|NCT05011760|Amphetamine|amphetamine|mesh-list
65364005|NCT05011760|Dextroamphetamine|dextroamphetamine|mesh-list
65364006|NCT05011760|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65364007|NCT05011760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364008|NCT05011760|Sympathomimetics|sympathomimetics|mesh-ancestor
65364009|NCT05011760|Autonomic Agents|autonomic agents|mesh-ancestor
65364010|NCT05011760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65364011|NCT05011760|Dopamine Agents|dopamine agents|mesh-ancestor
65364012|NCT05011760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65364013|NCT05011760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364014|NCT05011760|Adrenergic Agents|adrenergic agents|mesh-ancestor
65364015|NCT05011760|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65364016|NCT05011760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65364017|NCT05011760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65364018|NCT05011760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65364019|NCT00761228|Apomorphine|apomorphine|mesh-list
65364020|NCT00761228|Emetics|emetics|mesh-ancestor
65364021|NCT00761228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364022|NCT00761228|Autonomic Agents|autonomic agents|mesh-ancestor
65364023|NCT00761228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65364024|NCT00761228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65364025|NCT00761228|Dopamine Agonists|dopamine agonists|mesh-ancestor
65364026|NCT00761228|Dopamine Agents|dopamine agents|mesh-ancestor
65364027|NCT00761228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65364028|NCT00761228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364029|NCT00758732|Carboplatin|carboplatin|mesh-list
65364030|NCT00758732|Docetaxel|docetaxel|mesh-list
65364031|NCT00758732|Doxorubicin|doxorubicin|mesh-list
65273599|NCT01497509|Racepinephrine|racepinephrine|mesh-list
65273600|NCT01497509|Fentanyl|fentanyl|mesh-list
65273601|NCT01497509|Bupivacaine|bupivacaine|mesh-list
65364032|NCT00758732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65364033|NCT00758732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364065|NCT00759122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65364066|NCT00759122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65364067|NCT00759122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65364068|NCT00759122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364069|NCT00759122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65364070|NCT00759122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364071|NCT00759122|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65364072|NCT00759122|Antidepressive Agents|antidepressive agents|mesh-ancestor
65364073|NCT00759122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65364074|NCT00759200|Interferons|interferons|mesh-list
65364075|NCT00759200|Interferon-alpha|interferon-alpha|mesh-list
65364076|NCT00759200|Interferon alpha-2|interferon alpha-2|mesh-list
65364110|NCT02559440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65364111|NCT02559440|Nasal Decongestants|nasal decongestants|mesh-ancestor
65364112|NCT02559440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65364113|NCT02559440|Respiratory System Agents|respiratory system agents|mesh-ancestor
65364114|NCT02559440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65364116|NCT02559440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65364117|NCT02559440|Protective Agents|protective agents|mesh-ancestor
65364118|NCT00674570|Cycloserine|cycloserine|mesh-list
65364149|NCT00940953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65364150|NCT00940953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364151|NCT00940953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65364152|NCT00940953|Respiratory System Agents|respiratory system agents|mesh-ancestor
65364153|NCT00940953|Glucocorticoids|glucocorticoids|mesh-ancestor
65364154|NCT00940953|Hormones|hormones|mesh-ancestor
65364155|NCT00940953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65364156|NCT00940953|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65364157|NCT00940953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364158|NCT00940953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364159|NCT00940953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65364160|NCT00940953|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65364161|NCT00940953|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65364162|NCT00940953|Histamine Antagonists|histamine antagonists|mesh-ancestor
65364185|NCT00759824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65364186|NCT00759824|Antimanic Agents|antimanic agents|mesh-ancestor
65364187|NCT00759824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65364188|NCT00759824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65364189|NCT00759824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65364190|NCT00759824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65364191|NCT00759824|Tubulin Modulators|tubulin modulators|mesh-ancestor
65364192|NCT00759824|Antimitotic Agents|antimitotic agents|mesh-ancestor
65364193|NCT00759824|Mitosis Modulators|mitosis modulators|mesh-ancestor
65364194|NCT00561951|Fesoterodine|fesoterodine|mesh-list
65364195|NCT00561951|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65364196|NCT00561951|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65364197|NCT00561951|Cholinergic Agents|cholinergic agents|mesh-ancestor
65364198|NCT00561951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65364199|NCT00561951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364200|NCT00561951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364201|NCT00561951|Urological Agents|urological agents|mesh-ancestor
65364202|NCT00762398|Chrysarobin|chrysarobin|mesh-list
65364203|NCT00762398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65364204|NCT00762398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65364205|NCT00762398|Analgesics|analgesics|mesh-ancestor
65364206|NCT00762398|Sensory System Agents|sensory system agents|mesh-ancestor
65364207|NCT00762398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65364208|NCT00762398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364209|NCT00762398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65364210|NCT00762398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65364211|NCT00762632|Everolimus|everolimus|mesh-list
65364212|NCT00762632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364213|NCT00762632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65364214|NCT00762632|Immunologic Factors|immunologic factors|mesh-ancestor
64756345|NCT00056550|Antithrombin III|antithrombin iii|mesh-list
65364247|NCT00941265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273602|NCT01497509|Epinephryl borate|epinephryl borate|mesh-list
65273603|NCT01497509|Anesthetics, Local|anesthetics, local|mesh-ancestor
65364249|NCT00941343|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65364250|NCT00941343|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65364251|NCT00941343|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65364252|NCT00941343|Adrenergic Agents|adrenergic agents|mesh-ancestor
65364253|NCT00941343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65364254|NCT00941343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364255|NCT00941343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364256|NCT00941343|Urological Agents|urological agents|mesh-ancestor
65364257|NCT00561795|Paclitaxel|paclitaxel|mesh-list
65364258|NCT00561795|Carboplatin|carboplatin|mesh-list
65364290|NCT00941499|Immunoglobulins|immunoglobulins|mesh-list
65364291|NCT00941499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65364292|NCT00941499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364293|NCT00941499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65364294|NCT00941499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65364295|NCT00941499|Growth Substances|growth substances|mesh-ancestor
65364296|NCT00941499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364297|NCT00941499|Growth Inhibitors|growth inhibitors|mesh-ancestor
65364298|NCT00941499|Immunologic Factors|immunologic factors|mesh-ancestor
65364299|NCT00941499|Antimetabolites|antimetabolites|mesh-ancestor
65364300|NCT00941499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364301|NCT00941499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65364302|NCT00941499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65364329|NCT00945789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65364330|NCT00945789|Respiratory System Agents|respiratory system agents|mesh-ancestor
65364331|NCT00945789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65364332|NCT00945789|Antioxidants|antioxidants|mesh-ancestor
65364333|NCT00945789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364334|NCT00945789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65364335|NCT00945789|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65114174|NCT00449501|Hormones|hormones|mesh-ancestor
65364336|NCT00945789|Vasodilator Agents|vasodilator agents|mesh-ancestor
65364337|NCT00945789|Gasotransmitters|gasotransmitters|mesh-ancestor
65364338|NCT00945789|Protective Agents|protective agents|mesh-ancestor
65364340|NCT00941811|Imiquimod|imiquimod|mesh-list
65364341|NCT00941811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65364342|NCT00941811|Immunologic Factors|immunologic factors|mesh-ancestor
65364343|NCT00941811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364344|NCT00941811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364345|NCT00941811|Interferon Inducers|interferon inducers|mesh-ancestor
65364346|NCT02553018|Methotrexate|methotrexate|mesh-list
65364347|NCT02553018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65364348|NCT02553018|Abortifacient Agents|abortifacient agents|mesh-ancestor
65364349|NCT02553018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65364350|NCT02553018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364351|NCT02553018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65364352|NCT02553018|Antimetabolites|antimetabolites|mesh-ancestor
65364353|NCT02553018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756491|NCT01960530|Hormones|hormones|mesh-ancestor
65364372|NCT00941967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65364373|NCT00941967|Immunologic Factors|immunologic factors|mesh-ancestor
65364374|NCT00941967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364375|NCT00941967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65364376|NCT00655746|Dasatinib|dasatinib|mesh-list
65364377|NCT00655746|Omeprazole|omeprazole|mesh-list
65364378|NCT00655746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65364379|NCT00655746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65364380|NCT00655746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65364381|NCT00655746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364382|NCT00655746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364383|NCT00655746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364384|NCT00655746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65364385|NCT00338455|Dobutamine|dobutamine|mesh-list
65364386|NCT00338455|Milrinone|milrinone|mesh-list
65364387|NCT00338455|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65364388|NCT00338455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65364389|NCT00338455|Sympathomimetics|sympathomimetics|mesh-ancestor
65364390|NCT00338455|Autonomic Agents|autonomic agents|mesh-ancestor
65364391|NCT00338455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65364392|NCT00338455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364393|NCT00338455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65273604|NCT01497509|Anesthetics|anesthetics|mesh-ancestor
65364394|NCT00338455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65364395|NCT00338455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65364396|NCT00338455|Adrenergic Agents|adrenergic agents|mesh-ancestor
65364397|NCT00338455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65364398|NCT00338455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364399|NCT00338455|Protective Agents|protective agents|mesh-ancestor
65364400|NCT00338455|Natriuretic Agents|natriuretic agents|mesh-ancestor
65364401|NCT00338455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65364402|NCT00338455|Vasodilator Agents|vasodilator agents|mesh-ancestor
65364403|NCT00338455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65364404|NCT00338455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65364405|NCT00338455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364406|NCT00678392|Sorafenib|sorafenib|mesh-list
65364407|NCT00678392|Axitinib|axitinib|mesh-list
65364408|NCT00678392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364409|NCT00678392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65364410|NCT00678392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364411|NCT00678392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364442|NCT00942201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364443|NCT00942201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364445|NCT00942435|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65364446|NCT00942435|Antithrombins|antithrombins|mesh-ancestor
65364447|NCT00942435|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65364448|NCT00942435|Protease Inhibitors|protease inhibitors|mesh-ancestor
65364449|NCT00942435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364450|NCT00942435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364451|NCT00942435|Anticoagulants|anticoagulants|mesh-ancestor
65364452|NCT00946179|Vaccines|vaccines|mesh-list
65364453|NCT00946179|Immunologic Factors|immunologic factors|mesh-ancestor
65364454|NCT00946179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364455|NCT00950625|Lidocaine|lidocaine|mesh-list
65364456|NCT00950625|Anesthetics, Local|anesthetics, local|mesh-ancestor
65364488|NCT00946335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364489|NCT00946335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364490|NCT00946335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65364491|NCT00946335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364492|NCT00760370|Zoledronic Acid|zoledronic acid|mesh-list
65364493|NCT00760370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65364494|NCT00760370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364496|NCT00762944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65364497|NCT00762944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65364524|NCT00763178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65364526|NCT00763178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65364527|NCT00763178|Dopamine Agents|dopamine agents|mesh-ancestor
65364528|NCT04391348|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65364529|NCT04391348|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65364530|NCT04391348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364531|NCT00308581|Certolizumab Pegol|certolizumab pegol|mesh-list
65364532|NCT00308581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65364533|NCT00308581|Immunologic Factors|immunologic factors|mesh-ancestor
65364534|NCT00308581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364535|NCT00308581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65364536|NCT00678080|Metformin|metformin|mesh-list
65364537|NCT00678080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65364538|NCT00678080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364539|NCT00658320|Cyclosporine|cyclosporine|mesh-list
65364540|NCT00658320|Mycophenolic Acid|mycophenolic acid|mesh-list
65364541|NCT00658320|Everolimus|everolimus|mesh-list
65364542|NCT00658320|Cyclosporins|cyclosporins|mesh-list
65364543|NCT00658320|Basiliximab|basiliximab|mesh-list
65364578|NCT00806754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65364579|NCT00806754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65364580|NCT00806754|Respiratory System Agents|respiratory system agents|mesh-ancestor
65364581|NCT00806754|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65364582|NCT00806754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756727|NCT02091882|Serotonin Agents|serotonin agents|mesh-ancestor
65364606|NCT00806910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364607|NCT00807066|Gefitinib|gefitinib|mesh-list
65364608|NCT00807066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364609|NCT00807066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65364610|NCT00807066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364611|NCT00807066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364612|NCT00804960|Letrozole|letrozole|mesh-list
65364613|NCT00804960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364614|NCT00804960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65364615|NCT00804960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65364616|NCT00804960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364617|NCT00804960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364618|NCT00804960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65364619|NCT00804960|Hormone Antagonists|hormone antagonists|mesh-ancestor
65364620|NCT00804960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65364621|NCT00804960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364622|NCT00805116|Cod Liver Oil|cod liver oil|mesh-list
65364623|NCT00805116|Vitamins|vitamins|mesh-ancestor
65364624|NCT00805116|Micronutrients|micronutrients|mesh-ancestor
65364625|NCT00805116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364626|NCT03985735|Anesthetics|anesthetics|mesh-list
65364627|NCT03985735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65364628|NCT03985735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364629|NCT00807222|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64756768|NCT00254592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65364633|NCT00807222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65364634|NCT00807222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65364635|NCT00807222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364636|NCT00807222|Dopamine Agents|dopamine agents|mesh-ancestor
65364637|NCT00807222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65364638|NCT00657618|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
65364639|NCT00657618|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65364640|NCT00657618|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65364641|NCT00657618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65364642|NCT00657618|Schistosomicides|schistosomicides|mesh-ancestor
65364643|NCT00657618|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65364644|NCT00657618|Anthelmintics|anthelmintics|mesh-ancestor
65364645|NCT00672620|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65364646|NCT00672620|Vortioxetine|vortioxetine|mesh-list
65364647|NCT00672620|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65364648|NCT00672620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65364649|NCT00672620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65364650|NCT00672620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364651|NCT00672620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65364652|NCT00672620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364653|NCT00672620|Analgesics|analgesics|mesh-ancestor
65364654|NCT00672620|Sensory System Agents|sensory system agents|mesh-ancestor
65364655|NCT00672620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65364656|NCT00672620|Antidepressive Agents|antidepressive agents|mesh-ancestor
65364657|NCT00672620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65364658|NCT00672620|Dopamine Agents|dopamine agents|mesh-ancestor
65364659|NCT00672620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65364660|NCT00672620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65364661|NCT00672620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65364662|NCT00672620|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65364663|NCT00672620|Serotonin Agents|serotonin agents|mesh-ancestor
65364664|NCT00672620|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65364665|NCT00672620|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65364666|NCT00672620|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65364667|NCT00672620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65364668|NCT00764972|Sorafenib|sorafenib|mesh-list
65364669|NCT00764972|Vinorelbine|vinorelbine|mesh-list
65364670|NCT00764972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364671|NCT00764972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65364672|NCT00764972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364673|NCT00764972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364674|NCT00764972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65364675|NCT00764972|Tubulin Modulators|tubulin modulators|mesh-ancestor
65364676|NCT00764972|Antimitotic Agents|antimitotic agents|mesh-ancestor
65364677|NCT00764972|Mitosis Modulators|mitosis modulators|mesh-ancestor
65364678|NCT00673790|Losartan|losartan|mesh-list
65364679|NCT00673790|Lisinopril|lisinopril|mesh-list
65364680|NCT00673790|Nebivolol|nebivolol|mesh-list
65364681|NCT00673790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65364682|NCT00673790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65364683|NCT00673790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65364684|NCT00673790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65364685|NCT00673790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364686|NCT00673790|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65364687|NCT00673790|Protease Inhibitors|protease inhibitors|mesh-ancestor
65364688|NCT00673790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273605|NCT01497509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65364689|NCT00673790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65364690|NCT00673790|Protective Agents|protective agents|mesh-ancestor
65364691|NCT00673790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364692|NCT00673790|Vasodilator Agents|vasodilator agents|mesh-ancestor
65364693|NCT00673790|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65364694|NCT00673790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65364695|NCT00673790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65364696|NCT00673790|Adrenergic Agents|adrenergic agents|mesh-ancestor
65364697|NCT00673790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65364698|NCT00763646|Docetaxel|docetaxel|mesh-list
65364699|NCT00763646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364730|NCT00770354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364731|NCT00770354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364732|NCT00770354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65364733|NCT00770354|Hormone Antagonists|hormone antagonists|mesh-ancestor
65364734|NCT00770354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65364735|NCT00770354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364737|NCT00670748|Cyclophosphamide|cyclophosphamide|mesh-list
65364738|NCT00670748|Fludarabine|fludarabine|mesh-list
65364739|NCT00670748|Fludarabine phosphate|fludarabine phosphate|mesh-list
65364740|NCT00670748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65364741|NCT00670748|Immunologic Factors|immunologic factors|mesh-ancestor
65364742|NCT00670748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364762|NCT00646776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364764|NCT00646776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65364765|NCT00646776|Antiviral Agents|antiviral agents|mesh-ancestor
65364766|NCT00646776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65364767|NCT00646776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65364768|NCT00646776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65364769|NCT00646776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65364770|NCT00646776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65364771|NCT00646776|Antitubercular Agents|antitubercular agents|mesh-ancestor
65364772|NCT02558114|Ribavirin|ribavirin|mesh-list
65364773|NCT02558114|Antimetabolites|antimetabolites|mesh-ancestor
65364774|NCT02558114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364775|NCT02558114|Antiviral Agents|antiviral agents|mesh-ancestor
65364776|NCT02558114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65364777|NCT00770666|Bupropion|bupropion|mesh-list
65364778|NCT00770666|Nicotine|nicotine|mesh-list
65364779|NCT00770666|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65364780|NCT00770666|Autonomic Agents|autonomic agents|mesh-ancestor
65364781|NCT00770666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65114620|NCT05289492|Dexamethasone|dexamethasone|mesh-list
65364782|NCT00770666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364783|NCT00770666|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65364784|NCT00770666|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65364785|NCT00770666|Cholinergic Agents|cholinergic agents|mesh-ancestor
65364786|NCT00770666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65364787|NCT00770666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364788|NCT00770666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65364789|NCT00770666|Antidepressive Agents|antidepressive agents|mesh-ancestor
65364790|NCT00770666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65364791|NCT00770666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65364792|NCT00770666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65364793|NCT00770666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65364794|NCT00770666|Dopamine Agents|dopamine agents|mesh-ancestor
65364795|NCT00770666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65364796|NCT00770666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65364820|NCT00811200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364821|NCT00811200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65364822|NCT00811200|Glucocorticoids|glucocorticoids|mesh-ancestor
65364823|NCT00811200|Hormones|hormones|mesh-ancestor
65364824|NCT00811200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65364825|NCT00811200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65364826|NCT00811200|Immunologic Factors|immunologic factors|mesh-ancestor
65364827|NCT00811200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364828|NCT00811200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364829|NCT00811356|Rosiglitazone|rosiglitazone|mesh-list
65364830|NCT00811356|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65364831|NCT00811356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65364832|NCT00811356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65273606|NCT01497509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364833|NCT00811356|Antimetabolites|antimetabolites|mesh-ancestor
65364834|NCT00811356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364835|NCT00811356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65364836|NCT00811356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65364837|NCT00811356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364838|NCT00811356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65364839|NCT00811356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364840|NCT00765986|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65364841|NCT00765986|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
65364842|NCT00765986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65364843|NCT00765986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364844|NCT00766064|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65364845|NCT00766064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65364846|NCT00766064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65364847|NCT00766064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65364848|NCT00766064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364849|NCT00766064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65364872|NCT00770744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65364873|NCT00770744|Serotonin Agents|serotonin agents|mesh-ancestor
65364874|NCT00655668|Lenalidomide|lenalidomide|mesh-list
65364875|NCT00655668|Immunologic Factors|immunologic factors|mesh-ancestor
65364876|NCT00655668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364877|NCT00655668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65364878|NCT00655668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65364879|NCT00655668|Growth Substances|growth substances|mesh-ancestor
65364880|NCT00655668|Growth Inhibitors|growth inhibitors|mesh-ancestor
65364881|NCT00655668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364882|NCT00770900|Montelukast|montelukast|mesh-list
65364883|NCT00770900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65364884|NCT00770900|Respiratory System Agents|respiratory system agents|mesh-ancestor
65364885|NCT00770900|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65364886|NCT00770900|Hormone Antagonists|hormone antagonists|mesh-ancestor
65364887|NCT00770900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65364888|NCT00770900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364889|NCT00770900|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65364890|NCT00770900|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65364891|NCT00770900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364892|NCT00766220|Irinotecan|irinotecan|mesh-list
65364893|NCT00766220|Cetuximab|cetuximab|mesh-list
65364894|NCT00766220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65364895|NCT00766220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65364896|NCT00766220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364897|NCT00766220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364913|NCT00764582|Moxifloxacin|moxifloxacin|mesh-list
65364914|NCT00764582|Levofloxacin|levofloxacin|mesh-list
65364915|NCT00764582|Ofloxacin|ofloxacin|mesh-list
65364916|NCT00764582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65364917|NCT00764582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65364918|NCT00764582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65364919|NCT00764582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65364920|NCT00764582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65364921|NCT00764582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65364922|NCT00764582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364923|NCT00764582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364924|NCT00764582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364925|NCT00764582|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65364926|NCT00764582|Renal Agents|renal agents|mesh-ancestor
65364927|NCT00764582|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65364928|NCT00764582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65364929|NCT04048226|Dexmedetomidine|dexmedetomidine|mesh-list
65364930|NCT04048226|Ketamine|ketamine|mesh-list
65364931|NCT04048226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65364932|NCT04048226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65364933|NCT04048226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364934|NCT04048226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65364936|NCT04048226|Sensory System Agents|sensory system agents|mesh-ancestor
65364937|NCT04048226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65364938|NCT04048226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65364939|NCT04048226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65364940|NCT04048226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64484213|NCT01751113|Xhance|xhance|mesh-list
65364941|NCT04048226|Adrenergic Agents|adrenergic agents|mesh-ancestor
65364942|NCT04048226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65364943|NCT04048226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364944|NCT04048226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65364945|NCT04048226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65364946|NCT04048226|Anesthetics, General|anesthetics, general|mesh-ancestor
65364947|NCT04048226|Anesthetics|anesthetics|mesh-ancestor
65364948|NCT04048226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65364949|NCT04048226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65364950|NCT00811746|Eszopiclone|eszopiclone|mesh-list
65364951|NCT00811746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65364952|NCT00811746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65364953|NCT00811746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364954|NCT04048070|Flurbiprofen|flurbiprofen|mesh-list
65364955|NCT04048070|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
65364956|NCT04048070|Sufentanil|sufentanil|mesh-list
65364957|NCT04048070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65364958|NCT04048070|Narcotics|narcotics|mesh-ancestor
64757099|NCT00201864|Fulvestrant|fulvestrant|mesh-list
65364986|NCT00811980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65364987|NCT00811980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65364988|NCT00811980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364989|NCT00811980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364990|NCT00775034|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65364991|NCT00775034|Hemostatics|hemostatics|mesh-ancestor
65364992|NCT00775034|Coagulants|coagulants|mesh-ancestor
65364993|NCT00813696|Gemcitabine|gemcitabine|mesh-list
65364994|NCT00813696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364995|NCT00813696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65364996|NCT00813696|Antimetabolites|antimetabolites|mesh-ancestor
65364997|NCT00813696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364998|NCT00813696|Antiviral Agents|antiviral agents|mesh-ancestor
65364999|NCT00813696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65365000|NCT00813696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365001|NCT00813696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65365002|NCT00813696|Immunologic Factors|immunologic factors|mesh-ancestor
65365003|NCT00813696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365004|NCT00813774|Certolizumab Pegol|certolizumab pegol|mesh-list
64757158|NCT00211692|Interferons|interferons|mesh-list
65365035|NCT00807534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365036|NCT00807534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65365037|NCT00807534|Respiratory System Agents|respiratory system agents|mesh-ancestor
65365038|NCT00807534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65365039|NCT00807534|Cholinergic Agents|cholinergic agents|mesh-ancestor
65365040|NCT00807534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65365041|NCT00807534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365043|NCT05589064|Cholecalciferol|cholecalciferol|mesh-list
65365044|NCT05589064|Vitamins|vitamins|mesh-ancestor
65365045|NCT05589064|Micronutrients|micronutrients|mesh-ancestor
65365046|NCT05589064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365047|NCT05589064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65365048|NCT05589064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65365077|NCT00669110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65365078|NCT00654732|Rituximab|rituximab|mesh-list
65365079|NCT00654732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65365080|NCT00654732|Doxorubicin|doxorubicin|mesh-list
65365081|NCT00654732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65365082|NCT00654732|Dacarbazine|dacarbazine|mesh-list
65365083|NCT00654732|Bleomycin|bleomycin|mesh-list
65365084|NCT00654732|Vinblastine|vinblastine|mesh-list
65365085|NCT00654732|Antibodies|antibodies|mesh-list
65365086|NCT00654732|Immunoglobulins|immunoglobulins|mesh-list
65365087|NCT00654732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65365088|NCT00654732|Imidazole|imidazole|mesh-list
65365089|NCT00654732|Immunologic Factors|immunologic factors|mesh-ancestor
65365090|NCT00654732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365091|NCT00654732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365092|NCT00654732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65365093|NCT00654732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65365094|NCT00654732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65365162|NCT00767546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65365163|NCT00767546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365164|NCT00654498|Pramipexole|pramipexole|mesh-list
65365165|NCT00654498|Antioxidants|antioxidants|mesh-ancestor
65365166|NCT00654498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365167|NCT00654498|Protective Agents|protective agents|mesh-ancestor
65273607|NCT01497509|Sensory System Agents|sensory system agents|mesh-ancestor
65273608|NCT01497509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65365168|NCT00654498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365169|NCT00654498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65365170|NCT00654498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65365171|NCT00654498|Dopamine Agonists|dopamine agonists|mesh-ancestor
65365172|NCT00654498|Dopamine Agents|dopamine agents|mesh-ancestor
65365173|NCT00654498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65365197|NCT00560391|Antiemetics|antiemetics|mesh-ancestor
65365198|NCT00560391|Autonomic Agents|autonomic agents|mesh-ancestor
65365199|NCT00560391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65365200|NCT00560391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365201|NCT00560391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65365202|NCT00560391|Glucocorticoids|glucocorticoids|mesh-ancestor
65365203|NCT00560391|Hormones|hormones|mesh-ancestor
65365204|NCT00560391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65365205|NCT00560391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65365206|NCT00560391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365207|NCT00560391|Protease Inhibitors|protease inhibitors|mesh-ancestor
65365208|NCT00560391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365209|NCT00560391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365210|NCT00560391|Immunologic Factors|immunologic factors|mesh-ancestor
65365211|NCT00560391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65365212|NCT00560391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65365213|NCT00560391|Growth Substances|growth substances|mesh-ancestor
65365214|NCT00560391|Growth Inhibitors|growth inhibitors|mesh-ancestor
65365215|NCT00560391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65365216|NCT00775736|Insulin|insulin|mesh-list
65365217|NCT00775736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65365218|NCT00775736|Insulin Aspart|insulin aspart|mesh-list
65365219|NCT00775736|Insulin, Long-Acting|insulin, long-acting|mesh-list
65365220|NCT00775736|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65365221|NCT00775736|Biphasic Insulins|biphasic insulins|mesh-list
65365222|NCT00775736|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65365223|NCT00775736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65365224|NCT00775736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365225|NCT04047914|Mupirocin|mupirocin|mesh-list
65365226|NCT04047914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65365227|NCT04047914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65365245|NCT00537238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65365246|NCT00537238|Nootropic Agents|nootropic agents|mesh-ancestor
65365247|NCT03982771|Cyclophosphamide|cyclophosphamide|mesh-list
65365248|NCT03982771|Bortezomib|bortezomib|mesh-list
65365249|NCT03982771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65365250|NCT03982771|Immunologic Factors|immunologic factors|mesh-ancestor
65365251|NCT03982771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365252|NCT03982771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65365253|NCT03982771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65365254|NCT03982771|Alkylating Agents|alkylating agents|mesh-ancestor
65365255|NCT03982771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365256|NCT03982771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365257|NCT03982771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65365258|NCT00775814|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65365259|NCT00775814|Candesartan|candesartan|mesh-list
65365260|NCT00775814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65365261|NCT00775814|Diuretics|diuretics|mesh-ancestor
65365262|NCT00775814|Natriuretic Agents|natriuretic agents|mesh-ancestor
65365263|NCT00775814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365264|NCT00775814|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65365265|NCT00775814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65365266|NCT00775814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365267|NCT00775814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65365268|NCT00775814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65365269|NCT00942747|Sirolimus|sirolimus|mesh-list
65365270|NCT00942747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65365271|NCT00942747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65365272|NCT00942747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65365273|NCT00942747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365274|NCT00942747|Antifungal Agents|antifungal agents|mesh-ancestor
65365275|NCT00942747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65365276|NCT00942747|Immunologic Factors|immunologic factors|mesh-ancestor
65365277|NCT00942747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273609|NCT01497509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65273610|NCT01497509|Narcotics|narcotics|mesh-ancestor
65273611|NCT01497509|Analgesics|analgesics|mesh-ancestor
65365278|NCT00946491|Haloperidol|haloperidol|mesh-list
65365279|NCT00946491|Haloperidol decanoate|haloperidol decanoate|mesh-list
65365280|NCT00946491|Antiemetics|antiemetics|mesh-ancestor
65365281|NCT00946491|Autonomic Agents|autonomic agents|mesh-ancestor
65365282|NCT00946491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65365283|NCT00946491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365284|NCT00946491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65365321|NCT00552669|Mitosis Modulators|mitosis modulators|mesh-ancestor
65365322|NCT00552669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365323|NCT00552669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65365347|NCT00772616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65365348|NCT00772616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365349|NCT00772616|Analgesics|analgesics|mesh-ancestor
65365350|NCT00772616|Sensory System Agents|sensory system agents|mesh-ancestor
65365351|NCT00772616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65365352|NCT00772616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65365353|NCT00772616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65365354|NCT00772616|Anesthetics, General|anesthetics, general|mesh-ancestor
65365355|NCT00772616|Anesthetics|anesthetics|mesh-ancestor
65365356|NCT05488678|Ceftibuten|ceftibuten|mesh-list
65365357|NCT05488678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65365358|NCT05488678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65365359|NCT05406700|Niraparib|niraparib|mesh-list
65365360|NCT05406700|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65365361|NCT05406700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365362|NCT05406700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365363|NCT05406700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365364|NCT00768404|Phentermine|phentermine|mesh-list
65365365|NCT00768404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65365366|NCT00768404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365367|NCT00768404|Appetite Depressants|appetite depressants|mesh-ancestor
65365368|NCT00768404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65365369|NCT00768404|Sympathomimetics|sympathomimetics|mesh-ancestor
65365370|NCT00768404|Autonomic Agents|autonomic agents|mesh-ancestor
65365371|NCT00768404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65365372|NCT00768404|Adrenergic Agents|adrenergic agents|mesh-ancestor
65365373|NCT00768404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65365374|NCT00768404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365375|NCT05406622|Sirolimus|sirolimus|mesh-list
64757519|NCT00296322|Mitomycins|mitomycins|mesh-list
65365399|NCT00943293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365400|NCT00943293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65365401|NCT00943293|Immunologic Factors|immunologic factors|mesh-ancestor
65365402|NCT00943293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365403|NCT00943293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65365404|NCT00943293|Alkylating Agents|alkylating agents|mesh-ancestor
65365405|NCT00943293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65365406|NCT00943293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65365408|NCT00776360|Oxytocics|oxytocics|mesh-ancestor
65365409|NCT00776360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65365410|NCT00776360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365411|NCT00946725|Atenolol|atenolol|mesh-list
65365412|NCT00946725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65365413|NCT00946725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65365414|NCT00946725|Sympatholytics|sympatholytics|mesh-ancestor
65365415|NCT00946725|Autonomic Agents|autonomic agents|mesh-ancestor
65365416|NCT00946725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65365417|NCT00946725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365418|NCT00946725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65365419|NCT00946725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65365420|NCT00946725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65365421|NCT00946725|Adrenergic Agents|adrenergic agents|mesh-ancestor
65365422|NCT00946725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65365423|NCT00946725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365424|NCT03041740|Perflubron|perflubron|mesh-list
65365425|NCT03041740|Bromides|bromides|mesh-list
65365426|NCT03041740|Anticonvulsants|anticonvulsants|mesh-ancestor
65365427|NCT03041740|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65365456|NCT00952029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486773|NCT04381858|Antibodies|antibodies|mesh-list
65365457|NCT00952029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65365458|NCT00952029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65365459|NCT00952029|Immunologic Factors|immunologic factors|mesh-ancestor
65365460|NCT00952029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65365461|NCT00952029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65365462|NCT00952029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365463|NCT00952029|Antidotes|antidotes|mesh-ancestor
65365464|NCT00952029|Protective Agents|protective agents|mesh-ancestor
65365465|NCT00952029|Vitamin B Complex|vitamin b complex|mesh-ancestor
65365466|NCT00952029|Vitamins|vitamins|mesh-ancestor
65365467|NCT00952029|Micronutrients|micronutrients|mesh-ancestor
65365468|NCT00667862|Panobinostat|panobinostat|mesh-list
65365469|NCT00667862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365470|NCT00667862|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65365471|NCT00667862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365472|NCT00667862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365473|NCT00952185|Antibodies|antibodies|mesh-list
65365474|NCT00952185|Immunologic Factors|immunologic factors|mesh-ancestor
65365475|NCT00952185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365476|NCT00776516|Rifampin|rifampin|mesh-list
65365500|NCT00768638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65365501|NCT00768638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65365502|NCT00768638|Antimetabolites|antimetabolites|mesh-ancestor
65365503|NCT00768638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365504|NCT00768638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65365505|NCT00768638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65365506|NCT00768638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365507|NCT02557958|Azithromycin|azithromycin|mesh-list
65365508|NCT02557958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65365509|NCT02557958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65365510|NCT00776672|Fosinopril|fosinopril|mesh-list
65365511|NCT00776672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65365512|NCT00776672|Protease Inhibitors|protease inhibitors|mesh-ancestor
65365513|NCT00776672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365514|NCT00776672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365515|NCT00776672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65365516|NCT00535132|Risperidone|risperidone|mesh-list
65365517|NCT00535132|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65365518|NCT00535132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65365519|NCT00535132|Serotonin Agents|serotonin agents|mesh-ancestor
65365520|NCT00535132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65365521|NCT00535132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365522|NCT00535132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365523|NCT00535132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65365524|NCT00535132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65365559|NCT00773084|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65365561|NCT00773084|Natriuretic Agents|natriuretic agents|mesh-ancestor
65365562|NCT00773084|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65365563|NCT00773084|Protease Inhibitors|protease inhibitors|mesh-ancestor
65365564|NCT00773084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757720|NCT00303966|Sorafenib|sorafenib|mesh-list
65365595|NCT00776828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365596|NCT00776828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65365597|NCT00776828|Vasodilator Agents|vasodilator agents|mesh-ancestor
65365598|NCT00776828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65365599|NCT00776828|Protective Agents|protective agents|mesh-ancestor
65365600|NCT00776828|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65365601|NCT00776828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65365602|NCT00776828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365603|NCT01063933|Peramivir|peramivir|mesh-list
65365604|NCT01063933|Antiviral Agents|antiviral agents|mesh-ancestor
65115510|NCT02063295|CKD732|ckd732|mesh-list
65365627|NCT00308113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365628|NCT00308113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65365629|NCT00308113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365630|NCT00308113|Micronutrients|micronutrients|mesh-ancestor
65365631|NCT00308113|Vitamins|vitamins|mesh-ancestor
65365632|NCT03903640|Nivolumab|nivolumab|mesh-list
65365633|NCT03903640|Ipilimumab|ipilimumab|mesh-list
65365634|NCT03903640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65365635|NCT03903640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365636|NCT03903640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65365637|NCT03903640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365638|NCT03982849|Silymarin|silymarin|mesh-list
65365639|NCT03982849|Hydroquinone|hydroquinone|mesh-list
65273612|NCT01497509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65273613|NCT01497509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65365640|NCT03982849|Antioxidants|antioxidants|mesh-ancestor
65365641|NCT03982849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365642|NCT03982849|Protective Agents|protective agents|mesh-ancestor
65365643|NCT03982849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365644|NCT03982849|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65365645|NCT05357872|Anesthetics|anesthetics|mesh-list
65365646|NCT05357872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65365647|NCT05357872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365648|NCT05147402|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65365649|NCT05147402|Hallucinogens|hallucinogens|mesh-ancestor
65365650|NCT05147402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365651|NCT05147402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65365652|NCT05147402|Serotonin Agents|serotonin agents|mesh-ancestor
65365653|NCT05147402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65365654|NCT05147402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365655|NCT05147402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65365656|NCT05147402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65365657|NCT05147402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65365658|NCT05147402|Adrenergic Agents|adrenergic agents|mesh-ancestor
65365682|NCT04047758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365684|NCT04047758|Hormone Antagonists|hormone antagonists|mesh-ancestor
65365685|NCT04047758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65365686|NCT04047758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365687|NCT04047758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65365688|NCT00307801|Dienogest|dienogest|mesh-list
65365689|NCT00307801|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65365690|NCT00307801|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65365691|NCT00307801|Estradiol|estradiol|mesh-list
65365692|NCT00307801|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65365693|NCT00307801|Estrogens|estrogens|mesh-ancestor
65365694|NCT00307801|Hormones|hormones|mesh-ancestor
65365695|NCT00307801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65365696|NCT00307801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365697|NCT00307801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65365698|NCT00307801|Contraceptive Agents|contraceptive agents|mesh-ancestor
65365699|NCT00307801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65365700|NCT00307801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65365701|NCT00307801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65365702|NCT00307801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65365703|NCT00307801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65365704|NCT00307801|Hormone Antagonists|hormone antagonists|mesh-ancestor
65365705|NCT00307801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65365706|NCT00307801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365707|NCT00671060|Misoprostol|misoprostol|mesh-list
65365708|NCT00671060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64757855|NCT05266716|Sympathomimetics|sympathomimetics|mesh-ancestor
65365735|NCT04002700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65365736|NCT04002700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65365737|NCT04002700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65365738|NCT04002700|Dopamine Agents|dopamine agents|mesh-ancestor
65365739|NCT04002700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65365740|NCT04002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365741|NCT04002700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65365742|NCT04098653|Cyclophosphamide|cyclophosphamide|mesh-list
65365743|NCT04098653|Busulfan|busulfan|mesh-list
65365744|NCT04098653|Decitabine|decitabine|mesh-list
65365745|NCT04098653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65365746|NCT04098653|Immunologic Factors|immunologic factors|mesh-ancestor
65365747|NCT04098653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365748|NCT04098653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65365749|NCT04098653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65365750|NCT04098653|Alkylating Agents|alkylating agents|mesh-ancestor
65365751|NCT04098653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365752|NCT04098653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115603|NCT02912702|Dexamethasone|dexamethasone|mesh-list
65365753|NCT04098653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65365754|NCT04098653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65365755|NCT04098653|Antimetabolites|antimetabolites|mesh-ancestor
65273614|NCT01497509|Anesthetics, General|anesthetics, general|mesh-ancestor
65273615|NCT01497509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65273616|NCT01497509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65273617|NCT01497509|Adrenergic Agents|adrenergic agents|mesh-ancestor
65365756|NCT04098653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365757|NCT05297123|Tretinoin|tretinoin|mesh-list
65365775|NCT00773630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65365776|NCT00773630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365777|NCT00773630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65365778|NCT00773630|Vasodilator Agents|vasodilator agents|mesh-ancestor
65365779|NCT00773630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65365780|NCT00773630|Protective Agents|protective agents|mesh-ancestor
65365781|NCT00773630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65365782|NCT00773630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65365783|NCT00773630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365784|NCT04016922|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65365785|NCT04016922|Hematinics|hematinics|mesh-ancestor
65365786|NCT03646474|Tranexamic Acid|tranexamic acid|mesh-list
65365787|NCT03646474|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65365788|NCT03646474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65365789|NCT03646474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365790|NCT03646474|Hemostatics|hemostatics|mesh-ancestor
65365791|NCT03646474|Coagulants|coagulants|mesh-ancestor
65365792|NCT00808002|Tenofovir|tenofovir|mesh-list
65365793|NCT00808002|Emtricitabine|emtricitabine|mesh-list
65365794|NCT00808002|Raltegravir Potassium|raltegravir potassium|mesh-list
65365795|NCT00808002|Maraviroc|maraviroc|mesh-list
65365796|NCT00808002|Antiviral Agents|antiviral agents|mesh-ancestor
65365797|NCT00808002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65365798|NCT00808002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65365799|NCT00808002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65365800|NCT00808002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365801|NCT00808002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365802|NCT00808002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65365803|NCT00808002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65365804|NCT00808002|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65365805|NCT00808002|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65365806|NCT00808002|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65365807|NCT00808002|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65365808|NCT00808002|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65365809|NCT00307489|Tenofovir|tenofovir|mesh-list
65365810|NCT00307489|Emtricitabine|emtricitabine|mesh-list
65365811|NCT00307489|Antiviral Agents|antiviral agents|mesh-ancestor
65365812|NCT00307489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65365813|NCT00307489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65365814|NCT00307489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65365815|NCT00307489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365842|NCT00773708|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65365843|NCT00773708|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65365844|NCT00773708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365845|NCT00773708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365847|NCT00762359|Dexlansoprazole|dexlansoprazole|mesh-list
65365848|NCT00762359|Gefarnate|gefarnate|mesh-list
65365849|NCT00762359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65365850|NCT00762359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65365851|NCT00762359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65365852|NCT00762359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365853|NCT00762359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365854|NCT04003090|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
65365855|NCT04003090|Nootropic Agents|nootropic agents|mesh-ancestor
65365856|NCT01061749|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65365857|NCT01061749|Immunologic Factors|immunologic factors|mesh-ancestor
65365858|NCT01061749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365859|NCT00770042|Ritonavir|ritonavir|mesh-list
65365860|NCT00770042|Ketoconazole|ketoconazole|mesh-list
65365861|NCT00770042|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65365862|NCT00770042|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65365863|NCT00770042|Protease Inhibitors|protease inhibitors|mesh-ancestor
65365864|NCT00770042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758014|NCT04345926|Anesthetics|anesthetics|mesh-ancestor
65365897|NCT03979105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365898|NCT03979105|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65365900|NCT03979105|Anesthetics, General|anesthetics, general|mesh-ancestor
65273618|NCT01497509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65365901|NCT03979105|Anesthetics|anesthetics|mesh-ancestor
65365902|NCT03979105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65365903|NCT03979105|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65365932|NCT00761891|Sensory System Agents|sensory system agents|mesh-ancestor
65365933|NCT00761891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65365934|NCT00761891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365935|NCT00761891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65365936|NCT00761891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65365937|NCT00761891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65365938|NCT00761891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65365939|NCT00761891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365940|NCT00761891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65365941|NCT00761891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65365942|NCT00761891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365943|NCT00761891|Antipyretics|antipyretics|mesh-ancestor
65365944|NCT00321685|Calcium, Dietary|calcium, dietary|mesh-list
65365945|NCT00321685|Leucovorin|leucovorin|mesh-list
65365946|NCT00321685|Folic Acid|folic acid|mesh-list
65365947|NCT00321685|Bevacizumab|bevacizumab|mesh-list
65365948|NCT00321685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65365949|NCT00321685|Fluorouracil|fluorouracil|mesh-list
65365950|NCT00321685|Capecitabine|capecitabine|mesh-list
65365951|NCT00321685|Oxaliplatin|oxaliplatin|mesh-list
65366011|NCT05348200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65366012|NCT00778076|Hyaluronic Acid|hyaluronic acid|mesh-list
65366013|NCT00778076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65366014|NCT00778076|Immunologic Factors|immunologic factors|mesh-ancestor
65366015|NCT00778076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366016|NCT00778076|Viscosupplements|viscosupplements|mesh-ancestor
65366017|NCT00778076|Protective Agents|protective agents|mesh-ancestor
65366018|NCT00306787|Valacyclovir|valacyclovir|mesh-list
65366019|NCT00306787|Famciclovir|famciclovir|mesh-list
65366020|NCT00306787|Antiviral Agents|antiviral agents|mesh-ancestor
65366021|NCT00306787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65366022|NCT00306787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65366023|NCT00306787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366024|NCT00306787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366025|NCT00778232|Gabapentin|gabapentin|mesh-list
65366026|NCT00778232|Analgesics|analgesics|mesh-ancestor
65366027|NCT00778232|Sensory System Agents|sensory system agents|mesh-ancestor
65366028|NCT00778232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65366029|NCT00778232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366030|NCT00778232|Anticonvulsants|anticonvulsants|mesh-ancestor
65366031|NCT00778232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65366032|NCT00778232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65366033|NCT00778232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65366034|NCT00778232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65366035|NCT00778232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65366036|NCT00778232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65366037|NCT00778232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65366038|NCT00778232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366039|NCT00778232|Antimanic Agents|antimanic agents|mesh-ancestor
65366040|NCT00774488|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
64758183|NCT02982798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65366069|NCT05123092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65366070|NCT04001530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65366071|NCT00769067|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65366072|NCT00769067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366073|NCT00769067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65366074|NCT00769067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366075|NCT00769067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366076|NCT04001608|Sofosbuvir|sofosbuvir|mesh-list
65366077|NCT04001608|Antiviral Agents|antiviral agents|mesh-ancestor
65366078|NCT04001608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65366079|NCT00667394|Bevacizumab|bevacizumab|mesh-list
65366080|NCT00667394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65366081|NCT00667394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366082|NCT00667394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65366083|NCT00667394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64758234|NCT00354978|Antidotes|antidotes|mesh-ancestor
65366114|NCT00569946|Axitinib|axitinib|mesh-list
65366115|NCT00569946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366116|NCT00569946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65273619|NCT01497509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366117|NCT00569946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366118|NCT00569946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366119|NCT00778544|Amoxicillin|amoxicillin|mesh-list
65366120|NCT00778544|Clavulanic Acids|clavulanic acids|mesh-list
65366121|NCT00778544|Clavulanic Acid|clavulanic acid|mesh-list
65366122|NCT00778544|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65366123|NCT00778544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65366124|NCT00778544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65366125|NCT00778544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366126|NCT00778544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366127|NCT00778544|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65366128|NCT04001374|Ticagrelor|ticagrelor|mesh-list
65366153|NCT05265910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65366155|NCT05265910|Analgesics|analgesics|mesh-ancestor
65366156|NCT05265910|Sensory System Agents|sensory system agents|mesh-ancestor
65366157|NCT05265910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65366158|NCT05265910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65366159|NCT05265910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65366160|NCT05265910|Anticoagulants|anticoagulants|mesh-ancestor
65366161|NCT05265910|Plasma Substitutes|plasma substitutes|mesh-ancestor
65366162|NCT05265910|Blood Substitutes|blood substitutes|mesh-ancestor
65366163|NCT00814866|Adalimumab|adalimumab|mesh-list
65366164|NCT00814866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65366165|NCT00814866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65366166|NCT00991978|Bevacizumab|bevacizumab|mesh-list
65366167|NCT00991978|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
65366168|NCT00991978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65366169|NCT00991978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366170|NCT00991978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65366171|NCT00991978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65366172|NCT00991978|Growth Substances|growth substances|mesh-ancestor
65366173|NCT00991978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366174|NCT00991978|Growth Inhibitors|growth inhibitors|mesh-ancestor
65366175|NCT00991978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65366176|NCT00991978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366198|NCT00295633|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65366200|NCT00295633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366201|NCT00295633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366202|NCT00570674|Paclitaxel|paclitaxel|mesh-list
65366203|NCT00570674|Carboplatin|carboplatin|mesh-list
65366204|NCT00570674|Cetuximab|cetuximab|mesh-list
65366205|NCT00570674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65366206|NCT00570674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65366207|NCT00570674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366208|NCT00570674|Tubulin Modulators|tubulin modulators|mesh-ancestor
65366209|NCT00570674|Antimitotic Agents|antimitotic agents|mesh-ancestor
65366210|NCT00570674|Mitosis Modulators|mitosis modulators|mesh-ancestor
65366211|NCT00570674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366212|NCT00570674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65366213|NCT00808314|Dipyridamole|dipyridamole|mesh-list
65366214|NCT00808314|Regadenoson|regadenoson|mesh-list
65366215|NCT00808314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65366216|NCT00808314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366217|NCT00808314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366218|NCT00808314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65366219|NCT00808314|Vasodilator Agents|vasodilator agents|mesh-ancestor
65366220|NCT00808314|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65366221|NCT00808314|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65366222|NCT00808314|Purinergic Agonists|purinergic agonists|mesh-ancestor
65366223|NCT00808314|Purinergic Agents|purinergic agents|mesh-ancestor
65366224|NCT00808314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65366225|NCT00808314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366226|NCT04992052|Bone wax|bone wax|mesh-list
65366227|NCT04992052|Hemostatics|hemostatics|mesh-ancestor
65366228|NCT04992052|Coagulants|coagulants|mesh-ancestor
65366229|NCT00812682|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65366230|NCT00812682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65366266|NCT00779714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65366267|NCT00779714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65366268|NCT00779714|Immunologic Factors|immunologic factors|mesh-ancestor
65366269|NCT00779714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273620|NCT01497509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65273621|NCT01497509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65366270|NCT00779714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65366271|NCT00779714|Alkylating Agents|alkylating agents|mesh-ancestor
65366309|NCT00779792|Dermatologic Agents|dermatologic agents|mesh-ancestor
65366310|NCT00992134|Cytarabine|cytarabine|mesh-list
65366311|NCT00992134|Rituximab|rituximab|mesh-list
65366312|NCT00992134|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64758464|NCT00365274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65366343|NCT02551536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65366344|NCT00815022|Fentanyl|fentanyl|mesh-list
65366345|NCT00815022|Morphine|morphine|mesh-list
65366346|NCT00815022|Bupivacaine|bupivacaine|mesh-list
65366347|NCT00815022|Anesthetics, Local|anesthetics, local|mesh-ancestor
65366348|NCT00815022|Anesthetics|anesthetics|mesh-ancestor
65366349|NCT00815022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65366350|NCT00815022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366351|NCT00815022|Sensory System Agents|sensory system agents|mesh-ancestor
65366352|NCT00815022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65366353|NCT00815022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65366354|NCT00815022|Narcotics|narcotics|mesh-ancestor
65366389|NCT04045548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366390|NCT00780104|Cytarabine|cytarabine|mesh-list
65366391|NCT00780104|Sirolimus|sirolimus|mesh-list
65366392|NCT00780104|Etoposide|etoposide|mesh-list
65366393|NCT00780104|Mitoxantrone|mitoxantrone|mesh-list
65366394|NCT00780104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65366395|NCT00780104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366396|NCT00780104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65366397|NCT00780104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65366398|NCT00780104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758551|NCT02405676|Cytarabine|cytarabine|mesh-list
65366412|NCT00780104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65366414|NCT04047680|Sofosbuvir|sofosbuvir|mesh-list
65366415|NCT04047680|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
65366416|NCT04047680|Grazoprevir|grazoprevir|mesh-list
65366417|NCT04047680|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65366418|NCT04047680|Ledipasvir|ledipasvir|mesh-list
65366419|NCT04047680|Velpatasvir|velpatasvir|mesh-list
65366420|NCT04047680|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65366421|NCT04047680|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65366422|NCT04047680|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65366423|NCT04047680|Protease Inhibitors|protease inhibitors|mesh-ancestor
65366424|NCT04047680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366425|NCT04047680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366426|NCT04047680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65366427|NCT04047680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65366428|NCT04047680|Antiviral Agents|antiviral agents|mesh-ancestor
65366429|NCT04047680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65366430|NCT04047680|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65366431|NCT04047680|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65366432|NCT00774878|Fulvestrant|fulvestrant|mesh-list
65366433|NCT00774878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65366434|NCT00774878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366435|NCT00774878|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65366436|NCT00774878|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65366437|NCT00774878|Hormone Antagonists|hormone antagonists|mesh-ancestor
65366438|NCT00774878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65366439|NCT00774878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366441|NCT00815256|Vitamin B Complex|vitamin b complex|mesh-ancestor
65366442|NCT00815256|Vitamins|vitamins|mesh-ancestor
65366443|NCT00815256|Micronutrients|micronutrients|mesh-ancestor
65366444|NCT00815256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366445|NCT00815256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65366446|NCT00815256|Dermatologic Agents|dermatologic agents|mesh-ancestor
65366447|NCT00778778|Cefprozil|cefprozil|mesh-list
65366448|NCT00778778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65366449|NCT00778778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65366450|NCT00305773|Vorinostat|vorinostat|mesh-list
65366451|NCT00305773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366452|NCT00305773|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65366453|NCT00305773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366454|NCT00305773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366455|NCT00780182|Brincidofovir|brincidofovir|mesh-list
65366456|NCT00780182|Antiviral Agents|antiviral agents|mesh-ancestor
65273622|NCT01497509|Autonomic Agents|autonomic agents|mesh-ancestor
65366457|NCT00780182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65366458|NCT00812994|Citalopram|citalopram|mesh-list
65366459|NCT00812994|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65366460|NCT00812994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65366473|NCT00784394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366474|NCT00305695|Zoledronic Acid|zoledronic acid|mesh-list
65366475|NCT00305695|Imidazole|imidazole|mesh-list
65366476|NCT00305695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65366477|NCT00305695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366478|NCT00305695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366479|NCT00305695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366480|NCT00784472|Morphine|morphine|mesh-list
65366481|NCT00784472|Oxycodone|oxycodone|mesh-list
65366482|NCT00784472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65366483|NCT00784472|Narcotics|narcotics|mesh-ancestor
65366484|NCT00784472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65366485|NCT00784472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366486|NCT00784472|Analgesics|analgesics|mesh-ancestor
65366487|NCT00784472|Sensory System Agents|sensory system agents|mesh-ancestor
65366488|NCT00784472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65366489|NCT00779012|Infliximab|infliximab|mesh-list
65366490|NCT00779012|Dermatologic Agents|dermatologic agents|mesh-ancestor
65366491|NCT00779012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65366492|NCT00779012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65366493|NCT00647556|Adapalene|adapalene|mesh-list
65366494|NCT00647556|Tretinoin|tretinoin|mesh-list
65366495|NCT00647556|Emollients|emollients|mesh-list
65366496|NCT00647556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65366497|NCT00647556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65366498|NCT00647556|Analgesics|analgesics|mesh-ancestor
65366499|NCT00647556|Sensory System Agents|sensory system agents|mesh-ancestor
65366500|NCT00647556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65366501|NCT00647556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366502|NCT00647556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65366503|NCT00647556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65366504|NCT00647556|Dermatologic Agents|dermatologic agents|mesh-ancestor
65366505|NCT00647556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366506|NCT00647556|Keratolytic Agents|keratolytic agents|mesh-ancestor
65366507|NCT03978559|Trimethoprim|trimethoprim|mesh-list
65366508|NCT03978559|Caspofungin|caspofungin|mesh-list
65366509|NCT03978559|Sulfisoxazole|sulfisoxazole|mesh-list
65116358|NCT01818921|CKD732|ckd732|mesh-list
65366510|NCT03978559|Methylprednisolone|methylprednisolone|mesh-list
65366511|NCT03978559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65366513|NCT03978559|Autonomic Agents|autonomic agents|mesh-ancestor
65366514|NCT03978559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65366515|NCT03978559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366516|NCT03978559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65366517|NCT03978559|Glucocorticoids|glucocorticoids|mesh-ancestor
65366518|NCT03978559|Hormones|hormones|mesh-ancestor
65366519|NCT03978559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65366520|NCT03978559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65366521|NCT03978559|Protective Agents|protective agents|mesh-ancestor
65366522|NCT03978559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65366523|NCT03978559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65366524|NCT03978559|Renal Agents|renal agents|mesh-ancestor
65366548|NCT00813228|Incretins|incretins|mesh-ancestor
65366549|NCT00813228|Hormones|hormones|mesh-ancestor
65366550|NCT00813228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65366551|NCT00813228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65366552|NCT00813228|Protease Inhibitors|protease inhibitors|mesh-ancestor
65366553|NCT00813228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366554|NCT00813228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366555|NCT00808704|Epoetin Alfa|epoetin alfa|mesh-list
65366556|NCT00808704|Hematinics|hematinics|mesh-ancestor
65366557|NCT00320515|Pemetrexed|pemetrexed|mesh-list
65366558|NCT00320515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366559|NCT00320515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366560|NCT00320515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366561|NCT00320515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65366562|NCT00320515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65366563|NCT03982381|Metformin|metformin|mesh-list
65366564|NCT03982381|Dapagliflozin|dapagliflozin|mesh-list
65366565|NCT03982381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65366566|NCT03982381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273623|NCT01497509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64309844|NCT02438709|Analgesics|analgesics|mesh-ancestor
65366567|NCT03982381|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65366568|NCT03982381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366569|NCT00662012|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
65366570|NCT00662012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65366571|NCT00662012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65366572|NCT00662012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65366573|NCT00662012|Schistosomicides|schistosomicides|mesh-ancestor
65366574|NCT00662012|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65366575|NCT00662012|Anthelmintics|anthelmintics|mesh-ancestor
65366606|NCT00661778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65366607|NCT00661778|Growth Substances|growth substances|mesh-ancestor
65366608|NCT00661778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366609|NCT00661778|Growth Inhibitors|growth inhibitors|mesh-ancestor
65366610|NCT00661778|Tubulin Modulators|tubulin modulators|mesh-ancestor
65366611|NCT00661778|Antimitotic Agents|antimitotic agents|mesh-ancestor
65366612|NCT00661778|Mitosis Modulators|mitosis modulators|mesh-ancestor
65366613|NCT00661778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366615|NCT01062139|Levocetirizine|levocetirizine|mesh-list
65366616|NCT01062139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64758764|NCT00405288|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65366646|NCT01664182|Trebananib|trebananib|mesh-list
65366647|NCT01664182|Sorafenib|sorafenib|mesh-list
65366648|NCT01664182|Endothelial Growth Factors|endothelial growth factors|mesh-list
65366649|NCT01664182|Antibodies|antibodies|mesh-list
65366650|NCT01664182|Immunoglobulins|immunoglobulins|mesh-list
65366651|NCT01664182|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65366652|NCT01664182|Immunoglobulin G|immunoglobulin g|mesh-list
65366653|NCT01664182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366654|NCT01664182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65366655|NCT01664182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65366656|NCT01664182|Growth Substances|growth substances|mesh-ancestor
65366657|NCT01664182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366658|NCT01664182|Growth Inhibitors|growth inhibitors|mesh-ancestor
65366659|NCT01664182|Immunologic Factors|immunologic factors|mesh-ancestor
64758817|NCT00459732|Zinc Sulfate|zinc sulfate|mesh-list
65366688|NCT00809172|Antifungal Agents|antifungal agents|mesh-ancestor
65366689|NCT00809172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65366690|NCT00809172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65366691|NCT00784862|Tamoxifen|tamoxifen|mesh-list
65366692|NCT00784862|Anastrozole|anastrozole|mesh-list
65366693|NCT00784862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65366694|NCT00784862|Hormone Antagonists|hormone antagonists|mesh-ancestor
65366695|NCT00784862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65366696|NCT00784862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366697|NCT00784862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65366698|NCT00784862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366699|NCT00784862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65366700|NCT00784862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65366701|NCT00784862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65366702|NCT00784862|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65366703|NCT00784862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65366704|NCT00784862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758860|NCT00382590|Cytarabine|cytarabine|mesh-list
65366737|NCT00785018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366738|NCT00785018|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65366739|NCT00785018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65366741|NCT00534352|Darunavir|darunavir|mesh-list
65366742|NCT00534352|Etravirine|etravirine|mesh-list
65366743|NCT00534352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65366769|NCT02550444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65366770|NCT02550444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366772|NCT02550444|Sympatholytics|sympatholytics|mesh-ancestor
65366773|NCT02550444|Autonomic Agents|autonomic agents|mesh-ancestor
65366774|NCT02550444|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65366775|NCT02550444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65366776|NCT02550444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65366777|NCT02550444|Adrenergic Agents|adrenergic agents|mesh-ancestor
65366778|NCT02550444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65366779|NCT02550444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366780|NCT00665366|Valproic Acid|valproic acid|mesh-list
65366781|NCT00665366|Aripiprazole|aripiprazole|mesh-list
65366782|NCT00665366|Antidepressive Agents|antidepressive agents|mesh-ancestor
64545348|NCT05120622|Tremelimumab|tremelimumab|mesh-list
65366783|NCT00665366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65366784|NCT00665366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65366785|NCT00665366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65366786|NCT00665366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65366787|NCT00665366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366788|NCT00665366|Dopamine Agonists|dopamine agonists|mesh-ancestor
65366789|NCT00665366|Dopamine Agents|dopamine agents|mesh-ancestor
65366823|NCT00992524|Abortifacient Agents|abortifacient agents|mesh-ancestor
65366824|NCT00992524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65366825|NCT00992524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366826|NCT00992524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65366827|NCT00992524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65366828|NCT00992524|Oxytocics|oxytocics|mesh-ancestor
65366829|NCT00642018|Prednisone|prednisone|mesh-list
65366830|NCT00642018|Docetaxel|docetaxel|mesh-list
64758995|NCT00410904|Pemetrexed|pemetrexed|mesh-list
65366850|NCT00998920|Estrogens|estrogens|mesh-ancestor
65366851|NCT00998920|Hormones|hormones|mesh-ancestor
65366852|NCT00998920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65366853|NCT00998920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366854|NCT00992758|Tositumomab I-131|tositumomab i-131|mesh-list
65366855|NCT00992758|Antibodies|antibodies|mesh-list
65366856|NCT00992758|Immunologic Factors|immunologic factors|mesh-ancestor
65366857|NCT00992758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366858|NCT00992758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366859|NCT00641706|Bortezomib|bortezomib|mesh-list
65366860|NCT00641706|Vorinostat|vorinostat|mesh-list
65366861|NCT00641706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366862|NCT00641706|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65366863|NCT00641706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366864|NCT00641706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366865|NCT00995332|Cytarabine|cytarabine|mesh-list
65366866|NCT00995332|Tretinoin|tretinoin|mesh-list
65366867|NCT00995332|Valproic Acid|valproic acid|mesh-list
65366868|NCT00995332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65366869|NCT00995332|Antimetabolites|antimetabolites|mesh-ancestor
65366870|NCT00995332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366871|NCT00995332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366872|NCT00995332|Antiviral Agents|antiviral agents|mesh-ancestor
65366873|NCT00995332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65366874|NCT00995332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65366875|NCT00995332|Immunologic Factors|immunologic factors|mesh-ancestor
65366876|NCT00995332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366877|NCT00995332|Keratolytic Agents|keratolytic agents|mesh-ancestor
65366878|NCT00995332|Dermatologic Agents|dermatologic agents|mesh-ancestor
65366879|NCT00995332|Anticonvulsants|anticonvulsants|mesh-ancestor
65366880|NCT00995332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366881|NCT00995332|GABA Agents|gaba agents|mesh-ancestor
65366882|NCT00995332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65366883|NCT00995332|Antimanic Agents|antimanic agents|mesh-ancestor
65366884|NCT00995332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65366885|NCT00995332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65366886|NCT00995332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65366920|NCT00993304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65366922|NCT05189002|Anticoagulants|anticoagulants|mesh-ancestor
65366923|NCT05189002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65366924|NCT05189002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65366925|NCT05189002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366926|NCT00644358|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
65366927|NCT00644358|Antidepressive Agents|antidepressive agents|mesh-ancestor
65366957|NCT00821496|Norethindrone Acetate|norethindrone acetate|mesh-list
65366958|NCT00821496|Norinyl|norinyl|mesh-list
65366959|NCT00821496|Estradiol|estradiol|mesh-list
65366960|NCT00821496|Estrogens|estrogens|mesh-ancestor
65366961|NCT00821496|Hormones|hormones|mesh-ancestor
65366962|NCT00821496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65366963|NCT00821496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366964|NCT00821496|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65366965|NCT00821496|Contraceptive Agents|contraceptive agents|mesh-ancestor
65366966|NCT00821496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65366967|NCT00821496|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65366968|NCT00821496|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65366969|NCT00821496|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65366970|NCT00821496|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65366971|NCT00821496|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64471716|NCT04230252|Analgesics|analgesics|mesh-ancestor
65367002|NCT00818298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65367003|NCT00818298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65367004|NCT00818298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65367005|NCT00818298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65367006|NCT00818298|Dopamine Agents|dopamine agents|mesh-ancestor
65367008|NCT00821574|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65367009|NCT00821574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65367010|NCT00821574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65367011|NCT00821574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65367012|NCT00821574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367013|NCT00821574|Diuretics|diuretics|mesh-ancestor
65367014|NCT00821574|Natriuretic Agents|natriuretic agents|mesh-ancestor
65367015|NCT00821574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367016|NCT00821574|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65367047|NCT00319501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367048|NCT00319501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65367049|NCT00319501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65367050|NCT00319501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65367051|NCT00319501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65367052|NCT00319501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65367053|NCT00319501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65367054|NCT00319501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65367055|NCT00319501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65367056|NCT00319501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65367057|NCT00319501|Anesthetics, General|anesthetics, general|mesh-ancestor
65367059|NCT00319501|GABA Modulators|gaba modulators|mesh-ancestor
65367060|NCT00319501|GABA Agents|gaba agents|mesh-ancestor
65367061|NCT00319501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64759226|NCT00475878|Citalopram|citalopram|mesh-list
65367095|NCT00761579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65367096|NCT00761579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367097|NCT00761579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65367098|NCT00761579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65367100|NCT00627042|Ramucirumab|ramucirumab|mesh-list
65367101|NCT00627042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64759263|NCT00478218|Dexamethasone|dexamethasone|mesh-list
65367129|NCT00816426|Antitubercular Agents|antitubercular agents|mesh-ancestor
65367130|NCT00816426|Leprostatic Agents|leprostatic agents|mesh-ancestor
65367131|NCT00816426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65367132|NCT00816426|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65367133|NCT00816426|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65367134|NCT00816426|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65367135|NCT00816426|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65367136|NCT00816426|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65367137|NCT00816426|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65367138|NCT00816426|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65367139|NCT00816426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65367140|NCT00816426|Antimetabolites|antimetabolites|mesh-ancestor
65367141|NCT00816426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65367142|NCT00816426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65367143|NCT00996190|Phenylephrine|phenylephrine|mesh-list
65367144|NCT00996190|Oxymetazoline|oxymetazoline|mesh-list
65367145|NCT00996190|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65367146|NCT00996190|Mydriatics|mydriatics|mesh-ancestor
65367147|NCT00996190|Autonomic Agents|autonomic agents|mesh-ancestor
65367148|NCT00996190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65367149|NCT00996190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367176|NCT00640224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65367177|NCT00640224|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65367178|NCT00640224|Hormone Antagonists|hormone antagonists|mesh-ancestor
65367179|NCT00640224|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65367180|NCT00640224|Diuretics|diuretics|mesh-ancestor
65367181|NCT00640224|Natriuretic Agents|natriuretic agents|mesh-ancestor
65367182|NCT01000792|Cetirizine|cetirizine|mesh-list
65367183|NCT01000792|Levocetirizine|levocetirizine|mesh-list
65367184|NCT01000792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65367185|NCT01000792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65367186|NCT01000792|Histamine Antagonists|histamine antagonists|mesh-ancestor
65367187|NCT01000792|Histamine Agents|histamine agents|mesh-ancestor
65367188|NCT01000792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65367189|NCT01000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367190|NCT01000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367191|NCT01000792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65273624|NCT01497509|Respiratory System Agents|respiratory system agents|mesh-ancestor
65273625|NCT01497509|Mydriatics|mydriatics|mesh-ancestor
65367192|NCT02550756|Capsaicin|capsaicin|mesh-list
65367193|NCT02550756|Antipruritics|antipruritics|mesh-ancestor
65367194|NCT02550756|Dermatologic Agents|dermatologic agents|mesh-ancestor
65367195|NCT02550756|Sensory System Agents|sensory system agents|mesh-ancestor
65367196|NCT02550756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65367197|NCT02550756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367230|NCT05220280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367231|NCT05220280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367232|NCT05220280|Dermatologic Agents|dermatologic agents|mesh-ancestor
65367233|NCT05220280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65367234|NCT05220280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65367235|NCT00318643|Mitomycins|mitomycins|mesh-list
65367236|NCT00318643|Mitomycin|mitomycin|mesh-list
65367237|NCT00318643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65367238|NCT00318643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367239|NCT00318643|Alkylating Agents|alkylating agents|mesh-ancestor
65367240|NCT00318643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367242|NCT00318643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367244|NCT00994708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65367245|NCT00994708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65367246|NCT00994708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65367247|NCT00994708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367248|NCT00994708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367249|NCT01064557|Tretinoin|tretinoin|mesh-list
65367250|NCT01064557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367251|NCT01064557|Keratolytic Agents|keratolytic agents|mesh-ancestor
65367252|NCT01064557|Dermatologic Agents|dermatologic agents|mesh-ancestor
65367253|NCT01001962|Metformin|metformin|mesh-list
65367254|NCT01001962|Empagliflozin|empagliflozin|mesh-list
65367255|NCT01001962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65367256|NCT01001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367257|NCT01001962|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65367258|NCT01001962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367259|NCT01066429|Dexamethasone|dexamethasone|mesh-list
65367260|NCT01066429|Dexamethasone acetate|dexamethasone acetate|mesh-list
65367261|NCT01066429|BB 1101|bb 1101|mesh-list
65367262|NCT01066429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367263|NCT01066429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367264|NCT01066429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65367265|NCT01066429|Antiemetics|antiemetics|mesh-ancestor
65367266|NCT01066429|Autonomic Agents|autonomic agents|mesh-ancestor
65367267|NCT01066429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65367268|NCT01066429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65367269|NCT01066429|Glucocorticoids|glucocorticoids|mesh-ancestor
65367270|NCT01066429|Hormones|hormones|mesh-ancestor
65367271|NCT01066429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65367272|NCT01066429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65367273|NCT01066429|Protease Inhibitors|protease inhibitors|mesh-ancestor
65367274|NCT01066429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367275|NCT01066429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367276|NCT00994786|Pregabalin|pregabalin|mesh-list
65367277|NCT00994786|Analgesics|analgesics|mesh-ancestor
65367278|NCT00994786|Sensory System Agents|sensory system agents|mesh-ancestor
65367279|NCT00994786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65367280|NCT00994786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367281|NCT00994786|Anticonvulsants|anticonvulsants|mesh-ancestor
65367282|NCT00994786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65367283|NCT00994786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65367284|NCT00994786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367285|NCT00994786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65367286|NCT00994786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65367287|NCT00994786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65367288|NCT00994786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65367289|NCT00994786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65367290|NCT00994942|Morphine|morphine|mesh-list
65367291|NCT00994942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65367292|NCT00994942|Narcotics|narcotics|mesh-ancestor
65367293|NCT00994942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65367294|NCT00994942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367295|NCT00994942|Analgesics|analgesics|mesh-ancestor
65367296|NCT00994942|Sensory System Agents|sensory system agents|mesh-ancestor
65273626|NCT01497509|Sympathomimetics|sympathomimetics|mesh-ancestor
65273627|NCT01497509|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65367297|NCT00994942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65367298|NCT01002898|Ritonavir|ritonavir|mesh-list
65367299|NCT01002898|Lopinavir|lopinavir|mesh-list
65367300|NCT01002898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65367301|NCT01002898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65367302|NCT01002898|Protease Inhibitors|protease inhibitors|mesh-ancestor
65367303|NCT01002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367304|NCT01002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367305|NCT01002898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65367306|NCT01002898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65367307|NCT01002898|Antiviral Agents|antiviral agents|mesh-ancestor
65367308|NCT01002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65367309|NCT01002898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65367310|NCT01002898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65367311|NCT01003054|Cyclophosphamide|cyclophosphamide|mesh-list
65367312|NCT01003054|Busulfan|busulfan|mesh-list
65367313|NCT01003054|Imatinib Mesylate|imatinib mesylate|mesh-list
64759437|NCT02117934|Immunologic Factors|immunologic factors|mesh-ancestor
65367346|NCT00530920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65367347|NCT00530920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65367348|NCT00530920|Antiviral Agents|antiviral agents|mesh-ancestor
65367349|NCT00530920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65367350|NCT00530920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65367351|NCT00530920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65367352|NCT01004380|Carboplatin|carboplatin|mesh-list
65367353|NCT01004380|Farletuzumab|farletuzumab|mesh-list
65367354|NCT01004380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367355|NCT01003522|Anesthetics|anesthetics|mesh-list
65367380|NCT04000126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367382|NCT01008982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65367383|NCT01008982|Immunologic Factors|immunologic factors|mesh-ancestor
65367384|NCT01008982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367385|NCT01005160|Metformin|metformin|mesh-list
65367386|NCT01005160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65367387|NCT01005160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367388|NCT05230810|Fulvestrant|fulvestrant|mesh-list
65367389|NCT05230810|Tucatinib|tucatinib|mesh-list
65367390|NCT05230810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65367391|NCT05230810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367392|NCT05230810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65367393|NCT05230810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65367394|NCT05230810|Hormone Antagonists|hormone antagonists|mesh-ancestor
65367395|NCT05230810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65367396|NCT05230810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367397|NCT05230810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65367398|NCT05230810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367399|NCT05230810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367400|NCT01005238|Lamivudine|lamivudine|mesh-list
65367401|NCT01005238|Telbivudine|telbivudine|mesh-list
65367402|NCT01005238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65367403|NCT01005238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65367434|NCT03999580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367435|NCT03999580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65367436|NCT03999580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65367437|NCT00768755|Pemetrexed|pemetrexed|mesh-list
65367438|NCT00768755|Axitinib|axitinib|mesh-list
65367439|NCT00768755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367440|NCT00768755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367441|NCT00768755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367442|NCT00768755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65367443|NCT00768755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65367444|NCT00768755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65367445|NCT01005628|Bortezomib|bortezomib|mesh-list
65367446|NCT01005628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367447|NCT00530842|Fluticasone|fluticasone|mesh-list
65367469|NCT00530842|Glucocorticoids|glucocorticoids|mesh-ancestor
65367470|NCT00530842|Hormones|hormones|mesh-ancestor
65367471|NCT00530842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65367472|NCT00530842|Sympathomimetics|sympathomimetics|mesh-ancestor
65367473|NCT01005784|Cetrorelix|cetrorelix|mesh-list
65367474|NCT01005784|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65367475|NCT01005784|Fertility Agents|fertility agents|mesh-ancestor
65273628|NCT02844881|Apatinib|apatinib|mesh-list
64546364|NCT03805399|Tubulin Modulators|tubulin modulators|mesh-ancestor
65367476|NCT01005784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65367477|NCT01005784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367478|NCT01005784|Hormone Antagonists|hormone antagonists|mesh-ancestor
65367479|NCT01005784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65367480|NCT05154136|Itraconazole|itraconazole|mesh-list
65367481|NCT05154136|Antifungal Agents|antifungal agents|mesh-ancestor
65367482|NCT05154136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65367483|NCT05154136|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65367484|NCT05154136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65367486|NCT05154136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367487|NCT05154136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65367488|NCT05154136|Hormone Antagonists|hormone antagonists|mesh-ancestor
65367489|NCT05154136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65367490|NCT05154136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367491|NCT05154136|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65367492|NCT01006096|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65367493|NCT01006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367494|NCT01006096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65367495|NCT01006096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367496|NCT01006096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367497|NCT05733364|Vitamin B Complex|vitamin b complex|mesh-list
65367498|NCT05733364|Vitamins|vitamins|mesh-ancestor
65367499|NCT05733364|Micronutrients|micronutrients|mesh-ancestor
65367526|NCT03879772|Beclomethasone|beclomethasone|mesh-list
65367527|NCT03879772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367528|NCT03879772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65367529|NCT03879772|Dermatologic Agents|dermatologic agents|mesh-ancestor
65367530|NCT03879772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65367531|NCT03879772|Glucocorticoids|glucocorticoids|mesh-ancestor
65367532|NCT03879772|Hormones|hormones|mesh-ancestor
65367533|NCT03879772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65367534|NCT03879772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367535|NCT03879772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65367536|NCT03879772|Respiratory System Agents|respiratory system agents|mesh-ancestor
65367537|NCT03879772|Antipruritics|antipruritics|mesh-ancestor
65367538|NCT03879772|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65367539|NCT03879772|Histamine Antagonists|histamine antagonists|mesh-ancestor
65367540|NCT03879772|Histamine Agents|histamine agents|mesh-ancestor
65367541|NCT03879772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65367542|NCT05732506|Edoxaban|edoxaban|mesh-list
65367543|NCT05732506|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65367544|NCT05732506|Antithrombins|antithrombins|mesh-ancestor
65367545|NCT05732506|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65367546|NCT05732506|Protease Inhibitors|protease inhibitors|mesh-ancestor
65367547|NCT05732506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367548|NCT05732506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367575|NCT01007578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65367577|NCT01007578|Tubulin Modulators|tubulin modulators|mesh-ancestor
65367578|NCT01007578|Antimitotic Agents|antimitotic agents|mesh-ancestor
65367579|NCT01007578|Mitosis Modulators|mitosis modulators|mesh-ancestor
65367580|NCT01007578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367581|NCT05130814|Hyaluronic Acid|hyaluronic acid|mesh-list
65367582|NCT05130814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65367583|NCT05130814|Immunologic Factors|immunologic factors|mesh-ancestor
65367584|NCT05130814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367585|NCT05130814|Viscosupplements|viscosupplements|mesh-ancestor
65367586|NCT05130814|Protective Agents|protective agents|mesh-ancestor
65367587|NCT05129722|Empagliflozin|empagliflozin|mesh-list
65367588|NCT05129722|Eplerenone|eplerenone|mesh-list
65367589|NCT05129722|Bumetanide|bumetanide|mesh-list
65367590|NCT05129722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65367591|NCT05129722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367592|NCT05129722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65367593|NCT05129722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367594|NCT05129722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65367595|NCT05129722|Hormone Antagonists|hormone antagonists|mesh-ancestor
65367596|NCT05129722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65367659|NCT00819078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367660|NCT01008046|Metformin|metformin|mesh-list
64546714|NCT03699319|Vitamins|vitamins|mesh-ancestor
65367661|NCT01008046|Acetylcysteine|acetylcysteine|mesh-list
65367662|NCT01008046|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65367663|NCT01008046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65367664|NCT01008046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367665|NCT01008046|Antiviral Agents|antiviral agents|mesh-ancestor
65367666|NCT01008046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65367667|NCT01008046|Expectorants|expectorants|mesh-ancestor
65367668|NCT01008046|Respiratory System Agents|respiratory system agents|mesh-ancestor
65367669|NCT01008046|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65367670|NCT01008046|Antioxidants|antioxidants|mesh-ancestor
65367671|NCT01008046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367672|NCT01008046|Protective Agents|protective agents|mesh-ancestor
65367673|NCT01008046|Antidotes|antidotes|mesh-ancestor
65367674|NCT00317473|Vaccines|vaccines|mesh-list
65367675|NCT00317473|Immunologic Factors|immunologic factors|mesh-ancestor
65367676|NCT00317473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367677|NCT00530218|Ganciclovir|ganciclovir|mesh-list
65367678|NCT00530218|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65367679|NCT00530218|Antiviral Agents|antiviral agents|mesh-ancestor
65367680|NCT00530218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65367681|NCT00530218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65367682|NCT00530218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367683|NCT00530218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367684|NCT00761267|Fluconazole|fluconazole|mesh-list
65367716|NCT00303667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65367717|NCT00303667|Antimetabolites|antimetabolites|mesh-ancestor
65367718|NCT00303667|Antiviral Agents|antiviral agents|mesh-ancestor
65367719|NCT00303667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65367720|NCT00303667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367721|NCT00303667|Antifungal Agents|antifungal agents|mesh-ancestor
65367722|NCT00303667|Dermatologic Agents|dermatologic agents|mesh-ancestor
65367723|NCT00303667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65367724|NCT00303667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65367725|NCT00303667|Analgesics|analgesics|mesh-ancestor
65367726|NCT00303667|Sensory System Agents|sensory system agents|mesh-ancestor
65367727|NCT00303667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65367760|NCT00760877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65367761|NCT00760877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367762|NCT00760877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367763|NCT00302731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65367764|NCT00302731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65367765|NCT00302731|Hormones|hormones|mesh-list
65367766|NCT00302731|Estradiol|estradiol|mesh-list
65367767|NCT00302731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65367768|NCT00302731|Progesterone|progesterone|mesh-list
65367802|NCT05559112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367803|NCT05559112|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65367804|NCT00302107|Mirtazapine|mirtazapine|mesh-list
65367805|NCT00302107|Antidepressive Agents|antidepressive agents|mesh-ancestor
65367806|NCT00302107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65367807|NCT00302107|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65367808|NCT00302107|Histamine Antagonists|histamine antagonists|mesh-ancestor
65367809|NCT00302107|Histamine Agents|histamine agents|mesh-ancestor
65367810|NCT00302107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65367811|NCT00302107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367845|NCT00759941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65367846|NCT00759941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367847|NCT00759941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367848|NCT00315445|Acetaminophen|acetaminophen|mesh-list
65367849|NCT00315445|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65367850|NCT00315445|Oxycodone|oxycodone|mesh-list
65367851|NCT00315445|Buprenorphine|buprenorphine|mesh-list
65367877|NCT00779675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65367878|NCT00779675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65367879|NCT04102943|Tacrolimus|tacrolimus|mesh-list
65367880|NCT04102943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65367881|NCT04102943|Immunologic Factors|immunologic factors|mesh-ancestor
65367882|NCT04102943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367883|NCT04102943|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65367884|NCT04102943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367885|NCT04102943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367886|NCT00759785|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65367887|NCT00759785|Immunologic Factors|immunologic factors|mesh-ancestor
65367888|NCT00759785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367889|NCT00315055|Vaccines|vaccines|mesh-list
64487801|NCT01726816|Probucol|probucol|mesh-list
65367890|NCT00315055|Immunologic Factors|immunologic factors|mesh-ancestor
65367891|NCT00315055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367892|NCT00528970|Methylnaltrexone|methylnaltrexone|mesh-list
65367893|NCT00528970|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65367894|NCT00528970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367895|NCT00528970|Sensory System Agents|sensory system agents|mesh-ancestor
65367896|NCT00528970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65367897|NCT00293293|Taxane|taxane|mesh-list
65367898|NCT00293293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367899|NCT05774639|Omalizumab|omalizumab|mesh-list
65367900|NCT05774639|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65367901|NCT05774639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65367932|NCT05774028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65367933|NCT05774028|Antiemetics|antiemetics|mesh-ancestor
65367934|NCT05774028|Autonomic Agents|autonomic agents|mesh-ancestor
65367935|NCT05774028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65367936|NCT05774028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367937|NCT05774028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65367938|NCT05774028|Glucocorticoids|glucocorticoids|mesh-ancestor
65367939|NCT05774028|Hormones|hormones|mesh-ancestor
65367940|NCT05774028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65367941|NCT05774028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65367942|NCT05774028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367943|NCT05774028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65367944|NCT05774028|Antimetabolites|antimetabolites|mesh-ancestor
65367945|NCT05774028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367946|NCT05774028|Antiviral Agents|antiviral agents|mesh-ancestor
65367947|NCT05774028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65367948|NCT05774028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367978|NCT05773911|Sequestering Agents|sequestering agents|mesh-ancestor
65367979|NCT05773911|Hemostatics|hemostatics|mesh-ancestor
65367980|NCT05773911|Coagulants|coagulants|mesh-ancestor
65367981|NCT05773859|Vaccines|vaccines|mesh-list
65367982|NCT05773859|Immunologic Factors|immunologic factors|mesh-ancestor
65367983|NCT05773859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367984|NCT05773846|Ropivacaine|ropivacaine|mesh-list
65367985|NCT05773846|Anesthetics, Local|anesthetics, local|mesh-ancestor
65367986|NCT05773846|Anesthetics|anesthetics|mesh-ancestor
65367987|NCT05773846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65367988|NCT05773846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367989|NCT05773846|Sensory System Agents|sensory system agents|mesh-ancestor
65367990|NCT05773846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65367991|NCT05773807|Propofol|propofol|mesh-list
65367992|NCT05773807|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65367993|NCT05773807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65368030|NCT05773183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368031|NCT05773092|Osimertinib|osimertinib|mesh-list
65368032|NCT05773092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368033|NCT05773092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65368053|NCT05742438|Anesthetics|anesthetics|mesh-ancestor
65368054|NCT05742438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65368055|NCT05742438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368056|NCT05742438|Sensory System Agents|sensory system agents|mesh-ancestor
65368057|NCT05742438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65368058|NCT05742438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65368059|NCT05742438|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65368060|NCT05742438|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65368061|NCT05742438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65368062|NCT05742438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368063|NCT05742438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65368064|NCT05742438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65368065|NCT05742438|Analgesics|analgesics|mesh-ancestor
65368066|NCT05742438|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65368067|NCT05742438|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65368068|NCT05742438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65368069|NCT05742438|Adrenergic Agents|adrenergic agents|mesh-ancestor
65368070|NCT05742438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65368071|NCT05742438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65368072|NCT05742438|Narcotics|narcotics|mesh-ancestor
65368073|NCT05732051|Niacinamide|niacinamide|mesh-list
65368074|NCT05732051|Niacin|niacin|mesh-list
65368075|NCT05732051|Nicotinic Acids|nicotinic acids|mesh-list
65368076|NCT05732051|Vitamin B Complex|vitamin b complex|mesh-ancestor
65368077|NCT05732051|Vitamins|vitamins|mesh-ancestor
65368078|NCT05732051|Micronutrients|micronutrients|mesh-ancestor
65273629|NCT02844881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273630|NCT02844881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65368079|NCT05732051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368080|NCT05732051|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65368081|NCT05732051|Antimetabolites|antimetabolites|mesh-ancestor
65368082|NCT05732051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368083|NCT05732051|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65368084|NCT05732051|Vasodilator Agents|vasodilator agents|mesh-ancestor
65368085|NCT05695027|Niacinamide|niacinamide|mesh-list
65368086|NCT05695027|Niacin|niacin|mesh-list
65368087|NCT05695027|Nicotinic Acids|nicotinic acids|mesh-list
65368088|NCT05695027|Vitamin B Complex|vitamin b complex|mesh-ancestor
65368090|NCT05695027|Micronutrients|micronutrients|mesh-ancestor
65368123|NCT05667896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65368124|NCT05667896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368125|NCT05667896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368126|NCT05667896|Hormones|hormones|mesh-ancestor
65368127|NCT05667896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65368128|NCT05667883|Cyclophosphamide|cyclophosphamide|mesh-list
65368129|NCT05667883|Glucocorticoids|glucocorticoids|mesh-list
65368130|NCT05667883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65368131|NCT05667883|Immunologic Factors|immunologic factors|mesh-ancestor
65368132|NCT05667883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368147|NCT05660746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65368148|NCT05659381|Cisplatin|cisplatin|mesh-list
65368149|NCT05659381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368150|NCT05644496|Meloxicam|meloxicam|mesh-list
65368151|NCT05644496|Bupivacaine|bupivacaine|mesh-list
65368152|NCT05644496|Anesthetics, Local|anesthetics, local|mesh-ancestor
65368153|NCT05644496|Anesthetics|anesthetics|mesh-ancestor
65368154|NCT05644496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65368155|NCT05644496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368156|NCT05644496|Sensory System Agents|sensory system agents|mesh-ancestor
65368157|NCT05644496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65368158|NCT05644496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65368159|NCT05644496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65368160|NCT05644496|Analgesics|analgesics|mesh-ancestor
65368161|NCT05644496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65368162|NCT05644496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65368163|NCT05644496|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65118012|NCT00541073|Hematinics|hematinics|mesh-ancestor
65368164|NCT05644496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65368165|NCT05644496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368166|NCT05644496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368168|NCT05613608|Anticonvulsants|anticonvulsants|mesh-ancestor
65368169|NCT05592613|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65368170|NCT05592613|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65368171|NCT05592613|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65368172|NCT05592613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65368173|NCT05592613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368174|NCT05592613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368175|NCT05592613|Antiviral Agents|antiviral agents|mesh-ancestor
65368176|NCT05592613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65368177|NCT05592613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65368178|NCT05578872|Pembrolizumab|pembrolizumab|mesh-list
65368179|NCT05578872|Ipilimumab|ipilimumab|mesh-list
65368180|NCT05578872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65368181|NCT05578872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368182|NCT05578872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65368183|NCT05578872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368184|NCT05567562|Clopidogrel|clopidogrel|mesh-list
65368185|NCT05567562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368186|NCT05567562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368187|NCT05567562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65368188|NCT05567562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65368189|NCT05567562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65368190|NCT05567562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65368191|NCT05567562|Purinergic Agents|purinergic agents|mesh-ancestor
65368192|NCT05567562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65368227|NCT05545969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65368228|NCT05545969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273631|NCT02844881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273632|NCT02844881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273633|NCT02846519|Rifampin|rifampin|mesh-list
65368229|NCT05545969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65368230|NCT05545969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368231|NCT05545969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368268|NCT05476770|Abortifacient Agents|abortifacient agents|mesh-ancestor
65368269|NCT05476770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65368270|NCT05476770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65368271|NCT05476770|Antimetabolites|antimetabolites|mesh-ancestor
65368272|NCT05476770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368273|NCT05476770|Dermatologic Agents|dermatologic agents|mesh-ancestor
65368299|NCT05438888|Protease Inhibitors|protease inhibitors|mesh-ancestor
65368300|NCT05438888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368301|NCT05438888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368302|NCT05430074|Calpastatin|calpastatin|mesh-list
65368303|NCT05430074|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65368304|NCT05430074|Protease Inhibitors|protease inhibitors|mesh-ancestor
65368305|NCT05430074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368306|NCT05430074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368307|NCT05418972|Nivolumab|nivolumab|mesh-list
65368308|NCT05418972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65368309|NCT05418972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368310|NCT05418972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65368311|NCT05418972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368312|NCT05414136|Trastuzumab|trastuzumab|mesh-list
65368313|NCT05414136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65368314|NCT05414136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368315|NCT05351736|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65368316|NCT05351736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65368317|NCT05351736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65368318|NCT05351736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65368319|NCT05351736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368320|NCT05351736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65368321|NCT05351736|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65368322|NCT05351736|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65368323|NCT05351736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65368324|NCT05351736|Adrenergic Agents|adrenergic agents|mesh-ancestor
65368360|NCT05303064|Olanzapine|olanzapine|mesh-list
65368361|NCT05303064|Antiemetics|antiemetics|mesh-ancestor
65368362|NCT05303064|Autonomic Agents|autonomic agents|mesh-ancestor
65368363|NCT05303064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65368364|NCT05303064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368365|NCT05303064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64760537|NCT02783430|Ketamine|ketamine|mesh-list
65368422|NCT05255276|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65368423|NCT05255276|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65368424|NCT05255276|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65368425|NCT05255276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65368426|NCT05253833|Allopurinol|allopurinol|mesh-list
65368427|NCT05253833|Antimetabolites|antimetabolites|mesh-ancestor
65368428|NCT05253833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368429|NCT05253833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368430|NCT05253833|Gout Suppressants|gout suppressants|mesh-ancestor
65368431|NCT05253833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65368432|NCT05253833|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65368433|NCT05253833|Antioxidants|antioxidants|mesh-ancestor
65368434|NCT05253833|Protective Agents|protective agents|mesh-ancestor
65368435|NCT05253833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368436|NCT05246514|Trastuzumab|trastuzumab|mesh-list
65368437|NCT05246514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65368438|NCT05246514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368439|NCT05243199|Valsartan|valsartan|mesh-list
65368440|NCT05243199|Irbesartan|irbesartan|mesh-list
65368441|NCT05243199|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65368442|NCT05243199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65368443|NCT05243199|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65368444|NCT05243199|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65368445|NCT05243199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273634|NCT02846519|Esketamine|esketamine|mesh-list
65273635|NCT02846519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65368446|NCT05241873|Carboplatin|carboplatin|mesh-list
65368447|NCT05241873|Pemetrexed|pemetrexed|mesh-list
65368448|NCT05241873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368449|NCT05241873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368450|NCT05241873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368451|NCT05241873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65368476|NCT05201248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368477|NCT05201248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65368478|NCT05201248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65368479|NCT05201248|Alkylating Agents|alkylating agents|mesh-ancestor
65368480|NCT05201248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368481|NCT05201248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368482|NCT05201248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65368483|NCT05201248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65368484|NCT05201248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65368485|NCT05201248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65368486|NCT05201248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65368487|NCT05201248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368488|NCT05201248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65368489|NCT05201248|Glucocorticoids|glucocorticoids|mesh-ancestor
65368490|NCT05201248|Hormones|hormones|mesh-ancestor
65368491|NCT05201248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65368492|NCT05201248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65368493|NCT05201248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65368494|NCT05201248|Tubulin Modulators|tubulin modulators|mesh-ancestor
65368495|NCT05201248|Antimitotic Agents|antimitotic agents|mesh-ancestor
65368496|NCT05201248|Mitosis Modulators|mitosis modulators|mesh-ancestor
65368497|NCT05201248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65368498|NCT05201248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65368499|NCT05201248|Growth Substances|growth substances|mesh-ancestor
65368500|NCT05201248|Growth Inhibitors|growth inhibitors|mesh-ancestor
65368532|NCT05101564|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65368533|NCT05101564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65368534|NCT05101564|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65368535|NCT05076175|Ozanimod|ozanimod|mesh-list
65368536|NCT05076175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65368537|NCT05076175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368538|NCT05076175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65368539|NCT05076175|Immunologic Factors|immunologic factors|mesh-ancestor
65368540|NCT05076175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368541|NCT05073484|Antibodies|antibodies|mesh-list
65368569|NCT05025865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368570|NCT05025865|Viscosupplements|viscosupplements|mesh-ancestor
65368571|NCT05025865|Protective Agents|protective agents|mesh-ancestor
65368572|NCT05005741|Dulaglutide|dulaglutide|mesh-list
65368573|NCT05005741|Glucagon|glucagon|mesh-list
65368574|NCT05005741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65368575|NCT05005741|Incretins|incretins|mesh-ancestor
65368576|NCT05005741|Hormones|hormones|mesh-ancestor
65368577|NCT05005741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65368578|NCT05005741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368579|NCT05005741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65368580|NCT05005741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65368581|NCT05002829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65368582|NCT05002829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65368583|NCT05002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65368584|NCT05002829|Antitubercular Agents|antitubercular agents|mesh-ancestor
65368585|NCT04995029|Buprenorphine|buprenorphine|mesh-list
65368586|NCT04995029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65368587|NCT04995029|Narcotics|narcotics|mesh-ancestor
65368588|NCT04995029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65368589|NCT04995029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368590|NCT04995029|Analgesics|analgesics|mesh-ancestor
65368591|NCT04995029|Sensory System Agents|sensory system agents|mesh-ancestor
65368592|NCT04995029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65368593|NCT04995029|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64760755|NCT00610740|Gemcitabine|gemcitabine|mesh-list
65368622|NCT04974216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65368623|NCT04974216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65368624|NCT04974216|Growth Substances|growth substances|mesh-ancestor
65368625|NCT04974216|Growth Inhibitors|growth inhibitors|mesh-ancestor
65368626|NCT04972552|Ubiquinone|ubiquinone|mesh-list
65368627|NCT04972552|Coenzyme Q10|coenzyme q10|mesh-list
65368628|NCT04972552|Micronutrients|micronutrients|mesh-ancestor
65368629|NCT04972552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368630|NCT04972552|Vitamins|vitamins|mesh-ancestor
65368631|NCT04936685|Vaccines|vaccines|mesh-list
65368632|NCT04936685|Immunologic Factors|immunologic factors|mesh-ancestor
65368633|NCT04936685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368634|NCT04924699|Trastuzumab|trastuzumab|mesh-list
65368635|NCT04924699|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65368636|NCT04924699|Maytansine|maytansine|mesh-list
65368637|NCT04924699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65368638|NCT04924699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368639|NCT04924699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65368640|NCT04924699|Tubulin Modulators|tubulin modulators|mesh-ancestor
65368641|NCT04924699|Antimitotic Agents|antimitotic agents|mesh-ancestor
65368642|NCT04924699|Mitosis Modulators|mitosis modulators|mesh-ancestor
65368670|NCT04907227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368672|NCT04893798|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65368673|NCT04893798|Medroxyprogesterone|medroxyprogesterone|mesh-list
65368674|NCT04893798|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65368675|NCT04893798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65368676|NCT04893798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65368677|NCT04893798|Contraceptive Agents|contraceptive agents|mesh-ancestor
65368678|NCT04893798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65368679|NCT04893798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368680|NCT04893798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65368681|NCT04893798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65368682|NCT04893798|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65368683|NCT04893798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65368684|NCT04893798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368685|NCT04877288|Cyclosporine|cyclosporine|mesh-list
65368686|NCT04877288|Mycophenolic Acid|mycophenolic acid|mesh-list
65368687|NCT04877288|Abatacept|abatacept|mesh-list
65368688|NCT04877288|Tacrolimus|tacrolimus|mesh-list
65368724|NCT04873583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65368725|NCT04873583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368726|NCT04843566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64760901|NCT04142502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65368744|NCT04776993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65368746|NCT04729114|Dexamethasone|dexamethasone|mesh-list
65368747|NCT04729114|Prednisone|prednisone|mesh-list
65368748|NCT04729114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65368749|NCT04729114|Antiemetics|antiemetics|mesh-ancestor
65368750|NCT04729114|Autonomic Agents|autonomic agents|mesh-ancestor
65368751|NCT04729114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65368752|NCT04729114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368753|NCT04729114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65368754|NCT04729114|Glucocorticoids|glucocorticoids|mesh-ancestor
65368755|NCT04729114|Hormones|hormones|mesh-ancestor
65368756|NCT04729114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65368757|NCT04729114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65368758|NCT04729114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368760|NCT04671875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65368761|NCT04671875|Immunologic Factors|immunologic factors|mesh-ancestor
65368762|NCT04671875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368763|NCT04664972|Cyclophosphamide|cyclophosphamide|mesh-list
65368764|NCT04664972|Docetaxel|docetaxel|mesh-list
65368765|NCT04664972|Doxorubicin|doxorubicin|mesh-list
65368766|NCT04664972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65368767|NCT04664972|Immunologic Factors|immunologic factors|mesh-ancestor
65368768|NCT04664972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368769|NCT04664972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65368770|NCT04664972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65368771|NCT04664972|Alkylating Agents|alkylating agents|mesh-ancestor
65368772|NCT04664972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368773|NCT04664972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368774|NCT04664972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65368775|NCT04664972|Tubulin Modulators|tubulin modulators|mesh-ancestor
65368776|NCT04664972|Antimitotic Agents|antimitotic agents|mesh-ancestor
65368777|NCT04664972|Mitosis Modulators|mitosis modulators|mesh-ancestor
65368778|NCT04664972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65368779|NCT04664972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65368780|NCT04664972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65368781|NCT04664972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368782|NCT04652544|Vitamin D|vitamin d|mesh-list
65273636|NCT02846519|Antitubercular Agents|antitubercular agents|mesh-ancestor
65368783|NCT04652544|Cholecalciferol|cholecalciferol|mesh-list
65368784|NCT04652544|Vitamins|vitamins|mesh-ancestor
65368785|NCT04652544|Micronutrients|micronutrients|mesh-ancestor
65368800|NCT04632069|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65368801|NCT04632069|Antiviral Agents|antiviral agents|mesh-ancestor
65368802|NCT04632069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65368803|NCT04632069|Expectorants|expectorants|mesh-ancestor
65368804|NCT04632069|Respiratory System Agents|respiratory system agents|mesh-ancestor
65368805|NCT04632069|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65368806|NCT04632069|Antioxidants|antioxidants|mesh-ancestor
65368807|NCT04632069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368808|NCT04632069|Protective Agents|protective agents|mesh-ancestor
65368809|NCT04632069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368810|NCT04632069|Antidotes|antidotes|mesh-ancestor
65368811|NCT04618913|Rivaroxaban|rivaroxaban|mesh-list
65368812|NCT04618913|Apixaban|apixaban|mesh-list
65368813|NCT04618913|Edoxaban|edoxaban|mesh-list
65368814|NCT04618913|Dabigatran|dabigatran|mesh-list
65368815|NCT04618913|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65368816|NCT04618913|Antithrombins|antithrombins|mesh-ancestor
65368817|NCT04618913|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65368818|NCT04618913|Protease Inhibitors|protease inhibitors|mesh-ancestor
65368819|NCT04618913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368820|NCT04618913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368821|NCT04618913|Anticoagulants|anticoagulants|mesh-ancestor
65368822|NCT04616196|Cetuximab|cetuximab|mesh-list
65368823|NCT04616196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65368824|NCT04616196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368825|NCT04613518|BMS-986165|bms-986165|mesh-list
65368826|NCT04613518|Dermatologic Agents|dermatologic agents|mesh-ancestor
65368827|NCT04613518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65368828|NCT04613518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368829|NCT04613518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368830|NCT04599634|Venetoclax|venetoclax|mesh-list
65368831|NCT04599634|Obinutuzumab|obinutuzumab|mesh-list
65368832|NCT04599634|Magrolimab|magrolimab|mesh-list
65368833|NCT04599634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368834|NCT04599634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65368835|NCT04592913|Durvalumab|durvalumab|mesh-list
65368836|NCT04592913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65368837|NCT04592913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368838|NCT04585815|Axitinib|axitinib|mesh-list
65368839|NCT04585815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368840|NCT04585815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65368841|NCT04585815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368842|NCT04585815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368843|NCT04547907|Paclitaxel|paclitaxel|mesh-list
65368844|NCT04547907|Docetaxel|docetaxel|mesh-list
65368845|NCT04547907|Carboplatin|carboplatin|mesh-list
65368846|NCT04547907|Trastuzumab|trastuzumab|mesh-list
65368847|NCT04547907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65368848|NCT04547907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368875|NCT04460937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368877|NCT04454203|Mepivacaine|mepivacaine|mesh-list
65368878|NCT04454203|Anesthetics, Local|anesthetics, local|mesh-list
65368879|NCT04454203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65368880|NCT04454203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368881|NCT04454203|Sensory System Agents|sensory system agents|mesh-ancestor
65368882|NCT04454203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65368883|NCT04439149|GSK2636771|gsk2636771|mesh-list
65368884|NCT04439149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368885|NCT04439149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65368886|NCT04439149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368887|NCT04439149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368888|NCT04439110|Trastuzumab|trastuzumab|mesh-list
65368889|NCT04439110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65368890|NCT04439110|Maytansine|maytansine|mesh-list
65368891|NCT04439110|Immunoconjugates|immunoconjugates|mesh-list
65368892|NCT04439110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65368893|NCT04439110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368894|NCT04439110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65368895|NCT04439110|Tubulin Modulators|tubulin modulators|mesh-ancestor
65368896|NCT04439110|Antimitotic Agents|antimitotic agents|mesh-ancestor
64761054|NCT01107457|Ixekizumab|ixekizumab|mesh-list
65368919|NCT04393285|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65368920|NCT04393285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65273637|NCT02846519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64471743|NCT04189263|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65368921|NCT04393285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368922|NCT04393285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368923|NCT04393285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65368924|NCT04393285|Hormone Antagonists|hormone antagonists|mesh-ancestor
65368925|NCT04393285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65368926|NCT04393285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368927|NCT04391283|Osimertinib|osimertinib|mesh-list
65368928|NCT04391283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368929|NCT04391283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65368930|NCT04391283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368931|NCT04391283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368932|NCT04379596|Pembrolizumab|pembrolizumab|mesh-list
65368933|NCT04379596|Fluorouracil|fluorouracil|mesh-list
65368934|NCT04379596|Capecitabine|capecitabine|mesh-list
65368935|NCT04379596|Oxaliplatin|oxaliplatin|mesh-list
65368936|NCT04379596|Trastuzumab|trastuzumab|mesh-list
65368937|NCT04379596|Durvalumab|durvalumab|mesh-list
65368938|NCT04379596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368939|NCT04379596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65368940|NCT04379596|Antimetabolites|antimetabolites|mesh-ancestor
65368941|NCT04379596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368942|NCT04379596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65368943|NCT04379596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65368944|NCT04379596|Immunologic Factors|immunologic factors|mesh-ancestor
64761103|NCT05766540|Metformin|metformin|mesh-list
65368947|NCT04374799|Anticoagulants|anticoagulants|mesh-ancestor
65368948|NCT04374799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65368949|NCT04374799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65368950|NCT04374799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368951|NCT04367311|Docetaxel|docetaxel|mesh-list
65368952|NCT04367311|Pemetrexed|pemetrexed|mesh-list
65368953|NCT04367311|Atezolizumab|atezolizumab|mesh-list
65368954|NCT04367311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368955|NCT04367311|Tubulin Modulators|tubulin modulators|mesh-ancestor
65368956|NCT04367311|Antimitotic Agents|antimitotic agents|mesh-ancestor
65368957|NCT04367311|Mitosis Modulators|mitosis modulators|mesh-ancestor
65368958|NCT04367311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368959|NCT04367311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368960|NCT04367311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65368961|NCT04367311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65368962|NCT04338204|Tofacitinib|tofacitinib|mesh-list
65368963|NCT04338204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65368964|NCT04338204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368965|NCT04338204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368966|NCT04308785|Atezolizumab|atezolizumab|mesh-list
65368967|NCT04308785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368968|NCT04301076|Prednisone|prednisone|mesh-list
65368969|NCT04301076|Cortisone|cortisone|mesh-list
65368970|NCT04301076|Cyclophosphamide|cyclophosphamide|mesh-list
65368971|NCT04301076|Doxorubicin|doxorubicin|mesh-list
65368972|NCT04301076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65368973|NCT04301076|Etoposide|etoposide|mesh-list
65368974|NCT04301076|Vincristine|vincristine|mesh-list
65368975|NCT04301076|Lenalidomide|lenalidomide|mesh-list
65368976|NCT04301076|Etoposide phosphate|etoposide phosphate|mesh-list
65368977|NCT04301076|Podophyllotoxin|podophyllotoxin|mesh-list
65368978|NCT04301076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65368979|NCT04301076|Immunologic Factors|immunologic factors|mesh-ancestor
65368980|NCT04301076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368981|NCT04301076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65368982|NCT04301076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65368983|NCT04301076|Alkylating Agents|alkylating agents|mesh-ancestor
65368984|NCT04301076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368985|NCT04301076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368986|NCT04301076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65368987|NCT04301076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65368988|NCT04301076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65368989|NCT04301076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65368990|NCT04301076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368991|NCT04301076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65368992|NCT04301076|Glucocorticoids|glucocorticoids|mesh-ancestor
65368993|NCT04301076|Hormones|hormones|mesh-ancestor
65368994|NCT04301076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64488314|NCT02241148|Antipyretics|antipyretics|mesh-ancestor
65368995|NCT04301076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65368996|NCT04301076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65368997|NCT04301076|Tubulin Modulators|tubulin modulators|mesh-ancestor
65368998|NCT04301076|Antimitotic Agents|antimitotic agents|mesh-ancestor
65368999|NCT04301076|Mitosis Modulators|mitosis modulators|mesh-ancestor
65369000|NCT04301076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65369001|NCT04301076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65369002|NCT04301076|Growth Substances|growth substances|mesh-ancestor
65369003|NCT04301076|Growth Inhibitors|growth inhibitors|mesh-ancestor
65369004|NCT04301076|Keratolytic Agents|keratolytic agents|mesh-ancestor
65369005|NCT04301076|Dermatologic Agents|dermatologic agents|mesh-ancestor
65369006|NCT04266275|Curcumin|curcumin|mesh-list
65369007|NCT04266275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65369008|NCT04266275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65369009|NCT04266275|Analgesics|analgesics|mesh-ancestor
65369010|NCT04266275|Sensory System Agents|sensory system agents|mesh-ancestor
65369011|NCT04266275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65369012|NCT04266275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369013|NCT04266275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65369014|NCT04266275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65369015|NCT04266275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369016|NCT04266275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369017|NCT04266275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369018|NCT04252742|Erenumab|erenumab|mesh-list
64761153|NCT05766436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65369038|NCT04206319|Listerine|listerine|mesh-list
65369039|NCT04206319|Fluorides|fluorides|mesh-list
65369040|NCT04206319|Sodium Fluoride|sodium fluoride|mesh-list
65369041|NCT04206319|Cariostatic Agents|cariostatic agents|mesh-ancestor
65369042|NCT04206319|Protective Agents|protective agents|mesh-ancestor
65369043|NCT04206319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369044|NCT04206319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65369045|NCT04206319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65369046|NCT04194359|Bevacizumab|bevacizumab|mesh-list
65369047|NCT04194359|Capecitabine|capecitabine|mesh-list
65369048|NCT04194359|Oxaliplatin|oxaliplatin|mesh-list
65369049|NCT04194359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65369050|NCT04194359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369051|NCT04194359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65369052|NCT04194359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65369053|NCT04194359|Growth Substances|growth substances|mesh-ancestor
65369054|NCT04194359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369055|NCT04194359|Growth Inhibitors|growth inhibitors|mesh-ancestor
65369056|NCT04194359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65369057|NCT04194359|Antimetabolites|antimetabolites|mesh-ancestor
65369058|NCT04194359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369059|NCT04192955|Salicylates|salicylates|mesh-list
65369060|NCT04192955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65369061|NCT04192955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65369062|NCT04192955|Analgesics|analgesics|mesh-ancestor
65369063|NCT04192955|Sensory System Agents|sensory system agents|mesh-ancestor
65369064|NCT04192955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65369065|NCT04192955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761234|NCT05765825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65369101|NCT04030000|Carboplatin|carboplatin|mesh-list
65369102|NCT04030000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65369103|NCT04030000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761291|NCT05765357|Trastuzumab|trastuzumab|mesh-list
65369134|NCT03952637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65369135|NCT03952637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65369136|NCT03952637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65369137|NCT03952637|Antifungal Agents|antifungal agents|mesh-ancestor
65369138|NCT03952637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65369139|NCT03952637|Antiemetics|antiemetics|mesh-ancestor
65369140|NCT03952637|Autonomic Agents|autonomic agents|mesh-ancestor
65369141|NCT03952637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65369142|NCT03952637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65369143|NCT03952637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65369144|NCT03952637|Protective Agents|protective agents|mesh-ancestor
65369145|NCT03944941|Cetuximab|cetuximab|mesh-list
65369146|NCT03944941|Avelumab|avelumab|mesh-list
65369147|NCT03944941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65369148|NCT03944941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369149|NCT03921866|Palbociclib|palbociclib|mesh-list
64530036|NCT05800366|Hormones|hormones|mesh-ancestor
65273638|NCT02846519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65369164|NCT03919955|Autonomic Agents|autonomic agents|mesh-ancestor
65369165|NCT03919955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65369166|NCT03919955|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65369167|NCT03919955|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65369168|NCT03919955|Cholinergic Agents|cholinergic agents|mesh-ancestor
65369169|NCT03919955|Urological Agents|urological agents|mesh-ancestor
65369170|NCT03919799|Belumosudil|belumosudil|mesh-list
65369171|NCT03919799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65369172|NCT03919799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369173|NCT03919799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369174|NCT03885089|Infliximab|infliximab|mesh-list
65369175|NCT03885089|Dermatologic Agents|dermatologic agents|mesh-ancestor
65369176|NCT03885089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65369177|NCT03885089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65369178|NCT03884439|Infliximab|infliximab|mesh-list
65369179|NCT03884439|Dermatologic Agents|dermatologic agents|mesh-ancestor
65369180|NCT03884439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65369181|NCT03884439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65369182|NCT03864042|Losartan|losartan|mesh-list
65369183|NCT03864042|Midazolam|midazolam|mesh-list
65369184|NCT03864042|Dextromethorphan|dextromethorphan|mesh-list
65369185|NCT03864042|Caffeine|caffeine|mesh-list
65369186|NCT03864042|Modafinil|modafinil|mesh-list
65369187|NCT03864042|Bupropion|bupropion|mesh-list
65369188|NCT03864042|Omeprazole|omeprazole|mesh-list
65369189|NCT03864042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65369190|NCT03864042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65369191|NCT03864042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65369192|NCT03864042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65369193|NCT03864042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369194|NCT03864042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65369195|NCT03864042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65369196|NCT03864042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65369197|NCT03864042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65369198|NCT03864042|Anesthetics, General|anesthetics, general|mesh-ancestor
65369199|NCT03864042|Anesthetics|anesthetics|mesh-ancestor
65369200|NCT03864042|GABA Modulators|gaba modulators|mesh-ancestor
65369201|NCT03864042|GABA Agents|gaba agents|mesh-ancestor
65369202|NCT03864042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65369203|NCT03864042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369204|NCT03864042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65369205|NCT03864042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65369206|NCT03864042|Antimetabolites|antimetabolites|mesh-ancestor
65369207|NCT03864042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65369208|NCT03864042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65369209|NCT03864042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369210|NCT03864042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65369230|NCT03864042|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65369231|NCT03864042|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65369232|NCT03864042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65369233|NCT03864042|Antitussive Agents|antitussive agents|mesh-ancestor
65369234|NCT03864042|Respiratory System Agents|respiratory system agents|mesh-ancestor
65369235|NCT03864042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65369236|NCT03864042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65369237|NCT03762759|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65369238|NCT03762759|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65369239|NCT03762759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369241|NCT03760588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65369242|NCT03760588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65369243|NCT03760588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65369244|NCT03760588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65369245|NCT03760588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369246|NCT03729778|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65369247|NCT03729778|Immunologic Factors|immunologic factors|mesh-ancestor
65369248|NCT03729778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369249|NCT03710343|Metformin|metformin|mesh-list
65369250|NCT03710343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65369251|NCT03710343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369252|NCT03681561|Nivolumab|nivolumab|mesh-list
65369253|NCT03681561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65369254|NCT03681561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369255|NCT03681561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65369256|NCT03681561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273639|NCT02846519|Leprostatic Agents|leprostatic agents|mesh-ancestor
65369257|NCT03656081|Itraconazole|itraconazole|mesh-list
65369258|NCT03656081|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65369259|NCT03656081|Amphotericin B|amphotericin b|mesh-list
65369260|NCT03656081|Antifungal Agents|antifungal agents|mesh-ancestor
65369266|NCT03656081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65369267|NCT03656081|Hormone Antagonists|hormone antagonists|mesh-ancestor
65369268|NCT03656081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65369269|NCT03656081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369270|NCT03656081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65369271|NCT03656081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65369272|NCT03656081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65369273|NCT03656081|Amebicides|amebicides|mesh-ancestor
65369274|NCT03656081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65369275|NCT03649048|Cisplatin|cisplatin|mesh-list
65369276|NCT03649048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369277|NCT03642626|Vidarabine|vidarabine|mesh-list
65369278|NCT03642626|Cyclophosphamide|cyclophosphamide|mesh-list
65369279|NCT03642626|Fludarabine|fludarabine|mesh-list
65369280|NCT03642626|Fludarabine phosphate|fludarabine phosphate|mesh-list
65369281|NCT03642626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65369282|NCT03642626|Immunologic Factors|immunologic factors|mesh-ancestor
65369283|NCT03642626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369284|NCT03642626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65369285|NCT03642626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65369286|NCT03642626|Alkylating Agents|alkylating agents|mesh-ancestor
65369287|NCT03642626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369288|NCT03642626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369289|NCT03642626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65369290|NCT03642626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65369291|NCT03642626|Antimetabolites|antimetabolites|mesh-ancestor
65369292|NCT03642626|Antiviral Agents|antiviral agents|mesh-ancestor
65369293|NCT03642626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65369294|NCT03640481|Belumosudil|belumosudil|mesh-list
65369295|NCT03640481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65369296|NCT03640481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369297|NCT03640481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369298|NCT03637660|Penicillins|penicillins|mesh-list
65369299|NCT03637660|Penicillin G Benzathine|penicillin g benzathine|mesh-list
65369300|NCT03637660|Penicillin G|penicillin g|mesh-list
65369301|NCT03637660|Penicillin G Procaine|penicillin g procaine|mesh-list
65369302|NCT03637660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65369303|NCT03637660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65369304|NCT03621982|Pembrolizumab|pembrolizumab|mesh-list
65369305|NCT03621982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65369306|NCT03621982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369307|NCT03609216|Gemcitabine|gemcitabine|mesh-list
65369308|NCT03609216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369309|NCT03609216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65369310|NCT03609216|Antimetabolites|antimetabolites|mesh-ancestor
65369311|NCT03609216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369312|NCT03609216|Antiviral Agents|antiviral agents|mesh-ancestor
65369313|NCT03609216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65369314|NCT03609216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369315|NCT03609216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65369316|NCT03609216|Immunologic Factors|immunologic factors|mesh-ancestor
65369317|NCT03609216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369318|NCT03608163|Diazoxide|diazoxide|mesh-list
65369319|NCT03608163|Naloxone|naloxone|mesh-list
65369320|NCT03608163|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65369321|NCT03608163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369322|NCT03608163|Sensory System Agents|sensory system agents|mesh-ancestor
65369323|NCT03608163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65369324|NCT03608163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65369325|NCT03608163|Vasodilator Agents|vasodilator agents|mesh-ancestor
65369326|NCT03604406|Vaccines|vaccines|mesh-list
65369327|NCT03604406|Immunologic Factors|immunologic factors|mesh-ancestor
65369328|NCT03604406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369329|NCT03599635|Bupivacaine|bupivacaine|mesh-list
65369330|NCT03599635|Anesthetics, Local|anesthetics, local|mesh-ancestor
65369346|NCT03573700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65369347|NCT03573700|Immunologic Factors|immunologic factors|mesh-ancestor
65369348|NCT03573700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369349|NCT03573700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65369350|NCT03573700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65369351|NCT03573700|Alkylating Agents|alkylating agents|mesh-ancestor
65369352|NCT03573700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369353|NCT03573700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369354|NCT03573700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65369356|NCT03573024|Venetoclax|venetoclax|mesh-list
65369357|NCT03573024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65369358|NCT03573024|Antimetabolites|antimetabolites|mesh-ancestor
65369359|NCT03573024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369360|NCT03573024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369361|NCT03573024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369362|NCT03534947|Imiquimod|imiquimod|mesh-list
65369363|NCT03534947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65369364|NCT03534947|Immunologic Factors|immunologic factors|mesh-ancestor
65369365|NCT03534947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369366|NCT03534947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369367|NCT03534947|Interferon Inducers|interferon inducers|mesh-ancestor
65369368|NCT03530371|Dexmedetomidine|dexmedetomidine|mesh-list
65369369|NCT03530371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65369370|NCT03530371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65369371|NCT03530371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369372|NCT03530371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65369374|NCT03530371|Sensory System Agents|sensory system agents|mesh-ancestor
65369375|NCT03530371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65369376|NCT03530371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65369377|NCT03530371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65369378|NCT03530371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65369379|NCT03530371|Adrenergic Agents|adrenergic agents|mesh-ancestor
65369380|NCT03530371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65369381|NCT03530371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369382|NCT03521830|Nivolumab|nivolumab|mesh-list
65369383|NCT03521830|Ipilimumab|ipilimumab|mesh-list
65369384|NCT03521830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65369385|NCT03521830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369386|NCT03521830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65369387|NCT03521830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369388|NCT03496610|Bupivacaine|bupivacaine|mesh-list
64761549|NCT05486481|Venetoclax|venetoclax|mesh-list
65369417|NCT03434730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65369418|NCT03434730|Immunologic Factors|immunologic factors|mesh-ancestor
65369419|NCT03434730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369420|NCT03434730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369421|NCT03434730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369422|NCT03434730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65369423|NCT03434730|Antifungal Agents|antifungal agents|mesh-ancestor
65369424|NCT03434730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65369425|NCT03434730|Dermatologic Agents|dermatologic agents|mesh-ancestor
65369426|NCT03434730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65369427|NCT03434730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65369428|NCT03434730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65369429|NCT03434730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369430|NCT03434730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65369431|NCT03434730|Antitubercular Agents|antitubercular agents|mesh-ancestor
65369432|NCT03434730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65369433|NCT03418649|Eplerenone|eplerenone|mesh-list
65369434|NCT03418649|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65369435|NCT03418649|Hormone Antagonists|hormone antagonists|mesh-ancestor
65369452|NCT03375307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369453|NCT03375307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369454|NCT03315832|Valsartan|valsartan|mesh-list
65369455|NCT03315832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65369456|NCT03315832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65369457|NCT03315832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65369458|NCT03315832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369459|NCT03260920|Oxytocin|oxytocin|mesh-list
65369460|NCT03260920|Oxytocics|oxytocics|mesh-ancestor
65369461|NCT03260920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65369462|NCT03260920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369463|NCT03164616|Gemcitabine|gemcitabine|mesh-list
65369464|NCT03164616|Cisplatin|cisplatin|mesh-list
65369465|NCT03164616|Carboplatin|carboplatin|mesh-list
65369466|NCT03164616|Pemetrexed|pemetrexed|mesh-list
65369467|NCT03164616|Durvalumab|durvalumab|mesh-list
65369468|NCT03164616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65369469|NCT03164616|Tremelimumab|tremelimumab|mesh-list
65369470|NCT03164616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369471|NCT03164616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65273640|NCT02846519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65273641|NCT02846519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64471747|NCT04189263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65369472|NCT03164616|Antimetabolites|antimetabolites|mesh-ancestor
65369473|NCT03164616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369474|NCT03164616|Antiviral Agents|antiviral agents|mesh-ancestor
65369475|NCT03164616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65369476|NCT03164616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369477|NCT03164616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65369478|NCT03164616|Immunologic Factors|immunologic factors|mesh-ancestor
65369479|NCT03164616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369480|NCT03164616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65369481|NCT03164616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65369482|NCT03164616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65369483|NCT03124355|Bromides|bromides|mesh-list
65369484|NCT03124355|Galantamine|galantamine|mesh-list
65369485|NCT03124355|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
65369486|NCT03124355|Anticonvulsants|anticonvulsants|mesh-ancestor
65369487|NCT03124355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65369488|NCT03124355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369489|NCT03124355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369490|NCT03124355|Cholinergic Agents|cholinergic agents|mesh-ancestor
65369491|NCT03124355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65369492|NCT03124355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369493|NCT03124355|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65369494|NCT03124355|Autonomic Agents|autonomic agents|mesh-ancestor
65369525|NCT02944578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65369526|NCT02944578|Analgesics|analgesics|mesh-ancestor
65369527|NCT02944578|Sensory System Agents|sensory system agents|mesh-ancestor
65369528|NCT02944578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65369529|NCT02944578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369530|NCT02944578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65369531|NCT02944578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65369532|NCT02944578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369533|NCT02944578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369534|NCT02944578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369535|NCT02889523|Prednisolone|prednisolone|mesh-list
65369536|NCT02889523|Cyclophosphamide|cyclophosphamide|mesh-list
65369537|NCT02889523|Rituximab|rituximab|mesh-list
65369538|NCT02889523|Doxorubicin|doxorubicin|mesh-list
65369539|NCT02889523|Vincristine|vincristine|mesh-list
65369540|NCT02889523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65369541|NCT02889523|Immunologic Factors|immunologic factors|mesh-ancestor
65369572|NCT02616302|Lansoprazole|lansoprazole|mesh-list
65369573|NCT02616302|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65369574|NCT02616302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65369575|NCT02616302|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65369576|NCT02616302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369577|NCT02616302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369579|NCT02546661|Olaparib|olaparib|mesh-list
65369580|NCT02546661|Adavosertib|adavosertib|mesh-list
65369581|NCT02546661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65369582|NCT02546661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369612|NCT02375204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65369613|NCT02375204|Alkylating Agents|alkylating agents|mesh-ancestor
65369615|NCT02374242|Ipilimumab|ipilimumab|mesh-list
65369616|NCT02374242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65369617|NCT02374242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369618|NCT02374242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65369619|NCT02374242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369620|NCT02370329|Interferons|interferons|mesh-list
65369621|NCT02370329|Interferon-alpha|interferon-alpha|mesh-list
65369622|NCT02370329|Interferon alpha-2|interferon alpha-2|mesh-list
65369623|NCT02370329|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65369624|NCT02370329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65369625|NCT02370329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761837|NCT04964544|Calcium|calcium|mesh-list
65369652|NCT02272790|Immunologic Factors|immunologic factors|mesh-ancestor
65369653|NCT02272790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369654|NCT02113657|Ipilimumab|ipilimumab|mesh-list
65369655|NCT02113657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65369656|NCT02113657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369657|NCT02113657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65273642|NCT02846519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273643|NCT02846519|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65273644|NCT02846519|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65273645|NCT02846519|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65273646|NCT02846519|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65273647|NCT02846519|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65273648|NCT02846519|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65273649|NCT02846519|Antidepressive Agents|antidepressive agents|mesh-ancestor
64471748|NCT04189263|Hormone Antagonists|hormone antagonists|mesh-ancestor
64471749|NCT04189263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64776742|NCT04438902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776743|NCT04438902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776745|NCT04346394|Mydriatics|mydriatics|mesh-ancestor
64776746|NCT04346394|Autonomic Agents|autonomic agents|mesh-ancestor
64776747|NCT04346394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776748|NCT04346394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388204|NCT02351297|Caseins|caseins|mesh-list
64388360|NCT03157505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388362|NCT03157193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64388363|NCT03157193|Immunologic Factors|immunologic factors|mesh-ancestor
64388364|NCT03157193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388365|NCT03157193|Viscosupplements|viscosupplements|mesh-ancestor
64388366|NCT03157193|Protective Agents|protective agents|mesh-ancestor
64388367|NCT03149159|Nivolumab|nivolumab|mesh-list
64388819|NCT03111797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64388916|NCT02437825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64388922|NCT03512197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388923|NCT03512197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388925|NCT02442817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64388926|NCT02442817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388927|NCT02442817|Incretins|incretins|mesh-ancestor
64388928|NCT02442817|Hormones|hormones|mesh-ancestor
64388937|NCT02442739|Ketamine|ketamine|mesh-list
65273650|NCT02846519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65273651|NCT00618228|Balsalazide|balsalazide|mesh-list
65273652|NCT00618228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65273653|NCT00618228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65273654|NCT00618228|Analgesics|analgesics|mesh-ancestor
65273655|NCT00618228|Sensory System Agents|sensory system agents|mesh-ancestor
65273656|NCT00618228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65273657|NCT00618228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273659|NCT00618228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65273660|NCT00618228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65273661|NCT03711305|Carboplatin|carboplatin|mesh-list
65273662|NCT03711305|Etoposide|etoposide|mesh-list
65273663|NCT03711305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471750|NCT04189263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388939|NCT02442739|Sensory System Agents|sensory system agents|mesh-ancestor
64389000|NCT02331563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64389001|NCT02331563|Adrenergic Agents|adrenergic agents|mesh-ancestor
64389002|NCT02331563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64389003|NCT02331563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389004|NCT02441803|Cytarabine|cytarabine|mesh-list
64389005|NCT02441803|Mycophenolic Acid|mycophenolic acid|mesh-list
64389006|NCT02441803|Cyclophosphamide|cyclophosphamide|mesh-list
64389007|NCT02441803|Busulfan|busulfan|mesh-list
64389008|NCT02441803|Fludarabine|fludarabine|mesh-list
64389009|NCT02441803|Fludarabine phosphate|fludarabine phosphate|mesh-list
64389010|NCT02441803|Decitabine|decitabine|mesh-list
64389011|NCT02441803|Idarubicin|idarubicin|mesh-list
64389012|NCT02441803|Clofarabine|clofarabine|mesh-list
64389013|NCT02441803|Tacrolimus|tacrolimus|mesh-list
64389014|NCT02441803|Thymoglobulin|thymoglobulin|mesh-list
64389015|NCT02441803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64389016|NCT02441803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64389017|NCT02441803|Immunologic Factors|immunologic factors|mesh-ancestor
65369658|NCT02113657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369659|NCT02035787|Metformin|metformin|mesh-list
65369660|NCT02035787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65369661|NCT02035787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369662|NCT02032953|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
65369663|NCT02032953|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65369665|NCT01850355|Buspirone|buspirone|mesh-list
65369666|NCT01850355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65369667|NCT01850355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65369668|NCT01850355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65369669|NCT01850355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369670|NCT01850355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65369671|NCT01850355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64389320|NCT02328053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389321|NCT02328053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64389322|NCT02328053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64389323|NCT02328053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64389324|NCT02328053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64389325|NCT02022748|Ticagrelor|ticagrelor|mesh-list
64389326|NCT02022748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64389327|NCT02022748|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64389328|NCT02022748|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64389381|NCT02328443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389382|NCT02328443|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64389416|NCT03191539|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64389417|NCT03191539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369672|NCT01850355|Serotonin Agents|serotonin agents|mesh-ancestor
65369673|NCT01850355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65369674|NCT01850355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369675|NCT01582776|Lenalidomide|lenalidomide|mesh-list
65369676|NCT01582776|Obinutuzumab|obinutuzumab|mesh-list
65369706|NCT01377389|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65369707|NCT01377389|Fertility Agents|fertility agents|mesh-ancestor
65369708|NCT01377389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65369709|NCT01377389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369710|NCT01377389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65369711|NCT01194271|Ipilimumab|ipilimumab|mesh-list
65369712|NCT01194271|Leuprolide|leuprolide|mesh-list
65369713|NCT01194271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65369714|NCT01194271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369715|NCT01194271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65369716|NCT01194271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369717|NCT01194271|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65369718|NCT01194271|Fertility Agents|fertility agents|mesh-ancestor
65369719|NCT01194271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64761922|NCT04882540|Brivaracetam|brivaracetam|mesh-list
65369750|NCT00602459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369751|NCT00602459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65369752|NCT00602459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65369753|NCT00602459|Alkylating Agents|alkylating agents|mesh-ancestor
65369754|NCT00602459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369755|NCT00602459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369756|NCT00602459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65369757|NCT00602459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65369758|NCT00602459|Antimetabolites|antimetabolites|mesh-ancestor
65369759|NCT00602459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65369760|NCT00602459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65369761|NCT00602459|Growth Substances|growth substances|mesh-ancestor
65369762|NCT00602459|Growth Inhibitors|growth inhibitors|mesh-ancestor
65369763|NCT00199069|Cytarabine|cytarabine|mesh-list
65369764|NCT00199069|Dexamethasone|dexamethasone|mesh-list
65369792|NCT00199069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65369794|NCT00199069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65369795|NCT00199069|Abortifacient Agents|abortifacient agents|mesh-ancestor
65369796|NCT00199069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65369797|NCT00199069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65369798|NCT00199069|Antimetabolites|antimetabolites|mesh-ancestor
65369799|NCT00199069|Dermatologic Agents|dermatologic agents|mesh-ancestor
65369800|NCT00199069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369801|NCT00199069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65369802|NCT00199069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65369803|NCT00199069|Antiviral Agents|antiviral agents|mesh-ancestor
65273664|NCT03711305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65273665|NCT03711305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65273666|NCT03711305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65273667|NCT03711305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273668|NCT03711305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273669|NCT00618384|Sorafenib|sorafenib|mesh-list
65273670|NCT00618384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273671|NCT00618384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64488904|NCT01699022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64488905|NCT01699022|Contraceptive Agents|contraceptive agents|mesh-ancestor
64488906|NCT01699022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64488907|NCT01699022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488908|NCT01699022|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64488909|NCT01699022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64488910|NCT01670175|Sirolimus|sirolimus|mesh-list
64488911|NCT01670175|Cyclophosphamide|cyclophosphamide|mesh-list
64488912|NCT01670175|Topotecan|topotecan|mesh-list
64389472|NCT03145025|Hormones|hormones|mesh-ancestor
64389473|NCT03145025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64389547|NCT02327039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64389548|NCT02327039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389549|NCT03142607|Chlorhexidine|chlorhexidine|mesh-list
64389550|NCT03142607|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64389551|NCT03142607|Metronidazole|metronidazole|mesh-list
64389552|NCT03142607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64389553|NCT03142607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64389554|NCT03142607|Disinfectants|disinfectants|mesh-ancestor
64389555|NCT03142607|Dermatologic Agents|dermatologic agents|mesh-ancestor
64389571|NCT05077475|Antimitotic Agents|antimitotic agents|mesh-ancestor
64389614|NCT03588767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389615|NCT03588767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64389616|NCT03588767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64389617|NCT03588767|Anabolic Agents|anabolic agents|mesh-ancestor
64389618|NCT03588767|Hormones|hormones|mesh-ancestor
65369804|NCT00199069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65369805|NCT00199069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65369806|NCT00199069|Tubulin Modulators|tubulin modulators|mesh-ancestor
65369807|NCT00199069|Antimitotic Agents|antimitotic agents|mesh-ancestor
65369808|NCT00199069|Mitosis Modulators|mitosis modulators|mesh-ancestor
65369809|NCT00199069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65273672|NCT00618384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273673|NCT00618384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273674|NCT03608657|Apremilast|apremilast|mesh-list
65273675|NCT03608657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65273676|NCT03608657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65273677|NCT03608657|Analgesics|analgesics|mesh-ancestor
65273678|NCT03608657|Sensory System Agents|sensory system agents|mesh-ancestor
65273679|NCT03608657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65273680|NCT03608657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273681|NCT03608657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64488979|NCT04373356|Listerine|listerine|mesh-list
64488980|NCT04373356|Fluorides|fluorides|mesh-list
64389660|NCT02429713|Autonomic Agents|autonomic agents|mesh-ancestor
64389661|NCT02429713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64389662|NCT02429713|Nasal Decongestants|nasal decongestants|mesh-ancestor
64389663|NCT02429713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64389664|NCT02429713|Respiratory System Agents|respiratory system agents|mesh-ancestor
64389665|NCT03191305|Warfarin|warfarin|mesh-list
64778240|NCT02330172|Cholinergic Agents|cholinergic agents|mesh-ancestor
64389666|NCT03191305|Anticoagulants|anticoagulants|mesh-ancestor
64389668|NCT03144401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64389669|NCT03144401|Abortifacient Agents|abortifacient agents|mesh-ancestor
64389672|NCT03144401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65369810|NCT00199069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65369811|NCT00199069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65369812|NCT00199069|Analgesics|analgesics|mesh-ancestor
65369813|NCT00199069|Sensory System Agents|sensory system agents|mesh-ancestor
65369814|NCT00199043|Allopurinol|allopurinol|mesh-list
64762075|NCT04560972|Etoposide|etoposide|mesh-list
65369833|NCT01067053|Capecitabine|capecitabine|mesh-list
65369834|NCT01067053|Oxaliplatin|oxaliplatin|mesh-list
65369835|NCT01067053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65369836|NCT01067053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369837|NCT01067053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65369838|NCT01067053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65369839|NCT01067053|Growth Substances|growth substances|mesh-ancestor
65369840|NCT01067053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369841|NCT01067053|Growth Inhibitors|growth inhibitors|mesh-ancestor
65369842|NCT01067053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65369843|NCT01067053|Antimetabolites|antimetabolites|mesh-ancestor
65369844|NCT01067053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369845|NCT02601365|Molgramostim|molgramostim|mesh-list
65369846|NCT02601365|Sargramostim|sargramostim|mesh-list
65369847|NCT02601365|Immunologic Factors|immunologic factors|mesh-ancestor
65369848|NCT02601365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369849|NCT02601365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369850|NCT02601287|Botulinum Toxins|botulinum toxins|mesh-list
65369851|NCT02601287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65369852|NCT02601287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65369853|NCT02601287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65369854|NCT02601287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65369855|NCT02601287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273682|NCT03608657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65273683|NCT03608657|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65273684|NCT03608657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65273685|NCT03608657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273686|NCT03608657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273687|NCT05000658|Dexamethasone|dexamethasone|mesh-list
65273688|NCT05000658|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65273689|NCT05000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65273690|NCT05000658|Antiemetics|antiemetics|mesh-ancestor
65273691|NCT05000658|Autonomic Agents|autonomic agents|mesh-ancestor
65273692|NCT05000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65273693|NCT05000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471752|NCT04165317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65369856|NCT02601287|Cholinergic Agents|cholinergic agents|mesh-ancestor
65369857|NCT02601287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65369858|NCT02601287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369859|NCT02601287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65369860|NCT02601287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65369861|NCT01067365|Citric Acid|citric acid|mesh-list
65369862|NCT01067365|Sodium Citrate|sodium citrate|mesh-list
65369863|NCT01067365|Enclomiphene|enclomiphene|mesh-list
65369864|NCT01067365|Clomiphene|clomiphene|mesh-list
65369865|NCT01067365|Zuclomiphene|zuclomiphene|mesh-list
65369866|NCT01067365|Anticoagulants|anticoagulants|mesh-ancestor
65369867|NCT01067365|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65369868|NCT01067365|Chelating Agents|chelating agents|mesh-ancestor
65369869|NCT01067365|Sequestering Agents|sequestering agents|mesh-ancestor
65369870|NCT01067365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369871|NCT01067365|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65369872|NCT01067365|Hormone Antagonists|hormone antagonists|mesh-ancestor
65369902|NCT01065259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65369903|NCT01065259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369904|NCT01065259|Adrenergic Agents|adrenergic agents|mesh-ancestor
65369905|NCT01065259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65369906|NCT01065259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369907|NCT00822666|Clopidogrel|clopidogrel|mesh-list
65369908|NCT00822666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65369909|NCT00822666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65369910|NCT00822666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65369911|NCT00822666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65369912|NCT00822666|Purinergic Agents|purinergic agents|mesh-ancestor
65369913|NCT00822666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65369914|NCT00822666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369915|NCT00822666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369916|NCT00816816|Docetaxel|docetaxel|mesh-list
65369917|NCT00816816|Fluorouracil|fluorouracil|mesh-list
65369918|NCT00816816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369919|NCT00816816|Tubulin Modulators|tubulin modulators|mesh-ancestor
65369954|NCT00635154|Glucocorticoids|glucocorticoids|mesh-ancestor
65369955|NCT00635154|Hormones|hormones|mesh-ancestor
65369956|NCT00635154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65369957|NCT00635154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65369958|NCT00635154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369976|NCT00819468|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65369977|NCT00819468|Protective Agents|protective agents|mesh-ancestor
65369978|NCT00819468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369980|NCT01067599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65369981|NCT01067599|Autonomic Agents|autonomic agents|mesh-ancestor
65369982|NCT01067599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65369983|NCT01067599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369984|NCT01067599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65273694|NCT05000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65273695|NCT05000658|Glucocorticoids|glucocorticoids|mesh-ancestor
65273696|NCT05000658|Hormones|hormones|mesh-ancestor
65273697|NCT05000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65273698|NCT05000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65369985|NCT01067599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65369986|NCT01067599|Cholinergic Agents|cholinergic agents|mesh-ancestor
65369987|NCT01067599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65369988|NCT01067599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369989|NCT00778817|Mitotane|mitotane|mesh-list
65369990|NCT00778817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65369991|NCT00778817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369992|NCT00293059|Dienogest|dienogest|mesh-list
65369993|NCT00293059|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65369994|NCT00293059|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65369995|NCT00293059|Estradiol|estradiol|mesh-list
65369996|NCT00293059|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65369997|NCT00293059|Estrogens|estrogens|mesh-ancestor
65369998|NCT00293059|Hormones|hormones|mesh-ancestor
65369999|NCT00293059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65370000|NCT00293059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370001|NCT00293059|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65370002|NCT00293059|Contraceptive Agents|contraceptive agents|mesh-ancestor
65370003|NCT00293059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65370004|NCT00293059|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65370005|NCT00293059|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65370006|NCT00293059|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65370007|NCT00293059|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65370008|NCT00293059|Hormone Antagonists|hormone antagonists|mesh-ancestor
65370009|NCT00293059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65370010|NCT00293059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65370011|NCT00756275|Nicotine|nicotine|mesh-list
65370012|NCT00756275|Varenicline|varenicline|mesh-list
65370013|NCT00756275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65370014|NCT00756275|Autonomic Agents|autonomic agents|mesh-ancestor
64762249|NCT04240093|Analgesics|analgesics|mesh-ancestor
65370042|NCT00758069|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65370044|NCT00758069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370045|NCT00758069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370046|NCT01067677|Diphenhydramine|diphenhydramine|mesh-list
65370047|NCT01067677|Promethazine|promethazine|mesh-list
65370048|NCT01067677|Ondansetron|ondansetron|mesh-list
65370049|NCT01067677|Metoclopramide|metoclopramide|mesh-list
65370050|NCT01067677|Antiemetics|antiemetics|mesh-ancestor
65370051|NCT01067677|Autonomic Agents|autonomic agents|mesh-ancestor
65370052|NCT01067677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370053|NCT01067677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370054|NCT01067677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65370055|NCT01067677|Antipruritics|antipruritics|mesh-ancestor
65370056|NCT01067677|Dermatologic Agents|dermatologic agents|mesh-ancestor
65370057|NCT01067677|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65370058|NCT01067677|Serotonin Agents|serotonin agents|mesh-ancestor
65370059|NCT01067677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64762306|NCT04151667|Dexamethasone|dexamethasone|mesh-list
65370096|NCT02600741|Risperidone|risperidone|mesh-list
65370097|NCT02600741|Aripiprazole|aripiprazole|mesh-list
65370098|NCT02600741|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65370099|NCT02600741|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65370100|NCT02600741|Ziprasidone|ziprasidone|mesh-list
65370101|NCT02600741|Clozapine|clozapine|mesh-list
65370102|NCT02600741|Asenapine|asenapine|mesh-list
65370103|NCT02600741|Loxapine|loxapine|mesh-list
65370127|NCT02600741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65370128|NCT02600741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65370129|NCT02600741|Antidepressive Agents|antidepressive agents|mesh-ancestor
65370130|NCT02600741|Dopamine Agonists|dopamine agonists|mesh-ancestor
65370131|NCT02600741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65370132|NCT02600741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65370133|NCT02600741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65370134|NCT02600741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65370135|NCT02600741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65370137|NCT02600741|GABA Agents|gaba agents|mesh-ancestor
64489197|NCT03743025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65273699|NCT05000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273700|NCT02844803|Metformin|metformin|mesh-list
65273701|NCT02844803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65273702|NCT02844803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273703|NCT04211298|Dexmedetomidine|dexmedetomidine|mesh-list
65273704|NCT04211298|Propofol|propofol|mesh-list
65273705|NCT04211298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65273706|NCT04211298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64390109|NCT02427295|Octreotide|octreotide|mesh-list
65370138|NCT02600741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65370139|NCT01065649|Nortriptyline|nortriptyline|mesh-list
65370140|NCT01065649|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65370141|NCT01065649|Antidepressive Agents|antidepressive agents|mesh-ancestor
65370142|NCT01065649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65370143|NCT01065649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65370144|NCT01065649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65370145|NCT01065649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65370146|NCT01065649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370147|NCT01065649|Adrenergic Agents|adrenergic agents|mesh-ancestor
65370148|NCT01065649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65370149|NCT01065649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370150|NCT01065727|Mitoxantrone|mitoxantrone|mesh-list
65370151|NCT01065727|Natalizumab|natalizumab|mesh-list
65370152|NCT01065727|Immunologic Factors|immunologic factors|mesh-list
65370153|NCT01065727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
65370154|NCT01065727|Analgesics|analgesics|mesh-ancestor
65370155|NCT01065727|Sensory System Agents|sensory system agents|mesh-ancestor
65370156|NCT01065727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370157|NCT01065727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370162|NCT01065727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370163|NCT01065805|Alovudine|alovudine|mesh-list
65370164|NCT01065805|Antiviral Agents|antiviral agents|mesh-ancestor
65370165|NCT01065805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65370166|NCT00311623|Sirolimus|sirolimus|mesh-list
65370167|NCT00311623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65370168|NCT00311623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65370169|NCT00311623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65370170|NCT00311623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65370171|NCT00311623|Antifungal Agents|antifungal agents|mesh-ancestor
65370172|NCT00311623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65370173|NCT00311623|Immunologic Factors|immunologic factors|mesh-ancestor
65370174|NCT00311623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370175|NCT01067989|Zoledronic Acid|zoledronic acid|mesh-list
65370176|NCT01067989|Pamidronate|pamidronate|mesh-list
65370177|NCT01067989|Celecoxib|celecoxib|mesh-list
65370178|NCT01067989|Cyclophosphamide|cyclophosphamide|mesh-list
65370179|NCT01067989|Capecitabine|capecitabine|mesh-list
65370180|NCT01067989|Methotrexate|methotrexate|mesh-list
65370181|NCT01067989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65370182|NCT01067989|Immunologic Factors|immunologic factors|mesh-ancestor
65370183|NCT01067989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370184|NCT01067989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65370185|NCT01067989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65370186|NCT01067989|Alkylating Agents|alkylating agents|mesh-ancestor
65370187|NCT01067989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370188|NCT01067989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65370189|NCT01067989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65370190|NCT01067989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65370191|NCT01067989|Antimetabolites|antimetabolites|mesh-ancestor
65370192|NCT01067989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65370193|NCT01067989|Abortifacient Agents|abortifacient agents|mesh-ancestor
65370194|NCT01067989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65370195|NCT01067989|Dermatologic Agents|dermatologic agents|mesh-ancestor
65370196|NCT01067989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370197|NCT01067989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65370198|NCT01067989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65273707|NCT04211298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273708|NCT04211298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65273709|NCT04211298|Anesthetics, General|anesthetics, general|mesh-ancestor
65273710|NCT04211298|Anesthetics|anesthetics|mesh-ancestor
65273711|NCT04211298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65273712|NCT04211298|Analgesics|analgesics|mesh-ancestor
65273713|NCT04211298|Sensory System Agents|sensory system agents|mesh-ancestor
65273714|NCT04211298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370199|NCT01067989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65370200|NCT01067989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65370201|NCT01067989|Analgesics|analgesics|mesh-ancestor
65370202|NCT01067989|Sensory System Agents|sensory system agents|mesh-ancestor
65370203|NCT01067989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370204|NCT01067989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65370205|NCT01067989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65370206|NCT01067989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65370207|NCT01067989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65370208|NCT00633594|Rituximab|rituximab|mesh-list
65370209|NCT00633594|Lenalidomide|lenalidomide|mesh-list
65370210|NCT00633594|Bortezomib|bortezomib|mesh-list
65370211|NCT00633594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65370212|NCT00633594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65370213|NCT00633594|Immunologic Factors|immunologic factors|mesh-ancestor
65370214|NCT00633594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370215|NCT00633594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65370216|NCT00633594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65370217|NCT00633594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65370218|NCT00633594|Growth Substances|growth substances|mesh-ancestor
65370219|NCT00633594|Growth Inhibitors|growth inhibitors|mesh-ancestor
65370220|NCT04840888|Itraconazole|itraconazole|mesh-list
65370221|NCT04840888|Carbamazepine|carbamazepine|mesh-list
65370222|NCT04840888|Omeprazole|omeprazole|mesh-list
65370223|NCT04840888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65370224|NCT04840888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65370225|NCT04840888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65370226|NCT04840888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370227|NCT04840888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370228|NCT04840888|Antifungal Agents|antifungal agents|mesh-ancestor
65370229|NCT04840888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65370252|NCT00755807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65370253|NCT00755807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65370254|NCT00755807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370255|NCT00755807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65370256|NCT00755807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370257|NCT00755807|Analgesics|analgesics|mesh-ancestor
65370258|NCT00755807|Sensory System Agents|sensory system agents|mesh-ancestor
65370259|NCT00755807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370260|NCT00755807|Antidepressive Agents|antidepressive agents|mesh-ancestor
65370261|NCT00755807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65370262|NCT00755807|Dopamine Agents|dopamine agents|mesh-ancestor
65370263|NCT05372224|Cholecalciferol|cholecalciferol|mesh-list
65370265|NCT05372224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65370266|NCT05372224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370267|NCT05372224|Vitamins|vitamins|mesh-ancestor
65120090|NCT03533283|Atezolizumab|atezolizumab|mesh-list
65370268|NCT05372224|Micronutrients|micronutrients|mesh-ancestor
65370269|NCT05372224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65370270|NCT00631410|Sunitinib|sunitinib|mesh-list
65370271|NCT00631410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65370272|NCT00631410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65370273|NCT00631410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65370274|NCT00631410|Growth Substances|growth substances|mesh-ancestor
65370275|NCT00631410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370276|NCT00631410|Growth Inhibitors|growth inhibitors|mesh-ancestor
65370309|NCT00823290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370310|NCT00823290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65370312|NCT00755417|Analgesics|analgesics|mesh-ancestor
65273715|NCT04211298|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65273716|NCT04211298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64390464|NCT03194165|Darunavir|darunavir|mesh-list
65370313|NCT00755417|Sensory System Agents|sensory system agents|mesh-ancestor
65370314|NCT00755417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370315|NCT00755417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370316|NCT00755417|Anticonvulsants|anticonvulsants|mesh-ancestor
65370317|NCT00755417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65370318|NCT00755417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65370342|NCT00825864|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65370344|NCT00825864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65370345|NCT00825864|Antiemetics|antiemetics|mesh-ancestor
65370346|NCT00825864|Autonomic Agents|autonomic agents|mesh-ancestor
65370347|NCT00825864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370348|NCT00825864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370349|NCT00825864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65370350|NCT00825864|Glucocorticoids|glucocorticoids|mesh-ancestor
65370351|NCT00825864|Hormones|hormones|mesh-ancestor
65370352|NCT00825864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65370353|NCT00825864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65370354|NCT00825864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65370355|NCT00825864|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65370356|NCT00825864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65370357|NCT00825864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65370358|NCT00825864|Analgesics|analgesics|mesh-ancestor
65370359|NCT00825864|Sensory System Agents|sensory system agents|mesh-ancestor
65370360|NCT00825864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65370361|NCT00825864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65370362|NCT00825864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370363|NCT00825864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370364|NCT00825864|Protease Inhibitors|protease inhibitors|mesh-ancestor
65370365|NCT00825942|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65370366|NCT00825942|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65370367|NCT00527332|Fentanyl|fentanyl|mesh-list
65370397|NCT00820326|Antiemetics|antiemetics|mesh-ancestor
65370398|NCT00820326|Autonomic Agents|autonomic agents|mesh-ancestor
65370399|NCT00820326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370400|NCT00820326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370401|NCT00820326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65370402|NCT00820326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65370403|NCT00820326|Serotonin Agents|serotonin agents|mesh-ancestor
65370404|NCT00820326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65370405|NCT00820326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370406|NCT00916097|Docetaxel|docetaxel|mesh-list
65370407|NCT00916097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65370408|NCT00916097|Tubulin Modulators|tubulin modulators|mesh-ancestor
65370409|NCT00916097|Antimitotic Agents|antimitotic agents|mesh-ancestor
65370410|NCT00916097|Mitosis Modulators|mitosis modulators|mesh-ancestor
65370411|NCT00916097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370412|NCT00629772|Infliximab|infliximab|mesh-list
65370413|NCT00629772|Dermatologic Agents|dermatologic agents|mesh-ancestor
65370414|NCT00629772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65370439|NCT00826254|Vitamins|vitamins|mesh-list
65370440|NCT00826254|Vitamin K|vitamin k|mesh-list
65370441|NCT00826254|Micronutrients|micronutrients|mesh-ancestor
65370442|NCT00826254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370443|NCT00826254|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65370444|NCT00826254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65370445|NCT00826254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370446|NCT00826254|Hemostatics|hemostatics|mesh-ancestor
65370447|NCT00826254|Coagulants|coagulants|mesh-ancestor
65370448|NCT03875482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65370449|NCT03875482|Immunologic Factors|immunologic factors|mesh-ancestor
65370450|NCT03875482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370451|NCT00820404|BLI-489|bli-489|mesh-list
65370452|NCT00820404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65370453|NCT00820404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370454|NCT00820404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370455|NCT00820404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65370456|NCT00820404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65370457|NCT00820482|Menotropins|menotropins|mesh-list
65370458|NCT00820482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65370459|NCT00820482|Fertility Agents|fertility agents|mesh-ancestor
64390623|NCT02423863|Interferon Inducers|interferon inducers|mesh-ancestor
64390624|NCT02423863|Immunologic Factors|immunologic factors|mesh-ancestor
65370460|NCT00820482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65370461|NCT00820482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370462|NCT00754793|Dexetimide|dexetimide|mesh-list
65370463|NCT00754793|Citalopram|citalopram|mesh-list
65370464|NCT00754793|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65370477|NCT00754793|Autonomic Agents|autonomic agents|mesh-ancestor
65370478|NCT00754793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370479|NCT00754793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65370480|NCT00754793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65370481|NCT00754793|Cholinergic Agents|cholinergic agents|mesh-ancestor
65370482|NCT00826566|Caffeine|caffeine|mesh-list
65370483|NCT00826566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65370484|NCT00826566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370485|NCT00826566|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65370486|NCT00826566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370487|NCT00826566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370488|NCT00826566|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65370489|NCT00826566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65370490|NCT00826566|Purinergic Agents|purinergic agents|mesh-ancestor
65370491|NCT00826566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65370492|NCT03999190|Raclopride|raclopride|mesh-list
65370493|NCT03999190|Dextroamphetamine|dextroamphetamine|mesh-list
65370494|NCT03999190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65370495|NCT03999190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370496|NCT03999190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65370497|NCT03999190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65370498|NCT03999190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65370499|NCT03999190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370500|NCT03999190|Dopamine Agents|dopamine agents|mesh-ancestor
65370501|NCT03999190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65370502|NCT03999190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65370503|NCT03999190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65370504|NCT03999190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65370505|NCT03999190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65370506|NCT03999190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65370507|NCT05244694|Insulin|insulin|mesh-list
65370508|NCT05244694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65370509|NCT05244694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370510|NCT00626028|Nitric Oxide|nitric oxide|mesh-list
65370511|NCT00626028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65370512|NCT00626028|Autonomic Agents|autonomic agents|mesh-ancestor
65370513|NCT00626028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370514|NCT00626028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370515|NCT00626028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65370516|NCT00626028|Respiratory System Agents|respiratory system agents|mesh-ancestor
65370517|NCT00626028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65370518|NCT00626028|Antioxidants|antioxidants|mesh-ancestor
65370519|NCT00626028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370520|NCT00626028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65370521|NCT00626028|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65370522|NCT00626028|Vasodilator Agents|vasodilator agents|mesh-ancestor
65370523|NCT00626028|Gasotransmitters|gasotransmitters|mesh-ancestor
65370524|NCT00626028|Protective Agents|protective agents|mesh-ancestor
65370543|NCT05198050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65370545|NCT05198050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65370546|NCT05198050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370547|NCT05198050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370548|NCT05198050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65370549|NCT05198050|Hormone Antagonists|hormone antagonists|mesh-ancestor
65370550|NCT05198050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65370551|NCT05198050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370552|NCT05198050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65370553|NCT05198050|Abortifacient Agents|abortifacient agents|mesh-ancestor
65370554|NCT05198050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65370555|NCT05198050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65370556|NCT05198050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65370557|NCT05198050|Oxytocics|oxytocics|mesh-ancestor
65370558|NCT05198050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65370559|NCT05198050|Vasodilator Agents|vasodilator agents|mesh-ancestor
65273717|NCT04211298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65273718|NCT04211298|Adrenergic Agents|adrenergic agents|mesh-ancestor
65370560|NCT05198050|Urological Agents|urological agents|mesh-ancestor
65370561|NCT00820794|Lithium Carbonate|lithium carbonate|mesh-list
65370562|NCT00820794|Antidepressive Agents|antidepressive agents|mesh-ancestor
65370563|NCT00820794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65370564|NCT00820794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370565|NCT00820794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370566|NCT00820794|Antimanic Agents|antimanic agents|mesh-ancestor
65370567|NCT00820794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65370568|NCT00820794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65370569|NCT00820794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370570|NCT04044378|Ifosfamide|ifosfamide|mesh-list
65370571|NCT04044378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65370572|NCT04044378|Alkylating Agents|alkylating agents|mesh-ancestor
65370573|NCT04044378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370574|NCT04044378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65370575|NCT00628758|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65370576|NCT00628758|Formoterol Fumarate|formoterol fumarate|mesh-list
65370577|NCT00628758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65370578|NCT00628758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65370579|NCT00628758|Respiratory System Agents|respiratory system agents|mesh-ancestor
65370580|NCT00628758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65370581|NCT00628758|Autonomic Agents|autonomic agents|mesh-ancestor
65370605|NCT00525148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370606|NCT00525148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370608|NCT00754325|Fulvestrant|fulvestrant|mesh-list
65370609|NCT00754325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65370610|NCT00754325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65370611|NCT00754325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370612|NCT00754325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370613|NCT00754325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65370614|NCT00754325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65370615|NCT00754325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65370616|NCT00754325|Hormone Antagonists|hormone antagonists|mesh-ancestor
65370617|NCT00754325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65370618|NCT00754325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370619|NCT00524680|Cholecalciferol|cholecalciferol|mesh-list
65370620|NCT00524680|Vitamin D|vitamin d|mesh-list
65370621|NCT00524680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65370622|NCT00524680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370623|NCT00524680|Vitamins|vitamins|mesh-ancestor
65370624|NCT00524680|Micronutrients|micronutrients|mesh-ancestor
65370625|NCT00524680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65370626|NCT00298363|Tenofovir|tenofovir|mesh-list
65370627|NCT00298363|Emtricitabine|emtricitabine|mesh-list
65370628|NCT00298363|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65370629|NCT00298363|Entecavir|entecavir|mesh-list
65370630|NCT00298363|Antiviral Agents|antiviral agents|mesh-ancestor
65370631|NCT00298363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65370689|NCT00830856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65370690|NCT00830856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65370691|NCT00830856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65370692|NCT00830856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65370693|NCT00830856|Antimetabolites|antimetabolites|mesh-ancestor
65370694|NCT01068067|Tacrolimus|tacrolimus|mesh-list
65370695|NCT01068067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65370696|NCT01068067|Immunologic Factors|immunologic factors|mesh-ancestor
65370697|NCT01068067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370698|NCT01068067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65370699|NCT01068067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370700|NCT01068067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370701|NCT00524134|Carvedilol|carvedilol|mesh-list
65370702|NCT00524134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65370703|NCT00524134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65370704|NCT00524134|Adrenergic Agents|adrenergic agents|mesh-ancestor
65370705|NCT00524134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65370706|NCT00524134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370707|NCT00524134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370708|NCT00524134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65273719|NCT04211298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65273720|NCT04211298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273721|NCT04212702|Everolimus|everolimus|mesh-list
65273722|NCT04212702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273723|NCT04212702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65273724|NCT04212702|Immunologic Factors|immunologic factors|mesh-ancestor
65273725|NCT04212702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273726|NCT02691780|Sorafenib|sorafenib|mesh-list
65273727|NCT02691780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273728|NCT02691780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65370709|NCT00524134|Antioxidants|antioxidants|mesh-ancestor
65370710|NCT00524134|Protective Agents|protective agents|mesh-ancestor
64763046|NCT01250496|Aminophylline|aminophylline|mesh-list
65370720|NCT00777023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370721|NCT00777023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370722|NCT00777023|Anticonvulsants|anticonvulsants|mesh-ancestor
65370723|NCT00777023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65370724|NCT00777023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65370725|NCT00777023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65370726|NCT00777023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65370727|NCT00777023|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65370728|NCT00777023|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65370729|NCT00777023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65370730|NCT00777023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370731|NCT00777023|Antimanic Agents|antimanic agents|mesh-ancestor
65370732|NCT05062330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65370733|NCT05062330|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65370734|NCT00297037|Pimecrolimus|pimecrolimus|mesh-list
65370735|NCT00297037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65370736|NCT00297037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65370737|NCT00297037|Analgesics|analgesics|mesh-ancestor
65370738|NCT00297037|Sensory System Agents|sensory system agents|mesh-ancestor
65370739|NCT00297037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370740|NCT00297037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370741|NCT00297037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65370742|NCT00297037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65370743|NCT00297037|Dermatologic Agents|dermatologic agents|mesh-ancestor
65370744|NCT00297037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65370745|NCT00297037|Immunologic Factors|immunologic factors|mesh-ancestor
65370746|NCT00297037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65370747|NCT00297037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370748|NCT00297037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370749|NCT00292981|Complement C1s|complement c1s|mesh-list
65370750|NCT00292981|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
65370751|NCT00292981|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
65370752|NCT00292981|Immunologic Factors|immunologic factors|mesh-ancestor
65370753|NCT00292981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370754|NCT00292981|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65370755|NCT00292981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65370756|NCT02598869|Triamcinolone|triamcinolone|mesh-list
65370757|NCT02598869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65370758|NCT02598869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65370759|NCT02598869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65370760|NCT02598869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65370761|NCT02598869|Glucocorticoids|glucocorticoids|mesh-ancestor
65370762|NCT02598869|Hormones|hormones|mesh-ancestor
65370763|NCT02598869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65370764|NCT02598869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370765|NCT02598869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65370766|NCT02598869|Immunologic Factors|immunologic factors|mesh-ancestor
65370767|NCT02598869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370768|NCT02598869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370769|NCT04095455|Ketamine|ketamine|mesh-list
65370770|NCT04095455|Analgesics|analgesics|mesh-ancestor
65273729|NCT02691780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370771|NCT04095455|Sensory System Agents|sensory system agents|mesh-ancestor
65370772|NCT04095455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370773|NCT04095455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370774|NCT04095455|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65370775|NCT04095455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65370776|NCT04095455|Anesthetics, General|anesthetics, general|mesh-ancestor
65370799|NCT00296725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65370800|NCT00296725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65370801|NCT00296725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65370802|NCT00296725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370803|NCT00296725|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65370804|NCT00296725|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65370805|NCT00296725|Adrenergic Agents|adrenergic agents|mesh-ancestor
65370807|NCT00523978|Flecainide|flecainide|mesh-list
65370808|NCT00523978|Propafenone|propafenone|mesh-list
65370809|NCT00523978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65370810|NCT00523978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65370811|NCT00523978|Adrenergic Agents|adrenergic agents|mesh-ancestor
65370812|NCT00523978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65370813|NCT00523978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370814|NCT00523978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370815|NCT00523978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65370816|NCT00523978|Sympatholytics|sympatholytics|mesh-ancestor
65370817|NCT00523978|Autonomic Agents|autonomic agents|mesh-ancestor
65370818|NCT00523978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370819|NCT00523978|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65370820|NCT00523978|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65370821|NCT00523978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65370822|NCT00296647|Bupropion|bupropion|mesh-list
65370823|NCT00296647|Nicotine|nicotine|mesh-list
65370824|NCT00296647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65370825|NCT00296647|Autonomic Agents|autonomic agents|mesh-ancestor
65370851|NCT00523744|Amlodipine|amlodipine|mesh-list
65370852|NCT00523744|Valsartan|valsartan|mesh-list
65370853|NCT00523744|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65370854|NCT00523744|Olmesartan|olmesartan|mesh-list
65370855|NCT00523744|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65370856|NCT00523744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65370857|NCT00523744|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65370858|NCT00523744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65370859|NCT00523744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370860|NCT00523744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65370861|NCT00523744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370862|NCT00523744|Vasodilator Agents|vasodilator agents|mesh-ancestor
65370863|NCT00523744|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65370864|NCT00523744|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65370865|NCT00523744|Diuretics|diuretics|mesh-ancestor
65370866|NCT00523744|Natriuretic Agents|natriuretic agents|mesh-ancestor
65370867|NCT00523744|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65370868|NCT03979625|Heparin|heparin|mesh-list
65370869|NCT03979625|Antibodies|antibodies|mesh-list
65370870|NCT03979625|Immunologic Factors|immunologic factors|mesh-ancestor
65370871|NCT03979625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370872|NCT03979625|Anticoagulants|anticoagulants|mesh-ancestor
65370875|NCT03979625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370876|NCT02548494|Insulin|insulin|mesh-list
65370877|NCT02548494|Insulin Glargine|insulin glargine|mesh-list
65370878|NCT02548494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65370879|NCT02548494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370880|NCT00752219|Metronidazole|metronidazole|mesh-list
65370881|NCT00752219|Meropenem|meropenem|mesh-list
65370882|NCT00752219|Ceftazidime|ceftazidime|mesh-list
65370883|NCT00752219|Avibactam|avibactam|mesh-list
65370884|NCT00752219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65370885|NCT00752219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65370886|NCT00752219|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65370887|NCT00752219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65370888|NCT00752219|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65370889|NCT00752219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370890|NCT00752219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370891|NCT02598791|Glucagon|glucagon|mesh-list
65370892|NCT02598791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65370893|NCT02598791|Incretins|incretins|mesh-ancestor
65370894|NCT02598791|Hormones|hormones|mesh-ancestor
65273730|NCT02691780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471762|NCT04140396|Lidocaine|lidocaine|mesh-list
65370895|NCT02598791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65370896|NCT02598791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370897|NCT02598791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65370898|NCT00827346|Clopidogrel|clopidogrel|mesh-list
65370899|NCT00827346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65370900|NCT00827346|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65370901|NCT00827346|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65370902|NCT00827346|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65370903|NCT00827346|Purinergic Agents|purinergic agents|mesh-ancestor
65370904|NCT00827346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65370905|NCT00827346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370906|NCT00827346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370907|NCT00997750|Lornoxicam|lornoxicam|mesh-list
65370908|NCT00997750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65370909|NCT00997750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65370910|NCT00997750|Analgesics|analgesics|mesh-ancestor
65370911|NCT00997750|Sensory System Agents|sensory system agents|mesh-ancestor
65370912|NCT00997750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370913|NCT00997750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370914|NCT00997750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65370915|NCT00997750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65370916|NCT00622908|Besifloxacin|besifloxacin|mesh-list
65370917|NCT00622908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65370918|NCT00622908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65370919|NCT00622908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65370920|NCT00622908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65370921|NCT00622908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370922|NCT00622908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370923|NCT00622908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65370924|NCT00997828|Everolimus|everolimus|mesh-list
65370925|NCT00997828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65370926|NCT00997828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65370927|NCT00997828|Immunologic Factors|immunologic factors|mesh-ancestor
65370928|NCT00997828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370929|NCT02598635|Cholecalciferol|cholecalciferol|mesh-list
65370930|NCT02598635|Vitamin D|vitamin d|mesh-list
65370931|NCT02598635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65370932|NCT02598635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120735|NCT00547001|Estradiol|estradiol|mesh-list
65370933|NCT02598635|Vitamins|vitamins|mesh-ancestor
65370934|NCT02598635|Micronutrients|micronutrients|mesh-ancestor
65370935|NCT02598635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65370936|NCT04093271|Diphenhydramine|diphenhydramine|mesh-list
65370937|NCT04093271|Promethazine|promethazine|mesh-list
65370938|NCT04093271|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65370939|NCT04093271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65370940|NCT04093271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65370941|NCT04093271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370942|NCT04093271|Anesthetics, Local|anesthetics, local|mesh-ancestor
65370943|NCT04093271|Anesthetics|anesthetics|mesh-ancestor
65370944|NCT04093271|Sensory System Agents|sensory system agents|mesh-ancestor
65370945|NCT04093271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370973|NCT04094909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370974|NCT04094909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65370975|NCT04094909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65370976|NCT04094909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65370977|NCT04094909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65370978|NCT04094909|Growth Substances|growth substances|mesh-ancestor
65370979|NCT04094909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370980|NCT04094909|Growth Inhibitors|growth inhibitors|mesh-ancestor
65370981|NCT02599571|Nicotine|nicotine|mesh-list
65370982|NCT02599571|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65370983|NCT02599571|Autonomic Agents|autonomic agents|mesh-ancestor
65370984|NCT02599571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370985|NCT02599571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370986|NCT02599571|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65370987|NCT02599571|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65370988|NCT02599571|Cholinergic Agents|cholinergic agents|mesh-ancestor
65370989|NCT02599571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65273731|NCT01352520|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65273732|NCT01352520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65273733|NCT01352520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273734|NCT04485546|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65273735|NCT04485546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65273736|NCT02845661|Dexmedetomidine|dexmedetomidine|mesh-list
65273737|NCT02845661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65273738|NCT02845661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65273739|NCT02845661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273740|NCT02845661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65273741|NCT02845661|Analgesics|analgesics|mesh-ancestor
65273742|NCT02845661|Sensory System Agents|sensory system agents|mesh-ancestor
64471763|NCT04140396|Anesthetics, Local|anesthetics, local|mesh-ancestor
64391563|NCT02412085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391564|NCT01679405|Gemcitabine|gemcitabine|mesh-list
64391565|NCT01679405|Cisplatin|cisplatin|mesh-list
65370990|NCT02599571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370991|NCT00296491|Fluticasone|fluticasone|mesh-list
65370992|NCT00296491|Xhance|xhance|mesh-list
65370993|NCT00296491|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65370994|NCT00296491|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65370995|NCT00296491|Montelukast|montelukast|mesh-list
65371023|NCT02599493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65371024|NCT02599493|Antitubercular Agents|antitubercular agents|mesh-ancestor
65371025|NCT02599493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65371026|NCT02599493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65371027|NCT02599493|Leprostatic Agents|leprostatic agents|mesh-ancestor
65371028|NCT02599493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65371029|NCT02599493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371030|NCT02599493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371031|NCT02599493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65371032|NCT02599493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65371033|NCT02599493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65371034|NCT02599493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65371035|NCT02599493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65371036|NCT02599493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65371037|NCT04092725|Ibrexafungerp|ibrexafungerp|mesh-list
65371038|NCT04092725|Antifungal Agents|antifungal agents|mesh-ancestor
65371039|NCT04092725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65371040|NCT00296335|Mitomycins|mitomycins|mesh-list
65371041|NCT00296335|Mitomycin|mitomycin|mesh-list
65371042|NCT00296335|Doxifluridine|doxifluridine|mesh-list
65371067|NCT01065961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65371068|NCT01065961|Glucocorticoids|glucocorticoids|mesh-ancestor
65371069|NCT01065961|Hormones|hormones|mesh-ancestor
65371070|NCT01065961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65371071|NCT01065961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65371072|NCT01065961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371073|NCT01065961|Protease Inhibitors|protease inhibitors|mesh-ancestor
65371074|NCT01065961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371075|NCT01065961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371076|NCT01068223|Cetirizine|cetirizine|mesh-list
65371077|NCT01068223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65371078|NCT01068223|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65371079|NCT01068223|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65371080|NCT01068223|Histamine Antagonists|histamine antagonists|mesh-ancestor
65371081|NCT01068223|Histamine Agents|histamine agents|mesh-ancestor
65371082|NCT01068223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65120866|NCT00548678|Aspirin|aspirin|mesh-list
64489888|NCT01696214|Xhance|xhance|mesh-list
64391680|NCT05093231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391681|NCT05093231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391682|NCT02411149|Epinephrine|epinephrine|mesh-list
64391683|NCT02411149|Racepinephrine|racepinephrine|mesh-list
64391684|NCT02411149|Morphine|morphine|mesh-list
64391718|NCT04413227|Growth Substances|growth substances|mesh-ancestor
65371083|NCT01068223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371084|NCT01068223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371086|NCT04234360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65371087|NCT04234360|Glucocorticoids|glucocorticoids|mesh-ancestor
65371088|NCT04234360|Hormones|hormones|mesh-ancestor
65371089|NCT04234360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65371090|NCT04234360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371091|NCT04234360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65371092|NCT04234360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371120|NCT04219774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65371121|NCT04219774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65371122|NCT04219774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65371123|NCT04219774|Purinergic Agents|purinergic agents|mesh-ancestor
65371124|NCT04219774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65371125|NCT04187872|Pembrolizumab|pembrolizumab|mesh-list
65371126|NCT04187872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65371127|NCT04187872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371128|NCT01068301|Plerixafor|plerixafor|mesh-list
65371129|NCT01068301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65371130|NCT01068301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65371131|NCT01068301|Antiviral Agents|antiviral agents|mesh-ancestor
65371132|NCT01068301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65371133|NCT04999228|Mesalamine|mesalamine|mesh-list
65371134|NCT04999228|Infliximab|infliximab|mesh-list
65371135|NCT04999228|Dermatologic Agents|dermatologic agents|mesh-ancestor
65371136|NCT04999228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65371137|NCT04999228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65371138|NCT04999228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65371139|NCT04999228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65371140|NCT04999228|Analgesics|analgesics|mesh-ancestor
65371171|NCT00624780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371172|NCT00624780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65371174|NCT00624780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65371175|NCT00624780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65371176|NCT00624780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65371177|NCT00624780|Antiemetics|antiemetics|mesh-ancestor
65371178|NCT00624780|Autonomic Agents|autonomic agents|mesh-ancestor
65371179|NCT00624780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65371180|NCT00624780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65371181|NCT00624780|GABA Modulators|gaba modulators|mesh-ancestor
65371182|NCT00624780|GABA Agents|gaba agents|mesh-ancestor
65371183|NCT00624780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65371184|NCT02599337|Sorafenib|sorafenib|mesh-list
65371205|NCT00750737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65371206|NCT00750737|Antifungal Agents|antifungal agents|mesh-ancestor
65371207|NCT00750737|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65371208|NCT00750737|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65371209|NCT00750737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65371210|NCT00750737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371211|NCT00750737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371212|NCT00750737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65371213|NCT00750737|Hormone Antagonists|hormone antagonists|mesh-ancestor
65371214|NCT00750737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65371215|NCT00750737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371216|NCT04093505|Gemtuzumab|gemtuzumab|mesh-list
65371217|NCT04093505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65371218|NCT04093505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371219|NCT00831714|Rivaroxaban|rivaroxaban|mesh-list
65371220|NCT00831714|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65371221|NCT00831714|Antithrombins|antithrombins|mesh-ancestor
65371222|NCT00831714|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65371223|NCT00831714|Protease Inhibitors|protease inhibitors|mesh-ancestor
65273743|NCT02845661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65273744|NCT02845661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65273745|NCT02845661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65273746|NCT02845661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65273747|NCT02845661|Adrenergic Agents|adrenergic agents|mesh-ancestor
65273748|NCT02845661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65371224|NCT00831714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371225|NCT00831714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371226|NCT00831714|Anticoagulants|anticoagulants|mesh-ancestor
65371227|NCT02597699|Lidocaine|lidocaine|mesh-list
65371228|NCT02597699|Sufentanil|sufentanil|mesh-list
65371229|NCT02597699|Remifentanil|remifentanil|mesh-list
65371230|NCT02597699|Dsuvia|dsuvia|mesh-list
65371231|NCT02597699|Anesthetics, Local|anesthetics, local|mesh-ancestor
65371232|NCT02597699|Anesthetics|anesthetics|mesh-ancestor
65371233|NCT02597699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65371234|NCT02597699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371235|NCT02597699|Sensory System Agents|sensory system agents|mesh-ancestor
65371236|NCT02597699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65371237|NCT02597699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65371238|NCT02597699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64763569|NCT04357002|Tranexamic Acid|tranexamic acid|mesh-list
65371263|NCT00998218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371264|NCT00825396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65371265|NCT00825396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65371266|NCT00311311|Mycophenolic Acid|mycophenolic acid|mesh-list
65371267|NCT00311311|Sirolimus|sirolimus|mesh-list
65371268|NCT00311311|Prednisone|prednisone|mesh-list
65371269|NCT00311311|Tacrolimus|tacrolimus|mesh-list
65371270|NCT00311311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65371271|NCT00311311|Glucocorticoids|glucocorticoids|mesh-ancestor
65371272|NCT00311311|Hormones|hormones|mesh-ancestor
65371273|NCT00311311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65371274|NCT00311311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371275|NCT00311311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65371276|NCT00311311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371277|NCT00311311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65371278|NCT00311311|Immunologic Factors|immunologic factors|mesh-ancestor
65371279|NCT00311311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65371280|NCT00311311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371281|NCT00311311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371282|NCT00311311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65371283|NCT00311311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65371284|NCT00311311|Antitubercular Agents|antitubercular agents|mesh-ancestor
65371285|NCT00311311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65371286|NCT00311311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65371316|NCT00521404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371318|NCT00521404|Antiviral Agents|antiviral agents|mesh-ancestor
65371319|NCT00521404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65371320|NCT00521404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371321|NCT00521404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65371322|NCT00311155|Amlodipine|amlodipine|mesh-list
65371323|NCT00311155|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65371324|NCT00311155|Olmesartan|olmesartan|mesh-list
65371325|NCT00311155|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65371326|NCT00311155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65371327|NCT00311155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65371328|NCT00311155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65371329|NCT00311155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371330|NCT00311155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65371331|NCT00311155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371332|NCT00311155|Vasodilator Agents|vasodilator agents|mesh-ancestor
65371333|NCT00311155|Diuretics|diuretics|mesh-ancestor
65371352|NCT00274651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371353|NCT00274261|Nonoxynol|nonoxynol|mesh-list
65371354|NCT00274261|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
65371355|NCT00274261|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
65371356|NCT00274261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273749|NCT02845661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273750|NCT04375787|Atorvastatin|atorvastatin|mesh-list
65273751|NCT04375787|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65273752|NCT04375787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65273753|NCT04375787|Antimetabolites|antimetabolites|mesh-ancestor
65273754|NCT04375787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371357|NCT00274261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65371358|NCT00274261|Contraceptive Agents|contraceptive agents|mesh-ancestor
65371359|NCT00274261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65371360|NCT00274261|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65371361|NCT02367040|Rituximab|rituximab|mesh-list
65371362|NCT02367040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65371363|NCT02367040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371364|NCT02367040|Immunologic Factors|immunologic factors|mesh-ancestor
65371365|NCT02367040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371366|NCT02367040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65371367|NCT00827814|Dutasteride|dutasteride|mesh-list
65371368|NCT00827814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65371369|NCT00827814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65371370|NCT00827814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371371|NCT00827814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371372|NCT00827814|Hormone Antagonists|hormone antagonists|mesh-ancestor
65371373|NCT00827814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65371374|NCT00827814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371375|NCT01068847|Cycloserine|cycloserine|mesh-list
65371376|NCT01068847|Verapamil|verapamil|mesh-list
65371377|NCT01068847|Nifedipine|nifedipine|mesh-list
65371378|NCT01068847|Tizanidine|tizanidine|mesh-list
65371379|NCT01068847|Naloxone|naloxone|mesh-list
65371380|NCT01068847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65371381|NCT01068847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371382|NCT01068847|Sensory System Agents|sensory system agents|mesh-ancestor
65371383|NCT01068847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65371384|NCT01068847|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65371385|NCT01068847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65371386|NCT01068847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371387|NCT01068847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65371388|NCT01068847|Vasodilator Agents|vasodilator agents|mesh-ancestor
65371416|NCT01070875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65371417|NCT01070875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65371418|NCT01070875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371419|NCT04043676|Ponatinib|ponatinib|mesh-list
65371420|NCT04043676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371421|NCT04043676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65371422|NCT04043676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371423|NCT04043676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371424|NCT01325935|Clopidogrel|clopidogrel|mesh-list
65371425|NCT01325935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65371426|NCT01325935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65371427|NCT01325935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65371428|NCT01325935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65371429|NCT01325935|Purinergic Agents|purinergic agents|mesh-ancestor
65371430|NCT01325935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65371431|NCT01325935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371432|NCT01325935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371433|NCT02549742|Bleomycin|bleomycin|mesh-list
65371434|NCT02549742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65371435|NCT02549742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371436|NCT00521014|Cytarabine|cytarabine|mesh-list
65371437|NCT00521014|Rituximab|rituximab|mesh-list
65371438|NCT00521014|Etoposide|etoposide|mesh-list
65371439|NCT00521014|Melphalan|melphalan|mesh-list
65371440|NCT00521014|Carmustine|carmustine|mesh-list
65371470|NCT00825552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65371471|NCT00825552|Dopamine Agents|dopamine agents|mesh-ancestor
65371472|NCT00291577|Docetaxel|docetaxel|mesh-list
65371473|NCT00291577|Sunitinib|sunitinib|mesh-list
65371474|NCT00291577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371475|NCT00291577|Tubulin Modulators|tubulin modulators|mesh-ancestor
65273755|NCT04375787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65273756|NCT04375787|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65273757|NCT04375787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273758|NCT00825630|Esomeprazole|esomeprazole|mesh-list
65273759|NCT00825630|Pantoprazole|pantoprazole|mesh-list
65273760|NCT00825630|Lansoprazole|lansoprazole|mesh-list
65273761|NCT00825630|Dexlansoprazole|dexlansoprazole|mesh-list
65273762|NCT00825630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65273763|NCT00825630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65273764|NCT00825630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65273765|NCT00825630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273766|NCT00825630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273767|NCT00620100|Docetaxel|docetaxel|mesh-list
65273768|NCT00620100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273769|NCT00620100|Tubulin Modulators|tubulin modulators|mesh-ancestor
65273770|NCT00620100|Antimitotic Agents|antimitotic agents|mesh-ancestor
65273771|NCT00620100|Mitosis Modulators|mitosis modulators|mesh-ancestor
65273772|NCT00620100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371476|NCT00291577|Antimitotic Agents|antimitotic agents|mesh-ancestor
65371477|NCT00291577|Mitosis Modulators|mitosis modulators|mesh-ancestor
65371478|NCT00291577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371479|NCT00291577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65371480|NCT00291577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65371481|NCT00291577|Growth Substances|growth substances|mesh-ancestor
65371482|NCT00291577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371483|NCT00291577|Growth Inhibitors|growth inhibitors|mesh-ancestor
64763847|NCT04342728|Zinc|zinc|mesh-list
65371512|NCT00943839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65371513|NCT00943839|Growth Substances|growth substances|mesh-ancestor
65371514|NCT00943839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371515|NCT00943839|Growth Inhibitors|growth inhibitors|mesh-ancestor
65371516|NCT00943839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65371517|NCT00943839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371518|NCT00943839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371519|NCT00832182|Insulin|insulin|mesh-list
65371520|NCT00832182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65371521|NCT00832182|Insulin Aspart|insulin aspart|mesh-list
65371522|NCT00832182|Isophane Insulin, Human|isophane insulin, human|mesh-list
65371523|NCT00832182|Insulin, Isophane|insulin, isophane|mesh-list
65371524|NCT00832182|Isophane insulin, beef|isophane insulin, beef|mesh-list
65371525|NCT00832182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65371526|NCT00832182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371527|NCT00952497|Capecitabine|capecitabine|mesh-list
65371528|NCT00952497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371529|NCT00952497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65371559|NCT00944307|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
65371562|NCT00944307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65371563|NCT00944307|Antiviral Agents|antiviral agents|mesh-ancestor
65371564|NCT00944307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65371565|NCT00944307|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65371566|NCT00944307|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65371567|NCT00944307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371568|NCT00944307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371569|NCT00944307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65371570|NCT00944307|Antioxidants|antioxidants|mesh-ancestor
65273773|NCT02845349|Vortioxetine|vortioxetine|mesh-list
65273774|NCT02845349|Antidepressive Agents|antidepressive agents|mesh-ancestor
65273775|NCT02845349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65273776|NCT02845349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65273777|NCT02845349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65273778|NCT02845349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65273779|NCT02845349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371571|NCT00944307|Protective Agents|protective agents|mesh-ancestor
65371572|NCT00944307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371573|NCT00944385|Urinastatin|urinastatin|mesh-list
65371574|NCT00944385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65371606|NCT05300373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65371607|NCT05300373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371608|NCT05300373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65371609|NCT05300373|Vasodilator Agents|vasodilator agents|mesh-ancestor
65371610|NCT05300373|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65371611|NCT05300373|Purinergic Agonists|purinergic agonists|mesh-ancestor
65371612|NCT05300373|Purinergic Agents|purinergic agents|mesh-ancestor
65371613|NCT05300373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65371614|NCT05300373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371615|NCT00953589|Ribavirin|ribavirin|mesh-list
65371616|NCT00953589|Antimetabolites|antimetabolites|mesh-ancestor
64763968|NCT04338438|Apatinib|apatinib|mesh-list
65371677|NCT00623766|Respiratory System Agents|respiratory system agents|mesh-ancestor
65371678|NCT00832494|Paclitaxel|paclitaxel|mesh-list
65371679|NCT00832494|Carboplatin|carboplatin|mesh-list
65371680|NCT00832494|Vadimezan|vadimezan|mesh-list
65371681|NCT00832494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65371682|NCT00832494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371683|NCT00832494|Tubulin Modulators|tubulin modulators|mesh-ancestor
65371684|NCT00832494|Antimitotic Agents|antimitotic agents|mesh-ancestor
65371685|NCT00832494|Mitosis Modulators|mitosis modulators|mesh-ancestor
65371686|NCT00832494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371687|NCT00837564|Citalopram|citalopram|mesh-list
65371688|NCT00837564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65371689|NCT00837564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65371690|NCT00837564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65371691|NCT00837564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371692|NCT00837564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65371693|NCT00837564|Serotonin Agents|serotonin agents|mesh-ancestor
65371694|NCT00837564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371695|NCT00837564|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65371696|NCT00837564|Antidepressive Agents|antidepressive agents|mesh-ancestor
65371697|NCT00837564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65371698|NCT00954135|Cyclophosphamide|cyclophosphamide|mesh-list
65371724|NCT02549118|Tenoxicam|tenoxicam|mesh-list
65371725|NCT02549118|Meperidine|meperidine|mesh-list
65371726|NCT02549118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65371727|NCT02549118|Narcotics|narcotics|mesh-ancestor
65371728|NCT02549118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65371729|NCT02549118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371730|NCT02549118|Analgesics|analgesics|mesh-ancestor
65371731|NCT02549118|Sensory System Agents|sensory system agents|mesh-ancestor
65371732|NCT02549118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65371733|NCT02549118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65371734|NCT02549118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65371735|NCT02549118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65371736|NCT02549118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65371737|NCT02549118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65371738|NCT02549118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65371739|NCT02549118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371740|NCT02549118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371741|NCT00957177|Pregabalin|pregabalin|mesh-list
65371742|NCT00957177|Analgesics|analgesics|mesh-ancestor
65371743|NCT00957177|Sensory System Agents|sensory system agents|mesh-ancestor
65371744|NCT00957177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65371745|NCT00957177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371746|NCT00957177|Anticonvulsants|anticonvulsants|mesh-ancestor
64392489|NCT03847181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64392490|NCT03847181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392491|NCT03847181|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64392492|NCT03847181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64392493|NCT03847181|Hemostatics|hemostatics|mesh-ancestor
64392494|NCT03847181|Coagulants|coagulants|mesh-ancestor
64392495|NCT03477851|Tramadol|tramadol|mesh-list
64392496|NCT03477851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64392497|NCT03477851|Narcotics|narcotics|mesh-ancestor
64392498|NCT03477851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64392499|NCT03477851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371771|NCT00550407|Anticonvulsants|anticonvulsants|mesh-ancestor
65371772|NCT00550407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65371773|NCT00550407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65371774|NCT00550407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371775|NCT00550407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65371776|NCT00550407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371777|NCT00550407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65371778|NCT00550407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65371779|NCT00550407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65371780|NCT00550407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65371781|NCT00550407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65371782|NCT00957411|Cetuximab|cetuximab|mesh-list
65371783|NCT00957411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371784|NCT00957411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65371785|NCT00837954|Cellulose, Oxidized|cellulose, oxidized|mesh-list
65371786|NCT00837954|Hemostatics|hemostatics|mesh-ancestor
65371787|NCT00837954|Coagulants|coagulants|mesh-ancestor
65371788|NCT00954525|Gemcitabine|gemcitabine|mesh-list
65371789|NCT00954525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65371790|NCT00954525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371791|NCT00954525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65371792|NCT00954525|Antimetabolites|antimetabolites|mesh-ancestor
65371793|NCT00954525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371794|NCT00954525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371795|NCT00954525|Antiviral Agents|antiviral agents|mesh-ancestor
65371796|NCT00954525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65371829|NCT00954603|Autonomic Agents|autonomic agents|mesh-ancestor
65371830|NCT00954603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65371831|NCT00954603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65371833|NCT00954603|Dopamine Agents|dopamine agents|mesh-ancestor
65371834|NCT00954603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65371835|NCT00954603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371836|NCT00954603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65371837|NCT00531934|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65371838|NCT00531934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371839|NCT00531934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65371840|NCT00531934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371867|NCT00272779|Antiviral Agents|antiviral agents|mesh-ancestor
65371868|NCT00272779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65371869|NCT00272779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65371870|NCT00272779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65371871|NCT00272779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371872|NCT00272779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371873|NCT00272779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65371874|NCT00272779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65371875|NCT00272779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65371876|NCT00272779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65371877|NCT00272779|Protease Inhibitors|protease inhibitors|mesh-ancestor
65371878|NCT00957879|Calcitriol|calcitriol|mesh-list
65371879|NCT00957879|Ergocalciferols|ergocalciferols|mesh-list
65371880|NCT00957879|Vitamin D|vitamin d|mesh-list
65371881|NCT00957879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65273780|NCT02845349|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65273781|NCT02845349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65371882|NCT00957879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371883|NCT00957879|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65371884|NCT00957879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65371885|NCT00957879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371886|NCT00957879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65371905|NCT04011033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371907|NCT04011033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65371908|NCT04011033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65371909|NCT04011033|Analgesics|analgesics|mesh-ancestor
65371910|NCT04011033|Sensory System Agents|sensory system agents|mesh-ancestor
65371911|NCT04011033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65371912|NCT00998608|Risperidone|risperidone|mesh-list
65371913|NCT00998608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65371914|NCT00998608|Serotonin Agents|serotonin agents|mesh-ancestor
65371915|NCT00998608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65371916|NCT00998608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371917|NCT00998608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371918|NCT00998608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65371919|NCT00998608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65371920|NCT00998608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65371921|NCT00998608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65371922|NCT00998608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65371923|NCT00998608|Dopamine Agents|dopamine agents|mesh-ancestor
65371924|NCT04011813|Antioxidants|antioxidants|mesh-list
65371925|NCT04011813|Hypotaurine|hypotaurine|mesh-list
65371926|NCT04011813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371927|NCT04011813|Protective Agents|protective agents|mesh-ancestor
65371928|NCT04011813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371929|NCT00998686|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65371930|NCT00998686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65371931|NCT00998686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371932|NCT00998686|Incretins|incretins|mesh-ancestor
65371933|NCT00998686|Hormones|hormones|mesh-ancestor
65371934|NCT00998686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65371935|NCT00998686|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65371936|NCT00998686|Protease Inhibitors|protease inhibitors|mesh-ancestor
65371937|NCT00998686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371938|NCT00998686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371939|NCT00958269|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65371940|NCT00958269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65371941|NCT00958269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371975|NCT00834600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65371976|NCT00834600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65371977|NCT00834600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65371978|NCT00834600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371979|NCT00834600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65371980|NCT00834600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371981|NCT00834600|Vasodilator Agents|vasodilator agents|mesh-ancestor
65372018|NCT00829608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372019|NCT00553605|Ketoprofen|ketoprofen|mesh-list
65372020|NCT00553605|Parecoxib|parecoxib|mesh-list
65372021|NCT00553605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65372022|NCT00553605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65372056|NCT05352165|Immunologic Factors|immunologic factors|mesh-ancestor
65372057|NCT05352165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372058|NCT00948987|Aspirin|aspirin|mesh-list
65372059|NCT00948987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65372060|NCT00948987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65372061|NCT00948987|Analgesics|analgesics|mesh-ancestor
65372062|NCT00948987|Sensory System Agents|sensory system agents|mesh-ancestor
64764415|NCT03017430|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65372090|NCT00949065|Immunoglobulins|immunoglobulins|mesh-list
65372091|NCT00949065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65372092|NCT00949065|Antibodies|antibodies|mesh-list
65372093|NCT00949065|gamma-Globulins|gamma-globulins|mesh-list
65372094|NCT00949065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65372095|NCT00949065|Immunologic Factors|immunologic factors|mesh-ancestor
65372096|NCT00949065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372097|NCT00955149|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65273782|NCT02845349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65273783|NCT02845349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273784|NCT02845349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65273785|NCT02845349|Serotonin Agents|serotonin agents|mesh-ancestor
65273786|NCT02845349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65372098|NCT00955149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372099|NCT00955149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65372100|NCT00955149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372101|NCT00955149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372102|NCT05351385|Dimercaprol|dimercaprol|mesh-list
65372103|NCT05351385|Chelating Agents|chelating agents|mesh-ancestor
65372104|NCT05351385|Sequestering Agents|sequestering agents|mesh-ancestor
65372105|NCT05351385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372106|NCT00955227|Ezetimibe|ezetimibe|mesh-list
65372107|NCT00955227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65372108|NCT00955227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65372109|NCT00955227|Antimetabolites|antimetabolites|mesh-ancestor
65372143|NCT00548847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372144|NCT00548847|Antiviral Agents|antiviral agents|mesh-ancestor
65372145|NCT00548847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65372146|NCT00548847|Immunologic Factors|immunologic factors|mesh-ancestor
65372147|NCT00548847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372148|NCT00949377|Bromides|bromides|mesh-list
65372149|NCT00949377|Methylnaltrexone|methylnaltrexone|mesh-list
65372150|NCT00949377|Anticonvulsants|anticonvulsants|mesh-ancestor
65372151|NCT00949377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65372187|NCT00949455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372189|NCT05296161|Immunologic Factors|immunologic factors|mesh-ancestor
65372190|NCT05296161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372223|NCT00622284|Glimepiride|glimepiride|mesh-list
65372224|NCT00622284|Linagliptin|linagliptin|mesh-list
65372225|NCT00622284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65372226|NCT00622284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65372227|NCT00622284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372228|NCT00622284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65372229|NCT00622284|Immunologic Factors|immunologic factors|mesh-ancestor
65372230|NCT00622284|Incretins|incretins|mesh-ancestor
65372231|NCT00622284|Hormones|hormones|mesh-ancestor
65372232|NCT00622284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65372265|NCT01325779|Anticoagulants|anticoagulants|mesh-ancestor
65372266|NCT01325779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65372267|NCT01325779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65372268|NCT01325779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372269|NCT00956163|Diphosphonates|diphosphonates|mesh-list
65372270|NCT00956163|Methylene diphosphonate|methylene diphosphonate|mesh-list
65372271|NCT00956163|Listerine|listerine|mesh-list
65372272|NCT00956163|Fluorides|fluorides|mesh-list
65372273|NCT00956163|Sodium Fluoride|sodium fluoride|mesh-list
65372274|NCT00956163|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
65372298|NCT00956319|GABA Modulators|gaba modulators|mesh-ancestor
65372299|NCT00835848|Exenatide|exenatide|mesh-list
65372300|NCT00835848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65372301|NCT00835848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372302|NCT00835848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65372303|NCT00835848|Incretins|incretins|mesh-ancestor
65372304|NCT00835848|Hormones|hormones|mesh-ancestor
65372305|NCT00835848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65372306|NCT00961857|Metformin|metformin|mesh-list
65372307|NCT00961857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65372308|NCT00961857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65372309|NCT00961857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372310|NCT00961857|Incretins|incretins|mesh-ancestor
65372311|NCT00961857|Hormones|hormones|mesh-ancestor
65372312|NCT00961857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65372313|NCT00961857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65372314|NCT00961857|Protease Inhibitors|protease inhibitors|mesh-ancestor
65372315|NCT00961857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372316|NCT00961857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372317|NCT02547792|Vaccines|vaccines|mesh-list
65372318|NCT02547792|Immunologic Factors|immunologic factors|mesh-ancestor
64490455|NCT04601350|Midazolam|midazolam|mesh-list
64392999|NCT02658149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64393000|NCT02658149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64393001|NCT02658149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64393002|NCT02658149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64393003|NCT02658149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393004|NCT03701711|Lenalidomide|lenalidomide|mesh-list
64393005|NCT03701711|Immunologic Factors|immunologic factors|mesh-ancestor
64393006|NCT03701711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393007|NCT03701711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65372319|NCT02547792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372320|NCT00830466|Sirolimus|sirolimus|mesh-list
65372321|NCT00830466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65372322|NCT00830466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65372323|NCT00830466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65372324|NCT00830466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372325|NCT00830466|Antifungal Agents|antifungal agents|mesh-ancestor
64764674|NCT03004014|Anesthetics|anesthetics|mesh-ancestor
65372361|NCT00836316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65372362|NCT04913805|Niacinamide|niacinamide|mesh-list
65372363|NCT04913805|Niacin|niacin|mesh-list
65372364|NCT04913805|Nicotinic Acids|nicotinic acids|mesh-list
65372365|NCT04913805|Vitamin B Complex|vitamin b complex|mesh-ancestor
65372366|NCT04913805|Vitamins|vitamins|mesh-ancestor
65372391|NCT00548145|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65372392|NCT00548145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372393|NCT00547911|Carbidopa|carbidopa|mesh-list
65372394|NCT00547911|Entacapone|entacapone|mesh-list
65372395|NCT00547911|Droxidopa|droxidopa|mesh-list
65372396|NCT00547911|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65372397|NCT00547911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65372398|NCT00547911|Dopamine Agents|dopamine agents|mesh-ancestor
65372399|NCT00547911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65372400|NCT00547911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372401|NCT00547911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372402|NCT00547911|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65372403|NCT00547911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372404|NCT00547911|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65372405|NCT00839280|Pantothenic Acid|pantothenic acid|mesh-list
65372406|NCT00839280|Vitamin B Complex|vitamin b complex|mesh-ancestor
65372407|NCT00839280|Vitamins|vitamins|mesh-ancestor
65372408|NCT00839280|Micronutrients|micronutrients|mesh-ancestor
65372409|NCT00839280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372410|NCT00836628|Busulfan|busulfan|mesh-list
65372411|NCT00836628|Alkylating Agents|alkylating agents|mesh-ancestor
65372412|NCT00836628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372413|NCT00836628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65372414|NCT00836628|Immunologic Factors|immunologic factors|mesh-ancestor
65372415|NCT00836628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372416|NCT00836628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65372449|NCT00839358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65372450|NCT00839358|Adrenergic Agents|adrenergic agents|mesh-ancestor
65372451|NCT00839358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65372452|NCT00839358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372453|NCT00962715|Interferons|interferons|mesh-list
65372454|NCT00962715|Interferon-alpha|interferon-alpha|mesh-list
65372455|NCT00962715|Interferon alpha-2|interferon alpha-2|mesh-list
65372456|NCT00962715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65372457|NCT00962715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372458|NCT00962715|Antiviral Agents|antiviral agents|mesh-ancestor
65372459|NCT00962715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65372460|NCT00962715|Immunologic Factors|immunologic factors|mesh-ancestor
65372461|NCT00962715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372462|NCT00963027|Treprostinil|treprostinil|mesh-list
65372496|NCT00844350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65372497|NCT00844350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372498|NCT00844350|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65372499|NCT00844350|Hormone Antagonists|hormone antagonists|mesh-ancestor
65273787|NCT02845349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65273788|NCT02845349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65273789|NCT02845349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65273790|NCT03852251|Capecitabine|capecitabine|mesh-list
65273791|NCT03852251|Oxaliplatin|oxaliplatin|mesh-list
65273792|NCT03852251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65273793|NCT03852251|Antimetabolites|antimetabolites|mesh-ancestor
65273794|NCT03852251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273795|NCT03852251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490524|NCT04358146|Locust bean gum|locust bean gum|mesh-list
64393221|NCT05109299|Cariostatic Agents|cariostatic agents|mesh-ancestor
64393325|NCT04196075|Antiviral Agents|antiviral agents|mesh-ancestor
65372500|NCT00844350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65372501|NCT00844350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65372502|NCT00844350|Fertility Agents|fertility agents|mesh-ancestor
65372503|NCT00844350|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65372531|NCT04678089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372532|NCT00963573|Loratadine|loratadine|mesh-list
65372533|NCT00963573|Betamethasone|betamethasone|mesh-list
65372534|NCT00963573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65372535|NCT00963573|Glucocorticoids|glucocorticoids|mesh-ancestor
65372536|NCT00963573|Hormones|hormones|mesh-ancestor
65372537|NCT00963573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65372538|NCT00963573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372539|NCT00963573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65372540|NCT00963573|Respiratory System Agents|respiratory system agents|mesh-ancestor
65372541|NCT00963573|Antipruritics|antipruritics|mesh-ancestor
65372542|NCT00963573|Dermatologic Agents|dermatologic agents|mesh-ancestor
65372543|NCT00963573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65372544|NCT00963573|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65372545|NCT00963573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65372546|NCT00963573|Histamine Antagonists|histamine antagonists|mesh-ancestor
65372547|NCT00963573|Histamine Agents|histamine agents|mesh-ancestor
65372548|NCT00963573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65372549|NCT00963573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372550|NCT05299593|Timolol|timolol|mesh-list
65372551|NCT05299593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65372573|NCT00963729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65372574|NCT00963729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65372575|NCT00963729|Alkylating Agents|alkylating agents|mesh-ancestor
65372576|NCT00963729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372577|NCT00963729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372578|NCT00963729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65372579|NCT00963729|Tubulin Modulators|tubulin modulators|mesh-ancestor
65372580|NCT00963729|Antimitotic Agents|antimitotic agents|mesh-ancestor
65372581|NCT00963729|Mitosis Modulators|mitosis modulators|mesh-ancestor
65372582|NCT00963729|Antimetabolites|antimetabolites|mesh-ancestor
65372583|NCT00963729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65372584|NCT00963729|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65372585|NCT00963729|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65372586|NCT00963729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372587|NCT00963729|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65372588|NCT00963729|Hormone Antagonists|hormone antagonists|mesh-ancestor
65372589|NCT00963729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65372590|NCT00963729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65372591|NCT00963729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65372592|NCT00963729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65372594|NCT04534023|Antioxidants|antioxidants|mesh-ancestor
65372595|NCT04534023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372596|NCT04534023|Protective Agents|protective agents|mesh-ancestor
65372597|NCT04534023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273796|NCT00620178|Losartan|losartan|mesh-list
65273797|NCT00620178|Candesartan|candesartan|mesh-list
65273798|NCT00620178|Candesartan cilexetil|candesartan cilexetil|mesh-list
65273799|NCT00620178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65273800|NCT00620178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65273801|NCT00620178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65273802|NCT00620178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65273803|NCT00620178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023801|NCT00154778|Antidotes|antidotes|mesh-ancestor
64393430|NCT04521881|Hemostatics|hemostatics|mesh-ancestor
64393431|NCT04521881|Coagulants|coagulants|mesh-ancestor
64393432|NCT04305899|BMS-986165|bms-986165|mesh-list
64393445|NCT01675661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393446|NCT01675661|Protective Agents|protective agents|mesh-ancestor
64393447|NCT01675661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393448|NCT01675661|Antidotes|antidotes|mesh-ancestor
64393449|NCT04463693|Etonogestrel|etonogestrel|mesh-list
64393450|NCT04463693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64393451|NCT04463693|Contraceptive Agents|contraceptive agents|mesh-ancestor
64393452|NCT04463693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64393453|NCT04463693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393454|NCT04463693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64393455|NCT05113511|Bevacizumab|bevacizumab|mesh-list
64393456|NCT05113511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64393457|NCT05113511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372598|NCT00964041|Cycloserine|cycloserine|mesh-list
65372599|NCT00964041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65372600|NCT00964041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65372601|NCT00964041|Renal Agents|renal agents|mesh-ancestor
65372602|NCT00964041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65372603|NCT00964041|Antitubercular Agents|antitubercular agents|mesh-ancestor
65372604|NCT00964041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64764964|NCT02641782|Tretinoin|tretinoin|mesh-list
65372627|NCT00967629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372628|NCT00967629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65372629|NCT00967629|Chelating Agents|chelating agents|mesh-ancestor
65372630|NCT00967629|Sequestering Agents|sequestering agents|mesh-ancestor
65372631|NCT00289783|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65372632|NCT00289783|Immunologic Factors|immunologic factors|mesh-ancestor
65372633|NCT00289783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372635|NCT00840606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65372636|NCT00840606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65372637|NCT00840606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65372638|NCT00840606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372639|NCT00840606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65372640|NCT00840606|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65372641|NCT00840606|Serotonin Agents|serotonin agents|mesh-ancestor
65372642|NCT00840606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65273804|NCT04349982|Fibrin fragment D|fibrin fragment d|mesh-list
65273805|NCT04349982|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65273806|NCT04349982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65273807|NCT04349982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273808|NCT04349982|Hemostatics|hemostatics|mesh-ancestor
65273809|NCT04349982|Coagulants|coagulants|mesh-ancestor
65273811|NCT04474847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64782182|NCT00783510|Abortifacient Agents|abortifacient agents|mesh-ancestor
65372643|NCT00840606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372644|NCT00840684|Cytarabine|cytarabine|mesh-list
65372645|NCT00840684|Melphalan|melphalan|mesh-list
65372646|NCT00840684|Busulfan|busulfan|mesh-list
65372647|NCT00840684|Daunorubicin|daunorubicin|mesh-list
65372648|NCT00840684|Mitoxantrone|mitoxantrone|mesh-list
65372649|NCT00840684|Amsacrine|amsacrine|mesh-list
65372650|NCT00840684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65372651|NCT00840684|Antimetabolites|antimetabolites|mesh-ancestor
65372652|NCT00840684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372653|NCT00840684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372654|NCT00840684|Antiviral Agents|antiviral agents|mesh-ancestor
65372655|NCT00840684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65372656|NCT00840684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65372657|NCT00840684|Immunologic Factors|immunologic factors|mesh-ancestor
65372690|NCT00574080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372691|NCT00574080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65372692|NCT00574080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65372694|NCT00574080|Autonomic Agents|autonomic agents|mesh-ancestor
65372695|NCT00574080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65372696|NCT00574080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65372697|NCT00574080|Glucocorticoids|glucocorticoids|mesh-ancestor
65372698|NCT00574080|Hormones|hormones|mesh-ancestor
65372699|NCT00574080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65372700|NCT00574080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65372701|NCT00574080|Protease Inhibitors|protease inhibitors|mesh-ancestor
65372702|NCT00574080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372703|NCT00574080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65372729|NCT00546351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372731|NCT00267865|Rituximab|rituximab|mesh-list
65372732|NCT00267865|Methotrexate|methotrexate|mesh-list
65372733|NCT00267865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65372734|NCT00267865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372735|NCT00267865|Immunologic Factors|immunologic factors|mesh-ancestor
65372736|NCT00267865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372737|NCT00267865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65372738|NCT00267865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65372739|NCT00267865|Abortifacient Agents|abortifacient agents|mesh-ancestor
65372740|NCT00267865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65372741|NCT00267865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65372742|NCT00267865|Antimetabolites|antimetabolites|mesh-ancestor
65372743|NCT00267865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372744|NCT00267865|Dermatologic Agents|dermatologic agents|mesh-ancestor
65372745|NCT00267865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372746|NCT00267865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65372747|NCT00267865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65372748|NCT00267865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65372750|NCT00267865|Protective Agents|protective agents|mesh-ancestor
64765101|NCT05314140|Calcium|calcium|mesh-list
65372786|NCT00841074|Dermatologic Agents|dermatologic agents|mesh-ancestor
65372787|NCT00967707|Gabapentin|gabapentin|mesh-list
65372788|NCT00967707|Donepezil|donepezil|mesh-list
65372789|NCT00967707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65372853|NCT00845754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372854|NCT00845754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372855|NCT00964665|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65372856|NCT00964665|Interferon-alpha|interferon-alpha|mesh-list
65372857|NCT00964665|Antiviral Agents|antiviral agents|mesh-ancestor
65372858|NCT00964665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65372859|NCT00964665|Immunologic Factors|immunologic factors|mesh-ancestor
64393794|NCT02693119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64393814|NCT05121233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393815|NCT05121233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64393816|NCT05121233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64393817|NCT05121233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64393818|NCT05121233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393821|NCT05745259|Tenecteplase|tenecteplase|mesh-list
65372860|NCT00964665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372861|NCT00841386|Riboflavin|riboflavin|mesh-list
65372862|NCT00841386|Flavin Mononucleotide|flavin mononucleotide|mesh-list
65372863|NCT00841386|Vitamin B Complex|vitamin b complex|mesh-ancestor
65372894|NCT00852228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372895|NCT00267007|Epoetin Alfa|epoetin alfa|mesh-list
65372896|NCT00267007|Hematinics|hematinics|mesh-ancestor
65372897|NCT00841854|Metronidazole|metronidazole|mesh-list
65372898|NCT00841854|Tetracycline|tetracycline|mesh-list
65372899|NCT00841854|Pantoprazole|pantoprazole|mesh-list
65372900|NCT00841854|Bismuth|bismuth|mesh-list
65372901|NCT00841854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65372902|NCT00841854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65372903|NCT00841854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65372904|NCT00841854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65372905|NCT00841854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65372906|NCT00841854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65372907|NCT00841854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65372908|NCT00841854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372909|NCT00841854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372910|NCT00841854|Antacids|antacids|mesh-ancestor
65372911|NCT00841854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65372912|NCT00848562|Nicorandil|nicorandil|mesh-list
65372913|NCT00848562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65372914|NCT00848562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65372949|NCT00848640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372950|NCT00968565|Citric Acid|citric acid|mesh-list
65372951|NCT00968565|Sodium Citrate|sodium citrate|mesh-list
65372952|NCT00968565|Anticoagulants|anticoagulants|mesh-ancestor
65372953|NCT00968565|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65372954|NCT00968565|Chelating Agents|chelating agents|mesh-ancestor
65372955|NCT00968565|Sequestering Agents|sequestering agents|mesh-ancestor
65372956|NCT00968565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372958|NCT00848796|Calcium heparin|calcium heparin|mesh-list
65372959|NCT00848796|Anticoagulants|anticoagulants|mesh-ancestor
65372978|NCT00251641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65372979|NCT00251641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372980|NCT00251641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65372981|NCT00251641|Antimetabolites|antimetabolites|mesh-ancestor
65372982|NCT00251641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372983|NCT00251641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372984|NCT00251641|Dermatologic Agents|dermatologic agents|mesh-ancestor
65372985|NCT00251641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372986|NCT00251641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65372987|NCT00251641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65372988|NCT00251641|Immunologic Factors|immunologic factors|mesh-ancestor
65372989|NCT00251641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65372990|NCT00251641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65372991|NCT00251641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65372992|NCT00250705|Aripiprazole|aripiprazole|mesh-list
65372993|NCT00250705|Antidepressive Agents|antidepressive agents|mesh-ancestor
65372994|NCT00250705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65372995|NCT00250705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65372996|NCT00250705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65372997|NCT00250705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65372998|NCT00250705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372999|NCT00250705|Dopamine Agonists|dopamine agonists|mesh-ancestor
65373000|NCT00250705|Dopamine Agents|dopamine agents|mesh-ancestor
65373001|NCT00250705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65373002|NCT00250705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373003|NCT00250705|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65273812|NCT04474847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782863|NCT02844582|Prednisone|prednisone|mesh-list
65373004|NCT00250705|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65373005|NCT00250705|Serotonin Agents|serotonin agents|mesh-ancestor
65373006|NCT00250705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65373007|NCT00250705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65373008|NCT00250705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65373009|NCT00250705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65373010|NCT00849030|Tamoxifen|tamoxifen|mesh-list
65373011|NCT00849030|Anastrozole|anastrozole|mesh-list
65373012|NCT00849030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65373013|NCT00849030|Hormone Antagonists|hormone antagonists|mesh-ancestor
65373014|NCT00849030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64765343|NCT00589056|Protease Inhibitors|protease inhibitors|mesh-ancestor
65373040|NCT00849264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65373041|NCT00849264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373042|NCT00849264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65373043|NCT00849264|Immunologic Factors|immunologic factors|mesh-ancestor
65373044|NCT00849264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373045|NCT00849264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65373046|NCT00849264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65373047|NCT00849264|Growth Substances|growth substances|mesh-ancestor
65373048|NCT00849264|Growth Inhibitors|growth inhibitors|mesh-ancestor
65373049|NCT00849342|Insulin Detemir|insulin detemir|mesh-list
65373050|NCT00849342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65373051|NCT00849342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373052|NCT00842556|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65373053|NCT00842556|Dapagliflozin|dapagliflozin|mesh-list
65373054|NCT00842556|Glimepiride|glimepiride|mesh-list
65373055|NCT00842556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65373056|NCT00842556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373057|NCT00842556|Incretins|incretins|mesh-ancestor
65373058|NCT00842556|Hormones|hormones|mesh-ancestor
65373059|NCT00842556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65373060|NCT00842556|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65373061|NCT00842556|Protease Inhibitors|protease inhibitors|mesh-ancestor
65373094|NCT00853008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373095|NCT00853008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373096|NCT00853008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65373097|NCT00853008|Glucocorticoids|glucocorticoids|mesh-ancestor
65373098|NCT00853008|Hormones|hormones|mesh-ancestor
65373099|NCT00853008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65373100|NCT00853008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65373101|NCT00853008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373102|NCT00853008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65373103|NCT00853008|Abortifacient Agents|abortifacient agents|mesh-ancestor
65373104|NCT00853008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65373105|NCT00853008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65373106|NCT00853008|Antimetabolites|antimetabolites|mesh-ancestor
65373140|NCT00853320|Oxycodone|oxycodone|mesh-list
65373141|NCT00853320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65373142|NCT00853320|Narcotics|narcotics|mesh-ancestor
65373143|NCT00853320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65373144|NCT00853320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373145|NCT00853320|Analgesics|analgesics|mesh-ancestor
65373174|NCT00850044|Antiviral Agents|antiviral agents|mesh-ancestor
65373175|NCT00850044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65373176|NCT00850044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65373177|NCT00850044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65373179|NCT00266227|Methotrexate|methotrexate|mesh-list
65373180|NCT00266227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65373181|NCT00266227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373182|NCT00266227|Immunologic Factors|immunologic factors|mesh-ancestor
65373183|NCT00266227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373184|NCT00266227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65373185|NCT00266227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65373186|NCT00266227|Abortifacient Agents|abortifacient agents|mesh-ancestor
65373187|NCT00266227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65373188|NCT00266227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65373189|NCT00266227|Antimetabolites|antimetabolites|mesh-ancestor
64765531|NCT00632970|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65373212|NCT00850122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64490895|NCT03090880|Tinzaparin|tinzaparin|mesh-list
65373213|NCT00850122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65373214|NCT00968955|Ropivacaine|ropivacaine|mesh-list
65373215|NCT00968955|Anesthetics, Local|anesthetics, local|mesh-ancestor
65373216|NCT00968955|Anesthetics|anesthetics|mesh-ancestor
65373217|NCT00968955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65373218|NCT00968955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373219|NCT00968955|Sensory System Agents|sensory system agents|mesh-ancestor
65373220|NCT00968955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373221|NCT00853554|Hydromorphone|hydromorphone|mesh-list
65373222|NCT00853554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65373223|NCT00853554|Narcotics|narcotics|mesh-ancestor
65373224|NCT00853554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65373225|NCT00853554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373226|NCT00853554|Analgesics|analgesics|mesh-ancestor
65373227|NCT00853554|Sensory System Agents|sensory system agents|mesh-ancestor
65373228|NCT00853554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373229|NCT00969033|Irinotecan|irinotecan|mesh-list
65373230|NCT00969033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65373231|NCT00969033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65373232|NCT00969033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373233|NCT00969033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373234|NCT00969033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373235|NCT00573768|Diclofenac|diclofenac|mesh-list
65373236|NCT00573768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65373237|NCT00573768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65373238|NCT00573768|Analgesics|analgesics|mesh-ancestor
65373239|NCT00573768|Sensory System Agents|sensory system agents|mesh-ancestor
65373240|NCT00573768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373241|NCT00573768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373269|NCT00855660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373271|NCT00965991|Glyburide|glyburide|mesh-list
65373272|NCT00965991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65373273|NCT00965991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373274|NCT00853944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65373275|NCT00853944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65373276|NCT00853944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65373277|NCT00853944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373278|NCT00853944|Incretins|incretins|mesh-ancestor
65373279|NCT00853944|Hormones|hormones|mesh-ancestor
65373280|NCT00853944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65373281|NCT00853944|Protease Inhibitors|protease inhibitors|mesh-ancestor
65373282|NCT00853944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373283|NCT00853944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373284|NCT02545452|Anastrozole|anastrozole|mesh-list
65373285|NCT02545452|Levonorgestrel|levonorgestrel|mesh-list
65373294|NCT02545452|Hormone Antagonists|hormone antagonists|mesh-ancestor
65373295|NCT02545452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65373296|NCT02545452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373297|NCT02545452|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65373298|NCT02545452|Contraceptive Agents|contraceptive agents|mesh-ancestor
65373299|NCT02545452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65373300|NCT02545452|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65373301|NCT02545452|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65373302|NCT02545452|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65373303|NCT02545452|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
65373304|NCT02545452|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
65373305|NCT02545452|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65373306|NCT00547365|Immunoglobulins|immunoglobulins|mesh-list
65373307|NCT00547365|Antibodies|antibodies|mesh-list
65373308|NCT00547365|gamma-Globulins|gamma-globulins|mesh-list
65373309|NCT00547365|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65373310|NCT00547365|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65373311|NCT00547365|Immunologic Factors|immunologic factors|mesh-ancestor
65373312|NCT00547365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373313|NCT00854178|Anesthetics|anesthetics|mesh-list
65373314|NCT00854178|Isoflurane|isoflurane|mesh-list
65373315|NCT00854178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65373316|NCT00854178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373317|NCT00854178|Anesthetics, General|anesthetics, general|mesh-ancestor
65373318|NCT00854178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65373319|NCT00850668|Hypoxanthine arabinoside|hypoxanthine arabinoside|mesh-list
65373320|NCT00850668|Antiviral Agents|antiviral agents|mesh-ancestor
65373321|NCT00850668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64394876|NCT03161509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64394915|NCT05129033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64394916|NCT05129033|Respiratory System Agents|respiratory system agents|mesh-ancestor
64394917|NCT03113851|Molgramostim|molgramostim|mesh-list
64394918|NCT03113851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395065|NCT05132777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65373322|NCT00850746|Moxifloxacin|moxifloxacin|mesh-list
65373323|NCT00850746|Z 338|z 338|mesh-list
65373324|NCT00850746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65373325|NCT00850746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65373326|NCT00850746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65373327|NCT00850746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65373328|NCT00850746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373329|NCT00850746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373330|NCT00850746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373331|NCT00850746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373332|NCT00850746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65373333|NCT00850746|Cholinergic Agents|cholinergic agents|mesh-ancestor
65373334|NCT00850746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65373335|NCT00850746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65373336|NCT00969813|Tofacitinib|tofacitinib|mesh-list
65373337|NCT00969813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65373338|NCT00969813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373339|NCT00969813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373340|NCT00854256|Mitomycins|mitomycins|mesh-list
65373341|NCT00854256|Mitomycin|mitomycin|mesh-list
65373342|NCT00854256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65373343|NCT00854256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373344|NCT00854256|Alkylating Agents|alkylating agents|mesh-ancestor
65373345|NCT00854256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373346|NCT00854256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65373347|NCT00854256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373348|NCT00855972|Naltrexone|naltrexone|mesh-list
65373349|NCT00855972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65373350|NCT00855972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65373351|NCT00855972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373352|NCT00855972|Sensory System Agents|sensory system agents|mesh-ancestor
65373377|NCT00861510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373378|NCT01095003|Capecitabine|capecitabine|mesh-list
65373379|NCT01095003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65373380|NCT01095003|Antimetabolites|antimetabolites|mesh-ancestor
65373381|NCT01095003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373382|NCT01095003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373383|NCT00854646|ON 01910|on 01910|mesh-list
65373384|NCT00854646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373385|NCT00854646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65373386|NCT00854646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373387|NCT00854646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373388|NCT00856362|Moxidectin|moxidectin|mesh-list
65373389|NCT00856362|Midazolam|midazolam|mesh-list
65373390|NCT00856362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65373391|NCT00856362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65373392|NCT00856362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65373393|NCT00856362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373394|NCT00856362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65373395|NCT00856362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65373396|NCT00856362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65373397|NCT00856362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65373398|NCT00856362|Anesthetics, General|anesthetics, general|mesh-ancestor
65373399|NCT00856362|Anesthetics|anesthetics|mesh-ancestor
65373400|NCT00856362|GABA Modulators|gaba modulators|mesh-ancestor
65373401|NCT00856362|GABA Agents|gaba agents|mesh-ancestor
65373402|NCT00856362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65373403|NCT00856362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373437|NCT04119024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373438|NCT04119024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65373439|NCT04119024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65273813|NCT04474847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273814|NCT04474847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65273815|NCT04474847|Immunologic Factors|immunologic factors|mesh-ancestor
65273816|NCT04474847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273817|NCT04474847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65273818|NCT04315350|Prednisolone|prednisolone|mesh-list
65273819|NCT04315350|Curcumin|curcumin|mesh-list
65273820|NCT04315350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65273821|NCT04315350|Glucocorticoids|glucocorticoids|mesh-ancestor
64471772|NCT04140396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64783829|NCT03287310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64783830|NCT03287310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64395256|NCT01374217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64395257|NCT01374217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64395258|NCT01374217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395259|NCT01374217|Immunologic Factors|immunologic factors|mesh-ancestor
64395260|NCT01374217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64395261|NCT01374217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64395262|NCT01374217|Growth Substances|growth substances|mesh-ancestor
64395263|NCT01374217|Growth Inhibitors|growth inhibitors|mesh-ancestor
64395264|NCT01374217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64395399|NCT05136521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65373440|NCT04119024|Antimetabolites|antimetabolites|mesh-ancestor
65373441|NCT04119024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65373442|NCT04119024|Analgesics|analgesics|mesh-ancestor
65373443|NCT04119024|Sensory System Agents|sensory system agents|mesh-ancestor
65373444|NCT04119024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373445|NCT00966615|Dialysis Solutions|dialysis solutions|mesh-list
65373446|NCT00966615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65373447|NCT00966771|Copper|copper|mesh-list
65373476|NCT03937479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65373477|NCT03937479|Cholinergic Agents|cholinergic agents|mesh-ancestor
65373478|NCT03937479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65373479|NCT03937479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373480|NCT00970905|Ondansetron|ondansetron|mesh-list
65373481|NCT00970905|Aprepitant|aprepitant|mesh-list
65373482|NCT00970905|Antiemetics|antiemetics|mesh-ancestor
65373483|NCT00970905|Autonomic Agents|autonomic agents|mesh-ancestor
65373484|NCT00970905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373485|NCT00970905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373486|NCT00970905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65373487|NCT00970905|Antipruritics|antipruritics|mesh-ancestor
65373488|NCT00970905|Dermatologic Agents|dermatologic agents|mesh-ancestor
65373489|NCT00970905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65373490|NCT00970905|Serotonin Agents|serotonin agents|mesh-ancestor
65373491|NCT00970905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65373492|NCT00970905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373494|NCT00970905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65373495|NCT00970905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65373496|NCT00970905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65373529|NCT00865176|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65373530|NCT00865176|Hormone Antagonists|hormone antagonists|mesh-ancestor
65273822|NCT04315350|Hormones|hormones|mesh-ancestor
65273823|NCT04315350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65273824|NCT04315350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273825|NCT04315350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65273826|NCT04315350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273827|NCT04315350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65273828|NCT04315350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65273829|NCT04315350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64395869|NCT03938831|Analgesics|analgesics|mesh-ancestor
64395870|NCT03938831|Sensory System Agents|sensory system agents|mesh-ancestor
64395871|NCT03938831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395872|NCT03938831|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64395873|NCT03938831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64395874|NCT03938831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64395875|NCT03938831|Adrenergic Agents|adrenergic agents|mesh-ancestor
64395876|NCT03938831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64395894|NCT02592707|Hormones|hormones|mesh-ancestor
64395895|NCT02592707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64395896|NCT02592707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64395897|NCT02592707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395950|NCT02102477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65373531|NCT00865176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65373532|NCT00865176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373533|NCT00865176|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65373534|NCT00865176|Diuretics|diuretics|mesh-ancestor
65373535|NCT00865176|Natriuretic Agents|natriuretic agents|mesh-ancestor
65373536|NCT00865176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65373537|NCT00973869|Curcumin|curcumin|mesh-list
65373538|NCT00973869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65373569|NCT00857376|Thioctic Acid|thioctic acid|mesh-list
65373570|NCT00857376|Antioxidants|antioxidants|mesh-ancestor
65373571|NCT00857376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373572|NCT00857376|Protective Agents|protective agents|mesh-ancestor
65373573|NCT00857376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373574|NCT00857376|Vitamin B Complex|vitamin b complex|mesh-ancestor
65373575|NCT00857376|Vitamins|vitamins|mesh-ancestor
65373576|NCT00857376|Micronutrients|micronutrients|mesh-ancestor
65373577|NCT00618072|Metformin|metformin|mesh-list
65373578|NCT00618072|Rosiglitazone|rosiglitazone|mesh-list
65373579|NCT00618072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65373580|NCT00618072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373581|NCT00959517|Artesunate|artesunate|mesh-list
65373582|NCT00959517|Chloroquine|chloroquine|mesh-list
65373583|NCT00959517|Pyrimethamine|pyrimethamine|mesh-list
65373617|NCT00865410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65373618|NCT00865410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373620|NCT00865410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65373621|NCT00865410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273830|NCT04315350|Analgesics|analgesics|mesh-ancestor
65273831|NCT04315350|Sensory System Agents|sensory system agents|mesh-ancestor
65273832|NCT04315350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65273833|NCT04315350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273834|NCT04315350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273835|NCT04288206|Cefazolin|cefazolin|mesh-list
65273836|NCT04288206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65273837|NCT04288206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65273838|NCT04958772|Lenograstim|lenograstim|mesh-list
65273839|NCT04958772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65273840|NCT04958772|Immunologic Factors|immunologic factors|mesh-ancestor
64491194|NCT03483363|Bacitracin|bacitracin|mesh-list
64396149|NCT03101579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64396150|NCT03101579|Glucocorticoids|glucocorticoids|mesh-ancestor
64396151|NCT03101579|Hormones|hormones|mesh-ancestor
64396152|NCT03101579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64396153|NCT03101579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64396154|NCT03101579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396155|NCT03101579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396222|NCT01797523|Hormone Antagonists|hormone antagonists|mesh-ancestor
64396223|NCT01797523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64396224|NCT03412591|Suvorexant|suvorexant|mesh-list
64396225|NCT03412591|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64396226|NCT03412591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64396227|NCT03412591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64396228|NCT03412591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396229|NCT03412591|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64396230|NCT03412591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65373622|NCT00865410|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64765966|NCT00706836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65373650|NCT00971685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65373651|NCT00971685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65373652|NCT00971685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373653|NCT00971685|Immunologic Factors|immunologic factors|mesh-ancestor
65373654|NCT00971685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65373655|NCT00971685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65373656|NCT00971685|Growth Substances|growth substances|mesh-ancestor
65373657|NCT00971685|Growth Inhibitors|growth inhibitors|mesh-ancestor
65373658|NCT03861052|Dulaglutide|dulaglutide|mesh-list
65373659|NCT03861052|Tirzepatide|tirzepatide|mesh-list
65373660|NCT03861052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65373661|NCT03861052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373662|NCT03861052|Incretins|incretins|mesh-ancestor
65373664|NCT03861052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65373665|NCT00971763|Gemcitabine|gemcitabine|mesh-list
65273841|NCT04958772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273842|NCT02771249|Pyridoxine|pyridoxine|mesh-list
65273843|NCT02771249|Isoniazid|isoniazid|mesh-list
65273844|NCT02771249|Darunavir|darunavir|mesh-list
65273845|NCT02771249|Cobicistat|cobicistat|mesh-list
65273846|NCT02771249|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
65273847|NCT02771249|Antitubercular Agents|antitubercular agents|mesh-ancestor
65273848|NCT02771249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65273849|NCT02771249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65273850|NCT02771249|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64471773|NCT04140396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396358|NCT03105661|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64396359|NCT03105661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64396360|NCT03105661|Adrenergic Agents|adrenergic agents|mesh-ancestor
64396361|NCT03105661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64396362|NCT03105661|Sympathomimetics|sympathomimetics|mesh-ancestor
64396363|NCT03105661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64396364|NCT03105661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64785597|NCT00000336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64785598|NCT00000336|Protective Agents|protective agents|mesh-ancestor
64396766|NCT02369965|Tenofovir|tenofovir|mesh-list
64396767|NCT02369965|Lamivudine|lamivudine|mesh-list
64396768|NCT02369965|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65373666|NCT00971763|Prednisolone|prednisolone|mesh-list
65373667|NCT00971763|Cyclophosphamide|cyclophosphamide|mesh-list
65373668|NCT00971763|Rituximab|rituximab|mesh-list
65373669|NCT00971763|Vincristine|vincristine|mesh-list
65373670|NCT00971763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65373671|NCT00971763|Immunologic Factors|immunologic factors|mesh-ancestor
65373701|NCT00865644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65373702|NCT00865644|Immunologic Factors|immunologic factors|mesh-ancestor
65373703|NCT00865644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373704|NCT00865644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373705|NCT00865644|Interferon Inducers|interferon inducers|mesh-ancestor
65373706|NCT00785330|Rituximab|rituximab|mesh-list
65373707|NCT00785330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65373708|NCT00785330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373709|NCT00785330|Immunologic Factors|immunologic factors|mesh-ancestor
65373710|NCT00785330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373711|NCT00785330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65373712|NCT02555150|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65373713|NCT02555150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65373714|NCT02555150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373715|NCT02555150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65373716|NCT02555150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65373751|NCT00974805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373752|NCT00974805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373753|NCT00974805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65373754|NCT00974805|Respiratory System Agents|respiratory system agents|mesh-ancestor
65373787|NCT03897244|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65373788|NCT03897244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65373789|NCT03897244|Antitubercular Agents|antitubercular agents|mesh-ancestor
65373790|NCT03897244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65273851|NCT02771249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65373791|NCT03897244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65373792|NCT03897244|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65373793|NCT03897244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65373794|NCT03897244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373795|NCT03897244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373796|NCT03897244|Antacids|antacids|mesh-ancestor
65373797|NCT00666536|Amlodipine|amlodipine|mesh-list
65373798|NCT00666536|Valsartan|valsartan|mesh-list
65373820|NCT00666458|Hormones|hormones|mesh-ancestor
65373821|NCT00666458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65373822|NCT00666458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65373823|NCT00666458|Protease Inhibitors|protease inhibitors|mesh-ancestor
65373824|NCT00666458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373825|NCT00666458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373826|NCT00974961|Bupivacaine|bupivacaine|mesh-list
65373827|NCT00974961|Levobupivacaine|levobupivacaine|mesh-list
65373828|NCT00974961|Anesthetics, Local|anesthetics, local|mesh-ancestor
65373829|NCT00974961|Anesthetics|anesthetics|mesh-ancestor
65373830|NCT00974961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65373831|NCT00974961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373832|NCT00974961|Sensory System Agents|sensory system agents|mesh-ancestor
65373833|NCT00974961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373834|NCT00511108|Pioglitazone|pioglitazone|mesh-list
65373835|NCT00511108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65373836|NCT00511108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65373837|NCT00511108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373838|NCT00511108|Incretins|incretins|mesh-ancestor
65373839|NCT00511108|Hormones|hormones|mesh-ancestor
65373840|NCT00511108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65373841|NCT00511108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65373842|NCT00511108|Protease Inhibitors|protease inhibitors|mesh-ancestor
65373843|NCT00511108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373844|NCT00511108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373845|NCT00781586|Caffeine|caffeine|mesh-list
65373846|NCT00781586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373847|NCT00781586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64766183|NCT00733356|Dopamine Agents|dopamine agents|mesh-ancestor
65373879|NCT00617604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65373880|NCT00617604|Dermatologic Agents|dermatologic agents|mesh-ancestor
65373881|NCT01012570|Adalimumab|adalimumab|mesh-list
65373882|NCT01012570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65373883|NCT01012570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65373884|NCT00865878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65373885|NCT00865878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65373886|NCT00865878|Dermatologic Agents|dermatologic agents|mesh-ancestor
65373887|NCT00661622|Molgramostim|molgramostim|mesh-list
65373888|NCT00661622|Sargramostim|sargramostim|mesh-list
65373889|NCT00661622|Immunologic Factors|immunologic factors|mesh-ancestor
65373890|NCT00661622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373891|NCT00661622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373892|NCT00781820|Bifonazole|bifonazole|mesh-list
65373926|NCT00791960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65373927|NCT00791960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373929|NCT00792350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373930|NCT00792350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65373931|NCT00792350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373932|NCT00792350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373933|NCT00792584|Efavirenz|efavirenz|mesh-list
65373934|NCT00792584|Etravirine|etravirine|mesh-list
65373935|NCT00792584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65373965|NCT04093752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65373966|NCT04093752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373967|NCT04093752|Incretins|incretins|mesh-ancestor
65373968|NCT04093752|Hormones|hormones|mesh-ancestor
65373969|NCT04093752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65373970|NCT02544282|Acetaminophen|acetaminophen|mesh-list
65373971|NCT02544282|Sufentanil|sufentanil|mesh-list
65373972|NCT02544282|Tramadol|tramadol|mesh-list
65373973|NCT02544282|Pirinitramide|pirinitramide|mesh-list
65373974|NCT02544282|Propofol|propofol|mesh-list
65373975|NCT02544282|Sevoflurane|sevoflurane|mesh-list
65373976|NCT02544282|Levobupivacaine|levobupivacaine|mesh-list
65373977|NCT02544282|Atracurium|atracurium|mesh-list
65373978|NCT02544282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65374010|NCT00666224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374011|NCT00666224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65374012|NCT00666224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65374013|NCT00663962|Pregabalin|pregabalin|mesh-list
65374014|NCT00663962|Analgesics|analgesics|mesh-ancestor
65374015|NCT00663962|Sensory System Agents|sensory system agents|mesh-ancestor
65374016|NCT00663962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65374017|NCT00663962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374018|NCT00663962|Anticonvulsants|anticonvulsants|mesh-ancestor
65374019|NCT00663962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65374020|NCT00663962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65374021|NCT00663962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374022|NCT00663962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65374050|NCT00960453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374051|NCT00265759|Letrozole|letrozole|mesh-list
65374052|NCT00265759|Anastrozole|anastrozole|mesh-list
65374053|NCT00265759|Exemestane|exemestane|mesh-list
65374054|NCT00265759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374055|NCT00265759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65374056|NCT00265759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65374057|NCT00265759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374058|NCT00265759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374059|NCT00265759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65374060|NCT00265759|Hormone Antagonists|hormone antagonists|mesh-ancestor
65374061|NCT00265759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65374062|NCT00265759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374063|NCT00265759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65374064|NCT00972387|Prednisone|prednisone|mesh-list
65374065|NCT00972387|Prednisolone|prednisolone|mesh-list
65374066|NCT00972387|Cyclophosphamide|cyclophosphamide|mesh-list
65374067|NCT00972387|Doxorubicin|doxorubicin|mesh-list
65374068|NCT00972387|Vincristine|vincristine|mesh-list
65374069|NCT00972387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65374070|NCT00972387|Immunologic Factors|immunologic factors|mesh-ancestor
65374101|NCT00783068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374103|NCT00866736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374104|NCT00866736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65374105|NCT00866736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374106|NCT00866736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374107|NCT00792818|Ibuprofen|ibuprofen|mesh-list
65374108|NCT00792818|Curcumin|curcumin|mesh-list
65374109|NCT00792818|Turmeric extract|turmeric extract|mesh-list
65374110|NCT00792818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64766453|NCT00765648|Labetalol|labetalol|mesh-list
65374143|NCT00618774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65374144|NCT00618774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374145|NCT00618774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65374146|NCT00618774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374147|NCT00618774|Vasodilator Agents|vasodilator agents|mesh-ancestor
65374148|NCT00618774|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65374149|NCT00618774|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65374150|NCT00917345|Captopril|captopril|mesh-list
65374151|NCT00917345|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65374152|NCT00917345|Protease Inhibitors|protease inhibitors|mesh-ancestor
65374190|NCT02555852|Roxatidine acetate|roxatidine acetate|mesh-list
65374191|NCT02555852|Bismuth|bismuth|mesh-list
64766550|NCT00787332|Desirudin|desirudin|mesh-list
65374219|NCT04091009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65374220|NCT02597231|Melatonin|melatonin|mesh-list
65374221|NCT02597231|Antioxidants|antioxidants|mesh-ancestor
65374222|NCT02597231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374223|NCT02597231|Protective Agents|protective agents|mesh-ancestor
65374224|NCT02597231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374225|NCT02597231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65374226|NCT00545571|Epoetin Alfa|epoetin alfa|mesh-list
65374227|NCT00545571|Hematinics|hematinics|mesh-ancestor
65374228|NCT00783380|Vaccines|vaccines|mesh-list
65374229|NCT00783380|Immunologic Factors|immunologic factors|mesh-ancestor
65374230|NCT00783380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374231|NCT04008225|Dimercaprol|dimercaprol|mesh-list
65374232|NCT04008225|Chelating Agents|chelating agents|mesh-ancestor
65374233|NCT04008225|Sequestering Agents|sequestering agents|mesh-ancestor
65374234|NCT04008225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374235|NCT00748709|Afatinib|afatinib|mesh-list
65374236|NCT00748709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374237|NCT00748709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65374238|NCT00748709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273852|NCT02771249|Antimetabolites|antimetabolites|mesh-ancestor
65374239|NCT00748709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374266|NCT00263887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65374267|NCT00263887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374268|NCT00263887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374269|NCT00263887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65374270|NCT00263887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65374271|NCT00867126|Pioglitazone|pioglitazone|mesh-list
65374272|NCT00867126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65374273|NCT00867126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374274|NCT00748553|Paclitaxel|paclitaxel|mesh-list
65374275|NCT00748553|Azacitidine|azacitidine|mesh-list
65374276|NCT00748553|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65374277|NCT00748553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65374278|NCT00748553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374279|NCT00748553|Tubulin Modulators|tubulin modulators|mesh-ancestor
65374280|NCT00748553|Antimitotic Agents|antimitotic agents|mesh-ancestor
65374281|NCT00748553|Mitosis Modulators|mitosis modulators|mesh-ancestor
65374282|NCT00748553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374283|NCT00748553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65374284|NCT00748553|Antimetabolites|antimetabolites|mesh-ancestor
65374285|NCT00748553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374319|NCT00570128|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65374320|NCT00570128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374321|NCT00570128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374322|NCT00570128|Cholinergic Agents|cholinergic agents|mesh-ancestor
65374323|NCT00570128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65374324|NCT00570128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374325|NCT00570128|Nootropic Agents|nootropic agents|mesh-ancestor
65374326|NCT00960921|Iron|iron|mesh-list
65374327|NCT00960921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65374377|NCT00262951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65374378|NCT00262951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65374379|NCT00262951|Immunologic Factors|immunologic factors|mesh-ancestor
65374380|NCT00262951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374381|NCT00262951|Antiviral Agents|antiviral agents|mesh-ancestor
65374382|NCT00262951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65374383|NCT02597153|Mitoxantrone|mitoxantrone|mesh-list
65374384|NCT02597153|Analgesics|analgesics|mesh-ancestor
65374385|NCT02597153|Sensory System Agents|sensory system agents|mesh-ancestor
65374386|NCT02597153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65374387|NCT02597153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374388|NCT02597153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374389|NCT02597153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65374390|NCT02597153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65124174|NCT01737905|Mydriatics|mydriatics|mesh-ancestor
65374391|NCT02597153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374392|NCT02597153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374393|NCT00975741|Mometasone Furoate|mometasone furoate|mesh-list
65374394|NCT00975741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65374396|NCT00975741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65374397|NCT00262873|Bortezomib|bortezomib|mesh-list
65374398|NCT00262873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374399|NCT00975819|Sirolimus|sirolimus|mesh-list
65374400|NCT00975819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65374401|NCT00975819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65374402|NCT00975819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65374403|NCT00975819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374404|NCT00975819|Antifungal Agents|antifungal agents|mesh-ancestor
65374405|NCT00975819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65374406|NCT00975819|Immunologic Factors|immunologic factors|mesh-ancestor
65374407|NCT00975819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374408|NCT00859872|Haloperidol|haloperidol|mesh-list
65374409|NCT00859872|Risperidone|risperidone|mesh-list
65374410|NCT00859872|Haloperidol decanoate|haloperidol decanoate|mesh-list
65374411|NCT00859872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65374412|NCT00859872|Serotonin Agents|serotonin agents|mesh-ancestor
65374413|NCT00859872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65374414|NCT00859872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374415|NCT00859872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374416|NCT00859872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65374417|NCT00859872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65374418|NCT00859872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65374419|NCT00859872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65374420|NCT00859872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64471776|NCT04119284|Antioxidants|antioxidants|mesh-ancestor
65374421|NCT00859872|Dopamine Agents|dopamine agents|mesh-ancestor
65374422|NCT00859872|Antiemetics|antiemetics|mesh-ancestor
65374423|NCT00859872|Autonomic Agents|autonomic agents|mesh-ancestor
65374424|NCT00859872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65374425|NCT00859872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65374426|NCT00859872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65374427|NCT02555696|Paclitaxel|paclitaxel|mesh-list
65374428|NCT02555696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65374459|NCT05147493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65374460|NCT05147493|Growth Substances|growth substances|mesh-ancestor
65374461|NCT05147493|Growth Inhibitors|growth inhibitors|mesh-ancestor
65374462|NCT00573534|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65374463|NCT00573534|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65374464|NCT00573534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374465|NCT00573534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65374466|NCT00573534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65374467|NCT00573534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65374468|NCT00573534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374469|NCT00573534|Dopamine Agents|dopamine agents|mesh-ancestor
65374470|NCT00573534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65374471|NCT03974425|Aflibercept|aflibercept|mesh-list
65374472|NCT03974425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65374542|NCT00961155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65374543|NCT00961155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374544|NCT00961155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65374545|NCT00961155|Respiratory System Agents|respiratory system agents|mesh-ancestor
65374546|NCT00961155|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65374547|NCT00961155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65374548|NCT00961155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65374549|NCT00961155|Adrenergic Agents|adrenergic agents|mesh-ancestor
65374550|NCT00961155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65374551|NCT00961155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374552|NCT00961155|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65374553|NCT00961155|Hormone Antagonists|hormone antagonists|mesh-ancestor
65374554|NCT00961155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65374555|NCT00961155|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65374609|NCT00973323|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65374610|NCT00973323|Antithrombins|antithrombins|mesh-ancestor
65374611|NCT00973323|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65374612|NCT00973323|Protease Inhibitors|protease inhibitors|mesh-ancestor
65374613|NCT00973323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374614|NCT00973323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374615|NCT00793988|Anesthetics|anesthetics|mesh-list
65374616|NCT00793988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65374617|NCT00793988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374618|NCT00973401|Insulin|insulin|mesh-list
65374619|NCT00973401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65374620|NCT00973401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374621|NCT04040322|Iloprost|iloprost|mesh-list
65374622|NCT04040322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65374623|NCT04040322|Vasodilator Agents|vasodilator agents|mesh-ancestor
65374624|NCT00787436|Thalidomide|thalidomide|mesh-list
65374625|NCT00787436|Timolol|timolol|mesh-list
65374626|NCT00787436|Propranolol|propranolol|mesh-list
65374627|NCT00787436|Nadolol|nadolol|mesh-list
65374628|NCT00787436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65374629|NCT00787436|Immunologic Factors|immunologic factors|mesh-ancestor
65374630|NCT00787436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374631|NCT00787436|Leprostatic Agents|leprostatic agents|mesh-ancestor
65374632|NCT00787436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65374670|NCT00979563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65374700|NCT00863850|Alkylating Agents|alkylating agents|mesh-ancestor
65374701|NCT00863850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374702|NCT00863850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374704|NCT00860340|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65374705|NCT00860340|Hormone Antagonists|hormone antagonists|mesh-ancestor
65374706|NCT00860340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65374707|NCT00860340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374708|NCT00860340|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65374710|NCT00860340|Natriuretic Agents|natriuretic agents|mesh-ancestor
65374711|NCT00784316|Metoprolol|metoprolol|mesh-list
65374712|NCT00784316|Amiodarone|amiodarone|mesh-list
65374744|NCT00286429|Protease Inhibitors|protease inhibitors|mesh-ancestor
65374745|NCT00286429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374746|NCT00286429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374747|NCT00665444|Aripiprazole|aripiprazole|mesh-list
65374748|NCT00665444|Antidepressive Agents|antidepressive agents|mesh-ancestor
65374749|NCT00665444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65374750|NCT00665444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65374751|NCT00665444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64767096|NCT00830388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374768|NCT00864006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374769|NCT00864006|GABA Agents|gaba agents|mesh-ancestor
65374770|NCT00864006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65374771|NCT00864006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374772|NCT00864006|Antimanic Agents|antimanic agents|mesh-ancestor
65374773|NCT00864006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65374774|NCT00864006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65374775|NCT00864006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65374776|NCT00860496|Cyclosporine|cyclosporine|mesh-list
65374777|NCT00860496|Tacrolimus|tacrolimus|mesh-list
65374778|NCT00860496|Cyclosporins|cyclosporins|mesh-list
65374779|NCT00860496|Tofacitinib|tofacitinib|mesh-list
65374780|NCT00860496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65374781|NCT00860496|Immunologic Factors|immunologic factors|mesh-ancestor
65374782|NCT00860496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374783|NCT00860496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65374784|NCT00860496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374785|NCT00860496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374786|NCT00860496|Antifungal Agents|antifungal agents|mesh-ancestor
65374787|NCT00860496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65374788|NCT00860496|Dermatologic Agents|dermatologic agents|mesh-ancestor
65374789|NCT00860496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65374790|NCT00860496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65374791|NCT00864162|Ramipril|ramipril|mesh-list
65374792|NCT00864162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65374793|NCT00864162|Protease Inhibitors|protease inhibitors|mesh-ancestor
65374794|NCT00864162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374795|NCT00864162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374796|NCT00864162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65374797|NCT00787826|Vaccines|vaccines|mesh-list
65374798|NCT00787826|Immunologic Factors|immunologic factors|mesh-ancestor
65374799|NCT00787826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374800|NCT00795314|Fentanyl|fentanyl|mesh-list
65374801|NCT00795314|Butorphanol|butorphanol|mesh-list
65374802|NCT00795314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65374803|NCT00795314|Narcotics|narcotics|mesh-ancestor
65374804|NCT00795314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65374805|NCT00795314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374806|NCT00795314|Analgesics|analgesics|mesh-ancestor
65374807|NCT00795314|Sensory System Agents|sensory system agents|mesh-ancestor
65374808|NCT00795314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65374809|NCT00795314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65374841|NCT00864318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65374843|NCT00864318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374844|NCT00864318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65374845|NCT00864318|Alkylating Agents|alkylating agents|mesh-ancestor
65124609|NCT01161628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65374846|NCT00788060|Everolimus|everolimus|mesh-list
65374847|NCT00788060|Sunitinib|sunitinib|mesh-list
65374848|NCT00788060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374849|NCT00788060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65374850|NCT00788060|Immunologic Factors|immunologic factors|mesh-ancestor
65374851|NCT00788060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374852|NCT00788060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65374853|NCT00788060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65374885|NCT00961467|Prednisone|prednisone|mesh-list
65374886|NCT00961467|Melphalan|melphalan|mesh-list
65374887|NCT00961467|Lenalidomide|lenalidomide|mesh-list
65374888|NCT00961467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65374889|NCT00961467|Glucocorticoids|glucocorticoids|mesh-ancestor
65374890|NCT00961467|Hormones|hormones|mesh-ancestor
65374891|NCT00961467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65374892|NCT00961467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374893|NCT00961467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65374894|NCT00961467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374895|NCT00961467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65374916|NCT00980031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64491723|NCT05688345|Propofol|propofol|mesh-list
64786842|NCT00002340|Atovaquone|atovaquone|mesh-list
65374917|NCT00663260|Dapagliflozin|dapagliflozin|mesh-list
65374918|NCT00663260|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65374919|NCT00663260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374921|NCT00663260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374922|NCT00980109|Oseltamivir|oseltamivir|mesh-list
65374923|NCT00980109|Zanamivir|zanamivir|mesh-list
65374924|NCT00980109|Antiviral Agents|antiviral agents|mesh-ancestor
65374925|NCT00980109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65374926|NCT00980109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374927|NCT00980109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374928|NCT04988841|Nivolumab|nivolumab|mesh-list
65374929|NCT04988841|Ipilimumab|ipilimumab|mesh-list
65374930|NCT04988841|Laxatives|laxatives|mesh-list
65374931|NCT04988841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65374932|NCT04988841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65374933|NCT04988841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374934|NCT04988841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65374935|NCT04988841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374936|NCT04988841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65374937|NCT00980187|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65374938|NCT00980187|Indapamide|indapamide|mesh-list
65374939|NCT00980187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65374940|NCT00980187|Diuretics|diuretics|mesh-ancestor
65374941|NCT00980187|Natriuretic Agents|natriuretic agents|mesh-ancestor
65374942|NCT00980187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374943|NCT00980187|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65374944|NCT00980187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65374945|NCT00980187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374946|NCT00795470|Anti-Infective Agents|anti-infective agents|mesh-list
65374947|NCT00795470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65374948|NCT00284089|Ranibizumab|ranibizumab|mesh-list
65374949|NCT00284089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65374980|NCT00976755|Immunologic Factors|immunologic factors|mesh-ancestor
65374981|NCT00976755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374982|NCT00864474|Maraviroc|maraviroc|mesh-list
65374983|NCT00864474|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65374984|NCT00864474|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65374985|NCT00864474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374986|NCT00864474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65374987|NCT00864474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65374988|NCT00864474|Antiviral Agents|antiviral agents|mesh-ancestor
65374989|NCT00864474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65374990|NCT00864474|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65374991|NCT00283387|Betaine|betaine|mesh-list
65374992|NCT00283387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65374993|NCT00283387|Lipotropic Agents|lipotropic agents|mesh-ancestor
65374994|NCT00283387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65374995|NCT00283387|Antimetabolites|antimetabolites|mesh-ancestor
65375031|NCT00984789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65375033|NCT00984789|Progestins|progestins|mesh-ancestor
65375034|NCT00984789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65375035|NCT00864552|Factor VIII|factor viii|mesh-list
65375036|NCT00864552|Coagulants|coagulants|mesh-ancestor
65375067|NCT00742859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375069|NCT00742781|Cholecalciferol|cholecalciferol|mesh-list
65375070|NCT00742781|Vitamins|vitamins|mesh-ancestor
65375071|NCT00742781|Micronutrients|micronutrients|mesh-ancestor
65375072|NCT00742781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375073|NCT00742781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65375074|NCT00742781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65375075|NCT00280735|Carboplatin|carboplatin|mesh-list
65375076|NCT00280735|Docetaxel|docetaxel|mesh-list
65375077|NCT00280735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375078|NCT00280735|Tubulin Modulators|tubulin modulators|mesh-ancestor
65375079|NCT00280735|Antimitotic Agents|antimitotic agents|mesh-ancestor
65375080|NCT00280735|Mitosis Modulators|mitosis modulators|mesh-ancestor
65375081|NCT00280735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375082|NCT03975283|Bupivacaine|bupivacaine|mesh-list
64767420|NCT00887640|Sirolimus|sirolimus|mesh-list
65375149|NCT00506350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375150|NCT00788840|Isophane Insulin, Human|isophane insulin, human|mesh-list
65375180|NCT01070485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375181|NCT00618618|Deoxycholic Acid|deoxycholic acid|mesh-list
65375182|NCT00618618|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65375183|NCT00618618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65375184|NCT00796250|Prednisolone|prednisolone|mesh-list
65375185|NCT00796250|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65375186|NCT00796250|Methylprednisolone|methylprednisolone|mesh-list
65375187|NCT00796250|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65375188|NCT00796250|Prednisolone acetate|prednisolone acetate|mesh-list
65375189|NCT00796250|Azathioprine|azathioprine|mesh-list
65375190|NCT00796250|Infliximab|infliximab|mesh-list
65375191|NCT00796250|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65375192|NCT00796250|Prednisolone phosphate|prednisolone phosphate|mesh-list
65375193|NCT00796250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65375194|NCT00796250|Glucocorticoids|glucocorticoids|mesh-ancestor
65375195|NCT00796250|Hormones|hormones|mesh-ancestor
65375196|NCT00796250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65375197|NCT00796250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767543|NCT00904488|Metolazone|metolazone|mesh-list
65375211|NCT00796250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65375212|NCT00796250|Immunologic Factors|immunologic factors|mesh-ancestor
65375213|NCT00788918|Interferons|interferons|mesh-list
65375214|NCT00788918|Ribavirin|ribavirin|mesh-list
65375215|NCT00788918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375216|NCT00788918|Antiviral Agents|antiviral agents|mesh-ancestor
65375217|NCT00788918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65375218|NCT00788918|Antimetabolites|antimetabolites|mesh-ancestor
65375219|NCT00788918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375220|NCT02596373|Mitoxantrone|mitoxantrone|mesh-list
65375221|NCT02596373|Analgesics|analgesics|mesh-ancestor
65375222|NCT02596373|Sensory System Agents|sensory system agents|mesh-ancestor
65375223|NCT02596373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65375224|NCT02596373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375225|NCT02596373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375226|NCT02596373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65375227|NCT02596373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65375228|NCT02596373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375229|NCT02596373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375230|NCT00801866|Bevacizumab|bevacizumab|mesh-list
65375231|NCT00801866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65375232|NCT00801866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375233|NCT00801866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65375234|NCT00801866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65375235|NCT00801866|Growth Substances|growth substances|mesh-ancestor
65375236|NCT00801866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375237|NCT00801866|Growth Inhibitors|growth inhibitors|mesh-ancestor
65375238|NCT03973879|Atezolizumab|atezolizumab|mesh-list
65375239|NCT03973879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375240|NCT00860964|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65375241|NCT00860964|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65375243|NCT00860964|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65375244|NCT00860964|Estrogens|estrogens|mesh-ancestor
65375245|NCT00860964|Hormones|hormones|mesh-ancestor
65375246|NCT00860964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65375247|NCT00860964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375248|NCT00860964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65375249|NCT00860964|Contraceptive Agents|contraceptive agents|mesh-ancestor
65375250|NCT00860964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65375251|NCT00860964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65375252|NCT00861042|Lacosamide|lacosamide|mesh-list
65375253|NCT00861042|Anticonvulsants|anticonvulsants|mesh-ancestor
65375254|NCT00861042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65375255|NCT00861042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65375256|NCT00861042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65375257|NCT00861042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375258|NCT04088903|Daratumumab|daratumumab|mesh-list
65375259|NCT04088903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375293|NCT00864864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375295|NCT00868764|Antiemetics|antiemetics|mesh-ancestor
65375296|NCT00868764|Autonomic Agents|autonomic agents|mesh-ancestor
65375297|NCT00868764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65375298|NCT00868764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125065|NCT00561704|Losartan|losartan|mesh-list
65375329|NCT00870402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65375331|NCT00870402|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65375332|NCT00870402|Diuretics|diuretics|mesh-ancestor
65273853|NCT02771249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375333|NCT00870402|Natriuretic Agents|natriuretic agents|mesh-ancestor
65375334|NCT00742235|Vitamin D|vitamin d|mesh-list
65375335|NCT00742235|Ergocalciferols|ergocalciferols|mesh-list
65375336|NCT00742235|Vitamins|vitamins|mesh-ancestor
65375337|NCT00742235|Micronutrients|micronutrients|mesh-ancestor
65375338|NCT00742235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375391|NCT01565278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65375392|NCT00616902|Ergocalciferols|ergocalciferols|mesh-list
65375393|NCT00616902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65375394|NCT00616902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375418|NCT00870714|Tubulin Modulators|tubulin modulators|mesh-ancestor
65375419|NCT00870714|Antimitotic Agents|antimitotic agents|mesh-ancestor
65375420|NCT00870714|Mitosis Modulators|mitosis modulators|mesh-ancestor
65375421|NCT00870714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375422|NCT00870714|Antifungal Agents|antifungal agents|mesh-ancestor
65375423|NCT00870714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65375424|NCT00870714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65375425|NCT00870714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65375426|NCT00870714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375427|NCT00870714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65375428|NCT00870714|Hormone Antagonists|hormone antagonists|mesh-ancestor
65375429|NCT00870714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65375430|NCT00870714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375431|NCT00870714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65375432|NCT02596217|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65375433|NCT02596217|Immunologic Factors|immunologic factors|mesh-ancestor
65375434|NCT02596217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375435|NCT00876330|Antihypertensive Agents|antihypertensive agents|mesh-list
65375437|NCT02598011|Antifungal Agents|antifungal agents|mesh-ancestor
65375438|NCT02598011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65375439|NCT02598011|Antimetabolites|antimetabolites|mesh-ancestor
65375440|NCT02598011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375441|NCT00869310|Dexamethasone|dexamethasone|mesh-list
65375442|NCT00869310|Dexamethasone acetate|dexamethasone acetate|mesh-list
65375443|NCT00869310|Aprepitant|aprepitant|mesh-list
65375444|NCT00869310|Metoclopramide|metoclopramide|mesh-list
65375446|NCT00869310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65375447|NCT00869310|Antiemetics|antiemetics|mesh-ancestor
65375448|NCT00869310|Autonomic Agents|autonomic agents|mesh-ancestor
65375481|NCT00662558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65375482|NCT00869700|Lumefantrine|lumefantrine|mesh-list
65375483|NCT00869700|Artemether|artemether|mesh-list
65375484|NCT00869700|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65375485|NCT00869700|Antimalarials|antimalarials|mesh-ancestor
65375486|NCT00869700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65375487|NCT00869700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65375488|NCT00869700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65375555|NCT00802568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65375557|NCT00802802|Rifampin|rifampin|mesh-list
65375558|NCT00802802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65375559|NCT00802802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65375560|NCT00802802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375561|NCT00802802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375562|NCT00802802|Antiviral Agents|antiviral agents|mesh-ancestor
65375563|NCT00802802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65375564|NCT00802802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65375565|NCT00802802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65375583|NCT00802958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65375584|NCT00802958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375585|NCT01565512|Bupivacaine|bupivacaine|mesh-list
65375586|NCT01565512|Anesthetics, Local|anesthetics, local|mesh-ancestor
65375587|NCT01565512|Anesthetics|anesthetics|mesh-ancestor
65375588|NCT01565512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65375589|NCT01565512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375590|NCT01565512|Sensory System Agents|sensory system agents|mesh-ancestor
65375591|NCT01565512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65375592|NCT04895930|Aflutinib|aflutinib|mesh-list
65375593|NCT04895930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65375594|NCT04895930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375595|NCT04895930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375596|NCT00615030|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64491883|NCT00417664|GABA Modulators|gaba modulators|mesh-ancestor
65375597|NCT00615030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65375598|NCT00615030|Autonomic Agents|autonomic agents|mesh-ancestor
65375599|NCT00615030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65375600|NCT00615030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375601|NCT00615030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65375602|NCT00615030|Respiratory System Agents|respiratory system agents|mesh-ancestor
65375603|NCT00615030|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65375604|NCT00615030|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65375605|NCT00615030|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65375606|NCT00615030|Adrenergic Agents|adrenergic agents|mesh-ancestor
65375607|NCT00615030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65375608|NCT00615030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375609|NCT00789308|Cyclosporine|cyclosporine|mesh-list
65375611|NCT00789308|Mycophenolic Acid|mycophenolic acid|mesh-list
65375612|NCT00789308|Etanercept|etanercept|mesh-list
65375613|NCT00789308|Heparin|heparin|mesh-list
65375614|NCT00789308|Dextrans|dextrans|mesh-list
65375615|NCT00789308|Tacrolimus|tacrolimus|mesh-list
65375616|NCT00789308|Cyclosporins|cyclosporins|mesh-list
65375617|NCT00789308|Thymoglobulin|thymoglobulin|mesh-list
65375618|NCT00789308|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65375619|NCT00789308|Basiliximab|basiliximab|mesh-list
65375620|NCT00789308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65375621|NCT00789308|Immunologic Factors|immunologic factors|mesh-ancestor
65375622|NCT00789308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375623|NCT00789308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65375624|NCT00789308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375647|NCT00518284|Paclitaxel|paclitaxel|mesh-list
65375648|NCT00518284|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65375649|NCT00518284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65375650|NCT00518284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375651|NCT00518284|Tubulin Modulators|tubulin modulators|mesh-ancestor
65375652|NCT00518284|Antimitotic Agents|antimitotic agents|mesh-ancestor
65375653|NCT00518284|Mitosis Modulators|mitosis modulators|mesh-ancestor
65375654|NCT00518284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375655|NCT02595359|Moxifloxacin|moxifloxacin|mesh-list
65375656|NCT02595359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65375657|NCT02595359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65375658|NCT02595359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65375659|NCT02595359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65375660|NCT02595359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375661|NCT02595359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375662|NCT02595359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375663|NCT00871104|Vancomycin|vancomycin|mesh-list
65375664|NCT00871104|Imipenem|imipenem|mesh-list
65375665|NCT00871104|Fosfomycin|fosfomycin|mesh-list
65375666|NCT00871104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65375667|NCT00871104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65375668|NCT00614874|Rosiglitazone|rosiglitazone|mesh-list
65375669|NCT00614874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65375670|NCT00614874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375671|NCT00727415|Cyclophosphamide|cyclophosphamide|mesh-list
65375672|NCT00727415|Fludarabine|fludarabine|mesh-list
65375673|NCT00727415|Fludarabine phosphate|fludarabine phosphate|mesh-list
65375674|NCT00727415|Lenalidomide|lenalidomide|mesh-list
65375675|NCT00727415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65375676|NCT00727415|Immunologic Factors|immunologic factors|mesh-ancestor
65375677|NCT00727415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375709|NCT00544557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65375710|NCT00544557|Immunologic Factors|immunologic factors|mesh-ancestor
65375711|NCT00877110|Cyclophosphamide|cyclophosphamide|mesh-list
65375712|NCT00877110|Vincristine|vincristine|mesh-list
65375713|NCT00877110|Topotecan|topotecan|mesh-list
65375714|NCT00877110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65375715|NCT00877110|Immunologic Factors|immunologic factors|mesh-ancestor
65375716|NCT00877110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375717|NCT00877110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65375718|NCT00877110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65375719|NCT00877110|Alkylating Agents|alkylating agents|mesh-ancestor
65375745|NCT00789386|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65375746|NCT00789386|Anesthetics, General|anesthetics, general|mesh-ancestor
65375748|NCT00789386|GABA Modulators|gaba modulators|mesh-ancestor
65375749|NCT00789386|GABA Agents|gaba agents|mesh-ancestor
65375750|NCT00789386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65375751|NCT00789386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375752|NCT00789386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65375753|NCT00789386|Narcotics|narcotics|mesh-ancestor
65375754|NCT00789386|Analgesics|analgesics|mesh-ancestor
65375755|NCT00789386|Sensory System Agents|sensory system agents|mesh-ancestor
65375756|NCT00789386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65375757|NCT00789464|Trimethoprim|trimethoprim|mesh-list
65375758|NCT00789464|Sulfamethoxazole|sulfamethoxazole|mesh-list
65375759|NCT00789464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65375760|NCT00789464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65375761|NCT00789464|Renal Agents|renal agents|mesh-ancestor
65375762|NCT00789464|Antimalarials|antimalarials|mesh-ancestor
65375763|NCT00789464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65375764|NCT00789464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65375765|NCT00789464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65375766|NCT00789464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375767|NCT00789464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375768|NCT00789464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65375769|NCT00789464|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65375770|NCT00789464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65375858|NCT03721068|Immunologic Factors|immunologic factors|mesh-ancestor
65375859|NCT03721068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375860|NCT03721068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65375861|NCT03721068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65375862|NCT03721068|Alkylating Agents|alkylating agents|mesh-ancestor
65375863|NCT03721068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375864|NCT03721068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375865|NCT03721068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65375866|NCT00977301|Ritonavir|ritonavir|mesh-list
65375867|NCT00977301|Fosamprenavir|fosamprenavir|mesh-list
65375868|NCT00977301|Olanzapine|olanzapine|mesh-list
65375869|NCT00977301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65375870|NCT00977301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65375871|NCT00977301|Protease Inhibitors|protease inhibitors|mesh-ancestor
65375872|NCT00977301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375873|NCT00977301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375874|NCT00977301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65375875|NCT00977301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65375876|NCT00977301|Antiviral Agents|antiviral agents|mesh-ancestor
65375877|NCT00977301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65375878|NCT00977301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65375879|NCT00977301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65375880|NCT00977301|Antiemetics|antiemetics|mesh-ancestor
64768214|NCT01007994|Enalapril|enalapril|mesh-list
65375912|NCT00518206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65375913|NCT00984945|Vaccines|vaccines|mesh-list
65375914|NCT00984945|Immunologic Factors|immunologic factors|mesh-ancestor
65375915|NCT00984945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375916|NCT00879918|Nicotine|nicotine|mesh-list
65375917|NCT00879918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65375918|NCT00879918|Autonomic Agents|autonomic agents|mesh-ancestor
65375919|NCT00879918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65375949|NCT00877422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65375950|NCT00877422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65375951|NCT04039698|Sofosbuvir|sofosbuvir|mesh-list
65375952|NCT04039698|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65375953|NCT04039698|Velpatasvir|velpatasvir|mesh-list
65375954|NCT04039698|Antiviral Agents|antiviral agents|mesh-ancestor
65375955|NCT04039698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65375956|NCT04006821|Apatinib|apatinib|mesh-list
65375957|NCT04006821|Antibodies|antibodies|mesh-list
65375958|NCT04006821|Immunologic Factors|immunologic factors|mesh-ancestor
65375959|NCT04006821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375960|NCT04006821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375961|NCT04006821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65375962|NCT04006821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375963|NCT04006821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375964|NCT00803816|Everolimus|everolimus|mesh-list
65375965|NCT00803816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375994|NCT00981201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65375995|NCT00981201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65375996|NCT00981201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65375997|NCT00981201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375998|NCT00981201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375999|NCT05279391|Dexamethasone|dexamethasone|mesh-list
65376000|NCT05279391|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65376002|NCT05279391|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65376003|NCT05279391|Tinzaparin|tinzaparin|mesh-list
65376004|NCT05279391|Dalteparin|dalteparin|mesh-list
65273854|NCT02771249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65273855|NCT02771249|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64787293|NCT00002532|Vitamins|vitamins|mesh-ancestor
65376005|NCT05279391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65376006|NCT05279391|Antiemetics|antiemetics|mesh-ancestor
65376007|NCT05279391|Autonomic Agents|autonomic agents|mesh-ancestor
65376008|NCT05279391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65376009|NCT05279391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376010|NCT05279391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65376011|NCT05279391|Glucocorticoids|glucocorticoids|mesh-ancestor
65376033|NCT00789620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376035|NCT03970265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65376036|NCT03970265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65376037|NCT00877656|Zanolimumab|zanolimumab|mesh-list
65376038|NCT00877656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65376039|NCT00877656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376040|NCT05371925|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
65376041|NCT05371925|Anticoagulants|anticoagulants|mesh-ancestor
65376042|NCT05371925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65376043|NCT05371925|Antimetabolites|antimetabolites|mesh-ancestor
65376044|NCT05371925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376045|NCT05371925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65376046|NCT05371925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65376047|NCT05371925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65376048|NCT05371925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65376049|NCT05371925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376050|NCT00797420|Fluconazole|fluconazole|mesh-list
65376051|NCT00797420|Antifungal Agents|antifungal agents|mesh-ancestor
65376052|NCT00797420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65376053|NCT00797420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65376054|NCT00797420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65376055|NCT00797420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376056|NCT00797420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376057|NCT00797420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65376058|NCT00797420|Hormone Antagonists|hormone antagonists|mesh-ancestor
65376059|NCT00797420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65376060|NCT00797420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376092|NCT00726557|Antiviral Agents|antiviral agents|mesh-ancestor
65376093|NCT00726557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65376094|NCT00726557|Antimetabolites|antimetabolites|mesh-ancestor
65376095|NCT00726557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376096|NCT00726557|Immunologic Factors|immunologic factors|mesh-ancestor
65376097|NCT00726557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376098|NCT00803972|Insulin|insulin|mesh-list
65376099|NCT00803972|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65376100|NCT00803972|Insulin Lispro|insulin lispro|mesh-list
65376101|NCT00803972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65376102|NCT00803972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376103|NCT00880386|Losartan|losartan|mesh-list
65376135|NCT00978159|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65376136|NCT00978159|Histamine Antagonists|histamine antagonists|mesh-ancestor
65376137|NCT00978159|Histamine Agents|histamine agents|mesh-ancestor
65376138|NCT00978159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65376139|NCT00978159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376140|NCT00804206|Bevacizumab|bevacizumab|mesh-list
65376141|NCT00804206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65376142|NCT00804206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376143|NCT00804206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65376144|NCT00804206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65376172|NCT00657020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376174|NCT00657020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65376175|NCT00657020|Cholinergic Agents|cholinergic agents|mesh-ancestor
65376176|NCT00657020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65376177|NCT00657020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376178|NCT03921723|Dolutegravir|dolutegravir|mesh-list
65376179|NCT03921723|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65376180|NCT03921723|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65376181|NCT03921723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376182|NCT03921723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376183|NCT03921723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65376184|NCT03921723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65273856|NCT02771249|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65376185|NCT03921723|Antiviral Agents|antiviral agents|mesh-ancestor
65376186|NCT03921723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65376187|NCT00872664|Carotenoids|carotenoids|mesh-list
65376188|NCT00872664|Antioxidants|antioxidants|mesh-ancestor
65376189|NCT00872664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376190|NCT00872664|Protective Agents|protective agents|mesh-ancestor
64768528|NCT04308330|Vorinostat|vorinostat|mesh-list
65376220|NCT00872976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376221|NCT00872976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376222|NCT00872976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65376223|NCT00872976|Alkylating Agents|alkylating agents|mesh-ancestor
65376224|NCT00544167|Paclitaxel|paclitaxel|mesh-list
65376225|NCT00544167|Cyclophosphamide|cyclophosphamide|mesh-list
65376226|NCT00544167|Doxorubicin|doxorubicin|mesh-list
65376227|NCT00544167|Sorafenib|sorafenib|mesh-list
65376228|NCT00544167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65376229|NCT00544167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376230|NCT00544167|Tubulin Modulators|tubulin modulators|mesh-ancestor
65376231|NCT00544167|Antimitotic Agents|antimitotic agents|mesh-ancestor
65376232|NCT00544167|Mitosis Modulators|mitosis modulators|mesh-ancestor
65376233|NCT00544167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376234|NCT00544167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65376235|NCT00544167|Immunologic Factors|immunologic factors|mesh-ancestor
65376236|NCT00544167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376237|NCT00544167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65376238|NCT00544167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65126038|NCT04586361|Hyaluronic Acid|hyaluronic acid|mesh-list
65376268|NCT00804440|Ibuprofen|ibuprofen|mesh-list
65376269|NCT00804440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65376270|NCT00804440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65376271|NCT00804440|Analgesics|analgesics|mesh-ancestor
65376272|NCT00804440|Sensory System Agents|sensory system agents|mesh-ancestor
65376273|NCT00804440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65376274|NCT00804440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376275|NCT00804440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65376276|NCT00804440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65376277|NCT00804440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65376278|NCT00804440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376279|NCT00804440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376280|NCT00880854|Tremelimumab|tremelimumab|mesh-list
65376281|NCT00880854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376339|NCT00978471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65376340|NCT00978471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65376341|NCT00978471|Immunologic Factors|immunologic factors|mesh-ancestor
65376342|NCT00978471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376343|NCT00804674|Bupivacaine|bupivacaine|mesh-list
65376344|NCT00804674|Anesthetics, Local|anesthetics, local|mesh-ancestor
65376345|NCT00804674|Anesthetics|anesthetics|mesh-ancestor
65376346|NCT00804674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65376347|NCT00804674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376348|NCT00804674|Sensory System Agents|sensory system agents|mesh-ancestor
65376349|NCT00804674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65376351|NCT00881088|Nadroparin|nadroparin|mesh-list
65376352|NCT00881088|Fondaparinux|fondaparinux|mesh-list
65376353|NCT00881088|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65376354|NCT00881088|Antithrombins|antithrombins|mesh-ancestor
65376355|NCT00881088|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65376356|NCT00881088|Protease Inhibitors|protease inhibitors|mesh-ancestor
65376357|NCT00881088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376358|NCT00881088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376359|NCT00881088|Anticoagulants|anticoagulants|mesh-ancestor
65376360|NCT00881088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65376361|NCT00881088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65376362|NCT00978549|Docetaxel|docetaxel|mesh-list
65376363|NCT00978549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376364|NCT00978549|Tubulin Modulators|tubulin modulators|mesh-ancestor
65376365|NCT00978549|Antimitotic Agents|antimitotic agents|mesh-ancestor
65376366|NCT00978549|Mitosis Modulators|mitosis modulators|mesh-ancestor
65376367|NCT00978549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376368|NCT00656084|Gemcitabine|gemcitabine|mesh-list
65376369|NCT00656084|Rituximab|rituximab|mesh-list
65376382|NCT00656084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65376383|NCT00656084|Analgesics|analgesics|mesh-ancestor
65376384|NCT00656084|Sensory System Agents|sensory system agents|mesh-ancestor
65273857|NCT02771249|Protease Inhibitors|protease inhibitors|mesh-ancestor
65376385|NCT00656084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65376386|NCT00656084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65376387|NCT00656084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65376388|NCT00881166|Paclitaxel|paclitaxel|mesh-list
65376389|NCT00881166|Etoposide|etoposide|mesh-list
65376390|NCT00881166|Docetaxel|docetaxel|mesh-list
65376391|NCT00881166|Carboplatin|carboplatin|mesh-list
65376392|NCT00881166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65376393|NCT00881166|Topotecan|topotecan|mesh-list
65376394|NCT00881166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65376395|NCT00881166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376396|NCT00881166|Tubulin Modulators|tubulin modulators|mesh-ancestor
65376397|NCT00881166|Antimitotic Agents|antimitotic agents|mesh-ancestor
65376398|NCT00881166|Mitosis Modulators|mitosis modulators|mesh-ancestor
65376399|NCT00881166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376400|NCT00881166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65376401|NCT00881166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65376402|NCT00881166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376403|NCT00881166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65376404|NCT00881166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65376405|NCT00804752|Vitamin D|vitamin d|mesh-list
65376406|NCT00804752|Ergocalciferols|ergocalciferols|mesh-list
65376407|NCT00804752|Cholecalciferol|cholecalciferol|mesh-list
65376408|NCT00804752|Vitamins|vitamins|mesh-list
65376409|NCT00804752|Micronutrients|micronutrients|mesh-ancestor
65376410|NCT00804752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376411|NCT00804752|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65376412|NCT00804752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65376413|NCT05225766|Bupivacaine|bupivacaine|mesh-list
65376414|NCT05225766|Anesthetics, Local|anesthetics, local|mesh-ancestor
65376446|NCT00613938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376447|NCT00613938|Analgesics|analgesics|mesh-ancestor
65376448|NCT00613938|Sensory System Agents|sensory system agents|mesh-ancestor
65376449|NCT00613938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65376450|NCT00613938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65376451|NCT00613938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65376452|NCT00613938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65376453|NCT00613938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376454|NCT00613938|Adrenergic Agents|adrenergic agents|mesh-ancestor
65376455|NCT00613938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65376456|NCT00978861|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65376457|NCT00978861|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65376458|NCT00978861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64768809|NCT05821309|Glycerol|glycerol|mesh-list
65376490|NCT00873756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376491|NCT00873756|Growth Inhibitors|growth inhibitors|mesh-ancestor
65376492|NCT00873834|Fluoxetine|fluoxetine|mesh-list
65376493|NCT00873834|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65376494|NCT00873834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65376495|NCT00873834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65376496|NCT00873834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376497|NCT00873834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65376498|NCT00873834|Serotonin Agents|serotonin agents|mesh-ancestor
65376499|NCT00873834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376500|NCT00873834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65376501|NCT00873834|Antidepressive Agents|antidepressive agents|mesh-ancestor
65376537|NCT00805298|Autonomic Agents|autonomic agents|mesh-ancestor
65376538|NCT00805298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65376539|NCT00805298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376540|NCT00805298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65376541|NCT00805298|Glucocorticoids|glucocorticoids|mesh-ancestor
65376542|NCT00805298|Hormones|hormones|mesh-ancestor
65376578|NCT02553044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65376579|NCT00545103|Mesalamine|mesalamine|mesh-list
65376580|NCT00545103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65376581|NCT00545103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65376611|NCT00246337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65376612|NCT00246337|Serotonin Agents|serotonin agents|mesh-ancestor
65376613|NCT00246337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65376614|NCT00246337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376615|NCT00246337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376616|NCT05012943|Vaccines|vaccines|mesh-list
65376617|NCT05012943|Immunologic Factors|immunologic factors|mesh-ancestor
65376618|NCT05012943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376619|NCT01581853|Ritonavir|ritonavir|mesh-list
65376620|NCT01581853|Lopinavir|lopinavir|mesh-list
65376621|NCT01581853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65376622|NCT01581853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65376623|NCT01581853|Protease Inhibitors|protease inhibitors|mesh-ancestor
65376624|NCT01581853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376625|NCT01581853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768985|NCT05814991|Nitroglycerin|nitroglycerin|mesh-list
65376660|NCT02593721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376661|NCT02593721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65376692|NCT00798980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65376693|NCT00798980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376694|NCT00798980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65376695|NCT00798980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65376696|NCT00798980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65376697|NCT00725621|Infliximab|infliximab|mesh-list
65376698|NCT00725621|Dermatologic Agents|dermatologic agents|mesh-ancestor
65376699|NCT00725621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65376700|NCT00725621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65376701|NCT00613626|Etoposide|etoposide|mesh-list
65376702|NCT00613626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376703|NCT00613626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65376704|NCT00613626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65376705|NCT00613626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65376730|NCT00652340|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65376731|NCT00652340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376732|NCT00652340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65376733|NCT00652340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376734|NCT00652340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376736|NCT00257725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65376737|NCT00257725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376738|NCT00257725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65376739|NCT00257725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65376740|NCT00257725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65376741|NCT00257725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376742|NCT00257725|Dopamine Agents|dopamine agents|mesh-ancestor
65376743|NCT00257725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65376744|NCT00544869|Tolvaptan|tolvaptan|mesh-list
65376745|NCT00544869|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65376746|NCT00544869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376747|NCT00544869|Natriuretic Agents|natriuretic agents|mesh-ancestor
65376748|NCT00544869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376749|NCT02593643|Midazolam|midazolam|mesh-list
65376750|NCT02593643|Ketamine|ketamine|mesh-list
65376751|NCT02593643|Analgesics|analgesics|mesh-ancestor
64769113|NCT05665465|Nicotine|nicotine|mesh-list
65376776|NCT00881556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376777|NCT00881556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376778|NCT00881556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65376779|NCT00881556|Immunologic Factors|immunologic factors|mesh-ancestor
65376780|NCT00881556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376781|NCT00881556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65376782|NCT00881556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376783|NCT00881556|Alkylating Agents|alkylating agents|mesh-ancestor
65376784|NCT00881556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65376785|NCT00881556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65376786|NCT00881556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65376788|NCT00881556|Antiemetics|antiemetics|mesh-ancestor
65376789|NCT00881556|Autonomic Agents|autonomic agents|mesh-ancestor
65376790|NCT00881556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65376791|NCT00881556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65376792|NCT00881556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65376793|NCT00881556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65376794|NCT00881556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65376795|NCT00881556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65376796|NCT00881556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65376797|NCT00881556|GABA Modulators|gaba modulators|mesh-ancestor
65376798|NCT00881556|GABA Agents|gaba agents|mesh-ancestor
65376799|NCT00881556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65376800|NCT00881634|Cetirizine|cetirizine|mesh-list
65376801|NCT00881634|Pseudoephedrine|pseudoephedrine|mesh-list
65376802|NCT00881634|Ephedrine|ephedrine|mesh-list
65376866|NCT00652028|Anesthetics|anesthetics|mesh-ancestor
65376867|NCT00652028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65376868|NCT00652028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65376869|NCT00652028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65376870|NCT00652028|GABA Modulators|gaba modulators|mesh-ancestor
65126617|NCT00563771|Rasburicase|rasburicase|mesh-list
65376872|NCT00799136|Prednisone|prednisone|mesh-list
65376873|NCT00799136|Vincristine|vincristine|mesh-list
65376874|NCT00799136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65376875|NCT00799136|Glucocorticoids|glucocorticoids|mesh-ancestor
65376876|NCT00799136|Hormones|hormones|mesh-ancestor
65376877|NCT00799136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64769240|NCT05543629|Nivolumab|nivolumab|mesh-list
65376904|NCT00733421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65376905|NCT00733421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65376906|NCT00733421|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65376907|NCT00733421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65376908|NCT00733421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376909|NCT00733421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376910|NCT00613080|Leucovorin|leucovorin|mesh-list
65376911|NCT00613080|Fluorouracil|fluorouracil|mesh-list
65376912|NCT00613080|Capecitabine|capecitabine|mesh-list
65376913|NCT00613080|Oxaliplatin|oxaliplatin|mesh-list
65376914|NCT00613080|Antimetabolites|antimetabolites|mesh-ancestor
65376915|NCT00613080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376916|NCT00613080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65376917|NCT00613080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376918|NCT00613080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65376919|NCT00613080|Immunologic Factors|immunologic factors|mesh-ancestor
65376920|NCT00613080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376921|NCT00613080|Antidotes|antidotes|mesh-ancestor
65376922|NCT00613080|Protective Agents|protective agents|mesh-ancestor
65376923|NCT00613080|Vitamin B Complex|vitamin b complex|mesh-ancestor
65376924|NCT00613080|Vitamins|vitamins|mesh-ancestor
65376925|NCT00613080|Micronutrients|micronutrients|mesh-ancestor
65376926|NCT00917891|Dapivirine|dapivirine|mesh-list
65376927|NCT00917891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65376946|NCT00732875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65376947|NCT00732875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65376948|NCT00732875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65376949|NCT00881790|Fluorides|fluorides|mesh-list
65376950|NCT00881790|Fluorides, Topical|fluorides, topical|mesh-list
65376951|NCT00881790|Cariostatic Agents|cariostatic agents|mesh-ancestor
65376952|NCT00881790|Protective Agents|protective agents|mesh-ancestor
65376953|NCT00881790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376954|NCT00810446|Rifabutin|rifabutin|mesh-list
65376955|NCT00810446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65376956|NCT00810446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65376957|NCT00810446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65376958|NCT00810446|Antitubercular Agents|antitubercular agents|mesh-ancestor
65376959|NCT00810524|Lamivudine|lamivudine|mesh-list
65376960|NCT00810524|Adefovir|adefovir|mesh-list
65376961|NCT00810524|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65376962|NCT00810524|Telbivudine|telbivudine|mesh-list
65376963|NCT00810524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65376964|NCT00810524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65376965|NCT00810524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376966|NCT00810524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376967|NCT00810524|Antiviral Agents|antiviral agents|mesh-ancestor
65376968|NCT00810524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65376969|NCT00810524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65376970|NCT00810524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65376971|NCT00810680|Valproic Acid|valproic acid|mesh-list
65376972|NCT00810680|Anticonvulsants|anticonvulsants|mesh-ancestor
65376973|NCT00810680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376974|NCT00810680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376975|NCT00810680|GABA Agents|gaba agents|mesh-ancestor
65376976|NCT00810680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65376977|NCT00810680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376978|NCT00810680|Antimanic Agents|antimanic agents|mesh-ancestor
65376979|NCT00810680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65376980|NCT00810680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65376981|NCT00810680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65376982|NCT00799448|Insulin|insulin|mesh-list
65376983|NCT00799448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65376984|NCT00799448|Repaglinide|repaglinide|mesh-list
65377009|NCT03829020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377011|NCT03829020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65377012|NCT03829020|Antiviral Agents|antiviral agents|mesh-ancestor
65273858|NCT02771249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273859|NCT02771249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65273860|NCT02771249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65377013|NCT03829020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65377014|NCT00810836|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65377015|NCT00810836|Dermatologic Agents|dermatologic agents|mesh-ancestor
65377016|NCT00810836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65377017|NCT00810836|Immunologic Factors|immunologic factors|mesh-ancestor
65377018|NCT00810836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377019|NCT00874926|Factor VIII|factor viii|mesh-list
65377020|NCT00874926|Coagulants|coagulants|mesh-ancestor
65377021|NCT00810914|Bupivacaine|bupivacaine|mesh-list
65126767|NCT00575523|Mydriatics|mydriatics|mesh-ancestor
65377022|NCT00810914|Anesthetics, Local|anesthetics, local|mesh-ancestor
65377023|NCT00810914|Anesthetics|anesthetics|mesh-ancestor
65377024|NCT00810914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65377025|NCT00810914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377026|NCT00810914|Sensory System Agents|sensory system agents|mesh-ancestor
65377027|NCT00810914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377028|NCT00878904|Epirubicin|epirubicin|mesh-list
65377029|NCT00878904|Panobinostat|panobinostat|mesh-list
65377030|NCT00878904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65377031|NCT00878904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65377032|NCT00878904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65377033|NCT00878904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65377034|NCT00878904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377035|NCT00878904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377036|NCT00878904|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65377037|NCT00737711|Epoetin Alfa|epoetin alfa|mesh-list
65377052|NCT00875082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65377053|NCT00875082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377054|NCT00875082|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65377055|NCT00875082|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65377056|NCT00875082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377057|NCT02552342|Methylprednisolone|methylprednisolone|mesh-list
65377058|NCT02552342|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65377059|NCT02552342|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65377060|NCT02552342|Prednisolone|prednisolone|mesh-list
65377061|NCT02552342|Prednisolone acetate|prednisolone acetate|mesh-list
65377062|NCT02552342|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65377063|NCT02552342|Prednisolone phosphate|prednisolone phosphate|mesh-list
65377064|NCT02552342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65377065|NCT02552342|Antiemetics|antiemetics|mesh-ancestor
65377066|NCT02552342|Autonomic Agents|autonomic agents|mesh-ancestor
65377067|NCT02552342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377068|NCT02552342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377069|NCT02552342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65377070|NCT02552342|Glucocorticoids|glucocorticoids|mesh-ancestor
65377071|NCT02552342|Hormones|hormones|mesh-ancestor
65377072|NCT02552342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65377073|NCT02552342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65377074|NCT02552342|Protective Agents|protective agents|mesh-ancestor
65377075|NCT02552342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65377076|NCT02552342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65377077|NCT00811226|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65377078|NCT00811226|Olmesartan|olmesartan|mesh-list
65377079|NCT00811226|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65377080|NCT00811226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65377081|NCT00811226|Diuretics|diuretics|mesh-ancestor
65377082|NCT00811226|Natriuretic Agents|natriuretic agents|mesh-ancestor
65377083|NCT00811226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377084|NCT00811226|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65377085|NCT00811226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65377086|NCT00811226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377087|NCT00811226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65377088|NCT00811226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65377089|NCT00238303|Vorinostat|vorinostat|mesh-list
65377090|NCT00238303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65377091|NCT00238303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65377092|NCT00238303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377093|NCT00238303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273861|NCT02771249|Antiviral Agents|antiviral agents|mesh-ancestor
65273862|NCT02771249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65377094|NCT00811460|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65377095|NCT00811460|Incretins|incretins|mesh-ancestor
65377096|NCT00811460|Hormones|hormones|mesh-ancestor
65377097|NCT00811460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64769453|NCT05232409|Pembrolizumab|pembrolizumab|mesh-list
65377119|NCT00882024|Tranilast|tranilast|mesh-list
65377120|NCT00882024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65377121|NCT00882024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65377122|NCT00882024|Analgesics|analgesics|mesh-ancestor
65377123|NCT00882024|Sensory System Agents|sensory system agents|mesh-ancestor
65377124|NCT00882024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377125|NCT00882024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377126|NCT00882024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65377127|NCT00882024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65377128|NCT00882024|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65377129|NCT00882024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65377130|NCT00882024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377131|NCT00882024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65377132|NCT00882024|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65377133|NCT00882024|Histamine Antagonists|histamine antagonists|mesh-ancestor
65377134|NCT00882024|Histamine Agents|histamine agents|mesh-ancestor
65377135|NCT00882024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65377136|NCT00882024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65377137|NCT00882024|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65377138|NCT00799760|Oseltamivir|oseltamivir|mesh-list
65377139|NCT00799760|Zanamivir|zanamivir|mesh-list
65377140|NCT00799760|Antiviral Agents|antiviral agents|mesh-ancestor
65377141|NCT00799760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65377142|NCT00799760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377143|NCT00799760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377144|NCT00799838|Amoxicillin|amoxicillin|mesh-list
65377145|NCT00799838|Ketoprofen|ketoprofen|mesh-list
65377146|NCT00799838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65377147|NCT00799838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65377148|NCT00799838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65377149|NCT00799838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65377150|NCT00799838|Analgesics|analgesics|mesh-ancestor
65377179|NCT00800306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65377180|NCT00800306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377181|NCT00800306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377182|NCT00800306|Protective Agents|protective agents|mesh-ancestor
65377183|NCT00800306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377184|NCT00800306|Sympathomimetics|sympathomimetics|mesh-ancestor
65377185|NCT00800306|Autonomic Agents|autonomic agents|mesh-ancestor
65377186|NCT00800306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377187|NCT00800306|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65377188|NCT00800306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65377189|NCT00800306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65377190|NCT00800306|Adrenergic Agents|adrenergic agents|mesh-ancestor
65377191|NCT00800306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65377193|NCT01581775|Anticonvulsants|anticonvulsants|mesh-ancestor
65377194|NCT01581775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64769570|NCT05098938|Acyclovir|acyclovir|mesh-list
65377208|NCT01072747|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65377209|NCT01072747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65377210|NCT01072747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377211|NCT00879372|Tianeptine|tianeptine|mesh-list
65377212|NCT00879372|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65377213|NCT00879372|Antidepressive Agents|antidepressive agents|mesh-ancestor
65377214|NCT00879372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65377215|NCT00731783|Chlorhexidine|chlorhexidine|mesh-list
65377216|NCT00731783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65377217|NCT00731783|Mupirocin|mupirocin|mesh-list
65377218|NCT00731783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65377219|NCT00731783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65377220|NCT00731783|Disinfectants|disinfectants|mesh-ancestor
65377221|NCT00731783|Dermatologic Agents|dermatologic agents|mesh-ancestor
65377222|NCT00731783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65377223|NCT00731783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65377224|NCT00731783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377225|NCT00731783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273863|NCT02771249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65273864|NCT02771249|Vitamin B Complex|vitamin b complex|mesh-ancestor
65377226|NCT03691350|Nicotine|nicotine|mesh-list
65377227|NCT03691350|Dimercaprol|dimercaprol|mesh-list
65377228|NCT03691350|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65377229|NCT03691350|Autonomic Agents|autonomic agents|mesh-ancestor
65377230|NCT03691350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377231|NCT03691350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377232|NCT03691350|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65377233|NCT03691350|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65377234|NCT03691350|Cholinergic Agents|cholinergic agents|mesh-ancestor
65377235|NCT03691350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65377236|NCT03691350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377237|NCT03691350|Chelating Agents|chelating agents|mesh-ancestor
65377238|NCT03691350|Sequestering Agents|sequestering agents|mesh-ancestor
65377239|NCT02592083|Tamoxifen|tamoxifen|mesh-list
65377240|NCT02592083|Goserelin|goserelin|mesh-list
65377241|NCT02592083|Palbociclib|palbociclib|mesh-list
65377242|NCT02592083|Exemestane|exemestane|mesh-list
65377243|NCT02592083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65377244|NCT02592083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65377245|NCT02592083|Hormone Antagonists|hormone antagonists|mesh-ancestor
65377246|NCT02592083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65377247|NCT02592083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126977|NCT00576069|Adrenergic Agents|adrenergic agents|mesh-ancestor
65377272|NCT00724373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377273|NCT00724373|Antiviral Agents|antiviral agents|mesh-ancestor
65377274|NCT00724373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65377276|NCT02594579|Cholecalciferol|cholecalciferol|mesh-list
65377277|NCT02594579|Vitamins|vitamins|mesh-ancestor
65377278|NCT02594579|Micronutrients|micronutrients|mesh-ancestor
65377279|NCT02594579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377280|NCT02594579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65377281|NCT02594579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65377282|NCT02593409|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65377283|NCT02593409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65377284|NCT02593409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65377285|NCT02593409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377286|NCT02593409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377287|NCT02593409|Antiviral Agents|antiviral agents|mesh-ancestor
65377288|NCT02593409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65377289|NCT02593409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65377290|NCT02593409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65377291|NCT00724061|Interferons|interferons|mesh-list
65377292|NCT00724061|Interferon-alpha|interferon-alpha|mesh-list
65377293|NCT00724061|Interferon alpha-2|interferon alpha-2|mesh-list
65377294|NCT00724061|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65377362|NCT00882960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65377363|NCT00882960|Anesthetics, General|anesthetics, general|mesh-ancestor
65377364|NCT00882960|Anesthetics|anesthetics|mesh-ancestor
65377365|NCT00883194|Ropivacaine|ropivacaine|mesh-list
65377366|NCT00883194|Anesthetics, Local|anesthetics, local|mesh-ancestor
65377367|NCT00883194|Anesthetics|anesthetics|mesh-ancestor
65377368|NCT00883194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65377369|NCT00883194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377370|NCT00883194|Sensory System Agents|sensory system agents|mesh-ancestor
65377371|NCT00883194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377372|NCT00888732|Insulin|insulin|mesh-list
65377373|NCT00888732|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65377374|NCT00888732|Insulin Aspart|insulin aspart|mesh-list
65377404|NCT00236899|Immunologic Factors|immunologic factors|mesh-ancestor
65377405|NCT00236899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377407|NCT00611130|Anticonvulsants|anticonvulsants|mesh-ancestor
65377408|NCT00611130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377409|NCT00611130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377410|NCT00611130|GABA Agents|gaba agents|mesh-ancestor
65377411|NCT00611130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65377412|NCT00611130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377413|NCT00885690|Olanzapine|olanzapine|mesh-list
65377414|NCT00885690|Sertindole|sertindole|mesh-list
65377415|NCT00885690|Antiemetics|antiemetics|mesh-ancestor
65377416|NCT00885690|Autonomic Agents|autonomic agents|mesh-ancestor
65377417|NCT00885690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377418|NCT00885690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787940|NCT00002790|Cyclosporine|cyclosporine|mesh-list
65377419|NCT00885690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65377420|NCT00885690|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65377452|NCT00256243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65377453|NCT00256243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65377454|NCT00256243|Alkylating Agents|alkylating agents|mesh-ancestor
65377455|NCT00256243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65377456|NCT00256243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65377457|NCT00256243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65377458|NCT00256243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65377459|NCT00256243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377460|NCT00256243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65377461|NCT00236197|Rabeprazole|rabeprazole|mesh-list
65377462|NCT00236197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65377463|NCT00236197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65377490|NCT03973567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65377492|NCT00885924|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65377493|NCT00885924|Hemostatics|hemostatics|mesh-ancestor
65377494|NCT00885924|Coagulants|coagulants|mesh-ancestor
65377495|NCT00885924|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65377496|NCT00885924|Natriuretic Agents|natriuretic agents|mesh-ancestor
65377497|NCT00885924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377499|NCT01071889|Antidotes|antidotes|mesh-ancestor
65377500|NCT01071889|Protective Agents|protective agents|mesh-ancestor
65377501|NCT01071889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377502|NCT01071889|GABA Modulators|gaba modulators|mesh-ancestor
65377503|NCT01071889|GABA Agents|gaba agents|mesh-ancestor
65377504|NCT01071889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65377505|NCT01071889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377506|NCT03973411|Ondansetron|ondansetron|mesh-list
65377507|NCT03973411|Antiemetics|antiemetics|mesh-ancestor
65377508|NCT03973411|Autonomic Agents|autonomic agents|mesh-ancestor
65377509|NCT03973411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377510|NCT03973411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377511|NCT03973411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65377512|NCT03973411|Antipruritics|antipruritics|mesh-ancestor
65377513|NCT03973411|Dermatologic Agents|dermatologic agents|mesh-ancestor
64769965|NCT04652661|Midazolam|midazolam|mesh-list
65377540|NCT00889044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65377541|NCT00889044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65377542|NCT00889044|Purinergic Agents|purinergic agents|mesh-ancestor
65377543|NCT00889044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65377544|NCT00889044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377545|NCT00889044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377546|NCT00886002|Fentanyl|fentanyl|mesh-list
65377547|NCT00886002|Buprenorphine|buprenorphine|mesh-list
65377548|NCT00886002|Naloxone|naloxone|mesh-list
65377549|NCT00886002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65377550|NCT00886002|Narcotics|narcotics|mesh-ancestor
65377551|NCT00886002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65377552|NCT00886002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377553|NCT00886002|Analgesics|analgesics|mesh-ancestor
65377554|NCT00886002|Sensory System Agents|sensory system agents|mesh-ancestor
65377555|NCT00886002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377556|NCT00886002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65377557|NCT00886002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65377558|NCT00886002|Anesthetics, General|anesthetics, general|mesh-ancestor
65377559|NCT00886002|Anesthetics|anesthetics|mesh-ancestor
65377560|NCT00886002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65377591|NCT00889356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65377592|NCT00889356|Hormone Antagonists|hormone antagonists|mesh-ancestor
65377593|NCT00889356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65377594|NCT00889356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377595|NCT00889356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65377596|NCT00889356|Amebicides|amebicides|mesh-ancestor
65377597|NCT00889356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65377598|NCT00889356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65377599|NCT00889434|Tocotrienols|tocotrienols|mesh-list
65377600|NCT00889434|Vitamin E|vitamin e|mesh-list
65377601|NCT00889434|Tocopherols|tocopherols|mesh-list
65377602|NCT00889434|Antioxidants|antioxidants|mesh-ancestor
65377603|NCT00889434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377604|NCT00889434|Protective Agents|protective agents|mesh-ancestor
65377605|NCT00889434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377606|NCT00889434|Vitamins|vitamins|mesh-ancestor
65377668|NCT04037514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65273865|NCT02771249|Vitamins|vitamins|mesh-ancestor
64788034|NCT05746806|Androgens|androgens|mesh-list
65377670|NCT04037514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377671|NCT04037514|Antipyretics|antipyretics|mesh-ancestor
65377672|NCT00730847|Vaccines|vaccines|mesh-list
65377673|NCT00730847|Immunologic Factors|immunologic factors|mesh-ancestor
65377674|NCT00730847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377675|NCT04034004|Naloxone|naloxone|mesh-list
65377676|NCT04034004|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65377677|NCT04034004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377678|NCT04034004|Sensory System Agents|sensory system agents|mesh-ancestor
65377679|NCT04034004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377680|NCT00573066|Dexmedetomidine|dexmedetomidine|mesh-list
65377681|NCT00573066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65377682|NCT00573066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65377683|NCT00573066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377684|NCT00573066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65377685|NCT00573066|Analgesics|analgesics|mesh-ancestor
65377724|NCT00890214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65377725|NCT00890214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65377790|NCT02541396|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65377791|NCT02541396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65377792|NCT02541396|Anesthetics, General|anesthetics, general|mesh-ancestor
65377793|NCT02541396|Anesthetics|anesthetics|mesh-ancestor
65377794|NCT02541396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65377826|NCT03973957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377828|NCT03973957|Sensory System Agents|sensory system agents|mesh-ancestor
65377829|NCT03973957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377830|NCT03973957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65377831|NCT03973957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65377832|NCT03973957|Anesthetics, General|anesthetics, general|mesh-ancestor
65377833|NCT03973957|Anesthetics|anesthetics|mesh-ancestor
65377834|NCT00658658|Panitumumab|panitumumab|mesh-list
65377835|NCT00658658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65377836|NCT00658658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65377837|NCT00723203|Panobinostat|panobinostat|mesh-list
65377864|NCT00891072|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65377865|NCT00891072|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
65377866|NCT00891072|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
65377867|NCT02591927|Insulin|insulin|mesh-list
65377868|NCT02591927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65377869|NCT02591927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377870|NCT00891150|Oxytocin|oxytocin|mesh-list
65377871|NCT00891150|Oxytocics|oxytocics|mesh-ancestor
65377872|NCT00891150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65377873|NCT00891150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377874|NCT00800462|Bromides|bromides|mesh-list
65377875|NCT00800462|Oxybutynin|oxybutynin|mesh-list
65377876|NCT00800462|Darifenacin|darifenacin|mesh-list
65377877|NCT00800462|Anticonvulsants|anticonvulsants|mesh-ancestor
65377878|NCT00800462|Parasympatholytics|parasympatholytics|mesh-ancestor
65377879|NCT00800462|Autonomic Agents|autonomic agents|mesh-ancestor
65377880|NCT00800462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377881|NCT00800462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377882|NCT00800462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65377883|NCT00800462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65377884|NCT00800462|Cholinergic Agents|cholinergic agents|mesh-ancestor
65377885|NCT00800462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65377886|NCT00800462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377887|NCT00800462|Urological Agents|urological agents|mesh-ancestor
65377909|NCT00891306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65377910|NCT00891306|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65377911|NCT00891306|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65377912|NCT00891306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65377913|NCT00891306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65377914|NCT00891306|Antitubercular Agents|antitubercular agents|mesh-ancestor
65377915|NCT00891306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65377916|NCT00891306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65377918|NCT00891306|Autonomic Agents|autonomic agents|mesh-ancestor
65377919|NCT00891306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377920|NCT00891306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65377921|NCT00891306|Glucocorticoids|glucocorticoids|mesh-ancestor
65377922|NCT00891306|Hormones|hormones|mesh-ancestor
65377923|NCT00891306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65377924|NCT00891306|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64492757|NCT04323748|Rituximab|rituximab|mesh-list
65377925|NCT00891306|Protective Agents|protective agents|mesh-ancestor
65377926|NCT00891306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65377927|NCT00807872|Antibodies|antibodies|mesh-list
65377928|NCT00807872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65377929|NCT00807872|Immunologic Factors|immunologic factors|mesh-ancestor
65377930|NCT00807872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377932|NCT00813722|Atenolol|atenolol|mesh-list
65377933|NCT00813722|Amlodipine|amlodipine|mesh-list
65377934|NCT00813722|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65377935|NCT00813722|Calcium|calcium|mesh-list
65377936|NCT00813722|Diuretics|diuretics|mesh-list
65377937|NCT00813722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65377938|NCT00813722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65377939|NCT00813722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377940|NCT00813722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65377941|NCT00813722|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65377942|NCT00813722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64770520|NCT03128034|Cyclosporine|cyclosporine|mesh-list
65377965|NCT00812318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65377966|NCT00812396|Methyltestosterone|methyltestosterone|mesh-list
65377967|NCT00812396|Testosterone|testosterone|mesh-list
65377968|NCT00812396|Testosterone undecanoate|testosterone undecanoate|mesh-list
65377969|NCT00812396|Testosterone enanthate|testosterone enanthate|mesh-list
65377970|NCT00812396|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65377971|NCT00812396|Androgens|androgens|mesh-ancestor
65377973|NCT00812396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65377974|NCT00812396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377975|NCT00812396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65377976|NCT00812396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65377977|NCT00812396|Anabolic Agents|anabolic agents|mesh-ancestor
65377978|NCT00807950|Simvastatin|simvastatin|mesh-list
65377979|NCT00807950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65377980|NCT00807950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65377981|NCT00807950|Antimetabolites|antimetabolites|mesh-ancestor
65377982|NCT00807950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377983|NCT00807950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65377984|NCT00807950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65377985|NCT00807950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377986|NCT00649220|Memantine|memantine|mesh-list
65377987|NCT00649220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65377988|NCT00649220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65377989|NCT00649220|Dopamine Agents|dopamine agents|mesh-ancestor
65377990|NCT00649220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65377991|NCT00649220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377992|NCT00649220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378023|NCT00654368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378024|NCT00654368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378025|NCT00654368|Dermatologic Agents|dermatologic agents|mesh-ancestor
65378026|NCT00654368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378027|NCT00654368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65378028|NCT00654368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65378029|NCT00654368|Immunologic Factors|immunologic factors|mesh-ancestor
65378030|NCT00654368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65378031|NCT00654368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65378032|NCT00654368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65378033|NCT00654368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65378034|NCT00654368|Analgesics|analgesics|mesh-ancestor
65378035|NCT00654368|Sensory System Agents|sensory system agents|mesh-ancestor
65378036|NCT00654368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65378037|NCT00654368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65378073|NCT00647426|Mitosis Modulators|mitosis modulators|mesh-ancestor
65378074|NCT00647426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378075|NCT00647426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65127739|NCT04586465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127740|NCT04586465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65127741|NCT04586465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65378097|NCT00813332|Antimitotic Agents|antimitotic agents|mesh-ancestor
65378098|NCT00813332|Mitosis Modulators|mitosis modulators|mesh-ancestor
65378099|NCT00813332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378100|NCT00813332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65378101|NCT00813332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65378102|NCT00813332|Growth Substances|growth substances|mesh-ancestor
65273866|NCT02771249|Micronutrients|micronutrients|mesh-ancestor
65273867|NCT02771249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273868|NCT04208958|Vancomycin|vancomycin|mesh-list
65378103|NCT00813332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378104|NCT00813332|Growth Inhibitors|growth inhibitors|mesh-ancestor
65378105|NCT04708496|Efavirenz|efavirenz|mesh-list
65378106|NCT04708496|Dolutegravir|dolutegravir|mesh-list
65378107|NCT04708496|Lumefantrine|lumefantrine|mesh-list
65378108|NCT04708496|Artemether|artemether|mesh-list
65378109|NCT04708496|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65378110|NCT04708496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65378126|NCT04708496|Antimalarials|antimalarials|mesh-ancestor
65378127|NCT04708496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65378128|NCT04708496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65378129|NCT00646958|Linezolid|linezolid|mesh-list
65378130|NCT00646958|Radezolid|radezolid|mesh-list
65378131|NCT00646958|Oxazolidinones|oxazolidinones|mesh-list
65378132|NCT00646958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65378133|NCT00646958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65378134|NCT00646958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65378135|NCT00646958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378136|NCT00646958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378137|NCT00813410|Insulin|insulin|mesh-list
65378138|NCT00813410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65378139|NCT00813410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378140|NCT00642746|Leucovorin|leucovorin|mesh-list
65378141|NCT00642746|Fluorouracil|fluorouracil|mesh-list
65378142|NCT00642746|Oxaliplatin|oxaliplatin|mesh-list
65378143|NCT00642746|Irinotecan|irinotecan|mesh-list
65378144|NCT00642746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65378145|NCT00642746|Antimetabolites|antimetabolites|mesh-ancestor
65378146|NCT00642746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378147|NCT00642746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65378148|NCT00642746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378149|NCT00642746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65378150|NCT00642746|Immunologic Factors|immunologic factors|mesh-ancestor
65378151|NCT00642746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378152|NCT00642746|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65378153|NCT00642746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65378154|NCT00642746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378155|NCT00642746|Antidotes|antidotes|mesh-ancestor
65378156|NCT00642746|Protective Agents|protective agents|mesh-ancestor
65378157|NCT00642746|Vitamin B Complex|vitamin b complex|mesh-ancestor
65378158|NCT00642746|Vitamins|vitamins|mesh-ancestor
65378159|NCT00642746|Micronutrients|micronutrients|mesh-ancestor
65378160|NCT00642746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65378161|NCT00814268|Aspirin|aspirin|mesh-list
65378162|NCT00814268|Clopidogrel|clopidogrel|mesh-list
65378163|NCT00814268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65378164|NCT00814268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65378165|NCT00814268|Analgesics|analgesics|mesh-ancestor
65378166|NCT00814268|Sensory System Agents|sensory system agents|mesh-ancestor
65378167|NCT00814268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65378168|NCT00814268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378169|NCT00814268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65378197|NCT00642668|Hematinics|hematinics|mesh-ancestor
65378199|NCT00817934|Cathartics|cathartics|mesh-ancestor
65378200|NCT00817934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65378201|NCT00817934|Laxatives|laxatives|mesh-ancestor
65378202|NCT00729833|Sunitinib|sunitinib|mesh-list
65378203|NCT00729833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378204|NCT00729833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65378205|NCT00729833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65378206|NCT00729833|Growth Substances|growth substances|mesh-ancestor
65378207|NCT00729833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378208|NCT00729833|Growth Inhibitors|growth inhibitors|mesh-ancestor
65378209|NCT00729833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65378210|NCT00729833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378211|NCT00729833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378212|NCT00645788|Ciprofloxacin|ciprofloxacin|mesh-list
65378213|NCT00645788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65378214|NCT00645788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65378215|NCT00645788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65378216|NCT00645788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65378217|NCT00645788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378240|NCT00642356|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64492907|NCT04399395|Naltrexone|naltrexone|mesh-list
65378241|NCT00642356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65378242|NCT00642356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65378243|NCT00642356|Dopamine Agents|dopamine agents|mesh-ancestor
65378244|NCT00642356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65378245|NCT00642356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378246|NCT00642356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378247|NCT00642356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65378248|NCT00642356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378249|NCT00642356|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65378250|NCT00642356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65378251|NCT00642356|Immunologic Factors|immunologic factors|mesh-ancestor
65378252|NCT00642356|Dopamine Agonists|dopamine agonists|mesh-ancestor
65378253|NCT00642278|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65378254|NCT00642278|Canagliflozin|canagliflozin|mesh-list
65378255|NCT00642278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65378256|NCT00642278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378257|NCT00642278|Incretins|incretins|mesh-ancestor
65378259|NCT00642278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65378260|NCT00642278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65378261|NCT00642278|Protease Inhibitors|protease inhibitors|mesh-ancestor
65378262|NCT00642278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378263|NCT00642278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378264|NCT00642278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65378265|NCT00815048|Atropine|atropine|mesh-list
65378266|NCT00815048|Fentanyl|fentanyl|mesh-list
65378267|NCT00815048|Remifentanil|remifentanil|mesh-list
65378268|NCT00815048|Succinylcholine|succinylcholine|mesh-list
65378312|NCT02551796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65378313|NCT02551796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65378314|NCT02551796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378315|NCT02551796|Protease Inhibitors|protease inhibitors|mesh-ancestor
65378316|NCT02551796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378317|NCT02551796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378318|NCT02551796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65378319|NCT02551796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65378320|NCT02551796|Renal Agents|renal agents|mesh-ancestor
65378321|NCT02551796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65378322|NCT02551796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65378323|NCT02551796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65378324|NCT02551796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65378325|NCT02551796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65378326|NCT02551796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65378327|NCT02551796|Immunologic Factors|immunologic factors|mesh-ancestor
65378328|NCT02551796|Viscosupplements|viscosupplements|mesh-ancestor
65378329|NCT02551796|Protective Agents|protective agents|mesh-ancestor
65378330|NCT02551796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65378331|NCT02551796|Adrenergic Agents|adrenergic agents|mesh-ancestor
65378332|NCT02551796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65378333|NCT02551796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65378334|NCT02551796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65378336|NCT00723125|Bevacizumab|bevacizumab|mesh-list
65378337|NCT00723125|Carboplatin|carboplatin|mesh-list
65378338|NCT00723125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65378339|NCT00723125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65378340|NCT00723125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378341|NCT00723125|Tubulin Modulators|tubulin modulators|mesh-ancestor
65378342|NCT00723125|Antimitotic Agents|antimitotic agents|mesh-ancestor
65378343|NCT00723125|Mitosis Modulators|mitosis modulators|mesh-ancestor
65378344|NCT00723125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378345|NCT00723125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65378371|NCT00815204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65378372|NCT00815204|Glucocorticoids|glucocorticoids|mesh-ancestor
65378374|NCT00815204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65378375|NCT00815204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65378376|NCT00815204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378377|NCT00721955|Loxapine|loxapine|mesh-list
65378378|NCT00721955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65378379|NCT00721955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65378380|NCT00721955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65378381|NCT00721955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378382|NCT00721955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65378383|NCT00721955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65378384|NCT00721955|Dopamine Agents|dopamine agents|mesh-ancestor
65378385|NCT00721955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65378386|NCT00721955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378387|NCT00585689|Gemcitabine|gemcitabine|mesh-list
65378388|NCT00585689|Carboplatin|carboplatin|mesh-list
65378389|NCT00585689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65378390|NCT00585689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378391|NCT00585689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65378392|NCT00585689|Antimetabolites|antimetabolites|mesh-ancestor
65378393|NCT00585689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378394|NCT00585689|Antiviral Agents|antiviral agents|mesh-ancestor
65378410|NCT02593019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378411|NCT02593019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378412|NCT00729365|Ramipril|ramipril|mesh-list
65378413|NCT00729365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65378414|NCT00729365|Protease Inhibitors|protease inhibitors|mesh-ancestor
65378415|NCT00729365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378416|NCT00729365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378417|NCT00729365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65378418|NCT00818870|Omeprazole|omeprazole|mesh-list
65378419|NCT00818870|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65378420|NCT00818870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65378421|NCT00818870|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65378422|NCT00818870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378423|NCT00818870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378424|NCT00254293|Abatacept|abatacept|mesh-list
65378425|NCT00254293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65378426|NCT00254293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65378427|NCT00254293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378428|NCT00254293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378429|NCT00254293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65378430|NCT00254293|Immunologic Factors|immunologic factors|mesh-ancestor
65378431|NCT00254293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378432|NCT00254293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65378433|NCT00736385|Metformin|metformin|mesh-list
65378434|NCT00736385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65378435|NCT00736385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378436|NCT00585221|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65378437|NCT00585221|Imatinib Mesylate|imatinib mesylate|mesh-list
65378438|NCT00585221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378439|NCT00585221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65378440|NCT00585221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378441|NCT00585221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378442|NCT00585221|Antiviral Agents|antiviral agents|mesh-ancestor
65378443|NCT00585221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65378444|NCT02594033|Insulin Aspart|insulin aspart|mesh-list
65378445|NCT02594033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65378446|NCT02594033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378447|NCT00253747|Methylphenidate|methylphenidate|mesh-list
65378448|NCT00253747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65378449|NCT00253747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378450|NCT00253747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65378451|NCT00253747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65378452|NCT00253747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65378453|NCT00253747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378454|NCT00253747|Dopamine Agents|dopamine agents|mesh-ancestor
65378490|NCT00275509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65378492|NCT00275509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378493|NCT00275509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65378494|NCT00275509|Immunologic Factors|immunologic factors|mesh-ancestor
65378495|NCT00275509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65378496|NCT00275509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378529|NCT01073059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65378530|NCT01073059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65378531|NCT01073059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65378532|NCT01073059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65378533|NCT01073059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65378535|NCT00252577|Antidepressive Agents|antidepressive agents|mesh-ancestor
65378536|NCT00252577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65378537|NCT00252577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378558|NCT00163657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65378559|NCT00163657|Immunologic Factors|immunologic factors|mesh-ancestor
65273869|NCT04208958|Nivolumab|nivolumab|mesh-list
65273870|NCT04208958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65273871|NCT04208958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378560|NCT00163657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378561|NCT00163657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65378562|NCT00163657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378563|NCT00163657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378564|NCT00163657|Antifungal Agents|antifungal agents|mesh-ancestor
65378565|NCT00163657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65378566|NCT00163657|Dermatologic Agents|dermatologic agents|mesh-ancestor
65378567|NCT00163657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65378568|NCT00163657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65378569|NCT00163657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378570|NCT00163657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65378571|NCT00163657|Antitubercular Agents|antitubercular agents|mesh-ancestor
65378572|NCT00163657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65378573|NCT01073683|Docetaxel|docetaxel|mesh-list
65378574|NCT01073683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378575|NCT01073683|Tubulin Modulators|tubulin modulators|mesh-ancestor
65378576|NCT01073683|Antimitotic Agents|antimitotic agents|mesh-ancestor
65378577|NCT01073683|Mitosis Modulators|mitosis modulators|mesh-ancestor
65378578|NCT01073683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378579|NCT00609492|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65378580|NCT00609492|Immunologic Factors|immunologic factors|mesh-ancestor
65378581|NCT00609492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378582|NCT00230971|Metronidazole|metronidazole|mesh-list
65378583|NCT00230971|Ceftriaxone|ceftriaxone|mesh-list
65378584|NCT00230971|Tigecycline|tigecycline|mesh-list
65378585|NCT00230971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65378586|NCT00230971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65378587|NCT00230971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65378588|NCT00230971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65378589|NCT00230971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65378590|NCT00230971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378591|NCT00230971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378592|NCT00211081|Spironolactone|spironolactone|mesh-list
65378621|NCT00891384|Growth Inhibitors|growth inhibitors|mesh-ancestor
65378622|NCT00891384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378623|NCT00887328|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65378624|NCT00887328|Plasminogen|plasminogen|mesh-list
65378625|NCT00887328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65378626|NCT00887328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65378627|NCT00887328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378628|NCT00609336|Gemcitabine|gemcitabine|mesh-list
65378629|NCT00609336|Capecitabine|capecitabine|mesh-list
65378630|NCT00609336|Docetaxel|docetaxel|mesh-list
65378631|NCT00609336|Oxaliplatin|oxaliplatin|mesh-list
65378632|NCT00609336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65378633|NCT00609336|Antimetabolites|antimetabolites|mesh-ancestor
65378634|NCT00609336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378635|NCT00609336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378636|NCT00609336|Antiviral Agents|antiviral agents|mesh-ancestor
65378637|NCT00609336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65378638|NCT00609336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378639|NCT00609336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65378659|NCT04397406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65378660|NCT04397406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378661|NCT04397406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65378663|NCT04397406|Sensory System Agents|sensory system agents|mesh-ancestor
65378664|NCT04397406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65378665|NCT04397406|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65378666|NCT04397406|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65378667|NCT04397406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65378668|NCT04397406|Adrenergic Agents|adrenergic agents|mesh-ancestor
65378669|NCT04397406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65378670|NCT04397406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378671|NCT04397406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65378672|NCT04397406|Narcotics|narcotics|mesh-ancestor
65378673|NCT04397406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65378674|NCT04397406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65378675|NCT04397406|Anesthetics, General|anesthetics, general|mesh-ancestor
65378676|NCT04397406|Anesthetics|anesthetics|mesh-ancestor
65273872|NCT04208958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64471822|NCT04094961|Immunologic Factors|immunologic factors|mesh-ancestor
65378677|NCT04397406|Anesthetics, Local|anesthetics, local|mesh-ancestor
65378678|NCT00891540|Ropivacaine|ropivacaine|mesh-list
65378679|NCT00891540|Anesthetics, Local|anesthetics, local|mesh-ancestor
65378680|NCT00891540|Anesthetics|anesthetics|mesh-ancestor
65378681|NCT00891540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65378682|NCT00891540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378683|NCT00891540|Sensory System Agents|sensory system agents|mesh-ancestor
65378684|NCT00891540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65378685|NCT00573144|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65378686|NCT00573144|Natriuretic Agents|natriuretic agents|mesh-ancestor
65378687|NCT00573144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378689|NCT00891696|Nitroprusside|nitroprusside|mesh-list
65378690|NCT00891696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65378691|NCT00891696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65378692|NCT00891696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65378693|NCT00891696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378694|NCT00891696|Antifungal Agents|antifungal agents|mesh-ancestor
65378695|NCT00891696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65378696|NCT00891696|Immunologic Factors|immunologic factors|mesh-ancestor
64771314|NCT01128972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65378718|NCT00162097|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65378719|NCT00162097|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65378720|NCT00162097|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65378721|NCT00162097|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65378722|NCT00162097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65378723|NCT00162097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65378724|NCT02550782|Dexmedetomidine|dexmedetomidine|mesh-list
65378725|NCT02550782|Bupivacaine|bupivacaine|mesh-list
65378726|NCT02550782|Anesthetics, Local|anesthetics, local|mesh-ancestor
65378727|NCT02550782|Anesthetics|anesthetics|mesh-ancestor
65378728|NCT02550782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65378729|NCT02550782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378730|NCT02550782|Sensory System Agents|sensory system agents|mesh-ancestor
65378731|NCT02550782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65378732|NCT02550782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65378733|NCT02550782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65378734|NCT02550782|Analgesics|analgesics|mesh-ancestor
65378735|NCT02550782|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65378736|NCT02550782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65378737|NCT02550782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65378738|NCT02550782|Adrenergic Agents|adrenergic agents|mesh-ancestor
65378739|NCT02550782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65378740|NCT02550782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378741|NCT05278728|Irinotecan|irinotecan|mesh-list
65378742|NCT05278728|Nimotuzumab|nimotuzumab|mesh-list
65378743|NCT05278728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65378744|NCT05278728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65378745|NCT05278728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378746|NCT05278728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378747|NCT05278728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378748|NCT05278728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65378772|NCT00819104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65378773|NCT00819104|Sympatholytics|sympatholytics|mesh-ancestor
65378774|NCT00819104|Autonomic Agents|autonomic agents|mesh-ancestor
65378775|NCT00819104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65378776|NCT00819104|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65378777|NCT00819104|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65378778|NCT00819104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65378779|NCT00819104|Adrenergic Agents|adrenergic agents|mesh-ancestor
65378780|NCT00819104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65378781|NCT02542098|Hydrocodone|hydrocodone|mesh-list
65378782|NCT02542098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65378783|NCT02542098|Narcotics|narcotics|mesh-ancestor
65378784|NCT02542098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65378785|NCT02542098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378786|NCT02542098|Analgesics|analgesics|mesh-ancestor
65378787|NCT02542098|Sensory System Agents|sensory system agents|mesh-ancestor
65378788|NCT02542098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65378789|NCT02542098|Antitussive Agents|antitussive agents|mesh-ancestor
65378790|NCT02542098|Respiratory System Agents|respiratory system agents|mesh-ancestor
65273873|NCT04208958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378791|NCT00640016|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65378792|NCT00640016|Immunologic Factors|immunologic factors|mesh-ancestor
65378793|NCT00640016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378794|NCT00892242|Zoledronic Acid|zoledronic acid|mesh-list
65378795|NCT00892242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65378796|NCT00892242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378797|NCT00885066|Gemcitabine|gemcitabine|mesh-list
65378798|NCT00885066|Capecitabine|capecitabine|mesh-list
65378799|NCT00885066|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65378800|NCT00885066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65378801|NCT00885066|Antimetabolites|antimetabolites|mesh-ancestor
64771422|NCT01144494|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65378834|NCT00888186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65378835|NCT00888186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378836|NCT00892320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65378837|NCT00892320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65378838|NCT00892320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65378839|NCT00892320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65378840|NCT00892320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378841|NCT00892320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65378842|NCT00892320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65378843|NCT00892320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65378844|NCT00892320|Serotonin Agents|serotonin agents|mesh-ancestor
65378881|NCT00608868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378882|NCT00900978|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65378911|NCT00608322|Autonomic Agents|autonomic agents|mesh-ancestor
65378912|NCT00608322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65378913|NCT00608322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378914|NCT00608322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65378915|NCT00608322|Respiratory System Agents|respiratory system agents|mesh-ancestor
65378916|NCT00608322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65378918|NCT00608322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378919|NCT00608322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65378920|NCT00608322|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65378921|NCT00608322|Vasodilator Agents|vasodilator agents|mesh-ancestor
65378922|NCT00608322|Gasotransmitters|gasotransmitters|mesh-ancestor
65378923|NCT00608322|Protective Agents|protective agents|mesh-ancestor
65378924|NCT00606294|Misonidazole|misonidazole|mesh-list
65378925|NCT00606294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378926|NCT00606294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65378927|NCT00606294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65378928|NCT00606294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65378929|NCT00608244|Tacrolimus|tacrolimus|mesh-list
65378930|NCT00608244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65378974|NCT00893256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65378976|NCT00893256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65378977|NCT00893256|Antidepressive Agents|antidepressive agents|mesh-ancestor
65378978|NCT00901368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65378979|NCT00901368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65378980|NCT00901368|Autonomic Agents|autonomic agents|mesh-ancestor
65378981|NCT00901368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65378982|NCT00901368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378983|NCT00901368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65378984|NCT00901368|Respiratory System Agents|respiratory system agents|mesh-ancestor
65378985|NCT00901368|Glucocorticoids|glucocorticoids|mesh-ancestor
65378986|NCT00901368|Hormones|hormones|mesh-ancestor
65378987|NCT00901368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65378988|NCT00901368|Sympathomimetics|sympathomimetics|mesh-ancestor
65378989|NCT00901524|Interferons|interferons|mesh-list
65378990|NCT00901524|Ribavirin|ribavirin|mesh-list
65378991|NCT00901524|Interferon-alpha|interferon-alpha|mesh-list
65378992|NCT00901524|Interferon alpha-2|interferon alpha-2|mesh-list
65378993|NCT00901524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65378994|NCT00901524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378995|NCT00901524|Antiviral Agents|antiviral agents|mesh-ancestor
65378996|NCT00901524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65378997|NCT00901524|Antimetabolites|antimetabolites|mesh-ancestor
65378998|NCT00901524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378999|NCT00901524|Immunologic Factors|immunologic factors|mesh-ancestor
65379000|NCT00901524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379001|NCT00893412|Tramadol|tramadol|mesh-list
65273874|NCT04208958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64493275|NCT04399083|Caffeine|caffeine|mesh-list
65379002|NCT00893412|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65379003|NCT00893412|Narcotics|narcotics|mesh-ancestor
65379004|NCT00893412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65379005|NCT00893412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379006|NCT00893412|Analgesics|analgesics|mesh-ancestor
65379007|NCT00893412|Sensory System Agents|sensory system agents|mesh-ancestor
65379008|NCT00893412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65379009|NCT00893490|Mitomycins|mitomycins|mesh-list
65379010|NCT00893490|Mitomycin|mitomycin|mesh-list
65379011|NCT00893490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65379033|NCT00638690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65379034|NCT02540928|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
65379035|NCT02540928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379036|NCT02540928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379037|NCT00893724|Tocopherols|tocopherols|mesh-list
65379038|NCT00893724|Vitamin E|vitamin e|mesh-list
65379039|NCT00893724|Tocotrienols|tocotrienols|mesh-list
65379040|NCT00893724|alpha-Tocopherol|alpha-tocopherol|mesh-list
65379041|NCT00893724|Coenzyme Q10|coenzyme q10|mesh-list
65379042|NCT00893724|Niacinamide|niacinamide|mesh-list
65379043|NCT00893724|Niacin|niacin|mesh-list
65379044|NCT00893724|Nicotinic Acids|nicotinic acids|mesh-list
65379045|NCT00893724|Ubiquinone|ubiquinone|mesh-list
65379046|NCT00893724|Minocycline|minocycline|mesh-list
65379047|NCT00893724|Acetylcysteine|acetylcysteine|mesh-list
65379048|NCT00893724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65379049|NCT00893724|Vitamins|vitamins|mesh-ancestor
65379050|NCT00893724|Micronutrients|micronutrients|mesh-ancestor
65379051|NCT00893724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379052|NCT00893724|Antioxidants|antioxidants|mesh-ancestor
65379053|NCT00893724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379054|NCT00893724|Protective Agents|protective agents|mesh-ancestor
65379055|NCT00893724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65379056|NCT00893724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65379057|NCT00893724|Antiviral Agents|antiviral agents|mesh-ancestor
65379058|NCT00893724|Expectorants|expectorants|mesh-ancestor
65379059|NCT00893724|Respiratory System Agents|respiratory system agents|mesh-ancestor
65379060|NCT00893724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65379061|NCT00893724|Antidotes|antidotes|mesh-ancestor
65379062|NCT00893724|Vitamin B Complex|vitamin b complex|mesh-ancestor
65379063|NCT00893724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65379064|NCT00893724|Antimetabolites|antimetabolites|mesh-ancestor
65379065|NCT00893724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65379066|NCT00893724|Vasodilator Agents|vasodilator agents|mesh-ancestor
65379256|NCT00902460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65379257|NCT00902460|Anesthetics, General|anesthetics, general|mesh-ancestor
65379258|NCT00902460|Anesthetics|anesthetics|mesh-ancestor
65379259|NCT00902460|GABA Modulators|gaba modulators|mesh-ancestor
65379260|NCT00902460|GABA Agents|gaba agents|mesh-ancestor
65379261|NCT00902460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65379262|NCT00902460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379263|NCT00902460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65379264|NCT00902460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379265|NCT00989079|Ertugliflozin|ertugliflozin|mesh-list
65379266|NCT00989079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65379267|NCT00989079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379268|NCT00989079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65379269|NCT00989079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379270|NCT00809198|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65379271|NCT00809198|Hyaluronic Acid|hyaluronic acid|mesh-list
65379272|NCT00809198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65379273|NCT00809198|Immunologic Factors|immunologic factors|mesh-ancestor
65379274|NCT00809198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379275|NCT00809198|Viscosupplements|viscosupplements|mesh-ancestor
65379276|NCT00809198|Protective Agents|protective agents|mesh-ancestor
65379277|NCT00809198|Laxatives|laxatives|mesh-ancestor
65379278|NCT00809198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65379279|NCT00986505|Lidocaine|lidocaine|mesh-list
65379280|NCT00986505|Anesthetics, Local|anesthetics, local|mesh-ancestor
65379281|NCT00986505|Anesthetics|anesthetics|mesh-ancestor
65379282|NCT00986505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65379283|NCT00986505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379284|NCT00986505|Sensory System Agents|sensory system agents|mesh-ancestor
65379285|NCT00986505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65379286|NCT00986505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65273875|NCT04208958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65273876|NCT04048278|Lidocaine|lidocaine|mesh-list
65273877|NCT04048278|Anesthetics, Local|anesthetics, local|mesh-ancestor
65379287|NCT00986505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65379288|NCT00986505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65379289|NCT00986505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65379290|NCT00986505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379291|NCT03667443|Inositol|inositol|mesh-list
65379292|NCT03667443|Vitamin B Complex|vitamin b complex|mesh-ancestor
65379293|NCT03667443|Vitamins|vitamins|mesh-ancestor
64771908|NCT01235910|Cyclosporine|cyclosporine|mesh-list
65379308|NCT00902772|GABA Modulators|gaba modulators|mesh-ancestor
65379309|NCT00902772|GABA Agents|gaba agents|mesh-ancestor
65379310|NCT00902772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65379311|NCT00902772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379312|NCT00894660|Amodiaquine|amodiaquine|mesh-list
65379313|NCT00894660|Antimalarials|antimalarials|mesh-ancestor
65379314|NCT00894660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65379315|NCT00894660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65379316|NCT00894660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65379317|NCT00721409|Letrozole|letrozole|mesh-list
65379318|NCT00721409|Palbociclib|palbociclib|mesh-list
65379319|NCT00721409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379320|NCT00721409|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65379321|NCT00721409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65379322|NCT00721409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379323|NCT00721409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379324|NCT00721409|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65379325|NCT00721409|Hormone Antagonists|hormone antagonists|mesh-ancestor
65379326|NCT00721409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65379327|NCT00721409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379328|NCT00721409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65379329|NCT00542997|Immunoglobulins|immunoglobulins|mesh-list
65379330|NCT00542997|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65379331|NCT00542997|Antibodies|antibodies|mesh-list
65379332|NCT00542997|Immunologic Factors|immunologic factors|mesh-ancestor
65379333|NCT00542997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379334|NCT00903084|Tenofovir|tenofovir|mesh-list
65379335|NCT00903084|Antiviral Agents|antiviral agents|mesh-ancestor
65379336|NCT00903084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65379337|NCT00903084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65379338|NCT00903084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65379339|NCT00903084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379340|NCT00903084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379341|NCT00903084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65379342|NCT00903084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65379343|NCT02541006|Tiotropium Bromide|tiotropium bromide|mesh-list
65379344|NCT02541006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65379345|NCT02541006|Autonomic Agents|autonomic agents|mesh-ancestor
65379346|NCT02541006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65379347|NCT02541006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379348|NCT02541006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65379349|NCT02541006|Respiratory System Agents|respiratory system agents|mesh-ancestor
65379350|NCT02541006|Parasympatholytics|parasympatholytics|mesh-ancestor
65379351|NCT02541006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65379352|NCT02541006|Cholinergic Agents|cholinergic agents|mesh-ancestor
65379353|NCT02541006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65379354|NCT02541006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379355|NCT02591771|Epinephrine|epinephrine|mesh-list
65379371|NCT02591771|Sympathomimetics|sympathomimetics|mesh-ancestor
65379372|NCT02591771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65379373|NCT00986817|Terlipressin|terlipressin|mesh-list
65379374|NCT00986817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65379375|NCT00986817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65379376|NCT00572832|Vaccines|vaccines|mesh-list
65379377|NCT00572832|Immunologic Factors|immunologic factors|mesh-ancestor
65379378|NCT00572832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379379|NCT02591849|Glucagon|glucagon|mesh-list
65379380|NCT02591849|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65379381|NCT02591849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65379382|NCT02591849|Hormones|hormones|mesh-ancestor
65379383|NCT02591849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65379384|NCT02591849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273878|NCT04048278|Anesthetics|anesthetics|mesh-ancestor
65273879|NCT04048278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65273880|NCT04048278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273881|NCT04048278|Sensory System Agents|sensory system agents|mesh-ancestor
65273882|NCT04048278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65273883|NCT04048278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65273884|NCT04048278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65273885|NCT04048278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65273886|NCT04048278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65273887|NCT04048278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273888|NCT02697318|Timolol|timolol|mesh-list
65273889|NCT02697318|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65273890|NCT02697318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65273891|NCT02697318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273892|NCT02697318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65273893|NCT02697318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65273894|NCT02697318|Adrenergic Agents|adrenergic agents|mesh-ancestor
65273895|NCT02697318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65273896|NCT02697318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273897|NCT02697318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65273898|NCT02697318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65273899|NCT05242133|Interferons|interferons|mesh-list
65273900|NCT05242133|Interferon-beta|interferon-beta|mesh-list
65273901|NCT05242133|Interferon beta-1a|interferon beta-1a|mesh-list
65273902|NCT05242133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273903|NCT05242133|Antiviral Agents|antiviral agents|mesh-ancestor
65273904|NCT05242133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65273905|NCT05242133|Immunologic Factors|immunologic factors|mesh-ancestor
65379385|NCT02591849|Incretins|incretins|mesh-ancestor
65379386|NCT00898794|Bevacizumab|bevacizumab|mesh-list
65379387|NCT00898794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65379388|NCT00898794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379389|NCT00898794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65379390|NCT00898794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65379391|NCT00898794|Growth Substances|growth substances|mesh-ancestor
65379392|NCT00898794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379393|NCT00898794|Growth Inhibitors|growth inhibitors|mesh-ancestor
65379394|NCT04086719|Pyrimethamine|pyrimethamine|mesh-list
65379395|NCT04086719|BMS-986165|bms-986165|mesh-list
65379396|NCT04086719|Antimalarials|antimalarials|mesh-ancestor
65379397|NCT04086719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65379398|NCT04086719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65379399|NCT04086719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65379400|NCT04086719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65379401|NCT04086719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273906|NCT05242133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273907|NCT05242133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65273908|NCT00621816|Nitroprusside|nitroprusside|mesh-list
65273909|NCT00621816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65273910|NCT00621816|Vasodilator Agents|vasodilator agents|mesh-ancestor
65273911|NCT00621816|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65273912|NCT00621816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273913|NCT05368974|Antiviral Agents|antiviral agents|mesh-list
65273914|NCT05368974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65273915|NCT04186026|Glucagon|glucagon|mesh-list
65273916|NCT04186026|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65273917|NCT04186026|Incretins|incretins|mesh-ancestor
65273918|NCT04186026|Hormones|hormones|mesh-ancestor
65273919|NCT04186026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65273920|NCT04186026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379402|NCT04086719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379403|NCT04086719|Dermatologic Agents|dermatologic agents|mesh-ancestor
65379404|NCT04086719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65379405|NCT00898950|Aspirin|aspirin|mesh-list
65379406|NCT00898950|Salicylic Acid|salicylic acid|mesh-list
65379407|NCT00898950|Salicylates|salicylates|mesh-list
65379408|NCT00898950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65379409|NCT00898950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65379410|NCT00898950|Analgesics|analgesics|mesh-ancestor
65379411|NCT00898950|Sensory System Agents|sensory system agents|mesh-ancestor
65379412|NCT00898950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65379413|NCT00898950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379414|NCT00898950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65379415|NCT00898950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64772021|NCT01254552|Chelating Agents|chelating agents|mesh-ancestor
65379445|NCT04035798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65379446|NCT04035798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65379448|NCT01075477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65379449|NCT01075477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379450|NCT01075477|Immunologic Factors|immunologic factors|mesh-ancestor
65379451|NCT01075477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379452|NCT01075477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65379453|NCT01075555|Sorafenib|sorafenib|mesh-list
65379454|NCT01075555|Pravastatin|pravastatin|mesh-list
65379455|NCT01075555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379456|NCT01075555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65379457|NCT01075555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379458|NCT01075555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379459|NCT01075555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65379460|NCT01075555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65379461|NCT01075555|Antimetabolites|antimetabolites|mesh-ancestor
65379550|NCT00904176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65379551|NCT00904176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379552|NCT00904176|Anticoagulants|anticoagulants|mesh-ancestor
65379553|NCT00904176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65379554|NCT00904176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65379555|NCT00904176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379556|NCT00904176|Protective Agents|protective agents|mesh-ancestor
65379557|NCT02540070|Ketorolac|ketorolac|mesh-list
65379558|NCT02540070|Epinephrine|epinephrine|mesh-list
65379559|NCT02540070|Dexmedetomidine|dexmedetomidine|mesh-list
65379560|NCT02540070|Morphine|morphine|mesh-list
65379561|NCT02540070|Ropivacaine|ropivacaine|mesh-list
64772186|NCT01291056|Clomiphene|clomiphene|mesh-list
65379594|NCT00905814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65379595|NCT00905814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273921|NCT04186026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65273922|NCT00900731|Tiotropium Bromide|tiotropium bromide|mesh-list
65379596|NCT00905814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379597|NCT00900510|Trimethoprim|trimethoprim|mesh-list
65379598|NCT00900510|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65379599|NCT00900510|Sulfamethoxazole|sulfamethoxazole|mesh-list
65379600|NCT00900510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65379601|NCT00900510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65379602|NCT00900510|Renal Agents|renal agents|mesh-ancestor
64772228|NCT01295112|Antiemetics|antiemetics|mesh-ancestor
65379649|NCT00906126|Oxytocics|oxytocics|mesh-ancestor
65379650|NCT00900744|Tamoxifen|tamoxifen|mesh-list
65379651|NCT00900744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65379652|NCT00900744|Hormone Antagonists|hormone antagonists|mesh-ancestor
65379653|NCT00900744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65379654|NCT00900744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379655|NCT00900744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65379656|NCT00900744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379657|NCT00900744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65379658|NCT00900744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65379659|NCT00900744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65379660|NCT00643760|Pregabalin|pregabalin|mesh-list
65379661|NCT00643760|Gabapentin|gabapentin|mesh-list
65379662|NCT00643760|Analgesics|analgesics|mesh-ancestor
65379663|NCT00643760|Sensory System Agents|sensory system agents|mesh-ancestor
65379664|NCT00643760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65379665|NCT00643760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379666|NCT00643760|Anticonvulsants|anticonvulsants|mesh-ancestor
65379667|NCT00643760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65379668|NCT00643760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65379669|NCT00643760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379670|NCT00643760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65379671|NCT00643760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65379672|NCT00643760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65379673|NCT00643760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65379674|NCT00643760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65379675|NCT00643760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65379676|NCT00643760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65379677|NCT00643760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65379678|NCT00643760|Antimanic Agents|antimanic agents|mesh-ancestor
65379679|NCT00904644|Raltegravir Potassium|raltegravir potassium|mesh-list
65379680|NCT00904644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65379709|NCT00603798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379710|NCT00603798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379711|NCT00603798|Interferon Inducers|interferon inducers|mesh-ancestor
65379713|NCT00819572|Immunoglobulin Fragments|immunoglobulin fragments|mesh-list
65379714|NCT00819572|Immunologic Factors|immunologic factors|mesh-ancestor
65379715|NCT00819572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379716|NCT00630812|Mannitol|mannitol|mesh-list
65379717|NCT00630812|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65379718|NCT00630812|Diuretics|diuretics|mesh-ancestor
65379719|NCT00630812|Natriuretic Agents|natriuretic agents|mesh-ancestor
65379720|NCT00630812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379721|NCT00906516|Bevacizumab|bevacizumab|mesh-list
65379722|NCT00906516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65379723|NCT00906516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379724|NCT00906516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65379725|NCT00906516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65379726|NCT00906516|Growth Substances|growth substances|mesh-ancestor
65379727|NCT00906516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379728|NCT00906516|Growth Inhibitors|growth inhibitors|mesh-ancestor
65379786|NCT00604500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65379788|NCT00627458|Immunologic Factors|immunologic factors|mesh-ancestor
65379789|NCT00627458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379790|NCT00909168|Gemtuzumab|gemtuzumab|mesh-list
65379791|NCT00909168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65379792|NCT00909168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379793|NCT00816218|Pioglitazone|pioglitazone|mesh-list
65379794|NCT00816218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65379795|NCT00816218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379796|NCT00819728|Docetaxel|docetaxel|mesh-list
65379797|NCT00819728|Irinotecan|irinotecan|mesh-list
65379798|NCT00819728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273923|NCT00900731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65379799|NCT00819728|Tubulin Modulators|tubulin modulators|mesh-ancestor
65379800|NCT00819728|Antimitotic Agents|antimitotic agents|mesh-ancestor
65379801|NCT00819728|Mitosis Modulators|mitosis modulators|mesh-ancestor
65379802|NCT00819728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772437|NCT01324128|Iron|iron|mesh-list
65379855|NCT00819962|Anesthetics|anesthetics|mesh-ancestor
65379856|NCT00819962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65379857|NCT00819962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379858|NCT00819962|Sensory System Agents|sensory system agents|mesh-ancestor
65379859|NCT00819962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65379860|NCT00820118|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65379861|NCT00820118|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65379862|NCT00820118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65379863|NCT00820118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65379864|NCT00820118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379865|NCT00820118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379866|NCT00820118|Antiviral Agents|antiviral agents|mesh-ancestor
65379867|NCT00820118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65379868|NCT00820118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65379869|NCT00820118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65379870|NCT00820118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65379871|NCT00820118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65379872|NCT00820118|Protease Inhibitors|protease inhibitors|mesh-ancestor
65379874|NCT00927498|Daunorubicin|daunorubicin|mesh-list
65379875|NCT00927498|Gemtuzumab|gemtuzumab|mesh-list
65379876|NCT00927498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65379877|NCT00927498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379878|NCT00927498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65379879|NCT00927498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65379880|NCT00927498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379881|NCT00927498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129472|NCT00191451|Antiviral Agents|antiviral agents|mesh-ancestor
65379882|NCT00927498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65379883|NCT00927498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65379884|NCT00927498|Antimetabolites|antimetabolites|mesh-ancestor
65379885|NCT00927498|Antiviral Agents|antiviral agents|mesh-ancestor
65379886|NCT00927498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65379887|NCT00927498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65379888|NCT00927498|Immunologic Factors|immunologic factors|mesh-ancestor
65379889|NCT00927498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379890|NCT00159913|Sildenafil Citrate|sildenafil citrate|mesh-list
65379891|NCT00159913|Citric Acid|citric acid|mesh-list
65379892|NCT00159913|Sodium Citrate|sodium citrate|mesh-list
65379893|NCT00159913|Anticoagulants|anticoagulants|mesh-ancestor
65379894|NCT00159913|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65379909|NCT00821600|Risperidone|risperidone|mesh-list
65379910|NCT00821600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65379911|NCT00821600|Serotonin Agents|serotonin agents|mesh-ancestor
65379912|NCT00821600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65379913|NCT00821600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379914|NCT00821600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379915|NCT00821600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65379916|NCT00821600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65379917|NCT00821600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65379918|NCT00821600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65379919|NCT00821600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65379920|NCT00821600|Dopamine Agents|dopamine agents|mesh-ancestor
65379921|NCT00987207|Cyclosporine|cyclosporine|mesh-list
65379922|NCT00987207|Cyclosporins|cyclosporins|mesh-list
65379923|NCT00987207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379924|NCT00987207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379925|NCT00987207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65379926|NCT00987207|Immunologic Factors|immunologic factors|mesh-ancestor
65379927|NCT00987207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379928|NCT00987207|Antifungal Agents|antifungal agents|mesh-ancestor
65379929|NCT00987207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65379930|NCT00987207|Dermatologic Agents|dermatologic agents|mesh-ancestor
65379931|NCT00987207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65379932|NCT00987207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65379933|NCT00604188|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65379934|NCT00604188|Buprenorphine|buprenorphine|mesh-list
65379935|NCT00604188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65379936|NCT00604188|Narcotics|narcotics|mesh-ancestor
65273924|NCT00900731|Autonomic Agents|autonomic agents|mesh-ancestor
65379937|NCT00604188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65379938|NCT00604188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379939|NCT00604188|Analgesics|analgesics|mesh-ancestor
65379940|NCT00604188|Sensory System Agents|sensory system agents|mesh-ancestor
65379941|NCT00604188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65379942|NCT00604188|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65379943|NCT00820352|Bosentan|bosentan|mesh-list
65379944|NCT00820352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65379945|NCT00820352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65379946|NCT00820352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379947|NCT00927654|Iloprost|iloprost|mesh-list
65379948|NCT00927654|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65379949|NCT00927654|Vasodilator Agents|vasodilator agents|mesh-ancestor
65379950|NCT00927732|Quinidine|quinidine|mesh-list
65379951|NCT00927732|Hydroquinidine|hydroquinidine|mesh-list
65379952|NCT00927732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65379953|NCT00927732|Parasympatholytics|parasympatholytics|mesh-ancestor
65379954|NCT00927732|Autonomic Agents|autonomic agents|mesh-ancestor
65379955|NCT00927732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380017|NCT00924222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380018|NCT00924222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65380020|NCT00924222|Anesthetics|anesthetics|mesh-ancestor
65380021|NCT00924222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65380022|NCT00924222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65380023|NCT01075711|Prednisone|prednisone|mesh-list
65380024|NCT01075711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65380025|NCT01075711|Glucocorticoids|glucocorticoids|mesh-ancestor
65380026|NCT01075711|Hormones|hormones|mesh-ancestor
65380027|NCT01075711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65380028|NCT01075711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380029|NCT01075711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65380030|NCT01075711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066818|NCT00272636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65380031|NCT01073371|Prilocaine|prilocaine|mesh-list
65380032|NCT01073371|Anesthetics, Local|anesthetics, local|mesh-ancestor
65380033|NCT01073371|Anesthetics|anesthetics|mesh-ancestor
65380034|NCT01073371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65380035|NCT01073371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380036|NCT01073371|Sensory System Agents|sensory system agents|mesh-ancestor
65380037|NCT01073371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380038|NCT05470491|Maraviroc|maraviroc|mesh-list
65380039|NCT05470491|Plerixafor|plerixafor|mesh-list
65380040|NCT05470491|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65380041|NCT05470491|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65380042|NCT05470491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380043|NCT05470491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65380044|NCT05470491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65380045|NCT05470491|Antiviral Agents|antiviral agents|mesh-ancestor
65380046|NCT05470491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64772669|NCT01353144|Aspirin|aspirin|mesh-list
65380102|NCT05698407|Anesthetics, Local|anesthetics, local|mesh-ancestor
65380103|NCT05698407|Anesthetics|anesthetics|mesh-ancestor
65380104|NCT05698407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65380105|NCT05698407|Narcotics|narcotics|mesh-ancestor
65066819|NCT00281970|Docetaxel|docetaxel|mesh-list
65380106|NCT05698407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65380107|NCT05698407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65380108|NCT05698407|Anesthetics, General|anesthetics, general|mesh-ancestor
65380109|NCT00585533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65380110|NCT00585533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380111|NCT00585533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65380112|NCT00585533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380113|NCT00585533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380114|NCT00628862|Formoterol Fumarate|formoterol fumarate|mesh-list
65380115|NCT00628862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65380117|NCT00628862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380118|NCT00628862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380119|NCT00628862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65380120|NCT00628862|Respiratory System Agents|respiratory system agents|mesh-ancestor
65380121|NCT00628862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65380122|NCT00628862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65380123|NCT00628862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65380124|NCT00628862|Adrenergic Agents|adrenergic agents|mesh-ancestor
65273925|NCT00900731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380125|NCT00628862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380126|NCT00628862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380127|NCT05420727|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65380128|NCT05420727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65380129|NCT05420727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380130|NCT00987441|Sufentanil|sufentanil|mesh-list
65380131|NCT00987441|Dsuvia|dsuvia|mesh-list
64772752|NCT01365624|Ketorolac|ketorolac|mesh-list
65380159|NCT00584987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65380160|NCT00584987|Adrenergic Agents|adrenergic agents|mesh-ancestor
65380161|NCT00584987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380162|NCT00584987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380163|NCT00584987|Sympathomimetics|sympathomimetics|mesh-ancestor
65380164|NCT00584987|Nasal Decongestants|nasal decongestants|mesh-ancestor
65380165|NCT00584987|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65380166|NCT00584987|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65380167|NCT00584987|Mydriatics|mydriatics|mesh-ancestor
65380168|NCT00584987|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65380169|NCT00584987|Protective Agents|protective agents|mesh-ancestor
65380170|NCT00727961|Doxorubicin|doxorubicin|mesh-list
65380171|NCT00727961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65380172|NCT00727961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65380173|NCT00727961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380174|NCT00727961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65380175|NCT00727961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65380176|NCT00727961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380177|NCT00727961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129768|NCT04604795|Hormone Antagonists|hormone antagonists|mesh-ancestor
65380178|NCT00568958|Naltrexone|naltrexone|mesh-list
65380179|NCT00568958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65380180|NCT00568958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64772796|NCT01377636|Autonomic Agents|autonomic agents|mesh-ancestor
65380215|NCT00821054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65380216|NCT00821054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380217|NCT00821054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380218|NCT00567996|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65380219|NCT00567996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65380220|NCT00567996|Autonomic Agents|autonomic agents|mesh-ancestor
65380221|NCT00567996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380222|NCT00567996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380223|NCT00567996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65380246|NCT04388319|Anticonvulsants|anticonvulsants|mesh-ancestor
65380247|NCT04388319|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65380248|NCT04388319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65380249|NCT04085627|Amlodipine|amlodipine|mesh-list
65380250|NCT04085627|Valsartan|valsartan|mesh-list
65380251|NCT04085627|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
65380252|NCT04085627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65380253|NCT04085627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65380254|NCT04085627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65380255|NCT04085627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380256|NCT04085627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65380257|NCT04085627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380258|NCT04085627|Vasodilator Agents|vasodilator agents|mesh-ancestor
65380259|NCT04085627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65380260|NCT04085627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65380261|NCT04085393|Granisetron|granisetron|mesh-list
65380262|NCT04085393|Antiemetics|antiemetics|mesh-ancestor
65380263|NCT04085393|Autonomic Agents|autonomic agents|mesh-ancestor
65380264|NCT04085393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380265|NCT04085393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380266|NCT04085393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65380267|NCT04085393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65380268|NCT04085393|Serotonin Agents|serotonin agents|mesh-ancestor
65380269|NCT04085393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380270|NCT04085393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380271|NCT00717275|Temozolomide|temozolomide|mesh-list
65380388|NCT05315271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380389|NCT05315271|Analgesics|analgesics|mesh-ancestor
65380390|NCT05315271|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65380391|NCT05315271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65380392|NCT05315271|Anesthetics, General|anesthetics, general|mesh-ancestor
65380393|NCT05315271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65380394|NCT05315271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65380395|NCT05315271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380396|NCT05315271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380397|NCT00147745|Insulin Glargine|insulin glargine|mesh-list
65380398|NCT00147745|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65380399|NCT00147745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65380400|NCT00147745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380401|NCT00147745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65380402|NCT00147745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65380403|NCT00147745|Antimetabolites|antimetabolites|mesh-ancestor
65380404|NCT00147745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380405|NCT00147745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65380406|NCT05313477|Ergocalciferols|ergocalciferols|mesh-list
65380408|NCT05313477|Calcium Carbonate|calcium carbonate|mesh-list
65380409|NCT05313477|Calcium|calcium|mesh-list
65380410|NCT05313477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65380411|NCT05313477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380412|NCT05313477|Antacids|antacids|mesh-ancestor
65380413|NCT05313477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773035|NCT01434186|Metformin|metformin|mesh-list
65380472|NCT00822380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380473|NCT00822380|Protective Agents|protective agents|mesh-ancestor
65380475|NCT00720083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380476|NCT05621811|ATI 7505|ati 7505|mesh-list
65380477|NCT05621811|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65380478|NCT05621811|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65380479|NCT05621811|Serotonin Agents|serotonin agents|mesh-ancestor
65380480|NCT05621811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380481|NCT05621811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380482|NCT05621811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380483|NCT00209131|Tamsulosin|tamsulosin|mesh-list
65380484|NCT00209131|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65380485|NCT00209131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65380486|NCT00209131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65380487|NCT00209131|Adrenergic Agents|adrenergic agents|mesh-ancestor
65380488|NCT00209131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380489|NCT00209131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380490|NCT00209131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380509|NCT00929370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380510|NCT00907764|Regadenoson|regadenoson|mesh-list
65380511|NCT00907764|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65380512|NCT00907764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65380513|NCT00907764|Purinergic Agonists|purinergic agonists|mesh-ancestor
65380514|NCT00907764|Purinergic Agents|purinergic agents|mesh-ancestor
65380515|NCT00907764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380516|NCT00907764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380517|NCT00907764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380518|NCT02550314|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65380519|NCT02550314|Hemostatics|hemostatics|mesh-ancestor
65380520|NCT02550314|Coagulants|coagulants|mesh-ancestor
65380521|NCT01073527|Adenosine|adenosine|mesh-list
65380522|NCT01073527|Albuterol|albuterol|mesh-list
65380523|NCT01073527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65380524|NCT01073527|Autonomic Agents|autonomic agents|mesh-ancestor
65380525|NCT01073527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380526|NCT01073527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380527|NCT01073527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65380528|NCT01073527|Respiratory System Agents|respiratory system agents|mesh-ancestor
65380529|NCT01073527|Tocolytic Agents|tocolytic agents|mesh-ancestor
65380530|NCT01073527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65380531|NCT01073527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65380532|NCT01073527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65380533|NCT01073527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65380534|NCT01073527|Adrenergic Agents|adrenergic agents|mesh-ancestor
65380535|NCT01073527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380536|NCT01073527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380537|NCT01073527|Analgesics|analgesics|mesh-ancestor
65380538|NCT01073527|Sensory System Agents|sensory system agents|mesh-ancestor
65380539|NCT01073527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65380540|NCT01073527|Vasodilator Agents|vasodilator agents|mesh-ancestor
65380541|NCT01073527|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65273926|NCT00900731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380542|NCT01073527|Purinergic Agonists|purinergic agonists|mesh-ancestor
65380543|NCT01073527|Purinergic Agents|purinergic agents|mesh-ancestor
65380544|NCT02538432|Gemcitabine|gemcitabine|mesh-list
65380545|NCT02538432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65380546|NCT02538432|Antimetabolites|antimetabolites|mesh-ancestor
65380547|NCT02538432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380564|NCT00719849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380566|NCT00719849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65380567|NCT00719849|Alkylating Agents|alkylating agents|mesh-ancestor
65380568|NCT00719849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380569|NCT00719849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380570|NCT00719849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65380571|NCT00719849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65380572|NCT00719849|Antimetabolites|antimetabolites|mesh-ancestor
65380573|NCT00719849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380574|NCT00719849|Antifungal Agents|antifungal agents|mesh-ancestor
65380575|NCT00719849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65380576|NCT00719849|Dermatologic Agents|dermatologic agents|mesh-ancestor
65380577|NCT00719849|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65380578|NCT00719849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65380579|NCT00719849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65380580|NCT00719849|Antitubercular Agents|antitubercular agents|mesh-ancestor
65380581|NCT00719849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65380582|NCT00822536|Aspirin|aspirin|mesh-list
65380583|NCT00822536|Clopidogrel|clopidogrel|mesh-list
65380584|NCT00822536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65380585|NCT00822536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65380586|NCT00822536|Analgesics|analgesics|mesh-ancestor
65380587|NCT00822536|Sensory System Agents|sensory system agents|mesh-ancestor
65380588|NCT00822536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380589|NCT00822536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380590|NCT00822536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65380591|NCT00822536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65380592|NCT00822536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65380593|NCT00822536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65380594|NCT00822536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380595|NCT00822536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65380596|NCT00822536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65380597|NCT00822536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380598|NCT00822536|Antipyretics|antipyretics|mesh-ancestor
65380599|NCT00822536|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65380600|NCT00822536|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65380601|NCT00822536|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65380602|NCT00822536|Purinergic Agents|purinergic agents|mesh-ancestor
65380603|NCT00822536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380604|NCT00826826|Amiodarone|amiodarone|mesh-list
65380605|NCT00826826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65380606|NCT00826826|Vasodilator Agents|vasodilator agents|mesh-ancestor
65380607|NCT00826826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65380665|NCT00817466|Epinephrine|epinephrine|mesh-list
65380666|NCT00817466|Racepinephrine|racepinephrine|mesh-list
65380667|NCT00817466|Epinephryl borate|epinephryl borate|mesh-list
65380668|NCT00817466|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65380669|NCT00817466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65380670|NCT00817466|Adrenergic Agents|adrenergic agents|mesh-ancestor
65380671|NCT00817466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380672|NCT00817466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380673|NCT00817466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380674|NCT00817466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65380675|NCT00817466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65380676|NCT00817466|Autonomic Agents|autonomic agents|mesh-ancestor
65380677|NCT00817466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380678|NCT00817466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65380679|NCT00817466|Respiratory System Agents|respiratory system agents|mesh-ancestor
65380680|NCT00817466|Mydriatics|mydriatics|mesh-ancestor
65380681|NCT00817466|Sympathomimetics|sympathomimetics|mesh-ancestor
65380682|NCT00817466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65380683|NCT00930072|Clonidine|clonidine|mesh-list
65380684|NCT00930072|Bupivacaine|bupivacaine|mesh-list
65380685|NCT00930072|Anesthetics, Local|anesthetics, local|mesh-ancestor
65380686|NCT00930072|Anesthetics|anesthetics|mesh-ancestor
65380687|NCT00930072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65380688|NCT00930072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273927|NCT00900731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65380689|NCT00930072|Sensory System Agents|sensory system agents|mesh-ancestor
65380690|NCT00930072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380691|NCT00930072|Analgesics|analgesics|mesh-ancestor
65380692|NCT00930072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65380736|NCT00827216|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65380737|NCT00827216|Erythromycin stearate|erythromycin stearate|mesh-list
65380738|NCT00827216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65380739|NCT00827216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65380740|NCT00827216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65380741|NCT00827216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65380742|NCT00827216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380743|NCT00827216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380744|NCT00822848|Sorafenib|sorafenib|mesh-list
65380745|NCT00822848|Epirubicin|epirubicin|mesh-list
65380746|NCT00822848|Ifosfamide|ifosfamide|mesh-list
65380747|NCT00822848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380748|NCT00822848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65380749|NCT00822848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380750|NCT00822848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380751|NCT00822848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65380752|NCT00822848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65380753|NCT00822848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65380754|NCT00822848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65380755|NCT00822848|Alkylating Agents|alkylating agents|mesh-ancestor
65380756|NCT00926718|Remifentanil|remifentanil|mesh-list
65380757|NCT00926718|Rocuronium|rocuronium|mesh-list
65380758|NCT00926718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65380759|NCT00926718|Narcotics|narcotics|mesh-ancestor
65380760|NCT00926718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65380761|NCT00926718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380762|NCT00926718|Analgesics|analgesics|mesh-ancestor
65380763|NCT00926718|Sensory System Agents|sensory system agents|mesh-ancestor
65380764|NCT00926718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380765|NCT00926718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65380784|NCT00823004|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65380785|NCT00823004|Fertility Agents|fertility agents|mesh-ancestor
65380786|NCT00827450|Caffeine|caffeine|mesh-list
65380787|NCT00827450|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65380788|NCT00827450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380789|NCT00827450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65380790|NCT00827450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380791|NCT00827450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380792|NCT00827450|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65380793|NCT00827450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65380794|NCT00827450|Purinergic Agents|purinergic agents|mesh-ancestor
65380795|NCT00827450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380796|NCT00930306|Tolbutamide|tolbutamide|mesh-list
65380797|NCT00930306|Midazolam|midazolam|mesh-list
65380798|NCT00930306|Caffeine|caffeine|mesh-list
65380799|NCT00930306|Omeprazole|omeprazole|mesh-list
65380800|NCT00930306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65380801|NCT00930306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65380802|NCT00930306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65380803|NCT00930306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380804|NCT00930306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65380805|NCT00930306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65380806|NCT00930306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65380807|NCT00930306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65380808|NCT00930306|Anesthetics, General|anesthetics, general|mesh-ancestor
65380809|NCT00930306|Anesthetics|anesthetics|mesh-ancestor
65380810|NCT00930306|GABA Modulators|gaba modulators|mesh-ancestor
65380811|NCT00930306|GABA Agents|gaba agents|mesh-ancestor
65380812|NCT00930306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380813|NCT00930306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380814|NCT00930306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65380815|NCT00930306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65380816|NCT00930306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380817|NCT00930306|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65380818|NCT00930306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65380819|NCT00930306|Purinergic Agents|purinergic agents|mesh-ancestor
65380820|NCT00930306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65380821|NCT00930306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64773435|NCT01535664|4-Aminopyridine|4-aminopyridine|mesh-list
65380847|NCT00827684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65380848|NCT00827684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380849|NCT00827684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380850|NCT00827684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380851|NCT00827684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65380852|NCT00827684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65380853|NCT00827684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65380854|NCT00827684|Antifungal Agents|antifungal agents|mesh-ancestor
65380856|NCT00827684|Immunologic Factors|immunologic factors|mesh-ancestor
65380857|NCT00827684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380859|NCT00927030|Antioxidants|antioxidants|mesh-ancestor
65380860|NCT00927030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380861|NCT00927030|Protective Agents|protective agents|mesh-ancestor
65380862|NCT00927030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380863|NCT00927030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65380864|NCT00931866|Diclofenac|diclofenac|mesh-list
65380865|NCT00931866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65380866|NCT00931866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65380867|NCT00931866|Analgesics|analgesics|mesh-ancestor
65380868|NCT00931866|Sensory System Agents|sensory system agents|mesh-ancestor
65380869|NCT00931866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380870|NCT00931866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380871|NCT00931866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64773495|NCT01542684|Azacitidine|azacitidine|mesh-list
65380922|NCT00828230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65380923|NCT00828230|Autonomic Agents|autonomic agents|mesh-ancestor
65380924|NCT00828230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380925|NCT00828230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380926|NCT00828230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65380927|NCT00828230|Respiratory System Agents|respiratory system agents|mesh-ancestor
65380928|NCT00828230|Glucocorticoids|glucocorticoids|mesh-ancestor
65380929|NCT00828230|Hormones|hormones|mesh-ancestor
65380930|NCT00828230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65380931|NCT04469556|Leucovorin|leucovorin|mesh-list
65380932|NCT04469556|Gemcitabine|gemcitabine|mesh-list
65380933|NCT04469556|Paclitaxel|paclitaxel|mesh-list
65380934|NCT04469556|Oxaliplatin|oxaliplatin|mesh-list
65380935|NCT04469556|Irinotecan|irinotecan|mesh-list
65380936|NCT04469556|Folfirinox|folfirinox|mesh-list
65380937|NCT04469556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65380938|NCT04469556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380939|NCT04469556|Tubulin Modulators|tubulin modulators|mesh-ancestor
65380940|NCT04469556|Antimitotic Agents|antimitotic agents|mesh-ancestor
65380941|NCT04469556|Mitosis Modulators|mitosis modulators|mesh-ancestor
65380942|NCT04469556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380943|NCT04469556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65380944|NCT04469556|Antimetabolites|antimetabolites|mesh-ancestor
65380945|NCT04469556|Antiviral Agents|antiviral agents|mesh-ancestor
65380946|NCT04469556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65380947|NCT04469556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380948|NCT04469556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65380949|NCT04469556|Immunologic Factors|immunologic factors|mesh-ancestor
65380950|NCT04469556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380951|NCT04469556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65380952|NCT04469556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65380953|NCT04469556|Antidotes|antidotes|mesh-ancestor
65380954|NCT04469556|Protective Agents|protective agents|mesh-ancestor
65380990|NCT05046639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380991|NCT04521621|Pembrolizumab|pembrolizumab|mesh-list
65380992|NCT04521621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65380993|NCT04521621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381042|NCT00931086|Immunologic Factors|immunologic factors|mesh-ancestor
65381043|NCT00931086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381044|NCT04482621|Decitabine|decitabine|mesh-list
65381045|NCT04482621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65381046|NCT04482621|Antimetabolites|antimetabolites|mesh-ancestor
65381047|NCT04482621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381048|NCT04482621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381049|NCT04482621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381050|NCT04453839|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
65381051|NCT04453839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65381052|NCT04453839|Vasodilator Agents|vasodilator agents|mesh-ancestor
65381053|NCT04453839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65381054|NCT04453839|Protective Agents|protective agents|mesh-ancestor
65381055|NCT04453839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381056|NCT03977454|Ropivacaine|ropivacaine|mesh-list
65273928|NCT00900731|Respiratory System Agents|respiratory system agents|mesh-ancestor
65381057|NCT03977454|Anesthetics, Local|anesthetics, local|mesh-ancestor
65381058|NCT03977454|Anesthetics|anesthetics|mesh-ancestor
65381059|NCT03977454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65381060|NCT03977454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381061|NCT03977454|Sensory System Agents|sensory system agents|mesh-ancestor
65381062|NCT03977454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65381063|NCT02549066|Milrinone|milrinone|mesh-list
65381064|NCT02549066|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65381065|NCT02549066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65381066|NCT02549066|Vasodilator Agents|vasodilator agents|mesh-ancestor
65381067|NCT02549066|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65381068|NCT02549066|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65381069|NCT02549066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381070|NCT02549066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381071|NCT02549066|Protective Agents|protective agents|mesh-ancestor
65381072|NCT02549066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381073|NCT00831350|Ranibizumab|ranibizumab|mesh-list
65381074|NCT00831350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64773679|NCT01577706|Dopamine Agents|dopamine agents|mesh-ancestor
65381204|NCT00990639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65381205|NCT00990639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65381206|NCT00990639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65381207|NCT00990639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381208|NCT03025035|Pembrolizumab|pembrolizumab|mesh-list
65381209|NCT03025035|Olaparib|olaparib|mesh-list
65381210|NCT03025035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65381290|NCT04043858|Adrenergic Agents|adrenergic agents|mesh-ancestor
65381291|NCT04043858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65381292|NCT04043858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381293|NCT05359419|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65381294|NCT05359419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65381295|NCT05359419|Dermatologic Agents|dermatologic agents|mesh-ancestor
65381296|NCT00823862|Ribavirin|ribavirin|mesh-list
65381297|NCT00823862|Antimetabolites|antimetabolites|mesh-ancestor
65381298|NCT00823862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381299|NCT00823862|Antiviral Agents|antiviral agents|mesh-ancestor
65381300|NCT00823862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65381301|NCT00537771|Tamoxifen|tamoxifen|mesh-list
65381302|NCT00537771|Anastrozole|anastrozole|mesh-list
65381303|NCT00537771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65381304|NCT00537771|Hormone Antagonists|hormone antagonists|mesh-ancestor
65381305|NCT00537771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65381306|NCT00537771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381307|NCT00537771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65381308|NCT00537771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381309|NCT00537771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65381310|NCT00537771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65381311|NCT00537771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65381312|NCT00537771|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65381313|NCT00537771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65381314|NCT00537771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773926|NCT04992312|Glucagon|glucagon|mesh-list
65381339|NCT02513667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381340|NCT02513667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65381341|NCT02513667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381342|NCT02513667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381344|NCT03823911|Grazoprevir|grazoprevir|mesh-list
65381345|NCT03823911|Ledipasvir|ledipasvir|mesh-list
65381346|NCT03823911|Velpatasvir|velpatasvir|mesh-list
65381347|NCT03823911|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65381348|NCT03823911|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65381349|NCT03823911|Antiviral Agents|antiviral agents|mesh-ancestor
65381350|NCT03823911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65381351|NCT00829634|Methamphetamine|methamphetamine|mesh-list
65381352|NCT00829634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65381353|NCT00829634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381354|NCT00829634|Sympathomimetics|sympathomimetics|mesh-ancestor
65381355|NCT00829634|Autonomic Agents|autonomic agents|mesh-ancestor
65381356|NCT00829634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65381357|NCT00829634|Dopamine Agents|dopamine agents|mesh-ancestor
65381358|NCT00829634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65273929|NCT00900731|Parasympatholytics|parasympatholytics|mesh-ancestor
65273930|NCT00900731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65273931|NCT00900731|Cholinergic Agents|cholinergic agents|mesh-ancestor
65381359|NCT00829634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381360|NCT00829634|Adrenergic Agents|adrenergic agents|mesh-ancestor
65381361|NCT00829634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65381362|NCT00829634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65381387|NCT05361057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65381389|NCT05361057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381390|NCT05361057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381391|NCT05361057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65381392|NCT05361057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65381393|NCT05361057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65381394|NCT00832286|Ciprofloxacin|ciprofloxacin|mesh-list
65381395|NCT00832286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65381396|NCT00832286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65381397|NCT00832286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65381398|NCT00832286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65381399|NCT00832286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381400|NCT00832286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381401|NCT00832286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381402|NCT00832286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65381403|NCT00832286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65381404|NCT00832364|Etanercept|etanercept|mesh-list
65381405|NCT00832364|Acitretin|acitretin|mesh-list
65381406|NCT00832364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65381407|NCT00832364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65381408|NCT00832364|Analgesics|analgesics|mesh-ancestor
65381409|NCT00832364|Sensory System Agents|sensory system agents|mesh-ancestor
65381410|NCT00832364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65381411|NCT00832364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381412|NCT00832364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65381413|NCT00832364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65381486|NCT04043702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381487|NCT02550080|Dapsone|dapsone|mesh-list
65381488|NCT02550080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65381489|NCT02550080|Antimalarials|antimalarials|mesh-ancestor
65381490|NCT02550080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65381511|NCT00838214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381512|NCT00838214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65381513|NCT00838214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381514|NCT00838214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65381515|NCT00838214|Autonomic Agents|autonomic agents|mesh-ancestor
65381516|NCT00838214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65381517|NCT00838214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65381518|NCT00838214|Respiratory System Agents|respiratory system agents|mesh-ancestor
65381519|NCT00621764|Vaccines|vaccines|mesh-list
65381520|NCT00621764|Immunologic Factors|immunologic factors|mesh-ancestor
65381521|NCT00621764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381522|NCT00838370|Fluorouracil|fluorouracil|mesh-list
65381523|NCT00838370|Capecitabine|capecitabine|mesh-list
65381524|NCT00838370|Antimetabolites|antimetabolites|mesh-ancestor
65381525|NCT00838370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381526|NCT00838370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65381527|NCT00838370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381528|NCT00838370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65381530|NCT00838370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381531|NCT00537381|Prednisone|prednisone|mesh-list
65381532|NCT00537381|Docetaxel|docetaxel|mesh-list
65381533|NCT00537381|Intetumumab|intetumumab|mesh-list
65381534|NCT00537381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381535|NCT00537381|Tubulin Modulators|tubulin modulators|mesh-ancestor
65381536|NCT00537381|Antimitotic Agents|antimitotic agents|mesh-ancestor
65381537|NCT00537381|Mitosis Modulators|mitosis modulators|mesh-ancestor
65381538|NCT00537381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381539|NCT00537381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65381540|NCT00537381|Glucocorticoids|glucocorticoids|mesh-ancestor
65381541|NCT00537381|Hormones|hormones|mesh-ancestor
65381542|NCT00537381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65381543|NCT00537381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381544|NCT00537381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65381545|NCT00537381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65381546|NCT00833300|Haloperidol|haloperidol|mesh-list
65381596|NCT05398731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381597|NCT05398731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381599|NCT00838760|TMC-310911|tmc-310911|mesh-list
65381600|NCT00838760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65381601|NCT00838760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65381602|NCT00838760|Protease Inhibitors|protease inhibitors|mesh-ancestor
65381603|NCT00838760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381604|NCT00838760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381605|NCT00838760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65381606|NCT00838760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65381607|NCT00838760|Antiviral Agents|antiviral agents|mesh-ancestor
65381608|NCT00838760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65381609|NCT03791398|Nivolumab|nivolumab|mesh-list
65381610|NCT03791398|TIC10 compound|tic10 compound|mesh-list
65381611|NCT03791398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65381612|NCT03791398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381613|NCT03791398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65381614|NCT03791398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381615|NCT00838838|Methyltestosterone|methyltestosterone|mesh-list
65381616|NCT00838838|Testosterone|testosterone|mesh-list
65381617|NCT00838838|Testosterone undecanoate|testosterone undecanoate|mesh-list
65381618|NCT00838838|Testosterone enanthate|testosterone enanthate|mesh-list
65381619|NCT00838838|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65381620|NCT00838838|Androgens|androgens|mesh-ancestor
65381621|NCT00838838|Hormones|hormones|mesh-ancestor
65381622|NCT00838838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65381623|NCT00838838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381624|NCT00838838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65381625|NCT00838838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381626|NCT00838838|Anabolic Agents|anabolic agents|mesh-ancestor
65381627|NCT05360979|Endostatins|endostatins|mesh-list
65381628|NCT05360979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381629|NCT05360979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65381630|NCT05360979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65381631|NCT05360979|Growth Substances|growth substances|mesh-ancestor
65381632|NCT05360979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381633|NCT05360979|Growth Inhibitors|growth inhibitors|mesh-ancestor
65381634|NCT00833534|Rituximab|rituximab|mesh-list
65381635|NCT00833534|Lenalidomide|lenalidomide|mesh-list
65381636|NCT00833534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65381637|NCT00833534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774231|NCT01640340|Antipruritics|antipruritics|mesh-ancestor
65381672|NCT00517192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65381673|NCT00517192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65381674|NCT00517192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65381675|NCT00145327|Zoledronic Acid|zoledronic acid|mesh-list
65381676|NCT00145327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65381677|NCT00145327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381678|NCT00833768|Sevelamer|sevelamer|mesh-list
65381725|NCT01156389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65381726|NCT01156389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65381727|NCT01156389|Antiviral Agents|antiviral agents|mesh-ancestor
65381728|NCT01156389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65381729|NCT01156389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65381730|NCT01156389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65381731|NCT01156389|Antimalarials|antimalarials|mesh-ancestor
65381732|NCT01156389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65381733|NCT01156389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65381734|NCT01156389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381735|NCT01156389|Schistosomicides|schistosomicides|mesh-ancestor
65381736|NCT01156389|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65381737|NCT01156389|Anthelmintics|anthelmintics|mesh-ancestor
65381738|NCT04043624|Lidocaine|lidocaine|mesh-list
65381739|NCT04043624|Anesthetics, Local|anesthetics, local|mesh-ancestor
65381740|NCT04043624|Anesthetics|anesthetics|mesh-ancestor
65381741|NCT04043624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65381742|NCT04043624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381743|NCT04043624|Sensory System Agents|sensory system agents|mesh-ancestor
65381744|NCT04043624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65381745|NCT04043624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65381746|NCT04043624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65381747|NCT04043624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65381748|NCT04043624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65273932|NCT00900731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65381749|NCT04043624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131333|NCT04564638|Antifungal Agents|antifungal agents|mesh-ancestor
65381750|NCT01105767|Chlorhexidine|chlorhexidine|mesh-list
65381751|NCT01105767|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65381752|NCT01105767|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65381753|NCT01105767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65381754|NCT01105767|Disinfectants|disinfectants|mesh-ancestor
65381755|NCT01105767|Dermatologic Agents|dermatologic agents|mesh-ancestor
65381756|NCT00625742|Ibuprofen|ibuprofen|mesh-list
65381757|NCT00625742|Atenolol|atenolol|mesh-list
65381758|NCT00625742|Melatonin|melatonin|mesh-list
65381759|NCT00625742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65381760|NCT00625742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65381761|NCT00625742|Analgesics|analgesics|mesh-ancestor
65381762|NCT00625742|Sensory System Agents|sensory system agents|mesh-ancestor
65381763|NCT00625742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65381764|NCT00625742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381765|NCT00625742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65381766|NCT00625742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65381767|NCT00625742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65381768|NCT00625742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64774361|NCT01663272|Antimetabolites|antimetabolites|mesh-ancestor
65381802|NCT00825188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65381803|NCT00825188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65381804|NCT00825188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65381805|NCT00825188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381806|NCT00825188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65381807|NCT00825188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381808|NCT00825188|Vasodilator Agents|vasodilator agents|mesh-ancestor
64774421|NCT01684020|Hemostatics|hemostatics|mesh-ancestor
65381916|NCT00537303|Insulin|insulin|mesh-list
65381917|NCT00537303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65381918|NCT00537303|Insulin Aspart|insulin aspart|mesh-list
65381919|NCT00537303|Insulin, Long-Acting|insulin, long-acting|mesh-list
65381920|NCT00537303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65381921|NCT00537303|Insulin Detemir|insulin detemir|mesh-list
65381922|NCT00537303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65381923|NCT00537303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381924|NCT02548286|Amlodipine|amlodipine|mesh-list
65381925|NCT02548286|Candesartan|candesartan|mesh-list
65381926|NCT02548286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65381927|NCT02548286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65381928|NCT02548286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65381929|NCT02548286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381930|NCT02548286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65381931|NCT02548286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381967|NCT04696575|Antiviral Agents|antiviral agents|mesh-ancestor
65381968|NCT04696575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65381969|NCT04696575|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65381970|NCT04696575|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65381993|NCT00505414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65381994|NCT00505414|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65381995|NCT00505414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65381996|NCT00505414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65381997|NCT00505414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381998|NCT00505414|Adrenergic Agents|adrenergic agents|mesh-ancestor
65381999|NCT00505414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65382000|NCT02549924|Resveratrol|resveratrol|mesh-list
65382001|NCT02549924|Antioxidants|antioxidants|mesh-ancestor
65382002|NCT02549924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382003|NCT02549924|Protective Agents|protective agents|mesh-ancestor
65382004|NCT02549924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382005|NCT02549924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382006|NCT02549924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65382007|NCT01813227|Dexamethasone|dexamethasone|mesh-list
65382008|NCT01813227|Rituximab|rituximab|mesh-list
65382009|NCT01813227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65382010|NCT01813227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382011|NCT01813227|Immunologic Factors|immunologic factors|mesh-ancestor
65382012|NCT01813227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382013|NCT01813227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65382014|NCT01813227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65382015|NCT01813227|Antiemetics|antiemetics|mesh-ancestor
64790013|NCT00003960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65382016|NCT01813227|Autonomic Agents|autonomic agents|mesh-ancestor
65382017|NCT01813227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65382018|NCT01813227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65382019|NCT01813227|Glucocorticoids|glucocorticoids|mesh-ancestor
65382020|NCT01813227|Hormones|hormones|mesh-ancestor
65382021|NCT01813227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65382022|NCT01813227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65382023|NCT01012882|Immunologic Factors|immunologic factors|mesh-list
65382024|NCT01012882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382025|NCT00989469|Irinotecan|irinotecan|mesh-list
65382026|NCT00989469|Sorafenib|sorafenib|mesh-list
65382098|NCT00989625|Serotonin Agents|serotonin agents|mesh-ancestor
65382099|NCT00989625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65382100|NCT00841256|Glycerol|glycerol|mesh-list
65382101|NCT00841256|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65382102|NCT00841256|Protective Agents|protective agents|mesh-ancestor
64822086|NCT01519310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64822087|NCT01519310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64822088|NCT01519310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822089|NCT01519310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822090|NCT01519310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822091|NCT01519310|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65494583|NCT01143948|Insulin|insulin|mesh-list
65494584|NCT01143948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64560992|NCT01115517|Mitomycins|mitomycins|mesh-list
64822092|NCT01519310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64822093|NCT01519336|Ritonavir|ritonavir|mesh-list
64822094|NCT01519336|Darunavir|darunavir|mesh-list
64822095|NCT01519336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64822096|NCT01519336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64329958|NCT02030639|ON 01910|on 01910|mesh-list
64822142|NCT01519544|GABA Agents|gaba agents|mesh-ancestor
64822143|NCT01519544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64822144|NCT01519687|Tofisopam|tofisopam|mesh-list
64822145|NCT01519687|Antidepressive Agents|antidepressive agents|mesh-ancestor
64822146|NCT01519687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64822147|NCT01519726|Midazolam|midazolam|mesh-list
64822148|NCT01519726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64822149|NCT01519726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64822150|NCT01519726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64822151|NCT01519726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330279|NCT04469413|Antipyretics|antipyretics|mesh-ancestor
64822210|NCT01520116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64822232|NCT01520298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64822233|NCT01520298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822234|NCT01520298|Antipyretics|antipyretics|mesh-ancestor
64822235|NCT01520350|Aripiprazole|aripiprazole|mesh-list
64822236|NCT01520350|Antidepressive Agents|antidepressive agents|mesh-ancestor
64822237|NCT01520350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64822238|NCT01520350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64822239|NCT01520350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64822240|NCT01520350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64822241|NCT01520350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822242|NCT01520350|Dopamine Agonists|dopamine agonists|mesh-ancestor
64822243|NCT01520350|Dopamine Agents|dopamine agents|mesh-ancestor
64822244|NCT01520350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64822245|NCT01520350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331038|NCT05791331|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64822294|NCT01520467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822296|NCT01520584|Micronutrients|micronutrients|mesh-ancestor
64822297|NCT01520584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822298|NCT01520753|Insulin|insulin|mesh-list
64822299|NCT01520753|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64822300|NCT01520753|Insulin Aspart|insulin aspart|mesh-list
64822301|NCT01520753|Insulin, Long-Acting|insulin, long-acting|mesh-list
64822302|NCT01520753|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64822303|NCT01520753|Biphasic Insulins|biphasic insulins|mesh-list
64822340|NCT01520831|Biphasic Insulins|biphasic insulins|mesh-list
64822341|NCT01520831|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64332077|NCT03972657|Cemiplimab|cemiplimab|mesh-list
64822368|NCT01521299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64822369|NCT01521312|Saxagliptin|saxagliptin|mesh-list
64822370|NCT01521312|Incretins|incretins|mesh-ancestor
64822371|NCT01521312|Hormones|hormones|mesh-ancestor
64822372|NCT01521312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65273933|NCT00900731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273934|NCT02687490|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64822373|NCT01521312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822374|NCT01521312|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64822375|NCT01521312|Protease Inhibitors|protease inhibitors|mesh-ancestor
64822376|NCT01521312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822377|NCT01521312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822378|NCT01521312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64822379|NCT01521325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64822380|NCT01521325|Immunologic Factors|immunologic factors|mesh-ancestor
64822381|NCT01521325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822382|NCT01521377|Moxifloxacin|moxifloxacin|mesh-list
64822383|NCT01521377|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64822384|NCT01521377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64822417|NCT01521572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64822418|NCT01521572|Autonomic Agents|autonomic agents|mesh-ancestor
64822419|NCT01521572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64822457|NCT01521819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64822459|NCT01521819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822460|NCT01521819|Growth Inhibitors|growth inhibitors|mesh-ancestor
64822461|NCT01521819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822462|NCT01521936|Vitamin D|vitamin d|mesh-list
64822463|NCT01521936|Ergocalciferols|ergocalciferols|mesh-list
64822464|NCT01521936|Cholecalciferol|cholecalciferol|mesh-list
64822465|NCT01521936|Vitamins|vitamins|mesh-list
64822466|NCT01521936|Micronutrients|micronutrients|mesh-ancestor
64822467|NCT01521936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822468|NCT01521936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64822469|NCT01521936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64822470|NCT01521962|Alogliptin|alogliptin|mesh-list
64822471|NCT01521962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64822472|NCT01521962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822473|NCT01521962|Incretins|incretins|mesh-ancestor
64822474|NCT01521962|Hormones|hormones|mesh-ancestor
64822475|NCT01521962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64822476|NCT01521962|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64822477|NCT01521962|Protease Inhibitors|protease inhibitors|mesh-ancestor
64822478|NCT01521962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822479|NCT01521962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822480|NCT01521975|Adefovir|adefovir|mesh-list
64822481|NCT01521975|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64822482|NCT01521975|Telbivudine|telbivudine|mesh-list
64822483|NCT01521975|Antiviral Agents|antiviral agents|mesh-ancestor
64433623|NCT02456909|Morphine|morphine|mesh-list
64822500|NCT01522040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335844|NCT03510325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64822518|NCT01522326|Ibuprofen|ibuprofen|mesh-list
64822519|NCT01522326|Metoclopramide|metoclopramide|mesh-list
64822520|NCT01522326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64822521|NCT01522326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64822522|NCT01522326|Analgesics|analgesics|mesh-ancestor
64822523|NCT01522326|Sensory System Agents|sensory system agents|mesh-ancestor
64822524|NCT01522326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64822525|NCT01522326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822526|NCT01522326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64822527|NCT01522326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64822528|NCT01522326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64822529|NCT01522326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822530|NCT01522326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822531|NCT01522326|Antiemetics|antiemetics|mesh-ancestor
64822532|NCT01522326|Autonomic Agents|autonomic agents|mesh-ancestor
64822533|NCT01522326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64472771|NCT02790710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64561271|NCT01135329|Cyclophosphamide|cyclophosphamide|mesh-list
64822534|NCT01522326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64822535|NCT01522326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64822536|NCT01522326|Dopamine Agents|dopamine agents|mesh-ancestor
64822537|NCT01522326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64822538|NCT01522378|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64822539|NCT01522378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822558|NCT01522547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64822559|NCT01522547|Growth Substances|growth substances|mesh-ancestor
65273935|NCT02687490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273936|NCT05241821|Fibrinolytic Agents|fibrinolytic agents|mesh-list
65273937|NCT05241821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65273938|NCT05241821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273939|NCT03801642|Dapagliflozin|dapagliflozin|mesh-list
65273940|NCT03801642|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65273941|NCT03801642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273942|NCT03801642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65273943|NCT03801642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273944|NCT00650819|Simvastatin|simvastatin|mesh-list
65273945|NCT00650819|Ezetimibe|ezetimibe|mesh-list
65273946|NCT00650819|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65273947|NCT00650819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65273948|NCT00650819|Antimetabolites|antimetabolites|mesh-ancestor
65273949|NCT00650819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273950|NCT00650819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65273951|NCT00650819|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65273952|NCT00650819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273953|NCT05662410|Aflibercept|aflibercept|mesh-list
65273954|NCT05662410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65273955|NCT05662410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64822560|NCT01522547|Growth Inhibitors|growth inhibitors|mesh-ancestor
64822561|NCT01522547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822562|NCT01522612|Leucovorin|leucovorin|mesh-list
64822563|NCT01522612|Fluorouracil|fluorouracil|mesh-list
64822564|NCT01522612|Cetuximab|cetuximab|mesh-list
64822565|NCT01522612|Antimetabolites|antimetabolites|mesh-ancestor
64822566|NCT01522612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822567|NCT01522612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64822568|NCT01522612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822569|NCT01522612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64822570|NCT01522612|Immunologic Factors|immunologic factors|mesh-ancestor
64822571|NCT01522612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822572|NCT01522612|Antidotes|antidotes|mesh-ancestor
64822573|NCT01522612|Protective Agents|protective agents|mesh-ancestor
64822574|NCT01522612|Vitamin B Complex|vitamin b complex|mesh-ancestor
64822575|NCT01522612|Vitamins|vitamins|mesh-ancestor
64822615|NCT01522846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822616|NCT01522872|Dexamethasone|dexamethasone|mesh-list
64822617|NCT01522872|Dexamethasone acetate|dexamethasone acetate|mesh-list
64822618|NCT01522872|Bortezomib|bortezomib|mesh-list
64822619|NCT01522872|Pomalidomide|pomalidomide|mesh-list
64822620|NCT01522872|Phosphoramide Mustards|phosphoramide mustards|mesh-list
64822621|NCT01522872|BB 1101|bb 1101|mesh-list
64822622|NCT01522872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64822623|NCT01522872|Antiemetics|antiemetics|mesh-ancestor
64822624|NCT01522872|Autonomic Agents|autonomic agents|mesh-ancestor
64822625|NCT01522872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64822626|NCT01522872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822627|NCT01522872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64822628|NCT01522872|Glucocorticoids|glucocorticoids|mesh-ancestor
64822629|NCT01522872|Hormones|hormones|mesh-ancestor
64822630|NCT01522872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65273956|NCT05662410|Growth Substances|growth substances|mesh-ancestor
64822631|NCT01522872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64822632|NCT01522872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822633|NCT01522872|Protease Inhibitors|protease inhibitors|mesh-ancestor
64822634|NCT01522872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822663|NCT01523002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822664|NCT01523002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64822682|NCT01523015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822683|NCT01523015|Tubulin Modulators|tubulin modulators|mesh-ancestor
64822684|NCT01523015|Antimitotic Agents|antimitotic agents|mesh-ancestor
64822685|NCT01523015|Mitosis Modulators|mitosis modulators|mesh-ancestor
64822686|NCT01523015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822687|NCT01523015|Antimetabolites|antimetabolites|mesh-ancestor
64822688|NCT01523015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64822689|NCT01523015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64822690|NCT01523015|Immunologic Factors|immunologic factors|mesh-ancestor
64822691|NCT01523015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822692|NCT01523041|Insulin|insulin|mesh-list
64822693|NCT01523041|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64822694|NCT01523041|Insulin Aspart|insulin aspart|mesh-list
64822747|NCT01523119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64822748|NCT01523119|Serotonin Agents|serotonin agents|mesh-ancestor
64561421|NCT02078219|Allopurinol|allopurinol|mesh-list
64822749|NCT01523119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64822750|NCT01523119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822751|NCT01523119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64822752|NCT01523119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64822753|NCT01523119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64822754|NCT01523119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64822755|NCT01523119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64822756|NCT01523236|Mometasone Furoate|mometasone furoate|mesh-list
64822803|NCT01523418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822804|NCT01523418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822805|NCT01523418|Anticoagulants|anticoagulants|mesh-ancestor
64822806|NCT01523431|Leucovorin|leucovorin|mesh-list
64822807|NCT01523431|Fluorouracil|fluorouracil|mesh-list
64822808|NCT01523431|Irinotecan|irinotecan|mesh-list
64822809|NCT01523431|Antimetabolites|antimetabolites|mesh-ancestor
64822810|NCT01523431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822811|NCT01523431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64822874|NCT01523847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64822875|NCT01523847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64822876|NCT01523847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822877|NCT01523847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822879|NCT01523860|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64822880|NCT01523860|Mitoxantrone|mitoxantrone|mesh-list
64822881|NCT01523860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64822882|NCT01523860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822923|NCT01524081|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64822925|NCT01524094|Leucovorin|leucovorin|mesh-list
64822926|NCT01524094|Fluorouracil|fluorouracil|mesh-list
64822927|NCT01524094|Oxaliplatin|oxaliplatin|mesh-list
64822928|NCT01524094|Levoleucovorin|levoleucovorin|mesh-list
64822929|NCT01524094|Antimetabolites|antimetabolites|mesh-ancestor
64822930|NCT01524094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591554|NCT03582332|Indomethacin|indomethacin|mesh-list
64822931|NCT01524094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64822932|NCT01524094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822933|NCT01524094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64822934|NCT01524094|Immunologic Factors|immunologic factors|mesh-ancestor
64822935|NCT01524094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822936|NCT01524094|Antidotes|antidotes|mesh-ancestor
64822937|NCT01524094|Protective Agents|protective agents|mesh-ancestor
64822938|NCT01524094|Vitamin B Complex|vitamin b complex|mesh-ancestor
64822939|NCT01524094|Vitamins|vitamins|mesh-ancestor
64822940|NCT01524094|Micronutrients|micronutrients|mesh-ancestor
64822941|NCT01524237|Ketamine|ketamine|mesh-list
64822942|NCT01524237|Analgesics|analgesics|mesh-ancestor
64822943|NCT01524237|Sensory System Agents|sensory system agents|mesh-ancestor
64337969|NCT02265731|Rituximab|rituximab|mesh-list
64822985|NCT01524432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822986|NCT01524432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64822987|NCT01524432|Hormone Antagonists|hormone antagonists|mesh-ancestor
64822988|NCT01524432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64823028|NCT01524653|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64823029|NCT01524653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64823030|NCT01524653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64823031|NCT01524653|Antimetabolites|antimetabolites|mesh-ancestor
64823032|NCT01524653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823033|NCT01524653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64823034|NCT01524653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64823035|NCT01524653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64823036|NCT01524705|Insulin|insulin|mesh-list
64823037|NCT01524705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64823038|NCT01524705|Metformin|metformin|mesh-list
64823039|NCT01524705|Insulin Glargine|insulin glargine|mesh-list
64823040|NCT01524705|Exenatide|exenatide|mesh-list
64823041|NCT01524705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64823042|NCT01524705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64823043|NCT01524705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823044|NCT01524705|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64823045|NCT01524705|Incretins|incretins|mesh-ancestor
64823046|NCT01524705|Hormones|hormones|mesh-ancestor
64823084|NCT01524757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64823085|NCT01524757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823086|NCT01524809|Insulin|insulin|mesh-list
64823087|NCT01524809|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64823088|NCT01524809|Insulin Aspart|insulin aspart|mesh-list
64823089|NCT01524809|Insulin, Long-Acting|insulin, long-acting|mesh-list
64823090|NCT01524809|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64823091|NCT01524809|Biphasic Insulins|biphasic insulins|mesh-list
64823092|NCT01524809|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64823093|NCT01524809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64823121|NCT01524939|Immunoglobulin G|immunoglobulin g|mesh-list
64823122|NCT01524939|Immunologic Factors|immunologic factors|mesh-ancestor
64823123|NCT01524939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823124|NCT01525004|Vaccines|vaccines|mesh-list
64823125|NCT01525004|Immunologic Factors|immunologic factors|mesh-ancestor
64823126|NCT01525004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823127|NCT01525043|Naproxen|naproxen|mesh-list
64823128|NCT01525043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64823129|NCT01525043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64823130|NCT01525043|Analgesics|analgesics|mesh-ancestor
64472772|NCT02790710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561724|NCT03482297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64823131|NCT01525043|Sensory System Agents|sensory system agents|mesh-ancestor
64823132|NCT01525043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64823133|NCT01525043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823134|NCT01525043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64823135|NCT01525043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64823136|NCT01525043|Gout Suppressants|gout suppressants|mesh-ancestor
64823137|NCT01525043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64823138|NCT01525043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64823139|NCT01525043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434266|NCT02403635|Anesthetics|anesthetics|mesh-ancestor
64823145|NCT01525394|Lenvatinib|lenvatinib|mesh-list
64823180|NCT01525706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64823181|NCT01525706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823182|NCT01525719|Everolimus|everolimus|mesh-list
64823183|NCT01525719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823184|NCT01525719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64823185|NCT01525719|Immunologic Factors|immunologic factors|mesh-ancestor
64823186|NCT01525719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823187|NCT01525771|Cisplatin|cisplatin|mesh-list
64823188|NCT01525771|Docetaxel|docetaxel|mesh-list
64823264|NCT01526122|Sensory System Agents|sensory system agents|mesh-ancestor
64823265|NCT01526122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64823266|NCT01526122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823267|NCT01526122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64823268|NCT01526122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64823269|NCT01526122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64823348|NCT01526395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64823349|NCT01526395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823350|NCT01526395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64823351|NCT01526395|Anesthetics, General|anesthetics, general|mesh-ancestor
64823352|NCT01526395|Anesthetics|anesthetics|mesh-ancestor
64823353|NCT01526460|Atorvastatin|atorvastatin|mesh-list
64823354|NCT01526460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64823355|NCT01526460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64823356|NCT01526460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64823357|NCT01526460|Antimetabolites|antimetabolites|mesh-ancestor
65273957|NCT05662410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823358|NCT01526460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823359|NCT01526460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64434504|NCT02421419|Dexamethasone|dexamethasone|mesh-list
64823369|NCT01526499|Alkylating Agents|alkylating agents|mesh-ancestor
64823370|NCT01526499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823371|NCT01526499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823372|NCT01526499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64823373|NCT01526499|Tubulin Modulators|tubulin modulators|mesh-ancestor
64823374|NCT01526499|Antimitotic Agents|antimitotic agents|mesh-ancestor
64823375|NCT01526499|Mitosis Modulators|mitosis modulators|mesh-ancestor
64823413|NCT01526616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823414|NCT01526616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64823484|NCT01526980|Insulin|insulin|mesh-list
64823485|NCT01526980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64823486|NCT01526980|Insulin Aspart|insulin aspart|mesh-list
64823487|NCT01526980|Insulin, Long-Acting|insulin, long-acting|mesh-list
64823488|NCT01526980|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64823489|NCT01526980|Biphasic Insulins|biphasic insulins|mesh-list
64823490|NCT01526980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64823491|NCT01526980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64823492|NCT01526980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823493|NCT01527019|Cephalosporins|cephalosporins|mesh-list
64823494|NCT01527019|Norfloxacin|norfloxacin|mesh-list
64823495|NCT01527019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64823496|NCT01527019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64823497|NCT01527019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64823498|NCT01527019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64823499|NCT01527019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64823500|NCT01527019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823501|NCT01527019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823502|NCT01527019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64823549|NCT01527305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64823550|NCT01527305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64823551|NCT01527305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823552|NCT01527305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64823621|NCT01527552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823623|NCT01527565|Biphasic Insulins|biphasic insulins|mesh-list
64823624|NCT01527565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64823625|NCT01527565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823626|NCT01527630|Insulin Aspart|insulin aspart|mesh-list
64823627|NCT01527630|Biphasic Insulins|biphasic insulins|mesh-list
64823628|NCT01527630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64823629|NCT01527630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823630|NCT01527643|Insulin Aspart|insulin aspart|mesh-list
64823631|NCT01527643|Biphasic Insulins|biphasic insulins|mesh-list
64823632|NCT01527643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64823633|NCT01527643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823634|NCT01527656|Insulin Aspart|insulin aspart|mesh-list
64823635|NCT01527656|Biphasic Insulins|biphasic insulins|mesh-list
64823636|NCT01527656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64823637|NCT01527656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823638|NCT01527669|Lovastatin|lovastatin|mesh-list
64823639|NCT01527669|L 647318|l 647318|mesh-list
64823640|NCT01527669|Dihydromevinolin|dihydromevinolin|mesh-list
64823641|NCT01527669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64823642|NCT01527669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64823643|NCT01527669|Antimetabolites|antimetabolites|mesh-ancestor
64434791|NCT02013609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823651|NCT01527734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64823652|NCT01527734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823653|NCT01527734|Sensory System Agents|sensory system agents|mesh-ancestor
64823654|NCT01527734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64823655|NCT01527734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64823679|NCT01527864|Growth Substances|growth substances|mesh-ancestor
64823680|NCT01527864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823681|NCT01527864|Growth Inhibitors|growth inhibitors|mesh-ancestor
64823683|NCT01527890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64823684|NCT01527890|Narcotics|narcotics|mesh-ancestor
64823685|NCT01527890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64823686|NCT01527890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823687|NCT01527890|Analgesics|analgesics|mesh-ancestor
64823688|NCT01527890|Sensory System Agents|sensory system agents|mesh-ancestor
65273958|NCT05662410|Growth Inhibitors|growth inhibitors|mesh-ancestor
64823689|NCT01527890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64823690|NCT01527890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64823691|NCT01527890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64823692|NCT01527890|Anesthetics, General|anesthetics, general|mesh-ancestor
64823693|NCT01527890|Anesthetics|anesthetics|mesh-ancestor
64823694|NCT01527903|Midazolam|midazolam|mesh-list
64823695|NCT01527903|Propofol|propofol|mesh-list
64823696|NCT01527903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64823697|NCT01527903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64823698|NCT01527903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823699|NCT01527903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64823700|NCT01527903|Anesthetics, General|anesthetics, general|mesh-ancestor
64823701|NCT01527903|Anesthetics|anesthetics|mesh-ancestor
64823702|NCT01527903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64823703|NCT01527903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64823704|NCT01527903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64823705|NCT01527903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64823735|NCT01528137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823736|NCT01528163|Methotrexate|methotrexate|mesh-list
64823737|NCT01528163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64823738|NCT01528163|Abortifacient Agents|abortifacient agents|mesh-ancestor
64823739|NCT01528163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64823740|NCT01528163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823741|NCT01528163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64823742|NCT01528163|Antimetabolites|antimetabolites|mesh-ancestor
64823743|NCT01528163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823744|NCT01528163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823745|NCT01528163|Dermatologic Agents|dermatologic agents|mesh-ancestor
64823746|NCT01528163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64823747|NCT01528163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64823748|NCT01528163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64823749|NCT01528163|Immunologic Factors|immunologic factors|mesh-ancestor
64823750|NCT01528163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64823751|NCT01528163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64823752|NCT01528176|Cholecalciferol|cholecalciferol|mesh-list
64823753|NCT01528176|Vitamin D|vitamin d|mesh-list
64823754|NCT01528176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64823797|NCT01528618|Fluorouracil|fluorouracil|mesh-list
64823798|NCT01528618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823799|NCT01528618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64823800|NCT01528618|Antimetabolites|antimetabolites|mesh-ancestor
64823801|NCT01528618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823802|NCT01528618|Antiviral Agents|antiviral agents|mesh-ancestor
64823821|NCT01528722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64823822|NCT01528722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823824|NCT01528722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64823825|NCT01528800|Vitamin K|vitamin k|mesh-list
64823826|NCT01528800|Vitamin K 1|vitamin k 1|mesh-list
64823827|NCT01528800|Vitamins|vitamins|mesh-ancestor
64823828|NCT01528800|Micronutrients|micronutrients|mesh-ancestor
64823829|NCT01528800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823830|NCT01528800|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64823831|NCT01528800|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64823832|NCT01528800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823833|NCT01528800|Hemostatics|hemostatics|mesh-ancestor
64823834|NCT01528800|Coagulants|coagulants|mesh-ancestor
64823835|NCT01528813|Amorolfine|amorolfine|mesh-list
64823836|NCT01528813|Antifungal Agents|antifungal agents|mesh-ancestor
64823837|NCT01528813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64823838|NCT01528826|Oxaliplatin|oxaliplatin|mesh-list
64823839|NCT01528826|Vinorelbine|vinorelbine|mesh-list
64823840|NCT01528826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823841|NCT01528826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64823842|NCT01528826|Tubulin Modulators|tubulin modulators|mesh-ancestor
64823843|NCT01528826|Antimitotic Agents|antimitotic agents|mesh-ancestor
64823844|NCT01528826|Mitosis Modulators|mitosis modulators|mesh-ancestor
64823845|NCT01528826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823846|NCT01528852|Chlorhexidine|chlorhexidine|mesh-list
64823847|NCT01528852|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64823848|NCT01528852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64823849|NCT01528852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64823864|NCT01528930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64823865|NCT01528943|Epoprostenol|epoprostenol|mesh-list
64823866|NCT01528943|Tezosentan|tezosentan|mesh-list
64823867|NCT01528943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65273959|NCT05662410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273960|NCT03635489|Paclitaxel|paclitaxel|mesh-list
64823868|NCT01528943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64823869|NCT01528943|Vasodilator Agents|vasodilator agents|mesh-ancestor
64823870|NCT01529073|Nitazoxanide|nitazoxanide|mesh-list
64823871|NCT01529073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64823872|NCT01529073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64823873|NCT01529125|Lamivudine|lamivudine|mesh-list
64823874|NCT01529125|Zidovudine|zidovudine|mesh-list
64823905|NCT01529164|Antimetabolites|antimetabolites|mesh-ancestor
64823906|NCT01529164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823907|NCT01529164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64823908|NCT01529164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472781|NCT02779855|Tubulin Modulators|tubulin modulators|mesh-ancestor
64472782|NCT02779855|Antimitotic Agents|antimitotic agents|mesh-ancestor
64472783|NCT02779855|Mitosis Modulators|mitosis modulators|mesh-ancestor
64472784|NCT02779855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472785|NCT02779855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64472786|NCT02661035|Mycophenolic Acid|mycophenolic acid|mesh-list
64472787|NCT02661035|Cyclophosphamide|cyclophosphamide|mesh-list
64472788|NCT02661035|Fludarabine|fludarabine|mesh-list
64472789|NCT02661035|Allopurinol|allopurinol|mesh-list
64472790|NCT02661035|Tacrolimus|tacrolimus|mesh-list
64472796|NCT02661035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64823952|NCT01529190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64823953|NCT01529190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64823954|NCT01529190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64823955|NCT01529190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64823956|NCT01529229|Prednisolone|prednisolone|mesh-list
64823957|NCT01529229|Betamethasone|betamethasone|mesh-list
64823958|NCT01529229|Desloratadine|desloratadine|mesh-list
64823959|NCT01529229|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
64823960|NCT01529229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64823961|NCT01529229|Glucocorticoids|glucocorticoids|mesh-ancestor
64823962|NCT01529229|Hormones|hormones|mesh-ancestor
64823963|NCT01529229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64823964|NCT01529229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823965|NCT01529229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64823966|NCT01529229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823967|NCT01529229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64823968|NCT01529229|Respiratory System Agents|respiratory system agents|mesh-ancestor
64823982|NCT01529242|Glucocorticoids|glucocorticoids|mesh-ancestor
64823984|NCT01529242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64823985|NCT01529242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823986|NCT01529242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64823987|NCT01529242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823988|NCT01529242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64823989|NCT01529242|Respiratory System Agents|respiratory system agents|mesh-ancestor
64823990|NCT01529242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64823991|NCT01529242|Cholinergic Agents|cholinergic agents|mesh-ancestor
65494598|NCT01145976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824013|NCT01529320|Prednisolone|prednisolone|mesh-list
64824014|NCT01529320|Prednisolone acetate|prednisolone acetate|mesh-list
64824015|NCT01529320|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
64824016|NCT01529320|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64824047|NCT01529528|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64824048|NCT01529528|Protease Inhibitors|protease inhibitors|mesh-ancestor
64824049|NCT01529528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824050|NCT01529528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824051|NCT01529528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64824052|NCT01529528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824053|NCT01529541|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64824055|NCT01529541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64824056|NCT01529541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824057|NCT01529541|Incretins|incretins|mesh-ancestor
64824058|NCT01529541|Hormones|hormones|mesh-ancestor
64592702|NCT00673153|Vorinostat|vorinostat|mesh-list
64824059|NCT01529541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64824060|NCT01529541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64824061|NCT01529541|Protease Inhibitors|protease inhibitors|mesh-ancestor
64824062|NCT01529541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824063|NCT01529541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824064|NCT01529554|Everolimus|everolimus|mesh-list
65273961|NCT03635489|Bevacizumab|bevacizumab|mesh-list
65273962|NCT03635489|Carboplatin|carboplatin|mesh-list
65273963|NCT03635489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65273964|NCT03635489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273965|NCT03635489|Tubulin Modulators|tubulin modulators|mesh-ancestor
65273966|NCT03635489|Antimitotic Agents|antimitotic agents|mesh-ancestor
65273967|NCT03635489|Mitosis Modulators|mitosis modulators|mesh-ancestor
65273968|NCT03635489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273969|NCT03635489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65273970|NCT03635489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65273971|NCT03635489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65273972|NCT03635489|Growth Substances|growth substances|mesh-ancestor
64824065|NCT01529554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824066|NCT01529554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64824067|NCT01529554|Immunologic Factors|immunologic factors|mesh-ancestor
64824123|NCT01530022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64824125|NCT01530048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64824126|NCT01530048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824127|NCT01530126|Becaplermin|becaplermin|mesh-list
64824128|NCT01530126|Anticoagulants|anticoagulants|mesh-ancestor
64824129|NCT01530126|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
64824222|NCT01530503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64824223|NCT01530503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824224|NCT01530542|Oxycodone|oxycodone|mesh-list
64824225|NCT01530542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64824226|NCT01530542|Narcotics|narcotics|mesh-ancestor
64824227|NCT01530542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64824261|NCT01530620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824263|NCT01530620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64824264|NCT01530620|Cholinergic Agents|cholinergic agents|mesh-ancestor
65494612|NCT02282358|Mocetinostat|mocetinostat|mesh-list
64472800|NCT02661035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64472801|NCT02661035|Antimetabolites|antimetabolites|mesh-ancestor
64472802|NCT02661035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64824293|NCT01530815|Anesthetics, Local|anesthetics, local|mesh-ancestor
64824294|NCT01530815|Anesthetics|anesthetics|mesh-ancestor
64824295|NCT01530815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64824296|NCT01530815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824297|NCT01530815|Sensory System Agents|sensory system agents|mesh-ancestor
64824298|NCT01530815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824300|NCT01530984|Sargramostim|sargramostim|mesh-list
64824301|NCT01530984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64824302|NCT01530984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824303|NCT01530984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64824304|NCT01530984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824305|NCT01530984|Immunologic Factors|immunologic factors|mesh-ancestor
64824306|NCT01530984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824307|NCT01531049|Nicotine|nicotine|mesh-list
64824308|NCT01531049|Varenicline|varenicline|mesh-list
64824309|NCT01531049|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64824310|NCT01531049|Autonomic Agents|autonomic agents|mesh-ancestor
64824311|NCT01531049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824312|NCT01531049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824313|NCT01531049|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64824314|NCT01531049|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64824315|NCT01531049|Cholinergic Agents|cholinergic agents|mesh-ancestor
65494617|NCT01144260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65494618|NCT01144260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472807|NCT02661035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64472808|NCT02661035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64472809|NCT02661035|Gout Suppressants|gout suppressants|mesh-ancestor
64472810|NCT02661035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64472812|NCT02661035|Protective Agents|protective agents|mesh-ancestor
65273973|NCT03635489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472813|NCT02648477|Doxorubicin|doxorubicin|mesh-list
64824347|NCT01531192|Ionophores|ionophores|mesh-ancestor
64824348|NCT01531192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64824349|NCT01531192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824350|NCT01531218|Azithromycin|azithromycin|mesh-list
64824351|NCT01531218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64824352|NCT01531218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824353|NCT01531244|Dactinomycin|dactinomycin|mesh-list
64824354|NCT01531244|Cactinomycin|cactinomycin|mesh-list
64824355|NCT01531244|Melphalan|melphalan|mesh-list
64824356|NCT01531244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64824357|NCT01531244|Alkylating Agents|alkylating agents|mesh-ancestor
64824394|NCT01531569|Secoisolariciresinol|secoisolariciresinol|mesh-list
64824395|NCT01531569|Phytoestrogens|phytoestrogens|mesh-ancestor
64824396|NCT01531569|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64824397|NCT01531569|Estrogens|estrogens|mesh-ancestor
64824398|NCT01531569|Hormones|hormones|mesh-ancestor
64824430|NCT01531712|Gemcitabine|gemcitabine|mesh-list
64824431|NCT01531712|Oxaliplatin|oxaliplatin|mesh-list
64824432|NCT01531712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64824433|NCT01531712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64824434|NCT01531712|Antimetabolites|antimetabolites|mesh-ancestor
64824435|NCT01531712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824436|NCT01531712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824437|NCT01531712|Antiviral Agents|antiviral agents|mesh-ancestor
64824438|NCT01531712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824439|NCT01531712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824440|NCT01531712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64824441|NCT01531712|Immunologic Factors|immunologic factors|mesh-ancestor
64824442|NCT01531712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824443|NCT01531712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64824444|NCT01531764|Vinorelbine|vinorelbine|mesh-list
64824445|NCT01531764|Afatinib|afatinib|mesh-list
64824446|NCT01531764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64824447|NCT01531764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824448|NCT01531764|Tubulin Modulators|tubulin modulators|mesh-ancestor
64824449|NCT01531764|Antimitotic Agents|antimitotic agents|mesh-ancestor
64824450|NCT01531764|Mitosis Modulators|mitosis modulators|mesh-ancestor
64824451|NCT01531764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824483|NCT01531842|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64824484|NCT01531842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824485|NCT01531855|Insulin|insulin|mesh-list
64824486|NCT01531855|Insulin Lispro|insulin lispro|mesh-list
64824487|NCT01531855|Insulin, Short-Acting|insulin, short-acting|mesh-list
64824488|NCT01531855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64824489|NCT01531855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824490|NCT01531920|Ethanol|ethanol|mesh-list
64824491|NCT01531920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64824492|NCT01531920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824493|NCT01531920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64824494|NCT01531920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824495|NCT01532011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64824496|NCT01532011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824497|NCT01532011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64824498|NCT01532011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824499|NCT01532011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824500|NCT01532076|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64824501|NCT01532076|Hemostatics|hemostatics|mesh-ancestor
64824502|NCT01532076|Coagulants|coagulants|mesh-ancestor
64824504|NCT01532102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824505|NCT01532115|Moxifloxacin|moxifloxacin|mesh-list
64824506|NCT01532115|Opicapone|opicapone|mesh-list
64824507|NCT01532115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64824508|NCT01532115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824536|NCT01532466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824537|NCT01532518|MEN 11420|men 11420|mesh-list
64824560|NCT01532726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64824561|NCT01532726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824562|NCT01532804|Bevacizumab|bevacizumab|mesh-list
64824563|NCT01532804|Oxaliplatin|oxaliplatin|mesh-list
64824564|NCT01532804|Raltitrexed|raltitrexed|mesh-list
64824565|NCT01532804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64824566|NCT01532804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824567|NCT01532804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64824568|NCT01532804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64824569|NCT01532804|Growth Substances|growth substances|mesh-ancestor
64824570|NCT01532804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824571|NCT01532804|Growth Inhibitors|growth inhibitors|mesh-ancestor
64824572|NCT01532804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64824573|NCT01532804|Antimetabolites|antimetabolites|mesh-ancestor
64824574|NCT01532804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824614|NCT01532895|Hydromorphone|hydromorphone|mesh-list
64824615|NCT01532895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64824616|NCT01532895|Narcotics|narcotics|mesh-ancestor
64824617|NCT01532895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64824618|NCT01532895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824619|NCT01532895|Analgesics|analgesics|mesh-ancestor
64824620|NCT01532895|Sensory System Agents|sensory system agents|mesh-ancestor
64824621|NCT01532895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824622|NCT01532960|Poly ICLC|poly iclc|mesh-list
64824623|NCT01532960|Interferon Inducers|interferon inducers|mesh-ancestor
64824624|NCT01532960|Immunologic Factors|immunologic factors|mesh-ancestor
64824625|NCT01532960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824626|NCT01533090|Bisacodyl|bisacodyl|mesh-list
64824627|NCT01533090|Cathartics|cathartics|mesh-ancestor
64295389|NCT02477397|Hormones|hormones|mesh-ancestor
64824657|NCT01533155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64824659|NCT01533155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64824679|NCT01533220|Histamine Agents|histamine agents|mesh-ancestor
64824680|NCT01533220|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64824682|NCT01533272|Emtricitabine|emtricitabine|mesh-list
64824683|NCT01533272|Lopinavir|lopinavir|mesh-list
64824684|NCT01533272|Maraviroc|maraviroc|mesh-list
64824685|NCT01533272|Antiviral Agents|antiviral agents|mesh-ancestor
64824686|NCT01533272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824687|NCT01533272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64824688|NCT01533272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64824689|NCT01533272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824690|NCT01533272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824691|NCT01533272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64824692|NCT01533272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64824693|NCT01533272|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64297016|NCT03103568|Furosemide|furosemide|mesh-list
64824736|NCT01533441|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64824737|NCT01533441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64824738|NCT01533441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824739|NCT01533441|Hemostatics|hemostatics|mesh-ancestor
64824740|NCT01533441|Coagulants|coagulants|mesh-ancestor
64824741|NCT01533506|Stiripentol|stiripentol|mesh-list
64824742|NCT01533506|Anticonvulsants|anticonvulsants|mesh-ancestor
64824743|NCT01533545|Epinephrine|epinephrine|mesh-list
64824744|NCT01533545|Mepivacaine|mepivacaine|mesh-list
64824745|NCT01533545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64824774|NCT01533662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824775|NCT01533662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824776|NCT01533662|Sympathomimetics|sympathomimetics|mesh-ancestor
64824777|NCT01533662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64824778|NCT01533662|Nasal Decongestants|nasal decongestants|mesh-ancestor
64824779|NCT01533662|Respiratory System Agents|respiratory system agents|mesh-ancestor
64824798|NCT01533740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64824799|NCT01533740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64824800|NCT01533740|Growth Substances|growth substances|mesh-ancestor
64824801|NCT01533740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824802|NCT01533740|Growth Inhibitors|growth inhibitors|mesh-ancestor
64824803|NCT01533740|Antimetabolites|antimetabolites|mesh-ancestor
64824804|NCT01533740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824805|NCT01533740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65494627|NCT01239498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472819|NCT02648477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64824806|NCT01533740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64824807|NCT01533740|Immunologic Factors|immunologic factors|mesh-ancestor
64297093|NCT03299829|Trientine|trientine|mesh-list
64824865|NCT01534169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64824867|NCT01534169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824868|NCT01534247|Metronidazole|metronidazole|mesh-list
64824869|NCT01534247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824870|NCT01534247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64824871|NCT01534247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64824872|NCT01534247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64824873|NCT01534312|Mesalamine|mesalamine|mesh-list
64824930|NCT01534702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64824931|NCT01534702|Immunologic Factors|immunologic factors|mesh-ancestor
65273974|NCT03635489|Growth Inhibitors|growth inhibitors|mesh-ancestor
65494628|NCT01239498|Sensory System Agents|sensory system agents|mesh-ancestor
65494629|NCT01239498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64472820|NCT02648477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824932|NCT01534702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824933|NCT01534702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64824944|NCT01534754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64824945|NCT01534754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64824947|NCT01534806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64824948|NCT01534806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64824950|NCT01534806|Sensory System Agents|sensory system agents|mesh-ancestor
64824951|NCT01534806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824952|NCT01534806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824953|NCT01534806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64824954|NCT01534806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64824955|NCT01534806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64824956|NCT01534806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824957|NCT01534806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298312|NCT03298347|Caffeine|caffeine|mesh-list
64824990|NCT01535027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64824991|NCT01535027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64824992|NCT01535027|Hormone Antagonists|hormone antagonists|mesh-ancestor
64824993|NCT01535027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64824994|NCT01535027|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64824995|NCT01535027|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64824996|NCT01535079|Ibuprofen|ibuprofen|mesh-list
64824997|NCT01535079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64825011|NCT01535092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64825013|NCT01535157|Ketoconazole|ketoconazole|mesh-list
64825014|NCT01535157|Fenretinide|fenretinide|mesh-list
64825015|NCT01535157|Retinamide|retinamide|mesh-list
64825047|NCT01535417|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64825048|NCT01535417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64825050|NCT01535417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825089|NCT01535677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64825090|NCT01535677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825091|NCT01535677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64825092|NCT01535677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825093|NCT01535690|Methylene Blue|methylene blue|mesh-list
64825094|NCT01535690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825095|NCT01535690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825096|NCT01535768|Travoprost|travoprost|mesh-list
64825097|NCT01535768|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64825098|NCT01535768|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64825099|NCT01535768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64825100|NCT01535768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64825101|NCT01535768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64825102|NCT01535768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64825103|NCT01535768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64825104|NCT01535768|Adrenergic Agents|adrenergic agents|mesh-ancestor
64825105|NCT01535768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64825106|NCT01535768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825107|NCT01535768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825108|NCT01535781|Tranexamic Acid|tranexamic acid|mesh-list
64825116|NCT01535820|Contraceptive Agents|contraceptive agents|mesh-ancestor
64825117|NCT01535820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64825118|NCT01535820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825119|NCT01535859|Cabergoline|cabergoline|mesh-list
64825120|NCT01535859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64825121|NCT01535859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64825122|NCT01535859|Dopamine Agonists|dopamine agonists|mesh-ancestor
64825123|NCT01535859|Dopamine Agents|dopamine agents|mesh-ancestor
64825124|NCT01535859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64825125|NCT01535859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825126|NCT01535859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825127|NCT01535872|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64825128|NCT01535872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64825129|NCT01535872|Immunologic Factors|immunologic factors|mesh-ancestor
64300554|NCT02111629|Fluconazole|fluconazole|mesh-list
64825163|NCT01536054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825164|NCT01536054|Antifungal Agents|antifungal agents|mesh-ancestor
64790965|NCT00005010|Irbesartan|irbesartan|mesh-list
64825165|NCT01536054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64825166|NCT01536054|Immunologic Factors|immunologic factors|mesh-ancestor
64825167|NCT01536054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825168|NCT01536132|Simendan|simendan|mesh-list
64825169|NCT01536132|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64825170|NCT01536132|Vasodilator Agents|vasodilator agents|mesh-ancestor
64825171|NCT01536132|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64825200|NCT01536223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64825201|NCT01536223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64825202|NCT01536223|Immunologic Factors|immunologic factors|mesh-ancestor
64825203|NCT01536223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825204|NCT01536249|Pramipexole|pramipexole|mesh-list
64825205|NCT01536249|Cimetidine|cimetidine|mesh-list
64825206|NCT01536249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64825207|NCT01536249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64825208|NCT01536249|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64825209|NCT01536249|Histamine Antagonists|histamine antagonists|mesh-ancestor
64825210|NCT01536249|Histamine Agents|histamine agents|mesh-ancestor
64825211|NCT01536249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64825212|NCT01536249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825213|NCT01536249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825214|NCT01536249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64825215|NCT01536249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64825216|NCT01536249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825217|NCT01536249|Antioxidants|antioxidants|mesh-ancestor
64825218|NCT01536249|Protective Agents|protective agents|mesh-ancestor
64825219|NCT01536249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64825220|NCT01536249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64825221|NCT01536249|Dopamine Agonists|dopamine agonists|mesh-ancestor
64825222|NCT01536249|Dopamine Agents|dopamine agents|mesh-ancestor
64825223|NCT01536301|Morphine|morphine|mesh-list
64825224|NCT01536301|Oxycodone|oxycodone|mesh-list
64825225|NCT01536301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64825226|NCT01536301|Narcotics|narcotics|mesh-ancestor
64825227|NCT01536301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64825228|NCT01536301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825229|NCT01536301|Analgesics|analgesics|mesh-ancestor
64825230|NCT01536301|Sensory System Agents|sensory system agents|mesh-ancestor
64825231|NCT01536301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64825232|NCT01536314|Memantine|memantine|mesh-list
64825233|NCT01536314|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64825234|NCT01536314|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64825235|NCT01536314|Dopamine Agents|dopamine agents|mesh-ancestor
64825236|NCT01536314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64825237|NCT01536314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825238|NCT01536314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436387|NCT04428385|Antimalarials|antimalarials|mesh-ancestor
64825262|NCT01536600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825265|NCT01536613|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64825266|NCT01536613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64825267|NCT01536613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825268|NCT01536626|Insulin Aspart|insulin aspart|mesh-list
64825269|NCT01536626|Biphasic Insulins|biphasic insulins|mesh-list
64825270|NCT01536626|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64302085|NCT02133625|Carboplatin|carboplatin|mesh-list
64825349|NCT01537055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64825350|NCT01537094|Vitamins|vitamins|mesh-list
64825351|NCT01537094|Ascorbic Acid|ascorbic acid|mesh-list
64825352|NCT01537094|Micronutrients|micronutrients|mesh-ancestor
64825353|NCT01537094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825354|NCT01537094|Antioxidants|antioxidants|mesh-ancestor
64825355|NCT01537094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825356|NCT01537094|Protective Agents|protective agents|mesh-ancestor
64825357|NCT01537107|Sirolimus|sirolimus|mesh-list
64825358|NCT01537107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64825359|NCT01537107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64825360|NCT01537107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64825361|NCT01537107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64472822|NCT02648477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64563443|NCT00630877|Vitamins|vitamins|mesh-ancestor
64825362|NCT01537107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825363|NCT01537107|Antifungal Agents|antifungal agents|mesh-ancestor
64825364|NCT01537107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64825365|NCT01537107|Immunologic Factors|immunologic factors|mesh-ancestor
64825426|NCT01537744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273975|NCT02689362|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65273976|NCT02689362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65273977|NCT02689362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273978|NCT02689362|Incretins|incretins|mesh-ancestor
65273979|NCT02689362|Hormones|hormones|mesh-ancestor
64472015|NCT03915444|Antimetabolites|antimetabolites|mesh-ancestor
64825427|NCT01537744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825428|NCT01537744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64825430|NCT01537770|Anesthetics, Local|anesthetics, local|mesh-ancestor
64825431|NCT01537770|Anesthetics|anesthetics|mesh-ancestor
64825432|NCT01537770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64825498|NCT01538225|Sensory System Agents|sensory system agents|mesh-ancestor
64825499|NCT01538225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65494631|NCT01239498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65494632|NCT01239498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64472823|NCT02648477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825500|NCT01538225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825502|NCT01538316|Quercetin|quercetin|mesh-list
64825503|NCT01538316|Antioxidants|antioxidants|mesh-ancestor
64825504|NCT01538316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825505|NCT01538316|Protective Agents|protective agents|mesh-ancestor
64825506|NCT01538316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825507|NCT01538316|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64825508|NCT01538316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825509|NCT01538316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64825510|NCT01538316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825511|NCT01538316|Phytoestrogens|phytoestrogens|mesh-ancestor
64825512|NCT01538316|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64825513|NCT01538316|Estrogens|estrogens|mesh-ancestor
64825514|NCT01538316|Hormones|hormones|mesh-ancestor
64825515|NCT01538316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64825516|NCT01538329|Amantadine|amantadine|mesh-list
64825517|NCT01538329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64825518|NCT01538329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64825561|NCT01538459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825562|NCT01538459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64825563|NCT01538459|Glucocorticoids|glucocorticoids|mesh-ancestor
64825565|NCT01538459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64825566|NCT01538459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64825567|NCT01538459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825568|NCT01538459|Anesthetics, Local|anesthetics, local|mesh-ancestor
64825569|NCT01538459|Anesthetics|anesthetics|mesh-ancestor
64825570|NCT01538459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64825571|NCT01538459|Sensory System Agents|sensory system agents|mesh-ancestor
64825572|NCT01538485|Cholecalciferol|cholecalciferol|mesh-list
64825594|NCT01538563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825595|NCT01538563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64825596|NCT01538563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825597|NCT01538563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825598|NCT01538576|Insulin Aspart|insulin aspart|mesh-list
64825599|NCT01538576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64825600|NCT01538576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825601|NCT01538589|Insulin Aspart|insulin aspart|mesh-list
64825602|NCT01538589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64825603|NCT01538589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825604|NCT01538641|Gemcitabine|gemcitabine|mesh-list
64825605|NCT01538641|Rituximab|rituximab|mesh-list
64825606|NCT01538641|Oxaliplatin|oxaliplatin|mesh-list
64825607|NCT01538641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64825608|NCT01538641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825609|NCT01538641|Immunologic Factors|immunologic factors|mesh-ancestor
64825626|NCT01538667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825627|NCT01538667|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64825628|NCT01538667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64825630|NCT01538693|Dexetimide|dexetimide|mesh-list
64825631|NCT01538693|Citalopram|citalopram|mesh-list
64825632|NCT01538693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64825633|NCT01538693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64825634|NCT01538693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64825635|NCT01538693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273980|NCT02689362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65273981|NCT02689362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65273982|NCT02689362|Protease Inhibitors|protease inhibitors|mesh-ancestor
65273983|NCT02689362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273984|NCT02689362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559730|NCT00995475|Xhance|xhance|mesh-list
64825636|NCT01538693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64825637|NCT01538693|Serotonin Agents|serotonin agents|mesh-ancestor
64825667|NCT01538797|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64825671|NCT01538797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825673|NCT01538849|Esomeprazole|esomeprazole|mesh-list
64825674|NCT01538849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64825675|NCT01538849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64825676|NCT01538849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64825677|NCT01538849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494634|NCT01239498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494635|NCT01239498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64825678|NCT01538849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825679|NCT01538875|Labetalol|labetalol|mesh-list
64825680|NCT01538875|Hydralazine|hydralazine|mesh-list
64825681|NCT01538875|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64825682|NCT01538875|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64825683|NCT01538875|Adrenergic Agents|adrenergic agents|mesh-ancestor
64825684|NCT01538875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64825685|NCT01538875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825686|NCT01538875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825706|NCT01538953|Sodium Hypochlorite|sodium hypochlorite|mesh-list
64825707|NCT01538953|Disinfectants|disinfectants|mesh-list
64825708|NCT01538953|Eusol|eusol|mesh-list
64825709|NCT01538953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64825710|NCT01539018|Sorafenib|sorafenib|mesh-list
64825711|NCT01539018|Tegafur|tegafur|mesh-list
64825712|NCT01539018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825713|NCT01539018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64825714|NCT01539018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825715|NCT01539018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825716|NCT01539018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64825717|NCT01539018|Antimetabolites|antimetabolites|mesh-ancestor
64825718|NCT01539031|Donepezil|donepezil|mesh-list
64825719|NCT01539031|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64825720|NCT01539031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825721|NCT01539031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825722|NCT01539031|Cholinergic Agents|cholinergic agents|mesh-ancestor
64825723|NCT01539031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64825724|NCT01539031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825725|NCT01539031|Nootropic Agents|nootropic agents|mesh-ancestor
64825726|NCT01539044|Atropine|atropine|mesh-list
64825727|NCT01539044|Neostigmine|neostigmine|mesh-list
64825728|NCT01539044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64825729|NCT01539044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64825730|NCT01539044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64825731|NCT01539044|Autonomic Agents|autonomic agents|mesh-ancestor
64825732|NCT01539044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64825733|NCT01539044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825734|NCT01539044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64825735|NCT01539044|Respiratory System Agents|respiratory system agents|mesh-ancestor
64825736|NCT01539044|Mydriatics|mydriatics|mesh-ancestor
64825737|NCT01539044|Parasympatholytics|parasympatholytics|mesh-ancestor
64825738|NCT01539044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64825739|NCT01539044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64825740|NCT01539044|Cholinergic Agents|cholinergic agents|mesh-ancestor
64825767|NCT01539174|Glucocorticoids|glucocorticoids|mesh-ancestor
64825768|NCT01539174|Hormones|hormones|mesh-ancestor
64825769|NCT01539174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64825770|NCT01539174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64304233|NCT01651780|Heparin|heparin|mesh-list
64825834|NCT01539577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64825835|NCT01539577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825836|NCT01539603|Sirolimus|sirolimus|mesh-list
64825837|NCT01539603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64825838|NCT01539603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64825839|NCT01539603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64825840|NCT01539603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825841|NCT01539603|Antifungal Agents|antifungal agents|mesh-ancestor
64825842|NCT01539603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64825843|NCT01539603|Immunologic Factors|immunologic factors|mesh-ancestor
64436995|NCT05802849|Diuretics|diuretics|mesh-ancestor
64825852|NCT01539655|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
64825853|NCT01539655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64825854|NCT01539655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64825855|NCT01539655|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64825856|NCT01539655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304319|NCT01672736|Protease Inhibitors|protease inhibitors|mesh-ancestor
64825891|NCT01539733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825893|NCT01539733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64825952|NCT01540240|Zidovudine|zidovudine|mesh-list
64825953|NCT01540240|Antimetabolites|antimetabolites|mesh-ancestor
64825954|NCT01540240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825966|NCT01540435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64825967|NCT01540435|Growth Substances|growth substances|mesh-ancestor
64825968|NCT01540435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825969|NCT01540435|Growth Inhibitors|growth inhibitors|mesh-ancestor
64825970|NCT01540500|Fluvoxamine|fluvoxamine|mesh-list
64825971|NCT01540500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64825972|NCT01540500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64305605|NCT02037035|Ketamine|ketamine|mesh-list
64826027|NCT01540747|Inositol|inositol|mesh-list
64826028|NCT01540747|Melatonin|melatonin|mesh-list
64826029|NCT01540747|Antioxidants|antioxidants|mesh-ancestor
64826030|NCT01540747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826031|NCT01540747|Protective Agents|protective agents|mesh-ancestor
64826032|NCT01540747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826033|NCT01540747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64826034|NCT01540747|Hematinics|hematinics|mesh-ancestor
64826035|NCT01540747|Vitamins|vitamins|mesh-ancestor
64826036|NCT01540747|Micronutrients|micronutrients|mesh-ancestor
64826037|NCT01540812|Cytarabine|cytarabine|mesh-list
64826038|NCT01540812|Dexamethasone|dexamethasone|mesh-list
64826039|NCT01540812|Dexamethasone acetate|dexamethasone acetate|mesh-list
64826040|NCT01540812|Prednisone|prednisone|mesh-list
64826041|NCT01540812|Hydrocortisone|hydrocortisone|mesh-list
64826042|NCT01540812|Fludarabine|fludarabine|mesh-list
64826043|NCT01540812|Vincristine|vincristine|mesh-list
64826044|NCT01540812|Daunorubicin|daunorubicin|mesh-list
64826045|NCT01540812|Idarubicin|idarubicin|mesh-list
64826046|NCT01540812|Methotrexate|methotrexate|mesh-list
64826047|NCT01540812|Pegaspargase|pegaspargase|mesh-list
64826048|NCT01540812|Asparaginase|asparaginase|mesh-list
64826049|NCT01540812|BB 1101|bb 1101|mesh-list
64826050|NCT01540812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64826051|NCT01540812|Antiemetics|antiemetics|mesh-ancestor
64826052|NCT01540812|Autonomic Agents|autonomic agents|mesh-ancestor
64826053|NCT01540812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826054|NCT01540812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826055|NCT01540812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64826056|NCT01540812|Glucocorticoids|glucocorticoids|mesh-ancestor
64826057|NCT01540812|Hormones|hormones|mesh-ancestor
64826058|NCT01540812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64826059|NCT01540812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64826060|NCT01540812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64826061|NCT01540812|Protease Inhibitors|protease inhibitors|mesh-ancestor
64826062|NCT01540812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826063|NCT01540812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494638|NCT01239498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64826064|NCT01540812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64826065|NCT01540812|Antimetabolites|antimetabolites|mesh-ancestor
64826066|NCT01540812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64826067|NCT01540812|Immunologic Factors|immunologic factors|mesh-ancestor
64826068|NCT01540812|Antiviral Agents|antiviral agents|mesh-ancestor
64826110|NCT01541085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64826111|NCT01541085|Protease Inhibitors|protease inhibitors|mesh-ancestor
64826112|NCT01541085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826113|NCT01541085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826114|NCT01541085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64826115|NCT01541085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64826116|NCT01541085|Antiviral Agents|antiviral agents|mesh-ancestor
64826117|NCT01541085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64826118|NCT01541085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64826119|NCT01541085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64826120|NCT01541085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64826165|NCT01541280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826167|NCT01541293|Anesthetics, Local|anesthetics, local|mesh-ancestor
64826168|NCT01541293|Anesthetics|anesthetics|mesh-ancestor
64826169|NCT01541293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64826170|NCT01541293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826197|NCT01541332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826198|NCT01541332|Immunologic Factors|immunologic factors|mesh-ancestor
64826199|NCT01541332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64826200|NCT01541332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64826201|NCT01541332|Growth Substances|growth substances|mesh-ancestor
64826202|NCT01541332|Growth Inhibitors|growth inhibitors|mesh-ancestor
64826204|NCT01541436|Antipruritics|antipruritics|mesh-ancestor
64826205|NCT01541436|Dermatologic Agents|dermatologic agents|mesh-ancestor
64826206|NCT01541436|Sensory System Agents|sensory system agents|mesh-ancestor
64826207|NCT01541436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826208|NCT01541436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826209|NCT01541475|Dexetimide|dexetimide|mesh-list
64826210|NCT01541475|Citalopram|citalopram|mesh-list
64826211|NCT01541475|Bupropion|bupropion|mesh-list
64826212|NCT01541475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64826213|NCT01541475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64826214|NCT01541475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64826228|NCT01541475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64826229|NCT01541475|Cholinergic Agents|cholinergic agents|mesh-ancestor
64826230|NCT01541475|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64826299|NCT01542138|Niacinamide|niacinamide|mesh-list
64826301|NCT01542138|Nicotinic Acids|nicotinic acids|mesh-list
64826303|NCT01542138|Vitamin B Complex|vitamin b complex|mesh-ancestor
64826304|NCT01542138|Vitamins|vitamins|mesh-ancestor
64826305|NCT01542138|Micronutrients|micronutrients|mesh-ancestor
64826306|NCT01542138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826307|NCT01542138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64826308|NCT01542138|Antimetabolites|antimetabolites|mesh-ancestor
64826309|NCT01542138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826310|NCT01542138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64826311|NCT01542138|Vasodilator Agents|vasodilator agents|mesh-ancestor
64826312|NCT01542138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64826313|NCT01542190|Ketorolac|ketorolac|mesh-list
64826314|NCT01542190|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64826315|NCT01542190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64826316|NCT01542190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64826317|NCT01542190|Analgesics|analgesics|mesh-ancestor
64826318|NCT01542190|Sensory System Agents|sensory system agents|mesh-ancestor
64826319|NCT01542190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826320|NCT01542190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826321|NCT01542190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64826375|NCT01542489|Insulin Detemir|insulin detemir|mesh-list
64826376|NCT01542489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64826377|NCT01542489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826378|NCT01542697|Magnesium Sulfate|magnesium sulfate|mesh-list
64826379|NCT01542697|Analgesics|analgesics|mesh-ancestor
64826380|NCT01542697|Sensory System Agents|sensory system agents|mesh-ancestor
64306989|NCT03061058|Oxaliplatin|oxaliplatin|mesh-list
64826416|NCT01542801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64826417|NCT01542801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64826418|NCT01542801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64826419|NCT01542801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64826420|NCT01542801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826421|NCT01542801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826422|NCT01542801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64826423|NCT01542801|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64826424|NCT01542801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64826425|NCT01542827|Analgesics|analgesics|mesh-list
64826426|NCT01542827|Sensory System Agents|sensory system agents|mesh-ancestor
64826427|NCT01542827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826428|NCT01542827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826429|NCT01542918|Rituximab|rituximab|mesh-list
64826430|NCT01542918|Lenalidomide|lenalidomide|mesh-list
64826431|NCT01542918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64826432|NCT01542918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64826433|NCT01542918|Immunologic Factors|immunologic factors|mesh-ancestor
64826434|NCT01542918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826435|NCT01542918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64472023|NCT03892785|Methotrexate|methotrexate|mesh-list
64826436|NCT01542918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64826437|NCT01542918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64826438|NCT01542918|Growth Substances|growth substances|mesh-ancestor
64826439|NCT01542918|Growth Inhibitors|growth inhibitors|mesh-ancestor
64826440|NCT01543035|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64826441|NCT01543035|Antiviral Agents|antiviral agents|mesh-ancestor
64826442|NCT01543035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64826443|NCT01543061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64826444|NCT01543061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64826445|NCT01543139|Valproic Acid|valproic acid|mesh-list
64826446|NCT01543139|Anticonvulsants|anticonvulsants|mesh-ancestor
64826471|NCT01543165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64826472|NCT01543165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826473|NCT01543165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826474|NCT01543321|Tetrabenazine|tetrabenazine|mesh-list
64826518|NCT01543555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64826519|NCT01543555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64826520|NCT01543555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826521|NCT01543724|Lithium Carbonate|lithium carbonate|mesh-list
64826522|NCT01543724|Antidepressive Agents|antidepressive agents|mesh-ancestor
64826523|NCT01543724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64826524|NCT01543724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826525|NCT01543724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826526|NCT01543724|Antimanic Agents|antimanic agents|mesh-ancestor
64826527|NCT01543724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64826528|NCT01543724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64826529|NCT01543724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826530|NCT01543737|Hyaluronic Acid|hyaluronic acid|mesh-list
64826531|NCT01543737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64826532|NCT01543737|Immunologic Factors|immunologic factors|mesh-ancestor
64826533|NCT01543737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826534|NCT01543737|Viscosupplements|viscosupplements|mesh-ancestor
64826535|NCT01543737|Protective Agents|protective agents|mesh-ancestor
64826536|NCT01543750|4-Aminopyridine|4-aminopyridine|mesh-list
64826537|NCT01543750|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64826579|NCT01543945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64826580|NCT01543945|Serotonin Agents|serotonin agents|mesh-ancestor
64826581|NCT01543945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64826582|NCT01543945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64826583|NCT01543945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64826584|NCT01543945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64826585|NCT01543945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64826586|NCT01543945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64826587|NCT01543945|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64826588|NCT01543945|Histamine Antagonists|histamine antagonists|mesh-ancestor
64826589|NCT01543945|Histamine Agents|histamine agents|mesh-ancestor
64826590|NCT01543971|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
64826642|NCT01544283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64826643|NCT01544283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64826644|NCT01544283|Immunologic Factors|immunologic factors|mesh-ancestor
64826645|NCT01544283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826690|NCT01544634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64826691|NCT01544634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826692|NCT01544634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826693|NCT01544634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64826694|NCT01544634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64826695|NCT01544634|Vasodilator Agents|vasodilator agents|mesh-ancestor
64826696|NCT01544634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64826697|NCT01544634|Glucocorticoids|glucocorticoids|mesh-ancestor
64826699|NCT01544634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64826700|NCT01544634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64826727|NCT01544751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826728|NCT01544751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64826729|NCT01544751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64826730|NCT01544751|Antimetabolites|antimetabolites|mesh-ancestor
64437873|NCT04759248|Trastuzumab|trastuzumab|mesh-list
64826740|NCT01544829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64826741|NCT01544829|Respiratory System Agents|respiratory system agents|mesh-ancestor
64826742|NCT01544829|Vasodilator Agents|vasodilator agents|mesh-ancestor
64826743|NCT01544842|Triamcinolone|triamcinolone|mesh-list
64826744|NCT01544842|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64826745|NCT01544842|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64826746|NCT01544842|Tacrolimus|tacrolimus|mesh-list
64826747|NCT01544842|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65273985|NCT02687256|Heparin|heparin|mesh-list
64791452|NCT00357864|Carbachol|carbachol|mesh-list
64826748|NCT01544842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64826749|NCT01544842|Immunologic Factors|immunologic factors|mesh-ancestor
64826750|NCT01544842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826751|NCT01544842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64826752|NCT01544842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826753|NCT01544842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826754|NCT01544842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64826755|NCT01544842|Glucocorticoids|glucocorticoids|mesh-ancestor
64826788|NCT01544959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64826790|NCT01544959|Anesthetics|anesthetics|mesh-ancestor
64826791|NCT01544959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64826792|NCT01544959|Adrenergic Agents|adrenergic agents|mesh-ancestor
64826793|NCT01544959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64826808|NCT01544972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826809|NCT01544972|Antipyretics|antipyretics|mesh-ancestor
64826882|NCT01545804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64826883|NCT01545804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64826884|NCT01545804|Growth Substances|growth substances|mesh-ancestor
64826885|NCT01545804|Growth Inhibitors|growth inhibitors|mesh-ancestor
64826886|NCT01545804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64826887|NCT01545830|Vitamin D|vitamin d|mesh-list
64826888|NCT01545830|Cholecalciferol|cholecalciferol|mesh-list
64826889|NCT01545830|Vitamins|vitamins|mesh-ancestor
64826890|NCT01545830|Micronutrients|micronutrients|mesh-ancestor
64826891|NCT01545830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826892|NCT01545830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64826893|NCT01545830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64826894|NCT01545856|Levodopa|levodopa|mesh-list
64826895|NCT01545856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64826896|NCT01545856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64826897|NCT01545856|Dopamine Agents|dopamine agents|mesh-ancestor
64826898|NCT01545856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64826899|NCT01545856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826900|NCT01545856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826901|NCT01545947|Azacitidine|azacitidine|mesh-list
64826902|NCT01545947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64826903|NCT01545947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64826904|NCT01545947|Antimetabolites|antimetabolites|mesh-ancestor
64826905|NCT01545947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826906|NCT01545947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64826943|NCT01546116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64826944|NCT01546116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64826945|NCT01546389|Chloroquine|chloroquine|mesh-list
64564632|NCT01293825|Ziprasidone|ziprasidone|mesh-list
64826946|NCT01546389|Amebicides|amebicides|mesh-ancestor
64826947|NCT01546389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64826948|NCT01546389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64826949|NCT01546389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64826950|NCT01546389|Antimalarials|antimalarials|mesh-ancestor
64826951|NCT01546389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64826952|NCT01546558|Metformin|metformin|mesh-list
64826953|NCT01546558|Ranolazine|ranolazine|mesh-list
64826954|NCT01546558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64826955|NCT01546558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826956|NCT01546558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64826957|NCT01546558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64826958|NCT01546558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827014|NCT01547104|Protease Inhibitors|protease inhibitors|mesh-ancestor
64827015|NCT01547104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827016|NCT01547104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827017|NCT01547143|Cyclosporine|cyclosporine|mesh-list
64827080|NCT01547325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64827082|NCT01547377|Selenium|selenium|mesh-list
64827083|NCT01547377|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64827084|NCT01547377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64827085|NCT01547377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64827086|NCT01547377|Antimetabolites|antimetabolites|mesh-ancestor
64438246|NCT04188119|Aspirin|aspirin|mesh-list
64827113|NCT01547455|Antimetabolites|antimetabolites|mesh-ancestor
64827114|NCT01547455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827115|NCT01547455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64827116|NCT01547455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64827163|NCT01548066|GABA Agents|gaba agents|mesh-ancestor
64827164|NCT01548066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65273986|NCT02687256|Anticoagulants|anticoagulants|mesh-ancestor
65273987|NCT02687256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64827165|NCT01548066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827166|NCT01548066|Antimanic Agents|antimanic agents|mesh-ancestor
64827167|NCT01548066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64827168|NCT01548066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64827169|NCT01548066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64827204|NCT01548170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64827205|NCT01548170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64827206|NCT01548170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64827207|NCT01548170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64827208|NCT01548170|Hormone Antagonists|hormone antagonists|mesh-ancestor
64827209|NCT01548170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64827210|NCT01548170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64827211|NCT01548209|Dexmedetomidine|dexmedetomidine|mesh-list
64827212|NCT01548209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64827213|NCT01548209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64827214|NCT01548209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827241|NCT01548274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64827243|NCT01548274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64827244|NCT01548274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827245|NCT01548326|Atorvastatin|atorvastatin|mesh-list
64827246|NCT01548326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64827247|NCT01548326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64827248|NCT01548326|Antimetabolites|antimetabolites|mesh-ancestor
64827249|NCT01548326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827250|NCT01548326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64827251|NCT01548326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64827252|NCT01548326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827253|NCT01548482|Sirolimus|sirolimus|mesh-list
64827258|NCT01548482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827259|NCT01548482|Antifungal Agents|antifungal agents|mesh-ancestor
64827260|NCT01548482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64827261|NCT01548482|Immunologic Factors|immunologic factors|mesh-ancestor
64827262|NCT01548482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827263|NCT01548482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64827287|NCT01548703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64827288|NCT01548703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827289|NCT01548703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827291|NCT01548794|Bupivacaine|bupivacaine|mesh-list
64827292|NCT01548794|Anesthetics|anesthetics|mesh-list
64827293|NCT01548794|Anesthetics, Local|anesthetics, local|mesh-ancestor
64827294|NCT01548794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64827295|NCT01548794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827296|NCT01548794|Sensory System Agents|sensory system agents|mesh-ancestor
64827297|NCT01548794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827298|NCT01548794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64827299|NCT01548794|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64827300|NCT01548794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64827301|NCT01548794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64827302|NCT01548794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827303|NCT01548807|Everolimus|everolimus|mesh-list
64827304|NCT01548807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827305|NCT01548807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64827306|NCT01548807|Immunologic Factors|immunologic factors|mesh-ancestor
64827307|NCT01548807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827308|NCT01548859|Midazolam|midazolam|mesh-list
64827309|NCT01548859|Sevoflurane|sevoflurane|mesh-list
64827310|NCT01548859|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64827311|NCT01548859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64827312|NCT01548859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64309886|NCT03189771|Salicylic Acid|salicylic acid|mesh-list
64472828|NCT02648477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64827346|NCT01548950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827347|NCT01548950|Urological Agents|urological agents|mesh-ancestor
64827348|NCT01548950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64827349|NCT01548950|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64827350|NCT01549093|Gemcitabine|gemcitabine|mesh-list
64827351|NCT01549093|Carboplatin|carboplatin|mesh-list
64827352|NCT01549093|Endostar protein|endostar protein|mesh-list
64827353|NCT01549093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472025|NCT03892785|Glucocorticoids|glucocorticoids|mesh-ancestor
64827354|NCT01549093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64827355|NCT01549093|Antimetabolites|antimetabolites|mesh-ancestor
64827356|NCT01549093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827357|NCT01549093|Antiviral Agents|antiviral agents|mesh-ancestor
64827358|NCT01549093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64827359|NCT01549093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827360|NCT01549093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64827361|NCT01549093|Immunologic Factors|immunologic factors|mesh-ancestor
64827362|NCT01549093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827363|NCT01549093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64827364|NCT01549093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64827414|NCT01549431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64827415|NCT01549431|Glucocorticoids|glucocorticoids|mesh-ancestor
64827417|NCT01549431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64827418|NCT01549431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64827419|NCT01549431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827420|NCT01549431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64827421|NCT01549431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827422|NCT01549431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827423|NCT01549496|Amlodipine|amlodipine|mesh-list
64827424|NCT01549496|Diltiazem|diltiazem|mesh-list
64827425|NCT01549496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64827426|NCT01549496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64310193|NCT04899674|Bupropion|bupropion|mesh-list
64827465|NCT01549704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827466|NCT01549704|Sensory System Agents|sensory system agents|mesh-ancestor
64827467|NCT01549704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827468|NCT01549743|Celecoxib|celecoxib|mesh-list
64827469|NCT01549743|Rebamipide|rebamipide|mesh-list
64827470|NCT01549743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64827471|NCT01549743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64827472|NCT01549743|Analgesics|analgesics|mesh-ancestor
64827473|NCT01549743|Sensory System Agents|sensory system agents|mesh-ancestor
64827474|NCT01549743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827475|NCT01549743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827476|NCT01549743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64827477|NCT01549743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64827478|NCT01549743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64827479|NCT01549743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64827480|NCT01549743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827481|NCT01549743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827482|NCT01549743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64827483|NCT01549743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64827484|NCT01549743|Antioxidants|antioxidants|mesh-ancestor
64827485|NCT01549743|Protective Agents|protective agents|mesh-ancestor
64827486|NCT01549795|Capecitabine|capecitabine|mesh-list
64827487|NCT01549795|Liver Extracts|liver extracts|mesh-list
64827488|NCT01549795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64827489|NCT01549795|Antimetabolites|antimetabolites|mesh-ancestor
64310346|NCT04898270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64827525|NCT01550107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64827526|NCT01550107|Antioxidants|antioxidants|mesh-ancestor
64827527|NCT01550107|Protective Agents|protective agents|mesh-ancestor
64827528|NCT01550107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827529|NCT01550146|Dexamethasone|dexamethasone|mesh-list
64827530|NCT01550146|Dexamethasone acetate|dexamethasone acetate|mesh-list
65494648|NCT00251927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65494649|NCT00251927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64472830|NCT02648477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64565087|NCT01280409|Metformin|metformin|mesh-list
64827532|NCT01550146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64827533|NCT01550146|Antiemetics|antiemetics|mesh-ancestor
64827534|NCT01550146|Autonomic Agents|autonomic agents|mesh-ancestor
64827535|NCT01550146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827536|NCT01550146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310586|NCT02145715|Thalidomide|thalidomide|mesh-list
64827600|NCT01550640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64827612|NCT01550770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64827613|NCT01550770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64827614|NCT01550770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827615|NCT01550770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64827616|NCT01550770|Anesthetics, General|anesthetics, general|mesh-ancestor
64827617|NCT01550770|Anesthetics|anesthetics|mesh-ancestor
65273988|NCT02687256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64472026|NCT03892785|Hormones|hormones|mesh-ancestor
64827618|NCT01550848|Gemcitabine|gemcitabine|mesh-list
64827619|NCT01550848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64827620|NCT01550848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64827621|NCT01550848|Antimetabolites|antimetabolites|mesh-ancestor
64827622|NCT01550848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827623|NCT01550848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827624|NCT01550848|Antiviral Agents|antiviral agents|mesh-ancestor
64827625|NCT01550848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64827656|NCT01551225|Citalopram|citalopram|mesh-list
64827657|NCT01551225|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64827658|NCT01551225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64827659|NCT01551225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64827660|NCT01551225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827661|NCT01551225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64827662|NCT01551225|Serotonin Agents|serotonin agents|mesh-ancestor
64827663|NCT01551225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827696|NCT01551394|Cefotaxime|cefotaxime|mesh-list
64827697|NCT01551394|Cefoxitin|cefoxitin|mesh-list
64827698|NCT01551394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64827699|NCT01551394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64827700|NCT01551394|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64827701|NCT01551394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827702|NCT01551394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827703|NCT01551459|Sunitinib|sunitinib|mesh-list
64827704|NCT01551459|Dacarbazine|dacarbazine|mesh-list
64827705|NCT01551459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827706|NCT01551459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64827707|NCT01551459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64827708|NCT01551459|Growth Substances|growth substances|mesh-ancestor
64827709|NCT01551459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827710|NCT01551459|Growth Inhibitors|growth inhibitors|mesh-ancestor
64827711|NCT01551459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64827712|NCT01551459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827713|NCT01551459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827714|NCT01551459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64827715|NCT01551459|Alkylating Agents|alkylating agents|mesh-ancestor
64827716|NCT01551485|Zolpidem|zolpidem|mesh-list
64827717|NCT01551485|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64827718|NCT01551485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64827719|NCT01551485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64827720|NCT01551485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827721|NCT01551485|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64827722|NCT01551485|GABA Agonists|gaba agonists|mesh-ancestor
64827723|NCT01551485|GABA Agents|gaba agents|mesh-ancestor
64827754|NCT01551641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827755|NCT01551641|Leprostatic Agents|leprostatic agents|mesh-ancestor
64827756|NCT01551641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64827757|NCT01551641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64827758|NCT01551641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64827759|NCT01551641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64827760|NCT01551641|Growth Substances|growth substances|mesh-ancestor
64827761|NCT01551641|Growth Inhibitors|growth inhibitors|mesh-ancestor
64827762|NCT01551641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827763|NCT01551667|Antibodies|antibodies|mesh-list
64827806|NCT01552005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64827807|NCT01552005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827808|NCT01552005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64827810|NCT01552005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827811|NCT01552005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827812|NCT01552005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64827813|NCT01552018|Saxagliptin|saxagliptin|mesh-list
64827814|NCT01552018|Incretins|incretins|mesh-ancestor
64827848|NCT01552148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827849|NCT01552148|Analgesics|analgesics|mesh-ancestor
64827850|NCT01552148|Sensory System Agents|sensory system agents|mesh-ancestor
64827851|NCT01552148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827852|NCT01552187|Colchicine|colchicine|mesh-list
64827853|NCT01552187|Gout Suppressants|gout suppressants|mesh-ancestor
64827854|NCT01552187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64827855|NCT01552187|Tubulin Modulators|tubulin modulators|mesh-ancestor
64827856|NCT01552187|Antimitotic Agents|antimitotic agents|mesh-ancestor
65273989|NCT02687256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827857|NCT01552187|Mitosis Modulators|mitosis modulators|mesh-ancestor
64827858|NCT01552187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827859|NCT01552187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827860|NCT01552330|Artesunate|artesunate|mesh-list
64827861|NCT01552330|Primaquine|primaquine|mesh-list
64827862|NCT01552330|Pyronaridine|pyronaridine|mesh-list
64827863|NCT01552330|Antimalarials|antimalarials|mesh-ancestor
64827864|NCT01552330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64827865|NCT01552330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64827866|NCT01552330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64827937|NCT01552993|Sensory System Agents|sensory system agents|mesh-ancestor
64827938|NCT01552993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827939|NCT01552993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827940|NCT01552993|Antipyretics|antipyretics|mesh-ancestor
64827941|NCT01553006|Cefditoren|cefditoren|mesh-list
64827942|NCT01553006|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
64827943|NCT01553006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64827944|NCT01553006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64827945|NCT01553019|Gemcitabine|gemcitabine|mesh-list
64827946|NCT01553019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64827947|NCT01553019|Antimetabolites|antimetabolites|mesh-ancestor
64827948|NCT01553019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827949|NCT01553019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827950|NCT01553019|Antiviral Agents|antiviral agents|mesh-ancestor
64827999|NCT01553773|Estradiol|estradiol|mesh-list
64828000|NCT01553773|Estrogens|estrogens|mesh-ancestor
64828001|NCT01553773|Hormones|hormones|mesh-ancestor
64828002|NCT01553773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64828003|NCT01553773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828004|NCT01553786|Lenalidomide|lenalidomide|mesh-list
64828005|NCT01553786|Immunologic Factors|immunologic factors|mesh-ancestor
64828006|NCT01553786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828007|NCT01553786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64828008|NCT01553786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64828009|NCT01553786|Growth Substances|growth substances|mesh-ancestor
64828010|NCT01553786|Growth Inhibitors|growth inhibitors|mesh-ancestor
64828011|NCT01553786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828012|NCT01553903|Tamoxifen|tamoxifen|mesh-list
64828013|NCT01553903|Letrozole|letrozole|mesh-list
64828014|NCT01553903|Anastrozole|anastrozole|mesh-list
64828073|NCT01554540|Treprostinil|treprostinil|mesh-list
64828089|NCT01554657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64828090|NCT01554657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64828091|NCT01554657|Antitubercular Agents|antitubercular agents|mesh-ancestor
64828092|NCT01554813|Vaccines|vaccines|mesh-list
64828093|NCT01554813|Immunologic Factors|immunologic factors|mesh-ancestor
64828094|NCT01554813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828095|NCT01554826|Vaccines|vaccines|mesh-list
64828096|NCT01554826|Immunologic Factors|immunologic factors|mesh-ancestor
64828097|NCT01554826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828098|NCT01554852|Thalidomide|thalidomide|mesh-list
64828099|NCT01554852|Dexamethasone|dexamethasone|mesh-list
64311933|NCT02102633|Anticoagulants|anticoagulants|mesh-ancestor
64828223|NCT01555476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64828224|NCT01555476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64828225|NCT01555476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64828226|NCT01555476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828227|NCT01555476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828228|NCT01555580|Molgramostim|molgramostim|mesh-list
64828229|NCT01555580|Sargramostim|sargramostim|mesh-list
64828230|NCT01555580|Immunologic Factors|immunologic factors|mesh-ancestor
64828231|NCT01555580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828232|NCT01555580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828233|NCT01555632|Atorvastatin|atorvastatin|mesh-list
64828234|NCT01555632|Calcium|calcium|mesh-list
64828235|NCT01555632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64312273|NCT03041948|Acetaminophen|acetaminophen|mesh-list
64828278|NCT01555814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64828279|NCT01555814|Antidepressive Agents|antidepressive agents|mesh-ancestor
64828280|NCT01555853|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64828281|NCT01555853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828282|NCT01555866|Isavuconazole|isavuconazole|mesh-list
64828283|NCT01555866|Antifungal Agents|antifungal agents|mesh-ancestor
64828284|NCT01555866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64828286|NCT01555879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64828287|NCT01555879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828288|NCT01555879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828306|NCT01555970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828307|NCT01555970|Antidotes|antidotes|mesh-ancestor
64828308|NCT01556035|Lenalidomide|lenalidomide|mesh-list
64828309|NCT01556035|Immunologic Factors|immunologic factors|mesh-ancestor
64828310|NCT01556035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828311|NCT01556035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64828312|NCT01556035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64828313|NCT01556035|Growth Substances|growth substances|mesh-ancestor
64828314|NCT01556035|Growth Inhibitors|growth inhibitors|mesh-ancestor
64828315|NCT01556035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828365|NCT01556529|Protective Agents|protective agents|mesh-ancestor
64828366|NCT01556529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828367|NCT01556529|Chelating Agents|chelating agents|mesh-ancestor
64828368|NCT01556529|Sequestering Agents|sequestering agents|mesh-ancestor
64828369|NCT01556529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828371|NCT01556542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64828372|NCT01556542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828373|NCT01556542|Tubulin Modulators|tubulin modulators|mesh-ancestor
64828374|NCT01556542|Antimitotic Agents|antimitotic agents|mesh-ancestor
64828425|NCT01556815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64828426|NCT01556815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828427|NCT01556815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64828428|NCT01556867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
64828429|NCT01556867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64828430|NCT01557075|Atorvastatin|atorvastatin|mesh-list
64828465|NCT01557153|Amlodipine|amlodipine|mesh-list
64828466|NCT01557153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64828467|NCT01557153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64828468|NCT01557153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64828469|NCT01557153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828470|NCT01557153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64828471|NCT01557153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828472|NCT01557153|Vasodilator Agents|vasodilator agents|mesh-ancestor
64828473|NCT01557257|Naltrexone|naltrexone|mesh-list
64828474|NCT01557257|Oxycodone|oxycodone|mesh-list
64828475|NCT01557257|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64828476|NCT01557257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64828477|NCT01557257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828478|NCT01557257|Sensory System Agents|sensory system agents|mesh-ancestor
64828479|NCT01557257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64828480|NCT01557257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64828481|NCT01557257|Narcotics|narcotics|mesh-ancestor
64828482|NCT01557257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64828483|NCT01557257|Analgesics|analgesics|mesh-ancestor
64828516|NCT01557335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64828517|NCT01557335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64828518|NCT01557335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64828519|NCT01557335|Purinergic Agents|purinergic agents|mesh-ancestor
64828520|NCT01557335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64828521|NCT01557335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64828522|NCT01557335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64828523|NCT01557335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64828524|NCT01557374|Abatacept|abatacept|mesh-list
64828525|NCT01557374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64828526|NCT01557374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828527|NCT01557374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828528|NCT01557374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64828529|NCT01557374|Immunologic Factors|immunologic factors|mesh-ancestor
64828530|NCT01557374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828543|NCT01557478|Protective Agents|protective agents|mesh-ancestor
64828544|NCT01557478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828545|NCT01557478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64828546|NCT01557634|Insulin|insulin|mesh-list
64828547|NCT01557634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64828548|NCT01557634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828549|NCT01557647|Treprostinil|treprostinil|mesh-list
64828550|NCT01557647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64828551|NCT01557660|Treprostinil|treprostinil|mesh-list
64828552|NCT01557660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64828553|NCT01557712|Ketamine|ketamine|mesh-list
64828554|NCT01557712|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64828555|NCT01557712|Analgesics|analgesics|mesh-ancestor
65273990|NCT00622206|Ritonavir|ritonavir|mesh-list
64828556|NCT01557712|Sensory System Agents|sensory system agents|mesh-ancestor
64828557|NCT01557712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64828558|NCT01557712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828559|NCT01557712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64828560|NCT01557712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64828561|NCT01557712|Anesthetics, General|anesthetics, general|mesh-ancestor
64828562|NCT01557712|Anesthetics|anesthetics|mesh-ancestor
64828563|NCT01557712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64828564|NCT01557712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64828565|NCT01557712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64597156|NCT03316118|Bupivacaine|bupivacaine|mesh-list
64828566|NCT01557712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65494669|NCT03971201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565897|NCT05642026|Analgesics|analgesics|mesh-ancestor
64828567|NCT01557712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828568|NCT01557712|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64828569|NCT01557712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64828570|NCT01557712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64828571|NCT01557712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64828572|NCT01557712|Antidepressive Agents|antidepressive agents|mesh-ancestor
64828573|NCT01557712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64828574|NCT01557764|Trastuzumab|trastuzumab|mesh-list
64828575|NCT01557764|Lapatinib|lapatinib|mesh-list
64828583|NCT01557764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828584|NCT01557764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828585|NCT01557816|Naproxen|naproxen|mesh-list
64828586|NCT01557816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64828587|NCT01557816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64828588|NCT01557816|Analgesics|analgesics|mesh-ancestor
64828589|NCT01557816|Sensory System Agents|sensory system agents|mesh-ancestor
64828590|NCT01557816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64828591|NCT01557816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828592|NCT01557816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64828593|NCT01557816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64828594|NCT01557816|Gout Suppressants|gout suppressants|mesh-ancestor
64828595|NCT01557816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64828613|NCT01558011|Docetaxel|docetaxel|mesh-list
64828614|NCT01558011|Capecitabine|capecitabine|mesh-list
64828615|NCT01558011|Oxaliplatin|oxaliplatin|mesh-list
64828616|NCT01558011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828617|NCT01558011|Tubulin Modulators|tubulin modulators|mesh-ancestor
64828618|NCT01558011|Antimitotic Agents|antimitotic agents|mesh-ancestor
64828619|NCT01558011|Mitosis Modulators|mitosis modulators|mesh-ancestor
64828620|NCT01558011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828621|NCT01558011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64828622|NCT01558011|Antimetabolites|antimetabolites|mesh-ancestor
64828623|NCT01558167|Rituximab|rituximab|mesh-list
64828624|NCT01558167|Lenalidomide|lenalidomide|mesh-list
64828625|NCT01558167|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64828626|NCT01558167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64828627|NCT01558167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828628|NCT01558167|Immunologic Factors|immunologic factors|mesh-ancestor
64828629|NCT01558167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828630|NCT01558167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64828631|NCT01558167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64828632|NCT01558167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64828633|NCT01558167|Growth Substances|growth substances|mesh-ancestor
64828634|NCT01558167|Growth Inhibitors|growth inhibitors|mesh-ancestor
64828635|NCT01558167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64828636|NCT01558167|Alkylating Agents|alkylating agents|mesh-ancestor
64828637|NCT01558167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828638|NCT01558193|Vitamins|vitamins|mesh-list
64828639|NCT01558193|Evening primrose oil|evening primrose oil|mesh-list
64828640|NCT01558193|Micronutrients|micronutrients|mesh-ancestor
64828641|NCT01558193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828642|NCT01558193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64828643|NCT01558193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64828656|NCT01558245|Fertility Agents, Male|fertility agents, male|mesh-ancestor
64828657|NCT01558245|Fertility Agents|fertility agents|mesh-ancestor
64828658|NCT01558245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65494670|NCT01236144|Plerixafor|plerixafor|mesh-list
64472856|NCT02562235|Enzyme Activators|enzyme activators|mesh-ancestor
65273991|NCT00622206|Saquinavir|saquinavir|mesh-list
64514726|NCT02393157|Etoposide|etoposide|mesh-list
64472857|NCT02562235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472873|NCT02444429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64472874|NCT02444429|Prednisolone phosphate|prednisolone phosphate|mesh-list
64472875|NCT02444429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64316183|NCT00103285|Antidotes|antidotes|mesh-ancestor
64828693|NCT01558622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64828694|NCT01558622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64828695|NCT01558622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828696|NCT01558648|Analgesics|analgesics|mesh-list
64828697|NCT01558648|Sensory System Agents|sensory system agents|mesh-ancestor
64828698|NCT01558648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64828699|NCT01558648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828733|NCT01558934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828734|NCT01558934|Sensory System Agents|sensory system agents|mesh-ancestor
64828735|NCT01558934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64828736|NCT01558934|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64828737|NCT01558934|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64828738|NCT01558934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64828739|NCT01558934|Adrenergic Agents|adrenergic agents|mesh-ancestor
64828740|NCT01558934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64828741|NCT01558934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828742|NCT01558960|Melphalan|melphalan|mesh-list
64828743|NCT01558960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64828744|NCT01558960|Alkylating Agents|alkylating agents|mesh-ancestor
64828745|NCT01558960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828746|NCT01558960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828747|NCT01558960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64828784|NCT01559272|Serotonin Agents|serotonin agents|mesh-ancestor
64828785|NCT01559272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64828786|NCT01559272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828787|NCT01559272|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64828788|NCT01559272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64828789|NCT01559272|Dopamine Agents|dopamine agents|mesh-ancestor
64828791|NCT01559285|Anesthetics, Local|anesthetics, local|mesh-ancestor
64828792|NCT01559285|Anesthetics|anesthetics|mesh-ancestor
64828793|NCT01559285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64828794|NCT01559285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828795|NCT01559285|Sensory System Agents|sensory system agents|mesh-ancestor
64828815|NCT01559298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64828816|NCT01559298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64828817|NCT01559298|Purinergic Agents|purinergic agents|mesh-ancestor
64828818|NCT01559298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64828819|NCT01559480|Desogestrel|desogestrel|mesh-list
64828820|NCT01559480|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64828821|NCT01559480|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64828822|NCT01559480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64828823|NCT01559480|Contraceptive Agents|contraceptive agents|mesh-ancestor
64828824|NCT01559480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64828825|NCT01559480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828826|NCT01559480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64828827|NCT01559480|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64828828|NCT01559480|Progestins|progestins|mesh-ancestor
64828829|NCT01559480|Hormones|hormones|mesh-ancestor
64828830|NCT01559480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64828831|NCT01559545|Metronidazole|metronidazole|mesh-list
64828832|NCT01559545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64828833|NCT01559545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64828834|NCT01559545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64828835|NCT01559545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64828836|NCT01559584|Triamcinolone|triamcinolone|mesh-list
64828837|NCT01559584|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64828838|NCT01559584|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64828839|NCT01559584|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64828840|NCT01559584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64828841|NCT01559584|Glucocorticoids|glucocorticoids|mesh-ancestor
64828874|NCT01559753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64828875|NCT01559753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64828876|NCT01559753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828877|NCT01559753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828977|NCT05569031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65273992|NCT00622206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65273993|NCT00622206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64828978|NCT05569031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64828979|NCT05569031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828980|NCT05569031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64828981|NCT05569031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828982|NCT05569031|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64440129|NCT01911429|Dopamine Agents|dopamine agents|mesh-ancestor
64828987|NCT05569031|Sensory System Agents|sensory system agents|mesh-ancestor
64828988|NCT05569031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64828989|NCT05569031|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64828990|NCT05569031|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64828991|NCT05569031|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64828992|NCT05569031|Adrenergic Agents|adrenergic agents|mesh-ancestor
64828993|NCT05564741|Norepinephrine|norepinephrine|mesh-list
64828994|NCT05564741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64828995|NCT05564741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64828996|NCT05564741|Adrenergic Agents|adrenergic agents|mesh-ancestor
64828997|NCT05564741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64828998|NCT05564741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494690|NCT03971279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64566285|NCT04940052|Dabrafenib|dabrafenib|mesh-list
64566286|NCT04940052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566287|NCT04940052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64566288|NCT04940052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566289|NCT04940052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566290|NCT04935359|Gemcitabine|gemcitabine|mesh-list
64566291|NCT04935359|Paclitaxel|paclitaxel|mesh-list
64566306|NCT04818632|Everolimus|everolimus|mesh-list
64829014|NCT05522582|Antimetabolites|antimetabolites|mesh-ancestor
64829015|NCT05522582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829016|NCT05522582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829017|NCT05522582|Dermatologic Agents|dermatologic agents|mesh-ancestor
64829018|NCT05522582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829019|NCT05522582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64829020|NCT05522582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64829021|NCT05522582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64829022|NCT05522582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64829023|NCT05491304|Dexamethasone|dexamethasone|mesh-list
64829024|NCT05491304|Etoposide|etoposide|mesh-list
64829025|NCT05491304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64829098|NCT05229965|Caffeine|caffeine|mesh-list
64829099|NCT05229965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64829100|NCT05229965|Analgesics|analgesics|mesh-ancestor
64829101|NCT05229965|Sensory System Agents|sensory system agents|mesh-ancestor
64829102|NCT05229965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829103|NCT05229965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829104|NCT05229965|Antipyretics|antipyretics|mesh-ancestor
64829105|NCT05229965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64829106|NCT05229965|Narcotics|narcotics|mesh-ancestor
64829107|NCT05229965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64829108|NCT05229965|Antitussive Agents|antitussive agents|mesh-ancestor
64829109|NCT05229965|Respiratory System Agents|respiratory system agents|mesh-ancestor
64829144|NCT05166811|Anesthetics|anesthetics|mesh-ancestor
64829145|NCT05166811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64829175|NCT04818034|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64829176|NCT04818034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829178|NCT04818034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829179|NCT04787731|Lidocaine|lidocaine|mesh-list
64829180|NCT04787731|Bupivacaine|bupivacaine|mesh-list
64829181|NCT04787731|Anesthetics, Local|anesthetics, local|mesh-list
64829189|NCT04787731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64829190|NCT04787731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64829191|NCT04787731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829192|NCT04713358|Nalmefene|nalmefene|mesh-list
64829193|NCT04713358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64390604|NCT02423083|Guanabenz|guanabenz|mesh-list
64829224|NCT04474366|Anesthetics, Local|anesthetics, local|mesh-ancestor
64829226|NCT04474366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64829227|NCT04474366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829228|NCT04474366|Sensory System Agents|sensory system agents|mesh-ancestor
64829229|NCT04474366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829230|NCT04464265|Propofol|propofol|mesh-list
65273994|NCT00622206|Protease Inhibitors|protease inhibitors|mesh-ancestor
64792339|NCT00380484|Montelukast|montelukast|mesh-list
64829231|NCT04464265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64829232|NCT04464265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64829233|NCT04464265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829289|NCT04232683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65494699|NCT00165503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494701|NCT00165503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65494702|NCT00165503|Antidotes|antidotes|mesh-ancestor
65494703|NCT00165503|Protective Agents|protective agents|mesh-ancestor
65494704|NCT00165503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494705|NCT00165503|Antioxidants|antioxidants|mesh-ancestor
65494706|NCT00165503|Antitubercular Agents|antitubercular agents|mesh-ancestor
65494707|NCT00165503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65494709|NCT00165503|Chelating Agents|chelating agents|mesh-ancestor
65494710|NCT00165503|Sequestering Agents|sequestering agents|mesh-ancestor
65494711|NCT01144650|Dapsone|dapsone|mesh-list
65494712|NCT01144650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494713|NCT01144650|Antimalarials|antimalarials|mesh-ancestor
65494714|NCT01144650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65494715|NCT01144650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65494716|NCT01144650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65494717|NCT01144650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829491|NCT03104400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64829492|NCT03104400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64440635|NCT02301143|Antimetabolites|antimetabolites|mesh-ancestor
64829497|NCT03104374|Upadacitinib|upadacitinib|mesh-list
64829498|NCT03104374|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64829499|NCT03104374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64829500|NCT03104374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829501|NCT03104374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829502|NCT03104374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64829503|NCT03008369|Lenvatinib|lenvatinib|mesh-list
64829504|NCT03008369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829505|NCT03008369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64829506|NCT03008369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829507|NCT03008369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829508|NCT02965716|Pembrolizumab|pembrolizumab|mesh-list
64392833|NCT05106803|Amoxicillin|amoxicillin|mesh-list
64829561|NCT02686593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64829562|NCT02686593|Antimetabolites|antimetabolites|mesh-ancestor
64829563|NCT02658487|Cytarabine|cytarabine|mesh-list
64440701|NCT02274038|Pemetrexed|pemetrexed|mesh-list
64829581|NCT02553941|Antimetabolites|antimetabolites|mesh-ancestor
64829582|NCT02553941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494722|NCT03971045|Pembrolizumab|pembrolizumab|mesh-list
65494723|NCT03971045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65494724|NCT03971045|Immunologic Factors|immunologic factors|mesh-ancestor
64393748|NCT03727139|Rasagiline|rasagiline|mesh-list
64829605|NCT02179749|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64829607|NCT02179749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64829608|NCT02179749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829609|NCT02179749|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64829610|NCT02179749|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64829611|NCT02179749|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64829612|NCT02179749|Contraceptive Agents|contraceptive agents|mesh-ancestor
64829613|NCT02179749|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64829614|NCT02179749|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64829615|NCT02179749|Hormone Antagonists|hormone antagonists|mesh-ancestor
64829616|NCT02179749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64829651|NCT01561482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64829653|NCT01561586|Cisplatin|cisplatin|mesh-list
64829654|NCT01561586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829655|NCT01562704|Acetaminophen|acetaminophen|mesh-list
64829656|NCT01562704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64829657|NCT01562704|Analgesics|analgesics|mesh-ancestor
64829658|NCT01562704|Sensory System Agents|sensory system agents|mesh-ancestor
64829659|NCT01562704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829660|NCT01562704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829661|NCT01562704|Antipyretics|antipyretics|mesh-ancestor
64829662|NCT01564095|Tryptophan|tryptophan|mesh-list
64829663|NCT01564095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64829664|NCT01564095|Tacrolimus|tacrolimus|mesh-list
64829665|NCT01564095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65273995|NCT00622206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829666|NCT01564095|Immunologic Factors|immunologic factors|mesh-ancestor
64829667|NCT01564095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829668|NCT01564095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64829669|NCT01564095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829670|NCT01564095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494730|NCT03971045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829671|NCT01564095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64829672|NCT01564095|Antidepressive Agents|antidepressive agents|mesh-ancestor
64829673|NCT01564095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64829674|NCT01564238|Calcium, Dietary|calcium, dietary|mesh-list
64829675|NCT01564238|Calcium|calcium|mesh-list
64829676|NCT01564238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64829677|NCT01564238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829694|NCT01564823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64829695|NCT01564823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64829696|NCT01564823|Antimetabolites|antimetabolites|mesh-ancestor
64829697|NCT01564823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829698|NCT01564823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64829699|NCT01564823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829700|NCT01564823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64829701|NCT01564823|Immunologic Factors|immunologic factors|mesh-ancestor
64397587|NCT05056337|Lenvatinib|lenvatinib|mesh-list
64829734|NCT01566760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64829735|NCT01566760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829736|NCT01566760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440886|NCT01745380|Tetracaine|tetracaine|mesh-list
64829742|NCT01566890|Purinergic Agents|purinergic agents|mesh-ancestor
64829743|NCT01566890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64829744|NCT01566890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829745|NCT01566890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829747|NCT01567072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64829748|NCT01567072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64829802|NCT01569685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64440946|NCT01909791|Growth Inhibitors|growth inhibitors|mesh-ancestor
64829811|NCT01569685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64829812|NCT01570049|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64829813|NCT01570049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64829814|NCT01570049|Alkylating Agents|alkylating agents|mesh-ancestor
64829815|NCT01570049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829816|NCT01570049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829818|NCT01570088|Hematinics|hematinics|mesh-ancestor
64829819|NCT01570088|Vitamin B Complex|vitamin b complex|mesh-ancestor
64829820|NCT01570088|Vitamins|vitamins|mesh-ancestor
64829821|NCT01570088|Micronutrients|micronutrients|mesh-ancestor
64829822|NCT01570088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829823|NCT01570478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64829824|NCT01570478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64829825|NCT01570478|Autonomic Agents|autonomic agents|mesh-ancestor
64829826|NCT01570478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829827|NCT01570478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829828|NCT01570478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64829829|NCT01570478|Respiratory System Agents|respiratory system agents|mesh-ancestor
64829830|NCT01570478|Glucocorticoids|glucocorticoids|mesh-ancestor
64829831|NCT01570478|Hormones|hormones|mesh-ancestor
64829832|NCT01570478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64598422|NCT00654329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64829833|NCT01570478|Sympathomimetics|sympathomimetics|mesh-ancestor
64829834|NCT01570504|Ivermectin|ivermectin|mesh-list
64829835|NCT01570504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64829862|NCT01570569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64829863|NCT01570569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64829865|NCT01570569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64829866|NCT01570569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64829890|NCT01570582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64829891|NCT01570582|Immunologic Factors|immunologic factors|mesh-ancestor
64829892|NCT01570582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829893|NCT01570608|Ranibizumab|ranibizumab|mesh-list
64829894|NCT01570608|Verteporfin|verteporfin|mesh-list
64829895|NCT01570608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64829896|NCT01570608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64829897|NCT01570608|Growth Substances|growth substances|mesh-ancestor
64829898|NCT01570608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829899|NCT01570608|Growth Inhibitors|growth inhibitors|mesh-ancestor
64829900|NCT01570608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829901|NCT01570608|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64829902|NCT01570608|Dermatologic Agents|dermatologic agents|mesh-ancestor
64829903|NCT01570660|Pioglitazone|pioglitazone|mesh-list
64829904|NCT01570660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64829953|NCT01570985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829954|NCT01570985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64829955|NCT01570985|Immunologic Factors|immunologic factors|mesh-ancestor
64829956|NCT01570985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829957|NCT01570985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829958|NCT01571024|Leucovorin|leucovorin|mesh-list
65494731|NCT03971045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64829959|NCT01571024|Fluorouracil|fluorouracil|mesh-list
64829960|NCT01571024|Oxaliplatin|oxaliplatin|mesh-list
64829961|NCT01571024|Antimetabolites|antimetabolites|mesh-ancestor
64829962|NCT01571024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829963|NCT01571024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64829964|NCT01571024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829965|NCT01571024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64829966|NCT01571024|Immunologic Factors|immunologic factors|mesh-ancestor
64829967|NCT01571024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829968|NCT01571024|Antidotes|antidotes|mesh-ancestor
64830011|NCT01571323|Oxytocics|oxytocics|mesh-ancestor
64830012|NCT01571323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64830013|NCT01571323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830014|NCT01571323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64830015|NCT01571323|Abortifacient Agents|abortifacient agents|mesh-ancestor
64830016|NCT01571323|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64830017|NCT01571323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64830018|NCT01571414|Ritonavir|ritonavir|mesh-list
64830019|NCT01571414|Lopinavir|lopinavir|mesh-list
64830020|NCT01571414|Efavirenz|efavirenz|mesh-list
64830021|NCT01571414|Rifampin|rifampin|mesh-list
64830022|NCT01571414|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64830023|NCT01571414|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64830024|NCT01571414|Protease Inhibitors|protease inhibitors|mesh-ancestor
64830025|NCT01571414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397926|NCT02362165|Dexamethasone|dexamethasone|mesh-list
64830058|NCT01571583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64830059|NCT01571583|Antiviral Agents|antiviral agents|mesh-ancestor
64830060|NCT01571583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64830061|NCT01571583|Antimetabolites|antimetabolites|mesh-ancestor
64830062|NCT01571583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830063|NCT01571583|Immunologic Factors|immunologic factors|mesh-ancestor
64830064|NCT01571583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830066|NCT01571609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64830067|NCT01571609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830068|NCT01571648|Azacitidine|azacitidine|mesh-list
64830069|NCT01571648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64830070|NCT01571648|Antimetabolites|antimetabolites|mesh-ancestor
64830071|NCT01571648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830072|NCT01571648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64830073|NCT01571648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830074|NCT01571687|Antioxidants|antioxidants|mesh-list
64830075|NCT01571687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830076|NCT01571687|Protective Agents|protective agents|mesh-ancestor
64830077|NCT01571687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830078|NCT01571791|Ketorolac|ketorolac|mesh-list
64830079|NCT01571791|Lidocaine|lidocaine|mesh-list
64830080|NCT01571791|Anesthetics, Local|anesthetics, local|mesh-ancestor
64830125|NCT01571908|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64830126|NCT01571908|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64830128|NCT01571908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64830129|NCT01571908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830130|NCT01571908|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
64830131|NCT01571921|Tocotrienols|tocotrienols|mesh-list
64830132|NCT01571921|Vitamin E|vitamin e|mesh-list
64830133|NCT01571921|Tocopherols|tocopherols|mesh-list
64598726|NCT03721965|Prednisone|prednisone|mesh-list
64830177|NCT01572116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64830178|NCT01572116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64830179|NCT01572116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64830180|NCT01572116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65273996|NCT00622206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273997|NCT00622206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64830181|NCT01572116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830182|NCT01572116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64830183|NCT01572116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64830215|NCT01572181|Immunologic Factors|immunologic factors|mesh-ancestor
64830216|NCT01572181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830217|NCT01572181|Alkylating Agents|alkylating agents|mesh-ancestor
64830218|NCT01572181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64830219|NCT01572181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65494733|NCT00162773|Omalizumab|omalizumab|mesh-list
65494734|NCT00162773|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64567368|NCT02584933|Ceritinib|ceritinib|mesh-list
64830221|NCT01572259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64830222|NCT01572259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830260|NCT01572350|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64830261|NCT01572350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64830262|NCT01572350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64830263|NCT01572350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64830264|NCT01572350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64830265|NCT01572350|Growth Substances|growth substances|mesh-ancestor
64830266|NCT01572350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830267|NCT01572350|Growth Inhibitors|growth inhibitors|mesh-ancestor
64830268|NCT01572350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64830269|NCT01572350|Glucocorticoids|glucocorticoids|mesh-ancestor
64830271|NCT01572350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64830272|NCT01572350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64830273|NCT01572350|Immunologic Factors|immunologic factors|mesh-ancestor
64830274|NCT01572350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830275|NCT01572350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830276|NCT01572363|Sildenafil Citrate|sildenafil citrate|mesh-list
64830277|NCT01572363|Vasodilator Agents|vasodilator agents|mesh-ancestor
64830278|NCT01572363|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64398188|NCT00014443|Growth Inhibitors|growth inhibitors|mesh-ancestor
64830319|NCT01572597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64830320|NCT01572597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64830321|NCT01572597|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64830348|NCT01572623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64830349|NCT01572623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64830351|NCT01572623|Purinergic Agents|purinergic agents|mesh-ancestor
64830352|NCT01572623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64830353|NCT01572623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830354|NCT01572649|Lixisenatide|lixisenatide|mesh-list
64830355|NCT01572649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64830356|NCT01572649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830357|NCT01572688|Melphalan|melphalan|mesh-list
64598942|NCT00328523|Ezetimibe|ezetimibe|mesh-list
64830358|NCT01572688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64830359|NCT01572688|Alkylating Agents|alkylating agents|mesh-ancestor
64830360|NCT01572688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830361|NCT01572688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64830362|NCT01572688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64830363|NCT01572688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64830364|NCT01572688|Immunologic Factors|immunologic factors|mesh-ancestor
64830365|NCT01572688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830367|NCT01572805|Antioxidants|antioxidants|mesh-ancestor
64830418|NCT01573338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64830435|NCT01573377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64830436|NCT01573377|Estrogens|estrogens|mesh-ancestor
64830437|NCT01573377|Hormones|hormones|mesh-ancestor
64830438|NCT01573377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64830439|NCT01573377|Androgen Antagonists|androgen antagonists|mesh-ancestor
64830440|NCT01573377|Hormone Antagonists|hormone antagonists|mesh-ancestor
64830441|NCT01573377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64830442|NCT01573377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64830443|NCT01573468|Capecitabine|capecitabine|mesh-list
64830444|NCT01573468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64830445|NCT01573468|Antimetabolites|antimetabolites|mesh-ancestor
64830446|NCT01573468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830447|NCT01573468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273998|NCT00622206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65273999|NCT00622206|Antiviral Agents|antiviral agents|mesh-ancestor
64830448|NCT01573598|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
64830449|NCT01573598|Antidepressive Agents|antidepressive agents|mesh-ancestor
64830450|NCT01573598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64830451|NCT01573598|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64830452|NCT01573598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64830453|NCT01573598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64830454|NCT01573598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830482|NCT01573715|Cholinergic Agents|cholinergic agents|mesh-ancestor
64830483|NCT01573715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64830484|NCT01573715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830485|NCT01573741|Ketamine|ketamine|mesh-list
64830486|NCT01573741|Analgesics|analgesics|mesh-ancestor
64830487|NCT01573741|Sensory System Agents|sensory system agents|mesh-ancestor
64830488|NCT01573741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64830489|NCT01573741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830490|NCT01573741|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64830491|NCT01573741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64830492|NCT01573741|Anesthetics, General|anesthetics, general|mesh-ancestor
64830493|NCT01573741|Anesthetics|anesthetics|mesh-ancestor
64830494|NCT01573741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64830495|NCT01573741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64830496|NCT01573741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64472893|NCT02388906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830497|NCT01573741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64830498|NCT01573741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830499|NCT01573806|Exenatide|exenatide|mesh-list
64830500|NCT01573806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64830501|NCT01573806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830502|NCT01573806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64830534|NCT01574131|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64830535|NCT01574131|Antimetabolites|antimetabolites|mesh-ancestor
64830536|NCT01574131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830537|NCT01574131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64830538|NCT01574261|Inositol|inositol|mesh-list
64830539|NCT01574261|Vitamin B Complex|vitamin b complex|mesh-ancestor
64830540|NCT01574261|Vitamins|vitamins|mesh-ancestor
64830541|NCT01574261|Micronutrients|micronutrients|mesh-ancestor
64830542|NCT01574261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830543|NCT01574313|Tocopherols|tocopherols|mesh-list
64830544|NCT01574313|Vitamin E|vitamin e|mesh-list
64830545|NCT01574313|Tocotrienols|tocotrienols|mesh-list
64830590|NCT01575158|Antidepressive Agents|antidepressive agents|mesh-ancestor
64830591|NCT01575158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64830592|NCT01575158|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64830594|NCT01575236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64830595|NCT01575236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64830596|NCT01575236|Disinfectants|disinfectants|mesh-ancestor
64830597|NCT01575301|Liraglutide|liraglutide|mesh-list
64830599|NCT01575301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64830600|NCT01575301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830601|NCT01575301|Incretins|incretins|mesh-ancestor
64830602|NCT01575301|Hormones|hormones|mesh-ancestor
64830603|NCT01575301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64830604|NCT01575301|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64830605|NCT01575405|Tenofovir|tenofovir|mesh-list
64830633|NCT01575483|Hormones|hormones|mesh-ancestor
64830634|NCT01575483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64830635|NCT01575483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830636|NCT01575483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64830637|NCT01575483|Protease Inhibitors|protease inhibitors|mesh-ancestor
64830638|NCT01575483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830745|NCT01576315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64830817|NCT01576731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64830818|NCT01576731|Protease Inhibitors|protease inhibitors|mesh-ancestor
64830819|NCT01576731|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64830820|NCT01576731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64830821|NCT01576731|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64830830|NCT01576770|Sensory System Agents|sensory system agents|mesh-ancestor
64830831|NCT01576770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64830832|NCT01576770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64830833|NCT01576770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64830834|NCT01576770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64830835|NCT01576770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64830836|NCT01576770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830837|NCT01576848|Caseins|caseins|mesh-list
64830838|NCT01576848|Chelating Agents|chelating agents|mesh-ancestor
64830839|NCT01576848|Sequestering Agents|sequestering agents|mesh-ancestor
64830840|NCT01576848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830841|NCT01577017|Letrozole|letrozole|mesh-list
64830842|NCT01577017|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64830843|NCT01577017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64830844|NCT01577017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64830845|NCT01577017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830846|NCT01577017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830847|NCT01577017|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64398685|NCT03091595|Hormones|hormones|mesh-ancestor
64830876|NCT01577199|Enclomiphene|enclomiphene|mesh-list
64830877|NCT01577199|Zuclomiphene|zuclomiphene|mesh-list
64830878|NCT01577199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64830879|NCT01577199|Hormone Antagonists|hormone antagonists|mesh-ancestor
64830880|NCT01577199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64830881|NCT01577199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830882|NCT01577199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64830884|NCT01577199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64830885|NCT01577199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64830886|NCT01577199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64830887|NCT01577342|Moxifloxacin|moxifloxacin|mesh-list
64830888|NCT01577342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64830889|NCT01577342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64830890|NCT01577342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64830912|NCT01577459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64830913|NCT01577524|Povidone-Iodine|povidone-iodine|mesh-list
65494739|NCT03970577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64831163|NCT01578473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831165|NCT01578473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64831166|NCT01578564|SOR-C13|sor-c13|mesh-list
64831167|NCT01578564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831168|NCT01578564|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64831169|NCT01578564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64831170|NCT01578564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831171|NCT01578564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64831172|NCT01578564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831173|NCT01578603|Calcium|calcium|mesh-list
64831174|NCT01578603|Caseins|caseins|mesh-list
64831175|NCT01578603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64831176|NCT01578603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831177|NCT01578603|Chelating Agents|chelating agents|mesh-ancestor
64831178|NCT01578603|Sequestering Agents|sequestering agents|mesh-ancestor
64831179|NCT01578603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831198|NCT01578629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64831230|NCT01578824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831231|NCT01578889|Vaccines|vaccines|mesh-list
64831232|NCT01578889|Immunologic Factors|immunologic factors|mesh-ancestor
64831233|NCT01578889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831234|NCT01578928|Pasireotide|pasireotide|mesh-list
64831235|NCT01578928|Hormones|hormones|mesh-ancestor
64831236|NCT01578928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64399016|NCT02342509|Isoflurane|isoflurane|mesh-list
64831333|NCT01579461|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64831334|NCT01579461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64831335|NCT01579461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64831336|NCT01579461|Adrenergic Agents|adrenergic agents|mesh-ancestor
64831337|NCT01579461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64831387|NCT01579695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831388|NCT01579734|Tamoxifen|tamoxifen|mesh-list
64831389|NCT01579734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64831390|NCT01579734|Hormone Antagonists|hormone antagonists|mesh-ancestor
64831391|NCT01579734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64831392|NCT01579734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831393|NCT01579734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64831394|NCT01579734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831434|NCT01579890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64472033|NCT03892785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64831436|NCT01579890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831437|NCT01579903|Factor VIII|factor viii|mesh-list
64831438|NCT01579903|Coagulants|coagulants|mesh-ancestor
64831439|NCT01579929|Etoposide|etoposide|mesh-list
64831440|NCT01579929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831441|NCT01579929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64831442|NCT01579929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64831443|NCT01579929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64831444|NCT01579929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831445|NCT01579929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831446|NCT01579994|Crizotinib|crizotinib|mesh-list
64831470|NCT01581476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831472|NCT01581476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64831473|NCT01581476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831474|NCT01581476|Protease Inhibitors|protease inhibitors|mesh-ancestor
64831475|NCT01581476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64831476|NCT01582321|Cantharidin|cantharidin|mesh-list
64831477|NCT01582321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945452|NCT05619627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831505|NCT01583062|Clavulanic Acids|clavulanic acids|mesh-list
64831506|NCT01583062|Clavulanic Acid|clavulanic acid|mesh-list
64831507|NCT01583062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64831508|NCT01583062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494747|NCT03970577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64472907|NCT02085148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568326|NCT01364259|Amifostine|amifostine|mesh-list
64831509|NCT01583062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831510|NCT01583062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831511|NCT01583062|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64831512|NCT01583426|Paclitaxel|paclitaxel|mesh-list
64831513|NCT01583426|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64831514|NCT01583426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64831515|NCT01583426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831516|NCT01583426|Tubulin Modulators|tubulin modulators|mesh-ancestor
64831517|NCT01583426|Antimitotic Agents|antimitotic agents|mesh-ancestor
64831518|NCT01583426|Mitosis Modulators|mitosis modulators|mesh-ancestor
64399245|NCT05005637|Prednisone|prednisone|mesh-list
64831560|NCT01587339|Ezogabine|ezogabine|mesh-list
64831561|NCT01587339|Analgesics|analgesics|mesh-ancestor
64831562|NCT01587339|Sensory System Agents|sensory system agents|mesh-ancestor
64831563|NCT01587339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64831564|NCT01587339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831565|NCT01587339|Anticonvulsants|anticonvulsants|mesh-ancestor
64831566|NCT01587339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64831567|NCT01587339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64831568|NCT01587339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831569|NCT01587339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64831570|NCT01587339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64831717|NCT01590693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64831718|NCT01590693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831719|NCT01590693|Cholinergic Agents|cholinergic agents|mesh-ancestor
64831720|NCT01590693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64831721|NCT01590693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831722|NCT01590693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64831723|NCT01590693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64831724|NCT01590732|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64831725|NCT01590732|Carboplatin|carboplatin|mesh-list
64831726|NCT01590732|Etoposide|etoposide|mesh-list
64831727|NCT01590732|Etoposide phosphate|etoposide phosphate|mesh-list
64831728|NCT01590732|Ifosfamide|ifosfamide|mesh-list
64831729|NCT01590732|Isophosphamide mustard|isophosphamide mustard|mesh-list
64831730|NCT01590732|Podophyllotoxin|podophyllotoxin|mesh-list
64831731|NCT01590732|Romidepsin|romidepsin|mesh-list
64831732|NCT01590732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831733|NCT01590732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64831734|NCT01590732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64831798|NCT01591070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831800|NCT01591083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64831801|NCT01591083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64831802|NCT01591083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64831803|NCT01591083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274000|NCT00622206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64831804|NCT01591083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831805|NCT01591122|Prednisone|prednisone|mesh-list
64831806|NCT01591122|Abiraterone Acetate|abiraterone acetate|mesh-list
64831807|NCT01591122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64831808|NCT01591122|Glucocorticoids|glucocorticoids|mesh-ancestor
64831809|NCT01591122|Hormones|hormones|mesh-ancestor
64472908|NCT02085148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831810|NCT01591122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64399489|NCT05012033|Glucocorticoids|glucocorticoids|mesh-ancestor
64831855|NCT01591226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64600437|NCT00720629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64831856|NCT01591226|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64831858|NCT01591226|Natriuretic Agents|natriuretic agents|mesh-ancestor
64831859|NCT01591421|Panitumumab|panitumumab|mesh-list
64831860|NCT01591421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64831861|NCT01591421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831862|NCT01591434|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64831863|NCT01591434|Laxatives|laxatives|mesh-ancestor
64831864|NCT01591434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64831865|NCT01591551|Natalizumab|natalizumab|mesh-list
64831866|NCT01591551|Immunologic Factors|immunologic factors|mesh-ancestor
64831966|NCT01592162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64831967|NCT01592162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64831968|NCT01592162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831969|NCT01592162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64831970|NCT01592162|Anesthetics, General|anesthetics, general|mesh-ancestor
64831971|NCT01592162|Anesthetics|anesthetics|mesh-ancestor
64831972|NCT01592162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64831973|NCT01592162|Narcotics|narcotics|mesh-ancestor
64831974|NCT01592162|Analgesics|analgesics|mesh-ancestor
64831975|NCT01592162|Sensory System Agents|sensory system agents|mesh-ancestor
64831976|NCT01592162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64831977|NCT01592201|Olanzapine|olanzapine|mesh-list
64831978|NCT01592201|Risperidone|risperidone|mesh-list
64831979|NCT01592201|Aripiprazole|aripiprazole|mesh-list
64831980|NCT01592201|Antipsychotic Agents|antipsychotic agents|mesh-list
64831981|NCT01592201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64831982|NCT01592201|Serotonin Agents|serotonin agents|mesh-ancestor
64831983|NCT01592201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64831984|NCT01592201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832010|NCT01592214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832011|NCT01592227|Acetaminophen|acetaminophen|mesh-list
64832012|NCT01592227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64832013|NCT01592227|Analgesics|analgesics|mesh-ancestor
64832014|NCT01592227|Sensory System Agents|sensory system agents|mesh-ancestor
64832015|NCT01592227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832016|NCT01592227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832017|NCT01592227|Antipyretics|antipyretics|mesh-ancestor
64832018|NCT01592253|Sirolimus|sirolimus|mesh-list
64832019|NCT01592253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64832020|NCT01592253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64443162|NCT02209597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64832030|NCT01592279|Incretins|incretins|mesh-ancestor
64832031|NCT01592279|Hormones|hormones|mesh-ancestor
64832032|NCT01592279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64832033|NCT01592305|Ritonavir|ritonavir|mesh-list
64832034|NCT01592305|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64832035|NCT01592305|Tenofovir|tenofovir|mesh-list
64832036|NCT01592305|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64832037|NCT01592305|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64832038|NCT01592305|Protease Inhibitors|protease inhibitors|mesh-ancestor
64832039|NCT01592305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399707|NCT05003765|Tocolytic Agents|tocolytic agents|mesh-ancestor
64832072|NCT01592526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832106|NCT01593046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64832107|NCT01593046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64832108|NCT01593046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64832109|NCT01593124|Imiquimod|imiquimod|mesh-list
64832110|NCT01593124|Nonoxynol|nonoxynol|mesh-list
64832111|NCT01593124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64832112|NCT01593124|Immunologic Factors|immunologic factors|mesh-ancestor
64832113|NCT01593124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832114|NCT01593124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64832115|NCT01593124|Interferon Inducers|interferon inducers|mesh-ancestor
64832116|NCT01593124|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
64832117|NCT01593124|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
64832118|NCT01593124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64832119|NCT01593124|Contraceptive Agents|contraceptive agents|mesh-ancestor
64832120|NCT01593124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64832121|NCT01593124|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64832122|NCT01593137|Metformin|metformin|mesh-list
64832123|NCT01593137|Liraglutide|liraglutide|mesh-list
64832124|NCT01593137|Glimepiride|glimepiride|mesh-list
64832157|NCT01593280|Analgesics|analgesics|mesh-ancestor
64832158|NCT01593280|Sensory System Agents|sensory system agents|mesh-ancestor
64832159|NCT01593280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832240|NCT01593566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832241|NCT01593566|Sensory System Agents|sensory system agents|mesh-ancestor
64832242|NCT01593566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832243|NCT01593605|Resveratrol|resveratrol|mesh-list
64832244|NCT01593605|Antioxidants|antioxidants|mesh-ancestor
64832245|NCT01593605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832246|NCT01593605|Protective Agents|protective agents|mesh-ancestor
64832247|NCT01593605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832248|NCT01593605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832249|NCT01593605|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64832250|NCT01593644|Adenosine|adenosine|mesh-list
64832251|NCT01593644|Dipyridamole|dipyridamole|mesh-list
64832252|NCT01593644|Analgesics|analgesics|mesh-ancestor
64832253|NCT01593644|Sensory System Agents|sensory system agents|mesh-ancestor
64832254|NCT01593644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832255|NCT01593644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832303|NCT01593930|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64832305|NCT01593930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64832306|NCT01593930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832307|NCT01593995|Mitogens|mitogens|mesh-list
64832328|NCT01594047|Respiratory System Agents|respiratory system agents|mesh-ancestor
64832329|NCT01594060|Insulin|insulin|mesh-list
64832330|NCT01594060|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64832331|NCT01594060|Insulin Glargine|insulin glargine|mesh-list
64832332|NCT01594060|Insulin glulisine|insulin glulisine|mesh-list
64832333|NCT01594060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64832334|NCT01594060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832335|NCT01594099|Paclitaxel|paclitaxel|mesh-list
64832336|NCT01594099|Cisplatin|cisplatin|mesh-list
64832337|NCT01594099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64832338|NCT01594099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64832339|NCT01594099|Tubulin Modulators|tubulin modulators|mesh-ancestor
64832340|NCT01594099|Antimitotic Agents|antimitotic agents|mesh-ancestor
64832341|NCT01594099|Mitosis Modulators|mitosis modulators|mesh-ancestor
64832342|NCT01594099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832343|NCT01594177|Paclitaxel|paclitaxel|mesh-list
64832344|NCT01594177|Cyclophosphamide|cyclophosphamide|mesh-list
64832345|NCT01594177|Trastuzumab|trastuzumab|mesh-list
64832346|NCT01594177|Epirubicin|epirubicin|mesh-list
64832347|NCT01594177|Afatinib|afatinib|mesh-list
64832348|NCT01594177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64832349|NCT01594177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64832350|NCT01594177|Tubulin Modulators|tubulin modulators|mesh-ancestor
64832351|NCT01594177|Antimitotic Agents|antimitotic agents|mesh-ancestor
64832352|NCT01594177|Mitosis Modulators|mitosis modulators|mesh-ancestor
64832433|NCT01594619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64832434|NCT01594619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832435|NCT01594619|Vasodilator Agents|vasodilator agents|mesh-ancestor
64832436|NCT01594619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65494756|NCT00161213|Imatinib Mesylate|imatinib mesylate|mesh-list
64832437|NCT01594619|Sensory System Agents|sensory system agents|mesh-ancestor
64472912|NCT02085148|Mitosis Modulators|mitosis modulators|mesh-ancestor
64832438|NCT01594619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832439|NCT01594671|Tranexamic Acid|tranexamic acid|mesh-list
64832440|NCT01594671|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64832479|NCT01594879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64832480|NCT01594905|Tenofovir|tenofovir|mesh-list
64832481|NCT01594905|Entecavir|entecavir|mesh-list
64832482|NCT01594905|Antiviral Agents|antiviral agents|mesh-ancestor
64832483|NCT01594905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64832484|NCT01594905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64832485|NCT01594905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64832486|NCT01594905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832487|NCT01594905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832488|NCT01594905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64832489|NCT01594905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64832490|NCT01594918|Prednisone|prednisone|mesh-list
64832491|NCT01594918|Mitoxantrone|mitoxantrone|mesh-list
64793095|NCT01279434|Vitamins|vitamins|mesh-list
64832492|NCT01594918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64832493|NCT01594918|Glucocorticoids|glucocorticoids|mesh-ancestor
64832494|NCT01594918|Hormones|hormones|mesh-ancestor
64832495|NCT01594918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64832496|NCT01594918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832497|NCT01594918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64832498|NCT01594918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64832499|NCT01594918|Analgesics|analgesics|mesh-ancestor
64832500|NCT01594918|Sensory System Agents|sensory system agents|mesh-ancestor
64832501|NCT01594918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832502|NCT01594918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64832503|NCT01594918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64832504|NCT01594918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832552|NCT01595425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64832553|NCT01595425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64832554|NCT01595425|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64832555|NCT01595425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832556|NCT01595425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832557|NCT01595594|Doxycycline|doxycycline|mesh-list
64832558|NCT01595594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64832559|NCT01595594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64832560|NCT01595594|Antimalarials|antimalarials|mesh-ancestor
64832561|NCT01595594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64832562|NCT01595594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64832563|NCT01595633|Tenofovir|tenofovir|mesh-list
64832564|NCT01595633|Adefovir|adefovir|mesh-list
64832565|NCT01595633|Antiviral Agents|antiviral agents|mesh-ancestor
64832566|NCT01595633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64832567|NCT01595633|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64832568|NCT01595633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64832569|NCT01595633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832570|NCT01595633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832571|NCT01595633|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64443730|NCT02207816|Vaccines|vaccines|mesh-list
64832585|NCT01595724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64832621|NCT01595828|Pitavastatin|pitavastatin|mesh-list
64832622|NCT01595828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64832623|NCT01595828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64832638|NCT01595867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64832639|NCT01595867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64832641|NCT01595880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64832642|NCT01595880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832644|NCT01595893|Cholecalciferol|cholecalciferol|mesh-list
64832645|NCT01595893|Vitamins|vitamins|mesh-ancestor
64832646|NCT01595893|Micronutrients|micronutrients|mesh-ancestor
64832647|NCT01595893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832648|NCT01595893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64832649|NCT01595893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64832650|NCT01595958|Cyclosporine|cyclosporine|mesh-list
64832651|NCT01595958|Cyclosporins|cyclosporins|mesh-list
64832652|NCT01595958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832653|NCT01595958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832654|NCT01595958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64832655|NCT01595958|Immunologic Factors|immunologic factors|mesh-ancestor
64832656|NCT01595958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832657|NCT01595958|Antifungal Agents|antifungal agents|mesh-ancestor
64832658|NCT01595958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64832659|NCT01595958|Dermatologic Agents|dermatologic agents|mesh-ancestor
64832660|NCT01595958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64832661|NCT01595958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64832662|NCT01595984|Cyclosporine|cyclosporine|mesh-list
64832663|NCT01595984|Mycophenolic Acid|mycophenolic acid|mesh-list
64832664|NCT01595984|Everolimus|everolimus|mesh-list
64832665|NCT01595984|Cyclosporins|cyclosporins|mesh-list
64832666|NCT01595984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832667|NCT01595984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832668|NCT01595984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64832669|NCT01595984|Immunologic Factors|immunologic factors|mesh-ancestor
64832670|NCT01595984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832671|NCT01595984|Antifungal Agents|antifungal agents|mesh-ancestor
64832672|NCT01595984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64832673|NCT01595984|Dermatologic Agents|dermatologic agents|mesh-ancestor
64832674|NCT01595984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64832675|NCT01595984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64832676|NCT01595984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793184|NCT01271010|Rituximab|rituximab|mesh-list
64832677|NCT01595984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64832678|NCT01595984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64832679|NCT01595984|Antitubercular Agents|antitubercular agents|mesh-ancestor
64832680|NCT01595984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64832681|NCT01596010|Norethindrone|norethindrone|mesh-list
64832682|NCT01596010|Norethindrone Acetate|norethindrone acetate|mesh-list
64832683|NCT01596010|Estradiol|estradiol|mesh-list
64832684|NCT01596010|Estrogens|estrogens|mesh-ancestor
64832685|NCT01596010|Hormones|hormones|mesh-ancestor
64832686|NCT01596010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64832687|NCT01596010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832688|NCT01596010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64832689|NCT01596010|Contraceptive Agents|contraceptive agents|mesh-ancestor
64832690|NCT01596010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64832723|NCT01596166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832725|NCT01596166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64832726|NCT01596166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64832727|NCT01596166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832728|NCT01596166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832729|NCT01596166|Antiemetics|antiemetics|mesh-ancestor
64832730|NCT01596166|Autonomic Agents|autonomic agents|mesh-ancestor
64832731|NCT01596166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64832732|NCT01596166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64832733|NCT01596166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64832734|NCT01596166|Dopamine Agents|dopamine agents|mesh-ancestor
64832735|NCT01596166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64832736|NCT01596218|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64832737|NCT01596218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64832758|NCT01596400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64832759|NCT01596400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832760|NCT01596413|Granisetron|granisetron|mesh-list
64601352|NCT00765661|Tacrolimus|tacrolimus|mesh-list
64832762|NCT01596413|Autonomic Agents|autonomic agents|mesh-ancestor
64832763|NCT01596413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832764|NCT01596413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832765|NCT01596413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64832766|NCT01596413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64832767|NCT01596413|Serotonin Agents|serotonin agents|mesh-ancestor
64832768|NCT01596413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64832769|NCT01596413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832770|NCT01596426|Granisetron|granisetron|mesh-list
64832771|NCT01596426|Antiemetics|antiemetics|mesh-ancestor
64832772|NCT01596426|Autonomic Agents|autonomic agents|mesh-ancestor
64832773|NCT01596426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832774|NCT01596426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832775|NCT01596426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64832776|NCT01596426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64832777|NCT01596426|Serotonin Agents|serotonin agents|mesh-ancestor
64832791|NCT01596556|Autonomic Agents|autonomic agents|mesh-ancestor
64832792|NCT01596556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832793|NCT01596556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832794|NCT01596556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64832795|NCT01596556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64832796|NCT01596556|Cholinergic Agents|cholinergic agents|mesh-ancestor
64832797|NCT01596556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64832798|NCT01596556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832799|NCT01596634|Lactoferrin|lactoferrin|mesh-list
65494760|NCT00161213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64832800|NCT01596634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64832801|NCT01596647|Diclofenac|diclofenac|mesh-list
64832802|NCT01596647|Midazolam|midazolam|mesh-list
64832803|NCT01596647|Caffeine|caffeine|mesh-list
64832804|NCT01596647|Omeprazole|omeprazole|mesh-list
64832805|NCT01596647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64832806|NCT01596647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64832827|NCT01596647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64832828|NCT01596647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64832829|NCT01596647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64832830|NCT01596647|Analgesics|analgesics|mesh-ancestor
64832831|NCT01596647|Sensory System Agents|sensory system agents|mesh-ancestor
64832832|NCT01596647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832833|NCT01596647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64832834|NCT01596647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64832835|NCT01596647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64832836|NCT01596660|Bupivacaine|bupivacaine|mesh-list
65274001|NCT00622206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64832837|NCT01596660|Anesthetics, Local|anesthetics, local|mesh-ancestor
64832838|NCT01596660|Anesthetics|anesthetics|mesh-ancestor
64832839|NCT01596660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64832840|NCT01596660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832906|NCT01596855|Hematinics|hematinics|mesh-ancestor
64832907|NCT01596868|Gemcitabine|gemcitabine|mesh-list
64832908|NCT01596868|Cisplatin|cisplatin|mesh-list
64832909|NCT01596868|Docetaxel|docetaxel|mesh-list
64832910|NCT01596868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64832911|NCT01596868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64832912|NCT01596868|Antimetabolites|antimetabolites|mesh-ancestor
64832913|NCT01596868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832914|NCT01596868|Antiviral Agents|antiviral agents|mesh-ancestor
64444076|NCT01587274|Antipyretics|antipyretics|mesh-ancestor
64833545|NCT05689632|Ergocalciferols|ergocalciferols|mesh-list
64833546|NCT05689632|Cholecalciferol|cholecalciferol|mesh-list
64833547|NCT05689632|Vitamins|vitamins|mesh-list
64833548|NCT05689632|Micronutrients|micronutrients|mesh-ancestor
64833549|NCT05689632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833550|NCT05689632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64833551|NCT05689632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64833552|NCT05689619|Silybin|silybin|mesh-list
64833553|NCT05689619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64833554|NCT05689619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833555|NCT05689619|Protective Agents|protective agents|mesh-ancestor
64836735|NCT01614535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836736|NCT01614535|Analgesics|analgesics|mesh-ancestor
64447793|NCT02097134|Melphalan|melphalan|mesh-list
64837933|NCT01621620|Urological Agents|urological agents|mesh-ancestor
64837934|NCT01621698|Fentanyl|fentanyl|mesh-list
64837935|NCT01621698|Bupivacaine|bupivacaine|mesh-list
64837936|NCT01621698|Propofol|propofol|mesh-list
64837937|NCT01621698|Atracurium|atracurium|mesh-list
64837938|NCT01621698|Anesthetics, Local|anesthetics, local|mesh-ancestor
64837939|NCT01621698|Anesthetics|anesthetics|mesh-ancestor
64448961|NCT02191397|Dexetimide|dexetimide|mesh-list
64838279|NCT01624025|Antimitotic Agents|antimitotic agents|mesh-ancestor
64449564|NCT02162771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64449566|NCT02162771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64449567|NCT02162771|Tubulin Modulators|tubulin modulators|mesh-ancestor
64449568|NCT02162771|Antimitotic Agents|antimitotic agents|mesh-ancestor
64449569|NCT02162771|Mitosis Modulators|mitosis modulators|mesh-ancestor
64449570|NCT02160041|Infigratinib|infigratinib|mesh-list
64449571|NCT02160041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64449572|NCT02186873|Golimumab|golimumab|mesh-list
64449573|NCT02186873|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64449581|NCT01830543|Aspirin|aspirin|mesh-list
64838823|NCT01627678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839401|NCT01631409|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64839402|NCT01631409|Diuretics|diuretics|mesh-ancestor
64839403|NCT01631409|Natriuretic Agents|natriuretic agents|mesh-ancestor
64839404|NCT01631409|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64839405|NCT01631448|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64839406|NCT01631448|Hemostatics|hemostatics|mesh-ancestor
64839407|NCT01631448|Coagulants|coagulants|mesh-ancestor
64839409|NCT01631513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64839410|NCT01631513|Narcotics|narcotics|mesh-ancestor
64839411|NCT01631513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64839412|NCT01631513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839413|NCT01631513|Analgesics|analgesics|mesh-ancestor
64839414|NCT01631513|Sensory System Agents|sensory system agents|mesh-ancestor
64840387|NCT01637454|Terlipressin|terlipressin|mesh-list
64840388|NCT01637454|Norepinephrine|norepinephrine|mesh-list
64840389|NCT01637454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64840390|NCT01637454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64840391|NCT01637454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64840392|NCT01637454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64840393|NCT01637454|Adrenergic Agents|adrenergic agents|mesh-ancestor
64840394|NCT01637454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64840395|NCT01637454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840396|NCT01637454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840404|NCT01637532|Doxorubicin|doxorubicin|mesh-list
64840405|NCT01637532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840406|NCT01637532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64840407|NCT01637532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64840408|NCT01637532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64840409|NCT01637532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274002|NCT00622206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65274003|NCT03582293|Tranexamic Acid|tranexamic acid|mesh-list
64793349|NCT00242580|Hormones|hormones|mesh-ancestor
64840410|NCT01637532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840411|NCT01637532|Antiviral Agents|antiviral agents|mesh-ancestor
64840412|NCT01637532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64840413|NCT01637532|Immunologic Factors|immunologic factors|mesh-ancestor
64840414|NCT01637532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840415|NCT01637545|Ramosetron|ramosetron|mesh-list
64840416|NCT01637545|Antiemetics|antiemetics|mesh-ancestor
64840417|NCT01637545|Autonomic Agents|autonomic agents|mesh-ancestor
64840418|NCT01637545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64840419|NCT01637545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840438|NCT01637558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64840439|NCT01637558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64840440|NCT01637558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64840441|NCT01637558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64840442|NCT01637558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64840444|NCT01637571|Lansoprazole|lansoprazole|mesh-list
64840445|NCT01637571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64840446|NCT01637571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64840447|NCT01637571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64840448|NCT01637571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840449|NCT01637571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840450|NCT01637636|Rifampin|rifampin|mesh-list
64840451|NCT01637636|Ketoconazole|ketoconazole|mesh-list
64608943|NCT03304379|Celecoxib|celecoxib|mesh-list
64840452|NCT01637636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64840453|NCT01637636|Antitubercular Agents|antitubercular agents|mesh-ancestor
64840454|NCT01637636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64514734|NCT02393157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840455|NCT01637636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64840456|NCT01637636|Leprostatic Agents|leprostatic agents|mesh-ancestor
64840457|NCT01637636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64840458|NCT01637636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840459|NCT01637636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840460|NCT01637636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64840461|NCT01637636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64840462|NCT01637636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64840463|NCT01637636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64451381|NCT01821729|Leucovorin|leucovorin|mesh-list
64840476|NCT01637675|Citric Acid|citric acid|mesh-list
64840477|NCT01637675|Sodium Citrate|sodium citrate|mesh-list
64840478|NCT01637675|Anticoagulants|anticoagulants|mesh-ancestor
64840479|NCT01637675|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64840480|NCT01637675|Chelating Agents|chelating agents|mesh-ancestor
64840481|NCT01637675|Sequestering Agents|sequestering agents|mesh-ancestor
64840482|NCT01637675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840483|NCT01637675|Vasodilator Agents|vasodilator agents|mesh-ancestor
64400658|NCT04988789|Paclitaxel|paclitaxel|mesh-list
64840503|NCT01637753|Alkylating Agents|alkylating agents|mesh-ancestor
64840504|NCT01637753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840505|NCT01637753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840506|NCT01637766|Melphalan|melphalan|mesh-list
64840507|NCT01637766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64840508|NCT01637766|Alkylating Agents|alkylating agents|mesh-ancestor
64840509|NCT01637766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840510|NCT01637766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840511|NCT01637766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64840512|NCT01637766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64840513|NCT01637766|Immunologic Factors|immunologic factors|mesh-ancestor
64840514|NCT01637766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840515|NCT01637818|Acetaminophen|acetaminophen|mesh-list
64840516|NCT01637818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64840517|NCT01637818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64840518|NCT01637818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64840519|NCT01637818|Analgesics|analgesics|mesh-ancestor
64840520|NCT01637818|Sensory System Agents|sensory system agents|mesh-ancestor
64840521|NCT01637818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64840522|NCT01637818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840523|NCT01637818|Antipyretics|antipyretics|mesh-ancestor
65274004|NCT03582293|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65274005|NCT03582293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64840844|NCT01639521|Antiviral Agents|antiviral agents|mesh-ancestor
64840845|NCT01639521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64840846|NCT01639521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840847|NCT01639521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64840848|NCT01639521|Immunologic Factors|immunologic factors|mesh-ancestor
64840849|NCT01639521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840850|NCT01639521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64840851|NCT01639521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64840852|NCT01639521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64840853|NCT01639521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64840854|NCT01639521|Abortifacient Agents|abortifacient agents|mesh-ancestor
64840855|NCT01639521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64840856|NCT01639521|Dermatologic Agents|dermatologic agents|mesh-ancestor
65494764|NCT00161213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64842042|NCT01654965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64842158|NCT01655316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64842159|NCT01655316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842160|NCT01655316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64842161|NCT01655316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842162|NCT01655316|Vasodilator Agents|vasodilator agents|mesh-ancestor
64842163|NCT01655368|Psychotropic Drugs|psychotropic drugs|mesh-list
64842164|NCT01655524|Aminophylline|aminophylline|mesh-list
64842165|NCT01655524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64842166|NCT01655524|Autonomic Agents|autonomic agents|mesh-ancestor
64842167|NCT01655524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842168|NCT01655524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842169|NCT01655524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64842170|NCT01655524|Respiratory System Agents|respiratory system agents|mesh-ancestor
64842171|NCT01655524|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64842172|NCT01655524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64842173|NCT01655524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842174|NCT01655524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842175|NCT01655524|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64842176|NCT01655524|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64842177|NCT01655524|Purinergic Agents|purinergic agents|mesh-ancestor
64842178|NCT01655524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842179|NCT01655524|Protective Agents|protective agents|mesh-ancestor
64842180|NCT01655628|Gemcitabine|gemcitabine|mesh-list
64842181|NCT01655628|Cisplatin|cisplatin|mesh-list
64842182|NCT01655628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842183|NCT01655628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64842184|NCT01655628|Antimetabolites|antimetabolites|mesh-ancestor
64400791|NCT04572217|Appetite Depressants|appetite depressants|mesh-ancestor
64842736|NCT01657513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842737|NCT01657513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842738|NCT01657513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64842739|NCT01657513|Immunologic Factors|immunologic factors|mesh-ancestor
64842740|NCT01657981|Darexaban|darexaban|mesh-list
64842741|NCT01657981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64842742|NCT01657981|Antithrombins|antithrombins|mesh-ancestor
64842743|NCT01657981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64842744|NCT01657981|Protease Inhibitors|protease inhibitors|mesh-ancestor
64842745|NCT01657981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842746|NCT01657981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843078|NCT01659775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64843079|NCT01659775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64843080|NCT01659775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64843081|NCT01659775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64843161|NCT01660295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843162|NCT01660295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64843164|NCT01660295|Sensory System Agents|sensory system agents|mesh-ancestor
64843165|NCT01660295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843166|NCT01660373|Tirofiban|tirofiban|mesh-list
64843167|NCT01660373|Ticagrelor|ticagrelor|mesh-list
64843168|NCT01660373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64843169|NCT01660373|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64843170|NCT01660373|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64843171|NCT01660373|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64843172|NCT01660373|Purinergic Agents|purinergic agents|mesh-ancestor
64843173|NCT01660373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64793517|NCT03467256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843174|NCT01660373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843175|NCT01660373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843176|NCT01660373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64843177|NCT01660373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64843178|NCT01660386|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64843179|NCT01660386|Glimepiride|glimepiride|mesh-list
64843648|NCT01663753|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64843649|NCT01663753|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64400945|NCT05087797|Vasodilator Agents|vasodilator agents|mesh-ancestor
64843664|NCT01663961|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64843665|NCT01663961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64843666|NCT01663961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64843667|NCT01663961|Adrenergic Agents|adrenergic agents|mesh-ancestor
64843668|NCT01663961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64843669|NCT01663961|Urological Agents|urological agents|mesh-ancestor
64843670|NCT01664013|Botulinum Toxins|botulinum toxins|mesh-list
64843671|NCT01664013|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64843672|NCT01664013|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64843673|NCT01664013|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64843674|NCT01664013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64844341|NCT01668615|Dermatologic Agents|dermatologic agents|mesh-ancestor
64844342|NCT01668680|Celecoxib|celecoxib|mesh-list
64844343|NCT01668680|Capecitabine|capecitabine|mesh-list
64844344|NCT01668680|Methotrexate|methotrexate|mesh-list
64844345|NCT01668680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64844346|NCT01668680|Antimetabolites|antimetabolites|mesh-ancestor
64844347|NCT01668680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844348|NCT01668680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845117|NCT05433402|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64845118|NCT05433402|Dopamine Agents|dopamine agents|mesh-ancestor
64845119|NCT05433402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64845120|NCT05433402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845121|NCT05423951|Sufentanil|sufentanil|mesh-list
64845122|NCT05423951|Propofol|propofol|mesh-list
64845709|NCT03362515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845712|NCT03340129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64845713|NCT03340129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494766|NCT00161213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845714|NCT03340129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64845715|NCT03340129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845716|NCT03307746|Rituximab|rituximab|mesh-list
64845717|NCT03307746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64846071|NCT01687751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64846073|NCT01687751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64846074|NCT01687751|Adrenergic Agents|adrenergic agents|mesh-ancestor
64846075|NCT01687751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64846076|NCT01687751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846077|NCT01687751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64846078|NCT01687751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64846079|NCT01687751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64846080|NCT01687751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64846081|NCT01687751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64846082|NCT01687751|Anesthetics, General|anesthetics, general|mesh-ancestor
64846124|NCT01690091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846296|NCT01690702|Cyclophosphamide|cyclophosphamide|mesh-list
64846297|NCT01690702|Epirubicin|epirubicin|mesh-list
64846298|NCT01690702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64846299|NCT01690702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846300|NCT01690702|Tubulin Modulators|tubulin modulators|mesh-ancestor
64846301|NCT01690702|Antimitotic Agents|antimitotic agents|mesh-ancestor
64846357|NCT01690884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846358|NCT01690884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64846359|NCT01690884|Vasodilator Agents|vasodilator agents|mesh-ancestor
64846360|NCT01690884|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64846361|NCT01690884|Purinergic Agonists|purinergic agonists|mesh-ancestor
64846362|NCT01690884|Purinergic Agents|purinergic agents|mesh-ancestor
64846363|NCT01690884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64846364|NCT01690884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846365|NCT01690962|Vitamins|vitamins|mesh-list
64846366|NCT01690962|Hydroxocobalamin|hydroxocobalamin|mesh-list
64846367|NCT01690962|Vitamin B 12|vitamin b 12|mesh-list
64846368|NCT01690962|Vitamin B Complex|vitamin b complex|mesh-list
64846369|NCT01690962|Micronutrients|micronutrients|mesh-ancestor
64846370|NCT01690962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846371|NCT01690962|Hematinics|hematinics|mesh-ancestor
64846372|NCT01690975|Benzonatate|benzonatate|mesh-list
64846373|NCT01690975|Antitussive Agents|antitussive agents|mesh-ancestor
64846374|NCT01690975|Respiratory System Agents|respiratory system agents|mesh-ancestor
64846375|NCT01691001|Dexmedetomidine|dexmedetomidine|mesh-list
64846376|NCT01691001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64846459|NCT01691677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846461|NCT01691677|Respiratory System Agents|respiratory system agents|mesh-ancestor
64846463|NCT01691742|Laxatives|laxatives|mesh-list
64846464|NCT01691742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64846465|NCT01691807|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64846466|NCT01691807|Ofatumumab|ofatumumab|mesh-list
64846467|NCT01691807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64846468|NCT01691807|Alkylating Agents|alkylating agents|mesh-ancestor
64846469|NCT01691807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846493|NCT01692132|Prucalopride|prucalopride|mesh-list
64846494|NCT01692132|Laxatives|laxatives|mesh-ancestor
64846495|NCT01692132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64846496|NCT01692132|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64401064|NCT05047601|Ritonavir|ritonavir|mesh-list
64846574|NCT01692834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64846575|NCT01692834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64846577|NCT01692886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64846578|NCT01692886|Immunologic Factors|immunologic factors|mesh-ancestor
64846579|NCT01692886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846580|NCT01692925|Factor VIII|factor viii|mesh-list
64846581|NCT01692925|Coagulants|coagulants|mesh-ancestor
64846582|NCT01693003|Tiotropium Bromide|tiotropium bromide|mesh-list
64846583|NCT01693003|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64846584|NCT01693003|Autonomic Agents|autonomic agents|mesh-ancestor
64846585|NCT01693003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64846586|NCT01693003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846587|NCT01693003|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64846588|NCT01693003|Respiratory System Agents|respiratory system agents|mesh-ancestor
64846589|NCT01693003|Parasympatholytics|parasympatholytics|mesh-ancestor
64846590|NCT01693003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64846591|NCT01693003|Cholinergic Agents|cholinergic agents|mesh-ancestor
64846592|NCT01693003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64846593|NCT01693003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846897|NCT05290948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64846898|NCT05290948|Growth Substances|growth substances|mesh-ancestor
64846899|NCT05290948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846900|NCT05290948|Growth Inhibitors|growth inhibitors|mesh-ancestor
64846901|NCT05290948|Anticonvulsants|anticonvulsants|mesh-ancestor
64846902|NCT05290948|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64846903|NCT05290948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846904|NCT05290948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846905|NCT05290948|Diuretics|diuretics|mesh-ancestor
64615406|NCT03574779|Paclitaxel|paclitaxel|mesh-list
64846906|NCT05290948|Natriuretic Agents|natriuretic agents|mesh-ancestor
64846907|NCT05290935|Paclitaxel|paclitaxel|mesh-list
64846908|NCT05290935|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64846909|NCT05290935|Antibodies|antibodies|mesh-list
64846910|NCT05290935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64846986|NCT05291910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846988|NCT05291793|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64846989|NCT05291793|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64846990|NCT05291793|Prednisolone|prednisolone|mesh-list
64847052|NCT05294744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494769|NCT01075529|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64847054|NCT05294679|Propofol|propofol|mesh-list
64847055|NCT05294679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64847056|NCT05294679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64847057|NCT05294679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847058|NCT05294679|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64847059|NCT05294679|Anesthetics, General|anesthetics, general|mesh-ancestor
64847060|NCT05294679|Anesthetics|anesthetics|mesh-ancestor
64847061|NCT05294666|Cyclosporine|cyclosporine|mesh-list
64847062|NCT05294666|Tacrolimus|tacrolimus|mesh-list
64847063|NCT05294666|Cyclosporins|cyclosporins|mesh-list
64847064|NCT05294666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64847065|NCT05294666|Immunologic Factors|immunologic factors|mesh-ancestor
64847066|NCT05294666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847067|NCT05294666|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64847068|NCT05294666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64847069|NCT05294666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847070|NCT05294666|Antifungal Agents|antifungal agents|mesh-ancestor
64847071|NCT05294666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64847072|NCT05294666|Dermatologic Agents|dermatologic agents|mesh-ancestor
64847123|NCT05294393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64847124|NCT05294393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847125|NCT05294393|Sensory System Agents|sensory system agents|mesh-ancestor
64847126|NCT05294393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64847310|NCT05273242|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64847311|NCT05273242|Anthelmintics|anthelmintics|mesh-ancestor
64847312|NCT05269095|Anesthetics|anesthetics|mesh-list
64847313|NCT05269095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64847314|NCT05269095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847315|NCT05267938|Lidocaine|lidocaine|mesh-list
64847316|NCT05267938|Epinephrine|epinephrine|mesh-list
64847317|NCT05267938|Anesthetics, Local|anesthetics, local|mesh-list
64847318|NCT05267938|Anesthetics|anesthetics|mesh-list
64847319|NCT05267938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64847320|NCT05267938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847321|NCT05267938|Sensory System Agents|sensory system agents|mesh-ancestor
64847322|NCT05267938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64847323|NCT05267938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64847324|NCT05267938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64847325|NCT05267938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64847326|NCT05267938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64847353|NCT05267431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64847354|NCT05267431|Immunologic Factors|immunologic factors|mesh-ancestor
64847355|NCT05267431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64847356|NCT05267431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64847357|NCT05267431|Antioxidants|antioxidants|mesh-ancestor
64847358|NCT05267431|Protective Agents|protective agents|mesh-ancestor
64847359|NCT05267431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64847360|NCT05266248|Caffeine|caffeine|mesh-list
64847361|NCT05266248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64847362|NCT05266248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847363|NCT05266248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64847365|NCT05266248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847366|NCT05266248|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64847367|NCT05266248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64847368|NCT05266248|Purinergic Agents|purinergic agents|mesh-ancestor
64472919|NCT02043678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64847369|NCT05266248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64847370|NCT05264896|Leucovorin|leucovorin|mesh-list
64847371|NCT05264896|Docetaxel|docetaxel|mesh-list
64847372|NCT05264896|Oxaliplatin|oxaliplatin|mesh-list
64847513|NCT05175274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847515|NCT05169268|Aripiprazole|aripiprazole|mesh-list
64847516|NCT05169268|Brexpiprazole|brexpiprazole|mesh-list
64847517|NCT05169268|Antidepressive Agents|antidepressive agents|mesh-ancestor
64847518|NCT05169268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64847519|NCT05169268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64847520|NCT05169268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64847521|NCT05169268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64847522|NCT05169268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847523|NCT05169268|Dopamine Agonists|dopamine agonists|mesh-ancestor
64847524|NCT05169268|Dopamine Agents|dopamine agents|mesh-ancestor
64848479|NCT05801367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64848480|NCT05801367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848481|NCT05801328|Salicylic Acid|salicylic acid|mesh-list
64848482|NCT05801328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64848483|NCT05801328|Antifungal Agents|antifungal agents|mesh-ancestor
64848484|NCT05801328|Keratolytic Agents|keratolytic agents|mesh-ancestor
64848485|NCT05801328|Dermatologic Agents|dermatologic agents|mesh-ancestor
64848534|NCT05801133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848535|NCT05801068|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
64848536|NCT05801068|Antithrombins|antithrombins|mesh-ancestor
64848537|NCT05801068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64848538|NCT05801068|Protease Inhibitors|protease inhibitors|mesh-ancestor
64848539|NCT05801068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848540|NCT05801068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848541|NCT05801068|Anticoagulants|anticoagulants|mesh-ancestor
64848542|NCT05801029|Osimertinib|osimertinib|mesh-list
64848543|NCT05801029|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
64848544|NCT05801029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848545|NCT05801029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64848721|NCT05753644|Anesthetics|anesthetics|mesh-ancestor
64848722|NCT05753644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64848723|NCT05753644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848724|NCT05753644|Sensory System Agents|sensory system agents|mesh-ancestor
64848725|NCT05753644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64848726|NCT05752201|Vaccines|vaccines|mesh-list
64848727|NCT05752201|Immunologic Factors|immunologic factors|mesh-ancestor
64848728|NCT05752201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848729|NCT05734625|Methylprednisolone|methylprednisolone|mesh-list
64848730|NCT05734625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64848731|NCT05734625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64848732|NCT05734625|Prednisolone|prednisolone|mesh-list
64848884|NCT05559476|Immunologic Factors|immunologic factors|mesh-ancestor
64848885|NCT05559476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848886|NCT05544565|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64848887|NCT05544565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64848889|NCT05537766|Fludarabine|fludarabine|mesh-list
64848890|NCT05537766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64848891|NCT05537766|Immunologic Factors|immunologic factors|mesh-ancestor
64848892|NCT05537766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848893|NCT05537766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64849033|NCT05345782|Sensory System Agents|sensory system agents|mesh-ancestor
64849034|NCT05345782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64849035|NCT05340582|Acetaminophen|acetaminophen|mesh-list
64849138|NCT05216952|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64849139|NCT05216952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64849140|NCT05216952|Oxytocics|oxytocics|mesh-ancestor
64849141|NCT05216952|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64849142|NCT05216952|Contraceptive Agents|contraceptive agents|mesh-ancestor
64849143|NCT05216952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64849144|NCT05215951|Osimertinib|osimertinib|mesh-list
64849145|NCT05215951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849146|NCT05215951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64849178|NCT05161468|Immunologic Factors|immunologic factors|mesh-ancestor
64849179|NCT05161468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849180|NCT05120349|Osimertinib|osimertinib|mesh-list
64849181|NCT05120349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849182|NCT05120349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64849183|NCT05120349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849184|NCT05120349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849185|NCT05108389|Hemostatics|hemostatics|mesh-list
64849186|NCT05108389|Coagulants|coagulants|mesh-ancestor
64849187|NCT05104762|Immunoglobulins|immunoglobulins|mesh-list
64849188|NCT05104762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64849189|NCT05104762|Antibodies|antibodies|mesh-list
64849365|NCT04887935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64849366|NCT04887935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849367|NCT04887935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64849368|NCT04887935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849370|NCT04880278|Antiemetics|antiemetics|mesh-ancestor
64849371|NCT04880278|Autonomic Agents|autonomic agents|mesh-ancestor
64849372|NCT04880278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64849373|NCT04880278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849374|NCT04880278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64849376|NCT04880278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64849377|NCT04880278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64849378|NCT04880278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64849379|NCT04870125|Carbon Monoxide|carbon monoxide|mesh-list
64849380|NCT04870125|Antimetabolites|antimetabolites|mesh-ancestor
64849381|NCT04870125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849382|NCT04870125|Gasotransmitters|gasotransmitters|mesh-ancestor
64849383|NCT04870125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64849384|NCT04870125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849385|NCT04858425|Niclosamide|niclosamide|mesh-list
64849386|NCT04858425|Anticestodal Agents|anticestodal agents|mesh-ancestor
64849387|NCT04858425|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64849388|NCT04858425|Anthelmintics|anthelmintics|mesh-ancestor
64849389|NCT04858425|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64849390|NCT04858425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64849391|NCT04858425|Antinematodal Agents|antinematodal agents|mesh-ancestor
64849393|NCT04845035|Methotrexate|methotrexate|mesh-list
64849394|NCT04845035|Dasatinib|dasatinib|mesh-list
64849395|NCT04845035|Ponatinib|ponatinib|mesh-list
64849463|NCT04762758|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64849464|NCT04762758|GABA Agonists|gaba agonists|mesh-ancestor
64849466|NCT04762758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65274006|NCT03582293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274007|NCT03582293|Hemostatics|hemostatics|mesh-ancestor
64793874|NCT01834014|Cetuximab|cetuximab|mesh-list
64849467|NCT04762758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849469|NCT04762758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64849470|NCT04732065|Dopamine|dopamine|mesh-list
64849471|NCT04732065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64849472|NCT04732065|Sympathomimetics|sympathomimetics|mesh-ancestor
64849473|NCT04732065|Autonomic Agents|autonomic agents|mesh-ancestor
64849474|NCT04732065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64849475|NCT04732065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849476|NCT04732065|Dopamine Agents|dopamine agents|mesh-ancestor
64849558|NCT04483505|Hormone Antagonists|hormone antagonists|mesh-ancestor
64849559|NCT04483505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64850187|NCT01819064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64850188|NCT01819064|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64850189|NCT01819064|Autonomic Agents|autonomic agents|mesh-ancestor
64850190|NCT01819064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64850191|NCT01819064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850192|NCT01819064|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64850193|NCT01819064|Respiratory System Agents|respiratory system agents|mesh-ancestor
64850194|NCT01819064|Mydriatics|mydriatics|mesh-ancestor
64850195|NCT01819064|Parasympatholytics|parasympatholytics|mesh-ancestor
64850196|NCT01819064|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64850197|NCT01819064|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64850198|NCT01819064|Cholinergic Agents|cholinergic agents|mesh-ancestor
64850228|NCT00812669|Cyclophosphamide|cyclophosphamide|mesh-list
64850230|NCT00812669|Fludarabine|fludarabine|mesh-list
64850231|NCT00812669|Fludarabine phosphate|fludarabine phosphate|mesh-list
64850232|NCT00812669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64850233|NCT00812669|Immunologic Factors|immunologic factors|mesh-ancestor
64850234|NCT00812669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850235|NCT00812669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64850236|NCT00812669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64850237|NCT00812669|Alkylating Agents|alkylating agents|mesh-ancestor
64850238|NCT00812669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850239|NCT00812669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850240|NCT00812669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64850241|NCT00812669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64850242|NCT00812669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64850493|NCT03660839|Artefenomel|artefenomel|mesh-list
64850494|NCT03660839|Ferroquine|ferroquine|mesh-list
64850495|NCT03660839|Antimalarials|antimalarials|mesh-ancestor
64850496|NCT03660839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64850580|NCT03569475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64850581|NCT03569475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850582|NCT03569475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64850584|NCT03569475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850585|NCT03569475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64850586|NCT03569475|Antidepressive Agents|antidepressive agents|mesh-ancestor
64850587|NCT03569475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64850588|NCT03569475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64850589|NCT03569475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64850723|NCT05438316|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64850724|NCT05438316|Protease Inhibitors|protease inhibitors|mesh-ancestor
64850725|NCT05438316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850795|NCT05436964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850796|NCT05436964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64850798|NCT05436964|Sensory System Agents|sensory system agents|mesh-ancestor
64850799|NCT05436964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64850800|NCT05436964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64850848|NCT05006079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64850849|NCT05006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850850|NCT04970381|Rivaroxaban|rivaroxaban|mesh-list
64850851|NCT04970381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64850852|NCT04970381|Antithrombins|antithrombins|mesh-ancestor
64850853|NCT04970381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64850993|NCT02679144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64850995|NCT02679144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850996|NCT02663908|Leuprolide|leuprolide|mesh-list
64850997|NCT02663908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64850998|NCT02663908|Fertility Agents|fertility agents|mesh-ancestor
64850999|NCT02663908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64851000|NCT02663908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851379|NCT02623998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851380|NCT02623998|Incretins|incretins|mesh-ancestor
64851381|NCT02623998|Hormones|hormones|mesh-ancestor
64851496|NCT02368301|Lenalidomide|lenalidomide|mesh-list
64851497|NCT02368301|Elotuzumab|elotuzumab|mesh-list
64852364|NCT01695460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64852366|NCT01695707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64852696|NCT01697787|Artesunate|artesunate|mesh-list
64852697|NCT01697787|Lumefantrine|lumefantrine|mesh-list
64852995|NCT01699854|Antipruritics|antipruritics|mesh-ancestor
64852996|NCT01699854|Dermatologic Agents|dermatologic agents|mesh-ancestor
64852997|NCT01699854|Sensory System Agents|sensory system agents|mesh-ancestor
64852998|NCT01699854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64852999|NCT01699854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853000|NCT01699919|Lidocaine|lidocaine|mesh-list
64853001|NCT01699919|Anesthetics, Local|anesthetics, local|mesh-ancestor
64853246|NCT01701453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64853247|NCT01701453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64401809|NCT04821869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64853779|NCT01704690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64853780|NCT01704690|Immunologic Factors|immunologic factors|mesh-ancestor
64853781|NCT01704690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853783|NCT01704703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64853784|NCT01704703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853785|NCT01704716|Aldesleukin|aldesleukin|mesh-list
64853786|NCT01704716|Cyclophosphamide|cyclophosphamide|mesh-list
64853788|NCT01704716|Busulfan|busulfan|mesh-list
64853815|NCT01704716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64853816|NCT01704716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64853817|NCT01704716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64853818|NCT01704716|Antiviral Agents|antiviral agents|mesh-ancestor
64853819|NCT01704716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64853820|NCT01704794|Folic Acid|folic acid|mesh-list
64853821|NCT01704794|Vitamin B Complex|vitamin b complex|mesh-list
64853822|NCT01704794|Proguanil|proguanil|mesh-list
64853823|NCT01704794|Hematinics|hematinics|mesh-ancestor
64853824|NCT01704794|Vitamins|vitamins|mesh-ancestor
64853825|NCT01704794|Micronutrients|micronutrients|mesh-ancestor
64853826|NCT01704794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853827|NCT01704794|Antimalarials|antimalarials|mesh-ancestor
64853828|NCT01704794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64853829|NCT01704794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64854320|NCT01708369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401908|NCT05090761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64854999|NCT01711957|Liver Extracts|liver extracts|mesh-list
64855000|NCT01711957|Hematinics|hematinics|mesh-ancestor
64855001|NCT01711970|Paclitaxel|paclitaxel|mesh-list
64855002|NCT01711970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64855003|NCT01711970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855004|NCT01711970|Tubulin Modulators|tubulin modulators|mesh-ancestor
64855005|NCT01711970|Antimitotic Agents|antimitotic agents|mesh-ancestor
64855006|NCT01711970|Mitosis Modulators|mitosis modulators|mesh-ancestor
64855007|NCT01711970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855008|NCT01712100|Irbesartan|irbesartan|mesh-list
64855009|NCT01712100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64855010|NCT01712100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64855011|NCT01712100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64855012|NCT01712100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855013|NCT01712113|Irbesartan|irbesartan|mesh-list
64855014|NCT01712113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64401949|NCT04533841|Abortifacient Agents|abortifacient agents|mesh-ancestor
64855246|NCT01713361|Enoxaparin|enoxaparin|mesh-list
64855247|NCT01713361|Anticoagulants|anticoagulants|mesh-ancestor
64855248|NCT01713361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64855249|NCT01713361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64855345|NCT01714011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64855346|NCT01714011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64855347|NCT01714011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855389|NCT01714089|Analgesics|analgesics|mesh-ancestor
64855390|NCT01714089|Sensory System Agents|sensory system agents|mesh-ancestor
64855391|NCT01714089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64855392|NCT01714089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64855393|NCT01714089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64855394|NCT01714089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64794028|NCT01834248|Poly ICLC|poly iclc|mesh-list
64855395|NCT01714102|Resveratrol|resveratrol|mesh-list
64855396|NCT01714102|Antioxidants|antioxidants|mesh-ancestor
64855397|NCT01714102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855398|NCT01714102|Protective Agents|protective agents|mesh-ancestor
64855399|NCT01714102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855400|NCT01714102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855401|NCT01714102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64855402|NCT01714115|Aflibercept|aflibercept|mesh-list
64855403|NCT01714115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64855404|NCT01714115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64855405|NCT01714115|Growth Substances|growth substances|mesh-ancestor
64855406|NCT01714115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855439|NCT01714193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855441|NCT01714193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64855442|NCT01714206|Canagliflozin|canagliflozin|mesh-list
64855444|NCT01714206|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64855456|NCT01714297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64855457|NCT01714297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64855458|NCT01714297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855459|NCT01714388|Remifentanil|remifentanil|mesh-list
64855460|NCT01714388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64855461|NCT01714388|Narcotics|narcotics|mesh-ancestor
64855462|NCT01714388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64855463|NCT01714388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855464|NCT01714388|Analgesics|analgesics|mesh-ancestor
64855465|NCT01714388|Sensory System Agents|sensory system agents|mesh-ancestor
64855466|NCT01714388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64855467|NCT01714401|Albuterol|albuterol|mesh-list
64855468|NCT01714401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64855469|NCT01714401|Autonomic Agents|autonomic agents|mesh-ancestor
64855470|NCT01714401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64855471|NCT01714401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855472|NCT01714401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64855473|NCT01714401|Respiratory System Agents|respiratory system agents|mesh-ancestor
64855474|NCT01714401|Tocolytic Agents|tocolytic agents|mesh-ancestor
64402043|NCT04262869|Durvalumab|durvalumab|mesh-list
64472928|NCT02029846|Protease Inhibitors|protease inhibitors|mesh-ancestor
64472929|NCT02029846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855499|NCT01714414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64855500|NCT01714427|Dexamethasone|dexamethasone|mesh-list
64855501|NCT01714427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64855502|NCT01714427|Antiemetics|antiemetics|mesh-ancestor
64855503|NCT01714427|Autonomic Agents|autonomic agents|mesh-ancestor
64855504|NCT01714427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64855505|NCT01714427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855506|NCT01714427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64855650|NCT01715311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855651|NCT01715363|Leucovorin|leucovorin|mesh-list
64624137|NCT00089128|Immunologic Factors|immunologic factors|mesh-ancestor
64855652|NCT01715363|Folic Acid|folic acid|mesh-list
64855653|NCT01715363|Oxaliplatin|oxaliplatin|mesh-list
64855654|NCT01715363|Levoleucovorin|levoleucovorin|mesh-list
64855655|NCT01715363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855656|NCT01715363|Antidotes|antidotes|mesh-ancestor
64855657|NCT01715363|Protective Agents|protective agents|mesh-ancestor
64855658|NCT01715363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855659|NCT01715363|Vitamin B Complex|vitamin b complex|mesh-ancestor
64855660|NCT01715363|Vitamins|vitamins|mesh-ancestor
64855661|NCT01715363|Micronutrients|micronutrients|mesh-ancestor
64855691|NCT01715584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64855692|NCT01715584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855694|NCT01715584|Analgesics|analgesics|mesh-ancestor
64855695|NCT01715584|Sensory System Agents|sensory system agents|mesh-ancestor
64855696|NCT01715584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64855697|NCT01715597|Ascorbic Acid|ascorbic acid|mesh-list
64855698|NCT01715597|Antioxidants|antioxidants|mesh-ancestor
64855699|NCT01715597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855700|NCT01715597|Protective Agents|protective agents|mesh-ancestor
64855701|NCT01715597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855702|NCT01715597|Vitamins|vitamins|mesh-ancestor
64855703|NCT01715597|Micronutrients|micronutrients|mesh-ancestor
64855704|NCT01715610|Clindamycin|clindamycin|mesh-list
64855705|NCT01715610|Clindamycin palmitate|clindamycin palmitate|mesh-list
64855706|NCT01715610|Clindamycin phosphate|clindamycin phosphate|mesh-list
64855758|NCT01715922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64855759|NCT01715922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855760|NCT01715922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64855761|NCT01715922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64855762|NCT01715922|Antimetabolites|antimetabolites|mesh-ancestor
65494773|NCT01075529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65494774|NCT01075529|Serotonin Agents|serotonin agents|mesh-ancestor
65494775|NCT01075529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855774|NCT01715987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855775|NCT01715987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855776|NCT01715987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64855777|NCT01715987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64855778|NCT01716260|Chloroquine|chloroquine|mesh-list
64855780|NCT01716260|Amebicides|amebicides|mesh-ancestor
64855781|NCT01716260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64855782|NCT01716260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64855783|NCT01716260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855784|NCT01716260|Antimalarials|antimalarials|mesh-ancestor
64855785|NCT01716260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64855786|NCT01716273|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64855787|NCT01716273|Laxatives|laxatives|mesh-ancestor
64855788|NCT01716273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64855789|NCT01716338|Glyburide|glyburide|mesh-list
64855790|NCT01716338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64855791|NCT01716338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855792|NCT01716377|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64855793|NCT01716377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64855794|NCT01716377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64855795|NCT01716377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64855796|NCT01716377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855797|NCT01716377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64855798|NCT01716377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855851|NCT01716637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64855852|NCT01716637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855854|NCT01716637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64855855|NCT01716637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64855856|NCT01716637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64855857|NCT01716637|Immunologic Factors|immunologic factors|mesh-ancestor
64855858|NCT01716637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855859|NCT01716637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855860|NCT01716637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855861|NCT01716637|Antioxidants|antioxidants|mesh-ancestor
64855862|NCT01716637|Protective Agents|protective agents|mesh-ancestor
64855863|NCT01716637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64855864|NCT01716689|Cyclophosphamide|cyclophosphamide|mesh-list
64855865|NCT01716689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64855885|NCT01716858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855916|NCT01717157|Sensory System Agents|sensory system agents|mesh-ancestor
64855917|NCT01717157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64855918|NCT01717157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64855919|NCT01717157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64855920|NCT01717157|Anesthetics, General|anesthetics, general|mesh-ancestor
64855922|NCT01717222|Lidocaine|lidocaine|mesh-list
64855939|NCT01717235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64855940|NCT01717235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855941|NCT01717235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855943|NCT01717300|Anacetrapib|anacetrapib|mesh-list
64855944|NCT01717300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64855945|NCT01717300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64856064|NCT01718236|Neostigmine|neostigmine|mesh-list
64856065|NCT01718236|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64856066|NCT01718236|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64856067|NCT01718236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64856068|NCT01718236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64856120|NCT01718314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64856152|NCT01718379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856154|NCT01718379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64856155|NCT01718379|Growth Substances|growth substances|mesh-ancestor
64856156|NCT01718379|Growth Inhibitors|growth inhibitors|mesh-ancestor
64856157|NCT01718379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856158|NCT01718496|Morphine|morphine|mesh-list
64856159|NCT01718496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64856160|NCT01718496|Narcotics|narcotics|mesh-ancestor
64856161|NCT01718496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64856162|NCT01718496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274008|NCT03582293|Coagulants|coagulants|mesh-ancestor
65274009|NCT03574337|Neostigmine|neostigmine|mesh-list
64856163|NCT01718496|Analgesics|analgesics|mesh-ancestor
64856164|NCT01718496|Sensory System Agents|sensory system agents|mesh-ancestor
64856165|NCT01718496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64856166|NCT01718587|Lamivudine|lamivudine|mesh-list
64856196|NCT01718626|Mitosis Modulators|mitosis modulators|mesh-ancestor
64856197|NCT01718626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856198|NCT01718652|Canagliflozin|canagliflozin|mesh-list
64856314|NCT01719185|Micronutrients|micronutrients|mesh-ancestor
64856315|NCT01719302|Gemcitabine|gemcitabine|mesh-list
64856449|NCT01719926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64856450|NCT01719926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64856451|NCT01719926|Analgesics|analgesics|mesh-ancestor
64856452|NCT01719926|Sensory System Agents|sensory system agents|mesh-ancestor
64856453|NCT01719926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64856454|NCT01719926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856505|NCT01720537|Immunologic Factors|immunologic factors|mesh-ancestor
64856506|NCT01720537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856508|NCT01720719|Atorvastatin|atorvastatin|mesh-list
64856509|NCT01720719|Vitamins|vitamins|mesh-ancestor
64856510|NCT01720719|Micronutrients|micronutrients|mesh-ancestor
64856511|NCT01720719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856512|NCT01720719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64856513|NCT01720719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64856514|NCT01720719|Antimetabolites|antimetabolites|mesh-ancestor
64856515|NCT01720719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856516|NCT01720719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64856517|NCT01720719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65494784|NCT01073891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65494785|NCT01073891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494786|NCT01073891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65494787|NCT01073891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64472937|NCT02025010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472938|NCT02025010|Hormone Antagonists|hormone antagonists|mesh-ancestor
64472939|NCT02025010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64472940|NCT02025010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472941|NCT02025010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64472942|NCT02020694|Vitamin D|vitamin d|mesh-list
64856518|NCT01720719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856519|NCT01720719|Antioxidants|antioxidants|mesh-ancestor
64856520|NCT01720719|Protective Agents|protective agents|mesh-ancestor
64856552|NCT01724229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64856553|NCT01724450|Carvedilol|carvedilol|mesh-list
64856554|NCT01724450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64856555|NCT01724450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64856751|NCT01730508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856753|NCT01730612|Glycine|glycine|mesh-list
64856754|NCT01730612|Histamine Agonists|histamine agonists|mesh-ancestor
64856755|NCT01730612|Histamine Agents|histamine agents|mesh-ancestor
64856756|NCT01730612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64856757|NCT01730612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856758|NCT01730612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856759|NCT01730612|Glycine Agents|glycine agents|mesh-ancestor
64856760|NCT01730664|Ertapenem|ertapenem|mesh-list
64856761|NCT01730664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64856762|NCT01730664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64856763|NCT01730677|Vinorelbine|vinorelbine|mesh-list
64856764|NCT01730677|Lapatinib|lapatinib|mesh-list
64856765|NCT01730677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64856766|NCT01730677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856767|NCT01730677|Tubulin Modulators|tubulin modulators|mesh-ancestor
64856768|NCT01730677|Antimitotic Agents|antimitotic agents|mesh-ancestor
64856769|NCT01730677|Mitosis Modulators|mitosis modulators|mesh-ancestor
64856770|NCT01730677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856810|NCT01731067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64856914|NCT01731561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856915|NCT01731561|Immunologic Factors|immunologic factors|mesh-ancestor
64856916|NCT01731561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856917|NCT01731561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64856918|NCT01731574|Dapivirine|dapivirine|mesh-list
64856919|NCT01731574|Miconazole|miconazole|mesh-list
64856920|NCT01731574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64856921|NCT01731574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64856922|NCT01731574|Antiviral Agents|antiviral agents|mesh-ancestor
64856923|NCT01731574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64856924|NCT01731574|Antifungal Agents|antifungal agents|mesh-ancestor
64856925|NCT01731574|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65494788|NCT01073891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402587|NCT03062501|Antisickling Agents|antisickling agents|mesh-ancestor
64856963|NCT01731756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856964|NCT01731756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64856995|NCT01731925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64856997|NCT01731925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856998|NCT01731925|Growth Inhibitors|growth inhibitors|mesh-ancestor
64856999|NCT01731925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64857000|NCT01731925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857001|NCT01731925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857002|NCT01732055|Antidepressive Agents|antidepressive agents|mesh-list
64857003|NCT01732055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64857004|NCT01732068|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64857005|NCT01732068|Luteolytic Agents|luteolytic agents|mesh-ancestor
64857006|NCT01732068|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64857007|NCT01732068|Contraceptive Agents|contraceptive agents|mesh-ancestor
64857008|NCT01732068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64857069|NCT01732380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857071|NCT01732380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857073|NCT01732393|Antioxidants|antioxidants|mesh-ancestor
64857074|NCT01732393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857075|NCT01732393|Protective Agents|protective agents|mesh-ancestor
64857076|NCT01732393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857077|NCT01732666|Remifentanil|remifentanil|mesh-list
64857078|NCT01732666|Nefopam|nefopam|mesh-list
64857079|NCT01732666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64857080|NCT01732666|Narcotics|narcotics|mesh-ancestor
64857081|NCT01732666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64857082|NCT01732666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857083|NCT01732666|Analgesics|analgesics|mesh-ancestor
64857084|NCT01732666|Sensory System Agents|sensory system agents|mesh-ancestor
64857085|NCT01732666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857086|NCT01732666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64857087|NCT01732744|Sodium Hypochlorite|sodium hypochlorite|mesh-list
64857088|NCT01732744|Eusol|eusol|mesh-list
64857089|NCT01732744|Castor Oil|castor oil|mesh-list
64857090|NCT01732744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64857091|NCT01732744|Disinfectants|disinfectants|mesh-ancestor
64857092|NCT01732744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64857168|NCT01733394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857170|NCT01733394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64857171|NCT01733394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64857172|NCT01733394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64857173|NCT01733394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64857174|NCT01733459|Metformin|metformin|mesh-list
64857175|NCT01733459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64857176|NCT01733459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857177|NCT01733485|Aspirin|aspirin|mesh-list
64857178|NCT01733485|Indomethacin|indomethacin|mesh-list
64857179|NCT01733485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64857180|NCT01733485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64857224|NCT01733823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64857225|NCT01733823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64857227|NCT01733836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65494795|NCT01073891|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65494796|NCT01073891|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65494797|NCT01073891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64857228|NCT01733836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857229|NCT01733966|Amoxicillin|amoxicillin|mesh-list
64857230|NCT01733966|Clavulanic Acids|clavulanic acids|mesh-list
64857231|NCT01733966|Clavulanic Acid|clavulanic acid|mesh-list
64857261|NCT01734044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64857262|NCT01734044|Glucocorticoids|glucocorticoids|mesh-ancestor
64857264|NCT01734044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64857265|NCT01734044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64857266|NCT01734044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64857267|NCT01734044|Protease Inhibitors|protease inhibitors|mesh-ancestor
64857268|NCT01734044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857269|NCT01734044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857270|NCT01734057|Dexamethasone|dexamethasone|mesh-list
64857271|NCT01734057|Rituximab|rituximab|mesh-list
64857272|NCT01734057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65274010|NCT03574337|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64857273|NCT01734057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64857274|NCT01734057|Immunologic Factors|immunologic factors|mesh-ancestor
64857275|NCT01734057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857276|NCT01734057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64857277|NCT01734057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64857278|NCT01734057|Antiemetics|antiemetics|mesh-ancestor
64857304|NCT01734330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857306|NCT01734330|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64857307|NCT01734330|Cholinergic Agents|cholinergic agents|mesh-ancestor
64857308|NCT01734330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64625802|NCT00001354|Analgesics|analgesics|mesh-ancestor
64857309|NCT01734330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857310|NCT01734408|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64857311|NCT01734408|Aluminum sulfate|aluminum sulfate|mesh-list
64857312|NCT01734408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64857313|NCT01734408|Immunologic Factors|immunologic factors|mesh-ancestor
64857314|NCT01734408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857316|NCT01734408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857317|NCT01734408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64857318|NCT01734473|Caseins|caseins|mesh-list
64857319|NCT01734473|Chelating Agents|chelating agents|mesh-ancestor
64857320|NCT01734473|Sequestering Agents|sequestering agents|mesh-ancestor
64857321|NCT01734473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857322|NCT01734564|Poly I-C|poly i-c|mesh-list
64857323|NCT01734564|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64857324|NCT01734564|Poly ICLC|poly iclc|mesh-list
64857325|NCT01734564|Interferon Inducers|interferon inducers|mesh-ancestor
64857438|NCT01735240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64857439|NCT01735240|Hormone Antagonists|hormone antagonists|mesh-ancestor
64857440|NCT01735240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64857441|NCT01735240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857442|NCT01735240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64857443|NCT01735318|Lisinopril|lisinopril|mesh-list
64857444|NCT01735318|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64857445|NCT01735318|Protease Inhibitors|protease inhibitors|mesh-ancestor
64857446|NCT01735318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857447|NCT01735318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857462|NCT01735370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64857463|NCT01735370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64857464|NCT01735370|Analgesics|analgesics|mesh-ancestor
64857465|NCT01735370|Sensory System Agents|sensory system agents|mesh-ancestor
64857466|NCT01735370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857467|NCT01735370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857468|NCT01735370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64857469|NCT01735370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64857500|NCT01735669|Narcotics|narcotics|mesh-ancestor
64857501|NCT01735669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64857502|NCT01735669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857503|NCT01735669|Analgesics|analgesics|mesh-ancestor
64857504|NCT01735669|Sensory System Agents|sensory system agents|mesh-ancestor
64857505|NCT01735669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857510|NCT01735747|Vincristine|vincristine|mesh-list
64857511|NCT01735747|Temozolomide|temozolomide|mesh-list
64857512|NCT01735747|Nedaplatin|nedaplatin|mesh-list
64857513|NCT01735747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64857514|NCT01735747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64857515|NCT01735747|Tubulin Modulators|tubulin modulators|mesh-ancestor
64857516|NCT01735747|Antimitotic Agents|antimitotic agents|mesh-ancestor
64857517|NCT01735747|Mitosis Modulators|mitosis modulators|mesh-ancestor
64857551|NCT01736020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64857552|NCT01736020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64857553|NCT01736020|Adrenergic Agents|adrenergic agents|mesh-ancestor
64857554|NCT01736020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64857555|NCT01736020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857556|NCT01736020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64857557|NCT01736020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64857558|NCT01736020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64857559|NCT01736020|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64857560|NCT01736033|Tamsulosin|tamsulosin|mesh-list
64857561|NCT01736033|Finasteride|finasteride|mesh-list
64857562|NCT01736033|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64857563|NCT01736033|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65274011|NCT03574337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274012|NCT03574337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274013|NCT03574337|Cholinergic Agents|cholinergic agents|mesh-ancestor
65274014|NCT03574337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65274015|NCT03574337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274016|NCT03574337|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65274017|NCT03574337|Autonomic Agents|autonomic agents|mesh-ancestor
64857564|NCT01736033|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64857565|NCT01736033|Adrenergic Agents|adrenergic agents|mesh-ancestor
64857566|NCT01736033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64857567|NCT01736033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857568|NCT01736033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857569|NCT01736033|Urological Agents|urological agents|mesh-ancestor
64857570|NCT01736033|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64857571|NCT01736033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64857572|NCT01736033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857573|NCT01736033|Hormone Antagonists|hormone antagonists|mesh-ancestor
64857574|NCT01736033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64857575|NCT01736150|Sevelamer|sevelamer|mesh-list
64857576|NCT01736150|Chelating Agents|chelating agents|mesh-ancestor
64857577|NCT01736150|Sequestering Agents|sequestering agents|mesh-ancestor
64857578|NCT01736150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857579|NCT01736163|Hormones|hormones|mesh-list
64857580|NCT01736163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64857581|NCT01736163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857582|NCT01736371|Propofol|propofol|mesh-list
64857583|NCT01736371|Sevoflurane|sevoflurane|mesh-list
64857584|NCT01736371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64857585|NCT01736371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64857618|NCT01736488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857619|NCT01736488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857620|NCT01736488|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64857621|NCT01736488|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64857622|NCT01736488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64857623|NCT01736488|Adrenergic Agents|adrenergic agents|mesh-ancestor
64857624|NCT01736488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64857625|NCT01736488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857626|NCT01736514|Allopurinol|allopurinol|mesh-list
64857628|NCT01736514|Antimetabolites|antimetabolites|mesh-ancestor
64857629|NCT01736514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857630|NCT01736514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857631|NCT01736514|Gout Suppressants|gout suppressants|mesh-ancestor
64857632|NCT01736514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64857633|NCT01736514|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64857634|NCT01736514|Antioxidants|antioxidants|mesh-ancestor
64857635|NCT01736514|Protective Agents|protective agents|mesh-ancestor
64857636|NCT01736514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857637|NCT01736670|Triamcinolone|triamcinolone|mesh-list
64857638|NCT01736670|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64857639|NCT01736670|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64857640|NCT01736670|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64857641|NCT01736670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64857642|NCT01736670|Glucocorticoids|glucocorticoids|mesh-ancestor
64857644|NCT01736670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64857645|NCT01736670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857646|NCT01736670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64857647|NCT01736670|Immunologic Factors|immunologic factors|mesh-ancestor
64857648|NCT01736670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857649|NCT01736670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857650|NCT01736761|Ritonavir|ritonavir|mesh-list
64857651|NCT01736761|Darunavir|darunavir|mesh-list
64857652|NCT01736761|Rilpivirine|rilpivirine|mesh-list
64857686|NCT01736878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64857687|NCT01736878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857688|NCT01736878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857690|NCT01736891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64857691|NCT01736891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857692|NCT01736891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857693|NCT01736891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64857694|NCT01736891|Protective Agents|protective agents|mesh-ancestor
64857695|NCT01736891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857696|NCT01737008|Cisplatin|cisplatin|mesh-list
64857697|NCT01737008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64857698|NCT01737073|Analgesics, Opioid|analgesics, opioid|mesh-list
64857699|NCT01737073|Narcotics|narcotics|mesh-ancestor
64857700|NCT01737073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64857701|NCT01737073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857702|NCT01737073|Analgesics|analgesics|mesh-ancestor
64857703|NCT01737073|Sensory System Agents|sensory system agents|mesh-ancestor
64857704|NCT01737073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857705|NCT01737086|Zinc Sulfate|zinc sulfate|mesh-list
64857706|NCT01737086|Astringents|astringents|mesh-ancestor
64857707|NCT01737086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857708|NCT01737086|Dermatologic Agents|dermatologic agents|mesh-ancestor
64857709|NCT01737112|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
64857710|NCT01737112|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64857753|NCT01737346|Procarbazine|procarbazine|mesh-list
64857754|NCT01737346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64857755|NCT01737346|Alkylating Agents|alkylating agents|mesh-ancestor
64857756|NCT01737346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857757|NCT01737346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64857758|NCT01737359|Tenofovir|tenofovir|mesh-list
64857759|NCT01737359|Antiviral Agents|antiviral agents|mesh-ancestor
64857760|NCT01737359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64857761|NCT01737359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64857762|NCT01737359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64857763|NCT01737359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857764|NCT01737359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857765|NCT01737359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64857766|NCT01737359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64857767|NCT01737411|Solifenacin Succinate|solifenacin succinate|mesh-list
64857768|NCT01737411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64857769|NCT01737411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64857770|NCT01737411|Cholinergic Agents|cholinergic agents|mesh-ancestor
64857803|NCT01737671|Immunologic Factors|immunologic factors|mesh-ancestor
64857804|NCT01737671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64857805|NCT01737671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64857806|NCT01737671|Antidotes|antidotes|mesh-ancestor
64857807|NCT01737671|Protective Agents|protective agents|mesh-ancestor
64857808|NCT01737671|Vitamin B Complex|vitamin b complex|mesh-ancestor
65494798|NCT00209027|Aripiprazole|aripiprazole|mesh-list
64857809|NCT01737671|Vitamins|vitamins|mesh-ancestor
64857810|NCT01737671|Micronutrients|micronutrients|mesh-ancestor
64857811|NCT01737918|Solifenacin Succinate|solifenacin succinate|mesh-list
64857812|NCT01737918|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64857813|NCT01737918|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64857814|NCT01737918|Cholinergic Agents|cholinergic agents|mesh-ancestor
64857815|NCT01737918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64857816|NCT01737918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857817|NCT01737918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857818|NCT01737918|Urological Agents|urological agents|mesh-ancestor
64857819|NCT01738035|Budesonide|budesonide|mesh-list
64403228|NCT04418531|Antibodies|antibodies|mesh-list
64857855|NCT01738100|Analgesics|analgesics|mesh-ancestor
64857856|NCT01738100|Sensory System Agents|sensory system agents|mesh-ancestor
64857857|NCT01738100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857858|NCT01738100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64857859|NCT01738100|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64857860|NCT01738100|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64857861|NCT01738100|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64857862|NCT01738100|Purinergic Agents|purinergic agents|mesh-ancestor
64857863|NCT01738100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64857864|NCT01738100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857865|NCT01738178|Caffeine|caffeine|mesh-list
64857866|NCT01738178|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64857867|NCT01738178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857868|NCT01738178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64857869|NCT01738178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857870|NCT01738178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571748|NCT01452737|Cathartics|cathartics|mesh-ancestor
64857890|NCT01738282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857891|NCT01738295|Donepezil|donepezil|mesh-list
64857892|NCT01738295|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64857893|NCT01738295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857894|NCT01738295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857895|NCT01738295|Cholinergic Agents|cholinergic agents|mesh-ancestor
64857896|NCT01738295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64857897|NCT01738295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857898|NCT01738295|Nootropic Agents|nootropic agents|mesh-ancestor
64857899|NCT01738360|Arsenic Trioxide|arsenic trioxide|mesh-list
64857900|NCT01738360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64857901|NCT01738373|Plerixafor|plerixafor|mesh-list
64857902|NCT01738373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64857903|NCT01738373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64857904|NCT01738373|Antiviral Agents|antiviral agents|mesh-ancestor
64857905|NCT01738373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64857906|NCT01738425|Hydrogen Sulfide|hydrogen sulfide|mesh-list
64857907|NCT01738425|Gasotransmitters|gasotransmitters|mesh-ancestor
64857908|NCT01738425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64857909|NCT01738425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857910|NCT01738425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857911|NCT01738451|Dabrafenib|dabrafenib|mesh-list
64857912|NCT01738451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64857947|NCT01738763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857949|NCT01738802|Trace Elements|trace elements|mesh-list
64857950|NCT01738802|Antioxidants|antioxidants|mesh-list
64857951|NCT01738802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857952|NCT01738802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857953|NCT01738802|Protective Agents|protective agents|mesh-ancestor
64857960|NCT01738815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857961|NCT01738815|Antimanic Agents|antimanic agents|mesh-ancestor
64857962|NCT01738815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64857996|NCT01739049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857997|NCT01739049|Incretins|incretins|mesh-ancestor
64857998|NCT01739049|Hormones|hormones|mesh-ancestor
64857999|NCT01739049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64858000|NCT01739127|Risperidone|risperidone|mesh-list
64858001|NCT01739127|Aripiprazole|aripiprazole|mesh-list
64858002|NCT01739127|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64858003|NCT01739127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64858004|NCT01739127|Serotonin Agents|serotonin agents|mesh-ancestor
64858040|NCT01739218|Antimitotic Agents|antimitotic agents|mesh-ancestor
64858041|NCT01739218|Mitosis Modulators|mitosis modulators|mesh-ancestor
64858042|NCT01739218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858043|NCT01739218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64858044|NCT01739218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64858045|NCT01739218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64858046|NCT01739218|Growth Substances|growth substances|mesh-ancestor
64858047|NCT01739218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858048|NCT01739218|Growth Inhibitors|growth inhibitors|mesh-ancestor
64858049|NCT01739413|Anesthetics|anesthetics|mesh-list
64858050|NCT01739413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64858051|NCT01739413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858052|NCT01739439|Gemcitabine|gemcitabine|mesh-list
64858053|NCT01739439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64858054|NCT01739439|Antimetabolites|antimetabolites|mesh-ancestor
64858067|NCT01739556|Ticagrelor|ticagrelor|mesh-list
64858068|NCT01739556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64858069|NCT01739556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64858070|NCT01739556|Analgesics|analgesics|mesh-ancestor
64858071|NCT01739556|Sensory System Agents|sensory system agents|mesh-ancestor
64858072|NCT01739556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858073|NCT01739556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858074|NCT01739556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64858075|NCT01739556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64858076|NCT01739556|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64858077|NCT01739556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64858078|NCT01739556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858079|NCT01739556|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64858080|NCT01739556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64858081|NCT01739556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858082|NCT01739556|Antipyretics|antipyretics|mesh-ancestor
64858083|NCT01739556|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64858084|NCT01739556|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64794703|NCT02242656|Opium|opium|mesh-list
64858085|NCT01739556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64858093|NCT01739582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64858094|NCT01739582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858095|NCT01739582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64858096|NCT01739582|Fertility Agents|fertility agents|mesh-ancestor
64858097|NCT01739582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64858098|NCT01739582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64858099|NCT01739582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64858100|NCT01739634|Antidiarrheals|antidiarrheals|mesh-list
64858101|NCT01739634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
64858102|NCT01739634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64858103|NCT01739673|Riboflavin|riboflavin|mesh-list
64858104|NCT01739673|Vitamin B Complex|vitamin b complex|mesh-ancestor
64858105|NCT01739673|Vitamins|vitamins|mesh-ancestor
64858106|NCT01739673|Micronutrients|micronutrients|mesh-ancestor
64858107|NCT01739673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858108|NCT01739673|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64858109|NCT01739673|Dermatologic Agents|dermatologic agents|mesh-ancestor
64858110|NCT01739855|Ergocalciferols|ergocalciferols|mesh-list
64858111|NCT01739855|Calcium Carbonate|calcium carbonate|mesh-list
64858112|NCT01739855|Calcium|calcium|mesh-list
64858113|NCT01739855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64858114|NCT01739855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858115|NCT01739855|Antacids|antacids|mesh-ancestor
64858116|NCT01739855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858117|NCT01739855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64858118|NCT01739855|Vitamins|vitamins|mesh-ancestor
64858119|NCT01739855|Micronutrients|micronutrients|mesh-ancestor
64858120|NCT01739855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64858121|NCT01739894|Paclitaxel|paclitaxel|mesh-list
64858122|NCT01739894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64858123|NCT01739894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64858133|NCT01739920|Povidone-Iodine|povidone-iodine|mesh-list
64858134|NCT01739920|Povidone|povidone|mesh-list
64858135|NCT01739920|Plasma Substitutes|plasma substitutes|mesh-ancestor
64858136|NCT01739920|Blood Substitutes|blood substitutes|mesh-ancestor
64858137|NCT01739920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64858138|NCT01739920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64858139|NCT01739985|Dexamethasone|dexamethasone|mesh-list
64858140|NCT01739985|Dexamethasone acetate|dexamethasone acetate|mesh-list
64858141|NCT01739985|Droperidol|droperidol|mesh-list
64858142|NCT01739985|Ondansetron|ondansetron|mesh-list
64858143|NCT01739985|BB 1101|bb 1101|mesh-list
64858144|NCT01739985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64858145|NCT01739985|Antiemetics|antiemetics|mesh-ancestor
64858146|NCT01739985|Autonomic Agents|autonomic agents|mesh-ancestor
64858147|NCT01739985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858148|NCT01739985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858149|NCT01739985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64858150|NCT01739985|Glucocorticoids|glucocorticoids|mesh-ancestor
64858151|NCT01739985|Hormones|hormones|mesh-ancestor
64858152|NCT01739985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64858153|NCT01739985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64858154|NCT01739985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64858155|NCT01739985|Protease Inhibitors|protease inhibitors|mesh-ancestor
64858156|NCT01739985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858157|NCT01739985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858161|NCT01739985|Serotonin Agents|serotonin agents|mesh-ancestor
64858162|NCT01739985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64858163|NCT01739985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64858164|NCT01739985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64858165|NCT01739985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64858166|NCT01739985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64858167|NCT01739985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64858168|NCT01739985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64858169|NCT01739985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64858170|NCT01739985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64472947|NCT02020694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472948|NCT02020694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64472949|NCT02020694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64472951|NCT02019875|Rifampin|rifampin|mesh-list
64472952|NCT02019875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64472953|NCT02019875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64571975|NCT01458041|Iloprost|iloprost|mesh-list
64858171|NCT01739985|Dopamine Agents|dopamine agents|mesh-ancestor
64858172|NCT01740245|Biguanides|biguanides|mesh-list
65274018|NCT03574337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858173|NCT01740245|Chlorhexidine|chlorhexidine|mesh-list
64858174|NCT01740245|Polihexanide|polihexanide|mesh-list
64858175|NCT01740245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64626714|NCT00002194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64858176|NCT01740245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64858177|NCT01740245|Disinfectants|disinfectants|mesh-ancestor
64858178|NCT01740245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64858179|NCT01740245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858180|NCT01740271|Epirubicin|epirubicin|mesh-list
64858181|NCT01740271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64858182|NCT01740271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64858183|NCT01740271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64858184|NCT01740271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64858185|NCT01740271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858186|NCT01740271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858216|NCT01740921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64858217|NCT01740921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64858218|NCT01740921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64858219|NCT01740921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64858220|NCT01740921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858221|NCT01740921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64858222|NCT01740921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64858223|NCT01740921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858224|NCT01740921|Antipyretics|antipyretics|mesh-ancestor
64858225|NCT01740921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64858226|NCT01740921|Incretins|incretins|mesh-ancestor
64858228|NCT01740921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64858229|NCT01740947|Amphotericin B|amphotericin b|mesh-list
65494800|NCT00209027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64858230|NCT01740947|Tobramycin|tobramycin|mesh-list
65494801|NCT00209027|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64858257|NCT01741077|Hematinics|hematinics|mesh-ancestor
64858258|NCT01741077|Vitamin B Complex|vitamin b complex|mesh-ancestor
64858260|NCT01741077|Micronutrients|micronutrients|mesh-ancestor
64858261|NCT01741077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858262|NCT01741142|Citalopram|citalopram|mesh-list
64858263|NCT01741142|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64858264|NCT01741142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64858265|NCT01741142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64858266|NCT01741142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858267|NCT01741142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64858268|NCT01741142|Serotonin Agents|serotonin agents|mesh-ancestor
64858269|NCT01741142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858270|NCT01741142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64858271|NCT01741142|Antidepressive Agents|antidepressive agents|mesh-ancestor
64858272|NCT01741142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64858273|NCT01741181|Vitamin D|vitamin d|mesh-list
64858274|NCT01741181|Ergocalciferols|ergocalciferols|mesh-list
64858275|NCT01741181|Cholecalciferol|cholecalciferol|mesh-list
64858276|NCT01741181|Vitamins|vitamins|mesh-list
64858277|NCT01741181|Micronutrients|micronutrients|mesh-ancestor
64858278|NCT01741181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472954|NCT02019875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64858326|NCT01741506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64858327|NCT01741506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858328|NCT01741519|Landiolol|landiolol|mesh-list
64858329|NCT01741519|Esmolol|esmolol|mesh-list
64858330|NCT01741519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64858331|NCT01741519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64858332|NCT01741519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64858352|NCT01741558|Immunologic Factors|immunologic factors|mesh-ancestor
64858353|NCT01741558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64858354|NCT01741558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64858355|NCT01741558|Vitamin B Complex|vitamin b complex|mesh-ancestor
64858357|NCT01741558|Micronutrients|micronutrients|mesh-ancestor
64858358|NCT01741558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64858359|NCT01741623|Bisoprolol|bisoprolol|mesh-list
64858360|NCT01741623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64858361|NCT01741623|Sympatholytics|sympatholytics|mesh-ancestor
64858362|NCT01741623|Autonomic Agents|autonomic agents|mesh-ancestor
64858363|NCT01741623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858390|NCT01741831|Antiviral Agents|antiviral agents|mesh-ancestor
64858391|NCT01741831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64858392|NCT01741948|Contraceptive Agents|contraceptive agents|mesh-list
64858393|NCT01741948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64858394|NCT01741948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858396|NCT01742247|Analgesics|analgesics|mesh-ancestor
64858397|NCT01742247|Sensory System Agents|sensory system agents|mesh-ancestor
64858398|NCT01742247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858399|NCT01742247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858400|NCT01742247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64858401|NCT01742247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64858402|NCT01742247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64858403|NCT01742247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64858404|NCT01742247|Antiviral Agents|antiviral agents|mesh-ancestor
64858405|NCT01742247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64858406|NCT01742247|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64626940|NCT01153711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858407|NCT01742247|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64858408|NCT01742247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64858424|NCT01742338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64858425|NCT01742338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64858457|NCT01742390|Antidepressive Agents|antidepressive agents|mesh-ancestor
64858458|NCT01742390|Dopamine Agonists|dopamine agonists|mesh-ancestor
64858459|NCT01742390|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64858460|NCT01742390|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64858461|NCT01742390|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64858490|NCT01742533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858492|NCT01742624|Tacrolimus|tacrolimus|mesh-list
64858493|NCT01742624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64858494|NCT01742624|Immunologic Factors|immunologic factors|mesh-ancestor
64858495|NCT01742624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858496|NCT01742624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64858497|NCT01742624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858498|NCT01742624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858499|NCT01742624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64858500|NCT01742624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64858501|NCT01742624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64858502|NCT01742624|Antitubercular Agents|antitubercular agents|mesh-ancestor
64858503|NCT01742624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64858504|NCT01742624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64858505|NCT01742637|Adapalene|adapalene|mesh-list
64858506|NCT01742637|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64858507|NCT01742637|Dermatologic Agents|dermatologic agents|mesh-ancestor
64858508|NCT01742637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64858509|NCT01742637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64858510|NCT01742637|Analgesics|analgesics|mesh-ancestor
64858511|NCT01742637|Sensory System Agents|sensory system agents|mesh-ancestor
65494809|NCT00209027|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65494810|NCT00209027|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65494811|NCT00209027|Serotonin Agents|serotonin agents|mesh-ancestor
64472957|NCT02019875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64403934|NCT04516993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64858533|NCT01742676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858534|NCT01742676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858535|NCT01742689|Indomethacin|indomethacin|mesh-list
64858536|NCT01742689|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64858537|NCT01742689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64858538|NCT01742689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64858539|NCT01742689|Analgesics|analgesics|mesh-ancestor
64858540|NCT01742689|Sensory System Agents|sensory system agents|mesh-ancestor
64858541|NCT01742689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858542|NCT01742689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858548|NCT01742689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64858549|NCT01742689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858550|NCT01742689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858552|NCT01742689|Coagulants|coagulants|mesh-ancestor
64858553|NCT01742689|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64858554|NCT01742689|Natriuretic Agents|natriuretic agents|mesh-ancestor
64858555|NCT01742702|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
64858556|NCT01742702|Bisoprolol|bisoprolol|mesh-list
64858557|NCT01742702|Nitroglycerin|nitroglycerin|mesh-list
64858558|NCT01742702|Albuterol|albuterol|mesh-list
64858559|NCT01742702|Caseins|caseins|mesh-list
64858560|NCT01742702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64858561|NCT01742702|Autonomic Agents|autonomic agents|mesh-ancestor
64858562|NCT01742702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858563|NCT01742702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274019|NCT02689596|Oxytocin|oxytocin|mesh-list
64858564|NCT01742702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64858565|NCT01742702|Respiratory System Agents|respiratory system agents|mesh-ancestor
64858566|NCT01742702|Tocolytic Agents|tocolytic agents|mesh-ancestor
64858567|NCT01742702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64858568|NCT01742702|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64858569|NCT01742702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64858570|NCT01742702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64858603|NCT01742845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64858604|NCT01742845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858605|NCT01742845|Sensory System Agents|sensory system agents|mesh-ancestor
64858606|NCT01742845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858607|NCT01742988|Rituximab|rituximab|mesh-list
64858650|NCT01743144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858651|NCT01743144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858652|NCT01743144|Anesthetics|anesthetics|mesh-ancestor
64858653|NCT01743144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64858654|NCT01743144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64858655|NCT01743144|Anticonvulsants|anticonvulsants|mesh-ancestor
64858656|NCT01743144|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64858657|NCT01743144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64858658|NCT01743144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858659|NCT01743144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64858660|NCT01743144|Tocolytic Agents|tocolytic agents|mesh-ancestor
64858661|NCT01743144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64858662|NCT01743157|Bevacizumab|bevacizumab|mesh-list
64858663|NCT01743157|Ipilimumab|ipilimumab|mesh-list
64858664|NCT01743157|Interleukin-2|interleukin-2|mesh-list
64858665|NCT01743157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64858666|NCT01743157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64858667|NCT01743157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64858668|NCT01743157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64858676|NCT01743157|Sensory System Agents|sensory system agents|mesh-ancestor
64858677|NCT01743157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858678|NCT01743235|Buspirone|buspirone|mesh-list
64858679|NCT01743235|Testosterone|testosterone|mesh-list
64858680|NCT01743235|Androgens|androgens|mesh-ancestor
64858681|NCT01743235|Hormones|hormones|mesh-ancestor
64858682|NCT01743235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64858683|NCT01743235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858684|NCT01743235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64858685|NCT01743235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64858693|NCT01743300|Midazolam|midazolam|mesh-list
64858694|NCT01743300|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64858695|NCT01743300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64858696|NCT01743300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64858697|NCT01743300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858698|NCT01743300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64858699|NCT01743300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64858700|NCT01743300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64858701|NCT01743300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64858702|NCT01743300|Anesthetics, General|anesthetics, general|mesh-ancestor
64858703|NCT01743300|Anesthetics|anesthetics|mesh-ancestor
64858704|NCT01743300|GABA Modulators|gaba modulators|mesh-ancestor
64858705|NCT01743300|GABA Agents|gaba agents|mesh-ancestor
64858706|NCT01743300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64858707|NCT01743300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858708|NCT01743300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64858709|NCT01743300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64858710|NCT01743300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64858711|NCT01743300|Growth Substances|growth substances|mesh-ancestor
64858712|NCT01743300|Growth Inhibitors|growth inhibitors|mesh-ancestor
64858713|NCT01743300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64858714|NCT01743300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858715|NCT01743326|Anesthetics|anesthetics|mesh-list
64858716|NCT01743326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64858717|NCT01743326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858719|NCT01743365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64858720|NCT01743365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64858721|NCT01743365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858722|NCT01743365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858723|NCT01743378|Ropivacaine|ropivacaine|mesh-list
64858724|NCT01743378|Anesthetics, Local|anesthetics, local|mesh-ancestor
64858725|NCT01743378|Anesthetics|anesthetics|mesh-ancestor
65274020|NCT02689596|Oxytocics|oxytocics|mesh-ancestor
65274021|NCT02689596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64858726|NCT01743378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64858727|NCT01743378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858728|NCT01743378|Sensory System Agents|sensory system agents|mesh-ancestor
64858729|NCT01743378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858730|NCT01743456|Anesthetics|anesthetics|mesh-list
64858731|NCT01743456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64858732|NCT01743456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858733|NCT01743508|Misoprostol|misoprostol|mesh-list
64858734|NCT01743508|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64858735|NCT01743508|Abortifacient Agents|abortifacient agents|mesh-ancestor
64858738|NCT01743508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64858739|NCT01743508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64858740|NCT01743508|Oxytocics|oxytocics|mesh-ancestor
64858741|NCT01743690|Nystatin|nystatin|mesh-list
64858742|NCT01743690|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
64858743|NCT01743690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64858744|NCT01743690|Glucocorticoids|glucocorticoids|mesh-ancestor
64858778|NCT01743820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64858779|NCT01743820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64858790|NCT01743885|Vasodilator Agents|vasodilator agents|mesh-ancestor
64858792|NCT01743885|Autonomic Agents|autonomic agents|mesh-ancestor
64858793|NCT01743885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858794|NCT01743885|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64858795|NCT01743898|Rivaroxaban|rivaroxaban|mesh-list
64858796|NCT01743898|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64858797|NCT01743898|Antithrombins|antithrombins|mesh-ancestor
64858798|NCT01743898|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64858799|NCT01743898|Protease Inhibitors|protease inhibitors|mesh-ancestor
64858800|NCT01743898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858801|NCT01743898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858802|NCT01743898|Anticoagulants|anticoagulants|mesh-ancestor
64858803|NCT01743911|Tadalafil|tadalafil|mesh-list
64858804|NCT01743911|Vasodilator Agents|vasodilator agents|mesh-ancestor
64858805|NCT01743911|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64858806|NCT01743911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64858807|NCT01743911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858808|NCT01743911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858809|NCT01743911|Urological Agents|urological agents|mesh-ancestor
64858810|NCT01744106|Pseudoephedrine|pseudoephedrine|mesh-list
64858817|NCT01744106|Respiratory System Agents|respiratory system agents|mesh-ancestor
64858818|NCT01744106|Nasal Decongestants|nasal decongestants|mesh-ancestor
64858819|NCT01744106|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64858820|NCT01744106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64858822|NCT01744106|Adrenergic Agents|adrenergic agents|mesh-ancestor
64858823|NCT01744106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64858824|NCT01744106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858825|NCT01744184|Midazolam|midazolam|mesh-list
64858826|NCT01744184|Nitrous Oxide|nitrous oxide|mesh-list
64858827|NCT01744184|Entonox|entonox|mesh-list
64858828|NCT01744184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64858829|NCT01744184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64858830|NCT01744184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64858831|NCT01744184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858832|NCT01744184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64858833|NCT01744184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64858834|NCT01744184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64858835|NCT01744184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64858836|NCT01744184|Anesthetics, General|anesthetics, general|mesh-ancestor
64858837|NCT01744184|Anesthetics|anesthetics|mesh-ancestor
64858838|NCT01744184|GABA Modulators|gaba modulators|mesh-ancestor
64858839|NCT01744184|GABA Agents|gaba agents|mesh-ancestor
64858840|NCT01744184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64858841|NCT01744184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858842|NCT01744184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65494818|NCT00206375|Hormones|hormones|mesh-list
65494819|NCT00206375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64472961|NCT02019875|Leprostatic Agents|leprostatic agents|mesh-ancestor
64572567|NCT04842071|Fluorides|fluorides|mesh-list
64858843|NCT01744184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64858844|NCT01744184|Analgesics|analgesics|mesh-ancestor
64858845|NCT01744184|Sensory System Agents|sensory system agents|mesh-ancestor
64858846|NCT01744184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65274022|NCT02689596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274023|NCT04574856|Temozolomide|temozolomide|mesh-list
64472053|NCT03869034|Leucovorin|leucovorin|mesh-list
64858847|NCT01744184|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64858848|NCT01744236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64858883|NCT01744314|Pantoprazole|pantoprazole|mesh-list
64858884|NCT01744314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64858885|NCT01744314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64858886|NCT01744314|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64858887|NCT01744314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858888|NCT01744314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858889|NCT01744314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64858890|NCT01744314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64858891|NCT01744314|Analgesics|analgesics|mesh-ancestor
64858892|NCT01744314|Sensory System Agents|sensory system agents|mesh-ancestor
64858893|NCT01744314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404353|NCT04990921|Pembrolizumab|pembrolizumab|mesh-list
64858911|NCT01744444|Analgesics|analgesics|mesh-ancestor
64858912|NCT01744444|Sensory System Agents|sensory system agents|mesh-ancestor
64858913|NCT01744444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858914|NCT01744444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858915|NCT01744444|Anticonvulsants|anticonvulsants|mesh-ancestor
64858916|NCT01744444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64858917|NCT01744444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64858918|NCT01744444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64858919|NCT01744444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64858920|NCT01744444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64858921|NCT01744444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64858922|NCT01744444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64858923|NCT01744444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858924|NCT01744444|Antimanic Agents|antimanic agents|mesh-ancestor
64858925|NCT01744444|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64858926|NCT01744444|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64858927|NCT01744444|Dopamine Agents|dopamine agents|mesh-ancestor
64858928|NCT01744470|Tacrolimus|tacrolimus|mesh-list
64858929|NCT01744470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64858930|NCT01744470|Immunologic Factors|immunologic factors|mesh-ancestor
64858931|NCT01744470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858932|NCT01744470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64858933|NCT01744470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858934|NCT01744470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858936|NCT01744587|Antioxidants|antioxidants|mesh-ancestor
64858937|NCT01744587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858938|NCT01744587|Protective Agents|protective agents|mesh-ancestor
64858939|NCT01744587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858940|NCT01744587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64858941|NCT01744587|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64858942|NCT01744587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64858943|NCT01744587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64858944|NCT01744756|Bevacizumab|bevacizumab|mesh-list
64858945|NCT01744756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64858946|NCT01744756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64858947|NCT01744756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64858948|NCT01744756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64858949|NCT01744756|Growth Substances|growth substances|mesh-ancestor
64858950|NCT01744756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858951|NCT01744756|Growth Inhibitors|growth inhibitors|mesh-ancestor
64858958|NCT01744873|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64858959|NCT01744873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64404406|NCT04772209|Heparin|heparin|mesh-list
64858970|NCT01744886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858972|NCT01744626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64858973|NCT01744626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64858974|NCT01744626|Immunologic Factors|immunologic factors|mesh-ancestor
64858975|NCT01744626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858976|NCT01744626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64858977|NCT01744964|Apomorphine|apomorphine|mesh-list
64858978|NCT01744964|Emetics|emetics|mesh-ancestor
64858979|NCT01744964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858980|NCT01744964|Autonomic Agents|autonomic agents|mesh-ancestor
64858981|NCT01744964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858982|NCT01744964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65274024|NCT04574856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64858983|NCT01744964|Dopamine Agonists|dopamine agonists|mesh-ancestor
64858984|NCT01744964|Dopamine Agents|dopamine agents|mesh-ancestor
64858985|NCT01744964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64858986|NCT01744964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858987|NCT01745081|Mannitol|mannitol|mesh-list
64858988|NCT01745081|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64858989|NCT01745081|Diuretics|diuretics|mesh-ancestor
64858990|NCT01745081|Natriuretic Agents|natriuretic agents|mesh-ancestor
64858991|NCT01745081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858992|NCT01745159|Tacrolimus|tacrolimus|mesh-list
64858993|NCT01745159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64858994|NCT01745159|Immunologic Factors|immunologic factors|mesh-ancestor
64858995|NCT01745159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858996|NCT01745159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64858997|NCT01745159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858998|NCT01745159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472962|NCT02019875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64472963|NCT02019875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64404486|NCT03954613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64404487|NCT03954613|Dopamine Agents|dopamine agents|mesh-ancestor
64859010|NCT01745302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859012|NCT01745328|Levofloxacin|levofloxacin|mesh-list
64859013|NCT01745328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64859014|NCT01745328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64859015|NCT01745328|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64859016|NCT01745328|Renal Agents|renal agents|mesh-ancestor
64859017|NCT01745328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64859018|NCT01745328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64859019|NCT01745328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859020|NCT01745328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494825|NCT00160199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494826|NCT00157157|Factor VIII|factor viii|mesh-list
65494827|NCT00157157|Coagulants|coagulants|mesh-ancestor
65494828|NCT00203411|Bevacizumab|bevacizumab|mesh-list
65494829|NCT00203411|Capecitabine|capecitabine|mesh-list
65494830|NCT00203411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65494831|NCT00203411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494832|NCT00203411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65494833|NCT00203411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65494834|NCT00203411|Growth Substances|growth substances|mesh-ancestor
65494835|NCT00203411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494836|NCT00203411|Growth Inhibitors|growth inhibitors|mesh-ancestor
65494837|NCT00203411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65494838|NCT00203411|Antimetabolites|antimetabolites|mesh-ancestor
65494839|NCT00203411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494840|NCT00203021|Glatiramer Acetate|glatiramer acetate|mesh-list
65494841|NCT00203021|(T,G)-A-L|(t,g)-a-l|mesh-list
64472982|NCT01907009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64859054|NCT01745601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64859055|NCT01745601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859056|NCT01745601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64859057|NCT01745601|Serotonin Agents|serotonin agents|mesh-ancestor
64859058|NCT01745601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859059|NCT01745601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64859060|NCT01745601|Antidepressive Agents|antidepressive agents|mesh-ancestor
64859061|NCT01745601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64859062|NCT01745601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64859063|NCT01745601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64859064|NCT01745601|Parasympatholytics|parasympatholytics|mesh-ancestor
64859065|NCT01745601|Autonomic Agents|autonomic agents|mesh-ancestor
64859066|NCT01745601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64859067|NCT01745601|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64859068|NCT01745601|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64859069|NCT01745601|Cholinergic Agents|cholinergic agents|mesh-ancestor
64859070|NCT01745614|Nimesulide|nimesulide|mesh-list
64859078|NCT01745614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64859079|NCT01745614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64859080|NCT01745614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859081|NCT01745614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859082|NCT01745640|Dexamethasone|dexamethasone|mesh-list
64859083|NCT01745640|Pomalidomide|pomalidomide|mesh-list
64627640|NCT00002476|Vitamins|vitamins|mesh-ancestor
65274025|NCT04574856|Alkylating Agents|alkylating agents|mesh-ancestor
65274026|NCT04574856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859084|NCT01745640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64859085|NCT01745640|Antiemetics|antiemetics|mesh-ancestor
64859086|NCT01745640|Autonomic Agents|autonomic agents|mesh-ancestor
64859087|NCT01745640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64859088|NCT01745640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859089|NCT01745640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64859090|NCT01745640|Glucocorticoids|glucocorticoids|mesh-ancestor
64859091|NCT01745640|Hormones|hormones|mesh-ancestor
64859102|NCT01745666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64859103|NCT01745666|Adrenergic Agents|adrenergic agents|mesh-ancestor
64859104|NCT01745666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64859105|NCT01745666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859106|NCT01745666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859107|NCT01745666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64859108|NCT01745666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64859109|NCT01745666|Autonomic Agents|autonomic agents|mesh-ancestor
64859110|NCT01745666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64859111|NCT01745666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64859112|NCT01745666|Respiratory System Agents|respiratory system agents|mesh-ancestor
64859113|NCT01745666|Mydriatics|mydriatics|mesh-ancestor
64859114|NCT01745666|Sympathomimetics|sympathomimetics|mesh-ancestor
64859115|NCT01745666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64859116|NCT01745679|Ceftriaxone|ceftriaxone|mesh-list
64859117|NCT01745679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64859118|NCT01745679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64859119|NCT01745692|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64859120|NCT01745692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64859121|NCT01745692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64859122|NCT01745692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859123|NCT01745770|Mesalamine|mesalamine|mesh-list
64859124|NCT01745770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64859125|NCT01745770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64859126|NCT01745770|Analgesics|analgesics|mesh-ancestor
64859127|NCT01745770|Sensory System Agents|sensory system agents|mesh-ancestor
64859128|NCT01745770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64859129|NCT01745770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859130|NCT01745770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64859131|NCT01745770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64859132|NCT01745809|Dimercaprol|dimercaprol|mesh-list
65494842|NCT00203021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64859133|NCT01745809|Chelating Agents|chelating agents|mesh-ancestor
64859134|NCT01745809|Sequestering Agents|sequestering agents|mesh-ancestor
64859135|NCT01745809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859136|NCT01745835|Bisacodyl|bisacodyl|mesh-list
64859137|NCT01745835|Cathartics|cathartics|mesh-ancestor
64859148|NCT01746199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64859149|NCT01746199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64859151|NCT01746199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859152|NCT01746199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64859153|NCT01746199|Renal Agents|renal agents|mesh-ancestor
64859154|NCT01746199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64859155|NCT01746251|Afatinib|afatinib|mesh-list
64859156|NCT01746251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859157|NCT01746251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64859158|NCT01746251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627715|NCT00002488|Etoposide|etoposide|mesh-list
64859159|NCT01746251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859160|NCT01746277|Docetaxel|docetaxel|mesh-list
64859161|NCT01746277|Pemetrexed|pemetrexed|mesh-list
64859162|NCT01746277|Gefitinib|gefitinib|mesh-list
64859186|NCT01746602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859187|NCT01746602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859188|NCT01746602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64859189|NCT01746602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64859190|NCT01746641|Remifentanil|remifentanil|mesh-list
64859191|NCT01746641|Propofol|propofol|mesh-list
64859192|NCT01746641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64859193|NCT01746641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64859194|NCT01746641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859195|NCT01746641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64859196|NCT01746641|Anesthetics, General|anesthetics, general|mesh-ancestor
64859197|NCT01746641|Anesthetics|anesthetics|mesh-ancestor
64859198|NCT01746641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64859199|NCT01746641|Narcotics|narcotics|mesh-ancestor
64859200|NCT01746641|Analgesics|analgesics|mesh-ancestor
64859201|NCT01746641|Sensory System Agents|sensory system agents|mesh-ancestor
64859202|NCT01746641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64859209|NCT01746680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64859210|NCT01746680|Antimetabolites|antimetabolites|mesh-ancestor
64859211|NCT01746680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859212|NCT01746680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859213|NCT01746680|Dermatologic Agents|dermatologic agents|mesh-ancestor
64859214|NCT01746680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859215|NCT01746680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64859216|NCT01746680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64859217|NCT01746680|Immunologic Factors|immunologic factors|mesh-ancestor
64859218|NCT01746680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64859219|NCT01746680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64404715|NCT04910477|Mydriatics|mydriatics|mesh-ancestor
64859294|NCT01746992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64859295|NCT01746992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64859326|NCT01747148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64859327|NCT01747161|Botulinum Toxins|botulinum toxins|mesh-list
64859328|NCT01747161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64859329|NCT01747161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64859337|NCT01747174|Sensory System Agents|sensory system agents|mesh-ancestor
64859338|NCT01747174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404875|NCT03520231|Immunologic Factors|immunologic factors|mesh-ancestor
64859366|NCT01747278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64859367|NCT01747278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64859368|NCT01747278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64859369|NCT01747278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859370|NCT01747278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859371|NCT01747278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64859372|NCT01747278|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64859373|NCT01747278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64859375|NCT01747564|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64859376|NCT01747564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64859377|NCT01747564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64859378|NCT01747564|Adrenergic Agents|adrenergic agents|mesh-ancestor
64859379|NCT01747564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64859380|NCT01747564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859381|NCT01747564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859382|NCT01747564|Urological Agents|urological agents|mesh-ancestor
64627929|NCT00002524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64859383|NCT01747590|Zolpidem|zolpidem|mesh-list
64859384|NCT01747590|Alprazolam|alprazolam|mesh-list
64859385|NCT01747590|Caffeine|caffeine|mesh-list
64404922|NCT03055793|Hormones|hormones|mesh-ancestor
64859420|NCT01747616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64859421|NCT01747616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64859423|NCT01747616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64404973|NCT05132413|Cisplatin|cisplatin|mesh-list
64859453|NCT01747720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64859454|NCT01747720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64859456|NCT01747746|Warfarin|warfarin|mesh-list
64859457|NCT01747746|Rivaroxaban|rivaroxaban|mesh-list
64859458|NCT01747746|Anticoagulants|anticoagulants|mesh-ancestor
64859459|NCT01747746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64859460|NCT01747746|Antithrombins|antithrombins|mesh-ancestor
64859461|NCT01747746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64859462|NCT01747746|Protease Inhibitors|protease inhibitors|mesh-ancestor
64859463|NCT01747746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859464|NCT01747746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859465|NCT01747746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65494846|NCT00203021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64859466|NCT01747746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64859467|NCT01747798|Auranofin|auranofin|mesh-list
64859468|NCT01747798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64859469|NCT01747993|Tamsulosin|tamsulosin|mesh-list
64859470|NCT01747993|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64859471|NCT01747993|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64405009|NCT03933007|Fexofenadine|fexofenadine|mesh-list
64859534|NCT01748318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64859535|NCT01748318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64628079|NCT01823198|Busulfan|busulfan|mesh-list
64859537|NCT01748344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64859538|NCT01748344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65274027|NCT04574856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859539|NCT01748344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64859540|NCT01748344|Histamine Antagonists|histamine antagonists|mesh-ancestor
64859569|NCT01748422|Dermatologic Agents|dermatologic agents|mesh-ancestor
64859570|NCT01748422|Sensory System Agents|sensory system agents|mesh-ancestor
64859571|NCT01748422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64859572|NCT01748422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859573|NCT01748435|Capsaicin|capsaicin|mesh-list
64859574|NCT01748435|Antipruritics|antipruritics|mesh-ancestor
65494847|NCT00201851|Tamoxifen|tamoxifen|mesh-list
65494848|NCT00201851|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64573222|NCT00053989|Immunologic Factors|immunologic factors|mesh-ancestor
64859575|NCT01748435|Dermatologic Agents|dermatologic agents|mesh-ancestor
64859576|NCT01748435|Sensory System Agents|sensory system agents|mesh-ancestor
64859577|NCT01748435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64859578|NCT01748435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859579|NCT01748487|Dexamethasone|dexamethasone|mesh-list
64859580|NCT01748487|Dexamethasone acetate|dexamethasone acetate|mesh-list
64859581|NCT01748487|BB 1101|bb 1101|mesh-list
64859582|NCT01748487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64859583|NCT01748487|Antiemetics|antiemetics|mesh-ancestor
64859584|NCT01748487|Autonomic Agents|autonomic agents|mesh-ancestor
64859585|NCT01748487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64405111|NCT04430933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64859618|NCT01748630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64859619|NCT01748630|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64859620|NCT01748630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64859621|NCT01748630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64859622|NCT01748630|Adrenergic Agents|adrenergic agents|mesh-ancestor
64859623|NCT01748630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64859624|NCT01748630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859625|NCT01748630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64859626|NCT01748630|Narcotics|narcotics|mesh-ancestor
64859627|NCT01748630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64859628|NCT01748630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64859629|NCT01748630|Anesthetics, General|anesthetics, general|mesh-ancestor
64859630|NCT01748630|Anesthetics|anesthetics|mesh-ancestor
64859631|NCT01748630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64859632|NCT01748630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64859633|NCT01748630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64859634|NCT01748630|GABA Modulators|gaba modulators|mesh-ancestor
64859635|NCT01748630|GABA Agents|gaba agents|mesh-ancestor
64859636|NCT01748669|Allyl sulfide|allyl sulfide|mesh-list
64859637|NCT01748669|Antioxidants|antioxidants|mesh-ancestor
64405162|NCT05125549|Purinergic Agents|purinergic agents|mesh-ancestor
64859669|NCT01748929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64859670|NCT01748929|Anticestodal Agents|anticestodal agents|mesh-ancestor
64859671|NCT01748929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64859672|NCT01748929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64859673|NCT01748929|Tubulin Modulators|tubulin modulators|mesh-ancestor
64859674|NCT01748929|Antimitotic Agents|antimitotic agents|mesh-ancestor
64859675|NCT01748929|Mitosis Modulators|mitosis modulators|mesh-ancestor
64859676|NCT01748929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859677|NCT01748929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859679|NCT01749072|Ifosfamide|ifosfamide|mesh-list
64859680|NCT01749072|Gefitinib|gefitinib|mesh-list
64859681|NCT01749072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64859682|NCT01749072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859711|NCT01749098|Anesthetics|anesthetics|mesh-ancestor
64859712|NCT01749098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64859713|NCT01749098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64859714|NCT01749098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64859715|NCT01749098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64859716|NCT01749098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859717|NCT01749111|Cyclophosphamide|cyclophosphamide|mesh-list
64859718|NCT01749111|Methotrexate|methotrexate|mesh-list
64859719|NCT01749111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
64859720|NCT01749111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64859721|NCT01749111|Immunologic Factors|immunologic factors|mesh-ancestor
64859722|NCT01749111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859723|NCT01749111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64473000|NCT01726582|Tubulin Modulators|tubulin modulators|mesh-ancestor
64473001|NCT01726582|Antimitotic Agents|antimitotic agents|mesh-ancestor
64473002|NCT01726582|Mitosis Modulators|mitosis modulators|mesh-ancestor
64473003|NCT01726582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473004|NCT01726582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65274028|NCT00423995|Loratadine|loratadine|mesh-list
65274029|NCT00423995|Montelukast|montelukast|mesh-list
64473005|NCT01726582|Antimetabolites|antimetabolites|mesh-ancestor
64473006|NCT01726582|Antiviral Agents|antiviral agents|mesh-ancestor
64859728|NCT01749111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64859729|NCT01749111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64859741|NCT01749150|Interferon-alpha|interferon-alpha|mesh-list
64859742|NCT01749150|Lactams|lactams|mesh-list
64859743|NCT01749150|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64859744|NCT01749150|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64859745|NCT01749150|Protease Inhibitors|protease inhibitors|mesh-ancestor
64859746|NCT01749150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859747|NCT01749150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859748|NCT01749150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64859749|NCT01749150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64859750|NCT01749150|Antiviral Agents|antiviral agents|mesh-ancestor
64859751|NCT01749150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64859752|NCT01749150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64859753|NCT01749150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64859754|NCT01749150|Antimetabolites|antimetabolites|mesh-ancestor
64859755|NCT01749150|Immunologic Factors|immunologic factors|mesh-ancestor
64859756|NCT01749150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859757|NCT01749150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64859758|NCT01749228|Etodolac|etodolac|mesh-list
64859759|NCT01749228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64859760|NCT01749228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64859761|NCT01749228|Analgesics|analgesics|mesh-ancestor
64859762|NCT01749228|Sensory System Agents|sensory system agents|mesh-ancestor
64859763|NCT01749228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64859764|NCT01749228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859765|NCT01749228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64859766|NCT01749228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64859767|NCT01749228|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64859768|NCT01749228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64859769|NCT01749228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859770|NCT01749228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859771|NCT01749241|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64859772|NCT01749241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64859773|NCT01749319|Baclofen|baclofen|mesh-list
64859789|NCT01749371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859791|NCT01749371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859792|NCT01749371|Protective Agents|protective agents|mesh-ancestor
64859793|NCT01749384|Bevacizumab|bevacizumab|mesh-list
64859794|NCT01749384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64859795|NCT01749384|Endothelial Growth Factors|endothelial growth factors|mesh-list
64859809|NCT01749397|Veliparib|veliparib|mesh-list
64859810|NCT01749397|Deoxyuridine|deoxyuridine|mesh-list
64859811|NCT01749397|Antimetabolites|antimetabolites|mesh-ancestor
64859831|NCT01749475|Midazolam|midazolam|mesh-list
64859832|NCT01749475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64859833|NCT01749475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64859834|NCT01749475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64859835|NCT01749475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859836|NCT01749475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64859837|NCT01749475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64859838|NCT01749475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64859839|NCT01749475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64859840|NCT01749475|Anesthetics, General|anesthetics, general|mesh-ancestor
64859841|NCT01749475|Anesthetics|anesthetics|mesh-ancestor
64859842|NCT01749475|GABA Modulators|gaba modulators|mesh-ancestor
64859843|NCT01749475|GABA Agents|gaba agents|mesh-ancestor
64859844|NCT01749475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64859845|NCT01749475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859846|NCT01749514|Luspatercept|luspatercept|mesh-list
64859847|NCT01749514|Hematinics|hematinics|mesh-ancestor
64859848|NCT01749540|Luspatercept|luspatercept|mesh-list
64859849|NCT01749540|Hematinics|hematinics|mesh-ancestor
64859850|NCT01749566|Maraviroc|maraviroc|mesh-list
64859851|NCT01749566|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64859852|NCT01749566|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64859853|NCT01749566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859854|NCT01749566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64859855|NCT01749566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64859856|NCT01749566|Antiviral Agents|antiviral agents|mesh-ancestor
64859857|NCT01749566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64859858|NCT01749566|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65274030|NCT00423995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64859859|NCT01749579|Fentanyl|fentanyl|mesh-list
64859860|NCT01749579|Midazolam|midazolam|mesh-list
64859865|NCT01749579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64859866|NCT01749579|Anesthetics, General|anesthetics, general|mesh-ancestor
64859867|NCT01749579|Anesthetics|anesthetics|mesh-ancestor
64859868|NCT01749579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64859869|NCT01749579|Narcotics|narcotics|mesh-ancestor
64859870|NCT01749579|Analgesics|analgesics|mesh-ancestor
64859905|NCT01750099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64859906|NCT01750099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64859907|NCT01750099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64859908|NCT01750099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64859909|NCT01750099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64859910|NCT01750099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859911|NCT01750099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64859912|NCT01750099|Narcotics|narcotics|mesh-ancestor
64859913|NCT01750099|Analgesics|analgesics|mesh-ancestor
64405487|NCT03050957|Menthol|menthol|mesh-list
64859949|NCT01750437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859950|NCT01750463|Chrysarobin|chrysarobin|mesh-list
64859951|NCT01750463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64859952|NCT01750463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64859953|NCT01750463|Analgesics|analgesics|mesh-ancestor
64859954|NCT01750463|Sensory System Agents|sensory system agents|mesh-ancestor
64859955|NCT01750463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64859956|NCT01750463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859957|NCT01750463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64859958|NCT01750463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64859959|NCT01750476|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64859960|NCT01750476|Medroxyprogesterone|medroxyprogesterone|mesh-list
64859977|NCT01750541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64859978|NCT01750541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859979|NCT01750541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64859980|NCT01750541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64859981|NCT01750541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64859982|NCT01750541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64859983|NCT01750541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64859984|NCT01750541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64859986|NCT01750541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64859987|NCT01750541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859988|NCT01750541|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64859989|NCT01750541|Anticonvulsants|anticonvulsants|mesh-ancestor
64859990|NCT01750541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859991|NCT01750541|GABA Agents|gaba agents|mesh-ancestor
64859992|NCT01750541|Antimanic Agents|antimanic agents|mesh-ancestor
64859993|NCT01750580|Ipilimumab|ipilimumab|mesh-list
64859994|NCT01750580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64859995|NCT01750580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859996|NCT01750580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64859997|NCT01750580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859998|NCT01750645|Botulinum Toxins|botulinum toxins|mesh-list
64859999|NCT01750645|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64860000|NCT01750645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64860001|NCT01750645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860002|NCT01750645|Cholinergic Agents|cholinergic agents|mesh-ancestor
64860003|NCT01750645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64860004|NCT01750645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860011|NCT01750723|Natriuretic Agents|natriuretic agents|mesh-ancestor
64860012|NCT01750723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860013|NCT01750762|Lenalidomide|lenalidomide|mesh-list
64860014|NCT01750762|Immunologic Factors|immunologic factors|mesh-ancestor
64860015|NCT01750762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860016|NCT01750762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64860017|NCT01750762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64860018|NCT01750762|Growth Substances|growth substances|mesh-ancestor
64860019|NCT01750762|Growth Inhibitors|growth inhibitors|mesh-ancestor
64860020|NCT01750762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860021|NCT01750788|Rivaroxaban|rivaroxaban|mesh-list
64860022|NCT01750788|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64860023|NCT01750788|Antithrombins|antithrombins|mesh-ancestor
64405593|NCT03050411|Apatinib|apatinib|mesh-list
64860039|NCT01750866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64860041|NCT01750866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65274031|NCT00423995|Respiratory System Agents|respiratory system agents|mesh-ancestor
64795661|NCT05761431|Octreotide|octreotide|mesh-list
64860042|NCT01750866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860043|NCT01750866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64860044|NCT01750866|Immunologic Factors|immunologic factors|mesh-ancestor
64860045|NCT01750983|Lenalidomide|lenalidomide|mesh-list
64860046|NCT01750983|Ipilimumab|ipilimumab|mesh-list
64860047|NCT01750983|Immunologic Factors|immunologic factors|mesh-ancestor
64860048|NCT01750983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860049|NCT01750983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64860050|NCT01750983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64860051|NCT01750983|Growth Substances|growth substances|mesh-ancestor
64860052|NCT01750983|Growth Inhibitors|growth inhibitors|mesh-ancestor
64860053|NCT01750983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860054|NCT01750983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64860055|NCT01750983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64860056|NCT01750983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860057|NCT01751009|Vitamins|vitamins|mesh-list
64860058|NCT01751009|Vitamin A|vitamin a|mesh-list
64860059|NCT01751009|Retinol palmitate|retinol palmitate|mesh-list
64860060|NCT01751009|Micronutrients|micronutrients|mesh-ancestor
64860061|NCT01751009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860062|NCT01751009|Antioxidants|antioxidants|mesh-ancestor
64860063|NCT01751009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860064|NCT01751009|Protective Agents|protective agents|mesh-ancestor
64860065|NCT01751009|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64860066|NCT01751009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860067|NCT01751074|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64860068|NCT01751074|Darapladib|darapladib|mesh-list
64860069|NCT01751074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64860070|NCT01751074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64860071|NCT01751074|Antimetabolites|antimetabolites|mesh-ancestor
64860072|NCT01751074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860073|NCT01751074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64860074|NCT01751074|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64860075|NCT01751074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860076|NCT01751074|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
64860078|NCT01751204|Calcium|calcium|mesh-list
64860079|NCT01751204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64860080|NCT01751204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860081|NCT01751204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64860082|NCT01751269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
64860116|NCT01751347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64860117|NCT01751347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860118|NCT01751373|Botulinum Toxins|botulinum toxins|mesh-list
64860157|NCT01751854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860158|NCT01751854|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64860159|NCT01751854|Antidepressive Agents|antidepressive agents|mesh-ancestor
64860161|NCT01751919|Imatinib Mesylate|imatinib mesylate|mesh-list
64860162|NCT01751919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860163|NCT01751919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64860164|NCT01751919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860165|NCT01751919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860166|NCT01752010|Immunologic Factors|immunologic factors|mesh-list
64860167|NCT01752010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860168|NCT01752075|Lenalidomide|lenalidomide|mesh-list
64860169|NCT01752075|Immunologic Factors|immunologic factors|mesh-ancestor
64405755|NCT04676399|Diuretics|diuretics|mesh-ancestor
64860192|NCT01752205|Mitosis Modulators|mitosis modulators|mesh-ancestor
64860193|NCT01752205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860194|NCT01752205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64860195|NCT01752205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860196|NCT01752244|Alfacalcidol|alfacalcidol|mesh-list
64860197|NCT01752244|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
64860198|NCT01752244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64860199|NCT01752244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860200|NCT01752244|Vitamins|vitamins|mesh-ancestor
64860201|NCT01752244|Micronutrients|micronutrients|mesh-ancestor
64860202|NCT01752270|Cyproterone Acetate|cyproterone acetate|mesh-list
64860203|NCT01752270|Cyproterone|cyproterone|mesh-list
64860204|NCT01752270|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
64860205|NCT01752270|Androgen Antagonists|androgen antagonists|mesh-ancestor
65274032|NCT00423995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65274033|NCT00423995|Hormone Antagonists|hormone antagonists|mesh-ancestor
64860206|NCT01752270|Hormone Antagonists|hormone antagonists|mesh-ancestor
64860213|NCT01752322|Lidocaine|lidocaine|mesh-list
64860214|NCT01752322|Anesthetics, Local|anesthetics, local|mesh-ancestor
64860215|NCT01752322|Anesthetics|anesthetics|mesh-ancestor
64860216|NCT01752322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64860217|NCT01752322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860218|NCT01752322|Sensory System Agents|sensory system agents|mesh-ancestor
64860219|NCT01752322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64860220|NCT01752322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64860221|NCT01752322|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64860222|NCT01752322|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64860223|NCT01752322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64860224|NCT01752322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860225|NCT01752517|Vinorelbine|vinorelbine|mesh-list
64860226|NCT01752517|Ifosfamide|ifosfamide|mesh-list
64860227|NCT01752517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64860228|NCT01752517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860244|NCT01752699|Narcotics|narcotics|mesh-ancestor
64860245|NCT01752699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64860246|NCT01752699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860247|NCT01752699|Analgesics|analgesics|mesh-ancestor
64860248|NCT01752699|Sensory System Agents|sensory system agents|mesh-ancestor
64860249|NCT01752699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64860250|NCT01752699|Antitussive Agents|antitussive agents|mesh-ancestor
64860251|NCT01752699|Respiratory System Agents|respiratory system agents|mesh-ancestor
64860252|NCT01752790|Azathioprine|azathioprine|mesh-list
64860253|NCT01752790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64860254|NCT01752790|Antimetabolites|antimetabolites|mesh-ancestor
64860255|NCT01752790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860256|NCT01752790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64860257|NCT01752790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860258|NCT01752790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64860259|NCT01752790|Immunologic Factors|immunologic factors|mesh-ancestor
64860260|NCT01752790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860261|NCT01752881|Vaccines|vaccines|mesh-list
64860262|NCT01752881|Immunologic Factors|immunologic factors|mesh-ancestor
64860263|NCT01752881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860264|NCT01752959|Remifentanil|remifentanil|mesh-list
64860265|NCT01752959|Esmolol|esmolol|mesh-list
64860266|NCT01752959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64860267|NCT01752959|Narcotics|narcotics|mesh-ancestor
64860268|NCT01752959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65494868|NCT01074281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64473010|NCT01726582|Immunologic Factors|immunologic factors|mesh-ancestor
64860269|NCT01752959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860270|NCT01752959|Analgesics|analgesics|mesh-ancestor
64860271|NCT01752959|Sensory System Agents|sensory system agents|mesh-ancestor
64860282|NCT01752998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860283|NCT01752998|Analgesics|analgesics|mesh-ancestor
64860284|NCT01752998|Sensory System Agents|sensory system agents|mesh-ancestor
64860285|NCT01752998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64860286|NCT01753037|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64860288|NCT01753037|Immunologic Factors|immunologic factors|mesh-ancestor
64860289|NCT01753037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860290|NCT01753102|Estradiol|estradiol|mesh-list
64860291|NCT01753102|Estrogens|estrogens|mesh-ancestor
64860292|NCT01753102|Hormones|hormones|mesh-ancestor
64860293|NCT01753102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64860294|NCT01753102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860295|NCT01753128|Imipramine|imipramine|mesh-list
64860296|NCT01753128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64860324|NCT01753375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64860325|NCT01753453|Plerixafor|plerixafor|mesh-list
64860326|NCT01753453|Lenograstim|lenograstim|mesh-list
64860327|NCT01753453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64860328|NCT01753453|Immunologic Factors|immunologic factors|mesh-ancestor
64860329|NCT01753453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860330|NCT01753453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64860331|NCT01753453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64860332|NCT01753453|Antiviral Agents|antiviral agents|mesh-ancestor
64860333|NCT01753453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64860334|NCT01753596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64860335|NCT01753596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64860348|NCT01753752|Protective Agents|protective agents|mesh-ancestor
64860349|NCT01753752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860350|NCT01753752|Antidotes|antidotes|mesh-ancestor
64860351|NCT01753752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64860352|NCT01753752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64860353|NCT01753752|Antimetabolites|antimetabolites|mesh-ancestor
64860354|NCT01753752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64860371|NCT01754116|Midazolam|midazolam|mesh-list
64860372|NCT01754116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64860373|NCT01754116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64860374|NCT01754116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64860375|NCT01754116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860376|NCT01754116|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64860377|NCT01754116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64860378|NCT01754116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64860379|NCT01754116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64860380|NCT01754116|Anesthetics, General|anesthetics, general|mesh-ancestor
64860381|NCT01754116|Anesthetics|anesthetics|mesh-ancestor
64860382|NCT01754116|GABA Modulators|gaba modulators|mesh-ancestor
64860383|NCT01754116|GABA Agents|gaba agents|mesh-ancestor
64860384|NCT01754116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64860385|NCT01754116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860386|NCT01754116|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64860387|NCT01754116|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64860388|NCT01754116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860389|NCT01754116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64860390|NCT01754116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64860391|NCT01754116|Antiviral Agents|antiviral agents|mesh-ancestor
64860392|NCT01754116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64860393|NCT01754181|Insulin|insulin|mesh-list
64860394|NCT01754181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64860395|NCT01754181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860396|NCT01754220|Montelukast|montelukast|mesh-list
64860397|NCT01754220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64860398|NCT01754220|Respiratory System Agents|respiratory system agents|mesh-ancestor
64860399|NCT01754220|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64860400|NCT01754220|Hormone Antagonists|hormone antagonists|mesh-ancestor
64860407|NCT01754285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64860408|NCT01754285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64860409|NCT01754285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860410|NCT01754324|Methadone|methadone|mesh-list
64860411|NCT01754324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64860412|NCT01754324|Narcotics|narcotics|mesh-ancestor
64860413|NCT01754324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64860414|NCT01754324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860415|NCT01754324|Analgesics|analgesics|mesh-ancestor
64860416|NCT01754324|Sensory System Agents|sensory system agents|mesh-ancestor
64860417|NCT01754324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64860438|NCT01754805|Peficitinib|peficitinib|mesh-list
64860439|NCT01754805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64860440|NCT01754805|Abortifacient Agents|abortifacient agents|mesh-ancestor
64860441|NCT01754805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64860442|NCT01754805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860443|NCT01754805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64860444|NCT01754805|Antimetabolites|antimetabolites|mesh-ancestor
64574034|NCT04837170|Ketamine|ketamine|mesh-list
64860445|NCT01754805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860446|NCT01754805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860447|NCT01754805|Dermatologic Agents|dermatologic agents|mesh-ancestor
64860448|NCT01754805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860449|NCT01754805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64860450|NCT01754805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64860451|NCT01754805|Immunologic Factors|immunologic factors|mesh-ancestor
64860452|NCT01754805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64860453|NCT01754805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64860454|NCT01754831|Fluorides|fluorides|mesh-list
64860455|NCT01754831|Fluorides, Topical|fluorides, topical|mesh-list
64860456|NCT01754831|Cariostatic Agents|cariostatic agents|mesh-ancestor
64860457|NCT01754831|Protective Agents|protective agents|mesh-ancestor
64860458|NCT01754831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860459|NCT01754844|AZD7624|azd7624|mesh-list
64860460|NCT01754844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64860461|NCT01754844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860462|NCT01754844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860463|NCT01754870|Rituximab|rituximab|mesh-list
64860464|NCT01754870|Lenalidomide|lenalidomide|mesh-list
64472058|NCT03869034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64860465|NCT01754870|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64860466|NCT01754870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64860467|NCT01754870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860468|NCT01754870|Immunologic Factors|immunologic factors|mesh-ancestor
64860482|NCT01754883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860483|NCT01754883|Antimanic Agents|antimanic agents|mesh-ancestor
64860484|NCT01754883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64860485|NCT01754883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64860498|NCT01754974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860499|NCT01754974|Antiviral Agents|antiviral agents|mesh-ancestor
64860500|NCT01754974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64860501|NCT01755078|Calcium, Dietary|calcium, dietary|mesh-list
64860502|NCT01755078|Calcium Carbonate|calcium carbonate|mesh-list
64860503|NCT01755078|Calcium|calcium|mesh-list
64860504|NCT01755078|Sevelamer|sevelamer|mesh-list
64860505|NCT01755078|Calcium acetate|calcium acetate|mesh-list
64860506|NCT01755078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64860507|NCT01755078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860508|NCT01755078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64860509|NCT01755078|Antacids|antacids|mesh-ancestor
64860510|NCT01755078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860511|NCT01755078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64860512|NCT01755078|Chelating Agents|chelating agents|mesh-ancestor
64860513|NCT01755078|Sequestering Agents|sequestering agents|mesh-ancestor
64860514|NCT01755117|Ropivacaine|ropivacaine|mesh-list
64860515|NCT01755117|Anesthetics, Local|anesthetics, local|mesh-ancestor
64860516|NCT01755117|Anesthetics|anesthetics|mesh-ancestor
64860517|NCT01755117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64860518|NCT01755117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860519|NCT01755117|Sensory System Agents|sensory system agents|mesh-ancestor
64860520|NCT01755117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64860521|NCT01755182|Somatostatin|somatostatin|mesh-list
64860522|NCT01755182|Hormones|hormones|mesh-ancestor
64860523|NCT01755182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64860524|NCT01755182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860525|NCT01755286|Ciprofloxacin|ciprofloxacin|mesh-list
64860526|NCT01755286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64860527|NCT01755286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64860528|NCT01755286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64860529|NCT01755286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64860534|NCT01755286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65494870|NCT01074281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64473011|NCT01726582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473012|NCT01726582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64473013|NCT01726582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64473014|NCT01726582|Antidotes|antidotes|mesh-ancestor
64473015|NCT01726582|Protective Agents|protective agents|mesh-ancestor
64473017|NCT01726582|Vitamins|vitamins|mesh-ancestor
64473018|NCT01726582|Micronutrients|micronutrients|mesh-ancestor
64473019|NCT01718743|Lenalidomide|lenalidomide|mesh-list
64473020|NCT01718743|Ixazomib|ixazomib|mesh-list
64473021|NCT01718743|Glycine|glycine|mesh-list
64473022|NCT01718743|Immunologic Factors|immunologic factors|mesh-ancestor
64473023|NCT01718743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473024|NCT01718743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64860536|NCT01755299|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64860537|NCT01755299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860538|NCT01755299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64860539|NCT01755299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860540|NCT01755299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860562|NCT01755338|Protective Agents|protective agents|mesh-ancestor
64860563|NCT01755338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64860564|NCT01755338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860565|NCT01755377|Benzonidazole|benzonidazole|mesh-list
64860566|NCT01755377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64860567|NCT01755377|Immunologic Factors|immunologic factors|mesh-ancestor
64860568|NCT01755377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860569|NCT01755377|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64860570|NCT01755377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64860571|NCT01755377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64860572|NCT01755377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64860573|NCT01755403|Benzonidazole|benzonidazole|mesh-list
64860574|NCT01755403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65274034|NCT00423995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65274035|NCT00423995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274036|NCT00423995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65274037|NCT00423995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64311568|NCT02090309|Hydrocortisone|hydrocortisone|mesh-list
64860575|NCT01755403|Immunologic Factors|immunologic factors|mesh-ancestor
64860576|NCT01755403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860577|NCT01755403|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64860578|NCT01755403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64860579|NCT01755403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64860580|NCT01755403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64860582|NCT01755468|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64860583|NCT01755468|Metformin|metformin|mesh-list
64860584|NCT01755468|Insulin Glargine|insulin glargine|mesh-list
64860585|NCT01755468|Insulin Lispro|insulin lispro|mesh-list
64860586|NCT01755468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64860587|NCT01755468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860588|NCT01755494|Metformin|metformin|mesh-list
65494871|NCT01074281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494872|NCT01074281|Vasodilator Agents|vasodilator agents|mesh-ancestor
65494873|NCT03129100|Ixekizumab|ixekizumab|mesh-list
65494874|NCT03129100|Dermatologic Agents|dermatologic agents|mesh-ancestor
65494875|NCT03100006|Nivolumab|nivolumab|mesh-list
65494876|NCT03100006|Oregovomab|oregovomab|mesh-list
65494877|NCT03100006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65494878|NCT03100006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860651|NCT01755663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64860652|NCT01755663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860653|NCT01755663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64860654|NCT01755663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64860655|NCT01755663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64860656|NCT01755663|Adrenergic Agents|adrenergic agents|mesh-ancestor
64860657|NCT01755663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64860658|NCT01755663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860660|NCT01755676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860661|NCT01755676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860662|NCT01755676|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64860663|NCT01755676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64860664|NCT01755728|Acetaminophen|acetaminophen|mesh-list
64860665|NCT01755728|Ibuprofen|ibuprofen|mesh-list
65494883|NCT05149768|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64473025|NCT01718743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64860703|NCT01755923|Tubulin Modulators|tubulin modulators|mesh-ancestor
64860704|NCT01755923|Antimitotic Agents|antimitotic agents|mesh-ancestor
64860705|NCT01755923|Mitosis Modulators|mitosis modulators|mesh-ancestor
64860706|NCT01755923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860707|NCT01755923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64860708|NCT01755923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860710|NCT01756040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64860711|NCT01756040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64860712|NCT01756105|Insulin|insulin|mesh-list
64860713|NCT01756105|Metformin|metformin|mesh-list
64860714|NCT01756105|Insulin, Isophane|insulin, isophane|mesh-list
64860715|NCT01756105|Isophane Insulin, Human|isophane insulin, human|mesh-list
64860716|NCT01756105|Isophane insulin, beef|isophane insulin, beef|mesh-list
64860717|NCT01756105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64860718|NCT01756105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860719|NCT01756131|Cabotegravir|cabotegravir|mesh-list
64860720|NCT01756131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64860721|NCT01756131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64860749|NCT01756261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860750|NCT01756404|Canagliflozin|canagliflozin|mesh-list
65494884|NCT05149768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64860751|NCT01756404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64860752|NCT01756404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860753|NCT01756404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64860754|NCT01756404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860756|NCT01756417|Canagliflozin|canagliflozin|mesh-list
64860757|NCT01756417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64311876|NCT02098499|Diphenhydramine|diphenhydramine|mesh-list
64860758|NCT01756417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860759|NCT01756417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64860760|NCT01756417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860761|NCT01756430|Carvedilol|carvedilol|mesh-list
64860762|NCT01756430|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64860763|NCT01756430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64860764|NCT01756430|Adrenergic Agents|adrenergic agents|mesh-ancestor
64860765|NCT01756430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64860766|NCT01756430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860767|NCT01756430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860792|NCT01756443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860793|NCT01756443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64860794|NCT01756443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64860795|NCT01756443|Adrenergic Agents|adrenergic agents|mesh-ancestor
64860796|NCT01756443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64860797|NCT01756443|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64860798|NCT01756443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64860799|NCT01756443|Autonomic Agents|autonomic agents|mesh-ancestor
64860800|NCT01756443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64860801|NCT01756443|Respiratory System Agents|respiratory system agents|mesh-ancestor
64860802|NCT01756443|Mydriatics|mydriatics|mesh-ancestor
64860803|NCT01756443|Sympathomimetics|sympathomimetics|mesh-ancestor
64860804|NCT01756443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64860805|NCT01756495|Moxifloxacin|moxifloxacin|mesh-list
64860806|NCT01756495|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64860807|NCT01756495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64860808|NCT01756495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64860809|NCT01756495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64860810|NCT01756495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64860814|NCT01756495|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64860816|NCT01756495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64860817|NCT01756495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860818|NCT01756495|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64860819|NCT01756495|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64860820|NCT01756495|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64860821|NCT01756508|Eculizumab|eculizumab|mesh-list
64860840|NCT01756612|Epoetin Alfa|epoetin alfa|mesh-list
64860841|NCT01756612|Hematinics|hematinics|mesh-ancestor
64860842|NCT01756638|Prednisolone|prednisolone|mesh-list
64860843|NCT01756638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64860844|NCT01756638|Glucocorticoids|glucocorticoids|mesh-ancestor
64860845|NCT01756638|Hormones|hormones|mesh-ancestor
64860846|NCT01756638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64860847|NCT01756638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860848|NCT01756638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64860849|NCT01756638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860850|NCT01756651|Fentanyl|fentanyl|mesh-list
64860851|NCT01756651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64860852|NCT01756651|Narcotics|narcotics|mesh-ancestor
64860853|NCT01756651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64860854|NCT01756651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860855|NCT01756651|Analgesics|analgesics|mesh-ancestor
64860856|NCT01756651|Sensory System Agents|sensory system agents|mesh-ancestor
64860857|NCT01756651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64860858|NCT01756651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64860859|NCT01756651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64860860|NCT01756651|Anesthetics, General|anesthetics, general|mesh-ancestor
64860861|NCT01756651|Anesthetics|anesthetics|mesh-ancestor
64860862|NCT01756664|Sunscreening Agents|sunscreening agents|mesh-list
64860863|NCT01756664|Petrolatum|petrolatum|mesh-list
64860864|NCT01756664|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64860865|NCT01756664|Protective Agents|protective agents|mesh-ancestor
64860866|NCT01756664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860867|NCT01756664|Dermatologic Agents|dermatologic agents|mesh-ancestor
64860868|NCT01756664|Emollients|emollients|mesh-ancestor
64860869|NCT01756768|Palbociclib|palbociclib|mesh-list
64860870|NCT01756768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860871|NCT01756768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64860872|NCT01756768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860873|NCT01756768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860874|NCT01756781|Palbociclib|palbociclib|mesh-list
64860875|NCT01756781|Midazolam|midazolam|mesh-list
64860876|NCT01756781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64860877|NCT01756781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64860878|NCT01756781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64406504|NCT02439385|Analgesics|analgesics|mesh-ancestor
64860917|NCT01756989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64860918|NCT01756989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64860919|NCT01756989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64860920|NCT01756989|Growth Substances|growth substances|mesh-ancestor
64860921|NCT01756989|Growth Inhibitors|growth inhibitors|mesh-ancestor
64860922|NCT01757015|Glycopyrrolate|glycopyrrolate|mesh-list
64860923|NCT01757015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64860924|NCT01757015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64860925|NCT01757015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64860926|NCT01757015|Cholinergic Agents|cholinergic agents|mesh-ancestor
64860927|NCT01757015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64860954|NCT01757236|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64860955|NCT01757236|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64860956|NCT01757236|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64860957|NCT01757236|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64860958|NCT01757236|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64860959|NCT01757236|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64860960|NCT01757236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64860961|NCT01757236|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64860962|NCT01757236|Renal Agents|renal agents|mesh-ancestor
64860963|NCT01757236|Antimalarials|antimalarials|mesh-ancestor
64860964|NCT01757236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64860965|NCT01757236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64860966|NCT01757236|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64860967|NCT01757236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64860968|NCT01757236|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64860969|NCT01757236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64860970|NCT01757249|Contraceptive Agents|contraceptive agents|mesh-list
64860971|NCT01757249|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64860972|NCT01757249|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
64860973|NCT01757249|Contraceptives, Oral|contraceptives, oral|mesh-list
64860974|NCT01757249|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64860975|NCT01757249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64860976|NCT01757249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860977|NCT01757249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64860978|NCT01757249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64861009|NCT01757587|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64861010|NCT01757587|Metformin|metformin|mesh-list
64861011|NCT01757587|Vildagliptin|vildagliptin|mesh-list
64861012|NCT01757587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64861013|NCT01757587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861014|NCT01757587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64861015|NCT01757587|Protease Inhibitors|protease inhibitors|mesh-ancestor
64861016|NCT01757587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861017|NCT01757587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406666|NCT01553071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304152|NCT05728268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861102|NCT01758107|Immunologic Factors|immunologic factors|mesh-ancestor
64861103|NCT01758107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861104|NCT01758107|Antifungal Agents|antifungal agents|mesh-ancestor
64861105|NCT01758107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64861106|NCT01758107|Dermatologic Agents|dermatologic agents|mesh-ancestor
64861107|NCT01758107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64861108|NCT01758107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64861109|NCT01758120|Prednisone|prednisone|mesh-list
64861110|NCT01758120|Cyclophosphamide|cyclophosphamide|mesh-list
64861111|NCT01758120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64861112|NCT01758120|Immunologic Factors|immunologic factors|mesh-ancestor
64861113|NCT01758120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861114|NCT01758120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64861115|NCT01758120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64861116|NCT01758120|Alkylating Agents|alkylating agents|mesh-ancestor
64861117|NCT01758120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861118|NCT01758120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861119|NCT01758120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64861120|NCT01758120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64861121|NCT01758120|Glucocorticoids|glucocorticoids|mesh-ancestor
64861122|NCT01758120|Hormones|hormones|mesh-ancestor
64861123|NCT01758120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64796302|NCT04643002|Hormones|hormones|mesh-ancestor
64861124|NCT01758120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64861125|NCT01758146|Tamoxifen|tamoxifen|mesh-list
64861126|NCT01758146|Letrozole|letrozole|mesh-list
64861127|NCT01758146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861128|NCT01758146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64861129|NCT01758146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64861130|NCT01758146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861131|NCT01758146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861132|NCT01758146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64861133|NCT01758146|Hormone Antagonists|hormone antagonists|mesh-ancestor
64861134|NCT01758146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64861138|NCT01758146|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64861139|NCT01758146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64861140|NCT01758172|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
64861141|NCT01758172|Plasma Substitutes|plasma substitutes|mesh-ancestor
64861142|NCT01758172|Blood Substitutes|blood substitutes|mesh-ancestor
64861144|NCT01758185|Immunologic Factors|immunologic factors|mesh-ancestor
64861145|NCT01758185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861146|NCT01758198|Methotrexate|methotrexate|mesh-list
64861147|NCT01758198|Abatacept|abatacept|mesh-list
64861148|NCT01758198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64861174|NCT01758263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64861175|NCT01758263|Adrenergic Agents|adrenergic agents|mesh-ancestor
64861176|NCT01758263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64861177|NCT01758263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861178|NCT01758263|Vasodilator Agents|vasodilator agents|mesh-ancestor
64861179|NCT01758263|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64861180|NCT01758263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64861181|NCT01758263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64861182|NCT01758367|Decitabine|decitabine|mesh-list
64861183|NCT01758367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64861184|NCT01758367|Antimetabolites|antimetabolites|mesh-ancestor
64861185|NCT01758367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861186|NCT01758367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861187|NCT01758367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861188|NCT01758380|Metformin|metformin|mesh-list
64861189|NCT01758380|Vildagliptin|vildagliptin|mesh-list
64861191|NCT01758380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64861192|NCT01758380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861193|NCT01758380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64861194|NCT01758380|Protease Inhibitors|protease inhibitors|mesh-ancestor
64861195|NCT01758380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304153|NCT04882358|Dapagliflozin|dapagliflozin|mesh-list
64861220|NCT01758666|Calcium|calcium|mesh-list
64861221|NCT01758666|Levoleucovorin|levoleucovorin|mesh-list
64861222|NCT01758666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64861223|NCT01758666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861224|NCT01758666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64861225|NCT01758666|Abortifacient Agents|abortifacient agents|mesh-ancestor
64861226|NCT01758666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64861227|NCT01758666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64861228|NCT01758666|Antimetabolites|antimetabolites|mesh-ancestor
64861229|NCT01758666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861230|NCT01758666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861231|NCT01758666|Dermatologic Agents|dermatologic agents|mesh-ancestor
64861232|NCT01758666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861233|NCT01758666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64861234|NCT01758666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64861235|NCT01758666|Immunologic Factors|immunologic factors|mesh-ancestor
64861236|NCT01758666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64861237|NCT01758666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64861238|NCT01758666|Antidotes|antidotes|mesh-ancestor
64861239|NCT01758666|Protective Agents|protective agents|mesh-ancestor
64861240|NCT01758666|Vitamin B Complex|vitamin b complex|mesh-ancestor
64861241|NCT01758666|Vitamins|vitamins|mesh-ancestor
64861242|NCT01758666|Micronutrients|micronutrients|mesh-ancestor
64861243|NCT01758744|Treprostinil|treprostinil|mesh-list
64861244|NCT01758744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64861245|NCT01758809|Bupivacaine|bupivacaine|mesh-list
64861246|NCT01758809|Anesthetics, Local|anesthetics, local|mesh-ancestor
64861247|NCT01758809|Anesthetics|anesthetics|mesh-ancestor
64861248|NCT01758809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64861249|NCT01758809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861250|NCT01758809|Sensory System Agents|sensory system agents|mesh-ancestor
64472059|NCT03869034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796362|NCT04560595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796363|NCT04560595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64861251|NCT01758809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64861252|NCT01758835|Calpastatin|calpastatin|mesh-list
64861253|NCT01758835|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65494886|NCT00883480|Gemcitabine|gemcitabine|mesh-list
64861254|NCT01758835|Protease Inhibitors|protease inhibitors|mesh-ancestor
64861255|NCT01758835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861256|NCT01758835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861257|NCT01758913|Ibuprofen|ibuprofen|mesh-list
64861258|NCT01758913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64861259|NCT01758913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64861260|NCT01758913|Analgesics|analgesics|mesh-ancestor
64861261|NCT01758913|Sensory System Agents|sensory system agents|mesh-ancestor
64861262|NCT01758913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64406887|NCT04846673|Vitamin B Complex|vitamin b complex|mesh-ancestor
64861302|NCT01759485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64861303|NCT01759524|Lidocaine|lidocaine|mesh-list
64861304|NCT01759524|Clonidine|clonidine|mesh-list
64861305|NCT01759524|Bupivacaine|bupivacaine|mesh-list
64861306|NCT01759524|Anesthetics, Local|anesthetics, local|mesh-ancestor
64861307|NCT01759524|Anesthetics|anesthetics|mesh-ancestor
64861308|NCT01759524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64861309|NCT01759524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861310|NCT01759524|Sensory System Agents|sensory system agents|mesh-ancestor
64406955|NCT04853069|Hormones|hormones|mesh-ancestor
64861321|NCT01759524|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64861322|NCT01759524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64861323|NCT01759524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64861324|NCT01759524|Adrenergic Agents|adrenergic agents|mesh-ancestor
64861325|NCT01759524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64861326|NCT01759576|Canagliflozin|canagliflozin|mesh-list
64861327|NCT01759576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64861328|NCT01759576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861329|NCT01759576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64861330|NCT01759576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861331|NCT01759589|Remifentanil|remifentanil|mesh-list
64861332|NCT01759589|Propofol|propofol|mesh-list
64861333|NCT01759589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
64861334|NCT01759589|Anesthetics|anesthetics|mesh-list
64861335|NCT01759589|Sevoflurane|sevoflurane|mesh-list
64574862|NCT05617950|Keratolytic Agents|keratolytic agents|mesh-ancestor
64861336|NCT01759589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64861337|NCT01759589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64861338|NCT01759589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861339|NCT01759589|Anesthetics, General|anesthetics, general|mesh-ancestor
64861340|NCT01759589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64861342|NCT01759589|Analgesics|analgesics|mesh-ancestor
64861343|NCT01759589|Sensory System Agents|sensory system agents|mesh-ancestor
64861344|NCT01759589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64861350|NCT01759706|Ondansetron|ondansetron|mesh-list
64861351|NCT01759706|Anesthetics|anesthetics|mesh-list
64861352|NCT01759706|Ropivacaine|ropivacaine|mesh-list
64861353|NCT01759706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64861354|NCT01759706|Antiemetics|antiemetics|mesh-ancestor
64861355|NCT01759706|Autonomic Agents|autonomic agents|mesh-ancestor
64861356|NCT01759706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64861357|NCT01759706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861358|NCT01759706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64861359|NCT01759706|Glucocorticoids|glucocorticoids|mesh-ancestor
64861360|NCT01759706|Hormones|hormones|mesh-ancestor
64861361|NCT01759706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64861362|NCT01759706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64861363|NCT01759706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861364|NCT01759706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64861365|NCT01759706|Antipruritics|antipruritics|mesh-ancestor
64861366|NCT01759706|Dermatologic Agents|dermatologic agents|mesh-ancestor
64861367|NCT01759706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64861368|NCT01759706|Serotonin Agents|serotonin agents|mesh-ancestor
64861369|NCT01759706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64861370|NCT01759706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274038|NCT00423995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274039|NCT00423995|Antipruritics|antipruritics|mesh-ancestor
65274040|NCT00423995|Dermatologic Agents|dermatologic agents|mesh-ancestor
65274041|NCT00423995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65274042|NCT00423995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65274043|NCT00423995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65274044|NCT00423995|Histamine Antagonists|histamine antagonists|mesh-ancestor
65274045|NCT00423995|Histamine Agents|histamine agents|mesh-ancestor
65274046|NCT00423995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65274047|NCT00380627|Etoricoxib|etoricoxib|mesh-list
65274048|NCT00380627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64472060|NCT03869034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64472061|NCT03869034|Immunologic Factors|immunologic factors|mesh-ancestor
64472062|NCT03869034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861371|NCT01759706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64861372|NCT01759706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64861373|NCT01759706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64861374|NCT01759706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64861375|NCT01759706|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64861376|NCT01759706|Narcotics|narcotics|mesh-ancestor
64861377|NCT01759706|Analgesics|analgesics|mesh-ancestor
64861378|NCT01759706|Sensory System Agents|sensory system agents|mesh-ancestor
64861379|NCT01759706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64861380|NCT01759706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64861409|NCT01759771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861410|NCT01759771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64861411|NCT01759771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64861413|NCT01759810|Immunologic Factors|immunologic factors|mesh-ancestor
64861414|NCT01759810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861415|NCT01759875|Ritonavir|ritonavir|mesh-list
64861416|NCT01759875|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64861417|NCT01759875|Rabeprazole|rabeprazole|mesh-list
64574939|NCT00373217|Tubulin Modulators|tubulin modulators|mesh-ancestor
64861419|NCT01759875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64861425|NCT01759875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64861426|NCT01759875|Antiviral Agents|antiviral agents|mesh-ancestor
64861427|NCT01759875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64861428|NCT01759875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64861429|NCT01759875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64861430|NCT01759875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64861431|NCT01759875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64861432|NCT01759875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64861433|NCT01759875|Lipotropic Agents|lipotropic agents|mesh-ancestor
64861434|NCT01759875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64861435|NCT01759875|Antimetabolites|antimetabolites|mesh-ancestor
64861459|NCT01760096|Antifungal Agents|antifungal agents|mesh-ancestor
64861460|NCT01760096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64861461|NCT01760096|Dermatologic Agents|dermatologic agents|mesh-ancestor
64861462|NCT01760096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64861463|NCT01760096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64861464|NCT01760096|Hormones|hormones|mesh-ancestor
64861465|NCT01760096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64861466|NCT01760096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64861467|NCT01760096|Antinematodal Agents|antinematodal agents|mesh-ancestor
64861468|NCT01760096|Anthelmintics|anthelmintics|mesh-ancestor
64861469|NCT01760096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64861470|NCT01760109|Piperacillin|piperacillin|mesh-list
64861471|NCT01760109|Sulbactam|sulbactam|mesh-list
64861472|NCT01760109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64861473|NCT01760109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64861474|NCT01760109|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64861475|NCT01760109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861476|NCT01760109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861477|NCT01760122|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64861478|NCT01760122|Antiviral Agents|antiviral agents|mesh-ancestor
64861479|NCT01760122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64861480|NCT01760148|Interferons|interferons|mesh-list
64861481|NCT01760148|Ribavirin|ribavirin|mesh-list
64861482|NCT01760148|Interferon-alpha|interferon-alpha|mesh-list
64861483|NCT01760148|Interferon alpha-2|interferon alpha-2|mesh-list
64861484|NCT01760148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861485|NCT01760148|Antiviral Agents|antiviral agents|mesh-ancestor
64861486|NCT01760148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64861487|NCT01760148|Antimetabolites|antimetabolites|mesh-ancestor
64861488|NCT01760148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861489|NCT01760148|Immunologic Factors|immunologic factors|mesh-ancestor
64861490|NCT01760148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407148|NCT02684461|Tubulin Modulators|tubulin modulators|mesh-ancestor
64861511|NCT01760226|Etoposide|etoposide|mesh-list
64861512|NCT01760226|Vincristine|vincristine|mesh-list
64861513|NCT01760226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64861514|NCT01760226|Immunologic Factors|immunologic factors|mesh-ancestor
64861515|NCT01760226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861516|NCT01760226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64861517|NCT01760226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64861518|NCT01760226|Alkylating Agents|alkylating agents|mesh-ancestor
64861519|NCT01760226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861520|NCT01760226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861521|NCT01760226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64861522|NCT01760226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64861523|NCT01760226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64861524|NCT01760226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64861525|NCT01760226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64861526|NCT01760226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861527|NCT01760226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64861528|NCT01760226|Glucocorticoids|glucocorticoids|mesh-ancestor
64861529|NCT01760226|Hormones|hormones|mesh-ancestor
64861530|NCT01760226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64861531|NCT01760226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64861532|NCT01760226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64861533|NCT01760226|Abortifacient Agents|abortifacient agents|mesh-ancestor
64861534|NCT01760226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64861535|NCT01760226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64861536|NCT01760226|Antimetabolites|antimetabolites|mesh-ancestor
64861537|NCT01760226|Dermatologic Agents|dermatologic agents|mesh-ancestor
64861538|NCT01760226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64861539|NCT01760226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64861540|NCT01760226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64861541|NCT01760226|Tubulin Modulators|tubulin modulators|mesh-ancestor
64861542|NCT01760226|Antimitotic Agents|antimitotic agents|mesh-ancestor
64861543|NCT01760226|Mitosis Modulators|mitosis modulators|mesh-ancestor
64861544|NCT01760252|Capecitabine|capecitabine|mesh-list
64861545|NCT01760252|Oxaliplatin|oxaliplatin|mesh-list
64861546|NCT01760252|Irinotecan|irinotecan|mesh-list
64861547|NCT01760252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64861548|NCT01760252|Antimetabolites|antimetabolites|mesh-ancestor
64861549|NCT01760252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861550|NCT01760252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861551|NCT01760252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64861552|NCT01760252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64861553|NCT01760252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861554|NCT01760278|Cetrorelix|cetrorelix|mesh-list
64861596|NCT01760564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64861597|NCT01760564|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64861598|NCT01760564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64861599|NCT01760564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861600|NCT01760577|Botulinum Toxins|botulinum toxins|mesh-list
64861601|NCT01760577|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64861602|NCT01760577|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64861603|NCT01760577|Hyaluronic Acid|hyaluronic acid|mesh-list
64861620|NCT01760642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64861621|NCT01760642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64861622|NCT01760642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861623|NCT01760642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64861624|NCT01760642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64861625|NCT01760642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64861626|NCT01760642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65274049|NCT00380627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64796641|NCT04040959|Niacin|niacin|mesh-list
64861627|NCT01760642|Anesthetics, General|anesthetics, general|mesh-ancestor
64861628|NCT01760642|Anesthetics|anesthetics|mesh-ancestor
64861629|NCT01760642|GABA Modulators|gaba modulators|mesh-ancestor
64861630|NCT01760642|GABA Agents|gaba agents|mesh-ancestor
64861631|NCT01760642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64861636|NCT01760642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64861637|NCT01760642|Leprostatic Agents|leprostatic agents|mesh-ancestor
64861638|NCT01760642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64861639|NCT01760642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861640|NCT01760642|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64861641|NCT01760642|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64861642|NCT01760642|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64861643|NCT01760642|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64861644|NCT01760642|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64861645|NCT01760642|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64861646|NCT01760642|Antifungal Agents|antifungal agents|mesh-ancestor
64861647|NCT01760642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64861648|NCT01760642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64861649|NCT01760642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64861650|NCT01760642|Hormone Antagonists|hormone antagonists|mesh-ancestor
64861651|NCT01760642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64861652|NCT01760642|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64861653|NCT01760694|Leucovorin|leucovorin|mesh-list
64861654|NCT01760694|Oxaliplatin|oxaliplatin|mesh-list
64861655|NCT01760694|Irinotecan|irinotecan|mesh-list
64861656|NCT01760694|Folfirinox|folfirinox|mesh-list
64861657|NCT01760694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861658|NCT01760694|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64861659|NCT01760694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64861660|NCT01760694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861661|NCT01760694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861662|NCT01760694|Antidotes|antidotes|mesh-ancestor
64861663|NCT01760694|Protective Agents|protective agents|mesh-ancestor
64861664|NCT01760694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575166|NCT04781075|Anesthetics|anesthetics|mesh-ancestor
64861665|NCT01760694|Vitamin B Complex|vitamin b complex|mesh-ancestor
64861695|NCT01760824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64861696|NCT01760824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64861697|NCT01760824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64861698|NCT01760824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861699|NCT01760824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861700|NCT01760824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64861701|NCT01760824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64861717|NCT01760967|Adrenergic Agents|adrenergic agents|mesh-ancestor
64861718|NCT01760967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64861719|NCT01760967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861720|NCT01760980|Exemestane|exemestane|mesh-list
64861721|NCT01760980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861722|NCT01760980|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64861723|NCT01760980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64861724|NCT01760980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861725|NCT01760980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861726|NCT01760980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64861727|NCT01760980|Hormone Antagonists|hormone antagonists|mesh-ancestor
64407395|NCT03038321|Lornoxicam|lornoxicam|mesh-list
64861742|NCT01761071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861744|NCT01761110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64861745|NCT01761110|Narcotics|narcotics|mesh-ancestor
64861746|NCT01761110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64861747|NCT01761110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861748|NCT01761110|Analgesics|analgesics|mesh-ancestor
64861749|NCT01761110|Sensory System Agents|sensory system agents|mesh-ancestor
64861750|NCT01761110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64861751|NCT01761110|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65494889|NCT00883480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861752|NCT01761149|Remifentanil|remifentanil|mesh-list
64861753|NCT01761149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64473029|NCT01718743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473030|NCT01718743|Protease Inhibitors|protease inhibitors|mesh-ancestor
64473031|NCT01718743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473032|NCT01718743|Glycine Agents|glycine agents|mesh-ancestor
65274050|NCT00380627|Analgesics|analgesics|mesh-ancestor
65274051|NCT00380627|Sensory System Agents|sensory system agents|mesh-ancestor
64473033|NCT01718743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64861755|NCT01761149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64861756|NCT01761149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861757|NCT01761149|Analgesics|analgesics|mesh-ancestor
64861758|NCT01761149|Sensory System Agents|sensory system agents|mesh-ancestor
64861759|NCT01761149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64861760|NCT01761201|Levofloxacin|levofloxacin|mesh-list
64861770|NCT01761201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861771|NCT01761201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861772|NCT01761201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64861773|NCT01761201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64861774|NCT01761201|Antitubercular Agents|antitubercular agents|mesh-ancestor
64861775|NCT01761201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64861776|NCT01761201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64861778|NCT01761201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64861779|NCT01761214|Amoxicillin|amoxicillin|mesh-list
64861780|NCT01761214|Moxifloxacin|moxifloxacin|mesh-list
64861781|NCT01761214|Ciprofloxacin|ciprofloxacin|mesh-list
64861782|NCT01761214|Clavulanic Acid|clavulanic acid|mesh-list
64861783|NCT01761214|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64861784|NCT01761214|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
64861785|NCT01761214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64861786|NCT01761214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64861787|NCT01761214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64861788|NCT01761214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64861789|NCT01761214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861790|NCT01761214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861823|NCT01761526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861824|NCT01761552|Atropine|atropine|mesh-list
64861825|NCT01761552|Neostigmine|neostigmine|mesh-list
64861848|NCT01761656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494890|NCT00883480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65494891|NCT00883480|Antimetabolites|antimetabolites|mesh-ancestor
64861857|NCT01761916|Clonidine|clonidine|mesh-list
64861858|NCT01761916|Captopril|captopril|mesh-list
64861859|NCT01761916|Analgesics|analgesics|mesh-ancestor
64861860|NCT01761916|Sensory System Agents|sensory system agents|mesh-ancestor
64861861|NCT01761916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64861862|NCT01761916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861863|NCT01761916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64861864|NCT01761916|Sympatholytics|sympatholytics|mesh-ancestor
64861865|NCT01761916|Autonomic Agents|autonomic agents|mesh-ancestor
64861866|NCT01761916|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64861867|NCT01761916|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64861868|NCT01761916|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64861869|NCT01761916|Adrenergic Agents|adrenergic agents|mesh-ancestor
64861870|NCT01761916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64861871|NCT01761916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861872|NCT01761916|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64861873|NCT01761916|Protease Inhibitors|protease inhibitors|mesh-ancestor
64861874|NCT01761916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861875|NCT01761968|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
64861876|NCT01761968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64861877|NCT01761968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494905|NCT05418946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494906|NCT05418946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65494907|NCT05418946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494908|NCT03097588|Palonosetron|palonosetron|mesh-list
65494909|NCT03097588|Antiemetics|antiemetics|mesh-ancestor
64473051|NCT01701674|Analgesics|analgesics|mesh-ancestor
64861899|NCT01762046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64861900|NCT01762046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861901|NCT01762150|Gemcitabine|gemcitabine|mesh-list
64861903|NCT01762150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861904|NCT01762150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64861905|NCT01762150|Antimetabolites|antimetabolites|mesh-ancestor
64861906|NCT01762150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861907|NCT01762150|Antiviral Agents|antiviral agents|mesh-ancestor
64861908|NCT01762150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64861909|NCT01762150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318872|NCT05534750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861910|NCT01762150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64861911|NCT01762150|Immunologic Factors|immunologic factors|mesh-ancestor
64861912|NCT01762150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861913|NCT01762150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64861914|NCT01762163|Aspirin|aspirin|mesh-list
64861915|NCT01762163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64861916|NCT01762163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64861954|NCT01762306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861956|NCT01762306|Vitamin B Complex|vitamin b complex|mesh-ancestor
64861957|NCT01762306|Vitamins|vitamins|mesh-ancestor
64861958|NCT01762306|Micronutrients|micronutrients|mesh-ancestor
64861959|NCT01762319|Vitamin B 6|vitamin b 6|mesh-list
64861960|NCT01762319|Pyridoxal|pyridoxal|mesh-list
64861961|NCT01762319|Pyridoxine|pyridoxine|mesh-list
64861962|NCT01762319|Misoprostol|misoprostol|mesh-list
64861963|NCT01762319|Vitamins|vitamins|mesh-ancestor
64861964|NCT01762319|Micronutrients|micronutrients|mesh-ancestor
64861965|NCT01762319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861966|NCT01762319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64861967|NCT01762319|Abortifacient Agents|abortifacient agents|mesh-ancestor
64861968|NCT01762319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64861969|NCT01762319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64861970|NCT01762319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64861971|NCT01762319|Oxytocics|oxytocics|mesh-ancestor
64861972|NCT01762319|Vitamin B Complex|vitamin b complex|mesh-ancestor
64862006|NCT01762475|Urological Agents|urological agents|mesh-ancestor
64862007|NCT01762514|Amifostine|amifostine|mesh-list
64862008|NCT01762514|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64862009|NCT01762514|Protective Agents|protective agents|mesh-ancestor
64862010|NCT01762514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862011|NCT01762540|Prednisolone|prednisolone|mesh-list
64862036|NCT01762644|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64862037|NCT01762657|Cyclosporine|cyclosporine|mesh-list
64862038|NCT01762657|Lansoprazole|lansoprazole|mesh-list
64862039|NCT01762657|Dexlansoprazole|dexlansoprazole|mesh-list
64862040|NCT01762657|Cyclosporins|cyclosporins|mesh-list
64862041|NCT01762657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862042|NCT01762657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862043|NCT01762657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64862044|NCT01762657|Immunologic Factors|immunologic factors|mesh-ancestor
64862045|NCT01762657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862046|NCT01762657|Antifungal Agents|antifungal agents|mesh-ancestor
64862047|NCT01762657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64862048|NCT01762657|Dermatologic Agents|dermatologic agents|mesh-ancestor
64862049|NCT01762657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64862050|NCT01762657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64862051|NCT01762657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64862052|NCT01762657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64862053|NCT01762657|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64862054|NCT01762670|Metronidazole|metronidazole|mesh-list
64862055|NCT01762670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64862056|NCT01762670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64862057|NCT01762670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64862058|NCT01762670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64862059|NCT01762787|Aspirin|aspirin|mesh-list
64862060|NCT01762787|Prednisolone|prednisolone|mesh-list
64862061|NCT01762787|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64862062|NCT01762787|Methylprednisolone|methylprednisolone|mesh-list
64862063|NCT01762787|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64862064|NCT01762787|Prednisolone acetate|prednisolone acetate|mesh-list
64862065|NCT01762787|Cantharidin|cantharidin|mesh-list
64862066|NCT01762787|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65494910|NCT03097588|Autonomic Agents|autonomic agents|mesh-ancestor
64473053|NCT01701674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64473054|NCT01701674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64862067|NCT01762787|Prednisolone phosphate|prednisolone phosphate|mesh-list
64862068|NCT01762787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64862069|NCT01762787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64862070|NCT01762787|Analgesics|analgesics|mesh-ancestor
64862071|NCT01762787|Sensory System Agents|sensory system agents|mesh-ancestor
64862072|NCT01762787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64862073|NCT01762787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862074|NCT01762787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64862075|NCT01762787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64862076|NCT01762787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64862077|NCT01762787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64862078|NCT01762787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274052|NCT00380627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64862127|NCT01762891|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64862128|NCT01762891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64862139|NCT01762995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862140|NCT01762995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862141|NCT01762995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64862142|NCT01762995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64862143|NCT01762995|Antiviral Agents|antiviral agents|mesh-ancestor
64862151|NCT01763021|Antitubercular Agents|antitubercular agents|mesh-ancestor
64862152|NCT01763021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64862153|NCT01763021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64862154|NCT01763021|Leprostatic Agents|leprostatic agents|mesh-ancestor
65494911|NCT03097588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65494912|NCT03097588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862155|NCT01763021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64862156|NCT01763021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862157|NCT01763021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862158|NCT01763021|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64862159|NCT01763021|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64862160|NCT01763021|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64862161|NCT01763021|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64862162|NCT01763021|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64862163|NCT01763021|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64862164|NCT01763281|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
64862166|NCT01763281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64862167|NCT01763281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862168|NCT01763385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64862169|NCT01763385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862170|NCT01763385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64862171|NCT01763385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862172|NCT01763385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862173|NCT01763424|Calcitriol|calcitriol|mesh-list
64862174|NCT01763424|Niacinamide|niacinamide|mesh-list
64862175|NCT01763424|Niacin|niacin|mesh-list
64862176|NCT01763424|Nicotinic Acids|nicotinic acids|mesh-list
64862177|NCT01763424|Calcipotriene|calcipotriene|mesh-list
64630735|NCT04301492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64862178|NCT01763424|Vitamin B Complex|vitamin b complex|mesh-ancestor
64862179|NCT01763424|Vitamins|vitamins|mesh-ancestor
64862180|NCT01763424|Micronutrients|micronutrients|mesh-ancestor
64862181|NCT01763424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862182|NCT01763424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64862183|NCT01763424|Antimetabolites|antimetabolites|mesh-ancestor
64862184|NCT01763424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862185|NCT01763424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64862186|NCT01763424|Vasodilator Agents|vasodilator agents|mesh-ancestor
64862187|NCT01763424|Dermatologic Agents|dermatologic agents|mesh-ancestor
64862188|NCT01763424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64862189|NCT01763424|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64862190|NCT01763424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64862191|NCT01763424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64862192|NCT01763424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64862193|NCT01763437|Tetracycline|tetracycline|mesh-list
64862194|NCT01763437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64862195|NCT01763437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64862228|NCT01763463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64862229|NCT01763463|Sympathomimetics|sympathomimetics|mesh-ancestor
64862230|NCT01763476|Paclitaxel|paclitaxel|mesh-list
64862231|NCT01763476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64862232|NCT01763476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862233|NCT01763476|Tubulin Modulators|tubulin modulators|mesh-ancestor
64862234|NCT01763476|Antimitotic Agents|antimitotic agents|mesh-ancestor
64862235|NCT01763476|Mitosis Modulators|mitosis modulators|mesh-ancestor
64862236|NCT01763476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862265|NCT01763658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64862266|NCT01763658|Glucocorticoids|glucocorticoids|mesh-ancestor
64862268|NCT01763658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64862269|NCT01763658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64862270|NCT01763658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862271|NCT01763658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862272|NCT01763658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64862273|NCT01763658|Protective Agents|protective agents|mesh-ancestor
64862274|NCT01763658|Immunologic Factors|immunologic factors|mesh-ancestor
64862275|NCT01763710|Paclitaxel|paclitaxel|mesh-list
64862276|NCT01763710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64862277|NCT01763710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64862278|NCT01763710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862279|NCT01763710|Tubulin Modulators|tubulin modulators|mesh-ancestor
64862280|NCT01763710|Antimitotic Agents|antimitotic agents|mesh-ancestor
64862281|NCT01763710|Mitosis Modulators|mitosis modulators|mesh-ancestor
64862282|NCT01763710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862283|NCT01763749|Clopidogrel|clopidogrel|mesh-list
64862325|NCT01764178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64862326|NCT01764178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64862327|NCT01764178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862328|NCT01764178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64862329|NCT01764178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64862361|NCT01764451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64862362|NCT01764451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862364|NCT01764555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64862365|NCT01764555|Analgesics|analgesics|mesh-ancestor
64862366|NCT01764555|Sensory System Agents|sensory system agents|mesh-ancestor
64862367|NCT01764555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64862368|NCT01764555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862369|NCT01764555|Antipyretics|antipyretics|mesh-ancestor
64862370|NCT01764581|Tacrolimus|tacrolimus|mesh-list
64862371|NCT01764581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64862372|NCT01764581|Immunologic Factors|immunologic factors|mesh-ancestor
64862373|NCT01764581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862374|NCT01764581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64862375|NCT01764581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862376|NCT01764581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862377|NCT01764672|Methylphenidate|methylphenidate|mesh-list
64862378|NCT01764672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64862379|NCT01764672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862380|NCT01764672|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64862381|NCT01764672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64862382|NCT01764672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64862383|NCT01764672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862384|NCT01764672|Dopamine Agents|dopamine agents|mesh-ancestor
64862385|NCT01764672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64862386|NCT01764750|Vancomycin|vancomycin|mesh-list
64862433|NCT01764867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862434|NCT01764867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64862435|NCT01764867|Analgesics|analgesics|mesh-ancestor
64862436|NCT01764867|Sensory System Agents|sensory system agents|mesh-ancestor
64862437|NCT01764867|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64862438|NCT01764867|Histamine Antagonists|histamine antagonists|mesh-ancestor
64862439|NCT01764867|Histamine Agents|histamine agents|mesh-ancestor
64862440|NCT01764867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64862441|NCT01764867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64862442|NCT01764867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64862443|NCT01764867|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64862444|NCT01764867|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64862445|NCT01764867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64862473|NCT01765010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64862474|NCT01765023|Metformin|metformin|mesh-list
64862478|NCT01765023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64862479|NCT01765023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65494914|NCT03097588|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64473057|NCT01701674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64473059|NCT01686126|Levonorgestrel|levonorgestrel|mesh-list
64473060|NCT01686126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64473061|NCT01686126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473062|NCT01686126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64473063|NCT01686126|Contraceptive Agents|contraceptive agents|mesh-ancestor
64473064|NCT01686126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64473065|NCT01686126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64473066|NCT01686126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64473067|NCT01686126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64473068|NCT01531582|Minocycline|minocycline|mesh-list
64473069|NCT01531582|Tetracycline|tetracycline|mesh-list
64473070|NCT01531582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64862484|NCT01765023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862485|NCT01765088|Temozolomide|temozolomide|mesh-list
64862486|NCT01765088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64862487|NCT01765088|Alkylating Agents|alkylating agents|mesh-ancestor
64862488|NCT01765088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862489|NCT01765088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862490|NCT01765231|Entecavir|entecavir|mesh-list
64862491|NCT01765231|Antiviral Agents|antiviral agents|mesh-ancestor
64862492|NCT01765231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64862493|NCT01765257|Rasagiline|rasagiline|mesh-list
64862494|NCT01765257|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64862495|NCT01765257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862496|NCT01765257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862497|NCT01765257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64862498|NCT01765257|Protective Agents|protective agents|mesh-ancestor
64862499|NCT01765257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862500|NCT01765309|Botulinum Toxins|botulinum toxins|mesh-list
64862501|NCT01765309|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64862502|NCT01765309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64862503|NCT01765309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862504|NCT01765309|Cholinergic Agents|cholinergic agents|mesh-ancestor
64862505|NCT01765309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64862506|NCT01765309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862507|NCT01765374|Rituximab|rituximab|mesh-list
64862508|NCT01765374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65494915|NCT03097588|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65494916|NCT03097588|Serotonin Agents|serotonin agents|mesh-ancestor
65494917|NCT03097588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65494918|NCT03097588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494919|NCT04956640|Carboplatin|carboplatin|mesh-list
65494920|NCT04956640|Pembrolizumab|pembrolizumab|mesh-list
65494921|NCT04956640|Pemetrexed|pemetrexed|mesh-list
65494922|NCT04956640|Cetuximab|cetuximab|mesh-list
65494923|NCT04956640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494924|NCT04956640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65494925|NCT04956640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494926|NCT04956640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494927|NCT04956640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65494928|NCT04956640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65494929|NCT04939792|Vitamin D|vitamin d|mesh-list
65494930|NCT04939792|Ergocalciferols|ergocalciferols|mesh-list
65494931|NCT04939792|Cholecalciferol|cholecalciferol|mesh-list
65494932|NCT04939792|Vitamins|vitamins|mesh-list
65494933|NCT04939792|Micronutrients|micronutrients|mesh-ancestor
65494934|NCT04939792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494935|NCT04939792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65494936|NCT04939792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64408283|NCT05052619|Cefmetazole|cefmetazole|mesh-list
64862529|NCT01765556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862530|NCT01765556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64862531|NCT01765556|Hormone Antagonists|hormone antagonists|mesh-ancestor
64862532|NCT01765556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64862533|NCT01765556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862534|NCT01765556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64862535|NCT01765556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862536|NCT01765556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64862537|NCT01765608|Zonisamide|zonisamide|mesh-list
64862538|NCT01765608|Anticonvulsants|anticonvulsants|mesh-ancestor
64862539|NCT01765608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64862540|NCT01765608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64862541|NCT01765608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862542|NCT01765608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64862548|NCT01765738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64862549|NCT01765738|Antitubercular Agents|antitubercular agents|mesh-ancestor
64862550|NCT01765738|Leprostatic Agents|leprostatic agents|mesh-ancestor
64862551|NCT01765738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64862552|NCT01765738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862553|NCT01765738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862554|NCT01765738|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64862555|NCT01765738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64862556|NCT01765738|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64862557|NCT01765738|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64862558|NCT01765738|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64862559|NCT01765738|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64862560|NCT01765790|Antibodies|antibodies|mesh-list
64862561|NCT01765790|Immunoglobulins|immunoglobulins|mesh-list
64862562|NCT01765790|Immunologic Factors|immunologic factors|mesh-ancestor
64862563|NCT01765790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862564|NCT01765829|Droperidol|droperidol|mesh-list
64862565|NCT01765829|Haloperidol|haloperidol|mesh-list
64862590|NCT01765829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64862592|NCT01765829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64862593|NCT01765829|Dopamine Agents|dopamine agents|mesh-ancestor
64862594|NCT01765829|Antiemetics|antiemetics|mesh-ancestor
64862595|NCT01765829|Autonomic Agents|autonomic agents|mesh-ancestor
64862596|NCT01765829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64862597|NCT01765829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64862598|NCT01765829|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64862599|NCT01765829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64862600|NCT01765829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64862601|NCT01765829|Antidepressive Agents|antidepressive agents|mesh-ancestor
64862602|NCT01765829|Dopamine Agonists|dopamine agonists|mesh-ancestor
64862603|NCT01765829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64862604|NCT01765829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64862605|NCT01765829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64862606|NCT01765829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64862607|NCT01765829|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64862608|NCT01765829|GABA Antagonists|gaba antagonists|mesh-ancestor
64862609|NCT01765829|GABA Agents|gaba agents|mesh-ancestor
64862610|NCT01765829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64862611|NCT01765829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64862612|NCT01765842|Rituximab|rituximab|mesh-list
64862613|NCT01765842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64862614|NCT01765842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862616|NCT01765842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862617|NCT01765842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64862619|NCT01765855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64862653|NCT01766063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862654|NCT01766063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64862655|NCT01766089|Dexmedetomidine|dexmedetomidine|mesh-list
64862657|NCT01766089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64862658|NCT01766089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64862659|NCT01766089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862660|NCT01766089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64862661|NCT01766089|Analgesics|analgesics|mesh-ancestor
64862662|NCT01766089|Sensory System Agents|sensory system agents|mesh-ancestor
64408439|NCT05028049|Narcotics|narcotics|mesh-ancestor
64862686|NCT01766258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64862687|NCT01766258|Dopamine Agents|dopamine agents|mesh-ancestor
64862688|NCT01766258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64862689|NCT01766258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862703|NCT01766375|Cyclosporins|cyclosporins|mesh-list
64862704|NCT01766375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64862705|NCT01766375|Abortifacient Agents|abortifacient agents|mesh-ancestor
64862706|NCT01766375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64862707|NCT01766375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862708|NCT01766375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64862709|NCT01766375|Antimetabolites|antimetabolites|mesh-ancestor
64862710|NCT01766375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862711|NCT01766375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862712|NCT01766375|Dermatologic Agents|dermatologic agents|mesh-ancestor
64862713|NCT01766375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862714|NCT01766375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64862715|NCT01766375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64862716|NCT01766375|Immunologic Factors|immunologic factors|mesh-ancestor
64862717|NCT01766375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64862718|NCT01766375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64862719|NCT01766375|Antifungal Agents|antifungal agents|mesh-ancestor
64862720|NCT01766375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64862721|NCT01766375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64862722|NCT01766375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64862746|NCT01766583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64862748|NCT01766583|Growth Inhibitors|growth inhibitors|mesh-ancestor
64862765|NCT01766830|Immunologic Factors|immunologic factors|mesh-ancestor
65494938|NCT05418244|Antiemetics|antiemetics|mesh-ancestor
64862766|NCT01766830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274053|NCT00380627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472075|NCT03831425|Ubiquinone|ubiquinone|mesh-list
64862767|NCT01766843|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64862769|NCT01766843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64862770|NCT01766843|Autonomic Agents|autonomic agents|mesh-ancestor
64862771|NCT01766843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64862772|NCT01766843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631335|NCT00059228|Estrogens|estrogens|mesh-ancestor
64862773|NCT01766843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64862774|NCT01766843|Respiratory System Agents|respiratory system agents|mesh-ancestor
64862775|NCT01766843|Glucocorticoids|glucocorticoids|mesh-ancestor
64862776|NCT01766843|Hormones|hormones|mesh-ancestor
64862777|NCT01766843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64862778|NCT01766843|Sympathomimetics|sympathomimetics|mesh-ancestor
64862779|NCT01766843|Antidotes|antidotes|mesh-ancestor
64862780|NCT01766843|Protective Agents|protective agents|mesh-ancestor
64862781|NCT01766960|Morphine|morphine|mesh-list
64862782|NCT01766960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64862783|NCT01766960|Narcotics|narcotics|mesh-ancestor
64862784|NCT01766960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64862785|NCT01766960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862786|NCT01766960|Analgesics|analgesics|mesh-ancestor
64862787|NCT01766960|Sensory System Agents|sensory system agents|mesh-ancestor
64862802|NCT01767259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64862803|NCT01767259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64862804|NCT01767259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64862805|NCT01767259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862806|NCT01767259|Diuretics|diuretics|mesh-ancestor
64862814|NCT01767272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64862815|NCT01767272|Histamine Antagonists|histamine antagonists|mesh-ancestor
64862816|NCT01767272|Histamine Agents|histamine agents|mesh-ancestor
64862817|NCT01767272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64862818|NCT01767272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862819|NCT01767272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862821|NCT01767298|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64862822|NCT01767298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64862823|NCT01767298|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64862824|NCT01767298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64862825|NCT01767298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862826|NCT01767298|Diuretics|diuretics|mesh-ancestor
64862827|NCT01767298|Natriuretic Agents|natriuretic agents|mesh-ancestor
64862828|NCT01767298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862829|NCT01767298|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64862830|NCT01767298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64862831|NCT01767363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
64862832|NCT01767363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
64862833|NCT01767363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64862834|NCT01767363|Adrenergic Agents|adrenergic agents|mesh-ancestor
64862835|NCT01767363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64862836|NCT01767363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862837|NCT01767363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862838|NCT01767363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64862839|NCT01767363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862840|NCT01767363|Hormone Antagonists|hormone antagonists|mesh-ancestor
64862841|NCT01767363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64862842|NCT01767389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64862843|NCT01767389|Protease Inhibitors|protease inhibitors|mesh-ancestor
64862844|NCT01767389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473081|NCT01512888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64576254|NCT01535001|Acetaminophen|acetaminophen|mesh-list
64862845|NCT01767389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862846|NCT01767389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64862847|NCT01767389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862848|NCT01767402|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64862849|NCT01767402|Immunologic Factors|immunologic factors|mesh-ancestor
64862883|NCT01767545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64862884|NCT01767545|Glucocorticoids|glucocorticoids|mesh-ancestor
64862886|NCT01767545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64862887|NCT01767545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65274054|NCT00380627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65274055|NCT00380627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65274056|NCT00380627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65274057|NCT00380627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65274058|NCT00380627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274059|NCT00380627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274060|NCT00212771|Olanzapine|olanzapine|mesh-list
64862889|NCT01767571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64862890|NCT01767571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64862891|NCT01767584|Cephalexin|cephalexin|mesh-list
64862892|NCT01767584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64862893|NCT01767584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64862894|NCT01767610|Infliximab|infliximab|mesh-list
64862895|NCT01767610|Fenofibrate|fenofibrate|mesh-list
64862896|NCT01767610|Pitavastatin|pitavastatin|mesh-list
64862897|NCT01767610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64862898|NCT01767610|Antimetabolites|antimetabolites|mesh-ancestor
64862899|NCT01767610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862900|NCT01767610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64862901|NCT01767610|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64862902|NCT01767610|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64862903|NCT01767610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862904|NCT01767610|Dermatologic Agents|dermatologic agents|mesh-ancestor
64862905|NCT01767610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64862906|NCT01767610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65494939|NCT05418244|Autonomic Agents|autonomic agents|mesh-ancestor
65494940|NCT05418244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64473082|NCT01512888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862926|NCT01768039|Micronutrients|micronutrients|mesh-ancestor
64862927|NCT01768039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862928|NCT01768039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64862929|NCT01768078|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64862930|NCT01768078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64862931|NCT01768078|Betamethasone|betamethasone|mesh-list
64862932|NCT01768078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64862933|NCT01768078|Antitubercular Agents|antitubercular agents|mesh-ancestor
64862934|NCT01768078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64862935|NCT01768078|Glucocorticoids|glucocorticoids|mesh-ancestor
64862936|NCT01768078|Hormones|hormones|mesh-ancestor
64862937|NCT01768078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64862938|NCT01768078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862939|NCT01768078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64862940|NCT01768078|Respiratory System Agents|respiratory system agents|mesh-ancestor
64862941|NCT01768182|Leucovorin|leucovorin|mesh-list
64862942|NCT01768182|Folic Acid|folic acid|mesh-list
64862951|NCT01768195|Entecavir|entecavir|mesh-list
64862952|NCT01768195|Antiviral Agents|antiviral agents|mesh-ancestor
64862953|NCT01768195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64862954|NCT01768208|Saxagliptin|saxagliptin|mesh-list
64862955|NCT01768208|Incretins|incretins|mesh-ancestor
64862956|NCT01768208|Hormones|hormones|mesh-ancestor
64862957|NCT01768208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64862958|NCT01768208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862959|NCT01768208|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64862960|NCT01768208|Protease Inhibitors|protease inhibitors|mesh-ancestor
64862961|NCT01768208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862962|NCT01768208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862963|NCT01768208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64862964|NCT01768247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64862965|NCT01768247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64862966|NCT01768247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862967|NCT01768260|Aspirin|aspirin|mesh-list
64862968|NCT01768260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64862969|NCT01768260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64862970|NCT01768260|Analgesics|analgesics|mesh-ancestor
64862971|NCT01768260|Sensory System Agents|sensory system agents|mesh-ancestor
64862985|NCT01768273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64862986|NCT01768273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65274061|NCT00212771|Asenapine|asenapine|mesh-list
65274062|NCT00212771|Antiemetics|antiemetics|mesh-ancestor
65274063|NCT00212771|Autonomic Agents|autonomic agents|mesh-ancestor
64472079|NCT03831425|Vitamins|vitamins|mesh-ancestor
64862987|NCT01768273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862988|NCT01768273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64862989|NCT01768273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64862990|NCT01768273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64862991|NCT01768273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64862992|NCT01768273|Anesthetics, General|anesthetics, general|mesh-ancestor
64862993|NCT01768273|Anesthetics|anesthetics|mesh-ancestor
64862994|NCT01768273|GABA Modulators|gaba modulators|mesh-ancestor
64862995|NCT01768273|GABA Agents|gaba agents|mesh-ancestor
64862996|NCT01768273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64862997|NCT01768273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862998|NCT01768299|Misoprostol|misoprostol|mesh-list
64862999|NCT01768299|Mifepristone|mifepristone|mesh-list
64631558|NCT00003148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863000|NCT01768299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64863001|NCT01768299|Abortifacient Agents|abortifacient agents|mesh-ancestor
64863002|NCT01768299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64863003|NCT01768299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863004|NCT01768299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65494941|NCT05418244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473083|NCT01512888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64473084|NCT01493453|Cyclophosphamide|cyclophosphamide|mesh-list
64863005|NCT01768299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64863006|NCT01768299|Oxytocics|oxytocics|mesh-ancestor
64863007|NCT01768299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64863008|NCT01768299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64863009|NCT01768299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64863010|NCT01768299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64863020|NCT01768312|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64863021|NCT01768312|Cyclosporins|cyclosporins|mesh-list
64863022|NCT01768312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863023|NCT01768312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863024|NCT01768312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64863025|NCT01768312|Immunologic Factors|immunologic factors|mesh-ancestor
64863026|NCT01768312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863027|NCT01768312|Antifungal Agents|antifungal agents|mesh-ancestor
64863028|NCT01768312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863029|NCT01768312|Dermatologic Agents|dermatologic agents|mesh-ancestor
64863030|NCT01768312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64863031|NCT01768312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64863032|NCT01768312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64863033|NCT01768351|Calcitriol|calcitriol|mesh-list
64863034|NCT01768351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64863035|NCT01768351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863036|NCT01768351|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64863037|NCT01768351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64863056|NCT01768377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64863058|NCT01768377|Sensory System Agents|sensory system agents|mesh-ancestor
64863059|NCT01768377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64863060|NCT01768377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64863061|NCT01768377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64863062|NCT01768377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64863063|NCT01768377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64863064|NCT01768377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863065|NCT01768377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64863066|NCT01768377|Narcotics|narcotics|mesh-ancestor
64863067|NCT01768377|Analgesics|analgesics|mesh-ancestor
64863068|NCT01768377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64863069|NCT01768377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64863070|NCT01768377|Anesthetics, General|anesthetics, general|mesh-ancestor
64863071|NCT01768377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64863072|NCT01768377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64631643|NCT00002812|Antimetabolites|antimetabolites|mesh-ancestor
64863073|NCT01768377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64863097|NCT01768507|Antioxidants|antioxidants|mesh-ancestor
64863098|NCT01768507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863099|NCT01768507|Protective Agents|protective agents|mesh-ancestor
64863100|NCT01768507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863101|NCT01768507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274064|NCT00212771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65274065|NCT00212771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863102|NCT01768507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64863103|NCT01768663|Itraconazole|itraconazole|mesh-list
64863104|NCT01768663|Ciprofloxacin|ciprofloxacin|mesh-list
64863105|NCT01768663|Rifampin|rifampin|mesh-list
64863106|NCT01768663|Ivacaftor|ivacaftor|mesh-list
64863107|NCT01768663|Antifungal Agents|antifungal agents|mesh-ancestor
65494942|NCT05418244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65494943|NCT05418244|Antipruritics|antipruritics|mesh-ancestor
64576494|NCT04794738|Morphine|morphine|mesh-list
64863108|NCT01768663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863109|NCT01768663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64863110|NCT01768663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64863111|NCT01768663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863112|NCT01768663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863113|NCT01768663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64863460|NCT01770171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64863461|NCT01770171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64863462|NCT01770171|Growth Substances|growth substances|mesh-ancestor
64863463|NCT01770171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863464|NCT01770171|Growth Inhibitors|growth inhibitors|mesh-ancestor
64863465|NCT01770197|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64863466|NCT01770197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64863513|NCT01770444|Immunologic Factors|immunologic factors|mesh-ancestor
64863514|NCT01770444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863516|NCT01770470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64863517|NCT01770470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64863518|NCT01770470|Antimetabolites|antimetabolites|mesh-ancestor
64863519|NCT01770470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863520|NCT01770470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64863521|NCT01770470|Chelating Agents|chelating agents|mesh-ancestor
64863522|NCT01770470|Sequestering Agents|sequestering agents|mesh-ancestor
64863524|NCT01770470|Coagulants|coagulants|mesh-ancestor
64863525|NCT01770600|Risperidone|risperidone|mesh-list
64863526|NCT01770600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64863527|NCT01770600|Serotonin Agents|serotonin agents|mesh-ancestor
64863528|NCT01770600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64863529|NCT01770600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863530|NCT01770600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863531|NCT01770600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64863532|NCT01770600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65494944|NCT05418244|Dermatologic Agents|dermatologic agents|mesh-ancestor
64473085|NCT01493453|Fludarabine|fludarabine|mesh-list
64473086|NCT01493453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64863551|NCT01770795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863552|NCT01770795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863553|NCT01770795|Antiviral Agents|antiviral agents|mesh-ancestor
64863554|NCT01770795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863555|NCT01770795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863556|NCT01770795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64863557|NCT01770795|Immunologic Factors|immunologic factors|mesh-ancestor
64863558|NCT01770795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863559|NCT01770899|Montelukast|montelukast|mesh-list
64863560|NCT01770899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64863561|NCT01770899|Respiratory System Agents|respiratory system agents|mesh-ancestor
64863562|NCT01770899|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64863563|NCT01770899|Hormone Antagonists|hormone antagonists|mesh-ancestor
64863564|NCT01770899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64863565|NCT01770899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863566|NCT01770899|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64863567|NCT01770899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64863568|NCT01770899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863569|NCT01770964|Pregabalin|pregabalin|mesh-list
64863685|NCT01771874|Antidepressive Agents|antidepressive agents|mesh-ancestor
64863686|NCT01771874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64863687|NCT01771874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64863688|NCT01771874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64863689|NCT01771874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64863690|NCT01771874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863691|NCT01771874|Dopamine Agents|dopamine agents|mesh-ancestor
64797675|NCT01386398|Bortezomib|bortezomib|mesh-list
64863692|NCT01771874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64863693|NCT01771874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863694|NCT01771874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64863695|NCT01771874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64863696|NCT01771874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863697|NCT01771874|Hallucinogens|hallucinogens|mesh-ancestor
64863698|NCT01771874|Serotonin Agents|serotonin agents|mesh-ancestor
64863699|NCT01771874|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64863720|NCT01772212|Antifungal Agents|antifungal agents|mesh-ancestor
64863721|NCT01772212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863722|NCT01772212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863723|NCT01772212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863724|NCT01772238|Amoxicillin|amoxicillin|mesh-list
64863725|NCT01772238|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64863726|NCT01772238|Clavulanic Acids|clavulanic acids|mesh-list
64863727|NCT01772238|Clavulanic Acid|clavulanic acid|mesh-list
64863728|NCT01772238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64863729|NCT01772238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863730|NCT01772238|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64863731|NCT01772238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863732|NCT01772238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863733|NCT01772251|Insulin|insulin|mesh-list
65494945|NCT05418244|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65494946|NCT05418244|Serotonin Agents|serotonin agents|mesh-ancestor
64863734|NCT01772251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64863735|NCT01772251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863736|NCT01772290|Itraconazole|itraconazole|mesh-list
64863737|NCT01772290|Fluconazole|fluconazole|mesh-list
64863738|NCT01772290|Rabeprazole|rabeprazole|mesh-list
64863739|NCT01772290|Antifungal Agents|antifungal agents|mesh-ancestor
64863740|NCT01772290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863741|NCT01772290|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64863742|NCT01772290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64863743|NCT01772290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632318|NCT00003268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64864059|NCT01774812|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
64864060|NCT01774812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64864061|NCT01774812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864063|NCT01774812|Micronutrients|micronutrients|mesh-ancestor
64864064|NCT01774812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64864065|NCT01774838|Clopidogrel|clopidogrel|mesh-list
64409084|NCT03076099|Analgesics|analgesics|mesh-ancestor
64864234|NCT01776671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64864235|NCT01776671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64864236|NCT01776671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64864237|NCT01776671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64864238|NCT01776671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64864239|NCT01776671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864240|NCT01776671|Antimanic Agents|antimanic agents|mesh-ancestor
64864241|NCT01776684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64864243|NCT01776684|Afatinib|afatinib|mesh-list
64864244|NCT01776684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64864245|NCT01776684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64864246|NCT01776684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64864247|NCT01776684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864248|NCT01776788|Insulin|insulin|mesh-list
64864249|NCT01776788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64864250|NCT01776788|Exenatide|exenatide|mesh-list
64864251|NCT01776788|Insulin Lispro|insulin lispro|mesh-list
64864252|NCT01776788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64864253|NCT01776788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864254|NCT01776788|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64864255|NCT01776788|Incretins|incretins|mesh-ancestor
64864256|NCT01776788|Hormones|hormones|mesh-ancestor
64864257|NCT01776788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64864258|NCT01776853|Levan|levan|mesh-list
64864259|NCT01776853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64864260|NCT01776970|Nabiximols|nabiximols|mesh-list
64864261|NCT01776970|Analgesics|analgesics|mesh-ancestor
64864262|NCT01776970|Sensory System Agents|sensory system agents|mesh-ancestor
64864263|NCT01776970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64864264|NCT01776970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864265|NCT01777087|Capsaicin|capsaicin|mesh-list
64864266|NCT01777087|Antipruritics|antipruritics|mesh-ancestor
64864267|NCT01777087|Dermatologic Agents|dermatologic agents|mesh-ancestor
65274066|NCT00212771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65274067|NCT00212771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64797778|NCT01386671|Metformin|metformin|mesh-list
64864268|NCT01777087|Sensory System Agents|sensory system agents|mesh-ancestor
64864269|NCT01777087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64864270|NCT01777087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864271|NCT01777100|Sufentanil|sufentanil|mesh-list
64864272|NCT01777100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64864273|NCT01777100|Narcotics|narcotics|mesh-ancestor
64864274|NCT01777100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64864275|NCT01777100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864276|NCT01777100|Analgesics|analgesics|mesh-ancestor
64864277|NCT01777100|Sensory System Agents|sensory system agents|mesh-ancestor
64864278|NCT01777100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64864414|NCT01778309|Expectorants|expectorants|mesh-ancestor
64864415|NCT01778309|Respiratory System Agents|respiratory system agents|mesh-ancestor
64864416|NCT01778309|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64864417|NCT01778309|Antioxidants|antioxidants|mesh-ancestor
64864418|NCT01778309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864419|NCT01778309|Protective Agents|protective agents|mesh-ancestor
64864420|NCT01778309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864421|NCT01778309|Antidotes|antidotes|mesh-ancestor
64864422|NCT01778400|Ethanol|ethanol|mesh-list
64864423|NCT01778400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64864424|NCT01778400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64864425|NCT01778400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64864426|NCT01778400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864427|NCT01778413|Tenofovir|tenofovir|mesh-list
64864610|NCT01779687|Antiviral Agents|antiviral agents|mesh-ancestor
64864611|NCT01779687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64409229|NCT05012137|Ropivacaine|ropivacaine|mesh-list
64864625|NCT01779843|Idarubicin|idarubicin|mesh-list
64864626|NCT01779843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64864627|NCT01779843|Antimetabolites|antimetabolites|mesh-ancestor
64864628|NCT01779843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864629|NCT01779843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64864630|NCT01779843|Antiviral Agents|antiviral agents|mesh-ancestor
64864631|NCT01779843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64864632|NCT01779843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64864633|NCT01779843|Immunologic Factors|immunologic factors|mesh-ancestor
64864634|NCT01779843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864635|NCT01779843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64864636|NCT01779843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64864637|NCT01779843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64864638|NCT01779843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64864639|NCT01779882|Cyclophosphamide|cyclophosphamide|mesh-list
64864640|NCT01779882|Busulfan|busulfan|mesh-list
64864641|NCT01779882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64633234|NCT00004114|Cytarabine|cytarabine|mesh-list
64864642|NCT01779882|Immunologic Factors|immunologic factors|mesh-ancestor
64864643|NCT01779882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864644|NCT01779882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64864645|NCT01779882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64864646|NCT01779882|Alkylating Agents|alkylating agents|mesh-ancestor
64864647|NCT01779882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864648|NCT01779882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64864649|NCT01779882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64864651|NCT01779908|Vitamins|vitamins|mesh-ancestor
64864652|NCT01779908|Micronutrients|micronutrients|mesh-ancestor
64864653|NCT01779908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864654|NCT01779908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64864655|NCT01779921|Thrombin|thrombin|mesh-list
64864656|NCT01779921|Hemostatics|hemostatics|mesh-ancestor
64864657|NCT01779921|Coagulants|coagulants|mesh-ancestor
64864658|NCT01780051|Metformin|metformin|mesh-list
64864659|NCT01780051|Repaglinide|repaglinide|mesh-list
64864660|NCT01780051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64864661|NCT01780051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864662|NCT01780181|Gemcitabine|gemcitabine|mesh-list
64864699|NCT01780233|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64864700|NCT01780233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64864701|NCT01780259|Triazolam|triazolam|mesh-list
64864702|NCT01780259|Esketamine|esketamine|mesh-list
64864703|NCT01780259|Antidepressive Agents|antidepressive agents|mesh-ancestor
64864765|NCT01780558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64864767|NCT01780558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64864768|NCT01780558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64864769|NCT01780558|Progestins|progestins|mesh-ancestor
64864770|NCT01780610|Letrozole|letrozole|mesh-list
64864798|NCT01780740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64864799|NCT01780740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64864802|NCT01780753|Antimalarials|antimalarials|mesh-ancestor
64864839|NCT01780948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64864840|NCT01780948|Immunologic Factors|immunologic factors|mesh-ancestor
64864841|NCT01780948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864842|NCT01781052|Iloprost|iloprost|mesh-list
64864843|NCT01781052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64864844|NCT01781052|Vasodilator Agents|vasodilator agents|mesh-ancestor
64864914|NCT01781897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864915|NCT01781897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864916|NCT01781936|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
64864917|NCT01781936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64864918|NCT01781936|Glucocorticoids|glucocorticoids|mesh-ancestor
64473088|NCT01493453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473089|NCT01493453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64409396|NCT03074773|Bupivacaine|bupivacaine|mesh-list
64865193|NCT01784107|Belotecan|belotecan|mesh-list
64865194|NCT01784107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64865195|NCT01784107|Alkylating Agents|alkylating agents|mesh-ancestor
64865280|NCT01784549|Gemcitabine|gemcitabine|mesh-list
64865281|NCT01784549|Docetaxel|docetaxel|mesh-list
64865282|NCT01784549|Pemetrexed|pemetrexed|mesh-list
65494948|NCT05418244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494949|NCT05418244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65494950|NCT05418244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65494951|NCT05418244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65494952|NCT05418244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65494953|NCT05418244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65494954|NCT05418166|Evolocumab|evolocumab|mesh-list
64865341|NCT01785030|Nitrous Oxide|nitrous oxide|mesh-list
64865342|NCT01785030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64865343|NCT01785030|Anesthetics, General|anesthetics, general|mesh-ancestor
64865344|NCT01785030|Anesthetics|anesthetics|mesh-ancestor
64865345|NCT01785030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64865346|NCT01785030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865347|NCT01785030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64865348|NCT01785030|Analgesics|analgesics|mesh-ancestor
64865349|NCT01785030|Sensory System Agents|sensory system agents|mesh-ancestor
64865350|NCT01785030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865351|NCT01785043|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64865352|NCT01785043|Liraglutide|liraglutide|mesh-list
64865353|NCT01785043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64865354|NCT01785043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865355|NCT01785043|Incretins|incretins|mesh-ancestor
64865356|NCT01785043|Hormones|hormones|mesh-ancestor
64865357|NCT01785043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64865388|NCT01785290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865389|NCT01785290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865391|NCT01785290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64865392|NCT01785290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64865393|NCT01785290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64865394|NCT01785290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64865483|NCT01785836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64865484|NCT01785836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64865485|NCT01785836|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64865486|NCT01785836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409535|NCT04807829|Antiemetics|antiemetics|mesh-ancestor
64865735|NCT01787669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64865736|NCT01787669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865737|NCT01787669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64865738|NCT01787669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64865739|NCT01787669|Growth Substances|growth substances|mesh-ancestor
64865740|NCT01787669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865741|NCT01787669|Growth Inhibitors|growth inhibitors|mesh-ancestor
64865742|NCT01787669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64865794|NCT01788254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64865795|NCT01788254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64865796|NCT01788254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867049|NCT01805388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867050|NCT01807741|Asenapine|asenapine|mesh-list
64867051|NCT01807741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64867052|NCT01807741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65274068|NCT00212771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64867053|NCT01807741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64867333|NCT01809886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867335|NCT01809886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64867336|NCT01809886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867337|NCT01809886|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64867338|NCT01809886|Autonomic Agents|autonomic agents|mesh-ancestor
64867638|NCT01812122|Immunologic Factors|immunologic factors|mesh-ancestor
64867639|NCT01812122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64867640|NCT01812122|Protease Inhibitors|protease inhibitors|mesh-ancestor
64867641|NCT01812122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867642|NCT01812122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867718|NCT01812434|Urological Agents|urological agents|mesh-ancestor
64867719|NCT01812538|Diclofenac|diclofenac|mesh-list
64867720|NCT01812538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64867721|NCT01812538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64867722|NCT01812538|Analgesics|analgesics|mesh-ancestor
64867723|NCT01812538|Sensory System Agents|sensory system agents|mesh-ancestor
64867724|NCT01812538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64867725|NCT01812538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867764|NCT01812928|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64867766|NCT01812928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867767|NCT01812954|Cyclosporine|cyclosporine|mesh-list
64867768|NCT01812954|Adalimumab|adalimumab|mesh-list
64867769|NCT01812954|Etanercept|etanercept|mesh-list
64867770|NCT01812954|Methotrexate|methotrexate|mesh-list
64867771|NCT01812954|Infliximab|infliximab|mesh-list
64867772|NCT01812954|Ustekinumab|ustekinumab|mesh-list
64867773|NCT01812954|Acitretin|acitretin|mesh-list
64867774|NCT01812954|Cyclosporins|cyclosporins|mesh-list
64409698|NCT03069781|Estradiol|estradiol|mesh-list
64868018|NCT01814098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64868019|NCT01814098|Antidepressive Agents|antidepressive agents|mesh-ancestor
64868020|NCT01814098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64868022|NCT01814163|Bevacizumab|bevacizumab|mesh-list
64868023|NCT01814163|Carboplatin|carboplatin|mesh-list
64868024|NCT01814163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64868025|NCT01814163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868026|NCT01814163|Tubulin Modulators|tubulin modulators|mesh-ancestor
64868027|NCT01814163|Antimitotic Agents|antimitotic agents|mesh-ancestor
64409736|NCT02593097|Metformin|metformin|mesh-list
64868170|NCT01814683|Antimalarials|antimalarials|mesh-ancestor
64868171|NCT01814683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64868172|NCT01814683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64868173|NCT01814683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64868175|NCT01814709|Rifampin|rifampin|mesh-list
64868176|NCT01814709|Antifungal Agents|antifungal agents|mesh-ancestor
64868177|NCT01814709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64868315|NCT01815437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64868317|NCT01815528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64868401|NCT01816412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868402|NCT01816412|Tubulin Modulators|tubulin modulators|mesh-ancestor
64868403|NCT01816412|Antimitotic Agents|antimitotic agents|mesh-ancestor
64868404|NCT01816412|Mitosis Modulators|mitosis modulators|mesh-ancestor
64868586|NCT01817400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64868587|NCT01817439|Amiodarone|amiodarone|mesh-list
64868588|NCT01817439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64868589|NCT01817439|Vasodilator Agents|vasodilator agents|mesh-ancestor
64868590|NCT01817439|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64868591|NCT01817439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64868592|NCT01817439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868593|NCT01817439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64868594|NCT01817439|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64868595|NCT01817439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64409904|NCT05272605|Vaccines|vaccines|mesh-list
64868680|NCT01818713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64868978|NCT01820455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868980|NCT01820624|Lithium Carbonate|lithium carbonate|mesh-list
64868981|NCT01820624|Antidepressive Agents|antidepressive agents|mesh-ancestor
64868982|NCT01820624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64868983|NCT01820624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868984|NCT01820624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868985|NCT01820624|Antimanic Agents|antimanic agents|mesh-ancestor
64868986|NCT01820624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64868987|NCT01820624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65274069|NCT00212771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64868988|NCT01820624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868989|NCT01820624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868990|NCT01820624|Keratolytic Agents|keratolytic agents|mesh-ancestor
64868991|NCT01820624|Dermatologic Agents|dermatologic agents|mesh-ancestor
64869048|NCT01820962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64869049|NCT01820962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64869050|NCT01821001|Bromocriptine|bromocriptine|mesh-list
64869051|NCT01821001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64869052|NCT01821001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64869053|NCT01821001|Hormone Antagonists|hormone antagonists|mesh-ancestor
64869054|NCT01821001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64869055|NCT01821001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869056|NCT01821001|Dopamine Agonists|dopamine agonists|mesh-ancestor
64869057|NCT01821001|Dopamine Agents|dopamine agents|mesh-ancestor
64869058|NCT01821001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64869059|NCT01821001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869088|NCT01821066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64869089|NCT01821066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65494961|NCT01631214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64577521|NCT03849651|Cyclophosphamide|cyclophosphamide|mesh-list
64869090|NCT01821066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64869091|NCT01821066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64869092|NCT01821066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410086|NCT05157711|Bismuth subgallate|bismuth subgallate|mesh-list
64869141|NCT01821274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64869142|NCT01821274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869143|NCT01821274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64869144|NCT01821274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869145|NCT01821274|Vasodilator Agents|vasodilator agents|mesh-ancestor
64869147|NCT01821404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64869148|NCT01821404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64869149|NCT01821404|Antimetabolites|antimetabolites|mesh-ancestor
64869171|NCT01821573|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64869172|NCT01821573|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64869173|NCT01821573|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64869174|NCT01821573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64869175|NCT01821573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869176|NCT01821573|Cholinergic Agents|cholinergic agents|mesh-ancestor
64869177|NCT01821573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64869178|NCT01821573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869179|NCT01821573|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64869180|NCT01821573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64869181|NCT01821612|Leucovorin|leucovorin|mesh-list
64869182|NCT01821612|Gemcitabine|gemcitabine|mesh-list
64869183|NCT01821612|Fluorouracil|fluorouracil|mesh-list
64869184|NCT01821612|Capecitabine|capecitabine|mesh-list
64869185|NCT01821612|Oxaliplatin|oxaliplatin|mesh-list
64869186|NCT01821612|Irinotecan|irinotecan|mesh-list
64869280|NCT01822418|S 20098|s 20098|mesh-list
64869281|NCT01822418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64869282|NCT01822418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64869283|NCT01822418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869284|NCT01822431|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64869285|NCT01822431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869393|NCT01823042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64869394|NCT01823042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869395|NCT01823042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64869396|NCT01823042|Immunologic Factors|immunologic factors|mesh-ancestor
64869492|NCT01824043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869493|NCT01824043|Growth Inhibitors|growth inhibitors|mesh-ancestor
64869494|NCT01824043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869495|NCT01824056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64869496|NCT01824056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64869497|NCT01824056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869498|NCT01824199|Omeprazole|omeprazole|mesh-list
64869499|NCT01824199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64869500|NCT01824199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64869501|NCT01824199|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64869502|NCT01824199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869503|NCT01824199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869504|NCT01824225|Aflibercept|aflibercept|mesh-list
64869505|NCT01824225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64798134|NCT01389206|Bosentan|bosentan|mesh-list
64869506|NCT01824225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64869507|NCT01824225|Growth Substances|growth substances|mesh-ancestor
64410256|NCT04340141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64869831|NCT01826279|Antioxidants|antioxidants|mesh-ancestor
64869832|NCT01826279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869833|NCT01826279|Protective Agents|protective agents|mesh-ancestor
64869921|NCT01827228|Immunologic Factors|immunologic factors|mesh-ancestor
64869922|NCT01827228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869924|NCT01827280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64869925|NCT01827280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869926|NCT01827280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64869927|NCT01827280|Protease Inhibitors|protease inhibitors|mesh-ancestor
64869928|NCT01827280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869929|NCT01827280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869930|NCT01827293|Promethazine|promethazine|mesh-list
64869931|NCT01827293|Diphenhydramine|diphenhydramine|mesh-list
64869932|NCT01827293|Lorazepam|lorazepam|mesh-list
64869933|NCT01827293|Anticonvulsants|anticonvulsants|mesh-ancestor
64869934|NCT01827293|Antiemetics|antiemetics|mesh-ancestor
64869935|NCT01827293|Autonomic Agents|autonomic agents|mesh-ancestor
64869936|NCT01827293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870080|NCT01828359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64870081|NCT01828359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870082|NCT01828359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64870155|NCT01828736|Carboplatin|carboplatin|mesh-list
64870156|NCT01828736|Trastuzumab|trastuzumab|mesh-list
64870157|NCT01828736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870158|NCT01828736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64870159|NCT01828736|Antimetabolites|antimetabolites|mesh-ancestor
64870324|NCT01830530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870325|NCT01830530|Vasodilator Agents|vasodilator agents|mesh-ancestor
64870326|NCT01830530|Tocolytic Agents|tocolytic agents|mesh-ancestor
65494965|NCT01567774|Atorvastatin|atorvastatin|mesh-list
64870327|NCT01830530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64870328|NCT01830907|Vitamins|vitamins|mesh-list
64577819|NCT05614440|Anesthetics, Local|anesthetics, local|mesh-list
64870329|NCT01830907|Micronutrients|micronutrients|mesh-ancestor
64870330|NCT01830907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870331|NCT01831050|Vaccines|vaccines|mesh-list
64870332|NCT01831050|Immunologic Factors|immunologic factors|mesh-ancestor
64870333|NCT01831050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870334|NCT01831440|Antidepressive Agents|antidepressive agents|mesh-list
64870335|NCT01831440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64870336|NCT01832311|Ketorolac|ketorolac|mesh-list
64870337|NCT01832311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64870338|NCT01832311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64870339|NCT01832311|Analgesics|analgesics|mesh-ancestor
64410501|NCT05168813|Vaccines|vaccines|mesh-list
64870582|NCT01840449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870583|NCT01840683|Heparin|heparin|mesh-list
64870584|NCT01840683|Anticoagulants|anticoagulants|mesh-ancestor
64870585|NCT01840683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64870618|NCT01840813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64870619|NCT01840813|Abortifacient Agents|abortifacient agents|mesh-ancestor
64870620|NCT01840813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64410529|NCT04788407|Nitazoxanide|nitazoxanide|mesh-list
64870754|NCT01841658|Folic Acid|folic acid|mesh-list
64870755|NCT01841658|Hematinics|hematinics|mesh-ancestor
64870756|NCT01841658|Vitamin B Complex|vitamin b complex|mesh-ancestor
64870757|NCT01841658|Vitamins|vitamins|mesh-ancestor
64870758|NCT01841658|Micronutrients|micronutrients|mesh-ancestor
64870759|NCT01841658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870760|NCT01841684|Anacetrapib|anacetrapib|mesh-list
64870761|NCT01841684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64870762|NCT01841684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64870763|NCT01841684|Antimetabolites|antimetabolites|mesh-ancestor
64870764|NCT01841684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870824|NCT01842230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64870825|NCT01842230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64870826|NCT01842230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870827|NCT01842230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64870828|NCT01842230|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64870829|NCT01842230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64870830|NCT01842230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64871049|NCT01843556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64871050|NCT01843556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274070|NCT00212771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64871051|NCT01843556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871052|NCT01843556|Cholinergic Agents|cholinergic agents|mesh-ancestor
64871053|NCT01843556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64871054|NCT01843556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871111|NCT01843868|Immunologic Factors|immunologic factors|mesh-ancestor
64871112|NCT01843868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871113|NCT01843868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64871114|NCT01843868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64871115|NCT01843868|Alkylating Agents|alkylating agents|mesh-ancestor
64871116|NCT01843868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871117|NCT01843868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871118|NCT01843868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64871119|NCT01843868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64871120|NCT01843868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64871121|NCT01843868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64871460|NCT01845675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871461|NCT01845675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64871492|NCT01845844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64871493|NCT01845844|Growth Substances|growth substances|mesh-ancestor
64871494|NCT01845844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871495|NCT01845844|Growth Inhibitors|growth inhibitors|mesh-ancestor
64871496|NCT01845844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871497|NCT01846026|Vitamin D|vitamin d|mesh-list
64871498|NCT01846026|Cholecalciferol|cholecalciferol|mesh-list
64871499|NCT01846026|Vitamins|vitamins|mesh-ancestor
64871500|NCT01846026|Micronutrients|micronutrients|mesh-ancestor
64871501|NCT01846026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871509|NCT01846117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64871511|NCT01846117|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64871814|NCT01848197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871816|NCT01848236|Ergocalciferols|ergocalciferols|mesh-list
64871817|NCT01848236|Cholecalciferol|cholecalciferol|mesh-list
64871818|NCT01848236|Vitamins|vitamins|mesh-list
64871819|NCT01848236|Micronutrients|micronutrients|mesh-ancestor
64871820|NCT01848236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871821|NCT01848236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64871822|NCT01848236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64871823|NCT01848262|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64410698|NCT01667081|Grazoprevir|grazoprevir|mesh-list
64871851|NCT01848652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64871852|NCT01848652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871853|NCT01848652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64871854|NCT01848652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64871855|NCT01848652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871856|NCT01848652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871858|NCT01848665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64871859|NCT01848665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64871860|NCT01848665|Analgesics|analgesics|mesh-ancestor
64871861|NCT01848665|Sensory System Agents|sensory system agents|mesh-ancestor
64871862|NCT01848665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64871863|NCT01848665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871864|NCT01848665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64871865|NCT01848665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64871866|NCT01848665|Gout Suppressants|gout suppressants|mesh-ancestor
64871867|NCT01848665|Tocolytic Agents|tocolytic agents|mesh-ancestor
64872046|NCT01850147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872047|NCT01850147|Growth Inhibitors|growth inhibitors|mesh-ancestor
64872048|NCT01850147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64872049|NCT01850147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872050|NCT01850147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872051|NCT01850160|Valsartan|valsartan|mesh-list
64872052|NCT01850160|Antihypertensive Agents|antihypertensive agents|mesh-list
64872053|NCT01850160|Chlorthalidone|chlorthalidone|mesh-list
64872054|NCT01850160|Angiotensin II|angiotensin ii|mesh-list
64872055|NCT01850160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64872056|NCT01850160|Diuretics|diuretics|mesh-list
64872085|NCT01850511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64872086|NCT01850511|Adrenergic Agents|adrenergic agents|mesh-ancestor
64872087|NCT01850511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64872088|NCT01850511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872120|NCT01850680|Dermatologic Agents|dermatologic agents|mesh-ancestor
64872121|NCT01850680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274071|NCT00212771|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64872122|NCT01850680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64872123|NCT01850680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64410815|NCT04990869|Niacinamide|niacinamide|mesh-list
64872271|NCT01851551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494968|NCT01567774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64473104|NCT01208662|Glucocorticoids|glucocorticoids|mesh-ancestor
64872304|NCT01851941|Folic Acid|folic acid|mesh-list
64872305|NCT01851941|Fluorouracil|fluorouracil|mesh-list
64872306|NCT01851941|Oxaliplatin|oxaliplatin|mesh-list
64872307|NCT01851941|Levoleucovorin|levoleucovorin|mesh-list
64640896|NCT05299008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64872308|NCT01851941|Antimetabolites|antimetabolites|mesh-ancestor
64872380|NCT01852318|Histamine Antagonists|histamine antagonists|mesh-ancestor
64872483|NCT01853111|Antiviral Agents|antiviral agents|mesh-ancestor
64872484|NCT01853111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64872588|NCT01854073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872610|NCT01854216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872611|NCT01854216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872613|NCT01854411|Sensory System Agents|sensory system agents|mesh-ancestor
64872614|NCT01854411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64872615|NCT01854411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872617|NCT01854424|Chelating Agents|chelating agents|mesh-ancestor
64872618|NCT01854424|Sequestering Agents|sequestering agents|mesh-ancestor
64872743|NCT01855061|Anesthetics, General|anesthetics, general|mesh-ancestor
64873024|NCT01856621|Respiratory System Agents|respiratory system agents|mesh-ancestor
64873025|NCT01856621|Glucocorticoids|glucocorticoids|mesh-ancestor
64873026|NCT01856621|Hormones|hormones|mesh-ancestor
64873027|NCT01856621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64873028|NCT01856621|Sympathomimetics|sympathomimetics|mesh-ancestor
64873029|NCT01856621|Antidotes|antidotes|mesh-ancestor
64873030|NCT01856621|Protective Agents|protective agents|mesh-ancestor
64873031|NCT01856738|Rivastigmine|rivastigmine|mesh-list
64873032|NCT01856738|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64873089|NCT01856985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64873090|NCT01856985|Contraceptive Agents|contraceptive agents|mesh-ancestor
64873091|NCT01856985|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64873092|NCT01856985|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64873093|NCT01856985|Hormone Antagonists|hormone antagonists|mesh-ancestor
64873123|NCT01857141|Sensory System Agents|sensory system agents|mesh-ancestor
64873124|NCT01857141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64873299|NCT01857856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873300|NCT01857856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64873302|NCT01857856|Natriuretic Agents|natriuretic agents|mesh-ancestor
64873303|NCT01857856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64873304|NCT01857895|Exenatide|exenatide|mesh-list
64873305|NCT01857895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64873306|NCT01857895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873307|NCT01857895|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64873308|NCT01857895|Incretins|incretins|mesh-ancestor
64873309|NCT01857895|Hormones|hormones|mesh-ancestor
64873310|NCT01857895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64873311|NCT01857921|Trimetazidine|trimetazidine|mesh-list
64873312|NCT01857921|Atorvastatin|atorvastatin|mesh-list
64873313|NCT01857921|Pravastatin|pravastatin|mesh-list
64873314|NCT01857921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64873315|NCT01857921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64873316|NCT01857921|Antimetabolites|antimetabolites|mesh-ancestor
64873317|NCT01857921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873352|NCT01858077|Immunologic Factors|immunologic factors|mesh-ancestor
64873353|NCT01858077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873354|NCT01858090|Diphenhydramine|diphenhydramine|mesh-list
64873355|NCT01858090|Promethazine|promethazine|mesh-list
64873356|NCT01858090|Diclofenac|diclofenac|mesh-list
64873357|NCT01858090|Atropine|atropine|mesh-list
64873358|NCT01858090|Ephedrine|ephedrine|mesh-list
64873737|NCT01860183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873738|NCT01860183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64873739|NCT01860183|Antitubercular Agents|antitubercular agents|mesh-ancestor
65494971|NCT01567774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64873740|NCT01860183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64873741|NCT01860183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64873844|NCT01860729|Antimetabolites|antimetabolites|mesh-ancestor
64873845|NCT01860729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873846|NCT01860729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64873847|NCT01860742|Interferons|interferons|mesh-list
64873848|NCT01860742|Interferon-alpha|interferon-alpha|mesh-list
64873849|NCT01860742|Interferon alpha-2|interferon alpha-2|mesh-list
64873996|NCT01862003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64873997|NCT01862003|Immunologic Factors|immunologic factors|mesh-ancestor
64873998|NCT01862003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338736|NCT01660334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64338737|NCT01660334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64338738|NCT01660334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64874082|NCT01862835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64874083|NCT01862835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64874084|NCT01862835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874085|NCT01862835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64874086|NCT01862835|Hormone Antagonists|hormone antagonists|mesh-ancestor
64874087|NCT01862887|Moxifloxacin|moxifloxacin|mesh-list
64874088|NCT01862887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64874089|NCT01862887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64874090|NCT01862887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64874091|NCT01862887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64874092|NCT01862887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64874093|NCT01862887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874094|NCT01862887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64874095|NCT01862926|Cyclophosphamide|cyclophosphamide|mesh-list
64874096|NCT01862926|Rituximab|rituximab|mesh-list
64874097|NCT01862926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64874098|NCT01862926|Immunologic Factors|immunologic factors|mesh-ancestor
64874099|NCT01862926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874100|NCT01862926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64874101|NCT01862926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64411358|NCT04374461|Acetylcysteine|acetylcysteine|mesh-list
64874130|NCT01863147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64874131|NCT01863147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64874155|NCT01863199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64874156|NCT01863225|Atorvastatin|atorvastatin|mesh-list
64874157|NCT01863225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64874158|NCT01863225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64874159|NCT01863225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64874160|NCT01863225|Antimetabolites|antimetabolites|mesh-ancestor
64874161|NCT01863225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874162|NCT01863225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64874163|NCT01863225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64874164|NCT01863225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64874165|NCT01863238|Ivacaftor|ivacaftor|mesh-list
64874166|NCT01863238|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64874167|NCT01863238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64874168|NCT01863238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411416|NCT04277975|Narcotics|narcotics|mesh-ancestor
64874216|NCT01863459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874217|NCT01863459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64874218|NCT01863459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64874219|NCT01863459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64874220|NCT01863459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874263|NCT01863641|Vitamins|vitamins|mesh-ancestor
64874264|NCT01863641|Micronutrients|micronutrients|mesh-ancestor
64874290|NCT01863810|Sensory System Agents|sensory system agents|mesh-ancestor
64874291|NCT01863810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64874292|NCT01863810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874293|NCT01863810|Anticonvulsants|anticonvulsants|mesh-ancestor
64874294|NCT01863810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64874295|NCT01863810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64874296|NCT01863810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874297|NCT01863810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64874298|NCT01863810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64874299|NCT01863810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64874300|NCT01863810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64874301|NCT01863810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64874302|NCT01863823|Amoxicillin|amoxicillin|mesh-list
64874323|NCT01863888|Immunologic Factors|immunologic factors|mesh-ancestor
64874324|NCT01863888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64874325|NCT01863888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64874326|NCT01863888|Antimetabolites|antimetabolites|mesh-ancestor
64874327|NCT01863888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494974|NCT04663750|Aflibercept|aflibercept|mesh-list
65274072|NCT00212771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64473109|NCT01208662|Immunologic Factors|immunologic factors|mesh-ancestor
64578888|NCT00208975|Cyclophosphamide|cyclophosphamide|mesh-list
64874328|NCT01863888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64874329|NCT01863914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64411564|NCT02078141|Antimetabolites|antimetabolites|mesh-ancestor
64874378|NCT01864213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64874379|NCT01864252|Nitroglycerin|nitroglycerin|mesh-list
64874380|NCT01864252|Vasodilator Agents|vasodilator agents|mesh-ancestor
64874381|NCT01864265|Certolizumab Pegol|certolizumab pegol|mesh-list
64874382|NCT01864265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64874383|NCT01864265|Immunologic Factors|immunologic factors|mesh-ancestor
64874384|NCT01864265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874385|NCT01864265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65494975|NCT04663750|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65494976|NCT04663750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64473110|NCT01208662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64874416|NCT01864655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64874444|NCT01864915|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64874445|NCT01864915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64874446|NCT01864915|Serotonin Agents|serotonin agents|mesh-ancestor
64874447|NCT01864915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64874448|NCT01864915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874449|NCT01864915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874451|NCT01865175|Trace Elements|trace elements|mesh-ancestor
64874452|NCT01865175|Micronutrients|micronutrients|mesh-ancestor
64874453|NCT01865175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874454|NCT01865188|Amlodipine|amlodipine|mesh-list
64411667|NCT05548985|Antiemetics|antiemetics|mesh-ancestor
64874493|NCT01865305|Biphasic Insulins|biphasic insulins|mesh-list
64874494|NCT01865305|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64874495|NCT01865305|Insulin, Isophane|insulin, isophane|mesh-list
64874496|NCT01865305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64874497|NCT01865305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874498|NCT01865318|Insulin|insulin|mesh-list
64874499|NCT01865318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64874500|NCT01865318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874501|NCT01865331|Insulin|insulin|mesh-list
64874502|NCT01865331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64874503|NCT01865331|Insulin Aspart|insulin aspart|mesh-list
64874504|NCT01865331|Insulin, Long-Acting|insulin, long-acting|mesh-list
64874505|NCT01865331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64874506|NCT01865331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874507|NCT01865500|Prednisolone|prednisolone|mesh-list
64874508|NCT01865500|Budesonide|budesonide|mesh-list
64874509|NCT01865500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64874510|NCT01865500|Glucocorticoids|glucocorticoids|mesh-ancestor
64874511|NCT01865500|Hormones|hormones|mesh-ancestor
64874512|NCT01865500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64411728|NCT05552729|Vitamins|vitamins|mesh-list
64874555|NCT01865916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874556|NCT01865916|Vitamins|vitamins|mesh-ancestor
64874557|NCT01865916|Micronutrients|micronutrients|mesh-ancestor
64874558|NCT01865916|Cathartics|cathartics|mesh-ancestor
64874559|NCT01865916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64874560|NCT01865916|Laxatives|laxatives|mesh-ancestor
64874561|NCT01865968|Vaccines|vaccines|mesh-list
64874562|NCT01865968|Immunologic Factors|immunologic factors|mesh-ancestor
64874563|NCT01865968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874564|NCT01866007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64874565|NCT01866007|Immunologic Factors|immunologic factors|mesh-ancestor
64874566|NCT01866007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874567|NCT01866059|Methamphetamine|methamphetamine|mesh-list
64874568|NCT01866059|Calcium|calcium|mesh-list
64874569|NCT01866059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64874570|NCT01866059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874571|NCT01866059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64874572|NCT01866059|Sympathomimetics|sympathomimetics|mesh-ancestor
64874573|NCT01866059|Autonomic Agents|autonomic agents|mesh-ancestor
64874574|NCT01866059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64874575|NCT01866059|Dopamine Agents|dopamine agents|mesh-ancestor
64874576|NCT01866059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64874577|NCT01866059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874578|NCT01866059|Adrenergic Agents|adrenergic agents|mesh-ancestor
64874579|NCT01866059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64874580|NCT01866059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64874636|NCT01866553|Interferon alpha-2|interferon alpha-2|mesh-list
64874637|NCT01866553|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64874638|NCT01866553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64874639|NCT01866553|Antiviral Agents|antiviral agents|mesh-ancestor
64874640|NCT01866553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64874674|NCT01867138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64874675|NCT01867255|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64874676|NCT01867255|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64874792|NCT01867892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64874793|NCT01867892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64874794|NCT01867892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64874795|NCT01867892|Immunologic Factors|immunologic factors|mesh-ancestor
64874796|NCT01867892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874797|NCT01867892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64874860|NCT01868529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874861|NCT01868555|Insulin|insulin|mesh-list
64874862|NCT01868555|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64874863|NCT01868555|Insulin Aspart|insulin aspart|mesh-list
64874864|NCT01868555|Insulin, Long-Acting|insulin, long-acting|mesh-list
64874865|NCT01868555|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64874866|NCT01868555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64874867|NCT01868555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874868|NCT01868568|Insulin|insulin|mesh-list
64874869|NCT01868568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64874917|NCT01868880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64874918|NCT01868880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64874919|NCT01868906|Temozolomide|temozolomide|mesh-list
64411920|NCT02513823|Micronutrients|micronutrients|mesh-ancestor
64874973|NCT01869205|Abamectin|abamectin|mesh-list
64874974|NCT01869205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64874975|NCT01869205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64874976|NCT01869205|Anthelmintics|anthelmintics|mesh-ancestor
64874977|NCT01869257|Triclosan|triclosan|mesh-list
64874978|NCT01869257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64874979|NCT01869257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64874980|NCT01869257|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64874981|NCT01869257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64874982|NCT01869257|Antimetabolites|antimetabolites|mesh-ancestor
64874983|NCT01869257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874984|NCT01869257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64874985|NCT01869309|Ticagrelor|ticagrelor|mesh-list
64875005|NCT01869556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64875007|NCT01869569|Pregabalin|pregabalin|mesh-list
64875008|NCT01869569|Analgesics|analgesics|mesh-ancestor
64411973|NCT04620733|Seladelpar|seladelpar|mesh-list
64875067|NCT01869907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64875069|NCT01869946|Anesthetics, Local|anesthetics, local|mesh-ancestor
64875070|NCT01869946|Anesthetics|anesthetics|mesh-ancestor
64875071|NCT01869946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64875072|NCT01869946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875073|NCT01869946|Sensory System Agents|sensory system agents|mesh-ancestor
64875074|NCT01869946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64875160|NCT01870128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64875162|NCT01870128|Sensory System Agents|sensory system agents|mesh-ancestor
64875163|NCT01870167|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64875164|NCT01870167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64875165|NCT01870167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64875166|NCT01870167|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64875167|NCT01870167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875168|NCT01870167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875170|NCT01870219|Anesthetics|anesthetics|mesh-list
64875171|NCT01870219|Sevoflurane|sevoflurane|mesh-list
64875340|NCT01871376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64875341|NCT01871376|Growth Substances|growth substances|mesh-ancestor
64875342|NCT01871376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875343|NCT01871376|Growth Inhibitors|growth inhibitors|mesh-ancestor
64875344|NCT01871376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875345|NCT01871454|Pentoxifylline|pentoxifylline|mesh-list
64875346|NCT01871454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64875347|NCT01871454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875348|NCT01871454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875349|NCT01871454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64875350|NCT01871454|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64875351|NCT01871454|Protective Agents|protective agents|mesh-ancestor
64875352|NCT01871454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875353|NCT01871454|Vasodilator Agents|vasodilator agents|mesh-ancestor
64875354|NCT01871454|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64875355|NCT01871454|Antioxidants|antioxidants|mesh-ancestor
64875356|NCT01871467|Sargramostim|sargramostim|mesh-list
64875357|NCT01871467|Immunologic Factors|immunologic factors|mesh-ancestor
64875358|NCT01871467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875359|NCT01871480|Gefitinib|gefitinib|mesh-list
64875360|NCT01871480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412148|NCT05697809|Glucocorticoids|glucocorticoids|mesh-ancestor
64875413|NCT01871701|Moxifloxacin|moxifloxacin|mesh-list
64875414|NCT01871701|Dexetimide|dexetimide|mesh-list
64875444|NCT01871701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64875445|NCT01871701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64875446|NCT01871701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65494980|NCT04663750|Growth Inhibitors|growth inhibitors|mesh-ancestor
64875447|NCT01871701|Cholinergic Agents|cholinergic agents|mesh-ancestor
64875448|NCT01871701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64875449|NCT01871701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64875450|NCT01871701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64875451|NCT01871740|Folic Acid|folic acid|mesh-list
64875539|NCT01871961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875540|NCT01871961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64412257|NCT04977427|Hormones|hormones|mesh-ancestor
64875636|NCT01872494|Serotonin Agents|serotonin agents|mesh-ancestor
64875637|NCT01872494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64875638|NCT01872494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875673|NCT01872754|Analgesics|analgesics|mesh-ancestor
64875674|NCT01872754|Sensory System Agents|sensory system agents|mesh-ancestor
64875675|NCT01872754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64875676|NCT01872780|Rosiglitazone|rosiglitazone|mesh-list
64875677|NCT01872780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64875678|NCT01872780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875801|NCT01873144|Epinephrine|epinephrine|mesh-list
64875802|NCT01873144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64875803|NCT01873144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64875804|NCT01873144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64875805|NCT01873144|Adrenergic Agents|adrenergic agents|mesh-ancestor
64579622|NCT01680549|Antimanic Agents|antimanic agents|mesh-ancestor
64875806|NCT01873144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64875807|NCT01873144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875808|NCT01873144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875809|NCT01873144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64875810|NCT01873144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64875811|NCT01873144|Autonomic Agents|autonomic agents|mesh-ancestor
64875812|NCT01873144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64875813|NCT01873144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64875814|NCT01873144|Respiratory System Agents|respiratory system agents|mesh-ancestor
64875860|NCT01873378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64875861|NCT01873378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875862|NCT01873378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64875863|NCT01873378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64875864|NCT01873378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875865|NCT01873430|Melatonin|melatonin|mesh-list
64875866|NCT01873430|Antioxidants|antioxidants|mesh-ancestor
64875867|NCT01873430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875868|NCT01873430|Protective Agents|protective agents|mesh-ancestor
64875869|NCT01873430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875870|NCT01873430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64875871|NCT01873443|Folic Acid|folic acid|mesh-list
64875872|NCT01873443|Rituximab|rituximab|mesh-list
64875873|NCT01873443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64875932|NCT01873833|Cyclophosphamide|cyclophosphamide|mesh-list
64644499|NCT00583700|Vitamin E|vitamin e|mesh-list
64875933|NCT01873833|Capecitabine|capecitabine|mesh-list
64875934|NCT01873833|Trastuzumab|trastuzumab|mesh-list
64875935|NCT01873833|Lapatinib|lapatinib|mesh-list
64875936|NCT01873833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64875937|NCT01873833|Immunologic Factors|immunologic factors|mesh-ancestor
64875938|NCT01873833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875939|NCT01873833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64875940|NCT01873833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64412508|NCT02725177|Hormones|hormones|mesh-ancestor
64875991|NCT01874314|Moxifloxacin|moxifloxacin|mesh-list
64875992|NCT01874314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64875993|NCT01874314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64876086|NCT01875172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876087|NCT01875172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64472121|NCT03780543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64876088|NCT01875172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64876089|NCT01875172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876183|NCT01876004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64876184|NCT01876004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876185|NCT01876004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64876186|NCT01876004|Antimetabolites|antimetabolites|mesh-ancestor
64876237|NCT01876290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64876238|NCT01876290|Glucocorticoids|glucocorticoids|mesh-ancestor
64876239|NCT01876290|Hormones|hormones|mesh-ancestor
64876240|NCT01876290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64876241|NCT01876290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64876313|NCT01876797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876315|NCT01876849|Exenatide|exenatide|mesh-list
64876316|NCT01876849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64876317|NCT01876849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876318|NCT01876849|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64876319|NCT01876849|Incretins|incretins|mesh-ancestor
64876320|NCT01876849|Hormones|hormones|mesh-ancestor
64876321|NCT01876849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64876322|NCT01876862|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64876323|NCT01876862|Antiviral Agents|antiviral agents|mesh-ancestor
64876381|NCT01877577|Cholecalciferol|cholecalciferol|mesh-list
64876382|NCT01877577|Vitamins|vitamins|mesh-list
64876383|NCT01877577|Micronutrients|micronutrients|mesh-ancestor
64876384|NCT01877577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876385|NCT01877577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64876386|NCT01877577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64876387|NCT01877590|Thioctic Acid|thioctic acid|mesh-list
64876388|NCT01877590|Antioxidants|antioxidants|mesh-ancestor
64876389|NCT01877590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876390|NCT01877590|Protective Agents|protective agents|mesh-ancestor
64876546|NCT01878708|Antiemetics|antiemetics|mesh-ancestor
64876547|NCT01878708|Autonomic Agents|autonomic agents|mesh-ancestor
64876548|NCT01878708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64876549|NCT01878708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876550|NCT01878708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64876551|NCT01878708|Glucocorticoids|glucocorticoids|mesh-ancestor
64876552|NCT01878708|Hormones|hormones|mesh-ancestor
64876553|NCT01878708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64876554|NCT01878708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64876555|NCT01878708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876556|NCT01878708|Protease Inhibitors|protease inhibitors|mesh-ancestor
64876557|NCT01878708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876586|NCT01879007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64876587|NCT01879007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65494985|NCT01567930|Sirolimus|sirolimus|mesh-list
65494986|NCT01567930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64876588|NCT01879007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64876589|NCT01879007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876590|NCT01879007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876591|NCT01879007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876593|NCT01879033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64876594|NCT01879033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876621|NCT01879423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64876623|NCT01879423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64876624|NCT01879423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64876625|NCT01879423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64876626|NCT01879423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64876627|NCT01879423|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64876628|NCT01879488|Edetic Acid|edetic acid|mesh-list
64876629|NCT01879488|Pentetic Acid|pentetic acid|mesh-list
64876630|NCT01879488|Antidotes|antidotes|mesh-ancestor
64876631|NCT01879488|Protective Agents|protective agents|mesh-ancestor
64876632|NCT01879488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876633|NCT01879488|Chelating Agents|chelating agents|mesh-ancestor
64876634|NCT01879488|Sequestering Agents|sequestering agents|mesh-ancestor
64876635|NCT01879488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876636|NCT01879488|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64876637|NCT01879488|Anticoagulants|anticoagulants|mesh-ancestor
64876638|NCT01879488|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64876639|NCT01879514|Prednisone|prednisone|mesh-list
64876640|NCT01879514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64876641|NCT01879514|Glucocorticoids|glucocorticoids|mesh-ancestor
65274073|NCT00212771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64876642|NCT01879514|Hormones|hormones|mesh-ancestor
64876643|NCT01879514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64876644|NCT01879514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876645|NCT01879514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64876646|NCT01879514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876647|NCT01879527|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64876648|NCT01879527|Amiloride|amiloride|mesh-list
64876649|NCT01879527|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
64876650|NCT01879527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64876651|NCT01879527|Diuretics|diuretics|mesh-ancestor
64876652|NCT01879527|Natriuretic Agents|natriuretic agents|mesh-ancestor
64876653|NCT01879527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876654|NCT01879527|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64876659|NCT01879527|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64876660|NCT01879527|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64876661|NCT01879605|Bisacodyl|bisacodyl|mesh-list
64876662|NCT01879605|Sorbitol|sorbitol|mesh-list
64876663|NCT01879605|Cathartics|cathartics|mesh-ancestor
64876664|NCT01879605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64876665|NCT01879605|Laxatives|laxatives|mesh-ancestor
64876666|NCT01879748|Rasagiline|rasagiline|mesh-list
64876667|NCT01879748|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64876701|NCT01880138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876703|NCT01880216|Enoxaparin sodium|enoxaparin sodium|mesh-list
64876704|NCT01880216|Bemiparin|bemiparin|mesh-list
64876705|NCT01880216|Anticoagulants|anticoagulants|mesh-ancestor
64876706|NCT01880216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64876707|NCT01880216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64876708|NCT01880216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876709|NCT01880307|Prednisolone|prednisolone|mesh-list
64876760|NCT01880385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64876761|NCT01880385|Growth Substances|growth substances|mesh-ancestor
64876762|NCT01880385|Growth Inhibitors|growth inhibitors|mesh-ancestor
64876763|NCT01880385|Tubulin Modulators|tubulin modulators|mesh-ancestor
64876764|NCT01880385|Antimitotic Agents|antimitotic agents|mesh-ancestor
64876765|NCT01880385|Mitosis Modulators|mitosis modulators|mesh-ancestor
64876766|NCT01880385|Antimetabolites|antimetabolites|mesh-ancestor
64876767|NCT01880385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64876768|NCT01880385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64876769|NCT01880385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64876770|NCT01880385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64876771|NCT01880385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876773|NCT01880463|Ergocalciferols|ergocalciferols|mesh-list
64876774|NCT01880463|Cholecalciferol|cholecalciferol|mesh-list
64876775|NCT01880463|Vitamins|vitamins|mesh-list
64876776|NCT01880463|Micronutrients|micronutrients|mesh-ancestor
65494987|NCT01567930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64473119|NCT00920621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473120|NCT00920621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64876813|NCT01879241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876814|NCT01879241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876815|NCT01879241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64876816|NCT01879241|Protective Agents|protective agents|mesh-ancestor
64876817|NCT01879241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876818|NCT01880931|Remifentanil|remifentanil|mesh-list
64876819|NCT01880931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64876820|NCT01880931|Narcotics|narcotics|mesh-ancestor
64876821|NCT01880931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64876822|NCT01880931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876823|NCT01880931|Analgesics|analgesics|mesh-ancestor
64413030|NCT04201197|Dronabinol|dronabinol|mesh-list
64876873|NCT01881919|Protective Agents|protective agents|mesh-ancestor
64876874|NCT01881919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876875|NCT01881971|Calcium|calcium|mesh-list
64876876|NCT01881971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64876877|NCT01881971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876878|NCT01881997|Fentanyl|fentanyl|mesh-list
64877005|NCT01883193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877006|NCT01883232|Lidocaine|lidocaine|mesh-list
64877007|NCT01883232|Epinephrine|epinephrine|mesh-list
64877008|NCT01883232|Anesthetics, Local|anesthetics, local|mesh-ancestor
64877009|NCT01883232|Anesthetics|anesthetics|mesh-ancestor
64877028|NCT01883232|Mydriatics|mydriatics|mesh-ancestor
64877029|NCT01883232|Sympathomimetics|sympathomimetics|mesh-ancestor
64877030|NCT01883232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64877031|NCT01883323|Aldesleukin|aldesleukin|mesh-list
64398631|NCT03094481|Adrenergic Agents|adrenergic agents|mesh-ancestor
64877032|NCT01883323|Cyclophosphamide|cyclophosphamide|mesh-list
64877033|NCT01883323|Fludarabine|fludarabine|mesh-list
64877034|NCT01883323|Interleukin-2|interleukin-2|mesh-list
64877035|NCT01883323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64877036|NCT01883323|Immunologic Factors|immunologic factors|mesh-ancestor
64877037|NCT01883323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877038|NCT01883323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64877039|NCT01883323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64877040|NCT01883323|Alkylating Agents|alkylating agents|mesh-ancestor
64877041|NCT01883323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877042|NCT01883323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64877043|NCT01883323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64877044|NCT01883323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64877045|NCT01883323|Analgesics|analgesics|mesh-ancestor
64877046|NCT01883323|Sensory System Agents|sensory system agents|mesh-ancestor
64877047|NCT01883323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877093|NCT01883921|Immunologic Factors|immunologic factors|mesh-ancestor
64877094|NCT01883921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877095|NCT01884038|Treprostinil|treprostinil|mesh-list
64877096|NCT01884038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64877097|NCT01884116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64877098|NCT01884116|Capsaicin|capsaicin|mesh-list
64877099|NCT01884116|Antipruritics|antipruritics|mesh-ancestor
64877100|NCT01884116|Dermatologic Agents|dermatologic agents|mesh-ancestor
64877101|NCT01884116|Sensory System Agents|sensory system agents|mesh-ancestor
64877102|NCT01884116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877103|NCT01884116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877104|NCT01884116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64877105|NCT01884116|Analgesics|analgesics|mesh-ancestor
64877106|NCT01884116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64877107|NCT01884116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64877108|NCT01884272|Naproxen|naproxen|mesh-list
64877109|NCT01884272|Indomethacin|indomethacin|mesh-list
64877110|NCT01884272|Lesinurad|lesinurad|mesh-list
64877111|NCT01884272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64877112|NCT01884272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64877113|NCT01884272|Analgesics|analgesics|mesh-ancestor
64877114|NCT01884272|Sensory System Agents|sensory system agents|mesh-ancestor
64413171|NCT05645705|Protective Agents|protective agents|mesh-ancestor
64877153|NCT01884402|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64877154|NCT01884402|Antimetabolites|antimetabolites|mesh-ancestor
64877155|NCT01884402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877156|NCT01884402|Antiviral Agents|antiviral agents|mesh-ancestor
64877157|NCT01884402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64877158|NCT01884415|Vaccines|vaccines|mesh-list
64877159|NCT01884415|Immunologic Factors|immunologic factors|mesh-ancestor
64877160|NCT01884415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877284|NCT01884896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877285|NCT01884896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877286|NCT01884896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64877287|NCT01884896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64877288|NCT01884896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64877290|NCT01884896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64877291|NCT01884896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877292|NCT01884909|Metoprolol|metoprolol|mesh-list
64877293|NCT01884909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64877294|NCT01884909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64877295|NCT01884909|Sympatholytics|sympatholytics|mesh-ancestor
64877296|NCT01884909|Autonomic Agents|autonomic agents|mesh-ancestor
64514741|NCT01750697|Immunologic Factors|immunologic factors|mesh-ancestor
64514742|NCT01750697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514743|NCT01750697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64877463|NCT01886196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877464|NCT01886196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877466|NCT01886209|Methylprednisolone|methylprednisolone|mesh-list
64877467|NCT01886209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64877468|NCT01886209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64877544|NCT01886443|Vasodilator Agents|vasodilator agents|mesh-ancestor
64877545|NCT01886443|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64877546|NCT01886443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64877547|NCT01886443|Immunologic Factors|immunologic factors|mesh-ancestor
64877548|NCT01886534|Diuretics|diuretics|mesh-list
64877549|NCT01886534|Natriuretic Agents|natriuretic agents|mesh-ancestor
64877568|NCT01886599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274074|NCT00212771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877569|NCT01886638|Abacavir|abacavir|mesh-list
64877570|NCT01886638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64877571|NCT01886638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64877572|NCT01886638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877573|NCT01886638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877574|NCT01886638|Antiviral Agents|antiviral agents|mesh-ancestor
64877575|NCT01886638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64877576|NCT01886638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64877577|NCT01886638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64877578|NCT01886664|Sevoflurane|sevoflurane|mesh-list
64877579|NCT01886664|Desflurane|desflurane|mesh-list
64342196|NCT04158635|Antimetabolites|antimetabolites|mesh-ancestor
64877604|NCT01887184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64877605|NCT01887184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877606|NCT01887184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64877607|NCT01887184|Analgesics|analgesics|mesh-ancestor
64877608|NCT01887184|Sensory System Agents|sensory system agents|mesh-ancestor
64877609|NCT01887184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877610|NCT01887184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64877611|NCT01887184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64877612|NCT01887184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64877613|NCT01887184|Adrenergic Agents|adrenergic agents|mesh-ancestor
64877614|NCT01887184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64877615|NCT01887184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877616|NCT01887197|Mannitol|mannitol|mesh-list
64877617|NCT01887197|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64877618|NCT01887197|Diuretics|diuretics|mesh-ancestor
64877619|NCT01887197|Natriuretic Agents|natriuretic agents|mesh-ancestor
64877620|NCT01887197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877621|NCT01887223|Timolol|timolol|mesh-list
64877622|NCT01887223|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64877623|NCT01887223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64877624|NCT01887223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64877625|NCT01887223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64877626|NCT01887223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64877627|NCT01887223|Adrenergic Agents|adrenergic agents|mesh-ancestor
64877628|NCT01887223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64342256|NCT00615251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877652|NCT01887275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64877663|NCT01887379|Natriuretic Agents|natriuretic agents|mesh-ancestor
64877664|NCT01887379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877665|NCT01887379|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64877666|NCT01887379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64877667|NCT01887379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877668|NCT01887405|Epinephrine|epinephrine|mesh-list
64646221|NCT04387526|Sofosbuvir|sofosbuvir|mesh-list
64877670|NCT01887405|Epinephryl borate|epinephryl borate|mesh-list
64877671|NCT01887405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64877672|NCT01887405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64877673|NCT01887405|Adrenergic Agents|adrenergic agents|mesh-ancestor
64877674|NCT01887405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64877675|NCT01887405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877676|NCT01887405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877677|NCT01887405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64877678|NCT01887405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64877708|NCT01887613|Anticonvulsants|anticonvulsants|mesh-ancestor
64877709|NCT01887613|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64877710|NCT01887613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64877711|NCT01887613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64877712|NCT01887613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64877713|NCT01887613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64877714|NCT01887613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64877715|NCT01887613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64877716|NCT01887613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877717|NCT01887613|Antimanic Agents|antimanic agents|mesh-ancestor
64877719|NCT01887626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64877720|NCT01887626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64877750|NCT01887704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64877751|NCT01887704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64877752|NCT01887704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64799122|NCT01394757|Anesthetics, General|anesthetics, general|mesh-ancestor
64877753|NCT01887704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64877754|NCT01887704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877756|NCT01887704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64877757|NCT01887704|Immunologic Factors|immunologic factors|mesh-ancestor
64877758|NCT01887704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64877759|NCT01887704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64877760|NCT01887704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64877761|NCT01887704|Purinergic Agents|purinergic agents|mesh-ancestor
64877762|NCT01887704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64877763|NCT01887704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64877764|NCT01887704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64877783|NCT01887821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64877784|NCT01887821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64877786|NCT01887821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64877787|NCT01887847|Nicotine|nicotine|mesh-list
64877788|NCT01887847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64877789|NCT01887847|Autonomic Agents|autonomic agents|mesh-ancestor
64877790|NCT01887847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877791|NCT01887847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877792|NCT01887847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64877793|NCT01887847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64877822|NCT01888107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64877852|NCT01888250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64877853|NCT01888250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64877854|NCT01888263|Lamotrigine|lamotrigine|mesh-list
64877855|NCT01888263|Anticonvulsants|anticonvulsants|mesh-ancestor
64877856|NCT01888263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64877857|NCT01888263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64877858|NCT01888263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877859|NCT01888263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64877860|NCT01888263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877861|NCT01888263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64877862|NCT01888263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64877863|NCT01888263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64877864|NCT01888263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64877865|NCT01888263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64877894|NCT01888393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64877895|NCT01888393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877896|NCT01888445|Darbepoetin alfa|darbepoetin alfa|mesh-list
64877946|NCT01888718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64877947|NCT01888718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877948|NCT01888718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877949|NCT01888731|Lamotrigine|lamotrigine|mesh-list
64877950|NCT01888731|Anticonvulsants|anticonvulsants|mesh-ancestor
64877951|NCT01888731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64877952|NCT01888731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64877953|NCT01888731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877954|NCT01888731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64877955|NCT01888731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877956|NCT01888731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64877957|NCT01888731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64877958|NCT01888731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64877959|NCT01888731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64877960|NCT01888731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64877961|NCT01888744|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64877963|NCT01888744|Progesterone|progesterone|mesh-list
64877984|NCT01888757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64473136|NCT00694850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878011|NCT01888835|Antidepressive Agents|antidepressive agents|mesh-ancestor
64878012|NCT01888835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64878013|NCT01888835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64342650|NCT02682901|Bromocriptine|bromocriptine|mesh-list
64878046|NCT01888978|Antimetabolites|antimetabolites|mesh-ancestor
64878047|NCT01888978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878048|NCT01888978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878049|NCT01888978|Antiviral Agents|antiviral agents|mesh-ancestor
64878050|NCT01888978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878051|NCT01888978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878052|NCT01888978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64878053|NCT01888978|Immunologic Factors|immunologic factors|mesh-ancestor
64878054|NCT01888978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398894|NCT02347033|Sertraline|sertraline|mesh-list
64878055|NCT01888978|Tubulin Modulators|tubulin modulators|mesh-ancestor
64878056|NCT01888978|Antimitotic Agents|antimitotic agents|mesh-ancestor
64878057|NCT01888978|Mitosis Modulators|mitosis modulators|mesh-ancestor
64878115|NCT01889368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878117|NCT01889368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878119|NCT01889407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64878120|NCT01889407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878121|NCT01889407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64878209|NCT01889979|Sensory System Agents|sensory system agents|mesh-ancestor
64878210|NCT01889979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64878211|NCT01890538|Dimenhydrinate|dimenhydrinate|mesh-list
64878213|NCT01890538|Antiemetics|antiemetics|mesh-ancestor
64878214|NCT01890538|Autonomic Agents|autonomic agents|mesh-ancestor
64878215|NCT01890538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64878216|NCT01890538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878217|NCT01890538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64878218|NCT01890538|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64878219|NCT01890538|Histamine Antagonists|histamine antagonists|mesh-ancestor
64878305|NCT01894815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64878306|NCT01894815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64878307|NCT01894815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64878308|NCT01894815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878309|NCT01894815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64878310|NCT01894815|Serotonin Agents|serotonin agents|mesh-ancestor
64878311|NCT01894815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878312|NCT01894815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64878313|NCT01894815|Antidepressive Agents|antidepressive agents|mesh-ancestor
64878314|NCT01894815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64878369|NCT01897051|Vasodilator Agents|vasodilator agents|mesh-ancestor
64878370|NCT01897051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64878371|NCT01897051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878372|NCT01897051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64878373|NCT01897740|Sildenafil Citrate|sildenafil citrate|mesh-list
64878374|NCT01897740|Vasodilator Agents|vasodilator agents|mesh-ancestor
64878375|NCT01897740|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64878376|NCT01897740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64878377|NCT01897740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878453|NCT01900106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64878454|NCT01900106|Antiviral Agents|antiviral agents|mesh-ancestor
64878455|NCT01900106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878456|NCT01900106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64878457|NCT01900106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64878486|NCT01900301|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64878515|NCT01900405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64878516|NCT01900405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878517|NCT01900496|Rituximab|rituximab|mesh-list
64878518|NCT01900496|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64878519|NCT01900496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64878520|NCT01900496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878521|NCT01900496|Immunologic Factors|immunologic factors|mesh-ancestor
64878522|NCT01900496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878523|NCT01900496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64878524|NCT01900509|Dexamethasone|dexamethasone|mesh-list
64878525|NCT01900509|Etoposide|etoposide|mesh-list
64878526|NCT01900509|Etoposide phosphate|etoposide phosphate|mesh-list
64878527|NCT01900509|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64878528|NCT01900509|Clofarabine|clofarabine|mesh-list
64878529|NCT01900509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64878700|NCT01901172|Hormone Antagonists|hormone antagonists|mesh-ancestor
64878701|NCT01901172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64878702|NCT01901172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878703|NCT01901198|Interferons|interferons|mesh-list
64878704|NCT01901198|Interferon-alpha|interferon-alpha|mesh-list
64878705|NCT01901198|Interferon alpha-2|interferon alpha-2|mesh-list
64878706|NCT01901198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878707|NCT01901198|Antiviral Agents|antiviral agents|mesh-ancestor
64878708|NCT01901198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878709|NCT01901198|Immunologic Factors|immunologic factors|mesh-ancestor
64878710|NCT01901198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878711|NCT01901276|Omeprazole|omeprazole|mesh-list
64878712|NCT01901276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64878713|NCT01901276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64878714|NCT01901276|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65274075|NCT00212771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64799382|NCT01395875|Xhance|xhance|mesh-list
64878715|NCT01901276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878735|NCT01901471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64878736|NCT01901471|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64878737|NCT01901484|Praziquantel|praziquantel|mesh-list
65495017|NCT01144728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64473140|NCT00460486|Disinfectants|disinfectants|mesh-ancestor
64878801|NCT01902108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878848|NCT01902186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64878849|NCT01902186|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64878850|NCT01902186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64878851|NCT01902186|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64878852|NCT01902186|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64878854|NCT01902225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64878855|NCT01902225|Romidepsin|romidepsin|mesh-list
64878856|NCT01902225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64878857|NCT01902225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878858|NCT01902225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64878859|NCT01902225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64878860|NCT01902225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878861|NCT01902225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878862|NCT01902238|Ethanol|ethanol|mesh-list
64878863|NCT01902238|Ethiodized Oil|ethiodized oil|mesh-list
64878864|NCT01902238|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64878865|NCT01902238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878866|NCT01902238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64878867|NCT01902238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878868|NCT01902238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878869|NCT01902342|Oseltamivir|oseltamivir|mesh-list
64878870|NCT01902342|Antiviral Agents|antiviral agents|mesh-ancestor
64343498|NCT00355355|Talaporfin|talaporfin|mesh-list
64878922|NCT01902537|Serotonin Agents|serotonin agents|mesh-ancestor
64878923|NCT01902537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64879015|NCT01903083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879016|NCT01903083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879017|NCT01903083|Antiviral Agents|antiviral agents|mesh-ancestor
64879018|NCT01903083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879065|NCT01903681|Antioxidants|antioxidants|mesh-ancestor
64879066|NCT01903681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879067|NCT01903681|Protective Agents|protective agents|mesh-ancestor
64879068|NCT01903681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879069|NCT01903681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64879071|NCT01903694|Pravastatin|pravastatin|mesh-list
64879072|NCT01903694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879073|NCT01903694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64879074|NCT01903694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879075|NCT01903694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879076|NCT01903694|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64879077|NCT01903694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64879078|NCT01903694|Antimetabolites|antimetabolites|mesh-ancestor
64879079|NCT01903694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64879080|NCT01903694|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64879081|NCT01903785|Albuterol|albuterol|mesh-list
64879082|NCT01903785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64879163|NCT01904253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879164|NCT01904253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879165|NCT01904357|Cefazolin|cefazolin|mesh-list
64879166|NCT01904357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64879167|NCT01904357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879169|NCT01904487|Flumazenil|flumazenil|mesh-list
64879170|NCT01904487|Antidotes|antidotes|mesh-ancestor
64879171|NCT01904487|Protective Agents|protective agents|mesh-ancestor
64414325|NCT04909255|Oxybutynin|oxybutynin|mesh-list
64879241|NCT01904734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64879242|NCT01904734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879243|NCT01904734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64879288|NCT01905059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879289|NCT01905059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64879290|NCT01905059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64879291|NCT01905059|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64879292|NCT01905059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64879293|NCT01905059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65274076|NCT00212771|Serotonin Agents|serotonin agents|mesh-ancestor
64879294|NCT01905137|Botulinum Toxins|botulinum toxins|mesh-list
64879295|NCT01905137|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64879296|NCT01905137|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64879297|NCT01905137|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64414440|NCT04906915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64879425|NCT01906216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414488|NCT04393207|Methylprednisolone|methylprednisolone|mesh-list
64879516|NCT01906879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64879517|NCT01906944|Triamcinolone|triamcinolone|mesh-list
64879518|NCT01906944|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64879519|NCT01906944|Bupivacaine|bupivacaine|mesh-list
64879520|NCT01906944|Anesthetics, Local|anesthetics, local|mesh-ancestor
64879521|NCT01906944|Anesthetics|anesthetics|mesh-ancestor
64879522|NCT01906944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64879523|NCT01906944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879524|NCT01906944|Sensory System Agents|sensory system agents|mesh-ancestor
64879525|NCT01906944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64879573|NCT01907204|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64879574|NCT01907204|Prednisolone phosphate|prednisolone phosphate|mesh-list
64879575|NCT01907204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64879577|NCT01907204|Autonomic Agents|autonomic agents|mesh-ancestor
64879578|NCT01907204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64879579|NCT01907204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879580|NCT01907204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64879581|NCT01907204|Glucocorticoids|glucocorticoids|mesh-ancestor
64879582|NCT01907204|Hormones|hormones|mesh-ancestor
64879583|NCT01907204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64879584|NCT01907204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64879585|NCT01907204|Protective Agents|protective agents|mesh-ancestor
64879586|NCT01907204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64879587|NCT01907204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879588|NCT01907204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64879644|NCT01907594|Autonomic Agents|autonomic agents|mesh-ancestor
64879645|NCT01907594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64879646|NCT01907594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879647|NCT01907594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64879648|NCT01907594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64879649|NCT01907594|Cholinergic Agents|cholinergic agents|mesh-ancestor
64879698|NCT01907867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879699|NCT01907880|Zoledronic Acid|zoledronic acid|mesh-list
64879700|NCT01907880|Pamidronate|pamidronate|mesh-list
64879701|NCT01907880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64879702|NCT01907880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879703|NCT01907984|Diclofenac|diclofenac|mesh-list
64879704|NCT01907984|Midazolam|midazolam|mesh-list
64879705|NCT01907984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64879706|NCT01907984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64414685|NCT04918173|Antithrombins|antithrombins|mesh-ancestor
64879904|NCT01909622|Micronutrients|micronutrients|mesh-ancestor
64879905|NCT01909622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879906|NCT01909622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64879907|NCT01909622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64879909|NCT01909661|Chelating Agents|chelating agents|mesh-ancestor
64879910|NCT01909661|Sequestering Agents|sequestering agents|mesh-ancestor
64879911|NCT01909661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495021|NCT01239810|Immunologic Factors|immunologic factors|mesh-ancestor
65495022|NCT01239810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473143|NCT00378105|Lenalidomide|lenalidomide|mesh-list
64473144|NCT00378105|Bortezomib|bortezomib|mesh-list
64879912|NCT01909752|Cyclophosphamide|cyclophosphamide|mesh-list
64879913|NCT01909752|Imiquimod|imiquimod|mesh-list
64879914|NCT01909752|Vaccines|vaccines|mesh-list
64879965|NCT01910077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879966|NCT01910077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64879967|NCT01910077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879999|NCT01910155|Ciprofloxacin|ciprofloxacin|mesh-list
64880000|NCT01910155|Dexamethasone|dexamethasone|mesh-list
64880001|NCT01910155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64880002|NCT01910155|Antiemetics|antiemetics|mesh-ancestor
64880003|NCT01910155|Autonomic Agents|autonomic agents|mesh-ancestor
64880004|NCT01910155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64880005|NCT01910155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880006|NCT01910155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64880007|NCT01910155|Glucocorticoids|glucocorticoids|mesh-ancestor
64880008|NCT01910155|Hormones|hormones|mesh-ancestor
65248434|NCT00844207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65274260|NCT00092729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880009|NCT01910155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64880010|NCT01910155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64344659|NCT03529175|Gemcitabine|gemcitabine|mesh-list
64880041|NCT01910259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880042|NCT01910259|Anticonvulsants|anticonvulsants|mesh-ancestor
64557647|NCT03034707|Biotin|biotin|mesh-list
64880095|NCT01910415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64880096|NCT01910415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64880098|NCT01910428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880099|NCT01910480|Ketoconazole|ketoconazole|mesh-list
64880100|NCT01910480|Antifungal Agents|antifungal agents|mesh-ancestor
64880101|NCT01910480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64880102|NCT01910480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64557692|NCT04573920|Atrasentan|atrasentan|mesh-list
64880184|NCT01910883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880185|NCT01910883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880186|NCT01910883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880187|NCT01910883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64880188|NCT01910987|Dexamethasone|dexamethasone|mesh-list
64880189|NCT01910987|Dexamethasone acetate|dexamethasone acetate|mesh-list
64880190|NCT01910987|Bortezomib|bortezomib|mesh-list
64880191|NCT01910987|BB 1101|bb 1101|mesh-list
64880384|NCT01912066|Aceclofenac|aceclofenac|mesh-list
64880385|NCT01912066|Misoprostol|misoprostol|mesh-list
64880386|NCT01912066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64880387|NCT01912066|Abortifacient Agents|abortifacient agents|mesh-ancestor
64880388|NCT01912066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64880389|NCT01912066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880390|NCT01912066|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64880391|NCT01912066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64880392|NCT01912066|Oxytocics|oxytocics|mesh-ancestor
64345055|NCT04969276|Vaccines|vaccines|mesh-list
64880424|NCT01912391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880426|NCT01912391|Protective Agents|protective agents|mesh-ancestor
64880427|NCT01912391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880428|NCT01912443|Bevacizumab|bevacizumab|mesh-list
64880429|NCT01912443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64880430|NCT01912443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880431|NCT01912443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64880432|NCT01912443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64880433|NCT01912443|Growth Substances|growth substances|mesh-ancestor
64880434|NCT01912443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880435|NCT01912443|Growth Inhibitors|growth inhibitors|mesh-ancestor
64880658|NCT01914042|Levomilnacipran|levomilnacipran|mesh-list
64880659|NCT01914042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64880660|NCT01914042|Narcotics|narcotics|mesh-ancestor
64880661|NCT01914042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64880662|NCT01914042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880663|NCT01914042|Analgesics|analgesics|mesh-ancestor
64880664|NCT01914042|Sensory System Agents|sensory system agents|mesh-ancestor
64880665|NCT01914042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64557884|NCT02235701|Ifosfamide|ifosfamide|mesh-list
64880714|NCT01914380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880716|NCT01914419|Oxytocics|oxytocics|mesh-ancestor
64880717|NCT01914419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64880718|NCT01914419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880719|NCT01914432|Telmisartan|telmisartan|mesh-list
64880720|NCT01914432|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64880721|NCT01914432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64880722|NCT01914432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64880723|NCT01914432|Antimetabolites|antimetabolites|mesh-ancestor
64880818|NCT01915069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880819|NCT01915069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64880820|NCT01915069|Respiratory System Agents|respiratory system agents|mesh-ancestor
64345477|NCT02473250|Serotonin Agents|serotonin agents|mesh-ancestor
64880853|NCT01915186|Immunologic Factors|immunologic factors|mesh-ancestor
64880854|NCT01915186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880855|NCT01915264|Metformin|metformin|mesh-list
64880975|NCT01916200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64880976|NCT01916200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64880977|NCT01916200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64880978|NCT01916200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880980|NCT01916213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64880981|NCT01916213|Immunologic Factors|immunologic factors|mesh-ancestor
65274261|NCT00092729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64880982|NCT01916213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880983|NCT01916213|Viscosupplements|viscosupplements|mesh-ancestor
64880984|NCT01916213|Protective Agents|protective agents|mesh-ancestor
64880985|NCT01916252|Dexamethasone|dexamethasone|mesh-list
64880986|NCT01916252|Dexamethasone acetate|dexamethasone acetate|mesh-list
64880987|NCT01916252|Lenalidomide|lenalidomide|mesh-list
64880989|NCT01916252|Melphalan|melphalan|mesh-list
64880990|NCT01916252|Busulfan|busulfan|mesh-list
64881017|NCT01916265|Hormones|hormones|mesh-ancestor
64881071|NCT01916707|Enoxaparin|enoxaparin|mesh-list
64881072|NCT01916707|Anticoagulants|anticoagulants|mesh-ancestor
64881073|NCT01916707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64881074|NCT01916707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64881075|NCT01916707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881076|NCT01916733|Insulin|insulin|mesh-list
65495029|NCT01239888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881077|NCT01916733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64881078|NCT01916733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881079|NCT01916785|Dasatinib|dasatinib|mesh-list
64881080|NCT01916785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64881242|NCT01917448|Sensory System Agents|sensory system agents|mesh-ancestor
64881243|NCT01917448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64881244|NCT01917578|Paclitaxel|paclitaxel|mesh-list
64881245|NCT01917578|Docetaxel|docetaxel|mesh-list
64881246|NCT01917578|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64881389|NCT01918176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64473149|NCT00378105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881391|NCT01918241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64881393|NCT01918241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881395|NCT01918254|Pertuzumab|pertuzumab|mesh-list
64881396|NCT01918254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64881397|NCT01918254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64881398|NCT01918254|Tubulin Modulators|tubulin modulators|mesh-ancestor
64881399|NCT01918254|Antimitotic Agents|antimitotic agents|mesh-ancestor
64881400|NCT01918254|Mitosis Modulators|mitosis modulators|mesh-ancestor
64881401|NCT01918254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881402|NCT01918254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64650114|NCT02252432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64881579|NCT01919294|Androgens|androgens|mesh-ancestor
64881580|NCT01919294|Hormones|hormones|mesh-ancestor
64881581|NCT01919294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64881582|NCT01919294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881583|NCT01919294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64881584|NCT01919294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64881585|NCT01919294|Anabolic Agents|anabolic agents|mesh-ancestor
64881586|NCT01919346|Eculizumab|eculizumab|mesh-list
64881587|NCT01919346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64881588|NCT01919346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64881589|NCT01919346|Immunologic Factors|immunologic factors|mesh-ancestor
64881590|NCT01919346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881720|NCT01921374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64881722|NCT01921374|Sensory System Agents|sensory system agents|mesh-ancestor
64881723|NCT01921374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64881724|NCT01921374|Vitamin B Complex|vitamin b complex|mesh-ancestor
64881725|NCT01921374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64558247|NCT03881345|Anticoagulants|anticoagulants|mesh-list
64881818|NCT01927679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881819|NCT01927679|Protective Agents|protective agents|mesh-ancestor
64558304|NCT04364802|Iodine|iodine|mesh-list
64881977|NCT01930773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881978|NCT01930773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881980|NCT01930786|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64881981|NCT01930786|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64881982|NCT01930786|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64881983|NCT01930786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64881984|NCT01930786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881985|NCT01930786|Cholinergic Agents|cholinergic agents|mesh-ancestor
64881986|NCT01930786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64881987|NCT01930786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881988|NCT01930786|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64881989|NCT01930786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882081|NCT01931319|Baclofen|baclofen|mesh-list
64882082|NCT01931319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64882107|NCT01931410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65274262|NCT02686476|Empagliflozin|empagliflozin|mesh-list
64799641|NCT05267977|Cephalosporins|cephalosporins|mesh-list
64882108|NCT01931410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64882109|NCT01931410|Oxytocics|oxytocics|mesh-ancestor
64882110|NCT01931501|Montelukast|montelukast|mesh-list
64882111|NCT01931501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64882112|NCT01931501|Respiratory System Agents|respiratory system agents|mesh-ancestor
64882113|NCT01931501|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64882114|NCT01931501|Hormone Antagonists|hormone antagonists|mesh-ancestor
64882115|NCT01931501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64882116|NCT01931501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882117|NCT01931501|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64882118|NCT01931501|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64882119|NCT01931501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882166|NCT01931787|Protective Agents|protective agents|mesh-ancestor
64882167|NCT01931787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882168|NCT01931787|Vitamin B Complex|vitamin b complex|mesh-ancestor
64882170|NCT01931787|Micronutrients|micronutrients|mesh-ancestor
64882171|NCT01931982|Liraglutide|liraglutide|mesh-list
64882172|NCT01931982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64882173|NCT01931982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346849|NCT01190787|Prednisone|prednisone|mesh-list
64882208|NCT01932203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64882209|NCT01932203|Respiratory System Agents|respiratory system agents|mesh-ancestor
64882210|NCT01932203|Vasodilator Agents|vasodilator agents|mesh-ancestor
64882211|NCT01932203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64882212|NCT01932203|Protective Agents|protective agents|mesh-ancestor
64882213|NCT01932203|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64882214|NCT01932203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64882245|NCT01932320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882246|NCT01932320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64882248|NCT01932372|Antirheumatic Agents|antirheumatic agents|mesh-list
64882249|NCT01932372|Tofacitinib|tofacitinib|mesh-list
64882250|NCT01932372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64882251|NCT01932372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64882252|NCT01932372|Analgesics|analgesics|mesh-ancestor
64882253|NCT01932372|Sensory System Agents|sensory system agents|mesh-ancestor
64882315|NCT01932554|Analgesics|analgesics|mesh-ancestor
64473152|NCT00378105|Hormones|hormones|mesh-ancestor
64473153|NCT00378105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64582442|NCT01813149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64882316|NCT01932554|Sensory System Agents|sensory system agents|mesh-ancestor
64882317|NCT01932554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882318|NCT01932554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64882319|NCT01932554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64882320|NCT01932554|Anesthetics, General|anesthetics, general|mesh-ancestor
64882321|NCT01932554|Anesthetics|anesthetics|mesh-ancestor
64882322|NCT01932554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64882323|NCT01932554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64882324|NCT01932554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64882325|NCT01932554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64882326|NCT01932554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64882327|NCT01932554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882328|NCT01932554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882329|NCT01932554|Anticoagulants|anticoagulants|mesh-ancestor
64650870|NCT00882206|Cytarabine|cytarabine|mesh-list
64882330|NCT01932554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64882442|NCT01933906|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64882443|NCT01933906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882444|NCT01933906|Antiviral Agents|antiviral agents|mesh-ancestor
64882445|NCT01933906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64882446|NCT01933906|Immunologic Factors|immunologic factors|mesh-ancestor
64882447|NCT01933906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882448|NCT01933945|Sorafenib|sorafenib|mesh-list
64882449|NCT01933945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882450|NCT01933945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64882451|NCT01933945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882452|NCT01933945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882453|NCT01933971|Lenograstim|lenograstim|mesh-list
64882454|NCT01933971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64882455|NCT01933971|Immunologic Factors|immunologic factors|mesh-ancestor
64882456|NCT01933971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882457|NCT01933997|Pyridoxine|pyridoxine|mesh-list
64882458|NCT01933997|Metadoxine|metadoxine|mesh-list
65274077|NCT03842436|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64882459|NCT01933997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64882460|NCT01933997|Vitamin B Complex|vitamin b complex|mesh-ancestor
64882461|NCT01933997|Vitamins|vitamins|mesh-ancestor
64882462|NCT01933997|Micronutrients|micronutrients|mesh-ancestor
64882463|NCT01933997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882464|NCT01934023|Varenicline|varenicline|mesh-list
64882465|NCT01934023|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64882466|NCT01934023|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64882467|NCT01934023|Cholinergic Agents|cholinergic agents|mesh-ancestor
64882517|NCT01934569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64882518|NCT01934569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882519|NCT01934569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64882520|NCT01934569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64882577|NCT01934777|Protective Agents|protective agents|mesh-ancestor
64882578|NCT01934777|Lipotropic Agents|lipotropic agents|mesh-ancestor
64882579|NCT01934777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64882581|NCT01934777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64882582|NCT01934777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64882583|NCT01934777|Nootropic Agents|nootropic agents|mesh-ancestor
64882584|NCT01934816|Liraglutide|liraglutide|mesh-list
64882585|NCT01934816|Exenatide|exenatide|mesh-list
64882586|NCT01934816|Glucagon|glucagon|mesh-list
64882587|NCT01934816|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64882678|NCT01935310|Immunologic Factors|immunologic factors|mesh-ancestor
64882679|NCT01935310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882680|NCT01935310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882681|NCT01935310|Interferon Inducers|interferon inducers|mesh-ancestor
64882682|NCT01935492|Paclitaxel|paclitaxel|mesh-list
64558602|NCT01018095|Metronidazole|metronidazole|mesh-list
64882768|NCT01935596|Levobupivacaine|levobupivacaine|mesh-list
64882769|NCT01935596|Anesthetics, Local|anesthetics, local|mesh-ancestor
64882770|NCT01935596|Anesthetics|anesthetics|mesh-ancestor
64882771|NCT01935596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64882772|NCT01935596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882773|NCT01935596|Sensory System Agents|sensory system agents|mesh-ancestor
64558642|NCT00954681|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64882850|NCT01935882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64882851|NCT01935882|Antimalarials|antimalarials|mesh-ancestor
64882852|NCT01935882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64882853|NCT01935882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64882854|NCT01935882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64882855|NCT01935908|Levetiracetam|levetiracetam|mesh-list
64882856|NCT01935908|Anticonvulsants|anticonvulsants|mesh-ancestor
64882857|NCT01935908|Nootropic Agents|nootropic agents|mesh-ancestor
64882858|NCT01935973|Trametinib|trametinib|mesh-list
64882859|NCT01935973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882860|NCT01935973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64882861|NCT01935973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558680|NCT02246049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64882909|NCT01936090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64882910|NCT01936090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64882911|NCT01936090|Immunologic Factors|immunologic factors|mesh-ancestor
64882912|NCT01936090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882914|NCT01936103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64882915|NCT01936103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64882916|NCT01936103|Antimetabolites|antimetabolites|mesh-ancestor
64882917|NCT01936103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882918|NCT01936103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64882919|NCT01936103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64882920|NCT01936103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882921|NCT01936129|Glatiramer Acetate|glatiramer acetate|mesh-list
64882923|NCT01936129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64882924|NCT01936129|Immunologic Factors|immunologic factors|mesh-ancestor
64882925|NCT01936129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882926|NCT01936129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64882927|NCT01936129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64882928|NCT01936220|Antipsychotic Agents|antipsychotic agents|mesh-list
64882929|NCT01936220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64883107|NCT01937494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64883108|NCT01937494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883109|NCT01937494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883270|NCT01938300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64883272|NCT01938417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65274078|NCT03842436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64883273|NCT01938417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64883274|NCT01938443|Trametinib|trametinib|mesh-list
64883275|NCT01938443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883276|NCT01938443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64883277|NCT01938443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347922|NCT03506789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348015|NCT05062174|Abortifacient Agents|abortifacient agents|mesh-ancestor
64883422|NCT01939379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64883423|NCT01939379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64883424|NCT01939379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64883425|NCT01939379|Antipyretics|antipyretics|mesh-ancestor
64883426|NCT01939418|Gemcitabine|gemcitabine|mesh-list
64883428|NCT01939418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883429|NCT01939418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64883484|NCT01939561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64883586|NCT01939990|Nebivolol|nebivolol|mesh-list
64883587|NCT01939990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64883588|NCT01939990|Vasodilator Agents|vasodilator agents|mesh-ancestor
64883589|NCT01939990|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64883590|NCT01939990|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64737024|NCT00000791|Antiviral Agents|antiviral agents|mesh-ancestor
64737025|NCT00000791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737026|NCT00000791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64737027|NCT00000791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64737029|NCT00379847|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64737030|NCT00379847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737031|NCT00379847|Natriuretic Agents|natriuretic agents|mesh-ancestor
64737032|NCT00379847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737033|NCT00374543|Ziprasidone|ziprasidone|mesh-list
64737034|NCT00374543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64737035|NCT00374543|Serotonin Agents|serotonin agents|mesh-ancestor
64738365|NCT00001577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738367|NCT00002081|Zalcitabine|zalcitabine|mesh-list
64738368|NCT00002081|Antimetabolites|antimetabolites|mesh-ancestor
64738369|NCT00002081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738370|NCT00002081|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738371|NCT00002081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738372|NCT00002081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738373|NCT00002081|Antiviral Agents|antiviral agents|mesh-ancestor
64738374|NCT00002081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738375|NCT00002081|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738376|NCT00002081|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738377|NCT00002093|Doxorubicin|doxorubicin|mesh-list
64738378|NCT00002093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64738379|NCT00002093|Daunorubicin|daunorubicin|mesh-list
64738380|NCT00002093|Bleomycin|bleomycin|mesh-list
64738381|NCT00002093|Vincristine|vincristine|mesh-list
64738382|NCT00002093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64738383|NCT00002093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738384|NCT00002093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64738435|NCT00002339|Antifungal Agents|antifungal agents|mesh-ancestor
64738436|NCT00002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738437|NCT00002339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64738438|NCT00002339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64473154|NCT00378105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64738439|NCT00002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738440|NCT00002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738441|NCT00002339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64738442|NCT00002339|Hormone Antagonists|hormone antagonists|mesh-ancestor
64738443|NCT00002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64558943|NCT03728933|Rotigotine|rotigotine|mesh-list
64739058|NCT00002201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64739059|NCT00002201|Protease Inhibitors|protease inhibitors|mesh-ancestor
64739060|NCT00002201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739224|NCT00002531|Thioguanine|thioguanine|mesh-list
64739225|NCT00002531|Vindesine|vindesine|mesh-list
64739226|NCT00002531|Teniposide|teniposide|mesh-list
64739227|NCT00002531|Levoleucovorin|levoleucovorin|mesh-list
64739526|NCT00381875|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64739527|NCT00002669|Interferons|interferons|mesh-list
64739528|NCT00002669|Interferon-alpha|interferon-alpha|mesh-list
64739529|NCT00002669|Aldesleukin|aldesleukin|mesh-list
64739530|NCT00002669|Dacarbazine|dacarbazine|mesh-list
64739531|NCT00002669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739532|NCT00002669|Antiviral Agents|antiviral agents|mesh-ancestor
65274079|NCT03842436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64739533|NCT00002669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739534|NCT00002669|Immunologic Factors|immunologic factors|mesh-ancestor
64739535|NCT00002669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739536|NCT00002669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64739537|NCT00002669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64739538|NCT00002669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64739539|NCT00002669|Alkylating Agents|alkylating agents|mesh-ancestor
64739540|NCT00002669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739643|NCT00002747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739644|NCT00002747|Trace Elements|trace elements|mesh-ancestor
64739645|NCT00002747|Micronutrients|micronutrients|mesh-ancestor
64739646|NCT02973035|Amlodipine|amlodipine|mesh-list
64739647|NCT02973035|Valsartan|valsartan|mesh-list
64739648|NCT02973035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64739649|NCT02973035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64739650|NCT02973035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64739651|NCT02973035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739652|NCT02973035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64739653|NCT02973035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739654|NCT02973035|Vasodilator Agents|vasodilator agents|mesh-ancestor
64739655|NCT02973035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64739656|NCT02973035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64739657|NCT00002753|Antibodies|antibodies|mesh-list
64739739|NCT00002783|Antimetabolites|antimetabolites|mesh-ancestor
64739740|NCT00002783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739741|NCT00002783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64739742|NCT00002783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64739743|NCT00002783|Immunologic Factors|immunologic factors|mesh-ancestor
64739744|NCT00002783|Antidotes|antidotes|mesh-ancestor
64739745|NCT00002783|Protective Agents|protective agents|mesh-ancestor
64739746|NCT00002783|Vitamin B Complex|vitamin b complex|mesh-ancestor
64739747|NCT00002783|Vitamins|vitamins|mesh-ancestor
64740134|NCT00382889|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64740135|NCT00382889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64740136|NCT00382889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64740137|NCT00382889|Adrenergic Agents|adrenergic agents|mesh-ancestor
64740138|NCT00382889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64740139|NCT00382889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740140|NCT00382889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64740141|NCT00382889|Glucocorticoids|glucocorticoids|mesh-ancestor
64740142|NCT00382889|Hormones|hormones|mesh-ancestor
64740143|NCT00382889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64740144|NCT04977167|Antibodies|antibodies|mesh-list
64740145|NCT04977167|Immunologic Factors|immunologic factors|mesh-ancestor
64740146|NCT04977167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740147|NCT04482959|Carbetocin|carbetocin|mesh-list
64740148|NCT04482959|Oxytocics|oxytocics|mesh-ancestor
64740192|NCT05251259|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64740193|NCT05251259|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64740194|NCT05251259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740195|NCT04509791|Immunoglobulins|immunoglobulins|mesh-list
64740196|NCT04509791|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64740197|NCT04509791|Antibodies|antibodies|mesh-list
64740198|NCT04509791|Thymoglobulin|thymoglobulin|mesh-list
64352236|NCT01709981|Colchicine|colchicine|mesh-list
64740368|NCT00002939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740369|NCT00002939|Tubulin Modulators|tubulin modulators|mesh-ancestor
64740370|NCT00002939|Antimitotic Agents|antimitotic agents|mesh-ancestor
64740371|NCT00002939|Mitosis Modulators|mitosis modulators|mesh-ancestor
64740372|NCT00002939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740373|NCT00002939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64740374|NCT00002939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64740375|NCT00002939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740376|NCT04009967|Pembrolizumab|pembrolizumab|mesh-list
64740377|NCT04009967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64740378|NCT04009967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740379|NCT03085823|Sirolimus|sirolimus|mesh-list
64740380|NCT03085823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64740381|NCT03085823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64740382|NCT03085823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64740383|NCT03085823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740384|NCT03085823|Antifungal Agents|antifungal agents|mesh-ancestor
65274080|NCT03842436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800011|NCT05271253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64740385|NCT03085823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64740386|NCT03085823|Immunologic Factors|immunologic factors|mesh-ancestor
64352432|NCT03461627|Hormones|hormones|mesh-ancestor
64740534|NCT00003005|Antifungal Agents|antifungal agents|mesh-ancestor
64740535|NCT00003005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64740536|NCT03905603|Cosyntropin|cosyntropin|mesh-list
64740677|NCT00003101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740678|NCT00003101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64740679|NCT00003101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740680|NCT00003101|Tubulin Modulators|tubulin modulators|mesh-ancestor
64740681|NCT00003101|Antimitotic Agents|antimitotic agents|mesh-ancestor
64740682|NCT00003101|Mitosis Modulators|mitosis modulators|mesh-ancestor
64559349|NCT03656549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64740756|NCT00003119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740757|NCT00003119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740758|NCT00003119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64740759|NCT00003119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64352768|NCT02712905|Antimetabolites|antimetabolites|mesh-ancestor
64740789|NCT00003401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64740790|NCT00003401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64740791|NCT00003401|Glucocorticoids|glucocorticoids|mesh-ancestor
64740793|NCT00003401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65495041|NCT01318486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65495042|NCT01318486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64583406|NCT01794039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740794|NCT00003401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64740795|NCT00003401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64740796|NCT00003401|Antimetabolites|antimetabolites|mesh-ancestor
64740797|NCT00003401|Antiviral Agents|antiviral agents|mesh-ancestor
64740798|NCT00003401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64740799|NCT00003401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740800|NCT00003401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64740801|NCT00003401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64352862|NCT02181413|Protease Inhibitors|protease inhibitors|mesh-ancestor
64740883|NCT00001259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64740884|NCT00001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740885|NCT00001259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64740886|NCT00001259|Progestins|progestins|mesh-ancestor
64740887|NCT00001259|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64740888|NCT00001259|Fertility Agents|fertility agents|mesh-ancestor
64740889|NCT00001259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64740890|NCT00001259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740892|NCT00003143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64740893|NCT00003143|Protective Agents|protective agents|mesh-ancestor
64740894|NCT00003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740895|NCT00003431|Flt3 ligand protein|flt3 ligand protein|mesh-list
64740896|NCT00003431|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64740951|NCT00003437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64352965|NCT04937543|Formoterol Fumarate|formoterol fumarate|mesh-list
64741024|NCT00002819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741025|NCT00002819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64741026|NCT00002819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64741027|NCT00002819|Alkylating Agents|alkylating agents|mesh-ancestor
64741028|NCT00002819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64741030|NCT00002819|Sensory System Agents|sensory system agents|mesh-ancestor
64741090|NCT00002837|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64741091|NCT00002837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64741092|NCT00002837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741093|NCT00002837|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741094|NCT00002837|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741095|NCT00002837|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741096|NCT00002837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741097|NCT00002837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741098|NCT00002837|Immunologic Factors|immunologic factors|mesh-ancestor
64741099|NCT00002837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741100|NCT00002837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64741101|NCT00002837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64741102|NCT00002837|Alkylating Agents|alkylating agents|mesh-ancestor
64741103|NCT00002837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64559487|NCT03614741|Tinzaparin|tinzaparin|mesh-list
65274081|NCT03842436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800113|NCT05250141|Levodopa|levodopa|mesh-list
64741175|NCT00003173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741176|NCT00003173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741177|NCT00003173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64741178|NCT00003173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741179|NCT00003179|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64741181|NCT00003179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64741182|NCT00003179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64741183|NCT00003179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64741184|NCT00003179|Contraceptive Agents|contraceptive agents|mesh-ancestor
64741185|NCT00003179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64741186|NCT00003179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741187|NCT00003179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64741188|NCT00003179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64741189|NCT00003179|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64741190|NCT00003179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64741191|NCT00003179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741217|NCT00003557|Dolastatin 10|dolastatin 10|mesh-list
64741218|NCT00003557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741219|NCT00003557|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741220|NCT00003557|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741221|NCT00003557|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741222|NCT00003557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741241|NCT00003941|Bleomycin|bleomycin|mesh-list
64741242|NCT00003941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741243|NCT00003941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64741244|NCT00003941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64741245|NCT00003941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64741246|NCT00003941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741247|NCT00003941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741248|NCT00003941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64741249|NCT00003941|Alkylating Agents|alkylating agents|mesh-ancestor
64741250|NCT00003941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64741251|NCT00384527|Vancomycin|vancomycin|mesh-list
64741252|NCT00384527|Nitazoxanide|nitazoxanide|mesh-list
64741253|NCT00384527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64741254|NCT00384527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64741255|NCT00384527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64741539|NCT00003611|Dermatologic Agents|dermatologic agents|mesh-ancestor
64741540|NCT00003617|Clarithromycin|clarithromycin|mesh-list
64741541|NCT00003617|Tinidazole|tinidazole|mesh-list
64741542|NCT00003617|Chlorambucil|chlorambucil|mesh-list
64741543|NCT00003617|Omeprazole|omeprazole|mesh-list
64741544|NCT00003617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64741647|NCT00004073|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64741648|NCT00004073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64741649|NCT00004085|Antibodies|antibodies|mesh-list
64741650|NCT00004085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64741651|NCT00004085|Immunologic Factors|immunologic factors|mesh-ancestor
64741652|NCT00004085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741653|NCT00004091|Antibodies|antibodies|mesh-list
64741654|NCT00004091|Immunologic Factors|immunologic factors|mesh-ancestor
64741655|NCT00004091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741656|NCT00004097|Gemcitabine|gemcitabine|mesh-list
64741778|NCT00004145|Antimetabolites|antimetabolites|mesh-ancestor
64742002|NCT00003323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64742003|NCT00003323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742036|NCT00003335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742037|NCT00003335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64742038|NCT00003335|Immunologic Factors|immunologic factors|mesh-ancestor
64742039|NCT00003335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742040|NCT00003335|Antifungal Agents|antifungal agents|mesh-ancestor
64354011|NCT03425747|Calcium, Dietary|calcium, dietary|mesh-list
64742070|NCT00003353|Immunologic Factors|immunologic factors|mesh-ancestor
64742071|NCT00003353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742072|NCT00003353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64742073|NCT00003353|Alkylating Agents|alkylating agents|mesh-ancestor
64742223|NCT00004433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742225|NCT00004913|Docetaxel|docetaxel|mesh-list
64742226|NCT00004913|Fluorouracil|fluorouracil|mesh-list
64742227|NCT00004913|Calcium|calcium|mesh-list
64742228|NCT00004913|Levoleucovorin|levoleucovorin|mesh-list
64742229|NCT00004913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399822|NCT03144115|Oxytocin|oxytocin|mesh-list
64742230|NCT00004913|Tubulin Modulators|tubulin modulators|mesh-ancestor
64742231|NCT00004913|Antimitotic Agents|antimitotic agents|mesh-ancestor
64742232|NCT00004913|Mitosis Modulators|mitosis modulators|mesh-ancestor
64742233|NCT00004913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742234|NCT00004913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64742235|NCT00004913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742236|NCT00004913|Antimetabolites|antimetabolites|mesh-ancestor
64742237|NCT00004913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64742238|NCT00004913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64742239|NCT00004913|Immunologic Factors|immunologic factors|mesh-ancestor
64742240|NCT00004913|Antidotes|antidotes|mesh-ancestor
64742340|NCT00005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742342|NCT00005015|Serotonin Agents|serotonin agents|mesh-ancestor
64742343|NCT00005015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742344|NCT00005015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64742345|NCT00005015|Antidepressive Agents|antidepressive agents|mesh-ancestor
64742346|NCT00005015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64742347|NCT00005015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64742348|NCT00005015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64742349|NCT00005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742585|NCT00385463|Autonomic Agents|autonomic agents|mesh-ancestor
64742586|NCT00385463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64742587|NCT00385463|Glucocorticoids|glucocorticoids|mesh-ancestor
64742589|NCT00385463|Sympathomimetics|sympathomimetics|mesh-ancestor
64742590|NCT00423371|Hyaluronic Acid|hyaluronic acid|mesh-list
64742591|NCT00423371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64742592|NCT00423371|Immunologic Factors|immunologic factors|mesh-ancestor
64742593|NCT00423371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742594|NCT00423371|Viscosupplements|viscosupplements|mesh-ancestor
64742595|NCT00423371|Protective Agents|protective agents|mesh-ancestor
64742596|NCT00005579|Dolastatin 10|dolastatin 10|mesh-list
64742597|NCT00005579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742598|NCT00005579|Tubulin Modulators|tubulin modulators|mesh-ancestor
64742642|NCT00005585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64742644|NCT00005585|Protective Agents|protective agents|mesh-ancestor
64742645|NCT00005585|Vitamin B Complex|vitamin b complex|mesh-ancestor
64742646|NCT00005585|Vitamins|vitamins|mesh-ancestor
64742647|NCT00005585|Micronutrients|micronutrients|mesh-ancestor
64742648|NCT00005585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64742649|NCT00005585|Tubulin Modulators|tubulin modulators|mesh-ancestor
64742650|NCT00005585|Antimitotic Agents|antimitotic agents|mesh-ancestor
64742651|NCT00005585|Mitosis Modulators|mitosis modulators|mesh-ancestor
64742652|NCT00005585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64742653|NCT00005585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64742654|NCT00005585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64742655|NCT00005591|Gemcitabine|gemcitabine|mesh-list
64742710|NCT00005603|Autonomic Agents|autonomic agents|mesh-ancestor
64742711|NCT00005603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64742712|NCT00005603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64742713|NCT00005603|Glucocorticoids|glucocorticoids|mesh-ancestor
64742714|NCT00005603|Hormones|hormones|mesh-ancestor
64742715|NCT00005603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64742716|NCT00005603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64742717|NCT00005603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65495045|NCT03436108|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65495046|NCT03436108|Estrogens|estrogens|mesh-ancestor
64584015|NCT01859013|Topiramate|topiramate|mesh-list
64742718|NCT00005603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64742719|NCT00005603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64742720|NCT00005603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742721|NCT00005603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64742844|NCT00003653|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64742845|NCT00003653|Fertility Agents|fertility agents|mesh-ancestor
64742846|NCT00003653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64742847|NCT00003653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742848|NCT00003653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64560066|NCT01050153|Aspirin|aspirin|mesh-list
64742900|NCT00003671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64742901|NCT00003671|Tubulin Modulators|tubulin modulators|mesh-ancestor
64742902|NCT00003671|Antimitotic Agents|antimitotic agents|mesh-ancestor
64742903|NCT00003671|Mitosis Modulators|mitosis modulators|mesh-ancestor
64742904|NCT00003671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64742905|NCT00003671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64742906|NCT00003671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65274082|NCT03842436|Antiviral Agents|antiviral agents|mesh-ancestor
65274083|NCT03842436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64742907|NCT00003677|Dolastatin 10|dolastatin 10|mesh-list
64742908|NCT00003677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742909|NCT00003677|Tubulin Modulators|tubulin modulators|mesh-ancestor
64742983|NCT00003725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742985|NCT00003731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64742986|NCT00003731|Alkylating Agents|alkylating agents|mesh-ancestor
64742987|NCT00003731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743019|NCT00003797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64560142|NCT01053819|Etanercept|etanercept|mesh-list
64743060|NCT00003815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64743062|NCT00003815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64743063|NCT00003815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64743064|NCT00003815|Antimetabolites|antimetabolites|mesh-ancestor
64743065|NCT00003815|Antiviral Agents|antiviral agents|mesh-ancestor
64473160|NCT00378105|Growth Inhibitors|growth inhibitors|mesh-ancestor
64743066|NCT00003815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64743067|NCT00003815|Tubulin Modulators|tubulin modulators|mesh-ancestor
64743068|NCT00003815|Antimitotic Agents|antimitotic agents|mesh-ancestor
64743069|NCT00003815|Mitosis Modulators|mitosis modulators|mesh-ancestor
64743070|NCT00003815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64743071|NCT00003815|Glucocorticoids|glucocorticoids|mesh-ancestor
64743072|NCT00003815|Hormones|hormones|mesh-ancestor
64743073|NCT00003815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64743074|NCT00003815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64743075|NCT00003821|Aminopterin|aminopterin|mesh-list
64743076|NCT00003821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64743077|NCT00003821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743078|NCT00003821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743079|NCT00003827|Cytarabine|cytarabine|mesh-list
64743080|NCT00003827|Topotecan|topotecan|mesh-list
64743081|NCT00003827|Amifostine|amifostine|mesh-list
64743101|NCT00003851|Antiviral Agents|antiviral agents|mesh-ancestor
64743102|NCT00003851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64743103|NCT00003851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743104|NCT00003851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64743105|NCT00003851|Immunologic Factors|immunologic factors|mesh-ancestor
64743106|NCT00003851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743108|NCT00003881|Carboplatin|carboplatin|mesh-list
64743109|NCT00003881|Trastuzumab|trastuzumab|mesh-list
64743110|NCT00003881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64743111|NCT00003881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743112|NCT00003881|Tubulin Modulators|tubulin modulators|mesh-ancestor
64743113|NCT00003881|Antimitotic Agents|antimitotic agents|mesh-ancestor
64743114|NCT00003881|Mitosis Modulators|mitosis modulators|mesh-ancestor
64743115|NCT00003881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743116|NCT00003881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64743117|NCT00003893|Cyclophosphamide|cyclophosphamide|mesh-list
64743118|NCT00003893|Doxorubicin|doxorubicin|mesh-list
64743119|NCT00003893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64743120|NCT00003893|Fluorouracil|fluorouracil|mesh-list
64743121|NCT00003893|Methotrexate|methotrexate|mesh-list
64743122|NCT00003893|Epirubicin|epirubicin|mesh-list
64743237|NCT04568603|Respiratory System Agents|respiratory system agents|mesh-ancestor
64743238|NCT04568603|Antiviral Agents|antiviral agents|mesh-ancestor
64743239|NCT04568603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64743240|NCT04568603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495048|NCT03436108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64473162|NCT00139477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64743241|NCT04568603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743279|NCT02211443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64743280|NCT02211443|Immunologic Factors|immunologic factors|mesh-ancestor
64743281|NCT02211443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743282|NCT02211521|Hyaluronic Acid|hyaluronic acid|mesh-list
64743283|NCT02211521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64743284|NCT02211521|Immunologic Factors|immunologic factors|mesh-ancestor
64743285|NCT02211521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743286|NCT02211521|Viscosupplements|viscosupplements|mesh-ancestor
64743287|NCT02211521|Protective Agents|protective agents|mesh-ancestor
64743289|NCT01597908|Vemurafenib|vemurafenib|mesh-list
64743290|NCT01597908|Dabrafenib|dabrafenib|mesh-list
64743291|NCT01597908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743292|NCT01597908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64743293|NCT01597908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274084|NCT03842436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65274085|NCT03842436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65274086|NCT03829722|Paclitaxel|paclitaxel|mesh-list
64743294|NCT01597908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743295|NCT01948908|Midazolam|midazolam|mesh-list
64743296|NCT01948908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64743297|NCT01948908|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64560297|NCT04041843|Apixaban|apixaban|mesh-list
64743345|NCT01946880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64743346|NCT01946880|Glucocorticoids|glucocorticoids|mesh-ancestor
64743347|NCT01946880|Hormones|hormones|mesh-ancestor
64743348|NCT01946880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64743349|NCT01946880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743350|NCT01946880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64743351|NCT01946880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743352|NCT01946880|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64560336|NCT01072773|Autonomic Agents|autonomic agents|mesh-ancestor
64743409|NCT01918332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64743410|NCT01922934|Topiramate|topiramate|mesh-list
64743411|NCT01922934|Phentermine|phentermine|mesh-list
64743412|NCT01922934|Anticonvulsants|anticonvulsants|mesh-ancestor
64743413|NCT01922934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64743414|NCT01922934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743415|NCT01922934|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64743500|NCT01914666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64743501|NCT01914666|Antidepressive Agents|antidepressive agents|mesh-ancestor
64743502|NCT01914666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64743503|NCT01914666|Dopamine Agents|dopamine agents|mesh-ancestor
64743504|NCT01913340|Epoetin Alfa|epoetin alfa|mesh-list
64743505|NCT01913340|Hematinics|hematinics|mesh-ancestor
64743506|NCT01912872|Omalizumab|omalizumab|mesh-list
64743507|NCT01912872|Budesonide|budesonide|mesh-list
64743508|NCT01912872|Formoterol Fumarate|formoterol fumarate|mesh-list
64743509|NCT01912872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64743510|NCT01912872|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64743511|NCT01912872|Autonomic Agents|autonomic agents|mesh-ancestor
64743569|NCT01908582|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64743570|NCT01908582|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64743571|NCT01908582|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64743572|NCT01908582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64743573|NCT01908582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64743574|NCT01908582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64743575|NCT01908582|Antimetabolites|antimetabolites|mesh-ancestor
64743576|NCT01908582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64743577|NCT01907100|Cisplatin|cisplatin|mesh-list
64743578|NCT01907100|Pemetrexed|pemetrexed|mesh-list
64743579|NCT01907100|Nintedanib|nintedanib|mesh-list
64743580|NCT01907100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743581|NCT01907100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743582|NCT01907100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743583|NCT01907100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64743584|NCT01907100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64743585|NCT01907100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64743586|NCT01889862|Dextrans|dextrans|mesh-list
64743587|NCT01889862|Anticoagulants|anticoagulants|mesh-ancestor
64743588|NCT01889862|Plasma Substitutes|plasma substitutes|mesh-ancestor
64743589|NCT01889862|Blood Substitutes|blood substitutes|mesh-ancestor
64743590|NCT01887288|Capecitabine|capecitabine|mesh-list
64743591|NCT01887288|Digoxin|digoxin|mesh-list
64743592|NCT01887288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64743593|NCT01887288|Antimetabolites|antimetabolites|mesh-ancestor
64743594|NCT01887288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743595|NCT01887288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743596|NCT01887288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64743597|NCT01887288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64743598|NCT01887288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743599|NCT01887288|Protective Agents|protective agents|mesh-ancestor
64743620|NCT01906008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64743622|NCT01904760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64743623|NCT01904760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64743624|NCT01904760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743625|NCT01904760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64743626|NCT01904760|Analgesics|analgesics|mesh-ancestor
64743627|NCT01904760|Sensory System Agents|sensory system agents|mesh-ancestor
64743628|NCT01904760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65274087|NCT03829722|Carboplatin|carboplatin|mesh-list
65274088|NCT03829722|Nivolumab|nivolumab|mesh-list
64472155|NCT03772314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64743629|NCT01904760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64743630|NCT01904760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64743631|NCT01904760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64743726|NCT01862250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64743727|NCT01862250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743729|NCT01876446|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64743730|NCT01876446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64743731|NCT01876446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743732|NCT01876446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744056|NCT01848990|Insulin glulisine|insulin glulisine|mesh-list
64744057|NCT01848990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64744058|NCT01848990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744059|NCT01867086|Carboplatin|carboplatin|mesh-list
64744060|NCT01867086|Vaccines|vaccines|mesh-list
64744110|NCT01803282|Growth Inhibitors|growth inhibitors|mesh-ancestor
64744111|NCT01803282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64744112|NCT01803282|Antimetabolites|antimetabolites|mesh-ancestor
64744113|NCT01803282|Antiviral Agents|antiviral agents|mesh-ancestor
64744114|NCT01803282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64744115|NCT01803282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744116|NCT01803282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64744117|NCT01803282|Immunologic Factors|immunologic factors|mesh-ancestor
64744118|NCT01803282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64744119|NCT01803282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64744121|NCT01803282|Protective Agents|protective agents|mesh-ancestor
64744122|NCT01803282|Vitamin B Complex|vitamin b complex|mesh-ancestor
64744123|NCT01803282|Vitamins|vitamins|mesh-ancestor
64744124|NCT01803282|Micronutrients|micronutrients|mesh-ancestor
64744125|NCT01803282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64744126|NCT01803282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64744127|NCT01844778|Tobramycin|tobramycin|mesh-list
64744128|NCT01844778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64744129|NCT01844778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64744130|NCT01802580|Fluocinonide|fluocinonide|mesh-list
64356120|NCT03818061|Bevacizumab|bevacizumab|mesh-list
64744227|NCT01798992|Sympatholytics|sympatholytics|mesh-ancestor
64744228|NCT01798992|Autonomic Agents|autonomic agents|mesh-ancestor
64744229|NCT01798992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64744230|NCT01798992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560585|NCT04730531|Mydriatics|mydriatics|mesh-ancestor
64744305|NCT01794780|Fluticasone|fluticasone|mesh-list
64744306|NCT01794780|Budesonide|budesonide|mesh-list
64744307|NCT01794780|Theophylline|theophylline|mesh-list
64744308|NCT01794780|Formoterol Fumarate|formoterol fumarate|mesh-list
64744309|NCT01794780|Tiotropium Bromide|tiotropium bromide|mesh-list
64744310|NCT01794780|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64744311|NCT01794780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64744312|NCT01794780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64744313|NCT01794780|Autonomic Agents|autonomic agents|mesh-ancestor
64744314|NCT01794780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64744315|NCT01794780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744316|NCT01794780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64744317|NCT01794780|Respiratory System Agents|respiratory system agents|mesh-ancestor
64744318|NCT01794780|Dermatologic Agents|dermatologic agents|mesh-ancestor
64744410|NCT01817790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64744411|NCT01817790|Respiratory System Agents|respiratory system agents|mesh-ancestor
64744412|NCT01817790|Dermatologic Agents|dermatologic agents|mesh-ancestor
64744413|NCT01817790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64744414|NCT01793688|Ampicillin|ampicillin|mesh-list
64744415|NCT01793688|Sulbactam|sulbactam|mesh-list
64744416|NCT01793688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64744417|NCT01793688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64744418|NCT01793688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64744419|NCT01793688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744602|NCT01814046|Immunologic Factors|immunologic factors|mesh-ancestor
64744603|NCT01814046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744604|NCT01814046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64744605|NCT01814046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64744606|NCT01814046|Alkylating Agents|alkylating agents|mesh-ancestor
64744607|NCT01814046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744608|NCT01814046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744609|NCT01814046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65274089|NCT03829722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65274090|NCT03829722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744610|NCT01814046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64744611|NCT01814046|Analgesics|analgesics|mesh-ancestor
64744612|NCT01814046|Sensory System Agents|sensory system agents|mesh-ancestor
64744613|NCT01814046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64744614|NCT01814046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64483901|NCT01784029|Vitamin D|vitamin d|mesh-list
64744615|NCT01814046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65495050|NCT03436108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64744738|NCT01768572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64744739|NCT01768572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64744822|NCT01782690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64744824|NCT01782690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744825|NCT01782690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744826|NCT01782690|Antiviral Agents|antiviral agents|mesh-ancestor
64744827|NCT01782690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64744828|NCT01782690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744829|NCT01782690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64744830|NCT01782690|Immunologic Factors|immunologic factors|mesh-ancestor
64744831|NCT01782690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744832|NCT01782690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64744833|NCT01766310|Folic Acid|folic acid|mesh-list
64744834|NCT01766310|Hematinics|hematinics|mesh-ancestor
64744835|NCT01766310|Vitamin B Complex|vitamin b complex|mesh-ancestor
64744836|NCT01766310|Vitamins|vitamins|mesh-ancestor
64744837|NCT01766310|Micronutrients|micronutrients|mesh-ancestor
64744838|NCT01766310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484121|NCT03802084|Imatinib Mesylate|imatinib mesylate|mesh-list
64744839|NCT01782222|Rotigotine|rotigotine|mesh-list
64744898|NCT01780506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64744899|NCT01780506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64744900|NCT01780506|Antiviral Agents|antiviral agents|mesh-ancestor
64744901|NCT01780506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64744902|NCT01762800|Fluticasone|fluticasone|mesh-list
64744903|NCT01762800|Xhance|xhance|mesh-list
65495051|NCT03436108|Antioxidants|antioxidants|mesh-ancestor
64744904|NCT01762800|Bromides|bromides|mesh-list
64744905|NCT01762800|Tiotropium Bromide|tiotropium bromide|mesh-list
64744906|NCT01762800|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64744907|NCT01762800|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64744908|NCT01762800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64744909|NCT01762800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64744910|NCT01762800|Autonomic Agents|autonomic agents|mesh-ancestor
64744911|NCT01762800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64744912|NCT01762800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744913|NCT01762800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64744914|NCT01762800|Respiratory System Agents|respiratory system agents|mesh-ancestor
64744915|NCT01762800|Dermatologic Agents|dermatologic agents|mesh-ancestor
64744916|NCT01762800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64744917|NCT01762800|Parasympatholytics|parasympatholytics|mesh-ancestor
64744918|NCT01762800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64744919|NCT01762800|Cholinergic Agents|cholinergic agents|mesh-ancestor
64744920|NCT01762800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64744921|NCT01762800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744922|NCT01762800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64744923|NCT01762800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64744924|NCT01762800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64744925|NCT01762800|Adrenergic Agents|adrenergic agents|mesh-ancestor
64744926|NCT01762800|Anticonvulsants|anticonvulsants|mesh-ancestor
64745373|NCT01723254|Immunologic Factors|immunologic factors|mesh-ancestor
64745401|NCT01702428|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64745440|NCT01700946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64745441|NCT01700946|Alkylating Agents|alkylating agents|mesh-ancestor
64745442|NCT01700946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745443|NCT01700946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64745559|NCT01698918|Exemestane|exemestane|mesh-list
64745560|NCT01698918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64745561|NCT01698918|Antiemetics|antiemetics|mesh-ancestor
64745562|NCT01698918|Autonomic Agents|autonomic agents|mesh-ancestor
64745563|NCT01698918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64745564|NCT01698918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745565|NCT01698918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64745566|NCT01698918|Glucocorticoids|glucocorticoids|mesh-ancestor
64745567|NCT01698918|Hormones|hormones|mesh-ancestor
64745568|NCT01698918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64745569|NCT01698918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64745570|NCT01698918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64745571|NCT01698918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64745628|NCT01716156|Antimetabolites|antimetabolites|mesh-ancestor
64745629|NCT01716156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745630|NCT01716156|Antiviral Agents|antiviral agents|mesh-ancestor
64746300|NCT01578486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64746301|NCT01578486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64746303|NCT01555164|Ranolazine|ranolazine|mesh-list
64746304|NCT01555164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64746305|NCT01555164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746306|NCT01555164|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64746307|NCT01555164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64746308|NCT01555164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746309|NCT03028428|Hyaluronic Acid|hyaluronic acid|mesh-list
64746431|NCT01528254|Vildagliptin|vildagliptin|mesh-list
64746463|NCT01549002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746465|NCT01549002|Sensory System Agents|sensory system agents|mesh-ancestor
64746869|NCT01508676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746870|NCT02985372|Cytarabine|cytarabine|mesh-list
64746871|NCT02985372|Decitabine|decitabine|mesh-list
64746872|NCT02985372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64746873|NCT02985372|Antimetabolites|antimetabolites|mesh-ancestor
64746874|NCT02985372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746875|NCT02985372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746876|NCT02985372|Antiviral Agents|antiviral agents|mesh-ancestor
64746877|NCT02985372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64746988|NCT01458366|Carboplatin|carboplatin|mesh-list
64746989|NCT01458366|Etoposide|etoposide|mesh-list
64746990|NCT01458366|Etoposide phosphate|etoposide phosphate|mesh-list
64746991|NCT01458366|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64746992|NCT01458366|Ofatumumab|ofatumumab|mesh-list
64746993|NCT01458366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746994|NCT01458366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64746995|NCT01458366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64746996|NCT01458366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64746997|NCT01458366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746998|NCT01458366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746999|NCT01458366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64747000|NCT01458366|Alkylating Agents|alkylating agents|mesh-ancestor
64747001|NCT01458210|Dulaglutide|dulaglutide|mesh-list
64747002|NCT01458210|Moxifloxacin|moxifloxacin|mesh-list
64747003|NCT01458210|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64747004|NCT01458210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64747005|NCT01458210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747006|NCT01458210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64747007|NCT01458210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64747008|NCT01458210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64747009|NCT01458210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64747010|NCT01458210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747011|NCT01458210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747012|NCT01458210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747013|NCT01458210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64747014|NCT01458210|Contraceptive Agents|contraceptive agents|mesh-ancestor
64747045|NCT01455012|Rotigotine|rotigotine|mesh-list
64747046|NCT01455012|Dopamine Agonists|dopamine agonists|mesh-ancestor
64747047|NCT01455012|Dopamine Agents|dopamine agents|mesh-ancestor
64747048|NCT01455012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64747049|NCT01455012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747050|NCT01455012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747051|NCT01454934|Gemcitabine|gemcitabine|mesh-list
64747052|NCT01454934|Docetaxel|docetaxel|mesh-list
64747053|NCT01454934|Pemetrexed|pemetrexed|mesh-list
64747054|NCT01454934|Vinorelbine|vinorelbine|mesh-list
64561019|NCT01044771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747267|NCT01473732|Immunologic Factors|immunologic factors|mesh-ancestor
64747268|NCT01473732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747269|NCT01473732|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64747270|NCT01473732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747271|NCT01473732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747272|NCT01473732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747273|NCT01473732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64747274|NCT01473732|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64747275|NCT01473732|Antitubercular Agents|antitubercular agents|mesh-ancestor
64747276|NCT01473732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64747277|NCT01473732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64747279|NCT01450098|Propyl Gallate|propyl gallate|mesh-list
64747310|NCT04674774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64747311|NCT04674774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64747313|NCT04674774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747314|NCT01492686|Edaravone|edaravone|mesh-list
64747315|NCT01492686|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64747316|NCT01492686|Antioxidants|antioxidants|mesh-ancestor
64561078|NCT01047189|Dermatologic Agents|dermatologic agents|mesh-ancestor
64747400|NCT01490190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64747402|NCT01490190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64747403|NCT01490190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747404|NCT01490190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64747405|NCT01490190|Estrogens|estrogens|mesh-ancestor
64747406|NCT01490190|Hormones|hormones|mesh-ancestor
64473168|NCT00082706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747450|NCT04089852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747451|NCT04089852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64747453|NCT04089852|Sensory System Agents|sensory system agents|mesh-ancestor
64747454|NCT04089852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64747455|NCT01440816|Interleukin-12|interleukin-12|mesh-list
64747456|NCT01440816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64747457|NCT01440816|Immunologic Factors|immunologic factors|mesh-ancestor
64747458|NCT01440816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747459|NCT01440816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64747460|NCT01440816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64747461|NCT01440816|Growth Substances|growth substances|mesh-ancestor
64359473|NCT02889237|Vitamins|vitamins|mesh-list
64747557|NCT01468818|Alkylating Agents|alkylating agents|mesh-ancestor
64747558|NCT01468818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747559|NCT01468818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747560|NCT01468818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64747613|NCT03026478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64747614|NCT03026478|Glucocorticoids|glucocorticoids|mesh-ancestor
64747615|NCT03026478|Hormones|hormones|mesh-ancestor
64747616|NCT03026478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65495052|NCT03436108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495053|NCT03436108|Protective Agents|protective agents|mesh-ancestor
64585199|NCT01429298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747617|NCT03026478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747618|NCT03026478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64747619|NCT03026478|Respiratory System Agents|respiratory system agents|mesh-ancestor
64747620|NCT04066764|Nadroparin|nadroparin|mesh-list
64747621|NCT04066764|Warfarin|warfarin|mesh-list
64747622|NCT04066764|Rivaroxaban|rivaroxaban|mesh-list
64747623|NCT04066764|Anticoagulants|anticoagulants|mesh-ancestor
64747624|NCT04066764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64747625|NCT04066764|Antithrombins|antithrombins|mesh-ancestor
64747626|NCT04066764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64747627|NCT04066764|Protease Inhibitors|protease inhibitors|mesh-ancestor
64747628|NCT04066764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747629|NCT04066764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747630|NCT04066764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64747631|NCT04066764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64747632|NCT01437540|Bromides|bromides|mesh-list
64747633|NCT01437540|Formoterol Fumarate|formoterol fumarate|mesh-list
64747634|NCT01437540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64747635|NCT01437540|Autonomic Agents|autonomic agents|mesh-ancestor
64747636|NCT01437540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64747637|NCT01437540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747638|NCT01437540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64747808|NCT01391130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64747810|NCT01391130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747811|NCT01391130|Growth Inhibitors|growth inhibitors|mesh-ancestor
64747812|NCT01391130|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64747813|NCT01391130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747814|NCT01391130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747815|NCT04046094|Ascorbic Acid|ascorbic acid|mesh-list
64747816|NCT04046094|Vitamins|vitamins|mesh-ancestor
64747817|NCT04046094|Micronutrients|micronutrients|mesh-ancestor
64747818|NCT04046094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747819|NCT04046094|Antioxidants|antioxidants|mesh-ancestor
65274091|NCT03829722|Tubulin Modulators|tubulin modulators|mesh-ancestor
64400449|NCT04994951|Hormones|hormones|mesh-ancestor
64747820|NCT04046094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747821|NCT04046094|Protective Agents|protective agents|mesh-ancestor
64747822|NCT01410240|Hemostatics|hemostatics|mesh-list
64747823|NCT01410240|Coagulants|coagulants|mesh-ancestor
64747824|NCT01390584|Prednisone|prednisone|mesh-list
64747825|NCT01390584|Cyclophosphamide|cyclophosphamide|mesh-list
64747826|NCT01390584|Dacarbazine|dacarbazine|mesh-list
64747827|NCT01390584|Doxorubicin|doxorubicin|mesh-list
64747828|NCT01390584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64747829|NCT01390584|Etoposide|etoposide|mesh-list
64747830|NCT01390584|Vincristine|vincristine|mesh-list
64747831|NCT01390584|Etoposide phosphate|etoposide phosphate|mesh-list
64747832|NCT01390584|Bleomycin|bleomycin|mesh-list
64747833|NCT01390584|Vinblastine|vinblastine|mesh-list
64516632|NCT01673217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561261|NCT01188369|Simendan|simendan|mesh-list
64748028|NCT01388790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64748030|NCT01388478|Antioxidants|antioxidants|mesh-ancestor
64748031|NCT01388478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748032|NCT01388478|Protective Agents|protective agents|mesh-ancestor
64748033|NCT01388478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561321|NCT04403555|Ivermectin|ivermectin|mesh-list
64748121|NCT04413786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748122|NCT01422408|Fluocinonide|fluocinonide|mesh-list
64748123|NCT01422408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64748124|NCT01422408|Glucocorticoids|glucocorticoids|mesh-ancestor
64748125|NCT01422408|Hormones|hormones|mesh-ancestor
64360129|NCT04147221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64748199|NCT01384734|Raltegravir Potassium|raltegravir potassium|mesh-list
64748200|NCT01384734|Fostemsavir|fostemsavir|mesh-list
64473169|NCT00082706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64748201|NCT01384734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64748202|NCT01384734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64748203|NCT01384734|Protease Inhibitors|protease inhibitors|mesh-ancestor
64748204|NCT01384734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748230|NCT01383954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748232|NCT01383954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64748233|NCT01383954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64748234|NCT01383954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748235|NCT01383954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748236|NCT05365464|Progesterone|progesterone|mesh-list
64748237|NCT05365464|Progestins|progestins|mesh-ancestor
64748238|NCT05365464|Hormones|hormones|mesh-ancestor
64748239|NCT05365464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64748240|NCT05365464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748241|NCT01383486|Naproxen|naproxen|mesh-list
64748242|NCT01383486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64748243|NCT01383486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64748244|NCT01383486|Analgesics|analgesics|mesh-ancestor
64748245|NCT01383486|Sensory System Agents|sensory system agents|mesh-ancestor
64748246|NCT01383486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748247|NCT01383486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748248|NCT01383486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64748269|NCT05365074|Anesthetics, Local|anesthetics, local|mesh-ancestor
64748270|NCT05365074|Anesthetics|anesthetics|mesh-ancestor
64748289|NCT01382940|Immunologic Factors|immunologic factors|mesh-ancestor
64748290|NCT01382940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748291|NCT01382940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64748292|NCT01382940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64748293|NCT01382940|Abortifacient Agents|abortifacient agents|mesh-ancestor
64748294|NCT01382940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65495054|NCT02870218|Nicotine|nicotine|mesh-list
64458701|NCT04146610|Antibodies|antibodies|mesh-list
64473170|NCT00082706|Antimetabolites|antimetabolites|mesh-ancestor
64748295|NCT01382940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64748296|NCT01382940|Antimetabolites|antimetabolites|mesh-ancestor
64748297|NCT01382940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748298|NCT01382940|Dermatologic Agents|dermatologic agents|mesh-ancestor
64748299|NCT01382940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748300|NCT01382940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64748301|NCT01382940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64748302|NCT01382940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64748303|NCT01382940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64748304|NCT01382940|Analgesics|analgesics|mesh-ancestor
64748305|NCT01382940|Sensory System Agents|sensory system agents|mesh-ancestor
65274092|NCT03829722|Antimitotic Agents|antimitotic agents|mesh-ancestor
64748340|NCT01395888|Cholinergic Agents|cholinergic agents|mesh-ancestor
64748341|NCT01395888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64748342|NCT01395888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748343|NCT01381692|Sirolimus|sirolimus|mesh-list
64748344|NCT01381692|Dexamethasone|dexamethasone|mesh-list
64748345|NCT01381692|Dexamethasone acetate|dexamethasone acetate|mesh-list
64748346|NCT01381692|Rituximab|rituximab|mesh-list
64748347|NCT01381692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64748348|NCT01381692|Bortezomib|bortezomib|mesh-list
64748349|NCT01381692|Antibodies|antibodies|mesh-list
64748378|NCT01395030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748379|NCT01395030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64748380|NCT01395030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64748381|NCT01395030|Nootropic Agents|nootropic agents|mesh-ancestor
64748382|NCT01394952|Dulaglutide|dulaglutide|mesh-list
64748383|NCT01394952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64748384|NCT01394952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748385|NCT01394718|Acetaminophen|acetaminophen|mesh-list
64748386|NCT01394718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64748387|NCT01394718|Analgesics|analgesics|mesh-ancestor
64748388|NCT01394718|Sensory System Agents|sensory system agents|mesh-ancestor
64748389|NCT01394718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748390|NCT01394718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748391|NCT01394718|Antipyretics|antipyretics|mesh-ancestor
64748392|NCT01394250|Lidocaine|lidocaine|mesh-list
64748461|NCT03024450|Trastuzumab|trastuzumab|mesh-list
64748462|NCT03024450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64748463|NCT03024450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748464|NCT03997968|Gemcitabine|gemcitabine|mesh-list
64748465|NCT03997968|Rituximab|rituximab|mesh-list
64748466|NCT03997968|Capecitabine|capecitabine|mesh-list
64748467|NCT03997968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64748468|NCT03997968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64748469|NCT03997968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748470|NCT03997968|Immunologic Factors|immunologic factors|mesh-ancestor
64748471|NCT03997968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748472|NCT03997968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64748473|NCT03997968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65495055|NCT02870218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64473171|NCT00082706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473172|NCT00082706|Antiviral Agents|antiviral agents|mesh-ancestor
64748474|NCT03997968|Antimetabolites|antimetabolites|mesh-ancestor
64748475|NCT03997968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748476|NCT03997968|Antiviral Agents|antiviral agents|mesh-ancestor
64748477|NCT03997968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64748478|NCT03997968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748479|NCT03997968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64748480|NCT03997968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64748481|NCT03997968|Alkylating Agents|alkylating agents|mesh-ancestor
64748482|NCT04263090|Nivolumab|nivolumab|mesh-list
64748641|NCT03597594|Alkylating Agents|alkylating agents|mesh-ancestor
64748642|NCT03597594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64748643|NCT03597594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64748645|NCT05632224|Granisetron|granisetron|mesh-list
64748646|NCT05632224|Antiemetics|antiemetics|mesh-ancestor
64748647|NCT05632224|Autonomic Agents|autonomic agents|mesh-ancestor
64748648|NCT05632224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748649|NCT05632224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748650|NCT05632224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64748651|NCT05632224|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64748652|NCT05632224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64748653|NCT05632224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748729|NCT03595254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64748730|NCT03595254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64517531|NCT04779255|Sensory System Agents|sensory system agents|mesh-ancestor
64748731|NCT03595254|Cholinergic Agents|cholinergic agents|mesh-ancestor
64748732|NCT03595254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64748733|NCT03595254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748735|NCT03599466|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64748736|NCT03599466|Protease Inhibitors|protease inhibitors|mesh-ancestor
64748737|NCT03599466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748738|NCT03599466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748739|NCT03599466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64561599|NCT01195467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64748799|NCT00217620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64748800|NCT00217620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748801|NCT00217620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748802|NCT00217464|Fulvestrant|fulvestrant|mesh-list
64748803|NCT00217464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64748821|NCT03593304|Vitamin B 12|vitamin b 12|mesh-list
64748822|NCT03593304|Pyridoxine|pyridoxine|mesh-list
64748823|NCT03593304|Pyridoxal|pyridoxal|mesh-list
64748824|NCT03593304|Vitamin B 6|vitamin b 6|mesh-list
64748825|NCT03593304|Vitamin B Complex|vitamin b complex|mesh-list
64748826|NCT03593304|Micronutrients|micronutrients|mesh-ancestor
64748827|NCT03593304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748828|NCT00211536|Insulin|insulin|mesh-list
64748829|NCT00211536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64748830|NCT00211536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64561640|NCT02405585|Antidotes|antidotes|mesh-ancestor
64748923|NCT04196946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64748924|NCT04196946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64748925|NCT04196946|Anesthetics, General|anesthetics, general|mesh-ancestor
64748926|NCT04196946|Anesthetics|anesthetics|mesh-ancestor
64748927|NCT04194528|Acetaminophen|acetaminophen|mesh-list
64748928|NCT04194528|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64748929|NCT04194528|Oxycodone|oxycodone|mesh-list
64748930|NCT04194528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64748931|NCT04194528|Analgesics|analgesics|mesh-ancestor
64748932|NCT04194528|Sensory System Agents|sensory system agents|mesh-ancestor
64748933|NCT04194528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748934|NCT04194528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748935|NCT04194528|Antipyretics|antipyretics|mesh-ancestor
64748993|NCT03742986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64748994|NCT03742986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64749046|NCT04194294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64749047|NCT04194294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64749048|NCT04194294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64749049|NCT04194294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749050|NCT04029090|Edaravone|edaravone|mesh-list
64749051|NCT04029090|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64749052|NCT04029090|Antioxidants|antioxidants|mesh-ancestor
64749053|NCT04029090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749054|NCT04029090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64749055|NCT04029090|Protective Agents|protective agents|mesh-ancestor
64749056|NCT04029090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749057|NCT04194216|Clindamycin|clindamycin|mesh-list
64749058|NCT04194216|Clindamycin palmitate|clindamycin palmitate|mesh-list
64749059|NCT04194216|Clindamycin phosphate|clindamycin phosphate|mesh-list
64749060|NCT04194216|Cephalexin|cephalexin|mesh-list
64749061|NCT04194216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64749140|NCT03023358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65495060|NCT02870218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64473175|NCT00082706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64749141|NCT03023358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64749142|NCT03023358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749143|NCT03023358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64749144|NCT03023358|Glucocorticoids|glucocorticoids|mesh-ancestor
64749146|NCT03023358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64749147|NCT03023358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64749148|NCT03023358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64749199|NCT04192032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64749200|NCT04192032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64361219|NCT03340753|Hormones|hormones|mesh-ancestor
64749219|NCT04025736|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64749220|NCT04025736|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64749221|NCT04025736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749222|NCT04025736|Hemostatics|hemostatics|mesh-ancestor
64749223|NCT04025736|Coagulants|coagulants|mesh-ancestor
64749224|NCT04190160|Xultophy|xultophy|mesh-list
64749225|NCT04190160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64749226|NCT04190160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749227|NCT04190160|Incretins|incretins|mesh-ancestor
64749228|NCT04190160|Hormones|hormones|mesh-ancestor
64749229|NCT04190160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64749230|NCT04190004|Vasopressins|vasopressins|mesh-list
64749231|NCT04190004|Arginine Vasopressin|arginine vasopressin|mesh-list
64749232|NCT04190004|Hemostatics|hemostatics|mesh-ancestor
64749233|NCT04190004|Coagulants|coagulants|mesh-ancestor
64749234|NCT04190004|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64749235|NCT04190004|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65274093|NCT03829722|Mitosis Modulators|mitosis modulators|mesh-ancestor
64749236|NCT04190004|Natriuretic Agents|natriuretic agents|mesh-ancestor
64749237|NCT04190004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749238|NCT03949764|Sofosbuvir|sofosbuvir|mesh-list
64749239|NCT03949764|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64749240|NCT03949764|Velpatasvir|velpatasvir|mesh-list
64749241|NCT03949764|Antiviral Agents|antiviral agents|mesh-ancestor
64749242|NCT03949764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64749243|NCT04406376|Prednisone|prednisone|mesh-list
64749244|NCT04406376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64749245|NCT04406376|Glucocorticoids|glucocorticoids|mesh-ancestor
64749246|NCT04406376|Hormones|hormones|mesh-ancestor
64749247|NCT04406376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64749248|NCT04406376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749249|NCT04406376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64749250|NCT04406376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749251|NCT04024800|Pembrolizumab|pembrolizumab|mesh-list
64749252|NCT04024800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64749253|NCT04024800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749254|NCT04198662|Epinephrine|epinephrine|mesh-list
64749255|NCT04198662|Ropivacaine|ropivacaine|mesh-list
64749256|NCT04198662|Anesthetics, Local|anesthetics, local|mesh-ancestor
64749257|NCT04198662|Anesthetics|anesthetics|mesh-ancestor
64749258|NCT04198662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64749259|NCT04198662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749336|NCT04021992|Antimetabolites|antimetabolites|mesh-ancestor
64749337|NCT04021992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749369|NCT04020588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749370|NCT04020588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64749371|NCT04020588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64749372|NCT04020588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64749401|NCT04022226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749402|NCT04022226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64749403|NCT04022226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64749404|NCT04022226|Anesthetics, General|anesthetics, general|mesh-ancestor
64749406|NCT04022226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64749407|NCT04022226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64749408|NCT04022226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64749409|NCT04022226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64749410|NCT04022226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749516|NCT05583474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749517|NCT05583474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749518|NCT05583474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64749519|NCT05583474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64749520|NCT05583474|Sympatholytics|sympatholytics|mesh-ancestor
64749551|NCT04149678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64749552|NCT04149678|Immunologic Factors|immunologic factors|mesh-ancestor
64749553|NCT04149678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749554|NCT04149678|Antifungal Agents|antifungal agents|mesh-ancestor
64749555|NCT04149678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64749556|NCT04149678|Dermatologic Agents|dermatologic agents|mesh-ancestor
65495063|NCT02870218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473177|NCT00082706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749641|NCT03908892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749643|NCT04140318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64749644|NCT04140318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749645|NCT04140318|Tubulin Modulators|tubulin modulators|mesh-ancestor
64749646|NCT04140318|Antimitotic Agents|antimitotic agents|mesh-ancestor
64749647|NCT04140318|Mitosis Modulators|mitosis modulators|mesh-ancestor
64749648|NCT04140318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749649|NCT03021330|Cytarabine|cytarabine|mesh-list
64749734|NCT03941496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749735|NCT03941496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749736|NCT03941496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749737|NCT03580980|Acetaminophen|acetaminophen|mesh-list
64749738|NCT03580980|Ketamine|ketamine|mesh-list
64749739|NCT03580980|Morphine|morphine|mesh-list
64749740|NCT03580980|Levobupivacaine|levobupivacaine|mesh-list
64749741|NCT03580980|Analgesics|analgesics|mesh-ancestor
64749742|NCT03580980|Sensory System Agents|sensory system agents|mesh-ancestor
64749743|NCT03580980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749744|NCT03580980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274094|NCT03829722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749745|NCT03580980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64749746|NCT03580980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64749747|NCT03580980|Anesthetics, General|anesthetics, general|mesh-ancestor
64749748|NCT03580980|Anesthetics|anesthetics|mesh-ancestor
64749800|NCT04147806|Glucocorticoids|glucocorticoids|mesh-ancestor
64749801|NCT04147806|Hormones|hormones|mesh-ancestor
64749802|NCT04147806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64749803|NCT04147806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64749804|NCT04147806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749805|NCT04147806|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64749806|NCT04147806|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64749835|NCT03586674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64749836|NCT03586674|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64749837|NCT03586674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64749838|NCT03346668|Gabapentin|gabapentin|mesh-list
64749839|NCT03346668|Analgesics|analgesics|mesh-ancestor
64749899|NCT03589326|Mitosis Modulators|mitosis modulators|mesh-ancestor
64749900|NCT03589326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64749901|NCT05701956|Tenecteplase|tenecteplase|mesh-list
64749902|NCT05701956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64749903|NCT05701956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64749944|NCT03159702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749946|NCT03159702|Immunologic Factors|immunologic factors|mesh-ancestor
64749947|NCT03159702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749948|NCT03159702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64749949|NCT03159702|Alkylating Agents|alkylating agents|mesh-ancestor
64749950|NCT03159702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64749952|NCT03155646|Dexmedetomidine|dexmedetomidine|mesh-list
64749953|NCT03155646|Levobupivacaine|levobupivacaine|mesh-list
64749954|NCT03155646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64749955|NCT03155646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64749956|NCT03155646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749957|NCT03155646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64749958|NCT03155646|Analgesics|analgesics|mesh-ancestor
64749959|NCT03155646|Sensory System Agents|sensory system agents|mesh-ancestor
64749984|NCT04405206|Oxaliplatin|oxaliplatin|mesh-list
64749985|NCT04405206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64749986|NCT04405206|Antimetabolites|antimetabolites|mesh-ancestor
64749987|NCT04405206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749988|NCT04405206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749989|NCT03101046|Docetaxel|docetaxel|mesh-list
64749990|NCT03101046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749991|NCT03101046|Tubulin Modulators|tubulin modulators|mesh-ancestor
64749992|NCT03101046|Antimitotic Agents|antimitotic agents|mesh-ancestor
64749993|NCT03101046|Mitosis Modulators|mitosis modulators|mesh-ancestor
64749994|NCT03101046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749995|NCT03159936|Tofacitinib|tofacitinib|mesh-list
65495065|NCT02614690|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64586246|NCT01405742|Factor VIII|factor viii|mesh-list
64750068|NCT03159234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64750069|NCT03159234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64750070|NCT03159234|Adrenergic Agents|adrenergic agents|mesh-ancestor
64750071|NCT03159234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64750072|NCT03159234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750073|NCT03159234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750074|NCT03159234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64750075|NCT03159234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64750076|NCT03159234|Autonomic Agents|autonomic agents|mesh-ancestor
64750077|NCT03159234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64750109|NCT05703048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64750110|NCT05703048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64750111|NCT05703048|Adrenergic Agents|adrenergic agents|mesh-ancestor
64750112|NCT05703048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64750113|NCT05703048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750114|NCT05703048|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64750115|NCT05703048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64750116|NCT05703048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64750118|NCT05702970|Vitamins|vitamins|mesh-ancestor
64750119|NCT05702970|Micronutrients|micronutrients|mesh-ancestor
64750139|NCT03028740|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64750171|NCT01671774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274095|NCT03829722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64750172|NCT01671774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64750173|NCT01671852|Mometasone Furoate|mometasone furoate|mesh-list
64362140|NCT02488993|Rifaximin|rifaximin|mesh-list
64750196|NCT05547750|Hemostatics|hemostatics|mesh-ancestor
64750197|NCT05547750|Coagulants|coagulants|mesh-ancestor
64750198|NCT04296006|Amphetamine|amphetamine|mesh-list
64750199|NCT04296006|Dextroamphetamine|dextroamphetamine|mesh-list
64750200|NCT04296006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64750201|NCT04296006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750202|NCT04296006|Sympathomimetics|sympathomimetics|mesh-ancestor
64362190|NCT02476981|Anesthetics, General|anesthetics, general|mesh-ancestor
64750260|NCT03153072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64750261|NCT03153072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64750262|NCT03153072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64750263|NCT01673724|Pramipexole|pramipexole|mesh-list
64750264|NCT01673724|Bromocriptine|bromocriptine|mesh-list
64750265|NCT01673724|Antioxidants|antioxidants|mesh-ancestor
64750266|NCT01673724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750267|NCT01673724|Protective Agents|protective agents|mesh-ancestor
64750292|NCT03378102|Interferon-gamma|interferon-gamma|mesh-list
64750293|NCT03378102|Antiviral Agents|antiviral agents|mesh-ancestor
64750294|NCT03378102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64750295|NCT03032328|Vitamin D|vitamin d|mesh-list
64750296|NCT03032328|Vitamins|vitamins|mesh-ancestor
64750297|NCT03032328|Micronutrients|micronutrients|mesh-ancestor
64750298|NCT03032328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750299|NCT03032328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64750300|NCT04747392|Teriparatide|teriparatide|mesh-list
64750301|NCT04747392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64750302|NCT04747392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750303|NCT04747392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64750304|NCT01674192|Prucalopride|prucalopride|mesh-list
64750305|NCT01674192|Laxatives|laxatives|mesh-ancestor
64750306|NCT01674192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64750307|NCT01674192|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64562386|NCT02190903|Anesthetics|anesthetics|mesh-list
64750376|NCT01674738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750377|NCT01674738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64750378|NCT01674738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64750379|NCT01674738|Growth Substances|growth substances|mesh-ancestor
64750380|NCT01674738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750381|NCT01674738|Growth Inhibitors|growth inhibitors|mesh-ancestor
64750382|NCT01674738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750383|NCT01674738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750384|NCT01674738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64562434|NCT05685719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750417|NCT01059786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750419|NCT01059786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750420|NCT04747080|Dexamethasone|dexamethasone|mesh-list
64750421|NCT04747080|Dexamethasone acetate|dexamethasone acetate|mesh-list
64750422|NCT04747080|BB 1101|bb 1101|mesh-list
64750423|NCT04747080|Tacrolimus|tacrolimus|mesh-list
64473182|NCT00082706|Micronutrients|micronutrients|mesh-ancestor
64750424|NCT04747080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64750425|NCT04747080|Antiemetics|antiemetics|mesh-ancestor
64750426|NCT04747080|Autonomic Agents|autonomic agents|mesh-ancestor
64562473|NCT01219881|Desflurane|desflurane|mesh-list
64750513|NCT03873480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64750514|NCT03873480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64750515|NCT03873480|Autonomic Agents|autonomic agents|mesh-ancestor
64750516|NCT03873480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64750517|NCT03873480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64750518|NCT03873480|Respiratory System Agents|respiratory system agents|mesh-ancestor
64750519|NCT03873480|Mydriatics|mydriatics|mesh-ancestor
64750555|NCT03865992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64750579|NCT03749460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750581|NCT03749070|Antioxidants|antioxidants|mesh-ancestor
64750582|NCT03749070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750583|NCT03749070|Protective Agents|protective agents|mesh-ancestor
64750584|NCT03749070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750586|NCT03748134|Fluorouracil|fluorouracil|mesh-list
64750587|NCT03748134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64750588|NCT03748134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750679|NCT03727776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274096|NCT03829722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65274097|NCT03822312|Tobramycin|tobramycin|mesh-list
64750681|NCT03642210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64750682|NCT03642210|Contraceptive Agents|contraceptive agents|mesh-ancestor
64750683|NCT03642210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64750684|NCT03642210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750685|NCT03642210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64750686|NCT03642210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64750687|NCT03642210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64750688|NCT02082678|Ondansetron|ondansetron|mesh-list
64750727|NCT01677468|Doxorubicin|doxorubicin|mesh-list
64750728|NCT01677468|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64750729|NCT01677468|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
64750730|NCT01677468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64750731|NCT01677468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750732|NCT01677468|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64750733|NCT01677468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64750734|NCT01677468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750735|NCT01677468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750736|NCT01677468|Hemostatics|hemostatics|mesh-ancestor
64750737|NCT01677468|Coagulants|coagulants|mesh-ancestor
64750738|NCT00003816|Cyclophosphamide|cyclophosphamide|mesh-list
64750739|NCT00003816|Melphalan|melphalan|mesh-list
64750740|NCT00003816|Busulfan|busulfan|mesh-list
64750741|NCT00003816|Thiotepa|thiotepa|mesh-list
64750742|NCT00003816|Carboplatin|carboplatin|mesh-list
64750743|NCT00003816|Fludarabine|fludarabine|mesh-list
64750788|NCT03712878|Antitubercular Agents|antitubercular agents|mesh-ancestor
64750789|NCT03712878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64750790|NCT03712878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64750791|NCT04763070|Ciprofloxacin|ciprofloxacin|mesh-list
64750792|NCT04763070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64750793|NCT04763070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64750794|NCT04763070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64750795|NCT04763070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64750796|NCT04763070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750797|NCT04763070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750798|NCT04763070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750799|NCT04763070|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64750800|NCT04763070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64750801|NCT03611556|Leucovorin|leucovorin|mesh-list
64750802|NCT03611556|Gemcitabine|gemcitabine|mesh-list
64750803|NCT03611556|Paclitaxel|paclitaxel|mesh-list
64750804|NCT03611556|Oxaliplatin|oxaliplatin|mesh-list
64750857|NCT03826992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64750859|NCT03826992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750860|NCT03826992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64750861|NCT03826992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64750862|NCT03826992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64750863|NCT03826992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750864|NCT00004092|Paclitaxel|paclitaxel|mesh-list
64750916|NCT03825198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64750917|NCT03825198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64750918|NCT03825198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750919|NCT03825198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64750920|NCT03825198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64750921|NCT03825198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64750923|NCT03825198|Anesthetics|anesthetics|mesh-ancestor
64750924|NCT03825198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64750925|NCT03825198|Narcotics|narcotics|mesh-ancestor
64750983|NCT03817320|Antimetabolites|antimetabolites|mesh-ancestor
64750984|NCT03817320|Dermatologic Agents|dermatologic agents|mesh-ancestor
64750985|NCT03817320|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64750986|NCT03817320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64750987|NCT03817320|Immunologic Factors|immunologic factors|mesh-ancestor
64750989|NCT03817320|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64751011|NCT03580356|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64751012|NCT03580356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64562772|NCT04731467|Paclitaxel|paclitaxel|mesh-list
64751041|NCT01677546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751043|NCT04403724|Morphine|morphine|mesh-list
64751044|NCT04403724|Bupivacaine|bupivacaine|mesh-list
64751074|NCT04403568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64751075|NCT03550794|Thiamine|thiamine|mesh-list
64751076|NCT03550794|Vitamins|vitamins|mesh-ancestor
64751077|NCT03550794|Micronutrients|micronutrients|mesh-ancestor
65274098|NCT03822312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65274099|NCT03822312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64751078|NCT03550794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751079|NCT03550794|Vitamin B Complex|vitamin b complex|mesh-ancestor
64751080|NCT03798678|Dexamethasone|dexamethasone|mesh-list
64751081|NCT03798678|Dexamethasone acetate|dexamethasone acetate|mesh-list
64751082|NCT03798678|Ichthammol|ichthammol|mesh-list
64751083|NCT03798678|BB 1101|bb 1101|mesh-list
64751084|NCT03798678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64751085|NCT03798678|Antiemetics|antiemetics|mesh-ancestor
64751086|NCT03798678|Autonomic Agents|autonomic agents|mesh-ancestor
64751087|NCT03798678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64751088|NCT03798678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751192|NCT03522168|Dopamine Agonists|dopamine agonists|mesh-ancestor
64751193|NCT03522168|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64751194|NCT03522168|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64751195|NCT03522168|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64751196|NCT03522168|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64751197|NCT03457818|Denosumab|denosumab|mesh-list
64751198|NCT03457818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64751199|NCT03457818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751200|NCT01676844|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64562894|NCT01236105|Charcoal|charcoal|mesh-list
64751292|NCT00089544|Imidazole|imidazole|mesh-list
64751325|NCT03773562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751327|NCT03773562|Sensory System Agents|sensory system agents|mesh-ancestor
64751328|NCT03773562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64751329|NCT03773562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751330|NCT00088374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64751331|NCT00088374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64562938|NCT01237353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64751386|NCT00085566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64751387|NCT00085566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64363357|NCT03308149|Sensory System Agents|sensory system agents|mesh-ancestor
64751394|NCT00085098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64751395|NCT00085098|Immunologic Factors|immunologic factors|mesh-ancestor
64751396|NCT00085098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751397|NCT00085098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64751398|NCT00085098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64751399|NCT00085098|Alkylating Agents|alkylating agents|mesh-ancestor
64751400|NCT00085098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751422|NCT00084864|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64751423|NCT00084864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64751424|NCT00084864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751425|NCT00084864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64751426|NCT00084864|Vitamins|vitamins|mesh-ancestor
64751427|NCT00084864|Micronutrients|micronutrients|mesh-ancestor
64751428|NCT00084864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64751429|NCT01677702|Lactoferrin|lactoferrin|mesh-list
64751430|NCT01677702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64751431|NCT00084318|Docetaxel|docetaxel|mesh-list
64751432|NCT00084318|Cetuximab|cetuximab|mesh-list
64751433|NCT00084318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751434|NCT00084318|Tubulin Modulators|tubulin modulators|mesh-ancestor
64751435|NCT00084318|Antimitotic Agents|antimitotic agents|mesh-ancestor
64751436|NCT00084318|Mitosis Modulators|mitosis modulators|mesh-ancestor
64751437|NCT00084318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751438|NCT00084318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64751439|NCT00083616|Panitumumab|panitumumab|mesh-list
64751440|NCT00083616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64751441|NCT00083616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751442|NCT00083226|Doxorubicin|doxorubicin|mesh-list
64751443|NCT00083226|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64751444|NCT00083226|Bortezomib|bortezomib|mesh-list
64751445|NCT00083226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64751446|NCT00083226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563023|NCT01281501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751488|NCT03436056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751489|NCT03088176|Trametinib|trametinib|mesh-list
64751490|NCT03088176|Dabrafenib|dabrafenib|mesh-list
65495073|NCT01442194|Immunologic Factors|immunologic factors|mesh-ancestor
64751491|NCT03088176|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
64751492|NCT03088176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751493|NCT03088176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65274100|NCT03691493|Tamoxifen|tamoxifen|mesh-list
65274101|NCT03691493|Letrozole|letrozole|mesh-list
64751494|NCT03088176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751526|NCT00081510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751527|NCT00088452|Lamotrigine|lamotrigine|mesh-list
64751538|NCT00088452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64751540|NCT00088452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64751541|NCT00088452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751542|NCT00088452|GABA Agents|gaba agents|mesh-ancestor
64751543|NCT00088452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64751544|NCT00088452|Antimanic Agents|antimanic agents|mesh-ancestor
64751545|NCT01679106|Fentanyl|fentanyl|mesh-list
64751546|NCT01679106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64751547|NCT01679106|Narcotics|narcotics|mesh-ancestor
64751548|NCT01679106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64751584|NCT03473730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751585|NCT03081858|Paclitaxel|paclitaxel|mesh-list
64751586|NCT03081858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64751587|NCT03081858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751588|NCT03081858|Tubulin Modulators|tubulin modulators|mesh-ancestor
64751589|NCT03081858|Antimitotic Agents|antimitotic agents|mesh-ancestor
64751643|NCT03395184|PF-06700841|pf-06700841|mesh-list
64751644|NCT03395184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64751698|NCT05684718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751699|NCT05684718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64751700|NCT05684718|Hormone Antagonists|hormone antagonists|mesh-ancestor
64751701|NCT05684718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64751748|NCT03085992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751749|NCT03085992|Growth Inhibitors|growth inhibitors|mesh-ancestor
64751751|NCT03086070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64520529|NCT05718232|Lenvatinib|lenvatinib|mesh-list
64751752|NCT03086070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64751753|NCT03086070|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64751754|NCT03086070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563271|NCT01289457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751836|NCT03084978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64751837|NCT03084978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751838|NCT03084588|Methadone|methadone|mesh-list
64751839|NCT03084588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64751840|NCT03084588|Narcotics|narcotics|mesh-ancestor
64751841|NCT03084588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64751842|NCT03084588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751843|NCT03084588|Analgesics|analgesics|mesh-ancestor
64751844|NCT03084588|Sensory System Agents|sensory system agents|mesh-ancestor
64751845|NCT03084588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64751846|NCT03084588|Antitussive Agents|antitussive agents|mesh-ancestor
64751847|NCT03084588|Respiratory System Agents|respiratory system agents|mesh-ancestor
64751848|NCT05687136|Peposertib|peposertib|mesh-list
64751849|NCT05687136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64751850|NCT05687136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751851|NCT05687136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751884|NCT05582538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64751886|NCT05582538|Tubulin Modulators|tubulin modulators|mesh-ancestor
64751887|NCT05582538|Antimitotic Agents|antimitotic agents|mesh-ancestor
64563322|NCT01290237|Vancomycin|vancomycin|mesh-list
64751971|NCT03082092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64751973|NCT03082092|Autonomic Agents|autonomic agents|mesh-ancestor
64751974|NCT03082092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64751975|NCT03082092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520754|NCT05225116|Lenvatinib|lenvatinib|mesh-list
64751976|NCT03082092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64752030|NCT03318900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752031|NCT03318900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64752032|NCT03318900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64752033|NCT03318900|Alkylating Agents|alkylating agents|mesh-ancestor
64752034|NCT03318900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752035|NCT03318900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752067|NCT03399318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752068|NCT03399318|Antipyretics|antipyretics|mesh-ancestor
64752069|NCT03399318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64752070|NCT03399318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64752071|NCT03399318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64752072|NCT03399318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64752073|NCT03399318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274103|NCT03691493|Palbociclib|palbociclib|mesh-list
64752074|NCT03399318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752075|NCT03082482|Nicotine|nicotine|mesh-list
64752076|NCT03082482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64752077|NCT03082482|Autonomic Agents|autonomic agents|mesh-ancestor
64752078|NCT03082482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64752079|NCT03082482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752091|NCT03081702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64752092|NCT03081702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64752093|NCT03081702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752094|NCT03081702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752095|NCT03081702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64752096|NCT03081702|Antifungal Agents|antifungal agents|mesh-ancestor
64752097|NCT03081702|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64752098|NCT03081702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64752130|NCT03302910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752131|NCT03302910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64752132|NCT03302910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495074|NCT01442194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473185|NCT00004935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752133|NCT03302910|Vasodilator Agents|vasodilator agents|mesh-ancestor
64752134|NCT03302910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64752135|NCT03292926|Dexamethasone|dexamethasone|mesh-list
64752136|NCT03292926|Dexamethasone acetate|dexamethasone acetate|mesh-list
64752137|NCT03292926|Bupivacaine|bupivacaine|mesh-list
64752139|NCT03292926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64752140|NCT03292926|Antiemetics|antiemetics|mesh-ancestor
64752141|NCT03292926|Autonomic Agents|autonomic agents|mesh-ancestor
64752142|NCT03292926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64752143|NCT03292926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752195|NCT03261570|Protective Agents|protective agents|mesh-ancestor
64752196|NCT03261570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752197|NCT03261570|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64752198|NCT03261570|Cholinergic Agents|cholinergic agents|mesh-ancestor
64752199|NCT03261570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64752200|NCT03227562|Risperidone|risperidone|mesh-list
64752201|NCT03227562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64752202|NCT03227562|Serotonin Agents|serotonin agents|mesh-ancestor
64364176|NCT03290365|Hyaluronic Acid|hyaluronic acid|mesh-list
64752239|NCT04551144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64752337|NCT04433988|Antioxidants|antioxidants|mesh-ancestor
64752489|NCT03818802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752491|NCT03818802|Antimetabolites|antimetabolites|mesh-ancestor
64752492|NCT03818802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752493|NCT03818802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64364463|NCT01653925|Dutasteride|dutasteride|mesh-list
64752507|NCT01583322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64752508|NCT01583322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752509|NCT01583322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752510|NCT04204122|Moxifloxacin|moxifloxacin|mesh-list
64752511|NCT04204122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64752512|NCT04204122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64752513|NCT04204122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64752514|NCT04204122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64752515|NCT04204122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752516|NCT04204122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752517|NCT04204122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752546|NCT01176474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752547|NCT01176474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64752548|NCT01076868|Primaquine|primaquine|mesh-list
64752549|NCT01076868|Antimalarials|antimalarials|mesh-ancestor
64752550|NCT01076868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64752551|NCT01076868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64752552|NCT01076868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64752553|NCT03193866|Interferons|interferons|mesh-list
64752554|NCT03193866|Interferon-beta|interferon-beta|mesh-list
64752555|NCT03193866|Rituximab|rituximab|mesh-list
64752556|NCT03193866|Alemtuzumab|alemtuzumab|mesh-list
64364506|NCT03293641|Vitamins|vitamins|mesh-ancestor
64752583|NCT04198116|Varenicline|varenicline|mesh-list
64752584|NCT04198116|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64752595|NCT04195776|Tenofovir|tenofovir|mesh-list
64752596|NCT04195776|Antiviral Agents|antiviral agents|mesh-ancestor
64752597|NCT04195776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64752598|NCT04195776|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65274104|NCT03691493|Anastrozole|anastrozole|mesh-list
64752599|NCT04195776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64752600|NCT04195776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752601|NCT04195776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752705|NCT05244252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752706|NCT05244252|Sensory System Agents|sensory system agents|mesh-ancestor
64752707|NCT05244252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64752709|NCT03286842|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64752710|NCT03286842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752711|NCT03286842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752822|NCT02914158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64752823|NCT02914158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752846|NCT03136146|Immunoglobulins|immunoglobulins|mesh-list
64752847|NCT03136146|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64752848|NCT03136146|Lenograstim|lenograstim|mesh-list
64752849|NCT03136146|BB 1101|bb 1101|mesh-list
64752850|NCT03136146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64752851|NCT03136146|Immunologic Factors|immunologic factors|mesh-ancestor
64752852|NCT03136146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752853|NCT03136146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64752854|NCT03136146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64752855|NCT03136146|Alkylating Agents|alkylating agents|mesh-ancestor
64752856|NCT03136146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752909|NCT05241054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64752910|NCT05241054|Antipyretics|antipyretics|mesh-ancestor
64752911|NCT05241054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64752912|NCT05241054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64752913|NCT05241054|Vasodilator Agents|vasodilator agents|mesh-ancestor
64752914|NCT05241054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64752915|NCT05241054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64752916|NCT05241054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64752917|NCT05241054|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64752918|NCT05241054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64752919|NCT05241054|Cholinergic Agents|cholinergic agents|mesh-ancestor
64752920|NCT05241054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64752921|NCT05241054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752923|NCT00638508|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64753032|NCT01929252|Dexmedetomidine|dexmedetomidine|mesh-list
64753033|NCT01929252|Levobupivacaine|levobupivacaine|mesh-list
64753034|NCT01929252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65495079|NCT00468130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64753035|NCT01929252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64753036|NCT01929252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753037|NCT01929252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64753084|NCT01923012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64753085|NCT01923012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753086|NCT01923012|Hemostatics|hemostatics|mesh-ancestor
64753087|NCT01923012|Coagulants|coagulants|mesh-ancestor
64753088|NCT01923090|Finasteride|finasteride|mesh-list
64753089|NCT01923090|Dutasteride|dutasteride|mesh-list
64753090|NCT01923090|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64753091|NCT01923090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64753092|NCT01923090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753093|NCT01923090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753094|NCT01923090|Hormone Antagonists|hormone antagonists|mesh-ancestor
64753095|NCT01923090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64753096|NCT01923090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753097|NCT01923090|Urological Agents|urological agents|mesh-ancestor
64753150|NCT01921218|Mycophenolic Acid|mycophenolic acid|mesh-list
64753151|NCT01921218|Prednisone|prednisone|mesh-list
64753152|NCT01921218|Abatacept|abatacept|mesh-list
64753153|NCT01921218|Tacrolimus|tacrolimus|mesh-list
64753239|NCT01923948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753241|NCT01923948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64753242|NCT01923948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64753243|NCT01923948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753244|NCT01923948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64753245|NCT01923948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64753246|NCT01923948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64753247|NCT01923948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64753267|NCT01924104|Dalteparin|dalteparin|mesh-list
64753268|NCT01924104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64753269|NCT01924104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64753270|NCT01924104|Analgesics|analgesics|mesh-ancestor
64753271|NCT01924104|Sensory System Agents|sensory system agents|mesh-ancestor
64753301|NCT00636480|Dermatologic Agents|dermatologic agents|mesh-ancestor
64753302|NCT00630552|Conatumumab|conatumumab|mesh-list
64753303|NCT00630552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64753304|NCT00630552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64365244|NCT03359057|Folic Acid|folic acid|mesh-list
64753341|NCT01925820|Antiviral Agents|antiviral agents|mesh-ancestor
64753342|NCT01925820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64522124|NCT05312242|Folic Acid|folic acid|mesh-list
64753343|NCT01925898|Midazolam|midazolam|mesh-list
64753344|NCT01925898|Ketamine|ketamine|mesh-list
64753345|NCT01925898|Analgesics|analgesics|mesh-ancestor
64753377|NCT00983580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753378|NCT00983580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64753379|NCT00983580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64753381|NCT00983580|Antipyretics|antipyretics|mesh-ancestor
64753382|NCT00983580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753383|NCT00983580|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64564065|NCT04129255|Octreotide|octreotide|mesh-list
64753434|NCT01926210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64753436|NCT01926288|Entecavir|entecavir|mesh-list
64753451|NCT00981084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64753452|NCT00981084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64753453|NCT00981084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753454|NCT00980148|Azithromycin|azithromycin|mesh-list
64753455|NCT00980148|Doxycycline|doxycycline|mesh-list
64753456|NCT00980148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64753457|NCT00980148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64753458|NCT00980148|Antimalarials|antimalarials|mesh-ancestor
64753459|NCT00980148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64753460|NCT00980148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64753461|NCT03064854|Gemcitabine|gemcitabine|mesh-list
64753462|NCT03064854|Paclitaxel|paclitaxel|mesh-list
64753463|NCT03064854|Carboplatin|carboplatin|mesh-list
64753464|NCT03064854|Pemetrexed|pemetrexed|mesh-list
64753465|NCT03064854|Spartalizumab|spartalizumab|mesh-list
64753466|NCT03064854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64753467|NCT03064854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753468|NCT03064854|Tubulin Modulators|tubulin modulators|mesh-ancestor
64753484|NCT03063606|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64753486|NCT00983814|Droxidopa|droxidopa|mesh-list
64753508|NCT04275414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753509|NCT04275414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64753510|NCT04275414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64753511|NCT04275414|Growth Substances|growth substances|mesh-ancestor
64753512|NCT04275414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753513|NCT04275414|Growth Inhibitors|growth inhibitors|mesh-ancestor
64753514|NCT04395768|Vitamin D|vitamin d|mesh-list
64753515|NCT04395768|Cholecalciferol|cholecalciferol|mesh-list
64753516|NCT04395768|Vitamins|vitamins|mesh-list
64753517|NCT04395768|Ascorbic Acid|ascorbic acid|mesh-list
64753518|NCT04395768|Vitamin B 12|vitamin b 12|mesh-list
64753519|NCT04395768|Azithromycin|azithromycin|mesh-list
64753520|NCT04395768|Hydroxychloroquine|hydroxychloroquine|mesh-list
64753521|NCT04395768|Micronutrients|micronutrients|mesh-ancestor
64564164|NCT03015259|Hormones|hormones|mesh-ancestor
64753613|NCT03050736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64753614|NCT03050736|Alkylating Agents|alkylating agents|mesh-ancestor
64753615|NCT03050736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753616|NCT03050736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753617|NCT04559646|Hemostatics|hemostatics|mesh-list
65495080|NCT00468130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64753618|NCT04559646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64753619|NCT04559646|Coagulants|coagulants|mesh-ancestor
64753620|NCT04550520|Glucagon|glucagon|mesh-list
64753621|NCT04550520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64753622|NCT04550520|Hormones|hormones|mesh-ancestor
64753623|NCT04550520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64753624|NCT04550520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753625|NCT01928628|Valsartan|valsartan|mesh-list
64753654|NCT04554888|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64753655|NCT04554888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64753656|NCT04554888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64753726|NCT04123392|Cyclophosphamide|cyclophosphamide|mesh-list
64753728|NCT04123392|Decitabine|decitabine|mesh-list
64753729|NCT04123392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64753730|NCT04123392|Immunologic Factors|immunologic factors|mesh-ancestor
64753731|NCT04123392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753732|NCT04123392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64753733|NCT04123392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64753734|NCT04123392|Alkylating Agents|alkylating agents|mesh-ancestor
64753735|NCT04123392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753736|NCT04123392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753737|NCT04123392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64753738|NCT04123392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64753739|NCT04123392|Antimetabolites|antimetabolites|mesh-ancestor
64753740|NCT04123392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753741|NCT04760262|Remifentanil|remifentanil|mesh-list
64753742|NCT04760262|Propofol|propofol|mesh-list
64753743|NCT04760262|Sevoflurane|sevoflurane|mesh-list
64753744|NCT04760262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64753745|NCT04760262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64753746|NCT04760262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753747|NCT04760262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64753748|NCT04760262|Anesthetics, General|anesthetics, general|mesh-ancestor
64753749|NCT04760262|Anesthetics|anesthetics|mesh-ancestor
64753750|NCT04760262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64753751|NCT04760262|Narcotics|narcotics|mesh-ancestor
64753752|NCT04760262|Analgesics|analgesics|mesh-ancestor
64753769|NCT05607810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753771|NCT05607810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753794|NCT04121910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64753795|NCT04121910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753796|NCT04121910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753797|NCT04121910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64753798|NCT04121910|Hormone Antagonists|hormone antagonists|mesh-ancestor
64753799|NCT04121910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64753800|NCT04121910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753801|NCT04121910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64753802|NCT04129788|Bisacodyl|bisacodyl|mesh-list
64753803|NCT04129788|Cathartics|cathartics|mesh-ancestor
64753804|NCT04129788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64753805|NCT04129788|Laxatives|laxatives|mesh-ancestor
64753806|NCT03831126|Betamethasone|betamethasone|mesh-list
64753807|NCT03831126|Betamethasone Valerate|betamethasone valerate|mesh-list
64753808|NCT03831126|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64753809|NCT03831126|Betamethasone benzoate|betamethasone benzoate|mesh-list
64753810|NCT03831126|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64753811|NCT03831126|Glucocorticoids|glucocorticoids|mesh-ancestor
64753812|NCT03831126|Hormones|hormones|mesh-ancestor
64753813|NCT03831126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64564300|NCT00631475|Bosentan|bosentan|mesh-list
64753870|NCT04129008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64753871|NCT04129008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64365830|NCT03258697|Anesthetics|anesthetics|mesh-ancestor
64753902|NCT04120350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64753904|NCT04120350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65495081|NCT00468130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495082|NCT00468130|Dopamine Agonists|dopamine agonists|mesh-ancestor
65495083|NCT00468130|Dopamine Agents|dopamine agents|mesh-ancestor
65495084|NCT00468130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65495085|NCT00468130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495086|NCT00468130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65495087|NCT00468130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65495088|NCT00468130|Serotonin Agents|serotonin agents|mesh-ancestor
64753905|NCT04120350|Growth Substances|growth substances|mesh-ancestor
64753906|NCT04120350|Growth Inhibitors|growth inhibitors|mesh-ancestor
64753907|NCT04394598|Capecitabine|capecitabine|mesh-list
64753908|NCT04394598|Irinotecan|irinotecan|mesh-list
64753909|NCT04394598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64753910|NCT04394598|Antimetabolites|antimetabolites|mesh-ancestor
64753911|NCT04394598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753912|NCT04394598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64365871|NCT05505617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64564348|NCT03830827|Vortioxetine|vortioxetine|mesh-list
64754075|NCT04393584|Protective Agents|protective agents|mesh-ancestor
64754076|NCT04393584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754129|NCT03828084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754130|NCT03828084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754131|NCT04274166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64473199|NCT00119158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64754132|NCT04274166|Immunologic Factors|immunologic factors|mesh-ancestor
64754133|NCT04274166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754158|NCT03821454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754161|NCT02956590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64754162|NCT02956590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64754163|NCT02956590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64754164|NCT02956590|Antimetabolites|antimetabolites|mesh-ancestor
64754165|NCT02956590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754166|NCT02956590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754167|NCT02956590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64754168|NCT03820518|Calcitriol|calcitriol|mesh-list
64754169|NCT03820518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64754170|NCT03820518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754171|NCT03820518|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64754172|NCT03820518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64754173|NCT03820518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754236|NCT01453920|Ranibizumab|ranibizumab|mesh-list
64754237|NCT01453920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64754238|NCT01453920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64754239|NCT01453920|Growth Substances|growth substances|mesh-ancestor
64754240|NCT01453920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754241|NCT01453920|Growth Inhibitors|growth inhibitors|mesh-ancestor
64754242|NCT01453920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754243|NCT03820908|Bisantrene|bisantrene|mesh-list
64754244|NCT03820908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64754325|NCT04391868|Urological Agents|urological agents|mesh-ancestor
64754327|NCT03829332|Lenvatinib|lenvatinib|mesh-list
64754328|NCT03829332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64754329|NCT03829332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754330|NCT03829332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64754331|NCT03829332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754332|NCT03829332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754333|NCT03071406|Nivolumab|nivolumab|mesh-list
64754334|NCT03071406|Ipilimumab|ipilimumab|mesh-list
64754335|NCT03071406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64754336|NCT03071406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754337|NCT03071406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64754338|NCT03071406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754339|NCT02983188|Antipsychotic Agents|antipsychotic agents|mesh-list
64754340|NCT02983188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64754341|NCT02983188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64754342|NCT02983188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754343|NCT02983188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64754344|NCT01450176|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64754345|NCT01450176|Bepotastine besilate|bepotastine besilate|mesh-list
64754423|NCT03043014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64754424|NCT03043014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754425|NCT03043014|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64754426|NCT03043014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64754427|NCT03043014|Oxytocics|oxytocics|mesh-ancestor
64754509|NCT02861898|Mannitol|mannitol|mesh-list
64754510|NCT02861898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64754511|NCT02861898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754512|NCT02861898|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64754543|NCT01452906|Omeprazole|omeprazole|mesh-list
64754544|NCT01452906|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64754545|NCT01452906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64754546|NCT01452906|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64754547|NCT01452906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754548|NCT01452906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754549|NCT02781090|Nicotine|nicotine|mesh-list
64754550|NCT02781090|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64754551|NCT02781090|Autonomic Agents|autonomic agents|mesh-ancestor
64754552|NCT02781090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64754553|NCT02781090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754554|NCT02781090|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64754555|NCT02781090|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64754556|NCT02781090|Cholinergic Agents|cholinergic agents|mesh-ancestor
64754557|NCT02781090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64366501|NCT03347591|Coagulants|coagulants|mesh-ancestor
64754624|NCT04849650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64564683|NCT04120753|Amlodipine|amlodipine|mesh-list
64754703|NCT01891812|Sensory System Agents|sensory system agents|mesh-ancestor
64754704|NCT01891812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64754706|NCT04840602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64754707|NCT04840602|Venetoclax|venetoclax|mesh-list
65274105|NCT03691493|Exemestane|exemestane|mesh-list
64754708|NCT04840602|Antibodies|antibodies|mesh-list
64754709|NCT04840602|Immunoglobulins|immunoglobulins|mesh-list
64754710|NCT04840602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64754711|NCT04840602|Immunologic Factors|immunologic factors|mesh-ancestor
64754712|NCT04840602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754713|NCT04840602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495090|NCT00468130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64473200|NCT00119158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64754714|NCT04840602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64754715|NCT04390464|Ravulizumab|ravulizumab|mesh-list
64754716|NCT04390464|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64754717|NCT04390464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64754718|NCT04390464|Immunologic Factors|immunologic factors|mesh-ancestor
64754719|NCT04390464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754720|NCT01892748|Vitamin D|vitamin d|mesh-list
64754721|NCT01892748|Cholecalciferol|cholecalciferol|mesh-list
64754722|NCT01892748|Vitamins|vitamins|mesh-ancestor
64754723|NCT01892748|Micronutrients|micronutrients|mesh-ancestor
64564734|NCT01922141|Amlodipine|amlodipine|mesh-list
64754812|NCT01893450|Methimazole|methimazole|mesh-list
64754813|NCT01893450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64754814|NCT01893450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754815|NCT01893450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754816|NCT01893450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64754902|NCT02730546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64754903|NCT02730546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64754905|NCT02730546|Antidotes|antidotes|mesh-ancestor
64754906|NCT02730546|Protective Agents|protective agents|mesh-ancestor
64754907|NCT02730546|Vitamin B Complex|vitamin b complex|mesh-ancestor
64754909|NCT02730546|Micronutrients|micronutrients|mesh-ancestor
64754910|NCT02730546|Hematinics|hematinics|mesh-ancestor
64754911|NCT01459146|Lumefantrine|lumefantrine|mesh-list
64754912|NCT01459146|Artemether|artemether|mesh-list
64754913|NCT01459146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64754914|NCT01459146|Albendazole|albendazole|mesh-list
64754915|NCT01459146|Praziquantel|praziquantel|mesh-list
64754949|NCT02720094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754951|NCT02720094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64754952|NCT02720094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64754982|NCT01459380|Immunoglobulin G|immunoglobulin g|mesh-list
64754983|NCT01459380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754984|NCT01459380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64754985|NCT01459380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64754986|NCT01459380|Growth Substances|growth substances|mesh-ancestor
64754987|NCT01459380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754988|NCT01459380|Growth Inhibitors|growth inhibitors|mesh-ancestor
64754989|NCT01459380|Immunologic Factors|immunologic factors|mesh-ancestor
64755036|NCT02705196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755038|NCT02705196|Antimetabolites|antimetabolites|mesh-ancestor
64755039|NCT02705196|Antiviral Agents|antiviral agents|mesh-ancestor
64755040|NCT02705196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64755041|NCT02705196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755042|NCT02705196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64755043|NCT02705196|Immunologic Factors|immunologic factors|mesh-ancestor
64755044|NCT02705196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755045|NCT02703948|Lidocaine|lidocaine|mesh-list
64755046|NCT02703948|Anesthetics, Local|anesthetics, local|mesh-ancestor
64755047|NCT02703948|Anesthetics|anesthetics|mesh-ancestor
64755048|NCT02703948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64755049|NCT02703948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755050|NCT02703948|Sensory System Agents|sensory system agents|mesh-ancestor
64755051|NCT02703948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64755052|NCT02703948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64755053|NCT02703948|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64755054|NCT02703948|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64755078|NCT02666742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755220|NCT01451736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64755221|NCT02589600|Vitamin D|vitamin d|mesh-list
64755222|NCT02589600|Zoledronic Acid|zoledronic acid|mesh-list
64755223|NCT02589600|Calcium|calcium|mesh-list
64755224|NCT02589600|Vitamins|vitamins|mesh-ancestor
64755225|NCT02589600|Micronutrients|micronutrients|mesh-ancestor
64755226|NCT02589600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755227|NCT02589600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64755228|NCT02589600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64755229|NCT04758000|Metformin|metformin|mesh-list
64472167|NCT03760575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755230|NCT04758000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64755231|NCT04758000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755232|NCT01450956|Sevoflurane|sevoflurane|mesh-list
64755233|NCT01450956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64755234|NCT01450956|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64755235|NCT01450956|Anesthetics, General|anesthetics, general|mesh-ancestor
64755236|NCT01450956|Anesthetics|anesthetics|mesh-ancestor
64755237|NCT01450956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64755238|NCT01450956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755239|NCT02300922|Antibodies|antibodies|mesh-list
65495093|NCT05196256|Sufentanil|sufentanil|mesh-list
64473204|NCT00119158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64755322|NCT01989780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755323|NCT01989780|Tubulin Modulators|tubulin modulators|mesh-ancestor
64755324|NCT01989780|Antimitotic Agents|antimitotic agents|mesh-ancestor
64755325|NCT01989780|Mitosis Modulators|mitosis modulators|mesh-ancestor
64755326|NCT01989780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755327|NCT01989780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64755328|NCT01989780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64755329|NCT01989780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64755330|NCT01989780|Growth Substances|growth substances|mesh-ancestor
64755331|NCT01989780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755332|NCT01989780|Growth Inhibitors|growth inhibitors|mesh-ancestor
64755333|NCT01989780|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64755334|NCT01989780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64564996|NCT01920737|Antiemetics|antiemetics|mesh-ancestor
64755387|NCT05585580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64755388|NCT05585580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755389|NCT05585580|Tubulin Modulators|tubulin modulators|mesh-ancestor
64755483|NCT01943994|Autonomic Agents|autonomic agents|mesh-ancestor
64755484|NCT01943994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64755485|NCT01943994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755486|NCT01943994|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64755520|NCT02153580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755521|NCT02153580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755522|NCT02153580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64755523|NCT02153580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64755524|NCT02153580|Antimetabolites|antimetabolites|mesh-ancestor
64755525|NCT02153580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64367526|NCT03341117|Antipyretics|antipyretics|mesh-ancestor
64755615|NCT02425566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64755616|NCT02425566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755617|NCT02425566|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64755618|NCT02425566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64755619|NCT02425566|Cholinergic Agents|cholinergic agents|mesh-ancestor
64755620|NCT02425566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64755649|NCT04757532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755650|NCT04757532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64755651|NCT04757532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64755737|NCT00575718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64755738|NCT00575718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64755739|NCT00575718|Cholinergic Agents|cholinergic agents|mesh-ancestor
64755740|NCT00575718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64755741|NCT00575718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755742|NCT02087748|Diclofenac|diclofenac|mesh-list
64755743|NCT02087748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64755744|NCT02087748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64755745|NCT02087748|Analgesics|analgesics|mesh-ancestor
64755746|NCT02087748|Sensory System Agents|sensory system agents|mesh-ancestor
64755747|NCT02087748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64755876|NCT00262470|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
64755877|NCT00262470|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64755878|NCT00262470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64755879|NCT00262470|Cholinergic Agents|cholinergic agents|mesh-ancestor
64755881|NCT01851642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64755882|NCT01851642|Autonomic Agents|autonomic agents|mesh-ancestor
64755883|NCT01851642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64755884|NCT01851642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755885|NCT01851642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64755918|NCT01212822|Immunoglobulins|immunoglobulins|mesh-list
64755919|NCT01212822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64755920|NCT01212822|Levoleucovorin|levoleucovorin|mesh-list
64755921|NCT01212822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756043|NCT00869232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64756044|NCT00869232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64756046|NCT00869232|Autonomic Agents|autonomic agents|mesh-ancestor
64756047|NCT00869232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64756048|NCT00869232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64756049|NCT00869232|Glucocorticoids|glucocorticoids|mesh-ancestor
64756050|NCT00869232|Hormones|hormones|mesh-ancestor
64756051|NCT00869232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64756052|NCT00869232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64756053|NCT00869232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64756054|NCT00869232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64756055|NCT00869232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64756056|NCT00869232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756057|NCT00869232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64756058|NCT00869232|Leprostatic Agents|leprostatic agents|mesh-ancestor
64756059|NCT00869232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64756060|NCT00869232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64756061|NCT00869232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64565255|NCT01924637|Insulin|insulin|mesh-list
64756147|NCT04777968|Cariostatic Agents|cariostatic agents|mesh-ancestor
64756148|NCT04777968|Protective Agents|protective agents|mesh-ancestor
64756149|NCT04777968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756150|NCT01722708|Metronidazole|metronidazole|mesh-list
64756151|NCT01722708|Clindamycin|clindamycin|mesh-list
64756152|NCT01722708|Clindamycin palmitate|clindamycin palmitate|mesh-list
64756153|NCT01722708|Clindamycin phosphate|clindamycin phosphate|mesh-list
64756154|NCT01722708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64756155|NCT01722708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64756156|NCT01722708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64565304|NCT01926665|Hormones|hormones|mesh-ancestor
64756201|NCT01895400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64756202|NCT01895400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756203|NCT01895400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64756204|NCT01895400|Respiratory System Agents|respiratory system agents|mesh-ancestor
64756205|NCT01895400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65495097|NCT05196256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64756206|NCT01895400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64756207|NCT01895400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756208|NCT01895400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64756209|NCT01895400|Vasodilator Agents|vasodilator agents|mesh-ancestor
64756210|NCT01895400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64756211|NCT01895400|Protective Agents|protective agents|mesh-ancestor
64756212|NCT01895400|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64756244|NCT04773756|Sofosbuvir|sofosbuvir|mesh-list
64756245|NCT04773756|Antiviral Agents|antiviral agents|mesh-ancestor
64756246|NCT04773756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64756247|NCT03012984|Dexmedetomidine|dexmedetomidine|mesh-list
64756248|NCT03012984|Morphine|morphine|mesh-list
64756249|NCT03012984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64565336|NCT01927835|Immunologic Factors|immunologic factors|mesh-ancestor
64756388|NCT02538744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64756389|NCT02538744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64756390|NCT02538744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64756391|NCT02538744|Dopamine Agents|dopamine agents|mesh-ancestor
64756392|NCT02538744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64756393|NCT02538744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64756394|NCT02538744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64756395|NCT02538744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64756396|NCT02538744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64756397|NCT02538744|Adrenergic Agents|adrenergic agents|mesh-ancestor
64756513|NCT00024102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64756514|NCT00024102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64756515|NCT00024102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756516|NCT00024102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756517|NCT00024102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64756518|NCT00024102|Antimetabolites|antimetabolites|mesh-ancestor
64756520|NCT00074802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64756521|NCT00074802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64756522|NCT00074802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64756523|NCT00074802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756524|NCT00074802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64756525|NCT00074802|Serotonin Agents|serotonin agents|mesh-ancestor
64756526|NCT00074802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756527|NCT00074802|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65274106|NCT03691493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756528|NCT00074802|Antidepressive Agents|antidepressive agents|mesh-ancestor
64756529|NCT00074802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64756567|NCT01897116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64756568|NCT01897116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756569|NCT01897116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64756570|NCT00036738|Cyclosporine|cyclosporine|mesh-list
64756571|NCT00036738|Mycophenolic Acid|mycophenolic acid|mesh-list
64756572|NCT00036738|Fludarabine|fludarabine|mesh-list
64756573|NCT00036738|Fludarabine phosphate|fludarabine phosphate|mesh-list
64756574|NCT00036738|Imatinib Mesylate|imatinib mesylate|mesh-list
64756575|NCT00036738|Dasatinib|dasatinib|mesh-list
64756576|NCT00036738|Cyclosporins|cyclosporins|mesh-list
64756577|NCT00036738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756578|NCT00036738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64756579|NCT00036738|Antimetabolites|antimetabolites|mesh-ancestor
64756580|NCT00036738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756581|NCT00036738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64756582|NCT00036738|Immunologic Factors|immunologic factors|mesh-ancestor
64756583|NCT00036738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756584|NCT00036738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756585|NCT00036738|Antifungal Agents|antifungal agents|mesh-ancestor
64756586|NCT00036738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64756587|NCT00036738|Dermatologic Agents|dermatologic agents|mesh-ancestor
64756588|NCT00036738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64756589|NCT00036738|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64756590|NCT00036738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64756591|NCT00036738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64368521|NCT05016063|Fludarabine|fludarabine|mesh-list
64756622|NCT00038610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64756623|NCT00038610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65495098|NCT05196256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589449|NCT00475085|Glucocorticoids|glucocorticoids|mesh-ancestor
64756624|NCT00038610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756625|NCT00038610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64756626|NCT00038610|Abortifacient Agents|abortifacient agents|mesh-ancestor
64756627|NCT00038610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64756628|NCT00038610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64756724|NCT02091882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756725|NCT02091882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64756726|NCT02091882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64756761|NCT00254592|Tubulin Modulators|tubulin modulators|mesh-ancestor
64756762|NCT00254592|Antimitotic Agents|antimitotic agents|mesh-ancestor
64756763|NCT00254592|Mitosis Modulators|mitosis modulators|mesh-ancestor
64756764|NCT00254592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756765|NCT00254592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64756766|NCT00254592|Immunologic Factors|immunologic factors|mesh-ancestor
64756792|NCT00255684|Alkylating Agents|alkylating agents|mesh-ancestor
64756793|NCT00255684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756831|NCT00258180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64756833|NCT00258180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756834|NCT00258180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64565572|NCT04122755|Buprenorphine|buprenorphine|mesh-list
64756885|NCT00176904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64756886|NCT00179478|Interferons|interferons|mesh-list
64756887|NCT00179478|Interferon-beta|interferon-beta|mesh-list
64756888|NCT00179478|Interferon beta-1a|interferon beta-1a|mesh-list
64368801|NCT03227653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64756920|NCT00087672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756921|NCT00088218|Cytarabine|cytarabine|mesh-list
64756922|NCT00088218|Clofarabine|clofarabine|mesh-list
64756923|NCT00088218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64756924|NCT00088218|Antimetabolites|antimetabolites|mesh-ancestor
64756925|NCT00088218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756926|NCT00088218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756927|NCT00088218|Antiviral Agents|antiviral agents|mesh-ancestor
64756928|NCT00088218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64756929|NCT00088218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64756930|NCT00088218|Immunologic Factors|immunologic factors|mesh-ancestor
64756931|NCT00088218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756932|NCT00189228|Omalizumab|omalizumab|mesh-list
64756951|NCT00091260|Protease Inhibitors|protease inhibitors|mesh-ancestor
64756952|NCT00091260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756953|NCT00091260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756954|NCT00091260|Immunologic Factors|immunologic factors|mesh-ancestor
64756955|NCT00091260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64756956|NCT00091260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64756957|NCT00091260|Growth Substances|growth substances|mesh-ancestor
64756958|NCT00091260|Growth Inhibitors|growth inhibitors|mesh-ancestor
64756960|NCT00193128|Capecitabine|capecitabine|mesh-list
64756961|NCT00193128|Oxaliplatin|oxaliplatin|mesh-list
64756962|NCT00193128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756963|NCT00193128|Tubulin Modulators|tubulin modulators|mesh-ancestor
64756964|NCT00193128|Antimitotic Agents|antimitotic agents|mesh-ancestor
64756965|NCT00193128|Mitosis Modulators|mitosis modulators|mesh-ancestor
64756966|NCT00193128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756967|NCT00193128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64756968|NCT00193128|Antimetabolites|antimetabolites|mesh-ancestor
64756969|NCT00193596|Gemcitabine|gemcitabine|mesh-list
64756970|NCT00193596|Paclitaxel|paclitaxel|mesh-list
64756971|NCT00193596|Etoposide|etoposide|mesh-list
64756972|NCT00193596|Carboplatin|carboplatin|mesh-list
64756973|NCT00193596|Irinotecan|irinotecan|mesh-list
64756974|NCT00193596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64756975|NCT00193596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756976|NCT00193596|Tubulin Modulators|tubulin modulators|mesh-ancestor
64756977|NCT00193596|Antimitotic Agents|antimitotic agents|mesh-ancestor
64756978|NCT00193596|Mitosis Modulators|mitosis modulators|mesh-ancestor
64756979|NCT00193596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756980|NCT00193596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64756981|NCT00193596|Antimetabolites|antimetabolites|mesh-ancestor
64757031|NCT04118556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64757032|NCT04118556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64757033|NCT04118556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64757034|NCT04118556|Antifungal Agents|antifungal agents|mesh-ancestor
64757035|NCT04118556|Dermatologic Agents|dermatologic agents|mesh-ancestor
64757036|NCT04118556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64757037|NCT04118556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64757038|NCT04118556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64757039|NCT04118556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64368972|NCT03221881|Docetaxel|docetaxel|mesh-list
64473208|NCT00119158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757065|NCT00195624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757066|NCT00195624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757067|NCT00195624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64757068|NCT00195624|Immunologic Factors|immunologic factors|mesh-ancestor
64757069|NCT00195624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757070|NCT00195624|Antifungal Agents|antifungal agents|mesh-ancestor
64757071|NCT00195624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64757111|NCT00201864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757113|NCT00202722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64757114|NCT00202722|Narcotics|narcotics|mesh-ancestor
64757115|NCT00202722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64757116|NCT00202722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757117|NCT00202722|Analgesics|analgesics|mesh-ancestor
64757118|NCT00202722|Sensory System Agents|sensory system agents|mesh-ancestor
64757119|NCT00202722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64757120|NCT00100698|Hormones|hormones|mesh-list
64757121|NCT00100698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64757122|NCT00100698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757123|NCT00103116|Vaccines|vaccines|mesh-list
64757124|NCT00103116|Immunologic Factors|immunologic factors|mesh-ancestor
64757125|NCT00103116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757126|NCT00205374|Cidofovir|cidofovir|mesh-list
64757127|NCT00205374|Antiviral Agents|antiviral agents|mesh-ancestor
64757128|NCT00205374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64757129|NCT00205374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757130|NCT00205374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757131|NCT00103194|Lapatinib|lapatinib|mesh-list
64757132|NCT00103194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757133|NCT00103194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64757134|NCT00103194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757135|NCT00103194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757136|NCT00208026|Pimecrolimus|pimecrolimus|mesh-list
64757137|NCT00208026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64757138|NCT00208026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64757192|NCT00214890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64757193|NCT00214890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64757194|NCT00216060|Risedronic Acid|risedronic acid|mesh-list
64757195|NCT00216060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65274107|NCT03691493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64402079|NCT04884035|Rituximab|rituximab|mesh-list
64757196|NCT00216060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64757197|NCT00216060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757228|NCT00282828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64757229|NCT00282828|Serotonin Agents|serotonin agents|mesh-ancestor
64757230|NCT00282828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757231|NCT00282828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64757232|NCT00282828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64757233|NCT00282828|Anticonvulsants|anticonvulsants|mesh-ancestor
64757234|NCT00282828|GABA Modulators|gaba modulators|mesh-ancestor
64757235|NCT00282828|GABA Agents|gaba agents|mesh-ancestor
64757236|NCT00112242|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64757237|NCT00112242|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64757238|NCT00112242|Immunologic Factors|immunologic factors|mesh-ancestor
64757239|NCT00112242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757240|NCT00223236|Choline|choline|mesh-list
64369178|NCT03318731|Fenugreek seed meal|fenugreek seed meal|mesh-list
64757270|NCT00224952|Valproic Acid|valproic acid|mesh-list
64757271|NCT00224952|Anticonvulsants|anticonvulsants|mesh-ancestor
64757395|NCT00114504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64757396|NCT00114504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757397|NCT01898676|Valproic Acid|valproic acid|mesh-list
64757398|NCT01898676|Anticonvulsants|anticonvulsants|mesh-ancestor
64757446|NCT04752852|Antiemetics|antiemetics|mesh-ancestor
64757447|NCT04752852|Autonomic Agents|autonomic agents|mesh-ancestor
64757448|NCT04752852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64757449|NCT04752852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757450|NCT04752852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64757451|NCT04752852|Glucocorticoids|glucocorticoids|mesh-ancestor
64757453|NCT04752852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64757454|NCT04752852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64757455|NCT04752852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757456|NCT01899144|Albuterol|albuterol|mesh-list
64757457|NCT01899144|Procaterol|procaterol|mesh-list
64757458|NCT01899144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64757459|NCT01899144|Autonomic Agents|autonomic agents|mesh-ancestor
64757460|NCT01899144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64757461|NCT01899144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757462|NCT01899144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64757463|NCT01899144|Respiratory System Agents|respiratory system agents|mesh-ancestor
64757464|NCT01899144|Tocolytic Agents|tocolytic agents|mesh-ancestor
64757539|NCT00123162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64757541|NCT00123162|Urological Agents|urological agents|mesh-ancestor
64757542|NCT00123630|Omalizumab|omalizumab|mesh-list
64757543|NCT00123630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64757544|NCT00123630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64757545|NCT00123630|Respiratory System Agents|respiratory system agents|mesh-ancestor
64757546|NCT00124176|Albuterol|albuterol|mesh-list
64757547|NCT00124176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64757548|NCT00124176|Autonomic Agents|autonomic agents|mesh-ancestor
64757549|NCT00124176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64473209|NCT00119392|Cyclosporine|cyclosporine|mesh-list
64757550|NCT00124176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757551|NCT00124176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64757552|NCT00124176|Respiratory System Agents|respiratory system agents|mesh-ancestor
64757553|NCT00124176|Tocolytic Agents|tocolytic agents|mesh-ancestor
64757554|NCT00124176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64757555|NCT00124176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64757556|NCT00124176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64757557|NCT00124176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64757558|NCT00124176|Adrenergic Agents|adrenergic agents|mesh-ancestor
64757559|NCT00124176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64757560|NCT00124176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757561|NCT00240162|Vatalanib|vatalanib|mesh-list
64757562|NCT00240162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64757563|NCT00240162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757564|NCT00240162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757565|NCT00299988|Immunoglobulins|immunoglobulins|mesh-list
64757587|NCT00300456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757589|NCT00125034|Cetuximab|cetuximab|mesh-list
64757590|NCT00125034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757591|NCT00125034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64757592|NCT02100930|Molgramostim|molgramostim|mesh-list
65274108|NCT03691493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65274109|NCT03691493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757593|NCT02100930|Isotretinoin|isotretinoin|mesh-list
64757594|NCT02100930|Antibodies|antibodies|mesh-list
64757595|NCT02100930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64757596|NCT02100930|Sargramostim|sargramostim|mesh-list
64757597|NCT02100930|Immunologic Factors|immunologic factors|mesh-ancestor
64757654|NCT04389060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757655|NCT04389060|Antioxidants|antioxidants|mesh-ancestor
64757656|NCT04389060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757657|NCT04389060|Protective Agents|protective agents|mesh-ancestor
64757658|NCT04389060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757659|NCT01899066|Carboplatin|carboplatin|mesh-list
64757660|NCT01899066|Etoposide|etoposide|mesh-list
64757661|NCT01899066|Vincristine|vincristine|mesh-list
64757662|NCT01899066|Ranibizumab|ranibizumab|mesh-list
64757663|NCT01899066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757664|NCT01899066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64757665|NCT01899066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64757691|NCT00127218|Vitamins|vitamins|mesh-ancestor
64757692|NCT00127218|Micronutrients|micronutrients|mesh-ancestor
64757753|NCT00135798|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64757754|NCT00135798|Antiviral Agents|antiviral agents|mesh-ancestor
64757755|NCT00135798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64757756|NCT02103114|Antithrombin III|antithrombin iii|mesh-list
64757790|NCT00140556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64757791|NCT00140556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64757792|NCT00140556|Growth Substances|growth substances|mesh-ancestor
64757793|NCT00140556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757794|NCT00140556|Growth Inhibitors|growth inhibitors|mesh-ancestor
64757795|NCT00140556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64757796|NCT00140556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757797|NCT00140556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757798|NCT00142116|Thalidomide|thalidomide|mesh-list
64757799|NCT00142116|Rituximab|rituximab|mesh-list
64757821|NCT05201430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64757822|NCT05201430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757823|NCT00142506|Sildenafil Citrate|sildenafil citrate|mesh-list
64757824|NCT00142506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757825|NCT00142506|Vasodilator Agents|vasodilator agents|mesh-ancestor
64566048|NCT05341115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64757875|NCT00147966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757876|NCT00147966|Immunologic Factors|immunologic factors|mesh-ancestor
64757877|NCT00147966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757878|NCT00147966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64757880|NCT04528212|Curcumin|curcumin|mesh-list
64757881|NCT04528212|Fenofibrate|fenofibrate|mesh-list
64757882|NCT04528212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64757883|NCT04528212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64757884|NCT04528212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757885|NCT04528212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64757886|NCT04528212|Immunologic Factors|immunologic factors|mesh-ancestor
64757887|NCT04528212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64757888|NCT04528212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64757890|NCT04528212|Sensory System Agents|sensory system agents|mesh-ancestor
64757891|NCT04528212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64757892|NCT04528212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64757893|NCT04528212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64757894|NCT04528212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566104|NCT05292664|Vitamins|vitamins|mesh-ancestor
64758010|NCT04345926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64758011|NCT04345926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758012|NCT04345926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64758013|NCT04345926|Anesthetics, General|anesthetics, general|mesh-ancestor
64758040|NCT00343044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758041|NCT00343044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758042|NCT00344370|Atorvastatin|atorvastatin|mesh-list
64758043|NCT00344370|Pitavastatin|pitavastatin|mesh-list
64758044|NCT00344370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64758045|NCT00344370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64758046|NCT00344370|Antimetabolites|antimetabolites|mesh-ancestor
64758047|NCT00344370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758048|NCT00344370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64758049|NCT00344370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65274110|NCT03691493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758050|NCT00344370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758051|NCT00344682|Memantine|memantine|mesh-list
64758052|NCT00344682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64758053|NCT00344682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64758054|NCT00344682|Dopamine Agents|dopamine agents|mesh-ancestor
64758055|NCT00344682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64758056|NCT00344682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758057|NCT00344682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758058|NCT00344682|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64758059|NCT00344682|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64758060|NCT00345384|Dexmedetomidine|dexmedetomidine|mesh-list
64758061|NCT00345384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64758093|NCT00350142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758094|NCT00350142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758095|NCT00350142|Antiviral Agents|antiviral agents|mesh-ancestor
64758096|NCT00350142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64758097|NCT00350142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758098|NCT00350142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64758099|NCT00350142|Immunologic Factors|immunologic factors|mesh-ancestor
64758127|NCT00351936|Aripiprazole|aripiprazole|mesh-list
64758128|NCT00351936|Antidepressive Agents|antidepressive agents|mesh-ancestor
64758129|NCT00351936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64758130|NCT00351936|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64758131|NCT00351936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64758132|NCT00351936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64758133|NCT00351936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758134|NCT00351936|Dopamine Agonists|dopamine agonists|mesh-ancestor
64758135|NCT00351936|Dopamine Agents|dopamine agents|mesh-ancestor
64758136|NCT00351936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64758137|NCT00351936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758138|NCT00351936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64758139|NCT00351936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64758225|NCT00354978|Growth Inhibitors|growth inhibitors|mesh-ancestor
64758226|NCT00354978|Antimetabolites|antimetabolites|mesh-ancestor
64758227|NCT00354978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758228|NCT00354978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64758229|NCT00354978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64758230|NCT00354978|Immunologic Factors|immunologic factors|mesh-ancestor
64758231|NCT00354978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64758232|NCT00354978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64758233|NCT00354978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758263|NCT03984240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64758264|NCT03984240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64758265|NCT03984240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64758266|NCT03984240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64758267|NCT03984240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64758268|NCT03984240|Anesthetics, General|anesthetics, general|mesh-ancestor
64758269|NCT03984240|Anesthetics|anesthetics|mesh-ancestor
64758270|NCT03984240|GABA Modulators|gaba modulators|mesh-ancestor
64758271|NCT03984240|GABA Agents|gaba agents|mesh-ancestor
64758272|NCT00359736|Sildenafil Citrate|sildenafil citrate|mesh-list
64566257|NCT05023369|Glucocorticoids|glucocorticoids|mesh-ancestor
64758419|NCT00305760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758420|NCT00305760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758421|NCT00305760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64758422|NCT00305760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64758423|NCT00309738|Simvastatin|simvastatin|mesh-list
64758424|NCT00309738|Pitavastatin|pitavastatin|mesh-list
64758604|NCT00390234|Endothelial Growth Factors|endothelial growth factors|mesh-list
64758605|NCT00390234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64758606|NCT00390234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64758607|NCT00390234|Growth Substances|growth substances|mesh-ancestor
64758608|NCT00390234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758633|NCT00392496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64758634|NCT00392496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758635|NCT00392496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758636|NCT01958190|Sirolimus|sirolimus|mesh-list
64758637|NCT01958190|Tacrolimus|tacrolimus|mesh-list
64758638|NCT01958190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64758639|NCT01958190|Immunologic Factors|immunologic factors|mesh-ancestor
64758640|NCT01958190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274111|NCT03691493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64758641|NCT01958190|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64758642|NCT01958190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758643|NCT01958190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758644|NCT01958190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64758645|NCT01958190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64758646|NCT01958190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64758647|NCT01958190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758661|NCT00638898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64758662|NCT00638898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64758663|NCT00638898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64758664|NCT00638898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758665|NCT00393978|Topiramate|topiramate|mesh-list
64758666|NCT00393978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64758693|NCT00397020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64758694|NCT00397020|Antimanic Agents|antimanic agents|mesh-ancestor
64758696|NCT00397878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758697|NCT00397878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758698|NCT00397878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758699|NCT00400686|Epoetin Alfa|epoetin alfa|mesh-list
64758700|NCT00400686|Hematinics|hematinics|mesh-ancestor
64758701|NCT05220462|Midazolam|midazolam|mesh-list
64758702|NCT05220462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65495104|NCT05196256|Anesthetics, General|anesthetics, general|mesh-ancestor
65495105|NCT05196256|Anesthetics|anesthetics|mesh-ancestor
64758703|NCT05220462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64758704|NCT05220462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64758705|NCT05220462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758706|NCT05220462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64758707|NCT05220462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64758708|NCT05220462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64758709|NCT05220462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64758710|NCT05220462|Anesthetics, General|anesthetics, general|mesh-ancestor
64758712|NCT05220462|GABA Modulators|gaba modulators|mesh-ancestor
64758736|NCT00374244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64758737|NCT00374244|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64758738|NCT00374244|Dopamine Agents|dopamine agents|mesh-ancestor
64758739|NCT00374244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64758802|NCT00381810|Anesthetics|anesthetics|mesh-ancestor
64758803|NCT00381810|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64758804|NCT00381810|Histamine Antagonists|histamine antagonists|mesh-ancestor
64758805|NCT00381810|Histamine Agents|histamine agents|mesh-ancestor
64758806|NCT00381810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64758807|NCT00381810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758839|NCT00405522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64758840|NCT00405522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758842|NCT00405522|Anesthetics, General|anesthetics, general|mesh-ancestor
64758843|NCT00405522|Anesthetics|anesthetics|mesh-ancestor
64758844|NCT00405522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64758845|NCT00405522|Narcotics|narcotics|mesh-ancestor
64758846|NCT00405522|Analgesics|analgesics|mesh-ancestor
64758847|NCT00405522|Sensory System Agents|sensory system agents|mesh-ancestor
64758848|NCT00405522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64758970|NCT00464646|Mitosis Modulators|mitosis modulators|mesh-ancestor
64758971|NCT00464646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64758972|NCT00464646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64758973|NCT00464646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64758974|NCT00464646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758975|NCT00385008|Naproxen|naproxen|mesh-list
64758976|NCT00385008|Sumatriptan|sumatriptan|mesh-list
64758977|NCT00385008|Eletriptan|eletriptan|mesh-list
64758978|NCT00385008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64758979|NCT00385008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64758980|NCT00385008|Analgesics|analgesics|mesh-ancestor
64758981|NCT00385008|Sensory System Agents|sensory system agents|mesh-ancestor
64759059|NCT00466752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64759060|NCT00466752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759061|NCT00466752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759062|NCT02115750|Etanercept|etanercept|mesh-list
64759063|NCT02115750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64759064|NCT02115750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64759065|NCT02115750|Analgesics|analgesics|mesh-ancestor
64759066|NCT02115750|Sensory System Agents|sensory system agents|mesh-ancestor
64759067|NCT02115750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64759068|NCT02115750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759069|NCT02115750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65274112|NCT03691493|Hormone Antagonists|hormone antagonists|mesh-ancestor
64472172|NCT03738579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64759070|NCT02115750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64759071|NCT02115750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64759072|NCT02115750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64759073|NCT02115750|Immunologic Factors|immunologic factors|mesh-ancestor
64759074|NCT00413166|Idarubicin|idarubicin|mesh-list
64759075|NCT00413166|Tretinoin|tretinoin|mesh-list
64759076|NCT00413166|Arsenic Trioxide|arsenic trioxide|mesh-list
64759077|NCT00413166|Gemtuzumab|gemtuzumab|mesh-list
64759078|NCT00413166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64759079|NCT00413166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759080|NCT00413166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64759081|NCT00413166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64759082|NCT00413166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759083|NCT00413166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495106|NCT05196256|Anesthetics, Local|anesthetics, local|mesh-ancestor
65495107|NCT01375348|Remifentanil|remifentanil|mesh-list
64590575|NCT04144712|Caffeine|caffeine|mesh-list
64566708|NCT03351998|Atorvastatin|atorvastatin|mesh-list
64759332|NCT00425802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64759333|NCT00425802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64759334|NCT00425802|Antitubercular Agents|antitubercular agents|mesh-ancestor
64759335|NCT00425802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64759336|NCT00530634|Gemcitabine|gemcitabine|mesh-list
65495108|NCT01375348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64759337|NCT00530634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759338|NCT00530634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64759339|NCT00530634|Antimetabolites|antimetabolites|mesh-ancestor
64759391|NCT00428922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759392|NCT00428922|Growth Inhibitors|growth inhibitors|mesh-ancestor
64759393|NCT00428922|Tubulin Modulators|tubulin modulators|mesh-ancestor
64759425|NCT00535002|Mydriatics|mydriatics|mesh-ancestor
64759426|NCT00535002|Autonomic Agents|autonomic agents|mesh-ancestor
64759427|NCT00535002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64759428|NCT00535002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759429|NCT00535002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64759430|NCT00535002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64759431|NCT00535002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64759432|NCT00535002|Adrenergic Agents|adrenergic agents|mesh-ancestor
64759433|NCT00535002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64759434|NCT00535002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759435|NCT00535002|Urological Agents|urological agents|mesh-ancestor
64759439|NCT00429702|Diphenhydramine|diphenhydramine|mesh-list
64759440|NCT00429702|Promethazine|promethazine|mesh-list
64759441|NCT00429702|Dexamethasone|dexamethasone|mesh-list
64759442|NCT00429702|Lorazepam|lorazepam|mesh-list
64759443|NCT00429702|Ondansetron|ondansetron|mesh-list
64759444|NCT00429702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64759445|NCT00429702|Antiemetics|antiemetics|mesh-ancestor
64759446|NCT00429702|Autonomic Agents|autonomic agents|mesh-ancestor
64759447|NCT00429702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64759448|NCT00429702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473216|NCT00119392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64759476|NCT00429702|GABA Modulators|gaba modulators|mesh-ancestor
64759478|NCT00535392|Levetiracetam|levetiracetam|mesh-list
64759479|NCT00535392|Anticonvulsants|anticonvulsants|mesh-ancestor
64759480|NCT00535392|Nootropic Agents|nootropic agents|mesh-ancestor
64759481|NCT00535782|Methotrexate|methotrexate|mesh-list
64759482|NCT00535782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64759483|NCT00535782|Abortifacient Agents|abortifacient agents|mesh-ancestor
64759484|NCT00535782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64759485|NCT00535782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759486|NCT00535782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64759487|NCT00535782|Antimetabolites|antimetabolites|mesh-ancestor
64759488|NCT00535782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759489|NCT00535782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759490|NCT00535782|Dermatologic Agents|dermatologic agents|mesh-ancestor
64759491|NCT00535782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759492|NCT00535782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64566906|NCT01828112|Pemetrexed|pemetrexed|mesh-list
64759551|NCT00491244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759552|NCT00491244|Antiviral Agents|antiviral agents|mesh-ancestor
64759553|NCT00491244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64759554|NCT00491244|Antimetabolites|antimetabolites|mesh-ancestor
65248435|NCT00844207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64472173|NCT03720522|Adenosine|adenosine|mesh-list
64759579|NCT00538824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64759580|NCT00538824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64759582|NCT00538824|Immunologic Factors|immunologic factors|mesh-ancestor
64759583|NCT00538824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64759584|NCT00538824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64759585|NCT00538824|Growth Substances|growth substances|mesh-ancestor
64759586|NCT00538824|Growth Inhibitors|growth inhibitors|mesh-ancestor
64759587|NCT00538824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64759588|NCT00538824|Leprostatic Agents|leprostatic agents|mesh-ancestor
64759589|NCT00538824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64759590|NCT00538824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64759591|NCT00539526|Bimatoprost|bimatoprost|mesh-list
64759593|NCT00539526|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64759594|NCT00539526|Latanoprost|latanoprost|mesh-list
64759595|NCT00539526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64759596|NCT00539526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64759597|NCT01796106|Fluorides|fluorides|mesh-list
64759598|NCT01796106|Fluorides, Topical|fluorides, topical|mesh-list
64759599|NCT01796106|Cariostatic Agents|cariostatic agents|mesh-ancestor
64759600|NCT01796106|Protective Agents|protective agents|mesh-ancestor
64566949|NCT00251433|Antimitotic Agents|antimitotic agents|mesh-ancestor
64759678|NCT00439374|Progestins|progestins|mesh-ancestor
64759679|NCT00439374|Hormones|hormones|mesh-ancestor
64759680|NCT00439608|Paclitaxel|paclitaxel|mesh-list
64759681|NCT00439608|Carboplatin|carboplatin|mesh-list
64759682|NCT00439608|Cetuximab|cetuximab|mesh-list
64759683|NCT00439608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64759684|NCT00439608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759685|NCT00439608|Tubulin Modulators|tubulin modulators|mesh-ancestor
64759686|NCT00439608|Antimitotic Agents|antimitotic agents|mesh-ancestor
64759687|NCT00439608|Mitosis Modulators|mitosis modulators|mesh-ancestor
64759688|NCT00439608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759689|NCT00439608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64759690|NCT04750122|Carboplatin|carboplatin|mesh-list
64759691|NCT04750122|Docetaxel|docetaxel|mesh-list
64759692|NCT04750122|Trastuzumab|trastuzumab|mesh-list
64759693|NCT04750122|Pertuzumab|pertuzumab|mesh-list
64759694|NCT04750122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759695|NCT04750122|Tubulin Modulators|tubulin modulators|mesh-ancestor
64759696|NCT04750122|Antimitotic Agents|antimitotic agents|mesh-ancestor
64759697|NCT04750122|Mitosis Modulators|mitosis modulators|mesh-ancestor
64566999|NCT02713945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64759745|NCT00504660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64759746|NCT00504660|Antimetabolites|antimetabolites|mesh-ancestor
64759747|NCT00504660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759748|NCT00504660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759749|NCT00504660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64759750|NCT00504660|Alkylating Agents|alkylating agents|mesh-ancestor
64759751|NCT00504660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64759752|NCT00504660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64759753|NCT00504660|Analgesics|analgesics|mesh-ancestor
64759780|NCT00447330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759782|NCT02115048|Afatinib|afatinib|mesh-list
64759783|NCT02115048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759784|NCT02115048|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65495111|NCT01375348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473218|NCT00119392|Immunologic Factors|immunologic factors|mesh-ancestor
64759785|NCT02115048|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64759786|NCT02115048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759787|NCT02115048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759788|NCT02115048|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64759789|NCT02115048|Hormone Antagonists|hormone antagonists|mesh-ancestor
64759790|NCT02115048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64759791|NCT02115048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759792|NCT02115048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64759793|NCT00546156|Paclitaxel|paclitaxel|mesh-list
64759794|NCT00546156|Cyclophosphamide|cyclophosphamide|mesh-list
64759795|NCT00546156|Bevacizumab|bevacizumab|mesh-list
64759796|NCT00546156|Doxorubicin|doxorubicin|mesh-list
64759797|NCT00546156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64759798|NCT00546156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759799|NCT00546156|Tubulin Modulators|tubulin modulators|mesh-ancestor
64567044|NCT03825289|Trametinib|trametinib|mesh-list
64759885|NCT00511992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64759886|NCT00511992|Growth Substances|growth substances|mesh-ancestor
64759919|NCT00549822|Hormone Antagonists|hormone antagonists|mesh-ancestor
64759920|NCT00549822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64759921|NCT00549822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759923|NCT00550290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64759924|NCT00550290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64759925|NCT01797198|Repaglinide|repaglinide|mesh-list
64759926|NCT01797198|Gemfibrozil|gemfibrozil|mesh-list
64759927|NCT01797198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64759928|NCT01797198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759929|NCT01797198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64759930|NCT01797198|Antimetabolites|antimetabolites|mesh-ancestor
64759963|NCT00553098|Fludarabine phosphate|fludarabine phosphate|mesh-list
64759964|NCT00553098|Antibodies|antibodies|mesh-list
64759965|NCT00553098|Immunoglobulins|immunoglobulins|mesh-list
64759966|NCT00553098|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64759967|NCT00553098|Cyclosporins|cyclosporins|mesh-list
64759968|NCT00553098|Immunologic Factors|immunologic factors|mesh-ancestor
64759969|NCT00553098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759970|NCT00553098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759971|NCT00553098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64760003|NCT00554970|Glucocorticoids|glucocorticoids|mesh-ancestor
64760004|NCT00554970|Hormones|hormones|mesh-ancestor
64760005|NCT00554970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64760089|NCT00527124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760090|NCT00527124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64760091|NCT00527124|Glucocorticoids|glucocorticoids|mesh-ancestor
64760092|NCT00527124|Hormones|hormones|mesh-ancestor
64760093|NCT00527124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64760094|NCT00527124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760095|NCT00527124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64760096|NCT00527124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64760097|NCT00527124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64760098|NCT00527592|Travoprost|travoprost|mesh-list
64760099|NCT00527592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64760100|NCT00527592|Latanoprost|latanoprost|mesh-list
64760101|NCT00527592|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64760102|NCT00527592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64760131|NCT01797900|Cisplatin|cisplatin|mesh-list
64760132|NCT01797900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64760133|NCT01797900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760134|NCT01797900|Tubulin Modulators|tubulin modulators|mesh-ancestor
64760135|NCT01797900|Antimitotic Agents|antimitotic agents|mesh-ancestor
64760136|NCT01797900|Mitosis Modulators|mitosis modulators|mesh-ancestor
64760137|NCT01797900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760138|NCT03572790|Prucalopride|prucalopride|mesh-list
64760139|NCT03572790|Laxatives|laxatives|mesh-ancestor
64760145|NCT03572790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760146|NCT03572790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760148|NCT03428802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64760180|NCT03117972|Growth Inhibitors|growth inhibitors|mesh-ancestor
64760181|NCT03117972|Antimetabolites|antimetabolites|mesh-ancestor
64760182|NCT03117972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760183|NCT03117972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64760184|NCT03117972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64760185|NCT03117972|Immunologic Factors|immunologic factors|mesh-ancestor
64760186|NCT03117972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64760187|NCT03117972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64760189|NCT03117972|Antidotes|antidotes|mesh-ancestor
64760190|NCT03117972|Protective Agents|protective agents|mesh-ancestor
64760191|NCT03117972|Vitamin B Complex|vitamin b complex|mesh-ancestor
64760192|NCT03117972|Vitamins|vitamins|mesh-ancestor
64760193|NCT03117972|Micronutrients|micronutrients|mesh-ancestor
64760194|NCT05622162|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
64760195|NCT05622162|18F-JK-PSMA-7|18f-jk-psma-7|mesh-list
64760196|NCT05622162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760231|NCT02128230|Thalidomide|thalidomide|mesh-list
64760232|NCT02128230|Dexamethasone|dexamethasone|mesh-list
64760233|NCT02128230|Dexamethasone acetate|dexamethasone acetate|mesh-list
64760234|NCT02128230|Cyclophosphamide|cyclophosphamide|mesh-list
64760235|NCT02128230|Melphalan|melphalan|mesh-list
64760236|NCT02128230|Cisplatin|cisplatin|mesh-list
64760257|NCT02128230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64760258|NCT02128230|Glucocorticoids|glucocorticoids|mesh-ancestor
64760259|NCT02128230|Hormones|hormones|mesh-ancestor
64760260|NCT02128230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64803125|NCT01405326|Adalimumab|adalimumab|mesh-list
64473219|NCT00119392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760261|NCT02128230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64760262|NCT02128230|Protease Inhibitors|protease inhibitors|mesh-ancestor
64760263|NCT02128230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529022|NCT02382432|Narcotics|narcotics|mesh-ancestor
64760264|NCT02128230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64760265|NCT02128230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64760266|NCT02128230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64760267|NCT02128230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64760268|NCT02128230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64760269|NCT02128230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64760270|NCT02128230|Growth Substances|growth substances|mesh-ancestor
64760271|NCT02128230|Growth Inhibitors|growth inhibitors|mesh-ancestor
64760272|NCT02128230|Leprostatic Agents|leprostatic agents|mesh-ancestor
64760273|NCT02128230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64760274|NCT02128230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64760275|NCT02128230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64760276|NCT03416244|Nivolumab|nivolumab|mesh-list
64760277|NCT03416244|Ipilimumab|ipilimumab|mesh-list
64760278|NCT03416244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64760279|NCT03416244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760280|NCT03416244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64760281|NCT03416244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760282|NCT05560620|Caffeine|caffeine|mesh-list
64760283|NCT05560620|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64760284|NCT05560620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760285|NCT05560620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64760286|NCT05560620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64760287|NCT05560620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760288|NCT05560620|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64760289|NCT05560620|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64760290|NCT05560620|Purinergic Agents|purinergic agents|mesh-ancestor
64760291|NCT05560620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64760323|NCT00565266|Beclomethasone|beclomethasone|mesh-list
64760366|NCT05461092|Bupivacaine|bupivacaine|mesh-list
64760367|NCT05461092|Anesthetics, Local|anesthetics, local|mesh-ancestor
64760368|NCT05461092|Anesthetics|anesthetics|mesh-ancestor
64760369|NCT05461092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64760370|NCT05461092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760371|NCT05461092|Sensory System Agents|sensory system agents|mesh-ancestor
64760372|NCT05461092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64760373|NCT05461092|Narcotics|narcotics|mesh-ancestor
64760374|NCT05461092|Analgesics|analgesics|mesh-ancestor
64760375|NCT02129478|Olanzapine|olanzapine|mesh-list
64760376|NCT02129478|Antiemetics|antiemetics|mesh-ancestor
64760377|NCT02129478|Autonomic Agents|autonomic agents|mesh-ancestor
65495113|NCT01375348|Sensory System Agents|sensory system agents|mesh-ancestor
65495114|NCT01375348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64473220|NCT00119392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64760378|NCT02129478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64760379|NCT02129478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760380|NCT02129478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64760381|NCT02129478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64760382|NCT02129478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64760476|NCT04747236|Antimetabolites|antimetabolites|mesh-ancestor
64760477|NCT04747236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760503|NCT03856632|Liraglutide|liraglutide|mesh-list
64760504|NCT03856632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64760505|NCT03856632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64760506|NCT03856632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760507|NCT03856632|Incretins|incretins|mesh-ancestor
64760508|NCT03856632|Hormones|hormones|mesh-ancestor
64760509|NCT03856632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64760510|NCT04286178|Coenzyme Q10|coenzyme q10|mesh-list
64760511|NCT04286178|Micronutrients|micronutrients|mesh-ancestor
64760512|NCT04286178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760513|NCT04286178|Vitamins|vitamins|mesh-ancestor
64760514|NCT04655976|Docetaxel|docetaxel|mesh-list
64760515|NCT04655976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760516|NCT04655976|Tubulin Modulators|tubulin modulators|mesh-ancestor
64760517|NCT04655976|Antimitotic Agents|antimitotic agents|mesh-ancestor
64760518|NCT04655976|Mitosis Modulators|mitosis modulators|mesh-ancestor
64760519|NCT04655976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760520|NCT03781128|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
64760521|NCT03781128|Hallucinogens|hallucinogens|mesh-ancestor
64760522|NCT03781128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760523|NCT03781128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64760524|NCT03781128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64760525|NCT03781128|Serotonin Agents|serotonin agents|mesh-ancestor
64760526|NCT03781128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64760527|NCT03781128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760646|NCT05097846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64760647|NCT05097846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64760648|NCT05097846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64760649|NCT05097846|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64760650|NCT05097846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64760651|NCT05097846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760652|NCT05097846|Antimalarials|antimalarials|mesh-ancestor
64760653|NCT05097846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64760654|NCT05097846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64760655|NCT05097846|Antacids|antacids|mesh-ancestor
64760656|NCT05097846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64760657|NCT05097846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64760658|NCT05097846|Renal Agents|renal agents|mesh-ancestor
64760684|NCT02897700|Epirubicin|epirubicin|mesh-list
64760685|NCT02897700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64760686|NCT02897700|Immunologic Factors|immunologic factors|mesh-ancestor
64760687|NCT02897700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760688|NCT02897700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64760781|NCT02136420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760782|NCT02136420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760783|NCT02136420|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64760784|NCT02136420|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64567414|NCT04962672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760841|NCT04304274|Morphine|morphine|mesh-list
64760842|NCT04304274|Ropivacaine|ropivacaine|mesh-list
64760843|NCT04304274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64760844|NCT04304274|Narcotics|narcotics|mesh-ancestor
64760845|NCT04304274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64760846|NCT04304274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760847|NCT04304274|Analgesics|analgesics|mesh-ancestor
64760848|NCT04304274|Sensory System Agents|sensory system agents|mesh-ancestor
64760849|NCT04304274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64760850|NCT04304274|Anesthetics, Local|anesthetics, local|mesh-ancestor
64760878|NCT00614484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760879|NCT00614484|Tubulin Modulators|tubulin modulators|mesh-ancestor
64760880|NCT00614484|Antimitotic Agents|antimitotic agents|mesh-ancestor
64760881|NCT00614484|Mitosis Modulators|mitosis modulators|mesh-ancestor
64760969|NCT00570960|Plasma Substitutes|plasma substitutes|mesh-ancestor
64760970|NCT00570960|Blood Substitutes|blood substitutes|mesh-ancestor
64760971|NCT00571428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64760972|NCT00571428|Formoterol Fumarate|formoterol fumarate|mesh-list
64760973|NCT00571428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64760974|NCT00571428|Autonomic Agents|autonomic agents|mesh-ancestor
65495117|NCT05195086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65495118|NCT05195086|Immunologic Factors|immunologic factors|mesh-ancestor
64760975|NCT00571428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64567495|NCT04961970|Gemcitabine|gemcitabine|mesh-list
64761018|NCT01168219|Immunologic Factors|immunologic factors|mesh-ancestor
64761019|NCT01168219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64761020|NCT01168219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64761021|NCT01168219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64761022|NCT01168219|Alkylating Agents|alkylating agents|mesh-ancestor
64761023|NCT01168219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64761024|NCT01168219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64761026|NCT01115803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64761027|NCT01115803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761028|NCT01115803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64761029|NCT01115803|Immunologic Factors|immunologic factors|mesh-ancestor
64761030|NCT01115803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761031|NCT01115803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64761032|NCT01115803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761033|NCT01115803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567583|NCT01347255|Betamethasone|betamethasone|mesh-list
64761148|NCT05766436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64761149|NCT05766436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64761150|NCT05766436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64761151|NCT05766436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64761152|NCT05766436|Adrenergic Agents|adrenergic agents|mesh-ancestor
64571895|NCT04866498|Analgesics|analgesics|mesh-list
64761154|NCT05766436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761156|NCT05766436|Protective Agents|protective agents|mesh-ancestor
64761157|NCT05766397|Methoxyflurane|methoxyflurane|mesh-list
64761158|NCT05766397|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64761159|NCT05766397|Anesthetics, General|anesthetics, general|mesh-ancestor
64761160|NCT05766397|Anesthetics|anesthetics|mesh-ancestor
64761161|NCT05766397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64761162|NCT05766397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761164|NCT05766384|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64761165|NCT05766384|Anesthetics, General|anesthetics, general|mesh-ancestor
64761166|NCT05766384|Anesthetics|anesthetics|mesh-ancestor
64761167|NCT05766384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64761201|NCT05766267|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64761202|NCT05766267|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64761203|NCT05766267|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64761204|NCT05766267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64761205|NCT05766267|Antimetabolites|antimetabolites|mesh-ancestor
64761206|NCT05766267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64761264|NCT05765617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64761265|NCT05765617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761266|NCT05765617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64761267|NCT05765617|Vitamins|vitamins|mesh-ancestor
64761268|NCT05765617|Micronutrients|micronutrients|mesh-ancestor
64761269|NCT05765617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64761270|NCT05765578|Vaccines|vaccines|mesh-list
64761271|NCT05765578|Immunologic Factors|immunologic factors|mesh-ancestor
64761272|NCT05765578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761273|NCT05765500|Leuprolide|leuprolide|mesh-list
64761274|NCT05765500|Relugolix|relugolix|mesh-list
64761275|NCT05765500|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64761394|NCT05757622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64530105|NCT05800015|Paclitaxel|paclitaxel|mesh-list
64761395|NCT05757622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64761455|NCT05715931|Tubulin Modulators|tubulin modulators|mesh-ancestor
64761456|NCT05715931|Antimitotic Agents|antimitotic agents|mesh-ancestor
64761457|NCT05715931|Mitosis Modulators|mitosis modulators|mesh-ancestor
64761458|NCT05715931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761490|NCT05644041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761491|NCT05644041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761492|NCT05644041|Antiviral Agents|antiviral agents|mesh-ancestor
64761493|NCT05644041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64761494|NCT05644041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761495|NCT05644041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64761496|NCT05644041|Immunologic Factors|immunologic factors|mesh-ancestor
64761497|NCT05644041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761498|NCT05628623|Cytarabine|cytarabine|mesh-list
64761499|NCT05628623|Azacitidine|azacitidine|mesh-list
64761500|NCT05628623|Daunorubicin|daunorubicin|mesh-list
64761501|NCT05628623|Venetoclax|venetoclax|mesh-list
64761502|NCT05628623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64761503|NCT05628623|Antimetabolites|antimetabolites|mesh-ancestor
64761504|NCT05628623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761505|NCT05628623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761506|NCT05628623|Antiviral Agents|antiviral agents|mesh-ancestor
64761507|NCT05628623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64761508|NCT05628623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64761509|NCT05628623|Immunologic Factors|immunologic factors|mesh-ancestor
64761510|NCT05628623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761511|NCT05628623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761512|NCT05628623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65495121|NCT05195086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64591691|NCT00621049|Bevacizumab|bevacizumab|mesh-list
64761548|NCT05486481|Dexamethasone|dexamethasone|mesh-list
64761565|NCT05442567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64761567|NCT05441215|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64761568|NCT05441215|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64761592|NCT05372614|Immunologic Factors|immunologic factors|mesh-ancestor
64761593|NCT05372614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761594|NCT05327647|Bicalutamide|bicalutamide|mesh-list
64761595|NCT05327647|Androgen Antagonists|androgen antagonists|mesh-list
64761596|NCT05327647|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
64761597|NCT05327647|Hormone Antagonists|hormone antagonists|mesh-ancestor
64761598|NCT05327647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65274113|NCT03691493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64803384|NCT01406678|Sufentanil|sufentanil|mesh-list
64761599|NCT05327647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761600|NCT05327647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761601|NCT05320380|Cytarabine|cytarabine|mesh-list
64761602|NCT05320380|Prednisolone|prednisolone|mesh-list
64761603|NCT05320380|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64761604|NCT05320380|Methylprednisolone|methylprednisolone|mesh-list
64761605|NCT05320380|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64761606|NCT05320380|Prednisolone acetate|prednisolone acetate|mesh-list
64761607|NCT05320380|Hydrocortisone|hydrocortisone|mesh-list
64373540|NCT03284645|Tenofovir|tenofovir|mesh-list
64761635|NCT05320380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64761637|NCT05320380|Hormones|hormones|mesh-ancestor
64761638|NCT05320380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64761639|NCT05320380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64761640|NCT05320380|Antiemetics|antiemetics|mesh-ancestor
64761641|NCT05320380|Autonomic Agents|autonomic agents|mesh-ancestor
64761642|NCT05320380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64761643|NCT05320380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64761644|NCT05320380|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64761645|NCT05320380|Protective Agents|protective agents|mesh-ancestor
64761646|NCT05320380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64761820|NCT05012631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761823|NCT04989218|Durvalumab|durvalumab|mesh-list
64761824|NCT04989218|Tremelimumab|tremelimumab|mesh-list
64761825|NCT04989218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761826|NCT04989218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64761905|NCT04893109|Paclitaxel|paclitaxel|mesh-list
64761906|NCT04893109|Maytansine|maytansine|mesh-list
64761907|NCT04893109|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64761908|NCT04893109|Trastuzumab|trastuzumab|mesh-list
64761909|NCT04893109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64761910|NCT04893109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761911|NCT04893109|Tubulin Modulators|tubulin modulators|mesh-ancestor
64761912|NCT04893109|Antimitotic Agents|antimitotic agents|mesh-ancestor
64761913|NCT04893109|Mitosis Modulators|mitosis modulators|mesh-ancestor
64761914|NCT04893109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761915|NCT04893109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64761916|NCT04883645|Imiquimod|imiquimod|mesh-list
64761917|NCT04883645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64761918|NCT04883645|Immunologic Factors|immunologic factors|mesh-ancestor
64761919|NCT04883645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761920|NCT04883645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373803|NCT03278483|Antimetabolites|antimetabolites|mesh-ancestor
64761960|NCT04778267|Anesthetics, Local|anesthetics, local|mesh-ancestor
64761962|NCT04778267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64762097|NCT04521335|Micronutrients|micronutrients|mesh-ancestor
64762098|NCT04521335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762099|NCT04521335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64762100|NCT04521335|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
64762101|NCT04521335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762102|NCT04521335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762103|NCT04515615|Oxaliplatin|oxaliplatin|mesh-list
64530858|NCT05108688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64530859|NCT05108688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64530860|NCT05108688|Adrenergic Agents|adrenergic agents|mesh-ancestor
64762144|NCT04439136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762145|NCT04439136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762146|NCT04418661|Pembrolizumab|pembrolizumab|mesh-list
64762147|NCT04418661|Adagrasib|adagrasib|mesh-list
64762148|NCT04418661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64762149|NCT04418661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762150|NCT04370301|Mycophenolic Acid|mycophenolic acid|mesh-list
64762151|NCT04370301|Cyclophosphamide|cyclophosphamide|mesh-list
64762203|NCT04329325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64762204|NCT04329325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64762205|NCT04329325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64762206|NCT04280692|Lumefantrine|lumefantrine|mesh-list
64762207|NCT04280692|Artemether|artemether|mesh-list
64762208|NCT04280692|Pyrimethamine|pyrimethamine|mesh-list
64762244|NCT04247126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64762246|NCT04240093|Narcotics|narcotics|mesh-ancestor
64762247|NCT04240093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64762248|NCT04240093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762268|NCT04181996|Mitosis Modulators|mitosis modulators|mesh-ancestor
64762269|NCT04181996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762270|NCT04181996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495125|NCT05195086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65495126|NCT05195086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65495127|NCT05195086|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64473229|NCT00119392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64473230|NCT00119392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64473231|NCT00119392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64473232|NCT00119392|Antitubercular Agents|antitubercular agents|mesh-ancestor
64473233|NCT00119392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64473234|NCT00218062|Modafinil|modafinil|mesh-list
64762271|NCT04179162|Gemcitabine|gemcitabine|mesh-list
64762272|NCT04179162|BCG Vaccine|bcg vaccine|mesh-list
64762273|NCT04179162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64762274|NCT04179162|Antimetabolites|antimetabolites|mesh-ancestor
64762275|NCT04179162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762276|NCT04179162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762277|NCT04179162|Antiviral Agents|antiviral agents|mesh-ancestor
64568189|NCT02869789|Nivolumab|nivolumab|mesh-list
64762339|NCT04109482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762340|NCT04109482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762341|NCT04109482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64762343|NCT04099251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64762344|NCT04099251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762345|NCT04099251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64762346|NCT04099251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762406|NCT04004793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64762407|NCT04004793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762408|NCT04002180|Vedolizumab|vedolizumab|mesh-list
64762409|NCT04002180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64762410|NCT04002011|Warfarin|warfarin|mesh-list
64762411|NCT04002011|Rivaroxaban|rivaroxaban|mesh-list
64762412|NCT04002011|Dabigatran|dabigatran|mesh-list
64762413|NCT04002011|Apixaban|apixaban|mesh-list
64762414|NCT04002011|Edoxaban|edoxaban|mesh-list
64762415|NCT04002011|Anticoagulants|anticoagulants|mesh-ancestor
64762416|NCT04002011|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64762417|NCT04002011|Antithrombins|antithrombins|mesh-ancestor
64762418|NCT04002011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64762419|NCT04002011|Protease Inhibitors|protease inhibitors|mesh-ancestor
64762420|NCT04002011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568264|NCT01363479|Dexamethasone|dexamethasone|mesh-list
64762449|NCT03809624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64762450|NCT03809624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762451|NCT03789591|Hydroxyurea|hydroxyurea|mesh-list
64762452|NCT03789591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762453|NCT03789591|Antisickling Agents|antisickling agents|mesh-ancestor
64762454|NCT03789591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762455|NCT03789591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762456|NCT03789591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64762458|NCT03783026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64762459|NCT03783026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64762460|NCT03783026|Analgesics|analgesics|mesh-ancestor
64762461|NCT03783026|Sensory System Agents|sensory system agents|mesh-ancestor
64762462|NCT03783026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64762463|NCT03783026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762464|NCT03783026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64762465|NCT03783026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64762466|NCT03783026|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64762467|NCT03783026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64762468|NCT03783026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762469|NCT03783026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762470|NCT03775460|Prednisolone|prednisolone|mesh-list
64762471|NCT03775460|Methotrexate|methotrexate|mesh-list
64762472|NCT03775460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64762473|NCT03775460|Abortifacient Agents|abortifacient agents|mesh-ancestor
64762527|NCT03538691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64762528|NCT03538691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64762529|NCT03538691|Parasympatholytics|parasympatholytics|mesh-ancestor
64762530|NCT03538691|Autonomic Agents|autonomic agents|mesh-ancestor
64762531|NCT03538691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65274114|NCT03691493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803564|NCT01408199|Lenalidomide|lenalidomide|mesh-list
64762532|NCT03538691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64762533|NCT03538691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64762534|NCT03538691|Cholinergic Agents|cholinergic agents|mesh-ancestor
64762535|NCT03538691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64762537|NCT03538691|Sensory System Agents|sensory system agents|mesh-ancestor
64762538|NCT03538691|Dopamine Agents|dopamine agents|mesh-ancestor
64762716|NCT02983045|Mitosis Modulators|mitosis modulators|mesh-ancestor
64762717|NCT02983045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762718|NCT02983045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64762719|NCT02983045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64762720|NCT02983045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762721|NCT02983045|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64762722|NCT02983045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64762723|NCT02894398|Letrozole|letrozole|mesh-list
64762724|NCT02894398|Fulvestrant|fulvestrant|mesh-list
64762725|NCT02894398|Palbociclib|palbociclib|mesh-list
64762726|NCT02894398|Anastrozole|anastrozole|mesh-list
64762727|NCT02894398|Exemestane|exemestane|mesh-list
64762734|NCT02894398|Hormone Antagonists|hormone antagonists|mesh-ancestor
64762735|NCT02894398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64762736|NCT02894398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762775|NCT02540018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762776|NCT02540018|Tubulin Modulators|tubulin modulators|mesh-ancestor
64762777|NCT02540018|Antimitotic Agents|antimitotic agents|mesh-ancestor
64762778|NCT02540018|Mitosis Modulators|mitosis modulators|mesh-ancestor
64762779|NCT02540018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762786|NCT02437136|Pembrolizumab|pembrolizumab|mesh-list
64762787|NCT02437136|Entinostat|entinostat|mesh-list
64762788|NCT02437136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64762789|NCT02437136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762790|NCT02437136|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64762791|NCT02437136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762792|NCT02437136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762793|NCT02423265|Ranolazine|ranolazine|mesh-list
64762794|NCT02423265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64762795|NCT02423265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64762796|NCT02423265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762797|NCT02368886|Clobetasol|clobetasol|mesh-list
64762798|NCT02368886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64762799|NCT02368886|Glucocorticoids|glucocorticoids|mesh-ancestor
64762800|NCT02368886|Hormones|hormones|mesh-ancestor
64762801|NCT02368886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64762802|NCT02368886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762803|NCT02301286|Aspirin|aspirin|mesh-list
64762851|NCT02099188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762852|NCT02099188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64762853|NCT02099188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64762854|NCT02099188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64762855|NCT02099188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762856|NCT02099188|Antimetabolites|antimetabolites|mesh-ancestor
64762857|NCT02099188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64762858|NCT02099188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64762859|NCT02099188|Immunologic Factors|immunologic factors|mesh-ancestor
64762860|NCT02099188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762861|NCT02099188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64762862|NCT02099188|Antidotes|antidotes|mesh-ancestor
64762863|NCT02099188|Protective Agents|protective agents|mesh-ancestor
64762864|NCT02099188|Vitamin B Complex|vitamin b complex|mesh-ancestor
64762985|NCT01715285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762986|NCT01715285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64762987|NCT01715285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763101|NCT00651456|Pemetrexed|pemetrexed|mesh-list
64763102|NCT00651456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64763103|NCT00651456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763104|NCT00651456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64763105|NCT00651456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64763106|NCT00651456|Growth Substances|growth substances|mesh-ancestor
64763107|NCT00651456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763108|NCT00651456|Growth Inhibitors|growth inhibitors|mesh-ancestor
64763109|NCT00651456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274115|NCT03691493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64763110|NCT00651456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763111|NCT00651456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64763112|NCT00651456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64763113|NCT00280202|Dimercaprol|dimercaprol|mesh-list
64763114|NCT00280202|Chelating Agents|chelating agents|mesh-ancestor
64763115|NCT00280202|Sequestering Agents|sequestering agents|mesh-ancestor
64763116|NCT00280202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763117|NCT00079417|Iodine|iodine|mesh-list
64763118|NCT00079417|Cadexomer iodine|cadexomer iodine|mesh-list
64763119|NCT00079417|Carboplatin|carboplatin|mesh-list
64763120|NCT00079417|Vincristine|vincristine|mesh-list
64763121|NCT00079417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763122|NCT00079417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64763123|NCT00079417|Tubulin Modulators|tubulin modulators|mesh-ancestor
64763124|NCT00079417|Antimitotic Agents|antimitotic agents|mesh-ancestor
64763125|NCT00079417|Mitosis Modulators|mitosis modulators|mesh-ancestor
64763126|NCT00079417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763127|NCT00079417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64763128|NCT00079417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763129|NCT00079417|Trace Elements|trace elements|mesh-ancestor
64763130|NCT00079417|Micronutrients|micronutrients|mesh-ancestor
64763131|NCT00079417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763132|NCT04387500|Axitinib|axitinib|mesh-list
64763133|NCT04387500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763134|NCT04387500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64473237|NCT00218062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64763135|NCT04387500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763136|NCT04387500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763137|NCT04386876|Ritonavir|ritonavir|mesh-list
64763138|NCT04386876|Lopinavir|lopinavir|mesh-list
64763139|NCT04386876|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64763140|NCT04386876|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64763141|NCT04386876|Protease Inhibitors|protease inhibitors|mesh-ancestor
64763142|NCT04386876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763143|NCT04386876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763144|NCT04386876|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64763145|NCT04386876|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64763146|NCT04386876|Antiviral Agents|antiviral agents|mesh-ancestor
64763147|NCT04386876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763148|NCT04386876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64763201|NCT04380402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763202|NCT04380402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64763203|NCT04380402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64763204|NCT04380402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763205|NCT04380012|Trastuzumab|trastuzumab|mesh-list
64763206|NCT04380012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64374950|NCT03244319|Antithrombins|antithrombins|mesh-ancestor
64763233|NCT04376970|Dermatologic Agents|dermatologic agents|mesh-ancestor
64763234|NCT04376970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763235|NCT04376970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64763236|NCT04376970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64763237|NCT04376970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64763238|NCT04376970|Glucocorticoids|glucocorticoids|mesh-ancestor
64763240|NCT04376970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64763241|NCT04376970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64763242|NCT04377048|Gemcitabine|gemcitabine|mesh-list
64763243|NCT04377048|Tegafur|tegafur|mesh-list
64763244|NCT04377048|Nivolumab|nivolumab|mesh-list
64763245|NCT04377048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64763246|NCT04377048|Antimetabolites|antimetabolites|mesh-ancestor
64763247|NCT04377048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568678|NCT04037241|Antimetabolites|antimetabolites|mesh-ancestor
64763278|NCT04374942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64763279|NCT04374942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64763280|NCT04374942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763281|NCT04374942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763282|NCT04374942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763283|NCT04374942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763284|NCT04374318|Dexmedetomidine|dexmedetomidine|mesh-list
64763285|NCT04374318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64763286|NCT04374318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64763287|NCT04374318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274116|NCT03691493|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64763288|NCT04374318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64763289|NCT04374318|Analgesics|analgesics|mesh-ancestor
64763290|NCT04374318|Sensory System Agents|sensory system agents|mesh-ancestor
64763291|NCT04374318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64763292|NCT04374318|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64763323|NCT04372836|Vasopressins|vasopressins|mesh-list
64763324|NCT04372836|Arginine Vasopressin|arginine vasopressin|mesh-list
64763325|NCT04372836|Hemostatics|hemostatics|mesh-ancestor
64763326|NCT04372836|Coagulants|coagulants|mesh-ancestor
64763327|NCT04372836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64763328|NCT04372836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64763354|NCT04370262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763355|NCT04370262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763357|NCT04368546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763358|NCT04368546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64763359|NCT04368546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65495136|NCT05194852|Sensory System Agents|sensory system agents|mesh-ancestor
64763360|NCT04368546|Growth Substances|growth substances|mesh-ancestor
64763420|NCT04365270|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64763421|NCT04365426|Contraceptive Agents|contraceptive agents|mesh-list
64763422|NCT04365426|Contraceptives, Oral|contraceptives, oral|mesh-list
64763423|NCT04365426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64763448|NCT04364022|Antiviral Agents|antiviral agents|mesh-ancestor
64763449|NCT04364022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763450|NCT04364022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64763451|NCT04364022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64763452|NCT04363866|Hydroxychloroquine|hydroxychloroquine|mesh-list
64763453|NCT04363866|Antimalarials|antimalarials|mesh-ancestor
64763503|NCT04359966|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
64763504|NCT04359966|Esomeprazole|esomeprazole|mesh-list
64763505|NCT04359966|Bismuth|bismuth|mesh-list
64763506|NCT04359966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64763507|NCT04359966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763508|NCT04359966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64763509|NCT04359966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64763510|NCT04359966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64763511|NCT04359966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64763512|NCT04359966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64763513|NCT04359966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763514|NCT04359966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763515|NCT04359966|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64763516|NCT04359966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64763517|NCT04359966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64763518|NCT04359966|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64763519|NCT04359966|Renal Agents|renal agents|mesh-ancestor
64763520|NCT04359966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64763521|NCT04359966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64763555|NCT04358016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64763556|NCT04358016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64763557|NCT04358016|Hormones|hormones|mesh-ancestor
64763558|NCT04358016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64763559|NCT04358016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763561|NCT04357392|Prednisone|prednisone|mesh-list
64763562|NCT04357392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763563|NCT04357392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64763564|NCT04357392|Glucocorticoids|glucocorticoids|mesh-ancestor
64763565|NCT04357392|Hormones|hormones|mesh-ancestor
64568854|NCT02414269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64763614|NCT04355598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763616|NCT04355598|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64763617|NCT04355520|Fulvestrant|fulvestrant|mesh-list
64763618|NCT04355520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64763619|NCT04355520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763620|NCT04355520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64763621|NCT04355520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64375368|NCT02621931|Calcitonin|calcitonin|mesh-list
64763647|NCT04354662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763649|NCT04354662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64763650|NCT04354662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64763651|NCT04354662|Immunologic Factors|immunologic factors|mesh-ancestor
64763652|NCT04354662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763653|NCT04354662|Antidotes|antidotes|mesh-ancestor
65274117|NCT03691493|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64763716|NCT04352400|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64763717|NCT04352400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64763738|NCT04350528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763739|NCT04350528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64763740|NCT04350528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64763741|NCT04350528|GABA Modulators|gaba modulators|mesh-ancestor
64763742|NCT04350528|GABA Agents|gaba agents|mesh-ancestor
64763743|NCT04350684|Interferons|interferons|mesh-list
64763773|NCT04350450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763774|NCT04350450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763775|NCT04350450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763803|NCT04345848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763804|NCT04345692|Hydroxychloroquine|hydroxychloroquine|mesh-list
64763805|NCT04345692|Antimalarials|antimalarials|mesh-ancestor
64763806|NCT04345692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64763807|NCT04345692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64763808|NCT04345692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763809|NCT04345692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763810|NCT04345692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763811|NCT04345692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763813|NCT04345458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64763814|NCT04345458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64763815|NCT04345458|Analgesics|analgesics|mesh-ancestor
64763816|NCT04345458|Sensory System Agents|sensory system agents|mesh-ancestor
64568991|NCT02484391|Antimetabolites|antimetabolites|mesh-ancestor
64763907|NCT04340544|Antimalarials|antimalarials|mesh-ancestor
64763908|NCT04340544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64763909|NCT04340544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64763910|NCT04340544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763911|NCT04340544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763912|NCT04340544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763913|NCT04340544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763914|NCT04340778|Lidocaine|lidocaine|mesh-list
64763915|NCT04340778|Prilocaine|prilocaine|mesh-list
64763916|NCT04340778|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64763917|NCT04340778|Dinoprostone|dinoprostone|mesh-list
64569042|NCT04916574|Antibodies|antibodies|mesh-list
64764180|NCT05417100|Sensory System Agents|sensory system agents|mesh-ancestor
64764181|NCT05417100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764182|NCT05417100|Antitussive Agents|antitussive agents|mesh-ancestor
64764183|NCT05417100|Respiratory System Agents|respiratory system agents|mesh-ancestor
64764184|NCT05278884|Anesthetics|anesthetics|mesh-list
64764185|NCT05278884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64764186|NCT05278884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764187|NCT05136690|Nicotine|nicotine|mesh-list
64764219|NCT03063450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764220|NCT02748018|Insulin|insulin|mesh-list
64764221|NCT02748018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64764222|NCT02748018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764223|NCT01326000|Cetuximab|cetuximab|mesh-list
64764298|NCT03030690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64764299|NCT03030690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764300|NCT03030690|Adrenergic Agents|adrenergic agents|mesh-ancestor
64764301|NCT03030690|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64764302|NCT03030690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64764303|NCT03030690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64764304|NCT03030690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64764305|NCT03030300|Metformin|metformin|mesh-list
64764306|NCT03030300|Pioglitazone|pioglitazone|mesh-list
64764307|NCT03030300|Insulin|insulin|mesh-list
64764308|NCT03030300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64764309|NCT03030300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764310|NCT03029442|Denosumab|denosumab|mesh-list
64764331|NCT03019926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764332|NCT03019926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64376066|NCT02155660|Benralizumab|benralizumab|mesh-list
64764366|NCT03018756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64764367|NCT03018756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64764368|NCT03018756|Anesthetics, General|anesthetics, general|mesh-ancestor
64764370|NCT03018444|Atorvastatin|atorvastatin|mesh-list
64764371|NCT03018444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64764372|NCT03018444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64764373|NCT03018444|Antimetabolites|antimetabolites|mesh-ancestor
65248437|NCT00844207|Sensory System Agents|sensory system agents|mesh-ancestor
64403568|NCT04121299|Amlodipine|amlodipine|mesh-list
64764374|NCT03018444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764410|NCT03017430|Adrenergic Agents|adrenergic agents|mesh-ancestor
64764411|NCT03017430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64764412|NCT03017430|Antiemetics|antiemetics|mesh-ancestor
65495139|NCT01375426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65495140|NCT01375426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64473242|NCT00218062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764413|NCT03017430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64764414|NCT03017430|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64764451|NCT03016650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764452|NCT03016650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764453|NCT03016650|Antipyretics|antipyretics|mesh-ancestor
64764454|NCT03016650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64764455|NCT03016650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64764456|NCT03016650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64764457|NCT03016650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64764487|NCT03015246|Sensory System Agents|sensory system agents|mesh-ancestor
64764488|NCT03015246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764489|NCT03015246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64764490|NCT03015168|Capecitabine|capecitabine|mesh-list
64764491|NCT03015168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64764492|NCT03015168|Antimetabolites|antimetabolites|mesh-ancestor
64764493|NCT03015168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764494|NCT03015168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764629|NCT03005808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764630|NCT03005808|Sensory System Agents|sensory system agents|mesh-ancestor
64764661|NCT03005184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64764662|NCT03005184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64764663|NCT03005184|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
64764664|NCT03005184|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
64764665|NCT03005184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64764666|NCT03005184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64764667|NCT03005184|Immunologic Factors|immunologic factors|mesh-ancestor
64764669|NCT03004014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64764670|NCT03004014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64764695|NCT03002064|Docetaxel|docetaxel|mesh-list
64764696|NCT03002064|Fluorouracil|fluorouracil|mesh-list
64764697|NCT03002064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764698|NCT03002064|Tubulin Modulators|tubulin modulators|mesh-ancestor
64764757|NCT02989038|Nicotine|nicotine|mesh-list
64764758|NCT02989038|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64764759|NCT02989038|Autonomic Agents|autonomic agents|mesh-ancestor
64764760|NCT02989038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376510|NCT04875039|Analgesics|analgesics|mesh-ancestor
64764785|NCT02987244|Etoposide|etoposide|mesh-list
64764786|NCT02987244|Epirubicin|epirubicin|mesh-list
64764787|NCT02987244|Vindesine|vindesine|mesh-list
64764788|NCT02987244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64764789|NCT02987244|Immunologic Factors|immunologic factors|mesh-ancestor
64764790|NCT02987244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764791|NCT02987244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64764792|NCT02987244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64764793|NCT02987244|Alkylating Agents|alkylating agents|mesh-ancestor
64764794|NCT02987244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764795|NCT02987244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764796|NCT02987244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64764797|NCT02987244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64764798|NCT02987244|Glucocorticoids|glucocorticoids|mesh-ancestor
64764799|NCT02987244|Hormones|hormones|mesh-ancestor
64764800|NCT02987244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64764801|NCT02987244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64764890|NCT02975076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64764891|NCT02975076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764892|NCT02975076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64764893|NCT02975076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64764894|NCT02975076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764895|NCT02975076|Antipyretics|antipyretics|mesh-ancestor
64764922|NCT02974920|Anticoagulants|anticoagulants|mesh-ancestor
64764923|NCT02973204|Everolimus|everolimus|mesh-list
64764924|NCT02973204|Sorafenib|sorafenib|mesh-list
64764925|NCT02973204|Octreotide|octreotide|mesh-list
64764926|NCT02973204|Lanreotide|lanreotide|mesh-list
64764927|NCT02973204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764928|NCT02973204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65274118|NCT03691493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64472182|NCT03720522|Purinergic Agents|purinergic agents|mesh-ancestor
64764929|NCT02973204|Immunologic Factors|immunologic factors|mesh-ancestor
64764930|NCT02973204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473243|NCT00218062|Sympathomimetics|sympathomimetics|mesh-ancestor
64764931|NCT02973204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64764932|NCT02973204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764933|NCT02973204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764934|NCT02973204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64764935|NCT02973204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64764936|NCT02959476|Ropivacaine|ropivacaine|mesh-list
64764937|NCT02959476|Anesthetics, Local|anesthetics, local|mesh-ancestor
64764938|NCT02959476|Anesthetics|anesthetics|mesh-ancestor
64764939|NCT02959476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64764940|NCT02959476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764941|NCT02959476|Sensory System Agents|sensory system agents|mesh-ancestor
64569375|NCT04904406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764987|NCT02641314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64764988|NCT02641314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64764989|NCT02641314|Analgesics|analgesics|mesh-ancestor
64764990|NCT02641314|Sensory System Agents|sensory system agents|mesh-ancestor
64764991|NCT02641314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764992|NCT02641314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64764993|NCT02641314|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64764994|NCT02641314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64764995|NCT02641314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764996|NCT02641314|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64764997|NCT02641314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64376730|NCT03224039|Narcotics|narcotics|mesh-ancestor
64765020|NCT04768764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64765021|NCT04768764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765022|NCT04768764|Sensory System Agents|sensory system agents|mesh-ancestor
64765023|NCT04768764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64765024|NCT04768530|Nitazoxanide|nitazoxanide|mesh-list
64765025|NCT04768530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64765026|NCT04768530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64765027|NCT04748562|Progesterone|progesterone|mesh-list
64765028|NCT04748562|Progestins|progestins|mesh-ancestor
64765029|NCT04748562|Hormones|hormones|mesh-ancestor
64765030|NCT04748562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64765031|NCT04748562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765032|NCT04745286|Ketamine|ketamine|mesh-list
64765033|NCT04745286|Esketamine|esketamine|mesh-list
64765034|NCT04745286|Analgesics|analgesics|mesh-ancestor
64765035|NCT04745286|Sensory System Agents|sensory system agents|mesh-ancestor
64765036|NCT04745286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64765037|NCT04745286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765083|NCT04739202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765084|NCT04739202|Growth Inhibitors|growth inhibitors|mesh-ancestor
64765085|NCT04739202|Immunologic Factors|immunologic factors|mesh-ancestor
64765086|NCT04738188|Epirubicin|epirubicin|mesh-list
64765087|NCT04738188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64765088|NCT04738188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765089|NCT04738188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64765090|NCT04738188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64765091|NCT04738188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765119|NCT05313828|Glucocorticoids|glucocorticoids|mesh-ancestor
64765120|NCT05313828|Hormones|hormones|mesh-ancestor
64765121|NCT05313828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64765122|NCT05313828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64765123|NCT05313750|Levofloxacin|levofloxacin|mesh-list
64765124|NCT05313750|Ofloxacin|ofloxacin|mesh-list
64765125|NCT05313750|Sitafloxacin|sitafloxacin|mesh-list
64765126|NCT05313750|Anti-Infective Agents|anti-infective agents|mesh-list
64765127|NCT05313750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64765128|NCT05313750|Renal Agents|renal agents|mesh-ancestor
64765129|NCT05313750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64765130|NCT05313750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64765131|NCT05313750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64765132|NCT05313750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765133|NCT05313750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765134|NCT05313750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765135|NCT05313750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64765136|NCT05313750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64765137|NCT04662684|Rivaroxaban|rivaroxaban|mesh-list
64765138|NCT04662684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64765139|NCT04662684|Antithrombins|antithrombins|mesh-ancestor
64765175|NCT00578214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64765176|NCT00578214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64765177|NCT00578214|Anesthetics, General|anesthetics, general|mesh-ancestor
64765178|NCT00578214|GABA Modulators|gaba modulators|mesh-ancestor
64765244|NCT03527472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64765245|NCT03527472|Dopamine Agents|dopamine agents|mesh-ancestor
64765246|NCT03527472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64765247|NCT03527472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765248|NCT03527472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765338|NCT00589056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64765339|NCT00589056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765340|NCT00589056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765341|NCT00589056|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64765361|NCT00590772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64765362|NCT00590772|Respiratory System Agents|respiratory system agents|mesh-ancestor
64765363|NCT00590772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64765364|NCT00590772|Hormone Antagonists|hormone antagonists|mesh-ancestor
64765365|NCT00590772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64765366|NCT00590772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765367|NCT00590772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64765368|NCT00590772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64765424|NCT00598806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765426|NCT00601926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64765427|NCT00601926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765428|NCT00601926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64765429|NCT00601926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64765430|NCT00601926|Growth Substances|growth substances|mesh-ancestor
64765431|NCT00601926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765432|NCT00601926|Growth Inhibitors|growth inhibitors|mesh-ancestor
64765433|NCT00603018|Fluoxetine|fluoxetine|mesh-list
64765434|NCT00603018|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64765435|NCT00603018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64765436|NCT00603018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64765437|NCT00603018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765438|NCT00603018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64765524|NCT00632970|Antiviral Agents|antiviral agents|mesh-ancestor
64765525|NCT00632970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64765526|NCT00632970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64377281|NCT04849533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64765555|NCT00638820|Clofarabine|clofarabine|mesh-list
64765556|NCT00638820|Alkylating Agents|alkylating agents|mesh-ancestor
64765557|NCT00638820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765558|NCT00638820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64765559|NCT00638820|Immunologic Factors|immunologic factors|mesh-ancestor
64765560|NCT00638820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765561|NCT00638820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64765562|NCT00638820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765563|NCT00638820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64765564|NCT00638820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64765565|NCT00638820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64765566|NCT00638820|Antimetabolites|antimetabolites|mesh-ancestor
64765567|NCT00641862|Vitamin B 12|vitamin b 12|mesh-list
64765568|NCT00641862|Hydroxocobalamin|hydroxocobalamin|mesh-list
64765569|NCT00641862|Vitamins|vitamins|mesh-ancestor
64765570|NCT00641862|Micronutrients|micronutrients|mesh-ancestor
64765593|NCT00645450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64765594|NCT00645450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64765595|NCT00645450|Adrenergic Agents|adrenergic agents|mesh-ancestor
64765596|NCT00645450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64765597|NCT00645450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765598|NCT00645450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765599|NCT00645450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64765600|NCT00645450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64765665|NCT00666666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765666|NCT00666666|Androgen Antagonists|androgen antagonists|mesh-ancestor
64765667|NCT00666666|Hormone Antagonists|hormone antagonists|mesh-ancestor
64765668|NCT00666666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765669|NCT00666666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64765670|NCT00666666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64765679|NCT00666978|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64765680|NCT00666978|Antidepressive Agents|antidepressive agents|mesh-ancestor
64765682|NCT00666978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64765772|NCT00676806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64765773|NCT00676806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64765774|NCT00676806|Alkylating Agents|alkylating agents|mesh-ancestor
64765775|NCT00676806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765858|NCT00690924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64765860|NCT00690924|Micronutrients|micronutrients|mesh-ancestor
64765861|NCT00690924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64765862|NCT00691002|Calcitriol|calcitriol|mesh-list
64765863|NCT00691002|Hydrocortisone|hydrocortisone|mesh-list
64765864|NCT00691002|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64765865|NCT00691002|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64765866|NCT00691002|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64765867|NCT00691002|Calcipotriene|calcipotriene|mesh-list
64765868|NCT00691002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64765869|NCT00691002|Dermatologic Agents|dermatologic agents|mesh-ancestor
64765870|NCT00691002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64765871|NCT00691002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765872|NCT00691002|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64765873|NCT00691002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64765874|NCT00691002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765875|NCT00691002|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64765876|NCT00691002|Vitamins|vitamins|mesh-ancestor
64765910|NCT00702780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765911|NCT00702780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64765912|NCT00702780|Serotonin Agents|serotonin agents|mesh-ancestor
64765913|NCT00702780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765914|NCT00702780|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64765915|NCT00702780|Antidepressive Agents|antidepressive agents|mesh-ancestor
64765916|NCT00702780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64765917|NCT00704028|Dextrans|dextrans|mesh-list
64765918|NCT00704028|Iron-Dextran Complex|iron-dextran complex|mesh-list
64765919|NCT00704028|Anticoagulants|anticoagulants|mesh-ancestor
64765952|NCT00706446|Parasympatholytics|parasympatholytics|mesh-ancestor
64765953|NCT00706446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64766042|NCT00717054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64766043|NCT00717054|Cholinergic Agents|cholinergic agents|mesh-ancestor
64766044|NCT00717054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64766045|NCT00717054|Parasympatholytics|parasympatholytics|mesh-ancestor
64766046|NCT00717288|Insulin Detemir|insulin detemir|mesh-list
64766047|NCT00717288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64766048|NCT00717288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766049|NCT00719160|Esomeprazole|esomeprazole|mesh-list
64766051|NCT00719160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64766052|NCT00719160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64766053|NCT00719160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377791|NCT04835259|Protective Agents|protective agents|mesh-ancestor
64766082|NCT00722436|Hemostatics|hemostatics|mesh-ancestor
64766083|NCT00722436|Coagulants|coagulants|mesh-ancestor
64766084|NCT00724464|Interferons|interferons|mesh-list
64766085|NCT00724464|Ribavirin|ribavirin|mesh-list
64766086|NCT00724464|Interferon-alpha|interferon-alpha|mesh-list
64766087|NCT00724464|Interferon alpha-2|interferon alpha-2|mesh-list
64766088|NCT00724464|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64766089|NCT00724464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766090|NCT00724464|Antiviral Agents|antiviral agents|mesh-ancestor
64766091|NCT00724464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64766203|NCT00736242|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64766204|NCT00736242|Interferon alpha-2|interferon alpha-2|mesh-list
64766205|NCT00736242|Antiviral Agents|antiviral agents|mesh-ancestor
64766206|NCT00736242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64766207|NCT00736242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766209|NCT00736632|Ergocalciferols|ergocalciferols|mesh-list
64766210|NCT00736632|Cholecalciferol|cholecalciferol|mesh-list
64766211|NCT00736632|Vitamins|vitamins|mesh-list
64766212|NCT00736632|Micronutrients|micronutrients|mesh-ancestor
64766213|NCT00736632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766214|NCT00736632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64766215|NCT00736632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64766216|NCT00737178|Copper|copper|mesh-list
64766217|NCT00737178|Trace Elements|trace elements|mesh-ancestor
64766218|NCT00737178|Micronutrients|micronutrients|mesh-ancestor
64766219|NCT00737178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403924|NCT04516993|Aspirin|aspirin|mesh-list
64766220|NCT00741156|Enalaprilat|enalaprilat|mesh-list
64766221|NCT00741156|Enalapril|enalapril|mesh-list
64766222|NCT00741156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64766223|NCT00741156|Protease Inhibitors|protease inhibitors|mesh-ancestor
64766224|NCT00741156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766225|NCT00741156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766226|NCT00741156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64766227|NCT00741468|Tolbutamide|tolbutamide|mesh-list
64766228|NCT00741468|Midazolam|midazolam|mesh-list
64766229|NCT00741468|Dextromethorphan|dextromethorphan|mesh-list
64766353|NCT00756600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64766354|NCT00756600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766355|NCT00756678|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64766356|NCT00756678|Lubricant Eye Drops|lubricant eye drops|mesh-list
64766357|NCT00756678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64766358|NCT00758784|Bromfenac|bromfenac|mesh-list
64766359|NCT00758784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64766360|NCT00758784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64766389|NCT00759642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766391|NCT00759798|Rituximab|rituximab|mesh-list
64766392|NCT00759798|Fludarabine|fludarabine|mesh-list
64766393|NCT00759798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65495143|NCT05193838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473245|NCT00218062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593788|NCT03532880|Olaparib|olaparib|mesh-list
64766484|NCT00769314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64766485|NCT00769392|Lidocaine|lidocaine|mesh-list
64766486|NCT00769392|Tetracaine|tetracaine|mesh-list
64766487|NCT00769392|Proxymetacaine|proxymetacaine|mesh-list
64766488|NCT00769392|Anesthetics, Local|anesthetics, local|mesh-ancestor
64766489|NCT00769392|Anesthetics|anesthetics|mesh-ancestor
64766490|NCT00769392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64766491|NCT00769392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766492|NCT00769392|Sensory System Agents|sensory system agents|mesh-ancestor
64569974|NCT01406223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64766613|NCT00789672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64766614|NCT00789672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766615|NCT00789672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766616|NCT00789672|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64766618|NCT00789750|Pioglitazone|pioglitazone|mesh-list
64766619|NCT00789750|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
64766620|NCT00789750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64766621|NCT00789750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766622|NCT00789750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64766623|NCT00789750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64766652|NCT00793572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64766653|NCT00793572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64766654|NCT00793572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64766655|NCT00793572|Antitubercular Agents|antitubercular agents|mesh-ancestor
64766656|NCT00793572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64766657|NCT00793572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64766659|NCT00793572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64766661|NCT00793650|Melphalan|melphalan|mesh-list
64766662|NCT00793650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766663|NCT00793650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64766664|NCT00793650|Alkylating Agents|alkylating agents|mesh-ancestor
64766665|NCT00793650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766666|NCT00793650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64766667|NCT00793650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64766668|NCT00793650|Immunologic Factors|immunologic factors|mesh-ancestor
64766778|NCT00803010|Abortifacient Agents|abortifacient agents|mesh-ancestor
64766779|NCT00803010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64766780|NCT00803010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766781|NCT00803010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64766805|NCT00803400|GABA Agents|gaba agents|mesh-ancestor
64766806|NCT00803400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64766807|NCT00803400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766808|NCT00804648|Timolol|timolol|mesh-list
64766809|NCT00804648|Maleic acid|maleic acid|mesh-list
64766810|NCT00804648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766840|NCT00806598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64766842|NCT00806598|Autonomic Agents|autonomic agents|mesh-ancestor
64766843|NCT00806598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64766844|NCT00806598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64804402|NCT01414569|Hormones|hormones|mesh-ancestor
64766845|NCT00806598|Glucocorticoids|glucocorticoids|mesh-ancestor
64766846|NCT00806598|Hormones|hormones|mesh-ancestor
64766847|NCT00806598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64766848|NCT00806598|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64766849|NCT00806598|Protective Agents|protective agents|mesh-ancestor
64766850|NCT00806598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64766851|NCT00806598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766852|NCT00807768|Paclitaxel|paclitaxel|mesh-list
64766853|NCT00807768|Carboplatin|carboplatin|mesh-list
64766854|NCT00807768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64766855|NCT00807768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64378595|NCT04800081|Valsartan|valsartan|mesh-list
64766922|NCT00821184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766923|NCT00821184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766924|NCT00821184|Urological Agents|urological agents|mesh-ancestor
64766926|NCT05236842|Anticonvulsants|anticonvulsants|mesh-ancestor
64766927|NCT05209620|Pemetrexed|pemetrexed|mesh-list
65495146|NCT05193838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64766928|NCT05209620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766929|NCT05209620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570101|NCT01897441|Mitosis Modulators|mitosis modulators|mesh-ancestor
64767086|NCT00830076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64767087|NCT00830076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64767088|NCT00830076|Protease Inhibitors|protease inhibitors|mesh-ancestor
64767165|NCT00834678|Alkylating Agents|alkylating agents|mesh-ancestor
64767166|NCT00835224|Midodrine|midodrine|mesh-list
64767167|NCT00835224|Sympathomimetics|sympathomimetics|mesh-ancestor
64767168|NCT00835224|Autonomic Agents|autonomic agents|mesh-ancestor
64767169|NCT00835224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64767170|NCT00835224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767171|NCT00835224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64767172|NCT00835224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64767173|NCT00835224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64767174|NCT00835224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64535858|NCT00544713|Glycerol|glycerol|mesh-list
64767175|NCT00835224|Adrenergic Agents|adrenergic agents|mesh-ancestor
64767176|NCT00835224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64767177|NCT00835224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767179|NCT00835926|Immunologic Factors|immunologic factors|mesh-ancestor
64767180|NCT00835926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767181|NCT00837252|Finasteride|finasteride|mesh-list
64767182|NCT00837252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64767183|NCT00837252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64767184|NCT00837252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570189|NCT02177071|Methotrexate|methotrexate|mesh-list
64767278|NCT00868452|Valproic Acid|valproic acid|mesh-list
64767279|NCT00868452|Lithium Carbonate|lithium carbonate|mesh-list
64767300|NCT00868452|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64767301|NCT00868452|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64767302|NCT00868452|Dopamine Agents|dopamine agents|mesh-ancestor
64767303|NCT00869622|Vitamin D|vitamin d|mesh-list
64767304|NCT00869622|Risedronic Acid|risedronic acid|mesh-list
64767305|NCT00869622|Calcium|calcium|mesh-list
64767306|NCT00869622|Vitamins|vitamins|mesh-ancestor
64767364|NCT00878436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767367|NCT00878826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64767368|NCT00878826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64767369|NCT00878826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767370|NCT00879060|Spironolactone|spironolactone|mesh-list
64767371|NCT00879060|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64767372|NCT00879060|Hormone Antagonists|hormone antagonists|mesh-ancestor
64767373|NCT00879060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64767374|NCT00879060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767375|NCT00879060|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64767376|NCT00879060|Diuretics|diuretics|mesh-ancestor
64767462|NCT00892710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767464|NCT00892710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64767528|NCT00903162|Leuprolide|leuprolide|mesh-list
64767529|NCT00903162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767530|NCT00903162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64767557|NCT00905268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767559|NCT00905580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767560|NCT00905580|Analgesics|analgesics|mesh-ancestor
64767561|NCT00905580|Sensory System Agents|sensory system agents|mesh-ancestor
64767562|NCT00905580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64767563|NCT00905580|Anticonvulsants|anticonvulsants|mesh-ancestor
64767564|NCT00905580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64767565|NCT00905580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64767566|NCT00905580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767567|NCT00905580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64767568|NCT00905580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64767569|NCT00905580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64767570|NCT00905580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64767571|NCT00905580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64767572|NCT00908466|Sirolimus|sirolimus|mesh-list
64767573|NCT00908466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64379321|NCT02176018|Antimalarials|antimalarials|mesh-ancestor
64767588|NCT00911586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64767589|NCT00911586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767590|NCT00911586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64767591|NCT00911586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767592|NCT00911586|Anabolic Agents|anabolic agents|mesh-ancestor
64767593|NCT00911742|Tramadol|tramadol|mesh-list
64767594|NCT00911742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64767595|NCT00911742|Narcotics|narcotics|mesh-ancestor
65495147|NCT05193838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65495148|NCT05193838|Antioxidants|antioxidants|mesh-ancestor
64767596|NCT00911742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64767630|NCT00923910|Analgesics|analgesics|mesh-ancestor
64767631|NCT00923910|Sensory System Agents|sensory system agents|mesh-ancestor
64767632|NCT00923910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64767633|NCT00923910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767634|NCT00923910|Antipyretics|antipyretics|mesh-ancestor
64767635|NCT00923910|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64379357|NCT02589639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64767670|NCT00924612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64767672|NCT00924612|Anabolic Agents|anabolic agents|mesh-ancestor
64767673|NCT00925782|Melphalan|melphalan|mesh-list
64767815|NCT00943098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64767816|NCT00943098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64767817|NCT00943098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767819|NCT00943800|Fludarabine|fludarabine|mesh-list
64767820|NCT00943800|Fludarabine phosphate|fludarabine phosphate|mesh-list
64767821|NCT00943800|Melphalan|melphalan|mesh-list
64767822|NCT00943800|Busulfan|busulfan|mesh-list
64767823|NCT00943800|Thiotepa|thiotepa|mesh-list
64767824|NCT00943800|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64767970|NCT00974142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64767971|NCT00974142|Dermatologic Agents|dermatologic agents|mesh-ancestor
64767972|NCT00974142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64767973|NCT00974142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64767974|NCT00974376|Gabapentin|gabapentin|mesh-list
64767975|NCT00974376|Analgesics|analgesics|mesh-ancestor
64767976|NCT00974376|Sensory System Agents|sensory system agents|mesh-ancestor
64767977|NCT00974376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64767978|NCT00974376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767979|NCT00974376|Anticonvulsants|anticonvulsants|mesh-ancestor
64767980|NCT00974376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64767981|NCT00974376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64768004|NCT00976404|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64473249|NCT00218062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64473250|NCT00218062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64768027|NCT00987480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768028|NCT00987480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64768029|NCT00987480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768030|NCT00987480|Antifungal Agents|antifungal agents|mesh-ancestor
64768031|NCT00987480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64768032|NCT00987480|Dermatologic Agents|dermatologic agents|mesh-ancestor
64768033|NCT00987480|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64768034|NCT00987558|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64768035|NCT00987558|Simvastatin|simvastatin|mesh-list
64768036|NCT00987558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64768037|NCT00987558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64768038|NCT00987558|Antimetabolites|antimetabolites|mesh-ancestor
64768039|NCT00987558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768040|NCT00987558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64768041|NCT00987558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64768042|NCT00987558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768043|NCT00987558|Anticonvulsants|anticonvulsants|mesh-ancestor
64768044|NCT00987558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65274119|NCT03691493|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64768045|NCT00987558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64768046|NCT00987558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64768048|NCT00987948|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64768049|NCT00987948|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64768050|NCT00987948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768051|NCT00987948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64768052|NCT00987948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64768053|NCT00987948|Antiviral Agents|antiviral agents|mesh-ancestor
64768054|NCT00987948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64768246|NCT01008462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768247|NCT01008462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64768248|NCT01008462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64768249|NCT01008462|Alkylating Agents|alkylating agents|mesh-ancestor
64768250|NCT01008462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768251|NCT01008462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768252|NCT01008462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64768253|NCT01008462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64768254|NCT01008462|Antimetabolites|antimetabolites|mesh-ancestor
64768255|NCT01008462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64768256|NCT01008462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64768257|NCT01008462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64768258|NCT01008462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768259|NCT01008462|Antiviral Agents|antiviral agents|mesh-ancestor
64768260|NCT01008462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64379990|NCT05552391|Dexmedetomidine|dexmedetomidine|mesh-list
64768294|NCT01012674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768296|NCT01015170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64570533|NCT04121819|Cytarabine|cytarabine|mesh-list
64768482|NCT01032954|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64768483|NCT01032954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64768517|NCT05179668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64768518|NCT05179668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768519|NCT04780932|Macitentan|macitentan|mesh-list
64768520|NCT04780932|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64768521|NCT04780932|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64768522|NCT04780932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768732|NCT05821686|Aldesleukin|aldesleukin|mesh-list
64768733|NCT05821686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768734|NCT05821686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64768735|NCT05821686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64768736|NCT05821686|Antiviral Agents|antiviral agents|mesh-ancestor
64768737|NCT05821686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64768788|NCT05821478|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64768789|NCT05821478|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64768790|NCT05821478|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64768791|NCT05821478|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64768792|NCT05821452|Paclitaxel|paclitaxel|mesh-list
64768793|NCT05821452|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64768794|NCT05821452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64768795|NCT05821452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768796|NCT05821452|Tubulin Modulators|tubulin modulators|mesh-ancestor
64768797|NCT05821452|Antimitotic Agents|antimitotic agents|mesh-ancestor
64768798|NCT05821452|Mitosis Modulators|mitosis modulators|mesh-ancestor
64768799|NCT05821452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768832|NCT05821192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64768833|NCT05821192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64768834|NCT05821192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64769025|NCT05738057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64769327|NCT05453396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769328|NCT05450484|Durvalumab|durvalumab|mesh-list
64769329|NCT05450484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64769330|NCT05450484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769336|NCT05402293|Lidocaine|lidocaine|mesh-list
64769337|NCT05402293|Anesthetics, Local|anesthetics, local|mesh-ancestor
64769338|NCT05402293|Anesthetics|anesthetics|mesh-ancestor
64381037|NCT04529265|Methylene Blue|methylene blue|mesh-list
64769361|NCT05388058|Cannabidiol|cannabidiol|mesh-list
64769362|NCT05388058|Anticonvulsants|anticonvulsants|mesh-ancestor
64769363|NCT05354453|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
64769364|NCT05354453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274120|NCT03691493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65274121|NCT02687178|Canrenone|canrenone|mesh-list
64769365|NCT05354453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769366|NCT05354453|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64769367|NCT05354453|Protective Agents|protective agents|mesh-ancestor
64769368|NCT05354453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769369|NCT05354453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769370|NCT05351502|Nitric Oxide|nitric oxide|mesh-list
64769472|NCT05182840|Empagliflozin|empagliflozin|mesh-list
64769473|NCT05182840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64769474|NCT05182840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769475|NCT05182840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64769476|NCT05182840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769477|NCT05175547|Clevidipine|clevidipine|mesh-list
64769478|NCT05175547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64769479|NCT05175547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64769480|NCT05175547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769481|NCT05175547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64769508|NCT05137262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64769510|NCT05137262|Hormone Antagonists|hormone antagonists|mesh-ancestor
64769511|NCT05137262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64769512|NCT05137262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64381190|NCT02435537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64769536|NCT05118672|Sensory System Agents|sensory system agents|mesh-ancestor
64769537|NCT05118672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64769538|NCT05118672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769539|NCT05118672|Antipyretics|antipyretics|mesh-ancestor
64769540|NCT05118672|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64769541|NCT05118672|Mydriatics|mydriatics|mesh-ancestor
64769542|NCT05118672|Autonomic Agents|autonomic agents|mesh-ancestor
64769543|NCT05118672|Sympathomimetics|sympathomimetics|mesh-ancestor
64769544|NCT05118672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64769545|NCT05118672|Nasal Decongestants|nasal decongestants|mesh-ancestor
64769546|NCT05118672|Respiratory System Agents|respiratory system agents|mesh-ancestor
64769547|NCT05118672|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64769548|NCT05118672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64570934|NCT02946125|Phenylephrine|phenylephrine|mesh-list
64769613|NCT05047172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769614|NCT05047172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64769615|NCT05047172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64769616|NCT05047172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64769617|NCT05047172|Antipyretics|antipyretics|mesh-ancestor
64769618|NCT05047172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64769619|NCT05047172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64769620|NCT05047172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64769644|NCT05014087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64769645|NCT05014087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64769646|NCT05014087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538310|NCT00611403|Cyclosporins|cyclosporins|mesh-list
64769647|NCT05014087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769648|NCT05014087|Protective Agents|protective agents|mesh-ancestor
64769649|NCT05014087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769651|NCT04971226|Dasatinib|dasatinib|mesh-list
64769652|NCT04971226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769653|NCT04971226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64769654|NCT04971226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570979|NCT02064673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64769901|NCT04716296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64769902|NCT04716296|Anesthetics, General|anesthetics, general|mesh-ancestor
64381527|NCT02433041|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64769934|NCT04682041|Immunologic Factors|immunologic factors|mesh-ancestor
64769935|NCT04682041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769937|NCT04675931|Lumefantrine|lumefantrine|mesh-list
64769938|NCT04675931|Artemether|artemether|mesh-list
64769939|NCT04675931|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64770499|NCT03429543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64770500|NCT03295227|Pembrolizumab|pembrolizumab|mesh-list
64770501|NCT03295227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64770502|NCT03295227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770503|NCT03278691|Ketorolac|ketorolac|mesh-list
64770504|NCT03278691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64770505|NCT03278691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64770506|NCT03278691|Analgesics|analgesics|mesh-ancestor
64770533|NCT03128034|Antifungal Agents|antifungal agents|mesh-ancestor
64770534|NCT03128034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64571147|NCT04865250|Paclitaxel|paclitaxel|mesh-list
64770650|NCT02264678|Carboplatin|carboplatin|mesh-list
64770651|NCT02264678|Durvalumab|durvalumab|mesh-list
64770652|NCT02264678|Olaparib|olaparib|mesh-list
64770653|NCT02264678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64770654|NCT02264678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770655|NCT02264678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64770656|NCT02264678|Immunologic Factors|immunologic factors|mesh-ancestor
64770657|NCT02264678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770658|NCT02264678|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64770659|NCT02264678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64770660|NCT02264678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770661|NCT01995344|Cyclophosphamide|cyclophosphamide|mesh-list
64770662|NCT01995344|Fludarabine|fludarabine|mesh-list
64770663|NCT01995344|Interleukin-2|interleukin-2|mesh-list
64770664|NCT01995344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64770761|NCT00716066|Hormones|hormones|mesh-ancestor
64770813|NCT01055184|Vaccines|vaccines|mesh-list
64770814|NCT01055184|Immunologic Factors|immunologic factors|mesh-ancestor
64770815|NCT01055184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770816|NCT01060020|Sildenafil Citrate|sildenafil citrate|mesh-list
64770817|NCT01060020|Vasodilator Agents|vasodilator agents|mesh-ancestor
64770818|NCT01060020|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64770819|NCT01060020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64770820|NCT01060020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64770821|NCT01060020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770991|NCT01098318|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64770992|NCT01098318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64770993|NCT01098318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64770994|NCT01098318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770995|NCT01098318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64770997|NCT01098318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770998|NCT01100112|Budesonide|budesonide|mesh-list
64770999|NCT01100112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64771115|NCT01112670|Antimetabolites|antimetabolites|mesh-ancestor
64771116|NCT01112670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771117|NCT01112670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64771118|NCT01112670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64771119|NCT01112670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771120|NCT01112670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64771121|NCT01112670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771122|NCT01112670|Incretins|incretins|mesh-ancestor
64771123|NCT01112670|Hormones|hormones|mesh-ancestor
64771124|NCT01112670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64771125|NCT01112670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64771126|NCT01112670|Protease Inhibitors|protease inhibitors|mesh-ancestor
64771127|NCT01115556|Ranibizumab|ranibizumab|mesh-list
64771128|NCT01115556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65495164|NCT05193604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64595318|NCT04402580|Mycophenolic Acid|mycophenolic acid|mesh-list
64595319|NCT04402580|Rituximab|rituximab|mesh-list
64595320|NCT04402580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64595321|NCT04402580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595335|NCT02987751|Insulin|insulin|mesh-list
64771164|NCT01119222|Histamine Agents|histamine agents|mesh-ancestor
64771165|NCT01119222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64771166|NCT01119222|Antipruritics|antipruritics|mesh-ancestor
64771167|NCT01119222|Dermatologic Agents|dermatologic agents|mesh-ancestor
64771168|NCT01120236|Leuprolide|leuprolide|mesh-list
64771169|NCT01120236|Goserelin|goserelin|mesh-list
64771170|NCT01120236|Bicalutamide|bicalutamide|mesh-list
64382579|NCT02705105|Nivolumab|nivolumab|mesh-list
64771204|NCT05307042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64771205|NCT05307042|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64771206|NCT05307042|Natriuretic Agents|natriuretic agents|mesh-ancestor
64771207|NCT05307042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771208|NCT05304546|Pembrolizumab|pembrolizumab|mesh-list
64771307|NCT01128972|Listerine|listerine|mesh-list
65495165|NCT05193604|Immunologic Factors|immunologic factors|mesh-ancestor
64771308|NCT01128972|Fluorides|fluorides|mesh-list
64771309|NCT01128972|Sodium Fluoride|sodium fluoride|mesh-list
65495166|NCT05193604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495167|NCT01375816|Leucovorin|leucovorin|mesh-list
64771310|NCT01128972|Cariostatic Agents|cariostatic agents|mesh-ancestor
64771311|NCT01128972|Protective Agents|protective agents|mesh-ancestor
64771359|NCT01134510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
64771360|NCT01134510|Immunologic Factors|immunologic factors|mesh-ancestor
64771361|NCT01134510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771362|NCT01134510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64771363|NCT01134510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64771364|NCT01135368|Lansoprazole|lansoprazole|mesh-list
64771365|NCT01135368|Dexlansoprazole|dexlansoprazole|mesh-list
64771366|NCT01135368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64771367|NCT01135368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64771368|NCT01135368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64771369|NCT01135368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771390|NCT01139190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64771391|NCT01139190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771392|NCT01139190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64771466|NCT01149876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64771468|NCT01149876|Dermatologic Agents|dermatologic agents|mesh-ancestor
64771469|NCT01150500|Sirolimus|sirolimus|mesh-list
64771470|NCT01150500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64771471|NCT01150500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64771472|NCT01150500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64382868|NCT02415569|Laxatives|laxatives|mesh-ancestor
64771504|NCT01163604|Argatroban|argatroban|mesh-list
64771505|NCT01163604|Clopidogrel|clopidogrel|mesh-list
64771506|NCT01163604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771507|NCT01163604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771508|NCT01163604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64771509|NCT01163604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771510|NCT01163604|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64771511|NCT01163604|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64771512|NCT01163604|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64771950|NCT01244724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771951|NCT01244724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64771952|NCT01244724|Serotonin Agents|serotonin agents|mesh-ancestor
64771953|NCT01244724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771954|NCT01244724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64771955|NCT01244724|Antidepressive Agents|antidepressive agents|mesh-ancestor
64771956|NCT01244724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64771957|NCT01247064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64771958|NCT01247220|Ranibizumab|ranibizumab|mesh-list
64771959|NCT01247220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64771960|NCT01247220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64771961|NCT01247220|Growth Substances|growth substances|mesh-ancestor
64771971|NCT01249872|Analgesics|analgesics|mesh-ancestor
64771972|NCT01249872|Sensory System Agents|sensory system agents|mesh-ancestor
64771973|NCT01249872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64771974|NCT01249872|Anesthetics, Local|anesthetics, local|mesh-ancestor
64771975|NCT01249872|Anesthetics|anesthetics|mesh-ancestor
64771977|NCT01250184|Anesthetics, Local|anesthetics, local|mesh-ancestor
64771978|NCT01250184|Anesthetics|anesthetics|mesh-ancestor
64771979|NCT01250184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64771980|NCT01250184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771981|NCT01250184|Sensory System Agents|sensory system agents|mesh-ancestor
64771982|NCT01250184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64771983|NCT01250184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64771984|NCT01250184|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64771985|NCT01250184|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64771986|NCT01250184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64771987|NCT01250184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771989|NCT01250730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64772454|NCT01328184|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64772455|NCT01328184|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64772456|NCT01328184|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64571913|NCT01895569|Hormones|hormones|mesh-ancestor
64772534|NCT01331694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772535|NCT01331694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64772536|NCT01331694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64772537|NCT01331694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64772538|NCT01331694|Adrenergic Agents|adrenergic agents|mesh-ancestor
64772539|NCT01331694|Anticonvulsants|anticonvulsants|mesh-ancestor
64772540|NCT01331694|Tocolytic Agents|tocolytic agents|mesh-ancestor
64772541|NCT01331694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64772542|NCT01331694|Glucocorticoids|glucocorticoids|mesh-ancestor
64772544|NCT01331694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64772545|NCT01331694|Sympathomimetics|sympathomimetics|mesh-ancestor
64772546|NCT01333098|Mifepristone|mifepristone|mesh-list
64772547|NCT01333098|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64772548|NCT01333098|Abortifacient Agents|abortifacient agents|mesh-ancestor
64772549|NCT01333098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64772550|NCT01333098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772551|NCT01333098|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64772552|NCT01333098|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64772553|NCT01333098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64772596|NCT01337700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64772597|NCT01337700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772598|NCT01337700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64772599|NCT01337700|Analgesics|analgesics|mesh-ancestor
64772600|NCT01337700|Sensory System Agents|sensory system agents|mesh-ancestor
64772601|NCT01337700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772602|NCT01337700|Antidepressive Agents|antidepressive agents|mesh-ancestor
64772603|NCT01337700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64772604|NCT01339260|Dexamethasone|dexamethasone|mesh-list
64772605|NCT01339260|Palonosetron|palonosetron|mesh-list
64473260|NCT00121186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64772606|NCT01339260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64772697|NCT01363050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772698|NCT01363050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772699|NCT01363050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64772700|NCT01363050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64772701|NCT01363050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64772702|NCT01363050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772703|NCT01363050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772705|NCT01363128|Dexamethasone|dexamethasone|mesh-list
64772706|NCT01363128|Dexamethasone acetate|dexamethasone acetate|mesh-list
64772707|NCT01363128|Cyclophosphamide|cyclophosphamide|mesh-list
64572057|NCT01459133|Insulin|insulin|mesh-list
64772786|NCT01375140|Growth Substances|growth substances|mesh-ancestor
64772787|NCT01375140|Growth Inhibitors|growth inhibitors|mesh-ancestor
64772788|NCT01377636|Isoproterenol|isoproterenol|mesh-list
64772789|NCT01377636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64772790|NCT01377636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64772791|NCT01377636|Adrenergic Agents|adrenergic agents|mesh-ancestor
64772792|NCT01377636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64772793|NCT01377636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772794|NCT01377636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772820|NCT01387464|Bromfenac|bromfenac|mesh-list
64772821|NCT01387464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64772822|NCT01387464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65495177|NCT01375816|Growth Substances|growth substances|mesh-ancestor
65495178|NCT01375816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595985|NCT00576251|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64772823|NCT01387464|Analgesics|analgesics|mesh-ancestor
64772824|NCT01387464|Sensory System Agents|sensory system agents|mesh-ancestor
64772825|NCT01387464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772826|NCT01387464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772827|NCT01387464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64772828|NCT01387464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64772829|NCT01388946|Ropivacaine|ropivacaine|mesh-list
64772830|NCT01388946|Anesthetics, Local|anesthetics, local|mesh-ancestor
64772831|NCT01388946|Anesthetics|anesthetics|mesh-ancestor
64772832|NCT01388946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64772833|NCT01388946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772834|NCT01388946|Sensory System Agents|sensory system agents|mesh-ancestor
64773077|NCT01443546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64773078|NCT01443546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773079|NCT01443546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64773080|NCT01443546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773081|NCT01444716|Ofatumumab|ofatumumab|mesh-list
64773082|NCT01444716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64773139|NCT01463202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64773140|NCT01463202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64773141|NCT01463202|Contraceptive Agents|contraceptive agents|mesh-ancestor
64773142|NCT01463202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64773143|NCT01463202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773190|NCT01474590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64773191|NCT01474590|Dermatologic Agents|dermatologic agents|mesh-ancestor
64773192|NCT01477320|Pantoprazole|pantoprazole|mesh-list
64773193|NCT01477320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64404609|NCT01597193|Exemestane|exemestane|mesh-list
64773194|NCT01477320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64773195|NCT01477320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64773196|NCT01477320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773197|NCT01477320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773198|NCT01478256|Erythromycin|erythromycin|mesh-list
64773199|NCT01478256|Erythromycin Estolate|erythromycin estolate|mesh-list
64773200|NCT01478256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64773201|NCT01478256|Erythromycin stearate|erythromycin stearate|mesh-list
64773202|NCT01478256|Besifloxacin|besifloxacin|mesh-list
64773203|NCT01478256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64773959|NCT04868760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773960|NCT04666272|Trametinib|trametinib|mesh-list
64773961|NCT04666272|Dabrafenib|dabrafenib|mesh-list
64773962|NCT04666272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773963|NCT04666272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64773964|NCT04666272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773965|NCT04666272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773966|NCT04508166|Sodium Oxybate|sodium oxybate|mesh-list
64773967|NCT04508166|Dexmedetomidine|dexmedetomidine|mesh-list
64773968|NCT04508166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64773969|NCT04508166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64773970|NCT04508166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773971|NCT04508166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64773972|NCT04508166|Analgesics|analgesics|mesh-ancestor
64773973|NCT04508166|Sensory System Agents|sensory system agents|mesh-ancestor
64773974|NCT04508166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773975|NCT04508166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64774001|NCT03624270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774002|NCT03624270|Protective Agents|protective agents|mesh-ancestor
64774003|NCT03624270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774051|NCT01605942|Hormones|hormones|mesh-ancestor
64774052|NCT01605942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64774053|NCT01605942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64774054|NCT01605942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514747|NCT02127723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774055|NCT01608672|Botulinum Toxins|botulinum toxins|mesh-list
64774056|NCT01608672|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64774057|NCT01608672|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64774058|NCT01608672|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64774059|NCT01608672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64774060|NCT01608672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774061|NCT01608672|Cholinergic Agents|cholinergic agents|mesh-ancestor
64774062|NCT01608672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64774063|NCT01608672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774064|NCT01608672|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64774065|NCT01608672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774066|NCT01610154|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64774067|NCT01610154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64774068|NCT01610154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774069|NCT01610154|Incretins|incretins|mesh-ancestor
64774070|NCT01610154|Hormones|hormones|mesh-ancestor
64774071|NCT01610154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64572531|NCT01421589|Hormones|hormones|mesh-list
64774181|NCT01631682|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64774182|NCT01631682|Hormone Antagonists|hormone antagonists|mesh-ancestor
64774183|NCT01631682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64774184|NCT01631682|Luteolytic Agents|luteolytic agents|mesh-ancestor
64774185|NCT01631682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64774186|NCT01631682|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64774187|NCT01635504|Botulinum Toxins|botulinum toxins|mesh-list
64774188|NCT01635504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64774189|NCT01635504|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64774190|NCT01635504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64774191|NCT01635504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64774192|NCT01635504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774243|NCT01640340|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64774245|NCT01641120|Interferon-beta|interferon-beta|mesh-list
64774246|NCT01641120|Interferon beta-1a|interferon beta-1a|mesh-list
64774247|NCT01641120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774248|NCT01641120|Antiviral Agents|antiviral agents|mesh-ancestor
64774249|NCT01641120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64774250|NCT01641120|Immunologic Factors|immunologic factors|mesh-ancestor
64774457|NCT01701102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774458|NCT01701102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64774459|NCT01701102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64774460|NCT01701102|Anesthetics, General|anesthetics, general|mesh-ancestor
64774462|NCT01701102|Anesthetics, Local|anesthetics, local|mesh-ancestor
64774572|NCT05683548|REP 2139|rep 2139|mesh-list
64774573|NCT05683548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774574|NCT05683548|Antiviral Agents|antiviral agents|mesh-ancestor
64774575|NCT05683548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64774576|NCT05683548|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64774577|NCT05683548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64774578|NCT05683548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64774579|NCT05683548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774580|NCT05683548|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64774581|NCT05683548|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64331071|NCT05790902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331072|NCT05790902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572784|NCT00840853|Anesthetics, Local|anesthetics, local|mesh-ancestor
64335788|NCT05254899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335789|NCT05254899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335791|NCT05254899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64335792|NCT05254899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335793|NCT05254899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64335794|NCT03148509|Risperidone|risperidone|mesh-list
64335795|NCT03148509|Aripiprazole|aripiprazole|mesh-list
64335797|NCT03148509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64335957|NCT02300623|Lamivudine|lamivudine|mesh-list
64335958|NCT02300623|Stavudine|stavudine|mesh-list
64335959|NCT02300623|Indinavir|indinavir|mesh-list
64335960|NCT02300623|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64335961|NCT02300623|Interleukin-2|interleukin-2|mesh-list
64335962|NCT02300623|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64514750|NCT05586711|Estradiol|estradiol|mesh-list
64335963|NCT02300623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64335964|NCT02300623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335965|NCT02300623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336013|NCT02340117|Paclitaxel|paclitaxel|mesh-list
64336014|NCT02340117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64336015|NCT02340117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64336016|NCT02340117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336017|NCT02340117|Tubulin Modulators|tubulin modulators|mesh-ancestor
64336307|NCT03505489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64336308|NCT03505489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336310|NCT02310373|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64336311|NCT02310373|Autonomic Agents|autonomic agents|mesh-ancestor
64336312|NCT02310373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64336313|NCT02310373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336314|NCT02310373|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64336896|NCT02440009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336897|NCT02440009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64336898|NCT02440009|Hormone Antagonists|hormone antagonists|mesh-ancestor
64572914|NCT03040830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295433|NCT02469831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64295434|NCT02469831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64295435|NCT02469831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64295436|NCT02469831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64295437|NCT02469831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295438|NCT02995005|Tenofovir|tenofovir|mesh-list
64573414|NCT01668654|Ezogabine|ezogabine|mesh-list
64297090|NCT01499888|Immunologic Factors|immunologic factors|mesh-ancestor
64298248|NCT02071615|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64298249|NCT02071615|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64298250|NCT02071615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64298252|NCT02071615|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64298253|NCT02071615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64298254|NCT02071615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64298257|NCT02077231|Retinol palmitate|retinol palmitate|mesh-list
64298258|NCT02077231|Micronutrients|micronutrients|mesh-ancestor
64300511|NCT05016206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64300512|NCT05016206|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64300513|NCT05016206|Contraceptive Agents|contraceptive agents|mesh-ancestor
64300514|NCT05016206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64300515|NCT05016206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300550|NCT05016440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65495197|NCT03632824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495199|NCT03632824|Coagulants|coagulants|mesh-ancestor
64473269|NCT00121186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64597393|NCT00245011|Ifosfamide|ifosfamide|mesh-list
64300551|NCT05016440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64300552|NCT05016440|Protective Agents|protective agents|mesh-ancestor
64300778|NCT05014490|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64300779|NCT05014490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64300780|NCT05014490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300781|NCT05014490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300782|NCT05020964|Trastuzumab|trastuzumab|mesh-list
64300783|NCT05020964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64300784|NCT05020964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64300785|NCT05014100|Lenalidomide|lenalidomide|mesh-list
64300786|NCT05014100|Immunologic Factors|immunologic factors|mesh-ancestor
64300787|NCT05014100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300788|NCT05014100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64302101|NCT03071822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64302102|NCT03071822|Antiemetics|antiemetics|mesh-ancestor
64302103|NCT03071822|Autonomic Agents|autonomic agents|mesh-ancestor
64302104|NCT03071822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302105|NCT03071822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302106|NCT03071822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64302107|NCT03071822|Glucocorticoids|glucocorticoids|mesh-ancestor
64302108|NCT03071822|Hormones|hormones|mesh-ancestor
64302109|NCT03071822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64302110|NCT03071822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64302111|NCT03071822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302112|NCT03071822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64302113|NCT03071822|Antimetabolites|antimetabolites|mesh-ancestor
64302114|NCT03071822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302115|NCT03071822|Antiviral Agents|antiviral agents|mesh-ancestor
64302116|NCT03071822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64304052|NCT05729594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65019620|NCT02916238|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65019641|NCT00163761|Mitosis Modulators|mitosis modulators|mesh-ancestor
65019642|NCT00163761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65019643|NCT00163761|Alkylating Agents|alkylating agents|mesh-ancestor
65019645|NCT02916160|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65019646|NCT02916160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65019647|NCT02916160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64893390|NCT01995695|Vaccines|vaccines|mesh-list
65019648|NCT02916160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65019649|NCT02916160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019650|NCT02916121|Folic Acid|folic acid|mesh-list
65019651|NCT02916121|Vitamin B 12|vitamin b 12|mesh-list
65019652|NCT02916121|Vitamins|vitamins|mesh-ancestor
65019653|NCT02916121|Micronutrients|micronutrients|mesh-ancestor
65019654|NCT02916121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019655|NCT02916121|Hematinics|hematinics|mesh-ancestor
65019656|NCT02916121|Vitamin B Complex|vitamin b complex|mesh-ancestor
65019657|NCT00170976|Amlodipine|amlodipine|mesh-list
65019658|NCT00170976|Valsartan|valsartan|mesh-list
65019659|NCT00170976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65019660|NCT00170976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65019661|NCT00170976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65019662|NCT00170976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019663|NCT00170976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65019664|NCT00170976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019665|NCT00170976|Vasodilator Agents|vasodilator agents|mesh-ancestor
65019666|NCT00170976|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65019667|NCT00170976|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65019668|NCT00149864|Mycophenolic Acid|mycophenolic acid|mesh-list
65019669|NCT00149864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65019670|NCT00149864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019730|NCT05786547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019732|NCT05786495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65019733|NCT05786495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65019734|NCT05786443|Empagliflozin|empagliflozin|mesh-list
65019735|NCT05786443|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65019800|NCT05785429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64404902|NCT03171805|Vasodilator Agents|vasodilator agents|mesh-ancestor
65019801|NCT05785429|Tubulin Modulators|tubulin modulators|mesh-ancestor
65019802|NCT05785429|Antimitotic Agents|antimitotic agents|mesh-ancestor
65019803|NCT05785429|Mitosis Modulators|mitosis modulators|mesh-ancestor
65019804|NCT05785429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019805|NCT05785429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019806|NCT05785377|Bupivacaine|bupivacaine|mesh-list
65019807|NCT05785377|Neostigmine|neostigmine|mesh-list
65019808|NCT05785377|Anesthetics, Local|anesthetics, local|mesh-ancestor
65019809|NCT05785377|Anesthetics|anesthetics|mesh-ancestor
65019810|NCT05785377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65019811|NCT05785377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019812|NCT05785377|Sensory System Agents|sensory system agents|mesh-ancestor
65019813|NCT05785377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65019814|NCT05785377|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65019815|NCT05785377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019816|NCT05785377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019817|NCT05785377|Cholinergic Agents|cholinergic agents|mesh-ancestor
65019818|NCT05785377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65019847|NCT05785195|Nitric Oxide|nitric oxide|mesh-list
65019848|NCT05785195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65019849|NCT05785195|Autonomic Agents|autonomic agents|mesh-ancestor
65019850|NCT05785195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65019851|NCT05785195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019852|NCT05785195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65019853|NCT05785195|Respiratory System Agents|respiratory system agents|mesh-ancestor
65019854|NCT05785195|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65019855|NCT05785195|Antioxidants|antioxidants|mesh-ancestor
65019856|NCT05785195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019857|NCT05785195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65019858|NCT05785195|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65019859|NCT05785195|Vasodilator Agents|vasodilator agents|mesh-ancestor
65019860|NCT05785195|Gasotransmitters|gasotransmitters|mesh-ancestor
65019861|NCT05785195|Protective Agents|protective agents|mesh-ancestor
65019862|NCT05785065|Mycophenolic Acid|mycophenolic acid|mesh-list
65019863|NCT05785065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65019864|NCT05785065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019865|NCT05785065|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65019894|NCT05784987|Analgesics|analgesics|mesh-ancestor
65019895|NCT05784987|Sensory System Agents|sensory system agents|mesh-ancestor
65019896|NCT05784987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65019897|NCT05784987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65019898|NCT05784987|Alkylating Agents|alkylating agents|mesh-ancestor
65019899|NCT05784870|Ferrous succinate|ferrous succinate|mesh-list
65019900|NCT05784870|Hematinics|hematinics|mesh-ancestor
65019901|NCT05784571|Insulin|insulin|mesh-list
65019902|NCT05784571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65019903|NCT05784571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019904|NCT05784519|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65019905|NCT05784519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65019906|NCT05784467|Methamphetamine|methamphetamine|mesh-list
65019907|NCT05784467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65019908|NCT05784467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019909|NCT05784467|Sympathomimetics|sympathomimetics|mesh-ancestor
65019910|NCT05784467|Autonomic Agents|autonomic agents|mesh-ancestor
65019911|NCT05784467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65019912|NCT05784467|Dopamine Agents|dopamine agents|mesh-ancestor
65019913|NCT05784467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65019948|NCT05781516|Hormones|hormones|mesh-ancestor
65019949|NCT05781516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65019950|NCT05781516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019951|NCT05781516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65019952|NCT05781516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019954|NCT05781321|Levodopa|levodopa|mesh-list
65019955|NCT05781321|Fluorides|fluorides|mesh-list
64574035|NCT04837170|Esketamine|esketamine|mesh-list
65019990|NCT05774405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65019991|NCT05774405|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65019992|NCT05766683|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65019993|NCT05766683|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65019994|NCT05766683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64574076|NCT02101775|Antimetabolites|antimetabolites|mesh-ancestor
65020023|NCT05734105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65020024|NCT05734105|Growth Substances|growth substances|mesh-ancestor
65020025|NCT05734105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274122|NCT02687178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65020026|NCT05734105|Growth Inhibitors|growth inhibitors|mesh-ancestor
65020027|NCT05734105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65020028|NCT05734105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020029|NCT05734105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020030|NCT05724316|Vitamin D|vitamin d|mesh-list
65020031|NCT05724316|Cholecalciferol|cholecalciferol|mesh-list
65020032|NCT05724316|Vitamins|vitamins|mesh-ancestor
65020033|NCT05724316|Micronutrients|micronutrients|mesh-ancestor
65020034|NCT05724316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020035|NCT05724316|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65020036|NCT05724316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65020037|NCT05723705|Liver Extracts|liver extracts|mesh-list
65020038|NCT05723705|Hematinics|hematinics|mesh-ancestor
65020039|NCT05700422|Varenicline|varenicline|mesh-list
65020040|NCT05700422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65020041|NCT05700422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64574127|NCT02062463|Budesonide|budesonide|mesh-list
65020122|NCT05550597|Bupivacaine|bupivacaine|mesh-list
65020123|NCT05550597|Anesthetics, Local|anesthetics, local|mesh-ancestor
65020124|NCT05550597|Anesthetics|anesthetics|mesh-ancestor
65020125|NCT05550597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65020126|NCT05550597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020127|NCT05550597|Sensory System Agents|sensory system agents|mesh-ancestor
65020128|NCT05550597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65020129|NCT05550597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65020130|NCT05550597|Narcotics|narcotics|mesh-ancestor
65020131|NCT05550597|Analgesics|analgesics|mesh-ancestor
65020132|NCT05550597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65020133|NCT05550597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65020134|NCT05550597|Anesthetics, General|anesthetics, general|mesh-ancestor
65020135|NCT05541276|Melatonin|melatonin|mesh-list
65020136|NCT05541276|Antioxidants|antioxidants|mesh-ancestor
65020137|NCT05541276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020138|NCT05541276|Protective Agents|protective agents|mesh-ancestor
65020139|NCT05541276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020140|NCT05541276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65020141|NCT05535764|Interferons|interferons|mesh-list
65020197|NCT05319639|Leucovorin|leucovorin|mesh-list
65020198|NCT05319639|Paclitaxel|paclitaxel|mesh-list
65020199|NCT05319639|Fluorouracil|fluorouracil|mesh-list
65020200|NCT05319639|Oxaliplatin|oxaliplatin|mesh-list
65020201|NCT05319639|Irinotecan|irinotecan|mesh-list
65020202|NCT05319639|Levoleucovorin|levoleucovorin|mesh-list
65020203|NCT05319639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65020204|NCT05319639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020205|NCT05319639|Tubulin Modulators|tubulin modulators|mesh-ancestor
65020206|NCT05319639|Antimitotic Agents|antimitotic agents|mesh-ancestor
65020207|NCT05319639|Mitosis Modulators|mitosis modulators|mesh-ancestor
65020208|NCT05319639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020209|NCT05319639|Antimetabolites|antimetabolites|mesh-ancestor
65020210|NCT05319639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65020211|NCT05319639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65020212|NCT05319639|Immunologic Factors|immunologic factors|mesh-ancestor
65020213|NCT05319639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020214|NCT05319639|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65020215|NCT05319639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65020216|NCT05319639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020217|NCT05319639|Antidotes|antidotes|mesh-ancestor
65020218|NCT05319639|Protective Agents|protective agents|mesh-ancestor
65020219|NCT05319639|Vitamin B Complex|vitamin b complex|mesh-ancestor
65020220|NCT05319639|Vitamins|vitamins|mesh-ancestor
65020221|NCT05319639|Micronutrients|micronutrients|mesh-ancestor
65020222|NCT05292339|Triamcinolone|triamcinolone|mesh-list
64574302|NCT01502787|Metoprolol|metoprolol|mesh-list
65020328|NCT05094128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020329|NCT05094128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020330|NCT05094128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65020331|NCT05091242|Clonidine|clonidine|mesh-list
64476102|NCT00444028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65020370|NCT04969263|Immunologic Factors|immunologic factors|mesh-ancestor
65020371|NCT04969263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020372|NCT04947124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65020373|NCT04947124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65020376|NCT04933630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65020377|NCT04933630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65020378|NCT04933630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65020444|NCT04836429|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64476183|NCT00470392|Imiquimod|imiquimod|mesh-list
65020445|NCT04813926|Riociguat|riociguat|mesh-list
65020446|NCT04813926|Enzyme Activators|enzyme activators|mesh-ancestor
65020447|NCT04813926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020449|NCT04803877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65020450|NCT04803877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020451|NCT04803877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65020452|NCT04803877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020453|NCT04792502|Lenalidomide|lenalidomide|mesh-list
65020454|NCT04792502|Immunologic Factors|immunologic factors|mesh-ancestor
65020455|NCT04792502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020456|NCT04792502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64574567|NCT00066781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64574568|NCT00066781|Immunologic Factors|immunologic factors|mesh-ancestor
64574569|NCT00066781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020469|NCT04777422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020470|NCT04777422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65020472|NCT04766021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65020473|NCT04766021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65020474|NCT04766021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65020475|NCT04766021|Adrenergic Agents|adrenergic agents|mesh-ancestor
65020476|NCT04766021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65020477|NCT04766021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020478|NCT04766021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020479|NCT04766021|Urological Agents|urological agents|mesh-ancestor
65020480|NCT04761198|Nivolumab|nivolumab|mesh-list
65020481|NCT04761198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65020482|NCT04761198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020483|NCT04761198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65020484|NCT04761198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020485|NCT04748276|Norepinephrine|norepinephrine|mesh-list
65020486|NCT04748276|Serotonin|serotonin|mesh-list
65020487|NCT04748276|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65020488|NCT04748276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65020489|NCT04748276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65020490|NCT04748276|Adrenergic Agents|adrenergic agents|mesh-ancestor
65020491|NCT04748276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65020492|NCT04748276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020493|NCT04748276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020494|NCT04748276|Sympathomimetics|sympathomimetics|mesh-ancestor
65020495|NCT04748276|Autonomic Agents|autonomic agents|mesh-ancestor
65020496|NCT04748276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65020497|NCT04748276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65020498|NCT04748276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65020499|NCT04748276|Serotonin Agents|serotonin agents|mesh-ancestor
65020500|NCT04748276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65020501|NCT04748276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65020502|NCT04686305|Carboplatin|carboplatin|mesh-list
65020503|NCT04686305|Trastuzumab|trastuzumab|mesh-list
65020504|NCT04686305|Pemetrexed|pemetrexed|mesh-list
65020505|NCT04686305|Durvalumab|durvalumab|mesh-list
65020506|NCT04686305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020507|NCT04686305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65020508|NCT04686305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020509|NCT04686305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020510|NCT04686305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65020511|NCT04686305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65020512|NCT04681144|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65020513|NCT04681144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574572|NCT01189643|Bevacizumab|bevacizumab|mesh-list
65020546|NCT04595994|Gemcitabine|gemcitabine|mesh-list
65020547|NCT04595994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65020548|NCT04595994|Antimetabolites|antimetabolites|mesh-ancestor
65020549|NCT04595994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020550|NCT04595994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020551|NCT04595994|Antiviral Agents|antiviral agents|mesh-ancestor
65020552|NCT04595994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65020553|NCT04595994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020554|NCT04595994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65020555|NCT04595994|Immunologic Factors|immunologic factors|mesh-ancestor
65020592|NCT04532918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65020593|NCT04532918|Antioxidants|antioxidants|mesh-ancestor
64476357|NCT04062123|Fentanyl|fentanyl|mesh-list
65020629|NCT04466475|Mechlorethamine|mechlorethamine|mesh-list
64805620|NCT01422122|Vitamin D|vitamin d|mesh-list
65020630|NCT04466475|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65020631|NCT04466475|Daratumumab|daratumumab|mesh-list
65020632|NCT04466475|Antibodies|antibodies|mesh-list
65020633|NCT04466475|Immunoglobulins|immunoglobulins|mesh-list
65020634|NCT04466475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65020635|NCT04466475|Immunologic Factors|immunologic factors|mesh-ancestor
65020694|NCT04335669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65020695|NCT04335669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020696|NCT04334759|Cisplatin|cisplatin|mesh-list
65020697|NCT04334759|Carboplatin|carboplatin|mesh-list
65020698|NCT04334759|Nivolumab|nivolumab|mesh-list
65020699|NCT04334759|Pemetrexed|pemetrexed|mesh-list
65020700|NCT04334759|Ipilimumab|ipilimumab|mesh-list
65020701|NCT04334759|Durvalumab|durvalumab|mesh-list
65020702|NCT04334759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020703|NCT04334759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65020704|NCT04334759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65020705|NCT04334759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020706|NCT04334759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020707|NCT04334759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64574758|NCT02605824|Antioxidants|antioxidants|mesh-ancestor
65020737|NCT04310176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65020738|NCT04310176|Antimanic Agents|antimanic agents|mesh-ancestor
65020739|NCT04310176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65020740|NCT04310176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65020741|NCT04310176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65020742|NCT04298983|Androgens|androgens|mesh-list
65020743|NCT04298983|Hormones|hormones|mesh-ancestor
65020744|NCT04298983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64462018|NCT04039750|Clindamycin|clindamycin|mesh-list
65020745|NCT04298983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020746|NCT04267939|Niraparib|niraparib|mesh-list
65020747|NCT04267939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65020748|NCT04267939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020749|NCT04267939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020750|NCT04267939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020751|NCT04236609|Sirolimus|sirolimus|mesh-list
65020752|NCT04236609|Everolimus|everolimus|mesh-list
64574807|NCT02096107|Everolimus|everolimus|mesh-list
65020786|NCT04172987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65020788|NCT04138381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020789|NCT04138381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65020790|NCT04138381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020791|NCT04138381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020792|NCT04128501|Azacitidine|azacitidine|mesh-list
65020819|NCT04049331|Testosterone|testosterone|mesh-list
65020820|NCT04049331|Testosterone undecanoate|testosterone undecanoate|mesh-list
65020821|NCT04049331|Testosterone enanthate|testosterone enanthate|mesh-list
65020822|NCT04049331|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65020823|NCT04049331|Androgens|androgens|mesh-ancestor
65020824|NCT04049331|Hormones|hormones|mesh-ancestor
65020825|NCT04049331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65020826|NCT04049331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020827|NCT04049331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65020828|NCT04049331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020829|NCT04049331|Anabolic Agents|anabolic agents|mesh-ancestor
65020830|NCT04033055|Ropivacaine|ropivacaine|mesh-list
65020831|NCT04033055|Anesthetics, Local|anesthetics, local|mesh-ancestor
65020832|NCT04033055|Anesthetics|anesthetics|mesh-ancestor
65020833|NCT04033055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65020834|NCT04033055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020835|NCT04033055|Sensory System Agents|sensory system agents|mesh-ancestor
65020836|NCT04033055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65020837|NCT04015596|Naproxen|naproxen|mesh-list
65020838|NCT04015596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65020839|NCT04015596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65020840|NCT04015596|Analgesics|analgesics|mesh-ancestor
65020841|NCT04015596|Sensory System Agents|sensory system agents|mesh-ancestor
65020842|NCT04015596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64574897|NCT04834674|Apatinib|apatinib|mesh-list
65020868|NCT03954327|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65020869|NCT03762096|Resveratrol|resveratrol|mesh-list
65020870|NCT03762096|Antioxidants|antioxidants|mesh-ancestor
65020871|NCT03762096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020872|NCT03762096|Protective Agents|protective agents|mesh-ancestor
65020873|NCT03762096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020874|NCT03762096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020875|NCT03762096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65020876|NCT03737955|Gemtuzumab|gemtuzumab|mesh-list
65020877|NCT03737955|Calicheamicins|calicheamicins|mesh-list
65020878|NCT03737955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65020879|NCT03737955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020880|NCT03737955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65020881|NCT03736720|Leucovorin|leucovorin|mesh-list
65020882|NCT03736720|Fluorouracil|fluorouracil|mesh-list
65020883|NCT03736720|Irinotecan|irinotecan|mesh-list
65020884|NCT03736720|Antimetabolites|antimetabolites|mesh-ancestor
65020885|NCT03736720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020886|NCT03736720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65020887|NCT03736720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020888|NCT03736720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65020889|NCT03736720|Immunologic Factors|immunologic factors|mesh-ancestor
65020890|NCT03736720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020891|NCT03736720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65020916|NCT03490344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020918|NCT03473756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020919|NCT03460379|Citalopram|citalopram|mesh-list
65020920|NCT03460379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65020921|NCT03460379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65020922|NCT03460379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65020923|NCT03460379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020924|NCT03460379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65020925|NCT03460379|Serotonin Agents|serotonin agents|mesh-ancestor
65020926|NCT03460379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020927|NCT03460379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65020928|NCT03460379|Antidepressive Agents|antidepressive agents|mesh-ancestor
65020929|NCT03460379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65020930|NCT03460366|Enalapril|enalapril|mesh-list
65020931|NCT03460366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65020932|NCT03460366|Protease Inhibitors|protease inhibitors|mesh-ancestor
65020933|NCT03460366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020934|NCT03460366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020935|NCT03460366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65020936|NCT03460353|Dextroamphetamine|dextroamphetamine|mesh-list
65020937|NCT03460353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65020938|NCT03460353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020939|NCT03460353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65020940|NCT03460353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65020941|NCT03460353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65020973|NCT03449472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021029|NCT03277924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65021030|NCT03277924|Abortifacient Agents|abortifacient agents|mesh-ancestor
65021031|NCT03277924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65021032|NCT03277924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021033|NCT03277924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65021034|NCT03277924|Antimetabolites|antimetabolites|mesh-ancestor
65021035|NCT03277924|Dermatologic Agents|dermatologic agents|mesh-ancestor
65021036|NCT03277924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65021037|NCT03277924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65021038|NCT03277924|Immunologic Factors|immunologic factors|mesh-ancestor
65021039|NCT03277924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65021040|NCT03277924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65021041|NCT03277924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65021042|NCT03277924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65021043|NCT03277924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65021044|NCT03277924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64476769|NCT00540982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021045|NCT03277924|Growth Substances|growth substances|mesh-ancestor
65021046|NCT03277924|Growth Inhibitors|growth inhibitors|mesh-ancestor
65021047|NCT03277924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65021048|NCT03277924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65021049|NCT03277924|Alkylating Agents|alkylating agents|mesh-ancestor
65021050|NCT03249792|Pembrolizumab|pembrolizumab|mesh-list
65021051|NCT03249792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65021052|NCT03249792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021053|NCT03239340|Osimertinib|osimertinib|mesh-list
65021054|NCT03239340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021055|NCT03239340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65021089|NCT02873962|Bevacizumab|bevacizumab|mesh-list
65274123|NCT02687178|Hormone Antagonists|hormone antagonists|mesh-ancestor
65021090|NCT02873962|Nivolumab|nivolumab|mesh-list
65021091|NCT02873962|Rucaparib|rucaparib|mesh-list
65021092|NCT02873962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65021093|NCT02873962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021094|NCT02873962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65021095|NCT02873962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65021096|NCT02873962|Growth Substances|growth substances|mesh-ancestor
65021188|NCT02282059|Growth Substances|growth substances|mesh-ancestor
65021189|NCT02282059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021190|NCT02282059|Growth Inhibitors|growth inhibitors|mesh-ancestor
65021191|NCT02282059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65021227|NCT01711554|Growth Substances|growth substances|mesh-ancestor
65021228|NCT01711554|Growth Inhibitors|growth inhibitors|mesh-ancestor
65021229|NCT01711554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021230|NCT01711554|Keratolytic Agents|keratolytic agents|mesh-ancestor
65021263|NCT01386385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65021265|NCT01386385|Tubulin Modulators|tubulin modulators|mesh-ancestor
65021266|NCT01386385|Antimitotic Agents|antimitotic agents|mesh-ancestor
65021267|NCT01386385|Mitosis Modulators|mitosis modulators|mesh-ancestor
65021268|NCT01386385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021269|NCT01386385|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64476996|NCT00887380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65021270|NCT01386385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021271|NCT01364051|Cediranib|cediranib|mesh-list
65021293|NCT01064648|Cisplatin|cisplatin|mesh-list
65021294|NCT01064648|Pemetrexed|pemetrexed|mesh-list
65021295|NCT01064648|Cediranib|cediranib|mesh-list
65021296|NCT01064648|Maleic acid|maleic acid|mesh-list
65021297|NCT01064648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021298|NCT01064648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021299|NCT01064648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021300|NCT01064648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65021301|NCT01064648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65021302|NCT01064648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65021303|NCT00878163|Gemcitabine|gemcitabine|mesh-list
65021304|NCT00878163|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65021305|NCT00878163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65021306|NCT00878163|Antimetabolites|antimetabolites|mesh-ancestor
65021307|NCT00878163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021308|NCT00878163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021309|NCT00878163|Antiviral Agents|antiviral agents|mesh-ancestor
65021310|NCT00878163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65021311|NCT00878163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021312|NCT00878163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65021313|NCT00878163|Immunologic Factors|immunologic factors|mesh-ancestor
65021314|NCT00878163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021315|NCT00878163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65021316|NCT00635700|Ziprasidone|ziprasidone|mesh-list
65021317|NCT00635700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65021318|NCT00635700|Serotonin Agents|serotonin agents|mesh-ancestor
65493834|NCT04233866|Mitosis Modulators|mitosis modulators|mesh-ancestor
65021319|NCT00635700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65021320|NCT00635700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021321|NCT00635700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021322|NCT00635700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65021323|NCT00635700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65021324|NCT00635700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65021325|NCT00635700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65021355|NCT00392353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021356|NCT00392353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021357|NCT00392353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65021358|NCT00382070|Letrozole|letrozole|mesh-list
65021359|NCT00382070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021360|NCT00382070|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65021361|NCT00382070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65021362|NCT00382070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021363|NCT00382070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021364|NCT00382070|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65021365|NCT00382070|Hormone Antagonists|hormone antagonists|mesh-ancestor
65021366|NCT00382070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65021367|NCT00382070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021368|NCT00326456|Paclitaxel|paclitaxel|mesh-list
65021369|NCT00326456|Carboplatin|carboplatin|mesh-list
65021370|NCT00326456|Doxorubicin|doxorubicin|mesh-list
64575427|NCT01515657|Aspirin|aspirin|mesh-list
65021463|NCT00171093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65021464|NCT00171093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65021465|NCT00171093|Antimetabolites|antimetabolites|mesh-ancestor
65021466|NCT00171093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021493|NCT00150059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65021494|NCT00150059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65021495|NCT00150059|Dermatologic Agents|dermatologic agents|mesh-ancestor
64462755|NCT04397770|Apatinib|apatinib|mesh-list
65021496|NCT00150059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65021497|NCT00150059|Immunologic Factors|immunologic factors|mesh-ancestor
65021498|NCT00150059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65021499|NCT00150059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021500|NCT00150059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021501|NCT00171132|Atenolol|atenolol|mesh-list
65021502|NCT00171132|Valsartan|valsartan|mesh-list
65021503|NCT00171132|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65021504|NCT00171132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65021505|NCT00171132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65021506|NCT00171132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65021507|NCT00171132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021508|NCT00171132|Diuretics|diuretics|mesh-ancestor
65021509|NCT00171132|Natriuretic Agents|natriuretic agents|mesh-ancestor
65021510|NCT00171132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021511|NCT00171132|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64575572|NCT00074269|Antimetabolites|antimetabolites|mesh-ancestor
65021577|NCT02913469|Antiemetics|antiemetics|mesh-ancestor
65021578|NCT02913469|Autonomic Agents|autonomic agents|mesh-ancestor
65021579|NCT02913469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65021580|NCT02913469|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65021581|NCT02913469|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65021582|NCT02913469|Dopamine Agents|dopamine agents|mesh-ancestor
65021583|NCT02913469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65021584|NCT02913469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021585|NCT00150254|Varenicline|varenicline|mesh-list
65021586|NCT00150254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65021587|NCT00150254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65021588|NCT00150254|Cholinergic Agents|cholinergic agents|mesh-ancestor
65021669|NCT02912182|Prednisolone|prednisolone|mesh-list
65021670|NCT02912182|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65021671|NCT02912182|Methylprednisolone|methylprednisolone|mesh-list
65021672|NCT02912182|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65021705|NCT02843230|Lomustine|lomustine|mesh-list
65021706|NCT02843230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65021707|NCT02843230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021708|NCT02843230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65021709|NCT02843230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65021710|NCT02843230|Growth Substances|growth substances|mesh-ancestor
65021711|NCT02843230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021781|NCT00150605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65021782|NCT00150605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021819|NCT00150722|Atorvastatin|atorvastatin|mesh-list
65021820|NCT00150722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65021866|NCT00150839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65021867|NCT00150839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65021868|NCT00150839|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65021869|NCT00150839|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65021870|NCT00150839|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65021871|NCT00150839|Adrenergic Agents|adrenergic agents|mesh-ancestor
65021872|NCT00150839|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65021873|NCT00150839|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65021875|NCT00150839|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65021876|NCT03732820|Olaparib|olaparib|mesh-list
65021877|NCT03732820|Abiraterone Acetate|abiraterone acetate|mesh-list
65021878|NCT03732820|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65021879|NCT03732820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575948|NCT01527045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65021913|NCT00532168|Protease Inhibitors|protease inhibitors|mesh-ancestor
65021914|NCT00532168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021915|NCT00532168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021916|NCT00532168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65021917|NCT00532168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65021918|NCT00532168|Antiviral Agents|antiviral agents|mesh-ancestor
65021919|NCT00532168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64806162|NCT01425099|Prednisone|prednisone|mesh-list
65021920|NCT00532168|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64576009|NCT03001635|Oxytocin|oxytocin|mesh-list
65021970|NCT00532285|Antiviral Agents|antiviral agents|mesh-ancestor
65021971|NCT00532285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65021972|NCT00532285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021973|NCT00532285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65021974|NCT00532285|Immunologic Factors|immunologic factors|mesh-ancestor
65021975|NCT00532285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021977|NCT03138733|Ceftobiprole|ceftobiprole|mesh-list
65021978|NCT03138733|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
65021979|NCT03138733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65021980|NCT03138733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65021981|NCT00151034|Gemcitabine|gemcitabine|mesh-list
65021982|NCT00151034|Paclitaxel|paclitaxel|mesh-list
65021983|NCT00151034|Carboplatin|carboplatin|mesh-list
65493836|NCT04233866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65021984|NCT00151034|Trastuzumab|trastuzumab|mesh-list
65021985|NCT00151034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64576058|NCT00078559|Pentamidine|pentamidine|mesh-list
65022014|NCT02716012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65022015|NCT02716012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022016|NCT02716012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022017|NCT00151073|Zoledronic Acid|zoledronic acid|mesh-list
65022019|NCT00151073|Estramustine|estramustine|mesh-list
65022020|NCT00151073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65022021|NCT00151073|Tubulin Modulators|tubulin modulators|mesh-ancestor
65022022|NCT00151073|Antimitotic Agents|antimitotic agents|mesh-ancestor
65022023|NCT00151073|Mitosis Modulators|mitosis modulators|mesh-ancestor
65022024|NCT00151073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022025|NCT00151073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65022026|NCT00151073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022027|NCT00151073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65022028|NCT00151073|Alkylating Agents|alkylating agents|mesh-ancestor
65022029|NCT00151073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65022030|NCT00171561|Valsartan|valsartan|mesh-list
65022031|NCT00171561|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65022032|NCT00171561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65022064|NCT00171600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022065|NCT05467384|Amlodipine|amlodipine|mesh-list
65022066|NCT05467384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65022067|NCT05467384|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65022068|NCT05467384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65022069|NCT05467384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576152|NCT02596620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65022143|NCT00151346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65022144|NCT00151346|Narcotics|narcotics|mesh-ancestor
65022145|NCT00151346|Analgesics|analgesics|mesh-ancestor
65022174|NCT00171678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022175|NCT00151463|Sildenafil Citrate|sildenafil citrate|mesh-list
65022176|NCT00151463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022177|NCT00151463|Vasodilator Agents|vasodilator agents|mesh-ancestor
65022178|NCT00151463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65022179|NCT00151463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65022180|NCT00151463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022181|NCT00151463|Urological Agents|urological agents|mesh-ancestor
65022182|NCT00171717|Cyclosporine|cyclosporine|mesh-list
65022183|NCT00171717|Cyclosporins|cyclosporins|mesh-list
65022184|NCT00171717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022185|NCT00171717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022186|NCT00171717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65022187|NCT00171717|Immunologic Factors|immunologic factors|mesh-ancestor
65022188|NCT00171717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022189|NCT00171717|Antifungal Agents|antifungal agents|mesh-ancestor
65022190|NCT00171717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65022216|NCT00171756|Atenolol|atenolol|mesh-list
65022217|NCT00171756|Valsartan|valsartan|mesh-list
65022218|NCT00171756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65022219|NCT00171756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65022220|NCT00171756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65022221|NCT00171756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022222|NCT00171756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65022223|NCT00171756|Sympatholytics|sympatholytics|mesh-ancestor
65022224|NCT00171756|Autonomic Agents|autonomic agents|mesh-ancestor
65022225|NCT00171756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022226|NCT00171756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022227|NCT00171756|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65022228|NCT00171756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65022229|NCT00171756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65022230|NCT00171756|Adrenergic Agents|adrenergic agents|mesh-ancestor
65022231|NCT00171756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65022232|NCT05399173|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65022233|NCT05399173|Hemostatics|hemostatics|mesh-ancestor
65022234|NCT05399173|Coagulants|coagulants|mesh-ancestor
65022235|NCT05399173|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65022236|NCT05399173|Natriuretic Agents|natriuretic agents|mesh-ancestor
65022237|NCT05399173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022238|NCT00171795|Rivastigmine|rivastigmine|mesh-list
65022239|NCT00171795|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65022240|NCT00171795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576319|NCT01535937|Anesthetics|anesthetics|mesh-ancestor
65022271|NCT00151580|Antiviral Agents|antiviral agents|mesh-ancestor
65022272|NCT00151580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65022273|NCT00171912|Imatinib Mesylate|imatinib mesylate|mesh-list
65022274|NCT00171912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65022275|NCT00171912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65022276|NCT00171912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022277|NCT00171912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022278|NCT00151619|Amlodipine|amlodipine|mesh-list
65022279|NCT00151619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65022280|NCT00151619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65022281|NCT00151619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65022282|NCT00151619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022283|NCT00151619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64576365|NCT04803318|Everolimus|everolimus|mesh-list
65022313|NCT00532675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65022314|NCT00532675|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65022315|NCT00532675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022316|NCT00532675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022317|NCT05308030|Aspirin|aspirin|mesh-list
65022318|NCT05308030|Rivaroxaban|rivaroxaban|mesh-list
65022319|NCT05308030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65022320|NCT05308030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65022321|NCT05308030|Analgesics|analgesics|mesh-ancestor
65022322|NCT05308030|Sensory System Agents|sensory system agents|mesh-ancestor
65022323|NCT05308030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022324|NCT05308030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022325|NCT05308030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65022326|NCT05308030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65022327|NCT05308030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65022328|NCT05308030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65022359|NCT05293600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65022360|NCT05293600|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65022362|NCT05293600|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65022363|NCT05293600|Antidepressive Agents|antidepressive agents|mesh-ancestor
65022364|NCT00151697|Insulin Aspart|insulin aspart|mesh-list
65022365|NCT00151697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65022366|NCT00151697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65022367|NCT00151697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022368|NCT00532714|Capecitabine|capecitabine|mesh-list
65022369|NCT00532714|Irinotecan|irinotecan|mesh-list
65022370|NCT00532714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65022371|NCT00532714|Antimetabolites|antimetabolites|mesh-ancestor
65022404|NCT00406094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65022405|NCT00406094|Respiratory System Agents|respiratory system agents|mesh-ancestor
65022406|NCT00406094|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65022407|NCT00406094|Hormone Antagonists|hormone antagonists|mesh-ancestor
65022408|NCT00406094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65022409|NCT00406094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576499|NCT04794738|Analgesics|analgesics|mesh-ancestor
65022440|NCT04725383|Sensory System Agents|sensory system agents|mesh-ancestor
65022441|NCT04725383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022442|NCT04725383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022443|NCT04725383|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65022444|NCT04725383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65022445|NCT04725383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65022446|NCT04725383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022448|NCT04725383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65022449|NCT05177146|Ketamine|ketamine|mesh-list
65022450|NCT05177146|Analgesics|analgesics|mesh-ancestor
65022477|NCT00172068|Zoledronic Acid|zoledronic acid|mesh-list
65022478|NCT00172068|Calcium|calcium|mesh-list
65022479|NCT00172068|Vitamins|vitamins|mesh-ancestor
65022480|NCT00172068|Micronutrients|micronutrients|mesh-ancestor
65022481|NCT00172068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022482|NCT00172068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65022483|NCT00172068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65022484|NCT00151970|Methylphenidate|methylphenidate|mesh-list
65022485|NCT00151970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65022486|NCT00151970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022487|NCT00151970|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65022488|NCT00151970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65022489|NCT00151970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65022490|NCT00151970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022491|NCT00151970|Dopamine Agents|dopamine agents|mesh-ancestor
65022492|NCT00151970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65022493|NCT00152048|Eflornithine|eflornithine|mesh-list
65022494|NCT00152048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65022495|NCT00152048|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65022526|NCT00164775|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65022527|NCT00164775|Antidepressive Agents|antidepressive agents|mesh-ancestor
65022528|NCT00164775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64463805|NCT01927588|Tacrolimus|tacrolimus|mesh-list
65022529|NCT00164775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65022530|NCT00164775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65022531|NCT00164775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65022532|NCT00164775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022533|NCT00164775|Adrenergic Agents|adrenergic agents|mesh-ancestor
64576630|NCT04800978|Durvalumab|durvalumab|mesh-list
65022569|NCT00425451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65022570|NCT00425451|Disinfectants|disinfectants|mesh-ancestor
65022571|NCT00425451|Dermatologic Agents|dermatologic agents|mesh-ancestor
65022572|NCT00425451|Analgesics|analgesics|mesh-ancestor
65022599|NCT00533065|Cholinergic Agents|cholinergic agents|mesh-ancestor
65022600|NCT00533065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65022601|NCT00533065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478359|NCT03596385|Metoprolol|metoprolol|mesh-list
65022602|NCT00533065|Nootropic Agents|nootropic agents|mesh-ancestor
65022603|NCT00152243|Tegafur|tegafur|mesh-list
65022604|NCT00152243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65022605|NCT00152243|Antimetabolites|antimetabolites|mesh-ancestor
65022606|NCT00152243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022607|NCT00152243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65022608|NCT00172107|Parathyroid Hormone|parathyroid hormone|mesh-list
65022609|NCT00172107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65022610|NCT00172107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022611|NCT00152282|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65022612|NCT00152282|Estrogens|estrogens|mesh-ancestor
65022613|NCT00152282|Hormones|hormones|mesh-ancestor
65022614|NCT00152282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65022615|NCT00152282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022616|NCT04922983|Botulinum Toxins|botulinum toxins|mesh-list
65022617|NCT04922983|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65022684|NCT02937415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022685|NCT02937415|Antimetabolites|antimetabolites|mesh-ancestor
65022686|NCT02937415|Gasotransmitters|gasotransmitters|mesh-ancestor
65022687|NCT02937415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65022688|NCT00152594|Voriconazole|voriconazole|mesh-list
65022689|NCT00152594|Antifungal Agents|antifungal agents|mesh-ancestor
65022690|NCT00152594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65022691|NCT00152594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65022692|NCT00152594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64576791|NCT04799184|Mydriatics|mydriatics|mesh-ancestor
65022721|NCT04725422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65022722|NCT04725422|Antimetabolites|antimetabolites|mesh-ancestor
65022723|NCT04725422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022724|NCT04725422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65022725|NCT04725422|Dermatologic Agents|dermatologic agents|mesh-ancestor
65022726|NCT04725422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022727|NCT04725422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65022728|NCT04725422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65022729|NCT04725422|Immunologic Factors|immunologic factors|mesh-ancestor
65022730|NCT04725422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65022731|NCT04725422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65022732|NCT04725422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65022733|NCT04725422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65022734|NCT04725422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65022735|NCT04725422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65022736|NCT04725422|Analgesics|analgesics|mesh-ancestor
64576834|NCT04339101|Alkylating Agents|alkylating agents|mesh-ancestor
65022762|NCT00425490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65022763|NCT00425490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022764|NCT00425490|Incretins|incretins|mesh-ancestor
65022765|NCT00425490|Hormones|hormones|mesh-ancestor
65022766|NCT00425490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65022767|NCT00425490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65022768|NCT00425490|Protease Inhibitors|protease inhibitors|mesh-ancestor
65022769|NCT00425490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022770|NCT00425490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022771|NCT03457753|Riluzole|riluzole|mesh-list
65022772|NCT03457753|Anticonvulsants|anticonvulsants|mesh-ancestor
65022773|NCT03457753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65022774|NCT03457753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65022775|NCT03457753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65022776|NCT03457753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022777|NCT03457753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022778|NCT03457753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65022779|NCT03457753|Protective Agents|protective agents|mesh-ancestor
65022780|NCT02936830|Listerine|listerine|mesh-list
65022781|NCT02936830|Fluorides|fluorides|mesh-list
65022782|NCT02936830|Sodium Fluoride|sodium fluoride|mesh-list
65022783|NCT02936830|Fluorides, Topical|fluorides, topical|mesh-list
65022784|NCT02936830|Glycerol|glycerol|mesh-list
65022816|NCT00165087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65022817|NCT00165087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65022818|NCT00165087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65022819|NCT00165087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65022820|NCT00165087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022821|NCT00165087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022822|NCT00165087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65022823|NCT00165087|Protective Agents|protective agents|mesh-ancestor
65022824|NCT00165087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022825|NCT00165087|Antimitotic Agents|antimitotic agents|mesh-ancestor
65022826|NCT00165087|Mitosis Modulators|mitosis modulators|mesh-ancestor
65022828|NCT00152750|Analgesics|analgesics|mesh-ancestor
65022829|NCT00152750|Sensory System Agents|sensory system agents|mesh-ancestor
65022861|NCT02935933|Anesthetics|anesthetics|mesh-ancestor
65022862|NCT02935933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65022863|NCT02935933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022864|NCT02935933|Sensory System Agents|sensory system agents|mesh-ancestor
65022865|NCT02935933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022866|NCT02935933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65022867|NCT02935933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65022869|NCT02935933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65022870|NCT02935933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65022871|NCT02935933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65022872|NCT02935933|Adrenergic Agents|adrenergic agents|mesh-ancestor
65022903|NCT02935972|Anticonvulsants|anticonvulsants|mesh-ancestor
65022904|NCT02935972|Antiemetics|antiemetics|mesh-ancestor
65022905|NCT02935972|Autonomic Agents|autonomic agents|mesh-ancestor
65022906|NCT02935972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65022907|NCT02935972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65022908|NCT02935972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65022909|NCT02935972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65022910|NCT02935972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65022911|NCT02935972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65022912|NCT02935972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65022913|NCT02935972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65022914|NCT02935972|Anesthetics, General|anesthetics, general|mesh-ancestor
65022915|NCT02935972|GABA Modulators|gaba modulators|mesh-ancestor
65022916|NCT02935972|GABA Agents|gaba agents|mesh-ancestor
65022945|NCT00406172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65022948|NCT00406172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65022949|NCT00406172|Growth Substances|growth substances|mesh-ancestor
65022950|NCT00406172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022951|NCT00406172|Growth Inhibitors|growth inhibitors|mesh-ancestor
65022952|NCT00152945|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65022953|NCT00152945|Glycerol|glycerol|mesh-list
64405809|NCT03871049|Hormones|hormones|mesh-ancestor
64806668|NCT04425902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806669|NCT04425902|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65022954|NCT00152945|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65022955|NCT00152945|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65022956|NCT00152945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65022957|NCT00152945|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65022958|NCT00152945|Protective Agents|protective agents|mesh-ancestor
65022959|NCT00152945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022960|NCT02935114|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65022961|NCT02935114|Carbamide Peroxide|carbamide peroxide|mesh-list
65022962|NCT02935114|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65022963|NCT02935114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65022964|NCT02935231|Nicotine|nicotine|mesh-list
65022965|NCT02935231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64577074|NCT01625013|Hylan|hylan|mesh-list
65023019|NCT00172419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65023020|NCT00172419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65023021|NCT00172419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023022|NCT00153023|Valsartan|valsartan|mesh-list
65023023|NCT00153023|Telmisartan|telmisartan|mesh-list
65023024|NCT00153023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65023025|NCT00153023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65023026|NCT00153023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65023027|NCT00153023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023028|NCT00165204|Tibolone|tibolone|mesh-list
65023029|NCT00165204|Androgen Antagonists|androgen antagonists|mesh-ancestor
65023030|NCT00165204|Hormone Antagonists|hormone antagonists|mesh-ancestor
65023031|NCT00165204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65023032|NCT00165204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023033|NCT00165204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65023034|NCT00165204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65023035|NCT00165204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023036|NCT00165204|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65023037|NCT00165204|Anabolic Agents|anabolic agents|mesh-ancestor
65023038|NCT00165204|Hormones|hormones|mesh-ancestor
65023039|NCT02934763|Propranolol|propranolol|mesh-list
65023040|NCT02934763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65023041|NCT02934763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65023042|NCT02934763|Adrenergic Agents|adrenergic agents|mesh-ancestor
65023043|NCT02934763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65023044|NCT02934763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023073|NCT00153296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65023074|NCT00153296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65023075|NCT00153296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65023076|NCT00153296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023077|NCT00153296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65023078|NCT00153296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65023079|NCT02934295|Antibodies|antibodies|mesh-list
65023080|NCT02934295|Immunologic Factors|immunologic factors|mesh-ancestor
65023081|NCT02934295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023082|NCT02934022|Maraviroc|maraviroc|mesh-list
65023083|NCT02934022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65023084|NCT02934022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65023085|NCT02934022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023086|NCT02934022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65023087|NCT02934022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65023088|NCT02934022|Antiviral Agents|antiviral agents|mesh-ancestor
65023089|NCT02934022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65023091|NCT02934061|Tizanidine|tizanidine|mesh-list
65023118|NCT02934217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65023119|NCT00165360|Temozolomide|temozolomide|mesh-list
65023120|NCT00165360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65023121|NCT00165360|Alkylating Agents|alkylating agents|mesh-ancestor
65023122|NCT00165360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023123|NCT00165360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023125|NCT02933905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65023126|NCT02933905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65023127|NCT02933905|Growth Substances|growth substances|mesh-ancestor
65023128|NCT02933905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023129|NCT02933905|Growth Inhibitors|growth inhibitors|mesh-ancestor
65023130|NCT02933905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023131|NCT02933788|Aspirin|aspirin|mesh-list
65023132|NCT02933788|Cilostazol|cilostazol|mesh-list
65023133|NCT02933788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65023134|NCT02933788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65023135|NCT02933788|Analgesics|analgesics|mesh-ancestor
65023136|NCT02933788|Sensory System Agents|sensory system agents|mesh-ancestor
65023137|NCT02933788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65023138|NCT02933788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023139|NCT02933788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64577261|NCT05466318|Cytarabine|cytarabine|mesh-list
65023169|NCT00165399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65023170|NCT00165399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023171|NCT00165399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65023172|NCT00165399|Alkylating Agents|alkylating agents|mesh-ancestor
65023173|NCT02933593|Labetalol|labetalol|mesh-list
65023174|NCT02933593|Hydralazine|hydralazine|mesh-list
65023175|NCT02933593|Nifedipine|nifedipine|mesh-list
65023176|NCT02933593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65023177|NCT02933593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65023178|NCT02933593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023179|NCT02933593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65023180|NCT02933593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023181|NCT02933593|Vasodilator Agents|vasodilator agents|mesh-ancestor
65023182|NCT02933593|Tocolytic Agents|tocolytic agents|mesh-ancestor
65023183|NCT02933593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65023184|NCT02933593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64577293|NCT01469546|Axitinib|axitinib|mesh-list
65023211|NCT00153530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023212|NCT00153530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65023214|NCT00153530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023215|NCT00153530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023216|NCT00153530|Dermatologic Agents|dermatologic agents|mesh-ancestor
65023217|NCT00153530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023218|NCT00153530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65023219|NCT00153530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65023220|NCT00153530|Immunologic Factors|immunologic factors|mesh-ancestor
65023221|NCT00153530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65023222|NCT00153530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65023223|NCT00165477|Lenalidomide|lenalidomide|mesh-list
65023224|NCT00165477|Immunologic Factors|immunologic factors|mesh-ancestor
65023225|NCT00165477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023226|NCT00165477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65023227|NCT00165477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65023228|NCT00165477|Growth Substances|growth substances|mesh-ancestor
65023229|NCT00165477|Growth Inhibitors|growth inhibitors|mesh-ancestor
65023230|NCT00165477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023231|NCT02932930|Ropivacaine|ropivacaine|mesh-list
65023265|NCT02932774|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65023266|NCT02932774|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65023267|NCT02932774|Histamine Antagonists|histamine antagonists|mesh-ancestor
65023268|NCT02932774|Histamine Agents|histamine agents|mesh-ancestor
65023269|NCT02932774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65023270|NCT02932774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023271|NCT02932774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464561|NCT02809690|Antiviral Agents|antiviral agents|mesh-ancestor
65023272|NCT02932774|Antipruritics|antipruritics|mesh-ancestor
65023298|NCT00180102|Amsacrine|amsacrine|mesh-list
65023299|NCT00180102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65023300|NCT00180102|Antimetabolites|antimetabolites|mesh-ancestor
65023301|NCT00180102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023302|NCT00180102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023303|NCT00180102|Antiviral Agents|antiviral agents|mesh-ancestor
65023304|NCT00180102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65023305|NCT00180102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65023306|NCT00180102|Immunologic Factors|immunologic factors|mesh-ancestor
65023307|NCT00180102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023308|NCT00180102|Analgesics|analgesics|mesh-ancestor
65023309|NCT00180102|Sensory System Agents|sensory system agents|mesh-ancestor
65023310|NCT00180102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65023311|NCT00180102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65023312|NCT00180102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65023313|NCT00180102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023314|NCT04690309|Insulin|insulin|mesh-list
65493844|NCT04233866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65023315|NCT04690309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65023316|NCT04690309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65023317|NCT04690309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023318|NCT00153881|Carboplatin|carboplatin|mesh-list
65023319|NCT00153881|Docetaxel|docetaxel|mesh-list
65023320|NCT00153881|Capecitabine|capecitabine|mesh-list
65023321|NCT00153881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023322|NCT00153881|Tubulin Modulators|tubulin modulators|mesh-ancestor
65023350|NCT02931877|Anesthetics|anesthetics|mesh-ancestor
65023351|NCT02931877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65023352|NCT02931877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65023353|NCT00153998|Leucovorin|leucovorin|mesh-list
65023354|NCT00153998|Folic Acid|folic acid|mesh-list
65023355|NCT00153998|Fluorouracil|fluorouracil|mesh-list
65023356|NCT00153998|Oxaliplatin|oxaliplatin|mesh-list
65023357|NCT00153998|Irinotecan|irinotecan|mesh-list
65023358|NCT00153998|Cetuximab|cetuximab|mesh-list
65023359|NCT00153998|Levoleucovorin|levoleucovorin|mesh-list
65023360|NCT00153998|Antimetabolites|antimetabolites|mesh-ancestor
65023361|NCT00153998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023362|NCT00153998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65023363|NCT00153998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023364|NCT00153998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65023365|NCT00153998|Immunologic Factors|immunologic factors|mesh-ancestor
65023366|NCT00153998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577481|NCT05346419|Vitamin D|vitamin d|mesh-list
65023399|NCT02924974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65023400|NCT02924974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65023401|NCT02924974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65023402|NCT02924974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65023403|NCT02924974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65023404|NCT02924974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023405|NCT02924974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65023407|NCT02924974|Analgesics|analgesics|mesh-ancestor
65023408|NCT00154037|Pioglitazone|pioglitazone|mesh-list
65023409|NCT00154037|Candesartan|candesartan|mesh-list
65023429|NCT00154076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65023430|NCT00154076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023431|NCT00154076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65023433|NCT00154115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65023434|NCT00154115|Vasodilator Agents|vasodilator agents|mesh-ancestor
65023435|NCT00154115|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65023436|NCT00154115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65023437|NCT00154115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023438|NCT00154115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023439|NCT00154115|Protective Agents|protective agents|mesh-ancestor
65023440|NCT00154115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023441|NCT02924506|Meloxicam|meloxicam|mesh-list
65023442|NCT02924506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65023443|NCT02924506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65023444|NCT02924506|Analgesics|analgesics|mesh-ancestor
65023445|NCT02924506|Sensory System Agents|sensory system agents|mesh-ancestor
65023446|NCT02924506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65023447|NCT02924506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023448|NCT02924506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65023449|NCT02924506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65023450|NCT02924506|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65023451|NCT02924506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65023452|NCT02924506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023453|NCT02924506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023454|NCT02924311|Aflibercept|aflibercept|mesh-list
65023455|NCT02924311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65023456|NCT02924311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65023457|NCT02924311|Growth Substances|growth substances|mesh-ancestor
65023458|NCT02924311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023459|NCT02924311|Growth Inhibitors|growth inhibitors|mesh-ancestor
65023460|NCT02924311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023461|NCT02924233|Nivolumab|nivolumab|mesh-list
64577561|NCT04773366|Hormones|hormones|mesh-ancestor
65023494|NCT00154271|Valsartan|valsartan|mesh-list
65023495|NCT00154271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65023496|NCT00154271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65023497|NCT00154271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65023498|NCT00154271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023499|NCT00154349|Imatinib Mesylate|imatinib mesylate|mesh-list
65023500|NCT00154349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023501|NCT00154349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65023502|NCT00154349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577614|NCT02412228|Immunologic Factors|immunologic factors|mesh-ancestor
65023533|NCT02923258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023534|NCT02923258|Tubulin Modulators|tubulin modulators|mesh-ancestor
65023535|NCT02923258|Antimitotic Agents|antimitotic agents|mesh-ancestor
65023536|NCT02923258|Mitosis Modulators|mitosis modulators|mesh-ancestor
65023537|NCT02923258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023538|NCT02923336|Propranolol|propranolol|mesh-list
65023539|NCT02923336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65023540|NCT02923336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65023541|NCT02923336|Adrenergic Agents|adrenergic agents|mesh-ancestor
65023542|NCT02923336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65023543|NCT02923336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023544|NCT02923336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023545|NCT02923336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65023574|NCT02922673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65023575|NCT02922673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65023576|NCT02922673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023577|NCT02922673|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65023578|NCT02922673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65023579|NCT02922673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023581|NCT02922283|Interleukin-2|interleukin-2|mesh-list
65023582|NCT02922283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023583|NCT02922283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65023584|NCT02922283|Analgesics|analgesics|mesh-ancestor
65023585|NCT02922283|Sensory System Agents|sensory system agents|mesh-ancestor
65023586|NCT02922283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65023587|NCT02922283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023588|NCT04705454|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
65023614|NCT04689100|Levoleucovorin|levoleucovorin|mesh-list
65023615|NCT04689100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65023616|NCT04689100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023617|NCT04689100|Antimetabolites|antimetabolites|mesh-ancestor
65023618|NCT04689100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023619|NCT04689100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65023620|NCT04689100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023621|NCT04689100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65023622|NCT04689100|Immunologic Factors|immunologic factors|mesh-ancestor
65023623|NCT04689100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65023624|NCT04689100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65023625|NCT04689100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023626|NCT04689100|Antidotes|antidotes|mesh-ancestor
65023627|NCT04689100|Protective Agents|protective agents|mesh-ancestor
65023628|NCT04689100|Vitamin B Complex|vitamin b complex|mesh-ancestor
65023629|NCT04689100|Vitamins|vitamins|mesh-ancestor
65023630|NCT04689100|Micronutrients|micronutrients|mesh-ancestor
65023631|NCT00188136|Fludarabine|fludarabine|mesh-list
65023632|NCT00188136|Melphalan|melphalan|mesh-list
65023633|NCT00188136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023634|NCT00188136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023635|NCT00188136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65023636|NCT00188136|Immunologic Factors|immunologic factors|mesh-ancestor
65023637|NCT00188136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023638|NCT00188136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65023639|NCT00188136|Alkylating Agents|alkylating agents|mesh-ancestor
65023640|NCT00188136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65023641|NCT00406250|Bevacizumab|bevacizumab|mesh-list
65023672|NCT02920801|Saxagliptin|saxagliptin|mesh-list
65023673|NCT02920801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65023674|NCT02920801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023675|NCT02920801|Incretins|incretins|mesh-ancestor
65023676|NCT02920801|Hormones|hormones|mesh-ancestor
65023677|NCT02920801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65023678|NCT02920801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65023679|NCT02920801|Protease Inhibitors|protease inhibitors|mesh-ancestor
65023680|NCT02920801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023681|NCT02920801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023682|NCT00180843|Bromides|bromides|mesh-list
65023683|NCT00180843|Albuterol|albuterol|mesh-list
65023684|NCT00180843|Ipratropium|ipratropium|mesh-list
65023685|NCT00180843|Anticonvulsants|anticonvulsants|mesh-ancestor
65023686|NCT00180843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65023687|NCT00180843|Autonomic Agents|autonomic agents|mesh-ancestor
65023710|NCT00180882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023711|NCT00180882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65023713|NCT00180921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023714|NCT00180921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65023715|NCT00180921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023716|NCT00180921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023717|NCT02920489|Sufentanil|sufentanil|mesh-list
65023718|NCT02920489|Dsuvia|dsuvia|mesh-list
65023719|NCT02920489|Ropivacaine|ropivacaine|mesh-list
65023720|NCT02920489|Anesthetics, Local|anesthetics, local|mesh-ancestor
65023721|NCT02920489|Anesthetics|anesthetics|mesh-ancestor
65023722|NCT02920489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65023723|NCT02920489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023724|NCT02920489|Sensory System Agents|sensory system agents|mesh-ancestor
65023725|NCT02920489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65023726|NCT02920489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65023727|NCT02920489|Narcotics|narcotics|mesh-ancestor
65023728|NCT02920489|Analgesics|analgesics|mesh-ancestor
65023729|NCT02920489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65023730|NCT02920489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65023731|NCT02920489|Anesthetics, General|anesthetics, general|mesh-ancestor
65023732|NCT02920372|Epoetin Alfa|epoetin alfa|mesh-list
65023733|NCT02920372|Hematinics|hematinics|mesh-ancestor
65023734|NCT00154661|Pentoxifylline|pentoxifylline|mesh-list
65023735|NCT00154661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65023736|NCT00154661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023737|NCT00154661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023738|NCT00154661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65023739|NCT00154661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65023771|NCT04688983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023773|NCT02920060|Valproic Acid|valproic acid|mesh-list
65023774|NCT02920060|Anticonvulsants|anticonvulsants|mesh-ancestor
65023775|NCT02920060|Nootropic Agents|nootropic agents|mesh-ancestor
65023776|NCT02920060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023777|NCT02920060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023778|NCT02920060|GABA Agents|gaba agents|mesh-ancestor
65023779|NCT02920060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65023780|NCT02920060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023781|NCT02920060|Antimanic Agents|antimanic agents|mesh-ancestor
65023782|NCT02920060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65023818|NCT00154895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65023819|NCT00181116|Levetiracetam|levetiracetam|mesh-list
65023820|NCT00181116|Anticonvulsants|anticonvulsants|mesh-ancestor
65023821|NCT00181116|Nootropic Agents|nootropic agents|mesh-ancestor
65023822|NCT02918812|Diclofenac|diclofenac|mesh-list
65023823|NCT02918812|Lidocaine|lidocaine|mesh-list
65023824|NCT02918812|Anesthetics, Local|anesthetics, local|mesh-ancestor
65023825|NCT02918812|Anesthetics|anesthetics|mesh-ancestor
65023826|NCT02918812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65023827|NCT02918812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577941|NCT04661514|Psilocybin|psilocybin|mesh-list
65023854|NCT02910076|Antimalarials|antimalarials|mesh-ancestor
65023855|NCT02910076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65023856|NCT02910076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65023857|NCT02910076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65023858|NCT02910076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023859|NCT02910076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023860|NCT02910076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65023861|NCT02910115|Oxytocin|oxytocin|mesh-list
65023862|NCT02910115|Oxytocics|oxytocics|mesh-ancestor
65023863|NCT02910115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65023864|NCT02910115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023865|NCT00188565|Celecoxib|celecoxib|mesh-list
65023866|NCT00188565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65023867|NCT00188565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65023868|NCT00188565|Analgesics|analgesics|mesh-ancestor
65023869|NCT00188565|Sensory System Agents|sensory system agents|mesh-ancestor
65023870|NCT00188565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65023871|NCT00188565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023872|NCT00188565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65023891|NCT02909413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65023892|NCT02909413|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65023893|NCT02909413|Anesthetics, General|anesthetics, general|mesh-ancestor
65023895|NCT02909413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65023896|NCT02909413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023897|NCT02909257|Bupivacaine|bupivacaine|mesh-list
65023898|NCT02909257|Anesthetics, Local|anesthetics, local|mesh-ancestor
65023899|NCT02909257|Anesthetics|anesthetics|mesh-ancestor
65023900|NCT02909257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65023901|NCT02909257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023902|NCT02909257|Sensory System Agents|sensory system agents|mesh-ancestor
65023903|NCT02909257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65023904|NCT02908945|Ketamine|ketamine|mesh-list
65023905|NCT02908945|Analgesics|analgesics|mesh-ancestor
65023906|NCT02908945|Sensory System Agents|sensory system agents|mesh-ancestor
65023907|NCT02908945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65023908|NCT02908945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023909|NCT02908945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65023910|NCT02908945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65023911|NCT02908945|Anesthetics, General|anesthetics, general|mesh-ancestor
65023912|NCT02908945|Anesthetics|anesthetics|mesh-ancestor
65023913|NCT02908945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65023914|NCT02908945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65023915|NCT02908945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65023916|NCT02908945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65023917|NCT02908945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023918|NCT02939833|Ropivacaine|ropivacaine|mesh-list
65023919|NCT02939833|Anesthetics, Local|anesthetics, local|mesh-ancestor
65023920|NCT02939833|Anesthetics|anesthetics|mesh-ancestor
65023921|NCT02939833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65023922|NCT02939833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023923|NCT02939833|Sensory System Agents|sensory system agents|mesh-ancestor
65023924|NCT02939833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65023925|NCT00188604|Selenious Acid|selenious acid|mesh-list
65023926|NCT00188604|Sodium Selenite|sodium selenite|mesh-list
65023953|NCT00188643|Lamotrigine|lamotrigine|mesh-list
65023954|NCT00188643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65023955|NCT00188643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65023956|NCT00188643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65023957|NCT00188643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65023958|NCT00188643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023959|NCT00188643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65023960|NCT00188643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023961|NCT00188643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65023962|NCT00188643|Antidepressive Agents|antidepressive agents|mesh-ancestor
65023963|NCT00188643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65023964|NCT00188643|Anticonvulsants|anticonvulsants|mesh-ancestor
65023965|NCT00188643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65023966|NCT00188643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65023967|NCT00188643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65023968|NCT00188643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65023969|NCT00188643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65023970|NCT00188643|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65023971|NCT00533299|Hydralazine|hydralazine|mesh-list
65023972|NCT00533299|Valproic Acid|valproic acid|mesh-list
65023973|NCT00533299|Anticonvulsants|anticonvulsants|mesh-ancestor
65023974|NCT00533299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304056|NCT02631746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65024009|NCT00181662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024011|NCT00533416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024012|NCT00533416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65024013|NCT00533416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024049|NCT00533533|Mitosis Modulators|mitosis modulators|mesh-ancestor
65024050|NCT00533533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024051|NCT00533611|Niacin|niacin|mesh-list
65024052|NCT00533611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024053|NCT00533611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024067|NCT00155714|Sildenafil Citrate|sildenafil citrate|mesh-list
65024068|NCT00155714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
65024069|NCT00155714|Vasodilator Agents|vasodilator agents|mesh-ancestor
65024070|NCT00155714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65024071|NCT00155714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024072|NCT00155714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024073|NCT00155714|Urological Agents|urological agents|mesh-ancestor
65024074|NCT00181740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65024075|NCT00181740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65024076|NCT00181740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65024077|NCT00181740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65024078|NCT00181740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024079|NCT00181740|Adrenergic Agents|adrenergic agents|mesh-ancestor
65024080|NCT00181740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65024081|NCT00181740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024082|NCT04508023|Rivaroxaban|rivaroxaban|mesh-list
65024083|NCT04508023|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65024084|NCT04508023|Antithrombins|antithrombins|mesh-ancestor
65024085|NCT04508023|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65024086|NCT04508023|Protease Inhibitors|protease inhibitors|mesh-ancestor
65024087|NCT04508023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024088|NCT04508023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024089|NCT04508023|Anticoagulants|anticoagulants|mesh-ancestor
65024090|NCT00181779|Aripiprazole|aripiprazole|mesh-list
65024091|NCT00181779|Antidepressive Agents|antidepressive agents|mesh-ancestor
65024092|NCT00181779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65024093|NCT00181779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65024094|NCT00181779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65024095|NCT00181779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65024096|NCT00181779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024097|NCT00181779|Dopamine Agonists|dopamine agonists|mesh-ancestor
65024098|NCT00181779|Dopamine Agents|dopamine agents|mesh-ancestor
65024099|NCT00181779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65024100|NCT00181779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024101|NCT00181779|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65024102|NCT00181779|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65024103|NCT00181779|Serotonin Agents|serotonin agents|mesh-ancestor
65024104|NCT00181779|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65024105|NCT00181779|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65024106|NCT00181779|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65024107|NCT00181779|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65024108|NCT00533923|Cyclosporine|cyclosporine|mesh-list
65024109|NCT00533923|Cyclophosphamide|cyclophosphamide|mesh-list
65024110|NCT00533923|Fludarabine|fludarabine|mesh-list
65024111|NCT00533923|Alemtuzumab|alemtuzumab|mesh-list
65024112|NCT00533923|Cyclosporins|cyclosporins|mesh-list
65024113|NCT00533923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65024114|NCT00533923|Immunologic Factors|immunologic factors|mesh-ancestor
65024144|NCT00181818|Bupropion|bupropion|mesh-list
65024145|NCT00181818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65024146|NCT00181818|Antidepressive Agents|antidepressive agents|mesh-ancestor
65024147|NCT00181818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65024148|NCT00181818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65024149|NCT00181818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65024150|NCT00181818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65024151|NCT00181818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024152|NCT00181818|Dopamine Agents|dopamine agents|mesh-ancestor
65024153|NCT00181818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65024154|NCT00181818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024155|NCT00181818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65024156|NCT00181818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65024170|NCT00409305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65024171|NCT00409305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024172|NCT00409305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024174|NCT00406679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65024175|NCT00406679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65024176|NCT00406679|Analgesics|analgesics|mesh-ancestor
65024177|NCT00406679|Sensory System Agents|sensory system agents|mesh-ancestor
65024178|NCT00406679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65024179|NCT00406679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024180|NCT00406679|Antipyretics|antipyretics|mesh-ancestor
65024181|NCT00181896|Bupropion|bupropion|mesh-list
65024182|NCT00181896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65024183|NCT00181896|Antidepressive Agents|antidepressive agents|mesh-ancestor
65024184|NCT00181896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65024185|NCT00181896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65024186|NCT00181896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65024187|NCT00181896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65024188|NCT00181896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024189|NCT00181896|Dopamine Agents|dopamine agents|mesh-ancestor
65024190|NCT00181896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65024191|NCT00181896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024192|NCT00181896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65024193|NCT00181896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65024194|NCT00181896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024195|NCT04686448|Fentanyl|fentanyl|mesh-list
65024196|NCT04686448|Ketamine|ketamine|mesh-list
65024197|NCT04686448|Propofol|propofol|mesh-list
65024198|NCT04686448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65024199|NCT04686448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65024200|NCT04686448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024201|NCT04686448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65024202|NCT04686448|Anesthetics, General|anesthetics, general|mesh-ancestor
65024203|NCT04686448|Anesthetics|anesthetics|mesh-ancestor
65024204|NCT04686448|Analgesics|analgesics|mesh-ancestor
65024205|NCT04686448|Sensory System Agents|sensory system agents|mesh-ancestor
65024206|NCT04686448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65024207|NCT04686448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65024208|NCT04686448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65024209|NCT04686448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65024210|NCT04686448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65024211|NCT04686448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024212|NCT04686448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65024213|NCT04686448|Narcotics|narcotics|mesh-ancestor
65024214|NCT04686448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65024216|NCT00181935|Risperidone|risperidone|mesh-list
65024217|NCT00181935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65024218|NCT00181935|Serotonin Agents|serotonin agents|mesh-ancestor
65024219|NCT00181935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65024239|NCT00409383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65024241|NCT00409383|Tubulin Modulators|tubulin modulators|mesh-ancestor
65024242|NCT00409383|Antimitotic Agents|antimitotic agents|mesh-ancestor
65024243|NCT00409383|Mitosis Modulators|mitosis modulators|mesh-ancestor
65024244|NCT00409383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024245|NCT00409383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65024246|NCT00409383|Alkylating Agents|alkylating agents|mesh-ancestor
65024247|NCT04893148|Insulin Glargine|insulin glargine|mesh-list
65024248|NCT04893148|Dulaglutide|dulaglutide|mesh-list
65024249|NCT04893148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65024250|NCT04893148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024252|NCT04883632|Anesthetics, Local|anesthetics, local|mesh-ancestor
65024253|NCT04883632|Anesthetics|anesthetics|mesh-ancestor
65024254|NCT04883632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65024255|NCT04883632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024256|NCT04883632|Sensory System Agents|sensory system agents|mesh-ancestor
65024257|NCT04883632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65024258|NCT04883632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65024259|NCT04883632|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65024260|NCT04883632|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65024261|NCT04883632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65024262|NCT04883632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024263|NCT00181974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65024264|NCT00181974|Hemostatics|hemostatics|mesh-ancestor
65024265|NCT00181974|Coagulants|coagulants|mesh-ancestor
65024266|NCT02569645|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65024267|NCT02569645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65024268|NCT02569645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65024269|NCT02569645|Antimetabolites|antimetabolites|mesh-ancestor
65024270|NCT02569645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024271|NCT02569645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65024272|NCT02569645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65024273|NCT02569645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024274|NCT02500147|Metformin|metformin|mesh-list
65024301|NCT00182052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024302|NCT02115724|Vitamins|vitamins|mesh-list
65024303|NCT02115724|Vitamin E|vitamin e|mesh-list
65024304|NCT02115724|Thioctic Acid|thioctic acid|mesh-list
65024305|NCT02115724|Nitroglycerin|nitroglycerin|mesh-list
65024306|NCT02115724|Antioxidants|antioxidants|mesh-list
65024307|NCT02115724|Micronutrients|micronutrients|mesh-ancestor
65024308|NCT02115724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024309|NCT02115724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024310|NCT02115724|Protective Agents|protective agents|mesh-ancestor
65024311|NCT02115724|Vitamin B Complex|vitamin b complex|mesh-ancestor
65024312|NCT02115724|Vasodilator Agents|vasodilator agents|mesh-ancestor
65024313|NCT02081755|Mycophenolic Acid|mycophenolic acid|mesh-list
65024314|NCT02081755|Everolimus|everolimus|mesh-list
65024315|NCT02081755|Azathioprine|azathioprine|mesh-list
65024316|NCT02081755|Tacrolimus|tacrolimus|mesh-list
65024317|NCT02081755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65024318|NCT02081755|Immunologic Factors|immunologic factors|mesh-ancestor
65024319|NCT02081755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024320|NCT02081755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65024321|NCT02081755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024322|NCT02081755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024323|NCT02081755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024324|NCT02081755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65024347|NCT01413100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65024348|NCT01413100|Alkylating Agents|alkylating agents|mesh-ancestor
65024349|NCT01413100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024350|NCT01413100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024351|NCT01413100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65024352|NCT01413100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65024353|NCT01413100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65024354|NCT01413100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65024355|NCT01413100|Antitubercular Agents|antitubercular agents|mesh-ancestor
65024356|NCT01413100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65024357|NCT01413100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65024358|NCT01413100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024359|NCT01413100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65024360|NCT01413100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65024361|NCT01413100|Antiviral Agents|antiviral agents|mesh-ancestor
65024363|NCT05471479|Antidotes|antidotes|mesh-ancestor
65024364|NCT05471479|Protective Agents|protective agents|mesh-ancestor
65024365|NCT05471479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024366|NCT00188877|Fluorouracil|fluorouracil|mesh-list
65024367|NCT00188877|Antimetabolites|antimetabolites|mesh-ancestor
65024368|NCT00188877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024369|NCT00188877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65024370|NCT00188877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024371|NCT00188877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65024372|NCT00188877|Immunologic Factors|immunologic factors|mesh-ancestor
65024373|NCT00188877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024374|NCT00182169|Hormones|hormones|mesh-list
65024375|NCT00182169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65024376|NCT00182169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024377|NCT05471050|Danazol|danazol|mesh-list
65024378|NCT05471050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65024379|NCT05471050|Hormone Antagonists|hormone antagonists|mesh-ancestor
64304057|NCT02631746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024415|NCT00156299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65024416|NCT00156299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024417|NCT00156299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65024418|NCT00156299|Glucocorticoids|glucocorticoids|mesh-ancestor
65024419|NCT00156299|Hormones|hormones|mesh-ancestor
65024420|NCT00156299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65024452|NCT00536068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65024454|NCT00536068|Sensory System Agents|sensory system agents|mesh-ancestor
65024455|NCT00536068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65024456|NCT00536068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024457|NCT00536068|Antipyretics|antipyretics|mesh-ancestor
65024458|NCT00536068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65024459|NCT00536068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65024460|NCT00536068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65024461|NCT00536068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65024462|NCT00536068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024463|NCT00536068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024464|NCT00536068|Gout Suppressants|gout suppressants|mesh-ancestor
65024499|NCT05469529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65024500|NCT05469529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65024517|NCT00189072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024519|NCT00189072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65024520|NCT00189072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65024521|NCT00189072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65024522|NCT00189072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65024523|NCT00189072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65024524|NCT00189072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65024525|NCT00189072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65024526|NCT00189072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024527|NCT00189072|Antimanic Agents|antimanic agents|mesh-ancestor
65024528|NCT00156611|Abciximab|abciximab|mesh-list
65024529|NCT00156611|Anticoagulants|anticoagulants|mesh-ancestor
65024530|NCT00156611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65024531|NCT00156650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65024532|NCT00156650|Medroxyprogesterone|medroxyprogesterone|mesh-list
65024533|NCT00156650|Testosterone|testosterone|mesh-list
65024534|NCT00156650|Acyline|acyline|mesh-list
65024535|NCT00156650|Androgens|androgens|mesh-ancestor
65024536|NCT00156650|Hormones|hormones|mesh-ancestor
65024537|NCT00156650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65024538|NCT00156650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024539|NCT00156650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65024540|NCT00156650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024541|NCT00156650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65024542|NCT00156650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65024543|NCT00156650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65024544|NCT00156650|Contraceptive Agents|contraceptive agents|mesh-ancestor
65024545|NCT00156650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65024546|NCT00156650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65024547|NCT00156650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65024548|NCT00156650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65024549|NCT00156650|Hormone Antagonists|hormone antagonists|mesh-ancestor
65024550|NCT00536419|Methylphenidate|methylphenidate|mesh-list
65024551|NCT00536419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65024552|NCT00536419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024553|NCT00536419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65024554|NCT00536419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65024555|NCT00536419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65024556|NCT00536419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024557|NCT00536419|Dopamine Agents|dopamine agents|mesh-ancestor
64304058|NCT04699058|Antibodies|antibodies|mesh-list
65024607|NCT00182364|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65024608|NCT00182364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024609|NCT00536653|Calcium, Dietary|calcium, dietary|mesh-list
65024611|NCT00536653|Ergocalciferols|ergocalciferols|mesh-list
65024612|NCT00536653|Cholecalciferol|cholecalciferol|mesh-list
65024613|NCT00536653|Vitamins|vitamins|mesh-list
65024614|NCT00536653|Goserelin|goserelin|mesh-list
65024615|NCT00536653|Bicalutamide|bicalutamide|mesh-list
65024616|NCT00536653|Calcium|calcium|mesh-list
65024617|NCT00536653|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65024618|NCT00536653|Micronutrients|micronutrients|mesh-ancestor
65024619|NCT00536653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024620|NCT00536653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65024621|NCT00536653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65024622|NCT00536653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65024623|NCT00536653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024624|NCT00536653|Androgen Antagonists|androgen antagonists|mesh-ancestor
65024625|NCT00536653|Hormone Antagonists|hormone antagonists|mesh-ancestor
65024626|NCT00536653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64465924|NCT02608216|Paclitaxel|paclitaxel|mesh-list
65024628|NCT05467852|Dydrogesterone|dydrogesterone|mesh-list
65024629|NCT05467852|Progestins|progestins|mesh-ancestor
65024630|NCT05467852|Hormones|hormones|mesh-ancestor
65024631|NCT05467852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65024632|NCT05467852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024633|NCT00536692|Mecamylamine|mecamylamine|mesh-list
65024634|NCT00536692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65024635|NCT00536692|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
65024636|NCT00536692|Autonomic Agents|autonomic agents|mesh-ancestor
65024637|NCT00536692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65024638|NCT00536692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024639|NCT00536692|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65024640|NCT00536692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65024641|NCT00536692|Cholinergic Agents|cholinergic agents|mesh-ancestor
65024642|NCT00536692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65024643|NCT00536692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024644|NCT00189345|Catumaxomab|catumaxomab|mesh-list
65024645|NCT00189345|Muromonab-CD3|muromonab-cd3|mesh-list
65024646|NCT00189345|Immunologic Factors|immunologic factors|mesh-ancestor
65024647|NCT00189345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024648|NCT00189345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65024649|NCT00189345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65024650|NCT00156884|Cisplatin|cisplatin|mesh-list
65024651|NCT00156884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024652|NCT05464693|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65024653|NCT05464693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65024654|NCT00156962|Epoetin Alfa|epoetin alfa|mesh-list
65024655|NCT00156962|Hematinics|hematinics|mesh-ancestor
65024656|NCT00182442|Olanzapine|olanzapine|mesh-list
65024657|NCT00182442|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65024658|NCT00182442|Antiemetics|antiemetics|mesh-ancestor
65024659|NCT00182442|Autonomic Agents|autonomic agents|mesh-ancestor
65024691|NCT00536770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65024692|NCT00536770|Vitamins|vitamins|mesh-ancestor
65024693|NCT00536770|Micronutrients|micronutrients|mesh-ancestor
65024694|NCT00536770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65024695|NCT04685512|Tenofovir|tenofovir|mesh-list
65024696|NCT04685512|Emtricitabine|emtricitabine|mesh-list
65024697|NCT04685512|Antiviral Agents|antiviral agents|mesh-ancestor
65024698|NCT04685512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65024699|NCT04685512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65024700|NCT04685512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65024718|NCT00189384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024719|NCT00189384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024720|NCT00189384|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65024722|NCT00189384|Antimalarials|antimalarials|mesh-ancestor
65024723|NCT00189384|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65024724|NCT00189384|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65024725|NCT00189384|Anesthetics, Local|anesthetics, local|mesh-ancestor
65024726|NCT00189384|Anesthetics|anesthetics|mesh-ancestor
65024727|NCT00189384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65024728|NCT00189384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024729|NCT00189384|Sensory System Agents|sensory system agents|mesh-ancestor
65024730|NCT00189384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65024731|NCT00536848|Metronidazole|metronidazole|mesh-list
65024732|NCT00536848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65024733|NCT00536848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65024734|NCT00536848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65024735|NCT00536848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65024736|NCT00157079|Immunoglobulins|immunoglobulins|mesh-list
65024737|NCT00157079|Antibodies|antibodies|mesh-list
65024738|NCT00157079|gamma-Globulins|gamma-globulins|mesh-list
65024739|NCT00157079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65024740|NCT00157079|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65024741|NCT00157079|Immunologic Factors|immunologic factors|mesh-ancestor
65024742|NCT00157079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024743|NCT00189501|Cinacalcet|cinacalcet|mesh-list
65024744|NCT00189501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65493847|NCT04233866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65024745|NCT00189501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024746|NCT00189501|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65024747|NCT00189501|Hormone Antagonists|hormone antagonists|mesh-ancestor
65024748|NCT00189501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65024749|NCT00157118|Protein C|protein c|mesh-list
65024750|NCT00157118|Anticoagulants|anticoagulants|mesh-ancestor
65024751|NCT00157118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65024752|NCT00157118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65024753|NCT00157118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024754|NCT00189579|Trastuzumab|trastuzumab|mesh-list
65024755|NCT00189579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65024756|NCT00189579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024757|NCT00157235|Bromides|bromides|mesh-list
65024758|NCT00157235|Tiotropium Bromide|tiotropium bromide|mesh-list
64304059|NCT04699058|Immunologic Factors|immunologic factors|mesh-ancestor
65024793|NCT00182559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024794|NCT00182559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65024795|NCT00182559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024796|NCT00182559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024797|NCT00182559|Antifungal Agents|antifungal agents|mesh-ancestor
65024798|NCT00182559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64578919|NCT01702233|Hormones|hormones|mesh-ancestor
65024834|NCT00189618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024869|NCT00534508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024870|NCT00534508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024871|NCT00182715|Leucovorin|leucovorin|mesh-list
65024872|NCT00182715|Fluorouracil|fluorouracil|mesh-list
65024873|NCT00182715|Capecitabine|capecitabine|mesh-list
65024874|NCT00182715|Oxaliplatin|oxaliplatin|mesh-list
65024875|NCT00182715|Cetuximab|cetuximab|mesh-list
65024876|NCT00182715|Calcium|calcium|mesh-list
65024877|NCT00182715|Levoleucovorin|levoleucovorin|mesh-list
65024878|NCT00182715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65024879|NCT00182715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024880|NCT00182715|Antimetabolites|antimetabolites|mesh-ancestor
64579003|NCT04329624|Simendan|simendan|mesh-list
65024950|NCT04106830|Antitubercular Agents|antitubercular agents|mesh-ancestor
65024951|NCT04106830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65024952|NCT04106830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65024953|NCT04106830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579077|NCT00476190|Asparaginase|asparaginase|mesh-list
65024985|NCT00406952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024986|NCT04090879|Nicotine|nicotine|mesh-list
65024987|NCT04090879|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65024988|NCT04090879|Autonomic Agents|autonomic agents|mesh-ancestor
65024989|NCT04090879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65024990|NCT04090879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024991|NCT04090879|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65024992|NCT04090879|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65024993|NCT04090879|Cholinergic Agents|cholinergic agents|mesh-ancestor
65025026|NCT04061161|Autonomic Agents|autonomic agents|mesh-ancestor
65025027|NCT04061161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65025028|NCT04061161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025029|NCT04061161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65025030|NCT04061161|Respiratory System Agents|respiratory system agents|mesh-ancestor
65025031|NCT04061161|Parasympatholytics|parasympatholytics|mesh-ancestor
65025032|NCT04061161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65025033|NCT04061161|Cholinergic Agents|cholinergic agents|mesh-ancestor
65025058|NCT04686643|Valsartan|valsartan|mesh-list
65025059|NCT04686643|Indapamide|indapamide|mesh-list
65025060|NCT04686643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65025061|NCT04686643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65025062|NCT04686643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65025063|NCT04686643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025064|NCT04686643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65025065|NCT04686643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025066|NCT04686643|Vasodilator Agents|vasodilator agents|mesh-ancestor
65025067|NCT04686643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65025068|NCT04686643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65025069|NCT04686643|Diuretics|diuretics|mesh-ancestor
65025070|NCT04686643|Natriuretic Agents|natriuretic agents|mesh-ancestor
65025071|NCT04686643|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65025072|NCT04686643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65025073|NCT04686643|Antimetabolites|antimetabolites|mesh-ancestor
65025074|NCT04686643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65025075|NCT04686643|Vitamin B Complex|vitamin b complex|mesh-ancestor
65025076|NCT04686643|Vitamins|vitamins|mesh-ancestor
65025077|NCT04686643|Micronutrients|micronutrients|mesh-ancestor
65025078|NCT00534898|Fenretinide|fenretinide|mesh-list
65025079|NCT00534898|Bexarotene|bexarotene|mesh-list
65025080|NCT00534898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025081|NCT00534898|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65025082|NCT00534898|Protective Agents|protective agents|mesh-ancestor
65025152|NCT00158093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65025153|NCT00158093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65025154|NCT00158093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65025155|NCT00158093|Adrenergic Agents|adrenergic agents|mesh-ancestor
65025156|NCT00158093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65025157|NCT00158093|Vasodilator Agents|vasodilator agents|mesh-ancestor
65025158|NCT00158093|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65025159|NCT00158093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65025160|NCT00158093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65025161|NCT03429946|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64579274|NCT00115297|Hormone Antagonists|hormone antagonists|mesh-ancestor
65025180|NCT00158132|Vasodilator Agents|vasodilator agents|mesh-ancestor
65025181|NCT00158132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65025182|NCT00158132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65025183|NCT00158132|Antiviral Agents|antiviral agents|mesh-ancestor
65025184|NCT00158132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65025185|NCT00158132|Dopamine Agents|dopamine agents|mesh-ancestor
65025186|NCT00158132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65025187|NCT00158132|Analgesics|analgesics|mesh-ancestor
65025188|NCT00158132|Sensory System Agents|sensory system agents|mesh-ancestor
65025189|NCT00158132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65025191|NCT00158171|Nicotine|nicotine|mesh-list
65025192|NCT00158171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65025193|NCT00158171|Autonomic Agents|autonomic agents|mesh-ancestor
65025194|NCT00158171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65025195|NCT00158171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025196|NCT00158171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65025197|NCT00158171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64808234|NCT01432249|Etanercept|etanercept|mesh-list
65025198|NCT00158171|Cholinergic Agents|cholinergic agents|mesh-ancestor
65025199|NCT00158171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65025200|NCT00158171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025201|NCT00158171|Hematinics|hematinics|mesh-ancestor
65025202|NCT00158171|Vitamin B Complex|vitamin b complex|mesh-ancestor
65025203|NCT00158171|Vitamins|vitamins|mesh-ancestor
65025204|NCT00158171|Micronutrients|micronutrients|mesh-ancestor
65025205|NCT03370783|Ethanol|ethanol|mesh-list
65025206|NCT03370783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65025207|NCT03370783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65025208|NCT03370783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65025209|NCT03370783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025210|NCT00158210|Rivastigmine|rivastigmine|mesh-list
65025211|NCT00158210|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65025212|NCT00158210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025213|NCT00158210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025214|NCT00158210|Cholinergic Agents|cholinergic agents|mesh-ancestor
65025215|NCT00158210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65025216|NCT00158210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025217|NCT00158210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65025218|NCT00158210|Protective Agents|protective agents|mesh-ancestor
65025219|NCT03358693|Infliximab|infliximab|mesh-list
65025317|NCT00158561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025318|NCT00158561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65025319|NCT00158561|Renal Agents|renal agents|mesh-ancestor
65025320|NCT00158561|Leprostatic Agents|leprostatic agents|mesh-ancestor
65025321|NCT00158561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65025322|NCT05169229|Vancomycin|vancomycin|mesh-list
65025323|NCT05169229|Tobramycin|tobramycin|mesh-list
65025324|NCT05169229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65025325|NCT05169229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65025326|NCT00538018|Telithromycin|telithromycin|mesh-list
65025327|NCT00538018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65025328|NCT00538018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65025329|NCT00538096|Blinatumomab|blinatumomab|mesh-list
65025330|NCT00538096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025331|NCT00158678|Cisplatin|cisplatin|mesh-list
65025332|NCT00158678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025333|NCT00538174|Dapagliflozin|dapagliflozin|mesh-list
65025334|NCT00538174|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65025335|NCT00538174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025357|NCT00538330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65025359|NCT00538330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65025360|NCT00538330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025361|NCT00538330|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65025362|NCT00538330|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65025363|NCT00538330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65025364|NCT00158717|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65025365|NCT00158717|Antiviral Agents|antiviral agents|mesh-ancestor
65025366|NCT00158717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65025367|NCT00158717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65025368|NCT00158717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65025369|NCT00158717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025370|NCT00158717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025371|NCT00538486|Metformin|metformin|mesh-list
65025372|NCT00538486|Amlodipine|amlodipine|mesh-list
65025373|NCT00538486|Telmisartan|telmisartan|mesh-list
65025374|NCT00538486|Candesartan|candesartan|mesh-list
65025375|NCT00538486|Candesartan cilexetil|candesartan cilexetil|mesh-list
65025376|NCT00538486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65025377|NCT00538486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025378|NCT00538486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65025379|NCT00538486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65025380|NCT00538486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65025381|NCT00538486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025382|NCT00538486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65025383|NCT00538486|Vasodilator Agents|vasodilator agents|mesh-ancestor
65025384|NCT00538486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65025385|NCT00538486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65025386|NCT00538525|Docetaxel|docetaxel|mesh-list
65025420|NCT00158834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65025421|NCT00158834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65025422|NCT00158834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65025423|NCT00158834|Autonomic Agents|autonomic agents|mesh-ancestor
65025424|NCT00158834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65025425|NCT00158834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025426|NCT00158834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65025427|NCT00158834|Respiratory System Agents|respiratory system agents|mesh-ancestor
65025428|NCT00158834|Dermatologic Agents|dermatologic agents|mesh-ancestor
65025429|NCT00158834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64579536|NCT00073073|Vitamin D|vitamin d|mesh-list
65025457|NCT00158873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65025458|NCT00158873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65025459|NCT00158873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025460|NCT00158873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65025461|NCT00158873|Anesthetics, General|anesthetics, general|mesh-ancestor
65025462|NCT00158873|Anesthetics|anesthetics|mesh-ancestor
65025463|NCT00158873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65025464|NCT00158873|Narcotics|narcotics|mesh-ancestor
65025465|NCT00158873|Analgesics|analgesics|mesh-ancestor
65025466|NCT00158873|Sensory System Agents|sensory system agents|mesh-ancestor
65025467|NCT00158873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65025468|NCT00158873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65025469|NCT00158873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65025470|NCT00158873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65025471|NCT00158873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65025472|NCT00158873|GABA Modulators|gaba modulators|mesh-ancestor
65025473|NCT00158873|GABA Agents|gaba agents|mesh-ancestor
65025474|NCT00158873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65025475|NCT00158873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025476|NCT00158873|Anticonvulsants|anticonvulsants|mesh-ancestor
65025477|NCT00158873|Antiemetics|antiemetics|mesh-ancestor
65025478|NCT00158873|Autonomic Agents|autonomic agents|mesh-ancestor
65025479|NCT00158873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65025481|NCT00537121|Fluorouracil|fluorouracil|mesh-list
65025515|NCT00406991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025517|NCT00406991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65025518|NCT00406991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025519|NCT00406991|Antipyretics|antipyretics|mesh-ancestor
65025520|NCT00406991|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65025521|NCT00406991|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65025522|NCT00406991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65025523|NCT00406991|Purinergic Agents|purinergic agents|mesh-ancestor
65025592|NCT00537550|Antimitotic Agents|antimitotic agents|mesh-ancestor
65025593|NCT00537550|Mitosis Modulators|mitosis modulators|mesh-ancestor
65025594|NCT00537550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65025624|NCT00539071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025625|NCT00539071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025626|NCT00539071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65025627|NCT00539071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65025628|NCT00539071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65025629|NCT00539071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65025630|NCT00539071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65025631|NCT00539071|Dopamine Agents|dopamine agents|mesh-ancestor
65025632|NCT00539149|Amoxicillin|amoxicillin|mesh-list
65025633|NCT00539149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65025634|NCT00539149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65025635|NCT00183807|Celecoxib|celecoxib|mesh-list
65025636|NCT00183807|Irinotecan|irinotecan|mesh-list
65025670|NCT00539890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65025671|NCT00539890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025673|NCT00539968|Lonafarnib|lonafarnib|mesh-list
65025674|NCT00539968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025675|NCT00539968|Tubulin Modulators|tubulin modulators|mesh-ancestor
65025711|NCT00183885|Alkylating Agents|alkylating agents|mesh-ancestor
65025712|NCT00183885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025713|NCT00183885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65025714|NCT00183885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025715|NCT00540241|Pemetrexed|pemetrexed|mesh-list
65025744|NCT00540280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025747|NCT00183924|Estramustine|estramustine|mesh-list
65025748|NCT00183924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025749|NCT00183924|Tubulin Modulators|tubulin modulators|mesh-ancestor
65025750|NCT00183924|Antimitotic Agents|antimitotic agents|mesh-ancestor
65025751|NCT00183924|Mitosis Modulators|mitosis modulators|mesh-ancestor
65025752|NCT00183924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025753|NCT00183924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65025754|NCT00183924|Alkylating Agents|alkylating agents|mesh-ancestor
65025755|NCT00183924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65025756|NCT00159302|Nitric Oxide|nitric oxide|mesh-list
65025757|NCT00159302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65025758|NCT00159302|Autonomic Agents|autonomic agents|mesh-ancestor
65025759|NCT00159302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65025760|NCT00159302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579886|NCT01691313|Vanoxerine|vanoxerine|mesh-list
65025858|NCT00541021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025859|NCT00541021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65025860|NCT00541138|Tamoxifen|tamoxifen|mesh-list
65025861|NCT00541138|Carboplatin|carboplatin|mesh-list
65025862|NCT00541138|Topotecan|topotecan|mesh-list
65025863|NCT00541138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025864|NCT00541138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025865|NCT00541138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65025866|NCT00541138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65025867|NCT00541138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025868|NCT00541138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65025883|NCT00541177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025884|NCT00541177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65025885|NCT00541177|Respiratory System Agents|respiratory system agents|mesh-ancestor
65025887|NCT00541177|Parasympatholytics|parasympatholytics|mesh-ancestor
65025888|NCT00541177|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65025889|NCT00541177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65025890|NCT00541177|Cholinergic Agents|cholinergic agents|mesh-ancestor
65025891|NCT00541177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65025892|NCT00541177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025894|NCT00541216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65025895|NCT00541216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025896|NCT00541216|Sympathomimetics|sympathomimetics|mesh-ancestor
65025897|NCT00541216|Autonomic Agents|autonomic agents|mesh-ancestor
65025898|NCT00541216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65025899|NCT00541216|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65025900|NCT00541216|Adrenergic Agents|adrenergic agents|mesh-ancestor
65025901|NCT00541216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65025902|NCT00541216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025903|NCT00541333|Glatiramer Acetate|glatiramer acetate|mesh-list
65025904|NCT00541333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65025905|NCT00541333|Immunologic Factors|immunologic factors|mesh-ancestor
65025906|NCT00541333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025907|NCT00541333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65025908|NCT00541333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65025909|NCT00541372|Insulin|insulin|mesh-list
65025910|NCT00541372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65025911|NCT00541372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481643|NCT00717574|Propofol|propofol|mesh-list
65025912|NCT00159536|Metformin|metformin|mesh-list
65025913|NCT00159536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65025914|NCT00159536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025915|NCT00541411|Dactinomycin|dactinomycin|mesh-list
65025916|NCT00541411|Vincristine|vincristine|mesh-list
65025917|NCT00541411|Ifosfamide|ifosfamide|mesh-list
65025918|NCT00541411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65025919|NCT00541411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025920|NCT00541411|Tubulin Modulators|tubulin modulators|mesh-ancestor
65025921|NCT00541411|Antimitotic Agents|antimitotic agents|mesh-ancestor
65025922|NCT00541411|Mitosis Modulators|mitosis modulators|mesh-ancestor
65025923|NCT00541411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025924|NCT00541411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65025925|NCT00541411|Alkylating Agents|alkylating agents|mesh-ancestor
65025926|NCT00541411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65025927|NCT00541411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65025959|NCT00541567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65025961|NCT00408798|Botulinum Toxins|botulinum toxins|mesh-list
65025962|NCT00408798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65025963|NCT00408798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65025964|NCT00408798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65025965|NCT00408798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64580092|NCT00243061|Cediranib|cediranib|mesh-list
65025999|NCT00159653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65026000|NCT00159653|Adrenergic Agents|adrenergic agents|mesh-ancestor
65026001|NCT00159653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026002|NCT00159653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026003|NCT00159653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026036|NCT00542074|Dermatologic Agents|dermatologic agents|mesh-ancestor
65026037|NCT00542074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65026038|NCT00542074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65026039|NCT00542074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65026040|NCT00542074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026041|NCT00542152|Cyclosporine|cyclosporine|mesh-list
65026042|NCT00542152|Infliximab|infliximab|mesh-list
65026043|NCT00542152|Cyclosporins|cyclosporins|mesh-list
65026044|NCT00542152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026045|NCT00542152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026046|NCT00542152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65026047|NCT00542152|Immunologic Factors|immunologic factors|mesh-ancestor
64580157|NCT00145249|Fluconazole|fluconazole|mesh-list
65026084|NCT00542347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026115|NCT00159770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65026117|NCT00159770|Antidepressive Agents|antidepressive agents|mesh-ancestor
65026118|NCT00190593|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65026119|NCT00190593|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65026120|NCT00190593|Hormone Antagonists|hormone antagonists|mesh-ancestor
65026121|NCT00190593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65026122|NCT00190593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026123|NCT00190593|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65026124|NCT00190593|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65026125|NCT00190593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65026161|NCT00184041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65026162|NCT00184041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65026163|NCT00184041|Alkylating Agents|alkylating agents|mesh-ancestor
65026164|NCT00184041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65026165|NCT00184041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65026166|NCT00184041|Tubulin Modulators|tubulin modulators|mesh-ancestor
65026167|NCT00184041|Antimitotic Agents|antimitotic agents|mesh-ancestor
65026168|NCT00184041|Mitosis Modulators|mitosis modulators|mesh-ancestor
65026198|NCT00190632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026199|NCT00190632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026200|NCT00190632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026201|NCT00190632|Analgesics|analgesics|mesh-ancestor
65026202|NCT00190632|Sensory System Agents|sensory system agents|mesh-ancestor
65026203|NCT00190632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65026204|NCT00190632|Antidepressive Agents|antidepressive agents|mesh-ancestor
65026205|NCT00190632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65026206|NCT00190632|Dopamine Agents|dopamine agents|mesh-ancestor
65026207|NCT00543166|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65026208|NCT00543166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65026209|NCT00543166|Immunologic Factors|immunologic factors|mesh-ancestor
65026238|NCT00190710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65026240|NCT00190710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65026241|NCT00190710|Immunologic Factors|immunologic factors|mesh-ancestor
65026242|NCT00190710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026243|NCT03456661|Dexmedetomidine|dexmedetomidine|mesh-list
65026244|NCT03456661|Levobupivacaine|levobupivacaine|mesh-list
65026245|NCT03456661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65026246|NCT03456661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65026247|NCT03456661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026248|NCT03456661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65026249|NCT03456661|Analgesics|analgesics|mesh-ancestor
65026250|NCT03456661|Sensory System Agents|sensory system agents|mesh-ancestor
65026251|NCT03456661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65026252|NCT03456661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65026253|NCT03456661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64580372|NCT00100841|Leucovorin|leucovorin|mesh-list
65026286|NCT00543634|Hormones|hormones|mesh-ancestor
65026287|NCT00543634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65026288|NCT00184197|Botulinum Toxins|botulinum toxins|mesh-list
65026289|NCT00184197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65026290|NCT00184197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65026291|NCT00184197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026292|NCT00184197|Cholinergic Agents|cholinergic agents|mesh-ancestor
65026319|NCT00190827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65026320|NCT00190827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026321|NCT00190827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026322|NCT00190827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026323|NCT00190827|Analgesics|analgesics|mesh-ancestor
65026324|NCT00190827|Sensory System Agents|sensory system agents|mesh-ancestor
65026325|NCT00190827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65026326|NCT00190827|Antidepressive Agents|antidepressive agents|mesh-ancestor
65026327|NCT00190827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65026328|NCT00190827|Dopamine Agents|dopamine agents|mesh-ancestor
65026329|NCT00160043|Vatalanib|vatalanib|mesh-list
65026330|NCT00160043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65026331|NCT00160043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026332|NCT00160043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026333|NCT00544063|Oxaliplatin|oxaliplatin|mesh-list
65026334|NCT00544063|Irinotecan|irinotecan|mesh-list
65026335|NCT00544063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026336|NCT00544063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65026337|NCT00544063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65026367|NCT00544219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65026368|NCT00544219|Glucocorticoids|glucocorticoids|mesh-ancestor
65026369|NCT00544219|Hormones|hormones|mesh-ancestor
65026370|NCT00544219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65026371|NCT00544219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65026372|NCT00544219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65026373|NCT00544219|Tubulin Modulators|tubulin modulators|mesh-ancestor
65026374|NCT00544219|Antimitotic Agents|antimitotic agents|mesh-ancestor
65026375|NCT00544219|Mitosis Modulators|mitosis modulators|mesh-ancestor
65026376|NCT00190866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65026377|NCT00190866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65026378|NCT00190866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64580494|NCT00258817|Vaccines|vaccines|mesh-list
65026399|NCT00544570|Immunologic Factors|immunologic factors|mesh-ancestor
65026400|NCT00544570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026401|NCT00544570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65026402|NCT00544570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65026403|NCT00544570|Alkylating Agents|alkylating agents|mesh-ancestor
65026404|NCT00544570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026405|NCT00544570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026406|NCT00544570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65026407|NCT00544570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65026408|NCT00544570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65026409|NCT00544570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65026410|NCT00544570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026411|NCT00190905|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65026412|NCT00190905|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65026413|NCT00190905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65026414|NCT00190905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65026415|NCT00190905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026416|NCT00190905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026417|NCT00190905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026418|NCT00190905|Analgesics|analgesics|mesh-ancestor
65026419|NCT00190905|Sensory System Agents|sensory system agents|mesh-ancestor
65026420|NCT00190905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65026421|NCT00190905|Antidepressive Agents|antidepressive agents|mesh-ancestor
65026422|NCT00190905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65026423|NCT00190905|Dopamine Agents|dopamine agents|mesh-ancestor
65026424|NCT00544609|Sorafenib|sorafenib|mesh-list
65026425|NCT00544609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026426|NCT00544609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65026427|NCT00544609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026428|NCT00544609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026429|NCT00544687|Mometasone Furoate|mometasone furoate|mesh-list
65026430|NCT00544687|Nortriptyline|nortriptyline|mesh-list
65026431|NCT00544687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65026432|NCT00544687|Dermatologic Agents|dermatologic agents|mesh-ancestor
65026506|NCT03456466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65026566|NCT00545467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65026567|NCT00545467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65026568|NCT00545467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65026569|NCT00545467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026570|NCT00545467|Dopamine Agonists|dopamine agonists|mesh-ancestor
65026571|NCT00545467|Dopamine Agents|dopamine agents|mesh-ancestor
65026572|NCT00545467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026573|NCT00545467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026574|NCT00545467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65026575|NCT00545467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65026576|NCT00545467|Serotonin Agents|serotonin agents|mesh-ancestor
64467898|NCT00062764|Pioglitazone|pioglitazone|mesh-list
65026577|NCT00545467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64808852|NCT01436188|Ibuprofen|ibuprofen|mesh-list
65026578|NCT00545467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65026579|NCT00545467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65026580|NCT00545467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65026581|NCT00545857|Pioglitazone|pioglitazone|mesh-list
65026582|NCT00545857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65026583|NCT00545857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026616|NCT00160589|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65026617|NCT00160589|Histamine Antagonists|histamine antagonists|mesh-ancestor
65026619|NCT00160589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026620|NCT00160589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026621|NCT00160589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026622|NCT00546130|polysaccharide-K|polysaccharide-k|mesh-list
65026623|NCT00546130|Cisplatin|cisplatin|mesh-list
65026624|NCT00546130|Irinotecan|irinotecan|mesh-list
65026625|NCT00546130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026626|NCT00546130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65026627|NCT00546130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65026628|NCT00546130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026664|NCT00546286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026665|NCT00546286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65026666|NCT00546286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65026667|NCT00546286|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65026669|NCT00546325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65026670|NCT00546325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
64580810|NCT04734210|Hormones|hormones|mesh-ancestor
65026695|NCT00191256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026696|NCT00191256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65026697|NCT00191256|Antimetabolites|antimetabolites|mesh-ancestor
65026698|NCT00191256|Antiviral Agents|antiviral agents|mesh-ancestor
65026699|NCT00191256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65026700|NCT00191256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026701|NCT00191256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65026702|NCT00191256|Immunologic Factors|immunologic factors|mesh-ancestor
65026703|NCT00191256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026704|NCT00546520|Ciclesonide|ciclesonide|mesh-list
65026705|NCT00546520|Glucocorticoids|glucocorticoids|mesh-ancestor
65026707|NCT00546520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65026708|NCT00546520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026709|NCT00546520|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65026710|NCT00546559|Simvastatin|simvastatin|mesh-list
65026711|NCT00546559|Pravastatin|pravastatin|mesh-list
65026712|NCT00546559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65026713|NCT00546559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65026714|NCT00546559|Antimetabolites|antimetabolites|mesh-ancestor
65026715|NCT00546559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026716|NCT00546559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65026717|NCT00546559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65026718|NCT00546559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026719|NCT00160745|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65026738|NCT00546832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65026739|NCT00546832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65026740|NCT00546832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65026741|NCT00546832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65026742|NCT00546832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026743|NCT00546832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026744|NCT00184587|Candesartan|candesartan|mesh-list
65026745|NCT00184587|Candesartan cilexetil|candesartan cilexetil|mesh-list
65026746|NCT00184587|Angiotensin II|angiotensin ii|mesh-list
65026747|NCT00184587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65026748|NCT00184587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65026749|NCT00184587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65026750|NCT00184587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026751|NCT00184587|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65026752|NCT00547144|Gemcitabine|gemcitabine|mesh-list
65026753|NCT00547144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65026754|NCT00547144|Antimetabolites|antimetabolites|mesh-ancestor
65026755|NCT00547144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026756|NCT00547144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026757|NCT00547144|Antiviral Agents|antiviral agents|mesh-ancestor
65026758|NCT00547144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65026759|NCT00547144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026760|NCT00547144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65026761|NCT00547144|Immunologic Factors|immunologic factors|mesh-ancestor
65026762|NCT00547144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026763|NCT00547183|Tadalafil|tadalafil|mesh-list
65026764|NCT00547183|Vasodilator Agents|vasodilator agents|mesh-ancestor
65026765|NCT00547183|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65026766|NCT00547183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65493851|NCT04233866|Vitamins|vitamins|mesh-ancestor
65026767|NCT00547183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026768|NCT00547183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026769|NCT00547183|Urological Agents|urological agents|mesh-ancestor
65026770|NCT00184626|Insulin|insulin|mesh-list
65026771|NCT00184626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65026772|NCT00184626|Metformin|metformin|mesh-list
65026773|NCT00184626|Insulin Glargine|insulin glargine|mesh-list
65026774|NCT00184626|Insulin Aspart|insulin aspart|mesh-list
65026775|NCT00184626|Biphasic Insulins|biphasic insulins|mesh-list
65026794|NCT00547495|Vasodilator Agents|vasodilator agents|mesh-ancestor
65026795|NCT00547495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65026796|NCT00547495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65026797|NCT00547495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026798|NCT00547495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026799|NCT00547495|Urological Agents|urological agents|mesh-ancestor
65026800|NCT02277223|Curcumin|curcumin|mesh-list
65026801|NCT02277223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65026802|NCT02277223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65026803|NCT02277223|Analgesics|analgesics|mesh-ancestor
65026804|NCT02277223|Sensory System Agents|sensory system agents|mesh-ancestor
65026805|NCT02277223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65026806|NCT02277223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026807|NCT02277223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65026808|NCT02277223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65026809|NCT02277223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026810|NCT02277223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026811|NCT02277223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026812|NCT00547573|Tadalafil|tadalafil|mesh-list
65026813|NCT00547573|Vasodilator Agents|vasodilator agents|mesh-ancestor
65026814|NCT00547573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65026815|NCT00547573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65026816|NCT00547573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026817|NCT00547573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026818|NCT00547573|Urological Agents|urological agents|mesh-ancestor
65026819|NCT00191373|Gemcitabine|gemcitabine|mesh-list
65026820|NCT00191373|Trastuzumab|trastuzumab|mesh-list
65026821|NCT00191373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65026822|NCT00191373|Antimetabolites|antimetabolites|mesh-ancestor
65026823|NCT00191373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026824|NCT00191373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026825|NCT00191373|Antiviral Agents|antiviral agents|mesh-ancestor
65026826|NCT00191373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65026827|NCT00191373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026828|NCT00191373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65026829|NCT00191373|Immunologic Factors|immunologic factors|mesh-ancestor
65026885|NCT00161018|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65026886|NCT00161018|Fluphenazine|fluphenazine|mesh-list
65026887|NCT00161018|Fluphenazine depot|fluphenazine depot|mesh-list
65026888|NCT00161018|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
65026889|NCT00161018|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65026890|NCT00161018|Serotonin Agents|serotonin agents|mesh-ancestor
65026891|NCT00161018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026892|NCT00161018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026893|NCT00161018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026894|NCT00161018|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65026923|NCT00191490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026924|NCT00191490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65026925|NCT00191490|Antimetabolites|antimetabolites|mesh-ancestor
65026926|NCT00191490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026927|NCT00191490|Antiviral Agents|antiviral agents|mesh-ancestor
65026928|NCT00191490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65026929|NCT00191490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026930|NCT00191490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65026931|NCT00191490|Immunologic Factors|immunologic factors|mesh-ancestor
65026932|NCT00191490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026933|NCT00191490|Tubulin Modulators|tubulin modulators|mesh-ancestor
65026934|NCT00191490|Antimitotic Agents|antimitotic agents|mesh-ancestor
65026935|NCT00191490|Mitosis Modulators|mitosis modulators|mesh-ancestor
65026936|NCT00548080|Caspofungin|caspofungin|mesh-list
64407455|NCT03039491|Vaccines|vaccines|mesh-list
65026937|NCT00548080|Antifungal Agents|antifungal agents|mesh-ancestor
65026938|NCT00548080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65026939|NCT00548080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581074|NCT05679102|Amlodipine|amlodipine|mesh-list
65026953|NCT00184821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65026954|NCT00184821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026955|NCT00184821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65026956|NCT00184821|Vasodilator Agents|vasodilator agents|mesh-ancestor
65026957|NCT00184821|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65026958|NCT00184821|Purinergic Agonists|purinergic agonists|mesh-ancestor
65026959|NCT00184821|Purinergic Agents|purinergic agents|mesh-ancestor
65026960|NCT00184821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026961|NCT00184821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026962|NCT00184821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65026963|NCT00184821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65026964|NCT00184821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026965|NCT00548509|Vitamin K|vitamin k|mesh-list
65026966|NCT00548509|Vitamin K 2|vitamin k 2|mesh-list
65026967|NCT00548509|Menatetrenone|menatetrenone|mesh-list
65026968|NCT00548509|Vitamins|vitamins|mesh-ancestor
65026969|NCT00548509|Micronutrients|micronutrients|mesh-ancestor
65026970|NCT00548509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026971|NCT00548509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65026972|NCT00548509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65026973|NCT00548509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026974|NCT00548509|Hemostatics|hemostatics|mesh-ancestor
65026975|NCT00548509|Coagulants|coagulants|mesh-ancestor
65026976|NCT00548704|Dexrazoxane|dexrazoxane|mesh-list
65026977|NCT00548704|Razoxane|razoxane|mesh-list
65026978|NCT00548704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026979|NCT00548704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65026980|NCT00548704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65026981|NCT00548704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65026982|NCT00548704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026983|NCT00548704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026984|NCT00548704|Protective Agents|protective agents|mesh-ancestor
65026985|NCT00548704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026986|NCT00548704|Antimitotic Agents|antimitotic agents|mesh-ancestor
65026987|NCT00548704|Mitosis Modulators|mitosis modulators|mesh-ancestor
65026988|NCT00184899|Heparin|heparin|mesh-list
65026989|NCT00184899|Calcium heparin|calcium heparin|mesh-list
65026990|NCT00184899|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65026991|NCT00184899|Glycerol|glycerol|mesh-list
65026992|NCT00184899|Anticoagulants|anticoagulants|mesh-ancestor
65026993|NCT00184899|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65026994|NCT00184899|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65026995|NCT00184899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026996|NCT00184899|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65026997|NCT00184899|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65026998|NCT00184899|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65026999|NCT00184899|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65027000|NCT00184899|Protective Agents|protective agents|mesh-ancestor
65027001|NCT00184899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027002|NCT00548821|Cisplatin|cisplatin|mesh-list
65027003|NCT00548821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027004|NCT00161291|Bevacizumab|bevacizumab|mesh-list
65027043|NCT00161330|Amoxicillin|amoxicillin|mesh-list
65027044|NCT00161330|Ceftriaxone|ceftriaxone|mesh-list
65027045|NCT00161330|Clavulanic Acids|clavulanic acids|mesh-list
65027046|NCT00161330|Clavulanic Acid|clavulanic acid|mesh-list
65027047|NCT00161330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65027048|NCT00161330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027049|NCT00161330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027050|NCT00161330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027051|NCT00161330|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65027052|NCT04939480|Atezolizumab|atezolizumab|mesh-list
65027053|NCT04939480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027054|NCT00184938|Morphine|morphine|mesh-list
65027055|NCT00184938|Naloxone|naloxone|mesh-list
65027056|NCT00184938|Annexin A5|annexin a5|mesh-list
65027057|NCT00184938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65027058|NCT00184938|Narcotics|narcotics|mesh-ancestor
65027059|NCT00184938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65027060|NCT00184938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027061|NCT00184938|Analgesics|analgesics|mesh-ancestor
65027062|NCT00184938|Sensory System Agents|sensory system agents|mesh-ancestor
65027063|NCT00184938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65027064|NCT00184938|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65027065|NCT00184938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027066|NCT00184938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027067|NCT00549133|Irbesartan|irbesartan|mesh-list
65027068|NCT00549133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64900836|NCT02044250|Aspirin|aspirin|mesh-list
65493852|NCT04233866|Micronutrients|micronutrients|mesh-ancestor
65027069|NCT00549133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65027070|NCT00549133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65027071|NCT00549133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027072|NCT00191607|Gemcitabine|gemcitabine|mesh-list
65027073|NCT00191607|Doxorubicin|doxorubicin|mesh-list
65027110|NCT00184977|Respiratory System Agents|respiratory system agents|mesh-ancestor
65027111|NCT00184977|Dermatologic Agents|dermatologic agents|mesh-ancestor
65027112|NCT00184977|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65027180|NCT00191763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027181|NCT00191763|Antiviral Agents|antiviral agents|mesh-ancestor
65027182|NCT00191763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027183|NCT00191763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027184|NCT00191763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65027186|NCT00191763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027187|NCT00161564|Rituximab|rituximab|mesh-list
65027188|NCT00161564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65027189|NCT00161564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027190|NCT00161564|Immunologic Factors|immunologic factors|mesh-ancestor
65027191|NCT00161564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027192|NCT00161564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65027193|NCT00185055|Valsartan|valsartan|mesh-list
65027194|NCT00185055|Olmesartan|olmesartan|mesh-list
65027195|NCT00185055|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65027196|NCT00185055|Irbesartan|irbesartan|mesh-list
65027197|NCT00185055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65027198|NCT00185055|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65027199|NCT00185055|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65027200|NCT00185055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027201|NCT00550108|Ethanol|ethanol|mesh-list
65027202|NCT00550108|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65027203|NCT00550108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027204|NCT00550108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65027205|NCT00550108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027206|NCT00185094|Losartan|losartan|mesh-list
65027207|NCT00185094|Atenolol|atenolol|mesh-list
65027208|NCT00185094|Olmesartan|olmesartan|mesh-list
65027209|NCT00185094|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65027210|NCT00185094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65027211|NCT00185094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65027212|NCT00185094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65027213|NCT00185094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65027214|NCT00185094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027215|NCT00185094|Sympatholytics|sympatholytics|mesh-ancestor
65027216|NCT00185094|Autonomic Agents|autonomic agents|mesh-ancestor
65027249|NCT00161681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65027250|NCT00161681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65027251|NCT00161681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65027252|NCT00161681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65027253|NCT00161681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65027254|NCT02963454|Simendan|simendan|mesh-list
65027255|NCT02963454|Dobutamine|dobutamine|mesh-list
65027256|NCT02963454|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65027257|NCT02963454|Vasodilator Agents|vasodilator agents|mesh-ancestor
65027288|NCT00550810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027289|NCT00550810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027290|NCT00191841|Gemcitabine|gemcitabine|mesh-list
65027291|NCT00191841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027292|NCT00191841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65027293|NCT00191841|Antimetabolites|antimetabolites|mesh-ancestor
65027294|NCT00191841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027295|NCT00191841|Antiviral Agents|antiviral agents|mesh-ancestor
65027296|NCT00191841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027297|NCT00191841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027332|NCT00551005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027333|NCT00551005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027334|NCT00551005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65027372|NCT00551122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64809409|NCT04922567|Hormones|hormones|mesh-ancestor
65027373|NCT00551122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65027504|NCT00185328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027505|NCT00162110|Cetuximab|cetuximab|mesh-list
64581638|NCT05691426|Antioxidants|antioxidants|mesh-ancestor
65027563|NCT00552682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027564|NCT00552682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65027565|NCT00552682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027566|NCT00552682|Analgesics|analgesics|mesh-ancestor
65027567|NCT00552682|Sensory System Agents|sensory system agents|mesh-ancestor
65027568|NCT00552682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65027569|NCT00552682|Antidepressive Agents|antidepressive agents|mesh-ancestor
65027570|NCT00552682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65027571|NCT00552682|Dopamine Agents|dopamine agents|mesh-ancestor
65027572|NCT04652089|Simvastatin|simvastatin|mesh-list
65027573|NCT04652089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65027574|NCT04652089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65027575|NCT04652089|Antimetabolites|antimetabolites|mesh-ancestor
65027576|NCT04652089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027577|NCT04652089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65027578|NCT04652089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65027579|NCT04652089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027580|NCT04609306|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65027600|NCT04513015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027601|NCT04513015|Protective Agents|protective agents|mesh-ancestor
65027602|NCT04513015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027603|NCT00162344|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
65027604|NCT00162344|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65027605|NCT00162344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027607|NCT04382326|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65027608|NCT04382326|Immunologic Factors|immunologic factors|mesh-ancestor
65027609|NCT04382326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027610|NCT00162383|Dapsone|dapsone|mesh-list
65027611|NCT00162383|Debrisoquin|debrisoquin|mesh-list
65027612|NCT00162383|Mephenytoin|mephenytoin|mesh-list
65027613|NCT00162383|Caffeine|caffeine|mesh-list
65027614|NCT00162383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65027615|NCT00162383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027616|NCT00162383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65027617|NCT00162383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027618|NCT00162383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027619|NCT00162383|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65027620|NCT00162383|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65027621|NCT00162383|Purinergic Agents|purinergic agents|mesh-ancestor
65027622|NCT00162383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65027623|NCT00162383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027624|NCT00162383|Antimalarials|antimalarials|mesh-ancestor
65027625|NCT00162383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65027626|NCT00162383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65027627|NCT00162383|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65027628|NCT00162383|Leprostatic Agents|leprostatic agents|mesh-ancestor
65027629|NCT00162383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65027630|NCT00162383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65027631|NCT00162383|Sympatholytics|sympatholytics|mesh-ancestor
65027632|NCT00162383|Autonomic Agents|autonomic agents|mesh-ancestor
65027633|NCT00162383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65027634|NCT00162383|Adrenergic Agents|adrenergic agents|mesh-ancestor
65027635|NCT00162383|Anticonvulsants|anticonvulsants|mesh-ancestor
65027636|NCT00162422|Albuterol|albuterol|mesh-list
65027685|NCT00162461|Anticonvulsants|anticonvulsants|mesh-ancestor
65027686|NCT00162461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65027687|NCT00162461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65027688|NCT00162461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65027689|NCT00162461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027690|NCT00162461|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65027691|NCT00162461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65027692|NCT00185562|Adalimumab|adalimumab|mesh-list
65027693|NCT00185562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65027694|NCT00185562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65027695|NCT04095364|Paclitaxel|paclitaxel|mesh-list
65027696|NCT04095364|Carboplatin|carboplatin|mesh-list
65027697|NCT04095364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65027698|NCT04095364|Letrozole|letrozole|mesh-list
65027699|NCT04095364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65027700|NCT04095364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027701|NCT04095364|Tubulin Modulators|tubulin modulators|mesh-ancestor
65027702|NCT04095364|Antimitotic Agents|antimitotic agents|mesh-ancestor
65027703|NCT04095364|Mitosis Modulators|mitosis modulators|mesh-ancestor
65027704|NCT04095364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027705|NCT04095364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65027706|NCT04095364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65027707|NCT04095364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027708|NCT04095364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65027709|NCT04095364|Hormone Antagonists|hormone antagonists|mesh-ancestor
65027710|NCT04095364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65027769|NCT00185835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027770|NCT00185835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65027771|NCT00185835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027772|NCT00185835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027773|NCT00162968|Citalopram|citalopram|mesh-list
65027774|NCT00162968|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65027775|NCT00162968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65027776|NCT00162968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65027777|NCT00162968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027778|NCT00162968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65027779|NCT00162968|Serotonin Agents|serotonin agents|mesh-ancestor
65027780|NCT00162968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027781|NCT00162968|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65027782|NCT00162968|Antidepressive Agents|antidepressive agents|mesh-ancestor
65027783|NCT00162968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65027784|NCT03970330|Naltrexone|naltrexone|mesh-list
65027785|NCT03970330|Norethindrone|norethindrone|mesh-list
65027845|NCT03541447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027847|NCT03541447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027848|NCT00192621|Lamivudine|lamivudine|mesh-list
65027849|NCT00192621|Zidovudine|zidovudine|mesh-list
65027850|NCT00192621|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
65027851|NCT00192621|Lopinavir|lopinavir|mesh-list
65027852|NCT00192621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65027853|NCT00192621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65027854|NCT00192621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027855|NCT00192621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027856|NCT00192621|Antiviral Agents|antiviral agents|mesh-ancestor
65027857|NCT00192621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027858|NCT00192621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65027859|NCT00192621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65027860|NCT00192621|Antimetabolites|antimetabolites|mesh-ancestor
65027861|NCT00192621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65027862|NCT00192621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65027863|NCT00192621|Protease Inhibitors|protease inhibitors|mesh-ancestor
65027864|NCT00192621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64582014|NCT00186875|Analgesics|analgesics|mesh-ancestor
65027923|NCT00192660|Efavirenz|efavirenz|mesh-list
65027924|NCT00192660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65027925|NCT00192660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65027926|NCT00192660|Protease Inhibitors|protease inhibitors|mesh-ancestor
65027927|NCT00192660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582061|NCT05535036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028030|NCT00163358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65028031|NCT00163358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028063|NCT01628029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65028064|NCT01628029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65028065|NCT01628029|Dopamine Agents|dopamine agents|mesh-ancestor
65028066|NCT01628029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65028067|NCT00163514|Ciclesonide|ciclesonide|mesh-list
65028068|NCT00163514|Glucocorticoids|glucocorticoids|mesh-ancestor
65028069|NCT00163514|Hormones|hormones|mesh-ancestor
65028070|NCT00163514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65028071|NCT00163514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028072|NCT00163514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65028073|NCT00717652|Triamcinolone|triamcinolone|mesh-list
65028127|NCT00553072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028128|NCT00553072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65028129|NCT00553072|Tocolytic Agents|tocolytic agents|mesh-ancestor
65028130|NCT00553072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65028131|NCT05808764|Risdiplam|risdiplam|mesh-list
65028132|NCT05808764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65028133|NCT05808764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028134|NCT05808764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028135|NCT05808725|Amlodipine|amlodipine|mesh-list
65028136|NCT05808725|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65028137|NCT05808725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65028138|NCT05808725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65028193|NCT05807932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028194|NCT05807932|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65028195|NCT05807932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028196|NCT05807932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028197|NCT05807932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65028198|NCT05807932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028199|NCT05807932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65028200|NCT05807932|Antitubercular Agents|antitubercular agents|mesh-ancestor
65028201|NCT05807932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65028202|NCT05807932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65028203|NCT05807893|Bevacizumab|bevacizumab|mesh-list
65028204|NCT05807893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65028205|NCT05807893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028206|NCT05807893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65028207|NCT05807893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65028208|NCT05807893|Growth Substances|growth substances|mesh-ancestor
65028209|NCT05807893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028210|NCT05807893|Growth Inhibitors|growth inhibitors|mesh-ancestor
65028211|NCT05807880|Capecitabine|capecitabine|mesh-list
65028212|NCT05807880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65028213|NCT05807880|Antimetabolites|antimetabolites|mesh-ancestor
65028214|NCT05807880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028215|NCT05807880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028216|NCT05807776|Lenvatinib|lenvatinib|mesh-list
65028217|NCT05807776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028218|NCT05807776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65028219|NCT05807776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028220|NCT05807776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028221|NCT05807711|Vitamin B 12|vitamin b 12|mesh-list
65028222|NCT05807711|Vitamin B Complex|vitamin b complex|mesh-ancestor
65028223|NCT05807711|Vitamins|vitamins|mesh-ancestor
65028224|NCT05807711|Micronutrients|micronutrients|mesh-ancestor
65028252|NCT05807412|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65028253|NCT05807412|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65028254|NCT05807412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028255|NCT05807412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028256|NCT05807412|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65028257|NCT05807412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65028258|NCT05807412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028259|NCT05807412|Cholinergic Agents|cholinergic agents|mesh-ancestor
65028260|NCT05807412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65028261|NCT05807347|Cytarabine|cytarabine|mesh-list
65028262|NCT05807347|Azacitidine|azacitidine|mesh-list
65028263|NCT05807347|Venetoclax|venetoclax|mesh-list
65028264|NCT05807347|Aclacinomycins|aclacinomycins|mesh-list
65028265|NCT05807347|Lenograstim|lenograstim|mesh-list
65028266|NCT05807347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65028267|NCT05807347|Antimetabolites|antimetabolites|mesh-ancestor
65028268|NCT05807347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028269|NCT05807347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028270|NCT05807347|Antiviral Agents|antiviral agents|mesh-ancestor
65028271|NCT05807347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65028272|NCT05807347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65028297|NCT05807165|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65028298|NCT05807165|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65028299|NCT05807100|Salicylic Acid|salicylic acid|mesh-list
65028300|NCT05807100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65028301|NCT05807100|Antifungal Agents|antifungal agents|mesh-ancestor
65028302|NCT05807100|Keratolytic Agents|keratolytic agents|mesh-ancestor
65028303|NCT05807100|Dermatologic Agents|dermatologic agents|mesh-ancestor
65028305|NCT05807035|Immunologic Factors|immunologic factors|mesh-ancestor
65028306|NCT05807035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028307|NCT05798481|Acetylcysteine|acetylcysteine|mesh-list
65028308|NCT05798481|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65028309|NCT05798481|Antiviral Agents|antiviral agents|mesh-ancestor
65028310|NCT05798481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65028311|NCT05798481|Expectorants|expectorants|mesh-ancestor
65028312|NCT05798481|Respiratory System Agents|respiratory system agents|mesh-ancestor
65028313|NCT05798481|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65028314|NCT05798481|Antioxidants|antioxidants|mesh-ancestor
64407888|NCT05062681|Hormones|hormones|mesh-ancestor
65028315|NCT05798481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028316|NCT05798481|Protective Agents|protective agents|mesh-ancestor
65028317|NCT05798481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028318|NCT05798481|Antidotes|antidotes|mesh-ancestor
65028319|NCT05781698|Mesalamine|mesalamine|mesh-list
65028320|NCT05781698|Fenofibrate|fenofibrate|mesh-list
65028321|NCT05781698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65028322|NCT05781698|Antimetabolites|antimetabolites|mesh-ancestor
65028323|NCT05781698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028324|NCT05781698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65028325|NCT05781698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65028354|NCT05709509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028355|NCT05709509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028356|NCT05709509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65028357|NCT05709509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65028358|NCT05709509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65028359|NCT05709509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65028360|NCT05709509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028361|NCT05709509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65028362|NCT05709509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65028363|NCT05709509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028365|NCT05709509|Gout Suppressants|gout suppressants|mesh-ancestor
65028366|NCT05709509|Tubulin Modulators|tubulin modulators|mesh-ancestor
65028367|NCT05709509|Antimitotic Agents|antimitotic agents|mesh-ancestor
65028368|NCT05709509|Mitosis Modulators|mitosis modulators|mesh-ancestor
65028369|NCT05709509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028370|NCT05693844|Paclitaxel|paclitaxel|mesh-list
65028371|NCT05693844|Cyclophosphamide|cyclophosphamide|mesh-list
65493856|NCT04166318|Mitomycins|mitomycins|mesh-list
65028417|NCT05669482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65028418|NCT05669482|Antimetabolites|antimetabolites|mesh-ancestor
65028419|NCT05669482|Antiviral Agents|antiviral agents|mesh-ancestor
65028420|NCT05669482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65028443|NCT05630872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028444|NCT05630872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028445|NCT05630872|Antiviral Agents|antiviral agents|mesh-ancestor
65028446|NCT05630872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65028447|NCT05630872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65028448|NCT05630872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65028449|NCT05630872|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65028450|NCT05630872|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65028451|NCT05627947|Cyclosporine|cyclosporine|mesh-list
65028452|NCT05627947|Mitomycins|mitomycins|mesh-list
65028453|NCT05627947|Mitomycin|mitomycin|mesh-list
65028454|NCT05627947|Cyclosporins|cyclosporins|mesh-list
65028455|NCT05627947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028456|NCT05627947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028457|NCT05627947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65028458|NCT05627947|Immunologic Factors|immunologic factors|mesh-ancestor
65028459|NCT05627947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028460|NCT05627947|Antifungal Agents|antifungal agents|mesh-ancestor
65028461|NCT05627947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65028462|NCT05627947|Dermatologic Agents|dermatologic agents|mesh-ancestor
65028463|NCT05627947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65028464|NCT05627947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65028465|NCT05627947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65028466|NCT05627947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028467|NCT05627947|Alkylating Agents|alkylating agents|mesh-ancestor
65028468|NCT05627947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65028485|NCT05617118|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65028486|NCT05617118|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65028487|NCT05617118|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65028488|NCT05617118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64582579|NCT02193191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65028510|NCT05608837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028511|NCT05606341|1018 oligonucleotide|1018 oligonucleotide|mesh-list
65028512|NCT05606341|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65028513|NCT05606341|Immunologic Factors|immunologic factors|mesh-ancestor
65028514|NCT05606341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028515|NCT05594147|Sorafenib|sorafenib|mesh-list
65028516|NCT05594147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028517|NCT05594147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65028518|NCT05594147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028519|NCT05594147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028520|NCT05591105|Acetaminophen|acetaminophen|mesh-list
65028521|NCT05591105|Dipyrone|dipyrone|mesh-list
65028522|NCT05591105|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65028523|NCT05591105|Lidocaine|lidocaine|mesh-list
65028524|NCT05591105|Ketamine|ketamine|mesh-list
65028525|NCT05591105|Morphine|morphine|mesh-list
65028526|NCT05591105|Anesthetics, Local|anesthetics, local|mesh-ancestor
65028527|NCT05591105|Anesthetics|anesthetics|mesh-ancestor
65028528|NCT05591105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65028529|NCT05591105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028530|NCT05591105|Sensory System Agents|sensory system agents|mesh-ancestor
65028531|NCT05591105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028532|NCT05591105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65028533|NCT05591105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65028534|NCT05591105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65028535|NCT05591105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65028536|NCT05591105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028537|NCT05591105|Analgesics|analgesics|mesh-ancestor
65028538|NCT05591105|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65028539|NCT05591105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65028540|NCT05591105|Anesthetics, General|anesthetics, general|mesh-ancestor
64582632|NCT01444898|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65028575|NCT05494580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028576|NCT05494580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028577|NCT05494580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028579|NCT05464654|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65028580|NCT05464654|Hormones|hormones|mesh-ancestor
64582686|NCT01733745|Vitamins|vitamins|mesh-list
65028593|NCT05438602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65028594|NCT05438602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65028595|NCT05352516|Denosumab|denosumab|mesh-list
65028596|NCT05352516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65028597|NCT05352516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028598|NCT05307705|Paclitaxel|paclitaxel|mesh-list
65028599|NCT05307705|Letrozole|letrozole|mesh-list
65028600|NCT05307705|Fulvestrant|fulvestrant|mesh-list
65028601|NCT05307705|Anastrozole|anastrozole|mesh-list
65028602|NCT05307705|Exemestane|exemestane|mesh-list
65028603|NCT05307705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65028604|NCT05307705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028605|NCT05307705|Tubulin Modulators|tubulin modulators|mesh-ancestor
65028606|NCT05307705|Antimitotic Agents|antimitotic agents|mesh-ancestor
65028607|NCT05307705|Mitosis Modulators|mitosis modulators|mesh-ancestor
65028608|NCT05307705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028609|NCT05307705|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65028610|NCT05307705|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65028611|NCT05307705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028612|NCT05307705|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65028613|NCT05307705|Hormone Antagonists|hormone antagonists|mesh-ancestor
65028614|NCT05307705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65028615|NCT05307705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028616|NCT05307705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65028617|NCT05307705|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65028618|NCT05280704|Lidocaine|lidocaine|mesh-list
65028649|NCT05267873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65028650|NCT05267873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65028651|NCT05267873|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65028652|NCT05267873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65028653|NCT05259943|Psilocybin|psilocybin|mesh-list
65028654|NCT05259943|Hallucinogens|hallucinogens|mesh-ancestor
65028655|NCT05259943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028656|NCT05259943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65028657|NCT05232929|Risdiplam|risdiplam|mesh-list
65028658|NCT05232929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65028694|NCT05113901|Autonomic Agents|autonomic agents|mesh-ancestor
65028695|NCT05113901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028696|NCT05113901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028697|NCT05113901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65028698|NCT05113901|Glucocorticoids|glucocorticoids|mesh-ancestor
65028700|NCT05113901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65028736|NCT05018091|Protease Inhibitors|protease inhibitors|mesh-ancestor
65028737|NCT05018091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028738|NCT05018091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028739|NCT04999644|Nicotine|nicotine|mesh-list
65028768|NCT04892446|Dexamethasone|dexamethasone|mesh-list
65028769|NCT04892446|Bortezomib|bortezomib|mesh-list
65028770|NCT04892446|Daratumumab|daratumumab|mesh-list
65028772|NCT04892446|Magrolimab|magrolimab|mesh-list
65028773|NCT04892446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65028774|NCT04892446|Antiemetics|antiemetics|mesh-ancestor
65028775|NCT04892446|Autonomic Agents|autonomic agents|mesh-ancestor
65028776|NCT04892446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028777|NCT04892446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028778|NCT04892446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65028779|NCT04892446|Glucocorticoids|glucocorticoids|mesh-ancestor
65028780|NCT04892446|Hormones|hormones|mesh-ancestor
65028781|NCT04892446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65028782|NCT04892446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65028783|NCT04892446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028784|NCT04892446|Immunologic Factors|immunologic factors|mesh-ancestor
65028785|NCT04892446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65028786|NCT04892446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65028787|NCT04892446|Growth Substances|growth substances|mesh-ancestor
65028788|NCT04892446|Growth Inhibitors|growth inhibitors|mesh-ancestor
65028789|NCT04892446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65028816|NCT04862975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65028817|NCT04862975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65028818|NCT04862975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65028819|NCT04862975|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65028820|NCT04862975|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65028821|NCT04854369|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65028822|NCT04854369|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65028823|NCT04854369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028825|NCT04833140|Estrogens|estrogens|mesh-ancestor
65028826|NCT04833140|Hormones|hormones|mesh-ancestor
65028827|NCT04833140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65028828|NCT04833140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028829|NCT04832854|Gemcitabine|gemcitabine|mesh-list
65028830|NCT04832854|Paclitaxel|paclitaxel|mesh-list
65028831|NCT04832854|Carboplatin|carboplatin|mesh-list
65028832|NCT04832854|Pemetrexed|pemetrexed|mesh-list
65028833|NCT04832854|Atezolizumab|atezolizumab|mesh-list
65028834|NCT04832854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65028835|NCT04832854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028836|NCT04832854|Tubulin Modulators|tubulin modulators|mesh-ancestor
65028837|NCT04832854|Antimitotic Agents|antimitotic agents|mesh-ancestor
64582947|NCT01419236|Testosterone|testosterone|mesh-list
65028861|NCT04826562|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65028862|NCT04778618|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65028863|NCT04778618|Immunologic Factors|immunologic factors|mesh-ancestor
65028864|NCT04778618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028865|NCT04778618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65028866|NCT04776252|Islatravir|islatravir|mesh-list
65028867|NCT04776252|Antiviral Agents|antiviral agents|mesh-ancestor
65028868|NCT04776252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65028869|NCT04776252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028870|NCT04776252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028871|NCT04776252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65028872|NCT04776252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65028873|NCT04776252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65028874|NCT04767841|Metformin|metformin|mesh-list
65028875|NCT04767841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65028876|NCT04767841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028877|NCT04761861|Vildagliptin|vildagliptin|mesh-list
65028878|NCT04761861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65028879|NCT04761861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028880|NCT04761861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65028881|NCT04761861|Protease Inhibitors|protease inhibitors|mesh-ancestor
65028882|NCT04761861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028883|NCT04761861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028884|NCT04716699|Lidocaine|lidocaine|mesh-list
65028885|NCT04716699|Anesthetics, Local|anesthetics, local|mesh-ancestor
65028886|NCT04716699|Anesthetics|anesthetics|mesh-ancestor
65028887|NCT04716699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65028907|NCT04685980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028908|NCT04663997|Docetaxel|docetaxel|mesh-list
65028909|NCT04663997|177Lu-PSMA-617|177lu-psma-617|mesh-list
65028910|NCT04663997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028911|NCT04663997|Tubulin Modulators|tubulin modulators|mesh-ancestor
65028912|NCT04663997|Antimitotic Agents|antimitotic agents|mesh-ancestor
65028913|NCT04663997|Mitosis Modulators|mitosis modulators|mesh-ancestor
65028914|NCT04663997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028915|NCT04663997|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65028916|NCT04657692|Anesthetics|anesthetics|mesh-list
65028917|NCT04657692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65028918|NCT04657692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028919|NCT04624204|Pembrolizumab|pembrolizumab|mesh-list
65028920|NCT04624204|Etoposide|etoposide|mesh-list
65028921|NCT04624204|Olaparib|olaparib|mesh-list
65028922|NCT04624204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65028923|NCT04624204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028924|NCT04624204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65028925|NCT04624204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65028926|NCT04624204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65028927|NCT04624204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028928|NCT04624204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028929|NCT04624204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65028930|NCT04619797|Carboplatin|carboplatin|mesh-list
65028931|NCT04619797|Pembrolizumab|pembrolizumab|mesh-list
65028932|NCT04619797|Pemetrexed|pemetrexed|mesh-list
65028933|NCT04619797|Atezolizumab|atezolizumab|mesh-list
65028934|NCT04619797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028935|NCT04619797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65028936|NCT04619797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028937|NCT04619797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028938|NCT04619797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65028939|NCT04619797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65028965|NCT04564547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65028966|NCT04564547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028967|NCT04564547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028968|NCT04564547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65028969|NCT04564547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65028970|NCT04564547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65028971|NCT04539964|Antirheumatic Agents|antirheumatic agents|mesh-list
65028972|NCT04536298|Vitamin D|vitamin d|mesh-list
65028973|NCT04536298|Ergocalciferols|ergocalciferols|mesh-list
65028974|NCT04536298|Cholecalciferol|cholecalciferol|mesh-list
65028975|NCT04536298|Vitamins|vitamins|mesh-list
65028976|NCT04536298|Micronutrients|micronutrients|mesh-ancestor
65028977|NCT04536298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028978|NCT04536298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65028979|NCT04536298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65028980|NCT04531176|Liraglutide|liraglutide|mesh-list
65028981|NCT04531176|Topiramate|topiramate|mesh-list
65028982|NCT04531176|Orlistat|orlistat|mesh-list
65028983|NCT04531176|Phentermine|phentermine|mesh-list
65028984|NCT04531176|Naltrexone|naltrexone|mesh-list
65028985|NCT04531176|Bupropion|bupropion|mesh-list
65028986|NCT04531176|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65028987|NCT04531176|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65028988|NCT04531176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028989|NCT04531176|Sensory System Agents|sensory system agents|mesh-ancestor
65028990|NCT04531176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028991|NCT04531176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65028992|NCT04531176|Incretins|incretins|mesh-ancestor
65029013|NCT04531176|Autonomic Agents|autonomic agents|mesh-ancestor
65029014|NCT04531176|Adrenergic Agents|adrenergic agents|mesh-ancestor
65029017|NCT04472767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65029018|NCT04472767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029019|NCT04472767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65029020|NCT04472767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029021|NCT04456946|Salicylic Acid|salicylic acid|mesh-list
65029022|NCT04456946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65029023|NCT04456946|Antifungal Agents|antifungal agents|mesh-ancestor
65029024|NCT04456946|Keratolytic Agents|keratolytic agents|mesh-ancestor
65029025|NCT04456946|Dermatologic Agents|dermatologic agents|mesh-ancestor
65029026|NCT04428151|Paclitaxel|paclitaxel|mesh-list
65029027|NCT04428151|Docetaxel|docetaxel|mesh-list
65029028|NCT04428151|Pembrolizumab|pembrolizumab|mesh-list
65029029|NCT04428151|Capecitabine|capecitabine|mesh-list
65029030|NCT04428151|Cetuximab|cetuximab|mesh-list
65029031|NCT04428151|Lenvatinib|lenvatinib|mesh-list
65029032|NCT04428151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65029033|NCT04428151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029034|NCT04428151|Tubulin Modulators|tubulin modulators|mesh-ancestor
65029035|NCT04428151|Antimitotic Agents|antimitotic agents|mesh-ancestor
65029036|NCT04428151|Mitosis Modulators|mitosis modulators|mesh-ancestor
65029037|NCT04428151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029038|NCT04428151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65029039|NCT04428151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65029040|NCT04428151|Antimetabolites|antimetabolites|mesh-ancestor
65029041|NCT04428151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65029042|NCT04428151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029043|NCT04409860|Paclitaxel|paclitaxel|mesh-list
65029044|NCT04409860|Cisplatin|cisplatin|mesh-list
65029045|NCT04409860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64583141|NCT05327751|Celecoxib|celecoxib|mesh-list
65029065|NCT04380636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65029066|NCT04380636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65029067|NCT04380636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029068|NCT04380636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65029069|NCT04380636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65029070|NCT04380636|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65029071|NCT04311099|Ropivacaine|ropivacaine|mesh-list
65029072|NCT04311099|Anesthetics, Local|anesthetics, local|mesh-ancestor
65029073|NCT04311099|Anesthetics|anesthetics|mesh-ancestor
65029074|NCT04311099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65029075|NCT04311099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029076|NCT04311099|Sensory System Agents|sensory system agents|mesh-ancestor
65029077|NCT04311099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65029078|NCT04303559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65029079|NCT04303559|Immunologic Factors|immunologic factors|mesh-ancestor
65029080|NCT04303559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029081|NCT04303390|Cefazolin|cefazolin|mesh-list
65029082|NCT04303390|Cefuroxime|cefuroxime|mesh-list
65029083|NCT04303390|Cefuroxime axetil|cefuroxime axetil|mesh-list
65029084|NCT04303390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65029085|NCT04303390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65029086|NCT04232761|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65029087|NCT04232761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029088|NCT04216329|Temozolomide|temozolomide|mesh-list
65029089|NCT04216329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65029090|NCT04216329|Alkylating Agents|alkylating agents|mesh-ancestor
65029091|NCT04216329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029092|NCT04216329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029093|NCT04152200|Lumasiran|lumasiran|mesh-list
65029094|NCT04152200|Renal Agents|renal agents|mesh-ancestor
65029095|NCT04093167|Pembrolizumab|pembrolizumab|mesh-list
64470434|NCT05300152|Antibodies|antibodies|mesh-list
64514339|NCT02248701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64514340|NCT02248701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514341|NCT02248701|Anabolic Agents|anabolic agents|mesh-ancestor
64514342|NCT02248701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64514343|NCT02248701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64514344|NCT02248701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583194|NCT00226577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029104|NCT04075110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029105|NCT04075110|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65029106|NCT04075110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65029107|NCT04075110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029109|NCT04055909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65029110|NCT03978689|Pembrolizumab|pembrolizumab|mesh-list
65029111|NCT03978689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65029112|NCT03978689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029113|NCT03910387|Gemcitabine|gemcitabine|mesh-list
65029114|NCT03910387|Paclitaxel|paclitaxel|mesh-list
65029115|NCT03910387|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65029116|NCT03910387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65029117|NCT03910387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029118|NCT03910387|Tubulin Modulators|tubulin modulators|mesh-ancestor
65029119|NCT03910387|Antimitotic Agents|antimitotic agents|mesh-ancestor
65029120|NCT03910387|Mitosis Modulators|mitosis modulators|mesh-ancestor
65029121|NCT03910387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029122|NCT03910387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65029123|NCT03910387|Antimetabolites|antimetabolites|mesh-ancestor
65029124|NCT03910387|Antiviral Agents|antiviral agents|mesh-ancestor
65029125|NCT03910387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65029126|NCT03910387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029127|NCT03910387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65029128|NCT03910387|Immunologic Factors|immunologic factors|mesh-ancestor
65029129|NCT03910387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029130|NCT03905694|Lumasiran|lumasiran|mesh-list
65029131|NCT03905694|Renal Agents|renal agents|mesh-ancestor
65029132|NCT03861793|Pembrolizumab|pembrolizumab|mesh-list
65029152|NCT03760523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029153|NCT03760523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029154|NCT03742895|Olaparib|olaparib|mesh-list
65029155|NCT03742895|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65029156|NCT03742895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029157|NCT03742895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029158|NCT03742895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029159|NCT03729245|Nivolumab|nivolumab|mesh-list
65029160|NCT03729245|Sunitinib|sunitinib|mesh-list
65029161|NCT03729245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65029162|NCT03729245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029163|NCT03729245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65029164|NCT03729245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029165|NCT03729245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65029166|NCT03729245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65029167|NCT03729245|Growth Substances|growth substances|mesh-ancestor
64514466|NCT02721537|Niacin|niacin|mesh-list
65029168|NCT03729245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029169|NCT03729245|Growth Inhibitors|growth inhibitors|mesh-ancestor
65029170|NCT03729245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65029171|NCT03729245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029172|NCT03712397|Irinotecan|irinotecan|mesh-list
65029173|NCT03712397|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65029174|NCT03712397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65029175|NCT03712397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029176|NCT03712397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029177|NCT03712397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029178|NCT03681184|Lumasiran|lumasiran|mesh-list
65029179|NCT03681184|Renal Agents|renal agents|mesh-ancestor
65029180|NCT03653507|Capecitabine|capecitabine|mesh-list
65029181|NCT03653507|Oxaliplatin|oxaliplatin|mesh-list
65029182|NCT03653507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65029183|NCT03653507|Antimetabolites|antimetabolites|mesh-ancestor
65029184|NCT03653507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029185|NCT03653507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029221|NCT03501381|Entinostat|entinostat|mesh-list
65029222|NCT03501381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029223|NCT03501381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65029224|NCT03501381|Analgesics|analgesics|mesh-ancestor
65029225|NCT03501381|Sensory System Agents|sensory system agents|mesh-ancestor
64583357|NCT01791465|Hormones|hormones|mesh-ancestor
65029258|NCT03451331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65029259|NCT03451331|Immunologic Factors|immunologic factors|mesh-ancestor
65029260|NCT03451331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029261|NCT03451331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65029262|NCT03451331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65029263|NCT03412877|Aldesleukin|aldesleukin|mesh-list
65029264|NCT03412877|Cyclophosphamide|cyclophosphamide|mesh-list
65029265|NCT03412877|Pembrolizumab|pembrolizumab|mesh-list
65029266|NCT03412877|Fludarabine|fludarabine|mesh-list
65029267|NCT03412877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65029268|NCT03412877|Immunologic Factors|immunologic factors|mesh-ancestor
65029321|NCT03396445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65029322|NCT03396445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65029323|NCT03385655|Carboplatin|carboplatin|mesh-list
65029325|NCT03385655|Tremelimumab|tremelimumab|mesh-list
65029326|NCT03385655|Adavosertib|adavosertib|mesh-list
65029327|NCT03385655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029328|NCT03385655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65029329|NCT03385655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029330|NCT03385655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029331|NCT03355469|Metformin|metformin|mesh-list
65029332|NCT03355469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65029333|NCT03355469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029334|NCT03330028|Diphenhydramine|diphenhydramine|mesh-list
65029335|NCT03330028|Promethazine|promethazine|mesh-list
65029336|NCT03330028|Dexamethasone|dexamethasone|mesh-list
65029337|NCT03330028|Paclitaxel|paclitaxel|mesh-list
65029338|NCT03330028|Cisplatin|cisplatin|mesh-list
65029339|NCT03330028|Mitomycins|mitomycins|mesh-list
65029340|NCT03330028|Mitomycin|mitomycin|mesh-list
65029341|NCT03330028|Famotidine|famotidine|mesh-list
65029342|NCT03330028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65029343|NCT03330028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029344|NCT03330028|Tubulin Modulators|tubulin modulators|mesh-ancestor
65029345|NCT03330028|Antimitotic Agents|antimitotic agents|mesh-ancestor
65029346|NCT03330028|Mitosis Modulators|mitosis modulators|mesh-ancestor
65029347|NCT03330028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029348|NCT03330028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65029349|NCT03330028|Antiemetics|antiemetics|mesh-ancestor
65029350|NCT03330028|Autonomic Agents|autonomic agents|mesh-ancestor
65029389|NCT03311555|Tubulin Modulators|tubulin modulators|mesh-ancestor
65029390|NCT03311555|Antimitotic Agents|antimitotic agents|mesh-ancestor
65029391|NCT03311555|Mitosis Modulators|mitosis modulators|mesh-ancestor
65029392|NCT03311555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029394|NCT03311555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65029395|NCT03311555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029396|NCT03283917|Dexamethasone|dexamethasone|mesh-list
65029397|NCT03283917|Dexamethasone acetate|dexamethasone acetate|mesh-list
65029398|NCT03283917|Daratumumab|daratumumab|mesh-list
65029399|NCT03283917|Ixazomib|ixazomib|mesh-list
65029400|NCT03283917|Ichthammol|ichthammol|mesh-list
65029401|NCT03283917|BB 1101|bb 1101|mesh-list
65029402|NCT03283917|Glycine|glycine|mesh-list
65029403|NCT03283917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65029404|NCT03283917|Antiemetics|antiemetics|mesh-ancestor
65029405|NCT03283917|Autonomic Agents|autonomic agents|mesh-ancestor
65029406|NCT03283917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65029407|NCT03283917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029408|NCT03283917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65029409|NCT03283917|Glucocorticoids|glucocorticoids|mesh-ancestor
65029410|NCT03283917|Hormones|hormones|mesh-ancestor
65029411|NCT03283917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65029412|NCT03283917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65029413|NCT03283917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029414|NCT03283917|Protease Inhibitors|protease inhibitors|mesh-ancestor
65029415|NCT03283917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029416|NCT03283917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029417|NCT03283917|Dermatologic Agents|dermatologic agents|mesh-ancestor
65029418|NCT03283917|Glycine Agents|glycine agents|mesh-ancestor
65029419|NCT03283917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65029420|NCT03271866|Metformin|metformin|mesh-list
65029421|NCT03271866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65029422|NCT03271866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029423|NCT03259503|Gemcitabine|gemcitabine|mesh-list
65029424|NCT03259503|Rituximab|rituximab|mesh-list
65029425|NCT03259503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65029426|NCT03259503|Melphalan|melphalan|mesh-list
65029458|NCT03217565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029460|NCT03214562|Fludarabine|fludarabine|mesh-list
65029461|NCT03214562|Venetoclax|venetoclax|mesh-list
65029462|NCT03214562|Idarubicin|idarubicin|mesh-list
65029463|NCT03214562|Lenograstim|lenograstim|mesh-list
65029464|NCT03214562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029465|NCT03214562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65029466|NCT03214562|Antimetabolites|antimetabolites|mesh-ancestor
65029467|NCT03214562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029468|NCT03214562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65029469|NCT03214562|Immunologic Factors|immunologic factors|mesh-ancestor
65029470|NCT03214562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029471|NCT03214562|Antiviral Agents|antiviral agents|mesh-ancestor
65029472|NCT03214562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65029492|NCT03162627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029493|NCT03162627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029494|NCT03065335|Ketamine|ketamine|mesh-list
65029495|NCT03065335|Analgesics|analgesics|mesh-ancestor
65029496|NCT03065335|Sensory System Agents|sensory system agents|mesh-ancestor
65029497|NCT03065335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65029498|NCT03065335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029499|NCT03065335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65029500|NCT03065335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65029501|NCT03065335|Anesthetics, General|anesthetics, general|mesh-ancestor
65029502|NCT03065335|Anesthetics|anesthetics|mesh-ancestor
65029503|NCT03065335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65029504|NCT03065335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65029505|NCT03065335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65029506|NCT03065335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65029507|NCT03065335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029508|NCT02992743|Cyclophosphamide|cyclophosphamide|mesh-list
65029509|NCT02992743|Fludarabine|fludarabine|mesh-list
65029510|NCT02992743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65029511|NCT02992743|Immunologic Factors|immunologic factors|mesh-ancestor
65029512|NCT02992743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029513|NCT02992743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65029514|NCT02992743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65029515|NCT02992743|Alkylating Agents|alkylating agents|mesh-ancestor
65029516|NCT02992743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029517|NCT02992743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029518|NCT02992743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65029519|NCT02960022|Prednisone|prednisone|mesh-list
65029520|NCT02960022|Abiraterone Acetate|abiraterone acetate|mesh-list
65029521|NCT02960022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65029522|NCT02960022|Glucocorticoids|glucocorticoids|mesh-ancestor
65029523|NCT02960022|Hormones|hormones|mesh-ancestor
65029524|NCT02960022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65029525|NCT02960022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029553|NCT02579473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029555|NCT02578732|Oxaliplatin|oxaliplatin|mesh-list
65029556|NCT02578732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029557|NCT02578732|Antidotes|antidotes|mesh-ancestor
65029558|NCT02578732|Protective Agents|protective agents|mesh-ancestor
65029559|NCT02578732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029560|NCT02578732|Vitamin B Complex|vitamin b complex|mesh-ancestor
65029561|NCT02578732|Vitamins|vitamins|mesh-ancestor
65029562|NCT02578732|Micronutrients|micronutrients|mesh-ancestor
65029563|NCT02513394|Palbociclib|palbociclib|mesh-list
65029564|NCT02513394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029565|NCT02513394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65029566|NCT02513394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029567|NCT02513394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029568|NCT02427620|Cytarabine|cytarabine|mesh-list
65029569|NCT02427620|Dexamethasone|dexamethasone|mesh-list
65029570|NCT02427620|Dexamethasone acetate|dexamethasone acetate|mesh-list
65029571|NCT02427620|Cyclophosphamide|cyclophosphamide|mesh-list
65029572|NCT02427620|Rituximab|rituximab|mesh-list
65029573|NCT02427620|Doxorubicin|doxorubicin|mesh-list
65029606|NCT02427620|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65029607|NCT02427620|Abortifacient Agents|abortifacient agents|mesh-ancestor
65029608|NCT02427620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65029609|NCT02427620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65029610|NCT02427620|Antimetabolites|antimetabolites|mesh-ancestor
65029611|NCT02427620|Dermatologic Agents|dermatologic agents|mesh-ancestor
65029612|NCT02427620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65029613|NCT02427620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65029614|NCT02427620|Antiviral Agents|antiviral agents|mesh-ancestor
65029615|NCT02427620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65029616|NCT02427620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65029645|NCT02365766|Antimetabolites|antimetabolites|mesh-ancestor
65029646|NCT02365766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029647|NCT02365766|Antiviral Agents|antiviral agents|mesh-ancestor
65029648|NCT02365766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65029649|NCT02365766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029650|NCT02365766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65029651|NCT02365766|Immunologic Factors|immunologic factors|mesh-ancestor
65029652|NCT02365766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029653|NCT02365766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65029654|NCT02324387|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
65029655|NCT02324387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65029656|NCT02324387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029657|NCT02153944|Propranolol|propranolol|mesh-list
65029658|NCT02153944|Methylphenidate|methylphenidate|mesh-list
65029659|NCT02153944|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65029660|NCT02153944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029661|NCT02153944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65029698|NCT02112916|Vincristine|vincristine|mesh-list
65029699|NCT02112916|Etoposide phosphate|etoposide phosphate|mesh-list
65029700|NCT02112916|Bortezomib|bortezomib|mesh-list
65029701|NCT02112916|Daunorubicin|daunorubicin|mesh-list
65029702|NCT02112916|Asparaginase|asparaginase|mesh-list
65029704|NCT02112916|Podophyllotoxin|podophyllotoxin|mesh-list
64583847|NCT04272333|Nivolumab|nivolumab|mesh-list
65029763|NCT02060721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029764|NCT02060721|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65029765|NCT01631617|Doxycycline|doxycycline|mesh-list
65029766|NCT01631617|Cephalexin|cephalexin|mesh-list
65029767|NCT01631617|Trimethoprim|trimethoprim|mesh-list
65029768|NCT01631617|Sulfamethoxazole|sulfamethoxazole|mesh-list
64583898|NCT05748561|Hematinics|hematinics|mesh-ancestor
65029788|NCT01553214|Autonomic Agents|autonomic agents|mesh-ancestor
65029789|NCT01553214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65029790|NCT01553214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029791|NCT01553214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64472334|NCT03527043|Citalopram|citalopram|mesh-list
65029792|NCT01553214|Glucocorticoids|glucocorticoids|mesh-ancestor
65029793|NCT01553214|Hormones|hormones|mesh-ancestor
65029794|NCT01553214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65029795|NCT01553214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65029796|NCT01553214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029797|NCT01527149|Cytarabine|cytarabine|mesh-list
65029798|NCT01527149|Dexamethasone|dexamethasone|mesh-list
65029799|NCT01527149|Dexamethasone acetate|dexamethasone acetate|mesh-list
65029800|NCT01527149|Cyclophosphamide|cyclophosphamide|mesh-list
65029801|NCT01527149|Doxorubicin|doxorubicin|mesh-list
65029802|NCT01527149|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65029803|NCT01527149|Methotrexate|methotrexate|mesh-list
65029804|NCT01527149|Vincristine|vincristine|mesh-list
65029805|NCT01527149|Ofatumumab|ofatumumab|mesh-list
65029806|NCT01527149|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65029807|NCT01527149|BB 1101|bb 1101|mesh-list
65029808|NCT01527149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65029809|NCT01527149|Immunologic Factors|immunologic factors|mesh-ancestor
65029810|NCT01527149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029811|NCT01527149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65029812|NCT01527149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65029813|NCT01527149|Alkylating Agents|alkylating agents|mesh-ancestor
65029814|NCT01527149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029815|NCT01527149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029816|NCT01527149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65029817|NCT01527149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65029818|NCT01527149|Antiemetics|antiemetics|mesh-ancestor
65029819|NCT01527149|Autonomic Agents|autonomic agents|mesh-ancestor
65029820|NCT01527149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65029821|NCT01527149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65029822|NCT01527149|Glucocorticoids|glucocorticoids|mesh-ancestor
65029823|NCT01527149|Hormones|hormones|mesh-ancestor
64583935|NCT01591577|Temozolomide|temozolomide|mesh-list
65029941|NCT00576979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029942|NCT00576979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65029943|NCT00576979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65029944|NCT00576979|Alkylating Agents|alkylating agents|mesh-ancestor
65029945|NCT00576979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029946|NCT00576979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029947|NCT00576979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65029948|NCT00576979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65029949|NCT00576979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65029950|NCT00576979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65029951|NCT00576979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029952|NCT00324922|Vancomycin|vancomycin|mesh-list
65029953|NCT00324922|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65029954|NCT00324922|Trimethoprim|trimethoprim|mesh-list
65029955|NCT00324922|Sulfamethoxazole|sulfamethoxazole|mesh-list
65029956|NCT00324922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65029957|NCT00324922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65029958|NCT00324922|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65029989|NCT00324805|Antimetabolites|antimetabolites|mesh-ancestor
65029990|NCT00324805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029991|NCT00324805|Antiviral Agents|antiviral agents|mesh-ancestor
65029992|NCT00324805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65029993|NCT00324805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029994|NCT00324805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65029995|NCT00324805|Tubulin Modulators|tubulin modulators|mesh-ancestor
65029996|NCT00324805|Antimitotic Agents|antimitotic agents|mesh-ancestor
65029997|NCT00324805|Mitosis Modulators|mitosis modulators|mesh-ancestor
65029998|NCT00324805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65029999|NCT00324805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65030000|NCT00324805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65030002|NCT00192855|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65030003|NCT00192855|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65030004|NCT00192855|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65030005|NCT00192855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584089|NCT00328861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65030029|NCT00163748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030030|NCT00163748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65030031|NCT00163748|Tubulin Modulators|tubulin modulators|mesh-ancestor
65030032|NCT00163748|Antimitotic Agents|antimitotic agents|mesh-ancestor
65030033|NCT00163748|Mitosis Modulators|mitosis modulators|mesh-ancestor
65030034|NCT00193011|Cyclophosphamide|cyclophosphamide|mesh-list
65030035|NCT00193011|Docetaxel|docetaxel|mesh-list
65030036|NCT00193011|Fluorouracil|fluorouracil|mesh-list
65030037|NCT00193011|Methotrexate|methotrexate|mesh-list
65030038|NCT00193011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65030039|NCT00193011|Immunologic Factors|immunologic factors|mesh-ancestor
65030040|NCT00193011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030041|NCT00193011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65030042|NCT00193011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65030043|NCT00193011|Alkylating Agents|alkylating agents|mesh-ancestor
65030044|NCT00193011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030045|NCT00193011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030046|NCT00193011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65030047|NCT00193011|Tubulin Modulators|tubulin modulators|mesh-ancestor
65030048|NCT00193011|Antimitotic Agents|antimitotic agents|mesh-ancestor
65030049|NCT00193011|Mitosis Modulators|mitosis modulators|mesh-ancestor
65030050|NCT00193011|Antimetabolites|antimetabolites|mesh-ancestor
65030051|NCT00193011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65030052|NCT00193011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65030053|NCT00193011|Abortifacient Agents|abortifacient agents|mesh-ancestor
65030054|NCT00193011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65030055|NCT00193011|Dermatologic Agents|dermatologic agents|mesh-ancestor
65030056|NCT00193011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584136|NCT05192369|Moxifloxacin|moxifloxacin|mesh-list
65030085|NCT05208307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65030086|NCT05208307|Glucocorticoids|glucocorticoids|mesh-ancestor
65030087|NCT05208307|Hormones|hormones|mesh-ancestor
65030088|NCT05208307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65030089|NCT05208307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65030090|NCT05208307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030091|NCT05208307|Protease Inhibitors|protease inhibitors|mesh-ancestor
65030092|NCT05208307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030093|NCT05208307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030094|NCT05208307|Immunologic Factors|immunologic factors|mesh-ancestor
65030095|NCT05208307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65030096|NCT05208307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65030097|NCT05208307|Growth Substances|growth substances|mesh-ancestor
65030098|NCT05208307|Growth Inhibitors|growth inhibitors|mesh-ancestor
65030099|NCT05208307|Dermatologic Agents|dermatologic agents|mesh-ancestor
65030100|NCT00193245|Docetaxel|docetaxel|mesh-list
65030101|NCT00193245|Topotecan|topotecan|mesh-list
65030102|NCT00193245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030103|NCT00193245|Tubulin Modulators|tubulin modulators|mesh-ancestor
65030104|NCT00193245|Antimitotic Agents|antimitotic agents|mesh-ancestor
64584194|NCT00559845|Paclitaxel|paclitaxel|mesh-list
65030168|NCT00193362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030202|NCT05077969|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65030203|NCT05077969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65030205|NCT05077969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030206|NCT05077969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65030207|NCT05077969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65030208|NCT05077969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65030356|NCT04743934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65030357|NCT04743934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030358|NCT00176241|Gemcitabine|gemcitabine|mesh-list
65030359|NCT00176241|Paclitaxel|paclitaxel|mesh-list
65030360|NCT00176241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65030361|NCT00176241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584447|NCT01432574|Vaccines|vaccines|mesh-list
65030395|NCT00164801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65031406|NCT02906176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65031407|NCT02906176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031408|NCT02906176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031409|NCT02906176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65031410|NCT02906176|Hormone Antagonists|hormone antagonists|mesh-ancestor
65031411|NCT02906176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65031667|NCT02904109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65031669|NCT00178113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65031670|NCT00178113|Antioxidants|antioxidants|mesh-ancestor
65031671|NCT00178113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031672|NCT00178113|Protective Agents|protective agents|mesh-ancestor
65031673|NCT00178113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031674|NCT00178113|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65031675|NCT00178113|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65031676|NCT00178113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031677|NCT02903524|Cyclophosphamide|cyclophosphamide|mesh-list
65031678|NCT02903524|Doxorubicin|doxorubicin|mesh-list
65032068|NCT00408174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65032069|NCT00408174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65032070|NCT00408174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65032072|NCT00169520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032658|NCT00171002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65032659|NCT00171002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032660|NCT00171002|Vasodilator Agents|vasodilator agents|mesh-ancestor
65032661|NCT00171002|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65032662|NCT00171002|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65032663|NCT05400031|Propolis|propolis|mesh-list
65032664|NCT05400031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032665|NCT00171041|Valsartan|valsartan|mesh-list
65032666|NCT00171041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65032667|NCT00171041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65032668|NCT00171041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65032669|NCT00171041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032670|NCT05393674|Nivolumab|nivolumab|mesh-list
65032671|NCT05393674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65032672|NCT05393674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032673|NCT05393674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65032674|NCT05393674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032675|NCT05392699|Interleukin-12|interleukin-12|mesh-list
65032676|NCT05392699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65032677|NCT05392699|Immunologic Factors|immunologic factors|mesh-ancestor
65032678|NCT05392699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032679|NCT05392699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65032680|NCT05392699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65032681|NCT05392699|Growth Substances|growth substances|mesh-ancestor
65032682|NCT05392699|Growth Inhibitors|growth inhibitors|mesh-ancestor
65032711|NCT02102113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65032712|NCT02102113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032713|NCT02102113|Hormones|hormones|mesh-ancestor
65032714|NCT02102113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65032715|NCT05379790|Irinotecan|irinotecan|mesh-list
65032716|NCT05379790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65032717|NCT05379790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65032718|NCT05379790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032719|NCT05379790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032720|NCT05379790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032721|NCT05349448|Triamcinolone|triamcinolone|mesh-list
65032722|NCT05349448|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65032723|NCT05349448|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65032724|NCT05349448|Dexmedetomidine|dexmedetomidine|mesh-list
65032725|NCT05349448|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65032726|NCT05349448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65032727|NCT05349448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65032859|NCT00171626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65032860|NCT00171626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65032861|NCT00171626|Analgesics|analgesics|mesh-ancestor
65032862|NCT00171626|Sensory System Agents|sensory system agents|mesh-ancestor
64884818|NCT03623633|Denosumab|denosumab|mesh-list
65032878|NCT00171665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65032879|NCT00171665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65032880|NCT00171665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032881|NCT00171665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032882|NCT00179751|Gemcitabine|gemcitabine|mesh-list
65032883|NCT00179751|Lenalidomide|lenalidomide|mesh-list
65032884|NCT00179751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65032885|NCT00179751|Antimetabolites|antimetabolites|mesh-ancestor
65032886|NCT00179751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032887|NCT00179751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032888|NCT00179751|Antiviral Agents|antiviral agents|mesh-ancestor
65032889|NCT00179751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032890|NCT00179751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032891|NCT00179751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65032892|NCT00179751|Immunologic Factors|immunologic factors|mesh-ancestor
65032893|NCT00179751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032894|NCT00179751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65032895|NCT00179751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65032896|NCT00179751|Growth Substances|growth substances|mesh-ancestor
65032897|NCT00179751|Growth Inhibitors|growth inhibitors|mesh-ancestor
65032898|NCT05223478|Phentolamine|phentolamine|mesh-list
65032899|NCT05223478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64810800|NCT01443195|Iron|iron|mesh-list
65032900|NCT05223478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65032901|NCT05223478|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65032902|NCT05223478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65032903|NCT05223478|Adrenergic Agents|adrenergic agents|mesh-ancestor
65032904|NCT05223478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65032905|NCT05223478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032906|NCT05223478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032907|NCT05223478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65032908|NCT00171743|Cyclosporine|cyclosporine|mesh-list
65032909|NCT00171743|Cyclosporins|cyclosporins|mesh-list
65032910|NCT00171743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032911|NCT00171743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032912|NCT00171743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65032913|NCT00171743|Immunologic Factors|immunologic factors|mesh-ancestor
65032914|NCT00171743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032915|NCT00171743|Antifungal Agents|antifungal agents|mesh-ancestor
65032916|NCT00171743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032917|NCT00171743|Dermatologic Agents|dermatologic agents|mesh-ancestor
65032918|NCT00171743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65032919|NCT00171743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65032920|NCT05209360|Carbon Fiber|carbon fiber|mesh-list
65032951|NCT00197418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65032952|NCT00197418|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65032953|NCT00197418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032954|NCT00197418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032955|NCT00197418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65032956|NCT00197418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65032957|NCT00197418|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65032958|NCT00197418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65032959|NCT00197418|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65032960|NCT05103904|Lenvatinib|lenvatinib|mesh-list
65032961|NCT05103904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032962|NCT05103904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65032963|NCT05103904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884911|NCT02955082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033098|NCT04934449|Antifungal Agents|antifungal agents|mesh-ancestor
65033099|NCT04934449|Keratolytic Agents|keratolytic agents|mesh-ancestor
65033100|NCT04934449|Dermatologic Agents|dermatologic agents|mesh-ancestor
65033101|NCT03455179|Methamphetamine|methamphetamine|mesh-list
65033102|NCT03455179|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65033103|NCT03455179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033104|NCT03455179|Sympathomimetics|sympathomimetics|mesh-ancestor
65033105|NCT03455179|Autonomic Agents|autonomic agents|mesh-ancestor
65033106|NCT03455179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65033107|NCT03455179|Dopamine Agents|dopamine agents|mesh-ancestor
65033108|NCT03455179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65033109|NCT03455179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033110|NCT03455179|Adrenergic Agents|adrenergic agents|mesh-ancestor
65033111|NCT03455179|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65033229|NCT04534270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033230|NCT02908282|Povidone|povidone|mesh-list
65033231|NCT02908282|Plasma Substitutes|plasma substitutes|mesh-ancestor
65033232|NCT02908282|Blood Substitutes|blood substitutes|mesh-ancestor
65033233|NCT02908126|Oxytocin|oxytocin|mesh-list
65033234|NCT02908126|Oxytocics|oxytocics|mesh-ancestor
65033235|NCT02908126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65033236|NCT02908126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033476|NCT02072863|Glucocorticoids|glucocorticoids|mesh-ancestor
65033477|NCT02072863|Hormones|hormones|mesh-ancestor
65033478|NCT02072863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65033479|NCT02072863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033480|NCT02072863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65033481|NCT02072863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033482|NCT02072863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65033483|NCT02072863|Alkylating Agents|alkylating agents|mesh-ancestor
65033484|NCT02072863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033485|NCT02072863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65033486|NCT02072863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65033487|NCT02072863|Immunologic Factors|immunologic factors|mesh-ancestor
65033488|NCT02072161|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
65033489|NCT02072161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64885428|NCT03395704|Hepcidins|hepcidins|mesh-list
65033675|NCT00410631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033677|NCT00410631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65033678|NCT00410631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65033679|NCT00410631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65033680|NCT00410631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65033681|NCT00410631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033682|NCT00410631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65033683|NCT00410631|Tubulin Modulators|tubulin modulators|mesh-ancestor
65033684|NCT00410631|Antimitotic Agents|antimitotic agents|mesh-ancestor
65033685|NCT00410631|Mitosis Modulators|mitosis modulators|mesh-ancestor
65033686|NCT00410631|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65033687|NCT00410631|Dermatologic Agents|dermatologic agents|mesh-ancestor
65033688|NCT00410631|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65033689|NCT01930357|Vaccines|vaccines|mesh-list
65033690|NCT01930357|Immunologic Factors|immunologic factors|mesh-ancestor
65033691|NCT01930357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033692|NCT01913158|Hydrocortisone|hydrocortisone|mesh-list
65033693|NCT01913158|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65033694|NCT01913158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65033695|NCT01903954|Ribavirin|ribavirin|mesh-list
65033696|NCT01903954|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65033697|NCT01903954|Antimetabolites|antimetabolites|mesh-ancestor
65033698|NCT01903954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033699|NCT01903954|Antiviral Agents|antiviral agents|mesh-ancestor
65033700|NCT01903954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65033701|NCT01893190|Nimodipine|nimodipine|mesh-list
65033702|NCT01893190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65033703|NCT01893190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65033704|NCT01893190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65033705|NCT01893190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033706|NCT01893190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65033707|NCT01893190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033708|NCT01893190|Vasodilator Agents|vasodilator agents|mesh-ancestor
65033709|NCT00198588|Argatroban|argatroban|mesh-list
65033710|NCT00198588|Antithrombins|antithrombins|mesh-ancestor
65033711|NCT00198588|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65033712|NCT00198588|Protease Inhibitors|protease inhibitors|mesh-ancestor
65033713|NCT00198588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033714|NCT00198588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033715|NCT00198588|Anticoagulants|anticoagulants|mesh-ancestor
65033716|NCT00198588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65033717|NCT01887886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65033718|NCT01887886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033745|NCT00198627|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65033746|NCT00198627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65033747|NCT00198627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65033748|NCT00198627|Renal Agents|renal agents|mesh-ancestor
65033749|NCT00198627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65033750|NCT00198627|Antimalarials|antimalarials|mesh-ancestor
65033751|NCT00198627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65033752|NCT00198627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65033753|NCT01862224|Methotrexate|methotrexate|mesh-list
65033754|NCT01862224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65033755|NCT01862224|Abortifacient Agents|abortifacient agents|mesh-ancestor
65033756|NCT01862224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65033757|NCT01862224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033758|NCT01862224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65033759|NCT01862224|Antimetabolites|antimetabolites|mesh-ancestor
65033760|NCT01862224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033761|NCT01862224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033762|NCT01862224|Dermatologic Agents|dermatologic agents|mesh-ancestor
65033763|NCT01862224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033764|NCT01862224|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65033765|NCT01862224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65033777|NCT00173888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033778|NCT00173888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65033779|NCT00173888|Antimetabolites|antimetabolites|mesh-ancestor
65033780|NCT00173888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033781|NCT00173888|Antiviral Agents|antiviral agents|mesh-ancestor
65033782|NCT00173888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65033783|NCT00173888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033784|NCT00173888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65033785|NCT00173888|Immunologic Factors|immunologic factors|mesh-ancestor
65033786|NCT00173888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033787|NCT00173888|Tubulin Modulators|tubulin modulators|mesh-ancestor
65033788|NCT00173888|Antimitotic Agents|antimitotic agents|mesh-ancestor
65033789|NCT00173888|Mitosis Modulators|mitosis modulators|mesh-ancestor
65033790|NCT00555022|Bromides|bromides|mesh-list
65033791|NCT00555022|Tiotropium Bromide|tiotropium bromide|mesh-list
65033792|NCT00555022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65033793|NCT00555022|Autonomic Agents|autonomic agents|mesh-ancestor
65033794|NCT00555022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65033795|NCT00555022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033796|NCT00555022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65033797|NCT00555022|Respiratory System Agents|respiratory system agents|mesh-ancestor
65033798|NCT00555022|Parasympatholytics|parasympatholytics|mesh-ancestor
65033799|NCT00555022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65033800|NCT00555022|Cholinergic Agents|cholinergic agents|mesh-ancestor
65033801|NCT00555022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65033802|NCT00555022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033803|NCT00555022|Anticonvulsants|anticonvulsants|mesh-ancestor
65033804|NCT00203385|Valproic Acid|valproic acid|mesh-list
65033805|NCT00203385|Anticonvulsants|anticonvulsants|mesh-ancestor
65033806|NCT00203385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033807|NCT00203385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033808|NCT00203385|GABA Agents|gaba agents|mesh-ancestor
65033809|NCT00203385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65033810|NCT00203385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033811|NCT00203385|Antimanic Agents|antimanic agents|mesh-ancestor
65033812|NCT00203385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65033813|NCT00203385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65033814|NCT00203385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65033815|NCT00555100|Dexamethasone|dexamethasone|mesh-list
65033816|NCT00555100|Lenalidomide|lenalidomide|mesh-list
65033817|NCT00555100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65033818|NCT00555100|Antiemetics|antiemetics|mesh-ancestor
65033819|NCT00555100|Autonomic Agents|autonomic agents|mesh-ancestor
65033820|NCT00555100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65033821|NCT00555100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033822|NCT00555100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65033823|NCT00555100|Glucocorticoids|glucocorticoids|mesh-ancestor
65033824|NCT00555100|Hormones|hormones|mesh-ancestor
65033825|NCT00555100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65033826|NCT00555100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65033827|NCT00555100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033828|NCT00555100|Immunologic Factors|immunologic factors|mesh-ancestor
65033829|NCT00555100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65033830|NCT00555100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65033831|NCT00555100|Growth Substances|growth substances|mesh-ancestor
65033858|NCT00407849|Immunologic Factors|immunologic factors|mesh-ancestor
65033859|NCT00407849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033860|NCT00407849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033862|NCT00407927|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65033863|NCT00407927|Histamine Antagonists|histamine antagonists|mesh-ancestor
65033864|NCT00407927|Histamine Agents|histamine agents|mesh-ancestor
65033865|NCT00407927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65033866|NCT00407927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033867|NCT00407927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033868|NCT01818076|Botulinum Toxins|botulinum toxins|mesh-list
65033869|NCT01818076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65033870|NCT01818076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65033871|NCT01818076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65033872|NCT01818076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65033873|NCT01818076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033874|NCT01818076|Cholinergic Agents|cholinergic agents|mesh-ancestor
65033875|NCT01818076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65033876|NCT01818076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033877|NCT01818076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65033878|NCT01818076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65033879|NCT01807546|ON 01910|on 01910|mesh-list
65033894|NCT01785433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65033895|NCT01785433|Cholinergic Agents|cholinergic agents|mesh-ancestor
65033896|NCT01785433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65033897|NCT01785433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033898|NCT00203580|Tinzaparin|tinzaparin|mesh-list
65033899|NCT00203580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65033900|NCT00203580|Dalteparin|dalteparin|mesh-list
65033901|NCT00203580|Anticoagulants|anticoagulants|mesh-ancestor
65033902|NCT00203580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64472384|NCT03451487|Acetaminophen|acetaminophen|mesh-list
65033903|NCT00203580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65033904|NCT00203580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033905|NCT01777555|Levodopa|levodopa|mesh-list
65033906|NCT01777555|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65033907|NCT01777555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65033908|NCT01777555|Dopamine Agents|dopamine agents|mesh-ancestor
65033909|NCT01777555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65033910|NCT01777555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033911|NCT01777555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033912|NCT01773928|Vaccines|vaccines|mesh-list
65033913|NCT01773928|Immunologic Factors|immunologic factors|mesh-ancestor
65033914|NCT01773928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033915|NCT01768975|Dapansutrile|dapansutrile|mesh-list
65033916|NCT01768975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65033917|NCT01756924|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65033918|NCT01756924|Vancomycin|vancomycin|mesh-list
65033919|NCT01756924|Ciprofloxacin|ciprofloxacin|mesh-list
65033920|NCT01756924|Levofloxacin|levofloxacin|mesh-list
65033921|NCT01756924|Rifampin|rifampin|mesh-list
65033922|NCT01756924|Cefazolin|cefazolin|mesh-list
65033923|NCT01756924|Ceftriaxone|ceftriaxone|mesh-list
65033924|NCT01756924|Linezolid|linezolid|mesh-list
65033925|NCT01756924|Daptomycin|daptomycin|mesh-list
65033926|NCT01756924|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65033927|NCT01756924|Oxacillin|oxacillin|mesh-list
65033928|NCT01756924|Nafcillin|nafcillin|mesh-list
65033929|NCT01756924|Fusidic Acid|fusidic acid|mesh-list
65033930|NCT01756924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65033931|NCT01756924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65033932|NCT01756924|Antitubercular Agents|antitubercular agents|mesh-ancestor
65033933|NCT01756924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65033934|NCT01756924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65033935|NCT01756924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033936|NCT01756924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033937|NCT01756924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033938|NCT01756924|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65033939|NCT01756924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65033940|NCT01756924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65033959|NCT01756339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65033960|NCT01756339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033961|NCT01756339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033962|NCT01756339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033964|NCT00174200|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65033965|NCT00174200|Serotonin Agents|serotonin agents|mesh-ancestor
65033966|NCT00174200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65033967|NCT00174200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033968|NCT00174200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033969|NCT00174200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65033970|NCT00174200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65033971|NCT00174200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65033972|NCT00174200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65033973|NCT00174200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65033974|NCT00174200|Dopamine Agents|dopamine agents|mesh-ancestor
65033975|NCT00203658|Tinzaparin|tinzaparin|mesh-list
65033976|NCT00203658|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65033977|NCT00203658|Dalteparin|dalteparin|mesh-list
65033978|NCT00203658|Anticoagulants|anticoagulants|mesh-ancestor
65033979|NCT00203658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65033980|NCT00203658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65033981|NCT00203658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033982|NCT00174239|Levodopa|levodopa|mesh-list
65033983|NCT00174239|Carbidopa|carbidopa|mesh-list
65033984|NCT00174239|Cabergoline|cabergoline|mesh-list
65033985|NCT00174239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65033986|NCT00174239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65033987|NCT00174239|Dopamine Agents|dopamine agents|mesh-ancestor
65033988|NCT00174239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65033989|NCT00174239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033990|NCT00174239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033991|NCT00174239|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65033992|NCT00174239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033993|NCT00174239|Dopamine Agonists|dopamine agonists|mesh-ancestor
65033994|NCT00203697|Minocycline|minocycline|mesh-list
65033995|NCT00203697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65033996|NCT00203697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65033997|NCT00174317|Celecoxib|celecoxib|mesh-list
65033998|NCT00174317|Diclofenac|diclofenac|mesh-list
65034018|NCT01737892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034019|NCT01737892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034020|NCT01737892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65034021|NCT01737892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65034022|NCT01737892|Autonomic Agents|autonomic agents|mesh-ancestor
65034023|NCT01737892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65034024|NCT01737892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65034025|NCT01737892|Respiratory System Agents|respiratory system agents|mesh-ancestor
65034026|NCT01737892|Mydriatics|mydriatics|mesh-ancestor
65034027|NCT01737892|Sympathomimetics|sympathomimetics|mesh-ancestor
65034028|NCT01737892|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65034029|NCT00203736|Artesunate|artesunate|mesh-list
65034030|NCT00203736|Pyrimethamine|pyrimethamine|mesh-list
65034031|NCT00203736|Sulfadoxine|sulfadoxine|mesh-list
65034032|NCT00203736|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65034033|NCT00203736|Antimalarials|antimalarials|mesh-ancestor
65034034|NCT00203736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65034035|NCT00203736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65034036|NCT00203736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65034037|NCT00203736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034039|NCT00203736|Schistosomicides|schistosomicides|mesh-ancestor
65034040|NCT00203736|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65034041|NCT00203736|Anthelmintics|anthelmintics|mesh-ancestor
65034042|NCT00203736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65034043|NCT00203736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034044|NCT00203736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034045|NCT00203736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65034046|NCT00203736|Renal Agents|renal agents|mesh-ancestor
65034047|NCT01719016|Adenosine|adenosine|mesh-list
65034048|NCT01719016|Analgesics|analgesics|mesh-ancestor
65034049|NCT01719016|Sensory System Agents|sensory system agents|mesh-ancestor
65034050|NCT01719016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65034051|NCT01719016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034052|NCT01719016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65034053|NCT01719016|Vasodilator Agents|vasodilator agents|mesh-ancestor
65034054|NCT01719016|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65034055|NCT01719016|Purinergic Agonists|purinergic agonists|mesh-ancestor
65034083|NCT00203775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034084|NCT00203775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034085|NCT00203775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65034086|NCT00203775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65034087|NCT00203775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65034088|NCT00203775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65034089|NCT00203775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65034090|NCT00203775|Dopamine Agents|dopamine agents|mesh-ancestor
65034091|NCT00555256|Sirolimus|sirolimus|mesh-list
65034092|NCT00555256|Sunitinib|sunitinib|mesh-list
65034093|NCT00555256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034094|NCT00555256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65034095|NCT00555256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65034096|NCT00555256|Growth Substances|growth substances|mesh-ancestor
65034097|NCT00555256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034098|NCT00555256|Growth Inhibitors|growth inhibitors|mesh-ancestor
65034099|NCT00555256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65034100|NCT00555256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034101|NCT00555256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034102|NCT00555256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65034121|NCT00174434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65034122|NCT00174434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034124|NCT00203814|Pyrimethamine|pyrimethamine|mesh-list
65034125|NCT00203814|Sulfadoxine|sulfadoxine|mesh-list
65034126|NCT00203814|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65034127|NCT00203814|Antimalarials|antimalarials|mesh-ancestor
65034128|NCT00203814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65034129|NCT00203814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65034130|NCT00203814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65034131|NCT00203814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034132|NCT00203814|Antiviral Agents|antiviral agents|mesh-ancestor
65034133|NCT00203814|Schistosomicides|schistosomicides|mesh-ancestor
65034134|NCT00203814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65034135|NCT00203814|Anthelmintics|anthelmintics|mesh-ancestor
65034136|NCT00203814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65034137|NCT00203814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034138|NCT00203814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034139|NCT00203814|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65034140|NCT00203814|Renal Agents|renal agents|mesh-ancestor
65034141|NCT00174473|Voriconazole|voriconazole|mesh-list
65034142|NCT00174473|Antifungal Agents|antifungal agents|mesh-ancestor
65034143|NCT00174473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65034144|NCT00174473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65034145|NCT00174473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65034146|NCT00174473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034147|NCT00174473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034148|NCT00174473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65034149|NCT00174473|Hormone Antagonists|hormone antagonists|mesh-ancestor
65034150|NCT00174473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65034151|NCT00174473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034152|NCT00174473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65034153|NCT00174512|Moxifloxacin|moxifloxacin|mesh-list
65034154|NCT00174512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65034155|NCT00174512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65034156|NCT00174512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65034157|NCT00174512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65034171|NCT00199017|Thioguanine|thioguanine|mesh-list
65034173|NCT00199017|Vindesine|vindesine|mesh-list
65034174|NCT00199017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65034175|NCT00199017|Immunologic Factors|immunologic factors|mesh-ancestor
65034176|NCT00199017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034177|NCT00199017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65034178|NCT00199017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65034179|NCT00199017|Alkylating Agents|alkylating agents|mesh-ancestor
65034180|NCT00199017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034181|NCT00199017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034182|NCT00199017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65034183|NCT00199017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65034184|NCT00199017|Antiemetics|antiemetics|mesh-ancestor
65034185|NCT00199017|Autonomic Agents|autonomic agents|mesh-ancestor
64475508|NCT01793350|Benphothiamine|benphothiamine|mesh-list
65034186|NCT00199017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65034187|NCT00199017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65034188|NCT00199017|Glucocorticoids|glucocorticoids|mesh-ancestor
65034190|NCT00199017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65034191|NCT00199017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65034192|NCT00199017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65034193|NCT00199017|Abortifacient Agents|abortifacient agents|mesh-ancestor
65034194|NCT00199017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65034195|NCT00199017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65034196|NCT00199017|Antimetabolites|antimetabolites|mesh-ancestor
65034197|NCT00199017|Dermatologic Agents|dermatologic agents|mesh-ancestor
65034198|NCT00199017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034199|NCT00199017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65034200|NCT00199017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65034201|NCT00199017|Antiviral Agents|antiviral agents|mesh-ancestor
65034202|NCT00199017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65034203|NCT00199017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65034204|NCT00199017|Tubulin Modulators|tubulin modulators|mesh-ancestor
65034205|NCT00199017|Antimitotic Agents|antimitotic agents|mesh-ancestor
65034206|NCT00199017|Mitosis Modulators|mitosis modulators|mesh-ancestor
65034207|NCT00199017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65034208|NCT00199017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65034209|NCT00199017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65034210|NCT01665391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65034211|NCT01665391|Immunologic Factors|immunologic factors|mesh-ancestor
65034212|NCT01665391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034213|NCT01660633|Melphalan|melphalan|mesh-list
65034214|NCT01660633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65034215|NCT01660633|Alkylating Agents|alkylating agents|mesh-ancestor
65034216|NCT01660633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034217|NCT01660633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034218|NCT01660633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65034219|NCT01660633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65034220|NCT01660633|Immunologic Factors|immunologic factors|mesh-ancestor
65034221|NCT01660633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034222|NCT00174551|Prazosin|prazosin|mesh-list
65034237|NCT00174590|Serotonin Agents|serotonin agents|mesh-ancestor
65034238|NCT00174590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65034239|NCT00174590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034240|NCT00174590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034241|NCT00174590|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65034242|NCT00174590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65034243|NCT00174590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65034244|NCT00174590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65034245|NCT00174590|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65034246|NCT00174590|Dopamine Agents|dopamine agents|mesh-ancestor
65034247|NCT01652482|Leucovorin|leucovorin|mesh-list
65034248|NCT01652482|Fluorouracil|fluorouracil|mesh-list
65034249|NCT01652482|Irinotecan|irinotecan|mesh-list
65034250|NCT01652482|Cetuximab|cetuximab|mesh-list
65034251|NCT01652482|Antimetabolites|antimetabolites|mesh-ancestor
65034252|NCT01652482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034253|NCT01652482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65034254|NCT01652482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034255|NCT01652482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65034256|NCT01652482|Immunologic Factors|immunologic factors|mesh-ancestor
65034257|NCT01652482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034258|NCT01652482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65034259|NCT01652482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64519458|NCT00170157|Ipilimumab|ipilimumab|mesh-list
65034260|NCT01652482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034261|NCT01652482|Antidotes|antidotes|mesh-ancestor
65034262|NCT01652482|Protective Agents|protective agents|mesh-ancestor
65034263|NCT01652482|Vitamin B Complex|vitamin b complex|mesh-ancestor
65034264|NCT01652482|Vitamins|vitamins|mesh-ancestor
65034265|NCT01652482|Micronutrients|micronutrients|mesh-ancestor
65034266|NCT01652482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65034267|NCT00174629|Gemcitabine|gemcitabine|mesh-list
65034268|NCT00174629|Docetaxel|docetaxel|mesh-list
65034269|NCT00174629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65034270|NCT00174629|Antimetabolites|antimetabolites|mesh-ancestor
65034271|NCT00174629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034272|NCT00174629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034273|NCT00174629|Antiviral Agents|antiviral agents|mesh-ancestor
65034274|NCT00174629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65034275|NCT00174629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034276|NCT00174629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65034277|NCT00174629|Immunologic Factors|immunologic factors|mesh-ancestor
65034278|NCT00174629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034279|NCT00174629|Tubulin Modulators|tubulin modulators|mesh-ancestor
65034280|NCT00174629|Antimitotic Agents|antimitotic agents|mesh-ancestor
65034281|NCT00174629|Mitosis Modulators|mitosis modulators|mesh-ancestor
65034282|NCT02962947|Propranolol|propranolol|mesh-list
65034299|NCT00555334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65034300|NCT00555334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65034301|NCT00555334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65034303|NCT01640080|Antidepressive Agents|antidepressive agents|mesh-ancestor
65034304|NCT01640080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65034305|NCT00174668|Insulin|insulin|mesh-list
65034306|NCT00174668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65034307|NCT00174668|Insulin Glargine|insulin glargine|mesh-list
65034308|NCT00174668|Insulin glulisine|insulin glulisine|mesh-list
65034309|NCT00174668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65034310|NCT00174668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034311|NCT00174707|Cyclophosphamide|cyclophosphamide|mesh-list
65034312|NCT00174707|Docetaxel|docetaxel|mesh-list
65034313|NCT00174707|Methotrexate|methotrexate|mesh-list
65034314|NCT00174707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65034315|NCT00174707|Immunologic Factors|immunologic factors|mesh-ancestor
65034316|NCT00174707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034317|NCT00174707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65034318|NCT00174707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65034319|NCT00174707|Alkylating Agents|alkylating agents|mesh-ancestor
65034320|NCT00174707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034321|NCT00174707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034322|NCT00174707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65034323|NCT00174707|Tubulin Modulators|tubulin modulators|mesh-ancestor
65034324|NCT00174707|Antimitotic Agents|antimitotic agents|mesh-ancestor
65034325|NCT00174707|Mitosis Modulators|mitosis modulators|mesh-ancestor
65034326|NCT00174707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65034327|NCT00174707|Abortifacient Agents|abortifacient agents|mesh-ancestor
65034328|NCT00174707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65034329|NCT00174707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65034330|NCT00174707|Antimetabolites|antimetabolites|mesh-ancestor
65034331|NCT00174707|Dermatologic Agents|dermatologic agents|mesh-ancestor
65034332|NCT00174707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034333|NCT00174707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65066968|NCT00418704|Mitosis Modulators|mitosis modulators|mesh-ancestor
65034334|NCT00174707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65034336|NCT01235923|Hematinics|hematinics|mesh-ancestor
65034337|NCT00199134|Letrozole|letrozole|mesh-list
65034338|NCT00199134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034339|NCT00199134|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65034340|NCT00199134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65034341|NCT00199134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034372|NCT00712582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034373|NCT00712582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65034374|NCT00712582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65034375|NCT00712582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65034376|NCT00712582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65034377|NCT00712582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65034378|NCT00712582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034379|NCT00712582|Analgesics|analgesics|mesh-ancestor
65034380|NCT00712582|Sensory System Agents|sensory system agents|mesh-ancestor
65034381|NCT00712582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65034382|NCT00174902|Aspirin|aspirin|mesh-list
65034383|NCT00174902|Propranolol|propranolol|mesh-list
65034384|NCT00174902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65034385|NCT00174902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65034386|NCT00174902|Analgesics|analgesics|mesh-ancestor
64908243|NCT00001378|Fenretinide|fenretinide|mesh-list
65034409|NCT00373711|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65034410|NCT00373711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65034412|NCT00373711|Micronutrients|micronutrients|mesh-ancestor
65034413|NCT00373711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034414|NCT00373711|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65034415|NCT00373711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034416|NCT00199212|Trastuzumab|trastuzumab|mesh-list
65034417|NCT00199212|Bortezomib|bortezomib|mesh-list
65034418|NCT00199212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65034419|NCT00199212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034420|NCT00555373|Sirolimus|sirolimus|mesh-list
65034421|NCT00555373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65034422|NCT00555373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65034423|NCT00555373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65034424|NCT00555373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034425|NCT00555373|Antifungal Agents|antifungal agents|mesh-ancestor
65034426|NCT00555373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65034427|NCT00555373|Immunologic Factors|immunologic factors|mesh-ancestor
65034428|NCT00555373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034429|NCT00555412|Loxapine|loxapine|mesh-list
65034430|NCT00555412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65034431|NCT00555412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65034432|NCT00555412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65034433|NCT00555412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034434|NCT00555412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65034435|NCT00555412|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65034436|NCT00555412|Dopamine Agents|dopamine agents|mesh-ancestor
65034437|NCT00555412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65034438|NCT00555412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034439|NCT04676776|Levonorgestrel|levonorgestrel|mesh-list
65034450|NCT04676776|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65034452|NCT04676776|Hormone Antagonists|hormone antagonists|mesh-ancestor
65034453|NCT04676776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65034454|NCT04676776|Luteolytic Agents|luteolytic agents|mesh-ancestor
65034455|NCT04676776|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65034456|NCT00175253|Alemtuzumab|alemtuzumab|mesh-list
65034457|NCT00175253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65034458|NCT00175253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034459|NCT00199329|Ondansetron|ondansetron|mesh-list
65034460|NCT00199329|Antiemetics|antiemetics|mesh-ancestor
65034461|NCT00199329|Autonomic Agents|autonomic agents|mesh-ancestor
65034462|NCT00199329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65034463|NCT00199329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034464|NCT00199329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65034465|NCT00199329|Antipruritics|antipruritics|mesh-ancestor
65034466|NCT00199329|Dermatologic Agents|dermatologic agents|mesh-ancestor
65034467|NCT00199329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65034468|NCT00199329|Serotonin Agents|serotonin agents|mesh-ancestor
65034469|NCT00199329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65034470|NCT00199329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034471|NCT00199329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65034472|NCT00199329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65034473|NCT00199329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65034474|NCT00199329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65034475|NCT00199329|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65034476|NCT00555607|Prednisolone|prednisolone|mesh-list
65034477|NCT00555607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65034478|NCT00555607|Glucocorticoids|glucocorticoids|mesh-ancestor
65034479|NCT00555607|Hormones|hormones|mesh-ancestor
65034480|NCT00555607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65034481|NCT00555607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034482|NCT00555607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65034483|NCT00555607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034484|NCT00199368|Istradefylline|istradefylline|mesh-list
65034485|NCT00199368|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
65034486|NCT00199368|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65034487|NCT00199368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65034488|NCT00199368|Purinergic Agents|purinergic agents|mesh-ancestor
65034489|NCT00199368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65034490|NCT00199368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034491|NCT00199368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034493|NCT04675528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65034494|NCT04675528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034495|NCT04675528|Tubulin Modulators|tubulin modulators|mesh-ancestor
65034496|NCT04675528|Antimitotic Agents|antimitotic agents|mesh-ancestor
65034497|NCT04675528|Mitosis Modulators|mitosis modulators|mesh-ancestor
65034498|NCT04675528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034499|NCT04675177|Polidocanol|polidocanol|mesh-list
65034500|NCT04675177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65034501|NCT04675177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65034502|NCT00175370|Vancomycin|vancomycin|mesh-list
65034526|NCT04675372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65034527|NCT04675372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65034528|NCT04675372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65034529|NCT04675372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65034530|NCT04675372|Adrenergic Agents|adrenergic agents|mesh-ancestor
65034531|NCT04675372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65034532|NCT04675372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034533|NCT04675372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65034534|NCT04675372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65034535|NCT04675372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65034536|NCT04675372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65034537|NCT04675372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65034538|NCT04675372|Anesthetics, General|anesthetics, general|mesh-ancestor
65034539|NCT04675372|Anesthetics|anesthetics|mesh-ancestor
65034540|NCT04675372|GABA Modulators|gaba modulators|mesh-ancestor
65034541|NCT04675372|GABA Agents|gaba agents|mesh-ancestor
65034542|NCT04424602|Cyclophosphamide|cyclophosphamide|mesh-list
65034543|NCT04424602|Dimethoate|dimethoate|mesh-list
65034544|NCT04424602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034545|NCT04424602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034546|NCT04424602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034547|NCT04424602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65034548|NCT04424602|Cholinergic Agents|cholinergic agents|mesh-ancestor
65034549|NCT04424602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65034550|NCT04424602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034551|NCT04424602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65034552|NCT04424602|Immunologic Factors|immunologic factors|mesh-ancestor
65034553|NCT04424602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65034554|NCT04424602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65034555|NCT04424602|Alkylating Agents|alkylating agents|mesh-ancestor
64886469|NCT01947114|Ketamine|ketamine|mesh-list
65034588|NCT04306393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65034589|NCT04306393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034590|NCT04306393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65034591|NCT04306393|Respiratory System Agents|respiratory system agents|mesh-ancestor
65034592|NCT04306393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65034613|NCT00175565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65034614|NCT00175565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034615|NCT00175565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65034616|NCT00175565|Respiratory System Agents|respiratory system agents|mesh-ancestor
65034618|NCT00175565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65034619|NCT04230187|Leucovorin|leucovorin|mesh-list
65034620|NCT04230187|Bevacizumab|bevacizumab|mesh-list
65034621|NCT04230187|Fluorouracil|fluorouracil|mesh-list
65034622|NCT04230187|Oxaliplatin|oxaliplatin|mesh-list
65034623|NCT04230187|Irinotecan|irinotecan|mesh-list
65034624|NCT04230187|Levoleucovorin|levoleucovorin|mesh-list
65034625|NCT04230187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65034626|NCT04230187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034627|NCT04230187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65034628|NCT04230187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65034629|NCT04230187|Growth Substances|growth substances|mesh-ancestor
65034630|NCT04230187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034631|NCT04230187|Growth Inhibitors|growth inhibitors|mesh-ancestor
65034632|NCT04230187|Antimetabolites|antimetabolites|mesh-ancestor
65243438|NCT00694863|Adrenocorticotropin zinc|adrenocorticotropin zinc|mesh-list
65034633|NCT04230187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034634|NCT04230187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65034635|NCT04230187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65034636|NCT04230187|Immunologic Factors|immunologic factors|mesh-ancestor
65034637|NCT04230187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65034638|NCT04230187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65034639|NCT04230187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034641|NCT04230187|Protective Agents|protective agents|mesh-ancestor
65034642|NCT04230187|Vitamin B Complex|vitamin b complex|mesh-ancestor
65034643|NCT04230187|Vitamins|vitamins|mesh-ancestor
65034644|NCT04230187|Micronutrients|micronutrients|mesh-ancestor
65034645|NCT00175643|Imiquimod|imiquimod|mesh-list
65034646|NCT00175643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65034647|NCT00175643|Immunologic Factors|immunologic factors|mesh-ancestor
65034648|NCT00175643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034668|NCT00175682|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65034670|NCT00175682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65034671|NCT00175682|Adrenergic Agents|adrenergic agents|mesh-ancestor
65034672|NCT00175682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65034673|NCT00175682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034674|NCT00175682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034675|NCT00554086|Bicalutamide|bicalutamide|mesh-list
65034676|NCT00554086|Androgen Antagonists|androgen antagonists|mesh-ancestor
65034677|NCT00554086|Hormone Antagonists|hormone antagonists|mesh-ancestor
65034678|NCT00554086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65034679|NCT00554086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034680|NCT00554086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034681|NCT04173364|Ropivacaine|ropivacaine|mesh-list
65034682|NCT04173364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65034683|NCT04173364|Anesthetics, Local|anesthetics, local|mesh-ancestor
65034684|NCT04173364|Anesthetics|anesthetics|mesh-ancestor
65034685|NCT04173364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65034686|NCT04173364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034687|NCT04173364|Sensory System Agents|sensory system agents|mesh-ancestor
65034688|NCT04173364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65034689|NCT04171453|Pregabalin|pregabalin|mesh-list
65034690|NCT04171453|Analgesics|analgesics|mesh-ancestor
65034691|NCT04171453|Sensory System Agents|sensory system agents|mesh-ancestor
65034692|NCT04171453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65034693|NCT04171453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034694|NCT04171453|Anticonvulsants|anticonvulsants|mesh-ancestor
65034695|NCT04171453|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65034696|NCT04171453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65034697|NCT04171453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034698|NCT04171453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65034699|NCT04171453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65034700|NCT04171453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65034701|NCT04171453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65034702|NCT04171453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65034712|NCT04111315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65034713|NCT04111315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65034714|NCT04111315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034715|NCT04111315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034716|NCT04111315|Antipyretics|antipyretics|mesh-ancestor
65034717|NCT00199563|Sildenafil Citrate|sildenafil citrate|mesh-list
65034718|NCT00199563|Vasodilator Agents|vasodilator agents|mesh-ancestor
65034719|NCT00199563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65034720|NCT00199563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65034721|NCT00199563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034722|NCT00199563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034723|NCT00199563|Urological Agents|urological agents|mesh-ancestor
65034724|NCT04679506|Cytarabine|cytarabine|mesh-list
65034725|NCT04679506|Etoposide|etoposide|mesh-list
65034726|NCT04679506|Cladribine|cladribine|mesh-list
65034727|NCT04679506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65034728|NCT04679506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034729|NCT04679506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65034730|NCT04679506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65034731|NCT04679506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034732|NCT04679506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034733|NCT04679506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65034734|NCT04679506|Antimetabolites|antimetabolites|mesh-ancestor
65034735|NCT04679506|Antiviral Agents|antiviral agents|mesh-ancestor
65034736|NCT04679506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65034737|NCT04679506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65034738|NCT04679506|Immunologic Factors|immunologic factors|mesh-ancestor
65034739|NCT04679506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034740|NCT02962830|Sufentanil|sufentanil|mesh-list
65034741|NCT02962830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65034742|NCT02962830|Narcotics|narcotics|mesh-ancestor
65034743|NCT02962830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65034744|NCT02962830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034745|NCT02962830|Analgesics|analgesics|mesh-ancestor
65034746|NCT02962830|Sensory System Agents|sensory system agents|mesh-ancestor
65034747|NCT02962830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65034748|NCT02962830|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65034749|NCT02962830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65034750|NCT02962830|Anesthetics, General|anesthetics, general|mesh-ancestor
65034751|NCT02962830|Anesthetics|anesthetics|mesh-ancestor
65034752|NCT00199602|Heparin|heparin|mesh-list
65034753|NCT00199602|Anticoagulants|anticoagulants|mesh-ancestor
65034754|NCT00199602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65034755|NCT00199602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65034756|NCT00199602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034757|NCT00554125|Sirolimus|sirolimus|mesh-list
65034758|NCT00554125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65034759|NCT00554125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65034760|NCT00554125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65034761|NCT00554125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034762|NCT00554125|Antifungal Agents|antifungal agents|mesh-ancestor
65034763|NCT00554125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65034764|NCT00554125|Immunologic Factors|immunologic factors|mesh-ancestor
65034765|NCT00554125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034766|NCT00175838|Aspirin|aspirin|mesh-list
65034767|NCT00175838|Hydroxyurea|hydroxyurea|mesh-list
65034768|NCT00175838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65034785|NCT00175838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65034786|NCT00204555|Imiquimod|imiquimod|mesh-list
65034787|NCT00204555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65034788|NCT00204555|Immunologic Factors|immunologic factors|mesh-ancestor
65034789|NCT00204555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034791|NCT00204555|Interferon Inducers|interferon inducers|mesh-ancestor
65034792|NCT00175955|Levetiracetam|levetiracetam|mesh-list
65034793|NCT00175955|Anticonvulsants|anticonvulsants|mesh-ancestor
65034794|NCT00175955|Nootropic Agents|nootropic agents|mesh-ancestor
65034795|NCT03758287|Gefitinib|gefitinib|mesh-list
65034796|NCT03758287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034797|NCT03758287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65034798|NCT03758287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034799|NCT03758287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034800|NCT03733210|Panitumumab|panitumumab|mesh-list
65034801|NCT03733210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65034802|NCT03733210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034803|NCT00204633|Darbepoetin alfa|darbepoetin alfa|mesh-list
65034804|NCT00204633|Hematinics|hematinics|mesh-ancestor
65034805|NCT00199719|Ribavirin|ribavirin|mesh-list
65034806|NCT00199719|Antimetabolites|antimetabolites|mesh-ancestor
65034807|NCT00199719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034808|NCT00199719|Antiviral Agents|antiviral agents|mesh-ancestor
65034809|NCT00199719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65034810|NCT03430882|Paclitaxel|paclitaxel|mesh-list
65034811|NCT03430882|Carboplatin|carboplatin|mesh-list
65034812|NCT03430882|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65034813|NCT03430882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65034814|NCT03430882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034815|NCT03430882|Tubulin Modulators|tubulin modulators|mesh-ancestor
65034816|NCT03430882|Antimitotic Agents|antimitotic agents|mesh-ancestor
65034817|NCT03430882|Mitosis Modulators|mitosis modulators|mesh-ancestor
65034818|NCT03430882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034819|NCT03374254|Leucovorin|leucovorin|mesh-list
65034820|NCT03374254|Pembrolizumab|pembrolizumab|mesh-list
65034821|NCT03374254|Fluorouracil|fluorouracil|mesh-list
65034822|NCT03374254|Oxaliplatin|oxaliplatin|mesh-list
65034823|NCT03374254|Irinotecan|irinotecan|mesh-list
65034824|NCT03374254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65034825|NCT03374254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034826|NCT03374254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034827|NCT03374254|Antimetabolites|antimetabolites|mesh-ancestor
65034828|NCT03374254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034829|NCT03374254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65034849|NCT00199758|Immunologic Factors|immunologic factors|mesh-ancestor
65034850|NCT00199758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034851|NCT03291886|Exemestane|exemestane|mesh-list
65034852|NCT03291886|Entinostat|entinostat|mesh-list
65034853|NCT03291886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034854|NCT03291886|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65034855|NCT03291886|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65034856|NCT03291886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034857|NCT03291886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034858|NCT03291886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65034859|NCT03291886|Hormone Antagonists|hormone antagonists|mesh-ancestor
65034860|NCT03291886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65034861|NCT03291886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034862|NCT03291886|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65034863|NCT00176267|Paclitaxel|paclitaxel|mesh-list
64476191|NCT00470392|Hormones|hormones|mesh-ancestor
65034864|NCT00176267|Carboplatin|carboplatin|mesh-list
65034865|NCT00176267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65034866|NCT00176267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034867|NCT00176267|Tubulin Modulators|tubulin modulators|mesh-ancestor
65034868|NCT00176267|Antimitotic Agents|antimitotic agents|mesh-ancestor
65034869|NCT00176267|Mitosis Modulators|mitosis modulators|mesh-ancestor
65034870|NCT00176267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034871|NCT03252808|Gemcitabine|gemcitabine|mesh-list
65034872|NCT03252808|Paclitaxel|paclitaxel|mesh-list
65034873|NCT03252808|Tegafur|tegafur|mesh-list
65034874|NCT03252808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65034875|NCT03252808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034876|NCT03252808|Tubulin Modulators|tubulin modulators|mesh-ancestor
65034877|NCT03252808|Antimitotic Agents|antimitotic agents|mesh-ancestor
65034878|NCT03252808|Mitosis Modulators|mitosis modulators|mesh-ancestor
65034879|NCT03252808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034880|NCT03252808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65034881|NCT03252808|Antimetabolites|antimetabolites|mesh-ancestor
65034882|NCT03252808|Antiviral Agents|antiviral agents|mesh-ancestor
65034883|NCT03252808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65034884|NCT03252808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034885|NCT03252808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64886795|NCT01949168|Ribavirin|ribavirin|mesh-list
65034903|NCT00199953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65034905|NCT00199953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034906|NCT03184090|Palbociclib|palbociclib|mesh-list
65034907|NCT03184090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034908|NCT03184090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65034909|NCT03184090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034910|NCT03184090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034911|NCT03160846|Milrinone|milrinone|mesh-list
65034912|NCT03160846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65034913|NCT03160846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65034914|NCT03160846|Vasodilator Agents|vasodilator agents|mesh-ancestor
65034915|NCT03160846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65034916|NCT03160846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65034917|NCT03160846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034918|NCT03160846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034919|NCT03160846|Protective Agents|protective agents|mesh-ancestor
65034920|NCT03160846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034921|NCT00204789|Eflornithine|eflornithine|mesh-list
65034922|NCT00204789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034923|NCT00204789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65034924|NCT00204789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65034925|NCT00204789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65034926|NCT00204789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65034927|NCT00204789|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
65034928|NCT00204789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034929|NCT00204789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034930|NCT00176540|Dextromethorphan|dextromethorphan|mesh-list
65034931|NCT00176540|Antitussive Agents|antitussive agents|mesh-ancestor
65034932|NCT00176540|Respiratory System Agents|respiratory system agents|mesh-ancestor
65034933|NCT00176540|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65034934|NCT00176540|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65034935|NCT00176540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65034936|NCT00176540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476269|NCT00389818|Hormones|hormones|mesh-ancestor
65034939|NCT02830360|Sotalol|sotalol|mesh-list
65034940|NCT02830360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65034941|NCT02830360|Vasodilator Agents|vasodilator agents|mesh-ancestor
65034942|NCT02830360|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65034976|NCT00176618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65034977|NCT00176618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65034978|NCT00176618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034979|NCT00176618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034980|NCT00176618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035010|NCT00554164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64476332|NCT00453388|Mycophenolic Acid|mycophenolic acid|mesh-list
65035011|NCT00554164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035012|NCT00554164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65035013|NCT00554164|Glucocorticoids|glucocorticoids|mesh-ancestor
65035015|NCT00554164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65035016|NCT00554164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65035017|NCT00554164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65035018|NCT00554164|Tubulin Modulators|tubulin modulators|mesh-ancestor
65035019|NCT00554164|Antimitotic Agents|antimitotic agents|mesh-ancestor
65035020|NCT00554164|Mitosis Modulators|mitosis modulators|mesh-ancestor
65035021|NCT02572141|Leucovorin|leucovorin|mesh-list
65035022|NCT02572141|Fluorouracil|fluorouracil|mesh-list
65035023|NCT02572141|Capecitabine|capecitabine|mesh-list
65035024|NCT02572141|Oxaliplatin|oxaliplatin|mesh-list
65035025|NCT02572141|Levoleucovorin|levoleucovorin|mesh-list
65035037|NCT02572141|Micronutrients|micronutrients|mesh-ancestor
65035038|NCT02521363|Taxane|taxane|mesh-list
65035039|NCT02521363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035040|NCT02470039|Insulin|insulin|mesh-list
65035041|NCT02470039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65035042|NCT02470039|Insulin Glargine|insulin glargine|mesh-list
65035043|NCT02470039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65035044|NCT02470039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035045|NCT00554203|Sulfasalazine|sulfasalazine|mesh-list
65035046|NCT00554203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65035047|NCT00554203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65035048|NCT00554203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65035049|NCT00554203|Analgesics|analgesics|mesh-ancestor
65035050|NCT00554203|Sensory System Agents|sensory system agents|mesh-ancestor
65035051|NCT00554203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65035052|NCT00554203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035053|NCT00554203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65035054|NCT00554203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65035055|NCT00554203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65035056|NCT00554242|Ascorbic Acid|ascorbic acid|mesh-list
65035057|NCT00554242|Grape Seed Extract|grape seed extract|mesh-list
65035058|NCT00554242|Antioxidants|antioxidants|mesh-ancestor
65035059|NCT00554242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035060|NCT00554242|Protective Agents|protective agents|mesh-ancestor
65035061|NCT00554242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035062|NCT00554242|Vitamins|vitamins|mesh-ancestor
65035063|NCT00554242|Micronutrients|micronutrients|mesh-ancestor
65035064|NCT00554242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65035065|NCT00554242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035066|NCT00176735|Capecitabine|capecitabine|mesh-list
65035067|NCT00176735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65035068|NCT00176735|Antimetabolites|antimetabolites|mesh-ancestor
65035069|NCT00176735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035070|NCT00176735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035071|NCT00410943|Hydromorphone|hydromorphone|mesh-list
65035072|NCT00410943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65035073|NCT00410943|Narcotics|narcotics|mesh-ancestor
65035074|NCT00410943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65035075|NCT00410943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035076|NCT00410943|Analgesics|analgesics|mesh-ancestor
65035077|NCT00410943|Sensory System Agents|sensory system agents|mesh-ancestor
65035078|NCT00410943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65035079|NCT00176774|Leucovorin|leucovorin|mesh-list
65035080|NCT00176774|Fluorouracil|fluorouracil|mesh-list
65035081|NCT00176774|Irinotecan|irinotecan|mesh-list
65035082|NCT00176774|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
64472442|NCT03301506|Antimetabolites|antimetabolites|mesh-ancestor
65035083|NCT00176774|Antimetabolites|antimetabolites|mesh-ancestor
65035084|NCT00176774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035085|NCT00176774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65035086|NCT00176774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035087|NCT00176774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65035088|NCT00176774|Immunologic Factors|immunologic factors|mesh-ancestor
65035089|NCT00176774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035090|NCT00176774|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65035091|NCT00176774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65035105|NCT02434744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65035106|NCT02434744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035107|NCT02421679|Cyclobenzaprine|cyclobenzaprine|mesh-list
65035108|NCT02421679|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65035109|NCT02421679|Antidepressive Agents|antidepressive agents|mesh-ancestor
65035110|NCT02421679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65035111|NCT02421679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65035112|NCT02421679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035113|NCT02421679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65035114|NCT02421679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65035115|NCT02421679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65035116|NCT02421679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65035117|NCT00410982|Gemcitabine|gemcitabine|mesh-list
65035118|NCT00410982|Rituximab|rituximab|mesh-list
65035119|NCT00410982|Melphalan|melphalan|mesh-list
65035120|NCT00410982|Busulfan|busulfan|mesh-list
65035121|NCT00410982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65035122|NCT00410982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035123|NCT00410982|Immunologic Factors|immunologic factors|mesh-ancestor
65035124|NCT00410982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035125|NCT00410982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65035126|NCT00410982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65035127|NCT00410982|Antimetabolites|antimetabolites|mesh-ancestor
65035128|NCT00410982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035129|NCT00410982|Antiviral Agents|antiviral agents|mesh-ancestor
65035130|NCT00410982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65035131|NCT00410982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035132|NCT00410982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65035133|NCT00410982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65035134|NCT00410982|Alkylating Agents|alkylating agents|mesh-ancestor
65035135|NCT00410982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65035136|NCT02372578|Pregabalin|pregabalin|mesh-list
65035137|NCT02372578|Analgesics|analgesics|mesh-ancestor
65035138|NCT02372578|Sensory System Agents|sensory system agents|mesh-ancestor
65035139|NCT02372578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65035140|NCT02372578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035141|NCT02372578|Anticonvulsants|anticonvulsants|mesh-ancestor
65035142|NCT02372578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65035143|NCT02372578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65035144|NCT02372578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035145|NCT02372578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65035146|NCT02372578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65035147|NCT02372578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65035148|NCT02372578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65035149|NCT02372578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65035150|NCT00554398|Raltegravir Potassium|raltegravir potassium|mesh-list
65035151|NCT00554398|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65035152|NCT00554398|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65035153|NCT00554398|Antiviral Agents|antiviral agents|mesh-ancestor
65035154|NCT00554398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65035155|NCT00554398|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65035156|NCT00554398|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65035157|NCT00554398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035158|NCT00554398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035159|NCT00554476|Triamcinolone|triamcinolone|mesh-list
65035179|NCT00554476|Gout Suppressants|gout suppressants|mesh-ancestor
65035180|NCT00554476|Tocolytic Agents|tocolytic agents|mesh-ancestor
65035181|NCT00554476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65035182|NCT00554476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65035183|NCT02336698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65035184|NCT02336698|Immunologic Factors|immunologic factors|mesh-ancestor
65035185|NCT02336698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035186|NCT00204906|Vitamin D|vitamin d|mesh-list
65035187|NCT00204906|Vitamins|vitamins|mesh-ancestor
65035188|NCT00204906|Micronutrients|micronutrients|mesh-ancestor
65035189|NCT00204906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035190|NCT00204906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65035191|NCT02335918|Nivolumab|nivolumab|mesh-list
65035192|NCT02335918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65035193|NCT02335918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035194|NCT02335918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65035195|NCT02335918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035196|NCT00176813|Gemcitabine|gemcitabine|mesh-list
65035197|NCT00176813|Celecoxib|celecoxib|mesh-list
65035198|NCT00176813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035199|NCT00176813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65035200|NCT00176813|Antimetabolites|antimetabolites|mesh-ancestor
65035201|NCT00176813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035202|NCT00176813|Antiviral Agents|antiviral agents|mesh-ancestor
65035203|NCT00176813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65035204|NCT00176813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035205|NCT00176813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65035206|NCT00176813|Immunologic Factors|immunologic factors|mesh-ancestor
65035207|NCT00176813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035208|NCT00176813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65035209|NCT00176813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65035210|NCT00176813|Analgesics|analgesics|mesh-ancestor
65035211|NCT00176813|Sensory System Agents|sensory system agents|mesh-ancestor
64887117|NCT01951430|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65035225|NCT02320708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65035226|NCT02320708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035227|NCT02320708|Antipyretics|antipyretics|mesh-ancestor
65035228|NCT02320708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65035229|NCT02320708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65035230|NCT02320708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65035231|NCT02320708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65035232|NCT02320708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035233|NCT02320708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035234|NCT02309671|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65493860|NCT04166318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65035236|NCT02309671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64476555|NCT00529126|Autonomic Agents|autonomic agents|mesh-ancestor
65035237|NCT02309671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035239|NCT02296645|Chlorhexidine|chlorhexidine|mesh-list
65035240|NCT02296645|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65035241|NCT02296645|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65035242|NCT02296645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65035243|NCT02296645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65035244|NCT02296645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035245|NCT02296645|Disinfectants|disinfectants|mesh-ancestor
65035246|NCT02296645|Dermatologic Agents|dermatologic agents|mesh-ancestor
65035247|NCT02295865|Toreforant|toreforant|mesh-list
65035248|NCT02295865|Histamine Antagonists|histamine antagonists|mesh-ancestor
65035249|NCT02295865|Histamine Agents|histamine agents|mesh-ancestor
65035250|NCT02295865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65035251|NCT02295865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035252|NCT02295865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035253|NCT02282215|Lenograstim|lenograstim|mesh-list
65035254|NCT02282215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65035255|NCT02282215|Immunologic Factors|immunologic factors|mesh-ancestor
65035256|NCT02282215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035257|NCT00176969|Capsaicin|capsaicin|mesh-list
65035258|NCT00176969|Antipruritics|antipruritics|mesh-ancestor
65035259|NCT00176969|Dermatologic Agents|dermatologic agents|mesh-ancestor
65035260|NCT00176969|Sensory System Agents|sensory system agents|mesh-ancestor
65035261|NCT00176969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65035262|NCT00176969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035263|NCT00204945|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65035264|NCT00204945|Natriuretic Agents|natriuretic agents|mesh-ancestor
65035265|NCT00204945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035266|NCT00177008|Aripiprazole|aripiprazole|mesh-list
65035267|NCT00177008|Antidepressive Agents|antidepressive agents|mesh-ancestor
65035268|NCT00177008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65035269|NCT00177008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65035270|NCT00177008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65035271|NCT00177008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64887167|NCT01951508|Dopamine Agents|dopamine agents|mesh-ancestor
65035278|NCT00177008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65035279|NCT00177008|Serotonin Agents|serotonin agents|mesh-ancestor
65035280|NCT00177008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65035281|NCT00177008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65035282|NCT00177008|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65035283|NCT00177008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65035284|NCT04677985|Analgesics|analgesics|mesh-list
65035285|NCT04677985|Menthol|menthol|mesh-list
65035286|NCT04677985|Sensory System Agents|sensory system agents|mesh-ancestor
65035287|NCT04677985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65035288|NCT04677985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035289|NCT04677985|Antipruritics|antipruritics|mesh-ancestor
65035290|NCT04677985|Dermatologic Agents|dermatologic agents|mesh-ancestor
65035291|NCT00554632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65035292|NCT00554632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65035293|NCT00554632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65035294|NCT00554632|Norgestimate|norgestimate|mesh-list
65035295|NCT00554632|Norelgestromin|norelgestromin|mesh-list
65035296|NCT00554632|Ortho Evra|ortho evra|mesh-list
65035297|NCT00554632|Estradiol|estradiol|mesh-list
65035298|NCT00554632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65035299|NCT00554632|Estrogens|estrogens|mesh-ancestor
65035300|NCT00554632|Hormones|hormones|mesh-ancestor
65035301|NCT00554632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65035302|NCT00554632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035303|NCT00554632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65035304|NCT00554632|Contraceptive Agents|contraceptive agents|mesh-ancestor
65035305|NCT00554632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65035306|NCT00554632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65035307|NCT00554632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65035308|NCT00554632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65035309|NCT00554632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64476635|NCT01450761|Carboplatin|carboplatin|mesh-list
65035310|NCT00204984|Hydralazine|hydralazine|mesh-list
65035311|NCT00204984|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65035312|NCT00204984|Natriuretic Agents|natriuretic agents|mesh-ancestor
65035313|NCT00204984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035314|NCT00204984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65035315|NCT00204984|Vasodilator Agents|vasodilator agents|mesh-ancestor
65035317|NCT02236195|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65035318|NCT02236195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035319|NCT02236195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035320|NCT02236156|Metronidazole|metronidazole|mesh-list
65035321|NCT02236156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65035322|NCT02236156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65035323|NCT02236156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65035324|NCT02236156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65035325|NCT00177086|Alfuzosin|alfuzosin|mesh-list
65035326|NCT00177086|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65035327|NCT00177086|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65035328|NCT00177086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65035329|NCT00177086|Adrenergic Agents|adrenergic agents|mesh-ancestor
65035330|NCT00177086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65035331|NCT00177086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035332|NCT00177086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035333|NCT00177086|Urological Agents|urological agents|mesh-ancestor
65035334|NCT02207257|Edoxaban|edoxaban|mesh-list
65035335|NCT02207257|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65035336|NCT02207257|Antithrombins|antithrombins|mesh-ancestor
65035337|NCT02207257|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65035338|NCT02207257|Protease Inhibitors|protease inhibitors|mesh-ancestor
65035339|NCT02207257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887226|NCT01951898|Montelukast|montelukast|mesh-list
65035372|NCT04659109|Anticoagulants|anticoagulants|mesh-ancestor
65035373|NCT00177242|Gefitinib|gefitinib|mesh-list
65035374|NCT00177242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035375|NCT00177242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65035376|NCT00177242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035377|NCT00177242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035378|NCT04659070|Telmisartan|telmisartan|mesh-list
65035379|NCT04659070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65035380|NCT04659070|Ezetimibe|ezetimibe|mesh-list
65035381|NCT04659070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65035382|NCT04659070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65035383|NCT04659070|Antimetabolites|antimetabolites|mesh-ancestor
65035400|NCT00200226|Misoprostol|misoprostol|mesh-list
65035402|NCT00200226|Micronutrients|micronutrients|mesh-ancestor
65035403|NCT00200226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472445|NCT03290391|Naltrexone|naltrexone|mesh-list
65035404|NCT00200226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65035405|NCT00200226|Abortifacient Agents|abortifacient agents|mesh-ancestor
65035406|NCT00200226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65035407|NCT00200226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65035408|NCT00200226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65035409|NCT00200226|Oxytocics|oxytocics|mesh-ancestor
65035410|NCT00200226|Vitamin B Complex|vitamin b complex|mesh-ancestor
65035411|NCT04658329|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65035412|NCT04658329|Antiviral Agents|antiviral agents|mesh-ancestor
65035413|NCT04658329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65035414|NCT00557557|Oxaliplatin|oxaliplatin|mesh-list
65035415|NCT00557557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035416|NCT04658134|Glycine|glycine|mesh-list
65035417|NCT04658134|Glycine Agents|glycine agents|mesh-ancestor
65035418|NCT04658134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65035419|NCT04658134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035420|NCT04658134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035421|NCT00200382|Bortezomib|bortezomib|mesh-list
65035422|NCT00200382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035423|NCT04657744|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65035424|NCT04657744|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65035425|NCT04657744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035426|NCT04657744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65035427|NCT04657744|Immunologic Factors|immunologic factors|mesh-ancestor
65035428|NCT04657744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035429|NCT00177398|Insulin|insulin|mesh-list
65035430|NCT00177398|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65035431|NCT00177398|Insulin Glargine|insulin glargine|mesh-list
65035432|NCT00177398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65035433|NCT00177398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035434|NCT00200421|Atenolol|atenolol|mesh-list
65035435|NCT00200421|Nebivolol|nebivolol|mesh-list
65035436|NCT00200421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65035437|NCT00200421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65035438|NCT00200421|Sympatholytics|sympatholytics|mesh-ancestor
65035457|NCT04656262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65035459|NCT04656262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476776|NCT00542620|Insulin|insulin|mesh-list
65035460|NCT04656262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65035461|NCT04656262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65035462|NCT04656262|Alkylating Agents|alkylating agents|mesh-ancestor
65035463|NCT04656262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035464|NCT04656262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035465|NCT04656262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65035466|NCT04656262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65035467|NCT04656262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65035468|NCT04656262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65035469|NCT04656262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035470|NCT00200460|Nebivolol|nebivolol|mesh-list
65035471|NCT00200460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65035472|NCT00200460|Vasodilator Agents|vasodilator agents|mesh-ancestor
65035473|NCT00200460|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65035474|NCT00200460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65035475|NCT00200460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65035476|NCT00200460|Adrenergic Agents|adrenergic agents|mesh-ancestor
65035477|NCT00200460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65035478|NCT00200460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035479|NCT00200460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035480|NCT00200499|Nebivolol|nebivolol|mesh-list
65035481|NCT00200499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65035482|NCT00200499|Vasodilator Agents|vasodilator agents|mesh-ancestor
65035483|NCT00200499|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65035484|NCT00200499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65035485|NCT00200499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65035486|NCT00200499|Adrenergic Agents|adrenergic agents|mesh-ancestor
65035487|NCT00200499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65035488|NCT00200499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035489|NCT00200499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035490|NCT00200538|Memantine|memantine|mesh-list
65035521|NCT00205491|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65035522|NCT00205491|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65035523|NCT00205491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65035524|NCT00205491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65035525|NCT00205491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035526|NCT00205491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65035527|NCT00205491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035528|NCT00205491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65035529|NCT00205491|Antidepressive Agents|antidepressive agents|mesh-ancestor
65035530|NCT00205491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65035550|NCT04654195|Cyclophosphamide|cyclophosphamide|mesh-list
65035551|NCT04654195|Doxorubicin|doxorubicin|mesh-list
65035552|NCT04654195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65035553|NCT04654195|Immunologic Factors|immunologic factors|mesh-ancestor
65035554|NCT04654195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035555|NCT04654195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65035556|NCT04654195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65035557|NCT04654195|Alkylating Agents|alkylating agents|mesh-ancestor
65035558|NCT04654195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035559|NCT04654195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035560|NCT04654195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65035561|NCT04654195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65035562|NCT04654195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65035563|NCT04654195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65035564|NCT04654195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035565|NCT00200616|Anti-Infective Agents|anti-infective agents|mesh-list
65035566|NCT00200616|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65035567|NCT03454789|Lidocaine|lidocaine|mesh-list
65035568|NCT03454789|Anesthetics, Local|anesthetics, local|mesh-ancestor
65035569|NCT03454789|Anesthetics|anesthetics|mesh-ancestor
65035570|NCT03454789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65035571|NCT03454789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035572|NCT03454789|Sensory System Agents|sensory system agents|mesh-ancestor
65035573|NCT03454789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65035574|NCT03454789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65035575|NCT03454789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65035576|NCT03454789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65035577|NCT03454789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65035578|NCT03454789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035579|NCT00200655|Pravastatin|pravastatin|mesh-list
65035580|NCT00200655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65035581|NCT00200655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65035597|NCT04653493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65035598|NCT00200694|Valsartan|valsartan|mesh-list
65035599|NCT00200694|Ramipril|ramipril|mesh-list
65035600|NCT00200694|Furosemide|furosemide|mesh-list
65035601|NCT00200694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65035602|NCT00200694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65035603|NCT00200694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65035604|NCT00200694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035605|NCT00200694|Diuretics|diuretics|mesh-ancestor
65035606|NCT00200694|Natriuretic Agents|natriuretic agents|mesh-ancestor
65035607|NCT00200694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035608|NCT00200694|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65035609|NCT00200694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65035610|NCT00200694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65035611|NCT00200694|Protease Inhibitors|protease inhibitors|mesh-ancestor
65035612|NCT00200694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035613|NCT00557713|Bevacizumab|bevacizumab|mesh-list
65035614|NCT00557713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65035615|NCT00557713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035616|NCT00557713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65035617|NCT00557713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65035618|NCT00557713|Growth Substances|growth substances|mesh-ancestor
65035619|NCT00557713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035620|NCT00557713|Growth Inhibitors|growth inhibitors|mesh-ancestor
65035621|NCT00178100|Paroxetine|paroxetine|mesh-list
65035622|NCT00178100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65035623|NCT00178100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65035624|NCT00178100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65035625|NCT00178100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035626|NCT00178100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65035627|NCT00178100|Serotonin Agents|serotonin agents|mesh-ancestor
65035628|NCT00178100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035629|NCT00178100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65035630|NCT00178100|Antidepressive Agents|antidepressive agents|mesh-ancestor
65035631|NCT00178100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65035632|NCT00178100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65035633|NCT00178100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65035634|NCT00178100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035635|NCT04653415|Methylprednisolone|methylprednisolone|mesh-list
65035636|NCT04653415|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65035637|NCT04653415|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65035648|NCT04653415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65035649|NCT04653415|Glucocorticoids|glucocorticoids|mesh-ancestor
65035650|NCT04653415|Hormones|hormones|mesh-ancestor
65035651|NCT04653415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65035652|NCT04653415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65035653|NCT04653415|Protective Agents|protective agents|mesh-ancestor
65035654|NCT04653415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65035655|NCT04653415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035656|NCT04653415|Analgesics|analgesics|mesh-ancestor
65035657|NCT04653415|Sensory System Agents|sensory system agents|mesh-ancestor
65035658|NCT04653415|Anticonvulsants|anticonvulsants|mesh-ancestor
65035659|NCT04653415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65035660|NCT04653415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65035661|NCT04653415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65035662|NCT04653415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65035663|NCT04653415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65035664|NCT04653415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65035665|NCT04653415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65035666|NCT04653415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035667|NCT04653415|Antimanic Agents|antimanic agents|mesh-ancestor
65035668|NCT00557791|Ranibizumab|ranibizumab|mesh-list
65035669|NCT00557791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65035670|NCT00557791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65035671|NCT00557791|Growth Substances|growth substances|mesh-ancestor
65035672|NCT00557791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035673|NCT00557791|Growth Inhibitors|growth inhibitors|mesh-ancestor
65035674|NCT00557791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035675|NCT04652284|Amoxicillin|amoxicillin|mesh-list
65035676|NCT04652284|Clarithromycin|clarithromycin|mesh-list
65035677|NCT04652284|Rifabutin|rifabutin|mesh-list
65035678|NCT04652284|Tinidazole|tinidazole|mesh-list
65035679|NCT04652284|Esomeprazole|esomeprazole|mesh-list
64520870|NCT02447016|Rilpivirine|rilpivirine|mesh-list
65035680|NCT04652284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65035681|NCT04652284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65035682|NCT04652284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65035683|NCT04652284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65035684|NCT04652284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65035685|NCT04652284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035686|NCT04652284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035687|NCT04652284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65035688|NCT04652284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65035689|NCT04652284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65035690|NCT04652284|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65035691|NCT04652284|Antitubercular Agents|antitubercular agents|mesh-ancestor
65035692|NCT04652284|Alkylating Agents|alkylating agents|mesh-ancestor
65035693|NCT04652284|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65035694|NCT04652284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65035695|NCT04652284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65035696|NCT04652323|Calcium|calcium|mesh-list
65035697|NCT04652323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65035698|NCT04652323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035699|NCT04652011|Analgesics|analgesics|mesh-list
65035700|NCT04652011|Sensory System Agents|sensory system agents|mesh-ancestor
65035701|NCT04652011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65035702|NCT04652011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035703|NCT04652128|Zoledronic Acid|zoledronic acid|mesh-list
65035717|NCT00205725|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65035718|NCT00205725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65035719|NCT00205725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65035720|NCT00205725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035721|NCT00205725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65035722|NCT00205725|Serotonin Agents|serotonin agents|mesh-ancestor
65035723|NCT00205725|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65035724|NCT00205725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65035725|NCT00205725|Dopamine Agents|dopamine agents|mesh-ancestor
65035726|NCT00178373|Modafinil|modafinil|mesh-list
65035727|NCT00178373|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65035728|NCT00178373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035729|NCT00178373|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65035730|NCT00178373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65035731|NCT00178373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65035732|NCT00178373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035733|NCT00205764|Melphalan|melphalan|mesh-list
65035734|NCT00205764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65035735|NCT00205764|Alkylating Agents|alkylating agents|mesh-ancestor
65035736|NCT00205764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035737|NCT00205764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035738|NCT00205764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65035739|NCT00205764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65035740|NCT00205764|Immunologic Factors|immunologic factors|mesh-ancestor
65035741|NCT00205764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035742|NCT00558142|Acetylcysteine|acetylcysteine|mesh-list
65035743|NCT00558142|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65035744|NCT00558142|Antiviral Agents|antiviral agents|mesh-ancestor
65035745|NCT00558142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65035746|NCT00558142|Expectorants|expectorants|mesh-ancestor
65035747|NCT00558142|Respiratory System Agents|respiratory system agents|mesh-ancestor
65035748|NCT00558142|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65035749|NCT00558142|Antioxidants|antioxidants|mesh-ancestor
65035750|NCT00558142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035751|NCT00558142|Protective Agents|protective agents|mesh-ancestor
65035752|NCT00558142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035753|NCT00558142|Antidotes|antidotes|mesh-ancestor
65035754|NCT00205842|Alvimopan|alvimopan|mesh-list
65035755|NCT00205842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65035756|NCT00178451|Abciximab|abciximab|mesh-list
65035757|NCT00178451|Anticoagulants|anticoagulants|mesh-ancestor
65035758|NCT00178451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65035759|NCT00206115|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65035760|NCT00206115|Antidepressive Agents|antidepressive agents|mesh-ancestor
65035761|NCT00206115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65035762|NCT00206115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65035763|NCT00206115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65035764|NCT00206115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65035765|NCT00206115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035783|NCT00206154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035784|NCT00559702|Natalizumab|natalizumab|mesh-list
65035785|NCT00559702|Immunologic Factors|immunologic factors|mesh-ancestor
65035786|NCT00559702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035787|NCT00559741|Leucovorin|leucovorin|mesh-list
65035788|NCT00559741|Fluorouracil|fluorouracil|mesh-list
65035789|NCT00559741|Irinotecan|irinotecan|mesh-list
65035790|NCT00559741|Cetuximab|cetuximab|mesh-list
65035791|NCT00559741|Calcium|calcium|mesh-list
65035792|NCT00559741|Levoleucovorin|levoleucovorin|mesh-list
65035793|NCT00559741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65035794|NCT00559741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035795|NCT00559741|Antimetabolites|antimetabolites|mesh-ancestor
65035796|NCT00559741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035797|NCT00559741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65035798|NCT00559741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035799|NCT00559741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65035800|NCT00559741|Immunologic Factors|immunologic factors|mesh-ancestor
65035801|NCT00559741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65035802|NCT00559741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65035803|NCT00559741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035804|NCT00559741|Antidotes|antidotes|mesh-ancestor
65035805|NCT00559741|Protective Agents|protective agents|mesh-ancestor
65035806|NCT00559741|Vitamin B Complex|vitamin b complex|mesh-ancestor
65035807|NCT00559741|Vitamins|vitamins|mesh-ancestor
65035808|NCT00559741|Micronutrients|micronutrients|mesh-ancestor
65035809|NCT00559741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65035810|NCT00178763|Gemcitabine|gemcitabine|mesh-list
65035811|NCT00178763|Interferons|interferons|mesh-list
65035812|NCT00178763|Interferon-alpha|interferon-alpha|mesh-list
65035813|NCT00178763|Cisplatin|cisplatin|mesh-list
65035814|NCT00178763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035815|NCT00178763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65035816|NCT00178763|Antimetabolites|antimetabolites|mesh-ancestor
65035817|NCT00178763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035818|NCT00178763|Antiviral Agents|antiviral agents|mesh-ancestor
65035819|NCT00178763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65035820|NCT00178763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035821|NCT00178763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64472489|NCT03203850|Deferasirox|deferasirox|mesh-list
65035822|NCT00178763|Immunologic Factors|immunologic factors|mesh-ancestor
65035823|NCT00178763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035824|NCT00559858|Pyridoxine|pyridoxine|mesh-list
65035825|NCT00559858|Vitamin B 6|vitamin b 6|mesh-list
65035839|NCT00206193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035840|NCT00206193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65035841|NCT00206193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65035842|NCT00206193|Oxytocics|oxytocics|mesh-ancestor
65035843|NCT00206193|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65035844|NCT00206193|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65035845|NCT00206193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65035846|NCT00206193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65035847|NCT00206193|Contraceptive Agents|contraceptive agents|mesh-ancestor
65035848|NCT00206193|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65035849|NCT00206193|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65035850|NCT00206193|Hormone Antagonists|hormone antagonists|mesh-ancestor
65035851|NCT00206193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65035852|NCT00206193|Luteolytic Agents|luteolytic agents|mesh-ancestor
65035853|NCT00206193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65035854|NCT00206193|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65035856|NCT04638439|Nivolumab|nivolumab|mesh-list
65035857|NCT04638439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65035858|NCT04638439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035859|NCT04638439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65035860|NCT04638439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035861|NCT04638439|Antiviral Agents|antiviral agents|mesh-ancestor
65035862|NCT04638439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65035863|NCT00178802|Interferons|interferons|mesh-list
65035864|NCT00178802|Doxorubicin|doxorubicin|mesh-list
65035865|NCT00178802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65035866|NCT00178802|Fluorouracil|fluorouracil|mesh-list
65035867|NCT00178802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65035868|NCT00178802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035869|NCT00178802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65035870|NCT00178802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65035871|NCT00178802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035872|NCT00178802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035873|NCT00178802|Antimetabolites|antimetabolites|mesh-ancestor
65035874|NCT00178802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65035875|NCT00178802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65035876|NCT00178802|Immunologic Factors|immunologic factors|mesh-ancestor
65035877|NCT00178802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035878|NCT00178802|Antiviral Agents|antiviral agents|mesh-ancestor
65035879|NCT00178802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65035880|NCT00408239|Enoxaparin|enoxaparin|mesh-list
65035881|NCT00408239|Anticoagulants|anticoagulants|mesh-ancestor
65035882|NCT00408239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65035883|NCT00408239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65035884|NCT00408239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035885|NCT04637464|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65035886|NCT04637464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65035898|NCT00560092|Analgesics|analgesics|mesh-ancestor
65035899|NCT00560092|Sensory System Agents|sensory system agents|mesh-ancestor
65035900|NCT00560092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65035901|NCT00560092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035902|NCT00560092|Anesthetics|anesthetics|mesh-ancestor
65493862|NCT04166318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65035903|NCT00560092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65035904|NCT00560092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65035905|NCT00560092|Anticonvulsants|anticonvulsants|mesh-ancestor
64521099|NCT03192618|Leucovorin|leucovorin|mesh-list
65035906|NCT00560092|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65035907|NCT00560092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65035908|NCT00560092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035909|NCT00560092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65035910|NCT00560092|Tocolytic Agents|tocolytic agents|mesh-ancestor
65035911|NCT00560092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65035912|NCT00560170|Simvastatin|simvastatin|mesh-list
65035913|NCT00560170|Ezetimibe|ezetimibe|mesh-list
65035914|NCT00560170|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
65035915|NCT00560170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65035916|NCT00560170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65035917|NCT00560170|Antimetabolites|antimetabolites|mesh-ancestor
64472494|NCT03194867|Cemiplimab|cemiplimab|mesh-list
65035918|NCT00560170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035919|NCT00560170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65035920|NCT00560170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65035921|NCT00560170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035922|NCT04637152|Valsartan|valsartan|mesh-list
65035923|NCT04637152|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65035924|NCT04637152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65035925|NCT04637152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65035926|NCT04637152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65035927|NCT04637152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035928|NCT04636918|Cyclosporine|cyclosporine|mesh-list
65035929|NCT04636918|Cyclosporins|cyclosporins|mesh-list
65035930|NCT04636918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035931|NCT04636918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035932|NCT04636918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65035933|NCT04636918|Immunologic Factors|immunologic factors|mesh-ancestor
65035934|NCT04636918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035935|NCT04636918|Antifungal Agents|antifungal agents|mesh-ancestor
65035936|NCT04636918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65035937|NCT04636918|Dermatologic Agents|dermatologic agents|mesh-ancestor
65035938|NCT04636918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65035939|NCT04636918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65035940|NCT00560209|Landiolol|landiolol|mesh-list
65035941|NCT00560209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65035942|NCT00560209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65035943|NCT00560209|Adrenergic Agents|adrenergic agents|mesh-ancestor
65035944|NCT00560209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65035945|NCT00560209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887847|NCT01955655|Baclofen|baclofen|mesh-list
65035954|NCT04636957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65035955|NCT04636957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035956|NCT04636957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035957|NCT04636957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035958|NCT04636957|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65035959|NCT04636957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65035960|NCT04636957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65035961|NCT04636957|Glucocorticoids|glucocorticoids|mesh-ancestor
65035962|NCT04636957|Hormones|hormones|mesh-ancestor
65035963|NCT04636957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65035964|NCT04636957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035965|NCT00560326|Tacrolimus|tacrolimus|mesh-list
65035966|NCT00560326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65035967|NCT00560326|Immunologic Factors|immunologic factors|mesh-ancestor
65035968|NCT00560326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035969|NCT00560326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65035970|NCT00560326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035971|NCT00560326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035972|NCT00560443|Ketorolac|ketorolac|mesh-list
65035973|NCT00560443|Tramadol|tramadol|mesh-list
65493863|NCT04166318|Immunologic Factors|immunologic factors|mesh-ancestor
65035974|NCT00560443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65035975|NCT00560443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65035977|NCT00560443|Sensory System Agents|sensory system agents|mesh-ancestor
65035978|NCT00560443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65035979|NCT00560443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035980|NCT00560443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65035981|NCT00560443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65035982|NCT00560443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65035983|NCT00560443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035984|NCT00560443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035985|NCT00560443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65035986|NCT00560443|Narcotics|narcotics|mesh-ancestor
65035987|NCT00560443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65035988|NCT00179114|Baclofen|baclofen|mesh-list
65035989|NCT00179114|Botulinum Toxins|botulinum toxins|mesh-list
65035990|NCT00179114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65035991|NCT00179114|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65035992|NCT00179114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65035993|NCT00179114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65035994|NCT00179114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035995|NCT00179114|Cholinergic Agents|cholinergic agents|mesh-ancestor
65035996|NCT00179114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65035997|NCT00179114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035998|NCT00179114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65035999|NCT00179114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65036000|NCT00179114|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65036001|NCT00179114|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65036002|NCT00179114|GABA Agonists|gaba agonists|mesh-ancestor
65036003|NCT00179114|GABA Agents|gaba agents|mesh-ancestor
65036004|NCT00201318|Lamivudine|lamivudine|mesh-list
65036005|NCT00201318|Cyclophosphamide|cyclophosphamide|mesh-list
65036006|NCT00201318|Doxorubicin|doxorubicin|mesh-list
65036007|NCT00201318|Vincristine|vincristine|mesh-list
65036008|NCT00201318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65036009|NCT00201318|Immunologic Factors|immunologic factors|mesh-ancestor
65036010|NCT00201318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036011|NCT00201318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64887908|NCT01955967|Lidocaine|lidocaine|mesh-list
65036030|NCT00201318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65036032|NCT00201357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65036033|NCT00201357|Immunologic Factors|immunologic factors|mesh-ancestor
65036034|NCT00201357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036035|NCT00201357|Leprostatic Agents|leprostatic agents|mesh-ancestor
65036036|NCT00201357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65036037|NCT00201357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65036038|NCT00201357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65036039|NCT00201357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65036040|NCT00201357|Growth Substances|growth substances|mesh-ancestor
65036041|NCT00201357|Growth Inhibitors|growth inhibitors|mesh-ancestor
65036042|NCT00201357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036043|NCT00201396|Leucovorin|leucovorin|mesh-list
65036044|NCT00201396|Fluorouracil|fluorouracil|mesh-list
65036045|NCT00201396|Epirubicin|epirubicin|mesh-list
65036046|NCT00201396|Mitomycins|mitomycins|mesh-list
65036047|NCT00201396|Mitomycin|mitomycin|mesh-list
65036048|NCT00201396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036049|NCT00201396|Antimetabolites|antimetabolites|mesh-ancestor
65036050|NCT00201396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036051|NCT00201396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65036052|NCT00201396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65036053|NCT00201396|Immunologic Factors|immunologic factors|mesh-ancestor
65036054|NCT00201396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036055|NCT00201396|Antidotes|antidotes|mesh-ancestor
65036056|NCT00201396|Protective Agents|protective agents|mesh-ancestor
65036057|NCT00201396|Vitamin B Complex|vitamin b complex|mesh-ancestor
65036058|NCT00201396|Vitamins|vitamins|mesh-ancestor
65036059|NCT00201396|Micronutrients|micronutrients|mesh-ancestor
65036060|NCT00201396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65036061|NCT00201396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65036062|NCT00201396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65036063|NCT00201396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036064|NCT00201396|Alkylating Agents|alkylating agents|mesh-ancestor
65036065|NCT00201396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65036066|NCT00201435|Paclitaxel|paclitaxel|mesh-list
65036067|NCT00201435|Docetaxel|docetaxel|mesh-list
65036068|NCT00201435|Capecitabine|capecitabine|mesh-list
65036096|NCT04634656|Anesthetics|anesthetics|mesh-ancestor
65036097|NCT04634656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65036098|NCT04634656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036099|NCT04634656|Sensory System Agents|sensory system agents|mesh-ancestor
65036100|NCT04634656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65036101|NCT04634656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65036102|NCT04634656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65036103|NCT04634656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65036104|NCT04634656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65036105|NCT04634656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036106|NCT04634500|Dapagliflozin|dapagliflozin|mesh-list
65036107|NCT04634500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65036108|NCT04634500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036109|NCT04634500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65036110|NCT04634500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036111|NCT04633954|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65036112|NCT04633954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65036113|NCT04633954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65036114|NCT04633954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65036115|NCT04633954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65248438|NCT00844207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65036143|NCT00179231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036144|NCT00179231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65036145|NCT00179231|Serotonin Agents|serotonin agents|mesh-ancestor
65036146|NCT00179231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65036147|NCT00179231|GABA Antagonists|gaba antagonists|mesh-ancestor
65036148|NCT00179231|GABA Agents|gaba agents|mesh-ancestor
65036149|NCT00201669|Clofarabine|clofarabine|mesh-list
65036150|NCT00201669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65036151|NCT00201669|Antimetabolites|antimetabolites|mesh-ancestor
65036152|NCT00201669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036153|NCT00201669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036154|NCT00201708|Cyclophosphamide|cyclophosphamide|mesh-list
65036155|NCT00201708|Docetaxel|docetaxel|mesh-list
65036156|NCT00201708|Doxorubicin|doxorubicin|mesh-list
65036157|NCT00201708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65036158|NCT00201708|Immunologic Factors|immunologic factors|mesh-ancestor
65036159|NCT00201708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036160|NCT00201708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65036161|NCT00201708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65036170|NCT00201708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65036171|NCT00201708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65036172|NCT00201708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036173|NCT00179465|Tiagabine|tiagabine|mesh-list
65036174|NCT00179465|Antipsychotic Agents|antipsychotic agents|mesh-list
65036175|NCT00179465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65036176|NCT00179465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65036177|NCT00179465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036178|NCT00179465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65036179|NCT00179465|Anticonvulsants|anticonvulsants|mesh-ancestor
65036180|NCT00179465|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
65036181|NCT00179465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65036182|NCT00179465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65036183|NCT00179465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036184|NCT00179465|GABA Agents|gaba agents|mesh-ancestor
65036185|NCT00179465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65036186|NCT04632121|Nicorandil|nicorandil|mesh-list
65036187|NCT04632121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65036188|NCT04632121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65036189|NCT04632121|Vasodilator Agents|vasodilator agents|mesh-ancestor
65036190|NCT04632121|Vitamin B Complex|vitamin b complex|mesh-ancestor
65036191|NCT04632121|Vitamins|vitamins|mesh-ancestor
65036192|NCT04632121|Micronutrients|micronutrients|mesh-ancestor
65036193|NCT04632121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036194|NCT00179699|Pemetrexed|pemetrexed|mesh-list
65036195|NCT00179699|Lenalidomide|lenalidomide|mesh-list
65036196|NCT00179699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036197|NCT00179699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910037|NCT00390871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65493864|NCT04166318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036198|NCT00179699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036199|NCT00179699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65036200|NCT00179699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65036201|NCT00179699|Immunologic Factors|immunologic factors|mesh-ancestor
65036202|NCT00179699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036203|NCT00179699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65036204|NCT00179699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65036205|NCT00179699|Growth Substances|growth substances|mesh-ancestor
65036206|NCT00179699|Growth Inhibitors|growth inhibitors|mesh-ancestor
65036207|NCT00201747|Mitomycins|mitomycins|mesh-list
65036208|NCT00201747|Mitomycin|mitomycin|mesh-list
65036209|NCT00201747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65036210|NCT00201747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036211|NCT00201747|Alkylating Agents|alkylating agents|mesh-ancestor
65036212|NCT00201747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036213|NCT00201747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65036214|NCT00201747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036215|NCT00179738|Lenalidomide|lenalidomide|mesh-list
65036216|NCT00179738|Immunologic Factors|immunologic factors|mesh-ancestor
65036217|NCT00179738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036218|NCT00179738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65036219|NCT00179738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65036220|NCT00179738|Growth Substances|growth substances|mesh-ancestor
65036221|NCT00179738|Growth Inhibitors|growth inhibitors|mesh-ancestor
65036222|NCT00179738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036223|NCT04631341|Melatonin|melatonin|mesh-list
65036224|NCT04631341|Antioxidants|antioxidants|mesh-ancestor
65036225|NCT04631341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036226|NCT04631341|Protective Agents|protective agents|mesh-ancestor
65036248|NCT04630522|Calcium, Dietary|calcium, dietary|mesh-list
65036249|NCT04630522|Calcium|calcium|mesh-list
65036250|NCT04630522|Vitamins|vitamins|mesh-ancestor
65036251|NCT04630522|Micronutrients|micronutrients|mesh-ancestor
65036252|NCT04630522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036253|NCT04630522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65036254|NCT04630522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65036255|NCT00179816|Cyclophosphamide|cyclophosphamide|mesh-list
65036256|NCT00179816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65036257|NCT00179816|Immunologic Factors|immunologic factors|mesh-ancestor
65036258|NCT00179816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036259|NCT00179816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65036260|NCT00179816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65036261|NCT00179816|Alkylating Agents|alkylating agents|mesh-ancestor
65036262|NCT00179816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036263|NCT00179816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036264|NCT00179816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65036265|NCT04630444|Riluzole|riluzole|mesh-list
65036266|NCT04630444|Anticonvulsants|anticonvulsants|mesh-ancestor
65036267|NCT04630444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65036268|NCT04630444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65036269|NCT04630444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65036270|NCT04630444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036271|NCT04630444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036272|NCT04630444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65036273|NCT04630444|Protective Agents|protective agents|mesh-ancestor
65036274|NCT00186810|Cyclophosphamide|cyclophosphamide|mesh-list
64477599|NCT01727024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65036275|NCT00186810|Busulfan|busulfan|mesh-list
64888192|NCT01958372|Etoposide|etoposide|mesh-list
65036304|NCT00561067|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65036305|NCT00561067|Prednisolone phosphate|prednisolone phosphate|mesh-list
65036306|NCT00561067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65036307|NCT00561067|Antiemetics|antiemetics|mesh-ancestor
65036308|NCT00561067|Autonomic Agents|autonomic agents|mesh-ancestor
65036309|NCT00561067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65036310|NCT00561067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036311|NCT00561067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65036312|NCT00561067|Glucocorticoids|glucocorticoids|mesh-ancestor
65036313|NCT00561067|Hormones|hormones|mesh-ancestor
65036314|NCT00561067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65036315|NCT00561067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65036316|NCT00561067|Protective Agents|protective agents|mesh-ancestor
65036317|NCT00561067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65036318|NCT00561067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036319|NCT00561067|Hematinics|hematinics|mesh-ancestor
65036320|NCT00561106|Valacyclovir|valacyclovir|mesh-list
65036321|NCT00561106|Prednisone|prednisone|mesh-list
65036348|NCT00186849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65036349|NCT00186849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65036350|NCT00186849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65036351|NCT00186849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65036352|NCT00186849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036353|NCT00186849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65036354|NCT00186849|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65036355|NCT00201981|Rebamipide|rebamipide|mesh-list
65036356|NCT00201981|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65036357|NCT00201981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65036358|NCT00201981|Antioxidants|antioxidants|mesh-ancestor
65036359|NCT00201981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036360|NCT00201981|Protective Agents|protective agents|mesh-ancestor
65036361|NCT00201981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036362|NCT00201981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036363|NCT00561223|Iloprost|iloprost|mesh-list
65036364|NCT00561223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65036365|NCT00561223|Vasodilator Agents|vasodilator agents|mesh-ancestor
65036366|NCT00180011|Omalizumab|omalizumab|mesh-list
65036367|NCT00180011|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65036368|NCT00180011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65036369|NCT00180011|Respiratory System Agents|respiratory system agents|mesh-ancestor
65036370|NCT00186966|Cytarabine|cytarabine|mesh-list
65036371|NCT00186966|Cyclophosphamide|cyclophosphamide|mesh-list
65036372|NCT00186966|Melphalan|melphalan|mesh-list
65036401|NCT00180050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036402|NCT00180050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64472578|NCT03113500|Podophyllotoxin|podophyllotoxin|mesh-list
65036403|NCT00180050|Respiratory System Agents|respiratory system agents|mesh-ancestor
65036404|NCT00180050|Glucocorticoids|glucocorticoids|mesh-ancestor
65036406|NCT00180050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65036407|NCT00575302|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65036408|NCT00575302|Hormones|hormones|mesh-ancestor
65036409|NCT00575302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65036410|NCT00575302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036411|NCT00575341|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65036412|NCT00575341|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65036413|NCT00575341|Immunologic Factors|immunologic factors|mesh-ancestor
65036414|NCT00575341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036415|NCT00180089|Budesonide|budesonide|mesh-list
65036416|NCT00180089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65036417|NCT00180089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65036418|NCT00180089|Autonomic Agents|autonomic agents|mesh-ancestor
65036419|NCT00180089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65036449|NCT00180128|Immunologic Factors|immunologic factors|mesh-ancestor
65036450|NCT00180128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036451|NCT00180128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65036452|NCT00180128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65036453|NCT00180128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65036454|NCT00180128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036456|NCT00180128|Sensory System Agents|sensory system agents|mesh-ancestor
65036457|NCT00180128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65036458|NCT00575614|Prucalopride|prucalopride|mesh-list
65036459|NCT00575614|Laxatives|laxatives|mesh-ancestor
65036460|NCT00575614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65036461|NCT00575614|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65036462|NCT00575614|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65036463|NCT00575614|Serotonin Agents|serotonin agents|mesh-ancestor
65036464|NCT00575614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65036465|NCT00575614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888385|NCT01959477|Busulfan|busulfan|mesh-list
65036480|NCT00576238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65036482|NCT00576238|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65036483|NCT00576238|Respiratory System Agents|respiratory system agents|mesh-ancestor
65036484|NCT00576394|Insulin|insulin|mesh-list
65036485|NCT00576394|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65036486|NCT00576394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65036487|NCT00576394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036488|NCT00576433|Rituximab|rituximab|mesh-list
65036489|NCT00576433|Methotrexate|methotrexate|mesh-list
65036490|NCT00576433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65036491|NCT00576433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036492|NCT00576433|Immunologic Factors|immunologic factors|mesh-ancestor
65036493|NCT00576433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036494|NCT00576433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65036495|NCT00576433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65036496|NCT00576433|Abortifacient Agents|abortifacient agents|mesh-ancestor
65036497|NCT00576433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65036498|NCT00576433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65036499|NCT00576433|Antimetabolites|antimetabolites|mesh-ancestor
65036500|NCT00576433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036501|NCT00576433|Dermatologic Agents|dermatologic agents|mesh-ancestor
65036502|NCT00576433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036503|NCT00576433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65036504|NCT00576433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65036505|NCT00576433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65036506|NCT00576511|Prucalopride|prucalopride|mesh-list
65036507|NCT00576511|Laxatives|laxatives|mesh-ancestor
65036508|NCT00576511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65036509|NCT00576511|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65036510|NCT00576511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65036511|NCT00576511|Serotonin Agents|serotonin agents|mesh-ancestor
65036512|NCT00576511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65036513|NCT00576511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036514|NCT00576511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036515|NCT00576550|Betamethasone|betamethasone|mesh-list
65036516|NCT00576550|Betamethasone Valerate|betamethasone valerate|mesh-list
65036517|NCT00576550|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65036518|NCT00576550|Betamethasone benzoate|betamethasone benzoate|mesh-list
65036519|NCT00576550|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64472596|NCT03113500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036520|NCT00576550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65036521|NCT00576550|Glucocorticoids|glucocorticoids|mesh-ancestor
65036522|NCT00576550|Hormones|hormones|mesh-ancestor
65036523|NCT00576550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64888423|NCT01960049|Anesthetics, Local|anesthetics, local|mesh-ancestor
65036553|NCT00202020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65036554|NCT00202020|Analgesics|analgesics|mesh-ancestor
65036555|NCT00202020|Sensory System Agents|sensory system agents|mesh-ancestor
65036556|NCT00202020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65036557|NCT00202020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036558|NCT00202020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65036559|NCT00202020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65036560|NCT00202020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65036561|NCT00202020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65036562|NCT00202020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036563|NCT00202020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65036564|NCT00202020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65036565|NCT00202020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036566|NCT00202020|Antipyretics|antipyretics|mesh-ancestor
65036567|NCT00202020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65036568|NCT00202020|Autonomic Agents|autonomic agents|mesh-ancestor
65036569|NCT00202020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65036570|NCT00202020|Respiratory System Agents|respiratory system agents|mesh-ancestor
65036599|NCT00577057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036600|NCT00187005|Cytarabine|cytarabine|mesh-list
65036601|NCT00187005|Dexamethasone|dexamethasone|mesh-list
65036602|NCT00187005|Prednisone|prednisone|mesh-list
65036603|NCT00187005|Cyclophosphamide|cyclophosphamide|mesh-list
65036604|NCT00187005|Methotrexate|methotrexate|mesh-list
65036605|NCT00187005|Etoposide|etoposide|mesh-list
65036606|NCT00187005|Vincristine|vincristine|mesh-list
65036607|NCT00187005|Daunorubicin|daunorubicin|mesh-list
65036608|NCT00187005|Asparaginase|asparaginase|mesh-list
65036609|NCT00187005|Mercaptopurine|mercaptopurine|mesh-list
65036610|NCT00187005|Idarubicin|idarubicin|mesh-list
65036611|NCT00187005|Pegaspargase|pegaspargase|mesh-list
65036612|NCT00187005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65036613|NCT00187005|Immunologic Factors|immunologic factors|mesh-ancestor
65036614|NCT00187005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036615|NCT00187005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65036616|NCT00187005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65036617|NCT00187005|Alkylating Agents|alkylating agents|mesh-ancestor
65036618|NCT00187005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036619|NCT00187005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036620|NCT00187005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65036621|NCT00187005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65036622|NCT00187005|Antiemetics|antiemetics|mesh-ancestor
65036632|NCT00187005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65036633|NCT00187005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65036634|NCT00187005|Antimetabolites|antimetabolites|mesh-ancestor
65036635|NCT00187005|Dermatologic Agents|dermatologic agents|mesh-ancestor
65036636|NCT00187005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036637|NCT00187005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65036638|NCT00187005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65036639|NCT00187005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65036640|NCT00187005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65036641|NCT00187005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65036642|NCT00187005|Antiviral Agents|antiviral agents|mesh-ancestor
65036643|NCT00187005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65036644|NCT00187005|Tubulin Modulators|tubulin modulators|mesh-ancestor
65036645|NCT00187005|Antimitotic Agents|antimitotic agents|mesh-ancestor
65036646|NCT00187005|Mitosis Modulators|mitosis modulators|mesh-ancestor
65036647|NCT00187005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65036648|NCT00202059|Zoledronic Acid|zoledronic acid|mesh-list
65036649|NCT00202059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65493865|NCT04166318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65036650|NCT00202059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036652|NCT00577369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65036653|NCT00577369|Anesthetics, General|anesthetics, general|mesh-ancestor
65036654|NCT00577369|Anesthetics|anesthetics|mesh-ancestor
65036655|NCT00577369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65036656|NCT00577369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036657|NCT00577681|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65036658|NCT00577681|Antiviral Agents|antiviral agents|mesh-ancestor
65036659|NCT00577681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65036660|NCT00577798|Doxorubicin|doxorubicin|mesh-list
65036661|NCT00577798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65036662|NCT00577798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65036663|NCT00577798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036664|NCT00577798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65036665|NCT00577798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65036666|NCT00577798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036667|NCT00577798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036668|NCT00187083|Dexamethasone|dexamethasone|mesh-list
65036669|NCT00187083|Methotrexate|methotrexate|mesh-list
65036670|NCT00187083|Fludarabine|fludarabine|mesh-list
65036671|NCT00187083|Etoposide|etoposide|mesh-list
65036672|NCT00187083|Vincristine|vincristine|mesh-list
65036673|NCT00187083|Topotecan|topotecan|mesh-list
65036674|NCT00187083|Asparaginase|asparaginase|mesh-list
65036675|NCT00187083|Mercaptopurine|mercaptopurine|mesh-list
65036676|NCT00187083|Idarubicin|idarubicin|mesh-list
65036677|NCT00187083|Pegaspargase|pegaspargase|mesh-list
65036678|NCT00187083|Teniposide|teniposide|mesh-list
65036679|NCT00187083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65036680|NCT00187083|Antiemetics|antiemetics|mesh-ancestor
65036681|NCT00187083|Autonomic Agents|autonomic agents|mesh-ancestor
65036682|NCT00187083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65036683|NCT00187083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036684|NCT00187083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65036685|NCT00187083|Glucocorticoids|glucocorticoids|mesh-ancestor
65036686|NCT00187083|Hormones|hormones|mesh-ancestor
65036687|NCT00187083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65036688|NCT00187083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65036693|NCT00187083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65036695|NCT00187083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036696|NCT00187083|Dermatologic Agents|dermatologic agents|mesh-ancestor
65036697|NCT00187083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036698|NCT00187083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65036699|NCT00187083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65036700|NCT00187083|Immunologic Factors|immunologic factors|mesh-ancestor
65036701|NCT00187083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65036702|NCT00187083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65036703|NCT00187083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65036704|NCT00187083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65036705|NCT00187083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65036706|NCT00187083|Tubulin Modulators|tubulin modulators|mesh-ancestor
65036707|NCT00187083|Antimitotic Agents|antimitotic agents|mesh-ancestor
65036708|NCT00187083|Mitosis Modulators|mitosis modulators|mesh-ancestor
65036709|NCT00187083|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65036710|NCT00187083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65036711|NCT00577837|Risedronic Acid|risedronic acid|mesh-list
65036712|NCT00577837|Etidronic Acid|etidronic acid|mesh-list
65036713|NCT00577837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65036714|NCT00577837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65036715|NCT00577837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036716|NCT00577837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65036717|NCT00577837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036718|NCT00577837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65036719|NCT00578149|Paclitaxel|paclitaxel|mesh-list
65036720|NCT00578149|Bevacizumab|bevacizumab|mesh-list
65036721|NCT00578149|Carboplatin|carboplatin|mesh-list
65036722|NCT00578149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65036723|NCT00578149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036724|NCT00578149|Tubulin Modulators|tubulin modulators|mesh-ancestor
65036725|NCT00578149|Antimitotic Agents|antimitotic agents|mesh-ancestor
65036726|NCT00578149|Mitosis Modulators|mitosis modulators|mesh-ancestor
65036727|NCT00578149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036728|NCT00578149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65036729|NCT00578149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65036730|NCT00578149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65036731|NCT00578149|Growth Substances|growth substances|mesh-ancestor
65036732|NCT00578149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036733|NCT00578149|Growth Inhibitors|growth inhibitors|mesh-ancestor
65036734|NCT00187122|Cytarabine|cytarabine|mesh-list
65036735|NCT00187122|Dexamethasone|dexamethasone|mesh-list
65036736|NCT00187122|Prednisone|prednisone|mesh-list
65036737|NCT00187122|Cyclophosphamide|cyclophosphamide|mesh-list
65036738|NCT00187122|Methotrexate|methotrexate|mesh-list
65036739|NCT00187122|Etoposide|etoposide|mesh-list
65036740|NCT00187122|Vincristine|vincristine|mesh-list
65036741|NCT00187122|Asparaginase|asparaginase|mesh-list
65036742|NCT00187122|Mercaptopurine|mercaptopurine|mesh-list
64410864|NCT02588261|Gefitinib|gefitinib|mesh-list
65036743|NCT00187122|Daunorubicin|daunorubicin|mesh-list
65036744|NCT00187122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65036745|NCT00187122|Immunologic Factors|immunologic factors|mesh-ancestor
65036746|NCT00187122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036747|NCT00187122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65036748|NCT00187122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65036749|NCT00187122|Alkylating Agents|alkylating agents|mesh-ancestor
65036750|NCT00187122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036751|NCT00187122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036752|NCT00187122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65036753|NCT00187122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65036754|NCT00187122|Antiemetics|antiemetics|mesh-ancestor
65036755|NCT00187122|Autonomic Agents|autonomic agents|mesh-ancestor
65036756|NCT00187122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65036757|NCT00187122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65036758|NCT00187122|Glucocorticoids|glucocorticoids|mesh-ancestor
65036759|NCT00187122|Hormones|hormones|mesh-ancestor
65036789|NCT00578266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65036790|NCT00578266|Alkylating Agents|alkylating agents|mesh-ancestor
65036791|NCT00578266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036792|NCT00578266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036793|NCT00578266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65036794|NCT00578266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65036795|NCT04578496|Afamelanotide|afamelanotide|mesh-list
65036796|NCT04578496|Dermatologic Agents|dermatologic agents|mesh-ancestor
65036797|NCT00579046|Darbepoetin alfa|darbepoetin alfa|mesh-list
65036798|NCT00579046|Hematinics|hematinics|mesh-ancestor
65036799|NCT00579085|Ketamine|ketamine|mesh-list
65036800|NCT00579085|Analgesics|analgesics|mesh-ancestor
65036801|NCT00579085|Sensory System Agents|sensory system agents|mesh-ancestor
65493866|NCT04166318|Alkylating Agents|alkylating agents|mesh-ancestor
64557490|NCT03898037|Metformin|metformin|mesh-list
65036817|NCT00187161|Etoposide|etoposide|mesh-list
65036818|NCT00187161|Vincristine|vincristine|mesh-list
65036819|NCT00187161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65036820|NCT00187161|Immunologic Factors|immunologic factors|mesh-ancestor
65036821|NCT00187161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036822|NCT00187161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65036823|NCT00187161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65036824|NCT00187161|Alkylating Agents|alkylating agents|mesh-ancestor
65036825|NCT00187161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036826|NCT00187161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036827|NCT00187161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65036828|NCT00187161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65036829|NCT00187161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65036830|NCT00187161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65036831|NCT00187161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036832|NCT00187161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65036833|NCT00187161|Abortifacient Agents|abortifacient agents|mesh-ancestor
65036834|NCT00187161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65036835|NCT00187161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65036836|NCT00187161|Antimetabolites|antimetabolites|mesh-ancestor
65036837|NCT00187161|Dermatologic Agents|dermatologic agents|mesh-ancestor
65036838|NCT00187161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65036839|NCT00187161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65036840|NCT00187161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65036841|NCT00187161|Antiviral Agents|antiviral agents|mesh-ancestor
65036842|NCT00187161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65036843|NCT00187161|Tubulin Modulators|tubulin modulators|mesh-ancestor
65036844|NCT00187161|Antimitotic Agents|antimitotic agents|mesh-ancestor
65036845|NCT00187161|Mitosis Modulators|mitosis modulators|mesh-ancestor
65036846|NCT00579475|Mifepristone|mifepristone|mesh-list
65036847|NCT00579475|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65036848|NCT00579475|Abortifacient Agents|abortifacient agents|mesh-ancestor
65036849|NCT00579475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65036850|NCT00579475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036851|NCT00579475|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65036852|NCT00579475|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65036853|NCT00579475|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65036854|NCT00579475|Contraceptive Agents|contraceptive agents|mesh-ancestor
65036863|NCT00579592|Rituximab|rituximab|mesh-list
65036864|NCT00579592|Alemtuzumab|alemtuzumab|mesh-list
65036865|NCT00579592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65036866|NCT00579592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036867|NCT00579592|Immunologic Factors|immunologic factors|mesh-ancestor
65036868|NCT00579592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036869|NCT00579592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65036870|NCT00579592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65036871|NCT00579592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65036872|NCT00579592|Antitubercular Agents|antitubercular agents|mesh-ancestor
65036873|NCT00579592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65036874|NCT00579592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65036875|NCT00579592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036876|NCT00579592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036877|NCT00180791|Carboplatin|carboplatin|mesh-list
65036878|NCT00180791|Etoposide|etoposide|mesh-list
65036879|NCT00180791|Melphalan|melphalan|mesh-list
65036880|NCT00180791|Thiotepa|thiotepa|mesh-list
65036881|NCT00180791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478200|NCT05363553|Caseins|caseins|mesh-list
65036882|NCT00180791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65036883|NCT00180791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65036884|NCT00180791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65036885|NCT00180791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036886|NCT00180791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036887|NCT00180791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65036888|NCT00180791|Alkylating Agents|alkylating agents|mesh-ancestor
65036889|NCT00180791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65036890|NCT00180791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65036891|NCT00180791|Immunologic Factors|immunologic factors|mesh-ancestor
65036892|NCT00180791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036894|NCT01054248|Piperaquine|piperaquine|mesh-list
65036895|NCT01054248|Artenimol|artenimol|mesh-list
65036896|NCT01054248|Mefloquine|mefloquine|mesh-list
65036897|NCT01054248|Antimalarials|antimalarials|mesh-ancestor
65036898|NCT01054248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65036899|NCT01054248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65036900|NCT01054248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65036901|NCT01054248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036902|NCT01054248|Antiviral Agents|antiviral agents|mesh-ancestor
65036903|NCT01054248|Schistosomicides|schistosomicides|mesh-ancestor
65036904|NCT01054248|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65036905|NCT01054248|Anthelmintics|anthelmintics|mesh-ancestor
65036906|NCT00180830|Imatinib Mesylate|imatinib mesylate|mesh-list
65036907|NCT00180830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036908|NCT00180830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65036909|NCT00180830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036910|NCT00180830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036911|NCT00202176|Bromides|bromides|mesh-list
65036912|NCT00202176|Ipratropium|ipratropium|mesh-list
65036913|NCT00202176|Anticonvulsants|anticonvulsants|mesh-ancestor
65036914|NCT00202176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65036915|NCT00202176|Autonomic Agents|autonomic agents|mesh-ancestor
65036916|NCT00202176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65036917|NCT00202176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036918|NCT00202176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65036919|NCT00202176|Respiratory System Agents|respiratory system agents|mesh-ancestor
65036920|NCT00202176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65036921|NCT00202176|Cholinergic Agents|cholinergic agents|mesh-ancestor
65036943|NCT00180908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65036944|NCT00180908|Antimetabolites|antimetabolites|mesh-ancestor
65036945|NCT00180908|Dermatologic Agents|dermatologic agents|mesh-ancestor
65036946|NCT00180908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65036947|NCT00180908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65036948|NCT00180908|Immunologic Factors|immunologic factors|mesh-ancestor
65036949|NCT00180908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65036950|NCT00180908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65036951|NCT00180908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65493867|NCT04166318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65036952|NCT00180908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65036953|NCT00180908|Alkylating Agents|alkylating agents|mesh-ancestor
65036954|NCT00580450|Thymalfasin|thymalfasin|mesh-list
65036955|NCT00580450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65036956|NCT00580450|Immunologic Factors|immunologic factors|mesh-ancestor
64478274|NCT01721408|Tigecycline|tigecycline|mesh-list
65036957|NCT00580450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036959|NCT00180947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65036960|NCT00180947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036961|NCT00180947|Tubulin Modulators|tubulin modulators|mesh-ancestor
65036962|NCT00180947|Antimitotic Agents|antimitotic agents|mesh-ancestor
65036963|NCT00180947|Mitosis Modulators|mitosis modulators|mesh-ancestor
65036964|NCT00180947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036965|NCT00581035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65036966|NCT00581035|Immunologic Factors|immunologic factors|mesh-ancestor
65036967|NCT00581035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036968|NCT00581425|Interferons|interferons|mesh-list
65036969|NCT00581425|Interferon-alpha|interferon-alpha|mesh-list
65036971|NCT00581425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036972|NCT00581425|Antiviral Agents|antiviral agents|mesh-ancestor
65036973|NCT00581425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65036992|NCT04576975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65036993|NCT04576975|Analgesics|analgesics|mesh-ancestor
65036994|NCT04576975|Sensory System Agents|sensory system agents|mesh-ancestor
65036995|NCT04576975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65036996|NCT04576975|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65036997|NCT04576975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65036998|NCT04576975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65036999|NCT04576975|Adrenergic Agents|adrenergic agents|mesh-ancestor
65037000|NCT04576975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65037001|NCT04576975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037002|NCT04576975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65037003|NCT04576975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65037004|NCT04576975|Anesthetics, General|anesthetics, general|mesh-ancestor
65037005|NCT04576975|Anesthetics|anesthetics|mesh-ancestor
65037006|NCT04576975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65037007|NCT04576975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65037008|NCT00209118|Paroxetine|paroxetine|mesh-list
65037009|NCT00209118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65037010|NCT00209118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65037011|NCT00209118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65037012|NCT00209118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037013|NCT00209118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65037014|NCT00209118|Serotonin Agents|serotonin agents|mesh-ancestor
65037015|NCT00209118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037016|NCT00209118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65037017|NCT00209118|Antidepressive Agents|antidepressive agents|mesh-ancestor
65037018|NCT00209118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65037019|NCT00209118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65037020|NCT00209118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65037021|NCT00209118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037022|NCT00181025|Melphalan|melphalan|mesh-list
65037023|NCT00181025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65037024|NCT00181025|Alkylating Agents|alkylating agents|mesh-ancestor
65037025|NCT00181025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037026|NCT00181025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037027|NCT00181025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65037028|NCT00181025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65037039|NCT00582634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037040|NCT00209352|Acyclovir|acyclovir|mesh-list
65037041|NCT00209352|Antiviral Agents|antiviral agents|mesh-ancestor
65037042|NCT00209352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65037043|NCT00181142|Daclizumab|daclizumab|mesh-list
65037044|NCT00181142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65037045|NCT00181142|Immunologic Factors|immunologic factors|mesh-ancestor
65037046|NCT00181142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037047|NCT00582985|Antibodies|antibodies|mesh-list
65037048|NCT00582985|Immunologic Factors|immunologic factors|mesh-ancestor
65037049|NCT00582985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037050|NCT00187551|Enfuvirtide|enfuvirtide|mesh-list
65037051|NCT00187551|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65037052|NCT00187551|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65037053|NCT00187551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037054|NCT00187551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65037055|NCT00187551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65037056|NCT00187551|Antiviral Agents|antiviral agents|mesh-ancestor
65037057|NCT00187551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65037058|NCT00181181|Atorvastatin|atorvastatin|mesh-list
65037059|NCT00181181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65037060|NCT00181181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65037061|NCT00181181|Antimetabolites|antimetabolites|mesh-ancestor
65037062|NCT00181181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037063|NCT00181181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65037064|NCT00181181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65037065|NCT00181181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472631|NCT03065621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037066|NCT00181220|Valproic Acid|valproic acid|mesh-list
65037067|NCT00181220|Anticonvulsants|anticonvulsants|mesh-ancestor
65037068|NCT00181220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037069|NCT00181220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037070|NCT00181220|GABA Agents|gaba agents|mesh-ancestor
65037071|NCT00181220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65037072|NCT00181220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037073|NCT00181220|Antimanic Agents|antimanic agents|mesh-ancestor
65037074|NCT00181220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65037075|NCT00181220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65037076|NCT00181220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65037077|NCT00583063|Sirolimus|sirolimus|mesh-list
65037078|NCT00583063|Sunitinib|sunitinib|mesh-list
65037079|NCT00583063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037080|NCT00583063|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65037081|NCT00583063|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65037082|NCT00583063|Growth Substances|growth substances|mesh-ancestor
65037083|NCT00583063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037084|NCT00583063|Growth Inhibitors|growth inhibitors|mesh-ancestor
65037085|NCT00583063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65037086|NCT00583063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037087|NCT00583063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037088|NCT00583063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65037089|NCT00583063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65037090|NCT00583063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65037091|NCT00583063|Antifungal Agents|antifungal agents|mesh-ancestor
65037092|NCT00583063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65037093|NCT00583063|Immunologic Factors|immunologic factors|mesh-ancestor
65037094|NCT00181298|Memantine|memantine|mesh-list
65037095|NCT00181298|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65037096|NCT00181298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65037097|NCT00181298|Dopamine Agents|dopamine agents|mesh-ancestor
65037150|NCT00181571|Methylphenidate|methylphenidate|mesh-list
65037151|NCT00181571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65037152|NCT00181571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037153|NCT00181571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65037154|NCT00181571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65037155|NCT00181571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65037156|NCT00181571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037157|NCT00181571|Dopamine Agents|dopamine agents|mesh-ancestor
65037158|NCT00181571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65037160|NCT00187707|Analgesics|analgesics|mesh-ancestor
65037161|NCT00187707|Sensory System Agents|sensory system agents|mesh-ancestor
65037162|NCT00187707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65037163|NCT00187707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037164|NCT00187707|Anticonvulsants|anticonvulsants|mesh-ancestor
65037165|NCT00187707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65037166|NCT00187707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65037167|NCT00187707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65037168|NCT00187707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65037169|NCT00187707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65037170|NCT00187707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65037171|NCT00187707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65037172|NCT00187707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037173|NCT00187707|Antimanic Agents|antimanic agents|mesh-ancestor
65037174|NCT00187746|Adefovir|adefovir|mesh-list
65037175|NCT00187746|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65037176|NCT00187746|Antiviral Agents|antiviral agents|mesh-ancestor
65037177|NCT00187746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65037178|NCT00187746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64522406|NCT02429466|Guadecitabine|guadecitabine|mesh-list
65037179|NCT00187746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65037180|NCT00187746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037181|NCT00187746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037183|NCT00181688|Gefitinib|gefitinib|mesh-list
65037184|NCT00181688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65037185|NCT00181688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037186|NCT00181688|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65037187|NCT00181688|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65037188|NCT00181688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037199|NCT00181727|Anticonvulsants|anticonvulsants|mesh-ancestor
65037200|NCT00181727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037201|NCT00181727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037202|NCT00181727|GABA Agents|gaba agents|mesh-ancestor
65037203|NCT00181727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65037204|NCT00181727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037205|NCT00181727|Antimanic Agents|antimanic agents|mesh-ancestor
65037206|NCT00181727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65037207|NCT00181727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65037208|NCT00181727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65037209|NCT00584155|Ofloxacin|ofloxacin|mesh-list
65037210|NCT00584155|Levofloxacin|levofloxacin|mesh-list
65037211|NCT00584155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65037212|NCT00584155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65037213|NCT00584155|Renal Agents|renal agents|mesh-ancestor
65037214|NCT00584155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65037215|NCT00584155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65037216|NCT00584155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65037217|NCT00584155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037218|NCT00584155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037219|NCT00584155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037220|NCT00584155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65037221|NCT00584155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65037222|NCT00411372|Fluticasone|fluticasone|mesh-list
65037223|NCT00411372|Xhance|xhance|mesh-list
65037224|NCT00411372|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65037225|NCT00411372|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65037226|NCT00411372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65037227|NCT00411372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65037228|NCT00411372|Autonomic Agents|autonomic agents|mesh-ancestor
65037229|NCT00411372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65037230|NCT00411372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037231|NCT00411372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65037232|NCT00411372|Respiratory System Agents|respiratory system agents|mesh-ancestor
65037233|NCT00411372|Dermatologic Agents|dermatologic agents|mesh-ancestor
65037234|NCT00411372|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65037235|NCT00411372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65037236|NCT00411372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65037237|NCT00411372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65037238|NCT00411372|Adrenergic Agents|adrenergic agents|mesh-ancestor
65037239|NCT00411372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65037240|NCT00411372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037241|NCT00411372|Glucocorticoids|glucocorticoids|mesh-ancestor
65037242|NCT00411372|Hormones|hormones|mesh-ancestor
65037243|NCT00411372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65037244|NCT00411372|Sympathomimetics|sympathomimetics|mesh-ancestor
65037245|NCT00181922|Ziprasidone|ziprasidone|mesh-list
65037246|NCT00181922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65037247|NCT00181922|Serotonin Agents|serotonin agents|mesh-ancestor
65037248|NCT00181922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64911102|NCT00010192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65493868|NCT04166318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889079|NCT01964586|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65037253|NCT00181922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65037254|NCT00181922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65037255|NCT00181922|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65037257|NCT00182039|Metoprolol|metoprolol|mesh-list
65037258|NCT00182039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65037259|NCT00182039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65037260|NCT00182039|Sympatholytics|sympatholytics|mesh-ancestor
65037261|NCT00182039|Autonomic Agents|autonomic agents|mesh-ancestor
65037262|NCT00182039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65037263|NCT00182039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037264|NCT00182039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65037265|NCT00182039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65037266|NCT00182039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65037267|NCT00182039|Adrenergic Agents|adrenergic agents|mesh-ancestor
65037268|NCT00182039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65037269|NCT00182039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037270|NCT00584389|Rimonabant|rimonabant|mesh-list
65037271|NCT00584389|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65037272|NCT00584389|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65037273|NCT00584389|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65037274|NCT00584389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65037275|NCT00584389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037276|NCT00584389|Hormones|hormones|mesh-ancestor
65037277|NCT00584389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65037278|NCT00584389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037279|NCT00216372|Lanreotide|lanreotide|mesh-list
65037280|NCT00216372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037281|NCT00584662|Phenylephrine|phenylephrine|mesh-list
65037282|NCT00584662|Oxymetazoline|oxymetazoline|mesh-list
65037283|NCT00584662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65037284|NCT00584662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65037285|NCT00584662|Adrenergic Agents|adrenergic agents|mesh-ancestor
65037286|NCT00584662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65037287|NCT00584662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037288|NCT00584662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037289|NCT00584662|Sympathomimetics|sympathomimetics|mesh-ancestor
65037290|NCT00584662|Autonomic Agents|autonomic agents|mesh-ancestor
65037291|NCT00584662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65037292|NCT00584662|Nasal Decongestants|nasal decongestants|mesh-ancestor
65037293|NCT00584662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65037294|NCT00584662|Respiratory System Agents|respiratory system agents|mesh-ancestor
65037295|NCT00584662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65037296|NCT00584662|Mydriatics|mydriatics|mesh-ancestor
65037297|NCT00584662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65037298|NCT00584662|Protective Agents|protective agents|mesh-ancestor
65037299|NCT00584779|Gabapentin|gabapentin|mesh-list
65037300|NCT00584779|Analgesics|analgesics|mesh-ancestor
65037301|NCT00584779|Sensory System Agents|sensory system agents|mesh-ancestor
65037302|NCT00584779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65037303|NCT00584779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037304|NCT00584779|Anticonvulsants|anticonvulsants|mesh-ancestor
65037305|NCT00584779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65037306|NCT00584779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65037307|NCT00584779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65037308|NCT00584779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65037309|NCT00584779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65037310|NCT00584779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65037311|NCT00584779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65037312|NCT00584779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037313|NCT00584779|Antimanic Agents|antimanic agents|mesh-ancestor
65037314|NCT00216411|Botulinum Toxins|botulinum toxins|mesh-list
65037315|NCT00216411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65037316|NCT00216411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64889144|NCT01965080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65037332|NCT00585091|Sympathomimetics|sympathomimetics|mesh-ancestor
65037333|NCT00585091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65037334|NCT00585091|Nasal Decongestants|nasal decongestants|mesh-ancestor
65037335|NCT00585091|Respiratory System Agents|respiratory system agents|mesh-ancestor
65037336|NCT00585091|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65037337|NCT00585091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65037338|NCT00585091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65037339|NCT00585091|Adrenergic Agents|adrenergic agents|mesh-ancestor
65037340|NCT00585091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65037341|NCT00585091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037342|NCT00585091|Protective Agents|protective agents|mesh-ancestor
65037343|NCT00216450|Rabeprazole|rabeprazole|mesh-list
65037344|NCT00216450|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65037345|NCT00216450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65037346|NCT00216450|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65037347|NCT00216450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037348|NCT00216450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037349|NCT00585442|Vitamin D|vitamin d|mesh-list
65037350|NCT00585442|Calcitriol|calcitriol|mesh-list
65037351|NCT00585442|Vitamins|vitamins|mesh-ancestor
65037352|NCT00585442|Micronutrients|micronutrients|mesh-ancestor
65037353|NCT00585442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037354|NCT00585442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65037355|NCT00585442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65037356|NCT00585442|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65037357|NCT00585442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65037358|NCT00585442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037359|NCT00585442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65037360|NCT00585520|Progesterone|progesterone|mesh-list
65037361|NCT00585520|Progestins|progestins|mesh-ancestor
65037362|NCT00585520|Hormones|hormones|mesh-ancestor
65037363|NCT00585520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65037364|NCT00585520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037365|NCT00216489|Rabeprazole|rabeprazole|mesh-list
64813633|NCT01472783|Veliparib|veliparib|mesh-list
65037366|NCT00216489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65037367|NCT00216489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65037368|NCT00216489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65037369|NCT00216489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037370|NCT00216489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037371|NCT00585754|Guanfacine|guanfacine|mesh-list
65037372|NCT00585754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65037373|NCT00585754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65037374|NCT00585754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65037375|NCT00585754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65037376|NCT00585754|Adrenergic Agents|adrenergic agents|mesh-ancestor
65037390|NCT00585871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65037391|NCT00585871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037392|NCT00585871|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65037393|NCT00585871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65037394|NCT00585871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65037396|NCT00585871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65037397|NCT00585871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037398|NCT00585871|Analgesics|analgesics|mesh-ancestor
65037399|NCT00585871|Sensory System Agents|sensory system agents|mesh-ancestor
65037400|NCT00585871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65037401|NCT00585871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65037402|NCT00585871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65037403|NCT03452722|Plasminogen|plasminogen|mesh-list
65037404|NCT03452722|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65037405|NCT03452722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65037406|NCT03452722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65037407|NCT03452722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037408|NCT00408551|Leucovorin|leucovorin|mesh-list
65037409|NCT00408551|Fluorouracil|fluorouracil|mesh-list
65037410|NCT00408551|Floxuridine|floxuridine|mesh-list
65037411|NCT00408551|Oxaliplatin|oxaliplatin|mesh-list
65037412|NCT00408551|Irinotecan|irinotecan|mesh-list
65037413|NCT00408551|Calcium|calcium|mesh-list
65037414|NCT00408551|Levoleucovorin|levoleucovorin|mesh-list
65037415|NCT00408551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65037416|NCT00408551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037417|NCT00408551|Antimetabolites|antimetabolites|mesh-ancestor
65037418|NCT00408551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037419|NCT00408551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65037420|NCT00408551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037421|NCT00408551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65037422|NCT00408551|Immunologic Factors|immunologic factors|mesh-ancestor
65037423|NCT00408551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65037424|NCT00408551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65037425|NCT00408551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037426|NCT00408551|Antidotes|antidotes|mesh-ancestor
65037427|NCT00408551|Protective Agents|protective agents|mesh-ancestor
65037428|NCT00408551|Vitamin B Complex|vitamin b complex|mesh-ancestor
65037429|NCT00408551|Vitamins|vitamins|mesh-ancestor
65037430|NCT00408551|Micronutrients|micronutrients|mesh-ancestor
65037431|NCT04575415|Bevacizumab|bevacizumab|mesh-list
65037432|NCT04575415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65037433|NCT04575415|Gefitinib|gefitinib|mesh-list
65037434|NCT04575415|Osimertinib|osimertinib|mesh-list
65037435|NCT04575415|Afatinib|afatinib|mesh-list
65037436|NCT04575415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65037437|NCT04575415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037438|NCT04575415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64889281|NCT01966172|Ibuprofen|ibuprofen|mesh-list
65037466|NCT00209625|Vitamins|vitamins|mesh-ancestor
65037467|NCT00209625|Micronutrients|micronutrients|mesh-ancestor
65037468|NCT00216528|Risperidone|risperidone|mesh-list
65037469|NCT00216528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65037470|NCT00216528|Serotonin Agents|serotonin agents|mesh-ancestor
65037471|NCT00216528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65493870|NCT04147494|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65037472|NCT00216528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911324|NCT00005945|Thioguanine|thioguanine|mesh-list
65037473|NCT00216528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037474|NCT00216528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64522713|NCT00227019|Antiemetics|antiemetics|mesh-ancestor
65037475|NCT00216528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65037476|NCT00216528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65037477|NCT00216528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65037478|NCT00216528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65037480|NCT00182312|Caffeine|caffeine|mesh-list
65037481|NCT00182312|Caffeine citrate|caffeine citrate|mesh-list
65037482|NCT00182312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037483|NCT00182312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64889339|NCT01966484|Mivacurium|mivacurium|mesh-list
65037494|NCT00209664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037495|NCT00209664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037496|NCT00209664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037497|NCT04575493|Ciprofloxacin|ciprofloxacin|mesh-list
65037498|NCT04575493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65037499|NCT04575493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65037500|NCT04575493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65037501|NCT04575493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65037502|NCT04575493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037503|NCT04575493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037504|NCT04575493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037505|NCT04575493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65037506|NCT04575493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65037508|NCT00587119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65037509|NCT00587119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65037510|NCT00587119|Autonomic Agents|autonomic agents|mesh-ancestor
65037511|NCT00587119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65037512|NCT00587119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037513|NCT00587119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65037514|NCT00587119|Respiratory System Agents|respiratory system agents|mesh-ancestor
65037515|NCT00587119|Glucocorticoids|glucocorticoids|mesh-ancestor
65037516|NCT00587119|Hormones|hormones|mesh-ancestor
65037517|NCT00587119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65037518|NCT00216567|Topiramate|topiramate|mesh-list
65037519|NCT00216567|Anticonvulsants|anticonvulsants|mesh-ancestor
65037520|NCT00216567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65037521|NCT00216567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037522|NCT00182351|Fibrin fragment D|fibrin fragment d|mesh-list
65037523|NCT00182351|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65037524|NCT00182351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65037525|NCT00182351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037526|NCT00182351|Hemostatics|hemostatics|mesh-ancestor
65037527|NCT00182351|Coagulants|coagulants|mesh-ancestor
65037528|NCT00587470|Candesartan|candesartan|mesh-list
65037529|NCT00587470|Candesartan cilexetil|candesartan cilexetil|mesh-list
65037530|NCT00587470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65037531|NCT00587470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65037532|NCT00587470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65037533|NCT00587470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037534|NCT00209703|Leucovorin|leucovorin|mesh-list
65037535|NCT00209703|Fluorouracil|fluorouracil|mesh-list
65037536|NCT00209703|Oxaliplatin|oxaliplatin|mesh-list
65037537|NCT00209703|Levoleucovorin|levoleucovorin|mesh-list
65037538|NCT00209703|Antimetabolites|antimetabolites|mesh-ancestor
65037539|NCT00209703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037540|NCT00209703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65037541|NCT00209703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037542|NCT00209703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65037543|NCT00209703|Immunologic Factors|immunologic factors|mesh-ancestor
65037544|NCT00209703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037545|NCT00209703|Antidotes|antidotes|mesh-ancestor
65037546|NCT00209703|Protective Agents|protective agents|mesh-ancestor
65493871|NCT04147494|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65037572|NCT00587665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65037573|NCT00587665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65037574|NCT00587665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65037575|NCT00587665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037576|NCT00182429|Metronidazole|metronidazole|mesh-list
65037577|NCT00182429|Rifampin|rifampin|mesh-list
65037578|NCT00182429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65037579|NCT00182429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65037580|NCT00182429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65037581|NCT00182429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65037582|NCT00182429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65037583|NCT00182429|Antitubercular Agents|antitubercular agents|mesh-ancestor
65037584|NCT00182429|Leprostatic Agents|leprostatic agents|mesh-ancestor
65037585|NCT00182429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65037586|NCT00182429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037587|NCT00182429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472638|NCT03060434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65037588|NCT00182429|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65037589|NCT00182429|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65037590|NCT00182429|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65037591|NCT00182429|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65037592|NCT00182429|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65037593|NCT00182429|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65037594|NCT00216645|Doxorubicin|doxorubicin|mesh-list
65037595|NCT00216645|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65037596|NCT00216645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65037597|NCT00216645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037626|NCT00588133|Tranexamic Acid|tranexamic acid|mesh-list
65037627|NCT00588133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65037628|NCT00588133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65037629|NCT00588133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037630|NCT00588133|Hemostatics|hemostatics|mesh-ancestor
65037631|NCT00588133|Coagulants|coagulants|mesh-ancestor
65037632|NCT00588172|Metformin|metformin|mesh-list
65037633|NCT00588172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65037634|NCT00588172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037635|NCT00182507|Olanzapine|olanzapine|mesh-list
65037636|NCT00182507|Antiemetics|antiemetics|mesh-ancestor
65037637|NCT00182507|Autonomic Agents|autonomic agents|mesh-ancestor
65037638|NCT00182507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65037639|NCT00182507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037640|NCT00182507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65037671|NCT00209742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65037672|NCT00216723|Aripiprazole|aripiprazole|mesh-list
65037673|NCT00216723|Antidepressive Agents|antidepressive agents|mesh-ancestor
65037674|NCT00216723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65037675|NCT00216723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65037676|NCT00216723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65037677|NCT00216723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65037678|NCT00216723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037679|NCT00216723|Dopamine Agonists|dopamine agonists|mesh-ancestor
65037680|NCT00216723|Dopamine Agents|dopamine agents|mesh-ancestor
65037681|NCT00216723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65037682|NCT00216723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037683|NCT00216723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65037684|NCT00216723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65037685|NCT00216723|Serotonin Agents|serotonin agents|mesh-ancestor
65037719|NCT00182663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037720|NCT00182663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037721|NCT00182663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65037722|NCT00182663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65037723|NCT00182663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64889586|NCT01967979|Serotonin Agents|serotonin agents|mesh-ancestor
65037732|NCT00216762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037733|NCT00216762|Immunologic Factors|immunologic factors|mesh-ancestor
65037734|NCT00216762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037735|NCT00216762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65037736|NCT00182702|Epothilones|epothilones|mesh-list
65037737|NCT00182702|Epothilone B|epothilone b|mesh-list
65037738|NCT00182702|Tubulin Modulators|tubulin modulators|mesh-ancestor
65037739|NCT00182702|Antimitotic Agents|antimitotic agents|mesh-ancestor
65037740|NCT00182702|Mitosis Modulators|mitosis modulators|mesh-ancestor
65037741|NCT00182702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037742|NCT00182702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037743|NCT00588835|Dexamethasone|dexamethasone|mesh-list
65037744|NCT00588835|Ondansetron|ondansetron|mesh-list
65037746|NCT00588835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65037747|NCT00588835|Antiemetics|antiemetics|mesh-ancestor
65037748|NCT00588835|Autonomic Agents|autonomic agents|mesh-ancestor
65037749|NCT00588835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65037750|NCT00588835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037751|NCT00588835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65037752|NCT00588835|Glucocorticoids|glucocorticoids|mesh-ancestor
65037753|NCT00588835|Hormones|hormones|mesh-ancestor
65037754|NCT00588835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65037755|NCT00588835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65037756|NCT00588835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037757|NCT00588835|Antipruritics|antipruritics|mesh-ancestor
65037758|NCT00588835|Dermatologic Agents|dermatologic agents|mesh-ancestor
65037759|NCT00588835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65037760|NCT00588835|Serotonin Agents|serotonin agents|mesh-ancestor
65037761|NCT00588835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65037762|NCT00588835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037763|NCT00588835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65037764|NCT00588835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65037765|NCT00588835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65037766|NCT00588835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65037767|NCT00588835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65037768|NCT00588835|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65037769|NCT00209859|Cyclosporine|cyclosporine|mesh-list
65493874|NCT04147494|Sequestering Agents|sequestering agents|mesh-ancestor
65037770|NCT00209859|Betamethasone|betamethasone|mesh-list
65037771|NCT00209859|Methotrexate|methotrexate|mesh-list
65037772|NCT00209859|Cyclosporins|cyclosporins|mesh-list
65037773|NCT00209859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65037774|NCT00209859|Abortifacient Agents|abortifacient agents|mesh-ancestor
64523007|NCT01372410|Tiotropium Bromide|tiotropium bromide|mesh-list
65037775|NCT00209859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65037776|NCT00209859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037777|NCT00209859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65037778|NCT00209859|Antimetabolites|antimetabolites|mesh-ancestor
65037779|NCT00209859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037780|NCT00209859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037781|NCT00209859|Dermatologic Agents|dermatologic agents|mesh-ancestor
65037782|NCT00209859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037783|NCT00209859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65037784|NCT00209859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65037785|NCT00209859|Immunologic Factors|immunologic factors|mesh-ancestor
65037786|NCT00209859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65037787|NCT00209859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65037788|NCT00209859|Antifungal Agents|antifungal agents|mesh-ancestor
65037789|NCT00209859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65037800|NCT00588913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65037801|NCT00588913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65037802|NCT00588913|Antiviral Agents|antiviral agents|mesh-ancestor
65037803|NCT00588913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65037804|NCT00588913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65037805|NCT00588913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037806|NCT00182741|Calcitriol|calcitriol|mesh-list
65037807|NCT00182741|Prednisone|prednisone|mesh-list
65037808|NCT00182741|Mitoxantrone|mitoxantrone|mesh-list
65037809|NCT00182741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65037810|NCT00182741|Glucocorticoids|glucocorticoids|mesh-ancestor
65037811|NCT00182741|Hormones|hormones|mesh-ancestor
65037812|NCT00182741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65037813|NCT00182741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037814|NCT00182741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65037815|NCT00182741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037816|NCT00182741|Analgesics|analgesics|mesh-ancestor
65037817|NCT00182741|Sensory System Agents|sensory system agents|mesh-ancestor
65037818|NCT00182741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65037819|NCT00182741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65037820|NCT00182741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65037821|NCT00182741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037822|NCT00182741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037823|NCT00182741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65037824|NCT00182741|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65037825|NCT00182741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65037826|NCT00182741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65037827|NCT00182741|Vitamins|vitamins|mesh-ancestor
65037828|NCT00182741|Micronutrients|micronutrients|mesh-ancestor
65037829|NCT00182741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65037830|NCT00589186|Celecoxib|celecoxib|mesh-list
65037831|NCT00589186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65037832|NCT00589186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65037833|NCT00589186|Analgesics|analgesics|mesh-ancestor
65037834|NCT00589186|Sensory System Agents|sensory system agents|mesh-ancestor
65037835|NCT00589186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65037836|NCT00589186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037837|NCT00589186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65037838|NCT00589186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65037839|NCT00589186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65037840|NCT00589186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65037841|NCT00589186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248439|NCT00844207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037842|NCT00589186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037844|NCT00589264|Trace Elements|trace elements|mesh-ancestor
65037845|NCT00589264|Micronutrients|micronutrients|mesh-ancestor
65037846|NCT00589264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037847|NCT00589381|Fenretinide|fenretinide|mesh-list
65037848|NCT00589381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037849|NCT00589381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65037850|NCT00589381|Protective Agents|protective agents|mesh-ancestor
65037851|NCT00589381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037852|NCT00182819|Temozolomide|temozolomide|mesh-list
65037853|NCT00182819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65037854|NCT00182819|Alkylating Agents|alkylating agents|mesh-ancestor
65037875|NCT00589732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037876|NCT00216879|Betamethasone|betamethasone|mesh-list
65037877|NCT00216879|Betamethasone Valerate|betamethasone valerate|mesh-list
65037878|NCT00216879|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65037879|NCT00216879|Betamethasone benzoate|betamethasone benzoate|mesh-list
65037880|NCT00216879|Calcipotriene|calcipotriene|mesh-list
65037881|NCT00216879|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65037882|NCT00216879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65037883|NCT00216879|Glucocorticoids|glucocorticoids|mesh-ancestor
65037884|NCT00216879|Hormones|hormones|mesh-ancestor
65037885|NCT00216879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65037886|NCT00216879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037887|NCT00216879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65037888|NCT00216879|Respiratory System Agents|respiratory system agents|mesh-ancestor
65037889|NCT00216879|Dermatologic Agents|dermatologic agents|mesh-ancestor
65037890|NCT00589927|Cilostazol|cilostazol|mesh-list
65037891|NCT00589927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65037892|NCT00589927|Autonomic Agents|autonomic agents|mesh-ancestor
65037893|NCT00589927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65037894|NCT00589927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037895|NCT00589927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65037896|NCT00589927|Respiratory System Agents|respiratory system agents|mesh-ancestor
65037897|NCT00589927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65037898|NCT00589927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65037899|NCT00589927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037900|NCT00589927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65037901|NCT00589927|Vasodilator Agents|vasodilator agents|mesh-ancestor
65037902|NCT00589927|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65037903|NCT00589927|Protective Agents|protective agents|mesh-ancestor
65037904|NCT00589927|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65037905|NCT00589927|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65037906|NCT00589927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037907|NCT00209937|Gaboxadol|gaboxadol|mesh-list
65037918|NCT00590278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65037919|NCT00590278|Antimetabolites|antimetabolites|mesh-ancestor
65037920|NCT00590278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037921|NCT00590278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037922|NCT00590278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65037923|NCT00590278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037925|NCT00216918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65037926|NCT00216918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65037927|NCT00216918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65037928|NCT00216918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037929|NCT00216918|Adrenergic Agents|adrenergic agents|mesh-ancestor
65037930|NCT00216918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65037931|NCT00216918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037932|NCT04574791|Tizanidine|tizanidine|mesh-list
65037933|NCT04574791|Analgesics|analgesics|mesh-ancestor
65037934|NCT04574791|Sensory System Agents|sensory system agents|mesh-ancestor
65037935|NCT04574791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65037936|NCT04574791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037937|NCT04574791|Anticonvulsants|anticonvulsants|mesh-ancestor
65037938|NCT04574791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65037939|NCT04574791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65037940|NCT04574791|Parasympatholytics|parasympatholytics|mesh-ancestor
65037941|NCT04574791|Autonomic Agents|autonomic agents|mesh-ancestor
65037942|NCT04574791|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65037943|NCT04574791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65037944|NCT04574791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65037945|NCT04574791|Adrenergic Agents|adrenergic agents|mesh-ancestor
65037946|NCT04574791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64472648|NCT03060434|Anticonvulsants|anticonvulsants|mesh-ancestor
65037947|NCT04574791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037948|NCT03452332|Durvalumab|durvalumab|mesh-list
65037949|NCT03452332|Ipilimumab|ipilimumab|mesh-list
65037950|NCT03452332|Tremelimumab|tremelimumab|mesh-list
65037951|NCT03452332|Immunoglobulins|immunoglobulins|mesh-list
65037952|NCT03452332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65037953|NCT03452332|Immunoglobulin G|immunoglobulin g|mesh-list
65037954|NCT03452332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65037955|NCT03452332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037956|NCT03452332|Immunologic Factors|immunologic factors|mesh-ancestor
65037957|NCT03452332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037958|NCT03452332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65037959|NCT03452332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037960|NCT00590629|Niacin|niacin|mesh-list
65037961|NCT00590629|Nicotinic Acids|nicotinic acids|mesh-list
65037962|NCT00590629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65037963|NCT00590629|Antimetabolites|antimetabolites|mesh-ancestor
65037964|NCT00590629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037965|NCT00590629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65037966|NCT00590629|Vasodilator Agents|vasodilator agents|mesh-ancestor
65037967|NCT00590629|Vitamin B Complex|vitamin b complex|mesh-ancestor
65037968|NCT00590629|Vitamins|vitamins|mesh-ancestor
65037969|NCT00590629|Micronutrients|micronutrients|mesh-ancestor
65037970|NCT00590629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037971|NCT00590785|Tamoxifen|tamoxifen|mesh-list
65037972|NCT00590785|Ciprofloxacin|ciprofloxacin|mesh-list
65037973|NCT00590785|Cyclophosphamide|cyclophosphamide|mesh-list
65037974|NCT00590785|Doxorubicin|doxorubicin|mesh-list
65037979|NCT00590785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65037981|NCT00590785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037982|NCT00590785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037983|NCT00590785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65037984|NCT00590785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65037985|NCT00590785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65037986|NCT00590785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65037987|NCT00590785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037988|NCT00590785|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65037989|NCT00590785|Hormone Antagonists|hormone antagonists|mesh-ancestor
65037990|NCT00590785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65037991|NCT00590785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65037992|NCT00590785|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65037993|NCT00590785|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65037994|NCT00590785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65037995|NCT00590785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65037996|NCT00590785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65037997|NCT00590785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65037998|NCT00590785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65037999|NCT00477295|Carbamazepine|carbamazepine|mesh-list
65038000|NCT00477295|Zonisamide|zonisamide|mesh-list
65038001|NCT00477295|Anticonvulsants|anticonvulsants|mesh-ancestor
65038002|NCT00477295|Antimanic Agents|antimanic agents|mesh-ancestor
65038003|NCT00477295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65038004|NCT00477295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65038005|NCT00477295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038006|NCT00477295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65038007|NCT00477295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65038008|NCT00477295|Analgesics|analgesics|mesh-ancestor
65038009|NCT00477295|Sensory System Agents|sensory system agents|mesh-ancestor
65038010|NCT00477295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038011|NCT00477295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65038012|NCT00477295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65038013|NCT00477295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038014|NCT00477295|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65038015|NCT00477295|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65038016|NCT00477295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65038017|NCT00477295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65038018|NCT00476593|Dexamethasone|dexamethasone|mesh-list
65038019|NCT00476593|Diclofenac|diclofenac|mesh-list
65038020|NCT00476593|Lactitol|lactitol|mesh-list
65038021|NCT00476593|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65038022|NCT00476593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65038023|NCT00476593|Antiemetics|antiemetics|mesh-ancestor
65038024|NCT00476593|Autonomic Agents|autonomic agents|mesh-ancestor
65038025|NCT00476593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038026|NCT00476593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038027|NCT00476593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65038028|NCT00476593|Glucocorticoids|glucocorticoids|mesh-ancestor
65038029|NCT00476593|Hormones|hormones|mesh-ancestor
65038030|NCT00476593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65038031|NCT00476593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65038032|NCT00476593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038033|NCT00476593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65038034|NCT00476593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65038035|NCT00476593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65038036|NCT00476593|Analgesics|analgesics|mesh-ancestor
65038037|NCT00476593|Sensory System Agents|sensory system agents|mesh-ancestor
65038038|NCT00476593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65038039|NCT00476593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65038040|NCT00476593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038041|NCT00476593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038042|NCT00476593|Cathartics|cathartics|mesh-ancestor
65038056|NCT00183404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65038057|NCT00183404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65038058|NCT00183404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65038059|NCT00183404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65038060|NCT00183404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65038061|NCT00183404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65038062|NCT00183404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65038063|NCT00183404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038064|NCT00183404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65038065|NCT00183404|Serotonin Agents|serotonin agents|mesh-ancestor
65038066|NCT00476476|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65038067|NCT00476476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038068|NCT00476476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65038069|NCT00476476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038070|NCT00476476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038071|NCT00183560|Antidepressive Agents|antidepressive agents|mesh-list
65038072|NCT00183560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65038073|NCT00217152|Mycophenolic Acid|mycophenolic acid|mesh-list
65038074|NCT00217152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65038075|NCT00217152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038076|NCT00217152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65038077|NCT00217152|Antitubercular Agents|antitubercular agents|mesh-ancestor
65038078|NCT00217152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65038079|NCT00217152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65038080|NCT00217152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038081|NCT00217152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038082|NCT00210210|Ketamine|ketamine|mesh-list
65038083|NCT00210210|Analgesics|analgesics|mesh-ancestor
65038084|NCT00210210|Sensory System Agents|sensory system agents|mesh-ancestor
65038085|NCT00210210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038086|NCT00210210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038087|NCT00210210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65038088|NCT00210210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65038089|NCT00210210|Anesthetics, General|anesthetics, general|mesh-ancestor
65038090|NCT00210210|Anesthetics|anesthetics|mesh-ancestor
65038091|NCT00210210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65038092|NCT00210210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65038093|NCT00210210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65038094|NCT00210210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65038095|NCT00210210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038096|NCT00476086|Gemcitabine|gemcitabine|mesh-list
65038097|NCT00476086|Oxaliplatin|oxaliplatin|mesh-list
65038098|NCT00476086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65038099|NCT00476086|Antimetabolites|antimetabolites|mesh-ancestor
65038100|NCT00476086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038101|NCT00476086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038102|NCT00476086|Antiviral Agents|antiviral agents|mesh-ancestor
65038103|NCT00476086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65038112|NCT00217191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65038113|NCT00217191|Analgesics|analgesics|mesh-ancestor
65038114|NCT00217191|Sensory System Agents|sensory system agents|mesh-ancestor
65038115|NCT00217191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038116|NCT00217191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038117|NCT00217191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65038118|NCT00217191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65038119|NCT00217191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65038120|NCT00217191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038121|NCT00217191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038122|NCT00476008|Memantine|memantine|mesh-list
65038123|NCT00476008|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65038124|NCT00476008|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65038125|NCT00476008|Dopamine Agents|dopamine agents|mesh-ancestor
65038126|NCT00476008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65038127|NCT00476008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038128|NCT00476008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038129|NCT00476008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65038130|NCT00476008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65038131|NCT00412035|Botulinum Toxins|botulinum toxins|mesh-list
65038132|NCT00412035|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65038133|NCT00412035|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65038134|NCT00412035|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65038135|NCT00412035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65038136|NCT00412035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038137|NCT00412035|Cholinergic Agents|cholinergic agents|mesh-ancestor
65038138|NCT00412035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65038139|NCT00412035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038140|NCT00412035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65038141|NCT00412035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038143|NCT00183833|Imatinib Mesylate|imatinib mesylate|mesh-list
64523383|NCT02430714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038144|NCT00183833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65038145|NCT00183833|Antimetabolites|antimetabolites|mesh-ancestor
65038146|NCT00183833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038147|NCT00183833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038148|NCT00183833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65038149|NCT00183833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038150|NCT00183911|Leucovorin|leucovorin|mesh-list
65038151|NCT00183911|Fluorouracil|fluorouracil|mesh-list
65038152|NCT00183911|Floxuridine|floxuridine|mesh-list
65038153|NCT00183911|Antimetabolites|antimetabolites|mesh-ancestor
65038154|NCT00183911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038155|NCT00183911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65038156|NCT00183911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038157|NCT00183911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65038158|NCT00183911|Immunologic Factors|immunologic factors|mesh-ancestor
65038159|NCT00183911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038160|NCT00183911|Antidotes|antidotes|mesh-ancestor
65038161|NCT00183911|Protective Agents|protective agents|mesh-ancestor
65038162|NCT00183911|Vitamin B Complex|vitamin b complex|mesh-ancestor
65038163|NCT00183911|Vitamins|vitamins|mesh-ancestor
65038164|NCT00183911|Micronutrients|micronutrients|mesh-ancestor
65038165|NCT00412152|Oxycodone|oxycodone|mesh-list
65038166|NCT00412152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65038167|NCT00412152|Narcotics|narcotics|mesh-ancestor
65038168|NCT00412152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65038169|NCT00412152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038170|NCT00412152|Analgesics|analgesics|mesh-ancestor
65038192|NCT00425516|Antimitotic Agents|antimitotic agents|mesh-ancestor
65038193|NCT00425516|Mitosis Modulators|mitosis modulators|mesh-ancestor
65038194|NCT00425516|Antimetabolites|antimetabolites|mesh-ancestor
65038195|NCT00425516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65038196|NCT00425516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65038197|NCT00425516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65038198|NCT00425516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65038199|NCT00425516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038200|NCT00412191|Lamotrigine|lamotrigine|mesh-list
65038201|NCT00412191|Anticonvulsants|anticonvulsants|mesh-ancestor
65038202|NCT00412191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65038203|NCT00412191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65038204|NCT00412191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038205|NCT00412191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65038206|NCT00412191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038207|NCT00412191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65038208|NCT00412191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65038209|NCT00412191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65038210|NCT00412191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65038211|NCT00412191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65038212|NCT00183950|Noscapine|noscapine|mesh-list
65038213|NCT00183950|Antitussive Agents|antitussive agents|mesh-ancestor
65038214|NCT00183950|Respiratory System Agents|respiratory system agents|mesh-ancestor
64472667|NCT03021486|Haloperidol|haloperidol|mesh-list
65038215|NCT00210366|Idarubicin|idarubicin|mesh-list
65038216|NCT00210366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65038217|NCT00210366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038218|NCT00210366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65038219|NCT00210366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65038221|NCT00210366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038222|NCT00408785|Botulinum Toxins|botulinum toxins|mesh-list
65038223|NCT00408785|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65038224|NCT00408785|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65038225|NCT00408785|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65038226|NCT00408785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65038248|NCT00210405|Micronutrients|micronutrients|mesh-list
65038249|NCT00210405|Trace Elements|trace elements|mesh-list
65038250|NCT00210405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038251|NCT00408941|Propofol|propofol|mesh-list
65038252|NCT00408941|Prilocaine|prilocaine|mesh-list
65038253|NCT00408941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65038254|NCT00408941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65038255|NCT00408941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038256|NCT00408941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65038257|NCT00408941|Anesthetics, General|anesthetics, general|mesh-ancestor
65038258|NCT00408941|Anesthetics|anesthetics|mesh-ancestor
65038259|NCT00408941|Anesthetics, Local|anesthetics, local|mesh-ancestor
65038260|NCT00408941|Sensory System Agents|sensory system agents|mesh-ancestor
65038261|NCT00408941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038262|NCT00475423|Rituximab|rituximab|mesh-list
65038263|NCT00475423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65038264|NCT00475423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038265|NCT00475423|Immunologic Factors|immunologic factors|mesh-ancestor
65038266|NCT00475423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038267|NCT00475423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65038268|NCT00210444|Botulinum Toxins|botulinum toxins|mesh-list
65038269|NCT00210444|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65038270|NCT00210444|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65038271|NCT00210444|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65038272|NCT00210444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65038273|NCT00210444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038274|NCT00210444|Cholinergic Agents|cholinergic agents|mesh-ancestor
65038275|NCT00210444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65038276|NCT00210444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912151|NCT00006026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038289|NCT00475306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038290|NCT00475306|Antiemetics|antiemetics|mesh-ancestor
65038291|NCT00475306|Autonomic Agents|autonomic agents|mesh-ancestor
65038292|NCT00475306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65038293|NCT00475306|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65038294|NCT00475306|Histamine Antagonists|histamine antagonists|mesh-ancestor
65038295|NCT00475306|Histamine Agents|histamine agents|mesh-ancestor
65038296|NCT00475306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65038297|NCT00475306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038298|NCT00475306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65038299|NCT00475306|Antipruritics|antipruritics|mesh-ancestor
65038300|NCT00475306|Dermatologic Agents|dermatologic agents|mesh-ancestor
65038301|NCT00475306|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65038302|NCT00475306|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65038303|NCT00475306|Dopamine Agents|dopamine agents|mesh-ancestor
65038304|NCT00475228|Levonorgestrel|levonorgestrel|mesh-list
65038305|NCT00475228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65038306|NCT00475228|Contraceptive Agents|contraceptive agents|mesh-ancestor
65038307|NCT00475228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65038308|NCT00475228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038309|NCT00475228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65038310|NCT00475228|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65038311|NCT00475228|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65038312|NCT00183989|Rituximab|rituximab|mesh-list
65038313|NCT00183989|Fludarabine|fludarabine|mesh-list
65038314|NCT00183989|Mitoxantrone|mitoxantrone|mesh-list
65038315|NCT00183989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65038316|NCT00183989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038317|NCT00183989|Immunologic Factors|immunologic factors|mesh-ancestor
65038318|NCT00183989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038319|NCT00183989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65038320|NCT00183989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038321|NCT00183989|Analgesics|analgesics|mesh-ancestor
65038322|NCT00183989|Sensory System Agents|sensory system agents|mesh-ancestor
65038323|NCT00183989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038324|NCT00183989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65038325|NCT00183989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65038326|NCT00183989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038327|NCT00184067|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65038328|NCT00184067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65038329|NCT00184067|Immunologic Factors|immunologic factors|mesh-ancestor
65038330|NCT00184067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038331|NCT00184106|Paroxetine|paroxetine|mesh-list
65038332|NCT00184106|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65038333|NCT00184106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65038334|NCT00184106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65038335|NCT00184106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038336|NCT00184106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65038337|NCT00184106|Serotonin Agents|serotonin agents|mesh-ancestor
65038338|NCT00184106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038345|NCT00210483|Almotriptan|almotriptan|mesh-list
65038346|NCT00210483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65038347|NCT00210483|Serotonin Agents|serotonin agents|mesh-ancestor
65038348|NCT00210483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65038349|NCT00210483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038350|NCT00210483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038351|NCT00210561|Acetaminophen|acetaminophen|mesh-list
65038352|NCT00210561|Tramadol|tramadol|mesh-list
65038353|NCT00210561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65038354|NCT00210561|Analgesics|analgesics|mesh-ancestor
65038355|NCT00210561|Sensory System Agents|sensory system agents|mesh-ancestor
65038356|NCT00210561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038357|NCT00210561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038358|NCT00210561|Antipyretics|antipyretics|mesh-ancestor
65038359|NCT00210561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65038360|NCT00210561|Narcotics|narcotics|mesh-ancestor
65038361|NCT00210561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65038362|NCT00210600|Epoetin Alfa|epoetin alfa|mesh-list
65038363|NCT00210600|Hematinics|hematinics|mesh-ancestor
65038365|NCT00217386|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65038366|NCT00217386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65038367|NCT00217386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65038368|NCT00217386|Analgesics|analgesics|mesh-ancestor
65038369|NCT00217386|Sensory System Agents|sensory system agents|mesh-ancestor
65038370|NCT00217386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038371|NCT00217386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038373|NCT00217386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65038374|NCT00217386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65038375|NCT00217386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65038376|NCT00217386|Immunologic Factors|immunologic factors|mesh-ancestor
65038377|NCT00217503|Zidovudine|zidovudine|mesh-list
65038378|NCT00217503|Valganciclovir|valganciclovir|mesh-list
65038379|NCT00217503|Ganciclovir|ganciclovir|mesh-list
65038380|NCT00217503|Cyclophosphamide|cyclophosphamide|mesh-list
65038381|NCT00217503|Bevacizumab|bevacizumab|mesh-list
65038382|NCT00217503|Doxorubicin|doxorubicin|mesh-list
65038383|NCT00217503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65038384|NCT00217503|Etoposide|etoposide|mesh-list
65038385|NCT00217503|Bortezomib|bortezomib|mesh-list
65038386|NCT00217503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65038387|NCT00217503|Immunologic Factors|immunologic factors|mesh-ancestor
65038388|NCT00217503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038389|NCT00217503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65038390|NCT00217503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65038391|NCT00217503|Alkylating Agents|alkylating agents|mesh-ancestor
65038392|NCT00217503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038393|NCT00217503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038394|NCT00217503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65038395|NCT00217503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65038396|NCT00217503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65038397|NCT00217503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65038398|NCT00217503|Growth Substances|growth substances|mesh-ancestor
65038399|NCT00217503|Growth Inhibitors|growth inhibitors|mesh-ancestor
65038400|NCT00217503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65038401|NCT00217503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65038402|NCT00217503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65038403|NCT00217503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038404|NCT00217503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65038405|NCT00217503|Antimetabolites|antimetabolites|mesh-ancestor
65038406|NCT00217503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65038407|NCT00217503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65038408|NCT00217503|Antiviral Agents|antiviral agents|mesh-ancestor
65038409|NCT00217503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65038430|NCT00210717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65038431|NCT00210717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65038432|NCT00210717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038433|NCT00210717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65038434|NCT00210717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65038435|NCT00210717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65038436|NCT00210717|Serotonin Agents|serotonin agents|mesh-ancestor
65038437|NCT00210717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65038438|NCT00210717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038439|NCT00210717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65038440|NCT00210717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65038441|NCT00210717|Dopamine Agents|dopamine agents|mesh-ancestor
65038442|NCT00184496|Methadone|methadone|mesh-list
65038443|NCT00184496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65038444|NCT00184496|Narcotics|narcotics|mesh-ancestor
65038445|NCT00184496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65038446|NCT00184496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038448|NCT00184496|Sensory System Agents|sensory system agents|mesh-ancestor
65038449|NCT00184496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038450|NCT00184496|Antitussive Agents|antitussive agents|mesh-ancestor
65038451|NCT00184496|Respiratory System Agents|respiratory system agents|mesh-ancestor
65038452|NCT00210756|Epoetin Alfa|epoetin alfa|mesh-list
65038453|NCT00210756|Hematinics|hematinics|mesh-ancestor
65038454|NCT00217659|Anastrozole|anastrozole|mesh-list
65038455|NCT00217659|Goserelin|goserelin|mesh-list
65038456|NCT00217659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65038457|NCT00217659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038458|NCT00217659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65038459|NCT00217659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65038460|NCT00217659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038461|NCT00217659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038462|NCT00217659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65038463|NCT00217659|Hormone Antagonists|hormone antagonists|mesh-ancestor
65038464|NCT00217659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65038465|NCT00217659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038466|NCT00184574|Metformin|metformin|mesh-list
65038477|NCT00217698|Antimetabolites|antimetabolites|mesh-ancestor
65038478|NCT00217698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038479|NCT00217698|Antiviral Agents|antiviral agents|mesh-ancestor
65038480|NCT00217698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65038481|NCT00217698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038482|NCT00217698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65038483|NCT00217698|Immunologic Factors|immunologic factors|mesh-ancestor
65038484|NCT00217698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038485|NCT00217698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65038487|NCT00184613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65038488|NCT00184613|Insulin Glargine|insulin glargine|mesh-list
65038489|NCT00184613|Insulin Aspart|insulin aspart|mesh-list
65038490|NCT00184613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65038491|NCT00184613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038492|NCT00210834|Epoetin Alfa|epoetin alfa|mesh-list
65038493|NCT00210834|Hematinics|hematinics|mesh-ancestor
65038494|NCT00217815|Efungumab|efungumab|mesh-list
65038495|NCT00217815|Docetaxel|docetaxel|mesh-list
65038496|NCT00217815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038497|NCT00217815|Tubulin Modulators|tubulin modulators|mesh-ancestor
65038498|NCT00217815|Antimitotic Agents|antimitotic agents|mesh-ancestor
65038499|NCT00217815|Mitosis Modulators|mitosis modulators|mesh-ancestor
65038500|NCT00217815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038501|NCT00217815|Antifungal Agents|antifungal agents|mesh-ancestor
65038502|NCT00217815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65038503|NCT04722471|Progesterone|progesterone|mesh-list
65038504|NCT04722471|Progestins|progestins|mesh-ancestor
65038505|NCT04722471|Hormones|hormones|mesh-ancestor
65038506|NCT04722471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65038507|NCT04722471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038508|NCT00210873|Topiramate|topiramate|mesh-list
65038509|NCT00210873|Anticonvulsants|anticonvulsants|mesh-ancestor
65038510|NCT00210873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65038511|NCT00210873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038512|NCT00210912|Topiramate|topiramate|mesh-list
65038513|NCT00210912|Anticonvulsants|anticonvulsants|mesh-ancestor
65038514|NCT00210912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65038515|NCT00210912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038516|NCT00184847|Adenosine|adenosine|mesh-list
65038517|NCT00184847|Acetylcholine|acetylcholine|mesh-list
65038518|NCT00184847|Caffeine|caffeine|mesh-list
65038519|NCT00184847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65038520|NCT00184847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038521|NCT00184847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65038522|NCT00184847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038523|NCT00184847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038524|NCT00184847|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65038525|NCT00184847|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65038526|NCT00184847|Purinergic Agents|purinergic agents|mesh-ancestor
65038527|NCT00184847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65038528|NCT00184847|Analgesics|analgesics|mesh-ancestor
65038529|NCT00184847|Sensory System Agents|sensory system agents|mesh-ancestor
65038530|NCT00184847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038531|NCT00184847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65038532|NCT00184847|Vasodilator Agents|vasodilator agents|mesh-ancestor
65038533|NCT00184847|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65038534|NCT00184847|Purinergic Agonists|purinergic agonists|mesh-ancestor
64890358|NCT01973140|Tolvaptan|tolvaptan|mesh-list
65038560|NCT00217932|Antimanic Agents|antimanic agents|mesh-ancestor
65038561|NCT00217932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65038562|NCT00217932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65038563|NCT00217932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65038564|NCT00210990|Doripenem|doripenem|mesh-list
65038565|NCT00210990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65038566|NCT00210990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65038567|NCT00185003|Tolbutamide|tolbutamide|mesh-list
65038568|NCT00185003|Potassium Channel Blockers|potassium channel blockers|mesh-list
65038569|NCT00185003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038570|NCT00185003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65038571|NCT00185003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038572|NCT00185003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65038573|NCT00185120|Amlodipine|amlodipine|mesh-list
65038574|NCT00185120|Olmesartan|olmesartan|mesh-list
65038575|NCT00185120|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65038576|NCT00185120|Benazepril|benazepril|mesh-list
65038577|NCT00185120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65038578|NCT00185120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65038579|NCT00185120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65038580|NCT00185120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038581|NCT00185120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65038582|NCT00185120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890422|NCT01973751|Budesonide|budesonide|mesh-list
65038593|NCT00218049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038595|NCT00218049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65038596|NCT00218049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038597|NCT00185159|Olmesartan|olmesartan|mesh-list
65038598|NCT00185159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65038599|NCT00185159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65038600|NCT00185159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65038601|NCT00185159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65038602|NCT00185159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038603|NCT00218127|Methadyl Acetate|methadyl acetate|mesh-list
65038604|NCT00218127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65038605|NCT00218127|Narcotics|narcotics|mesh-ancestor
65038606|NCT00218127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65038607|NCT00218127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038608|NCT00218127|Analgesics|analgesics|mesh-ancestor
65038609|NCT00218127|Sensory System Agents|sensory system agents|mesh-ancestor
65038610|NCT00218127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038611|NCT00185198|Testosterone|testosterone|mesh-list
65038612|NCT00185198|Androgens|androgens|mesh-ancestor
65038613|NCT00185198|Hormones|hormones|mesh-ancestor
65038614|NCT00185198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65038615|NCT00185198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038616|NCT00185237|Estradiol|estradiol|mesh-list
65038617|NCT00185237|Estrogens|estrogens|mesh-ancestor
65038618|NCT00185237|Hormones|hormones|mesh-ancestor
65038619|NCT00185237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65038620|NCT00185237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038621|NCT00218166|Triazolam|triazolam|mesh-list
65038622|NCT00218166|Tiagabine|tiagabine|mesh-list
64472670|NCT03021486|Antiemetics|antiemetics|mesh-ancestor
65038623|NCT00218166|Baclofen|baclofen|mesh-list
65038624|NCT00218166|GABA Agonists|gaba agonists|mesh-list
65038625|NCT00218166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65038626|NCT00218166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038627|NCT00218166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65038628|NCT00218166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038629|NCT00218166|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65038630|NCT00218166|GABA Agents|gaba agents|mesh-ancestor
65038631|NCT00218166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65038632|NCT00218166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038633|NCT00218166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65038634|NCT00218166|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65038635|NCT00218166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65038636|NCT00218166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65038637|NCT00218166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65038638|NCT00218166|GABA Modulators|gaba modulators|mesh-ancestor
65038639|NCT00218166|Anticonvulsants|anticonvulsants|mesh-ancestor
65038640|NCT00218166|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
65038641|NCT00218166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65038642|NCT00218166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65038643|NCT00185315|Iloprost|iloprost|mesh-list
65038644|NCT00185315|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65038645|NCT00185315|Vasodilator Agents|vasodilator agents|mesh-ancestor
65038665|NCT00211224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038667|NCT00211224|Protective Agents|protective agents|mesh-ancestor
65038668|NCT00409097|Rosiglitazone|rosiglitazone|mesh-list
65038670|NCT00409097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038671|NCT00218205|Celecoxib|celecoxib|mesh-list
65038672|NCT00218205|Epirubicin|epirubicin|mesh-list
65038673|NCT00218205|Estramustine|estramustine|mesh-list
65038674|NCT00218205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65038675|NCT00218205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65038676|NCT00218205|Analgesics|analgesics|mesh-ancestor
65038677|NCT00218205|Sensory System Agents|sensory system agents|mesh-ancestor
65038678|NCT00218205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038679|NCT00218205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038680|NCT00218205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65038681|NCT00218205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65038682|NCT00218205|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65038683|NCT00218205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65038684|NCT00218205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038685|NCT00218205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038686|NCT00218205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65038687|NCT00218205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038688|NCT00218205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65038689|NCT00218205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65038690|NCT00218205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65038691|NCT00218205|Alkylating Agents|alkylating agents|mesh-ancestor
65038692|NCT00218205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65038693|NCT00185510|Methylprednisolone|methylprednisolone|mesh-list
65038694|NCT00185510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65038695|NCT00185510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65038696|NCT00185510|Prednisolone|prednisolone|mesh-list
65038697|NCT00185510|Prednisolone acetate|prednisolone acetate|mesh-list
65038698|NCT00185510|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
65038699|NCT00185510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65038700|NCT00185510|Prednisolone phosphate|prednisolone phosphate|mesh-list
65038701|NCT00185510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65038702|NCT00185510|Antiemetics|antiemetics|mesh-ancestor
65038713|NCT00185510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038714|NCT00218244|Lobeline|lobeline|mesh-list
65038715|NCT00218244|Nicotine|nicotine|mesh-list
65038716|NCT00218244|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65038717|NCT00218244|Autonomic Agents|autonomic agents|mesh-ancestor
65038718|NCT00218244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038719|NCT00218244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038720|NCT00218244|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65038721|NCT00218244|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65038722|NCT00218244|Cholinergic Agents|cholinergic agents|mesh-ancestor
65038723|NCT00218244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65038724|NCT00218244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038725|NCT00218244|Respiratory System Agents|respiratory system agents|mesh-ancestor
65038726|NCT00211302|Aripiprazole|aripiprazole|mesh-list
65038727|NCT00211302|Antidepressive Agents|antidepressive agents|mesh-ancestor
64472671|NCT03021486|Autonomic Agents|autonomic agents|mesh-ancestor
65038728|NCT00211302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65038729|NCT00211302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65038730|NCT00211302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65038731|NCT00211302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65038732|NCT00211302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038733|NCT00211302|Dopamine Agonists|dopamine agonists|mesh-ancestor
65038734|NCT00211302|Dopamine Agents|dopamine agents|mesh-ancestor
65038735|NCT00211302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65038736|NCT00211302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038737|NCT00211302|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65038738|NCT00211302|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65038739|NCT00211302|Serotonin Agents|serotonin agents|mesh-ancestor
65038740|NCT00211302|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65038741|NCT00211302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64912614|NCT00001563|Rituximab|rituximab|mesh-list
65038743|NCT00211302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65038744|NCT00218283|Nicotine|nicotine|mesh-list
64480081|NCT00579280|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65038745|NCT00218283|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65038746|NCT00218283|Autonomic Agents|autonomic agents|mesh-ancestor
65038747|NCT00218283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038748|NCT00218283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038749|NCT00218283|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65038750|NCT00218283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65038751|NCT00218283|Cholinergic Agents|cholinergic agents|mesh-ancestor
65038752|NCT00218283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65038753|NCT00218283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038754|NCT00185705|Telmisartan|telmisartan|mesh-list
65038755|NCT00185705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65038756|NCT00185705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65038757|NCT00185705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65038758|NCT00185705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038759|NCT00211341|Vitamin A|vitamin a|mesh-list
65038760|NCT00211341|Vitamins|vitamins|mesh-ancestor
65038761|NCT00211341|Micronutrients|micronutrients|mesh-ancestor
65038762|NCT00211341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038763|NCT00185783|Hydrocortisone|hydrocortisone|mesh-list
65038764|NCT00185783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65038765|NCT00185861|Arsenic Trioxide|arsenic trioxide|mesh-list
65038796|NCT00218322|Adrenergic Agents|adrenergic agents|mesh-ancestor
65038797|NCT00218322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65038798|NCT00218322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038799|NCT00218361|Hydromorphone|hydromorphone|mesh-list
65038800|NCT00218361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65038801|NCT00218361|Narcotics|narcotics|mesh-ancestor
65038802|NCT00218361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65038803|NCT00218361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038804|NCT00218361|Analgesics|analgesics|mesh-ancestor
65038805|NCT00218361|Sensory System Agents|sensory system agents|mesh-ancestor
65038831|NCT00211419|Growth Inhibitors|growth inhibitors|mesh-ancestor
65038832|NCT00211419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038833|NCT00211458|Anecortave|anecortave|mesh-list
65038834|NCT00211458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65038835|NCT00211458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65038836|NCT00211458|Growth Substances|growth substances|mesh-ancestor
65038837|NCT00211458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038838|NCT00211458|Growth Inhibitors|growth inhibitors|mesh-ancestor
65038839|NCT00211458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038840|NCT00211497|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
65038841|NCT00211497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65038842|NCT00186329|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65038843|NCT00186329|Natriuretic Agents|natriuretic agents|mesh-ancestor
65038844|NCT00186329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038845|NCT00211614|Lansoprazole|lansoprazole|mesh-list
65038846|NCT00211614|Dexlansoprazole|dexlansoprazole|mesh-list
65038847|NCT00211614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65038848|NCT00211614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65038849|NCT00211614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65038850|NCT00211614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038851|NCT00211614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038852|NCT00218790|Dialysis Solutions|dialysis solutions|mesh-list
65038853|NCT00218790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64890699|NCT01975662|Vancomycin|vancomycin|mesh-list
65038871|NCT00211653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65038872|NCT00211653|Antioxidants|antioxidants|mesh-ancestor
65038873|NCT00211653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038874|NCT00211653|Protective Agents|protective agents|mesh-ancestor
65038875|NCT00211653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038876|NCT00211653|Antidotes|antidotes|mesh-ancestor
65038878|NCT00187031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65038879|NCT00187031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65038880|NCT00187031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038881|NCT00187031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038882|NCT00187031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038883|NCT00187070|Cytarabine|cytarabine|mesh-list
65038884|NCT00187070|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65038885|NCT00187070|Dexamethasone|dexamethasone|mesh-list
65038886|NCT00187070|Prednisone|prednisone|mesh-list
65038887|NCT00187070|Cyclophosphamide|cyclophosphamide|mesh-list
65038888|NCT00187070|Ifosfamide|ifosfamide|mesh-list
65038889|NCT00187070|Carboplatin|carboplatin|mesh-list
65038891|NCT00187070|Methotrexate|methotrexate|mesh-list
65038892|NCT00187070|Etoposide|etoposide|mesh-list
65038893|NCT00187070|Vincristine|vincristine|mesh-list
65038894|NCT00187070|Vinblastine|vinblastine|mesh-list
65038895|NCT00187070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65038896|NCT00187070|Immunologic Factors|immunologic factors|mesh-ancestor
65038897|NCT00187070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038898|NCT00187070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65038899|NCT00187070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65038900|NCT00187070|Alkylating Agents|alkylating agents|mesh-ancestor
65038901|NCT00187070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038902|NCT00187070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038903|NCT00187070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65038904|NCT00187070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65038905|NCT00187070|Antiemetics|antiemetics|mesh-ancestor
65038906|NCT00187070|Autonomic Agents|autonomic agents|mesh-ancestor
65038907|NCT00187070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038908|NCT00187070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65038909|NCT00187070|Glucocorticoids|glucocorticoids|mesh-ancestor
65038910|NCT00187070|Hormones|hormones|mesh-ancestor
65038911|NCT00187070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65038912|NCT00187070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64890739|NCT01975753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65038931|NCT00187070|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65038932|NCT00187070|Renal Agents|renal agents|mesh-ancestor
65038933|NCT00187070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65038934|NCT00187070|Antimalarials|antimalarials|mesh-ancestor
65038935|NCT00187070|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65038936|NCT00187070|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65038937|NCT00211848|Interferons|interferons|mesh-list
65038939|NCT00211848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038940|NCT00211848|Antiviral Agents|antiviral agents|mesh-ancestor
65038941|NCT00211848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65038942|NCT00211848|Antimetabolites|antimetabolites|mesh-ancestor
65038943|NCT00211848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038944|NCT00412347|Insulin|insulin|mesh-list
65038945|NCT00412347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65038946|NCT00412347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038947|NCT00187499|Fluticasone|fluticasone|mesh-list
65038948|NCT00187499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65038949|NCT00187499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65038950|NCT00187499|Autonomic Agents|autonomic agents|mesh-ancestor
65038951|NCT00187499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038952|NCT00187499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038953|NCT00187499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65038954|NCT00187499|Respiratory System Agents|respiratory system agents|mesh-ancestor
65038955|NCT00187499|Dermatologic Agents|dermatologic agents|mesh-ancestor
65038956|NCT00187499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65038957|NCT00212004|Pioglitazone|pioglitazone|mesh-list
65038958|NCT00212004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65038959|NCT00212004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038960|NCT00187577|Bimatoprost|bimatoprost|mesh-list
65038961|NCT00187577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65038962|NCT00187577|Latanoprost|latanoprost|mesh-list
65038963|NCT00187577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65038964|NCT00187577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65038965|NCT00212043|Gemcitabine|gemcitabine|mesh-list
65038966|NCT00212043|Carboplatin|carboplatin|mesh-list
65038967|NCT00212043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038968|NCT00212043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65038969|NCT00212043|Antimetabolites|antimetabolites|mesh-ancestor
64890797|NCT01976195|Dexamethasone|dexamethasone|mesh-list
65039006|NCT00188006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65039007|NCT00188006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890856|NCT01976923|Bevacizumab|bevacizumab|mesh-list
65039024|NCT00188045|Natriuretic Agents|natriuretic agents|mesh-ancestor
65039025|NCT00212277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65039026|NCT00212277|Norethindrone|norethindrone|mesh-list
65039027|NCT00212277|Norethindrone Acetate|norethindrone acetate|mesh-list
65039028|NCT00212277|Estradiol|estradiol|mesh-list
65039029|NCT00212277|Estrogens|estrogens|mesh-ancestor
65039030|NCT00212277|Hormones|hormones|mesh-ancestor
65039031|NCT00212277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65039032|NCT00212277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039033|NCT00212277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65039034|NCT00212277|Contraceptive Agents|contraceptive agents|mesh-ancestor
65039035|NCT00212277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65039036|NCT00212277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65039037|NCT00212277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65039038|NCT00212277|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65039039|NCT00212277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65039040|NCT00212316|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
65039041|NCT00212316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039042|NCT00219375|Sivelestat|sivelestat|mesh-list
65039043|NCT00219375|Glycine|glycine|mesh-list
65039044|NCT00219375|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65039045|NCT00219375|Protease Inhibitors|protease inhibitors|mesh-ancestor
65039046|NCT00219375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524276|NCT02422602|Anticoagulants|anticoagulants|mesh-ancestor
65039047|NCT00219375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039048|NCT00219375|Glycine Agents|glycine agents|mesh-ancestor
65039049|NCT00219375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039050|NCT00219375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039051|NCT00188240|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65039052|NCT00188240|Antiviral Agents|antiviral agents|mesh-ancestor
65039053|NCT00188240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65039055|NCT00188396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65039056|NCT00188396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65039057|NCT00188396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65039058|NCT00188396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039059|NCT00188396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039060|NCT00188396|Serotonin Agents|serotonin agents|mesh-ancestor
65039061|NCT00188396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039062|NCT00188396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65039063|NCT00188396|Antidepressive Agents|antidepressive agents|mesh-ancestor
65039064|NCT00188396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65039100|NCT00188630|Expectorants|expectorants|mesh-ancestor
65039101|NCT00188630|Respiratory System Agents|respiratory system agents|mesh-ancestor
65039102|NCT00188630|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65039103|NCT00188630|Antioxidants|antioxidants|mesh-ancestor
65039104|NCT00188630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039105|NCT00188630|Protective Agents|protective agents|mesh-ancestor
65039106|NCT00188630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039107|NCT00188630|Antidotes|antidotes|mesh-ancestor
65039120|NCT00188669|Vasodilator Agents|vasodilator agents|mesh-ancestor
65039121|NCT00188669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65039122|NCT00188669|Antioxidants|antioxidants|mesh-ancestor
65039123|NCT00188669|Vitamins|vitamins|mesh-ancestor
65039125|NCT00409214|Talaporfin|talaporfin|mesh-list
65039126|NCT00409214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039127|NCT00409214|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65039128|NCT00409214|Dermatologic Agents|dermatologic agents|mesh-ancestor
65039129|NCT02963051|Copper|copper|mesh-list
65039130|NCT02963051|Disulfiram|disulfiram|mesh-list
65039131|NCT02963051|Trace Elements|trace elements|mesh-ancestor
65039132|NCT02963051|Micronutrients|micronutrients|mesh-ancestor
65039133|NCT02963051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039134|NCT02963051|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65039135|NCT02963051|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65039136|NCT02963051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039137|NCT02963051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039138|NCT00219726|Imatinib Mesylate|imatinib mesylate|mesh-list
65039139|NCT00219726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039140|NCT00219726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65039141|NCT00219726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039142|NCT00219726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815083|NCT01482052|Immunologic Factors|immunologic factors|mesh-ancestor
65039143|NCT00409253|Nicardipine|nicardipine|mesh-list
65039144|NCT00409253|Urapidil|urapidil|mesh-list
65039145|NCT00409253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65039146|NCT00409253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65039147|NCT00409253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65039148|NCT00409253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039149|NCT00409253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65039150|NCT00409253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039151|NCT00409253|Vasodilator Agents|vasodilator agents|mesh-ancestor
65039152|NCT00409253|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65039153|NCT00409253|Serotonin Agents|serotonin agents|mesh-ancestor
65039154|NCT00409253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039155|NCT00409253|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65039156|NCT00409253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65039157|NCT00409253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65039158|NCT00409253|Adrenergic Agents|adrenergic agents|mesh-ancestor
65039159|NCT00219765|Cytarabine|cytarabine|mesh-list
65039160|NCT00219765|Imatinib Mesylate|imatinib mesylate|mesh-list
65039161|NCT00219765|Daunorubicin|daunorubicin|mesh-list
65039162|NCT00219765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65039163|NCT00219765|Antimetabolites|antimetabolites|mesh-ancestor
65039164|NCT00219765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039165|NCT00219765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039166|NCT00219765|Antiviral Agents|antiviral agents|mesh-ancestor
65039167|NCT00219765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65039168|NCT00219765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65039169|NCT00219765|Immunologic Factors|immunologic factors|mesh-ancestor
65039170|NCT00219765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039171|NCT00219765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65039172|NCT00219765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039184|NCT00212589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039185|NCT00212589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65039186|NCT00212589|Immunologic Factors|immunologic factors|mesh-ancestor
65039187|NCT00212589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039189|NCT00212589|Protective Agents|protective agents|mesh-ancestor
65039190|NCT00212589|Vitamin B Complex|vitamin b complex|mesh-ancestor
65039191|NCT00212589|Vitamins|vitamins|mesh-ancestor
65039192|NCT00212589|Micronutrients|micronutrients|mesh-ancestor
65039193|NCT00212589|Hematinics|hematinics|mesh-ancestor
65039194|NCT00188825|Basiliximab|basiliximab|mesh-list
65039195|NCT00188825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65039196|NCT00188825|Immunologic Factors|immunologic factors|mesh-ancestor
65039197|NCT00188825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524434|NCT02517580|Vitamin K|vitamin k|mesh-list
65039198|NCT00219804|Tetrabenazine|tetrabenazine|mesh-list
65039199|NCT00219804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65039200|NCT00219804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65039201|NCT00219804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65039202|NCT00219804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039203|NCT00219804|Adrenergic Agents|adrenergic agents|mesh-ancestor
65039204|NCT00219804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039205|NCT00219804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039206|NCT00188864|Dexamethasone|dexamethasone|mesh-list
65039207|NCT00188864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65039208|NCT00188864|Antiemetics|antiemetics|mesh-ancestor
65039209|NCT00188864|Autonomic Agents|autonomic agents|mesh-ancestor
65039210|NCT00188864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65039211|NCT00188864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039212|NCT00188864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65039213|NCT00188864|Glucocorticoids|glucocorticoids|mesh-ancestor
65039215|NCT00188864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65039216|NCT00188864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65039217|NCT00188864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039218|NCT00188942|Olanzapine|olanzapine|mesh-list
65039219|NCT00188942|Fluoxetine|fluoxetine|mesh-list
65039220|NCT00188942|Antiemetics|antiemetics|mesh-ancestor
65039221|NCT00188942|Autonomic Agents|autonomic agents|mesh-ancestor
65039222|NCT00188942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65039223|NCT00188942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039224|NCT00188942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65039225|NCT00188942|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65039226|NCT00188942|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65039227|NCT00188942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65039228|NCT00188942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65039229|NCT00188942|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65039230|NCT00188942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65039231|NCT00188942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65039232|NCT00188942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039233|NCT00188942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039234|NCT00188942|Serotonin Agents|serotonin agents|mesh-ancestor
65039235|NCT00188942|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65039236|NCT00188942|Antidepressive Agents|antidepressive agents|mesh-ancestor
64891051|NCT01978665|Prednisone|prednisone|mesh-list
65039241|NCT00219882|Antioxidants|antioxidants|mesh-ancestor
65039242|NCT00219882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039243|NCT00219882|Protective Agents|protective agents|mesh-ancestor
65039244|NCT00219882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039245|NCT00189020|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65039246|NCT00189020|Immunologic Factors|immunologic factors|mesh-ancestor
65039247|NCT00189020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039248|NCT00219921|Morphine|morphine|mesh-list
65039249|NCT00219921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65039250|NCT00219921|Narcotics|narcotics|mesh-ancestor
65039251|NCT00219921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65039252|NCT00219921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039253|NCT00219921|Analgesics|analgesics|mesh-ancestor
65039254|NCT00219921|Sensory System Agents|sensory system agents|mesh-ancestor
65039255|NCT00219921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65039256|NCT00212823|Almotriptan|almotriptan|mesh-list
65039257|NCT00212823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65039258|NCT00212823|Serotonin Agents|serotonin agents|mesh-ancestor
65039259|NCT00212823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039260|NCT00212823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039261|NCT00212823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039262|NCT00189059|Amitriptyline|amitriptyline|mesh-list
65039263|NCT00189059|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65039264|NCT00189059|Antidepressive Agents|antidepressive agents|mesh-ancestor
65039265|NCT00189059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65039266|NCT00189059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65039267|NCT00189059|Analgesics|analgesics|mesh-ancestor
65039268|NCT00189059|Sensory System Agents|sensory system agents|mesh-ancestor
65039269|NCT00189059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65039270|NCT00189059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039271|NCT00189059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65039272|NCT00189059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65039273|NCT00189059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65039274|NCT00189059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039276|NCT00189059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039277|NCT00189176|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
65039278|NCT00189176|Chelating Agents|chelating agents|mesh-ancestor
65039279|NCT00189176|Sequestering Agents|sequestering agents|mesh-ancestor
65039280|NCT00189176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039281|NCT00189176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039282|NCT00189176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65039283|NCT00189176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65039284|NCT00189176|Growth Substances|growth substances|mesh-ancestor
65039285|NCT00189176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039286|NCT00189176|Growth Inhibitors|growth inhibitors|mesh-ancestor
65039287|NCT00189176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039288|NCT00189371|Paclitaxel|paclitaxel|mesh-list
65039289|NCT00189371|Carboplatin|carboplatin|mesh-list
65039290|NCT00189371|Epoetin Alfa|epoetin alfa|mesh-list
65039291|NCT00189371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65039292|NCT00189371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039293|NCT00189371|Tubulin Modulators|tubulin modulators|mesh-ancestor
65039294|NCT00189371|Antimitotic Agents|antimitotic agents|mesh-ancestor
65039295|NCT00189371|Mitosis Modulators|mitosis modulators|mesh-ancestor
65039296|NCT00189371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039297|NCT00189371|Hematinics|hematinics|mesh-ancestor
65039298|NCT00189410|Carboplatin|carboplatin|mesh-list
65039299|NCT00189410|Doxorubicin|doxorubicin|mesh-list
65039300|NCT00189410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65039301|NCT00189410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039302|NCT00189410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65039303|NCT00189410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65039304|NCT00189410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65039305|NCT00189410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248440|NCT00844207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65039306|NCT00189410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039307|NCT00189566|Paclitaxel|paclitaxel|mesh-list
65039322|NCT00220116|Antimetabolites|antimetabolites|mesh-ancestor
65039323|NCT00220116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039324|NCT00220116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039325|NCT02963129|Mupirocin|mupirocin|mesh-list
65039326|NCT02963129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65039327|NCT02963129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65039328|NCT02963129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65039329|NCT02963129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039330|NCT02963129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039331|NCT00220155|Gemcitabine|gemcitabine|mesh-list
65039332|NCT00220155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65039333|NCT00220155|Antimetabolites|antimetabolites|mesh-ancestor
65039334|NCT00220155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039335|NCT00220155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039336|NCT00220155|Antiviral Agents|antiviral agents|mesh-ancestor
65039337|NCT00220155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65039338|NCT00220155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039339|NCT00220155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65039340|NCT00220155|Immunologic Factors|immunologic factors|mesh-ancestor
65039341|NCT00220155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039342|NCT00189644|Cyclophosphamide|cyclophosphamide|mesh-list
65039343|NCT00189644|Fluorouracil|fluorouracil|mesh-list
65039344|NCT00189644|Epirubicin|epirubicin|mesh-list
65039345|NCT00189644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65039346|NCT00189644|Immunologic Factors|immunologic factors|mesh-ancestor
65039347|NCT00189644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039348|NCT00189644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65039349|NCT00189644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65039350|NCT00189644|Alkylating Agents|alkylating agents|mesh-ancestor
65039351|NCT00189644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039352|NCT00189644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039353|NCT00189644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65039354|NCT00189644|Antimetabolites|antimetabolites|mesh-ancestor
65039355|NCT00189644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65039356|NCT00189644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65039357|NCT00189644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65039358|NCT00189644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65039359|NCT00189644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039360|NCT00189683|Capecitabine|capecitabine|mesh-list
65039361|NCT00189683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65039362|NCT00189683|Antimetabolites|antimetabolites|mesh-ancestor
65039363|NCT00189683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039364|NCT00189683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039365|NCT00189722|Tacrolimus|tacrolimus|mesh-list
65039366|NCT00189722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65039367|NCT00189722|Immunologic Factors|immunologic factors|mesh-ancestor
65039368|NCT00189722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039393|NCT00213096|Estradiol|estradiol|mesh-list
65039394|NCT00213096|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65039395|NCT00213096|Estrogens|estrogens|mesh-ancestor
65039396|NCT00213096|Hormones|hormones|mesh-ancestor
65039397|NCT00213096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65039398|NCT00213096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039399|NCT00213096|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65039400|NCT00213096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65039401|NCT00213096|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65039402|NCT00213096|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65039403|NCT00213096|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65039404|NCT00189800|Solifenacin Succinate|solifenacin succinate|mesh-list
65039405|NCT00189800|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65039406|NCT00189800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65039407|NCT00189800|Cholinergic Agents|cholinergic agents|mesh-ancestor
65039408|NCT00189800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039409|NCT00189800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039410|NCT00189800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039411|NCT00189800|Urological Agents|urological agents|mesh-ancestor
65039412|NCT00220233|Amlodipine|amlodipine|mesh-list
65039413|NCT00220233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65039414|NCT00220233|Olmesartan|olmesartan|mesh-list
65039415|NCT00220233|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65039416|NCT00220233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65039417|NCT00220233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65039418|NCT00220233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64891252|NCT01980407|Vitamins|vitamins|mesh-ancestor
65039437|NCT00189878|Abortifacient Agents|abortifacient agents|mesh-ancestor
65039438|NCT00189878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65039439|NCT00189878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039440|NCT00189878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65039441|NCT00189878|Antimetabolites|antimetabolites|mesh-ancestor
65039442|NCT00189878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039443|NCT00189878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039444|NCT00189878|Dermatologic Agents|dermatologic agents|mesh-ancestor
65039445|NCT00189878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039446|NCT00189878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65039447|NCT00189878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65039448|NCT00189878|Immunologic Factors|immunologic factors|mesh-ancestor
65039449|NCT00189878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65039450|NCT00189878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65039451|NCT00220311|Fludarabine|fludarabine|mesh-list
65039452|NCT00220311|Fludarabine phosphate|fludarabine phosphate|mesh-list
65039453|NCT00220311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039454|NCT00220311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65039455|NCT00220311|Antimetabolites|antimetabolites|mesh-ancestor
65039456|NCT00220311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039457|NCT00220311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65039458|NCT00220311|Immunologic Factors|immunologic factors|mesh-ancestor
65039459|NCT00220311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039460|NCT00213252|Prednisolone|prednisolone|mesh-list
65039461|NCT00213252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65039462|NCT00213252|Methylprednisolone|methylprednisolone|mesh-list
65039463|NCT00213252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65039464|NCT00213252|Prednisolone acetate|prednisolone acetate|mesh-list
65039465|NCT00213252|Montelukast|montelukast|mesh-list
65039466|NCT00213252|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65039467|NCT00213252|Prednisolone phosphate|prednisolone phosphate|mesh-list
65039468|NCT00213252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65039469|NCT00213252|Glucocorticoids|glucocorticoids|mesh-ancestor
65039470|NCT00213252|Hormones|hormones|mesh-ancestor
65039471|NCT00213252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65039472|NCT00213252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891302|NCT01980680|Progestins|progestins|mesh-ancestor
65039486|NCT00213252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65039487|NCT00213252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039489|NCT00189995|Haloperidol decanoate|haloperidol decanoate|mesh-list
65039490|NCT00189995|Clozapine|clozapine|mesh-list
65039491|NCT00189995|Antiemetics|antiemetics|mesh-ancestor
65039492|NCT00189995|Autonomic Agents|autonomic agents|mesh-ancestor
65039493|NCT00189995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65039494|NCT00189995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039495|NCT00189995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64480821|NCT00642694|Serotonin Agents|serotonin agents|mesh-ancestor
65039496|NCT00189995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65039497|NCT00189995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65039498|NCT00189995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65039499|NCT00189995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65039500|NCT00189995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65039501|NCT00189995|Dopamine Agents|dopamine agents|mesh-ancestor
65039502|NCT00189995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039503|NCT00189995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039504|NCT00189995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65039505|NCT00189995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65039506|NCT00189995|Serotonin Agents|serotonin agents|mesh-ancestor
65039507|NCT00189995|GABA Antagonists|gaba antagonists|mesh-ancestor
65039508|NCT00189995|GABA Agents|gaba agents|mesh-ancestor
65039509|NCT00213291|Darbepoetin alfa|darbepoetin alfa|mesh-list
65039510|NCT00213291|Hematinics|hematinics|mesh-ancestor
65039511|NCT00190034|Acetylcysteine|acetylcysteine|mesh-list
65039512|NCT00190034|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65039513|NCT00190034|Antiviral Agents|antiviral agents|mesh-ancestor
65039514|NCT00190034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65039515|NCT00190034|Expectorants|expectorants|mesh-ancestor
65039516|NCT00190034|Respiratory System Agents|respiratory system agents|mesh-ancestor
65039517|NCT00190034|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65039518|NCT00190034|Antioxidants|antioxidants|mesh-ancestor
65039519|NCT00190034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039520|NCT00190034|Protective Agents|protective agents|mesh-ancestor
65039521|NCT00190034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039522|NCT00190034|Antidotes|antidotes|mesh-ancestor
64815457|NCT01485211|Vitamins|vitamins|mesh-ancestor
65039523|NCT00412503|Temozolomide|temozolomide|mesh-list
65039524|NCT00412503|Topotecan|topotecan|mesh-list
65039525|NCT00412503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65039526|NCT00412503|Alkylating Agents|alkylating agents|mesh-ancestor
65039527|NCT00412503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039528|NCT00412503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039529|NCT00412503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65039530|NCT00412503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65039531|NCT00412503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039532|NCT00412581|Lenalidomide|lenalidomide|mesh-list
65039533|NCT00412581|Dacarbazine|dacarbazine|mesh-list
65039534|NCT00412581|Immunologic Factors|immunologic factors|mesh-ancestor
65039549|NCT00190151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039550|NCT00190151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039551|NCT00190151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039552|NCT00190151|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65039553|NCT00190151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65039554|NCT00190229|Cyclophosphamide|cyclophosphamide|mesh-list
65039555|NCT00190229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65039556|NCT00190229|Immunologic Factors|immunologic factors|mesh-ancestor
65039557|NCT00190229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039558|NCT00190229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65039559|NCT00190229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65039560|NCT00190229|Alkylating Agents|alkylating agents|mesh-ancestor
65039561|NCT00190229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039562|NCT00190229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039563|NCT00190229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65039564|NCT00190268|Amifampridine|amifampridine|mesh-list
65039565|NCT00190268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65039566|NCT00190268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65039567|NCT00190268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039568|NCT00190268|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64480901|NCT00687076|Vitamins|vitamins|mesh-ancestor
65039569|NCT00190268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65039570|NCT00190268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039572|NCT00220350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65039573|NCT00220350|Fertility Agents|fertility agents|mesh-ancestor
65039574|NCT00220350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65039575|NCT00220350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039576|NCT00220350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65039577|NCT00220350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039578|NCT00190307|Aspirin|aspirin|mesh-list
65039579|NCT00190307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65039580|NCT00190307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65039581|NCT00190307|Analgesics|analgesics|mesh-ancestor
65039582|NCT00190307|Sensory System Agents|sensory system agents|mesh-ancestor
65039583|NCT00190307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65039584|NCT00190307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039585|NCT00190307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65039586|NCT00190307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65039587|NCT00190307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65039588|NCT00190307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65039589|NCT00190307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039590|NCT00190307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65039591|NCT00190307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65039626|NCT00122837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039627|NCT00122837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039628|NCT00122837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039630|NCT00122837|Sensory System Agents|sensory system agents|mesh-ancestor
64891477|NCT01982201|Lesinurad|lesinurad|mesh-list
65039647|NCT00220506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039648|NCT00190619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65039649|NCT00190619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65039650|NCT00190619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65039651|NCT00190619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65039652|NCT00190619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039653|NCT00190619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039654|NCT00190619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039656|NCT00190619|Sensory System Agents|sensory system agents|mesh-ancestor
65039657|NCT00190619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65039658|NCT00190619|Antidepressive Agents|antidepressive agents|mesh-ancestor
65039659|NCT00190619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65039660|NCT00190619|Dopamine Agents|dopamine agents|mesh-ancestor
65039661|NCT00213564|Methotrexate|methotrexate|mesh-list
65039662|NCT00213564|Infliximab|infliximab|mesh-list
65039663|NCT00213564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65039664|NCT00213564|Abortifacient Agents|abortifacient agents|mesh-ancestor
65039665|NCT00213564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65039666|NCT00213564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039667|NCT00213564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65039668|NCT00213564|Antimetabolites|antimetabolites|mesh-ancestor
65039669|NCT00213564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039670|NCT00213564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039671|NCT00213564|Dermatologic Agents|dermatologic agents|mesh-ancestor
65039672|NCT00213564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039673|NCT00213564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65039674|NCT00213564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65039675|NCT00213564|Immunologic Factors|immunologic factors|mesh-ancestor
65039676|NCT00213564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65039677|NCT00213564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65039678|NCT00213564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65039679|NCT00122876|Talaporfin|talaporfin|mesh-list
65039680|NCT00122876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039681|NCT00122876|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65039682|NCT00122876|Dermatologic Agents|dermatologic agents|mesh-ancestor
65039683|NCT00190736|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65039684|NCT00190736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64891517|NCT01982734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65039701|NCT00190814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65039702|NCT00190814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65039703|NCT00190814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039704|NCT00190814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039705|NCT00190814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039706|NCT00190814|Analgesics|analgesics|mesh-ancestor
65039707|NCT00190814|Sensory System Agents|sensory system agents|mesh-ancestor
65039708|NCT00190814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65039709|NCT00190814|Antidepressive Agents|antidepressive agents|mesh-ancestor
65039710|NCT00190814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65039711|NCT00190814|Dopamine Agents|dopamine agents|mesh-ancestor
65039712|NCT00220623|Antidepressive Agents|antidepressive agents|mesh-list
65039713|NCT00220623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65039714|NCT00220818|Lansoprazole|lansoprazole|mesh-list
65039715|NCT00220818|Dexlansoprazole|dexlansoprazole|mesh-list
65039716|NCT00220818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65039717|NCT00220818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65039718|NCT00220818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65039719|NCT00220818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039720|NCT00220818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039721|NCT00213759|Lenograstim|lenograstim|mesh-list
65039722|NCT00213759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65039723|NCT00213759|Immunologic Factors|immunologic factors|mesh-ancestor
65039724|NCT00213759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039725|NCT00190853|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65039726|NCT00190853|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65039727|NCT00190853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65039728|NCT00190853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65039729|NCT00190853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039730|NCT00190853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039731|NCT00190853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039732|NCT00190853|Analgesics|analgesics|mesh-ancestor
65039733|NCT00190853|Sensory System Agents|sensory system agents|mesh-ancestor
65039734|NCT00190853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65039735|NCT00190853|Antidepressive Agents|antidepressive agents|mesh-ancestor
65039736|NCT00190853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65039737|NCT00190853|Dopamine Agents|dopamine agents|mesh-ancestor
65039738|NCT00190892|Carbamazepine|carbamazepine|mesh-list
65039739|NCT00190892|Olanzapine|olanzapine|mesh-list
65039766|NCT00220857|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65039767|NCT00220857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039768|NCT00220857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039769|NCT00190931|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65039770|NCT00190931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64472674|NCT03021486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65039771|NCT00190931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65039772|NCT00190931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65039773|NCT00190931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039774|NCT00190931|Adrenergic Agents|adrenergic agents|mesh-ancestor
65039775|NCT00190931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039776|NCT00190931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039777|NCT00220896|Donepezil|donepezil|mesh-list
65039778|NCT00220896|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65039779|NCT00220896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039780|NCT00220896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039781|NCT00220896|Cholinergic Agents|cholinergic agents|mesh-ancestor
65039782|NCT00220896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039783|NCT00220896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039784|NCT00220896|Nootropic Agents|nootropic agents|mesh-ancestor
65039785|NCT00190970|Ruboxistaurin|ruboxistaurin|mesh-list
65039786|NCT00190970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039793|NCT00191009|Adrenergic Agents|adrenergic agents|mesh-ancestor
65039794|NCT00191009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039795|NCT00191009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039796|NCT00191048|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65039797|NCT00191048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65039798|NCT00191048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65039799|NCT00191048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65039800|NCT00191048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039801|NCT00191048|Adrenergic Agents|adrenergic agents|mesh-ancestor
65039802|NCT00191048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039803|NCT00191048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039804|NCT00123149|Epoetin Alfa|epoetin alfa|mesh-list
65039805|NCT00123149|Hematinics|hematinics|mesh-ancestor
65039806|NCT00191087|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65039807|NCT00191087|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65039808|NCT00191087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65039809|NCT00191087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65039810|NCT00191087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039811|NCT00191087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039812|NCT00191087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039813|NCT00191087|Analgesics|analgesics|mesh-ancestor
65039814|NCT00191087|Sensory System Agents|sensory system agents|mesh-ancestor
65039815|NCT00191087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65039816|NCT00191087|Antidepressive Agents|antidepressive agents|mesh-ancestor
65039817|NCT00191087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65039818|NCT00191087|Dopamine Agents|dopamine agents|mesh-ancestor
65039819|NCT00191126|Gemcitabine|gemcitabine|mesh-list
65039820|NCT00191126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039821|NCT00191126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65039822|NCT00191126|Antimetabolites|antimetabolites|mesh-ancestor
65039823|NCT00191126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039824|NCT00191126|Antiviral Agents|antiviral agents|mesh-ancestor
65039825|NCT00191126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65039826|NCT00191126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039827|NCT00191126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65039828|NCT00191126|Immunologic Factors|immunologic factors|mesh-ancestor
65039829|NCT00191126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039830|NCT00221052|Diclofenac|diclofenac|mesh-list
65039831|NCT00221052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65039832|NCT00221052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65039833|NCT00221052|Analgesics|analgesics|mesh-ancestor
65039834|NCT00221052|Sensory System Agents|sensory system agents|mesh-ancestor
65039835|NCT00221052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65039836|NCT00221052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039837|NCT00221052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65039838|NCT00221052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65039839|NCT00221052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65039840|NCT00221052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039841|NCT00221052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039842|NCT00191204|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65039843|NCT00191204|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65039844|NCT00191204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65039845|NCT00191204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64472675|NCT03021486|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65039846|NCT00191204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039847|NCT00191204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039860|NCT00191243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65039861|NCT00191243|Antimetabolites|antimetabolites|mesh-ancestor
65039862|NCT00191243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039863|NCT00191243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039864|NCT00191243|Antiviral Agents|antiviral agents|mesh-ancestor
65039865|NCT00191243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65039866|NCT00191243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039867|NCT00191243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65039868|NCT00191243|Immunologic Factors|immunologic factors|mesh-ancestor
65039869|NCT00191243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039870|NCT00191243|Tubulin Modulators|tubulin modulators|mesh-ancestor
65039871|NCT00191243|Antimitotic Agents|antimitotic agents|mesh-ancestor
65039872|NCT00191243|Mitosis Modulators|mitosis modulators|mesh-ancestor
65039873|NCT00214032|Pycnogenols|pycnogenols|mesh-list
65039874|NCT00214032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65039875|NCT00214032|Immunologic Factors|immunologic factors|mesh-ancestor
65039876|NCT00214032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039877|NCT00214032|Antioxidants|antioxidants|mesh-ancestor
65039878|NCT00214032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039879|NCT00214032|Protective Agents|protective agents|mesh-ancestor
65039880|NCT00214032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65039881|NCT00123266|Plasminogen|plasminogen|mesh-list
65039882|NCT00123266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65039883|NCT00123266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65039884|NCT00123266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039885|NCT00191321|Teriparatide|teriparatide|mesh-list
65039886|NCT00191321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65039887|NCT00191321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039888|NCT00191321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65039889|NCT00123305|Plasminogen|plasminogen|mesh-list
65039890|NCT00123305|Fibrinolysin|fibrinolysin|mesh-list
65039891|NCT00123305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65039892|NCT00123305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65039893|NCT00123305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039894|NCT00214110|Tamoxifen|tamoxifen|mesh-list
65039895|NCT00214110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65039896|NCT00214110|Hormone Antagonists|hormone antagonists|mesh-ancestor
65039897|NCT00214110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65039898|NCT00214110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039899|NCT00214110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65039900|NCT00214110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039901|NCT00214110|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65039902|NCT00214110|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65039903|NCT00214110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65039904|NCT00191399|Olanzapine|olanzapine|mesh-list
65039905|NCT00191399|Fluoxetine|fluoxetine|mesh-list
65039906|NCT00191399|Antiemetics|antiemetics|mesh-ancestor
65039907|NCT00191399|Autonomic Agents|autonomic agents|mesh-ancestor
65039908|NCT00191399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65039909|NCT00191399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039910|NCT00191399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65039911|NCT00191399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65039912|NCT00191399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65039913|NCT00191399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65039926|NCT00191438|Gemcitabine|gemcitabine|mesh-list
65039927|NCT00191438|Capecitabine|capecitabine|mesh-list
65039928|NCT00191438|Docetaxel|docetaxel|mesh-list
65039929|NCT00191438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65039930|NCT00191438|Antimetabolites|antimetabolites|mesh-ancestor
65039931|NCT00191438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039932|NCT00191438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039933|NCT00191438|Antiviral Agents|antiviral agents|mesh-ancestor
65039934|NCT00191438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65039935|NCT00191438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039936|NCT00191438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65039937|NCT00191438|Immunologic Factors|immunologic factors|mesh-ancestor
65039938|NCT00191438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039939|NCT00191438|Tubulin Modulators|tubulin modulators|mesh-ancestor
65039940|NCT00191438|Antimitotic Agents|antimitotic agents|mesh-ancestor
65039941|NCT00191438|Mitosis Modulators|mitosis modulators|mesh-ancestor
65039942|NCT00221286|Interferons|interferons|mesh-list
65039943|NCT00221286|Tenofovir|tenofovir|mesh-list
65039944|NCT00221286|Interferon-alpha|interferon-alpha|mesh-list
65039945|NCT00221286|Interferon alpha-2|interferon alpha-2|mesh-list
65039946|NCT00221286|Emtricitabine|emtricitabine|mesh-list
65039947|NCT00221286|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65039948|NCT00221286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039949|NCT00221286|Antiviral Agents|antiviral agents|mesh-ancestor
65039950|NCT00221286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65039951|NCT00221286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65039952|NCT00221286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65039953|NCT00221286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039954|NCT00221286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039955|NCT00221286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65039956|NCT00221286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65039957|NCT00221286|Immunologic Factors|immunologic factors|mesh-ancestor
65039958|NCT00221286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039959|NCT00123383|Modafinil|modafinil|mesh-list
65039960|NCT00123383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65039961|NCT00123383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039962|NCT00123383|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65039963|NCT00123383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65039964|NCT00123383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65039965|NCT00123383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039966|NCT00214266|Mycophenolic Acid|mycophenolic acid|mesh-list
65039967|NCT00214266|Rituximab|rituximab|mesh-list
65039968|NCT00214266|Alemtuzumab|alemtuzumab|mesh-list
65039969|NCT00214266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65039970|NCT00214266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039971|NCT00214266|Immunologic Factors|immunologic factors|mesh-ancestor
65039972|NCT00214266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039973|NCT00214266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64891820|NCT01984567|Vitamin E|vitamin e|mesh-list
65039996|NCT00191516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039998|NCT00191516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039999|NCT00191516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040000|NCT00191555|Haloperidol|haloperidol|mesh-list
65040001|NCT00191555|Olanzapine|olanzapine|mesh-list
65040002|NCT00191555|Haloperidol decanoate|haloperidol decanoate|mesh-list
65040003|NCT00191555|Antiemetics|antiemetics|mesh-ancestor
65040004|NCT00191555|Autonomic Agents|autonomic agents|mesh-ancestor
65040005|NCT00191555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65040006|NCT00191555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040007|NCT00191555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65040008|NCT00191555|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65040009|NCT00191555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65040010|NCT00191555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65040011|NCT00191555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65040012|NCT00191555|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65040013|NCT00191555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65040014|NCT00191555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65040015|NCT00191555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040016|NCT00191555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65040017|NCT00191555|Serotonin Agents|serotonin agents|mesh-ancestor
65040018|NCT00191555|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65040019|NCT00191555|Dopamine Agents|dopamine agents|mesh-ancestor
65040020|NCT00191555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65040021|NCT00221364|Azithromycin|azithromycin|mesh-list
65040022|NCT00221364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64891881|NCT01984931|GABA Agents|gaba agents|mesh-ancestor
65040031|NCT00191594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65040032|NCT00191594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040033|NCT00191594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65040034|NCT00191594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040035|NCT00191594|Analgesics|analgesics|mesh-ancestor
65040036|NCT00191594|Sensory System Agents|sensory system agents|mesh-ancestor
65040037|NCT00191594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65040038|NCT00191594|Antidepressive Agents|antidepressive agents|mesh-ancestor
65040039|NCT00191594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65040040|NCT00191594|Dopamine Agents|dopamine agents|mesh-ancestor
65040041|NCT00221442|Zonisamide|zonisamide|mesh-list
65040042|NCT00221442|Anticonvulsants|anticonvulsants|mesh-ancestor
65040043|NCT00221442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65040044|NCT00221442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65040045|NCT00221442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248441|NCT00844207|Filaricides|filaricides|mesh-ancestor
65040046|NCT00221442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65040047|NCT00221442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040048|NCT00123578|Pentobarbital|pentobarbital|mesh-list
65040049|NCT00123578|Lorazepam|lorazepam|mesh-list
65040050|NCT00123578|Anticonvulsants|anticonvulsants|mesh-ancestor
65040051|NCT00123578|Antiemetics|antiemetics|mesh-ancestor
65040052|NCT00123578|Autonomic Agents|autonomic agents|mesh-ancestor
65040053|NCT00123578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65040054|NCT00123578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040055|NCT00123578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65040056|NCT00123578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65040057|NCT00123578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65040058|NCT00123578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65040059|NCT00123578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65040060|NCT00123578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65040061|NCT00123578|GABA Modulators|gaba modulators|mesh-ancestor
65040062|NCT00123578|GABA Agents|gaba agents|mesh-ancestor
65040063|NCT00123578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65040064|NCT00123578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040065|NCT00123578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65040066|NCT00221481|Valproic Acid|valproic acid|mesh-list
65040067|NCT00221481|Olanzapine|olanzapine|mesh-list
65040068|NCT00221481|Antiemetics|antiemetics|mesh-ancestor
65040069|NCT00221481|Autonomic Agents|autonomic agents|mesh-ancestor
65040070|NCT00221481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65040071|NCT00221481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040072|NCT00221481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65040073|NCT00221481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65040074|NCT00221481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65040075|NCT00221481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65040076|NCT00221481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65040077|NCT00221481|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65040078|NCT00221481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65040079|NCT00221481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65040080|NCT00221481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040081|NCT00221481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65040082|NCT00221481|Serotonin Agents|serotonin agents|mesh-ancestor
65040083|NCT00221481|Anticonvulsants|anticonvulsants|mesh-ancestor
65040084|NCT00221481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040086|NCT00221481|Antimanic Agents|antimanic agents|mesh-ancestor
65040087|NCT00191633|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65040088|NCT00191633|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65040103|NCT00221520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65040104|NCT00221520|Anesthetics, General|anesthetics, general|mesh-ancestor
65040105|NCT00221520|Anesthetics|anesthetics|mesh-ancestor
65040106|NCT00221520|GABA Modulators|gaba modulators|mesh-ancestor
65040107|NCT00221520|GABA Agents|gaba agents|mesh-ancestor
65040108|NCT00221520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65040109|NCT00221520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040110|NCT00191672|Gemcitabine|gemcitabine|mesh-list
65040112|NCT00191672|Docetaxel|docetaxel|mesh-list
65040113|NCT00191672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65040114|NCT00191672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040115|NCT00191672|Tubulin Modulators|tubulin modulators|mesh-ancestor
65040116|NCT00191672|Antimitotic Agents|antimitotic agents|mesh-ancestor
65040117|NCT00191672|Mitosis Modulators|mitosis modulators|mesh-ancestor
65040118|NCT00191672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040119|NCT00191672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65040120|NCT00191672|Antimetabolites|antimetabolites|mesh-ancestor
65040121|NCT00191672|Antiviral Agents|antiviral agents|mesh-ancestor
65040122|NCT00191672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65040123|NCT00191672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040124|NCT00191672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65040125|NCT00191672|Immunologic Factors|immunologic factors|mesh-ancestor
65040126|NCT00191672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040127|NCT00214578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65040128|NCT00214578|Antidepressive Agents|antidepressive agents|mesh-ancestor
65040129|NCT00214578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65040130|NCT00214578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65040131|NCT00214578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65040132|NCT00214578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65040133|NCT00214578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040134|NCT00191711|Gemcitabine|gemcitabine|mesh-list
65040135|NCT00191711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65040136|NCT00191711|Antimetabolites|antimetabolites|mesh-ancestor
65040137|NCT00191711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040138|NCT00191711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040139|NCT00191711|Antiviral Agents|antiviral agents|mesh-ancestor
65040140|NCT00191711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65040141|NCT00191711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040142|NCT00191711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65040143|NCT00191711|Immunologic Factors|immunologic factors|mesh-ancestor
65040144|NCT00191711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040145|NCT00221637|Valproic Acid|valproic acid|mesh-list
65040146|NCT00221637|Anticonvulsants|anticonvulsants|mesh-ancestor
65040147|NCT00221637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64891996|NCT01985789|Diphenhydramine|diphenhydramine|mesh-list
65040173|NCT00214617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65040174|NCT00214617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65040175|NCT00214617|Antimetabolites|antimetabolites|mesh-ancestor
65040176|NCT00214617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040177|NCT00214617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65040178|NCT00214617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65040179|NCT00214617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040181|NCT00191750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040182|NCT00191750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040183|NCT00191750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040184|NCT00191750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65040185|NCT00191750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65040186|NCT00214695|Dialysis Solutions|dialysis solutions|mesh-list
65040187|NCT00214695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65040188|NCT00221754|Pravastatin|pravastatin|mesh-list
65040189|NCT00221754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65040190|NCT00221754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65040191|NCT00221754|Antimetabolites|antimetabolites|mesh-ancestor
65040192|NCT00221754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040193|NCT00221754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65040194|NCT00221754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65040195|NCT00221754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040196|NCT00191828|Olanzapine|olanzapine|mesh-list
64892058|NCT01985893|Lapatinib|lapatinib|mesh-list
65040209|NCT00191828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040211|NCT00191828|Serotonin Agents|serotonin agents|mesh-ancestor
65040212|NCT00191867|Teriparatide|teriparatide|mesh-list
65040213|NCT00191867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65040214|NCT00191867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040215|NCT00191867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65040216|NCT00123851|Capecitabine|capecitabine|mesh-list
65040217|NCT00123851|Oxaliplatin|oxaliplatin|mesh-list
65040218|NCT00123851|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65040219|NCT00123851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65040220|NCT00123851|Antimetabolites|antimetabolites|mesh-ancestor
65040221|NCT00123851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040222|NCT00123851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040223|NCT00123851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65040224|NCT00123851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040225|NCT00123890|Aplaviroc|aplaviroc|mesh-list
65040226|NCT00123890|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64525490|NCT02402400|Ticagrelor|ticagrelor|mesh-list
65040227|NCT00123890|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65040228|NCT00123890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040229|NCT00123890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65040230|NCT00123890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65040231|NCT00123890|Antiviral Agents|antiviral agents|mesh-ancestor
65040232|NCT00123890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65040234|NCT00412698|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65040235|NCT00412698|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65040236|NCT00412698|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65040237|NCT00412698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65040238|NCT00412698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040239|NCT00412698|Hormones|hormones|mesh-ancestor
65040240|NCT00412698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65040241|NCT00412698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040242|NCT00123929|Docetaxel|docetaxel|mesh-list
65040243|NCT00123929|Doxorubicin|doxorubicin|mesh-list
65040244|NCT00123929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040245|NCT00123929|Tubulin Modulators|tubulin modulators|mesh-ancestor
65040246|NCT00123929|Antimitotic Agents|antimitotic agents|mesh-ancestor
65040247|NCT00123929|Mitosis Modulators|mitosis modulators|mesh-ancestor
65040248|NCT00123929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040249|NCT00123929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65040250|NCT00123929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65040251|NCT00123929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65040252|NCT00123929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040253|NCT00475033|Vaccines|vaccines|mesh-list
65040254|NCT00475033|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65040255|NCT00475033|Immunologic Factors|immunologic factors|mesh-ancestor
65040256|NCT00475033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040267|NCT00192062|Immunologic Factors|immunologic factors|mesh-ancestor
65040268|NCT00192062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040269|NCT00192062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65040270|NCT00192062|Tubulin Modulators|tubulin modulators|mesh-ancestor
65040271|NCT00192062|Antimitotic Agents|antimitotic agents|mesh-ancestor
65040272|NCT00192062|Mitosis Modulators|mitosis modulators|mesh-ancestor
65040274|NCT00192101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040275|NCT00192101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65040276|NCT00192101|Antimetabolites|antimetabolites|mesh-ancestor
65040277|NCT00192101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040278|NCT00192101|Antiviral Agents|antiviral agents|mesh-ancestor
65040279|NCT00192101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65040280|NCT00192101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040281|NCT00192101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65040282|NCT00192101|Immunologic Factors|immunologic factors|mesh-ancestor
65040283|NCT00192101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040284|NCT00215007|Levofloxacin|levofloxacin|mesh-list
65040285|NCT00215007|Ofloxacin|ofloxacin|mesh-list
65040286|NCT00215007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65040287|NCT00215007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65040288|NCT00215007|Renal Agents|renal agents|mesh-ancestor
65040289|NCT00215007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65040290|NCT00215007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65040291|NCT00215007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65040292|NCT00215007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040293|NCT00215007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040294|NCT00215007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040295|NCT00215007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65040296|NCT00215007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65040297|NCT00474994|Sunitinib|sunitinib|mesh-list
65040298|NCT00474994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040299|NCT00474994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65040300|NCT00474994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65040301|NCT00474994|Growth Substances|growth substances|mesh-ancestor
65040302|NCT00474994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040303|NCT00474994|Growth Inhibitors|growth inhibitors|mesh-ancestor
65040304|NCT00474994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65040305|NCT00474994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040306|NCT00474994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040307|NCT00474955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65040308|NCT00474955|Antiviral Agents|antiviral agents|mesh-ancestor
65040309|NCT00474955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65040310|NCT00215046|Methotrexate|methotrexate|mesh-list
65040311|NCT00215046|Vinblastine|vinblastine|mesh-list
65040312|NCT00215046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65040313|NCT00215046|Abortifacient Agents|abortifacient agents|mesh-ancestor
65040314|NCT00215046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65040315|NCT00215046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040316|NCT00215046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65040317|NCT00215046|Antimetabolites|antimetabolites|mesh-ancestor
65040318|NCT00215046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040319|NCT00215046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040320|NCT00215046|Dermatologic Agents|dermatologic agents|mesh-ancestor
65040352|NCT00221871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65040353|NCT00221871|Anesthetics, General|anesthetics, general|mesh-ancestor
65040354|NCT00221871|Anesthetics|anesthetics|mesh-ancestor
65040355|NCT00221871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65040356|NCT00221871|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65040357|NCT00221871|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65040358|NCT00221871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65040359|NCT00221871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040360|NCT00474058|Rotigotine|rotigotine|mesh-list
65040361|NCT00474058|Dopamine Agonists|dopamine agonists|mesh-ancestor
65040362|NCT00474058|Dopamine Agents|dopamine agents|mesh-ancestor
65040363|NCT00474058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65040389|NCT04571437|Antimetabolites|antimetabolites|mesh-ancestor
65040390|NCT04571437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040391|NCT04571437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040392|NCT04571437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65040393|NCT04571437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65040394|NCT04571437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040395|NCT04571437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65040396|NCT04571437|Hormone Antagonists|hormone antagonists|mesh-ancestor
65040397|NCT04571437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65040398|NCT04571437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040399|NCT00215124|Lenograstim|lenograstim|mesh-list
65040400|NCT00215124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65040401|NCT00215124|Immunologic Factors|immunologic factors|mesh-ancestor
65040402|NCT00215124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040403|NCT00473824|Immunoglobulins|immunoglobulins|mesh-list
65040404|NCT00473824|Antibodies|antibodies|mesh-list
65040405|NCT00473824|gamma-Globulins|gamma-globulins|mesh-list
65040406|NCT00473824|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65040407|NCT00473824|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65040408|NCT00473824|Immunologic Factors|immunologic factors|mesh-ancestor
65040409|NCT00473824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040410|NCT00215163|Paroxetine|paroxetine|mesh-list
65040411|NCT00215163|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65040412|NCT00215163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65040413|NCT00215163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65040414|NCT00215163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040443|NCT00215241|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65040444|NCT00215241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65040445|NCT00215241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65040447|NCT00124241|Telbivudine|telbivudine|mesh-list
65040448|NCT00124241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64525710|NCT02397486|Vitamin E|vitamin e|mesh-list
65040449|NCT00124241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65040451|NCT00124241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040452|NCT00124241|Antiviral Agents|antiviral agents|mesh-ancestor
65040453|NCT00124241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65040454|NCT00124241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65040455|NCT00124241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65040457|NCT00124280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040458|NCT00124280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65040459|NCT00124280|Immunologic Factors|immunologic factors|mesh-ancestor
64892339|NCT01987804|Oxytocin|oxytocin|mesh-list
65040477|NCT00215358|Formoterol Fumarate|formoterol fumarate|mesh-list
65040478|NCT00215358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65040480|NCT00215358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65040481|NCT00215358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040482|NCT00215358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65040483|NCT00215358|Respiratory System Agents|respiratory system agents|mesh-ancestor
65040484|NCT00215358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65040485|NCT00215358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65040486|NCT00215358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65040487|NCT00215358|Adrenergic Agents|adrenergic agents|mesh-ancestor
65040488|NCT00215358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65040489|NCT00215358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040490|NCT00192569|Interferons|interferons|mesh-list
65040491|NCT00192569|Ribavirin|ribavirin|mesh-list
65040492|NCT00192569|Interferon-alpha|interferon-alpha|mesh-list
65040493|NCT00192569|Interferon alpha-2|interferon alpha-2|mesh-list
65040494|NCT00192569|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65040495|NCT00192569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040496|NCT00192569|Antiviral Agents|antiviral agents|mesh-ancestor
65040497|NCT00192569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65040498|NCT00192569|Antimetabolites|antimetabolites|mesh-ancestor
65040499|NCT00192569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040500|NCT00192569|Immunologic Factors|immunologic factors|mesh-ancestor
65040501|NCT00192569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040502|NCT00215397|Formoterol Fumarate|formoterol fumarate|mesh-list
65040503|NCT00215397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65040504|NCT00215397|Autonomic Agents|autonomic agents|mesh-ancestor
65040505|NCT00215397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65040506|NCT00215397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040507|NCT00215397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65040508|NCT00215397|Respiratory System Agents|respiratory system agents|mesh-ancestor
65040509|NCT00215397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65040510|NCT00215397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65040511|NCT00215397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65040512|NCT00215397|Adrenergic Agents|adrenergic agents|mesh-ancestor
65040513|NCT00215397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65040514|NCT00215397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040515|NCT00192608|Saquinavir|saquinavir|mesh-list
65040516|NCT00192608|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65040517|NCT00192608|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65040530|NCT00215436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65040531|NCT00215436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040532|NCT00215436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65040533|NCT00215436|Respiratory System Agents|respiratory system agents|mesh-ancestor
65040534|NCT00215436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65040535|NCT00215436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65040536|NCT00215436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65040537|NCT00215436|Adrenergic Agents|adrenergic agents|mesh-ancestor
65040538|NCT00215436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65040539|NCT00215436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040540|NCT00215514|Fluorouracil|fluorouracil|mesh-list
65040541|NCT00215514|Epirubicin|epirubicin|mesh-list
65040542|NCT00215514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040543|NCT00215514|Antimetabolites|antimetabolites|mesh-ancestor
65040544|NCT00215514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040545|NCT00215514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65040546|NCT00215514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65040547|NCT00215514|Immunologic Factors|immunologic factors|mesh-ancestor
65040548|NCT00215514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040549|NCT00215514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65040550|NCT00215514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65040551|NCT00215514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65040552|NCT00215514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040553|NCT00192725|Tryptophan|tryptophan|mesh-list
65040554|NCT00192725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65040555|NCT00192725|Antidepressive Agents|antidepressive agents|mesh-ancestor
65040556|NCT00192725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65040557|NCT00215592|Zonisamide|zonisamide|mesh-list
65040558|NCT00215592|Anticonvulsants|anticonvulsants|mesh-ancestor
65040559|NCT00215592|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65040560|NCT00215592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65040561|NCT00215592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040562|NCT00215592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65040563|NCT00215592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040564|NCT00222144|Docetaxel|docetaxel|mesh-list
65040565|NCT00222144|Imatinib Mesylate|imatinib mesylate|mesh-list
65040566|NCT00222144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040567|NCT00222144|Tubulin Modulators|tubulin modulators|mesh-ancestor
65040568|NCT00222144|Antimitotic Agents|antimitotic agents|mesh-ancestor
65040569|NCT00222144|Mitosis Modulators|mitosis modulators|mesh-ancestor
65040570|NCT00222144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040571|NCT00222144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65040572|NCT00222144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040573|NCT00411879|Vasopressins|vasopressins|mesh-list
65040574|NCT00411879|Arginine Vasopressin|arginine vasopressin|mesh-list
65040575|NCT00411879|Epinephrine|epinephrine|mesh-list
65040576|NCT00411879|Racepinephrine|racepinephrine|mesh-list
65040577|NCT00411879|Epinephryl borate|epinephryl borate|mesh-list
65040578|NCT00411879|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65040579|NCT00411879|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65493875|NCT04147494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040600|NCT00222183|Analgesics|analgesics|mesh-ancestor
65040601|NCT00222183|Sensory System Agents|sensory system agents|mesh-ancestor
65040602|NCT00222183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65040603|NCT00222183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040604|NCT00222183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65040605|NCT00222183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65040606|NCT00222183|Dermatologic Agents|dermatologic agents|mesh-ancestor
65040607|NCT00222183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65040608|NCT00222183|Immunologic Factors|immunologic factors|mesh-ancestor
65040609|NCT00222183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65040610|NCT00222183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040611|NCT00222183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040612|NCT00192764|Cyclophosphamide|cyclophosphamide|mesh-list
65040613|NCT00192764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65040614|NCT00192764|Immunologic Factors|immunologic factors|mesh-ancestor
65040615|NCT00192764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040616|NCT00192764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65040617|NCT00192764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65040618|NCT00192764|Alkylating Agents|alkylating agents|mesh-ancestor
65040619|NCT00192764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040620|NCT00192764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040621|NCT00192764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65040622|NCT00411957|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65040623|NCT00411957|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65040624|NCT00411957|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65040625|NCT00411957|Protease Inhibitors|protease inhibitors|mesh-ancestor
65040626|NCT00411957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040627|NCT00411957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040628|NCT00411957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65040629|NCT00411957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65040630|NCT00411957|Antiviral Agents|antiviral agents|mesh-ancestor
65040631|NCT00411957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65040632|NCT00192803|Candesartan|candesartan|mesh-list
65040639|NCT00192842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65040640|NCT00192842|Antimetabolites|antimetabolites|mesh-ancestor
65040641|NCT00192842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040642|NCT00192842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040643|NCT00192842|Antiviral Agents|antiviral agents|mesh-ancestor
65040644|NCT00192842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65040645|NCT00192842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040646|NCT00192842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65040647|NCT00192842|Immunologic Factors|immunologic factors|mesh-ancestor
65040648|NCT00192842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040649|NCT00192842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65040650|NCT00192842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65040652|NCT00192842|Sensory System Agents|sensory system agents|mesh-ancestor
65040653|NCT00192842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65040654|NCT00192842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65040655|NCT00192842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65040656|NCT00411996|Ritonavir|ritonavir|mesh-list
65040657|NCT00411996|Indinavir|indinavir|mesh-list
65040658|NCT00411996|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65040659|NCT00411996|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65040660|NCT00411996|Protease Inhibitors|protease inhibitors|mesh-ancestor
65040661|NCT00411996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040662|NCT00411996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040663|NCT00411996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65040664|NCT00411996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65040665|NCT00411996|Antiviral Agents|antiviral agents|mesh-ancestor
65040666|NCT00411996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65040667|NCT00411996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65040668|NCT00411996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65040669|NCT00222261|Aspirin|aspirin|mesh-list
65040670|NCT00222261|Clopidogrel|clopidogrel|mesh-list
65040671|NCT00222261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65040672|NCT00222261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65040673|NCT00222261|Analgesics|analgesics|mesh-ancestor
65040674|NCT00222261|Sensory System Agents|sensory system agents|mesh-ancestor
65493876|NCT04147494|Anticoagulants|anticoagulants|mesh-ancestor
65040675|NCT00222261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65040676|NCT00222261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040677|NCT00222261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65040678|NCT00222261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65040679|NCT00222261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65040680|NCT00222261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65040681|NCT00222261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040682|NCT00222261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65040683|NCT00222261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65040684|NCT00222261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040685|NCT00222261|Antipyretics|antipyretics|mesh-ancestor
65040686|NCT00222261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65040687|NCT00222261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65040688|NCT00222261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65040689|NCT00222261|Purinergic Agents|purinergic agents|mesh-ancestor
65040690|NCT00222261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65040691|NCT00192959|Propofol|propofol|mesh-list
65040692|NCT00192959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65040693|NCT00192959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65040694|NCT00192959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040695|NCT00192959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65040696|NCT00192959|Anesthetics, General|anesthetics, general|mesh-ancestor
65040697|NCT00192959|Anesthetics|anesthetics|mesh-ancestor
65040698|NCT00215631|Tadalafil|tadalafil|mesh-list
65040699|NCT00215631|Vasodilator Agents|vasodilator agents|mesh-ancestor
65040700|NCT00215631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65040712|NCT00193076|Antiviral Agents|antiviral agents|mesh-ancestor
65040713|NCT00193076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65040714|NCT00193076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040715|NCT00193076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65040716|NCT00193076|Immunologic Factors|immunologic factors|mesh-ancestor
65040717|NCT00193076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040718|NCT00193076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65040719|NCT00193115|Cyclophosphamide|cyclophosphamide|mesh-list
65040720|NCT00193115|Docetaxel|docetaxel|mesh-list
65040721|NCT00193115|Doxorubicin|doxorubicin|mesh-list
65040722|NCT00193115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65040723|NCT00193115|Immunologic Factors|immunologic factors|mesh-ancestor
65040724|NCT00193115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040725|NCT00193115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65040726|NCT00193115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65040727|NCT00193115|Alkylating Agents|alkylating agents|mesh-ancestor
65040728|NCT00193115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040729|NCT00193115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040730|NCT00193115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65040731|NCT00193115|Tubulin Modulators|tubulin modulators|mesh-ancestor
65040732|NCT00193115|Antimitotic Agents|antimitotic agents|mesh-ancestor
65040733|NCT00193115|Mitosis Modulators|mitosis modulators|mesh-ancestor
65040734|NCT00193115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65040735|NCT00193115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65040736|NCT00193115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65040737|NCT00193115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040738|NCT00193154|Bevacizumab|bevacizumab|mesh-list
65040739|NCT00193154|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65040740|NCT00193154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65040741|NCT00193154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040742|NCT00193154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65040743|NCT00193154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65040744|NCT00193154|Growth Substances|growth substances|mesh-ancestor
65040745|NCT00193154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040746|NCT00193154|Growth Inhibitors|growth inhibitors|mesh-ancestor
65040747|NCT00193154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65040748|NCT00193154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040749|NCT00193154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040750|NCT00193193|Paclitaxel|paclitaxel|mesh-list
65040751|NCT00193193|Carboplatin|carboplatin|mesh-list
65040752|NCT00193193|Estramustine|estramustine|mesh-list
65040753|NCT00193193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65040754|NCT00193193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040755|NCT00193193|Tubulin Modulators|tubulin modulators|mesh-ancestor
65040756|NCT00193193|Antimitotic Agents|antimitotic agents|mesh-ancestor
65040757|NCT00193193|Mitosis Modulators|mitosis modulators|mesh-ancestor
65040758|NCT00193193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040759|NCT00193193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65040760|NCT00193193|Alkylating Agents|alkylating agents|mesh-ancestor
65040761|NCT00193193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65040762|NCT00193232|Docetaxel|docetaxel|mesh-list
65040763|NCT00193232|Bortezomib|bortezomib|mesh-list
65040764|NCT00193232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040789|NCT00222495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65040791|NCT00193271|Docetaxel|docetaxel|mesh-list
65040792|NCT00193271|Estramustine|estramustine|mesh-list
65040793|NCT00193271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040794|NCT00193271|Tubulin Modulators|tubulin modulators|mesh-ancestor
65040795|NCT00193271|Antimitotic Agents|antimitotic agents|mesh-ancestor
65040796|NCT00193271|Mitosis Modulators|mitosis modulators|mesh-ancestor
65040797|NCT00193271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040798|NCT00193271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65040799|NCT00193271|Alkylating Agents|alkylating agents|mesh-ancestor
65040800|NCT00193271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65040801|NCT00222534|Acetazolamide|acetazolamide|mesh-list
65040802|NCT00222534|Anticonvulsants|anticonvulsants|mesh-ancestor
65040803|NCT00222534|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65040804|NCT00222534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040805|NCT00222534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040806|NCT00222534|Diuretics|diuretics|mesh-ancestor
65040807|NCT00222534|Natriuretic Agents|natriuretic agents|mesh-ancestor
65040808|NCT00222534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040809|NCT00193310|Paclitaxel|paclitaxel|mesh-list
65040810|NCT00193310|Carboplatin|carboplatin|mesh-list
65040811|NCT00193310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65040812|NCT00193310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040813|NCT00193310|Tubulin Modulators|tubulin modulators|mesh-ancestor
65040814|NCT00193310|Antimitotic Agents|antimitotic agents|mesh-ancestor
65040825|NCT00193349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65040827|NCT00193388|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65040828|NCT00193388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65040829|NCT00193388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040830|NCT00193388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040831|NCT00193388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040832|NCT00215709|Docetaxel|docetaxel|mesh-list
65040833|NCT00215709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040834|NCT00215709|Tubulin Modulators|tubulin modulators|mesh-ancestor
65040835|NCT00215709|Antimitotic Agents|antimitotic agents|mesh-ancestor
65040836|NCT00215709|Mitosis Modulators|mitosis modulators|mesh-ancestor
65040837|NCT00215709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040838|NCT00193466|Rituximab|rituximab|mesh-list
65040839|NCT00193466|Fludarabine|fludarabine|mesh-list
65040840|NCT00193466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65040841|NCT00193466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040842|NCT00193466|Immunologic Factors|immunologic factors|mesh-ancestor
65040843|NCT00193466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040844|NCT00193466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65040845|NCT00215748|Dexamethasone|dexamethasone|mesh-list
65040846|NCT00215748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65040847|NCT00215748|Antiemetics|antiemetics|mesh-ancestor
65040848|NCT00215748|Autonomic Agents|autonomic agents|mesh-ancestor
65040849|NCT00215748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65040850|NCT00215748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040851|NCT00215748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65040852|NCT00215748|Glucocorticoids|glucocorticoids|mesh-ancestor
65040853|NCT00215748|Hormones|hormones|mesh-ancestor
65040854|NCT00215748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65040855|NCT00215748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65040856|NCT00215748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040857|NCT00193505|Rituximab|rituximab|mesh-list
65040858|NCT00193505|Carboplatin|carboplatin|mesh-list
65040859|NCT00193505|Etoposide|etoposide|mesh-list
65040860|NCT00193505|Ifosfamide|ifosfamide|mesh-list
65040861|NCT00193505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65040862|NCT00193505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040863|NCT00193505|Immunologic Factors|immunologic factors|mesh-ancestor
65040864|NCT00193505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040865|NCT00193505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65040866|NCT00193505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65040867|NCT00193505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65040868|NCT00193505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65040869|NCT00193505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040870|NCT00193505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040871|NCT00193505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65040872|NCT00193505|Alkylating Agents|alkylating agents|mesh-ancestor
65040873|NCT00215826|Interferon-alpha|interferon-alpha|mesh-list
65040874|NCT00215826|Antiviral Agents|antiviral agents|mesh-ancestor
65040875|NCT00215826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65040876|NCT00215826|Immunologic Factors|immunologic factors|mesh-ancestor
65040877|NCT00215826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040878|NCT00193544|Thalidomide|thalidomide|mesh-list
65040879|NCT00193544|Arsenic Trioxide|arsenic trioxide|mesh-list
65040880|NCT00193544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65040908|NCT00193583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040909|NCT00193583|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65040910|NCT00193583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65040911|NCT00193583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040912|NCT00193583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040913|NCT00215982|Capecitabine|capecitabine|mesh-list
65040914|NCT00215982|Oxaliplatin|oxaliplatin|mesh-list
65040916|NCT00215982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65040917|NCT00215982|Antimetabolites|antimetabolites|mesh-ancestor
65040918|NCT00215982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040919|NCT00215982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040920|NCT00215982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65040921|NCT00215982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65040922|NCT00215982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040923|NCT00124397|Atorvastatin|atorvastatin|mesh-list
65040924|NCT00124397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65040925|NCT00124397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65040926|NCT00124397|Antimetabolites|antimetabolites|mesh-ancestor
65040927|NCT00124397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040928|NCT00124397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65040929|NCT00124397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65040930|NCT00124397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040935|NCT00216021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040936|NCT00216021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040937|NCT00409526|Iloprost|iloprost|mesh-list
65040938|NCT00409526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65040939|NCT00409526|Vasodilator Agents|vasodilator agents|mesh-ancestor
65040940|NCT00216138|Docetaxel|docetaxel|mesh-list
65040941|NCT00216138|Capecitabine|capecitabine|mesh-list
65040942|NCT00216138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040943|NCT00216138|Tubulin Modulators|tubulin modulators|mesh-ancestor
65040944|NCT00216138|Antimitotic Agents|antimitotic agents|mesh-ancestor
65040945|NCT00216138|Mitosis Modulators|mitosis modulators|mesh-ancestor
65040946|NCT00216138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040947|NCT00216138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65040948|NCT00216138|Antimetabolites|antimetabolites|mesh-ancestor
65040949|NCT00216177|Adalimumab|adalimumab|mesh-list
65040950|NCT00216177|Infliximab|infliximab|mesh-list
65040951|NCT00216177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65040952|NCT00216177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65040953|NCT00216177|Dermatologic Agents|dermatologic agents|mesh-ancestor
65040954|NCT00216177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65040955|NCT00124436|Alitretinoin|alitretinoin|mesh-list
65040956|NCT00124436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040957|NCT00124436|Dermatologic Agents|dermatologic agents|mesh-ancestor
65040958|NCT00216216|Pemetrexed|pemetrexed|mesh-list
65040959|NCT00216216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040960|NCT00216216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040961|NCT00216216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040962|NCT00216216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65040963|NCT00216216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65040964|NCT00473746|Dexamethasone|dexamethasone|mesh-list
65040965|NCT00473746|Prednisone|prednisone|mesh-list
65040966|NCT00473746|Prednisolone|prednisolone|mesh-list
65040967|NCT00473746|Abiraterone Acetate|abiraterone acetate|mesh-list
65040968|NCT00473746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65040969|NCT00473746|Antiemetics|antiemetics|mesh-ancestor
65040970|NCT00473746|Autonomic Agents|autonomic agents|mesh-ancestor
65040971|NCT00473746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65040972|NCT00473746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040973|NCT00473746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64482334|NCT03585465|Nivolumab|nivolumab|mesh-list
65040974|NCT00473746|Glucocorticoids|glucocorticoids|mesh-ancestor
65040975|NCT00473746|Hormones|hormones|mesh-ancestor
65040976|NCT00473746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65493877|NCT04147494|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65040977|NCT00473746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65040978|NCT00473746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040979|NCT00473746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65040980|NCT00473746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040981|NCT00473746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040982|NCT00473746|Hormone Antagonists|hormone antagonists|mesh-ancestor
65040983|NCT00473746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65040984|NCT00409643|Amlodipine|amlodipine|mesh-list
65040985|NCT00409643|Valsartan|valsartan|mesh-list
65040986|NCT00409643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65040987|NCT00409643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65040988|NCT00409643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65040989|NCT00409643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040990|NCT00409643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65040991|NCT00409643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040992|NCT00409643|Vasodilator Agents|vasodilator agents|mesh-ancestor
65040993|NCT00409643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65040994|NCT00409643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65040995|NCT00216294|Secretin|secretin|mesh-list
65040996|NCT00216294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65040997|NCT00216294|Hormones|hormones|mesh-ancestor
65040998|NCT00216294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65040999|NCT00216294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041000|NCT00124475|Alitretinoin|alitretinoin|mesh-list
64892840|NCT01991587|Vaccines|vaccines|mesh-list
65041024|NCT00473590|Bevacizumab|bevacizumab|mesh-list
65041025|NCT00473590|Bortezomib|bortezomib|mesh-list
65041026|NCT00473590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65041027|NCT00473590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041028|NCT00473590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65041029|NCT00473590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65041030|NCT00473590|Growth Substances|growth substances|mesh-ancestor
65041031|NCT00473590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041032|NCT00473590|Growth Inhibitors|growth inhibitors|mesh-ancestor
65041033|NCT00223275|Naltrexone|naltrexone|mesh-list
65041034|NCT00223275|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65041035|NCT00223275|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65041036|NCT00223275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041037|NCT00223275|Sensory System Agents|sensory system agents|mesh-ancestor
65041038|NCT00223275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65041039|NCT00124787|Dimenhydrinate|dimenhydrinate|mesh-list
65041040|NCT00124787|Antiemetics|antiemetics|mesh-ancestor
65041041|NCT00124787|Autonomic Agents|autonomic agents|mesh-ancestor
65041042|NCT00124787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65041043|NCT00124787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041044|NCT00124787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65041045|NCT00124787|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65041046|NCT00124787|Histamine Antagonists|histamine antagonists|mesh-ancestor
65041047|NCT00124787|Histamine Agents|histamine agents|mesh-ancestor
64482400|NCT01611259|Rituximab|rituximab|mesh-list
65041048|NCT00124787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65041049|NCT00124787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041068|NCT00124826|Insulin|insulin|mesh-list
65041069|NCT00124826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65041070|NCT00124826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041071|NCT00193739|Paclitaxel|paclitaxel|mesh-list
65041072|NCT00193739|Carboplatin|carboplatin|mesh-list
65041073|NCT00193739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65041074|NCT00193739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041075|NCT00193739|Tubulin Modulators|tubulin modulators|mesh-ancestor
65041076|NCT00193739|Antimitotic Agents|antimitotic agents|mesh-ancestor
65041077|NCT00193739|Mitosis Modulators|mitosis modulators|mesh-ancestor
65041078|NCT00193739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041079|NCT00206310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65041080|NCT00206310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65041081|NCT00206310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65041082|NCT00206310|Antimetabolites|antimetabolites|mesh-ancestor
65041083|NCT00206310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041084|NCT00206310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65041085|NCT00206310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65041086|NCT00206310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041087|NCT00206388|Cyclophosphamide|cyclophosphamide|mesh-list
65041088|NCT00206388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65041089|NCT00206388|Immunologic Factors|immunologic factors|mesh-ancestor
65041090|NCT00206388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041091|NCT00206388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65041092|NCT00206388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65041093|NCT00206388|Alkylating Agents|alkylating agents|mesh-ancestor
65041094|NCT00206388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041095|NCT00206388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041096|NCT00206388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65041097|NCT00125021|Capecitabine|capecitabine|mesh-list
65041098|NCT00125021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65041099|NCT00125021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65041100|NCT00125021|Antimetabolites|antimetabolites|mesh-ancestor
65041101|NCT00125021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041102|NCT00125021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041103|NCT00125021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64892968|NCT01992601|Telmisartan|telmisartan|mesh-list
65041118|NCT00223509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041119|NCT00223509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65041120|NCT00223509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041122|NCT00223509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65041123|NCT00223509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65041124|NCT00223509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65041125|NCT00223509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64472683|NCT03021486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65041127|NCT00193895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041129|NCT00223548|Protective Agents|protective agents|mesh-ancestor
65041130|NCT00223548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041131|NCT00125060|Simvastatin|simvastatin|mesh-list
65041132|NCT00125060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65041133|NCT00125060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65041134|NCT00125060|Antimetabolites|antimetabolites|mesh-ancestor
65041135|NCT00125060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041136|NCT00125060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65041137|NCT00125060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65041138|NCT00125060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041139|NCT00223626|Topiramate|topiramate|mesh-list
65041140|NCT00223626|Anticonvulsants|anticonvulsants|mesh-ancestor
65041141|NCT00223626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65041142|NCT00223626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041143|NCT00223743|Zonisamide|zonisamide|mesh-list
65041144|NCT00223743|Anticonvulsants|anticonvulsants|mesh-ancestor
65041145|NCT00223743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65041146|NCT00223743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65041147|NCT00223743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041148|NCT00223743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65041149|NCT00223743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041150|NCT00193973|Methotrexate|methotrexate|mesh-list
65041151|NCT00193973|Idarubicin|idarubicin|mesh-list
65041152|NCT00193973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65041153|NCT00193973|Abortifacient Agents|abortifacient agents|mesh-ancestor
65041154|NCT00193973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65041155|NCT00193973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041156|NCT00193973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65041157|NCT00193973|Antimetabolites|antimetabolites|mesh-ancestor
65041158|NCT00193973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041159|NCT00193973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041160|NCT00193973|Dermatologic Agents|dermatologic agents|mesh-ancestor
65041161|NCT00193973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041162|NCT00193973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65041163|NCT00193973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65041164|NCT00193973|Immunologic Factors|immunologic factors|mesh-ancestor
65041165|NCT00193973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65041194|NCT00125294|Narcotics|narcotics|mesh-ancestor
65041195|NCT00125294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64915084|NCT03152318|Cyclophosphamide|cyclophosphamide|mesh-list
65041196|NCT00125294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041197|NCT00125294|Analgesics|analgesics|mesh-ancestor
65041198|NCT00125294|Sensory System Agents|sensory system agents|mesh-ancestor
65041199|NCT00125294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65041200|NCT00125294|Antitussive Agents|antitussive agents|mesh-ancestor
65041201|NCT00125294|Respiratory System Agents|respiratory system agents|mesh-ancestor
65041202|NCT00206466|Docetaxel|docetaxel|mesh-list
65041203|NCT00206466|Doxorubicin|doxorubicin|mesh-list
65041204|NCT00206466|Cyclophosphamide|cyclophosphamide|mesh-list
65041205|NCT00206466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65041206|NCT00206466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041207|NCT00206466|Tubulin Modulators|tubulin modulators|mesh-ancestor
65041208|NCT00206466|Antimitotic Agents|antimitotic agents|mesh-ancestor
65041209|NCT00206466|Mitosis Modulators|mitosis modulators|mesh-ancestor
64661605|NCT04769297|Ketamine|ketamine|mesh-list
65041244|NCT00206544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65041246|NCT00206544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65041247|NCT00206544|Hormone Antagonists|hormone antagonists|mesh-ancestor
65041248|NCT00206544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65041271|NCT00206622|Estradiol|estradiol|mesh-list
65041272|NCT00206622|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65041273|NCT00206622|Estrogens|estrogens|mesh-ancestor
65041274|NCT00206622|Hormones|hormones|mesh-ancestor
65041275|NCT00206622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65041276|NCT00206622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041277|NCT00206622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65041278|NCT00206622|Contraceptive Agents|contraceptive agents|mesh-ancestor
65041279|NCT00206622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65041280|NCT00206622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65041281|NCT00206622|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65041282|NCT00206622|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65041284|NCT00194402|Niacinamide|niacinamide|mesh-list
65041285|NCT00194402|Nicotinic Acids|nicotinic acids|mesh-list
65041286|NCT00194402|Atorvastatin|atorvastatin|mesh-list
65041287|NCT00194402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65041302|NCT00473512|Antiemetics|antiemetics|mesh-ancestor
65041303|NCT00473512|Autonomic Agents|autonomic agents|mesh-ancestor
65041304|NCT00473512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65041305|NCT00473512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041306|NCT00473512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65041307|NCT00473512|Glucocorticoids|glucocorticoids|mesh-ancestor
65041308|NCT00473512|Hormones|hormones|mesh-ancestor
65041309|NCT00473512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65041310|NCT00473512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65041311|NCT00473512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041312|NCT00473512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65041313|NCT00473512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041314|NCT00473512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041315|NCT00473512|Hormone Antagonists|hormone antagonists|mesh-ancestor
65041316|NCT00473512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65041317|NCT00125489|Chloroquine|chloroquine|mesh-list
65041318|NCT00125489|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65041319|NCT00125489|Pyrimethamine|pyrimethamine|mesh-list
65041320|NCT00125489|Sulfadoxine|sulfadoxine|mesh-list
65041321|NCT00125489|Amebicides|amebicides|mesh-ancestor
65041322|NCT00125489|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65041323|NCT00125489|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65041324|NCT00125489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65041325|NCT00125489|Antimalarials|antimalarials|mesh-ancestor
65041326|NCT00125489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65041327|NCT00125489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65041328|NCT00125489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65041329|NCT00125489|Analgesics|analgesics|mesh-ancestor
65041330|NCT00125489|Sensory System Agents|sensory system agents|mesh-ancestor
65041331|NCT00125489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65041332|NCT00125489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041333|NCT00125489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65041334|NCT00125489|Filaricides|filaricides|mesh-ancestor
65041335|NCT00125489|Antinematodal Agents|antinematodal agents|mesh-ancestor
65041336|NCT00125489|Anthelmintics|anthelmintics|mesh-ancestor
65041337|NCT00125489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65041338|NCT00125489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041339|NCT00125489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041340|NCT00125489|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64482705|NCT02000531|Gemcitabine|gemcitabine|mesh-list
65041341|NCT00125489|Renal Agents|renal agents|mesh-ancestor
65041343|NCT00206661|Sargramostim|sargramostim|mesh-list
65041344|NCT00206661|Immunologic Factors|immunologic factors|mesh-ancestor
65041345|NCT00206661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041346|NCT00206661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041347|NCT00473434|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65041348|NCT00473434|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64893217|NCT01994733|Calcium|calcium|mesh-list
65041360|NCT00473434|Dopamine Agents|dopamine agents|mesh-ancestor
65041361|NCT00125567|Levodopa|levodopa|mesh-list
65041362|NCT00125567|Carbidopa|carbidopa|mesh-list
65041363|NCT00125567|Entacapone|entacapone|mesh-list
65041364|NCT00125567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65041365|NCT00125567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65041366|NCT00125567|Dopamine Agents|dopamine agents|mesh-ancestor
65041367|NCT00125567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65041368|NCT00125567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041369|NCT00125567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041370|NCT00125567|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65041371|NCT00125567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041372|NCT00125567|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65041373|NCT00473083|Minocycline|minocycline|mesh-list
65041374|NCT00473083|Clindamycin|clindamycin|mesh-list
65041375|NCT00473083|Clindamycin palmitate|clindamycin palmitate|mesh-list
65041376|NCT00473083|Clindamycin phosphate|clindamycin phosphate|mesh-list
65041377|NCT00473083|Triamcinolone|triamcinolone|mesh-list
65041378|NCT00473083|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65041379|NCT00473083|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65041380|NCT00473083|Hydrocortisone|hydrocortisone|mesh-list
65041381|NCT00473083|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65041382|NCT00473083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041383|NCT00473083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041384|NCT00473083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65041385|NCT00473083|Glucocorticoids|glucocorticoids|mesh-ancestor
65041386|NCT00473083|Hormones|hormones|mesh-ancestor
64414512|NCT04393207|Anesthetics|anesthetics|mesh-ancestor
65041387|NCT00473083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65041388|NCT00473083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041389|NCT00473083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65041390|NCT00473083|Immunologic Factors|immunologic factors|mesh-ancestor
65041391|NCT00473083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65041392|NCT00473083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65041393|NCT00473083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65041394|NCT00194480|Interferons|interferons|mesh-list
65041395|NCT00194480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041396|NCT00194480|Antiviral Agents|antiviral agents|mesh-ancestor
65041397|NCT00194480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65041398|NCT00472420|Rituximab|rituximab|mesh-list
65041399|NCT00472420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65041400|NCT00472420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041401|NCT00472420|Immunologic Factors|immunologic factors|mesh-ancestor
65041402|NCT00472420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041403|NCT00472420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65041404|NCT00194519|Acyclovir|acyclovir|mesh-list
65041405|NCT00194519|Antiviral Agents|antiviral agents|mesh-ancestor
65041406|NCT00194519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65041407|NCT00206700|Sargramostim|sargramostim|mesh-list
65041408|NCT00206700|Immunologic Factors|immunologic factors|mesh-ancestor
65041409|NCT00206700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041410|NCT00125645|Irbesartan|irbesartan|mesh-list
65041411|NCT00125645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64893274|NCT01995006|Antipyretics|antipyretics|mesh-ancestor
65041427|NCT00194597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65041428|NCT00194597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041429|NCT00194597|Urological Agents|urological agents|mesh-ancestor
65041430|NCT00206739|Pyrimethamine|pyrimethamine|mesh-list
65041431|NCT00206739|Sulfadoxine|sulfadoxine|mesh-list
65041432|NCT00206739|Antimalarials|antimalarials|mesh-ancestor
65041433|NCT00206739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65041434|NCT00206739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65041435|NCT00206739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65041436|NCT00206739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65041437|NCT00206739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041438|NCT00206739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041439|NCT00206739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65041440|NCT00206739|Renal Agents|renal agents|mesh-ancestor
65041441|NCT00206778|Lamotrigine|lamotrigine|mesh-list
65041442|NCT00206778|Valproic Acid|valproic acid|mesh-list
65041443|NCT00206778|Anticonvulsants|anticonvulsants|mesh-ancestor
65041444|NCT00206778|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65041445|NCT00206778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65041446|NCT00206778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041447|NCT00206778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65041448|NCT00206778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041449|NCT00206778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65041450|NCT00206778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65041451|NCT00206778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65041452|NCT00206778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65041453|NCT00206778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65041454|NCT00206778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041455|NCT00206778|GABA Agents|gaba agents|mesh-ancestor
65041456|NCT00206778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65041457|NCT00206778|Antimanic Agents|antimanic agents|mesh-ancestor
65041458|NCT00125801|Hydromorphone|hydromorphone|mesh-list
65041459|NCT00125801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65041460|NCT00125801|Narcotics|narcotics|mesh-ancestor
65041461|NCT00125801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65041462|NCT00125801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041463|NCT00125801|Analgesics|analgesics|mesh-ancestor
65041464|NCT00125801|Sensory System Agents|sensory system agents|mesh-ancestor
65041465|NCT00125801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65041466|NCT00125840|Clofarabine|clofarabine|mesh-list
65041467|NCT00125840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65041468|NCT00125840|Antimetabolites|antimetabolites|mesh-ancestor
65041469|NCT00125840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041470|NCT00125840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041471|NCT00224445|Ritonavir|ritonavir|mesh-list
65041496|NCT00194753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65041497|NCT00194753|Immunologic Factors|immunologic factors|mesh-ancestor
65041498|NCT00194753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041499|NCT00194753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64817245|NCT01495117|Chlorhexidine|chlorhexidine|mesh-list
65041500|NCT00194753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65041501|NCT00194753|Alkylating Agents|alkylating agents|mesh-ancestor
65041502|NCT00194753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65041503|NCT00194753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65041504|NCT00194753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65041505|NCT00194753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65041506|NCT00194753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041507|NCT00206856|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65041508|NCT00206856|Natriuretic Agents|natriuretic agents|mesh-ancestor
65041509|NCT00206856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041511|NCT00125918|Vasodilator Agents|vasodilator agents|mesh-ancestor
65041512|NCT00125918|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65041513|NCT00125918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65041514|NCT00125918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041515|NCT00125918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041516|NCT00125918|Urological Agents|urological agents|mesh-ancestor
65041517|NCT00224523|Mometasone Furoate|mometasone furoate|mesh-list
65041518|NCT00224523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65041519|NCT00224523|Dermatologic Agents|dermatologic agents|mesh-ancestor
65041541|NCT00206934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65041542|NCT00206934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65041543|NCT00206934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041545|NCT00206934|Serotonin Agents|serotonin agents|mesh-ancestor
65041546|NCT00206934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041547|NCT00206934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65041548|NCT00206934|Antidepressive Agents|antidepressive agents|mesh-ancestor
65041549|NCT00206934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65041550|NCT00206934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65041551|NCT00206934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65041552|NCT00206934|Parasympatholytics|parasympatholytics|mesh-ancestor
65041553|NCT00206934|Autonomic Agents|autonomic agents|mesh-ancestor
65041554|NCT00206934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65041555|NCT00206934|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65041556|NCT00206934|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65041557|NCT00206934|Cholinergic Agents|cholinergic agents|mesh-ancestor
65041558|NCT00194909|Sildenafil Citrate|sildenafil citrate|mesh-list
65041559|NCT00194909|Vasodilator Agents|vasodilator agents|mesh-ancestor
65041560|NCT00194909|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65041561|NCT00194909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65041562|NCT00194909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041563|NCT00194909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041564|NCT00194909|Urological Agents|urological agents|mesh-ancestor
65041565|NCT00224640|Iron Chelating Agents|iron chelating agents|mesh-list
65041566|NCT00224640|Chelating Agents|chelating agents|mesh-ancestor
65041567|NCT00224640|Sequestering Agents|sequestering agents|mesh-ancestor
65041568|NCT00224640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041569|NCT00194948|Citalopram|citalopram|mesh-list
65041570|NCT00194948|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65041571|NCT00194948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64893449|NCT01996306|Irinotecan|irinotecan|mesh-list
65041602|NCT00471445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65041603|NCT00471445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65041604|NCT00471445|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65041605|NCT00471445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65041606|NCT00471445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65041607|NCT00471445|Adrenergic Agents|adrenergic agents|mesh-ancestor
65041609|NCT00207051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65041610|NCT00207051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041611|NCT00402467|Enoxaparin|enoxaparin|mesh-list
65041612|NCT00402467|Rivaroxaban|rivaroxaban|mesh-list
65041613|NCT00402467|Enoxaparin sodium|enoxaparin sodium|mesh-list
64893517|NCT01996475|Dexetimide|dexetimide|mesh-list
65041628|NCT00224679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65041629|NCT00224679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041630|NCT00224679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65041631|NCT00224679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65041632|NCT00224679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65041633|NCT00224679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65041634|NCT00224679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041635|NCT00224679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65041636|NCT00224679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65041637|NCT00224679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041638|NCT00224679|Antipyretics|antipyretics|mesh-ancestor
64526887|NCT03295240|Alkylating Agents|alkylating agents|mesh-ancestor
65041639|NCT00402506|Pyridoxal|pyridoxal|mesh-list
65041640|NCT00402506|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
65041641|NCT00402506|Vitamin B Complex|vitamin b complex|mesh-ancestor
65041642|NCT00402506|Vitamins|vitamins|mesh-ancestor
65041643|NCT00402506|Micronutrients|micronutrients|mesh-ancestor
65041644|NCT00402506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041645|NCT00207129|Capecitabine|capecitabine|mesh-list
65041646|NCT00207129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65041647|NCT00207129|Antimetabolites|antimetabolites|mesh-ancestor
65041648|NCT00207129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041649|NCT00207129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041650|NCT00402545|Docetaxel|docetaxel|mesh-list
65041651|NCT00402545|Fluorouracil|fluorouracil|mesh-list
65041652|NCT00402545|Cetuximab|cetuximab|mesh-list
65041653|NCT00402545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041654|NCT00402545|Tubulin Modulators|tubulin modulators|mesh-ancestor
65041655|NCT00402545|Antimitotic Agents|antimitotic agents|mesh-ancestor
65041656|NCT00402545|Mitosis Modulators|mitosis modulators|mesh-ancestor
65041657|NCT00402545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041658|NCT00402545|Antimetabolites|antimetabolites|mesh-ancestor
65041659|NCT00402545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65041660|NCT00402545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65041661|NCT00402545|Immunologic Factors|immunologic factors|mesh-ancestor
65041662|NCT00402545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041663|NCT00402545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65041664|NCT00126074|Tedisamil|tedisamil|mesh-list
65041665|NCT00126074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65041666|NCT00126074|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65041667|NCT00126074|Protective Agents|protective agents|mesh-ancestor
65041668|NCT00126074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041669|NCT00195104|Cytarabine|cytarabine|mesh-list
65041670|NCT00195104|Arsenic Trioxide|arsenic trioxide|mesh-list
65041671|NCT00195104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65041672|NCT00195104|Antimetabolites|antimetabolites|mesh-ancestor
65041673|NCT00195104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041674|NCT00195104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041685|NCT00409760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65041686|NCT00409760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65041687|NCT00409760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041688|NCT00409760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65041689|NCT00409760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041690|NCT00409760|Vasodilator Agents|vasodilator agents|mesh-ancestor
65041691|NCT00409760|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65041692|NCT00409760|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65041693|NCT00413127|Lidocaine|lidocaine|mesh-list
65041694|NCT00413127|Anesthetics, Local|anesthetics, local|mesh-ancestor
65041695|NCT00413127|Anesthetics|anesthetics|mesh-ancestor
65041696|NCT00413127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65041697|NCT00413127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041698|NCT00413127|Sensory System Agents|sensory system agents|mesh-ancestor
65041699|NCT00413127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65041700|NCT00413127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65041701|NCT00413127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65041702|NCT00413127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65041703|NCT00413127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65041704|NCT00413127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041705|NCT00126230|Docetaxel|docetaxel|mesh-list
65041706|NCT00126230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041707|NCT00126230|Tubulin Modulators|tubulin modulators|mesh-ancestor
65041708|NCT00126230|Antimitotic Agents|antimitotic agents|mesh-ancestor
65041709|NCT00126230|Mitosis Modulators|mitosis modulators|mesh-ancestor
65041710|NCT00126230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041711|NCT00207363|Interferons|interferons|mesh-list
65041712|NCT00207363|Ribavirin|ribavirin|mesh-list
65041713|NCT00207363|Interferon-alpha|interferon-alpha|mesh-list
65041714|NCT00207363|Interferon alpha-2|interferon alpha-2|mesh-list
64483076|NCT00746512|Prednisone|prednisone|mesh-list
65041716|NCT00207363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041717|NCT00207363|Antiviral Agents|antiviral agents|mesh-ancestor
65041718|NCT00207363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65041719|NCT00207363|Antimetabolites|antimetabolites|mesh-ancestor
65041720|NCT00207363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041721|NCT00207363|Immunologic Factors|immunologic factors|mesh-ancestor
65248442|NCT00844207|Antinematodal Agents|antinematodal agents|mesh-ancestor
65041722|NCT00207363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041723|NCT00126269|Gemcitabine|gemcitabine|mesh-list
65041724|NCT00126269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041725|NCT00126269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65041726|NCT00126269|Antimetabolites|antimetabolites|mesh-ancestor
65041727|NCT00126269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041728|NCT00126269|Antiviral Agents|antiviral agents|mesh-ancestor
65041729|NCT00126269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65041730|NCT00126269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041731|NCT00126269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65041732|NCT00126269|Immunologic Factors|immunologic factors|mesh-ancestor
65041733|NCT00126269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041734|NCT00207402|Rosiglitazone|rosiglitazone|mesh-list
65041735|NCT00207402|Interferons|interferons|mesh-list
65041736|NCT00207402|Ribavirin|ribavirin|mesh-list
65041737|NCT00207402|Interferon alfacon-1|interferon alfacon-1|mesh-list
65041738|NCT00207402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041739|NCT00207402|Antiviral Agents|antiviral agents|mesh-ancestor
65041740|NCT00207402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64893603|NCT01997099|Diazepam|diazepam|mesh-list
65041760|NCT00471328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041761|NCT00471328|Growth Inhibitors|growth inhibitors|mesh-ancestor
65041762|NCT00471328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65041763|NCT00471328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041764|NCT00471328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041765|NCT00225030|Antihypertensive Agents|antihypertensive agents|mesh-list
65041766|NCT00126308|Mannitol|mannitol|mesh-list
65041767|NCT00126308|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65041768|NCT00126308|Diuretics|diuretics|mesh-ancestor
65041769|NCT00126308|Natriuretic Agents|natriuretic agents|mesh-ancestor
65041770|NCT00126308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041771|NCT00195377|Etanercept|etanercept|mesh-list
65041772|NCT00195377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65041773|NCT00195377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65041774|NCT00195377|Analgesics|analgesics|mesh-ancestor
65041775|NCT00195377|Sensory System Agents|sensory system agents|mesh-ancestor
65041776|NCT00195377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65041777|NCT00195377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041778|NCT00195377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65041779|NCT00195377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65041780|NCT00195377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65041781|NCT00195377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65041782|NCT00195377|Immunologic Factors|immunologic factors|mesh-ancestor
65041783|NCT00225108|Tinzaparin|tinzaparin|mesh-list
65041784|NCT00225108|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65041785|NCT00225108|Dalteparin|dalteparin|mesh-list
65041786|NCT00225108|Anticoagulants|anticoagulants|mesh-ancestor
65041787|NCT00225108|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65041788|NCT00225108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65041789|NCT00225108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041790|NCT00195416|Etanercept|etanercept|mesh-list
65041791|NCT00195416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65041792|NCT00195416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65041793|NCT00195416|Analgesics|analgesics|mesh-ancestor
65493879|NCT04138706|Vancomycin|vancomycin|mesh-list
65041794|NCT00195416|Sensory System Agents|sensory system agents|mesh-ancestor
65041795|NCT00195416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65041796|NCT00195416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041831|NCT00225264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65041832|NCT00225264|Immunologic Factors|immunologic factors|mesh-ancestor
65041833|NCT00126464|Tamoxifen|tamoxifen|mesh-list
65041834|NCT00126464|Fulvestrant|fulvestrant|mesh-list
65041835|NCT00126464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65041836|NCT00126464|Hormone Antagonists|hormone antagonists|mesh-ancestor
65041837|NCT00126464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65041838|NCT00126464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041839|NCT00126464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65041862|NCT00195572|Protective Agents|protective agents|mesh-ancestor
65041863|NCT00195572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041864|NCT00195572|Vitamin B Complex|vitamin b complex|mesh-ancestor
65041865|NCT00195572|Vitamins|vitamins|mesh-ancestor
65041866|NCT00195572|Micronutrients|micronutrients|mesh-ancestor
65041867|NCT00470704|Trastuzumab|trastuzumab|mesh-list
65041868|NCT00470704|Lapatinib|lapatinib|mesh-list
65041869|NCT00470704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65041870|NCT00470704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041871|NCT00470704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64817534|NCT01496742|Paclitaxel|paclitaxel|mesh-list
65041873|NCT00470704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041874|NCT00202280|Folic Acid|folic acid|mesh-list
65041875|NCT00202280|Vitamin B 12|vitamin b 12|mesh-list
65041876|NCT00202280|Hydroxocobalamin|hydroxocobalamin|mesh-list
65041877|NCT00202280|Vitamins|vitamins|mesh-ancestor
65041878|NCT00202280|Micronutrients|micronutrients|mesh-ancestor
65041879|NCT00202280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041880|NCT00202280|Hematinics|hematinics|mesh-ancestor
65041881|NCT00202280|Vitamin B Complex|vitamin b complex|mesh-ancestor
65041882|NCT00225303|Etravirine|etravirine|mesh-list
65041883|NCT00225303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65041884|NCT00225303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65041885|NCT00225303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041886|NCT00225303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041887|NCT00225303|Antiviral Agents|antiviral agents|mesh-ancestor
65041888|NCT00225303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65041889|NCT00225342|Rosiglitazone|rosiglitazone|mesh-list
65041890|NCT00225342|Gliclazide|gliclazide|mesh-list
65041891|NCT00225342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65041892|NCT00225342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041893|NCT00195611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65041894|NCT00195611|Immunologic Factors|immunologic factors|mesh-ancestor
65041895|NCT00195611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041918|NCT00225381|Anesthetics|anesthetics|mesh-list
65041919|NCT00225381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65041920|NCT00225381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041921|NCT00195728|Acetaminophen|acetaminophen|mesh-list
65041922|NCT00195728|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65041923|NCT00195728|Hydrocodone|hydrocodone|mesh-list
65041924|NCT00195728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65041925|NCT00195728|Analgesics|analgesics|mesh-ancestor
65041926|NCT00195728|Sensory System Agents|sensory system agents|mesh-ancestor
65041927|NCT00195728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65041928|NCT00195728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041929|NCT00195728|Antipyretics|antipyretics|mesh-ancestor
65041930|NCT00195728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65041931|NCT00195728|Narcotics|narcotics|mesh-ancestor
65041932|NCT00195728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65041933|NCT00195728|Antitussive Agents|antitussive agents|mesh-ancestor
65041934|NCT00195728|Respiratory System Agents|respiratory system agents|mesh-ancestor
65041935|NCT00195728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65041936|NCT00195728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65041937|NCT00195728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65041938|NCT00470158|Iron|iron|mesh-list
65041939|NCT00470158|Zinc|zinc|mesh-list
65041940|NCT00470158|Trace Elements|trace elements|mesh-ancestor
65041941|NCT00470158|Micronutrients|micronutrients|mesh-ancestor
65041942|NCT00470158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041943|NCT00472186|Lansoprazole|lansoprazole|mesh-list
65041944|NCT00472186|Dexlansoprazole|dexlansoprazole|mesh-list
65041945|NCT00472186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65041947|NCT00472186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65041948|NCT00472186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915842|NCT00085696|Rituximab|rituximab|mesh-list
65041949|NCT00472186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041968|NCT00202358|Sympatholytics|sympatholytics|mesh-ancestor
65041969|NCT00202358|Autonomic Agents|autonomic agents|mesh-ancestor
65041970|NCT00202358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65041971|NCT00202358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041972|NCT00202358|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65041973|NCT00202358|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65041974|NCT00202358|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65041975|NCT00202358|Adrenergic Agents|adrenergic agents|mesh-ancestor
65041976|NCT00202358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65041977|NCT00202358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041978|NCT00479713|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65041979|NCT00479713|Simvastatin|simvastatin|mesh-list
65041980|NCT00479713|Ezetimibe|ezetimibe|mesh-list
65041981|NCT00479713|Calcium|calcium|mesh-list
65041982|NCT00479713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65041983|NCT00479713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041984|NCT00479713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65041985|NCT00479713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65041986|NCT00479713|Antimetabolites|antimetabolites|mesh-ancestor
65041987|NCT00479713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557794|NCT05729646|Oxaliplatin|oxaliplatin|mesh-list
65041988|NCT00479713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65041989|NCT00479713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65041990|NCT00479713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041991|NCT00207753|Ivermectin|ivermectin|mesh-list
65041992|NCT00207753|Albendazole|albendazole|mesh-list
65041993|NCT00207753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65041994|NCT00207753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65041995|NCT00207753|Anthelmintics|anthelmintics|mesh-ancestor
65041996|NCT00207753|Anticestodal Agents|anticestodal agents|mesh-ancestor
65041997|NCT00207753|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65041998|NCT00207753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65041999|NCT00207753|Tubulin Modulators|tubulin modulators|mesh-ancestor
65042000|NCT00207753|Antimitotic Agents|antimitotic agents|mesh-ancestor
65042001|NCT00207753|Mitosis Modulators|mitosis modulators|mesh-ancestor
65042002|NCT00207753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042003|NCT00207753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65042004|NCT00202397|Riluzole|riluzole|mesh-list
65042005|NCT00202397|Anticonvulsants|anticonvulsants|mesh-ancestor
65042006|NCT00202397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65042007|NCT00202397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65042008|NCT00202397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64893883|NCT01998698|Lidocaine|lidocaine|mesh-list
65042025|NCT00207792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042026|NCT00195806|Valproic Acid|valproic acid|mesh-list
65042027|NCT00195806|Anticonvulsants|anticonvulsants|mesh-ancestor
65042028|NCT00195806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042029|NCT00195806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042030|NCT00195806|GABA Agents|gaba agents|mesh-ancestor
65042031|NCT00195806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042032|NCT00195806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042033|NCT00195806|Antimanic Agents|antimanic agents|mesh-ancestor
65042034|NCT00195806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65042035|NCT00195806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65042036|NCT00195806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65042037|NCT00477529|Docetaxel|docetaxel|mesh-list
65042038|NCT00477529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65042039|NCT00477529|Tubulin Modulators|tubulin modulators|mesh-ancestor
65042040|NCT00477529|Antimitotic Agents|antimitotic agents|mesh-ancestor
65042041|NCT00477529|Mitosis Modulators|mitosis modulators|mesh-ancestor
65042042|NCT00477529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042043|NCT00472693|Bevacizumab|bevacizumab|mesh-list
65042044|NCT00472693|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65042045|NCT00472693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65042046|NCT00472693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65042047|NCT00472693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65042048|NCT00472693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65042049|NCT00472693|Growth Substances|growth substances|mesh-ancestor
65042050|NCT00472693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042051|NCT00472693|Growth Inhibitors|growth inhibitors|mesh-ancestor
65042052|NCT00195845|Galantamine|galantamine|mesh-list
65042053|NCT00195845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65042054|NCT00195845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042055|NCT00195845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042056|NCT00195845|Cholinergic Agents|cholinergic agents|mesh-ancestor
65042057|NCT00195845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042058|NCT00195845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042059|NCT00195845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65042060|NCT00195845|Autonomic Agents|autonomic agents|mesh-ancestor
65042061|NCT00195845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65042062|NCT00195845|Nootropic Agents|nootropic agents|mesh-ancestor
65042063|NCT00202514|Valproic Acid|valproic acid|mesh-list
65042064|NCT00202514|Anticonvulsants|anticonvulsants|mesh-ancestor
65042065|NCT00202514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042089|NCT00195923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042090|NCT00225615|Verapamil|verapamil|mesh-list
65042091|NCT00225615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65042092|NCT00225615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65042093|NCT00225615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65042094|NCT00225615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042095|NCT00225615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65042096|NCT00225615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042097|NCT00225615|Vasodilator Agents|vasodilator agents|mesh-ancestor
65042099|NCT00202553|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65042100|NCT00202553|Protease Inhibitors|protease inhibitors|mesh-ancestor
65042101|NCT00202553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042102|NCT00202553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042103|NCT00202553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65042104|NCT00202592|Perindopril|perindopril|mesh-list
65042105|NCT00202592|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65042106|NCT00202592|Protease Inhibitors|protease inhibitors|mesh-ancestor
65042107|NCT00202592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042108|NCT00202592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042109|NCT00202592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65042110|NCT00411333|Triamcinolone|triamcinolone|mesh-list
65042111|NCT00411333|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65042112|NCT00411333|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65042113|NCT00411333|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65042114|NCT00411333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65042115|NCT00411333|Glucocorticoids|glucocorticoids|mesh-ancestor
65042116|NCT00411333|Hormones|hormones|mesh-ancestor
65042117|NCT00411333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65042132|NCT00225849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65042133|NCT00225849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65042134|NCT00225849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042135|NCT00225849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65042136|NCT00225849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65042137|NCT00225849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042138|NCT00225849|Antipyretics|antipyretics|mesh-ancestor
65042139|NCT00202787|Leucovorin|leucovorin|mesh-list
65042140|NCT00202787|Cetuximab|cetuximab|mesh-list
65042141|NCT00202787|Fluorouracil|fluorouracil|mesh-list
65042142|NCT00202787|Oxaliplatin|oxaliplatin|mesh-list
65042143|NCT00202787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65042144|NCT00202787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65042145|NCT00202787|Antimetabolites|antimetabolites|mesh-ancestor
65042146|NCT00202787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042147|NCT00202787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65042148|NCT00202787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65042149|NCT00202787|Immunologic Factors|immunologic factors|mesh-ancestor
65042150|NCT00202787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042151|NCT00202787|Antidotes|antidotes|mesh-ancestor
65042152|NCT00202787|Protective Agents|protective agents|mesh-ancestor
65042153|NCT00202787|Vitamin B Complex|vitamin b complex|mesh-ancestor
65042154|NCT00202787|Vitamins|vitamins|mesh-ancestor
65042155|NCT00202787|Micronutrients|micronutrients|mesh-ancestor
65042156|NCT00424437|Insulin|insulin|mesh-list
65042157|NCT00424437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65042158|NCT00424437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65042159|NCT00424437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042160|NCT00202865|Infliximab|infliximab|mesh-list
65042161|NCT00202865|Dermatologic Agents|dermatologic agents|mesh-ancestor
65042162|NCT00202865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65042163|NCT00202865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65042164|NCT00226005|Vatalanib|vatalanib|mesh-list
65042165|NCT00226005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65042166|NCT00226005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042167|NCT00226005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042168|NCT00196352|Levonorgestrel|levonorgestrel|mesh-list
65042169|NCT00196352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65042170|NCT00196352|Contraceptive Agents|contraceptive agents|mesh-ancestor
65042171|NCT00196352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65042172|NCT00196352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042173|NCT00196352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65042174|NCT00196352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65042175|NCT00196352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65042177|NCT00226044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65042178|NCT00226044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65042179|NCT00226044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65042187|NCT00202982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65042189|NCT00207948|Ritonavir|ritonavir|mesh-list
65042190|NCT00207948|Lopinavir|lopinavir|mesh-list
65042191|NCT00207948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65042192|NCT00207948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65042193|NCT00207948|Protease Inhibitors|protease inhibitors|mesh-ancestor
65042194|NCT00207948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042195|NCT00207948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042196|NCT00207948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65042197|NCT00207948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65042198|NCT00207948|Antiviral Agents|antiviral agents|mesh-ancestor
65042199|NCT00207948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65042200|NCT00207948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65042201|NCT00207948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65042202|NCT00196391|Progesterone|progesterone|mesh-list
65042203|NCT00196391|Progestins|progestins|mesh-ancestor
65042204|NCT00196391|Hormones|hormones|mesh-ancestor
65042205|NCT00196391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65042206|NCT00196391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042207|NCT00203060|Rasagiline|rasagiline|mesh-list
65042208|NCT00203060|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65042209|NCT00203060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042210|NCT00203060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042211|NCT00203060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65042212|NCT00203060|Protective Agents|protective agents|mesh-ancestor
65042213|NCT00203060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042214|NCT00226122|Indomethacin|indomethacin|mesh-list
65042215|NCT00226122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65042216|NCT00226122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65042217|NCT00226122|Analgesics|analgesics|mesh-ancestor
65042218|NCT00226122|Sensory System Agents|sensory system agents|mesh-ancestor
65042219|NCT00226122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65042220|NCT00226122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042221|NCT00226122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65042222|NCT00226122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65042223|NCT00226122|Gout Suppressants|gout suppressants|mesh-ancestor
65042224|NCT00226122|Tocolytic Agents|tocolytic agents|mesh-ancestor
65042225|NCT00226122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65042226|NCT00226122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65042227|NCT00226122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042228|NCT00226122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042229|NCT00196469|Heparin|heparin|mesh-list
65042230|NCT00196469|Anticoagulants|anticoagulants|mesh-ancestor
65042231|NCT00196469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65042232|NCT00196469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65042233|NCT00196469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042234|NCT00208065|Pseudoephedrine|pseudoephedrine|mesh-list
65042235|NCT00208065|Ephedrine|ephedrine|mesh-list
65042236|NCT00208065|Almotriptan|almotriptan|mesh-list
65042237|NCT00208065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65042238|NCT00208065|Autonomic Agents|autonomic agents|mesh-ancestor
65042239|NCT00208065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65042240|NCT00208065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042241|NCT00208065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65042242|NCT00208065|Respiratory System Agents|respiratory system agents|mesh-ancestor
65042243|NCT00208065|Nasal Decongestants|nasal decongestants|mesh-ancestor
65042244|NCT00208065|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65042245|NCT00208065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65042246|NCT00208065|Sympathomimetics|sympathomimetics|mesh-ancestor
65042247|NCT00208065|Adrenergic Agents|adrenergic agents|mesh-ancestor
65042248|NCT00208065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042276|NCT00203138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042277|NCT00203138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042278|NCT00203138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65042279|NCT00203138|Protective Agents|protective agents|mesh-ancestor
65042280|NCT00203138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042282|NCT00196547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65042283|NCT00196547|Respiratory System Agents|respiratory system agents|mesh-ancestor
65042284|NCT00196547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65042285|NCT00196547|Hormone Antagonists|hormone antagonists|mesh-ancestor
65042286|NCT00196547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65042287|NCT00196547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042288|NCT00196547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65042289|NCT00196547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65042290|NCT00196547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042291|NCT00203177|Rasagiline|rasagiline|mesh-list
65042292|NCT00203177|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65042293|NCT00203177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042294|NCT00203177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042295|NCT00203177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65042296|NCT00203177|Protective Agents|protective agents|mesh-ancestor
65042297|NCT00203177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042320|NCT00196586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65248443|NCT00844207|Anthelmintics|anthelmintics|mesh-ancestor
65042322|NCT00196586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042323|NCT00196586|Immunologic Factors|immunologic factors|mesh-ancestor
65042324|NCT00196586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042325|NCT00196586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65042327|NCT00196586|Sensory System Agents|sensory system agents|mesh-ancestor
65042328|NCT00196586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65042329|NCT00226317|Aripiprazole|aripiprazole|mesh-list
65042330|NCT00226317|Antidepressive Agents|antidepressive agents|mesh-ancestor
65042331|NCT00226317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65042332|NCT00226317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65042333|NCT00226317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65042334|NCT00226317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65042335|NCT00226317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042336|NCT00226317|Dopamine Agonists|dopamine agonists|mesh-ancestor
65042337|NCT00226317|Dopamine Agents|dopamine agents|mesh-ancestor
65042338|NCT00226317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042339|NCT00226317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042340|NCT00226317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65042341|NCT00226317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65042342|NCT00226317|Serotonin Agents|serotonin agents|mesh-ancestor
65042343|NCT00226317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65042344|NCT00226317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65042345|NCT00226317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65042346|NCT00226317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65042347|NCT00226356|Betaine|betaine|mesh-list
65042348|NCT00226356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65042349|NCT00226356|Lipotropic Agents|lipotropic agents|mesh-ancestor
65042350|NCT00226356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65042351|NCT00226356|Antimetabolites|antimetabolites|mesh-ancestor
65042352|NCT00226356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042353|NCT00226356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65042367|NCT00226395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65042368|NCT00226395|Narcotics|narcotics|mesh-ancestor
65042369|NCT00226395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65042370|NCT00226395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042371|NCT00226395|Analgesics|analgesics|mesh-ancestor
65042372|NCT00226395|Sensory System Agents|sensory system agents|mesh-ancestor
65042373|NCT00226395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65042374|NCT00226395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65042375|NCT00208221|Telmisartan|telmisartan|mesh-list
65042376|NCT00208221|Ramipril|ramipril|mesh-list
65042377|NCT00208221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65042378|NCT00208221|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65042379|NCT00208221|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65042380|NCT00208221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042381|NCT00208221|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65042382|NCT00208221|Protease Inhibitors|protease inhibitors|mesh-ancestor
65042383|NCT00208221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042384|NCT00196625|Ritonavir|ritonavir|mesh-list
65042385|NCT00196625|Amprenavir|amprenavir|mesh-list
65042386|NCT00196625|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65042387|NCT00196625|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65042388|NCT00196625|Protease Inhibitors|protease inhibitors|mesh-ancestor
65042389|NCT00196625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042390|NCT00196625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042391|NCT00196625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65042392|NCT00196625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65042393|NCT00196625|Antiviral Agents|antiviral agents|mesh-ancestor
65042394|NCT00196625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65042395|NCT00196625|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65042396|NCT00196625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65042397|NCT00196625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65042398|NCT00196625|Antitubercular Agents|antitubercular agents|mesh-ancestor
65042399|NCT00196625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65042400|NCT00226434|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65042401|NCT00226434|Antiviral Agents|antiviral agents|mesh-ancestor
65042402|NCT00226434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65042403|NCT00208260|Leucovorin|leucovorin|mesh-list
65042404|NCT00208260|Fluorouracil|fluorouracil|mesh-list
65042405|NCT00208260|Oxaliplatin|oxaliplatin|mesh-list
65042406|NCT00208260|Folfirinox|folfirinox|mesh-list
65042407|NCT00208260|Antimetabolites|antimetabolites|mesh-ancestor
65042408|NCT00208260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042409|NCT00208260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65042410|NCT00208260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65042411|NCT00208260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65042412|NCT00208260|Immunologic Factors|immunologic factors|mesh-ancestor
65042413|NCT00208260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042414|NCT00208260|Antidotes|antidotes|mesh-ancestor
65042415|NCT00208260|Protective Agents|protective agents|mesh-ancestor
64894283|NCT02001584|GABA Agents|gaba agents|mesh-ancestor
65042446|NCT00196664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65042447|NCT00196664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042448|NCT00196664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042449|NCT00196664|Serotonin Agents|serotonin agents|mesh-ancestor
65042450|NCT00196664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042451|NCT00196664|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65042452|NCT00196664|Antidepressive Agents|antidepressive agents|mesh-ancestor
65042453|NCT00196664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65042454|NCT00196664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65042455|NCT00196664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65042456|NCT00196664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042458|NCT00196703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64894337|NCT02001909|Neomycin|neomycin|mesh-list
65042482|NCT00413361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042483|NCT00413361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042484|NCT00413361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65042486|NCT00410657|Methylprednisolone|methylprednisolone|mesh-list
65042487|NCT00410657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65042488|NCT00410657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65042490|NCT00410657|Prednisolone acetate|prednisolone acetate|mesh-list
65042491|NCT00410657|Alemtuzumab|alemtuzumab|mesh-list
65042492|NCT00410657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65042493|NCT00410657|Prednisolone phosphate|prednisolone phosphate|mesh-list
65042494|NCT00410657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65042495|NCT00410657|Glucocorticoids|glucocorticoids|mesh-ancestor
65042496|NCT00410657|Hormones|hormones|mesh-ancestor
65042497|NCT00410657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65042498|NCT00410657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042499|NCT00410657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65042500|NCT00410657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65042501|NCT00410657|Antiemetics|antiemetics|mesh-ancestor
65042502|NCT00410657|Autonomic Agents|autonomic agents|mesh-ancestor
65042503|NCT00410657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65042504|NCT00410657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65042505|NCT00410657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65042506|NCT00410657|Protective Agents|protective agents|mesh-ancestor
65042507|NCT00410657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65042516|NCT00410696|Lenograstim|lenograstim|mesh-list
65042517|NCT00410696|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65042518|NCT00410696|Immunologic Factors|immunologic factors|mesh-ancestor
65042519|NCT00410696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042520|NCT00226512|Alemtuzumab|alemtuzumab|mesh-list
65042521|NCT00226512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65042522|NCT00226512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65042523|NCT00410735|Pranlukast|pranlukast|mesh-list
65042524|NCT00410735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65042525|NCT00410735|Respiratory System Agents|respiratory system agents|mesh-ancestor
65042526|NCT00410735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65042527|NCT00410735|Hormone Antagonists|hormone antagonists|mesh-ancestor
64527790|NCT05676216|Sensory System Agents|sensory system agents|mesh-ancestor
64527791|NCT05676216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64527792|NCT05676216|Antiemetics|antiemetics|mesh-ancestor
64527793|NCT05676216|Autonomic Agents|autonomic agents|mesh-ancestor
64527794|NCT05676216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64527795|NCT05676216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64527796|NCT05676216|Histamine Antagonists|histamine antagonists|mesh-ancestor
64527797|NCT05676216|Histamine Agents|histamine agents|mesh-ancestor
64527798|NCT05676216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64527799|NCT05676216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527800|NCT05676216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64527801|NCT05676216|Antipruritics|antipruritics|mesh-ancestor
64527802|NCT05676216|Dermatologic Agents|dermatologic agents|mesh-ancestor
64527803|NCT03163914|Phenylephrine|phenylephrine|mesh-list
64527804|NCT03163914|Epinephrine|epinephrine|mesh-list
64527805|NCT03163914|Oxymetazoline|oxymetazoline|mesh-list
65042528|NCT00410735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65042529|NCT00410735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042530|NCT00203372|Cyclophosphamide|cyclophosphamide|mesh-list
65042531|NCT00203372|Bevacizumab|bevacizumab|mesh-list
65042532|NCT00203372|Docetaxel|docetaxel|mesh-list
65042533|NCT00203372|Doxorubicin|doxorubicin|mesh-list
65493881|NCT04138706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65042534|NCT00203372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65042535|NCT00203372|Immunologic Factors|immunologic factors|mesh-ancestor
65042536|NCT00203372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042537|NCT00203372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65042538|NCT00203372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65042539|NCT00203372|Alkylating Agents|alkylating agents|mesh-ancestor
65042540|NCT00203372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042541|NCT00203372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65042542|NCT00203372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65042543|NCT00203372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65042544|NCT00203372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65042545|NCT00203372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65042546|NCT00203372|Growth Substances|growth substances|mesh-ancestor
65042547|NCT00203372|Growth Inhibitors|growth inhibitors|mesh-ancestor
65042548|NCT00203372|Tubulin Modulators|tubulin modulators|mesh-ancestor
65042549|NCT00203372|Antimitotic Agents|antimitotic agents|mesh-ancestor
65042550|NCT00203372|Mitosis Modulators|mitosis modulators|mesh-ancestor
65042551|NCT00203372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65042552|NCT00203372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65042553|NCT00203372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65042554|NCT00203372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042555|NCT00226551|Isoproterenol|isoproterenol|mesh-list
65042556|NCT00226551|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65042557|NCT00226551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65042558|NCT00226551|Adrenergic Agents|adrenergic agents|mesh-ancestor
65042575|NCT00196859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65042576|NCT00196859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65042577|NCT00196859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042578|NCT00208533|Aripiprazole|aripiprazole|mesh-list
65042579|NCT00208533|Antidepressive Agents|antidepressive agents|mesh-ancestor
65042580|NCT00208533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65042581|NCT00208533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65042582|NCT00208533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65042583|NCT00208533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65042584|NCT00208533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042585|NCT00208533|Dopamine Agonists|dopamine agonists|mesh-ancestor
65042586|NCT00208533|Dopamine Agents|dopamine agents|mesh-ancestor
65042587|NCT00208533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042588|NCT00208533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042589|NCT00208533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65042590|NCT00208533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65042591|NCT00208533|Serotonin Agents|serotonin agents|mesh-ancestor
65042592|NCT00208533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65042593|NCT00208533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65042594|NCT00208533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65042595|NCT00208533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65042596|NCT00203450|Zonisamide|zonisamide|mesh-list
65042597|NCT00203450|Anticonvulsants|anticonvulsants|mesh-ancestor
65042598|NCT00203450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65042599|NCT00203450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65042600|NCT00203450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042601|NCT00203450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65042602|NCT00203450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042603|NCT00226668|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
65042605|NCT00226668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65042606|NCT00226668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042607|NCT00208572|Citalopram|citalopram|mesh-list
65042608|NCT00208572|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65042609|NCT00208572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65042610|NCT00208572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65042611|NCT00208572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042612|NCT00208572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042613|NCT00208572|Serotonin Agents|serotonin agents|mesh-ancestor
65042614|NCT00208572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042632|NCT00226707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042633|NCT00203528|Valproic Acid|valproic acid|mesh-list
65042634|NCT00203528|Risperidone|risperidone|mesh-list
65042635|NCT00203528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65042636|NCT00203528|Serotonin Agents|serotonin agents|mesh-ancestor
64818237|NCT01500928|Insulin|insulin|mesh-list
65042637|NCT00203528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042638|NCT00203528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042639|NCT00203528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042640|NCT00203528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65042641|NCT00203528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65042642|NCT00203528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65042643|NCT00203528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65042644|NCT00203528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65042645|NCT00203528|Dopamine Agents|dopamine agents|mesh-ancestor
65042646|NCT00203528|Anticonvulsants|anticonvulsants|mesh-ancestor
65042647|NCT00203528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042648|NCT00203528|GABA Agents|gaba agents|mesh-ancestor
65042649|NCT00203528|Antimanic Agents|antimanic agents|mesh-ancestor
65042650|NCT00208611|Vitamins|vitamins|mesh-list
65042651|NCT00208611|Vitamin B 12|vitamin b 12|mesh-list
65042652|NCT00208611|Hydroxocobalamin|hydroxocobalamin|mesh-list
65042653|NCT00208611|Vitamin B Complex|vitamin b complex|mesh-list
65042654|NCT00208611|Micronutrients|micronutrients|mesh-ancestor
65042655|NCT00208611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042656|NCT00208611|Hematinics|hematinics|mesh-ancestor
65042657|NCT00203567|Carbamazepine|carbamazepine|mesh-list
65042658|NCT00203567|Anticonvulsants|anticonvulsants|mesh-ancestor
65042659|NCT00203567|Antimanic Agents|antimanic agents|mesh-ancestor
65042660|NCT00203567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65042661|NCT00203567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65042662|NCT00203567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042663|NCT00203567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64527940|NCT03162588|Hematinics|hematinics|mesh-ancestor
64527941|NCT03320070|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64527942|NCT03320070|Hormones|hormones|mesh-ancestor
64527943|NCT03320070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64527944|NCT03320070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527945|NCT03306264|Decitabine|decitabine|mesh-list
64527946|NCT03306264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64527947|NCT03306264|Antimetabolites|antimetabolites|mesh-ancestor
64527948|NCT03306264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894558|NCT02002715|Hormones|hormones|mesh-ancestor
65042688|NCT00226746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042689|NCT00203606|Interferons|interferons|mesh-list
65042691|NCT00203606|Interferon-alpha|interferon-alpha|mesh-list
65042692|NCT00203606|Interferon alpha-2|interferon alpha-2|mesh-list
65042693|NCT00203606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65042694|NCT00203606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65042695|NCT00203606|Antiviral Agents|antiviral agents|mesh-ancestor
65042696|NCT00203606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65042697|NCT00203606|Antimetabolites|antimetabolites|mesh-ancestor
65042698|NCT00203606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042699|NCT00203606|Immunologic Factors|immunologic factors|mesh-ancestor
65042700|NCT00203606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042701|NCT00203684|Flunisolide|flunisolide|mesh-list
65042702|NCT00203684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65042723|NCT00226824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65042724|NCT00226824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042725|NCT00226824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042726|NCT00226824|Cholinergic Agents|cholinergic agents|mesh-ancestor
65042727|NCT00226824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042728|NCT00226824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042729|NCT00226824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65042730|NCT00226824|Autonomic Agents|autonomic agents|mesh-ancestor
65042731|NCT00226824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65042732|NCT00226824|Nootropic Agents|nootropic agents|mesh-ancestor
65042733|NCT00197249|Vaccines|vaccines|mesh-list
65042734|NCT00197249|Immunologic Factors|immunologic factors|mesh-ancestor
65042735|NCT00197249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042736|NCT00203723|Risperidone|risperidone|mesh-list
65042737|NCT00203723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64528017|NCT02135874|Autonomic Agents|autonomic agents|mesh-ancestor
65042739|NCT00203723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042740|NCT00203723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916671|NCT00091312|Leucovorin|leucovorin|mesh-list
65493883|NCT04064060|Hematinics|hematinics|mesh-ancestor
65042741|NCT00203723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042742|NCT00203723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65042743|NCT00203723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65042744|NCT00203723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65042745|NCT00203723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65042746|NCT00203723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65042747|NCT00203723|Dopamine Agents|dopamine agents|mesh-ancestor
65042748|NCT00226902|Chrysarobin|chrysarobin|mesh-list
65042749|NCT00226902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65042750|NCT00226902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65042751|NCT00226902|Analgesics|analgesics|mesh-ancestor
65042752|NCT00226902|Sensory System Agents|sensory system agents|mesh-ancestor
65042753|NCT00226902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65042754|NCT00226902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042770|NCT00226980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65042771|NCT00226980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65042772|NCT00226980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65042773|NCT00226980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65042774|NCT00226980|Growth Substances|growth substances|mesh-ancestor
65042775|NCT00226980|Growth Inhibitors|growth inhibitors|mesh-ancestor
65042776|NCT00203801|Artesunate|artesunate|mesh-list
65042777|NCT00203801|Lumefantrine|lumefantrine|mesh-list
65042778|NCT00203801|Artemether|artemether|mesh-list
65042779|NCT00203801|Pyrimethamine|pyrimethamine|mesh-list
65042780|NCT00203801|Sulfadoxine|sulfadoxine|mesh-list
65042781|NCT00203801|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65042782|NCT00203801|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65042783|NCT00203801|Antimalarials|antimalarials|mesh-ancestor
65042784|NCT00203801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65042785|NCT00203801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65042786|NCT00203801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65042787|NCT00203801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65042788|NCT00203801|Antiviral Agents|antiviral agents|mesh-ancestor
65042789|NCT00203801|Schistosomicides|schistosomicides|mesh-ancestor
65042790|NCT00203801|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65042791|NCT00203801|Anthelmintics|anthelmintics|mesh-ancestor
65042792|NCT00203801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65042793|NCT00203801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042794|NCT00203801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042795|NCT00203801|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65042796|NCT00203801|Renal Agents|renal agents|mesh-ancestor
65042797|NCT00197327|Bupivacaine|bupivacaine|mesh-list
65042798|NCT00197327|Anesthetics, Local|anesthetics, local|mesh-ancestor
65042799|NCT00197327|Anesthetics|anesthetics|mesh-ancestor
65042800|NCT00197327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65042801|NCT00197327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042802|NCT00197327|Sensory System Agents|sensory system agents|mesh-ancestor
65042803|NCT00197327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65042804|NCT00227097|Anticoagulants|anticoagulants|mesh-list
65042805|NCT00208923|Cyclophosphamide|cyclophosphamide|mesh-list
65042806|NCT00208923|Busulfan|busulfan|mesh-list
65042807|NCT00208923|Fludarabine|fludarabine|mesh-list
65042808|NCT00208923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65042809|NCT00208923|Immunologic Factors|immunologic factors|mesh-ancestor
65042810|NCT00208923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042811|NCT00208923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65042812|NCT00208923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65042813|NCT00208923|Alkylating Agents|alkylating agents|mesh-ancestor
65042814|NCT00208923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042815|NCT00208923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493884|NCT04002934|Bazedoxifene|bazedoxifene|mesh-list
65042833|NCT00204074|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65042834|NCT00204074|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65042836|NCT00204074|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65042837|NCT00204074|Estrogens|estrogens|mesh-ancestor
65042838|NCT00204074|Hormones|hormones|mesh-ancestor
65042839|NCT00204074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65042840|NCT00204074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042841|NCT00204074|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65042842|NCT00204074|Contraceptive Agents|contraceptive agents|mesh-ancestor
65042843|NCT00204074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65042844|NCT00204074|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65042845|NCT00227292|Citalopram|citalopram|mesh-list
65042846|NCT00227292|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65042847|NCT00227292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65042848|NCT00227292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65042849|NCT00227292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042850|NCT00227292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042851|NCT00227292|Serotonin Agents|serotonin agents|mesh-ancestor
65042852|NCT00227292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248444|NCT02841722|Lenograstim|lenograstim|mesh-list
65042853|NCT00227292|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65042854|NCT00227292|Antidepressive Agents|antidepressive agents|mesh-ancestor
65042855|NCT00227292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65042856|NCT00197483|Pergolide|pergolide|mesh-list
65042857|NCT00197483|Dopamine Agonists|dopamine agonists|mesh-ancestor
65042858|NCT00197483|Dopamine Agents|dopamine agents|mesh-ancestor
65042859|NCT00197483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042860|NCT00197483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042861|NCT00197483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042862|NCT00230529|Infliximab|infliximab|mesh-list
65042863|NCT00230529|Dermatologic Agents|dermatologic agents|mesh-ancestor
65042864|NCT00230529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65042865|NCT00230529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65042866|NCT00230568|Donepezil|donepezil|mesh-list
65042867|NCT00230568|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65042868|NCT00230568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042869|NCT00230568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042870|NCT00230568|Cholinergic Agents|cholinergic agents|mesh-ancestor
65042871|NCT00230568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042872|NCT00230568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042873|NCT00230568|Nootropic Agents|nootropic agents|mesh-ancestor
65042874|NCT00227331|Amoxicillin|amoxicillin|mesh-list
65042884|NCT00227409|Edetic Acid|edetic acid|mesh-list
65042885|NCT00227409|Calcium|calcium|mesh-list
65042886|NCT00227409|Pentetic Acid|pentetic acid|mesh-list
65042887|NCT00227409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65042888|NCT00227409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042889|NCT00227409|Anticoagulants|anticoagulants|mesh-ancestor
65042890|NCT00227409|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65042891|NCT00227409|Chelating Agents|chelating agents|mesh-ancestor
65042892|NCT00227409|Sequestering Agents|sequestering agents|mesh-ancestor
65042893|NCT00227409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042895|NCT00227409|Protective Agents|protective agents|mesh-ancestor
65042896|NCT00227409|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65042897|NCT00197639|Ritonavir|ritonavir|mesh-list
65042898|NCT00197639|Indinavir|indinavir|mesh-list
65042899|NCT00197639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65042900|NCT00197639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65042901|NCT00197639|Protease Inhibitors|protease inhibitors|mesh-ancestor
65042902|NCT00197639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042903|NCT00197639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042904|NCT00197639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65042905|NCT00197639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65042906|NCT00197639|Antiviral Agents|antiviral agents|mesh-ancestor
65042907|NCT00197639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65042908|NCT00197639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65042909|NCT00197639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65042910|NCT00227448|Phenylephrine|phenylephrine|mesh-list
65042911|NCT00227448|Oxymetazoline|oxymetazoline|mesh-list
65042912|NCT00227448|Midodrine|midodrine|mesh-list
65042913|NCT00227448|Norepinephrine|norepinephrine|mesh-list
65042914|NCT00227448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65042915|NCT00227448|Mydriatics|mydriatics|mesh-ancestor
65042916|NCT00227448|Autonomic Agents|autonomic agents|mesh-ancestor
65042917|NCT00227448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65042918|NCT00227448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042919|NCT00227448|Sympathomimetics|sympathomimetics|mesh-ancestor
65042920|NCT00227448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65042921|NCT00227448|Nasal Decongestants|nasal decongestants|mesh-ancestor
65042922|NCT00227448|Respiratory System Agents|respiratory system agents|mesh-ancestor
65042923|NCT00227448|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65042924|NCT00227448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65042925|NCT00227448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65042926|NCT00227448|Adrenergic Agents|adrenergic agents|mesh-ancestor
65042927|NCT00227448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042928|NCT00227448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042929|NCT00227448|Protective Agents|protective agents|mesh-ancestor
65042930|NCT00204191|Tacrolimus|tacrolimus|mesh-list
65042931|NCT00204191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65042932|NCT00204191|Immunologic Factors|immunologic factors|mesh-ancestor
65042933|NCT00204191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042934|NCT00204191|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65042935|NCT00204191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042936|NCT00204191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042937|NCT00204230|Mycophenolic Acid|mycophenolic acid|mesh-list
65042938|NCT00204230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65042939|NCT00204230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65042940|NCT00204230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65042941|NCT00204230|Antitubercular Agents|antitubercular agents|mesh-ancestor
65042942|NCT00204230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64894832|NCT02005120|Bevacizumab|bevacizumab|mesh-list
65042964|NCT00227565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042965|NCT00227565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042966|NCT00227565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65042967|NCT00227565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65042969|NCT00204308|Emtricitabine|emtricitabine|mesh-list
65042970|NCT00204308|Antiviral Agents|antiviral agents|mesh-ancestor
65042971|NCT00204308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65042972|NCT00204308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65042973|NCT00204308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65042974|NCT00204308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042975|NCT00204308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042976|NCT00204308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65042977|NCT00204308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65042978|NCT00204347|Risperidone|risperidone|mesh-list
65042979|NCT00204347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65042980|NCT00204347|Serotonin Agents|serotonin agents|mesh-ancestor
65042981|NCT00204347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042982|NCT00204347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042983|NCT00204347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042984|NCT00204347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65042985|NCT00204347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65042986|NCT00204347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65042987|NCT00204347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65042988|NCT00204347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65042989|NCT00204347|Dopamine Agents|dopamine agents|mesh-ancestor
65042990|NCT00227682|Ascorbic Acid|ascorbic acid|mesh-list
65042991|NCT00227682|Thalidomide|thalidomide|mesh-list
65042992|NCT00227682|Dexamethasone|dexamethasone|mesh-list
65042993|NCT00227682|Arsenic Trioxide|arsenic trioxide|mesh-list
65042994|NCT00227682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65042995|NCT00227682|Antiemetics|antiemetics|mesh-ancestor
65042996|NCT00227682|Autonomic Agents|autonomic agents|mesh-ancestor
65042997|NCT00227682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65043022|NCT00230763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65043023|NCT00230763|Adrenergic Agents|adrenergic agents|mesh-ancestor
65043024|NCT00230763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65043025|NCT00230763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043026|NCT00230763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043027|NCT00230763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65043028|NCT00230763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65043029|NCT00230763|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65043030|NCT00230763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65043032|NCT00204386|Anticonvulsants|anticonvulsants|mesh-ancestor
65043033|NCT00204386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65043034|NCT00204386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043035|NCT04721964|Ferrous fumarate|ferrous fumarate|mesh-list
65043036|NCT04721964|Trace Elements|trace elements|mesh-ancestor
65043037|NCT04721964|Micronutrients|micronutrients|mesh-ancestor
65043038|NCT04721964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043039|NCT00197834|Valproic Acid|valproic acid|mesh-list
65043040|NCT00197834|Anticonvulsants|anticonvulsants|mesh-ancestor
65043041|NCT00197834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043042|NCT00197834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043044|NCT00197834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65043045|NCT00197834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043046|NCT00197834|Antimanic Agents|antimanic agents|mesh-ancestor
65043047|NCT00197834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65043048|NCT00197834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65043049|NCT00197834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65043074|NCT02962323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043075|NCT02962323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65043077|NCT02962323|Antimetabolites|antimetabolites|mesh-ancestor
65043078|NCT02962323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043079|NCT02962323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65043080|NCT02962323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65043081|NCT02962323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043082|NCT00204503|Valproic Acid|valproic acid|mesh-list
65043083|NCT00204503|Anticonvulsants|anticonvulsants|mesh-ancestor
65043084|NCT00204503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043085|NCT00204503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558531|NCT03019809|Plerixafor|plerixafor|mesh-list
65043086|NCT00204503|GABA Agents|gaba agents|mesh-ancestor
65043087|NCT00204503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65043088|NCT00204503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043089|NCT00204503|Antimanic Agents|antimanic agents|mesh-ancestor
65043090|NCT00204503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65043091|NCT00204503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65043092|NCT00204503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65043093|NCT00204542|Diclofenac|diclofenac|mesh-list
65043094|NCT00204542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65043095|NCT00204542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65043096|NCT00204542|Analgesics|analgesics|mesh-ancestor
65043097|NCT00204542|Sensory System Agents|sensory system agents|mesh-ancestor
65043098|NCT00204542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65043117|NCT00230958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043119|NCT00227955|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65043120|NCT00227955|Antidepressive Agents|antidepressive agents|mesh-ancestor
65043121|NCT00227955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65043122|NCT00227955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65043123|NCT00227955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65043124|NCT00227955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65043125|NCT00227955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043126|NCT00227955|Adrenergic Agents|adrenergic agents|mesh-ancestor
65043127|NCT00227955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65043128|NCT00227955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043129|NCT00228033|Calcium Carbonate|calcium carbonate|mesh-list
65043130|NCT00228033|Calcium|calcium|mesh-list
65043131|NCT00228033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65043132|NCT00228033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043133|NCT00228033|Antacids|antacids|mesh-ancestor
65043134|NCT00228033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043135|NCT00228033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65043136|NCT00230997|Galantamine|galantamine|mesh-list
65043137|NCT00230997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65043138|NCT00230997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043139|NCT00230997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043140|NCT00230997|Cholinergic Agents|cholinergic agents|mesh-ancestor
65043141|NCT00230997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65043142|NCT00230997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043143|NCT00230997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65043144|NCT00230997|Autonomic Agents|autonomic agents|mesh-ancestor
65043145|NCT00230997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65043146|NCT00230997|Nootropic Agents|nootropic agents|mesh-ancestor
65043147|NCT00204581|Aldesleukin|aldesleukin|mesh-list
65043148|NCT00204581|Interleukin-2|interleukin-2|mesh-list
65043149|NCT00204581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043150|NCT00204581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65043151|NCT00204581|Analgesics|analgesics|mesh-ancestor
65043152|NCT00204581|Sensory System Agents|sensory system agents|mesh-ancestor
65043153|NCT00204581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65043181|NCT02962518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043183|NCT00204659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65043184|NCT00204659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043185|NCT00204659|Immunologic Factors|immunologic factors|mesh-ancestor
65043186|NCT00204659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043187|NCT00204659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65043188|NCT00231192|Repaglinide|repaglinide|mesh-list
65043189|NCT00231192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65043190|NCT00231192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043191|NCT00204698|Rabeprazole|rabeprazole|mesh-list
65043192|NCT00204698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65043193|NCT00204698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65043194|NCT00204698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65043195|NCT00204698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043196|NCT00204698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043198|NCT00204737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65043199|NCT00204737|Glucocorticoids|glucocorticoids|mesh-ancestor
65043200|NCT00204737|Hormones|hormones|mesh-ancestor
64895104|NCT02007148|Antimetabolites|antimetabolites|mesh-ancestor
65043228|NCT00231348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65043229|NCT00231348|Serotonin Agents|serotonin agents|mesh-ancestor
65043230|NCT00231387|Rosiglitazone|rosiglitazone|mesh-list
65043231|NCT00231387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65043232|NCT00231387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043233|NCT00198536|Ecabet|ecabet|mesh-list
65043234|NCT00198536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65043235|NCT00198536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65043236|NCT00198536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65043237|NCT00198536|Protease Inhibitors|protease inhibitors|mesh-ancestor
65043238|NCT00198536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043239|NCT00198536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043240|NCT00198536|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65043241|NCT00198536|Protective Agents|protective agents|mesh-ancestor
65043242|NCT00198536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043243|NCT00198536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043254|NCT00410033|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65043255|NCT00410033|Insulin Aspart|insulin aspart|mesh-list
65043256|NCT00410033|Isophane Insulin, Human|isophane insulin, human|mesh-list
65043257|NCT00410033|Insulin, Isophane|insulin, isophane|mesh-list
65043258|NCT00410033|Isophane insulin, beef|isophane insulin, beef|mesh-list
65043259|NCT00410033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65043260|NCT00410033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043261|NCT00228462|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65043262|NCT00228462|Antidepressive Agents|antidepressive agents|mesh-ancestor
65043263|NCT00228462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65043264|NCT00228462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64528539|NCT01664910|Tacrolimus|tacrolimus|mesh-list
65043265|NCT00228462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65043266|NCT00228462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65043267|NCT00228462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043268|NCT00198614|Metoprolol|metoprolol|mesh-list
65043269|NCT00198614|Carvedilol|carvedilol|mesh-list
65043270|NCT00198614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65043271|NCT00198614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65043272|NCT00198614|Sympatholytics|sympatholytics|mesh-ancestor
65043273|NCT00198614|Autonomic Agents|autonomic agents|mesh-ancestor
65043274|NCT00198614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65043275|NCT00198614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043276|NCT00198614|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65043277|NCT00198614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65043278|NCT00198614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65043279|NCT00198614|Adrenergic Agents|adrenergic agents|mesh-ancestor
65043280|NCT00198614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65043281|NCT00198614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043282|NCT00198614|Antioxidants|antioxidants|mesh-ancestor
65043283|NCT00198614|Protective Agents|protective agents|mesh-ancestor
65043284|NCT00198614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65043285|NCT00198614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65043286|NCT00198614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65043287|NCT00198614|Vasodilator Agents|vasodilator agents|mesh-ancestor
65043288|NCT00198614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65043289|NCT00198614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65043290|NCT00231582|Paclitaxel|paclitaxel|mesh-list
65043291|NCT00231582|Etoposide|etoposide|mesh-list
65043292|NCT00231582|Carboplatin|carboplatin|mesh-list
65043293|NCT00231582|Epirubicin|epirubicin|mesh-list
65043294|NCT00231582|Ifosfamide|ifosfamide|mesh-list
65043295|NCT00231582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65043296|NCT00231582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043297|NCT00231582|Tubulin Modulators|tubulin modulators|mesh-ancestor
65043298|NCT00231582|Antimitotic Agents|antimitotic agents|mesh-ancestor
65043299|NCT00231582|Mitosis Modulators|mitosis modulators|mesh-ancestor
65043300|NCT00231582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043301|NCT00231582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65043302|NCT00231582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65043303|NCT00231582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043304|NCT00231582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65043305|NCT00231582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65043306|NCT00231582|Alkylating Agents|alkylating agents|mesh-ancestor
65043307|NCT02963324|Ivermectin|ivermectin|mesh-list
65043308|NCT02963324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64895197|NCT02007837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043332|NCT00198848|Folic Acid|folic acid|mesh-list
65043333|NCT00198848|Hematinics|hematinics|mesh-ancestor
65043334|NCT00198848|Vitamin B Complex|vitamin b complex|mesh-ancestor
65043335|NCT00198848|Vitamins|vitamins|mesh-ancestor
65043336|NCT00198848|Micronutrients|micronutrients|mesh-ancestor
65043337|NCT00198848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043338|NCT00478426|Sunitinib|sunitinib|mesh-list
65043339|NCT00478426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043340|NCT00478426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65043341|NCT00478426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65043342|NCT00478426|Growth Substances|growth substances|mesh-ancestor
65043343|NCT00478426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043344|NCT00478426|Growth Inhibitors|growth inhibitors|mesh-ancestor
65043345|NCT00478426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65043346|NCT00478426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043347|NCT00478426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043349|NCT00231855|Topotecan|topotecan|mesh-list
65043350|NCT00231855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043351|NCT00231855|Tubulin Modulators|tubulin modulators|mesh-ancestor
65043352|NCT00231855|Antimitotic Agents|antimitotic agents|mesh-ancestor
65043353|NCT00231855|Mitosis Modulators|mitosis modulators|mesh-ancestor
65043354|NCT00231855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043355|NCT00231855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65043356|NCT00231855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65043357|NCT00231855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043358|NCT00199004|Cytarabine|cytarabine|mesh-list
65043359|NCT00199004|Dexamethasone|dexamethasone|mesh-list
65043360|NCT00199004|Prednisolone|prednisolone|mesh-list
64895261|NCT02008123|Primidone|primidone|mesh-list
65043373|NCT00199004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043375|NCT00199004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65043376|NCT00199004|Alkylating Agents|alkylating agents|mesh-ancestor
65043377|NCT00199004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043378|NCT00199004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043379|NCT00199004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65043380|NCT00199004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65043381|NCT00199004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65043382|NCT00199004|Antiemetics|antiemetics|mesh-ancestor
65043383|NCT00199004|Autonomic Agents|autonomic agents|mesh-ancestor
65043384|NCT00199004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65043385|NCT00199004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65043386|NCT00199004|Glucocorticoids|glucocorticoids|mesh-ancestor
65043387|NCT00199004|Hormones|hormones|mesh-ancestor
65043388|NCT00199004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65043389|NCT00199004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65043390|NCT00199004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65043391|NCT00199004|Abortifacient Agents|abortifacient agents|mesh-ancestor
65043392|NCT00199004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65043393|NCT00199004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65043394|NCT00199004|Antimetabolites|antimetabolites|mesh-ancestor
65043395|NCT00199004|Dermatologic Agents|dermatologic agents|mesh-ancestor
65043396|NCT00199004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043397|NCT00199004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65043398|NCT00199004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65043399|NCT00199004|Antiviral Agents|antiviral agents|mesh-ancestor
65043400|NCT00199004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65043401|NCT00199004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65043402|NCT00199004|Tubulin Modulators|tubulin modulators|mesh-ancestor
65043403|NCT00199004|Antimitotic Agents|antimitotic agents|mesh-ancestor
65043404|NCT00199004|Mitosis Modulators|mitosis modulators|mesh-ancestor
65043405|NCT00199004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65043406|NCT00199004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65043407|NCT00199004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65043408|NCT00228852|Fludarabine|fludarabine|mesh-list
65043409|NCT00228852|Busulfan|busulfan|mesh-list
65043410|NCT00228852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043411|NCT00228852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043412|NCT00228852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65043413|NCT00228852|Immunologic Factors|immunologic factors|mesh-ancestor
65043414|NCT00228852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043415|NCT00228852|Alkylating Agents|alkylating agents|mesh-ancestor
65043416|NCT00228852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64484800|NCT01968707|Ethanol|ethanol|mesh-list
65043417|NCT00228852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65043418|NCT00204776|Capecitabine|capecitabine|mesh-list
65043419|NCT00204776|Oxaliplatin|oxaliplatin|mesh-list
65043420|NCT00204776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65043421|NCT00204776|Antimetabolites|antimetabolites|mesh-ancestor
65043422|NCT00204776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043423|NCT00204776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043425|NCT00228891|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65043426|NCT00228891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65043454|NCT00477412|Antiemetics|antiemetics|mesh-ancestor
65043455|NCT00477412|Autonomic Agents|autonomic agents|mesh-ancestor
65043456|NCT00477412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65043457|NCT00477412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65043458|NCT00477412|Glucocorticoids|glucocorticoids|mesh-ancestor
65043459|NCT00477412|Hormones|hormones|mesh-ancestor
65043460|NCT00477412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65043461|NCT00477412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65043462|NCT00477412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65043463|NCT00477412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65043464|NCT00477412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65043465|NCT00477412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043466|NCT00477412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65043467|NCT00477412|Abortifacient Agents|abortifacient agents|mesh-ancestor
65043468|NCT00477412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65043469|NCT00477412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65043470|NCT00477412|Antimetabolites|antimetabolites|mesh-ancestor
65043471|NCT00477412|Dermatologic Agents|dermatologic agents|mesh-ancestor
65043472|NCT00477412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65043473|NCT00477412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65043474|NCT00477412|Antiviral Agents|antiviral agents|mesh-ancestor
65043475|NCT00477412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65043476|NCT00477412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64895375|NCT02008968|Allopurinol|allopurinol|mesh-list
65043486|NCT00410774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65043487|NCT00410774|Growth Substances|growth substances|mesh-ancestor
65043488|NCT00410774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043489|NCT00410774|Growth Inhibitors|growth inhibitors|mesh-ancestor
65043490|NCT00410774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65043491|NCT00410774|Antimetabolites|antimetabolites|mesh-ancestor
65043492|NCT00410774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043493|NCT00410774|Antiviral Agents|antiviral agents|mesh-ancestor
65043494|NCT00410774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65043495|NCT00410774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043496|NCT00410774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65043497|NCT00410774|Immunologic Factors|immunologic factors|mesh-ancestor
65043499|NCT00228930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65043500|NCT00228930|Hormone Antagonists|hormone antagonists|mesh-ancestor
65043501|NCT00228930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65043502|NCT00228930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043503|NCT00228930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65043504|NCT00228930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043505|NCT00228930|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65043506|NCT00228930|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65043507|NCT00228930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65043508|NCT00410852|Insulin|insulin|mesh-list
65043509|NCT00410852|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65043510|NCT00410852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65043511|NCT00410852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043512|NCT01086982|Octreotide|octreotide|mesh-list
65043513|NCT01086982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65043514|NCT01086982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65043515|NCT01086982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043516|NCT00204893|Calcium|calcium|mesh-list
65043517|NCT00204893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65043518|NCT00204893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043519|NCT00232011|Pimecrolimus|pimecrolimus|mesh-list
65043520|NCT00232011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65043521|NCT00232011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65043522|NCT00232011|Analgesics|analgesics|mesh-ancestor
65043523|NCT00232011|Sensory System Agents|sensory system agents|mesh-ancestor
65043524|NCT00232011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65043525|NCT00232011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043526|NCT00232011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65043527|NCT00232011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65043528|NCT00232011|Dermatologic Agents|dermatologic agents|mesh-ancestor
65043529|NCT00232011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65043530|NCT00232011|Immunologic Factors|immunologic factors|mesh-ancestor
65043531|NCT00232011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65043532|NCT00232011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043533|NCT00232011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043534|NCT00232050|Omalizumab|omalizumab|mesh-list
65043535|NCT00232050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65043536|NCT00232050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65043537|NCT00232050|Respiratory System Agents|respiratory system agents|mesh-ancestor
65043538|NCT00232089|Tegaserod|tegaserod|mesh-list
65043539|NCT00232089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65043540|NCT00232089|Serotonin Agents|serotonin agents|mesh-ancestor
65043541|NCT00232089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64895423|NCT02009007|Dopamine Agents|dopamine agents|mesh-ancestor
65043568|NCT00229125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043569|NCT00229125|Antimanic Agents|antimanic agents|mesh-ancestor
65043571|NCT00229125|Autonomic Agents|autonomic agents|mesh-ancestor
65043573|NCT00229125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65043574|NCT00229125|GABA Modulators|gaba modulators|mesh-ancestor
65043576|NCT00205283|Nelfinavir|nelfinavir|mesh-list
65043577|NCT00205283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65043578|NCT00205283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65043579|NCT00205283|Protease Inhibitors|protease inhibitors|mesh-ancestor
65043580|NCT00205283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043581|NCT00205283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043582|NCT00205283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65043583|NCT00205283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65043584|NCT00205283|Antiviral Agents|antiviral agents|mesh-ancestor
65043585|NCT00205283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65043586|NCT00232167|Indiplon|indiplon|mesh-list
65043587|NCT00232167|Sertraline|sertraline|mesh-list
65043588|NCT00232167|Antidepressive Agents|antidepressive agents|mesh-ancestor
65043589|NCT00232167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65043590|NCT00232167|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65043626|NCT00232284|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65043627|NCT00232284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65043628|NCT00232284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65043629|NCT00232284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043630|NCT00232284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65043665|NCT00205751|Immunologic Factors|immunologic factors|mesh-ancestor
65043666|NCT00205751|Leprostatic Agents|leprostatic agents|mesh-ancestor
65043667|NCT00205751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65043668|NCT00205751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65043669|NCT00205751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65043670|NCT00205751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65043671|NCT00205751|Growth Substances|growth substances|mesh-ancestor
64895583|NCT05777278|Docetaxel|docetaxel|mesh-list
65043690|NCT00205946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043692|NCT00205946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65043693|NCT00205946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043694|NCT00205946|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65043695|NCT00205946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65043696|NCT00205946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043697|NCT00229515|Sirolimus|sirolimus|mesh-list
65043698|NCT00229515|polysaccharide-K|polysaccharide-k|mesh-list
65043699|NCT00229515|Tirofiban|tirofiban|mesh-list
65043700|NCT00229515|Abciximab|abciximab|mesh-list
65043701|NCT00229515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65043702|NCT00229515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65043703|NCT00229515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65043704|NCT00229515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043705|NCT00229515|Antifungal Agents|antifungal agents|mesh-ancestor
65043706|NCT00229515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65043707|NCT00229515|Immunologic Factors|immunologic factors|mesh-ancestor
65043708|NCT00229515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043709|NCT00229515|Anticoagulants|anticoagulants|mesh-ancestor
65043710|NCT00229515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65043711|NCT00229515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65043712|NCT00229515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65043713|NCT00229515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043714|NCT00229515|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65043715|NCT00229515|Antiviral Agents|antiviral agents|mesh-ancestor
65043716|NCT00229515|Interferon Inducers|interferon inducers|mesh-ancestor
65043717|NCT00229515|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65043718|NCT00229515|Protective Agents|protective agents|mesh-ancestor
65043719|NCT00206024|Esomeprazole|esomeprazole|mesh-list
65043720|NCT00206024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65043721|NCT00206024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65043722|NCT00206024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65043723|NCT00206024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043724|NCT00206024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043725|NCT00206063|Ximelagatran|ximelagatran|mesh-list
65043735|NCT00206141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65043736|NCT00206141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65043737|NCT00206141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65043738|NCT00206141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043739|NCT00229593|ST 1435|st 1435|mesh-list
64558916|NCT02630472|Quinine|quinine|mesh-list
65043740|NCT00229593|Testosterone|testosterone|mesh-list
65043741|NCT00229593|Androgens|androgens|mesh-ancestor
65043742|NCT00229593|Hormones|hormones|mesh-ancestor
65043743|NCT00229593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65043744|NCT00229593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043745|NCT00229593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65043746|NCT00229593|Contraceptive Agents|contraceptive agents|mesh-ancestor
65043747|NCT00229593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65043748|NCT00229593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65043749|NCT00229632|Idebenone|idebenone|mesh-list
65043750|NCT00229632|Antioxidants|antioxidants|mesh-ancestor
65043751|NCT00229632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043752|NCT00229632|Protective Agents|protective agents|mesh-ancestor
65043753|NCT00229632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043754|NCT00206180|Esomeprazole|esomeprazole|mesh-list
65043755|NCT00206180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65043756|NCT00206180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65043757|NCT00206180|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65043758|NCT00206180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043759|NCT00206180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043760|NCT00206219|Methotrexate|methotrexate|mesh-list
65043761|NCT00206219|Gefitinib|gefitinib|mesh-list
65043762|NCT00206219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65043763|NCT00206219|Abortifacient Agents|abortifacient agents|mesh-ancestor
65043764|NCT00206219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65043765|NCT00206219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043766|NCT00206219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65043767|NCT00206219|Antimetabolites|antimetabolites|mesh-ancestor
65043768|NCT00206219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043769|NCT00206219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043770|NCT00206219|Dermatologic Agents|dermatologic agents|mesh-ancestor
65043771|NCT00206219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043772|NCT00206219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65043773|NCT00206219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65043774|NCT00206219|Immunologic Factors|immunologic factors|mesh-ancestor
65043775|NCT00206219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65043776|NCT00206219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65043777|NCT00206219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65043778|NCT00206258|Pramlintide|pramlintide|mesh-list
65043779|NCT00206258|Glucagon|glucagon|mesh-list
65043780|NCT00206258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65043781|NCT00206258|Hormones|hormones|mesh-ancestor
65043782|NCT00206258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65043783|NCT00206258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043784|NCT00206258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65043785|NCT00206297|Pramlintide|pramlintide|mesh-list
65043786|NCT00206297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65043787|NCT00206297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043788|NCT00411047|Gefitinib|gefitinib|mesh-list
65043789|NCT00411047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043790|NCT00411047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65043791|NCT00411047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043800|NCT00411125|Vasodilator Agents|vasodilator agents|mesh-ancestor
65043802|NCT00411164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65043803|NCT00411164|Narcotics|narcotics|mesh-ancestor
65043804|NCT00411164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65043805|NCT00411164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043806|NCT00411164|Analgesics|analgesics|mesh-ancestor
65043807|NCT00411164|Sensory System Agents|sensory system agents|mesh-ancestor
65043808|NCT00411164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65043809|NCT00411203|Tamoxifen|tamoxifen|mesh-list
65043810|NCT00411203|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65043811|NCT00411203|Hormone Antagonists|hormone antagonists|mesh-ancestor
65043812|NCT00411203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65043813|NCT00411203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043814|NCT00411203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65043815|NCT00411203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043816|NCT00411203|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65043817|NCT00411203|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65043818|NCT00411203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65043819|NCT00411281|Cytarabine|cytarabine|mesh-list
65043820|NCT00411281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65043821|NCT00411281|Antimetabolites|antimetabolites|mesh-ancestor
65043822|NCT00411281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043823|NCT00411281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043824|NCT00411281|Antiviral Agents|antiviral agents|mesh-ancestor
65043825|NCT00411281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65043826|NCT00411281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65043827|NCT00411281|Immunologic Factors|immunologic factors|mesh-ancestor
65043828|NCT00411281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043829|NCT00206414|Gefitinib|gefitinib|mesh-list
65043830|NCT00206414|Fulvestrant|fulvestrant|mesh-list
65043831|NCT00206414|Anastrozole|anastrozole|mesh-list
65043832|NCT00206414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043833|NCT00206414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65043834|NCT00206414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043835|NCT00206414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043836|NCT00206414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65043837|NCT00206414|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65043838|NCT00206414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65043839|NCT00206414|Hormone Antagonists|hormone antagonists|mesh-ancestor
65043840|NCT00206414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65043841|NCT00206414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043842|NCT00206414|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65043843|NCT00206414|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65043844|NCT00232674|Budesonide|budesonide|mesh-list
65043845|NCT00232674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65043846|NCT00232674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65043847|NCT00232674|Autonomic Agents|autonomic agents|mesh-ancestor
65043848|NCT00232674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65043849|NCT00232674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043850|NCT00232674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65043851|NCT00232674|Respiratory System Agents|respiratory system agents|mesh-ancestor
65043852|NCT00232674|Glucocorticoids|glucocorticoids|mesh-ancestor
65043853|NCT00232674|Hormones|hormones|mesh-ancestor
65043854|NCT00232674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65043855|NCT00206453|Docetaxel|docetaxel|mesh-list
65043856|NCT00206453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895741|NCT05548270|Antiemetics|antiemetics|mesh-ancestor
65043871|NCT00206570|Estradiol|estradiol|mesh-list
65043873|NCT00206570|Hormones|hormones|mesh-ancestor
65043874|NCT00206570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65043875|NCT00206570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043876|NCT00206648|Interferon beta-1b|interferon beta-1b|mesh-list
65043877|NCT00206648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65043878|NCT00206648|Immunologic Factors|immunologic factors|mesh-ancestor
65043879|NCT00206648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043880|NCT01056159|Albuterol|albuterol|mesh-list
65043881|NCT01056159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65043882|NCT01056159|Autonomic Agents|autonomic agents|mesh-ancestor
65043883|NCT01056159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65043884|NCT01056159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043885|NCT01056159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65043886|NCT01056159|Respiratory System Agents|respiratory system agents|mesh-ancestor
65043887|NCT01056159|Tocolytic Agents|tocolytic agents|mesh-ancestor
65043888|NCT01056159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65043889|NCT01056159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65043890|NCT01056159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65043891|NCT01056159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65043892|NCT01056159|Adrenergic Agents|adrenergic agents|mesh-ancestor
65043893|NCT01056159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65043894|NCT01056159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043895|NCT00206765|Risperidone|risperidone|mesh-list
65043896|NCT00206765|Paroxetine|paroxetine|mesh-list
65043897|NCT00206765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65043898|NCT00206765|Serotonin Agents|serotonin agents|mesh-ancestor
65043899|NCT00206765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65043900|NCT00206765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043901|NCT00206765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043902|NCT00206765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65043903|NCT00206765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65043904|NCT00206765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65043905|NCT00206765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65043906|NCT00206765|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65043907|NCT00206765|Dopamine Agents|dopamine agents|mesh-ancestor
65043908|NCT00206765|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65043909|NCT00206765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65043910|NCT00206765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65043911|NCT00206765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65043912|NCT00206765|Antidepressive Agents|antidepressive agents|mesh-ancestor
65043913|NCT00206765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65043914|NCT00206765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65043943|NCT00206999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043944|NCT00206999|Adrenergic Agents|adrenergic agents|mesh-ancestor
65043945|NCT00206999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65043946|NCT00206999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043947|NCT00229944|Azithromycin|azithromycin|mesh-list
65043948|NCT00229944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65043949|NCT00229944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65043950|NCT00207077|Cetuximab|cetuximab|mesh-list
65043951|NCT00207077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65043952|NCT00207077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65043953|NCT00207077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043954|NCT00207077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65043955|NCT00207077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043956|NCT00207077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043957|NCT00207116|Cetuximab|cetuximab|mesh-list
65043958|NCT00207116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65043973|NCT00232947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043975|NCT00413712|Calcium Channel Blockers|calcium channel blockers|mesh-list
65043976|NCT00413712|Calcium|calcium|mesh-list
65043977|NCT00413712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65043978|NCT00413712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043979|NCT00413712|Analgesics|analgesics|mesh-ancestor
65043980|NCT00413712|Sensory System Agents|sensory system agents|mesh-ancestor
65043981|NCT00413712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65043982|NCT00413712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65043983|NCT00413712|Vasodilator Agents|vasodilator agents|mesh-ancestor
65043984|NCT00413712|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65043985|NCT00413712|Purinergic Agonists|purinergic agonists|mesh-ancestor
65043986|NCT00413712|Purinergic Agents|purinergic agents|mesh-ancestor
65043987|NCT00413712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65043988|NCT00413712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043989|NCT00413712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65043990|NCT00230217|Rasburicase|rasburicase|mesh-list
65043991|NCT00230217|Gout Suppressants|gout suppressants|mesh-ancestor
65043992|NCT00230217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65043993|NCT00207311|Interferons|interferons|mesh-list
65043994|NCT00207311|Interferon-alpha|interferon-alpha|mesh-list
65043995|NCT00207311|Interferon alpha-2|interferon alpha-2|mesh-list
65043996|NCT00207311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65043997|NCT00207311|Orlistat|orlistat|mesh-list
65043998|NCT00207311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043999|NCT00207311|Antiviral Agents|antiviral agents|mesh-ancestor
65044000|NCT00207311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65044001|NCT00207311|Immunologic Factors|immunologic factors|mesh-ancestor
65044002|NCT00207311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044003|NCT00207311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044004|NCT00207311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044005|NCT00207311|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65044006|NCT00207311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65044007|NCT00233025|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65044008|NCT00233025|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65044009|NCT00233025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65044010|NCT00233025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65044011|NCT00233025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044012|NCT00233025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044013|NCT00233025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044015|NCT00233025|Sensory System Agents|sensory system agents|mesh-ancestor
65044016|NCT00233025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044017|NCT00233025|Antidepressive Agents|antidepressive agents|mesh-ancestor
65044018|NCT00233025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65044019|NCT00233025|Dopamine Agents|dopamine agents|mesh-ancestor
65044031|NCT00207428|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65044032|NCT00207428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65044033|NCT00207428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044034|NCT00207428|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65044035|NCT00207428|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65044036|NCT00230334|Imatinib Mesylate|imatinib mesylate|mesh-list
65044037|NCT00230334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044038|NCT00230334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65044039|NCT00230334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044040|NCT00230334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044041|NCT00207584|Doxycycline|doxycycline|mesh-list
65044042|NCT00207584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65044043|NCT00207584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65044044|NCT00207584|Antimalarials|antimalarials|mesh-ancestor
65044045|NCT00207584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65044046|NCT00207584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65044047|NCT00207662|Infliximab|infliximab|mesh-list
65044048|NCT00207662|Dermatologic Agents|dermatologic agents|mesh-ancestor
65044049|NCT00207662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65044050|NCT00207662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65044051|NCT00207701|Infliximab|infliximab|mesh-list
65044052|NCT00207701|Dermatologic Agents|dermatologic agents|mesh-ancestor
65044053|NCT00207701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65044054|NCT00207701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65044055|NCT00207779|Heparin|heparin|mesh-list
65044056|NCT00207779|Anticoagulants|anticoagulants|mesh-ancestor
65044057|NCT00207779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65044058|NCT00207779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65044059|NCT00207779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044060|NCT00230373|Imiquimod|imiquimod|mesh-list
65044061|NCT00230373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65044062|NCT00230373|Immunologic Factors|immunologic factors|mesh-ancestor
65044063|NCT00230373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044064|NCT00230373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044065|NCT00230373|Interferon Inducers|interferon inducers|mesh-ancestor
65044066|NCT00230451|Paclitaxel|paclitaxel|mesh-list
65044067|NCT00230451|Fluorouracil|fluorouracil|mesh-list
65044068|NCT00230451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65044069|NCT00230451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044070|NCT00230451|Tubulin Modulators|tubulin modulators|mesh-ancestor
65044071|NCT00230451|Antimitotic Agents|antimitotic agents|mesh-ancestor
65044072|NCT00230451|Mitosis Modulators|mitosis modulators|mesh-ancestor
65044073|NCT00230451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044074|NCT00230451|Antimetabolites|antimetabolites|mesh-ancestor
65044075|NCT00230451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65044076|NCT00230451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65044077|NCT00230451|Immunologic Factors|immunologic factors|mesh-ancestor
65044078|NCT00230451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044079|NCT00411320|Dexamethasone|dexamethasone|mesh-list
65044080|NCT00411320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65044081|NCT00411320|Antiemetics|antiemetics|mesh-ancestor
65044082|NCT00411320|Autonomic Agents|autonomic agents|mesh-ancestor
65044083|NCT00411320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044084|NCT00411320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895975|NCT04782830|Sympathomimetics|sympathomimetics|mesh-ancestor
65044110|NCT01089556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044111|NCT01089556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044112|NCT01089556|Anticonvulsants|anticonvulsants|mesh-ancestor
65044113|NCT01089556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65044114|NCT01089556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65044115|NCT01089556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044116|NCT01089556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65044117|NCT01089556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65044118|NCT01089556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65044119|NCT01089556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65044120|NCT01089556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65044121|NCT01089556|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65044122|NCT01089556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65044123|NCT01089556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044124|NCT01089556|Antidepressive Agents|antidepressive agents|mesh-ancestor
65044125|NCT01089556|Dopamine Agents|dopamine agents|mesh-ancestor
65044126|NCT00233376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65044127|NCT00233376|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65044128|NCT00233376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65044129|NCT00233376|Antitubercular Agents|antitubercular agents|mesh-ancestor
65044130|NCT00237159|Zoledronic Acid|zoledronic acid|mesh-list
65044131|NCT00237159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65044132|NCT00237159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044133|NCT01089127|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65044134|NCT01089127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65044135|NCT01089127|Autonomic Agents|autonomic agents|mesh-ancestor
64896028|NCT04558281|Anesthetics|anesthetics|mesh-ancestor
65044167|NCT00233532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65044168|NCT00233532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65044169|NCT00233532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044170|NCT00233532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65044171|NCT00233532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044195|NCT00233610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044196|NCT00233610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65044197|NCT00233610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044198|NCT00233610|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65044199|NCT00233610|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65044200|NCT00233610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65044201|NCT00233610|Androgen Antagonists|androgen antagonists|mesh-ancestor
65044202|NCT00208130|Topiramate|topiramate|mesh-list
65044203|NCT00208130|Anticonvulsants|anticonvulsants|mesh-ancestor
65044204|NCT00208130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65044205|NCT00208130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044206|NCT00237237|Vildagliptin|vildagliptin|mesh-list
65044207|NCT00237237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65044208|NCT00237237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044209|NCT00237237|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65044210|NCT00237237|Protease Inhibitors|protease inhibitors|mesh-ancestor
65044211|NCT00237237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044212|NCT00237237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044213|NCT00208169|Aripiprazole|aripiprazole|mesh-list
65044214|NCT00208169|Antidepressive Agents|antidepressive agents|mesh-ancestor
65044215|NCT00208169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65044216|NCT00208169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65044217|NCT00208169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65044218|NCT00208169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65044219|NCT00208169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044220|NCT00208169|Dopamine Agonists|dopamine agonists|mesh-ancestor
65044221|NCT00208169|Dopamine Agents|dopamine agents|mesh-ancestor
65044222|NCT00208169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64896118|NCT04200911|Immunologic Factors|immunologic factors|mesh-ancestor
65044250|NCT00208208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65044251|NCT00208208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65044252|NCT00208208|Dopamine Agents|dopamine agents|mesh-ancestor
65044253|NCT01085812|Milnacipran|milnacipran|mesh-list
65044254|NCT01085812|Levomilnacipran|levomilnacipran|mesh-list
65044255|NCT01085812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65044256|NCT01085812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65044257|NCT01085812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65044258|NCT01085812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044259|NCT01085812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044260|NCT01085812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044261|NCT01085812|Antidepressive Agents|antidepressive agents|mesh-ancestor
65044262|NCT01085812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65044263|NCT01085812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65044264|NCT01085812|Analgesics|analgesics|mesh-ancestor
65044265|NCT01085812|Sensory System Agents|sensory system agents|mesh-ancestor
65044266|NCT01085812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044267|NCT01085734|Bevacizumab|bevacizumab|mesh-list
65044285|NCT01084603|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65044286|NCT01084603|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65044287|NCT01084603|Cholinergic Agents|cholinergic agents|mesh-ancestor
65044288|NCT01084603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044289|NCT01084603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044290|NCT00208442|Methyclothiazide|methyclothiazide|mesh-list
65044291|NCT00208442|Diuretics|diuretics|mesh-ancestor
65044292|NCT00208442|Natriuretic Agents|natriuretic agents|mesh-ancestor
65044293|NCT00208442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044294|NCT00208442|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65044295|NCT00208442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65044296|NCT00208442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044297|NCT00233766|Sirolimus|sirolimus|mesh-list
65044298|NCT00233766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65044299|NCT00233766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65044300|NCT00233766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65044301|NCT00233766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044302|NCT00233766|Antifungal Agents|antifungal agents|mesh-ancestor
65044303|NCT00233766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65044304|NCT00233766|Immunologic Factors|immunologic factors|mesh-ancestor
65044305|NCT00233766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472694|NCT02981628|Cyclophosphamide|cyclophosphamide|mesh-list
64819711|NCT01507077|CKD732|ckd732|mesh-list
65044306|NCT00208520|Lamotrigine|lamotrigine|mesh-list
64529546|NCT01498679|Fluticasone|fluticasone|mesh-list
65044308|NCT00208520|Levetiracetam|levetiracetam|mesh-list
65044309|NCT00208520|Anticonvulsants|anticonvulsants|mesh-ancestor
65044310|NCT00208520|Nootropic Agents|nootropic agents|mesh-ancestor
65044311|NCT00208520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65044312|NCT00208520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65044313|NCT00208520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044314|NCT00208520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65044315|NCT00208520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044316|NCT00208520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65044317|NCT00208520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65044318|NCT00208520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65044319|NCT00208520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65044320|NCT00208520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65044321|NCT00208520|Antimanic Agents|antimanic agents|mesh-ancestor
65044322|NCT00208520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65044323|NCT00208520|Analgesics|analgesics|mesh-ancestor
64896219|NCT03994731|Antiemetics|antiemetics|mesh-ancestor
65044336|NCT00208559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65044337|NCT00208559|Serotonin Agents|serotonin agents|mesh-ancestor
65044338|NCT00208559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044339|NCT00208559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044340|NCT00208559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044341|NCT00208559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65044342|NCT00208559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65044343|NCT00208559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65044344|NCT00208559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65044345|NCT00208559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65044346|NCT00208559|Dopamine Agents|dopamine agents|mesh-ancestor
65044347|NCT00233805|Sirolimus|sirolimus|mesh-list
65044348|NCT00233805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65044349|NCT00233805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65044350|NCT00233805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65044351|NCT00233805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044352|NCT00233805|Antifungal Agents|antifungal agents|mesh-ancestor
65044353|NCT00233805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65044354|NCT00233805|Immunologic Factors|immunologic factors|mesh-ancestor
65044355|NCT00233805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044356|NCT01084135|Rivastigmine|rivastigmine|mesh-list
65044357|NCT01084135|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65044358|NCT01084135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044359|NCT01084135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044360|NCT01084135|Cholinergic Agents|cholinergic agents|mesh-ancestor
65044361|NCT01084135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044362|NCT01084135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044363|NCT01084135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65044364|NCT01084135|Protective Agents|protective agents|mesh-ancestor
65044365|NCT01083316|Dexamethasone|dexamethasone|mesh-list
65044366|NCT01083316|Bortezomib|bortezomib|mesh-list
65044367|NCT01083316|Melphalan|melphalan|mesh-list
65044368|NCT01083316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65044369|NCT01083316|Antiemetics|antiemetics|mesh-ancestor
65044370|NCT01083316|Autonomic Agents|autonomic agents|mesh-ancestor
65044371|NCT01083316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044372|NCT01083316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044373|NCT01083316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65044374|NCT01083316|Glucocorticoids|glucocorticoids|mesh-ancestor
65044375|NCT01083316|Hormones|hormones|mesh-ancestor
65044376|NCT01083316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65044377|NCT01083316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65044378|NCT01083316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044379|NCT01083316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65044380|NCT01083316|Alkylating Agents|alkylating agents|mesh-ancestor
65044381|NCT01083316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044382|NCT01083316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65044383|NCT01083316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65044384|NCT01083316|Immunologic Factors|immunologic factors|mesh-ancestor
65044404|NCT00233883|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65044405|NCT00233883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044406|NCT00233883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65044407|NCT00233883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64559372|NCT05056974|UB-421|ub-421|mesh-list
65044408|NCT00233883|Antiviral Agents|antiviral agents|mesh-ancestor
65044409|NCT00233883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65044410|NCT01081873|Leuprolide|leuprolide|mesh-list
65044411|NCT01081873|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65044412|NCT01081873|Fertility Agents|fertility agents|mesh-ancestor
65044413|NCT01081873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65044414|NCT01081873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044415|NCT01081873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65044416|NCT01081873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044417|NCT00237471|Insulin|insulin|mesh-list
65044418|NCT00237471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65044419|NCT00237471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044420|NCT00237510|Terazosin|terazosin|mesh-list
65044421|NCT00237510|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65044422|NCT00237510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65044423|NCT00237510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65044424|NCT00237510|Adrenergic Agents|adrenergic agents|mesh-ancestor
65044425|NCT00237510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044426|NCT00237510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044427|NCT00237510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044428|NCT00237510|Urological Agents|urological agents|mesh-ancestor
65044429|NCT01081795|Topiramate|topiramate|mesh-list
65044430|NCT01081795|Anticonvulsants|anticonvulsants|mesh-ancestor
65044431|NCT01081795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65044432|NCT01081795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044433|NCT00233961|Lenograstim|lenograstim|mesh-list
65044434|NCT00233961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65044435|NCT00233961|Immunologic Factors|immunologic factors|mesh-ancestor
65044436|NCT00233961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044437|NCT00234000|Azacitidine|azacitidine|mesh-list
65044438|NCT00234000|Arsenic Trioxide|arsenic trioxide|mesh-list
65044439|NCT00234000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65044440|NCT00234000|Antimetabolites|antimetabolites|mesh-ancestor
65044441|NCT00234000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896344|NCT03459846|Durvalumab|durvalumab|mesh-list
65044475|NCT00209222|Autonomic Agents|autonomic agents|mesh-ancestor
65044476|NCT00209222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044477|NCT00209222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65044478|NCT00209222|Glucocorticoids|glucocorticoids|mesh-ancestor
65044479|NCT00209222|Hormones|hormones|mesh-ancestor
65044480|NCT00209222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65044481|NCT00209222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65044482|NCT00209222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65044483|NCT00209222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65044484|NCT00209222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65044485|NCT00209222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044486|NCT00209222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65044487|NCT00209222|Tubulin Modulators|tubulin modulators|mesh-ancestor
65044513|NCT00209261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044515|NCT00209300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65044516|NCT00209300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65044517|NCT00209300|Analgesics|analgesics|mesh-ancestor
65044518|NCT00209300|Sensory System Agents|sensory system agents|mesh-ancestor
65044519|NCT00209300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044520|NCT00209300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044521|NCT00209300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65044522|NCT00209300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65044523|NCT00234234|Adalimumab|adalimumab|mesh-list
65044524|NCT00234234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65044525|NCT00234234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65044526|NCT00237588|Losartan|losartan|mesh-list
65044527|NCT00237588|Amlodipine|amlodipine|mesh-list
65044528|NCT00237588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65044529|NCT00237588|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65044530|NCT00237588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65044531|NCT00237588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044532|NCT00237588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65044533|NCT00237588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044534|NCT00237588|Vasodilator Agents|vasodilator agents|mesh-ancestor
64896440|NCT03145272|Oxycodone|oxycodone|mesh-list
65044567|NCT00411515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65044568|NCT00411515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65044569|NCT00411515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248445|NCT02841722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64472695|NCT02981628|Methotrexate|methotrexate|mesh-list
65044570|NCT00411515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044571|NCT00237627|Doxorubicin|doxorubicin|mesh-list
65044572|NCT00237627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65044573|NCT00237627|Bortezomib|bortezomib|mesh-list
65044574|NCT00237627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65044575|NCT00237627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044576|NCT00237627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65044584|NCT00209495|Autonomic Agents|autonomic agents|mesh-ancestor
65044585|NCT00209495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044586|NCT00209495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044587|NCT00209495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65044588|NCT00209495|Glucocorticoids|glucocorticoids|mesh-ancestor
65044589|NCT00209495|Hormones|hormones|mesh-ancestor
65044590|NCT00209495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65044591|NCT00209495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65044592|NCT00209495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044593|NCT00209495|Analgesics|analgesics|mesh-ancestor
65044594|NCT00209495|Sensory System Agents|sensory system agents|mesh-ancestor
65044595|NCT00209495|Anticonvulsants|anticonvulsants|mesh-ancestor
65044596|NCT00209495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65044597|NCT00209495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65044598|NCT00209495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044599|NCT00209495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65044600|NCT00209495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65044601|NCT00209495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65044602|NCT00209495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65044603|NCT00209495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65044604|NCT00234390|Budesonide|budesonide|mesh-list
65044605|NCT00234390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65044606|NCT00234390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65044607|NCT00234390|Autonomic Agents|autonomic agents|mesh-ancestor
65044608|NCT00234390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044609|NCT00234390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044610|NCT00234390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65044611|NCT00234390|Respiratory System Agents|respiratory system agents|mesh-ancestor
65044612|NCT00234390|Glucocorticoids|glucocorticoids|mesh-ancestor
65044613|NCT00234390|Hormones|hormones|mesh-ancestor
65044614|NCT00234390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65044615|NCT00209534|Fospropofol|fospropofol|mesh-list
65044616|NCT00209534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65044617|NCT00209534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65044618|NCT00209534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044619|NCT00209573|Fospropofol|fospropofol|mesh-list
65044620|NCT00209573|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65044621|NCT00209573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65044622|NCT00209573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044624|NCT00209612|Irinotecan|irinotecan|mesh-list
65044625|NCT00209612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65044626|NCT00209612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044627|NCT00209612|Tubulin Modulators|tubulin modulators|mesh-ancestor
65044628|NCT00209612|Antimitotic Agents|antimitotic agents|mesh-ancestor
65044629|NCT00209612|Mitosis Modulators|mitosis modulators|mesh-ancestor
65044630|NCT00209612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044631|NCT00209612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65044632|NCT00209612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65044633|NCT00209612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044634|NCT01081249|Oxytocin|oxytocin|mesh-list
65044635|NCT01081249|Oxytocics|oxytocics|mesh-ancestor
65044636|NCT01081249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65044637|NCT01081249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044638|NCT00234429|Gefitinib|gefitinib|mesh-list
65044639|NCT00234429|Raltitrexed|raltitrexed|mesh-list
65044640|NCT00234429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044641|NCT00234429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65044642|NCT00234429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044643|NCT00234429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044644|NCT00234429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65044645|NCT00234429|Antimetabolites|antimetabolites|mesh-ancestor
65044675|NCT00209690|Fluorouracil|fluorouracil|mesh-list
65044676|NCT00209690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044677|NCT00209690|Tubulin Modulators|tubulin modulators|mesh-ancestor
65044678|NCT00209690|Antimitotic Agents|antimitotic agents|mesh-ancestor
65044679|NCT00209690|Mitosis Modulators|mitosis modulators|mesh-ancestor
65044680|NCT00209690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044681|NCT00209690|Antimetabolites|antimetabolites|mesh-ancestor
65044682|NCT00209690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65044683|NCT00209690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65044684|NCT00209690|Immunologic Factors|immunologic factors|mesh-ancestor
65044685|NCT00209690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044686|NCT01081132|Guanfacine|guanfacine|mesh-list
65044687|NCT01081132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65044688|NCT01081132|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65044689|NCT01081132|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65044690|NCT01081132|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65044710|NCT01080625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65044711|NCT01080625|Autonomic Agents|autonomic agents|mesh-ancestor
65044712|NCT01080625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044713|NCT01080625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65044714|NCT01080625|Respiratory System Agents|respiratory system agents|mesh-ancestor
65044715|NCT01080625|Mydriatics|mydriatics|mesh-ancestor
65044716|NCT01080625|Sympathomimetics|sympathomimetics|mesh-ancestor
65044717|NCT01080625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65044718|NCT01080625|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65044719|NCT01080625|Nasal Decongestants|nasal decongestants|mesh-ancestor
65044720|NCT01080625|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65044721|NCT01080625|Protective Agents|protective agents|mesh-ancestor
65044722|NCT00209729|Docetaxel|docetaxel|mesh-list
65044723|NCT00209729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044724|NCT00209729|Tubulin Modulators|tubulin modulators|mesh-ancestor
65044725|NCT00209729|Antimitotic Agents|antimitotic agents|mesh-ancestor
65044726|NCT00209729|Mitosis Modulators|mitosis modulators|mesh-ancestor
65044727|NCT00209729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044728|NCT00414180|Bupropion|bupropion|mesh-list
65044729|NCT00414180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65044730|NCT00414180|Antidepressive Agents|antidepressive agents|mesh-ancestor
65044731|NCT00414180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65044732|NCT00414180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65044733|NCT00414180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65044734|NCT00414180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65044735|NCT00414180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044736|NCT00414180|Dopamine Agents|dopamine agents|mesh-ancestor
65044737|NCT00414180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044738|NCT00414180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044739|NCT00414180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65044740|NCT00414180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65044741|NCT00414180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044742|NCT01089790|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65044743|NCT01089790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64896645|NCT02038452|Glucocorticoids|glucocorticoids|mesh-ancestor
65044768|NCT01084330|Mitosis Modulators|mitosis modulators|mesh-ancestor
65044769|NCT01084330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044770|NCT01084330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65044771|NCT01084330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65044772|NCT01084330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044773|NCT00209807|Citalopram|citalopram|mesh-list
65044774|NCT00209807|Reboxetine|reboxetine|mesh-list
65044775|NCT00209807|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65044776|NCT00209807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65044777|NCT00209807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65044778|NCT00209807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044779|NCT00209807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044780|NCT00209807|Serotonin Agents|serotonin agents|mesh-ancestor
65044781|NCT00209807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044782|NCT00209807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65044783|NCT00209807|Antidepressive Agents|antidepressive agents|mesh-ancestor
65044784|NCT00209807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65044785|NCT00209807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65044786|NCT00209807|Adrenergic Agents|adrenergic agents|mesh-ancestor
65044787|NCT00209846|Gaboxadol|gaboxadol|mesh-list
65044788|NCT00209846|Analgesics|analgesics|mesh-ancestor
65044789|NCT00209846|Sensory System Agents|sensory system agents|mesh-ancestor
65044790|NCT00209846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044791|NCT00209846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044792|NCT00209846|Anticonvulsants|anticonvulsants|mesh-ancestor
65044793|NCT00209846|GABA Agonists|gaba agonists|mesh-ancestor
65044815|NCT01086748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65044817|NCT01086748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65044818|NCT01086748|Dopamine Agents|dopamine agents|mesh-ancestor
65044819|NCT00237705|Metoclopramide|metoclopramide|mesh-list
65044820|NCT00237705|Antiemetics|antiemetics|mesh-ancestor
65044821|NCT00237705|Autonomic Agents|autonomic agents|mesh-ancestor
65044822|NCT00237705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044823|NCT00237705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044824|NCT00237705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65044825|NCT00237705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65044826|NCT00237705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65044827|NCT00237705|Dopamine Agents|dopamine agents|mesh-ancestor
64530077|NCT05800106|Sunitinib|sunitinib|mesh-list
65044828|NCT00237705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044829|NCT00237705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044830|NCT00209885|Lidocaine|lidocaine|mesh-list
65044831|NCT00209885|Droperidol|droperidol|mesh-list
65044832|NCT00209885|Ketamine|ketamine|mesh-list
65044833|NCT00209885|Gabapentin|gabapentin|mesh-list
65044834|NCT00209885|Esketamine|esketamine|mesh-list
65044835|NCT00209885|Anesthetics, Local|anesthetics, local|mesh-ancestor
65044836|NCT00209885|Anesthetics|anesthetics|mesh-ancestor
65044837|NCT00209885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65044838|NCT00209885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044839|NCT00209885|Sensory System Agents|sensory system agents|mesh-ancestor
65044840|NCT00209885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044841|NCT00209885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65044842|NCT00209885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65044843|NCT00209885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64896753|NCT00863369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044859|NCT00209885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65044860|NCT00209885|Antiemetics|antiemetics|mesh-ancestor
65044861|NCT00209885|Autonomic Agents|autonomic agents|mesh-ancestor
65044862|NCT00209885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65044863|NCT00209885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65044864|NCT00209885|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65044865|NCT00209885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65044866|NCT00209885|Dopamine Agents|dopamine agents|mesh-ancestor
65044867|NCT00234546|Botulinum Toxins|botulinum toxins|mesh-list
65044868|NCT00234546|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65044869|NCT00234546|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65044870|NCT00234546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65044871|NCT00234546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65044872|NCT00234546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044873|NCT00234546|Cholinergic Agents|cholinergic agents|mesh-ancestor
65044874|NCT00234546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044875|NCT00234546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044876|NCT00234546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65044877|NCT00234546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044879|NCT00209924|Analgesics|analgesics|mesh-ancestor
65044880|NCT00209924|Sensory System Agents|sensory system agents|mesh-ancestor
65044881|NCT00209924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044882|NCT00209924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044883|NCT00209924|Anticonvulsants|anticonvulsants|mesh-ancestor
65044884|NCT00209924|GABA Agonists|gaba agonists|mesh-ancestor
65044885|NCT00209924|GABA Agents|gaba agents|mesh-ancestor
65044886|NCT00209924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044887|NCT00209924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044888|NCT00209963|Gaboxadol|gaboxadol|mesh-list
65044889|NCT00209963|Analgesics|analgesics|mesh-ancestor
65044890|NCT00209963|Sensory System Agents|sensory system agents|mesh-ancestor
65044891|NCT00209963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044892|NCT00209963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044893|NCT00209963|Anticonvulsants|anticonvulsants|mesh-ancestor
65044894|NCT00209963|GABA Agonists|gaba agonists|mesh-ancestor
65044895|NCT00209963|GABA Agents|gaba agents|mesh-ancestor
65044896|NCT00209963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044897|NCT00209963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044898|NCT00210002|Darbepoetin alfa|darbepoetin alfa|mesh-list
65044899|NCT00210002|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65044900|NCT00210002|Hematinics|hematinics|mesh-ancestor
65044901|NCT02277886|Esomeprazole|esomeprazole|mesh-list
65044902|NCT02277886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65044903|NCT02277886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65044904|NCT02277886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65044920|NCT00210041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65044922|NCT00210041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044923|NCT00210041|Antiviral Agents|antiviral agents|mesh-ancestor
65044924|NCT00210041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64820076|NCT01508663|Everolimus|everolimus|mesh-list
65044925|NCT00210041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044926|NCT00210041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65044927|NCT00210041|Immunologic Factors|immunologic factors|mesh-ancestor
65044928|NCT00210041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044929|NCT04990804|Analgesics, Opioid|analgesics, opioid|mesh-list
65044930|NCT04990804|Analgesics|analgesics|mesh-list
65044931|NCT04990804|Narcotics|narcotics|mesh-ancestor
65044932|NCT04990804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65044933|NCT04990804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044934|NCT04990804|Sensory System Agents|sensory system agents|mesh-ancestor
65044935|NCT04990804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044936|NCT00237783|Dialysis Solutions|dialysis solutions|mesh-list
65044937|NCT00237783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65044938|NCT04991662|Phenylephrine|phenylephrine|mesh-list
65044939|NCT04991662|Oxymetazoline|oxymetazoline|mesh-list
65044940|NCT04991662|Norepinephrine|norepinephrine|mesh-list
65044941|NCT04991662|Metaraminol|metaraminol|mesh-list
65044942|NCT04991662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65044943|NCT04991662|Mydriatics|mydriatics|mesh-ancestor
65044944|NCT04991662|Autonomic Agents|autonomic agents|mesh-ancestor
65044945|NCT04991662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044946|NCT04991662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044947|NCT04991662|Sympathomimetics|sympathomimetics|mesh-ancestor
65044948|NCT04991662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65044949|NCT04991662|Nasal Decongestants|nasal decongestants|mesh-ancestor
65044950|NCT04991662|Respiratory System Agents|respiratory system agents|mesh-ancestor
65044951|NCT04991662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65044952|NCT04991662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65044953|NCT04991662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65044954|NCT04991662|Adrenergic Agents|adrenergic agents|mesh-ancestor
65044955|NCT04991662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044956|NCT04991662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044957|NCT04991662|Protective Agents|protective agents|mesh-ancestor
65044958|NCT04997941|Tamoxifen|tamoxifen|mesh-list
65044959|NCT04997941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65044960|NCT04997941|Hormone Antagonists|hormone antagonists|mesh-ancestor
65044961|NCT04997941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65044962|NCT04997941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044978|NCT00413790|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65044979|NCT00413790|Darifenacin|darifenacin|mesh-list
65044980|NCT00413790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65044981|NCT00413790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65044982|NCT00413790|Cholinergic Agents|cholinergic agents|mesh-ancestor
65044983|NCT00413790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044984|NCT00413790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044985|NCT00413790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044986|NCT00413790|Urological Agents|urological agents|mesh-ancestor
65044987|NCT04571164|Rotigotine|rotigotine|mesh-list
65044988|NCT04571164|Dopamine Agonists|dopamine agonists|mesh-ancestor
65044990|NCT04571164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044991|NCT04571164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044992|NCT04571164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044993|NCT01059903|Rotigotine|rotigotine|mesh-list
65044994|NCT01059903|Dopamine Agonists|dopamine agonists|mesh-ancestor
65044995|NCT01059903|Dopamine Agents|dopamine agents|mesh-ancestor
65044996|NCT01059903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044997|NCT01059903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044998|NCT01059903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044999|NCT04996771|Cisplatin|cisplatin|mesh-list
65045000|NCT04996771|Etoposide|etoposide|mesh-list
65045001|NCT04996771|Etoposide phosphate|etoposide phosphate|mesh-list
65045002|NCT04996771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045003|NCT04996771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65045004|NCT04996771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65045005|NCT04996771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65045006|NCT04996771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045007|NCT04996771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045008|NCT00210314|Cytarabine|cytarabine|mesh-list
65045009|NCT00210314|Methotrexate|methotrexate|mesh-list
65045010|NCT00210314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65045011|NCT00210314|Abortifacient Agents|abortifacient agents|mesh-ancestor
65045012|NCT00210314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65045013|NCT00210314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045014|NCT00210314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64559740|NCT03062436|Tin Fluorides|tin fluorides|mesh-list
65045015|NCT00210314|Antimetabolites|antimetabolites|mesh-ancestor
65045016|NCT00210314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045017|NCT00210314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045018|NCT00210314|Dermatologic Agents|dermatologic agents|mesh-ancestor
65045019|NCT00210314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045020|NCT00210314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65045021|NCT00210314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65045074|NCT02210182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65045075|NCT02210182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65045076|NCT02210182|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65045077|NCT00210509|Almotriptan|almotriptan|mesh-list
65045078|NCT00210509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65045079|NCT00210509|Serotonin Agents|serotonin agents|mesh-ancestor
65045080|NCT00210509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65045081|NCT00210509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045082|NCT00210509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045083|NCT02210260|Heroin|heroin|mesh-list
65045084|NCT02210260|Bupivacaine|bupivacaine|mesh-list
65045085|NCT02210260|Anesthetics, Local|anesthetics, local|mesh-list
65045086|NCT02210260|Anesthetics|anesthetics|mesh-list
65045087|NCT02210260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65045088|NCT02210260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045089|NCT02210260|Sensory System Agents|sensory system agents|mesh-ancestor
65045090|NCT02210260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65045091|NCT02210260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65045092|NCT02210260|Narcotics|narcotics|mesh-ancestor
65045093|NCT02210260|Analgesics|analgesics|mesh-ancestor
65045094|NCT00210548|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65045095|NCT00210548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65045096|NCT00210548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65045097|NCT00210548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65045098|NCT00210548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045099|NCT00210548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65045100|NCT00210548|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65045101|NCT00210548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65045102|NCT00210548|Serotonin Agents|serotonin agents|mesh-ancestor
65045103|NCT00210548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65045104|NCT00210548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045105|NCT00210548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65045106|NCT00210548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65045107|NCT00210548|Dopamine Agents|dopamine agents|mesh-ancestor
65045108|NCT00210587|Epoetin Alfa|epoetin alfa|mesh-list
65045109|NCT00210587|Hematinics|hematinics|mesh-ancestor
65045110|NCT00210665|Trabectedin|trabectedin|mesh-list
65045111|NCT00210665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65045112|NCT00210665|Alkylating Agents|alkylating agents|mesh-ancestor
65045113|NCT00210665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045114|NCT00210665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045115|NCT04570345|Aspirin|aspirin|mesh-list
65045116|NCT04570345|Ticagrelor|ticagrelor|mesh-list
65045117|NCT04570345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65045118|NCT04570345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65045119|NCT04570345|Analgesics|analgesics|mesh-ancestor
65045137|NCT00234819|Bazedoxifene|bazedoxifene|mesh-list
65045139|NCT00234819|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65045140|NCT00234819|Hormones|hormones|mesh-ancestor
65045141|NCT00234819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65045142|NCT00234819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045143|NCT00234819|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65045144|NCT00234819|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65045145|NCT00234819|Hormone Antagonists|hormone antagonists|mesh-ancestor
65045146|NCT00234819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65045147|NCT04570150|Neostigmine|neostigmine|mesh-list
65045148|NCT04570150|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65045149|NCT04570150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045150|NCT04570150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045151|NCT04570150|Cholinergic Agents|cholinergic agents|mesh-ancestor
65045152|NCT04570150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65045153|NCT04570150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045154|NCT04570150|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65045155|NCT04570150|Autonomic Agents|autonomic agents|mesh-ancestor
65045156|NCT04570150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65045157|NCT04570306|Belimumab|belimumab|mesh-list
65045158|NCT04570306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64472730|NCT02981628|Tubulin Modulators|tubulin modulators|mesh-ancestor
65045159|NCT04570306|Immunologic Factors|immunologic factors|mesh-ancestor
65045160|NCT04570306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045161|NCT04570033|Parathyroid Hormone|parathyroid hormone|mesh-list
65045162|NCT04570033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65045163|NCT04570033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045164|NCT00234858|Losartan|losartan|mesh-list
65045165|NCT00234858|Verapamil|verapamil|mesh-list
65045166|NCT00234858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65045167|NCT00234858|Trandolapril|trandolapril|mesh-list
65045168|NCT00234858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65045169|NCT00234858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65045170|NCT00234858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65045171|NCT00234858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65045172|NCT00234858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045173|NCT00234858|Diuretics|diuretics|mesh-ancestor
65045174|NCT00234858|Natriuretic Agents|natriuretic agents|mesh-ancestor
64897081|NCT02011750|Valproic Acid|valproic acid|mesh-list
65045205|NCT00210782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65045206|NCT00210782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045207|NCT00210782|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65045208|NCT00210782|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65045209|NCT00210782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65045210|NCT00210782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045211|NCT00210782|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65045212|NCT00210782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65045214|NCT00237900|Fluorouracil|fluorouracil|mesh-list
65045215|NCT00237900|Gefitinib|gefitinib|mesh-list
65045216|NCT00237900|Antimetabolites|antimetabolites|mesh-ancestor
65045217|NCT00237900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045232|NCT00210821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65045233|NCT00210821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045234|NCT00237939|Aripiprazole|aripiprazole|mesh-list
65045235|NCT00237939|Antidepressive Agents|antidepressive agents|mesh-ancestor
65045236|NCT00237939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65045237|NCT00237939|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65045238|NCT00237939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65045239|NCT00237939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65045240|NCT00237939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045241|NCT00237939|Dopamine Agonists|dopamine agonists|mesh-ancestor
65045242|NCT00237939|Dopamine Agents|dopamine agents|mesh-ancestor
65045243|NCT00237939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65045244|NCT00237939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045245|NCT00237939|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65045246|NCT00237939|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65045247|NCT00237939|Serotonin Agents|serotonin agents|mesh-ancestor
65045248|NCT00237939|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65045249|NCT00237939|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65045250|NCT00237939|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65045251|NCT00237939|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65045252|NCT04569214|PAZ320|paz320|mesh-list
65045253|NCT04569214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65045254|NCT04569214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045255|NCT00210860|Topiramate|topiramate|mesh-list
65045256|NCT00210860|Anticonvulsants|anticonvulsants|mesh-ancestor
65045257|NCT00210860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65045258|NCT00210860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045259|NCT00210899|Vancomycin|vancomycin|mesh-list
65045260|NCT00210899|Ceftazidime|ceftazidime|mesh-list
65045261|NCT00210899|Ceftobiprole|ceftobiprole|mesh-list
65045262|NCT00210899|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
65045263|NCT00210899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65045264|NCT00210899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65045265|NCT04568863|Melatonin|melatonin|mesh-list
65045266|NCT04568863|Antioxidants|antioxidants|mesh-ancestor
65045267|NCT04568863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045268|NCT04568863|Protective Agents|protective agents|mesh-ancestor
65045269|NCT04568863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045270|NCT04568863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65045271|NCT00210938|Doripenem|doripenem|mesh-list
65045272|NCT00210938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65045273|NCT00210938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65045274|NCT02278081|Lansoprazole|lansoprazole|mesh-list
65045275|NCT02278081|Dexlansoprazole|dexlansoprazole|mesh-list
65045276|NCT02278081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65045277|NCT02278081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65045278|NCT02278081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65045279|NCT02278081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045280|NCT02278081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045281|NCT00211016|Doripenem|doripenem|mesh-list
65045292|NCT04568161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045293|NCT04568161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65045295|NCT00238017|Amodiaquine|amodiaquine|mesh-list
65045296|NCT00238017|Antimalarials|antimalarials|mesh-ancestor
65045297|NCT00238017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65045298|NCT00238017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65045299|NCT00238017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65045300|NCT00238017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045301|NCT00238017|Antiviral Agents|antiviral agents|mesh-ancestor
65045302|NCT00238017|Schistosomicides|schistosomicides|mesh-ancestor
65045303|NCT00238017|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65045304|NCT00238017|Anthelmintics|anthelmintics|mesh-ancestor
65045305|NCT04567576|Antirheumatic Agents|antirheumatic agents|mesh-list
65045306|NCT00238056|Domperidone|domperidone|mesh-list
65045307|NCT00238056|Antiemetics|antiemetics|mesh-ancestor
65045308|NCT00238056|Autonomic Agents|autonomic agents|mesh-ancestor
65045309|NCT00238056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65045310|NCT00238056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045311|NCT00238056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65045312|NCT00238056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65045313|NCT00238056|Dopamine Agents|dopamine agents|mesh-ancestor
65045314|NCT00238056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65045315|NCT00238056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045316|NCT04566952|Olaparib|olaparib|mesh-list
65045317|NCT04566952|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65045318|NCT04566952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045319|NCT04566952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045320|NCT04566952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045321|NCT04567069|Vaccines|vaccines|mesh-list
65045322|NCT04567069|Immunologic Factors|immunologic factors|mesh-ancestor
65045323|NCT04567069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045324|NCT04566796|Neostigmine|neostigmine|mesh-list
65045325|NCT04566796|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65045326|NCT04566796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045327|NCT04566796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045328|NCT04566796|Cholinergic Agents|cholinergic agents|mesh-ancestor
65045329|NCT04566796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65045330|NCT04566796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045331|NCT04566796|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65045332|NCT04566796|Autonomic Agents|autonomic agents|mesh-ancestor
65045333|NCT04566796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65045334|NCT00238173|Acetylcysteine|acetylcysteine|mesh-list
65045335|NCT00238173|Sodium thiosulfate|sodium thiosulfate|mesh-list
65045336|NCT00238173|Cyclophosphamide|cyclophosphamide|mesh-list
65045337|NCT00238173|Carboplatin|carboplatin|mesh-list
65045338|NCT00238173|Etoposide|etoposide|mesh-list
65045339|NCT00238173|Etoposide phosphate|etoposide phosphate|mesh-list
65045340|NCT00238173|Mannitol|mannitol|mesh-list
65045341|NCT00238173|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65045342|NCT00238173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65045343|NCT00238173|Immunologic Factors|immunologic factors|mesh-ancestor
65045344|NCT00238173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045345|NCT00238173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65045346|NCT00238173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64897242|NCT02012322|Ubiquinone|ubiquinone|mesh-list
65045358|NCT00238173|Respiratory System Agents|respiratory system agents|mesh-ancestor
65045359|NCT00238173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65045360|NCT00238173|Antioxidants|antioxidants|mesh-ancestor
65045361|NCT00238173|Protective Agents|protective agents|mesh-ancestor
65045362|NCT00238173|Antidotes|antidotes|mesh-ancestor
65045363|NCT00238173|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65045364|NCT00238173|Diuretics|diuretics|mesh-ancestor
65045365|NCT00238173|Natriuretic Agents|natriuretic agents|mesh-ancestor
65045366|NCT00238173|Antitubercular Agents|antitubercular agents|mesh-ancestor
65045367|NCT00238173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65045368|NCT00238173|Chelating Agents|chelating agents|mesh-ancestor
65045369|NCT00238173|Sequestering Agents|sequestering agents|mesh-ancestor
65045370|NCT00211133|Epoetin Alfa|epoetin alfa|mesh-list
65045371|NCT00211133|Hematinics|hematinics|mesh-ancestor
65045372|NCT00238212|Sorafenib|sorafenib|mesh-list
65045373|NCT00238212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045374|NCT00238212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65045375|NCT00238212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045376|NCT00238212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472731|NCT02981628|Antimitotic Agents|antimitotic agents|mesh-ancestor
65045377|NCT00211250|Valproic Acid|valproic acid|mesh-list
65045378|NCT00211250|Anticonvulsants|anticonvulsants|mesh-ancestor
65045379|NCT00211250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045380|NCT00211250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045381|NCT00211250|GABA Agents|gaba agents|mesh-ancestor
65045382|NCT00211250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65045383|NCT00211250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045384|NCT00211250|Antimanic Agents|antimanic agents|mesh-ancestor
65045385|NCT00211250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65045386|NCT00211250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65045387|NCT00211250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65045388|NCT00238251|Temozolomide|temozolomide|mesh-list
65045389|NCT00238251|Gefitinib|gefitinib|mesh-list
65045390|NCT00238251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65045391|NCT00238251|Alkylating Agents|alkylating agents|mesh-ancestor
65045392|NCT00238251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045393|NCT00238251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045394|NCT00238251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65045395|NCT00238251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045396|NCT04566718|Metformin|metformin|mesh-list
65045397|NCT04566718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65045398|NCT04566718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045399|NCT02210884|Vitamin D|vitamin d|mesh-list
65045400|NCT02210884|Ergocalciferols|ergocalciferols|mesh-list
65045401|NCT02210884|Cholecalciferol|cholecalciferol|mesh-list
65045402|NCT02210884|Vitamins|vitamins|mesh-list
65045403|NCT02210884|Micronutrients|micronutrients|mesh-ancestor
65045404|NCT02210884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045405|NCT02210884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65045406|NCT02210884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65045407|NCT00238290|Trastuzumab|trastuzumab|mesh-list
65045408|NCT00238290|Letrozole|letrozole|mesh-list
65045409|NCT00238290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65045428|NCT00238329|Interferon alpha-2|interferon alpha-2|mesh-list
65045429|NCT00238329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65045430|NCT00238329|Thalidomide|thalidomide|mesh-list
65045431|NCT00238329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045432|NCT00238329|Antiviral Agents|antiviral agents|mesh-ancestor
65045433|NCT00238329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65045434|NCT00238329|Immunologic Factors|immunologic factors|mesh-ancestor
65045435|NCT00238329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045436|NCT00238329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65045437|NCT00238329|Leprostatic Agents|leprostatic agents|mesh-ancestor
65045438|NCT00238329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65045439|NCT00238329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65045440|NCT00238329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65045441|NCT00238329|Growth Substances|growth substances|mesh-ancestor
65045442|NCT00238329|Growth Inhibitors|growth inhibitors|mesh-ancestor
65045443|NCT02894905|Adafosbuvir|adafosbuvir|mesh-list
65045444|NCT02894905|Antiviral Agents|antiviral agents|mesh-ancestor
65045445|NCT02894905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65045446|NCT00211367|Anecortave|anecortave|mesh-list
65045447|NCT00211367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65045448|NCT00211367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65045449|NCT00211367|Growth Substances|growth substances|mesh-ancestor
65045450|NCT00211367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045451|NCT00211367|Growth Inhibitors|growth inhibitors|mesh-ancestor
65045452|NCT00211367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045453|NCT00238368|Cytarabine|cytarabine|mesh-list
65045454|NCT00238368|Prednisone|prednisone|mesh-list
65045455|NCT00238368|Methylprednisolone|methylprednisolone|mesh-list
65045456|NCT00238368|Cyclophosphamide|cyclophosphamide|mesh-list
65045457|NCT00238368|Busulfan|busulfan|mesh-list
65045458|NCT00238368|Rituximab|rituximab|mesh-list
65045459|NCT00238368|Doxorubicin|doxorubicin|mesh-list
65045460|NCT00238368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65045461|NCT00238368|Etoposide|etoposide|mesh-list
65045462|NCT00238368|Vincristine|vincristine|mesh-list
65045463|NCT00238368|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65045464|NCT00238368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65045465|NCT00238368|Immunologic Factors|immunologic factors|mesh-ancestor
65045466|NCT00238368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045467|NCT00238368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64897370|NCT02013115|Glucocorticoids|glucocorticoids|mesh-ancestor
65045476|NCT00238368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65045477|NCT00238368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045478|NCT00238368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65045480|NCT00238368|Hormones|hormones|mesh-ancestor
65045481|NCT00238368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65045482|NCT00238368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65045483|NCT00238368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65045484|NCT00238368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65045485|NCT00238368|Antimetabolites|antimetabolites|mesh-ancestor
65045486|NCT00238368|Antiviral Agents|antiviral agents|mesh-ancestor
65045487|NCT00238368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65045488|NCT00238368|Tubulin Modulators|tubulin modulators|mesh-ancestor
65045489|NCT00238368|Antimitotic Agents|antimitotic agents|mesh-ancestor
65045490|NCT00238368|Mitosis Modulators|mitosis modulators|mesh-ancestor
65045491|NCT00238368|Antiemetics|antiemetics|mesh-ancestor
65045492|NCT00238368|Autonomic Agents|autonomic agents|mesh-ancestor
65045493|NCT00238368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65045494|NCT00238368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65045495|NCT00238368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65045496|NCT00238368|Protective Agents|protective agents|mesh-ancestor
65045497|NCT00238368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65045498|NCT02894593|Ethanol|ethanol|mesh-list
65045499|NCT02894593|Chlorhexidine|chlorhexidine|mesh-list
65045500|NCT02894593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65045501|NCT02894593|Listerine|listerine|mesh-list
65045502|NCT02894593|Sodium Fluoride|sodium fluoride|mesh-list
65045503|NCT02894593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65045504|NCT02894593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65045505|NCT02894593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65045506|NCT02894593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045507|NCT02894593|Disinfectants|disinfectants|mesh-ancestor
65045508|NCT02894593|Dermatologic Agents|dermatologic agents|mesh-ancestor
65045509|NCT02894593|Cariostatic Agents|cariostatic agents|mesh-ancestor
65045510|NCT02894593|Protective Agents|protective agents|mesh-ancestor
65045511|NCT00211406|Anecortave|anecortave|mesh-list
64486898|NCT03218722|Thrombin|thrombin|mesh-list
65045512|NCT00211406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65045513|NCT00211406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65045514|NCT00211406|Growth Substances|growth substances|mesh-ancestor
65045515|NCT00211406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045516|NCT00211406|Growth Inhibitors|growth inhibitors|mesh-ancestor
65045517|NCT00211406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045519|NCT02894554|Telbivudine|telbivudine|mesh-list
65045520|NCT02894554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65045521|NCT02894554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65045523|NCT02894554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045524|NCT02894554|Antiviral Agents|antiviral agents|mesh-ancestor
65045525|NCT02894554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65045526|NCT02894554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65045527|NCT02894554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65045528|NCT00238407|Docetaxel|docetaxel|mesh-list
65045529|NCT00238407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045530|NCT00238407|Tubulin Modulators|tubulin modulators|mesh-ancestor
65045531|NCT00238407|Antimitotic Agents|antimitotic agents|mesh-ancestor
65045532|NCT00238407|Mitosis Modulators|mitosis modulators|mesh-ancestor
65045533|NCT00238407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045534|NCT00211445|Verteporfin|verteporfin|mesh-list
65045545|NCT02894710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65045546|NCT02894710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65045547|NCT02894710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65045548|NCT02894710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045549|NCT00211484|Anecortave|anecortave|mesh-list
65045550|NCT00211484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65045551|NCT00211484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65045552|NCT00211484|Growth Substances|growth substances|mesh-ancestor
65045553|NCT00211484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045554|NCT00211484|Growth Inhibitors|growth inhibitors|mesh-ancestor
65045555|NCT00211484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045556|NCT05428072|Aspirin|aspirin|mesh-list
65045557|NCT05428072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65045558|NCT05428072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65045559|NCT05428072|Analgesics|analgesics|mesh-ancestor
65045560|NCT05428072|Sensory System Agents|sensory system agents|mesh-ancestor
65045561|NCT05428072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65045562|NCT05428072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045563|NCT05428072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65045564|NCT05428072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65045565|NCT05428072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65045566|NCT05428072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65248446|NCT02841722|Immunologic Factors|immunologic factors|mesh-ancestor
64472732|NCT02981628|Mitosis Modulators|mitosis modulators|mesh-ancestor
65045567|NCT05428072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045568|NCT05428072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65045569|NCT05428072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65045570|NCT05428072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045571|NCT05428072|Antipyretics|antipyretics|mesh-ancestor
65045572|NCT00211523|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
65045573|NCT00211523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65045574|NCT00211562|Vitamin E|vitamin e|mesh-list
65045575|NCT00211562|Olanzapine|olanzapine|mesh-list
65045576|NCT00211562|Vitamins|vitamins|mesh-ancestor
65045577|NCT00211562|Micronutrients|micronutrients|mesh-ancestor
65045578|NCT00211562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045579|NCT00211562|Antiemetics|antiemetics|mesh-ancestor
65045580|NCT00211562|Autonomic Agents|autonomic agents|mesh-ancestor
65045581|NCT00211562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65045582|NCT00211562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65045583|NCT00211562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65045584|NCT00211562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65045585|NCT00211562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65045586|NCT00211562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65045587|NCT00211562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65045588|NCT00211562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65045589|NCT00211562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65045590|NCT00211562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045591|NCT00211562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65045592|NCT00211562|Serotonin Agents|serotonin agents|mesh-ancestor
65045593|NCT00211562|Antioxidants|antioxidants|mesh-ancestor
65045594|NCT00211562|Protective Agents|protective agents|mesh-ancestor
65045595|NCT05427721|Thymol|thymol|mesh-list
65045596|NCT05427721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65045597|NCT05427721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65045598|NCT05427721|Antifungal Agents|antifungal agents|mesh-ancestor
65045599|NCT00238641|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
65045632|NCT00211679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65045633|NCT00211679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045634|NCT00211679|Cholinergic Agents|cholinergic agents|mesh-ancestor
65045635|NCT00211679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65045636|NCT00211679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045637|NCT00211679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65045638|NCT00211679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65045639|NCT04680091|Efavirenz|efavirenz|mesh-list
65045666|NCT00238719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65045667|NCT00238719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045668|NCT00238719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65045669|NCT00238719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045670|NCT00238719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65045671|NCT00238719|Antidepressive Agents|antidepressive agents|mesh-ancestor
65045672|NCT00238719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65045673|NCT04680208|Anesthetics|anesthetics|mesh-list
65045674|NCT04680208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65045675|NCT04680208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045676|NCT00211796|Valproic Acid|valproic acid|mesh-list
65045677|NCT00211796|Anticonvulsants|anticonvulsants|mesh-ancestor
65045678|NCT00211796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045679|NCT00211796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045711|NCT05425654|Alkylating Agents|alkylating agents|mesh-ancestor
65045712|NCT05425654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045713|NCT05425654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045714|NCT05425654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65045715|NCT05425654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65045716|NCT05425654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65045717|NCT05425654|Abortifacient Agents|abortifacient agents|mesh-ancestor
65045718|NCT05425654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65045719|NCT05425654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65045720|NCT05425654|Antimetabolites|antimetabolites|mesh-ancestor
65045721|NCT05425654|Dermatologic Agents|dermatologic agents|mesh-ancestor
65045722|NCT05425654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045723|NCT05425654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65045724|NCT05425654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65045735|NCT05425576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045736|NCT00238914|Naltrexone|naltrexone|mesh-list
65045737|NCT00238914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64560184|NCT02168361|Sofosbuvir|sofosbuvir|mesh-list
65045738|NCT00238914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65045739|NCT00238914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045740|NCT00238914|Sensory System Agents|sensory system agents|mesh-ancestor
65045741|NCT00238914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65045742|NCT04668976|Gemcitabine|gemcitabine|mesh-list
65045743|NCT04668976|Fluorouracil|fluorouracil|mesh-list
65045744|NCT04668976|Floxuridine|floxuridine|mesh-list
65045745|NCT04668976|Oxaliplatin|oxaliplatin|mesh-list
65045746|NCT04668976|Irinotecan|irinotecan|mesh-list
65045747|NCT04668976|Cetuximab|cetuximab|mesh-list
65045748|NCT04668976|Panitumumab|panitumumab|mesh-list
65045749|NCT04668976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65045750|NCT04668976|Antimetabolites|antimetabolites|mesh-ancestor
65045751|NCT04668976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045752|NCT04668976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045753|NCT04668976|Antiviral Agents|antiviral agents|mesh-ancestor
65045754|NCT04668976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65045755|NCT04668976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045756|NCT04668976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65045757|NCT04668976|Immunologic Factors|immunologic factors|mesh-ancestor
65045758|NCT04668976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045759|NCT04668976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65045760|NCT04668976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65045761|NCT04668976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65045762|NCT00238953|Mycophenolic Acid|mycophenolic acid|mesh-list
65045763|NCT00238953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65045764|NCT00238953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045765|NCT00238953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65045766|NCT00238953|Antitubercular Agents|antitubercular agents|mesh-ancestor
65045767|NCT00238953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65045768|NCT00238953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65045769|NCT00238953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045770|NCT00238953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045771|NCT04669366|Sunitinib|sunitinib|mesh-list
65045772|NCT04669366|Axitinib|axitinib|mesh-list
65045773|NCT04669366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045774|NCT04669366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65045775|NCT04669366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65045776|NCT04669366|Growth Substances|growth substances|mesh-ancestor
65045777|NCT04669366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045778|NCT04669366|Growth Inhibitors|growth inhibitors|mesh-ancestor
65045779|NCT04669366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65045780|NCT04669366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045781|NCT04669366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045782|NCT04721301|Maraviroc|maraviroc|mesh-list
65045783|NCT04721301|Nivolumab|nivolumab|mesh-list
65045784|NCT04721301|Ipilimumab|ipilimumab|mesh-list
65045785|NCT04721301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65045786|NCT04721301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045787|NCT04721301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65045788|NCT04721301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897683|NCT02015299|Hormones|hormones|mesh-ancestor
65045797|NCT00238992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65045798|NCT00238992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045799|NCT00238992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65045800|NCT00238992|Antitubercular Agents|antitubercular agents|mesh-ancestor
65045801|NCT00238992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65045802|NCT00238992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65045803|NCT00238992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045804|NCT00238992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045805|NCT00556465|Acetylcysteine|acetylcysteine|mesh-list
65045806|NCT00556465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65045807|NCT00556465|Antiviral Agents|antiviral agents|mesh-ancestor
65045808|NCT00556465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65045809|NCT00556465|Expectorants|expectorants|mesh-ancestor
64487200|NCT00904618|Lidocaine|lidocaine|mesh-list
65045810|NCT00556465|Respiratory System Agents|respiratory system agents|mesh-ancestor
65045811|NCT00556465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65045812|NCT00556465|Antioxidants|antioxidants|mesh-ancestor
65045813|NCT00556465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045814|NCT00556465|Protective Agents|protective agents|mesh-ancestor
65045815|NCT00556465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045816|NCT00556465|Antidotes|antidotes|mesh-ancestor
65045817|NCT04668469|Acetaminophen|acetaminophen|mesh-list
65045818|NCT04668469|Vitamins|vitamins|mesh-list
65045819|NCT04668469|Ascorbic Acid|ascorbic acid|mesh-list
65045820|NCT04668469|Zinc|zinc|mesh-list
65045821|NCT04668469|Azithromycin|azithromycin|mesh-list
65045822|NCT04668469|Hydroxychloroquine|hydroxychloroquine|mesh-list
65045823|NCT04668469|Ivermectin|ivermectin|mesh-list
65045824|NCT04668469|Lactoferrin|lactoferrin|mesh-list
65045825|NCT04668469|Fibrin fragment D|fibrin fragment d|mesh-list
65045826|NCT04668469|Micronutrients|micronutrients|mesh-ancestor
65045827|NCT04668469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045828|NCT04668469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65045829|NCT04668469|Analgesics|analgesics|mesh-ancestor
65045830|NCT04668469|Sensory System Agents|sensory system agents|mesh-ancestor
65045831|NCT04668469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65045832|NCT04668469|Antipyretics|antipyretics|mesh-ancestor
65045833|NCT04668469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65045834|NCT04668469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65045835|NCT04668469|Antimalarials|antimalarials|mesh-ancestor
65045836|NCT04668469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65045837|NCT04668469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65045838|NCT04668469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045839|NCT04668469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045840|NCT04668469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65045841|NCT04668469|Trace Elements|trace elements|mesh-ancestor
65045842|NCT04668469|Antioxidants|antioxidants|mesh-ancestor
65045843|NCT04668469|Protective Agents|protective agents|mesh-ancestor
65045844|NCT04668469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65045845|NCT04668469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65045846|NCT04668469|Hemostatics|hemostatics|mesh-ancestor
65045847|NCT04668469|Coagulants|coagulants|mesh-ancestor
65045848|NCT00239031|Mycophenolic Acid|mycophenolic acid|mesh-list
65045849|NCT00239031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65045850|NCT00239031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045851|NCT00239031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65045852|NCT00239031|Antitubercular Agents|antitubercular agents|mesh-ancestor
65045853|NCT00239031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65045854|NCT00239031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65045855|NCT00239031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045856|NCT00239031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045857|NCT00239070|Mycophenolic Acid|mycophenolic acid|mesh-list
65045858|NCT00239070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65045871|NCT00211952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65045872|NCT00211952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045873|NCT00211952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65045874|NCT00211952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65045875|NCT00211952|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65045876|NCT00211952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65045877|NCT00211952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045878|NCT00211952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045879|NCT00239109|Olanzapine|olanzapine|mesh-list
65045880|NCT00239109|Ziprasidone|ziprasidone|mesh-list
65045881|NCT00239109|Antiemetics|antiemetics|mesh-ancestor
65045882|NCT00239109|Autonomic Agents|autonomic agents|mesh-ancestor
65045883|NCT00239109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65045884|NCT00239109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045885|NCT00239109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65045886|NCT00239109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65045887|NCT00239109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65045888|NCT00239109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65045889|NCT00239109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65045890|NCT00239109|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65045891|NCT00239109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65045892|NCT00239109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65045893|NCT00239109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045894|NCT00239109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65045895|NCT00239109|Serotonin Agents|serotonin agents|mesh-ancestor
65045896|NCT00239109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65045897|NCT00239109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65045898|NCT00239109|Dopamine Agents|dopamine agents|mesh-ancestor
65045899|NCT00212030|Nicorandil|nicorandil|mesh-list
65045900|NCT00212030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65045901|NCT00212030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65045902|NCT00212030|Vasodilator Agents|vasodilator agents|mesh-ancestor
65045903|NCT00212030|Vitamin B Complex|vitamin b complex|mesh-ancestor
65045904|NCT00212030|Vitamins|vitamins|mesh-ancestor
65045905|NCT00212030|Micronutrients|micronutrients|mesh-ancestor
65045906|NCT00212030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045907|NCT00212069|Gemcitabine|gemcitabine|mesh-list
65045908|NCT00212069|Carboplatin|carboplatin|mesh-list
65045909|NCT00212069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821104|NCT01514110|Everolimus|everolimus|mesh-list
65045910|NCT00212069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65045911|NCT00212069|Antimetabolites|antimetabolites|mesh-ancestor
65045912|NCT00212069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045913|NCT00212069|Antiviral Agents|antiviral agents|mesh-ancestor
65045914|NCT00212069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65045915|NCT00212069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045916|NCT00212069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65045917|NCT00212069|Immunologic Factors|immunologic factors|mesh-ancestor
65045918|NCT00212069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045919|NCT00212108|Celecoxib|celecoxib|mesh-list
65045920|NCT00212108|Gefitinib|gefitinib|mesh-list
65045921|NCT00212108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65045944|NCT00414336|Immunologic Factors|immunologic factors|mesh-ancestor
65045945|NCT00414336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045947|NCT00414336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045948|NCT00414336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65045949|NCT00212342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65045950|NCT00212342|Norethindrone|norethindrone|mesh-list
65045951|NCT00212342|Norethindrone Acetate|norethindrone acetate|mesh-list
65045952|NCT00212342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65045953|NCT00212342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65045954|NCT00212342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65045955|NCT00212342|Contraceptive Agents|contraceptive agents|mesh-ancestor
65045956|NCT00212342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65045957|NCT00212342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045958|NCT00212342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65045959|NCT00212342|Estrogens|estrogens|mesh-ancestor
65045960|NCT00212342|Hormones|hormones|mesh-ancestor
65045961|NCT00212342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65045962|NCT00212342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65045964|NCT00414414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65045965|NCT00414414|Glucocorticoids|glucocorticoids|mesh-ancestor
65045966|NCT00414414|Hormones|hormones|mesh-ancestor
65045967|NCT00414414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65045968|NCT00414414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045969|NCT00414414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65045970|NCT00414414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045971|NCT00239304|Gefitinib|gefitinib|mesh-list
65045972|NCT00239304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045973|NCT00239304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65046008|NCT00239421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65046009|NCT00239421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65046010|NCT00239421|Autonomic Agents|autonomic agents|mesh-ancestor
65046011|NCT00239421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65046012|NCT00239421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046013|NCT00239421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65046014|NCT00239421|Respiratory System Agents|respiratory system agents|mesh-ancestor
65046046|NCT00239499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65046047|NCT00239499|Respiratory System Agents|respiratory system agents|mesh-ancestor
65046048|NCT00239499|Dermatologic Agents|dermatologic agents|mesh-ancestor
65046049|NCT00239499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65046050|NCT00239499|Parasympatholytics|parasympatholytics|mesh-ancestor
65046051|NCT00239499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65046052|NCT00239499|Cholinergic Agents|cholinergic agents|mesh-ancestor
65046053|NCT00239499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64897970|NCT02016976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65046087|NCT00212654|Adrenergic Agents|adrenergic agents|mesh-ancestor
65046088|NCT00212654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65046089|NCT00212654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046090|NCT00212654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046091|NCT00212654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65046092|NCT00239538|Valsartan|valsartan|mesh-list
64531414|NCT03859427|Lenalidomide|lenalidomide|mesh-list
64531415|NCT03859427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64531416|NCT03859427|Antiemetics|antiemetics|mesh-ancestor
64531417|NCT03859427|Autonomic Agents|autonomic agents|mesh-ancestor
64531420|NCT03859427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65046106|NCT00212810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65046107|NCT00212810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046108|NCT00222651|Tenecteplase|tenecteplase|mesh-list
65046109|NCT00222651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65046110|NCT00222651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65046111|NCT00222651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046112|NCT00239616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65046113|NCT00239616|Hematinics|hematinics|mesh-ancestor
65046115|NCT00213122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046116|NCT00213122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046117|NCT00213122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65046118|NCT00213122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046119|NCT00213122|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65046120|NCT00213200|Morphine|morphine|mesh-list
65046121|NCT00213200|Tetracaine|tetracaine|mesh-list
65046122|NCT00213200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65046123|NCT00213200|Narcotics|narcotics|mesh-ancestor
65046124|NCT00213200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65046125|NCT00213200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046126|NCT00213200|Analgesics|analgesics|mesh-ancestor
65046127|NCT00213200|Sensory System Agents|sensory system agents|mesh-ancestor
65046128|NCT00213200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65046129|NCT00213200|Anesthetics, Local|anesthetics, local|mesh-ancestor
65046130|NCT00213200|Anesthetics|anesthetics|mesh-ancestor
65046131|NCT00239811|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65046132|NCT00239811|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65046133|NCT00239811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046134|NCT00239811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65046135|NCT00239811|Immunologic Factors|immunologic factors|mesh-ancestor
65046136|NCT00239811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046137|NCT00213278|Vinblastine|vinblastine|mesh-list
65046138|NCT00213278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65046139|NCT00213278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046140|NCT00213278|Tubulin Modulators|tubulin modulators|mesh-ancestor
65046141|NCT00213278|Antimitotic Agents|antimitotic agents|mesh-ancestor
65046142|NCT00213278|Mitosis Modulators|mitosis modulators|mesh-ancestor
65046143|NCT00213278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046144|NCT00239889|Calcitonin|calcitonin|mesh-list
65046145|NCT00239889|Salmon calcitonin|salmon calcitonin|mesh-list
65046146|NCT00239889|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
65046147|NCT00239889|Katacalcin|katacalcin|mesh-list
65046148|NCT00239889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65046166|NCT00213512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65046167|NCT00213512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046168|NCT00213512|Immunologic Factors|immunologic factors|mesh-ancestor
65046169|NCT00213512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046170|NCT00213512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65046171|NCT00213551|Antioxidants|antioxidants|mesh-list
65046172|NCT00213551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487575|NCT01722448|Choline|choline|mesh-list
64531490|NCT03493854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64531491|NCT03478878|Vitamin A|vitamin a|mesh-list
64531492|NCT03478878|Retinol palmitate|retinol palmitate|mesh-list
64531493|NCT03478878|Vitamins|vitamins|mesh-ancestor
64531494|NCT03478878|Micronutrients|micronutrients|mesh-ancestor
64531495|NCT03478878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046173|NCT00213551|Protective Agents|protective agents|mesh-ancestor
65046174|NCT00213551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046175|NCT00240006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65046176|NCT00213590|Cyclosporine|cyclosporine|mesh-list
65046177|NCT00213590|Cyclosporins|cyclosporins|mesh-list
65046178|NCT00213590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046179|NCT00213590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046180|NCT00213590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65046181|NCT00213590|Immunologic Factors|immunologic factors|mesh-ancestor
65046182|NCT00213590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046183|NCT00213590|Antifungal Agents|antifungal agents|mesh-ancestor
65046184|NCT00213590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65046185|NCT00213590|Dermatologic Agents|dermatologic agents|mesh-ancestor
65046186|NCT00213590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65046187|NCT00213590|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65046188|NCT00240045|Octreotide|octreotide|mesh-list
65046189|NCT00240045|Midodrine|midodrine|mesh-list
65046190|NCT00240045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65046191|NCT00240045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65046192|NCT00240045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046193|NCT00240045|Sympathomimetics|sympathomimetics|mesh-ancestor
65046194|NCT00240045|Autonomic Agents|autonomic agents|mesh-ancestor
65046195|NCT00240045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65046196|NCT00240045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046197|NCT00240045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65046198|NCT00240045|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65046223|NCT00243711|Laxatives|laxatives|mesh-ancestor
65046224|NCT00243711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65046225|NCT00240123|Diphenhydramine|diphenhydramine|mesh-list
65046226|NCT00240123|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65046227|NCT00240123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65046228|NCT00240123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65046229|NCT00240123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046230|NCT00240123|Anesthetics, Local|anesthetics, local|mesh-ancestor
65046231|NCT00240123|Anesthetics|anesthetics|mesh-ancestor
65046232|NCT00240123|Sensory System Agents|sensory system agents|mesh-ancestor
65046233|NCT00240123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65046234|NCT00240123|Antiemetics|antiemetics|mesh-ancestor
65046235|NCT00240123|Autonomic Agents|autonomic agents|mesh-ancestor
65046236|NCT00240123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65046237|NCT00240123|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65046238|NCT00240123|Histamine Antagonists|histamine antagonists|mesh-ancestor
65046239|NCT00240123|Histamine Agents|histamine agents|mesh-ancestor
65046240|NCT00240123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65046241|NCT00240123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046242|NCT00240123|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65046243|NCT00240279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65046244|NCT00240279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65046245|NCT00240279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65046246|NCT00240279|Antimetabolites|antimetabolites|mesh-ancestor
64898171|NCT02018523|Growth Substances|growth substances|mesh-ancestor
65046265|NCT00243750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65046266|NCT00243750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65046268|NCT00243789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65046269|NCT00243789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046270|NCT00243789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046271|NCT00243789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65046272|NCT00243789|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65046273|NCT00243789|Protective Agents|protective agents|mesh-ancestor
65046274|NCT00243789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046275|NCT00243789|Vasodilator Agents|vasodilator agents|mesh-ancestor
65046276|NCT00243789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65046277|NCT00243789|Antioxidants|antioxidants|mesh-ancestor
65046278|NCT00214058|Carboplatin|carboplatin|mesh-list
65046280|NCT00214058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046281|NCT00214058|Tubulin Modulators|tubulin modulators|mesh-ancestor
65046282|NCT00214058|Antimitotic Agents|antimitotic agents|mesh-ancestor
65046283|NCT00214058|Mitosis Modulators|mitosis modulators|mesh-ancestor
65046284|NCT00214058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046285|NCT00240318|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65046286|NCT00240318|Calcium|calcium|mesh-list
65046287|NCT00240318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65046288|NCT00240318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046289|NCT00240318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65046290|NCT00240318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65046291|NCT00240318|Antimetabolites|antimetabolites|mesh-ancestor
65046292|NCT00240318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046293|NCT00240318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65046294|NCT00240318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65046295|NCT00240318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046296|NCT00243945|Rotigotine|rotigotine|mesh-list
65046297|NCT00243945|Dopamine Agonists|dopamine agonists|mesh-ancestor
65046298|NCT00243945|Dopamine Agents|dopamine agents|mesh-ancestor
65046299|NCT00243945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65046300|NCT00243945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046301|NCT00243945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046365|NCT00244023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65046366|NCT00244023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046367|NCT00244023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65046368|NCT00244023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046369|NCT00244023|Anabolic Agents|anabolic agents|mesh-ancestor
65046370|NCT00240474|Amlodipine|amlodipine|mesh-list
65046371|NCT00240474|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65046372|NCT00240474|Telmisartan|telmisartan|mesh-list
65046373|NCT00240474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65046374|NCT00240474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65046375|NCT00240474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65046376|NCT00240474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046377|NCT00240474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65046378|NCT00240474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046379|NCT00240474|Vasodilator Agents|vasodilator agents|mesh-ancestor
65046380|NCT00240474|Diuretics|diuretics|mesh-ancestor
65046381|NCT00240474|Natriuretic Agents|natriuretic agents|mesh-ancestor
65046382|NCT00240474|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65046383|NCT00240474|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65046384|NCT00240474|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65046385|NCT00214604|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65046386|NCT00214604|Pravastatin|pravastatin|mesh-list
65046387|NCT00214604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65046388|NCT00214604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65046389|NCT00214604|Antimetabolites|antimetabolites|mesh-ancestor
65046390|NCT00214604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046402|NCT00214643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046404|NCT00414531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65046405|NCT00414531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65046406|NCT00414531|Antimetabolites|antimetabolites|mesh-ancestor
65046407|NCT00414531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046408|NCT00414531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65046409|NCT00414531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65046410|NCT00414531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046411|NCT00214682|Vitamin B 12|vitamin b 12|mesh-list
65046412|NCT00214682|Hydroxocobalamin|hydroxocobalamin|mesh-list
65046413|NCT00214682|Vitamins|vitamins|mesh-ancestor
65046414|NCT00214682|Micronutrients|micronutrients|mesh-ancestor
65046415|NCT00214682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046416|NCT00214682|Vitamin B Complex|vitamin b complex|mesh-ancestor
65046417|NCT00214682|Hematinics|hematinics|mesh-ancestor
65046418|NCT00214721|Dialysis Solutions|dialysis solutions|mesh-list
65046419|NCT00214721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65046420|NCT00240513|Minocycline|minocycline|mesh-list
65046421|NCT00240513|Tretinoin|tretinoin|mesh-list
65046422|NCT00240513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65046423|NCT00240513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65046424|NCT00240513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046425|NCT00240513|Keratolytic Agents|keratolytic agents|mesh-ancestor
65046426|NCT00240513|Dermatologic Agents|dermatologic agents|mesh-ancestor
65046427|NCT00240552|Fosamprenavir|fosamprenavir|mesh-list
65046428|NCT00240552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65046429|NCT00240552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65046430|NCT00240552|Protease Inhibitors|protease inhibitors|mesh-ancestor
65046431|NCT00240552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046432|NCT00240552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046433|NCT00240552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65046434|NCT00240552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65046435|NCT00240552|Antiviral Agents|antiviral agents|mesh-ancestor
65046436|NCT00240552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65046437|NCT00214877|Methylene Blue|methylene blue|mesh-list
65046438|NCT00214877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046439|NCT00214877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046440|NCT00214955|Fentanyl|fentanyl|mesh-list
65046441|NCT00214955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65046442|NCT00214955|Narcotics|narcotics|mesh-ancestor
65046443|NCT00214955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65046444|NCT00214955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046445|NCT00214955|Analgesics|analgesics|mesh-ancestor
65046446|NCT00214955|Sensory System Agents|sensory system agents|mesh-ancestor
65046465|NCT00214994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65046466|NCT00214994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046467|NCT00214994|GABA Agents|gaba agents|mesh-ancestor
65046468|NCT00214994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65046469|NCT00214994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046471|NCT00240630|Sumatriptan|sumatriptan|mesh-list
65046472|NCT00240630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65046473|NCT00240630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65046474|NCT00240630|Analgesics|analgesics|mesh-ancestor
65046475|NCT00240630|Sensory System Agents|sensory system agents|mesh-ancestor
65046476|NCT00240630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65046477|NCT00240630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046478|NCT00240630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65046479|NCT00240630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65046480|NCT00240630|Gout Suppressants|gout suppressants|mesh-ancestor
65046481|NCT00240630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65046482|NCT00240630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046483|NCT00240630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046484|NCT00240630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65046485|NCT00240630|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65046486|NCT00240630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65046487|NCT00240630|Serotonin Agents|serotonin agents|mesh-ancestor
65046488|NCT00240630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65046489|NCT00244296|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65046490|NCT00244296|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65046491|NCT00244296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65046492|NCT00244296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65046493|NCT00244296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046494|NCT00244296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65046495|NCT00244296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046496|NCT00244296|Analgesics|analgesics|mesh-ancestor
65046497|NCT00244296|Sensory System Agents|sensory system agents|mesh-ancestor
65046498|NCT00244296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65046499|NCT00244296|Antidepressive Agents|antidepressive agents|mesh-ancestor
65046500|NCT00244296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65046501|NCT00244296|Dopamine Agents|dopamine agents|mesh-ancestor
65046502|NCT00215228|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65046503|NCT00215228|Citalopram|citalopram|mesh-list
65046504|NCT00215228|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64898429|NCT02020122|Pregabalin|pregabalin|mesh-list
65046532|NCT00240708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65046533|NCT00240708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65046534|NCT00240708|Dopamine Agents|dopamine agents|mesh-ancestor
65046536|NCT00215345|Docetaxel|docetaxel|mesh-list
65046537|NCT00215345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046538|NCT00215345|Tubulin Modulators|tubulin modulators|mesh-ancestor
65046539|NCT00215345|Antimitotic Agents|antimitotic agents|mesh-ancestor
65046540|NCT00215345|Mitosis Modulators|mitosis modulators|mesh-ancestor
65046541|NCT00215345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046542|NCT00215345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65046543|NCT00215345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65046544|NCT00215345|Analgesics|analgesics|mesh-ancestor
65046545|NCT00215345|Sensory System Agents|sensory system agents|mesh-ancestor
65046546|NCT00215345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65046547|NCT00215345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046574|NCT00215423|Autonomic Agents|autonomic agents|mesh-ancestor
65046575|NCT00215423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65046576|NCT00215423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046577|NCT00215423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65046578|NCT00215423|Respiratory System Agents|respiratory system agents|mesh-ancestor
65046579|NCT00215423|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65046580|NCT00215423|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65046581|NCT00215423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65046582|NCT00215423|Adrenergic Agents|adrenergic agents|mesh-ancestor
65046583|NCT00215423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65046584|NCT00215423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046585|NCT04668352|Dactolisib|dactolisib|mesh-list
65046586|NCT04668352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046587|NCT00215462|Vinorelbine|vinorelbine|mesh-list
65046588|NCT00215462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65046589|NCT00215462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046590|NCT00215462|Tubulin Modulators|tubulin modulators|mesh-ancestor
65046591|NCT00215462|Antimitotic Agents|antimitotic agents|mesh-ancestor
65046592|NCT00215462|Mitosis Modulators|mitosis modulators|mesh-ancestor
64898536|NCT02020681|Fluorides|fluorides|mesh-list
65046620|NCT00215579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65046621|NCT00215579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65046622|NCT00215579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65046623|NCT00215579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65046624|NCT00215579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65046625|NCT00215579|Dopamine Agents|dopamine agents|mesh-ancestor
65046627|NCT00556621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046628|NCT00556621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65046630|NCT00556621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046631|NCT00556621|Antiviral Agents|antiviral agents|mesh-ancestor
65046632|NCT00556621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65046633|NCT00556621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046634|NCT00556621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65046635|NCT00556621|Immunologic Factors|immunologic factors|mesh-ancestor
65046636|NCT00556621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046637|NCT00244452|Cetrorelix|cetrorelix|mesh-list
64560679|NCT01034553|Bortezomib|bortezomib|mesh-list
65046638|NCT00244452|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65046655|NCT00411866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046656|NCT00411866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046657|NCT00411866|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65046658|NCT00411866|Hormone Antagonists|hormone antagonists|mesh-ancestor
65046659|NCT00411866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65046660|NCT00411866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046661|NCT00411866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65046662|NCT04667299|Amoxicillin|amoxicillin|mesh-list
65046663|NCT04667299|Metronidazole|metronidazole|mesh-list
65046664|NCT04667299|Potassium Citrate|potassium citrate|mesh-list
65046665|NCT04667299|Rabeprazole|rabeprazole|mesh-list
65046666|NCT04667299|Bismuth|bismuth|mesh-list
65046667|NCT04667299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046668|NCT04667299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65046669|NCT04667299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65046670|NCT04667299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65046671|NCT04667299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65046672|NCT04667299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65046673|NCT04667299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65046674|NCT04667299|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65046675|NCT04667299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046676|NCT04667299|Antacids|antacids|mesh-ancestor
65046677|NCT04667299|Diuretics|diuretics|mesh-ancestor
65046678|NCT04667299|Natriuretic Agents|natriuretic agents|mesh-ancestor
65046679|NCT04667299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046680|NCT04667299|Expectorants|expectorants|mesh-ancestor
65046681|NCT04667299|Respiratory System Agents|respiratory system agents|mesh-ancestor
65046682|NCT04667143|Metformin|metformin|mesh-list
65046683|NCT04667143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65046684|NCT04667143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046685|NCT00240825|Acetaminophen|acetaminophen|mesh-list
65046686|NCT00240825|Ibuprofen|ibuprofen|mesh-list
65046687|NCT00240825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65046688|NCT00240825|Analgesics|analgesics|mesh-ancestor
65046689|NCT00240825|Sensory System Agents|sensory system agents|mesh-ancestor
64532012|NCT04505280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65046690|NCT00240825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65046691|NCT00240825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046692|NCT00240825|Antipyretics|antipyretics|mesh-ancestor
65046693|NCT00240825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65046694|NCT00240825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65046695|NCT00240825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65046717|NCT00240864|Ibuprofen|ibuprofen|mesh-list
65046718|NCT00240864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65046719|NCT00240864|Analgesics|analgesics|mesh-ancestor
65046720|NCT00240864|Sensory System Agents|sensory system agents|mesh-ancestor
65046721|NCT00240864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65046722|NCT00240864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046723|NCT00240864|Antipyretics|antipyretics|mesh-ancestor
65046724|NCT00240864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65046725|NCT00240864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65046726|NCT00240864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65046727|NCT00240864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65046728|NCT00240864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046729|NCT00240864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046730|NCT00557011|Amphetamine|amphetamine|mesh-list
65046731|NCT00557011|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65046732|NCT00557011|Adderall|adderall|mesh-list
65046733|NCT00557011|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65046734|NCT00557011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046735|NCT00557011|Sympathomimetics|sympathomimetics|mesh-ancestor
65046736|NCT00557011|Autonomic Agents|autonomic agents|mesh-ancestor
65046737|NCT00557011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65046738|NCT00557011|Dopamine Agents|dopamine agents|mesh-ancestor
65046739|NCT00557011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65046740|NCT00557011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046741|NCT00557011|Adrenergic Agents|adrenergic agents|mesh-ancestor
65046742|NCT00557011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65046743|NCT00557011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65046744|NCT00557011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65046745|NCT00557011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65046765|NCT00244608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472767|NCT02790710|Propranolol|propranolol|mesh-list
65046767|NCT00244608|Respiratory System Agents|respiratory system agents|mesh-ancestor
65046768|NCT00244608|Glucocorticoids|glucocorticoids|mesh-ancestor
65046769|NCT00244608|Hormones|hormones|mesh-ancestor
65046770|NCT00244608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65046771|NCT00244608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65046772|NCT00244608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65046773|NCT00244608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65046774|NCT00244608|Adrenergic Agents|adrenergic agents|mesh-ancestor
65046775|NCT00244608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65493886|NCT04002934|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65046776|NCT00244608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046777|NCT00244608|Sympathomimetics|sympathomimetics|mesh-ancestor
65046778|NCT00244608|Tocolytic Agents|tocolytic agents|mesh-ancestor
65046779|NCT00244608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65046780|NCT04666168|Cyclophosphamide|cyclophosphamide|mesh-list
65046781|NCT04666168|Fludarabine|fludarabine|mesh-list
65046782|NCT04666168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65046783|NCT04666168|Immunologic Factors|immunologic factors|mesh-ancestor
65046784|NCT04666168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046785|NCT04666168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65046786|NCT04666168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65046787|NCT04666168|Alkylating Agents|alkylating agents|mesh-ancestor
65046788|NCT04666168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046789|NCT04666168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046790|NCT04666168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65046791|NCT00215774|Flecainide|flecainide|mesh-list
65046792|NCT00215774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65046793|NCT00215774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65046794|NCT00215774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65046795|NCT00215774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65046796|NCT00215774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046797|NCT00240942|Letrozole|letrozole|mesh-list
65046798|NCT00240942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046822|NCT02961816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046823|NCT02961816|Immunologic Factors|immunologic factors|mesh-ancestor
65046824|NCT02961816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046825|NCT02961816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65046826|NCT02961816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65046827|NCT02961816|Antiemetics|antiemetics|mesh-ancestor
65046828|NCT02961816|Autonomic Agents|autonomic agents|mesh-ancestor
65046829|NCT02961816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65046830|NCT02961816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65046831|NCT02961816|Glucocorticoids|glucocorticoids|mesh-ancestor
65046833|NCT02961816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65046834|NCT02961816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65046835|NCT02961816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65046836|NCT02961816|Antimetabolites|antimetabolites|mesh-ancestor
65046837|NCT02961816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046838|NCT02961816|Antiviral Agents|antiviral agents|mesh-ancestor
64532171|NCT02362152|Diclofenac|diclofenac|mesh-list
65046839|NCT02961816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65046841|NCT02961816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65046842|NCT02961816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65046843|NCT02961816|Alkylating Agents|alkylating agents|mesh-ancestor
65046844|NCT02961816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65046845|NCT02961816|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65046846|NCT02961816|Vitamin B Complex|vitamin b complex|mesh-ancestor
65046847|NCT02961816|Vitamins|vitamins|mesh-ancestor
65046848|NCT02961816|Micronutrients|micronutrients|mesh-ancestor
65046849|NCT04665232|Progesterone|progesterone|mesh-list
65046850|NCT04665232|Progestins|progestins|mesh-ancestor
65046851|NCT04665232|Hormones|hormones|mesh-ancestor
64898779|NCT02022488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65046864|NCT04665076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046865|NCT04665076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65046866|NCT04665076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65046867|NCT04665076|Alkylating Agents|alkylating agents|mesh-ancestor
65046868|NCT04665076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046869|NCT04665076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046870|NCT04665076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65046872|NCT00241020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65046873|NCT00241020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65046874|NCT00241020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046875|NCT00216047|Trastuzumab|trastuzumab|mesh-list
65046876|NCT00216047|Vatalanib|vatalanib|mesh-list
65046877|NCT00216047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65046878|NCT00216047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046879|NCT00216047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65046880|NCT00216047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046881|NCT00216047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046882|NCT04665310|Tacrolimus|tacrolimus|mesh-list
65046883|NCT04665310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65046884|NCT04665310|Immunologic Factors|immunologic factors|mesh-ancestor
65046885|NCT04665310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046886|NCT04665310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65046887|NCT04665310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046888|NCT04665310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046889|NCT00241059|Mycophenolic Acid|mycophenolic acid|mesh-list
65046890|NCT00241059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65046891|NCT00241059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046892|NCT00241059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65046893|NCT00241059|Antitubercular Agents|antitubercular agents|mesh-ancestor
65046894|NCT00241059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65046895|NCT00241059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65046896|NCT00241059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046897|NCT00241059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046898|NCT00216164|Gemcitabine|gemcitabine|mesh-list
65046899|NCT00216164|Rituximab|rituximab|mesh-list
65046900|NCT00216164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65046901|NCT00216164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046902|NCT00216164|Immunologic Factors|immunologic factors|mesh-ancestor
65046903|NCT00216164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046904|NCT00216164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65046905|NCT00216164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65046906|NCT00216164|Antimetabolites|antimetabolites|mesh-ancestor
65046907|NCT00216164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046908|NCT00216164|Antiviral Agents|antiviral agents|mesh-ancestor
65046909|NCT00216164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65046910|NCT00216164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046911|NCT00216164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65046912|NCT04664803|Cefdinir|cefdinir|mesh-list
65046922|NCT04664725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65046923|NCT04664725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65046924|NCT04664725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046925|NCT04664725|Dopamine Agents|dopamine agents|mesh-ancestor
65046926|NCT04664725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65046927|NCT04664725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046928|NCT04664725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65046929|NCT04664725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65046930|NCT04664725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046931|NCT04664725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65046932|NCT04664764|Insulin, Isophane|insulin, isophane|mesh-list
65046933|NCT04664764|Isophane Insulin, Human|isophane insulin, human|mesh-list
65046934|NCT04664764|Isophane insulin, beef|isophane insulin, beef|mesh-list
65046935|NCT04664764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65046936|NCT04664764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046937|NCT00241098|Valsartan|valsartan|mesh-list
65046938|NCT00241098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65046939|NCT00241098|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65046940|NCT00241098|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65046941|NCT00241098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046942|NCT00216281|Clozapine|clozapine|mesh-list
65046943|NCT00216281|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65046944|NCT00216281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65046945|NCT00216281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65046946|NCT00216281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65046947|NCT00216281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046948|NCT00216281|Adrenergic Agents|adrenergic agents|mesh-ancestor
65046949|NCT00216281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65046950|NCT00216281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046951|NCT00216281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65046952|NCT00216281|Serotonin Agents|serotonin agents|mesh-ancestor
65046953|NCT00216281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65046954|NCT00216281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65046955|NCT00216281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65046956|NCT00216281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65046957|NCT00216281|GABA Antagonists|gaba antagonists|mesh-ancestor
65046958|NCT00216281|GABA Agents|gaba agents|mesh-ancestor
65046959|NCT00241137|Valsartan|valsartan|mesh-list
65046960|NCT00241137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65046961|NCT00241137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65046962|NCT00241137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65046963|NCT00241137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046964|NCT00216359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65046965|NCT00216359|Enfuvirtide|enfuvirtide|mesh-list
65046966|NCT00216359|Antiviral Agents|antiviral agents|mesh-ancestor
65046967|NCT00216359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65046968|NCT00216359|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65046969|NCT00216359|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65046970|NCT00216359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046971|NCT00216359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65046972|NCT04664530|Esketamine|esketamine|mesh-list
65046973|NCT04664530|Antidepressive Agents|antidepressive agents|mesh-ancestor
65046974|NCT04664530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65046975|NCT00216398|Lanreotide|lanreotide|mesh-list
65046976|NCT00216398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046977|NCT00241215|Botulinum Toxins|botulinum toxins|mesh-list
65046978|NCT00241215|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65046979|NCT00241215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65046994|NCT00244920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65046996|NCT00244920|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65046997|NCT00244920|Fertility Agents|fertility agents|mesh-ancestor
65046998|NCT00244920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65046999|NCT00244920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65493887|NCT04002934|Hormone Antagonists|hormone antagonists|mesh-ancestor
65047000|NCT00244920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047001|NCT00244920|Hormone Antagonists|hormone antagonists|mesh-ancestor
65047002|NCT00244920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65047003|NCT00244920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65047004|NCT00244920|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65047005|NCT00244920|Protective Agents|protective agents|mesh-ancestor
65047006|NCT00244920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65047007|NCT00244920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65047008|NCT00244920|Growth Substances|growth substances|mesh-ancestor
65047009|NCT00244920|Growth Inhibitors|growth inhibitors|mesh-ancestor
65047010|NCT04663438|Antineoplastic Agents|antineoplastic agents|mesh-list
65047011|NCT00216515|Galantamine|galantamine|mesh-list
65047012|NCT00216515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65047013|NCT00216515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047014|NCT00216515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047015|NCT00216515|Cholinergic Agents|cholinergic agents|mesh-ancestor
65047016|NCT00216515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65047017|NCT00216515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047018|NCT00216515|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65047019|NCT00216515|Autonomic Agents|autonomic agents|mesh-ancestor
65047020|NCT00216515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65047021|NCT00216515|Nootropic Agents|nootropic agents|mesh-ancestor
65047022|NCT00244959|Anastrozole|anastrozole|mesh-list
65047023|NCT00244959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65047024|NCT00244959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047025|NCT00244959|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65047026|NCT00244959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65047027|NCT00244959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047028|NCT00244959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047029|NCT00244959|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65047030|NCT00244959|Hormone Antagonists|hormone antagonists|mesh-ancestor
65047031|NCT00244959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65047032|NCT00244959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047033|NCT00244998|Fulvestrant|fulvestrant|mesh-list
65047034|NCT00244998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65047035|NCT00244998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047036|NCT00244998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64898961|NCT02023554|Autonomic Agents|autonomic agents|mesh-ancestor
65047054|NCT00241254|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65047055|NCT00241254|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65047056|NCT00241254|Prednisolone|prednisolone|mesh-list
65047057|NCT00241254|Prednisolone acetate|prednisolone acetate|mesh-list
65047058|NCT00241254|Cyclophosphamide|cyclophosphamide|mesh-list
65047059|NCT00241254|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65047060|NCT00241254|Prednisolone phosphate|prednisolone phosphate|mesh-list
64472770|NCT02790710|Adrenergic Agents|adrenergic agents|mesh-ancestor
65047061|NCT00241254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65047062|NCT00241254|Immunologic Factors|immunologic factors|mesh-ancestor
65047063|NCT00241254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047064|NCT00241254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65047065|NCT00241254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65047066|NCT00241254|Alkylating Agents|alkylating agents|mesh-ancestor
65047067|NCT00241254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047068|NCT00241254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047069|NCT00241254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65047070|NCT00241254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65047071|NCT00241254|Antiemetics|antiemetics|mesh-ancestor
65047072|NCT00241254|Autonomic Agents|autonomic agents|mesh-ancestor
65047073|NCT00241254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65047074|NCT00241254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65047075|NCT00241254|Glucocorticoids|glucocorticoids|mesh-ancestor
65047077|NCT00241254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65047078|NCT00241254|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65047079|NCT00241254|Protective Agents|protective agents|mesh-ancestor
65047080|NCT00241254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65047081|NCT00216632|Risperidone|risperidone|mesh-list
65047082|NCT00216632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65047083|NCT00216632|Serotonin Agents|serotonin agents|mesh-ancestor
65047084|NCT00216632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65047085|NCT00216632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047086|NCT00216632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047087|NCT00216632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65047088|NCT00216632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65047089|NCT00216632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65047090|NCT00216632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65047091|NCT00216632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65047092|NCT00216632|Dopamine Agents|dopamine agents|mesh-ancestor
65047093|NCT04662736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65047116|NCT00245115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047117|NCT00245115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047118|NCT00245115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65047119|NCT04662385|Listerine|listerine|mesh-list
65047120|NCT04662385|Sodium Fluoride|sodium fluoride|mesh-list
65047121|NCT04662385|Cariostatic Agents|cariostatic agents|mesh-ancestor
65047122|NCT04662385|Protective Agents|protective agents|mesh-ancestor
65047123|NCT04662385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047124|NCT04662385|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65047125|NCT04662385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65047126|NCT00216827|Betamethasone|betamethasone|mesh-list
65047127|NCT00216827|Betamethasone Valerate|betamethasone valerate|mesh-list
65047128|NCT00216827|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65047129|NCT00216827|Betamethasone benzoate|betamethasone benzoate|mesh-list
65047130|NCT00216827|Calcipotriene|calcipotriene|mesh-list
65047131|NCT00216827|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65047132|NCT00216827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65047133|NCT00216827|Glucocorticoids|glucocorticoids|mesh-ancestor
65047134|NCT00216827|Hormones|hormones|mesh-ancestor
64532463|NCT01554241|Vitamins|vitamins|mesh-ancestor
65047135|NCT00216827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65047136|NCT00216827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047137|NCT00216827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65047138|NCT00216827|Respiratory System Agents|respiratory system agents|mesh-ancestor
65047139|NCT00216827|Dermatologic Agents|dermatologic agents|mesh-ancestor
65047140|NCT00241332|Fentanyl|fentanyl|mesh-list
65047141|NCT00241332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65047142|NCT00241332|Narcotics|narcotics|mesh-ancestor
65047143|NCT00241332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65047144|NCT00241332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047145|NCT00241332|Analgesics|analgesics|mesh-ancestor
65047146|NCT00241332|Sensory System Agents|sensory system agents|mesh-ancestor
65047147|NCT00241332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65047182|NCT00241371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047183|NCT04660786|Vitamin D|vitamin d|mesh-list
65047184|NCT04660786|Triamcinolone|triamcinolone|mesh-list
65047185|NCT04660786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65047186|NCT04660786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65047187|NCT04660786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65047188|NCT04660786|Vitamins|vitamins|mesh-ancestor
65047189|NCT04660786|Micronutrients|micronutrients|mesh-ancestor
65047190|NCT04660786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047191|NCT04660786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65047192|NCT04660786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65047217|NCT00241449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65047218|NCT00412100|Oxycodone|oxycodone|mesh-list
65047219|NCT00412100|Naloxone|naloxone|mesh-list
65047220|NCT00412100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65047221|NCT00412100|Narcotics|narcotics|mesh-ancestor
65047222|NCT00412100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65047223|NCT00412100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047224|NCT00412100|Analgesics|analgesics|mesh-ancestor
65047225|NCT00412100|Sensory System Agents|sensory system agents|mesh-ancestor
65047226|NCT00412100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65047227|NCT00412100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65047228|NCT00241488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65047229|NCT00241488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65047230|NCT00241488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65047231|NCT00241488|Antimetabolites|antimetabolites|mesh-ancestor
65047232|NCT00241488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047233|NCT00241488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65047234|NCT00241488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65047235|NCT00241488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047236|NCT04659499|Paclitaxel|paclitaxel|mesh-list
65047237|NCT04659499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65047238|NCT04659499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047239|NCT04659499|Tubulin Modulators|tubulin modulators|mesh-ancestor
65047240|NCT04659499|Antimitotic Agents|antimitotic agents|mesh-ancestor
65047241|NCT04659499|Mitosis Modulators|mitosis modulators|mesh-ancestor
64899172|NCT02024568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65047258|NCT04648813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65047259|NCT04648813|Cholinergic Agents|cholinergic agents|mesh-ancestor
65047260|NCT04648813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65047261|NCT04648813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047263|NCT04648423|Sodium Oxybate|sodium oxybate|mesh-list
65047264|NCT04648423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65047265|NCT04648423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65047266|NCT04648423|Anesthetics, General|anesthetics, general|mesh-ancestor
65047267|NCT04648423|Anesthetics|anesthetics|mesh-ancestor
65047268|NCT04648423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65047269|NCT04648423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047270|NCT00558181|Methylprednisolone|methylprednisolone|mesh-list
65047271|NCT00558181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65047272|NCT00558181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65047273|NCT00558181|Prednisolone|prednisolone|mesh-list
65047274|NCT00558181|Prednisolone acetate|prednisolone acetate|mesh-list
65047275|NCT00558181|Rituximab|rituximab|mesh-list
65047276|NCT00558181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65047277|NCT00558181|Prednisolone phosphate|prednisolone phosphate|mesh-list
65047278|NCT00558181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65047279|NCT00558181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047280|NCT00558181|Immunologic Factors|immunologic factors|mesh-ancestor
65047281|NCT00558181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047282|NCT00558181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65047283|NCT00558181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65047284|NCT00558181|Antiemetics|antiemetics|mesh-ancestor
65047285|NCT00558181|Autonomic Agents|autonomic agents|mesh-ancestor
65047286|NCT00558181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65047287|NCT00558181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65047288|NCT00558181|Glucocorticoids|glucocorticoids|mesh-ancestor
65047289|NCT00558181|Hormones|hormones|mesh-ancestor
65047290|NCT00558181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65047291|NCT00558181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65047292|NCT00558181|Protective Agents|protective agents|mesh-ancestor
65047293|NCT00558181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65047294|NCT00217295|Topiramate|topiramate|mesh-list
65047295|NCT00217295|Anticonvulsants|anticonvulsants|mesh-ancestor
65047296|NCT00217295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65047297|NCT00217295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047298|NCT00245427|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65047299|NCT00245427|Lactams|lactams|mesh-list
65047300|NCT00245427|beta-Lactams|beta-lactams|mesh-list
65047333|NCT04647838|Tepotinib|tepotinib|mesh-list
65047334|NCT04647838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047335|NCT00217373|Interferons|interferons|mesh-list
65047336|NCT00217373|Interferon-alpha|interferon-alpha|mesh-list
65047337|NCT00217373|Interferon alpha-2|interferon alpha-2|mesh-list
65047338|NCT00217373|Metronidazole|metronidazole|mesh-list
65047339|NCT00217373|Vaccines|vaccines|mesh-list
65047340|NCT00217373|Sargramostim|sargramostim|mesh-list
65047341|NCT00217373|Immunologic Factors|immunologic factors|mesh-ancestor
64899277|NCT02025192|Capecitabine|capecitabine|mesh-list
65047365|NCT04646824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65047366|NCT04646824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65047368|NCT00217451|Clindamycin palmitate|clindamycin palmitate|mesh-list
65047369|NCT00217451|Clindamycin phosphate|clindamycin phosphate|mesh-list
65047371|NCT00217451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65047372|NCT00217451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65047373|NCT00217451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65047374|NCT00217451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047375|NCT00217451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047376|NCT04646707|Lidocaine|lidocaine|mesh-list
65047377|NCT04646707|Bupivacaine|bupivacaine|mesh-list
65047378|NCT04646707|Anesthetics, Local|anesthetics, local|mesh-ancestor
65047379|NCT04646707|Anesthetics|anesthetics|mesh-ancestor
65047380|NCT04646707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65047381|NCT04646707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047382|NCT04646707|Sensory System Agents|sensory system agents|mesh-ancestor
65047383|NCT04646707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65047384|NCT04646707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65047385|NCT04646707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65047386|NCT04646707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65047387|NCT04646707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65047388|NCT04646707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047389|NCT00217529|Carboplatin|carboplatin|mesh-list
65047390|NCT00217529|Docetaxel|docetaxel|mesh-list
65047391|NCT00217529|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65047392|NCT00217529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047393|NCT00217529|Tubulin Modulators|tubulin modulators|mesh-ancestor
65047394|NCT00217529|Antimitotic Agents|antimitotic agents|mesh-ancestor
65047409|NCT00245661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047410|NCT04646317|Dexmedetomidine|dexmedetomidine|mesh-list
65047411|NCT04646317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65047412|NCT04646317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65047413|NCT04646317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047414|NCT04646317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65047415|NCT04646317|Analgesics|analgesics|mesh-ancestor
65047416|NCT04646317|Sensory System Agents|sensory system agents|mesh-ancestor
65047417|NCT04646317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65047418|NCT04646317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65047419|NCT04646317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65047420|NCT04646317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65047421|NCT04646317|Adrenergic Agents|adrenergic agents|mesh-ancestor
65047422|NCT04646317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65047423|NCT04646317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047424|NCT00217568|Carboplatin|carboplatin|mesh-list
65047425|NCT00217568|Docetaxel|docetaxel|mesh-list
65047426|NCT00217568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047427|NCT00217568|Tubulin Modulators|tubulin modulators|mesh-ancestor
65047428|NCT00217568|Antimitotic Agents|antimitotic agents|mesh-ancestor
65047429|NCT00217568|Mitosis Modulators|mitosis modulators|mesh-ancestor
65047430|NCT00217568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047431|NCT04646161|Misoprostol|misoprostol|mesh-list
65047432|NCT04646161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65047433|NCT04646161|Abortifacient Agents|abortifacient agents|mesh-ancestor
65047434|NCT04646161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65047435|NCT04646161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047436|NCT04646161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65047437|NCT04646161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65047438|NCT04646161|Oxytocics|oxytocics|mesh-ancestor
65047439|NCT00241722|Alvimopan|alvimopan|mesh-list
65047440|NCT00241722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65047441|NCT00217607|Paclitaxel|paclitaxel|mesh-list
65047442|NCT00217607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65047443|NCT00217607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047444|NCT00217607|Tubulin Modulators|tubulin modulators|mesh-ancestor
65047445|NCT00217607|Antimitotic Agents|antimitotic agents|mesh-ancestor
65047446|NCT00217607|Mitosis Modulators|mitosis modulators|mesh-ancestor
65047447|NCT00217607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047448|NCT00558337|Levodopa|levodopa|mesh-list
65047449|NCT00558337|Carbidopa|carbidopa|mesh-list
65047450|NCT00558337|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65047451|NCT00558337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65047452|NCT00558337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65047453|NCT00558337|Dopamine Agents|dopamine agents|mesh-ancestor
65047454|NCT00558337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65047455|NCT00558337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047488|NCT04645303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047489|NCT04645303|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65047490|NCT04645303|Viscosupplements|viscosupplements|mesh-ancestor
65047491|NCT04645303|Protective Agents|protective agents|mesh-ancestor
65047493|NCT04644484|Immunoglobulins|immunoglobulins|mesh-list
65047494|NCT04644484|Antibodies|antibodies|mesh-list
65047495|NCT04644484|gamma-Globulins|gamma-globulins|mesh-list
65047496|NCT04644484|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65047497|NCT04644484|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65047498|NCT04644484|Immunologic Factors|immunologic factors|mesh-ancestor
65047499|NCT04644484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047500|NCT04644250|Paclitaxel|paclitaxel|mesh-list
65047501|NCT04644250|Carboplatin|carboplatin|mesh-list
65047534|NCT04644094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65047535|NCT04644094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047536|NCT04644406|Trastuzumab|trastuzumab|mesh-list
65047537|NCT04644406|Pertuzumab|pertuzumab|mesh-list
65047538|NCT04644406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65047539|NCT04644406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047540|NCT04643821|Calcitriol|calcitriol|mesh-list
65047541|NCT04643821|Acetylcysteine|acetylcysteine|mesh-list
65047542|NCT04643821|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65047543|NCT04643821|Antiviral Agents|antiviral agents|mesh-ancestor
65047544|NCT04643821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65047545|NCT04643821|Expectorants|expectorants|mesh-ancestor
65047560|NCT00218075|Levodopa|levodopa|mesh-list
65047561|NCT00218075|Carbidopa|carbidopa|mesh-list
65047562|NCT00218075|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65047563|NCT00218075|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65047564|NCT00218075|Dopamine Agents|dopamine agents|mesh-ancestor
65047565|NCT00218075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65047566|NCT00218075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047567|NCT00218075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047568|NCT00218075|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65047569|NCT00218075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047570|NCT00218114|Valproic Acid|valproic acid|mesh-list
65047571|NCT00218114|Anticonvulsants|anticonvulsants|mesh-ancestor
65047572|NCT00218114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047573|NCT00218114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047574|NCT00218114|GABA Agents|gaba agents|mesh-ancestor
65047575|NCT00218114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65047576|NCT00218114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047577|NCT00218114|Antimanic Agents|antimanic agents|mesh-ancestor
65047578|NCT00218114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65047579|NCT00218114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65047580|NCT00218114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65047581|NCT00424788|Natalizumab|natalizumab|mesh-list
65047582|NCT00424788|Immunologic Factors|immunologic factors|mesh-ancestor
65047583|NCT00424788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047584|NCT00218153|Naltrexone|naltrexone|mesh-list
65047585|NCT00218153|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65047586|NCT00218153|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65047587|NCT00218153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047588|NCT00218153|Sensory System Agents|sensory system agents|mesh-ancestor
65047589|NCT00218153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65047590|NCT04642846|Fluorides|fluorides|mesh-list
65047591|NCT04642846|Cariostatic Agents|cariostatic agents|mesh-ancestor
65047592|NCT04642846|Protective Agents|protective agents|mesh-ancestor
65047593|NCT04642846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047594|NCT00245895|Darbepoetin alfa|darbepoetin alfa|mesh-list
65047595|NCT00245895|Hematinics|hematinics|mesh-ancestor
65047596|NCT00559195|Epoetin Alfa|epoetin alfa|mesh-list
65047597|NCT00559195|Hematinics|hematinics|mesh-ancestor
65047598|NCT00245934|Etanercept|etanercept|mesh-list
65047599|NCT00245934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65047600|NCT00245934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65047601|NCT00245934|Analgesics|analgesics|mesh-ancestor
65047602|NCT00245934|Sensory System Agents|sensory system agents|mesh-ancestor
65047603|NCT00245934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65047604|NCT00245934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047605|NCT00245934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65047606|NCT00245934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64899518|NCT02026778|Betahistine|betahistine|mesh-list
65047634|NCT00218348|Dextroamphetamine|dextroamphetamine|mesh-list
65047635|NCT00218348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65047636|NCT00218348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047637|NCT00218348|Sympathomimetics|sympathomimetics|mesh-ancestor
65047638|NCT00218348|Autonomic Agents|autonomic agents|mesh-ancestor
65047639|NCT00218348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65047640|NCT00218348|Dopamine Agents|dopamine agents|mesh-ancestor
65047641|NCT00218348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65047642|NCT00218348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047643|NCT00218348|Adrenergic Agents|adrenergic agents|mesh-ancestor
65047644|NCT00218348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65047645|NCT00218348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65047646|NCT00218348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65047647|NCT00218348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65047648|NCT00559312|Fluticasone|fluticasone|mesh-list
65047649|NCT00559312|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65047661|NCT00559312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65047662|NCT00559312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65047663|NCT00559312|Adrenergic Agents|adrenergic agents|mesh-ancestor
65047664|NCT00559312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65047665|NCT00559312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047666|NCT00559312|Glucocorticoids|glucocorticoids|mesh-ancestor
65047667|NCT00559312|Hormones|hormones|mesh-ancestor
65047668|NCT00559312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64489071|NCT03854799|Capecitabine|capecitabine|mesh-list
65047669|NCT00559312|Sympathomimetics|sympathomimetics|mesh-ancestor
65047670|NCT00559351|Fluorouracil|fluorouracil|mesh-list
65047671|NCT00559351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047672|NCT00559351|Antimetabolites|antimetabolites|mesh-ancestor
65047673|NCT00559351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047674|NCT00559351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65047675|NCT00559351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65047676|NCT00559351|Immunologic Factors|immunologic factors|mesh-ancestor
65047677|NCT00559351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047678|NCT00218504|Dronabinol|dronabinol|mesh-list
65047679|NCT00218504|Hallucinogens|hallucinogens|mesh-ancestor
65047680|NCT00218504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047681|NCT00218504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65047682|NCT00218504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65047683|NCT00218504|Analgesics|analgesics|mesh-ancestor
65047684|NCT00218504|Sensory System Agents|sensory system agents|mesh-ancestor
65047685|NCT00218504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65047686|NCT00218504|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65047687|NCT00218504|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65047688|NCT00218504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65047689|NCT00218504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047690|NCT00218504|Hormones|hormones|mesh-ancestor
65047691|NCT00218504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65047692|NCT00559429|Docetaxel|docetaxel|mesh-list
65047693|NCT00559429|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
65047694|NCT00559429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047695|NCT00559429|Tubulin Modulators|tubulin modulators|mesh-ancestor
65047696|NCT00559429|Antimitotic Agents|antimitotic agents|mesh-ancestor
65047697|NCT00559429|Mitosis Modulators|mitosis modulators|mesh-ancestor
65047698|NCT00559429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047699|NCT00559429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65047700|NCT00559429|Analgesics|analgesics|mesh-ancestor
65047701|NCT00559429|Sensory System Agents|sensory system agents|mesh-ancestor
65047702|NCT00559429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65047703|NCT00559429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047704|NCT00218621|Buprenorphine|buprenorphine|mesh-list
65047705|NCT00218621|Methadone|methadone|mesh-list
65047706|NCT00218621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65047707|NCT00218621|Narcotics|narcotics|mesh-ancestor
65047708|NCT00218621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65047709|NCT00218621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047710|NCT00218621|Analgesics|analgesics|mesh-ancestor
65047742|NCT00559546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047743|NCT00246207|Methylphenidate|methylphenidate|mesh-list
65047744|NCT00246207|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65047745|NCT00246207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047746|NCT00246207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65047747|NCT00246207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65047748|NCT00246207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65047749|NCT00246207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047750|NCT00246207|Dopamine Agents|dopamine agents|mesh-ancestor
64822655|NCT01523002|Artesunate|artesunate|mesh-list
65047786|NCT00246246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65047787|NCT00246246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65047788|NCT00246246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65047789|NCT00246246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65047821|NCT00561379|Immunologic Factors|immunologic factors|mesh-ancestor
65047822|NCT00561379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047823|NCT00561379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65047824|NCT04629118|Sirolimus|sirolimus|mesh-list
65047825|NCT04629118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65047826|NCT04629118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65047827|NCT04629118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65047828|NCT04629118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047829|NCT04629118|Antifungal Agents|antifungal agents|mesh-ancestor
65047830|NCT04629118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65047831|NCT04629118|Immunologic Factors|immunologic factors|mesh-ancestor
65047832|NCT04629118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047833|NCT00561496|Tenofovir|tenofovir|mesh-list
65047834|NCT00561496|Antiviral Agents|antiviral agents|mesh-ancestor
64899770|NCT02028260|Modafinil|modafinil|mesh-list
65047855|NCT00242268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65047856|NCT00242268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65047857|NCT00242268|Antimetabolites|antimetabolites|mesh-ancestor
65047858|NCT00242268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047859|NCT00242268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65047860|NCT00242268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65047861|NCT00242268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047862|NCT00246363|Silymarin|silymarin|mesh-list
65047863|NCT00246363|Antioxidants|antioxidants|mesh-ancestor
65047864|NCT00246363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047865|NCT00246363|Protective Agents|protective agents|mesh-ancestor
65047866|NCT00246363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047867|NCT04628533|Oxymetazoline|oxymetazoline|mesh-list
65047868|NCT04628533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65047869|NCT04628533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65047870|NCT04628533|Adrenergic Agents|adrenergic agents|mesh-ancestor
65047871|NCT04628533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65047872|NCT04628533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047873|NCT04628533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047874|NCT04628533|Sympathomimetics|sympathomimetics|mesh-ancestor
65047875|NCT04628533|Autonomic Agents|autonomic agents|mesh-ancestor
65047876|NCT04628533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65047877|NCT04628533|Nasal Decongestants|nasal decongestants|mesh-ancestor
65047878|NCT04628533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65047879|NCT04628533|Respiratory System Agents|respiratory system agents|mesh-ancestor
65047880|NCT00246402|Acipimox|acipimox|mesh-list
65047881|NCT00246402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65047882|NCT00246402|Antimetabolites|antimetabolites|mesh-ancestor
65047883|NCT00246402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047884|NCT00246402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65047885|NCT00561613|Spermatocidal Agents|spermatocidal agents|mesh-list
65047886|NCT00561613|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
65047887|NCT00561613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047908|NCT04628143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65047909|NCT04628143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65047910|NCT04628143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65047911|NCT04628143|Immunologic Factors|immunologic factors|mesh-ancestor
65047912|NCT00242346|Candesartan|candesartan|mesh-list
65047913|NCT00242346|Candesartan cilexetil|candesartan cilexetil|mesh-list
65047914|NCT00242346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65047915|NCT00242346|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65047916|NCT00242346|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65047917|NCT00242346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047918|NCT00219245|Rivastigmine|rivastigmine|mesh-list
65047919|NCT00219245|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65047920|NCT00219245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047921|NCT00219245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047922|NCT00219245|Cholinergic Agents|cholinergic agents|mesh-ancestor
65047923|NCT00219245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65047924|NCT00219245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047925|NCT00219245|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65047926|NCT00219245|Protective Agents|protective agents|mesh-ancestor
65047927|NCT04627363|Bevacizumab|bevacizumab|mesh-list
65047928|NCT04627363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65047929|NCT04627363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047930|NCT04627363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65047931|NCT04627363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65047932|NCT04627363|Growth Substances|growth substances|mesh-ancestor
65047933|NCT04627363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047934|NCT04627363|Growth Inhibitors|growth inhibitors|mesh-ancestor
65047936|NCT00219323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65047937|NCT00219323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65047964|NCT04627129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65047966|NCT04627129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65047967|NCT00246636|Fenofibrate|fenofibrate|mesh-list
65047968|NCT00246636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65047969|NCT00246636|Antimetabolites|antimetabolites|mesh-ancestor
65047970|NCT00246636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047971|NCT00246636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65047972|NCT00219440|Metformin|metformin|mesh-list
65047973|NCT00219440|Pioglitazone|pioglitazone|mesh-list
65047974|NCT00219440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65047975|NCT00219440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047976|NCT00246675|Furosemide|furosemide|mesh-list
65047977|NCT00246675|Diuretics|diuretics|mesh-ancestor
65047978|NCT00246675|Natriuretic Agents|natriuretic agents|mesh-ancestor
65047979|NCT00246675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047980|NCT00246675|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65047981|NCT00246675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64899917|NCT02029105|Protective Agents|protective agents|mesh-ancestor
65048007|NCT00242463|Hormones|hormones|mesh-ancestor
65048008|NCT00242463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65048009|NCT00242463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048010|NCT00242463|Anabolic Agents|anabolic agents|mesh-ancestor
65048011|NCT00242463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65048012|NCT00561886|Formoterol Fumarate|formoterol fumarate|mesh-list
65048013|NCT00561886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65048014|NCT00561886|Autonomic Agents|autonomic agents|mesh-ancestor
65048015|NCT00561886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65048016|NCT00561886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048017|NCT00561886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65048018|NCT00561886|Respiratory System Agents|respiratory system agents|mesh-ancestor
65048019|NCT00561886|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65048020|NCT00561886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65048021|NCT00561886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65048022|NCT00561886|Adrenergic Agents|adrenergic agents|mesh-ancestor
65048023|NCT00561886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65048024|NCT00561886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048025|NCT00561964|Irbesartan|irbesartan|mesh-list
65048026|NCT00561964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65048027|NCT00561964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64899965|NCT02029378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65048040|NCT00219596|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65048041|NCT00219596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65048042|NCT04626193|Amoxicillin|amoxicillin|mesh-list
65048043|NCT04626193|Doxycycline|doxycycline|mesh-list
65048044|NCT04626193|Levofloxacin|levofloxacin|mesh-list
65048045|NCT04626193|Ofloxacin|ofloxacin|mesh-list
65048046|NCT04626193|Esomeprazole|esomeprazole|mesh-list
65048047|NCT04626193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65048048|NCT04626193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65048049|NCT04626193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65048050|NCT04626193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65048051|NCT04626193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65048052|NCT04626193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048053|NCT04626193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048055|NCT04626193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65048056|NCT04626193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65048057|NCT04626193|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65048058|NCT04626193|Renal Agents|renal agents|mesh-ancestor
65048059|NCT04626193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65048060|NCT04626193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65048061|NCT04626193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048062|NCT04626193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65048063|NCT04626193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65048064|NCT00242541|Octreotide|octreotide|mesh-list
65048065|NCT00242541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65048066|NCT00242541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64561495|NCT03527147|Acalabrutinib|acalabrutinib|mesh-list
65048067|NCT00242541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048068|NCT04625608|Acetaminophen|acetaminophen|mesh-list
65048069|NCT04625608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65048070|NCT04625608|Analgesics|analgesics|mesh-ancestor
65048071|NCT04625608|Sensory System Agents|sensory system agents|mesh-ancestor
65048072|NCT04625608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65048073|NCT04625608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048074|NCT04625608|Antipyretics|antipyretics|mesh-ancestor
65048075|NCT00219713|Nitrous Oxide|nitrous oxide|mesh-list
65048076|NCT00219713|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65048077|NCT00219713|Anesthetics, General|anesthetics, general|mesh-ancestor
65048078|NCT00219713|Anesthetics|anesthetics|mesh-ancestor
65048079|NCT00219713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65048080|NCT00219713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048081|NCT00219713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65048082|NCT00219713|Analgesics|analgesics|mesh-ancestor
65048083|NCT00219713|Sensory System Agents|sensory system agents|mesh-ancestor
65048084|NCT00219713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65048085|NCT00219752|Imatinib Mesylate|imatinib mesylate|mesh-list
65048086|NCT00219752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048087|NCT00219752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65048088|NCT00219752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048089|NCT00219752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048090|NCT00242697|Anesthetics|anesthetics|mesh-list
65048091|NCT00242697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65048092|NCT00242697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048093|NCT04625179|Melatonin|melatonin|mesh-list
65048120|NCT00219869|Cholinergic Agents|cholinergic agents|mesh-ancestor
65048121|NCT00219869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65048122|NCT00219869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048123|NCT00219869|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65048124|NCT00219869|Autonomic Agents|autonomic agents|mesh-ancestor
65048125|NCT00219869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65048126|NCT00219869|Nootropic Agents|nootropic agents|mesh-ancestor
65048127|NCT04624360|Dexamethasone|dexamethasone|mesh-list
65048128|NCT04624360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65048129|NCT04624360|Antiemetics|antiemetics|mesh-ancestor
65048130|NCT04624360|Autonomic Agents|autonomic agents|mesh-ancestor
65048131|NCT04624360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65048132|NCT04624360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048133|NCT04624360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65048134|NCT04624360|Glucocorticoids|glucocorticoids|mesh-ancestor
65048136|NCT04624360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65048137|NCT04624360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65048138|NCT04624360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048139|NCT00219908|Mitoxantrone|mitoxantrone|mesh-list
65048140|NCT00219908|Analgesics|analgesics|mesh-ancestor
65048141|NCT00219908|Sensory System Agents|sensory system agents|mesh-ancestor
64900073|NCT02029950|Daunorubicin|daunorubicin|mesh-list
65048169|NCT00242775|Hormones|hormones|mesh-ancestor
65048170|NCT00242775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65048171|NCT00242775|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65048172|NCT00242775|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65048173|NCT00242775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65048174|NCT00242775|Adrenergic Agents|adrenergic agents|mesh-ancestor
65048175|NCT00242775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65048176|NCT00242775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048177|NCT04623619|Acetylcarnitine|acetylcarnitine|mesh-list
65048178|NCT04623619|Vitamin B Complex|vitamin b complex|mesh-ancestor
65048179|NCT04623619|Vitamins|vitamins|mesh-ancestor
65048180|NCT04623619|Micronutrients|micronutrients|mesh-ancestor
65048181|NCT04623619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048182|NCT04623619|Nootropic Agents|nootropic agents|mesh-ancestor
65048183|NCT00562198|Carbidopa|carbidopa|mesh-list
65048184|NCT00562198|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65048185|NCT00562198|Entacapone|entacapone|mesh-list
65048186|NCT00562198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65048220|NCT00220103|Antimetabolites|antimetabolites|mesh-ancestor
65048221|NCT00220103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048222|NCT00220103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65048223|NCT00220103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65048224|NCT00220103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65048225|NCT00220103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048226|NCT00247026|Ubiquinone|ubiquinone|mesh-list
65048227|NCT00247026|Coenzyme Q10|coenzyme q10|mesh-list
65048228|NCT00247026|Curcumin|curcumin|mesh-list
65048229|NCT00247026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65048230|NCT00247026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65048231|NCT00247026|Analgesics|analgesics|mesh-ancestor
65048232|NCT00247026|Sensory System Agents|sensory system agents|mesh-ancestor
64900172|NCT02033733|Atracurium|atracurium|mesh-list
65048261|NCT04623385|Isotretinoin|isotretinoin|mesh-list
65048262|NCT04623385|Testosterone|testosterone|mesh-list
65048263|NCT04623385|Androgens|androgens|mesh-ancestor
65048264|NCT04623385|Hormones|hormones|mesh-ancestor
64533600|NCT04681443|Phenol|phenol|mesh-list
65048265|NCT04623385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65048266|NCT04623385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048267|NCT04623385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048268|NCT04623385|Keratolytic Agents|keratolytic agents|mesh-ancestor
65048269|NCT04623385|Dermatologic Agents|dermatologic agents|mesh-ancestor
65048270|NCT00220220|Amlodipine|amlodipine|mesh-list
65048271|NCT00220220|Olmesartan|olmesartan|mesh-list
65048272|NCT00220220|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65048273|NCT00220220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65048274|NCT00220220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65048275|NCT00220220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65048276|NCT00220220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900207|NCT02035709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65048298|NCT00220259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65048299|NCT00220259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65048301|NCT00220259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65048302|NCT00220259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048303|NCT00220259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65048304|NCT00220259|Respiratory System Agents|respiratory system agents|mesh-ancestor
65048305|NCT00220259|Dermatologic Agents|dermatologic agents|mesh-ancestor
65048306|NCT00220259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65048307|NCT04622956|Methotrexate|methotrexate|mesh-list
65048308|NCT04622956|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65048309|NCT04622956|Abortifacient Agents|abortifacient agents|mesh-ancestor
65048310|NCT04622956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65048311|NCT04622956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048312|NCT04622956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65048313|NCT04622956|Antimetabolites|antimetabolites|mesh-ancestor
65048314|NCT04622956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048315|NCT04622956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048316|NCT04622956|Dermatologic Agents|dermatologic agents|mesh-ancestor
65048317|NCT04622956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048318|NCT04622956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65048319|NCT04622956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65048320|NCT04622956|Immunologic Factors|immunologic factors|mesh-ancestor
65048321|NCT04622956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65048322|NCT04622956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65048323|NCT04622566|Pembrolizumab|pembrolizumab|mesh-list
65048324|NCT04622566|Lenvatinib|lenvatinib|mesh-list
65048325|NCT04622566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65048326|NCT04622566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900255|NCT02039492|Hormone Antagonists|hormone antagonists|mesh-ancestor
65048358|NCT00220337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65048359|NCT00220337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048361|NCT00412412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65048362|NCT00412412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048363|NCT04621669|Metformin|metformin|mesh-list
65048364|NCT04621669|Digoxin|digoxin|mesh-list
65048365|NCT04621669|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65048366|NCT04621669|Calcium|calcium|mesh-list
65048367|NCT04621669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65048368|NCT04621669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900306|NCT02040285|Laxatives|laxatives|mesh-ancestor
65048402|NCT00243009|Dermatologic Agents|dermatologic agents|mesh-ancestor
65048403|NCT00243009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65048404|NCT00243009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65048405|NCT00243009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65048406|NCT00243009|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65048407|NCT00243009|Antitubercular Agents|antitubercular agents|mesh-ancestor
65048408|NCT00243009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65048469|NCT04620772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65048470|NCT04620772|Alkylating Agents|alkylating agents|mesh-ancestor
65048471|NCT04620772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048472|NCT04620772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048473|NCT04620772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65048474|NCT00243204|Docetaxel|docetaxel|mesh-list
65048475|NCT00243204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048476|NCT00243204|Tubulin Modulators|tubulin modulators|mesh-ancestor
65048477|NCT00243204|Antimitotic Agents|antimitotic agents|mesh-ancestor
65048478|NCT00243204|Mitosis Modulators|mitosis modulators|mesh-ancestor
65048479|NCT00243204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048480|NCT04620577|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65048481|NCT04620577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65048482|NCT04620031|Propofol|propofol|mesh-list
65048483|NCT04620031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65048484|NCT04620031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65048485|NCT04620031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048486|NCT04620031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65048488|NCT04620031|Anesthetics|anesthetics|mesh-ancestor
65048489|NCT04620109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65048490|NCT04620109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65048491|NCT00220649|Leucovorin|leucovorin|mesh-list
65048517|NCT04619914|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65048518|NCT04619914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65048519|NCT04619914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048520|NCT04619914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048521|NCT04619914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65048522|NCT04619914|Hormone Antagonists|hormone antagonists|mesh-ancestor
65048523|NCT04619914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65048524|NCT04619914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048525|NCT00220766|Immunoglobulins|immunoglobulins|mesh-list
65048526|NCT00220766|Antibodies|antibodies|mesh-list
65048527|NCT00220766|gamma-Globulins|gamma-globulins|mesh-list
65048528|NCT00220766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65048529|NCT00220766|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65048530|NCT00220766|Immunoglobulin G|immunoglobulin g|mesh-list
65048531|NCT00220766|Immunologic Factors|immunologic factors|mesh-ancestor
65048532|NCT00220766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048533|NCT04619875|Lactulose|lactulose|mesh-list
65048534|NCT04619875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65048535|NCT04619290|Methylene Blue|methylene blue|mesh-list
65048536|NCT04619290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048537|NCT04619290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048538|NCT04619563|Docetaxel|docetaxel|mesh-list
65048539|NCT04619563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048540|NCT04619563|Tubulin Modulators|tubulin modulators|mesh-ancestor
65048541|NCT04619563|Antimitotic Agents|antimitotic agents|mesh-ancestor
65048542|NCT04619563|Mitosis Modulators|mitosis modulators|mesh-ancestor
65048543|NCT04619563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048544|NCT00220844|Amitriptyline|amitriptyline|mesh-list
65048545|NCT00220844|Desipramine|desipramine|mesh-list
65048546|NCT00220844|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65048547|NCT00220844|Antidepressive Agents|antidepressive agents|mesh-ancestor
65048574|NCT04619251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65048576|NCT04619251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048577|NCT04619251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65048578|NCT04619251|Hormone Antagonists|hormone antagonists|mesh-ancestor
65048579|NCT04619251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65048580|NCT04619251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048581|NCT04619251|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65048582|NCT00243399|Oxandrolone|oxandrolone|mesh-list
65048583|NCT00243399|Androgens|androgens|mesh-ancestor
65048584|NCT00243399|Hormones|hormones|mesh-ancestor
65048585|NCT00243399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65048586|NCT00243399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048587|NCT00243399|Anabolic Agents|anabolic agents|mesh-ancestor
65048588|NCT00220922|Ethanol|ethanol|mesh-list
65048589|NCT00220922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65048590|NCT00220922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65048591|NCT00220922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65048614|NCT00221156|Acarbose|acarbose|mesh-list
65048615|NCT00221156|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65048616|NCT00221156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048617|NCT00221156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048618|NCT00221156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65048619|NCT00221156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048620|NCT04617613|Amoxicillin|amoxicillin|mesh-list
65048621|NCT04617613|Metronidazole|metronidazole|mesh-list
65048622|NCT04617613|Clarithromycin|clarithromycin|mesh-list
65048623|NCT04617613|Omeprazole|omeprazole|mesh-list
64823155|NCT01525537|Dsuvia|dsuvia|mesh-list
65048624|NCT04617613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65048625|NCT04617613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65048626|NCT04617613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65048627|NCT04617613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65048628|NCT04617613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65048629|NCT04617613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65048630|NCT04617613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65048631|NCT04617613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048632|NCT04617613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048633|NCT04617613|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65048634|NCT04617613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65048635|NCT04617613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65048636|NCT04617652|Magnesium Sulfate|magnesium sulfate|mesh-list
65048637|NCT04617652|Analgesics|analgesics|mesh-ancestor
65048638|NCT04617652|Sensory System Agents|sensory system agents|mesh-ancestor
65048639|NCT04617652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65048640|NCT04617652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048641|NCT04617652|Anesthetics|anesthetics|mesh-ancestor
65048642|NCT04617652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64900574|NCT02042196|Cetrorelix|cetrorelix|mesh-list
65048661|NCT00221312|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65048662|NCT00221312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048663|NCT04616872|Methotrexate|methotrexate|mesh-list
65048664|NCT04616872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65048665|NCT04616872|Abortifacient Agents|abortifacient agents|mesh-ancestor
65048666|NCT04616872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65048667|NCT04616872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048668|NCT04616872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65048669|NCT04616872|Antimetabolites|antimetabolites|mesh-ancestor
65048670|NCT04616872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048671|NCT04616872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048672|NCT04616872|Dermatologic Agents|dermatologic agents|mesh-ancestor
65048673|NCT04616872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048674|NCT04616872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65048675|NCT04616872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65048676|NCT04616872|Immunologic Factors|immunologic factors|mesh-ancestor
65048677|NCT04616872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65048678|NCT04616872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65048679|NCT00221390|Ropinirole|ropinirole|mesh-list
65048680|NCT00221390|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65048681|NCT00221390|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65048682|NCT00221390|Dopamine Agonists|dopamine agonists|mesh-ancestor
65048683|NCT00221390|Dopamine Agents|dopamine agents|mesh-ancestor
65048684|NCT00221390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65048685|NCT00221390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048686|NCT00221390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048687|NCT00247650|Zoledronic Acid|zoledronic acid|mesh-list
65048688|NCT00247650|Letrozole|letrozole|mesh-list
65048689|NCT00247650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048690|NCT00247650|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65048691|NCT00247650|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65048692|NCT00247650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048693|NCT00247650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048694|NCT00247650|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65048715|NCT00563017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048717|NCT00563017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65048718|NCT00563017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65048719|NCT00563017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65048720|NCT00563017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65048721|NCT00563017|Dopamine Agents|dopamine agents|mesh-ancestor
65048722|NCT00563056|Fluticasone|fluticasone|mesh-list
65048723|NCT00563056|Formoterol Fumarate|formoterol fumarate|mesh-list
65048724|NCT00563056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65048725|NCT00563056|Autonomic Agents|autonomic agents|mesh-ancestor
65048726|NCT00563056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65048727|NCT00563056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048728|NCT00563056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65048729|NCT00563056|Respiratory System Agents|respiratory system agents|mesh-ancestor
65048730|NCT00563056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65048731|NCT00563056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65048732|NCT00563056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65048733|NCT00563056|Adrenergic Agents|adrenergic agents|mesh-ancestor
65048734|NCT00563056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64472773|NCT02790710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561801|NCT02185131|Serotonin Agents|serotonin agents|mesh-ancestor
64823207|NCT01525888|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64823208|NCT01525888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64823209|NCT01525888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823210|NCT01525888|Protease Inhibitors|protease inhibitors|mesh-ancestor
64823226|NCT01526005|Cholinergic Agents|cholinergic agents|mesh-ancestor
64823227|NCT01526005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64823228|NCT01526005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823230|NCT01526070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64823231|NCT01526070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64823232|NCT01526070|Growth Substances|growth substances|mesh-ancestor
64823233|NCT01526070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048735|NCT00563056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048736|NCT00563056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65048737|NCT00563056|Dermatologic Agents|dermatologic agents|mesh-ancestor
65048738|NCT00563056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65048739|NCT00563095|Interferons|interferons|mesh-list
65048740|NCT00563095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048741|NCT00563095|Antiviral Agents|antiviral agents|mesh-ancestor
65048742|NCT00563095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65048743|NCT00221468|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65048744|NCT00221468|Antidepressive Agents|antidepressive agents|mesh-ancestor
65048745|NCT00221468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65048776|NCT00221624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048778|NCT00221624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65048779|NCT00221624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65048780|NCT00221624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65048781|NCT00221624|Dopamine Agents|dopamine agents|mesh-ancestor
65048782|NCT00221624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65048783|NCT00221624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048784|NCT00221624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65048786|NCT00221624|Sensory System Agents|sensory system agents|mesh-ancestor
65048787|NCT00221624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65048788|NCT04720092|Rivaroxaban|rivaroxaban|mesh-list
65048789|NCT04720092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65048790|NCT04720092|Antithrombins|antithrombins|mesh-ancestor
65048791|NCT04720092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65048792|NCT04720092|Protease Inhibitors|protease inhibitors|mesh-ancestor
65048793|NCT04720092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048794|NCT04720092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048822|NCT04615702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048823|NCT04615702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65048824|NCT04615702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65048825|NCT04615702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048826|NCT04615702|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65048827|NCT04615702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65048828|NCT04615702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65048830|NCT04615702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65048831|NCT04615702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65048832|NCT04615702|Hormones|hormones|mesh-ancestor
65048833|NCT04615702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65048834|NCT04615702|Antioxidants|antioxidants|mesh-ancestor
65048835|NCT04615702|Protective Agents|protective agents|mesh-ancestor
65048836|NCT04615351|Metformin|metformin|mesh-list
65048837|NCT04615351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65048838|NCT04615351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048839|NCT04615156|Deoxyglucose|deoxyglucose|mesh-list
65048840|NCT04615156|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65048841|NCT04615156|Antimetabolites|antimetabolites|mesh-ancestor
65048842|NCT04615156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048843|NCT04615156|Antiviral Agents|antiviral agents|mesh-ancestor
65048879|NCT00251277|Rituximab|rituximab|mesh-list
65048880|NCT00251277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65048881|NCT00251277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048882|NCT00251277|Immunologic Factors|immunologic factors|mesh-ancestor
65048883|NCT00251277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048884|NCT00251277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65048885|NCT00412802|Enoxaparin|enoxaparin|mesh-list
65048886|NCT00412802|Enoxaparin sodium|enoxaparin sodium|mesh-list
65048922|NCT00251355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048923|NCT00251355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048924|NCT00251355|Antiviral Agents|antiviral agents|mesh-ancestor
65048925|NCT00251355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65048957|NCT00248118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65048958|NCT00248118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65048959|NCT00248118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65048960|NCT00248118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048961|NCT00248118|Dopamine Agents|dopamine agents|mesh-ancestor
65048962|NCT00248118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65048963|NCT00248118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048964|NCT00248118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65048965|NCT00248118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65048966|NCT00248118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048967|NCT04612894|Apatinib|apatinib|mesh-list
65048968|NCT04612894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048994|NCT00221975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65048995|NCT04612582|Thalidomide|thalidomide|mesh-list
65048996|NCT04612582|Cyclophosphamide|cyclophosphamide|mesh-list
65048997|NCT04612582|Bortezomib|bortezomib|mesh-list
65048998|NCT04612582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65048999|NCT04612582|Immunologic Factors|immunologic factors|mesh-ancestor
65049000|NCT04612582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049001|NCT04612582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65049002|NCT04612582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65049003|NCT04612582|Alkylating Agents|alkylating agents|mesh-ancestor
65049004|NCT04612582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049005|NCT04612582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049006|NCT04612582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65049007|NCT04612582|Leprostatic Agents|leprostatic agents|mesh-ancestor
65049008|NCT04612582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65049009|NCT04612582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65049010|NCT04612582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65049011|NCT04612582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65049012|NCT04612582|Growth Substances|growth substances|mesh-ancestor
65049013|NCT04612582|Growth Inhibitors|growth inhibitors|mesh-ancestor
65049014|NCT00248157|Octreotide|octreotide|mesh-list
65049015|NCT00248157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65049016|NCT00248157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65049017|NCT00248157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049037|NCT00222053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049038|NCT00222053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65049039|NCT00251511|Arsenic Trioxide|arsenic trioxide|mesh-list
65049040|NCT00251511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049041|NCT04611958|Bupivacaine|bupivacaine|mesh-list
65049042|NCT04611958|Anesthetics, Local|anesthetics, local|mesh-ancestor
65049043|NCT04611958|Anesthetics|anesthetics|mesh-ancestor
65049044|NCT04611958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65049045|NCT04611958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049046|NCT04611958|Sensory System Agents|sensory system agents|mesh-ancestor
65049047|NCT04611958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65049048|NCT00412919|Azacitidine|azacitidine|mesh-list
65049049|NCT00412919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65049050|NCT00412919|Antimetabolites|antimetabolites|mesh-ancestor
65049051|NCT00412919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049052|NCT00412919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049053|NCT00412919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049054|NCT00222170|Rabeprazole|rabeprazole|mesh-list
65049055|NCT00222170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65049056|NCT00222170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65049057|NCT00222170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65049058|NCT00222170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248447|NCT02841722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823475|NCT01526941|Insulin|insulin|mesh-list
65049059|NCT00222170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049060|NCT04611724|Folfirinox|folfirinox|mesh-list
65049061|NCT04611724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049062|NCT00563758|Tegaserod|tegaserod|mesh-list
65049063|NCT00563758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65049064|NCT00563758|Serotonin Agents|serotonin agents|mesh-ancestor
65049065|NCT00563758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65049066|NCT00563758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049067|NCT00563758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049068|NCT00563836|Catumaxomab|catumaxomab|mesh-list
65049069|NCT00563836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65049070|NCT00563875|Aspirin|aspirin|mesh-list
65049071|NCT00563875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65049072|NCT00563875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65049095|NCT04611685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65049096|NCT04611685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65049097|NCT04611685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65049098|NCT04611685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049099|NCT04611685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049100|NCT04611685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65049101|NCT04611685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65049102|NCT04611685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65049103|NCT04611685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65049105|NCT00563914|Ferroquine|ferroquine|mesh-list
65049106|NCT00563914|Antimalarials|antimalarials|mesh-ancestor
65049107|NCT00563914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65049108|NCT00563914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65049109|NCT00563914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65049110|NCT00563953|Doxorubicin|doxorubicin|mesh-list
65049111|NCT00563953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65049112|NCT00563953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049113|NCT00563953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65049114|NCT00563953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65049115|NCT00563953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049116|NCT00563953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049117|NCT00563992|Valproic Acid|valproic acid|mesh-list
65049118|NCT00563992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65049119|NCT00563992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049120|NCT00563992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049121|NCT00563992|Antimanic Agents|antimanic agents|mesh-ancestor
65049122|NCT00563992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65049123|NCT00563992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65049124|NCT00563992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901050|NCT02045914|Calcium|calcium|mesh-list
65049149|NCT04611373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65049150|NCT00564031|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65049151|NCT00564031|Medroxyprogesterone|medroxyprogesterone|mesh-list
65049152|NCT00564031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65049153|NCT00564031|Contraceptive Agents|contraceptive agents|mesh-ancestor
65049154|NCT00564031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65049155|NCT00564031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049156|NCT00564031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65049157|NCT00564031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65049158|NCT00564031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65049159|NCT00564031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049160|NCT00564031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64490575|NCT03422523|Gemcitabine|gemcitabine|mesh-list
65049161|NCT00564031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65049162|NCT00564031|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65049163|NCT02961426|Sofosbuvir|sofosbuvir|mesh-list
65049164|NCT02961426|Antiviral Agents|antiviral agents|mesh-ancestor
65049165|NCT02961426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65049166|NCT04610164|Tranexamic Acid|tranexamic acid|mesh-list
65049167|NCT04610164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65049168|NCT04610164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65049169|NCT04610164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049170|NCT04610164|Hemostatics|hemostatics|mesh-ancestor
65049171|NCT04610164|Coagulants|coagulants|mesh-ancestor
65049172|NCT00222443|Irinotecan|irinotecan|mesh-list
65049173|NCT00222443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65049174|NCT00222443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65049175|NCT00222443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049203|NCT04610125|Fludarabine|fludarabine|mesh-list
65049204|NCT04610125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64823558|NCT01527305|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65049205|NCT04610125|Immunologic Factors|immunologic factors|mesh-ancestor
65049206|NCT04610125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049207|NCT04610125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65049208|NCT04610125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65049209|NCT04610125|Alkylating Agents|alkylating agents|mesh-ancestor
65049210|NCT04610125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049211|NCT04610125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049212|NCT04610125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65049213|NCT00564148|Bevacizumab|bevacizumab|mesh-list
65049214|NCT00564148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65049215|NCT00564148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049216|NCT00564148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65049217|NCT00564148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65049218|NCT00564148|Growth Substances|growth substances|mesh-ancestor
65049219|NCT00564148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049220|NCT00564148|Growth Inhibitors|growth inhibitors|mesh-ancestor
65049221|NCT00222521|Insulin Glargine|insulin glargine|mesh-list
65049222|NCT00222521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65049254|NCT00222677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65049255|NCT00222677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049256|NCT00222677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65049257|NCT00222677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65049259|NCT00222677|Antipyretics|antipyretics|mesh-ancestor
65049260|NCT00564460|Finasteride|finasteride|mesh-list
65049261|NCT00564460|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65049262|NCT00564460|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65049263|NCT00564460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901198|NCT02046538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65049290|NCT00248313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65049291|NCT00248313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65049292|NCT00248313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049293|NCT00248313|Antifungal Agents|antifungal agents|mesh-ancestor
65049294|NCT00248313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65049295|NCT00248313|Immunologic Factors|immunologic factors|mesh-ancestor
65049296|NCT00248313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049297|NCT00222794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65049298|NCT00222794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65049299|NCT00222794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65049300|NCT00222794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65049301|NCT00222794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049302|NCT00222794|Adrenergic Agents|adrenergic agents|mesh-ancestor
65049303|NCT00222794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65049304|NCT00222794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049305|NCT04608253|Choline|choline|mesh-list
65049306|NCT04608253|Lipotropic Agents|lipotropic agents|mesh-ancestor
65049307|NCT04608253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65049308|NCT04608253|Antimetabolites|antimetabolites|mesh-ancestor
65049309|NCT04608253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049310|NCT04608253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65049343|NCT00251706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65049344|NCT00251706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65049345|NCT00251706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049346|NCT00251706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65049347|NCT00251706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65049348|NCT00251706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65049349|NCT00251706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049350|NCT00251706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65049351|NCT00251706|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65049352|NCT00251706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65049353|NCT00199121|Zidovudine|zidovudine|mesh-list
65049381|NCT04607629|Autonomic Agents|autonomic agents|mesh-ancestor
65049382|NCT04607629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65049383|NCT04607629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049384|NCT04607629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65049385|NCT04607629|Respiratory System Agents|respiratory system agents|mesh-ancestor
65049386|NCT04607629|Glucocorticoids|glucocorticoids|mesh-ancestor
65049387|NCT04607629|Hormones|hormones|mesh-ancestor
65049388|NCT04607629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65049389|NCT04607629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64472775|NCT02790710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65049390|NCT04607629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65049391|NCT04607629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65049392|NCT04607629|Adrenergic Agents|adrenergic agents|mesh-ancestor
65049393|NCT04607629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65049394|NCT04607629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049396|NCT04607629|Immunologic Factors|immunologic factors|mesh-ancestor
65049397|NCT00251784|Sildenafil Citrate|sildenafil citrate|mesh-list
65049398|NCT00251784|Vasodilator Agents|vasodilator agents|mesh-ancestor
65049399|NCT00251784|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65049400|NCT00251784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65049401|NCT00251784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049423|NCT05556356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049425|NCT00564655|Epinephrine|epinephrine|mesh-list
65049426|NCT00564655|Racepinephrine|racepinephrine|mesh-list
65049427|NCT00564655|Bupivacaine|bupivacaine|mesh-list
65049428|NCT00564655|Epinephryl borate|epinephryl borate|mesh-list
65049429|NCT00564655|Anesthetics, Local|anesthetics, local|mesh-ancestor
65049430|NCT00564655|Anesthetics|anesthetics|mesh-ancestor
65049431|NCT00564655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65049432|NCT00564655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049433|NCT00564655|Sensory System Agents|sensory system agents|mesh-ancestor
65049434|NCT00564655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65049435|NCT00564655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65049436|NCT00564655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65049437|NCT00564655|Adrenergic Agents|adrenergic agents|mesh-ancestor
65049438|NCT00564655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65049439|NCT00564655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049440|NCT00564655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65049441|NCT00564655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65049442|NCT00564655|Autonomic Agents|autonomic agents|mesh-ancestor
65049443|NCT00564655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65049444|NCT00564655|Respiratory System Agents|respiratory system agents|mesh-ancestor
65049445|NCT00564655|Mydriatics|mydriatics|mesh-ancestor
65049446|NCT00564655|Sympathomimetics|sympathomimetics|mesh-ancestor
65049447|NCT00564655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65049448|NCT04606537|Itraconazole|itraconazole|mesh-list
65049449|NCT04606537|Rifampin|rifampin|mesh-list
65049450|NCT04606537|Antifungal Agents|antifungal agents|mesh-ancestor
65049451|NCT04606537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65049452|NCT04606537|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65049453|NCT04606537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65049454|NCT04606537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901376|NCT02047175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049473|NCT00251823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65049475|NCT04606225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65049476|NCT04606225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65049477|NCT04606225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65049478|NCT04606225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65049479|NCT04606225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049480|NCT04606108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65049481|NCT04606108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049482|NCT04606108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049483|NCT04719507|Meperidine|meperidine|mesh-list
65049484|NCT04719507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65049485|NCT04719507|Narcotics|narcotics|mesh-ancestor
65049486|NCT04719507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65049487|NCT04719507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049488|NCT04719507|Analgesics|analgesics|mesh-ancestor
65049489|NCT04719507|Sensory System Agents|sensory system agents|mesh-ancestor
65049490|NCT04719507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65049491|NCT04719507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65049492|NCT04605952|Antibodies|antibodies|mesh-list
65049493|NCT04605952|Immunoglobulin G|immunoglobulin g|mesh-list
65049494|NCT04605952|Immunologic Factors|immunologic factors|mesh-ancestor
65049495|NCT04605952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049496|NCT04605562|Palbociclib|palbociclib|mesh-list
65049497|NCT04605562|Antibodies|antibodies|mesh-list
65049498|NCT04605562|Antibodies, Blocking|antibodies, blocking|mesh-list
65049499|NCT04605562|Immunologic Factors|immunologic factors|mesh-ancestor
65049500|NCT04605562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049501|NCT04605562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049502|NCT04605562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65049503|NCT04605562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248448|NCT02548117|Finasteride|finasteride|mesh-list
65049504|NCT04605562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049537|NCT04604938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049539|NCT00565006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65049540|NCT00565006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65049541|NCT00565006|Antimetabolites|antimetabolites|mesh-ancestor
65049542|NCT00565006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049543|NCT00565006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65049545|NCT00565123|Ofloxacin|ofloxacin|mesh-list
65049546|NCT00565123|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65049547|NCT00565123|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65049572|NCT04604509|Antidepressive Agents|antidepressive agents|mesh-ancestor
65049573|NCT04604509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65049574|NCT04604509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65049575|NCT04604509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65049576|NCT04604509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65049578|NCT04604509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65049579|NCT04604509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65049580|NCT04604509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049581|NCT00565162|Insulin Glargine|insulin glargine|mesh-list
65049582|NCT00565162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65049583|NCT00565162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049584|NCT04603729|Dexamethasone|dexamethasone|mesh-list
65049585|NCT04603729|Methylprednisolone|methylprednisolone|mesh-list
65049586|NCT04603729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65049587|NCT04603729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65049588|NCT04603729|Prednisolone|prednisolone|mesh-list
65049589|NCT04603729|Prednisolone acetate|prednisolone acetate|mesh-list
65049590|NCT04603729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65049591|NCT04603729|Prednisolone phosphate|prednisolone phosphate|mesh-list
65049592|NCT04603729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65049593|NCT04603729|Antiemetics|antiemetics|mesh-ancestor
65049594|NCT04603729|Autonomic Agents|autonomic agents|mesh-ancestor
65049595|NCT04603729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64901532|NCT00005859|Tipifarnib|tipifarnib|mesh-list
65049616|NCT04603573|Cariostatic Agents|cariostatic agents|mesh-ancestor
65049617|NCT04603573|Protective Agents|protective agents|mesh-ancestor
65049618|NCT04603573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049620|NCT04603573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65049621|NCT05361824|Acetaminophen|acetaminophen|mesh-list
65049622|NCT05361824|Ketorolac|ketorolac|mesh-list
65049623|NCT05361824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65049624|NCT05361824|Analgesics|analgesics|mesh-ancestor
65049625|NCT05361824|Sensory System Agents|sensory system agents|mesh-ancestor
65049626|NCT05361824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65049627|NCT05361824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049628|NCT05361824|Antipyretics|antipyretics|mesh-ancestor
65049629|NCT05361824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65049630|NCT05361824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65049631|NCT05361824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65049632|NCT05361824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65049633|NCT05361824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049634|NCT05361824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049635|NCT04603456|Calcium Carbonate|calcium carbonate|mesh-list
65049636|NCT04603456|Antacids|antacids|mesh-ancestor
65049637|NCT04603456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049638|NCT04603456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65049639|NCT04603066|Ondansetron|ondansetron|mesh-list
65049640|NCT04603066|Antiemetics|antiemetics|mesh-ancestor
65049641|NCT04603066|Autonomic Agents|autonomic agents|mesh-ancestor
65049642|NCT04603066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65049643|NCT04603066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049644|NCT04603066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65049645|NCT04603066|Antipruritics|antipruritics|mesh-ancestor
65049646|NCT04603066|Dermatologic Agents|dermatologic agents|mesh-ancestor
65049647|NCT04603066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65049648|NCT04603066|Serotonin Agents|serotonin agents|mesh-ancestor
65049649|NCT04603066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65049650|NCT04603066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049651|NCT04603066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65049652|NCT04603066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65049653|NCT04603066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65049679|NCT05285813|Anesthetics|anesthetics|mesh-ancestor
65049680|NCT05285813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65049681|NCT05285813|Histamine Antagonists|histamine antagonists|mesh-ancestor
65049682|NCT05285813|Histamine Agents|histamine agents|mesh-ancestor
65049683|NCT05285813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65049684|NCT05285813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049685|NCT05285813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65049686|NCT05285813|Antipruritics|antipruritics|mesh-ancestor
65049687|NCT05285813|Dermatologic Agents|dermatologic agents|mesh-ancestor
65049688|NCT00252291|Methacholine Chloride|methacholine chloride|mesh-list
65049689|NCT00252291|Miotics|miotics|mesh-ancestor
65049690|NCT00252291|Autonomic Agents|autonomic agents|mesh-ancestor
65049691|NCT00252291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65049692|NCT00252291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049693|NCT00252291|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65049694|NCT00252291|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
65049695|NCT00252291|Respiratory System Agents|respiratory system agents|mesh-ancestor
65049696|NCT00252291|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65049697|NCT00252291|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65049698|NCT00252291|Cholinergic Agents|cholinergic agents|mesh-ancestor
65049699|NCT00252291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65049700|NCT00252291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049702|NCT00565240|NuvaRing|nuvaring|mesh-list
65049703|NCT00565240|Desogestrel|desogestrel|mesh-list
65049704|NCT00565240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049705|NCT00565240|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65049706|NCT00565240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65049733|NCT00252330|Adrenergic Agents|adrenergic agents|mesh-ancestor
65049734|NCT00252330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65049735|NCT00252330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049736|NCT00252330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049737|NCT04602013|Paclitaxel|paclitaxel|mesh-list
65049738|NCT04602013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65049739|NCT04602013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65049740|NCT04602013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049741|NCT04602013|Tubulin Modulators|tubulin modulators|mesh-ancestor
65049742|NCT04602013|Antimitotic Agents|antimitotic agents|mesh-ancestor
65049743|NCT04602013|Mitosis Modulators|mitosis modulators|mesh-ancestor
65049744|NCT04602013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049745|NCT04601701|Dexamethasone|dexamethasone|mesh-list
65049746|NCT04601701|Bevacizumab|bevacizumab|mesh-list
65049747|NCT04601701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65049748|NCT04601701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049749|NCT04601701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65049750|NCT04601701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65049751|NCT04601701|Growth Substances|growth substances|mesh-ancestor
64901677|NCT00005922|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65049783|NCT05201144|Urological Agents|urological agents|mesh-ancestor
65049784|NCT00252408|Hormones|hormones|mesh-list
65049785|NCT00252408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65049786|NCT00252408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049787|NCT04601389|Omalizumab|omalizumab|mesh-list
65049788|NCT04601389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65049789|NCT04601389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65049790|NCT04601389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65049791|NCT04601389|Respiratory System Agents|respiratory system agents|mesh-ancestor
65049792|NCT04601389|Immunologic Factors|immunologic factors|mesh-ancestor
65049793|NCT04601389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049794|NCT00565396|Losartan|losartan|mesh-list
65049795|NCT00565396|Fosinopril|fosinopril|mesh-list
65049796|NCT00565396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65049797|NCT00565396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65049826|NCT00249132|Dopamine Agents|dopamine agents|mesh-ancestor
65049827|NCT04600414|Analgesics, Opioid|analgesics, opioid|mesh-list
65049828|NCT04600414|Narcotics|narcotics|mesh-ancestor
65049829|NCT04600414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65049830|NCT04600414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049831|NCT04600414|Analgesics|analgesics|mesh-ancestor
65049832|NCT04600414|Sensory System Agents|sensory system agents|mesh-ancestor
65049833|NCT04600414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65049834|NCT04600492|Riociguat|riociguat|mesh-list
65049835|NCT04600492|Enzyme Activators|enzyme activators|mesh-ancestor
65049836|NCT04600492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049838|NCT04599712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65049839|NCT04599712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049840|NCT00414648|Sirolimus|sirolimus|mesh-list
65049841|NCT00414648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65049842|NCT00414648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65049866|NCT04598737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65049867|NCT04598737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65049868|NCT04598737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049870|NCT05055128|Dexlansoprazole|dexlansoprazole|mesh-list
65049871|NCT05055128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65049872|NCT05055128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65049873|NCT05055128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65049874|NCT05055128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049875|NCT05055128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049876|NCT00565591|Albuterol|albuterol|mesh-list
65049877|NCT00565591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65049878|NCT00565591|Autonomic Agents|autonomic agents|mesh-ancestor
65049879|NCT00565591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65049880|NCT00565591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049881|NCT00565591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65049882|NCT00565591|Respiratory System Agents|respiratory system agents|mesh-ancestor
65049883|NCT00565591|Tocolytic Agents|tocolytic agents|mesh-ancestor
65049884|NCT00565591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65049885|NCT00565591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65049886|NCT00565591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65049887|NCT00565591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65049888|NCT00565591|Adrenergic Agents|adrenergic agents|mesh-ancestor
65049889|NCT00565591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65049890|NCT00565591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049891|NCT00252603|Galantamine|galantamine|mesh-list
65049892|NCT00252603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65049893|NCT00252603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049894|NCT00252603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049913|NCT00565630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65049914|NCT00565630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049915|NCT00565630|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65049917|NCT00565630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65049919|NCT00565708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65049920|NCT00565708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65049921|NCT00565708|Analgesics|analgesics|mesh-ancestor
65049922|NCT00565708|Sensory System Agents|sensory system agents|mesh-ancestor
65049923|NCT00565708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65049924|NCT00565708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049925|NCT00565708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65049926|NCT00565708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65049927|NCT00565708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65049928|NCT00565708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65049929|NCT00565708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049930|NCT00565708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65049931|NCT00565708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65049932|NCT00565708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049933|NCT00565708|Antipyretics|antipyretics|mesh-ancestor
65049934|NCT00252642|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65049935|NCT00252642|Antiviral Agents|antiviral agents|mesh-ancestor
65049936|NCT00252642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65049937|NCT04598542|Triamcinolone|triamcinolone|mesh-list
65049938|NCT04598542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65049939|NCT04598542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65049940|NCT04598542|Lorecivivint|lorecivivint|mesh-list
65049941|NCT04598542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65049942|NCT04598542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65049943|NCT04598542|Glucocorticoids|glucocorticoids|mesh-ancestor
65049944|NCT04598542|Hormones|hormones|mesh-ancestor
65049945|NCT04598542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65049946|NCT04598542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049947|NCT04598542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64670399|NCT02249546|Acetylcysteine|acetylcysteine|mesh-list
65049973|NCT04955366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65049974|NCT00249171|Risperidone|risperidone|mesh-list
65049975|NCT00249171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65049976|NCT00249171|Serotonin Agents|serotonin agents|mesh-ancestor
65049977|NCT00249171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65049978|NCT00249171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049979|NCT00249171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049980|NCT00249171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65049981|NCT00249171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65049982|NCT00249171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65049983|NCT00249171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65049984|NCT00249171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65049985|NCT00249171|Dopamine Agents|dopamine agents|mesh-ancestor
65049986|NCT00565981|Fludarabine|fludarabine|mesh-list
65049987|NCT00565981|Fludarabine phosphate|fludarabine phosphate|mesh-list
65049988|NCT00565981|Alemtuzumab|alemtuzumab|mesh-list
65049989|NCT00565981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049990|NCT00565981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65049991|NCT00565981|Antimetabolites|antimetabolites|mesh-ancestor
65049992|NCT00565981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049993|NCT00565981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65049994|NCT00565981|Immunologic Factors|immunologic factors|mesh-ancestor
65050014|NCT00414921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65050015|NCT00414921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65050016|NCT00414921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65050017|NCT00414921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050018|NCT00414921|Dopamine Agents|dopamine agents|mesh-ancestor
65050019|NCT00414921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65050020|NCT00414921|Analgesics|analgesics|mesh-ancestor
65050021|NCT00414921|Sensory System Agents|sensory system agents|mesh-ancestor
65050022|NCT00414921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050023|NCT00414921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65050024|NCT00414921|Sympatholytics|sympatholytics|mesh-ancestor
65050025|NCT00414921|Autonomic Agents|autonomic agents|mesh-ancestor
65050026|NCT00414921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65050027|NCT00414921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65050028|NCT00414921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65050029|NCT00414921|Adrenergic Agents|adrenergic agents|mesh-ancestor
65050030|NCT04597762|Cyclosporine|cyclosporine|mesh-list
65050031|NCT04597762|Hydrocortisone|hydrocortisone|mesh-list
65050032|NCT04597762|Cyclosporins|cyclosporins|mesh-list
65050033|NCT04597762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050034|NCT04597762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050035|NCT04597762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65050036|NCT04597762|Immunologic Factors|immunologic factors|mesh-ancestor
65050037|NCT04597762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050038|NCT04597762|Antifungal Agents|antifungal agents|mesh-ancestor
65050039|NCT04597762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65050040|NCT04597762|Dermatologic Agents|dermatologic agents|mesh-ancestor
65050041|NCT04597762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65050042|NCT04597762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65050043|NCT04597762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65050044|NCT00249210|Levofloxacin|levofloxacin|mesh-list
65050045|NCT00249210|Ofloxacin|ofloxacin|mesh-list
65050046|NCT00249210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65050047|NCT00249210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65050048|NCT00249210|Renal Agents|renal agents|mesh-ancestor
65050049|NCT00249210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65050050|NCT00249210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65050074|NCT00566332|Fludarabine|fludarabine|mesh-list
65050075|NCT00566332|Chlorambucil|chlorambucil|mesh-list
65050076|NCT00566332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050077|NCT00566332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050078|NCT00566332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65050079|NCT00566332|Alkylating Agents|alkylating agents|mesh-ancestor
65050080|NCT00403052|1018 oligonucleotide|1018 oligonucleotide|mesh-list
65050081|NCT00403052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65050082|NCT00403052|Immunologic Factors|immunologic factors|mesh-ancestor
65050083|NCT00403052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050084|NCT00566371|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65050085|NCT00566371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65050086|NCT00566371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65050087|NCT00566371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65050088|NCT00566371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050089|NCT00566371|Adrenergic Agents|adrenergic agents|mesh-ancestor
65050090|NCT00566371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65050091|NCT00566371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050092|NCT04595929|Leucovorin|leucovorin|mesh-list
65050093|NCT04595929|Docetaxel|docetaxel|mesh-list
65050094|NCT04595929|Fluorouracil|fluorouracil|mesh-list
65050095|NCT04595929|Oxaliplatin|oxaliplatin|mesh-list
65050096|NCT04595929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050097|NCT04595929|Tubulin Modulators|tubulin modulators|mesh-ancestor
65050098|NCT04595929|Antimitotic Agents|antimitotic agents|mesh-ancestor
65050099|NCT04595929|Mitosis Modulators|mitosis modulators|mesh-ancestor
65050100|NCT04595929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050101|NCT04595929|Antimetabolites|antimetabolites|mesh-ancestor
65050102|NCT04595929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65050141|NCT00249366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050143|NCT04635683|Immunologic Factors|immunologic factors|mesh-ancestor
64902084|NCT00006015|Antidotes|antidotes|mesh-ancestor
65050175|NCT00253110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050176|NCT00253110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050177|NCT00253110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65050178|NCT00253110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65050179|NCT00253110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65050180|NCT00253110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65050181|NCT00253110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65050182|NCT00253110|Dopamine Agents|dopamine agents|mesh-ancestor
65050183|NCT00253110|Antiemetics|antiemetics|mesh-ancestor
65050184|NCT00253110|Autonomic Agents|autonomic agents|mesh-ancestor
65050218|NCT00566761|Bevacizumab|bevacizumab|mesh-list
65050219|NCT00566761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65050220|NCT00566761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050221|NCT00566761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65050222|NCT00566761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65050223|NCT00566761|Growth Substances|growth substances|mesh-ancestor
65050224|NCT00566761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050225|NCT00566761|Growth Inhibitors|growth inhibitors|mesh-ancestor
65050226|NCT00566761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65050227|NCT00566761|Glucocorticoids|glucocorticoids|mesh-ancestor
65050228|NCT00566761|Hormones|hormones|mesh-ancestor
65050229|NCT00566761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65050230|NCT00566800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65050231|NCT00566800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050262|NCT04593706|Glucocorticoids|glucocorticoids|mesh-ancestor
65050263|NCT04593706|Hormones|hormones|mesh-ancestor
65050264|NCT04593706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65050265|NCT04593706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65050266|NCT04593706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050267|NCT04593706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65050268|NCT04593706|Protective Agents|protective agents|mesh-ancestor
65050269|NCT04593706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65050270|NCT04593706|Immunologic Factors|immunologic factors|mesh-ancestor
65050271|NCT04593706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050272|NCT04593706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050273|NCT04593706|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65050274|NCT04593706|Respiratory System Agents|respiratory system agents|mesh-ancestor
65050275|NCT04593706|Protease Inhibitors|protease inhibitors|mesh-ancestor
65050276|NCT04587830|Temozolomide|temozolomide|mesh-list
65050277|NCT04587830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65050303|NCT00253149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65050304|NCT00253149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050305|NCT00253149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050306|NCT00253149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65050307|NCT00253149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65050308|NCT00253149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65050309|NCT00253149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65050310|NCT00253149|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65050311|NCT00253149|Dopamine Agents|dopamine agents|mesh-ancestor
65050312|NCT04539236|Lenalidomide|lenalidomide|mesh-list
65050313|NCT04539236|Luspatercept|luspatercept|mesh-list
65050314|NCT04539236|Immunologic Factors|immunologic factors|mesh-ancestor
65050315|NCT04539236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050316|NCT04539236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65050317|NCT04539236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65050318|NCT04539236|Growth Substances|growth substances|mesh-ancestor
65050319|NCT04539236|Growth Inhibitors|growth inhibitors|mesh-ancestor
65050320|NCT04539236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050321|NCT04539236|Hematinics|hematinics|mesh-ancestor
65050322|NCT00249483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65050323|NCT00249483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65050324|NCT00249483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65050349|NCT04484363|Antimetabolites|antimetabolites|mesh-ancestor
65050350|NCT04484363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050351|NCT04484363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050352|NCT04484363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050353|NCT04592380|Clevidipine|clevidipine|mesh-list
65050354|NCT04592380|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65050355|NCT04592380|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65050356|NCT04592380|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65050357|NCT04592380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65050358|NCT04592380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64824187|NCT01530386|Lacosamide|lacosamide|mesh-list
64535632|NCT01690988|Anesthetics|anesthetics|mesh-ancestor
65050359|NCT04592380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65050360|NCT04592380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050361|NCT04592380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65050362|NCT04592380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050364|NCT00253188|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65050365|NCT00253188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050366|NCT00253188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050367|NCT00253188|Cholinergic Agents|cholinergic agents|mesh-ancestor
65050368|NCT00253188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65050369|NCT00253188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050370|NCT00253188|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65050371|NCT00253188|Autonomic Agents|autonomic agents|mesh-ancestor
65050372|NCT00253188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050373|NCT00253188|Nootropic Agents|nootropic agents|mesh-ancestor
65050397|NCT04591795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050399|NCT04591639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65050400|NCT04591639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050401|NCT04591639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65050402|NCT04591639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050403|NCT04719585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65050404|NCT04719585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050405|NCT04719585|Analgesics|analgesics|mesh-ancestor
65050406|NCT04719585|Sensory System Agents|sensory system agents|mesh-ancestor
65050407|NCT04719585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050408|NCT04719585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65050409|NCT04719585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65050410|NCT04719585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65050411|NCT04719585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050412|NCT04719585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65050413|NCT04719585|Antidepressive Agents|antidepressive agents|mesh-ancestor
65050414|NCT04719585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65050415|NCT04719585|Dopamine Agents|dopamine agents|mesh-ancestor
65050416|NCT04592029|Bevacizumab|bevacizumab|mesh-list
65050417|NCT04592029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65050418|NCT04592029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050419|NCT04592029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65050420|NCT04592029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65050421|NCT04592029|Growth Substances|growth substances|mesh-ancestor
65050455|NCT04396730|Anticonvulsants|anticonvulsants|mesh-ancestor
65050456|NCT04396730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65050457|NCT04396730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050458|NCT04396730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65050459|NCT00253266|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65050460|NCT00253266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65050461|NCT00253266|Antidepressive Agents|antidepressive agents|mesh-ancestor
65050462|NCT00253266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65050463|NCT00253266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65050464|NCT00253266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65050465|NCT00253266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65050466|NCT00253266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050492|NCT00253344|Lenalidomide|lenalidomide|mesh-list
65050493|NCT00253344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050494|NCT00253344|Tubulin Modulators|tubulin modulators|mesh-ancestor
65050495|NCT00253344|Antimitotic Agents|antimitotic agents|mesh-ancestor
65050496|NCT00253344|Mitosis Modulators|mitosis modulators|mesh-ancestor
65050497|NCT00253344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050498|NCT00253344|Immunologic Factors|immunologic factors|mesh-ancestor
65050499|NCT00253344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050500|NCT00253344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65050501|NCT00253344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65050502|NCT00253344|Growth Substances|growth substances|mesh-ancestor
65050503|NCT00253344|Growth Inhibitors|growth inhibitors|mesh-ancestor
65050504|NCT04316117|Deoxyglucose|deoxyglucose|mesh-list
64491868|NCT00417664|Anesthetics|anesthetics|mesh-ancestor
65050505|NCT04316117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65050506|NCT04316117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65050507|NCT04316117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050508|NCT04316117|Antimetabolites|antimetabolites|mesh-ancestor
65050509|NCT04316117|Antiviral Agents|antiviral agents|mesh-ancestor
65050510|NCT04316117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65050511|NCT00567463|Fluticasone|fluticasone|mesh-list
65050512|NCT00567463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65050513|NCT00567463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65050514|NCT00567463|Autonomic Agents|autonomic agents|mesh-ancestor
65050536|NCT04590937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65050537|NCT04590937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65050538|NCT04590937|Antimetabolites|antimetabolites|mesh-ancestor
65050539|NCT04590937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050540|NCT04590937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65050541|NCT04590937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65050542|NCT04590937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050543|NCT04590625|Carboplatin|carboplatin|mesh-list
65050544|NCT04590625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65050545|NCT04590625|Apatinib|apatinib|mesh-list
65050546|NCT04590625|Cisplatin|cisplatin|mesh-list
65050547|NCT04590625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050548|NCT04590625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050549|NCT04590625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65050550|NCT04590625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050551|NCT00253461|Topotecan|topotecan|mesh-list
65050552|NCT00253461|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65050553|NCT00253461|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65050554|NCT00253461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65050555|NCT00253461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050556|NCT00253461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050557|NCT00253461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050558|NCT00253461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65050559|NCT04272242|Pyridoxine|pyridoxine|mesh-list
65050560|NCT04272242|Pyridoxal|pyridoxal|mesh-list
65050561|NCT04272242|Vitamin B 6|vitamin b 6|mesh-list
65050562|NCT04272242|Isoniazid|isoniazid|mesh-list
65050563|NCT04272242|Rifapentine|rifapentine|mesh-list
65050564|NCT04272242|Dolutegravir|dolutegravir|mesh-list
65050565|NCT04272242|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65050566|NCT04272242|Vitamins|vitamins|mesh-ancestor
65050567|NCT04272242|Micronutrients|micronutrients|mesh-ancestor
64902521|NCT03913221|Caffeine|caffeine|mesh-list
65050600|NCT04590196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050601|NCT04590196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050602|NCT04590196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65050603|NCT04590196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65050604|NCT04590196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050605|NCT04590196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050606|NCT04590196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050607|NCT00567658|Esomeprazole|esomeprazole|mesh-list
65050608|NCT00567658|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65050609|NCT00567658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65050610|NCT00567658|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65050611|NCT00567658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902545|NCT03869736|Analgesics|analgesics|mesh-ancestor
65050648|NCT04588987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050682|NCT00567814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65050684|NCT04588441|Analgesics|analgesics|mesh-ancestor
65050685|NCT04588441|Sensory System Agents|sensory system agents|mesh-ancestor
65050686|NCT04588441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050687|NCT04588441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050688|NCT04588441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65050689|NCT04588441|Vasodilator Agents|vasodilator agents|mesh-ancestor
65050690|NCT04588441|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65050723|NCT00253617|Dermatologic Agents|dermatologic agents|mesh-ancestor
65050724|NCT00253617|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65050725|NCT04587778|Ketamine|ketamine|mesh-list
65050726|NCT04587778|Esketamine|esketamine|mesh-list
65050727|NCT04587778|Analgesics|analgesics|mesh-ancestor
65050728|NCT04587778|Sensory System Agents|sensory system agents|mesh-ancestor
65050729|NCT04587778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050730|NCT04587778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050731|NCT04587778|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65050732|NCT04587778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65050733|NCT04587778|Anesthetics, General|anesthetics, general|mesh-ancestor
65050763|NCT04128683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65050764|NCT04128683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050765|NCT04128683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65050766|NCT04128683|Antidepressive Agents|antidepressive agents|mesh-ancestor
65050768|NCT04128683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65050769|NCT04128683|Hormone Antagonists|hormone antagonists|mesh-ancestor
65050770|NCT04128683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65050771|NCT04128683|Dopamine Agonists|dopamine agonists|mesh-ancestor
65050772|NCT04587115|Oxycodone|oxycodone|mesh-list
65050773|NCT04587115|Risperidone|risperidone|mesh-list
65050774|NCT04587115|Ziprasidone|ziprasidone|mesh-list
65050775|NCT04587115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65050776|NCT04587115|Narcotics|narcotics|mesh-ancestor
65050777|NCT04587115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65050778|NCT04587115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050779|NCT04587115|Analgesics|analgesics|mesh-ancestor
65050780|NCT04587115|Sensory System Agents|sensory system agents|mesh-ancestor
64671235|NCT03327051|Omeprazole|omeprazole|mesh-list
65050812|NCT00403286|Autonomic Agents|autonomic agents|mesh-ancestor
65050813|NCT00403286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050814|NCT00403286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050815|NCT00403286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65050816|NCT00403286|Respiratory System Agents|respiratory system agents|mesh-ancestor
65050817|NCT00403286|Dermatologic Agents|dermatologic agents|mesh-ancestor
65050818|NCT00403286|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65050819|NCT00403286|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65050820|NCT00403286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65050821|NCT00403286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65050822|NCT00403286|Adrenergic Agents|adrenergic agents|mesh-ancestor
65050823|NCT00403286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65050824|NCT00403286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050825|NCT04586491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65050826|NCT04586218|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65050827|NCT04585867|Bupivacaine|bupivacaine|mesh-list
65050828|NCT04585867|Anesthetics, Local|anesthetics, local|mesh-ancestor
65050860|NCT00223223|Levetiracetam|levetiracetam|mesh-list
65050861|NCT00223223|Anticonvulsants|anticonvulsants|mesh-ancestor
65050862|NCT00223223|Nootropic Agents|nootropic agents|mesh-ancestor
65050863|NCT00567931|Tryptophan|tryptophan|mesh-list
65050864|NCT00567931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65050865|NCT00567931|Antidepressive Agents|antidepressive agents|mesh-ancestor
65050866|NCT00567931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65050867|NCT00223301|Mycophenolic Acid|mycophenolic acid|mesh-list
65050868|NCT00223301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65050869|NCT00223301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902808|NCT00006054|Antiemetics|antiemetics|mesh-ancestor
65050903|NCT00253929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65050904|NCT00253929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65050905|NCT00253929|Purinergic Agents|purinergic agents|mesh-ancestor
65050906|NCT00253929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65050931|NCT04584580|Enoxaparin|enoxaparin|mesh-list
65050932|NCT04584580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65050933|NCT04584580|Tinzaparin|tinzaparin|mesh-list
65050934|NCT04584580|Dalteparin|dalteparin|mesh-list
65050935|NCT04584580|Anticoagulants|anticoagulants|mesh-ancestor
65050936|NCT04584580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65050937|NCT04584580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65050938|NCT04584580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050939|NCT00250029|Capecitabine|capecitabine|mesh-list
65050940|NCT00250029|Oxaliplatin|oxaliplatin|mesh-list
65050941|NCT00250029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65050942|NCT00250029|Antimetabolites|antimetabolites|mesh-ancestor
65050943|NCT00250029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050944|NCT00250029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050945|NCT00223418|Aripiprazole|aripiprazole|mesh-list
65050946|NCT00223418|Antidepressive Agents|antidepressive agents|mesh-ancestor
65050947|NCT00223418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65050948|NCT00223418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65050949|NCT00223418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65050950|NCT00223418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65050951|NCT00223418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050952|NCT00223418|Dopamine Agonists|dopamine agonists|mesh-ancestor
65050953|NCT00223418|Dopamine Agents|dopamine agents|mesh-ancestor
65050954|NCT00223418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65050955|NCT00223418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050956|NCT00223418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65050957|NCT00223418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65050977|NCT00250068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050978|NCT04584307|Pomalidomide|pomalidomide|mesh-list
65050979|NCT04584307|Elotuzumab|elotuzumab|mesh-list
65050980|NCT04584307|Immunologic Factors|immunologic factors|mesh-ancestor
65050981|NCT04584307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472814|NCT02648477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65050982|NCT04584307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65050983|NCT04584307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65050984|NCT04584307|Growth Substances|growth substances|mesh-ancestor
65050985|NCT04584307|Growth Inhibitors|growth inhibitors|mesh-ancestor
65050986|NCT04584307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050987|NCT04584034|Albuterol|albuterol|mesh-list
65050988|NCT04584034|Bronchodilator Agents|bronchodilator agents|mesh-list
65050989|NCT04584034|Autonomic Agents|autonomic agents|mesh-ancestor
65050990|NCT04584034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050991|NCT04584034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050992|NCT04584034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65050993|NCT04584034|Respiratory System Agents|respiratory system agents|mesh-ancestor
65050994|NCT04584034|Tocolytic Agents|tocolytic agents|mesh-ancestor
65050995|NCT04584034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65050996|NCT04584034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65050997|NCT04584034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65050998|NCT04584034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65050999|NCT04584034|Adrenergic Agents|adrenergic agents|mesh-ancestor
65051000|NCT04584034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65051001|NCT04584034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051002|NCT04583410|Nicotine|nicotine|mesh-list
65051003|NCT04583410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65051004|NCT04583410|Autonomic Agents|autonomic agents|mesh-ancestor
65051005|NCT04583410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65051006|NCT04583410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051007|NCT04583410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65051008|NCT04583410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65051009|NCT04583410|Cholinergic Agents|cholinergic agents|mesh-ancestor
65051010|NCT04583410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65051011|NCT04583410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051012|NCT00254007|Citalopram|citalopram|mesh-list
65051013|NCT00254007|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65051031|NCT04583137|Sensory System Agents|sensory system agents|mesh-ancestor
64536305|NCT01471093|Rebamipide|rebamipide|mesh-list
65051032|NCT04583137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65051033|NCT04583137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65051034|NCT04583137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65051035|NCT04583137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65051036|NCT04583137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65051037|NCT04583137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051038|NCT00223691|Acarbose|acarbose|mesh-list
65051039|NCT00223691|Diphenhydramine|diphenhydramine|mesh-list
65051040|NCT00223691|Promethazine|promethazine|mesh-list
65051041|NCT00223691|Ibuprofen|ibuprofen|mesh-list
65051042|NCT00223691|Celecoxib|celecoxib|mesh-list
65051043|NCT00223691|Indomethacin|indomethacin|mesh-list
65051044|NCT00223691|Octreotide|octreotide|mesh-list
65051045|NCT00223691|Phenylephrine|phenylephrine|mesh-list
65051046|NCT00223691|Acetazolamide|acetazolamide|mesh-list
65051047|NCT00223691|Midodrine|midodrine|mesh-list
65051048|NCT00223691|Pseudoephedrine|pseudoephedrine|mesh-list
65051049|NCT00223691|Ephedrine|ephedrine|mesh-list
65051050|NCT00223691|Oxymetazoline|oxymetazoline|mesh-list
65051051|NCT00223691|Ergotamine|ergotamine|mesh-list
65051052|NCT00223691|Bromides|bromides|mesh-list
65051053|NCT00223691|Levodopa|levodopa|mesh-list
65051054|NCT00223691|Carbidopa|carbidopa|mesh-list
65051055|NCT00223691|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65051056|NCT00223691|Tranylcypromine|tranylcypromine|mesh-list
65051057|NCT00223691|Caffeine|caffeine|mesh-list
65051058|NCT00223691|Methylphenidate|methylphenidate|mesh-list
65051059|NCT00223691|Modafinil|modafinil|mesh-list
65051060|NCT00223691|Rivastigmine|rivastigmine|mesh-list
65051061|NCT00223691|Ranitidine|ranitidine|mesh-list
65051062|NCT00223691|Yohimbine|yohimbine|mesh-list
65051063|NCT00223691|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
65051064|NCT00223691|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65051065|NCT00223691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65051066|NCT00223691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65051067|NCT00223691|Analgesics|analgesics|mesh-ancestor
65051068|NCT00223691|Sensory System Agents|sensory system agents|mesh-ancestor
65051069|NCT00223691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65051070|NCT00223691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051071|NCT00223691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65051072|NCT00223691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65051073|NCT00223691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65051098|NCT00223691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65051099|NCT00223691|Anesthetics, Local|anesthetics, local|mesh-ancestor
64824503|NCT01532102|Antiviral Agents|antiviral agents|mesh-list
65051100|NCT00223691|Anesthetics|anesthetics|mesh-ancestor
65051101|NCT00223691|Antiemetics|antiemetics|mesh-ancestor
65051102|NCT00223691|Autonomic Agents|autonomic agents|mesh-ancestor
65051103|NCT00223691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65051104|NCT00223691|Histamine Antagonists|histamine antagonists|mesh-ancestor
65051105|NCT00223691|Histamine Agents|histamine agents|mesh-ancestor
65051106|NCT00223691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65051107|NCT00223691|Antipruritics|antipruritics|mesh-ancestor
65051108|NCT00223691|Dermatologic Agents|dermatologic agents|mesh-ancestor
65051109|NCT00223691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65051110|NCT00223691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65051111|NCT00223691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65051112|NCT00223691|Gout Suppressants|gout suppressants|mesh-ancestor
65051114|NCT00223691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65051115|NCT00223691|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65051116|NCT00223691|Diuretics|diuretics|mesh-ancestor
65051117|NCT00223691|Natriuretic Agents|natriuretic agents|mesh-ancestor
65051118|NCT00223691|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65051119|NCT00223691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65051120|NCT00223691|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65051121|NCT00223691|Cholinergic Agents|cholinergic agents|mesh-ancestor
64903044|NCT00006198|Thalidomide|thalidomide|mesh-list
65051148|NCT00223691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65051149|NCT00223691|Oxytocics|oxytocics|mesh-ancestor
65051150|NCT00223691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65051151|NCT00223691|Serotonin Agents|serotonin agents|mesh-ancestor
65051152|NCT04583020|Temozolomide|temozolomide|mesh-list
65051153|NCT04583020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65051154|NCT04583020|Alkylating Agents|alkylating agents|mesh-ancestor
65051155|NCT04583020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051156|NCT04583020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051157|NCT04582552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65051158|NCT04582552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051159|NCT04582552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051160|NCT04582552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051161|NCT04582786|Morphine|morphine|mesh-list
65051162|NCT04582786|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65051163|NCT04582786|Narcotics|narcotics|mesh-ancestor
65051164|NCT04582786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65051165|NCT04582786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051166|NCT04582786|Analgesics|analgesics|mesh-ancestor
65051167|NCT04582786|Sensory System Agents|sensory system agents|mesh-ancestor
65051168|NCT04582786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65051169|NCT00223769|Oxandrolone|oxandrolone|mesh-list
65051170|NCT00223769|Androgens|androgens|mesh-ancestor
65051171|NCT00223769|Hormones|hormones|mesh-ancestor
64903088|NCT00006219|Clarithromycin|clarithromycin|mesh-list
65051189|NCT00254046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65051191|NCT00254046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051192|NCT00254046|Antiviral Agents|antiviral agents|mesh-ancestor
65051193|NCT00254046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65051194|NCT00223925|Maribavir|maribavir|mesh-list
65051195|NCT00223925|Antiviral Agents|antiviral agents|mesh-ancestor
65051196|NCT00223925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65051197|NCT00254085|Insulin Aspart|insulin aspart|mesh-list
65051198|NCT00254085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65051199|NCT00254085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051200|NCT04581967|Cyclophosphamide|cyclophosphamide|mesh-list
65051201|NCT04581967|Doxorubicin|doxorubicin|mesh-list
65051202|NCT04581967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64925214|NCT00031876|Paclitaxel|paclitaxel|mesh-list
65051203|NCT04581967|Immunologic Factors|immunologic factors|mesh-ancestor
65051204|NCT04581967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051205|NCT04581967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65051206|NCT04581967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65051207|NCT04581967|Alkylating Agents|alkylating agents|mesh-ancestor
65051208|NCT04581967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051209|NCT04581967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051210|NCT04581967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65051211|NCT04581967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65051212|NCT04581967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65051213|NCT04581967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65051214|NCT04581967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051215|NCT00223964|Ferric gluconate|ferric gluconate|mesh-list
65051216|NCT00223964|Hematinics|hematinics|mesh-ancestor
65051217|NCT00224081|Ferric gluconate|ferric gluconate|mesh-list
64472816|NCT02648477|Letrozole|letrozole|mesh-list
65051218|NCT00224081|Hematinics|hematinics|mesh-ancestor
65051219|NCT04581265|Paclitaxel|paclitaxel|mesh-list
65051220|NCT04581265|Ifosfamide|ifosfamide|mesh-list
65051221|NCT04581265|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65051222|NCT04581265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65051223|NCT04581265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051224|NCT04581265|Tubulin Modulators|tubulin modulators|mesh-ancestor
65051225|NCT04581265|Antimitotic Agents|antimitotic agents|mesh-ancestor
65051226|NCT04581265|Mitosis Modulators|mitosis modulators|mesh-ancestor
65051227|NCT04581265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051246|NCT00568711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65051247|NCT00568711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65051248|NCT00568711|Antitubercular Agents|antitubercular agents|mesh-ancestor
65051249|NCT00568711|Leprostatic Agents|leprostatic agents|mesh-ancestor
65051250|NCT00568711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65051251|NCT00568711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051252|NCT00568711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051253|NCT00568711|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65051254|NCT00568711|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65051255|NCT00568711|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65051256|NCT00568711|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65051257|NCT00568711|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64536528|NCT01603628|Cholinergic Agents|cholinergic agents|mesh-ancestor
65051258|NCT00568711|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65051259|NCT00415116|Carboplatin|carboplatin|mesh-list
65051260|NCT00415116|Docetaxel|docetaxel|mesh-list
65051261|NCT00415116|Lenalidomide|lenalidomide|mesh-list
65051262|NCT00415116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051263|NCT00415116|Tubulin Modulators|tubulin modulators|mesh-ancestor
65051264|NCT00415116|Antimitotic Agents|antimitotic agents|mesh-ancestor
65051265|NCT00415116|Mitosis Modulators|mitosis modulators|mesh-ancestor
65051266|NCT00415116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051267|NCT00415116|Immunologic Factors|immunologic factors|mesh-ancestor
65051268|NCT00415116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051269|NCT00415116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65051270|NCT00415116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65051271|NCT00415116|Growth Substances|growth substances|mesh-ancestor
65051272|NCT00415116|Growth Inhibitors|growth inhibitors|mesh-ancestor
65051273|NCT00568750|Dasatinib|dasatinib|mesh-list
65051274|NCT00568750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051275|NCT00568750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65494055|NCT03773302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051276|NCT00568750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051277|NCT00568750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051278|NCT00568789|Zolpidem|zolpidem|mesh-list
65051279|NCT00568789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65051280|NCT00568789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64903197|NCT00006258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65051304|NCT00254241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051305|NCT00254241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65051306|NCT00254241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65051307|NCT00254241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65051308|NCT00254241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65051309|NCT00254241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65051310|NCT00254241|Dopamine Agents|dopamine agents|mesh-ancestor
65051311|NCT00254241|Antidepressive Agents|antidepressive agents|mesh-ancestor
65051312|NCT00224315|Risperidone|risperidone|mesh-list
65051313|NCT00224315|Ziprasidone|ziprasidone|mesh-list
65051314|NCT00224315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65051315|NCT00224315|Serotonin Agents|serotonin agents|mesh-ancestor
65051316|NCT00224315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65051317|NCT00224315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051318|NCT00224315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051319|NCT00224315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65051320|NCT00224315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65051321|NCT00224315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65051322|NCT00224315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65051323|NCT00224315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65051324|NCT00224315|Dopamine Agents|dopamine agents|mesh-ancestor
65051325|NCT00569101|Tacrolimus|tacrolimus|mesh-list
65051326|NCT00569101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65051327|NCT00569101|Immunologic Factors|immunologic factors|mesh-ancestor
65051328|NCT00569101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051329|NCT00569101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65051330|NCT00569101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051331|NCT00569101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051332|NCT00224354|Interleukin-2|interleukin-2|mesh-list
65051368|NCT00224393|Sensory System Agents|sensory system agents|mesh-ancestor
65051369|NCT00224393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65051370|NCT00224393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051371|NCT00224393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65051372|NCT00224393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65051373|NCT00224393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65051374|NCT00224393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65051402|NCT00569920|Dexamethasone|dexamethasone|mesh-list
65051403|NCT00569920|Dexamethasone acetate|dexamethasone acetate|mesh-list
65051404|NCT00569920|BB 1101|bb 1101|mesh-list
65051405|NCT00569920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65051406|NCT00569920|Antiemetics|antiemetics|mesh-ancestor
65051407|NCT00569920|Autonomic Agents|autonomic agents|mesh-ancestor
65051408|NCT00569920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65051409|NCT00569920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051410|NCT00569920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64492767|NCT04704999|Amebicides|amebicides|mesh-ancestor
65051411|NCT00569920|Glucocorticoids|glucocorticoids|mesh-ancestor
65051412|NCT00569920|Hormones|hormones|mesh-ancestor
65051413|NCT00569920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65051414|NCT00569920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65051415|NCT00569920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051416|NCT00569920|Protease Inhibitors|protease inhibitors|mesh-ancestor
65051417|NCT00569920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051418|NCT00569920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051419|NCT00224510|Lamotrigine|lamotrigine|mesh-list
65051420|NCT00224510|Anticonvulsants|anticonvulsants|mesh-ancestor
65051421|NCT00224510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65051422|NCT00224510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65051448|NCT00224549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65051449|NCT00224549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051450|NCT00224549|Vasodilator Agents|vasodilator agents|mesh-ancestor
65051451|NCT00224549|Diuretics|diuretics|mesh-ancestor
65051452|NCT00224549|Natriuretic Agents|natriuretic agents|mesh-ancestor
65051453|NCT00224549|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65051454|NCT00224549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65051455|NCT00224549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65051456|NCT00570544|Tiotropium Bromide|tiotropium bromide|mesh-list
65051457|NCT00570544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65051458|NCT00570544|Autonomic Agents|autonomic agents|mesh-ancestor
65051459|NCT00570544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65051460|NCT00570544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051461|NCT00570544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65051462|NCT00570544|Respiratory System Agents|respiratory system agents|mesh-ancestor
65051463|NCT00570544|Parasympatholytics|parasympatholytics|mesh-ancestor
65051464|NCT00570544|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65051465|NCT00570544|Cholinergic Agents|cholinergic agents|mesh-ancestor
65051466|NCT00570544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65051467|NCT00570544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051468|NCT00254436|Epoetin Alfa|epoetin alfa|mesh-list
65051490|NCT00254475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65051491|NCT00254475|Antimetabolites|antimetabolites|mesh-ancestor
65051492|NCT00254475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051493|NCT00254475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65051494|NCT00254475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65051495|NCT00254475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051496|NCT00254475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65051497|NCT00254475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65051498|NCT00254475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65051499|NCT00570856|Folic Acid|folic acid|mesh-list
65051500|NCT00570856|Hematinics|hematinics|mesh-ancestor
65051501|NCT00570856|Vitamin B Complex|vitamin b complex|mesh-ancestor
65051502|NCT00570856|Vitamins|vitamins|mesh-ancestor
65051503|NCT00570856|Micronutrients|micronutrients|mesh-ancestor
65051504|NCT00570856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051505|NCT00570934|Calcium, Dietary|calcium, dietary|mesh-list
65051506|NCT00570934|Cholecalciferol|cholecalciferol|mesh-list
65051507|NCT00570934|Vitamin D|vitamin d|mesh-list
65051508|NCT00570934|Calcium|calcium|mesh-list
65051509|NCT00570934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65051510|NCT00570934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472818|NCT02648477|Exemestane|exemestane|mesh-list
65051511|NCT00570934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65051512|NCT00570934|Vitamins|vitamins|mesh-ancestor
65051513|NCT00570934|Micronutrients|micronutrients|mesh-ancestor
65051514|NCT00254553|Methyltestosterone|methyltestosterone|mesh-list
65051515|NCT00254553|Testosterone|testosterone|mesh-list
65051516|NCT00254553|Testosterone undecanoate|testosterone undecanoate|mesh-list
65051517|NCT00254553|Testosterone enanthate|testosterone enanthate|mesh-list
65051518|NCT00254553|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65051519|NCT00254553|Androgens|androgens|mesh-ancestor
65051520|NCT00254553|Hormones|hormones|mesh-ancestor
65051521|NCT00254553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65051522|NCT00254553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051523|NCT00254553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65051548|NCT00571246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051550|NCT00571246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65051551|NCT00571246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051552|NCT00571246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65051553|NCT00571246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65051554|NCT00571246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65051555|NCT00571246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65051556|NCT00571246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65051557|NCT00571246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65051558|NCT00254631|Oxycodone|oxycodone|mesh-list
65051559|NCT00254631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65051560|NCT00254631|Narcotics|narcotics|mesh-ancestor
65051561|NCT00254631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65051562|NCT00254631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051563|NCT00254631|Analgesics|analgesics|mesh-ancestor
65051564|NCT00254631|Sensory System Agents|sensory system agents|mesh-ancestor
65051565|NCT00254631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65051566|NCT00571285|Vitamin D|vitamin d|mesh-list
65051567|NCT00571285|Ergocalciferols|ergocalciferols|mesh-list
65051568|NCT00571285|Cholecalciferol|cholecalciferol|mesh-list
65051569|NCT00571285|Vitamins|vitamins|mesh-list
65051570|NCT00571285|Micronutrients|micronutrients|mesh-ancestor
65051571|NCT00571285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051572|NCT00571285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65051573|NCT00571285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65051603|NCT00571675|Glucocorticoids|glucocorticoids|mesh-ancestor
65051604|NCT00571675|Hormones|hormones|mesh-ancestor
65051605|NCT00571675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65051606|NCT00571675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051607|NCT00571675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65051608|NCT00571714|Ribavirin|ribavirin|mesh-list
65051609|NCT00571714|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65051610|NCT00571714|Interferon-alpha|interferon-alpha|mesh-list
65051611|NCT00571714|Betaine|betaine|mesh-list
65051612|NCT00571714|Antimetabolites|antimetabolites|mesh-ancestor
65051613|NCT00571714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051614|NCT00571714|Antiviral Agents|antiviral agents|mesh-ancestor
65051615|NCT00571714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65051616|NCT00571714|Immunologic Factors|immunologic factors|mesh-ancestor
65051617|NCT00571714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051618|NCT00571714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65051619|NCT00571714|Lipotropic Agents|lipotropic agents|mesh-ancestor
65051650|NCT00224822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051651|NCT00224822|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65051652|NCT00224822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65051653|NCT00224822|Serotonin Agents|serotonin agents|mesh-ancestor
65051654|NCT00224822|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65051655|NCT00224822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65051656|NCT00224822|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65051657|NCT00224822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65051658|NCT00571870|Cetrorelix|cetrorelix|mesh-list
65051659|NCT00571870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65051660|NCT00571870|Fertility Agents|fertility agents|mesh-ancestor
65051661|NCT00571870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64903588|NCT00006339|Antisickling Agents|antisickling agents|mesh-ancestor
65051689|NCT00572065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65051690|NCT00572065|Immunologic Factors|immunologic factors|mesh-ancestor
65051691|NCT00572065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051693|NCT00234897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65051694|NCT00234897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65051695|NCT00572299|Alendronate|alendronate|mesh-list
65051696|NCT00572299|Prednisone|prednisone|mesh-list
65051697|NCT00572299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65051698|NCT00572299|Glucocorticoids|glucocorticoids|mesh-ancestor
65051699|NCT00572299|Hormones|hormones|mesh-ancestor
65051700|NCT00572299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65051701|NCT00572299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051702|NCT00572299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65051703|NCT00572299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051704|NCT00572299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65051705|NCT00234936|Adalimumab|adalimumab|mesh-list
65051730|NCT00572650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051731|NCT00572650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65051732|NCT00572650|Protease Inhibitors|protease inhibitors|mesh-ancestor
65051733|NCT00572650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051734|NCT00572650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051736|NCT00572689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65051737|NCT00572689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051738|NCT00572689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65051739|NCT00572689|Incretins|incretins|mesh-ancestor
65051740|NCT00572689|Hormones|hormones|mesh-ancestor
65051741|NCT00572689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65051742|NCT00572806|Insulin Aspart|insulin aspart|mesh-list
65051743|NCT00572806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65051744|NCT00572806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051745|NCT00224978|Chloroquine|chloroquine|mesh-list
65051746|NCT00224978|Amebicides|amebicides|mesh-ancestor
65051747|NCT00224978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65051748|NCT00224978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65051749|NCT00224978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65051750|NCT00224978|Antimalarials|antimalarials|mesh-ancestor
65051751|NCT00224978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65051752|NCT00572884|Permethrin|permethrin|mesh-list
65051753|NCT00572884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051754|NCT00572884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051755|NCT00573001|Ritonavir|ritonavir|mesh-list
65051756|NCT00573001|Lopinavir|lopinavir|mesh-list
65051765|NCT00573001|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65051766|NCT00573001|Protease Inhibitors|protease inhibitors|mesh-ancestor
65051767|NCT00573001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051768|NCT00573001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051769|NCT00573001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65051770|NCT00573001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65051771|NCT00573001|Antiviral Agents|antiviral agents|mesh-ancestor
65051772|NCT00573001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65051773|NCT00573001|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65051774|NCT00573001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65051775|NCT00573001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65051776|NCT00573001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65051777|NCT00573001|Antimetabolites|antimetabolites|mesh-ancestor
65051778|NCT00573001|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65051779|NCT00573001|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65051780|NCT00573001|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65051781|NCT00573001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65051782|NCT00573001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65051783|NCT00254787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65051784|NCT00254787|Antidepressive Agents|antidepressive agents|mesh-ancestor
65051785|NCT00254787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65051786|NCT00254787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65051787|NCT00254787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65051788|NCT00254787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65051789|NCT00254787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051791|NCT00225056|Capecitabine|capecitabine|mesh-list
65051792|NCT00225056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051793|NCT00225056|Tubulin Modulators|tubulin modulators|mesh-ancestor
65051794|NCT00225056|Antimitotic Agents|antimitotic agents|mesh-ancestor
65051795|NCT00225056|Mitosis Modulators|mitosis modulators|mesh-ancestor
65051796|NCT00225056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051797|NCT00225056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65051798|NCT00225056|Antimetabolites|antimetabolites|mesh-ancestor
64925819|NCT00013962|Vitamin D|vitamin d|mesh-list
65051800|NCT00225173|Prednisone|prednisone|mesh-list
65051801|NCT00225173|Cyclophosphamide|cyclophosphamide|mesh-list
65051802|NCT00225173|Doxorubicin|doxorubicin|mesh-list
65051803|NCT00225173|Etoposide|etoposide|mesh-list
65051804|NCT00225173|Etoposide phosphate|etoposide phosphate|mesh-list
65051805|NCT00225173|Vincristine|vincristine|mesh-list
64472821|NCT02648477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65051806|NCT00225173|Vinorelbine|vinorelbine|mesh-list
65051807|NCT00225173|Bleomycin|bleomycin|mesh-list
65051808|NCT00225173|Vinblastine|vinblastine|mesh-list
65051809|NCT00225173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65051810|NCT00225173|Immunologic Factors|immunologic factors|mesh-ancestor
65051811|NCT00225173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051812|NCT00225173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65051813|NCT00225173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65051814|NCT00225173|Alkylating Agents|alkylating agents|mesh-ancestor
65051844|NCT00234975|Antiviral Agents|antiviral agents|mesh-ancestor
65051845|NCT00234975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65051846|NCT00234975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65051847|NCT00234975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65051848|NCT00235014|Verapamil|verapamil|mesh-list
65051849|NCT00235014|Trandolapril|trandolapril|mesh-list
65051850|NCT00235014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65051851|NCT00235014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65051852|NCT00235014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65051853|NCT00235014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051854|NCT00235014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65051855|NCT00235014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051856|NCT00235014|Vasodilator Agents|vasodilator agents|mesh-ancestor
65051857|NCT00235014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64903791|NCT00387738|Histamine|histamine|mesh-list
65051890|NCT00573664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65051891|NCT00573664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051892|NCT00573664|Anticonvulsants|anticonvulsants|mesh-ancestor
65051893|NCT00573664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65051894|NCT00573664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65051895|NCT00573664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64903822|NCT00005965|Bryostatin 1|bryostatin 1|mesh-list
65051925|NCT00235053|Autonomic Agents|autonomic agents|mesh-ancestor
65051926|NCT00235053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65051927|NCT00235053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051928|NCT00235053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65051929|NCT00235053|Respiratory System Agents|respiratory system agents|mesh-ancestor
65051930|NCT00235053|Dermatologic Agents|dermatologic agents|mesh-ancestor
65051931|NCT00235053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65051932|NCT00235053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65051933|NCT00235053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65051934|NCT00235053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65051935|NCT00235053|Adrenergic Agents|adrenergic agents|mesh-ancestor
65051936|NCT00235053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64903855|NCT00005974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903857|NCT00005977|Leucovorin|leucovorin|mesh-list
65051968|NCT00225485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051969|NCT00225485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65051970|NCT00225485|Antidepressive Agents|antidepressive agents|mesh-ancestor
65051971|NCT00225485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65051972|NCT00574093|Ranibizumab|ranibizumab|mesh-list
65051973|NCT00574093|Verteporfin|verteporfin|mesh-list
65051974|NCT00574093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65051975|NCT00574093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65051976|NCT00574093|Growth Substances|growth substances|mesh-ancestor
65051977|NCT00574093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051978|NCT00574093|Growth Inhibitors|growth inhibitors|mesh-ancestor
65052009|NCT00574483|Antinematodal Agents|antinematodal agents|mesh-ancestor
65052010|NCT00574483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052011|NCT00574483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052012|NCT00574483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052014|NCT00235092|Paclitaxel|paclitaxel|mesh-list
65052015|NCT00235092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65052016|NCT00235092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052017|NCT00235092|Tubulin Modulators|tubulin modulators|mesh-ancestor
65052018|NCT00235092|Antimitotic Agents|antimitotic agents|mesh-ancestor
65494060|NCT03773302|Immunologic Factors|immunologic factors|mesh-ancestor
65052019|NCT00235092|Mitosis Modulators|mitosis modulators|mesh-ancestor
65052055|NCT00255255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65052056|NCT00255255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65052057|NCT00255255|Adrenergic Agents|adrenergic agents|mesh-ancestor
65052058|NCT00255255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64903992|NCT00006004|Gemcitabine|gemcitabine|mesh-list
65052077|NCT00575224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65052078|NCT00575224|Antimetabolites|antimetabolites|mesh-ancestor
64563275|NCT01289457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65052079|NCT00575224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052081|NCT00225797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65052082|NCT00225797|Narcotics|narcotics|mesh-ancestor
65052083|NCT00225797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65052084|NCT00225797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052085|NCT00225797|Analgesics|analgesics|mesh-ancestor
65052086|NCT00225797|Sensory System Agents|sensory system agents|mesh-ancestor
65052087|NCT00225797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65052088|NCT00225797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65052089|NCT00235209|Anti-Infective Agents|anti-infective agents|mesh-list
65052090|NCT00235209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65052091|NCT00591487|Lidocaine|lidocaine|mesh-list
65052092|NCT00591487|Anesthetics, Local|anesthetics, local|mesh-ancestor
65052093|NCT00591487|Anesthetics|anesthetics|mesh-ancestor
64926119|NCT00000689|Antidotes|antidotes|mesh-ancestor
65052094|NCT00591487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65052095|NCT00591487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052096|NCT00591487|Sensory System Agents|sensory system agents|mesh-ancestor
65052097|NCT00591487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65052098|NCT00591487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65052099|NCT00591487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65052100|NCT00591487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65052101|NCT00591487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65052102|NCT00591487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052103|NCT00225875|Rituximab|rituximab|mesh-list
65052104|NCT00225875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65052105|NCT00225875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052106|NCT00225875|Immunologic Factors|immunologic factors|mesh-ancestor
65052107|NCT00225875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052108|NCT00225875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65052109|NCT03451981|Chlorhexidine|chlorhexidine|mesh-list
65052110|NCT03451981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65052111|NCT03451981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65052112|NCT03451981|Disinfectants|disinfectants|mesh-ancestor
65052113|NCT00255372|Lactulose|lactulose|mesh-list
65052114|NCT00255372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65052115|NCT00225914|Paroxetine|paroxetine|mesh-list
65052140|NCT00235248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65052141|NCT00235248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052142|NCT00235248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65052143|NCT00235248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65052144|NCT00235248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65052145|NCT00235248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65052146|NCT00235248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052147|NCT00235248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65052148|NCT00235248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65052149|NCT00235248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052150|NCT00235248|Antipyretics|antipyretics|mesh-ancestor
65052151|NCT00235248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65052152|NCT00235248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65052153|NCT00235248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65052154|NCT00235248|Purinergic Agents|purinergic agents|mesh-ancestor
65052155|NCT00235248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65052156|NCT00235248|Anticoagulants|anticoagulants|mesh-ancestor
65052157|NCT00225992|Arsenic Trioxide|arsenic trioxide|mesh-list
64537424|NCT05418777|Renal Agents|renal agents|mesh-ancestor
65052159|NCT03451435|Acetylcysteine|acetylcysteine|mesh-list
65052160|NCT03451435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65052161|NCT03451435|Antiviral Agents|antiviral agents|mesh-ancestor
65052162|NCT03451435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65052163|NCT03451435|Expectorants|expectorants|mesh-ancestor
65052198|NCT04573426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65052199|NCT04573426|Analgesics|analgesics|mesh-ancestor
65052200|NCT04573426|Sensory System Agents|sensory system agents|mesh-ancestor
65052201|NCT04573426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65052202|NCT04573426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052203|NCT04573426|Antipyretics|antipyretics|mesh-ancestor
65052204|NCT00235287|Candesartan|candesartan|mesh-list
65052237|NCT00255528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65052238|NCT00255528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65052239|NCT00255528|Sympatholytics|sympatholytics|mesh-ancestor
65052240|NCT00255528|Autonomic Agents|autonomic agents|mesh-ancestor
65052241|NCT00255528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65052242|NCT00255528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052243|NCT00255528|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65494061|NCT03773302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052244|NCT00255528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65052245|NCT00255528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65052273|NCT00255567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65052274|NCT00255567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65052275|NCT00255567|Schistosomicides|schistosomicides|mesh-ancestor
65052276|NCT00255567|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65052277|NCT00255567|Anthelmintics|anthelmintics|mesh-ancestor
65052279|NCT03450967|Tremelimumab|tremelimumab|mesh-list
65052280|NCT03450967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65052281|NCT03450967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052282|NCT00255606|Prednisone|prednisone|mesh-list
65052283|NCT00255606|Docetaxel|docetaxel|mesh-list
65052284|NCT00255606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052285|NCT00255606|Tubulin Modulators|tubulin modulators|mesh-ancestor
65052286|NCT00255606|Antimitotic Agents|antimitotic agents|mesh-ancestor
65052287|NCT00255606|Mitosis Modulators|mitosis modulators|mesh-ancestor
65052288|NCT00255606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052289|NCT00255606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65052311|NCT03450499|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65052312|NCT03450499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65052313|NCT03450499|Anesthetics, General|anesthetics, general|mesh-ancestor
65052314|NCT03450499|Anesthetics|anesthetics|mesh-ancestor
65052315|NCT03450499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65052316|NCT03450499|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65052317|NCT03450499|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65052318|NCT03450499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65052319|NCT03450499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052320|NCT00226382|Interferons|interferons|mesh-list
65052321|NCT00226382|Interferon-alpha|interferon-alpha|mesh-list
65052322|NCT00226382|Interferon alpha-2|interferon alpha-2|mesh-list
65052323|NCT00226382|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65052324|NCT00226382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052325|NCT00226382|Antiviral Agents|antiviral agents|mesh-ancestor
65052326|NCT00226382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65052327|NCT00226382|Immunologic Factors|immunologic factors|mesh-ancestor
65052328|NCT00226382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052329|NCT01580839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65052330|NCT01580839|Plasminogen|plasminogen|mesh-list
65052331|NCT01580839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65052332|NCT01580839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65052333|NCT01580839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052334|NCT03450226|Bupivacaine|bupivacaine|mesh-list
65052335|NCT03450226|Anesthetics, Local|anesthetics, local|mesh-ancestor
65052336|NCT03450226|Anesthetics|anesthetics|mesh-ancestor
65052337|NCT03450226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65052338|NCT03450226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052339|NCT03450226|Sensory System Agents|sensory system agents|mesh-ancestor
65052340|NCT03450226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65052341|NCT00226421|Oxymorphone|oxymorphone|mesh-list
65052342|NCT00226421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65052343|NCT00226421|Narcotics|narcotics|mesh-ancestor
65052344|NCT00226421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64904265|NCT00006378|Paclitaxel|paclitaxel|mesh-list
65052362|NCT00413387|Autonomic Agents|autonomic agents|mesh-ancestor
65052363|NCT00413387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65052364|NCT00413387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052365|NCT00413387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65052366|NCT00413387|Respiratory System Agents|respiratory system agents|mesh-ancestor
65052367|NCT00413387|Glucocorticoids|glucocorticoids|mesh-ancestor
65052368|NCT00413387|Hormones|hormones|mesh-ancestor
65052369|NCT00413387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65052370|NCT00413387|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65052371|NCT00413387|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65052372|NCT00413387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65052373|NCT00413387|Adrenergic Agents|adrenergic agents|mesh-ancestor
65052374|NCT00413387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65052375|NCT00413387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052376|NCT00413426|Darifenacin|darifenacin|mesh-list
65052377|NCT00413426|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65052378|NCT00413426|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65052379|NCT00413426|Cholinergic Agents|cholinergic agents|mesh-ancestor
65052380|NCT00413426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65052381|NCT00413426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052382|NCT00413426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052383|NCT00413426|Urological Agents|urological agents|mesh-ancestor
65052384|NCT00255762|Paclitaxel|paclitaxel|mesh-list
65052385|NCT00255762|Bevacizumab|bevacizumab|mesh-list
65052386|NCT00255762|Carboplatin|carboplatin|mesh-list
65052387|NCT00255762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65052388|NCT00255762|Antibodies|antibodies|mesh-list
65052389|NCT00255762|Immunoglobulins|immunoglobulins|mesh-list
65052390|NCT00255762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65052391|NCT00255762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65052392|NCT00255762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052393|NCT00255762|Tubulin Modulators|tubulin modulators|mesh-ancestor
65052394|NCT00255762|Antimitotic Agents|antimitotic agents|mesh-ancestor
65052395|NCT00255762|Mitosis Modulators|mitosis modulators|mesh-ancestor
65052396|NCT00255762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052397|NCT00255762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65052398|NCT00255762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65052399|NCT00255762|Growth Substances|growth substances|mesh-ancestor
65052400|NCT00255762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052401|NCT00255762|Growth Inhibitors|growth inhibitors|mesh-ancestor
65052402|NCT00255762|Immunologic Factors|immunologic factors|mesh-ancestor
65052403|NCT02277457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65052428|NCT00255879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65052429|NCT00255879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65052430|NCT00255879|Antidepressive Agents|antidepressive agents|mesh-ancestor
65052431|NCT00413504|PENTA|penta|mesh-list
65052432|NCT00413504|Fondaparinux|fondaparinux|mesh-list
65052433|NCT00413504|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65052434|NCT00413504|Antithrombins|antithrombins|mesh-ancestor
65052435|NCT00413504|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65052436|NCT00413504|Protease Inhibitors|protease inhibitors|mesh-ancestor
65052437|NCT00413504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052438|NCT00413504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052439|NCT00413504|Anticoagulants|anticoagulants|mesh-ancestor
65052440|NCT00413504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65052441|NCT00413504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65052442|NCT04721223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65052443|NCT04721223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052444|NCT04721223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052445|NCT04710498|Atezolizumab|atezolizumab|mesh-list
65052446|NCT04710498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052447|NCT00226538|Fluconazole|fluconazole|mesh-list
65052448|NCT00226538|Rifampin|rifampin|mesh-list
65052449|NCT00226538|Diclofenac|diclofenac|mesh-list
65052450|NCT00226538|Phenytoin|phenytoin|mesh-list
65052451|NCT00226538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65052452|NCT00226538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65052453|NCT00226538|Analgesics|analgesics|mesh-ancestor
65052454|NCT00226538|Sensory System Agents|sensory system agents|mesh-ancestor
64904372|NCT03996148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65052482|NCT00226538|Anticonvulsants|anticonvulsants|mesh-ancestor
65052483|NCT00226538|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65052484|NCT00226538|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65052485|NCT00226538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65052486|NCT00226538|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65052487|NCT00255918|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
65052488|NCT00255918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65052489|NCT00255918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65052490|NCT00255918|Cholinergic Agents|cholinergic agents|mesh-ancestor
64904423|NCT05552404|Purinergic Agents|purinergic agents|mesh-ancestor
65052516|NCT00226967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65052517|NCT00226967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65052518|NCT00226967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052520|NCT00199381|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
65052521|NCT00199381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65052522|NCT00199381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65052523|NCT00199381|Purinergic Agents|purinergic agents|mesh-ancestor
65052524|NCT00199381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65052525|NCT00199381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052526|NCT00199381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052527|NCT00227084|Hemostatics|hemostatics|mesh-list
65052528|NCT00227084|Coagulants|coagulants|mesh-ancestor
65052530|NCT00227123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65052531|NCT00227123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65052532|NCT00227123|Serotonin Agents|serotonin agents|mesh-ancestor
65052533|NCT00227123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65052534|NCT00227123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052535|NCT00227123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904478|NCT05431543|Aceclidine|aceclidine|mesh-list
65052570|NCT00227357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65052571|NCT00227357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65052572|NCT00227357|Antitussive Agents|antitussive agents|mesh-ancestor
65052573|NCT00227357|Respiratory System Agents|respiratory system agents|mesh-ancestor
65052575|NCT00198133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052576|NCT00198133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052597|NCT00256230|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65052598|NCT00256230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052599|NCT00256230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052600|NCT00227669|Gemcitabine|gemcitabine|mesh-list
65052602|NCT00227669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65052603|NCT00227669|Antimetabolites|antimetabolites|mesh-ancestor
65052604|NCT00227669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052605|NCT00227669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052606|NCT00227669|Antiviral Agents|antiviral agents|mesh-ancestor
65052607|NCT00227669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65052608|NCT00227669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052609|NCT00227669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65052610|NCT00227669|Immunologic Factors|immunologic factors|mesh-ancestor
65052611|NCT00227669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052612|NCT00227669|Tubulin Modulators|tubulin modulators|mesh-ancestor
65052613|NCT00227669|Antimitotic Agents|antimitotic agents|mesh-ancestor
65052614|NCT00227669|Mitosis Modulators|mitosis modulators|mesh-ancestor
65052615|NCT00235794|Sirolimus|sirolimus|mesh-list
65052616|NCT00235794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65052617|NCT00235794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65052618|NCT00235794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65052619|NCT00235794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052620|NCT00235794|Antifungal Agents|antifungal agents|mesh-ancestor
65052621|NCT00235794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65052622|NCT00235794|Immunologic Factors|immunologic factors|mesh-ancestor
65052623|NCT00235794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052624|NCT00256269|Oxaliplatin|oxaliplatin|mesh-list
65052625|NCT00256269|Irinotecan|irinotecan|mesh-list
65052626|NCT00256269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052627|NCT00256269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65052628|NCT00256269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65052629|NCT00256269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904553|NCT00006441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65052651|NCT00235911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65052652|NCT00235911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65052653|NCT00235911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65052654|NCT00235911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65052655|NCT00235911|Adrenergic Agents|adrenergic agents|mesh-ancestor
65052656|NCT00235911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65052657|NCT00235911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052658|NCT00256347|Morphine|morphine|mesh-list
65052659|NCT00256347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65052660|NCT00256347|Narcotics|narcotics|mesh-ancestor
65052661|NCT00256347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65052662|NCT00256347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052663|NCT00256347|Analgesics|analgesics|mesh-ancestor
65052664|NCT00256347|Sensory System Agents|sensory system agents|mesh-ancestor
65052665|NCT00256347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65052666|NCT00227747|Capecitabine|capecitabine|mesh-list
65052667|NCT00227747|Oxaliplatin|oxaliplatin|mesh-list
65052668|NCT00227747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65052669|NCT00227747|Antimetabolites|antimetabolites|mesh-ancestor
65052670|NCT00227747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052671|NCT00227747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052672|NCT00235950|Clopidogrel|clopidogrel|mesh-list
65052673|NCT00235950|Atorvastatin|atorvastatin|mesh-list
65052674|NCT00235950|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65052675|NCT00235950|Simvastatin|simvastatin|mesh-list
65052676|NCT00235950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65052677|NCT00235950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64537955|NCT01444781|Vaccines|vaccines|mesh-list
65052678|NCT00235950|Antimetabolites|antimetabolites|mesh-ancestor
65052679|NCT00235950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052680|NCT00235950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65052681|NCT00235950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65052699|NCT00227942|GABA Agonists|gaba agonists|mesh-ancestor
65052700|NCT00227942|GABA Agents|gaba agents|mesh-ancestor
65052701|NCT00227942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65052702|NCT00227942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052703|NCT00227981|Fluoxetine|fluoxetine|mesh-list
65052704|NCT00227981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65052705|NCT00227981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65052706|NCT00227981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65052707|NCT00227981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052708|NCT00227981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65052709|NCT00227981|Serotonin Agents|serotonin agents|mesh-ancestor
65052710|NCT00227981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052711|NCT00227981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65052712|NCT00227981|Antidepressive Agents|antidepressive agents|mesh-ancestor
65052713|NCT00227981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65052714|NCT00227981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65052715|NCT00227981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65052716|NCT00227981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052717|NCT00236028|Infliximab|infliximab|mesh-list
65052718|NCT00236028|Dermatologic Agents|dermatologic agents|mesh-ancestor
65052719|NCT00236028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65052720|NCT00236028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65052721|NCT00256542|Lidocaine|lidocaine|mesh-list
65052722|NCT00256542|Heparin|heparin|mesh-list
65052723|NCT00256542|Anesthetics, Local|anesthetics, local|mesh-ancestor
65052724|NCT00256542|Anesthetics|anesthetics|mesh-ancestor
65052725|NCT00256542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65052726|NCT00256542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052727|NCT00256542|Sensory System Agents|sensory system agents|mesh-ancestor
65052728|NCT00256542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65052729|NCT00256542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65052730|NCT00256542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65052731|NCT00256542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65052732|NCT00256542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65052733|NCT00256542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052734|NCT00256542|Anticoagulants|anticoagulants|mesh-ancestor
65052735|NCT00256542|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65052736|NCT00256542|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65052763|NCT00236067|Anticonvulsants|anticonvulsants|mesh-ancestor
65052764|NCT00236067|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
65052765|NCT00236067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65052766|NCT00236067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65052767|NCT00236067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052768|NCT00236067|GABA Agents|gaba agents|mesh-ancestor
65052769|NCT00236067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65052770|NCT00236067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052771|NCT00195715|Adalimumab|adalimumab|mesh-list
65052772|NCT00195715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65052773|NCT00195715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65052774|NCT00236106|Mometasone Furoate|mometasone furoate|mesh-list
65052775|NCT00236106|Tacrolimus|tacrolimus|mesh-list
65052776|NCT00236106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65052777|NCT00236106|Immunologic Factors|immunologic factors|mesh-ancestor
65052778|NCT00236106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052779|NCT00236106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65052780|NCT00236106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052781|NCT00236106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052782|NCT00236106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65052783|NCT00236106|Dermatologic Agents|dermatologic agents|mesh-ancestor
65052784|NCT00236106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65052785|NCT00236145|Fentanyl|fentanyl|mesh-list
64904720|NCT04201834|Risperidone|risperidone|mesh-list
65052815|NCT00194077|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65052817|NCT00194077|Serotonin Agents|serotonin agents|mesh-ancestor
65052818|NCT00194077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65052819|NCT00194077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65052820|NCT00194077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65052821|NCT00194077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65052822|NCT00193609|Capecitabine|capecitabine|mesh-list
65052823|NCT00193609|Oxaliplatin|oxaliplatin|mesh-list
65052824|NCT00193609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65052825|NCT00193609|Antimetabolites|antimetabolites|mesh-ancestor
65052826|NCT00193609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052827|NCT00193609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052828|NCT00228410|Vancomycin|vancomycin|mesh-list
65052829|NCT00228410|Tigecycline|tigecycline|mesh-list
65052830|NCT00228410|Aztreonam|aztreonam|mesh-list
65052831|NCT00228410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65052832|NCT00228410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65052853|NCT00193063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052854|NCT00193063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65052855|NCT00193063|Immunologic Factors|immunologic factors|mesh-ancestor
65052856|NCT00193063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052857|NCT00193063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65052858|NCT00228488|Gefitinib|gefitinib|mesh-list
65052859|NCT00228488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052860|NCT00228488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65052861|NCT00228488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052862|NCT00228488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052863|NCT00228527|Esomeprazole|esomeprazole|mesh-list
65052864|NCT00228527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65052865|NCT00228527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65052866|NCT00228527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65052867|NCT00228527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052868|NCT00228527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052869|NCT00191854|Gemcitabine|gemcitabine|mesh-list
65052870|NCT00191854|Paclitaxel|paclitaxel|mesh-list
65052871|NCT00191854|Carboplatin|carboplatin|mesh-list
65052872|NCT00191854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65052873|NCT00191854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052874|NCT00191854|Tubulin Modulators|tubulin modulators|mesh-ancestor
65052875|NCT00191854|Antimitotic Agents|antimitotic agents|mesh-ancestor
65052876|NCT00191854|Mitosis Modulators|mitosis modulators|mesh-ancestor
65052877|NCT00191854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052878|NCT00191854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65052879|NCT00191854|Antimetabolites|antimetabolites|mesh-ancestor
65052880|NCT00191854|Antiviral Agents|antiviral agents|mesh-ancestor
65052881|NCT00191854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65052882|NCT00191854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052883|NCT00191854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65052884|NCT00191854|Immunologic Factors|immunologic factors|mesh-ancestor
65052885|NCT00191854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052886|NCT00228605|Fentanyl|fentanyl|mesh-list
65052887|NCT00228605|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65052915|NCT00191386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65052916|NCT00191386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052918|NCT00191308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052919|NCT00191308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052920|NCT00191308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052921|NCT00191308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65052922|NCT00191308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65052923|NCT00228839|Infliximab|infliximab|mesh-list
65052924|NCT00228839|Dermatologic Agents|dermatologic agents|mesh-ancestor
65052925|NCT00228839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65052926|NCT00228839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65052927|NCT00191269|Gemcitabine|gemcitabine|mesh-list
65052928|NCT00191269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65052929|NCT00191269|Antimetabolites|antimetabolites|mesh-ancestor
65052930|NCT00191269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052931|NCT00191269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052932|NCT00191269|Antiviral Agents|antiviral agents|mesh-ancestor
65052933|NCT00191269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904890|NCT02409238|Metformin|metformin|mesh-list
65052953|NCT00229112|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65052954|NCT00229112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052955|NCT00256737|Omeprazole|omeprazole|mesh-list
65052956|NCT00256737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65052957|NCT00256737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65052958|NCT00256737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65052959|NCT00256737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052960|NCT00256737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052961|NCT00191191|Pemetrexed|pemetrexed|mesh-list
65052962|NCT00191191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052963|NCT00191191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052964|NCT00191191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052965|NCT00191191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65052966|NCT00191191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65052967|NCT00414024|Tegaserod|tegaserod|mesh-list
65052968|NCT00414024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65052969|NCT00414024|Serotonin Agents|serotonin agents|mesh-ancestor
65052970|NCT00414024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64825806|NCT01539473|Tedizolid|tedizolid|mesh-list
65052971|NCT00414024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052972|NCT00414024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052973|NCT00256893|Ropinirole|ropinirole|mesh-list
65052974|NCT00256893|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65052975|NCT00256893|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65052976|NCT00256893|Dopamine Agonists|dopamine agonists|mesh-ancestor
65052977|NCT00256893|Dopamine Agents|dopamine agents|mesh-ancestor
65052978|NCT00256893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65052979|NCT00256893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052980|NCT00256893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052982|NCT00229385|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65052983|NCT00229385|Serotonin Agents|serotonin agents|mesh-ancestor
65052984|NCT00229385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65052985|NCT00229385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052986|NCT00229385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052987|NCT00229385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65052988|NCT00229385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65052989|NCT00229385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65052990|NCT00229385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65052991|NCT00229385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65052992|NCT00229385|Dopamine Agents|dopamine agents|mesh-ancestor
65053027|NCT00229424|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65053028|NCT00229424|Histamine Antagonists|histamine antagonists|mesh-ancestor
65053029|NCT00229424|Histamine Agents|histamine agents|mesh-ancestor
65053030|NCT00229424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65053031|NCT00229424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053032|NCT00229424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053034|NCT00256932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65053056|NCT00257049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65053057|NCT00257049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65053059|NCT00257049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053060|NCT00257049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053061|NCT00257049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053062|NCT00257049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65053063|NCT00257049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65053064|NCT01059188|Docetaxel|docetaxel|mesh-list
65053065|NCT01059188|Cetuximab|cetuximab|mesh-list
65053066|NCT01059188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053067|NCT01059188|Tubulin Modulators|tubulin modulators|mesh-ancestor
65053068|NCT01059188|Antimitotic Agents|antimitotic agents|mesh-ancestor
65053069|NCT01059188|Mitosis Modulators|mitosis modulators|mesh-ancestor
65053070|NCT01059188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053071|NCT01059188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65053072|NCT00236301|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65053073|NCT00236301|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65053074|NCT00236301|Estradiol|estradiol|mesh-list
65053075|NCT00236301|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65053076|NCT00236301|Estrogens|estrogens|mesh-ancestor
65053077|NCT00236301|Hormones|hormones|mesh-ancestor
65053078|NCT00236301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65053079|NCT00236301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053080|NCT00236301|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65053081|NCT00236301|Contraceptive Agents|contraceptive agents|mesh-ancestor
65053082|NCT00236301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65053083|NCT00236301|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65053084|NCT00229697|Tamoxifen|tamoxifen|mesh-list
65053085|NCT00229697|Gefitinib|gefitinib|mesh-list
65053086|NCT00229697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65053087|NCT00229697|Hormone Antagonists|hormone antagonists|mesh-ancestor
65053088|NCT00229697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65053089|NCT00229697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905016|NCT00006747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65053126|NCT00229775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65053154|NCT00236457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053155|NCT00236457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053156|NCT00236457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65053157|NCT00236457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65053158|NCT00236457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65053159|NCT00236457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65053160|NCT00236457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65053161|NCT00236457|Dopamine Agents|dopamine agents|mesh-ancestor
65053162|NCT00236496|Topiramate|topiramate|mesh-list
65053163|NCT00236496|Anticonvulsants|anticonvulsants|mesh-ancestor
65053164|NCT00236496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65053165|NCT00236496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053166|NCT00199277|Iron|iron|mesh-list
65053167|NCT00199277|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65053168|NCT00199277|Trace Elements|trace elements|mesh-ancestor
65053169|NCT00199277|Micronutrients|micronutrients|mesh-ancestor
65053170|NCT00199277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053171|NCT00199277|Hematinics|hematinics|mesh-ancestor
65053172|NCT00236535|Acetaminophen|acetaminophen|mesh-list
65053206|NCT00193219|Vitamins|vitamins|mesh-ancestor
65053207|NCT00193219|Micronutrients|micronutrients|mesh-ancestor
65053208|NCT00199316|Morphine|morphine|mesh-list
65053209|NCT00199316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65053210|NCT00199316|Narcotics|narcotics|mesh-ancestor
65053211|NCT00199316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65053212|NCT00199316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053213|NCT00199316|Analgesics|analgesics|mesh-ancestor
65053214|NCT00199316|Sensory System Agents|sensory system agents|mesh-ancestor
65053215|NCT00199316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65053216|NCT00196339|Cyproterone Acetate|cyproterone acetate|mesh-list
65053217|NCT00196339|Cyproterone|cyproterone|mesh-list
64905154|NCT00006055|Hormones|hormones|mesh-ancestor
65053243|NCT00179959|Mupirocin|mupirocin|mesh-list
65053244|NCT00179959|Sodium Hypochlorite|sodium hypochlorite|mesh-list
65053246|NCT00179959|Petrolatum|petrolatum|mesh-list
65053247|NCT00179959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65053248|NCT00179959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65053249|NCT00179959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65053250|NCT00179959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053251|NCT00179959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053252|NCT00179959|Disinfectants|disinfectants|mesh-ancestor
65053253|NCT00179959|Emollients|emollients|mesh-ancestor
65053254|NCT00179959|Dermatologic Agents|dermatologic agents|mesh-ancestor
65053255|NCT00199394|Istradefylline|istradefylline|mesh-list
65053256|NCT00199394|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
65053257|NCT00199394|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65053258|NCT00199394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65053259|NCT00199394|Purinergic Agents|purinergic agents|mesh-ancestor
65053260|NCT00199394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65053261|NCT00199394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053262|NCT00199394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053263|NCT00236574|Galantamine|galantamine|mesh-list
65053294|NCT00236652|Levofloxacin|levofloxacin|mesh-list
65053295|NCT00236652|Ofloxacin|ofloxacin|mesh-list
65053296|NCT00236652|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65494066|NCT03743636|Antioxidants|antioxidants|mesh-ancestor
65053297|NCT00236652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65053298|NCT00236652|Renal Agents|renal agents|mesh-ancestor
65053299|NCT00236652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65053300|NCT00236652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65053301|NCT00236652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65053302|NCT00236652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053303|NCT00236652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053304|NCT00236652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053305|NCT00236652|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65053306|NCT00236652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65053307|NCT00257595|Cetirizine|cetirizine|mesh-list
64905243|NCT00006103|Antidotes|antidotes|mesh-ancestor
65053340|NCT00199745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053341|NCT04709172|Cefditoren|cefditoren|mesh-list
65053342|NCT04709172|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
65053343|NCT04709172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65053344|NCT04709172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65053345|NCT00199784|Phenylephrine|phenylephrine|mesh-list
65053346|NCT00199784|Oxymetazoline|oxymetazoline|mesh-list
65053347|NCT00199784|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65053348|NCT00199784|Mydriatics|mydriatics|mesh-ancestor
65053349|NCT00199784|Autonomic Agents|autonomic agents|mesh-ancestor
65053384|NCT00199940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65053385|NCT00199940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053386|NCT00199940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053387|NCT00199940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65053388|NCT00199940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65053389|NCT00199940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65053390|NCT00199940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65053391|NCT00199940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65053424|NCT00257634|Glucocorticoids|glucocorticoids|mesh-ancestor
65053425|NCT00257634|Hormones|hormones|mesh-ancestor
65053426|NCT00257634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65053427|NCT00257634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65053428|NCT00257634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053429|NCT00236847|Topiramate|topiramate|mesh-list
65053430|NCT00236847|Anticonvulsants|anticonvulsants|mesh-ancestor
65053431|NCT00236847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65053432|NCT00236847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053433|NCT00410306|Methyltestosterone|methyltestosterone|mesh-list
65053463|NCT00179647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053464|NCT00179647|Immunologic Factors|immunologic factors|mesh-ancestor
65053465|NCT00179647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65053466|NCT00179647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65053467|NCT00179647|Growth Substances|growth substances|mesh-ancestor
65053468|NCT00179647|Growth Inhibitors|growth inhibitors|mesh-ancestor
65053469|NCT00257751|Aprotinin|aprotinin|mesh-list
65053470|NCT00257751|Hemostatics|hemostatics|mesh-ancestor
65053471|NCT00257751|Coagulants|coagulants|mesh-ancestor
65053472|NCT00257751|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65053473|NCT00257751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65053474|NCT00257751|Protease Inhibitors|protease inhibitors|mesh-ancestor
65053475|NCT00257751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053476|NCT00257751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053477|NCT00179413|Interferons|interferons|mesh-list
65053478|NCT00179413|Interferon-alpha|interferon-alpha|mesh-list
65053479|NCT00179413|Interferon alpha-2|interferon alpha-2|mesh-list
65053480|NCT00179413|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65053481|NCT00179413|Colchicine|colchicine|mesh-list
65053512|NCT00200174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65053513|NCT00200174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65053515|NCT00236925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65053516|NCT00236964|Epoetin Alfa|epoetin alfa|mesh-list
65053517|NCT00236964|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65053518|NCT00236964|Hematinics|hematinics|mesh-ancestor
65053520|NCT00200252|Oxytocics|oxytocics|mesh-ancestor
65053521|NCT00200252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65053522|NCT00200252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053523|NCT00177307|Bevacizumab|bevacizumab|mesh-list
65053524|NCT00177307|Capecitabine|capecitabine|mesh-list
65053525|NCT00177307|Oxaliplatin|oxaliplatin|mesh-list
65053555|NCT02484664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65053556|NCT02484664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65053557|NCT02484664|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65053558|NCT02484664|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65053559|NCT02484664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053560|NCT02484664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053561|NCT00257868|Rivastigmine|rivastigmine|mesh-list
65053562|NCT00257868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65053563|NCT00257868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053564|NCT00257868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053565|NCT00257868|Cholinergic Agents|cholinergic agents|mesh-ancestor
65053566|NCT00257868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65053567|NCT00257868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053595|NCT00176488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65053596|NCT00176488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053597|NCT00176254|Paclitaxel|paclitaxel|mesh-list
65053598|NCT00176254|Carboplatin|carboplatin|mesh-list
65053599|NCT00176254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65053600|NCT00176254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053601|NCT00176254|Tubulin Modulators|tubulin modulators|mesh-ancestor
65053602|NCT00176254|Antimitotic Agents|antimitotic agents|mesh-ancestor
65053603|NCT00176254|Mitosis Modulators|mitosis modulators|mesh-ancestor
65053604|NCT00176254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053605|NCT00200447|Carbidopa|carbidopa|mesh-list
65053606|NCT00200447|Levodopa|levodopa|mesh-list
65053607|NCT00200447|Entacapone|entacapone|mesh-list
65053608|NCT00200447|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
65053609|NCT00200447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65053610|NCT00200447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65053611|NCT00200447|Dopamine Agents|dopamine agents|mesh-ancestor
65053612|NCT00200447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64905552|NCT00006232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053641|NCT00200525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053642|NCT00174967|Febuxostat|febuxostat|mesh-list
65053643|NCT00174967|Gout Suppressants|gout suppressants|mesh-ancestor
65053644|NCT00174967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65053645|NCT00200564|Ketamine|ketamine|mesh-list
65053646|NCT00200564|Analgesics|analgesics|mesh-ancestor
65053647|NCT00200564|Sensory System Agents|sensory system agents|mesh-ancestor
65053648|NCT00200564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65053649|NCT00200564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053650|NCT00200564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65053651|NCT00200564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65053652|NCT00200564|Anesthetics, General|anesthetics, general|mesh-ancestor
65053653|NCT00200564|Anesthetics|anesthetics|mesh-ancestor
65053654|NCT00200564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65053655|NCT00200564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65053656|NCT00200564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65053657|NCT00200564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64905598|NCT00006250|Antimetabolites|antimetabolites|mesh-ancestor
65053689|NCT00258063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65053690|NCT00258063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65053691|NCT00258063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65053692|NCT00258063|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65053693|NCT00258063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65053694|NCT00258102|Levofloxacin|levofloxacin|mesh-list
65053695|NCT00258102|Ofloxacin|ofloxacin|mesh-list
65053696|NCT00258102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65053697|NCT00258102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65053698|NCT00258102|Renal Agents|renal agents|mesh-ancestor
65053699|NCT00258102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65053700|NCT00258102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65053701|NCT00258102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64905648|NCT00007605|Amiodarone|amiodarone|mesh-list
64538985|NCT00637923|Antiviral Agents|antiviral agents|mesh-ancestor
65053734|NCT00258336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053735|NCT00258336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65053736|NCT00171925|Vitamin D|vitamin d|mesh-list
65053737|NCT00171925|Zoledronic Acid|zoledronic acid|mesh-list
65053738|NCT00171925|Calcium|calcium|mesh-list
65053739|NCT00171925|Vitamins|vitamins|mesh-ancestor
65053740|NCT00171925|Micronutrients|micronutrients|mesh-ancestor
65053741|NCT00171925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053742|NCT00171925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65053773|NCT00265551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65053774|NCT00265551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65053775|NCT00265551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65053776|NCT00265551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65053777|NCT00265551|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65053778|NCT00265551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65053779|NCT00265551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65053780|NCT00265551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053781|NCT00265551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65053782|NCT00265551|Serotonin Agents|serotonin agents|mesh-ancestor
65053783|NCT00201344|Leucovorin|leucovorin|mesh-list
65053784|NCT00201344|Antidotes|antidotes|mesh-ancestor
65053785|NCT00201344|Protective Agents|protective agents|mesh-ancestor
65053786|NCT00201344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053787|NCT00201344|Vitamin B Complex|vitamin b complex|mesh-ancestor
65053788|NCT00201344|Vitamins|vitamins|mesh-ancestor
65053789|NCT00201344|Micronutrients|micronutrients|mesh-ancestor
65053790|NCT00201383|Cisplatin|cisplatin|mesh-list
65053791|NCT00201383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053826|NCT00201539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65053828|NCT00265824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65053829|NCT00265824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65053830|NCT00265824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053861|NCT00201695|Antimitotic Agents|antimitotic agents|mesh-ancestor
65053862|NCT00201695|Mitosis Modulators|mitosis modulators|mesh-ancestor
65053863|NCT00410345|Mifepristone|mifepristone|mesh-list
65053864|NCT00410345|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65053865|NCT00410345|Abortifacient Agents|abortifacient agents|mesh-ancestor
65053866|NCT00410345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65053867|NCT00410345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053868|NCT00410345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65053869|NCT00410345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65053870|NCT00410345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65053871|NCT00410345|Contraceptive Agents|contraceptive agents|mesh-ancestor
65053872|NCT00410345|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64905827|NCT00006361|Semaxinib|semaxinib|mesh-list
65053898|NCT00258765|Tubulin Modulators|tubulin modulators|mesh-ancestor
65053899|NCT00258765|Antimitotic Agents|antimitotic agents|mesh-ancestor
65053900|NCT00258765|Mitosis Modulators|mitosis modulators|mesh-ancestor
65053901|NCT00258765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053902|NCT00258765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64564029|NCT03047005|Naltrexone|naltrexone|mesh-list
65053903|NCT00258765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053905|NCT00410540|Hydromorphone|hydromorphone|mesh-list
65053906|NCT00410540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65053907|NCT00410540|Narcotics|narcotics|mesh-ancestor
65053908|NCT00410540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65053909|NCT00410540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053910|NCT00410540|Analgesics|analgesics|mesh-ancestor
65053911|NCT00410540|Sensory System Agents|sensory system agents|mesh-ancestor
65053912|NCT00410540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65053913|NCT00258804|Insulin Glargine|insulin glargine|mesh-list
65053914|NCT00258804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65053915|NCT00258804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053916|NCT00201812|Dexamethasone|dexamethasone|mesh-list
65053917|NCT00201812|Etanercept|etanercept|mesh-list
65053918|NCT00201812|Docetaxel|docetaxel|mesh-list
65053919|NCT00201812|Glucocorticoids|glucocorticoids|mesh-list
65053920|NCT00201812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65053921|NCT00201812|Antiemetics|antiemetics|mesh-ancestor
65053947|NCT04709094|Norethindrone|norethindrone|mesh-list
65053948|NCT04709094|Norethindrone Acetate|norethindrone acetate|mesh-list
65053949|NCT04709094|Norinyl|norinyl|mesh-list
65053950|NCT04709094|Estradiol|estradiol|mesh-list
65053951|NCT04709094|Estrogens|estrogens|mesh-ancestor
65053952|NCT04709094|Hormones|hormones|mesh-ancestor
65053953|NCT04709094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65053954|NCT04709094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053955|NCT04709094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65053956|NCT04709094|Contraceptive Agents|contraceptive agents|mesh-ancestor
65053957|NCT04709094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65053958|NCT04709094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65053959|NCT04709094|Anticoagulants|anticoagulants|mesh-ancestor
65053960|NCT04709094|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65053961|NCT04709094|Antidepressive Agents|antidepressive agents|mesh-ancestor
65053963|NCT04709094|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65053964|NCT04709094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65053965|NCT04709094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65053966|NCT04709094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053967|NCT04709094|Dopamine Agents|dopamine agents|mesh-ancestor
65053968|NCT04709094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65053969|NCT04709094|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65053970|NCT04709094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65053971|NCT04709094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053992|NCT00202007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65053993|NCT00202007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053994|NCT00202007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053995|NCT00202007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65053996|NCT00202007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65053997|NCT00202007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65053998|NCT00202007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65053999|NCT00202007|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65054000|NCT00202007|Dopamine Agents|dopamine agents|mesh-ancestor
65054001|NCT00202007|Antidepressive Agents|antidepressive agents|mesh-ancestor
65054002|NCT00202007|Dopamine Agonists|dopamine agonists|mesh-ancestor
65054003|NCT00202007|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65054004|NCT00202007|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65054005|NCT00202007|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65054006|NCT00202007|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65054007|NCT00171301|Deferasirox|deferasirox|mesh-list
65054008|NCT00171301|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65054009|NCT00171301|Chelating Agents|chelating agents|mesh-ancestor
65054010|NCT00171301|Sequestering Agents|sequestering agents|mesh-ancestor
65054011|NCT00171301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054013|NCT00266058|Lopinavir|lopinavir|mesh-list
65054014|NCT00266058|Efavirenz|efavirenz|mesh-list
65054015|NCT00266058|Lumefantrine|lumefantrine|mesh-list
65054016|NCT00266058|Artemether|artemether|mesh-list
65054017|NCT00266058|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65054018|NCT00266058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65054019|NCT00266058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65054020|NCT00266058|Protease Inhibitors|protease inhibitors|mesh-ancestor
65054021|NCT00266058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054022|NCT00266058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054023|NCT00266058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65054024|NCT00266058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65054025|NCT00266058|Antiviral Agents|antiviral agents|mesh-ancestor
64905968|NCT00006391|Oxaliplatin|oxaliplatin|mesh-list
65054051|NCT00266097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65054052|NCT00266097|Antimetabolites|antimetabolites|mesh-ancestor
65054053|NCT00266097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054054|NCT00266097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054055|NCT00266097|Antiviral Agents|antiviral agents|mesh-ancestor
65054056|NCT00266097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65054057|NCT00266097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054058|NCT00266097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65054059|NCT00266097|Immunologic Factors|immunologic factors|mesh-ancestor
65054060|NCT00266097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054061|NCT00266097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65054063|NCT00202163|Androgens|androgens|mesh-ancestor
65054064|NCT00202163|Hormones|hormones|mesh-ancestor
65054065|NCT00202163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65054066|NCT00202163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054067|NCT00476554|Sapacitabine|sapacitabine|mesh-list
65054068|NCT00476554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054069|NCT04709289|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65054070|NCT04709289|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65054071|NCT04709289|Dermatologic Agents|dermatologic agents|mesh-ancestor
65054072|NCT00202241|Testosterone|testosterone|mesh-list
65054073|NCT00202241|Androgens|androgens|mesh-ancestor
65054074|NCT00202241|Hormones|hormones|mesh-ancestor
64906012|NCT00006412|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65054103|NCT00230594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054105|NCT00259077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65054106|NCT00259077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65054107|NCT00259077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65054108|NCT00259077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054109|NCT00259077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054110|NCT00479674|Paclitaxel|paclitaxel|mesh-list
65054111|NCT00479674|Bevacizumab|bevacizumab|mesh-list
65054112|NCT00479674|Carboplatin|carboplatin|mesh-list
65054113|NCT00479674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65054114|NCT00479674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65054115|NCT00479674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054116|NCT00479674|Tubulin Modulators|tubulin modulators|mesh-ancestor
65054117|NCT00479674|Antimitotic Agents|antimitotic agents|mesh-ancestor
65054118|NCT00479674|Mitosis Modulators|mitosis modulators|mesh-ancestor
65054119|NCT00479674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054120|NCT00479674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65054152|NCT00259155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65054153|NCT00259155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65054154|NCT00259155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65054155|NCT00479401|Pramipexole|pramipexole|mesh-list
65054156|NCT00479401|Antioxidants|antioxidants|mesh-ancestor
65054157|NCT00479401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054158|NCT00479401|Protective Agents|protective agents|mesh-ancestor
65054159|NCT00479401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054160|NCT00479401|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65054161|NCT00479401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65054162|NCT00479401|Dopamine Agonists|dopamine agonists|mesh-ancestor
65054163|NCT00479401|Dopamine Agents|dopamine agents|mesh-ancestor
65054164|NCT00479401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65054195|NCT00477607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054196|NCT00477607|Vitamin B Complex|vitamin b complex|mesh-ancestor
65054197|NCT00477607|Vitamins|vitamins|mesh-ancestor
65054198|NCT00477607|Micronutrients|micronutrients|mesh-ancestor
65054199|NCT00230867|Acyclovir|acyclovir|mesh-list
65054200|NCT00230867|Antiviral Agents|antiviral agents|mesh-ancestor
64928226|NCT04731961|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65054201|NCT00230867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65054202|NCT00266214|Lidocaine|lidocaine|mesh-list
65054203|NCT00266214|Anesthetics, Local|anesthetics, local|mesh-ancestor
65054204|NCT00266214|Anesthetics|anesthetics|mesh-ancestor
65054205|NCT00266214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65054206|NCT00266214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906153|NCT00006457|Oltipraz|oltipraz|mesh-list
65054239|NCT00231023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65054240|NCT00231023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054242|NCT00231023|Immunologic Factors|immunologic factors|mesh-ancestor
65054243|NCT00231023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054244|NCT00231023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054245|NCT00231101|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64472826|NCT02648477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65054246|NCT00231101|Antidepressive Agents|antidepressive agents|mesh-ancestor
64906208|NCT00008307|Antiemetics|antiemetics|mesh-ancestor
65054260|NCT00231140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65054261|NCT00231140|Growth Substances|growth substances|mesh-ancestor
65054262|NCT00231140|Growth Inhibitors|growth inhibitors|mesh-ancestor
65054263|NCT00231140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054264|NCT00231218|Propolis|propolis|mesh-list
65054265|NCT00231218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65054266|NCT00266448|Chlorhexidine|chlorhexidine|mesh-list
65054267|NCT00266448|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65054268|NCT00266448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65054269|NCT00266448|Disinfectants|disinfectants|mesh-ancestor
65054270|NCT00231335|Citalopram|citalopram|mesh-list
65054271|NCT00231335|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65054272|NCT00231335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65054273|NCT00231335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65054274|NCT00231335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054275|NCT00231335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65054276|NCT00231335|Serotonin Agents|serotonin agents|mesh-ancestor
65054277|NCT00231335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054278|NCT00231335|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65054279|NCT00231335|Antidepressive Agents|antidepressive agents|mesh-ancestor
65054280|NCT00231335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65054281|NCT00266487|Vitamins|vitamins|mesh-list
65054282|NCT00266487|Folic Acid|folic acid|mesh-list
65054283|NCT00266487|Vitamin B 12|vitamin b 12|mesh-list
65054284|NCT00266487|Vitamin B 6|vitamin b 6|mesh-list
65054285|NCT00266487|Pyridoxal|pyridoxal|mesh-list
65054286|NCT00266487|Pyridoxine|pyridoxine|mesh-list
65054287|NCT00266487|Vitamin B Complex|vitamin b complex|mesh-list
65054288|NCT00266487|Micronutrients|micronutrients|mesh-ancestor
65054289|NCT00266487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054290|NCT00266487|Hematinics|hematinics|mesh-ancestor
65054291|NCT00231452|Artesunate|artesunate|mesh-list
65054292|NCT00231452|Pyrimethamine|pyrimethamine|mesh-list
65054293|NCT00231452|Sulfadoxine|sulfadoxine|mesh-list
65054294|NCT00231452|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65054295|NCT00231452|Antimalarials|antimalarials|mesh-ancestor
65054296|NCT00231452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65054297|NCT00231452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65054298|NCT00231452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65054299|NCT00231452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054300|NCT00231452|Antiviral Agents|antiviral agents|mesh-ancestor
65054301|NCT00231452|Schistosomicides|schistosomicides|mesh-ancestor
65054302|NCT00231452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65054303|NCT00231452|Anthelmintics|anthelmintics|mesh-ancestor
65054304|NCT00231452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65054305|NCT00231452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054306|NCT00231452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054307|NCT00231452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65054308|NCT00231452|Renal Agents|renal agents|mesh-ancestor
65054309|NCT00231491|Botulinum Toxins|botulinum toxins|mesh-list
65054310|NCT00231491|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65054311|NCT00231491|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65054345|NCT00231608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054346|NCT00266604|Topiramate|topiramate|mesh-list
65054347|NCT00266604|Anticonvulsants|anticonvulsants|mesh-ancestor
65054348|NCT00266604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65054349|NCT00266604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054350|NCT04561336|Cetuximab|cetuximab|mesh-list
65054351|NCT04561336|Avelumab|avelumab|mesh-list
65054352|NCT04561336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65054388|NCT04560049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65054389|NCT04560049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65054390|NCT04560049|Disinfectants|disinfectants|mesh-ancestor
65054391|NCT04560049|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65054392|NCT04560049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65054393|NCT04559425|Dexamethasone|dexamethasone|mesh-list
65054394|NCT04559425|Dexamethasone acetate|dexamethasone acetate|mesh-list
65054425|NCT04559308|Immunologic Factors|immunologic factors|mesh-ancestor
65054426|NCT04559308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054427|NCT04559308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65054428|NCT04559308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65054430|NCT04559308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65054431|NCT04559308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65054432|NCT04559308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65054433|NCT04559308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65054434|NCT04559308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65054435|NCT04559308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054437|NCT04559113|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65054438|NCT04559113|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65054457|NCT00266721|Pancreatin|pancreatin|mesh-list
65054458|NCT00266721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65054459|NCT04559074|Amlodipine|amlodipine|mesh-list
65054460|NCT04559074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65054461|NCT04559074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65054462|NCT04559074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65054463|NCT04559074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054464|NCT04559074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65054465|NCT04559074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054466|NCT04559074|Vasodilator Agents|vasodilator agents|mesh-ancestor
65054467|NCT02211976|Bisacodyl|bisacodyl|mesh-list
65054468|NCT02211976|Cathartics|cathartics|mesh-ancestor
65054469|NCT02211976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65054470|NCT02211976|Laxatives|laxatives|mesh-ancestor
65054471|NCT00231959|Pramipexole|pramipexole|mesh-list
65054472|NCT00231959|Antioxidants|antioxidants|mesh-ancestor
65054473|NCT00231959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054474|NCT00231959|Protective Agents|protective agents|mesh-ancestor
65054475|NCT00231959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054476|NCT00231959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65054477|NCT00231959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65054478|NCT00231959|Dopamine Agonists|dopamine agonists|mesh-ancestor
65054479|NCT00231959|Dopamine Agents|dopamine agents|mesh-ancestor
65054480|NCT00231959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65054481|NCT00231998|Pimecrolimus|pimecrolimus|mesh-list
65054482|NCT00231998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65054483|NCT00231998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65054484|NCT00231998|Analgesics|analgesics|mesh-ancestor
65054485|NCT00231998|Sensory System Agents|sensory system agents|mesh-ancestor
65054486|NCT00231998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65054487|NCT00231998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054488|NCT00231998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65054489|NCT00231998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65054490|NCT00231998|Dermatologic Agents|dermatologic agents|mesh-ancestor
65054491|NCT00231998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65054492|NCT00231998|Immunologic Factors|immunologic factors|mesh-ancestor
65054493|NCT00231998|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65054494|NCT00231998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054495|NCT00231998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906428|NCT00007813|Etoposide|etoposide|mesh-list
65054531|NCT02212210|Protective Agents|protective agents|mesh-ancestor
65054532|NCT02212210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65054553|NCT00232115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65054554|NCT00232115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65054555|NCT00232115|Dermatologic Agents|dermatologic agents|mesh-ancestor
65054556|NCT00232115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65054557|NCT00232115|Immunologic Factors|immunologic factors|mesh-ancestor
65054558|NCT00232115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65054559|NCT00232115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054560|NCT00232115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054561|NCT04558021|Niclosamide|niclosamide|mesh-list
65054562|NCT04558021|Anticestodal Agents|anticestodal agents|mesh-ancestor
65054563|NCT04558021|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65054564|NCT04558021|Anthelmintics|anthelmintics|mesh-ancestor
65054565|NCT04558021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65054566|NCT04558021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65054567|NCT04558021|Antinematodal Agents|antinematodal agents|mesh-ancestor
65054568|NCT00232154|Azithromycin|azithromycin|mesh-list
65054569|NCT00232154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65054570|NCT00232154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65054571|NCT00259662|Atorvastatin|atorvastatin|mesh-list
65054572|NCT00259662|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65054573|NCT00259662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65054574|NCT00259662|Antimetabolites|antimetabolites|mesh-ancestor
65054575|NCT00259662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054576|NCT00259662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65054577|NCT00259662|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65054578|NCT00259662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054579|NCT04557943|Hyaluronic Acid|hyaluronic acid|mesh-list
65054580|NCT04557943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65054581|NCT04557943|Immunologic Factors|immunologic factors|mesh-ancestor
65054582|NCT04557943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054583|NCT04557943|Viscosupplements|viscosupplements|mesh-ancestor
65054584|NCT04557943|Protective Agents|protective agents|mesh-ancestor
65054585|NCT04557475|Aspirin|aspirin|mesh-list
65054586|NCT04557475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65054587|NCT04557475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65054614|NCT04557397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65054615|NCT04557397|Hormone Antagonists|hormone antagonists|mesh-ancestor
65054616|NCT04557397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65054617|NCT04557397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054618|NCT04557397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65054619|NCT04557397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65054620|NCT04557397|Antitubercular Agents|antitubercular agents|mesh-ancestor
65054621|NCT04557397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65054622|NCT04557397|Leprostatic Agents|leprostatic agents|mesh-ancestor
65054623|NCT04557397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65054624|NCT04557397|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65054625|NCT04557397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65054626|NCT04557397|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65054627|NCT04557397|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65054628|NCT04557397|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65054629|NCT04557397|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65054631|NCT04557202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65054632|NCT04557202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65054669|NCT04566211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65054670|NCT04566211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65054671|NCT04566211|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65054672|NCT04566211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054737|NCT00232661|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65054738|NCT00232661|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65054739|NCT00232661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65054740|NCT00232661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65054741|NCT00232661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65054742|NCT00232661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054743|NCT00232661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054744|NCT00267267|Atorvastatin|atorvastatin|mesh-list
65054745|NCT00267267|Simvastatin|simvastatin|mesh-list
65054746|NCT00267267|Ezetimibe|ezetimibe|mesh-list
65054747|NCT00267267|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
65054748|NCT00267267|Torcetrapib|torcetrapib|mesh-list
65054749|NCT00267267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65054750|NCT00267267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65054751|NCT00267267|Antimetabolites|antimetabolites|mesh-ancestor
65054752|NCT00267267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054778|NCT04564456|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65054779|NCT04564456|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65054780|NCT04564456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65054781|NCT04564456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65054782|NCT04564456|Autonomic Agents|autonomic agents|mesh-ancestor
65054783|NCT04564456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65054784|NCT04564456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054785|NCT04564456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65054786|NCT04564456|Respiratory System Agents|respiratory system agents|mesh-ancestor
65054787|NCT04564456|Dermatologic Agents|dermatologic agents|mesh-ancestor
65054788|NCT04564456|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65054789|NCT04564456|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65054790|NCT04564456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65054791|NCT04564456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65054792|NCT04564456|Adrenergic Agents|adrenergic agents|mesh-ancestor
65054793|NCT04564456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65054794|NCT04564456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054795|NCT04564456|Glucocorticoids|glucocorticoids|mesh-ancestor
65054796|NCT04564456|Hormones|hormones|mesh-ancestor
65054797|NCT04564456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65054798|NCT04564456|Sympathomimetics|sympathomimetics|mesh-ancestor
65054799|NCT04564144|Meclizine|meclizine|mesh-list
65054800|NCT04564144|Antiemetics|antiemetics|mesh-ancestor
65054801|NCT04564144|Autonomic Agents|autonomic agents|mesh-ancestor
65054802|NCT04564144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65054803|NCT04564144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054827|NCT04721795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65054828|NCT04721795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65054829|NCT04721795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64564403|NCT03822169|Choline|choline|mesh-list
65054830|NCT04721795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65054831|NCT04721795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65054832|NCT04675021|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65054833|NCT04564222|Micronutrients|micronutrients|mesh-list
65054834|NCT04564222|Trace Elements|trace elements|mesh-list
65054835|NCT04564222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054836|NCT00232817|Nicotine|nicotine|mesh-list
65054837|NCT00232817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65054838|NCT00232817|Autonomic Agents|autonomic agents|mesh-ancestor
65054839|NCT00232817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65054840|NCT00232817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054841|NCT00232817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65054842|NCT00232817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65054843|NCT00232817|Cholinergic Agents|cholinergic agents|mesh-ancestor
65054844|NCT00232817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65054845|NCT00232817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054846|NCT00267384|Acetylcysteine|acetylcysteine|mesh-list
65054847|NCT00267384|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65054848|NCT00267384|Antiviral Agents|antiviral agents|mesh-ancestor
65054849|NCT00267384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65054850|NCT00267384|Expectorants|expectorants|mesh-ancestor
65054851|NCT00267384|Respiratory System Agents|respiratory system agents|mesh-ancestor
65054852|NCT00267384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65054853|NCT00267384|Antioxidants|antioxidants|mesh-ancestor
65054854|NCT00267384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054855|NCT00267384|Protective Agents|protective agents|mesh-ancestor
65054856|NCT00267384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054857|NCT00267384|Antidotes|antidotes|mesh-ancestor
65054929|NCT04673500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65054931|NCT04673500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65054960|NCT00233051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65054961|NCT00233051|Adrenergic Agents|adrenergic agents|mesh-ancestor
65054962|NCT00233051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65054963|NCT00233051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054965|NCT04672759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65054966|NCT04672759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65054967|NCT04672759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054968|NCT04672759|Immunologic Factors|immunologic factors|mesh-ancestor
65054969|NCT04672759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054970|NCT00260247|Carbamazepine|carbamazepine|mesh-list
65054971|NCT00260247|Oxcarbazepine|oxcarbazepine|mesh-list
65054972|NCT00260247|Anticonvulsants|anticonvulsants|mesh-ancestor
65054973|NCT00260247|Antimanic Agents|antimanic agents|mesh-ancestor
65054974|NCT00260247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65054975|NCT00260247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65054976|NCT00260247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054977|NCT00260247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65054978|NCT00260247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65054979|NCT00260247|Analgesics|analgesics|mesh-ancestor
65054980|NCT00260247|Sensory System Agents|sensory system agents|mesh-ancestor
65055010|NCT04671394|Photosensitizing Agents|photosensitizing agents|mesh-list
65055011|NCT04671394|Dermatologic Agents|dermatologic agents|mesh-ancestor
65055014|NCT00233558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65055015|NCT00233558|Abortifacient Agents|abortifacient agents|mesh-ancestor
65055016|NCT00233558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65055017|NCT00233558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055018|NCT00233558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65055019|NCT00233558|Antimetabolites|antimetabolites|mesh-ancestor
65055020|NCT00233558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055021|NCT00233558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055022|NCT00233558|Dermatologic Agents|dermatologic agents|mesh-ancestor
65055051|NCT04670809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055052|NCT04670809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65055054|NCT00233714|Sirolimus|sirolimus|mesh-list
65055055|NCT00233714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65055056|NCT00233714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65055057|NCT00233714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65055058|NCT00233714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055059|NCT00233714|Antifungal Agents|antifungal agents|mesh-ancestor
65055060|NCT00233714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65055061|NCT00233714|Immunologic Factors|immunologic factors|mesh-ancestor
65055062|NCT00233714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055063|NCT04670497|Epinephrine|epinephrine|mesh-list
65055064|NCT04670497|Racepinephrine|racepinephrine|mesh-list
65055065|NCT04670497|Bupivacaine|bupivacaine|mesh-list
65055066|NCT04670497|Epinephryl borate|epinephryl borate|mesh-list
65055080|NCT04670497|Autonomic Agents|autonomic agents|mesh-ancestor
65055081|NCT04670497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65055082|NCT04670497|Respiratory System Agents|respiratory system agents|mesh-ancestor
65055083|NCT04670497|Mydriatics|mydriatics|mesh-ancestor
65055085|NCT04670497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65055086|NCT04670107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65055087|NCT04670107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055088|NCT04670107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055089|NCT00260364|Gemcitabine|gemcitabine|mesh-list
65055090|NCT00260364|Bevacizumab|bevacizumab|mesh-list
65055091|NCT00260364|Capecitabine|capecitabine|mesh-list
65055092|NCT00260364|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65055093|NCT00260364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65055094|NCT00260364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055095|NCT00260364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65055096|NCT00260364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65055097|NCT00260364|Growth Substances|growth substances|mesh-ancestor
65055098|NCT00260364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055099|NCT00260364|Growth Inhibitors|growth inhibitors|mesh-ancestor
65055100|NCT00260364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65055101|NCT00260364|Antimetabolites|antimetabolites|mesh-ancestor
65055102|NCT00260364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055104|NCT00260364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65055105|NCT00260364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055106|NCT00260364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65055107|NCT00260364|Immunologic Factors|immunologic factors|mesh-ancestor
65055108|NCT00260364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65055109|NCT04557007|Pembrolizumab|pembrolizumab|mesh-list
65055110|NCT04557007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65055111|NCT04557007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055112|NCT00233792|Sirolimus|sirolimus|mesh-list
65055113|NCT00233792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65055114|NCT00233792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65055115|NCT00233792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65055116|NCT00233792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055117|NCT00233792|Antifungal Agents|antifungal agents|mesh-ancestor
65055118|NCT00233792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65055119|NCT00233792|Immunologic Factors|immunologic factors|mesh-ancestor
65055120|NCT00233792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055121|NCT00556153|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
65055122|NCT00556153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055123|NCT00556192|Rituximab|rituximab|mesh-list
65055124|NCT00556192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65055125|NCT00556192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055126|NCT00556192|Immunologic Factors|immunologic factors|mesh-ancestor
65055127|NCT00556192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055155|NCT00267813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65055156|NCT00267813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65055157|NCT00267813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64540400|NCT03139500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65055158|NCT00267813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055159|NCT00267813|Dopamine Agents|dopamine agents|mesh-ancestor
65055160|NCT00267813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65055161|NCT00267813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055162|NCT00267813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65055163|NCT00267813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65055164|NCT00267813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055165|NCT00234026|Gemcitabine|gemcitabine|mesh-list
65055166|NCT00234026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65055167|NCT00234026|Antimetabolites|antimetabolites|mesh-ancestor
65055168|NCT00234026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055169|NCT00234026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055170|NCT00234026|Antiviral Agents|antiviral agents|mesh-ancestor
65055171|NCT00234026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65055172|NCT00234026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055173|NCT00234026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65055174|NCT00234026|Immunologic Factors|immunologic factors|mesh-ancestor
64907117|NCT00000517|Warfarin|warfarin|mesh-list
65055210|NCT00556387|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65055211|NCT00556387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65055212|NCT00556387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494641|NCT01239498|Autonomic Agents|autonomic agents|mesh-ancestor
65055213|NCT04552093|Floxuridine|floxuridine|mesh-list
65055214|NCT04552093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65055215|NCT04552093|Antimetabolites|antimetabolites|mesh-ancestor
65055216|NCT04552093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055249|NCT04556071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65055250|NCT04556071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65055252|NCT04556071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055253|NCT04556071|Growth Inhibitors|growth inhibitors|mesh-ancestor
65055254|NCT04556071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65055255|NCT04556071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907198|NCT00000556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65055291|NCT00234416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055292|NCT00234416|Antiviral Agents|antiviral agents|mesh-ancestor
65055327|NCT00415935|Dermatologic Agents|dermatologic agents|mesh-ancestor
65055328|NCT00415935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055329|NCT00415935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65055330|NCT00415935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65055331|NCT00415935|Immunologic Factors|immunologic factors|mesh-ancestor
65055332|NCT00415935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65055363|NCT04561921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055364|NCT04561921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65055365|NCT04561921|Tocolytic Agents|tocolytic agents|mesh-ancestor
65055366|NCT04561921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65055367|NCT04561921|Anesthetics, Local|anesthetics, local|mesh-ancestor
65055368|NCT04561921|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65055369|NCT04561687|Azelastine|azelastine|mesh-list
65055370|NCT04561687|Budesonide|budesonide|mesh-list
65055371|NCT04561687|Montelukast|montelukast|mesh-list
65055372|NCT04561687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65055373|NCT04561687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65055374|NCT04561687|Autonomic Agents|autonomic agents|mesh-ancestor
65055375|NCT04561687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65055376|NCT04561687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055377|NCT04561687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65055378|NCT04561687|Respiratory System Agents|respiratory system agents|mesh-ancestor
65055410|NCT00234845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65055411|NCT00234845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65055412|NCT00234845|Immunologic Factors|immunologic factors|mesh-ancestor
65055413|NCT00234845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65055414|NCT00234845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65055415|NCT00234845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65055416|NCT02211625|Oxycodone|oxycodone|mesh-list
65055417|NCT02211625|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65055418|NCT02211625|Narcotics|narcotics|mesh-ancestor
65055419|NCT02211625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65055420|NCT02211625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055452|NCT00234962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65055453|NCT00234962|Protease Inhibitors|protease inhibitors|mesh-ancestor
65055454|NCT00234962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055455|NCT00234962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055457|NCT00234962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65055458|NCT00234962|Antiviral Agents|antiviral agents|mesh-ancestor
65055459|NCT00234962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65055460|NCT00234962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65055461|NCT00234962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65055463|NCT04551703|Racepinephrine|racepinephrine|mesh-list
65055464|NCT04551703|Epinephryl borate|epinephryl borate|mesh-list
65055465|NCT04551703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65055485|NCT00235001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055486|NCT00235001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65055488|NCT00235001|Vasodilator Agents|vasodilator agents|mesh-ancestor
65055489|NCT00235001|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65055490|NCT00235001|Protease Inhibitors|protease inhibitors|mesh-ancestor
65055491|NCT00235001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055492|NCT00235001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65055493|NCT04551781|Prednisone|prednisone|mesh-list
65055494|NCT04551781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65055495|NCT04551781|Glucocorticoids|glucocorticoids|mesh-ancestor
65055496|NCT04551781|Hormones|hormones|mesh-ancestor
65055497|NCT04551781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65055498|NCT04551781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055499|NCT04551781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65055500|NCT04551781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055501|NCT00424944|Vaccines|vaccines|mesh-list
65055502|NCT00424944|Immunologic Factors|immunologic factors|mesh-ancestor
65055503|NCT00424944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055504|NCT02214004|Trastuzumab|trastuzumab|mesh-list
65055505|NCT02214004|Letrozole|letrozole|mesh-list
65055506|NCT02214004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65055507|NCT02214004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055508|NCT02214004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65055509|NCT02214004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65055510|NCT02214004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055511|NCT02214004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055512|NCT02214004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65055513|NCT02214004|Hormone Antagonists|hormone antagonists|mesh-ancestor
65055514|NCT02214004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65055515|NCT02214004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055516|NCT00235079|Colchicine|colchicine|mesh-list
65055517|NCT00235079|Gout Suppressants|gout suppressants|mesh-ancestor
65055518|NCT00235079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65055519|NCT00235079|Tubulin Modulators|tubulin modulators|mesh-ancestor
65055553|NCT00235196|Anti-Infective Agents|anti-infective agents|mesh-list
65055554|NCT00235196|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65055556|NCT00261027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055557|NCT00261027|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65055558|NCT00261027|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65055559|NCT00261027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055560|NCT00261027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055593|NCT00268359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65055595|NCT00268359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65055596|NCT00268359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65055597|NCT00268359|Growth Substances|growth substances|mesh-ancestor
65055598|NCT00268359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055599|NCT00268359|Growth Inhibitors|growth inhibitors|mesh-ancestor
65055600|NCT00268359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65055601|NCT00268359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65055602|NCT00268359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055669|NCT00268515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055670|NCT00268515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65055671|NCT00268515|Immunologic Factors|immunologic factors|mesh-ancestor
65055672|NCT00268515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65055673|NCT00268515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055674|NCT00268515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540926|NCT03025477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540934|NCT03147378|Docetaxel|docetaxel|mesh-list
64540935|NCT03147378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540936|NCT03147378|Tubulin Modulators|tubulin modulators|mesh-ancestor
64540937|NCT03147378|Antimitotic Agents|antimitotic agents|mesh-ancestor
64540938|NCT03147378|Mitosis Modulators|mitosis modulators|mesh-ancestor
64907620|NCT00000826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055699|NCT04548700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65055701|NCT04548700|Antimitotic Agents|antimitotic agents|mesh-ancestor
65055702|NCT04548700|Mitosis Modulators|mitosis modulators|mesh-ancestor
65055703|NCT04548700|Analgesics|analgesics|mesh-ancestor
65055704|NCT04548700|Sensory System Agents|sensory system agents|mesh-ancestor
65055705|NCT04548700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65055706|NCT04548700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65055707|NCT04548700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65055708|NCT04548700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055709|NCT02214433|Pantoprazole|pantoprazole|mesh-list
65055710|NCT02214433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65055711|NCT02214433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65055712|NCT02214433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65055713|NCT02214433|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65055714|NCT02214433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055715|NCT02214433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055716|NCT02212561|Cytarabine|cytarabine|mesh-list
65055717|NCT02212561|Hydrocortisone|hydrocortisone|mesh-list
65055718|NCT02212561|Methotrexate|methotrexate|mesh-list
65055719|NCT02212561|Fludarabine phosphate|fludarabine phosphate|mesh-list
65055720|NCT02212561|Fludarabine|fludarabine|mesh-list
65055721|NCT02212561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64907671|NCT00000883|Azithromycin|azithromycin|mesh-list
65055751|NCT00268554|Vasodilator Agents|vasodilator agents|mesh-ancestor
65055753|NCT00268593|Docetaxel|docetaxel|mesh-list
65055754|NCT00268593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055755|NCT00268593|Tubulin Modulators|tubulin modulators|mesh-ancestor
65055756|NCT00268593|Antimitotic Agents|antimitotic agents|mesh-ancestor
65055757|NCT00268593|Mitosis Modulators|mitosis modulators|mesh-ancestor
65055758|NCT00268593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055759|NCT00268593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65055760|NCT00268593|Glucocorticoids|glucocorticoids|mesh-ancestor
65055761|NCT00268593|Hormones|hormones|mesh-ancestor
65055762|NCT00268593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65055763|NCT00268593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907710|NCT00000898|Ritonavir|ritonavir|mesh-list
65055788|NCT04554979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65055789|NCT04554979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055790|NCT04554979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055791|NCT04554979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65055792|NCT00235703|Anti-Infective Agents|anti-infective agents|mesh-list
65055793|NCT00235703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65055794|NCT00261222|Amodiaquine|amodiaquine|mesh-list
65055795|NCT00261222|Antimalarials|antimalarials|mesh-ancestor
65055796|NCT00261222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65055797|NCT00261222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65055798|NCT00261222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65055799|NCT00235781|Thymoglobulin|thymoglobulin|mesh-list
65055800|NCT00235781|Immunologic Factors|immunologic factors|mesh-ancestor
65055801|NCT00235781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055802|NCT00235781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65055803|NCT04554589|Glycopyrrolate|glycopyrrolate|mesh-list
65055804|NCT04554589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65055805|NCT04554589|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65055806|NCT04554589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65055807|NCT04554589|Cholinergic Agents|cholinergic agents|mesh-ancestor
65055808|NCT04554589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65055809|NCT04554589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055810|NCT04554589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055811|NCT00268671|Docetaxel|docetaxel|mesh-list
65055812|NCT00268671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055813|NCT00268671|Tubulin Modulators|tubulin modulators|mesh-ancestor
65055850|NCT02212795|Renal Agents|renal agents|mesh-ancestor
65055851|NCT02212795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65055852|NCT02212795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65055853|NCT02212795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65055854|NCT02212795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055880|NCT00268710|Tubulin Modulators|tubulin modulators|mesh-ancestor
65055881|NCT00268710|Antimitotic Agents|antimitotic agents|mesh-ancestor
65055882|NCT00268710|Mitosis Modulators|mitosis modulators|mesh-ancestor
65055883|NCT00268710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055885|NCT00261300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65055886|NCT00261300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65055887|NCT00261300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65055888|NCT00261300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055889|NCT00261300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055890|NCT02212990|Acetaminophen|acetaminophen|mesh-list
65055891|NCT02212990|Ibuprofen|ibuprofen|mesh-list
65055892|NCT02212990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65055893|NCT02212990|Analgesics|analgesics|mesh-ancestor
65055894|NCT02212990|Sensory System Agents|sensory system agents|mesh-ancestor
65055895|NCT02212990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65055896|NCT02212990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055897|NCT02212990|Antipyretics|antipyretics|mesh-ancestor
65055898|NCT02212990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65055899|NCT02212990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65055900|NCT02212990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65055901|NCT02212990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64541158|NCT03113994|Vitamin D|vitamin d|mesh-list
65055902|NCT02212990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055924|NCT02213029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65055925|NCT02213029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055926|NCT02213146|Insulin|insulin|mesh-list
65055927|NCT02213146|Insulin Lispro|insulin lispro|mesh-list
65055928|NCT02213146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65055929|NCT02213146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65055930|NCT02213146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055931|NCT00268749|Glycine|glycine|mesh-list
65055932|NCT00268749|Glycine Agents|glycine agents|mesh-ancestor
65055933|NCT00268749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65055934|NCT00268749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055935|NCT00268749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055936|NCT00235898|Leucovorin|leucovorin|mesh-list
65055937|NCT00235898|Fluorouracil|fluorouracil|mesh-list
64827193|NCT01548170|Sunitinib|sunitinib|mesh-list
65055938|NCT00235898|Antimetabolites|antimetabolites|mesh-ancestor
65055939|NCT00235898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055940|NCT00235898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65055941|NCT00235898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055942|NCT00235898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65055943|NCT00235898|Immunologic Factors|immunologic factors|mesh-ancestor
65055944|NCT00235898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055945|NCT00235898|Antidotes|antidotes|mesh-ancestor
65055946|NCT00235898|Protective Agents|protective agents|mesh-ancestor
65055947|NCT00235898|Vitamin B Complex|vitamin b complex|mesh-ancestor
65055948|NCT00235898|Vitamins|vitamins|mesh-ancestor
65055949|NCT00235898|Micronutrients|micronutrients|mesh-ancestor
65055950|NCT02213224|Amlodipine|amlodipine|mesh-list
65055951|NCT02213224|Telmisartan|telmisartan|mesh-list
65055952|NCT02213224|Perindopril|perindopril|mesh-list
65055953|NCT02213224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65055954|NCT02213224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65055955|NCT02213224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65055956|NCT02213224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055957|NCT02213224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65055986|NCT00261339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65055987|NCT00261339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65055988|NCT00261339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055989|NCT00261339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055990|NCT04553380|Insulin|insulin|mesh-list
65055991|NCT04553380|Insulin Glargine|insulin glargine|mesh-list
65055992|NCT04553380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65055993|NCT04553380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055994|NCT00236015|Tiagabine|tiagabine|mesh-list
65055995|NCT00236015|Anticonvulsants|anticonvulsants|mesh-ancestor
65055996|NCT00236015|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
65055997|NCT00236015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65055998|NCT00236015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65055999|NCT00236015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056000|NCT00236015|GABA Agents|gaba agents|mesh-ancestor
65056001|NCT00236015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65056002|NCT00236015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056021|NCT00236054|Tiagabine|tiagabine|mesh-list
65056022|NCT00236054|Anticonvulsants|anticonvulsants|mesh-ancestor
65056023|NCT00236054|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
65056024|NCT00236054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65056025|NCT00236054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65056026|NCT00236054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056027|NCT00236054|GABA Agents|gaba agents|mesh-ancestor
65056028|NCT00236054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65056029|NCT00236054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056030|NCT04552951|Vitamin D|vitamin d|mesh-list
65056031|NCT04552951|Cholecalciferol|cholecalciferol|mesh-list
65056032|NCT04552951|Vitamins|vitamins|mesh-ancestor
65056033|NCT04552951|Micronutrients|micronutrients|mesh-ancestor
65056034|NCT04552951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056035|NCT04552951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65056036|NCT04552951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65056037|NCT02213419|Ethanol|ethanol|mesh-list
65056038|NCT02213419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65056039|NCT02213419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65056040|NCT02213419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65056041|NCT02213419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056042|NCT00236093|Fentanyl|fentanyl|mesh-list
65056043|NCT00236093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65056044|NCT00236093|Narcotics|narcotics|mesh-ancestor
65056045|NCT00236093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65056046|NCT00236093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056047|NCT00236093|Analgesics|analgesics|mesh-ancestor
65056048|NCT00236093|Sensory System Agents|sensory system agents|mesh-ancestor
65056049|NCT00236093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65056050|NCT00236093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65056051|NCT00236093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65056052|NCT00236093|Anesthetics, General|anesthetics, general|mesh-ancestor
65056053|NCT00236093|Anesthetics|anesthetics|mesh-ancestor
65056054|NCT04552483|Nitazoxanide|nitazoxanide|mesh-list
65056055|NCT04552483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65056056|NCT04552483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65056057|NCT02213614|Lithium Carbonate|lithium carbonate|mesh-list
65056058|NCT02213614|Antidepressive Agents|antidepressive agents|mesh-ancestor
64908002|NCT00001048|Cytarabine|cytarabine|mesh-list
65056077|NCT02213848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056078|NCT00261573|Galantamine|galantamine|mesh-list
65056079|NCT00261573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65056080|NCT00261573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056081|NCT00261573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056082|NCT00261573|Cholinergic Agents|cholinergic agents|mesh-ancestor
65056083|NCT00261573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65056084|NCT00261573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056085|NCT00261573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65056086|NCT00261573|Autonomic Agents|autonomic agents|mesh-ancestor
65056087|NCT00261573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65056088|NCT00261573|Nootropic Agents|nootropic agents|mesh-ancestor
65056089|NCT04548271|Apatinib|apatinib|mesh-list
65056090|NCT04548271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056091|NCT04548271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65056092|NCT04548271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056093|NCT04548271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056094|NCT04541719|Remifentanil|remifentanil|mesh-list
65056095|NCT04541719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65056096|NCT04541719|Narcotics|narcotics|mesh-ancestor
65056097|NCT04541719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65056098|NCT04541719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056099|NCT04541719|Analgesics|analgesics|mesh-ancestor
65056100|NCT04541719|Sensory System Agents|sensory system agents|mesh-ancestor
65056101|NCT04541719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65056102|NCT00414089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65056103|NCT00414089|Immunologic Factors|immunologic factors|mesh-ancestor
65056104|NCT00414089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056105|NCT00261612|Dexamethasone|dexamethasone|mesh-list
65056106|NCT00261612|Rituximab|rituximab|mesh-list
65056107|NCT00261612|Bortezomib|bortezomib|mesh-list
65056108|NCT00261612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65056109|NCT00261612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056110|NCT00261612|Immunologic Factors|immunologic factors|mesh-ancestor
65056111|NCT00261612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056112|NCT00261612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65056113|NCT00261612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65056114|NCT00261612|Antiemetics|antiemetics|mesh-ancestor
65056115|NCT00261612|Autonomic Agents|autonomic agents|mesh-ancestor
65056116|NCT00261612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65056117|NCT00261612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65056145|NCT00236249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65056146|NCT00236249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65056147|NCT00236249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65056148|NCT00236249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65056149|NCT00236249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65056150|NCT00236249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056152|NCT00269061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65056153|NCT00269061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056154|NCT04547452|Antibodies|antibodies|mesh-list
65056155|NCT04547452|Immunologic Factors|immunologic factors|mesh-ancestor
65056156|NCT04547452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056157|NCT04547335|Voriconazole|voriconazole|mesh-list
65056158|NCT04547335|Antifungal Agents|antifungal agents|mesh-ancestor
65056159|NCT04547335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65056160|NCT04547335|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65056161|NCT04547335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65056183|NCT04547296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65056184|NCT00236327|Fentanyl|fentanyl|mesh-list
65056185|NCT00236327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65056186|NCT00236327|Narcotics|narcotics|mesh-ancestor
65056187|NCT00236327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65056188|NCT00236327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056189|NCT00236327|Analgesics|analgesics|mesh-ancestor
65056190|NCT00236327|Sensory System Agents|sensory system agents|mesh-ancestor
65056191|NCT00236327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65056192|NCT00236327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65056193|NCT00236327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65056194|NCT00236327|Anesthetics, General|anesthetics, general|mesh-ancestor
65056195|NCT00236327|Anesthetics|anesthetics|mesh-ancestor
65056196|NCT00236366|Fentanyl|fentanyl|mesh-list
65056197|NCT00236366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65056198|NCT00236366|Narcotics|narcotics|mesh-ancestor
65056199|NCT00236366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64564926|NCT01270659|Oxycodone|oxycodone|mesh-list
65056200|NCT00236366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056202|NCT00236366|Sensory System Agents|sensory system agents|mesh-ancestor
65056203|NCT00236366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65056204|NCT00236366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65056205|NCT00236366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65056206|NCT00236366|Anesthetics, General|anesthetics, general|mesh-ancestor
65056207|NCT00236366|Anesthetics|anesthetics|mesh-ancestor
65056208|NCT04547179|Erenumab|erenumab|mesh-list
65056209|NCT04547179|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65056210|NCT04547179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056211|NCT04547179|Analgesics|analgesics|mesh-ancestor
65056240|NCT00269217|Vasodilator Agents|vasodilator agents|mesh-ancestor
65056241|NCT00269217|Vitamin B Complex|vitamin b complex|mesh-ancestor
65056242|NCT00269217|Vitamins|vitamins|mesh-ancestor
65056243|NCT00269217|Micronutrients|micronutrients|mesh-ancestor
65056244|NCT00269217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056245|NCT04546282|Osimertinib|osimertinib|mesh-list
65056246|NCT04546282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056247|NCT04546282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65056248|NCT04546282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056249|NCT04546282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056250|NCT00236483|Acetaminophen|acetaminophen|mesh-list
65056251|NCT00236483|Tramadol|tramadol|mesh-list
65056252|NCT00236483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65056253|NCT00236483|Analgesics|analgesics|mesh-ancestor
65056254|NCT00236483|Sensory System Agents|sensory system agents|mesh-ancestor
65056255|NCT00236483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65056256|NCT00236483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056257|NCT00236483|Antipyretics|antipyretics|mesh-ancestor
65056258|NCT00236483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65056259|NCT00236483|Narcotics|narcotics|mesh-ancestor
64908210|NCT00001303|Nitric Oxide|nitric oxide|mesh-list
65056293|NCT00261729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056294|NCT00261729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65056296|NCT00261729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65056297|NCT00261729|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65056298|NCT00261729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65056332|NCT02278510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056334|NCT04545892|Antipruritics|antipruritics|mesh-ancestor
65056335|NCT04545892|Dermatologic Agents|dermatologic agents|mesh-ancestor
65056336|NCT04545892|Sensory System Agents|sensory system agents|mesh-ancestor
65056337|NCT04545892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64908309|NCT00001495|Irinotecan|irinotecan|mesh-list
65056367|NCT00269334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65056368|NCT00269334|Serotonin Agents|serotonin agents|mesh-ancestor
65056369|NCT00269334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056370|NCT00269334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65056371|NCT00269334|Antidepressive Agents|antidepressive agents|mesh-ancestor
65056372|NCT00269334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65056373|NCT00269334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65056374|NCT00269334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65056375|NCT00269334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056376|NCT04541251|Paclitaxel|paclitaxel|mesh-list
65056377|NCT04541251|Carboplatin|carboplatin|mesh-list
65056378|NCT04541251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65056379|NCT04541251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056380|NCT04541251|Tubulin Modulators|tubulin modulators|mesh-ancestor
65056381|NCT04541251|Antimitotic Agents|antimitotic agents|mesh-ancestor
65056382|NCT04541251|Mitosis Modulators|mitosis modulators|mesh-ancestor
65056383|NCT04541251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056384|NCT00236717|Topiramate|topiramate|mesh-list
65056385|NCT00236717|Carbamazepine|carbamazepine|mesh-list
65056409|NCT04540666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056411|NCT04540666|Anesthetics, General|anesthetics, general|mesh-ancestor
65056412|NCT04540666|Anesthetics|anesthetics|mesh-ancestor
65056413|NCT00236756|Topiramate|topiramate|mesh-list
65056414|NCT00236756|Anticonvulsants|anticonvulsants|mesh-ancestor
65056415|NCT00236756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65056416|NCT00236756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056417|NCT00269412|Rifaximin|rifaximin|mesh-list
65056418|NCT00269412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65056419|NCT00269412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65056420|NCT00269412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65056421|NCT00236795|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65056422|NCT00236795|Norelgestromin|norelgestromin|mesh-list
65056423|NCT00236795|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
65056424|NCT00236795|Estradiol|estradiol|mesh-list
65056425|NCT00236795|Estrogens|estrogens|mesh-ancestor
65056426|NCT00236795|Hormones|hormones|mesh-ancestor
65056427|NCT00236795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65056428|NCT00236795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056429|NCT00236795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65056430|NCT00236795|Contraceptive Agents|contraceptive agents|mesh-ancestor
65056431|NCT00236795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65056432|NCT00236795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65056433|NCT00236795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65056434|NCT00236795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65056435|NCT00236795|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65056436|NCT00236795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65056460|NCT00236873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056461|NCT00236912|Metronidazole|metronidazole|mesh-list
65056462|NCT00236912|Levofloxacin|levofloxacin|mesh-list
65056463|NCT00236912|Ofloxacin|ofloxacin|mesh-list
65056464|NCT00236912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65056465|NCT00236912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65056466|NCT00236912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65056467|NCT00236912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65056468|NCT00236912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65056469|NCT00236912|Renal Agents|renal agents|mesh-ancestor
65056470|NCT00236912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65056471|NCT00236912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65056472|NCT00236912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056473|NCT00236912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056474|NCT00236912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056475|NCT00236912|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65056476|NCT00236912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65056477|NCT02215447|Paclitaxel|paclitaxel|mesh-list
65056478|NCT02215447|Carboplatin|carboplatin|mesh-list
65056479|NCT02215447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65056480|NCT02215447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056481|NCT02215447|Tubulin Modulators|tubulin modulators|mesh-ancestor
65056482|NCT02215447|Antimitotic Agents|antimitotic agents|mesh-ancestor
65056483|NCT02215447|Mitosis Modulators|mitosis modulators|mesh-ancestor
65056484|NCT02215447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056485|NCT00236990|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
65056486|NCT00236990|Anticoagulants|anticoagulants|mesh-ancestor
65056487|NCT00237068|Lansoprazole|lansoprazole|mesh-list
65056488|NCT00237068|Dexlansoprazole|dexlansoprazole|mesh-list
65056489|NCT00237068|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65056490|NCT00237068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65056521|NCT04544059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65056522|NCT04544059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65056523|NCT04544059|Growth Substances|growth substances|mesh-ancestor
65056524|NCT04544059|Growth Inhibitors|growth inhibitors|mesh-ancestor
65056525|NCT04544059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056526|NCT00269607|Naltrexone|naltrexone|mesh-list
65056527|NCT00269607|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65056528|NCT00269607|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65056529|NCT00269607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056530|NCT00269607|Sensory System Agents|sensory system agents|mesh-ancestor
65056531|NCT00269607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65056532|NCT00237224|Letrozole|letrozole|mesh-list
65056533|NCT00237224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056561|NCT00262275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65056562|NCT00262275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65056563|NCT00262275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65056564|NCT00262275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056565|NCT00262275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65056566|NCT00262275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65056567|NCT00262275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056568|NCT00262275|Antipyretics|antipyretics|mesh-ancestor
65056569|NCT00262275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65056570|NCT00262275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65056571|NCT00262275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65056572|NCT00262275|Purinergic Agents|purinergic agents|mesh-ancestor
65056573|NCT00262275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65056574|NCT02214979|Telmisartan|telmisartan|mesh-list
65056575|NCT02214979|Ramipril|ramipril|mesh-list
65056576|NCT02214979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65056577|NCT02214979|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65056578|NCT02214979|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65056611|NCT00416130|Vorinostat|vorinostat|mesh-list
65056612|NCT00416130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056613|NCT00416130|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65056614|NCT00416130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056615|NCT00416130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056616|NCT00416169|Galantamine|galantamine|mesh-list
65056617|NCT00416169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65056618|NCT00416169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056619|NCT00416169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056620|NCT00416169|Cholinergic Agents|cholinergic agents|mesh-ancestor
65056621|NCT00416169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65056622|NCT00416169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056623|NCT00416169|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65056682|NCT00269685|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65056683|NCT00269685|Natriuretic Agents|natriuretic agents|mesh-ancestor
65056684|NCT00269685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056686|NCT04543123|Antidepressive Agents|antidepressive agents|mesh-list
65056687|NCT04543123|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65056688|NCT04543123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65056689|NCT04543123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65056690|NCT04543123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056691|NCT04543123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65056692|NCT04543123|Serotonin Agents|serotonin agents|mesh-ancestor
65056693|NCT04543123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056694|NCT04543123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65056695|NCT04543123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65056696|NCT04539418|Vitamin K|vitamin k|mesh-list
65056697|NCT04539418|Vitamin K 2|vitamin k 2|mesh-list
65056698|NCT04539418|Vitamins|vitamins|mesh-ancestor
65056699|NCT04539418|Micronutrients|micronutrients|mesh-ancestor
65056700|NCT04539418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056731|NCT04710017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65056732|NCT04710017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65056733|NCT04710017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65056734|NCT04710017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65056735|NCT04710017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056736|NCT04538521|Niacin|niacin|mesh-list
65056737|NCT04538521|Nicotinic Acids|nicotinic acids|mesh-list
65056738|NCT04538521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65056739|NCT04538521|Antimetabolites|antimetabolites|mesh-ancestor
65056740|NCT04538521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056741|NCT04538521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65056742|NCT04538521|Vasodilator Agents|vasodilator agents|mesh-ancestor
65056743|NCT04538521|Vitamin B Complex|vitamin b complex|mesh-ancestor
65056744|NCT04538521|Vitamins|vitamins|mesh-ancestor
65056812|NCT00414128|Cyclophosphamide|cyclophosphamide|mesh-list
65056813|NCT00414128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65056814|NCT00414128|Immunologic Factors|immunologic factors|mesh-ancestor
65056815|NCT00414128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056816|NCT00414128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65056817|NCT00414128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65056818|NCT00414128|Alkylating Agents|alkylating agents|mesh-ancestor
65056819|NCT00414128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056820|NCT00414128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056821|NCT00414128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65056822|NCT00414128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65056857|NCT00237653|Antiviral Agents|antiviral agents|mesh-ancestor
65056858|NCT00237653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65056859|NCT00269958|Epoetin Alfa|epoetin alfa|mesh-list
65056860|NCT00269958|Hematinics|hematinics|mesh-ancestor
65056861|NCT02215876|Cyclophosphamide|cyclophosphamide|mesh-list
65056862|NCT02215876|Doxorubicin|doxorubicin|mesh-list
65056863|NCT02215876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65056864|NCT02215876|Immunologic Factors|immunologic factors|mesh-ancestor
65056896|NCT04537780|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65056897|NCT04537780|Hormone Antagonists|hormone antagonists|mesh-ancestor
64930865|NCT00054340|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65056898|NCT04537780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65056899|NCT04537780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056900|NCT04537780|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65056901|NCT04537780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65056902|NCT04537780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056903|NCT00237887|Adalimumab|adalimumab|mesh-list
64565154|NCT02197455|Tofacitinib|tofacitinib|mesh-list
65056904|NCT00237887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65056905|NCT00237887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65056938|NCT00262548|Antimetabolites|antimetabolites|mesh-ancestor
65056939|NCT00262548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056940|NCT00262548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65056941|NCT00262548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65056942|NCT00262548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056943|NCT00238043|Epoetin Alfa|epoetin alfa|mesh-list
65056944|NCT00238043|Hematinics|hematinics|mesh-ancestor
65056945|NCT00415584|Cinacalcet|cinacalcet|mesh-list
65056946|NCT00415584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65056947|NCT00415584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056948|NCT00415584|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65056977|NCT00238082|Respiratory System Agents|respiratory system agents|mesh-ancestor
65056979|NCT00238082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65056980|NCT04536961|BMS-986165|bms-986165|mesh-list
65056981|NCT04536961|Famotidine|famotidine|mesh-list
65056982|NCT04536961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65056983|NCT04536961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65056984|NCT04536961|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65056985|NCT04536961|Histamine Antagonists|histamine antagonists|mesh-ancestor
65056986|NCT04536961|Histamine Agents|histamine agents|mesh-ancestor
65056987|NCT04536961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65056988|NCT04536961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056989|NCT04536961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056990|NCT04536961|Dermatologic Agents|dermatologic agents|mesh-ancestor
65056991|NCT04536961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65056992|NCT04536961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056993|NCT00238160|Fluorouracil|fluorouracil|mesh-list
65056994|NCT00238160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057019|NCT02961998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057020|NCT02961998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65057021|NCT02961998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65057022|NCT02961998|Analgesics|analgesics|mesh-ancestor
65057023|NCT02961998|Sensory System Agents|sensory system agents|mesh-ancestor
65057024|NCT02961998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65057025|NCT02961998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057026|NCT02961998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65057027|NCT02961998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65057028|NCT02961998|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65057029|NCT02961998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65057030|NCT04536415|Oseltamivir|oseltamivir|mesh-list
65057031|NCT04536415|Antiviral Agents|antiviral agents|mesh-ancestor
65057032|NCT04536415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65057033|NCT04536415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057034|NCT04536415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057035|NCT00262587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65057036|NCT00262587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65057037|NCT00262587|Autonomic Agents|autonomic agents|mesh-ancestor
65057038|NCT00262587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65057039|NCT00262587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057040|NCT00262587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65057041|NCT00262587|Respiratory System Agents|respiratory system agents|mesh-ancestor
65057042|NCT00262587|Glucocorticoids|glucocorticoids|mesh-ancestor
65057044|NCT00262587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65057075|NCT04536493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65057076|NCT04536493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057077|NCT04536493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65057078|NCT04536493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65057079|NCT04536493|Adrenergic Agents|adrenergic agents|mesh-ancestor
65057080|NCT04536493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65057081|NCT04536493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65057082|NCT04536493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65057083|NCT04536493|Autonomic Agents|autonomic agents|mesh-ancestor
65057084|NCT04536493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65057085|NCT04536493|Respiratory System Agents|respiratory system agents|mesh-ancestor
65057086|NCT04536493|Mydriatics|mydriatics|mesh-ancestor
65057087|NCT04536493|Sympathomimetics|sympathomimetics|mesh-ancestor
65057088|NCT04536493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65057090|NCT04536181|Prednisolone|prednisolone|mesh-list
65057124|NCT00238277|Alkylating Agents|alkylating agents|mesh-ancestor
65248449|NCT02548117|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65057125|NCT00238277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057126|NCT00238277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057127|NCT02216266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65057128|NCT02216266|Physostigmine|physostigmine|mesh-list
65057129|NCT02216266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65057130|NCT02216266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057131|NCT02216266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057132|NCT02216266|Cholinergic Agents|cholinergic agents|mesh-ancestor
65057133|NCT02216266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65057163|NCT04535518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65057164|NCT04535518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057165|NCT04535518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65057166|NCT04535518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65057167|NCT04535518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057168|NCT04535518|Antipyretics|antipyretics|mesh-ancestor
65057169|NCT04535518|Immunologic Factors|immunologic factors|mesh-ancestor
65057170|NCT04535518|Dermatologic Agents|dermatologic agents|mesh-ancestor
65057171|NCT04535518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65057172|NCT02216383|Oxytocin|oxytocin|mesh-list
65057173|NCT02216383|Carbetocin|carbetocin|mesh-list
65057174|NCT02216383|Syntometrine|syntometrine|mesh-list
65057175|NCT02216383|Ergonovine|ergonovine|mesh-list
65057176|NCT02216383|Oxytocics|oxytocics|mesh-ancestor
65057177|NCT02216383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65057178|NCT02216383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057179|NCT00262782|Fludarabine|fludarabine|mesh-list
64909121|NCT04862221|Hormones|hormones|mesh-ancestor
65057205|NCT00262977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65057206|NCT00262977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057207|NCT00262977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65057208|NCT00262977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65057209|NCT00262977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65057210|NCT00262977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65057211|NCT00262977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057212|NCT00262977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65057213|NCT00262977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65057214|NCT00262977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057215|NCT00262977|Antipyretics|antipyretics|mesh-ancestor
65057216|NCT00238667|Aspirin|aspirin|mesh-list
65057217|NCT00238667|Heparin|heparin|mesh-list
65057218|NCT00238667|Calcium heparin|calcium heparin|mesh-list
65057219|NCT00238667|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65057220|NCT00238667|Dalteparin|dalteparin|mesh-list
65057221|NCT00238667|Dipyridamole|dipyridamole|mesh-list
65057222|NCT00238667|Warfarin|warfarin|mesh-list
65057223|NCT00238667|Anticoagulants|anticoagulants|mesh-list
65057224|NCT00238667|Clopidogrel|clopidogrel|mesh-list
65057225|NCT00238667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65057226|NCT00238667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65057227|NCT00238667|Analgesics|analgesics|mesh-ancestor
65057228|NCT00238667|Sensory System Agents|sensory system agents|mesh-ancestor
65057229|NCT00238667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65057230|NCT00238667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057251|NCT00263016|Mitosis Modulators|mitosis modulators|mesh-ancestor
65057252|NCT00263016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057253|NCT04534465|Mannitol|mannitol|mesh-list
65057254|NCT04534465|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65057255|NCT04534465|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65057256|NCT04534465|Diuretics|diuretics|mesh-ancestor
65057257|NCT04534465|Natriuretic Agents|natriuretic agents|mesh-ancestor
64498610|NCT01850615|Insulin|insulin|mesh-list
65057258|NCT04534465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057259|NCT04534465|Laxatives|laxatives|mesh-ancestor
65057260|NCT04534465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65057261|NCT02216656|Cinacalcet|cinacalcet|mesh-list
65057262|NCT02216656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65057263|NCT02216656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057264|NCT02216656|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65057265|NCT02216656|Hormone Antagonists|hormone antagonists|mesh-ancestor
65057266|NCT02216656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65057267|NCT00263055|Oxaliplatin|oxaliplatin|mesh-list
65057268|NCT00263055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057269|NCT00238745|Bazedoxifene|bazedoxifene|mesh-list
65057270|NCT00238745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65057271|NCT00238745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65057272|NCT00238745|Hormone Antagonists|hormone antagonists|mesh-ancestor
65057273|NCT00238745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65057274|NCT00238745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057275|NCT00238745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65057277|NCT04534231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65057278|NCT04534231|Autonomic Agents|autonomic agents|mesh-ancestor
65057279|NCT04534231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65057280|NCT04534231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057281|NCT04534231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65057282|NCT04534231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65057283|NCT04534231|Cholinergic Agents|cholinergic agents|mesh-ancestor
64909213|NCT00390091|Immunologic Factors|immunologic factors|mesh-ancestor
65057305|NCT00238784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057306|NCT00238784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65057307|NCT00238784|Respiratory System Agents|respiratory system agents|mesh-ancestor
65057308|NCT00238784|Glucocorticoids|glucocorticoids|mesh-ancestor
65057310|NCT00238784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65057311|NCT00238784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65057312|NCT00238784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65057313|NCT00238784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65057314|NCT00238784|Adrenergic Agents|adrenergic agents|mesh-ancestor
65057315|NCT00238784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65057316|NCT00238784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057317|NCT00263133|Sertraline|sertraline|mesh-list
65057318|NCT00263133|Antidepressive Agents|antidepressive agents|mesh-ancestor
65057319|NCT00263133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65057320|NCT00263133|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65057321|NCT00263133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65057322|NCT00263133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65057323|NCT00263133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057324|NCT00263133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65057325|NCT00263133|Serotonin Agents|serotonin agents|mesh-ancestor
65057326|NCT00263133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057327|NCT04533724|Amisulpride|amisulpride|mesh-list
65057328|NCT04533724|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65057329|NCT04533724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64542571|NCT03594565|Xhance|xhance|mesh-list
65057330|NCT04533724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65057331|NCT04533724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057332|NCT04533724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65057333|NCT04533724|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65057362|NCT00239018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65057363|NCT00239018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057364|NCT00239018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65057365|NCT00239018|Antitubercular Agents|antitubercular agents|mesh-ancestor
65057366|NCT00239018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65057367|NCT00239018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65057368|NCT00239018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057369|NCT00239018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057370|NCT04532671|Ether|ether|mesh-list
65057371|NCT04532671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65057372|NCT04532671|Anesthetics, General|anesthetics, general|mesh-ancestor
65057373|NCT04532671|Anesthetics|anesthetics|mesh-ancestor
65057374|NCT04532671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65057375|NCT04532671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057376|NCT00239057|Mycophenolic Acid|mycophenolic acid|mesh-list
65057377|NCT00239057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65057378|NCT00239057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057379|NCT00239057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65057399|NCT04532554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65057400|NCT04532554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057401|NCT04532281|Carbamide Peroxide|carbamide peroxide|mesh-list
64542647|NCT03976375|Docetaxel|docetaxel|mesh-list
65057402|NCT04532281|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65057403|NCT04532281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65057404|NCT02217163|Dexamethasone|dexamethasone|mesh-list
65057405|NCT02217163|Cyclophosphamide|cyclophosphamide|mesh-list
65057406|NCT02217163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65057407|NCT02217163|Immunologic Factors|immunologic factors|mesh-ancestor
65057408|NCT02217163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057409|NCT02217163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65057410|NCT02217163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65057411|NCT02217163|Alkylating Agents|alkylating agents|mesh-ancestor
65057412|NCT02217163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057413|NCT02217163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472831|NCT02648477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057414|NCT02217163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65057415|NCT02217163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65057416|NCT02217163|Antiemetics|antiemetics|mesh-ancestor
65057417|NCT02217163|Autonomic Agents|autonomic agents|mesh-ancestor
65057418|NCT02217163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65243441|NCT00694863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057419|NCT02217163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65057420|NCT02217163|Glucocorticoids|glucocorticoids|mesh-ancestor
65057421|NCT02217163|Hormones|hormones|mesh-ancestor
65057422|NCT02217163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65057423|NCT02217163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65057424|NCT02217202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65057425|NCT02217202|Laxatives|laxatives|mesh-ancestor
65057426|NCT02217202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65057427|NCT00239174|Surinabant|surinabant|mesh-list
65057428|NCT00239174|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65057429|NCT00239174|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65057430|NCT00239174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64909363|NCT00390247|Leprostatic Agents|leprostatic agents|mesh-ancestor
65057452|NCT04531267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057454|NCT04531228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057455|NCT04531228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65057456|NCT04531228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057457|NCT04531228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057458|NCT04531072|Ritonavir|ritonavir|mesh-list
65057459|NCT04531072|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65057460|NCT04531072|Lumefantrine|lumefantrine|mesh-list
65057461|NCT04531072|Artemether|artemether|mesh-list
65057462|NCT04531072|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65057463|NCT04531072|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65057464|NCT04531072|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65057465|NCT04531072|Protease Inhibitors|protease inhibitors|mesh-ancestor
65057466|NCT04531072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057467|NCT04531072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057468|NCT04531072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65057469|NCT04531072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65057470|NCT04531072|Antiviral Agents|antiviral agents|mesh-ancestor
65057471|NCT04531072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65057472|NCT04531072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65057473|NCT04531072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65057474|NCT04531072|Antimalarials|antimalarials|mesh-ancestor
65057475|NCT04531072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65057477|NCT00414323|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65057478|NCT00414323|Citalopram|citalopram|mesh-list
65057479|NCT00414323|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65057480|NCT00414323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65057481|NCT00414323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64909419|NCT00390403|Acetic Acid|acetic acid|mesh-list
65057516|NCT00263484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65057517|NCT00263484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65057518|NCT00263484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65057519|NCT00263484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65057520|NCT00263484|Growth Substances|growth substances|mesh-ancestor
65057521|NCT00263484|Growth Inhibitors|growth inhibitors|mesh-ancestor
65057522|NCT00263484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65057549|NCT02217553|Vitamins|vitamins|mesh-ancestor
65057550|NCT02217553|Micronutrients|micronutrients|mesh-ancestor
65057551|NCT02217553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65057553|NCT02217631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65057554|NCT02217631|Methylprednisolone|methylprednisolone|mesh-list
65057555|NCT02217631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65057556|NCT02217631|Prednisolone acetate|prednisolone acetate|mesh-list
65057557|NCT02217631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65057558|NCT02217631|Prednisolone phosphate|prednisolone phosphate|mesh-list
65057559|NCT02217631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65057560|NCT02217631|Glucocorticoids|glucocorticoids|mesh-ancestor
65057561|NCT02217631|Hormones|hormones|mesh-ancestor
65057562|NCT02217631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65057563|NCT02217631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057564|NCT02217631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65057565|NCT02217631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057566|NCT02217631|Antiemetics|antiemetics|mesh-ancestor
65057567|NCT02217631|Autonomic Agents|autonomic agents|mesh-ancestor
64472832|NCT02648477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65057568|NCT02217631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65057569|NCT02217631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65057570|NCT02217631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65057571|NCT02217631|Protective Agents|protective agents|mesh-ancestor
65057572|NCT02217670|Metformin|metformin|mesh-list
65057573|NCT02217670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65057601|NCT00239369|Telmisartan|telmisartan|mesh-list
65057602|NCT00239369|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65057603|NCT00239369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65057604|NCT00239369|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65057605|NCT00239369|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65057606|NCT00239369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057607|NCT00239369|Diuretics|diuretics|mesh-ancestor
65057608|NCT00239369|Natriuretic Agents|natriuretic agents|mesh-ancestor
65057609|NCT00239369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057610|NCT00239369|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65057611|NCT00239369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65057612|NCT04529668|Vitamin D|vitamin d|mesh-list
65057613|NCT04529668|Vitamins|vitamins|mesh-ancestor
65057614|NCT04529668|Micronutrients|micronutrients|mesh-ancestor
65057615|NCT04529668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057616|NCT04529668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65057617|NCT00239408|Bromides|bromides|mesh-list
65057618|NCT00239408|Tiotropium Bromide|tiotropium bromide|mesh-list
65057619|NCT00239408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65057620|NCT00239408|Autonomic Agents|autonomic agents|mesh-ancestor
65057628|NCT00239408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65057629|NCT00239408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057630|NCT00239408|Anticonvulsants|anticonvulsants|mesh-ancestor
65057631|NCT02218177|Ranibizumab|ranibizumab|mesh-list
65057632|NCT02218177|Aflibercept|aflibercept|mesh-list
65057633|NCT02218177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65057634|NCT02218177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65057635|NCT02218177|Growth Substances|growth substances|mesh-ancestor
65057636|NCT02218177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057637|NCT02218177|Growth Inhibitors|growth inhibitors|mesh-ancestor
65057638|NCT02218177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057639|NCT00263718|Betamethasone|betamethasone|mesh-list
65057640|NCT00263718|Betamethasone Valerate|betamethasone valerate|mesh-list
65057641|NCT00263718|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65057642|NCT00263718|Betamethasone benzoate|betamethasone benzoate|mesh-list
65243442|NCT00629213|Acarbose|acarbose|mesh-list
65057643|NCT00263718|Calcipotriene|calcipotriene|mesh-list
65057644|NCT00263718|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65057645|NCT00263718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65057646|NCT00263718|Glucocorticoids|glucocorticoids|mesh-ancestor
65057647|NCT00263718|Hormones|hormones|mesh-ancestor
65057648|NCT00263718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65057649|NCT00263718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057650|NCT00263718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65057651|NCT00263718|Respiratory System Agents|respiratory system agents|mesh-ancestor
65057652|NCT00263718|Dermatologic Agents|dermatologic agents|mesh-ancestor
65057653|NCT02218645|Brotizolam|brotizolam|mesh-list
65057654|NCT02218645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65057655|NCT02218645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65057656|NCT02218645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057657|NCT02218684|Telmisartan|telmisartan|mesh-list
65057658|NCT02218684|Lacidipine|lacidipine|mesh-list
65057659|NCT02218684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65057660|NCT02218684|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65057661|NCT02218684|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65057662|NCT02218684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057663|NCT02218684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65057664|NCT02218684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65057665|NCT02218684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65057666|NCT02218684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057667|NCT02278861|Tretinoin|tretinoin|mesh-list
65057668|NCT02278861|Isotretinoin|isotretinoin|mesh-list
65057669|NCT02278861|Sunscreening Agents|sunscreening agents|mesh-list
65057670|NCT02278861|Dermatologic Agents|dermatologic agents|mesh-ancestor
65057671|NCT02278861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057672|NCT02278861|Keratolytic Agents|keratolytic agents|mesh-ancestor
65057673|NCT02278861|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65057674|NCT02278861|Protective Agents|protective agents|mesh-ancestor
65057675|NCT02278861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057676|NCT01642030|Buprenorphine|buprenorphine|mesh-list
65057677|NCT01642030|Hydromorphone|hydromorphone|mesh-list
65057678|NCT01642030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65057679|NCT01642030|Narcotics|narcotics|mesh-ancestor
65057680|NCT01642030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65057681|NCT01642030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057682|NCT01642030|Analgesics|analgesics|mesh-ancestor
65057683|NCT01642030|Sensory System Agents|sensory system agents|mesh-ancestor
65057684|NCT01642030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65057685|NCT01642030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65057717|NCT00250185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057718|NCT00250185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057720|NCT00239486|Antioxidants|antioxidants|mesh-ancestor
65057721|NCT00239486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057722|NCT00239486|Protective Agents|protective agents|mesh-ancestor
65057723|NCT00239486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057724|NCT00239486|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65057790|NCT01644838|Scopolamine|scopolamine|mesh-list
65243444|NCT00629213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057791|NCT01644838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65057792|NCT01644838|Antiemetics|antiemetics|mesh-ancestor
65057793|NCT01644838|Autonomic Agents|autonomic agents|mesh-ancestor
65057794|NCT01644838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65057795|NCT01644838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057796|NCT01644838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65057797|NCT01644838|Mydriatics|mydriatics|mesh-ancestor
65057798|NCT01644838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65057799|NCT01644838|Cholinergic Agents|cholinergic agents|mesh-ancestor
65057800|NCT01644838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65057801|NCT01644838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057802|NCT01644838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65057803|NCT01644838|Antipruritics|antipruritics|mesh-ancestor
65057804|NCT01644838|Dermatologic Agents|dermatologic agents|mesh-ancestor
65057805|NCT01644838|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64909764|NCT00000792|Hypericin|hypericin|mesh-list
65057839|NCT04528888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65057840|NCT04528888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057841|NCT01645384|Atorvastatin|atorvastatin|mesh-list
65057842|NCT01645384|Calcium|calcium|mesh-list
65057843|NCT01645384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65057844|NCT01645384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057845|NCT01645384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65057846|NCT01645384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65057847|NCT01645384|Antimetabolites|antimetabolites|mesh-ancestor
65057848|NCT01645384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909805|NCT03877549|Hormones|hormones|mesh-ancestor
65057877|NCT01645774|Autonomic Agents|autonomic agents|mesh-ancestor
65057878|NCT01645774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65057879|NCT01645774|Nasal Decongestants|nasal decongestants|mesh-ancestor
65057880|NCT01645774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65057881|NCT01645774|Respiratory System Agents|respiratory system agents|mesh-ancestor
65057882|NCT00239876|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65057883|NCT00239876|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65057884|NCT00239876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057885|NCT00239876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65057886|NCT00239876|Immunologic Factors|immunologic factors|mesh-ancestor
65057887|NCT00239876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057888|NCT02961075|Anesthetics|anesthetics|mesh-list
65057889|NCT02961075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65057924|NCT00239954|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65057925|NCT00239954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65057926|NCT00239954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65057927|NCT00239954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057928|NCT00239954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65057929|NCT00239954|Serotonin Agents|serotonin agents|mesh-ancestor
65057957|NCT00239993|(T,G)-A-L|(t,g)-a-l|mesh-list
65057958|NCT00239993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65057959|NCT00239993|Immunologic Factors|immunologic factors|mesh-ancestor
65057960|NCT00239993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057961|NCT00239993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65057962|NCT00239993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65057963|NCT00264108|Epoetin Alfa|epoetin alfa|mesh-list
65057964|NCT00264108|Darbepoetin alfa|darbepoetin alfa|mesh-list
65057965|NCT00264108|Hematinics|hematinics|mesh-ancestor
65057966|NCT01647412|Curcumin|curcumin|mesh-list
65057967|NCT01647412|Hormones|hormones|mesh-list
65057968|NCT01647412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65057969|NCT01647412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057970|NCT01647412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65057971|NCT01647412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65057972|NCT01647412|Analgesics|analgesics|mesh-ancestor
65057973|NCT01647412|Sensory System Agents|sensory system agents|mesh-ancestor
65057974|NCT01647412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65057975|NCT01647412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65057976|NCT01647412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65057977|NCT01647412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057978|NCT01647412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057979|NCT01647412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058015|NCT01647646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65058017|NCT01647685|Methylprednisolone|methylprednisolone|mesh-list
65058018|NCT01647685|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65058019|NCT01647685|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65058042|NCT00240266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65058043|NCT00240266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65058044|NCT00240266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058045|NCT01648036|Heparin|heparin|mesh-list
65058046|NCT01648036|Calcium heparin|calcium heparin|mesh-list
65058047|NCT01648036|Dalteparin|dalteparin|mesh-list
65058048|NCT01648036|Tinzaparin|tinzaparin|mesh-list
65058049|NCT01648036|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65058050|NCT01648036|Anticoagulants|anticoagulants|mesh-ancestor
65058051|NCT01648036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65058052|NCT01648036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65058053|NCT01648036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058054|NCT00240305|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65058055|NCT00240305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65058056|NCT00240305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65058057|NCT00240305|Antimetabolites|antimetabolites|mesh-ancestor
65058058|NCT00240305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058059|NCT00240305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65058060|NCT00240305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65058061|NCT00240305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058062|NCT01648231|Losartan|losartan|mesh-list
65058063|NCT01648231|Amlodipine|amlodipine|mesh-list
65058064|NCT01648231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65058065|NCT01648231|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65058066|NCT01648231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65058067|NCT01648231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058068|NCT01648231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65058069|NCT01648231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058070|NCT01648231|Vasodilator Agents|vasodilator agents|mesh-ancestor
64910031|NCT00390871|Fentanyl|fentanyl|mesh-list
65058107|NCT00264225|Antitussive Agents|antitussive agents|mesh-ancestor
65058132|NCT01649245|Interferons|interferons|mesh-list
65058133|NCT01649245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058134|NCT01649245|Antiviral Agents|antiviral agents|mesh-ancestor
65058135|NCT01649245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65058136|NCT01649284|Afatinib|afatinib|mesh-list
65058137|NCT01649284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058138|NCT01649284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65058139|NCT01649284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058140|NCT01649284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058141|NCT00415740|Levodopa|levodopa|mesh-list
65058142|NCT00415740|Carbidopa|carbidopa|mesh-list
65058143|NCT00415740|Entacapone|entacapone|mesh-list
65058144|NCT00415740|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65058145|NCT00415740|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65058146|NCT00415740|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65058147|NCT00415740|Dopamine Agents|dopamine agents|mesh-ancestor
64543438|NCT04026685|Phenylephrine|phenylephrine|mesh-list
65058148|NCT00415740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65058149|NCT00415740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058150|NCT00415740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058151|NCT00415740|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65058152|NCT00415740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058153|NCT00415740|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65058154|NCT00415740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65058155|NCT00415740|Immunologic Factors|immunologic factors|mesh-ancestor
65058156|NCT00415740|Dopamine Agonists|dopamine agonists|mesh-ancestor
65058157|NCT01649479|Antibodies|antibodies|mesh-list
64910112|NCT00000891|Antiviral Agents|antiviral agents|mesh-ancestor
65058183|NCT00250536|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
65058184|NCT00250536|Androgens|androgens|mesh-ancestor
65058185|NCT00250536|Hormones|hormones|mesh-ancestor
65058186|NCT00250536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65058187|NCT00250536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058188|NCT00250536|Anabolic Agents|anabolic agents|mesh-ancestor
65058189|NCT00250536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65058190|NCT00240617|Naproxen|naproxen|mesh-list
65058191|NCT00240617|Sumatriptan|sumatriptan|mesh-list
65058192|NCT00240617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65058193|NCT00240617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65058194|NCT00240617|Analgesics|analgesics|mesh-ancestor
65058195|NCT00240617|Sensory System Agents|sensory system agents|mesh-ancestor
65058196|NCT00240617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058197|NCT00240617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058198|NCT00240617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65058199|NCT00240617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65058200|NCT00240617|Gout Suppressants|gout suppressants|mesh-ancestor
65058201|NCT00240617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65058202|NCT00240617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058203|NCT00240617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058204|NCT00240617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65058205|NCT00240617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65058206|NCT00240617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65058207|NCT00240617|Serotonin Agents|serotonin agents|mesh-ancestor
65058232|NCT00240656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65058233|NCT00240656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65058234|NCT00240656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65058236|NCT00240656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65058237|NCT00240656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65058238|NCT00240656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65058239|NCT00240656|Protease Inhibitors|protease inhibitors|mesh-ancestor
65058240|NCT00240656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058241|NCT00250575|Clozapine|clozapine|mesh-list
65058242|NCT00250575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65058243|NCT00250575|Serotonin Agents|serotonin agents|mesh-ancestor
65058244|NCT00250575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65058245|NCT00250575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058246|NCT00250575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058247|NCT00250575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65058248|NCT00250575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65058249|NCT00250575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65058250|NCT00250575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65058251|NCT00250575|GABA Antagonists|gaba antagonists|mesh-ancestor
65058252|NCT00250575|GABA Agents|gaba agents|mesh-ancestor
65058253|NCT00240695|Galantamine|galantamine|mesh-list
65058254|NCT00240695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65058255|NCT00240695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058287|NCT00240773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058288|NCT00240773|Antipyretics|antipyretics|mesh-ancestor
65058289|NCT00240773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65058290|NCT00240773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65058291|NCT00240773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65058292|NCT00240773|Gout Suppressants|gout suppressants|mesh-ancestor
65058293|NCT00240773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65058294|NCT00240773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058295|NCT00240773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058296|NCT01688401|Melphalan|melphalan|mesh-list
65058297|NCT01688401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65058325|NCT04708821|Sensory System Agents|sensory system agents|mesh-ancestor
65058326|NCT04708821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65058327|NCT04708821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65058328|NCT04708821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65058329|NCT04708821|Histamine Antagonists|histamine antagonists|mesh-ancestor
65058331|NCT04708821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65058332|NCT04708821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058333|NCT00240812|Ibuprofen|ibuprofen|mesh-list
65058334|NCT00240812|Pseudoephedrine|pseudoephedrine|mesh-list
65058335|NCT00240812|Ephedrine|ephedrine|mesh-list
65058336|NCT00240812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65058337|NCT00240812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65058338|NCT00240812|Analgesics|analgesics|mesh-ancestor
65058339|NCT00240812|Sensory System Agents|sensory system agents|mesh-ancestor
65058340|NCT00240812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058341|NCT00240812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058342|NCT00240812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65058343|NCT00240812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65058374|NCT00240851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058375|NCT00240851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058376|NCT00240851|Antipyretics|antipyretics|mesh-ancestor
65058377|NCT00240929|Palivizumab|palivizumab|mesh-list
65058378|NCT00240929|Antiviral Agents|antiviral agents|mesh-ancestor
65058379|NCT00240929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65058380|NCT00250692|Nitrous Oxide|nitrous oxide|mesh-list
65058381|NCT00250692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65058382|NCT00250692|Anesthetics, General|anesthetics, general|mesh-ancestor
65058383|NCT00250692|Anesthetics|anesthetics|mesh-ancestor
65058384|NCT00250692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65058385|NCT00250692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058386|NCT00250692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65058387|NCT00250692|Analgesics|analgesics|mesh-ancestor
65058420|NCT00241007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058421|NCT00241007|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65058422|NCT00241007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65058424|NCT01689142|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65058425|NCT01689142|Insulin Glargine|insulin glargine|mesh-list
65058426|NCT01689142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65058427|NCT01689142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058456|NCT00241085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65058457|NCT00241085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058458|NCT02271919|Nicotine|nicotine|mesh-list
65058459|NCT02271919|Varenicline|varenicline|mesh-list
65058460|NCT02271919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65058461|NCT02271919|Autonomic Agents|autonomic agents|mesh-ancestor
65494069|NCT03743636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058462|NCT02271919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058463|NCT02271919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058464|NCT02271919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65058465|NCT02271919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65058466|NCT02271919|Cholinergic Agents|cholinergic agents|mesh-ancestor
65058467|NCT02271919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65058468|NCT02271919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058470|NCT00241124|Lisinopril|lisinopril|mesh-list
65058471|NCT00241124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64910434|NCT01889992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058503|NCT02279602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058504|NCT02279602|Tubulin Modulators|tubulin modulators|mesh-ancestor
65058505|NCT02279602|Antimitotic Agents|antimitotic agents|mesh-ancestor
65058506|NCT02279602|Mitosis Modulators|mitosis modulators|mesh-ancestor
65058507|NCT02279602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058508|NCT00241436|Anastrozole|anastrozole|mesh-list
65058509|NCT00241436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65058510|NCT00241436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058511|NCT00241436|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65058512|NCT00241436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65058513|NCT00241436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058514|NCT00241436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910490|NCT00001014|Antimetabolites|antimetabolites|mesh-ancestor
65058545|NCT02218762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65058546|NCT02218762|Autonomic Agents|autonomic agents|mesh-ancestor
65058547|NCT02218762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058548|NCT02218762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058549|NCT02218762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65058550|NCT02218762|Respiratory System Agents|respiratory system agents|mesh-ancestor
65058551|NCT02218762|Dermatologic Agents|dermatologic agents|mesh-ancestor
65058552|NCT02218762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65058553|NCT02218762|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65058554|NCT02218762|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65058555|NCT02218762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65058587|NCT02219152|Coagulants|coagulants|mesh-ancestor
65058588|NCT00264615|Lamotrigine|lamotrigine|mesh-list
65058589|NCT00264615|Anticonvulsants|anticonvulsants|mesh-ancestor
65058590|NCT00264615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65058591|NCT00264615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65058592|NCT00264615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058593|NCT00264615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65058594|NCT00264615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058596|NCT00264615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65058597|NCT00264615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65058626|NCT04720131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058627|NCT04720131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058628|NCT04720131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65058629|NCT04720131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058630|NCT00241670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65058631|NCT00241670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65058632|NCT00241670|Dermatologic Agents|dermatologic agents|mesh-ancestor
65058634|NCT02219737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65058635|NCT02219737|Carboplatin|carboplatin|mesh-list
65058636|NCT02219737|Etoposide|etoposide|mesh-list
65058637|NCT02219737|Etoposide phosphate|etoposide phosphate|mesh-list
65058638|NCT02219737|Ifosfamide|ifosfamide|mesh-list
65058639|NCT02219737|Isophosphamide mustard|isophosphamide mustard|mesh-list
65058640|NCT02219737|Podophyllotoxin|podophyllotoxin|mesh-list
65058641|NCT02219737|Antibodies|antibodies|mesh-list
65058642|NCT02219737|Immunoglobulins|immunoglobulins|mesh-list
65058643|NCT02219737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65058644|NCT02219737|Immunologic Factors|immunologic factors|mesh-ancestor
65058645|NCT02219737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058680|NCT02210806|Albuterol|albuterol|mesh-list
65058681|NCT02210806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65058682|NCT02210806|Autonomic Agents|autonomic agents|mesh-ancestor
65058683|NCT02210806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058684|NCT02210806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058685|NCT02210806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64932668|NCT00067093|Hemostatics|hemostatics|mesh-ancestor
65058717|NCT02219659|Anesthetics|anesthetics|mesh-ancestor
65058718|NCT02219659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65058719|NCT02219659|Narcotics|narcotics|mesh-ancestor
65058720|NCT02219659|Analgesics|analgesics|mesh-ancestor
65058721|NCT02219659|Sensory System Agents|sensory system agents|mesh-ancestor
65058722|NCT02219659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058723|NCT02219659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65058724|NCT02219659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65058725|NCT02219659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65058726|NCT02219659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65058727|NCT02219659|GABA Modulators|gaba modulators|mesh-ancestor
65058749|NCT00241982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058750|NCT02212015|Paclitaxel|paclitaxel|mesh-list
65058751|NCT02212015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65058752|NCT02212015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058753|NCT02212015|Tubulin Modulators|tubulin modulators|mesh-ancestor
65058754|NCT02212015|Antimitotic Agents|antimitotic agents|mesh-ancestor
65058755|NCT02212015|Mitosis Modulators|mitosis modulators|mesh-ancestor
65058756|NCT02212015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058757|NCT04720859|Canagliflozin|canagliflozin|mesh-list
65494071|NCT03743636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65058758|NCT04720859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65058759|NCT04720859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058760|NCT04720859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65058761|NCT04720859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058762|NCT02279134|Paclitaxel|paclitaxel|mesh-list
65058763|NCT02279134|Nedaplatin|nedaplatin|mesh-list
65058764|NCT02279134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65058765|NCT02279134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058766|NCT02279134|Tubulin Modulators|tubulin modulators|mesh-ancestor
65058767|NCT02279134|Antimitotic Agents|antimitotic agents|mesh-ancestor
65058768|NCT02279134|Mitosis Modulators|mitosis modulators|mesh-ancestor
65058769|NCT02279134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058770|NCT02961842|Ephedrine|ephedrine|mesh-list
65058771|NCT02961842|Fentanyl|fentanyl|mesh-list
65058772|NCT02961842|Bupivacaine|bupivacaine|mesh-list
65058773|NCT02961842|Anesthetics, Local|anesthetics, local|mesh-ancestor
65058774|NCT02961842|Anesthetics|anesthetics|mesh-ancestor
65058775|NCT02961842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65058800|NCT00272805|Antioxidants|antioxidants|mesh-ancestor
65058801|NCT00272805|Protective Agents|protective agents|mesh-ancestor
65058802|NCT00272805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65058803|NCT00272805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65058804|NCT00272805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65058805|NCT00272805|Vasodilator Agents|vasodilator agents|mesh-ancestor
65058806|NCT00272805|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65058807|NCT00272805|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65058808|NCT00242177|Pioglitazone|pioglitazone|mesh-list
65058809|NCT00242177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65058810|NCT00242177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058811|NCT00264927|Satavaptan|satavaptan|mesh-list
65058812|NCT00264927|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65058813|NCT00264927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544117|NCT04022941|Sodium Benzoate|sodium benzoate|mesh-list
65058814|NCT00264927|Natriuretic Agents|natriuretic agents|mesh-ancestor
65058815|NCT00264927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058817|NCT00242372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65058818|NCT00242372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058819|NCT00265005|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65058820|NCT00265005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65058821|NCT00265005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65058822|NCT00265005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058823|NCT00242411|Budesonide|budesonide|mesh-list
65058824|NCT00242411|Formoterol Fumarate|formoterol fumarate|mesh-list
65058850|NCT00282399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058851|NCT00282399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058852|NCT00282399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058853|NCT00242450|Metoclopramide|metoclopramide|mesh-list
65058854|NCT00242450|Antiemetics|antiemetics|mesh-ancestor
65058855|NCT00242450|Autonomic Agents|autonomic agents|mesh-ancestor
65058856|NCT00242450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058857|NCT00242450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058858|NCT00242450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65058859|NCT00242450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65058860|NCT00242450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65058861|NCT00242450|Dopamine Agents|dopamine agents|mesh-ancestor
65058862|NCT00242450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65058863|NCT00242450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058864|NCT00273039|Paroxetine|paroxetine|mesh-list
65058865|NCT00273039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65058866|NCT00273039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65058867|NCT00273039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65058868|NCT00273039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058869|NCT00273039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65058870|NCT00273039|Serotonin Agents|serotonin agents|mesh-ancestor
65058871|NCT00273039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058894|NCT00242606|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65058895|NCT00242762|Docetaxel|docetaxel|mesh-list
65058896|NCT00242762|Gefitinib|gefitinib|mesh-list
65058897|NCT00242762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058898|NCT00242762|Tubulin Modulators|tubulin modulators|mesh-ancestor
65058899|NCT00242762|Antimitotic Agents|antimitotic agents|mesh-ancestor
65058900|NCT00242762|Mitosis Modulators|mitosis modulators|mesh-ancestor
65058901|NCT00242762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058902|NCT00242762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65058903|NCT00242762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058904|NCT00242801|Gefitinib|gefitinib|mesh-list
65058905|NCT00242801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058906|NCT00242801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65058907|NCT00242801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058908|NCT00242801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058909|NCT00242879|Ritonavir|ritonavir|mesh-list
65058910|NCT00242879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65058911|NCT00242879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65058912|NCT00242879|Protease Inhibitors|protease inhibitors|mesh-ancestor
65058913|NCT00242879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058914|NCT00242879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058915|NCT00242879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65058916|NCT00242879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65058917|NCT00242879|Antiviral Agents|antiviral agents|mesh-ancestor
65058918|NCT00242879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65058919|NCT00242879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65058920|NCT00242879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65058921|NCT00282594|Insulin|insulin|mesh-list
64910897|NCT00009217|Haloperidol|haloperidol|mesh-list
65058939|NCT00242996|Cyclophosphamide|cyclophosphamide|mesh-list
65058941|NCT00242996|Rituximab|rituximab|mesh-list
65058942|NCT00242996|Etoposide|etoposide|mesh-list
65058943|NCT00242996|Sargramostim|sargramostim|mesh-list
65058944|NCT00242996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65058945|NCT00242996|Immunologic Factors|immunologic factors|mesh-ancestor
65058946|NCT00242996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058947|NCT00242996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65058948|NCT00242996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65058949|NCT00242996|Alkylating Agents|alkylating agents|mesh-ancestor
65058950|NCT00242996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058951|NCT00242996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058952|NCT00242996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65058953|NCT00242996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65058954|NCT00242996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65058955|NCT00242996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65058956|NCT00242996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65058957|NCT00242996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058958|NCT00273390|Infliximab|infliximab|mesh-list
65058959|NCT00273390|Dermatologic Agents|dermatologic agents|mesh-ancestor
65058960|NCT00273390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65058961|NCT00273390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65058962|NCT00243035|Bortezomib|bortezomib|mesh-list
65058963|NCT00243035|Tipifarnib|tipifarnib|mesh-list
65058964|NCT00243035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058965|NCT00243113|Docetaxel|docetaxel|mesh-list
65058966|NCT00243113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058967|NCT00243113|Tubulin Modulators|tubulin modulators|mesh-ancestor
65058968|NCT00243113|Antimitotic Agents|antimitotic agents|mesh-ancestor
65058969|NCT00243113|Mitosis Modulators|mitosis modulators|mesh-ancestor
65058970|NCT00243113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058971|NCT00273429|Timolol|timolol|mesh-list
65058972|NCT00273429|Dorzolamide|dorzolamide|mesh-list
65058973|NCT00273429|Latanoprost|latanoprost|mesh-list
65058974|NCT00273429|Maleic acid|maleic acid|mesh-list
65058975|NCT00273429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058976|NCT00273429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058977|NCT00273429|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65058978|NCT00273429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65058979|NCT00273429|Adrenergic Agents|adrenergic agents|mesh-ancestor
65058980|NCT00273429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64910959|NCT00009802|Calcitriol|calcitriol|mesh-list
65059013|NCT00273507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65059014|NCT00273507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059015|NCT00273507|Tubulin Modulators|tubulin modulators|mesh-ancestor
65059016|NCT00273507|Antimitotic Agents|antimitotic agents|mesh-ancestor
65059017|NCT00273507|Mitosis Modulators|mitosis modulators|mesh-ancestor
65059018|NCT00273507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059019|NCT00282945|Metformin|metformin|mesh-list
65059020|NCT00282945|Rosiglitazone|rosiglitazone|mesh-list
65059021|NCT00282945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65059022|NCT00282945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059023|NCT00273546|Docetaxel|docetaxel|mesh-list
65059060|NCT00243815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65059061|NCT00243815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059088|NCT00243854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65059089|NCT00243854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059090|NCT00243854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059091|NCT00273741|Methylphenidate|methylphenidate|mesh-list
65059092|NCT00273741|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65059093|NCT00273741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059094|NCT00273741|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65059095|NCT00273741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65059096|NCT00273741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65059097|NCT00273741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059098|NCT00273741|Dopamine Agents|dopamine agents|mesh-ancestor
65059099|NCT00273741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65059100|NCT00243893|Doxycycline|doxycycline|mesh-list
65059101|NCT00243893|Minocycline|minocycline|mesh-list
65059102|NCT00243893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65059103|NCT00243893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65059104|NCT00243893|Antimalarials|antimalarials|mesh-ancestor
65059105|NCT00243893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65059106|NCT00243893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65059107|NCT00283218|Insulin Aspart|insulin aspart|mesh-list
65059138|NCT00244166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65059140|NCT00244166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65059141|NCT00244166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059142|NCT00273975|Lamivudine|lamivudine|mesh-list
65059143|NCT00273975|Zidovudine|zidovudine|mesh-list
65059144|NCT00273975|Nevirapine|nevirapine|mesh-list
65059145|NCT00273975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65059146|NCT00273975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65059147|NCT00273975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059148|NCT00273975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059149|NCT00273975|Antiviral Agents|antiviral agents|mesh-ancestor
65059185|NCT00274014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65059186|NCT00274014|Cholinergic Agents|cholinergic agents|mesh-ancestor
65059187|NCT00274014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65059219|NCT00274053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65059220|NCT00274053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059221|NCT00417183|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65059222|NCT00417183|Ganirelix|ganirelix|mesh-list
65059223|NCT00417183|Luteolytic Agents|luteolytic agents|mesh-ancestor
65059224|NCT00417183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65059225|NCT00417183|Contraceptive Agents|contraceptive agents|mesh-ancestor
65059226|NCT00417183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65059227|NCT00417183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059228|NCT00417183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65059262|NCT00244556|Methotrexate|methotrexate|mesh-list
65059263|NCT00244556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65059264|NCT00244556|Abortifacient Agents|abortifacient agents|mesh-ancestor
65059265|NCT00244556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65059266|NCT00244556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059267|NCT00244556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65059268|NCT00244556|Antimetabolites|antimetabolites|mesh-ancestor
65059269|NCT00244556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059270|NCT00244556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059306|NCT00244907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65059307|NCT00244907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65059308|NCT00244907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059309|NCT00244907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65059310|NCT00244907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059343|NCT00245024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65059344|NCT00245024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65059345|NCT00245024|Analgesics|analgesics|mesh-ancestor
65059346|NCT00245024|Sensory System Agents|sensory system agents|mesh-ancestor
65059347|NCT00245024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65059348|NCT00245024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059349|NCT00245024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65059350|NCT00245024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65059351|NCT00245024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059352|NCT00245024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65059353|NCT00245024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059387|NCT00416637|Growth Substances|growth substances|mesh-ancestor
65059388|NCT00416637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059389|NCT00416637|Growth Inhibitors|growth inhibitors|mesh-ancestor
65059426|NCT00245375|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65059427|NCT00245375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059428|NCT00245375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059452|NCT00245453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65059453|NCT00245453|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65059454|NCT00245453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059455|NCT00245453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059456|NCT00245453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65059457|NCT00245453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65059458|NCT00274560|Tiotropium Bromide|tiotropium bromide|mesh-list
65059459|NCT00274560|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65059460|NCT00274560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65059461|NCT00274560|Autonomic Agents|autonomic agents|mesh-ancestor
65059462|NCT00274560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65059463|NCT00274560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059464|NCT00274560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65059465|NCT00274560|Respiratory System Agents|respiratory system agents|mesh-ancestor
65059466|NCT00274560|Parasympatholytics|parasympatholytics|mesh-ancestor
65059467|NCT00274560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65059468|NCT00274560|Cholinergic Agents|cholinergic agents|mesh-ancestor
65059469|NCT00274560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65059470|NCT00274560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059471|NCT00274560|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65059472|NCT00274560|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65059473|NCT00274560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64472876|NCT02444429|Antiemetics|antiemetics|mesh-ancestor
65059474|NCT00274560|Adrenergic Agents|adrenergic agents|mesh-ancestor
65059475|NCT00245609|Pregabalin|pregabalin|mesh-list
65059476|NCT00245609|Alprazolam|alprazolam|mesh-list
65059477|NCT00245609|Analgesics|analgesics|mesh-ancestor
65059478|NCT00245609|Sensory System Agents|sensory system agents|mesh-ancestor
65059479|NCT00245609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65059507|NCT00274638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65059508|NCT00274638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65059509|NCT00274638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65059510|NCT00274638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059511|NCT00274638|Diuretics|diuretics|mesh-ancestor
65059512|NCT00274638|Natriuretic Agents|natriuretic agents|mesh-ancestor
65059513|NCT00274638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059514|NCT00274638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65059515|NCT00274638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65059516|NCT00274677|Lamotrigine|lamotrigine|mesh-list
65059517|NCT00274677|Anticonvulsants|anticonvulsants|mesh-ancestor
65059518|NCT00274677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65059519|NCT00274677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65059520|NCT00274677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059521|NCT00274677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65059522|NCT00274677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059523|NCT00274677|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65059524|NCT00274677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65059553|NCT00246155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059554|NCT00246155|Cholinergic Agents|cholinergic agents|mesh-ancestor
65059555|NCT00246155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65059556|NCT00246155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059557|NCT00246155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65059558|NCT00246155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65059559|NCT00284193|Thrombin|thrombin|mesh-list
65059560|NCT00284193|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
65059561|NCT00284193|Factor VIII|factor viii|mesh-list
65059563|NCT00284193|Coagulants|coagulants|mesh-ancestor
65059564|NCT00246194|Risperidone|risperidone|mesh-list
65059565|NCT00246194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65059566|NCT00246194|Serotonin Agents|serotonin agents|mesh-ancestor
65059567|NCT00246194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65059568|NCT00246194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059569|NCT00246194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059570|NCT00246194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65059571|NCT00246194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65059596|NCT00274872|Leucovorin|leucovorin|mesh-list
65059597|NCT00274872|Fluorouracil|fluorouracil|mesh-list
65059598|NCT00274872|Oxaliplatin|oxaliplatin|mesh-list
65059599|NCT00274872|Calcium|calcium|mesh-list
65059600|NCT00274872|Levoleucovorin|levoleucovorin|mesh-list
65059601|NCT00274872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65059602|NCT00274872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059603|NCT00274872|Antimetabolites|antimetabolites|mesh-ancestor
65059604|NCT00274872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059605|NCT00274872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65059606|NCT00274872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059607|NCT00274872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65059608|NCT00274872|Immunologic Factors|immunologic factors|mesh-ancestor
65059609|NCT00274872|Antidotes|antidotes|mesh-ancestor
65059610|NCT00274872|Protective Agents|protective agents|mesh-ancestor
65059611|NCT00274872|Vitamin B Complex|vitamin b complex|mesh-ancestor
65059612|NCT00274872|Vitamins|vitamins|mesh-ancestor
65059613|NCT00274872|Micronutrients|micronutrients|mesh-ancestor
65059614|NCT00246272|Risperidone|risperidone|mesh-list
65059615|NCT00246272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65059616|NCT00246272|Serotonin Agents|serotonin agents|mesh-ancestor
65059617|NCT00246272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65059618|NCT00246272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911594|NCT00014209|Autonomic Agents|autonomic agents|mesh-ancestor
65059647|NCT00284271|Antimitotic Agents|antimitotic agents|mesh-ancestor
65059648|NCT00284271|Mitosis Modulators|mitosis modulators|mesh-ancestor
65059650|NCT00284271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65059651|NCT00246389|Cyclobenzaprine|cyclobenzaprine|mesh-list
65059652|NCT00246389|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65059653|NCT00246389|Antidepressive Agents|antidepressive agents|mesh-ancestor
65059654|NCT00246389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65059655|NCT00246389|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64472882|NCT02444429|Hormones|hormones|mesh-ancestor
65059656|NCT00246389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059657|NCT00246389|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65059658|NCT00246389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65059659|NCT00246389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65059660|NCT00246389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65059661|NCT00274911|Vincristine|vincristine|mesh-list
65059662|NCT00274911|Lomustine|lomustine|mesh-list
65059663|NCT00274911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059664|NCT00274911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65059665|NCT00274911|Tubulin Modulators|tubulin modulators|mesh-ancestor
65059666|NCT00274911|Antimitotic Agents|antimitotic agents|mesh-ancestor
65059699|NCT00416676|Antimitotic Agents|antimitotic agents|mesh-ancestor
65059700|NCT00416676|Mitosis Modulators|mitosis modulators|mesh-ancestor
65059701|NCT00246623|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65059702|NCT00246623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059703|NCT00284427|Ascorbic Acid|ascorbic acid|mesh-list
65059704|NCT00284427|Vitamins|vitamins|mesh-ancestor
65059705|NCT00284427|Micronutrients|micronutrients|mesh-ancestor
65059706|NCT00284427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059707|NCT00284427|Antioxidants|antioxidants|mesh-ancestor
64911689|NCT00005981|Carmustine|carmustine|mesh-list
65059743|NCT00284583|Lidocaine|lidocaine|mesh-list
65059744|NCT00284583|Anesthetics, Local|anesthetics, local|mesh-ancestor
65059745|NCT00284583|Anesthetics|anesthetics|mesh-ancestor
64911727|NCT00005984|Interferons|interferons|mesh-list
65059777|NCT00277641|Anticonvulsants|anticonvulsants|mesh-ancestor
65059778|NCT00277641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65059779|NCT00277641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65059780|NCT00277641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059781|NCT00277641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65059782|NCT00277641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059783|NCT00277641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65059810|NCT00247208|Antimitotic Agents|antimitotic agents|mesh-ancestor
65059811|NCT00247208|Mitosis Modulators|mitosis modulators|mesh-ancestor
65059812|NCT00247208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059814|NCT00284778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059815|NCT00284778|Tubulin Modulators|tubulin modulators|mesh-ancestor
65059816|NCT00284778|Antimitotic Agents|antimitotic agents|mesh-ancestor
65059817|NCT00284778|Mitosis Modulators|mitosis modulators|mesh-ancestor
65059818|NCT00284778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059819|NCT00247247|Entacapone|entacapone|mesh-list
65059820|NCT00247247|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65059821|NCT00247247|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65059822|NCT00247247|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65059823|NCT00247247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059824|NCT00247247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059825|NCT00277758|Interferons|interferons|mesh-list
65059826|NCT00277758|Ribavirin|ribavirin|mesh-list
65059827|NCT00277758|Interferon-alpha|interferon-alpha|mesh-list
65059828|NCT00277758|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65059829|NCT00277758|Interleukin-2|interleukin-2|mesh-list
65059830|NCT00277758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059831|NCT00277758|Antiviral Agents|antiviral agents|mesh-ancestor
65059832|NCT00277758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65059866|NCT00424814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65059868|NCT00284973|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65059869|NCT00284973|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65059870|NCT00284973|Immunologic Factors|immunologic factors|mesh-ancestor
65059871|NCT00284973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059872|NCT00247481|Docetaxel|docetaxel|mesh-list
65059900|NCT00285051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65059901|NCT00285051|Serotonin Agents|serotonin agents|mesh-ancestor
65059902|NCT00285051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65059903|NCT00285051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059904|NCT00285051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65059905|NCT00285051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65059906|NCT00285051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65059907|NCT00285051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65059908|NCT00285051|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65059909|NCT00247715|Pantoprazole|pantoprazole|mesh-list
65059910|NCT00247715|Ranitidine|ranitidine|mesh-list
65059911|NCT00247715|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65059912|NCT00247715|Magnesium Oxide|magnesium oxide|mesh-list
65059913|NCT00247715|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65059914|NCT00247715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65059915|NCT00247715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64566284|NCT04940052|Trametinib|trametinib|mesh-list
65059916|NCT00247715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65059917|NCT00247715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059918|NCT00247715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059919|NCT00247715|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64911891|NCT00015301|Methylphenidate|methylphenidate|mesh-list
65059952|NCT00424983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059953|NCT00247910|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65059954|NCT00247910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65059955|NCT00247910|Diuretics|diuretics|mesh-ancestor
65059956|NCT00247910|Natriuretic Agents|natriuretic agents|mesh-ancestor
65059957|NCT00247910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059958|NCT00247910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65059959|NCT00247910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65059960|NCT00247910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059991|NCT00278265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059992|NCT00278265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65059993|NCT00278265|Antimetabolites|antimetabolites|mesh-ancestor
65059994|NCT00278265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059995|NCT00278265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059996|NCT00278265|Dermatologic Agents|dermatologic agents|mesh-ancestor
65059997|NCT00278265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059998|NCT00278265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65059999|NCT00278265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65060000|NCT00278265|Immunologic Factors|immunologic factors|mesh-ancestor
65060001|NCT00278265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65060002|NCT00278265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65060003|NCT00248183|Naluzotan|naluzotan|mesh-list
64911978|NCT00006005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65060019|NCT00248261|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65060020|NCT00248261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65060021|NCT00248261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65060022|NCT00248261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060024|NCT00248261|Serotonin Agents|serotonin agents|mesh-ancestor
65060025|NCT00248261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060026|NCT00248261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65060027|NCT00248261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65060028|NCT00248261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65060029|NCT00248261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65060030|NCT00248261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65060032|NCT00248300|Chlorhexidine|chlorhexidine|mesh-list
65060033|NCT00248300|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65060034|NCT00248300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65060035|NCT00248300|Disinfectants|disinfectants|mesh-ancestor
65060036|NCT00278382|Sorafenib|sorafenib|mesh-list
65060037|NCT00278382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060038|NCT00278382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65060039|NCT00278382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060040|NCT00278382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060041|NCT00248339|Ribavirin|ribavirin|mesh-list
65060042|NCT00248339|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65060043|NCT00248339|Epoetin Alfa|epoetin alfa|mesh-list
65060044|NCT00248339|Antimetabolites|antimetabolites|mesh-ancestor
65060045|NCT00248339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060046|NCT00248339|Antiviral Agents|antiviral agents|mesh-ancestor
65060047|NCT00248339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65060048|NCT00248339|Hematinics|hematinics|mesh-ancestor
65060049|NCT00278421|Prednisone|prednisone|mesh-list
65060050|NCT00278421|Cyclophosphamide|cyclophosphamide|mesh-list
65060051|NCT00278421|Rituximab|rituximab|mesh-list
65060052|NCT00278421|Doxorubicin|doxorubicin|mesh-list
65060053|NCT00278421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65060054|NCT00278421|Vincristine|vincristine|mesh-list
65060055|NCT00278421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65060056|NCT00278421|Immunologic Factors|immunologic factors|mesh-ancestor
65060057|NCT00278421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060058|NCT00278421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65060059|NCT00278421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65060060|NCT00278421|Alkylating Agents|alkylating agents|mesh-ancestor
65060061|NCT00278421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060062|NCT00278421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060063|NCT00278421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65060094|NCT00278460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65060095|NCT00278460|Antimetabolites|antimetabolites|mesh-ancestor
64566352|NCT04713969|Pantoprazole|pantoprazole|mesh-list
64829162|NCT05137080|Hormones|hormones|mesh-ancestor
65060096|NCT00278460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060097|NCT00278460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060098|NCT00278460|Antiviral Agents|antiviral agents|mesh-ancestor
65060099|NCT00278460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65060100|NCT00278460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060101|NCT00278460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65060102|NCT00278460|Immunologic Factors|immunologic factors|mesh-ancestor
65060103|NCT00278460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060104|NCT00278460|Tubulin Modulators|tubulin modulators|mesh-ancestor
65060105|NCT00278460|Antimitotic Agents|antimitotic agents|mesh-ancestor
65060106|NCT00278460|Mitosis Modulators|mitosis modulators|mesh-ancestor
65060144|NCT00249041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65060145|NCT00249041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060146|NCT00249041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65060177|NCT00249119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65060178|NCT00249119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65494077|NCT03743636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65060179|NCT00249119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65060180|NCT00249119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65060181|NCT00249119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65060182|NCT00249119|Dopamine Agents|dopamine agents|mesh-ancestor
65060183|NCT00285597|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65060184|NCT00285597|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65060185|NCT00285597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65060186|NCT00249158|Risperidone|risperidone|mesh-list
65060187|NCT00249158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65060188|NCT00249158|Serotonin Agents|serotonin agents|mesh-ancestor
65060189|NCT00249158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65060219|NCT00249236|Risperidone|risperidone|mesh-list
65060220|NCT00249236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65060221|NCT00249236|Serotonin Agents|serotonin agents|mesh-ancestor
65060222|NCT00249236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65060223|NCT00249236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060224|NCT00249236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060225|NCT00249236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65060226|NCT00249236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65060227|NCT00249236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65060228|NCT00249236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65060229|NCT00249236|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65060230|NCT00249236|Dopamine Agents|dopamine agents|mesh-ancestor
65060231|NCT00285675|Calcitriol|calcitriol|mesh-list
65060232|NCT00285675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65060233|NCT00285675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060234|NCT00285675|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64912209|NCT00016978|Fluorouracil|fluorouracil|mesh-list
65060267|NCT00249431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65060268|NCT00249431|Serotonin Agents|serotonin agents|mesh-ancestor
65060269|NCT00249431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060270|NCT00249509|Bupropion|bupropion|mesh-list
65060271|NCT00249509|Nefazodone|nefazodone|mesh-list
65060272|NCT00249509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65060273|NCT00249509|Antidepressive Agents|antidepressive agents|mesh-ancestor
65060274|NCT00249509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65060281|NCT00249509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060282|NCT00249509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65060283|NCT00249509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65060284|NCT00249509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060285|NCT00249509|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65060286|NCT00249509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65060287|NCT00249509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65060288|NCT00249509|Serotonin Agents|serotonin agents|mesh-ancestor
65060289|NCT00279084|Chrysarobin|chrysarobin|mesh-list
65060290|NCT00279084|Epoetin Alfa|epoetin alfa|mesh-list
65060291|NCT00279084|Hematinics|hematinics|mesh-ancestor
65060292|NCT00279084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65060293|NCT00279084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65060294|NCT00279084|Analgesics|analgesics|mesh-ancestor
65060295|NCT00279084|Sensory System Agents|sensory system agents|mesh-ancestor
65060296|NCT00279084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65060297|NCT00279084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060298|NCT00279084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65060299|NCT00279084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64566429|NCT04513314|Anticonvulsants|anticonvulsants|mesh-ancestor
65060300|NCT00249587|Methadone|methadone|mesh-list
65060301|NCT00249587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65060302|NCT00249587|Narcotics|narcotics|mesh-ancestor
65060303|NCT00249587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65060304|NCT00249587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060305|NCT00249587|Analgesics|analgesics|mesh-ancestor
65060306|NCT00249587|Sensory System Agents|sensory system agents|mesh-ancestor
65060307|NCT00249587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65060308|NCT00249587|Antitussive Agents|antitussive agents|mesh-ancestor
65060309|NCT00249587|Respiratory System Agents|respiratory system agents|mesh-ancestor
65060310|NCT00279123|Pantoprazole|pantoprazole|mesh-list
65060311|NCT00279123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65060312|NCT00279123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65060313|NCT00279123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65060314|NCT00279123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060315|NCT00279123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060316|NCT00279162|Betamethasone|betamethasone|mesh-list
65060317|NCT00279162|Calcipotriene|calcipotriene|mesh-list
65060318|NCT00279162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65060319|NCT00279162|Glucocorticoids|glucocorticoids|mesh-ancestor
65060320|NCT00279162|Hormones|hormones|mesh-ancestor
65060321|NCT00279162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65060322|NCT00279162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060323|NCT00279162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65060324|NCT00279162|Respiratory System Agents|respiratory system agents|mesh-ancestor
65060325|NCT00279162|Dermatologic Agents|dermatologic agents|mesh-ancestor
65060326|NCT00249704|Vitamin D|vitamin d|mesh-list
65060327|NCT00249704|Ergocalciferols|ergocalciferols|mesh-list
65060328|NCT00249704|Cholecalciferol|cholecalciferol|mesh-list
65060329|NCT00249704|Vitamins|vitamins|mesh-list
65060330|NCT00249704|Micronutrients|micronutrients|mesh-ancestor
65060331|NCT00249704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060332|NCT00249704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65060333|NCT00249704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65060334|NCT00249782|Metronidazole|metronidazole|mesh-list
65060335|NCT00249782|Dapsone|dapsone|mesh-list
65060336|NCT00249782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65060337|NCT00249782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65060338|NCT00249782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65060339|NCT00249782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65060340|NCT00249782|Antimalarials|antimalarials|mesh-ancestor
65060341|NCT00249782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65060342|NCT00249782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912296|NCT00001482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65060379|NCT00249977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65060380|NCT00249977|Antimetabolites|antimetabolites|mesh-ancestor
65060410|NCT02961608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060412|NCT00286104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65060413|NCT00286143|Fentanyl|fentanyl|mesh-list
65060414|NCT00286143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65060415|NCT00286143|Narcotics|narcotics|mesh-ancestor
65060416|NCT00286143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65060417|NCT00286143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060418|NCT00286143|Analgesics|analgesics|mesh-ancestor
65060419|NCT00286143|Sensory System Agents|sensory system agents|mesh-ancestor
65060420|NCT00286143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65060421|NCT00286143|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65060422|NCT00286143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65060423|NCT00286143|Anesthetics, General|anesthetics, general|mesh-ancestor
64912408|NCT00017290|Hormones|hormones|mesh-ancestor
65060451|NCT02960880|Rivaroxaban|rivaroxaban|mesh-list
65060452|NCT02960880|Phenprocoumon|phenprocoumon|mesh-list
65060453|NCT02960880|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65060454|NCT02960880|Antithrombins|antithrombins|mesh-ancestor
65060455|NCT02960880|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65060456|NCT02960880|Protease Inhibitors|protease inhibitors|mesh-ancestor
65060457|NCT02960880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060458|NCT02960880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060459|NCT02960880|Anticoagulants|anticoagulants|mesh-ancestor
65060460|NCT00279747|Naproxen|naproxen|mesh-list
65060461|NCT00279747|Meloxicam|meloxicam|mesh-list
65060462|NCT00279747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65060463|NCT00279747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65060464|NCT00279747|Analgesics|analgesics|mesh-ancestor
65060465|NCT00279747|Sensory System Agents|sensory system agents|mesh-ancestor
65060466|NCT00279747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64566508|NCT04318405|Iron|iron|mesh-list
65060467|NCT00279747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060468|NCT00279747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65060469|NCT00279747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65060470|NCT00279747|Gout Suppressants|gout suppressants|mesh-ancestor
65060471|NCT00279747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65060500|NCT00286416|Respiratory System Agents|respiratory system agents|mesh-ancestor
65060502|NCT00250874|Doxorubicin|doxorubicin|mesh-list
65060503|NCT00250874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65060504|NCT00250874|Trastuzumab|trastuzumab|mesh-list
65060505|NCT00250874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060506|NCT00250874|Tubulin Modulators|tubulin modulators|mesh-ancestor
65060507|NCT00250874|Antimitotic Agents|antimitotic agents|mesh-ancestor
65060508|NCT00250874|Mitosis Modulators|mitosis modulators|mesh-ancestor
65060509|NCT00250874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060510|NCT00250874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65060511|NCT00250874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65060512|NCT00250874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65060513|NCT00250874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060514|NCT00250874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65060515|NCT00279825|Levodopa|levodopa|mesh-list
65060516|NCT00279825|Carbidopa|carbidopa|mesh-list
65060517|NCT00279825|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65060518|NCT00279825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65060519|NCT00279825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65060520|NCT00279825|Dopamine Agents|dopamine agents|mesh-ancestor
65060556|NCT00416832|Procarbazine|procarbazine|mesh-list
65060557|NCT00416832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65060558|NCT00416832|Immunologic Factors|immunologic factors|mesh-ancestor
65060559|NCT00416832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060583|NCT00251030|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65060584|NCT00251030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060585|NCT00251030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060586|NCT00251030|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65060587|NCT00251030|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65060588|NCT00251030|Protease Inhibitors|protease inhibitors|mesh-ancestor
65060589|NCT00251030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65060590|NCT00251030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65060591|NCT00251030|Antiviral Agents|antiviral agents|mesh-ancestor
65060592|NCT00251030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65060593|NCT00286689|Hormones|hormones|mesh-list
65060594|NCT00286689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65060595|NCT00286689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060596|NCT02961491|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65060597|NCT02961491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060598|NCT02961491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060599|NCT02961491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060600|NCT02961491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65060601|NCT01640002|Bromides|bromides|mesh-list
65060602|NCT01640002|Propantheline|propantheline|mesh-list
65060603|NCT01640002|Anticonvulsants|anticonvulsants|mesh-ancestor
65060604|NCT01640002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65060605|NCT01640002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64912589|NCT00017992|Antimetabolites|antimetabolites|mesh-ancestor
65060629|NCT01640275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060630|NCT01640275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65060631|NCT01640275|Anesthetics, General|anesthetics, general|mesh-ancestor
65060632|NCT01640275|Anesthetics|anesthetics|mesh-ancestor
65060633|NCT01640275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65060634|NCT04529356|Acetaminophen|acetaminophen|mesh-list
65060635|NCT04529356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65060636|NCT04529356|Analgesics|analgesics|mesh-ancestor
65060637|NCT04529356|Sensory System Agents|sensory system agents|mesh-ancestor
65060638|NCT04529356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65060639|NCT04529356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060640|NCT04529356|Antipyretics|antipyretics|mesh-ancestor
65060641|NCT01640665|Capecitabine|capecitabine|mesh-list
65060642|NCT01640665|Sorafenib|sorafenib|mesh-list
65060679|NCT01641250|Cytarabine|cytarabine|mesh-list
65060680|NCT01641250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65060681|NCT01641250|Antimetabolites|antimetabolites|mesh-ancestor
65060682|NCT01641250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060708|NCT01641406|Alkylating Agents|alkylating agents|mesh-ancestor
65060709|NCT01641406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060710|NCT01641406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060711|NCT01641406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65060712|NCT01641406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65060713|NCT01641406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65060714|NCT01641406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65060715|NCT01641406|Growth Substances|growth substances|mesh-ancestor
65060716|NCT01641406|Growth Inhibitors|growth inhibitors|mesh-ancestor
65060717|NCT01641406|Tubulin Modulators|tubulin modulators|mesh-ancestor
65060718|NCT01641406|Antimitotic Agents|antimitotic agents|mesh-ancestor
65060719|NCT01641406|Mitosis Modulators|mitosis modulators|mesh-ancestor
65060720|NCT01641406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65060721|NCT01641406|Antimetabolites|antimetabolites|mesh-ancestor
65060722|NCT01641406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65060723|NCT01641406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65060724|NCT01641406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65060725|NCT01641406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060726|NCT01641406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65060727|NCT01641523|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
65060728|NCT01641523|Vasodilator Agents|vasodilator agents|mesh-ancestor
65060729|NCT01641523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65060730|NCT01641523|Protective Agents|protective agents|mesh-ancestor
65060731|NCT01641523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060733|NCT01641796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65060734|NCT01641796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65060762|NCT05140096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65060764|NCT05140096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060765|NCT05140096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65060766|NCT05140096|Hormone Antagonists|hormone antagonists|mesh-ancestor
65060767|NCT05140096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65060768|NCT05140096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060769|NCT05140096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65060770|NCT05140096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65060771|NCT05140096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060772|NCT00251459|Ranibizumab|ranibizumab|mesh-list
65060773|NCT00251459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65060774|NCT00251459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65060775|NCT00251459|Growth Substances|growth substances|mesh-ancestor
65060776|NCT00251459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060777|NCT00251459|Growth Inhibitors|growth inhibitors|mesh-ancestor
65060778|NCT00251459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060781|NCT04823065|Antidiarrheals|antidiarrheals|mesh-list
65060782|NCT04823065|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65060783|NCT04823065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65060815|NCT00280215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65060816|NCT00280215|Protective Agents|protective agents|mesh-ancestor
65060817|NCT00280215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060818|NCT04828135|Xenon|xenon|mesh-list
65060819|NCT04828135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65060820|NCT04828135|Anesthetics, General|anesthetics, general|mesh-ancestor
65060821|NCT04828135|Anesthetics|anesthetics|mesh-ancestor
65060822|NCT04828135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65060823|NCT04828135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060824|NCT00251498|Cetuximab|cetuximab|mesh-list
65060825|NCT00251498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65060826|NCT00251498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060849|NCT00280371|Formoterol Fumarate|formoterol fumarate|mesh-list
65060850|NCT00280371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65060851|NCT00280371|Autonomic Agents|autonomic agents|mesh-ancestor
65060852|NCT00280371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65060853|NCT00280371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060854|NCT00280371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65060855|NCT00280371|Respiratory System Agents|respiratory system agents|mesh-ancestor
65060856|NCT00280371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65060857|NCT00280371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65060858|NCT00280371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65060859|NCT00280371|Adrenergic Agents|adrenergic agents|mesh-ancestor
65060860|NCT00280371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65060861|NCT00280371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060862|NCT04455139|Melphalan|melphalan|mesh-list
65060863|NCT04455139|Topotecan|topotecan|mesh-list
65060864|NCT04455139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65060865|NCT04455139|Alkylating Agents|alkylating agents|mesh-ancestor
65060866|NCT04455139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060867|NCT04455139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060868|NCT04455139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65060869|NCT04455139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65060870|NCT04455139|Immunologic Factors|immunologic factors|mesh-ancestor
65060871|NCT04455139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060872|NCT04455139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65060873|NCT04455139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65060874|NCT04455139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060875|NCT00251654|Anesthetics|anesthetics|mesh-list
65060876|NCT00251654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65060877|NCT00251654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060878|NCT00286923|Topiramate|topiramate|mesh-list
65060910|NCT00251849|Antitubercular Agents|antitubercular agents|mesh-ancestor
65060911|NCT00251849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65060912|NCT00251849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65060913|NCT00251849|Leprostatic Agents|leprostatic agents|mesh-ancestor
65060915|NCT04822597|Anesthetics, Local|anesthetics, local|mesh-ancestor
65060916|NCT04822597|Anesthetics|anesthetics|mesh-ancestor
65060917|NCT04822597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65060918|NCT04822597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060919|NCT04822597|Sensory System Agents|sensory system agents|mesh-ancestor
65060920|NCT04822597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65060921|NCT04822597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65060956|NCT00280605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060957|NCT00280605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912946|NCT00392158|Anesthetics|anesthetics|mesh-list
65060989|NCT00287157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65060990|NCT00287157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65060991|NCT00287157|Adrenergic Agents|adrenergic agents|mesh-ancestor
65060992|NCT00287157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65060993|NCT00287157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060994|NCT00280644|Leflunomide|leflunomide|mesh-list
65060995|NCT00280644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060996|NCT00280644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060997|NCT00280644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65060998|NCT00280644|Immunologic Factors|immunologic factors|mesh-ancestor
64912982|NCT00001749|Antifungal Agents|antifungal agents|mesh-ancestor
65061029|NCT02753998|Antimitotic Agents|antimitotic agents|mesh-ancestor
65061030|NCT02753998|Mitosis Modulators|mitosis modulators|mesh-ancestor
65061031|NCT02753998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061033|NCT02754154|Rivaroxaban|rivaroxaban|mesh-list
65061034|NCT02754154|Dabigatran|dabigatran|mesh-list
65061035|NCT02754154|Apixaban|apixaban|mesh-list
65061036|NCT02754154|Anticoagulants|anticoagulants|mesh-ancestor
65061037|NCT02754154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65061038|NCT02754154|Antithrombins|antithrombins|mesh-ancestor
65061039|NCT02754154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65061040|NCT02754154|Protease Inhibitors|protease inhibitors|mesh-ancestor
65061074|NCT00280878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65061075|NCT00280878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65061076|NCT00280878|Antimetabolites|antimetabolites|mesh-ancestor
65061077|NCT00280878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061078|NCT00280878|Antiviral Agents|antiviral agents|mesh-ancestor
65061079|NCT00280878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65061080|NCT00280878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061081|NCT00280878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65061082|NCT00280878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65061083|NCT00280878|Tubulin Modulators|tubulin modulators|mesh-ancestor
65061113|NCT01680250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061114|NCT01680250|Antifungal Agents|antifungal agents|mesh-ancestor
65061115|NCT01680250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65061116|NCT01680250|Immunologic Factors|immunologic factors|mesh-ancestor
65061117|NCT01680250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061118|NCT00280956|Natalizumab|natalizumab|mesh-list
65061119|NCT00280956|Immunologic Factors|immunologic factors|mesh-ancestor
65061120|NCT00280956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061121|NCT02279875|Rifampin|rifampin|mesh-list
65061122|NCT02279875|Isoniazid|isoniazid|mesh-list
65061123|NCT02279875|Linezolid|linezolid|mesh-list
65061124|NCT02279875|Pyrazinamide|pyrazinamide|mesh-list
65061125|NCT02279875|Ethambutol|ethambutol|mesh-list
65061126|NCT02279875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65061127|NCT02279875|Antitubercular Agents|antitubercular agents|mesh-ancestor
65061128|NCT02279875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65061129|NCT02279875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65061130|NCT02279875|Leprostatic Agents|leprostatic agents|mesh-ancestor
65061131|NCT02279875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65061132|NCT02279875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566753|NCT03173248|Antimetabolites|antimetabolites|mesh-ancestor
65061133|NCT02279875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061165|NCT00287352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65061166|NCT00287352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65061167|NCT00287352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65061168|NCT00287352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65061169|NCT00287352|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65061170|NCT00287352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65061171|NCT00287352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65061172|NCT00287352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061173|NCT00287352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64913154|NCT04734730|Prednisone|prednisone|mesh-list
65061230|NCT01680406|Chloroquine|chloroquine|mesh-list
65061231|NCT01680406|Lumefantrine|lumefantrine|mesh-list
65061232|NCT01680406|Artemether|artemether|mesh-list
65061233|NCT01680406|Primaquine|primaquine|mesh-list
65061234|NCT01680406|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65061235|NCT01680406|Amebicides|amebicides|mesh-ancestor
65061236|NCT01680406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65061237|NCT01680406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65061238|NCT01680406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65061239|NCT01680406|Antimalarials|antimalarials|mesh-ancestor
65061240|NCT01680406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65061241|NCT00287430|Hormones|hormones|mesh-list
65061242|NCT00287430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65061243|NCT00287430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061244|NCT01680679|Vaccines|vaccines|mesh-list
65061245|NCT01680679|Immunologic Factors|immunologic factors|mesh-ancestor
65061246|NCT01680679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061247|NCT01680718|Vasopressins|vasopressins|mesh-list
65061248|NCT01680718|Arginine Vasopressin|arginine vasopressin|mesh-list
65061249|NCT01680718|Oxytocin|oxytocin|mesh-list
65061250|NCT01680718|Oxytocics|oxytocics|mesh-ancestor
65061251|NCT01680718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65061252|NCT01680718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061253|NCT01680718|Hemostatics|hemostatics|mesh-ancestor
65061254|NCT01680718|Coagulants|coagulants|mesh-ancestor
65061255|NCT01680718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65061256|NCT01680718|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65061257|NCT01680718|Natriuretic Agents|natriuretic agents|mesh-ancestor
65061258|NCT01680796|Dexamethasone|dexamethasone|mesh-list
65061259|NCT01680796|Bortezomib|bortezomib|mesh-list
65061260|NCT01680796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65061261|NCT01680796|Antiemetics|antiemetics|mesh-ancestor
65061262|NCT01680796|Autonomic Agents|autonomic agents|mesh-ancestor
65061263|NCT01680796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65061264|NCT01680796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061265|NCT01680796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65061266|NCT01680796|Glucocorticoids|glucocorticoids|mesh-ancestor
65061267|NCT01680796|Hormones|hormones|mesh-ancestor
64304106|NCT03067688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061293|NCT00252785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65061294|NCT00252785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65061295|NCT00252785|Purinergic Agents|purinergic agents|mesh-ancestor
65061296|NCT01680913|Anesthetics|anesthetics|mesh-list
65061297|NCT01680913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65061298|NCT01680913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061299|NCT01680952|Mycophenolic Acid|mycophenolic acid|mesh-list
65061301|NCT01680952|Tacrolimus|tacrolimus|mesh-list
65061302|NCT01680952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65061303|NCT01680952|Immunologic Factors|immunologic factors|mesh-ancestor
65061304|NCT01680952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061305|NCT01680952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65061306|NCT01680952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061307|NCT01680952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061308|NCT01680952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65061309|NCT01680952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061310|NCT01680952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65061311|NCT01680952|Antitubercular Agents|antitubercular agents|mesh-ancestor
65061312|NCT01680952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65061313|NCT01680952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65061314|NCT01680952|Antifungal Agents|antifungal agents|mesh-ancestor
65061346|NCT00252863|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65061347|NCT00252863|Montelukast|montelukast|mesh-list
65061348|NCT00252863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65061349|NCT00252863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65061350|NCT00252863|Autonomic Agents|autonomic agents|mesh-ancestor
65061351|NCT00252863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65061352|NCT00252863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061353|NCT00252863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65061354|NCT00252863|Respiratory System Agents|respiratory system agents|mesh-ancestor
65061355|NCT00252863|Dermatologic Agents|dermatologic agents|mesh-ancestor
65061356|NCT00252863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65061357|NCT00252863|Glucocorticoids|glucocorticoids|mesh-ancestor
65061358|NCT00252863|Hormones|hormones|mesh-ancestor
65061359|NCT00252863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65061360|NCT00252863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65061361|NCT00252863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65061390|NCT01681537|Antimetabolites|antimetabolites|mesh-ancestor
65061391|NCT01681537|Antiviral Agents|antiviral agents|mesh-ancestor
65061392|NCT01681537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65061393|NCT01681537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65061394|NCT01681537|Immunologic Factors|immunologic factors|mesh-ancestor
65061395|NCT01681537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061396|NCT01681537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65061397|NCT01681537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65061398|NCT01681537|Growth Substances|growth substances|mesh-ancestor
65061399|NCT01681537|Growth Inhibitors|growth inhibitors|mesh-ancestor
65061401|NCT01681537|Sensory System Agents|sensory system agents|mesh-ancestor
65061402|NCT01681537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65061403|NCT01681693|Metformin|metformin|mesh-list
65061404|NCT01681693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65061405|NCT01681693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061406|NCT01681966|Ropivacaine|ropivacaine|mesh-list
65061407|NCT01681966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65061408|NCT01681966|Anesthetics, Local|anesthetics, local|mesh-ancestor
65061409|NCT01681966|Anesthetics|anesthetics|mesh-ancestor
65061431|NCT02279914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65061432|NCT02279914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061433|NCT02279914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65061434|NCT02279914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65061435|NCT02279914|Oxytocics|oxytocics|mesh-ancestor
65061436|NCT00281307|Tocopherols|tocopherols|mesh-list
65061437|NCT00281307|Vitamin E|vitamin e|mesh-list
65061438|NCT00281307|Tocotrienols|tocotrienols|mesh-list
65061439|NCT00281307|alpha-Tocopherol|alpha-tocopherol|mesh-list
65061441|NCT00281307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061442|NCT00281307|Protective Agents|protective agents|mesh-ancestor
65061443|NCT00281307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061444|NCT00281307|Vitamins|vitamins|mesh-ancestor
65061445|NCT00281307|Micronutrients|micronutrients|mesh-ancestor
65061446|NCT01682746|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
65061447|NCT01682746|Trioxsalen|trioxsalen|mesh-list
65061448|NCT01682746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061449|NCT01682746|Dermatologic Agents|dermatologic agents|mesh-ancestor
65061450|NCT01682746|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65061451|NCT00287664|Terlipressin|terlipressin|mesh-list
65061452|NCT00287664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65061453|NCT00287664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65061454|NCT01682902|Insulin|insulin|mesh-list
65061455|NCT01682902|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65061456|NCT01682902|Insulin Aspart|insulin aspart|mesh-list
65061457|NCT01682902|Insulin, Long-Acting|insulin, long-acting|mesh-list
65061458|NCT01682902|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64935450|NCT00137995|Etoposide|etoposide|mesh-list
65061459|NCT01682902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65061460|NCT01682902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061461|NCT01683175|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65061462|NCT01683175|Cisplatin|cisplatin|mesh-list
65061463|NCT01683175|Vinorelbine|vinorelbine|mesh-list
65061499|NCT00253058|Cetirizine|cetirizine|mesh-list
65061500|NCT00253058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65061501|NCT00253058|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65061502|NCT00253058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65061503|NCT00253058|Histamine Antagonists|histamine antagonists|mesh-ancestor
65061538|NCT04527562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061539|NCT01684072|Vaccines|vaccines|mesh-list
65061540|NCT01684072|Immunologic Factors|immunologic factors|mesh-ancestor
65061541|NCT01684072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061542|NCT01684111|Vinorelbine|vinorelbine|mesh-list
65061543|NCT01684111|Nintedanib|nintedanib|mesh-list
65061544|NCT01684111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65061569|NCT01684306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64566905|NCT01828112|Docetaxel|docetaxel|mesh-list
65061570|NCT01684306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061572|NCT00287781|Anesthetics, Local|anesthetics, local|mesh-ancestor
65061573|NCT00287781|Anesthetics|anesthetics|mesh-ancestor
65061574|NCT00287781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65061575|NCT00287781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061576|NCT00287781|Sensory System Agents|sensory system agents|mesh-ancestor
65061577|NCT00287781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65061578|NCT00287781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65061579|NCT00287781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65061580|NCT00287781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65061581|NCT00287781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65061582|NCT00287781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061583|NCT00416871|Interferons|interferons|mesh-list
65061584|NCT00416871|Interferon-alpha|interferon-alpha|mesh-list
65061585|NCT00416871|Aldesleukin|aldesleukin|mesh-list
65061586|NCT00416871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061587|NCT00416871|Antiviral Agents|antiviral agents|mesh-ancestor
65061588|NCT00416871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64546905|NCT00005803|Keratolytic Agents|keratolytic agents|mesh-ancestor
65061589|NCT00416871|Immunologic Factors|immunologic factors|mesh-ancestor
65061590|NCT00416871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061591|NCT00416871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65061623|NCT01684774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65061624|NCT02279992|Carboplatin|carboplatin|mesh-list
65061625|NCT02279992|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65061626|NCT02279992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061627|NCT02279992|Vasodilator Agents|vasodilator agents|mesh-ancestor
65061628|NCT02279992|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65061629|NCT02279992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65061630|NCT02279992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061631|NCT02279992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061632|NCT02279992|Urological Agents|urological agents|mesh-ancestor
65061633|NCT00253175|Topiramate|topiramate|mesh-list
65061634|NCT00253175|Anticonvulsants|anticonvulsants|mesh-ancestor
65061635|NCT00253175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65061668|NCT00253214|Autonomic Agents|autonomic agents|mesh-ancestor
65061669|NCT00253214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65061670|NCT00253214|Nootropic Agents|nootropic agents|mesh-ancestor
65061672|NCT00287859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65061673|NCT00287859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65061674|NCT00287859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061675|NCT00287859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913658|NCT03151720|Loratadine|loratadine|mesh-list
65061701|NCT01685125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65061703|NCT01685125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65061704|NCT01685125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061705|NCT01685125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061706|NCT01685125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65061707|NCT01685125|Hormone Antagonists|hormone antagonists|mesh-ancestor
65061708|NCT01685125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65061709|NCT04527679|Lenvatinib|lenvatinib|mesh-list
65061710|NCT04527679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061711|NCT04527679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65061712|NCT04527679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061713|NCT04527679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061714|NCT01685281|Metadoxine|metadoxine|mesh-list
65061715|NCT01685281|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65061716|NCT00417066|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65061717|NCT00417066|Ganirelix|ganirelix|mesh-list
65061718|NCT00417066|Luteolytic Agents|luteolytic agents|mesh-ancestor
65061719|NCT00417066|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65061720|NCT00417066|Contraceptive Agents|contraceptive agents|mesh-ancestor
65061721|NCT00417066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65061722|NCT00417066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061723|NCT00417066|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65061724|NCT00417066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65061744|NCT01685515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061745|NCT01685515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061746|NCT00281502|Rifaximin|rifaximin|mesh-list
65061747|NCT00281502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65061748|NCT00281502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65061749|NCT00281502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65061750|NCT00253331|Nitroglycerin|nitroglycerin|mesh-list
65061751|NCT00253331|Vasodilator Agents|vasodilator agents|mesh-ancestor
65061752|NCT00253487|Temozolomide|temozolomide|mesh-list
65061753|NCT00253487|Busulfan|busulfan|mesh-list
65061754|NCT00253487|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
65061755|NCT00253487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65061756|NCT00253487|Alkylating Agents|alkylating agents|mesh-ancestor
65061757|NCT00253487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061758|NCT00253487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061759|NCT00253487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65061760|NCT00253487|Immunologic Factors|immunologic factors|mesh-ancestor
65061761|NCT00253487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061762|NCT00253487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65061763|NCT00253487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061764|NCT00281619|Mycophenolic Acid|mycophenolic acid|mesh-list
65061765|NCT00281619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65061766|NCT00281619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061767|NCT00281619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65061768|NCT00281619|Antitubercular Agents|antitubercular agents|mesh-ancestor
65061769|NCT00281619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65061770|NCT00281619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65061771|NCT00281619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061772|NCT00281619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061773|NCT04527211|Ivermectin|ivermectin|mesh-list
65061774|NCT04527211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65061775|NCT04527211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65061776|NCT00253526|Gemcitabine|gemcitabine|mesh-list
65061777|NCT00253526|Bevacizumab|bevacizumab|mesh-list
65061778|NCT00253526|Antibodies|antibodies|mesh-list
65061779|NCT00253526|Immunoglobulins|immunoglobulins|mesh-list
65061780|NCT00253526|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65061801|NCT01686217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061802|NCT01686217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65061803|NCT01686217|Immunologic Factors|immunologic factors|mesh-ancestor
65061804|NCT01686217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061805|NCT01686217|Vitamin B Complex|vitamin b complex|mesh-ancestor
65061806|NCT01686217|Vitamins|vitamins|mesh-ancestor
65061807|NCT01686217|Micronutrients|micronutrients|mesh-ancestor
65061808|NCT01686256|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
65061809|NCT01686256|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65061810|NCT01686256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061811|NCT00253565|Capecitabine|capecitabine|mesh-list
65061812|NCT00253565|Imatinib Mesylate|imatinib mesylate|mesh-list
65061813|NCT00253565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65061814|NCT00253565|Antimetabolites|antimetabolites|mesh-ancestor
65061815|NCT00253565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061816|NCT00253565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061817|NCT00253565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65061818|NCT00253565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061819|NCT01686529|Bevacizumab|bevacizumab|mesh-list
65061820|NCT01686529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65061821|NCT01686529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061822|NCT01686529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65061823|NCT01686529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65061824|NCT01686529|Growth Substances|growth substances|mesh-ancestor
65061825|NCT01686529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061826|NCT01686529|Growth Inhibitors|growth inhibitors|mesh-ancestor
65061827|NCT01686607|Itraconazole|itraconazole|mesh-list
65061828|NCT01686607|Fluconazole|fluconazole|mesh-list
65061829|NCT01686607|Voriconazole|voriconazole|mesh-list
65061830|NCT01686607|Amphotericin B|amphotericin b|mesh-list
65061831|NCT01686607|Caspofungin|caspofungin|mesh-list
65061832|NCT01686607|Micafungin|micafungin|mesh-list
65061833|NCT01686607|Antifungal Agents|antifungal agents|mesh-list
65061834|NCT01686607|Clotrimazole|clotrimazole|mesh-list
65061835|NCT01686607|Miconazole|miconazole|mesh-list
65061837|NCT01686607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65495203|NCT00911820|Irinotecan|irinotecan|mesh-list
65061864|NCT01686802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65061865|NCT01686802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65061866|NCT01686802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65061867|NCT01686802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65061868|NCT01686802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061869|NCT01686802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061870|NCT00253721|Melphalan|melphalan|mesh-list
65061871|NCT00253721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65061872|NCT00253721|Alkylating Agents|alkylating agents|mesh-ancestor
65061873|NCT00253721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567055|NCT01450345|Analgesics|analgesics|mesh-ancestor
65061874|NCT00253721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061875|NCT00253721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65061876|NCT00253721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65061877|NCT00253721|Immunologic Factors|immunologic factors|mesh-ancestor
65061878|NCT00253721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061879|NCT00281892|Vidarabine|vidarabine|mesh-list
65061880|NCT00281892|Fludarabine|fludarabine|mesh-list
65061881|NCT00281892|Fludarabine phosphate|fludarabine phosphate|mesh-list
64913851|NCT03150316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061908|NCT00281931|Alkylating Agents|alkylating agents|mesh-ancestor
65061909|NCT00281931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061910|NCT00281931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061911|NCT00281931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65061912|NCT00281931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65061913|NCT00281931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65061915|NCT01687348|Lidocaine|lidocaine|mesh-list
65061916|NCT01687348|Anesthetics, Local|anesthetics, local|mesh-ancestor
65061917|NCT01687348|Anesthetics|anesthetics|mesh-ancestor
65061918|NCT01687348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65061919|NCT01687348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061920|NCT01687348|Sensory System Agents|sensory system agents|mesh-ancestor
65061921|NCT01687348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65061922|NCT01687348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65061923|NCT01687348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65061924|NCT01687348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65061925|NCT01687348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65061926|NCT01687348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061927|NCT01687426|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65061928|NCT01687426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65061929|NCT01687426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65061930|NCT01687426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65061931|NCT01687426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65061962|NCT00287937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061963|NCT01687894|Vasopressins|vasopressins|mesh-list
65061964|NCT01687894|Arginine Vasopressin|arginine vasopressin|mesh-list
65061965|NCT01687894|Propofol|propofol|mesh-list
65061966|NCT01687894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
65061967|NCT01687894|Anesthetics|anesthetics|mesh-list
65061968|NCT01687894|Sevoflurane|sevoflurane|mesh-list
65061969|NCT01687894|Anesthetics, General|anesthetics, general|mesh-list
65061970|NCT01687894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65061971|NCT01687894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65061972|NCT01687894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061973|NCT01687894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65061974|NCT01687894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65061975|NCT01687894|Hemostatics|hemostatics|mesh-ancestor
65062009|NCT00288171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062010|NCT00253955|Levofloxacin|levofloxacin|mesh-list
65062011|NCT00253955|Ofloxacin|ofloxacin|mesh-list
65062012|NCT00253955|Tazobactam|tazobactam|mesh-list
65062013|NCT00253955|Piperacillin|piperacillin|mesh-list
65062014|NCT00253955|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65062015|NCT00253955|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65062016|NCT00253955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65062017|NCT00253955|Renal Agents|renal agents|mesh-ancestor
65062050|NCT01600612|Oxytocin|oxytocin|mesh-list
65062051|NCT01600612|Carbetocin|carbetocin|mesh-list
65062052|NCT01600612|Oxytocics|oxytocics|mesh-ancestor
65062053|NCT01600612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65062054|NCT01600612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062055|NCT01600768|Lactams|lactams|mesh-list
65062056|NCT01600768|beta-Lactams|beta-lactams|mesh-list
65062057|NCT01600768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65062089|NCT00415064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062090|NCT00415064|Immunologic Factors|immunologic factors|mesh-ancestor
65062091|NCT00415064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65062092|NCT00415064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65062093|NCT00415064|Growth Substances|growth substances|mesh-ancestor
65062094|NCT00415064|Growth Inhibitors|growth inhibitors|mesh-ancestor
65062096|NCT00415103|Palonosetron|palonosetron|mesh-list
65062097|NCT00415103|Granisetron|granisetron|mesh-list
65062098|NCT00415103|Antiemetics|antiemetics|mesh-ancestor
65062099|NCT00415103|Autonomic Agents|autonomic agents|mesh-ancestor
65062100|NCT00415103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64914067|NCT00387413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65062130|NCT00254189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64567129|NCT02654119|Antibodies|antibodies|mesh-list
65062131|NCT00254189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65062132|NCT00254189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65062133|NCT00254189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65062134|NCT01600807|Gemcitabine|gemcitabine|mesh-list
65062135|NCT01600807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65062136|NCT01600807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65062137|NCT01600807|Antimetabolites|antimetabolites|mesh-ancestor
65062138|NCT01600807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062139|NCT01600807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062140|NCT01600807|Antiviral Agents|antiviral agents|mesh-ancestor
65062141|NCT01600807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65062142|NCT01600807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062143|NCT01600807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65062144|NCT01600807|Immunologic Factors|immunologic factors|mesh-ancestor
65062170|NCT01601002|Histamine Antagonists|histamine antagonists|mesh-ancestor
65062171|NCT01601002|Histamine Agents|histamine agents|mesh-ancestor
65062172|NCT01601002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65062173|NCT01601002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062174|NCT01601002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062175|NCT01601002|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65062176|NCT01601002|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65062177|NCT01601002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65062178|NCT01601002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65062179|NCT01601002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65062180|NCT01601002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65062181|NCT01601002|Adrenergic Agents|adrenergic agents|mesh-ancestor
65062182|NCT01601002|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65062183|NCT01601002|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65062184|NCT01601002|Serotonin Agents|serotonin agents|mesh-ancestor
65062185|NCT01601002|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65062186|NCT00288561|Ranibizumab|ranibizumab|mesh-list
65062187|NCT00288561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65062188|NCT00288561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65062189|NCT00288561|Growth Substances|growth substances|mesh-ancestor
65062190|NCT00288561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062191|NCT00288561|Growth Inhibitors|growth inhibitors|mesh-ancestor
65062192|NCT00288561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062193|NCT01607086|Lamotrigine|lamotrigine|mesh-list
65062218|NCT01607125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65062219|NCT01607125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65062220|NCT01607125|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65062221|NCT01607125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65062222|NCT00254345|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
65062223|NCT00254345|Vasodilator Agents|vasodilator agents|mesh-ancestor
65062224|NCT00254345|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65062225|NCT00254345|Protective Agents|protective agents|mesh-ancestor
65062226|NCT00254345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062228|NCT00254618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65062229|NCT00254618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65062231|NCT00254618|Sensory System Agents|sensory system agents|mesh-ancestor
65062232|NCT00254618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65062233|NCT00254618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062234|NCT00254618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65062235|NCT00254618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65062236|NCT00288717|Telmisartan|telmisartan|mesh-list
65062237|NCT00288717|Candesartan|candesartan|mesh-list
65062238|NCT00288717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65062239|NCT00288717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65062240|NCT00288717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65062274|NCT01607671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65062275|NCT01607671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65062276|NCT01607671|Adrenergic Agents|adrenergic agents|mesh-ancestor
65062277|NCT01607671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65062278|NCT01607671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062279|NCT01607671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65062280|NCT01607671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65062312|NCT01608139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65062314|NCT01608139|Analgesics|analgesics|mesh-ancestor
65062315|NCT01608139|Sensory System Agents|sensory system agents|mesh-ancestor
65062316|NCT01608139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65062317|NCT01608139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062318|NCT01608139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65062319|NCT01608139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65062320|NCT00288951|Travoprost|travoprost|mesh-list
65062321|NCT00288951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65062322|NCT00254774|Valproic Acid|valproic acid|mesh-list
65062323|NCT00254774|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65062324|NCT00254774|Antidepressive Agents|antidepressive agents|mesh-ancestor
65062354|NCT01608373|Sensory System Agents|sensory system agents|mesh-ancestor
65062355|NCT01608373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65062356|NCT01608373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65062357|NCT01608373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64936347|NCT00143299|Varenicline|varenicline|mesh-list
65062358|NCT01608373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65062359|NCT01608373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65062360|NCT01608373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062362|NCT01608412|Tacrolimus|tacrolimus|mesh-list
65062363|NCT01608412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65062364|NCT01608412|Immunologic Factors|immunologic factors|mesh-ancestor
65062365|NCT01608412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062366|NCT01608412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65062367|NCT01608412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062368|NCT01608412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062399|NCT02273440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65062400|NCT02273440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062401|NCT02273440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65062402|NCT02273440|Respiratory System Agents|respiratory system agents|mesh-ancestor
65062403|NCT02273440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65062404|NCT02273440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062405|NCT02273440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062406|NCT02273440|Vasodilator Agents|vasodilator agents|mesh-ancestor
65062407|NCT02273440|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65062408|NCT02273440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65062409|NCT02273440|Purinergic Agents|purinergic agents|mesh-ancestor
65062410|NCT02273440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65062411|NCT01588717|Glycopyrrolate|glycopyrrolate|mesh-list
64914375|NCT01465009|Aspirin|aspirin|mesh-list
65062433|NCT04719104|Antioxidants|antioxidants|mesh-ancestor
65062434|NCT04719104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062435|NCT04719104|Protective Agents|protective agents|mesh-ancestor
65062436|NCT04719104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062437|NCT01588795|Vitamin D|vitamin d|mesh-list
65062438|NCT01588795|Cholecalciferol|cholecalciferol|mesh-list
65062439|NCT01588795|Diuretics|diuretics|mesh-list
65062440|NCT01588795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65062441|NCT01588795|Vitamins|vitamins|mesh-ancestor
65062442|NCT01588795|Micronutrients|micronutrients|mesh-ancestor
65062443|NCT01588795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062444|NCT01588795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65062445|NCT01588795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65062446|NCT01588795|Natriuretic Agents|natriuretic agents|mesh-ancestor
65062447|NCT01588795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062448|NCT00107614|Rituximab|rituximab|mesh-list
65062449|NCT00107614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65062450|NCT00107614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062451|NCT00107614|Immunologic Factors|immunologic factors|mesh-ancestor
65062452|NCT00107614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062453|NCT00107614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65062454|NCT00255242|Simvastatin|simvastatin|mesh-list
65062455|NCT00255242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65062456|NCT00255242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65062457|NCT00255242|Antimetabolites|antimetabolites|mesh-ancestor
65062458|NCT00255242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062459|NCT00255242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65062460|NCT00255242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65062461|NCT00255242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062462|NCT00270114|Epoetin Alfa|epoetin alfa|mesh-list
65062463|NCT00270114|Hematinics|hematinics|mesh-ancestor
65062464|NCT00107380|Prednisone|prednisone|mesh-list
65062465|NCT00107380|Cyclophosphamide|cyclophosphamide|mesh-list
65062466|NCT00107380|Rituximab|rituximab|mesh-list
65062467|NCT00107380|Doxorubicin|doxorubicin|mesh-list
65062480|NCT00107380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65062481|NCT00107380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65062482|NCT00107380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65062483|NCT00107380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64830143|NCT01572012|Ondansetron|ondansetron|mesh-list
64503865|NCT02507076|Melphalan|melphalan|mesh-list
65062484|NCT00107380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062485|NCT00107380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65062486|NCT00107380|Glucocorticoids|glucocorticoids|mesh-ancestor
65062487|NCT00107380|Hormones|hormones|mesh-ancestor
65062488|NCT00107380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65062489|NCT00107380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65062490|NCT00107380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65062491|NCT00107380|Tubulin Modulators|tubulin modulators|mesh-ancestor
65062492|NCT00107380|Antimitotic Agents|antimitotic agents|mesh-ancestor
65062493|NCT00107380|Mitosis Modulators|mitosis modulators|mesh-ancestor
65062494|NCT00270153|Enalapril|enalapril|mesh-list
65062495|NCT00270153|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65062496|NCT00270153|Protease Inhibitors|protease inhibitors|mesh-ancestor
65062497|NCT00270153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062498|NCT00270153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062499|NCT00270153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65062500|NCT04050085|Nivolumab|nivolumab|mesh-list
65062501|NCT04050085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65062502|NCT04050085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062503|NCT04050085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65062504|NCT04050085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062505|NCT04054531|Paclitaxel|paclitaxel|mesh-list
65062507|NCT04054531|Pemetrexed|pemetrexed|mesh-list
65062508|NCT04054531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65062509|NCT04054531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062510|NCT04054531|Tubulin Modulators|tubulin modulators|mesh-ancestor
65062511|NCT04054531|Antimitotic Agents|antimitotic agents|mesh-ancestor
65062512|NCT04054531|Mitosis Modulators|mitosis modulators|mesh-ancestor
65062513|NCT04054531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062514|NCT04054531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062515|NCT04054531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65062516|NCT04054531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65062517|NCT00289263|Paclitaxel|paclitaxel|mesh-list
65062518|NCT00289263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65062519|NCT00289263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062520|NCT00289263|Tubulin Modulators|tubulin modulators|mesh-ancestor
65062521|NCT00289263|Antimitotic Agents|antimitotic agents|mesh-ancestor
65062522|NCT00289263|Mitosis Modulators|mitosis modulators|mesh-ancestor
65062523|NCT00289263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062524|NCT00255437|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65062525|NCT00255437|Hematinics|hematinics|mesh-ancestor
65062526|NCT00255437|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65062527|NCT00255437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65062528|NCT00255476|Gefitinib|gefitinib|mesh-list
65062529|NCT00255476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062554|NCT00289419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062556|NCT00289419|Sensory System Agents|sensory system agents|mesh-ancestor
65062557|NCT00289419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65062558|NCT00289419|Anesthetics, Local|anesthetics, local|mesh-ancestor
65062559|NCT00289419|Anesthetics|anesthetics|mesh-ancestor
65062560|NCT00289419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65062561|NCT00289419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65062562|NCT00289419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65062563|NCT00289419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65062564|NCT00289419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65062565|NCT00289419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062566|NCT00289419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062567|NCT00289419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65062568|NCT00289419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65062569|NCT00289419|Adrenergic Agents|adrenergic agents|mesh-ancestor
65062570|NCT00289419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65062571|NCT00289419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65062572|NCT00289419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65062573|NCT00289419|Autonomic Agents|autonomic agents|mesh-ancestor
65062574|NCT00289419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65062575|NCT00289419|Respiratory System Agents|respiratory system agents|mesh-ancestor
65062576|NCT00289419|Mydriatics|mydriatics|mesh-ancestor
65062577|NCT00289419|Sympathomimetics|sympathomimetics|mesh-ancestor
65062578|NCT00289419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65062579|NCT00255554|Citalopram|citalopram|mesh-list
65062580|NCT00255554|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65062581|NCT00255554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65062603|NCT00270387|Natriuretic Agents|natriuretic agents|mesh-ancestor
65062604|NCT00270387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062605|NCT00255710|Mycophenolic Acid|mycophenolic acid|mesh-list
65062606|NCT00255710|Cyclophosphamide|cyclophosphamide|mesh-list
65062607|NCT00255710|Fludarabine|fludarabine|mesh-list
65062608|NCT00255710|Fludarabine phosphate|fludarabine phosphate|mesh-list
65062609|NCT00255710|Tacrolimus|tacrolimus|mesh-list
65062610|NCT00255710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65062611|NCT00255710|Immunologic Factors|immunologic factors|mesh-ancestor
65062612|NCT00255710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062613|NCT00255710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65062614|NCT00255710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65062615|NCT00255710|Alkylating Agents|alkylating agents|mesh-ancestor
65062616|NCT00255710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062617|NCT00255710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062618|NCT00255710|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65062619|NCT00255710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65062620|NCT00255710|Antimetabolites|antimetabolites|mesh-ancestor
65062621|NCT00255710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65062622|NCT00255710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062623|NCT00255710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65062624|NCT00255710|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65062625|NCT00255710|Antitubercular Agents|antitubercular agents|mesh-ancestor
65062626|NCT00255710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65062627|NCT00255710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65062628|NCT00270426|Benazepril|benazepril|mesh-list
65062629|NCT00270426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65062630|NCT00270426|Protease Inhibitors|protease inhibitors|mesh-ancestor
65062631|NCT00270426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062632|NCT00270426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062633|NCT00270426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65062662|NCT02960919|Amoxicillin|amoxicillin|mesh-list
65062663|NCT02960919|Gentamicins|gentamicins|mesh-list
65062664|NCT02960919|Penicillins|penicillins|mesh-list
65062665|NCT02960919|Ampicillin|ampicillin|mesh-list
65062666|NCT02960919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65062667|NCT02960919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65062668|NCT02960919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65062669|NCT02960919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062670|NCT02960919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062671|NCT00270582|Gemcitabine|gemcitabine|mesh-list
65062672|NCT00270582|Docetaxel|docetaxel|mesh-list
65062673|NCT00270582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062674|NCT00270582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65062675|NCT00270582|Antimetabolites|antimetabolites|mesh-ancestor
65062676|NCT00270582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062677|NCT00270582|Antiviral Agents|antiviral agents|mesh-ancestor
65062678|NCT00270582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65062679|NCT00270582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062680|NCT00270582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65062681|NCT00270582|Immunologic Factors|immunologic factors|mesh-ancestor
65062682|NCT00270582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062683|NCT00270582|Tubulin Modulators|tubulin modulators|mesh-ancestor
65062684|NCT00270582|Antimitotic Agents|antimitotic agents|mesh-ancestor
65062685|NCT00270582|Mitosis Modulators|mitosis modulators|mesh-ancestor
65062756|NCT00270777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65062758|NCT00270777|Adrenergic Agents|adrenergic agents|mesh-ancestor
65062759|NCT00270777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65062760|NCT00270777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062761|NCT00270777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062762|NCT00270777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65062763|NCT00270777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65062764|NCT00270777|Autonomic Agents|autonomic agents|mesh-ancestor
65062765|NCT00270777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65062793|NCT00256334|Antioxidants|antioxidants|mesh-ancestor
65062794|NCT00256334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062795|NCT00256334|Protective Agents|protective agents|mesh-ancestor
65062796|NCT00256334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062797|NCT00256334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062798|NCT00256334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65062799|NCT01609855|Scopolamine|scopolamine|mesh-list
65062800|NCT01609855|Bromides|bromides|mesh-list
65062801|NCT01609855|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65062802|NCT01609855|Anticonvulsants|anticonvulsants|mesh-ancestor
65062803|NCT01609855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65062804|NCT01609855|Antiemetics|antiemetics|mesh-ancestor
64567437|NCT02541955|Hormones|hormones|mesh-ancestor
65062805|NCT01609855|Autonomic Agents|autonomic agents|mesh-ancestor
65062806|NCT01609855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65062807|NCT01609855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062808|NCT01609855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65062809|NCT01609855|Mydriatics|mydriatics|mesh-ancestor
65062810|NCT01609855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65062811|NCT01609855|Cholinergic Agents|cholinergic agents|mesh-ancestor
65062812|NCT01609855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65062813|NCT01609855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062814|NCT01609855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65062840|NCT00290082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65062841|NCT00290082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65062842|NCT00290082|Anesthetics, General|anesthetics, general|mesh-ancestor
65062844|NCT00290082|GABA Modulators|gaba modulators|mesh-ancestor
65062845|NCT00290082|GABA Agents|gaba agents|mesh-ancestor
65062846|NCT00290082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65062847|NCT00290082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062848|NCT00290082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65062849|NCT00290082|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65062850|NCT00290082|Dopamine Agents|dopamine agents|mesh-ancestor
65062851|NCT00256646|Rosiglitazone|rosiglitazone|mesh-list
65062852|NCT00256646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65062853|NCT00256646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062854|NCT02270437|Epinephrine|epinephrine|mesh-list
65062855|NCT02270437|Racepinephrine|racepinephrine|mesh-list
65062856|NCT02270437|Fentanyl|fentanyl|mesh-list
65062857|NCT02270437|Ropivacaine|ropivacaine|mesh-list
65062858|NCT02270437|Epinephryl borate|epinephryl borate|mesh-list
65062859|NCT02270437|Anesthetics, Local|anesthetics, local|mesh-ancestor
65062860|NCT02270437|Anesthetics|anesthetics|mesh-ancestor
65062861|NCT02270437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65062862|NCT02270437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062863|NCT02270437|Sensory System Agents|sensory system agents|mesh-ancestor
65062864|NCT02270437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65062865|NCT02270437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65062866|NCT02270437|Narcotics|narcotics|mesh-ancestor
64914814|NCT03521570|Nivolumab|nivolumab|mesh-list
65062900|NCT02270788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062901|NCT02270788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65062902|NCT02270788|Antimetabolites|antimetabolites|mesh-ancestor
65062903|NCT02270788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062904|NCT02270788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062905|NCT02270788|Dermatologic Agents|dermatologic agents|mesh-ancestor
65062906|NCT02270788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062907|NCT02270788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65062908|NCT02270788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65062909|NCT02270788|Immunologic Factors|immunologic factors|mesh-ancestor
65062910|NCT02270788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65062911|NCT02270788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65062912|NCT02270788|Antiviral Agents|antiviral agents|mesh-ancestor
65062913|NCT02270788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65062944|NCT00290121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65062945|NCT00290121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65062946|NCT00290121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65062947|NCT00290121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65062948|NCT00290121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65062949|NCT00290121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65062950|NCT00290121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65062951|NCT00290121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65062952|NCT00290121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062953|NCT00290121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65062956|NCT04709744|Ergocalciferols|ergocalciferols|mesh-list
65062957|NCT04709744|Cholecalciferol|cholecalciferol|mesh-list
65062958|NCT04709744|Vitamins|vitamins|mesh-list
65062959|NCT04709744|Micronutrients|micronutrients|mesh-ancestor
65062960|NCT04709744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914906|NCT00276757|Mitosis Modulators|mitosis modulators|mesh-ancestor
65062984|NCT02271646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062985|NCT02271646|Sensory System Agents|sensory system agents|mesh-ancestor
65062986|NCT02271646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65062987|NCT02271802|Butyric Acid|butyric acid|mesh-list
65062988|NCT02271802|Histamine Antagonists|histamine antagonists|mesh-ancestor
65062989|NCT02271802|Histamine Agents|histamine agents|mesh-ancestor
65062990|NCT02271802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65248450|NCT02548117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65062991|NCT02271802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062992|NCT02271802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062993|NCT02271958|Mifepristone|mifepristone|mesh-list
65062994|NCT02271958|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65062995|NCT02271958|Abortifacient Agents|abortifacient agents|mesh-ancestor
65062996|NCT02271958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65062997|NCT02271958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062998|NCT02271958|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65062999|NCT02271958|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65063000|NCT02271958|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65063001|NCT02271958|Contraceptive Agents|contraceptive agents|mesh-ancestor
65063002|NCT02271958|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65063003|NCT02271958|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65063004|NCT02271958|Hormone Antagonists|hormone antagonists|mesh-ancestor
65063005|NCT02271958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65063006|NCT02271958|Luteolytic Agents|luteolytic agents|mesh-ancestor
64914953|NCT00276601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65063036|NCT02272270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65063037|NCT02272270|Alkylating Agents|alkylating agents|mesh-ancestor
65063038|NCT02272270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063040|NCT02272270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65063041|NCT02272270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65063043|NCT02272387|Cholecalciferol|cholecalciferol|mesh-list
65063044|NCT02272387|Vitamins|vitamins|mesh-ancestor
65063045|NCT02272387|Micronutrients|micronutrients|mesh-ancestor
65063046|NCT02272387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063047|NCT02272387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65063048|NCT02272387|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65063049|NCT00257114|Bortezomib|bortezomib|mesh-list
65063050|NCT00257114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063051|NCT00271206|Progesterone|progesterone|mesh-list
64915002|NCT00276250|Abatacept|abatacept|mesh-list
65063082|NCT02272699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64548361|NCT05740449|Decitabine|decitabine|mesh-list
64548362|NCT05740449|Venetoclax|venetoclax|mesh-list
64548363|NCT05740449|Navitoclax|navitoclax|mesh-list
64548364|NCT05740449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64548365|NCT05740449|Antimetabolites|antimetabolites|mesh-ancestor
64548366|NCT05740449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548367|NCT05740449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548368|NCT05740449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64548369|NCT03485677|Eliglustat|eliglustat|mesh-list
64548370|NCT03485677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915046|NCT00276055|Antiviral Agents|antiviral agents|mesh-ancestor
65063113|NCT00257270|Gabapentin|gabapentin|mesh-list
65063114|NCT00257270|Analgesics|analgesics|mesh-ancestor
65063115|NCT00257270|Sensory System Agents|sensory system agents|mesh-ancestor
65063116|NCT00257270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65063117|NCT00257270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063118|NCT00257270|Anticonvulsants|anticonvulsants|mesh-ancestor
65063119|NCT00257270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65063120|NCT00257270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65063121|NCT00257270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65063122|NCT00257270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65063123|NCT00257270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65063124|NCT00257270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65063157|NCT00257426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65063158|NCT00257426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65063159|NCT00257426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063162|NCT01601509|Autonomic Agents|autonomic agents|mesh-ancestor
65063163|NCT01601509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65063164|NCT01601509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063165|NCT00416325|Lycopene|lycopene|mesh-list
65063166|NCT00416325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65063167|NCT00416325|Antioxidants|antioxidants|mesh-ancestor
64915132|NCT02921555|Hormones|hormones|mesh-ancestor
65063195|NCT01601899|Antimetabolites|antimetabolites|mesh-ancestor
65063197|NCT01601938|Antioxidants|antioxidants|mesh-ancestor
65063198|NCT01601938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063199|NCT01601938|Protective Agents|protective agents|mesh-ancestor
65063200|NCT01601938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063201|NCT01601938|Trace Elements|trace elements|mesh-ancestor
65063202|NCT01601938|Micronutrients|micronutrients|mesh-ancestor
65063203|NCT01602055|Azithromycin|azithromycin|mesh-list
65063204|NCT01602055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65063205|NCT01602055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65063206|NCT01602250|Ropivacaine|ropivacaine|mesh-list
65063207|NCT01602250|Levobupivacaine|levobupivacaine|mesh-list
65063208|NCT01602250|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65063209|NCT01602250|Anesthetics, Local|anesthetics, local|mesh-ancestor
65063210|NCT01602250|Anesthetics|anesthetics|mesh-ancestor
65063211|NCT01602250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65063212|NCT01602250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063213|NCT01602250|Sensory System Agents|sensory system agents|mesh-ancestor
65063241|NCT00257621|Antiviral Agents|antiviral agents|mesh-ancestor
65063242|NCT00257621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65063243|NCT00257621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65063244|NCT00257621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65063245|NCT01602406|Trastuzumab|trastuzumab|mesh-list
65063246|NCT01602406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65063247|NCT01602406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063248|NCT00290628|Cyclosporine|cyclosporine|mesh-list
65063249|NCT00290628|Mycophenolic Acid|mycophenolic acid|mesh-list
65063250|NCT00290628|Methylprednisolone|methylprednisolone|mesh-list
65063251|NCT00290628|Cyclophosphamide|cyclophosphamide|mesh-list
65063252|NCT00290628|Melphalan|melphalan|mesh-list
65063253|NCT00290628|Busulfan|busulfan|mesh-list
65063254|NCT00290628|Cyclosporins|cyclosporins|mesh-list
65063255|NCT00290628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65063256|NCT00290628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65063257|NCT00290628|Immunologic Factors|immunologic factors|mesh-ancestor
65063258|NCT00290628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063259|NCT00290628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65063260|NCT00290628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65063261|NCT00290628|Alkylating Agents|alkylating agents|mesh-ancestor
64915222|NCT04599478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65063279|NCT00290628|Glucocorticoids|glucocorticoids|mesh-ancestor
65063280|NCT00290628|Hormones|hormones|mesh-ancestor
65063281|NCT00290628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65063282|NCT00290628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65063283|NCT00290628|Protective Agents|protective agents|mesh-ancestor
65063284|NCT01602523|Budesonide|budesonide|mesh-list
65063285|NCT01602523|Formoterol Fumarate|formoterol fumarate|mesh-list
65063286|NCT01602523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65063287|NCT01602523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65063288|NCT01602523|Autonomic Agents|autonomic agents|mesh-ancestor
65063289|NCT01602523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65063290|NCT01602523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063291|NCT01602523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65063292|NCT01602523|Respiratory System Agents|respiratory system agents|mesh-ancestor
65063293|NCT01602523|Glucocorticoids|glucocorticoids|mesh-ancestor
65063294|NCT01602523|Hormones|hormones|mesh-ancestor
65063295|NCT01602523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65063296|NCT01602523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65063297|NCT01602523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65063298|NCT01602523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65063299|NCT01602523|Adrenergic Agents|adrenergic agents|mesh-ancestor
65063300|NCT01602523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65063301|NCT01602523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063302|NCT00415298|Oxaliplatin|oxaliplatin|mesh-list
65063303|NCT00415298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063304|NCT01602640|Fentanyl|fentanyl|mesh-list
65063305|NCT01602640|Midazolam|midazolam|mesh-list
65063306|NCT01602640|Morphine|morphine|mesh-list
65063307|NCT01602640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65063308|NCT01602640|Narcotics|narcotics|mesh-ancestor
65063309|NCT01602640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65063310|NCT01602640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063311|NCT01602640|Analgesics|analgesics|mesh-ancestor
65063312|NCT01602640|Sensory System Agents|sensory system agents|mesh-ancestor
65063313|NCT01602640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65063314|NCT01602640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65063315|NCT01602640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65063316|NCT01602640|Anesthetics, General|anesthetics, general|mesh-ancestor
65063317|NCT01602640|Anesthetics|anesthetics|mesh-ancestor
65063318|NCT01602640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65063319|NCT01602640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65063352|NCT00290667|Tubulin Modulators|tubulin modulators|mesh-ancestor
65063353|NCT00290667|Antimitotic Agents|antimitotic agents|mesh-ancestor
65063354|NCT00290667|Mitosis Modulators|mitosis modulators|mesh-ancestor
65063356|NCT01602757|Tetracaine|tetracaine|mesh-list
65063357|NCT01602757|Anesthetics, Local|anesthetics, local|mesh-ancestor
65063358|NCT01602757|Anesthetics|anesthetics|mesh-ancestor
65063359|NCT01602757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64472897|NCT02318342|Warfarin|warfarin|mesh-list
65063360|NCT01602757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063361|NCT01602757|Sensory System Agents|sensory system agents|mesh-ancestor
65063389|NCT01602913|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65063390|NCT01602913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65063391|NCT01602913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063392|NCT01602913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65063393|NCT01602913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65063394|NCT01602913|Antimetabolites|antimetabolites|mesh-ancestor
65063395|NCT01602913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65063396|NCT01602913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65063397|NCT00257699|Metronidazole|metronidazole|mesh-list
65063398|NCT00257699|Ciprofloxacin|ciprofloxacin|mesh-list
65063399|NCT00257699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65063400|NCT00257699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65063401|NCT00257699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65063402|NCT00257699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65063403|NCT00257699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65063404|NCT00257699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65063405|NCT00257699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063435|NCT01603030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65063436|NCT01603030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063437|NCT01603030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063438|NCT01603030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65063439|NCT01603030|Contraceptive Agents|contraceptive agents|mesh-ancestor
65063440|NCT01603030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65063441|NCT01603030|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65063442|NCT01603030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65063443|NCT01603030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65063444|NCT01603108|Rifaximin|rifaximin|mesh-list
65063445|NCT01603108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65063446|NCT01603108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65063478|NCT01603186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65063479|NCT01603186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65063480|NCT01603186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65063481|NCT01603186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063482|NCT00271284|Insulin|insulin|mesh-list
65063483|NCT00271284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65063484|NCT00271284|Insulin Glargine|insulin glargine|mesh-list
65063485|NCT00271284|Insulin Detemir|insulin detemir|mesh-list
65063486|NCT00271284|Insulin glulisine|insulin glulisine|mesh-list
65063487|NCT00271284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65063488|NCT00271284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063489|NCT00257816|Topotecan|topotecan|mesh-list
65063490|NCT00257816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063522|NCT01603498|Dexamethasone|dexamethasone|mesh-list
65063523|NCT01603498|Methylprednisolone|methylprednisolone|mesh-list
65063524|NCT01603498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65063525|NCT01603498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65063526|NCT01603498|Prednisolone|prednisolone|mesh-list
65063527|NCT01603498|Prednisolone acetate|prednisolone acetate|mesh-list
65063528|NCT01603498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65063529|NCT01603498|Prednisolone phosphate|prednisolone phosphate|mesh-list
65063530|NCT01603498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65063557|NCT00257972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65063558|NCT00257972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65063559|NCT00257972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65063560|NCT00257972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063561|NCT00257972|Dopamine Agonists|dopamine agonists|mesh-ancestor
65063562|NCT00257972|Dopamine Agents|dopamine agents|mesh-ancestor
65063563|NCT00257972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65063564|NCT00257972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063565|NCT00257972|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65063566|NCT00257972|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65063567|NCT00257972|Serotonin Agents|serotonin agents|mesh-ancestor
65063568|NCT00257972|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65063569|NCT00257972|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65063570|NCT00257972|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65063571|NCT00257972|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65063573|NCT01603693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65063574|NCT01603693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063575|NCT00258050|Lapatinib|lapatinib|mesh-list
65063576|NCT00258050|Midazolam|midazolam|mesh-list
65063577|NCT00258050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65063578|NCT00258050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64567733|NCT01890889|Ezetimibe|ezetimibe|mesh-list
65063610|NCT00258089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65063611|NCT00258089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65063613|NCT00290901|Tramadol|tramadol|mesh-list
65063614|NCT00290901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65063615|NCT00290901|Narcotics|narcotics|mesh-ancestor
65063616|NCT00290901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65063617|NCT00290901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063618|NCT00290901|Analgesics|analgesics|mesh-ancestor
65063619|NCT00290901|Sensory System Agents|sensory system agents|mesh-ancestor
65063620|NCT00290901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65063621|NCT00290901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65063651|NCT00258245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063652|NCT00258245|Protease Inhibitors|protease inhibitors|mesh-ancestor
65063653|NCT00258245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063654|NCT00258245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063655|NCT00258245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65063656|NCT00258245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65063657|NCT00258245|Analgesics|analgesics|mesh-ancestor
65063658|NCT00258245|Sensory System Agents|sensory system agents|mesh-ancestor
65063659|NCT00258245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65063660|NCT00258245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65063661|NCT00258245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65063662|NCT00258245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65063663|NCT00258245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65063664|NCT00258245|Antipyretics|antipyretics|mesh-ancestor
65063665|NCT00258245|Antioxidants|antioxidants|mesh-ancestor
65063666|NCT00258245|Protective Agents|protective agents|mesh-ancestor
65063667|NCT00258245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65063668|NCT00258245|Immunologic Factors|immunologic factors|mesh-ancestor
65063697|NCT01604629|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65063699|NCT00258284|Capecitabine|capecitabine|mesh-list
65063700|NCT00258284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063701|NCT00258284|Tubulin Modulators|tubulin modulators|mesh-ancestor
65063702|NCT00258284|Antimitotic Agents|antimitotic agents|mesh-ancestor
65063703|NCT00258284|Mitosis Modulators|mitosis modulators|mesh-ancestor
65063704|NCT00258284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063705|NCT00258284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65063706|NCT00258284|Antimetabolites|antimetabolites|mesh-ancestor
65063707|NCT00290940|Metformin|metformin|mesh-list
65063709|NCT00290940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65063710|NCT00290940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063711|NCT00258323|Fluorouracil|fluorouracil|mesh-list
65063712|NCT00258323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063713|NCT00258323|Antimetabolites|antimetabolites|mesh-ancestor
65063714|NCT00258323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063715|NCT00258323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65063716|NCT00258323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65063717|NCT00258323|Immunologic Factors|immunologic factors|mesh-ancestor
64915681|NCT00084916|Sirolimus|sirolimus|mesh-list
65063749|NCT01340014|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65063750|NCT01340014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65063751|NCT01340014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65063752|NCT01340014|Adrenergic Agents|adrenergic agents|mesh-ancestor
65063753|NCT01340014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65063754|NCT01340014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063755|NCT01340014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063756|NCT01340014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65063757|NCT01340014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65063758|NCT01340014|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65063759|NCT01340014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063787|NCT00258596|Immunologic Factors|immunologic factors|mesh-ancestor
65063788|NCT00258596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063789|NCT01339273|Anesthetics|anesthetics|mesh-list
65063790|NCT01339273|Anesthetics, Local|anesthetics, local|mesh-list
65063791|NCT01339273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65063792|NCT01339273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063793|NCT01339273|Sensory System Agents|sensory system agents|mesh-ancestor
65063794|NCT01339273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65063795|NCT04709315|Choline|choline|mesh-list
65063796|NCT04709315|Rocuronium|rocuronium|mesh-list
65063797|NCT04709315|Succinylcholine|succinylcholine|mesh-list
65063798|NCT04709315|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65063799|NCT04709315|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64472899|NCT02134184|Vaccines|vaccines|mesh-list
65063800|NCT04709315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65063801|NCT04709315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65063802|NCT04709315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063803|NCT04709315|Lipotropic Agents|lipotropic agents|mesh-ancestor
65063804|NCT04709315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65063805|NCT04709315|Antimetabolites|antimetabolites|mesh-ancestor
65063806|NCT04709315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063843|NCT01332799|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65063844|NCT01332799|Antioxidants|antioxidants|mesh-ancestor
65063845|NCT01332799|Protective Agents|protective agents|mesh-ancestor
65063846|NCT01332799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063873|NCT00291369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65063875|NCT00291369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65063876|NCT00291369|Contraceptive Agents|contraceptive agents|mesh-ancestor
65063877|NCT00291369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65063878|NCT00291369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65063879|NCT00291369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65063880|NCT00291369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65063881|NCT00291369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65063882|NCT00291408|Nitric Oxide|nitric oxide|mesh-list
65063883|NCT00291408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65063884|NCT00291408|Autonomic Agents|autonomic agents|mesh-ancestor
65063885|NCT00291408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65063886|NCT00291408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063887|NCT00291408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65063888|NCT00291408|Respiratory System Agents|respiratory system agents|mesh-ancestor
65063889|NCT00291408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65063890|NCT00291408|Antioxidants|antioxidants|mesh-ancestor
65063891|NCT00291408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063892|NCT00291408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65063893|NCT00291408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65063929|NCT00259142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65063930|NCT00259142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65063931|NCT00259142|Antimalarials|antimalarials|mesh-ancestor
65063932|NCT00259142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65063933|NCT00259142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65063934|NCT00259142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063935|NCT00259142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063936|NCT00259142|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65063971|NCT00291759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65063972|NCT00291759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063973|NCT00291759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65063975|NCT00291759|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65063976|NCT00291759|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64915948|NCT00006098|Bortezomib|bortezomib|mesh-list
65064002|NCT04709081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65064003|NCT04709081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65064004|NCT04709081|Anesthetics, General|anesthetics, general|mesh-ancestor
65064005|NCT04709081|Anesthetics|anesthetics|mesh-ancestor
65064006|NCT04709081|GABA Modulators|gaba modulators|mesh-ancestor
65064007|NCT04709081|GABA Agents|gaba agents|mesh-ancestor
65064008|NCT04709081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65064009|NCT04709081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064010|NCT04709081|Antifungal Agents|antifungal agents|mesh-ancestor
65064011|NCT04709081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65064012|NCT04709081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65064013|NCT04709081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65064014|NCT04709081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064015|NCT04709081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65064016|NCT04709081|Hormone Antagonists|hormone antagonists|mesh-ancestor
65064017|NCT04709081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65064018|NCT04709081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65064019|NCT04709081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65064020|NCT04709081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65064021|NCT04709081|Protective Agents|protective agents|mesh-ancestor
65064023|NCT00272064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64915990|NCT00086944|Rituximab|rituximab|mesh-list
65064052|NCT00291915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064054|NCT00291915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064055|NCT00291915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65064056|NCT00291915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64830914|NCT01577524|Povidone|povidone|mesh-list
65064057|NCT00291915|Immunologic Factors|immunologic factors|mesh-ancestor
65064058|NCT00291915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64505435|NCT03858322|Cyclophosphamide|cyclophosphamide|mesh-list
64549335|NCT05685277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549340|NCT05685277|Protease Inhibitors|protease inhibitors|mesh-ancestor
65064059|NCT00291915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65064060|NCT00291915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65064061|NCT00259766|Budesonide|budesonide|mesh-list
65064062|NCT00259766|Terbutaline|terbutaline|mesh-list
65064063|NCT00259766|Formoterol Fumarate|formoterol fumarate|mesh-list
65064064|NCT00259766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65064065|NCT00259766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65064066|NCT00259766|Autonomic Agents|autonomic agents|mesh-ancestor
65064067|NCT00259766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65064068|NCT00259766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064069|NCT00259766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65064070|NCT00259766|Respiratory System Agents|respiratory system agents|mesh-ancestor
65064071|NCT00259766|Glucocorticoids|glucocorticoids|mesh-ancestor
65064105|NCT00259883|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65064106|NCT00259883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65064107|NCT00259883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65064108|NCT00259883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064109|NCT00259883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65064110|NCT00259883|Serotonin Agents|serotonin agents|mesh-ancestor
65064111|NCT00259883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916086|NCT04762953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064125|NCT04718376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65064126|NCT04718376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064127|NCT04718376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064128|NCT00272415|Temozolomide|temozolomide|mesh-list
65064129|NCT00272415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65064130|NCT00272415|Alkylating Agents|alkylating agents|mesh-ancestor
65064131|NCT00272415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064132|NCT00272415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064134|NCT00259922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65064135|NCT00272454|Aspirin|aspirin|mesh-list
65064136|NCT00272454|Cilostazol|cilostazol|mesh-list
65064137|NCT00272454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65064138|NCT00272454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65064139|NCT00272454|Analgesics|analgesics|mesh-ancestor
65064140|NCT00272454|Sensory System Agents|sensory system agents|mesh-ancestor
65064141|NCT00272454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64938157|NCT00847587|Hormones|hormones|mesh-ancestor
65064166|NCT00292266|Immunologic Factors|immunologic factors|mesh-ancestor
65064167|NCT00292266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064168|NCT00292266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064170|NCT00292266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65064171|NCT00260039|Vaccines|vaccines|mesh-list
65064172|NCT00260039|Immunologic Factors|immunologic factors|mesh-ancestor
65064173|NCT00260039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064174|NCT00292344|Rifaximin|rifaximin|mesh-list
65064175|NCT00292344|Loperamide|loperamide|mesh-list
65064176|NCT00292344|Antidiarrheals|antidiarrheals|mesh-list
65064177|NCT00292344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65064178|NCT00292344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65064179|NCT00292344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65064180|NCT00417768|Plasminogen|plasminogen|mesh-list
65064181|NCT00417768|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65064182|NCT00417768|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65064183|NCT00417768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65064184|NCT00417768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064185|NCT00272610|Vitamin A|vitamin a|mesh-list
65064186|NCT00272610|Vitamins|vitamins|mesh-ancestor
65064187|NCT00272610|Micronutrients|micronutrients|mesh-ancestor
65064188|NCT00272610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064189|NCT00260351|Vaccines|vaccines|mesh-list
65064190|NCT00260351|Immunologic Factors|immunologic factors|mesh-ancestor
65064191|NCT00260351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064192|NCT00272688|Levodopa|levodopa|mesh-list
65064193|NCT00272688|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65064224|NCT00292734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65064225|NCT00292734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65064226|NCT00292734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064227|NCT00292734|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65064228|NCT00292734|GABA Agonists|gaba agonists|mesh-ancestor
65064229|NCT00292734|GABA Agents|gaba agents|mesh-ancestor
65064230|NCT00292734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65064231|NCT00292734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064232|NCT00260702|Omalizumab|omalizumab|mesh-list
65064233|NCT00260702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65064234|NCT00260702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65064266|NCT00424853|Antimetabolites|antimetabolites|mesh-ancestor
65064267|NCT00424853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064268|NCT00424853|Antiviral Agents|antiviral agents|mesh-ancestor
64505657|NCT01726738|Dabrafenib|dabrafenib|mesh-list
65064269|NCT00424853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65064270|NCT00424853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064271|NCT00424853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65064272|NCT00424853|Immunologic Factors|immunologic factors|mesh-ancestor
65064273|NCT00424853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064274|NCT00424853|Tubulin Modulators|tubulin modulators|mesh-ancestor
65064275|NCT00424853|Antimitotic Agents|antimitotic agents|mesh-ancestor
65064276|NCT00424853|Mitosis Modulators|mitosis modulators|mesh-ancestor
65064277|NCT00298506|Mycophenolic Acid|mycophenolic acid|mesh-list
65064278|NCT00298506|Tacrolimus|tacrolimus|mesh-list
65064279|NCT00298506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65064280|NCT00298506|Immunologic Factors|immunologic factors|mesh-ancestor
65064313|NCT00298545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064314|NCT00298545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65064315|NCT00298545|Vitamins|vitamins|mesh-ancestor
65064316|NCT00298545|Micronutrients|micronutrients|mesh-ancestor
65064340|NCT01330459|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65064341|NCT01330459|Lidocaine|lidocaine|mesh-list
65064342|NCT01330459|Hydrocodone|hydrocodone|mesh-list
65064344|NCT01330459|Anesthetics, Local|anesthetics, local|mesh-ancestor
65064345|NCT01330459|Anesthetics|anesthetics|mesh-ancestor
65064346|NCT01330459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65064347|NCT01330459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064348|NCT01330459|Sensory System Agents|sensory system agents|mesh-ancestor
65064349|NCT01330459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65064350|NCT01330459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65064351|NCT01330459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65064352|NCT01330459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65064353|NCT01330459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65064354|NCT01330459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064355|NCT01330459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65064356|NCT01330459|Analgesics|analgesics|mesh-ancestor
65064357|NCT01330459|Antipyretics|antipyretics|mesh-ancestor
65064358|NCT01330459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65064359|NCT01330459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65064360|NCT01330459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65064361|NCT01330459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65064362|NCT01330459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064363|NCT01330459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65064364|NCT01330459|Narcotics|narcotics|mesh-ancestor
65064365|NCT01330459|Antitussive Agents|antitussive agents|mesh-ancestor
65064366|NCT01330459|Respiratory System Agents|respiratory system agents|mesh-ancestor
65064367|NCT01330459|Anticonvulsants|anticonvulsants|mesh-ancestor
65064368|NCT01330459|Antiemetics|antiemetics|mesh-ancestor
65064369|NCT01330459|Autonomic Agents|autonomic agents|mesh-ancestor
64916360|NCT00088933|Docetaxel|docetaxel|mesh-list
65064404|NCT01330381|Laxatives|laxatives|mesh-ancestor
65064405|NCT01330381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65064406|NCT01330381|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65064407|NCT01330381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65064408|NCT01330381|Serotonin Agents|serotonin agents|mesh-ancestor
65064409|NCT01330381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65064410|NCT01330381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916403|NCT00089089|Antimetabolites|antimetabolites|mesh-ancestor
65064436|NCT00261170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65064437|NCT00261170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65064438|NCT00261170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65064439|NCT00261170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064440|NCT00261170|Dopamine Agents|dopamine agents|mesh-ancestor
65064441|NCT00261170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65064442|NCT00261170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064443|NCT00261170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65064444|NCT00261170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65064445|NCT00261170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064447|NCT00261287|Glucocorticoids|glucocorticoids|mesh-ancestor
65064448|NCT00261287|Hormones|hormones|mesh-ancestor
65064449|NCT00261287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65064450|NCT00261287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064451|NCT00261287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65064452|NCT00261326|Simvastatin|simvastatin|mesh-list
65064453|NCT00261326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65064454|NCT00261326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65064455|NCT00261326|Antimetabolites|antimetabolites|mesh-ancestor
65064456|NCT00261326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064487|NCT00261482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65064488|NCT00261482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064489|NCT00261482|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65064490|NCT00261482|Contraceptive Agents|contraceptive agents|mesh-ancestor
65064491|NCT00261482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65064492|NCT00261482|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65064493|NCT00261482|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65064494|NCT00261482|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65064497|NCT00298857|Valproic Acid|valproic acid|mesh-list
65064498|NCT00298857|Anticonvulsants|anticonvulsants|mesh-ancestor
65064499|NCT00298857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064500|NCT00298857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064501|NCT00298857|GABA Agents|gaba agents|mesh-ancestor
65064502|NCT00298857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65064503|NCT00298857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064532|NCT00293319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064533|NCT00293319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064534|NCT00293319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064535|NCT00293319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65064536|NCT00293358|Carboplatin|carboplatin|mesh-list
65064538|NCT00293358|Ifosfamide|ifosfamide|mesh-list
65064539|NCT00293358|Etoposide phosphate|etoposide phosphate|mesh-list
65064540|NCT00293358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064541|NCT00293358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65064542|NCT00293358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65064543|NCT00293358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65064544|NCT00293358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064545|NCT00293358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064546|NCT00293358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65064547|NCT00293358|Alkylating Agents|alkylating agents|mesh-ancestor
65064548|NCT00261677|Epoetin Alfa|epoetin alfa|mesh-list
65064549|NCT00261677|Hematinics|hematinics|mesh-ancestor
65064550|NCT00261755|Analgesics|analgesics|mesh-list
65064577|NCT00293436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65064578|NCT00293436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65064580|NCT00293436|Sensory System Agents|sensory system agents|mesh-ancestor
65064581|NCT00293436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65064582|NCT00293436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064583|NCT00293436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65064584|NCT00293436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65064585|NCT00293436|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65064586|NCT00293436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65064587|NCT00261872|Methylphenidate|methylphenidate|mesh-list
65064588|NCT00261872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65064589|NCT00261872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064590|NCT00261872|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65064591|NCT00261872|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65064592|NCT00261872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65064593|NCT00261872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064595|NCT00261872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65064627|NCT00293475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65064628|NCT00293475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65064629|NCT00293475|Chelating Agents|chelating agents|mesh-ancestor
65064630|NCT00293475|Sequestering Agents|sequestering agents|mesh-ancestor
65064631|NCT00261911|Sibutramine|sibutramine|mesh-list
65064632|NCT00261911|Antidepressive Agents|antidepressive agents|mesh-ancestor
65064633|NCT00261911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65064634|NCT00261911|Appetite Depressants|appetite depressants|mesh-ancestor
65064635|NCT00261911|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65064636|NCT00299013|Prednisolone|prednisolone|mesh-list
65064637|NCT00299013|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65064638|NCT00299013|Methylprednisolone|methylprednisolone|mesh-list
65064639|NCT00299013|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65064640|NCT00299013|Prednisolone acetate|prednisolone acetate|mesh-list
65064641|NCT00299013|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64506040|NCT03833362|Ritonavir|ritonavir|mesh-list
64916633|NCT00006185|Rosiglitazone|rosiglitazone|mesh-list
65064657|NCT00293514|Hemostatics|hemostatics|mesh-ancestor
65064658|NCT00293514|Coagulants|coagulants|mesh-ancestor
65064659|NCT00299091|Efavirenz|efavirenz|mesh-list
65064660|NCT00299091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65064661|NCT00299091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65064662|NCT00299091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064663|NCT00299091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064664|NCT00299091|Antiviral Agents|antiviral agents|mesh-ancestor
65064665|NCT00299091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65064666|NCT00299091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65064667|NCT00299091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65064668|NCT00299091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65064669|NCT00299091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65064670|NCT00299091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65064671|NCT00299091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65064672|NCT00299208|Azithromycin|azithromycin|mesh-list
65064673|NCT00299208|Artesunate|artesunate|mesh-list
65064674|NCT00299208|Quinine|quinine|mesh-list
65064675|NCT00299208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65064676|NCT00299208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65064677|NCT00299208|Antimalarials|antimalarials|mesh-ancestor
65064678|NCT00299208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65064679|NCT00299208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65064680|NCT00299208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064681|NCT00299208|Antiviral Agents|antiviral agents|mesh-ancestor
65064682|NCT00299208|Schistosomicides|schistosomicides|mesh-ancestor
65064683|NCT00299208|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65064684|NCT00299208|Anthelmintics|anthelmintics|mesh-ancestor
65064685|NCT00299208|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65064686|NCT00299208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064687|NCT00299208|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65064688|NCT00299208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65064689|NCT00299208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65064690|NCT00299208|Analgesics|analgesics|mesh-ancestor
65064691|NCT00299208|Sensory System Agents|sensory system agents|mesh-ancestor
65064692|NCT00418119|Epoetin Alfa|epoetin alfa|mesh-list
65064693|NCT00418119|Hematinics|hematinics|mesh-ancestor
65064694|NCT00293592|Dexamethasone|dexamethasone|mesh-list
65064695|NCT00293592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65064696|NCT00293592|Antiemetics|antiemetics|mesh-ancestor
65064697|NCT00293592|Autonomic Agents|autonomic agents|mesh-ancestor
65064698|NCT00293592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65064699|NCT00293592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064700|NCT00293592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65064701|NCT00293592|Glucocorticoids|glucocorticoids|mesh-ancestor
65064702|NCT00293592|Hormones|hormones|mesh-ancestor
64916672|NCT00091312|Fluorouracil|fluorouracil|mesh-list
65064732|NCT00299247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65064733|NCT00299247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65064734|NCT00299247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65064735|NCT00299247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064736|NCT00299247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064737|NCT00299247|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65064738|NCT00299247|Renal Agents|renal agents|mesh-ancestor
65064739|NCT00262418|Ivermectin|ivermectin|mesh-list
65064740|NCT00262418|Permethrin|permethrin|mesh-list
65064741|NCT00262418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65064742|NCT00262418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65064743|NCT00262418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064744|NCT00262418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064745|NCT00299286|Lapatinib|lapatinib|mesh-list
65064746|NCT00299286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064747|NCT00299286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65064749|NCT00299286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064750|NCT00293787|Timolol|timolol|mesh-list
65064751|NCT00293787|Travoprost|travoprost|mesh-list
65064785|NCT00262769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064786|NCT00262769|Antiviral Agents|antiviral agents|mesh-ancestor
65064787|NCT00262769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65064788|NCT00262769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064789|NCT00262769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65064790|NCT00262769|Immunologic Factors|immunologic factors|mesh-ancestor
65064791|NCT00262769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064792|NCT00299520|Linezolid|linezolid|mesh-list
65064829|NCT00262886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65064830|NCT00262886|Alkylating Agents|alkylating agents|mesh-ancestor
64831315|NCT01579279|Analgesics|analgesics|mesh-ancestor
65064831|NCT00262886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064832|NCT00262886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064833|NCT00262886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65064834|NCT00262886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65064866|NCT00263198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65064867|NCT00263198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064868|NCT00263198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064869|NCT00263198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65064870|NCT00263198|Hormone Antagonists|hormone antagonists|mesh-ancestor
65064871|NCT00263198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65064872|NCT00263198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064873|NCT00263198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65064874|NCT00294099|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65064875|NCT00294099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65064876|NCT00294099|Immunologic Factors|immunologic factors|mesh-ancestor
65064877|NCT00294099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064878|NCT00294099|Antacids|antacids|mesh-ancestor
65064911|NCT00263315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65064912|NCT00263315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65064913|NCT00263315|Antifungal Agents|antifungal agents|mesh-ancestor
65064914|NCT00417807|Imatinib Mesylate|imatinib mesylate|mesh-list
65064915|NCT00417807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064916|NCT00417807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65064917|NCT00417807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064918|NCT00417807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064919|NCT00263354|Oxaliplatin|oxaliplatin|mesh-list
65064920|NCT00263354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064921|NCT00263393|Atenolol|atenolol|mesh-list
65064922|NCT00263393|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65064950|NCT00299910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65064952|NCT00299910|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65064953|NCT00299910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65064954|NCT00299910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064955|NCT00425594|Bisacodyl|bisacodyl|mesh-list
65064956|NCT00425594|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65064957|NCT00425594|Cathartics|cathartics|mesh-ancestor
65064958|NCT00425594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65064959|NCT00425594|Laxatives|laxatives|mesh-ancestor
65064960|NCT00294255|Risperidone|risperidone|mesh-list
65064961|NCT00294255|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65064962|NCT00294255|Serotonin Agents|serotonin agents|mesh-ancestor
65064963|NCT00294255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65064964|NCT00294255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064965|NCT00294255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916947|NCT00093301|Sympathomimetics|sympathomimetics|mesh-ancestor
65064993|NCT00300222|Antipruritics|antipruritics|mesh-ancestor
65064994|NCT00300222|Dermatologic Agents|dermatologic agents|mesh-ancestor
65064995|NCT00300222|Sensory System Agents|sensory system agents|mesh-ancestor
65064996|NCT00300222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65064997|NCT00300222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064999|NCT00263978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65065000|NCT00263978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65065001|NCT00263978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065002|NCT00263978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65065003|NCT00264134|Carboplatin|carboplatin|mesh-list
65065004|NCT00264134|Docetaxel|docetaxel|mesh-list
65065005|NCT00264134|Irinotecan|irinotecan|mesh-list
65065006|NCT00264134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065007|NCT00264134|Tubulin Modulators|tubulin modulators|mesh-ancestor
65065008|NCT00264134|Antimitotic Agents|antimitotic agents|mesh-ancestor
65065009|NCT00264134|Mitosis Modulators|mitosis modulators|mesh-ancestor
65065010|NCT00264134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916997|NCT00006233|Cyclosporine|cyclosporine|mesh-list
65065043|NCT00264212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65243445|NCT00629213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065044|NCT00264212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65065046|NCT00300378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64917041|NCT00006239|Tretinoin|tretinoin|mesh-list
65065072|NCT00294606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65065073|NCT00294606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065074|NCT00294606|Sympathomimetics|sympathomimetics|mesh-ancestor
64831405|NCT01579786|Acetaminophen|acetaminophen|mesh-list
65065075|NCT00294606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65065076|NCT00294606|Nasal Decongestants|nasal decongestants|mesh-ancestor
65065077|NCT00294606|Respiratory System Agents|respiratory system agents|mesh-ancestor
65065078|NCT00294606|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65065079|NCT00294606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65065080|NCT00294606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65065081|NCT00294606|Adrenergic Agents|adrenergic agents|mesh-ancestor
65065082|NCT00294606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65065083|NCT00294606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065084|NCT00294606|Protective Agents|protective agents|mesh-ancestor
65065085|NCT04708964|Flurbiprofen|flurbiprofen|mesh-list
65065086|NCT04708964|Analgesics|analgesics|mesh-ancestor
65065087|NCT04708964|Sensory System Agents|sensory system agents|mesh-ancestor
65065088|NCT04708964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65065089|NCT04708964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065090|NCT04708964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65065091|NCT04708964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65065092|NCT04708964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65065093|NCT04708964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65065094|NCT04708964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65065095|NCT04708964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065164|NCT00300729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065166|NCT00264719|Antiemetics|antiemetics|mesh-ancestor
65065167|NCT00264719|Autonomic Agents|autonomic agents|mesh-ancestor
65065168|NCT00264719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65065169|NCT00264719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065170|NCT00264719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64917186|NCT00094978|Alvocidib|alvocidib|mesh-list
65065207|NCT00300846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65065208|NCT00300846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65065239|NCT00265031|Immunologic Factors|immunologic factors|mesh-ancestor
65065240|NCT00265031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065241|NCT00265031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65065242|NCT00265031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65065243|NCT00265031|Alkylating Agents|alkylating agents|mesh-ancestor
65065244|NCT00265031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065245|NCT00265031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065246|NCT00265031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65065247|NCT00265031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65065248|NCT00265031|Glucocorticoids|glucocorticoids|mesh-ancestor
65065249|NCT00265031|Hormones|hormones|mesh-ancestor
65065250|NCT00265031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65065251|NCT00265031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65065278|NCT00295035|Curcumin|curcumin|mesh-list
65065279|NCT00295035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65065280|NCT00295035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65065281|NCT00295035|Analgesics|analgesics|mesh-ancestor
65065282|NCT00295035|Sensory System Agents|sensory system agents|mesh-ancestor
65065283|NCT00295035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65065284|NCT00295035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065285|NCT00295035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65065286|NCT00295035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65065287|NCT00295035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65065288|NCT00295035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65065289|NCT00295035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065290|NCT00295035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065291|NCT00295035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065292|NCT00265265|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65065293|NCT00265265|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65065294|NCT00265265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65065295|NCT00265265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65065296|NCT00265265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065297|NCT00265265|Adrenergic Agents|adrenergic agents|mesh-ancestor
65065298|NCT00265265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64917296|NCT04492566|Pancrelipase|pancrelipase|mesh-list
65065325|NCT00265460|Cholinergic Agents|cholinergic agents|mesh-ancestor
65065326|NCT00265460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65065327|NCT00265460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065328|NCT00265460|Respiratory System Agents|respiratory system agents|mesh-ancestor
65065329|NCT00301002|Alefacept|alefacept|mesh-list
65065330|NCT00301002|Dermatologic Agents|dermatologic agents|mesh-ancestor
65065331|NCT00301002|Immunologic Factors|immunologic factors|mesh-ancestor
65065332|NCT00301002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065333|NCT00265694|Gemcitabine|gemcitabine|mesh-list
65065334|NCT00265694|Carboplatin|carboplatin|mesh-list
65065335|NCT00265694|Vinorelbine|vinorelbine|mesh-list
65065336|NCT00265694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065337|NCT00265694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65065338|NCT00265694|Antimetabolites|antimetabolites|mesh-ancestor
65065339|NCT00265694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065340|NCT00265694|Antiviral Agents|antiviral agents|mesh-ancestor
65065341|NCT00265694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65065342|NCT00265694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065343|NCT00265694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65065344|NCT00265694|Immunologic Factors|immunologic factors|mesh-ancestor
65065345|NCT00265694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917334|NCT00095719|Antidepressive Agents|antidepressive agents|mesh-ancestor
65065380|NCT00295308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65065381|NCT00295308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65065382|NCT00295308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65065383|NCT00295308|Adrenergic Agents|adrenergic agents|mesh-ancestor
65065384|NCT00295308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65065385|NCT00295308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065387|NCT00265928|Bortezomib|bortezomib|mesh-list
65065416|NCT00295347|Natriuretic Agents|natriuretic agents|mesh-ancestor
65065417|NCT00295347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65065418|NCT00265967|Irbesartan|irbesartan|mesh-list
65065419|NCT00265967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65065420|NCT00265967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65065421|NCT00265967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65065422|NCT00265967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065423|NCT00295386|Zopiclone|zopiclone|mesh-list
65065424|NCT00295386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65065425|NCT00295386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65065426|NCT00295386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065427|NCT00301236|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
65065428|NCT00301236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65065429|NCT00301236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917436|NCT00096187|Pemetrexed|pemetrexed|mesh-list
65065457|NCT00266123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65065458|NCT00266123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065459|NCT00266123|Antifungal Agents|antifungal agents|mesh-ancestor
65065460|NCT00266123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65065461|NCT00266123|Immunologic Factors|immunologic factors|mesh-ancestor
65065462|NCT00266123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065463|NCT00266162|Bosentan|bosentan|mesh-list
64550762|NCT04278547|Valganciclovir|valganciclovir|mesh-list
65065464|NCT00266162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65065465|NCT00266162|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65065466|NCT00266162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065467|NCT00295464|Betamethasone|betamethasone|mesh-list
65065468|NCT00295464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65065469|NCT00295464|Glucocorticoids|glucocorticoids|mesh-ancestor
65065470|NCT00295464|Hormones|hormones|mesh-ancestor
65065471|NCT00295464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65065472|NCT00295464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065473|NCT00295464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65065474|NCT00295464|Respiratory System Agents|respiratory system agents|mesh-ancestor
64917468|NCT00096616|Tocolytic Agents|tocolytic agents|mesh-ancestor
65065505|NCT00415883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65065506|NCT00415883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065507|NCT00295542|Atenolol|atenolol|mesh-list
65065508|NCT00295542|Valsartan|valsartan|mesh-list
65065509|NCT00295542|Telmisartan|telmisartan|mesh-list
65065510|NCT00295542|Carvedilol|carvedilol|mesh-list
65065511|NCT00295542|Olmesartan|olmesartan|mesh-list
65065512|NCT00295542|Enalapril|enalapril|mesh-list
65065513|NCT00295542|Lisinopril|lisinopril|mesh-list
65065514|NCT00295542|Nebivolol|nebivolol|mesh-list
65065515|NCT00295542|Antihypertensive Agents|antihypertensive agents|mesh-list
65065516|NCT00295542|Doxazosin|doxazosin|mesh-list
65065517|NCT00295542|Indapamide|indapamide|mesh-list
65065518|NCT00295542|Quinapril|quinapril|mesh-list
65065519|NCT00295542|Torsemide|torsemide|mesh-list
65065520|NCT00295542|Spirapril|spirapril|mesh-list
65065521|NCT00295542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65065584|NCT00295698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065586|NCT00266552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64568399|NCT04921566|Torsemide|torsemide|mesh-list
65065587|NCT00266552|Serotonin Agents|serotonin agents|mesh-ancestor
65065588|NCT00266552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65065589|NCT00266552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065590|NCT00266552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065591|NCT00266552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65065592|NCT00266552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65065593|NCT00266552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65065594|NCT00266552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65065595|NCT00266552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65065596|NCT00266552|Dopamine Agents|dopamine agents|mesh-ancestor
65065597|NCT00301587|Folic Acid|folic acid|mesh-list
65065598|NCT00301587|Moxifloxacin|moxifloxacin|mesh-list
65065599|NCT00301587|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65065600|NCT00301587|Norgestimate|norgestimate|mesh-list
65065601|NCT00301587|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65065602|NCT00301587|Estradiol|estradiol|mesh-list
65065603|NCT00301587|Estrogens|estrogens|mesh-ancestor
65065604|NCT00301587|Hormones|hormones|mesh-ancestor
65065635|NCT00301665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065636|NCT00301665|Cholinergic Agents|cholinergic agents|mesh-ancestor
65065637|NCT00301665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65065638|NCT00301665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065639|NCT00301665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65065640|NCT00301665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65065641|NCT00295776|Lamotrigine|lamotrigine|mesh-list
65065642|NCT00295776|Anticonvulsants|anticonvulsants|mesh-ancestor
65065643|NCT00295776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65065644|NCT00295776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65065645|NCT00295776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917611|NCT00390312|Morphine|morphine|mesh-list
65065676|NCT00295815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65065677|NCT00295815|Alkylating Agents|alkylating agents|mesh-ancestor
65065678|NCT00295815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065679|NCT00295815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065680|NCT00295971|Fludarabine|fludarabine|mesh-list
65065681|NCT00295971|Fludarabine phosphate|fludarabine phosphate|mesh-list
65065682|NCT00295971|Thiotepa|thiotepa|mesh-list
65065683|NCT00295971|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65065684|NCT00295971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065685|NCT00295971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65065686|NCT00295971|Antimetabolites|antimetabolites|mesh-ancestor
65065713|NCT00296010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065714|NCT00296010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65065715|NCT00296010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65065716|NCT00296010|Alkylating Agents|alkylating agents|mesh-ancestor
65065717|NCT00296010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065718|NCT00296010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065719|NCT00296010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65065720|NCT00296010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65065721|NCT00296010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65065722|NCT00296010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65065723|NCT00296010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065724|NCT00296010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65065725|NCT00296010|Abortifacient Agents|abortifacient agents|mesh-ancestor
65065726|NCT00296010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65065727|NCT00296010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65065728|NCT00296010|Antimetabolites|antimetabolites|mesh-ancestor
65065729|NCT00296010|Dermatologic Agents|dermatologic agents|mesh-ancestor
65065730|NCT00296010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65065731|NCT00296010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65065732|NCT00267215|Lumiracoxib|lumiracoxib|mesh-list
65065763|NCT00301782|Etoposide phosphate|etoposide phosphate|mesh-list
65065764|NCT00301782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065765|NCT00301782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65065766|NCT00301782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65065767|NCT00301782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65065768|NCT00301782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065769|NCT00301782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065770|NCT00301782|Tubulin Modulators|tubulin modulators|mesh-ancestor
65065771|NCT00301782|Antimitotic Agents|antimitotic agents|mesh-ancestor
65065772|NCT00301782|Mitosis Modulators|mitosis modulators|mesh-ancestor
65065773|NCT00301782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65065774|NCT00267332|Modafinil|modafinil|mesh-list
65065775|NCT00267332|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65065776|NCT00267332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065805|NCT00301860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65065806|NCT00301860|Antimetabolites|antimetabolites|mesh-ancestor
65065807|NCT00301860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065808|NCT00301860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065809|NCT00301860|Dermatologic Agents|dermatologic agents|mesh-ancestor
65065810|NCT00301860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065811|NCT00301860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65065812|NCT00301860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65065813|NCT00301860|Immunologic Factors|immunologic factors|mesh-ancestor
65065814|NCT00301860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65065815|NCT00301860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65065816|NCT00301860|Antifungal Agents|antifungal agents|mesh-ancestor
65065817|NCT00301860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65065818|NCT00301860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65065819|NCT00301860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65065820|NCT00301860|Alkylating Agents|alkylating agents|mesh-ancestor
65065821|NCT00301860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65065846|NCT00296205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065847|NCT00296205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065848|NCT00296205|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65065849|NCT00267683|Insulin Aspart|insulin aspart|mesh-list
65065850|NCT00267683|Glyburide|glyburide|mesh-list
65065851|NCT00267683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65065852|NCT00267683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065853|NCT00267722|Visilizumab|visilizumab|mesh-list
65065854|NCT00267722|Immunologic Factors|immunologic factors|mesh-ancestor
65065855|NCT00267722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065856|NCT00301938|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
65065857|NCT00301938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065858|NCT00301938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65065859|NCT00301938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065860|NCT00301938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065861|NCT00267917|Fenoterol|fenoterol|mesh-list
65065862|NCT00267917|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
65065863|NCT00267917|Ipratropium|ipratropium|mesh-list
65065864|NCT00267917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65065865|NCT00267917|Autonomic Agents|autonomic agents|mesh-ancestor
65065866|NCT00267917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65065867|NCT00267917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065868|NCT00267917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65065869|NCT00267917|Respiratory System Agents|respiratory system agents|mesh-ancestor
65065870|NCT00267917|Sympathomimetics|sympathomimetics|mesh-ancestor
65065871|NCT00267917|Tocolytic Agents|tocolytic agents|mesh-ancestor
65065884|NCT00296361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065886|NCT00296361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065887|NCT00296361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065888|NCT00415922|Levodopa|levodopa|mesh-list
65065889|NCT00415922|Carbidopa|carbidopa|mesh-list
65065890|NCT00415922|Entacapone|entacapone|mesh-list
65065891|NCT00415922|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65065892|NCT00415922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65065893|NCT00415922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65065894|NCT00415922|Dopamine Agents|dopamine agents|mesh-ancestor
65065895|NCT00415922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65065896|NCT00415922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065897|NCT00415922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065898|NCT00415922|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65065899|NCT00415922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065900|NCT00415922|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65065901|NCT00415922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65065902|NCT00415922|Immunologic Factors|immunologic factors|mesh-ancestor
65065903|NCT00415922|Dopamine Agonists|dopamine agonists|mesh-ancestor
65065904|NCT00415961|Paclitaxel|paclitaxel|mesh-list
65065905|NCT00415961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65065906|NCT00415961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065907|NCT00415961|Tubulin Modulators|tubulin modulators|mesh-ancestor
65065908|NCT00415961|Antimitotic Agents|antimitotic agents|mesh-ancestor
65065909|NCT00415961|Mitosis Modulators|mitosis modulators|mesh-ancestor
65065910|NCT00415961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065911|NCT00416039|Midazolam|midazolam|mesh-list
65065912|NCT00416039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65065913|NCT00416039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65065914|NCT00416039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65065915|NCT00416039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065916|NCT00416039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65065917|NCT00416039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65065918|NCT00416039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65065919|NCT00416039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65065920|NCT00416039|Anesthetics, General|anesthetics, general|mesh-ancestor
65065921|NCT00416039|Anesthetics|anesthetics|mesh-ancestor
65065922|NCT00416039|GABA Modulators|gaba modulators|mesh-ancestor
65065923|NCT00416039|GABA Agents|gaba agents|mesh-ancestor
65065924|NCT00416039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65065925|NCT00416039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065926|NCT00296478|Progesterone|progesterone|mesh-list
65065927|NCT00296478|Progestins|progestins|mesh-ancestor
65065928|NCT00296478|Hormones|hormones|mesh-ancestor
65065929|NCT00296478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65065930|NCT00296478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065931|NCT00268151|Capecitabine|capecitabine|mesh-list
65065932|NCT00268151|Oxaliplatin|oxaliplatin|mesh-list
64917891|NCT00006362|Bortezomib|bortezomib|mesh-list
65065962|NCT00302289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065963|NCT00302289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65065964|NCT00302289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065965|NCT00302289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065966|NCT00302289|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65065967|NCT00302289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65065968|NCT00302289|Purinergic Agents|purinergic agents|mesh-ancestor
65065969|NCT00302289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65065971|NCT00296634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65065972|NCT00296634|Immunologic Factors|immunologic factors|mesh-ancestor
65065973|NCT00296634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066002|NCT00296712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65066003|NCT00296712|Cholinergic Agents|cholinergic agents|mesh-ancestor
65066004|NCT00296712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65066005|NCT00296712|Dopamine Agents|dopamine agents|mesh-ancestor
65066006|NCT00296712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65066007|NCT00296712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65066008|NCT00296712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066009|NCT00268697|Ezetimibe|ezetimibe|mesh-list
65066010|NCT00268697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65066011|NCT00268697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65066012|NCT00268697|Antimetabolites|antimetabolites|mesh-ancestor
65066013|NCT00268697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066014|NCT00268697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65066015|NCT00296751|Fentanyl|fentanyl|mesh-list
65066016|NCT00296751|Meperidine|meperidine|mesh-list
65066017|NCT00296751|Bupivacaine|bupivacaine|mesh-list
65066018|NCT00296751|Anesthetics, Local|anesthetics, local|mesh-ancestor
65066019|NCT00296751|Anesthetics|anesthetics|mesh-ancestor
65066052|NCT00302406|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65066053|NCT00302406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65066054|NCT00302406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65066055|NCT00302406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918030|NCT00006377|Paclitaxel|paclitaxel|mesh-list
65066068|NCT00268814|Respiratory System Agents|respiratory system agents|mesh-ancestor
65066069|NCT00302484|Zoledronic Acid|zoledronic acid|mesh-list
65066070|NCT00302484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65066071|NCT00302484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066072|NCT00296868|Ascorbic Acid|ascorbic acid|mesh-list
65066073|NCT00296868|Vitamins|vitamins|mesh-ancestor
65066074|NCT00296868|Micronutrients|micronutrients|mesh-ancestor
65066075|NCT00296868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066076|NCT00296868|Antioxidants|antioxidants|mesh-ancestor
65066077|NCT00296868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066078|NCT00296868|Protective Agents|protective agents|mesh-ancestor
65066079|NCT00268970|Paclitaxel|paclitaxel|mesh-list
65066080|NCT00268970|Satraplatin|satraplatin|mesh-list
65066081|NCT00268970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65066082|NCT00268970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066083|NCT00268970|Tubulin Modulators|tubulin modulators|mesh-ancestor
65066084|NCT00268970|Antimitotic Agents|antimitotic agents|mesh-ancestor
65066085|NCT00268970|Mitosis Modulators|mitosis modulators|mesh-ancestor
65066086|NCT00268970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066087|NCT00296946|Bromides|bromides|mesh-list
65066088|NCT00296946|Ipratropium|ipratropium|mesh-list
65066089|NCT00296946|Anticonvulsants|anticonvulsants|mesh-ancestor
65066090|NCT00296946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65066091|NCT00296946|Autonomic Agents|autonomic agents|mesh-ancestor
65066092|NCT00296946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066093|NCT00296946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066094|NCT00296946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65066095|NCT00296946|Respiratory System Agents|respiratory system agents|mesh-ancestor
65066096|NCT00296946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64551406|NCT02912988|Letrozole|letrozole|mesh-list
65066097|NCT00296946|Cholinergic Agents|cholinergic agents|mesh-ancestor
65066098|NCT00296946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65066099|NCT00296946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066100|NCT00302523|Tacrolimus|tacrolimus|mesh-list
65066101|NCT00302523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65066102|NCT00302523|Immunologic Factors|immunologic factors|mesh-ancestor
65066103|NCT00302523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066104|NCT00302523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65066105|NCT00302523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066106|NCT00302523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066137|NCT00269204|Niacin|niacin|mesh-list
65066138|NCT00269204|Niacinamide|niacinamide|mesh-list
65066139|NCT00269204|Nicotinic Acids|nicotinic acids|mesh-list
65066140|NCT00269204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65066141|NCT00269204|Antimetabolites|antimetabolites|mesh-ancestor
65066142|NCT00269204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066143|NCT00269204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65066144|NCT00269204|Vasodilator Agents|vasodilator agents|mesh-ancestor
65066145|NCT00269204|Vitamin B Complex|vitamin b complex|mesh-ancestor
65066146|NCT00269204|Vitamins|vitamins|mesh-ancestor
65066147|NCT00269204|Micronutrients|micronutrients|mesh-ancestor
65066148|NCT00269204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066175|NCT00302640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65066176|NCT00302640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65066177|NCT00418353|Dexamethasone|dexamethasone|mesh-list
65066178|NCT00418353|Betamethasone|betamethasone|mesh-list
65066179|NCT00418353|Betamethasone Valerate|betamethasone valerate|mesh-list
65066180|NCT00418353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65066181|NCT00418353|Betamethasone benzoate|betamethasone benzoate|mesh-list
65066182|NCT00418353|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
65066183|NCT00418353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65066184|NCT00418353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65066185|NCT00418353|Antiemetics|antiemetics|mesh-ancestor
65066186|NCT00418353|Autonomic Agents|autonomic agents|mesh-ancestor
65066187|NCT00418353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066188|NCT00418353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066189|NCT00418353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65066190|NCT00418353|Glucocorticoids|glucocorticoids|mesh-ancestor
65066191|NCT00418353|Hormones|hormones|mesh-ancestor
65066192|NCT00418353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65243449|NCT00978341|Analgesics|analgesics|mesh-ancestor
65066193|NCT00418353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64918155|NCT00400777|Vasodilator Agents|vasodilator agents|mesh-ancestor
65066222|NCT00269594|Lamotrigine|lamotrigine|mesh-list
65066223|NCT00269594|Anticonvulsants|anticonvulsants|mesh-ancestor
65066224|NCT00269594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65066225|NCT00269594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65066226|NCT00269594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066227|NCT00269594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65066228|NCT00269594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066229|NCT00269594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65066230|NCT00269594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65066231|NCT00269594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65066232|NCT00269594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65066233|NCT00269594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65066234|NCT00418470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65066235|NCT00418470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65066236|NCT00418470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65066237|NCT00418470|Antitubercular Agents|antitubercular agents|mesh-ancestor
65066238|NCT00269672|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65066241|NCT00302835|Analgesics|analgesics|mesh-list
65066242|NCT00302835|Sensory System Agents|sensory system agents|mesh-ancestor
65066243|NCT00302835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066244|NCT00302835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066246|NCT00269750|Parasympatholytics|parasympatholytics|mesh-ancestor
65066247|NCT00269750|Autonomic Agents|autonomic agents|mesh-ancestor
65066248|NCT00269750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568719|NCT04918914|Dapsone|dapsone|mesh-list
65066249|NCT00269750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066250|NCT00269750|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65066251|NCT00269750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65066252|NCT00269750|Cholinergic Agents|cholinergic agents|mesh-ancestor
65066253|NCT00269750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65066254|NCT00269750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066255|NCT00269750|Urological Agents|urological agents|mesh-ancestor
65066256|NCT00269789|Methylphenidate|methylphenidate|mesh-list
65066257|NCT00269789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65066258|NCT00269789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066259|NCT00269789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65066260|NCT00269789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65066261|NCT00269789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65066262|NCT00269789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066263|NCT00269789|Dopamine Agents|dopamine agents|mesh-ancestor
65066264|NCT00269789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65066265|NCT00302913|Clopidogrel|clopidogrel|mesh-list
65066266|NCT00302913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65066267|NCT00302913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65066268|NCT00302913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65066269|NCT00302913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65066270|NCT00302913|Purinergic Agents|purinergic agents|mesh-ancestor
65066271|NCT00302913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65066272|NCT00302913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066273|NCT00302913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066274|NCT00269828|Paclitaxel|paclitaxel|mesh-list
65066275|NCT00269828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65066276|NCT00269828|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
65066277|NCT00269828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65066278|NCT00269828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066279|NCT00269828|Tubulin Modulators|tubulin modulators|mesh-ancestor
65066280|NCT00269828|Antimitotic Agents|antimitotic agents|mesh-ancestor
65066281|NCT00269828|Mitosis Modulators|mitosis modulators|mesh-ancestor
65066282|NCT00269828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066283|NCT00269867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65066284|NCT00269867|Infliximab|infliximab|mesh-list
65066285|NCT00269867|Antibodies|antibodies|mesh-list
65066286|NCT00269867|Immunoglobulins|immunoglobulins|mesh-list
65066287|NCT00269867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65066288|NCT00269867|Immunologic Factors|immunologic factors|mesh-ancestor
65066289|NCT00269867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066290|NCT00269867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066291|NCT00269867|Dermatologic Agents|dermatologic agents|mesh-ancestor
65066292|NCT00269867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64918251|NCT03991884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65066314|NCT00297375|Antipyretics|antipyretics|mesh-ancestor
65066315|NCT00297375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65066316|NCT00297375|Narcotics|narcotics|mesh-ancestor
65066317|NCT00297375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64507749|NCT03108300|Vasodilator Agents|vasodilator agents|mesh-ancestor
65066318|NCT00270062|Epoetin Alfa|epoetin alfa|mesh-list
65066319|NCT00270062|Hematinics|hematinics|mesh-ancestor
65066320|NCT00270101|Epoetin Alfa|epoetin alfa|mesh-list
65066322|NCT00270140|Epoetin Alfa|epoetin alfa|mesh-list
65066323|NCT00270140|Hematinics|hematinics|mesh-ancestor
65066324|NCT00270179|Epoetin Alfa|epoetin alfa|mesh-list
65066325|NCT00270179|Hematinics|hematinics|mesh-ancestor
65066326|NCT00297570|Interferons|interferons|mesh-list
65066327|NCT00297570|Imatinib Mesylate|imatinib mesylate|mesh-list
65066328|NCT00297570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066329|NCT00297570|Antiviral Agents|antiviral agents|mesh-ancestor
65066330|NCT00297570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65066331|NCT00297570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65066332|NCT00297570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066333|NCT00297570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066334|NCT00270335|Propofol|propofol|mesh-list
65066335|NCT00270335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65066336|NCT00270335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65066337|NCT00270335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066338|NCT00270335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65066339|NCT00270335|Anesthetics, General|anesthetics, general|mesh-ancestor
65066340|NCT00270335|Anesthetics|anesthetics|mesh-ancestor
65066341|NCT00270374|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65066342|NCT00270374|Natriuretic Agents|natriuretic agents|mesh-ancestor
65066343|NCT00270374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066344|NCT00270491|Paclitaxel|paclitaxel|mesh-list
65243450|NCT00978341|Sensory System Agents|sensory system agents|mesh-ancestor
65066345|NCT00270491|Capecitabine|capecitabine|mesh-list
65066346|NCT00270491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65066347|NCT00270491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066348|NCT00270491|Tubulin Modulators|tubulin modulators|mesh-ancestor
65066349|NCT00270491|Antimitotic Agents|antimitotic agents|mesh-ancestor
65066350|NCT00270491|Mitosis Modulators|mitosis modulators|mesh-ancestor
65066351|NCT00270491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066352|NCT00270491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65066382|NCT00270647|Vitamins|vitamins|mesh-list
65066383|NCT00270647|Vitamin E|vitamin e|mesh-list
65066384|NCT00270647|Beta Carotene|beta carotene|mesh-list
65066385|NCT00270647|Carotenoids|carotenoids|mesh-list
65066386|NCT00270647|Micronutrients|micronutrients|mesh-ancestor
65066387|NCT00270647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066388|NCT00270647|Antioxidants|antioxidants|mesh-ancestor
65066389|NCT00270647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066390|NCT00270647|Protective Agents|protective agents|mesh-ancestor
65066391|NCT00270647|Provitamins|provitamins|mesh-ancestor
65066392|NCT00297960|Olanzapine|olanzapine|mesh-list
65066393|NCT00297960|Ziprasidone|ziprasidone|mesh-list
65066394|NCT00297960|Antiemetics|antiemetics|mesh-ancestor
65066395|NCT00297960|Autonomic Agents|autonomic agents|mesh-ancestor
65066396|NCT00297960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066397|NCT00297960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066398|NCT00297960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65066399|NCT00297960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65066400|NCT00297960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65066430|NCT00298194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066432|NCT00298194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65066433|NCT00298194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066434|NCT00298194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65066435|NCT00418548|Etanercept|etanercept|mesh-list
65066436|NCT00418548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65066437|NCT00418548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65066438|NCT00418548|Analgesics|analgesics|mesh-ancestor
65066439|NCT00418548|Sensory System Agents|sensory system agents|mesh-ancestor
65066440|NCT00418548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066441|NCT00418548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066442|NCT00418548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65066470|NCT00306462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65066471|NCT00306462|Tocolytic Agents|tocolytic agents|mesh-ancestor
65066472|NCT00306462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65066473|NCT00306462|Vasodilator Agents|vasodilator agents|mesh-ancestor
65066475|NCT00416390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65066476|NCT00416390|Antioxidants|antioxidants|mesh-ancestor
65066477|NCT00416390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066478|NCT00416390|Protective Agents|protective agents|mesh-ancestor
65066479|NCT00416390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066480|NCT00416390|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65066481|NCT00416390|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65066482|NCT00416390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066483|NCT00416429|Interferons|interferons|mesh-list
65066484|NCT00416429|Interferon-alpha|interferon-alpha|mesh-list
65066485|NCT00416429|Interferon alpha-2|interferon alpha-2|mesh-list
65066486|NCT00416429|Aldesleukin|aldesleukin|mesh-list
65066487|NCT00416429|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65066488|NCT00416429|Medroxyprogesterone|medroxyprogesterone|mesh-list
65066489|NCT00416429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066490|NCT00416429|Antiviral Agents|antiviral agents|mesh-ancestor
65066491|NCT00416429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65066492|NCT00416429|Immunologic Factors|immunologic factors|mesh-ancestor
65066520|NCT00271271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65066521|NCT00271271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066522|NCT00271271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65066523|NCT00271271|Immunologic Factors|immunologic factors|mesh-ancestor
65066524|NCT00271271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066525|NCT00271271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65066526|NCT00271271|Tubulin Modulators|tubulin modulators|mesh-ancestor
65066527|NCT00271271|Antimitotic Agents|antimitotic agents|mesh-ancestor
65066528|NCT00271271|Mitosis Modulators|mitosis modulators|mesh-ancestor
65066529|NCT00306618|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
65066530|NCT00306618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066531|NCT00306618|Tubulin Modulators|tubulin modulators|mesh-ancestor
65066532|NCT00306618|Antimitotic Agents|antimitotic agents|mesh-ancestor
65066533|NCT00306618|Mitosis Modulators|mitosis modulators|mesh-ancestor
65066534|NCT00306618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066536|NCT00271349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65066537|NCT00271349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65066538|NCT00271349|Autonomic Agents|autonomic agents|mesh-ancestor
65066539|NCT00271349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066568|NCT00271427|Trace Elements|trace elements|mesh-ancestor
65066569|NCT00271427|Micronutrients|micronutrients|mesh-ancestor
65066571|NCT00271466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65066572|NCT00271466|Narcotics|narcotics|mesh-ancestor
65066573|NCT00271466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65066574|NCT00271466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066575|NCT00271466|Analgesics|analgesics|mesh-ancestor
65066576|NCT00271466|Sensory System Agents|sensory system agents|mesh-ancestor
65066577|NCT00271466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066578|NCT00271466|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65066579|NCT00271466|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65066580|NCT00271466|Anesthetics, General|anesthetics, general|mesh-ancestor
65066581|NCT00271466|Anesthetics|anesthetics|mesh-ancestor
65066582|NCT00306735|Palonosetron|palonosetron|mesh-list
65066583|NCT00306735|Antiemetics|antiemetics|mesh-ancestor
65066612|NCT00306813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65066613|NCT00306813|Growth Substances|growth substances|mesh-ancestor
65066614|NCT00306813|Growth Inhibitors|growth inhibitors|mesh-ancestor
65066615|NCT00306813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066616|NCT04717986|Dapagliflozin|dapagliflozin|mesh-list
65066617|NCT04717986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65066618|NCT04717986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066619|NCT04717986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65066620|NCT04717986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066621|NCT00271973|Oxycodone|oxycodone|mesh-list
65066622|NCT00271973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65066623|NCT00271973|Narcotics|narcotics|mesh-ancestor
65066624|NCT00271973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65066625|NCT00271973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066626|NCT00271973|Analgesics|analgesics|mesh-ancestor
65066627|NCT00271973|Sensory System Agents|sensory system agents|mesh-ancestor
65066628|NCT00271973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066629|NCT00306969|Bexarotene|bexarotene|mesh-list
65066630|NCT00306969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066696|NCT00272324|Sensory System Agents|sensory system agents|mesh-ancestor
65066697|NCT00272324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066698|NCT00272324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066699|NCT00272324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65066700|NCT00272324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65066701|NCT00272324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65066702|NCT00272324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65066703|NCT00272324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066704|NCT00272324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65066705|NCT00272324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65066706|NCT00272324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066707|NCT00272324|Antipyretics|antipyretics|mesh-ancestor
65066708|NCT00307593|Rituximab|rituximab|mesh-list
65066709|NCT00307593|Infliximab|infliximab|mesh-list
65066710|NCT00307593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65066734|NCT00272480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066735|NCT00272480|Antiviral Agents|antiviral agents|mesh-ancestor
65066736|NCT00272480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65066737|NCT00272480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65066738|NCT00272480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65066739|NCT00272480|Antimetabolites|antimetabolites|mesh-ancestor
65066740|NCT00307671|Mycophenolic Acid|mycophenolic acid|mesh-list
65066741|NCT00307671|Prednisone|prednisone|mesh-list
65066742|NCT00307671|Methylprednisolone|methylprednisolone|mesh-list
65066743|NCT00307671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65066744|NCT00307671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65066745|NCT00307671|Prednisolone|prednisolone|mesh-list
65066746|NCT00307671|Prednisolone acetate|prednisolone acetate|mesh-list
65066747|NCT00307671|Cyclophosphamide|cyclophosphamide|mesh-list
65066748|NCT00307671|Methotrexate|methotrexate|mesh-list
65066749|NCT00307671|Azathioprine|azathioprine|mesh-list
65066750|NCT00307671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65066751|NCT00307671|Prednisolone phosphate|prednisolone phosphate|mesh-list
65066752|NCT00307671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65066753|NCT00307671|Immunologic Factors|immunologic factors|mesh-ancestor
65066754|NCT00307671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066755|NCT00307671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64568923|NCT02389309|Dasatinib|dasatinib|mesh-list
65066756|NCT00307671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65066757|NCT00307671|Alkylating Agents|alkylating agents|mesh-ancestor
65066758|NCT00307671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066759|NCT00307671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066760|NCT00307671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65066761|NCT00307671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65066762|NCT00307671|Glucocorticoids|glucocorticoids|mesh-ancestor
65066763|NCT00307671|Hormones|hormones|mesh-ancestor
65066788|NCT00272558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066789|NCT00272558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65066790|NCT00272558|Tubulin Modulators|tubulin modulators|mesh-ancestor
65066791|NCT00272558|Antimitotic Agents|antimitotic agents|mesh-ancestor
65066792|NCT00272558|Mitosis Modulators|mitosis modulators|mesh-ancestor
65066793|NCT00272558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066794|NCT00272597|Risperidone|risperidone|mesh-list
65066795|NCT00272597|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65066796|NCT00272597|Serotonin Agents|serotonin agents|mesh-ancestor
65066797|NCT00272597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65243452|NCT00978341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243453|NCT00978341|Anticonvulsants|anticonvulsants|mesh-ancestor
65243454|NCT00978341|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65243455|NCT00978341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65243456|NCT00978341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243457|NCT00978341|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65243458|NCT00978341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65243459|NCT00978341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65243460|NCT00978341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65243461|NCT00978341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65243462|NCT00695331|Misoprostol|misoprostol|mesh-list
65243463|NCT00695331|Oxytocin|oxytocin|mesh-list
65243464|NCT00695331|Oxytocics|oxytocics|mesh-ancestor
65243465|NCT00695331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65243466|NCT00695331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243497|NCT04135833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243498|NCT04135833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65243499|NCT04135833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65243500|NCT04135833|Antitubercular Agents|antitubercular agents|mesh-ancestor
65243501|NCT04135833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65243502|NCT04135833|Leprostatic Agents|leprostatic agents|mesh-ancestor
65243503|NCT04135833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65243504|NCT04135833|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65243505|NCT04135833|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65243506|NCT04135833|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65243507|NCT04135833|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65243543|NCT00696111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65243544|NCT00696111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243546|NCT02623569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65243547|NCT02623569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65243579|NCT02866253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243580|NCT02865785|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65243581|NCT02865785|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65243582|NCT02865785|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65243584|NCT04049669|Cyclophosphamide|cyclophosphamide|mesh-list
65243585|NCT04049669|Temozolomide|temozolomide|mesh-list
65243586|NCT04049669|Lomustine|lomustine|mesh-list
65243587|NCT04049669|Etoposide|etoposide|mesh-list
65243588|NCT04049669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65243589|NCT04049669|Immunologic Factors|immunologic factors|mesh-ancestor
65243590|NCT04049669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243625|NCT00976937|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65243626|NCT00976937|Lixisenatide|lixisenatide|mesh-list
65243627|NCT00976937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65243628|NCT00976937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243629|NCT00976937|Incretins|incretins|mesh-ancestor
65243630|NCT00976937|Hormones|hormones|mesh-ancestor
65243657|NCT02622555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65243658|NCT02622555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243659|NCT02622555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243660|NCT02622555|Urological Agents|urological agents|mesh-ancestor
65243661|NCT05329454|Ibuprofen|ibuprofen|mesh-list
65243662|NCT05329454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65243663|NCT05329454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64472913|NCT02043678|Prednisone|prednisone|mesh-list
65243664|NCT05329454|Analgesics|analgesics|mesh-ancestor
65243665|NCT05329454|Sensory System Agents|sensory system agents|mesh-ancestor
65243666|NCT05329454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65243667|NCT05329454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243668|NCT05329454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65243669|NCT05329454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65243670|NCT05329454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65243671|NCT05329454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243672|NCT05329454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243673|NCT00629447|Tinzaparin|tinzaparin|mesh-list
65243694|NCT02622243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65243695|NCT02622243|Respiratory System Agents|respiratory system agents|mesh-ancestor
65243696|NCT02622243|Parasympatholytics|parasympatholytics|mesh-ancestor
65243697|NCT02622243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65243698|NCT02622243|Cholinergic Agents|cholinergic agents|mesh-ancestor
65243699|NCT02622243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65243700|NCT02622243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243701|NCT02622243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65243702|NCT02622243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65243703|NCT04289675|Interferons|interferons|mesh-list
65243704|NCT04289675|Interferon-beta|interferon-beta|mesh-list
65243705|NCT04289675|Teriflunomide|teriflunomide|mesh-list
65243706|NCT04289675|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65243707|NCT04289675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243708|NCT04289675|Antiviral Agents|antiviral agents|mesh-ancestor
65243709|NCT04289675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65243710|NCT04289675|Immunologic Factors|immunologic factors|mesh-ancestor
65243711|NCT04289675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243712|NCT04289675|Dermatologic Agents|dermatologic agents|mesh-ancestor
65243713|NCT04289675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65243714|NCT04289675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65243715|NCT04289675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65243716|NCT04289675|Analgesics|analgesics|mesh-ancestor
65243717|NCT04289675|Sensory System Agents|sensory system agents|mesh-ancestor
65243718|NCT04289675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65243719|NCT04289675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65243720|NCT04289675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65243721|NCT00696579|Gemcitabine|gemcitabine|mesh-list
65243722|NCT00696579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65243723|NCT00696579|Antimetabolites|antimetabolites|mesh-ancestor
65243724|NCT00696579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243725|NCT00696579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243726|NCT00696579|Antiviral Agents|antiviral agents|mesh-ancestor
65243727|NCT00696579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919010|NCT00107263|Letrozole|letrozole|mesh-list
65243754|NCT02867345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65243755|NCT02867345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65243757|NCT02867345|Sensory System Agents|sensory system agents|mesh-ancestor
65243758|NCT02867345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65243759|NCT00975689|Acetylcysteine|acetylcysteine|mesh-list
65243760|NCT00975689|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65243761|NCT00975689|Antiviral Agents|antiviral agents|mesh-ancestor
65243762|NCT00975689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65243763|NCT00975689|Expectorants|expectorants|mesh-ancestor
65243764|NCT00975689|Respiratory System Agents|respiratory system agents|mesh-ancestor
65243765|NCT00975689|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65243766|NCT00975689|Antioxidants|antioxidants|mesh-ancestor
65243767|NCT00975689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243768|NCT00975689|Protective Agents|protective agents|mesh-ancestor
65243769|NCT00975689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243770|NCT00975689|Antidotes|antidotes|mesh-ancestor
65243771|NCT02621385|Midazolam|midazolam|mesh-list
65243772|NCT02621385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65243773|NCT02621385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65243774|NCT02621385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65243775|NCT02621385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919067|NCT00107458|Valproic Acid|valproic acid|mesh-list
65243811|NCT02620605|Dopamine Agonists|dopamine agonists|mesh-ancestor
65243812|NCT02620605|Dopamine Agents|dopamine agents|mesh-ancestor
65243813|NCT02620605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65243814|NCT02620605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243815|NCT02620605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243816|NCT00976391|Insulin|insulin|mesh-list
65243842|NCT00696969|Antifungal Agents|antifungal agents|mesh-ancestor
65243843|NCT00696969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472914|NCT02043678|Prednisolone|prednisolone|mesh-list
65243844|NCT00696969|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65243845|NCT00696969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65243846|NCT04203680|Cardioplegic Solutions|cardioplegic solutions|mesh-list
65243848|NCT04203680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65243849|NCT04203680|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65243850|NCT04203680|Antidepressive Agents|antidepressive agents|mesh-ancestor
65243851|NCT04203680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65243852|NCT02620215|Dinoprostone|dinoprostone|mesh-list
65243853|NCT02620215|Oxytocics|oxytocics|mesh-ancestor
65243854|NCT02620215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65243855|NCT02620215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243856|NCT02620293|Emollients|emollients|mesh-list
65243857|NCT02620293|Dermatologic Agents|dermatologic agents|mesh-ancestor
65243858|NCT02619981|Lidocaine|lidocaine|mesh-list
65243859|NCT02619981|Anesthetics, Local|anesthetics, local|mesh-ancestor
65243860|NCT02619981|Anesthetics|anesthetics|mesh-ancestor
65243861|NCT02619981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65243862|NCT02619981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243863|NCT02619981|Sensory System Agents|sensory system agents|mesh-ancestor
65243864|NCT02619981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65243865|NCT02619981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65243866|NCT02619981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65243892|NCT03965117|Adrenergic Agents|adrenergic agents|mesh-ancestor
65243893|NCT03965117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65243894|NCT03965117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243895|NCT03965117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243896|NCT03965117|Sympathomimetics|sympathomimetics|mesh-ancestor
65243897|NCT03965117|Autonomic Agents|autonomic agents|mesh-ancestor
65243898|NCT03965117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65243899|NCT03965117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65243900|NCT00917462|Sorafenib|sorafenib|mesh-list
65243901|NCT00917462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243902|NCT00917462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65243903|NCT00917462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243904|NCT00917462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243905|NCT02619513|Dexmedetomidine|dexmedetomidine|mesh-list
65243906|NCT02619513|Ropivacaine|ropivacaine|mesh-list
65243907|NCT02619513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65243908|NCT02619513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65243909|NCT02619513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243910|NCT02619513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65243911|NCT02619513|Analgesics|analgesics|mesh-ancestor
65243912|NCT02619513|Sensory System Agents|sensory system agents|mesh-ancestor
65243945|NCT03853187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243946|NCT03849443|Tranexamic Acid|tranexamic acid|mesh-list
65243947|NCT03849443|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65243948|NCT03849443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65243970|NCT00979901|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65243971|NCT00979901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65243972|NCT00979901|Histamine Antagonists|histamine antagonists|mesh-ancestor
65243973|NCT00979901|Histamine Agents|histamine agents|mesh-ancestor
64994232|NCT00089453|Antiemetics|antiemetics|mesh-ancestor
65243974|NCT00979901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65243976|NCT02619201|Metoclopramide|metoclopramide|mesh-list
65243977|NCT02619201|Antiemetics|antiemetics|mesh-ancestor
65243978|NCT02619201|Autonomic Agents|autonomic agents|mesh-ancestor
65243979|NCT02619201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65243980|NCT02619201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243981|NCT02619201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65243982|NCT02619201|Antipruritics|antipruritics|mesh-ancestor
65243983|NCT02619201|Dermatologic Agents|dermatologic agents|mesh-ancestor
65243984|NCT02619201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65243985|NCT02619201|Serotonin Agents|serotonin agents|mesh-ancestor
65243986|NCT02619201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65243987|NCT02619201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243988|NCT02619201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65243989|NCT02619201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65243990|NCT02619201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65243991|NCT02619201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65243992|NCT02619201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65243993|NCT02619201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65243994|NCT02619201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65243995|NCT02619201|Dopamine Agents|dopamine agents|mesh-ancestor
65243996|NCT00975611|Amantadine|amantadine|mesh-list
64832643|NCT01595893|Vitamin D|vitamin d|mesh-list
65243997|NCT00975611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65243998|NCT00975611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65243999|NCT00975611|Antiviral Agents|antiviral agents|mesh-ancestor
65244033|NCT02862977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65244035|NCT02862977|Sensory System Agents|sensory system agents|mesh-ancestor
65244036|NCT02862977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65244037|NCT02862977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65244038|NCT02862977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65244039|NCT02862977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65244068|NCT04133961|Respiratory System Agents|respiratory system agents|mesh-ancestor
65244069|NCT04133961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65244070|NCT04133961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65244071|NCT04133961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65244072|NCT04133961|Adrenergic Agents|adrenergic agents|mesh-ancestor
65244073|NCT04133961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65244074|NCT04133961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244075|NCT04133961|Protective Agents|protective agents|mesh-ancestor
65244076|NCT02618733|Clopidogrel|clopidogrel|mesh-list
65244077|NCT02618733|Ticagrelor|ticagrelor|mesh-list
65244078|NCT02618733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65244079|NCT02618733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65244080|NCT02618733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65244081|NCT02618733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65244082|NCT02618733|Purinergic Agents|purinergic agents|mesh-ancestor
65244083|NCT02618733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65244084|NCT02618733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244085|NCT02618733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244086|NCT00970307|Vaccines|vaccines|mesh-list
64919366|NCT00006929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65244116|NCT00629681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65244117|NCT00629681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65244119|NCT02617485|Cyclophosphamide|cyclophosphamide|mesh-list
65244120|NCT02617485|Rituximab|rituximab|mesh-list
65244121|NCT02617485|Doxorubicin|doxorubicin|mesh-list
65244122|NCT02617485|Vincristine|vincristine|mesh-list
64994379|NCT00343096|GABA Agents|gaba agents|mesh-ancestor
65244123|NCT02617485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65244124|NCT02617485|Immunologic Factors|immunologic factors|mesh-ancestor
65244125|NCT02617485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244126|NCT02617485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65244127|NCT02617485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65244128|NCT02617485|Alkylating Agents|alkylating agents|mesh-ancestor
65244161|NCT02863835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65244162|NCT02863835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65244163|NCT02863835|Adrenergic Agents|adrenergic agents|mesh-ancestor
65244164|NCT02863835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65244165|NCT02863835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244166|NCT00697437|Ketoconazole|ketoconazole|mesh-list
65244167|NCT00697437|Docetaxel|docetaxel|mesh-list
65244191|NCT04252274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65244192|NCT04252274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65244193|NCT04252274|Antiviral Agents|antiviral agents|mesh-ancestor
65244194|NCT04252274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65244195|NCT04252274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65244196|NCT04252274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65244198|NCT00864513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244199|NCT00864513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244200|NCT00864513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244201|NCT00864513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65244202|NCT00864513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65244203|NCT04128891|Valsartan|valsartan|mesh-list
65244204|NCT04128891|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65244205|NCT04128891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65244206|NCT04128891|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65244207|NCT04128891|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65244208|NCT04128891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244209|NCT04251962|Fentanyl|fentanyl|mesh-list
65244210|NCT04251962|Bupivacaine|bupivacaine|mesh-list
65244211|NCT04251962|Anesthetics, Local|anesthetics, local|mesh-ancestor
65244212|NCT04251962|Anesthetics|anesthetics|mesh-ancestor
65244213|NCT04251962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65244214|NCT04251962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832715|NCT01596166|Ketorolac|ketorolac|mesh-list
65244215|NCT04251962|Sensory System Agents|sensory system agents|mesh-ancestor
65244246|NCT00631514|Ibuprofen|ibuprofen|mesh-list
65244247|NCT00631514|Piroxicam|piroxicam|mesh-list
65244248|NCT00631514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65244249|NCT00631514|Analgesics|analgesics|mesh-ancestor
65244250|NCT00631514|Sensory System Agents|sensory system agents|mesh-ancestor
65244251|NCT00631514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65244252|NCT00631514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244253|NCT00631514|Antipyretics|antipyretics|mesh-ancestor
65244254|NCT00631514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65244255|NCT00631514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65244256|NCT00631514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65244257|NCT00631514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65244258|NCT00631514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244259|NCT00631514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244260|NCT04623944|Cytarabine|cytarabine|mesh-list
65244277|NCT05253014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65244278|NCT05253014|Analgesics|analgesics|mesh-ancestor
65244279|NCT05253014|Sensory System Agents|sensory system agents|mesh-ancestor
65244280|NCT05253014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65244281|NCT05253014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244282|NCT05253014|Antipyretics|antipyretics|mesh-ancestor
65244283|NCT00659425|Immunotoxin HA22|immunotoxin ha22|mesh-list
65244284|NCT00659425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244285|NCT00656851|Pioglitazone|pioglitazone|mesh-list
65244286|NCT00656851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65244287|NCT00656851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244288|NCT00803335|Estrogens|estrogens|mesh-list
65244289|NCT00803335|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65244290|NCT00803335|Hormones|hormones|mesh-ancestor
65244291|NCT00803335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65244292|NCT00803335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244293|NCT00797953|Cardiotonic Agents|cardiotonic agents|mesh-list
65244294|NCT00656617|Cytarabine|cytarabine|mesh-list
65244295|NCT00656617|Vorinostat|vorinostat|mesh-list
65244296|NCT00656617|Idarubicin|idarubicin|mesh-list
65244297|NCT00656617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65244298|NCT00656617|Antimetabolites|antimetabolites|mesh-ancestor
65244299|NCT00656617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244300|NCT00656617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244301|NCT00656617|Antiviral Agents|antiviral agents|mesh-ancestor
65244302|NCT00656617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65244303|NCT00656617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65244304|NCT00656617|Immunologic Factors|immunologic factors|mesh-ancestor
65244305|NCT00656617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244306|NCT00656617|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65244307|NCT00656617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244308|NCT00656617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65244309|NCT00656617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65244310|NCT00656617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65244311|NCT00798343|Vaccines|vaccines|mesh-list
65244312|NCT00798343|Immunologic Factors|immunologic factors|mesh-ancestor
65244313|NCT00798343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244314|NCT00803725|Fentanyl|fentanyl|mesh-list
65244315|NCT00803725|Mepivacaine|mepivacaine|mesh-list
65244316|NCT00803725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65244317|NCT00803725|Narcotics|narcotics|mesh-ancestor
65244318|NCT00803725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65244319|NCT00803725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244320|NCT00803725|Analgesics|analgesics|mesh-ancestor
64919594|NCT00111046|Ibuprofen|ibuprofen|mesh-list
65244353|NCT00659269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65244354|NCT00659269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244355|NCT00659269|Tubulin Modulators|tubulin modulators|mesh-ancestor
65244356|NCT00659269|Antimitotic Agents|antimitotic agents|mesh-ancestor
65244357|NCT00659269|Mitosis Modulators|mitosis modulators|mesh-ancestor
65244358|NCT00659269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244359|NCT00659269|Micronutrients|micronutrients|mesh-ancestor
65244360|NCT00659269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244361|NCT00922129|Cyclosporine|cyclosporine|mesh-list
65244362|NCT00922129|Sirolimus|sirolimus|mesh-list
65244363|NCT00922129|Tacrolimus|tacrolimus|mesh-list
65244364|NCT00922129|Cyclosporins|cyclosporins|mesh-list
65244365|NCT00922129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65244366|NCT00922129|Immunologic Factors|immunologic factors|mesh-ancestor
65244367|NCT00922129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248451|NCT02548117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244368|NCT00922129|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65244369|NCT00922129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244370|NCT00922129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244371|NCT00922129|Antifungal Agents|antifungal agents|mesh-ancestor
65244390|NCT00804115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65244391|NCT00804115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65244393|NCT00804115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65244394|NCT00804115|Miotics|miotics|mesh-ancestor
65244395|NCT00804115|Autonomic Agents|autonomic agents|mesh-ancestor
65244396|NCT00804115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65244397|NCT00804115|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65244398|NCT00804115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65244399|NCT00804115|Cholinergic Agents|cholinergic agents|mesh-ancestor
65244400|NCT02554123|Vitamin E|vitamin e|mesh-list
65244401|NCT02554123|Petrolatum|petrolatum|mesh-list
65244402|NCT02554123|Vitamins|vitamins|mesh-ancestor
65244403|NCT02554123|Micronutrients|micronutrients|mesh-ancestor
65244404|NCT02554123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244405|NCT02554123|Antioxidants|antioxidants|mesh-ancestor
65244406|NCT02554123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244407|NCT02554123|Protective Agents|protective agents|mesh-ancestor
65244408|NCT02554123|Emollients|emollients|mesh-ancestor
65244409|NCT02554123|Dermatologic Agents|dermatologic agents|mesh-ancestor
65244410|NCT00799045|Clopidogrel|clopidogrel|mesh-list
65244411|NCT00799045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65244412|NCT00799045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65244413|NCT00799045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65244414|NCT00799045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65244415|NCT00799045|Purinergic Agents|purinergic agents|mesh-ancestor
65244416|NCT00799045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65244417|NCT00799045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244418|NCT00799045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244419|NCT00658333|Mycophenolic Acid|mycophenolic acid|mesh-list
65244420|NCT00658333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65244421|NCT00658333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244422|NCT00658333|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65244423|NCT00658333|Antitubercular Agents|antitubercular agents|mesh-ancestor
65244424|NCT00658333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65244425|NCT00658333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65244426|NCT00658333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244427|NCT00658333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244429|NCT00804271|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65244430|NCT00804271|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65244452|NCT00799513|Growth Substances|growth substances|mesh-ancestor
65244453|NCT00799513|Growth Inhibitors|growth inhibitors|mesh-ancestor
65244454|NCT00799513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244455|NCT00806767|Fludarabine|fludarabine|mesh-list
65244456|NCT00806767|Fludarabine phosphate|fludarabine phosphate|mesh-list
65244457|NCT00806767|Busulfan|busulfan|mesh-list
65244458|NCT00806767|Immunoglobulins|immunoglobulins|mesh-list
65244459|NCT00806767|Antibodies|antibodies|mesh-list
65244460|NCT00806767|gamma-Globulins|gamma-globulins|mesh-list
65244461|NCT00806767|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65244462|NCT00806767|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65244463|NCT00806767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244464|NCT00806767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65244465|NCT00806767|Antimetabolites|antimetabolites|mesh-ancestor
65244466|NCT00806767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244467|NCT00806767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65244468|NCT00806767|Immunologic Factors|immunologic factors|mesh-ancestor
65244469|NCT00806767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244470|NCT00806767|Alkylating Agents|alkylating agents|mesh-ancestor
65244471|NCT00806767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65244472|NCT00806767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65244473|NCT00863655|Everolimus|everolimus|mesh-list
65244474|NCT00863655|Exemestane|exemestane|mesh-list
65244475|NCT00863655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244476|NCT00863655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65244477|NCT00863655|Immunologic Factors|immunologic factors|mesh-ancestor
65244478|NCT00863655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244479|NCT00863655|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65244480|NCT00863655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65244481|NCT00863655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244482|NCT00863655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919755|NCT00401674|Paclitaxel|paclitaxel|mesh-list
65244508|NCT00698607|Immunologic Factors|immunologic factors|mesh-ancestor
65244509|NCT00698607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244510|NCT00698607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65244511|NCT00698607|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65244512|NCT00698607|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65244513|NCT00698607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65244514|NCT00698607|Purinergic Agents|purinergic agents|mesh-ancestor
65244515|NCT00698607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65244516|NCT00698607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244517|NCT00698607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65244518|NCT00698607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65244519|NCT00698607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65244520|NCT00698607|Antifungal Agents|antifungal agents|mesh-ancestor
65244521|NCT04124757|Rocuronium|rocuronium|mesh-list
65244522|NCT04124757|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65244523|NCT04124757|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65244524|NCT04124757|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65244525|NCT04124757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65244526|NCT04124757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244527|NCT04123041|Nicotine|nicotine|mesh-list
65244528|NCT04123041|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65244529|NCT04123041|Autonomic Agents|autonomic agents|mesh-ancestor
65244530|NCT04123041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65244531|NCT04123041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244532|NCT04123041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65244533|NCT04123041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65244534|NCT04123041|Cholinergic Agents|cholinergic agents|mesh-ancestor
65244535|NCT04123041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65244536|NCT04123041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244537|NCT00698763|Simendan|simendan|mesh-list
65244538|NCT00698763|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65244565|NCT00800137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244567|NCT00807079|Topotecan|topotecan|mesh-list
65244568|NCT00807079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244569|NCT00807079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65244570|NCT00807079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65244571|NCT00807079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244572|NCT00807079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244583|NCT00800293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65244584|NCT00800293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65244585|NCT00800293|Glucocorticoids|glucocorticoids|mesh-ancestor
65244586|NCT00800293|Hormones|hormones|mesh-ancestor
65244587|NCT00800293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65244588|NCT00800293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244589|NCT00800293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65244590|NCT00800293|Respiratory System Agents|respiratory system agents|mesh-ancestor
65244591|NCT00658021|Exenatide|exenatide|mesh-list
65244592|NCT00658021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65244593|NCT00658021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244594|NCT00658021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65244595|NCT00658021|Incretins|incretins|mesh-ancestor
65244596|NCT00658021|Hormones|hormones|mesh-ancestor
64919860|NCT00112567|Thiotepa|thiotepa|mesh-list
65244622|NCT05251610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244623|NCT05251610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65244624|NCT05251610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65244625|NCT05251610|Vasodilator Agents|vasodilator agents|mesh-ancestor
65244626|NCT00657709|Vaccines|vaccines|mesh-list
65244627|NCT00657709|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65244628|NCT00657709|Immunologic Factors|immunologic factors|mesh-ancestor
65244629|NCT00657709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244630|NCT00657553|Bortezomib|bortezomib|mesh-list
65244631|NCT00657553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244632|NCT04253912|Povidone-Iodine|povidone-iodine|mesh-list
65244633|NCT04253912|Povidone|povidone|mesh-list
65244634|NCT04253912|Plasma Substitutes|plasma substitutes|mesh-ancestor
65244635|NCT04253912|Blood Substitutes|blood substitutes|mesh-ancestor
65244636|NCT04253912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65244637|NCT04253912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65244638|NCT00800527|Diclofenac|diclofenac|mesh-list
65244639|NCT00800527|Gabapentin|gabapentin|mesh-list
65244640|NCT00800527|Analgesics|analgesics|mesh-ancestor
65244641|NCT00800527|Sensory System Agents|sensory system agents|mesh-ancestor
65244642|NCT00800527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65244643|NCT00800527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244644|NCT00800527|Anticonvulsants|anticonvulsants|mesh-ancestor
64451340|NCT01822665|Ibuprofen|ibuprofen|mesh-list
65244645|NCT00800527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65244646|NCT00800527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65244647|NCT00800527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65244674|NCT00862641|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65244675|NCT00862641|Purinergic Agonists|purinergic agonists|mesh-ancestor
65244676|NCT00862641|Purinergic Agents|purinergic agents|mesh-ancestor
65244677|NCT00862641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65244678|NCT00862641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244679|NCT00862641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244680|NCT04119921|Ketorolac|ketorolac|mesh-list
65244681|NCT04119921|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65244682|NCT04119921|Lubricant Eye Drops|lubricant eye drops|mesh-list
65244683|NCT04119921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65244684|NCT04119921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65244685|NCT04119921|Analgesics|analgesics|mesh-ancestor
65244686|NCT04119921|Sensory System Agents|sensory system agents|mesh-ancestor
65244687|NCT04119921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65244688|NCT04119921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244689|NCT04119921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65244690|NCT04119921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65244691|NCT04119921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65244722|NCT00699465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65244723|NCT00699465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65244724|NCT00699465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244726|NCT00858117|Alemtuzumab|alemtuzumab|mesh-list
65244727|NCT00858117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65244728|NCT00858117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244729|NCT00858117|Immunologic Factors|immunologic factors|mesh-ancestor
65244730|NCT00858117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244731|NCT00858117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65244732|NCT00700947|Metoprolol|metoprolol|mesh-list
65244733|NCT00700947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65244734|NCT00700947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65244735|NCT00700947|Adrenergic Agents|adrenergic agents|mesh-ancestor
65244736|NCT00700947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65244737|NCT00700947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244762|NCT00805519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65244763|NCT00805519|Glucocorticoids|glucocorticoids|mesh-ancestor
65244764|NCT00805519|Hormones|hormones|mesh-ancestor
65244765|NCT00805519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65244766|NCT00805519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244767|NCT00805519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65244768|NCT00805519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244769|NCT00805519|Antiemetics|antiemetics|mesh-ancestor
65244770|NCT00805519|Autonomic Agents|autonomic agents|mesh-ancestor
65244771|NCT00805519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65244772|NCT00805519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65244773|NCT00805519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65244774|NCT00805519|Protective Agents|protective agents|mesh-ancestor
65244775|NCT00805519|Amebicides|amebicides|mesh-ancestor
65244776|NCT00805519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65244777|NCT00805519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65244778|NCT00805519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65244779|NCT00805519|Antimalarials|antimalarials|mesh-ancestor
65244780|NCT00805519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65244781|NCT00805519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65244782|NCT00805519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65244783|NCT00805519|Analgesics|analgesics|mesh-ancestor
65244784|NCT00805519|Sensory System Agents|sensory system agents|mesh-ancestor
65244785|NCT00805519|Filaricides|filaricides|mesh-ancestor
65244786|NCT00805519|Antinematodal Agents|antinematodal agents|mesh-ancestor
65244787|NCT00805519|Anthelmintics|anthelmintics|mesh-ancestor
65244788|NCT00592683|Aripiprazole|aripiprazole|mesh-list
65244789|NCT00592683|Antidepressive Agents|antidepressive agents|mesh-ancestor
65244820|NCT00701259|Dexlansoprazole|dexlansoprazole|mesh-list
65244821|NCT00701259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65244822|NCT00701259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65244823|NCT00701259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65244824|NCT00701259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244825|NCT00701259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244826|NCT00701337|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65244827|NCT00701337|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65244828|NCT00701337|Estradiol|estradiol|mesh-list
65244829|NCT00701337|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65244830|NCT00701337|Estrogens|estrogens|mesh-ancestor
65244831|NCT00701337|Hormones|hormones|mesh-ancestor
65244832|NCT00701337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65244833|NCT00701337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244866|NCT02551861|Sofosbuvir|sofosbuvir|mesh-list
65244867|NCT02551861|Antimetabolites|antimetabolites|mesh-ancestor
65244868|NCT02551861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244869|NCT02551861|Antiviral Agents|antiviral agents|mesh-ancestor
65244870|NCT02551861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65244871|NCT00846495|Topiramate|topiramate|mesh-list
65244872|NCT00846495|Frovatriptan|frovatriptan|mesh-list
65244873|NCT00846495|Anticonvulsants|anticonvulsants|mesh-ancestor
65244874|NCT00846495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65244875|NCT00846495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244898|NCT00809887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65244899|NCT00846027|Gemcitabine|gemcitabine|mesh-list
65244900|NCT00846027|Paclitaxel|paclitaxel|mesh-list
65244901|NCT00846027|Bevacizumab|bevacizumab|mesh-list
65244902|NCT00846027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65244903|NCT00846027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244904|NCT00846027|Tubulin Modulators|tubulin modulators|mesh-ancestor
65244905|NCT00846027|Antimitotic Agents|antimitotic agents|mesh-ancestor
65244906|NCT00846027|Mitosis Modulators|mitosis modulators|mesh-ancestor
65244907|NCT00846027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244908|NCT00846027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65244909|NCT00846027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65244910|NCT00846027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65244911|NCT00846027|Growth Substances|growth substances|mesh-ancestor
65244912|NCT00846027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244913|NCT00846027|Growth Inhibitors|growth inhibitors|mesh-ancestor
65244914|NCT00846027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65244915|NCT00846027|Antimetabolites|antimetabolites|mesh-ancestor
65244916|NCT00846027|Antiviral Agents|antiviral agents|mesh-ancestor
65244917|NCT00846027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65244918|NCT00846027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244919|NCT00846027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65244920|NCT00846027|Immunologic Factors|immunologic factors|mesh-ancestor
65244921|NCT00807625|Copper|copper|mesh-list
65244922|NCT00807625|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65244923|NCT00807625|Medroxyprogesterone|medroxyprogesterone|mesh-list
65244924|NCT00807625|Trace Elements|trace elements|mesh-ancestor
65244925|NCT00807625|Micronutrients|micronutrients|mesh-ancestor
65244926|NCT00807625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244927|NCT00807625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65244959|NCT00652327|Antimetabolites|antimetabolites|mesh-ancestor
65244960|NCT00652327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244961|NCT00652327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65244962|NCT00652327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244963|NCT00814021|Sunitinib|sunitinib|mesh-list
65244964|NCT00814021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244965|NCT00814021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65244966|NCT00814021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65244967|NCT00814021|Growth Substances|growth substances|mesh-ancestor
65244968|NCT00814021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244969|NCT00814021|Growth Inhibitors|growth inhibitors|mesh-ancestor
65244970|NCT00814021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65244994|NCT00651937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65244996|NCT00651937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244997|NCT00651937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244998|NCT00651937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65244999|NCT00651937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65245000|NCT00651937|Immunologic Factors|immunologic factors|mesh-ancestor
65245001|NCT00651937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245002|NCT00651937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65245003|NCT00654355|Tacrolimus|tacrolimus|mesh-list
65245004|NCT00654355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65245005|NCT00654355|Immunologic Factors|immunologic factors|mesh-ancestor
65245006|NCT00654355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245007|NCT00654355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65245008|NCT00654355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65245009|NCT00654355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245010|NCT00651313|Lidocaine|lidocaine|mesh-list
65245011|NCT00651313|Anesthetics, Local|anesthetics, local|mesh-ancestor
65245012|NCT00651313|Anesthetics|anesthetics|mesh-ancestor
65245013|NCT00651313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65245014|NCT00651313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245015|NCT00651313|Sensory System Agents|sensory system agents|mesh-ancestor
65245016|NCT00651313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65245017|NCT00651313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65245018|NCT00651313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65245019|NCT00651313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65245020|NCT00651313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65245021|NCT00651313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245041|NCT00808171|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65245043|NCT04703257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65245044|NCT04703257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65245045|NCT04703257|Analgesics|analgesics|mesh-ancestor
65245046|NCT04703257|Sensory System Agents|sensory system agents|mesh-ancestor
65245047|NCT04703257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65245048|NCT04703257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245049|NCT04703257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65245050|NCT04703257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65245051|NCT04703257|Antipyretics|antipyretics|mesh-ancestor
65245052|NCT00808327|Fentanyl|fentanyl|mesh-list
65245053|NCT00808327|Bupivacaine|bupivacaine|mesh-list
65245054|NCT00808327|Anesthetics, Local|anesthetics, local|mesh-ancestor
65245055|NCT00808327|Anesthetics|anesthetics|mesh-ancestor
65245056|NCT00808327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65245057|NCT00808327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245058|NCT00808327|Sensory System Agents|sensory system agents|mesh-ancestor
65245059|NCT00808327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65245060|NCT00808327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65245061|NCT00808327|Narcotics|narcotics|mesh-ancestor
65245062|NCT00808327|Analgesics|analgesics|mesh-ancestor
65245063|NCT00808327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65245064|NCT00808327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65245065|NCT00808327|Anesthetics, General|anesthetics, general|mesh-ancestor
65245066|NCT00814645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65245067|NCT00814723|Ezetimibe|ezetimibe|mesh-list
65245068|NCT00814723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65245069|NCT00814723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65245070|NCT00814723|Antimetabolites|antimetabolites|mesh-ancestor
65245071|NCT00814723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245072|NCT00814723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65245073|NCT00845871|Deferasirox|deferasirox|mesh-list
65245074|NCT00845871|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65245075|NCT00845871|Chelating Agents|chelating agents|mesh-ancestor
65245076|NCT00845871|Sequestering Agents|sequestering agents|mesh-ancestor
65245077|NCT00845871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245114|NCT02863913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245115|NCT02863913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245116|NCT02863913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65245117|NCT02863913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65245118|NCT02863913|Analgesics|analgesics|mesh-ancestor
65245145|NCT00844857|Antiemetics|antiemetics|mesh-ancestor
65245146|NCT00844857|Autonomic Agents|autonomic agents|mesh-ancestor
65245147|NCT00844857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65245148|NCT00844857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245149|NCT00844857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65245150|NCT00844857|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65245151|NCT00844857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65245152|NCT00844857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65245153|NCT00844857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65245154|NCT00844857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65245155|NCT00844857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65245156|NCT00844857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65245157|NCT00844857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245158|NCT00844857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65245159|NCT00844857|Serotonin Agents|serotonin agents|mesh-ancestor
65245160|NCT00844857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65245161|NCT00844857|Antidepressive Agents|antidepressive agents|mesh-ancestor
65245162|NCT00844857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65245163|NCT00844857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65245164|NCT00844857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65245165|NCT00702117|Flecainide|flecainide|mesh-list
65245196|NCT00569803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245197|NCT00569803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65245198|NCT00569803|Immunologic Factors|immunologic factors|mesh-ancestor
65245199|NCT00569803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842734|NCT01657513|Analgesics|analgesics|mesh-ancestor
65245200|NCT00569803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65245201|NCT00920426|Cabotegravir|cabotegravir|mesh-list
65245202|NCT00920426|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65245203|NCT00920426|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65245204|NCT00920426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495204|NCT00911820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65245229|NCT04253132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65245230|NCT04253132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65245231|NCT04253132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65245232|NCT04253132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65245233|NCT04253132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65245234|NCT04253132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65245235|NCT04253132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245236|NCT04253132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65245237|NCT04253132|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
65245238|NCT04253132|Hormone Antagonists|hormone antagonists|mesh-ancestor
65245239|NCT04253132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65245240|NCT04253132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65245241|NCT04253132|Serotonin Agents|serotonin agents|mesh-ancestor
65245242|NCT04253132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65245243|NCT00914966|Complement C1s|complement c1s|mesh-list
65245244|NCT00914966|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
65245245|NCT00914966|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
65245246|NCT00914966|Immunologic Factors|immunologic factors|mesh-ancestor
65245247|NCT00914966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245248|NCT00914966|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65245249|NCT00914966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64995515|NCT00426985|Ketoprofen|ketoprofen|mesh-list
65245250|NCT00815269|Sevoflurane|sevoflurane|mesh-list
65245251|NCT00815269|Desflurane|desflurane|mesh-list
65245252|NCT00815269|Isoflurane|isoflurane|mesh-list
65245253|NCT00815269|Halothane|halothane|mesh-list
65245281|NCT00844545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65245282|NCT00844545|Immunologic Factors|immunologic factors|mesh-ancestor
65245283|NCT00844545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245284|NCT00815503|Ropivacaine|ropivacaine|mesh-list
65245285|NCT00815503|Anesthetics, Local|anesthetics, local|mesh-ancestor
65245286|NCT00815503|Anesthetics|anesthetics|mesh-ancestor
65245287|NCT00815503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65245288|NCT00815503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245289|NCT00815503|Sensory System Agents|sensory system agents|mesh-ancestor
65245290|NCT00815503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65245291|NCT04648046|Cyclophosphamide|cyclophosphamide|mesh-list
65245292|NCT04648046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65245293|NCT04648046|Immunologic Factors|immunologic factors|mesh-ancestor
65245294|NCT04648046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245295|NCT04648046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65245296|NCT04648046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65245297|NCT04648046|Alkylating Agents|alkylating agents|mesh-ancestor
65245298|NCT04648046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245299|NCT04648046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245300|NCT04648046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65245301|NCT00702819|Bevacizumab|bevacizumab|mesh-list
65245328|NCT00842985|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65245329|NCT00842985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65245331|NCT00842985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65245332|NCT00808795|Acetylcysteine|acetylcysteine|mesh-list
65245333|NCT00808795|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65245334|NCT00808795|Antiviral Agents|antiviral agents|mesh-ancestor
65245335|NCT00808795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65245336|NCT00808795|Expectorants|expectorants|mesh-ancestor
65245337|NCT00808795|Respiratory System Agents|respiratory system agents|mesh-ancestor
65245338|NCT00808795|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65245339|NCT00808795|Antioxidants|antioxidants|mesh-ancestor
65245340|NCT00808795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245341|NCT00808795|Protective Agents|protective agents|mesh-ancestor
65245342|NCT00808795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245343|NCT00808795|Antidotes|antidotes|mesh-ancestor
65245344|NCT00808951|Artesunate|artesunate|mesh-list
65245345|NCT00808951|Lumefantrine|lumefantrine|mesh-list
65245346|NCT00808951|Artemether|artemether|mesh-list
65245369|NCT00842829|Analgesics|analgesics|mesh-ancestor
65245370|NCT00842829|Sensory System Agents|sensory system agents|mesh-ancestor
65245371|NCT00842829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65245372|NCT00842829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65245373|NCT00842829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65245374|NCT00842829|Anesthetics, General|anesthetics, general|mesh-ancestor
65245375|NCT00842829|Anesthetics|anesthetics|mesh-ancestor
65245376|NCT04045093|Warfarin|warfarin|mesh-list
65245377|NCT04045093|Dabigatran|dabigatran|mesh-list
65245378|NCT04045093|Anticoagulants|anticoagulants|mesh-ancestor
65245379|NCT04045093|Antithrombins|antithrombins|mesh-ancestor
65245380|NCT04045093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65245381|NCT04045093|Protease Inhibitors|protease inhibitors|mesh-ancestor
65245382|NCT04045093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65245383|NCT04045093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245384|NCT00811291|Calcium, Dietary|calcium, dietary|mesh-list
65245385|NCT00811291|Folic Acid|folic acid|mesh-list
65245386|NCT00811291|Calcium|calcium|mesh-list
65245387|NCT00811291|Vitamins|vitamins|mesh-ancestor
65245388|NCT00811291|Micronutrients|micronutrients|mesh-ancestor
65245389|NCT00811291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245390|NCT00811291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65245391|NCT00811291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65245392|NCT00811291|Hematinics|hematinics|mesh-ancestor
65245393|NCT00811291|Vitamin B Complex|vitamin b complex|mesh-ancestor
65245394|NCT00811369|Fulvestrant|fulvestrant|mesh-list
65245395|NCT00811369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65245396|NCT00811369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245397|NCT00811369|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65245398|NCT00811369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65245399|NCT00811369|Hormone Antagonists|hormone antagonists|mesh-ancestor
65245400|NCT00811369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64920674|NCT02909322|Hydromorphone|hydromorphone|mesh-list
65245433|NCT00702975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65245435|NCT00702975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65245436|NCT00702975|Growth Substances|growth substances|mesh-ancestor
65245437|NCT00702975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245438|NCT00702975|Growth Inhibitors|growth inhibitors|mesh-ancestor
65245439|NCT00702975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65245440|NCT00702975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65245441|NCT00809107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65245467|NCT00642811|Aspirin|aspirin|mesh-list
65245468|NCT00642811|Clopidogrel|clopidogrel|mesh-list
65245469|NCT00642811|Ticagrelor|ticagrelor|mesh-list
65245470|NCT00642811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65245471|NCT00642811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65245472|NCT00642811|Analgesics|analgesics|mesh-ancestor
65245473|NCT00642811|Sensory System Agents|sensory system agents|mesh-ancestor
65245474|NCT00642811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65245475|NCT00642811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245476|NCT00642811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65245477|NCT00642811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65245478|NCT00642811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65245479|NCT00642811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65245480|NCT00642811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245481|NCT00642811|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65245482|NCT00642811|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65245483|NCT00642811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65245484|NCT00642811|Antipyretics|antipyretics|mesh-ancestor
65245485|NCT00642811|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65245486|NCT00642811|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65245487|NCT00642811|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65245523|NCT00815893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65245524|NCT00815893|Adrenergic Agents|adrenergic agents|mesh-ancestor
65245525|NCT00815893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64920809|NCT00117520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920812|NCT00117520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65245553|NCT04648033|Vinorelbine|vinorelbine|mesh-list
65245554|NCT04648033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245555|NCT04648033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65245556|NCT04648033|Tubulin Modulators|tubulin modulators|mesh-ancestor
65245557|NCT04648033|Antimitotic Agents|antimitotic agents|mesh-ancestor
65245558|NCT04648033|Mitosis Modulators|mitosis modulators|mesh-ancestor
65245559|NCT04648033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245560|NCT04648033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65245561|NCT04648033|Antimalarials|antimalarials|mesh-ancestor
65245562|NCT04648033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65245563|NCT04648033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65245564|NCT04648033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65245565|NCT00811837|Midazolam|midazolam|mesh-list
64569840|NCT01525069|Hormones|hormones|mesh-ancestor
65245566|NCT00811837|Remifentanil|remifentanil|mesh-list
65245567|NCT00811837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65245568|NCT00811837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65245569|NCT00811837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65245570|NCT00811837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920850|NCT05636111|Paclitaxel|paclitaxel|mesh-list
65245604|NCT00916058|Alkylating Agents|alkylating agents|mesh-ancestor
65245605|NCT00916058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245606|NCT00916058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245607|NCT00916058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65245608|NCT00916058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65245609|NCT00916058|Immunologic Factors|immunologic factors|mesh-ancestor
65245610|NCT00916058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245611|NCT04559906|Ethyl Chloride|ethyl chloride|mesh-list
65245612|NCT04559906|Anesthetics, Local|anesthetics, local|mesh-ancestor
65245613|NCT04559906|Anesthetics|anesthetics|mesh-ancestor
65245614|NCT04559906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65245637|NCT04186442|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65245638|NCT04186442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65245639|NCT04186442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245640|NCT04186442|Cholinergic Agents|cholinergic agents|mesh-ancestor
65245641|NCT04186442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65245642|NCT04186442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245643|NCT04186442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65245644|NCT04186442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65245645|NCT04203368|Adenosine|adenosine|mesh-list
65245646|NCT04203368|Verapamil|verapamil|mesh-list
65245647|NCT04203368|Analgesics|analgesics|mesh-ancestor
65245648|NCT04203368|Sensory System Agents|sensory system agents|mesh-ancestor
65245649|NCT04203368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65245650|NCT04203368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245651|NCT04203368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65245652|NCT04203368|Vasodilator Agents|vasodilator agents|mesh-ancestor
65245653|NCT04203368|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65245654|NCT04203368|Purinergic Agonists|purinergic agonists|mesh-ancestor
65245655|NCT04203368|Purinergic Agents|purinergic agents|mesh-ancestor
65245656|NCT04203368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65245657|NCT04203368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245658|NCT04203368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65245659|NCT04203368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65245660|NCT04203368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65245661|NCT04133948|Nivolumab|nivolumab|mesh-list
65245662|NCT04133948|Ipilimumab|ipilimumab|mesh-list
65245663|NCT04133948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65245664|NCT04133948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920937|NCT00118261|Levoleucovorin|levoleucovorin|mesh-list
65245694|NCT00911144|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65245695|NCT00911144|Immunologic Factors|immunologic factors|mesh-ancestor
65245696|NCT00911144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245697|NCT04285580|Bimatoprost|bimatoprost|mesh-list
65245698|NCT04285580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65245699|NCT04395248|Anesthetics|anesthetics|mesh-list
65245700|NCT04395248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65245701|NCT04395248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245702|NCT00632216|Risedronic Acid|risedronic acid|mesh-list
64995989|NCT00093743|Cyclosporine|cyclosporine|mesh-list
65245703|NCT00632216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65245704|NCT00632216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65245705|NCT00632216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245706|NCT00632216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65245707|NCT00632216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245708|NCT00632216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65245709|NCT04276298|Metronidazole|metronidazole|mesh-list
65245710|NCT04276298|Lidocaine|lidocaine|mesh-list
65245711|NCT04276298|Diltiazem|diltiazem|mesh-list
65245712|NCT04276298|Anesthetics, Local|anesthetics, local|mesh-ancestor
65245741|NCT04273880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65245742|NCT04273880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65245743|NCT04273880|Dopamine Agents|dopamine agents|mesh-ancestor
65245744|NCT04273880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65245745|NCT00910988|Olanzapine|olanzapine|mesh-list
65245746|NCT00910988|Ziprasidone|ziprasidone|mesh-list
65245747|NCT00910988|Antiemetics|antiemetics|mesh-ancestor
65245748|NCT00910988|Autonomic Agents|autonomic agents|mesh-ancestor
65245749|NCT00910988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65245750|NCT00910988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245751|NCT00910988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65245752|NCT00910988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65245753|NCT00910988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65245754|NCT00910988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65245755|NCT00910988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65245756|NCT00910988|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65245794|NCT00811993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245795|NCT00811993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65245796|NCT00811993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65245797|NCT00811993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65245798|NCT00811993|Growth Substances|growth substances|mesh-ancestor
65245819|NCT00817765|Protease Inhibitors|protease inhibitors|mesh-ancestor
65245820|NCT00817765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65245821|NCT00817765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245822|NCT00817765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65245823|NCT00817765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65245824|NCT00817765|Antiviral Agents|antiviral agents|mesh-ancestor
65245825|NCT00817765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65245826|NCT00817765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65245827|NCT00817765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65245828|NCT00817765|Antifungal Agents|antifungal agents|mesh-ancestor
65245829|NCT00817765|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65245830|NCT00817765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65245831|NCT00817765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65245832|NCT00817765|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65245833|NCT00817765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65245834|NCT00817765|Hormone Antagonists|hormone antagonists|mesh-ancestor
65245835|NCT00817765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65245836|NCT00817765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245838|NCT00816205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65245839|NCT00816205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65245840|NCT00816205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245841|NCT00816205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65245842|NCT00816205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245843|NCT00816205|Vasodilator Agents|vasodilator agents|mesh-ancestor
65245844|NCT00816205|Tocolytic Agents|tocolytic agents|mesh-ancestor
65245845|NCT00816205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65245846|NCT00816283|Dasatinib|dasatinib|mesh-list
65245847|NCT00816283|Vorinostat|vorinostat|mesh-list
65245848|NCT00816283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245849|NCT00816283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65245850|NCT00816283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996119|NCT05393817|Caffeine|caffeine|mesh-list
65245851|NCT00816283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245886|NCT04384562|Antidepressive Agents|antidepressive agents|mesh-ancestor
65245887|NCT04384562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65245888|NCT04384562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65245889|NCT04384562|Adrenergic Agents|adrenergic agents|mesh-ancestor
65245890|NCT04515134|Ubiquinone|ubiquinone|mesh-list
64921183|NCT00402181|Hormones|hormones|mesh-ancestor
65245926|NCT03408236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65245927|NCT03408236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245928|NCT03408236|Cholinergic Agents|cholinergic agents|mesh-ancestor
65245929|NCT03408236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65245930|NCT03408236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921221|NCT00120484|Vitamin B 12|vitamin b 12|mesh-list
65245962|NCT02973386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245964|NCT00909428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65245965|NCT00909428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65245966|NCT00909428|Cholinergic Agents|cholinergic agents|mesh-ancestor
65245967|NCT00909428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65245968|NCT00909428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245969|NCT00909428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245970|NCT00909428|Urological Agents|urological agents|mesh-ancestor
65245971|NCT03718130|Vaccines|vaccines|mesh-list
65245972|NCT03718130|Immunologic Factors|immunologic factors|mesh-ancestor
65245973|NCT03718130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245974|NCT00908960|Enoxaparin|enoxaparin|mesh-list
65246007|NCT05332028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514736|NCT02393157|Alkylating Agents|alkylating agents|mesh-ancestor
65246008|NCT05332028|Sensory System Agents|sensory system agents|mesh-ancestor
65246009|NCT05332028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246010|NCT05332028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65246011|NCT05332028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65246012|NCT05332028|Anesthetics, General|anesthetics, general|mesh-ancestor
65246013|NCT05332028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65246014|NCT05332028|Narcotics|narcotics|mesh-ancestor
65246015|NCT05332028|Analgesics|analgesics|mesh-ancestor
65246016|NCT05332028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65246017|NCT00816517|Botulinum Toxins|botulinum toxins|mesh-list
65246018|NCT00816517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65246019|NCT00816517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65246047|NCT00643123|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65246049|NCT00643123|Protective Agents|protective agents|mesh-ancestor
65246050|NCT00643123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246051|NCT00816673|Melatonin|melatonin|mesh-list
65246052|NCT00816673|Antioxidants|antioxidants|mesh-ancestor
65246053|NCT00816673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246054|NCT00816673|Protective Agents|protective agents|mesh-ancestor
65246055|NCT00816673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246056|NCT00816673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65246057|NCT00818155|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65246058|NCT00818155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65246059|NCT00818155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65246060|NCT00818155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65246061|NCT00818155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246062|NCT00818155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65246063|NCT00818155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246064|NCT00818155|Antidepressive Agents|antidepressive agents|mesh-ancestor
65246065|NCT00818155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65246091|NCT02863367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65246092|NCT00648895|Metoprolol|metoprolol|mesh-list
65246093|NCT00648895|Nebivolol|nebivolol|mesh-list
65246094|NCT00648895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65246095|NCT00648895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65246096|NCT00648895|Sympatholytics|sympatholytics|mesh-ancestor
65246097|NCT00648895|Autonomic Agents|autonomic agents|mesh-ancestor
65246098|NCT00648895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246099|NCT00648895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246100|NCT00648895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65246101|NCT00648895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65246102|NCT00648895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65246103|NCT00648895|Adrenergic Agents|adrenergic agents|mesh-ancestor
65246104|NCT00648895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65246105|NCT00648895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246106|NCT00648895|Vasodilator Agents|vasodilator agents|mesh-ancestor
65246107|NCT00648895|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65246108|NCT00648895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65246109|NCT00648895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65246110|NCT00975221|Cinacalcet|cinacalcet|mesh-list
65246111|NCT00975221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65246145|NCT03396926|Immunoglobulin G|immunoglobulin g|mesh-list
65246146|NCT03396926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65246147|NCT03396926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65246148|NCT03396926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65246149|NCT03396926|Growth Substances|growth substances|mesh-ancestor
65246150|NCT03396926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246151|NCT03396926|Growth Inhibitors|growth inhibitors|mesh-ancestor
65246152|NCT03396926|Immunologic Factors|immunologic factors|mesh-ancestor
64996421|NCT01803594|Nicotinic Acids|nicotinic acids|mesh-list
65246186|NCT00971867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65246187|NCT00971867|Tubulin Modulators|tubulin modulators|mesh-ancestor
65246188|NCT00971867|Antimitotic Agents|antimitotic agents|mesh-ancestor
65246189|NCT00971867|Mitosis Modulators|mitosis modulators|mesh-ancestor
65246190|NCT00971867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246191|NCT03667820|Osimertinib|osimertinib|mesh-list
65246192|NCT03667820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921482|NCT00122434|Tiotropium Bromide|tiotropium bromide|mesh-list
65246223|NCT00817375|Sertraline|sertraline|mesh-list
65246224|NCT00817375|Fluoxetine|fluoxetine|mesh-list
64996495|NCT01726452|Protective Agents|protective agents|mesh-ancestor
65246225|NCT00817375|Paroxetine|paroxetine|mesh-list
65246226|NCT00817375|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65246227|NCT00817375|Nortriptyline|nortriptyline|mesh-list
65246228|NCT00817375|Antidepressive Agents|antidepressive agents|mesh-ancestor
65246229|NCT00817375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65246230|NCT00817375|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65246231|NCT00817375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65246232|NCT00817375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65246233|NCT00817375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246234|NCT00817375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65246235|NCT00817375|Serotonin Agents|serotonin agents|mesh-ancestor
65246265|NCT00818701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65246266|NCT00818701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65246267|NCT00818701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246268|NCT00818701|Urological Agents|urological agents|mesh-ancestor
65246269|NCT00818701|Natriuretic Agents|natriuretic agents|mesh-ancestor
65246270|NCT00818701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246271|NCT00813241|Celecoxib|celecoxib|mesh-list
65246272|NCT00813241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65246273|NCT00813241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65246274|NCT00813241|Analgesics|analgesics|mesh-ancestor
65246275|NCT00813241|Sensory System Agents|sensory system agents|mesh-ancestor
64921567|NCT00129298|Tiagabine|tiagabine|mesh-list
65246309|NCT00627445|Biphasic Insulins|biphasic insulins|mesh-list
65246310|NCT00627445|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65246311|NCT00627445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65246312|NCT00627445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246313|NCT02030990|Fluorometholone|fluorometholone|mesh-list
65246315|NCT02030990|Mitomycin|mitomycin|mesh-list
65246316|NCT02030990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65246345|NCT00822055|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65246347|NCT00822133|Ketamine|ketamine|mesh-list
65246348|NCT00822133|Anesthetics, Local|anesthetics, local|mesh-ancestor
65246349|NCT00822133|Anesthetics|anesthetics|mesh-ancestor
65246350|NCT00822133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65246351|NCT00822133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246352|NCT00822133|Sensory System Agents|sensory system agents|mesh-ancestor
65246353|NCT00822133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246354|NCT00822133|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65246355|NCT00822133|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65246356|NCT00822133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65246357|NCT00822133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65246358|NCT00822133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246359|NCT00822133|Analgesics|analgesics|mesh-ancestor
65246380|NCT04018417|Antifungal Agents|antifungal agents|mesh-ancestor
65246381|NCT01791920|Botulinum Toxins|botulinum toxins|mesh-list
65246382|NCT01791920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65246383|NCT01791920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65246384|NCT01791920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65246385|NCT01791920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65246386|NCT01791920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246387|NCT01791920|Cholinergic Agents|cholinergic agents|mesh-ancestor
65246388|NCT01791920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65246389|NCT01791920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246390|NCT01791920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65246391|NCT01791920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246392|NCT00826657|Vitamin B 12|vitamin b 12|mesh-list
65246393|NCT00826657|Hydroxocobalamin|hydroxocobalamin|mesh-list
65246394|NCT00826657|Vitamins|vitamins|mesh-ancestor
65246395|NCT00826657|Micronutrients|micronutrients|mesh-ancestor
65246396|NCT00826657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246397|NCT00826657|Vitamin B Complex|vitamin b complex|mesh-ancestor
65246398|NCT00826657|Hematinics|hematinics|mesh-ancestor
65246399|NCT02992964|Nivolumab|nivolumab|mesh-list
65246400|NCT02992964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65246401|NCT02992964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65246402|NCT02992964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65246403|NCT02992964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246404|NCT03597776|Lidocaine|lidocaine|mesh-list
65246405|NCT03597776|Anesthetics, Local|anesthetics, local|mesh-ancestor
65246406|NCT03597776|Anesthetics|anesthetics|mesh-ancestor
65246407|NCT03597776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65246408|NCT03597776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246409|NCT03597776|Sensory System Agents|sensory system agents|mesh-ancestor
65246410|NCT03597776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246411|NCT03597776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65246412|NCT03597776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65246413|NCT03597776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65246444|NCT03560882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246445|NCT03560882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65246446|NCT03560882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65246447|NCT03560882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996720|NCT00431197|Ketoconazole|ketoconazole|mesh-list
65246448|NCT04044547|Rotigotine|rotigotine|mesh-list
65246449|NCT04044547|Dopamine Agonists|dopamine agonists|mesh-ancestor
65246450|NCT04044547|Dopamine Agents|dopamine agents|mesh-ancestor
65246451|NCT04044547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65246452|NCT04044547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246453|NCT04044547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246454|NCT03553004|Niraparib|niraparib|mesh-list
65246455|NCT03553004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65246456|NCT03553004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921747|NCT00009555|Testosterone|testosterone|mesh-list
65246492|NCT02768948|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65246493|NCT02768948|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64921791|NCT00128323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65246526|NCT00822913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246527|NCT00822913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246528|NCT00822913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65246529|NCT00822913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65246530|NCT00822913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246531|NCT00822913|Cholinergic Agents|cholinergic agents|mesh-ancestor
65246532|NCT00822913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65246533|NCT04400383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65246535|NCT04400383|Immunoglobulins|immunoglobulins|mesh-list
65246536|NCT04400383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65246537|NCT04400383|Immunologic Factors|immunologic factors|mesh-ancestor
65246538|NCT04400383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246571|NCT00827281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246572|NCT00823381|Resveratrol|resveratrol|mesh-list
65246573|NCT00823381|Antioxidants|antioxidants|mesh-ancestor
65246574|NCT00823381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246575|NCT00823381|Protective Agents|protective agents|mesh-ancestor
65246576|NCT00823381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246577|NCT00823381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65246578|NCT00823381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65246609|NCT00568399|Sodium thiosulfate|sodium thiosulfate|mesh-list
65246610|NCT00568399|Antidotes|antidotes|mesh-ancestor
65246611|NCT00568399|Protective Agents|protective agents|mesh-ancestor
65246612|NCT00568399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246613|NCT00568399|Antioxidants|antioxidants|mesh-ancestor
65246614|NCT00568399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246615|NCT00568399|Antitubercular Agents|antitubercular agents|mesh-ancestor
65246616|NCT00568399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65246617|NCT00568399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65246618|NCT00568399|Chelating Agents|chelating agents|mesh-ancestor
65246619|NCT00568399|Sequestering Agents|sequestering agents|mesh-ancestor
65246620|NCT00975143|Isotretinoin|isotretinoin|mesh-list
65246621|NCT00975143|Dermatologic Agents|dermatologic agents|mesh-ancestor
65246622|NCT04286087|Anesthetics|anesthetics|mesh-list
65246623|NCT04286087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65246624|NCT04286087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246625|NCT04288349|Epinephrine|epinephrine|mesh-list
65246626|NCT04288349|Racepinephrine|racepinephrine|mesh-list
65246627|NCT04288349|Ropivacaine|ropivacaine|mesh-list
65246655|NCT03667313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246656|NCT03667313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65246657|NCT03667313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65246658|NCT03667313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65246659|NCT03667313|Antifungal Agents|antifungal agents|mesh-ancestor
65246660|NCT03667313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65246661|NCT03667313|Immunologic Factors|immunologic factors|mesh-ancestor
65246662|NCT03667313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246663|NCT00974675|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65246664|NCT00974675|Immunologic Factors|immunologic factors|mesh-ancestor
65246665|NCT00974675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246666|NCT03657797|Latanoprost|latanoprost|mesh-list
65246667|NCT03657797|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65246668|NCT03657797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65246669|NCT04925531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65246670|NCT04925531|Ampicillin|ampicillin|mesh-list
65246671|NCT04925531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65246672|NCT00634933|Prednisone|prednisone|mesh-list
65246673|NCT00634933|Methylprednisolone|methylprednisolone|mesh-list
65246674|NCT00634933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65246675|NCT00634933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65246677|NCT00634933|Prednisolone acetate|prednisolone acetate|mesh-list
65246703|NCT00967499|Serotonin Agents|serotonin agents|mesh-ancestor
65246704|NCT00967499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65246705|NCT00967499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246706|NCT00967499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65246707|NCT00967499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65246708|NCT00967499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65246709|NCT00967499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65246710|NCT00967499|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65246711|NCT00967499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65246712|NCT04286399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65246713|NCT04286399|Angiotensin II|angiotensin ii|mesh-list
65246714|NCT04286399|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65246715|NCT04286399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65246716|NCT04286399|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65246717|NCT04286399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65246718|NCT04286399|Adrenergic Agents|adrenergic agents|mesh-ancestor
65246719|NCT04286399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65246720|NCT04286399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246721|NCT04286399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246722|NCT04286399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65246723|NCT04286399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65246724|NCT04286399|Protease Inhibitors|protease inhibitors|mesh-ancestor
65246754|NCT00823849|Probucol|probucol|mesh-list
65246755|NCT00823849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65246756|NCT00823849|Autonomic Agents|autonomic agents|mesh-ancestor
65246757|NCT00823849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246758|NCT00823849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246759|NCT00823849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65246760|NCT00823849|Respiratory System Agents|respiratory system agents|mesh-ancestor
65246761|NCT00823849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65246762|NCT00823849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65246763|NCT00823849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246764|NCT00823849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65246765|NCT00823849|Vasodilator Agents|vasodilator agents|mesh-ancestor
65246766|NCT00823849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65246767|NCT00823849|Protective Agents|protective agents|mesh-ancestor
65246768|NCT00823849|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65246797|NCT02862509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246798|NCT02862509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246799|NCT02862509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65246800|NCT02862509|Respiratory System Agents|respiratory system agents|mesh-ancestor
65246801|NCT02862509|Glucocorticoids|glucocorticoids|mesh-ancestor
65246802|NCT02862509|Hormones|hormones|mesh-ancestor
65246803|NCT02862509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65246804|NCT04285775|Chrysarobin|chrysarobin|mesh-list
65246805|NCT04285775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65246806|NCT04285775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65246807|NCT04285775|Analgesics|analgesics|mesh-ancestor
65246808|NCT04285775|Sensory System Agents|sensory system agents|mesh-ancestor
65246809|NCT04285775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246810|NCT04285775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246811|NCT04285775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65246812|NCT04285775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65246813|NCT00965081|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65246814|NCT00965081|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64922107|NCT00020254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65246842|NCT04267601|Protease Inhibitors|protease inhibitors|mesh-ancestor
65246843|NCT04267601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65246844|NCT04267601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246845|NCT04267601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65246846|NCT04267601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246847|NCT02861261|Promethazine|promethazine|mesh-list
65246848|NCT02861261|Diphenhydramine|diphenhydramine|mesh-list
65246849|NCT02861261|Antipruritics|antipruritics|mesh-ancestor
65246850|NCT02861261|Dermatologic Agents|dermatologic agents|mesh-ancestor
64849375|NCT04880278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65246851|NCT02861261|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65246852|NCT02861261|Histamine Antagonists|histamine antagonists|mesh-ancestor
65246853|NCT02861261|Histamine Agents|histamine agents|mesh-ancestor
65246854|NCT02861261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65246855|NCT02861261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246856|NCT02861261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246857|NCT02861261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65246858|NCT02861261|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65246859|NCT02861261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65246890|NCT04284761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65246891|NCT04284761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246893|NCT00632125|Epoetin Alfa|epoetin alfa|mesh-list
65246894|NCT00632125|Hematinics|hematinics|mesh-ancestor
65246895|NCT00903968|Plerixafor|plerixafor|mesh-list
65246896|NCT00903968|Dexamethasone|dexamethasone|mesh-list
65246897|NCT00903968|Bortezomib|bortezomib|mesh-list
64997183|NCT00433459|Hormones|hormones|mesh-ancestor
65246898|NCT00903968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65246899|NCT00903968|Antiemetics|antiemetics|mesh-ancestor
65246900|NCT00903968|Autonomic Agents|autonomic agents|mesh-ancestor
65246901|NCT00903968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246902|NCT00903968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922203|NCT00020566|Etoposide|etoposide|mesh-list
65246934|NCT00632606|Dopamine Agents|dopamine agents|mesh-ancestor
65246935|NCT00632606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65246936|NCT02586038|Thalidomide|thalidomide|mesh-list
65246937|NCT02586038|Dexamethasone|dexamethasone|mesh-list
65246938|NCT02586038|Cyclophosphamide|cyclophosphamide|mesh-list
65246939|NCT02586038|Ixazomib|ixazomib|mesh-list
65246940|NCT02586038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65246941|NCT02586038|Immunologic Factors|immunologic factors|mesh-ancestor
65246942|NCT02586038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246943|NCT02586038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65246944|NCT02586038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65246945|NCT02586038|Alkylating Agents|alkylating agents|mesh-ancestor
64922245|NCT00020644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65246972|NCT00903344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65246973|NCT00903344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65246976|NCT02847338|Chlorthalidone|chlorthalidone|mesh-list
65246977|NCT02847338|Amiloride|amiloride|mesh-list
65246978|NCT02847338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65246979|NCT02847338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65246980|NCT02847338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65246981|NCT02847338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246982|NCT02847338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65246983|NCT02847338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246984|NCT02847338|Vasodilator Agents|vasodilator agents|mesh-ancestor
65246985|NCT02847338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65246986|NCT02847338|Protease Inhibitors|protease inhibitors|mesh-ancestor
65246987|NCT02847338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65246988|NCT02847338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65246989|NCT02847338|Protective Agents|protective agents|mesh-ancestor
65246990|NCT02847338|Diuretics|diuretics|mesh-ancestor
65246991|NCT02847338|Natriuretic Agents|natriuretic agents|mesh-ancestor
65246992|NCT02847338|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65246993|NCT02847338|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
64922291|NCT00010140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247027|NCT00626197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247028|NCT00626197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65247029|NCT00626197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65247030|NCT00626197|Alkylating Agents|alkylating agents|mesh-ancestor
65247031|NCT00626197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247032|NCT00626197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247033|NCT00626197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65247034|NCT00626197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64922336|NCT00021034|Taurolidine|taurolidine|mesh-list
65247064|NCT04029116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65247065|NCT04029116|Hormone Antagonists|hormone antagonists|mesh-ancestor
65247066|NCT04029116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65247067|NCT04029116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247068|NCT04029116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65247069|NCT04029116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64850583|NCT03569475|Serotonin Agents|serotonin agents|mesh-ancestor
65247070|NCT00623779|Aspirin|aspirin|mesh-list
65247071|NCT00623779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65247072|NCT00623779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65247073|NCT00623779|Analgesics|analgesics|mesh-ancestor
65247074|NCT00623779|Sensory System Agents|sensory system agents|mesh-ancestor
65247075|NCT00623779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65247076|NCT00623779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247077|NCT00623779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64922382|NCT00021151|Alemtuzumab|alemtuzumab|mesh-list
65247110|NCT00824239|Sensory System Agents|sensory system agents|mesh-ancestor
65247111|NCT00824239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65247112|NCT00824239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65247113|NCT00824239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65247114|NCT00824239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65247115|NCT00824239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65247116|NCT00824239|GABA Modulators|gaba modulators|mesh-ancestor
65247117|NCT00824239|GABA Agents|gaba agents|mesh-ancestor
65247118|NCT00824239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65247119|NCT00824239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922424|NCT00021463|Dideoxynucleosides|dideoxynucleosides|mesh-list
65247152|NCT02847806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65247153|NCT02847806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247154|NCT02847806|Estrogens|estrogens|mesh-ancestor
65247155|NCT02847806|Hormones|hormones|mesh-ancestor
65247156|NCT02847806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65247157|NCT02847806|Androgens|androgens|mesh-ancestor
65247158|NCT00828529|Bedaquiline|bedaquiline|mesh-list
65247159|NCT00828529|Antitubercular Agents|antitubercular agents|mesh-ancestor
65247160|NCT00828529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64922468|NCT00010452|Picibanil|picibanil|mesh-list
65247232|NCT00824863|Hormone Antagonists|hormone antagonists|mesh-ancestor
65247233|NCT00824863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65247234|NCT00824863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247235|NCT00824863|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65247304|NCT00474032|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65247305|NCT00474032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65247306|NCT00474032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247307|NCT00474032|Cholinergic Agents|cholinergic agents|mesh-ancestor
65247308|NCT00474032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65247309|NCT00474032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247344|NCT05241938|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65247345|NCT05241938|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65247346|NCT05337332|Triamcinolone|triamcinolone|mesh-list
65247347|NCT05337332|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65247348|NCT05337332|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65247349|NCT05337332|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65247350|NCT05337332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65247383|NCT05337254|Sensory System Agents|sensory system agents|mesh-ancestor
65247384|NCT05337254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65247385|NCT00896532|Zoledronic Acid|zoledronic acid|mesh-list
65247386|NCT00896532|Denosumab|denosumab|mesh-list
65247387|NCT00896532|Alendronate|alendronate|mesh-list
65247388|NCT00896532|Teriparatide|teriparatide|mesh-list
65247389|NCT00896532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65247390|NCT00896532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65247391|NCT00896532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247392|NCT00896532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65247393|NCT00896532|Immunologic Factors|immunologic factors|mesh-ancestor
65247394|NCT00574873|Imatinib Mesylate|imatinib mesylate|mesh-list
65247425|NCT01341600|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65247427|NCT01341600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65247428|NCT01341600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247429|NCT01341600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247430|NCT01341600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65247431|NCT01341600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65247432|NCT01341600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65247433|NCT01341600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922748|NCT00010842|Antioxidants|antioxidants|mesh-ancestor
65247465|NCT04345796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65247466|NCT04345796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65247467|NCT04345796|Adrenergic Agents|adrenergic agents|mesh-ancestor
65247468|NCT04345796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65247469|NCT04345796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64570416|NCT04124081|Antiviral Agents|antiviral agents|mesh-ancestor
64851075|NCT01555541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64851078|NCT01555541|Antimetabolites|antimetabolites|mesh-ancestor
65247470|NCT04345796|Antioxidants|antioxidants|mesh-ancestor
65247471|NCT04345796|Protective Agents|protective agents|mesh-ancestor
65247472|NCT04345796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65247473|NCT04345796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64922787|NCT00022945|Doxorubicin|doxorubicin|mesh-list
64922788|NCT00022945|Vincristine|vincristine|mesh-list
65247502|NCT04224584|Analgesics|analgesics|mesh-ancestor
65247503|NCT04224584|Sensory System Agents|sensory system agents|mesh-ancestor
65247504|NCT04224584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65247505|NCT04224584|Antidepressive Agents|antidepressive agents|mesh-ancestor
65247506|NCT04224584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65247507|NCT04224584|Dopamine Agents|dopamine agents|mesh-ancestor
65247508|NCT02993198|Carvedilol|carvedilol|mesh-list
65247509|NCT02993198|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65247510|NCT02993198|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65247511|NCT02993198|Adrenergic Agents|adrenergic agents|mesh-ancestor
65247512|NCT02993198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65247513|NCT02993198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247514|NCT02993198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247515|NCT02993198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65247549|NCT00901628|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65247550|NCT00901628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65247551|NCT00901628|Autonomic Agents|autonomic agents|mesh-ancestor
65247552|NCT00901628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65247553|NCT00901628|Respiratory System Agents|respiratory system agents|mesh-ancestor
65247554|NCT00901628|Mydriatics|mydriatics|mesh-ancestor
65247555|NCT00901628|Sympathomimetics|sympathomimetics|mesh-ancestor
65247556|NCT00901628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65247557|NCT00901628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65247558|NCT00901628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65247590|NCT02839668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65247591|NCT02839668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65247592|NCT02839668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65247593|NCT02839668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65247594|NCT02839668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65247595|NCT02839668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247596|NCT02839668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65247598|NCT02839668|Antipyretics|antipyretics|mesh-ancestor
65247599|NCT02839668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65247600|NCT02839668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65247601|NCT02839668|Anesthetics, General|anesthetics, general|mesh-ancestor
65247602|NCT02839668|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65247603|NCT02839668|Narcotics|narcotics|mesh-ancestor
65247604|NCT02839668|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65247633|NCT02839356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247634|NCT02839356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65247635|NCT02839356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65247636|NCT02839356|Autonomic Agents|autonomic agents|mesh-ancestor
65247637|NCT02839356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65247638|NCT02839356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65247639|NCT02839356|Respiratory System Agents|respiratory system agents|mesh-ancestor
65247640|NCT02839356|Mydriatics|mydriatics|mesh-ancestor
65247641|NCT02839356|Sympathomimetics|sympathomimetics|mesh-ancestor
64997916|NCT00400790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65247642|NCT02839356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65247643|NCT04674410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65247644|NCT04674410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65247645|NCT02840526|Acetaminophen|acetaminophen|mesh-list
65247646|NCT02840526|Fentanyl|fentanyl|mesh-list
65247647|NCT02840526|Bupivacaine|bupivacaine|mesh-list
65247648|NCT02840526|Propofol|propofol|mesh-list
65247649|NCT02840526|Sevoflurane|sevoflurane|mesh-list
65247650|NCT02840526|Anesthetics, Local|anesthetics, local|mesh-ancestor
65247668|NCT02342444|Enoxaparin sodium|enoxaparin sodium|mesh-list
65247669|NCT02342444|Anticoagulants|anticoagulants|mesh-ancestor
65247670|NCT02342444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65247671|NCT02342444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65247672|NCT02342444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247673|NCT00825253|Insulin|insulin|mesh-list
65247674|NCT00825253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65247675|NCT00825253|Insulin Aspart|insulin aspart|mesh-list
65247676|NCT00825253|Biphasic Insulins|biphasic insulins|mesh-list
65247677|NCT00825253|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65247678|NCT00825253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65247679|NCT00825253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247680|NCT00820885|Teduglutide|teduglutide|mesh-list
65247681|NCT00820885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65247682|NCT00820885|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65247683|NCT00820885|Protective Agents|protective agents|mesh-ancestor
65247684|NCT00820885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247685|NCT03845582|Vitamin A|vitamin a|mesh-list
65247686|NCT03845582|Retinol acetate|retinol acetate|mesh-list
65247687|NCT03845582|Vitamins|vitamins|mesh-ancestor
65247688|NCT03845582|Micronutrients|micronutrients|mesh-ancestor
65247689|NCT03845582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247690|NCT03845582|Protective Agents|protective agents|mesh-ancestor
65247691|NCT03845582|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65247692|NCT03845582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247693|NCT03845582|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65247694|NCT03845582|Immunologic Factors|immunologic factors|mesh-ancestor
65247695|NCT00820963|Temozolomide|temozolomide|mesh-list
65247696|NCT00820963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65247697|NCT00820963|Alkylating Agents|alkylating agents|mesh-ancestor
65247698|NCT00820963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247699|NCT00820963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247700|NCT02834676|Ethanol|ethanol|mesh-list
65247701|NCT02834676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65247702|NCT02834676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65247703|NCT02834676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65247704|NCT02834676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247705|NCT00632840|Atorvastatin|atorvastatin|mesh-list
65247706|NCT00632840|Fenofibrate|fenofibrate|mesh-list
65247707|NCT00632840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65247708|NCT00632840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65247709|NCT00632840|Antimetabolites|antimetabolites|mesh-ancestor
64923004|NCT00000179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65247741|NCT00633282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
65247742|NCT00633282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65247743|NCT00633282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247744|NCT00830089|Levobupivacaine|levobupivacaine|mesh-list
65247745|NCT00830089|Anesthetics, Local|anesthetics, local|mesh-ancestor
65247746|NCT00830089|Anesthetics|anesthetics|mesh-ancestor
65247747|NCT00830089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65247748|NCT00830089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247749|NCT00830089|Sensory System Agents|sensory system agents|mesh-ancestor
65247750|NCT00830089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65247751|NCT00830245|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65247785|NCT04044079|Oxytocics|oxytocics|mesh-ancestor
65247786|NCT00830323|Oseltamivir|oseltamivir|mesh-list
65247787|NCT00830323|Amantadine|amantadine|mesh-list
65247788|NCT00830323|Zanamivir|zanamivir|mesh-list
65247789|NCT00830323|Antiviral Agents|antiviral agents|mesh-ancestor
65247790|NCT00830323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65247791|NCT00830323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247817|NCT02837640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65247818|NCT02837640|Dopamine Agents|dopamine agents|mesh-ancestor
65247819|NCT02837640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65247820|NCT02837640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247821|NCT02837640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247822|NCT02837640|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65247823|NCT02837640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247824|NCT02837640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65247825|NCT02837640|Immunologic Factors|immunologic factors|mesh-ancestor
65247826|NCT02837640|Dopamine Agonists|dopamine agonists|mesh-ancestor
65247827|NCT02834286|Dexamethasone|dexamethasone|mesh-list
65247828|NCT02834286|Rituximab|rituximab|mesh-list
65247829|NCT02834286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65247830|NCT02834286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247831|NCT02834286|Immunologic Factors|immunologic factors|mesh-ancestor
65247832|NCT02834286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247833|NCT02834286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65247834|NCT02834286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65247835|NCT02834286|Antiemetics|antiemetics|mesh-ancestor
65247836|NCT02834286|Autonomic Agents|autonomic agents|mesh-ancestor
65247837|NCT02834286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65247838|NCT02834286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65247839|NCT02834286|Glucocorticoids|glucocorticoids|mesh-ancestor
65247840|NCT02834286|Hormones|hormones|mesh-ancestor
65248452|NCT02548117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472920|NCT02043678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247841|NCT02834286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65247873|NCT00838539|Antifungal Agents|antifungal agents|mesh-ancestor
65247874|NCT00838539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65247875|NCT00838539|Immunologic Factors|immunologic factors|mesh-ancestor
65247876|NCT00838539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247877|NCT02836548|Vorinostat|vorinostat|mesh-list
65247878|NCT02836548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65247879|NCT02836548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247880|NCT02836548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247881|NCT02836548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247882|NCT02836704|Metformin|metformin|mesh-list
65247883|NCT02836704|Insulin Glargine|insulin glargine|mesh-list
65247884|NCT02836704|Acarbose|acarbose|mesh-list
65247885|NCT02836704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65247886|NCT02836704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923203|NCT00024232|Antibodies|antibodies|mesh-list
65247916|NCT00703365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247917|NCT00703365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247918|NCT00703365|Antiviral Agents|antiviral agents|mesh-ancestor
65247919|NCT00703365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65247920|NCT00703365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247921|NCT00703365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65247922|NCT00703365|Immunologic Factors|immunologic factors|mesh-ancestor
65247923|NCT00703365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247924|NCT00703365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65247925|NCT04249284|BMS-986165|bms-986165|mesh-list
65247926|NCT04249284|Dermatologic Agents|dermatologic agents|mesh-ancestor
65247927|NCT04249284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65247928|NCT04249284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247929|NCT04249284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247930|NCT04474938|Dexamethasone|dexamethasone|mesh-list
65247931|NCT04474938|Bortezomib|bortezomib|mesh-list
64923240|NCT00024310|Vitamins|vitamins|mesh-ancestor
65247966|NCT02833038|Anticonvulsants|anticonvulsants|mesh-ancestor
65247967|NCT02833038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65247968|NCT02833038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65247969|NCT02833038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247970|NCT02833038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65247971|NCT02833038|Tocolytic Agents|tocolytic agents|mesh-ancestor
65247972|NCT02833038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65247974|NCT00703755|Fenofibrate|fenofibrate|mesh-list
65248005|NCT05333640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65248006|NCT05333640|Antifungal Agents|antifungal agents|mesh-ancestor
65248007|NCT05333640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65248008|NCT05333640|Immunologic Factors|immunologic factors|mesh-ancestor
65248009|NCT05333640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248011|NCT02838264|Antifungal Agents|antifungal agents|mesh-ancestor
65248012|NCT02838264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65248013|NCT02838264|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65248014|NCT02838264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65248015|NCT02838264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248016|NCT02838264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248017|NCT02838264|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65248048|NCT02833116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65248049|NCT02833116|Respiratory System Agents|respiratory system agents|mesh-ancestor
65248050|NCT00703989|Thioctic Acid|thioctic acid|mesh-list
65248051|NCT00703989|Benphothiamine|benphothiamine|mesh-list
65248052|NCT00703989|Antioxidants|antioxidants|mesh-ancestor
65248053|NCT00703989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248054|NCT00703989|Protective Agents|protective agents|mesh-ancestor
65248055|NCT00703989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248056|NCT00703989|Vitamin B Complex|vitamin b complex|mesh-ancestor
65248057|NCT00703989|Vitamins|vitamins|mesh-ancestor
65248058|NCT00703989|Micronutrients|micronutrients|mesh-ancestor
65248059|NCT00703989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65248097|NCT02297516|Viscosupplements|viscosupplements|mesh-ancestor
65248098|NCT02297516|Protective Agents|protective agents|mesh-ancestor
65248130|NCT00836277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65248132|NCT00835731|Hydroxocobalamin|hydroxocobalamin|mesh-list
65248133|NCT00835731|Misoprostol|misoprostol|mesh-list
65248134|NCT00835731|Vitamins|vitamins|mesh-ancestor
65248135|NCT00835731|Micronutrients|micronutrients|mesh-ancestor
65248136|NCT00835731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570641|NCT04537962|Listerine|listerine|mesh-list
65248137|NCT00835731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65248138|NCT00835731|Abortifacient Agents|abortifacient agents|mesh-ancestor
65248139|NCT00835731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65248140|NCT00835731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65248141|NCT00835731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65248142|NCT00835731|Oxytocics|oxytocics|mesh-ancestor
65248143|NCT00835731|Vitamin B Complex|vitamin b complex|mesh-ancestor
65248144|NCT00835731|Hematinics|hematinics|mesh-ancestor
65248145|NCT03721406|Ropivacaine|ropivacaine|mesh-list
65248178|NCT00704145|Tubulin Modulators|tubulin modulators|mesh-ancestor
65248179|NCT00704145|Antimitotic Agents|antimitotic agents|mesh-ancestor
65248180|NCT00704145|Mitosis Modulators|mitosis modulators|mesh-ancestor
65248181|NCT00704145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248182|NCT03508232|Doxycycline|doxycycline|mesh-list
65248183|NCT03508232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65248184|NCT03508232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65248185|NCT03508232|Antimalarials|antimalarials|mesh-ancestor
65248186|NCT03508232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65248187|NCT03508232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65248224|NCT00704925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248225|NCT00574249|Adalimumab|adalimumab|mesh-list
65248226|NCT00574249|Betamethasone|betamethasone|mesh-list
65248257|NCT00896168|Dermatologic Agents|dermatologic agents|mesh-ancestor
65248258|NCT00896168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248259|NCT00896168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65248260|NCT00896168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65248261|NCT00896168|Immunologic Factors|immunologic factors|mesh-ancestor
65248262|NCT00896168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65248263|NCT00896168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65248264|NCT00896168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65248265|NCT00833703|Clopidogrel|clopidogrel|mesh-list
65248266|NCT00833703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65248267|NCT00833703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65248268|NCT00833703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65248269|NCT00833703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65248299|NCT00837655|Antacids|antacids|mesh-ancestor
65248300|NCT00837655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248301|NCT00837655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65248302|NCT00837655|Chelating Agents|chelating agents|mesh-ancestor
65248303|NCT00837655|Sequestering Agents|sequestering agents|mesh-ancestor
65248304|NCT00843661|Ezetimibe|ezetimibe|mesh-list
65248305|NCT00843661|Pravastatin|pravastatin|mesh-list
65248306|NCT00843661|Fenofibrate|fenofibrate|mesh-list
65248307|NCT00843661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65248308|NCT00843661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65248309|NCT00843661|Antimetabolites|antimetabolites|mesh-ancestor
65248310|NCT00843661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248311|NCT00843661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64923624|NCT00025636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65248335|NCT00705315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65248336|NCT00705315|Growth Substances|growth substances|mesh-ancestor
65248337|NCT00705315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248338|NCT00705315|Growth Inhibitors|growth inhibitors|mesh-ancestor
65248339|NCT00705315|Tubulin Modulators|tubulin modulators|mesh-ancestor
65248340|NCT00705315|Antimitotic Agents|antimitotic agents|mesh-ancestor
65248341|NCT00705315|Mitosis Modulators|mitosis modulators|mesh-ancestor
65248342|NCT00705315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248343|NCT00705315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65248344|NCT00705315|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65248345|NCT00705315|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65248346|NCT00705315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248347|NCT00892008|Pregabalin|pregabalin|mesh-list
65248348|NCT00892008|Analgesics|analgesics|mesh-ancestor
65248349|NCT00892008|Sensory System Agents|sensory system agents|mesh-ancestor
65248350|NCT00892008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65248351|NCT00892008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248352|NCT00892008|Anticonvulsants|anticonvulsants|mesh-ancestor
65248353|NCT00892008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65248354|NCT00892008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65248355|NCT00892008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248356|NCT00892008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65248357|NCT00892008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65248358|NCT00892008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65248359|NCT00892008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65569517|NCT01238705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65569518|NCT01238705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65569519|NCT01238705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65569520|NCT01238705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65569521|NCT01238705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65569522|NCT01238705|Vasodilator Agents|vasodilator agents|mesh-ancestor
65569523|NCT03779347|Praziquantel|praziquantel|mesh-list
65569524|NCT03779347|Anthelmintics|anthelmintics|mesh-ancestor
65569525|NCT03779347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65569526|NCT03779347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65569527|NCT01321099|Fe(III)-EDTA|fe(iii)-edta|mesh-list
65569528|NCT01321099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569529|NCT01321099|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65569530|NCT01321099|Chelating Agents|chelating agents|mesh-ancestor
65569531|NCT01321099|Sequestering Agents|sequestering agents|mesh-ancestor
65569532|NCT01245725|Tirofiban|tirofiban|mesh-list
65569533|NCT01245725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65569534|NCT01245725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65569535|NCT01245725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569536|NCT01245725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65569538|NCT01143545|Cyclophosphamide|cyclophosphamide|mesh-list
65569539|NCT01143545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65569540|NCT01143545|Immunologic Factors|immunologic factors|mesh-ancestor
65569541|NCT01143545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569542|NCT01143545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65569543|NCT01143545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65569544|NCT01143545|Alkylating Agents|alkylating agents|mesh-ancestor
65569545|NCT01143545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569546|NCT01143545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569547|NCT01143545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65569548|NCT01143545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65569549|NCT01143545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65569550|NCT01143545|Analgesics|analgesics|mesh-ancestor
65569551|NCT01143545|Sensory System Agents|sensory system agents|mesh-ancestor
65569552|NCT01143545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65569553|NCT01143545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65569554|NCT01143545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65569555|NCT01143545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65569556|NCT01143545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569557|NCT03779035|Gemcitabine|gemcitabine|mesh-list
65569558|NCT03779035|Capecitabine|capecitabine|mesh-list
65569559|NCT03779035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65569560|NCT03779035|Antimetabolites|antimetabolites|mesh-ancestor
65569561|NCT03779035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569562|NCT03779035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569563|NCT03779035|Antiviral Agents|antiviral agents|mesh-ancestor
65569564|NCT03779035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65569565|NCT03779035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569566|NCT03779035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65569567|NCT03779035|Immunologic Factors|immunologic factors|mesh-ancestor
65569568|NCT03779035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569569|NCT01586117|Amifostine|amifostine|mesh-list
65569570|NCT01586117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65569571|NCT01586117|Protective Agents|protective agents|mesh-ancestor
65569572|NCT01586117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569573|NCT03301415|Valganciclovir|valganciclovir|mesh-list
65569574|NCT03301415|Antiviral Agents|antiviral agents|mesh-ancestor
65569575|NCT03301415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65569576|NCT05449015|Atropine|atropine|mesh-list
65569577|NCT05449015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65569578|NCT05449015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65569579|NCT05449015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65569580|NCT05449015|Autonomic Agents|autonomic agents|mesh-ancestor
65569581|NCT05449015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65569582|NCT05449015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569583|NCT05449015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65569584|NCT05449015|Respiratory System Agents|respiratory system agents|mesh-ancestor
65569585|NCT05449015|Mydriatics|mydriatics|mesh-ancestor
65569586|NCT05449015|Parasympatholytics|parasympatholytics|mesh-ancestor
65569587|NCT05449015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65569588|NCT05449015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65569589|NCT05449015|Cholinergic Agents|cholinergic agents|mesh-ancestor
65569590|NCT05449015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65569591|NCT05449015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569592|NCT01239017|Fasinumab|fasinumab|mesh-list
65569593|NCT01239017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65569594|NCT01239017|Analgesics|analgesics|mesh-ancestor
65569595|NCT01239017|Sensory System Agents|sensory system agents|mesh-ancestor
65569596|NCT01239017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65569597|NCT01239017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569598|NCT02732938|Gemcitabine|gemcitabine|mesh-list
65569599|NCT02732938|Paclitaxel|paclitaxel|mesh-list
65569600|NCT02732938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65569601|NCT02732938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569602|NCT02732938|Tubulin Modulators|tubulin modulators|mesh-ancestor
65569603|NCT02732938|Antimitotic Agents|antimitotic agents|mesh-ancestor
65569604|NCT02732938|Mitosis Modulators|mitosis modulators|mesh-ancestor
65569605|NCT02732938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569606|NCT02732938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65569607|NCT02732938|Antimetabolites|antimetabolites|mesh-ancestor
65569608|NCT02732938|Antiviral Agents|antiviral agents|mesh-ancestor
65569609|NCT02732938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65569610|NCT02732938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569611|NCT02732938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65569612|NCT02732938|Immunologic Factors|immunologic factors|mesh-ancestor
65569613|NCT02732938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569614|NCT03778723|Fentanyl|fentanyl|mesh-list
65569615|NCT03778723|Anesthetics|anesthetics|mesh-list
65569616|NCT03778723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65569617|NCT03778723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569618|NCT03778723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65569619|NCT03778723|Narcotics|narcotics|mesh-ancestor
65569620|NCT03778723|Analgesics|analgesics|mesh-ancestor
65569621|NCT03778723|Sensory System Agents|sensory system agents|mesh-ancestor
65569622|NCT03778723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65569623|NCT03778723|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65569624|NCT03778723|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65569625|NCT03778723|Anesthetics, General|anesthetics, general|mesh-ancestor
65569626|NCT01245959|Cisplatin|cisplatin|mesh-list
65569627|NCT01245959|Docetaxel|docetaxel|mesh-list
65569628|NCT01245959|Fluorouracil|fluorouracil|mesh-list
65569629|NCT01245959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569630|NCT01245959|Tubulin Modulators|tubulin modulators|mesh-ancestor
65569631|NCT01245959|Antimitotic Agents|antimitotic agents|mesh-ancestor
65569632|NCT01245959|Mitosis Modulators|mitosis modulators|mesh-ancestor
65569633|NCT01245959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569634|NCT01245959|Antimetabolites|antimetabolites|mesh-ancestor
65569635|NCT01245959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65569636|NCT01245959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65569637|NCT01245959|Immunologic Factors|immunologic factors|mesh-ancestor
65569638|NCT01245959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569639|NCT04327024|Allopurinol|allopurinol|mesh-list
65569640|NCT04327024|Verinurad|verinurad|mesh-list
65569641|NCT04327024|Antimetabolites|antimetabolites|mesh-ancestor
65569642|NCT04327024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569643|NCT04327024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569644|NCT04327024|Gout Suppressants|gout suppressants|mesh-ancestor
65569645|NCT04327024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65569646|NCT04327024|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65569647|NCT04327024|Antioxidants|antioxidants|mesh-ancestor
65569648|NCT04327024|Protective Agents|protective agents|mesh-ancestor
65569649|NCT04327024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569650|NCT03778645|Epinephrine|epinephrine|mesh-list
65569651|NCT03778645|Racepinephrine|racepinephrine|mesh-list
65569652|NCT03778645|Epinephryl borate|epinephryl borate|mesh-list
65569653|NCT03778645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65569654|NCT03778645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65569655|NCT03778645|Adrenergic Agents|adrenergic agents|mesh-ancestor
65569656|NCT03778645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65569657|NCT03778645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569658|NCT03778645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569659|NCT03778645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65569660|NCT03778645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65569661|NCT03778645|Autonomic Agents|autonomic agents|mesh-ancestor
65569662|NCT03778645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65569663|NCT03778645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65569664|NCT03778645|Respiratory System Agents|respiratory system agents|mesh-ancestor
65569665|NCT03778645|Mydriatics|mydriatics|mesh-ancestor
65569666|NCT03778645|Sympathomimetics|sympathomimetics|mesh-ancestor
65569667|NCT03778645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65569668|NCT04326478|Azithromycin|azithromycin|mesh-list
65569669|NCT04326478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65569670|NCT04326478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65569671|NCT01239173|Propranolol|propranolol|mesh-list
65569672|NCT01239173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65569673|NCT01239173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65569674|NCT01239173|Adrenergic Agents|adrenergic agents|mesh-ancestor
65569675|NCT01239173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65569676|NCT01239173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569677|NCT01239173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569678|NCT01239173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65569679|NCT01239173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65569680|NCT01239173|Vasodilator Agents|vasodilator agents|mesh-ancestor
65569681|NCT04647721|Hyaluronic Acid|hyaluronic acid|mesh-list
65569682|NCT04647721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569683|NCT04647721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65569684|NCT04647721|Immunologic Factors|immunologic factors|mesh-ancestor
65569685|NCT04647721|Viscosupplements|viscosupplements|mesh-ancestor
65569686|NCT04647721|Protective Agents|protective agents|mesh-ancestor
65569687|NCT03470038|Mitogens|mitogens|mesh-list
65569688|NCT03470038|Mitosis Modulators|mitosis modulators|mesh-ancestor
65569689|NCT03470038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569690|NCT03250325|Cyclophosphamide|cyclophosphamide|mesh-list
65569691|NCT03250325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65569692|NCT03250325|Immunologic Factors|immunologic factors|mesh-ancestor
65569693|NCT03250325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569694|NCT03250325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65569695|NCT03250325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65569696|NCT03250325|Alkylating Agents|alkylating agents|mesh-ancestor
65569697|NCT03250325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569698|NCT03250325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569699|NCT03250325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65569700|NCT03778567|Lamivudine|lamivudine|mesh-list
65569701|NCT03778567|Telbivudine|telbivudine|mesh-list
65569702|NCT03778567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65569703|NCT03778567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65569704|NCT03778567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569705|NCT03778567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569706|NCT03778567|Antiviral Agents|antiviral agents|mesh-ancestor
65569707|NCT03778567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65569708|NCT03778567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65569709|NCT03778567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65569710|NCT03784066|Durvalumab|durvalumab|mesh-list
65569711|NCT03784066|Tremelimumab|tremelimumab|mesh-list
65569712|NCT03784066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65569713|NCT03784066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65569714|NCT03784066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569715|NCT03784066|Immunologic Factors|immunologic factors|mesh-ancestor
65569716|NCT03784066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569717|NCT05168683|Rasburicase|rasburicase|mesh-list
65569718|NCT05168683|Uric Acid|uric acid|mesh-list
65569719|NCT05168683|Antioxidants|antioxidants|mesh-ancestor
65569720|NCT05168683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569721|NCT05168683|Protective Agents|protective agents|mesh-ancestor
65569722|NCT05168683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569723|NCT05168683|Gout Suppressants|gout suppressants|mesh-ancestor
65569724|NCT05168683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65569725|NCT03113123|Tenofovir|tenofovir|mesh-list
65569726|NCT03113123|Emtricitabine|emtricitabine|mesh-list
65569727|NCT03113123|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65569728|NCT03113123|Antiviral Agents|antiviral agents|mesh-ancestor
65569729|NCT03113123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65569730|NCT03113123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65569731|NCT03113123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65569732|NCT03113123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569733|NCT03113123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569734|NCT03113123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65569735|NCT03113123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65569736|NCT04451122|Tea Tree Oil|tea tree oil|mesh-list
65569737|NCT04451122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65569738|NCT04451122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65569739|NCT01143857|Varenicline|varenicline|mesh-list
65569740|NCT01143857|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65569741|NCT01143857|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65569742|NCT01143857|Cholinergic Agents|cholinergic agents|mesh-ancestor
65569743|NCT01143857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65569744|NCT01143857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569745|NCT01143857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569746|NCT05159284|Hydrocortisone|hydrocortisone|mesh-list
65569747|NCT05159284|Lubricant Eye Drops|lubricant eye drops|mesh-list
65569748|NCT05159284|Hyaluronic Acid|hyaluronic acid|mesh-list
65569749|NCT05159284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65569750|NCT05159284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65569751|NCT05159284|Immunologic Factors|immunologic factors|mesh-ancestor
65569752|NCT05159284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569753|NCT05159284|Viscosupplements|viscosupplements|mesh-ancestor
65569754|NCT05159284|Protective Agents|protective agents|mesh-ancestor
65569755|NCT05159284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65569756|NCT05159284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65569757|NCT03063203|Decitabine|decitabine|mesh-list
65569758|NCT03063203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65569759|NCT03063203|Antimetabolites|antimetabolites|mesh-ancestor
65569760|NCT03063203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569761|NCT03063203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569762|NCT03063203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569763|NCT03435094|Alendronate|alendronate|mesh-list
65569764|NCT03435094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65569765|NCT03435094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569766|NCT03772483|Anesthetics|anesthetics|mesh-list
65569767|NCT03772483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65569768|NCT03772483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569769|NCT01236911|Calcium|calcium|mesh-list
65569770|NCT01236911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65569771|NCT01236911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569772|NCT03772561|Durvalumab|durvalumab|mesh-list
65569773|NCT03772561|Olaparib|olaparib|mesh-list
65569774|NCT03772561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65569775|NCT03772561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569776|NCT03772561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65569777|NCT03772561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569778|NCT03772561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569779|NCT01239485|Irinotecan|irinotecan|mesh-list
65569780|NCT01239485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65569781|NCT01239485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65569782|NCT01239485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569783|NCT01239485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569784|NCT01239485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569785|NCT01146041|Rivastigmine|rivastigmine|mesh-list
65569786|NCT01146041|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65569787|NCT01146041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569788|NCT01146041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569789|NCT01146041|Cholinergic Agents|cholinergic agents|mesh-ancestor
65569790|NCT01146041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65569791|NCT01146041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569792|NCT01146041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65569793|NCT01146041|Protective Agents|protective agents|mesh-ancestor
65569794|NCT04450576|Chrysarobin|chrysarobin|mesh-list
65569795|NCT04450576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65569796|NCT04450576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65569797|NCT04450576|Analgesics|analgesics|mesh-ancestor
65569798|NCT04450576|Sensory System Agents|sensory system agents|mesh-ancestor
65569799|NCT04450576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65569800|NCT04450576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569801|NCT04450576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65569802|NCT04450576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65569803|NCT03430180|Naloxone|naloxone|mesh-list
65569804|NCT03430180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65569805|NCT03430180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569806|NCT03430180|Sensory System Agents|sensory system agents|mesh-ancestor
65569807|NCT03430180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65569808|NCT03777787|Denatonium|denatonium|mesh-list
65569809|NCT03777787|Aversive Agents|aversive agents|mesh-ancestor
65569810|NCT03777787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569811|NCT03777787|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
65569812|NCT03777787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569813|NCT03777787|Sensory System Agents|sensory system agents|mesh-ancestor
65569814|NCT03777787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65569815|NCT03395314|Midazolam|midazolam|mesh-list
65569816|NCT03395314|Ketamine|ketamine|mesh-list
65569817|NCT03395314|Analgesics|analgesics|mesh-ancestor
65569818|NCT03395314|Sensory System Agents|sensory system agents|mesh-ancestor
65569819|NCT03395314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65569820|NCT03395314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569821|NCT03395314|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65569822|NCT03395314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65569823|NCT03395314|Anesthetics, General|anesthetics, general|mesh-ancestor
65569824|NCT03395314|Anesthetics|anesthetics|mesh-ancestor
65569825|NCT03395314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65569826|NCT03395314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65569827|NCT03395314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65569828|NCT03395314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65569829|NCT03395314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569830|NCT03395314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65569831|NCT03395314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65569832|NCT03395314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65569833|NCT03395314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65569834|NCT03395314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65569835|NCT03395314|GABA Modulators|gaba modulators|mesh-ancestor
65569836|NCT03395314|GABA Agents|gaba agents|mesh-ancestor
65569837|NCT03430024|Estrogens|estrogens|mesh-list
65569838|NCT03430024|Hormones|hormones|mesh-ancestor
65569839|NCT03430024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65569840|NCT03430024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569841|NCT03434782|Listerine|listerine|mesh-list
65569842|NCT03434782|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65569843|NCT03434782|Fluorides|fluorides|mesh-list
65569844|NCT03434782|Sodium Fluoride|sodium fluoride|mesh-list
65569845|NCT03434782|Cariostatic Agents|cariostatic agents|mesh-ancestor
65569846|NCT03434782|Protective Agents|protective agents|mesh-ancestor
65569847|NCT03434782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569848|NCT03434782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65569849|NCT03434782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65569850|NCT01320397|Losartan|losartan|mesh-list
65569851|NCT01320397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65569852|NCT01320397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65569853|NCT01320397|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65569854|NCT01320397|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65569855|NCT01320397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569856|NCT03434704|Antifungal Agents|antifungal agents|mesh-list
65569857|NCT03434704|Clotrimazole|clotrimazole|mesh-list
65569858|NCT03434704|Miconazole|miconazole|mesh-list
65569859|NCT03434704|Fludarabine|fludarabine|mesh-list
65569860|NCT03434704|Thiotepa|thiotepa|mesh-list
65569861|NCT03434704|Treosulfan|treosulfan|mesh-list
65569862|NCT03434704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569863|NCT03434704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569864|NCT03434704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65569865|NCT03434704|Immunologic Factors|immunologic factors|mesh-ancestor
65569866|NCT03434704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569867|NCT03434704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65569868|NCT03434704|Alkylating Agents|alkylating agents|mesh-ancestor
65569869|NCT03434704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65569870|NCT03434704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65569871|NCT03434704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65569872|NCT03434704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65569873|NCT03434704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65569874|NCT03434704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569875|NCT03434704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65569876|NCT03434704|Hormone Antagonists|hormone antagonists|mesh-ancestor
65569877|NCT03434704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65569878|NCT03434704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65569879|NCT03434704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65569880|NCT02521636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65569881|NCT02521636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65569882|NCT04779151|Niraparib|niraparib|mesh-list
65569883|NCT04779151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65569884|NCT04779151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569885|NCT04779151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569886|NCT04779151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569887|NCT02891226|Mirikizumab|mirikizumab|mesh-list
65569888|NCT02891226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65569889|NCT02891226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65569890|NCT02891226|Analgesics|analgesics|mesh-ancestor
65569891|NCT02891226|Sensory System Agents|sensory system agents|mesh-ancestor
65569892|NCT02891226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65569893|NCT02891226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569894|NCT02891226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65569895|NCT02891226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65569896|NCT02891226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65569897|NCT02891226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65569898|NCT03654274|Norethindrone|norethindrone|mesh-list
65569899|NCT03654274|Norethindrone Acetate|norethindrone acetate|mesh-list
65569900|NCT03654274|Estradiol|estradiol|mesh-list
65569901|NCT03654274|Relugolix|relugolix|mesh-list
65569902|NCT03654274|Estrogens|estrogens|mesh-ancestor
65569903|NCT03654274|Hormones|hormones|mesh-ancestor
65569904|NCT03654274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65569905|NCT03654274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569906|NCT03654274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65569907|NCT03654274|Contraceptive Agents|contraceptive agents|mesh-ancestor
65569908|NCT03654274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65569909|NCT03654274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65569910|NCT03654274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65569911|NCT03654274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65569912|NCT03654274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65569913|NCT03654274|Androgen Antagonists|androgen antagonists|mesh-ancestor
65569914|NCT03654274|Hormone Antagonists|hormone antagonists|mesh-ancestor
65569915|NCT03771781|Empagliflozin|empagliflozin|mesh-list
65569916|NCT03771781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65569917|NCT03771781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569918|NCT03771781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65569919|NCT03771781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569920|NCT04140721|Moxonidine|moxonidine|mesh-list
65569921|NCT04140721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65569922|NCT03224104|Temozolomide|temozolomide|mesh-list
65569923|NCT03224104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65569924|NCT03224104|Alkylating Agents|alkylating agents|mesh-ancestor
65569925|NCT03224104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569926|NCT03224104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569927|NCT01320475|Sufentanil|sufentanil|mesh-list
65569928|NCT01320475|Ketamine|ketamine|mesh-list
65569929|NCT01320475|Analgesics|analgesics|mesh-ancestor
65569930|NCT01320475|Sensory System Agents|sensory system agents|mesh-ancestor
65569931|NCT01320475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65569932|NCT01320475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569933|NCT01320475|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65569934|NCT01320475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65569935|NCT01320475|Anesthetics, General|anesthetics, general|mesh-ancestor
65569936|NCT01320475|Anesthetics|anesthetics|mesh-ancestor
65569937|NCT01320475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65569938|NCT01320475|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65569939|NCT01320475|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65569940|NCT01320475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65569941|NCT01320475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569942|NCT01320475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65569943|NCT01320475|Narcotics|narcotics|mesh-ancestor
65569944|NCT01320475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65569945|NCT05177406|Erenumab|erenumab|mesh-list
65569946|NCT05177406|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65569947|NCT05177406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569948|NCT05177406|Analgesics|analgesics|mesh-ancestor
65569949|NCT05177406|Sensory System Agents|sensory system agents|mesh-ancestor
65569950|NCT05177406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65569951|NCT05177406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569952|NCT05413980|Moxifloxacin|moxifloxacin|mesh-list
65569953|NCT05413980|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65569954|NCT05413980|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65569955|NCT05413980|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65569956|NCT05413980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65569957|NCT05413980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65569958|NCT05413980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65569959|NCT05413980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65569960|NCT05413980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569961|NCT05413980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569962|NCT05413980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65569963|NCT05413980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65569964|NCT05413980|Contraceptive Agents|contraceptive agents|mesh-ancestor
65569965|NCT05413980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65569966|NCT05413980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569967|NCT05413980|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65569968|NCT05413980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65569969|NCT05413980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65569970|NCT02521246|Losartan|losartan|mesh-list
65569971|NCT02521246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65569972|NCT02521246|Candesartan|candesartan|mesh-list
65569973|NCT02521246|Candesartan cilexetil|candesartan cilexetil|mesh-list
65569974|NCT02521246|Chlorthalidone|chlorthalidone|mesh-list
65569975|NCT02521246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65569976|NCT02521246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65569977|NCT02521246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65569978|NCT02521246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65569979|NCT02521246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569980|NCT02521246|Diuretics|diuretics|mesh-ancestor
65569981|NCT02521246|Natriuretic Agents|natriuretic agents|mesh-ancestor
65569982|NCT02521246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569983|NCT02521246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65367485|NCT05154136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65569984|NCT02521246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65569986|NCT05309070|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65569987|NCT05309070|Antiviral Agents|antiviral agents|mesh-ancestor
65569988|NCT05309070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65569989|NCT05309070|Expectorants|expectorants|mesh-ancestor
65569990|NCT05309070|Respiratory System Agents|respiratory system agents|mesh-ancestor
65569991|NCT05309070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65569992|NCT05309070|Antioxidants|antioxidants|mesh-ancestor
65569993|NCT05309070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65569994|NCT05309070|Protective Agents|protective agents|mesh-ancestor
65569995|NCT05309070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65569996|NCT05309070|Antidotes|antidotes|mesh-ancestor
65569997|NCT04735549|Hormones|hormones|mesh-list
65569998|NCT04735549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65569999|NCT04735549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570000|NCT04763928|Decitabine|decitabine|mesh-list
65570001|NCT04763928|Venetoclax|venetoclax|mesh-list
65570002|NCT04763928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65570003|NCT04763928|Antimetabolites|antimetabolites|mesh-ancestor
65570004|NCT04763928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570005|NCT04763928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570006|NCT04763928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570007|NCT01567501|Cetirizine|cetirizine|mesh-list
65570008|NCT01567501|Levocetirizine|levocetirizine|mesh-list
65570009|NCT01567501|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65570010|NCT01567501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65570011|NCT01567501|Histamine Antagonists|histamine antagonists|mesh-ancestor
65570012|NCT01567501|Histamine Agents|histamine agents|mesh-ancestor
65570013|NCT01567501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65570014|NCT01567501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570015|NCT01567501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570016|NCT01567501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65570017|NCT01321957|Bevacizumab|bevacizumab|mesh-list
65570018|NCT01321957|Oxaliplatin|oxaliplatin|mesh-list
65570019|NCT01321957|Irinotecan|irinotecan|mesh-list
65570020|NCT01321957|Fluorouracil|fluorouracil|mesh-list
65570021|NCT01321957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65570022|NCT01321957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570023|NCT01321957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65570024|NCT01321957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65570025|NCT01321957|Growth Substances|growth substances|mesh-ancestor
65570026|NCT01321957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570027|NCT01321957|Growth Inhibitors|growth inhibitors|mesh-ancestor
65570028|NCT01321957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65570029|NCT01321957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65570030|NCT01321957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570031|NCT01321957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570032|NCT01321957|Antimetabolites|antimetabolites|mesh-ancestor
65570033|NCT01321957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65570034|NCT01321957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65570035|NCT01321957|Immunologic Factors|immunologic factors|mesh-ancestor
65570036|NCT01321255|Aspirin|aspirin|mesh-list
65570037|NCT01321255|Ramipril|ramipril|mesh-list
65570038|NCT01321255|Simvastatin|simvastatin|mesh-list
65570039|NCT01321255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65570040|NCT01321255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65570041|NCT01321255|Analgesics|analgesics|mesh-ancestor
65570042|NCT01321255|Sensory System Agents|sensory system agents|mesh-ancestor
65570043|NCT01321255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65570044|NCT01321255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570045|NCT01321255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65570046|NCT01321255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65570047|NCT01321255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65570048|NCT01321255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65570049|NCT01321255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570050|NCT01321255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65570051|NCT01321255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65570052|NCT01321255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570053|NCT01321255|Antipyretics|antipyretics|mesh-ancestor
65570054|NCT01321255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65570055|NCT01321255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65570056|NCT01321255|Antimetabolites|antimetabolites|mesh-ancestor
65570057|NCT01321255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65570058|NCT01321255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65570059|NCT01321255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65570060|NCT01321255|Protease Inhibitors|protease inhibitors|mesh-ancestor
65570061|NCT01321255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65570062|NCT05363592|Metformin|metformin|mesh-list
65570063|NCT05363592|Alogliptin|alogliptin|mesh-list
65570064|NCT05363592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65570065|NCT05363592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570066|NCT05363592|Incretins|incretins|mesh-ancestor
65570067|NCT05363592|Hormones|hormones|mesh-ancestor
65570068|NCT05363592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65570069|NCT05363592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65570070|NCT05363592|Protease Inhibitors|protease inhibitors|mesh-ancestor
65570071|NCT05363592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570072|NCT05363592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570073|NCT03708211|Esomeprazole|esomeprazole|mesh-list
65570074|NCT03708211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65570075|NCT03708211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65570076|NCT03708211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65570077|NCT03708211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570078|NCT03708211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570079|NCT03770923|Montelukast|montelukast|mesh-list
65570080|NCT03770923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65570081|NCT03770923|Respiratory System Agents|respiratory system agents|mesh-ancestor
65570082|NCT03770923|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65570083|NCT03770923|Hormone Antagonists|hormone antagonists|mesh-ancestor
65570084|NCT03770923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65570085|NCT03770923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570086|NCT03770923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65570087|NCT03770923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65570088|NCT03770923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570089|NCT03433534|Nivolumab|nivolumab|mesh-list
65570090|NCT03433534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65570091|NCT03433534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570092|NCT03433534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65570093|NCT03433534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570094|NCT05445895|Clopidogrel|clopidogrel|mesh-list
65570095|NCT05445895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65570096|NCT05445895|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65570097|NCT05445895|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65570098|NCT05445895|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65570099|NCT05445895|Purinergic Agents|purinergic agents|mesh-ancestor
65570100|NCT05445895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65570101|NCT05445895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570102|NCT05445895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570103|NCT03367299|Blinatumomab|blinatumomab|mesh-list
65570104|NCT03367299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570105|NCT04449952|Listerine|listerine|mesh-list
65570106|NCT04449952|Sodium Fluoride|sodium fluoride|mesh-list
65570107|NCT04449952|Cariostatic Agents|cariostatic agents|mesh-ancestor
65570108|NCT04449952|Protective Agents|protective agents|mesh-ancestor
65570109|NCT04449952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570110|NCT04449952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65570111|NCT04449952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65570112|NCT03705793|Mometasone Furoate|mometasone furoate|mesh-list
65570113|NCT03705793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65570114|NCT03705793|Dermatologic Agents|dermatologic agents|mesh-ancestor
65570115|NCT03705793|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65570116|NCT04449718|Vitamin D|vitamin d|mesh-list
65570117|NCT04449718|Vitamins|vitamins|mesh-ancestor
65570118|NCT04449718|Micronutrients|micronutrients|mesh-ancestor
65570119|NCT04449718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570120|NCT04449718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65570121|NCT03763279|Triclosan|triclosan|mesh-list
65570122|NCT03763279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65570123|NCT03763279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65570124|NCT03763279|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65570125|NCT03763279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65570126|NCT03763279|Antimetabolites|antimetabolites|mesh-ancestor
65570127|NCT03763279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570128|NCT03763279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65570129|NCT03638037|Vitamin D|vitamin d|mesh-list
65570130|NCT03638037|Vitamins|vitamins|mesh-ancestor
65570131|NCT03638037|Micronutrients|micronutrients|mesh-ancestor
65570132|NCT03638037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570133|NCT03638037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65570134|NCT03526354|Antipsychotic Agents|antipsychotic agents|mesh-list
65570135|NCT03526354|Brexpiprazole|brexpiprazole|mesh-list
65570136|NCT03526354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65570137|NCT03526354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65570138|NCT03526354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570139|NCT03526354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65570140|NCT03526354|Serotonin Agents|serotonin agents|mesh-ancestor
65570141|NCT03526354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65570142|NCT03526354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570143|NCT03526354|Dopamine Agonists|dopamine agonists|mesh-ancestor
65570144|NCT03526354|Dopamine Agents|dopamine agents|mesh-ancestor
65570145|NCT03763123|Paclitaxel|paclitaxel|mesh-list
65570146|NCT03763123|Topotecan|topotecan|mesh-list
65570147|NCT03763123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65570148|NCT03763123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570149|NCT03763123|Tubulin Modulators|tubulin modulators|mesh-ancestor
65570150|NCT03763123|Antimitotic Agents|antimitotic agents|mesh-ancestor
65570151|NCT03763123|Mitosis Modulators|mitosis modulators|mesh-ancestor
65570152|NCT03763123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570153|NCT03763123|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65570154|NCT03763123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65570155|NCT03763123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570156|NCT03429400|Morphine|morphine|mesh-list
65570157|NCT03429400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65570158|NCT03429400|Narcotics|narcotics|mesh-ancestor
65570159|NCT03429400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65570160|NCT03429400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570161|NCT03429400|Analgesics|analgesics|mesh-ancestor
65570162|NCT03429400|Sensory System Agents|sensory system agents|mesh-ancestor
65570163|NCT03429400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65570164|NCT03429010|Anesthetics|anesthetics|mesh-list
65570165|NCT03429010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65570166|NCT03429010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570167|NCT02944656|Gabapentin|gabapentin|mesh-list
65570168|NCT02944656|Analgesics|analgesics|mesh-ancestor
65570169|NCT02944656|Sensory System Agents|sensory system agents|mesh-ancestor
65570170|NCT02944656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65570171|NCT02944656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570172|NCT02944656|Anticonvulsants|anticonvulsants|mesh-ancestor
65570173|NCT02944656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65570174|NCT02944656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65570175|NCT02944656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65570176|NCT02944656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65570177|NCT02944656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65570178|NCT02944656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65570179|NCT02944656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65570180|NCT02944656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570181|NCT02944656|Antimanic Agents|antimanic agents|mesh-ancestor
65570182|NCT02713529|Pembrolizumab|pembrolizumab|mesh-list
65570183|NCT02713529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65570184|NCT02713529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570185|NCT03763045|Sildenafil Citrate|sildenafil citrate|mesh-list
65570186|NCT03763045|Vasodilator Agents|vasodilator agents|mesh-ancestor
65570187|NCT03763045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65570188|NCT03763045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65570189|NCT03763045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570190|NCT03763045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570191|NCT03763045|Urological Agents|urological agents|mesh-ancestor
65570192|NCT01321489|Sildenafil Citrate|sildenafil citrate|mesh-list
65570193|NCT01321489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570194|NCT01321489|Vasodilator Agents|vasodilator agents|mesh-ancestor
65570195|NCT01321489|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65570196|NCT01321489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65570197|NCT01321489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570198|NCT01321489|Urological Agents|urological agents|mesh-ancestor
65570199|NCT04800627|Pembrolizumab|pembrolizumab|mesh-list
65570200|NCT04800627|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65570201|NCT04800627|Pevonedistat|pevonedistat|mesh-list
65570202|NCT04800627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65570203|NCT04800627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570204|NCT04800627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570205|NCT05308602|Vaccines|vaccines|mesh-list
65570206|NCT05308602|Immunologic Factors|immunologic factors|mesh-ancestor
65570207|NCT05308602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570208|NCT03768037|Pemetrexed|pemetrexed|mesh-list
65570209|NCT03768037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570210|NCT03768037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570211|NCT03768037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570212|NCT03768037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65570213|NCT03768037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65570214|NCT01146977|Cytarabine|cytarabine|mesh-list
65570215|NCT01146977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65570216|NCT01146977|Antimetabolites|antimetabolites|mesh-ancestor
65570217|NCT01146977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570218|NCT01146977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570219|NCT01146977|Antiviral Agents|antiviral agents|mesh-ancestor
65570220|NCT01146977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65570221|NCT01146977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65570222|NCT01146977|Immunologic Factors|immunologic factors|mesh-ancestor
65570223|NCT01146977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570224|NCT03762967|Hormones|hormones|mesh-list
65570225|NCT03762967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65570226|NCT03762967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570227|NCT02664935|Docetaxel|docetaxel|mesh-list
65570228|NCT02664935|Durvalumab|durvalumab|mesh-list
65570229|NCT02664935|Palbociclib|palbociclib|mesh-list
65570230|NCT02664935|Osimertinib|osimertinib|mesh-list
65570231|NCT02664935|Crizotinib|crizotinib|mesh-list
65570232|NCT02664935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570233|NCT02664935|Tubulin Modulators|tubulin modulators|mesh-ancestor
65570234|NCT02664935|Antimitotic Agents|antimitotic agents|mesh-ancestor
65570235|NCT02664935|Mitosis Modulators|mitosis modulators|mesh-ancestor
65570236|NCT02664935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570237|NCT02664935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65570238|NCT02664935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65570239|NCT02664935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570240|NCT03762889|Anesthetics|anesthetics|mesh-list
65570241|NCT03762889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65570242|NCT03762889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570243|NCT03746041|Abaloparatide|abaloparatide|mesh-list
65570244|NCT03746041|Bevacizumab|bevacizumab|mesh-list
65570245|NCT03746041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65570246|NCT03746041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570247|NCT03746041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65570248|NCT03746041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65570249|NCT03746041|Growth Substances|growth substances|mesh-ancestor
65570250|NCT03746041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570251|NCT03746041|Growth Inhibitors|growth inhibitors|mesh-ancestor
65570252|NCT03746041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65570253|NCT01236989|Liver Extracts|liver extracts|mesh-list
65570254|NCT01236989|Hematinics|hematinics|mesh-ancestor
65570255|NCT03423472|Vitamin A|vitamin a|mesh-list
65570256|NCT03423472|Vitamins|vitamins|mesh-ancestor
65570257|NCT03423472|Micronutrients|micronutrients|mesh-ancestor
65570258|NCT03423472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570259|NCT01239563|Thymoglobulin|thymoglobulin|mesh-list
65570260|NCT01239563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65570261|NCT01239563|Basiliximab|basiliximab|mesh-list
65570262|NCT01239563|Immunologic Factors|immunologic factors|mesh-ancestor
65570263|NCT01239563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570264|NCT01239563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65570265|NCT01883297|Aldesleukin|aldesleukin|mesh-list
65570266|NCT01883297|Cyclophosphamide|cyclophosphamide|mesh-list
65570267|NCT01883297|Interleukin-2|interleukin-2|mesh-list
65570268|NCT01883297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65570269|NCT01883297|Immunologic Factors|immunologic factors|mesh-ancestor
65570270|NCT01883297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570271|NCT01883297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65570272|NCT01883297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65570273|NCT01883297|Alkylating Agents|alkylating agents|mesh-ancestor
65570274|NCT01883297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570275|NCT01883297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570276|NCT01883297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65570277|NCT01883297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65570278|NCT01883297|Analgesics|analgesics|mesh-ancestor
65570279|NCT01883297|Sensory System Agents|sensory system agents|mesh-ancestor
65570280|NCT01883297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65570281|NCT01883297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65570282|NCT01883297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65367792|NCT00779909|Vitamin D|vitamin d|mesh-list
65570283|NCT01883297|Antiviral Agents|antiviral agents|mesh-ancestor
65570284|NCT01883297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65570285|NCT04546581|Remdesivir|remdesivir|mesh-list
65570286|NCT04546581|Immunoglobulins|immunoglobulins|mesh-list
65570287|NCT04546581|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65570288|NCT04546581|Antibodies|antibodies|mesh-list
65570289|NCT04546581|Immunologic Factors|immunologic factors|mesh-ancestor
65570290|NCT04546581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570291|NCT04546581|Antimetabolites|antimetabolites|mesh-ancestor
65570292|NCT04546581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570293|NCT04546581|Antiviral Agents|antiviral agents|mesh-ancestor
65570294|NCT04546581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65570295|NCT02204254|Doxycycline|doxycycline|mesh-list
65570296|NCT02204254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65570297|NCT02204254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65570298|NCT02204254|Antimalarials|antimalarials|mesh-ancestor
65570299|NCT02204254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65570300|NCT02204254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65570301|NCT01321567|Rabeprazole|rabeprazole|mesh-list
65570302|NCT01321567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65570303|NCT01321567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65570304|NCT01321567|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65570305|NCT01321567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570306|NCT01321567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570307|NCT03417076|Bexagliflozin|bexagliflozin|mesh-list
65570308|NCT03417076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65570309|NCT03417076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570310|NCT05294172|Gemcitabine|gemcitabine|mesh-list
65570311|NCT05294172|Cisplatin|cisplatin|mesh-list
65570312|NCT05294172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570313|NCT05294172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65570314|NCT05294172|Antimetabolites|antimetabolites|mesh-ancestor
65570315|NCT05294172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570316|NCT05294172|Antiviral Agents|antiviral agents|mesh-ancestor
65570317|NCT05294172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65570318|NCT05294172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570319|NCT05294172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65570320|NCT05294172|Immunologic Factors|immunologic factors|mesh-ancestor
65570321|NCT05294172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570322|NCT03164655|Leucovorin|leucovorin|mesh-list
65570323|NCT03164655|Bevacizumab|bevacizumab|mesh-list
65570324|NCT03164655|Cetuximab|cetuximab|mesh-list
65570325|NCT03164655|Panitumumab|panitumumab|mesh-list
65570326|NCT03164655|Fluorouracil|fluorouracil|mesh-list
65570327|NCT03164655|Oxaliplatin|oxaliplatin|mesh-list
65570328|NCT03164655|Irinotecan|irinotecan|mesh-list
65570329|NCT03164655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65570330|NCT03164655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570331|NCT03164655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65570332|NCT03164655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65570333|NCT03164655|Growth Substances|growth substances|mesh-ancestor
65570334|NCT03164655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570335|NCT03164655|Growth Inhibitors|growth inhibitors|mesh-ancestor
65570336|NCT03164655|Antimetabolites|antimetabolites|mesh-ancestor
65570337|NCT03164655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570338|NCT03164655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65570339|NCT03164655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65570340|NCT03164655|Immunologic Factors|immunologic factors|mesh-ancestor
65570341|NCT03164655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65570342|NCT03164655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65570343|NCT03164655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570344|NCT03164655|Antidotes|antidotes|mesh-ancestor
65570345|NCT03164655|Protective Agents|protective agents|mesh-ancestor
65570346|NCT03164655|Vitamin B Complex|vitamin b complex|mesh-ancestor
65570347|NCT03164655|Vitamins|vitamins|mesh-ancestor
65570348|NCT03164655|Micronutrients|micronutrients|mesh-ancestor
65570349|NCT02561273|Prednisone|prednisone|mesh-list
65570350|NCT02561273|Cortisone|cortisone|mesh-list
65570351|NCT02561273|Cyclophosphamide|cyclophosphamide|mesh-list
65570352|NCT02561273|Doxorubicin|doxorubicin|mesh-list
65570353|NCT02561273|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65570354|NCT02561273|Etoposide|etoposide|mesh-list
65570355|NCT02561273|Vincristine|vincristine|mesh-list
65570356|NCT02561273|Lenalidomide|lenalidomide|mesh-list
65570357|NCT02561273|Etoposide phosphate|etoposide phosphate|mesh-list
65570358|NCT02561273|Podophyllotoxin|podophyllotoxin|mesh-list
65570359|NCT02561273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65570360|NCT02561273|Immunologic Factors|immunologic factors|mesh-ancestor
65570361|NCT02561273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570362|NCT02561273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65570363|NCT02561273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65570364|NCT02561273|Alkylating Agents|alkylating agents|mesh-ancestor
65570365|NCT02561273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570366|NCT02561273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570367|NCT02561273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65570368|NCT02561273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65570369|NCT02561273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65570370|NCT02561273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65570371|NCT02561273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570372|NCT02561273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65570373|NCT02561273|Glucocorticoids|glucocorticoids|mesh-ancestor
65570374|NCT02561273|Hormones|hormones|mesh-ancestor
65570375|NCT02561273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65570376|NCT02561273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65570377|NCT02561273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65570378|NCT02561273|Tubulin Modulators|tubulin modulators|mesh-ancestor
65570379|NCT02561273|Antimitotic Agents|antimitotic agents|mesh-ancestor
65570380|NCT02561273|Mitosis Modulators|mitosis modulators|mesh-ancestor
65570381|NCT02561273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65570382|NCT02561273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65570383|NCT02561273|Growth Substances|growth substances|mesh-ancestor
65570384|NCT02561273|Growth Inhibitors|growth inhibitors|mesh-ancestor
65570385|NCT02561273|Keratolytic Agents|keratolytic agents|mesh-ancestor
65570386|NCT02561273|Dermatologic Agents|dermatologic agents|mesh-ancestor
65570387|NCT02521012|Vitamin D|vitamin d|mesh-list
65570388|NCT02521012|Ergocalciferols|ergocalciferols|mesh-list
65570389|NCT02521012|Cholecalciferol|cholecalciferol|mesh-list
65570390|NCT02521012|Vitamins|vitamins|mesh-list
65570391|NCT02521012|Micronutrients|micronutrients|mesh-ancestor
65570392|NCT02521012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570393|NCT02521012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65570394|NCT02521012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65570395|NCT05302986|Tranexamic Acid|tranexamic acid|mesh-list
65570396|NCT05302986|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65570397|NCT05302986|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65570398|NCT05302986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570399|NCT05302986|Hemostatics|hemostatics|mesh-ancestor
65570400|NCT05302986|Coagulants|coagulants|mesh-ancestor
65570401|NCT04756128|Colchicine|colchicine|mesh-list
65570402|NCT04756128|Naltrexone|naltrexone|mesh-list
65570403|NCT04756128|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65570404|NCT04756128|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65570405|NCT04756128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570406|NCT04756128|Sensory System Agents|sensory system agents|mesh-ancestor
65570407|NCT04756128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65570408|NCT04756128|Gout Suppressants|gout suppressants|mesh-ancestor
65570409|NCT04756128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65570410|NCT04756128|Tubulin Modulators|tubulin modulators|mesh-ancestor
65570411|NCT04756128|Antimitotic Agents|antimitotic agents|mesh-ancestor
65570412|NCT04756128|Mitosis Modulators|mitosis modulators|mesh-ancestor
65570413|NCT04756128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570414|NCT04756128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570415|NCT03427216|Diazepam|diazepam|mesh-list
65570416|NCT03427216|Baclofen|baclofen|mesh-list
65570417|NCT03427216|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65570418|NCT03427216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570419|NCT03427216|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65570420|NCT03427216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65570421|NCT03427216|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65570422|NCT03427216|GABA Agonists|gaba agonists|mesh-ancestor
65570423|NCT03427216|GABA Agents|gaba agents|mesh-ancestor
65570424|NCT03427216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65570425|NCT03427216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570426|NCT03427216|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65570427|NCT03427216|Anticonvulsants|anticonvulsants|mesh-ancestor
65570428|NCT03427216|Antiemetics|antiemetics|mesh-ancestor
65570429|NCT03427216|Autonomic Agents|autonomic agents|mesh-ancestor
65570430|NCT03427216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65570431|NCT03427216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65570432|NCT03427216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65570433|NCT03427216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65570434|NCT03427216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65570435|NCT03427216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65570436|NCT03427216|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65570437|NCT03427216|Anesthetics, General|anesthetics, general|mesh-ancestor
65570438|NCT03427216|Anesthetics|anesthetics|mesh-ancestor
65570439|NCT03427216|GABA Modulators|gaba modulators|mesh-ancestor
65570440|NCT01144091|Pentoxifylline|pentoxifylline|mesh-list
65570441|NCT01144091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65570442|NCT01144091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570443|NCT01144091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570444|NCT01144091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65570445|NCT01144091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65570446|NCT01144091|Protective Agents|protective agents|mesh-ancestor
65570447|NCT01144091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570448|NCT01144091|Vasodilator Agents|vasodilator agents|mesh-ancestor
65570449|NCT01144091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65570450|NCT01144091|Antioxidants|antioxidants|mesh-ancestor
65570451|NCT02392559|Evolocumab|evolocumab|mesh-list
65570452|NCT02392559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65570453|NCT02392559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65570454|NCT02392559|Antimetabolites|antimetabolites|mesh-ancestor
65570455|NCT02392559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570456|NCT02392559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65570457|NCT03332589|Dabrafenib|dabrafenib|mesh-list
65570458|NCT03332589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570459|NCT03332589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65570460|NCT03332589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570461|NCT03332589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570462|NCT03767569|Folic Acid|folic acid|mesh-list
65570463|NCT03767569|Inositol|inositol|mesh-list
65570464|NCT03767569|Hematinics|hematinics|mesh-ancestor
65570465|NCT03767569|Vitamin B Complex|vitamin b complex|mesh-ancestor
65570466|NCT03767569|Vitamins|vitamins|mesh-ancestor
65570467|NCT03767569|Micronutrients|micronutrients|mesh-ancestor
65570468|NCT03767569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570469|NCT03620916|Morphine|morphine|mesh-list
65570470|NCT03620916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65570471|NCT03620916|Narcotics|narcotics|mesh-ancestor
65570472|NCT03620916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65570473|NCT03620916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570474|NCT03620916|Analgesics|analgesics|mesh-ancestor
65570475|NCT03620916|Sensory System Agents|sensory system agents|mesh-ancestor
65570476|NCT03620916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65570477|NCT01237067|Carboplatin|carboplatin|mesh-list
65570478|NCT01237067|Olaparib|olaparib|mesh-list
65570479|NCT01237067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570480|NCT01237067|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65570481|NCT01237067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570482|NCT01237067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570483|NCT01864109|Cyclophosphamide|cyclophosphamide|mesh-list
65570484|NCT01864109|Temozolomide|temozolomide|mesh-list
65570485|NCT01864109|Ifosfamide|ifosfamide|mesh-list
65570486|NCT01864109|Doxorubicin|doxorubicin|mesh-list
65570487|NCT01864109|Irinotecan|irinotecan|mesh-list
65570488|NCT01864109|Etoposide|etoposide|mesh-list
65570489|NCT01864109|Vincristine|vincristine|mesh-list
65570490|NCT01864109|Dexrazoxane|dexrazoxane|mesh-list
65570491|NCT01864109|Razoxane|razoxane|mesh-list
65570492|NCT01864109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65570493|NCT01864109|Immunologic Factors|immunologic factors|mesh-ancestor
65570494|NCT01864109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570495|NCT01864109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65570496|NCT01864109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65570497|NCT01864109|Alkylating Agents|alkylating agents|mesh-ancestor
65570498|NCT01864109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570499|NCT01864109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570500|NCT01864109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65570501|NCT01864109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65570502|NCT01864109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65570503|NCT01864109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65570504|NCT01864109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570505|NCT01864109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65570506|NCT01864109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65570507|NCT01864109|Tubulin Modulators|tubulin modulators|mesh-ancestor
65570508|NCT01864109|Antimitotic Agents|antimitotic agents|mesh-ancestor
65570509|NCT01864109|Mitosis Modulators|mitosis modulators|mesh-ancestor
65570510|NCT01864109|Protective Agents|protective agents|mesh-ancestor
65570511|NCT01864109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65570512|NCT03767335|Trastuzumab|trastuzumab|mesh-list
65570513|NCT03767335|Fulvestrant|fulvestrant|mesh-list
65570514|NCT03767335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65570515|NCT03767335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570516|NCT03767335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65570517|NCT03767335|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65570518|NCT03767335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65570519|NCT03767335|Hormone Antagonists|hormone antagonists|mesh-ancestor
65570520|NCT03767335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65570521|NCT03767335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570522|NCT03426982|Heparin|heparin|mesh-list
65570523|NCT03426982|Calcium heparin|calcium heparin|mesh-list
65570524|NCT03426982|Anticoagulants|anticoagulants|mesh-ancestor
65570525|NCT03426982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65570526|NCT03426982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65570527|NCT03426982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570528|NCT01862315|Gemcitabine|gemcitabine|mesh-list
65570529|NCT01862315|Dexamethasone|dexamethasone|mesh-list
65570530|NCT01862315|Oxaliplatin|oxaliplatin|mesh-list
65570531|NCT01862315|Floxuridine|floxuridine|mesh-list
65570532|NCT01862315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65570533|NCT01862315|Antiemetics|antiemetics|mesh-ancestor
65570534|NCT01862315|Autonomic Agents|autonomic agents|mesh-ancestor
65570535|NCT01862315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65570536|NCT01862315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570537|NCT01862315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65570538|NCT01862315|Glucocorticoids|glucocorticoids|mesh-ancestor
65570539|NCT01862315|Hormones|hormones|mesh-ancestor
65570540|NCT01862315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65570541|NCT01862315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65570542|NCT01862315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570543|NCT01862315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65570544|NCT01862315|Antimetabolites|antimetabolites|mesh-ancestor
65570545|NCT01862315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570546|NCT01862315|Antiviral Agents|antiviral agents|mesh-ancestor
65570547|NCT01862315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65570548|NCT01862315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570549|NCT01862315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65570550|NCT01862315|Immunologic Factors|immunologic factors|mesh-ancestor
65570551|NCT01546948|Methadone|methadone|mesh-list
65570552|NCT01546948|Hydromorphone|hydromorphone|mesh-list
65570553|NCT01546948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65570554|NCT01546948|Narcotics|narcotics|mesh-ancestor
65570555|NCT01546948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65570556|NCT01546948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570557|NCT01546948|Analgesics|analgesics|mesh-ancestor
65570558|NCT01546948|Sensory System Agents|sensory system agents|mesh-ancestor
65570559|NCT01546948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65570560|NCT01546948|Antitussive Agents|antitussive agents|mesh-ancestor
65570561|NCT01546948|Respiratory System Agents|respiratory system agents|mesh-ancestor
65570562|NCT00458003|Phenylephrine|phenylephrine|mesh-list
65570563|NCT00458003|Oxymetazoline|oxymetazoline|mesh-list
65570564|NCT00458003|Ephedrine|ephedrine|mesh-list
65570565|NCT00458003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65570566|NCT00458003|Mydriatics|mydriatics|mesh-ancestor
65570567|NCT00458003|Autonomic Agents|autonomic agents|mesh-ancestor
65570568|NCT00458003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65570569|NCT00458003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570570|NCT00458003|Sympathomimetics|sympathomimetics|mesh-ancestor
65570571|NCT00458003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65570572|NCT00458003|Nasal Decongestants|nasal decongestants|mesh-ancestor
65570573|NCT00458003|Respiratory System Agents|respiratory system agents|mesh-ancestor
65570574|NCT00458003|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65248360|NCT00892008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65570575|NCT00458003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65570576|NCT00458003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65570577|NCT00458003|Adrenergic Agents|adrenergic agents|mesh-ancestor
65570578|NCT00458003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65570579|NCT00458003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570580|NCT00458003|Protective Agents|protective agents|mesh-ancestor
65570581|NCT00458003|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65570582|NCT04599972|Pilocarpine|pilocarpine|mesh-list
65570583|NCT04599972|Miotics|miotics|mesh-ancestor
65570584|NCT04599972|Autonomic Agents|autonomic agents|mesh-ancestor
65570585|NCT04599972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65570586|NCT04599972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570587|NCT04599972|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65570588|NCT04599972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65570589|NCT04599972|Cholinergic Agents|cholinergic agents|mesh-ancestor
65570590|NCT04599972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65570591|NCT04599972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570592|NCT03008616|Digoxin|digoxin|mesh-list
65368089|NCT05695027|Vitamins|vitamins|mesh-ancestor
65570593|NCT03008616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65570594|NCT03008616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65570595|NCT03008616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570596|NCT03008616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570597|NCT03008616|Protective Agents|protective agents|mesh-ancestor
65570598|NCT03008616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570599|NCT03422146|Tea Tree Oil|tea tree oil|mesh-list
65570600|NCT03422146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65570601|NCT03422146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65570602|NCT03426592|Vitamin D|vitamin d|mesh-list
65570603|NCT03426592|Cholecalciferol|cholecalciferol|mesh-list
65570604|NCT03426592|Vitamins|vitamins|mesh-ancestor
65570605|NCT03426592|Micronutrients|micronutrients|mesh-ancestor
65570606|NCT03426592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570607|NCT03426592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65570608|NCT03426592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65570609|NCT01567657|Midazolam|midazolam|mesh-list
65570610|NCT01567657|Meperidine|meperidine|mesh-list
65570611|NCT01567657|Propofol|propofol|mesh-list
65570612|NCT01567657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65570613|NCT01567657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65570614|NCT01567657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570615|NCT01567657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65570616|NCT01567657|Anesthetics, General|anesthetics, general|mesh-ancestor
65570617|NCT01567657|Anesthetics|anesthetics|mesh-ancestor
65570618|NCT01567657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65570619|NCT01567657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65570620|NCT01567657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65570621|NCT01567657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65570622|NCT01567657|GABA Modulators|gaba modulators|mesh-ancestor
65570623|NCT01567657|GABA Agents|gaba agents|mesh-ancestor
65570624|NCT01567657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65570625|NCT01567657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570626|NCT01567657|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65570627|NCT01567657|Narcotics|narcotics|mesh-ancestor
65570628|NCT01567657|Analgesics|analgesics|mesh-ancestor
65570629|NCT01567657|Sensory System Agents|sensory system agents|mesh-ancestor
65570630|NCT01567657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65570631|NCT03416062|Niacinamide|niacinamide|mesh-list
65570632|NCT03416062|Vitamin B Complex|vitamin b complex|mesh-ancestor
65570633|NCT03416062|Vitamins|vitamins|mesh-ancestor
65570634|NCT03416062|Micronutrients|micronutrients|mesh-ancestor
65570635|NCT03416062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570636|NCT03761485|Fluorides|fluorides|mesh-list
65570637|NCT03761485|Cariostatic Agents|cariostatic agents|mesh-ancestor
65570638|NCT03761485|Protective Agents|protective agents|mesh-ancestor
65570639|NCT03761485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570640|NCT03766867|Vortioxetine|vortioxetine|mesh-list
65570641|NCT03766867|Antidepressive Agents|antidepressive agents|mesh-ancestor
65570642|NCT03766867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65570643|NCT03766867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65570644|NCT03766867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65570645|NCT03766867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65570646|NCT03766867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570647|NCT03766867|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65570648|NCT03766867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65570649|NCT03766867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65570650|NCT03766867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570651|NCT03766867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65570652|NCT03766867|Serotonin Agents|serotonin agents|mesh-ancestor
65570653|NCT03766867|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65570654|NCT03766867|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65570655|NCT03766867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65570656|NCT03766867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65570657|NCT02061293|Diphenhydramine|diphenhydramine|mesh-list
65570658|NCT02061293|Promethazine|promethazine|mesh-list
65570659|NCT02061293|Psilocybin|psilocybin|mesh-list
65570660|NCT02061293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65570661|NCT02061293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65570662|NCT02061293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65570663|NCT02061293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570664|NCT02061293|Anesthetics, Local|anesthetics, local|mesh-ancestor
65570665|NCT02061293|Anesthetics|anesthetics|mesh-ancestor
65570666|NCT02061293|Sensory System Agents|sensory system agents|mesh-ancestor
65368167|NCT05613608|Cannabidiol|cannabidiol|mesh-list
65570667|NCT02061293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65570668|NCT02061293|Antiemetics|antiemetics|mesh-ancestor
65570669|NCT02061293|Autonomic Agents|autonomic agents|mesh-ancestor
65570670|NCT02061293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65570671|NCT02061293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65570672|NCT02061293|Histamine Antagonists|histamine antagonists|mesh-ancestor
65570673|NCT02061293|Histamine Agents|histamine agents|mesh-ancestor
65570674|NCT02061293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65570675|NCT02061293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570676|NCT02061293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65570677|NCT02061293|Antipruritics|antipruritics|mesh-ancestor
65570678|NCT02061293|Dermatologic Agents|dermatologic agents|mesh-ancestor
65570679|NCT02061293|Hallucinogens|hallucinogens|mesh-ancestor
65570680|NCT02061293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65570681|NCT03761329|Lidocaine|lidocaine|mesh-list
65570682|NCT03761329|Anesthetics|anesthetics|mesh-list
65570683|NCT03761329|Anesthetics, Local|anesthetics, local|mesh-ancestor
65570684|NCT03761329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65570685|NCT03761329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570686|NCT03761329|Sensory System Agents|sensory system agents|mesh-ancestor
65570687|NCT03761329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65570688|NCT03761329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65570689|NCT03761329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65570690|NCT03761329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65570691|NCT03761329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65570692|NCT03761329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570693|NCT03415906|Valsartan|valsartan|mesh-list
65570694|NCT03415906|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65570695|NCT03415906|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65570696|NCT03415906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65570697|NCT03415906|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65570698|NCT03415906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570699|NCT03415750|Mycophenolic Acid|mycophenolic acid|mesh-list
65570700|NCT03415750|Everolimus|everolimus|mesh-list
65570701|NCT03415750|Tacrolimus|tacrolimus|mesh-list
65570702|NCT03415750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65570703|NCT03415750|Immunologic Factors|immunologic factors|mesh-ancestor
65570704|NCT03415750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570705|NCT03415750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65570706|NCT03415750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570707|NCT03415750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570708|NCT03415750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570709|NCT03415750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65570710|NCT03415750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65570711|NCT03415750|Antitubercular Agents|antitubercular agents|mesh-ancestor
65570712|NCT03415750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65570713|NCT03415750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65570714|NCT01239719|Clemastine|clemastine|mesh-list
65570715|NCT01239719|Dexamethasone|dexamethasone|mesh-list
65570716|NCT01239719|Dexamethasone acetate|dexamethasone acetate|mesh-list
65570717|NCT01239719|BB 1101|bb 1101|mesh-list
65570718|NCT01239719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65570719|NCT01239719|Antiemetics|antiemetics|mesh-ancestor
65570720|NCT01239719|Autonomic Agents|autonomic agents|mesh-ancestor
65570721|NCT01239719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65570722|NCT01239719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570723|NCT01239719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65570724|NCT01239719|Glucocorticoids|glucocorticoids|mesh-ancestor
65570725|NCT01239719|Hormones|hormones|mesh-ancestor
65570726|NCT01239719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65570727|NCT01239719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65570728|NCT01239719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570729|NCT01239719|Protease Inhibitors|protease inhibitors|mesh-ancestor
65570730|NCT01239719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570731|NCT01239719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570732|NCT01239719|Antipruritics|antipruritics|mesh-ancestor
65570733|NCT01239719|Dermatologic Agents|dermatologic agents|mesh-ancestor
65570734|NCT01239719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65570735|NCT01239719|Histamine Antagonists|histamine antagonists|mesh-ancestor
65570736|NCT01239719|Histamine Agents|histamine agents|mesh-ancestor
65570737|NCT01239719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65570738|NCT01239719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65570739|NCT03916679|Cyclophosphamide|cyclophosphamide|mesh-list
65570740|NCT03916679|Fludarabine|fludarabine|mesh-list
65570741|NCT03916679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65570742|NCT03916679|Immunologic Factors|immunologic factors|mesh-ancestor
65570743|NCT03916679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570744|NCT03916679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65368249|NCT05476770|Cytarabine|cytarabine|mesh-list
65570745|NCT03916679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65570746|NCT03916679|Alkylating Agents|alkylating agents|mesh-ancestor
65570747|NCT03916679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570748|NCT03916679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570749|NCT03916679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65570750|NCT03421990|Anesthetics|anesthetics|mesh-list
65570751|NCT03421990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65570752|NCT03421990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570754|NCT02913612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65570755|NCT02913612|Maleic acid|maleic acid|mesh-list
65570756|NCT02913612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570757|NCT02913612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570758|NCT02913612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65570759|NCT02913612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65570760|NCT02913612|Adrenergic Agents|adrenergic agents|mesh-ancestor
65570761|NCT02913612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65570762|NCT02913612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570763|NCT02913612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65570764|NCT02913612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65570765|NCT03426202|Modafinil|modafinil|mesh-list
65570766|NCT03426202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65570767|NCT03426202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570768|NCT03426202|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65570769|NCT03426202|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65570770|NCT03426202|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65570771|NCT03426202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570772|NCT01248299|Cisplatin|cisplatin|mesh-list
65570773|NCT01248299|Docetaxel|docetaxel|mesh-list
65570774|NCT01248299|Oxaliplatin|oxaliplatin|mesh-list
65570775|NCT01248299|Fluorouracil|fluorouracil|mesh-list
65570776|NCT01248299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570777|NCT01248299|Tubulin Modulators|tubulin modulators|mesh-ancestor
65570778|NCT01248299|Antimitotic Agents|antimitotic agents|mesh-ancestor
65570779|NCT01248299|Mitosis Modulators|mitosis modulators|mesh-ancestor
65570780|NCT01248299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570781|NCT01248299|Antimetabolites|antimetabolites|mesh-ancestor
65570782|NCT01248299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65570783|NCT01248299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65570784|NCT01248299|Immunologic Factors|immunologic factors|mesh-ancestor
65570785|NCT01248299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570786|NCT01239875|Vaccines|vaccines|mesh-list
65570787|NCT01239875|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65570788|NCT01239875|Immunologic Factors|immunologic factors|mesh-ancestor
65570789|NCT01239875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570790|NCT03415594|Glucagon|glucagon|mesh-list
65570791|NCT03415594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65570792|NCT03415594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65570793|NCT03415594|Hormones|hormones|mesh-ancestor
65570794|NCT03415594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65570795|NCT03415594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570796|NCT03415594|Incretins|incretins|mesh-ancestor
65570797|NCT04219254|Pembrolizumab|pembrolizumab|mesh-list
65570798|NCT04219254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65570799|NCT04219254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570800|NCT01144169|Hydroxychloroquine|hydroxychloroquine|mesh-list
65570801|NCT01144169|Antimalarials|antimalarials|mesh-ancestor
65570802|NCT01144169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65570803|NCT01144169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65570804|NCT01144169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65570805|NCT01144169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570806|NCT01144169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570807|NCT01144169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65570808|NCT02709954|Ethanol|ethanol|mesh-list
65570809|NCT02709954|Dronabinol|dronabinol|mesh-list
65570810|NCT02709954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65570811|NCT02709954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65570812|NCT02709954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65570813|NCT02709954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570814|NCT02709954|Hallucinogens|hallucinogens|mesh-ancestor
65570815|NCT02709954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65570816|NCT02709954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65570817|NCT02709954|Analgesics|analgesics|mesh-ancestor
65570818|NCT02709954|Sensory System Agents|sensory system agents|mesh-ancestor
65368333|NCT05335928|Abatacept|abatacept|mesh-list
65570819|NCT02709954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65570820|NCT02709954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65570821|NCT02709954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65570822|NCT02709954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65570823|NCT02709954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570824|NCT02709954|Hormones|hormones|mesh-ancestor
65570825|NCT02709954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65570826|NCT03620838|Contraceptive Agents|contraceptive agents|mesh-list
65570827|NCT03620838|Contraceptives, Oral|contraceptives, oral|mesh-list
65570828|NCT03620838|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65570829|NCT03620838|Progesterone|progesterone|mesh-list
65570830|NCT03620838|Progestins|progestins|mesh-ancestor
65570831|NCT03620838|Hormones|hormones|mesh-ancestor
65570832|NCT03620838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65570833|NCT03620838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570834|NCT03620838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65570835|NCT03620838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65570836|NCT01239953|Paclitaxel|paclitaxel|mesh-list
65570837|NCT01239953|Everolimus|everolimus|mesh-list
65570838|NCT01239953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65570839|NCT01239953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570840|NCT01239953|Tubulin Modulators|tubulin modulators|mesh-ancestor
65570841|NCT01239953|Antimitotic Agents|antimitotic agents|mesh-ancestor
65570842|NCT01239953|Mitosis Modulators|mitosis modulators|mesh-ancestor
65570843|NCT01239953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570844|NCT01239953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65570845|NCT01239953|Immunologic Factors|immunologic factors|mesh-ancestor
65570846|NCT01239953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570847|NCT01322191|Morphine|morphine|mesh-list
65570848|NCT01322191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65570849|NCT01322191|Narcotics|narcotics|mesh-ancestor
65570850|NCT01322191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65570851|NCT01322191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570852|NCT01322191|Analgesics|analgesics|mesh-ancestor
65570853|NCT01322191|Sensory System Agents|sensory system agents|mesh-ancestor
65570854|NCT01322191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65570855|NCT03620760|Aspirin|aspirin|mesh-list
65570856|NCT03620760|Ticagrelor|ticagrelor|mesh-list
65570857|NCT03620760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65570858|NCT03620760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65570859|NCT03620760|Analgesics|analgesics|mesh-ancestor
65570860|NCT03620760|Sensory System Agents|sensory system agents|mesh-ancestor
65570861|NCT03620760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65570862|NCT03620760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570863|NCT03620760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65570864|NCT03620760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65570865|NCT03620760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65570866|NCT03620760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65570867|NCT03620760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570868|NCT03620760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65570869|NCT03620760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65570870|NCT03620760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570871|NCT03620760|Antipyretics|antipyretics|mesh-ancestor
65570872|NCT03620760|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65570873|NCT03620760|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65570874|NCT03620760|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65570875|NCT03620760|Purinergic Agents|purinergic agents|mesh-ancestor
65570876|NCT03620760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65570877|NCT03765931|Amoxicillin|amoxicillin|mesh-list
65570878|NCT03765931|Doxycycline|doxycycline|mesh-list
65570879|NCT03765931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65570880|NCT03765931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65570881|NCT03765931|Antimalarials|antimalarials|mesh-ancestor
65570882|NCT03765931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65570883|NCT03765931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65570884|NCT01240265|Vitamin D|vitamin d|mesh-list
65570885|NCT01240265|Ergocalciferols|ergocalciferols|mesh-list
65570886|NCT01240265|Cholecalciferol|cholecalciferol|mesh-list
65570887|NCT01240265|Vitamins|vitamins|mesh-list
65570888|NCT01240265|Micronutrients|micronutrients|mesh-ancestor
65570889|NCT01240265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368396|NCT05260008|Autonomic Agents|autonomic agents|mesh-ancestor
65570890|NCT01240265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65570891|NCT01240265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65570892|NCT02327455|Dobutamine|dobutamine|mesh-list
65570893|NCT02327455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65570895|NCT02327455|Autonomic Agents|autonomic agents|mesh-ancestor
65570896|NCT02327455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65570897|NCT02327455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570898|NCT02327455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65570899|NCT02327455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65570900|NCT02327455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65570901|NCT02327455|Adrenergic Agents|adrenergic agents|mesh-ancestor
65570902|NCT02327455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65570903|NCT02327455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570904|NCT02327455|Protective Agents|protective agents|mesh-ancestor
65570905|NCT03638076|Ritonavir|ritonavir|mesh-list
65570906|NCT03638076|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65570907|NCT03638076|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65570908|NCT03638076|Protease Inhibitors|protease inhibitors|mesh-ancestor
65570909|NCT03638076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570910|NCT03638076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570911|NCT03638076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65570912|NCT03638076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65570913|NCT03638076|Antiviral Agents|antiviral agents|mesh-ancestor
65570914|NCT03638076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65570915|NCT03638076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65570916|NCT03638076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65570917|NCT01329731|Olaflur|olaflur|mesh-list
65570918|NCT01329731|Cariostatic Agents|cariostatic agents|mesh-ancestor
65570919|NCT01329731|Protective Agents|protective agents|mesh-ancestor
65570920|NCT01329731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570921|NCT03765697|Lidocaine|lidocaine|mesh-list
65570922|NCT03765697|Anesthetics, Local|anesthetics, local|mesh-ancestor
65570923|NCT03765697|Anesthetics|anesthetics|mesh-ancestor
65570924|NCT03765697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65570925|NCT03765697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570926|NCT03765697|Sensory System Agents|sensory system agents|mesh-ancestor
65570927|NCT03765697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65570928|NCT03765697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65570929|NCT03765697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65570930|NCT03765697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65570931|NCT03765697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65570932|NCT03765697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570933|NCT03311841|Rifampin|rifampin|mesh-list
65570934|NCT03311841|Midazolam|midazolam|mesh-list
65570935|NCT03311841|Dabigatran|dabigatran|mesh-list
65570936|NCT03311841|Atorvastatin|atorvastatin|mesh-list
65570937|NCT03311841|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65570938|NCT03311841|Pitavastatin|pitavastatin|mesh-list
65570939|NCT03311841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65570940|NCT03311841|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65570941|NCT03311841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65570942|NCT03311841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65570943|NCT03311841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570944|NCT03311841|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65570945|NCT03311841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65570946|NCT03311841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65570947|NCT03311841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65570948|NCT03311841|Anesthetics, General|anesthetics, general|mesh-ancestor
65570949|NCT03311841|Anesthetics|anesthetics|mesh-ancestor
65570950|NCT03311841|GABA Modulators|gaba modulators|mesh-ancestor
65570951|NCT03311841|GABA Agents|gaba agents|mesh-ancestor
65570952|NCT03311841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65570953|NCT03311841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570954|NCT03311841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65570955|NCT03311841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65570956|NCT03311841|Antimetabolites|antimetabolites|mesh-ancestor
65570957|NCT03311841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65570958|NCT03311841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65570959|NCT03311841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570960|NCT03311841|Antithrombins|antithrombins|mesh-ancestor
65570961|NCT03311841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65570962|NCT03311841|Protease Inhibitors|protease inhibitors|mesh-ancestor
65570963|NCT03311841|Anticoagulants|anticoagulants|mesh-ancestor
65570964|NCT03311841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65570965|NCT03311841|Antitubercular Agents|antitubercular agents|mesh-ancestor
65570966|NCT03311841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65570967|NCT03311841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65570968|NCT03311841|Leprostatic Agents|leprostatic agents|mesh-ancestor
65570969|NCT03311841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65570970|NCT03311841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65570971|NCT03311841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65570972|NCT03311841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65570973|NCT03311841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65570974|NCT03311841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65570975|NCT03311841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65570976|NCT02115295|Cytarabine|cytarabine|mesh-list
65570977|NCT02115295|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
65570978|NCT02115295|Venetoclax|venetoclax|mesh-list
65570979|NCT02115295|Idarubicin|idarubicin|mesh-list
65570980|NCT02115295|Cladribine|cladribine|mesh-list
65570981|NCT02115295|Midostaurin|midostaurin|mesh-list
65570982|NCT02115295|Staurosporine|staurosporine|mesh-list
65570983|NCT02115295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65570984|NCT02115295|Antimetabolites|antimetabolites|mesh-ancestor
65570985|NCT02115295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65570986|NCT02115295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65570987|NCT02115295|Antiviral Agents|antiviral agents|mesh-ancestor
65570988|NCT02115295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65570989|NCT02115295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65570990|NCT02115295|Immunologic Factors|immunologic factors|mesh-ancestor
65570991|NCT02115295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65570992|NCT02115295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65570993|NCT02115295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65570994|NCT02115295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65570995|NCT02115295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65570996|NCT02115295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65570997|NCT01249937|Triamcinolone|triamcinolone|mesh-list
65570998|NCT01249937|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65570999|NCT01249937|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65571000|NCT01249937|Ranibizumab|ranibizumab|mesh-list
65571001|NCT01249937|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65571002|NCT01249937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65571003|NCT01249937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65571004|NCT01249937|Growth Substances|growth substances|mesh-ancestor
65571005|NCT01249937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571006|NCT01249937|Growth Inhibitors|growth inhibitors|mesh-ancestor
65571007|NCT01249937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571008|NCT01249937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65571009|NCT01249937|Glucocorticoids|glucocorticoids|mesh-ancestor
65571010|NCT01249937|Hormones|hormones|mesh-ancestor
65571011|NCT01249937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65571012|NCT01249937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65571013|NCT01249937|Immunologic Factors|immunologic factors|mesh-ancestor
65571014|NCT01249937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571015|NCT01249937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571016|NCT02528201|Celecoxib|celecoxib|mesh-list
65571017|NCT02528201|Diclofenac|diclofenac|mesh-list
65571018|NCT02528201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65571019|NCT02528201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65571020|NCT02528201|Analgesics|analgesics|mesh-ancestor
65571021|NCT02528201|Sensory System Agents|sensory system agents|mesh-ancestor
65571022|NCT02528201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571023|NCT02528201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571024|NCT02528201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65571025|NCT02528201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65571026|NCT02528201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65571027|NCT02528201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65571028|NCT02528201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571029|NCT02528201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571030|NCT03758677|Gemcitabine|gemcitabine|mesh-list
65571031|NCT03758677|Docetaxel|docetaxel|mesh-list
65571032|NCT03758677|Pemetrexed|pemetrexed|mesh-list
65571033|NCT03758677|Apatinib|apatinib|mesh-list
65571034|NCT03758677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65571035|NCT03758677|Antimetabolites|antimetabolites|mesh-ancestor
65571036|NCT03758677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571037|NCT03758677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571038|NCT03758677|Antiviral Agents|antiviral agents|mesh-ancestor
65571039|NCT03758677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65571040|NCT03758677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571041|NCT03758677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65571042|NCT03758677|Immunologic Factors|immunologic factors|mesh-ancestor
65571043|NCT03758677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571044|NCT03758677|Tubulin Modulators|tubulin modulators|mesh-ancestor
65571045|NCT03758677|Antimitotic Agents|antimitotic agents|mesh-ancestor
65571046|NCT03758677|Mitosis Modulators|mitosis modulators|mesh-ancestor
65571047|NCT03758677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65571048|NCT03758677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65571049|NCT03758677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65571050|NCT03764683|Suvorexant|suvorexant|mesh-list
65571051|NCT03764683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65571052|NCT03764683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65571053|NCT03764683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65571054|NCT03764683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571055|NCT03764683|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65571056|NCT03764683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65571057|NCT03764683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571058|NCT03414892|Globalagliatin|globalagliatin|mesh-list
65571059|NCT03414892|Enzyme Activators|enzyme activators|mesh-ancestor
65571060|NCT03414892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571061|NCT01242605|Gemcitabine|gemcitabine|mesh-list
65571062|NCT01242605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571063|NCT01242605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65571064|NCT01242605|Antimetabolites|antimetabolites|mesh-ancestor
65571065|NCT01242605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571066|NCT01242605|Antiviral Agents|antiviral agents|mesh-ancestor
65571067|NCT01242605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65571068|NCT01242605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571069|NCT01242605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65571070|NCT01242605|Immunologic Factors|immunologic factors|mesh-ancestor
65571071|NCT01242605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571072|NCT03414814|Osimertinib|osimertinib|mesh-list
65571073|NCT03414814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571074|NCT03414814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65571075|NCT03414814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571076|NCT03414814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571077|NCT03421366|Posaconazole|posaconazole|mesh-list
65571078|NCT03421366|Antifungal Agents|antifungal agents|mesh-ancestor
65571079|NCT03421366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65571080|NCT03421366|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65571081|NCT03421366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65571082|NCT03421366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65571083|NCT03421366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65571084|NCT03421366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65571085|NCT03421366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571086|NCT03421366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571087|NCT03421366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65571088|NCT03421366|Hormone Antagonists|hormone antagonists|mesh-ancestor
65571089|NCT03421366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65571090|NCT03421366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571091|NCT03764605|Metformin|metformin|mesh-list
65571092|NCT03764605|Tolvaptan|tolvaptan|mesh-list
65571093|NCT03764605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65571094|NCT03764605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571095|NCT03764605|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65571096|NCT03764605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571097|NCT03764605|Natriuretic Agents|natriuretic agents|mesh-ancestor
65571098|NCT03764527|Artesunate|artesunate|mesh-list
65571099|NCT03764527|Lumefantrine|lumefantrine|mesh-list
65571100|NCT03764527|Artemether|artemether|mesh-list
65571101|NCT03764527|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65571102|NCT03764527|Amodiaquine|amodiaquine|mesh-list
65571103|NCT03764527|Antimalarials|antimalarials|mesh-ancestor
65571104|NCT03764527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65571105|NCT03764527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65571106|NCT03764527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65571107|NCT03764527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571108|NCT03764527|Antiviral Agents|antiviral agents|mesh-ancestor
65571109|NCT03764527|Schistosomicides|schistosomicides|mesh-ancestor
65571110|NCT03764527|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65571111|NCT03764527|Anthelmintics|anthelmintics|mesh-ancestor
65571112|NCT01321801|Pregabalin|pregabalin|mesh-list
65571113|NCT01321801|Analgesics|analgesics|mesh-ancestor
65571114|NCT01321801|Sensory System Agents|sensory system agents|mesh-ancestor
65571115|NCT01321801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571116|NCT01321801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571117|NCT01321801|Anticonvulsants|anticonvulsants|mesh-ancestor
65571118|NCT01321801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65368608|NCT04976855|Narcotics|narcotics|mesh-ancestor
65571119|NCT01321801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65571120|NCT01321801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571121|NCT01321801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65571122|NCT01321801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65571123|NCT01321801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65571124|NCT01321801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65571125|NCT01321801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65571126|NCT01155375|Ferrous fumarate|ferrous fumarate|mesh-list
65571127|NCT01155375|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65571128|NCT01155375|Hematinics|hematinics|mesh-ancestor
65571129|NCT01155375|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65571130|NCT01155375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65571131|NCT01155375|Trace Elements|trace elements|mesh-ancestor
65571132|NCT01155375|Micronutrients|micronutrients|mesh-ancestor
65571133|NCT01155375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571134|NCT03759301|Cetrorelix|cetrorelix|mesh-list
65571135|NCT03759301|Hormones|hormones|mesh-list
65571136|NCT03759301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65571137|NCT03759301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571138|NCT03759301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65571139|NCT03759301|Fertility Agents|fertility agents|mesh-ancestor
65571140|NCT03759301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65571141|NCT03759301|Hormone Antagonists|hormone antagonists|mesh-ancestor
65571142|NCT03764059|Chlorhexidine|chlorhexidine|mesh-list
65571143|NCT03764059|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65571144|NCT03764059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65571145|NCT03764059|Disinfectants|disinfectants|mesh-ancestor
65571146|NCT02260102|Temocillin|temocillin|mesh-list
65571147|NCT02260102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65571148|NCT02260102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65571149|NCT03425734|Dexmedetomidine|dexmedetomidine|mesh-list
65571150|NCT03425734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65571151|NCT03425734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65571152|NCT03425734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571153|NCT03425734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65571154|NCT03425734|Analgesics|analgesics|mesh-ancestor
65571155|NCT03425734|Sensory System Agents|sensory system agents|mesh-ancestor
65571156|NCT03425734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571157|NCT03425734|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65571158|NCT03425734|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65571159|NCT03425734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65571160|NCT03425734|Adrenergic Agents|adrenergic agents|mesh-ancestor
65571161|NCT03425734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65571162|NCT03425734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571163|NCT03420586|Nitrous Oxide|nitrous oxide|mesh-list
65571164|NCT03420586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65571165|NCT03420586|Anesthetics, General|anesthetics, general|mesh-ancestor
65571166|NCT03420586|Anesthetics|anesthetics|mesh-ancestor
65571167|NCT03420586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65571168|NCT03420586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571169|NCT03420586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65571170|NCT03420586|Analgesics|analgesics|mesh-ancestor
65571171|NCT03420586|Sensory System Agents|sensory system agents|mesh-ancestor
65571172|NCT03420586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571173|NCT03759067|Clopidogrel|clopidogrel|mesh-list
65571174|NCT03759067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65571175|NCT03759067|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65571176|NCT03759067|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65571177|NCT03759067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65571178|NCT03759067|Purinergic Agents|purinergic agents|mesh-ancestor
65571179|NCT03759067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65571180|NCT03759067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571181|NCT03759067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571182|NCT03425656|Cyclophosphamide|cyclophosphamide|mesh-list
65571183|NCT03425656|Docetaxel|docetaxel|mesh-list
65571184|NCT03425656|Doxorubicin|doxorubicin|mesh-list
65571185|NCT03425656|Trastuzumab|trastuzumab|mesh-list
65571186|NCT03425656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65571187|NCT03425656|Immunologic Factors|immunologic factors|mesh-ancestor
65571188|NCT03425656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571189|NCT03425656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65571190|NCT03425656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65571191|NCT03425656|Alkylating Agents|alkylating agents|mesh-ancestor
65571192|NCT03425656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571194|NCT03425656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65571195|NCT03425656|Tubulin Modulators|tubulin modulators|mesh-ancestor
65571196|NCT03425656|Antimitotic Agents|antimitotic agents|mesh-ancestor
65571197|NCT03425656|Mitosis Modulators|mitosis modulators|mesh-ancestor
65571198|NCT03425656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65571199|NCT03425656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65571200|NCT03425656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65571201|NCT03425656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571202|NCT03425656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65571203|NCT03413722|Everolimus|everolimus|mesh-list
65571204|NCT03413722|Tacrolimus|tacrolimus|mesh-list
65571205|NCT03413722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65571206|NCT03413722|Immunologic Factors|immunologic factors|mesh-ancestor
65571207|NCT03413722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571208|NCT03413722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65571209|NCT03413722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571210|NCT03413722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571211|NCT03413722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571212|NCT04843462|Esketamine|esketamine|mesh-list
65571213|NCT04843462|Antidepressive Agents|antidepressive agents|mesh-ancestor
65571214|NCT04843462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65571215|NCT03420040|Insulin Glargine|insulin glargine|mesh-list
65571216|NCT03420040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65571217|NCT03420040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571218|NCT03413410|Metoprolol|metoprolol|mesh-list
65571219|NCT03413410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65571220|NCT03413410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65571221|NCT03413410|Sympatholytics|sympatholytics|mesh-ancestor
65571222|NCT03413410|Autonomic Agents|autonomic agents|mesh-ancestor
65571223|NCT03413410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571224|NCT03413410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571225|NCT03413410|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65571226|NCT03413410|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65571227|NCT03413410|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65571228|NCT03413410|Adrenergic Agents|adrenergic agents|mesh-ancestor
65571229|NCT03413410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65571230|NCT03413410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571231|NCT03419806|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65571232|NCT03419806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65571233|NCT03419806|Immunologic Factors|immunologic factors|mesh-ancestor
65571234|NCT03419806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571235|NCT03419806|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65571236|NCT03419806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65571237|NCT03419806|Dopamine Agonists|dopamine agonists|mesh-ancestor
65571238|NCT03419806|Dopamine Agents|dopamine agents|mesh-ancestor
65571239|NCT03419806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65571240|NCT03419806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571241|NCT03424876|Sunitinib|sunitinib|mesh-list
65571242|NCT03424876|Imatinib Mesylate|imatinib mesylate|mesh-list
65571243|NCT03424876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571244|NCT03424876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65571245|NCT03424876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65571246|NCT03424876|Growth Substances|growth substances|mesh-ancestor
65571247|NCT03424876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571248|NCT03424876|Growth Inhibitors|growth inhibitors|mesh-ancestor
65571249|NCT03424876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65571250|NCT03424876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571251|NCT03424876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571252|NCT03476577|Ibuprofen|ibuprofen|mesh-list
65571253|NCT03476577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65571254|NCT03476577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65571255|NCT03476577|Analgesics|analgesics|mesh-ancestor
65571256|NCT03476577|Sensory System Agents|sensory system agents|mesh-ancestor
65571257|NCT03476577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571258|NCT03476577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571259|NCT03476577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65571260|NCT03476577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65571261|NCT03476577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65571262|NCT03476577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571263|NCT03476577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571264|NCT03419650|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65571265|NCT03419650|Hormones|hormones|mesh-ancestor
65368759|NCT04671875|Antibodies|antibodies|mesh-list
65571266|NCT03419650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65571267|NCT03419650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571268|NCT04893915|Cyclophosphamide|cyclophosphamide|mesh-list
65571269|NCT04893915|Fludarabine|fludarabine|mesh-list
65571270|NCT04893915|Interleukin-2|interleukin-2|mesh-list
65571271|NCT04893915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65571272|NCT04893915|Immunologic Factors|immunologic factors|mesh-ancestor
65571273|NCT04893915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571274|NCT04893915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65571275|NCT04893915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65571276|NCT04893915|Alkylating Agents|alkylating agents|mesh-ancestor
65571277|NCT04893915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571278|NCT04893915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571279|NCT04893915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65571280|NCT04893915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65571281|NCT04893915|Analgesics|analgesics|mesh-ancestor
65571282|NCT04893915|Sensory System Agents|sensory system agents|mesh-ancestor
65571283|NCT04893915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571284|NCT03419494|Doxorubicin|doxorubicin|mesh-list
65571285|NCT03419494|Daunorubicin|daunorubicin|mesh-list
65571286|NCT03419494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65571287|NCT03419494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65571288|NCT03419494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571289|NCT03419494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65571290|NCT03419494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65571291|NCT03419494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571292|NCT03419494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571293|NCT03413020|Amoxicillin|amoxicillin|mesh-list
65571294|NCT03413020|Metronidazole|metronidazole|mesh-list
65571295|NCT03413020|Clarithromycin|clarithromycin|mesh-list
65571296|NCT03413020|Levofloxacin|levofloxacin|mesh-list
65571297|NCT03413020|Ofloxacin|ofloxacin|mesh-list
65571298|NCT03413020|Potassium Citrate|potassium citrate|mesh-list
65571299|NCT03413020|Esomeprazole|esomeprazole|mesh-list
65571300|NCT03413020|Bismuth|bismuth|mesh-list
65571301|NCT03413020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571302|NCT03413020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65571303|NCT03413020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65571304|NCT03413020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65571305|NCT03413020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65571306|NCT03413020|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65571307|NCT03413020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65571308|NCT03413020|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65571309|NCT03413020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571310|NCT03413020|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65571311|NCT03413020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65571312|NCT03413020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65571313|NCT03413020|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65571314|NCT03413020|Renal Agents|renal agents|mesh-ancestor
65571315|NCT03413020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65571316|NCT03413020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65571317|NCT03413020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571318|NCT03413020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65571319|NCT03413020|Antacids|antacids|mesh-ancestor
65571320|NCT03413020|Diuretics|diuretics|mesh-ancestor
65571321|NCT03413020|Natriuretic Agents|natriuretic agents|mesh-ancestor
65571322|NCT03413020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571323|NCT03413020|Expectorants|expectorants|mesh-ancestor
65571324|NCT03413020|Respiratory System Agents|respiratory system agents|mesh-ancestor
65571325|NCT03424408|Aspirin|aspirin|mesh-list
65571326|NCT03424408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65571327|NCT03424408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65571328|NCT03424408|Analgesics|analgesics|mesh-ancestor
65571329|NCT03424408|Sensory System Agents|sensory system agents|mesh-ancestor
65571330|NCT03424408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571331|NCT03424408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571332|NCT03424408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65571333|NCT03424408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65571334|NCT03424408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65571335|NCT03424408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65571336|NCT03424408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571337|NCT03424408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65571338|NCT03424408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65571339|NCT03424408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571340|NCT03424408|Antipyretics|antipyretics|mesh-ancestor
65571341|NCT03305055|Fentanyl|fentanyl|mesh-list
65571342|NCT03305055|Ketamine|ketamine|mesh-list
65571343|NCT03305055|Analgesics|analgesics|mesh-ancestor
65571344|NCT03305055|Sensory System Agents|sensory system agents|mesh-ancestor
65571345|NCT03305055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571346|NCT03305055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571347|NCT03305055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65571348|NCT03305055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65571349|NCT03305055|Anesthetics, General|anesthetics, general|mesh-ancestor
65571350|NCT03305055|Anesthetics|anesthetics|mesh-ancestor
65571351|NCT03305055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65571352|NCT03305055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65571353|NCT03305055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65571354|NCT03305055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65571355|NCT03305055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571356|NCT03305055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65571357|NCT03305055|Narcotics|narcotics|mesh-ancestor
65571358|NCT03305055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65571359|NCT04547985|Naltrexone|naltrexone|mesh-list
65571360|NCT04547985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65571361|NCT04547985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65571362|NCT04547985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571363|NCT04547985|Sensory System Agents|sensory system agents|mesh-ancestor
65571364|NCT04547985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571365|NCT03412552|Magnesium Sulfate|magnesium sulfate|mesh-list
65571366|NCT03412552|Analgesics|analgesics|mesh-ancestor
65571367|NCT03412552|Sensory System Agents|sensory system agents|mesh-ancestor
65571368|NCT03412552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571369|NCT03412552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571370|NCT03412552|Anesthetics|anesthetics|mesh-ancestor
65571371|NCT03412552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65571372|NCT03412552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65571373|NCT03412552|Anticonvulsants|anticonvulsants|mesh-ancestor
65571374|NCT03412552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65571375|NCT03412552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65571376|NCT03412552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571377|NCT03412552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65571378|NCT03412552|Tocolytic Agents|tocolytic agents|mesh-ancestor
65571379|NCT03412552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65571380|NCT03412474|Acetaminophen|acetaminophen|mesh-list
65571381|NCT03412474|Dexmedetomidine|dexmedetomidine|mesh-list
65571382|NCT03412474|Bupivacaine|bupivacaine|mesh-list
65571383|NCT03412474|Anesthetics, Local|anesthetics, local|mesh-ancestor
65571384|NCT03412474|Anesthetics|anesthetics|mesh-ancestor
65571385|NCT03412474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65571386|NCT03412474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571387|NCT03412474|Sensory System Agents|sensory system agents|mesh-ancestor
65571388|NCT03412474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571389|NCT03412474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65571390|NCT03412474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65571391|NCT03412474|Analgesics|analgesics|mesh-ancestor
65571392|NCT03412474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65571393|NCT03412474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65571394|NCT03412474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65571395|NCT03412474|Adrenergic Agents|adrenergic agents|mesh-ancestor
65571396|NCT03412474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65571397|NCT03412474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571398|NCT03412474|Antipyretics|antipyretics|mesh-ancestor
65571399|NCT03273387|Trimetazidine|trimetazidine|mesh-list
65571400|NCT03273387|Vasodilator Agents|vasodilator agents|mesh-ancestor
65571401|NCT04527003|Cannabidiol|cannabidiol|mesh-list
65571402|NCT04527003|Norethindrone|norethindrone|mesh-list
65571403|NCT04527003|Norethindrone Acetate|norethindrone acetate|mesh-list
65571404|NCT04527003|Anticonvulsants|anticonvulsants|mesh-ancestor
65571405|NCT04527003|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65571406|NCT04527003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65571407|NCT04527003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65571408|NCT04527003|Contraceptive Agents|contraceptive agents|mesh-ancestor
65571409|NCT04527003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65571410|NCT04527003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571411|NCT04527003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65571412|NCT04527003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65571413|NCT04447612|Gemcitabine|gemcitabine|mesh-list
65571414|NCT04447612|Durvalumab|durvalumab|mesh-list
65571415|NCT04447612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571416|NCT04447612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65571417|NCT04447612|Antimetabolites|antimetabolites|mesh-ancestor
65571418|NCT04447612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571419|NCT04447612|Antiviral Agents|antiviral agents|mesh-ancestor
65571420|NCT04447612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65571421|NCT04447612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571422|NCT04447612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65571423|NCT04447612|Immunologic Factors|immunologic factors|mesh-ancestor
65571424|NCT04447612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571425|NCT04447612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65571426|NCT03418558|Trastuzumab|trastuzumab|mesh-list
65571427|NCT03418558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65571428|NCT03418558|Maytansine|maytansine|mesh-list
65571429|NCT03418558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65571430|NCT03418558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571431|NCT03418558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65571432|NCT03418558|Tubulin Modulators|tubulin modulators|mesh-ancestor
65571433|NCT03418558|Antimitotic Agents|antimitotic agents|mesh-ancestor
65571434|NCT03418558|Mitosis Modulators|mitosis modulators|mesh-ancestor
65571435|NCT03418558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571436|NCT05170828|Mycophenolic Acid|mycophenolic acid|mesh-list
65571437|NCT05170828|Sirolimus|sirolimus|mesh-list
65571438|NCT05170828|Cyclophosphamide|cyclophosphamide|mesh-list
65571439|NCT05170828|Busulfan|busulfan|mesh-list
65571440|NCT05170828|Fludarabine|fludarabine|mesh-list
65571441|NCT05170828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65571442|NCT05170828|Immunologic Factors|immunologic factors|mesh-ancestor
65571443|NCT05170828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571444|NCT05170828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65571445|NCT05170828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65571446|NCT05170828|Alkylating Agents|alkylating agents|mesh-ancestor
65571447|NCT05170828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571448|NCT05170828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571449|NCT05170828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65571450|NCT05170828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65571451|NCT05170828|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65571452|NCT05170828|Antitubercular Agents|antitubercular agents|mesh-ancestor
65571453|NCT05170828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65571454|NCT05170828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65571455|NCT05170828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571456|NCT05170828|Antifungal Agents|antifungal agents|mesh-ancestor
65571457|NCT03412006|Fulacimstat|fulacimstat|mesh-list
65571458|NCT03412006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571459|NCT03412006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571460|NCT03418246|Calcium|calcium|mesh-list
65571461|NCT03418246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65571462|NCT03418246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571463|NCT03411850|Abatacept|abatacept|mesh-list
65571464|NCT03411850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65571465|NCT03411850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571466|NCT03411850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571467|NCT03411850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65571468|NCT03411850|Immunologic Factors|immunologic factors|mesh-ancestor
65571469|NCT03411850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571470|NCT03411850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65571471|NCT05170594|Bevacizumab|bevacizumab|mesh-list
65571472|NCT05170594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
65571473|NCT05170594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65571474|NCT05170594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571475|NCT05170594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65571476|NCT05170594|Growth Substances|growth substances|mesh-ancestor
65571477|NCT05170594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571478|NCT05170594|Growth Inhibitors|growth inhibitors|mesh-ancestor
65571479|NCT03410836|Lidocaine|lidocaine|mesh-list
65571480|NCT03410836|Anesthetics, Local|anesthetics, local|mesh-ancestor
65571481|NCT03410836|Anesthetics|anesthetics|mesh-ancestor
65571482|NCT03410836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65571483|NCT03410836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571484|NCT03410836|Sensory System Agents|sensory system agents|mesh-ancestor
65571485|NCT03410836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571486|NCT03410836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65571487|NCT03410836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65571488|NCT03410836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65571489|NCT03410836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65571490|NCT03410836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571491|NCT03273153|Pembrolizumab|pembrolizumab|mesh-list
65571492|NCT03273153|Atezolizumab|atezolizumab|mesh-list
65571493|NCT03273153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65571494|NCT03273153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571495|NCT03418090|Xenon|xenon|mesh-list
65571496|NCT03418090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65571497|NCT03418090|Anesthetics, General|anesthetics, general|mesh-ancestor
65571498|NCT03418090|Anesthetics|anesthetics|mesh-ancestor
65571499|NCT03418090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65571500|NCT03418090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571501|NCT03323034|Irinotecan|irinotecan|mesh-list
65571502|NCT03323034|Temozolomide|temozolomide|mesh-list
65571503|NCT03323034|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65571504|NCT03323034|Pevonedistat|pevonedistat|mesh-list
65571505|NCT03323034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65571506|NCT03323034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65571507|NCT03323034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571508|NCT03323034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571509|NCT03323034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65571510|NCT03323034|Alkylating Agents|alkylating agents|mesh-ancestor
65571511|NCT02520934|Miglustat|miglustat|mesh-list
65571512|NCT02520934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571513|NCT02520934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571514|NCT02520934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65571515|NCT02520934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65571516|NCT02520934|Antiviral Agents|antiviral agents|mesh-ancestor
65571517|NCT02520934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65571518|NCT02520934|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65571519|NCT02520934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65571520|NCT02520934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571521|NCT02749968|Bupivacaine|bupivacaine|mesh-list
65571522|NCT02749968|Anesthetics, Local|anesthetics, local|mesh-ancestor
65571523|NCT02749968|Anesthetics|anesthetics|mesh-ancestor
65571524|NCT02749968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65571525|NCT02749968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571526|NCT02749968|Sensory System Agents|sensory system agents|mesh-ancestor
65571527|NCT02749968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571528|NCT04787250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65571529|NCT04787250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65571530|NCT04787250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65571531|NCT04787250|Antitubercular Agents|antitubercular agents|mesh-ancestor
65571532|NCT03417700|Vitamin D|vitamin d|mesh-list
65571533|NCT03417700|Vitamins|vitamins|mesh-ancestor
65571534|NCT03417700|Micronutrients|micronutrients|mesh-ancestor
65571535|NCT03417700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571536|NCT03417700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65571537|NCT03410524|Simethicone|simethicone|mesh-list
65571538|NCT03410524|Antifoaming Agents|antifoaming agents|mesh-ancestor
65571539|NCT03410524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571540|NCT03410524|Emollients|emollients|mesh-ancestor
65571541|NCT03410524|Dermatologic Agents|dermatologic agents|mesh-ancestor
65571542|NCT02713776|Pasireotide|pasireotide|mesh-list
65571543|NCT02713776|Somatostatin|somatostatin|mesh-list
65571544|NCT02713776|Hormones|hormones|mesh-ancestor
65571545|NCT02713776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65571546|NCT02713776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571547|NCT05215990|Metformin|metformin|mesh-list
65571548|NCT05215990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65571549|NCT05215990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571550|NCT03268941|Metoclopramide|metoclopramide|mesh-list
65571551|NCT03268941|Maleic acid|maleic acid|mesh-list
65571552|NCT03268941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571553|NCT03268941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571554|NCT03268941|Antiemetics|antiemetics|mesh-ancestor
65571555|NCT03268941|Autonomic Agents|autonomic agents|mesh-ancestor
65571556|NCT03268941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571557|NCT03268941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571558|NCT03268941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65571559|NCT03268941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65571560|NCT03268941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65571561|NCT03268941|Dopamine Agents|dopamine agents|mesh-ancestor
65571562|NCT03268941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65571563|NCT05215834|Remifentanil|remifentanil|mesh-list
65571564|NCT05215834|Propofol|propofol|mesh-list
65571565|NCT05215834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65571566|NCT05215834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65571567|NCT05215834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571568|NCT05215834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65571569|NCT05215834|Anesthetics, General|anesthetics, general|mesh-ancestor
65571570|NCT05215834|Anesthetics|anesthetics|mesh-ancestor
65571571|NCT05215834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65571572|NCT05215834|Narcotics|narcotics|mesh-ancestor
65571573|NCT05215834|Analgesics|analgesics|mesh-ancestor
65571574|NCT05215834|Sensory System Agents|sensory system agents|mesh-ancestor
65571575|NCT05215834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571576|NCT03394144|Durvalumab|durvalumab|mesh-list
65571577|NCT03394144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65571578|NCT03394144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571579|NCT05011149|Ibuprofen|ibuprofen|mesh-list
65571580|NCT05011149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65571581|NCT05011149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65571582|NCT05011149|Analgesics|analgesics|mesh-ancestor
65571583|NCT05011149|Sensory System Agents|sensory system agents|mesh-ancestor
65571584|NCT05011149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571585|NCT05011149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571586|NCT05011149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65571587|NCT05011149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65571588|NCT05011149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65571589|NCT05011149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571590|NCT05011149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571591|NCT03393988|Fentanyl|fentanyl|mesh-list
65571592|NCT03393988|Dexmedetomidine|dexmedetomidine|mesh-list
65571593|NCT03393988|Sympathomimetics|sympathomimetics|mesh-list
65571594|NCT03393988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65571595|NCT03393988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65571596|NCT03393988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571597|NCT03393988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65571598|NCT03393988|Analgesics|analgesics|mesh-ancestor
65571599|NCT03393988|Sensory System Agents|sensory system agents|mesh-ancestor
65571600|NCT03393988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571601|NCT03393988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65571602|NCT03393988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65571603|NCT03393988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65571604|NCT03393988|Adrenergic Agents|adrenergic agents|mesh-ancestor
65571605|NCT03393988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65571606|NCT03393988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571607|NCT03393988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65571608|NCT03393988|Narcotics|narcotics|mesh-ancestor
65571609|NCT03393988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65571610|NCT03393988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65571611|NCT03393988|Anesthetics, General|anesthetics, general|mesh-ancestor
65571612|NCT03393988|Anesthetics|anesthetics|mesh-ancestor
65571613|NCT03393988|Autonomic Agents|autonomic agents|mesh-ancestor
65571614|NCT03410212|Ketorolac|ketorolac|mesh-list
65571615|NCT03410212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65571616|NCT03410212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65571617|NCT03410212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65571618|NCT03410212|Analgesics|analgesics|mesh-ancestor
65571619|NCT03410212|Sensory System Agents|sensory system agents|mesh-ancestor
65571620|NCT03410212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571621|NCT03410212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571622|NCT03410212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65571623|NCT03410212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65571624|NCT03410212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65571625|NCT03410212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571626|NCT03410212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571627|NCT03397264|Aflibercept|aflibercept|mesh-list
65571628|NCT03397264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65571629|NCT03397264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65571630|NCT03397264|Growth Substances|growth substances|mesh-ancestor
65571631|NCT03397264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571632|NCT03397264|Growth Inhibitors|growth inhibitors|mesh-ancestor
65571633|NCT03397264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571634|NCT03397186|Trabectedin|trabectedin|mesh-list
65571635|NCT03397186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65571636|NCT03397186|Alkylating Agents|alkylating agents|mesh-ancestor
65571637|NCT03397186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571638|NCT03397186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571639|NCT03393364|Ketorolac|ketorolac|mesh-list
65571640|NCT03393364|Oxycodone|oxycodone|mesh-list
65571641|NCT03393364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65571642|NCT03393364|Narcotics|narcotics|mesh-ancestor
65571643|NCT03393364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65571644|NCT03393364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571646|NCT03393364|Sensory System Agents|sensory system agents|mesh-ancestor
65571647|NCT03393364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571648|NCT03393364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65571649|NCT03393364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65571650|NCT03393364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65571651|NCT03393364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65571652|NCT03393364|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65571653|NCT03393364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571654|NCT03393364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571655|NCT04632706|Ivermectin|ivermectin|mesh-list
65571656|NCT04632706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65571657|NCT04632706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65571658|NCT03405454|Durvalumab|durvalumab|mesh-list
65571659|NCT03405454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65571660|NCT03405454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571661|NCT05168176|Dolutegravir|dolutegravir|mesh-list
65571662|NCT05168176|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65571663|NCT05168176|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65571664|NCT05168176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571665|NCT05168176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571666|NCT05168176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65571667|NCT05168176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65571668|NCT05168176|Antiviral Agents|antiviral agents|mesh-ancestor
65571669|NCT05168176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65571670|NCT04539730|Bupivacaine|bupivacaine|mesh-list
65571671|NCT04539730|Ropivacaine|ropivacaine|mesh-list
65571672|NCT04539730|Anesthetics, Local|anesthetics, local|mesh-ancestor
65571673|NCT04539730|Anesthetics|anesthetics|mesh-ancestor
65571674|NCT04539730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65571675|NCT04539730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571676|NCT04539730|Sensory System Agents|sensory system agents|mesh-ancestor
65571677|NCT04539730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571678|NCT03396484|Methyldopa|methyldopa|mesh-list
65571679|NCT03396484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65571680|NCT03396484|Sympatholytics|sympatholytics|mesh-ancestor
65571681|NCT03396484|Autonomic Agents|autonomic agents|mesh-ancestor
65571682|NCT03396484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571683|NCT03396484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571684|NCT03396484|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65571685|NCT03396484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65571686|NCT03396484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65571687|NCT03396484|Adrenergic Agents|adrenergic agents|mesh-ancestor
65571688|NCT03396484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65571689|NCT03396484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571690|NCT03321396|Calcium|calcium|mesh-list
65571691|NCT03321396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65571692|NCT03321396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571693|NCT04809376|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
65571694|NCT04809376|Anticoagulants|anticoagulants|mesh-ancestor
65571695|NCT03321006|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65571696|NCT03321006|Citalopram|citalopram|mesh-list
65571697|NCT03321006|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65571698|NCT03321006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65571699|NCT03321006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65248361|NCT00623233|Gemcitabine|gemcitabine|mesh-list
65571700|NCT03321006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571701|NCT03321006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65571702|NCT03321006|Serotonin Agents|serotonin agents|mesh-ancestor
65571703|NCT03321006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571704|NCT03321006|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65571705|NCT03321006|Antidepressive Agents|antidepressive agents|mesh-ancestor
65571706|NCT03321006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65571707|NCT03321006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571708|NCT03321006|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65571709|NCT03321006|Analgesics|analgesics|mesh-ancestor
65571710|NCT03321006|Sensory System Agents|sensory system agents|mesh-ancestor
65571711|NCT03321006|Dopamine Agents|dopamine agents|mesh-ancestor
65571712|NCT04760626|Insulin|insulin|mesh-list
65571713|NCT04760626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65571714|NCT04760626|Insulin Glargine|insulin glargine|mesh-list
65571715|NCT04760626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65369240|NCT03760588|Valsartan|valsartan|mesh-list
65571716|NCT04760626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571717|NCT01974609|Acetaminophen|acetaminophen|mesh-list
65571718|NCT01974609|Ibuprofen|ibuprofen|mesh-list
65571719|NCT01974609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65571721|NCT01974609|Narcotics|narcotics|mesh-list
65571722|NCT01974609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65571723|NCT01974609|Analgesics|analgesics|mesh-ancestor
65571724|NCT01974609|Sensory System Agents|sensory system agents|mesh-ancestor
65571725|NCT01974609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571726|NCT01974609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571727|NCT01974609|Antipyretics|antipyretics|mesh-ancestor
65571728|NCT01974609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65571729|NCT01974609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65571730|NCT01974609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65571731|NCT01974609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65571732|NCT01974609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571733|NCT01974609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571734|NCT01974609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65571735|NCT01974609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65571736|NCT01974609|Antitussive Agents|antitussive agents|mesh-ancestor
65571737|NCT01974609|Respiratory System Agents|respiratory system agents|mesh-ancestor
65571738|NCT02593123|Mycophenolic Acid|mycophenolic acid|mesh-list
65571739|NCT02593123|Molgramostim|molgramostim|mesh-list
65571740|NCT02593123|Lenograstim|lenograstim|mesh-list
65571741|NCT02593123|Sargramostim|sargramostim|mesh-list
65571742|NCT02593123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65571743|NCT02593123|Immunologic Factors|immunologic factors|mesh-ancestor
65571744|NCT02593123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571745|NCT02593123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65571746|NCT02593123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571747|NCT02593123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65571748|NCT02593123|Antitubercular Agents|antitubercular agents|mesh-ancestor
65571749|NCT02593123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65571750|NCT02593123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65571751|NCT02593123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571752|NCT02593123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571753|NCT03396250|Diphenhydramine|diphenhydramine|mesh-list
65571754|NCT03396250|Promethazine|promethazine|mesh-list
65571755|NCT03396250|Naproxen|naproxen|mesh-list
65571756|NCT03396250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65571757|NCT03396250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65571758|NCT03396250|Analgesics|analgesics|mesh-ancestor
65571759|NCT03396250|Sensory System Agents|sensory system agents|mesh-ancestor
65571760|NCT03396250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571761|NCT03396250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571762|NCT03396250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65571763|NCT03396250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65571764|NCT03396250|Gout Suppressants|gout suppressants|mesh-ancestor
65571765|NCT03396250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65571766|NCT03396250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571767|NCT03396250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571768|NCT03396250|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65571769|NCT03396250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65571770|NCT03396250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65571771|NCT03396250|Anesthetics, Local|anesthetics, local|mesh-ancestor
65571772|NCT03396250|Anesthetics|anesthetics|mesh-ancestor
65571773|NCT03396250|Antiemetics|antiemetics|mesh-ancestor
64572850|NCT04772287|Gemcitabine|gemcitabine|mesh-list
65571774|NCT03396250|Autonomic Agents|autonomic agents|mesh-ancestor
65571775|NCT03396250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65571776|NCT03396250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65571777|NCT03396250|Histamine Antagonists|histamine antagonists|mesh-ancestor
65571778|NCT03396250|Histamine Agents|histamine agents|mesh-ancestor
65571779|NCT03396250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65571780|NCT03396250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65571781|NCT03396250|Antipruritics|antipruritics|mesh-ancestor
65571782|NCT03396250|Dermatologic Agents|dermatologic agents|mesh-ancestor
65571783|NCT03302559|Vitamin A|vitamin a|mesh-list
65571784|NCT03302559|Retinol palmitate|retinol palmitate|mesh-list
65571785|NCT03302559|Sunscreening Agents|sunscreening agents|mesh-list
65571786|NCT03302559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65571787|NCT03302559|Protective Agents|protective agents|mesh-ancestor
65571788|NCT03302559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571789|NCT03302559|Dermatologic Agents|dermatologic agents|mesh-ancestor
65571790|NCT03302559|Vitamins|vitamins|mesh-ancestor
65571791|NCT03302559|Micronutrients|micronutrients|mesh-ancestor
65571792|NCT03302559|Antioxidants|antioxidants|mesh-ancestor
65571793|NCT03302559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571794|NCT03302559|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65571795|NCT03302559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571796|NCT03763669|Folic Acid|folic acid|mesh-list
65571797|NCT03763669|Vitamin B Complex|vitamin b complex|mesh-list
65571798|NCT03763669|Inositol|inositol|mesh-list
65571799|NCT03763669|Hematinics|hematinics|mesh-ancestor
65571800|NCT03763669|Vitamins|vitamins|mesh-ancestor
65571801|NCT03763669|Micronutrients|micronutrients|mesh-ancestor
65571802|NCT03763669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571803|NCT03302247|Gemcitabine|gemcitabine|mesh-list
65571804|NCT03302247|Nivolumab|nivolumab|mesh-list
65571805|NCT03302247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65571806|NCT03302247|Antimetabolites|antimetabolites|mesh-ancestor
65571807|NCT03302247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571808|NCT03302247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571809|NCT03302247|Antiviral Agents|antiviral agents|mesh-ancestor
65571810|NCT03302247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65571811|NCT03302247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571812|NCT03302247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65571813|NCT03302247|Immunologic Factors|immunologic factors|mesh-ancestor
65571814|NCT03302247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571815|NCT03302247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65571816|NCT03302247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65571817|NCT01758081|Vitamin D|vitamin d|mesh-list
65571818|NCT01758081|Ergocalciferols|ergocalciferols|mesh-list
65571819|NCT01758081|Cholecalciferol|cholecalciferol|mesh-list
65571820|NCT01758081|Vitamins|vitamins|mesh-list
65571821|NCT01758081|Micronutrients|micronutrients|mesh-ancestor
65571822|NCT01758081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571823|NCT01758081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65571824|NCT01758081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65571825|NCT04363840|Aspirin|aspirin|mesh-list
65571826|NCT04363840|Vitamin D|vitamin d|mesh-list
65571827|NCT04363840|Vitamins|vitamins|mesh-ancestor
65571828|NCT04363840|Micronutrients|micronutrients|mesh-ancestor
65571829|NCT04363840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571830|NCT04363840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65571831|NCT04363840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65571832|NCT04363840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65571833|NCT04363840|Analgesics|analgesics|mesh-ancestor
65571834|NCT04363840|Sensory System Agents|sensory system agents|mesh-ancestor
65571835|NCT04363840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571836|NCT04363840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65571837|NCT04363840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65571838|NCT04363840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65571839|NCT04363840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65571840|NCT04363840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571841|NCT04363840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65571842|NCT04363840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65571843|NCT04363840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571844|NCT04363840|Antipyretics|antipyretics|mesh-ancestor
65571845|NCT03392740|Lisinopril|lisinopril|mesh-list
65571846|NCT03392740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65571847|NCT03392740|Protease Inhibitors|protease inhibitors|mesh-ancestor
65571848|NCT03392740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571849|NCT03392740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571850|NCT03392740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65571851|NCT03392740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65571852|NCT03392740|Protective Agents|protective agents|mesh-ancestor
65571853|NCT03392740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571854|NCT04919317|Dexamethasone|dexamethasone|mesh-list
65571855|NCT04919317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65571856|NCT04919317|Antiemetics|antiemetics|mesh-ancestor
65571857|NCT04919317|Autonomic Agents|autonomic agents|mesh-ancestor
65571858|NCT04919317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571859|NCT04919317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571860|NCT04919317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65571861|NCT04919317|Glucocorticoids|glucocorticoids|mesh-ancestor
65571862|NCT04919317|Hormones|hormones|mesh-ancestor
65571863|NCT04919317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65571864|NCT04919317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65571865|NCT04919317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571866|NCT02818023|Pembrolizumab|pembrolizumab|mesh-list
65571867|NCT02818023|Vemurafenib|vemurafenib|mesh-list
65369373|NCT03530371|Analgesics|analgesics|mesh-ancestor
65571868|NCT02818023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65571869|NCT02818023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571870|NCT02818023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65571871|NCT02818023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571872|NCT02818023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571873|NCT03262389|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65571874|NCT03262389|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65571875|NCT03262389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571876|NCT04631536|Folic Acid|folic acid|mesh-list
65571877|NCT04631536|Vitamin B Complex|vitamin b complex|mesh-list
65571878|NCT04631536|Nicorandil|nicorandil|mesh-list
65571879|NCT04631536|Nebivolol|nebivolol|mesh-list
65571880|NCT04631536|Atorvastatin|atorvastatin|mesh-list
65571881|NCT04631536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65571882|NCT04631536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65571883|NCT04631536|Antimetabolites|antimetabolites|mesh-ancestor
65571884|NCT04631536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571885|NCT04631536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65571886|NCT04631536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65571887|NCT04631536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571888|NCT04631536|Hematinics|hematinics|mesh-ancestor
65571889|NCT04631536|Vitamins|vitamins|mesh-ancestor
65571890|NCT04631536|Micronutrients|micronutrients|mesh-ancestor
65571891|NCT04631536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571892|NCT04631536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65571893|NCT04631536|Vasodilator Agents|vasodilator agents|mesh-ancestor
65571894|NCT04631536|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65571895|NCT04631536|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65571896|NCT04631536|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65571897|NCT04631536|Adrenergic Agents|adrenergic agents|mesh-ancestor
65571898|NCT04631536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65571899|NCT04631536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65571900|NCT03262233|Nicotine|nicotine|mesh-list
65571901|NCT03262233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65571902|NCT03262233|Autonomic Agents|autonomic agents|mesh-ancestor
65571903|NCT03262233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571904|NCT03262233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571905|NCT03262233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65571906|NCT03262233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65571907|NCT03262233|Cholinergic Agents|cholinergic agents|mesh-ancestor
65571908|NCT03262233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65571909|NCT03262233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571910|NCT05166538|Clopidogrel|clopidogrel|mesh-list
65571911|NCT05166538|Ticagrelor|ticagrelor|mesh-list
65571912|NCT05166538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65571913|NCT05166538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65571914|NCT05166538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65571915|NCT05166538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65571916|NCT05166538|Purinergic Agents|purinergic agents|mesh-ancestor
65571917|NCT05166538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65571918|NCT05166538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571919|NCT05166538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571920|NCT03260205|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65571921|NCT03260205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65571922|NCT03260205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571923|NCT03260205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65571924|NCT03260205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65248453|NCT02548117|Hormone Antagonists|hormone antagonists|mesh-ancestor
65571925|NCT03260205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65571926|NCT03260205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571927|NCT03260205|Dopamine Agents|dopamine agents|mesh-ancestor
65571928|NCT03260205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65571929|NCT03320850|Botulinum Toxins|botulinum toxins|mesh-list
65571930|NCT03320850|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65571931|NCT03320850|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65571932|NCT03320850|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65571933|NCT03320850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65571934|NCT03320850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571935|NCT03320850|Cholinergic Agents|cholinergic agents|mesh-ancestor
65571936|NCT03320850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65571937|NCT03320850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571938|NCT03320850|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65571939|NCT03320850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65571941|NCT04447378|Fondaparinux|fondaparinux|mesh-list
65571942|NCT04447378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65571943|NCT04447378|Antithrombins|antithrombins|mesh-ancestor
65369442|NCT03406897|Vitamin D|vitamin d|mesh-list
65571944|NCT04447378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65571945|NCT04447378|Protease Inhibitors|protease inhibitors|mesh-ancestor
65571946|NCT04447378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571947|NCT04447378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571948|NCT04447378|Anticoagulants|anticoagulants|mesh-ancestor
65571949|NCT04447378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65571950|NCT04447378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65571951|NCT04150887|Azacitidine|azacitidine|mesh-list
65571952|NCT04150887|Venetoclax|venetoclax|mesh-list
65571953|NCT04150887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65571954|NCT04150887|Antimetabolites|antimetabolites|mesh-ancestor
65571955|NCT04150887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571956|NCT04150887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571957|NCT04150887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65571958|NCT03125980|Capecitabine|capecitabine|mesh-list
65571959|NCT03125980|Oxaliplatin|oxaliplatin|mesh-list
65571960|NCT03125980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65571961|NCT03125980|Antimetabolites|antimetabolites|mesh-ancestor
65571962|NCT03125980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571963|NCT03125980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65571964|NCT03399604|Treprostinil|treprostinil|mesh-list
65571965|NCT03399604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65571966|NCT04697823|Hyaluronic Acid|hyaluronic acid|mesh-list
65571967|NCT04697823|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65571968|NCT04697823|Immunologic Factors|immunologic factors|mesh-ancestor
65571969|NCT04697823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571970|NCT04697823|Viscosupplements|viscosupplements|mesh-ancestor
65571971|NCT04697823|Protective Agents|protective agents|mesh-ancestor
65571972|NCT04082520|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65571973|NCT04082520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571974|NCT04082520|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65571975|NCT03399526|Calcitriol|calcitriol|mesh-list
65571976|NCT03399526|Betamethasone|betamethasone|mesh-list
65571977|NCT03399526|Betamethasone Valerate|betamethasone valerate|mesh-list
65571978|NCT03399526|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65571979|NCT03399526|Betamethasone benzoate|betamethasone benzoate|mesh-list
65571980|NCT03399526|Clobetasol|clobetasol|mesh-list
65571981|NCT03399526|Prednicarbate|prednicarbate|mesh-list
65571982|NCT03399526|Calcipotriene|calcipotriene|mesh-list
65571983|NCT03399526|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65571984|NCT03399526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65571985|NCT03399526|Glucocorticoids|glucocorticoids|mesh-ancestor
65571986|NCT03399526|Hormones|hormones|mesh-ancestor
65571987|NCT03399526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65571988|NCT03399526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65571989|NCT03399526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65571990|NCT03399526|Respiratory System Agents|respiratory system agents|mesh-ancestor
65571991|NCT03399526|Dermatologic Agents|dermatologic agents|mesh-ancestor
65571992|NCT03399526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65571993|NCT03399526|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65571994|NCT03399526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65571995|NCT03399526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65571996|NCT03399526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65571997|NCT03399526|Vitamins|vitamins|mesh-ancestor
65571998|NCT03399526|Micronutrients|micronutrients|mesh-ancestor
65571999|NCT03399526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65572000|NCT03392272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65572001|NCT03392272|Hemostatics|hemostatics|mesh-ancestor
65572002|NCT03392272|Coagulants|coagulants|mesh-ancestor
65572003|NCT03905902|Vaccines|vaccines|mesh-list
65572004|NCT03905902|Immunologic Factors|immunologic factors|mesh-ancestor
65572005|NCT03905902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572006|NCT03638310|Gentamicins|gentamicins|mesh-list
65572007|NCT03638310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65572008|NCT03638310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65572009|NCT03638310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65572010|NCT03638310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572011|NCT03638310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572012|NCT04656691|Bamlanivimab|bamlanivimab|mesh-list
65572013|NCT04656691|Antiviral Agents|antiviral agents|mesh-ancestor
65572014|NCT04656691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65572015|NCT03399448|Cyclophosphamide|cyclophosphamide|mesh-list
65572016|NCT03399448|Fludarabine|fludarabine|mesh-list
65572017|NCT03399448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65572018|NCT03399448|Immunologic Factors|immunologic factors|mesh-ancestor
65572019|NCT03399448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572020|NCT03399448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65572021|NCT03399448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65572022|NCT03399448|Alkylating Agents|alkylating agents|mesh-ancestor
65572023|NCT03399448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572024|NCT03399448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572025|NCT03399448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65572026|NCT03755947|Venetoclax|venetoclax|mesh-list
65572027|NCT03755947|Obinutuzumab|obinutuzumab|mesh-list
65572028|NCT03755947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572029|NCT03755947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65572030|NCT03395470|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65572031|NCT03395470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65572032|NCT03395470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65572033|NCT03395470|Antimetabolites|antimetabolites|mesh-ancestor
65572034|NCT03395470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572035|NCT03395470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65572036|NCT03395470|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65572037|NCT03395470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572038|NCT03257865|Brexpiprazole|brexpiprazole|mesh-list
65572039|NCT03257865|Serotonin Agents|serotonin agents|mesh-ancestor
65572040|NCT03257865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65572041|NCT03257865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572042|NCT03257865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572043|NCT03257865|Dopamine Agonists|dopamine agonists|mesh-ancestor
65572044|NCT03257865|Dopamine Agents|dopamine agents|mesh-ancestor
65572045|NCT01610700|Nabiximols|nabiximols|mesh-list
65572046|NCT01610700|Analgesics|analgesics|mesh-ancestor
65572047|NCT01610700|Sensory System Agents|sensory system agents|mesh-ancestor
65572048|NCT01610700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572049|NCT01610700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572050|NCT04632459|Pembrolizumab|pembrolizumab|mesh-list
65572051|NCT04632459|Ramucirumab|ramucirumab|mesh-list
65572052|NCT04632459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65572053|NCT04632459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572054|NCT03985371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65572055|NCT03985371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65572056|NCT03316872|Pembrolizumab|pembrolizumab|mesh-list
65572057|NCT03316872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65572058|NCT03316872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572059|NCT03256695|Albuterol|albuterol|mesh-list
65572060|NCT03256695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65572061|NCT03256695|Autonomic Agents|autonomic agents|mesh-ancestor
65572062|NCT03256695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572063|NCT03256695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572064|NCT03256695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65572065|NCT03256695|Respiratory System Agents|respiratory system agents|mesh-ancestor
65572066|NCT03256695|Tocolytic Agents|tocolytic agents|mesh-ancestor
65572067|NCT03256695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65572068|NCT03256695|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65572069|NCT03256695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65572070|NCT03256695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65572071|NCT03256695|Adrenergic Agents|adrenergic agents|mesh-ancestor
65572072|NCT03256695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65572073|NCT03256695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572074|NCT04623684|Phenylephrine|phenylephrine|mesh-list
65572075|NCT04623684|Oxymetazoline|oxymetazoline|mesh-list
65572076|NCT04623684|Tropicamide|tropicamide|mesh-list
65572077|NCT04623684|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65572078|NCT04623684|Mydriatics|mydriatics|mesh-ancestor
65572079|NCT04623684|Autonomic Agents|autonomic agents|mesh-ancestor
65572080|NCT04623684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572081|NCT04623684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572082|NCT04623684|Sympathomimetics|sympathomimetics|mesh-ancestor
65572083|NCT04623684|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65572084|NCT04623684|Nasal Decongestants|nasal decongestants|mesh-ancestor
65572085|NCT04623684|Respiratory System Agents|respiratory system agents|mesh-ancestor
65572086|NCT04623684|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65572087|NCT04623684|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65572088|NCT04623684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65572089|NCT04623684|Adrenergic Agents|adrenergic agents|mesh-ancestor
65572090|NCT04623684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65572091|NCT04623684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572092|NCT04623684|Protective Agents|protective agents|mesh-ancestor
65572093|NCT04623684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65572094|NCT04623684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65572095|NCT04623684|Cholinergic Agents|cholinergic agents|mesh-ancestor
65572097|NCT03297021|Antiemetics|antiemetics|mesh-ancestor
65572098|NCT03297021|Autonomic Agents|autonomic agents|mesh-ancestor
65572099|NCT03297021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572100|NCT03297021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572101|NCT03297021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65572102|NCT03297021|Antipruritics|antipruritics|mesh-ancestor
65572103|NCT03297021|Dermatologic Agents|dermatologic agents|mesh-ancestor
65572104|NCT03297021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65572105|NCT03297021|Serotonin Agents|serotonin agents|mesh-ancestor
65572106|NCT03297021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65572107|NCT03297021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572108|NCT03297021|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65572109|NCT03297021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65572110|NCT03297021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65572111|NCT03297021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65572112|NCT03297021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65572113|NCT03752749|Prednisolone|prednisolone|mesh-list
65572114|NCT03752749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65572115|NCT03752749|Glucocorticoids|glucocorticoids|mesh-ancestor
65572116|NCT03752749|Hormones|hormones|mesh-ancestor
65572117|NCT03752749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65572118|NCT03752749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572119|NCT03752749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65572120|NCT03752749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572121|NCT01988571|Atorvastatin|atorvastatin|mesh-list
65572122|NCT01988571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65572123|NCT01988571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65572124|NCT01988571|Antimetabolites|antimetabolites|mesh-ancestor
65572125|NCT01988571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572126|NCT01988571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65572127|NCT01988571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65572128|NCT01988571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572129|NCT00536172|Citalopram|citalopram|mesh-list
65572130|NCT00536172|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65572131|NCT00536172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65572132|NCT00536172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65572133|NCT00536172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572134|NCT00536172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65572135|NCT00536172|Serotonin Agents|serotonin agents|mesh-ancestor
65572136|NCT00536172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572137|NCT00536172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65572138|NCT00536172|Antidepressive Agents|antidepressive agents|mesh-ancestor
65572139|NCT00536172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65572140|NCT03755557|Budesonide|budesonide|mesh-list
65572141|NCT03755557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65572142|NCT03755557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65572143|NCT03755557|Autonomic Agents|autonomic agents|mesh-ancestor
65572144|NCT03755557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572145|NCT03755557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572146|NCT03755557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65572147|NCT03755557|Respiratory System Agents|respiratory system agents|mesh-ancestor
65572148|NCT03755557|Glucocorticoids|glucocorticoids|mesh-ancestor
65572149|NCT03755557|Hormones|hormones|mesh-ancestor
65572150|NCT03755557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65572151|NCT03511599|Cycloserine|cycloserine|mesh-list
65572152|NCT03511599|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65572153|NCT03511599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65572154|NCT03511599|Renal Agents|renal agents|mesh-ancestor
65572155|NCT03511599|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65572156|NCT03511599|Antitubercular Agents|antitubercular agents|mesh-ancestor
65572157|NCT03511599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65572158|NCT03511599|Antimetabolites|antimetabolites|mesh-ancestor
65572159|NCT03511599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572160|NCT01140867|Zonisamide|zonisamide|mesh-list
65572161|NCT01140867|Anticonvulsants|anticonvulsants|mesh-ancestor
65572162|NCT01140867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65572163|NCT01140867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65572164|NCT01140867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572165|NCT01140867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65572166|NCT01140867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572167|NCT04572997|Apremilast|apremilast|mesh-list
65369664|NCT02032953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65572168|NCT04572997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65572169|NCT04572997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65572170|NCT04572997|Analgesics|analgesics|mesh-ancestor
65572171|NCT04572997|Sensory System Agents|sensory system agents|mesh-ancestor
65572172|NCT04572997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572173|NCT04572997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572174|NCT04572997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65572175|NCT04572997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65572176|NCT04572997|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65572177|NCT04572997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65572178|NCT04572997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572179|NCT04572997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572180|NCT03292653|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65572181|NCT03292653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65572182|NCT03292653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572183|NCT03292653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65572184|NCT03292653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572185|NCT02891070|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65572186|NCT02891070|Hemostatics|hemostatics|mesh-ancestor
65572187|NCT02891070|Coagulants|coagulants|mesh-ancestor
65572188|NCT00381381|Donepezil|donepezil|mesh-list
65572189|NCT00381381|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65572190|NCT00381381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572191|NCT00381381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572192|NCT00381381|Cholinergic Agents|cholinergic agents|mesh-ancestor
65572193|NCT00381381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65572194|NCT00381381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572195|NCT00381381|Nootropic Agents|nootropic agents|mesh-ancestor
65572196|NCT03637335|Carboplatin|carboplatin|mesh-list
65572197|NCT03637335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572198|NCT02939937|Phenytoin|phenytoin|mesh-list
65572199|NCT02939937|Anticonvulsants|anticonvulsants|mesh-ancestor
65572200|NCT02939937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65572201|NCT02939937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65572202|NCT02939937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65572203|NCT02939937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572204|NCT02939937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65572205|NCT02939937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65572206|NCT02939079|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65572207|NCT02939079|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65572208|NCT02939079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572209|NCT02939079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65572210|NCT02939079|Immunologic Factors|immunologic factors|mesh-ancestor
65572211|NCT02939079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572212|NCT02774265|Aspirin|aspirin|mesh-list
65572213|NCT02774265|Heparin|heparin|mesh-list
65572214|NCT02774265|Enoxaparin|enoxaparin|mesh-list
65572215|NCT02774265|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65572216|NCT02774265|Tinzaparin|tinzaparin|mesh-list
65572217|NCT02774265|Dalteparin|dalteparin|mesh-list
65572218|NCT02774265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65572219|NCT02774265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65572220|NCT02774265|Analgesics|analgesics|mesh-ancestor
65572221|NCT02774265|Sensory System Agents|sensory system agents|mesh-ancestor
65572222|NCT02774265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572223|NCT02774265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572224|NCT02774265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65572225|NCT02774265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65572226|NCT02774265|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65572227|NCT02774265|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65572228|NCT02774265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572229|NCT02774265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65572230|NCT02774265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65572231|NCT02774265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572232|NCT02774265|Antipyretics|antipyretics|mesh-ancestor
65572233|NCT02774265|Anticoagulants|anticoagulants|mesh-ancestor
65572234|NCT04755595|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65572235|NCT04755595|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65572236|NCT04755595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65572237|NCT04755595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572238|NCT04755595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572239|NCT04755595|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65572241|NCT04755595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572242|NCT04755595|Cholinergic Agents|cholinergic agents|mesh-ancestor
65572243|NCT04755595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65572244|NCT03755479|Insulin|insulin|mesh-list
65572245|NCT03755479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65572246|NCT03755479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572247|NCT05239390|Dronabinol|dronabinol|mesh-list
65572248|NCT05239390|Hallucinogens|hallucinogens|mesh-ancestor
65572249|NCT05239390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572250|NCT05239390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65572251|NCT05239390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65572252|NCT05239390|Analgesics|analgesics|mesh-ancestor
65572253|NCT05239390|Sensory System Agents|sensory system agents|mesh-ancestor
65572254|NCT05239390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572255|NCT05239390|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65572256|NCT05239390|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65572257|NCT05239390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65572258|NCT05239390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572259|NCT05239390|Hormones|hormones|mesh-ancestor
65572260|NCT05239390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65572261|NCT03752437|Heparin|heparin|mesh-list
65572262|NCT03752437|Anticoagulants|anticoagulants|mesh-ancestor
65572263|NCT03752437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65572264|NCT03752437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65572265|NCT03752437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572266|NCT05239312|Anti-Infective Agents|anti-infective agents|mesh-list
65572267|NCT05239312|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65572268|NCT04748341|Benzocaine|benzocaine|mesh-list
65572269|NCT04748341|Anesthetics, Local|anesthetics, local|mesh-ancestor
65572270|NCT04748341|Anesthetics|anesthetics|mesh-ancestor
65572271|NCT04748341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65572272|NCT04748341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572273|NCT04748341|Sensory System Agents|sensory system agents|mesh-ancestor
65572274|NCT04748341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572275|NCT01328002|Milnacipran|milnacipran|mesh-list
65572276|NCT01328002|Levomilnacipran|levomilnacipran|mesh-list
65572277|NCT01328002|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65572278|NCT01328002|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65572279|NCT01328002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65572280|NCT01328002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572281|NCT01328002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65572282|NCT01328002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572283|NCT01328002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65572284|NCT01328002|Analgesics|analgesics|mesh-ancestor
65572285|NCT01328002|Sensory System Agents|sensory system agents|mesh-ancestor
65572286|NCT01328002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572287|NCT01328002|Antidepressive Agents|antidepressive agents|mesh-ancestor
65572288|NCT01328002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65572289|NCT05239078|Anesthetics|anesthetics|mesh-list
65572290|NCT05239078|Anesthetics, Local|anesthetics, local|mesh-list
65572291|NCT05239078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65572292|NCT05239078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572293|NCT05239078|Sensory System Agents|sensory system agents|mesh-ancestor
65572294|NCT05239078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572295|NCT02579265|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65572296|NCT02579265|SMOFlipid|smoflipid|mesh-list
65572297|NCT02579265|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
65572298|NCT02579265|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65572299|NCT02579265|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65572300|NCT05238220|Valganciclovir|valganciclovir|mesh-list
65572301|NCT05238220|Antiviral Agents|antiviral agents|mesh-ancestor
65572302|NCT05238220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65572303|NCT04446598|Tadalafil|tadalafil|mesh-list
65572304|NCT04446598|Vasodilator Agents|vasodilator agents|mesh-ancestor
65572305|NCT04446598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65572306|NCT04446598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65572307|NCT04446598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572308|NCT04446598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572309|NCT04446598|Urological Agents|urological agents|mesh-ancestor
65572310|NCT03391570|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
65572311|NCT03391570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65572312|NCT03391570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572313|NCT03391570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572314|NCT03391570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65572315|NCT03391570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65572316|NCT03391570|Analgesics|analgesics|mesh-ancestor
65572317|NCT03391570|Sensory System Agents|sensory system agents|mesh-ancestor
65572318|NCT03391570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572319|NCT03391570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572320|NCT03391570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65572321|NCT03391570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65572322|NCT03755089|Lidocaine|lidocaine|mesh-list
65572323|NCT03755089|Anesthetics, Local|anesthetics, local|mesh-ancestor
65572324|NCT03755089|Anesthetics|anesthetics|mesh-ancestor
65572325|NCT03755089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65572326|NCT03755089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572327|NCT03755089|Sensory System Agents|sensory system agents|mesh-ancestor
65572328|NCT03755089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572329|NCT03755089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65572330|NCT03755089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65572331|NCT03755089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65572332|NCT03755089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65572333|NCT03755089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572334|NCT03757117|Hormones|hormones|mesh-list
65572335|NCT03757117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65572336|NCT03757117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572337|NCT03752125|Caffeine|caffeine|mesh-list
65572338|NCT03752125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65572339|NCT03752125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572340|NCT03752125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65572341|NCT03752125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572342|NCT03752125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572343|NCT03752125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65572344|NCT03752125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65572345|NCT03752125|Purinergic Agents|purinergic agents|mesh-ancestor
65572346|NCT03752125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65572347|NCT03289533|Avelumab|avelumab|mesh-list
65572348|NCT03289533|Axitinib|axitinib|mesh-list
65572349|NCT03289533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65572350|NCT03289533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572351|NCT03289533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65572352|NCT03289533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572353|NCT03289533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572354|NCT03395002|Fluticasone|fluticasone|mesh-list
65572356|NCT03395002|Tiotropium Bromide|tiotropium bromide|mesh-list
65572357|NCT03395002|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65572358|NCT03395002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65572359|NCT03395002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65572360|NCT03395002|Autonomic Agents|autonomic agents|mesh-ancestor
65572361|NCT03395002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572362|NCT03395002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572363|NCT03395002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65572364|NCT03395002|Respiratory System Agents|respiratory system agents|mesh-ancestor
65572365|NCT03395002|Dermatologic Agents|dermatologic agents|mesh-ancestor
65572366|NCT03395002|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65572367|NCT03395002|Parasympatholytics|parasympatholytics|mesh-ancestor
65572368|NCT03395002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65572369|NCT03395002|Cholinergic Agents|cholinergic agents|mesh-ancestor
65572370|NCT03395002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65572371|NCT03395002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572372|NCT03395002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65572373|NCT03395002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65572374|NCT03395002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65572375|NCT03395002|Adrenergic Agents|adrenergic agents|mesh-ancestor
65572376|NCT05238064|Cyclophosphamide|cyclophosphamide|mesh-list
65572377|NCT05238064|Doxorubicin|doxorubicin|mesh-list
65572378|NCT05238064|Vincristine|vincristine|mesh-list
65572379|NCT05238064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65572380|NCT05238064|Immunologic Factors|immunologic factors|mesh-ancestor
65572381|NCT05238064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572382|NCT05238064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65572383|NCT05238064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65572384|NCT05238064|Alkylating Agents|alkylating agents|mesh-ancestor
65369892|NCT01067443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65572385|NCT05238064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572386|NCT05238064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572387|NCT05238064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65572388|NCT05238064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65572389|NCT05238064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65572390|NCT05238064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65572391|NCT05238064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572392|NCT05238064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65572393|NCT05238064|Tubulin Modulators|tubulin modulators|mesh-ancestor
65572394|NCT05238064|Antimitotic Agents|antimitotic agents|mesh-ancestor
65572395|NCT05238064|Mitosis Modulators|mitosis modulators|mesh-ancestor
65572396|NCT03390790|Lidocaine|lidocaine|mesh-list
65572397|NCT03390790|Anesthetics, Local|anesthetics, local|mesh-ancestor
65572398|NCT03390790|Anesthetics|anesthetics|mesh-ancestor
65572399|NCT03390790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65572400|NCT03390790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572401|NCT03390790|Sensory System Agents|sensory system agents|mesh-ancestor
65572402|NCT03390790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572403|NCT03390790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65572404|NCT03390790|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65572405|NCT03390790|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65572406|NCT03390790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65572407|NCT03390790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572408|NCT03697993|Levofloxacin|levofloxacin|mesh-list
65572409|NCT03697993|Ofloxacin|ofloxacin|mesh-list
65572410|NCT03697993|Fosfomycin|fosfomycin|mesh-list
65572411|NCT03697993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65572412|NCT03697993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65572413|NCT03697993|Renal Agents|renal agents|mesh-ancestor
65572414|NCT03697993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65572415|NCT03697993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65572416|NCT03697993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65572417|NCT03697993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572418|NCT03697993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572419|NCT03697993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572420|NCT03697993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65572421|NCT03697993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65572422|NCT05393245|Tiotropium Bromide|tiotropium bromide|mesh-list
65572423|NCT05393245|Olodaterol|olodaterol|mesh-list
65572424|NCT05393245|Cholinergic Agents|cholinergic agents|mesh-list
65572425|NCT05393245|Muscarinic Antagonists|muscarinic antagonists|mesh-list
65572426|NCT05393245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65572427|NCT05393245|Autonomic Agents|autonomic agents|mesh-ancestor
65572428|NCT05393245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572429|NCT05393245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572430|NCT05393245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65572431|NCT05393245|Respiratory System Agents|respiratory system agents|mesh-ancestor
65572432|NCT05393245|Parasympatholytics|parasympatholytics|mesh-ancestor
65572433|NCT05393245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65572434|NCT05393245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65572435|NCT05393245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572436|NCT04544995|Niraparib|niraparib|mesh-list
65572437|NCT04544995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65572438|NCT04544995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572439|NCT04544995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572440|NCT04544995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572441|NCT03390712|Risperidone|risperidone|mesh-list
65572442|NCT03390712|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65572443|NCT03390712|Antipsychotic Agents|antipsychotic agents|mesh-list
65572444|NCT03390712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65572445|NCT03390712|Serotonin Agents|serotonin agents|mesh-ancestor
65572446|NCT03390712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65572447|NCT03390712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572448|NCT03390712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572449|NCT03390712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65572450|NCT03390712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65572451|NCT03390712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65572452|NCT03390712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65572453|NCT03390712|Dopamine Agents|dopamine agents|mesh-ancestor
65572454|NCT03390712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65572455|NCT03390712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65572456|NCT03756727|Ascorbic Acid|ascorbic acid|mesh-list
65572457|NCT03756727|Vitamins|vitamins|mesh-ancestor
65369979|NCT01067599|Nicotine|nicotine|mesh-list
65572458|NCT03756727|Micronutrients|micronutrients|mesh-ancestor
65572459|NCT03756727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572460|NCT03756727|Antioxidants|antioxidants|mesh-ancestor
65572461|NCT03756727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572462|NCT03756727|Protective Agents|protective agents|mesh-ancestor
65572463|NCT04962724|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65572464|NCT03398434|Apixaban|apixaban|mesh-list
65572465|NCT03398434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65572466|NCT03398434|Antithrombins|antithrombins|mesh-ancestor
65572467|NCT03398434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65572468|NCT03398434|Protease Inhibitors|protease inhibitors|mesh-ancestor
65572469|NCT03398434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572470|NCT03398434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572471|NCT03398434|Anticoagulants|anticoagulants|mesh-ancestor
65572472|NCT03398122|Apatinib|apatinib|mesh-list
65572473|NCT03398122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572474|NCT03398122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65572475|NCT03398122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572476|NCT03398122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572477|NCT05459857|Menthol|menthol|mesh-list
65572478|NCT05459857|Antipruritics|antipruritics|mesh-ancestor
65572479|NCT05459857|Dermatologic Agents|dermatologic agents|mesh-ancestor
65572480|NCT03394222|Budesonide|budesonide|mesh-list
65572481|NCT03394222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65572482|NCT03394222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65572483|NCT03394222|Autonomic Agents|autonomic agents|mesh-ancestor
65572484|NCT03394222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572485|NCT03394222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572486|NCT03394222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65572487|NCT03394222|Respiratory System Agents|respiratory system agents|mesh-ancestor
65572488|NCT03394222|Glucocorticoids|glucocorticoids|mesh-ancestor
65572489|NCT03394222|Hormones|hormones|mesh-ancestor
65572490|NCT03394222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65572491|NCT03398044|Dexamethasone|dexamethasone|mesh-list
65572492|NCT03398044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65572493|NCT03398044|Antiemetics|antiemetics|mesh-ancestor
65572494|NCT03398044|Autonomic Agents|autonomic agents|mesh-ancestor
65572495|NCT03398044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572496|NCT03398044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572497|NCT03398044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65572498|NCT03398044|Glucocorticoids|glucocorticoids|mesh-ancestor
65572499|NCT03398044|Hormones|hormones|mesh-ancestor
65572500|NCT03398044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65572501|NCT03398044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65572502|NCT03398044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572503|NCT03389776|Anesthetics|anesthetics|mesh-list
65572504|NCT03389776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65572505|NCT03389776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572506|NCT02813200|Tiotropium Bromide|tiotropium bromide|mesh-list
65572507|NCT02813200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65572508|NCT02813200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65572509|NCT02813200|Autonomic Agents|autonomic agents|mesh-ancestor
65572510|NCT02813200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572511|NCT02813200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572512|NCT02813200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65572513|NCT02813200|Respiratory System Agents|respiratory system agents|mesh-ancestor
65572514|NCT02813200|Parasympatholytics|parasympatholytics|mesh-ancestor
65572515|NCT02813200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65572516|NCT02813200|Cholinergic Agents|cholinergic agents|mesh-ancestor
65572517|NCT02813200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65572518|NCT02813200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572519|NCT02813200|Glucocorticoids|glucocorticoids|mesh-ancestor
65572520|NCT02813200|Hormones|hormones|mesh-ancestor
65572521|NCT02813200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65572522|NCT02813200|Sympathomimetics|sympathomimetics|mesh-ancestor
65572523|NCT04535947|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65572524|NCT04535947|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65572525|NCT03750721|Rifampin|rifampin|mesh-list
65572526|NCT03750721|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65572527|NCT03750721|Antitubercular Agents|antitubercular agents|mesh-ancestor
65572528|NCT03750721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65572529|NCT03750721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65572530|NCT03750721|Leprostatic Agents|leprostatic agents|mesh-ancestor
65572531|NCT03750721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65572532|NCT03750721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572533|NCT03750721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572534|NCT03750721|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65572535|NCT03750721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65572536|NCT03750721|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65572537|NCT03750721|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65572538|NCT03750721|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65572539|NCT03750721|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65572540|NCT01481272|Leucovorin|leucovorin|mesh-list
65572541|NCT01481272|Cytarabine|cytarabine|mesh-list
65572542|NCT01481272|Methotrexate|methotrexate|mesh-list
65572543|NCT01481272|Etoposide|etoposide|mesh-list
65572544|NCT01481272|Ofatumumab|ofatumumab|mesh-list
65572545|NCT01481272|Lenograstim|lenograstim|mesh-list
65572546|NCT01481272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65572547|NCT01481272|Abortifacient Agents|abortifacient agents|mesh-ancestor
65572548|NCT01481272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65572549|NCT01481272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572550|NCT01481272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65572551|NCT01481272|Antimetabolites|antimetabolites|mesh-ancestor
65572552|NCT01481272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572553|NCT01481272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572554|NCT01481272|Dermatologic Agents|dermatologic agents|mesh-ancestor
65572555|NCT01481272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572556|NCT01481272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65572557|NCT01481272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65572558|NCT01481272|Immunologic Factors|immunologic factors|mesh-ancestor
65572559|NCT01481272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65572560|NCT01481272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65572561|NCT01481272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65572562|NCT01481272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65572563|NCT01481272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65572564|NCT01481272|Antiviral Agents|antiviral agents|mesh-ancestor
65572565|NCT01481272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65572566|NCT01481272|Antidotes|antidotes|mesh-ancestor
65572567|NCT01481272|Protective Agents|protective agents|mesh-ancestor
65572568|NCT01481272|Vitamin B Complex|vitamin b complex|mesh-ancestor
65572569|NCT01481272|Vitamins|vitamins|mesh-ancestor
65572570|NCT01481272|Micronutrients|micronutrients|mesh-ancestor
65572571|NCT01481272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65572572|NCT04478695|Pembrolizumab|pembrolizumab|mesh-list
65572573|NCT04478695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65572574|NCT04478695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572575|NCT02687386|Mitoxantrone|mitoxantrone|mesh-list
65572576|NCT02687386|Analgesics|analgesics|mesh-ancestor
65572577|NCT02687386|Sensory System Agents|sensory system agents|mesh-ancestor
65572578|NCT02687386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572579|NCT02687386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572580|NCT02687386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572581|NCT02687386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65572582|NCT02687386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65572583|NCT02687386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572584|NCT02687386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572585|NCT04531813|Butenafine|butenafine|mesh-list
65572586|NCT04531813|Antifungal Agents|antifungal agents|mesh-ancestor
65572587|NCT04531813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65572588|NCT01380028|Prednisone|prednisone|mesh-list
65572589|NCT01380028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65572590|NCT01380028|Glucocorticoids|glucocorticoids|mesh-ancestor
65572591|NCT01380028|Hormones|hormones|mesh-ancestor
65248387|NCT02841488|Sensory System Agents|sensory system agents|mesh-ancestor
65572592|NCT01380028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65572593|NCT01380028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572594|NCT01380028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65572595|NCT01380028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572596|NCT01305460|Azacitidine|azacitidine|mesh-list
65572597|NCT01305460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65572598|NCT01305460|Antimetabolites|antimetabolites|mesh-ancestor
65572599|NCT01305460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572600|NCT01305460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572601|NCT01305460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572603|NCT03754543|Trace Elements|trace elements|mesh-ancestor
65572604|NCT03754543|Micronutrients|micronutrients|mesh-ancestor
65572605|NCT03754543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572606|NCT01199302|Brodalumab|brodalumab|mesh-list
65572607|NCT01199302|Dermatologic Agents|dermatologic agents|mesh-ancestor
65370122|NCT02600741|Antiemetics|antiemetics|mesh-ancestor
65572608|NCT03754387|Ceftazidime|ceftazidime|mesh-list
65572609|NCT03754387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65572610|NCT03754387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65572611|NCT04918147|Acetaminophen|acetaminophen|mesh-list
65572612|NCT04918147|Diphenhydramine|diphenhydramine|mesh-list
65572613|NCT04918147|Promethazine|promethazine|mesh-list
65572615|NCT04918147|Methylprednisolone|methylprednisolone|mesh-list
65572616|NCT04918147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65572617|NCT04918147|Elotuzumab|elotuzumab|mesh-list
65572618|NCT04918147|Famotidine|famotidine|mesh-list
65572619|NCT04918147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65572620|NCT04918147|Glucocorticoids|glucocorticoids|mesh-ancestor
65572621|NCT04918147|Hormones|hormones|mesh-ancestor
65572622|NCT04918147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65572623|NCT04918147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572624|NCT04918147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65572625|NCT04918147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572626|NCT04918147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65572627|NCT04918147|Analgesics|analgesics|mesh-ancestor
65572628|NCT04918147|Sensory System Agents|sensory system agents|mesh-ancestor
65572629|NCT04918147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572630|NCT04918147|Antipyretics|antipyretics|mesh-ancestor
65572631|NCT04918147|Antiemetics|antiemetics|mesh-ancestor
65572632|NCT04918147|Autonomic Agents|autonomic agents|mesh-ancestor
65572633|NCT04918147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65572634|NCT04918147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65572635|NCT04918147|Protective Agents|protective agents|mesh-ancestor
65572636|NCT04918147|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65572637|NCT04918147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65572638|NCT04918147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65572639|NCT04918147|Anesthetics, Local|anesthetics, local|mesh-ancestor
65572640|NCT04918147|Anesthetics|anesthetics|mesh-ancestor
65572641|NCT04918147|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65572642|NCT04918147|Histamine Antagonists|histamine antagonists|mesh-ancestor
65572643|NCT04918147|Histamine Agents|histamine agents|mesh-ancestor
65572644|NCT04918147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65572645|NCT04918147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572646|NCT04918147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65572647|NCT04918147|Antipruritics|antipruritics|mesh-ancestor
65572648|NCT04918147|Dermatologic Agents|dermatologic agents|mesh-ancestor
65572649|NCT04918147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65572650|NCT04918147|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65572651|NCT03171480|Isosorbide|isosorbide|mesh-list
65572652|NCT03171480|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65572653|NCT03171480|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65572654|NCT03171480|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65572655|NCT03171480|Diuretics|diuretics|mesh-ancestor
65572656|NCT03171480|Natriuretic Agents|natriuretic agents|mesh-ancestor
65572657|NCT03171480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572658|NCT03171480|Vasodilator Agents|vasodilator agents|mesh-ancestor
65572659|NCT03171480|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65572660|NCT03171480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572661|NCT04465357|Erenumab|erenumab|mesh-list
65572662|NCT04465357|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65572663|NCT04465357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572664|NCT04465357|Analgesics|analgesics|mesh-ancestor
65572665|NCT04465357|Sensory System Agents|sensory system agents|mesh-ancestor
65572666|NCT04465357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572667|NCT04465357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572669|NCT02761694|Fulvestrant|fulvestrant|mesh-list
65572670|NCT02761694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65572671|NCT02761694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572672|NCT02761694|Tubulin Modulators|tubulin modulators|mesh-ancestor
65572673|NCT02761694|Antimitotic Agents|antimitotic agents|mesh-ancestor
65572674|NCT02761694|Mitosis Modulators|mitosis modulators|mesh-ancestor
65572675|NCT02761694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572676|NCT02761694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65572677|NCT02761694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65572678|NCT02761694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65572679|NCT02761694|Hormone Antagonists|hormone antagonists|mesh-ancestor
65572680|NCT02761694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65572681|NCT02761694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572682|NCT05396690|Sevoflurane|sevoflurane|mesh-list
65572683|NCT05396690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65572684|NCT05396690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65572685|NCT05396690|Anesthetics, General|anesthetics, general|mesh-ancestor
65572686|NCT05396690|Anesthetics|anesthetics|mesh-ancestor
65572687|NCT05396690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65572688|NCT05396690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572689|NCT01384058|Simvastatin|simvastatin|mesh-list
65572690|NCT01384058|Ezetimibe|ezetimibe|mesh-list
65572691|NCT01384058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65572692|NCT01384058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65572693|NCT01384058|Antimetabolites|antimetabolites|mesh-ancestor
65572694|NCT01384058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572695|NCT01384058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65572696|NCT01384058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65572697|NCT01384058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572698|NCT04401384|Pyridoxine|pyridoxine|mesh-list
65572699|NCT04401384|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
65572700|NCT04401384|Doxylamine|doxylamine|mesh-list
65572701|NCT04401384|Dicyclomine|dicyclomine|mesh-list
65572702|NCT04401384|Antiemetics|antiemetics|mesh-ancestor
65572703|NCT04401384|Autonomic Agents|autonomic agents|mesh-ancestor
65572704|NCT04401384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572705|NCT04401384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572706|NCT04401384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65572707|NCT04401384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65572708|NCT04401384|Histamine Antagonists|histamine antagonists|mesh-ancestor
65572709|NCT04401384|Histamine Agents|histamine agents|mesh-ancestor
65572710|NCT04401384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65572711|NCT04401384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572712|NCT04401384|Parasympatholytics|parasympatholytics|mesh-ancestor
65572713|NCT04401384|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65572714|NCT04401384|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65572715|NCT04401384|Cholinergic Agents|cholinergic agents|mesh-ancestor
65572716|NCT04401384|Vitamin B Complex|vitamin b complex|mesh-ancestor
65572717|NCT04401384|Vitamins|vitamins|mesh-ancestor
65572718|NCT04401384|Micronutrients|micronutrients|mesh-ancestor
65572719|NCT03312114|Avelumab|avelumab|mesh-list
65572720|NCT03312114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65572721|NCT03312114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572722|NCT04239222|Ibuprofen|ibuprofen|mesh-list
65572723|NCT04239222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65572724|NCT04239222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65572725|NCT04239222|Analgesics|analgesics|mesh-ancestor
65572726|NCT04239222|Sensory System Agents|sensory system agents|mesh-ancestor
65572727|NCT04239222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572728|NCT04239222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572729|NCT04239222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65572730|NCT04239222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65572731|NCT04239222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65572732|NCT04239222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572733|NCT04239222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572734|NCT02566304|Mycophenolic Acid|mycophenolic acid|mesh-list
65572735|NCT02566304|Cyclophosphamide|cyclophosphamide|mesh-list
65572736|NCT02566304|Fludarabine|fludarabine|mesh-list
65572737|NCT02566304|Fludarabine phosphate|fludarabine phosphate|mesh-list
65572738|NCT02566304|Tacrolimus|tacrolimus|mesh-list
65572739|NCT02566304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65572740|NCT02566304|Immunologic Factors|immunologic factors|mesh-ancestor
65572741|NCT02566304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572742|NCT02566304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65572743|NCT02566304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65572744|NCT02566304|Alkylating Agents|alkylating agents|mesh-ancestor
65572745|NCT02566304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572746|NCT02566304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572747|NCT02566304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65572748|NCT02566304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65572749|NCT02566304|Antimetabolites|antimetabolites|mesh-ancestor
65572750|NCT02566304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65572751|NCT02566304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65572752|NCT02566304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572753|NCT02566304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65572754|NCT02566304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65572755|NCT02566304|Antitubercular Agents|antitubercular agents|mesh-ancestor
65572756|NCT02566304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65572757|NCT04732260|Letermovir|letermovir|mesh-list
65572758|NCT04732260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65572759|NCT04732260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572760|NCT04732260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572761|NCT04732260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572762|NCT04732260|Antiviral Agents|antiviral agents|mesh-ancestor
65572763|NCT04732260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65572764|NCT03084536|Acetaminophen|acetaminophen|mesh-list
65572765|NCT03084536|Celecoxib|celecoxib|mesh-list
65572766|NCT03084536|Fentanyl|fentanyl|mesh-list
65572767|NCT03084536|Midazolam|midazolam|mesh-list
65572768|NCT03084536|Gabapentin|gabapentin|mesh-list
65572769|NCT03084536|Bupivacaine|bupivacaine|mesh-list
65572770|NCT03084536|Anesthetics, Local|anesthetics, local|mesh-ancestor
65572771|NCT03084536|Anesthetics|anesthetics|mesh-ancestor
65572772|NCT03084536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65572773|NCT03084536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572774|NCT03084536|Sensory System Agents|sensory system agents|mesh-ancestor
65572775|NCT03084536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572776|NCT03084536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65572777|NCT03084536|Narcotics|narcotics|mesh-ancestor
65572778|NCT03084536|Analgesics|analgesics|mesh-ancestor
65572779|NCT03084536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65572780|NCT03084536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65572781|NCT03084536|Anesthetics, General|anesthetics, general|mesh-ancestor
65572782|NCT03084536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65572783|NCT03084536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65572784|NCT03084536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65572785|NCT03084536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65572786|NCT03084536|GABA Modulators|gaba modulators|mesh-ancestor
65572787|NCT03084536|GABA Agents|gaba agents|mesh-ancestor
65572788|NCT03084536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65572789|NCT03084536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572790|NCT03084536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65572791|NCT03084536|Antipyretics|antipyretics|mesh-ancestor
65572792|NCT03084536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65572793|NCT03084536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65572794|NCT03084536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65572795|NCT03084536|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65572796|NCT03084536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65572797|NCT03084536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572798|NCT03084536|Anticonvulsants|anticonvulsants|mesh-ancestor
65572799|NCT03084536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65572800|NCT03084536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65572801|NCT03084536|Antimanic Agents|antimanic agents|mesh-ancestor
65572802|NCT03311724|Tirzepatide|tirzepatide|mesh-list
65572803|NCT03311724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65572804|NCT03311724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572805|NCT03311724|Incretins|incretins|mesh-ancestor
65572806|NCT03311724|Hormones|hormones|mesh-ancestor
65572807|NCT03311724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65572808|NCT05213312|Paclitaxel|paclitaxel|mesh-list
65572809|NCT05213312|Fluorouracil|fluorouracil|mesh-list
65572810|NCT05213312|Nivolumab|nivolumab|mesh-list
65572811|NCT05213312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65572812|NCT05213312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572813|NCT05213312|Tubulin Modulators|tubulin modulators|mesh-ancestor
65572814|NCT05213312|Antimitotic Agents|antimitotic agents|mesh-ancestor
65572815|NCT05213312|Mitosis Modulators|mitosis modulators|mesh-ancestor
65572816|NCT05213312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572817|NCT05213312|Antimetabolites|antimetabolites|mesh-ancestor
65572818|NCT05213312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65370343|NCT00825864|BB 1101|bb 1101|mesh-list
65572819|NCT05213312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65572820|NCT05213312|Immunologic Factors|immunologic factors|mesh-ancestor
65572821|NCT05213312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572822|NCT05213312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65572823|NCT05213312|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65572825|NCT04080804|Ipilimumab|ipilimumab|mesh-list
65572826|NCT04080804|Antibodies|antibodies|mesh-list
65572827|NCT04080804|Immunoglobulins|immunoglobulins|mesh-list
65572828|NCT04080804|Immunologic Factors|immunologic factors|mesh-ancestor
65572829|NCT04080804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572830|NCT04080804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65572831|NCT04080804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572832|NCT04080804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65572833|NCT04080804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572834|NCT03311646|Nicotine|nicotine|mesh-list
65572835|NCT03311646|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65572836|NCT03311646|Autonomic Agents|autonomic agents|mesh-ancestor
65572837|NCT03311646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572838|NCT03311646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572839|NCT03311646|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65572840|NCT03311646|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65572841|NCT03311646|Cholinergic Agents|cholinergic agents|mesh-ancestor
65572842|NCT03311646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65572843|NCT03311646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572844|NCT03680274|Ascorbic Acid|ascorbic acid|mesh-list
65572845|NCT03680274|Vitamins|vitamins|mesh-ancestor
65572846|NCT03680274|Micronutrients|micronutrients|mesh-ancestor
65572847|NCT03680274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572848|NCT03680274|Antioxidants|antioxidants|mesh-ancestor
65572849|NCT03680274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572850|NCT03680274|Protective Agents|protective agents|mesh-ancestor
65572851|NCT03288987|Leucovorin|leucovorin|mesh-list
65572852|NCT03288987|Bevacizumab|bevacizumab|mesh-list
65572853|NCT03288987|Fluorouracil|fluorouracil|mesh-list
65572854|NCT03288987|Irinotecan|irinotecan|mesh-list
65572855|NCT03288987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65572856|NCT03288987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572857|NCT03288987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65572858|NCT03288987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65572859|NCT03288987|Growth Substances|growth substances|mesh-ancestor
65572860|NCT03288987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572861|NCT03288987|Growth Inhibitors|growth inhibitors|mesh-ancestor
65572862|NCT03288987|Antimetabolites|antimetabolites|mesh-ancestor
65572863|NCT03288987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572864|NCT03288987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65572865|NCT03288987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65572866|NCT03288987|Immunologic Factors|immunologic factors|mesh-ancestor
65572867|NCT03288987|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65572868|NCT03288987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65572869|NCT03288987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572870|NCT03288987|Antidotes|antidotes|mesh-ancestor
65572871|NCT03288987|Protective Agents|protective agents|mesh-ancestor
65572872|NCT03288987|Vitamin B Complex|vitamin b complex|mesh-ancestor
65572873|NCT03288987|Vitamins|vitamins|mesh-ancestor
65572874|NCT03288987|Micronutrients|micronutrients|mesh-ancestor
65572875|NCT01379846|Vaccines|vaccines|mesh-list
65572876|NCT01379846|Immunologic Factors|immunologic factors|mesh-ancestor
65572877|NCT01379846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572878|NCT01379300|Rivaroxaban|rivaroxaban|mesh-list
65572879|NCT01379300|Dabigatran|dabigatran|mesh-list
65572880|NCT01379300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65572881|NCT01379300|Antithrombins|antithrombins|mesh-ancestor
65572882|NCT01379300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65572883|NCT01379300|Protease Inhibitors|protease inhibitors|mesh-ancestor
65572884|NCT01379300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572885|NCT01379300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572886|NCT01379300|Anticoagulants|anticoagulants|mesh-ancestor
65572887|NCT03682224|Epinephrine|epinephrine|mesh-list
65572888|NCT03682224|Bupivacaine|bupivacaine|mesh-list
65572889|NCT03682224|Anesthetics, Local|anesthetics, local|mesh-ancestor
65572890|NCT03682224|Anesthetics|anesthetics|mesh-ancestor
65572891|NCT03682224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65572892|NCT03682224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572893|NCT03682224|Sensory System Agents|sensory system agents|mesh-ancestor
65572894|NCT03682224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572895|NCT03682224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65572896|NCT03682224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65572897|NCT03682224|Adrenergic Agents|adrenergic agents|mesh-ancestor
65572898|NCT03682224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65572899|NCT03682224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572900|NCT03682224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65572901|NCT03682224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65572902|NCT03682224|Autonomic Agents|autonomic agents|mesh-ancestor
65572903|NCT03682224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65572904|NCT03682224|Respiratory System Agents|respiratory system agents|mesh-ancestor
65572905|NCT03682224|Mydriatics|mydriatics|mesh-ancestor
65572906|NCT03682224|Sympathomimetics|sympathomimetics|mesh-ancestor
65572907|NCT03682224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65572908|NCT01383044|Carvedilol|carvedilol|mesh-list
65572909|NCT01383044|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65572910|NCT01383044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65572911|NCT01383044|Adrenergic Agents|adrenergic agents|mesh-ancestor
65572912|NCT01383044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65572913|NCT01383044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572914|NCT01383044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572915|NCT01383044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65572916|NCT01383044|Antioxidants|antioxidants|mesh-ancestor
65572917|NCT01383044|Protective Agents|protective agents|mesh-ancestor
65572918|NCT01383044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65572919|NCT01383044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65572920|NCT01383044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65572921|NCT01383044|Vasodilator Agents|vasodilator agents|mesh-ancestor
65572922|NCT01383044|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65572923|NCT01383044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65572924|NCT01377428|Formoterol Fumarate|formoterol fumarate|mesh-list
65572925|NCT01377428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65572926|NCT01377428|Autonomic Agents|autonomic agents|mesh-ancestor
65572927|NCT01377428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65572928|NCT01377428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572929|NCT01377428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65572930|NCT01377428|Respiratory System Agents|respiratory system agents|mesh-ancestor
65572931|NCT01377428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65572932|NCT01377428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65572933|NCT01377428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65572934|NCT01377428|Adrenergic Agents|adrenergic agents|mesh-ancestor
65572935|NCT01377428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65572936|NCT01377428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572937|NCT03083990|Bevacizumab|bevacizumab|mesh-list
65572938|NCT03083990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65572939|NCT03083990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572940|NCT03083990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65572941|NCT03083990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65572942|NCT03083990|Growth Substances|growth substances|mesh-ancestor
65572943|NCT03083990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572944|NCT03083990|Growth Inhibitors|growth inhibitors|mesh-ancestor
65572945|NCT03252015|Lasmiditan|lasmiditan|mesh-list
65572946|NCT03252015|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65572947|NCT03252015|Serotonin Agents|serotonin agents|mesh-ancestor
65572948|NCT03252015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65572949|NCT03252015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572950|NCT03252015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572951|NCT01314027|Gemcitabine|gemcitabine|mesh-list
65572952|NCT01314027|Oxaliplatin|oxaliplatin|mesh-list
65572953|NCT01314027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65572954|NCT01314027|Antimetabolites|antimetabolites|mesh-ancestor
65572955|NCT01314027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572956|NCT01314027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572957|NCT01314027|Antiviral Agents|antiviral agents|mesh-ancestor
65572958|NCT01314027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65572959|NCT01314027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65572960|NCT01314027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65572961|NCT01314027|Immunologic Factors|immunologic factors|mesh-ancestor
65572962|NCT01314027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572963|NCT03708003|Venetoclax|venetoclax|mesh-list
65572964|NCT03708003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572965|NCT03083132|Modafinil|modafinil|mesh-list
65572966|NCT03083132|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65572967|NCT03083132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572968|NCT03083132|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65572969|NCT03083132|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65572970|NCT03083132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65572971|NCT03083132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572972|NCT04121468|Metformin|metformin|mesh-list
65572973|NCT04121468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65572974|NCT04121468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572975|NCT03354728|Vaccines|vaccines|mesh-list
65572976|NCT03354728|Immunologic Factors|immunologic factors|mesh-ancestor
65572977|NCT03354728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65572978|NCT03341936|Nivolumab|nivolumab|mesh-list
65572979|NCT03341936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65572980|NCT03341936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572981|NCT03341936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65572982|NCT03341936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572983|NCT03648489|Paclitaxel|paclitaxel|mesh-list
65572984|NCT03648489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65572985|NCT03648489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65572986|NCT03648489|Tubulin Modulators|tubulin modulators|mesh-ancestor
65572987|NCT03648489|Antimitotic Agents|antimitotic agents|mesh-ancestor
65572988|NCT03648489|Mitosis Modulators|mitosis modulators|mesh-ancestor
65572989|NCT03648489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572990|NCT01382888|Heparin|heparin|mesh-list
65572991|NCT01382888|Anticoagulants|anticoagulants|mesh-ancestor
65572992|NCT01382888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65572993|NCT01382888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65572994|NCT01382888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65572995|NCT03249909|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65572996|NCT03249909|Laxatives|laxatives|mesh-ancestor
65572997|NCT03249909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65572998|NCT04809116|Pimavanserin|pimavanserin|mesh-list
65572999|NCT04809116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65573000|NCT04809116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65573001|NCT04809116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65573002|NCT04809116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65573003|NCT04809116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65573004|NCT04809116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573005|NCT04809116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65573006|NCT04809116|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65573007|NCT04809116|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65573008|NCT04809116|Serotonin Agents|serotonin agents|mesh-ancestor
65573009|NCT04809116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65573010|NCT04809116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573011|NCT02199236|Capecitabine|capecitabine|mesh-list
65573012|NCT02199236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65573013|NCT02199236|Antimetabolites|antimetabolites|mesh-ancestor
65573014|NCT02199236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573015|NCT02199236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573016|NCT03077438|Vaccines|vaccines|mesh-list
65573017|NCT03077438|Immunologic Factors|immunologic factors|mesh-ancestor
65573018|NCT03077438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573019|NCT01382732|Oxytocin|oxytocin|mesh-list
65573020|NCT01382732|Carbetocin|carbetocin|mesh-list
65573021|NCT01382732|Oxytocics|oxytocics|mesh-ancestor
65573022|NCT01382732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65573023|NCT01382732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573024|NCT02183870|Crizotinib|crizotinib|mesh-list
65573025|NCT02183870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573026|NCT02183870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65573027|NCT02183870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573028|NCT02183870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573029|NCT03076970|Sumatriptan|sumatriptan|mesh-list
65573030|NCT03076970|Lasmiditan|lasmiditan|mesh-list
65573031|NCT03076970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65573032|NCT03076970|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65573033|NCT03076970|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65573034|NCT03076970|Serotonin Agents|serotonin agents|mesh-ancestor
65573035|NCT03076970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65573036|NCT03076970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573037|NCT03076970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573038|NCT00726596|Hydroxychloroquine|hydroxychloroquine|mesh-list
65573039|NCT00726596|Antimalarials|antimalarials|mesh-ancestor
65573040|NCT00726596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65573041|NCT00726596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65573042|NCT00726596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65573043|NCT00726596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573044|NCT00726596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573045|NCT00726596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65573046|NCT04897880|Panobinostat|panobinostat|mesh-list
65573047|NCT04897880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573048|NCT04897880|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65573049|NCT04897880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573050|NCT04897880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573051|NCT02890992|Nicotinic Acids|nicotinic acids|mesh-list
65573052|NCT02890992|Niacin|niacin|mesh-list
65573053|NCT02890992|Niacinamide|niacinamide|mesh-list
65573054|NCT02890992|Ezetimibe|ezetimibe|mesh-list
65573055|NCT02890992|Cholestyramine Resin|cholestyramine resin|mesh-list
65573056|NCT02890992|Fenofibrate|fenofibrate|mesh-list
65573057|NCT02890992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65573058|NCT02890992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65573059|NCT02890992|Antimetabolites|antimetabolites|mesh-ancestor
65573060|NCT02890992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573061|NCT02890992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65573062|NCT02890992|Vitamin B Complex|vitamin b complex|mesh-ancestor
65573063|NCT02890992|Vitamins|vitamins|mesh-ancestor
65573064|NCT02890992|Micronutrients|micronutrients|mesh-ancestor
65573065|NCT02890992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573066|NCT02890992|Vasodilator Agents|vasodilator agents|mesh-ancestor
65573067|NCT03603912|Metformin|metformin|mesh-list
65573068|NCT03603912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65573069|NCT03603912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573070|NCT04357730|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65573071|NCT04357730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65573072|NCT04357730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65573073|NCT04357730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573074|NCT05274984|Lidocaine|lidocaine|mesh-list
65573075|NCT05274984|Anesthetics, Local|anesthetics, local|mesh-ancestor
65573076|NCT05274984|Anesthetics|anesthetics|mesh-ancestor
65573077|NCT05274984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65573078|NCT05274984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573079|NCT05274984|Sensory System Agents|sensory system agents|mesh-ancestor
65573080|NCT05274984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65573081|NCT05274984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65573082|NCT05274984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65573083|NCT05274984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65573084|NCT05274984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65573085|NCT05274984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573086|NCT05274672|Ciprofloxacin|ciprofloxacin|mesh-list
65573087|NCT05274672|Cephalexin|cephalexin|mesh-list
65573088|NCT05274672|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65573089|NCT05274672|Nitrofurantoin|nitrofurantoin|mesh-list
65573090|NCT05274672|Trimethoprim|trimethoprim|mesh-list
65573091|NCT05274672|Sulfamethoxazole|sulfamethoxazole|mesh-list
65573092|NCT05274672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65573093|NCT05274672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65573094|NCT05274672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65573095|NCT05274672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65573096|NCT05274672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573097|NCT05274672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573098|NCT05274672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573099|NCT05274672|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65573100|NCT05274672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65573101|NCT05274672|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65573102|NCT05274672|Renal Agents|renal agents|mesh-ancestor
65573103|NCT05274672|Antimalarials|antimalarials|mesh-ancestor
65573104|NCT05274672|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65573105|NCT05274672|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65573106|NCT05274672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65573107|NCT05274672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65573108|NCT05274672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65573109|NCT01379144|Latanoprost|latanoprost|mesh-list
65573110|NCT01379144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65573111|NCT01379144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65573112|NCT04179890|Afatinib|afatinib|mesh-list
65573113|NCT04179890|Mitogens|mitogens|mesh-list
65573114|NCT04179890|Mitosis Modulators|mitosis modulators|mesh-ancestor
65573115|NCT04179890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573116|NCT04179890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573117|NCT04179890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65573118|NCT04179890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573119|NCT01376882|Caffeine|caffeine|mesh-list
65573120|NCT01376882|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65573121|NCT01376882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573122|NCT01376882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65573123|NCT01376882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573124|NCT01376882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573125|NCT01376882|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65573126|NCT01376882|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65573127|NCT01376882|Purinergic Agents|purinergic agents|mesh-ancestor
65573128|NCT01376882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65573129|NCT03329196|Darbepoetin alfa|darbepoetin alfa|mesh-list
65573130|NCT03329196|Hematinics|hematinics|mesh-ancestor
65573131|NCT01382498|Calcium Dobesilate|calcium dobesilate|mesh-list
65573133|NCT01382498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65573134|NCT01382498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573135|NCT01382498|Hemostatics|hemostatics|mesh-ancestor
65573136|NCT01382498|Coagulants|coagulants|mesh-ancestor
65573137|NCT05322902|Propofol|propofol|mesh-list
65573138|NCT05322902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65573139|NCT05322902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65573140|NCT05322902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573141|NCT05322902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65573142|NCT05322902|Anesthetics, General|anesthetics, general|mesh-ancestor
65573143|NCT05322902|Anesthetics|anesthetics|mesh-ancestor
65573144|NCT03476538|Gabapentin|gabapentin|mesh-list
65573145|NCT03476538|Analgesics|analgesics|mesh-ancestor
65573146|NCT03476538|Sensory System Agents|sensory system agents|mesh-ancestor
65573147|NCT03476538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65573148|NCT03476538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573149|NCT03476538|Anticonvulsants|anticonvulsants|mesh-ancestor
65573150|NCT03476538|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65573151|NCT03476538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65573152|NCT03476538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65573153|NCT03476538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65573154|NCT03476538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65573155|NCT03476538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65573156|NCT03476538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65573157|NCT03476538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573158|NCT03476538|Antimanic Agents|antimanic agents|mesh-ancestor
65573159|NCT03326856|Botulinum Toxins|botulinum toxins|mesh-list
65573160|NCT03326856|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65573161|NCT03326856|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65573162|NCT03326856|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65573163|NCT03326856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65573164|NCT03326856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573165|NCT03326856|Cholinergic Agents|cholinergic agents|mesh-ancestor
65573166|NCT03326856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65573167|NCT03326856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573168|NCT03326856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65573169|NCT03326856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65573170|NCT00000116|Vitamin A|vitamin a|mesh-list
65573171|NCT00000116|Vitamins|vitamins|mesh-ancestor
65573172|NCT00000116|Micronutrients|micronutrients|mesh-ancestor
65573173|NCT00000116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573174|NCT05232396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65573175|NCT05232396|Antibodies|antibodies|mesh-list
65573176|NCT05232396|Immunoglobulins|immunoglobulins|mesh-list
65573177|NCT05232396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65573178|NCT05232396|Immunologic Factors|immunologic factors|mesh-ancestor
65573179|NCT05232396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573180|NCT05232396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573181|NCT05222724|Ibuprofen|ibuprofen|mesh-list
65573182|NCT05222724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65573183|NCT05222724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65573184|NCT05222724|Analgesics|analgesics|mesh-ancestor
65573185|NCT05222724|Sensory System Agents|sensory system agents|mesh-ancestor
65573186|NCT05222724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65573187|NCT05222724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573188|NCT05222724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65573189|NCT05222724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65573190|NCT05222724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65573191|NCT05222724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573192|NCT05222724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573193|NCT01382342|Rasagiline|rasagiline|mesh-list
65370714|NCT00524134|Vasodilator Agents|vasodilator agents|mesh-ancestor
65573194|NCT01382342|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65573196|NCT01382342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573197|NCT01382342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65573198|NCT01382342|Protective Agents|protective agents|mesh-ancestor
65573199|NCT01382342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573200|NCT03471728|Linaclotide|linaclotide|mesh-list
65573201|NCT03471728|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65573202|NCT03471728|Enzyme Activators|enzyme activators|mesh-ancestor
65573203|NCT03471728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573204|NCT03471728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65573205|NCT03630614|Nicotine|nicotine|mesh-list
65573206|NCT03630614|Varenicline|varenicline|mesh-list
65573207|NCT03630614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65573208|NCT03630614|Autonomic Agents|autonomic agents|mesh-ancestor
65573209|NCT03630614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65573210|NCT03630614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573211|NCT03630614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65573212|NCT03630614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65573213|NCT03630614|Cholinergic Agents|cholinergic agents|mesh-ancestor
65573214|NCT03630614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65573215|NCT03630614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573216|NCT01378832|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65573217|NCT01378832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65573218|NCT05060432|Pembrolizumab|pembrolizumab|mesh-list
65573219|NCT05060432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65573220|NCT05060432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573221|NCT01378754|Fospropofol|fospropofol|mesh-list
65573222|NCT01378754|Propofol|propofol|mesh-list
65573223|NCT01378754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65573224|NCT01378754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65573225|NCT01378754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573226|NCT01378754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65573227|NCT01378754|Anesthetics, General|anesthetics, general|mesh-ancestor
65573228|NCT01378754|Anesthetics|anesthetics|mesh-ancestor
65573229|NCT05764304|Sinomenine|sinomenine|mesh-list
65573230|NCT05764304|Glucocorticoids|glucocorticoids|mesh-list
65573231|NCT05764304|Hormones|hormones|mesh-ancestor
65573232|NCT05764304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65573233|NCT05764304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573234|NCT05764304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65573235|NCT03075410|GSK656|gsk656|mesh-list
65573236|NCT03075410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65573237|NCT03075410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65573238|NCT05764226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65573239|NCT02826512|Niraparib|niraparib|mesh-list
65573240|NCT02826512|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65573241|NCT02826512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573242|NCT02826512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573243|NCT02826512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573244|NCT05391230|Permethrin|permethrin|mesh-list
65573245|NCT05391230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573246|NCT05391230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573247|NCT02731352|Apatinib|apatinib|mesh-list
65573248|NCT02731352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573249|NCT02731352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65573250|NCT02731352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573251|NCT02731352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573252|NCT05132660|Levodopa|levodopa|mesh-list
65573253|NCT05132660|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65573254|NCT05132660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65573255|NCT05132660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65573256|NCT05132660|Dopamine Agents|dopamine agents|mesh-ancestor
65573257|NCT05132660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65573258|NCT05132660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573259|NCT05132660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573260|NCT05132660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65573261|NCT05132660|Immunologic Factors|immunologic factors|mesh-ancestor
65573262|NCT05132660|Dopamine Agonists|dopamine agonists|mesh-ancestor
65573263|NCT05762744|Exenatide|exenatide|mesh-list
65573264|NCT05762744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65573265|NCT05762744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573266|NCT05762744|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65573267|NCT05762744|Incretins|incretins|mesh-ancestor
65370787|NCT04095299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573268|NCT05762744|Hormones|hormones|mesh-ancestor
65573269|NCT05762744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65573270|NCT02257424|Hydroxychloroquine|hydroxychloroquine|mesh-list
65573271|NCT02257424|Trametinib|trametinib|mesh-list
65573272|NCT02257424|Dabrafenib|dabrafenib|mesh-list
65573273|NCT02257424|Antimalarials|antimalarials|mesh-ancestor
65573274|NCT02257424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65573275|NCT02257424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65573276|NCT02257424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65573277|NCT02257424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573278|NCT02257424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573279|NCT02257424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65573280|NCT02257424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573281|NCT02257424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65573282|NCT01858922|Cytarabine|cytarabine|mesh-list
65573283|NCT01858922|Dexamethasone|dexamethasone|mesh-list
65573284|NCT01858922|Prednisone|prednisone|mesh-list
65573285|NCT01858922|Cyclophosphamide|cyclophosphamide|mesh-list
65573286|NCT01858922|Cisplatin|cisplatin|mesh-list
65573287|NCT01858922|Doxorubicin|doxorubicin|mesh-list
65573288|NCT01858922|Etoposide|etoposide|mesh-list
65573289|NCT01858922|Etoposide phosphate|etoposide phosphate|mesh-list
65573290|NCT01858922|Vincristine|vincristine|mesh-list
65573291|NCT01858922|Bleomycin|bleomycin|mesh-list
65573292|NCT01858922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65573293|NCT01858922|Immunologic Factors|immunologic factors|mesh-ancestor
65573294|NCT01858922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573295|NCT01858922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65573296|NCT01858922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65573297|NCT01858922|Alkylating Agents|alkylating agents|mesh-ancestor
65573298|NCT01858922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573299|NCT01858922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573300|NCT01858922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65573301|NCT01858922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65573302|NCT01858922|Antiemetics|antiemetics|mesh-ancestor
65573303|NCT01858922|Autonomic Agents|autonomic agents|mesh-ancestor
65573304|NCT01858922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65573305|NCT01858922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65573306|NCT01858922|Glucocorticoids|glucocorticoids|mesh-ancestor
65573307|NCT01858922|Hormones|hormones|mesh-ancestor
65573308|NCT01858922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65573309|NCT01858922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65573310|NCT01858922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573311|NCT01858922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65573312|NCT01858922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65573313|NCT01858922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65573314|NCT01858922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65573315|NCT01858922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65573316|NCT01858922|Antimetabolites|antimetabolites|mesh-ancestor
65573317|NCT01858922|Antiviral Agents|antiviral agents|mesh-ancestor
65573318|NCT01858922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65573319|NCT01858922|Tubulin Modulators|tubulin modulators|mesh-ancestor
65573320|NCT01858922|Antimitotic Agents|antimitotic agents|mesh-ancestor
65573321|NCT01858922|Mitosis Modulators|mitosis modulators|mesh-ancestor
65573322|NCT01378286|Artesunate|artesunate|mesh-list
65573323|NCT01378286|Chloroquine|chloroquine|mesh-list
65573324|NCT01378286|Amodiaquine|amodiaquine|mesh-list
65573325|NCT01378286|Antimalarials|antimalarials|mesh-ancestor
65573326|NCT01378286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65573327|NCT01378286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65573328|NCT01378286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65573329|NCT01378286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573330|NCT01378286|Antiviral Agents|antiviral agents|mesh-ancestor
65573331|NCT01378286|Schistosomicides|schistosomicides|mesh-ancestor
65573332|NCT01378286|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65573333|NCT01378286|Anthelmintics|anthelmintics|mesh-ancestor
65573334|NCT01378286|Amebicides|amebicides|mesh-ancestor
65573335|NCT01378286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65573336|NCT01377974|Miltefosine|miltefosine|mesh-list
65573337|NCT01377974|Meglumine Antimoniate|meglumine antimoniate|mesh-list
65573338|NCT01377974|Antifungal Agents|antifungal agents|mesh-ancestor
65573339|NCT01377974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65573340|NCT01377974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573341|NCT01377974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65573342|NCT01377974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65573343|NCT04929080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65573344|NCT04929080|Antibodies|antibodies|mesh-list
65573345|NCT04929080|Immunoglobulins|immunoglobulins|mesh-list
65573346|NCT04929080|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65573347|NCT04929080|Immunoglobulin G|immunoglobulin g|mesh-list
65573348|NCT04929080|Immunologic Factors|immunologic factors|mesh-ancestor
65573349|NCT04929080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573350|NCT04929080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573351|NCT03071276|Cytarabine|cytarabine|mesh-list
65573352|NCT03071276|Hydrocortisone|hydrocortisone|mesh-list
65573353|NCT03071276|Methotrexate|methotrexate|mesh-list
65573354|NCT03071276|Fludarabine phosphate|fludarabine phosphate|mesh-list
65573355|NCT03071276|Fludarabine|fludarabine|mesh-list
65573356|NCT03071276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65573357|NCT03071276|Abortifacient Agents|abortifacient agents|mesh-ancestor
65573358|NCT03071276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65573359|NCT03071276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573360|NCT03071276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65573361|NCT03071276|Antimetabolites|antimetabolites|mesh-ancestor
65573362|NCT03071276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573363|NCT03071276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573364|NCT03071276|Dermatologic Agents|dermatologic agents|mesh-ancestor
65573365|NCT03071276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573366|NCT03071276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65573367|NCT03071276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65573368|NCT03071276|Immunologic Factors|immunologic factors|mesh-ancestor
65573369|NCT03071276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65573370|NCT03071276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65573371|NCT03071276|Antiviral Agents|antiviral agents|mesh-ancestor
65573372|NCT03071276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65573373|NCT03071276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65573374|NCT03629600|Indomethacin|indomethacin|mesh-list
65573375|NCT03629600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65573376|NCT03629600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65573377|NCT03629600|Analgesics|analgesics|mesh-ancestor
65573378|NCT03629600|Sensory System Agents|sensory system agents|mesh-ancestor
65573379|NCT03629600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65573380|NCT03629600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573381|NCT03629600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65573382|NCT03629600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65573383|NCT03629600|Gout Suppressants|gout suppressants|mesh-ancestor
65573384|NCT03629600|Tocolytic Agents|tocolytic agents|mesh-ancestor
65573385|NCT03629600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65573386|NCT03629600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65573387|NCT03629600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573388|NCT03629600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573389|NCT03074162|Diclofenac|diclofenac|mesh-list
65573390|NCT03074162|Capsaicin|capsaicin|mesh-list
65573391|NCT03074162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65573392|NCT03074162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65573393|NCT03074162|Analgesics|analgesics|mesh-ancestor
65573394|NCT03074162|Sensory System Agents|sensory system agents|mesh-ancestor
65573395|NCT03074162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65573396|NCT03074162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573397|NCT03074162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65573398|NCT03074162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65573399|NCT03074162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65573400|NCT03074162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573401|NCT03074162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573402|NCT03074162|Antipruritics|antipruritics|mesh-ancestor
65573403|NCT03074162|Dermatologic Agents|dermatologic agents|mesh-ancestor
65573404|NCT05069012|Morphine|morphine|mesh-list
65573405|NCT05069012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65573406|NCT05069012|Narcotics|narcotics|mesh-ancestor
65573407|NCT05069012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65573408|NCT05069012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573409|NCT05069012|Analgesics|analgesics|mesh-ancestor
65573410|NCT05069012|Sensory System Agents|sensory system agents|mesh-ancestor
65573411|NCT05069012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65573412|NCT04065074|FX006|fx006|mesh-list
65573413|NCT04065074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65573414|NCT04065074|Glucocorticoids|glucocorticoids|mesh-ancestor
65573415|NCT04065074|Hormones|hormones|mesh-ancestor
65573416|NCT04065074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65573417|NCT04065074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573418|NCT04065074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65573419|NCT04065074|Immunologic Factors|immunologic factors|mesh-ancestor
65573420|NCT03947216|Pimavanserin|pimavanserin|mesh-list
65573421|NCT03947216|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65573422|NCT03947216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65573423|NCT03947216|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65573424|NCT03947216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65573425|NCT03947216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65573426|NCT03947216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573427|NCT03947216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65573428|NCT03947216|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65573429|NCT03947216|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65573430|NCT03947216|Serotonin Agents|serotonin agents|mesh-ancestor
65573431|NCT03947216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65573432|NCT03947216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573433|NCT03920306|Silver Nitrate|silver nitrate|mesh-list
65573434|NCT03920306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65573435|NCT03920306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65573436|NCT02888106|Tenofovir|tenofovir|mesh-list
65573437|NCT02888106|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65573438|NCT02888106|Interferon alpha-2|interferon alpha-2|mesh-list
65573439|NCT02888106|Antiviral Agents|antiviral agents|mesh-ancestor
65573440|NCT02888106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65573441|NCT02888106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65573442|NCT02888106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65573443|NCT02888106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573444|NCT02888106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573445|NCT02888106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65573446|NCT02888106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65573447|NCT02888106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573448|NCT03793010|FX006|fx006|mesh-list
65573449|NCT03793010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65573450|NCT03793010|Glucocorticoids|glucocorticoids|mesh-ancestor
65573451|NCT03793010|Hormones|hormones|mesh-ancestor
65573452|NCT03793010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65573453|NCT03793010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573454|NCT03793010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65573455|NCT03793010|Immunologic Factors|immunologic factors|mesh-ancestor
65573456|NCT03055026|Rivaroxaban|rivaroxaban|mesh-list
65573457|NCT03055026|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65573458|NCT03055026|Antithrombins|antithrombins|mesh-ancestor
65573459|NCT03055026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65573460|NCT03055026|Protease Inhibitors|protease inhibitors|mesh-ancestor
65573461|NCT03055026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573462|NCT03055026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573463|NCT03055026|Anticoagulants|anticoagulants|mesh-ancestor
65573464|NCT03304626|Prednisone|prednisone|mesh-list
65573465|NCT03304626|Budesonide|budesonide|mesh-list
65573466|NCT03304626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65573467|NCT03304626|Glucocorticoids|glucocorticoids|mesh-ancestor
65573468|NCT03304626|Hormones|hormones|mesh-ancestor
65573469|NCT03304626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65573470|NCT03304626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573471|NCT03304626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65573472|NCT03304626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573473|NCT03304626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65573474|NCT03304626|Autonomic Agents|autonomic agents|mesh-ancestor
65573475|NCT03304626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65573476|NCT03304626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65573477|NCT03304626|Respiratory System Agents|respiratory system agents|mesh-ancestor
65573478|NCT05121714|Fluvoxamine|fluvoxamine|mesh-list
65573479|NCT05121714|Caffeine|caffeine|mesh-list
65573480|NCT05121714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65573481|NCT05121714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573482|NCT05121714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65573483|NCT05121714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573484|NCT05121714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573485|NCT05121714|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65573486|NCT05121714|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65573487|NCT05121714|Purinergic Agents|purinergic agents|mesh-ancestor
65573488|NCT05121714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65573489|NCT05121714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65573490|NCT05121714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65573491|NCT05121714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65573492|NCT05121714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65573493|NCT05121714|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65573494|NCT05121714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65573495|NCT05121714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65573496|NCT05121714|Serotonin Agents|serotonin agents|mesh-ancestor
65573497|NCT05121714|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65371016|NCT00296491|Glucocorticoids|glucocorticoids|mesh-ancestor
65573499|NCT05121714|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65573500|NCT05121714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65573501|NCT05121714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65573502|NCT02958150|Dexmedetomidine|dexmedetomidine|mesh-list
65573503|NCT02958150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65573504|NCT02958150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65573505|NCT02958150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573506|NCT02958150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65573507|NCT02958150|Analgesics|analgesics|mesh-ancestor
65573508|NCT02958150|Sensory System Agents|sensory system agents|mesh-ancestor
65573509|NCT02958150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65573510|NCT02958150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65573511|NCT02958150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65573512|NCT02958150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65573513|NCT02958150|Adrenergic Agents|adrenergic agents|mesh-ancestor
65573514|NCT02958150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65573515|NCT02958150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573516|NCT04250142|Methamphetamine|methamphetamine|mesh-list
65573517|NCT04250142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65573518|NCT04250142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573519|NCT04250142|Sympathomimetics|sympathomimetics|mesh-ancestor
65573520|NCT04250142|Autonomic Agents|autonomic agents|mesh-ancestor
65573521|NCT04250142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65573522|NCT04250142|Dopamine Agents|dopamine agents|mesh-ancestor
65573523|NCT04250142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65573524|NCT04250142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573525|NCT04250142|Adrenergic Agents|adrenergic agents|mesh-ancestor
65573526|NCT04250142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65573527|NCT04250142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65573528|NCT04250142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65573529|NCT04250142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65573530|NCT02714322|Adalimumab|adalimumab|mesh-list
65573531|NCT02714322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65573532|NCT02714322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65573533|NCT03267576|Metformin|metformin|mesh-list
65573534|NCT03267576|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65573535|NCT03267576|Canagliflozin|canagliflozin|mesh-list
65573536|NCT03267576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65573537|NCT03267576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573538|NCT03267576|Incretins|incretins|mesh-ancestor
65573539|NCT03267576|Hormones|hormones|mesh-ancestor
65573540|NCT03267576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65573541|NCT03267576|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65573542|NCT03267576|Protease Inhibitors|protease inhibitors|mesh-ancestor
65573543|NCT03267576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573544|NCT03267576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573545|NCT03267576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65573546|NCT02472912|Adalimumab|adalimumab|mesh-list
65573547|NCT02472912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65573548|NCT02472912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65573549|NCT02356458|Bortezomib|bortezomib|mesh-list
65573550|NCT02356458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573551|NCT03243630|Menthol|menthol|mesh-list
65573552|NCT03243630|Nicotine|nicotine|mesh-list
65573553|NCT03243630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65573554|NCT03243630|Autonomic Agents|autonomic agents|mesh-ancestor
65573555|NCT03243630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65573556|NCT03243630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573557|NCT03243630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65573558|NCT03243630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65573559|NCT03243630|Cholinergic Agents|cholinergic agents|mesh-ancestor
65573560|NCT03243630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65573561|NCT03243630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573562|NCT03243630|Antipruritics|antipruritics|mesh-ancestor
65573563|NCT03243630|Dermatologic Agents|dermatologic agents|mesh-ancestor
65573564|NCT04725331|Pembrolizumab|pembrolizumab|mesh-list
65573565|NCT04725331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65573566|NCT04725331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573567|NCT03753685|Ensartinib|ensartinib|mesh-list
65573568|NCT03753685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573569|NCT03753685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65573570|NCT03753685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371085|NCT04234360|Prednisone|prednisone|mesh-list
65573571|NCT03753685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573572|NCT04573946|Vitamin D|vitamin d|mesh-list
65573573|NCT04573946|Ergocalciferols|ergocalciferols|mesh-list
65573574|NCT04573946|Cholecalciferol|cholecalciferol|mesh-list
65573575|NCT04573946|Vitamins|vitamins|mesh-list
65573576|NCT04573946|Micronutrients|micronutrients|mesh-ancestor
65573577|NCT04573946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573578|NCT04573946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65573579|NCT04573946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65573580|NCT05172050|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65573581|NCT05172050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65573582|NCT05172050|Hormone Antagonists|hormone antagonists|mesh-ancestor
65573583|NCT05172050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65573584|NCT05172050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573585|NCT05172050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65573586|NCT05172050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65573587|NCT05172050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65573588|NCT02787044|Vaccines|vaccines|mesh-list
65573589|NCT02787044|Immunologic Factors|immunologic factors|mesh-ancestor
65573590|NCT02787044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573591|NCT01345019|Zoledronic Acid|zoledronic acid|mesh-list
65573592|NCT01345019|Denosumab|denosumab|mesh-list
65573593|NCT01345019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65573594|NCT01345019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573595|NCT03629522|Ondansetron|ondansetron|mesh-list
65573596|NCT03629522|Antiemetics|antiemetics|mesh-ancestor
65573597|NCT03629522|Autonomic Agents|autonomic agents|mesh-ancestor
65573598|NCT03629522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65573599|NCT03629522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573600|NCT03629522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65573601|NCT03629522|Antipruritics|antipruritics|mesh-ancestor
65573602|NCT03629522|Dermatologic Agents|dermatologic agents|mesh-ancestor
65573603|NCT03629522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65573604|NCT03629522|Serotonin Agents|serotonin agents|mesh-ancestor
65573605|NCT03629522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65573606|NCT03629522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573607|NCT03629522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65573608|NCT03629522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65573609|NCT03629522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65573610|NCT03629522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65573611|NCT03629522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65573612|NCT03751111|Naloxone|naloxone|mesh-list
65573613|NCT03751111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65573614|NCT03751111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573615|NCT03751111|Sensory System Agents|sensory system agents|mesh-ancestor
65573616|NCT03751111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65573617|NCT05167370|Amifostine|amifostine|mesh-list
65573618|NCT05167370|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65573619|NCT05167370|Protective Agents|protective agents|mesh-ancestor
65573620|NCT05167370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573621|NCT01265537|Tacrolimus|tacrolimus|mesh-list
65573622|NCT01265537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65573623|NCT01265537|Immunologic Factors|immunologic factors|mesh-ancestor
65573624|NCT01265537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573625|NCT01265537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65573626|NCT01265537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573627|NCT01265537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573628|NCT05763836|Ibuprofen|ibuprofen|mesh-list
65573629|NCT05763836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65573630|NCT05763836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65573631|NCT05763836|Analgesics|analgesics|mesh-ancestor
65573632|NCT05763836|Sensory System Agents|sensory system agents|mesh-ancestor
65573633|NCT05763836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65573634|NCT05763836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573635|NCT05763836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65573636|NCT05763836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65573637|NCT05763836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65573638|NCT05763836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573639|NCT05763836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573640|NCT01237535|Progesterone|progesterone|mesh-list
65573641|NCT01237535|Estrogens|estrogens|mesh-list
65573642|NCT01237535|Progestins|progestins|mesh-ancestor
65573643|NCT01237535|Hormones|hormones|mesh-ancestor
65573644|NCT01237535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65371158|NCT04093895|Taurolidine|taurolidine|mesh-list
65573645|NCT01237535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573646|NCT04396639|Factor VIII|factor viii|mesh-list
65573647|NCT04396639|Coagulants|coagulants|mesh-ancestor
65573648|NCT01146431|Anesthetics|anesthetics|mesh-list
65573649|NCT01146431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65573650|NCT01146431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573651|NCT01250249|Vaccines|vaccines|mesh-list
65573652|NCT01250249|BCG Vaccine|bcg vaccine|mesh-list
65573653|NCT01250249|Immunologic Factors|immunologic factors|mesh-ancestor
65573654|NCT01250249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573655|NCT01250249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65573656|NCT03747679|Mannitol|mannitol|mesh-list
65573657|NCT03747679|Sorbitol|sorbitol|mesh-list
65573658|NCT03747679|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65573659|NCT03747679|Diuretics|diuretics|mesh-ancestor
65573660|NCT03747679|Natriuretic Agents|natriuretic agents|mesh-ancestor
65573661|NCT03747679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573662|NCT03747679|Cathartics|cathartics|mesh-ancestor
65573663|NCT03747679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65573664|NCT04669457|Midazolam|midazolam|mesh-list
65573665|NCT04669457|Dexmedetomidine|dexmedetomidine|mesh-list
65573666|NCT04669457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65573667|NCT04669457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65573668|NCT04669457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573669|NCT04669457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65573670|NCT04669457|Analgesics|analgesics|mesh-ancestor
65573671|NCT04669457|Sensory System Agents|sensory system agents|mesh-ancestor
65573672|NCT04669457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65573673|NCT04669457|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65573674|NCT04669457|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65573675|NCT04669457|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65573676|NCT04669457|Adrenergic Agents|adrenergic agents|mesh-ancestor
65573677|NCT04669457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65573678|NCT04669457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573679|NCT04669457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65573680|NCT04669457|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65573681|NCT04669457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65573682|NCT04669457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65573683|NCT04669457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65573684|NCT04669457|Anesthetics, General|anesthetics, general|mesh-ancestor
65573685|NCT04669457|Anesthetics|anesthetics|mesh-ancestor
65573686|NCT04669457|GABA Modulators|gaba modulators|mesh-ancestor
65573687|NCT04669457|GABA Agents|gaba agents|mesh-ancestor
65573688|NCT01243385|Metformin|metformin|mesh-list
65573689|NCT01243385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65573690|NCT01243385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573691|NCT01147133|Clopidogrel|clopidogrel|mesh-list
65573692|NCT01147133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65573693|NCT01147133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65573694|NCT01147133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65573695|NCT01147133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65573696|NCT01147133|Purinergic Agents|purinergic agents|mesh-ancestor
65573697|NCT01147133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65573698|NCT01147133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573699|NCT01147133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573700|NCT02162420|Cyclophosphamide|cyclophosphamide|mesh-list
65573701|NCT02162420|Fludarabine|fludarabine|mesh-list
65573702|NCT02162420|Alemtuzumab|alemtuzumab|mesh-list
65573703|NCT02162420|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65573704|NCT02162420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65573705|NCT02162420|Immunologic Factors|immunologic factors|mesh-ancestor
65573706|NCT02162420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573707|NCT02162420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65573708|NCT02162420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65573709|NCT02162420|Alkylating Agents|alkylating agents|mesh-ancestor
65573710|NCT02162420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573711|NCT02162420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573712|NCT02162420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65573713|NCT02162420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65573714|NCT04167085|Doxycycline|doxycycline|mesh-list
65573715|NCT04167085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65573716|NCT04167085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65573717|NCT04167085|Antimalarials|antimalarials|mesh-ancestor
65573718|NCT04167085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65573719|NCT04167085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65573720|NCT01147289|Meloxicam|meloxicam|mesh-list
65573721|NCT01147289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65573722|NCT01147289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65573724|NCT01147289|Sensory System Agents|sensory system agents|mesh-ancestor
65573725|NCT01147289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65573726|NCT01147289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573727|NCT01147289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65573728|NCT01147289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65573729|NCT01147289|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65573730|NCT01147289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65573731|NCT01147289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573732|NCT01147289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573733|NCT01237769|Vitamin D|vitamin d|mesh-list
65573734|NCT01237769|Ergocalciferols|ergocalciferols|mesh-list
65573735|NCT01237769|Cholecalciferol|cholecalciferol|mesh-list
65573736|NCT01237769|Vitamins|vitamins|mesh-list
65573737|NCT01237769|Micronutrients|micronutrients|mesh-ancestor
65573738|NCT01237769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573739|NCT01237769|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65573740|NCT01237769|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65573741|NCT03914963|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65573742|NCT03914963|Hemostatics|hemostatics|mesh-ancestor
65573743|NCT03914963|Coagulants|coagulants|mesh-ancestor
65573744|NCT04162795|Loratadine|loratadine|mesh-list
65573745|NCT04162795|Antipruritics|antipruritics|mesh-ancestor
65573746|NCT04162795|Dermatologic Agents|dermatologic agents|mesh-ancestor
65573747|NCT04162795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65573748|NCT04162795|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65573749|NCT04162795|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65573750|NCT04162795|Histamine Antagonists|histamine antagonists|mesh-ancestor
65573751|NCT04162795|Histamine Agents|histamine agents|mesh-ancestor
65573752|NCT04162795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65573753|NCT04162795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573754|NCT04162795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573755|NCT01250951|Deferasirox|deferasirox|mesh-list
65573756|NCT01250951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65573757|NCT01250951|Chelating Agents|chelating agents|mesh-ancestor
65573758|NCT01250951|Sequestering Agents|sequestering agents|mesh-ancestor
65573759|NCT01250951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573760|NCT03069482|Nicotine|nicotine|mesh-list
65573761|NCT03069482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65573762|NCT03069482|Autonomic Agents|autonomic agents|mesh-ancestor
65573763|NCT03069482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65573764|NCT03069482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573765|NCT03069482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65573766|NCT03069482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65573767|NCT03069482|Cholinergic Agents|cholinergic agents|mesh-ancestor
65573768|NCT03069482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65573769|NCT03069482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573770|NCT01250405|Cinacalcet|cinacalcet|mesh-list
65573771|NCT01250405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65573772|NCT01250405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573773|NCT01250405|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65573774|NCT01250405|Hormone Antagonists|hormone antagonists|mesh-ancestor
65573775|NCT01250405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65573776|NCT05083910|Misoprostol|misoprostol|mesh-list
65573777|NCT05083910|Oxytocin|oxytocin|mesh-list
65573778|NCT05083910|Carbetocin|carbetocin|mesh-list
65573779|NCT05083910|Oxytocics|oxytocics|mesh-ancestor
65573780|NCT05083910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65573781|NCT05083910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573782|NCT05083910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65573783|NCT05083910|Abortifacient Agents|abortifacient agents|mesh-ancestor
65573784|NCT05083910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65573785|NCT05083910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65573786|NCT01250561|Valacyclovir|valacyclovir|mesh-list
65573787|NCT01250561|Gabapentin|gabapentin|mesh-list
65573788|NCT01250561|Analgesics|analgesics|mesh-ancestor
65573789|NCT01250561|Sensory System Agents|sensory system agents|mesh-ancestor
65573790|NCT01250561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65573791|NCT01250561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573792|NCT01250561|Anticonvulsants|anticonvulsants|mesh-ancestor
65573793|NCT01250561|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65573794|NCT01250561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65573795|NCT01250561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65573796|NCT01250561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65371311|NCT00521404|Antibodies|antibodies|mesh-list
65573797|NCT01250561|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65573798|NCT01250561|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65573799|NCT01250561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65573800|NCT01250561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573801|NCT01250561|Antimanic Agents|antimanic agents|mesh-ancestor
65573802|NCT01250561|Antiviral Agents|antiviral agents|mesh-ancestor
65573803|NCT01250561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65573804|NCT05055908|Atezolizumab|atezolizumab|mesh-list
65573805|NCT05055908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573806|NCT01147523|Vitamin E|vitamin e|mesh-list
65573807|NCT01147523|Spironolactone|spironolactone|mesh-list
65573808|NCT01147523|Vitamins|vitamins|mesh-ancestor
65573809|NCT01147523|Micronutrients|micronutrients|mesh-ancestor
65573810|NCT01147523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573811|NCT01147523|Antioxidants|antioxidants|mesh-ancestor
65573812|NCT01147523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573813|NCT01147523|Protective Agents|protective agents|mesh-ancestor
65573814|NCT01147523|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65573815|NCT01147523|Hormone Antagonists|hormone antagonists|mesh-ancestor
65573816|NCT01147523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65573817|NCT01147523|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65573818|NCT01147523|Diuretics|diuretics|mesh-ancestor
65573819|NCT01147523|Natriuretic Agents|natriuretic agents|mesh-ancestor
65573820|NCT01251029|Acetylcysteine|acetylcysteine|mesh-list
65573821|NCT01251029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65573822|NCT01251029|Antiviral Agents|antiviral agents|mesh-ancestor
65573823|NCT01251029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65573824|NCT01251029|Expectorants|expectorants|mesh-ancestor
65573825|NCT01251029|Respiratory System Agents|respiratory system agents|mesh-ancestor
65573826|NCT01251029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65573827|NCT01251029|Antioxidants|antioxidants|mesh-ancestor
65573828|NCT01251029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573829|NCT01251029|Protective Agents|protective agents|mesh-ancestor
65573830|NCT01251029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573831|NCT01251029|Antidotes|antidotes|mesh-ancestor
65573832|NCT01251107|Prednisone|prednisone|mesh-list
65573833|NCT01251107|Cyclophosphamide|cyclophosphamide|mesh-list
65573834|NCT01251107|Dacarbazine|dacarbazine|mesh-list
65573835|NCT01251107|Doxorubicin|doxorubicin|mesh-list
65573836|NCT01251107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65573837|NCT01251107|Etoposide|etoposide|mesh-list
65573838|NCT01251107|Etoposide phosphate|etoposide phosphate|mesh-list
65573839|NCT01251107|Vincristine|vincristine|mesh-list
65573840|NCT01251107|Bleomycin|bleomycin|mesh-list
65573841|NCT01251107|Vinblastine|vinblastine|mesh-list
65573842|NCT01251107|Procarbazine|procarbazine|mesh-list
65573843|NCT01251107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65573844|NCT01251107|Immunologic Factors|immunologic factors|mesh-ancestor
65573845|NCT01251107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573846|NCT01251107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65573847|NCT01251107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65573848|NCT01251107|Alkylating Agents|alkylating agents|mesh-ancestor
65573849|NCT01251107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573850|NCT01251107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573851|NCT01251107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65573852|NCT01251107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65573853|NCT01251107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65573854|NCT01251107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65573855|NCT01251107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573856|NCT01251107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65573857|NCT01251107|Glucocorticoids|glucocorticoids|mesh-ancestor
65573858|NCT01251107|Hormones|hormones|mesh-ancestor
65573859|NCT01251107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65573860|NCT01251107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65573861|NCT01251107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65573862|NCT01251107|Tubulin Modulators|tubulin modulators|mesh-ancestor
65573863|NCT01251107|Antimitotic Agents|antimitotic agents|mesh-ancestor
65573864|NCT01251107|Mitosis Modulators|mitosis modulators|mesh-ancestor
65573865|NCT01125176|Thalidomide|thalidomide|mesh-list
65573866|NCT01125176|Rituximab|rituximab|mesh-list
65573867|NCT01125176|Lenalidomide|lenalidomide|mesh-list
65573868|NCT01125176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65573869|NCT01125176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573870|NCT01125176|Immunologic Factors|immunologic factors|mesh-ancestor
65573871|NCT01125176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371389|NCT01068847|Tocolytic Agents|tocolytic agents|mesh-ancestor
65573872|NCT01125176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65573873|NCT01125176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65573874|NCT01125176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65573875|NCT01125176|Growth Substances|growth substances|mesh-ancestor
65573876|NCT01125176|Growth Inhibitors|growth inhibitors|mesh-ancestor
65573877|NCT01125176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65573878|NCT01125176|Leprostatic Agents|leprostatic agents|mesh-ancestor
64861418|NCT01759875|Betaine|betaine|mesh-list
65573879|NCT01125176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65573880|NCT01125176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65573881|NCT00882050|Exenatide|exenatide|mesh-list
65573882|NCT00882050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65573883|NCT00882050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573884|NCT00882050|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65573885|NCT00882050|Incretins|incretins|mesh-ancestor
65573886|NCT00882050|Hormones|hormones|mesh-ancestor
65573887|NCT00882050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65573888|NCT03912857|Apatinib|apatinib|mesh-list
65573889|NCT03912857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573890|NCT03912857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65573891|NCT03912857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65573892|NCT03912857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573893|NCT04316390|Vitamins|vitamins|mesh-list
65573894|NCT04316390|Ascorbic Acid|ascorbic acid|mesh-list
65573895|NCT04316390|Micronutrients|micronutrients|mesh-ancestor
65573896|NCT04316390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573897|NCT04316390|Antioxidants|antioxidants|mesh-ancestor
65573898|NCT04316390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573899|NCT04316390|Protective Agents|protective agents|mesh-ancestor
65573900|NCT04892420|Dexamethasone|dexamethasone|mesh-list
65573901|NCT04892420|Magnesium Sulfate|magnesium sulfate|mesh-list
65573902|NCT04892420|Dexmedetomidine|dexmedetomidine|mesh-list
65573903|NCT04892420|Bupivacaine|bupivacaine|mesh-list
65573904|NCT04892420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65573905|NCT04892420|Antiemetics|antiemetics|mesh-ancestor
65573906|NCT04892420|Autonomic Agents|autonomic agents|mesh-ancestor
65573907|NCT04892420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65573908|NCT04892420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573909|NCT04892420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65573910|NCT04892420|Glucocorticoids|glucocorticoids|mesh-ancestor
65573911|NCT04892420|Hormones|hormones|mesh-ancestor
65573912|NCT04892420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65573913|NCT04892420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65573914|NCT04892420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573915|NCT04892420|Anesthetics, Local|anesthetics, local|mesh-ancestor
65573916|NCT04892420|Anesthetics|anesthetics|mesh-ancestor
65573917|NCT04892420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65573918|NCT04892420|Sensory System Agents|sensory system agents|mesh-ancestor
65573919|NCT04892420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65573920|NCT04892420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65573921|NCT04892420|Analgesics|analgesics|mesh-ancestor
65573922|NCT04892420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65573923|NCT04892420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65573924|NCT04892420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65573925|NCT04892420|Adrenergic Agents|adrenergic agents|mesh-ancestor
65573926|NCT04892420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65573927|NCT04892420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573928|NCT04892420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65573929|NCT04892420|Anticonvulsants|anticonvulsants|mesh-ancestor
65573930|NCT04892420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65573931|NCT04892420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65573932|NCT04892420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65573933|NCT04892420|Tocolytic Agents|tocolytic agents|mesh-ancestor
65573934|NCT04892420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65573935|NCT01251263|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65573936|NCT01251263|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65573937|NCT01251263|Estradiol|estradiol|mesh-list
65573938|NCT01251263|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65573939|NCT01251263|Estrogens|estrogens|mesh-ancestor
65573940|NCT01251263|Hormones|hormones|mesh-ancestor
65573941|NCT01251263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65573942|NCT01251263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573943|NCT01251263|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65573944|NCT01251263|Contraceptive Agents|contraceptive agents|mesh-ancestor
65573945|NCT01251263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65573946|NCT01251263|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65573947|NCT04707534|Dexamethasone|dexamethasone|mesh-list
65573948|NCT04707534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65573949|NCT04707534|Antiemetics|antiemetics|mesh-ancestor
65573950|NCT04707534|Autonomic Agents|autonomic agents|mesh-ancestor
65573951|NCT04707534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65573952|NCT04707534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573953|NCT04707534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65573954|NCT04707534|Glucocorticoids|glucocorticoids|mesh-ancestor
65573955|NCT04707534|Hormones|hormones|mesh-ancestor
65573956|NCT04707534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65573957|NCT04707534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65573958|NCT04707534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573959|NCT05761730|Dexamethasone|dexamethasone|mesh-list
65573960|NCT05761730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65573961|NCT05761730|Antiemetics|antiemetics|mesh-ancestor
65573962|NCT05761730|Autonomic Agents|autonomic agents|mesh-ancestor
65573963|NCT05761730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65573964|NCT05761730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573965|NCT05761730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65573966|NCT05761730|Glucocorticoids|glucocorticoids|mesh-ancestor
65573967|NCT05761730|Hormones|hormones|mesh-ancestor
65573968|NCT05761730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65573969|NCT05761730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65573970|NCT05761730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65573971|NCT04257500|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65573972|NCT04257500|Etonogestrel|etonogestrel|mesh-list
65573973|NCT04257500|NuvaRing|nuvaring|mesh-list
65573974|NCT04257500|Estradiol|estradiol|mesh-list
65573975|NCT04257500|Estrogens|estrogens|mesh-ancestor
65573976|NCT04257500|Hormones|hormones|mesh-ancestor
65573977|NCT04257500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65573978|NCT04257500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65573979|NCT04257500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65573980|NCT04257500|Contraceptive Agents|contraceptive agents|mesh-ancestor
65573981|NCT04257500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65573982|NCT04257500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65573983|NCT04257500|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65573984|NCT04257500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65573985|NCT04353817|Ivacaftor|ivacaftor|mesh-list
65573986|NCT04353817|Elexacaftor|elexacaftor|mesh-list
65573987|NCT04353817|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65573988|NCT04353817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65573989|NCT04353817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65573990|NCT00159588|Angiotensin II|angiotensin ii|mesh-list
65573991|NCT00159588|Gabapentin|gabapentin|mesh-list
65573992|NCT00159588|Valproic Acid|valproic acid|mesh-list
65573993|NCT00159588|Antidepressive Agents|antidepressive agents|mesh-list
65573994|NCT00159588|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
65573995|NCT00159588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65573996|NCT00159588|Analgesics|analgesics|mesh-ancestor
65573997|NCT00159588|Sensory System Agents|sensory system agents|mesh-ancestor
65573998|NCT00159588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65573999|NCT00159588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574000|NCT00159588|Anticonvulsants|anticonvulsants|mesh-ancestor
65574001|NCT00159588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65574002|NCT00159588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65574003|NCT00159588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65574004|NCT00159588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65574005|NCT00159588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65574006|NCT00159588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65574007|NCT00159588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65574008|NCT00159588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574009|NCT00159588|Antimanic Agents|antimanic agents|mesh-ancestor
65574010|NCT00159588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574011|NCT00159588|GABA Agents|gaba agents|mesh-ancestor
65574012|NCT00159588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65574013|NCT00159588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65574014|NCT00159588|Adrenergic Agents|adrenergic agents|mesh-ancestor
65574015|NCT04166942|Belumosudil|belumosudil|mesh-list
65574016|NCT04166942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65574017|NCT04166942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574018|NCT04166942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574019|NCT03903653|Botulinum Toxins|botulinum toxins|mesh-list
65574020|NCT03903653|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65574021|NCT03903653|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65574022|NCT03903653|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65574023|NCT03903653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65574024|NCT03903653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574025|NCT03903653|Cholinergic Agents|cholinergic agents|mesh-ancestor
65574026|NCT03903653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65574027|NCT03903653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574028|NCT03903653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65574029|NCT03903653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65574030|NCT04349917|Methylphenidate|methylphenidate|mesh-list
65574031|NCT04349917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65574032|NCT04349917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574033|NCT04349917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65574034|NCT04349917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65574035|NCT04349917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65574036|NCT04349917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574037|NCT04349917|Dopamine Agents|dopamine agents|mesh-ancestor
65574038|NCT04349917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65574039|NCT03903029|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65574040|NCT03903029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65574041|NCT03903029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65574042|NCT03903029|Antimetabolites|antimetabolites|mesh-ancestor
65574043|NCT03903029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574044|NCT03903029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65574045|NCT03903029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65574046|NCT03903029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574047|NCT04691856|Acetaminophen|acetaminophen|mesh-list
65574048|NCT04691856|Ibuprofen|ibuprofen|mesh-list
65574049|NCT04691856|Morphine|morphine|mesh-list
65574050|NCT04691856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65574051|NCT04691856|Narcotics|narcotics|mesh-ancestor
65574052|NCT04691856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65574053|NCT04691856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574054|NCT04691856|Analgesics|analgesics|mesh-ancestor
65574055|NCT04691856|Sensory System Agents|sensory system agents|mesh-ancestor
65574056|NCT04691856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65574057|NCT04691856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65574058|NCT04691856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65574059|NCT04691856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65574060|NCT04691856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65574061|NCT04691856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65574062|NCT04691856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574063|NCT04691856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574064|NCT04691856|Antipyretics|antipyretics|mesh-ancestor
65574065|NCT03924986|Gemcitabine|gemcitabine|mesh-list
65574066|NCT03924986|Cisplatin|cisplatin|mesh-list
65574067|NCT03924986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574068|NCT03924986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65574069|NCT03924986|Antimetabolites|antimetabolites|mesh-ancestor
65574070|NCT03924986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574071|NCT03924986|Antiviral Agents|antiviral agents|mesh-ancestor
65574072|NCT03924986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65574073|NCT03924986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574074|NCT03924986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65574075|NCT03924986|Immunologic Factors|immunologic factors|mesh-ancestor
65574076|NCT03924986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574077|NCT01254929|Frovatriptan|frovatriptan|mesh-list
65574078|NCT01254929|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65574079|NCT01254929|Serotonin Agents|serotonin agents|mesh-ancestor
65574080|NCT01254929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65574081|NCT01254929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574082|NCT01254929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574083|NCT03300570|Dolcanatide|dolcanatide|mesh-list
65574084|NCT03300570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65574085|NCT03300570|Enzyme Activators|enzyme activators|mesh-ancestor
65574086|NCT03300570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574087|NCT03300570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65574088|NCT03853694|Morphine|morphine|mesh-list
65574089|NCT03853694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65574090|NCT03853694|Narcotics|narcotics|mesh-ancestor
65574091|NCT03853694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65574092|NCT03853694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574093|NCT03853694|Analgesics|analgesics|mesh-ancestor
65574094|NCT03853694|Sensory System Agents|sensory system agents|mesh-ancestor
65574095|NCT03853694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65574096|NCT04154293|Isotretinoin|isotretinoin|mesh-list
65574097|NCT04154293|Dermatologic Agents|dermatologic agents|mesh-ancestor
65574098|NCT01148147|Adenosine|adenosine|mesh-list
65574099|NCT01148147|Analgesics|analgesics|mesh-ancestor
65574100|NCT01148147|Sensory System Agents|sensory system agents|mesh-ancestor
65574101|NCT01148147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65574102|NCT01148147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574103|NCT01148147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65574104|NCT01148147|Vasodilator Agents|vasodilator agents|mesh-ancestor
65574105|NCT01148147|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65574106|NCT01148147|Purinergic Agonists|purinergic agonists|mesh-ancestor
65574107|NCT01148147|Purinergic Agents|purinergic agents|mesh-ancestor
65574108|NCT01148147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65574109|NCT01148147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574110|NCT03902249|Dexamethasone|dexamethasone|mesh-list
65574111|NCT03902249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65574112|NCT03902249|Antiemetics|antiemetics|mesh-ancestor
65574113|NCT03902249|Autonomic Agents|autonomic agents|mesh-ancestor
65574114|NCT03902249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65574115|NCT03902249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574116|NCT03902249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65574117|NCT03902249|Glucocorticoids|glucocorticoids|mesh-ancestor
65574118|NCT03902249|Hormones|hormones|mesh-ancestor
65574119|NCT03902249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65574120|NCT03902249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65574121|NCT03902249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574122|NCT03908489|Allyl sulfide|allyl sulfide|mesh-list
65574123|NCT03908489|Antioxidants|antioxidants|mesh-ancestor
65574124|NCT03908489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574125|NCT03908489|Protective Agents|protective agents|mesh-ancestor
65574126|NCT03908489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574127|NCT03908489|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65574128|NCT03908489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574129|NCT03908489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65574130|NCT03908489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574131|NCT04342897|Zansecimab|zansecimab|mesh-list
65574132|NCT04342897|Antiviral Agents|antiviral agents|mesh-ancestor
65574133|NCT04342897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65574134|NCT03263767|Cyclophosphamide|cyclophosphamide|mesh-list
65574135|NCT03263767|Fludarabine|fludarabine|mesh-list
65574136|NCT03263767|Clofarabine|clofarabine|mesh-list
65574137|NCT03263767|Thymoglobulin|thymoglobulin|mesh-list
65574138|NCT03263767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65574139|NCT03263767|Immunologic Factors|immunologic factors|mesh-ancestor
65574140|NCT03263767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574141|NCT03263767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65574142|NCT03263767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65574143|NCT03263767|Alkylating Agents|alkylating agents|mesh-ancestor
65574144|NCT03263767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574145|NCT03263767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574146|NCT03263767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65574147|NCT03263767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65574148|NCT03263767|Antimetabolites|antimetabolites|mesh-ancestor
65574149|NCT04603742|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65574150|NCT04603742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65574151|NCT03908333|Ascorbic Acid|ascorbic acid|mesh-list
65574152|NCT03908333|Gemcitabine|gemcitabine|mesh-list
65574153|NCT03908333|Paclitaxel|paclitaxel|mesh-list
65574154|NCT03908333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65574155|NCT03908333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65574156|NCT03908333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574157|NCT03908333|Tubulin Modulators|tubulin modulators|mesh-ancestor
65574158|NCT03908333|Antimitotic Agents|antimitotic agents|mesh-ancestor
65574159|NCT03908333|Mitosis Modulators|mitosis modulators|mesh-ancestor
65574160|NCT03908333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574161|NCT03908333|Vitamins|vitamins|mesh-ancestor
65574162|NCT03908333|Micronutrients|micronutrients|mesh-ancestor
65574163|NCT03908333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574164|NCT03908333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65574165|NCT03908333|Antimetabolites|antimetabolites|mesh-ancestor
65574166|NCT03908333|Antiviral Agents|antiviral agents|mesh-ancestor
65574167|NCT03908333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65574168|NCT03908333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574169|NCT03908333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65574170|NCT03908333|Immunologic Factors|immunologic factors|mesh-ancestor
65574171|NCT03908333|Antioxidants|antioxidants|mesh-ancestor
65574172|NCT03908333|Protective Agents|protective agents|mesh-ancestor
65574173|NCT04340557|Losartan|losartan|mesh-list
65574174|NCT04340557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65574175|NCT04340557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65574176|NCT04340557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65574177|NCT04340557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65574178|NCT04340557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574180|NCT04566692|gamma-Globulins|gamma-globulins|mesh-list
65574181|NCT04566692|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65574182|NCT04566692|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65574183|NCT04566692|Immunologic Factors|immunologic factors|mesh-ancestor
65574184|NCT04566692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574185|NCT04549376|Iodine|iodine|mesh-list
65574186|NCT04549376|Cadexomer iodine|cadexomer iodine|mesh-list
65574187|NCT04549376|Povidone-Iodine|povidone-iodine|mesh-list
65574188|NCT04549376|Povidone|povidone|mesh-list
65574189|NCT04549376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65574190|NCT04549376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65574191|NCT04549376|Trace Elements|trace elements|mesh-ancestor
65574192|NCT04549376|Micronutrients|micronutrients|mesh-ancestor
65574193|NCT04549376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574194|NCT04549376|Plasma Substitutes|plasma substitutes|mesh-ancestor
65574195|NCT04549376|Blood Substitutes|blood substitutes|mesh-ancestor
65574196|NCT01149395|Dexlansoprazole|dexlansoprazole|mesh-list
65574197|NCT01149395|Lansoprazole|lansoprazole|mesh-list
65574198|NCT01149395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65574199|NCT01149395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65574200|NCT01149395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65574201|NCT01149395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574202|NCT01149395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574203|NCT02527733|Ranibizumab|ranibizumab|mesh-list
65574204|NCT02527733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65574205|NCT02527733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65574206|NCT02527733|Growth Substances|growth substances|mesh-ancestor
65574207|NCT02527733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574208|NCT02527733|Growth Inhibitors|growth inhibitors|mesh-ancestor
65574209|NCT02527733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574210|NCT04135495|Ivacaftor|ivacaftor|mesh-list
65574211|NCT04135495|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65574212|NCT04135495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65574213|NCT04135495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574214|NCT01148303|Etoricoxib|etoricoxib|mesh-list
65574215|NCT01148303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65574216|NCT01148303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65574217|NCT01148303|Analgesics|analgesics|mesh-ancestor
65574218|NCT01148303|Sensory System Agents|sensory system agents|mesh-ancestor
65574219|NCT01148303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65574220|NCT01148303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574221|NCT01148303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65574222|NCT01148303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65574223|NCT01148303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65574224|NCT01148303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65574225|NCT01148303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574226|NCT01148303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574227|NCT03066830|Metformin|metformin|mesh-list
65574228|NCT03066830|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65574229|NCT03066830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65574230|NCT03066830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574231|NCT03066830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65574232|NCT03066830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574233|NCT03900377|Rituximab|rituximab|mesh-list
65574234|NCT03900377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65574235|NCT03900377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574236|NCT03900377|Immunologic Factors|immunologic factors|mesh-ancestor
65574237|NCT03900377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574238|NCT03900377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65574239|NCT05205200|Paclitaxel|paclitaxel|mesh-list
65574240|NCT05205200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65574241|NCT05205200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574242|NCT05205200|Tubulin Modulators|tubulin modulators|mesh-ancestor
65574243|NCT05205200|Antimitotic Agents|antimitotic agents|mesh-ancestor
65574244|NCT05205200|Mitosis Modulators|mitosis modulators|mesh-ancestor
65574245|NCT05205200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574246|NCT01149629|Droxidopa|droxidopa|mesh-list
65574247|NCT01149629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65371761|NCT00828594|Sorafenib|sorafenib|mesh-list
65574248|NCT01149629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65574250|NCT05205122|Mitomycin|mitomycin|mesh-list
65574251|NCT05205122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65574252|NCT05205122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574253|NCT05205122|Alkylating Agents|alkylating agents|mesh-ancestor
65574254|NCT05205122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574255|NCT05205122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65574256|NCT05205122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574257|NCT03907163|Dronabinol|dronabinol|mesh-list
65574258|NCT03907163|Hallucinogens|hallucinogens|mesh-ancestor
65574259|NCT03907163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574260|NCT03907163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65574261|NCT03907163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65574262|NCT03907163|Analgesics|analgesics|mesh-ancestor
65574263|NCT03907163|Sensory System Agents|sensory system agents|mesh-ancestor
65574264|NCT03907163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65574265|NCT03907163|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65574266|NCT03907163|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65574267|NCT03907163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65574268|NCT03907163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574269|NCT03907163|Hormones|hormones|mesh-ancestor
65574270|NCT03907163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65574271|NCT01253681|Paclitaxel|paclitaxel|mesh-list
65574272|NCT01253681|Carboplatin|carboplatin|mesh-list
65574273|NCT01253681|Trebananib|trebananib|mesh-list
65574274|NCT01253681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65574275|NCT01253681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574276|NCT01253681|Tubulin Modulators|tubulin modulators|mesh-ancestor
65574277|NCT01253681|Antimitotic Agents|antimitotic agents|mesh-ancestor
65574278|NCT01253681|Mitosis Modulators|mitosis modulators|mesh-ancestor
65574279|NCT01253681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574280|NCT01253681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65574281|NCT01253681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65574282|NCT01253681|Growth Substances|growth substances|mesh-ancestor
65574283|NCT01253681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574284|NCT01253681|Growth Inhibitors|growth inhibitors|mesh-ancestor
65574285|NCT01149941|Ibuprofen|ibuprofen|mesh-list
65574286|NCT01149941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65574287|NCT01149941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65574288|NCT01149941|Analgesics|analgesics|mesh-ancestor
65574289|NCT01149941|Sensory System Agents|sensory system agents|mesh-ancestor
65574290|NCT01149941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65574291|NCT01149941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574292|NCT01149941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65574293|NCT01149941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65574294|NCT01149941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65574295|NCT01149941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574296|NCT01149941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574297|NCT01589549|Methylprednisolone|methylprednisolone|mesh-list
65574298|NCT01589549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65574299|NCT01589549|Antiemetics|antiemetics|mesh-ancestor
65574300|NCT01589549|Autonomic Agents|autonomic agents|mesh-ancestor
65574301|NCT01589549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65574302|NCT01589549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574303|NCT01589549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65574304|NCT01589549|Glucocorticoids|glucocorticoids|mesh-ancestor
65574305|NCT01589549|Hormones|hormones|mesh-ancestor
65574306|NCT01589549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65574307|NCT01589549|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65574308|NCT01589549|Protective Agents|protective agents|mesh-ancestor
65574309|NCT03899675|Caffeine|caffeine|mesh-list
65574310|NCT03899675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65574311|NCT03899675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574312|NCT03899675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65574313|NCT03899675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574314|NCT03899675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574315|NCT03899675|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65574316|NCT03899675|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65574317|NCT03899675|Purinergic Agents|purinergic agents|mesh-ancestor
65574318|NCT03899675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65574319|NCT01562197|Axitinib|axitinib|mesh-list
65371832|NCT00954603|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65574320|NCT01562197|Lomustine|lomustine|mesh-list
65574321|NCT01562197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574322|NCT01562197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65574323|NCT01562197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574324|NCT01562197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574325|NCT01562197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65574326|NCT01562197|Alkylating Agents|alkylating agents|mesh-ancestor
65574327|NCT03905837|Lidocaine|lidocaine|mesh-list
65574328|NCT03905837|Piperidine|piperidine|mesh-list
65574329|NCT03905837|Remifentanil|remifentanil|mesh-list
65574330|NCT03905837|Anesthetics, Local|anesthetics, local|mesh-ancestor
65574331|NCT03905837|Anesthetics|anesthetics|mesh-ancestor
65574332|NCT03905837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65574333|NCT03905837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574334|NCT03905837|Sensory System Agents|sensory system agents|mesh-ancestor
65574335|NCT03905837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65574336|NCT03905837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65574337|NCT03905837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65574338|NCT03905837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65574339|NCT03905837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65574340|NCT03905837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574341|NCT03905837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65574342|NCT03905837|Narcotics|narcotics|mesh-ancestor
65574343|NCT03905837|Analgesics|analgesics|mesh-ancestor
65574344|NCT03905837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65574345|NCT03905837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65574346|NCT03063632|Interferons|interferons|mesh-list
65574347|NCT03063632|Interferon-gamma|interferon-gamma|mesh-list
65574348|NCT03063632|Pembrolizumab|pembrolizumab|mesh-list
65574349|NCT03063632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65574350|NCT03063632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574351|NCT03063632|Antiviral Agents|antiviral agents|mesh-ancestor
65574352|NCT03063632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65574353|NCT04328467|Hydroxychloroquine|hydroxychloroquine|mesh-list
65574354|NCT04328467|Antimalarials|antimalarials|mesh-ancestor
65574355|NCT04328467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65574356|NCT04328467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65574357|NCT04328467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65574358|NCT04328467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574359|NCT04328467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574360|NCT04328467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65574361|NCT01148615|Docetaxel|docetaxel|mesh-list
65574362|NCT01148615|Aflibercept|aflibercept|mesh-list
65574363|NCT01148615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574364|NCT01148615|Tubulin Modulators|tubulin modulators|mesh-ancestor
65574365|NCT01148615|Antimitotic Agents|antimitotic agents|mesh-ancestor
65574366|NCT01148615|Mitosis Modulators|mitosis modulators|mesh-ancestor
65574367|NCT01148615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574368|NCT01148615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65574369|NCT01148615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65574370|NCT01148615|Growth Substances|growth substances|mesh-ancestor
65574371|NCT01148615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574372|NCT01148615|Growth Inhibitors|growth inhibitors|mesh-ancestor
65574373|NCT04161248|Gemcitabine|gemcitabine|mesh-list
65574374|NCT04161248|Dexamethasone|dexamethasone|mesh-list
65574375|NCT04161248|Rituximab|rituximab|mesh-list
65574376|NCT04161248|Venetoclax|venetoclax|mesh-list
65574377|NCT04161248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65574378|NCT04161248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574379|NCT04161248|Immunologic Factors|immunologic factors|mesh-ancestor
65574380|NCT04161248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574381|NCT04161248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65574382|NCT04161248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65574383|NCT04161248|Antiemetics|antiemetics|mesh-ancestor
65574384|NCT04161248|Autonomic Agents|autonomic agents|mesh-ancestor
65574385|NCT04161248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65574386|NCT04161248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65574387|NCT04161248|Glucocorticoids|glucocorticoids|mesh-ancestor
65574388|NCT04161248|Hormones|hormones|mesh-ancestor
65574389|NCT04161248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65574390|NCT04161248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65574391|NCT04161248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65574392|NCT04161248|Antimetabolites|antimetabolites|mesh-ancestor
65574393|NCT04161248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574394|NCT04161248|Antiviral Agents|antiviral agents|mesh-ancestor
65574395|NCT04161248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65574396|NCT04161248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574397|NCT04161248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65574398|NCT03905759|Colchicine|colchicine|mesh-list
65574399|NCT03905759|Amiodarone|amiodarone|mesh-list
65574400|NCT03905759|Dronedarone|dronedarone|mesh-list
64861986|NCT01762436|Atenolol|atenolol|mesh-list
65574401|NCT03905759|Gout Suppressants|gout suppressants|mesh-ancestor
65574402|NCT03905759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65574403|NCT03905759|Tubulin Modulators|tubulin modulators|mesh-ancestor
65574404|NCT03905759|Antimitotic Agents|antimitotic agents|mesh-ancestor
65574405|NCT03905759|Mitosis Modulators|mitosis modulators|mesh-ancestor
65574406|NCT03905759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574407|NCT03905759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574408|NCT03905759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65574409|NCT03905759|Vasodilator Agents|vasodilator agents|mesh-ancestor
65574410|NCT03905759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65574411|NCT03905759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65574412|NCT03905759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65574413|NCT03905759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65574414|NCT03905759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65574415|NCT03905759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574416|NCT03905759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65574417|NCT03905759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65574418|NCT03905759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65574419|NCT01255475|Amlodipine|amlodipine|mesh-list
65574420|NCT01255475|Hydralazine|hydralazine|mesh-list
65574421|NCT01255475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65574422|NCT01255475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65574423|NCT01255475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65574424|NCT01255475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574425|NCT01255475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65574426|NCT01255475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574427|NCT01255475|Vasodilator Agents|vasodilator agents|mesh-ancestor
65574428|NCT05208398|Warfarin|warfarin|mesh-list
65574429|NCT05208398|Apixaban|apixaban|mesh-list
65574430|NCT05208398|Anticoagulants|anticoagulants|mesh-ancestor
65574431|NCT05208398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65574432|NCT05208398|Antithrombins|antithrombins|mesh-ancestor
65574433|NCT05208398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65574434|NCT05208398|Protease Inhibitors|protease inhibitors|mesh-ancestor
65574435|NCT05208398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574436|NCT05208398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574437|NCT05593601|Neomycin|neomycin|mesh-list
65574438|NCT05593601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65574439|NCT05593601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65574440|NCT05593601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65574441|NCT05593601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574442|NCT05593601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574443|NCT03629210|Dexamethasone|dexamethasone|mesh-list
65574444|NCT03629210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65574445|NCT03629210|Antiemetics|antiemetics|mesh-ancestor
65574446|NCT03629210|Autonomic Agents|autonomic agents|mesh-ancestor
65574447|NCT03629210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65574448|NCT03629210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574449|NCT03629210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65574450|NCT03629210|Glucocorticoids|glucocorticoids|mesh-ancestor
65574451|NCT03629210|Hormones|hormones|mesh-ancestor
65574452|NCT03629210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65574453|NCT03629210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65574454|NCT03629210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574455|NCT05569811|Letrozole|letrozole|mesh-list
65574456|NCT05569811|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
65574457|NCT05569811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574458|NCT05569811|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65574459|NCT05569811|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65574460|NCT05569811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574461|NCT05569811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574462|NCT05569811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65574463|NCT05569811|Hormone Antagonists|hormone antagonists|mesh-ancestor
65574464|NCT05569811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65574465|NCT05569811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574466|NCT05569811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65574467|NCT03899285|Citalopram|citalopram|mesh-list
65574468|NCT03899285|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65574469|NCT03899285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65574470|NCT03899285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65574471|NCT03899285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574472|NCT03899285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65574473|NCT03899285|Serotonin Agents|serotonin agents|mesh-ancestor
65574474|NCT03899285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574475|NCT03899285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65574476|NCT03899285|Antidepressive Agents|antidepressive agents|mesh-ancestor
65574477|NCT03899285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65574478|NCT01254071|Tamsulosin|tamsulosin|mesh-list
65574479|NCT01254071|Dutasteride|dutasteride|mesh-list
65574480|NCT01254071|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65574481|NCT01254071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65574482|NCT01254071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65574483|NCT01254071|Adrenergic Agents|adrenergic agents|mesh-ancestor
65574484|NCT01254071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65574485|NCT01254071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574486|NCT01254071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574487|NCT01254071|Urological Agents|urological agents|mesh-ancestor
65574488|NCT01254071|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65574489|NCT01254071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65574490|NCT01254071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574491|NCT01254071|Hormone Antagonists|hormone antagonists|mesh-ancestor
65574492|NCT01254071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65574493|NCT05761418|Misoprostol|misoprostol|mesh-list
65574494|NCT05761418|Dinoprostone|dinoprostone|mesh-list
65574495|NCT05761418|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65574496|NCT05761418|Abortifacient Agents|abortifacient agents|mesh-ancestor
65574497|NCT05761418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65574498|NCT05761418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574499|NCT05761418|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65574500|NCT05761418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65574501|NCT05761418|Oxytocics|oxytocics|mesh-ancestor
65574502|NCT05207774|Oxytocin|oxytocin|mesh-list
65574503|NCT05207774|Oxytocics|oxytocics|mesh-ancestor
65574504|NCT05207774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65574505|NCT05207774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574506|NCT02528123|Tobramycin|tobramycin|mesh-list
65574507|NCT02528123|Ofloxacin|ofloxacin|mesh-list
65574508|NCT02528123|Dexamethasone|dexamethasone|mesh-list
65574509|NCT02528123|Benoxinate|benoxinate|mesh-list
65574510|NCT02528123|Proxymetacaine|proxymetacaine|mesh-list
65574511|NCT02528123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65574512|NCT02528123|Antiemetics|antiemetics|mesh-ancestor
65574513|NCT02528123|Autonomic Agents|autonomic agents|mesh-ancestor
65574514|NCT02528123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65574515|NCT02528123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574516|NCT02528123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65574517|NCT02528123|Glucocorticoids|glucocorticoids|mesh-ancestor
65574518|NCT02528123|Hormones|hormones|mesh-ancestor
65574519|NCT02528123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65574520|NCT02528123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65574521|NCT02528123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574522|NCT02528123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65574523|NCT02528123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65574524|NCT02528123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65574525|NCT02528123|Renal Agents|renal agents|mesh-ancestor
65574526|NCT02528123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65574527|NCT02528123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65574528|NCT02528123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574529|NCT02528123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574530|NCT02528123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65574531|NCT02528123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65574532|NCT02528123|Anesthetics, Local|anesthetics, local|mesh-ancestor
65574533|NCT02528123|Anesthetics|anesthetics|mesh-ancestor
65574534|NCT02528123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65574535|NCT02528123|Sensory System Agents|sensory system agents|mesh-ancestor
65574536|NCT02527811|Urinastatin|urinastatin|mesh-list
65574537|NCT02527811|Trypsin Inhibitors|trypsin inhibitors|mesh-list
65574538|NCT02527811|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65574539|NCT02527811|Protease Inhibitors|protease inhibitors|mesh-ancestor
65574540|NCT02527811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574541|NCT02527811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574542|NCT03691831|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65574543|NCT03691831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65574544|NCT03691831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65574545|NCT01254383|Sildenafil Citrate|sildenafil citrate|mesh-list
65574546|NCT01254383|Vasodilator Agents|vasodilator agents|mesh-ancestor
65574547|NCT01254383|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64862165|NCT01763281|Hormones|hormones|mesh-ancestor
65574548|NCT01254383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65574549|NCT01254383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574550|NCT01254383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574551|NCT01254383|Urological Agents|urological agents|mesh-ancestor
65574552|NCT03700970|Bupivacaine|bupivacaine|mesh-list
65574553|NCT03700970|Anesthetics, Local|anesthetics, local|mesh-ancestor
65574554|NCT03700970|Anesthetics|anesthetics|mesh-ancestor
65574555|NCT03700970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65574556|NCT03700970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574557|NCT03700970|Sensory System Agents|sensory system agents|mesh-ancestor
65574558|NCT03700970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65574559|NCT01256021|Botulinum Toxins|botulinum toxins|mesh-list
65574560|NCT01256021|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65574561|NCT01256021|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65574562|NCT01256021|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65574563|NCT01256021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65574564|NCT01256021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574565|NCT01256021|Cholinergic Agents|cholinergic agents|mesh-ancestor
65574566|NCT01256021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65574567|NCT01256021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574568|NCT01256021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65574569|NCT01256021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65574570|NCT04320745|Testosterone|testosterone|mesh-list
65574571|NCT04320745|Androgens|androgens|mesh-ancestor
65574573|NCT04320745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65574574|NCT04320745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574575|NCT05741060|Equol|equol|mesh-list
65574576|NCT05741060|Phytoestrogens|phytoestrogens|mesh-ancestor
65574577|NCT05741060|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65574578|NCT05741060|Estrogens|estrogens|mesh-ancestor
65574579|NCT05741060|Hormones|hormones|mesh-ancestor
65574580|NCT05741060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65574581|NCT05741060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574582|NCT01254461|Pravastatin|pravastatin|mesh-list
65574583|NCT01254461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65574584|NCT01254461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65574585|NCT01254461|Antimetabolites|antimetabolites|mesh-ancestor
65574586|NCT01254461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574587|NCT01254461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65574588|NCT01254461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65574589|NCT01254461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574590|NCT03747523|Vitamin D|vitamin d|mesh-list
65574591|NCT03747523|Ergocalciferols|ergocalciferols|mesh-list
65574592|NCT03747523|Vitamins|vitamins|mesh-ancestor
65574593|NCT03747523|Micronutrients|micronutrients|mesh-ancestor
65574594|NCT03747523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574595|NCT03747523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65574596|NCT03747523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65574597|NCT05293171|Moxifloxacin|moxifloxacin|mesh-list
65574598|NCT05293171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65574599|NCT05293171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65574600|NCT05293171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65574601|NCT05293171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65574602|NCT05293171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574603|NCT05293171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574604|NCT05293171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574605|NCT03063086|Fluticasone|fluticasone|mesh-list
65574606|NCT03063086|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65574607|NCT03063086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65574608|NCT03063086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65574609|NCT03063086|Autonomic Agents|autonomic agents|mesh-ancestor
65574610|NCT03063086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65574611|NCT03063086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574612|NCT03063086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65574613|NCT03063086|Respiratory System Agents|respiratory system agents|mesh-ancestor
65574614|NCT03063086|Dermatologic Agents|dermatologic agents|mesh-ancestor
65574615|NCT03063086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65574616|NCT03063086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65574617|NCT03063086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65574618|NCT03063086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65574619|NCT03063086|Adrenergic Agents|adrenergic agents|mesh-ancestor
65574620|NCT03063086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65574621|NCT03063086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574622|NCT03904745|Atosiban|atosiban|mesh-list
65574623|NCT03904745|Hormone Antagonists|hormone antagonists|mesh-ancestor
65574624|NCT03904745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65574625|NCT03904745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574626|NCT03904745|Tocolytic Agents|tocolytic agents|mesh-ancestor
65574627|NCT03904745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65574628|NCT05187338|Pembrolizumab|pembrolizumab|mesh-list
65574629|NCT05187338|Ipilimumab|ipilimumab|mesh-list
65574630|NCT05187338|Durvalumab|durvalumab|mesh-list
65574631|NCT05187338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65574632|NCT05187338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574633|NCT05187338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65574634|NCT05187338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574635|NCT03898583|Calcitriol|calcitriol|mesh-list
65574636|NCT03898583|Betamethasone|betamethasone|mesh-list
65574637|NCT03898583|Betamethasone Valerate|betamethasone valerate|mesh-list
65574638|NCT03898583|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65574639|NCT03898583|Betamethasone benzoate|betamethasone benzoate|mesh-list
65574640|NCT03898583|Calcipotriene|calcipotriene|mesh-list
65574641|NCT03898583|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65574642|NCT03898583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65574643|NCT03898583|Glucocorticoids|glucocorticoids|mesh-ancestor
65574644|NCT03898583|Hormones|hormones|mesh-ancestor
65574645|NCT03898583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65574646|NCT03898583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574647|NCT03898583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65574648|NCT03898583|Respiratory System Agents|respiratory system agents|mesh-ancestor
65574649|NCT03898583|Dermatologic Agents|dermatologic agents|mesh-ancestor
65574650|NCT03898583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65574651|NCT03898583|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65574652|NCT03898583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65574653|NCT03898583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574654|NCT03898583|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65574655|NCT03898583|Vitamins|vitamins|mesh-ancestor
65574656|NCT03898583|Micronutrients|micronutrients|mesh-ancestor
65574657|NCT03898583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65574658|NCT03898193|Montelukast|montelukast|mesh-list
65574659|NCT03898193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65574660|NCT03898193|Respiratory System Agents|respiratory system agents|mesh-ancestor
65574661|NCT03898193|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65574662|NCT03898193|Hormone Antagonists|hormone antagonists|mesh-ancestor
65574663|NCT03898193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65574664|NCT03898193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574665|NCT03898193|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65574666|NCT03898193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65574667|NCT03898193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574668|NCT03321188|Paclitaxel|paclitaxel|mesh-list
65574669|NCT03321188|Carboplatin|carboplatin|mesh-list
65574670|NCT03321188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65574671|NCT03321188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574672|NCT03321188|Tubulin Modulators|tubulin modulators|mesh-ancestor
65574673|NCT03321188|Antimitotic Agents|antimitotic agents|mesh-ancestor
65574674|NCT03321188|Mitosis Modulators|mitosis modulators|mesh-ancestor
65574675|NCT03321188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574676|NCT03904355|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65574677|NCT03904355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65574678|NCT03904355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574679|NCT01254617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65574680|NCT01254617|Cetuximab|cetuximab|mesh-list
65574681|NCT01254617|Lenalidomide|lenalidomide|mesh-list
65574682|NCT01254617|Antibodies|antibodies|mesh-list
65574683|NCT01254617|Immunoglobulins|immunoglobulins|mesh-list
65574684|NCT01254617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65574685|NCT01254617|Immunologic Factors|immunologic factors|mesh-ancestor
65574686|NCT01254617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574687|NCT01254617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574688|NCT01254617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65574689|NCT01254617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65574690|NCT01254617|Growth Substances|growth substances|mesh-ancestor
65574691|NCT01254617|Growth Inhibitors|growth inhibitors|mesh-ancestor
65574692|NCT01150331|Levetiracetam|levetiracetam|mesh-list
65574693|NCT01150331|Clonazepam|clonazepam|mesh-list
65574694|NCT01150331|Anticonvulsants|anticonvulsants|mesh-list
65574695|NCT01150331|Nootropic Agents|nootropic agents|mesh-ancestor
65574696|NCT01150331|GABA Modulators|gaba modulators|mesh-ancestor
65574697|NCT01150331|GABA Agents|gaba agents|mesh-ancestor
65574698|NCT01150331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65574699|NCT01150331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574700|NCT01150331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574701|NCT03191084|Dronabinol|dronabinol|mesh-list
65574702|NCT03191084|Hallucinogens|hallucinogens|mesh-ancestor
65574703|NCT03191084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574704|NCT03191084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65574705|NCT03191084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65574706|NCT03191084|Analgesics|analgesics|mesh-ancestor
65574707|NCT03191084|Sensory System Agents|sensory system agents|mesh-ancestor
65574708|NCT03191084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65574709|NCT03191084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65574710|NCT03191084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65574711|NCT03191084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65574712|NCT03191084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574713|NCT03191084|Hormones|hormones|mesh-ancestor
65574714|NCT03191084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65574715|NCT01256489|Infliximab|infliximab|mesh-list
65574716|NCT01256489|Dermatologic Agents|dermatologic agents|mesh-ancestor
65574717|NCT01256489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65574718|NCT01256489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65574719|NCT03746119|Nicotine|nicotine|mesh-list
65574720|NCT03746119|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65574721|NCT03746119|Autonomic Agents|autonomic agents|mesh-ancestor
65574722|NCT03746119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65574723|NCT03746119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574724|NCT03746119|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65574725|NCT03746119|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65574726|NCT03746119|Cholinergic Agents|cholinergic agents|mesh-ancestor
65574727|NCT03746119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65574728|NCT03746119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574729|NCT01149005|Insulin|insulin|mesh-list
65574730|NCT01149005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65574731|NCT01149005|Insulin Lispro|insulin lispro|mesh-list
65574732|NCT01149005|Insulin Aspart|insulin aspart|mesh-list
65574733|NCT01149005|Insulin, Short-Acting|insulin, short-acting|mesh-list
65574734|NCT01149005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65574735|NCT01149005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574736|NCT03903887|Antibodies|antibodies|mesh-list
65574737|NCT03903887|Immunologic Factors|immunologic factors|mesh-ancestor
65574738|NCT03903887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574739|NCT03903419|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65574740|NCT03903419|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65574741|NCT03903419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574742|NCT05122130|Melatonin|melatonin|mesh-list
65574743|NCT05122130|Antioxidants|antioxidants|mesh-ancestor
65574744|NCT05122130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574745|NCT05122130|Protective Agents|protective agents|mesh-ancestor
65574746|NCT05122130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574747|NCT05122130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65574748|NCT02898506|Liraglutide|liraglutide|mesh-list
65574749|NCT02898506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65574750|NCT02898506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574751|NCT02898506|Incretins|incretins|mesh-ancestor
65574752|NCT02898506|Hormones|hormones|mesh-ancestor
65574753|NCT02898506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65574754|NCT04123405|Acetylcysteine|acetylcysteine|mesh-list
65574755|NCT04123405|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65574756|NCT04123405|Antiviral Agents|antiviral agents|mesh-ancestor
65574757|NCT04123405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65574758|NCT04123405|Expectorants|expectorants|mesh-ancestor
65574759|NCT04123405|Respiratory System Agents|respiratory system agents|mesh-ancestor
65574760|NCT04123405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65574761|NCT04123405|Antioxidants|antioxidants|mesh-ancestor
65574762|NCT04123405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574763|NCT04123405|Protective Agents|protective agents|mesh-ancestor
65574764|NCT04123405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574765|NCT04123405|Antidotes|antidotes|mesh-ancestor
65574766|NCT02611232|Liraglutide|liraglutide|mesh-list
65574767|NCT02611232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65574768|NCT02611232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574769|NCT02611232|Incretins|incretins|mesh-ancestor
65574770|NCT02611232|Hormones|hormones|mesh-ancestor
65574771|NCT02611232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65574772|NCT01150877|Vitamin D|vitamin d|mesh-list
65574773|NCT01150877|Vitamins|vitamins|mesh-ancestor
65574774|NCT01150877|Micronutrients|micronutrients|mesh-ancestor
65574775|NCT01150877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574776|NCT01150877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65574777|NCT03893591|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65574778|NCT03893591|Dalteparin|dalteparin|mesh-list
65574779|NCT03893591|Anticoagulants|anticoagulants|mesh-ancestor
65574780|NCT03893591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65574781|NCT03893591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65574782|NCT03893591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574783|NCT01256801|Interleukin-2|interleukin-2|mesh-list
65574784|NCT01256801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574785|NCT01256801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65574786|NCT01256801|Analgesics|analgesics|mesh-ancestor
65574787|NCT01256801|Sensory System Agents|sensory system agents|mesh-ancestor
65574788|NCT01256801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65574789|NCT01256801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574790|NCT02519738|Silver Nitrate|silver nitrate|mesh-list
65574791|NCT02519738|Triamcinolone|triamcinolone|mesh-list
65574792|NCT02519738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65574793|NCT02519738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65574794|NCT02519738|Glucocorticoids|glucocorticoids|mesh-ancestor
65574795|NCT02519738|Hormones|hormones|mesh-ancestor
65574796|NCT02519738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65574797|NCT02519738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574798|NCT02519738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65574799|NCT02519738|Immunologic Factors|immunologic factors|mesh-ancestor
65574800|NCT02519738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65574801|NCT02519738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65574802|NCT03893747|Vaccines|vaccines|mesh-list
65574803|NCT03893747|Immunologic Factors|immunologic factors|mesh-ancestor
65574804|NCT03893747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574805|NCT02343224|Interferons|interferons|mesh-list
65574806|NCT02343224|Interferon-alpha|interferon-alpha|mesh-list
65574807|NCT02343224|Interferon alpha-2|interferon alpha-2|mesh-list
65574808|NCT02343224|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65574809|NCT02343224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574810|NCT02343224|Antiviral Agents|antiviral agents|mesh-ancestor
65574811|NCT02343224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65574812|NCT02343224|Immunologic Factors|immunologic factors|mesh-ancestor
65574813|NCT02343224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574814|NCT01257035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
65574815|NCT01257035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65574816|NCT01257035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574817|NCT04314037|Praziquantel|praziquantel|mesh-list
65574818|NCT04314037|Anthelmintics|anthelmintics|mesh-ancestor
65574819|NCT04314037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65574820|NCT04314037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65574821|NCT05737862|Folic Acid|folic acid|mesh-list
65574822|NCT05737862|Hematinics|hematinics|mesh-ancestor
65574823|NCT05737862|Vitamin B Complex|vitamin b complex|mesh-ancestor
65574824|NCT05737862|Vitamins|vitamins|mesh-ancestor
65574825|NCT05737862|Micronutrients|micronutrients|mesh-ancestor
65574826|NCT05737862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574827|NCT02097680|Letrozole|letrozole|mesh-list
65574828|NCT02097680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574829|NCT02097680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65574830|NCT02097680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65574831|NCT02097680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574832|NCT02097680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574833|NCT02097680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65574834|NCT02097680|Hormone Antagonists|hormone antagonists|mesh-ancestor
65574835|NCT02097680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65574836|NCT02097680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574837|NCT01150955|Resveratrol|resveratrol|mesh-list
65574838|NCT01150955|Antioxidants|antioxidants|mesh-ancestor
65574839|NCT01150955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574840|NCT01150955|Protective Agents|protective agents|mesh-ancestor
65574841|NCT01150955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574842|NCT01150955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574843|NCT01150955|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65574844|NCT03897413|Antacids|antacids|mesh-list
65574845|NCT03897413|Calcium Carbonate|calcium carbonate|mesh-list
65574846|NCT03897413|Calcium|calcium|mesh-list
65574847|NCT03897413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65574848|NCT03897413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574849|NCT03897413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574850|NCT03897413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65574851|NCT01258439|Ritonavir|ritonavir|mesh-list
65574852|NCT01258439|Darunavir|darunavir|mesh-list
65574853|NCT01258439|Tenofovir|tenofovir|mesh-list
65574854|NCT01258439|Emtricitabine|emtricitabine|mesh-list
65574855|NCT01258439|Raltegravir Potassium|raltegravir potassium|mesh-list
65574856|NCT01258439|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65574857|NCT01258439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65574858|NCT01258439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65574859|NCT01258439|Protease Inhibitors|protease inhibitors|mesh-ancestor
65574860|NCT01258439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574861|NCT01258439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574862|NCT01258439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65574863|NCT01258439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65574864|NCT01258439|Antiviral Agents|antiviral agents|mesh-ancestor
65574865|NCT01258439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65574866|NCT01258439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65574867|NCT01258439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65574868|NCT01258439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65574869|NCT01258439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65574870|NCT01258439|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65574871|NCT01258439|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65574872|NCT01850888|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65574873|NCT01850888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65574874|NCT01850888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574875|NCT01850888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574876|NCT01850888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574877|NCT01850888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65574878|NCT03893045|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65574879|NCT03893045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65574880|NCT03893045|Hematinics|hematinics|mesh-ancestor
65574881|NCT03893045|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65574882|NCT03893045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65574883|NCT01560572|Mycophenolic Acid|mycophenolic acid|mesh-list
65574884|NCT01560572|Prednisolone|prednisolone|mesh-list
65574885|NCT01560572|Tacrolimus|tacrolimus|mesh-list
65574886|NCT01560572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65574887|NCT01560572|Immunologic Factors|immunologic factors|mesh-ancestor
65574888|NCT01560572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574889|NCT01560572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65574890|NCT01560572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574891|NCT01560572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574892|NCT01560572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65574893|NCT01560572|Glucocorticoids|glucocorticoids|mesh-ancestor
65574894|NCT01560572|Hormones|hormones|mesh-ancestor
65574895|NCT01560572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65574896|NCT01560572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65574897|NCT01560572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574898|NCT01560572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65574899|NCT01560572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65574900|NCT01560572|Antitubercular Agents|antitubercular agents|mesh-ancestor
65574901|NCT01560572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65574902|NCT01560572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65574903|NCT05209256|Pemetrexed|pemetrexed|mesh-list
65574904|NCT05209256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574905|NCT05209256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574906|NCT05209256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574907|NCT05209256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65574908|NCT05209256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65574909|NCT03896321|Anticoagulants|anticoagulants|mesh-list
65574910|NCT03896321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65574911|NCT05211050|Cromakalim|cromakalim|mesh-list
65574912|NCT05211050|Sumatriptan|sumatriptan|mesh-list
65574913|NCT05211050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65574914|NCT05211050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65574915|NCT05211050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65574916|NCT05211050|Serotonin Agents|serotonin agents|mesh-ancestor
65574917|NCT05211050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65574918|NCT05211050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574919|NCT05211050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574920|NCT05211050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65372437|NCT00962637|Fertility Agents|fertility agents|mesh-ancestor
65574921|NCT05211050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65574923|NCT05211050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65574924|NCT05211050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65574925|NCT05211050|Respiratory System Agents|respiratory system agents|mesh-ancestor
65574926|NCT05211050|Parasympatholytics|parasympatholytics|mesh-ancestor
65574927|NCT05211050|Vasodilator Agents|vasodilator agents|mesh-ancestor
65574928|NCT03892499|Itraconazole|itraconazole|mesh-list
65574929|NCT03892499|Antifungal Agents|antifungal agents|mesh-ancestor
65574930|NCT03892499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65574931|NCT03892499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65574932|NCT03892499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65574933|NCT03892499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574934|NCT03892499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574935|NCT03892499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65574936|NCT03892499|Hormone Antagonists|hormone antagonists|mesh-ancestor
65574937|NCT03892499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65574938|NCT03892499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574939|NCT03892499|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65574940|NCT01152047|Oxytocin|oxytocin|mesh-list
65574941|NCT01152047|Oxytocics|oxytocics|mesh-ancestor
65574942|NCT01152047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65574943|NCT01152047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574944|NCT01151267|Anesthetics|anesthetics|mesh-list
65574945|NCT01151267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65574946|NCT01151267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574947|NCT01259141|Azithromycin|azithromycin|mesh-list
65574948|NCT01259141|Moxifloxacin|moxifloxacin|mesh-list
65574949|NCT01259141|Cephalosporins|cephalosporins|mesh-list
65574950|NCT01259141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65574951|NCT01259141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65574952|NCT01259141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65574953|NCT01259141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65574954|NCT01259141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65574955|NCT01259141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574956|NCT01259141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574957|NCT05210192|Lidocaine|lidocaine|mesh-list
65574958|NCT05210192|Anesthetics, Local|anesthetics, local|mesh-ancestor
65574959|NCT05210192|Anesthetics|anesthetics|mesh-ancestor
65574960|NCT05210192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65574961|NCT05210192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574962|NCT05210192|Sensory System Agents|sensory system agents|mesh-ancestor
65574963|NCT05210192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65574964|NCT05210192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65574965|NCT05210192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65574966|NCT05210192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65574967|NCT05210192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65574968|NCT05210192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574969|NCT01152203|Bevacizumab|bevacizumab|mesh-list
65574970|NCT01152203|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65574971|NCT01152203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65574972|NCT01152203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574973|NCT01152203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65574974|NCT01152203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65574975|NCT01152203|Growth Substances|growth substances|mesh-ancestor
65574976|NCT01152203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574977|NCT01152203|Growth Inhibitors|growth inhibitors|mesh-ancestor
65574978|NCT01152203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65574979|NCT01152203|Alkylating Agents|alkylating agents|mesh-ancestor
65574980|NCT01152203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65574981|NCT01257815|Ranibizumab|ranibizumab|mesh-list
65574982|NCT01257815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65574983|NCT01257815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65574984|NCT01257815|Growth Substances|growth substances|mesh-ancestor
65574985|NCT01257815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574986|NCT01257815|Growth Inhibitors|growth inhibitors|mesh-ancestor
65574987|NCT01257815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574988|NCT03892421|Cytarabine|cytarabine|mesh-list
65574989|NCT03892421|Dexamethasone|dexamethasone|mesh-list
65574990|NCT03892421|Rituximab|rituximab|mesh-list
65574991|NCT03892421|Carboplatin|carboplatin|mesh-list
65574992|NCT03892421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65372511|NCT00844506|Alkylating Agents|alkylating agents|mesh-ancestor
65574993|NCT03892421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65574994|NCT03892421|Immunologic Factors|immunologic factors|mesh-ancestor
65574995|NCT03892421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65574996|NCT03892421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65574997|NCT03892421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65574998|NCT03892421|Antiemetics|antiemetics|mesh-ancestor
65574999|NCT03892421|Autonomic Agents|autonomic agents|mesh-ancestor
65575000|NCT03892421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65575001|NCT03892421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65575002|NCT03892421|Glucocorticoids|glucocorticoids|mesh-ancestor
65575003|NCT03892421|Hormones|hormones|mesh-ancestor
65575004|NCT03892421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65575005|NCT03892421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65575006|NCT03892421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65575007|NCT03892421|Antimetabolites|antimetabolites|mesh-ancestor
65575008|NCT03892421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575009|NCT03892421|Antiviral Agents|antiviral agents|mesh-ancestor
65575010|NCT03892421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65575011|NCT03892421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65575012|NCT05546567|Niacinamide|niacinamide|mesh-list
65575013|NCT05546567|Niacin|niacin|mesh-list
65575014|NCT05546567|Nicotinic Acids|nicotinic acids|mesh-list
65575015|NCT05546567|Vitamin B Complex|vitamin b complex|mesh-ancestor
65575016|NCT05546567|Vitamins|vitamins|mesh-ancestor
65575017|NCT05546567|Micronutrients|micronutrients|mesh-ancestor
65575018|NCT05546567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575019|NCT05546567|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65575020|NCT05546567|Antimetabolites|antimetabolites|mesh-ancestor
65575021|NCT05546567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575022|NCT05546567|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65575023|NCT05546567|Vasodilator Agents|vasodilator agents|mesh-ancestor
65575024|NCT03895229|Empagliflozin|empagliflozin|mesh-list
65575025|NCT03895229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65575026|NCT03895229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575027|NCT03895229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65575028|NCT03895229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575029|NCT01257893|Aspirin|aspirin|mesh-list
65575030|NCT01257893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65575031|NCT01257893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65575032|NCT01257893|Analgesics|analgesics|mesh-ancestor
65575033|NCT01257893|Sensory System Agents|sensory system agents|mesh-ancestor
65575034|NCT01257893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65575035|NCT01257893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575036|NCT01257893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65575037|NCT01257893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65575038|NCT01257893|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65575039|NCT01257893|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65575040|NCT01257893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575041|NCT01257893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65575042|NCT01257893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65575043|NCT01257893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575044|NCT01257893|Antipyretics|antipyretics|mesh-ancestor
65575045|NCT01152593|Mupirocin|mupirocin|mesh-list
65575046|NCT01152593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65575047|NCT01152593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65575048|NCT01152593|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65575049|NCT01152593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575050|NCT01152593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575051|NCT01259219|Rifabutin|rifabutin|mesh-list
65575052|NCT01259219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65575053|NCT01259219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65575054|NCT01259219|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65575055|NCT01259219|Antitubercular Agents|antitubercular agents|mesh-ancestor
65575056|NCT03891095|Oxytocin|oxytocin|mesh-list
65575057|NCT03891095|Oxytocics|oxytocics|mesh-ancestor
65575058|NCT03891095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65575059|NCT03891095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575060|NCT05102591|Ketorolac|ketorolac|mesh-list
65575061|NCT05102591|Metoclopramide|metoclopramide|mesh-list
65575062|NCT05102591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65575063|NCT05102591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65575064|NCT05102591|Analgesics|analgesics|mesh-ancestor
65575065|NCT05102591|Sensory System Agents|sensory system agents|mesh-ancestor
65575066|NCT05102591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65575067|NCT05102591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372593|NCT04534023|Idebenone|idebenone|mesh-list
65575068|NCT05102591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65575069|NCT05102591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65575070|NCT05102591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65575071|NCT05102591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575072|NCT05102591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575073|NCT05102591|Antiemetics|antiemetics|mesh-ancestor
65575074|NCT05102591|Autonomic Agents|autonomic agents|mesh-ancestor
65575075|NCT05102591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65575076|NCT05102591|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65575077|NCT05102591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65575078|NCT05102591|Dopamine Agents|dopamine agents|mesh-ancestor
65575079|NCT05102591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65575080|NCT05667077|Amantadine|amantadine|mesh-list
65575081|NCT05667077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65575082|NCT05667077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65575083|NCT05667077|Antiviral Agents|antiviral agents|mesh-ancestor
65575084|NCT05667077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65575085|NCT05667077|Dopamine Agents|dopamine agents|mesh-ancestor
65575086|NCT05667077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65575087|NCT05667077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575088|NCT05667077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575089|NCT05667077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65575090|NCT05667077|Analgesics|analgesics|mesh-ancestor
65575091|NCT05667077|Sensory System Agents|sensory system agents|mesh-ancestor
65575092|NCT05667077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65575093|NCT03894839|Chlorhexidine|chlorhexidine|mesh-list
65575094|NCT03894839|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65575095|NCT03894839|Sodium Hypochlorite|sodium hypochlorite|mesh-list
65575096|NCT03894839|Glutaral|glutaral|mesh-list
65575097|NCT03894839|Eusol|eusol|mesh-list
65575098|NCT03894839|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65575099|NCT03894839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65575100|NCT03894839|Disinfectants|disinfectants|mesh-ancestor
65575101|NCT03894839|Dermatologic Agents|dermatologic agents|mesh-ancestor
65575102|NCT01152749|Nicotine|nicotine|mesh-list
65575103|NCT01152749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65575104|NCT01152749|Autonomic Agents|autonomic agents|mesh-ancestor
65575105|NCT01152749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65575106|NCT01152749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575107|NCT01152749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65575108|NCT01152749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65575109|NCT01152749|Cholinergic Agents|cholinergic agents|mesh-ancestor
65575110|NCT01152749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65575111|NCT01152749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575112|NCT03894683|Melatonin|melatonin|mesh-list
65575113|NCT03894683|Antioxidants|antioxidants|mesh-ancestor
65575114|NCT03894683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575115|NCT03894683|Protective Agents|protective agents|mesh-ancestor
65575116|NCT03894683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575117|NCT03894683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65575118|NCT01259531|Silodosin|silodosin|mesh-list
65575119|NCT01259531|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65575120|NCT01259531|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65575121|NCT01259531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65575122|NCT01259531|Adrenergic Agents|adrenergic agents|mesh-ancestor
65575123|NCT01259531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65575124|NCT01259531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575125|NCT01259531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575126|NCT01259531|Urological Agents|urological agents|mesh-ancestor
65575127|NCT01151735|Complement C1s|complement c1s|mesh-list
65575128|NCT01151735|Immunologic Factors|immunologic factors|mesh-ancestor
65575129|NCT01151735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575130|NCT03061214|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65575131|NCT03061214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65575132|NCT03061214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575133|NCT03061214|Incretins|incretins|mesh-ancestor
65575134|NCT03061214|Hormones|hormones|mesh-ancestor
65575135|NCT03061214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65575136|NCT03061214|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65575137|NCT03061214|Protease Inhibitors|protease inhibitors|mesh-ancestor
65575138|NCT03061214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575139|NCT03061214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575140|NCT01152827|Everolimus|everolimus|mesh-list
65575141|NCT01152827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575142|NCT01152827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65575143|NCT01152827|Immunologic Factors|immunologic factors|mesh-ancestor
65575144|NCT01152827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575145|NCT01153373|Ethanol|ethanol|mesh-list
65575146|NCT01153373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65575147|NCT01153373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65575148|NCT01153373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65575149|NCT01153373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575150|NCT03889145|Amlodipine|amlodipine|mesh-list
65575151|NCT03889145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65575152|NCT03889145|Telmisartan|telmisartan|mesh-list
65575153|NCT03889145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65575154|NCT03889145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65575155|NCT03889145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65575156|NCT03889145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575157|NCT03889145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65575158|NCT03889145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575159|NCT03889145|Vasodilator Agents|vasodilator agents|mesh-ancestor
65575160|NCT03889145|Diuretics|diuretics|mesh-ancestor
65575161|NCT03889145|Natriuretic Agents|natriuretic agents|mesh-ancestor
65575162|NCT03889145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65575163|NCT03889145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65575164|NCT03889145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65575165|NCT03888677|Cyclophosphamide|cyclophosphamide|mesh-list
65575166|NCT03888677|Epirubicin|epirubicin|mesh-list
65575167|NCT03888677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65575168|NCT03888677|Immunologic Factors|immunologic factors|mesh-ancestor
65575169|NCT03888677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575170|NCT03888677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65575171|NCT03888677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65575172|NCT03888677|Alkylating Agents|alkylating agents|mesh-ancestor
65575173|NCT03888677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575174|NCT03888677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575175|NCT03888677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65575176|NCT03888677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65575177|NCT03888677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65575178|NCT03888677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65575179|NCT03888677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575180|NCT04655690|Insulin Aspart|insulin aspart|mesh-list
65575181|NCT04655690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65575182|NCT04655690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575183|NCT01260233|Nicotine|nicotine|mesh-list
65575184|NCT01260233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65575185|NCT01260233|Autonomic Agents|autonomic agents|mesh-ancestor
65575186|NCT01260233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65575187|NCT01260233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575188|NCT01260233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65575189|NCT01260233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65575190|NCT01260233|Cholinergic Agents|cholinergic agents|mesh-ancestor
65575191|NCT01260233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65575192|NCT01260233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575193|NCT01153919|Interferons|interferons|mesh-list
65575194|NCT01153919|Ribavirin|ribavirin|mesh-list
65575195|NCT01153919|Interferon-alpha|interferon-alpha|mesh-list
65575196|NCT01153919|Interferon alpha-2|interferon alpha-2|mesh-list
65575197|NCT01153919|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65575198|NCT01153919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575199|NCT01153919|Antiviral Agents|antiviral agents|mesh-ancestor
65575200|NCT01153919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65575201|NCT01153919|Antimetabolites|antimetabolites|mesh-ancestor
65575202|NCT01153919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575203|NCT01153919|Immunologic Factors|immunologic factors|mesh-ancestor
65575204|NCT01153919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575205|NCT03912389|Carboplatin|carboplatin|mesh-list
65575206|NCT03912389|Pemetrexed|pemetrexed|mesh-list
65575207|NCT03912389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575208|NCT03912389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575209|NCT03912389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575210|NCT03912389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65575211|NCT03912389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65575212|NCT01147757|Remifentanil|remifentanil|mesh-list
65575213|NCT01147757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65575214|NCT01147757|Narcotics|narcotics|mesh-ancestor
65575215|NCT01147757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65575216|NCT01147757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372749|NCT00267865|Antidotes|antidotes|mesh-ancestor
65575217|NCT01147757|Analgesics|analgesics|mesh-ancestor
65575218|NCT01147757|Sensory System Agents|sensory system agents|mesh-ancestor
65575219|NCT01147757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65575220|NCT01251809|Pegaspargase|pegaspargase|mesh-list
65575221|NCT01251809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575222|NCT01154387|Mycophenolic Acid|mycophenolic acid|mesh-list
65575223|NCT01154387|Tacrolimus|tacrolimus|mesh-list
65575224|NCT01154387|Thymoglobulin|thymoglobulin|mesh-list
65575225|NCT01154387|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65575226|NCT01154387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65575227|NCT01154387|Immunologic Factors|immunologic factors|mesh-ancestor
65575228|NCT01154387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575229|NCT01154387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65575230|NCT01154387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575231|NCT01154387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575232|NCT01154387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65575233|NCT01154387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575234|NCT01154387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65575235|NCT01154387|Antitubercular Agents|antitubercular agents|mesh-ancestor
65575236|NCT01154387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65575237|NCT01154387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65575238|NCT01154465|Povidone-Iodine|povidone-iodine|mesh-list
65575239|NCT01154465|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65575240|NCT01154465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65575241|NCT01260623|Prednisone|prednisone|mesh-list
65575242|NCT01260623|Prednisolone|prednisolone|mesh-list
65575243|NCT01260623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65575244|NCT01260623|Glucocorticoids|glucocorticoids|mesh-ancestor
65575245|NCT01260623|Hormones|hormones|mesh-ancestor
65575246|NCT01260623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65575247|NCT01260623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575248|NCT01260623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65575249|NCT01260623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575250|NCT01252121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65575251|NCT01252121|Lubricant Eye Drops|lubricant eye drops|mesh-list
65575252|NCT01252121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65575253|NCT01260857|Hydroflumethiazide|hydroflumethiazide|mesh-list
65575254|NCT01260857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65575255|NCT01260857|Diuretics|diuretics|mesh-ancestor
65575256|NCT01260857|Natriuretic Agents|natriuretic agents|mesh-ancestor
65575257|NCT01260857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575258|NCT01260857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65575259|NCT01260857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65575260|NCT01260857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575261|NCT03890003|Insulin Lispro|insulin lispro|mesh-list
65575262|NCT03890003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65575263|NCT03890003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575264|NCT01153217|Tenofovir|tenofovir|mesh-list
65575265|NCT01153217|Abacavir|abacavir|mesh-list
65575266|NCT01153217|Antiviral Agents|antiviral agents|mesh-ancestor
65575267|NCT01153217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65575268|NCT01153217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65575269|NCT01153217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65575270|NCT01153217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575271|NCT01153217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575272|NCT01153217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65575273|NCT01153217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65575274|NCT01261169|Mycophenolic Acid|mycophenolic acid|mesh-list
65575275|NCT01261169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65575276|NCT01261169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575277|NCT01261169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65575278|NCT01261169|Antitubercular Agents|antitubercular agents|mesh-ancestor
65575279|NCT01261169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65575280|NCT01261169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65575281|NCT01261169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575282|NCT01261169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575283|NCT03889379|Albuterol|albuterol|mesh-list
65575284|NCT03889379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65575285|NCT03889379|Autonomic Agents|autonomic agents|mesh-ancestor
65575286|NCT03889379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65575287|NCT03889379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575288|NCT03889379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65575289|NCT03889379|Respiratory System Agents|respiratory system agents|mesh-ancestor
65575290|NCT03889379|Tocolytic Agents|tocolytic agents|mesh-ancestor
65575291|NCT03889379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64576331|NCT01535937|GABA Agents|gaba agents|mesh-ancestor
65575292|NCT03889379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65575293|NCT03889379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65575294|NCT03889379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65575295|NCT03889379|Adrenergic Agents|adrenergic agents|mesh-ancestor
65575296|NCT03889379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65575297|NCT03889379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575298|NCT01586507|Tramadol|tramadol|mesh-list
65575299|NCT01586507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65575300|NCT01586507|Narcotics|narcotics|mesh-ancestor
65575301|NCT01586507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65575302|NCT01586507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575303|NCT01586507|Analgesics|analgesics|mesh-ancestor
65575304|NCT01586507|Sensory System Agents|sensory system agents|mesh-ancestor
65575305|NCT01586507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65575306|NCT03910361|Pioglitazone|pioglitazone|mesh-list
65575307|NCT03910361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65575308|NCT03910361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575309|NCT03700658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65575310|NCT03700658|Medroxyprogesterone|medroxyprogesterone|mesh-list
65575311|NCT03700658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65575312|NCT03700658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65575313|NCT03700658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65575314|NCT03700658|Contraceptive Agents|contraceptive agents|mesh-ancestor
65575315|NCT03700658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65575316|NCT03700658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575317|NCT03700658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65575318|NCT03700658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65575319|NCT03700658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65575320|NCT03700658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65575321|NCT03700658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575322|NCT03885947|Fludarabine|fludarabine|mesh-list
65575323|NCT03885947|Cyclophosphamide|cyclophosphamide|mesh-list
65575324|NCT03885947|Thiotepa|thiotepa|mesh-list
65575325|NCT03885947|Valproic Acid|valproic acid|mesh-list
65575326|NCT03885947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575327|NCT03885947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575328|NCT03885947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65575329|NCT03885947|Immunologic Factors|immunologic factors|mesh-ancestor
65575330|NCT03885947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575331|NCT03885947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65575332|NCT03885947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65575333|NCT03885947|Alkylating Agents|alkylating agents|mesh-ancestor
65575334|NCT03885947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65575335|NCT03885947|Anticonvulsants|anticonvulsants|mesh-ancestor
65575336|NCT03885947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575337|NCT03885947|GABA Agents|gaba agents|mesh-ancestor
65575338|NCT03885947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65575339|NCT03885947|Antimanic Agents|antimanic agents|mesh-ancestor
65575340|NCT03885947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65575341|NCT03885947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65575342|NCT03885947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65575343|NCT01261481|Tolvaptan|tolvaptan|mesh-list
65575344|NCT01261481|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65575345|NCT01261481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575346|NCT01261481|Natriuretic Agents|natriuretic agents|mesh-ancestor
65575347|NCT01261481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575348|NCT01261637|Ropivacaine|ropivacaine|mesh-list
65575349|NCT01261637|Anesthetics, Local|anesthetics, local|mesh-ancestor
65575350|NCT01261637|Anesthetics|anesthetics|mesh-ancestor
65575351|NCT01261637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65575352|NCT01261637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575353|NCT01261637|Sensory System Agents|sensory system agents|mesh-ancestor
65575354|NCT01261637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65575355|NCT01262183|Panitumumab|panitumumab|mesh-list
65575356|NCT01262183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65575357|NCT01262183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575358|NCT01154933|Exenatide|exenatide|mesh-list
65575359|NCT01154933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65575360|NCT01154933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575361|NCT01154933|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65575362|NCT01154933|Incretins|incretins|mesh-ancestor
65575363|NCT01154933|Hormones|hormones|mesh-ancestor
65575364|NCT01154933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65575365|NCT01155635|Carvedilol|carvedilol|mesh-list
65575366|NCT01155635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65372887|NCT00852228|Oxaliplatin|oxaliplatin|mesh-list
65575367|NCT01155635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65575368|NCT01155635|Adrenergic Agents|adrenergic agents|mesh-ancestor
65575369|NCT01155635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65575370|NCT01155635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575371|NCT01155635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575372|NCT01155635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65575373|NCT01155635|Antioxidants|antioxidants|mesh-ancestor
65575374|NCT01155635|Protective Agents|protective agents|mesh-ancestor
65575375|NCT01155635|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65575376|NCT01155635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65575377|NCT01155635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65575378|NCT01155635|Vasodilator Agents|vasodilator agents|mesh-ancestor
65575379|NCT01155635|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65575380|NCT01155635|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65575381|NCT01155089|Anastrozole|anastrozole|mesh-list
65575382|NCT01155089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65575383|NCT01155089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575384|NCT01155089|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65575385|NCT01155089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65575386|NCT01155089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575387|NCT01155089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575388|NCT01155089|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65575389|NCT01155089|Hormone Antagonists|hormone antagonists|mesh-ancestor
65575390|NCT01155089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65575391|NCT01155089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575392|NCT01155245|Teriparatide|teriparatide|mesh-list
65575393|NCT01155245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65575394|NCT01155245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575395|NCT01155245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65575396|NCT01262417|Hyaluronic Acid|hyaluronic acid|mesh-list
65575397|NCT01262417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65575398|NCT01262417|Immunologic Factors|immunologic factors|mesh-ancestor
65575399|NCT01262417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575400|NCT01262417|Viscosupplements|viscosupplements|mesh-ancestor
65575401|NCT01262417|Protective Agents|protective agents|mesh-ancestor
65575403|NCT01155791|Docetaxel|docetaxel|mesh-list
65575404|NCT01155791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575405|NCT01155791|Tubulin Modulators|tubulin modulators|mesh-ancestor
65575406|NCT01155791|Antimitotic Agents|antimitotic agents|mesh-ancestor
65575407|NCT01155791|Mitosis Modulators|mitosis modulators|mesh-ancestor
65575408|NCT01155791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575409|NCT01155791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65575410|NCT01155791|Glucocorticoids|glucocorticoids|mesh-ancestor
65575411|NCT01155791|Hormones|hormones|mesh-ancestor
65575412|NCT01155791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65575413|NCT01155791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575414|NCT01155791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65575415|NCT01157507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65575416|NCT01157507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65575417|NCT01157507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65575418|NCT01157507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65575419|NCT01157507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575420|NCT01157507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65575421|NCT01157507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65575422|NCT01157507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575423|NCT01157507|Cholinergic Agents|cholinergic agents|mesh-ancestor
65575424|NCT01157507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65575425|NCT03881423|Bromides|bromides|mesh-list
65575426|NCT03881423|Rocuronium|rocuronium|mesh-list
65575427|NCT03881423|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
65575428|NCT03881423|Anticonvulsants|anticonvulsants|mesh-ancestor
65575429|NCT03881423|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65575430|NCT03881423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65575431|NCT03881423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65575432|NCT03881423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575433|NCT03884465|Treprostinil|treprostinil|mesh-list
65575434|NCT03884465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65575435|NCT01155947|Anastrozole|anastrozole|mesh-list
65575436|NCT01155947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65575437|NCT01155947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575438|NCT01155947|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65372969|NCT04042506|Nivolumab|nivolumab|mesh-list
65575439|NCT01155947|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65575440|NCT01155947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575441|NCT01155947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575442|NCT01155947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65575443|NCT01155947|Hormone Antagonists|hormone antagonists|mesh-ancestor
65575444|NCT01155947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65575445|NCT01155947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575446|NCT01157585|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65575447|NCT01157585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65575448|NCT01157585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65575449|NCT01157585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65575450|NCT01157585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575451|NCT01157585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65575452|NCT01157585|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65575453|NCT01157585|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65575454|NCT01157585|Serotonin Agents|serotonin agents|mesh-ancestor
65575455|NCT01157585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65575456|NCT01157585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575457|NCT01157585|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65575458|NCT01157585|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65575459|NCT01157585|Dopamine Agents|dopamine agents|mesh-ancestor
65575460|NCT01264133|Adefovir|adefovir|mesh-list
65575461|NCT01264133|Clevudine|clevudine|mesh-list
65575462|NCT01264133|Antiviral Agents|antiviral agents|mesh-ancestor
65575463|NCT01264133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65575464|NCT01264133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65575465|NCT01264133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65575466|NCT01264133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575467|NCT01264133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575468|NCT02527577|Ropivacaine|ropivacaine|mesh-list
65575469|NCT02527577|Anesthetics, Local|anesthetics, local|mesh-ancestor
65575470|NCT02527577|Anesthetics|anesthetics|mesh-ancestor
65575471|NCT02527577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65575472|NCT02527577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575473|NCT02527577|Sensory System Agents|sensory system agents|mesh-ancestor
65575474|NCT02527577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65575475|NCT03883841|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65575476|NCT03883841|Hematinics|hematinics|mesh-ancestor
65575477|NCT03881111|Pembrolizumab|pembrolizumab|mesh-list
65575478|NCT03881111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575479|NCT03881111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65575480|NCT01264211|Diacetylrhein|diacetylrhein|mesh-list
65575481|NCT01264211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65575482|NCT03880877|Leucovorin|leucovorin|mesh-list
65575483|NCT03880877|Antidotes|antidotes|mesh-ancestor
65575484|NCT03880877|Protective Agents|protective agents|mesh-ancestor
65575485|NCT03880877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575486|NCT03880877|Vitamin B Complex|vitamin b complex|mesh-ancestor
65575487|NCT03880877|Vitamins|vitamins|mesh-ancestor
65575488|NCT03880877|Micronutrients|micronutrients|mesh-ancestor
65575489|NCT05666999|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65575490|NCT05666999|Laxatives|laxatives|mesh-ancestor
65575491|NCT05666999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65575492|NCT01262729|Xenon|xenon|mesh-list
65575493|NCT01262729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65575494|NCT01262729|Anesthetics, General|anesthetics, general|mesh-ancestor
65575495|NCT01262729|Anesthetics|anesthetics|mesh-ancestor
65575496|NCT01262729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65575497|NCT01262729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575498|NCT01264289|Finasteride|finasteride|mesh-list
65575499|NCT01264289|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65575500|NCT01264289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65575501|NCT01264289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575502|NCT01264289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575503|NCT01264289|Hormone Antagonists|hormone antagonists|mesh-ancestor
65575504|NCT01264289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65575505|NCT01264289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575506|NCT01264289|Urological Agents|urological agents|mesh-ancestor
65575507|NCT03880487|Oxycodone|oxycodone|mesh-list
65575508|NCT03880487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65575509|NCT03880487|Narcotics|narcotics|mesh-ancestor
65575510|NCT03880487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65575511|NCT03880487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575512|NCT03880487|Analgesics|analgesics|mesh-ancestor
65575513|NCT03880487|Sensory System Agents|sensory system agents|mesh-ancestor
65575514|NCT03880487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65575515|NCT03880409|Lidocaine|lidocaine|mesh-list
65575516|NCT03880409|Epinephrine|epinephrine|mesh-list
65575517|NCT03880409|Racepinephrine|racepinephrine|mesh-list
65575518|NCT03880409|Carticaine|carticaine|mesh-list
65575519|NCT03880409|Epinephryl borate|epinephryl borate|mesh-list
65575520|NCT03880409|Anesthetics, Local|anesthetics, local|mesh-ancestor
65575521|NCT03880409|Anesthetics|anesthetics|mesh-ancestor
65575522|NCT03880409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65575523|NCT03880409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575524|NCT03880409|Sensory System Agents|sensory system agents|mesh-ancestor
65575525|NCT03880409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65575526|NCT03880409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65575527|NCT03880409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65575528|NCT03880409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65575529|NCT03880409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65575530|NCT03880409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575531|NCT03880409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65575532|NCT03880409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65575533|NCT03880409|Adrenergic Agents|adrenergic agents|mesh-ancestor
65575534|NCT03880409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65575535|NCT03880409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65575536|NCT03880409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65575537|NCT03880409|Autonomic Agents|autonomic agents|mesh-ancestor
65575538|NCT03880409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65575539|NCT03880409|Respiratory System Agents|respiratory system agents|mesh-ancestor
65575540|NCT03880409|Mydriatics|mydriatics|mesh-ancestor
65575541|NCT03880409|Sympathomimetics|sympathomimetics|mesh-ancestor
65575542|NCT03880409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65575543|NCT01157819|Ciprofloxacin|ciprofloxacin|mesh-list
65575544|NCT01157819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65575545|NCT01157819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65575546|NCT01157819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65575547|NCT01157819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65575548|NCT01157819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575549|NCT01157819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575550|NCT01157819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575551|NCT01157819|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65575552|NCT01157819|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65575553|NCT01264367|Interferons|interferons|mesh-list
65575554|NCT01264367|Clevudine|clevudine|mesh-list
65575555|NCT01264367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575556|NCT01264367|Antiviral Agents|antiviral agents|mesh-ancestor
65575557|NCT01264367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65575558|NCT05097716|Tolbutamide|tolbutamide|mesh-list
65575559|NCT05097716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65575560|NCT05097716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575561|NCT01262963|Dabrafenib|dabrafenib|mesh-list
65575562|NCT01262963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575563|NCT01262963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65575564|NCT01262963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575565|NCT01262963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575566|NCT01264445|Vaccines|vaccines|mesh-list
65575567|NCT01264445|Immunologic Factors|immunologic factors|mesh-ancestor
65575568|NCT01264445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575569|NCT01157975|Pioglitazone|pioglitazone|mesh-list
65575570|NCT01157975|Prednisone|prednisone|mesh-list
65575571|NCT01157975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65575572|NCT01157975|Glucocorticoids|glucocorticoids|mesh-ancestor
65575573|NCT01157975|Hormones|hormones|mesh-ancestor
65575574|NCT01157975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65575575|NCT01157975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575576|NCT01157975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65575577|NCT01157975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575578|NCT01157975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65575579|NCT03060512|Naloxegol|naloxegol|mesh-list
65575580|NCT03060512|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65575581|NCT03060512|Laxatives|laxatives|mesh-ancestor
65575582|NCT03060512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65575583|NCT03060512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65575584|NCT03060512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575585|NCT03060512|Sensory System Agents|sensory system agents|mesh-ancestor
65575586|NCT03060512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65575587|NCT01263353|Everolimus|everolimus|mesh-list
65575588|NCT01263353|Pasireotide|pasireotide|mesh-list
65575589|NCT01263353|Somatostatin|somatostatin|mesh-list
65575590|NCT01263353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575591|NCT01263353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65575592|NCT01263353|Immunologic Factors|immunologic factors|mesh-ancestor
65575593|NCT01263353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575594|NCT01263353|Hormones|hormones|mesh-ancestor
65575595|NCT01263353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65575596|NCT01158287|Sorafenib|sorafenib|mesh-list
65575597|NCT01158287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575598|NCT01158287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65575599|NCT01158287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575600|NCT01158287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575601|NCT01158365|Glycerol|glycerol|mesh-list
65575602|NCT01158365|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65575603|NCT01158365|Protective Agents|protective agents|mesh-ancestor
65575604|NCT01158365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575605|NCT01156649|Acetaminophen|acetaminophen|mesh-list
65575606|NCT01156649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65575607|NCT01156649|Analgesics|analgesics|mesh-ancestor
65575608|NCT01156649|Sensory System Agents|sensory system agents|mesh-ancestor
65575609|NCT01156649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65575610|NCT01156649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575611|NCT01156649|Antipyretics|antipyretics|mesh-ancestor
65575612|NCT01158755|Moxifloxacin|moxifloxacin|mesh-list
65575613|NCT01158755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65575614|NCT01158755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65575615|NCT01158755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65575616|NCT01158755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65575617|NCT01158755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575618|NCT01158755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575619|NCT01158755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575620|NCT03879707|Melatonin|melatonin|mesh-list
65575621|NCT03879707|Antioxidants|antioxidants|mesh-ancestor
65575622|NCT03879707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575623|NCT03879707|Protective Agents|protective agents|mesh-ancestor
65575624|NCT03879707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575625|NCT03879707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65575626|NCT01265147|Nedaplatin|nedaplatin|mesh-list
65575627|NCT01265147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575628|NCT01159145|Omeprazole|omeprazole|mesh-list
65575629|NCT01159145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65575630|NCT01159145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65575631|NCT01159145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65575632|NCT01159145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575633|NCT01159145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575634|NCT01156883|Cytarabine|cytarabine|mesh-list
65575635|NCT01156883|Dexamethasone|dexamethasone|mesh-list
65575636|NCT01156883|Prednisone|prednisone|mesh-list
65575637|NCT01156883|Methylprednisolone|methylprednisolone|mesh-list
65575638|NCT01156883|Cyclophosphamide|cyclophosphamide|mesh-list
65575639|NCT01156883|Ifosfamide|ifosfamide|mesh-list
65575640|NCT01156883|Doxorubicin|doxorubicin|mesh-list
65575641|NCT01156883|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65575642|NCT01156883|Methotrexate|methotrexate|mesh-list
65575643|NCT01156883|Vincristine|vincristine|mesh-list
65575644|NCT01156883|Daunorubicin|daunorubicin|mesh-list
65575645|NCT01156883|Asparaginase|asparaginase|mesh-list
65575646|NCT01156883|Mercaptopurine|mercaptopurine|mesh-list
65575647|NCT01156883|Thioguanine|thioguanine|mesh-list
65575648|NCT01156883|Vindesine|vindesine|mesh-list
65575649|NCT01156883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65575650|NCT01156883|Immunologic Factors|immunologic factors|mesh-ancestor
65575651|NCT01156883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575652|NCT01156883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65575653|NCT01156883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65575654|NCT01156883|Alkylating Agents|alkylating agents|mesh-ancestor
65575655|NCT01156883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575656|NCT01156883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575657|NCT01156883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65575658|NCT01156883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65575659|NCT01156883|Antiemetics|antiemetics|mesh-ancestor
65575660|NCT01156883|Autonomic Agents|autonomic agents|mesh-ancestor
65575661|NCT01156883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65575662|NCT01156883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65575663|NCT01156883|Glucocorticoids|glucocorticoids|mesh-ancestor
65575664|NCT01156883|Hormones|hormones|mesh-ancestor
65575665|NCT01156883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65575666|NCT01156883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65575667|NCT01156883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65575668|NCT01156883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65575669|NCT01156883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65575670|NCT01156883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575671|NCT01156883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65575672|NCT01156883|Abortifacient Agents|abortifacient agents|mesh-ancestor
65575673|NCT01156883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65575674|NCT01156883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65575675|NCT01156883|Antimetabolites|antimetabolites|mesh-ancestor
65575676|NCT01156883|Dermatologic Agents|dermatologic agents|mesh-ancestor
65575677|NCT01156883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65575678|NCT01156883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65575679|NCT01156883|Antiviral Agents|antiviral agents|mesh-ancestor
65575680|NCT01156883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65575681|NCT01156883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65575682|NCT01156883|Tubulin Modulators|tubulin modulators|mesh-ancestor
65575683|NCT01156883|Antimitotic Agents|antimitotic agents|mesh-ancestor
65575684|NCT01156883|Mitosis Modulators|mitosis modulators|mesh-ancestor
65575685|NCT01156883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65575686|NCT01156883|Protective Agents|protective agents|mesh-ancestor
65575687|NCT01156961|Paclitaxel|paclitaxel|mesh-list
65575688|NCT01156961|Bevacizumab|bevacizumab|mesh-list
65575689|NCT01156961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65575690|NCT01156961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575691|NCT01156961|Tubulin Modulators|tubulin modulators|mesh-ancestor
65575692|NCT01156961|Antimitotic Agents|antimitotic agents|mesh-ancestor
65575693|NCT01156961|Mitosis Modulators|mitosis modulators|mesh-ancestor
65575694|NCT01156961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575695|NCT01156961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65575696|NCT01156961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65575697|NCT01156961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65575698|NCT01156961|Growth Substances|growth substances|mesh-ancestor
65575699|NCT01156961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575700|NCT01156961|Growth Inhibitors|growth inhibitors|mesh-ancestor
65575701|NCT01159301|Sorafenib|sorafenib|mesh-list
65575702|NCT01159301|Entinostat|entinostat|mesh-list
65575703|NCT01159301|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65575704|NCT01159301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575705|NCT01159301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65575706|NCT01159301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575707|NCT01159301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575708|NCT01159379|Ertapenem|ertapenem|mesh-list
65575709|NCT01159379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65575710|NCT01159379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65575711|NCT01159847|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65575712|NCT01159847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65575713|NCT01159847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575714|NCT01159847|Incretins|incretins|mesh-ancestor
65575715|NCT01159847|Hormones|hormones|mesh-ancestor
65575716|NCT01159847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65575717|NCT01159847|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65575718|NCT01159847|Protease Inhibitors|protease inhibitors|mesh-ancestor
65575719|NCT01159847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575720|NCT01159847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575721|NCT02539160|Ticagrelor|ticagrelor|mesh-list
65575722|NCT02539160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65575723|NCT02539160|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65575724|NCT02539160|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65575725|NCT02539160|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65575726|NCT02539160|Purinergic Agents|purinergic agents|mesh-ancestor
65575727|NCT02539160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65575728|NCT02539160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575729|NCT02539160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575730|NCT01265927|Trastuzumab|trastuzumab|mesh-list
65575731|NCT01265927|Imetelstat|imetelstat|mesh-list
65575732|NCT01265927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65575733|NCT01265927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575734|NCT01265927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575735|NCT01265927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575736|NCT01266005|Entecavir|entecavir|mesh-list
65575737|NCT01266005|Clevudine|clevudine|mesh-list
65575738|NCT01266005|Antiviral Agents|antiviral agents|mesh-ancestor
65575739|NCT01266005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65575740|NCT04292899|Remdesivir|remdesivir|mesh-list
65575741|NCT04292899|Antimetabolites|antimetabolites|mesh-ancestor
65575742|NCT04292899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575743|NCT04292899|Antiviral Agents|antiviral agents|mesh-ancestor
65575744|NCT04292899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65575745|NCT03876899|Evening primrose oil|evening primrose oil|mesh-list
65575746|NCT03876899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65575747|NCT03876899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65575748|NCT03876899|Analgesics|analgesics|mesh-ancestor
65575749|NCT03876899|Sensory System Agents|sensory system agents|mesh-ancestor
65575750|NCT03876899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65575751|NCT03876899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575752|NCT03876899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65575753|NCT03876899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65575754|NCT03876899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65575755|NCT03876899|Antimetabolites|antimetabolites|mesh-ancestor
65575756|NCT03876899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575757|NCT03876899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65575758|NCT03876899|Dermatologic Agents|dermatologic agents|mesh-ancestor
65575760|NCT03241173|Ipilimumab|ipilimumab|mesh-list
65575761|NCT03241173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65575762|NCT03241173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575763|NCT03241173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65575764|NCT03241173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575765|NCT03264066|Atezolizumab|atezolizumab|mesh-list
65575766|NCT03264066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65575767|NCT03264066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575768|NCT03264066|Immunologic Factors|immunologic factors|mesh-ancestor
65575769|NCT03264066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575770|NCT03759041|Vancomycin|vancomycin|mesh-list
65575771|NCT03759041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65575772|NCT03759041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65575773|NCT04110145|Linaclotide|linaclotide|mesh-list
65575774|NCT04110145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65575775|NCT04110145|Enzyme Activators|enzyme activators|mesh-ancestor
65575776|NCT04110145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575777|NCT04110145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65575778|NCT02477618|Brexanolone|brexanolone|mesh-list
65575779|NCT02477618|Neurosteroids|neurosteroids|mesh-ancestor
65575780|NCT02477618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65575781|NCT02477618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575782|NCT02477618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575783|NCT02477618|GABA Modulators|gaba modulators|mesh-ancestor
65575784|NCT02477618|GABA Agents|gaba agents|mesh-ancestor
65575785|NCT01268033|Rituximab|rituximab|mesh-list
65575786|NCT01268033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65575787|NCT01268033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575788|NCT01268033|Immunologic Factors|immunologic factors|mesh-ancestor
65575789|NCT01268033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575790|NCT01268033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65575791|NCT01162031|Bortezomib|bortezomib|mesh-list
65575792|NCT01162031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575793|NCT02879162|Durvalumab|durvalumab|mesh-list
65575794|NCT02879162|Tremelimumab|tremelimumab|mesh-list
65575795|NCT02879162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65575796|NCT02879162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575797|NCT03285477|Tirbanibulin|tirbanibulin|mesh-list
65575798|NCT03285477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575799|NCT03285477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575800|NCT02285504|Brexanolone|brexanolone|mesh-list
65575801|NCT02285504|Neurosteroids|neurosteroids|mesh-ancestor
65575802|NCT02285504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65575803|NCT02285504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575804|NCT02285504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575805|NCT02285504|GABA Modulators|gaba modulators|mesh-ancestor
65575806|NCT02285504|GABA Agents|gaba agents|mesh-ancestor
65575807|NCT05009927|Imatinib Mesylate|imatinib mesylate|mesh-list
65575808|NCT05009927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575809|NCT05009927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65575810|NCT05009927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575811|NCT05009927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575812|NCT02227394|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65575813|NCT02227394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65575814|NCT02227394|Respiratory System Agents|respiratory system agents|mesh-ancestor
65575815|NCT05158491|Irinotecan|irinotecan|mesh-list
65575816|NCT05158491|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65575817|NCT05158491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65575818|NCT05158491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575819|NCT05158491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575820|NCT05158491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575821|NCT04276207|Insulin Lispro|insulin lispro|mesh-list
65575822|NCT04276207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65575823|NCT04276207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575824|NCT03240081|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65575825|NCT03240081|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65575826|NCT03240081|Estradiol|estradiol|mesh-list
65575827|NCT03240081|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65575828|NCT03240081|Estrogens|estrogens|mesh-ancestor
65575829|NCT03240081|Hormones|hormones|mesh-ancestor
65575830|NCT03240081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65575831|NCT03240081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575832|NCT03240081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65575833|NCT03240081|Contraceptive Agents|contraceptive agents|mesh-ancestor
65575834|NCT03240081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65575835|NCT03240081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65575836|NCT03876587|Docetaxel|docetaxel|mesh-list
65575837|NCT03876587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575838|NCT03876587|Tubulin Modulators|tubulin modulators|mesh-ancestor
65575839|NCT03876587|Antimitotic Agents|antimitotic agents|mesh-ancestor
65575840|NCT03876587|Mitosis Modulators|mitosis modulators|mesh-ancestor
65575841|NCT03876587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575842|NCT01162889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65575843|NCT01162889|Immunologic Factors|immunologic factors|mesh-ancestor
65575844|NCT01162889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575845|NCT04635423|Vaccines|vaccines|mesh-list
65575846|NCT04635423|Immunologic Factors|immunologic factors|mesh-ancestor
65575847|NCT04635423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575848|NCT03282357|Hyaluronic Acid|hyaluronic acid|mesh-list
65575849|NCT03282357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575850|NCT03282357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65575851|NCT03282357|Immunologic Factors|immunologic factors|mesh-ancestor
65575852|NCT03282357|Viscosupplements|viscosupplements|mesh-ancestor
65575853|NCT03282357|Protective Agents|protective agents|mesh-ancestor
65575854|NCT01162967|Posaconazole|posaconazole|mesh-list
65575855|NCT01162967|Benzonidazole|benzonidazole|mesh-list
65575856|NCT01162967|Antifungal Agents|antifungal agents|mesh-ancestor
65575857|NCT01162967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65575858|NCT01162967|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65575859|NCT01162967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65575860|NCT01162967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65575861|NCT01162967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65575862|NCT01162967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65575863|NCT01162967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575864|NCT01162967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575865|NCT01162967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65575866|NCT01162967|Hormone Antagonists|hormone antagonists|mesh-ancestor
65575867|NCT01162967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65575868|NCT01162967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575869|NCT01162967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65575870|NCT01162967|Immunologic Factors|immunologic factors|mesh-ancestor
65575871|NCT01268735|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65575872|NCT01268735|Lubricant Eye Drops|lubricant eye drops|mesh-list
65575873|NCT01268735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65575874|NCT04272775|Dexamethasone|dexamethasone|mesh-list
65575875|NCT04272775|Lenalidomide|lenalidomide|mesh-list
65575876|NCT04272775|Ixazomib|ixazomib|mesh-list
65575877|NCT04272775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65575878|NCT04272775|Antiemetics|antiemetics|mesh-ancestor
65575879|NCT04272775|Autonomic Agents|autonomic agents|mesh-ancestor
65575880|NCT04272775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65575881|NCT04272775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575882|NCT04272775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65575883|NCT04272775|Glucocorticoids|glucocorticoids|mesh-ancestor
65575884|NCT04272775|Hormones|hormones|mesh-ancestor
65575885|NCT04272775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65575886|NCT04272775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65575887|NCT04272775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575888|NCT04272775|Immunologic Factors|immunologic factors|mesh-ancestor
65575889|NCT04272775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65575890|NCT04272775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65575891|NCT04272775|Growth Substances|growth substances|mesh-ancestor
65575892|NCT04272775|Growth Inhibitors|growth inhibitors|mesh-ancestor
65575893|NCT04272775|Protease Inhibitors|protease inhibitors|mesh-ancestor
65575894|NCT04272775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575895|NCT04272775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575896|NCT03232983|Insulin Lispro|insulin lispro|mesh-list
65575897|NCT03232983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65575898|NCT03232983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575899|NCT01163201|Cyclophosphamide|cyclophosphamide|mesh-list
65575900|NCT01163201|Fludarabine|fludarabine|mesh-list
65575901|NCT01163201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65575902|NCT01163201|Immunologic Factors|immunologic factors|mesh-ancestor
65575903|NCT01163201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575904|NCT01163201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65575905|NCT01163201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65575906|NCT01163201|Alkylating Agents|alkylating agents|mesh-ancestor
65575907|NCT01163201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575908|NCT01163201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575909|NCT01163201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65575910|NCT03876041|Dexamethasone|dexamethasone|mesh-list
65575911|NCT03876041|Dexamethasone acetate|dexamethasone acetate|mesh-list
65575912|NCT03876041|Methylprednisolone|methylprednisolone|mesh-list
65575913|NCT03876041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65575914|NCT03876041|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65575915|NCT03876041|BB 1101|bb 1101|mesh-list
65575916|NCT03876041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65575917|NCT03876041|Antiemetics|antiemetics|mesh-ancestor
65575918|NCT03876041|Autonomic Agents|autonomic agents|mesh-ancestor
65575919|NCT03876041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65575920|NCT03876041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575921|NCT03876041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65575922|NCT03876041|Glucocorticoids|glucocorticoids|mesh-ancestor
65575923|NCT03876041|Hormones|hormones|mesh-ancestor
65575924|NCT03876041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65575925|NCT03876041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65575926|NCT03876041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575927|NCT03876041|Protease Inhibitors|protease inhibitors|mesh-ancestor
65575928|NCT03876041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575929|NCT03876041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575930|NCT03876041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65575931|NCT03876041|Protective Agents|protective agents|mesh-ancestor
65575932|NCT04102345|Zolpidem|zolpidem|mesh-list
65575933|NCT04102345|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65575934|NCT04102345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65575935|NCT04102345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65575936|NCT04102345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575937|NCT04102345|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65575938|NCT04102345|GABA Agonists|gaba agonists|mesh-ancestor
65575939|NCT04102345|GABA Agents|gaba agents|mesh-ancestor
65575940|NCT04102345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65575941|NCT04102345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575942|NCT01163435|Clarithromycin|clarithromycin|mesh-list
65575943|NCT01163435|Levofloxacin|levofloxacin|mesh-list
65575944|NCT01163435|Ofloxacin|ofloxacin|mesh-list
65575945|NCT01163435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65575946|NCT01163435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65575947|NCT01163435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65575948|NCT01163435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575949|NCT01163435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575950|NCT01163435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65575951|NCT01163435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65575952|NCT01163435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65575953|NCT01163435|Renal Agents|renal agents|mesh-ancestor
65575954|NCT01163435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65575955|NCT01163435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65575956|NCT01163435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575957|NCT01163435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65575958|NCT03299244|Cinacalcet|cinacalcet|mesh-list
65575959|NCT03299244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65575960|NCT03299244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575961|NCT03299244|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65575962|NCT03299244|Hormone Antagonists|hormone antagonists|mesh-ancestor
65575963|NCT03299244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65575964|NCT03875963|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65575965|NCT03875963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65575966|NCT03757715|Dexamethasone|dexamethasone|mesh-list
65575967|NCT03757715|Bupivacaine|bupivacaine|mesh-list
65373493|NCT00970905|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65575968|NCT03757715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65575969|NCT03757715|Antiemetics|antiemetics|mesh-ancestor
65575970|NCT03757715|Autonomic Agents|autonomic agents|mesh-ancestor
65575971|NCT03757715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65575972|NCT03757715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65575973|NCT03757715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65575974|NCT03757715|Glucocorticoids|glucocorticoids|mesh-ancestor
65575975|NCT03757715|Hormones|hormones|mesh-ancestor
65575976|NCT03757715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65575977|NCT03757715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65575978|NCT03757715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575979|NCT03757715|Anesthetics, Local|anesthetics, local|mesh-ancestor
65575980|NCT03757715|Anesthetics|anesthetics|mesh-ancestor
65575981|NCT03757715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65575982|NCT03757715|Sensory System Agents|sensory system agents|mesh-ancestor
65575983|NCT01163825|Mitogens|mitogens|mesh-list
65575984|NCT01163825|Mitosis Modulators|mitosis modulators|mesh-ancestor
65575985|NCT01163825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575986|NCT01163903|Doxorubicin|doxorubicin|mesh-list
65575987|NCT01163903|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65575988|NCT01163903|Pantoprazole|pantoprazole|mesh-list
65575989|NCT01163903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65575990|NCT01163903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65575991|NCT01163903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65575992|NCT01163903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65575993|NCT01163903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65575994|NCT01163903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65575995|NCT01163903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65575996|NCT01163903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65575997|NCT01163903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65575998|NCT03759587|Niraparib|niraparib|mesh-list
65575999|NCT03759587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65576000|NCT03759587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576001|NCT03759587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576002|NCT03759587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576003|NCT03745807|Nivolumab|nivolumab|mesh-list
65576004|NCT03745807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65576005|NCT03745807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576006|NCT03745807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65576007|NCT03745807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576008|NCT01164059|Haloperidol|haloperidol|mesh-list
65576009|NCT01164059|Olanzapine|olanzapine|mesh-list
65576010|NCT01164059|Aripiprazole|aripiprazole|mesh-list
65576011|NCT01164059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65576012|NCT01164059|Haloperidol decanoate|haloperidol decanoate|mesh-list
65576013|NCT01164059|Flupenthixol|flupenthixol|mesh-list
65576014|NCT01164059|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
65576015|NCT01164059|Antiemetics|antiemetics|mesh-ancestor
65576016|NCT01164059|Autonomic Agents|autonomic agents|mesh-ancestor
65576017|NCT01164059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65576018|NCT01164059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576019|NCT01164059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65576020|NCT01164059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65576021|NCT01164059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65576022|NCT01164059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65576023|NCT01164059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65576024|NCT01164059|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65576025|NCT01164059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65576026|NCT01164059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65576027|NCT01164059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576028|NCT01164059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65576029|NCT01164059|Serotonin Agents|serotonin agents|mesh-ancestor
65576030|NCT01164059|Antidepressive Agents|antidepressive agents|mesh-ancestor
65576031|NCT01164059|Dopamine Agonists|dopamine agonists|mesh-ancestor
65576032|NCT01164059|Dopamine Agents|dopamine agents|mesh-ancestor
65576033|NCT01164059|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65576034|NCT01164059|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65576035|NCT01164059|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65576036|NCT01164059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65576037|NCT01164059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65576038|NCT01164059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65576039|NCT01164059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65576040|NCT03879005|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
65576041|NCT03879005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65576042|NCT03879005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576044|NCT03878771|Benzocaine|benzocaine|mesh-list
65576045|NCT03878771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65576046|NCT03878771|Glucocorticoids|glucocorticoids|mesh-ancestor
65576047|NCT03878771|Hormones|hormones|mesh-ancestor
65576048|NCT03878771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65576049|NCT03878771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576050|NCT03878771|Anesthetics, Local|anesthetics, local|mesh-ancestor
65576051|NCT03878771|Anesthetics|anesthetics|mesh-ancestor
65576052|NCT03878771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65576053|NCT03878771|Sensory System Agents|sensory system agents|mesh-ancestor
65576054|NCT03878771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65576055|NCT02959918|Sirolimus|sirolimus|mesh-list
65576056|NCT02959918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65576057|NCT02959918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65576058|NCT02959918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65576059|NCT02959918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576060|NCT02959918|Antifungal Agents|antifungal agents|mesh-ancestor
65576061|NCT02959918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65576062|NCT02959918|Immunologic Factors|immunologic factors|mesh-ancestor
65576063|NCT02959918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576064|NCT04256317|Azacitidine|azacitidine|mesh-list
65576065|NCT04256317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65576066|NCT04256317|Antimetabolites|antimetabolites|mesh-ancestor
65576067|NCT04256317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576068|NCT04256317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576069|NCT04256317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576070|NCT01266707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
65576071|NCT01266707|Vaccines|vaccines|mesh-list
65576072|NCT01266707|Immunologic Factors|immunologic factors|mesh-ancestor
65576073|NCT01266707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576074|NCT01266707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65576075|NCT01266707|Growth Substances|growth substances|mesh-ancestor
65576076|NCT01266707|Growth Inhibitors|growth inhibitors|mesh-ancestor
65576077|NCT01266707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576078|NCT03263442|Thiamine|thiamine|mesh-list
65576079|NCT03263442|Vitamin B Complex|vitamin b complex|mesh-ancestor
65576080|NCT03263442|Vitamins|vitamins|mesh-ancestor
65576081|NCT03263442|Micronutrients|micronutrients|mesh-ancestor
65576082|NCT03263442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576083|NCT01164215|Leucovorin|leucovorin|mesh-list
65576084|NCT01164215|Fluorouracil|fluorouracil|mesh-list
65576085|NCT01164215|Oxaliplatin|oxaliplatin|mesh-list
65576086|NCT01164215|Levoleucovorin|levoleucovorin|mesh-list
65576087|NCT01164215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576088|NCT01164215|Antimetabolites|antimetabolites|mesh-ancestor
65576089|NCT01164215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576090|NCT01164215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65576091|NCT01164215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576092|NCT01164215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65576093|NCT01164215|Immunologic Factors|immunologic factors|mesh-ancestor
65576094|NCT01164215|Antidotes|antidotes|mesh-ancestor
65576095|NCT01164215|Protective Agents|protective agents|mesh-ancestor
65576096|NCT01164215|Vitamin B Complex|vitamin b complex|mesh-ancestor
65576097|NCT01164215|Vitamins|vitamins|mesh-ancestor
65576098|NCT01164215|Micronutrients|micronutrients|mesh-ancestor
65576099|NCT04245709|Clenbuterol|clenbuterol|mesh-list
65576100|NCT04245709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65576101|NCT04245709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65576102|NCT04245709|Adrenergic Agents|adrenergic agents|mesh-ancestor
65576103|NCT04245709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65576104|NCT04245709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576105|NCT04245709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576106|NCT04245709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65576107|NCT04245709|Autonomic Agents|autonomic agents|mesh-ancestor
65576108|NCT04245709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65576109|NCT04245709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65576110|NCT04245709|Respiratory System Agents|respiratory system agents|mesh-ancestor
65576111|NCT04245709|Sympathomimetics|sympathomimetics|mesh-ancestor
65576112|NCT03878693|Fomepizole|fomepizole|mesh-list
65576113|NCT03878693|Antidotes|antidotes|mesh-ancestor
65576114|NCT03878693|Protective Agents|protective agents|mesh-ancestor
65576115|NCT03878693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576116|NCT03878693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576117|NCT03878693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576118|NCT05305495|Empagliflozin|empagliflozin|mesh-list
65576119|NCT05305495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65576120|NCT05305495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576121|NCT05305495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65576122|NCT05305495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576123|NCT03748537|Hydrocortisone|hydrocortisone|mesh-list
65576124|NCT03748537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65576125|NCT02527109|Nifedipine|nifedipine|mesh-list
65576126|NCT02527109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65576127|NCT02527109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65576128|NCT02527109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576129|NCT02527109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65576130|NCT02527109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576131|NCT02527109|Vasodilator Agents|vasodilator agents|mesh-ancestor
65576132|NCT02527109|Tocolytic Agents|tocolytic agents|mesh-ancestor
65576133|NCT02527109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65576134|NCT02940522|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
65576135|NCT02940522|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
65576136|NCT02940522|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65576137|NCT02940522|Hormone Antagonists|hormone antagonists|mesh-ancestor
65576138|NCT02940522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65576139|NCT02940522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576140|NCT02940522|Progestins|progestins|mesh-ancestor
65576141|NCT02940522|Hormones|hormones|mesh-ancestor
65576142|NCT01266785|Infliximab|infliximab|mesh-list
65576143|NCT01266785|Dermatologic Agents|dermatologic agents|mesh-ancestor
65576144|NCT01266785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65576145|NCT01266785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65576146|NCT03262038|Ondansetron|ondansetron|mesh-list
65576147|NCT03262038|Antiemetics|antiemetics|mesh-ancestor
65576148|NCT03262038|Autonomic Agents|autonomic agents|mesh-ancestor
65576149|NCT03262038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65576150|NCT03262038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576151|NCT03262038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65576152|NCT03262038|Antipruritics|antipruritics|mesh-ancestor
65576153|NCT03262038|Dermatologic Agents|dermatologic agents|mesh-ancestor
65576154|NCT03262038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65576155|NCT03262038|Serotonin Agents|serotonin agents|mesh-ancestor
65576156|NCT03262038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65576157|NCT03262038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576158|NCT03262038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65576159|NCT03262038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65576160|NCT03262038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65576161|NCT03262038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65576162|NCT03262038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65576163|NCT03746821|Biotin|biotin|mesh-list
65576164|NCT03746821|Vitamin B Complex|vitamin b complex|mesh-ancestor
65576165|NCT03746821|Vitamins|vitamins|mesh-ancestor
65576166|NCT03746821|Micronutrients|micronutrients|mesh-ancestor
65576167|NCT03746821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576168|NCT02785224|Vasopressins|vasopressins|mesh-list
65576169|NCT02785224|Arginine Vasopressin|arginine vasopressin|mesh-list
65576170|NCT02785224|Epinephrine|epinephrine|mesh-list
65576171|NCT02785224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65576172|NCT02785224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65576173|NCT02785224|Adrenergic Agents|adrenergic agents|mesh-ancestor
65576174|NCT02785224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65576175|NCT02785224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576176|NCT02785224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576177|NCT02785224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65576178|NCT02785224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65576179|NCT02785224|Autonomic Agents|autonomic agents|mesh-ancestor
65576180|NCT02785224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65576181|NCT02785224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65576182|NCT02785224|Respiratory System Agents|respiratory system agents|mesh-ancestor
65576183|NCT02785224|Mydriatics|mydriatics|mesh-ancestor
65576184|NCT02785224|Sympathomimetics|sympathomimetics|mesh-ancestor
65576185|NCT02785224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65576186|NCT02785224|Hemostatics|hemostatics|mesh-ancestor
65576187|NCT02785224|Coagulants|coagulants|mesh-ancestor
65576188|NCT02785224|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65576189|NCT02785224|Natriuretic Agents|natriuretic agents|mesh-ancestor
65576190|NCT02472964|Paclitaxel|paclitaxel|mesh-list
65576191|NCT02472964|Docetaxel|docetaxel|mesh-list
65576192|NCT02472964|Trastuzumab|trastuzumab|mesh-list
65576193|NCT02472964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65576194|NCT02472964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576195|NCT02472964|Tubulin Modulators|tubulin modulators|mesh-ancestor
65576196|NCT02472964|Antimitotic Agents|antimitotic agents|mesh-ancestor
65576197|NCT02472964|Mitosis Modulators|mitosis modulators|mesh-ancestor
65576198|NCT02472964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576199|NCT02472964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65576200|NCT01160315|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65576201|NCT01160315|Norethindrone|norethindrone|mesh-list
65576202|NCT01160315|Norethindrone Acetate|norethindrone acetate|mesh-list
65576203|NCT01160315|Luteolytic Agents|luteolytic agents|mesh-ancestor
65576204|NCT01160315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65576205|NCT01160315|Contraceptive Agents|contraceptive agents|mesh-ancestor
65576206|NCT01160315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65576207|NCT01160315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576208|NCT01160315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65576209|NCT01160315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65576210|NCT01160315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576211|NCT01160315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65576212|NCT01160315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65576213|NCT01160315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65576214|NCT04223791|Islatravir|islatravir|mesh-list
65576215|NCT04223791|Antiviral Agents|antiviral agents|mesh-ancestor
65576216|NCT04223791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65576217|NCT04223791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576218|NCT04223791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576219|NCT04223791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65576220|NCT04223791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65576221|NCT04223791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65576222|NCT03385174|Carbon Monoxide|carbon monoxide|mesh-list
65576223|NCT03385174|Antimetabolites|antimetabolites|mesh-ancestor
65576224|NCT03385174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576225|NCT03385174|Gasotransmitters|gasotransmitters|mesh-ancestor
65576226|NCT03385174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65576227|NCT03385174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576228|NCT01164605|Raltegravir Potassium|raltegravir potassium|mesh-list
65576229|NCT01164605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65576230|NCT01164605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65576231|NCT01164605|Antiviral Agents|antiviral agents|mesh-ancestor
65576232|NCT01164605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65576233|NCT01164605|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65576234|NCT01164605|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65576235|NCT01164605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576236|NCT01164605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576237|NCT03380728|Ibogaine|ibogaine|mesh-list
65576238|NCT03380728|Hallucinogens|hallucinogens|mesh-ancestor
65576239|NCT03380728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576240|NCT03380728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65576241|NCT03380728|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65576242|NCT03380728|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65576243|NCT03380728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65576244|NCT03380728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576245|NCT01104922|Cetuximab|cetuximab|mesh-list
65576246|NCT01104922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65576247|NCT01104922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576248|NCT01164761|Ramipril|ramipril|mesh-list
65576249|NCT01164761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65576250|NCT01164761|Protease Inhibitors|protease inhibitors|mesh-ancestor
65576251|NCT01164761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576252|NCT01164761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576253|NCT01164761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65576254|NCT03385096|Cyclophosphamide|cyclophosphamide|mesh-list
65576255|NCT03385096|Melphalan|melphalan|mesh-list
65576256|NCT03385096|Busulfan|busulfan|mesh-list
65576257|NCT03385096|Etoposide|etoposide|mesh-list
65576258|NCT03385096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65576259|NCT03385096|Immunologic Factors|immunologic factors|mesh-ancestor
65576260|NCT03385096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576261|NCT03385096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65576262|NCT03385096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65576263|NCT03385096|Alkylating Agents|alkylating agents|mesh-ancestor
65576264|NCT03385096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576265|NCT03385096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576266|NCT03385096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65576267|NCT03385096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65576268|NCT03385096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65576269|NCT03385096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65576270|NCT03385096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576272|NCT02526875|Telmisartan|telmisartan|mesh-list
65576273|NCT02526875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65576274|NCT02526875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65576275|NCT02526875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65576276|NCT02526875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576277|NCT02526875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65576278|NCT02526875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576279|NCT02526875|Vasodilator Agents|vasodilator agents|mesh-ancestor
65576280|NCT02526875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65576281|NCT02526875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65576282|NCT04222699|Chlorhexidine|chlorhexidine|mesh-list
65576283|NCT04222699|Mupirocin|mupirocin|mesh-list
65576284|NCT04222699|Calcium|calcium|mesh-list
65576285|NCT04222699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65576286|NCT04222699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576287|NCT04222699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65576288|NCT04222699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65576289|NCT04222699|Disinfectants|disinfectants|mesh-ancestor
65576290|NCT04222699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65576291|NCT04222699|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65576292|NCT04222699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576293|NCT04222699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576294|NCT01269203|Curcumin|curcumin|mesh-list
65576295|NCT01269203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65576296|NCT01269203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65576297|NCT01269203|Analgesics|analgesics|mesh-ancestor
65576298|NCT01269203|Sensory System Agents|sensory system agents|mesh-ancestor
65576299|NCT01269203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65576300|NCT01269203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576301|NCT01269203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65576302|NCT01269203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65576303|NCT01269203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576304|NCT01269203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576305|NCT01269203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576306|NCT01160627|Acetylcysteine|acetylcysteine|mesh-list
65576307|NCT01160627|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65576308|NCT01160627|Antiviral Agents|antiviral agents|mesh-ancestor
65576309|NCT01160627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65576310|NCT01160627|Expectorants|expectorants|mesh-ancestor
65576311|NCT01160627|Respiratory System Agents|respiratory system agents|mesh-ancestor
65576312|NCT01160627|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65576313|NCT01160627|Antioxidants|antioxidants|mesh-ancestor
65576314|NCT01160627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576315|NCT01160627|Protective Agents|protective agents|mesh-ancestor
65576316|NCT01160627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576317|NCT01160627|Antidotes|antidotes|mesh-ancestor
65576318|NCT04075513|Insulin|insulin|mesh-list
65576319|NCT04075513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65576320|NCT04075513|Insulin Glargine|insulin glargine|mesh-list
65576321|NCT04075513|Insulin, Short-Acting|insulin, short-acting|mesh-list
65576322|NCT04075513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65576323|NCT04075513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576324|NCT03877679|Triamcinolone|triamcinolone|mesh-list
65576325|NCT03877679|Curcumin|curcumin|mesh-list
65576326|NCT03877679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65576327|NCT03877679|Glucocorticoids|glucocorticoids|mesh-ancestor
65576328|NCT03877679|Hormones|hormones|mesh-ancestor
65576329|NCT03877679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65576330|NCT03877679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576331|NCT03877679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576332|NCT03877679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576333|NCT03877679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65576334|NCT03877679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65576335|NCT03877679|Analgesics|analgesics|mesh-ancestor
65576336|NCT03877679|Sensory System Agents|sensory system agents|mesh-ancestor
65576337|NCT03877679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65576338|NCT03877679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65576339|NCT03877679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576340|NCT03330249|Cisplatin|cisplatin|mesh-list
65576341|NCT03330249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576342|NCT04652206|Gemcitabine|gemcitabine|mesh-list
65576343|NCT04652206|Paclitaxel|paclitaxel|mesh-list
65576344|NCT04652206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65576345|NCT04652206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576346|NCT04652206|Tubulin Modulators|tubulin modulators|mesh-ancestor
65576347|NCT04652206|Antimitotic Agents|antimitotic agents|mesh-ancestor
65576348|NCT04652206|Mitosis Modulators|mitosis modulators|mesh-ancestor
65576349|NCT04652206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576350|NCT04652206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65576352|NCT04652206|Antiviral Agents|antiviral agents|mesh-ancestor
65576353|NCT04652206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65576354|NCT04652206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576355|NCT04652206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65576356|NCT04652206|Immunologic Factors|immunologic factors|mesh-ancestor
65576357|NCT04652206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576358|NCT01269281|Sumatriptan|sumatriptan|mesh-list
65576359|NCT01269281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65576360|NCT01269281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65576361|NCT01269281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65576362|NCT01269281|Serotonin Agents|serotonin agents|mesh-ancestor
65576363|NCT01269281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65576364|NCT01269281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576365|NCT01269281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576366|NCT02778204|Maraviroc|maraviroc|mesh-list
65576367|NCT02778204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65576368|NCT02778204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65576369|NCT02778204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576370|NCT02778204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65576371|NCT02778204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65576372|NCT02778204|Antiviral Agents|antiviral agents|mesh-ancestor
65576373|NCT02778204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65576374|NCT02778204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65576375|NCT01160705|Docetaxel|docetaxel|mesh-list
65576376|NCT01160705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576377|NCT01160705|Tubulin Modulators|tubulin modulators|mesh-ancestor
65576378|NCT01160705|Antimitotic Agents|antimitotic agents|mesh-ancestor
65576379|NCT01160705|Mitosis Modulators|mitosis modulators|mesh-ancestor
65576380|NCT01160705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576381|NCT03232281|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65576382|NCT03232281|Luteolytic Agents|luteolytic agents|mesh-ancestor
65576383|NCT03232281|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65576384|NCT03232281|Contraceptive Agents|contraceptive agents|mesh-ancestor
65576385|NCT03232281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65576386|NCT03232281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576387|NCT03232281|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65576388|NCT03232281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65576389|NCT03232281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576390|NCT04498780|Valsartan|valsartan|mesh-list
65576391|NCT04498780|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65576392|NCT04498780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65576393|NCT04498780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65576394|NCT04498780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65576395|NCT04498780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576396|NCT03261336|Vitamin D|vitamin d|mesh-list
65576397|NCT03261336|Calcitriol|calcitriol|mesh-list
65576398|NCT03261336|Ketoconazole|ketoconazole|mesh-list
65576399|NCT03261336|Hydrocortisone|hydrocortisone|mesh-list
65576400|NCT03261336|Vitamins|vitamins|mesh-ancestor
65576401|NCT03261336|Micronutrients|micronutrients|mesh-ancestor
65576402|NCT03261336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576403|NCT03261336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65576404|NCT03261336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65576405|NCT03261336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65576406|NCT03261336|Antifungal Agents|antifungal agents|mesh-ancestor
65576407|NCT03261336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65576408|NCT03261336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65576409|NCT03261336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65576410|NCT03261336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576411|NCT03261336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576412|NCT03261336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65576413|NCT03261336|Hormone Antagonists|hormone antagonists|mesh-ancestor
65576414|NCT03261336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65576415|NCT03261336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65373947|NCT00792662|Methylphenidate|methylphenidate|mesh-list
65576416|NCT03261336|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65576417|NCT03261336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65576418|NCT03261336|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65576419|NCT05540223|Sirolimus|sirolimus|mesh-list
65576420|NCT05540223|Everolimus|everolimus|mesh-list
65576421|NCT05540223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576422|NCT05540223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65576423|NCT05540223|Immunologic Factors|immunologic factors|mesh-ancestor
65576424|NCT05540223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576425|NCT05540223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65576426|NCT05540223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65576427|NCT05540223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65576428|NCT05540223|Antifungal Agents|antifungal agents|mesh-ancestor
65576429|NCT03384862|Folic Acid|folic acid|mesh-list
65576430|NCT03384862|Vitamin B 12|vitamin b 12|mesh-list
65576431|NCT03384862|Hydroxocobalamin|hydroxocobalamin|mesh-list
65576432|NCT03384862|Vitamins|vitamins|mesh-ancestor
65576433|NCT03384862|Micronutrients|micronutrients|mesh-ancestor
65576434|NCT03384862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576435|NCT03384862|Hematinics|hematinics|mesh-ancestor
65576436|NCT03384862|Vitamin B Complex|vitamin b complex|mesh-ancestor
65576437|NCT01269437|Budesonide|budesonide|mesh-list
65576438|NCT01269437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65576439|NCT01269437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65576440|NCT01269437|Autonomic Agents|autonomic agents|mesh-ancestor
65576441|NCT01269437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65576442|NCT01269437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576443|NCT01269437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65576444|NCT01269437|Respiratory System Agents|respiratory system agents|mesh-ancestor
65576445|NCT01269437|Glucocorticoids|glucocorticoids|mesh-ancestor
65576446|NCT01269437|Hormones|hormones|mesh-ancestor
65576447|NCT01269437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65576448|NCT04163952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65576449|NCT04163952|Panitumumab|panitumumab|mesh-list
65576450|NCT04163952|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
65576451|NCT04163952|Antibodies|antibodies|mesh-list
65576452|NCT04163952|Immunoglobulins|immunoglobulins|mesh-list
65576453|NCT04163952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65576454|NCT04163952|Immunologic Factors|immunologic factors|mesh-ancestor
65576455|NCT04163952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576456|NCT04163952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576457|NCT03909269|Carbon Monoxide|carbon monoxide|mesh-list
65576458|NCT03909269|Antimetabolites|antimetabolites|mesh-ancestor
65576459|NCT03909269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576460|NCT03909269|Gasotransmitters|gasotransmitters|mesh-ancestor
65576461|NCT03909269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65576462|NCT03909269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576463|NCT00462748|Atorvastatin|atorvastatin|mesh-list
65576464|NCT00462748|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65576465|NCT00462748|Simvastatin|simvastatin|mesh-list
65576466|NCT00462748|Ezetimibe|ezetimibe|mesh-list
65576467|NCT00462748|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65576468|NCT00462748|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65576469|NCT00462748|Antimetabolites|antimetabolites|mesh-ancestor
65576470|NCT00462748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576471|NCT00462748|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65576472|NCT00462748|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65576473|NCT00462748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576474|NCT01161017|Topiramate|topiramate|mesh-list
65576475|NCT01161017|Amitriptyline|amitriptyline|mesh-list
65576476|NCT01161017|Anticonvulsants|anticonvulsants|mesh-ancestor
65576477|NCT01161017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65576478|NCT01161017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576479|NCT01161017|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65576480|NCT01161017|Antidepressive Agents|antidepressive agents|mesh-ancestor
65576481|NCT01161017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65576482|NCT01161017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65576483|NCT01161017|Analgesics|analgesics|mesh-ancestor
65576484|NCT01161017|Sensory System Agents|sensory system agents|mesh-ancestor
65576485|NCT01161017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65576486|NCT01161017|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65576487|NCT01161017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65576488|NCT01161017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65374027|NCT00858624|Ketamine|ketamine|mesh-list
65576489|NCT01161017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576490|NCT01161017|Adrenergic Agents|adrenergic agents|mesh-ancestor
65576491|NCT01161017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65576492|NCT03935685|Mirtazapine|mirtazapine|mesh-list
65576493|NCT03935685|Antidepressive Agents|antidepressive agents|mesh-ancestor
65576494|NCT03935685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65576495|NCT03935685|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65576496|NCT03935685|Histamine Antagonists|histamine antagonists|mesh-ancestor
65576497|NCT03935685|Histamine Agents|histamine agents|mesh-ancestor
65576498|NCT03935685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65576499|NCT03935685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576500|NCT03935685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576501|NCT03935685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65576502|NCT03935685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65576503|NCT03935685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65576504|NCT03935685|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65576505|NCT03935685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65576506|NCT03935685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65576507|NCT03935685|Adrenergic Agents|adrenergic agents|mesh-ancestor
65576508|NCT03935685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65576509|NCT03935685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65576510|NCT03935685|Serotonin Agents|serotonin agents|mesh-ancestor
65576511|NCT03935685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65576512|NCT01164917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65576513|NCT01164917|Immunologic Factors|immunologic factors|mesh-ancestor
65576514|NCT01164917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576515|NCT03238911|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65576516|NCT03238911|Hematinics|hematinics|mesh-ancestor
65576517|NCT01269515|Etoricoxib|etoricoxib|mesh-list
65576518|NCT01269515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65576519|NCT01269515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65576520|NCT01269515|Analgesics|analgesics|mesh-ancestor
65576521|NCT01269515|Sensory System Agents|sensory system agents|mesh-ancestor
65576522|NCT01269515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65576523|NCT01269515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576524|NCT01269515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65576525|NCT01269515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65576526|NCT01269515|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65576527|NCT01269515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65576528|NCT01269515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576529|NCT01269515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576530|NCT00418834|Atorvastatin|atorvastatin|mesh-list
65576531|NCT00418834|Ezetimibe|ezetimibe|mesh-list
65576532|NCT00418834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65576533|NCT00418834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65576534|NCT00418834|Antimetabolites|antimetabolites|mesh-ancestor
65576535|NCT00418834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576536|NCT00418834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65576537|NCT00418834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65576538|NCT00418834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576539|NCT01269671|Peppermint oil|peppermint oil|mesh-list
65576540|NCT01269671|Melatonin|melatonin|mesh-list
65576541|NCT01269671|Simethicone|simethicone|mesh-list
65576542|NCT01269671|Antioxidants|antioxidants|mesh-ancestor
65576543|NCT01269671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576544|NCT01269671|Protective Agents|protective agents|mesh-ancestor
65576545|NCT01269671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576546|NCT01269671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65576547|NCT01269671|Antifoaming Agents|antifoaming agents|mesh-ancestor
65576548|NCT01269671|Emollients|emollients|mesh-ancestor
65576549|NCT01269671|Dermatologic Agents|dermatologic agents|mesh-ancestor
65576550|NCT01269671|Antiemetics|antiemetics|mesh-ancestor
65576551|NCT01269671|Autonomic Agents|autonomic agents|mesh-ancestor
65576552|NCT01269671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65576553|NCT01269671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65576554|NCT01269671|Parasympatholytics|parasympatholytics|mesh-ancestor
65576555|NCT04407286|Vitamin D|vitamin d|mesh-list
65576556|NCT04407286|Cholecalciferol|cholecalciferol|mesh-list
65576557|NCT04407286|Vitamins|vitamins|mesh-ancestor
65576558|NCT04407286|Micronutrients|micronutrients|mesh-ancestor
65576559|NCT04407286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576560|NCT04407286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65576561|NCT04407286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65576562|NCT03276975|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65576563|NCT03276975|Hemostatics|hemostatics|mesh-ancestor
65576564|NCT03276975|Coagulants|coagulants|mesh-ancestor
65576565|NCT03125746|Exemestane|exemestane|mesh-list
65576566|NCT03125746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576567|NCT03125746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65576568|NCT03125746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65576570|NCT03125746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576571|NCT03125746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65576572|NCT03125746|Hormone Antagonists|hormone antagonists|mesh-ancestor
65576573|NCT03125746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65576574|NCT03125746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576575|NCT03877601|Bevacizumab|bevacizumab|mesh-list
65576576|NCT03877601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65576577|NCT03877601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576578|NCT03877601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65576579|NCT03877601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65576580|NCT03877601|Growth Substances|growth substances|mesh-ancestor
65576581|NCT03877601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576582|NCT03877601|Growth Inhibitors|growth inhibitors|mesh-ancestor
65576583|NCT03297216|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
65576584|NCT03297216|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
65576585|NCT03297216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65576586|NCT03297216|Hormone Antagonists|hormone antagonists|mesh-ancestor
65576587|NCT03297216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65576588|NCT03297216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576589|NCT03297216|Progestins|progestins|mesh-ancestor
65576590|NCT03297216|Hormones|hormones|mesh-ancestor
65576591|NCT03260868|Insulin|insulin|mesh-list
65576592|NCT03260868|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65576593|NCT03260868|Insulin Glargine|insulin glargine|mesh-list
65576594|NCT03260868|Insulin Lispro|insulin lispro|mesh-list
65576595|NCT03260868|Insulin Aspart|insulin aspart|mesh-list
65576596|NCT03260868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65576597|NCT03260868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576598|NCT01165385|Cisplatin|cisplatin|mesh-list
65576599|NCT01165385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576600|NCT01267487|Heparin|heparin|mesh-list
65576601|NCT01267487|Calcium heparin|calcium heparin|mesh-list
65576602|NCT01267487|Protamines|protamines|mesh-list
65576603|NCT01267487|Anticoagulants|anticoagulants|mesh-ancestor
65576604|NCT01267487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65576605|NCT01267487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65576606|NCT01267487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576607|NCT01267487|Heparin Antagonists|heparin antagonists|mesh-ancestor
65576608|NCT01267487|Coagulants|coagulants|mesh-ancestor
65576609|NCT01267643|Alefacept|alefacept|mesh-list
65576610|NCT01267643|Dermatologic Agents|dermatologic agents|mesh-ancestor
65576611|NCT01267643|Immunologic Factors|immunologic factors|mesh-ancestor
65576612|NCT01267643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576613|NCT01269827|Pentoxifylline|pentoxifylline|mesh-list
65576614|NCT01269827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65576615|NCT01269827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576616|NCT01269827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576617|NCT01269827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65576618|NCT01269827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65576619|NCT01269827|Protective Agents|protective agents|mesh-ancestor
65576620|NCT01269827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576621|NCT01269827|Vasodilator Agents|vasodilator agents|mesh-ancestor
65576622|NCT01269827|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65576623|NCT01269827|Antioxidants|antioxidants|mesh-ancestor
65576624|NCT03388372|Temozolomide|temozolomide|mesh-list
65576625|NCT03388372|Nimotuzumab|nimotuzumab|mesh-list
65576626|NCT03388372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65576627|NCT03388372|Alkylating Agents|alkylating agents|mesh-ancestor
65576628|NCT03388372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576629|NCT03388372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576630|NCT03388372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65576631|NCT05173246|Paclitaxel|paclitaxel|mesh-list
65576632|NCT05173246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65576633|NCT05173246|Cisplatin|cisplatin|mesh-list
65576634|NCT05173246|Carboplatin|carboplatin|mesh-list
65576635|NCT05173246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65576636|NCT05173246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576637|NCT05173246|Tubulin Modulators|tubulin modulators|mesh-ancestor
65576638|NCT05173246|Antimitotic Agents|antimitotic agents|mesh-ancestor
65576639|NCT05173246|Mitosis Modulators|mitosis modulators|mesh-ancestor
65576640|NCT05173246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576641|NCT01167101|Pantoprazole|pantoprazole|mesh-list
65576642|NCT01167101|Rebamipide|rebamipide|mesh-list
65576643|NCT01167101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65576644|NCT01167101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65576645|NCT01167101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65576646|NCT01167101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576647|NCT01167101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576648|NCT01167101|Antioxidants|antioxidants|mesh-ancestor
65576649|NCT01167101|Protective Agents|protective agents|mesh-ancestor
65576650|NCT01167101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576651|NCT05173090|Ropivacaine|ropivacaine|mesh-list
65576652|NCT05173090|Anesthetics, Local|anesthetics, local|mesh-ancestor
65576653|NCT05173090|Anesthetics|anesthetics|mesh-ancestor
65576654|NCT05173090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65576655|NCT05173090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576656|NCT05173090|Sensory System Agents|sensory system agents|mesh-ancestor
65576657|NCT05173090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65576658|NCT02526953|Paclitaxel|paclitaxel|mesh-list
65576659|NCT02526953|Capecitabine|capecitabine|mesh-list
65576660|NCT02526953|Mitomycins|mitomycins|mesh-list
65576661|NCT02526953|Mitomycin|mitomycin|mesh-list
65576662|NCT02526953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65576663|NCT02526953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576664|NCT02526953|Tubulin Modulators|tubulin modulators|mesh-ancestor
65576665|NCT02526953|Antimitotic Agents|antimitotic agents|mesh-ancestor
65576666|NCT02526953|Mitosis Modulators|mitosis modulators|mesh-ancestor
65576667|NCT02526953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576668|NCT02526953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65576669|NCT02526953|Antimetabolites|antimetabolites|mesh-ancestor
65576670|NCT02526953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65576671|NCT02526953|Alkylating Agents|alkylating agents|mesh-ancestor
65576672|NCT02526953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65576673|NCT02526953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576674|NCT03258762|Leucovorin|leucovorin|mesh-list
65576675|NCT03258762|Pyrimethamine|pyrimethamine|mesh-list
65576676|NCT03258762|Calcium|calcium|mesh-list
65576677|NCT03258762|Levoleucovorin|levoleucovorin|mesh-list
65576678|NCT03258762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65576679|NCT03258762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576680|NCT03258762|Antidotes|antidotes|mesh-ancestor
65576681|NCT03258762|Protective Agents|protective agents|mesh-ancestor
65576682|NCT03258762|Vitamin B Complex|vitamin b complex|mesh-ancestor
65576683|NCT03258762|Vitamins|vitamins|mesh-ancestor
65576684|NCT03258762|Micronutrients|micronutrients|mesh-ancestor
65576685|NCT03258762|Antimalarials|antimalarials|mesh-ancestor
65576686|NCT03258762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65576687|NCT03258762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65576688|NCT03258762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65576689|NCT03258762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65576690|NCT03258762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576691|NCT03258762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576692|NCT05427669|Leucovorin|leucovorin|mesh-list
65576693|NCT05427669|Fluorouracil|fluorouracil|mesh-list
65576694|NCT05427669|Oxaliplatin|oxaliplatin|mesh-list
65576695|NCT05427669|Irinotecan|irinotecan|mesh-list
65576696|NCT05427669|Levoleucovorin|levoleucovorin|mesh-list
65576697|NCT05427669|Antimetabolites|antimetabolites|mesh-ancestor
65576698|NCT05427669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576699|NCT05427669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65576700|NCT05427669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576701|NCT05427669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65576702|NCT05427669|Immunologic Factors|immunologic factors|mesh-ancestor
65576703|NCT05427669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576704|NCT05427669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65576705|NCT05427669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65576706|NCT05427669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576707|NCT05427669|Antidotes|antidotes|mesh-ancestor
65576708|NCT05427669|Protective Agents|protective agents|mesh-ancestor
65576709|NCT05427669|Vitamin B Complex|vitamin b complex|mesh-ancestor
65576710|NCT05427669|Vitamins|vitamins|mesh-ancestor
65576711|NCT05427669|Micronutrients|micronutrients|mesh-ancestor
65576712|NCT01270373|Docetaxel|docetaxel|mesh-list
65576713|NCT01270373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576714|NCT01270373|Tubulin Modulators|tubulin modulators|mesh-ancestor
65576715|NCT01270373|Antimitotic Agents|antimitotic agents|mesh-ancestor
65576716|NCT01270373|Mitosis Modulators|mitosis modulators|mesh-ancestor
65576717|NCT01270373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576718|NCT03713086|Vaccines|vaccines|mesh-list
65576719|NCT03713086|Immunologic Factors|immunologic factors|mesh-ancestor
65576720|NCT03713086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576721|NCT01271231|Azithromycin|azithromycin|mesh-list
65576722|NCT01271231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65576723|NCT01271231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65576724|NCT03697876|Hyaluronic Acid|hyaluronic acid|mesh-list
65576725|NCT03697876|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65576726|NCT03697876|Immunologic Factors|immunologic factors|mesh-ancestor
65576727|NCT03697876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576728|NCT03697876|Viscosupplements|viscosupplements|mesh-ancestor
65576729|NCT03697876|Protective Agents|protective agents|mesh-ancestor
65576730|NCT04526691|Carboplatin|carboplatin|mesh-list
65576731|NCT04526691|Pembrolizumab|pembrolizumab|mesh-list
65576732|NCT04526691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576733|NCT04526691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65576734|NCT01280669|Sirolimus|sirolimus|mesh-list
65576735|NCT01280669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65576736|NCT01280669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65576737|NCT01280669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65576738|NCT01280669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576739|NCT01280669|Antifungal Agents|antifungal agents|mesh-ancestor
65576740|NCT01280669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65576741|NCT01280669|Immunologic Factors|immunologic factors|mesh-ancestor
65576742|NCT01280669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576743|NCT01169909|Ranibizumab|ranibizumab|mesh-list
65576744|NCT01169909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65576745|NCT01169909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65576746|NCT01169909|Growth Substances|growth substances|mesh-ancestor
65576747|NCT01169909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576748|NCT01169909|Growth Inhibitors|growth inhibitors|mesh-ancestor
65576749|NCT01169909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576750|NCT04502589|Disulfiram|disulfiram|mesh-list
65576751|NCT04502589|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65576752|NCT04502589|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65576753|NCT04502589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576754|NCT04502589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576755|NCT04485039|Sevelamer|sevelamer|mesh-list
65576756|NCT04485039|Calcium acetate|calcium acetate|mesh-list
65576757|NCT04485039|Chelating Agents|chelating agents|mesh-ancestor
65576758|NCT04485039|Sequestering Agents|sequestering agents|mesh-ancestor
65576759|NCT04485039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576760|NCT03387904|Irinotecan|irinotecan|mesh-list
65576761|NCT03387904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65576762|NCT03387904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65576763|NCT03387904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576764|NCT03387904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576765|NCT03387904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576766|NCT03291288|Tolbutamide|tolbutamide|mesh-list
65576767|NCT03291288|Midazolam|midazolam|mesh-list
65576768|NCT03291288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65576769|NCT03291288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65576770|NCT03291288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65576771|NCT03291288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576772|NCT03291288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65576773|NCT03291288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65576774|NCT03291288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65576775|NCT03291288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65576776|NCT03291288|Anesthetics, General|anesthetics, general|mesh-ancestor
65576777|NCT03291288|Anesthetics|anesthetics|mesh-ancestor
65576778|NCT03291288|GABA Modulators|gaba modulators|mesh-ancestor
65576779|NCT03291288|GABA Agents|gaba agents|mesh-ancestor
65576780|NCT03291288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65576781|NCT03291288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576782|NCT03291288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65576783|NCT05172310|FAPI-46|fapi-46|mesh-list
65576784|NCT05172310|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65576785|NCT05172310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576786|NCT03636711|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65576787|NCT03636711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65576788|NCT04084626|Lenalidomide|lenalidomide|mesh-list
65576789|NCT04084626|Antibodies|antibodies|mesh-list
65576790|NCT04084626|Immunologic Factors|immunologic factors|mesh-ancestor
65576791|NCT04084626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576792|NCT04084626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65576793|NCT04084626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65576794|NCT04084626|Growth Substances|growth substances|mesh-ancestor
65576795|NCT04084626|Growth Inhibitors|growth inhibitors|mesh-ancestor
65576796|NCT04084626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576797|NCT03387826|Ticagrelor|ticagrelor|mesh-list
65576798|NCT03387826|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65576799|NCT03387826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65576800|NCT03387826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65576801|NCT03387826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65576802|NCT03387826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65576803|NCT03387826|Purinergic Agents|purinergic agents|mesh-ancestor
65576804|NCT03387826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65576805|NCT03387826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576806|NCT03387826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576807|NCT03384238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65576808|NCT03384238|Panitumumab|panitumumab|mesh-list
65576809|NCT03384238|Antibodies|antibodies|mesh-list
65576810|NCT03384238|Immunoglobulins|immunoglobulins|mesh-list
65576811|NCT03384238|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65576812|NCT03384238|Immunologic Factors|immunologic factors|mesh-ancestor
65576813|NCT03384238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576814|NCT03384238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576815|NCT03871517|Aspirin|aspirin|mesh-list
65576816|NCT03871517|Indobufen|indobufen|mesh-list
65576817|NCT03871517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65576818|NCT03871517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65576819|NCT03871517|Analgesics|analgesics|mesh-ancestor
65576820|NCT03871517|Sensory System Agents|sensory system agents|mesh-ancestor
65576821|NCT03871517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65576822|NCT03871517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576823|NCT03871517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65576824|NCT03871517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65576825|NCT03871517|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65576826|NCT03871517|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65576827|NCT03871517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576828|NCT03871517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65576829|NCT03871517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65576830|NCT03871517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576831|NCT03871517|Antipyretics|antipyretics|mesh-ancestor
65576832|NCT03387592|Leucovorin|leucovorin|mesh-list
65576833|NCT03387592|Fluorouracil|fluorouracil|mesh-list
65576834|NCT03387592|Capecitabine|capecitabine|mesh-list
65576835|NCT03387592|Temozolomide|temozolomide|mesh-list
65576836|NCT03387592|Levoleucovorin|levoleucovorin|mesh-list
65576837|NCT03387592|Antimetabolites|antimetabolites|mesh-ancestor
65576838|NCT03387592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576839|NCT03387592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65576840|NCT03387592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576841|NCT03387592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65576842|NCT03387592|Immunologic Factors|immunologic factors|mesh-ancestor
65576843|NCT03387592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576844|NCT03387592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65576845|NCT03387592|Alkylating Agents|alkylating agents|mesh-ancestor
65576846|NCT03387592|Antidotes|antidotes|mesh-ancestor
65576847|NCT03387592|Protective Agents|protective agents|mesh-ancestor
65576848|NCT03387592|Vitamin B Complex|vitamin b complex|mesh-ancestor
65576849|NCT03387592|Vitamins|vitamins|mesh-ancestor
65576850|NCT03387592|Micronutrients|micronutrients|mesh-ancestor
65576851|NCT04445506|Dexamethasone|dexamethasone|mesh-list
65576852|NCT04445506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65576853|NCT04445506|Antiemetics|antiemetics|mesh-ancestor
65576854|NCT04445506|Autonomic Agents|autonomic agents|mesh-ancestor
65576855|NCT04445506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65576856|NCT04445506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576857|NCT04445506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65576858|NCT04445506|Glucocorticoids|glucocorticoids|mesh-ancestor
65576859|NCT04445506|Hormones|hormones|mesh-ancestor
65576860|NCT04445506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65576861|NCT04445506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65576862|NCT04445506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576863|NCT04428333|Pembrolizumab|pembrolizumab|mesh-list
65576864|NCT04428333|Fluorouracil|fluorouracil|mesh-list
65576865|NCT04428333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65576866|NCT04428333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576867|NCT04428333|Antimetabolites|antimetabolites|mesh-ancestor
65576868|NCT04428333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576869|NCT04428333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65576870|NCT04428333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65576871|NCT04428333|Immunologic Factors|immunologic factors|mesh-ancestor
65576872|NCT04428333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576873|NCT03379012|Sunitinib|sunitinib|mesh-list
65576874|NCT03379012|Methyltestosterone|methyltestosterone|mesh-list
65374395|NCT00975741|Dermatologic Agents|dermatologic agents|mesh-ancestor
65576875|NCT03379012|Testosterone|testosterone|mesh-list
65576876|NCT03379012|Testosterone undecanoate|testosterone undecanoate|mesh-list
65576877|NCT03379012|Testosterone enanthate|testosterone enanthate|mesh-list
65576878|NCT03379012|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65576879|NCT03379012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576880|NCT03379012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65576881|NCT03379012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65576882|NCT03379012|Growth Substances|growth substances|mesh-ancestor
65576883|NCT03379012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576884|NCT03379012|Growth Inhibitors|growth inhibitors|mesh-ancestor
65576885|NCT03379012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65576886|NCT03379012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576887|NCT03379012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576888|NCT03379012|Androgens|androgens|mesh-ancestor
65576890|NCT03379012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65576891|NCT03379012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65576892|NCT03379012|Anabolic Agents|anabolic agents|mesh-ancestor
65576893|NCT03383302|Nivolumab|nivolumab|mesh-list
65576894|NCT03383302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65576895|NCT03383302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576896|NCT03383302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65576897|NCT03383302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576898|NCT03493126|Estradiol|estradiol|mesh-list
65576899|NCT03493126|Estrogens|estrogens|mesh-ancestor
65576900|NCT03493126|Hormones|hormones|mesh-ancestor
65576901|NCT03493126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65576902|NCT03493126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576903|NCT03257358|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65576904|NCT03257358|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65576905|NCT03257358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576906|NCT03257358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65576907|NCT03257358|Immunologic Factors|immunologic factors|mesh-ancestor
65576908|NCT03257358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576909|NCT03386656|Tranexamic Acid|tranexamic acid|mesh-list
65576910|NCT03386656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65576911|NCT03386656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65576912|NCT03386656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576913|NCT03386656|Hemostatics|hemostatics|mesh-ancestor
65576914|NCT03386656|Coagulants|coagulants|mesh-ancestor
65576915|NCT01281527|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65576916|NCT01281527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65576917|NCT01281527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65576918|NCT01281527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65576919|NCT01281527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576920|NCT01281527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65576921|NCT01281527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65576922|NCT01281527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65576923|NCT01281527|Serotonin Agents|serotonin agents|mesh-ancestor
65576924|NCT01281527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65576925|NCT01281527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576926|NCT01281527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65576927|NCT01281527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65576928|NCT01281527|Dopamine Agents|dopamine agents|mesh-ancestor
65576929|NCT01281605|Insulin|insulin|mesh-list
65576930|NCT01281605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65576931|NCT01281605|Insulin Detemir|insulin detemir|mesh-list
65576932|NCT01281605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65576933|NCT01281605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576934|NCT01170143|Trastuzumab|trastuzumab|mesh-list
65576935|NCT01170143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65576936|NCT01170143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576937|NCT05171530|Lenvatinib|lenvatinib|mesh-list
65576938|NCT05171530|Taxane|taxane|mesh-list
65576939|NCT05171530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576940|NCT05171530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65576941|NCT05171530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576942|NCT05171530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576943|NCT02936037|Biotin|biotin|mesh-list
65576944|NCT02936037|Vitamin B Complex|vitamin b complex|mesh-ancestor
65576945|NCT02936037|Vitamins|vitamins|mesh-ancestor
65576946|NCT02936037|Micronutrients|micronutrients|mesh-ancestor
65576947|NCT02936037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576948|NCT04068181|Pembrolizumab|pembrolizumab|mesh-list
65576949|NCT04068181|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
65576950|NCT04068181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65576951|NCT04068181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576953|NCT01283789|Lapatinib|lapatinib|mesh-list
65576954|NCT01283789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576955|NCT01283789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65576956|NCT01283789|Immunologic Factors|immunologic factors|mesh-ancestor
65576957|NCT01283789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576958|NCT01283789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65576959|NCT01283789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576960|NCT01283789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576961|NCT03383068|Metformin|metformin|mesh-list
65576962|NCT03383068|Exenatide|exenatide|mesh-list
65576963|NCT03383068|Acarbose|acarbose|mesh-list
65576964|NCT03383068|Orlistat|orlistat|mesh-list
65576965|NCT03383068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65576966|NCT03383068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576967|NCT03383068|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65576968|NCT03383068|Incretins|incretins|mesh-ancestor
65576969|NCT03383068|Hormones|hormones|mesh-ancestor
65576970|NCT03383068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65576971|NCT03383068|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65576972|NCT03383068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576973|NCT03383068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576974|NCT03383068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65576975|NCT03378310|Linrodostat|linrodostat|mesh-list
65576976|NCT03378310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576977|NCT03378310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576978|NCT01283867|Mycophenolic Acid|mycophenolic acid|mesh-list
65576979|NCT01283867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65576980|NCT01283867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65576981|NCT01283867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65576982|NCT01283867|Antitubercular Agents|antitubercular agents|mesh-ancestor
65576983|NCT01283867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65576984|NCT01283867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65576985|NCT01283867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65576986|NCT01283867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65576987|NCT04094298|FX006|fx006|mesh-list
65576988|NCT04094298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65576989|NCT04094298|Glucocorticoids|glucocorticoids|mesh-ancestor
65576990|NCT04094298|Hormones|hormones|mesh-ancestor
65576991|NCT04094298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65576992|NCT04094298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576993|NCT04094298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65576994|NCT04094298|Immunologic Factors|immunologic factors|mesh-ancestor
65576995|NCT04194151|Propofol|propofol|mesh-list
65576996|NCT04194151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65576997|NCT04194151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65576998|NCT04194151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65576999|NCT04194151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65577000|NCT04194151|Anesthetics, General|anesthetics, general|mesh-ancestor
65577001|NCT04194151|Anesthetics|anesthetics|mesh-ancestor
65577002|NCT01281761|Irinotecan|irinotecan|mesh-list
65577003|NCT01281761|Cetuximab|cetuximab|mesh-list
65577004|NCT01281761|Simvastatin|simvastatin|mesh-list
65577005|NCT01281761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65577006|NCT01281761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65577007|NCT01281761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577008|NCT01281761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577009|NCT01281761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577010|NCT01281761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65577011|NCT01281761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65577012|NCT01281761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65577013|NCT01281761|Antimetabolites|antimetabolites|mesh-ancestor
65577014|NCT01281761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64578047|NCT03908736|Sequestering Agents|sequestering agents|mesh-ancestor
65577015|NCT01281761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65577016|NCT04280328|Daratumumab|daratumumab|mesh-list
65577017|NCT04280328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577018|NCT03748147|Misoprostol|misoprostol|mesh-list
65577019|NCT03748147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65577020|NCT03748147|Abortifacient Agents|abortifacient agents|mesh-ancestor
65577021|NCT03748147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65577022|NCT03748147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577023|NCT03748147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65577024|NCT03748147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65577025|NCT03748147|Oxytocics|oxytocics|mesh-ancestor
65577026|NCT01580813|Acipimox|acipimox|mesh-list
65577027|NCT01580813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65577028|NCT01580813|Antimetabolites|antimetabolites|mesh-ancestor
65577029|NCT01580813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577030|NCT01580813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65577031|NCT04446364|Disinfectants|disinfectants|mesh-list
65577032|NCT04446364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65577033|NCT01588535|Benzocaine|benzocaine|mesh-list
65577034|NCT01588535|Anesthetics, Local|anesthetics, local|mesh-ancestor
65577035|NCT01588535|Anesthetics|anesthetics|mesh-ancestor
65577036|NCT01588535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65577037|NCT01588535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577038|NCT01588535|Sensory System Agents|sensory system agents|mesh-ancestor
65577039|NCT01588535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65577040|NCT01165931|Riociguat|riociguat|mesh-list
65577041|NCT01165931|Enzyme Activators|enzyme activators|mesh-ancestor
65577042|NCT01165931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577043|NCT03441282|Fentanyl|fentanyl|mesh-list
65577044|NCT03441282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65577045|NCT03441282|Narcotics|narcotics|mesh-ancestor
65577046|NCT03441282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65577047|NCT03441282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577048|NCT03441282|Analgesics|analgesics|mesh-ancestor
65577049|NCT03441282|Sensory System Agents|sensory system agents|mesh-ancestor
65577050|NCT03441282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65577051|NCT03441282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65577052|NCT03441282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65577053|NCT03441282|Anesthetics, General|anesthetics, general|mesh-ancestor
65577054|NCT03441282|Anesthetics|anesthetics|mesh-ancestor
65577055|NCT01274273|Interferons|interferons|mesh-list
65577056|NCT01274273|Interferon-alpha|interferon-alpha|mesh-list
65577057|NCT01274273|Interferon alpha-2|interferon alpha-2|mesh-list
65577058|NCT01274273|Aldesleukin|aldesleukin|mesh-list
65577059|NCT01274273|Bevacizumab|bevacizumab|mesh-list
65577060|NCT01274273|Interleukin-2|interleukin-2|mesh-list
65577061|NCT01274273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65577062|NCT01274273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577063|NCT01274273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65577064|NCT01274273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65577065|NCT01274273|Growth Substances|growth substances|mesh-ancestor
65577066|NCT01274273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577067|NCT01274273|Growth Inhibitors|growth inhibitors|mesh-ancestor
65577068|NCT01274273|Antiviral Agents|antiviral agents|mesh-ancestor
65577069|NCT01274273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65577070|NCT01274273|Immunologic Factors|immunologic factors|mesh-ancestor
65577071|NCT01274273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65577072|NCT01274273|Analgesics|analgesics|mesh-ancestor
65577073|NCT01274273|Sensory System Agents|sensory system agents|mesh-ancestor
65577074|NCT01274273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65577075|NCT01274273|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65577076|NCT01274273|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65577077|NCT03452865|Esomeprazole|esomeprazole|mesh-list
65577078|NCT03452865|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65577079|NCT03452865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65577080|NCT03452865|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65577081|NCT03452865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577082|NCT03452865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577083|NCT04058353|Ivacaftor|ivacaftor|mesh-list
65577084|NCT04058353|Elexacaftor|elexacaftor|mesh-list
65577085|NCT04058353|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65577086|NCT04058353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65577087|NCT04058353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577088|NCT01167725|Leucovorin|leucovorin|mesh-list
65577089|NCT01167725|Bevacizumab|bevacizumab|mesh-list
65577090|NCT01167725|Cetuximab|cetuximab|mesh-list
65577091|NCT01167725|Fluorouracil|fluorouracil|mesh-list
65577092|NCT01167725|Capecitabine|capecitabine|mesh-list
65577093|NCT01167725|Oxaliplatin|oxaliplatin|mesh-list
65577094|NCT01167725|Irinotecan|irinotecan|mesh-list
65577095|NCT01167725|Mitomycins|mitomycins|mesh-list
65577096|NCT01167725|Mitomycin|mitomycin|mesh-list
65577097|NCT01167725|Levoleucovorin|levoleucovorin|mesh-list
65577098|NCT01167725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65577099|NCT01167725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577100|NCT01167725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65577101|NCT01167725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65577102|NCT01167725|Growth Substances|growth substances|mesh-ancestor
65577103|NCT01167725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577104|NCT01167725|Growth Inhibitors|growth inhibitors|mesh-ancestor
65577105|NCT01167725|Antimetabolites|antimetabolites|mesh-ancestor
65577106|NCT01167725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577107|NCT01167725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65577108|NCT01167725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65577109|NCT01167725|Immunologic Factors|immunologic factors|mesh-ancestor
65577110|NCT01167725|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65577111|NCT01167725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65577112|NCT01167725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577113|NCT01167725|Antidotes|antidotes|mesh-ancestor
65577114|NCT01167725|Protective Agents|protective agents|mesh-ancestor
65577115|NCT01167725|Vitamin B Complex|vitamin b complex|mesh-ancestor
65577116|NCT01167725|Vitamins|vitamins|mesh-ancestor
65577117|NCT01167725|Micronutrients|micronutrients|mesh-ancestor
65577118|NCT01167725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65577119|NCT01167725|Alkylating Agents|alkylating agents|mesh-ancestor
65577120|NCT01167725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65577121|NCT04446130|Decitabine|decitabine|mesh-list
65577122|NCT04446130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65577123|NCT04446130|Antimetabolites|antimetabolites|mesh-ancestor
65577124|NCT04446130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577125|NCT04446130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577126|NCT04446130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577127|NCT03226275|Amlodipine|amlodipine|mesh-list
65577128|NCT03226275|Bisoprolol|bisoprolol|mesh-list
65577129|NCT03226275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65577130|NCT03226275|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65577131|NCT03226275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65577132|NCT03226275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577133|NCT03226275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65577134|NCT03226275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577135|NCT03226275|Vasodilator Agents|vasodilator agents|mesh-ancestor
65577136|NCT03226275|Sympatholytics|sympatholytics|mesh-ancestor
65577137|NCT03226275|Autonomic Agents|autonomic agents|mesh-ancestor
65577138|NCT03226275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65577139|NCT03226275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65577140|NCT03226275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65577141|NCT03226275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65577142|NCT03226275|Adrenergic Agents|adrenergic agents|mesh-ancestor
65577143|NCT03226275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65577144|NCT03382756|Choline|choline|mesh-list
65577145|NCT03382756|Atorvastatin|atorvastatin|mesh-list
65577146|NCT03382756|Fenofibrate|fenofibrate|mesh-list
65577147|NCT03382756|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65577148|NCT03382756|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65577149|NCT03382756|Antimetabolites|antimetabolites|mesh-ancestor
65577150|NCT03382756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577151|NCT03382756|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65577152|NCT03382756|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65577153|NCT03382756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577154|NCT03382756|Lipotropic Agents|lipotropic agents|mesh-ancestor
65577155|NCT03382756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65577156|NCT03382756|Nootropic Agents|nootropic agents|mesh-ancestor
65577157|NCT01166087|Fluoxetine|fluoxetine|mesh-list
65577158|NCT01166087|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65577159|NCT01166087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65577160|NCT01166087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65577161|NCT01166087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577162|NCT01166087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65577163|NCT01166087|Serotonin Agents|serotonin agents|mesh-ancestor
65577164|NCT01166087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577165|NCT01166087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65577166|NCT01166087|Antidepressive Agents|antidepressive agents|mesh-ancestor
65577167|NCT01166087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65577168|NCT01166087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65577169|NCT01166087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65577170|NCT01166087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577171|NCT01170767|Bevacizumab|bevacizumab|mesh-list
65577172|NCT01170767|Ranibizumab|ranibizumab|mesh-list
65577173|NCT01170767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65577174|NCT01170767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577175|NCT01170767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65577176|NCT01170767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65577177|NCT01170767|Growth Substances|growth substances|mesh-ancestor
65374703|NCT00860340|Spironolactone|spironolactone|mesh-list
65577178|NCT01170767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577179|NCT01170767|Growth Inhibitors|growth inhibitors|mesh-ancestor
65577180|NCT01170845|Sivelestat|sivelestat|mesh-list
65577181|NCT01170845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65577182|NCT01170845|Protease Inhibitors|protease inhibitors|mesh-ancestor
65577183|NCT01170845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577184|NCT01170845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577185|NCT01150890|Brodalumab|brodalumab|mesh-list
65577186|NCT01150890|Dermatologic Agents|dermatologic agents|mesh-ancestor
65577187|NCT01167803|Desflurane|desflurane|mesh-list
65577188|NCT01167803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65577189|NCT01167803|Anesthetics, General|anesthetics, general|mesh-ancestor
65577190|NCT01167803|Anesthetics|anesthetics|mesh-ancestor
65577191|NCT01167803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65577192|NCT01167803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577193|NCT01275521|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65577194|NCT01275521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65577195|NCT01275521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65577196|NCT01275521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577197|NCT01275521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65577198|NCT01275521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65577199|NCT01275521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577200|NCT01275521|Cholinergic Agents|cholinergic agents|mesh-ancestor
65577201|NCT01275521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65577202|NCT01275911|Remifentanil|remifentanil|mesh-list
65577203|NCT01275911|Esmolol|esmolol|mesh-list
65577204|NCT01275911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65577205|NCT01275911|Narcotics|narcotics|mesh-ancestor
65577206|NCT01275911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65577207|NCT01275911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577208|NCT01275911|Analgesics|analgesics|mesh-ancestor
65577209|NCT01275911|Sensory System Agents|sensory system agents|mesh-ancestor
65577210|NCT01275911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65577211|NCT01275911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65577212|NCT01275911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65577213|NCT01275911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65577214|NCT01275911|Adrenergic Agents|adrenergic agents|mesh-ancestor
65577215|NCT01275911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65577216|NCT01275911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577217|NCT01166165|Cholecalciferol|cholecalciferol|mesh-list
65577218|NCT01166165|Vitamin D|vitamin d|mesh-list
65577219|NCT01166165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65577220|NCT01166165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577221|NCT01166165|Vitamins|vitamins|mesh-ancestor
65577222|NCT01166165|Micronutrients|micronutrients|mesh-ancestor
65577223|NCT01166165|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65577224|NCT03286218|Alprazolam|alprazolam|mesh-list
65577225|NCT03286218|Lasmiditan|lasmiditan|mesh-list
65577226|NCT03286218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65577227|NCT03286218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65577228|NCT03286218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577229|NCT03286218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65577230|NCT03286218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65577231|NCT03286218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65577232|NCT03286218|GABA Modulators|gaba modulators|mesh-ancestor
65577233|NCT03286218|GABA Agents|gaba agents|mesh-ancestor
65577234|NCT03286218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65577235|NCT03286218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577236|NCT03286218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65577237|NCT03286218|Serotonin Agents|serotonin agents|mesh-ancestor
65577238|NCT03745261|Fluticasone|fluticasone|mesh-list
65577239|NCT03745261|Xhance|xhance|mesh-list
65577240|NCT03745261|Bromides|bromides|mesh-list
65577241|NCT03745261|Albuterol|albuterol|mesh-list
65577242|NCT03745261|Tiotropium Bromide|tiotropium bromide|mesh-list
65577243|NCT03745261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65577244|NCT03745261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65577245|NCT03745261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65577246|NCT03745261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65577247|NCT03745261|Autonomic Agents|autonomic agents|mesh-ancestor
65577248|NCT03745261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65577249|NCT03745261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577250|NCT03745261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65577251|NCT03745261|Respiratory System Agents|respiratory system agents|mesh-ancestor
65577252|NCT03745261|Dermatologic Agents|dermatologic agents|mesh-ancestor
65577253|NCT03745261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65577254|NCT03745261|Parasympatholytics|parasympatholytics|mesh-ancestor
65577255|NCT03745261|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65577256|NCT03745261|Cholinergic Agents|cholinergic agents|mesh-ancestor
65577257|NCT03745261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65577258|NCT03745261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577259|NCT03745261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65577260|NCT03745261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65577261|NCT03745261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65577262|NCT03745261|Adrenergic Agents|adrenergic agents|mesh-ancestor
65577263|NCT03745261|Anticonvulsants|anticonvulsants|mesh-ancestor
65577264|NCT03745261|Tocolytic Agents|tocolytic agents|mesh-ancestor
65577265|NCT03745261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65577266|NCT03745261|Glucocorticoids|glucocorticoids|mesh-ancestor
65577267|NCT03745261|Hormones|hormones|mesh-ancestor
65577268|NCT03745261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65577269|NCT03745261|Sympathomimetics|sympathomimetics|mesh-ancestor
65577270|NCT03744949|Remifentanil|remifentanil|mesh-list
65577271|NCT03744949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65577272|NCT03744949|Narcotics|narcotics|mesh-ancestor
65577273|NCT03744949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65577274|NCT03744949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577275|NCT03744949|Analgesics|analgesics|mesh-ancestor
65577276|NCT03744949|Sensory System Agents|sensory system agents|mesh-ancestor
65577277|NCT03744949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65577278|NCT03870581|Warfarin|warfarin|mesh-list
65577279|NCT03870581|Anticoagulants|anticoagulants|mesh-ancestor
65577280|NCT01277315|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65577281|NCT01277315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65577282|NCT04016779|Viloxazine|viloxazine|mesh-list
65577283|NCT04016779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65577284|NCT04016779|Antidepressive Agents|antidepressive agents|mesh-ancestor
65577285|NCT04016779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65577286|NCT04016779|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65577287|NCT04016779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65577288|NCT04016779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65577289|NCT04016779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577290|NCT04016779|Adrenergic Agents|adrenergic agents|mesh-ancestor
65577291|NCT04016779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65577292|NCT04016779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577293|NCT03870503|Misoprostol|misoprostol|mesh-list
65577294|NCT03870503|Oxytocin|oxytocin|mesh-list
65577295|NCT03870503|Carbetocin|carbetocin|mesh-list
65577296|NCT03870503|Oxytocics|oxytocics|mesh-ancestor
65577297|NCT03870503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65577298|NCT03870503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577299|NCT03870503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65577300|NCT03870503|Abortifacient Agents|abortifacient agents|mesh-ancestor
65577301|NCT03870503|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65577302|NCT03870503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65577303|NCT02857426|Nivolumab|nivolumab|mesh-list
65577304|NCT02857426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65577305|NCT02857426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577306|NCT02857426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65577307|NCT02857426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577308|NCT05181033|Letrozole|letrozole|mesh-list
65577309|NCT05181033|Lenvatinib|lenvatinib|mesh-list
65577310|NCT05181033|Fulvestrant|fulvestrant|mesh-list
65577311|NCT05181033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577312|NCT05181033|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65577313|NCT05181033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65577314|NCT05181033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577315|NCT05181033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577316|NCT05181033|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65577317|NCT05181033|Hormone Antagonists|hormone antagonists|mesh-ancestor
65248388|NCT02841488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65577318|NCT05181033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65577319|NCT05181033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577320|NCT05181033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65577321|NCT05181033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65577322|NCT05181033|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65577323|NCT05666765|Isotretinoin|isotretinoin|mesh-list
65577324|NCT05666765|Silymarin|silymarin|mesh-list
65577325|NCT05666765|Dermatologic Agents|dermatologic agents|mesh-ancestor
65577326|NCT05666765|Antioxidants|antioxidants|mesh-ancestor
65577327|NCT05666765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577328|NCT05666765|Protective Agents|protective agents|mesh-ancestor
65577329|NCT05666765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577330|NCT01127256|Carbamazepine|carbamazepine|mesh-list
65577332|NCT01127256|Anticonvulsants|anticonvulsants|mesh-ancestor
65577333|NCT01127256|Antimanic Agents|antimanic agents|mesh-ancestor
65577334|NCT01127256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65577335|NCT01127256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65577336|NCT01127256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577337|NCT01127256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65577338|NCT01127256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65577339|NCT01127256|Analgesics|analgesics|mesh-ancestor
65577340|NCT01127256|Sensory System Agents|sensory system agents|mesh-ancestor
65577341|NCT01127256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65577342|NCT01127256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65577343|NCT01127256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65577344|NCT01127256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577345|NCT01127256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65577346|NCT01127256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65577347|NCT01127256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65577348|NCT01127256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65577349|NCT03377842|Leucovorin|leucovorin|mesh-list
65577350|NCT03377842|Apatinib|apatinib|mesh-list
65577351|NCT03377842|Fluorouracil|fluorouracil|mesh-list
65577352|NCT03377842|Oxaliplatin|oxaliplatin|mesh-list
65577353|NCT03377842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577354|NCT03377842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65577355|NCT03377842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577356|NCT03377842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577357|NCT03377842|Antimetabolites|antimetabolites|mesh-ancestor
65577358|NCT03377842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65577359|NCT03377842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65577360|NCT03377842|Immunologic Factors|immunologic factors|mesh-ancestor
65577361|NCT03377842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577362|NCT03377842|Antidotes|antidotes|mesh-ancestor
65577363|NCT03377842|Protective Agents|protective agents|mesh-ancestor
65577364|NCT03377842|Vitamin B Complex|vitamin b complex|mesh-ancestor
65577365|NCT03377842|Vitamins|vitamins|mesh-ancestor
65577366|NCT03377842|Micronutrients|micronutrients|mesh-ancestor
65577367|NCT03668613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65577368|NCT03668613|Immunologic Factors|immunologic factors|mesh-ancestor
65577369|NCT03668613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577370|NCT01277705|Vaccines|vaccines|mesh-list
65577371|NCT01277705|Immunologic Factors|immunologic factors|mesh-ancestor
65577372|NCT01277705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577373|NCT04757337|Cyclophosphamide|cyclophosphamide|mesh-list
65577374|NCT04757337|Doxorubicin|doxorubicin|mesh-list
65577375|NCT04757337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65577376|NCT04757337|Immunologic Factors|immunologic factors|mesh-ancestor
65577377|NCT04757337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577378|NCT04757337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65577379|NCT04757337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65577380|NCT04757337|Alkylating Agents|alkylating agents|mesh-ancestor
65577381|NCT04757337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577382|NCT04757337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577383|NCT04757337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65577384|NCT04757337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65577385|NCT04757337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65577386|NCT04757337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65577387|NCT04757337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577388|NCT03946527|Lanreotide|lanreotide|mesh-list
65577389|NCT03946527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577390|NCT03377608|Tenofovir|tenofovir|mesh-list
65577391|NCT03377608|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65577392|NCT03377608|Medroxyprogesterone|medroxyprogesterone|mesh-list
65577393|NCT03377608|Antiviral Agents|antiviral agents|mesh-ancestor
65577394|NCT03377608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65577395|NCT03377608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65577396|NCT03377608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65577397|NCT03377608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577398|NCT03377608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577399|NCT03377608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65577400|NCT03377608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65577401|NCT03377608|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65577402|NCT03377608|Contraceptive Agents|contraceptive agents|mesh-ancestor
65577403|NCT03377608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65577404|NCT03377608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374920|NCT00663260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65577405|NCT03377608|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65577406|NCT03377608|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65577407|NCT03377608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65577408|NCT03377608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577409|NCT03377608|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65577410|NCT03377608|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65577411|NCT03377608|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65577413|NCT01282073|Mycophenolic Acid|mycophenolic acid|mesh-list
65577414|NCT01282073|Cyclosporins|cyclosporins|mesh-list
65577415|NCT01282073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577416|NCT01282073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577417|NCT01282073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65577418|NCT01282073|Immunologic Factors|immunologic factors|mesh-ancestor
65577419|NCT01282073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577420|NCT01282073|Antifungal Agents|antifungal agents|mesh-ancestor
65577421|NCT01282073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65577422|NCT01282073|Dermatologic Agents|dermatologic agents|mesh-ancestor
65577423|NCT01282073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65577424|NCT01282073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65577425|NCT01282073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65577426|NCT01282073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577427|NCT01282073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65577428|NCT01282073|Antitubercular Agents|antitubercular agents|mesh-ancestor
65577429|NCT01282073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65577430|NCT01166477|Ritonavir|ritonavir|mesh-list
65577431|NCT01166477|Lopinavir|lopinavir|mesh-list
65577432|NCT01166477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65577433|NCT01166477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65577434|NCT01166477|Protease Inhibitors|protease inhibitors|mesh-ancestor
65577435|NCT01166477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577436|NCT01166477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577437|NCT01166477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65577438|NCT01166477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65577439|NCT01166477|Antiviral Agents|antiviral agents|mesh-ancestor
65577440|NCT01166477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65577441|NCT01166477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65577442|NCT01166477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65577443|NCT01282151|Cisplatin|cisplatin|mesh-list
65577444|NCT01282151|Pemetrexed|pemetrexed|mesh-list
65577445|NCT01282151|Docetaxel|docetaxel|mesh-list
65577446|NCT01282151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577447|NCT01282151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577448|NCT01282151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577449|NCT01282151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65577450|NCT01282151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65577451|NCT01282151|Tubulin Modulators|tubulin modulators|mesh-ancestor
65577452|NCT01282151|Antimitotic Agents|antimitotic agents|mesh-ancestor
65577453|NCT01282151|Mitosis Modulators|mitosis modulators|mesh-ancestor
65577454|NCT03377218|Iodine|iodine|mesh-list
65577455|NCT03377218|Selenium|selenium|mesh-list
65577456|NCT03377218|Cadexomer iodine|cadexomer iodine|mesh-list
65577457|NCT03377218|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65577458|NCT03377218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65577459|NCT03377218|Trace Elements|trace elements|mesh-ancestor
65577460|NCT03377218|Micronutrients|micronutrients|mesh-ancestor
65577461|NCT03377218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577462|NCT03377218|Antioxidants|antioxidants|mesh-ancestor
65577463|NCT03377218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577464|NCT03377218|Protective Agents|protective agents|mesh-ancestor
65577465|NCT01168505|Teferrol|teferrol|mesh-list
65577466|NCT01168505|Hematinics|hematinics|mesh-ancestor
65577467|NCT03382600|Pembrolizumab|pembrolizumab|mesh-list
65577468|NCT03382600|Oxaliplatin|oxaliplatin|mesh-list
65577469|NCT03382600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577470|NCT03382600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65577471|NCT03867929|Vitamin D|vitamin d|mesh-list
65577472|NCT03867929|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65577473|NCT03867929|Calcifediol|calcifediol|mesh-list
65577474|NCT03867929|Vitamins|vitamins|mesh-ancestor
65577475|NCT03867929|Micronutrients|micronutrients|mesh-ancestor
65577476|NCT03867929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577477|NCT03867929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65577478|NCT03285594|Insulin Glargine|insulin glargine|mesh-list
65577479|NCT03285594|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65577480|NCT03285594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65577481|NCT03285594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577482|NCT03285594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65577483|NCT03285594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577484|NCT01171469|Imiquimod|imiquimod|mesh-list
65577485|NCT01171469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65577486|NCT01171469|Immunologic Factors|immunologic factors|mesh-ancestor
65577487|NCT01171469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577488|NCT01171469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577489|NCT01171469|Interferon Inducers|interferon inducers|mesh-ancestor
65577490|NCT02695992|Metoprolol|metoprolol|mesh-list
65577491|NCT02695992|Diltiazem|diltiazem|mesh-list
65577492|NCT02695992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65577493|NCT02695992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65577494|NCT02695992|Sympatholytics|sympatholytics|mesh-ancestor
65577495|NCT02695992|Autonomic Agents|autonomic agents|mesh-ancestor
65577496|NCT02695992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65577497|NCT02695992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577498|NCT02695992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65577499|NCT02695992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65577500|NCT02695992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65577501|NCT02695992|Adrenergic Agents|adrenergic agents|mesh-ancestor
65577502|NCT02695992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65577503|NCT02695992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577504|NCT02695992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65577505|NCT02695992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65577506|NCT02695992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65577507|NCT02695992|Vasodilator Agents|vasodilator agents|mesh-ancestor
65577508|NCT04050865|Dexamethasone|dexamethasone|mesh-list
65577509|NCT04050865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65577510|NCT04050865|Antiemetics|antiemetics|mesh-ancestor
65577511|NCT04050865|Autonomic Agents|autonomic agents|mesh-ancestor
65577512|NCT04050865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65577513|NCT04050865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577514|NCT04050865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65577515|NCT04050865|Glucocorticoids|glucocorticoids|mesh-ancestor
65577516|NCT04050865|Hormones|hormones|mesh-ancestor
65577517|NCT04050865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65577518|NCT04050865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65577519|NCT04050865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577520|NCT03283566|Hydroxychloroquine|hydroxychloroquine|mesh-list
65577521|NCT03283566|Antimalarials|antimalarials|mesh-ancestor
65577522|NCT03283566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65577523|NCT03283566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65577524|NCT03283566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65577525|NCT03283566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577526|NCT03283566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577527|NCT03283566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65577528|NCT01171547|Daptomycin|daptomycin|mesh-list
65577529|NCT01171547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65577530|NCT01171547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65577531|NCT04048681|Cocaine|cocaine|mesh-list
65577532|NCT04048681|Anesthetics, Local|anesthetics, local|mesh-ancestor
65577533|NCT04048681|Anesthetics|anesthetics|mesh-ancestor
65577534|NCT04048681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65577535|NCT04048681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577536|NCT04048681|Sensory System Agents|sensory system agents|mesh-ancestor
65577537|NCT04048681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65577538|NCT04048681|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65577539|NCT04048681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65577540|NCT04048681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65577541|NCT04048681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64578573|NCT01664559|Analgesics|analgesics|mesh-ancestor
65577542|NCT04048681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577543|NCT04048681|Dopamine Agents|dopamine agents|mesh-ancestor
65577544|NCT04048681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65577545|NCT01282385|Simvastatin|simvastatin|mesh-list
65577546|NCT01282385|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65577547|NCT01282385|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65577548|NCT01282385|Antimetabolites|antimetabolites|mesh-ancestor
65577549|NCT01282385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577550|NCT01282385|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65577551|NCT01282385|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65577552|NCT01282385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577553|NCT01166711|Chromium|chromium|mesh-list
65577554|NCT01166711|Paclitaxel|paclitaxel|mesh-list
65577555|NCT01166711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65577556|NCT01166711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65577557|NCT01166711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577558|NCT01166711|Tubulin Modulators|tubulin modulators|mesh-ancestor
65577559|NCT01166711|Antimitotic Agents|antimitotic agents|mesh-ancestor
65577560|NCT01166711|Mitosis Modulators|mitosis modulators|mesh-ancestor
65577561|NCT01166711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577562|NCT01166711|Trace Elements|trace elements|mesh-ancestor
65577563|NCT01166711|Micronutrients|micronutrients|mesh-ancestor
65577564|NCT01166711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577565|NCT01168739|Quercetin|quercetin|mesh-list
65577566|NCT01168739|Antioxidants|antioxidants|mesh-ancestor
65577567|NCT01168739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577568|NCT01168739|Protective Agents|protective agents|mesh-ancestor
65577569|NCT01168739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577570|NCT01171781|Cisplatin|cisplatin|mesh-list
65577571|NCT01171781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577572|NCT04006171|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
65577573|NCT04006171|Natriuretic Agents|natriuretic agents|mesh-ancestor
65577574|NCT04006171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577575|NCT01171859|Doxycycline|doxycycline|mesh-list
65577576|NCT01171859|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
65577577|NCT01171859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65577578|NCT01171859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65577579|NCT01171859|Antimalarials|antimalarials|mesh-ancestor
65577580|NCT01171859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65577581|NCT01171859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65577582|NCT01171859|Antiviral Agents|antiviral agents|mesh-ancestor
65577583|NCT01171859|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65577584|NCT01171859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65577585|NCT02652468|Mycophenolic Acid|mycophenolic acid|mesh-list
65577586|NCT02652468|Cyclophosphamide|cyclophosphamide|mesh-list
65577587|NCT02652468|Rituximab|rituximab|mesh-list
65577588|NCT02652468|Fludarabine|fludarabine|mesh-list
65577589|NCT02652468|Fludarabine phosphate|fludarabine phosphate|mesh-list
65577590|NCT02652468|Tacrolimus|tacrolimus|mesh-list
65577591|NCT02652468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65577592|NCT02652468|Immunologic Factors|immunologic factors|mesh-ancestor
65577593|NCT02652468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577594|NCT02652468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65577595|NCT02652468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65577596|NCT02652468|Alkylating Agents|alkylating agents|mesh-ancestor
65577597|NCT02652468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577598|NCT02652468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577599|NCT02652468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65577600|NCT02652468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65577601|NCT02652468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65577602|NCT02652468|Antimetabolites|antimetabolites|mesh-ancestor
65577603|NCT02652468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65577604|NCT02652468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577605|NCT02652468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65577606|NCT02652468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65577607|NCT02652468|Antitubercular Agents|antitubercular agents|mesh-ancestor
65577608|NCT02652468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65577609|NCT02652468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65577610|NCT04673877|Vancomycin|vancomycin|mesh-list
65577611|NCT04673877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65577612|NCT04673877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65577613|NCT01166789|Lubiprostone|lubiprostone|mesh-list
65577614|NCT01166789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65577615|NCT01166789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65577616|NCT01166789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577617|NCT01314339|Desloratadine|desloratadine|mesh-list
65577618|NCT01314339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65577619|NCT01314339|Cholinergic Agents|cholinergic agents|mesh-ancestor
65577620|NCT01314339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65577621|NCT01314339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577622|NCT01314339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577623|NCT01314339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65577624|NCT01314339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65577625|NCT01314339|Histamine Antagonists|histamine antagonists|mesh-ancestor
65577626|NCT01314339|Histamine Agents|histamine agents|mesh-ancestor
65577627|NCT05179512|Fluticasone|fluticasone|mesh-list
65577628|NCT05179512|Tiotropium Bromide|tiotropium bromide|mesh-list
65577629|NCT05179512|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65577630|NCT05179512|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65577631|NCT05179512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65577632|NCT05179512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65577634|NCT05179512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65577635|NCT05179512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577636|NCT05179512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65577637|NCT05179512|Respiratory System Agents|respiratory system agents|mesh-ancestor
65577638|NCT05179512|Dermatologic Agents|dermatologic agents|mesh-ancestor
65577639|NCT05179512|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65577640|NCT05179512|Parasympatholytics|parasympatholytics|mesh-ancestor
65577641|NCT05179512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65577642|NCT05179512|Cholinergic Agents|cholinergic agents|mesh-ancestor
65577643|NCT05179512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65577644|NCT05179512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577645|NCT05179512|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65577646|NCT05179512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65577647|NCT05179512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65577648|NCT05179512|Adrenergic Agents|adrenergic agents|mesh-ancestor
65577649|NCT05179512|Glucocorticoids|glucocorticoids|mesh-ancestor
65577650|NCT05179512|Hormones|hormones|mesh-ancestor
65577651|NCT05179512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65577652|NCT05179512|Sympathomimetics|sympathomimetics|mesh-ancestor
65577653|NCT01168817|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65577654|NCT01168817|Vasodilator Agents|vasodilator agents|mesh-ancestor
65577655|NCT01168817|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65577656|NCT01168817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65577657|NCT01168817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577658|NCT01168817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577659|NCT01168817|Urological Agents|urological agents|mesh-ancestor
65577660|NCT01279811|Dopamine|dopamine|mesh-list
65577661|NCT01279811|Norepinephrine|norepinephrine|mesh-list
65577662|NCT01279811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65577663|NCT01279811|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65577664|NCT01279811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65577665|NCT01279811|Adrenergic Agents|adrenergic agents|mesh-ancestor
65577666|NCT01279811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65577667|NCT01279811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577668|NCT01279811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577669|NCT01279811|Sympathomimetics|sympathomimetics|mesh-ancestor
65577670|NCT01279811|Autonomic Agents|autonomic agents|mesh-ancestor
65577671|NCT01279811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65577672|NCT01279811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65577673|NCT01279811|Dopamine Agents|dopamine agents|mesh-ancestor
65577674|NCT01279811|Protective Agents|protective agents|mesh-ancestor
65577675|NCT01168895|Ciprofloxacin|ciprofloxacin|mesh-list
65577676|NCT01168895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65577677|NCT01168895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65577678|NCT01168895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65577679|NCT01168895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65577680|NCT01168895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577681|NCT01168895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577682|NCT01168895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577683|NCT01168895|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65577684|NCT01168895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65577685|NCT03745105|Dexamethasone|dexamethasone|mesh-list
65577686|NCT03745105|Dexamethasone acetate|dexamethasone acetate|mesh-list
65577687|NCT03745105|Piroxicam|piroxicam|mesh-list
65577688|NCT03745105|Mepivacaine|mepivacaine|mesh-list
65577689|NCT03745105|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65577690|NCT03745105|BB 1101|bb 1101|mesh-list
65577691|NCT03745105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65577692|NCT03745105|Antiemetics|antiemetics|mesh-ancestor
65577693|NCT03745105|Autonomic Agents|autonomic agents|mesh-ancestor
65577694|NCT03745105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65577695|NCT03745105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577696|NCT03745105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65577697|NCT03745105|Glucocorticoids|glucocorticoids|mesh-ancestor
65577698|NCT03745105|Hormones|hormones|mesh-ancestor
65577699|NCT03745105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65577700|NCT03745105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65577701|NCT03745105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577702|NCT03745105|Anesthetics, Local|anesthetics, local|mesh-ancestor
65577703|NCT03745105|Anesthetics|anesthetics|mesh-ancestor
65375242|NCT00860964|Estradiol|estradiol|mesh-list
65577704|NCT03745105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65577705|NCT03745105|Sensory System Agents|sensory system agents|mesh-ancestor
65577706|NCT03745105|Protease Inhibitors|protease inhibitors|mesh-ancestor
65577707|NCT03745105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577708|NCT03745105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577709|NCT03745105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65577710|NCT03745105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65577711|NCT03745105|Analgesics|analgesics|mesh-ancestor
65577712|NCT03745105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65577713|NCT03745105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65577714|NCT01282541|Botulinum Toxins|botulinum toxins|mesh-list
65577715|NCT01282541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65577716|NCT01282541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65577717|NCT01282541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65577718|NCT01282541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65577719|NCT01282541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577720|NCT01282541|Cholinergic Agents|cholinergic agents|mesh-ancestor
65577721|NCT01282541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65577722|NCT01282541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577723|NCT01282541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65577724|NCT01282541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65577725|NCT03744247|Lenvatinib|lenvatinib|mesh-list
65577726|NCT03744247|Antibodies|antibodies|mesh-list
65577727|NCT03744247|Immunoglobulins|immunoglobulins|mesh-list
65577728|NCT03744247|Immunologic Factors|immunologic factors|mesh-ancestor
65577729|NCT03744247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577730|NCT03744247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577731|NCT03744247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65577732|NCT03744247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577733|NCT03744247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577734|NCT01282619|Huperzine A|huperzine a|mesh-list
65577735|NCT01282619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65577736|NCT01282619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577737|NCT01282619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577738|NCT01282619|Cholinergic Agents|cholinergic agents|mesh-ancestor
65577739|NCT01282619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65577740|NCT01282619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577741|NCT01282619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65577742|NCT01282619|Protective Agents|protective agents|mesh-ancestor
65577743|NCT01282697|Sirolimus|sirolimus|mesh-list
65577744|NCT01282697|Irinotecan|irinotecan|mesh-list
65577745|NCT01282697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65577746|NCT01282697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65577747|NCT01282697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577748|NCT01282697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577749|NCT01282697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577750|NCT01282697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65577751|NCT01282697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65577752|NCT01282697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65577753|NCT01282697|Antifungal Agents|antifungal agents|mesh-ancestor
65577754|NCT01282697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65577755|NCT01282697|Immunologic Factors|immunologic factors|mesh-ancestor
65577756|NCT01282697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577757|NCT01169597|Prednisone|prednisone|mesh-list
65577758|NCT01169597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65577759|NCT01169597|Glucocorticoids|glucocorticoids|mesh-ancestor
65577760|NCT01169597|Hormones|hormones|mesh-ancestor
65577761|NCT01169597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65577762|NCT01169597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577763|NCT01169597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65577764|NCT01169597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577765|NCT02527798|Furosemide|furosemide|mesh-list
65577766|NCT02527798|Diuretics|diuretics|mesh-ancestor
65577767|NCT02527798|Natriuretic Agents|natriuretic agents|mesh-ancestor
65577768|NCT02527798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577769|NCT02527798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65577770|NCT02527798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65577771|NCT02527798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577772|NCT05331911|Propofol|propofol|mesh-list
65577773|NCT05331911|Sevoflurane|sevoflurane|mesh-list
65577774|NCT05331911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65577775|NCT05331911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65577776|NCT05331911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577777|NCT05331911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65577778|NCT05331911|Anesthetics, General|anesthetics, general|mesh-ancestor
65577780|NCT05331911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65577781|NCT05331911|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65577782|NCT03857542|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65577783|NCT03857542|Pilocarpine|pilocarpine|mesh-list
65577784|NCT03857542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65577785|NCT03857542|Miotics|miotics|mesh-ancestor
65577786|NCT03857542|Autonomic Agents|autonomic agents|mesh-ancestor
65577787|NCT03857542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65577788|NCT03857542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577789|NCT03857542|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65577790|NCT03857542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65577791|NCT03857542|Cholinergic Agents|cholinergic agents|mesh-ancestor
65577792|NCT03857542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65577793|NCT03857542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577794|NCT01172717|Panitumumab|panitumumab|mesh-list
65577795|NCT01172717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65577796|NCT01172717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577797|NCT03751631|Phenylephrine|phenylephrine|mesh-list
65577798|NCT03751631|Oxymetazoline|oxymetazoline|mesh-list
65577799|NCT03751631|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65577800|NCT03751631|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65577801|NCT03751631|Tropicamide|tropicamide|mesh-list
65577802|NCT03751631|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65577803|NCT03751631|Mydriatics|mydriatics|mesh-ancestor
65577804|NCT03751631|Autonomic Agents|autonomic agents|mesh-ancestor
65577805|NCT03751631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65577806|NCT03751631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577807|NCT03751631|Sympathomimetics|sympathomimetics|mesh-ancestor
65577808|NCT03751631|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65577809|NCT03751631|Nasal Decongestants|nasal decongestants|mesh-ancestor
65577810|NCT03751631|Respiratory System Agents|respiratory system agents|mesh-ancestor
65577811|NCT03751631|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65577812|NCT03751631|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65577813|NCT03751631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65577814|NCT03751631|Adrenergic Agents|adrenergic agents|mesh-ancestor
65577815|NCT03751631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65577816|NCT03751631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577817|NCT03751631|Protective Agents|protective agents|mesh-ancestor
65577818|NCT03751631|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65577819|NCT03751631|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65577820|NCT03751631|Cholinergic Agents|cholinergic agents|mesh-ancestor
65577821|NCT03866681|Sirolimus|sirolimus|mesh-list
65577822|NCT03866681|Warfarin|warfarin|mesh-list
65577823|NCT03866681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65577824|NCT03866681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65577825|NCT03866681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65577826|NCT03866681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577827|NCT03866681|Antifungal Agents|antifungal agents|mesh-ancestor
65577828|NCT03866681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65577829|NCT03866681|Immunologic Factors|immunologic factors|mesh-ancestor
65577830|NCT03866681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577831|NCT03866681|Anticoagulants|anticoagulants|mesh-ancestor
65577832|NCT03649659|Fluorides|fluorides|mesh-list
65577833|NCT03649659|Cariostatic Agents|cariostatic agents|mesh-ancestor
65577834|NCT03649659|Protective Agents|protective agents|mesh-ancestor
65577835|NCT03649659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577836|NCT03736369|Esomeprazole|esomeprazole|mesh-list
65577837|NCT03736369|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65577838|NCT03736369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65577839|NCT03736369|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65577840|NCT03736369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577841|NCT03736369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577842|NCT03867695|Ropivacaine|ropivacaine|mesh-list
65577843|NCT03867695|Anesthetics, Local|anesthetics, local|mesh-ancestor
65577844|NCT03867695|Anesthetics|anesthetics|mesh-ancestor
65577845|NCT03867695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65577846|NCT03867695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577847|NCT03867695|Sensory System Agents|sensory system agents|mesh-ancestor
65577848|NCT03867695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65577849|NCT03579771|Gemcitabine|gemcitabine|mesh-list
65577850|NCT03579771|Paclitaxel|paclitaxel|mesh-list
65577851|NCT03579771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65577852|NCT03579771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65577853|NCT03579771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577854|NCT03579771|Tubulin Modulators|tubulin modulators|mesh-ancestor
65577855|NCT03579771|Antimitotic Agents|antimitotic agents|mesh-ancestor
65577856|NCT03579771|Mitosis Modulators|mitosis modulators|mesh-ancestor
65577857|NCT03579771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577858|NCT03579771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65577859|NCT03579771|Antimetabolites|antimetabolites|mesh-ancestor
65577860|NCT03579771|Antiviral Agents|antiviral agents|mesh-ancestor
65577861|NCT03579771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65577862|NCT03579771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577863|NCT03579771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65577864|NCT03579771|Immunologic Factors|immunologic factors|mesh-ancestor
65577865|NCT03579771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577866|NCT01172171|Melatonin|melatonin|mesh-list
65577867|NCT01172171|Antioxidants|antioxidants|mesh-ancestor
65577868|NCT01172171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577869|NCT01172171|Protective Agents|protective agents|mesh-ancestor
65577870|NCT01172171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577871|NCT01172171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65577872|NCT03655717|Ethanol|ethanol|mesh-list
65577873|NCT03655717|Dronabinol|dronabinol|mesh-list
65577874|NCT03655717|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65577875|NCT03655717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65577876|NCT03655717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65577877|NCT03655717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577878|NCT03655717|Hallucinogens|hallucinogens|mesh-ancestor
65577879|NCT03655717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65577880|NCT03655717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65577881|NCT03655717|Analgesics|analgesics|mesh-ancestor
65577882|NCT03655717|Sensory System Agents|sensory system agents|mesh-ancestor
65577883|NCT03655717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65577884|NCT03655717|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65577885|NCT03655717|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65577886|NCT03655717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65577887|NCT03655717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577888|NCT03655717|Hormones|hormones|mesh-ancestor
65577889|NCT03655717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65577890|NCT03222531|Sofosbuvir|sofosbuvir|mesh-list
65577891|NCT03222531|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65577892|NCT03222531|Velpatasvir|velpatasvir|mesh-list
65577893|NCT03222531|Antiviral Agents|antiviral agents|mesh-ancestor
65577894|NCT03222531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65577895|NCT03867071|Epoetin Alfa|epoetin alfa|mesh-list
65577896|NCT03867071|Hematinics|hematinics|mesh-ancestor
65577897|NCT01284413|Gemcitabine|gemcitabine|mesh-list
65577898|NCT01284413|Cisplatin|cisplatin|mesh-list
65577899|NCT01284413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577900|NCT01284413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65577901|NCT01284413|Antimetabolites|antimetabolites|mesh-ancestor
65577902|NCT01284413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577903|NCT01284413|Antiviral Agents|antiviral agents|mesh-ancestor
65577904|NCT01284413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65577905|NCT01284413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577906|NCT01284413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65577907|NCT01284413|Immunologic Factors|immunologic factors|mesh-ancestor
65577908|NCT01284413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577909|NCT05152017|Vaccines|vaccines|mesh-list
65577910|NCT05152017|Immunologic Factors|immunologic factors|mesh-ancestor
65577911|NCT05152017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577912|NCT03866993|Paclitaxel|paclitaxel|mesh-list
65577913|NCT03866993|Carboplatin|carboplatin|mesh-list
65577914|NCT03866993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65577915|NCT03866993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577916|NCT03866993|Tubulin Modulators|tubulin modulators|mesh-ancestor
65577917|NCT03866993|Antimitotic Agents|antimitotic agents|mesh-ancestor
65577918|NCT03866993|Mitosis Modulators|mitosis modulators|mesh-ancestor
65577919|NCT03866993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577920|NCT05142735|Acetylcysteine|acetylcysteine|mesh-list
65577921|NCT05142735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65577922|NCT05142735|Antiviral Agents|antiviral agents|mesh-ancestor
65577923|NCT05142735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65577924|NCT05142735|Expectorants|expectorants|mesh-ancestor
65577925|NCT05142735|Respiratory System Agents|respiratory system agents|mesh-ancestor
65577926|NCT05142735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65577927|NCT05142735|Antioxidants|antioxidants|mesh-ancestor
65577928|NCT05142735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577929|NCT05142735|Protective Agents|protective agents|mesh-ancestor
65375445|NCT00869310|BB 1101|bb 1101|mesh-list
65577930|NCT05142735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577932|NCT01172405|Ibuprofen|ibuprofen|mesh-list
65577933|NCT01172405|Caffeine|caffeine|mesh-list
65577934|NCT01172405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65577935|NCT01172405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65577936|NCT01172405|Analgesics|analgesics|mesh-ancestor
65577937|NCT01172405|Sensory System Agents|sensory system agents|mesh-ancestor
65577938|NCT01172405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65577939|NCT01172405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577940|NCT01172405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65577941|NCT01172405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65577942|NCT01172405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65577943|NCT01172405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577944|NCT01172405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577945|NCT01172405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65577946|NCT01172405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65577947|NCT01172405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65577948|NCT01172405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65577949|NCT01172405|Purinergic Agents|purinergic agents|mesh-ancestor
65577950|NCT01172405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65577951|NCT03375424|Vedolizumab|vedolizumab|mesh-list
65577952|NCT03375424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65577953|NCT03187197|Dabigatran|dabigatran|mesh-list
65577954|NCT03187197|Antithrombins|antithrombins|mesh-ancestor
65577955|NCT03187197|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65577956|NCT03187197|Protease Inhibitors|protease inhibitors|mesh-ancestor
65577957|NCT03187197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577958|NCT03187197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577959|NCT03187197|Anticoagulants|anticoagulants|mesh-ancestor
65577960|NCT01284647|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
65577961|NCT01284647|Sucralfate|sucralfate|mesh-list
65577962|NCT01284647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65577963|NCT01284647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65577964|NCT01284647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577965|NCT04000009|Pimavanserin|pimavanserin|mesh-list
65577966|NCT04000009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65577967|NCT04000009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65577968|NCT04000009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65577969|NCT04000009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65577970|NCT04000009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65577971|NCT04000009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577972|NCT04000009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65577973|NCT04000009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65577974|NCT04000009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65577975|NCT04000009|Serotonin Agents|serotonin agents|mesh-ancestor
65577976|NCT04000009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65577977|NCT04000009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577978|NCT03282240|Vaccines|vaccines|mesh-list
65577979|NCT03282240|Immunologic Factors|immunologic factors|mesh-ancestor
65577980|NCT03282240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577981|NCT01284725|Mycophenolic Acid|mycophenolic acid|mesh-list
65577982|NCT01284725|Azathioprine|azathioprine|mesh-list
65577983|NCT01284725|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65577984|NCT01284725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65577985|NCT01284725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65577986|NCT01284725|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65577987|NCT01284725|Antitubercular Agents|antitubercular agents|mesh-ancestor
65577988|NCT01284725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65577989|NCT01284725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65577990|NCT01284725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65577991|NCT01284725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65577992|NCT01284725|Antimetabolites|antimetabolites|mesh-ancestor
65577993|NCT01284725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65577994|NCT01284725|Immunologic Factors|immunologic factors|mesh-ancestor
65577995|NCT01284725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65577996|NCT01284725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65577997|NCT03510598|Deoxycholic Acid|deoxycholic acid|mesh-list
65577998|NCT03510598|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65577999|NCT03510598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65578000|NCT01173107|Colchicine|colchicine|mesh-list
65578001|NCT01173107|Gout Suppressants|gout suppressants|mesh-ancestor
65578002|NCT01173107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65578003|NCT01173107|Tubulin Modulators|tubulin modulators|mesh-ancestor
65375534|NCT00739973|Amlodipine|amlodipine|mesh-list
65578004|NCT01173107|Antimitotic Agents|antimitotic agents|mesh-ancestor
65578005|NCT01173107|Mitosis Modulators|mitosis modulators|mesh-ancestor
65578006|NCT01173107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578007|NCT01173107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578008|NCT03744091|Dronabinol|dronabinol|mesh-list
65578009|NCT03744091|Hallucinogens|hallucinogens|mesh-ancestor
65578010|NCT03744091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578011|NCT03744091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65578012|NCT03744091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65578013|NCT03744091|Analgesics|analgesics|mesh-ancestor
65578014|NCT03744091|Sensory System Agents|sensory system agents|mesh-ancestor
65578015|NCT03744091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65578016|NCT03744091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65578017|NCT03744091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65578018|NCT03744091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65578019|NCT03744091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578020|NCT03744091|Hormones|hormones|mesh-ancestor
65578021|NCT03744091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65578022|NCT03376594|Loratadine|loratadine|mesh-list
65578023|NCT03376594|Antipruritics|antipruritics|mesh-ancestor
65578024|NCT03376594|Dermatologic Agents|dermatologic agents|mesh-ancestor
65578025|NCT03376594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65578026|NCT03376594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65578027|NCT03376594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65578028|NCT03376594|Histamine Antagonists|histamine antagonists|mesh-ancestor
65578029|NCT03376594|Histamine Agents|histamine agents|mesh-ancestor
65578030|NCT03376594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65578031|NCT03376594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578032|NCT03376594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578033|NCT03381664|Quinidine|quinidine|mesh-list
65578034|NCT03381664|Dextromethorphan|dextromethorphan|mesh-list
65578035|NCT03381664|Antitussive Agents|antitussive agents|mesh-ancestor
65578036|NCT03381664|Respiratory System Agents|respiratory system agents|mesh-ancestor
65578037|NCT03381664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65578038|NCT03381664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65578039|NCT03381664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65578040|NCT03381664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578041|NCT03381664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578042|NCT03381664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65578043|NCT03381664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65578044|NCT03381664|Adrenergic Agents|adrenergic agents|mesh-ancestor
65578045|NCT03381664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65578046|NCT03381664|Antimalarials|antimalarials|mesh-ancestor
65578047|NCT03381664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65578048|NCT03381664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65578049|NCT03381664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65578050|NCT03381664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578051|NCT03381664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65578052|NCT03381664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65578053|NCT03381664|Cholinergic Agents|cholinergic agents|mesh-ancestor
65578054|NCT03381664|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65578055|NCT03381664|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65578056|NCT03381664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65578057|NCT03381664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65578058|NCT03381664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65578059|NCT04060758|Latanoprost|latanoprost|mesh-list
65578060|NCT04060758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65578061|NCT04060758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65578062|NCT03376438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
65578063|NCT03863405|Metformin|metformin|mesh-list
65578064|NCT03863405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65578065|NCT03863405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578066|NCT03866369|Moxifloxacin|moxifloxacin|mesh-list
65578067|NCT03866369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65578068|NCT03866369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65578069|NCT03866369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65578070|NCT03866369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65578071|NCT03866369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578072|NCT03866369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578073|NCT03866369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578074|NCT04024891|Phentolamine|phentolamine|mesh-list
65578075|NCT04024891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65578076|NCT04024891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65578077|NCT04024891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65578078|NCT04024891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65375610|NCT00789308|Sirolimus|sirolimus|mesh-list
65578079|NCT04024891|Adrenergic Agents|adrenergic agents|mesh-ancestor
65578080|NCT04024891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65578081|NCT04024891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578082|NCT04024891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578083|NCT04024891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65578084|NCT01178021|Chloroquine|chloroquine|mesh-list
65578085|NCT01178021|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65578086|NCT01178021|Primaquine|primaquine|mesh-list
65578087|NCT01178021|Amebicides|amebicides|mesh-ancestor
65578088|NCT01178021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65578089|NCT01178021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65578090|NCT01178021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65578091|NCT01178021|Antimalarials|antimalarials|mesh-ancestor
65578092|NCT01178021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65578093|NCT01178021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65578094|NCT01178021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65578095|NCT01178021|Analgesics|analgesics|mesh-ancestor
65578096|NCT01178021|Sensory System Agents|sensory system agents|mesh-ancestor
65578097|NCT01178021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65578098|NCT01178021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578099|NCT01178021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65578100|NCT01178021|Filaricides|filaricides|mesh-ancestor
65578101|NCT01178021|Antinematodal Agents|antinematodal agents|mesh-ancestor
65578102|NCT01178021|Anthelmintics|anthelmintics|mesh-ancestor
65578103|NCT03250182|Budesonide|budesonide|mesh-list
65578104|NCT03250182|Glycopyrrolate|glycopyrrolate|mesh-list
65578105|NCT03250182|Formoterol Fumarate|formoterol fumarate|mesh-list
65578106|NCT03250182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65578107|NCT03250182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65578108|NCT03250182|Autonomic Agents|autonomic agents|mesh-ancestor
65578109|NCT03250182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65578110|NCT03250182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578111|NCT03250182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65578112|NCT03250182|Respiratory System Agents|respiratory system agents|mesh-ancestor
65578113|NCT03250182|Glucocorticoids|glucocorticoids|mesh-ancestor
65578114|NCT03250182|Hormones|hormones|mesh-ancestor
65578115|NCT03250182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65578116|NCT03250182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65578117|NCT03250182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65578118|NCT03250182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65578119|NCT03250182|Adrenergic Agents|adrenergic agents|mesh-ancestor
65578120|NCT03250182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65578121|NCT03250182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578122|NCT03250182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65578123|NCT03250182|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65578124|NCT03250182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65578125|NCT03250182|Cholinergic Agents|cholinergic agents|mesh-ancestor
65578126|NCT04478734|Thiamine|thiamine|mesh-list
65578127|NCT04478734|Biotin|biotin|mesh-list
65578128|NCT04478734|Vitamin B Complex|vitamin b complex|mesh-ancestor
65578129|NCT04478734|Vitamins|vitamins|mesh-ancestor
65578130|NCT04478734|Micronutrients|micronutrients|mesh-ancestor
65578131|NCT04478734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578132|NCT01173263|Propofol|propofol|mesh-list
65578133|NCT01173263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65578134|NCT01173263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65578135|NCT01173263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578136|NCT01173263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65578137|NCT01173263|Anesthetics, General|anesthetics, general|mesh-ancestor
65578138|NCT01173263|Anesthetics|anesthetics|mesh-ancestor
65578139|NCT03381430|Gefitinib|gefitinib|mesh-list
64579169|NCT00057785|Fluorouracil|fluorouracil|mesh-list
65578140|NCT03381430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578141|NCT03381430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65578142|NCT03381430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578143|NCT03381430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578144|NCT01288157|Golimumab|golimumab|mesh-list
65578145|NCT01288157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65578146|NCT01288157|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65578147|NCT01288157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65578148|NCT01288157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65578149|NCT01288157|Immunologic Factors|immunologic factors|mesh-ancestor
65578150|NCT01288157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578151|NCT03993379|Ipilimumab|ipilimumab|mesh-list
65578152|NCT03993379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65578153|NCT03993379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578154|NCT03993379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65578155|NCT03993379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578156|NCT03866447|Vitamin D|vitamin d|mesh-list
65578157|NCT03866447|Adapalene|adapalene|mesh-list
65578158|NCT03866447|Vitamins|vitamins|mesh-ancestor
65578159|NCT03866447|Micronutrients|micronutrients|mesh-ancestor
65578160|NCT03866447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578161|NCT03866447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65578162|NCT03866447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65578163|NCT03866447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65578164|NCT03866447|Analgesics|analgesics|mesh-ancestor
65578165|NCT03866447|Sensory System Agents|sensory system agents|mesh-ancestor
65578166|NCT03866447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65578167|NCT03866447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65578168|NCT03866447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65578169|NCT03866447|Dermatologic Agents|dermatologic agents|mesh-ancestor
65578170|NCT01175291|Leucovorin|leucovorin|mesh-list
65578171|NCT01175291|Bevacizumab|bevacizumab|mesh-list
65578172|NCT01175291|Fluorouracil|fluorouracil|mesh-list
65578173|NCT01175291|Oxaliplatin|oxaliplatin|mesh-list
65578174|NCT01175291|Levoleucovorin|levoleucovorin|mesh-list
65578175|NCT01175291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65578176|NCT01175291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578177|NCT01175291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65578178|NCT01175291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65578179|NCT01175291|Growth Substances|growth substances|mesh-ancestor
65578180|NCT01175291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578181|NCT01175291|Growth Inhibitors|growth inhibitors|mesh-ancestor
65578182|NCT01175291|Antimetabolites|antimetabolites|mesh-ancestor
65578183|NCT01175291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578184|NCT01175291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65578185|NCT01175291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65578186|NCT01175291|Immunologic Factors|immunologic factors|mesh-ancestor
65578187|NCT01175291|Antidotes|antidotes|mesh-ancestor
65578188|NCT01175291|Protective Agents|protective agents|mesh-ancestor
65578189|NCT01175291|Vitamin B Complex|vitamin b complex|mesh-ancestor
65578190|NCT01175291|Vitamins|vitamins|mesh-ancestor
65578191|NCT01175291|Micronutrients|micronutrients|mesh-ancestor
65578192|NCT03230266|Insulin|insulin|mesh-list
65578193|NCT03230266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65578194|NCT03230266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578195|NCT03732469|Acetaminophen|acetaminophen|mesh-list
65578196|NCT03732469|Fentanyl|fentanyl|mesh-list
65578197|NCT03732469|Propofol|propofol|mesh-list
65578198|NCT03732469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65578199|NCT03732469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65578200|NCT03732469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578201|NCT03732469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65578202|NCT03732469|Anesthetics, General|anesthetics, general|mesh-ancestor
65578203|NCT03732469|Anesthetics|anesthetics|mesh-ancestor
65578204|NCT03732469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65578205|NCT03732469|Narcotics|narcotics|mesh-ancestor
65578206|NCT03732469|Analgesics|analgesics|mesh-ancestor
65578207|NCT03732469|Sensory System Agents|sensory system agents|mesh-ancestor
65578208|NCT03732469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65578209|NCT03732469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65578210|NCT03732469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65578211|NCT03732469|Antipyretics|antipyretics|mesh-ancestor
65578212|NCT03381352|Capecitabine|capecitabine|mesh-list
65578213|NCT03381352|Mitomycins|mitomycins|mesh-list
65578214|NCT03381352|Mitomycin|mitomycin|mesh-list
65578215|NCT03381352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65578216|NCT03381352|Antimetabolites|antimetabolites|mesh-ancestor
65578217|NCT03381352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578218|NCT03381352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578219|NCT03381352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65578220|NCT03381352|Alkylating Agents|alkylating agents|mesh-ancestor
65578221|NCT03381352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65578222|NCT03381352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578223|NCT01175525|Cromolyn Sodium|cromolyn sodium|mesh-list
65578224|NCT01175525|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
65578225|NCT01175525|Immunologic Factors|immunologic factors|mesh-ancestor
65578226|NCT01175525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578227|NCT01175525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65578228|NCT01175525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65578229|NCT01175525|Respiratory System Agents|respiratory system agents|mesh-ancestor
65578230|NCT03863249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65375747|NCT00789386|Anesthetics|anesthetics|mesh-ancestor
65578231|NCT03863249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65578232|NCT03381118|Cytarabine|cytarabine|mesh-list
65578233|NCT03381118|Nivolumab|nivolumab|mesh-list
65578234|NCT03381118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65578235|NCT03381118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578236|NCT03381118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65578237|NCT03381118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578238|NCT03381118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65578239|NCT03381118|Antimetabolites|antimetabolites|mesh-ancestor
65578240|NCT03381118|Antiviral Agents|antiviral agents|mesh-ancestor
65578241|NCT03381118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65578242|NCT03381118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65578243|NCT03381118|Immunologic Factors|immunologic factors|mesh-ancestor
65578244|NCT03381118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578245|NCT03375112|Bupivacaine|bupivacaine|mesh-list
65578246|NCT03375112|Anesthetics, Local|anesthetics, local|mesh-ancestor
65578247|NCT03375112|Anesthetics|anesthetics|mesh-ancestor
65578248|NCT03375112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65578249|NCT03375112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578250|NCT03375112|Sensory System Agents|sensory system agents|mesh-ancestor
65578251|NCT03375112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65578252|NCT02954575|Factor VIII|factor viii|mesh-list
65578253|NCT02954575|Coagulants|coagulants|mesh-ancestor
65578254|NCT02997358|Doxorubicin|doxorubicin|mesh-list
65578255|NCT02997358|Trabectedin|trabectedin|mesh-list
65578256|NCT02997358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65578257|NCT02997358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578258|NCT02997358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65578259|NCT02997358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65578260|NCT02997358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578261|NCT02997358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578262|NCT02997358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65578263|NCT02997358|Alkylating Agents|alkylating agents|mesh-ancestor
65578264|NCT03375034|Clonazepam|clonazepam|mesh-list
65578265|NCT03375034|Anticonvulsants|anticonvulsants|mesh-ancestor
65578266|NCT03375034|GABA Modulators|gaba modulators|mesh-ancestor
65578267|NCT03375034|GABA Agents|gaba agents|mesh-ancestor
65578268|NCT03375034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65578269|NCT03375034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578270|NCT03375034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578271|NCT03381040|Hyaluronic Acid|hyaluronic acid|mesh-list
65578272|NCT03381040|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65578273|NCT03381040|Immunologic Factors|immunologic factors|mesh-ancestor
65578274|NCT03381040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578275|NCT03381040|Viscosupplements|viscosupplements|mesh-ancestor
65578276|NCT03381040|Protective Agents|protective agents|mesh-ancestor
65578277|NCT03376048|Ropivacaine|ropivacaine|mesh-list
65578278|NCT03376048|Anesthetics, Local|anesthetics, local|mesh-ancestor
65578279|NCT03376048|Anesthetics|anesthetics|mesh-ancestor
65578280|NCT03376048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65578281|NCT03376048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578282|NCT03376048|Sensory System Agents|sensory system agents|mesh-ancestor
65578283|NCT03376048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65578284|NCT03374878|Contraceptive Agents|contraceptive agents|mesh-list
65578285|NCT03374878|Contraceptives, Oral|contraceptives, oral|mesh-list
65578286|NCT03374878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65578287|NCT03374878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578288|NCT03374878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65578289|NCT01285037|Gemcitabine|gemcitabine|mesh-list
65578290|NCT01285037|Cetuximab|cetuximab|mesh-list
65578291|NCT01285037|Ramucirumab|ramucirumab|mesh-list
65578292|NCT01285037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578293|NCT01285037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65578294|NCT01285037|Antimetabolites|antimetabolites|mesh-ancestor
65578295|NCT01285037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578296|NCT01285037|Antiviral Agents|antiviral agents|mesh-ancestor
65578297|NCT01285037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65578298|NCT01285037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578299|NCT01285037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65578300|NCT01285037|Immunologic Factors|immunologic factors|mesh-ancestor
65578301|NCT01285037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578302|NCT01285037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65578303|NCT03732391|Carboplatin|carboplatin|mesh-list
65578304|NCT03732391|Pembrolizumab|pembrolizumab|mesh-list
65578305|NCT03732391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578306|NCT03732391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65578307|NCT03374722|Analgesics, Opioid|analgesics, opioid|mesh-list
65578308|NCT03374722|Narcotics|narcotics|mesh-ancestor
65578309|NCT03374722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65578310|NCT03374722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578311|NCT03374722|Analgesics|analgesics|mesh-ancestor
65578312|NCT03374722|Sensory System Agents|sensory system agents|mesh-ancestor
65578313|NCT03374722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65578314|NCT03207243|Fluticasone|fluticasone|mesh-list
65578315|NCT03207243|Xhance|xhance|mesh-list
65578316|NCT03207243|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65578317|NCT03207243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65578318|NCT03207243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65578319|NCT03207243|Autonomic Agents|autonomic agents|mesh-ancestor
65578320|NCT03207243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65578321|NCT03207243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578322|NCT03207243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65578323|NCT03207243|Respiratory System Agents|respiratory system agents|mesh-ancestor
65578324|NCT03207243|Dermatologic Agents|dermatologic agents|mesh-ancestor
65578325|NCT03207243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65578326|NCT03207243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65578327|NCT03207243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65578328|NCT03207243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65578329|NCT03207243|Adrenergic Agents|adrenergic agents|mesh-ancestor
65578330|NCT03207243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65578331|NCT03207243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578332|NCT01285271|Sevoflurane|sevoflurane|mesh-list
65578333|NCT01285271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65578334|NCT01285271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65578335|NCT01285271|Anesthetics, General|anesthetics, general|mesh-ancestor
65578336|NCT01285271|Anesthetics|anesthetics|mesh-ancestor
65578337|NCT01285271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65578338|NCT01285271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578339|NCT03982069|Vaccines|vaccines|mesh-list
65578340|NCT03982069|Immunologic Factors|immunologic factors|mesh-ancestor
65578341|NCT03982069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578342|NCT03219723|Amoxicillin|amoxicillin|mesh-list
65578343|NCT03219723|Metronidazole|metronidazole|mesh-list
65578344|NCT03219723|Clarithromycin|clarithromycin|mesh-list
65578345|NCT03219723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65578346|NCT03219723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65578347|NCT03219723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65578348|NCT03219723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65578349|NCT03219723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65578350|NCT03219723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578351|NCT03219723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578352|NCT03219723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65578353|NCT03219723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65578354|NCT03628417|Bleomycin|bleomycin|mesh-list
65578355|NCT03628417|Calcium|calcium|mesh-list
65578356|NCT03628417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65578357|NCT03628417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578358|NCT03628417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65578359|NCT03628417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578360|NCT03369964|Atezolizumab|atezolizumab|mesh-list
65578361|NCT03369964|Obinutuzumab|obinutuzumab|mesh-list
65578362|NCT03369964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578363|NCT03369964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65578364|NCT03245736|Tisotumab vedotin|tisotumab vedotin|mesh-list
65578365|NCT03245736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65578366|NCT03245736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578367|NCT01173809|Amiodarone|amiodarone|mesh-list
65578368|NCT01173809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65578369|NCT01173809|Vasodilator Agents|vasodilator agents|mesh-ancestor
65578370|NCT01173809|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65578371|NCT01173809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65578372|NCT01173809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578373|NCT01173809|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65578374|NCT01173809|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65578375|NCT01173809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65578376|NCT01173809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578377|NCT01173809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65578378|NCT01173809|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65578379|NCT01173809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65578380|NCT03375580|Metformin|metformin|mesh-list
65578381|NCT03375580|Simvastatin|simvastatin|mesh-list
65578382|NCT03375580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65578383|NCT03375580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578384|NCT03375580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65578385|NCT03375580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65578387|NCT03375580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578388|NCT03375580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65578389|NCT03375580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65578390|NCT03375580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578391|NCT03340896|Docetaxel|docetaxel|mesh-list
65578392|NCT03340896|Fluorouracil|fluorouracil|mesh-list
65578393|NCT03340896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578394|NCT03340896|Tubulin Modulators|tubulin modulators|mesh-ancestor
65578395|NCT03340896|Antimitotic Agents|antimitotic agents|mesh-ancestor
65578396|NCT03340896|Mitosis Modulators|mitosis modulators|mesh-ancestor
65578397|NCT03340896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578398|NCT03340896|Antimetabolites|antimetabolites|mesh-ancestor
65578399|NCT03340896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65578400|NCT03340896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65578401|NCT03340896|Immunologic Factors|immunologic factors|mesh-ancestor
65578402|NCT03340896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578403|NCT03282981|Timolol|timolol|mesh-list
65578404|NCT03282981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65578405|NCT03282981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65578406|NCT03282981|Adrenergic Agents|adrenergic agents|mesh-ancestor
65578407|NCT03282981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65578408|NCT03282981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578409|NCT03282981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578410|NCT03282981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65578411|NCT03282981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65578412|NCT01286909|Lycopene|lycopene|mesh-list
65578413|NCT01286909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65578414|NCT01286909|Antioxidants|antioxidants|mesh-ancestor
65578415|NCT01286909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578416|NCT01286909|Protective Agents|protective agents|mesh-ancestor
65578417|NCT01286909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578418|NCT01286909|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65578419|NCT01286909|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65578420|NCT01286909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578421|NCT02954887|Cannabidiol|cannabidiol|mesh-list
65578422|NCT02954887|Anticonvulsants|anticonvulsants|mesh-ancestor
65578423|NCT03860129|Sevoflurane|sevoflurane|mesh-list
65578424|NCT03860129|Desflurane|desflurane|mesh-list
65578425|NCT03860129|Isoflurane|isoflurane|mesh-list
65578426|NCT03860129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65578427|NCT03860129|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65578428|NCT03860129|Anesthetics, General|anesthetics, general|mesh-ancestor
65578429|NCT03860129|Anesthetics|anesthetics|mesh-ancestor
65578430|NCT03860129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65578431|NCT03860129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578432|NCT03369808|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65578433|NCT03369808|Vaccines|vaccines|mesh-list
65578434|NCT03369808|Immunologic Factors|immunologic factors|mesh-ancestor
65578435|NCT03369808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578436|NCT03369808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65578437|NCT03369808|Antacids|antacids|mesh-ancestor
65578438|NCT03369808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578439|NCT03369808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65578440|NCT02525237|Apatinib|apatinib|mesh-list
65578441|NCT02525237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578442|NCT02525237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65578443|NCT02525237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248389|NCT02841488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65578444|NCT02525237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578445|NCT01173887|Mogamulizumab|mogamulizumab|mesh-list
65578446|NCT01173887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578447|NCT03369574|Reslizumab|reslizumab|mesh-list
65578448|NCT03369574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65578449|NCT03369574|Respiratory System Agents|respiratory system agents|mesh-ancestor
65578450|NCT03278028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65578451|NCT02651740|Rifaximin|rifaximin|mesh-list
65578452|NCT02651740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65578453|NCT02651740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65578454|NCT02651740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65578455|NCT03862391|Analgesics|analgesics|mesh-list
65578456|NCT03862391|Antiemetics|antiemetics|mesh-list
65578457|NCT03862391|Sensory System Agents|sensory system agents|mesh-ancestor
65578458|NCT03862391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65578459|NCT03862391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578460|NCT03862391|Autonomic Agents|autonomic agents|mesh-ancestor
65578461|NCT03862391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65578462|NCT03859583|Capsaicin|capsaicin|mesh-list
65578463|NCT03859583|Antipruritics|antipruritics|mesh-ancestor
65578464|NCT03859583|Dermatologic Agents|dermatologic agents|mesh-ancestor
65578465|NCT03859583|Sensory System Agents|sensory system agents|mesh-ancestor
65578466|NCT03859583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65578467|NCT03859583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578468|NCT03369262|Atosiban|atosiban|mesh-list
65578469|NCT03369262|Hormone Antagonists|hormone antagonists|mesh-ancestor
65578470|NCT03369262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65578471|NCT03369262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578472|NCT03369262|Tocolytic Agents|tocolytic agents|mesh-ancestor
65578473|NCT03369262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65578474|NCT03276078|Bromides|bromides|mesh-list
65578475|NCT03276078|Formoterol Fumarate|formoterol fumarate|mesh-list
65578476|NCT03276078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65578477|NCT03276078|Autonomic Agents|autonomic agents|mesh-ancestor
65578478|NCT03276078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65578479|NCT03276078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578480|NCT03276078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65578481|NCT03276078|Respiratory System Agents|respiratory system agents|mesh-ancestor
65578482|NCT03276078|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65578483|NCT03276078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65578484|NCT03276078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65578485|NCT03276078|Adrenergic Agents|adrenergic agents|mesh-ancestor
65578486|NCT03276078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65578487|NCT03276078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578488|NCT03276078|Anticonvulsants|anticonvulsants|mesh-ancestor
65578489|NCT01288547|Theobromine|theobromine|mesh-list
65578490|NCT01288547|Caffeine|caffeine|mesh-list
65578491|NCT01288547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65578492|NCT01288547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578493|NCT01288547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65578494|NCT01288547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578495|NCT01288547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578496|NCT01288547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65578497|NCT01288547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65578498|NCT01288547|Purinergic Agents|purinergic agents|mesh-ancestor
65578499|NCT01288547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65578500|NCT01288547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65578501|NCT01288547|Autonomic Agents|autonomic agents|mesh-ancestor
65578502|NCT01288547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65578503|NCT01288547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65578504|NCT01288547|Respiratory System Agents|respiratory system agents|mesh-ancestor
65578505|NCT01288547|Vasodilator Agents|vasodilator agents|mesh-ancestor
65578506|NCT03373864|Anesthetics|anesthetics|mesh-list
65578507|NCT03373864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65578508|NCT03373864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578509|NCT04597320|Fentanyl|fentanyl|mesh-list
65578510|NCT04597320|Midazolam|midazolam|mesh-list
65578511|NCT04597320|Esketamine|esketamine|mesh-list
65578512|NCT04597320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65578513|NCT04597320|Narcotics|narcotics|mesh-ancestor
65578514|NCT04597320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65578515|NCT04597320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578516|NCT04597320|Analgesics|analgesics|mesh-ancestor
65578517|NCT04597320|Sensory System Agents|sensory system agents|mesh-ancestor
65578518|NCT04597320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65578519|NCT04597320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65578520|NCT04597320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65578521|NCT04597320|Anesthetics, General|anesthetics, general|mesh-ancestor
65578522|NCT04597320|Anesthetics|anesthetics|mesh-ancestor
65578523|NCT04597320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65578524|NCT04597320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65578525|NCT04597320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65578526|NCT04597320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65578527|NCT04597320|GABA Modulators|gaba modulators|mesh-ancestor
65578528|NCT04597320|GABA Agents|gaba agents|mesh-ancestor
65578529|NCT04597320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65578530|NCT04597320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578531|NCT04597320|Antidepressive Agents|antidepressive agents|mesh-ancestor
65578532|NCT03373708|Tamoxifen|tamoxifen|mesh-list
65578533|NCT03373708|Cyclophosphamide|cyclophosphamide|mesh-list
65578534|NCT03373708|Docetaxel|docetaxel|mesh-list
65578535|NCT03373708|Letrozole|letrozole|mesh-list
65578536|NCT03373708|Epirubicin|epirubicin|mesh-list
65578537|NCT03373708|Goserelin|goserelin|mesh-list
65578538|NCT03373708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65578539|NCT03373708|Immunologic Factors|immunologic factors|mesh-ancestor
65578540|NCT03373708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578541|NCT03373708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65578542|NCT03373708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65578543|NCT03373708|Alkylating Agents|alkylating agents|mesh-ancestor
65578544|NCT03373708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578545|NCT03373708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578546|NCT03373708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65578547|NCT03373708|Tubulin Modulators|tubulin modulators|mesh-ancestor
65578548|NCT03373708|Antimitotic Agents|antimitotic agents|mesh-ancestor
65578549|NCT03373708|Mitosis Modulators|mitosis modulators|mesh-ancestor
65578550|NCT03373708|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65578551|NCT03373708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65578552|NCT03373708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578553|NCT03373708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65578554|NCT03373708|Hormone Antagonists|hormone antagonists|mesh-ancestor
65578555|NCT03373708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65578556|NCT03373708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65578557|NCT03373708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65578558|NCT03373708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65578559|NCT03373708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65578560|NCT03373708|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65578561|NCT03373708|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65578562|NCT03373708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65578563|NCT02519608|Aspirin|aspirin|mesh-list
65578564|NCT02519608|Clopidogrel|clopidogrel|mesh-list
65578565|NCT02519608|Ticagrelor|ticagrelor|mesh-list
65578566|NCT02519608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65578567|NCT02519608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65578568|NCT02519608|Analgesics|analgesics|mesh-ancestor
65578569|NCT02519608|Sensory System Agents|sensory system agents|mesh-ancestor
65578570|NCT02519608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65578571|NCT02519608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578572|NCT02519608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65578573|NCT02519608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65578574|NCT02519608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65578575|NCT02519608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65578576|NCT02519608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578577|NCT02519608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65578578|NCT02519608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65578579|NCT02519608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578580|NCT02519608|Antipyretics|antipyretics|mesh-ancestor
65578581|NCT02519608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65578582|NCT02519608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65578583|NCT02519608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65578584|NCT02519608|Purinergic Agents|purinergic agents|mesh-ancestor
65578585|NCT02519608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65578586|NCT05181852|Pregabalin|pregabalin|mesh-list
65578587|NCT05181852|Analgesics|analgesics|mesh-ancestor
65578588|NCT05181852|Sensory System Agents|sensory system agents|mesh-ancestor
65578589|NCT05181852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65578590|NCT05181852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578591|NCT05181852|Anticonvulsants|anticonvulsants|mesh-ancestor
65578592|NCT05181852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65578593|NCT05181852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65248390|NCT02841488|Narcotics|narcotics|mesh-ancestor
65578594|NCT05181852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578595|NCT05181852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65578596|NCT05181852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65578597|NCT05181852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65578598|NCT05181852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65578599|NCT05181852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65578600|NCT04584684|Ethanol|ethanol|mesh-list
65578601|NCT04584684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65578602|NCT04584684|Cetylpyridinium|cetylpyridinium|mesh-list
65578603|NCT04584684|Povidone|povidone|mesh-list
65578604|NCT04584684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65578605|NCT04584684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65578606|NCT04584684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65578607|NCT04584684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578608|NCT04584684|Plasma Substitutes|plasma substitutes|mesh-ancestor
65578609|NCT04584684|Blood Substitutes|blood substitutes|mesh-ancestor
65578611|NCT03748823|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65578612|NCT03748823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65578613|NCT03748823|Immunologic Factors|immunologic factors|mesh-ancestor
65578614|NCT03748823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578615|NCT03373318|Plasma-lyte 148|plasma-lyte 148|mesh-list
65578616|NCT03373318|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65578617|NCT03373318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65578618|NCT03124420|Amoxicillin|amoxicillin|mesh-list
65578619|NCT03124420|Clarithromycin|clarithromycin|mesh-list
65578620|NCT03124420|Lansoprazole|lansoprazole|mesh-list
65578621|NCT03124420|Dexlansoprazole|dexlansoprazole|mesh-list
65578622|NCT03124420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65578623|NCT03124420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65578624|NCT03124420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65578625|NCT03124420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578626|NCT03124420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578627|NCT03124420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65578628|NCT03124420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65578629|NCT03124420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65578630|NCT03124420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65578631|NCT03124420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65578632|NCT03231228|Cefazolin|cefazolin|mesh-list
65578633|NCT03231228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65578634|NCT03231228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65578635|NCT03510468|Pyridoxine|pyridoxine|mesh-list
65578636|NCT03510468|Isoniazid|isoniazid|mesh-list
65578637|NCT03510468|Rifapentine|rifapentine|mesh-list
65578638|NCT03510468|Antitubercular Agents|antitubercular agents|mesh-ancestor
65578639|NCT03510468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65578640|NCT03510468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65578641|NCT03510468|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65578642|NCT03510468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65578643|NCT03510468|Antimetabolites|antimetabolites|mesh-ancestor
65578644|NCT03510468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578645|NCT03510468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65578646|NCT03510468|Vitamin B Complex|vitamin b complex|mesh-ancestor
65578647|NCT03510468|Vitamins|vitamins|mesh-ancestor
65578648|NCT03510468|Micronutrients|micronutrients|mesh-ancestor
65578649|NCT03510468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578650|NCT03510468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65578651|NCT03510468|Leprostatic Agents|leprostatic agents|mesh-ancestor
65578652|NCT01178645|Cytarabine|cytarabine|mesh-list
65578653|NCT01178645|Etoposide|etoposide|mesh-list
65578654|NCT01178645|Melphalan|melphalan|mesh-list
65578655|NCT01178645|Busulfan|busulfan|mesh-list
65578656|NCT01178645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65578657|NCT01178645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578658|NCT01178645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65578659|NCT01178645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65578660|NCT01178645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578661|NCT01178645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578662|NCT01178645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65578663|NCT01178645|Antimetabolites|antimetabolites|mesh-ancestor
65578664|NCT01178645|Antiviral Agents|antiviral agents|mesh-ancestor
65578665|NCT01178645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65578666|NCT01178645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65578667|NCT01178645|Immunologic Factors|immunologic factors|mesh-ancestor
65578668|NCT01178645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578669|NCT01178645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65578670|NCT01178645|Alkylating Agents|alkylating agents|mesh-ancestor
65578671|NCT01178645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65578672|NCT01285505|Alprazolam|alprazolam|mesh-list
65578673|NCT01285505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65578674|NCT01285505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65578675|NCT01285505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578676|NCT01285505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65578677|NCT01285505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65578678|NCT01285505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65578679|NCT01285505|GABA Modulators|gaba modulators|mesh-ancestor
65578680|NCT01285505|GABA Agents|gaba agents|mesh-ancestor
65578681|NCT01285505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65578682|NCT01285505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578683|NCT03372850|Esomeprazole|esomeprazole|mesh-list
65578684|NCT03372850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65578685|NCT03372850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65578686|NCT03372850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65578687|NCT03372850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578688|NCT03372850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578689|NCT04525066|Hyaluronic Acid|hyaluronic acid|mesh-list
65578690|NCT04525066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65578691|NCT04525066|Immunologic Factors|immunologic factors|mesh-ancestor
65578692|NCT04525066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578693|NCT04525066|Viscosupplements|viscosupplements|mesh-ancestor
65578694|NCT04525066|Protective Agents|protective agents|mesh-ancestor
65578695|NCT03230838|Meropenem|meropenem|mesh-list
65578696|NCT03230838|Tazobactam|tazobactam|mesh-list
65578697|NCT03230838|Ceftolozane|ceftolozane|mesh-list
65578698|NCT03230838|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
65578699|NCT03230838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65578700|NCT03230838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65578701|NCT03230838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65578702|NCT03230838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578703|NCT03230838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578704|NCT03230838|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65578705|NCT03230838|Renal Agents|renal agents|mesh-ancestor
65578706|NCT03362788|Vitamin K|vitamin k|mesh-list
65578707|NCT03362788|Anticoagulants|anticoagulants|mesh-list
65578708|NCT03362788|Vitamins|vitamins|mesh-ancestor
65578709|NCT03362788|Micronutrients|micronutrients|mesh-ancestor
65578710|NCT03362788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578711|NCT03362788|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65578712|NCT03362788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65578713|NCT03362788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578714|NCT03362788|Hemostatics|hemostatics|mesh-ancestor
65578715|NCT03362788|Coagulants|coagulants|mesh-ancestor
65578716|NCT03368794|Analgesics, Opioid|analgesics, opioid|mesh-list
65578717|NCT03368794|Narcotics|narcotics|mesh-ancestor
65578718|NCT03368794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65578719|NCT03368794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578720|NCT03368794|Analgesics|analgesics|mesh-ancestor
65578721|NCT03368794|Sensory System Agents|sensory system agents|mesh-ancestor
65578722|NCT03368794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65578723|NCT03862079|Tazobactam|tazobactam|mesh-list
65578724|NCT03862079|Piperacillin|piperacillin|mesh-list
65578725|NCT03862079|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65578726|NCT03862079|Nystatin|nystatin|mesh-list
65578727|NCT03862079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65578728|NCT03862079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65578729|NCT03862079|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65578730|NCT03862079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578731|NCT03862079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578732|NCT03862079|Antifungal Agents|antifungal agents|mesh-ancestor
65578733|NCT03862079|Ionophores|ionophores|mesh-ancestor
65578734|NCT03862079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65578735|NCT03362632|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65578736|NCT03362632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65578737|NCT01179269|Paclitaxel|paclitaxel|mesh-list
65578738|NCT01179269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65578739|NCT01179269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578740|NCT01179269|Tubulin Modulators|tubulin modulators|mesh-ancestor
65578741|NCT01179269|Antimitotic Agents|antimitotic agents|mesh-ancestor
65578742|NCT01179269|Mitosis Modulators|mitosis modulators|mesh-ancestor
65578743|NCT01179269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578744|NCT00165724|Donepezil|donepezil|mesh-list
65578745|NCT00165724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65578746|NCT00165724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578747|NCT00165724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578748|NCT00165724|Cholinergic Agents|cholinergic agents|mesh-ancestor
65578749|NCT00165724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65578750|NCT00165724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578751|NCT00165724|Nootropic Agents|nootropic agents|mesh-ancestor
65578752|NCT01287455|Vitamin D|vitamin d|mesh-list
65578753|NCT01287455|Cholecalciferol|cholecalciferol|mesh-list
65578754|NCT01287455|Vitamins|vitamins|mesh-ancestor
65578755|NCT01287455|Micronutrients|micronutrients|mesh-ancestor
65578756|NCT01287455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578757|NCT01287455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65578758|NCT01287455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65578759|NCT04965090|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
65578760|NCT04965090|Lazertinib|lazertinib|mesh-list
65578761|NCT04965090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65578762|NCT04965090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578763|NCT04965090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578764|NCT04965090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65578765|NCT04965090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578766|NCT03865511|Osimertinib|osimertinib|mesh-list
65578767|NCT03865511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578768|NCT03865511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65578769|NCT03865511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578770|NCT03865511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578771|NCT03498612|Pembrolizumab|pembrolizumab|mesh-list
65578772|NCT03498612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65578773|NCT03498612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578774|NCT01287533|Ibandronic Acid|ibandronic acid|mesh-list
65578775|NCT01287533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65578776|NCT01287533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578777|NCT03368404|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65578778|NCT03368404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65578779|NCT01287689|Immunoglobulins|immunoglobulins|mesh-list
65578780|NCT01287689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65578781|NCT01287689|Antibodies|antibodies|mesh-list
65578782|NCT01287689|Immunoglobulin G|immunoglobulin g|mesh-list
65578783|NCT01287689|Immunologic Factors|immunologic factors|mesh-ancestor
65578784|NCT01287689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578785|NCT01179503|Calcium, Dietary|calcium, dietary|mesh-list
65578786|NCT01179503|Vitamin D|vitamin d|mesh-list
65578787|NCT01179503|Calcium|calcium|mesh-list
65578788|NCT01179503|Vitamins|vitamins|mesh-ancestor
65578789|NCT01179503|Micronutrients|micronutrients|mesh-ancestor
65578790|NCT01179503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578791|NCT01179503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65578792|NCT01179503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65578793|NCT03117049|Paclitaxel|paclitaxel|mesh-list
65578794|NCT03117049|Bevacizumab|bevacizumab|mesh-list
65578795|NCT03117049|Carboplatin|carboplatin|mesh-list
65578796|NCT03117049|Nivolumab|nivolumab|mesh-list
65578797|NCT03117049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65578798|NCT03117049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578799|NCT03117049|Tubulin Modulators|tubulin modulators|mesh-ancestor
65578800|NCT03117049|Antimitotic Agents|antimitotic agents|mesh-ancestor
65578801|NCT03117049|Mitosis Modulators|mitosis modulators|mesh-ancestor
65578802|NCT03117049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578803|NCT03117049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65578804|NCT03117049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65578805|NCT03117049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65578806|NCT03117049|Growth Substances|growth substances|mesh-ancestor
65578807|NCT03117049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578808|NCT03117049|Growth Inhibitors|growth inhibitors|mesh-ancestor
65578809|NCT03117049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65578810|NCT03372304|Ropivacaine|ropivacaine|mesh-list
65578811|NCT03372304|Anesthetics, Local|anesthetics, local|mesh-ancestor
65578812|NCT03372304|Anesthetics|anesthetics|mesh-ancestor
65578813|NCT03372304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65578814|NCT03372304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578815|NCT03372304|Sensory System Agents|sensory system agents|mesh-ancestor
65578816|NCT03372304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65578817|NCT02525081|Ramipril|ramipril|mesh-list
65578818|NCT02525081|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65578819|NCT02525081|Protease Inhibitors|protease inhibitors|mesh-ancestor
65578820|NCT02525081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578821|NCT02525081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578822|NCT02525081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65578823|NCT05566548|Bilirubin|bilirubin|mesh-list
65578824|NCT05566548|Antioxidants|antioxidants|mesh-ancestor
65578825|NCT05566548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578826|NCT05566548|Protective Agents|protective agents|mesh-ancestor
65578827|NCT05566548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578828|NCT02525003|Vitamin D|vitamin d|mesh-list
65578829|NCT02525003|Ergocalciferols|ergocalciferols|mesh-list
65578830|NCT02525003|Cholecalciferol|cholecalciferol|mesh-list
65578831|NCT02525003|Vitamins|vitamins|mesh-list
65578832|NCT02525003|Micronutrients|micronutrients|mesh-ancestor
65578833|NCT02525003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578834|NCT02525003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65578835|NCT02525003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65578836|NCT05181150|Glucagon|glucagon|mesh-list
65578837|NCT05181150|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65578838|NCT05181150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65578839|NCT05181150|Hormones|hormones|mesh-ancestor
65578840|NCT05181150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65578841|NCT05181150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578842|NCT05181150|Incretins|incretins|mesh-ancestor
65578843|NCT03464448|Teriflunomide|teriflunomide|mesh-list
65578844|NCT03464448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65578845|NCT03464448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65578846|NCT03464448|Analgesics|analgesics|mesh-ancestor
65578847|NCT03464448|Sensory System Agents|sensory system agents|mesh-ancestor
65578848|NCT03464448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65578849|NCT03464448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578850|NCT03464448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65578851|NCT03464448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65578852|NCT03464448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65578853|NCT03464448|Immunologic Factors|immunologic factors|mesh-ancestor
65578854|NCT03362008|Varenicline|varenicline|mesh-list
65578855|NCT03362008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65578856|NCT03362008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65578857|NCT03362008|Cholinergic Agents|cholinergic agents|mesh-ancestor
65578858|NCT03362008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65578859|NCT03362008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578860|NCT03362008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578861|NCT03123406|Cinacalcet|cinacalcet|mesh-list
65578862|NCT03123406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65578863|NCT03123406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578864|NCT03123406|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65578865|NCT03123406|Hormone Antagonists|hormone antagonists|mesh-ancestor
65578866|NCT03123406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65578867|NCT01179659|Pantoprazole|pantoprazole|mesh-list
65578868|NCT01179659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65578869|NCT01179659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65578870|NCT01179659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65578871|NCT01179659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578872|NCT01179659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578873|NCT04523818|Fluorouracil|fluorouracil|mesh-list
65578874|NCT04523818|Capecitabine|capecitabine|mesh-list
65578875|NCT04523818|Antimetabolites|antimetabolites|mesh-ancestor
65578876|NCT04523818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578877|NCT04523818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65578878|NCT04523818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578879|NCT04523818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65578880|NCT04523818|Immunologic Factors|immunologic factors|mesh-ancestor
65578881|NCT04523818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578882|NCT03361774|Fluorides|fluorides|mesh-list
65578883|NCT03361774|Cariostatic Agents|cariostatic agents|mesh-ancestor
65578884|NCT03361774|Protective Agents|protective agents|mesh-ancestor
65578885|NCT03361774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578886|NCT04523740|Acetaminophen|acetaminophen|mesh-list
65578887|NCT04523740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65578888|NCT04523740|Analgesics|analgesics|mesh-ancestor
65578889|NCT04523740|Sensory System Agents|sensory system agents|mesh-ancestor
65578890|NCT04523740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65578891|NCT04523740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578892|NCT04523740|Antipyretics|antipyretics|mesh-ancestor
65578893|NCT03410706|Rivaroxaban|rivaroxaban|mesh-list
65578894|NCT03410706|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65578895|NCT03410706|Antithrombins|antithrombins|mesh-ancestor
65578896|NCT03410706|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65578897|NCT03410706|Protease Inhibitors|protease inhibitors|mesh-ancestor
65578898|NCT03410706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248391|NCT02841488|Analgesics|analgesics|mesh-ancestor
65578899|NCT03410706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578900|NCT03410706|Anticoagulants|anticoagulants|mesh-ancestor
65578901|NCT04523662|Apatinib|apatinib|mesh-list
65578902|NCT04523662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578903|NCT04523662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65578904|NCT04523662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578905|NCT04523662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578906|NCT03371992|Pembrolizumab|pembrolizumab|mesh-list
65578907|NCT03371992|Nivolumab|nivolumab|mesh-list
65578908|NCT03371992|Atezolizumab|atezolizumab|mesh-list
65578909|NCT03371992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65578910|NCT03371992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578911|NCT03371992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65578912|NCT03371992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376426|NCT00804830|Growth Substances|growth substances|mesh-ancestor
65578914|NCT03682705|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65578915|NCT03682705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65578916|NCT03682705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578917|NCT03682705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578918|NCT03682705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65578919|NCT03361618|Zinc Sulfate|zinc sulfate|mesh-list
65578920|NCT03361618|Astringents|astringents|mesh-ancestor
65578921|NCT03361618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578922|NCT03361618|Dermatologic Agents|dermatologic agents|mesh-ancestor
65578923|NCT01314495|Abatacept|abatacept|mesh-list
65578924|NCT01314495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65578925|NCT01314495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578926|NCT01314495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578927|NCT01314495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65578928|NCT01314495|Immunologic Factors|immunologic factors|mesh-ancestor
65578929|NCT01314495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578930|NCT01314495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65578931|NCT03123484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65578932|NCT03123484|Gefitinib|gefitinib|mesh-list
65578933|NCT03123484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578934|NCT03123484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65578935|NCT03123484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65578936|NCT03123484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578937|NCT03179787|Aripiprazole|aripiprazole|mesh-list
65578938|NCT03179787|Antidepressive Agents|antidepressive agents|mesh-ancestor
65578939|NCT03179787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65578940|NCT03179787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65578941|NCT03179787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65578942|NCT03179787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65578943|NCT03179787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578944|NCT03179787|Dopamine Agonists|dopamine agonists|mesh-ancestor
65578945|NCT03179787|Dopamine Agents|dopamine agents|mesh-ancestor
65578946|NCT03179787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65578947|NCT03179787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578948|NCT03179787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65578949|NCT03179787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65578950|NCT03179787|Serotonin Agents|serotonin agents|mesh-ancestor
65578951|NCT03179787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65578952|NCT03179787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65578953|NCT03179787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65578954|NCT03179787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65578955|NCT02956057|Ascorbic Acid|ascorbic acid|mesh-list
65578956|NCT02956057|Picosulfate sodium|picosulfate sodium|mesh-list
65578957|NCT02956057|Magnesium citrate|magnesium citrate|mesh-list
65578958|NCT02956057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578959|NCT02956057|Antioxidants|antioxidants|mesh-ancestor
65578960|NCT02956057|Protective Agents|protective agents|mesh-ancestor
65578961|NCT02956057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578962|NCT02956057|Vitamins|vitamins|mesh-ancestor
65578963|NCT02956057|Micronutrients|micronutrients|mesh-ancestor
65578964|NCT02956057|Cathartics|cathartics|mesh-ancestor
65578965|NCT02956057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65578966|NCT04526470|Paclitaxel|paclitaxel|mesh-list
65578967|NCT04526470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65578968|NCT04526470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65578969|NCT04526470|Tubulin Modulators|tubulin modulators|mesh-ancestor
65578970|NCT04526470|Antimitotic Agents|antimitotic agents|mesh-ancestor
65578971|NCT04526470|Mitosis Modulators|mitosis modulators|mesh-ancestor
65578972|NCT04526470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578973|NCT03367390|Insulin Lispro|insulin lispro|mesh-list
65578974|NCT03367390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65578975|NCT03367390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578976|NCT01176851|Glycopyrrolate|glycopyrrolate|mesh-list
65578977|NCT01176851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65578978|NCT01176851|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65578979|NCT01176851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65578980|NCT01176851|Cholinergic Agents|cholinergic agents|mesh-ancestor
65578981|NCT01176851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65578982|NCT01176851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65578983|NCT01176851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578984|NCT04526236|Methadone|methadone|mesh-list
65578985|NCT04526236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65578986|NCT04526236|Narcotics|narcotics|mesh-ancestor
65578987|NCT04526236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65578988|NCT04526236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65578989|NCT04526236|Analgesics|analgesics|mesh-ancestor
65578990|NCT04526236|Sensory System Agents|sensory system agents|mesh-ancestor
65578991|NCT04526236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65578992|NCT04526236|Antitussive Agents|antitussive agents|mesh-ancestor
65578993|NCT04526236|Respiratory System Agents|respiratory system agents|mesh-ancestor
65578994|NCT01179971|Evening primrose oil|evening primrose oil|mesh-list
65578995|NCT01179971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65578996|NCT01179971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65578997|NCT01179971|Analgesics|analgesics|mesh-ancestor
65578998|NCT01179971|Sensory System Agents|sensory system agents|mesh-ancestor
65578999|NCT01179971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579000|NCT01179971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579001|NCT01179971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65579002|NCT01179971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65579003|NCT01179971|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65579004|NCT01179971|Antimetabolites|antimetabolites|mesh-ancestor
65579005|NCT01179971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579006|NCT01179971|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65579007|NCT01179971|Dermatologic Agents|dermatologic agents|mesh-ancestor
65579008|NCT04237584|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65579009|NCT04237584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65579010|NCT03681691|Estradiol|estradiol|mesh-list
65579011|NCT03681691|Estrogens|estrogens|mesh-ancestor
65579012|NCT03681691|Hormones|hormones|mesh-ancestor
65579013|NCT03681691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65579014|NCT03681691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579015|NCT01289171|Glycolic acid|glycolic acid|mesh-list
65579016|NCT01289171|Keratolytic Agents|keratolytic agents|mesh-ancestor
65579017|NCT01289171|Dermatologic Agents|dermatologic agents|mesh-ancestor
65579018|NCT03360760|Doxorubicin|doxorubicin|mesh-list
65579019|NCT03360760|Methotrexate|methotrexate|mesh-list
65579020|NCT03360760|Ifosfamide|ifosfamide|mesh-list
65579021|NCT03360760|Isophosphamide mustard|isophosphamide mustard|mesh-list
65579022|NCT03360760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65579023|NCT03360760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65579024|NCT03360760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65579025|NCT03360760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65579026|NCT03360760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579027|NCT03360760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579028|NCT03360760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65579029|NCT03360760|Abortifacient Agents|abortifacient agents|mesh-ancestor
65579030|NCT03360760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65579031|NCT03360760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579032|NCT03360760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65579033|NCT03360760|Antimetabolites|antimetabolites|mesh-ancestor
65579034|NCT03360760|Dermatologic Agents|dermatologic agents|mesh-ancestor
65579035|NCT03360760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65579036|NCT03360760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65579037|NCT03360760|Immunologic Factors|immunologic factors|mesh-ancestor
65579038|NCT03360760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65579039|NCT03360760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65579040|NCT03360760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65579041|NCT03360760|Alkylating Agents|alkylating agents|mesh-ancestor
65579042|NCT01285661|Vitamin K|vitamin k|mesh-list
65579043|NCT01285661|Warfarin|warfarin|mesh-list
65579044|NCT01285661|Anticoagulants|anticoagulants|mesh-list
65579045|NCT01285661|Vitamins|vitamins|mesh-ancestor
65579046|NCT01285661|Micronutrients|micronutrients|mesh-ancestor
65579047|NCT01285661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579048|NCT01285661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65579049|NCT01285661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65579050|NCT01285661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579051|NCT01285661|Hemostatics|hemostatics|mesh-ancestor
65579052|NCT01285661|Coagulants|coagulants|mesh-ancestor
65579053|NCT03360682|Tenofovir|tenofovir|mesh-list
65579054|NCT03360682|Lamivudine|lamivudine|mesh-list
65579055|NCT03360682|Emtricitabine|emtricitabine|mesh-list
65579056|NCT03360682|Dolutegravir|dolutegravir|mesh-list
65579057|NCT03360682|Abacavir|abacavir|mesh-list
65579058|NCT03360682|Antiviral Agents|antiviral agents|mesh-ancestor
65579059|NCT03360682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65376574|NCT02553044|Vitamins|vitamins|mesh-ancestor
65579060|NCT03360682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65579061|NCT03360682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65579062|NCT03360682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579063|NCT03360682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579064|NCT03360682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65579065|NCT03360682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65579066|NCT03360682|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65579067|NCT03360682|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65579068|NCT01180205|Amlodipine|amlodipine|mesh-list
65579069|NCT01180205|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65579070|NCT01180205|Telmisartan|telmisartan|mesh-list
65579071|NCT01180205|Olmesartan|olmesartan|mesh-list
65579072|NCT01180205|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65579073|NCT01180205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65579074|NCT01180205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65579075|NCT01180205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65579076|NCT01180205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579077|NCT01180205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65579078|NCT01180205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579079|NCT01180205|Vasodilator Agents|vasodilator agents|mesh-ancestor
65579080|NCT01180205|Diuretics|diuretics|mesh-ancestor
65579081|NCT01180205|Natriuretic Agents|natriuretic agents|mesh-ancestor
65579082|NCT01180205|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65579083|NCT01180205|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65579084|NCT01180205|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65579085|NCT04523506|Botulinum Toxins|botulinum toxins|mesh-list
65579086|NCT04523506|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65579087|NCT04523506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65579088|NCT04523506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579089|NCT04523506|Cholinergic Agents|cholinergic agents|mesh-ancestor
65579090|NCT04523506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65579091|NCT04523506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579092|NCT03867084|Pembrolizumab|pembrolizumab|mesh-list
65579093|NCT03867084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65579094|NCT03867084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65579095|NCT03860831|Midazolam|midazolam|mesh-list
65579096|NCT03860831|Ketamine|ketamine|mesh-list
65579097|NCT03860831|Analgesics|analgesics|mesh-ancestor
65579098|NCT03860831|Sensory System Agents|sensory system agents|mesh-ancestor
65579099|NCT03860831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579100|NCT03860831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579101|NCT03860831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65579102|NCT03860831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65579103|NCT03860831|Anesthetics, General|anesthetics, general|mesh-ancestor
65579104|NCT03860831|Anesthetics|anesthetics|mesh-ancestor
65579105|NCT03860831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65579106|NCT03860831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65579107|NCT03860831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65579108|NCT03860831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65579109|NCT03860831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579110|NCT03860831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65579111|NCT03860831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65579112|NCT03860831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65579113|NCT03860831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65579114|NCT03860831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65579115|NCT03860831|GABA Modulators|gaba modulators|mesh-ancestor
65579116|NCT03860831|GABA Agents|gaba agents|mesh-ancestor
65579117|NCT04006210|Levodopa|levodopa|mesh-list
65579118|NCT04006210|Carbidopa|carbidopa|mesh-list
65579119|NCT04006210|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65579120|NCT04006210|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65579121|NCT04006210|Dopamine Agents|dopamine agents|mesh-ancestor
65579122|NCT04006210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65579123|NCT04006210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579124|NCT04006210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579125|NCT04006210|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65579126|NCT04006210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579127|NCT01064479|Cisplatin|cisplatin|mesh-list
65579128|NCT01064479|Carboplatin|carboplatin|mesh-list
65579129|NCT01064479|Docetaxel|docetaxel|mesh-list
65579130|NCT01064479|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65579131|NCT01064479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65579132|NCT01064479|Tubulin Modulators|tubulin modulators|mesh-ancestor
65579133|NCT01064479|Antimitotic Agents|antimitotic agents|mesh-ancestor
65579134|NCT01064479|Mitosis Modulators|mitosis modulators|mesh-ancestor
65579135|NCT01064479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579136|NCT01064479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65579137|NCT01064479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579138|NCT04218708|Nicotine|nicotine|mesh-list
65579139|NCT04218708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65579140|NCT04218708|Autonomic Agents|autonomic agents|mesh-ancestor
65579141|NCT04218708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579142|NCT04218708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579143|NCT04218708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65579144|NCT04218708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65579145|NCT04218708|Cholinergic Agents|cholinergic agents|mesh-ancestor
65579146|NCT04218708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65579147|NCT04218708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579148|NCT03667326|Aspirin|aspirin|mesh-list
65579149|NCT03667326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65579150|NCT03667326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65579151|NCT03667326|Analgesics|analgesics|mesh-ancestor
65579152|NCT03667326|Sensory System Agents|sensory system agents|mesh-ancestor
65579153|NCT03667326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579154|NCT03667326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579155|NCT03667326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65579156|NCT03667326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65579157|NCT03667326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65579158|NCT03667326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65579159|NCT03667326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579160|NCT03667326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65579161|NCT03667326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65579162|NCT03667326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579163|NCT03667326|Antipyretics|antipyretics|mesh-ancestor
65579164|NCT04525300|Liraglutide|liraglutide|mesh-list
65579165|NCT04525300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65579166|NCT04525300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579167|NCT04525300|Incretins|incretins|mesh-ancestor
65579168|NCT04525300|Hormones|hormones|mesh-ancestor
65579169|NCT04525300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65579170|NCT05305248|Dexmedetomidine|dexmedetomidine|mesh-list
65579171|NCT05305248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65579172|NCT05305248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65579173|NCT05305248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579174|NCT05305248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65579175|NCT05305248|Analgesics|analgesics|mesh-ancestor
65579176|NCT05305248|Sensory System Agents|sensory system agents|mesh-ancestor
65579177|NCT05305248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579178|NCT05305248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65579179|NCT05305248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65579180|NCT05305248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65579181|NCT05305248|Adrenergic Agents|adrenergic agents|mesh-ancestor
65579182|NCT05305248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65579183|NCT05305248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579184|NCT03865121|Nicotine|nicotine|mesh-list
65579185|NCT03865121|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65579186|NCT03865121|Autonomic Agents|autonomic agents|mesh-ancestor
65579187|NCT03865121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579188|NCT03865121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579189|NCT03865121|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65579190|NCT03865121|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65579191|NCT03865121|Cholinergic Agents|cholinergic agents|mesh-ancestor
65579192|NCT03865121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65579193|NCT03865121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579194|NCT03680911|Acetylcysteine|acetylcysteine|mesh-list
65579195|NCT03680911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65579196|NCT03680911|Antiviral Agents|antiviral agents|mesh-ancestor
65579197|NCT03680911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65579198|NCT03680911|Expectorants|expectorants|mesh-ancestor
65579199|NCT03680911|Respiratory System Agents|respiratory system agents|mesh-ancestor
65579200|NCT03680911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65579201|NCT03680911|Antioxidants|antioxidants|mesh-ancestor
65579202|NCT03680911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579203|NCT03680911|Protective Agents|protective agents|mesh-ancestor
65579204|NCT03680911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579205|NCT03680911|Antidotes|antidotes|mesh-ancestor
65579206|NCT03370588|Dexmedetomidine|dexmedetomidine|mesh-list
65579207|NCT03370588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65579208|NCT03370588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65579209|NCT03370588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579210|NCT03370588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65579211|NCT03370588|Analgesics|analgesics|mesh-ancestor
65579212|NCT03370588|Sensory System Agents|sensory system agents|mesh-ancestor
65579213|NCT03370588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579214|NCT03370588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65579215|NCT03370588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65579216|NCT03370588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65579217|NCT03370588|Adrenergic Agents|adrenergic agents|mesh-ancestor
65579218|NCT03370588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65579219|NCT03370588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579220|NCT05156814|Dydrogesterone|dydrogesterone|mesh-list
65579221|NCT05156814|Progestins|progestins|mesh-ancestor
65579222|NCT05156814|Hormones|hormones|mesh-ancestor
65579223|NCT05156814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65579224|NCT05156814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579225|NCT01289483|Fospropofol|fospropofol|mesh-list
65579226|NCT01289483|Propofol|propofol|mesh-list
65579227|NCT01289483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65579228|NCT01289483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65579229|NCT01289483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579230|NCT01289483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65579231|NCT01289483|Anesthetics, General|anesthetics, general|mesh-ancestor
65579232|NCT01289483|Anesthetics|anesthetics|mesh-ancestor
65579233|NCT03680521|Nivolumab|nivolumab|mesh-list
65579234|NCT03680521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65579235|NCT03680521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65579236|NCT03680521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65579237|NCT03680521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579238|NCT01289327|Midazolam|midazolam|mesh-list
65579239|NCT01289327|Alfentanil|alfentanil|mesh-list
65579240|NCT01289327|Propofol|propofol|mesh-list
65579241|NCT01289327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65579242|NCT01289327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65579243|NCT01289327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579244|NCT01289327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65579245|NCT01289327|Anesthetics, General|anesthetics, general|mesh-ancestor
65579246|NCT01289327|Anesthetics|anesthetics|mesh-ancestor
65579247|NCT01289327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65579248|NCT01289327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65579249|NCT01289327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65579250|NCT01289327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65579251|NCT01289327|GABA Modulators|gaba modulators|mesh-ancestor
65579252|NCT01289327|GABA Agents|gaba agents|mesh-ancestor
65579253|NCT01289327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65579254|NCT01289327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579255|NCT01289327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65579256|NCT01289327|Narcotics|narcotics|mesh-ancestor
65579257|NCT01289327|Analgesics|analgesics|mesh-ancestor
65579258|NCT01289327|Sensory System Agents|sensory system agents|mesh-ancestor
65579259|NCT01289327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579260|NCT01181063|Budesonide|budesonide|mesh-list
65579261|NCT01181063|Formoterol Fumarate|formoterol fumarate|mesh-list
65579262|NCT01181063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65579263|NCT01181063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65579264|NCT01181063|Autonomic Agents|autonomic agents|mesh-ancestor
65579265|NCT01181063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579266|NCT01181063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579267|NCT01181063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65579268|NCT01181063|Respiratory System Agents|respiratory system agents|mesh-ancestor
65579269|NCT01181063|Glucocorticoids|glucocorticoids|mesh-ancestor
65579270|NCT01181063|Hormones|hormones|mesh-ancestor
65579271|NCT01181063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65579272|NCT01181063|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65579273|NCT01181063|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65579274|NCT01181063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65579275|NCT01181063|Adrenergic Agents|adrenergic agents|mesh-ancestor
65579276|NCT01181063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65579277|NCT01181063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579278|NCT02596997|Brincidofovir|brincidofovir|mesh-list
65579279|NCT02596997|Antiviral Agents|antiviral agents|mesh-ancestor
65579280|NCT02596997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65579281|NCT03649477|Carbetocin|carbetocin|mesh-list
65579282|NCT03649477|Oxytocin|oxytocin|mesh-list
65579283|NCT03649477|Oxytocics|oxytocics|mesh-ancestor
65579284|NCT03649477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65579285|NCT03649477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579286|NCT03359746|Grazoprevir|grazoprevir|mesh-list
65579287|NCT03359746|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65579288|NCT03359746|Antiviral Agents|antiviral agents|mesh-ancestor
65579289|NCT03359746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65579290|NCT01310101|Dexamethasone|dexamethasone|mesh-list
65579291|NCT01310101|Ofatumumab|ofatumumab|mesh-list
65579292|NCT01310101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65579293|NCT01310101|Antiemetics|antiemetics|mesh-ancestor
65579294|NCT01310101|Autonomic Agents|autonomic agents|mesh-ancestor
65579295|NCT01310101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579296|NCT01310101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579297|NCT01310101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65579298|NCT01310101|Glucocorticoids|glucocorticoids|mesh-ancestor
65579299|NCT01310101|Hormones|hormones|mesh-ancestor
65579300|NCT01310101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65579301|NCT01310101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65579302|NCT01310101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65579303|NCT03639727|Mannitol|mannitol|mesh-list
65579304|NCT03639727|Citric Acid|citric acid|mesh-list
65579305|NCT03639727|Sodium Citrate|sodium citrate|mesh-list
65579306|NCT03639727|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65579307|NCT03639727|Diuretics|diuretics|mesh-ancestor
65579308|NCT03639727|Natriuretic Agents|natriuretic agents|mesh-ancestor
65579309|NCT03639727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579310|NCT03639727|Anticoagulants|anticoagulants|mesh-ancestor
65579311|NCT03639727|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65579312|NCT03639727|Chelating Agents|chelating agents|mesh-ancestor
65579313|NCT03639727|Sequestering Agents|sequestering agents|mesh-ancestor
65579314|NCT03639727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579315|NCT01180751|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65579316|NCT01180751|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65579317|NCT01180751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579318|NCT04523272|Sunitinib|sunitinib|mesh-list
65579319|NCT04523272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65579320|NCT04523272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65579321|NCT04523272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65579322|NCT04523272|Growth Substances|growth substances|mesh-ancestor
65579323|NCT04523272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579324|NCT04523272|Growth Inhibitors|growth inhibitors|mesh-ancestor
65579325|NCT04523272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65579326|NCT04523272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579327|NCT04523272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579328|NCT01289561|Ethanol|ethanol|mesh-list
65579329|NCT01289561|Quinine|quinine|mesh-list
65579330|NCT01289561|Caffeine|caffeine|mesh-list
65579331|NCT01289561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65579332|NCT01289561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65579333|NCT01289561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65579334|NCT01289561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579335|NCT01289561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65579336|NCT01289561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65579337|NCT01289561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579338|NCT01289561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579339|NCT01289561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65579340|NCT01289561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65579341|NCT01289561|Purinergic Agents|purinergic agents|mesh-ancestor
65579342|NCT01289561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65579343|NCT01289561|Antimalarials|antimalarials|mesh-ancestor
65579344|NCT01289561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65579345|NCT01289561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65579346|NCT01289561|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65579347|NCT01289561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65579348|NCT01289561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579349|NCT01289561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65579350|NCT01289561|Analgesics|analgesics|mesh-ancestor
65579351|NCT01289561|Sensory System Agents|sensory system agents|mesh-ancestor
65579352|NCT03855527|Chlorhexidine|chlorhexidine|mesh-list
65579353|NCT03855527|Fluorides|fluorides|mesh-list
65579354|NCT03855527|Cariostatic Agents|cariostatic agents|mesh-ancestor
65579355|NCT03855527|Protective Agents|protective agents|mesh-ancestor
65579356|NCT03855527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579357|NCT03855527|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65579358|NCT03855527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65579359|NCT03855527|Disinfectants|disinfectants|mesh-ancestor
65579360|NCT03366064|Pemetrexed|pemetrexed|mesh-list
65579361|NCT03366064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65579362|NCT03366064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579363|NCT03366064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579364|NCT03366064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65579365|NCT03366064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65376871|NCT00652028|GABA Agents|gaba agents|mesh-ancestor
65579366|NCT03677401|Serlopitant|serlopitant|mesh-list
65579367|NCT03677401|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65579368|NCT03677401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65579369|NCT03677401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579370|NCT03677401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579371|NCT03357874|Clopidogrel|clopidogrel|mesh-list
65579372|NCT03357874|Ticagrelor|ticagrelor|mesh-list
65579373|NCT03357874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65579374|NCT03357874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65579375|NCT03357874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65579376|NCT03357874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65579377|NCT03357874|Purinergic Agents|purinergic agents|mesh-ancestor
65579378|NCT03357874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65579379|NCT03357874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579380|NCT03357874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579381|NCT01286051|Ganirelix|ganirelix|mesh-list
65579382|NCT01286051|Hormone Antagonists|hormone antagonists|mesh-ancestor
65579383|NCT01286051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65579384|NCT01286051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579385|NCT03357796|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65579386|NCT03357796|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65579387|NCT03357796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65579388|NCT03357796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65579389|NCT03357796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579390|NCT03357796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65579391|NCT03357796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579392|NCT03357796|Antidepressive Agents|antidepressive agents|mesh-ancestor
65579393|NCT03357796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65579394|NCT02359513|Fluoxetine|fluoxetine|mesh-list
65579395|NCT02359513|Antidepressive Agents|antidepressive agents|mesh-list
65579396|NCT02359513|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65579397|NCT02359513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65579398|NCT02359513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65579399|NCT02359513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579400|NCT02359513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65579401|NCT02359513|Serotonin Agents|serotonin agents|mesh-ancestor
65579402|NCT02359513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579403|NCT02359513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65579404|NCT02359513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65579405|NCT02359513|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65579406|NCT02359513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65579407|NCT02359513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579408|NCT01184495|Epoetin Alfa|epoetin alfa|mesh-list
65579409|NCT01184495|Hematinics|hematinics|mesh-ancestor
65579410|NCT03864575|Celecoxib|celecoxib|mesh-list
65579411|NCT03864575|Nivolumab|nivolumab|mesh-list
65579412|NCT03864575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65579413|NCT03864575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65579414|NCT03864575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65579415|NCT03864575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579416|NCT03864575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65579417|NCT03864575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65579418|NCT03864575|Analgesics|analgesics|mesh-ancestor
65579419|NCT03864575|Sensory System Agents|sensory system agents|mesh-ancestor
65579420|NCT03864575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579421|NCT03864575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579422|NCT03864575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65579423|NCT03864575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65579424|NCT03864575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65579425|NCT03864575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65579426|NCT03864575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579427|NCT03357718|Midazolam|midazolam|mesh-list
65579428|NCT03357718|Dexmedetomidine|dexmedetomidine|mesh-list
65579429|NCT03357718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65579430|NCT03357718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65579431|NCT03357718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579432|NCT03357718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65579433|NCT03357718|Analgesics|analgesics|mesh-ancestor
65579434|NCT03357718|Sensory System Agents|sensory system agents|mesh-ancestor
65579435|NCT03357718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579436|NCT03357718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65579437|NCT03357718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65579438|NCT03357718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65579439|NCT03357718|Adrenergic Agents|adrenergic agents|mesh-ancestor
65579440|NCT03357718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65579441|NCT03357718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579442|NCT03357718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65579443|NCT03357718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65579444|NCT03357718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65579445|NCT03357718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65579446|NCT03357718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65579447|NCT03357718|Anesthetics, General|anesthetics, general|mesh-ancestor
65579448|NCT03357718|Anesthetics|anesthetics|mesh-ancestor
65579449|NCT03357718|GABA Modulators|gaba modulators|mesh-ancestor
65579450|NCT03357718|GABA Agents|gaba agents|mesh-ancestor
65579451|NCT04521400|Interferons|interferons|mesh-list
65579452|NCT04521400|Ritonavir|ritonavir|mesh-list
65579453|NCT04521400|Lopinavir|lopinavir|mesh-list
65579454|NCT04521400|Interferon-beta|interferon-beta|mesh-list
65579455|NCT04521400|Interferon beta-1a|interferon beta-1a|mesh-list
65579456|NCT04521400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65579457|NCT04521400|Antiviral Agents|antiviral agents|mesh-ancestor
65579458|NCT04521400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65579459|NCT04521400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65579460|NCT04521400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65579461|NCT04521400|Protease Inhibitors|protease inhibitors|mesh-ancestor
65579462|NCT04521400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579463|NCT04521400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579464|NCT04521400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65579465|NCT04521400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65579466|NCT04521400|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65579467|NCT04521400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65579468|NCT04521400|Immunologic Factors|immunologic factors|mesh-ancestor
65579469|NCT04521400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579470|NCT04521400|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65579471|NCT03864185|Rituximab|rituximab|mesh-list
65579472|NCT03864185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65579473|NCT03864185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65579474|NCT03864185|Immunologic Factors|immunologic factors|mesh-ancestor
65579475|NCT03864185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579476|NCT03864185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65579477|NCT01185119|Glucagon|glucagon|mesh-list
65579478|NCT01185119|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65579479|NCT01185119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65579480|NCT01185119|Hormones|hormones|mesh-ancestor
65579481|NCT01185119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65579482|NCT01185119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579483|NCT01185119|Incretins|incretins|mesh-ancestor
65579484|NCT03357640|Contraceptive Agents|contraceptive agents|mesh-list
65579485|NCT03357640|Contraceptives, Oral|contraceptives, oral|mesh-list
65579486|NCT03357640|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65579487|NCT03357640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65579488|NCT03357640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579489|NCT03357640|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65579490|NCT01185197|Mycophenolic Acid|mycophenolic acid|mesh-list
65579491|NCT01185197|Prednisolone|prednisolone|mesh-list
65579492|NCT01185197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65579493|NCT01185197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65579494|NCT01185197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65579495|NCT01185197|Antitubercular Agents|antitubercular agents|mesh-ancestor
65579496|NCT01185197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65579497|NCT01185197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65579498|NCT01185197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579499|NCT01185197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579500|NCT01185197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65579501|NCT01185197|Glucocorticoids|glucocorticoids|mesh-ancestor
65579502|NCT01185197|Hormones|hormones|mesh-ancestor
65579503|NCT01185197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65579504|NCT01185197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579505|NCT01185197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65579506|NCT03733873|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65579507|NCT03733873|Hemostatics|hemostatics|mesh-ancestor
65579508|NCT03733873|Coagulants|coagulants|mesh-ancestor
65579509|NCT03733873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65579510|NCT03733873|Natriuretic Agents|natriuretic agents|mesh-ancestor
65579511|NCT03733873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579512|NCT03733639|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65579513|NCT03733639|Hemostatics|hemostatics|mesh-ancestor
65579514|NCT03733639|Coagulants|coagulants|mesh-ancestor
65579515|NCT03733561|Rotigotine|rotigotine|mesh-list
65579516|NCT03733561|Dopamine Agonists|dopamine agonists|mesh-ancestor
65579517|NCT03733561|Dopamine Agents|dopamine agents|mesh-ancestor
65579518|NCT03733561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65579519|NCT03733561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579520|NCT03733561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579521|NCT03358888|Analgesics, Opioid|analgesics, opioid|mesh-list
65579522|NCT03358888|Narcotics|narcotics|mesh-ancestor
65579523|NCT03358888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65579524|NCT03358888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579525|NCT03358888|Analgesics|analgesics|mesh-ancestor
65579526|NCT03358888|Sensory System Agents|sensory system agents|mesh-ancestor
65579527|NCT03358888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579528|NCT01291121|Ranibizumab|ranibizumab|mesh-list
65579529|NCT01291121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65579530|NCT01291121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65579531|NCT01291121|Growth Substances|growth substances|mesh-ancestor
65579532|NCT01291121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579533|NCT01291121|Growth Inhibitors|growth inhibitors|mesh-ancestor
65579534|NCT01291121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65579535|NCT01187849|Metformin|metformin|mesh-list
65579536|NCT01187849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65579537|NCT01187849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579538|NCT04522882|Insulin|insulin|mesh-list
65579539|NCT04522882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65579540|NCT04522882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579541|NCT03123718|Methotrexate|methotrexate|mesh-list
65579542|NCT03123718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65579543|NCT03123718|Abortifacient Agents|abortifacient agents|mesh-ancestor
65579544|NCT03123718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65579545|NCT03123718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579546|NCT03123718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65579547|NCT03123718|Antimetabolites|antimetabolites|mesh-ancestor
65579548|NCT03123718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579549|NCT03123718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65579550|NCT03123718|Dermatologic Agents|dermatologic agents|mesh-ancestor
65579551|NCT03123718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579552|NCT03123718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65579553|NCT03123718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65579554|NCT03123718|Immunologic Factors|immunologic factors|mesh-ancestor
65579555|NCT03123718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65579556|NCT03123718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65579557|NCT01185743|Olanzapine|olanzapine|mesh-list
65579558|NCT01185743|Ziprasidone|ziprasidone|mesh-list
65579559|NCT01185743|Antiemetics|antiemetics|mesh-ancestor
65579560|NCT01185743|Autonomic Agents|autonomic agents|mesh-ancestor
65579561|NCT01185743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579562|NCT01185743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579563|NCT01185743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65579564|NCT01185743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65579565|NCT01185743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65579566|NCT01185743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65579567|NCT01185743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65579568|NCT01185743|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65579569|NCT01185743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65579570|NCT01185743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65579571|NCT01185743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579572|NCT01185743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65579573|NCT01185743|Serotonin Agents|serotonin agents|mesh-ancestor
65579574|NCT01185743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65579575|NCT01185743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65579576|NCT01185743|Dopamine Agents|dopamine agents|mesh-ancestor
65579577|NCT01188005|Vitamins|vitamins|mesh-list
65579578|NCT01188005|Vitamin E|vitamin e|mesh-list
65579579|NCT01188005|Vitamin A|vitamin a|mesh-list
65579580|NCT01188005|Acetylcysteine|acetylcysteine|mesh-list
65579581|NCT01188005|Allopurinol|allopurinol|mesh-list
65579582|NCT01188005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65579583|NCT01188005|Micronutrients|micronutrients|mesh-ancestor
65579584|NCT01188005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579585|NCT01188005|Antioxidants|antioxidants|mesh-ancestor
65579586|NCT01188005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579587|NCT01188005|Protective Agents|protective agents|mesh-ancestor
65579588|NCT01188005|Antiviral Agents|antiviral agents|mesh-ancestor
65579589|NCT01188005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65579591|NCT01188005|Respiratory System Agents|respiratory system agents|mesh-ancestor
65579592|NCT01188005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65579593|NCT01188005|Antidotes|antidotes|mesh-ancestor
65579594|NCT01188005|Antimetabolites|antimetabolites|mesh-ancestor
65579595|NCT01188005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579596|NCT01188005|Gout Suppressants|gout suppressants|mesh-ancestor
65579597|NCT01188005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65579598|NCT04445194|Vaccines|vaccines|mesh-list
65579599|NCT04445194|Immunologic Factors|immunologic factors|mesh-ancestor
65579600|NCT04445194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579601|NCT01291199|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65579602|NCT01291199|Vasodilator Agents|vasodilator agents|mesh-ancestor
65579603|NCT01291199|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65579604|NCT01291199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65579605|NCT01291199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579606|NCT01291199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579607|NCT01291199|Urological Agents|urological agents|mesh-ancestor
65579608|NCT04444726|Betamethasone|betamethasone|mesh-list
65579609|NCT04444726|Betamethasone Valerate|betamethasone valerate|mesh-list
65579610|NCT04444726|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65579611|NCT04444726|Betamethasone benzoate|betamethasone benzoate|mesh-list
65579612|NCT04444726|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65579613|NCT04444726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65579614|NCT04444726|Glucocorticoids|glucocorticoids|mesh-ancestor
65579615|NCT04444726|Hormones|hormones|mesh-ancestor
65579616|NCT04444726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65579617|NCT04444726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579618|NCT04444726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65579619|NCT04444726|Respiratory System Agents|respiratory system agents|mesh-ancestor
65579620|NCT03733327|Cyclophosphamide|cyclophosphamide|mesh-list
65579621|NCT03733327|Busulfan|busulfan|mesh-list
65579622|NCT03733327|Etoposide|etoposide|mesh-list
65579623|NCT03733327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65579624|NCT03733327|Immunologic Factors|immunologic factors|mesh-ancestor
65579625|NCT03733327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579626|NCT03733327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65579627|NCT03733327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65579628|NCT03733327|Alkylating Agents|alkylating agents|mesh-ancestor
65579629|NCT03733327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579630|NCT03733327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65579631|NCT03733327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65579632|NCT03733327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65579633|NCT03733327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65579634|NCT03733327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65579635|NCT03733327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579636|NCT03733171|Epinephrine|epinephrine|mesh-list
65579637|NCT03733171|Hemostatics|hemostatics|mesh-list
65579638|NCT03733171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65579639|NCT03733171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65579640|NCT03733171|Adrenergic Agents|adrenergic agents|mesh-ancestor
65579641|NCT03733171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65579642|NCT03733171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579643|NCT03733171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579644|NCT03733171|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65579645|NCT03733171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65579646|NCT03733171|Autonomic Agents|autonomic agents|mesh-ancestor
65579647|NCT03733171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579648|NCT03733171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65579649|NCT03733171|Respiratory System Agents|respiratory system agents|mesh-ancestor
65579650|NCT03733171|Mydriatics|mydriatics|mesh-ancestor
65579651|NCT03733171|Sympathomimetics|sympathomimetics|mesh-ancestor
65579652|NCT03733171|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65579653|NCT03733171|Coagulants|coagulants|mesh-ancestor
65579654|NCT03207750|Vaccines|vaccines|mesh-list
65579655|NCT03207750|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65579656|NCT03207750|Immunologic Factors|immunologic factors|mesh-ancestor
65579657|NCT03207750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579658|NCT01185977|Fluoxetine|fluoxetine|mesh-list
65579659|NCT01185977|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65579660|NCT01185977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65579661|NCT01185977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65579662|NCT01185977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579663|NCT01185977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65579664|NCT01185977|Serotonin Agents|serotonin agents|mesh-ancestor
65579665|NCT01185977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579666|NCT01185977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65579667|NCT01185977|Antidepressive Agents|antidepressive agents|mesh-ancestor
65579668|NCT01185977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65579669|NCT01185977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65579670|NCT01185977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65579671|NCT01185977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579672|NCT03857399|Caspofungin|caspofungin|mesh-list
65579673|NCT03857399|Antifungal Agents|antifungal agents|mesh-ancestor
65579674|NCT03857399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65579675|NCT03857399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579676|NCT03857399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579677|NCT04520620|Enoxaparin|enoxaparin|mesh-list
65579678|NCT04520620|Anticoagulants|anticoagulants|mesh-ancestor
65579679|NCT04520620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65579680|NCT04520620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65579681|NCT04520620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579682|NCT03857711|Amiodarone|amiodarone|mesh-list
65579683|NCT03857711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65579684|NCT03857711|Vasodilator Agents|vasodilator agents|mesh-ancestor
65579685|NCT03857711|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65579686|NCT03857711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65579687|NCT03857711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579688|NCT03857711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65579689|NCT03857711|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65579690|NCT03857711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65579691|NCT03857711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579692|NCT03857711|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65579693|NCT03857711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65579694|NCT03857711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65579695|NCT03672097|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65579696|NCT03672097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65579697|NCT03847896|Budesonide|budesonide|mesh-list
65579698|NCT03847896|Albuterol|albuterol|mesh-list
65579699|NCT03847896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65579700|NCT03847896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65579701|NCT03847896|Autonomic Agents|autonomic agents|mesh-ancestor
65579702|NCT03847896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579703|NCT03847896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579704|NCT03847896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65579705|NCT03847896|Respiratory System Agents|respiratory system agents|mesh-ancestor
65579706|NCT03847896|Glucocorticoids|glucocorticoids|mesh-ancestor
65579707|NCT03847896|Hormones|hormones|mesh-ancestor
65579708|NCT03847896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65579709|NCT03847896|Tocolytic Agents|tocolytic agents|mesh-ancestor
65579710|NCT03847896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65579711|NCT03847896|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65579712|NCT03847896|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65579713|NCT03847896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65579714|NCT03847896|Adrenergic Agents|adrenergic agents|mesh-ancestor
65579715|NCT03847896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65579716|NCT03847896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579717|NCT01186289|Atorvastatin|atorvastatin|mesh-list
65579718|NCT01186289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65579719|NCT01186289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65579720|NCT01186289|Antimetabolites|antimetabolites|mesh-ancestor
65579721|NCT01186289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579722|NCT01186289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65579723|NCT01186289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65579724|NCT01186289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579725|NCT01760005|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65579726|NCT01760005|Immunologic Factors|immunologic factors|mesh-ancestor
65579727|NCT01760005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579728|NCT01291823|Gefitinib|gefitinib|mesh-list
65579729|NCT01291823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65579730|NCT01291823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65579731|NCT01291823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579732|NCT01291823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579733|NCT01181765|Infliximab|infliximab|mesh-list
65579734|NCT01181765|Dermatologic Agents|dermatologic agents|mesh-ancestor
65579735|NCT01181765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65579736|NCT01181765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65377254|NCT02592083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579737|NCT01186445|Morphine|morphine|mesh-list
65579738|NCT01186445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65579739|NCT01186445|Narcotics|narcotics|mesh-ancestor
65579740|NCT01186445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65579741|NCT01186445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579742|NCT01186445|Analgesics|analgesics|mesh-ancestor
65579743|NCT01186445|Sensory System Agents|sensory system agents|mesh-ancestor
65579744|NCT01186445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579745|NCT03739333|Carbon-11 methionine|carbon-11 methionine|mesh-list
65579746|NCT03739333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65579747|NCT03739333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579748|NCT04520230|Budesonide|budesonide|mesh-list
65579749|NCT04520230|Formoterol Fumarate|formoterol fumarate|mesh-list
65579750|NCT04520230|Tiotropium Bromide|tiotropium bromide|mesh-list
65579751|NCT04520230|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65579752|NCT04520230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65579753|NCT04520230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65579754|NCT04520230|Autonomic Agents|autonomic agents|mesh-ancestor
65579755|NCT04520230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579756|NCT04520230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579757|NCT04520230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65579758|NCT04520230|Respiratory System Agents|respiratory system agents|mesh-ancestor
65579759|NCT04520230|Glucocorticoids|glucocorticoids|mesh-ancestor
65579760|NCT04520230|Hormones|hormones|mesh-ancestor
65579761|NCT04520230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65579762|NCT04520230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65579763|NCT04520230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65579764|NCT04520230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65579765|NCT04520230|Adrenergic Agents|adrenergic agents|mesh-ancestor
65579766|NCT04520230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65579767|NCT04520230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579768|NCT04520230|Parasympatholytics|parasympatholytics|mesh-ancestor
65579769|NCT04520230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65579770|NCT04520230|Cholinergic Agents|cholinergic agents|mesh-ancestor
65579771|NCT03619837|Sofosbuvir|sofosbuvir|mesh-list
65579772|NCT03619837|Velpatasvir|velpatasvir|mesh-list
65579773|NCT03619837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65579774|NCT03619837|Antiviral Agents|antiviral agents|mesh-ancestor
65579775|NCT03619837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65579776|NCT03852563|Petrolatum|petrolatum|mesh-list
65579777|NCT03852563|Emollients|emollients|mesh-ancestor
65579778|NCT03852563|Dermatologic Agents|dermatologic agents|mesh-ancestor
65579779|NCT01188317|Ibuprofen|ibuprofen|mesh-list
65579780|NCT01188317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65579781|NCT01188317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65579782|NCT01188317|Analgesics|analgesics|mesh-ancestor
65579783|NCT01188317|Sensory System Agents|sensory system agents|mesh-ancestor
65579784|NCT01188317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579785|NCT01188317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579786|NCT01188317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65579787|NCT01188317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65579788|NCT01188317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65579789|NCT01188317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579790|NCT01188317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579791|NCT03206970|Zanubrutinib|zanubrutinib|mesh-list
65579792|NCT03206970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65579793|NCT03206970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65579794|NCT03206970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579795|NCT03206970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579796|NCT03739021|Ropivacaine|ropivacaine|mesh-list
65579797|NCT03739021|Anesthetics, Local|anesthetics, local|mesh-ancestor
65579798|NCT03739021|Anesthetics|anesthetics|mesh-ancestor
65579799|NCT03739021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65579800|NCT03739021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579801|NCT03739021|Sensory System Agents|sensory system agents|mesh-ancestor
65579802|NCT03739021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579803|NCT03738943|Pyridoxine|pyridoxine|mesh-list
65579804|NCT03738943|Pyridoxal|pyridoxal|mesh-list
65579805|NCT03738943|Vitamin B 6|vitamin b 6|mesh-list
65579806|NCT03738943|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
65579807|NCT03738943|Adenosine|adenosine|mesh-list
65579808|NCT03738943|Nitroprusside|nitroprusside|mesh-list
65579809|NCT03738943|Acetylcholine|acetylcholine|mesh-list
65579810|NCT03738943|Vitamins|vitamins|mesh-ancestor
65579811|NCT03738943|Micronutrients|micronutrients|mesh-ancestor
65579812|NCT03738943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579813|NCT03738943|Vitamin B Complex|vitamin b complex|mesh-ancestor
65579814|NCT03738943|Analgesics|analgesics|mesh-ancestor
65579815|NCT03738943|Sensory System Agents|sensory system agents|mesh-ancestor
65579816|NCT03738943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579817|NCT03738943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65579818|NCT03738943|Vasodilator Agents|vasodilator agents|mesh-ancestor
65579819|NCT03738943|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65579820|NCT03738943|Purinergic Agonists|purinergic agonists|mesh-ancestor
65579821|NCT03738943|Purinergic Agents|purinergic agents|mesh-ancestor
65579822|NCT03738943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65579823|NCT03738943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579824|NCT03738943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65579825|NCT03738943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65579826|NCT03738943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65579827|NCT03738943|Cholinergic Agents|cholinergic agents|mesh-ancestor
65579828|NCT03178851|Atezolizumab|atezolizumab|mesh-list
65579829|NCT03178851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65579830|NCT03178851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65579831|NCT03178851|Immunologic Factors|immunologic factors|mesh-ancestor
65579832|NCT03178851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579833|NCT01291979|Lidocaine|lidocaine|mesh-list
65579834|NCT01291979|Anesthetics, Local|anesthetics, local|mesh-ancestor
65579835|NCT01291979|Anesthetics|anesthetics|mesh-ancestor
65579836|NCT01291979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65579837|NCT01291979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579838|NCT01291979|Sensory System Agents|sensory system agents|mesh-ancestor
65579839|NCT01291979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579840|NCT01291979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65579841|NCT01291979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65579842|NCT01291979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65579843|NCT01291979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65579844|NCT01291979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579845|NCT04443634|Bupivacaine|bupivacaine|mesh-list
65579846|NCT04443634|Anesthetics, Local|anesthetics, local|mesh-ancestor
65579847|NCT04443634|Anesthetics|anesthetics|mesh-ancestor
65579848|NCT04443634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65579849|NCT04443634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579850|NCT04443634|Sensory System Agents|sensory system agents|mesh-ancestor
65579851|NCT04443634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579852|NCT03643159|Aripiprazole|aripiprazole|mesh-list
65579853|NCT03643159|Antipsychotic Agents|antipsychotic agents|mesh-list
65579854|NCT03643159|Antidepressive Agents|antidepressive agents|mesh-ancestor
65579855|NCT03643159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65579856|NCT03643159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65579857|NCT03643159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65579858|NCT03643159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579859|NCT03643159|Dopamine Agonists|dopamine agonists|mesh-ancestor
65579860|NCT03643159|Dopamine Agents|dopamine agents|mesh-ancestor
65579861|NCT03643159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65579862|NCT03643159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579863|NCT03643159|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65579864|NCT03643159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65579865|NCT03643159|Serotonin Agents|serotonin agents|mesh-ancestor
65579866|NCT03643159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65579867|NCT03643159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65579868|NCT03643159|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65579869|NCT03643159|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65579870|NCT03205566|Lamivudine|lamivudine|mesh-list
65579871|NCT03205566|Raltegravir Potassium|raltegravir potassium|mesh-list
65579872|NCT03205566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65579873|NCT03205566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65579874|NCT03205566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579875|NCT03205566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579876|NCT03205566|Antiviral Agents|antiviral agents|mesh-ancestor
65579877|NCT03205566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65579878|NCT03205566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65579879|NCT03205566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65579880|NCT03205566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65579881|NCT03205566|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65579882|NCT01181999|Rituximab|rituximab|mesh-list
65579883|NCT01181999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65579884|NCT01181999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65579885|NCT01181999|Immunologic Factors|immunologic factors|mesh-ancestor
65579886|NCT01181999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377406|NCT00611130|Vigabatrin|vigabatrin|mesh-list
65579887|NCT01181999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65579888|NCT04509232|Fluorides|fluorides|mesh-list
65579889|NCT04509232|Cariostatic Agents|cariostatic agents|mesh-ancestor
65579890|NCT04509232|Protective Agents|protective agents|mesh-ancestor
65579891|NCT04509232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579892|NCT03732235|Bevacizumab|bevacizumab|mesh-list
65579893|NCT03732235|Chlorotrianisene|chlorotrianisene|mesh-list
65579894|NCT03732235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65579895|NCT03732235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65579896|NCT03732235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65579897|NCT03732235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65579898|NCT03732235|Growth Substances|growth substances|mesh-ancestor
65579899|NCT03732235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579900|NCT03732235|Growth Inhibitors|growth inhibitors|mesh-ancestor
65579901|NCT03732235|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65579902|NCT03732235|Estrogens|estrogens|mesh-ancestor
65579903|NCT03732235|Hormones|hormones|mesh-ancestor
65579904|NCT03732235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65579905|NCT03732235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65579906|NCT01289951|Raltegravir Potassium|raltegravir potassium|mesh-list
65579907|NCT01289951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65579908|NCT01289951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65579909|NCT01289951|Antiviral Agents|antiviral agents|mesh-ancestor
65579910|NCT01289951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65579911|NCT01289951|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65579912|NCT01289951|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65579913|NCT01289951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579914|NCT01289951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579915|NCT01182077|Midazolam|midazolam|mesh-list
65579916|NCT01182077|Peficitinib|peficitinib|mesh-list
65579917|NCT01182077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65579918|NCT01182077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65579919|NCT01182077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65579920|NCT01182077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579921|NCT01182077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65579922|NCT01182077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65579923|NCT01182077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65579924|NCT01182077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65579925|NCT01182077|Anesthetics, General|anesthetics, general|mesh-ancestor
65579926|NCT01182077|Anesthetics|anesthetics|mesh-ancestor
65579927|NCT01182077|GABA Modulators|gaba modulators|mesh-ancestor
65579928|NCT01182077|GABA Agents|gaba agents|mesh-ancestor
65579929|NCT01182077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65579930|NCT01182077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579931|NCT01182077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579932|NCT01182077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65579933|NCT01182077|Immunologic Factors|immunologic factors|mesh-ancestor
65579934|NCT03618823|Acetaminophen|acetaminophen|mesh-list
65579935|NCT03618823|Ibuprofen|ibuprofen|mesh-list
65579936|NCT03618823|Oxycodone|oxycodone|mesh-list
65579937|NCT03618823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65579938|NCT03618823|Analgesics|analgesics|mesh-ancestor
65579939|NCT03618823|Sensory System Agents|sensory system agents|mesh-ancestor
65579940|NCT03618823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579941|NCT03618823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579942|NCT03618823|Antipyretics|antipyretics|mesh-ancestor
65579943|NCT03618823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65579944|NCT03618823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65579945|NCT03618823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65579946|NCT03618823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65579947|NCT03618823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579948|NCT03618823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579949|NCT03618823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65579950|NCT03618823|Narcotics|narcotics|mesh-ancestor
65579951|NCT03618823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65579952|NCT01188707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65579953|NCT01188707|Belinostat|belinostat|mesh-list
65579954|NCT01188707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65579955|NCT01188707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65579956|NCT01188707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579957|NCT01188707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579958|NCT01188707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65579959|NCT03356158|Cetuximab|cetuximab|mesh-list
65579960|NCT03356158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65579961|NCT03356158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65377498|NCT01071889|Flumazenil|flumazenil|mesh-list
65579962|NCT03356080|Cytarabine|cytarabine|mesh-list
65579963|NCT03356080|Decitabine|decitabine|mesh-list
65579964|NCT03356080|Tretinoin|tretinoin|mesh-list
65579965|NCT03356080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65579966|NCT03356080|Antimetabolites|antimetabolites|mesh-ancestor
65579967|NCT03356080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65579968|NCT03356080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65579969|NCT03356080|Antiviral Agents|antiviral agents|mesh-ancestor
65579970|NCT03356080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65579971|NCT03356080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65579972|NCT03356080|Immunologic Factors|immunologic factors|mesh-ancestor
65579973|NCT03356080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579974|NCT03356080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65579975|NCT03356080|Keratolytic Agents|keratolytic agents|mesh-ancestor
65579976|NCT03356080|Dermatologic Agents|dermatologic agents|mesh-ancestor
65579977|NCT03640507|Chlorhexidine|chlorhexidine|mesh-list
65579978|NCT03640507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65579979|NCT03640507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65579980|NCT03640507|Disinfectants|disinfectants|mesh-ancestor
65579981|NCT02937636|Fluorides|fluorides|mesh-list
65579982|NCT02937636|Tin Fluorides|tin fluorides|mesh-list
65579983|NCT02937636|Fluorophosphate|fluorophosphate|mesh-list
65579984|NCT02937636|Cariostatic Agents|cariostatic agents|mesh-ancestor
65579985|NCT02937636|Protective Agents|protective agents|mesh-ancestor
65579986|NCT02937636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579987|NCT03638635|Bupivacaine|bupivacaine|mesh-list
65579988|NCT03638635|Anesthetics, Local|anesthetics, local|mesh-ancestor
65579989|NCT03638635|Anesthetics|anesthetics|mesh-ancestor
65579990|NCT03638635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65579991|NCT03638635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65579992|NCT03638635|Sensory System Agents|sensory system agents|mesh-ancestor
65579993|NCT03638635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65579994|NCT02518516|Atorvastatin|atorvastatin|mesh-list
65579995|NCT02518516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65579996|NCT02518516|Simvastatin|simvastatin|mesh-list
65579997|NCT02518516|Pravastatin|pravastatin|mesh-list
65579998|NCT02518516|Lovastatin|lovastatin|mesh-list
65579999|NCT02518516|L 647318|l 647318|mesh-list
65580000|NCT02518516|Dihydromevinolin|dihydromevinolin|mesh-list
65580001|NCT02518516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65580002|NCT02518516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65580003|NCT02518516|Antimetabolites|antimetabolites|mesh-ancestor
65580004|NCT02518516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580005|NCT02518516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65580006|NCT02518516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65580007|NCT02518516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580008|NCT04508686|Capecitabine|capecitabine|mesh-list
65580009|NCT04508686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65580010|NCT04508686|Antimetabolites|antimetabolites|mesh-ancestor
65580011|NCT04508686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580012|NCT04508686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580013|NCT02518438|Tramadol|tramadol|mesh-list
65580014|NCT02518438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65580015|NCT02518438|Narcotics|narcotics|mesh-ancestor
65580016|NCT02518438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65580017|NCT02518438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580018|NCT02518438|Analgesics|analgesics|mesh-ancestor
65580019|NCT02518438|Sensory System Agents|sensory system agents|mesh-ancestor
65580020|NCT02518438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65580021|NCT04521556|Morphine|morphine|mesh-list
65580022|NCT04521556|Tramadol|tramadol|mesh-list
65580023|NCT04521556|Anesthetics|anesthetics|mesh-list
65580024|NCT04521556|Ropivacaine|ropivacaine|mesh-list
65580025|NCT04521556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65580026|NCT04521556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580027|NCT04521556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65580028|NCT04521556|Narcotics|narcotics|mesh-ancestor
65580029|NCT04521556|Analgesics|analgesics|mesh-ancestor
65580030|NCT04521556|Sensory System Agents|sensory system agents|mesh-ancestor
65580031|NCT04521556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65580032|NCT04521556|Anesthetics, Local|anesthetics, local|mesh-ancestor
65580033|NCT03204279|Palonosetron|palonosetron|mesh-list
65580034|NCT03204279|Antiemetics|antiemetics|mesh-ancestor
65580035|NCT03204279|Autonomic Agents|autonomic agents|mesh-ancestor
65580036|NCT03204279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65580037|NCT03204279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580038|NCT03204279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65580039|NCT03204279|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65580040|NCT03204279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65580041|NCT03204279|Serotonin Agents|serotonin agents|mesh-ancestor
65580042|NCT03204279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65580043|NCT03204279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580044|NCT02524301|Diprenorphine|diprenorphine|mesh-list
65580045|NCT02524301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65580046|NCT02524301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580047|NCT02524301|Sensory System Agents|sensory system agents|mesh-ancestor
65580048|NCT02524301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65580049|NCT03122782|Tranexamic Acid|tranexamic acid|mesh-list
65580050|NCT03122782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65580051|NCT03122782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65580052|NCT03122782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580053|NCT03122782|Hemostatics|hemostatics|mesh-ancestor
65580054|NCT03122782|Coagulants|coagulants|mesh-ancestor
65580055|NCT01291433|Clodronic Acid|clodronic acid|mesh-list
65580056|NCT01291433|Tocopherols|tocopherols|mesh-list
65580057|NCT01291433|Vitamin E|vitamin e|mesh-list
65580058|NCT01291433|Tocotrienols|tocotrienols|mesh-list
65580059|NCT01291433|alpha-Tocopherol|alpha-tocopherol|mesh-list
65580060|NCT01291433|Pentoxifylline|pentoxifylline|mesh-list
65580061|NCT01291433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65580062|NCT01291433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580063|NCT01291433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580064|NCT01291433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65580065|NCT01291433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65580066|NCT01291433|Protective Agents|protective agents|mesh-ancestor
65580067|NCT01291433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580068|NCT01291433|Vasodilator Agents|vasodilator agents|mesh-ancestor
65580069|NCT01291433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65580070|NCT01291433|Antioxidants|antioxidants|mesh-ancestor
65580071|NCT01291433|Vitamins|vitamins|mesh-ancestor
65580072|NCT01291433|Micronutrients|micronutrients|mesh-ancestor
65580073|NCT01291433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65580074|NCT01314144|Bupivacaine|bupivacaine|mesh-list
65580075|NCT01314144|Anesthetics, Local|anesthetics, local|mesh-ancestor
65580076|NCT01314144|Anesthetics|anesthetics|mesh-ancestor
65580077|NCT01314144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65580078|NCT01314144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580079|NCT01314144|Sensory System Agents|sensory system agents|mesh-ancestor
65580080|NCT01314144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65580081|NCT02954653|Cytarabine|cytarabine|mesh-list
65580082|NCT02954653|Azacitidine|azacitidine|mesh-list
65580083|NCT02954653|Decitabine|decitabine|mesh-list
65580084|NCT02954653|Daunorubicin|daunorubicin|mesh-list
65580085|NCT02954653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65580086|NCT02954653|Antimetabolites|antimetabolites|mesh-ancestor
65580087|NCT02954653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580088|NCT02954653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580089|NCT02954653|Antiviral Agents|antiviral agents|mesh-ancestor
65580090|NCT02954653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65580091|NCT02954653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65580092|NCT02954653|Immunologic Factors|immunologic factors|mesh-ancestor
65580093|NCT02954653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580094|NCT02954653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580095|NCT02954653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65580096|NCT02954653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65580097|NCT02954653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65580098|NCT04895748|Everolimus|everolimus|mesh-list
65580099|NCT04895748|Spartalizumab|spartalizumab|mesh-list
65580100|NCT04895748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580101|NCT04895748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65580102|NCT04895748|Immunologic Factors|immunologic factors|mesh-ancestor
65580103|NCT04895748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580104|NCT04895748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65580105|NCT04895748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580106|NCT04508452|Bevacizumab|bevacizumab|mesh-list
65580107|NCT04508452|Capecitabine|capecitabine|mesh-list
65580108|NCT04508452|Oxaliplatin|oxaliplatin|mesh-list
65580109|NCT04508452|Irinotecan|irinotecan|mesh-list
65580110|NCT04508452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65580111|NCT04508452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580112|NCT04508452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65580113|NCT04508452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65580114|NCT04508452|Growth Substances|growth substances|mesh-ancestor
65580115|NCT04508452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580116|NCT04508452|Growth Inhibitors|growth inhibitors|mesh-ancestor
65580117|NCT04508452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65580118|NCT04508452|Antimetabolites|antimetabolites|mesh-ancestor
65580119|NCT04508452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580120|NCT04508452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65580121|NCT04508452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65580122|NCT04508452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580124|NCT03856853|Analgesics|analgesics|mesh-ancestor
65580125|NCT03856853|Sensory System Agents|sensory system agents|mesh-ancestor
65580126|NCT03856853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65580127|NCT03856853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580128|NCT03856853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65580129|NCT03856853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65580130|NCT03856853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65580131|NCT03856853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65580132|NCT03856853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580133|NCT03732703|Thalidomide|thalidomide|mesh-list
65580134|NCT03732703|Dexamethasone|dexamethasone|mesh-list
65580135|NCT03732703|Dexamethasone acetate|dexamethasone acetate|mesh-list
65580136|NCT03732703|Venetoclax|venetoclax|mesh-list
65580137|NCT03732703|Daratumumab|daratumumab|mesh-list
65580138|NCT03732703|Pomalidomide|pomalidomide|mesh-list
65580139|NCT03732703|Ixazomib|ixazomib|mesh-list
65580140|NCT03732703|BB 1101|bb 1101|mesh-list
65580141|NCT03732703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65580142|NCT03732703|Glycine|glycine|mesh-list
65580143|NCT03732703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65580144|NCT03732703|Antiemetics|antiemetics|mesh-ancestor
65580145|NCT03732703|Autonomic Agents|autonomic agents|mesh-ancestor
65580146|NCT03732703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65580147|NCT03732703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580148|NCT03732703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65580149|NCT03732703|Glucocorticoids|glucocorticoids|mesh-ancestor
65580150|NCT03732703|Hormones|hormones|mesh-ancestor
65580151|NCT03732703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65580152|NCT03732703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65580153|NCT03732703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580154|NCT03732703|Protease Inhibitors|protease inhibitors|mesh-ancestor
65580155|NCT03732703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580156|NCT03732703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580157|NCT03732703|Immunologic Factors|immunologic factors|mesh-ancestor
65580158|NCT03732703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65580159|NCT03732703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65580160|NCT03732703|Growth Substances|growth substances|mesh-ancestor
65580161|NCT03732703|Growth Inhibitors|growth inhibitors|mesh-ancestor
65580162|NCT03732703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65580163|NCT03732703|Leprostatic Agents|leprostatic agents|mesh-ancestor
65580164|NCT03732703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65580165|NCT03732703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65580166|NCT03732703|Glycine Agents|glycine agents|mesh-ancestor
65580167|NCT03732703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65580168|NCT03636555|Oxytocin|oxytocin|mesh-list
65580169|NCT03636555|Oxytocics|oxytocics|mesh-ancestor
65580170|NCT03636555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65580171|NCT03636555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580172|NCT03123016|Apremilast|apremilast|mesh-list
65580173|NCT03123016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65580174|NCT03123016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65580175|NCT03123016|Analgesics|analgesics|mesh-ancestor
65580176|NCT03123016|Sensory System Agents|sensory system agents|mesh-ancestor
65580177|NCT03123016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65580178|NCT03123016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580179|NCT03123016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65580180|NCT03123016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65580181|NCT03123016|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65580182|NCT03123016|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65580183|NCT03123016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580184|NCT03123016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580185|NCT03636477|Nivolumab|nivolumab|mesh-list
65580186|NCT03636477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65580187|NCT03636477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580188|NCT03636477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65580189|NCT03636477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580190|NCT03732001|Docetaxel|docetaxel|mesh-list
65580191|NCT03732001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580192|NCT03732001|Tubulin Modulators|tubulin modulators|mesh-ancestor
65580193|NCT03732001|Antimitotic Agents|antimitotic agents|mesh-ancestor
65377706|NCT00886314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65580194|NCT03732001|Mitosis Modulators|mitosis modulators|mesh-ancestor
65580195|NCT03732001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580196|NCT01186835|Botulinum Toxins|botulinum toxins|mesh-list
65580197|NCT01186835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65580198|NCT01186835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65580199|NCT01186835|Hyaluronic Acid|hyaluronic acid|mesh-list
65580200|NCT01186835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65580201|NCT01186835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65580202|NCT01186835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580203|NCT01186835|Cholinergic Agents|cholinergic agents|mesh-ancestor
65580204|NCT01186835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65580205|NCT01186835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580206|NCT01186835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65580207|NCT01186835|Immunologic Factors|immunologic factors|mesh-ancestor
65580208|NCT01186835|Viscosupplements|viscosupplements|mesh-ancestor
65580209|NCT01186835|Protective Agents|protective agents|mesh-ancestor
65580210|NCT01186835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65580211|NCT01186835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65580212|NCT03649464|Antineoplastic Agents|antineoplastic agents|mesh-list
65580213|NCT04812951|Cyclosporine|cyclosporine|mesh-list
65580214|NCT04812951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65580215|NCT04812951|Cyclosporins|cyclosporins|mesh-list
65580216|NCT04812951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580217|NCT04812951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580218|NCT04812951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65580219|NCT04812951|Immunologic Factors|immunologic factors|mesh-ancestor
65580220|NCT04812951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580221|NCT04812951|Antifungal Agents|antifungal agents|mesh-ancestor
65580222|NCT04812951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65580223|NCT04812951|Dermatologic Agents|dermatologic agents|mesh-ancestor
65580224|NCT04812951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65580225|NCT04812951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65580226|NCT04812951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65580227|NCT05666089|Acetylcysteine|acetylcysteine|mesh-list
65580228|NCT05666089|Calcium|calcium|mesh-list
65580229|NCT05666089|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65580230|NCT05666089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65580231|NCT05666089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580232|NCT05666089|Antiviral Agents|antiviral agents|mesh-ancestor
65580233|NCT05666089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65580234|NCT05666089|Expectorants|expectorants|mesh-ancestor
65580235|NCT05666089|Respiratory System Agents|respiratory system agents|mesh-ancestor
65580236|NCT05666089|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65580237|NCT05666089|Antioxidants|antioxidants|mesh-ancestor
65580238|NCT05666089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580239|NCT05666089|Protective Agents|protective agents|mesh-ancestor
65580240|NCT05666089|Antidotes|antidotes|mesh-ancestor
65580241|NCT03732625|Raltegravir Potassium|raltegravir potassium|mesh-list
65580242|NCT03732625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65580243|NCT03732625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65580244|NCT03732625|Antiviral Agents|antiviral agents|mesh-ancestor
65580245|NCT03732625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65580246|NCT03732625|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65580247|NCT03732625|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65580248|NCT03732625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580249|NCT03732625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580250|NCT04597476|Fucoidan|fucoidan|mesh-list
65580251|NCT04597476|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65580252|NCT04597476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65580253|NCT04597476|Anticoagulants|anticoagulants|mesh-ancestor
65580254|NCT04597476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580255|NCT01188863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65580256|NCT01188863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65580257|NCT01188863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580258|NCT01188863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65580259|NCT01188863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580260|NCT02730208|Ivacaftor|ivacaftor|mesh-list
65580261|NCT02730208|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65580262|NCT02730208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65580263|NCT02730208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580264|NCT01291511|Iloperidone|iloperidone|mesh-list
65580265|NCT01291511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65580266|NCT01291511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65580267|NCT01291511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65580269|NCT01291511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65580270|NCT01292213|Dimercaprol|dimercaprol|mesh-list
65580271|NCT01292213|Chelating Agents|chelating agents|mesh-ancestor
65580272|NCT01292213|Sequestering Agents|sequestering agents|mesh-ancestor
65580273|NCT01292213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580274|NCT03122938|Lactoferrin|lactoferrin|mesh-list
65580275|NCT03122938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65580276|NCT04971005|Alemtuzumab|alemtuzumab|mesh-list
65580277|NCT04971005|Ocrelizumab|ocrelizumab|mesh-list
65580278|NCT04971005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65580279|NCT04971005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580280|NCT04971005|Immunologic Factors|immunologic factors|mesh-ancestor
65580281|NCT04971005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580282|NCT03782532|Prednisone|prednisone|mesh-list
65580283|NCT03782532|Prednisolone|prednisolone|mesh-list
65580284|NCT03782532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65580285|NCT03782532|Glucocorticoids|glucocorticoids|mesh-ancestor
65580286|NCT03782532|Hormones|hormones|mesh-ancestor
65580287|NCT03782532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65580288|NCT03782532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580289|NCT03782532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65580290|NCT03782532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580291|NCT03355768|Romidepsin|romidepsin|mesh-list
65580292|NCT03355768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65580293|NCT03355768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580294|NCT03349840|Insulin|insulin|mesh-list
65580295|NCT03349840|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65580296|NCT03349840|Insulin Glargine|insulin glargine|mesh-list
65580297|NCT03349840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65580298|NCT03349840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580299|NCT03170271|Benralizumab|benralizumab|mesh-list
65580300|NCT03170271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65580301|NCT03170271|Respiratory System Agents|respiratory system agents|mesh-ancestor
65580302|NCT03355612|Capecitabine|capecitabine|mesh-list
65580303|NCT03355612|Oxaliplatin|oxaliplatin|mesh-list
65580304|NCT03355612|Apatinib|apatinib|mesh-list
65580305|NCT03355612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65580306|NCT03355612|Antimetabolites|antimetabolites|mesh-ancestor
65580307|NCT03355612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580308|NCT03355612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580309|NCT03355612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65580310|NCT03355612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580311|NCT03732547|Poly I-C|poly i-c|mesh-list
65580312|NCT03732547|Antiviral Agents|antiviral agents|mesh-ancestor
65580313|NCT03732547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65580314|NCT03732547|Interferon Inducers|interferon inducers|mesh-ancestor
65580315|NCT03732547|Immunologic Factors|immunologic factors|mesh-ancestor
65580316|NCT03732547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580317|NCT04503850|Mirabegron|mirabegron|mesh-list
65580318|NCT04503850|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
65580319|NCT04503850|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65580320|NCT04503850|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65580321|NCT04503850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65580322|NCT04503850|Adrenergic Agents|adrenergic agents|mesh-ancestor
65580323|NCT04503850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65580324|NCT04503850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580325|NCT04503850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580326|NCT04503850|Urological Agents|urological agents|mesh-ancestor
65580327|NCT04503850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65580328|NCT03349684|Metformin|metformin|mesh-list
65580329|NCT03349684|Acarbose|acarbose|mesh-list
65580330|NCT03349684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65580331|NCT03349684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580332|NCT03349684|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65580333|NCT03349684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580334|NCT03349684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580335|NCT03856697|Gefitinib|gefitinib|mesh-list
65580336|NCT03856697|Maleic acid|maleic acid|mesh-list
65580337|NCT03856697|Abivertinib|abivertinib|mesh-list
65580338|NCT03856697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580339|NCT03856697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580340|NCT03856697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580341|NCT03856697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65580342|NCT03349606|Amphetamine|amphetamine|mesh-list
65580343|NCT03349606|Dextroamphetamine|dextroamphetamine|mesh-list
65580344|NCT03349606|FLB 457|flb 457|mesh-list
65580345|NCT03349606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65580346|NCT03349606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580348|NCT03349606|Autonomic Agents|autonomic agents|mesh-ancestor
65580349|NCT03349606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65580350|NCT03349606|Dopamine Agents|dopamine agents|mesh-ancestor
65580351|NCT03349606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65580352|NCT03349606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580353|NCT03349606|Adrenergic Agents|adrenergic agents|mesh-ancestor
65580354|NCT03349606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65580355|NCT03349606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65580356|NCT03349606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65580357|NCT03349606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65580358|NCT03349606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65580359|NCT02843451|Silymarin|silymarin|mesh-list
65580360|NCT02843451|Antioxidants|antioxidants|mesh-ancestor
65580361|NCT02843451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580362|NCT02843451|Protective Agents|protective agents|mesh-ancestor
65580363|NCT02843451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580364|NCT03355300|Cannabidiol|cannabidiol|mesh-list
65580365|NCT03355300|Anticonvulsants|anticonvulsants|mesh-ancestor
65580366|NCT01292525|Tacrolimus|tacrolimus|mesh-list
65580367|NCT01292525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65580368|NCT01292525|Immunologic Factors|immunologic factors|mesh-ancestor
65580369|NCT01292525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580370|NCT01292525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65580371|NCT01292525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580372|NCT01292525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580373|NCT01189019|Ranibizumab|ranibizumab|mesh-list
65580374|NCT01189019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65580375|NCT01189019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65580376|NCT01189019|Growth Substances|growth substances|mesh-ancestor
65580377|NCT01189019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580378|NCT01189019|Growth Inhibitors|growth inhibitors|mesh-ancestor
65580379|NCT01189019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580380|NCT01183247|Sirolimus|sirolimus|mesh-list
65580381|NCT01183247|Prednisone|prednisone|mesh-list
65580382|NCT01183247|Everolimus|everolimus|mesh-list
65580383|NCT01183247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65580384|NCT01183247|Glucocorticoids|glucocorticoids|mesh-ancestor
65580385|NCT01183247|Hormones|hormones|mesh-ancestor
65580386|NCT01183247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65580387|NCT01183247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580388|NCT01183247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65580389|NCT01183247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580390|NCT01183247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65580391|NCT01183247|Immunologic Factors|immunologic factors|mesh-ancestor
65580392|NCT01183247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65580393|NCT01183247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65580394|NCT01183247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65580395|NCT01183247|Antifungal Agents|antifungal agents|mesh-ancestor
65580396|NCT03349216|Anesthetics|anesthetics|mesh-list
65580397|NCT03349216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65580398|NCT03349216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580399|NCT04507750|Apatinib|apatinib|mesh-list
65580400|NCT04507750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580401|NCT04507750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65580402|NCT04507750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580403|NCT04507750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580404|NCT03633331|Letrozole|letrozole|mesh-list
65580405|NCT03633331|Fulvestrant|fulvestrant|mesh-list
65580406|NCT03633331|Palbociclib|palbociclib|mesh-list
65580407|NCT03633331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580408|NCT03633331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65580409|NCT03633331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65580410|NCT03633331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580411|NCT03633331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580412|NCT03633331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65580413|NCT03633331|Hormone Antagonists|hormone antagonists|mesh-ancestor
65580414|NCT03633331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65580415|NCT03633331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580416|NCT03633331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65580417|NCT03633331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65377931|NCT00813722|Losartan|losartan|mesh-list
65580418|NCT03633331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65580419|NCT01189097|Dextromethorphan|dextromethorphan|mesh-list
65580420|NCT01189097|Antitussive Agents|antitussive agents|mesh-ancestor
65580421|NCT01189097|Respiratory System Agents|respiratory system agents|mesh-ancestor
65580422|NCT01189097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65580423|NCT01189097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65580424|NCT01189097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65580425|NCT01189097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580426|NCT01189097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580427|NCT01187303|Ofatumumab|ofatumumab|mesh-list
65580428|NCT01187303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580429|NCT01187459|Vitamin D|vitamin d|mesh-list
65580430|NCT01187459|Ergocalciferols|ergocalciferols|mesh-list
65580431|NCT01187459|Cholecalciferol|cholecalciferol|mesh-list
65580432|NCT01187459|Vitamins|vitamins|mesh-list
65580433|NCT01187459|Micronutrients|micronutrients|mesh-ancestor
65580434|NCT01187459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580435|NCT01187459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65580436|NCT01187459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65580437|NCT01187537|Bupivacaine|bupivacaine|mesh-list
65580438|NCT01187537|Anesthetics, Local|anesthetics, local|mesh-ancestor
65580439|NCT01187537|Anesthetics|anesthetics|mesh-ancestor
65580440|NCT01187537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65580441|NCT01187537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580442|NCT01187537|Sensory System Agents|sensory system agents|mesh-ancestor
65580443|NCT01187537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65580444|NCT03348826|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65580445|NCT03348826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65580446|NCT03348826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65580447|NCT03348826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65580448|NCT03348826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580449|NCT01290419|Vaccines|vaccines|mesh-list
65580450|NCT01290419|Immunologic Factors|immunologic factors|mesh-ancestor
65580451|NCT01290419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580452|NCT03737773|Methamphetamine|methamphetamine|mesh-list
65580453|NCT03737773|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65580454|NCT03737773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580455|NCT03737773|Sympathomimetics|sympathomimetics|mesh-ancestor
65580456|NCT03737773|Autonomic Agents|autonomic agents|mesh-ancestor
65580457|NCT03737773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65580458|NCT03737773|Dopamine Agents|dopamine agents|mesh-ancestor
65580459|NCT03737773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65580460|NCT03737773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580461|NCT03737773|Adrenergic Agents|adrenergic agents|mesh-ancestor
65580462|NCT03737773|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65580463|NCT03737773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65580464|NCT03737773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65580465|NCT03737773|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65580466|NCT01060579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65580467|NCT01060579|Latanoprost|latanoprost|mesh-list
65580468|NCT01060579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65580469|NCT04443946|Sufentanil|sufentanil|mesh-list
65580470|NCT04443946|Propofol|propofol|mesh-list
65580471|NCT04443946|Sevoflurane|sevoflurane|mesh-list
65580472|NCT04443946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65580473|NCT04443946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65580474|NCT04443946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580475|NCT04443946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65580476|NCT04443946|Anesthetics, General|anesthetics, general|mesh-ancestor
65580477|NCT04443946|Anesthetics|anesthetics|mesh-ancestor
65580478|NCT04443946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65580479|NCT04443946|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65580480|NCT04443946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65580481|NCT04443946|Narcotics|narcotics|mesh-ancestor
65580482|NCT04443946|Analgesics|analgesics|mesh-ancestor
65580483|NCT04443946|Sensory System Agents|sensory system agents|mesh-ancestor
65580484|NCT04443946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65580485|NCT04443946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65580486|NCT03729973|Lidocaine|lidocaine|mesh-list
65580487|NCT03729973|Magnesium Sulfate|magnesium sulfate|mesh-list
65580488|NCT03729973|Ketamine|ketamine|mesh-list
65580489|NCT03729973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65580490|NCT03729973|Anesthetics, Local|anesthetics, local|mesh-ancestor
65580491|NCT03729973|Anesthetics|anesthetics|mesh-ancestor
65580492|NCT03729973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65580493|NCT03729973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580494|NCT03729973|Sensory System Agents|sensory system agents|mesh-ancestor
65580495|NCT03729973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65580496|NCT03729973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65580497|NCT03729973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65580498|NCT03729973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65580499|NCT03729973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65580500|NCT03729973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580501|NCT03729973|Analgesics|analgesics|mesh-ancestor
65580502|NCT03729973|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65580503|NCT03729973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65580504|NCT03729973|Anesthetics, General|anesthetics, general|mesh-ancestor
65580505|NCT03729973|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65580506|NCT03729973|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65580507|NCT03729973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65580508|NCT03729973|Anticonvulsants|anticonvulsants|mesh-ancestor
65580509|NCT03729973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65580510|NCT03729973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65580511|NCT03729973|Tocolytic Agents|tocolytic agents|mesh-ancestor
65580512|NCT03729973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65580513|NCT01189253|Doxorubicin|doxorubicin|mesh-list
65580514|NCT01189253|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65580515|NCT01189253|Trabectedin|trabectedin|mesh-list
65580516|NCT01189253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65580517|NCT01189253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580518|NCT01189253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65580519|NCT01189253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65580520|NCT01189253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580521|NCT01189253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580522|NCT01189253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65580523|NCT01189253|Alkylating Agents|alkylating agents|mesh-ancestor
65580524|NCT04443868|Nitric Oxide|nitric oxide|mesh-list
65580525|NCT04443868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65580526|NCT04443868|Autonomic Agents|autonomic agents|mesh-ancestor
65580527|NCT04443868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65580528|NCT04443868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580529|NCT04443868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65580530|NCT04443868|Respiratory System Agents|respiratory system agents|mesh-ancestor
65580531|NCT04443868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65580532|NCT04443868|Antioxidants|antioxidants|mesh-ancestor
65580533|NCT04443868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580534|NCT04443868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65580535|NCT04443868|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65580536|NCT04443868|Vasodilator Agents|vasodilator agents|mesh-ancestor
65580537|NCT04443868|Gasotransmitters|gasotransmitters|mesh-ancestor
65580538|NCT04443868|Protective Agents|protective agents|mesh-ancestor
65580539|NCT03851393|Citric Acid|citric acid|mesh-list
65580540|NCT03851393|Sodium Citrate|sodium citrate|mesh-list
65580541|NCT03851393|Anticoagulants|anticoagulants|mesh-ancestor
65580542|NCT03851393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65580543|NCT03851393|Chelating Agents|chelating agents|mesh-ancestor
65580544|NCT03851393|Sequestering Agents|sequestering agents|mesh-ancestor
65580545|NCT03851393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580546|NCT04443556|Tramadol|tramadol|mesh-list
65580547|NCT04443556|Anesthetics|anesthetics|mesh-list
65580548|NCT04443556|Anesthetics, Local|anesthetics, local|mesh-list
65580549|NCT04443556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65580550|NCT04443556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580551|NCT04443556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65580552|NCT04443556|Narcotics|narcotics|mesh-ancestor
65580553|NCT04443556|Analgesics|analgesics|mesh-ancestor
65580554|NCT04443556|Sensory System Agents|sensory system agents|mesh-ancestor
65580555|NCT04443556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65580556|NCT01187615|Cisplatin|cisplatin|mesh-list
65580557|NCT01187615|Pemetrexed|pemetrexed|mesh-list
65580558|NCT01187615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580559|NCT01187615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580560|NCT01187615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580561|NCT01187615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65580562|NCT01187615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65580563|NCT05375097|Erenumab|erenumab|mesh-list
65580564|NCT05375097|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65580565|NCT05375097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580566|NCT05375097|Analgesics|analgesics|mesh-ancestor
65580567|NCT05375097|Sensory System Agents|sensory system agents|mesh-ancestor
65580568|NCT05375097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65580569|NCT05375097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580571|NCT02752191|Hematinics|hematinics|mesh-ancestor
65580572|NCT02752191|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65580573|NCT02752191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65580574|NCT01290497|Hyaluronic Acid|hyaluronic acid|mesh-list
65580575|NCT01290497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65580576|NCT01290497|Immunologic Factors|immunologic factors|mesh-ancestor
65580577|NCT01290497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580578|NCT01290497|Viscosupplements|viscosupplements|mesh-ancestor
65580579|NCT01290497|Protective Agents|protective agents|mesh-ancestor
65580580|NCT04509466|Mitoxantrone|mitoxantrone|mesh-list
65580581|NCT04509466|Pegaspargase|pegaspargase|mesh-list
65580582|NCT04509466|Asparaginase|asparaginase|mesh-list
65580583|NCT04509466|Analgesics|analgesics|mesh-ancestor
65580584|NCT04509466|Sensory System Agents|sensory system agents|mesh-ancestor
65580585|NCT04509466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65580586|NCT04509466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580587|NCT04509466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580588|NCT04509466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65580589|NCT04509466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65580590|NCT04509466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580591|NCT04509466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580592|NCT03738215|Cariprazine|cariprazine|mesh-list
65580593|NCT03738215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65580594|NCT03738215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65580595|NCT03738215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65580596|NCT03738215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580597|NCT03738215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65580598|NCT03016377|Cyclophosphamide|cyclophosphamide|mesh-list
65580599|NCT03016377|Fludarabine|fludarabine|mesh-list
65580600|NCT03016377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65580601|NCT03016377|Immunologic Factors|immunologic factors|mesh-ancestor
65580602|NCT03016377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580603|NCT03016377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65580604|NCT03016377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65580605|NCT03016377|Alkylating Agents|alkylating agents|mesh-ancestor
65580606|NCT03016377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580607|NCT03016377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580608|NCT03016377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65580609|NCT05352321|Gemcitabine|gemcitabine|mesh-list
65580610|NCT05352321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580611|NCT05352321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65580612|NCT05352321|Antimetabolites|antimetabolites|mesh-ancestor
65580613|NCT05352321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580614|NCT05352321|Antiviral Agents|antiviral agents|mesh-ancestor
65580615|NCT05352321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65580616|NCT05352321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580617|NCT05352321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65580618|NCT05352321|Immunologic Factors|immunologic factors|mesh-ancestor
65580619|NCT05352321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580620|NCT03199911|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65580621|NCT03199911|Erythromycin|erythromycin|mesh-list
65580622|NCT03199911|Bacitracin|bacitracin|mesh-list
65580623|NCT03199911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65580624|NCT03199911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65580625|NCT03199911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65580626|NCT03199911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580627|NCT03199911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580628|NCT03199911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65580629|NCT02517814|Vitamin D|vitamin d|mesh-list
65580630|NCT02517814|Vitamins|vitamins|mesh-ancestor
65580631|NCT02517814|Micronutrients|micronutrients|mesh-ancestor
65580632|NCT02517814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580633|NCT02517814|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65580634|NCT05303727|Cyclosporine|cyclosporine|mesh-list
65580635|NCT05303727|Mycophenolic Acid|mycophenolic acid|mesh-list
65580636|NCT05303727|Cyclophosphamide|cyclophosphamide|mesh-list
65580637|NCT05303727|Melphalan|melphalan|mesh-list
65580638|NCT05303727|Busulfan|busulfan|mesh-list
65580639|NCT05303727|Thiotepa|thiotepa|mesh-list
65580640|NCT05303727|Methotrexate|methotrexate|mesh-list
65580641|NCT05303727|Fludarabine|fludarabine|mesh-list
65580642|NCT05303727|Topotecan|topotecan|mesh-list
65580643|NCT05303727|Tacrolimus|tacrolimus|mesh-list
65580644|NCT05303727|Cyclosporins|cyclosporins|mesh-list
65580645|NCT05303727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65580646|NCT05303727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65580647|NCT05303727|Immunologic Factors|immunologic factors|mesh-ancestor
65580648|NCT05303727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580649|NCT05303727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65580650|NCT05303727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65580651|NCT05303727|Alkylating Agents|alkylating agents|mesh-ancestor
65580652|NCT05303727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580653|NCT05303727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580654|NCT05303727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65580655|NCT05303727|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65580656|NCT05303727|Abortifacient Agents|abortifacient agents|mesh-ancestor
65580657|NCT05303727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65580658|NCT05303727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65580660|NCT05303727|Dermatologic Agents|dermatologic agents|mesh-ancestor
65580661|NCT05303727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580662|NCT05303727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65580663|NCT05303727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65580664|NCT05303727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65580665|NCT05303727|Antifungal Agents|antifungal agents|mesh-ancestor
65580666|NCT05303727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65580667|NCT05303727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65580668|NCT05303727|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65580669|NCT05303727|Antitubercular Agents|antitubercular agents|mesh-ancestor
65580670|NCT05303727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65580671|NCT05303727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65580672|NCT05303727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65580673|NCT05480800|Vaccines|vaccines|mesh-list
65580674|NCT05480800|Immunologic Factors|immunologic factors|mesh-ancestor
65580675|NCT05480800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580676|NCT04502368|Dimercaprol|dimercaprol|mesh-list
65580677|NCT04502368|Chelating Agents|chelating agents|mesh-ancestor
65580678|NCT04502368|Sequestering Agents|sequestering agents|mesh-ancestor
65580679|NCT04502368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580680|NCT04984083|Vitamin K|vitamin k|mesh-list
65580681|NCT04984083|Vitamins|vitamins|mesh-ancestor
65580682|NCT04984083|Micronutrients|micronutrients|mesh-ancestor
65580683|NCT04984083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580684|NCT04984083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65580685|NCT04984083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65580686|NCT04984083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580687|NCT04984083|Hemostatics|hemostatics|mesh-ancestor
65580688|NCT04984083|Coagulants|coagulants|mesh-ancestor
65580689|NCT03736967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65580690|NCT03736967|Immunologic Factors|immunologic factors|mesh-ancestor
65580691|NCT03736967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580692|NCT05224089|Dexamethasone|dexamethasone|mesh-list
65580693|NCT05224089|Epinephrine|epinephrine|mesh-list
65580694|NCT05224089|Bupivacaine|bupivacaine|mesh-list
65580695|NCT05224089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65580696|NCT05224089|Antiemetics|antiemetics|mesh-ancestor
65580697|NCT05224089|Autonomic Agents|autonomic agents|mesh-ancestor
65580698|NCT05224089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65580699|NCT05224089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580700|NCT05224089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65580701|NCT05224089|Glucocorticoids|glucocorticoids|mesh-ancestor
65580702|NCT05224089|Hormones|hormones|mesh-ancestor
65580703|NCT05224089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65580704|NCT05224089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65580705|NCT05224089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580706|NCT05224089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306901|NCT04975022|Insulin|insulin|mesh-list
65580707|NCT05224089|Anesthetics, Local|anesthetics, local|mesh-ancestor
65580708|NCT05224089|Anesthetics|anesthetics|mesh-ancestor
65580709|NCT05224089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65580710|NCT05224089|Sensory System Agents|sensory system agents|mesh-ancestor
65580711|NCT05224089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65580712|NCT05224089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65580713|NCT05224089|Adrenergic Agents|adrenergic agents|mesh-ancestor
65580714|NCT05224089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65580715|NCT05224089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65580716|NCT05224089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65580717|NCT05224089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65580718|NCT05224089|Respiratory System Agents|respiratory system agents|mesh-ancestor
65580719|NCT05224089|Mydriatics|mydriatics|mesh-ancestor
65580720|NCT05224089|Sympathomimetics|sympathomimetics|mesh-ancestor
65580722|NCT01581203|Interferons|interferons|mesh-list
65580723|NCT01581203|Ribavirin|ribavirin|mesh-list
65580724|NCT01581203|Interferon-alpha|interferon-alpha|mesh-list
65580725|NCT01581203|Interferon alpha-2|interferon alpha-2|mesh-list
65580726|NCT01581203|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65580727|NCT01581203|Asunaprevir|asunaprevir|mesh-list
65580728|NCT01581203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580729|NCT01581203|Antiviral Agents|antiviral agents|mesh-ancestor
65580730|NCT01581203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65580731|NCT01581203|Antimetabolites|antimetabolites|mesh-ancestor
65580732|NCT01581203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580733|NCT01581203|Immunologic Factors|immunologic factors|mesh-ancestor
65580734|NCT01581203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580735|NCT01581203|Protease Inhibitors|protease inhibitors|mesh-ancestor
65580736|NCT01581203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580737|NCT03168555|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
65580738|NCT03168555|Cathartics|cathartics|mesh-ancestor
65580739|NCT03168555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65580740|NCT03235050|Liraglutide|liraglutide|mesh-list
65580741|NCT03235050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65580742|NCT03235050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580743|NCT03235050|Incretins|incretins|mesh-ancestor
65580744|NCT03235050|Hormones|hormones|mesh-ancestor
65580745|NCT03235050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65580746|NCT04933149|Ketamine|ketamine|mesh-list
65580747|NCT04933149|Analgesics|analgesics|mesh-ancestor
65580748|NCT04933149|Sensory System Agents|sensory system agents|mesh-ancestor
65580749|NCT04933149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65580750|NCT04933149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580751|NCT04933149|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65580752|NCT04933149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65580753|NCT04933149|Anesthetics, General|anesthetics, general|mesh-ancestor
65580754|NCT04933149|Anesthetics|anesthetics|mesh-ancestor
65580755|NCT04933149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65580756|NCT04933149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65580757|NCT04933149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65580758|NCT04933149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65580759|NCT04933149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580760|NCT01189721|Propofol|propofol|mesh-list
65580761|NCT01189721|Sevoflurane|sevoflurane|mesh-list
65580762|NCT01189721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65580763|NCT01189721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65580764|NCT01189721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580765|NCT01189721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65580766|NCT01189721|Anesthetics, General|anesthetics, general|mesh-ancestor
65580767|NCT01189721|Anesthetics|anesthetics|mesh-ancestor
65580768|NCT01189721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65580769|NCT01189721|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65580770|NCT03167619|Durvalumab|durvalumab|mesh-list
65580771|NCT03167619|Olaparib|olaparib|mesh-list
65580772|NCT03167619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65580773|NCT03167619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580774|NCT03167619|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65580775|NCT03167619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580776|NCT03167619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580777|NCT03198507|Amoxicillin|amoxicillin|mesh-list
65580778|NCT03198507|Rifabutin|rifabutin|mesh-list
65580779|NCT03198507|Omeprazole|omeprazole|mesh-list
65580780|NCT03198507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65580781|NCT03198507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65580782|NCT03198507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65580783|NCT03198507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65580784|NCT03198507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65580785|NCT03198507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580786|NCT03198507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580787|NCT03198507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65580788|NCT03198507|Antitubercular Agents|antitubercular agents|mesh-ancestor
65580789|NCT03850769|Paclitaxel|paclitaxel|mesh-list
65580790|NCT03850769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65580791|NCT03850769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580792|NCT03850769|Tubulin Modulators|tubulin modulators|mesh-ancestor
65580793|NCT03850769|Antimitotic Agents|antimitotic agents|mesh-ancestor
65580794|NCT03850769|Mitosis Modulators|mitosis modulators|mesh-ancestor
65580795|NCT03850769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580796|NCT04663464|Abaloparatide|abaloparatide|mesh-list
65580797|NCT04663464|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
65580798|NCT04663464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65580799|NCT04663464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580800|NCT04663464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65580801|NCT04469595|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
65580802|NCT04469595|Aflibercept|aflibercept|mesh-list
65580803|NCT04469595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65580804|NCT04469595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65580805|NCT04469595|Growth Substances|growth substances|mesh-ancestor
65580806|NCT04469595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580807|NCT04469595|Growth Inhibitors|growth inhibitors|mesh-ancestor
65580808|NCT04469595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580809|NCT04469595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65580810|NCT04469595|Glucocorticoids|glucocorticoids|mesh-ancestor
65580812|NCT04469595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65580813|NCT01292993|Metformin|metformin|mesh-list
65580814|NCT01292993|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65580815|NCT01292993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65580816|NCT01292993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580817|NCT01292993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65580818|NCT01292993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580819|NCT03849833|Vitamin D|vitamin d|mesh-list
65580820|NCT03849833|Cholecalciferol|cholecalciferol|mesh-list
65580821|NCT03849833|Vitamins|vitamins|mesh-ancestor
65580822|NCT03849833|Micronutrients|micronutrients|mesh-ancestor
65580823|NCT03849833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580824|NCT03849833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65580825|NCT03849833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65580826|NCT03167151|Pembrolizumab|pembrolizumab|mesh-list
65580827|NCT03167151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65580828|NCT03167151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580829|NCT04910711|Dolutegravir|dolutegravir|mesh-list
65580830|NCT04910711|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65580831|NCT04910711|Levonorgestrel|levonorgestrel|mesh-list
65580832|NCT04910711|Medroxyprogesterone|medroxyprogesterone|mesh-list
65580833|NCT04910711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65580834|NCT04910711|Contraceptive Agents|contraceptive agents|mesh-ancestor
65580835|NCT04910711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65580836|NCT04910711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580837|NCT04910711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65580838|NCT04910711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65580839|NCT04910711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65580840|NCT04910711|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65580841|NCT04910711|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65580842|NCT04910711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580843|NCT04910711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580844|NCT04910711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65580845|NCT04910711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65580846|NCT04910711|Antiviral Agents|antiviral agents|mesh-ancestor
65580847|NCT04910711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65580848|NCT04910711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65580849|NCT04910711|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65580850|NCT04910711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65580851|NCT04910711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580852|NCT01191203|Copper|copper|mesh-list
65580853|NCT01191203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65580854|NCT01191203|Medroxyprogesterone|medroxyprogesterone|mesh-list
65580855|NCT01191203|Trace Elements|trace elements|mesh-ancestor
65580856|NCT01191203|Micronutrients|micronutrients|mesh-ancestor
65580857|NCT01191203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580858|NCT01191203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65580859|NCT01191203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65580860|NCT01191203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65580861|NCT01191203|Contraceptive Agents|contraceptive agents|mesh-ancestor
65580862|NCT01191203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65580863|NCT01191203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65580864|NCT01191203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65580865|NCT01191203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65580866|NCT01191203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65580867|NCT01191203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580868|NCT03197883|Sunscreening Agents|sunscreening agents|mesh-list
65580869|NCT03197883|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65580870|NCT03197883|Protective Agents|protective agents|mesh-ancestor
65580871|NCT03197883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580872|NCT03197883|Dermatologic Agents|dermatologic agents|mesh-ancestor
65580873|NCT03729505|Lidocaine|lidocaine|mesh-list
65580874|NCT03729505|Magnesium Sulfate|magnesium sulfate|mesh-list
65580875|NCT03729505|Anesthetics, Local|anesthetics, local|mesh-ancestor
65580876|NCT03729505|Anesthetics|anesthetics|mesh-ancestor
65580877|NCT03729505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65580878|NCT03729505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580879|NCT03729505|Sensory System Agents|sensory system agents|mesh-ancestor
65580880|NCT03729505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65580881|NCT03729505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65580882|NCT03729505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65580883|NCT03729505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65580884|NCT03729505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65580885|NCT03729505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580886|NCT03729505|Analgesics|analgesics|mesh-ancestor
65580887|NCT03729505|Anticonvulsants|anticonvulsants|mesh-ancestor
65580888|NCT03729505|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65580889|NCT03729505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65580890|NCT03729505|Tocolytic Agents|tocolytic agents|mesh-ancestor
65580891|NCT03729505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65580892|NCT03234036|Ritonavir|ritonavir|mesh-list
65580893|NCT03234036|GSK-2838232|gsk-2838232|mesh-list
65580894|NCT03234036|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65580895|NCT03234036|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65580896|NCT03234036|Protease Inhibitors|protease inhibitors|mesh-ancestor
65580897|NCT03234036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580898|NCT03234036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580899|NCT03234036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65580900|NCT03234036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65580901|NCT03234036|Antiviral Agents|antiviral agents|mesh-ancestor
65580902|NCT03234036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65580903|NCT03234036|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65580904|NCT03234036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65580905|NCT03606109|Tranexamic Acid|tranexamic acid|mesh-list
65580906|NCT03606109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65580907|NCT03606109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65580908|NCT03606109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580909|NCT03606109|Hemostatics|hemostatics|mesh-ancestor
65580910|NCT03606109|Coagulants|coagulants|mesh-ancestor
65580911|NCT01293071|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65580912|NCT01293071|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65580913|NCT01293071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65580914|NCT01293071|Antitubercular Agents|antitubercular agents|mesh-ancestor
65580915|NCT01193855|Dutasteride|dutasteride|mesh-list
65580916|NCT01193855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65580917|NCT01193855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65580918|NCT01193855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580919|NCT01193855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580920|NCT01193855|Hormone Antagonists|hormone antagonists|mesh-ancestor
65580921|NCT01193855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65580922|NCT01193855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580923|NCT01190345|Bevacizumab|bevacizumab|mesh-list
65580924|NCT01190345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65580925|NCT01190345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580926|NCT01190345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65580927|NCT01190345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65580928|NCT01190345|Growth Substances|growth substances|mesh-ancestor
65580929|NCT01190345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580930|NCT01190345|Growth Inhibitors|growth inhibitors|mesh-ancestor
65580931|NCT02729896|Rituximab|rituximab|mesh-list
65580932|NCT02729896|Obinutuzumab|obinutuzumab|mesh-list
65580933|NCT02729896|Atezolizumab|atezolizumab|mesh-list
65580934|NCT02729896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65580935|NCT02729896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580936|NCT02729896|Immunologic Factors|immunologic factors|mesh-ancestor
65580937|NCT02729896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580938|NCT02729896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65580939|NCT04540380|Cyclophosphamide|cyclophosphamide|mesh-list
65580940|NCT04540380|Rituximab|rituximab|mesh-list
65580941|NCT04540380|Fludarabine|fludarabine|mesh-list
65580942|NCT04540380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65378462|NCT03974035|Ropivacaine|ropivacaine|mesh-list
65580943|NCT04540380|Immunologic Factors|immunologic factors|mesh-ancestor
65580944|NCT04540380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580945|NCT04540380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65580946|NCT04540380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65580947|NCT04540380|Alkylating Agents|alkylating agents|mesh-ancestor
65580948|NCT04540380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580949|NCT04540380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65580950|NCT04540380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65580951|NCT04540380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65580952|NCT04506034|Lidocaine|lidocaine|mesh-list
65580953|NCT04506034|Anesthetics, Local|anesthetics, local|mesh-ancestor
65580954|NCT04506034|Anesthetics|anesthetics|mesh-ancestor
65580955|NCT04506034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65580956|NCT04506034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580957|NCT04506034|Sensory System Agents|sensory system agents|mesh-ancestor
65580958|NCT04506034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65580959|NCT04506034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65580960|NCT04506034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65580961|NCT04506034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65580962|NCT04506034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65580963|NCT04506034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580964|NCT01294631|Canagliflozin|canagliflozin|mesh-list
65580965|NCT01294631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65580966|NCT01294631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580967|NCT01294631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65580968|NCT01294631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580969|NCT03849209|Pancrelipase|pancrelipase|mesh-list
65580970|NCT03849209|Pancreatin|pancreatin|mesh-list
65580971|NCT03849209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65580972|NCT05342662|Methamphetamine|methamphetamine|mesh-list
65580973|NCT05342662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65580974|NCT05342662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580975|NCT05342662|Sympathomimetics|sympathomimetics|mesh-ancestor
65580976|NCT05342662|Autonomic Agents|autonomic agents|mesh-ancestor
65580977|NCT05342662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65580978|NCT05342662|Dopamine Agents|dopamine agents|mesh-ancestor
65580979|NCT05342662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65580980|NCT05342662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580981|NCT05342662|Adrenergic Agents|adrenergic agents|mesh-ancestor
65580982|NCT05342662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65580983|NCT05342662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65580984|NCT05342662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65580985|NCT05342662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65580986|NCT03847571|Acetazolamide|acetazolamide|mesh-list
65580987|NCT03847571|Anticonvulsants|anticonvulsants|mesh-ancestor
65580988|NCT03847571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65580989|NCT03847571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65580990|NCT03847571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65580991|NCT03847571|Diuretics|diuretics|mesh-ancestor
65580992|NCT03847571|Natriuretic Agents|natriuretic agents|mesh-ancestor
65580993|NCT03847571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65580994|NCT01293149|Clonidine|clonidine|mesh-list
65580995|NCT01293149|Ropivacaine|ropivacaine|mesh-list
65580996|NCT01293149|Anesthetics, Local|anesthetics, local|mesh-ancestor
65580997|NCT01293149|Anesthetics|anesthetics|mesh-ancestor
65580998|NCT01293149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65580999|NCT01293149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581000|NCT01293149|Sensory System Agents|sensory system agents|mesh-ancestor
65581001|NCT01293149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65581002|NCT01293149|Analgesics|analgesics|mesh-ancestor
65581003|NCT01293149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65581004|NCT01293149|Sympatholytics|sympatholytics|mesh-ancestor
65581005|NCT01293149|Autonomic Agents|autonomic agents|mesh-ancestor
65581006|NCT01293149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65581007|NCT01293149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65581008|NCT01293149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65581009|NCT01293149|Adrenergic Agents|adrenergic agents|mesh-ancestor
65581010|NCT01293149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65581011|NCT01293149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581012|NCT04454424|Midazolam|midazolam|mesh-list
65581013|NCT04454424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65581014|NCT04454424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65581015|NCT04454424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65581016|NCT04454424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581018|NCT04454424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65581019|NCT04454424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65581020|NCT04454424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65581021|NCT04454424|Anesthetics, General|anesthetics, general|mesh-ancestor
65581022|NCT04454424|Anesthetics|anesthetics|mesh-ancestor
65581023|NCT04454424|GABA Modulators|gaba modulators|mesh-ancestor
65581024|NCT04454424|GABA Agents|gaba agents|mesh-ancestor
65581025|NCT04454424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65581026|NCT04454424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581027|NCT03348046|Infliximab|infliximab|mesh-list
65581028|NCT03348046|Dermatologic Agents|dermatologic agents|mesh-ancestor
65581029|NCT03348046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65581030|NCT03348046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65581031|NCT05653492|Sulforaphane|sulforaphane|mesh-list
65581032|NCT05653492|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65581033|NCT05653492|Protective Agents|protective agents|mesh-ancestor
65581034|NCT05653492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581035|NCT05653492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581036|NCT04505644|Lidocaine|lidocaine|mesh-list
65581037|NCT04505644|Anesthetics, Local|anesthetics, local|mesh-ancestor
65581038|NCT04505644|Anesthetics|anesthetics|mesh-ancestor
65581039|NCT04505644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65581040|NCT04505644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581041|NCT04505644|Sensory System Agents|sensory system agents|mesh-ancestor
65581042|NCT04505644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65581043|NCT04505644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65581044|NCT04505644|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65581045|NCT04505644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65581046|NCT04505644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65581047|NCT04505644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581048|NCT04505800|Tryptophan|tryptophan|mesh-list
65581049|NCT04505800|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65581050|NCT04505800|Antidepressive Agents|antidepressive agents|mesh-ancestor
65581051|NCT04505800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65581052|NCT05200156|Choline|choline|mesh-list
65581053|NCT05200156|Lipotropic Agents|lipotropic agents|mesh-ancestor
65581054|NCT05200156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65581055|NCT05200156|Antimetabolites|antimetabolites|mesh-ancestor
65581056|NCT05200156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581057|NCT05200156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65581058|NCT05200156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65581059|NCT05200156|Nootropic Agents|nootropic agents|mesh-ancestor
65581060|NCT03347968|Warfarin|warfarin|mesh-list
65581061|NCT03347968|Esmolol|esmolol|mesh-list
65581062|NCT03347968|Anticoagulants|anticoagulants|mesh-ancestor
65581063|NCT03347968|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65581064|NCT03347968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65581065|NCT03347968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65581066|NCT03347968|Adrenergic Agents|adrenergic agents|mesh-ancestor
65581067|NCT03347968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65581068|NCT03347968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581069|NCT03347968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581070|NCT01191593|Ropivacaine|ropivacaine|mesh-list
65581071|NCT01191593|Anesthetics, Local|anesthetics, local|mesh-ancestor
65581072|NCT01191593|Anesthetics|anesthetics|mesh-ancestor
65581073|NCT01191593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65581074|NCT01191593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581075|NCT01191593|Sensory System Agents|sensory system agents|mesh-ancestor
65581076|NCT01191593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65581077|NCT03347890|Liraglutide|liraglutide|mesh-list
65581078|NCT03347890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64582074|NCT04887285|Anesthetics|anesthetics|mesh-list
65581079|NCT03347890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581080|NCT03347890|Incretins|incretins|mesh-ancestor
65581081|NCT03347890|Hormones|hormones|mesh-ancestor
65581082|NCT03347890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65581083|NCT01296503|Thalidomide|thalidomide|mesh-list
65581084|NCT01296503|Dexamethasone|dexamethasone|mesh-list
65581085|NCT01296503|Dexamethasone acetate|dexamethasone acetate|mesh-list
65581086|NCT01296503|BB 1101|bb 1101|mesh-list
65581087|NCT01296503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65581088|NCT01296503|Antiemetics|antiemetics|mesh-ancestor
65581089|NCT01296503|Autonomic Agents|autonomic agents|mesh-ancestor
65581090|NCT01296503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65378608|NCT00884676|Growth Inhibitors|growth inhibitors|mesh-ancestor
65581091|NCT01296503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581092|NCT01296503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65581093|NCT01296503|Glucocorticoids|glucocorticoids|mesh-ancestor
65581094|NCT01296503|Hormones|hormones|mesh-ancestor
65581095|NCT01296503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65581096|NCT01296503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65581097|NCT01296503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581098|NCT01296503|Protease Inhibitors|protease inhibitors|mesh-ancestor
65581099|NCT01296503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65581100|NCT01296503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581101|NCT01296503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65581102|NCT01296503|Immunologic Factors|immunologic factors|mesh-ancestor
65581103|NCT01296503|Leprostatic Agents|leprostatic agents|mesh-ancestor
65581104|NCT01296503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65581105|NCT01296503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65581106|NCT01296503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65581107|NCT01296503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65581108|NCT01296503|Growth Substances|growth substances|mesh-ancestor
65581109|NCT01296503|Growth Inhibitors|growth inhibitors|mesh-ancestor
65581110|NCT01295099|Triamcinolone|triamcinolone|mesh-list
65581111|NCT01295099|Fluorouracil|fluorouracil|mesh-list
65581112|NCT01295099|Antimetabolites|antimetabolites|mesh-ancestor
65581113|NCT01295099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581114|NCT01295099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65581115|NCT01295099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581116|NCT01295099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65581117|NCT01295099|Immunologic Factors|immunologic factors|mesh-ancestor
65581118|NCT01295099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581119|NCT01295099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65581120|NCT01295099|Glucocorticoids|glucocorticoids|mesh-ancestor
65581121|NCT01295099|Hormones|hormones|mesh-ancestor
65581122|NCT01295099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65581123|NCT01426529|Norepinephrine|norepinephrine|mesh-list
65581124|NCT01426529|Angiotensin II|angiotensin ii|mesh-list
65581125|NCT01426529|Giapreza|giapreza|mesh-list
65581126|NCT01426529|Angiotensinogen|angiotensinogen|mesh-list
65581127|NCT01426529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65581128|NCT01426529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65581129|NCT01426529|Adrenergic Agents|adrenergic agents|mesh-ancestor
65581130|NCT01426529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65581131|NCT01426529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581132|NCT01426529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581133|NCT01426529|Sympathomimetics|sympathomimetics|mesh-ancestor
65581134|NCT01426529|Autonomic Agents|autonomic agents|mesh-ancestor
65581135|NCT01426529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65581136|NCT01426529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65581137|NCT01426529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65581138|NCT01426529|Protease Inhibitors|protease inhibitors|mesh-ancestor
65581139|NCT01426529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65581140|NCT03122158|Citalopram|citalopram|mesh-list
65581141|NCT03122158|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65581142|NCT03122158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65581143|NCT03122158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65581144|NCT03122158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581145|NCT03122158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65581146|NCT03122158|Serotonin Agents|serotonin agents|mesh-ancestor
65581147|NCT03122158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581148|NCT03122158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65581149|NCT03122158|Antidepressive Agents|antidepressive agents|mesh-ancestor
65581150|NCT03122158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65581151|NCT02668653|Cytarabine|cytarabine|mesh-list
65581152|NCT02668653|Daunorubicin|daunorubicin|mesh-list
65581153|NCT02668653|Idarubicin|idarubicin|mesh-list
65581154|NCT02668653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65581155|NCT02668653|Antimetabolites|antimetabolites|mesh-ancestor
65581156|NCT02668653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581157|NCT02668653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581158|NCT02668653|Antiviral Agents|antiviral agents|mesh-ancestor
65581159|NCT02668653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65581160|NCT02668653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65581161|NCT02668653|Immunologic Factors|immunologic factors|mesh-ancestor
65581162|NCT02668653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581163|NCT02668653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65581164|NCT02668653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65378688|NCT00891696|Sirolimus|sirolimus|mesh-list
65581165|NCT02668653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65581166|NCT02668653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65581167|NCT03555565|Metformin|metformin|mesh-list
65581168|NCT03555565|Alogliptin|alogliptin|mesh-list
65581169|NCT03555565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65581170|NCT03555565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581171|NCT03555565|Incretins|incretins|mesh-ancestor
65581172|NCT03555565|Hormones|hormones|mesh-ancestor
65581173|NCT03555565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65581174|NCT03555565|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65581175|NCT03555565|Protease Inhibitors|protease inhibitors|mesh-ancestor
65581176|NCT03555565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65581177|NCT03555565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581178|NCT01190735|Caffeine|caffeine|mesh-list
65581179|NCT01190735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65581180|NCT01190735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581181|NCT01190735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65581182|NCT01190735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65581183|NCT01190735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581184|NCT01190735|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65581185|NCT01190735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65581186|NCT01190735|Purinergic Agents|purinergic agents|mesh-ancestor
65581187|NCT01190735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65581188|NCT05097118|Ketamine|ketamine|mesh-list
65581189|NCT05097118|Bupivacaine|bupivacaine|mesh-list
65581190|NCT05097118|Anesthetics, Local|anesthetics, local|mesh-ancestor
65581191|NCT05097118|Anesthetics|anesthetics|mesh-ancestor
65581192|NCT05097118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65581193|NCT05097118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581194|NCT05097118|Sensory System Agents|sensory system agents|mesh-ancestor
65581195|NCT05097118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65581196|NCT05097118|Analgesics|analgesics|mesh-ancestor
65581197|NCT05097118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65581198|NCT05097118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65581199|NCT05097118|Anesthetics, General|anesthetics, general|mesh-ancestor
65581200|NCT05097118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65581201|NCT05097118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65581202|NCT05097118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65581203|NCT05097118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581204|NCT01194791|Dexamethasone|dexamethasone|mesh-list
65581205|NCT01194791|Cyclophosphamide|cyclophosphamide|mesh-list
65581206|NCT01194791|Lenalidomide|lenalidomide|mesh-list
65581207|NCT01194791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65581208|NCT01194791|Immunologic Factors|immunologic factors|mesh-ancestor
65581209|NCT01194791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581210|NCT01194791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65581211|NCT01194791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65581212|NCT01194791|Alkylating Agents|alkylating agents|mesh-ancestor
65581213|NCT01194791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581214|NCT01194791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581215|NCT01194791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65581216|NCT01194791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65581217|NCT01194791|Antiemetics|antiemetics|mesh-ancestor
65581218|NCT01194791|Autonomic Agents|autonomic agents|mesh-ancestor
65581219|NCT01194791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65581220|NCT01194791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65581221|NCT01194791|Glucocorticoids|glucocorticoids|mesh-ancestor
65581222|NCT01194791|Hormones|hormones|mesh-ancestor
65581223|NCT01194791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65581224|NCT01194791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65581225|NCT01194791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65581226|NCT01194791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65581227|NCT01194791|Growth Substances|growth substances|mesh-ancestor
65581228|NCT01194791|Growth Inhibitors|growth inhibitors|mesh-ancestor
65581229|NCT03351322|Minoxidil|minoxidil|mesh-list
65581230|NCT03351322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65581231|NCT03351322|Vasodilator Agents|vasodilator agents|mesh-ancestor
65581232|NCT01296971|Ribavirin|ribavirin|mesh-list
65581233|NCT01296971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65581234|NCT01296971|Antimetabolites|antimetabolites|mesh-ancestor
65581235|NCT01296971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581236|NCT01296971|Antiviral Agents|antiviral agents|mesh-ancestor
65581237|NCT01296971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65581238|NCT01195181|Ribavirin|ribavirin|mesh-list
65378758|NCT01073761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65581239|NCT01195181|Antimetabolites|antimetabolites|mesh-ancestor
65581240|NCT01195181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581241|NCT01195181|Antiviral Agents|antiviral agents|mesh-ancestor
65581242|NCT01195181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65581243|NCT03845699|Fentanyl|fentanyl|mesh-list
65581244|NCT03845699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65581245|NCT03845699|Narcotics|narcotics|mesh-ancestor
65581246|NCT03845699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65581247|NCT03845699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581248|NCT03845699|Analgesics|analgesics|mesh-ancestor
65581249|NCT03845699|Sensory System Agents|sensory system agents|mesh-ancestor
65581250|NCT03845699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65581251|NCT03845699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65581252|NCT03845699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65581253|NCT03845699|Anesthetics, General|anesthetics, general|mesh-ancestor
65581254|NCT03845699|Anesthetics|anesthetics|mesh-ancestor
65581255|NCT03845777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
65581256|NCT03845777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65581257|NCT00709618|Vinorelbine|vinorelbine|mesh-list
65581258|NCT00709618|Lapatinib|lapatinib|mesh-list
65581259|NCT00709618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65581260|NCT00709618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581261|NCT00709618|Tubulin Modulators|tubulin modulators|mesh-ancestor
65581262|NCT00709618|Antimitotic Agents|antimitotic agents|mesh-ancestor
65581263|NCT00709618|Mitosis Modulators|mitosis modulators|mesh-ancestor
65581264|NCT00709618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581265|NCT00709618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65581266|NCT00709618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65581267|NCT01195259|Metformin|metformin|mesh-list
65581268|NCT01195259|Rosiglitazone|rosiglitazone|mesh-list
65581269|NCT01195259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65581270|NCT01195259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581271|NCT05584228|Azathioprine|azathioprine|mesh-list
65581272|NCT05584228|Infliximab|infliximab|mesh-list
65581273|NCT05584228|Dermatologic Agents|dermatologic agents|mesh-ancestor
65581274|NCT05584228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65581275|NCT05584228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65581276|NCT05584228|Antimetabolites|antimetabolites|mesh-ancestor
65581277|NCT05584228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581278|NCT05584228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65581279|NCT05584228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581280|NCT05584228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65581281|NCT05584228|Immunologic Factors|immunologic factors|mesh-ancestor
65581282|NCT05584228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581283|NCT03193047|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
65581284|NCT03193047|Evolocumab|evolocumab|mesh-list
65581285|NCT03193047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65581286|NCT03193047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65581287|NCT03193047|Antimetabolites|antimetabolites|mesh-ancestor
65581288|NCT03193047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581289|NCT03193047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65581290|NCT03193047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65581291|NCT03193047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65581292|NCT03193047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581293|NCT04504552|Avelumab|avelumab|mesh-list
65581294|NCT04504552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65581295|NCT04504552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581296|NCT03845387|Pramipexole|pramipexole|mesh-list
65581297|NCT03845387|Antioxidants|antioxidants|mesh-ancestor
65581298|NCT03845387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581299|NCT03845387|Protective Agents|protective agents|mesh-ancestor
65581300|NCT03845387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581301|NCT03845387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65581302|NCT03845387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65581303|NCT03845387|Dopamine Agonists|dopamine agonists|mesh-ancestor
65581304|NCT03845387|Dopamine Agents|dopamine agents|mesh-ancestor
65581305|NCT03845387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65581306|NCT01295177|Insulin|insulin|mesh-list
65581307|NCT01295177|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65581308|NCT01295177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65581309|NCT01295177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581310|NCT02918019|Astegolimab|astegolimab|mesh-list
65581311|NCT02918019|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65581312|NCT02918019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65581313|NCT02918019|Antiviral Agents|antiviral agents|mesh-ancestor
65581314|NCT02918019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65581315|NCT04848454|Vinorelbine|vinorelbine|mesh-list
65581316|NCT04848454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581317|NCT04848454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65581318|NCT04848454|Tubulin Modulators|tubulin modulators|mesh-ancestor
65581319|NCT04848454|Antimitotic Agents|antimitotic agents|mesh-ancestor
65581320|NCT04848454|Mitosis Modulators|mitosis modulators|mesh-ancestor
65581321|NCT04848454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581322|NCT04842292|Heparin|heparin|mesh-list
65581323|NCT04842292|Anticoagulants|anticoagulants|mesh-ancestor
65581324|NCT04842292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65581325|NCT04842292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65581326|NCT04842292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581327|NCT01191983|Epoetin Alfa|epoetin alfa|mesh-list
65581328|NCT01191983|Hematinics|hematinics|mesh-ancestor
65581329|NCT03055988|Fluticasone|fluticasone|mesh-list
65581331|NCT03055988|Tiotropium Bromide|tiotropium bromide|mesh-list
65581332|NCT03055988|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65581333|NCT03055988|Olodaterol|olodaterol|mesh-list
65581334|NCT03055988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65581335|NCT03055988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65581336|NCT03055988|Autonomic Agents|autonomic agents|mesh-ancestor
65581337|NCT03055988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65581338|NCT03055988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581339|NCT03055988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65581340|NCT03055988|Respiratory System Agents|respiratory system agents|mesh-ancestor
65581341|NCT03055988|Dermatologic Agents|dermatologic agents|mesh-ancestor
65581342|NCT03055988|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65581343|NCT03055988|Parasympatholytics|parasympatholytics|mesh-ancestor
65581344|NCT03055988|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65581345|NCT03055988|Cholinergic Agents|cholinergic agents|mesh-ancestor
65581346|NCT03055988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65581347|NCT03055988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581348|NCT03055988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65581349|NCT03055988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65581350|NCT03055988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65581351|NCT03055988|Adrenergic Agents|adrenergic agents|mesh-ancestor
65581352|NCT03346642|Decitabine|decitabine|mesh-list
65581353|NCT03346642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65581354|NCT03346642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65581355|NCT03346642|Antimetabolites|antimetabolites|mesh-ancestor
65581356|NCT03346642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581357|NCT03346642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581358|NCT03346642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65581359|NCT02912949|Immunoglobulin G|immunoglobulin g|mesh-list
65581360|NCT02912949|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65581361|NCT02912949|Immunologic Factors|immunologic factors|mesh-ancestor
65581362|NCT02912949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581363|NCT01250912|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65581364|NCT01250912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581365|NCT01250912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65581366|NCT01250912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581367|NCT01250912|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65581368|NCT04789304|Midazolam|midazolam|mesh-list
65581369|NCT04789304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65581370|NCT04789304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65581371|NCT04789304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65581372|NCT04789304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581373|NCT04789304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65581374|NCT04789304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65581375|NCT04789304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65581376|NCT04789304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65581377|NCT04789304|Anesthetics, General|anesthetics, general|mesh-ancestor
65581378|NCT04789304|Anesthetics|anesthetics|mesh-ancestor
65581379|NCT04789304|GABA Modulators|gaba modulators|mesh-ancestor
65581380|NCT04789304|GABA Agents|gaba agents|mesh-ancestor
65581381|NCT04789304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65581382|NCT04789304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581383|NCT04780724|Nitrox|nitrox|mesh-list
65581384|NCT04780724|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65581385|NCT04780724|Protective Agents|protective agents|mesh-ancestor
65581386|NCT04780724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581387|NCT03128866|Tranexamic Acid|tranexamic acid|mesh-list
65581388|NCT03128866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65581389|NCT03128866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65581390|NCT03128866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581391|NCT03128866|Hemostatics|hemostatics|mesh-ancestor
65581393|NCT05583214|Dexamethasone|dexamethasone|mesh-list
65581394|NCT05583214|Ondansetron|ondansetron|mesh-list
65581395|NCT05583214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65581396|NCT05583214|Antiemetics|antiemetics|mesh-ancestor
65581397|NCT05583214|Autonomic Agents|autonomic agents|mesh-ancestor
65581398|NCT05583214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65581399|NCT05583214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581400|NCT05583214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65581401|NCT05583214|Glucocorticoids|glucocorticoids|mesh-ancestor
65581402|NCT05583214|Hormones|hormones|mesh-ancestor
65581403|NCT05583214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65581404|NCT05583214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65581405|NCT05583214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581406|NCT05583214|Antipruritics|antipruritics|mesh-ancestor
65581407|NCT05583214|Dermatologic Agents|dermatologic agents|mesh-ancestor
65581408|NCT05583214|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65581409|NCT05583214|Serotonin Agents|serotonin agents|mesh-ancestor
65581410|NCT05583214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65581411|NCT05583214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581412|NCT05583214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65581413|NCT05583214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65581414|NCT05583214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65581415|NCT05583214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65581416|NCT05583214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65581417|NCT02871297|Vortioxetine|vortioxetine|mesh-list
65581418|NCT02871297|Antidepressive Agents|antidepressive agents|mesh-ancestor
65581419|NCT02871297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65581420|NCT02871297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65581421|NCT02871297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65581422|NCT02871297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65581423|NCT02871297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581424|NCT02871297|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65581425|NCT02871297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65581426|NCT02871297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65581427|NCT02871297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581428|NCT02871297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65581429|NCT02871297|Serotonin Agents|serotonin agents|mesh-ancestor
65581430|NCT02871297|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65581431|NCT02871297|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65581432|NCT02871297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65581433|NCT02871297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65581434|NCT03628430|Lidocaine|lidocaine|mesh-list
65581435|NCT03628430|Epinephrine|epinephrine|mesh-list
65581436|NCT03628430|Anesthetics, Local|anesthetics, local|mesh-ancestor
65581437|NCT03628430|Anesthetics|anesthetics|mesh-ancestor
65581438|NCT03628430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65581439|NCT03628430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581440|NCT03628430|Sensory System Agents|sensory system agents|mesh-ancestor
65581441|NCT03628430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65581442|NCT03628430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65581443|NCT03628430|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65581444|NCT03628430|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65581445|NCT03628430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65581446|NCT03628430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581447|NCT03628430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65581448|NCT03628430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65581449|NCT03628430|Adrenergic Agents|adrenergic agents|mesh-ancestor
65581450|NCT03628430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65581451|NCT03628430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65581452|NCT03628430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65581453|NCT03628430|Autonomic Agents|autonomic agents|mesh-ancestor
65581454|NCT03628430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65581455|NCT03628430|Respiratory System Agents|respiratory system agents|mesh-ancestor
65581456|NCT03628430|Mydriatics|mydriatics|mesh-ancestor
65581457|NCT03628430|Sympathomimetics|sympathomimetics|mesh-ancestor
65581458|NCT03628430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65581459|NCT03121846|Apatinib|apatinib|mesh-list
65581460|NCT03121846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581461|NCT03121846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65581462|NCT03121846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65581463|NCT03121846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581464|NCT03122314|Acetaminophen|acetaminophen|mesh-list
65581465|NCT03122314|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65581466|NCT03122314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65581467|NCT03122314|Analgesics|analgesics|mesh-ancestor
65581468|NCT03122314|Sensory System Agents|sensory system agents|mesh-ancestor
65581469|NCT03122314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65581470|NCT03122314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581471|NCT03122314|Antipyretics|antipyretics|mesh-ancestor
65581472|NCT03122314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65581473|NCT03122314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65581474|NCT03122314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65581475|NCT03554005|Acetaminophen|acetaminophen|mesh-list
65581476|NCT03554005|Interferons|interferons|mesh-list
65581477|NCT03554005|Interferon-alpha|interferon-alpha|mesh-list
65581478|NCT03554005|Interferon alpha-2|interferon alpha-2|mesh-list
65581479|NCT03554005|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65581480|NCT03554005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581481|NCT03554005|Antiviral Agents|antiviral agents|mesh-ancestor
65581482|NCT03554005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65581483|NCT03554005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65581484|NCT03554005|Analgesics|analgesics|mesh-ancestor
65581485|NCT03554005|Sensory System Agents|sensory system agents|mesh-ancestor
65581486|NCT03554005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65581487|NCT03554005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581488|NCT03554005|Antipyretics|antipyretics|mesh-ancestor
65581489|NCT03554005|Immunologic Factors|immunologic factors|mesh-ancestor
65581490|NCT00709228|Ribavirin|ribavirin|mesh-list
65581491|NCT00709228|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65581492|NCT00709228|Antimetabolites|antimetabolites|mesh-ancestor
65581493|NCT00709228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581494|NCT00709228|Antiviral Agents|antiviral agents|mesh-ancestor
65581495|NCT00709228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65581496|NCT01584557|Tolvaptan|tolvaptan|mesh-list
65581497|NCT01584557|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65581498|NCT01584557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581499|NCT01584557|Natriuretic Agents|natriuretic agents|mesh-ancestor
65581500|NCT01584557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581501|NCT05214872|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65581502|NCT05214872|Calcium|calcium|mesh-list
65581503|NCT05214872|Mitogens|mitogens|mesh-list
65581504|NCT05214872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65581505|NCT05214872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581506|NCT05214872|Mitosis Modulators|mitosis modulators|mesh-ancestor
65581507|NCT05214872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581508|NCT05214872|Natriuretic Agents|natriuretic agents|mesh-ancestor
65581509|NCT01195571|Vaccines|vaccines|mesh-list
65581510|NCT01195571|Immunologic Factors|immunologic factors|mesh-ancestor
65581511|NCT01195571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581512|NCT03219372|Pravastatin|pravastatin|mesh-list
65581513|NCT03219372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65581514|NCT03219372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65581515|NCT03219372|Antimetabolites|antimetabolites|mesh-ancestor
65581516|NCT03219372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581517|NCT03219372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65581518|NCT03219372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65581519|NCT03219372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65581520|NCT03304080|Trastuzumab|trastuzumab|mesh-list
65581521|NCT03304080|Pertuzumab|pertuzumab|mesh-list
65581522|NCT03304080|Palbociclib|palbociclib|mesh-list
65581523|NCT03304080|Anastrozole|anastrozole|mesh-list
65581524|NCT03304080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65581525|NCT03304080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581526|NCT03304080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65581527|NCT03304080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65581528|NCT03304080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581529|NCT03304080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65581530|NCT03304080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65581531|NCT03304080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65581532|NCT03304080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65581533|NCT03304080|Hormone Antagonists|hormone antagonists|mesh-ancestor
65581534|NCT03304080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65581535|NCT03304080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581536|NCT02422641|Methotrexate|methotrexate|mesh-list
65581537|NCT02422641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65581538|NCT02422641|Abortifacient Agents|abortifacient agents|mesh-ancestor
65581539|NCT02422641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65581540|NCT02422641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581541|NCT02422641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65581542|NCT02422641|Antimetabolites|antimetabolites|mesh-ancestor
65581543|NCT02422641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581544|NCT02422641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581545|NCT02422641|Dermatologic Agents|dermatologic agents|mesh-ancestor
65581546|NCT02422641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65581547|NCT02422641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65581548|NCT02422641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65581549|NCT02422641|Immunologic Factors|immunologic factors|mesh-ancestor
65581550|NCT02422641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65581551|NCT02422641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65581552|NCT03628040|Ropivacaine|ropivacaine|mesh-list
65581553|NCT03628040|Anesthetics, Local|anesthetics, local|mesh-ancestor
65581554|NCT03628040|Anesthetics|anesthetics|mesh-ancestor
65581555|NCT03628040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65581556|NCT03628040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581557|NCT03628040|Sensory System Agents|sensory system agents|mesh-ancestor
65581558|NCT03628040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65581559|NCT04715763|Telmisartan|telmisartan|mesh-list
65581560|NCT04715763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65581561|NCT04715763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65581562|NCT04715763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65581563|NCT04715763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581564|NCT04338828|Nitric Oxide|nitric oxide|mesh-list
65581565|NCT04338828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65581566|NCT04338828|Autonomic Agents|autonomic agents|mesh-ancestor
65581567|NCT04338828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65581568|NCT04338828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581569|NCT04338828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65581570|NCT04338828|Respiratory System Agents|respiratory system agents|mesh-ancestor
65581571|NCT04338828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65581572|NCT04338828|Antioxidants|antioxidants|mesh-ancestor
65581573|NCT04338828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581574|NCT04338828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65581575|NCT04338828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65581576|NCT04338828|Vasodilator Agents|vasodilator agents|mesh-ancestor
65581577|NCT04338828|Gasotransmitters|gasotransmitters|mesh-ancestor
65581578|NCT04338828|Protective Agents|protective agents|mesh-ancestor
65581579|NCT01295567|Dipyridamole|dipyridamole|mesh-list
65581580|NCT01295567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65581581|NCT01295567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65581582|NCT01295567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581583|NCT01295567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65581584|NCT01295567|Vasodilator Agents|vasodilator agents|mesh-ancestor
65581585|NCT01192529|Phentermine|phentermine|mesh-list
65581586|NCT01192529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65581587|NCT01192529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581588|NCT01192529|Appetite Depressants|appetite depressants|mesh-ancestor
65581589|NCT01192529|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65581590|NCT01192529|Sympathomimetics|sympathomimetics|mesh-ancestor
65581591|NCT01192529|Autonomic Agents|autonomic agents|mesh-ancestor
65581592|NCT01192529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65581593|NCT01192529|Adrenergic Agents|adrenergic agents|mesh-ancestor
65581594|NCT01192529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65581595|NCT01192529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581596|NCT01195649|Sorafenib|sorafenib|mesh-list
65581597|NCT01195649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581598|NCT01195649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65581599|NCT01195649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882590|NCT01934816|Incretins|incretins|mesh-ancestor
65581600|NCT01195649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581601|NCT01195727|Apixaban|apixaban|mesh-list
65581602|NCT01195727|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65581603|NCT01195727|Antithrombins|antithrombins|mesh-ancestor
65581604|NCT01195727|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65581605|NCT01195727|Protease Inhibitors|protease inhibitors|mesh-ancestor
65581606|NCT01195727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65581607|NCT01195727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581608|NCT01195727|Anticoagulants|anticoagulants|mesh-ancestor
65581609|NCT04958876|Naltrexone|naltrexone|mesh-list
65581610|NCT04958876|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65581611|NCT04958876|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65581612|NCT04958876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581613|NCT04958876|Sensory System Agents|sensory system agents|mesh-ancestor
65581614|NCT04958876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65581615|NCT01195805|Amiloride|amiloride|mesh-list
65581616|NCT01195805|Spironolactone|spironolactone|mesh-list
65581617|NCT01195805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65581618|NCT01195805|Hormone Antagonists|hormone antagonists|mesh-ancestor
65581619|NCT01195805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65581620|NCT01195805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581621|NCT01195805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65581622|NCT01195805|Diuretics|diuretics|mesh-ancestor
65581623|NCT01195805|Natriuretic Agents|natriuretic agents|mesh-ancestor
65581624|NCT01195805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65581625|NCT01195805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65581626|NCT01195805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65581627|NCT01195805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581628|NCT01195805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65581629|NCT04899986|Chlorhexidine|chlorhexidine|mesh-list
65581630|NCT04899986|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65581631|NCT04899986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65581632|NCT04899986|Disinfectants|disinfectants|mesh-ancestor
65581633|NCT01791478|Letrozole|letrozole|mesh-list
65581634|NCT01791478|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
65581635|NCT01791478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581636|NCT01791478|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65581637|NCT01791478|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65581638|NCT01791478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65581639|NCT01791478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581640|NCT01791478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65581641|NCT01791478|Hormone Antagonists|hormone antagonists|mesh-ancestor
65581642|NCT01791478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65581643|NCT01791478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581644|NCT03845153|Metformin|metformin|mesh-list
65581645|NCT03845153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65581646|NCT03845153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581647|NCT00198718|Vitamin A|vitamin a|mesh-list
65581648|NCT00198718|Retinol palmitate|retinol palmitate|mesh-list
65581649|NCT00198718|Vitamins|vitamins|mesh-ancestor
65581650|NCT00198718|Micronutrients|micronutrients|mesh-ancestor
65581651|NCT00198718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581652|NCT00198718|Antioxidants|antioxidants|mesh-ancestor
65581653|NCT00198718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581654|NCT00198718|Protective Agents|protective agents|mesh-ancestor
65581655|NCT00198718|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65581656|NCT00198718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581657|NCT04500808|Macitentan|macitentan|mesh-list
65581658|NCT04500808|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65581659|NCT04500808|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65581660|NCT04500808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581661|NCT04500808|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65581662|NCT01192763|R04929097|r04929097|mesh-list
65581663|NCT01192763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65581664|NCT01192763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581665|NCT04539548|Prednisolone|prednisolone|mesh-list
65581666|NCT04539548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65581667|NCT04539548|Glucocorticoids|glucocorticoids|mesh-ancestor
65581668|NCT04539548|Hormones|hormones|mesh-ancestor
65581669|NCT04539548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65581670|NCT04539548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581671|NCT04539548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64882814|NCT01935817|Vitamin E|vitamin e|mesh-list
65581672|NCT04539548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581673|NCT00708916|Apremilast|apremilast|mesh-list
65581674|NCT00708916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65581675|NCT00708916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65581676|NCT00708916|Analgesics|analgesics|mesh-ancestor
65581677|NCT00708916|Sensory System Agents|sensory system agents|mesh-ancestor
65581678|NCT00708916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65581679|NCT00708916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581680|NCT00708916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65581681|NCT00708916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65581682|NCT00708916|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65581683|NCT00708916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65581684|NCT00708916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65581685|NCT00708916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581686|NCT02352753|Denosumab|denosumab|mesh-list
65581687|NCT02352753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65581688|NCT02352753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581689|NCT04245514|Durvalumab|durvalumab|mesh-list
65581690|NCT04245514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65581691|NCT04245514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581692|NCT02517736|Sorafenib|sorafenib|mesh-list
65581693|NCT02517736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581694|NCT02517736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65581695|NCT02517736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65581696|NCT02517736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581697|NCT03727971|Omalizumab|omalizumab|mesh-list
65581698|NCT03727971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65581699|NCT03727971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65581700|NCT03727971|Respiratory System Agents|respiratory system agents|mesh-ancestor
65581701|NCT03939104|Artesunate|artesunate|mesh-list
65581702|NCT03939104|Lumefantrine|lumefantrine|mesh-list
65581703|NCT03939104|Artemether|artemether|mesh-list
65581704|NCT03939104|Piperaquine|piperaquine|mesh-list
65581705|NCT03939104|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65581706|NCT03939104|Amodiaquine|amodiaquine|mesh-list
65581707|NCT03939104|Mefloquine|mefloquine|mesh-list
65581708|NCT03939104|Antimalarials|antimalarials|mesh-ancestor
65581709|NCT03939104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65581710|NCT03939104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65581711|NCT03939104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65581712|NCT03939104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581713|NCT03939104|Antiviral Agents|antiviral agents|mesh-ancestor
65581714|NCT03939104|Schistosomicides|schistosomicides|mesh-ancestor
65581715|NCT03939104|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65581716|NCT03939104|Anthelmintics|anthelmintics|mesh-ancestor
65581717|NCT03844841|Dexmedetomidine|dexmedetomidine|mesh-list
65581718|NCT03844841|Propofol|propofol|mesh-list
65581719|NCT03844841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65581720|NCT03844841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65581721|NCT03844841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581722|NCT03844841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65581723|NCT03844841|Anesthetics, General|anesthetics, general|mesh-ancestor
65581724|NCT03844841|Anesthetics|anesthetics|mesh-ancestor
65581725|NCT03844841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65581726|NCT03844841|Analgesics|analgesics|mesh-ancestor
65581727|NCT03844841|Sensory System Agents|sensory system agents|mesh-ancestor
65581728|NCT03844841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65581729|NCT03844841|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65581730|NCT03844841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65581731|NCT03844841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65581732|NCT03844841|Adrenergic Agents|adrenergic agents|mesh-ancestor
65581733|NCT03844841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65581734|NCT03844841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581735|NCT03197766|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
65581736|NCT03197766|Natriuretic Agents|natriuretic agents|mesh-ancestor
65581737|NCT03197766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581738|NCT04501900|Clopidogrel|clopidogrel|mesh-list
65581739|NCT04501900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65581740|NCT04501900|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65581741|NCT04501900|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65581742|NCT04501900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65581743|NCT04501900|Purinergic Agents|purinergic agents|mesh-ancestor
65581744|NCT04501900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65581745|NCT04501900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581746|NCT04501900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581747|NCT03637556|Deferasirox|deferasirox|mesh-list
65581748|NCT03637556|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65581749|NCT03637556|Chelating Agents|chelating agents|mesh-ancestor
65581750|NCT03637556|Sequestering Agents|sequestering agents|mesh-ancestor
65581751|NCT03637556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581752|NCT04641351|Triamcinolone|triamcinolone|mesh-list
65581753|NCT04641351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65581754|NCT04641351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65581755|NCT04641351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65581756|NCT04641351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65581757|NCT04641351|Glucocorticoids|glucocorticoids|mesh-ancestor
65581758|NCT04641351|Hormones|hormones|mesh-ancestor
65581759|NCT04641351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65581760|NCT04641351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581761|NCT04641351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65581762|NCT04641351|Immunologic Factors|immunologic factors|mesh-ancestor
65581763|NCT04641351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65581764|NCT04641351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581766|NCT01193387|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65581767|NCT01193387|Insulin, Long-Acting|insulin, long-acting|mesh-list
65581768|NCT01193387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65581769|NCT01193387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581770|NCT01198223|Nystatin|nystatin|mesh-list
65581771|NCT01198223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65581772|NCT01198223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65581773|NCT01198223|Antifungal Agents|antifungal agents|mesh-ancestor
65581774|NCT01198223|Ionophores|ionophores|mesh-ancestor
65581775|NCT01198223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65581776|NCT01198223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581777|NCT05049278|Phenylephrine|phenylephrine|mesh-list
65581778|NCT05049278|Oxymetazoline|oxymetazoline|mesh-list
65581779|NCT05049278|Norepinephrine|norepinephrine|mesh-list
65581780|NCT05049278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65581781|NCT05049278|Mydriatics|mydriatics|mesh-ancestor
65581782|NCT05049278|Autonomic Agents|autonomic agents|mesh-ancestor
65581783|NCT05049278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65581784|NCT05049278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581785|NCT05049278|Sympathomimetics|sympathomimetics|mesh-ancestor
65581786|NCT05049278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65581787|NCT05049278|Nasal Decongestants|nasal decongestants|mesh-ancestor
65581788|NCT05049278|Respiratory System Agents|respiratory system agents|mesh-ancestor
65581789|NCT05049278|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65581790|NCT05049278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65581791|NCT05049278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65581792|NCT05049278|Adrenergic Agents|adrenergic agents|mesh-ancestor
65581793|NCT05049278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65581794|NCT05049278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581795|NCT05049278|Protective Agents|protective agents|mesh-ancestor
65581796|NCT01193465|Anesthetics|anesthetics|mesh-list
65581797|NCT01193465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65581798|NCT01193465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581799|NCT03347344|Riluzole|riluzole|mesh-list
65581800|NCT03347344|Anticonvulsants|anticonvulsants|mesh-ancestor
65581801|NCT03347344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65581802|NCT03347344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65581803|NCT03347344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65581804|NCT03347344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581805|NCT03347344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581806|NCT03347344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65581807|NCT03347344|Protective Agents|protective agents|mesh-ancestor
65581808|NCT04220866|Pembrolizumab|pembrolizumab|mesh-list
65581809|NCT04220866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65581810|NCT04220866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581811|NCT03173456|Acetaminophen|acetaminophen|mesh-list
65581812|NCT03173456|Ibuprofen|ibuprofen|mesh-list
65581813|NCT03173456|Oxycodone|oxycodone|mesh-list
65581814|NCT03173456|Hydrocodone|hydrocodone|mesh-list
65581815|NCT03173456|Codeine|codeine|mesh-list
65581816|NCT03173456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65581817|NCT03173456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65581818|NCT03173456|Analgesics|analgesics|mesh-ancestor
65581819|NCT03173456|Sensory System Agents|sensory system agents|mesh-ancestor
65581820|NCT03173456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65581821|NCT03173456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348116|NCT02308553|Paclitaxel|paclitaxel|mesh-list
65581822|NCT03173456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65581823|NCT03173456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65581824|NCT03173456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65581825|NCT03173456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65581826|NCT03173456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581827|NCT03173456|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65581828|NCT03173456|Narcotics|narcotics|mesh-ancestor
65581829|NCT03173456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65581830|NCT03173456|Antipyretics|antipyretics|mesh-ancestor
65581831|NCT03173456|Antitussive Agents|antitussive agents|mesh-ancestor
65581832|NCT03173456|Respiratory System Agents|respiratory system agents|mesh-ancestor
65581833|NCT01193621|Haloperidol|haloperidol|mesh-list
65581834|NCT01193621|Haloperidol decanoate|haloperidol decanoate|mesh-list
65581835|NCT01193621|Antiemetics|antiemetics|mesh-ancestor
65581836|NCT01193621|Autonomic Agents|autonomic agents|mesh-ancestor
65581837|NCT01193621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65581838|NCT01193621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581839|NCT01193621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65581840|NCT01193621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65581841|NCT01193621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65581842|NCT01193621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65581843|NCT01193621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65581844|NCT01193621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65581845|NCT01193621|Dopamine Agents|dopamine agents|mesh-ancestor
65581846|NCT01193621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65581847|NCT01193621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581848|NCT01193621|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65581849|NCT02517424|Dronabinol|dronabinol|mesh-list
65581850|NCT02517424|Hallucinogens|hallucinogens|mesh-ancestor
65581851|NCT02517424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581852|NCT02517424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65581853|NCT02517424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65581854|NCT02517424|Analgesics|analgesics|mesh-ancestor
65581855|NCT02517424|Sensory System Agents|sensory system agents|mesh-ancestor
65581856|NCT02517424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65581857|NCT02517424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65581858|NCT02517424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65581859|NCT02517424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65581860|NCT02517424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581861|NCT02517424|Hormones|hormones|mesh-ancestor
65581862|NCT02517424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65581863|NCT01567904|Semuloparin|semuloparin|mesh-list
65581864|NCT01567904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65581865|NCT01567904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65581866|NCT01567904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581867|NCT01196507|Carvedilol|carvedilol|mesh-list
65581868|NCT01196507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65581869|NCT01196507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65581870|NCT01196507|Adrenergic Agents|adrenergic agents|mesh-ancestor
65581871|NCT01196507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65581872|NCT01196507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581873|NCT01196507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581874|NCT01196507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65581875|NCT01196507|Antioxidants|antioxidants|mesh-ancestor
65581876|NCT01196507|Protective Agents|protective agents|mesh-ancestor
65581877|NCT01196507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65581878|NCT01196507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65581879|NCT01196507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65581880|NCT01196507|Vasodilator Agents|vasodilator agents|mesh-ancestor
65581881|NCT01196507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65581882|NCT01196507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65581883|NCT05670509|Midazolam|midazolam|mesh-list
65581884|NCT05670509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65581885|NCT05670509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65581886|NCT05670509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65581887|NCT05670509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581888|NCT05670509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65581889|NCT05670509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65581890|NCT05670509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65581891|NCT05670509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65581892|NCT05670509|Anesthetics, General|anesthetics, general|mesh-ancestor
65581893|NCT05670509|Anesthetics|anesthetics|mesh-ancestor
65581894|NCT05670509|GABA Modulators|gaba modulators|mesh-ancestor
65581895|NCT05670509|GABA Agents|gaba agents|mesh-ancestor
65581896|NCT05670509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65581897|NCT05670509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581898|NCT05282771|Nicotinic Acids|nicotinic acids|mesh-list
65581899|NCT05282771|Clobetasol|clobetasol|mesh-list
65581900|NCT05282771|Halobetasol|halobetasol|mesh-list
65581901|NCT05282771|Tazarotene|tazarotene|mesh-list
65581902|NCT05282771|Dermatologic Agents|dermatologic agents|mesh-ancestor
65581903|NCT05282771|Keratolytic Agents|keratolytic agents|mesh-ancestor
65581904|NCT05282771|Vitamin B Complex|vitamin b complex|mesh-ancestor
65581905|NCT05282771|Vitamins|vitamins|mesh-ancestor
65581906|NCT05282771|Micronutrients|micronutrients|mesh-ancestor
65581907|NCT05282771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581908|NCT05282771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65581909|NCT05282771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65581910|NCT05282771|Glucocorticoids|glucocorticoids|mesh-ancestor
65581911|NCT05282771|Hormones|hormones|mesh-ancestor
65581912|NCT05282771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65379438|NCT04035798|Memantine|memantine|mesh-list
65581913|NCT05487833|Insulin|insulin|mesh-list
65581914|NCT05487833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65581915|NCT05487833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581916|NCT03600805|Prednisone|prednisone|mesh-list
65581917|NCT03600805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65581918|NCT03600805|Glucocorticoids|glucocorticoids|mesh-ancestor
65581919|NCT03600805|Hormones|hormones|mesh-ancestor
65581920|NCT03600805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65581921|NCT03600805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581922|NCT03600805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65581923|NCT03600805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581924|NCT01198379|Aspirin|aspirin|mesh-list
65581925|NCT01198379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65581926|NCT01198379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65581927|NCT01198379|Analgesics|analgesics|mesh-ancestor
65581928|NCT01198379|Sensory System Agents|sensory system agents|mesh-ancestor
65581929|NCT01198379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65581930|NCT01198379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581931|NCT01198379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65581932|NCT01198379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65581933|NCT01198379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65581934|NCT01198379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65581935|NCT01198379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581936|NCT01198379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65581937|NCT01198379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65581938|NCT01198379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65581939|NCT01198379|Antipyretics|antipyretics|mesh-ancestor
65581940|NCT03848039|Vaccines|vaccines|mesh-list
65581941|NCT03848039|Immunologic Factors|immunologic factors|mesh-ancestor
65581942|NCT03848039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581943|NCT01296269|Vasopressins|vasopressins|mesh-list
65581944|NCT01296269|Arginine Vasopressin|arginine vasopressin|mesh-list
65581945|NCT01296269|Oxytocin|oxytocin|mesh-list
65581946|NCT01296269|Oxytocics|oxytocics|mesh-ancestor
65581947|NCT01296269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65581948|NCT01296269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581949|NCT01296269|Hemostatics|hemostatics|mesh-ancestor
65581950|NCT01296269|Coagulants|coagulants|mesh-ancestor
65581951|NCT01296269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65581952|NCT01296269|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65581953|NCT01296269|Natriuretic Agents|natriuretic agents|mesh-ancestor
65581954|NCT05595772|Mitogens|mitogens|mesh-list
65581955|NCT05595772|Mitosis Modulators|mitosis modulators|mesh-ancestor
65581956|NCT05595772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581957|NCT03844451|Epinephrine|epinephrine|mesh-list
65581958|NCT03844451|Bupivacaine|bupivacaine|mesh-list
65581959|NCT03844451|Anesthetics, Local|anesthetics, local|mesh-ancestor
65581960|NCT03844451|Anesthetics|anesthetics|mesh-ancestor
65581961|NCT03844451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65581962|NCT03844451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581963|NCT03844451|Sensory System Agents|sensory system agents|mesh-ancestor
65581964|NCT03844451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65581965|NCT03844451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65581966|NCT03844451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65581967|NCT03844451|Adrenergic Agents|adrenergic agents|mesh-ancestor
65581968|NCT03844451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65581969|NCT03844451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581970|NCT03844451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65581971|NCT03844451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65581972|NCT03844451|Autonomic Agents|autonomic agents|mesh-ancestor
65581973|NCT03844451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65581974|NCT03844451|Respiratory System Agents|respiratory system agents|mesh-ancestor
65581975|NCT03844451|Mydriatics|mydriatics|mesh-ancestor
65581976|NCT03844451|Sympathomimetics|sympathomimetics|mesh-ancestor
65581977|NCT03844451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65581978|NCT03346096|Thiotepa|thiotepa|mesh-list
65581979|NCT03346096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65581980|NCT03346096|Alkylating Agents|alkylating agents|mesh-ancestor
65581981|NCT03346096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581982|NCT03346096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65581983|NCT03346096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65581984|NCT03346096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65581985|NCT03346096|Immunologic Factors|immunologic factors|mesh-ancestor
65581986|NCT03346096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581987|NCT01198457|Clodronic Acid|clodronic acid|mesh-list
65581988|NCT01198457|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65581989|NCT01198457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65581990|NCT03386214|Pevonedistat|pevonedistat|mesh-list
65581991|NCT03386214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65581992|NCT03386214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65581993|NCT01198535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65581994|NCT01198535|Cetuximab|cetuximab|mesh-list
65581995|NCT01198535|Antibodies|antibodies|mesh-list
65581996|NCT01198535|Immunoglobulins|immunoglobulins|mesh-list
65581997|NCT01198535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65581998|NCT01198535|R04929097|r04929097|mesh-list
65581999|NCT01198535|Immunologic Factors|immunologic factors|mesh-ancestor
65582000|NCT01198535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582001|NCT01198535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582002|NCT01198535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582003|NCT01198535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582004|NCT05081219|Insulin|insulin|mesh-list
65582005|NCT05081219|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65582006|NCT05081219|Empagliflozin|empagliflozin|mesh-list
65582007|NCT05081219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65582008|NCT05081219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582009|NCT05081219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65582010|NCT05081219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582011|NCT03909334|Osimertinib|osimertinib|mesh-list
65582012|NCT03909334|Ramucirumab|ramucirumab|mesh-list
65582013|NCT03909334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582014|NCT03909334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65582015|NCT03909334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582016|NCT03909334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582017|NCT03860038|Dexamethasone|dexamethasone|mesh-list
65582018|NCT03860038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65582019|NCT03860038|Antiemetics|antiemetics|mesh-ancestor
65582020|NCT03860038|Autonomic Agents|autonomic agents|mesh-ancestor
65582021|NCT03860038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582022|NCT03860038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582023|NCT03860038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65582024|NCT03860038|Glucocorticoids|glucocorticoids|mesh-ancestor
65582025|NCT03860038|Hormones|hormones|mesh-ancestor
65582026|NCT03860038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65582027|NCT03860038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65582028|NCT03860038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582029|NCT03844763|Cyclophosphamide|cyclophosphamide|mesh-list
65582030|NCT03844763|Avelumab|avelumab|mesh-list
65582031|NCT03844763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65582032|NCT03844763|Immunologic Factors|immunologic factors|mesh-ancestor
65582033|NCT03844763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582034|NCT03844763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65582035|NCT03844763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65582036|NCT03844763|Alkylating Agents|alkylating agents|mesh-ancestor
65582037|NCT03844763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582038|NCT03844763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582039|NCT03844763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65582040|NCT03844763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65582041|NCT04897841|Bupivacaine|bupivacaine|mesh-list
65582042|NCT04897841|Anesthetics, Local|anesthetics, local|mesh-ancestor
65582043|NCT04897841|Anesthetics|anesthetics|mesh-ancestor
65582044|NCT04897841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65582045|NCT04897841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582046|NCT04897841|Sensory System Agents|sensory system agents|mesh-ancestor
65582047|NCT04897841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582048|NCT05016947|Dexamethasone|dexamethasone|mesh-list
65582049|NCT05016947|Venetoclax|venetoclax|mesh-list
65582050|NCT05016947|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65582051|NCT05016947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65582052|NCT05016947|Antiemetics|antiemetics|mesh-ancestor
65582053|NCT05016947|Autonomic Agents|autonomic agents|mesh-ancestor
65582054|NCT05016947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582055|NCT05016947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582056|NCT05016947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65582057|NCT05016947|Glucocorticoids|glucocorticoids|mesh-ancestor
65582058|NCT05016947|Hormones|hormones|mesh-ancestor
65582059|NCT05016947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65582060|NCT05016947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65582061|NCT05016947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582062|NCT05016947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65379584|NCT02540070|Mydriatics|mydriatics|mesh-ancestor
65582063|NCT05016947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65582064|NCT01198925|Piperacillin|piperacillin|mesh-list
65582065|NCT01198925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65582066|NCT01198925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65582067|NCT03844139|Glycerol|glycerol|mesh-list
65582068|NCT03844139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65582069|NCT03844139|Protective Agents|protective agents|mesh-ancestor
65582070|NCT03844139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582071|NCT04883255|Dronabinol|dronabinol|mesh-list
65582072|NCT04883255|Cannabidiol|cannabidiol|mesh-list
65582073|NCT04883255|Anticonvulsants|anticonvulsants|mesh-ancestor
65582074|NCT04883255|Hallucinogens|hallucinogens|mesh-ancestor
65582075|NCT04883255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582076|NCT04883255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65582077|NCT04883255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65582078|NCT04883255|Analgesics|analgesics|mesh-ancestor
65582079|NCT04883255|Sensory System Agents|sensory system agents|mesh-ancestor
65582080|NCT04883255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582081|NCT04883255|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65582082|NCT04883255|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65582083|NCT04883255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65582084|NCT04883255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582085|NCT04883255|Hormones|hormones|mesh-ancestor
65582086|NCT04883255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65582087|NCT04500496|Isoniazid|isoniazid|mesh-list
65582088|NCT04500496|Dinoprostone|dinoprostone|mesh-list
65582089|NCT04500496|Oxytocics|oxytocics|mesh-ancestor
65582090|NCT04500496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65582091|NCT04500496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582092|NCT04500496|Antitubercular Agents|antitubercular agents|mesh-ancestor
65582093|NCT04500496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65582094|NCT04500496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65582095|NCT04500496|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65582096|NCT04500496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65582097|NCT04500496|Antimetabolites|antimetabolites|mesh-ancestor
65582098|NCT04500496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582099|NCT04500496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65582100|NCT01199081|Dronedarone|dronedarone|mesh-list
65582101|NCT01199081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65582102|NCT04989335|Fludarabine|fludarabine|mesh-list
65582103|NCT04989335|Clofarabine|clofarabine|mesh-list
65582104|NCT04989335|Bisantrene|bisantrene|mesh-list
65582105|NCT04989335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582106|NCT04989335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65582107|NCT04989335|Antimetabolites|antimetabolites|mesh-ancestor
65582108|NCT04989335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582109|NCT04989335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65582110|NCT02297438|Letrozole|letrozole|mesh-list
65582111|NCT02297438|Palbociclib|palbociclib|mesh-list
65582112|NCT02297438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582113|NCT02297438|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65582114|NCT02297438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65582115|NCT02297438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582116|NCT02297438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582117|NCT02297438|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65582118|NCT02297438|Hormone Antagonists|hormone antagonists|mesh-ancestor
65582119|NCT02297438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65582120|NCT02297438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582121|NCT02297438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65582122|NCT03345940|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65582123|NCT03345940|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65582124|NCT03345940|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65582125|NCT03345940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582126|NCT03345940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65582127|NCT03345940|Immunologic Factors|immunologic factors|mesh-ancestor
65582128|NCT03345940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582129|NCT03345940|Dermatologic Agents|dermatologic agents|mesh-ancestor
65582130|NCT05670353|Contraceptive Agents|contraceptive agents|mesh-list
65582131|NCT05670353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-list
65582132|NCT05670353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65582133|NCT05670353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582134|NCT01199159|Vitamin B 6|vitamin b 6|mesh-list
65582135|NCT01199159|Pyridoxal|pyridoxal|mesh-list
65582136|NCT01199159|Pyridoxine|pyridoxine|mesh-list
65582137|NCT01199159|Misoprostol|misoprostol|mesh-list
65582138|NCT01199159|Vitamins|vitamins|mesh-ancestor
65582139|NCT01199159|Micronutrients|micronutrients|mesh-ancestor
65582140|NCT01199159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582141|NCT01199159|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65582142|NCT01199159|Abortifacient Agents|abortifacient agents|mesh-ancestor
65582143|NCT01199159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65582144|NCT01199159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65582145|NCT01199159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65582146|NCT01199159|Oxytocics|oxytocics|mesh-ancestor
65582147|NCT01199159|Vitamin B Complex|vitamin b complex|mesh-ancestor
65582148|NCT05669963|Lactoferrin|lactoferrin|mesh-list
65582149|NCT05669963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65582150|NCT02507440|Lidocaine|lidocaine|mesh-list
65582151|NCT02507440|Propofol|propofol|mesh-list
65582152|NCT02507440|Anesthetics, Local|anesthetics, local|mesh-ancestor
65582153|NCT02507440|Anesthetics|anesthetics|mesh-ancestor
65582154|NCT02507440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65582155|NCT02507440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582156|NCT02507440|Sensory System Agents|sensory system agents|mesh-ancestor
65582157|NCT02507440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582158|NCT02507440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65582159|NCT02507440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65582160|NCT02507440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65582161|NCT02507440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65582162|NCT02507440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582163|NCT02507440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65582164|NCT02507440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65582165|NCT02507440|Anesthetics, General|anesthetics, general|mesh-ancestor
65582166|NCT02507362|Riboflavin|riboflavin|mesh-list
65582167|NCT02507362|Dextrans|dextrans|mesh-list
65582168|NCT02507362|Vitamin B Complex|vitamin b complex|mesh-ancestor
65582169|NCT02507362|Vitamins|vitamins|mesh-ancestor
65582170|NCT02507362|Micronutrients|micronutrients|mesh-ancestor
65582171|NCT02507362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582172|NCT02507362|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65582173|NCT02507362|Dermatologic Agents|dermatologic agents|mesh-ancestor
65582174|NCT02507362|Anticoagulants|anticoagulants|mesh-ancestor
65582175|NCT02507362|Plasma Substitutes|plasma substitutes|mesh-ancestor
65582176|NCT02507362|Blood Substitutes|blood substitutes|mesh-ancestor
65582177|NCT05640830|Paclitaxel|paclitaxel|mesh-list
65582178|NCT05640830|Bevacizumab|bevacizumab|mesh-list
65582179|NCT05640830|Trastuzumab|trastuzumab|mesh-list
65582180|NCT05640830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65582181|NCT05640830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582182|NCT05640830|Tubulin Modulators|tubulin modulators|mesh-ancestor
65582183|NCT05640830|Antimitotic Agents|antimitotic agents|mesh-ancestor
65582184|NCT05640830|Mitosis Modulators|mitosis modulators|mesh-ancestor
65582185|NCT05640830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582186|NCT05640830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65582187|NCT05640830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65582188|NCT05640830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65582189|NCT05640830|Growth Substances|growth substances|mesh-ancestor
65582190|NCT05640830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582191|NCT05640830|Growth Inhibitors|growth inhibitors|mesh-ancestor
65582192|NCT02507284|SRX246|srx246|mesh-list
65582193|NCT02507284|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65582194|NCT02507284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582195|NCT02507284|Natriuretic Agents|natriuretic agents|mesh-ancestor
65582196|NCT02507284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582197|NCT03730961|Furosemide|furosemide|mesh-list
65582198|NCT03730961|Diuretics|diuretics|mesh-ancestor
65582199|NCT03730961|Natriuretic Agents|natriuretic agents|mesh-ancestor
65582200|NCT03730961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582201|NCT03730961|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65582202|NCT03730961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65582203|NCT03730961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582204|NCT01078454|Dexamethasone|dexamethasone|mesh-list
65582205|NCT01078454|Bortezomib|bortezomib|mesh-list
65582206|NCT01078454|Melphalan|melphalan|mesh-list
65582207|NCT01078454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65582208|NCT01078454|Antiemetics|antiemetics|mesh-ancestor
65582209|NCT01078454|Autonomic Agents|autonomic agents|mesh-ancestor
65582210|NCT01078454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582211|NCT01078454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582212|NCT01078454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65582213|NCT01078454|Glucocorticoids|glucocorticoids|mesh-ancestor
65582214|NCT01078454|Hormones|hormones|mesh-ancestor
65582215|NCT01078454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65582216|NCT01078454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65582217|NCT01078454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582218|NCT01078454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65582219|NCT01078454|Alkylating Agents|alkylating agents|mesh-ancestor
65582220|NCT01078454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582221|NCT01078454|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65582222|NCT01078454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65582223|NCT01078454|Immunologic Factors|immunologic factors|mesh-ancestor
65582224|NCT02968602|Minocycline|minocycline|mesh-list
65582225|NCT02968602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65582226|NCT02968602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65582227|NCT03345004|Vitamin D|vitamin d|mesh-list
65582228|NCT03345004|Ergocalciferols|ergocalciferols|mesh-list
65582229|NCT03345004|Cholecalciferol|cholecalciferol|mesh-list
65582230|NCT03345004|Vitamins|vitamins|mesh-list
65582231|NCT03345004|Micronutrients|micronutrients|mesh-ancestor
65582232|NCT03345004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582233|NCT03345004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65582234|NCT03345004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65582235|NCT03034356|Levetiracetam|levetiracetam|mesh-list
65582236|NCT03034356|Anticonvulsants|anticonvulsants|mesh-ancestor
65582237|NCT03034356|Nootropic Agents|nootropic agents|mesh-ancestor
65582238|NCT03003468|Pembrolizumab|pembrolizumab|mesh-list
65582239|NCT03003468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65582240|NCT03003468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582241|NCT03345628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65582242|NCT03345628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65582243|NCT03345628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582244|NCT03552523|Pancrelipase|pancrelipase|mesh-list
65582245|NCT03552523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65582246|NCT03728101|Dabigatran|dabigatran|mesh-list
65582247|NCT03728101|Simvastatin|simvastatin|mesh-list
65582248|NCT03728101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65582249|NCT03728101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65582250|NCT03728101|Antimetabolites|antimetabolites|mesh-ancestor
65582251|NCT03728101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582252|NCT03728101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65582253|NCT03728101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65582254|NCT03728101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582255|NCT03728101|Antithrombins|antithrombins|mesh-ancestor
65582256|NCT03728101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65582257|NCT03728101|Protease Inhibitors|protease inhibitors|mesh-ancestor
65582258|NCT03728101|Anticoagulants|anticoagulants|mesh-ancestor
65582259|NCT03844217|Tryptophan|tryptophan|mesh-list
65582260|NCT03844217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65582261|NCT03844217|Antidepressive Agents|antidepressive agents|mesh-ancestor
65582262|NCT03844217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65582263|NCT04170972|Insulin|insulin|mesh-list
65582264|NCT04170972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65582265|NCT04170972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582266|NCT02515864|Moxifloxacin|moxifloxacin|mesh-list
65582267|NCT02515864|Dotinurad|dotinurad|mesh-list
65582268|NCT02515864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65582269|NCT02515864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65582270|NCT02515864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65582271|NCT02515864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65582272|NCT02515864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65582273|NCT02515864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248392|NCT02841488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65582274|NCT02515864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582275|NCT02515864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582276|NCT02515864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65582277|NCT02515864|Contraceptive Agents|contraceptive agents|mesh-ancestor
65582278|NCT02515864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65582279|NCT02515864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582280|NCT02515864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65582281|NCT02515864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65582282|NCT02515864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65582283|NCT02515864|Uricosuric Agents|uricosuric agents|mesh-ancestor
65582284|NCT02515864|Gout Suppressants|gout suppressants|mesh-ancestor
65582285|NCT02515864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65582286|NCT02515864|Renal Agents|renal agents|mesh-ancestor
65582287|NCT02507206|Dihydrexidine|dihydrexidine|mesh-list
65582288|NCT02507206|Dopamine Agonists|dopamine agonists|mesh-ancestor
65582289|NCT02507206|Dopamine Agents|dopamine agents|mesh-ancestor
65582290|NCT02507206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65582291|NCT02507206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582292|NCT02507206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582294|NCT02892409|Clarithromycin|clarithromycin|mesh-list
65582295|NCT02892409|Lansoprazole|lansoprazole|mesh-list
65582296|NCT02892409|Dexlansoprazole|dexlansoprazole|mesh-list
65582297|NCT02892409|Bismuth|bismuth|mesh-list
65582298|NCT02892409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65582299|NCT02892409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65582300|NCT02892409|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65582301|NCT02892409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582302|NCT02892409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582303|NCT02892409|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65582304|NCT02892409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65582305|NCT02892409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65582306|NCT02892409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65582307|NCT02892409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65582308|NCT02892409|Antacids|antacids|mesh-ancestor
65582309|NCT02507128|Liraglutide|liraglutide|mesh-list
65582310|NCT02507128|Glucagon|glucagon|mesh-list
65582311|NCT02507128|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65582312|NCT02507128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65582313|NCT02507128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582314|NCT02507128|Incretins|incretins|mesh-ancestor
65582315|NCT02507128|Hormones|hormones|mesh-ancestor
65582316|NCT02507128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65582317|NCT02507128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65582318|NCT03844529|Lidocaine|lidocaine|mesh-list
65582319|NCT03844529|Anesthetics, Local|anesthetics, local|mesh-ancestor
65582320|NCT03844529|Anesthetics|anesthetics|mesh-ancestor
65582321|NCT03844529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65582322|NCT03844529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582323|NCT03844529|Sensory System Agents|sensory system agents|mesh-ancestor
65582324|NCT03844529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582325|NCT03844529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65582326|NCT03844529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65582327|NCT03844529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65582328|NCT03844529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65582329|NCT03844529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582330|NCT02292758|Bevacizumab|bevacizumab|mesh-list
65582331|NCT02292758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65582332|NCT02292758|Cetuximab|cetuximab|mesh-list
65582333|NCT02292758|Irinotecan|irinotecan|mesh-list
65582334|NCT02292758|Endothelial Growth Factors|endothelial growth factors|mesh-list
65582335|NCT02292758|Antibodies|antibodies|mesh-list
65582336|NCT02292758|Immunoglobulins|immunoglobulins|mesh-list
65582337|NCT02292758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65582338|NCT02292758|Immunoglobulin G|immunoglobulin g|mesh-list
65582339|NCT02292758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582340|NCT02292758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65582341|NCT02292758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65582342|NCT02292758|Growth Substances|growth substances|mesh-ancestor
65582343|NCT02292758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582344|NCT02292758|Growth Inhibitors|growth inhibitors|mesh-ancestor
65582345|NCT02292758|Immunologic Factors|immunologic factors|mesh-ancestor
65582346|NCT02292758|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65582347|NCT02292758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65582348|NCT02292758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582349|NCT02292758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582350|NCT03727867|Mitogens|mitogens|mesh-list
65582351|NCT03727867|Mitosis Modulators|mitosis modulators|mesh-ancestor
65582352|NCT03727867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582353|NCT02832648|Selenium|selenium|mesh-list
65582354|NCT02832648|Antioxidants|antioxidants|mesh-ancestor
65582355|NCT02832648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582356|NCT02832648|Protective Agents|protective agents|mesh-ancestor
65582357|NCT02832648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582358|NCT02832648|Trace Elements|trace elements|mesh-ancestor
65582359|NCT02832648|Micronutrients|micronutrients|mesh-ancestor
65582360|NCT04497766|Magnesium Sulfate|magnesium sulfate|mesh-list
65582361|NCT04497766|Analgesics|analgesics|mesh-ancestor
65582362|NCT04497766|Sensory System Agents|sensory system agents|mesh-ancestor
65582363|NCT04497766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582364|NCT04497766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582365|NCT04497766|Anesthetics|anesthetics|mesh-ancestor
65582366|NCT04497766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65582367|NCT04497766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65582368|NCT04497766|Anticonvulsants|anticonvulsants|mesh-ancestor
65582369|NCT04497766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65582370|NCT04497766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65582371|NCT04497766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582372|NCT04497766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65582373|NCT04497766|Tocolytic Agents|tocolytic agents|mesh-ancestor
65582374|NCT04497766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65582375|NCT03841721|Linezolid|linezolid|mesh-list
65582376|NCT03841721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65582377|NCT03841721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65582378|NCT03841721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65582379|NCT03841721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582380|NCT03841721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582381|NCT03164057|Cytarabine|cytarabine|mesh-list
65582382|NCT03164057|Hydrocortisone|hydrocortisone|mesh-list
65582383|NCT03164057|Methotrexate|methotrexate|mesh-list
65582384|NCT03164057|Azacitidine|azacitidine|mesh-list
65582385|NCT03164057|Decitabine|decitabine|mesh-list
65582386|NCT03164057|Fludarabine|fludarabine|mesh-list
65582387|NCT03164057|Etoposide|etoposide|mesh-list
65582388|NCT03164057|Etoposide phosphate|etoposide phosphate|mesh-list
65582389|NCT03164057|Sorafenib|sorafenib|mesh-list
65582390|NCT03164057|Daunorubicin|daunorubicin|mesh-list
65582391|NCT03164057|Asparaginase|asparaginase|mesh-list
65582392|NCT03164057|Mitoxantrone|mitoxantrone|mesh-list
65582393|NCT03164057|Idarubicin|idarubicin|mesh-list
65582394|NCT03164057|Dexrazoxane|dexrazoxane|mesh-list
65582395|NCT03164057|Razoxane|razoxane|mesh-list
65582396|NCT03164057|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
65582397|NCT03164057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65582398|NCT03164057|Abortifacient Agents|abortifacient agents|mesh-ancestor
65582399|NCT03164057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65582400|NCT03164057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582401|NCT03164057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65582402|NCT03164057|Antimetabolites|antimetabolites|mesh-ancestor
65582403|NCT03164057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582404|NCT03164057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582405|NCT03164057|Dermatologic Agents|dermatologic agents|mesh-ancestor
65582406|NCT03164057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582407|NCT03164057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65582408|NCT03164057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65582409|NCT03164057|Immunologic Factors|immunologic factors|mesh-ancestor
65582410|NCT03164057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65582411|NCT03164057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65582412|NCT03164057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65582413|NCT03164057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65582414|NCT03164057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65582415|NCT03164057|Antiviral Agents|antiviral agents|mesh-ancestor
65582416|NCT03164057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65582417|NCT03164057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65582418|NCT03164057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65582419|NCT03164057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65582420|NCT03164057|Analgesics|analgesics|mesh-ancestor
65582421|NCT03164057|Sensory System Agents|sensory system agents|mesh-ancestor
65582422|NCT03164057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582423|NCT03164057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65582424|NCT03164057|Protective Agents|protective agents|mesh-ancestor
65582425|NCT03164057|Antimitotic Agents|antimitotic agents|mesh-ancestor
65582426|NCT03164057|Mitosis Modulators|mitosis modulators|mesh-ancestor
65582427|NCT03620526|Iloprost|iloprost|mesh-list
65582428|NCT03620526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65582429|NCT03620526|Vasodilator Agents|vasodilator agents|mesh-ancestor
65582430|NCT04532346|Hydroxychloroquine|hydroxychloroquine|mesh-list
65582431|NCT04532346|Antimalarials|antimalarials|mesh-ancestor
65582432|NCT04532346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65582433|NCT04532346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65582434|NCT04532346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65582435|NCT04532346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582436|NCT04532346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582437|NCT04532346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65582438|NCT03843749|Trastuzumab|trastuzumab|mesh-list
65582439|NCT03843749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65582440|NCT03843749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582441|NCT01199783|Vancomycin|vancomycin|mesh-list
65582442|NCT01199783|Daptomycin|daptomycin|mesh-list
65582443|NCT01199783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65582444|NCT01199783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65582445|NCT03192306|Ethanol|ethanol|mesh-list
65582446|NCT03192306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65582447|NCT03192306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65582448|NCT03192306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65582449|NCT03192306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582450|NCT03216954|Acetylcysteine|acetylcysteine|mesh-list
65582451|NCT03216954|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65582452|NCT03216954|Antiviral Agents|antiviral agents|mesh-ancestor
65582453|NCT03216954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65582454|NCT03216954|Expectorants|expectorants|mesh-ancestor
65582455|NCT03216954|Respiratory System Agents|respiratory system agents|mesh-ancestor
65582456|NCT03216954|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65582457|NCT03216954|Antioxidants|antioxidants|mesh-ancestor
65582458|NCT03216954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582459|NCT03216954|Protective Agents|protective agents|mesh-ancestor
65582460|NCT03216954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582461|NCT03216954|Antidotes|antidotes|mesh-ancestor
65582462|NCT05669807|Paclitaxel|paclitaxel|mesh-list
65582463|NCT05669807|Irinotecan|irinotecan|mesh-list
65582464|NCT05669807|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65582465|NCT05669807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65582466|NCT05669807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582467|NCT05669807|Tubulin Modulators|tubulin modulators|mesh-ancestor
65582468|NCT05669807|Antimitotic Agents|antimitotic agents|mesh-ancestor
65582469|NCT05669807|Mitosis Modulators|mitosis modulators|mesh-ancestor
65582470|NCT05669807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582471|NCT05669807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65582472|NCT05669807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65582473|NCT05669807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582474|NCT03599089|Acetaminophen|acetaminophen|mesh-list
65582475|NCT03599089|Ketorolac|ketorolac|mesh-list
65582476|NCT03599089|Oxycodone|oxycodone|mesh-list
65582477|NCT03599089|Bupivacaine|bupivacaine|mesh-list
65582478|NCT03599089|Anesthetics, Local|anesthetics, local|mesh-ancestor
65582479|NCT03599089|Anesthetics|anesthetics|mesh-ancestor
65582480|NCT03599089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65582481|NCT03599089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582482|NCT03599089|Sensory System Agents|sensory system agents|mesh-ancestor
65582483|NCT03599089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582484|NCT03599089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65582485|NCT03599089|Analgesics|analgesics|mesh-ancestor
65582486|NCT03599089|Antipyretics|antipyretics|mesh-ancestor
65582487|NCT03599089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65582488|NCT03599089|Narcotics|narcotics|mesh-ancestor
65582489|NCT03599089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65582490|NCT03599089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65582491|NCT03599089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65582492|NCT03599089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65582493|NCT03599089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582494|NCT03599089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582495|NCT03597529|Melatonin|melatonin|mesh-list
65582496|NCT03597529|Antioxidants|antioxidants|mesh-ancestor
65582497|NCT03597529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582498|NCT03597529|Protective Agents|protective agents|mesh-ancestor
65582499|NCT03597529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582500|NCT03597529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65582501|NCT03991091|Oxytocin|oxytocin|mesh-list
65582502|NCT03991091|Oxytocics|oxytocics|mesh-ancestor
65582503|NCT03991091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64583482|NCT03972397|Bupivacaine|bupivacaine|mesh-list
65582504|NCT03991091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582505|NCT05420454|Paclitaxel|paclitaxel|mesh-list
65582506|NCT05420454|Docetaxel|docetaxel|mesh-list
65582507|NCT05420454|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65582508|NCT05420454|Cyclophosphamide|cyclophosphamide|mesh-list
65582509|NCT05420454|Carboplatin|carboplatin|mesh-list
65582510|NCT05420454|Trastuzumab|trastuzumab|mesh-list
65582511|NCT05420454|Epirubicin|epirubicin|mesh-list
65582512|NCT05420454|Pertuzumab|pertuzumab|mesh-list
65582513|NCT05420454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65582514|NCT05420454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582515|NCT05420454|Tubulin Modulators|tubulin modulators|mesh-ancestor
65582516|NCT05420454|Antimitotic Agents|antimitotic agents|mesh-ancestor
65582517|NCT05420454|Mitosis Modulators|mitosis modulators|mesh-ancestor
65582518|NCT05420454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582519|NCT05420454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65582520|NCT05420454|Immunologic Factors|immunologic factors|mesh-ancestor
65582521|NCT05420454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582522|NCT05420454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65582523|NCT05420454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65582524|NCT05420454|Alkylating Agents|alkylating agents|mesh-ancestor
65582526|NCT05420454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65582527|NCT05420454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65582528|NCT05420454|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65582529|NCT05420454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65582530|NCT05420454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582531|NCT03180528|Benzoic Acid|benzoic acid|mesh-list
65582532|NCT03180528|Antifungal Agents|antifungal agents|mesh-ancestor
65582533|NCT03180528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65582534|NCT04667507|Dexamethasone|dexamethasone|mesh-list
65582535|NCT04667507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65582536|NCT04667507|Antiemetics|antiemetics|mesh-ancestor
65582537|NCT04667507|Autonomic Agents|autonomic agents|mesh-ancestor
65582538|NCT04667507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582539|NCT04667507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582540|NCT04667507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65582541|NCT04667507|Glucocorticoids|glucocorticoids|mesh-ancestor
65582542|NCT04667507|Hormones|hormones|mesh-ancestor
65582543|NCT04667507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65582544|NCT04667507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65582545|NCT04667507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582546|NCT01200251|Bimatoprost|bimatoprost|mesh-list
65582547|NCT01200251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65582548|NCT03597139|Cyclosporine|cyclosporine|mesh-list
65582549|NCT03597139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65582550|NCT03597139|Cyclosporins|cyclosporins|mesh-list
65582551|NCT03597139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582552|NCT03597139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582553|NCT03597139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65582554|NCT03597139|Immunologic Factors|immunologic factors|mesh-ancestor
65582555|NCT03597139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582556|NCT03597139|Antifungal Agents|antifungal agents|mesh-ancestor
65582557|NCT03597139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65582558|NCT03597139|Dermatologic Agents|dermatologic agents|mesh-ancestor
65582559|NCT03597139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65582560|NCT03597139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65582561|NCT03597139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65582562|NCT01202435|Pregabalin|pregabalin|mesh-list
65582563|NCT01202435|Analgesics|analgesics|mesh-ancestor
65582564|NCT01202435|Sensory System Agents|sensory system agents|mesh-ancestor
65582565|NCT01202435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582566|NCT01202435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582567|NCT01202435|Anticonvulsants|anticonvulsants|mesh-ancestor
65582568|NCT01202435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65582569|NCT01202435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65582570|NCT01202435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582571|NCT01202435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65582572|NCT01202435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65582573|NCT01202435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65582574|NCT01202435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65582575|NCT01202435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65582576|NCT05406102|Propofol|propofol|mesh-list
65582577|NCT05406102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65582578|NCT05406102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65582579|NCT05406102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582580|NCT05406102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65582581|NCT05406102|Anesthetics, General|anesthetics, general|mesh-ancestor
65582582|NCT05406102|Anesthetics|anesthetics|mesh-ancestor
65582583|NCT01204307|Cisplatin|cisplatin|mesh-list
65582584|NCT01204307|Docetaxel|docetaxel|mesh-list
65582585|NCT01204307|Pemetrexed|pemetrexed|mesh-list
65582586|NCT01204307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582587|NCT01204307|Tubulin Modulators|tubulin modulators|mesh-ancestor
65582588|NCT01204307|Antimitotic Agents|antimitotic agents|mesh-ancestor
65582589|NCT01204307|Mitosis Modulators|mitosis modulators|mesh-ancestor
65582590|NCT01204307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582591|NCT01204307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582592|NCT01204307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65582593|NCT01204307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65582594|NCT00708214|Letrozole|letrozole|mesh-list
65582595|NCT00708214|Afatinib|afatinib|mesh-list
65582596|NCT00708214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582597|NCT00708214|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65582598|NCT00708214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65582599|NCT00708214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380116|NCT00628862|Autonomic Agents|autonomic agents|mesh-ancestor
65582600|NCT00708214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582601|NCT00708214|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65582602|NCT00708214|Hormone Antagonists|hormone antagonists|mesh-ancestor
65582603|NCT00708214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65582604|NCT00708214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582605|NCT00708214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65582606|NCT02506894|Magnesium Sulfate|magnesium sulfate|mesh-list
65582607|NCT02506894|Analgesics|analgesics|mesh-ancestor
65582608|NCT02506894|Sensory System Agents|sensory system agents|mesh-ancestor
65582609|NCT02506894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582610|NCT02506894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582611|NCT02506894|Anesthetics|anesthetics|mesh-ancestor
65582612|NCT02506894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65582613|NCT02506894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65582614|NCT02506894|Anticonvulsants|anticonvulsants|mesh-ancestor
65582615|NCT02506894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65582616|NCT02506894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65582617|NCT02506894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582618|NCT02506894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65582619|NCT02506894|Tocolytic Agents|tocolytic agents|mesh-ancestor
65582620|NCT02506894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65582621|NCT03909737|Azithromycin|azithromycin|mesh-list
65582622|NCT03909737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65582623|NCT03909737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65582624|NCT04891250|Ivermectin|ivermectin|mesh-list
65582625|NCT04891250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65582626|NCT04891250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65582627|NCT03570697|Evolocumab|evolocumab|mesh-list
65582628|NCT03570697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65582629|NCT03570697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65582630|NCT03570697|Antimetabolites|antimetabolites|mesh-ancestor
65582631|NCT03570697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582632|NCT03570697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65582633|NCT02511574|Progesterone|progesterone|mesh-list
65582634|NCT02511574|Progestins|progestins|mesh-ancestor
65582635|NCT02511574|Hormones|hormones|mesh-ancestor
65582636|NCT02511574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65582637|NCT02511574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582638|NCT01200641|Gabapentin|gabapentin|mesh-list
65582639|NCT01200641|Melatonin|melatonin|mesh-list
65582640|NCT01200641|Analgesics|analgesics|mesh-ancestor
65582641|NCT01200641|Sensory System Agents|sensory system agents|mesh-ancestor
65582642|NCT01200641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582643|NCT01200641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582644|NCT01200641|Anticonvulsants|anticonvulsants|mesh-ancestor
65582645|NCT01200641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65582646|NCT01200641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65582647|NCT01200641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65582648|NCT01200641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65582649|NCT01200641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65582650|NCT01200641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65582651|NCT01200641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65582652|NCT01200641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582653|NCT01200641|Antimanic Agents|antimanic agents|mesh-ancestor
65582654|NCT01200641|Antioxidants|antioxidants|mesh-ancestor
65582655|NCT01200641|Protective Agents|protective agents|mesh-ancestor
65582656|NCT01856270|Amitriptyline|amitriptyline|mesh-list
65582657|NCT01856270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65582658|NCT01856270|Antidepressive Agents|antidepressive agents|mesh-ancestor
65582659|NCT01856270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65582660|NCT01856270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65582661|NCT01856270|Analgesics|analgesics|mesh-ancestor
65582662|NCT01856270|Sensory System Agents|sensory system agents|mesh-ancestor
65582663|NCT01856270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582664|NCT01856270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582665|NCT01856270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65582666|NCT01856270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65582667|NCT01856270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65582668|NCT01856270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582669|NCT01856270|Adrenergic Agents|adrenergic agents|mesh-ancestor
65582670|NCT01856270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65582671|NCT02511340|HH-GV-678|hh-gv-678|mesh-list
65582672|NCT02511340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65582673|NCT02511340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582674|NCT02511340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582675|NCT02506348|Diclofenac|diclofenac|mesh-list
65582676|NCT02506348|Nepafenac|nepafenac|mesh-list
65582677|NCT02506348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65582678|NCT02506348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65582679|NCT02506348|Analgesics|analgesics|mesh-ancestor
65582680|NCT02506348|Sensory System Agents|sensory system agents|mesh-ancestor
65582681|NCT02506348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582682|NCT02506348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582683|NCT02506348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65582684|NCT02506348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65582685|NCT02506348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65582686|NCT02506348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582687|NCT02506348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582688|NCT01318070|Pioglitazone|pioglitazone|mesh-list
65582689|NCT01318070|Alogliptin|alogliptin|mesh-list
65582690|NCT01318070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65582691|NCT01318070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582692|NCT01318070|Incretins|incretins|mesh-ancestor
65582693|NCT01318070|Hormones|hormones|mesh-ancestor
65582694|NCT01318070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65582695|NCT01318070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65582696|NCT01318070|Protease Inhibitors|protease inhibitors|mesh-ancestor
65582697|NCT01318070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582698|NCT01318070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582699|NCT01202513|Bimatoprost|bimatoprost|mesh-list
65582700|NCT01202513|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65582701|NCT01202513|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65582702|NCT01202513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65582703|NCT03835715|Vortioxetine|vortioxetine|mesh-list
65582704|NCT03835715|Antidepressive Agents|antidepressive agents|mesh-ancestor
65582705|NCT03835715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65582706|NCT03835715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65582707|NCT03835715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65582708|NCT03835715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65582709|NCT03835715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582710|NCT03835715|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65582711|NCT03835715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65582712|NCT03835715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65582713|NCT03835715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582714|NCT03835715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65582715|NCT03835715|Serotonin Agents|serotonin agents|mesh-ancestor
65582716|NCT03835715|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65582717|NCT03835715|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65582718|NCT03835715|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65582719|NCT03835715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65582720|NCT02505802|Botulinum Toxins|botulinum toxins|mesh-list
65582721|NCT02505802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65582722|NCT02505802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65582723|NCT02505802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65582724|NCT02505802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582725|NCT02505802|Cholinergic Agents|cholinergic agents|mesh-ancestor
65582726|NCT02505802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65582727|NCT02505802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582728|NCT02505802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65582729|NCT02505802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582730|NCT03627884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65582731|NCT03843281|Acetaminophen|acetaminophen|mesh-list
65582732|NCT03843281|Morphine|morphine|mesh-list
65582733|NCT03843281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65582734|NCT03843281|Narcotics|narcotics|mesh-ancestor
65582735|NCT03843281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65582736|NCT03843281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582737|NCT03843281|Analgesics|analgesics|mesh-ancestor
65582738|NCT03843281|Sensory System Agents|sensory system agents|mesh-ancestor
65582739|NCT03843281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582740|NCT03843281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65582741|NCT03843281|Antipyretics|antipyretics|mesh-ancestor
65582742|NCT02515240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65582743|NCT02515240|Immunologic Factors|immunologic factors|mesh-ancestor
65582744|NCT02515240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582745|NCT03843515|Nivolumab|nivolumab|mesh-list
65380276|NCT04006353|Rifampin|rifampin|mesh-list
65582746|NCT03843515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65582747|NCT03843515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582748|NCT03843515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65582749|NCT03843515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582750|NCT00245960|Etanercept|etanercept|mesh-list
65582751|NCT00245960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65582752|NCT00245960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65582753|NCT00245960|Analgesics|analgesics|mesh-ancestor
65582754|NCT00245960|Sensory System Agents|sensory system agents|mesh-ancestor
65582755|NCT00245960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582756|NCT00245960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582757|NCT00245960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65582758|NCT00245960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65582759|NCT00245960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65582760|NCT00245960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65582761|NCT00245960|Immunologic Factors|immunologic factors|mesh-ancestor
65582762|NCT04443322|Durvalumab|durvalumab|mesh-list
65582763|NCT04443322|Lenvatinib|lenvatinib|mesh-list
65582764|NCT04443322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65582765|NCT04443322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65582766|NCT04443322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582767|NCT04443322|Immunologic Factors|immunologic factors|mesh-ancestor
65582768|NCT04443322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582769|NCT04443322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65582770|NCT04443322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582771|NCT04443322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582772|NCT01202825|Simeprevir|simeprevir|mesh-list
65582773|NCT01202825|Antiviral Agents|antiviral agents|mesh-ancestor
65582774|NCT01202825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65582775|NCT01202825|Protease Inhibitors|protease inhibitors|mesh-ancestor
65582776|NCT01202825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582777|NCT01202825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582778|NCT02510872|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65582779|NCT02510872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65582780|NCT02510872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582781|NCT05222204|Gemcitabine|gemcitabine|mesh-list
65582782|NCT05222204|Paclitaxel|paclitaxel|mesh-list
65582783|NCT05222204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65582784|NCT05222204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582785|NCT05222204|Tubulin Modulators|tubulin modulators|mesh-ancestor
65582786|NCT05222204|Antimitotic Agents|antimitotic agents|mesh-ancestor
65582787|NCT05222204|Mitosis Modulators|mitosis modulators|mesh-ancestor
65582788|NCT05222204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582789|NCT05222204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65582790|NCT05222204|Antimetabolites|antimetabolites|mesh-ancestor
65582791|NCT05222204|Antiviral Agents|antiviral agents|mesh-ancestor
65582792|NCT05222204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65582793|NCT05222204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582794|NCT05222204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65582795|NCT05222204|Immunologic Factors|immunologic factors|mesh-ancestor
65582796|NCT05222204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582797|NCT02558465|Rivaroxaban|rivaroxaban|mesh-list
65582798|NCT02558465|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65582799|NCT02558465|Antithrombins|antithrombins|mesh-ancestor
65582800|NCT02558465|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65582801|NCT02558465|Protease Inhibitors|protease inhibitors|mesh-ancestor
65582802|NCT02558465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582803|NCT02558465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582804|NCT02558465|Anticoagulants|anticoagulants|mesh-ancestor
65582805|NCT05218616|Sunitinib|sunitinib|mesh-list
65582806|NCT05218616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582807|NCT05218616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65582808|NCT05218616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65582809|NCT05218616|Growth Substances|growth substances|mesh-ancestor
65582810|NCT05218616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582811|NCT05218616|Growth Inhibitors|growth inhibitors|mesh-ancestor
65582812|NCT05218616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65582813|NCT05218616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582814|NCT05218616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582815|NCT02505880|Anesthetics|anesthetics|mesh-list
65582816|NCT02505880|Anesthetics, Local|anesthetics, local|mesh-list
65582817|NCT02505880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65582818|NCT02505880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582819|NCT02505880|Sensory System Agents|sensory system agents|mesh-ancestor
65582820|NCT02505880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582821|NCT03215706|Paclitaxel|paclitaxel|mesh-list
65582822|NCT03215706|Carboplatin|carboplatin|mesh-list
65582823|NCT03215706|Nivolumab|nivolumab|mesh-list
65582824|NCT03215706|Pemetrexed|pemetrexed|mesh-list
65582825|NCT03215706|Ipilimumab|ipilimumab|mesh-list
65582826|NCT03215706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65582827|NCT03215706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582828|NCT03215706|Tubulin Modulators|tubulin modulators|mesh-ancestor
65582829|NCT03215706|Antimitotic Agents|antimitotic agents|mesh-ancestor
65582830|NCT03215706|Mitosis Modulators|mitosis modulators|mesh-ancestor
65582831|NCT03215706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582832|NCT03215706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65582833|NCT03215706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65582834|NCT03215706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582835|NCT03215706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65582836|NCT03215706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65582837|NCT02510950|Temozolomide|temozolomide|mesh-list
65582838|NCT02510950|Poly ICLC|poly iclc|mesh-list
65582839|NCT02510950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65582840|NCT02510950|Alkylating Agents|alkylating agents|mesh-ancestor
65582841|NCT02510950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582842|NCT02510950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582843|NCT02510950|Interferon Inducers|interferon inducers|mesh-ancestor
65582844|NCT02510950|Immunologic Factors|immunologic factors|mesh-ancestor
65582845|NCT02510950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582846|NCT05221892|Thiamine|thiamine|mesh-list
65582847|NCT05221892|Pyridoxine|pyridoxine|mesh-list
65582848|NCT05221892|Vitamin B 12|vitamin b 12|mesh-list
65582849|NCT05221892|Hydroxocobalamin|hydroxocobalamin|mesh-list
65582850|NCT05221892|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
65582851|NCT05221892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582852|NCT05221892|Vitamin B Complex|vitamin b complex|mesh-ancestor
65582853|NCT05221892|Vitamins|vitamins|mesh-ancestor
65582854|NCT05221892|Micronutrients|micronutrients|mesh-ancestor
65582855|NCT05221892|Hematinics|hematinics|mesh-ancestor
65582856|NCT05221892|GABA Agents|gaba agents|mesh-ancestor
65582857|NCT05221892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65582858|NCT05221892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582859|NCT05221736|Ethanol|ethanol|mesh-list
65582860|NCT05221736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65582861|NCT05221736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65582862|NCT05221736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65582863|NCT05221736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582864|NCT05651594|Leucovorin|leucovorin|mesh-list
65582865|NCT05651594|Pembrolizumab|pembrolizumab|mesh-list
65582866|NCT05651594|Fluorouracil|fluorouracil|mesh-list
65582867|NCT05651594|Oxaliplatin|oxaliplatin|mesh-list
65582868|NCT05651594|Propranolol|propranolol|mesh-list
65582869|NCT05651594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65582870|NCT05651594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582871|NCT05651594|Antimetabolites|antimetabolites|mesh-ancestor
65582872|NCT05651594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582873|NCT05651594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65582874|NCT05651594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65582875|NCT05651594|Immunologic Factors|immunologic factors|mesh-ancestor
65582876|NCT05651594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582877|NCT05651594|Antidotes|antidotes|mesh-ancestor
65582878|NCT05651594|Protective Agents|protective agents|mesh-ancestor
65582879|NCT05651594|Vitamin B Complex|vitamin b complex|mesh-ancestor
65582880|NCT05651594|Vitamins|vitamins|mesh-ancestor
65582881|NCT05651594|Micronutrients|micronutrients|mesh-ancestor
65582882|NCT05651594|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65582883|NCT05651594|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65582884|NCT05651594|Adrenergic Agents|adrenergic agents|mesh-ancestor
65582885|NCT05651594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65582886|NCT05651594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65582887|NCT05651594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65582888|NCT05651594|Vasodilator Agents|vasodilator agents|mesh-ancestor
65582889|NCT02514850|Insulin Lispro|insulin lispro|mesh-list
65582890|NCT02514850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65582891|NCT02514850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582892|NCT04454411|Naltrexone|naltrexone|mesh-list
65582893|NCT04454411|Buprenorphine|buprenorphine|mesh-list
65582894|NCT04454411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65582895|NCT04454411|Narcotics|narcotics|mesh-ancestor
65582896|NCT04454411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65582897|NCT04454411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380407|NCT05313477|Vitamin D|vitamin d|mesh-list
65582898|NCT04454411|Analgesics|analgesics|mesh-ancestor
65582899|NCT04454411|Sensory System Agents|sensory system agents|mesh-ancestor
65582900|NCT04454411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582901|NCT04454411|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65582902|NCT04454411|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65582903|NCT02505568|Infliximab|infliximab|mesh-list
65582904|NCT02505568|Dermatologic Agents|dermatologic agents|mesh-ancestor
65582905|NCT02505568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65582906|NCT02505568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65582907|NCT05356728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65582908|NCT05356728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65582909|NCT05217836|Hepcidins|hepcidins|mesh-list
65582910|NCT05217836|Chrysarobin|chrysarobin|mesh-list
65582911|NCT05217836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65582912|NCT05217836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65582913|NCT05217836|Analgesics|analgesics|mesh-ancestor
65582914|NCT05217836|Sensory System Agents|sensory system agents|mesh-ancestor
65582915|NCT05217836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582916|NCT05217836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582917|NCT05217836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65582918|NCT05217836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65582919|NCT05217836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65582920|NCT02510248|1-2-isopropoxy-2-oxidodihydro-4H,6H-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1H,3H)-dione|1-2-isopropoxy-2-oxidodihydro-4h,6h-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1h,3h)-dione|mesh-list
65582921|NCT02510248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582922|NCT02510248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582923|NCT02514538|Acetaminophen|acetaminophen|mesh-list
65582924|NCT02514538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65582925|NCT02514538|Analgesics|analgesics|mesh-ancestor
65582926|NCT02514538|Sensory System Agents|sensory system agents|mesh-ancestor
65582927|NCT02514538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582928|NCT02514538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582929|NCT02514538|Antipyretics|antipyretics|mesh-ancestor
65582930|NCT05669417|Magnesium Sulfate|magnesium sulfate|mesh-list
65582931|NCT05669417|Analgesics|analgesics|mesh-ancestor
65582932|NCT05669417|Sensory System Agents|sensory system agents|mesh-ancestor
65582933|NCT05669417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582934|NCT05669417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582935|NCT05669417|Anesthetics|anesthetics|mesh-ancestor
65582936|NCT05669417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65582937|NCT05669417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65582938|NCT05669417|Anticonvulsants|anticonvulsants|mesh-ancestor
65582939|NCT05669417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65582940|NCT05669417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65582941|NCT05669417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582942|NCT05669417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65582943|NCT05669417|Tocolytic Agents|tocolytic agents|mesh-ancestor
65582944|NCT05669417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65582945|NCT03832673|Pembrolizumab|pembrolizumab|mesh-list
65582946|NCT03832673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65582947|NCT03832673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582948|NCT02504944|Propranolol|propranolol|mesh-list
65582949|NCT02504944|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65582950|NCT02504944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65582951|NCT02504944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65582952|NCT02504944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65582953|NCT02504944|Adrenergic Agents|adrenergic agents|mesh-ancestor
65582954|NCT02504944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65582955|NCT02504944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582956|NCT02504944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582957|NCT02504944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65582958|NCT02504944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65582959|NCT02504944|Vasodilator Agents|vasodilator agents|mesh-ancestor
65582960|NCT01201499|Morphine|morphine|mesh-list
65582961|NCT01201499|Remifentanil|remifentanil|mesh-list
65582962|NCT01201499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65582963|NCT01201499|Narcotics|narcotics|mesh-ancestor
65582964|NCT01201499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65582965|NCT01201499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582966|NCT01201499|Analgesics|analgesics|mesh-ancestor
65582967|NCT01201499|Sensory System Agents|sensory system agents|mesh-ancestor
65582968|NCT01201499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65582969|NCT03473639|Capecitabine|capecitabine|mesh-list
65582970|NCT03473639|Entinostat|entinostat|mesh-list
65582971|NCT03473639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65582972|NCT03473639|Antimetabolites|antimetabolites|mesh-ancestor
65582973|NCT03473639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65582974|NCT03473639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582975|NCT03473639|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65582976|NCT03473639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65582977|NCT03121690|Prednisone|prednisone|mesh-list
65582978|NCT03121690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65582979|NCT03121690|Glucocorticoids|glucocorticoids|mesh-ancestor
65582980|NCT03121690|Hormones|hormones|mesh-ancestor
65582981|NCT03121690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65582982|NCT03121690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582983|NCT03121690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65582984|NCT03121690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65582985|NCT03831269|Azithromycin|azithromycin|mesh-list
65582986|NCT03831269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65582987|NCT03831269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65582988|NCT02504476|Midazolam|midazolam|mesh-list
65582989|NCT02504476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65582990|NCT02504476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65582991|NCT02504476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65582992|NCT02504476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65582993|NCT02504476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65582994|NCT02504476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65582995|NCT02504476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65582996|NCT02504476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65582997|NCT02504476|Anesthetics, General|anesthetics, general|mesh-ancestor
65582998|NCT02504476|Anesthetics|anesthetics|mesh-ancestor
65582999|NCT02504476|GABA Modulators|gaba modulators|mesh-ancestor
65583000|NCT02504476|GABA Agents|gaba agents|mesh-ancestor
65583001|NCT02504476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65583002|NCT02504476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583003|NCT02504398|Methamphetamine|methamphetamine|mesh-list
65583004|NCT02504398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65583005|NCT02504398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583006|NCT02504398|Sympathomimetics|sympathomimetics|mesh-ancestor
65583007|NCT02504398|Autonomic Agents|autonomic agents|mesh-ancestor
65583008|NCT02504398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65583009|NCT02504398|Dopamine Agents|dopamine agents|mesh-ancestor
65583010|NCT02504398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65583011|NCT02504398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583012|NCT02504398|Adrenergic Agents|adrenergic agents|mesh-ancestor
65583013|NCT02504398|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65583014|NCT02504398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65583015|NCT02504398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65583016|NCT02504398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65583017|NCT01205009|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65583018|NCT01205009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65583019|NCT01205009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583020|NCT03830489|Ascorbic Acid|ascorbic acid|mesh-list
65583021|NCT03830489|Antioxidants|antioxidants|mesh-ancestor
65583022|NCT03830489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583023|NCT03830489|Protective Agents|protective agents|mesh-ancestor
65583024|NCT03830489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583025|NCT03830489|Vitamins|vitamins|mesh-ancestor
65583026|NCT03830489|Micronutrients|micronutrients|mesh-ancestor
65583027|NCT02509468|Sirolimus|sirolimus|mesh-list
65583028|NCT02509468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65583029|NCT02509468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65583030|NCT02509468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65583031|NCT02509468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583032|NCT02509468|Antifungal Agents|antifungal agents|mesh-ancestor
65583033|NCT02509468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65583034|NCT02509468|Immunologic Factors|immunologic factors|mesh-ancestor
65583035|NCT02509468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583036|NCT03344614|Apatinib|apatinib|mesh-list
65583037|NCT03344614|Raltitrexed|raltitrexed|mesh-list
65583038|NCT03344614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583039|NCT03344614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65583040|NCT03344614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583041|NCT03344614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583042|NCT03344614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65583043|NCT03344614|Antimetabolites|antimetabolites|mesh-ancestor
65583044|NCT03344614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65583045|NCT01205087|Omeprazole|omeprazole|mesh-list
65583046|NCT01205087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65583047|NCT01205087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65583048|NCT01205087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65583049|NCT01205087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583050|NCT01205087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583052|NCT01205243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65583053|NCT01205243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65583054|NCT01205243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583055|NCT01205243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583056|NCT01205243|Antiviral Agents|antiviral agents|mesh-ancestor
65583057|NCT01205243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65583058|NCT01205243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65583059|NCT01205243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65583060|NCT02504164|Midazolam|midazolam|mesh-list
65583061|NCT02504164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65583062|NCT02504164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65583063|NCT02504164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65583064|NCT02504164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583065|NCT02504164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65583066|NCT02504164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65583067|NCT02504164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65583068|NCT02504164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65583069|NCT02504164|Anesthetics, General|anesthetics, general|mesh-ancestor
65583070|NCT02504164|Anesthetics|anesthetics|mesh-ancestor
65583071|NCT02504164|GABA Modulators|gaba modulators|mesh-ancestor
65583072|NCT02504164|GABA Agents|gaba agents|mesh-ancestor
65583073|NCT02504164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65583074|NCT02504164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583075|NCT02509234|Irinotecan|irinotecan|mesh-list
65583076|NCT02509234|Trabectedin|trabectedin|mesh-list
65583077|NCT02509234|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65583078|NCT02509234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65583079|NCT02509234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583080|NCT02509234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583081|NCT02509234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583082|NCT02509234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65583083|NCT02509234|Alkylating Agents|alkylating agents|mesh-ancestor
65583084|NCT01205321|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
65583085|NCT01205321|Bombesin|bombesin|mesh-list
65583086|NCT01205321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65583087|NCT01205321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583088|NCT01205321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583089|NCT01205321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65583090|NCT02504008|Zoledronic Acid|zoledronic acid|mesh-list
65583091|NCT02504008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65583092|NCT02504008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583093|NCT03566485|Atezolizumab|atezolizumab|mesh-list
65583094|NCT03566485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583095|NCT02513290|Loratadine|loratadine|mesh-list
65583096|NCT02513290|Antipruritics|antipruritics|mesh-ancestor
65583097|NCT02513290|Dermatologic Agents|dermatologic agents|mesh-ancestor
65583098|NCT02513290|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65583099|NCT02513290|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65583100|NCT02513290|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65583101|NCT02513290|Histamine Antagonists|histamine antagonists|mesh-ancestor
65583102|NCT02513290|Histamine Agents|histamine agents|mesh-ancestor
65583103|NCT02513290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65583104|NCT02513290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583105|NCT02513290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583106|NCT02501200|Ezetimibe|ezetimibe|mesh-list
65583107|NCT02501200|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65583108|NCT02501200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65583109|NCT02501200|Antimetabolites|antimetabolites|mesh-ancestor
65583110|NCT02501200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583111|NCT02501200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65583112|NCT01205477|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65583113|NCT01205477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65583114|NCT02501278|Cisplatin|cisplatin|mesh-list
65583115|NCT02501278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583116|NCT03176238|Everolimus|everolimus|mesh-list
65583117|NCT03176238|Exemestane|exemestane|mesh-list
65583118|NCT03176238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583119|NCT03176238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65583120|NCT03176238|Immunologic Factors|immunologic factors|mesh-ancestor
65583121|NCT03176238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583122|NCT03176238|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65583123|NCT03176238|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65583124|NCT03176238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583125|NCT03176238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583127|NCT03176238|Hormone Antagonists|hormone antagonists|mesh-ancestor
65583128|NCT03176238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65583129|NCT01957332|Trastuzumab|trastuzumab|mesh-list
65583130|NCT01957332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65583131|NCT01957332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583132|NCT01205711|Leucovorin|leucovorin|mesh-list
65583133|NCT01205711|Fluorouracil|fluorouracil|mesh-list
65583134|NCT01205711|Irinotecan|irinotecan|mesh-list
65583135|NCT01205711|Calcium|calcium|mesh-list
65583136|NCT01205711|Levoleucovorin|levoleucovorin|mesh-list
65583137|NCT01205711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65583138|NCT01205711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583139|NCT01205711|Antimetabolites|antimetabolites|mesh-ancestor
65583140|NCT01205711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583141|NCT01205711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65583142|NCT01205711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583143|NCT01205711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65583144|NCT01205711|Immunologic Factors|immunologic factors|mesh-ancestor
65583145|NCT01205711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65583146|NCT01205711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65583147|NCT01205711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583148|NCT01205711|Antidotes|antidotes|mesh-ancestor
65583149|NCT01205711|Protective Agents|protective agents|mesh-ancestor
65583150|NCT01205711|Vitamin B Complex|vitamin b complex|mesh-ancestor
65583151|NCT01205711|Vitamins|vitamins|mesh-ancestor
65583152|NCT01205711|Micronutrients|micronutrients|mesh-ancestor
65583153|NCT02508922|Vitamin D|vitamin d|mesh-list
65583154|NCT02508922|Cholecalciferol|cholecalciferol|mesh-list
65583155|NCT02508922|Vitamins|vitamins|mesh-ancestor
65583156|NCT02508922|Micronutrients|micronutrients|mesh-ancestor
65583157|NCT02508922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583158|NCT02508922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65583159|NCT02508922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65583160|NCT01860456|Imatinib Mesylate|imatinib mesylate|mesh-list
65583161|NCT01860456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583162|NCT01860456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65583163|NCT01860456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583164|NCT01860456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583165|NCT03730675|Sorafenib|sorafenib|mesh-list
65583166|NCT03730675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583167|NCT03730675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65583168|NCT03730675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583169|NCT03730675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583170|NCT01765140|Amifampridine|amifampridine|mesh-list
65583171|NCT01765140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65583172|NCT01765140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65583173|NCT01765140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583174|NCT01765140|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65583175|NCT01765140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65583176|NCT01765140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583177|NCT01345682|Methotrexate|methotrexate|mesh-list
65583178|NCT01345682|Afatinib|afatinib|mesh-list
65583179|NCT01345682|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65583180|NCT01345682|Abortifacient Agents|abortifacient agents|mesh-ancestor
65583181|NCT01345682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65583182|NCT01345682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583183|NCT01345682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65583184|NCT01345682|Antimetabolites|antimetabolites|mesh-ancestor
65583185|NCT01345682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583186|NCT01345682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583187|NCT01345682|Dermatologic Agents|dermatologic agents|mesh-ancestor
65583188|NCT01345682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583189|NCT01345682|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65583190|NCT01345682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65583191|NCT01345682|Immunologic Factors|immunologic factors|mesh-ancestor
65583192|NCT01345682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65583193|NCT01345682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65583194|NCT01345682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65583195|NCT02503462|Ritonavir|ritonavir|mesh-list
65583196|NCT02503462|Darunavir|darunavir|mesh-list
65583197|NCT02503462|Cobicistat|cobicistat|mesh-list
65583198|NCT02503462|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65380715|NCT00626522|Anticonvulsants|anticonvulsants|mesh-ancestor
65583199|NCT02503462|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65583200|NCT02503462|Protease Inhibitors|protease inhibitors|mesh-ancestor
65583201|NCT02503462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583202|NCT02503462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583203|NCT02503462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65583204|NCT02503462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65583205|NCT02503462|Antiviral Agents|antiviral agents|mesh-ancestor
65583206|NCT02503462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65583207|NCT02503462|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65583208|NCT02503462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65583210|NCT03343678|BI 836826|bi 836826|mesh-list
65583211|NCT03343678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583212|NCT03343678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65583213|NCT05216822|Racecadotril|racecadotril|mesh-list
65583214|NCT05216822|Antidiarrheals|antidiarrheals|mesh-ancestor
65583215|NCT05216822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65583216|NCT05216822|Protease Inhibitors|protease inhibitors|mesh-ancestor
65583217|NCT05216822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583218|NCT05216822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583219|NCT04498936|Sofosbuvir|sofosbuvir|mesh-list
65583220|NCT04498936|Ledipasvir|ledipasvir|mesh-list
65583221|NCT04498936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
65583222|NCT04498936|Nitazoxanide|nitazoxanide|mesh-list
65583223|NCT04498936|Antiviral Agents|antiviral agents|mesh-ancestor
65583224|NCT04498936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65583225|NCT04498936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65583226|NCT03627260|Sunscreening Agents|sunscreening agents|mesh-list
65583227|NCT03627260|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65583228|NCT03627260|Protective Agents|protective agents|mesh-ancestor
65583229|NCT03627260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583230|NCT03627260|Dermatologic Agents|dermatologic agents|mesh-ancestor
65583231|NCT05706038|Adalimumab|adalimumab|mesh-list
65583232|NCT05706038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65583233|NCT05706038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65583234|NCT03546907|Cholinergic Agents|cholinergic agents|mesh-list
65583235|NCT03546907|Muscarinic Agonists|muscarinic agonists|mesh-list
65583236|NCT03546907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65583237|NCT03546907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583238|NCT03546907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583239|NCT03546907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65583240|NCT05126264|Ibuprofen|ibuprofen|mesh-list
65583241|NCT05126264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65583242|NCT05126264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65583243|NCT05126264|Analgesics|analgesics|mesh-ancestor
65583244|NCT05126264|Sensory System Agents|sensory system agents|mesh-ancestor
65583245|NCT05126264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65583246|NCT05126264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583247|NCT05126264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65583248|NCT05126264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65583249|NCT05126264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65583250|NCT05126264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583251|NCT05126264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583252|NCT03001817|Fenofibrate|fenofibrate|mesh-list
65583253|NCT03001817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65583254|NCT03001817|Antimetabolites|antimetabolites|mesh-ancestor
65583255|NCT03001817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583256|NCT03001817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65583257|NCT02502682|Chlorhexidine|chlorhexidine|mesh-list
65583258|NCT02502682|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65583259|NCT02502682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65583260|NCT02502682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65583261|NCT02502682|Disinfectants|disinfectants|mesh-ancestor
65583262|NCT02502682|Dermatologic Agents|dermatologic agents|mesh-ancestor
65583263|NCT03590743|Apixaban|apixaban|mesh-list
65583264|NCT03590743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65583265|NCT03590743|Antithrombins|antithrombins|mesh-ancestor
65583266|NCT03590743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65583267|NCT03590743|Protease Inhibitors|protease inhibitors|mesh-ancestor
65583268|NCT03590743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583269|NCT03590743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583270|NCT03590743|Anticoagulants|anticoagulants|mesh-ancestor
65583271|NCT03343600|Imatinib Mesylate|imatinib mesylate|mesh-list
65583272|NCT03343600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583273|NCT03343600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65583274|NCT03343600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583275|NCT03343600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583277|NCT03589885|Immunologic Factors|immunologic factors|mesh-ancestor
65583278|NCT03589885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583279|NCT03121222|Acetylcysteine|acetylcysteine|mesh-list
65583280|NCT03121222|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65583281|NCT03121222|Antiviral Agents|antiviral agents|mesh-ancestor
65583282|NCT03121222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65583283|NCT03121222|Expectorants|expectorants|mesh-ancestor
65583284|NCT03121222|Respiratory System Agents|respiratory system agents|mesh-ancestor
65583285|NCT03121222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65583286|NCT03121222|Antioxidants|antioxidants|mesh-ancestor
65583287|NCT03121222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583288|NCT03121222|Protective Agents|protective agents|mesh-ancestor
65583289|NCT03121222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583290|NCT03121222|Antidotes|antidotes|mesh-ancestor
65583291|NCT03639493|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
65583292|NCT03639493|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65583293|NCT03639493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65583294|NCT03639493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65583295|NCT03639493|Antimetabolites|antimetabolites|mesh-ancestor
65583296|NCT03639493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583297|NCT03639493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65583298|NCT03639493|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65583299|NCT03639493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583300|NCT03639493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65583301|NCT05705804|Atorvastatin|atorvastatin|mesh-list
65583302|NCT05705804|Pitavastatin|pitavastatin|mesh-list
65583303|NCT05705804|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65583304|NCT05705804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65583305|NCT05705804|Antimetabolites|antimetabolites|mesh-ancestor
65583306|NCT05705804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583307|NCT05705804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65583308|NCT05705804|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65583309|NCT05705804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583310|NCT03344302|Oxytocin|oxytocin|mesh-list
65583311|NCT03344302|Oxytocics|oxytocics|mesh-ancestor
65583312|NCT03344302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65583313|NCT03344302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583314|NCT03545503|Ketamine|ketamine|mesh-list
65583315|NCT03545503|Etomidate|etomidate|mesh-list
65583316|NCT03545503|Analgesics|analgesics|mesh-ancestor
65583317|NCT03545503|Sensory System Agents|sensory system agents|mesh-ancestor
65583318|NCT03545503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65583319|NCT03545503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583320|NCT03545503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65583321|NCT03545503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65583322|NCT03545503|Anesthetics, General|anesthetics, general|mesh-ancestor
65583323|NCT03545503|Anesthetics|anesthetics|mesh-ancestor
65583324|NCT03545503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65583325|NCT03545503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65583326|NCT03545503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65583327|NCT03545503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65583328|NCT03545503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583329|NCT03545503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65583330|NCT01297829|Ibuprofen|ibuprofen|mesh-list
65583331|NCT01297829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65583332|NCT01297829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65583333|NCT01297829|Analgesics|analgesics|mesh-ancestor
65583334|NCT01297829|Sensory System Agents|sensory system agents|mesh-ancestor
65583335|NCT01297829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65583336|NCT01297829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583337|NCT01297829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65583338|NCT01297829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65583339|NCT01297829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65583340|NCT01297829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583341|NCT01297829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583342|NCT03829943|Vitamin D|vitamin d|mesh-list
65583343|NCT03829943|Vitamins|vitamins|mesh-ancestor
65583344|NCT03829943|Micronutrients|micronutrients|mesh-ancestor
65583345|NCT03829943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583346|NCT03829943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65583347|NCT02508142|Scopolamine|scopolamine|mesh-list
65380855|NCT00827684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65583348|NCT02508142|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65583349|NCT02508142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65583350|NCT02508142|Antiemetics|antiemetics|mesh-ancestor
65583351|NCT02508142|Autonomic Agents|autonomic agents|mesh-ancestor
65583352|NCT02508142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65583353|NCT02508142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583354|NCT02508142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65583355|NCT02508142|Mydriatics|mydriatics|mesh-ancestor
65583356|NCT02508142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65583357|NCT02508142|Cholinergic Agents|cholinergic agents|mesh-ancestor
65583358|NCT02508142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65583359|NCT02508142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583360|NCT02508142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65583361|NCT02508142|Parasympatholytics|parasympatholytics|mesh-ancestor
65583362|NCT02508220|Oxytocin|oxytocin|mesh-list
65583363|NCT02508220|Oxytocics|oxytocics|mesh-ancestor
65583364|NCT02508220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65583365|NCT02508220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583366|NCT01297907|Methacholine Chloride|methacholine chloride|mesh-list
65583367|NCT01297907|Miotics|miotics|mesh-ancestor
65583368|NCT01297907|Autonomic Agents|autonomic agents|mesh-ancestor
65583369|NCT01297907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65583370|NCT01297907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583371|NCT01297907|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65583372|NCT01297907|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
65583373|NCT01297907|Respiratory System Agents|respiratory system agents|mesh-ancestor
65583374|NCT01297907|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65583375|NCT01297907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65583376|NCT01297907|Cholinergic Agents|cholinergic agents|mesh-ancestor
65583377|NCT01297907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65583378|NCT01297907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583379|NCT02508064|Fostemsavir|fostemsavir|mesh-list
65583380|NCT02508064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65583381|NCT02508064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65583382|NCT02508064|Antiviral Agents|antiviral agents|mesh-ancestor
65583383|NCT02508064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65583384|NCT02508064|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65583385|NCT02508064|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65583386|NCT02508064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583387|NCT05705570|Cyclophosphamide|cyclophosphamide|mesh-list
65583388|NCT05705570|Fludarabine|fludarabine|mesh-list
65583389|NCT05705570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65583390|NCT05705570|Immunologic Factors|immunologic factors|mesh-ancestor
65583391|NCT05705570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583392|NCT05705570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65583393|NCT05705570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65583394|NCT05705570|Alkylating Agents|alkylating agents|mesh-ancestor
65583395|NCT05705570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583396|NCT05705570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583397|NCT05705570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65583398|NCT05670236|Lidocaine|lidocaine|mesh-list
65583399|NCT05670236|Anesthetics, Local|anesthetics, local|mesh-ancestor
65583400|NCT05670236|Anesthetics|anesthetics|mesh-ancestor
65583401|NCT05670236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65583402|NCT05670236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583403|NCT05670236|Sensory System Agents|sensory system agents|mesh-ancestor
64743498|NCT01914666|Analgesics|analgesics|mesh-ancestor
65583404|NCT05670236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65583405|NCT05670236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65583406|NCT05670236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65583407|NCT05670236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65583408|NCT05670236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65583409|NCT05670236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583410|NCT03214380|Insulin|insulin|mesh-list
65583411|NCT03214380|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65583412|NCT03214380|Metformin|metformin|mesh-list
65583413|NCT03214380|Insulin Glargine|insulin glargine|mesh-list
65583414|NCT03214380|Insulin Lispro|insulin lispro|mesh-list
65583415|NCT03214380|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65583416|NCT03214380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65583417|NCT03214380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583418|NCT03214380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583419|NCT04498234|Bupivacaine|bupivacaine|mesh-list
65583420|NCT04498234|Anesthetics, Local|anesthetics, local|mesh-ancestor
65583421|NCT04498234|Anesthetics|anesthetics|mesh-ancestor
65583422|NCT04498234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65583423|NCT04498234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583424|NCT04498234|Sensory System Agents|sensory system agents|mesh-ancestor
65583425|NCT04498234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65583426|NCT03343444|Sofosbuvir|sofosbuvir|mesh-list
65583427|NCT03343444|Ledipasvir|ledipasvir|mesh-list
65583428|NCT03343444|Antiviral Agents|antiviral agents|mesh-ancestor
65583429|NCT03343444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65583430|NCT03819101|Aspirin|aspirin|mesh-list
65583431|NCT03819101|Atorvastatin|atorvastatin|mesh-list
65583432|NCT03819101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65583433|NCT03819101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65583434|NCT03819101|Antimetabolites|antimetabolites|mesh-ancestor
65583435|NCT03819101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583436|NCT03819101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65583437|NCT03819101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65583438|NCT03819101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583439|NCT03819101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65583440|NCT03819101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65583441|NCT03819101|Analgesics|analgesics|mesh-ancestor
65583442|NCT03819101|Sensory System Agents|sensory system agents|mesh-ancestor
65583443|NCT03819101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65583444|NCT03819101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583445|NCT03819101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65583446|NCT03819101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65583447|NCT03819101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65583448|NCT03819101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65583449|NCT03819101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65583450|NCT03819101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65583451|NCT03819101|Antipyretics|antipyretics|mesh-ancestor
65583452|NCT05199324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65583453|NCT05199324|Ciprofloxacin|ciprofloxacin|mesh-list
65583454|NCT05199324|Ceftriaxone|ceftriaxone|mesh-list
65583455|NCT05199324|Cefazolin|cefazolin|mesh-list
65583456|NCT05199324|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65583457|NCT05199324|Fluoroquinolones|fluoroquinolones|mesh-list
65583458|NCT05199324|Trimethoprim|trimethoprim|mesh-list
65583459|NCT05199324|Sulfamethoxazole|sulfamethoxazole|mesh-list
65583460|NCT05199324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65583461|NCT05199324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65583462|NCT05199324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65583463|NCT05199324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583464|NCT05199324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583465|NCT05199324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583466|NCT05199324|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65583467|NCT05199324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65583468|NCT05199324|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65583469|NCT05199324|Renal Agents|renal agents|mesh-ancestor
65583470|NCT05199324|Antimalarials|antimalarials|mesh-ancestor
65583471|NCT05199324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65583472|NCT05199324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65583473|NCT05199324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65583474|NCT05199324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65583475|NCT05199324|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65583476|NCT05199324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65583477|NCT03343366|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65583478|NCT03343366|Metronidazole|metronidazole|mesh-list
65583479|NCT03343366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65583480|NCT03343366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65583481|NCT03343366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65583482|NCT05648006|Bevacizumab|bevacizumab|mesh-list
65583483|NCT05648006|Capecitabine|capecitabine|mesh-list
65583484|NCT05648006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65583485|NCT05648006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583486|NCT05648006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65583487|NCT05648006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65583488|NCT05648006|Growth Substances|growth substances|mesh-ancestor
65583489|NCT05648006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583490|NCT05648006|Growth Inhibitors|growth inhibitors|mesh-ancestor
65583491|NCT05648006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65583492|NCT05648006|Antimetabolites|antimetabolites|mesh-ancestor
65583493|NCT05648006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583494|NCT01298297|Morphine|morphine|mesh-list
65583495|NCT01298297|Buprenorphine|buprenorphine|mesh-list
65583496|NCT01298297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65583497|NCT01298297|Narcotics|narcotics|mesh-ancestor
65583498|NCT01298297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65583499|NCT01298297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583500|NCT01298297|Analgesics|analgesics|mesh-ancestor
65583501|NCT01298297|Sensory System Agents|sensory system agents|mesh-ancestor
65583502|NCT01298297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65583503|NCT01298297|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65583504|NCT03818945|Listerine|listerine|mesh-list
65583505|NCT03818945|Fluorides|fluorides|mesh-list
65583506|NCT03818945|Sodium Fluoride|sodium fluoride|mesh-list
65583507|NCT03818945|Fluorides, Topical|fluorides, topical|mesh-list
65583508|NCT03818945|Cariostatic Agents|cariostatic agents|mesh-ancestor
65583509|NCT03818945|Protective Agents|protective agents|mesh-ancestor
65583510|NCT03818945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583511|NCT03818945|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65583512|NCT03818945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65583513|NCT04300751|Analgesics, Opioid|analgesics, opioid|mesh-list
65583514|NCT04300751|Narcotics|narcotics|mesh-ancestor
65583515|NCT04300751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65583516|NCT04300751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583517|NCT04300751|Analgesics|analgesics|mesh-ancestor
65583518|NCT04300751|Sensory System Agents|sensory system agents|mesh-ancestor
65583519|NCT04300751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65583520|NCT03842423|Anesthetics|anesthetics|mesh-list
65583521|NCT03842423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65583522|NCT03842423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583523|NCT03172026|Maraviroc|maraviroc|mesh-list
65583524|NCT03172026|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65583525|NCT03172026|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65583526|NCT03172026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583527|NCT03172026|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65583528|NCT03172026|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65583529|NCT03172026|Antiviral Agents|antiviral agents|mesh-ancestor
65583530|NCT03172026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65583531|NCT03172026|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65583532|NCT01201577|Azithromycin|azithromycin|mesh-list
65583533|NCT01201577|Sulfalene|sulfalene|mesh-list
65583534|NCT01201577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65583535|NCT01201577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65583536|NCT01201577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65583537|NCT01201577|Renal Agents|renal agents|mesh-ancestor
65583538|NCT01201577|Antimalarials|antimalarials|mesh-ancestor
65583539|NCT01201577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65583540|NCT01201577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65583541|NCT04496050|Alprostadil|alprostadil|mesh-list
65583542|NCT04496050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65583543|NCT04496050|Vasodilator Agents|vasodilator agents|mesh-ancestor
65583544|NCT04496050|Urological Agents|urological agents|mesh-ancestor
65583545|NCT01300793|Rituximab|rituximab|mesh-list
65583546|NCT01300793|Carboplatin|carboplatin|mesh-list
65583547|NCT01300793|Etoposide|etoposide|mesh-list
65583548|NCT01300793|Bortezomib|bortezomib|mesh-list
65583549|NCT01300793|Ifosfamide|ifosfamide|mesh-list
65583550|NCT01300793|Isophosphamide mustard|isophosphamide mustard|mesh-list
65583551|NCT01300793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65583552|NCT01300793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583553|NCT01300793|Immunologic Factors|immunologic factors|mesh-ancestor
65583554|NCT01300793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583555|NCT01300793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65583556|NCT01300793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65583557|NCT01300793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65583558|NCT01300793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65583559|NCT01300793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583560|NCT01300793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583561|NCT01300793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65583562|NCT01300793|Alkylating Agents|alkylating agents|mesh-ancestor
65583563|NCT03342040|Bupivacaine|bupivacaine|mesh-list
65583564|NCT03342040|Ropivacaine|ropivacaine|mesh-list
65583565|NCT03342040|Anesthetics, Local|anesthetics, local|mesh-ancestor
65583566|NCT03342040|Anesthetics|anesthetics|mesh-ancestor
65583567|NCT03342040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65583568|NCT03342040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381080|NCT00938184|Paroxetine|paroxetine|mesh-list
65583569|NCT03342040|Sensory System Agents|sensory system agents|mesh-ancestor
65583570|NCT03342040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65583571|NCT01298843|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
65583572|NCT01298843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65583573|NCT01298843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65583574|NCT03336970|Calcium|calcium|mesh-list
65583575|NCT03336970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65583576|NCT03336970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583577|NCT03336814|Terlipressin|terlipressin|mesh-list
65583578|NCT03336814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65583579|NCT03336814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65583580|NCT02495584|Vitamin D|vitamin d|mesh-list
65583581|NCT02495584|Ergocalciferols|ergocalciferols|mesh-list
65583582|NCT02495584|Cholecalciferol|cholecalciferol|mesh-list
65583583|NCT02495584|Vitamins|vitamins|mesh-list
65583584|NCT02495584|Micronutrients|micronutrients|mesh-ancestor
65583585|NCT02495584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583586|NCT02495584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65583587|NCT02495584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65583588|NCT02495818|Lidocaine|lidocaine|mesh-list
65583589|NCT02495818|Anesthetics, Local|anesthetics, local|mesh-ancestor
65583590|NCT02495818|Anesthetics|anesthetics|mesh-ancestor
65583591|NCT02495818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65583592|NCT02495818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583593|NCT02495818|Sensory System Agents|sensory system agents|mesh-ancestor
65583594|NCT02495818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65583595|NCT02495818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65583596|NCT02495818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65583597|NCT02495818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65583598|NCT02495818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65583599|NCT02495818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583600|NCT02495662|Prednisolone|prednisolone|mesh-list
65583601|NCT02495662|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65583602|NCT02495662|Methylprednisolone|methylprednisolone|mesh-list
65583603|NCT02495662|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65583604|NCT02495662|Prednisolone acetate|prednisolone acetate|mesh-list
65583605|NCT02495662|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65583606|NCT02495662|Prednisolone phosphate|prednisolone phosphate|mesh-list
65583607|NCT02495662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65583608|NCT02495662|Glucocorticoids|glucocorticoids|mesh-ancestor
65583609|NCT02495662|Hormones|hormones|mesh-ancestor
65583610|NCT02495662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65583611|NCT02495662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583612|NCT02495662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65583613|NCT02495662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583614|NCT02495662|Antiemetics|antiemetics|mesh-ancestor
65583615|NCT02495662|Autonomic Agents|autonomic agents|mesh-ancestor
65583616|NCT02495662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65583617|NCT02495662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65583618|NCT02495662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65583619|NCT02495662|Protective Agents|protective agents|mesh-ancestor
65583620|NCT02496052|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65583621|NCT02496052|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65583622|NCT02496052|Estradiol|estradiol|mesh-list
65583623|NCT02496052|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65583624|NCT02496052|Dydrogesterone|dydrogesterone|mesh-list
65583625|NCT02496052|Estrogens|estrogens|mesh-ancestor
65583626|NCT02496052|Hormones|hormones|mesh-ancestor
65583627|NCT02496052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65583628|NCT02496052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583629|NCT02496052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65583630|NCT02496052|Contraceptive Agents|contraceptive agents|mesh-ancestor
65583631|NCT02496052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65583632|NCT02496052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65583633|NCT02496052|Progestins|progestins|mesh-ancestor
65583634|NCT01206569|Tacrolimus|tacrolimus|mesh-list
65583635|NCT01206569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65583636|NCT01206569|Immunologic Factors|immunologic factors|mesh-ancestor
65583637|NCT01206569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583638|NCT01206569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65583639|NCT01206569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583640|NCT01206569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583641|NCT01206647|Metformin|metformin|mesh-list
65583642|NCT01206647|Saxagliptin|saxagliptin|mesh-list
65583643|NCT01206647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65583644|NCT01206647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583645|NCT01206647|Incretins|incretins|mesh-ancestor
65583646|NCT01206647|Hormones|hormones|mesh-ancestor
65583647|NCT01206647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65583648|NCT01206647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65583649|NCT01206647|Protease Inhibitors|protease inhibitors|mesh-ancestor
65583650|NCT01206647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381159|NCT00938730|Warfarin|warfarin|mesh-list
65583651|NCT01206647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583652|NCT03560245|Bryostatin 1|bryostatin 1|mesh-list
65583653|NCT03560245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65583654|NCT03560245|Immunologic Factors|immunologic factors|mesh-ancestor
65583655|NCT03560245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583656|NCT03560245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583657|NCT02495272|Oxytocin|oxytocin|mesh-list
65583658|NCT02495272|Oxytocics|oxytocics|mesh-ancestor
65583659|NCT02495272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65583660|NCT02495272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583661|NCT03336346|Efavirenz|efavirenz|mesh-list
65583662|NCT03336346|Dolutegravir|dolutegravir|mesh-list
65583663|NCT03336346|Etonogestrel|etonogestrel|mesh-list
65583664|NCT03336346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65583665|NCT03336346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65583666|NCT03336346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583667|NCT03336346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583668|NCT03336346|Antiviral Agents|antiviral agents|mesh-ancestor
65583669|NCT03336346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65583670|NCT03336346|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65583671|NCT03336346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65583672|NCT03336346|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65583673|NCT03336346|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65583674|NCT03336346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65583675|NCT03336346|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65583676|NCT03336346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65583677|NCT03336346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65583678|NCT03336346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65583679|NCT03336346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65583680|NCT03336346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65583681|NCT03336346|Contraceptive Agents|contraceptive agents|mesh-ancestor
65583682|NCT03336346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65583683|NCT03336346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583684|NCT03336346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65583685|NCT03841292|Varenicline|varenicline|mesh-list
65583686|NCT03841292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65583687|NCT03841292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65583688|NCT03841292|Cholinergic Agents|cholinergic agents|mesh-ancestor
65583689|NCT03841292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65583690|NCT03841292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583691|NCT03841292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583692|NCT03814577|Antioxidants|antioxidants|mesh-list
65583693|NCT03814577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583694|NCT03814577|Protective Agents|protective agents|mesh-ancestor
65583695|NCT03814577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583696|NCT03730363|Pentamidine|pentamidine|mesh-list
65583697|NCT03730363|Antifungal Agents|antifungal agents|mesh-ancestor
65583698|NCT03730363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65583699|NCT03730363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65583700|NCT03730363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65583701|NCT03730363|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65583702|NCT01206803|Ganirelix|ganirelix|mesh-list
65583703|NCT01206803|Hormone Antagonists|hormone antagonists|mesh-ancestor
65248393|NCT02841488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65583704|NCT01206803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65583705|NCT01206803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583706|NCT03335956|Pioglitazone|pioglitazone|mesh-list
65583707|NCT03335956|Prednisone|prednisone|mesh-list
65583708|NCT03335956|Cortisone|cortisone|mesh-list
65583709|NCT03335956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65583710|NCT03335956|Glucocorticoids|glucocorticoids|mesh-ancestor
65583711|NCT03335956|Hormones|hormones|mesh-ancestor
65583712|NCT03335956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65583713|NCT03335956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583714|NCT03335956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65583715|NCT03335956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583716|NCT03335956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65583717|NCT03817931|Solifenacin Succinate|solifenacin succinate|mesh-list
65583718|NCT03817931|Mirabegron|mirabegron|mesh-list
65583719|NCT03817931|Cholinergic Antagonists|cholinergic antagonists|mesh-list
65583720|NCT03817931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
65583721|NCT03817931|Adrenergic Agents|adrenergic agents|mesh-list
65583722|NCT03817931|Adrenergic Agonists|adrenergic agonists|mesh-list
65583723|NCT03817931|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65583724|NCT03817931|Cholinergic Agents|cholinergic agents|mesh-ancestor
65583725|NCT03817931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65583726|NCT03817931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583727|NCT03817931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583728|NCT03817931|Urological Agents|urological agents|mesh-ancestor
65583729|NCT03817931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65583730|NCT01206881|Cyclophosphamide|cyclophosphamide|mesh-list
65583731|NCT01206881|Docetaxel|docetaxel|mesh-list
65583732|NCT01206881|Doxorubicin|doxorubicin|mesh-list
65583733|NCT01206881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65583734|NCT01206881|Trastuzumab|trastuzumab|mesh-list
65583735|NCT01206881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65583736|NCT01206881|Immunologic Factors|immunologic factors|mesh-ancestor
65583737|NCT01206881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583738|NCT01206881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65583739|NCT01206881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65583740|NCT01206881|Alkylating Agents|alkylating agents|mesh-ancestor
65583741|NCT01206881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583742|NCT01206881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583743|NCT01206881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65583744|NCT01206881|Tubulin Modulators|tubulin modulators|mesh-ancestor
65583745|NCT01206881|Antimitotic Agents|antimitotic agents|mesh-ancestor
65583746|NCT01206881|Mitosis Modulators|mitosis modulators|mesh-ancestor
65583747|NCT01206881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65583748|NCT01206881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65583749|NCT01206881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65583750|NCT01206881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583751|NCT01206881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65583752|NCT02494804|Temozolomide|temozolomide|mesh-list
65583753|NCT02494804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65583754|NCT02494804|Alkylating Agents|alkylating agents|mesh-ancestor
65583755|NCT02494804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583756|NCT02494804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583757|NCT04724252|Gabapentin|gabapentin|mesh-list
65583758|NCT04724252|Analgesics|analgesics|mesh-ancestor
65583759|NCT04724252|Sensory System Agents|sensory system agents|mesh-ancestor
65583760|NCT04724252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65583761|NCT04724252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583762|NCT04724252|Anticonvulsants|anticonvulsants|mesh-ancestor
65583763|NCT04724252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65583764|NCT04724252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65583765|NCT04724252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65583766|NCT04724252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65583767|NCT04724252|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65583768|NCT04724252|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65583769|NCT04724252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65583770|NCT04724252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583771|NCT04724252|Antimanic Agents|antimanic agents|mesh-ancestor
65583772|NCT04666454|Adenosine|adenosine|mesh-list
65583773|NCT04666454|Dipyridamole|dipyridamole|mesh-list
65583774|NCT04666454|Apixaban|apixaban|mesh-list
65583775|NCT04666454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65583776|NCT04666454|Antithrombins|antithrombins|mesh-ancestor
65583777|NCT04666454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65583778|NCT04666454|Protease Inhibitors|protease inhibitors|mesh-ancestor
65583779|NCT04666454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583780|NCT04666454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583781|NCT04666454|Anticoagulants|anticoagulants|mesh-ancestor
65583782|NCT04666454|Analgesics|analgesics|mesh-ancestor
65583783|NCT04666454|Sensory System Agents|sensory system agents|mesh-ancestor
65583784|NCT04666454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65583785|NCT04666454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583786|NCT04666454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65583787|NCT04666454|Vasodilator Agents|vasodilator agents|mesh-ancestor
65583788|NCT04666454|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65583789|NCT04666454|Purinergic Agonists|purinergic agonists|mesh-ancestor
65583790|NCT04666454|Purinergic Agents|purinergic agents|mesh-ancestor
65583791|NCT04666454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65583792|NCT04666454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65583793|NCT04666454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65583794|NCT03558997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65583795|NCT03558997|Immunologic Factors|immunologic factors|mesh-ancestor
65583796|NCT03558997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583797|NCT03814343|Amphotericin B|amphotericin b|mesh-list
65583798|NCT03814343|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65583799|NCT03814343|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
65583800|NCT03814343|Amebicides|amebicides|mesh-ancestor
65583801|NCT03814343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65583802|NCT03814343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65583803|NCT03814343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65583804|NCT03814343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65583805|NCT03814343|Antifungal Agents|antifungal agents|mesh-ancestor
65583806|NCT03814343|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65583807|NCT03814343|Protective Agents|protective agents|mesh-ancestor
65583808|NCT03814343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583809|NCT03814343|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65583811|NCT03814343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583812|NCT03817541|Propofol|propofol|mesh-list
65583813|NCT03817541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65583814|NCT03817541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65583815|NCT03817541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583816|NCT03817541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65583817|NCT03817541|Anesthetics, General|anesthetics, general|mesh-ancestor
65583818|NCT03817541|Anesthetics|anesthetics|mesh-ancestor
65583819|NCT03341494|Thalidomide|thalidomide|mesh-list
65583820|NCT03341494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65583821|NCT03341494|Immunologic Factors|immunologic factors|mesh-ancestor
65583822|NCT03341494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583823|NCT03341494|Leprostatic Agents|leprostatic agents|mesh-ancestor
65583824|NCT03341494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65583825|NCT03341494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65583826|NCT03341494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65583827|NCT03341494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65583828|NCT03341494|Growth Substances|growth substances|mesh-ancestor
65583829|NCT03341494|Growth Inhibitors|growth inhibitors|mesh-ancestor
65583830|NCT03341494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583831|NCT03586609|Cytarabine|cytarabine|mesh-list
65583832|NCT03586609|Azacitidine|azacitidine|mesh-list
65583833|NCT03586609|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
65583834|NCT03586609|Venetoclax|venetoclax|mesh-list
65583835|NCT03586609|Cladribine|cladribine|mesh-list
65583836|NCT03586609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65583837|NCT03586609|Antimetabolites|antimetabolites|mesh-ancestor
65583838|NCT03586609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583839|NCT03586609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583840|NCT03586609|Antiviral Agents|antiviral agents|mesh-ancestor
65583841|NCT03586609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65583842|NCT03586609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65583843|NCT03586609|Immunologic Factors|immunologic factors|mesh-ancestor
65583844|NCT03586609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583845|NCT03586609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583846|NCT03817619|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65583847|NCT03817619|Antiviral Agents|antiviral agents|mesh-ancestor
65583848|NCT03817619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65583849|NCT03725995|Lidocaine|lidocaine|mesh-list
65583850|NCT03725995|Midazolam|midazolam|mesh-list
65583851|NCT03725995|Anesthetics, Local|anesthetics, local|mesh-ancestor
65583852|NCT03725995|Anesthetics|anesthetics|mesh-ancestor
65583853|NCT03725995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65583854|NCT03725995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583855|NCT03725995|Sensory System Agents|sensory system agents|mesh-ancestor
65583856|NCT03725995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65583857|NCT03725995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65583858|NCT03725995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65583859|NCT03725995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65583860|NCT03725995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65583861|NCT03725995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583862|NCT03725995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65583863|NCT03725995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65583864|NCT03725995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65583865|NCT03725995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65583866|NCT03725995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65583867|NCT03725995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65583868|NCT03725995|Anesthetics, General|anesthetics, general|mesh-ancestor
65583869|NCT03725995|GABA Modulators|gaba modulators|mesh-ancestor
65583870|NCT03725995|GABA Agents|gaba agents|mesh-ancestor
65583871|NCT03725995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65583872|NCT03341260|Diclofenac|diclofenac|mesh-list
65583873|NCT03341260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65583874|NCT03341260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65583875|NCT03341260|Analgesics|analgesics|mesh-ancestor
65583876|NCT03341260|Sensory System Agents|sensory system agents|mesh-ancestor
65583877|NCT03341260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65583878|NCT03341260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583879|NCT03341260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65583880|NCT03341260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65583881|NCT03341260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65583882|NCT03341260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583883|NCT03341260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583884|NCT03052400|Mifepristone|mifepristone|mesh-list
65583885|NCT03052400|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65583886|NCT03052400|Abortifacient Agents|abortifacient agents|mesh-ancestor
65583887|NCT03052400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65583888|NCT03052400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583889|NCT03052400|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65583890|NCT03052400|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65583891|NCT03052400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65583892|NCT03052400|Contraceptive Agents|contraceptive agents|mesh-ancestor
65583893|NCT03052400|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65583894|NCT03052400|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65583895|NCT03052400|Hormone Antagonists|hormone antagonists|mesh-ancestor
65583896|NCT03052400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65583897|NCT03052400|Luteolytic Agents|luteolytic agents|mesh-ancestor
65583898|NCT03052400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65583899|NCT03052400|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65583900|NCT03341104|Bupivacaine|bupivacaine|mesh-list
65583901|NCT03341104|Anesthetics, Local|anesthetics, local|mesh-ancestor
65583902|NCT03341104|Anesthetics|anesthetics|mesh-ancestor
65583903|NCT03341104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65583904|NCT03341104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583905|NCT03341104|Sensory System Agents|sensory system agents|mesh-ancestor
65583906|NCT03341104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65583907|NCT03335098|Thalidomide|thalidomide|mesh-list
65583908|NCT03335098|Dexamethasone|dexamethasone|mesh-list
65583909|NCT03335098|Bortezomib|bortezomib|mesh-list
65583910|NCT03335098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65583911|NCT03335098|Antiemetics|antiemetics|mesh-ancestor
65583912|NCT03335098|Autonomic Agents|autonomic agents|mesh-ancestor
65583913|NCT03335098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65583914|NCT03335098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583915|NCT03335098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65583916|NCT03335098|Glucocorticoids|glucocorticoids|mesh-ancestor
65583917|NCT03335098|Hormones|hormones|mesh-ancestor
65583918|NCT03335098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65583919|NCT03335098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65583920|NCT03335098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583921|NCT03335098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65583922|NCT03335098|Immunologic Factors|immunologic factors|mesh-ancestor
65583923|NCT03335098|Leprostatic Agents|leprostatic agents|mesh-ancestor
65583924|NCT03335098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65583925|NCT03335098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65583926|NCT03335098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65583927|NCT03335098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65583928|NCT03335098|Growth Substances|growth substances|mesh-ancestor
65583929|NCT03335098|Growth Inhibitors|growth inhibitors|mesh-ancestor
65583930|NCT03639571|Ibuprofen|ibuprofen|mesh-list
65583931|NCT03639571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65583932|NCT03639571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65583933|NCT03639571|Analgesics|analgesics|mesh-ancestor
65583934|NCT03639571|Sensory System Agents|sensory system agents|mesh-ancestor
65583935|NCT03639571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65583936|NCT03639571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583937|NCT03639571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65583938|NCT03639571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65583939|NCT03639571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65583940|NCT03639571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583941|NCT03639571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583942|NCT03052322|Adalimumab|adalimumab|mesh-list
65583943|NCT03052322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65583944|NCT03052322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65583945|NCT03722173|Itraconazole|itraconazole|mesh-list
65583946|NCT03722173|Antifungal Agents|antifungal agents|mesh-ancestor
65583947|NCT03722173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65583948|NCT03722173|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65583949|NCT03722173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65583950|NCT03722173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583951|NCT03722173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583952|NCT03722173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65583953|NCT03722173|Hormone Antagonists|hormone antagonists|mesh-ancestor
65583954|NCT03722173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65583955|NCT03722173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583956|NCT03722173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65583957|NCT03521791|Bromfenac|bromfenac|mesh-list
65583958|NCT03521791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65583959|NCT03521791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65583960|NCT03521791|Analgesics|analgesics|mesh-ancestor
65583961|NCT03521791|Sensory System Agents|sensory system agents|mesh-ancestor
65583962|NCT03521791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65583963|NCT03521791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583964|NCT03521791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65583965|NCT03521791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65583966|NCT03521635|Pramipexole|pramipexole|mesh-list
65583967|NCT03521635|Antioxidants|antioxidants|mesh-ancestor
65583968|NCT03521635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583969|NCT03521635|Protective Agents|protective agents|mesh-ancestor
65583970|NCT03521635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583971|NCT03521635|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65583972|NCT03521635|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65583973|NCT03521635|Dopamine Agonists|dopamine agonists|mesh-ancestor
65583974|NCT03521635|Dopamine Agents|dopamine agents|mesh-ancestor
65583975|NCT03521635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65583976|NCT03170544|Insulin Glargine|insulin glargine|mesh-list
65583977|NCT03170544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65583978|NCT03170544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583979|NCT03813641|Capecitabine|capecitabine|mesh-list
65583980|NCT03813641|Raltitrexed|raltitrexed|mesh-list
65583981|NCT03813641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65583982|NCT03813641|Antimetabolites|antimetabolites|mesh-ancestor
65583983|NCT03813641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583984|NCT03813641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65583985|NCT03813641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65583986|NCT03813641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583987|NCT02492464|Red yeast rice|red yeast rice|mesh-list
65583988|NCT02492464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65583989|NCT02492464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65583990|NCT02492464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65583991|NCT02492464|Antimetabolites|antimetabolites|mesh-ancestor
65583992|NCT02492464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65583993|NCT02492464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65583994|NCT02492464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65583995|NCT05255159|Furosemide|furosemide|mesh-list
65583996|NCT05255159|Diuretics|diuretics|mesh-ancestor
65583997|NCT05255159|Natriuretic Agents|natriuretic agents|mesh-ancestor
65583998|NCT05255159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65583999|NCT05255159|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65584000|NCT05255159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65584001|NCT05255159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584002|NCT03340558|Atezolizumab|atezolizumab|mesh-list
65584003|NCT03340558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584004|NCT04905108|Riboflavin|riboflavin|mesh-list
65584005|NCT04905108|Vitamin B Complex|vitamin b complex|mesh-ancestor
65584006|NCT04905108|Vitamins|vitamins|mesh-ancestor
65584007|NCT04905108|Micronutrients|micronutrients|mesh-ancestor
65584008|NCT04905108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584009|NCT04905108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65584010|NCT04905108|Dermatologic Agents|dermatologic agents|mesh-ancestor
65584011|NCT04443166|Hyaluronic Acid|hyaluronic acid|mesh-list
65584012|NCT04443166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65584013|NCT04443166|Immunologic Factors|immunologic factors|mesh-ancestor
65584014|NCT04443166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584015|NCT04443166|Viscosupplements|viscosupplements|mesh-ancestor
65584016|NCT04443166|Protective Agents|protective agents|mesh-ancestor
65584017|NCT01560221|Buprenorphine|buprenorphine|mesh-list
65584018|NCT01560221|Methadone|methadone|mesh-list
65584019|NCT01560221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65584020|NCT01560221|Narcotics|narcotics|mesh-ancestor
65584021|NCT01560221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65584022|NCT01560221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584023|NCT01560221|Analgesics|analgesics|mesh-ancestor
65584024|NCT01560221|Sensory System Agents|sensory system agents|mesh-ancestor
65584025|NCT01560221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65381529|NCT00838370|Immunologic Factors|immunologic factors|mesh-ancestor
65584026|NCT01560221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65584027|NCT01560221|Antitussive Agents|antitussive agents|mesh-ancestor
65584028|NCT01560221|Respiratory System Agents|respiratory system agents|mesh-ancestor
65584029|NCT03813329|Calcium Carbonate|calcium carbonate|mesh-list
65584030|NCT03813329|Calcium|calcium|mesh-list
65584031|NCT03813329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65584032|NCT03813329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584033|NCT03813329|Antacids|antacids|mesh-ancestor
65584034|NCT03813329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584035|NCT03813329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65584036|NCT03639415|Oxycodone|oxycodone|mesh-list
65584037|NCT03639415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65584038|NCT03639415|Narcotics|narcotics|mesh-ancestor
65584039|NCT03639415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65584040|NCT03639415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584041|NCT03639415|Analgesics|analgesics|mesh-ancestor
65584042|NCT03639415|Sensory System Agents|sensory system agents|mesh-ancestor
65584043|NCT03639415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584044|NCT02492386|Everolimus|everolimus|mesh-list
65584045|NCT02492386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584046|NCT02492386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65584047|NCT02492386|Immunologic Factors|immunologic factors|mesh-ancestor
65584048|NCT02492386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584049|NCT03340168|Bisphenol A|bisphenol a|mesh-list
65584050|NCT03340168|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65584051|NCT03340168|Estrogens|estrogens|mesh-ancestor
65584052|NCT03340168|Hormones|hormones|mesh-ancestor
65584053|NCT03340168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65584054|NCT03340168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584055|NCT03340168|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65584056|NCT03340168|Antioxidants|antioxidants|mesh-ancestor
65584057|NCT03340168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584058|NCT03340168|Protective Agents|protective agents|mesh-ancestor
65584059|NCT01299701|Vadimezan|vadimezan|mesh-list
65584060|NCT01299701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584061|NCT01299779|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65584062|NCT01299779|Laxatives|laxatives|mesh-ancestor
65584063|NCT01299779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65584064|NCT02343042|Clarithromycin|clarithromycin|mesh-list
65584065|NCT02343042|Dexamethasone|dexamethasone|mesh-list
65584066|NCT02343042|Lenalidomide|lenalidomide|mesh-list
65584067|NCT02343042|Bortezomib|bortezomib|mesh-list
65584068|NCT02343042|Daratumumab|daratumumab|mesh-list
65584069|NCT02343042|Pomalidomide|pomalidomide|mesh-list
65584070|NCT02343042|Ixazomib|ixazomib|mesh-list
65584071|NCT02343042|Elotuzumab|elotuzumab|mesh-list
65584072|NCT02343042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65584073|NCT02343042|Antiemetics|antiemetics|mesh-ancestor
65584074|NCT02343042|Autonomic Agents|autonomic agents|mesh-ancestor
65584075|NCT02343042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584076|NCT02343042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584077|NCT02343042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65584078|NCT02343042|Glucocorticoids|glucocorticoids|mesh-ancestor
65584079|NCT02343042|Hormones|hormones|mesh-ancestor
64473167|NCT00082706|Fluorouracil|fluorouracil|mesh-list
65584080|NCT02343042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65584081|NCT02343042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65584082|NCT02343042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584083|NCT02343042|Immunologic Factors|immunologic factors|mesh-ancestor
65584084|NCT02343042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65584085|NCT02343042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65584086|NCT02343042|Growth Substances|growth substances|mesh-ancestor
65584087|NCT02343042|Growth Inhibitors|growth inhibitors|mesh-ancestor
65584088|NCT02343042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65584089|NCT02343042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65584090|NCT02343042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65584091|NCT02343042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65584092|NCT02343042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584093|NCT02343042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65584094|NCT02343042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65584095|NCT02343042|Protease Inhibitors|protease inhibitors|mesh-ancestor
65584096|NCT03812939|Octreotide|octreotide|mesh-list
65584097|NCT03812939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65584098|NCT03812939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65584099|NCT03812939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584100|NCT03339700|Gemcitabine|gemcitabine|mesh-list
65584101|NCT03339700|Cyclophosphamide|cyclophosphamide|mesh-list
65584102|NCT03339700|Busulfan|busulfan|mesh-list
65584103|NCT03339700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65584104|NCT03339700|Immunologic Factors|immunologic factors|mesh-ancestor
65584105|NCT03339700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584106|NCT03339700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65584107|NCT03339700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65584108|NCT03339700|Alkylating Agents|alkylating agents|mesh-ancestor
65584109|NCT03339700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584110|NCT03339700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584111|NCT03339700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65584112|NCT03339700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65584113|NCT03339700|Antimetabolites|antimetabolites|mesh-ancestor
65584114|NCT03339700|Antiviral Agents|antiviral agents|mesh-ancestor
65584115|NCT03339700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65584116|NCT03339700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65584117|NCT05661149|Insulin|insulin|mesh-list
65584118|NCT05661149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65584119|NCT05661149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584120|NCT01299857|Rituximab|rituximab|mesh-list
65584121|NCT01299857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65584122|NCT01299857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584123|NCT01299857|Immunologic Factors|immunologic factors|mesh-ancestor
65584124|NCT01299857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584125|NCT01299857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65584126|NCT03478969|Insulin|insulin|mesh-list
65584127|NCT03478969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65584128|NCT03478969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584129|NCT03812783|Sorafenib|sorafenib|mesh-list
65584130|NCT03812783|Folfirinox|folfirinox|mesh-list
65584131|NCT03812783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584132|NCT03812783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65584133|NCT03812783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65584134|NCT03812783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584135|NCT02500498|Abatacept|abatacept|mesh-list
65584136|NCT02500498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65584137|NCT02500498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584138|NCT02500498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584139|NCT02500498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65584140|NCT02500498|Immunologic Factors|immunologic factors|mesh-ancestor
65584141|NCT02500498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584142|NCT02500498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65584143|NCT05644223|Edaravone|edaravone|mesh-list
65584144|NCT05644223|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65584145|NCT05644223|Antioxidants|antioxidants|mesh-ancestor
65584146|NCT05644223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584147|NCT05644223|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65584148|NCT05644223|Protective Agents|protective agents|mesh-ancestor
65584149|NCT05644223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584150|NCT02500108|Domperidone|domperidone|mesh-list
65584151|NCT02500108|Antiemetics|antiemetics|mesh-ancestor
65584152|NCT02500108|Autonomic Agents|autonomic agents|mesh-ancestor
65584153|NCT02500108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584154|NCT02500108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584155|NCT02500108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65584156|NCT02500108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65584157|NCT02500108|Dopamine Agents|dopamine agents|mesh-ancestor
65584158|NCT02500108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65584159|NCT02500108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584160|NCT02499874|Tenofovir|tenofovir|mesh-list
65584161|NCT02499874|Lamivudine|lamivudine|mesh-list
65584162|NCT02499874|Zidovudine|zidovudine|mesh-list
65584163|NCT02499874|Emtricitabine|emtricitabine|mesh-list
65584164|NCT02499874|Efavirenz|efavirenz|mesh-list
65584165|NCT02499874|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
65584166|NCT02499874|Antiviral Agents|antiviral agents|mesh-ancestor
65584167|NCT02499874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65584168|NCT02499874|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65584169|NCT02499874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65584170|NCT02499874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65584171|NCT02499874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584172|NCT02499874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65584173|NCT02499874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65584174|NCT02499874|Antimetabolites|antimetabolites|mesh-ancestor
65584175|NCT02499874|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65584176|NCT02499874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65584177|NCT02499874|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65584178|NCT02499874|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65584179|NCT02499874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65584180|NCT02499874|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65584182|NCT02492308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65584183|NCT02492308|Immunologic Factors|immunologic factors|mesh-ancestor
65584184|NCT02492308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584185|NCT01302275|Oxcarbazepine|oxcarbazepine|mesh-list
65584186|NCT01302275|Anticonvulsants|anticonvulsants|mesh-ancestor
65584187|NCT01302275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65584188|NCT01302275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65584189|NCT01302275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65584190|NCT01302275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584191|NCT01302275|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65584192|NCT01302275|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65584193|NCT03339544|Celecoxib|celecoxib|mesh-list
65584194|NCT03339544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65584195|NCT03339544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65584196|NCT03339544|Analgesics|analgesics|mesh-ancestor
65584197|NCT03339544|Sensory System Agents|sensory system agents|mesh-ancestor
65584198|NCT03339544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584199|NCT03339544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584200|NCT03339544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65584201|NCT03339544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65584202|NCT03339544|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65584203|NCT03339544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65584204|NCT03339544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65584205|NCT03339544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584206|NCT03332602|Vitamins|vitamins|mesh-list
65584207|NCT03332602|Folic Acid|folic acid|mesh-list
65584208|NCT03332602|Vitamin A|vitamin a|mesh-list
65584209|NCT03332602|Retinol palmitate|retinol palmitate|mesh-list
65584210|NCT03332602|Fesoterodine|fesoterodine|mesh-list
65584211|NCT03332602|Hyaluronic Acid|hyaluronic acid|mesh-list
65584212|NCT03332602|Micronutrients|micronutrients|mesh-ancestor
65584213|NCT03332602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584214|NCT03332602|Hematinics|hematinics|mesh-ancestor
65584215|NCT03332602|Vitamin B Complex|vitamin b complex|mesh-ancestor
65584216|NCT03332602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65584217|NCT03332602|Immunologic Factors|immunologic factors|mesh-ancestor
65584218|NCT03332602|Viscosupplements|viscosupplements|mesh-ancestor
65584219|NCT03332602|Protective Agents|protective agents|mesh-ancestor
65584220|NCT03332602|Antioxidants|antioxidants|mesh-ancestor
65584221|NCT03332602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584222|NCT03332602|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65584223|NCT03332602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584224|NCT03332602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65584225|NCT03332602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65584226|NCT03332602|Cholinergic Agents|cholinergic agents|mesh-ancestor
65584227|NCT03332602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65584228|NCT03332602|Urological Agents|urological agents|mesh-ancestor
65584229|NCT01302353|Isoflurane|isoflurane|mesh-list
65584230|NCT01302353|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65584231|NCT01302353|Anesthetics, General|anesthetics, general|mesh-ancestor
65584232|NCT01302353|Anesthetics|anesthetics|mesh-ancestor
65584233|NCT01302353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65584234|NCT01302353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584235|NCT03812315|Propolis|propolis|mesh-list
65584236|NCT03812315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65584237|NCT03332524|Chlorpheniramine|chlorpheniramine|mesh-list
65584238|NCT03332524|Ibuprofen|ibuprofen|mesh-list
65584239|NCT03332524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65584240|NCT03332524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65584241|NCT03332524|Analgesics|analgesics|mesh-ancestor
65584242|NCT03332524|Sensory System Agents|sensory system agents|mesh-ancestor
65584243|NCT03332524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584244|NCT03332524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584245|NCT03332524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65584246|NCT03332524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65584247|NCT03332524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65584248|NCT03332524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65584249|NCT03332524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584250|NCT03332524|Antipruritics|antipruritics|mesh-ancestor
65584251|NCT03332524|Dermatologic Agents|dermatologic agents|mesh-ancestor
65584252|NCT03332524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65584253|NCT03332524|Histamine Antagonists|histamine antagonists|mesh-ancestor
65584254|NCT03332524|Histamine Agents|histamine agents|mesh-ancestor
65584255|NCT03332524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65584256|NCT03332524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65584257|NCT02499484|Nitroglycerin|nitroglycerin|mesh-list
65584258|NCT02499484|Vasodilator Agents|vasodilator agents|mesh-ancestor
65584259|NCT03812003|Remifentanil|remifentanil|mesh-list
65584260|NCT03812003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65584261|NCT03812003|Narcotics|narcotics|mesh-ancestor
65584262|NCT03812003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65584263|NCT03812003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584264|NCT03812003|Analgesics|analgesics|mesh-ancestor
65584265|NCT03812003|Sensory System Agents|sensory system agents|mesh-ancestor
65584266|NCT03812003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584267|NCT04874610|Methylprednisolone|methylprednisolone|mesh-list
65584268|NCT04874610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65584269|NCT04874610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65584270|NCT04874610|Prednisolone|prednisolone|mesh-list
65584271|NCT04874610|Prednisolone acetate|prednisolone acetate|mesh-list
65584272|NCT04874610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65584273|NCT04874610|Prednisolone phosphate|prednisolone phosphate|mesh-list
65584274|NCT04874610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65584275|NCT04874610|Antiemetics|antiemetics|mesh-ancestor
65584276|NCT04874610|Autonomic Agents|autonomic agents|mesh-ancestor
65584277|NCT04874610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584278|NCT04874610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584279|NCT04874610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65584280|NCT04874610|Glucocorticoids|glucocorticoids|mesh-ancestor
65584281|NCT04874610|Hormones|hormones|mesh-ancestor
65584282|NCT04874610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65584283|NCT04874610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65584284|NCT04874610|Protective Agents|protective agents|mesh-ancestor
65584285|NCT04874610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65584286|NCT04874610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584287|NCT03518125|Vaccines|vaccines|mesh-list
65584288|NCT03518125|Immunologic Factors|immunologic factors|mesh-ancestor
65584289|NCT03518125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584290|NCT02492230|Warfarin|warfarin|mesh-list
65584291|NCT02492230|Anticoagulants|anticoagulants|mesh-ancestor
65584292|NCT05623319|Pembrolizumab|pembrolizumab|mesh-list
65584293|NCT05623319|Olaparib|olaparib|mesh-list
65584294|NCT05623319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65584295|NCT05623319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584296|NCT05623319|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65584297|NCT05623319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65584298|NCT05623319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584299|NCT03169530|Ethanol|ethanol|mesh-list
65584300|NCT03169530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65584301|NCT03169530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65584302|NCT03169530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65584303|NCT03169530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584304|NCT03723187|Heparin|heparin|mesh-list
65584305|NCT03723187|Anticoagulants|anticoagulants|mesh-ancestor
65584306|NCT03723187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65584307|NCT03723187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65584308|NCT03723187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584309|NCT02440230|Anastrozole|anastrozole|mesh-list
65584310|NCT02440230|Exemestane|exemestane|mesh-list
65584311|NCT02440230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65584312|NCT02440230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584313|NCT02440230|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65584314|NCT02440230|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65584315|NCT02440230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65584316|NCT02440230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584317|NCT02440230|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65584318|NCT02440230|Hormone Antagonists|hormone antagonists|mesh-ancestor
65584319|NCT02440230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65584320|NCT02440230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584321|NCT03478891|Ansuvimab|ansuvimab|mesh-list
65584322|NCT03478891|Antiviral Agents|antiviral agents|mesh-ancestor
65584323|NCT03478891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65584324|NCT00706966|Dutasteride|dutasteride|mesh-list
65584325|NCT00706966|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65584326|NCT00706966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65584327|NCT00706966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65584328|NCT00706966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584329|NCT00706966|Hormone Antagonists|hormone antagonists|mesh-ancestor
65381831|NCT00834470|Mydriatics|mydriatics|mesh-ancestor
65584330|NCT00706966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65584331|NCT00706966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584332|NCT01330524|Triamcinolone|triamcinolone|mesh-list
65584333|NCT01330524|Bevacizumab|bevacizumab|mesh-list
65584334|NCT01330524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65584335|NCT01330524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584336|NCT01330524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65584337|NCT01330524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65584338|NCT01330524|Growth Substances|growth substances|mesh-ancestor
65584339|NCT01330524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584340|NCT01330524|Growth Inhibitors|growth inhibitors|mesh-ancestor
65584341|NCT01330524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65584342|NCT01330524|Glucocorticoids|glucocorticoids|mesh-ancestor
65584343|NCT01330524|Hormones|hormones|mesh-ancestor
65584344|NCT01330524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65584345|NCT01560065|Folic Acid|folic acid|mesh-list
65584346|NCT01560065|Vitamin B Complex|vitamin b complex|mesh-list
65584347|NCT01560065|Inositol|inositol|mesh-list
65584348|NCT01560065|Hematinics|hematinics|mesh-ancestor
65584349|NCT01560065|Vitamins|vitamins|mesh-ancestor
65584350|NCT01560065|Micronutrients|micronutrients|mesh-ancestor
65584351|NCT01560065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584352|NCT01302587|Albuterol|albuterol|mesh-list
65584353|NCT01302587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65584354|NCT01302587|Autonomic Agents|autonomic agents|mesh-ancestor
65584355|NCT01302587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584356|NCT01302587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584357|NCT01302587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65584358|NCT01302587|Respiratory System Agents|respiratory system agents|mesh-ancestor
65584359|NCT01302587|Tocolytic Agents|tocolytic agents|mesh-ancestor
65584360|NCT01302587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65584361|NCT01302587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65584362|NCT01302587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65584363|NCT01302587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65584364|NCT01302587|Adrenergic Agents|adrenergic agents|mesh-ancestor
65584365|NCT01302587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65584366|NCT01302587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584367|NCT03723109|Anesthetics|anesthetics|mesh-list
65584368|NCT03723109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65584369|NCT03723109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584370|NCT03018288|Pembrolizumab|pembrolizumab|mesh-list
65584371|NCT03018288|Temozolomide|temozolomide|mesh-list
65584372|NCT03018288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65584373|NCT03018288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584374|NCT03018288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65584375|NCT03018288|Alkylating Agents|alkylating agents|mesh-ancestor
65584376|NCT03018288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584377|NCT03515941|Leucovorin|leucovorin|mesh-list
65584378|NCT03515941|Fluorouracil|fluorouracil|mesh-list
65584379|NCT03515941|Capecitabine|capecitabine|mesh-list
65584380|NCT03515941|Oxaliplatin|oxaliplatin|mesh-list
65584381|NCT03515941|Antimetabolites|antimetabolites|mesh-ancestor
65584382|NCT03515941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584383|NCT03515941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65584384|NCT03515941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584385|NCT03515941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65584386|NCT03515941|Immunologic Factors|immunologic factors|mesh-ancestor
65584387|NCT03515941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584388|NCT03515941|Antidotes|antidotes|mesh-ancestor
65584389|NCT03515941|Protective Agents|protective agents|mesh-ancestor
65584390|NCT03515941|Vitamin B Complex|vitamin b complex|mesh-ancestor
65584391|NCT03515941|Vitamins|vitamins|mesh-ancestor
65584392|NCT03515941|Micronutrients|micronutrients|mesh-ancestor
65584393|NCT04606914|Maytansine|maytansine|mesh-list
65584394|NCT04606914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65584395|NCT04606914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584396|NCT04606914|Tubulin Modulators|tubulin modulators|mesh-ancestor
65584397|NCT04606914|Antimitotic Agents|antimitotic agents|mesh-ancestor
65584398|NCT04606914|Mitosis Modulators|mitosis modulators|mesh-ancestor
65584399|NCT04606914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584400|NCT02492074|Dronabinol|dronabinol|mesh-list
65584401|NCT02492074|Cannabidiol|cannabidiol|mesh-list
65584402|NCT02492074|Anticonvulsants|anticonvulsants|mesh-ancestor
65584403|NCT02492074|Hallucinogens|hallucinogens|mesh-ancestor
65584404|NCT02492074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584405|NCT02492074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65584406|NCT02492074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65584407|NCT02492074|Analgesics|analgesics|mesh-ancestor
65584408|NCT02492074|Sensory System Agents|sensory system agents|mesh-ancestor
65584409|NCT02492074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584410|NCT02492074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65584411|NCT02492074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65584412|NCT02492074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65584413|NCT02492074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584414|NCT02492074|Hormones|hormones|mesh-ancestor
65584415|NCT02492074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65584416|NCT03819647|Stiripentol|stiripentol|mesh-list
65584417|NCT03819647|Anticonvulsants|anticonvulsants|mesh-ancestor
65584418|NCT02498938|Protease Inhibitors|protease inhibitors|mesh-list
65584419|NCT02498938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65584420|NCT02498938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584421|NCT02498860|Pemetrexed|pemetrexed|mesh-list
65584422|NCT02498860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584423|NCT02498860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65584424|NCT02498860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584425|NCT02498860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65584426|NCT02498860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65584427|NCT03011034|Daratumumab|daratumumab|mesh-list
65584428|NCT03011034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584429|NCT05464966|Insulin|insulin|mesh-list
65584430|NCT05464966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65584431|NCT05464966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584432|NCT03515629|Pembrolizumab|pembrolizumab|mesh-list
65584433|NCT03515629|Cemiplimab|cemiplimab|mesh-list
65584434|NCT03515629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65584435|NCT03515629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584436|NCT01302821|Tryptophan|tryptophan|mesh-list
65584437|NCT01302821|Vaccines|vaccines|mesh-list
65584438|NCT01302821|Immunologic Factors|immunologic factors|mesh-ancestor
65584439|NCT01302821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584440|NCT01302821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65584441|NCT01302821|Antidepressive Agents|antidepressive agents|mesh-ancestor
65584442|NCT01302821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65584443|NCT04971954|Nicotine|nicotine|mesh-list
65584444|NCT04971954|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65584445|NCT04971954|Autonomic Agents|autonomic agents|mesh-ancestor
65584446|NCT04971954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584447|NCT04971954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584448|NCT04971954|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65584449|NCT04971954|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65584450|NCT04971954|Cholinergic Agents|cholinergic agents|mesh-ancestor
65584451|NCT04971954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65584452|NCT04971954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584453|NCT03331432|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
65584454|NCT03331432|Antiviral Agents|antiviral agents|mesh-ancestor
65584455|NCT03331432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65584456|NCT03331432|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65584457|NCT03331432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65584458|NCT03512353|Dexamethasone|dexamethasone|mesh-list
65584459|NCT03512353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65584460|NCT03512353|Antiemetics|antiemetics|mesh-ancestor
65584461|NCT03512353|Autonomic Agents|autonomic agents|mesh-ancestor
65584462|NCT03512353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584463|NCT03512353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584464|NCT03512353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65584465|NCT03512353|Glucocorticoids|glucocorticoids|mesh-ancestor
65584466|NCT03512353|Hormones|hormones|mesh-ancestor
65584467|NCT03512353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65584468|NCT03512353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65584469|NCT03512353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584470|NCT04959006|Antioxidants|antioxidants|mesh-list
65584471|NCT04959006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584472|NCT04959006|Protective Agents|protective agents|mesh-ancestor
65584473|NCT04959006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584474|NCT01300637|Metformin|metformin|mesh-list
65584475|NCT01300637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65584476|NCT01300637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584477|NCT04851522|Sodium Hypochlorite|sodium hypochlorite|mesh-list
65584479|NCT04851522|Petrolatum|petrolatum|mesh-list
65584480|NCT04851522|Disinfectants|disinfectants|mesh-ancestor
65584481|NCT04851522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65381978|NCT00825422|Ropivacaine|ropivacaine|mesh-list
65584482|NCT04851522|Emollients|emollients|mesh-ancestor
65584483|NCT04851522|Dermatologic Agents|dermatologic agents|mesh-ancestor
65584484|NCT03512275|Antibodies|antibodies|mesh-list
65584485|NCT03512275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65584486|NCT03512275|Immunologic Factors|immunologic factors|mesh-ancestor
65584487|NCT03512275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584488|NCT03809897|Nicotine|nicotine|mesh-list
65584489|NCT03809897|Varenicline|varenicline|mesh-list
65584490|NCT03809897|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65584491|NCT03809897|Autonomic Agents|autonomic agents|mesh-ancestor
65584492|NCT03809897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584493|NCT03809897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584494|NCT03809897|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65584495|NCT03809897|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65584496|NCT03809897|Cholinergic Agents|cholinergic agents|mesh-ancestor
65584497|NCT03809897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65584498|NCT03809897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584499|NCT03473197|Diacetylrhein|diacetylrhein|mesh-list
65584500|NCT03473197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65584501|NCT01560299|Methimazole|methimazole|mesh-list
65584502|NCT01560299|Antithyroid Agents|antithyroid agents|mesh-ancestor
65584503|NCT01560299|Hormone Antagonists|hormone antagonists|mesh-ancestor
65584504|NCT01560299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65584505|NCT01560299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584506|NCT03337828|Ethanol|ethanol|mesh-list
65584507|NCT03337828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65584508|NCT03337828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65584509|NCT03337828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65584510|NCT03337828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584511|NCT03510715|Nicotinic Acids|nicotinic acids|mesh-list
65584512|NCT03510715|Niacin|niacin|mesh-list
65584513|NCT03510715|Niacinamide|niacinamide|mesh-list
65584514|NCT03510715|Atorvastatin|atorvastatin|mesh-list
65584515|NCT03510715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65584516|NCT03510715|Simvastatin|simvastatin|mesh-list
65584517|NCT03510715|Ezetimibe|ezetimibe|mesh-list
65584518|NCT03510715|Pravastatin|pravastatin|mesh-list
65584519|NCT03510715|Lovastatin|lovastatin|mesh-list
65584520|NCT03510715|Cholestyramine Resin|cholestyramine resin|mesh-list
65584521|NCT03510715|Fenofibrate|fenofibrate|mesh-list
65584522|NCT03510715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65584523|NCT03510715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65584524|NCT03510715|Antimetabolites|antimetabolites|mesh-ancestor
65584525|NCT03510715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584526|NCT03510715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65584527|NCT03510715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65584528|NCT03510715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65584529|NCT03510715|Vitamin B Complex|vitamin b complex|mesh-ancestor
65584530|NCT03510715|Vitamins|vitamins|mesh-ancestor
65584531|NCT03510715|Micronutrients|micronutrients|mesh-ancestor
65584532|NCT03510715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584533|NCT03510715|Vasodilator Agents|vasodilator agents|mesh-ancestor
65584534|NCT03815279|Dexamethasone|dexamethasone|mesh-list
65584535|NCT03815279|Lenalidomide|lenalidomide|mesh-list
65584536|NCT03815279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65584537|NCT03815279|Antiemetics|antiemetics|mesh-ancestor
65584538|NCT03815279|Autonomic Agents|autonomic agents|mesh-ancestor
65584539|NCT03815279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584540|NCT03815279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584541|NCT03815279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65584542|NCT03815279|Glucocorticoids|glucocorticoids|mesh-ancestor
65584543|NCT03815279|Hormones|hormones|mesh-ancestor
65584544|NCT03815279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65584545|NCT03815279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65584546|NCT03815279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584547|NCT03815279|Immunologic Factors|immunologic factors|mesh-ancestor
65584548|NCT03815279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65584549|NCT03815279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65584550|NCT03815279|Growth Substances|growth substances|mesh-ancestor
65584551|NCT03815279|Growth Inhibitors|growth inhibitors|mesh-ancestor
65584552|NCT03814733|Ketamine|ketamine|mesh-list
65584553|NCT03814733|Alprazolam|alprazolam|mesh-list
65584554|NCT03814733|Analgesics|analgesics|mesh-ancestor
65584555|NCT03814733|Sensory System Agents|sensory system agents|mesh-ancestor
65584556|NCT03814733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584557|NCT03814733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584558|NCT03814733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65584559|NCT03814733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65584560|NCT03814733|Anesthetics, General|anesthetics, general|mesh-ancestor
65584561|NCT03814733|Anesthetics|anesthetics|mesh-ancestor
65584562|NCT03814733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65584563|NCT03814733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65584564|NCT03814733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65584565|NCT03814733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65584566|NCT03814733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584567|NCT03814733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65584568|NCT03814733|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65584569|NCT03814733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65584570|NCT03814733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65584571|NCT03814733|GABA Modulators|gaba modulators|mesh-ancestor
65584572|NCT03814733|GABA Agents|gaba agents|mesh-ancestor
65584573|NCT03721627|Sofosbuvir|sofosbuvir|mesh-list
65584574|NCT03721627|Ledipasvir|ledipasvir|mesh-list
65584575|NCT03721627|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
65584576|NCT03721627|Antiviral Agents|antiviral agents|mesh-ancestor
65584577|NCT03721627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65584578|NCT03811223|Evolocumab|evolocumab|mesh-list
65584579|NCT03811223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65584580|NCT03811223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65584581|NCT03811223|Antimetabolites|antimetabolites|mesh-ancestor
65584582|NCT03811223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584583|NCT03811223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65584584|NCT03723031|Misoprostol|misoprostol|mesh-list
65584585|NCT03723031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65584586|NCT03723031|Abortifacient Agents|abortifacient agents|mesh-ancestor
65584587|NCT03723031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65584588|NCT03723031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584589|NCT03723031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65584590|NCT03723031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65584591|NCT03723031|Oxytocics|oxytocics|mesh-ancestor
65584592|NCT03722875|Apatinib|apatinib|mesh-list
65584593|NCT03722875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584594|NCT03722875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65584595|NCT03722875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65584596|NCT03722875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584597|NCT04860713|Aspirin|aspirin|mesh-list
65584598|NCT04860713|Ketamine|ketamine|mesh-list
65584599|NCT04860713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65584600|NCT04860713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65584601|NCT04860713|Analgesics|analgesics|mesh-ancestor
65584602|NCT04860713|Sensory System Agents|sensory system agents|mesh-ancestor
65584603|NCT04860713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584604|NCT04860713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584605|NCT04860713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65584606|NCT04860713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65584607|NCT04860713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65584608|NCT04860713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65584609|NCT04860713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584610|NCT04860713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65584611|NCT04860713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65584612|NCT04860713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65584613|NCT04860713|Antipyretics|antipyretics|mesh-ancestor
65584614|NCT04860713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65584615|NCT04860713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65584616|NCT04860713|Anesthetics, General|anesthetics, general|mesh-ancestor
65584617|NCT04860713|Anesthetics|anesthetics|mesh-ancestor
65584618|NCT04860713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65584619|NCT04860713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65584620|NCT04860713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65584621|NCT04860713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65584622|NCT03528577|Albuterol|albuterol|mesh-list
65584623|NCT03528577|Procaterol|procaterol|mesh-list
65584624|NCT03528577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65584625|NCT03528577|Autonomic Agents|autonomic agents|mesh-ancestor
65584626|NCT03528577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584627|NCT03528577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584628|NCT03528577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65584629|NCT03528577|Respiratory System Agents|respiratory system agents|mesh-ancestor
65584630|NCT03528577|Tocolytic Agents|tocolytic agents|mesh-ancestor
65584631|NCT03528577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65584632|NCT03528577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65584633|NCT03528577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65584634|NCT03528577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65584635|NCT03528577|Adrenergic Agents|adrenergic agents|mesh-ancestor
65584636|NCT03528577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65584637|NCT03528577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584638|NCT03528577|Sympathomimetics|sympathomimetics|mesh-ancestor
65584639|NCT05432414|Dexamethasone|dexamethasone|mesh-list
65584640|NCT05432414|Bortezomib|bortezomib|mesh-list
65584641|NCT05432414|Pomalidomide|pomalidomide|mesh-list
65584642|NCT05432414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65584643|NCT05432414|Antiemetics|antiemetics|mesh-ancestor
65584644|NCT05432414|Autonomic Agents|autonomic agents|mesh-ancestor
65584645|NCT05432414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584646|NCT05432414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584647|NCT05432414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65584648|NCT05432414|Glucocorticoids|glucocorticoids|mesh-ancestor
65584649|NCT05432414|Hormones|hormones|mesh-ancestor
65584650|NCT05432414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65584651|NCT05432414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65584652|NCT05432414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584653|NCT05432414|Immunologic Factors|immunologic factors|mesh-ancestor
65584654|NCT05432414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65584655|NCT05432414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65584656|NCT05432414|Growth Substances|growth substances|mesh-ancestor
65584657|NCT05432414|Growth Inhibitors|growth inhibitors|mesh-ancestor
65584658|NCT03796403|Diclofenac|diclofenac|mesh-list
65584659|NCT03796403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65584660|NCT03796403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65584661|NCT03796403|Analgesics|analgesics|mesh-ancestor
65584662|NCT03796403|Sensory System Agents|sensory system agents|mesh-ancestor
65584663|NCT03796403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584664|NCT03796403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584665|NCT03796403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65584666|NCT03796403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65584667|NCT03796403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65584668|NCT03796403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65584669|NCT03796403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584670|NCT00706654|Aripiprazole|aripiprazole|mesh-list
65584671|NCT00706654|Antidepressive Agents|antidepressive agents|mesh-ancestor
65584672|NCT00706654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65584673|NCT00706654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65584674|NCT00706654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65584675|NCT00706654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65584676|NCT00706654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584677|NCT00706654|Dopamine Agonists|dopamine agonists|mesh-ancestor
65584678|NCT00706654|Dopamine Agents|dopamine agents|mesh-ancestor
65584679|NCT00706654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65584680|NCT00706654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584681|NCT00706654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65584682|NCT00706654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65584683|NCT00706654|Serotonin Agents|serotonin agents|mesh-ancestor
65584684|NCT00706654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65584685|NCT00706654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65584686|NCT00706654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65584687|NCT00706654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65584688|NCT03471871|Lemborexant|lemborexant|mesh-list
65584689|NCT03471871|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65584690|NCT03471871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65584691|NCT03471871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584692|NCT03471871|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65584693|NCT03471871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65584694|NCT03471871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65584695|NCT03471871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584696|NCT04313153|Darbepoetin alfa|darbepoetin alfa|mesh-list
65584697|NCT04313153|Hematinics|hematinics|mesh-ancestor
65584698|NCT05372744|Antidepressive Agents|antidepressive agents|mesh-list
65584699|NCT05372744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65584700|NCT03337672|Midazolam|midazolam|mesh-list
65584701|NCT03337672|Dexmedetomidine|dexmedetomidine|mesh-list
65584702|NCT03337672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65584703|NCT03337672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65584704|NCT03337672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584705|NCT03337672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65584706|NCT03337672|Analgesics|analgesics|mesh-ancestor
65584707|NCT03337672|Sensory System Agents|sensory system agents|mesh-ancestor
65584708|NCT03337672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584709|NCT03337672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65584710|NCT03337672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65584711|NCT03337672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65584712|NCT03337672|Adrenergic Agents|adrenergic agents|mesh-ancestor
65584713|NCT03337672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65584714|NCT03337672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584715|NCT03337672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65584716|NCT03337672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65584717|NCT03337672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65584718|NCT03337672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65584719|NCT03337672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65584720|NCT03337672|Anesthetics, General|anesthetics, general|mesh-ancestor
65584721|NCT03337672|Anesthetics|anesthetics|mesh-ancestor
65584722|NCT03337672|GABA Modulators|gaba modulators|mesh-ancestor
65584723|NCT03337672|GABA Agents|gaba agents|mesh-ancestor
65584724|NCT03330808|Anesthetics|anesthetics|mesh-list
65584725|NCT03330808|Ropivacaine|ropivacaine|mesh-list
65584726|NCT03330808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65584727|NCT03330808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584728|NCT03330808|Anesthetics, Local|anesthetics, local|mesh-ancestor
65584729|NCT03330808|Sensory System Agents|sensory system agents|mesh-ancestor
65584730|NCT03330808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584731|NCT01303055|Metformin|metformin|mesh-list
65584732|NCT01303055|Alogliptin|alogliptin|mesh-list
65584733|NCT01303055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65584734|NCT01303055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584735|NCT01303055|Incretins|incretins|mesh-ancestor
65584736|NCT01303055|Hormones|hormones|mesh-ancestor
65584737|NCT01303055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65584738|NCT01303055|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65584739|NCT01303055|Protease Inhibitors|protease inhibitors|mesh-ancestor
65584740|NCT01303055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65584741|NCT01303055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584742|NCT05474560|Allopurinol|allopurinol|mesh-list
65584743|NCT05474560|Febuxostat|febuxostat|mesh-list
65584744|NCT05474560|Antimetabolites|antimetabolites|mesh-ancestor
65584745|NCT05474560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584746|NCT05474560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65584747|NCT05474560|Gout Suppressants|gout suppressants|mesh-ancestor
65584748|NCT05474560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65584749|NCT05474560|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65584750|NCT05474560|Antioxidants|antioxidants|mesh-ancestor
65584751|NCT05474560|Protective Agents|protective agents|mesh-ancestor
65584752|NCT05474560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584753|NCT03636048|Bupivacaine|bupivacaine|mesh-list
65584754|NCT03636048|Anesthetics|anesthetics|mesh-list
65584755|NCT03636048|Propofol|propofol|mesh-list
65584756|NCT03636048|Anesthetics, Local|anesthetics, local|mesh-ancestor
65584757|NCT03636048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65584758|NCT03636048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584759|NCT03636048|Sensory System Agents|sensory system agents|mesh-ancestor
65584760|NCT03636048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584761|NCT03636048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65584762|NCT03636048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65584763|NCT03636048|Anesthetics, General|anesthetics, general|mesh-ancestor
65584764|NCT03527173|Vaccines|vaccines|mesh-list
65584765|NCT03527173|Immunologic Factors|immunologic factors|mesh-ancestor
65584766|NCT03527173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584767|NCT04718922|Chlorhexidine|chlorhexidine|mesh-list
65584768|NCT04718922|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65584769|NCT04718922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65584770|NCT04718922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65584771|NCT04718922|Disinfectants|disinfectants|mesh-ancestor
65584772|NCT04718922|Dermatologic Agents|dermatologic agents|mesh-ancestor
65584773|NCT01303601|Olanzapine|olanzapine|mesh-list
65584774|NCT01303601|Antiemetics|antiemetics|mesh-ancestor
65584775|NCT01303601|Autonomic Agents|autonomic agents|mesh-ancestor
65584776|NCT01303601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584777|NCT01303601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584778|NCT01303601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65584779|NCT01303601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65584780|NCT01303601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65584781|NCT01303601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65584782|NCT01303601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65382275|NCT00536991|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65584783|NCT01303601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65584784|NCT01303601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65584785|NCT01303601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65584786|NCT01303601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584788|NCT01303601|Serotonin Agents|serotonin agents|mesh-ancestor
65584789|NCT00707980|Vortioxetine|vortioxetine|mesh-list
65584790|NCT00707980|Antidepressive Agents|antidepressive agents|mesh-ancestor
65584791|NCT00707980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65584792|NCT00707980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65584793|NCT00707980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65584794|NCT00707980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65584795|NCT00707980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584796|NCT00707980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65584797|NCT00707980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65584798|NCT00707980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65584799|NCT00707980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584800|NCT00707980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65584801|NCT00707980|Serotonin Agents|serotonin agents|mesh-ancestor
65584802|NCT00707980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65584803|NCT00707980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65584804|NCT00707980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65584805|NCT00707980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65584806|NCT01304537|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65584807|NCT01304537|Protein C Inhibitor|protein c inhibitor|mesh-list
65584808|NCT01304537|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65584809|NCT01304537|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65584810|NCT01304537|Protease Inhibitors|protease inhibitors|mesh-ancestor
65584811|NCT01304537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65584812|NCT01304537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584813|NCT03051620|Alendronate|alendronate|mesh-list
65584814|NCT03051620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65584815|NCT03051620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584816|NCT02861183|Hyaluronic Acid|hyaluronic acid|mesh-list
65584817|NCT02861183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65584818|NCT02861183|Immunologic Factors|immunologic factors|mesh-ancestor
65584819|NCT02861183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584820|NCT02861183|Viscosupplements|viscosupplements|mesh-ancestor
65584821|NCT02861183|Protective Agents|protective agents|mesh-ancestor
65584822|NCT02498002|Lidocaine|lidocaine|mesh-list
65584823|NCT02498002|Anesthetics, Local|anesthetics, local|mesh-ancestor
65584824|NCT02498002|Anesthetics|anesthetics|mesh-ancestor
65584825|NCT02498002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65584826|NCT02498002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584827|NCT02498002|Sensory System Agents|sensory system agents|mesh-ancestor
65584828|NCT02498002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584829|NCT02498002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65584830|NCT02498002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65584831|NCT02498002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65584832|NCT02498002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65584833|NCT02498002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584834|NCT03810209|Magnesium Sulfate|magnesium sulfate|mesh-list
65584835|NCT03810209|Analgesics|analgesics|mesh-ancestor
65584836|NCT03810209|Sensory System Agents|sensory system agents|mesh-ancestor
65584837|NCT03810209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584838|NCT03810209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584839|NCT03810209|Anesthetics|anesthetics|mesh-ancestor
65584840|NCT03810209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65584841|NCT03810209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65584842|NCT03810209|Anticonvulsants|anticonvulsants|mesh-ancestor
65584843|NCT03810209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65584844|NCT03810209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65584845|NCT03810209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584846|NCT03810209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65584847|NCT03810209|Tocolytic Agents|tocolytic agents|mesh-ancestor
65584848|NCT03810209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65584849|NCT04186988|9-arabinofuranosylguanine|9-arabinofuranosylguanine|mesh-list
65584850|NCT04186988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584851|NCT01303679|Paclitaxel|paclitaxel|mesh-list
65584852|NCT01303679|Bevacizumab|bevacizumab|mesh-list
65584853|NCT01303679|Exemestane|exemestane|mesh-list
65584854|NCT01303679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65584855|NCT01303679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584856|NCT01303679|Tubulin Modulators|tubulin modulators|mesh-ancestor
65584857|NCT01303679|Antimitotic Agents|antimitotic agents|mesh-ancestor
65584858|NCT01303679|Mitosis Modulators|mitosis modulators|mesh-ancestor
65382347|NCT00842660|Gemcitabine|gemcitabine|mesh-list
65584859|NCT01303679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584860|NCT01303679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65584861|NCT01303679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65584862|NCT01303679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65584863|NCT01303679|Growth Substances|growth substances|mesh-ancestor
65584864|NCT01303679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584865|NCT01303679|Growth Inhibitors|growth inhibitors|mesh-ancestor
65584866|NCT01303679|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65584867|NCT01303679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65584868|NCT01303679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65584869|NCT01303679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65584870|NCT01303679|Hormone Antagonists|hormone antagonists|mesh-ancestor
65584871|NCT01303679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65584873|NCT03337282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65584874|NCT03337282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584875|NCT03801707|Sofosbuvir|sofosbuvir|mesh-list
65584876|NCT03801707|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65584877|NCT03801707|Velpatasvir|velpatasvir|mesh-list
65584878|NCT03801707|Antiviral Agents|antiviral agents|mesh-ancestor
65584879|NCT03801707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65584880|NCT04576871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65584881|NCT04576871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65584882|NCT04576871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584883|NCT04239872|Calcium, Dietary|calcium, dietary|mesh-list
65584884|NCT04239872|Calcium|calcium|mesh-list
65584885|NCT04239872|Fluorides|fluorides|mesh-list
65584886|NCT04239872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65584887|NCT04239872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584888|NCT04239872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65584889|NCT04239872|Cariostatic Agents|cariostatic agents|mesh-ancestor
65584890|NCT04239872|Protective Agents|protective agents|mesh-ancestor
65584891|NCT03164772|Durvalumab|durvalumab|mesh-list
65584892|NCT03164772|Tremelimumab|tremelimumab|mesh-list
65584893|NCT03164772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65584894|NCT03164772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584895|NCT03801317|Micronutrients|micronutrients|mesh-list
65584896|NCT03801317|Trace Elements|trace elements|mesh-list
65584897|NCT03801317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584898|NCT03337126|Metronidazole|metronidazole|mesh-list
65584899|NCT03337126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65584900|NCT03337126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65584901|NCT03337126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65584902|NCT03337126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65584903|NCT04710732|Enoxaparin|enoxaparin|mesh-list
65584904|NCT04710732|Enoxaparin sodium|enoxaparin sodium|mesh-list
65584905|NCT04710732|Anticoagulants|anticoagulants|mesh-ancestor
65584906|NCT04710732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65584907|NCT04710732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65584908|NCT04710732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584909|NCT05014334|Amoxicillin|amoxicillin|mesh-list
65584910|NCT05014334|Clarithromycin|clarithromycin|mesh-list
65584911|NCT05014334|Rabeprazole|rabeprazole|mesh-list
65584912|NCT05014334|Bismuth|bismuth|mesh-list
65584913|NCT05014334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65584914|NCT05014334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65584915|NCT05014334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65584916|NCT05014334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65584917|NCT05014334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584918|NCT05014334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65584919|NCT05014334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65584920|NCT05014334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65584921|NCT05014334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65584922|NCT05014334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65584923|NCT05014334|Antacids|antacids|mesh-ancestor
65584924|NCT02497378|Dexamethasone|dexamethasone|mesh-list
65584925|NCT02497378|Bortezomib|bortezomib|mesh-list
65584926|NCT02497378|Daratumumab|daratumumab|mesh-list
65584927|NCT02497378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65584928|NCT02497378|Antiemetics|antiemetics|mesh-ancestor
65584929|NCT02497378|Autonomic Agents|autonomic agents|mesh-ancestor
65584930|NCT02497378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584931|NCT02497378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584932|NCT02497378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65584933|NCT02497378|Glucocorticoids|glucocorticoids|mesh-ancestor
65382421|NCT04688788|Histamine Agents|histamine agents|mesh-ancestor
65584934|NCT02497378|Hormones|hormones|mesh-ancestor
65584935|NCT02497378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65584936|NCT02497378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65584937|NCT02497378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584939|NCT02497222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65584940|NCT02497222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65584941|NCT02497222|Analgesics|analgesics|mesh-ancestor
65584942|NCT02497222|Sensory System Agents|sensory system agents|mesh-ancestor
65584943|NCT02497222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65584944|NCT02497222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584945|NCT02497222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65584946|NCT02497222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65584947|NCT02497222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65584948|NCT02491606|Tafenoquine|tafenoquine|mesh-list
65584949|NCT02491606|Antimalarials|antimalarials|mesh-ancestor
65584950|NCT02491606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65584951|NCT02491606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65584952|NCT02491606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65584953|NCT03329638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65584954|NCT03329638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65584955|NCT03050450|Lenalidomide|lenalidomide|mesh-list
65584956|NCT03050450|Vorinostat|vorinostat|mesh-list
65584957|NCT03050450|Immunologic Factors|immunologic factors|mesh-ancestor
65584958|NCT03050450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584959|NCT03050450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65584960|NCT03050450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65584961|NCT03050450|Growth Substances|growth substances|mesh-ancestor
65584962|NCT03050450|Growth Inhibitors|growth inhibitors|mesh-ancestor
65584963|NCT03050450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584964|NCT03050450|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65584965|NCT03050450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65584966|NCT03050450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584967|NCT03799679|Antineoplastic Agents|antineoplastic agents|mesh-list
65584968|NCT03505021|Simendan|simendan|mesh-list
65584969|NCT03505021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65584970|NCT03505021|Vasodilator Agents|vasodilator agents|mesh-ancestor
65584971|NCT03505021|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65584972|NCT03505021|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65584973|NCT03505021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65584974|NCT03505021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584975|NCT03505021|Protective Agents|protective agents|mesh-ancestor
65584976|NCT03505021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584977|NCT03793283|Insulin|insulin|mesh-list
65584978|NCT03793283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65584979|NCT03793283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65584980|NCT03793283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584981|NCT02496988|Temozolomide|temozolomide|mesh-list
65584982|NCT02496988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65584983|NCT02496988|Alkylating Agents|alkylating agents|mesh-ancestor
65584984|NCT02496988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65584985|NCT02496988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65584986|NCT03793205|Lenograstim|lenograstim|mesh-list
65584987|NCT03793205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65584988|NCT03793205|Immunologic Factors|immunologic factors|mesh-ancestor
65584989|NCT03793205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65584990|NCT03329248|Leucovorin|leucovorin|mesh-list
65584991|NCT03329248|Paclitaxel|paclitaxel|mesh-list
65584992|NCT03329248|Cyclophosphamide|cyclophosphamide|mesh-list
65584993|NCT03329248|Bevacizumab|bevacizumab|mesh-list
65584994|NCT03329248|Fluorouracil|fluorouracil|mesh-list
65584995|NCT03329248|Capecitabine|capecitabine|mesh-list
65584996|NCT03329248|Oxaliplatin|oxaliplatin|mesh-list
65584997|NCT03329248|Avelumab|avelumab|mesh-list
65584998|NCT03329248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65584999|NCT03329248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585000|NCT03329248|Tubulin Modulators|tubulin modulators|mesh-ancestor
65585001|NCT03329248|Antimitotic Agents|antimitotic agents|mesh-ancestor
65585002|NCT03329248|Mitosis Modulators|mitosis modulators|mesh-ancestor
65585003|NCT03329248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585004|NCT03329248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65585005|NCT03329248|Immunologic Factors|immunologic factors|mesh-ancestor
65585006|NCT03329248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585007|NCT03329248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65585008|NCT03329248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65585009|NCT03329248|Alkylating Agents|alkylating agents|mesh-ancestor
65585010|NCT03329248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65585011|NCT03329248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65585012|NCT03329248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65585013|NCT03329248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65585014|NCT03329248|Growth Substances|growth substances|mesh-ancestor
65585015|NCT03329248|Growth Inhibitors|growth inhibitors|mesh-ancestor
65585016|NCT03329248|Antimetabolites|antimetabolites|mesh-ancestor
65585017|NCT03329248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65585018|NCT03329248|Antidotes|antidotes|mesh-ancestor
65585019|NCT03329248|Protective Agents|protective agents|mesh-ancestor
65585020|NCT03329248|Vitamin B Complex|vitamin b complex|mesh-ancestor
65585021|NCT03329248|Vitamins|vitamins|mesh-ancestor
65585022|NCT03329248|Micronutrients|micronutrients|mesh-ancestor
65585023|NCT03795311|Bevacizumab|bevacizumab|mesh-list
65585024|NCT03795311|Folfirinox|folfirinox|mesh-list
65585025|NCT03795311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65585026|NCT03795311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585027|NCT03795311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65585028|NCT03795311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65585029|NCT03795311|Growth Substances|growth substances|mesh-ancestor
65585030|NCT03795311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585031|NCT03795311|Growth Inhibitors|growth inhibitors|mesh-ancestor
65585032|NCT03792971|Dextromethorphan|dextromethorphan|mesh-list
65585033|NCT03792971|Avasopasem manganese|avasopasem manganese|mesh-list
65585034|NCT03792971|Antitussive Agents|antitussive agents|mesh-ancestor
65585035|NCT03792971|Respiratory System Agents|respiratory system agents|mesh-ancestor
65585036|NCT03792971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65585037|NCT03792971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65585038|NCT03792971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65585039|NCT03792971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585040|NCT03792971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585041|NCT03792971|Antioxidants|antioxidants|mesh-ancestor
65585042|NCT03792971|Protective Agents|protective agents|mesh-ancestor
65585043|NCT03328936|Melphalan|melphalan|mesh-list
65585044|NCT03328936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65585045|NCT03328936|Alkylating Agents|alkylating agents|mesh-ancestor
65585046|NCT03328936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585047|NCT03328936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585048|NCT03328936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65585049|NCT03328936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65585050|NCT03328936|Immunologic Factors|immunologic factors|mesh-ancestor
65585051|NCT03328936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585052|NCT02496754|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65585053|NCT02496754|Hormones|hormones|mesh-ancestor
65585054|NCT02496754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65585055|NCT02496754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585056|NCT04887194|Nivolumab|nivolumab|mesh-list
65585057|NCT04887194|Digoxin|digoxin|mesh-list
65585058|NCT04887194|Midazolam|midazolam|mesh-list
65585059|NCT04887194|Dextromethorphan|dextromethorphan|mesh-list
65585060|NCT04887194|Warfarin|warfarin|mesh-list
65585061|NCT04887194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65585062|NCT04887194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65585063|NCT04887194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585064|NCT04887194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65585065|NCT04887194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585066|NCT04887194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65585067|NCT04887194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65585068|NCT04887194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65585069|NCT04887194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585070|NCT04887194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65585071|NCT04887194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65585072|NCT04887194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65585073|NCT04887194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65585074|NCT04887194|Anesthetics, General|anesthetics, general|mesh-ancestor
65585075|NCT04887194|Anesthetics|anesthetics|mesh-ancestor
65585076|NCT04887194|GABA Modulators|gaba modulators|mesh-ancestor
65585077|NCT04887194|GABA Agents|gaba agents|mesh-ancestor
65585078|NCT04887194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65585079|NCT04887194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65585080|NCT04887194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65585081|NCT04887194|Antimetabolites|antimetabolites|mesh-ancestor
65585082|NCT04887194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65585083|NCT04887194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65585084|NCT04887194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65585085|NCT04887194|Anticoagulants|anticoagulants|mesh-ancestor
65585086|NCT04887194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65585087|NCT04887194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65585088|NCT04887194|Protective Agents|protective agents|mesh-ancestor
65585089|NCT04887194|Antitussive Agents|antitussive agents|mesh-ancestor
65585090|NCT04887194|Respiratory System Agents|respiratory system agents|mesh-ancestor
65585091|NCT04887194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65585092|NCT04887194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65585094|NCT02496910|Telmisartan|telmisartan|mesh-list
65585095|NCT02496910|Chlorthalidone|chlorthalidone|mesh-list
65585096|NCT02496910|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
65585097|NCT02496910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65585098|NCT02496910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65585099|NCT02496910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65585100|NCT02496910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585101|NCT02496910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65585102|NCT02496910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585103|NCT02496910|Vasodilator Agents|vasodilator agents|mesh-ancestor
65585104|NCT02496910|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65585105|NCT02496910|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65585106|NCT02496910|Diuretics|diuretics|mesh-ancestor
65585107|NCT02496910|Natriuretic Agents|natriuretic agents|mesh-ancestor
65585108|NCT02496910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65585109|NCT03342352|Carboplatin|carboplatin|mesh-list
65585110|NCT03342352|Fluorouracil|fluorouracil|mesh-list
65585111|NCT03342352|Nivolumab|nivolumab|mesh-list
65585112|NCT03342352|Cetuximab|cetuximab|mesh-list
65585113|NCT03342352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585114|NCT03342352|Antimetabolites|antimetabolites|mesh-ancestor
65585115|NCT03342352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585116|NCT03342352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65585117|NCT03342352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65585118|NCT03342352|Immunologic Factors|immunologic factors|mesh-ancestor
65585119|NCT03342352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585120|NCT03342352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65585121|NCT03342352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65585122|NCT03120442|Fentanyl|fentanyl|mesh-list
65585123|NCT03120442|Dexmedetomidine|dexmedetomidine|mesh-list
65585124|NCT03120442|Propofol|propofol|mesh-list
65585125|NCT03120442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65585126|NCT03120442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65585127|NCT03120442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585128|NCT03120442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65585129|NCT03120442|Anesthetics, General|anesthetics, general|mesh-ancestor
65585130|NCT03120442|Anesthetics|anesthetics|mesh-ancestor
65585131|NCT03120442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65585132|NCT03120442|Analgesics|analgesics|mesh-ancestor
65585133|NCT03120442|Sensory System Agents|sensory system agents|mesh-ancestor
65585134|NCT03120442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65585135|NCT03120442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65585136|NCT03120442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65585137|NCT03120442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65585138|NCT03120442|Adrenergic Agents|adrenergic agents|mesh-ancestor
65585139|NCT03120442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65585140|NCT03120442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585141|NCT03120442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65585142|NCT03120442|Narcotics|narcotics|mesh-ancestor
65585143|NCT03120442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65585144|NCT00852696|Solifenacin Succinate|solifenacin succinate|mesh-list
65585145|NCT00852696|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65585146|NCT00852696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65585147|NCT00852696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65585148|NCT00852696|Cholinergic Agents|cholinergic agents|mesh-ancestor
65585149|NCT00852696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65585150|NCT00852696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585151|NCT00852696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585152|NCT00852696|Urological Agents|urological agents|mesh-ancestor
65585153|NCT02496832|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
65585154|NCT02496832|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65585155|NCT02496832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585156|NCT03324490|Fentanyl|fentanyl|mesh-list
65585157|NCT03324490|Dexmedetomidine|dexmedetomidine|mesh-list
65585158|NCT03324490|Bupivacaine|bupivacaine|mesh-list
65585159|NCT03324490|Anesthetics|anesthetics|mesh-list
65585160|NCT03324490|Anesthetics, Local|anesthetics, local|mesh-ancestor
65382647|NCT05018481|Protective Agents|protective agents|mesh-ancestor
65585161|NCT03324490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65585162|NCT03324490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585163|NCT03324490|Sensory System Agents|sensory system agents|mesh-ancestor
65585164|NCT03324490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65585165|NCT03324490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65585166|NCT03324490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65585168|NCT03324490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65585169|NCT03324490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65585170|NCT03324490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65585171|NCT03324490|Adrenergic Agents|adrenergic agents|mesh-ancestor
65585172|NCT03324490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65585173|NCT03324490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585174|NCT03324490|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65585175|NCT03324490|Narcotics|narcotics|mesh-ancestor
65585176|NCT03324490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65585177|NCT03324490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65585178|NCT03324490|Anesthetics, General|anesthetics, general|mesh-ancestor
65585179|NCT03798899|Methoxyflurane|methoxyflurane|mesh-list
65585180|NCT03798899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65585181|NCT03798899|Anesthetics, General|anesthetics, general|mesh-ancestor
65585182|NCT03798899|Anesthetics|anesthetics|mesh-ancestor
65585183|NCT03798899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65585184|NCT03798899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585185|NCT03274661|Pembrolizumab|pembrolizumab|mesh-list
65585186|NCT03274661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65585187|NCT03274661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585188|NCT04072952|Palbociclib|palbociclib|mesh-list
65585189|NCT04072952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585190|NCT04072952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65585191|NCT04072952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65585192|NCT04072952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585193|NCT04509050|Ivacaftor|ivacaftor|mesh-list
65585194|NCT04509050|Elexacaftor|elexacaftor|mesh-list
65585195|NCT04509050|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65585196|NCT04509050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65585197|NCT04509050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585198|NCT03798821|Sulfalene|sulfalene|mesh-list
65585199|NCT03798821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65585200|NCT03798821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65585201|NCT03798821|Renal Agents|renal agents|mesh-ancestor
65585202|NCT03798821|Antimalarials|antimalarials|mesh-ancestor
65585203|NCT03798821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65585204|NCT03798821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65585205|NCT03324334|Antibodies|antibodies|mesh-list
65585206|NCT03324334|Immunologic Factors|immunologic factors|mesh-ancestor
65585207|NCT03324334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585208|NCT03792815|Etoposide|etoposide|mesh-list
65585209|NCT03792815|Melphalan|melphalan|mesh-list
65585210|NCT03792815|Busulfan|busulfan|mesh-list
65585211|NCT03792815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65585212|NCT03792815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585213|NCT03792815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65585214|NCT03792815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65585215|NCT03792815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65585216|NCT03792815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585217|NCT03792815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65585218|NCT03792815|Alkylating Agents|alkylating agents|mesh-ancestor
65585219|NCT03792815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65585220|NCT03792815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65585221|NCT03792815|Immunologic Factors|immunologic factors|mesh-ancestor
65585222|NCT03792815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585223|NCT04381364|Ciclesonide|ciclesonide|mesh-list
65585224|NCT04381364|Glucocorticoids|glucocorticoids|mesh-ancestor
65585225|NCT04381364|Hormones|hormones|mesh-ancestor
65585226|NCT04381364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65585227|NCT04381364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585228|NCT04381364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65585229|NCT01331382|Resveratrol|resveratrol|mesh-list
65585230|NCT01331382|Antioxidants|antioxidants|mesh-ancestor
65585231|NCT01331382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585232|NCT01331382|Protective Agents|protective agents|mesh-ancestor
65585233|NCT01331382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585234|NCT01331382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382723|NCT00855608|Adalimumab|adalimumab|mesh-list
65585235|NCT01331382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65585237|NCT03794765|Ceftriaxone|ceftriaxone|mesh-list
65585238|NCT03794765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65585239|NCT03794765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65585240|NCT03794765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65585241|NCT03794765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65585242|NCT03043664|Pembrolizumab|pembrolizumab|mesh-list
65585243|NCT03043664|Lanreotide|lanreotide|mesh-list
65585244|NCT03043664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65585245|NCT03043664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585246|NCT02496286|Bevacizumab|bevacizumab|mesh-list
65585247|NCT02496286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65585248|NCT02496286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585249|NCT02496286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65585250|NCT02496286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65585251|NCT02496286|Growth Substances|growth substances|mesh-ancestor
65585252|NCT02496286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585253|NCT02496286|Growth Inhibitors|growth inhibitors|mesh-ancestor
65585254|NCT01489176|Regadenoson|regadenoson|mesh-list
65585255|NCT01489176|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65585256|NCT01489176|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65585257|NCT01489176|Purinergic Agonists|purinergic agonists|mesh-ancestor
65585258|NCT01489176|Purinergic Agents|purinergic agents|mesh-ancestor
65585259|NCT01489176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65585260|NCT01489176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585261|NCT01489176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585262|NCT03792503|Pemetrexed|pemetrexed|mesh-list
65585263|NCT03792503|Apatinib|apatinib|mesh-list
65585264|NCT03792503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585265|NCT03792503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65585266|NCT03792503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585267|NCT03792503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65585268|NCT03792503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65585269|NCT03792503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65585270|NCT03794843|Nimodipine|nimodipine|mesh-list
65585271|NCT03794843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65585272|NCT03794843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65585273|NCT03794843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65585274|NCT03794843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585275|NCT03794843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65585276|NCT03794843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585277|NCT03794843|Vasodilator Agents|vasodilator agents|mesh-ancestor
65585278|NCT01333800|Ciclesonide|ciclesonide|mesh-list
65585279|NCT01333800|Beclomethasone|beclomethasone|mesh-list
65585280|NCT01333800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65585281|NCT01333800|Glucocorticoids|glucocorticoids|mesh-ancestor
65585282|NCT01333800|Hormones|hormones|mesh-ancestor
65585283|NCT01333800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65585284|NCT01333800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585285|NCT01333800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65585286|NCT01333800|Respiratory System Agents|respiratory system agents|mesh-ancestor
65585287|NCT01333800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65585288|NCT04024436|Fulvestrant|fulvestrant|mesh-list
65585289|NCT04024436|Futibatinib|futibatinib|mesh-list
65585290|NCT04024436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65585291|NCT04024436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585292|NCT04024436|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65585293|NCT04024436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65585294|NCT04024436|Hormone Antagonists|hormone antagonists|mesh-ancestor
65585295|NCT04024436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65585296|NCT04024436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585297|NCT04494100|Lidocaine|lidocaine|mesh-list
65585298|NCT04494100|Epinephrine|epinephrine|mesh-list
65585299|NCT04494100|Ropivacaine|ropivacaine|mesh-list
65585300|NCT04494100|Anesthetics, Local|anesthetics, local|mesh-ancestor
65585301|NCT04494100|Anesthetics|anesthetics|mesh-ancestor
65585302|NCT04494100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65585303|NCT04494100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585304|NCT04494100|Sensory System Agents|sensory system agents|mesh-ancestor
65585305|NCT04494100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65585306|NCT04494100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65585307|NCT04494100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65585308|NCT04494100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65585309|NCT04494100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65585310|NCT04494100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585311|NCT04494100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65585312|NCT04494100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65585313|NCT04494100|Adrenergic Agents|adrenergic agents|mesh-ancestor
65585314|NCT04494100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65585315|NCT04494100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65585316|NCT04494100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65585317|NCT04494100|Autonomic Agents|autonomic agents|mesh-ancestor
65585318|NCT04494100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65585319|NCT04494100|Respiratory System Agents|respiratory system agents|mesh-ancestor
65585320|NCT04494100|Mydriatics|mydriatics|mesh-ancestor
65585321|NCT04494100|Sympathomimetics|sympathomimetics|mesh-ancestor
65585322|NCT04494100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65585323|NCT01333878|Abatacept|abatacept|mesh-list
65585324|NCT01333878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65585325|NCT01333878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585326|NCT01333878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585327|NCT01333878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65585328|NCT01333878|Immunologic Factors|immunologic factors|mesh-ancestor
65585329|NCT01333878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585330|NCT01333878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65585331|NCT03328312|Atropine|atropine|mesh-list
65585332|NCT03328312|Neostigmine|neostigmine|mesh-list
65585333|NCT03328312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65585334|NCT03328312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65585335|NCT03328312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65585336|NCT03328312|Autonomic Agents|autonomic agents|mesh-ancestor
65585337|NCT03328312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65585338|NCT03328312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585339|NCT03328312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65585340|NCT03328312|Respiratory System Agents|respiratory system agents|mesh-ancestor
65585341|NCT03328312|Mydriatics|mydriatics|mesh-ancestor
65585342|NCT03328312|Parasympatholytics|parasympatholytics|mesh-ancestor
65585343|NCT03328312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65585344|NCT03328312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65585345|NCT03328312|Cholinergic Agents|cholinergic agents|mesh-ancestor
65585346|NCT03328312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65585347|NCT03328312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585348|NCT03328312|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65585349|NCT03328312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65585350|NCT03328312|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65585351|NCT04051580|Plasma-lyte 148|plasma-lyte 148|mesh-list
65585352|NCT04051580|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65585353|NCT04051580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65585354|NCT03328234|Paclitaxel|paclitaxel|mesh-list
65585355|NCT03328234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65585356|NCT03328234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65585357|NCT03328234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585358|NCT03328234|Tubulin Modulators|tubulin modulators|mesh-ancestor
65585359|NCT03328234|Antimitotic Agents|antimitotic agents|mesh-ancestor
65585360|NCT03328234|Mitosis Modulators|mitosis modulators|mesh-ancestor
65585361|NCT03328234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585362|NCT04781192|Durvalumab|durvalumab|mesh-list
65585363|NCT04781192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65585364|NCT04781192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585365|NCT03323710|Sunitinib|sunitinib|mesh-list
65585366|NCT03323710|Propranolol|propranolol|mesh-list
65585367|NCT03323710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585368|NCT03323710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65585369|NCT03323710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65585370|NCT03323710|Growth Substances|growth substances|mesh-ancestor
65585371|NCT03323710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585372|NCT03323710|Growth Inhibitors|growth inhibitors|mesh-ancestor
65585373|NCT03323710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65585374|NCT03323710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65585375|NCT03323710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585376|NCT03323710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65585377|NCT03323710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65585378|NCT03323710|Adrenergic Agents|adrenergic agents|mesh-ancestor
65585379|NCT03323710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65585380|NCT03323710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65585381|NCT03323710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65585382|NCT03323710|Vasodilator Agents|vasodilator agents|mesh-ancestor
65585383|NCT03792269|Capecitabine|capecitabine|mesh-list
65585384|NCT03792269|Oxaliplatin|oxaliplatin|mesh-list
65585385|NCT03792269|Irinotecan|irinotecan|mesh-list
65585386|NCT03792269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65585387|NCT03792269|Antimetabolites|antimetabolites|mesh-ancestor
65585388|NCT03792269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585389|NCT03792269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585390|NCT03792269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65585391|NCT03792269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65585392|NCT03792269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65585393|NCT02488564|Metformin|metformin|mesh-list
65585394|NCT02488564|Docetaxel|docetaxel|mesh-list
65585395|NCT02488564|Doxorubicin|doxorubicin|mesh-list
65585396|NCT02488564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65585397|NCT02488564|Trastuzumab|trastuzumab|mesh-list
65585398|NCT02488564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65585399|NCT02488564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585400|NCT02488564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585401|NCT02488564|Tubulin Modulators|tubulin modulators|mesh-ancestor
65585402|NCT02488564|Antimitotic Agents|antimitotic agents|mesh-ancestor
65585403|NCT02488564|Mitosis Modulators|mitosis modulators|mesh-ancestor
65585404|NCT02488564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585405|NCT02488564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65585406|NCT02488564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65585407|NCT02488564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65585408|NCT02488564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65585409|NCT02488564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65585410|NCT02966873|Acetylcysteine|acetylcysteine|mesh-list
65585411|NCT02966873|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65585412|NCT02966873|Antiviral Agents|antiviral agents|mesh-ancestor
65585413|NCT02966873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65585414|NCT02966873|Expectorants|expectorants|mesh-ancestor
65585415|NCT02966873|Respiratory System Agents|respiratory system agents|mesh-ancestor
65585416|NCT02966873|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65585417|NCT02966873|Antioxidants|antioxidants|mesh-ancestor
65585418|NCT02966873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585419|NCT02966873|Protective Agents|protective agents|mesh-ancestor
65585420|NCT02966873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585421|NCT02966873|Antidotes|antidotes|mesh-ancestor
65585422|NCT03792347|Pembrolizumab|pembrolizumab|mesh-list
65585423|NCT03792347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65585424|NCT03792347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585425|NCT04697186|Amoxicillin|amoxicillin|mesh-list
65585426|NCT04697186|Clarithromycin|clarithromycin|mesh-list
65585427|NCT04697186|Rabeprazole|rabeprazole|mesh-list
65585428|NCT04697186|Bismuth|bismuth|mesh-list
65585429|NCT04697186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65585430|NCT04697186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65585431|NCT04697186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65585432|NCT04697186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65585433|NCT04697186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585434|NCT04697186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65585435|NCT04697186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65585436|NCT04697186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65585437|NCT04697186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65585438|NCT04697186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65585439|NCT04697186|Antacids|antacids|mesh-ancestor
65585440|NCT02488642|Isosorbide|isosorbide|mesh-list
65585441|NCT02488642|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65585442|NCT02488642|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65585443|NCT02488642|Misoprostol|misoprostol|mesh-list
65585444|NCT02488642|Oxytocin|oxytocin|mesh-list
65585445|NCT02488642|Oxytocics|oxytocics|mesh-ancestor
65585446|NCT02488642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65585447|NCT02488642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585448|NCT02488642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65585449|NCT02488642|Abortifacient Agents|abortifacient agents|mesh-ancestor
65585450|NCT02488642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65585451|NCT02488642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65585452|NCT02488642|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65585453|NCT02488642|Diuretics|diuretics|mesh-ancestor
65585454|NCT02488642|Natriuretic Agents|natriuretic agents|mesh-ancestor
65585455|NCT02488642|Vasodilator Agents|vasodilator agents|mesh-ancestor
65585456|NCT02488642|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65585457|NCT02488642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382947|NCT00845546|Pseudoephedrine|pseudoephedrine|mesh-list
65585458|NCT02488486|Remifentanil|remifentanil|mesh-list
65585459|NCT02488486|Propofol|propofol|mesh-list
65585460|NCT02488486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65585461|NCT02488486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65585462|NCT02488486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585463|NCT02488486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65585464|NCT02488486|Anesthetics, General|anesthetics, general|mesh-ancestor
65585465|NCT02488486|Anesthetics|anesthetics|mesh-ancestor
65585466|NCT02488486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65585467|NCT02488486|Narcotics|narcotics|mesh-ancestor
65585468|NCT02488486|Analgesics|analgesics|mesh-ancestor
65585469|NCT02488486|Sensory System Agents|sensory system agents|mesh-ancestor
65585470|NCT02488486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65585471|NCT04144517|Pembrolizumab|pembrolizumab|mesh-list
65585472|NCT04144517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65585473|NCT04144517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585474|NCT01389024|Hydroxyurea|hydroxyurea|mesh-list
65585475|NCT01389024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585476|NCT01389024|Antisickling Agents|antisickling agents|mesh-ancestor
65585477|NCT01389024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65585478|NCT01389024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585479|NCT01389024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65585480|NCT03327766|Calcifediol|calcifediol|mesh-list
65585481|NCT03327766|Vitamins|vitamins|mesh-ancestor
65585482|NCT03327766|Micronutrients|micronutrients|mesh-ancestor
65585483|NCT03327766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585484|NCT03327766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65585485|NCT03798119|Tenofovir|tenofovir|mesh-list
65585486|NCT03798119|Antiviral Agents|antiviral agents|mesh-ancestor
65585487|NCT03798119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65585488|NCT03798119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65585489|NCT03798119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65585490|NCT03798119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65585491|NCT03798119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585492|NCT03798119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65585493|NCT03798119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65585494|NCT03794219|Naproxen|naproxen|mesh-list
65585495|NCT03794219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65585496|NCT03794219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65585497|NCT03794219|Analgesics|analgesics|mesh-ancestor
65585498|NCT03794219|Sensory System Agents|sensory system agents|mesh-ancestor
65585499|NCT03794219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65585500|NCT03794219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585501|NCT03794219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65585502|NCT03794219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65585503|NCT03794219|Gout Suppressants|gout suppressants|mesh-ancestor
65585504|NCT03794219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65585505|NCT03794219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65585506|NCT03794219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585507|NCT01297764|Dexamethasone|dexamethasone|mesh-list
65585508|NCT01297764|Dexamethasone acetate|dexamethasone acetate|mesh-list
65585509|NCT01297764|Lenalidomide|lenalidomide|mesh-list
65585510|NCT01297764|Vorinostat|vorinostat|mesh-list
65585511|NCT01297764|BB 1101|bb 1101|mesh-list
65585512|NCT01297764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65585513|NCT01297764|Antiemetics|antiemetics|mesh-ancestor
65585514|NCT01297764|Autonomic Agents|autonomic agents|mesh-ancestor
65585515|NCT01297764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65585516|NCT01297764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585517|NCT01297764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65585518|NCT01297764|Glucocorticoids|glucocorticoids|mesh-ancestor
65585519|NCT01297764|Hormones|hormones|mesh-ancestor
65585520|NCT01297764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65585521|NCT01297764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65585522|NCT01297764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585523|NCT01297764|Protease Inhibitors|protease inhibitors|mesh-ancestor
65585524|NCT01297764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65585525|NCT01297764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585526|NCT01297764|Immunologic Factors|immunologic factors|mesh-ancestor
65585527|NCT01297764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65585528|NCT01297764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65585529|NCT01297764|Growth Substances|growth substances|mesh-ancestor
65585530|NCT01297764|Growth Inhibitors|growth inhibitors|mesh-ancestor
65585531|NCT01297764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65585532|NCT01334034|Insulin Glargine|insulin glargine|mesh-list
65585533|NCT01334034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65585534|NCT01334034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585535|NCT03050060|Nelfinavir|nelfinavir|mesh-list
65585536|NCT03050060|Pembrolizumab|pembrolizumab|mesh-list
65383033|NCT00573794|Adalimumab|adalimumab|mesh-list
65585537|NCT03050060|Nivolumab|nivolumab|mesh-list
65585538|NCT03050060|Atezolizumab|atezolizumab|mesh-list
65585539|NCT03050060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65585540|NCT03050060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65585541|NCT03050060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585542|NCT03050060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65585543|NCT03050060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585544|NCT03050060|Immunologic Factors|immunologic factors|mesh-ancestor
65585545|NCT03050060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585546|NCT03050060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65585547|NCT03050060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65585548|NCT03050060|Protease Inhibitors|protease inhibitors|mesh-ancestor
65585549|NCT03050060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65585550|NCT03050060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65585551|NCT03050060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65585552|NCT03050060|Antiviral Agents|antiviral agents|mesh-ancestor
65585553|NCT03050060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65585554|NCT01334112|Axitinib|axitinib|mesh-list
65585555|NCT01334112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585556|NCT01334112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65585557|NCT01334112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65585558|NCT01334112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585559|NCT03791957|Chrysarobin|chrysarobin|mesh-list
65585560|NCT03791957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65585561|NCT03791957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65585562|NCT03791957|Analgesics|analgesics|mesh-ancestor
65585563|NCT03791957|Sensory System Agents|sensory system agents|mesh-ancestor
65585564|NCT03791957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65585565|NCT03791957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585566|NCT03791957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65585567|NCT03791957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65585568|NCT02491450|Sofosbuvir|sofosbuvir|mesh-list
65585569|NCT02491450|Antiviral Agents|antiviral agents|mesh-ancestor
65585570|NCT02491450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65585571|NCT03792113|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65585572|NCT03792113|Hemostatics|hemostatics|mesh-ancestor
65585573|NCT03792113|Coagulants|coagulants|mesh-ancestor
65585574|NCT02491528|Insulin|insulin|mesh-list
65585575|NCT02491528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65585576|NCT02491528|Insulin Aspart|insulin aspart|mesh-list
65585577|NCT02491528|Insulin, Long-Acting|insulin, long-acting|mesh-list
65585578|NCT02491528|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65585579|NCT02491528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65585580|NCT02491528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585581|NCT01304927|Vitamin D|vitamin d|mesh-list
65585582|NCT01304927|Cholecalciferol|cholecalciferol|mesh-list
65585583|NCT01304927|Calcium|calcium|mesh-list
65585584|NCT01304927|Vitamins|vitamins|mesh-ancestor
65585585|NCT01304927|Micronutrients|micronutrients|mesh-ancestor
65585586|NCT01304927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585587|NCT01304927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65585588|NCT01304927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65585589|NCT05464940|Caffeine|caffeine|mesh-list
65585590|NCT05464940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65585591|NCT05464940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585592|NCT05464940|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65585593|NCT05464940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65585594|NCT05464940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585595|NCT05464940|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65585596|NCT05464940|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65585597|NCT05464940|Purinergic Agents|purinergic agents|mesh-ancestor
65585598|NCT05464940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65585599|NCT01305551|Metformin|metformin|mesh-list
65585600|NCT01305551|Saxagliptin|saxagliptin|mesh-list
65585601|NCT01305551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65585602|NCT01305551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585603|NCT01305551|Incretins|incretins|mesh-ancestor
65585604|NCT01305551|Hormones|hormones|mesh-ancestor
65585605|NCT01305551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65585606|NCT01305551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65585607|NCT01305551|Protease Inhibitors|protease inhibitors|mesh-ancestor
65585608|NCT01305551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65585609|NCT01305551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585610|NCT03799757|Bupivacaine|bupivacaine|mesh-list
65585611|NCT03799757|Anesthetics, Local|anesthetics, local|mesh-ancestor
65585612|NCT03799757|Anesthetics|anesthetics|mesh-ancestor
65585613|NCT03799757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65585614|NCT03799757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585615|NCT03799757|Sensory System Agents|sensory system agents|mesh-ancestor
65585616|NCT03799757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65585617|NCT03611738|Docetaxel|docetaxel|mesh-list
65585618|NCT03611738|Ceritinib|ceritinib|mesh-list
65585619|NCT03611738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585620|NCT03611738|Tubulin Modulators|tubulin modulators|mesh-ancestor
65585621|NCT03611738|Antimitotic Agents|antimitotic agents|mesh-ancestor
65585622|NCT03611738|Mitosis Modulators|mitosis modulators|mesh-ancestor
65585623|NCT03611738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585624|NCT03611738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65585625|NCT03611738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65585626|NCT03327454|Etanercept|etanercept|mesh-list
65585627|NCT03327454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65585628|NCT03327454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65585629|NCT03327454|Analgesics|analgesics|mesh-ancestor
65585630|NCT03327454|Sensory System Agents|sensory system agents|mesh-ancestor
65585631|NCT03327454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65585632|NCT03327454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585633|NCT03327454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65585634|NCT03327454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65585635|NCT03327454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65585636|NCT03327454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65585637|NCT03327454|Immunologic Factors|immunologic factors|mesh-ancestor
65585638|NCT03799913|Cyclophosphamide|cyclophosphamide|mesh-list
65585639|NCT03799913|Fludarabine|fludarabine|mesh-list
65585640|NCT03799913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65585641|NCT03799913|Immunologic Factors|immunologic factors|mesh-ancestor
65585642|NCT03799913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585643|NCT03799913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65585644|NCT03799913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65585645|NCT03799913|Alkylating Agents|alkylating agents|mesh-ancestor
65585646|NCT03799913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585647|NCT03799913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585648|NCT03799913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65585649|NCT01304069|Etoricoxib|etoricoxib|mesh-list
65585650|NCT01304069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65585651|NCT01304069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65585652|NCT01304069|Analgesics|analgesics|mesh-ancestor
65585653|NCT01304069|Sensory System Agents|sensory system agents|mesh-ancestor
65585654|NCT01304069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65585655|NCT01304069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585656|NCT01304069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65585657|NCT01304069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65585658|NCT01304069|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65585659|NCT01304069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65585660|NCT01304069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65585661|NCT01304069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585662|NCT05459402|Methadone|methadone|mesh-list
65585663|NCT05459402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65585664|NCT05459402|Narcotics|narcotics|mesh-ancestor
65585665|NCT05459402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65248394|NCT02841488|Anesthetics, General|anesthetics, general|mesh-ancestor
65585666|NCT05459402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585667|NCT05459402|Analgesics|analgesics|mesh-ancestor
65585668|NCT05459402|Sensory System Agents|sensory system agents|mesh-ancestor
65585669|NCT05459402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65585670|NCT05459402|Antitussive Agents|antitussive agents|mesh-ancestor
65585671|NCT05459402|Respiratory System Agents|respiratory system agents|mesh-ancestor
65585672|NCT03799601|Carboplatin|carboplatin|mesh-list
65585673|NCT03799601|Docetaxel|docetaxel|mesh-list
65585674|NCT03799601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585675|NCT03799601|Tubulin Modulators|tubulin modulators|mesh-ancestor
65585676|NCT03799601|Antimitotic Agents|antimitotic agents|mesh-ancestor
65585677|NCT03799601|Mitosis Modulators|mitosis modulators|mesh-ancestor
65585678|NCT03799601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585679|NCT03535688|Cycloserine|cycloserine|mesh-list
65585680|NCT03535688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65585681|NCT03535688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65585682|NCT03535688|Renal Agents|renal agents|mesh-ancestor
65585683|NCT03535688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65585684|NCT03535688|Antitubercular Agents|antitubercular agents|mesh-ancestor
65585685|NCT03535688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65585686|NCT03535688|Antimetabolites|antimetabolites|mesh-ancestor
65585687|NCT03535688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585688|NCT03791801|Glycopyrrolate|glycopyrrolate|mesh-list
65585689|NCT03791801|Rocuronium|rocuronium|mesh-list
65585690|NCT03791801|Neostigmine|neostigmine|mesh-list
65585691|NCT03791801|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65585692|NCT03791801|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65585693|NCT03791801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65585694|NCT03791801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65585695|NCT03791801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585696|NCT03791801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65585697|NCT03791801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65585698|NCT03791801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585699|NCT03791801|Cholinergic Agents|cholinergic agents|mesh-ancestor
65585700|NCT03791801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65585701|NCT03791801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65585702|NCT03791801|Autonomic Agents|autonomic agents|mesh-ancestor
65585703|NCT03791801|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65585704|NCT03791801|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65585705|NCT03791801|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65585706|NCT01305083|Udenafil|udenafil|mesh-list
65585707|NCT01305083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65585708|NCT01305083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65585709|NCT01305083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65585710|NCT01305083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585711|NCT03791723|Valsartan|valsartan|mesh-list
65585712|NCT03791723|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65585713|NCT03791723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65585714|NCT03791723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65585715|NCT03791723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65585716|NCT03791723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585717|NCT05452070|Lidocaine|lidocaine|mesh-list
65585718|NCT05452070|Anesthetics, Local|anesthetics, local|mesh-ancestor
65585719|NCT05452070|Anesthetics|anesthetics|mesh-ancestor
65585720|NCT05452070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65585721|NCT05452070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585722|NCT05452070|Sensory System Agents|sensory system agents|mesh-ancestor
65585723|NCT05452070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65585724|NCT05452070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65585725|NCT05452070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65585726|NCT05452070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65585727|NCT05452070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65585728|NCT05452070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585729|NCT03920657|Deferasirox|deferasirox|mesh-list
65585730|NCT03920657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65585731|NCT03920657|Chelating Agents|chelating agents|mesh-ancestor
65585732|NCT03920657|Sequestering Agents|sequestering agents|mesh-ancestor
65585733|NCT03920657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585734|NCT03420950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65585735|NCT03420950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65585736|NCT03420950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585737|NCT03501277|Pioglitazone|pioglitazone|mesh-list
65585738|NCT03501277|Alogliptin|alogliptin|mesh-list
65585739|NCT03501277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65585740|NCT03501277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585741|NCT03501277|Incretins|incretins|mesh-ancestor
65585742|NCT03501277|Hormones|hormones|mesh-ancestor
65585743|NCT03501277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65585744|NCT03501277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65585745|NCT03501277|Protease Inhibitors|protease inhibitors|mesh-ancestor
65585746|NCT03501277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65585747|NCT03501277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585748|NCT03797729|Tirofiban|tirofiban|mesh-list
65585749|NCT03797729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65585750|NCT03797729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65585751|NCT03797729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585752|NCT03797729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65585753|NCT02487940|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65585754|NCT02487940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65585755|NCT02487940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65585756|NCT02487940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65585757|NCT02487706|Dolutegravir|dolutegravir|mesh-list
65585758|NCT02487706|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65585759|NCT02487706|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65585760|NCT02487706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383250|NCT02544854|Propofol|propofol|mesh-list
65585761|NCT02487706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585762|NCT02487706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65585763|NCT02487706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65585764|NCT02487706|Antiviral Agents|antiviral agents|mesh-ancestor
65585765|NCT02487706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65585767|NCT04551950|Bevacizumab|bevacizumab|mesh-list
65585768|NCT04551950|Carboplatin|carboplatin|mesh-list
65585769|NCT04551950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65585770|NCT04551950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585771|NCT04551950|Tubulin Modulators|tubulin modulators|mesh-ancestor
65585772|NCT04551950|Antimitotic Agents|antimitotic agents|mesh-ancestor
65585773|NCT04551950|Mitosis Modulators|mitosis modulators|mesh-ancestor
65585774|NCT04551950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585775|NCT04551950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65585776|NCT04551950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65585777|NCT04551950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65585778|NCT04551950|Growth Substances|growth substances|mesh-ancestor
65585779|NCT04551950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585780|NCT04551950|Growth Inhibitors|growth inhibitors|mesh-ancestor
65585781|NCT03772925|Belinostat|belinostat|mesh-list
65585782|NCT03772925|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65585783|NCT03772925|Pevonedistat|pevonedistat|mesh-list
65585784|NCT03772925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585785|NCT03772925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585786|NCT03772925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65585787|NCT03326752|Nivolumab|nivolumab|mesh-list
65585788|NCT03326752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65585789|NCT03326752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65585790|NCT03326752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585791|NCT03326752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585792|NCT03326674|Capecitabine|capecitabine|mesh-list
65585793|NCT03326674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65585794|NCT03326674|Antimetabolites|antimetabolites|mesh-ancestor
65585795|NCT03326674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585796|NCT03326674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585797|NCT01316900|Bromides|bromides|mesh-list
65585798|NCT01316900|Tiotropium Bromide|tiotropium bromide|mesh-list
65585799|NCT01316900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65585800|NCT01316900|Autonomic Agents|autonomic agents|mesh-ancestor
65585801|NCT01316900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65585802|NCT01316900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585803|NCT01316900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65585804|NCT01316900|Respiratory System Agents|respiratory system agents|mesh-ancestor
65585805|NCT01316900|Parasympatholytics|parasympatholytics|mesh-ancestor
65585806|NCT01316900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65585807|NCT01316900|Cholinergic Agents|cholinergic agents|mesh-ancestor
65585808|NCT01316900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65585809|NCT01316900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585810|NCT01316900|Anticonvulsants|anticonvulsants|mesh-ancestor
65585811|NCT03714815|Macitentan|macitentan|mesh-list
65585812|NCT03714815|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65585813|NCT03714815|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65585814|NCT03714815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585815|NCT03714815|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65585816|NCT02490982|Teriflunomide|teriflunomide|mesh-list
65585817|NCT02490982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65585818|NCT02490982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65585819|NCT02490982|Analgesics|analgesics|mesh-ancestor
65585820|NCT02490982|Sensory System Agents|sensory system agents|mesh-ancestor
65585821|NCT02490982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65585822|NCT02490982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585823|NCT02490982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65585824|NCT02490982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65585825|NCT02490982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65585826|NCT02490982|Immunologic Factors|immunologic factors|mesh-ancestor
65585827|NCT03322150|Atropine|atropine|mesh-list
65585828|NCT03322150|Glycopyrrolate|glycopyrrolate|mesh-list
65585829|NCT03322150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65585830|NCT03322150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65585831|NCT03322150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65585832|NCT03322150|Autonomic Agents|autonomic agents|mesh-ancestor
65585833|NCT03322150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65383333|NCT00861926|Tocolytic Agents|tocolytic agents|mesh-ancestor
65585834|NCT03322150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585835|NCT03322150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65585836|NCT03322150|Respiratory System Agents|respiratory system agents|mesh-ancestor
65585838|NCT03322150|Parasympatholytics|parasympatholytics|mesh-ancestor
65585839|NCT03322150|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65585840|NCT03322150|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65585841|NCT03322150|Cholinergic Agents|cholinergic agents|mesh-ancestor
65585842|NCT03322150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65585843|NCT03322150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585844|NCT00936390|Leuprolide|leuprolide|mesh-list
65585845|NCT00936390|Goserelin|goserelin|mesh-list
65585846|NCT00936390|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65585847|NCT00936390|Flutamide|flutamide|mesh-list
65585848|NCT00936390|Bicalutamide|bicalutamide|mesh-list
65585849|NCT00936390|Buserelin|buserelin|mesh-list
65585850|NCT00936390|Androgens|androgens|mesh-list
65585851|NCT00936390|Androgen Antagonists|androgen antagonists|mesh-list
65585852|NCT00936390|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65585853|NCT00936390|Fertility Agents|fertility agents|mesh-ancestor
65585854|NCT00936390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65585855|NCT00936390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585856|NCT00936390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65585857|NCT00936390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585858|NCT00936390|Hormones|hormones|mesh-ancestor
65585859|NCT00936390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65585860|NCT00936390|Hormone Antagonists|hormone antagonists|mesh-ancestor
65585861|NCT00936390|Luteolytic Agents|luteolytic agents|mesh-ancestor
65585862|NCT00936390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65585863|NCT00936390|Contraceptive Agents|contraceptive agents|mesh-ancestor
65585864|NCT00936390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65585865|NCT03326596|Tranexamic Acid|tranexamic acid|mesh-list
65585866|NCT03326596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65585867|NCT03326596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65585868|NCT03326596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585869|NCT03326596|Hemostatics|hemostatics|mesh-ancestor
65585870|NCT03326596|Coagulants|coagulants|mesh-ancestor
65585871|NCT03499873|Nepafenac|nepafenac|mesh-list
65585872|NCT03499873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65585873|NCT03499873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65585874|NCT03499873|Analgesics|analgesics|mesh-ancestor
65585875|NCT03499873|Sensory System Agents|sensory system agents|mesh-ancestor
65585876|NCT03499873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65585877|NCT03499873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585878|NCT03499873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65585879|NCT03499873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65585880|NCT01305707|Diazepam|diazepam|mesh-list
65585881|NCT01305707|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65585882|NCT01305707|Lorazepam|lorazepam|mesh-list
65585883|NCT01305707|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
65585884|NCT01305707|Dexetimide|dexetimide|mesh-list
65585885|NCT01305707|Olanzapine|olanzapine|mesh-list
65585886|NCT01305707|Risperidone|risperidone|mesh-list
65585887|NCT01305707|Aripiprazole|aripiprazole|mesh-list
65585888|NCT01305707|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65585889|NCT01305707|Antipsychotic Agents|antipsychotic agents|mesh-list
65585890|NCT01305707|Lithium Carbonate|lithium carbonate|mesh-list
65585891|NCT01305707|Mirtazapine|mirtazapine|mesh-list
65585892|NCT01305707|Citalopram|citalopram|mesh-list
65585893|NCT01305707|Sertraline|sertraline|mesh-list
65585894|NCT01305707|Fluoxetine|fluoxetine|mesh-list
65585895|NCT01305707|Paroxetine|paroxetine|mesh-list
65585896|NCT01305707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65585897|NCT01305707|Nortriptyline|nortriptyline|mesh-list
65585898|NCT01305707|Imipramine|imipramine|mesh-list
65585899|NCT01305707|Clomipramine|clomipramine|mesh-list
65585900|NCT01305707|Mianserin|mianserin|mesh-list
65585901|NCT01305707|Antidepressive Agents|antidepressive agents|mesh-list
65585902|NCT01305707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65585903|NCT01305707|Serotonin Agents|serotonin agents|mesh-ancestor
65585904|NCT01305707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65585905|NCT01305707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585906|NCT01305707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585907|NCT01305707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65383397|NCT00850382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65585908|NCT01305707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65585909|NCT01305707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65585910|NCT01305707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65585911|NCT01305707|Dopamine Agents|dopamine agents|mesh-ancestor
65585912|NCT01305707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65585913|NCT01305707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65585914|NCT01305707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65585915|NCT01305707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65585916|NCT01305707|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65585917|NCT01305707|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65585918|NCT01305707|Parasympatholytics|parasympatholytics|mesh-ancestor
65585920|NCT01305707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65585921|NCT01305707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65585922|NCT01305707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65585923|NCT01305707|Cholinergic Agents|cholinergic agents|mesh-ancestor
65585924|NCT01305707|Antiemetics|antiemetics|mesh-ancestor
65585925|NCT01305707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65585926|NCT01305707|Dopamine Agonists|dopamine agonists|mesh-ancestor
65585927|NCT01305707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65585928|NCT01305707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65585929|NCT01305707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65585930|NCT01305707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65585931|NCT01305707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65585932|NCT01305707|Analgesics|analgesics|mesh-ancestor
65585933|NCT01305707|Sensory System Agents|sensory system agents|mesh-ancestor
65585934|NCT01305707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65585935|NCT01305707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65585936|NCT01305707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65585937|NCT01305707|Antimanic Agents|antimanic agents|mesh-ancestor
65585938|NCT01305707|Anticonvulsants|anticonvulsants|mesh-ancestor
65585939|NCT01305707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65585940|NCT01305707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65585941|NCT01305707|GABA Modulators|gaba modulators|mesh-ancestor
65585942|NCT01305707|GABA Agents|gaba agents|mesh-ancestor
65585943|NCT01305707|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65585944|NCT01305707|Histamine Antagonists|histamine antagonists|mesh-ancestor
65585945|NCT01305707|Histamine Agents|histamine agents|mesh-ancestor
65585946|NCT01305707|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65585947|NCT01305707|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65585948|NCT01305707|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65585949|NCT01305707|Adrenergic Agents|adrenergic agents|mesh-ancestor
65585950|NCT01305707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65585951|NCT01305707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65585952|NCT01305707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65585953|NCT01305707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65585954|NCT01305707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65585955|NCT01305707|Anesthetics, General|anesthetics, general|mesh-ancestor
65585956|NCT01305707|Anesthetics|anesthetics|mesh-ancestor
65585957|NCT01305707|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65585958|NCT01305707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65585959|NCT04051970|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65585960|NCT04051970|Antiviral Agents|antiviral agents|mesh-ancestor
65585961|NCT04051970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65585962|NCT03722329|Eculizumab|eculizumab|mesh-list
65585963|NCT03722329|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65585964|NCT03722329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65585965|NCT03722329|Immunologic Factors|immunologic factors|mesh-ancestor
65585966|NCT03722329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585967|NCT03467971|Metformin|metformin|mesh-list
65585968|NCT03467971|Gliclazide|gliclazide|mesh-list
65585969|NCT03467971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65585970|NCT03467971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585971|NCT03319498|Peppermint oil|peppermint oil|mesh-list
65585972|NCT03319498|Mineral Oil|mineral oil|mesh-list
65585973|NCT03319498|Antiemetics|antiemetics|mesh-ancestor
65585974|NCT03319498|Autonomic Agents|autonomic agents|mesh-ancestor
65585975|NCT03319498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65585976|NCT03319498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585977|NCT03319498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65585978|NCT03319498|Parasympatholytics|parasympatholytics|mesh-ancestor
65585979|NCT03319498|Emollients|emollients|mesh-ancestor
65585980|NCT03319498|Dermatologic Agents|dermatologic agents|mesh-ancestor
65585981|NCT03791099|Metronidazole|metronidazole|mesh-list
65585982|NCT03791099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65585983|NCT03791099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65585984|NCT03791099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65585985|NCT03791099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65585986|NCT03791255|Calcium, Dietary|calcium, dietary|mesh-list
65585987|NCT03791255|Calcium|calcium|mesh-list
65585988|NCT03791255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65585989|NCT03791255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65585990|NCT03791255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65585991|NCT03742349|Spartalizumab|spartalizumab|mesh-list
65585992|NCT03742349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65585993|NCT03742349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65585994|NCT03742349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65585995|NCT03326128|Bupropion|bupropion|mesh-list
65585996|NCT03326128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65585997|NCT03326128|Antidepressive Agents|antidepressive agents|mesh-ancestor
65585998|NCT03326128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65585999|NCT03326128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65586000|NCT03326128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65586001|NCT03326128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65586002|NCT03326128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586003|NCT03326128|Dopamine Agents|dopamine agents|mesh-ancestor
65586004|NCT03326128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65586005|NCT03326128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586006|NCT03326128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65586007|NCT03326128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65586008|NCT03326128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586009|NCT03319420|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65586010|NCT03319420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65586011|NCT03794297|Trametinib|trametinib|mesh-list
65586012|NCT03794297|Dabrafenib|dabrafenib|mesh-list
65586013|NCT03794297|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
65586014|NCT03794297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586015|NCT03794297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65586016|NCT03794297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586017|NCT03794297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586018|NCT03794297|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65586019|NCT03794297|Protective Agents|protective agents|mesh-ancestor
65586020|NCT03794297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586021|NCT03794297|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65586022|NCT03794297|Antioxidants|antioxidants|mesh-ancestor
65586023|NCT03048500|Metformin|metformin|mesh-list
65586024|NCT03048500|Nivolumab|nivolumab|mesh-list
65586025|NCT03048500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65586026|NCT03048500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586027|NCT03048500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65586028|NCT03048500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586029|NCT03048500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65586030|NCT03048500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586031|NCT03790787|Empagliflozin|empagliflozin|mesh-list
65586032|NCT03790787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65586033|NCT03790787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586034|NCT03790787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65586035|NCT03790787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586036|NCT01334268|Paclitaxel|paclitaxel|mesh-list
65586037|NCT01334268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65586038|NCT01334268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586039|NCT01334268|Tubulin Modulators|tubulin modulators|mesh-ancestor
65586040|NCT01334268|Antimitotic Agents|antimitotic agents|mesh-ancestor
65586041|NCT01334268|Mitosis Modulators|mitosis modulators|mesh-ancestor
65586042|NCT01334268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586043|NCT04493398|Erythritol|erythritol|mesh-list
65586044|NCT04493398|Vasodilator Agents|vasodilator agents|mesh-ancestor
65586045|NCT00908076|Lubiprostone|lubiprostone|mesh-list
65586046|NCT00908076|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65586047|NCT00908076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65586048|NCT00908076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586049|NCT01305317|Atorvastatin|atorvastatin|mesh-list
65586050|NCT01305317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65586051|NCT01305317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65586052|NCT01305317|Antimetabolites|antimetabolites|mesh-ancestor
65586053|NCT01305317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586054|NCT01305317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65586055|NCT01305317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65586056|NCT01305317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586057|NCT02613416|Denosumab|denosumab|mesh-list
65586058|NCT02613416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65586059|NCT02613416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586060|NCT03326050|Ciprofloxacin|ciprofloxacin|mesh-list
65586061|NCT03326050|Rifampin|rifampin|mesh-list
65586063|NCT03326050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65586064|NCT03326050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65586065|NCT03326050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65586066|NCT03326050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65586067|NCT03326050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586068|NCT03326050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586069|NCT03326050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586070|NCT03326050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65586071|NCT03326050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65586072|NCT03326050|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65586073|NCT03326050|Antitubercular Agents|antitubercular agents|mesh-ancestor
65586074|NCT03326050|Leprostatic Agents|leprostatic agents|mesh-ancestor
65586075|NCT03326050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65586076|NCT03326050|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65586077|NCT03326050|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65586078|NCT03326050|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65586079|NCT03326050|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65586080|NCT03326050|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65586081|NCT03326050|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65586082|NCT01334424|Propofol|propofol|mesh-list
65586083|NCT01334424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65586084|NCT01334424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65586085|NCT01334424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586086|NCT01334424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65586087|NCT01334424|Anesthetics, General|anesthetics, general|mesh-ancestor
65586088|NCT01334424|Anesthetics|anesthetics|mesh-ancestor
65586089|NCT05083637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65586090|NCT05664685|Bismuth|bismuth|mesh-list
65586091|NCT05664685|Antacids|antacids|mesh-ancestor
65586092|NCT05664685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586093|NCT05664685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65586094|NCT03793517|Decitabine|decitabine|mesh-list
65586095|NCT03793517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65586096|NCT03793517|Antimetabolites|antimetabolites|mesh-ancestor
65586097|NCT03793517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586098|NCT03793517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586099|NCT03793517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586100|NCT02886702|Nicotinic Acids|nicotinic acids|mesh-list
65586101|NCT02886702|Tazarotene|tazarotene|mesh-list
65586102|NCT02886702|Dermatologic Agents|dermatologic agents|mesh-ancestor
65586103|NCT02886702|Keratolytic Agents|keratolytic agents|mesh-ancestor
65586104|NCT02886702|Vitamin B Complex|vitamin b complex|mesh-ancestor
65586105|NCT02886702|Vitamins|vitamins|mesh-ancestor
65586106|NCT02886702|Micronutrients|micronutrients|mesh-ancestor
65586107|NCT02886702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586108|NCT03498313|Estradiol|estradiol|mesh-list
65586109|NCT03498313|Progesterone|progesterone|mesh-list
65586110|NCT03498313|Estrogens|estrogens|mesh-ancestor
65586111|NCT03498313|Hormones|hormones|mesh-ancestor
65586112|NCT03498313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65586113|NCT03498313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586114|NCT03498313|Progestins|progestins|mesh-ancestor
65586115|NCT03721081|Lidocaine|lidocaine|mesh-list
65586116|NCT03721081|Anesthetics, Local|anesthetics, local|mesh-ancestor
65586117|NCT03721081|Anesthetics|anesthetics|mesh-ancestor
65586118|NCT03721081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65586119|NCT03721081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586120|NCT03721081|Sensory System Agents|sensory system agents|mesh-ancestor
65586121|NCT03721081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586122|NCT03721081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65586123|NCT03721081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65586124|NCT03721081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65586125|NCT03721081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65586126|NCT03721081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586127|NCT04493554|Vasopressins|vasopressins|mesh-list
65586128|NCT04493554|Arginine Vasopressin|arginine vasopressin|mesh-list
65586129|NCT04493554|Hemostatics|hemostatics|mesh-ancestor
65586130|NCT04493554|Coagulants|coagulants|mesh-ancestor
65586131|NCT04493554|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65586132|NCT04493554|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65586133|NCT04493554|Natriuretic Agents|natriuretic agents|mesh-ancestor
65586134|NCT04493554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586135|NCT02601014|Nivolumab|nivolumab|mesh-list
65586136|NCT02601014|Ipilimumab|ipilimumab|mesh-list
65586137|NCT02601014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65586138|NCT02601014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586139|NCT02601014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65586140|NCT02601014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586142|NCT01307046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65586143|NCT01307046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65586144|NCT01307046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65586145|NCT01307046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65586146|NCT01307046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586147|NCT05419115|Furosemide|furosemide|mesh-list
65586148|NCT05419115|Diuretics|diuretics|mesh-ancestor
65586149|NCT05419115|Natriuretic Agents|natriuretic agents|mesh-ancestor
65586150|NCT05419115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586151|NCT05419115|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65586152|NCT05419115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65586153|NCT05419115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586154|NCT02490592|Fluorides|fluorides|mesh-list
65586155|NCT02490592|Cariostatic Agents|cariostatic agents|mesh-ancestor
65586156|NCT02490592|Protective Agents|protective agents|mesh-ancestor
65586157|NCT02490592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586158|NCT03075462|Apatinib|apatinib|mesh-list
65586159|NCT03075462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586160|NCT03075462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65586161|NCT03075462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586162|NCT03075462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586163|NCT01305395|Sirolimus|sirolimus|mesh-list
65586164|NCT01305395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65586165|NCT01305395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65586166|NCT01305395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65586167|NCT01305395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586168|NCT01305395|Antifungal Agents|antifungal agents|mesh-ancestor
65586169|NCT01305395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65586170|NCT01305395|Immunologic Factors|immunologic factors|mesh-ancestor
65586171|NCT01305395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586172|NCT02886624|Grazoprevir|grazoprevir|mesh-list
65586173|NCT02886624|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65586174|NCT02886624|Antiviral Agents|antiviral agents|mesh-ancestor
65586175|NCT02886624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65586176|NCT02516696|Clarithromycin|clarithromycin|mesh-list
65586177|NCT02516696|Dexamethasone|dexamethasone|mesh-list
65586178|NCT02516696|Lenalidomide|lenalidomide|mesh-list
65586179|NCT02516696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65586180|NCT02516696|Antiemetics|antiemetics|mesh-ancestor
65586181|NCT02516696|Autonomic Agents|autonomic agents|mesh-ancestor
65586182|NCT02516696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586183|NCT02516696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586184|NCT02516696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65586185|NCT02516696|Glucocorticoids|glucocorticoids|mesh-ancestor
65586186|NCT02516696|Hormones|hormones|mesh-ancestor
65586187|NCT02516696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65586188|NCT02516696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65586189|NCT02516696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586190|NCT02516696|Immunologic Factors|immunologic factors|mesh-ancestor
65586191|NCT02516696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65586192|NCT02516696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65586193|NCT02516696|Growth Substances|growth substances|mesh-ancestor
65586194|NCT02516696|Growth Inhibitors|growth inhibitors|mesh-ancestor
65586195|NCT02516696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65586196|NCT02516696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65586197|NCT02516696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65586198|NCT02516696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586199|NCT02516696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586200|NCT02516696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65586201|NCT02516696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65586202|NCT02487316|Crizotinib|crizotinib|mesh-list
65586203|NCT02487316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586204|NCT02487316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65586205|NCT02487316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586206|NCT02487316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586207|NCT02490436|Cetuximab|cetuximab|mesh-list
65586208|NCT02490436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65383701|NCT00506662|Insulin Detemir|insulin detemir|mesh-list
65586209|NCT02490436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586210|NCT03318718|Rocuronium|rocuronium|mesh-list
65586211|NCT03318718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586212|NCT03318718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65586213|NCT03318718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65586214|NCT03318718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65586215|NCT03318718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586216|NCT03325348|Labetalol|labetalol|mesh-list
65586217|NCT03325348|Nifedipine|nifedipine|mesh-list
65586218|NCT03325348|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65586219|NCT03325348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65586220|NCT03325348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586221|NCT03325348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65586222|NCT03325348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586223|NCT03325348|Vasodilator Agents|vasodilator agents|mesh-ancestor
65586224|NCT03325348|Tocolytic Agents|tocolytic agents|mesh-ancestor
65586225|NCT03325348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65586226|NCT03325348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65586227|NCT03325348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65586228|NCT03325348|Adrenergic Agents|adrenergic agents|mesh-ancestor
65586229|NCT03325348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65586230|NCT03325348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65586231|NCT03325348|Sympathomimetics|sympathomimetics|mesh-ancestor
65586232|NCT03325348|Autonomic Agents|autonomic agents|mesh-ancestor
65586233|NCT03325348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586234|NCT03325348|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65586235|NCT03325348|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65586236|NCT03790163|Levobupivacaine|levobupivacaine|mesh-list
65586237|NCT03790163|Anesthetics, Local|anesthetics, local|mesh-ancestor
65586238|NCT03790163|Anesthetics|anesthetics|mesh-ancestor
65586239|NCT03790163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65586240|NCT03790163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586241|NCT03790163|Sensory System Agents|sensory system agents|mesh-ancestor
65586242|NCT03790163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586243|NCT03325270|Ferrous fumarate|ferrous fumarate|mesh-list
65586244|NCT03325270|Trace Elements|trace elements|mesh-ancestor
65586245|NCT03325270|Micronutrients|micronutrients|mesh-ancestor
65586246|NCT03325270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586247|NCT02963766|Dulaglutide|dulaglutide|mesh-list
65586248|NCT02963766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65586249|NCT02963766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586250|NCT01334502|Prednisone|prednisone|mesh-list
65586251|NCT01334502|Cyclophosphamide|cyclophosphamide|mesh-list
65586252|NCT01334502|Rituximab|rituximab|mesh-list
65586253|NCT01334502|Doxorubicin|doxorubicin|mesh-list
65586254|NCT01334502|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65586255|NCT01334502|Vincristine|vincristine|mesh-list
65586256|NCT01334502|Everolimus|everolimus|mesh-list
65586257|NCT01334502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65586258|NCT01334502|Immunologic Factors|immunologic factors|mesh-ancestor
65586259|NCT01334502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586260|NCT01334502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65586261|NCT01334502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65586262|NCT01334502|Alkylating Agents|alkylating agents|mesh-ancestor
65586263|NCT01334502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586264|NCT01334502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586265|NCT01334502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65586266|NCT01334502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65586267|NCT01334502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65586268|NCT01334502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65586269|NCT01334502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65586270|NCT01334502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586271|NCT01334502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65586272|NCT01334502|Glucocorticoids|glucocorticoids|mesh-ancestor
65586273|NCT01334502|Hormones|hormones|mesh-ancestor
65586274|NCT01334502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65586275|NCT01334502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65586276|NCT01334502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65586277|NCT01334502|Tubulin Modulators|tubulin modulators|mesh-ancestor
65586278|NCT01334502|Antimitotic Agents|antimitotic agents|mesh-ancestor
65586279|NCT01334502|Mitosis Modulators|mitosis modulators|mesh-ancestor
65586280|NCT02487082|Melatonin|melatonin|mesh-list
65586281|NCT02487082|Donepezil|donepezil|mesh-list
65586282|NCT02487082|Antioxidants|antioxidants|mesh-ancestor
65586283|NCT02487082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586284|NCT02487082|Protective Agents|protective agents|mesh-ancestor
65586285|NCT02487082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586286|NCT02487082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65586287|NCT02487082|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65586288|NCT02487082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586289|NCT02487082|Cholinergic Agents|cholinergic agents|mesh-ancestor
65586290|NCT02487082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65586291|NCT02487082|Nootropic Agents|nootropic agents|mesh-ancestor
65586292|NCT03788681|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65586293|NCT03788681|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65586295|NCT03788681|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65586296|NCT03788681|Estrogens|estrogens|mesh-ancestor
65586297|NCT03788681|Hormones|hormones|mesh-ancestor
65586298|NCT03788681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65586299|NCT03788681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586300|NCT03788681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65586301|NCT03788681|Contraceptive Agents|contraceptive agents|mesh-ancestor
65586302|NCT03788681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65586303|NCT03788681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65586304|NCT01308203|Niacin|niacin|mesh-list
65586305|NCT01308203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65586306|NCT01308203|Antimetabolites|antimetabolites|mesh-ancestor
65586307|NCT01308203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586308|NCT01308203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65586309|NCT01308203|Vasodilator Agents|vasodilator agents|mesh-ancestor
65586310|NCT01308203|Vitamin B Complex|vitamin b complex|mesh-ancestor
65586311|NCT01308203|Vitamins|vitamins|mesh-ancestor
65586312|NCT01308203|Micronutrients|micronutrients|mesh-ancestor
65586313|NCT01308203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586314|NCT03790085|Olanzapine|olanzapine|mesh-list
65586315|NCT03790085|Risperidone|risperidone|mesh-list
65586316|NCT03790085|Aripiprazole|aripiprazole|mesh-list
65586317|NCT03790085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65586318|NCT03790085|Serotonin Agents|serotonin agents|mesh-ancestor
65586319|NCT03790085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65586320|NCT03790085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586321|NCT03790085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586322|NCT03790085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65586323|NCT03790085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65586324|NCT03790085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65586325|NCT03790085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65586326|NCT03790085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65586327|NCT03790085|Dopamine Agents|dopamine agents|mesh-ancestor
65586328|NCT03790085|Antiemetics|antiemetics|mesh-ancestor
65586329|NCT03790085|Autonomic Agents|autonomic agents|mesh-ancestor
65586330|NCT03790085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586331|NCT03790085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65586332|NCT03790085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65586333|NCT03790085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65586334|NCT03790085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65586335|NCT03790085|Antidepressive Agents|antidepressive agents|mesh-ancestor
65586336|NCT03790085|Dopamine Agonists|dopamine agonists|mesh-ancestor
65586337|NCT03790085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65586338|NCT03790085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65586339|NCT03790085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65586340|NCT03790085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65586341|NCT01306097|Zinc|zinc|mesh-list
65586342|NCT01306097|Zinc Sulfate|zinc sulfate|mesh-list
65586343|NCT01306097|Trace Elements|trace elements|mesh-ancestor
65586344|NCT01306097|Micronutrients|micronutrients|mesh-ancestor
65586345|NCT01306097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586346|NCT01306097|Astringents|astringents|mesh-ancestor
65586347|NCT01306097|Dermatologic Agents|dermatologic agents|mesh-ancestor
65586348|NCT03790007|Bupivacaine|bupivacaine|mesh-list
65586349|NCT03790007|Anesthetics, Local|anesthetics, local|mesh-ancestor
65586350|NCT03790007|Anesthetics|anesthetics|mesh-ancestor
65586351|NCT03790007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65586352|NCT03790007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586353|NCT03790007|Sensory System Agents|sensory system agents|mesh-ancestor
65586354|NCT03790007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586355|NCT03789695|Dabigatran|dabigatran|mesh-list
65586356|NCT03789695|Antithrombins|antithrombins|mesh-ancestor
65586357|NCT03789695|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65586358|NCT03789695|Protease Inhibitors|protease inhibitors|mesh-ancestor
65586359|NCT03789695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586360|NCT03789695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586361|NCT03789695|Anticoagulants|anticoagulants|mesh-ancestor
65586362|NCT03785873|Leucovorin|leucovorin|mesh-list
65586363|NCT03785873|Fluorouracil|fluorouracil|mesh-list
65586364|NCT03785873|Nivolumab|nivolumab|mesh-list
65586365|NCT03785873|Irinotecan|irinotecan|mesh-list
65586366|NCT03785873|Antimetabolites|antimetabolites|mesh-ancestor
65586367|NCT03785873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586368|NCT03785873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65586369|NCT03785873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586370|NCT03785873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65586371|NCT03785873|Immunologic Factors|immunologic factors|mesh-ancestor
65586372|NCT03785873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586373|NCT03785873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65586374|NCT03785873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65586375|NCT03785873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65586376|NCT03785873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65586377|NCT03785873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586378|NCT03785873|Antidotes|antidotes|mesh-ancestor
65586379|NCT03785873|Protective Agents|protective agents|mesh-ancestor
65586380|NCT03785873|Vitamin B Complex|vitamin b complex|mesh-ancestor
65586381|NCT03785873|Vitamins|vitamins|mesh-ancestor
65586382|NCT03785873|Micronutrients|micronutrients|mesh-ancestor
65586383|NCT00739674|Losartan|losartan|mesh-list
65586384|NCT00739674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65586385|NCT00739674|Calcium Channel Blockers|calcium channel blockers|mesh-list
65586386|NCT00739674|Calcium|calcium|mesh-list
65586387|NCT00739674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65586388|NCT00739674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586389|NCT00739674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65586390|NCT00739674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65586391|NCT00739674|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65586392|NCT00739674|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65586393|NCT00739674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586394|NCT00739674|Diuretics|diuretics|mesh-ancestor
65586395|NCT00739674|Natriuretic Agents|natriuretic agents|mesh-ancestor
65586396|NCT00739674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65586397|NCT00739674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65586398|NCT01306409|Darbepoetin alfa|darbepoetin alfa|mesh-list
65586399|NCT01306409|Hematinics|hematinics|mesh-ancestor
65586400|NCT05060315|Treprostinil|treprostinil|mesh-list
65586401|NCT05060315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65586402|NCT01331928|Docetaxel|docetaxel|mesh-list
65586403|NCT01331928|Capecitabine|capecitabine|mesh-list
65586404|NCT01331928|Oxaliplatin|oxaliplatin|mesh-list
65586405|NCT01331928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586406|NCT01331928|Tubulin Modulators|tubulin modulators|mesh-ancestor
65586407|NCT01331928|Antimitotic Agents|antimitotic agents|mesh-ancestor
65586408|NCT01331928|Mitosis Modulators|mitosis modulators|mesh-ancestor
65586409|NCT01331928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586410|NCT01331928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65586411|NCT01331928|Antimetabolites|antimetabolites|mesh-ancestor
65586412|NCT01334580|Methadone|methadone|mesh-list
65586413|NCT01334580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65586414|NCT01334580|Narcotics|narcotics|mesh-ancestor
65586415|NCT01334580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65586416|NCT01334580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586417|NCT01334580|Analgesics|analgesics|mesh-ancestor
65586418|NCT01334580|Sensory System Agents|sensory system agents|mesh-ancestor
65586419|NCT01334580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586420|NCT01334580|Antitussive Agents|antitussive agents|mesh-ancestor
65586421|NCT01334580|Respiratory System Agents|respiratory system agents|mesh-ancestor
65586422|NCT02694588|Infliximab|infliximab|mesh-list
65586423|NCT02694588|Vedolizumab|vedolizumab|mesh-list
65586424|NCT02694588|Dermatologic Agents|dermatologic agents|mesh-ancestor
65586425|NCT02694588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65586426|NCT02694588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65586427|NCT03789539|Vaccines|vaccines|mesh-list
65586428|NCT03789539|Immunologic Factors|immunologic factors|mesh-ancestor
65586429|NCT03789539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586430|NCT00400218|Losartan|losartan|mesh-list
65586431|NCT00400218|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65586432|NCT00400218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65586433|NCT00400218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65586434|NCT00400218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65586435|NCT00400218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65586436|NCT00400218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586437|NCT00400218|Diuretics|diuretics|mesh-ancestor
65586438|NCT00400218|Natriuretic Agents|natriuretic agents|mesh-ancestor
65586439|NCT00400218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586440|NCT00400218|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65586441|NCT00400218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65586443|NCT02486848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65586444|NCT02486848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65586445|NCT02486848|Vasodilator Agents|vasodilator agents|mesh-ancestor
65586446|NCT01306565|Atorvastatin|atorvastatin|mesh-list
65586447|NCT01306565|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65586448|NCT01306565|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65586449|NCT01306565|Antimetabolites|antimetabolites|mesh-ancestor
65586450|NCT01306565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586451|NCT01306565|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65586452|NCT01306565|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65586453|NCT01306565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586454|NCT03716791|Dimethyl sulfone|dimethyl sulfone|mesh-list
65586455|NCT03716791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65586456|NCT03786029|Acetaminophen|acetaminophen|mesh-list
65586457|NCT03786029|Ibuprofen|ibuprofen|mesh-list
65586458|NCT03786029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65586459|NCT03786029|Analgesics|analgesics|mesh-ancestor
65586460|NCT03786029|Sensory System Agents|sensory system agents|mesh-ancestor
65586461|NCT03786029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586462|NCT03786029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586463|NCT03786029|Antipyretics|antipyretics|mesh-ancestor
65586464|NCT03786029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65586465|NCT03786029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65586466|NCT03786029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65586467|NCT03786029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65586468|NCT03786029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586469|NCT03786029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586470|NCT01334892|Cyclosporine|cyclosporine|mesh-list
65586471|NCT01334892|Cyclosporins|cyclosporins|mesh-list
65586472|NCT01334892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586473|NCT01334892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586474|NCT01334892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65586475|NCT01334892|Immunologic Factors|immunologic factors|mesh-ancestor
65586476|NCT01334892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586477|NCT01334892|Antifungal Agents|antifungal agents|mesh-ancestor
65586478|NCT01334892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65586479|NCT01334892|Dermatologic Agents|dermatologic agents|mesh-ancestor
65586480|NCT01334892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65586481|NCT01334892|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65586482|NCT04730219|Paclitaxel|paclitaxel|mesh-list
65586483|NCT04730219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65586484|NCT04730219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586485|NCT04730219|Tubulin Modulators|tubulin modulators|mesh-ancestor
65586486|NCT04730219|Antimitotic Agents|antimitotic agents|mesh-ancestor
65586487|NCT04730219|Mitosis Modulators|mitosis modulators|mesh-ancestor
65586488|NCT04730219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586489|NCT04492774|Dexamethasone|dexamethasone|mesh-list
65586490|NCT04492774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65586491|NCT04492774|Antiemetics|antiemetics|mesh-ancestor
65586492|NCT04492774|Autonomic Agents|autonomic agents|mesh-ancestor
65586493|NCT04492774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586494|NCT04492774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586495|NCT04492774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65586496|NCT04492774|Glucocorticoids|glucocorticoids|mesh-ancestor
65586497|NCT04492774|Hormones|hormones|mesh-ancestor
65586498|NCT04492774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65586499|NCT04492774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65586500|NCT04492774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586501|NCT03321292|Aspirin|aspirin|mesh-list
65586502|NCT03321292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65586503|NCT03321292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65586504|NCT03321292|Analgesics|analgesics|mesh-ancestor
65586505|NCT03321292|Sensory System Agents|sensory system agents|mesh-ancestor
65586506|NCT03321292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586507|NCT03321292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586508|NCT03321292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65586509|NCT03321292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65586510|NCT03321292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65586511|NCT03321292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65586512|NCT03321292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586513|NCT03321292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65586514|NCT03321292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65586515|NCT03321292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586516|NCT03321292|Antipyretics|antipyretics|mesh-ancestor
65586517|NCT01306721|Fexofenadine|fexofenadine|mesh-list
65586518|NCT01306721|Pseudoephedrine|pseudoephedrine|mesh-list
65586519|NCT01306721|Ephedrine|ephedrine|mesh-list
65586520|NCT01306721|Terfenadine|terfenadine|mesh-list
65586521|NCT01306721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65586522|NCT01306721|Autonomic Agents|autonomic agents|mesh-ancestor
65586523|NCT01306721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586524|NCT01306721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586525|NCT01306721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65586526|NCT01306721|Respiratory System Agents|respiratory system agents|mesh-ancestor
65586527|NCT01306721|Nasal Decongestants|nasal decongestants|mesh-ancestor
65586528|NCT01306721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65586529|NCT01306721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65586530|NCT01306721|Sympathomimetics|sympathomimetics|mesh-ancestor
65586531|NCT01306721|Adrenergic Agents|adrenergic agents|mesh-ancestor
65586532|NCT01306721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65586533|NCT01306721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586534|NCT01306721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65586535|NCT01306721|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65586536|NCT01306721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65586537|NCT01306721|Histamine Antagonists|histamine antagonists|mesh-ancestor
65586538|NCT01306721|Histamine Agents|histamine agents|mesh-ancestor
65586539|NCT01337466|Fialuridine|fialuridine|mesh-list
65586540|NCT01337466|Antiviral Agents|antiviral agents|mesh-ancestor
65586541|NCT01337466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65586542|NCT01337466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65586543|NCT01337466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586544|NCT01337466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586545|NCT02486926|Remifentanil|remifentanil|mesh-list
65586546|NCT02486926|Alfentanil|alfentanil|mesh-list
65586547|NCT02486926|Thiopental|thiopental|mesh-list
65586548|NCT02486926|Sevoflurane|sevoflurane|mesh-list
65586549|NCT02486926|Rocuronium|rocuronium|mesh-list
65586550|NCT02486926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65586551|NCT02486926|Narcotics|narcotics|mesh-ancestor
65586552|NCT02486926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65586553|NCT02486926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586554|NCT02486926|Analgesics|analgesics|mesh-ancestor
65586555|NCT02486926|Sensory System Agents|sensory system agents|mesh-ancestor
65586556|NCT02486926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586557|NCT02486926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65586558|NCT02486926|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65586559|NCT02486926|Anesthetics, General|anesthetics, general|mesh-ancestor
65586560|NCT02486926|Anesthetics|anesthetics|mesh-ancestor
65586561|NCT02486926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65586562|NCT02486926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65586563|NCT02486926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65586564|NCT02486926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65586565|NCT02486926|Anticonvulsants|anticonvulsants|mesh-ancestor
65586566|NCT02486926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65586567|NCT02486926|GABA Modulators|gaba modulators|mesh-ancestor
65586568|NCT02486926|GABA Agents|gaba agents|mesh-ancestor
65586569|NCT02486926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65586570|NCT02486926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586571|NCT01335048|Clopidogrel|clopidogrel|mesh-list
65586572|NCT01335048|Atorvastatin|atorvastatin|mesh-list
65586573|NCT01335048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65586574|NCT01335048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65586575|NCT01335048|Antimetabolites|antimetabolites|mesh-ancestor
65586576|NCT01335048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586577|NCT01335048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65586578|NCT01335048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65586579|NCT01335048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586580|NCT01335048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65586581|NCT01335048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65586582|NCT01335048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65586583|NCT01335048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65586584|NCT01335048|Purinergic Agents|purinergic agents|mesh-ancestor
65586585|NCT01335048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65586586|NCT01335048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586587|NCT05693675|Methadone|methadone|mesh-list
65586588|NCT05693675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65586589|NCT05693675|Narcotics|narcotics|mesh-ancestor
65586590|NCT05693675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65586591|NCT05693675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586592|NCT05693675|Analgesics|analgesics|mesh-ancestor
65586593|NCT05693675|Sensory System Agents|sensory system agents|mesh-ancestor
65586594|NCT05693675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586595|NCT05693675|Antitussive Agents|antitussive agents|mesh-ancestor
65586596|NCT05693675|Respiratory System Agents|respiratory system agents|mesh-ancestor
65586597|NCT01335126|Lubricant Eye Drops|lubricant eye drops|mesh-list
65586598|NCT01335126|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65586599|NCT01335126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65586600|NCT01567475|Rituximab|rituximab|mesh-list
65586601|NCT01567475|Everolimus|everolimus|mesh-list
65586602|NCT01567475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65586603|NCT01567475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586604|NCT01567475|Immunologic Factors|immunologic factors|mesh-ancestor
65586605|NCT01567475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586606|NCT01567475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65586607|NCT01567475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65586608|NCT03435055|Nitrous Oxide|nitrous oxide|mesh-list
65586609|NCT03435055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65586610|NCT03435055|Anesthetics, General|anesthetics, general|mesh-ancestor
65586611|NCT03435055|Anesthetics|anesthetics|mesh-ancestor
65586612|NCT03435055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65586613|NCT03435055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586614|NCT03435055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65586615|NCT03435055|Analgesics|analgesics|mesh-ancestor
65586616|NCT03435055|Sensory System Agents|sensory system agents|mesh-ancestor
65586617|NCT03435055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586618|NCT05693246|Glycopyrrolate|glycopyrrolate|mesh-list
65586619|NCT05693246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65586620|NCT05693246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65586621|NCT05693246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65586622|NCT05693246|Cholinergic Agents|cholinergic agents|mesh-ancestor
65586623|NCT05693246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65586624|NCT05693246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586625|NCT05693246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586626|NCT03316066|Ropivacaine|ropivacaine|mesh-list
65586627|NCT03316066|Anesthetics, Local|anesthetics, local|mesh-ancestor
65586628|NCT03316066|Anesthetics|anesthetics|mesh-ancestor
65586629|NCT03316066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65586630|NCT03316066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586631|NCT03316066|Sensory System Agents|sensory system agents|mesh-ancestor
65586632|NCT03316066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586633|NCT01308437|Insulin|insulin|mesh-list
65586634|NCT01308437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65586635|NCT01308437|Isophane Insulin, Human|isophane insulin, human|mesh-list
65586636|NCT01308437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65586637|NCT01308437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586638|NCT03318016|Cyclophosphamide|cyclophosphamide|mesh-list
65586639|NCT03318016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65586640|NCT03318016|Immunologic Factors|immunologic factors|mesh-ancestor
65586641|NCT03318016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586642|NCT03318016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65586643|NCT03318016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65586644|NCT03318016|Alkylating Agents|alkylating agents|mesh-ancestor
65586645|NCT03318016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586646|NCT03318016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586647|NCT03318016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65586648|NCT03434977|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65586649|NCT03434977|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65586650|NCT03434977|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65586651|NCT03434977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586652|NCT01335360|Nevirapine|nevirapine|mesh-list
65586653|NCT01335360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65586654|NCT01335360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65586655|NCT01335360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586656|NCT01335360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586657|NCT01335360|Antiviral Agents|antiviral agents|mesh-ancestor
65586658|NCT01335360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65586659|NCT01335360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65586660|NCT01335360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65586661|NCT01335360|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65384156|NCT05213481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586662|NCT01335360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65586664|NCT02489266|Cyclophosphamide|cyclophosphamide|mesh-list
65586665|NCT02489266|Fludarabine|fludarabine|mesh-list
65586666|NCT02489266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65586667|NCT02489266|Immunologic Factors|immunologic factors|mesh-ancestor
65586668|NCT02489266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586669|NCT02489266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65586670|NCT02489266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65586671|NCT02489266|Alkylating Agents|alkylating agents|mesh-ancestor
65586672|NCT02489266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586673|NCT02489266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586674|NCT02489266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65586675|NCT02489266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65586676|NCT02489266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65586677|NCT02489266|Antiviral Agents|antiviral agents|mesh-ancestor
65586678|NCT02489266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65586679|NCT03434119|Insulin|insulin|mesh-list
65586680|NCT03434119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65586681|NCT03434119|Insulin Glargine|insulin glargine|mesh-list
65586682|NCT03434119|Lixisenatide|lixisenatide|mesh-list
65586683|NCT03434119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65586684|NCT03434119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586685|NCT02484352|Oxycodone|oxycodone|mesh-list
65586686|NCT02484352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65586687|NCT02484352|Narcotics|narcotics|mesh-ancestor
65586688|NCT02484352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65586689|NCT02484352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586690|NCT02484352|Analgesics|analgesics|mesh-ancestor
65586691|NCT02484352|Sensory System Agents|sensory system agents|mesh-ancestor
65586692|NCT02484352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586693|NCT01308671|Varenicline|varenicline|mesh-list
65586694|NCT01308671|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65586695|NCT01308671|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65586696|NCT01308671|Cholinergic Agents|cholinergic agents|mesh-ancestor
65586697|NCT01308671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65586698|NCT01308671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586699|NCT01308671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586700|NCT00378378|Mometasone Furoate|mometasone furoate|mesh-list
65586701|NCT00378378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65586702|NCT00378378|Dermatologic Agents|dermatologic agents|mesh-ancestor
65586703|NCT00378378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65586704|NCT03315676|Esomeprazole|esomeprazole|mesh-list
65586705|NCT03315676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65586706|NCT03315676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65586707|NCT03315676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65586708|NCT03315676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586709|NCT03315676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586710|NCT01307189|Tiotropium Bromide|tiotropium bromide|mesh-list
65586711|NCT01307189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65586712|NCT01307189|Autonomic Agents|autonomic agents|mesh-ancestor
65586713|NCT01307189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586714|NCT01307189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586715|NCT01307189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65586716|NCT01307189|Respiratory System Agents|respiratory system agents|mesh-ancestor
65586717|NCT01307189|Parasympatholytics|parasympatholytics|mesh-ancestor
65586718|NCT01307189|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65586719|NCT01307189|Cholinergic Agents|cholinergic agents|mesh-ancestor
65586720|NCT01307189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65586721|NCT01307189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586722|NCT02486458|Listerine|listerine|mesh-list
65586723|NCT02486458|Fluorides|fluorides|mesh-list
65586724|NCT02486458|Sodium Fluoride|sodium fluoride|mesh-list
65586725|NCT02486458|Fluorides, Topical|fluorides, topical|mesh-list
65586726|NCT02486458|Cariostatic Agents|cariostatic agents|mesh-ancestor
65586727|NCT02486458|Protective Agents|protective agents|mesh-ancestor
65586728|NCT02486458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586729|NCT02486458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65586730|NCT02486458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65586731|NCT01335516|Terlipressin|terlipressin|mesh-list
65586732|NCT01335516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65586733|NCT01335516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65586734|NCT05694923|Empagliflozin|empagliflozin|mesh-list
65586735|NCT05694923|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65586736|NCT05694923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586737|NCT05694923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65586738|NCT05694923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586739|NCT01332396|Lapatinib|lapatinib|mesh-list
65586740|NCT01332396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586741|NCT01332396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65586742|NCT01332396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586743|NCT01332396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586744|NCT03719053|Tenofovir|tenofovir|mesh-list
65586745|NCT03719053|Antiviral Agents|antiviral agents|mesh-ancestor
65586746|NCT03719053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65586747|NCT03719053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65586748|NCT03719053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65586749|NCT03719053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586750|NCT03719053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586751|NCT03719053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65586752|NCT03719053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65586753|NCT03526848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65586754|NCT03526848|Antibodies|antibodies|mesh-list
65586755|NCT03526848|Immunoglobulins|immunoglobulins|mesh-list
65586756|NCT03526848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65586757|NCT03526848|Immunologic Factors|immunologic factors|mesh-ancestor
65586758|NCT03526848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586759|NCT03526848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586760|NCT03321136|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
65586761|NCT03321136|Hallucinogens|hallucinogens|mesh-ancestor
65586762|NCT03321136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586763|NCT03321136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65586764|NCT03321136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65586765|NCT03321136|Serotonin Agents|serotonin agents|mesh-ancestor
65586766|NCT03321136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65586767|NCT03321136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586768|NCT03321136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65586769|NCT01332552|Ritonavir|ritonavir|mesh-list
65586770|NCT01332552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65586771|NCT01332552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65586772|NCT01332552|Protease Inhibitors|protease inhibitors|mesh-ancestor
65586773|NCT01332552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586774|NCT01332552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586775|NCT01332552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65586776|NCT01332552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65586777|NCT01332552|Antiviral Agents|antiviral agents|mesh-ancestor
65586778|NCT01332552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65586779|NCT01332552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65586780|NCT01332552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65586781|NCT03720223|Bupivacaine|bupivacaine|mesh-list
65586782|NCT03720223|Anesthetics, Local|anesthetics, local|mesh-ancestor
65586783|NCT03720223|Anesthetics|anesthetics|mesh-ancestor
65586784|NCT03720223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65586785|NCT03720223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586786|NCT03720223|Sensory System Agents|sensory system agents|mesh-ancestor
65586787|NCT03720223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586788|NCT03160716|Lidocaine|lidocaine|mesh-list
65586789|NCT03160716|Anesthetics, Local|anesthetics, local|mesh-ancestor
65586790|NCT03160716|Anesthetics|anesthetics|mesh-ancestor
65586791|NCT03160716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65586792|NCT03160716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586793|NCT03160716|Sensory System Agents|sensory system agents|mesh-ancestor
65586794|NCT03160716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586795|NCT03160716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65586796|NCT03160716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65586797|NCT03160716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65586798|NCT03160716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65586799|NCT03160716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586800|NCT00092664|Simvastatin|simvastatin|mesh-list
65586801|NCT00092664|Ezetimibe|ezetimibe|mesh-list
65586802|NCT00092664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65586803|NCT00092664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65586804|NCT00092664|Antimetabolites|antimetabolites|mesh-ancestor
65586805|NCT00092664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586806|NCT00092664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65586807|NCT00092664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65586808|NCT00092664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586809|NCT02483884|Bombesin|bombesin|mesh-list
65586810|NCT02483884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65586811|NCT02483884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586812|NCT02483884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586814|NCT03317548|Progestins|progestins|mesh-ancestor
65586815|NCT03317548|Hormones|hormones|mesh-ancestor
65586816|NCT03317548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65586817|NCT03317548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586818|NCT00092586|Ezetimibe|ezetimibe|mesh-list
65586819|NCT00092586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65586820|NCT00092586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65586821|NCT00092586|Antimetabolites|antimetabolites|mesh-ancestor
65586822|NCT00092586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586823|NCT00092586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65586824|NCT03786887|Nalbuphine|nalbuphine|mesh-list
65586825|NCT03786887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65586826|NCT03786887|Narcotics|narcotics|mesh-ancestor
65586827|NCT03786887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65586828|NCT03786887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586829|NCT03786887|Analgesics|analgesics|mesh-ancestor
65586830|NCT03786887|Sensory System Agents|sensory system agents|mesh-ancestor
65586831|NCT03786887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586832|NCT03787043|Metformin|metformin|mesh-list
65586833|NCT03787043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65586834|NCT03787043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586835|NCT00090168|Atorvastatin|atorvastatin|mesh-list
65586836|NCT00090168|Simvastatin|simvastatin|mesh-list
65586837|NCT00090168|Ezetimibe|ezetimibe|mesh-list
65586838|NCT00090168|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65586839|NCT00090168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65586840|NCT00090168|Antimetabolites|antimetabolites|mesh-ancestor
65586841|NCT00090168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586842|NCT00090168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65586843|NCT00090168|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65586844|NCT00090168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586845|NCT01332786|Tigecycline|tigecycline|mesh-list
65586846|NCT01332786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65586847|NCT01332786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65586848|NCT01332786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65586849|NCT01332786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586850|NCT01332786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586851|NCT01338090|Bevacizumab|bevacizumab|mesh-list
65586852|NCT01338090|Everolimus|everolimus|mesh-list
65586853|NCT01338090|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
65586854|NCT01338090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65586855|NCT01338090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586856|NCT01338090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65586857|NCT01338090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65586858|NCT01338090|Growth Substances|growth substances|mesh-ancestor
65586859|NCT01338090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586860|NCT01338090|Growth Inhibitors|growth inhibitors|mesh-ancestor
65586861|NCT01338090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65586862|NCT01338090|Immunologic Factors|immunologic factors|mesh-ancestor
65586863|NCT01338090|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65586864|NCT01338090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586865|NCT01307969|Lidocaine|lidocaine|mesh-list
65586866|NCT01307969|Epinephrine|epinephrine|mesh-list
65586867|NCT01307969|Racepinephrine|racepinephrine|mesh-list
65586868|NCT01307969|Ropivacaine|ropivacaine|mesh-list
65586869|NCT01307969|Epinephryl borate|epinephryl borate|mesh-list
65586870|NCT01307969|Anesthetics, Local|anesthetics, local|mesh-ancestor
65586871|NCT01307969|Anesthetics|anesthetics|mesh-ancestor
65586872|NCT01307969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65586873|NCT01307969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586874|NCT01307969|Sensory System Agents|sensory system agents|mesh-ancestor
65586875|NCT01307969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586876|NCT01307969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65586877|NCT01307969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65586878|NCT01307969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65586879|NCT01307969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65586880|NCT01307969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586881|NCT01307969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65586882|NCT01307969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65586883|NCT01307969|Adrenergic Agents|adrenergic agents|mesh-ancestor
65586884|NCT01307969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65384385|NCT00994539|Morphine|morphine|mesh-list
65586885|NCT01307969|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65586886|NCT01307969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65586887|NCT01307969|Autonomic Agents|autonomic agents|mesh-ancestor
65586888|NCT01307969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65586889|NCT01307969|Respiratory System Agents|respiratory system agents|mesh-ancestor
65586890|NCT01307969|Mydriatics|mydriatics|mesh-ancestor
65586891|NCT01307969|Sympathomimetics|sympathomimetics|mesh-ancestor
65586892|NCT01307969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65586893|NCT03786419|Atezolizumab|atezolizumab|mesh-list
65586894|NCT03786419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586895|NCT01338324|Simvastatin|simvastatin|mesh-list
65586896|NCT01338324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65586897|NCT01338324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65586898|NCT01338324|Antimetabolites|antimetabolites|mesh-ancestor
65586899|NCT01338324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586900|NCT01338324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65586901|NCT01338324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65586902|NCT01338324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586903|NCT01336062|Paclitaxel|paclitaxel|mesh-list
65586904|NCT01336062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65586905|NCT01336062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65586906|NCT01336062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586907|NCT01336062|Tubulin Modulators|tubulin modulators|mesh-ancestor
65586908|NCT01336062|Antimitotic Agents|antimitotic agents|mesh-ancestor
65586909|NCT01336062|Mitosis Modulators|mitosis modulators|mesh-ancestor
65586910|NCT01336062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586911|NCT05694221|Metformin|metformin|mesh-list
65586912|NCT05694221|Digoxin|digoxin|mesh-list
65586913|NCT05694221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65586914|NCT05694221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586915|NCT05694221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65586916|NCT05694221|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65586917|NCT05694221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586918|NCT05694221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586919|NCT05694221|Protective Agents|protective agents|mesh-ancestor
65586920|NCT01308047|Bupivacaine|bupivacaine|mesh-list
65586921|NCT01308047|Anesthetics, Local|anesthetics, local|mesh-ancestor
65586922|NCT01308047|Anesthetics|anesthetics|mesh-ancestor
65586923|NCT01308047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65586924|NCT01308047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586925|NCT01308047|Sensory System Agents|sensory system agents|mesh-ancestor
65586926|NCT01308047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586927|NCT03777605|Nitroglycerin|nitroglycerin|mesh-list
65586928|NCT03777605|Vasodilator Agents|vasodilator agents|mesh-ancestor
65586929|NCT03777761|Moxifloxacin|moxifloxacin|mesh-list
65586930|NCT03777761|Tucatinib|tucatinib|mesh-list
65586931|NCT03777761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65586932|NCT03777761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65586933|NCT03777761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65586934|NCT03777761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65586935|NCT03777761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586936|NCT03777761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586937|NCT03777761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586938|NCT03777761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65586939|NCT01316861|Acarbose|acarbose|mesh-list
65586940|NCT01316861|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65586941|NCT01316861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586942|NCT01316861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586943|NCT01316861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65586944|NCT01316861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586945|NCT01336218|Rifampin|rifampin|mesh-list
65586946|NCT01336218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65586947|NCT01336218|Antitubercular Agents|antitubercular agents|mesh-ancestor
65586948|NCT01336218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65586949|NCT01336218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65586950|NCT01336218|Leprostatic Agents|leprostatic agents|mesh-ancestor
65586951|NCT01336218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65586952|NCT01336218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586953|NCT01336218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586954|NCT01336218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65586955|NCT01336218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65586956|NCT01336218|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65384456|NCT05059223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65586957|NCT01336218|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65586958|NCT01336218|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65586959|NCT01336218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65586960|NCT05029115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65586961|NCT05029115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586963|NCT05029115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586964|NCT03776279|Mitoxantrone|mitoxantrone|mesh-list
65586965|NCT03776279|Analgesics|analgesics|mesh-ancestor
65586966|NCT03776279|Sensory System Agents|sensory system agents|mesh-ancestor
65586967|NCT03776279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586968|NCT03776279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586969|NCT03776279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65586970|NCT03776279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65586971|NCT03776279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65586972|NCT03776279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65586973|NCT03776279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586974|NCT01561391|Factor VIII|factor viii|mesh-list
65586975|NCT01561391|Coagulants|coagulants|mesh-ancestor
65586976|NCT03775655|Dexmedetomidine|dexmedetomidine|mesh-list
65586977|NCT03775655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65586978|NCT03775655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65586979|NCT03775655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586980|NCT03775655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65586981|NCT03775655|Analgesics|analgesics|mesh-ancestor
65586982|NCT03775655|Sensory System Agents|sensory system agents|mesh-ancestor
65586983|NCT03775655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65586984|NCT03775655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65586985|NCT03775655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65586986|NCT03775655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65586987|NCT03775655|Adrenergic Agents|adrenergic agents|mesh-ancestor
65586988|NCT03775655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65586989|NCT03775655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65586990|NCT01310465|Zoledronic Acid|zoledronic acid|mesh-list
65586991|NCT01310465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65586992|NCT01310465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586993|NCT03781895|Cholecalciferol|cholecalciferol|mesh-list
65586994|NCT03781895|Vitamin D|vitamin d|mesh-list
65586995|NCT03781895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65586996|NCT03781895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65586997|NCT03781895|Vitamins|vitamins|mesh-ancestor
65586998|NCT03781895|Micronutrients|micronutrients|mesh-ancestor
65586999|NCT03781895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65587000|NCT00706030|Vinorelbine|vinorelbine|mesh-list
65587001|NCT00706030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65587002|NCT00706030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587003|NCT00706030|Tubulin Modulators|tubulin modulators|mesh-ancestor
65587004|NCT00706030|Antimitotic Agents|antimitotic agents|mesh-ancestor
65587005|NCT00706030|Mitosis Modulators|mitosis modulators|mesh-ancestor
65587006|NCT00706030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587007|NCT03781505|Acetaminophen|acetaminophen|mesh-list
65587008|NCT03781505|Ropivacaine|ropivacaine|mesh-list
65587009|NCT03781505|Anesthetics, Local|anesthetics, local|mesh-ancestor
65587010|NCT03781505|Anesthetics|anesthetics|mesh-ancestor
65587011|NCT03781505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65587012|NCT03781505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587013|NCT03781505|Sensory System Agents|sensory system agents|mesh-ancestor
65587014|NCT03781505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587015|NCT03781505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65587016|NCT03781505|Analgesics|analgesics|mesh-ancestor
65587017|NCT03781505|Antipyretics|antipyretics|mesh-ancestor
65587018|NCT03781115|Olanzapine|olanzapine|mesh-list
65587019|NCT03781115|Ziprasidone|ziprasidone|mesh-list
65587020|NCT03781115|Antiemetics|antiemetics|mesh-ancestor
65587021|NCT03781115|Autonomic Agents|autonomic agents|mesh-ancestor
65587022|NCT03781115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587023|NCT03781115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587024|NCT03781115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65587025|NCT03781115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65587026|NCT03781115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65587027|NCT03781115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65587028|NCT03781115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65587029|NCT03781115|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65587030|NCT03781115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65384530|NCT02587871|Cytarabine|cytarabine|mesh-list
65587031|NCT03781115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65587032|NCT03781115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587033|NCT03781115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65587035|NCT03781115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65587036|NCT03781115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65587037|NCT03781115|Dopamine Agents|dopamine agents|mesh-ancestor
65587038|NCT03317236|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65587039|NCT03317236|Antidepressive Agents|antidepressive agents|mesh-ancestor
65587040|NCT03317236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65587041|NCT03317236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65587042|NCT03317236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65587043|NCT03317236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65587044|NCT03317236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587045|NCT01313429|Celecoxib|celecoxib|mesh-list
65587046|NCT01313429|Cyclophosphamide|cyclophosphamide|mesh-list
65587047|NCT01313429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65587048|NCT01313429|Immunologic Factors|immunologic factors|mesh-ancestor
65587049|NCT01313429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587050|NCT01313429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65587051|NCT01313429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65587052|NCT01313429|Alkylating Agents|alkylating agents|mesh-ancestor
65587053|NCT01313429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587054|NCT01313429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587055|NCT01313429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65587056|NCT01313429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65587057|NCT01313429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65587058|NCT01313429|Analgesics|analgesics|mesh-ancestor
65587059|NCT01313429|Sensory System Agents|sensory system agents|mesh-ancestor
65587060|NCT01313429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587061|NCT01313429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65587062|NCT01313429|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65587063|NCT01313429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65587064|NCT01313429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587065|NCT03488251|Gemcitabine|gemcitabine|mesh-list
65587066|NCT03488251|Oxaliplatin|oxaliplatin|mesh-list
65587067|NCT03488251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65587068|NCT03488251|Antimetabolites|antimetabolites|mesh-ancestor
65587069|NCT03488251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587070|NCT03488251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587071|NCT03488251|Antiviral Agents|antiviral agents|mesh-ancestor
65587072|NCT03488251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65587073|NCT03488251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587074|NCT03488251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65587075|NCT03488251|Immunologic Factors|immunologic factors|mesh-ancestor
65587076|NCT03488251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587077|NCT03158688|Dexamethasone|dexamethasone|mesh-list
65587078|NCT03158688|Daratumumab|daratumumab|mesh-list
65587079|NCT03158688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65587080|NCT03158688|Antiemetics|antiemetics|mesh-ancestor
65587081|NCT03158688|Autonomic Agents|autonomic agents|mesh-ancestor
65587082|NCT03158688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587083|NCT03158688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587084|NCT03158688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65587085|NCT03158688|Glucocorticoids|glucocorticoids|mesh-ancestor
65587086|NCT03158688|Hormones|hormones|mesh-ancestor
65587087|NCT03158688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65587088|NCT03158688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65587089|NCT03158688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587090|NCT02727322|Nitrofurantoin|nitrofurantoin|mesh-list
65587091|NCT02727322|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64753305|NCT01925352|Mitogens|mitogens|mesh-list
65587092|NCT02727322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65587093|NCT02727322|Renal Agents|renal agents|mesh-ancestor
65587094|NCT02727322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65587095|NCT03315520|Cytarabine|cytarabine|mesh-list
65587096|NCT03315520|Cyclophosphamide|cyclophosphamide|mesh-list
65587097|NCT03315520|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65587098|NCT03315520|Etoposide|etoposide|mesh-list
65587099|NCT03315520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65587100|NCT03315520|Immunologic Factors|immunologic factors|mesh-ancestor
65587101|NCT03315520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587102|NCT03315520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65587103|NCT03315520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65587104|NCT03315520|Alkylating Agents|alkylating agents|mesh-ancestor
65587105|NCT03315520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587106|NCT03315520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587107|NCT03315520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65587108|NCT03315520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65587109|NCT03315520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65587110|NCT03315520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65587111|NCT03315520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587112|NCT03315520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65587113|NCT03315520|Antimetabolites|antimetabolites|mesh-ancestor
65587114|NCT03315520|Antiviral Agents|antiviral agents|mesh-ancestor
65587115|NCT03315520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65587116|NCT02483182|Acyclovir|acyclovir|mesh-list
65587117|NCT02483182|Antiviral Agents|antiviral agents|mesh-ancestor
65587118|NCT02483182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65587119|NCT01338558|Bevacizumab|bevacizumab|mesh-list
65587120|NCT01338558|Cetuximab|cetuximab|mesh-list
65587121|NCT01338558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65587122|NCT01338558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587123|NCT01338558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65587124|NCT01338558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65587125|NCT01338558|Growth Substances|growth substances|mesh-ancestor
65587126|NCT01338558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587127|NCT01338558|Growth Inhibitors|growth inhibitors|mesh-ancestor
65587128|NCT03780569|Temozolomide|temozolomide|mesh-list
65587129|NCT03780569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65587130|NCT03780569|Alkylating Agents|alkylating agents|mesh-ancestor
65587131|NCT03780569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587132|NCT03780569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587133|NCT03487549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65587134|NCT03487549|Cantharidin|cantharidin|mesh-list
65587135|NCT03487549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587136|NCT03487549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587137|NCT01313585|Beclomethasone|beclomethasone|mesh-list
65587138|NCT01313585|Albuterol|albuterol|mesh-list
65587139|NCT01313585|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65587140|NCT01313585|Autonomic Agents|autonomic agents|mesh-ancestor
65587141|NCT01313585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587142|NCT01313585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587143|NCT01313585|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65587144|NCT01313585|Respiratory System Agents|respiratory system agents|mesh-ancestor
65587145|NCT01313585|Tocolytic Agents|tocolytic agents|mesh-ancestor
65587146|NCT01313585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65587147|NCT01313585|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65587148|NCT01313585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65587149|NCT01313585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65587150|NCT01313585|Adrenergic Agents|adrenergic agents|mesh-ancestor
65587151|NCT01313585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65587152|NCT01313585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587153|NCT01313585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65587154|NCT01313585|Glucocorticoids|glucocorticoids|mesh-ancestor
65587155|NCT01313585|Hormones|hormones|mesh-ancestor
65587156|NCT01313585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65587157|NCT01561235|Hormones|hormones|mesh-list
65587158|NCT01561235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65587159|NCT01561235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587160|NCT02485990|Olaparib|olaparib|mesh-list
65587161|NCT02485990|Tremelimumab|tremelimumab|mesh-list
65587162|NCT02485990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65587163|NCT02485990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587164|NCT02485990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587165|NCT02485990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587166|NCT01313819|Amantadine|amantadine|mesh-list
65587167|NCT01313819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65587168|NCT01313819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65587169|NCT01313819|Antiviral Agents|antiviral agents|mesh-ancestor
65587170|NCT01313819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65587171|NCT01313819|Dopamine Agents|dopamine agents|mesh-ancestor
65587172|NCT01313819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65587173|NCT01313819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587174|NCT01313819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587175|NCT01313819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65587176|NCT01313819|Analgesics|analgesics|mesh-ancestor
65587177|NCT01313819|Sensory System Agents|sensory system agents|mesh-ancestor
65587178|NCT01313819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587179|NCT03315442|Caffeine|caffeine|mesh-list
65587180|NCT03315442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65384681|NCT00873236|Interferons|interferons|mesh-list
65587181|NCT03315442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587182|NCT03315442|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65587183|NCT03315442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587184|NCT03315442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587185|NCT03315442|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65587186|NCT03315442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65587187|NCT03315442|Purinergic Agents|purinergic agents|mesh-ancestor
65587188|NCT03315442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65587189|NCT03464383|Citalopram|citalopram|mesh-list
65587190|NCT03464383|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65587191|NCT03464383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65587192|NCT03464383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65587193|NCT03464383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587194|NCT03464383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65587195|NCT03464383|Serotonin Agents|serotonin agents|mesh-ancestor
65587196|NCT03464383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587197|NCT03464383|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65587198|NCT03464383|Antidepressive Agents|antidepressive agents|mesh-ancestor
65587199|NCT03464383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65587200|NCT03315364|Paclitaxel|paclitaxel|mesh-list
65587201|NCT03315364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65587202|NCT03315364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65587203|NCT03315364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587204|NCT03315364|Tubulin Modulators|tubulin modulators|mesh-ancestor
65587205|NCT03315364|Antimitotic Agents|antimitotic agents|mesh-ancestor
65587206|NCT03315364|Mitosis Modulators|mitosis modulators|mesh-ancestor
65587207|NCT03315364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587208|NCT03779633|Estradiol|estradiol|mesh-list
65587209|NCT03779633|Estrogens|estrogens|mesh-ancestor
65587210|NCT03779633|Hormones|hormones|mesh-ancestor
65587211|NCT03779633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65587212|NCT03779633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587213|NCT03720067|Propranolol|propranolol|mesh-list
65587214|NCT03720067|Carvedilol|carvedilol|mesh-list
65587215|NCT03720067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65587216|NCT03720067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65587217|NCT03720067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65587218|NCT03720067|Antimetabolites|antimetabolites|mesh-ancestor
65587219|NCT03720067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587220|NCT03720067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65587221|NCT03720067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65587222|NCT03720067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587223|NCT03720067|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65587224|NCT03720067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65587225|NCT03720067|Adrenergic Agents|adrenergic agents|mesh-ancestor
65587226|NCT03720067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65587227|NCT03720067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587228|NCT03720067|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65587229|NCT03720067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65587230|NCT03720067|Vasodilator Agents|vasodilator agents|mesh-ancestor
65587231|NCT03720067|Antioxidants|antioxidants|mesh-ancestor
65587232|NCT03720067|Protective Agents|protective agents|mesh-ancestor
65587233|NCT03720067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65587234|NCT03720067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65587235|NCT03720067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65587236|NCT03720067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65587237|NCT03720067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65587238|NCT01444092|Budesonide|budesonide|mesh-list
65587239|NCT01444092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65587240|NCT01444092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65587241|NCT01444092|Autonomic Agents|autonomic agents|mesh-ancestor
65587242|NCT01444092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587243|NCT01444092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587244|NCT01444092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65587245|NCT01444092|Respiratory System Agents|respiratory system agents|mesh-ancestor
65587246|NCT01444092|Glucocorticoids|glucocorticoids|mesh-ancestor
65587247|NCT01444092|Hormones|hormones|mesh-ancestor
65587248|NCT01444092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65587249|NCT03719989|Azacitidine|azacitidine|mesh-list
65587250|NCT03719989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65587251|NCT03719989|Antimetabolites|antimetabolites|mesh-ancestor
65587252|NCT03719989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384754|NCT00879008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587253|NCT03719989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587254|NCT03719989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587256|NCT05462470|Hematinics|hematinics|mesh-ancestor
65587257|NCT03779087|Amoxicillin|amoxicillin|mesh-list
65587258|NCT03779087|Levofloxacin|levofloxacin|mesh-list
65587259|NCT03779087|Ofloxacin|ofloxacin|mesh-list
65587260|NCT03779087|Tetracycline|tetracycline|mesh-list
65587261|NCT03779087|Esomeprazole|esomeprazole|mesh-list
65587262|NCT03779087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65587263|NCT03779087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65587264|NCT03779087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65587265|NCT03779087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65587266|NCT03779087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65587267|NCT03779087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587268|NCT03779087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587269|NCT03779087|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65587270|NCT03779087|Renal Agents|renal agents|mesh-ancestor
65587271|NCT03779087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65587272|NCT03779087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65587273|NCT03779087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587274|NCT03779087|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65587275|NCT03779087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65587276|NCT03779087|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65587277|NCT01265784|Ertapenem|ertapenem|mesh-list
65587278|NCT01265784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65587279|NCT01265784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65587280|NCT05692271|Propranolol|propranolol|mesh-list
65587281|NCT05692271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65587282|NCT05692271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65587283|NCT05692271|Adrenergic Agents|adrenergic agents|mesh-ancestor
65587284|NCT05692271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65587285|NCT05692271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587286|NCT05692271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587287|NCT05692271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65587288|NCT05692271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65587289|NCT05692271|Vasodilator Agents|vasodilator agents|mesh-ancestor
65587290|NCT03774953|Vitamins|vitamins|mesh-list
65587291|NCT03774953|Micronutrients|micronutrients|mesh-ancestor
65587292|NCT03774953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587293|NCT02483026|Vitamin D|vitamin d|mesh-list
65587294|NCT02483026|Vitamins|vitamins|mesh-list
65587295|NCT02483026|Micronutrients|micronutrients|mesh-ancestor
65587296|NCT02483026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587297|NCT02483026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65587298|NCT02483104|Paclitaxel|paclitaxel|mesh-list
65587299|NCT02483104|Carboplatin|carboplatin|mesh-list
65587300|NCT02483104|Veliparib|veliparib|mesh-list
65587301|NCT02483104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65587302|NCT02483104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587303|NCT02483104|Tubulin Modulators|tubulin modulators|mesh-ancestor
65587304|NCT02483104|Antimitotic Agents|antimitotic agents|mesh-ancestor
65587305|NCT02483104|Mitosis Modulators|mitosis modulators|mesh-ancestor
65587306|NCT02483104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587307|NCT02483104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65587308|NCT02483104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587309|NCT00116220|Goserelin|goserelin|mesh-list
65587310|NCT00116220|Flutamide|flutamide|mesh-list
65587311|NCT00116220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587312|NCT00116220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65587313|NCT00116220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587314|NCT00116220|Androgen Antagonists|androgen antagonists|mesh-ancestor
65587315|NCT00116220|Hormone Antagonists|hormone antagonists|mesh-ancestor
65587316|NCT00116220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65587317|NCT03785015|Aspirin|aspirin|mesh-list
65587318|NCT03785015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65587319|NCT03785015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65587320|NCT03785015|Analgesics|analgesics|mesh-ancestor
65587321|NCT03785015|Sensory System Agents|sensory system agents|mesh-ancestor
65587322|NCT03785015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587323|NCT03785015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587324|NCT03785015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65587325|NCT03785015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65587326|NCT03785015|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65587327|NCT03785015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65587328|NCT03785015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587329|NCT03785015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65587330|NCT03785015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65587331|NCT03785015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587333|NCT04867343|Fentanyl|fentanyl|mesh-list
65587334|NCT04867343|Remifentanil|remifentanil|mesh-list
65587335|NCT04867343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65587336|NCT04867343|Narcotics|narcotics|mesh-ancestor
65587337|NCT04867343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65587338|NCT04867343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587339|NCT04867343|Analgesics|analgesics|mesh-ancestor
65587340|NCT04867343|Sensory System Agents|sensory system agents|mesh-ancestor
65587341|NCT04867343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587342|NCT04867343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65587343|NCT04867343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65587344|NCT04867343|Anesthetics, General|anesthetics, general|mesh-ancestor
65587345|NCT04867343|Anesthetics|anesthetics|mesh-ancestor
65587346|NCT05185518|Insulin|insulin|mesh-list
65587347|NCT05185518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65587348|NCT05185518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587349|NCT03316690|Metformin|metformin|mesh-list
65587350|NCT03316690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65587351|NCT03316690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587352|NCT03315052|Mycophenolic Acid|mycophenolic acid|mesh-list
65587353|NCT03315052|Prednisone|prednisone|mesh-list
65587354|NCT03315052|Budesonide|budesonide|mesh-list
65587355|NCT03315052|Tacrolimus|tacrolimus|mesh-list
65587356|NCT03315052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65587357|NCT03315052|Glucocorticoids|glucocorticoids|mesh-ancestor
65587358|NCT03315052|Hormones|hormones|mesh-ancestor
65587359|NCT03315052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65587360|NCT03315052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587361|NCT03315052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65587362|NCT03315052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587363|NCT03315052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65587364|NCT03315052|Immunologic Factors|immunologic factors|mesh-ancestor
65587365|NCT03315052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65587366|NCT03315052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587367|NCT03315052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587368|NCT03315052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65587369|NCT03315052|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65587370|NCT03315052|Antitubercular Agents|antitubercular agents|mesh-ancestor
65587371|NCT03315052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65587372|NCT03315052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65587373|NCT03315052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65587374|NCT03315052|Autonomic Agents|autonomic agents|mesh-ancestor
65587375|NCT03315052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587376|NCT03315052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65587377|NCT03315052|Respiratory System Agents|respiratory system agents|mesh-ancestor
65587378|NCT03778619|Cyclophosphamide|cyclophosphamide|mesh-list
65587379|NCT03778619|Rituximab|rituximab|mesh-list
65587380|NCT03778619|Fludarabine|fludarabine|mesh-list
65587381|NCT03778619|Interleukin-2|interleukin-2|mesh-list
65587382|NCT03778619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65587383|NCT03778619|Immunologic Factors|immunologic factors|mesh-ancestor
65587384|NCT03778619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587385|NCT03778619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65587386|NCT03778619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65587387|NCT03778619|Alkylating Agents|alkylating agents|mesh-ancestor
65587388|NCT03778619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587389|NCT03778619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587390|NCT03778619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65587391|NCT03778619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65587392|NCT03778619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65587393|NCT03778619|Analgesics|analgesics|mesh-ancestor
65587394|NCT03778619|Sensory System Agents|sensory system agents|mesh-ancestor
65587395|NCT03778619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587396|NCT05714176|Lactoferrin|lactoferrin|mesh-list
65587397|NCT05714176|Dextrans|dextrans|mesh-list
65587398|NCT05714176|Iron-Dextran Complex|iron-dextran complex|mesh-list
65587399|NCT05714176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65587400|NCT05714176|Anticoagulants|anticoagulants|mesh-ancestor
65587401|NCT05714176|Plasma Substitutes|plasma substitutes|mesh-ancestor
65587402|NCT05714176|Blood Substitutes|blood substitutes|mesh-ancestor
65587403|NCT05714176|Hematinics|hematinics|mesh-ancestor
65587404|NCT03156504|Ketamine|ketamine|mesh-list
65587405|NCT03156504|Analgesics|analgesics|mesh-ancestor
65587406|NCT03156504|Sensory System Agents|sensory system agents|mesh-ancestor
65587407|NCT03156504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587408|NCT03156504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587409|NCT03156504|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65587410|NCT03156504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65587411|NCT03156504|Anesthetics, General|anesthetics, general|mesh-ancestor
65587412|NCT03156504|Anesthetics|anesthetics|mesh-ancestor
65587413|NCT03156504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65587414|NCT03156504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65587415|NCT03156504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65587416|NCT03156504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65587417|NCT03156504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587418|NCT01333332|Capecitabine|capecitabine|mesh-list
65587419|NCT01333332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65587420|NCT01333332|Antimetabolites|antimetabolites|mesh-ancestor
65587421|NCT01333332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587422|NCT01333332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587423|NCT03316534|Aspirin|aspirin|mesh-list
65587424|NCT03316534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65587425|NCT03316534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65587426|NCT03316534|Analgesics|analgesics|mesh-ancestor
65587427|NCT03316534|Sensory System Agents|sensory system agents|mesh-ancestor
65587428|NCT03316534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587429|NCT03316534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587430|NCT03316534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65587431|NCT03316534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65587432|NCT03316534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65587433|NCT03316534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65587434|NCT03316534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587435|NCT03316534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65587436|NCT03316534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65587437|NCT03316534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587438|NCT03316534|Antipyretics|antipyretics|mesh-ancestor
65587439|NCT04476420|Betamethasone|betamethasone|mesh-list
65587440|NCT04476420|Betamethasone Valerate|betamethasone valerate|mesh-list
65587441|NCT04476420|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65587442|NCT04476420|Betamethasone benzoate|betamethasone benzoate|mesh-list
65587443|NCT04476420|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65587444|NCT04476420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65587445|NCT04476420|Glucocorticoids|glucocorticoids|mesh-ancestor
65587446|NCT04476420|Hormones|hormones|mesh-ancestor
65587447|NCT04476420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65587448|NCT04476420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587449|NCT04476420|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65587450|NCT04476420|Respiratory System Agents|respiratory system agents|mesh-ancestor
65587451|NCT03778541|Temozolomide|temozolomide|mesh-list
65587452|NCT03778541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65587453|NCT03778541|Alkylating Agents|alkylating agents|mesh-ancestor
65587454|NCT03778541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587455|NCT03778541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587456|NCT02479828|Ropivacaine|ropivacaine|mesh-list
65587457|NCT02479828|Anesthetics, Local|anesthetics, local|mesh-ancestor
65587458|NCT02479828|Anesthetics|anesthetics|mesh-ancestor
65587459|NCT02479828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65587460|NCT02479828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587461|NCT02479828|Sensory System Agents|sensory system agents|mesh-ancestor
65587462|NCT02479828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587463|NCT01320449|Epoetin Alfa|epoetin alfa|mesh-list
65587464|NCT01320449|Hematinics|hematinics|mesh-ancestor
65587465|NCT03430063|Ipilimumab|ipilimumab|mesh-list
65587466|NCT03430063|Cemiplimab|cemiplimab|mesh-list
65587467|NCT03430063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65587468|NCT03430063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587469|NCT03430063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65587470|NCT03430063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587471|NCT03158220|Vaccines|vaccines|mesh-list
65587472|NCT03158220|Immunologic Factors|immunologic factors|mesh-ancestor
65587473|NCT03158220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587474|NCT01308983|Amiloride|amiloride|mesh-list
65587475|NCT01308983|Diuretics|diuretics|mesh-ancestor
65587476|NCT01308983|Natriuretic Agents|natriuretic agents|mesh-ancestor
65587477|NCT01308983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587478|NCT01308983|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65587479|NCT01308983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65587480|NCT01308983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65587481|NCT01308983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587482|NCT01308983|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65587483|NCT01308983|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65587484|NCT01336842|Pemetrexed|pemetrexed|mesh-list
65587485|NCT01336842|Panobinostat|panobinostat|mesh-list
65587486|NCT01336842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587487|NCT01336842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587488|NCT01336842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587489|NCT01336842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65587490|NCT01336842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65587491|NCT01336842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65587492|NCT05178407|Micronutrients|micronutrients|mesh-list
65587493|NCT05178407|Trace Elements|trace elements|mesh-list
65587494|NCT05178407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587495|NCT01339026|Clopidogrel|clopidogrel|mesh-list
65587496|NCT01339026|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65587497|NCT01339026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65587498|NCT01339026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65587499|NCT01339026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65587500|NCT01339026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65587501|NCT01339026|Purinergic Agents|purinergic agents|mesh-ancestor
65587502|NCT01339026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65587503|NCT01339026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587504|NCT01339026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587505|NCT05683223|Sertraline|sertraline|mesh-list
65587506|NCT05683223|Antidepressive Agents|antidepressive agents|mesh-ancestor
65587507|NCT05683223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65587508|NCT05683223|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65587509|NCT05683223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65587510|NCT05683223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65587511|NCT05683223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587512|NCT05683223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65587513|NCT05683223|Serotonin Agents|serotonin agents|mesh-ancestor
65587514|NCT05683223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587515|NCT03314740|Paclitaxel|paclitaxel|mesh-list
65587516|NCT03314740|Olaparib|olaparib|mesh-list
65587517|NCT03314740|Cediranib|cediranib|mesh-list
65587518|NCT03314740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65587519|NCT03314740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587520|NCT03314740|Tubulin Modulators|tubulin modulators|mesh-ancestor
65587521|NCT03314740|Antimitotic Agents|antimitotic agents|mesh-ancestor
65587522|NCT03314740|Mitosis Modulators|mitosis modulators|mesh-ancestor
65587523|NCT03314740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587524|NCT03314740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65587525|NCT03314740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587526|NCT03314740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65587527|NCT02482636|Vaccines|vaccines|mesh-list
65587528|NCT02482636|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65587529|NCT02482636|Immunologic Factors|immunologic factors|mesh-ancestor
65587530|NCT02482636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587531|NCT02482402|Iloprost|iloprost|mesh-list
65587532|NCT02482402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65587533|NCT02482402|Vasodilator Agents|vasodilator agents|mesh-ancestor
65587534|NCT03774095|Pycnogenols|pycnogenols|mesh-list
65587535|NCT03774095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65587536|NCT03774095|Immunologic Factors|immunologic factors|mesh-ancestor
65587537|NCT03774095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587538|NCT03774095|Antioxidants|antioxidants|mesh-ancestor
65587539|NCT03774095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587540|NCT03774095|Protective Agents|protective agents|mesh-ancestor
65587541|NCT03774095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65587542|NCT01333410|Mometasone Furoate|mometasone furoate|mesh-list
65587543|NCT01333410|Tacrolimus|tacrolimus|mesh-list
65587544|NCT01333410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65587545|NCT01333410|Immunologic Factors|immunologic factors|mesh-ancestor
65587546|NCT01333410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587547|NCT01333410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65587548|NCT01333410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587549|NCT01333410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587550|NCT01333410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65587551|NCT01333410|Dermatologic Agents|dermatologic agents|mesh-ancestor
65587552|NCT01333410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65587553|NCT02482090|Cyclophosphamide|cyclophosphamide|mesh-list
65587554|NCT02482090|Fludarabine|fludarabine|mesh-list
65587555|NCT02482090|Interleukin-2|interleukin-2|mesh-list
65587556|NCT02482090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65587557|NCT02482090|Immunologic Factors|immunologic factors|mesh-ancestor
65587558|NCT02482090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587559|NCT02482090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65587560|NCT02482090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65587561|NCT02482090|Alkylating Agents|alkylating agents|mesh-ancestor
65587562|NCT02482090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587563|NCT02482090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587564|NCT02482090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65587565|NCT02482090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65587566|NCT02482090|Analgesics|analgesics|mesh-ancestor
65587567|NCT02482090|Sensory System Agents|sensory system agents|mesh-ancestor
65587568|NCT02482090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587569|NCT02482324|Ibuprofen|ibuprofen|mesh-list
65587570|NCT02482324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65587571|NCT02482324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65587572|NCT02482324|Analgesics|analgesics|mesh-ancestor
65587573|NCT02482324|Sensory System Agents|sensory system agents|mesh-ancestor
65587574|NCT02482324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587575|NCT02482324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587576|NCT02482324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65587577|NCT02482324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65587578|NCT02482324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65587579|NCT02482324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587580|NCT02482324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587581|NCT05185284|Remdesivir|remdesivir|mesh-list
65587582|NCT05185284|Favipiravir|favipiravir|mesh-list
65587583|NCT05185284|Antimetabolites|antimetabolites|mesh-ancestor
65587584|NCT05185284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587585|NCT05185284|Antiviral Agents|antiviral agents|mesh-ancestor
65587586|NCT05185284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65587587|NCT03784703|Atorvastatin|atorvastatin|mesh-list
65587588|NCT03784703|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65587589|NCT03784703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65587590|NCT03784703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65587591|NCT03784703|Antimetabolites|antimetabolites|mesh-ancestor
65587592|NCT03784703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587593|NCT03784703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65587594|NCT03784703|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65587595|NCT03784703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587596|NCT02724592|Fluorides|fluorides|mesh-list
65587597|NCT02724592|Fluorides, Topical|fluorides, topical|mesh-list
65587598|NCT02724592|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
65587599|NCT02724592|Cariostatic Agents|cariostatic agents|mesh-ancestor
65587600|NCT02724592|Protective Agents|protective agents|mesh-ancestor
65587601|NCT02724592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587602|NCT02476864|Macitentan|macitentan|mesh-list
65587603|NCT02476864|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65587604|NCT02476864|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65587605|NCT02476864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587606|NCT02476864|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65587607|NCT05451550|Anesthetics|anesthetics|mesh-list
65587608|NCT05451550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65587609|NCT05451550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587610|NCT02476708|Curcumin|curcumin|mesh-list
65587611|NCT02476708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65587612|NCT02476708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65587613|NCT02476708|Analgesics|analgesics|mesh-ancestor
65248395|NCT02832726|Vitamin B 12|vitamin b 12|mesh-list
65587614|NCT02476708|Sensory System Agents|sensory system agents|mesh-ancestor
65587615|NCT02476708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587616|NCT02476708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587617|NCT02476708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65587618|NCT02476708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65587619|NCT02476708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587620|NCT02476708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587621|NCT02476708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587622|NCT02479204|Atenolol|atenolol|mesh-list
65587623|NCT02479204|Diltiazem|diltiazem|mesh-list
65587624|NCT02479204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65587625|NCT02479204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65587626|NCT02479204|Sympatholytics|sympatholytics|mesh-ancestor
65587627|NCT02479204|Autonomic Agents|autonomic agents|mesh-ancestor
65587628|NCT02479204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587629|NCT02479204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587630|NCT02479204|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65587631|NCT02479204|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65587632|NCT02479204|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65587633|NCT02479204|Adrenergic Agents|adrenergic agents|mesh-ancestor
65587634|NCT02479204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65587635|NCT02479204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587636|NCT02479204|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65587637|NCT02479204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65587638|NCT02479204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65587639|NCT02479204|Vasodilator Agents|vasodilator agents|mesh-ancestor
65587640|NCT03784547|Ocrelizumab|ocrelizumab|mesh-list
65587641|NCT03784547|Immunologic Factors|immunologic factors|mesh-ancestor
65587642|NCT03784547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587643|NCT01339572|Plerixafor|plerixafor|mesh-list
65587644|NCT01339572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65587645|NCT01339572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65587646|NCT01339572|Antiviral Agents|antiviral agents|mesh-ancestor
65587647|NCT01339572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65587648|NCT05481736|Psilocybin|psilocybin|mesh-list
65587649|NCT05481736|Hallucinogens|hallucinogens|mesh-ancestor
65587650|NCT05481736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587651|NCT05481736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65587652|NCT04199117|Nicotine|nicotine|mesh-list
65587653|NCT04199117|Varenicline|varenicline|mesh-list
65587654|NCT04199117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65587655|NCT04199117|Autonomic Agents|autonomic agents|mesh-ancestor
65587656|NCT04199117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587657|NCT04199117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587658|NCT04199117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65587659|NCT04199117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65587660|NCT04199117|Cholinergic Agents|cholinergic agents|mesh-ancestor
65587661|NCT04199117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65587662|NCT04199117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587663|NCT01309139|Tiotropium Bromide|tiotropium bromide|mesh-list
65587664|NCT01309139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65587665|NCT01309139|Autonomic Agents|autonomic agents|mesh-ancestor
65587666|NCT01309139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587667|NCT01309139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587668|NCT01309139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65587669|NCT01309139|Respiratory System Agents|respiratory system agents|mesh-ancestor
65587670|NCT01309139|Parasympatholytics|parasympatholytics|mesh-ancestor
65587671|NCT01309139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65587672|NCT01309139|Cholinergic Agents|cholinergic agents|mesh-ancestor
65587673|NCT01309139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65587674|NCT01309139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587675|NCT03154476|Sildenafil Citrate|sildenafil citrate|mesh-list
65587676|NCT03154476|Vasodilator Agents|vasodilator agents|mesh-ancestor
65587677|NCT03154476|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65587678|NCT03154476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65587679|NCT03154476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587680|NCT03154476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587681|NCT03154476|Urological Agents|urological agents|mesh-ancestor
65587682|NCT03784391|Nifurtimox|nifurtimox|mesh-list
65587683|NCT03784391|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65587684|NCT03784391|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65587685|NCT03784391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65587686|NCT03784391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65587687|NCT02476552|Niraparib|niraparib|mesh-list
65587688|NCT02476552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65587689|NCT02476552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587690|NCT02476552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587691|NCT02476552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587692|NCT01316718|Mesalamine|mesalamine|mesh-list
65587693|NCT01316718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65587694|NCT01316718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65587695|NCT01316718|Analgesics|analgesics|mesh-ancestor
65587696|NCT01316718|Sensory System Agents|sensory system agents|mesh-ancestor
65587697|NCT01316718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587698|NCT01316718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587699|NCT01316718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65587700|NCT01316718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65587701|NCT01316952|Carvedilol|carvedilol|mesh-list
65587702|NCT01316952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65385209|NCT05304533|Verapamil|verapamil|mesh-list
65587704|NCT01316952|Adrenergic Antagonists|adrenergic antagonists|mesh-list
65587705|NCT01316952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65587706|NCT01316952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587707|NCT01316952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587708|NCT01316952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65587709|NCT01316952|Antioxidants|antioxidants|mesh-ancestor
65587710|NCT01316952|Protective Agents|protective agents|mesh-ancestor
65587711|NCT01316952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65587712|NCT01316952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65587713|NCT01316952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65587714|NCT01316952|Vasodilator Agents|vasodilator agents|mesh-ancestor
65587715|NCT01316952|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65587716|NCT01316952|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65587717|NCT03768869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65587718|NCT03768869|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65587719|NCT03768869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65587720|NCT03768869|Antitubercular Agents|antitubercular agents|mesh-ancestor
65587721|NCT01320917|Levonorgestrel|levonorgestrel|mesh-list
65587722|NCT01320917|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65587723|NCT01320917|Contraceptive Agents|contraceptive agents|mesh-ancestor
65587724|NCT01320917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65587725|NCT01320917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587726|NCT01320917|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65587727|NCT01320917|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65587728|NCT01320917|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65587729|NCT03768713|Suvorexant|suvorexant|mesh-list
65587730|NCT03768713|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65587731|NCT03768713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65587732|NCT03768713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65587733|NCT03768713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587734|NCT03768713|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65587735|NCT03768713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65587736|NCT03768713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587737|NCT02481076|Monensin|monensin|mesh-list
65587738|NCT02481076|Antifungal Agents|antifungal agents|mesh-ancestor
65587739|NCT02481076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65587740|NCT02481076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65587741|NCT02481076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65587742|NCT02481076|Coccidiostats|coccidiostats|mesh-ancestor
65587743|NCT02481076|Proton Ionophores|proton ionophores|mesh-ancestor
65587744|NCT02481076|Uncoupling Agents|uncoupling agents|mesh-ancestor
65587745|NCT02481076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587746|NCT02481076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587747|NCT02481076|Ionophores|ionophores|mesh-ancestor
65587748|NCT02481076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65587749|NCT02481076|Sodium Ionophores|sodium ionophores|mesh-ancestor
65587750|NCT05386888|Paclitaxel|paclitaxel|mesh-list
65587751|NCT05386888|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65587752|NCT05386888|Carboplatin|carboplatin|mesh-list
65587753|NCT05386888|Pemetrexed|pemetrexed|mesh-list
65587754|NCT05386888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65587755|NCT05386888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587756|NCT05386888|Tubulin Modulators|tubulin modulators|mesh-ancestor
65587757|NCT05386888|Antimitotic Agents|antimitotic agents|mesh-ancestor
65587758|NCT05386888|Mitosis Modulators|mitosis modulators|mesh-ancestor
65587759|NCT05386888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587760|NCT05386888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587761|NCT05386888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64473201|NCT00119158|Analgesics|analgesics|mesh-ancestor
65587762|NCT05386888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65587763|NCT05713396|Losartan|losartan|mesh-list
65587764|NCT05713396|Quinapril|quinapril|mesh-list
65587765|NCT05713396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65587766|NCT05713396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65587767|NCT05713396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65587768|NCT05713396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65587769|NCT05713396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587770|NCT05713396|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65587771|NCT05713396|Protease Inhibitors|protease inhibitors|mesh-ancestor
65587772|NCT05713396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587773|NCT02480608|Imatinib Mesylate|imatinib mesylate|mesh-list
65587774|NCT02480608|Hydroxyurea|hydroxyurea|mesh-list
65587775|NCT02480608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385277|NCT02582177|Antiemetics|antiemetics|mesh-ancestor
65587776|NCT02480608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65587777|NCT02480608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587778|NCT02480608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587779|NCT02480608|Antisickling Agents|antisickling agents|mesh-ancestor
65587780|NCT02480608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65587781|NCT02480686|Sofosbuvir|sofosbuvir|mesh-list
65587782|NCT02480686|Antiviral Agents|antiviral agents|mesh-ancestor
65587783|NCT02480686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65587784|NCT02475382|Nivolumab|nivolumab|mesh-list
65587785|NCT02475382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65587786|NCT02475382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587787|NCT02475382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65587788|NCT02475382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587789|NCT02475304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65587790|NCT02475304|Dermatologic Agents|dermatologic agents|mesh-ancestor
65587791|NCT02475304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65587792|NCT02475304|Immunologic Factors|immunologic factors|mesh-ancestor
65587793|NCT02475304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587794|NCT05371288|Thioctic Acid|thioctic acid|mesh-list
65587795|NCT05371288|Acetylcysteine|acetylcysteine|mesh-list
65587796|NCT05371288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65587797|NCT05371288|Antioxidants|antioxidants|mesh-ancestor
65587798|NCT05371288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587799|NCT05371288|Protective Agents|protective agents|mesh-ancestor
65587800|NCT05371288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587801|NCT05371288|Vitamin B Complex|vitamin b complex|mesh-ancestor
65587802|NCT05371288|Vitamins|vitamins|mesh-ancestor
65587803|NCT05371288|Micronutrients|micronutrients|mesh-ancestor
65587804|NCT05371288|Antiviral Agents|antiviral agents|mesh-ancestor
65587805|NCT05371288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65587806|NCT05371288|Expectorants|expectorants|mesh-ancestor
65587807|NCT05371288|Respiratory System Agents|respiratory system agents|mesh-ancestor
65587808|NCT05371288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65587809|NCT05371288|Antidotes|antidotes|mesh-ancestor
65587810|NCT02478424|Cyclosporine|cyclosporine|mesh-list
65587811|NCT02478424|Methotrexate|methotrexate|mesh-list
65587812|NCT02478424|Cannabidiol|cannabidiol|mesh-list
65587813|NCT02478424|Cyclosporins|cyclosporins|mesh-list
65587814|NCT02478424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65587815|NCT02478424|Abortifacient Agents|abortifacient agents|mesh-ancestor
65587816|NCT02478424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65587817|NCT02478424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587818|NCT02478424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65587819|NCT02478424|Antimetabolites|antimetabolites|mesh-ancestor
65587820|NCT02478424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587821|NCT02478424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587822|NCT02478424|Dermatologic Agents|dermatologic agents|mesh-ancestor
65587823|NCT02478424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587824|NCT02478424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65587825|NCT02478424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65587826|NCT02478424|Immunologic Factors|immunologic factors|mesh-ancestor
65587827|NCT02478424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65587828|NCT02478424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65587829|NCT02478424|Antifungal Agents|antifungal agents|mesh-ancestor
65587830|NCT02478424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65587831|NCT02478424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65587832|NCT02478424|Anticonvulsants|anticonvulsants|mesh-ancestor
65587833|NCT03712787|Tilavonemab|tilavonemab|mesh-list
65587834|NCT03712787|Nootropic Agents|nootropic agents|mesh-ancestor
65587835|NCT02478268|Xenon|xenon|mesh-list
65587836|NCT02478268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65587837|NCT02478268|Anesthetics, General|anesthetics, general|mesh-ancestor
65587838|NCT02478268|Anesthetics|anesthetics|mesh-ancestor
65587839|NCT02478268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65587840|NCT02478268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587841|NCT04053881|Certolizumab Pegol|certolizumab pegol|mesh-list
65587842|NCT04053881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65587843|NCT04053881|Immunologic Factors|immunologic factors|mesh-ancestor
65587844|NCT04053881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587845|NCT04053881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65587846|NCT03768557|Minocycline|minocycline|mesh-list
65587847|NCT03768557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65587848|NCT03768557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65587849|NCT03783845|Amoxicillin|amoxicillin|mesh-list
65587850|NCT03783845|Metronidazole|metronidazole|mesh-list
65587851|NCT03783845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65587852|NCT03783845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65587853|NCT03783845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65587854|NCT03783845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65587855|NCT01560689|Budesonide|budesonide|mesh-list
65587856|NCT01560689|Formoterol Fumarate|formoterol fumarate|mesh-list
65587857|NCT01560689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65587858|NCT01560689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65587859|NCT01560689|Autonomic Agents|autonomic agents|mesh-ancestor
65587860|NCT01560689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587861|NCT01560689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587862|NCT01560689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65587863|NCT01560689|Respiratory System Agents|respiratory system agents|mesh-ancestor
65587864|NCT01560689|Glucocorticoids|glucocorticoids|mesh-ancestor
65587865|NCT01560689|Hormones|hormones|mesh-ancestor
65587866|NCT01560689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65587867|NCT01560689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65587868|NCT01560689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65587869|NCT01560689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65587870|NCT01560689|Adrenergic Agents|adrenergic agents|mesh-ancestor
65587871|NCT01560689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65587872|NCT01560689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587873|NCT02474914|Octreotide|octreotide|mesh-list
65587874|NCT02474914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65587875|NCT02474914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65587876|NCT02474914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587877|NCT03769103|Osimertinib|osimertinib|mesh-list
65587878|NCT03769103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587879|NCT03769103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65587880|NCT03769103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587881|NCT03769103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587882|NCT04998214|Thrombin|thrombin|mesh-list
65587883|NCT04998214|Hemostatics|hemostatics|mesh-ancestor
65587884|NCT04998214|Coagulants|coagulants|mesh-ancestor
65587885|NCT01309607|Paclitaxel|paclitaxel|mesh-list
65587886|NCT01309607|Carboplatin|carboplatin|mesh-list
65587887|NCT01309607|Lapatinib|lapatinib|mesh-list
65587888|NCT01309607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65587889|NCT01309607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587890|NCT01309607|Tubulin Modulators|tubulin modulators|mesh-ancestor
65587891|NCT01309607|Antimitotic Agents|antimitotic agents|mesh-ancestor
65587892|NCT01309607|Mitosis Modulators|mitosis modulators|mesh-ancestor
65587893|NCT01309607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587894|NCT01309607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65587895|NCT01309607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587896|NCT03783455|Hyaluronic Acid|hyaluronic acid|mesh-list
65587897|NCT03783455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65587898|NCT03783455|Immunologic Factors|immunologic factors|mesh-ancestor
65587899|NCT03783455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587900|NCT03783455|Viscosupplements|viscosupplements|mesh-ancestor
65587901|NCT03783455|Protective Agents|protective agents|mesh-ancestor
65587902|NCT05305066|Adalimumab|adalimumab|mesh-list
65587903|NCT05305066|Etanercept|etanercept|mesh-list
65587904|NCT05305066|Golimumab|golimumab|mesh-list
65587905|NCT05305066|Upadacitinib|upadacitinib|mesh-list
65587906|NCT05305066|Tofacitinib|tofacitinib|mesh-list
65587907|NCT05305066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65587908|NCT05305066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65587909|NCT05305066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65587910|NCT05305066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65587911|NCT05305066|Analgesics|analgesics|mesh-ancestor
65587912|NCT05305066|Sensory System Agents|sensory system agents|mesh-ancestor
65587913|NCT05305066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587914|NCT05305066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587915|NCT05305066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65587916|NCT05305066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65587917|NCT05305066|Immunologic Factors|immunologic factors|mesh-ancestor
65587918|NCT05305066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65587919|NCT05305066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587920|NCT05305066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587921|NCT05305066|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65587922|NCT05305066|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65587923|NCT05251714|Fulvestrant|fulvestrant|mesh-list
65587924|NCT05251714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65587925|NCT05251714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65587926|NCT05251714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65587927|NCT05251714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65587928|NCT05251714|Hormone Antagonists|hormone antagonists|mesh-ancestor
65587929|NCT05251714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65587930|NCT05251714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587931|NCT02478034|Fludrocortisone|fludrocortisone|mesh-list
65587932|NCT02478034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65587934|NCT02477956|Ergocalciferols|ergocalciferols|mesh-list
65587935|NCT02477956|Cholecalciferol|cholecalciferol|mesh-list
65587936|NCT02477956|Vitamins|vitamins|mesh-list
65587937|NCT02477956|Micronutrients|micronutrients|mesh-ancestor
65587938|NCT02477956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587939|NCT02477956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65587940|NCT02477956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65587941|NCT02472574|Plasminogen|plasminogen|mesh-list
65587942|NCT02472574|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65587943|NCT02472574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65587944|NCT02472574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65587945|NCT02472574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587946|NCT05708248|Pentoxifylline|pentoxifylline|mesh-list
65587947|NCT05708248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65587948|NCT05708248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65587949|NCT05708248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587950|NCT05708248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65587951|NCT05708248|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65587952|NCT05708248|Protective Agents|protective agents|mesh-ancestor
65587953|NCT05708248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587954|NCT05708248|Vasodilator Agents|vasodilator agents|mesh-ancestor
65587955|NCT05708248|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65587956|NCT05708248|Antioxidants|antioxidants|mesh-ancestor
65587957|NCT05685394|Dapagliflozin|dapagliflozin|mesh-list
65587958|NCT05685394|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65587959|NCT05685394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587960|NCT05685394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65587961|NCT05685394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587962|NCT03772223|Budesonide|budesonide|mesh-list
65587963|NCT03772223|Albuterol|albuterol|mesh-list
65587964|NCT03772223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65587965|NCT03772223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65587966|NCT03772223|Autonomic Agents|autonomic agents|mesh-ancestor
65587967|NCT03772223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587968|NCT03772223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587969|NCT03772223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65587970|NCT03772223|Respiratory System Agents|respiratory system agents|mesh-ancestor
65587971|NCT03772223|Glucocorticoids|glucocorticoids|mesh-ancestor
65587972|NCT03772223|Hormones|hormones|mesh-ancestor
65587973|NCT03772223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65587974|NCT03772223|Tocolytic Agents|tocolytic agents|mesh-ancestor
65587975|NCT03772223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65587976|NCT03772223|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65587977|NCT03772223|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65587978|NCT03772223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65587979|NCT03772223|Adrenergic Agents|adrenergic agents|mesh-ancestor
65587980|NCT03772223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65587981|NCT03772223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65587982|NCT03783299|Lumefantrine|lumefantrine|mesh-list
65587983|NCT03783299|Artemether|artemether|mesh-list
65587984|NCT03783299|Primaquine|primaquine|mesh-list
65587985|NCT03783299|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65587986|NCT03783299|Antimalarials|antimalarials|mesh-ancestor
65587987|NCT03783299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65587988|NCT03783299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65587989|NCT03783299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65587990|NCT03771755|Acetaminophen|acetaminophen|mesh-list
65587991|NCT03771755|Ibuprofen|ibuprofen|mesh-list
65587992|NCT03771755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65587993|NCT03771755|Analgesics|analgesics|mesh-ancestor
65587994|NCT03771755|Sensory System Agents|sensory system agents|mesh-ancestor
65587995|NCT03771755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65587996|NCT03771755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65587997|NCT03771755|Antipyretics|antipyretics|mesh-ancestor
65587998|NCT03771755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65587999|NCT03771755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65588000|NCT03771755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65588001|NCT03771755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65588002|NCT03771755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588003|NCT03771755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588004|NCT02477566|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65588005|NCT02477566|Luteolytic Agents|luteolytic agents|mesh-ancestor
65588006|NCT02477566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65588007|NCT02477566|Contraceptive Agents|contraceptive agents|mesh-ancestor
65588008|NCT02477566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65588009|NCT02477566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588010|NCT02477566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65588011|NCT02477566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65588012|NCT02477566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588013|NCT05432531|Cyclophosphamide|cyclophosphamide|mesh-list
65588014|NCT05432531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65588015|NCT05432531|Immunologic Factors|immunologic factors|mesh-ancestor
65588016|NCT05432531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588017|NCT05432531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65588018|NCT05432531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65588019|NCT05432531|Alkylating Agents|alkylating agents|mesh-ancestor
65588020|NCT05432531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588021|NCT05432531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588022|NCT05432531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65588023|NCT01309685|Varenicline|varenicline|mesh-list
65588024|NCT01309685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65588025|NCT01309685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65588026|NCT01309685|Cholinergic Agents|cholinergic agents|mesh-ancestor
65588027|NCT01309685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65588028|NCT01309685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588029|NCT01309685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588030|NCT03782987|Itraconazole|itraconazole|mesh-list
65588031|NCT03782987|Antifungal Agents|antifungal agents|mesh-ancestor
65588032|NCT03782987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588033|NCT03782987|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65588034|NCT03782987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65588035|NCT03782987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588036|NCT03782987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588037|NCT03782987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65588038|NCT03782987|Hormone Antagonists|hormone antagonists|mesh-ancestor
65588039|NCT03782987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65588040|NCT03782987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588041|NCT03782987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65588042|NCT03972527|Analgesics|analgesics|mesh-list
65588043|NCT03972527|Sensory System Agents|sensory system agents|mesh-ancestor
65588044|NCT03972527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65588045|NCT03972527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588046|NCT03772067|Insulin|insulin|mesh-list
65588047|NCT03772067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65588048|NCT03772067|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65588049|NCT03772067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65588050|NCT03772067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588051|NCT03772067|Incretins|incretins|mesh-ancestor
65588052|NCT03772067|Hormones|hormones|mesh-ancestor
65588053|NCT03772067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65588054|NCT03771677|Interferons|interferons|mesh-list
65588055|NCT03771677|Interferon-alpha|interferon-alpha|mesh-list
65588056|NCT03771677|Interferon alpha-2|interferon alpha-2|mesh-list
65588057|NCT03771677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588058|NCT03771677|Antiviral Agents|antiviral agents|mesh-ancestor
65588059|NCT03771677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588060|NCT03771677|Immunologic Factors|immunologic factors|mesh-ancestor
65588061|NCT03771677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588062|NCT03783065|Propranolol|propranolol|mesh-list
65588063|NCT03783065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65588064|NCT03783065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65588065|NCT03783065|Adrenergic Agents|adrenergic agents|mesh-ancestor
65588066|NCT03783065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65588067|NCT03783065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588068|NCT03783065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588069|NCT03783065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65588070|NCT03783065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65588071|NCT03783065|Vasodilator Agents|vasodilator agents|mesh-ancestor
65588072|NCT03766997|Hydrocortisone|hydrocortisone|mesh-list
65588073|NCT03766997|Betamethasone|betamethasone|mesh-list
65588074|NCT03766997|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
65588075|NCT03766997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65588076|NCT03766997|Glucocorticoids|glucocorticoids|mesh-ancestor
65588077|NCT03766997|Hormones|hormones|mesh-ancestor
65385576|NCT04166110|Nasal Decongestants|nasal decongestants|mesh-ancestor
65588078|NCT03766997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65588079|NCT03766997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588081|NCT03766997|Respiratory System Agents|respiratory system agents|mesh-ancestor
65588082|NCT03766997|Dermatologic Agents|dermatologic agents|mesh-ancestor
65588083|NCT03782831|Antibodies|antibodies|mesh-list
65588084|NCT03782831|Immunologic Factors|immunologic factors|mesh-ancestor
65588085|NCT03782831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588086|NCT05539391|Rocuronium|rocuronium|mesh-list
65588087|NCT05539391|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65588088|NCT05539391|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65588089|NCT05539391|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65588090|NCT05539391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65588091|NCT05539391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588092|NCT03766607|Paclitaxel|paclitaxel|mesh-list
65588093|NCT03766607|Trastuzumab|trastuzumab|mesh-list
65588094|NCT03766607|Ramucirumab|ramucirumab|mesh-list
65588095|NCT03766607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65588096|NCT03766607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588097|NCT03766607|Tubulin Modulators|tubulin modulators|mesh-ancestor
65588098|NCT03766607|Antimitotic Agents|antimitotic agents|mesh-ancestor
65588099|NCT03766607|Mitosis Modulators|mitosis modulators|mesh-ancestor
65588100|NCT03766607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588101|NCT03766607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65588102|NCT01567709|Vorinostat|vorinostat|mesh-list
65588103|NCT01567709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588104|NCT01567709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65588105|NCT01567709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588106|NCT01567709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588107|NCT03765827|Vitamins|vitamins|mesh-list
65588108|NCT03765827|Vitamin E|vitamin e|mesh-list
65588109|NCT03765827|Tocopherols|tocopherols|mesh-list
65588110|NCT03765827|Tocotrienols|tocotrienols|mesh-list
65588111|NCT03765827|alpha-Tocopherol|alpha-tocopherol|mesh-list
65588112|NCT03765827|Micronutrients|micronutrients|mesh-ancestor
65588113|NCT03765827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588114|NCT03765827|Antioxidants|antioxidants|mesh-ancestor
65588115|NCT03765827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588116|NCT03765827|Protective Agents|protective agents|mesh-ancestor
65588117|NCT03771053|Simvastatin|simvastatin|mesh-list
65588118|NCT03771053|Ezetimibe|ezetimibe|mesh-list
65588119|NCT03771053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65588120|NCT03771053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65588121|NCT03771053|Antimetabolites|antimetabolites|mesh-ancestor
65588122|NCT03771053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588123|NCT03771053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65588124|NCT03771053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65588125|NCT03771053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588126|NCT03770663|Cyclophosphamide|cyclophosphamide|mesh-list
65588127|NCT03770663|Azathioprine|azathioprine|mesh-list
65588128|NCT03770663|Tacrolimus|tacrolimus|mesh-list
65588129|NCT03770663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65588130|NCT03770663|Immunologic Factors|immunologic factors|mesh-ancestor
65588131|NCT03770663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588132|NCT03770663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65588133|NCT03770663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65588134|NCT03770663|Alkylating Agents|alkylating agents|mesh-ancestor
65588135|NCT03770663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588136|NCT03770663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588137|NCT03770663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65588138|NCT03770663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65588139|NCT03770663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588140|NCT03770663|Antimetabolites|antimetabolites|mesh-ancestor
65588141|NCT03770663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65588142|NCT03048422|Tenofovir|tenofovir|mesh-list
65588143|NCT03048422|Emtricitabine|emtricitabine|mesh-list
65588144|NCT03048422|Efavirenz|efavirenz|mesh-list
65588145|NCT03048422|Dolutegravir|dolutegravir|mesh-list
65588146|NCT03048422|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65588147|NCT03048422|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65588148|NCT03048422|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65588149|NCT03048422|Antiviral Agents|antiviral agents|mesh-ancestor
65588150|NCT03048422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588151|NCT03048422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65588152|NCT03048422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65588153|NCT03048422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588154|NCT03048422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588155|NCT03048422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65588156|NCT03048422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65588157|NCT03048422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65588158|NCT03048422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65588159|NCT03048422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65588160|NCT03048422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65588161|NCT03048422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65588162|NCT03048422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65588163|NCT03048422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65588164|NCT03048422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65588165|NCT01561781|Digoxin|digoxin|mesh-list
65588166|NCT01561781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65588167|NCT01561781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65588168|NCT01561781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588169|NCT01561781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588170|NCT01561781|Protective Agents|protective agents|mesh-ancestor
65588171|NCT01561781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588172|NCT04259255|Edaravone|edaravone|mesh-list
65588173|NCT04259255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65588174|NCT04259255|Antioxidants|antioxidants|mesh-ancestor
65588175|NCT04259255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588176|NCT04259255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65588177|NCT04259255|Protective Agents|protective agents|mesh-ancestor
65588178|NCT04259255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588179|NCT03770039|PF-06700841|pf-06700841|mesh-list
65588180|NCT03770039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65588181|NCT03770039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588182|NCT03770039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588183|NCT01321775|Paclitaxel|paclitaxel|mesh-list
65588184|NCT01321775|Cyclophosphamide|cyclophosphamide|mesh-list
65588185|NCT01321775|Bevacizumab|bevacizumab|mesh-list
65588186|NCT01321775|Trastuzumab|trastuzumab|mesh-list
65588187|NCT01321775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65588188|NCT01321775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588189|NCT01321775|Tubulin Modulators|tubulin modulators|mesh-ancestor
65588190|NCT01321775|Antimitotic Agents|antimitotic agents|mesh-ancestor
65588191|NCT01321775|Mitosis Modulators|mitosis modulators|mesh-ancestor
65588192|NCT01321775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588193|NCT01321775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65588194|NCT01321775|Immunologic Factors|immunologic factors|mesh-ancestor
65588195|NCT01321775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588196|NCT01321775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65588197|NCT01321775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65588198|NCT01321775|Alkylating Agents|alkylating agents|mesh-ancestor
65588199|NCT01321775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65588200|NCT01321775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65588201|NCT01321775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65588202|NCT01321775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65588203|NCT01321775|Growth Substances|growth substances|mesh-ancestor
65588204|NCT01321775|Growth Inhibitors|growth inhibitors|mesh-ancestor
65588205|NCT05514509|Cabotegravir|cabotegravir|mesh-list
65588206|NCT05514509|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65588207|NCT05514509|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65588208|NCT05514509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588209|NCT05514509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588210|NCT05514509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65588211|NCT05514509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65588212|NCT05514509|Antiviral Agents|antiviral agents|mesh-ancestor
65588213|NCT05514509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588214|NCT03764267|Lidocaine|lidocaine|mesh-list
65588215|NCT03764267|Remifentanil|remifentanil|mesh-list
65588216|NCT03764267|Anesthetics|anesthetics|mesh-list
65588217|NCT03764267|Anesthetics, General|anesthetics, general|mesh-list
65588218|NCT03764267|Anesthetics, Local|anesthetics, local|mesh-ancestor
65588219|NCT03764267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65588220|NCT03764267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588221|NCT03764267|Sensory System Agents|sensory system agents|mesh-ancestor
65588222|NCT03764267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65588223|NCT03764267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65588224|NCT03764267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65385729|NCT01014832|Insulin|insulin|mesh-list
65588225|NCT03764267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65588226|NCT03764267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65588227|NCT03764267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588228|NCT03764267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65588229|NCT03764267|Narcotics|narcotics|mesh-ancestor
65588230|NCT03764267|Analgesics|analgesics|mesh-ancestor
65588231|NCT01321931|Nicotine|nicotine|mesh-list
65588232|NCT01321931|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65588233|NCT01321931|Autonomic Agents|autonomic agents|mesh-ancestor
65588234|NCT01321931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65588235|NCT01321931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588236|NCT01321931|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65588237|NCT01321931|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65588238|NCT01321931|Cholinergic Agents|cholinergic agents|mesh-ancestor
65588239|NCT01321931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65588240|NCT01321931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588241|NCT03763409|Losartan|losartan|mesh-list
65588242|NCT03763409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65588243|NCT03763409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65588244|NCT03763409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65588245|NCT03763409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65588246|NCT03763409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588247|NCT01322477|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65588248|NCT01322477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65588249|NCT01322477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588250|NCT03762785|Dexmedetomidine|dexmedetomidine|mesh-list
65588251|NCT03762785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65588252|NCT03762785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65588253|NCT03762785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588254|NCT03762785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65588255|NCT03762785|Analgesics|analgesics|mesh-ancestor
65588256|NCT03762785|Sensory System Agents|sensory system agents|mesh-ancestor
65588257|NCT03762785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65588258|NCT03762785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65588259|NCT03762785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65588260|NCT03762785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65588261|NCT03762785|Adrenergic Agents|adrenergic agents|mesh-ancestor
65588262|NCT03762785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65588263|NCT03762785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588264|NCT03758729|Nivolumab|nivolumab|mesh-list
65588265|NCT03758729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65588266|NCT03758729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588267|NCT03758729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65588268|NCT03758729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588269|NCT03756623|Metformin|metformin|mesh-list
65588270|NCT03756623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65588271|NCT03756623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588272|NCT03599453|Interferons|interferons|mesh-list
65588273|NCT03599453|Interferon-alpha|interferon-alpha|mesh-list
65588274|NCT03599453|Interferon alpha-2|interferon alpha-2|mesh-list
65588275|NCT03599453|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
65588276|NCT03599453|Poly I-C|poly i-c|mesh-list
65588277|NCT03599453|Celecoxib|celecoxib|mesh-list
65588278|NCT03599453|Pembrolizumab|pembrolizumab|mesh-list
65588279|NCT03599453|Immunoglobulins|immunoglobulins|mesh-list
65588280|NCT03599453|Immunoglobulin G|immunoglobulin g|mesh-list
65588281|NCT03599453|Benzenesulfonamide|benzenesulfonamide|mesh-list
65588282|NCT03599453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65588283|NCT03599453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588284|NCT03599453|Antiviral Agents|antiviral agents|mesh-ancestor
65588285|NCT03599453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588286|NCT03599453|Immunologic Factors|immunologic factors|mesh-ancestor
65588287|NCT03599453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588288|NCT03599453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65588289|NCT03599453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65588290|NCT03599453|Analgesics|analgesics|mesh-ancestor
65588291|NCT03599453|Sensory System Agents|sensory system agents|mesh-ancestor
65588292|NCT03599453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65588293|NCT03599453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65588294|NCT03599453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65588295|NCT03599453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65588296|NCT03599453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65588297|NCT03599453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588298|NCT03599453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588299|NCT03599453|Interferon Inducers|interferon inducers|mesh-ancestor
65588300|NCT03599453|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65588302|NCT03756233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65588303|NCT03756233|Narcotics|narcotics|mesh-ancestor
65588304|NCT03756233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65588305|NCT03756233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588306|NCT03756233|Analgesics|analgesics|mesh-ancestor
65588307|NCT03756233|Sensory System Agents|sensory system agents|mesh-ancestor
65588308|NCT03756233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65588309|NCT03758339|Tucatinib|tucatinib|mesh-list
65588310|NCT03758339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588311|NCT03758339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65588312|NCT03758339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588313|NCT03758339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588314|NCT03565913|Calcium, Dietary|calcium, dietary|mesh-list
65588315|NCT03565913|Magnesium citrate|magnesium citrate|mesh-list
65588316|NCT03565913|Calcium|calcium|mesh-list
65588317|NCT03565913|Calcium acetate|calcium acetate|mesh-list
65588318|NCT03565913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65588319|NCT03565913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588320|NCT03565913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65588321|NCT03565913|Chelating Agents|chelating agents|mesh-ancestor
65588322|NCT03565913|Sequestering Agents|sequestering agents|mesh-ancestor
65588323|NCT03565913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588324|NCT03565913|Cathartics|cathartics|mesh-ancestor
65588325|NCT03565913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65588326|NCT05085665|Ivermectin|ivermectin|mesh-list
65588327|NCT05085665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65588328|NCT05085665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588329|NCT05004077|Amiodarone|amiodarone|mesh-list
65588330|NCT05004077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65588331|NCT05004077|Vasodilator Agents|vasodilator agents|mesh-ancestor
65588332|NCT05004077|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65588333|NCT05004077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65588334|NCT05004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588335|NCT05004077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65588336|NCT05004077|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65588337|NCT05004077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65588338|NCT05004077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588339|NCT05004077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65588340|NCT05004077|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65588341|NCT05004077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65588342|NCT03755609|Fentanyl|fentanyl|mesh-list
65588343|NCT03755609|Oxycodone|oxycodone|mesh-list
65588344|NCT03755609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65588345|NCT03755609|Narcotics|narcotics|mesh-ancestor
65588346|NCT03755609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65588347|NCT03755609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588348|NCT03755609|Analgesics|analgesics|mesh-ancestor
65588349|NCT03755609|Sensory System Agents|sensory system agents|mesh-ancestor
65588350|NCT03755609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65588351|NCT03755609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65588352|NCT03755609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65588353|NCT03755609|Anesthetics, General|anesthetics, general|mesh-ancestor
65588354|NCT03755609|Anesthetics|anesthetics|mesh-ancestor
65588355|NCT03760445|Cytarabine|cytarabine|mesh-list
65588356|NCT03760445|Posaconazole|posaconazole|mesh-list
65588357|NCT03760445|Daunorubicin|daunorubicin|mesh-list
65588358|NCT03760445|Idarubicin|idarubicin|mesh-list
65588359|NCT03760445|Midostaurin|midostaurin|mesh-list
65588360|NCT03760445|Midazolam|midazolam|mesh-list
65588361|NCT03760445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65588362|NCT03760445|Antimetabolites|antimetabolites|mesh-ancestor
65588363|NCT03760445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588364|NCT03760445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588365|NCT03760445|Antiviral Agents|antiviral agents|mesh-ancestor
65588366|NCT03760445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588367|NCT03760445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65588368|NCT03760445|Immunologic Factors|immunologic factors|mesh-ancestor
65588369|NCT03760445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588370|NCT03760445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65588371|NCT03760445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65588372|NCT03760445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65588373|NCT03760445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65588374|NCT03760445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65588376|NCT03760445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65588377|NCT03760445|Anesthetics, General|anesthetics, general|mesh-ancestor
65588378|NCT03760445|Anesthetics|anesthetics|mesh-ancestor
65588379|NCT03760445|GABA Modulators|gaba modulators|mesh-ancestor
65588380|NCT03760445|GABA Agents|gaba agents|mesh-ancestor
65588381|NCT03760445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65588382|NCT03760445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65588383|NCT03760445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65588384|NCT03760445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65588385|NCT03760445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588386|NCT03760445|Antifungal Agents|antifungal agents|mesh-ancestor
65588387|NCT03760445|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65588388|NCT03760445|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65588389|NCT03760445|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65588390|NCT03760445|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65588391|NCT03760445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65588392|NCT03760445|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65588393|NCT03760445|Hormone Antagonists|hormone antagonists|mesh-ancestor
65588394|NCT03760445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65588395|NCT03760445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65588396|NCT05460377|Vaccines|vaccines|mesh-list
65588397|NCT05460377|Immunologic Factors|immunologic factors|mesh-ancestor
65588398|NCT05460377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588399|NCT04956575|Vaccines|vaccines|mesh-list
65588400|NCT04956575|Immunologic Factors|immunologic factors|mesh-ancestor
65588401|NCT04956575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588402|NCT05692856|Clenbuterol|clenbuterol|mesh-list
65588403|NCT05692856|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65588404|NCT05692856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65588405|NCT05692856|Adrenergic Agents|adrenergic agents|mesh-ancestor
65588406|NCT05692856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65588407|NCT05692856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588408|NCT05692856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588409|NCT05692856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65588410|NCT05692856|Autonomic Agents|autonomic agents|mesh-ancestor
65588411|NCT05692856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65588412|NCT05692856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65588413|NCT05692856|Respiratory System Agents|respiratory system agents|mesh-ancestor
65588414|NCT05692856|Sympathomimetics|sympathomimetics|mesh-ancestor
65588415|NCT04300556|Farletuzumab|farletuzumab|mesh-list
65588416|NCT04300556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588417|NCT03755531|Oxytocin|oxytocin|mesh-list
65588418|NCT03755531|Carbetocin|carbetocin|mesh-list
65588419|NCT03755531|Oxytocics|oxytocics|mesh-ancestor
65588420|NCT03755531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65588421|NCT03755531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588422|NCT04854707|Menotropins|menotropins|mesh-list
65588423|NCT04854707|Hormones|hormones|mesh-list
65588424|NCT04854707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65588425|NCT04854707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65588426|NCT04854707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588427|NCT04854707|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65588428|NCT04854707|Fertility Agents|fertility agents|mesh-ancestor
65588429|NCT04854707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65588430|NCT03215069|Empagliflozin|empagliflozin|mesh-list
65588431|NCT03215069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65588432|NCT03215069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588433|NCT03215069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65588434|NCT03215069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588435|NCT03759353|Lactoferrin|lactoferrin|mesh-list
65588436|NCT03759353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588437|NCT03757559|Hydromorphone|hydromorphone|mesh-list
65588438|NCT03757559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65588439|NCT03757559|Narcotics|narcotics|mesh-ancestor
65588440|NCT03757559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65588441|NCT03757559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588442|NCT03757559|Analgesics|analgesics|mesh-ancestor
65588443|NCT03757559|Sensory System Agents|sensory system agents|mesh-ancestor
65588444|NCT03757559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65588445|NCT05668949|Pembrolizumab|pembrolizumab|mesh-list
65588446|NCT05668949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65588447|NCT05668949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588448|NCT05415917|Gemcitabine|gemcitabine|mesh-list
65588449|NCT05415917|Capecitabine|capecitabine|mesh-list
65385956|NCT05674565|Analgesics|analgesics|mesh-ancestor
65588450|NCT05415917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65588451|NCT05415917|Antimetabolites|antimetabolites|mesh-ancestor
65588452|NCT05415917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588453|NCT05415917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588454|NCT05415917|Antiviral Agents|antiviral agents|mesh-ancestor
65588455|NCT05415917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588456|NCT05415917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588457|NCT05415917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65588458|NCT05415917|Immunologic Factors|immunologic factors|mesh-ancestor
65588459|NCT05415917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588460|NCT04792073|Avelumab|avelumab|mesh-list
65588461|NCT04792073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65588462|NCT04792073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588463|NCT02780804|Entinostat|entinostat|mesh-list
65588464|NCT02780804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588465|NCT02780804|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65588466|NCT02780804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588467|NCT02780804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588468|NCT01322711|Atorvastatin|atorvastatin|mesh-list
65588469|NCT01322711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65588470|NCT01322711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65588471|NCT01322711|Antimetabolites|antimetabolites|mesh-ancestor
65588472|NCT01322711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588473|NCT01322711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65588474|NCT01322711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65588475|NCT01322711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588476|NCT04532099|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65588477|NCT04532099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65588478|NCT04532099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588479|NCT03041792|Liraglutide|liraglutide|mesh-list
65588480|NCT03041792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65588481|NCT03041792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588482|NCT03041792|Incretins|incretins|mesh-ancestor
65588483|NCT03041792|Hormones|hormones|mesh-ancestor
65588484|NCT03041792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65588485|NCT03753581|Cytarabine|cytarabine|mesh-list
65588486|NCT03753581|Methotrexate|methotrexate|mesh-list
65588487|NCT03753581|Etoposide|etoposide|mesh-list
65588488|NCT03753581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65588489|NCT03753581|Antimetabolites|antimetabolites|mesh-ancestor
65588490|NCT03753581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588491|NCT03753581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588492|NCT03753581|Antiviral Agents|antiviral agents|mesh-ancestor
65588493|NCT03753581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588494|NCT03753581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65588495|NCT03753581|Immunologic Factors|immunologic factors|mesh-ancestor
65588496|NCT03753581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588497|NCT03753581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65588498|NCT03753581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65588499|NCT03753581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65588500|NCT03753581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588501|NCT03753581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65588502|NCT03753581|Abortifacient Agents|abortifacient agents|mesh-ancestor
65588503|NCT03753581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65588504|NCT03753581|Dermatologic Agents|dermatologic agents|mesh-ancestor
65588505|NCT03753581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65588506|NCT03753581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65588507|NCT03753581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65588508|NCT04507763|Etanercept|etanercept|mesh-list
65588509|NCT04507763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65588510|NCT04507763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65588511|NCT04507763|Analgesics|analgesics|mesh-ancestor
65588512|NCT04507763|Sensory System Agents|sensory system agents|mesh-ancestor
64368580|NCT05015829|Dobutamine|dobutamine|mesh-list
65588513|NCT04507763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65588514|NCT04507763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588515|NCT04507763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65588516|NCT04507763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65588517|NCT04507763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65588518|NCT04507763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65588519|NCT04507763|Immunologic Factors|immunologic factors|mesh-ancestor
65588520|NCT00705484|Infliximab|infliximab|mesh-list
65588521|NCT00705484|Dermatologic Agents|dermatologic agents|mesh-ancestor
65588522|NCT00705484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65588523|NCT00705484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65386029|NCT01005537|Alkylating Agents|alkylating agents|mesh-ancestor
65588524|NCT05459597|Anticonvulsants|anticonvulsants|mesh-list
65588526|NCT05358626|Immunoglobulin G|immunoglobulin g|mesh-list
65588527|NCT05358626|Immunologic Factors|immunologic factors|mesh-ancestor
65588528|NCT05358626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588529|NCT03753269|Fasudil|fasudil|mesh-list
65588530|NCT03753269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65588531|NCT03753269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65588532|NCT03753269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588533|NCT03753269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65588534|NCT03753269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588535|NCT03753269|Vasodilator Agents|vasodilator agents|mesh-ancestor
65588536|NCT03753269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65588537|NCT03753269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588538|NCT05459441|Pemetrexed|pemetrexed|mesh-list
65588539|NCT05459441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588540|NCT05459441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588541|NCT05459441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588542|NCT05459441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65588543|NCT05459441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65588544|NCT04523831|Doxycycline|doxycycline|mesh-list
65588545|NCT04523831|Ivermectin|ivermectin|mesh-list
65588546|NCT04523831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65588547|NCT04523831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588548|NCT04523831|Antimalarials|antimalarials|mesh-ancestor
65588549|NCT04523831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65588550|NCT04523831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65588551|NCT05691764|Cyclosporine|cyclosporine|mesh-list
65588552|NCT05691764|Cyclosporins|cyclosporins|mesh-list
65588553|NCT05691764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588554|NCT05691764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588555|NCT05691764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65588556|NCT05691764|Immunologic Factors|immunologic factors|mesh-ancestor
65588557|NCT05691764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588558|NCT05691764|Antifungal Agents|antifungal agents|mesh-ancestor
65588559|NCT05691764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588560|NCT05691764|Dermatologic Agents|dermatologic agents|mesh-ancestor
65588561|NCT05691764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65588562|NCT05691764|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65588563|NCT04707664|Sargramostim|sargramostim|mesh-list
65588564|NCT04707664|Immunologic Factors|immunologic factors|mesh-ancestor
65588565|NCT04707664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588566|NCT01316276|Amikacin|amikacin|mesh-list
65588567|NCT01316276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65588568|NCT01316276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588569|NCT02474290|Sorafenib|sorafenib|mesh-list
65588570|NCT02474290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588571|NCT02474290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65588572|NCT02474290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588573|NCT02474290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588574|NCT02474212|Enoxaparin|enoxaparin|mesh-list
65588575|NCT02474212|Anticoagulants|anticoagulants|mesh-ancestor
65588576|NCT02474212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65588577|NCT02474212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65588578|NCT02474212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588579|NCT05200286|Olorofim|olorofim|mesh-list
65588580|NCT05200286|Antifungal Agents|antifungal agents|mesh-ancestor
65588581|NCT05200286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588582|NCT02474446|Vitamin D|vitamin d|mesh-list
65588583|NCT02474446|Vitamins|vitamins|mesh-ancestor
65588584|NCT02474446|Micronutrients|micronutrients|mesh-ancestor
65588585|NCT02474446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588586|NCT02474446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65588587|NCT05199818|Palonosetron|palonosetron|mesh-list
65588588|NCT05199818|Antiemetics|antiemetics|mesh-ancestor
65588589|NCT05199818|Autonomic Agents|autonomic agents|mesh-ancestor
65588590|NCT05199818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65588591|NCT05199818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588592|NCT05199818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65588593|NCT05199818|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65588594|NCT05199818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65588595|NCT05199818|Serotonin Agents|serotonin agents|mesh-ancestor
65588596|NCT05199818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65588597|NCT05199818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588598|NCT02474134|Interferons|interferons|mesh-list
65588599|NCT02474134|Interferon-beta|interferon-beta|mesh-list
65588600|NCT02474134|Interferon beta-1b|interferon beta-1b|mesh-list
65588601|NCT02474134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588602|NCT02474134|Antiviral Agents|antiviral agents|mesh-ancestor
65588603|NCT02474134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588604|NCT02474134|Immunologic Factors|immunologic factors|mesh-ancestor
65588605|NCT02474134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588606|NCT02474134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65588608|NCT02473900|Antiviral Agents|antiviral agents|mesh-ancestor
65588609|NCT02473900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588610|NCT02473900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588611|NCT02473900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588612|NCT02471950|Isoflurane|isoflurane|mesh-list
65588613|NCT02471950|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65588614|NCT02471950|Anesthetics, General|anesthetics, general|mesh-ancestor
65588615|NCT02471950|Anesthetics|anesthetics|mesh-ancestor
65588616|NCT02471950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65588617|NCT02471950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588618|NCT01322867|Alprazolam|alprazolam|mesh-list
65588619|NCT01322867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65588620|NCT01322867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65588621|NCT01322867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588622|NCT01322867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65588623|NCT01322867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65588624|NCT01322867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65588625|NCT01322867|GABA Modulators|gaba modulators|mesh-ancestor
65588626|NCT01322867|GABA Agents|gaba agents|mesh-ancestor
65588627|NCT01322867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65588628|NCT01322867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588629|NCT04624828|Androgens|androgens|mesh-list
65588630|NCT04624828|Hormones|hormones|mesh-ancestor
65588631|NCT04624828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65588632|NCT04624828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588633|NCT02471560|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65588634|NCT02471560|Dermatologic Agents|dermatologic agents|mesh-ancestor
65588635|NCT02471560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65588636|NCT02471560|Immunologic Factors|immunologic factors|mesh-ancestor
65588637|NCT02471560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588638|NCT02477488|Allopurinol|allopurinol|mesh-list
65588639|NCT02477488|Antimetabolites|antimetabolites|mesh-ancestor
65588640|NCT02477488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588641|NCT02477488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588642|NCT02477488|Gout Suppressants|gout suppressants|mesh-ancestor
65588643|NCT02477488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65588644|NCT02477488|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65588645|NCT02477488|Antioxidants|antioxidants|mesh-ancestor
65588646|NCT02477488|Protective Agents|protective agents|mesh-ancestor
65588647|NCT02477488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588648|NCT05163106|Letrozole|letrozole|mesh-list
65588649|NCT05163106|Goserelin|goserelin|mesh-list
65588650|NCT05163106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588651|NCT05163106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65588652|NCT05163106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65588653|NCT05163106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588654|NCT05163106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588655|NCT05163106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65588656|NCT05163106|Hormone Antagonists|hormone antagonists|mesh-ancestor
65588657|NCT05163106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65588658|NCT05163106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588659|NCT05163106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65588660|NCT02477098|Ropivacaine|ropivacaine|mesh-list
65588661|NCT02477098|Anesthetics, Local|anesthetics, local|mesh-ancestor
65588662|NCT02477098|Anesthetics|anesthetics|mesh-ancestor
65588663|NCT02477098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65588664|NCT02477098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588665|NCT02477098|Sensory System Agents|sensory system agents|mesh-ancestor
65588666|NCT02477098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65588667|NCT04518046|Nivolumab|nivolumab|mesh-list
65588668|NCT04518046|Ipilimumab|ipilimumab|mesh-list
65588669|NCT04518046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65588670|NCT04518046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588671|NCT04518046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65588672|NCT04518046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588673|NCT05571670|Sirolimus|sirolimus|mesh-list
65588674|NCT05571670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588675|NCT05571670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65588676|NCT05571670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588677|NCT05571670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65588678|NCT05571670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588679|NCT05571670|Antifungal Agents|antifungal agents|mesh-ancestor
65588680|NCT05571670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65588681|NCT05571670|Immunologic Factors|immunologic factors|mesh-ancestor
65588682|NCT02473354|Remifentanil|remifentanil|mesh-list
65588683|NCT02473354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65588684|NCT02473354|Narcotics|narcotics|mesh-ancestor
65588685|NCT02473354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65588686|NCT02473354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588687|NCT02473354|Analgesics|analgesics|mesh-ancestor
65588688|NCT02473354|Sensory System Agents|sensory system agents|mesh-ancestor
65588689|NCT02473354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65588690|NCT02470858|Sofosbuvir|sofosbuvir|mesh-list
65588691|NCT02470858|Asunaprevir|asunaprevir|mesh-list
65588692|NCT02470858|Antiviral Agents|antiviral agents|mesh-ancestor
65588693|NCT02470858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588694|NCT02470858|Protease Inhibitors|protease inhibitors|mesh-ancestor
65588695|NCT02470858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588696|NCT02470858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588697|NCT02473198|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65588698|NCT02473198|Morphine|morphine|mesh-list
65588699|NCT02473198|Bupivacaine|bupivacaine|mesh-list
65588700|NCT02473198|Anesthetics, Local|anesthetics, local|mesh-ancestor
65588701|NCT02473198|Anesthetics|anesthetics|mesh-ancestor
65588702|NCT02473198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65588703|NCT02473198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588704|NCT02473198|Sensory System Agents|sensory system agents|mesh-ancestor
65588705|NCT02473198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65588706|NCT02473198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65588707|NCT02473198|Narcotics|narcotics|mesh-ancestor
65588708|NCT02473198|Analgesics|analgesics|mesh-ancestor
65588709|NCT02473198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65588710|NCT02473198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65588711|NCT02473198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65588712|NCT02473198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65588713|NCT02473198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65588714|NCT02473198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588715|NCT02473198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588716|NCT03614728|Azacitidine|azacitidine|mesh-list
65588717|NCT03614728|GSK-3326595|gsk-3326595|mesh-list
65588718|NCT03614728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65588719|NCT03614728|Antimetabolites|antimetabolites|mesh-ancestor
65588720|NCT03614728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588721|NCT03614728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588722|NCT03614728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588723|NCT05069974|Linezolid|linezolid|mesh-list
65588724|NCT05069974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65588725|NCT05069974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588726|NCT05069974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65588727|NCT05069974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588728|NCT05069974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588729|NCT05190770|Triamcinolone|triamcinolone|mesh-list
65588730|NCT05190770|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65588731|NCT05190770|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65588732|NCT05190770|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65588733|NCT05190770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65588734|NCT05190770|Glucocorticoids|glucocorticoids|mesh-ancestor
65588735|NCT05190770|Hormones|hormones|mesh-ancestor
65588736|NCT05190770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65588737|NCT05190770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588738|NCT05190770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65588739|NCT05190770|Immunologic Factors|immunologic factors|mesh-ancestor
65588740|NCT05190770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588741|NCT05190770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588742|NCT05336266|Ketorolac|ketorolac|mesh-list
65588743|NCT05336266|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65588744|NCT05336266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65588745|NCT05336266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65588746|NCT05336266|Analgesics|analgesics|mesh-ancestor
65588747|NCT05336266|Sensory System Agents|sensory system agents|mesh-ancestor
65588748|NCT05336266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65588749|NCT05336266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588750|NCT05336266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65588751|NCT05336266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65588752|NCT05336266|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65588753|NCT05336266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588754|NCT05336266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588755|NCT02470780|Rifaximin|rifaximin|mesh-list
65588756|NCT02470780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65588757|NCT02470780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588758|NCT02470780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65588759|NCT04283500|Buprenorphine|buprenorphine|mesh-list
65588760|NCT04283500|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65588761|NCT04283500|Naloxone|naloxone|mesh-list
65588762|NCT04283500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65588763|NCT04283500|Narcotics|narcotics|mesh-ancestor
65588764|NCT04283500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65588765|NCT04283500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588766|NCT04283500|Analgesics|analgesics|mesh-ancestor
65588767|NCT04283500|Sensory System Agents|sensory system agents|mesh-ancestor
65588768|NCT04283500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65588769|NCT04283500|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65588770|NCT05180292|Carvedilol|carvedilol|mesh-list
65588771|NCT05180292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65588772|NCT05180292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65588773|NCT05180292|Adrenergic Agents|adrenergic agents|mesh-ancestor
65588774|NCT05180292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65588775|NCT05180292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588776|NCT05180292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588777|NCT05180292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65588778|NCT05180292|Antioxidants|antioxidants|mesh-ancestor
65588779|NCT05180292|Protective Agents|protective agents|mesh-ancestor
65588780|NCT05180292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65588781|NCT05180292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65588782|NCT05180292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65588783|NCT05180292|Vasodilator Agents|vasodilator agents|mesh-ancestor
65588784|NCT05180292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65588785|NCT05180292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65588786|NCT01315938|Abatacept|abatacept|mesh-list
65588787|NCT01315938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65588788|NCT01315938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588789|NCT01315938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588790|NCT01315938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65588791|NCT01315938|Immunologic Factors|immunologic factors|mesh-ancestor
65588792|NCT01315938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588793|NCT01315938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65588794|NCT01339884|Resveratrol|resveratrol|mesh-list
65588795|NCT01339884|Antioxidants|antioxidants|mesh-ancestor
65588796|NCT01339884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588797|NCT01339884|Protective Agents|protective agents|mesh-ancestor
65588798|NCT01339884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588799|NCT01339884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588800|NCT01339884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65588801|NCT04736394|Epirubicin|epirubicin|mesh-list
65588802|NCT04736394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65588803|NCT04736394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588804|NCT04736394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65588805|NCT04736394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65588806|NCT04736394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588807|NCT04736394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588808|NCT01341834|Everolimus|everolimus|mesh-list
65588809|NCT01341834|Panobinostat|panobinostat|mesh-list
65588810|NCT01341834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588811|NCT01341834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65588812|NCT01341834|Immunologic Factors|immunologic factors|mesh-ancestor
65588813|NCT01341834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588814|NCT01341834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65588815|NCT01341834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588816|NCT01341834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588817|NCT01340118|Budesonide|budesonide|mesh-list
65588818|NCT01340118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65588819|NCT01340118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65588820|NCT01340118|Autonomic Agents|autonomic agents|mesh-ancestor
65588821|NCT01340118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65588822|NCT01340118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588823|NCT01340118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65588824|NCT01340118|Respiratory System Agents|respiratory system agents|mesh-ancestor
65386337|NCT00143455|Cisplatin|cisplatin|mesh-list
65588825|NCT01340118|Glucocorticoids|glucocorticoids|mesh-ancestor
65588826|NCT01340118|Hormones|hormones|mesh-ancestor
65588827|NCT01340118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65588828|NCT03401398|Hydrocortisone|hydrocortisone|mesh-list
65588829|NCT03401398|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65588830|NCT03401398|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65588831|NCT03401398|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65588832|NCT03401398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65588833|NCT02470702|Oritavancin|oritavancin|mesh-list
65588834|NCT02470702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65588835|NCT02470702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588836|NCT01375582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65588837|NCT01375582|Lubricant Eye Drops|lubricant eye drops|mesh-list
65588838|NCT01375582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65588839|NCT04409964|Lidocaine|lidocaine|mesh-list
65588840|NCT04409964|Dexmedetomidine|dexmedetomidine|mesh-list
65588841|NCT04409964|Remifentanil|remifentanil|mesh-list
65588842|NCT04409964|Anesthetics, Local|anesthetics, local|mesh-ancestor
65588843|NCT04409964|Anesthetics|anesthetics|mesh-ancestor
65588844|NCT04409964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65588845|NCT04409964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588846|NCT04409964|Sensory System Agents|sensory system agents|mesh-ancestor
65588847|NCT04409964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65588848|NCT04409964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65588849|NCT04409964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65588850|NCT04409964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65588851|NCT04409964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65588852|NCT04409964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588853|NCT04409964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65588854|NCT04409964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65588855|NCT04409964|Analgesics|analgesics|mesh-ancestor
65588856|NCT04409964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65588857|NCT04409964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65588858|NCT04409964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65588859|NCT04409964|Adrenergic Agents|adrenergic agents|mesh-ancestor
65588860|NCT04409964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65588861|NCT04409964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65588862|NCT04409964|Narcotics|narcotics|mesh-ancestor
65588863|NCT01342146|Hormones|hormones|mesh-list
65588864|NCT01342146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65588865|NCT01342146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588866|NCT03212716|Oseltamivir|oseltamivir|mesh-list
65588867|NCT03212716|Diltiazem|diltiazem|mesh-list
65588868|NCT03212716|Antiviral Agents|antiviral agents|mesh-ancestor
65588869|NCT03212716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588870|NCT03212716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588871|NCT03212716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588872|NCT03212716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65588873|NCT03212716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65588874|NCT03212716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65588875|NCT03212716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65588876|NCT03212716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588877|NCT03212716|Vasodilator Agents|vasodilator agents|mesh-ancestor
65588878|NCT04762836|Cycloserine|cycloserine|mesh-list
65588879|NCT04762836|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65588880|NCT04762836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588881|NCT04762836|Renal Agents|renal agents|mesh-ancestor
65588882|NCT04762836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65588883|NCT04762836|Antitubercular Agents|antitubercular agents|mesh-ancestor
65588884|NCT04762836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65588885|NCT04762836|Antimetabolites|antimetabolites|mesh-ancestor
65588886|NCT04762836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588887|NCT00705406|Peramivir|peramivir|mesh-list
65588888|NCT00705406|Antiviral Agents|antiviral agents|mesh-ancestor
65588889|NCT00705406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588890|NCT00705406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588891|NCT00705406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588892|NCT01342224|Gemcitabine|gemcitabine|mesh-list
65588893|NCT01342224|Tadalafil|tadalafil|mesh-list
65588894|NCT01342224|Sargramostim|sargramostim|mesh-list
65588895|NCT01342224|Immunologic Factors|immunologic factors|mesh-ancestor
65588896|NCT01342224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588897|NCT01342224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65588898|NCT01342224|Antimetabolites|antimetabolites|mesh-ancestor
65588899|NCT01342224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588900|NCT01342224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588901|NCT01342224|Antiviral Agents|antiviral agents|mesh-ancestor
65588902|NCT01342224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588903|NCT01342224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588904|NCT01342224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65588905|NCT01342224|Vasodilator Agents|vasodilator agents|mesh-ancestor
65588906|NCT01342224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65588907|NCT01342224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65588908|NCT01342224|Urological Agents|urological agents|mesh-ancestor
65588909|NCT03155178|Ethanol|ethanol|mesh-list
65588910|NCT03155178|Chlorhexidine|chlorhexidine|mesh-list
65588911|NCT03155178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65588912|NCT03155178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65588913|NCT03155178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588914|NCT03155178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65588915|NCT03155178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588916|NCT03155178|Disinfectants|disinfectants|mesh-ancestor
65588917|NCT03155178|Dermatologic Agents|dermatologic agents|mesh-ancestor
65588918|NCT02470546|Metformin|metformin|mesh-list
65588919|NCT02470546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65588920|NCT02470546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588921|NCT03310762|Silicon|silicon|mesh-list
65588922|NCT03310762|Trace Elements|trace elements|mesh-ancestor
65588923|NCT03310762|Micronutrients|micronutrients|mesh-ancestor
65588924|NCT03310762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588925|NCT03173950|Nivolumab|nivolumab|mesh-list
65588926|NCT03173950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65588927|NCT03173950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588928|NCT03173950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65588929|NCT03173950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588930|NCT03310606|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65588931|NCT03310606|Lactams|lactams|mesh-list
65588932|NCT03310606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65588933|NCT01315704|Vitamin D|vitamin d|mesh-list
65588934|NCT01315704|Vitamins|vitamins|mesh-ancestor
65588935|NCT01315704|Micronutrients|micronutrients|mesh-ancestor
65588936|NCT01315704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588937|NCT01315704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65588938|NCT03107884|Metformin|metformin|mesh-list
65588939|NCT03107884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65588940|NCT03107884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588941|NCT05158608|Cyclophosphamide|cyclophosphamide|mesh-list
65588942|NCT05158608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65588943|NCT05158608|Immunologic Factors|immunologic factors|mesh-ancestor
65588944|NCT05158608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588945|NCT05158608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65588946|NCT05158608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65588947|NCT05158608|Alkylating Agents|alkylating agents|mesh-ancestor
65588948|NCT05158608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588949|NCT05158608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588950|NCT05158608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65588951|NCT04702776|Hyaluronic Acid|hyaluronic acid|mesh-list
65588952|NCT04702776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65588953|NCT04702776|Immunologic Factors|immunologic factors|mesh-ancestor
65588954|NCT04702776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588955|NCT04702776|Viscosupplements|viscosupplements|mesh-ancestor
65588956|NCT04702776|Protective Agents|protective agents|mesh-ancestor
65588957|NCT03310372|Temozolomide|temozolomide|mesh-list
65588958|NCT03310372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65588959|NCT03310372|Alkylating Agents|alkylating agents|mesh-ancestor
65588960|NCT03310372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588961|NCT03310372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588962|NCT02980276|Metformin|metformin|mesh-list
65588963|NCT02980276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65588964|NCT02980276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588965|NCT03108664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65588966|NCT03108664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65588967|NCT01342614|Metformin|metformin|mesh-list
65588968|NCT01342614|Fosinopril|fosinopril|mesh-list
65588969|NCT01342614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65588970|NCT01342614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588971|NCT01342614|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65588972|NCT01342614|Protease Inhibitors|protease inhibitors|mesh-ancestor
65588973|NCT01342614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588974|NCT01342614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588975|NCT01342614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65588976|NCT01342692|Lenalidomide|lenalidomide|mesh-list
65588977|NCT01342692|Azacitidine|azacitidine|mesh-list
65588978|NCT01342692|Idarubicin|idarubicin|mesh-list
65588979|NCT01342692|Valproic Acid|valproic acid|mesh-list
65588980|NCT01342692|Immunologic Factors|immunologic factors|mesh-ancestor
65588981|NCT01342692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65588982|NCT01342692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65588983|NCT01342692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65588984|NCT01342692|Growth Substances|growth substances|mesh-ancestor
65588985|NCT01342692|Growth Inhibitors|growth inhibitors|mesh-ancestor
65588986|NCT01342692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65588987|NCT01342692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65588988|NCT01342692|Antimetabolites|antimetabolites|mesh-ancestor
65588989|NCT01342692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65588990|NCT01342692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65588991|NCT01342692|Anticonvulsants|anticonvulsants|mesh-ancestor
65588992|NCT01342692|GABA Agents|gaba agents|mesh-ancestor
65588993|NCT01342692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65588994|NCT01342692|Antimanic Agents|antimanic agents|mesh-ancestor
65588995|NCT01342692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65588996|NCT01342692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65588997|NCT01342692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65588998|NCT01342692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65588999|NCT01342692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65589000|NCT01342692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65589001|NCT05153772|Octreotide|octreotide|mesh-list
65589002|NCT05153772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65589003|NCT05153772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65589004|NCT05153772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589005|NCT03310060|Tranexamic Acid|tranexamic acid|mesh-list
65589006|NCT03310060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65589007|NCT03310060|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65589008|NCT03310060|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65589009|NCT03310060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589010|NCT03310060|Hemostatics|hemostatics|mesh-ancestor
65589011|NCT03310060|Coagulants|coagulants|mesh-ancestor
65589012|NCT03879694|Octreotide|octreotide|mesh-list
65589013|NCT03879694|Sargramostim|sargramostim|mesh-list
65589014|NCT03879694|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65589015|NCT03879694|Freund's Adjuvant|freund's adjuvant|mesh-list
65589016|NCT03879694|Immunologic Factors|immunologic factors|mesh-ancestor
65589017|NCT03879694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589018|NCT03879694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589019|NCT03879694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65589020|NCT03879694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65589021|NCT03879694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65589022|NCT02520778|Osimertinib|osimertinib|mesh-list
65589023|NCT02520778|Navitoclax|navitoclax|mesh-list
65589024|NCT02520778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589025|NCT02520778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65589026|NCT02520778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589027|NCT02520778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589028|NCT03740958|Argatroban|argatroban|mesh-list
65589029|NCT03740958|Antithrombins|antithrombins|mesh-ancestor
65589030|NCT03740958|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65589031|NCT03740958|Protease Inhibitors|protease inhibitors|mesh-ancestor
65589032|NCT03740958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589033|NCT03740958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589034|NCT03740958|Anticoagulants|anticoagulants|mesh-ancestor
65589035|NCT03740958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65589036|NCT01340820|BCG Vaccine|bcg vaccine|mesh-list
65589037|NCT01340820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65589038|NCT01340820|Immunologic Factors|immunologic factors|mesh-ancestor
65248396|NCT02832726|Hydroxocobalamin|hydroxocobalamin|mesh-list
65589039|NCT01340820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589040|NCT03685188|Sufentanil|sufentanil|mesh-list
65589041|NCT03685188|Oxycodone|oxycodone|mesh-list
65589042|NCT03685188|Dsuvia|dsuvia|mesh-list
65589043|NCT03685188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65589044|NCT03685188|Narcotics|narcotics|mesh-ancestor
65589045|NCT03685188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65589046|NCT03685188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589047|NCT03685188|Analgesics|analgesics|mesh-ancestor
65589048|NCT03685188|Sensory System Agents|sensory system agents|mesh-ancestor
65589049|NCT03685188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65589050|NCT03685188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65589051|NCT03685188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65589052|NCT03685188|Anesthetics, General|anesthetics, general|mesh-ancestor
65589053|NCT03685188|Anesthetics|anesthetics|mesh-ancestor
65589054|NCT02305654|Paclitaxel|paclitaxel|mesh-list
65589055|NCT02305654|Ifosfamide|ifosfamide|mesh-list
65589056|NCT02305654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65589057|NCT02305654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589058|NCT02305654|Tubulin Modulators|tubulin modulators|mesh-ancestor
65589059|NCT02305654|Antimitotic Agents|antimitotic agents|mesh-ancestor
65589060|NCT02305654|Mitosis Modulators|mitosis modulators|mesh-ancestor
65589061|NCT02305654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589062|NCT02305654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65589063|NCT02305654|Alkylating Agents|alkylating agents|mesh-ancestor
65589064|NCT05251584|Gentamicins|gentamicins|mesh-list
65589065|NCT05251584|Mupirocin|mupirocin|mesh-list
65589066|NCT05251584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65589067|NCT05251584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65589068|NCT05251584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65589069|NCT05251584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589070|NCT05251584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589071|NCT03309748|Anti-Infective Agents|anti-infective agents|mesh-list
65589072|NCT03309748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65589073|NCT02108860|Abatacept|abatacept|mesh-list
65589074|NCT02108860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65589075|NCT02108860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589076|NCT02108860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589077|NCT02108860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65589078|NCT02108860|Immunologic Factors|immunologic factors|mesh-ancestor
65589079|NCT02108860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589080|NCT02108860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65589081|NCT00705250|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65589082|NCT00705250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65589083|NCT00705250|Alkylating Agents|alkylating agents|mesh-ancestor
65589084|NCT00705250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589085|NCT00705250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589086|NCT03309592|Ambrisentan|ambrisentan|mesh-list
65589087|NCT03309592|Tadalafil|tadalafil|mesh-list
65589088|NCT03309592|Vasodilator Agents|vasodilator agents|mesh-ancestor
65589089|NCT03309592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65589090|NCT03309592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65589091|NCT03309592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589092|NCT03309592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589093|NCT03309592|Urological Agents|urological agents|mesh-ancestor
65589094|NCT03309592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65589095|NCT04641312|Dulaglutide|dulaglutide|mesh-list
65589096|NCT04641312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65589097|NCT04641312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589098|NCT03078192|Xenon|xenon|mesh-list
65589099|NCT03078192|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65589100|NCT03078192|Anesthetics, General|anesthetics, general|mesh-ancestor
65589101|NCT03078192|Anesthetics|anesthetics|mesh-ancestor
65589102|NCT03078192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65589103|NCT03078192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589104|NCT00703846|Ketoconazole|ketoconazole|mesh-list
65589105|NCT00703846|Antifungal Agents|antifungal agents|mesh-ancestor
65589106|NCT00703846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65589107|NCT00703846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65589108|NCT00703846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65589109|NCT00703846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589110|NCT00703846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589111|NCT00703846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65589112|NCT00703846|Hormone Antagonists|hormone antagonists|mesh-ancestor
64757889|NCT04528212|Analgesics|analgesics|mesh-ancestor
65589113|NCT00703846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65589114|NCT00703846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589115|NCT00703846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65589116|NCT05130060|Trifluridine|trifluridine|mesh-list
65589117|NCT05130060|Vaccines|vaccines|mesh-list
65589118|NCT05130060|Immunologic Factors|immunologic factors|mesh-ancestor
65589119|NCT05130060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589120|NCT05130060|Antimetabolites|antimetabolites|mesh-ancestor
65589121|NCT05130060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589122|NCT05130060|Antiviral Agents|antiviral agents|mesh-ancestor
65589123|NCT05130060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65589124|NCT03309436|Clomiphene|clomiphene|mesh-list
65589125|NCT03309436|Enclomiphene|enclomiphene|mesh-list
65589126|NCT03309436|Zuclomiphene|zuclomiphene|mesh-list
65589127|NCT03309436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65589128|NCT03309436|Hormone Antagonists|hormone antagonists|mesh-ancestor
65589129|NCT03309436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65589130|NCT03309436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589131|NCT03309436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65589132|NCT03309436|Fertility Agents|fertility agents|mesh-ancestor
65589133|NCT03309436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65589134|NCT03309436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65589135|NCT03309436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65589136|NCT05183334|Sildenafil Citrate|sildenafil citrate|mesh-list
65589138|NCT05183334|Vasodilator Agents|vasodilator agents|mesh-ancestor
65589139|NCT05183334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65589140|NCT05183334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65589141|NCT05183334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589142|NCT05183334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589143|NCT05183334|Urological Agents|urological agents|mesh-ancestor
65589144|NCT05183334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65589145|NCT05183334|Narcotics|narcotics|mesh-ancestor
65589146|NCT05183334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65589147|NCT05183334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589148|NCT05183334|Analgesics|analgesics|mesh-ancestor
65589149|NCT05183334|Sensory System Agents|sensory system agents|mesh-ancestor
65589150|NCT05183334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65589151|NCT03304444|Bupivacaine|bupivacaine|mesh-list
65589152|NCT03304444|Anesthetics, Local|anesthetics, local|mesh-ancestor
65589153|NCT03304444|Anesthetics|anesthetics|mesh-ancestor
65589154|NCT03304444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65589155|NCT03304444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589156|NCT03304444|Sensory System Agents|sensory system agents|mesh-ancestor
65589157|NCT03304444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65589158|NCT03304288|Rituximab|rituximab|mesh-list
65589159|NCT03304288|Tretinoin|tretinoin|mesh-list
65589160|NCT03304288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65589161|NCT03304288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589162|NCT03304288|Immunologic Factors|immunologic factors|mesh-ancestor
65589163|NCT03304288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589164|NCT03304288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65589165|NCT03304288|Keratolytic Agents|keratolytic agents|mesh-ancestor
65589166|NCT03304288|Dermatologic Agents|dermatologic agents|mesh-ancestor
65589167|NCT03304210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65589168|NCT03304210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589169|NCT03313960|Insulin|insulin|mesh-list
65589170|NCT03313960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65589171|NCT03313960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589172|NCT03308890|Entecavir|entecavir|mesh-list
65589173|NCT03308890|Antiviral Agents|antiviral agents|mesh-ancestor
65589174|NCT03308890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65589175|NCT03313726|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65589176|NCT03313726|Hormones|hormones|mesh-ancestor
65589177|NCT03313726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65589178|NCT03313726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589179|NCT03303976|Vaccines|vaccines|mesh-list
65589180|NCT03303976|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65589181|NCT03303976|Immunologic Factors|immunologic factors|mesh-ancestor
65589182|NCT03303976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589183|NCT03313414|Sofosbuvir|sofosbuvir|mesh-list
65589184|NCT03313414|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65589185|NCT03313414|Velpatasvir|velpatasvir|mesh-list
65589186|NCT03313414|Antiviral Agents|antiviral agents|mesh-ancestor
65589187|NCT03313414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65589188|NCT02468518|Vitamin E|vitamin e|mesh-list
65589189|NCT02468518|Vitamins|vitamins|mesh-ancestor
65589190|NCT02468518|Micronutrients|micronutrients|mesh-ancestor
65589191|NCT02468518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589192|NCT02468518|Antioxidants|antioxidants|mesh-ancestor
65589193|NCT02468518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589194|NCT02468518|Protective Agents|protective agents|mesh-ancestor
65589195|NCT03313336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65589196|NCT03313336|Anesthetics, Local|anesthetics, local|mesh-ancestor
65589197|NCT03313336|Anesthetics|anesthetics|mesh-ancestor
65589198|NCT03313336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65589199|NCT03313336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589200|NCT03313336|Sensory System Agents|sensory system agents|mesh-ancestor
65589201|NCT03313336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65589202|NCT03313336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65589203|NCT05262322|Rivaroxaban|rivaroxaban|mesh-list
65589204|NCT05262322|Apixaban|apixaban|mesh-list
65589205|NCT05262322|Edoxaban|edoxaban|mesh-list
65589206|NCT05262322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65589207|NCT05262322|Antithrombins|antithrombins|mesh-ancestor
65589208|NCT05262322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65589209|NCT05262322|Protease Inhibitors|protease inhibitors|mesh-ancestor
65589210|NCT05262322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589211|NCT05262322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589212|NCT05262322|Anticoagulants|anticoagulants|mesh-ancestor
65589213|NCT04490980|Butorphanol|butorphanol|mesh-list
65589214|NCT04490980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65589215|NCT04490980|Narcotics|narcotics|mesh-ancestor
65589216|NCT04490980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65589217|NCT04490980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589218|NCT04490980|Analgesics|analgesics|mesh-ancestor
65589219|NCT04490980|Sensory System Agents|sensory system agents|mesh-ancestor
65589220|NCT04490980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65589221|NCT04490980|Antitussive Agents|antitussive agents|mesh-ancestor
65589222|NCT04490980|Respiratory System Agents|respiratory system agents|mesh-ancestor
65589223|NCT04490980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65589224|NCT03307720|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65589225|NCT03307720|Hormones|hormones|mesh-list
65589226|NCT03307720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65589227|NCT03307720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589228|NCT03307720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65589229|NCT04608786|Capecitabine|capecitabine|mesh-list
65589230|NCT04608786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65589231|NCT04608786|Antimetabolites|antimetabolites|mesh-ancestor
65589232|NCT04608786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589233|NCT04608786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589234|NCT01314872|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65589235|NCT01314872|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65589236|NCT01314872|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65589237|NCT01314872|Cholinergic Agents|cholinergic agents|mesh-ancestor
65589238|NCT01314872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65589239|NCT01314872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589240|NCT01314872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589241|NCT01314872|Urological Agents|urological agents|mesh-ancestor
65589242|NCT01343628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65589243|NCT01343628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65589244|NCT01343628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65589245|NCT01343628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65589246|NCT01343628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589247|NCT01343628|Adrenergic Agents|adrenergic agents|mesh-ancestor
65589248|NCT01343628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65589249|NCT01343628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589250|NCT00703924|Paromomycin|paromomycin|mesh-list
65589251|NCT00703924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65589252|NCT00703924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65589253|NCT00703924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65589254|NCT00703924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65589255|NCT03302650|Norepinephrine|norepinephrine|mesh-list
65589256|NCT03302650|Angiotensin II|angiotensin ii|mesh-list
65589257|NCT03302650|Giapreza|giapreza|mesh-list
65589258|NCT03302650|Angiotensinogen|angiotensinogen|mesh-list
65589259|NCT03302650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65589260|NCT03302650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65589261|NCT03302650|Adrenergic Agents|adrenergic agents|mesh-ancestor
65589262|NCT03302650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65248397|NCT02832726|Vitamins|vitamins|mesh-ancestor
65589263|NCT03302650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589264|NCT03302650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589265|NCT03302650|Sympathomimetics|sympathomimetics|mesh-ancestor
65589266|NCT03302650|Autonomic Agents|autonomic agents|mesh-ancestor
65589267|NCT03302650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65589268|NCT03302650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65589269|NCT03302650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65589270|NCT03302650|Protease Inhibitors|protease inhibitors|mesh-ancestor
65589271|NCT03302650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589272|NCT01343706|BI 409306|bi 409306|mesh-list
65589273|NCT01343706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65589274|NCT01343706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589275|NCT01343706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589276|NCT03312478|Antibodies|antibodies|mesh-list
65589277|NCT03312478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589278|NCT03312478|Immunologic Factors|immunologic factors|mesh-ancestor
65589279|NCT03312244|Bromides|bromides|mesh-list
65589280|NCT03312244|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
65589281|NCT03312244|Anticonvulsants|anticonvulsants|mesh-ancestor
65589282|NCT03312244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65589283|NCT03312244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589284|NCT03312244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589285|NCT03312244|Cholinergic Agents|cholinergic agents|mesh-ancestor
65589286|NCT03312244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65589287|NCT03312244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589288|NCT03306940|Botulinum Toxins|botulinum toxins|mesh-list
65589289|NCT03306940|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65589290|NCT03306940|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65589291|NCT03306940|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65589292|NCT03306940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65589293|NCT03306940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589294|NCT03306940|Cholinergic Agents|cholinergic agents|mesh-ancestor
65589295|NCT03306940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65589296|NCT03306940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589297|NCT03306940|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65589298|NCT03306940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65589299|NCT00739050|Simvastatin|simvastatin|mesh-list
65589300|NCT00739050|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65589301|NCT00739050|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65589302|NCT00739050|Antimetabolites|antimetabolites|mesh-ancestor
65589303|NCT00739050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589304|NCT00739050|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65589305|NCT00739050|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65589306|NCT00739050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589307|NCT03302182|Ritonavir|ritonavir|mesh-list
65589308|NCT03302182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65589309|NCT03302182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65589310|NCT03302182|Protease Inhibitors|protease inhibitors|mesh-ancestor
65589311|NCT03302182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589312|NCT03302182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589313|NCT03302182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65589314|NCT03302182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65589315|NCT03302182|Antiviral Agents|antiviral agents|mesh-ancestor
65589316|NCT03302182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65589317|NCT03302182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65589318|NCT03302182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65589319|NCT01343862|Cycloserine|cycloserine|mesh-list
65589320|NCT01343862|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65589321|NCT01343862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65589322|NCT01343862|Renal Agents|renal agents|mesh-ancestor
65589323|NCT01343862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65589324|NCT01343862|Antitubercular Agents|antitubercular agents|mesh-ancestor
65589325|NCT01343862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65589326|NCT01343862|Antimetabolites|antimetabolites|mesh-ancestor
65589327|NCT01343862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589328|NCT00604812|Rizatriptan|rizatriptan|mesh-list
65589329|NCT00604812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65589330|NCT00604812|Serotonin Agents|serotonin agents|mesh-ancestor
65589331|NCT00604812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65589332|NCT00604812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589333|NCT00604812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589334|NCT04347408|Antibodies|antibodies|mesh-list
65589335|NCT04347408|Immunologic Factors|immunologic factors|mesh-ancestor
65589336|NCT04347408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589337|NCT03306550|Aspirin|aspirin|mesh-list
65589338|NCT03306550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65589339|NCT03306550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65589340|NCT03306550|Analgesics|analgesics|mesh-ancestor
65589341|NCT03306550|Sensory System Agents|sensory system agents|mesh-ancestor
65589342|NCT03306550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65589343|NCT03306550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589344|NCT03306550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65589345|NCT03306550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65589346|NCT03306550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65589347|NCT03306550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65589348|NCT03306550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589349|NCT03306550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65589350|NCT03306550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65589351|NCT03306550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589352|NCT03306550|Antipyretics|antipyretics|mesh-ancestor
65589353|NCT03306472|Letrozole|letrozole|mesh-list
65589354|NCT03306472|Megestrol|megestrol|mesh-list
65589355|NCT03306472|Megestrol Acetate|megestrol acetate|mesh-list
65589356|NCT03306472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589357|NCT03306472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65589358|NCT03306472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65589359|NCT03306472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589360|NCT03306472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589361|NCT03306472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65589362|NCT03306472|Hormone Antagonists|hormone antagonists|mesh-ancestor
65589363|NCT03306472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65589364|NCT03306472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589365|NCT03306472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65589366|NCT03306472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65589367|NCT03306472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65589368|NCT03306472|Contraceptive Agents|contraceptive agents|mesh-ancestor
65589369|NCT03306472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65589370|NCT03306472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65589371|NCT03306472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65589372|NCT03306472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65589373|NCT03306472|Appetite Stimulants|appetite stimulants|mesh-ancestor
65589374|NCT03306472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65589376|NCT03311542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65589377|NCT03311542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589378|NCT04506372|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65589379|NCT04506372|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65589380|NCT04506372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589381|NCT04506372|Protease Inhibitors|protease inhibitors|mesh-ancestor
65589382|NCT03311464|Adalimumab|adalimumab|mesh-list
65589383|NCT03311464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65589384|NCT03311464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65589385|NCT05214066|Thymoglobulin|thymoglobulin|mesh-list
65589386|NCT05214066|Immunologic Factors|immunologic factors|mesh-ancestor
65589387|NCT05214066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589388|NCT05214066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65589389|NCT05211024|Penicillins|penicillins|mesh-list
65589390|NCT05211024|Penicillin G|penicillin g|mesh-list
65589391|NCT05211024|Penicillin G Benzathine|penicillin g benzathine|mesh-list
65589392|NCT05211024|Penicillin G Procaine|penicillin g procaine|mesh-list
65589393|NCT05211024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65589394|NCT05211024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65589395|NCT02468206|Polidocanol|polidocanol|mesh-list
65589396|NCT02468206|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65589397|NCT02468206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65589398|NCT03233854|Cyclophosphamide|cyclophosphamide|mesh-list
65589399|NCT03233854|Fludarabine|fludarabine|mesh-list
65589400|NCT03233854|Fludarabine phosphate|fludarabine phosphate|mesh-list
65589401|NCT03233854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65589402|NCT03233854|Immunologic Factors|immunologic factors|mesh-ancestor
65589403|NCT03233854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589404|NCT03233854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65589405|NCT03233854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65589406|NCT03233854|Alkylating Agents|alkylating agents|mesh-ancestor
65589407|NCT03233854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589408|NCT03233854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589409|NCT03233854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65589410|NCT03233854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65589411|NCT03233854|Antimetabolites|antimetabolites|mesh-ancestor
65589412|NCT01344174|Lamivudine|lamivudine|mesh-list
65589413|NCT01344174|Dexamethasone|dexamethasone|mesh-list
65589414|NCT01344174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65589415|NCT01344174|Antiemetics|antiemetics|mesh-ancestor
65589416|NCT01344174|Autonomic Agents|autonomic agents|mesh-ancestor
65589417|NCT01344174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65589418|NCT01344174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589419|NCT01344174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65589420|NCT01344174|Glucocorticoids|glucocorticoids|mesh-ancestor
65589421|NCT01344174|Hormones|hormones|mesh-ancestor
65589422|NCT01344174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65589423|NCT01344174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65589424|NCT01344174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589425|NCT01344174|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65589426|NCT01344174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65589427|NCT01344174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386937|NCT00142519|Methadone|methadone|mesh-list
65589428|NCT01344174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589429|NCT01344174|Antiviral Agents|antiviral agents|mesh-ancestor
65589430|NCT01344174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65589431|NCT01344174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65589432|NCT01344174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65589433|NCT05162274|Lazertinib|lazertinib|mesh-list
65589434|NCT05162274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65589435|NCT05162274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589436|NCT05162274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589437|NCT03023566|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
65589438|NCT03023566|Chelating Agents|chelating agents|mesh-ancestor
65589439|NCT03023566|Sequestering Agents|sequestering agents|mesh-ancestor
65589440|NCT03023566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589441|NCT03311386|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65589442|NCT03311386|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65589443|NCT03311386|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65589444|NCT03311386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589445|NCT02468908|Molgramostim|molgramostim|mesh-list
65589446|NCT02468908|Sargramostim|sargramostim|mesh-list
65589447|NCT02468908|Immunologic Factors|immunologic factors|mesh-ancestor
65589448|NCT02468908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589449|NCT02468908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589450|NCT02468128|Nalbuphine|nalbuphine|mesh-list
65589451|NCT02468128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65589452|NCT02468128|Narcotics|narcotics|mesh-ancestor
65589453|NCT02468128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65589454|NCT02468128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589455|NCT02468128|Analgesics|analgesics|mesh-ancestor
65589456|NCT02468128|Sensory System Agents|sensory system agents|mesh-ancestor
65589457|NCT02468128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65589458|NCT03305536|Vitamin D|vitamin d|mesh-list
65589459|NCT03305536|Vitamins|vitamins|mesh-list
65589460|NCT03305536|Vitamin K|vitamin k|mesh-list
65589461|NCT03305536|Vitamin K 2|vitamin k 2|mesh-list
65589462|NCT03305536|Vitamin MK 7|vitamin mk 7|mesh-list
65589463|NCT03305536|Micronutrients|micronutrients|mesh-ancestor
65589464|NCT03305536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589465|NCT03305536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65589466|NCT03305536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65589467|NCT03305536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65589468|NCT03305536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589469|NCT03305536|Hemostatics|hemostatics|mesh-ancestor
65589470|NCT03305536|Coagulants|coagulants|mesh-ancestor
65589471|NCT03210688|Alfacalcidol|alfacalcidol|mesh-list
65589472|NCT03210688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65589473|NCT03210688|Prednisone|prednisone|mesh-list
65589474|NCT03210688|Prednisolone|prednisolone|mesh-list
65589475|NCT03210688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65589476|NCT03210688|Glucocorticoids|glucocorticoids|mesh-ancestor
65589477|NCT03210688|Hormones|hormones|mesh-ancestor
65589478|NCT03210688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65589479|NCT03210688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589480|NCT03210688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65589481|NCT03210688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589482|NCT03210688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65589483|NCT03210688|Vitamins|vitamins|mesh-ancestor
65589484|NCT03210688|Micronutrients|micronutrients|mesh-ancestor
65589485|NCT02467426|Mitoxantrone|mitoxantrone|mesh-list
65589486|NCT02467426|Analgesics|analgesics|mesh-ancestor
64758711|NCT05220462|Anesthetics|anesthetics|mesh-ancestor
65589487|NCT02467426|Sensory System Agents|sensory system agents|mesh-ancestor
65589488|NCT02467426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65589489|NCT02467426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589490|NCT02467426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589491|NCT02467426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65589492|NCT02467426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65589493|NCT02467426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589494|NCT02467426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589495|NCT04296942|Trastuzumab|trastuzumab|mesh-list
65589496|NCT04296942|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65589497|NCT04296942|Maytansine|maytansine|mesh-list
65589498|NCT04296942|Entinostat|entinostat|mesh-list
65387016|NCT00201643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65589499|NCT04296942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65589500|NCT04296942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589501|NCT04296942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65589502|NCT04296942|Tubulin Modulators|tubulin modulators|mesh-ancestor
65589503|NCT04296942|Antimitotic Agents|antimitotic agents|mesh-ancestor
65589504|NCT04296942|Mitosis Modulators|mitosis modulators|mesh-ancestor
65589505|NCT04296942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589506|NCT04296942|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65589507|NCT04296942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589508|NCT01344564|Leuprolide|leuprolide|mesh-list
65589509|NCT01344564|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65589510|NCT01344564|Fertility Agents|fertility agents|mesh-ancestor
65589511|NCT01344564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65589512|NCT01344564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589513|NCT01344564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65589514|NCT01344564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589515|NCT01344720|Etoricoxib|etoricoxib|mesh-list
65589516|NCT01344720|Oxycodone|oxycodone|mesh-list
65589517|NCT01344720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65589518|NCT01344720|Narcotics|narcotics|mesh-ancestor
65589519|NCT01344720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65589520|NCT01344720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589521|NCT01344720|Analgesics|analgesics|mesh-ancestor
65589522|NCT01344720|Sensory System Agents|sensory system agents|mesh-ancestor
65589523|NCT01344720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65589524|NCT01344720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65589525|NCT01344720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65589526|NCT01344720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65589527|NCT01344720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65589528|NCT01344720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65589529|NCT01344720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65589530|NCT01344720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589531|NCT01344720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589532|NCT03220854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65589533|NCT03220854|Antibodies|antibodies|mesh-list
65589534|NCT03220854|Immunoglobulins|immunoglobulins|mesh-list
65589535|NCT03220854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65589536|NCT03220854|Immunologic Factors|immunologic factors|mesh-ancestor
65589537|NCT03220854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589538|NCT03220854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589539|NCT03305068|Celecoxib|celecoxib|mesh-list
65589540|NCT03305068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65589541|NCT03305068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65589542|NCT03305068|Analgesics|analgesics|mesh-ancestor
65589543|NCT03305068|Sensory System Agents|sensory system agents|mesh-ancestor
65589544|NCT03305068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65589545|NCT03305068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589546|NCT03305068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65589547|NCT03305068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65589548|NCT03305068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65589549|NCT03305068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65589550|NCT03305068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589551|NCT03305068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589552|NCT04490590|Etoposide|etoposide|mesh-list
65589553|NCT04490590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65589554|NCT04490590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589555|NCT04490590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65589556|NCT04490590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65589557|NCT04490590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589558|NCT04490590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589559|NCT03299998|Anesthetics|anesthetics|mesh-list
65589560|NCT03299998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65589561|NCT03299998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589562|NCT01522976|Lenalidomide|lenalidomide|mesh-list
65589563|NCT01522976|Azacitidine|azacitidine|mesh-list
65589564|NCT01522976|Vorinostat|vorinostat|mesh-list
65589565|NCT01522976|Immunologic Factors|immunologic factors|mesh-ancestor
65589566|NCT01522976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589567|NCT01522976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65589568|NCT01522976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65589569|NCT01522976|Growth Substances|growth substances|mesh-ancestor
65589570|NCT01522976|Growth Inhibitors|growth inhibitors|mesh-ancestor
65589571|NCT01522976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589572|NCT01522976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65589573|NCT01522976|Antimetabolites|antimetabolites|mesh-ancestor
65589574|NCT01522976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589575|NCT01522976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589576|NCT01522976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65589578|NCT03144804|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65589579|NCT03144804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65589580|NCT03144804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589581|NCT03144804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589582|NCT03144804|Antiviral Agents|antiviral agents|mesh-ancestor
65589583|NCT03144804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65589584|NCT03144804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65589585|NCT03144804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65589586|NCT03735420|Xanthohumol|xanthohumol|mesh-list
65589587|NCT03735420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589588|NCT03735420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65589589|NCT03735420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65589590|NCT03735420|Growth Substances|growth substances|mesh-ancestor
65589591|NCT03735420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589592|NCT03735420|Growth Inhibitors|growth inhibitors|mesh-ancestor
65589593|NCT03299842|Fenfluramine|fenfluramine|mesh-list
65589594|NCT03299842|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65589595|NCT03299842|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65589596|NCT03299842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65589597|NCT03299842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589598|NCT03299842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65589599|NCT03299842|Serotonin Agents|serotonin agents|mesh-ancestor
65589600|NCT03299842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589601|NCT02720536|Deferasirox|deferasirox|mesh-list
65589602|NCT02720536|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65589603|NCT02720536|Chelating Agents|chelating agents|mesh-ancestor
65589604|NCT02720536|Sequestering Agents|sequestering agents|mesh-ancestor
65589605|NCT02720536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589606|NCT03168438|Cyclophosphamide|cyclophosphamide|mesh-list
65589607|NCT03168438|Pembrolizumab|pembrolizumab|mesh-list
65589608|NCT03168438|Fludarabine|fludarabine|mesh-list
65589609|NCT03168438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65589610|NCT03168438|Immunologic Factors|immunologic factors|mesh-ancestor
65589611|NCT03168438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589612|NCT03168438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65589613|NCT03168438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65589614|NCT03168438|Alkylating Agents|alkylating agents|mesh-ancestor
65589615|NCT03168438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589616|NCT03168438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589617|NCT03168438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65589618|NCT03168438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65589619|NCT03299296|Enoxaparin|enoxaparin|mesh-list
65589620|NCT03299296|Rivaroxaban|rivaroxaban|mesh-list
65589621|NCT03299296|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65589622|NCT03299296|Antithrombins|antithrombins|mesh-ancestor
65589623|NCT03299296|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65589624|NCT03299296|Protease Inhibitors|protease inhibitors|mesh-ancestor
65589625|NCT03299296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589626|NCT03299296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589627|NCT03299296|Anticoagulants|anticoagulants|mesh-ancestor
65589628|NCT03299296|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65589629|NCT03299296|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65589630|NCT03137784|Glycopyrrolate|glycopyrrolate|mesh-list
65589631|NCT03137784|Bromides|bromides|mesh-list
65589632|NCT03137784|Anticonvulsants|anticonvulsants|mesh-ancestor
65589633|NCT03137784|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65589634|NCT03137784|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65589635|NCT03137784|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65589636|NCT03137784|Cholinergic Agents|cholinergic agents|mesh-ancestor
65589637|NCT03137784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65589638|NCT03137784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589639|NCT03137784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589640|NCT05384938|Benralizumab|benralizumab|mesh-list
65589641|NCT05384938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65589642|NCT05384938|Respiratory System Agents|respiratory system agents|mesh-ancestor
65589643|NCT01344954|Rivaroxaban|rivaroxaban|mesh-list
65589644|NCT01344954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65589645|NCT01344954|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65589646|NCT01344954|Antithrombins|antithrombins|mesh-ancestor
65589647|NCT01344954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65589648|NCT01344954|Protease Inhibitors|protease inhibitors|mesh-ancestor
65589649|NCT01344954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589650|NCT01344954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387162|NCT00883298|Growth Substances|growth substances|mesh-ancestor
65589651|NCT01344954|Anticoagulants|anticoagulants|mesh-ancestor
65589652|NCT01344954|Immunologic Factors|immunologic factors|mesh-ancestor
65589653|NCT01344954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589654|NCT01347996|Interleukin-2|interleukin-2|mesh-list
65589655|NCT01347996|Histamine|histamine|mesh-list
65589656|NCT01347996|Histamine phosphate|histamine phosphate|mesh-list
65589657|NCT01347996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589658|NCT01347996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65589659|NCT01347996|Analgesics|analgesics|mesh-ancestor
65589660|NCT01347996|Sensory System Agents|sensory system agents|mesh-ancestor
65589661|NCT01347996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65589662|NCT01347996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589663|NCT01347996|Histamine Agonists|histamine agonists|mesh-ancestor
65589664|NCT01347996|Histamine Agents|histamine agents|mesh-ancestor
65589665|NCT01347996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65589666|NCT01347996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589667|NCT01352988|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65589668|NCT01352988|Dermatologic Agents|dermatologic agents|mesh-ancestor
65589669|NCT01352988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65589670|NCT01352988|Immunologic Factors|immunologic factors|mesh-ancestor
65589671|NCT01352988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589672|NCT02466802|Sildenafil Citrate|sildenafil citrate|mesh-list
65589673|NCT02466802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589674|NCT02466802|Vasodilator Agents|vasodilator agents|mesh-ancestor
65589675|NCT02466802|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65589676|NCT02466802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65589677|NCT02466802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589678|NCT02466802|Urological Agents|urological agents|mesh-ancestor
65589679|NCT01348308|Maraviroc|maraviroc|mesh-list
65589680|NCT01348308|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65589681|NCT01348308|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65589682|NCT01348308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589683|NCT01348308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65589684|NCT01348308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65589685|NCT01348308|Antiviral Agents|antiviral agents|mesh-ancestor
65589686|NCT01348308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65589687|NCT01348308|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65589688|NCT04074174|Acetaminophen|acetaminophen|mesh-list
65589689|NCT04074174|Contraceptive Agents|contraceptive agents|mesh-list
65589690|NCT04074174|Contraceptives, Oral|contraceptives, oral|mesh-list
65589691|NCT04074174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65589692|NCT04074174|Analgesics|analgesics|mesh-ancestor
65589693|NCT04074174|Sensory System Agents|sensory system agents|mesh-ancestor
65589694|NCT04074174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65589695|NCT04074174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589696|NCT04074174|Antipyretics|antipyretics|mesh-ancestor
65589697|NCT04074174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65589698|NCT04074174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65589699|NCT04752826|Pembrolizumab|pembrolizumab|mesh-list
65589700|NCT04752826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65589701|NCT04752826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589702|NCT03620292|Bevacizumab|bevacizumab|mesh-list
65589703|NCT03620292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65589704|NCT03620292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589705|NCT03620292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65589706|NCT03620292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65589707|NCT03620292|Growth Substances|growth substances|mesh-ancestor
65589708|NCT03620292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589709|NCT03620292|Growth Inhibitors|growth inhibitors|mesh-ancestor
65589710|NCT01353378|Dexmedetomidine|dexmedetomidine|mesh-list
65589711|NCT01353378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65589712|NCT01353378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65589713|NCT01353378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589714|NCT01353378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65589715|NCT01353378|Analgesics|analgesics|mesh-ancestor
65589716|NCT01353378|Sensory System Agents|sensory system agents|mesh-ancestor
65589717|NCT01353378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65589718|NCT01353378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65589719|NCT01353378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65589720|NCT01353378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65589721|NCT01353378|Adrenergic Agents|adrenergic agents|mesh-ancestor
65589722|NCT01353378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65589723|NCT01353378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589724|NCT05245006|Antibodies|antibodies|mesh-list
65387236|NCT04387240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65589726|NCT05245006|Immunologic Factors|immunologic factors|mesh-ancestor
65589727|NCT05245006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589728|NCT01465334|Methylprednisolone|methylprednisolone|mesh-list
65589729|NCT01465334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65589730|NCT01465334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65589731|NCT01465334|Prednisolone|prednisolone|mesh-list
65589732|NCT01465334|Prednisolone acetate|prednisolone acetate|mesh-list
65589733|NCT01465334|Alemtuzumab|alemtuzumab|mesh-list
65589734|NCT01465334|Ofatumumab|ofatumumab|mesh-list
65589735|NCT01465334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65589736|NCT01465334|Prednisolone phosphate|prednisolone phosphate|mesh-list
65589737|NCT01465334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65589738|NCT01465334|Antiemetics|antiemetics|mesh-ancestor
65589739|NCT01465334|Autonomic Agents|autonomic agents|mesh-ancestor
65589740|NCT01465334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65589741|NCT01465334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589742|NCT01465334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65589743|NCT01465334|Glucocorticoids|glucocorticoids|mesh-ancestor
65589744|NCT01465334|Hormones|hormones|mesh-ancestor
65589745|NCT01465334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65589746|NCT01465334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65589747|NCT01465334|Protective Agents|protective agents|mesh-ancestor
65589748|NCT01465334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65589749|NCT01465334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589750|NCT01465334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65589751|NCT04019262|Temozolomide|temozolomide|mesh-list
65589752|NCT04019262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65589753|NCT04019262|Alkylating Agents|alkylating agents|mesh-ancestor
65589754|NCT04019262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589755|NCT04019262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589756|NCT03694002|Paclitaxel|paclitaxel|mesh-list
65589757|NCT03694002|Carboplatin|carboplatin|mesh-list
65589758|NCT03694002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65589759|NCT03694002|Ramucirumab|ramucirumab|mesh-list
65589760|NCT03694002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65589761|NCT03694002|Antibodies|antibodies|mesh-list
65589762|NCT03694002|Immunoglobulins|immunoglobulins|mesh-list
65589763|NCT03694002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65589764|NCT03694002|Lexatumumab|lexatumumab|mesh-list
65589765|NCT03694002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65589766|NCT03694002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589767|NCT03694002|Tubulin Modulators|tubulin modulators|mesh-ancestor
65589768|NCT03694002|Antimitotic Agents|antimitotic agents|mesh-ancestor
65589769|NCT03694002|Mitosis Modulators|mitosis modulators|mesh-ancestor
65589770|NCT03694002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589771|NCT03694002|Immunologic Factors|immunologic factors|mesh-ancestor
65589772|NCT03694002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589773|NCT05549726|Cabotegravir|cabotegravir|mesh-list
65589774|NCT05549726|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65589775|NCT05549726|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65589776|NCT05549726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589777|NCT05549726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589778|NCT05549726|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65589779|NCT05549726|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65589780|NCT05549726|Antiviral Agents|antiviral agents|mesh-ancestor
65589781|NCT05549726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65589782|NCT01353456|Dexmedetomidine|dexmedetomidine|mesh-list
65589783|NCT01353456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65589784|NCT01353456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64473214|NCT00119392|Cyclosporins|cyclosporins|mesh-list
65589785|NCT01353456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589786|NCT01353456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65589787|NCT01353456|Analgesics|analgesics|mesh-ancestor
65589788|NCT01353456|Sensory System Agents|sensory system agents|mesh-ancestor
65589789|NCT01353456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65589790|NCT01353456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65589791|NCT01353456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65589792|NCT01353456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65589793|NCT01353456|Adrenergic Agents|adrenergic agents|mesh-ancestor
65589794|NCT01353456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65589795|NCT01353456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589796|NCT04289142|Dexmedetomidine|dexmedetomidine|mesh-list
65589797|NCT04289142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65589798|NCT04289142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65589799|NCT04289142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589800|NCT04289142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65589801|NCT04289142|Analgesics|analgesics|mesh-ancestor
65589802|NCT04289142|Sensory System Agents|sensory system agents|mesh-ancestor
65589803|NCT04289142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65589804|NCT04289142|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65589805|NCT04289142|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65589806|NCT04289142|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65589807|NCT04289142|Adrenergic Agents|adrenergic agents|mesh-ancestor
65589808|NCT04289142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65589809|NCT04289142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589810|NCT04953962|Nivolumab|nivolumab|mesh-list
65589811|NCT04953962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589812|NCT04953962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65589813|NCT04953962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65589814|NCT04953962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589815|NCT04948814|Vancomycin|vancomycin|mesh-list
65589816|NCT04948814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65589817|NCT04948814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65589818|NCT02718898|Ixekizumab|ixekizumab|mesh-list
65589819|NCT02718898|Dermatologic Agents|dermatologic agents|mesh-ancestor
65589820|NCT05726734|Amoxicillin|amoxicillin|mesh-list
65589821|NCT05726734|Metronidazole|metronidazole|mesh-list
65589822|NCT05726734|Potassium Citrate|potassium citrate|mesh-list
65589823|NCT05726734|Esomeprazole|esomeprazole|mesh-list
65589824|NCT05726734|Bismuth|bismuth|mesh-list
65589825|NCT05726734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589826|NCT05726734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65589827|NCT05726734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65589828|NCT05726734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65589829|NCT05726734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65589830|NCT05726734|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65589831|NCT05726734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65589832|NCT05726734|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65589833|NCT05726734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589834|NCT05726734|Antacids|antacids|mesh-ancestor
65589835|NCT05726734|Diuretics|diuretics|mesh-ancestor
65589836|NCT05726734|Natriuretic Agents|natriuretic agents|mesh-ancestor
65589837|NCT05726734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589838|NCT05726734|Expectorants|expectorants|mesh-ancestor
65589839|NCT05726734|Respiratory System Agents|respiratory system agents|mesh-ancestor
65589840|NCT01317966|Rituximab|rituximab|mesh-list
65589841|NCT01317966|Oprelvekin|oprelvekin|mesh-list
65589842|NCT01317966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65589843|NCT01317966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589844|NCT01317966|Immunologic Factors|immunologic factors|mesh-ancestor
65589845|NCT01317966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589846|NCT01317966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65589847|NCT01345734|Liraglutide|liraglutide|mesh-list
65589848|NCT01345734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65589849|NCT01345734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589850|NCT01345734|Incretins|incretins|mesh-ancestor
65589851|NCT01345734|Hormones|hormones|mesh-ancestor
65589852|NCT01345734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65589853|NCT04674670|Naltrexone|naltrexone|mesh-list
65589854|NCT04674670|Bromocriptine|bromocriptine|mesh-list
65589855|NCT04674670|Amisulpride|amisulpride|mesh-list
65589856|NCT04674670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65589857|NCT04674670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65589858|NCT04674670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589859|NCT04674670|Sensory System Agents|sensory system agents|mesh-ancestor
65589860|NCT04674670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65589861|NCT04674670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65589862|NCT04674670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65589863|NCT04674670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65589864|NCT04674670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65589865|NCT04674670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65589866|NCT04674670|Dopamine Agents|dopamine agents|mesh-ancestor
65589867|NCT04674670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65589868|NCT04674670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589869|NCT04674670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65589870|NCT04674670|Antidepressive Agents|antidepressive agents|mesh-ancestor
65589871|NCT04674670|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65589872|NCT04674670|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65589873|NCT04674670|Hormone Antagonists|hormone antagonists|mesh-ancestor
65589874|NCT04674670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65589875|NCT04674670|Dopamine Agonists|dopamine agonists|mesh-ancestor
65387389|NCT01582555|Acetylcysteine|acetylcysteine|mesh-list
65589877|NCT01318044|Propofol|propofol|mesh-list
65589878|NCT01318044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65589879|NCT01318044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65589880|NCT01318044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589881|NCT01318044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65589882|NCT01318044|Anesthetics, General|anesthetics, general|mesh-ancestor
65589883|NCT01318044|Anesthetics|anesthetics|mesh-ancestor
65589884|NCT01318044|Anticonvulsants|anticonvulsants|mesh-ancestor
65589885|NCT01318044|GABA Modulators|gaba modulators|mesh-ancestor
65589886|NCT01318044|GABA Agents|gaba agents|mesh-ancestor
65589887|NCT01318044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65589888|NCT01318044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589889|NCT01353846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65589890|NCT01353846|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65589891|NCT01353846|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65589892|NCT01353846|Estradiol|estradiol|mesh-list
65589893|NCT01353846|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65589894|NCT01353846|Progesterone|progesterone|mesh-list
65589895|NCT01353846|Estrogens|estrogens|mesh-ancestor
65589896|NCT01353846|Hormones|hormones|mesh-ancestor
65589897|NCT01353846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65589898|NCT01353846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589899|NCT01353846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65589900|NCT01353846|Contraceptive Agents|contraceptive agents|mesh-ancestor
65589901|NCT01353846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65589902|NCT01353846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65589903|NCT01353846|Progestins|progestins|mesh-ancestor
65589904|NCT01353846|Luteolytic Agents|luteolytic agents|mesh-ancestor
65589905|NCT01353846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65589906|NCT01353846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589907|NCT01349010|Probucol|probucol|mesh-list
65589908|NCT01349010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65589909|NCT01349010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65589910|NCT01349010|Antimetabolites|antimetabolites|mesh-ancestor
65589911|NCT01349010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589912|NCT01349010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65589913|NCT01349010|Antioxidants|antioxidants|mesh-ancestor
65589914|NCT01349010|Protective Agents|protective agents|mesh-ancestor
65589915|NCT01349010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589916|NCT05232370|Losartan|losartan|mesh-list
65589917|NCT05232370|Enalapril|enalapril|mesh-list
65589918|NCT05232370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65589919|NCT05232370|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65589920|NCT05232370|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65589921|NCT05232370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65589922|NCT05232370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65589923|NCT05232370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65589924|NCT05232370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589925|NCT05232370|Protease Inhibitors|protease inhibitors|mesh-ancestor
65589926|NCT01349088|Niacinamide|niacinamide|mesh-list
65589927|NCT01349088|Capecitabine|capecitabine|mesh-list
65589928|NCT01349088|Motesanib diphosphate|motesanib diphosphate|mesh-list
65589929|NCT01349088|Imetelstat|imetelstat|mesh-list
65589930|NCT01349088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65589931|NCT01349088|Antimetabolites|antimetabolites|mesh-ancestor
65589932|NCT01349088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589933|NCT01349088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589934|NCT01349088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65589935|NCT01349088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589936|NCT01349088|Vitamin B Complex|vitamin b complex|mesh-ancestor
65589937|NCT01349088|Vitamins|vitamins|mesh-ancestor
65589938|NCT01349088|Micronutrients|micronutrients|mesh-ancestor
65589939|NCT01349088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589940|NCT04490434|Celecoxib|celecoxib|mesh-list
65589941|NCT04490434|Naproxen|naproxen|mesh-list
65589942|NCT04490434|Meloxicam|meloxicam|mesh-list
65589943|NCT04490434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65589944|NCT04490434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65589945|NCT04490434|Analgesics|analgesics|mesh-ancestor
65589946|NCT04490434|Sensory System Agents|sensory system agents|mesh-ancestor
65589947|NCT04490434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65589948|NCT04490434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589949|NCT04490434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65589950|NCT04490434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65387476|NCT00939588|Valsartan|valsartan|mesh-list
65589951|NCT04490434|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65589952|NCT04490434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65589953|NCT04490434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589954|NCT04490434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589955|NCT04490434|Gout Suppressants|gout suppressants|mesh-ancestor
65589956|NCT01353924|Aluminum sulfate|aluminum sulfate|mesh-list
65589957|NCT01353924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65589958|NCT01353924|Immunologic Factors|immunologic factors|mesh-ancestor
65589959|NCT01353924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589960|NCT03143166|Telmisartan|telmisartan|mesh-list
65589961|NCT03143166|Dabigatran|dabigatran|mesh-list
65589962|NCT03143166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65589963|NCT03143166|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65589964|NCT03143166|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65589965|NCT03143166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589966|NCT03143166|Antithrombins|antithrombins|mesh-ancestor
65589967|NCT03143166|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65589968|NCT03143166|Protease Inhibitors|protease inhibitors|mesh-ancestor
65589969|NCT03143166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65589970|NCT03143166|Anticoagulants|anticoagulants|mesh-ancestor
65589971|NCT02466568|Nivolumab|nivolumab|mesh-list
65589972|NCT02466568|Vaccines|vaccines|mesh-list
65589973|NCT02466568|Immunologic Factors|immunologic factors|mesh-ancestor
65589974|NCT02466568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589975|NCT02466568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65589976|NCT02466568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589977|NCT02466568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65589978|NCT02466568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65589979|NCT02879994|Pembrolizumab|pembrolizumab|mesh-list
65589980|NCT02879994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65589981|NCT02879994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65589982|NCT02466022|Fentanyl|fentanyl|mesh-list
65589983|NCT02466022|Midazolam|midazolam|mesh-list
65589984|NCT02466022|Dexmedetomidine|dexmedetomidine|mesh-list
65589985|NCT02466022|Bupivacaine|bupivacaine|mesh-list
65589986|NCT02466022|Anesthetics, Local|anesthetics, local|mesh-ancestor
65589987|NCT02466022|Anesthetics|anesthetics|mesh-ancestor
65589988|NCT02466022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65589989|NCT02466022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65589990|NCT02466022|Sensory System Agents|sensory system agents|mesh-ancestor
65589991|NCT02466022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65589992|NCT02466022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65589993|NCT02466022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65589994|NCT02466022|Analgesics|analgesics|mesh-ancestor
65589995|NCT02466022|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65589996|NCT02466022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65589997|NCT02466022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65589998|NCT02466022|Adrenergic Agents|adrenergic agents|mesh-ancestor
65589999|NCT02466022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65590000|NCT02466022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590001|NCT02466022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65590002|NCT02466022|Narcotics|narcotics|mesh-ancestor
65590003|NCT02466022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65590004|NCT02466022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65590005|NCT02466022|Anesthetics, General|anesthetics, general|mesh-ancestor
65590006|NCT02466022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65590007|NCT02466022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65590008|NCT02466022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65590009|NCT02466022|GABA Modulators|gaba modulators|mesh-ancestor
65590010|NCT02466022|GABA Agents|gaba agents|mesh-ancestor
65590011|NCT03937596|Cycloserine|cycloserine|mesh-list
65590012|NCT03937596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65590013|NCT03937596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65590014|NCT03937596|Renal Agents|renal agents|mesh-ancestor
65590015|NCT03937596|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65590016|NCT03937596|Antitubercular Agents|antitubercular agents|mesh-ancestor
65590017|NCT03937596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65590018|NCT03937596|Antimetabolites|antimetabolites|mesh-ancestor
65590019|NCT03937596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590020|NCT04606264|Dexamethasone|dexamethasone|mesh-list
65590021|NCT04606264|Morphine|morphine|mesh-list
65590022|NCT04606264|Hydromorphone|hydromorphone|mesh-list
65590023|NCT04606264|Ondansetron|ondansetron|mesh-list
65590024|NCT04606264|Aprepitant|aprepitant|mesh-list
65590025|NCT04606264|Dimenhydrinate|dimenhydrinate|mesh-list
65590026|NCT04606264|Perphenazine|perphenazine|mesh-list
65590027|NCT04606264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65590028|NCT04606264|Antiemetics|antiemetics|mesh-ancestor
65590029|NCT04606264|Autonomic Agents|autonomic agents|mesh-ancestor
65590030|NCT04606264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65590031|NCT04606264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590032|NCT04606264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65590033|NCT04606264|Glucocorticoids|glucocorticoids|mesh-ancestor
65590034|NCT04606264|Hormones|hormones|mesh-ancestor
65590035|NCT04606264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65590036|NCT04606264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65590037|NCT04606264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590038|NCT04606264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65590039|NCT04606264|Narcotics|narcotics|mesh-ancestor
65590040|NCT04606264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65590041|NCT04606264|Analgesics|analgesics|mesh-ancestor
65590042|NCT04606264|Sensory System Agents|sensory system agents|mesh-ancestor
65590043|NCT04606264|Antipruritics|antipruritics|mesh-ancestor
65590044|NCT04606264|Dermatologic Agents|dermatologic agents|mesh-ancestor
65590045|NCT04606264|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65590046|NCT04606264|Serotonin Agents|serotonin agents|mesh-ancestor
65590047|NCT04606264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65590048|NCT04606264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590049|NCT04606264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65590050|NCT04606264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65590051|NCT04606264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65590052|NCT04606264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65590053|NCT04606264|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65590054|NCT04606264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65590055|NCT04606264|Dopamine Agents|dopamine agents|mesh-ancestor
65590056|NCT04606264|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65590057|NCT04606264|Histamine Antagonists|histamine antagonists|mesh-ancestor
65590058|NCT04606264|Histamine Agents|histamine agents|mesh-ancestor
65590059|NCT03578172|Menotropins|menotropins|mesh-list
65590060|NCT03578172|Hormones|hormones|mesh-list
65590061|NCT03578172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65590062|NCT03578172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590063|NCT03578172|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65590064|NCT03578172|Fertility Agents|fertility agents|mesh-ancestor
65590065|NCT03578172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65590066|NCT03928158|Valsartan|valsartan|mesh-list
65590067|NCT03928158|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65590068|NCT03928158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65590069|NCT03928158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65590070|NCT03928158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65590071|NCT03928158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590072|NCT05174884|Etonogestrel|etonogestrel|mesh-list
65590073|NCT05174884|Desogestrel|desogestrel|mesh-list
65590074|NCT05174884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65590075|NCT05174884|Contraceptive Agents|contraceptive agents|mesh-ancestor
65590076|NCT05174884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65590077|NCT05174884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590078|NCT05174884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65590079|NCT05174884|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65590080|NCT05174884|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65590081|NCT05174884|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65590082|NCT05174884|Progestins|progestins|mesh-ancestor
65590083|NCT05174884|Hormones|hormones|mesh-ancestor
65590084|NCT05174884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65590085|NCT01354158|Droxidopa|droxidopa|mesh-list
65590086|NCT01354158|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65590087|NCT01354158|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65590088|NCT02466490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65590089|NCT02466490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65590090|NCT02466490|Diuretics|diuretics|mesh-ancestor
65590091|NCT02466490|Natriuretic Agents|natriuretic agents|mesh-ancestor
65590092|NCT02466490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590093|NCT02466490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65590094|NCT02466490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65590095|NCT02466490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590096|NCT04547842|Dexamethasone|dexamethasone|mesh-list
65590097|NCT04547842|Mirtazapine|mirtazapine|mesh-list
65590098|NCT04547842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65590099|NCT04547842|Antiemetics|antiemetics|mesh-ancestor
65590100|NCT04547842|Autonomic Agents|autonomic agents|mesh-ancestor
65590101|NCT04547842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65590102|NCT04547842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387616|NCT00884546|Hormones|hormones|mesh-ancestor
65590103|NCT04547842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65590104|NCT04547842|Glucocorticoids|glucocorticoids|mesh-ancestor
65590105|NCT04547842|Hormones|hormones|mesh-ancestor
65590106|NCT04547842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65590107|NCT04547842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65590108|NCT04547842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590109|NCT04547842|Antidepressive Agents|antidepressive agents|mesh-ancestor
65590110|NCT04547842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65590111|NCT04547842|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65590112|NCT04547842|Histamine Antagonists|histamine antagonists|mesh-ancestor
65590113|NCT04547842|Histamine Agents|histamine agents|mesh-ancestor
65590114|NCT04547842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65590115|NCT04547842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590116|NCT04547842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65590117|NCT04547842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65590118|NCT04547842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65590119|NCT04547842|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65590120|NCT04547842|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65590121|NCT04547842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65590122|NCT04547842|Adrenergic Agents|adrenergic agents|mesh-ancestor
65590123|NCT04547842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65590124|NCT04547842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65590125|NCT04547842|Serotonin Agents|serotonin agents|mesh-ancestor
65590126|NCT04547842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65590127|NCT03142932|Carbon Monoxide|carbon monoxide|mesh-list
65590128|NCT03142932|Antimetabolites|antimetabolites|mesh-ancestor
65590129|NCT03142932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590130|NCT03142932|Gasotransmitters|gasotransmitters|mesh-ancestor
65590131|NCT03142932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65590132|NCT03142932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590133|NCT00702052|Everolimus|everolimus|mesh-list
65590134|NCT00702052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590135|NCT00702052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65590136|NCT00702052|Immunologic Factors|immunologic factors|mesh-ancestor
65590137|NCT00702052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590138|NCT00658814|Azacitidine|azacitidine|mesh-list
65590139|NCT00658814|Gemtuzumab|gemtuzumab|mesh-list
65590140|NCT00658814|Calicheamicins|calicheamicins|mesh-list
65590141|NCT00658814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65590142|NCT00658814|Antimetabolites|antimetabolites|mesh-ancestor
65590143|NCT00658814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590144|NCT00658814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590145|NCT00658814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65590146|NCT00658814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65590147|NCT00658814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65590148|NCT01354470|Modafinil|modafinil|mesh-list
65590149|NCT01354470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65590150|NCT01354470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590151|NCT01354470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65590152|NCT01354470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65590153|NCT01354470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65590154|NCT01354470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590155|NCT01349556|Tretinoin|tretinoin|mesh-list
65590156|NCT01349556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590157|NCT01349556|Keratolytic Agents|keratolytic agents|mesh-ancestor
65590158|NCT01349556|Dermatologic Agents|dermatologic agents|mesh-ancestor
65590159|NCT01354704|Enoxaparin|enoxaparin|mesh-list
65590160|NCT01354704|Anticoagulants|anticoagulants|mesh-ancestor
65590161|NCT01354704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65590162|NCT01354704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65590163|NCT01354704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590164|NCT01346670|Lovastatin|lovastatin|mesh-list
65590165|NCT01346670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65590166|NCT01346670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65590167|NCT01346670|Antimetabolites|antimetabolites|mesh-ancestor
65590168|NCT01346670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590169|NCT01346670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65590170|NCT01346670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65590171|NCT01346670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65590172|NCT03136068|Digoxin|digoxin|mesh-list
65590173|NCT03136068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65590174|NCT03136068|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65590175|NCT03136068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65590176|NCT03136068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590178|NCT03136068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590179|NCT01350024|Lidocaine|lidocaine|mesh-list
65590180|NCT01350024|Epinephrine|epinephrine|mesh-list
65590181|NCT01350024|Racepinephrine|racepinephrine|mesh-list
65590182|NCT01350024|Epinephryl borate|epinephryl borate|mesh-list
65590183|NCT01350024|Anesthetics, Local|anesthetics, local|mesh-ancestor
65590184|NCT01350024|Anesthetics|anesthetics|mesh-ancestor
65590185|NCT01350024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65590186|NCT01350024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590187|NCT01350024|Sensory System Agents|sensory system agents|mesh-ancestor
65590188|NCT01350024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65590189|NCT01350024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65590190|NCT01350024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65590191|NCT01350024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65590192|NCT01350024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65590193|NCT01350024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590194|NCT01350024|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65590195|NCT01350024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65590196|NCT01350024|Adrenergic Agents|adrenergic agents|mesh-ancestor
65590197|NCT01350024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65590198|NCT01350024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65590199|NCT01350024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65590200|NCT01350024|Autonomic Agents|autonomic agents|mesh-ancestor
65590201|NCT01350024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65590202|NCT01350024|Respiratory System Agents|respiratory system agents|mesh-ancestor
65590203|NCT01350024|Mydriatics|mydriatics|mesh-ancestor
65590204|NCT01350024|Sympathomimetics|sympathomimetics|mesh-ancestor
65590205|NCT01350024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65590206|NCT01318590|Triamcinolone|triamcinolone|mesh-list
65590207|NCT01318590|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65590208|NCT01318590|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65590209|NCT01318590|Bupivacaine|bupivacaine|mesh-list
65590210|NCT01318590|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65590211|NCT01318590|Anesthetics, Local|anesthetics, local|mesh-ancestor
65590212|NCT01318590|Anesthetics|anesthetics|mesh-ancestor
65590213|NCT01318590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65590214|NCT01318590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590215|NCT01318590|Sensory System Agents|sensory system agents|mesh-ancestor
65590216|NCT01318590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65590217|NCT01318590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65590218|NCT01318590|Glucocorticoids|glucocorticoids|mesh-ancestor
65590219|NCT01318590|Hormones|hormones|mesh-ancestor
65590220|NCT01318590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65590221|NCT01318590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65590222|NCT01318590|Immunologic Factors|immunologic factors|mesh-ancestor
65590223|NCT01318590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65590224|NCT01318590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590225|NCT01346826|Infliximab|infliximab|mesh-list
65590226|NCT01346826|Dermatologic Agents|dermatologic agents|mesh-ancestor
65590227|NCT01346826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65590228|NCT01346826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65590229|NCT01354860|Lobeline|lobeline|mesh-list
65590230|NCT01354860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65590231|NCT01354860|Autonomic Agents|autonomic agents|mesh-ancestor
65590232|NCT01354860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65590233|NCT01354860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590234|NCT01354860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65590235|NCT01354860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65590236|NCT01354860|Cholinergic Agents|cholinergic agents|mesh-ancestor
64760644|NCT05097846|Bismuth|bismuth|mesh-list
65590237|NCT01354860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65590238|NCT01354860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590239|NCT01354860|Respiratory System Agents|respiratory system agents|mesh-ancestor
65590240|NCT02556606|Midazolam|midazolam|mesh-list
65590241|NCT02556606|Ketamine|ketamine|mesh-list
65590242|NCT02556606|Analgesics|analgesics|mesh-ancestor
65590243|NCT02556606|Sensory System Agents|sensory system agents|mesh-ancestor
65590244|NCT02556606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65590245|NCT02556606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590246|NCT02556606|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65590247|NCT02556606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65590248|NCT02556606|Anesthetics, General|anesthetics, general|mesh-ancestor
65590249|NCT02556606|Anesthetics|anesthetics|mesh-ancestor
65590250|NCT02556606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65590251|NCT02556606|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65590252|NCT02556606|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65590253|NCT02556606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65590254|NCT02556606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590255|NCT02556606|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65590256|NCT02556606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65590257|NCT02556606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65590258|NCT02556606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65590259|NCT02556606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65590260|NCT02556606|GABA Modulators|gaba modulators|mesh-ancestor
65590261|NCT02556606|GABA Agents|gaba agents|mesh-ancestor
65590262|NCT01355562|Interleukin-2|interleukin-2|mesh-list
65590263|NCT01355562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590264|NCT01355562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65590265|NCT01355562|Analgesics|analgesics|mesh-ancestor
65590266|NCT01355562|Sensory System Agents|sensory system agents|mesh-ancestor
65590267|NCT01355562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65590268|NCT01355562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590269|NCT01350570|Loperamide|loperamide|mesh-list
65590270|NCT01350570|Antidiarrheals|antidiarrheals|mesh-list
65590271|NCT01350570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65590272|NCT01355718|Repaglinide|repaglinide|mesh-list
65590273|NCT01355718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65590274|NCT01355718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590275|NCT03377790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65590276|NCT03377790|Cantharidin|cantharidin|mesh-list
65590277|NCT03377790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65590278|NCT03377790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590279|NCT01347294|Bleomycin|bleomycin|mesh-list
65590280|NCT01347294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65590281|NCT01347294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590282|NCT02422368|Methylprednisolone|methylprednisolone|mesh-list
65590283|NCT02422368|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65590284|NCT02422368|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65590285|NCT02422368|Prednisolone|prednisolone|mesh-list
65590286|NCT02422368|Prednisolone acetate|prednisolone acetate|mesh-list
65590287|NCT02422368|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65590288|NCT02422368|Prednisolone phosphate|prednisolone phosphate|mesh-list
65590289|NCT02422368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65590290|NCT02422368|Antiemetics|antiemetics|mesh-ancestor
65590291|NCT02422368|Autonomic Agents|autonomic agents|mesh-ancestor
65590292|NCT02422368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65590293|NCT02422368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590294|NCT02422368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65590295|NCT02422368|Glucocorticoids|glucocorticoids|mesh-ancestor
65590296|NCT02422368|Hormones|hormones|mesh-ancestor
65590297|NCT02422368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65590298|NCT02422368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65590299|NCT02422368|Protective Agents|protective agents|mesh-ancestor
65590300|NCT02422368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65590301|NCT02422368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590302|NCT01355952|Thioctic Acid|thioctic acid|mesh-list
65590303|NCT01355952|Antioxidants|antioxidants|mesh-ancestor
65590304|NCT01355952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590305|NCT01355952|Protective Agents|protective agents|mesh-ancestor
65590306|NCT01355952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590307|NCT01355952|Vitamin B Complex|vitamin b complex|mesh-ancestor
65590308|NCT01355952|Vitamins|vitamins|mesh-ancestor
65590309|NCT01355952|Micronutrients|micronutrients|mesh-ancestor
65590310|NCT04483414|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65590311|NCT04483414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65590312|NCT04483414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590313|NCT00644228|Dexamethasone|dexamethasone|mesh-list
65590314|NCT00644228|Dexamethasone acetate|dexamethasone acetate|mesh-list
65590315|NCT00644228|Lenalidomide|lenalidomide|mesh-list
65590316|NCT00644228|Bortezomib|bortezomib|mesh-list
65590317|NCT00644228|Ichthammol|ichthammol|mesh-list
65590318|NCT00644228|BB 1101|bb 1101|mesh-list
65590319|NCT00644228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65590320|NCT00644228|Antiemetics|antiemetics|mesh-ancestor
65590321|NCT00644228|Autonomic Agents|autonomic agents|mesh-ancestor
65590322|NCT00644228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65590323|NCT00644228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590324|NCT00644228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65590325|NCT00644228|Glucocorticoids|glucocorticoids|mesh-ancestor
65387781|NCT02542748|Norepinephrine|norepinephrine|mesh-list
65590326|NCT00644228|Hormones|hormones|mesh-ancestor
65590327|NCT00644228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65590328|NCT00644228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65590329|NCT00644228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590331|NCT00644228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65590332|NCT00644228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590333|NCT00644228|Immunologic Factors|immunologic factors|mesh-ancestor
65590334|NCT00644228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65590335|NCT00644228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65590336|NCT00644228|Growth Substances|growth substances|mesh-ancestor
65590337|NCT00644228|Growth Inhibitors|growth inhibitors|mesh-ancestor
65590338|NCT00644228|Dermatologic Agents|dermatologic agents|mesh-ancestor
65590339|NCT05720572|Antazoline|antazoline|mesh-list
65590340|NCT05720572|Propafenone|propafenone|mesh-list
65590341|NCT05720572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65590342|NCT05720572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65590343|NCT05720572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65590344|NCT05720572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65590345|NCT05720572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590346|NCT05720572|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65590347|NCT05720572|Histamine Antagonists|histamine antagonists|mesh-ancestor
65590348|NCT05720572|Histamine Agents|histamine agents|mesh-ancestor
65590349|NCT05720572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65590350|NCT05720572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590351|NCT05720572|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65590352|NCT05111002|Doxycycline|doxycycline|mesh-list
65590353|NCT05111002|Lefamulin|lefamulin|mesh-list
65590354|NCT05111002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65590355|NCT05111002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65590356|NCT05111002|Antimalarials|antimalarials|mesh-ancestor
65590357|NCT05111002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65590358|NCT05111002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65590359|NCT01347684|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
65590360|NCT01347684|Antidepressive Agents|antidepressive agents|mesh-ancestor
65590361|NCT01347684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65590362|NCT05716750|Vitamin D|vitamin d|mesh-list
65590363|NCT05716750|Vitamins|vitamins|mesh-ancestor
65590364|NCT05716750|Micronutrients|micronutrients|mesh-ancestor
65590365|NCT05716750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590366|NCT05716750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65590367|NCT01350882|Rituximab|rituximab|mesh-list
65590368|NCT01350882|Citric Acid|citric acid|mesh-list
65590369|NCT01350882|Sodium Citrate|sodium citrate|mesh-list
65590370|NCT01350882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65590371|NCT01350882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590372|NCT01350882|Immunologic Factors|immunologic factors|mesh-ancestor
65590373|NCT01350882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590374|NCT01350882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65590375|NCT01350882|Anticoagulants|anticoagulants|mesh-ancestor
65590376|NCT01350882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65590377|NCT01350882|Chelating Agents|chelating agents|mesh-ancestor
65590378|NCT01350882|Sequestering Agents|sequestering agents|mesh-ancestor
65590379|NCT01350882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590380|NCT01844856|Ertapenem|ertapenem|mesh-list
65590381|NCT01844856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65590382|NCT01844856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65590383|NCT00618098|Thrombin|thrombin|mesh-list
65590384|NCT00618098|Hemostatics|hemostatics|mesh-ancestor
65590385|NCT00618098|Coagulants|coagulants|mesh-ancestor
65590386|NCT02464228|Tipifarnib|tipifarnib|mesh-list
65590387|NCT02464228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590388|NCT01351038|Capecitabine|capecitabine|mesh-list
65590389|NCT01351038|Oxaliplatin|oxaliplatin|mesh-list
65590390|NCT01351038|Panitumumab|panitumumab|mesh-list
65590391|NCT01351038|Epirubicin|epirubicin|mesh-list
65590392|NCT01351038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65590393|NCT01351038|Antimetabolites|antimetabolites|mesh-ancestor
65590394|NCT01351038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590395|NCT01351038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590396|NCT01351038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65590397|NCT01351038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65590398|NCT01351038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65590399|NCT01351038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65590400|NCT01351038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65590401|NCT01817166|Vitamin D|vitamin d|mesh-list
65590402|NCT01817166|Cholecalciferol|cholecalciferol|mesh-list
65590403|NCT01817166|Vitamins|vitamins|mesh-ancestor
65590404|NCT01817166|Micronutrients|micronutrients|mesh-ancestor
65590405|NCT01817166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590406|NCT01817166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65590407|NCT01817166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65590408|NCT02464462|Vitamin D|vitamin d|mesh-list
65590409|NCT02464462|Cholecalciferol|cholecalciferol|mesh-list
65590410|NCT02464462|Calcium|calcium|mesh-list
65590411|NCT02464462|Vitamins|vitamins|mesh-ancestor
65590412|NCT02464462|Micronutrients|micronutrients|mesh-ancestor
65590413|NCT02464462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590414|NCT02464462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65590415|NCT02464462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65590416|NCT04270864|Nivolumab|nivolumab|mesh-list
65590417|NCT04270864|Ipilimumab|ipilimumab|mesh-list
65590418|NCT04270864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65590419|NCT04270864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590420|NCT04270864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65590421|NCT04270864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590422|NCT01318668|Vaccines|vaccines|mesh-list
65590423|NCT01318668|Immunologic Factors|immunologic factors|mesh-ancestor
65590424|NCT01318668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590425|NCT01351272|Methylphenidate|methylphenidate|mesh-list
65590426|NCT01351272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65590427|NCT01351272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590428|NCT01351272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65590429|NCT01351272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65590430|NCT01351272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65590431|NCT01351272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590432|NCT01351272|Dopamine Agents|dopamine agents|mesh-ancestor
65590433|NCT01351272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65590434|NCT01351428|Nifedipine|nifedipine|mesh-list
65590435|NCT01351428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65590436|NCT01351428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65590437|NCT01351428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590438|NCT01351428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65590439|NCT01351428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590440|NCT01351428|Vasodilator Agents|vasodilator agents|mesh-ancestor
65590441|NCT01351428|Tocolytic Agents|tocolytic agents|mesh-ancestor
65590442|NCT01351428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65590443|NCT05006326|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65590444|NCT05006326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65590445|NCT05006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590446|NCT00588770|Bevacizumab|bevacizumab|mesh-list
65590447|NCT00588770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65590448|NCT00588770|Cisplatin|cisplatin|mesh-list
65590449|NCT00588770|Carboplatin|carboplatin|mesh-list
65590450|NCT00588770|Docetaxel|docetaxel|mesh-list
65590451|NCT00588770|Fluorouracil|fluorouracil|mesh-list
65590452|NCT00588770|Endothelial Growth Factors|endothelial growth factors|mesh-list
65590453|NCT00588770|Antibodies|antibodies|mesh-list
65590454|NCT00588770|Immunoglobulins|immunoglobulins|mesh-list
65590455|NCT00588770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65590456|NCT00588770|Immunoglobulin G|immunoglobulin g|mesh-list
65590457|NCT00588770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590458|NCT00588770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65590459|NCT00588770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65590460|NCT00588770|Growth Substances|growth substances|mesh-ancestor
65590461|NCT00588770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590462|NCT00588770|Growth Inhibitors|growth inhibitors|mesh-ancestor
65590463|NCT00588770|Immunologic Factors|immunologic factors|mesh-ancestor
65590464|NCT00588770|Tubulin Modulators|tubulin modulators|mesh-ancestor
65590465|NCT00588770|Antimitotic Agents|antimitotic agents|mesh-ancestor
65590466|NCT00588770|Mitosis Modulators|mitosis modulators|mesh-ancestor
65590467|NCT00588770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590468|NCT00588770|Antimetabolites|antimetabolites|mesh-ancestor
65590469|NCT00588770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65590470|NCT00588770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65590471|NCT00701662|Immunoglobulins|immunoglobulins|mesh-list
65590472|NCT00701662|Immunologic Factors|immunologic factors|mesh-ancestor
65590473|NCT00701662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590474|NCT02464306|Fidaxomicin|fidaxomicin|mesh-list
65590475|NCT02464306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65590476|NCT02464306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65590477|NCT01351818|Hormones|hormones|mesh-list
65590478|NCT01351818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65590479|NCT01351818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590480|NCT02463994|Atezolizumab|atezolizumab|mesh-list
65590481|NCT02463994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590483|NCT04235686|Dextroamphetamine|dextroamphetamine|mesh-list
65590484|NCT04235686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65590485|NCT04235686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590486|NCT04235686|Sympathomimetics|sympathomimetics|mesh-ancestor
65590487|NCT04235686|Autonomic Agents|autonomic agents|mesh-ancestor
65590488|NCT04235686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65590489|NCT04235686|Dopamine Agents|dopamine agents|mesh-ancestor
65590490|NCT04235686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65590491|NCT04235686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590492|NCT04235686|Adrenergic Agents|adrenergic agents|mesh-ancestor
65590493|NCT04235686|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65590494|NCT04235686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65590495|NCT04235686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65590496|NCT04235686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65590497|NCT02079948|Folic Acid|folic acid|mesh-list
65590498|NCT02079948|Vitamin B Complex|vitamin b complex|mesh-list
65590499|NCT02079948|Methotrexate|methotrexate|mesh-list
65590500|NCT02079948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65590501|NCT02079948|Abortifacient Agents|abortifacient agents|mesh-ancestor
65590502|NCT02079948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65590503|NCT02079948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590504|NCT02079948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65590505|NCT02079948|Antimetabolites|antimetabolites|mesh-ancestor
65590506|NCT02079948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590507|NCT02079948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590508|NCT02079948|Dermatologic Agents|dermatologic agents|mesh-ancestor
65590509|NCT02079948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65590510|NCT02079948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65590511|NCT02079948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65590512|NCT02079948|Immunologic Factors|immunologic factors|mesh-ancestor
65590513|NCT02079948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65590514|NCT02079948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65590515|NCT02079948|Hematinics|hematinics|mesh-ancestor
65590516|NCT02079948|Vitamins|vitamins|mesh-ancestor
65590517|NCT02079948|Micronutrients|micronutrients|mesh-ancestor
65590518|NCT01357902|Lamotrigine|lamotrigine|mesh-list
65590519|NCT01357902|Anticonvulsants|anticonvulsants|mesh-ancestor
65590520|NCT01357902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65590521|NCT01357902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65590522|NCT01357902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590523|NCT01357902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65590524|NCT01357902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590525|NCT01357902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65590526|NCT01357902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65590527|NCT01357902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65590528|NCT01357902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65590529|NCT01357902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65590530|NCT05394350|Pembrolizumab|pembrolizumab|mesh-list
65590531|NCT05394350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65590532|NCT05394350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590533|NCT04634409|Bamlanivimab|bamlanivimab|mesh-list
65590534|NCT04634409|Antiviral Agents|antiviral agents|mesh-ancestor
65590535|NCT04634409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65590536|NCT01352130|Ondansetron|ondansetron|mesh-list
65590537|NCT01352130|Granisetron|granisetron|mesh-list
65590538|NCT01352130|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
65590539|NCT01352130|Antiemetics|antiemetics|mesh-ancestor
65590540|NCT01352130|Autonomic Agents|autonomic agents|mesh-ancestor
65590541|NCT01352130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65590542|NCT01352130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590543|NCT01352130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65590544|NCT01352130|Antipruritics|antipruritics|mesh-ancestor
65590545|NCT01352130|Dermatologic Agents|dermatologic agents|mesh-ancestor
65590546|NCT01352130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65590547|NCT01352130|Serotonin Agents|serotonin agents|mesh-ancestor
65590548|NCT01352130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65590549|NCT01352130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590550|NCT01352130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65590551|NCT01352130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65590552|NCT01352130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65590553|NCT01352130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65590554|NCT01352130|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65590555|NCT05605834|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65590556|NCT05605834|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65590557|NCT05605834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65590558|NCT00005780|Prednisone|prednisone|mesh-list
65590559|NCT00005780|Cyclophosphamide|cyclophosphamide|mesh-list
65590560|NCT00005780|Doxorubicin|doxorubicin|mesh-list
65590561|NCT00005780|Etoposide|etoposide|mesh-list
65590562|NCT00005780|Vincristine|vincristine|mesh-list
65590563|NCT00005780|Sargramostim|sargramostim|mesh-list
65590564|NCT00005780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65590565|NCT00005780|Immunologic Factors|immunologic factors|mesh-ancestor
65590566|NCT00005780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590567|NCT00005780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65590568|NCT00005780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65590569|NCT00005780|Alkylating Agents|alkylating agents|mesh-ancestor
65590570|NCT00005780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590571|NCT00005780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590572|NCT00005780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65590573|NCT00005780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65590574|NCT00005780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65590575|NCT00005780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65590576|NCT00005780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65590577|NCT00005780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65590578|NCT00005780|Glucocorticoids|glucocorticoids|mesh-ancestor
65590579|NCT00005780|Hormones|hormones|mesh-ancestor
65590580|NCT00005780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65590581|NCT00005780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65590582|NCT00005780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65590583|NCT00005780|Tubulin Modulators|tubulin modulators|mesh-ancestor
65590584|NCT00005780|Antimitotic Agents|antimitotic agents|mesh-ancestor
65590585|NCT00005780|Mitosis Modulators|mitosis modulators|mesh-ancestor
65590586|NCT01356732|Sufentanil|sufentanil|mesh-list
65590587|NCT01356732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65590588|NCT01356732|Narcotics|narcotics|mesh-ancestor
65590589|NCT01356732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65590590|NCT01356732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590591|NCT01356732|Analgesics|analgesics|mesh-ancestor
65590592|NCT01356732|Sensory System Agents|sensory system agents|mesh-ancestor
65590593|NCT01356732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65590594|NCT01356732|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65590595|NCT01356732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65590596|NCT01356732|Anesthetics, General|anesthetics, general|mesh-ancestor
65590597|NCT01356732|Anesthetics|anesthetics|mesh-ancestor
65590598|NCT02463682|Insulin|insulin|mesh-list
65590599|NCT02463682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65590600|NCT02463682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590601|NCT05315648|Anesthetics|anesthetics|mesh-list
65590602|NCT05315648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65590603|NCT05315648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590604|NCT01978938|Levofloxacin|levofloxacin|mesh-list
65590605|NCT01978938|Ofloxacin|ofloxacin|mesh-list
65590606|NCT01978938|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65590607|NCT01978938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65590608|NCT01978938|Renal Agents|renal agents|mesh-ancestor
65590609|NCT01978938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65590610|NCT01978938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65590611|NCT01978938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65590612|NCT01978938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65590613|NCT01978938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590614|NCT01978938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590615|NCT01978938|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65590616|NCT01978938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65590617|NCT02465320|Lidocaine|lidocaine|mesh-list
65590618|NCT02465320|Anesthetics, Local|anesthetics, local|mesh-ancestor
65590619|NCT02465320|Anesthetics|anesthetics|mesh-ancestor
65590620|NCT02465320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65590621|NCT02465320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590622|NCT02465320|Sensory System Agents|sensory system agents|mesh-ancestor
65590623|NCT02465320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65590624|NCT02465320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65590625|NCT02465320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65590626|NCT02465320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65590627|NCT02465320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65590628|NCT02465320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590629|NCT02465008|Levobupivacaine|levobupivacaine|mesh-list
65590630|NCT02465008|Anesthetics, Local|anesthetics, local|mesh-ancestor
65590631|NCT02465008|Anesthetics|anesthetics|mesh-ancestor
65590632|NCT02465008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65590633|NCT02465008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590634|NCT02465008|Sensory System Agents|sensory system agents|mesh-ancestor
65590635|NCT02465008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65590636|NCT04141696|Midazolam|midazolam|mesh-list
65590637|NCT04141696|Ketamine|ketamine|mesh-list
65590638|NCT04141696|Analgesics|analgesics|mesh-ancestor
65590639|NCT04141696|Sensory System Agents|sensory system agents|mesh-ancestor
65590640|NCT04141696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65590641|NCT04141696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590642|NCT04141696|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65590643|NCT04141696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65590644|NCT04141696|Anesthetics, General|anesthetics, general|mesh-ancestor
65590645|NCT04141696|Anesthetics|anesthetics|mesh-ancestor
65590646|NCT04141696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65590647|NCT04141696|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65590648|NCT04141696|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65590649|NCT04141696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65590650|NCT04141696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590651|NCT04141696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65590652|NCT04141696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65590653|NCT04141696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65590654|NCT04141696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65590655|NCT04141696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65590656|NCT04141696|GABA Modulators|gaba modulators|mesh-ancestor
65590657|NCT04141696|GABA Agents|gaba agents|mesh-ancestor
65590658|NCT03228186|Docetaxel|docetaxel|mesh-list
65590659|NCT03228186|Pevonedistat|pevonedistat|mesh-list
65590660|NCT03228186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590661|NCT03228186|Tubulin Modulators|tubulin modulators|mesh-ancestor
65590662|NCT03228186|Antimitotic Agents|antimitotic agents|mesh-ancestor
65590663|NCT03228186|Mitosis Modulators|mitosis modulators|mesh-ancestor
65590664|NCT03228186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590665|NCT03228186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65590666|NCT04105114|Buspirone|buspirone|mesh-list
65590667|NCT04105114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65590668|NCT04105114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65590669|NCT04105114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65590670|NCT04105114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590671|NCT04105114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65590672|NCT04105114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65590673|NCT04105114|Serotonin Agents|serotonin agents|mesh-ancestor
65590674|NCT04105114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65590675|NCT04105114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590676|NCT05573230|Cyclosporine|cyclosporine|mesh-list
65590677|NCT05573230|Midazolam|midazolam|mesh-list
65590678|NCT05573230|Cyclosporins|cyclosporins|mesh-list
65590679|NCT05573230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65590680|NCT05573230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65590681|NCT05573230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65590682|NCT05573230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590683|NCT05573230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65590684|NCT05573230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65590685|NCT05573230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65590686|NCT05573230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65590687|NCT05573230|Anesthetics, General|anesthetics, general|mesh-ancestor
65590688|NCT05573230|Anesthetics|anesthetics|mesh-ancestor
65590689|NCT05573230|GABA Modulators|gaba modulators|mesh-ancestor
65590690|NCT05573230|GABA Agents|gaba agents|mesh-ancestor
65590691|NCT05573230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65590692|NCT05573230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590693|NCT05573230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65590694|NCT05573230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65590695|NCT05573230|Immunologic Factors|immunologic factors|mesh-ancestor
65590696|NCT05573230|Antifungal Agents|antifungal agents|mesh-ancestor
65590697|NCT05573230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65590698|NCT05573230|Dermatologic Agents|dermatologic agents|mesh-ancestor
65590699|NCT05573230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65590700|NCT05573230|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65590701|NCT04088188|Gemcitabine|gemcitabine|mesh-list
65590702|NCT04088188|Cisplatin|cisplatin|mesh-list
65590703|NCT04088188|Ivosidenib|ivosidenib|mesh-list
65590704|NCT04088188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590705|NCT04088188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65590706|NCT04088188|Antimetabolites|antimetabolites|mesh-ancestor
65590707|NCT04088188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590708|NCT04088188|Antiviral Agents|antiviral agents|mesh-ancestor
65590709|NCT04088188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65590710|NCT04088188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65590711|NCT04088188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65590712|NCT04088188|Immunologic Factors|immunologic factors|mesh-ancestor
65590713|NCT04088188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590715|NCT05550142|Immunologic Factors|immunologic factors|mesh-ancestor
65590716|NCT05550142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590717|NCT04047862|Paclitaxel|paclitaxel|mesh-list
65590718|NCT04047862|Etoposide|etoposide|mesh-list
65590719|NCT04047862|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65590720|NCT04047862|Carboplatin|carboplatin|mesh-list
65590721|NCT04047862|Fluorouracil|fluorouracil|mesh-list
65590722|NCT04047862|Capecitabine|capecitabine|mesh-list
65590723|NCT04047862|Oxaliplatin|oxaliplatin|mesh-list
65590724|NCT04047862|Pemetrexed|pemetrexed|mesh-list
65590725|NCT04047862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65590726|NCT04047862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590727|NCT04047862|Tubulin Modulators|tubulin modulators|mesh-ancestor
65590728|NCT04047862|Antimitotic Agents|antimitotic agents|mesh-ancestor
65590729|NCT04047862|Mitosis Modulators|mitosis modulators|mesh-ancestor
65590730|NCT04047862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590731|NCT04047862|Antimetabolites|antimetabolites|mesh-ancestor
65590732|NCT04047862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65590733|NCT04047862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65590734|NCT04047862|Immunologic Factors|immunologic factors|mesh-ancestor
65590735|NCT04047862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590736|NCT04047862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65590737|NCT04047862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65590738|NCT04047862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65590739|NCT04047862|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65590740|NCT04047862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65590741|NCT00116142|Ascorbic Acid|ascorbic acid|mesh-list
65590742|NCT00116142|Docetaxel|docetaxel|mesh-list
65590743|NCT00116142|Methyltestosterone|methyltestosterone|mesh-list
65590744|NCT00116142|Androgens|androgens|mesh-list
65590745|NCT00116142|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65590746|NCT00116142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590747|NCT00116142|Tubulin Modulators|tubulin modulators|mesh-ancestor
65590748|NCT00116142|Antimitotic Agents|antimitotic agents|mesh-ancestor
65590749|NCT00116142|Mitosis Modulators|mitosis modulators|mesh-ancestor
65590750|NCT00116142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590751|NCT00116142|Hormones|hormones|mesh-ancestor
65590752|NCT00116142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65590753|NCT00116142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590754|NCT00116142|Antioxidants|antioxidants|mesh-ancestor
65590755|NCT00116142|Protective Agents|protective agents|mesh-ancestor
65590756|NCT00116142|Vitamins|vitamins|mesh-ancestor
65590757|NCT00116142|Micronutrients|micronutrients|mesh-ancestor
65590758|NCT00116142|Estrogens|estrogens|mesh-ancestor
65590759|NCT00116142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65590760|NCT00116142|Anabolic Agents|anabolic agents|mesh-ancestor
65590761|NCT05547256|Vaccines|vaccines|mesh-list
65590762|NCT05547256|Immunologic Factors|immunologic factors|mesh-ancestor
65590763|NCT05547256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590764|NCT01757782|Sildenafil Citrate|sildenafil citrate|mesh-list
65590765|NCT01757782|Vasodilator Agents|vasodilator agents|mesh-ancestor
65590766|NCT01757782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65590767|NCT01757782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65590768|NCT01757782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65590769|NCT01757782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590770|NCT01757782|Urological Agents|urological agents|mesh-ancestor
65590771|NCT02023905|Everolimus|everolimus|mesh-list
65590772|NCT02023905|Temozolomide|temozolomide|mesh-list
65590773|NCT02023905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590774|NCT02023905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65590775|NCT02023905|Immunologic Factors|immunologic factors|mesh-ancestor
65590776|NCT02023905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590777|NCT02023905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65590778|NCT02023905|Alkylating Agents|alkylating agents|mesh-ancestor
65590779|NCT02023905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590780|NCT01330563|Ketoconazole|ketoconazole|mesh-list
65590781|NCT01330563|Antifungal Agents|antifungal agents|mesh-ancestor
65590782|NCT01330563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65590783|NCT01330563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65590784|NCT01330563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65590785|NCT01330563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65590786|NCT01330563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590787|NCT01330563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65590788|NCT01330563|Hormone Antagonists|hormone antagonists|mesh-ancestor
65590789|NCT01330563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65590790|NCT01330563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590791|NCT01330563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65590792|NCT01991379|Imatinib Mesylate|imatinib mesylate|mesh-list
65590793|NCT01991379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590794|NCT01991379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65590795|NCT01991379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65590796|NCT01991379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590797|NCT02875080|Brexpiprazole|brexpiprazole|mesh-list
65590798|NCT02875080|Serotonin Agents|serotonin agents|mesh-ancestor
65590799|NCT02875080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65590800|NCT02875080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590801|NCT02875080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590802|NCT02875080|Dopamine Agonists|dopamine agonists|mesh-ancestor
65590803|NCT02875080|Dopamine Agents|dopamine agents|mesh-ancestor
65590804|NCT04897503|Riboflavin|riboflavin|mesh-list
65590805|NCT04897503|Vitamin B Complex|vitamin b complex|mesh-ancestor
65590806|NCT04897503|Vitamins|vitamins|mesh-ancestor
65590807|NCT04897503|Micronutrients|micronutrients|mesh-ancestor
65590808|NCT04897503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590809|NCT04897503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65590810|NCT04897503|Dermatologic Agents|dermatologic agents|mesh-ancestor
65590811|NCT01333917|Curcumin|curcumin|mesh-list
65590812|NCT01333917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65590813|NCT01333917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65590814|NCT01333917|Analgesics|analgesics|mesh-ancestor
65590815|NCT01333917|Sensory System Agents|sensory system agents|mesh-ancestor
65590816|NCT01333917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65590817|NCT01333917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590818|NCT01333917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65590819|NCT01333917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65590820|NCT01333917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590821|NCT01333917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65590822|NCT01333917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590823|NCT03129360|Levetiracetam|levetiracetam|mesh-list
65590824|NCT03129360|Anticonvulsants|anticonvulsants|mesh-ancestor
65590825|NCT03129360|Nootropic Agents|nootropic agents|mesh-ancestor
65590826|NCT01315275|Ranibizumab|ranibizumab|mesh-list
65590827|NCT01315275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65590828|NCT01315275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65590829|NCT01315275|Growth Substances|growth substances|mesh-ancestor
65590830|NCT01315275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590831|NCT01315275|Growth Inhibitors|growth inhibitors|mesh-ancestor
65590832|NCT01315275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590833|NCT01319448|Artesunate|artesunate|mesh-list
65590834|NCT01319448|Pyrimethamine|pyrimethamine|mesh-list
65590835|NCT01319448|Sulfadoxine|sulfadoxine|mesh-list
65590836|NCT01319448|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65590837|NCT01319448|Amodiaquine|amodiaquine|mesh-list
65590838|NCT01319448|Mefloquine|mefloquine|mesh-list
65590839|NCT01319448|Proguanil|proguanil|mesh-list
65590840|NCT01319448|Antimalarials|antimalarials|mesh-ancestor
65590841|NCT01319448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65590842|NCT01319448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65590843|NCT01319448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65590844|NCT01319448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590845|NCT01319448|Antiviral Agents|antiviral agents|mesh-ancestor
65590846|NCT01319448|Schistosomicides|schistosomicides|mesh-ancestor
65590847|NCT01319448|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65590848|NCT01319448|Anthelmintics|anthelmintics|mesh-ancestor
65590849|NCT01319448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65590850|NCT01319448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65590851|NCT01319448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590852|NCT01319448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65590853|NCT01319448|Renal Agents|renal agents|mesh-ancestor
65590854|NCT01319448|Antimetabolites|antimetabolites|mesh-ancestor
65590855|NCT04360551|Telmisartan|telmisartan|mesh-list
65590856|NCT04360551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65590857|NCT04360551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65590858|NCT04360551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65590859|NCT04360551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590860|NCT01334073|Everolimus|everolimus|mesh-list
65590861|NCT01334073|Axitinib|axitinib|mesh-list
65590862|NCT01334073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590863|NCT01334073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65590864|NCT01334073|Immunologic Factors|immunologic factors|mesh-ancestor
65590865|NCT01334073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590866|NCT01334073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65590867|NCT01334073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65590868|NCT01334073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590869|NCT01928199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65590870|NCT01928199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65590871|NCT01928199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590872|NCT01928199|Incretins|incretins|mesh-ancestor
65590873|NCT01928199|Hormones|hormones|mesh-ancestor
65590874|NCT01928199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65590875|NCT01928199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65590876|NCT01928199|Protease Inhibitors|protease inhibitors|mesh-ancestor
65590877|NCT01928199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65590878|NCT01928199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590879|NCT01845441|Fentanyl|fentanyl|mesh-list
65590880|NCT01845441|Midazolam|midazolam|mesh-list
65590881|NCT01845441|Dexmedetomidine|dexmedetomidine|mesh-list
65590882|NCT01845441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65590883|NCT01845441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65590884|NCT01845441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590885|NCT01845441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65590886|NCT01845441|Analgesics|analgesics|mesh-ancestor
65590887|NCT01845441|Sensory System Agents|sensory system agents|mesh-ancestor
65590888|NCT01845441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65590889|NCT01845441|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65590890|NCT01845441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65590891|NCT01845441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65590892|NCT01845441|Adrenergic Agents|adrenergic agents|mesh-ancestor
65590893|NCT01845441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65590894|NCT01845441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590895|NCT01845441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65590896|NCT01845441|Narcotics|narcotics|mesh-ancestor
65590897|NCT01845441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65590898|NCT01845441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65590899|NCT01845441|Anesthetics, General|anesthetics, general|mesh-ancestor
65590900|NCT01845441|Anesthetics|anesthetics|mesh-ancestor
65590901|NCT01845441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65590902|NCT01845441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65590903|NCT01845441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65590904|NCT01845441|GABA Modulators|gaba modulators|mesh-ancestor
65590905|NCT01845441|GABA Agents|gaba agents|mesh-ancestor
65590906|NCT03296488|Fentanyl|fentanyl|mesh-list
65590907|NCT03296488|Nalbuphine|nalbuphine|mesh-list
65590908|NCT03296488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65590909|NCT03296488|Narcotics|narcotics|mesh-ancestor
65590910|NCT03296488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65590911|NCT03296488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590912|NCT03296488|Analgesics|analgesics|mesh-ancestor
65590913|NCT03296488|Sensory System Agents|sensory system agents|mesh-ancestor
65590914|NCT03296488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65590915|NCT03296488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65590916|NCT03296488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65590917|NCT03296488|Anesthetics, General|anesthetics, general|mesh-ancestor
65590918|NCT03296488|Anesthetics|anesthetics|mesh-ancestor
65590919|NCT01365936|Menotropins|menotropins|mesh-list
65590920|NCT01365936|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65590921|NCT01365936|Fertility Agents|fertility agents|mesh-ancestor
65590922|NCT01365936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65590923|NCT01365936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590924|NCT01334151|Insulin|insulin|mesh-list
65590925|NCT01334151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65590926|NCT01334151|Insulin Lispro|insulin lispro|mesh-list
65590927|NCT01334151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65590928|NCT01334151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590929|NCT04216017|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65590930|NCT04216017|Lidocaine|lidocaine|mesh-list
65590931|NCT04216017|Anesthetics, Local|anesthetics, local|mesh-ancestor
65590932|NCT04216017|Anesthetics|anesthetics|mesh-ancestor
65590933|NCT04216017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65590934|NCT04216017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590935|NCT04216017|Sensory System Agents|sensory system agents|mesh-ancestor
65590936|NCT04216017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65388405|NCT00129259|Iron|iron|mesh-list
65590937|NCT04216017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65590938|NCT04216017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65590939|NCT04216017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65590940|NCT04216017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65590941|NCT04216017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590942|NCT04216017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65590943|NCT04216017|Glucocorticoids|glucocorticoids|mesh-ancestor
65590944|NCT04216017|Hormones|hormones|mesh-ancestor
65590945|NCT04216017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65590946|NCT04216017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65590947|NCT04216017|Immunologic Factors|immunologic factors|mesh-ancestor
65590948|NCT03296410|Vaccines|vaccines|mesh-list
65590949|NCT03296410|Immunologic Factors|immunologic factors|mesh-ancestor
65590950|NCT03296410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590951|NCT05189184|Paclitaxel|paclitaxel|mesh-list
65590952|NCT05189184|Apatinib|apatinib|mesh-list
65590953|NCT05189184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65590954|NCT05189184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65590955|NCT05189184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590956|NCT05189184|Tubulin Modulators|tubulin modulators|mesh-ancestor
65590957|NCT05189184|Antimitotic Agents|antimitotic agents|mesh-ancestor
65590958|NCT05189184|Mitosis Modulators|mitosis modulators|mesh-ancestor
65590959|NCT05189184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590960|NCT05189184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65590961|NCT05189184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65590962|NCT01362036|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
65590963|NCT01362036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65590964|NCT01362036|Vasodilator Agents|vasodilator agents|mesh-ancestor
65590965|NCT04623099|Citalopram|citalopram|mesh-list
65590966|NCT04623099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65590967|NCT04623099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65590968|NCT04623099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65590969|NCT04623099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65590970|NCT04623099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65590971|NCT04623099|Serotonin Agents|serotonin agents|mesh-ancestor
65590972|NCT04623099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590973|NCT04623099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65590974|NCT04623099|Antidepressive Agents|antidepressive agents|mesh-ancestor
65590975|NCT04623099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65590976|NCT01358916|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65590977|NCT01358916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65590978|NCT03735290|Pembrolizumab|pembrolizumab|mesh-list
65590979|NCT03735290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65590980|NCT03735290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65590981|NCT03619538|Nefopam|nefopam|mesh-list
65590982|NCT03619538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65590983|NCT03619538|Analgesics|analgesics|mesh-ancestor
65590984|NCT03619538|Sensory System Agents|sensory system agents|mesh-ancestor
65590985|NCT03619538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65590986|NCT03619538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590987|NCT03296098|Ulipristal acetate|ulipristal acetate|mesh-list
65590988|NCT03296098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65590989|NCT03296098|Contraceptive Agents|contraceptive agents|mesh-ancestor
65590990|NCT03296098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65590991|NCT03296098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590992|NCT03296098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65590993|NCT01366326|Bromides|bromides|mesh-list
65590994|NCT01366326|Methylnaltrexone|methylnaltrexone|mesh-list
65590995|NCT01366326|Anticonvulsants|anticonvulsants|mesh-ancestor
65590996|NCT01366326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65590997|NCT01366326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65590998|NCT01366326|Sensory System Agents|sensory system agents|mesh-ancestor
65590999|NCT01366326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65591000|NCT01822275|Temozolomide|temozolomide|mesh-list
65591001|NCT01822275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65591002|NCT01822275|Alkylating Agents|alkylating agents|mesh-ancestor
65591003|NCT01822275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591004|NCT01822275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591005|NCT01331421|Exemestane|exemestane|mesh-list
65591006|NCT01331421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591007|NCT01331421|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65591008|NCT01331421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65591009|NCT01331421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591010|NCT01331421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591011|NCT01331421|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65591012|NCT01331421|Hormone Antagonists|hormone antagonists|mesh-ancestor
65591013|NCT01331421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65591014|NCT01331421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591016|NCT01656434|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65591017|NCT01656434|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65591018|NCT01656434|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65591019|NCT01656434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65591020|NCT01656434|Contraceptive Agents|contraceptive agents|mesh-ancestor
65591021|NCT01656434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65591022|NCT01656434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591023|NCT01656434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65591024|NCT01656434|Estrogens|estrogens|mesh-ancestor
65591025|NCT01656434|Hormones|hormones|mesh-ancestor
65591026|NCT01656434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65591027|NCT01656434|Trace Elements|trace elements|mesh-ancestor
65591028|NCT01656434|Micronutrients|micronutrients|mesh-ancestor
65591029|NCT01319214|Propranolol|propranolol|mesh-list
65591030|NCT01319214|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65591031|NCT01319214|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65591032|NCT01319214|Adrenergic Agents|adrenergic agents|mesh-ancestor
65591033|NCT01319214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65591034|NCT01319214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591035|NCT01319214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591036|NCT01319214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65591037|NCT01319214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65591038|NCT01319214|Vasodilator Agents|vasodilator agents|mesh-ancestor
65591039|NCT01359228|Rifaximin|rifaximin|mesh-list
65591040|NCT01359228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65591041|NCT01359228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65591042|NCT01359228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65591043|NCT02461030|Listerine|listerine|mesh-list
65591044|NCT02461030|Sodium Fluoride|sodium fluoride|mesh-list
65591045|NCT02461030|Cariostatic Agents|cariostatic agents|mesh-ancestor
65591046|NCT02461030|Protective Agents|protective agents|mesh-ancestor
65591047|NCT02461030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591048|NCT02461030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65591049|NCT02461030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65591050|NCT05168618|Atezolizumab|atezolizumab|mesh-list
65591051|NCT05168618|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65591052|NCT05168618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591053|NCT05168618|Immunologic Factors|immunologic factors|mesh-ancestor
65591054|NCT05168618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591055|NCT01599494|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65591056|NCT01599494|Progesterone|progesterone|mesh-list
65591057|NCT01599494|Ganirelix|ganirelix|mesh-list
65591058|NCT01599494|Progestins|progestins|mesh-ancestor
65591059|NCT01599494|Hormones|hormones|mesh-ancestor
65591060|NCT01599494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65591061|NCT01599494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591062|NCT01599494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65591063|NCT01599494|Hormone Antagonists|hormone antagonists|mesh-ancestor
65591064|NCT03295786|Dopamine|dopamine|mesh-list
65591065|NCT03295786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65591066|NCT03295786|Sympathomimetics|sympathomimetics|mesh-ancestor
65591067|NCT03295786|Autonomic Agents|autonomic agents|mesh-ancestor
65591068|NCT03295786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65591069|NCT03295786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591070|NCT03295786|Dopamine Agents|dopamine agents|mesh-ancestor
65591071|NCT03295786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65591072|NCT03295786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591073|NCT03295786|Protective Agents|protective agents|mesh-ancestor
65591074|NCT03194932|Cytarabine|cytarabine|mesh-list
65591075|NCT03194932|Hydrocortisone|hydrocortisone|mesh-list
65591076|NCT03194932|Methotrexate|methotrexate|mesh-list
65591077|NCT03194932|Azacitidine|azacitidine|mesh-list
65591078|NCT03194932|Venetoclax|venetoclax|mesh-list
65591079|NCT03194932|Idarubicin|idarubicin|mesh-list
65591080|NCT03194932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65591081|NCT03194932|Abortifacient Agents|abortifacient agents|mesh-ancestor
65591082|NCT03194932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65591083|NCT03194932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591084|NCT03194932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65591085|NCT03194932|Antimetabolites|antimetabolites|mesh-ancestor
65591086|NCT03194932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591087|NCT03194932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591088|NCT03194932|Dermatologic Agents|dermatologic agents|mesh-ancestor
65591089|NCT03194932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591090|NCT03194932|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65591091|NCT03194932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65591092|NCT03194932|Immunologic Factors|immunologic factors|mesh-ancestor
65591093|NCT03194932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65591094|NCT03194932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65591095|NCT03194932|Antiviral Agents|antiviral agents|mesh-ancestor
65591096|NCT03194932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65591097|NCT03194932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65591098|NCT03194932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65591099|NCT03194932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65591100|NCT03194932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65591101|NCT03037580|Treprostinil|treprostinil|mesh-list
65591102|NCT03037580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65591103|NCT05154734|Belimumab|belimumab|mesh-list
65591104|NCT05154734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65591105|NCT05154734|Immunologic Factors|immunologic factors|mesh-ancestor
65591106|NCT05154734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591107|NCT05262764|Empagliflozin|empagliflozin|mesh-list
65591108|NCT05262764|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65591109|NCT05262764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591110|NCT05262764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65591111|NCT05262764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591112|NCT02978404|Nivolumab|nivolumab|mesh-list
65591113|NCT02978404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65591114|NCT02978404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591115|NCT02978404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65591116|NCT02978404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591117|NCT04441918|Antibodies|antibodies|mesh-list
65591118|NCT04441918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65591119|NCT04441918|Immunologic Factors|immunologic factors|mesh-ancestor
65591120|NCT04441918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591121|NCT05014412|Dexamethasone|dexamethasone|mesh-list
65591122|NCT05014412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65591123|NCT05014412|Antiemetics|antiemetics|mesh-ancestor
65591124|NCT05014412|Autonomic Agents|autonomic agents|mesh-ancestor
65591125|NCT05014412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65591126|NCT05014412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591127|NCT05014412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65591128|NCT05014412|Glucocorticoids|glucocorticoids|mesh-ancestor
65591129|NCT05014412|Hormones|hormones|mesh-ancestor
65591130|NCT05014412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65591131|NCT05014412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65591132|NCT05014412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591133|NCT01331655|Tetrahydrofolates|tetrahydrofolates|mesh-list
65591134|NCT01331655|Drospirenone|drospirenone|mesh-list
65591135|NCT01331655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65591136|NCT01331655|Hormone Antagonists|hormone antagonists|mesh-ancestor
65591137|NCT01331655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65591138|NCT01331655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591139|NCT01331655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65591140|NCT01331655|Diuretics|diuretics|mesh-ancestor
65591141|NCT01331655|Natriuretic Agents|natriuretic agents|mesh-ancestor
65591142|NCT01331655|Vitamin B Complex|vitamin b complex|mesh-ancestor
65591143|NCT01331655|Vitamins|vitamins|mesh-ancestor
65591144|NCT01331655|Micronutrients|micronutrients|mesh-ancestor
65591145|NCT03289390|Acetaminophen|acetaminophen|mesh-list
65591146|NCT03289390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65591147|NCT03289390|Analgesics|analgesics|mesh-ancestor
65591148|NCT03289390|Sensory System Agents|sensory system agents|mesh-ancestor
65591149|NCT03289390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65591150|NCT03289390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591151|NCT03289390|Antipyretics|antipyretics|mesh-ancestor
65591152|NCT02308527|Cyclophosphamide|cyclophosphamide|mesh-list
65591153|NCT02308527|Temozolomide|temozolomide|mesh-list
65591154|NCT02308527|Bevacizumab|bevacizumab|mesh-list
65591155|NCT02308527|Irinotecan|irinotecan|mesh-list
65591156|NCT02308527|Topotecan|topotecan|mesh-list
65591157|NCT02308527|Dinutuximab|dinutuximab|mesh-list
65591158|NCT02308527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65591159|NCT02308527|Immunologic Factors|immunologic factors|mesh-ancestor
65591160|NCT02308527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591161|NCT02308527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65591162|NCT02308527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65591163|NCT02308527|Alkylating Agents|alkylating agents|mesh-ancestor
65388590|NCT00943566|Sufentanil|sufentanil|mesh-list
65591164|NCT02308527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591165|NCT02308527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591166|NCT02308527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65591167|NCT02308527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65591168|NCT02308527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65591169|NCT02308527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65591170|NCT02308527|Growth Substances|growth substances|mesh-ancestor
65591171|NCT02308527|Growth Inhibitors|growth inhibitors|mesh-ancestor
65591172|NCT02308527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65591173|NCT02308527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65591174|NCT02308527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591176|NCT03382977|Lomustine|lomustine|mesh-list
65591177|NCT03382977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65591178|NCT03382977|Alkylating Agents|alkylating agents|mesh-ancestor
65591179|NCT03382977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591180|NCT03382977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591181|NCT00897104|Sumatriptan|sumatriptan|mesh-list
65591182|NCT00897104|Rizatriptan|rizatriptan|mesh-list
65591183|NCT00897104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65591184|NCT00897104|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65591185|NCT00897104|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65591186|NCT00897104|Serotonin Agents|serotonin agents|mesh-ancestor
65591187|NCT00897104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65591188|NCT00897104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591189|NCT00897104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591190|NCT00792506|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
65591191|NCT00792506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65591192|NCT00792506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591193|NCT00792506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591194|NCT03295162|Melatonin|melatonin|mesh-list
65591195|NCT03295162|Antioxidants|antioxidants|mesh-ancestor
65591196|NCT03295162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591197|NCT03295162|Protective Agents|protective agents|mesh-ancestor
65591198|NCT03295162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591199|NCT03295162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65591200|NCT05237492|Tramadol|tramadol|mesh-list
65591201|NCT05237492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65591202|NCT05237492|Narcotics|narcotics|mesh-ancestor
65591203|NCT05237492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65591204|NCT05237492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591205|NCT05237492|Analgesics|analgesics|mesh-ancestor
65591206|NCT05237492|Sensory System Agents|sensory system agents|mesh-ancestor
65591207|NCT05237492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65591208|NCT03295084|Capecitabine|capecitabine|mesh-list
65591209|NCT03295084|Irinotecan|irinotecan|mesh-list
65591210|NCT03295084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65591211|NCT03295084|Antimetabolites|antimetabolites|mesh-ancestor
65591212|NCT03295084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591213|NCT03295084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591214|NCT03295084|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65591215|NCT03295084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65591216|NCT03295084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591217|NCT04710134|Reslizumab|reslizumab|mesh-list
65591218|NCT04710134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65591219|NCT04710134|Respiratory System Agents|respiratory system agents|mesh-ancestor
65591220|NCT01339689|Ganaxolone|ganaxolone|mesh-list
65591221|NCT01339689|Neurosteroids|neurosteroids|mesh-ancestor
65591222|NCT01339689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65591223|NCT01339689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591224|NCT01339689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591225|NCT01339689|GABA Modulators|gaba modulators|mesh-ancestor
65591226|NCT01339689|GABA Agents|gaba agents|mesh-ancestor
65591227|NCT00702806|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65591228|NCT00702806|Ganirelix|ganirelix|mesh-list
65591229|NCT00702806|Hormone Antagonists|hormone antagonists|mesh-ancestor
65591230|NCT00702806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65591231|NCT00702806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591232|NCT00702806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65591233|NCT01336803|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65591234|NCT01336803|Hematinics|hematinics|mesh-ancestor
65591235|NCT01336803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65591236|NCT01336803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65591237|NCT03635931|Mitogens|mitogens|mesh-list
65591238|NCT03635931|Mitosis Modulators|mitosis modulators|mesh-ancestor
65591239|NCT03635931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591240|NCT02550652|Mycophenolic Acid|mycophenolic acid|mesh-list
65591241|NCT02550652|Prednisone|prednisone|mesh-list
65591242|NCT02550652|Methylprednisolone|methylprednisolone|mesh-list
65591243|NCT02550652|Obinutuzumab|obinutuzumab|mesh-list
65591244|NCT02550652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65591245|NCT02550652|Glucocorticoids|glucocorticoids|mesh-ancestor
65591246|NCT02550652|Hormones|hormones|mesh-ancestor
65591247|NCT02550652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65591248|NCT02550652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591249|NCT02550652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65591250|NCT02550652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591251|NCT02550652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65591252|NCT02550652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65591253|NCT02550652|Antitubercular Agents|antitubercular agents|mesh-ancestor
65591254|NCT02550652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65591255|NCT02550652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65591256|NCT02550652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591257|NCT02550652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591258|NCT02550652|Antiemetics|antiemetics|mesh-ancestor
65591259|NCT02550652|Autonomic Agents|autonomic agents|mesh-ancestor
65591260|NCT02550652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65591261|NCT02550652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65591262|NCT02550652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65591263|NCT02550652|Protective Agents|protective agents|mesh-ancestor
65591264|NCT02550652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65591265|NCT01331967|Pioglitazone|pioglitazone|mesh-list
65591266|NCT01331967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65591267|NCT01331967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591268|NCT00696878|Progesterone|progesterone|mesh-list
65591269|NCT00696878|Progestins|progestins|mesh-ancestor
65591270|NCT00696878|Hormones|hormones|mesh-ancestor
65591271|NCT00696878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65591272|NCT00696878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591273|NCT04493151|Imipenem|imipenem|mesh-list
65591274|NCT04493151|Relebactam|relebactam|mesh-list
65591275|NCT04493151|Cilastatin|cilastatin|mesh-list
65591276|NCT04493151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65591277|NCT04493151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65591278|NCT04493151|Protease Inhibitors|protease inhibitors|mesh-ancestor
65591279|NCT04493151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591280|NCT04493151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591281|NCT04493151|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65591282|NCT00731757|Adalimumab|adalimumab|mesh-list
65591283|NCT00731757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65591284|NCT00731757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65591285|NCT03108274|Fexofenadine|fexofenadine|mesh-list
65591286|NCT03108274|Mycophenolic Acid|mycophenolic acid|mesh-list
65591287|NCT03108274|Midazolam|midazolam|mesh-list
65591288|NCT03108274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65591289|NCT03108274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65591290|NCT03108274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65591291|NCT03108274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591292|NCT03108274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65591293|NCT03108274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65591294|NCT03108274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65591295|NCT03108274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65591296|NCT03108274|Anesthetics, General|anesthetics, general|mesh-ancestor
65591297|NCT03108274|Anesthetics|anesthetics|mesh-ancestor
65591298|NCT03108274|GABA Modulators|gaba modulators|mesh-ancestor
65591299|NCT03108274|GABA Agents|gaba agents|mesh-ancestor
65591300|NCT03108274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65591301|NCT03108274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591302|NCT03108274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65591303|NCT03108274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591304|NCT03108274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65591305|NCT03108274|Antitubercular Agents|antitubercular agents|mesh-ancestor
65591306|NCT03108274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65591307|NCT03108274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65591308|NCT03108274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591309|NCT03108274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65591310|NCT03108274|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65591311|NCT03108274|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65591312|NCT03108274|Histamine Antagonists|histamine antagonists|mesh-ancestor
65591313|NCT03108274|Histamine Agents|histamine agents|mesh-ancestor
65591314|NCT02278588|Rasagiline|rasagiline|mesh-list
65591315|NCT02278588|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65591316|NCT02278588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591317|NCT02278588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591318|NCT02278588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65591319|NCT02278588|Protective Agents|protective agents|mesh-ancestor
65591320|NCT02278588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591321|NCT03288610|Vasopressins|vasopressins|mesh-list
65591322|NCT03288610|Hemostatics|hemostatics|mesh-ancestor
65591323|NCT03288610|Coagulants|coagulants|mesh-ancestor
65591324|NCT03288610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65591325|NCT03288610|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65591326|NCT03288610|Natriuretic Agents|natriuretic agents|mesh-ancestor
65591327|NCT03288610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591328|NCT00696800|Progesterone|progesterone|mesh-list
65591329|NCT00696800|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65591330|NCT00696800|Ganirelix|ganirelix|mesh-list
65591331|NCT00696800|Progestins|progestins|mesh-ancestor
65591332|NCT00696800|Hormones|hormones|mesh-ancestor
65591333|NCT00696800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65591334|NCT00696800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591335|NCT00696800|Hormone Antagonists|hormone antagonists|mesh-ancestor
65591336|NCT03294772|Hand Sanitizers|hand sanitizers|mesh-list
65591337|NCT03294772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65591338|NCT03294772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65591339|NCT03294772|Disinfectants|disinfectants|mesh-ancestor
65591340|NCT03288532|Durvalumab|durvalumab|mesh-list
65591341|NCT03288532|Tremelimumab|tremelimumab|mesh-list
65591342|NCT03288532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65591343|NCT03288532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591344|NCT00598208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65591345|NCT00598208|Hormones|hormones|mesh-ancestor
65591346|NCT00598208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65591347|NCT00598208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591348|NCT00480662|Alendronate|alendronate|mesh-list
65591349|NCT00480662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65591350|NCT00480662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591351|NCT00398606|Alendronate|alendronate|mesh-list
65591352|NCT00398606|Calcium Carbonate|calcium carbonate|mesh-list
65591353|NCT00398606|Calcium|calcium|mesh-list
65591354|NCT00398606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65591355|NCT00398606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591356|NCT00398606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591357|NCT00398606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65591358|NCT00398606|Antacids|antacids|mesh-ancestor
65591359|NCT00398606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65591360|NCT00395408|Beclomethasone|beclomethasone|mesh-list
65591361|NCT00395408|Montelukast|montelukast|mesh-list
65591362|NCT00395408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591363|NCT00395408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591364|NCT00395408|Respiratory System Agents|respiratory system agents|mesh-ancestor
65591365|NCT00395408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65591366|NCT00395408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65591367|NCT00395408|Hormone Antagonists|hormone antagonists|mesh-ancestor
65591368|NCT00395408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65591369|NCT00395408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65591370|NCT00395408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65591371|NCT00395408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65591372|NCT00395408|Glucocorticoids|glucocorticoids|mesh-ancestor
65591373|NCT00395408|Hormones|hormones|mesh-ancestor
65591374|NCT02462044|Iodine|iodine|mesh-list
65591375|NCT02462044|Cadexomer iodine|cadexomer iodine|mesh-list
65591376|NCT02462044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65591377|NCT02462044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65591378|NCT02462044|Trace Elements|trace elements|mesh-ancestor
65591379|NCT02462044|Micronutrients|micronutrients|mesh-ancestor
65591380|NCT02462044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591381|NCT00289874|Montelukast|montelukast|mesh-list
65591382|NCT00289874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65591383|NCT00289874|Respiratory System Agents|respiratory system agents|mesh-ancestor
65591384|NCT00289874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65591385|NCT00289874|Hormone Antagonists|hormone antagonists|mesh-ancestor
65591386|NCT00289874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65591387|NCT00289874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591388|NCT00289874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65591389|NCT00289874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65591390|NCT00289874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591391|NCT00245570|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65591392|NCT00245570|Montelukast|montelukast|mesh-list
65591393|NCT00245570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65591394|NCT00245570|Autonomic Agents|autonomic agents|mesh-ancestor
65591395|NCT00245570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65591396|NCT00245570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591397|NCT00245570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65591398|NCT00245570|Respiratory System Agents|respiratory system agents|mesh-ancestor
65591399|NCT00245570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65591400|NCT00245570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65591401|NCT00245570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65591402|NCT00245570|Adrenergic Agents|adrenergic agents|mesh-ancestor
65591403|NCT00245570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65591404|NCT00245570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591405|NCT00245570|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65591406|NCT00245570|Hormone Antagonists|hormone antagonists|mesh-ancestor
65591407|NCT00245570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65591408|NCT00245570|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65591409|NCT00245570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65591410|NCT02461888|Dexamethasone|dexamethasone|mesh-list
65591411|NCT02461888|Cyclophosphamide|cyclophosphamide|mesh-list
65591412|NCT02461888|Ixazomib|ixazomib|mesh-list
65591413|NCT02461888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65591414|NCT02461888|Immunologic Factors|immunologic factors|mesh-ancestor
65591415|NCT02461888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591416|NCT02461888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65591417|NCT02461888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65591418|NCT02461888|Alkylating Agents|alkylating agents|mesh-ancestor
65591419|NCT02461888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591420|NCT02461888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591421|NCT02461888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65591422|NCT02461888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65591423|NCT02461888|Antiemetics|antiemetics|mesh-ancestor
65591424|NCT02461888|Autonomic Agents|autonomic agents|mesh-ancestor
65591425|NCT02461888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65591426|NCT02461888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65591427|NCT02461888|Glucocorticoids|glucocorticoids|mesh-ancestor
65591428|NCT02461888|Hormones|hormones|mesh-ancestor
65591429|NCT02461888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65591430|NCT02461888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65591431|NCT02461888|Protease Inhibitors|protease inhibitors|mesh-ancestor
65591432|NCT02461888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591433|NCT00229970|Montelukast|montelukast|mesh-list
65591434|NCT00229970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65591435|NCT00229970|Respiratory System Agents|respiratory system agents|mesh-ancestor
65591436|NCT00229970|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65591437|NCT00229970|Hormone Antagonists|hormone antagonists|mesh-ancestor
65591438|NCT00229970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65591439|NCT00229970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591440|NCT00229970|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65591441|NCT00229970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65591442|NCT00229970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591443|NCT00111722|Rizatriptan|rizatriptan|mesh-list
65591444|NCT00111722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65591445|NCT00111722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591446|NCT00111722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591447|NCT00111722|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65591448|NCT00111722|Serotonin Agents|serotonin agents|mesh-ancestor
65591449|NCT04626596|Etonogestrel|etonogestrel|mesh-list
65591450|NCT04626596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65591451|NCT04626596|Contraceptive Agents|contraceptive agents|mesh-ancestor
65591452|NCT04626596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65591453|NCT04626596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591454|NCT04626596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65591455|NCT05235100|Apatinib|apatinib|mesh-list
65591456|NCT05235100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591457|NCT05235100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65591458|NCT05235100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591459|NCT05235100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591460|NCT03294382|Botulinum Toxins|botulinum toxins|mesh-list
65591461|NCT03294382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65591462|NCT03294382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65591463|NCT03294382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65591464|NCT03294382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65591465|NCT03294382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591466|NCT03294382|Cholinergic Agents|cholinergic agents|mesh-ancestor
65591467|NCT03294382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65591468|NCT03294382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591469|NCT03294382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65591470|NCT03294382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65591471|NCT00092066|Cholecalciferol|cholecalciferol|mesh-list
65591472|NCT00092066|Vitamin D|vitamin d|mesh-list
65591473|NCT00092066|Alendronate|alendronate|mesh-list
65591474|NCT00092066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65591475|NCT00092066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591476|NCT00092066|Vitamins|vitamins|mesh-ancestor
65591477|NCT00092066|Micronutrients|micronutrients|mesh-ancestor
65591478|NCT00092066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65591479|NCT01466686|Temozolomide|temozolomide|mesh-list
65591480|NCT01466686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65591481|NCT01466686|Alkylating Agents|alkylating agents|mesh-ancestor
65591482|NCT01466686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591483|NCT01466686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591484|NCT00840177|Cytarabine|cytarabine|mesh-list
65591485|NCT00840177|Idarubicin|idarubicin|mesh-list
65591486|NCT00840177|Pravastatin|pravastatin|mesh-list
65591487|NCT00840177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65591488|NCT00840177|Antimetabolites|antimetabolites|mesh-ancestor
65591489|NCT00840177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591490|NCT00840177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591491|NCT00840177|Antiviral Agents|antiviral agents|mesh-ancestor
65591492|NCT00840177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65591493|NCT00840177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65591494|NCT00840177|Immunologic Factors|immunologic factors|mesh-ancestor
65591495|NCT00840177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591496|NCT00840177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65591497|NCT00840177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65591498|NCT00840177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65591499|NCT00840177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591500|NCT00840177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65591501|NCT00840177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65591502|NCT00840177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65591503|NCT00840177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65591504|NCT04091750|Nivolumab|nivolumab|mesh-list
65591505|NCT04091750|Ipilimumab|ipilimumab|mesh-list
65591506|NCT04091750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65591507|NCT04091750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591508|NCT04091750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65591509|NCT04091750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591510|NCT01334619|Ropivacaine|ropivacaine|mesh-list
65591511|NCT01334619|Anesthetics, Local|anesthetics, local|mesh-ancestor
65591512|NCT01334619|Anesthetics|anesthetics|mesh-ancestor
65591513|NCT01334619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65591514|NCT01334619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591515|NCT01334619|Sensory System Agents|sensory system agents|mesh-ancestor
65591516|NCT01334619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65591517|NCT03287128|Gemtuzumab|gemtuzumab|mesh-list
65591518|NCT03287128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65591519|NCT03287128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591520|NCT00457275|Ezetimibe|ezetimibe|mesh-list
65591521|NCT00457275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65591522|NCT00457275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65591523|NCT00457275|Antimetabolites|antimetabolites|mesh-ancestor
65591524|NCT00457275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591525|NCT00457275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65591526|NCT03294070|Amlodipine|amlodipine|mesh-list
65591527|NCT03294070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65591528|NCT03294070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65591529|NCT03294070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65591530|NCT03294070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591531|NCT03294070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65591532|NCT03294070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591533|NCT03294070|Vasodilator Agents|vasodilator agents|mesh-ancestor
65591534|NCT04479566|Lithium Carbonate|lithium carbonate|mesh-list
65591535|NCT04479566|Calcium Carbonate|calcium carbonate|mesh-list
65591537|NCT04479566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65591538|NCT04479566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591539|NCT04479566|Antidepressive Agents|antidepressive agents|mesh-ancestor
65591540|NCT04479566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65591541|NCT04479566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591542|NCT04479566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591543|NCT04479566|Antimanic Agents|antimanic agents|mesh-ancestor
65591544|NCT04479566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65591545|NCT04479566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65591546|NCT04479566|Antacids|antacids|mesh-ancestor
65591547|NCT04479566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65591548|NCT03293992|Latanoprost|latanoprost|mesh-list
65591549|NCT03293992|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65591550|NCT03293992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65591551|NCT01332201|Tacrolimus|tacrolimus|mesh-list
65591552|NCT01332201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65591553|NCT01332201|Immunologic Factors|immunologic factors|mesh-ancestor
65591554|NCT01332201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591555|NCT01332201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65591556|NCT01332201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591557|NCT01332201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591558|NCT01332279|Everolimus|everolimus|mesh-list
65591559|NCT01332279|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65591560|NCT01332279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591561|NCT01332279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65591562|NCT01332279|Immunologic Factors|immunologic factors|mesh-ancestor
65591563|NCT01332279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591564|NCT01332279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65591565|NCT01332279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591566|NCT01332279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591567|NCT03298906|Ticlopidine|ticlopidine|mesh-list
65591568|NCT03298906|Esketamine|esketamine|mesh-list
65591569|NCT03298906|Antidepressive Agents|antidepressive agents|mesh-ancestor
65591570|NCT03298906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65591571|NCT03298906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65591572|NCT03298906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65591573|NCT03298906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591574|NCT03298906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65591575|NCT03298906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65591576|NCT03298906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65591577|NCT03298906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65591578|NCT03298906|Purinergic Agents|purinergic agents|mesh-ancestor
65591579|NCT03298906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65591580|NCT03298906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591581|NCT03298906|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65591582|NCT03298906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65591583|NCT03298906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591584|NCT03697629|Daratumumab|daratumumab|mesh-list
65591585|NCT03697629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591586|NCT00398541|Losartan|losartan|mesh-list
65591587|NCT00398541|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65591588|NCT00398541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65591589|NCT00398541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65591590|NCT00398541|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65591591|NCT00398541|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65591592|NCT00398541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591593|NCT00398541|Diuretics|diuretics|mesh-ancestor
65591594|NCT00398541|Natriuretic Agents|natriuretic agents|mesh-ancestor
65591595|NCT00398541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591596|NCT00398541|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65591597|NCT00398541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65591598|NCT03286582|Clobetasol|clobetasol|mesh-list
65591599|NCT03286582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65591600|NCT03286582|Glucocorticoids|glucocorticoids|mesh-ancestor
65591601|NCT03286582|Hormones|hormones|mesh-ancestor
65591602|NCT03286582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65591603|NCT03286582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591604|NCT05202002|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65591605|NCT05202002|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
65591606|NCT05202002|beta-Endorphin|beta-endorphin|mesh-list
65591607|NCT05202002|Hormones|hormones|mesh-ancestor
65591608|NCT05202002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65591609|NCT05202002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591610|NCT05202002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65591611|NCT05202002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591612|NCT02460640|Morphine|morphine|mesh-list
65591613|NCT02460640|Ropivacaine|ropivacaine|mesh-list
65591614|NCT02460640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65591615|NCT02460640|Narcotics|narcotics|mesh-ancestor
65591616|NCT02460640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65591617|NCT02460640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591618|NCT02460640|Analgesics|analgesics|mesh-ancestor
65591619|NCT02460640|Sensory System Agents|sensory system agents|mesh-ancestor
65591620|NCT02460640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65591621|NCT02460640|Anesthetics, Local|anesthetics, local|mesh-ancestor
65591622|NCT02460640|Anesthetics|anesthetics|mesh-ancestor
65591623|NCT03298516|Azacitidine|azacitidine|mesh-list
65591624|NCT03298516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65591625|NCT03298516|Antimetabolites|antimetabolites|mesh-ancestor
65591626|NCT03298516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591627|NCT03298516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591628|NCT03298516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591629|NCT05120960|Osimertinib|osimertinib|mesh-list
65591630|NCT05120960|Tepotinib|tepotinib|mesh-list
65591631|NCT05120960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591632|NCT05120960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65591633|NCT05120960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591634|NCT05120960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591635|NCT05169866|Amiodarone|amiodarone|mesh-list
65591636|NCT05169866|Nifekalant|nifekalant|mesh-list
65591637|NCT05169866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65591638|NCT05169866|Vasodilator Agents|vasodilator agents|mesh-ancestor
65591639|NCT05169866|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65591640|NCT05169866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65591641|NCT05169866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591642|NCT05169866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65591643|NCT05169866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65591644|NCT05169866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65591645|NCT05169866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591646|NCT05169866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65591647|NCT05169866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65591648|NCT05169866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65591649|NCT03843008|Melatonin|melatonin|mesh-list
65591650|NCT03843008|Antioxidants|antioxidants|mesh-ancestor
65591651|NCT03843008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591652|NCT03843008|Protective Agents|protective agents|mesh-ancestor
65591653|NCT03843008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591654|NCT03843008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65591655|NCT03285802|Everolimus|everolimus|mesh-list
65591656|NCT03285802|Letrozole|letrozole|mesh-list
65591657|NCT03285802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591658|NCT03285802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65591659|NCT03285802|Immunologic Factors|immunologic factors|mesh-ancestor
65591660|NCT03285802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591661|NCT03285802|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65591662|NCT03285802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65591663|NCT03285802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591664|NCT03285802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591665|NCT03285802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65591666|NCT03285802|Hormone Antagonists|hormone antagonists|mesh-ancestor
65591667|NCT03285802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65591668|NCT05130086|Islatravir|islatravir|mesh-list
65591669|NCT05130086|Antiviral Agents|antiviral agents|mesh-ancestor
65591670|NCT05130086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65591671|NCT05130086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248398|NCT02832726|Micronutrients|micronutrients|mesh-ancestor
65591672|NCT05130086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591673|NCT05130086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65591674|NCT05130086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65591675|NCT05130086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65591676|NCT02461186|Piperaquine|piperaquine|mesh-list
65591677|NCT02461186|Artenimol|artenimol|mesh-list
65591678|NCT02461186|Antimalarials|antimalarials|mesh-ancestor
65591679|NCT02461186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65591680|NCT02461186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65591681|NCT02461186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65591682|NCT04921670|Infliximab|infliximab|mesh-list
65389115|NCT00132691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591683|NCT04921670|Dermatologic Agents|dermatologic agents|mesh-ancestor
65591684|NCT04921670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65591685|NCT04921670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65591686|NCT03512210|Sofosbuvir|sofosbuvir|mesh-list
65591687|NCT03512210|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65591688|NCT03512210|Velpatasvir|velpatasvir|mesh-list
65591689|NCT03512210|Antiviral Agents|antiviral agents|mesh-ancestor
65591690|NCT03512210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65591691|NCT00383721|Mometasone Furoate|mometasone furoate|mesh-list
65591692|NCT00383721|Formoterol Fumarate|formoterol fumarate|mesh-list
65591693|NCT00383721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65591694|NCT00383721|Autonomic Agents|autonomic agents|mesh-ancestor
65591695|NCT00383721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65591696|NCT00383721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591697|NCT00383721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65591698|NCT00383721|Respiratory System Agents|respiratory system agents|mesh-ancestor
65591699|NCT00383721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65591700|NCT00383721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65591701|NCT00383721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65591702|NCT00383721|Adrenergic Agents|adrenergic agents|mesh-ancestor
65591703|NCT00383721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65591704|NCT00383721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591705|NCT00383721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65591706|NCT00383721|Dermatologic Agents|dermatologic agents|mesh-ancestor
65591707|NCT00383721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65591708|NCT03292822|Paclitaxel|paclitaxel|mesh-list
65591709|NCT03292822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65591710|NCT03292822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591711|NCT03292822|Tubulin Modulators|tubulin modulators|mesh-ancestor
65591712|NCT03292822|Antimitotic Agents|antimitotic agents|mesh-ancestor
65591713|NCT03292822|Mitosis Modulators|mitosis modulators|mesh-ancestor
65591714|NCT03292822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591715|NCT03297502|Pimecrolimus|pimecrolimus|mesh-list
65591716|NCT03297502|Tacrolimus|tacrolimus|mesh-list
65591717|NCT03297502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65591718|NCT03297502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65591719|NCT03297502|Analgesics|analgesics|mesh-ancestor
65591720|NCT03297502|Sensory System Agents|sensory system agents|mesh-ancestor
65591721|NCT03297502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65591722|NCT03297502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591723|NCT03297502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65591724|NCT03297502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65591725|NCT03297502|Dermatologic Agents|dermatologic agents|mesh-ancestor
65591726|NCT03297502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65591727|NCT03297502|Immunologic Factors|immunologic factors|mesh-ancestor
65591728|NCT03297502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65591729|NCT03297502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591730|NCT03297502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591731|NCT03292744|Cholecalciferol|cholecalciferol|mesh-list
65591732|NCT03292744|Alfacalcidol|alfacalcidol|mesh-list
65591733|NCT03292744|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65591734|NCT03292744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65591735|NCT03292744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591736|NCT03292744|Vitamins|vitamins|mesh-ancestor
65591737|NCT03292744|Micronutrients|micronutrients|mesh-ancestor
65591738|NCT03292744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65591739|NCT03035942|Dexamethasone|dexamethasone|mesh-list
65591740|NCT03035942|Ondansetron|ondansetron|mesh-list
65591741|NCT03035942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65591742|NCT03035942|Antiemetics|antiemetics|mesh-ancestor
65591743|NCT03035942|Autonomic Agents|autonomic agents|mesh-ancestor
65591744|NCT03035942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65591745|NCT03035942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591746|NCT03035942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65591747|NCT03035942|Glucocorticoids|glucocorticoids|mesh-ancestor
65591748|NCT03035942|Hormones|hormones|mesh-ancestor
65591749|NCT03035942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65591750|NCT03035942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65591751|NCT03035942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591752|NCT03035942|Antipruritics|antipruritics|mesh-ancestor
65591753|NCT03035942|Dermatologic Agents|dermatologic agents|mesh-ancestor
65591754|NCT03035942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65591755|NCT03035942|Serotonin Agents|serotonin agents|mesh-ancestor
65591756|NCT03035942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65591757|NCT03035942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591758|NCT03035942|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65591759|NCT03035942|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65591760|NCT03035942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65591761|NCT03035942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65591762|NCT03035942|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65591763|NCT02820519|Loxapine|loxapine|mesh-list
65591764|NCT02820519|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65591765|NCT02820519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65591766|NCT02820519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65591767|NCT02820519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591768|NCT02820519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65591769|NCT02820519|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65591770|NCT02820519|Dopamine Agents|dopamine agents|mesh-ancestor
65591771|NCT02820519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65591772|NCT02820519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591773|NCT02616146|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65591774|NCT02616146|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65591775|NCT02616146|Levonorgestrel|levonorgestrel|mesh-list
65591776|NCT02616146|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65591777|NCT02616146|Etonogestrel|etonogestrel|mesh-list
65591778|NCT02616146|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65591779|NCT02616146|Estradiol|estradiol|mesh-list
65591780|NCT02616146|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65591781|NCT02616146|Estrogens|estrogens|mesh-ancestor
65591782|NCT02616146|Hormones|hormones|mesh-ancestor
65591783|NCT02616146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65591784|NCT02616146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591785|NCT02616146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65591786|NCT02616146|Contraceptive Agents|contraceptive agents|mesh-ancestor
65591787|NCT02616146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65591788|NCT02616146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65591789|NCT02616146|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65591790|NCT02616146|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65591791|NCT02616146|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65591792|NCT02616146|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65591793|NCT01332747|Atorvastatin|atorvastatin|mesh-list
65591794|NCT01332747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65591795|NCT01332747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65591796|NCT01332747|Antimetabolites|antimetabolites|mesh-ancestor
65591797|NCT01332747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591798|NCT01332747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65591799|NCT01332747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65591800|NCT01332747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591801|NCT03442413|Nicotine|nicotine|mesh-list
65591802|NCT03442413|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65591803|NCT03442413|Autonomic Agents|autonomic agents|mesh-ancestor
65591804|NCT03442413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65591805|NCT03442413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591806|NCT03442413|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65591807|NCT03442413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65591808|NCT03442413|Cholinergic Agents|cholinergic agents|mesh-ancestor
65591809|NCT03442413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65591810|NCT03442413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591811|NCT01337427|Interferons|interferons|mesh-list
65591812|NCT01337427|Interferon-beta|interferon-beta|mesh-list
65591813|NCT01337427|Interferon beta-1a|interferon beta-1a|mesh-list
65591814|NCT01337427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591815|NCT01337427|Antiviral Agents|antiviral agents|mesh-ancestor
65591816|NCT01337427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65591817|NCT01337427|Immunologic Factors|immunologic factors|mesh-ancestor
65591818|NCT01337427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591819|NCT01337427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65591820|NCT02459938|Glucagon|glucagon|mesh-list
65591821|NCT02459938|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65591822|NCT02459938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65591823|NCT02459938|Hormones|hormones|mesh-ancestor
65591824|NCT02459938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65591825|NCT02459938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591826|NCT02459938|Incretins|incretins|mesh-ancestor
65591827|NCT03284164|Tenofovir|tenofovir|mesh-list
65591828|NCT03284164|Antiviral Agents|antiviral agents|mesh-ancestor
65591829|NCT03284164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65591830|NCT03284164|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65591831|NCT03284164|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65591832|NCT03284164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591833|NCT03284164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591834|NCT03284164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65591835|NCT03284164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65591836|NCT01337583|Dapivirine|dapivirine|mesh-list
65591837|NCT01337583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65591838|NCT01337583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65591839|NCT01337583|Antiviral Agents|antiviral agents|mesh-ancestor
65591840|NCT01337583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65591841|NCT03107962|Pembrolizumab|pembrolizumab|mesh-list
65591842|NCT03107962|Antibodies|antibodies|mesh-list
65591843|NCT03107962|Antibodies, Blocking|antibodies, blocking|mesh-list
65591844|NCT03107962|Immunologic Factors|immunologic factors|mesh-ancestor
65591845|NCT03107962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591846|NCT03107962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65591847|NCT03107962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591848|NCT04891172|Immunoglobulins|immunoglobulins|mesh-list
65591849|NCT04891172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65591850|NCT04891172|Antibodies|antibodies|mesh-list
65591851|NCT04891172|gamma-Globulins|gamma-globulins|mesh-list
65591852|NCT04891172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65591853|NCT04891172|Immunologic Factors|immunologic factors|mesh-ancestor
65591854|NCT04891172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591855|NCT03135249|Alemtuzumab|alemtuzumab|mesh-list
65591856|NCT03135249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65591857|NCT03135249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591858|NCT01335321|Triamcinolone|triamcinolone|mesh-list
65591859|NCT01335321|Hyaluronic Acid|hyaluronic acid|mesh-list
65591860|NCT01335321|Hylan|hylan|mesh-list
65591861|NCT01335321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65591862|NCT01335321|Glucocorticoids|glucocorticoids|mesh-ancestor
65591863|NCT01335321|Hormones|hormones|mesh-ancestor
65591864|NCT01335321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65591865|NCT01335321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591866|NCT01335321|Immunologic Factors|immunologic factors|mesh-ancestor
65591867|NCT01335321|Viscosupplements|viscosupplements|mesh-ancestor
65591868|NCT01335321|Protective Agents|protective agents|mesh-ancestor
65591869|NCT01335321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65591870|NCT01333137|Gemcitabine|gemcitabine|mesh-list
65591871|NCT01333137|Carboplatin|carboplatin|mesh-list
65591872|NCT01333137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591873|NCT01333137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65591874|NCT01333137|Antimetabolites|antimetabolites|mesh-ancestor
65591875|NCT01333137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591876|NCT01333137|Antiviral Agents|antiviral agents|mesh-ancestor
65591877|NCT01333137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65591878|NCT01333137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591879|NCT01333137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65591880|NCT01333137|Immunologic Factors|immunologic factors|mesh-ancestor
65591881|NCT01333137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591882|NCT03282838|Celecoxib|celecoxib|mesh-list
65591883|NCT03282838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65591884|NCT03282838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65591885|NCT03282838|Analgesics|analgesics|mesh-ancestor
65591886|NCT03282838|Sensory System Agents|sensory system agents|mesh-ancestor
65591887|NCT03282838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65591888|NCT03282838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591889|NCT03282838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65591890|NCT03282838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65591891|NCT03282838|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65591892|NCT03282838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65591893|NCT03282838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591894|NCT03282838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591895|NCT04431466|Ivermectin|ivermectin|mesh-list
65591896|NCT04431466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65591897|NCT04431466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65591898|NCT03291418|Naproxen|naproxen|mesh-list
65591899|NCT03291418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65591900|NCT03291418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65591901|NCT03291418|Analgesics|analgesics|mesh-ancestor
65591902|NCT03291418|Sensory System Agents|sensory system agents|mesh-ancestor
65591903|NCT03291418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65591904|NCT03291418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591905|NCT03291418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65591906|NCT03291418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65591907|NCT03291418|Gout Suppressants|gout suppressants|mesh-ancestor
65591908|NCT03291418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65591909|NCT03291418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591910|NCT03291418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591911|NCT02885181|Methotrexate|methotrexate|mesh-list
65591912|NCT02885181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65591913|NCT02885181|Abortifacient Agents|abortifacient agents|mesh-ancestor
65591914|NCT02885181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65591915|NCT02885181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591916|NCT02885181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65591917|NCT02885181|Antimetabolites|antimetabolites|mesh-ancestor
65591918|NCT02885181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591919|NCT02885181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591920|NCT02885181|Dermatologic Agents|dermatologic agents|mesh-ancestor
65591921|NCT02885181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591922|NCT02885181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65591923|NCT02885181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65591924|NCT02885181|Immunologic Factors|immunologic factors|mesh-ancestor
65591925|NCT02885181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65591926|NCT02885181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65591927|NCT02459782|Anesthetics|anesthetics|mesh-list
65591928|NCT02459782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65591929|NCT02459782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591930|NCT04239040|Nivolumab|nivolumab|mesh-list
65591931|NCT04239040|Ipilimumab|ipilimumab|mesh-list
65591932|NCT04239040|Vaccines|vaccines|mesh-list
65591933|NCT04239040|Immunologic Factors|immunologic factors|mesh-ancestor
65591934|NCT04239040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591935|NCT04239040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65591936|NCT04239040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591937|NCT04239040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65591938|NCT04239040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591939|NCT02884089|Metformin|metformin|mesh-list
65591940|NCT02884089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65591941|NCT02884089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591942|NCT01315431|Capecitabine|capecitabine|mesh-list
65591943|NCT01315431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65591944|NCT01315431|Antimetabolites|antimetabolites|mesh-ancestor
65591945|NCT01315431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591946|NCT01315431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591947|NCT00092625|Ezetimibe|ezetimibe|mesh-list
65591948|NCT00092625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65591949|NCT00092625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65591950|NCT00092625|Antimetabolites|antimetabolites|mesh-ancestor
65591951|NCT00092625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591952|NCT00092625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65591953|NCT04135846|Doxazosin|doxazosin|mesh-list
65591954|NCT04135846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65591955|NCT04135846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65591956|NCT04135846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65591957|NCT04135846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65591958|NCT04135846|Adrenergic Agents|adrenergic agents|mesh-ancestor
65591959|NCT04135846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65591960|NCT04135846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591961|NCT04135846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591962|NCT01333449|Decitabine|decitabine|mesh-list
65591963|NCT01333449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65591964|NCT01333449|Antimetabolites|antimetabolites|mesh-ancestor
65591965|NCT01333449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591966|NCT01333449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591967|NCT01333449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591968|NCT04853199|Quercetin|quercetin|mesh-list
65591969|NCT04853199|Antioxidants|antioxidants|mesh-ancestor
65591970|NCT04853199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591971|NCT04853199|Protective Agents|protective agents|mesh-ancestor
65591972|NCT04853199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591973|NCT01341717|Metformin|metformin|mesh-list
65591974|NCT01341717|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65591975|NCT01341717|Glimepiride|glimepiride|mesh-list
65591976|NCT01341717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65591977|NCT01341717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591978|NCT01341717|Incretins|incretins|mesh-ancestor
65591979|NCT01341717|Hormones|hormones|mesh-ancestor
65591980|NCT01341717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65591981|NCT01341717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65591982|NCT01341717|Protease Inhibitors|protease inhibitors|mesh-ancestor
65591983|NCT01341717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591984|NCT01341717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591985|NCT01341717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65591986|NCT01341717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65591987|NCT01341717|Immunologic Factors|immunologic factors|mesh-ancestor
65591988|NCT03157089|Pembrolizumab|pembrolizumab|mesh-list
65591989|NCT03157089|Afatinib|afatinib|mesh-list
65591990|NCT03157089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65591991|NCT03157089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65591992|NCT03157089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65591993|NCT03157089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65591994|NCT03157089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65591995|NCT01338129|Ascorbic Acid|ascorbic acid|mesh-list
65591996|NCT01338129|Vitamins|vitamins|mesh-ancestor
65591997|NCT01338129|Micronutrients|micronutrients|mesh-ancestor
65591998|NCT01338129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65591999|NCT01338129|Antioxidants|antioxidants|mesh-ancestor
65592000|NCT01338129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592001|NCT01338129|Protective Agents|protective agents|mesh-ancestor
65592002|NCT05181969|Dextrans|dextrans|mesh-list
65592003|NCT05181969|Anticoagulants|anticoagulants|mesh-ancestor
65592004|NCT05181969|Plasma Substitutes|plasma substitutes|mesh-ancestor
65592005|NCT05181969|Blood Substitutes|blood substitutes|mesh-ancestor
65592006|NCT00092157|Simvastatin|simvastatin|mesh-list
65592007|NCT00092157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65592008|NCT00092157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65592009|NCT00092157|Antimetabolites|antimetabolites|mesh-ancestor
65592010|NCT00092157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592011|NCT00092157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65592012|NCT00092157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65592013|NCT00092157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592014|NCT00089895|Eptifibatide|eptifibatide|mesh-list
65592015|NCT00089895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65592016|NCT05166291|Anesthetics|anesthetics|mesh-list
65592017|NCT05166291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65592018|NCT05166291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592019|NCT01338441|Erythromycin|erythromycin|mesh-list
65592020|NCT01338441|Erythromycin Estolate|erythromycin estolate|mesh-list
65592021|NCT01338441|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65592022|NCT01338441|Erythromycin stearate|erythromycin stearate|mesh-list
65592023|NCT01338441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65592024|NCT01338441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65592025|NCT01338441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65592026|NCT01338441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65592027|NCT01338441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592028|NCT01338441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592029|NCT01341951|Lenograstim|lenograstim|mesh-list
65592030|NCT01341951|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65592031|NCT01341951|Immunologic Factors|immunologic factors|mesh-ancestor
65592032|NCT01341951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592033|NCT01342185|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
65592034|NCT01342185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65592035|NCT02714218|Nivolumab|nivolumab|mesh-list
65592036|NCT02714218|Ipilimumab|ipilimumab|mesh-list
65592037|NCT02714218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65592038|NCT02714218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592039|NCT02714218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65592040|NCT02714218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592041|NCT05185869|Gemcitabine|gemcitabine|mesh-list
65592042|NCT05185869|Paclitaxel|paclitaxel|mesh-list
65592043|NCT05185869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65592044|NCT05185869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592045|NCT05185869|Tubulin Modulators|tubulin modulators|mesh-ancestor
65592046|NCT05185869|Antimitotic Agents|antimitotic agents|mesh-ancestor
65592047|NCT05185869|Mitosis Modulators|mitosis modulators|mesh-ancestor
65592048|NCT05185869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592049|NCT05185869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65592050|NCT05185869|Antimetabolites|antimetabolites|mesh-ancestor
65592051|NCT05185869|Antiviral Agents|antiviral agents|mesh-ancestor
65592052|NCT05185869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65592053|NCT05185869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592054|NCT05185869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65592055|NCT05185869|Immunologic Factors|immunologic factors|mesh-ancestor
65592056|NCT05185869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592057|NCT01338675|Busulfan|busulfan|mesh-list
65592058|NCT01338675|Alkylating Agents|alkylating agents|mesh-ancestor
65592059|NCT01338675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389490|NCT00487084|Narcotics|narcotics|mesh-ancestor
65592060|NCT01338675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65592061|NCT01338675|Immunologic Factors|immunologic factors|mesh-ancestor
65592062|NCT01338675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592063|NCT01338675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65592064|NCT01338675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592065|NCT01338675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65592066|NCT01338753|Bevacizumab|bevacizumab|mesh-list
65592067|NCT01338753|Docetaxel|docetaxel|mesh-list
65592068|NCT01338753|Doxorubicin|doxorubicin|mesh-list
65592069|NCT01338753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65592070|NCT01338753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592071|NCT01338753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65592072|NCT01338753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65592073|NCT01338753|Growth Substances|growth substances|mesh-ancestor
65592074|NCT01338753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592075|NCT01338753|Growth Inhibitors|growth inhibitors|mesh-ancestor
65592076|NCT01338753|Tubulin Modulators|tubulin modulators|mesh-ancestor
65592077|NCT01338753|Antimitotic Agents|antimitotic agents|mesh-ancestor
65592078|NCT01338753|Mitosis Modulators|mitosis modulators|mesh-ancestor
65592079|NCT01338753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592080|NCT01338753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65592081|NCT01338753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65592082|NCT01338753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65592083|NCT01338753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592084|NCT02457286|Metformin|metformin|mesh-list
65592085|NCT02457286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65592086|NCT02457286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592087|NCT01338909|Clopidogrel|clopidogrel|mesh-list
65592088|NCT01338909|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65592089|NCT01338909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65592090|NCT01338909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65592091|NCT01338909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65592092|NCT01338909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65592093|NCT01338909|Purinergic Agents|purinergic agents|mesh-ancestor
65592094|NCT01338909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65592095|NCT01338909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592096|NCT01338909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592097|NCT03282136|Incretins|incretins|mesh-list
65592098|NCT03282136|Hormones|hormones|mesh-ancestor
65592099|NCT03282136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65592100|NCT03282136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592101|NCT03264586|Lidocaine|lidocaine|mesh-list
65592102|NCT03264586|Prilocaine|prilocaine|mesh-list
65592103|NCT03264586|Mepivacaine|mepivacaine|mesh-list
65592104|NCT03264586|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65592105|NCT03264586|Anesthetics, Local|anesthetics, local|mesh-ancestor
65592106|NCT03264586|Anesthetics|anesthetics|mesh-ancestor
65592107|NCT03264586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65592108|NCT03264586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592109|NCT03264586|Sensory System Agents|sensory system agents|mesh-ancestor
65592110|NCT03264586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592111|NCT03264586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65592112|NCT03264586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65592113|NCT03264586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65592114|NCT03264586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65592115|NCT03264586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592116|NCT03264586|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65592117|NCT01342731|Tigecycline|tigecycline|mesh-list
65592118|NCT01342731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65592119|NCT01342731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65592120|NCT01342731|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65592121|NCT01342731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592122|NCT01342731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592123|NCT01339065|Ketamine|ketamine|mesh-list
65592124|NCT01339065|Analgesics|analgesics|mesh-ancestor
65592125|NCT01339065|Sensory System Agents|sensory system agents|mesh-ancestor
65592126|NCT01339065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592127|NCT01339065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592128|NCT01339065|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65592129|NCT01339065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65592130|NCT01339065|Anesthetics, General|anesthetics, general|mesh-ancestor
65592131|NCT01339065|Anesthetics|anesthetics|mesh-ancestor
65592132|NCT01339065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65389564|NCT00485758|Niacin|niacin|mesh-list
65592133|NCT01339065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65592134|NCT01339065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65592135|NCT01339065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65592136|NCT01339065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592137|NCT02460016|Ziresovir|ziresovir|mesh-list
65592138|NCT02460016|Antiviral Agents|antiviral agents|mesh-ancestor
65592139|NCT02460016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65592140|NCT05151159|Antibodies|antibodies|mesh-list
65592141|NCT05151159|Immunologic Factors|immunologic factors|mesh-ancestor
65592142|NCT05151159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592143|NCT05187507|Theobromine|theobromine|mesh-list
65592144|NCT05187507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65592145|NCT05187507|Autonomic Agents|autonomic agents|mesh-ancestor
65592146|NCT05187507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592147|NCT05187507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592148|NCT05187507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65592149|NCT05187507|Respiratory System Agents|respiratory system agents|mesh-ancestor
65592150|NCT05187507|Vasodilator Agents|vasodilator agents|mesh-ancestor
65592151|NCT01339143|Pioglitazone|pioglitazone|mesh-list
65592152|NCT01339143|Vildagliptin|vildagliptin|mesh-list
65592153|NCT01339143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65592154|NCT01339143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592155|NCT01339143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65592156|NCT01339143|Protease Inhibitors|protease inhibitors|mesh-ancestor
65592157|NCT01339143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592158|NCT01339143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592159|NCT03264430|Ketamine|ketamine|mesh-list
65592160|NCT03264430|Bupivacaine|bupivacaine|mesh-list
65592161|NCT03264430|Anesthetics, Local|anesthetics, local|mesh-ancestor
65592162|NCT03264430|Anesthetics|anesthetics|mesh-ancestor
65592163|NCT03264430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65592164|NCT03264430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592165|NCT03264430|Sensory System Agents|sensory system agents|mesh-ancestor
65592166|NCT03264430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592167|NCT03264430|Analgesics|analgesics|mesh-ancestor
65592168|NCT03264430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65592169|NCT03264430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65592170|NCT03264430|Anesthetics, General|anesthetics, general|mesh-ancestor
65592171|NCT03264430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65592172|NCT03264430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65592173|NCT03264430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65592174|NCT03264430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592175|NCT05250843|Lenvatinib|lenvatinib|mesh-list
65592176|NCT05250843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592177|NCT05250843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65592178|NCT05250843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592179|NCT05250843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592180|NCT03264274|Aflibercept|aflibercept|mesh-list
65592181|NCT03264274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65592182|NCT03264274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65592183|NCT03264274|Growth Substances|growth substances|mesh-ancestor
65592184|NCT03264274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592185|NCT03264274|Growth Inhibitors|growth inhibitors|mesh-ancestor
65592186|NCT03264274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592187|NCT02457208|Rifampin|rifampin|mesh-list
65592188|NCT02457208|Isoniazid|isoniazid|mesh-list
65592189|NCT02457208|Pyrazinamide|pyrazinamide|mesh-list
65592190|NCT02457208|Ethambutol|ethambutol|mesh-list
65592191|NCT02457208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65592192|NCT02457208|Antitubercular Agents|antitubercular agents|mesh-ancestor
65592193|NCT02457208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65592194|NCT02457208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65592195|NCT02457208|Leprostatic Agents|leprostatic agents|mesh-ancestor
65592196|NCT02457208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65592197|NCT02457208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592198|NCT02457208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592199|NCT02457208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65592200|NCT02457208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65592201|NCT02457208|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65592202|NCT02457208|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65592203|NCT02457208|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65592204|NCT02457208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65592205|NCT02457208|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65592206|NCT02457208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65592208|NCT02457208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65592209|NCT02457130|Clopidogrel|clopidogrel|mesh-list
65592210|NCT02457130|Ticagrelor|ticagrelor|mesh-list
65592211|NCT02457130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65592212|NCT02457130|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65592213|NCT02457130|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65592214|NCT02457130|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65592215|NCT02457130|Purinergic Agents|purinergic agents|mesh-ancestor
65592216|NCT02457130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65592217|NCT02457130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592218|NCT02457130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592219|NCT01340235|Erythromycin|erythromycin|mesh-list
65592220|NCT01340235|Erythromycin Estolate|erythromycin estolate|mesh-list
65592221|NCT01340235|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65592222|NCT01340235|Erythromycin stearate|erythromycin stearate|mesh-list
65592223|NCT01340235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65592224|NCT01340235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65592225|NCT01340235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65592226|NCT01340235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65592227|NCT01340235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592228|NCT01340235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592229|NCT03263962|Canrenone|canrenone|mesh-list
65592230|NCT03263962|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65592231|NCT03263962|Hormone Antagonists|hormone antagonists|mesh-ancestor
65592232|NCT03263962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65592233|NCT03263962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592234|NCT03263962|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65592235|NCT03263962|Diuretics|diuretics|mesh-ancestor
65592236|NCT03263962|Natriuretic Agents|natriuretic agents|mesh-ancestor
65592237|NCT05186649|Warfarin|warfarin|mesh-list
65592238|NCT05186649|Anticoagulants|anticoagulants|mesh-ancestor
65592239|NCT05184465|Anesthetics|anesthetics|mesh-list
65592240|NCT05184465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65592241|NCT05184465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592242|NCT03152019|Tacrolimus|tacrolimus|mesh-list
65592243|NCT03152019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65592244|NCT03152019|Immunologic Factors|immunologic factors|mesh-ancestor
65592245|NCT03152019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592246|NCT03152019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65592247|NCT03152019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592248|NCT03152019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592249|NCT02714062|Topiramate|topiramate|mesh-list
65592250|NCT02714062|Phentermine|phentermine|mesh-list
65592251|NCT02714062|Anticonvulsants|anticonvulsants|mesh-ancestor
65592252|NCT02714062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65592253|NCT02714062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592254|NCT02714062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65592255|NCT02714062|Appetite Depressants|appetite depressants|mesh-ancestor
65592256|NCT02714062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65592257|NCT02714062|Sympathomimetics|sympathomimetics|mesh-ancestor
65592258|NCT02714062|Autonomic Agents|autonomic agents|mesh-ancestor
65592259|NCT02714062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592260|NCT02714062|Adrenergic Agents|adrenergic agents|mesh-ancestor
65592261|NCT02714062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65592262|NCT02714062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592263|NCT03280342|Topiramate|topiramate|mesh-list
65592264|NCT03280342|Anticonvulsants|anticonvulsants|mesh-ancestor
65592265|NCT03280342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65592266|NCT03280342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592267|NCT04965519|Trastuzumab|trastuzumab|mesh-list
65592268|NCT04965519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65592269|NCT04965519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592270|NCT03279796|Betamethasone|betamethasone|mesh-list
65592271|NCT03279796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65592272|NCT03279796|Glucocorticoids|glucocorticoids|mesh-ancestor
65592273|NCT03279796|Hormones|hormones|mesh-ancestor
65592274|NCT03279796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65592275|NCT03279796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592276|NCT03279796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65592277|NCT03279796|Respiratory System Agents|respiratory system agents|mesh-ancestor
65592278|NCT04838223|Proxymetacaine|proxymetacaine|mesh-list
65592279|NCT04838223|Anesthetics, Local|anesthetics, local|mesh-ancestor
65389724|NCT00519285|Hormones|hormones|mesh-ancestor
65592280|NCT04838223|Anesthetics|anesthetics|mesh-ancestor
65592281|NCT04838223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65592282|NCT04838223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592283|NCT04838223|Sensory System Agents|sensory system agents|mesh-ancestor
65592284|NCT04838223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592285|NCT02713828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
65592286|NCT02713828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65592287|NCT02713828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65592288|NCT02713828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592289|NCT02713828|Immunologic Factors|immunologic factors|mesh-ancestor
65592290|NCT02713828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592291|NCT05183997|Verapamil|verapamil|mesh-list
65592292|NCT05183997|Thrombin|thrombin|mesh-list
65592293|NCT05183997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65592294|NCT05183997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65592295|NCT05183997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65592296|NCT05183997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592297|NCT05183997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65592298|NCT05183997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592299|NCT05183997|Vasodilator Agents|vasodilator agents|mesh-ancestor
65592300|NCT05183997|Hemostatics|hemostatics|mesh-ancestor
65592301|NCT05183997|Coagulants|coagulants|mesh-ancestor
65592302|NCT05119101|Magnesium Sulfate|magnesium sulfate|mesh-list
65592303|NCT05119101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65592304|NCT05119101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592305|NCT05119101|Analgesics|analgesics|mesh-ancestor
65592306|NCT05119101|Sensory System Agents|sensory system agents|mesh-ancestor
65592307|NCT05119101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592308|NCT05119101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592309|NCT05119101|Anesthetics|anesthetics|mesh-ancestor
65592310|NCT05119101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65592311|NCT05119101|Anticonvulsants|anticonvulsants|mesh-ancestor
65592312|NCT05119101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65592313|NCT05119101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65592314|NCT05119101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65592315|NCT05119101|Tocolytic Agents|tocolytic agents|mesh-ancestor
65592316|NCT05119101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65592317|NCT01340547|Isophosphamide mustard|isophosphamide mustard|mesh-list
65592318|NCT01340547|Ifosfamide|ifosfamide|mesh-list
65592319|NCT01340547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65592320|NCT01340547|Alkylating Agents|alkylating agents|mesh-ancestor
65592321|NCT01340547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592322|NCT01340547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592323|NCT05183841|Fenoterol|fenoterol|mesh-list
65592324|NCT05183841|Ipratropium|ipratropium|mesh-list
65592325|NCT05183841|Bronchodilator Agents|bronchodilator agents|mesh-list
65592326|NCT05183841|Autonomic Agents|autonomic agents|mesh-ancestor
65592327|NCT05183841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592328|NCT05183841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592329|NCT05183841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65592330|NCT05183841|Respiratory System Agents|respiratory system agents|mesh-ancestor
65592331|NCT05183841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65592332|NCT05183841|Cholinergic Agents|cholinergic agents|mesh-ancestor
65592333|NCT05183841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65592334|NCT05183841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592335|NCT05183841|Sympathomimetics|sympathomimetics|mesh-ancestor
65592336|NCT05183841|Tocolytic Agents|tocolytic agents|mesh-ancestor
65592337|NCT05183841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65592338|NCT05183841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65592339|NCT05183841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65592340|NCT05183841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65592341|NCT05183841|Adrenergic Agents|adrenergic agents|mesh-ancestor
65592342|NCT03277222|Insulin|insulin|mesh-list
65592343|NCT03277222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65592344|NCT03277222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592345|NCT04931667|Lorecivivint|lorecivivint|mesh-list
65592346|NCT04931667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65592347|NCT03262948|Paclitaxel|paclitaxel|mesh-list
65592348|NCT03262948|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65592349|NCT03262948|Carboplatin|carboplatin|mesh-list
65592350|NCT03262948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65592351|NCT03262948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592352|NCT03262948|Tubulin Modulators|tubulin modulators|mesh-ancestor
65592353|NCT03262948|Antimitotic Agents|antimitotic agents|mesh-ancestor
65592354|NCT03262948|Mitosis Modulators|mitosis modulators|mesh-ancestor
65592355|NCT03262948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592356|NCT03276598|Losartan|losartan|mesh-list
65592357|NCT03276598|Amlodipine|amlodipine|mesh-list
65592358|NCT03276598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65592359|NCT03276598|Bisoprolol|bisoprolol|mesh-list
65592360|NCT03276598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65592361|NCT03276598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65592362|NCT03276598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65592363|NCT03276598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592364|NCT03276598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65592365|NCT03276598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592366|NCT03276598|Vasodilator Agents|vasodilator agents|mesh-ancestor
65592367|NCT03276598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65592368|NCT03276598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65592369|NCT03276598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65592370|NCT03276598|Diuretics|diuretics|mesh-ancestor
65592371|NCT03276598|Natriuretic Agents|natriuretic agents|mesh-ancestor
65592372|NCT03276598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65592373|NCT03276598|Sympatholytics|sympatholytics|mesh-ancestor
65592374|NCT03276598|Autonomic Agents|autonomic agents|mesh-ancestor
65592375|NCT03276598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592376|NCT03276598|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65592377|NCT03276598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65592378|NCT03276598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65592379|NCT03276598|Adrenergic Agents|adrenergic agents|mesh-ancestor
65592380|NCT03276598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65592381|NCT03262792|Andrographolide|andrographolide|mesh-list
65592382|NCT03262792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65592383|NCT03262792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65592384|NCT03262792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65592385|NCT03262792|Analgesics|analgesics|mesh-ancestor
65592386|NCT03262792|Sensory System Agents|sensory system agents|mesh-ancestor
65592387|NCT03262792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592388|NCT03262792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592389|NCT03262792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65592390|NCT03262792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65592391|NCT03262792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65592392|NCT03262792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65592393|NCT03262792|Antiviral Agents|antiviral agents|mesh-ancestor
65592394|NCT03262792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65592395|NCT01359462|Tolvaptan|tolvaptan|mesh-list
65592396|NCT01359462|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65592397|NCT01359462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592398|NCT01359462|Natriuretic Agents|natriuretic agents|mesh-ancestor
65592399|NCT01359462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592400|NCT02875392|Fucoidan|fucoidan|mesh-list
65592401|NCT02875392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65592402|NCT02875392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65592403|NCT02875392|Anticoagulants|anticoagulants|mesh-ancestor
65592404|NCT02875392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592405|NCT01359618|Moxifloxacin|moxifloxacin|mesh-list
65592406|NCT01359618|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65592407|NCT01359618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65592408|NCT01359618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65592409|NCT01359618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65592410|NCT01359618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65592411|NCT01359618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592412|NCT01359618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592413|NCT01359618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592414|NCT01359618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65592415|NCT01359618|Contraceptive Agents|contraceptive agents|mesh-ancestor
65592416|NCT01359618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65592417|NCT01359618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592418|NCT01359618|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65592419|NCT01359618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65592420|NCT01359618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65592421|NCT03267628|Morphine|morphine|mesh-list
65592422|NCT03267628|Anesthetics|anesthetics|mesh-list
65592423|NCT03267628|Anesthetics, Local|anesthetics, local|mesh-list
65592424|NCT03267628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65592425|NCT03267628|Narcotics|narcotics|mesh-ancestor
65592426|NCT03267628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65592427|NCT03267628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592428|NCT03267628|Analgesics|analgesics|mesh-ancestor
65592429|NCT03267628|Sensory System Agents|sensory system agents|mesh-ancestor
65592430|NCT03267628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592431|NCT01359696|Gemcitabine|gemcitabine|mesh-list
65592432|NCT01359696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65592433|NCT01359696|Antimetabolites|antimetabolites|mesh-ancestor
65592434|NCT01359696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592435|NCT01359696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592436|NCT01359696|Antiviral Agents|antiviral agents|mesh-ancestor
65592437|NCT01359696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65592438|NCT01359696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592439|NCT01359696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65592440|NCT01359696|Immunologic Factors|immunologic factors|mesh-ancestor
65592441|NCT01359696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592442|NCT03268018|Calcium|calcium|mesh-list
65592443|NCT03268018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65592444|NCT03268018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592445|NCT01362426|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65592446|NCT01362426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65592447|NCT01362426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65592448|NCT01362426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65592449|NCT01362426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592450|NCT01362426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65592451|NCT01362426|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65592452|NCT01362426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65592453|NCT01362426|Serotonin Agents|serotonin agents|mesh-ancestor
65592454|NCT01362426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65592455|NCT01362426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592456|NCT01362426|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65592457|NCT01362426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65592458|NCT01362426|Dopamine Agents|dopamine agents|mesh-ancestor
65592459|NCT01367028|Bevacizumab|bevacizumab|mesh-list
65592460|NCT01367028|Trastuzumab|trastuzumab|mesh-list
65592461|NCT01367028|Docetaxel|docetaxel|mesh-list
65592462|NCT01367028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65592463|NCT01367028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592464|NCT01367028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65592465|NCT01367028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65592466|NCT01367028|Growth Substances|growth substances|mesh-ancestor
65592467|NCT01367028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592468|NCT01367028|Growth Inhibitors|growth inhibitors|mesh-ancestor
65592469|NCT01367028|Tubulin Modulators|tubulin modulators|mesh-ancestor
65592470|NCT01367028|Antimitotic Agents|antimitotic agents|mesh-ancestor
65592471|NCT01367028|Mitosis Modulators|mitosis modulators|mesh-ancestor
65592472|NCT01367028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592473|NCT03965962|Vaccines|vaccines|mesh-list
65592474|NCT03965962|Immunoglobulins|immunoglobulins|mesh-list
65592475|NCT03965962|Antibodies|antibodies|mesh-list
65592476|NCT03965962|gamma-Globulins|gamma-globulins|mesh-list
65592477|NCT03965962|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65592478|NCT03965962|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65592479|NCT03965962|Immunologic Factors|immunologic factors|mesh-ancestor
65592480|NCT03965962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592481|NCT03273088|Etanercept|etanercept|mesh-list
65592482|NCT03273088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65592483|NCT03273088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65592484|NCT03273088|Analgesics|analgesics|mesh-ancestor
65592485|NCT03273088|Sensory System Agents|sensory system agents|mesh-ancestor
65592486|NCT03273088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592487|NCT03273088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592488|NCT03273088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65592489|NCT03273088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65592490|NCT03273088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65592491|NCT03273088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65592492|NCT03273088|Immunologic Factors|immunologic factors|mesh-ancestor
65592493|NCT04235634|Alprostadil|alprostadil|mesh-list
65592494|NCT04235634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65592495|NCT04235634|Vasodilator Agents|vasodilator agents|mesh-ancestor
65592496|NCT04235634|Urological Agents|urological agents|mesh-ancestor
65592497|NCT03262090|Dexmedetomidine|dexmedetomidine|mesh-list
65592498|NCT03262090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65592499|NCT03262090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65592500|NCT03262090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592501|NCT03262090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65592502|NCT03262090|Analgesics|analgesics|mesh-ancestor
65592503|NCT03262090|Sensory System Agents|sensory system agents|mesh-ancestor
65592504|NCT03262090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592505|NCT03262090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65592506|NCT03262090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65592507|NCT03262090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65592508|NCT03262090|Adrenergic Agents|adrenergic agents|mesh-ancestor
65592509|NCT03262090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65592510|NCT03262090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592511|NCT03151551|Adalimumab|adalimumab|mesh-list
65592512|NCT03151551|Ixekizumab|ixekizumab|mesh-list
65592513|NCT03151551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65592514|NCT03151551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65592515|NCT03151551|Dermatologic Agents|dermatologic agents|mesh-ancestor
65592516|NCT03267316|Gemcitabine|gemcitabine|mesh-list
65592517|NCT03267316|Paclitaxel|paclitaxel|mesh-list
65592518|NCT03267316|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65592519|NCT03267316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592520|NCT03267316|Tubulin Modulators|tubulin modulators|mesh-ancestor
65592521|NCT03267316|Antimitotic Agents|antimitotic agents|mesh-ancestor
65592522|NCT03267316|Mitosis Modulators|mitosis modulators|mesh-ancestor
65592523|NCT03267316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592524|NCT03267316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65592525|NCT03267316|Antimetabolites|antimetabolites|mesh-ancestor
65592526|NCT03267316|Antiviral Agents|antiviral agents|mesh-ancestor
65592527|NCT03267316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65592528|NCT03267316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592529|NCT03267316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65592530|NCT03267316|Immunologic Factors|immunologic factors|mesh-ancestor
65592531|NCT03267316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592532|NCT01359930|Naltrexone|naltrexone|mesh-list
65592533|NCT01359930|Bupropion|bupropion|mesh-list
65592534|NCT01359930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65592535|NCT01359930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65592536|NCT01359930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592537|NCT01359930|Sensory System Agents|sensory system agents|mesh-ancestor
65592538|NCT01359930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592539|NCT01359930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65592540|NCT01359930|Antidepressive Agents|antidepressive agents|mesh-ancestor
65592541|NCT01359930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65592542|NCT01359930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65592543|NCT01359930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65592544|NCT01359930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65592545|NCT01359930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592546|NCT01359930|Dopamine Agents|dopamine agents|mesh-ancestor
65592547|NCT01359930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65592548|NCT01359930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65592549|NCT01359930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65592550|NCT01359930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592551|NCT05075512|Fulvestrant|fulvestrant|mesh-list
65592552|NCT05075512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65592553|NCT05075512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592554|NCT05075512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65592555|NCT05075512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65592556|NCT05075512|Hormone Antagonists|hormone antagonists|mesh-ancestor
65592557|NCT05075512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65592558|NCT05075512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592559|NCT01316757|Paclitaxel|paclitaxel|mesh-list
65592560|NCT01316757|Carboplatin|carboplatin|mesh-list
65592561|NCT01316757|Cetuximab|cetuximab|mesh-list
65592562|NCT01316757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65592563|NCT01316757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65592564|NCT01316757|Antibodies|antibodies|mesh-list
65592565|NCT01316757|Immunoglobulins|immunoglobulins|mesh-list
65592566|NCT01316757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65592567|NCT01316757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65592568|NCT01316757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592569|NCT01316757|Tubulin Modulators|tubulin modulators|mesh-ancestor
65592570|NCT01316757|Antimitotic Agents|antimitotic agents|mesh-ancestor
65592571|NCT01316757|Mitosis Modulators|mitosis modulators|mesh-ancestor
65592572|NCT01316757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592573|NCT01316757|Immunologic Factors|immunologic factors|mesh-ancestor
65592574|NCT01316757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592575|NCT01316757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65592576|NCT01316757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592577|NCT05074966|Cetuximab|cetuximab|mesh-list
65390020|NCT00956436|Sorafenib|sorafenib|mesh-list
65592578|NCT05074966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65592579|NCT05074966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592580|NCT03266926|Bupivacaine|bupivacaine|mesh-list
65592581|NCT03266926|Estrogens|estrogens|mesh-list
65592582|NCT03266926|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65592583|NCT03266926|Anesthetics, Local|anesthetics, local|mesh-ancestor
65592584|NCT03266926|Anesthetics|anesthetics|mesh-ancestor
65592585|NCT03266926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65592586|NCT03266926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592587|NCT03266926|Sensory System Agents|sensory system agents|mesh-ancestor
65592588|NCT03266926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592589|NCT03266926|Hormones|hormones|mesh-ancestor
65592590|NCT03266926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65592591|NCT01343745|Formoterol Fumarate|formoterol fumarate|mesh-list
65592592|NCT01343745|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65592593|NCT01343745|Autonomic Agents|autonomic agents|mesh-ancestor
65592594|NCT01343745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592595|NCT01343745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592596|NCT01343745|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65592597|NCT01343745|Respiratory System Agents|respiratory system agents|mesh-ancestor
65592598|NCT01343745|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65592599|NCT01343745|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65592600|NCT01343745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65592601|NCT01343745|Adrenergic Agents|adrenergic agents|mesh-ancestor
65592602|NCT01343745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65592603|NCT01343745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592604|NCT01367418|Sufentanil|sufentanil|mesh-list
65592605|NCT01367418|Morphine|morphine|mesh-list
65592606|NCT01367418|Bupivacaine|bupivacaine|mesh-list
65592607|NCT01367418|Ropivacaine|ropivacaine|mesh-list
65592608|NCT01367418|Anesthetics, Local|anesthetics, local|mesh-ancestor
65592609|NCT01367418|Anesthetics|anesthetics|mesh-ancestor
65592610|NCT01367418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65592611|NCT01367418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592612|NCT01367418|Sensory System Agents|sensory system agents|mesh-ancestor
65592613|NCT01367418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592614|NCT01367418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65592615|NCT01367418|Narcotics|narcotics|mesh-ancestor
65592616|NCT01367418|Analgesics|analgesics|mesh-ancestor
65592617|NCT01367418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65592618|NCT01367418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65592619|NCT01367418|Anesthetics, General|anesthetics, general|mesh-ancestor
65592620|NCT01360086|Leucovorin|leucovorin|mesh-list
65592621|NCT01360086|Fluorouracil|fluorouracil|mesh-list
65592622|NCT01360086|Cetuximab|cetuximab|mesh-list
65592623|NCT01360086|Calcium|calcium|mesh-list
65592624|NCT01360086|Levoleucovorin|levoleucovorin|mesh-list
65592625|NCT01360086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592626|NCT01360086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65592627|NCT01360086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592628|NCT01360086|Antimetabolites|antimetabolites|mesh-ancestor
65592629|NCT01360086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592630|NCT01360086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65592631|NCT01360086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65592632|NCT01360086|Immunologic Factors|immunologic factors|mesh-ancestor
65592633|NCT01360086|Antidotes|antidotes|mesh-ancestor
65592634|NCT01360086|Protective Agents|protective agents|mesh-ancestor
65592635|NCT01360086|Vitamin B Complex|vitamin b complex|mesh-ancestor
65592636|NCT01360086|Vitamins|vitamins|mesh-ancestor
65592637|NCT01360086|Micronutrients|micronutrients|mesh-ancestor
65592638|NCT01360086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65592639|NCT02458924|Niacin|niacin|mesh-list
65592640|NCT02458924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65592641|NCT02458924|Antimetabolites|antimetabolites|mesh-ancestor
65592642|NCT02458924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592643|NCT02458924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65592644|NCT02458924|Vasodilator Agents|vasodilator agents|mesh-ancestor
65592645|NCT02458924|Vitamin B Complex|vitamin b complex|mesh-ancestor
65592646|NCT02458924|Vitamins|vitamins|mesh-ancestor
65592647|NCT02458924|Micronutrients|micronutrients|mesh-ancestor
65592648|NCT02458924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592649|NCT01367496|Naltrexone|naltrexone|mesh-list
65592650|NCT01367496|Methylnaltrexone|methylnaltrexone|mesh-list
65592651|NCT01367496|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65592652|NCT01367496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592653|NCT01367496|Sensory System Agents|sensory system agents|mesh-ancestor
65592654|NCT01367496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592655|NCT01367496|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65592657|NCT02459158|Dibekacin|dibekacin|mesh-list
65592658|NCT02459158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65592659|NCT02459158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65592660|NCT02459158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65592661|NCT01367574|Methylnaltrexone|methylnaltrexone|mesh-list
65592662|NCT01367574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65592663|NCT01367574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592664|NCT01367574|Sensory System Agents|sensory system agents|mesh-ancestor
65592665|NCT01367574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592666|NCT04693689|Vaccines|vaccines|mesh-list
65592667|NCT04693689|Immunologic Factors|immunologic factors|mesh-ancestor
65592668|NCT04693689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592669|NCT03126786|Triamcinolone|triamcinolone|mesh-list
65592670|NCT03126786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65592671|NCT03126786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65592672|NCT03126786|Aflibercept|aflibercept|mesh-list
65592673|NCT03126786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65592674|NCT03126786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65592675|NCT03126786|Glucocorticoids|glucocorticoids|mesh-ancestor
65592676|NCT03126786|Hormones|hormones|mesh-ancestor
65592677|NCT03126786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65592678|NCT03126786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592679|NCT03126786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65592680|NCT03126786|Immunologic Factors|immunologic factors|mesh-ancestor
65592681|NCT03126786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592682|NCT03126786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592683|NCT03126786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65592684|NCT03126786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65592685|NCT03126786|Growth Substances|growth substances|mesh-ancestor
65592686|NCT03126786|Growth Inhibitors|growth inhibitors|mesh-ancestor
65592687|NCT03126786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592688|NCT01367652|Letrozole|letrozole|mesh-list
65592689|NCT01367652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592690|NCT01367652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65592691|NCT01367652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65592692|NCT01367652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592693|NCT01367652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592694|NCT01367652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65592695|NCT01367652|Hormone Antagonists|hormone antagonists|mesh-ancestor
65592696|NCT01367652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65592697|NCT01367652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592698|NCT02456584|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65592699|NCT02456584|Medroxyprogesterone|medroxyprogesterone|mesh-list
65592700|NCT02456584|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65592701|NCT02456584|Contraceptive Agents|contraceptive agents|mesh-ancestor
65592702|NCT02456584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65592703|NCT02456584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592704|NCT02456584|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65592705|NCT02456584|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65592706|NCT02456584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65592707|NCT02456584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592708|NCT02456584|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65592709|NCT02456584|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65592710|NCT02456584|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65592711|NCT03146403|Vaccines|vaccines|mesh-list
65592712|NCT03146403|Immunologic Factors|immunologic factors|mesh-ancestor
65592713|NCT03146403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592714|NCT01360476|Vitamin D|vitamin d|mesh-list
65592715|NCT01360476|Cholecalciferol|cholecalciferol|mesh-list
65592716|NCT01360476|Vitamins|vitamins|mesh-ancestor
65592717|NCT01360476|Micronutrients|micronutrients|mesh-ancestor
65592718|NCT01360476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592719|NCT01360476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65592720|NCT01360476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65592721|NCT01317069|Fluorouracil|fluorouracil|mesh-list
65592722|NCT01317069|Antimetabolites|antimetabolites|mesh-ancestor
65592723|NCT01317069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592724|NCT01317069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65592725|NCT01317069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592726|NCT01317069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65390164|NCT00168805|Anticoagulants|anticoagulants|mesh-ancestor
65592727|NCT01317069|Immunologic Factors|immunologic factors|mesh-ancestor
65592728|NCT01317069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592729|NCT01317225|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
65592730|NCT01317225|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
65592731|NCT01317225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65592732|NCT01317225|Hormone Antagonists|hormone antagonists|mesh-ancestor
65592733|NCT01317225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65592734|NCT01317225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592735|NCT01317225|Progestins|progestins|mesh-ancestor
65592736|NCT01317225|Hormones|hormones|mesh-ancestor
65592737|NCT01363206|Ipilimumab|ipilimumab|mesh-list
65592738|NCT01363206|Molgramostim|molgramostim|mesh-list
65592739|NCT01363206|Sargramostim|sargramostim|mesh-list
65592740|NCT01363206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65592741|NCT01363206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592742|NCT01363206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65592743|NCT01363206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592744|NCT01363206|Immunologic Factors|immunologic factors|mesh-ancestor
65592745|NCT01363206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592746|NCT04962022|Ritonavir|ritonavir|mesh-list
65592747|NCT04962022|Itraconazole|itraconazole|mesh-list
65592748|NCT04962022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65592749|NCT04962022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65592750|NCT04962022|Protease Inhibitors|protease inhibitors|mesh-ancestor
65592751|NCT04962022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592752|NCT04962022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592753|NCT04962022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65592754|NCT04962022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65592755|NCT04962022|Antiviral Agents|antiviral agents|mesh-ancestor
65592756|NCT04962022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65592757|NCT04962022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65592758|NCT04962022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65592759|NCT04962022|Antifungal Agents|antifungal agents|mesh-ancestor
65592760|NCT04962022|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65592761|NCT04962022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65592762|NCT04962022|Hormone Antagonists|hormone antagonists|mesh-ancestor
65592763|NCT04962022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65592764|NCT04962022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592765|NCT01344213|Celecoxib|celecoxib|mesh-list
65592766|NCT01344213|Pregabalin|pregabalin|mesh-list
65592767|NCT01344213|Analgesics|analgesics|mesh-ancestor
65592768|NCT01344213|Sensory System Agents|sensory system agents|mesh-ancestor
65592769|NCT01344213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592770|NCT01344213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592771|NCT01344213|Anticonvulsants|anticonvulsants|mesh-ancestor
65592772|NCT01344213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65592773|NCT01344213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65592774|NCT01344213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592775|NCT01344213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65592776|NCT01344213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65592777|NCT01344213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65592778|NCT01344213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65592779|NCT01344213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65592780|NCT01344213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65592781|NCT01344213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65592782|NCT01344213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65592783|NCT01344213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65592784|NCT01344213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65592785|NCT01344213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65592786|NCT01344213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592787|NCT04416048|Rivaroxaban|rivaroxaban|mesh-list
65592788|NCT04416048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65592789|NCT04416048|Antithrombins|antithrombins|mesh-ancestor
65592790|NCT04416048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65592791|NCT04416048|Protease Inhibitors|protease inhibitors|mesh-ancestor
65592792|NCT04416048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592793|NCT04416048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592794|NCT04416048|Anticoagulants|anticoagulants|mesh-ancestor
65592795|NCT01363284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65592796|NCT01363284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65592797|NCT01363284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65592798|NCT01363284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65592799|NCT01363284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592800|NCT01363284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65390241|NCT00956748|Acetylcysteine|acetylcysteine|mesh-list
65592801|NCT01363284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592802|NCT01363284|Analgesics|analgesics|mesh-ancestor
65592803|NCT01363284|Sensory System Agents|sensory system agents|mesh-ancestor
65592804|NCT01363284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592805|NCT01363284|Antidepressive Agents|antidepressive agents|mesh-ancestor
65592806|NCT01363284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65592807|NCT01363284|Dopamine Agents|dopamine agents|mesh-ancestor
65592808|NCT03265834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65592809|NCT03265834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65592810|NCT03265834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65592811|NCT03265834|Antitubercular Agents|antitubercular agents|mesh-ancestor
65592812|NCT01344291|Curcumin|curcumin|mesh-list
65592813|NCT01344291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65592814|NCT01344291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65592815|NCT01344291|Analgesics|analgesics|mesh-ancestor
65592816|NCT01344291|Sensory System Agents|sensory system agents|mesh-ancestor
65592817|NCT01344291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592818|NCT01344291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592819|NCT01344291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65592820|NCT01344291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65592821|NCT01344291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592822|NCT01344291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592823|NCT01344291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592824|NCT01367964|Hormones|hormones|mesh-list
65592825|NCT01367964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65592826|NCT01367964|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
65592827|NCT01367964|beta-Endorphin|beta-endorphin|mesh-list
65592828|NCT01367964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65592829|NCT01367964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592830|NCT01367964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65592831|NCT01367964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592832|NCT04326933|Imatinib Mesylate|imatinib mesylate|mesh-list
65592833|NCT04326933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592834|NCT04326933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65592835|NCT04326933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592836|NCT04326933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592837|NCT04733560|Bupivacaine|bupivacaine|mesh-list
65592838|NCT04733560|Anesthetics, Local|anesthetics, local|mesh-ancestor
65592839|NCT04733560|Anesthetics|anesthetics|mesh-ancestor
65592840|NCT04733560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65592841|NCT04733560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592842|NCT04733560|Sensory System Agents|sensory system agents|mesh-ancestor
65592843|NCT04733560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592844|NCT01347957|Nitric Oxide|nitric oxide|mesh-list
65592845|NCT01347957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65592846|NCT01347957|Autonomic Agents|autonomic agents|mesh-ancestor
65592847|NCT01347957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592848|NCT01347957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592849|NCT01347957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65592850|NCT01347957|Respiratory System Agents|respiratory system agents|mesh-ancestor
65592851|NCT01347957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65592852|NCT01347957|Antioxidants|antioxidants|mesh-ancestor
65592853|NCT01347957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592854|NCT01347957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65592855|NCT01347957|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65592856|NCT01347957|Vasodilator Agents|vasodilator agents|mesh-ancestor
65592857|NCT01347957|Gasotransmitters|gasotransmitters|mesh-ancestor
65592858|NCT01347957|Protective Agents|protective agents|mesh-ancestor
65592859|NCT03632044|Ropivacaine|ropivacaine|mesh-list
65592860|NCT03632044|Anesthetics, Local|anesthetics, local|mesh-ancestor
65592861|NCT03632044|Anesthetics|anesthetics|mesh-ancestor
65592862|NCT03632044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65592863|NCT03632044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592864|NCT03632044|Sensory System Agents|sensory system agents|mesh-ancestor
65592865|NCT03632044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592866|NCT04735965|Meperidine|meperidine|mesh-list
65592867|NCT04735965|Dexmedetomidine|dexmedetomidine|mesh-list
65592868|NCT04735965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65592869|NCT04735965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65592870|NCT04735965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592871|NCT04735965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65592872|NCT04735965|Analgesics|analgesics|mesh-ancestor
65592873|NCT04735965|Sensory System Agents|sensory system agents|mesh-ancestor
65592874|NCT04735965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592875|NCT04735965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65592876|NCT04735965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65592877|NCT04735965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65592878|NCT04735965|Adrenergic Agents|adrenergic agents|mesh-ancestor
65592879|NCT04735965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65592880|NCT04735965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592881|NCT04735965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65592882|NCT04735965|Narcotics|narcotics|mesh-ancestor
65592883|NCT04735965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65592884|NCT04291599|Ketorolac|ketorolac|mesh-list
65592885|NCT04291599|Morphine|morphine|mesh-list
65592886|NCT04291599|Hydromorphone|hydromorphone|mesh-list
65592887|NCT04291599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65592888|NCT04291599|Narcotics|narcotics|mesh-ancestor
65592889|NCT04291599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65592890|NCT04291599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592891|NCT04291599|Analgesics|analgesics|mesh-ancestor
65592892|NCT04291599|Sensory System Agents|sensory system agents|mesh-ancestor
65592893|NCT04291599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65592894|NCT04291599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65592895|NCT04291599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65592896|NCT04291599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65592897|NCT04291599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65592898|NCT04291599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65592899|NCT04291599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592900|NCT04291599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592901|NCT02456428|Insulin|insulin|mesh-list
65592902|NCT02456428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65592903|NCT02456428|Metformin|metformin|mesh-list
65592904|NCT02456428|Pioglitazone|pioglitazone|mesh-list
65592905|NCT02456428|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65592906|NCT02456428|Liraglutide|liraglutide|mesh-list
65592907|NCT02456428|Exenatide|exenatide|mesh-list
65592908|NCT02456428|Glimepiride|glimepiride|mesh-list
65592909|NCT02456428|Rosiglitazone|rosiglitazone|mesh-list
65592910|NCT02456428|Vildagliptin|vildagliptin|mesh-list
65592911|NCT02456428|Saxagliptin|saxagliptin|mesh-list
65592912|NCT02456428|Acarbose|acarbose|mesh-list
65592913|NCT02456428|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65592914|NCT02456428|Repaglinide|repaglinide|mesh-list
65592915|NCT02456428|Gliclazide|gliclazide|mesh-list
65592916|NCT02456428|Glipizide|glipizide|mesh-list
65592917|NCT02456428|Biguanides|biguanides|mesh-list
65592918|NCT02456428|Tolbutamide|tolbutamide|mesh-list
65592919|NCT02456428|Voglibose|voglibose|mesh-list
65592920|NCT02456428|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
65592921|NCT02456428|Nateglinide|nateglinide|mesh-list
65592922|NCT02456428|Miglitol|miglitol|mesh-list
65592923|NCT02456428|Troglitazone|troglitazone|mesh-list
65592924|NCT02456428|Meglitinide|meglitinide|mesh-list
65592925|NCT02456428|Acetohexamide|acetohexamide|mesh-list
65592926|NCT02456428|Chlorpropamide|chlorpropamide|mesh-list
65592927|NCT02456428|Phenformin|phenformin|mesh-list
65592928|NCT02456428|Buformin|buformin|mesh-list
65592929|NCT02456428|Glibornuride|glibornuride|mesh-list
65592930|NCT02456428|Tolazamide|tolazamide|mesh-list
65592931|NCT02456428|Carbutamide|carbutamide|mesh-list
65592932|NCT02456428|Gliquidone|gliquidone|mesh-list
65592933|NCT02456428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65592934|NCT02456428|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
65592935|NCT02456428|Incretins|incretins|mesh-list
65592936|NCT02456428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592937|NCT02456428|Hormones|hormones|mesh-ancestor
65592938|NCT02456428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65592939|NCT02456428|Protease Inhibitors|protease inhibitors|mesh-ancestor
65592940|NCT02456428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592941|NCT02456428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592942|NCT02456428|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65592943|NCT02456428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65592944|NCT02456428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65592945|NCT02456428|Immunologic Factors|immunologic factors|mesh-ancestor
65592946|NCT03259516|Cytarabine|cytarabine|mesh-list
65592947|NCT03259516|Cyclophosphamide|cyclophosphamide|mesh-list
65592948|NCT03259516|Melphalan|melphalan|mesh-list
65592949|NCT03259516|Nivolumab|nivolumab|mesh-list
65592950|NCT03259516|Fludarabine|fludarabine|mesh-list
65592951|NCT03259516|Azacitidine|azacitidine|mesh-list
65592952|NCT03259516|Tretinoin|tretinoin|mesh-list
65592953|NCT03259516|Sildenafil Citrate|sildenafil citrate|mesh-list
65592954|NCT03259516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65592955|NCT03259516|Immunologic Factors|immunologic factors|mesh-ancestor
65592956|NCT03259516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592957|NCT03259516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65592958|NCT03259516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65592959|NCT03259516|Alkylating Agents|alkylating agents|mesh-ancestor
65592960|NCT03259516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592961|NCT03259516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65592962|NCT03259516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65592963|NCT03259516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65592964|NCT03259516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65592965|NCT03259516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65592966|NCT03259516|Antimetabolites|antimetabolites|mesh-ancestor
65592967|NCT03259516|Antiviral Agents|antiviral agents|mesh-ancestor
65592968|NCT03259516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65592969|NCT03259516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592970|NCT03259516|Vasodilator Agents|vasodilator agents|mesh-ancestor
65592971|NCT03259516|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65592972|NCT03259516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65592973|NCT03259516|Urological Agents|urological agents|mesh-ancestor
65592974|NCT03259516|Keratolytic Agents|keratolytic agents|mesh-ancestor
65592975|NCT03259516|Dermatologic Agents|dermatologic agents|mesh-ancestor
65592976|NCT01344681|Itraconazole|itraconazole|mesh-list
65592977|NCT01344681|Micafungin|micafungin|mesh-list
65592978|NCT01344681|Antifungal Agents|antifungal agents|mesh-ancestor
65592979|NCT01344681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65592980|NCT01344681|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65592981|NCT01344681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65592982|NCT01344681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65592983|NCT01344681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65592984|NCT01344681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65592985|NCT01344681|Hormone Antagonists|hormone antagonists|mesh-ancestor
65592986|NCT01344681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65592987|NCT01344681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592988|NCT01344681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65592989|NCT01348269|Zoledronic Acid|zoledronic acid|mesh-list
65592990|NCT01348269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65592991|NCT01348269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65592992|NCT03259672|Sevoflurane|sevoflurane|mesh-list
65592993|NCT03259672|Desflurane|desflurane|mesh-list
65592994|NCT03259672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65592995|NCT03259672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65592996|NCT03259672|Anesthetics, General|anesthetics, general|mesh-ancestor
65592997|NCT03259672|Anesthetics|anesthetics|mesh-ancestor
65592998|NCT03259672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65592999|NCT03259672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593000|NCT03259282|gamma-Globulins|gamma-globulins|mesh-list
65593001|NCT03259282|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65593002|NCT03259282|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65593003|NCT03259282|Immunologic Factors|immunologic factors|mesh-ancestor
65593004|NCT03259282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593005|NCT02456194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65593006|NCT02456194|Calcium|calcium|mesh-list
65593007|NCT02456194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65593008|NCT02456194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593009|NCT02456194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65593010|NCT03265288|Fenretinide|fenretinide|mesh-list
65593011|NCT03265288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593012|NCT03265288|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65593013|NCT03265288|Protective Agents|protective agents|mesh-ancestor
65593014|NCT03265288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593015|NCT03261310|Acetaminophen|acetaminophen|mesh-list
65593016|NCT03261310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65593017|NCT03261310|Analgesics|analgesics|mesh-ancestor
65593018|NCT03261310|Sensory System Agents|sensory system agents|mesh-ancestor
65593019|NCT03261310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593020|NCT03261310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593021|NCT03261310|Antipyretics|antipyretics|mesh-ancestor
65593022|NCT02456350|Cyclophosphamide|cyclophosphamide|mesh-list
65593023|NCT02456350|Fludarabine|fludarabine|mesh-list
65593024|NCT02456350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65593025|NCT02456350|Immunologic Factors|immunologic factors|mesh-ancestor
65593026|NCT02456350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593027|NCT02456350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65593028|NCT02456350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65593029|NCT02456350|Alkylating Agents|alkylating agents|mesh-ancestor
65593030|NCT02456350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593031|NCT02456350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593032|NCT02456350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65593033|NCT03132636|Cemiplimab|cemiplimab|mesh-list
65593034|NCT03132636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65593035|NCT03132636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593036|NCT01319370|Minoxidil|minoxidil|mesh-list
65593037|NCT01319370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65593038|NCT01319370|Vasodilator Agents|vasodilator agents|mesh-ancestor
65593039|NCT01363752|Mycophenolic Acid|mycophenolic acid|mesh-list
65593040|NCT01363752|Sirolimus|sirolimus|mesh-list
65593041|NCT01363752|Tacrolimus|tacrolimus|mesh-list
65593042|NCT01363752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65593043|NCT01363752|Immunologic Factors|immunologic factors|mesh-ancestor
65593044|NCT01363752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593045|NCT01363752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65593046|NCT01363752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593047|NCT01363752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593048|NCT01363752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65593049|NCT01363752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593050|NCT01363752|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65593051|NCT01363752|Antitubercular Agents|antitubercular agents|mesh-ancestor
65593052|NCT01363752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65593053|NCT01363752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65593054|NCT01363752|Antifungal Agents|antifungal agents|mesh-ancestor
65593055|NCT01368198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65593056|NCT01368198|Lubricant Eye Drops|lubricant eye drops|mesh-list
65593057|NCT01368198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65593058|NCT01360710|Irbesartan|irbesartan|mesh-list
65593059|NCT01360710|Moxonidine|moxonidine|mesh-list
65593060|NCT01360710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65593061|NCT01360710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65593062|NCT01360710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65593063|NCT01360710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593064|NCT01360788|Albuterol|albuterol|mesh-list
65593065|NCT01360788|Ipratropium|ipratropium|mesh-list
65593066|NCT01360788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65593067|NCT01360788|Autonomic Agents|autonomic agents|mesh-ancestor
65593068|NCT01360788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593069|NCT01360788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593070|NCT01360788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65593071|NCT01360788|Respiratory System Agents|respiratory system agents|mesh-ancestor
65593072|NCT01360788|Tocolytic Agents|tocolytic agents|mesh-ancestor
65593073|NCT01360788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65593074|NCT01360788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65593075|NCT01360788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65593076|NCT01360788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65593077|NCT01360788|Adrenergic Agents|adrenergic agents|mesh-ancestor
65593078|NCT01360788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65593079|NCT01360788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593080|NCT01360788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65593081|NCT01360788|Cholinergic Agents|cholinergic agents|mesh-ancestor
65593082|NCT01361022|Brotizolam|brotizolam|mesh-list
65593083|NCT01361022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65593084|NCT01361022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65593085|NCT01361022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593086|NCT01364220|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65593087|NCT01364220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65593088|NCT01364220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65593089|NCT01364220|Antimetabolites|antimetabolites|mesh-ancestor
65593090|NCT01364220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593091|NCT01364220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65593092|NCT01364220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65593093|NCT01364220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593094|NCT02713204|Aflibercept|aflibercept|mesh-list
65593095|NCT02713204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65593096|NCT02713204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65593097|NCT02713204|Growth Substances|growth substances|mesh-ancestor
65593098|NCT02713204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593099|NCT02713204|Growth Inhibitors|growth inhibitors|mesh-ancestor
65593100|NCT02713204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593101|NCT03695172|Ropivacaine|ropivacaine|mesh-list
65593102|NCT03695172|Anesthetics, Local|anesthetics, local|mesh-ancestor
65593103|NCT03695172|Anesthetics|anesthetics|mesh-ancestor
65593104|NCT03695172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65593105|NCT03695172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593106|NCT03695172|Sensory System Agents|sensory system agents|mesh-ancestor
65593107|NCT03695172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593109|NCT01364376|Oxaliplatin|oxaliplatin|mesh-list
65593110|NCT01364376|Calcium|calcium|mesh-list
65593111|NCT01364376|Levoleucovorin|levoleucovorin|mesh-list
65593112|NCT01364376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65593113|NCT01364376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593114|NCT01364376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593115|NCT01364376|Antidotes|antidotes|mesh-ancestor
65593116|NCT01364376|Protective Agents|protective agents|mesh-ancestor
65593117|NCT01364376|Vitamin B Complex|vitamin b complex|mesh-ancestor
65593118|NCT01364376|Vitamins|vitamins|mesh-ancestor
65593119|NCT01364376|Micronutrients|micronutrients|mesh-ancestor
65593120|NCT01348503|Lenalidomide|lenalidomide|mesh-list
65593121|NCT01348503|Sorafenib|sorafenib|mesh-list
65593122|NCT01348503|Immunologic Factors|immunologic factors|mesh-ancestor
65593123|NCT01348503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593124|NCT01348503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65593125|NCT01348503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65593126|NCT01348503|Growth Substances|growth substances|mesh-ancestor
65593127|NCT01348503|Growth Inhibitors|growth inhibitors|mesh-ancestor
65593128|NCT01348503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593129|NCT01348503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65593130|NCT01348503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593131|NCT01348503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593132|NCT01369290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65593133|NCT01369290|Citalopram|citalopram|mesh-list
65593134|NCT01369290|Bupropion|bupropion|mesh-list
65593135|NCT01369290|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65593136|NCT01369290|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65593137|NCT01369290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65593138|NCT01369290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65593139|NCT01369290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593140|NCT01369290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65593141|NCT01369290|Serotonin Agents|serotonin agents|mesh-ancestor
65593142|NCT01369290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593143|NCT01369290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65593144|NCT01369290|Antidepressive Agents|antidepressive agents|mesh-ancestor
65593145|NCT01369290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65593146|NCT01369290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593147|NCT01369290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65593148|NCT01369290|Dopamine Agents|dopamine agents|mesh-ancestor
65593149|NCT01369290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65593150|NCT01369290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65593151|NCT01369290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593152|NCT01369290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65593153|NCT01369290|Analgesics|analgesics|mesh-ancestor
65593154|NCT01369290|Sensory System Agents|sensory system agents|mesh-ancestor
65593155|NCT03533452|Ropivacaine|ropivacaine|mesh-list
65593156|NCT03533452|Anesthetics, Local|anesthetics, local|mesh-ancestor
65593157|NCT03533452|Anesthetics|anesthetics|mesh-ancestor
65593158|NCT03533452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65593159|NCT03533452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593160|NCT03533452|Sensory System Agents|sensory system agents|mesh-ancestor
65593161|NCT03533452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593162|NCT04359147|Hydrocortisone|hydrocortisone|mesh-list
65593163|NCT04359147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65593164|NCT04359147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65593165|NCT04359147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65593166|NCT04359147|Yohimbine|yohimbine|mesh-list
65593167|NCT04359147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65593168|NCT04359147|Mydriatics|mydriatics|mesh-ancestor
65593169|NCT04359147|Autonomic Agents|autonomic agents|mesh-ancestor
65593170|NCT04359147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593171|NCT04359147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593172|NCT04359147|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65593173|NCT04359147|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65593174|NCT04359147|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65593175|NCT04359147|Adrenergic Agents|adrenergic agents|mesh-ancestor
65593176|NCT04359147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65593177|NCT04359147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593178|NCT04359147|Urological Agents|urological agents|mesh-ancestor
65593179|NCT01369368|Azacitidine|azacitidine|mesh-list
65593180|NCT01369368|Valproic Acid|valproic acid|mesh-list
65593181|NCT01369368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65593182|NCT01369368|Antimetabolites|antimetabolites|mesh-ancestor
65593183|NCT01369368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593184|NCT01369368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593186|NCT01369368|Anticonvulsants|anticonvulsants|mesh-ancestor
65593187|NCT01369368|GABA Agents|gaba agents|mesh-ancestor
65593188|NCT01369368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65593189|NCT01369368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593190|NCT01369368|Antimanic Agents|antimanic agents|mesh-ancestor
65593191|NCT01369368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65593192|NCT01369368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65593193|NCT01369368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65593194|NCT04074759|Pembrolizumab|pembrolizumab|mesh-list
65593195|NCT04074759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65593196|NCT04074759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593197|NCT01369602|Nicotinic Acids|nicotinic acids|mesh-list
65593198|NCT01369602|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
65593199|NCT01369602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593200|NCT01369602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593201|NCT01369602|Vitamin B Complex|vitamin b complex|mesh-ancestor
65593202|NCT01369602|Vitamins|vitamins|mesh-ancestor
65593203|NCT01369602|Micronutrients|micronutrients|mesh-ancestor
65593204|NCT01369602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593205|NCT03252496|Ephedrine|ephedrine|mesh-list
65593206|NCT03252496|Fentanyl|fentanyl|mesh-list
65593207|NCT03252496|Bupivacaine|bupivacaine|mesh-list
65593208|NCT03252496|Oxytocin|oxytocin|mesh-list
65593209|NCT03252496|Anesthetics, Local|anesthetics, local|mesh-ancestor
65593210|NCT03252496|Anesthetics|anesthetics|mesh-ancestor
65593211|NCT03252496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65593212|NCT03252496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593213|NCT03252496|Sensory System Agents|sensory system agents|mesh-ancestor
65593214|NCT03252496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593215|NCT03252496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65593216|NCT03252496|Narcotics|narcotics|mesh-ancestor
65593217|NCT03252496|Analgesics|analgesics|mesh-ancestor
65593218|NCT03252496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65593219|NCT03252496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65593220|NCT03252496|Anesthetics, General|anesthetics, general|mesh-ancestor
65593221|NCT03252496|Oxytocics|oxytocics|mesh-ancestor
65593222|NCT03252496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65593223|NCT03252496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65593224|NCT03252496|Sympathomimetics|sympathomimetics|mesh-ancestor
65593225|NCT03252496|Autonomic Agents|autonomic agents|mesh-ancestor
65593226|NCT03252496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65593227|NCT03252496|Adrenergic Agents|adrenergic agents|mesh-ancestor
65593228|NCT03252496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65593229|NCT03252496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593230|NCT03252418|Ascorbic Acid|ascorbic acid|mesh-list
65593231|NCT03252418|Antioxidants|antioxidants|mesh-ancestor
65593232|NCT03252418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593233|NCT03252418|Protective Agents|protective agents|mesh-ancestor
65593234|NCT03252418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593235|NCT03252418|Vitamins|vitamins|mesh-ancestor
65593236|NCT03252418|Micronutrients|micronutrients|mesh-ancestor
65593237|NCT01364688|Alfacalcidol|alfacalcidol|mesh-list
65593238|NCT01364688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65593239|NCT01364688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65593240|NCT01364688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593241|NCT01364688|Vitamins|vitamins|mesh-ancestor
65593242|NCT01364688|Micronutrients|micronutrients|mesh-ancestor
65593243|NCT01370148|Conivaptan|conivaptan|mesh-list
65593244|NCT01370148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65593245|NCT01370148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593246|NCT01370148|Natriuretic Agents|natriuretic agents|mesh-ancestor
65593247|NCT01370148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593248|NCT04684953|Hormones|hormones|mesh-list
65593249|NCT04684953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65593250|NCT04684953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593251|NCT01349127|Calcium, Dietary|calcium, dietary|mesh-list
65593252|NCT01349127|Vitamin D|vitamin d|mesh-list
65593253|NCT01349127|Ergocalciferols|ergocalciferols|mesh-list
65593254|NCT01349127|Cholecalciferol|cholecalciferol|mesh-list
65593255|NCT01349127|Vitamins|vitamins|mesh-list
65593256|NCT01349127|Calcium|calcium|mesh-list
65593257|NCT01349127|Micronutrients|micronutrients|mesh-ancestor
65593258|NCT01349127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593259|NCT01349127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65593260|NCT01349127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65593261|NCT03486964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65593262|NCT03486964|Protease Inhibitors|protease inhibitors|mesh-ancestor
65593263|NCT03486964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593264|NCT03486964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593265|NCT03486964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65593266|NCT03486964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593267|NCT01349205|Sodium Benzoate|sodium benzoate|mesh-list
65593268|NCT01349205|Caffeine, sodium benzoate drug combination|caffeine, sodium benzoate drug combination|mesh-list
65593269|NCT01349205|Caffeine|caffeine|mesh-list
65593270|NCT01349205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65593271|NCT01349205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593272|NCT01349205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65593273|NCT01349205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593274|NCT01349205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593275|NCT01349205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65593276|NCT01349205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65593277|NCT01349205|Purinergic Agents|purinergic agents|mesh-ancestor
65593278|NCT01349205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65593279|NCT01349205|Antifungal Agents|antifungal agents|mesh-ancestor
65593280|NCT01349205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65593281|NCT01349205|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65593282|NCT01349205|Protective Agents|protective agents|mesh-ancestor
65593283|NCT01349205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65593284|NCT01349205|Analgesics|analgesics|mesh-ancestor
65593285|NCT01349205|Sensory System Agents|sensory system agents|mesh-ancestor
65593286|NCT01349205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593287|NCT01370304|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65593288|NCT01370304|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65593289|NCT01370304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65593290|NCT01370304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65593291|NCT01370304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593292|NCT01370304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65593293|NCT01370304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593294|NCT01370304|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65593295|NCT01370304|Antidepressive Agents|antidepressive agents|mesh-ancestor
65593296|NCT01370304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65593297|NCT03982485|Paclitaxel|paclitaxel|mesh-list
65593298|NCT03982485|Apatinib|apatinib|mesh-list
65593299|NCT03982485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65593300|NCT03982485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593301|NCT03982485|Tubulin Modulators|tubulin modulators|mesh-ancestor
65593302|NCT03982485|Antimitotic Agents|antimitotic agents|mesh-ancestor
65593303|NCT03982485|Mitosis Modulators|mitosis modulators|mesh-ancestor
65593304|NCT03982485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593305|NCT03982485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65593306|NCT03982485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593307|NCT03966339|Hormones|hormones|mesh-list
65593308|NCT03966339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65593309|NCT03966339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593310|NCT03251872|Olaparib|olaparib|mesh-list
65593311|NCT03251872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65593312|NCT03251872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593313|NCT03251872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593314|NCT03251872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593315|NCT03160521|Risperidone|risperidone|mesh-list
65593316|NCT03160521|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65593317|NCT03160521|Serotonin Agents|serotonin agents|mesh-ancestor
65593318|NCT03160521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65593319|NCT03160521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593320|NCT03160521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593321|NCT03160521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65593322|NCT03160521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65593323|NCT03160521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65593324|NCT03160521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65593325|NCT03160521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65593326|NCT03160521|Dopamine Agents|dopamine agents|mesh-ancestor
65593327|NCT01365000|Naloxegol|naloxegol|mesh-list
65593328|NCT01365000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65593329|NCT01365000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593330|NCT01365000|Sensory System Agents|sensory system agents|mesh-ancestor
65593331|NCT01365000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593333|NCT03147040|Atezolizumab|atezolizumab|mesh-list
65593334|NCT03147040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593335|NCT03251170|Fentanyl|fentanyl|mesh-list
65593336|NCT03251170|Midazolam|midazolam|mesh-list
65593337|NCT03251170|Ketamine|ketamine|mesh-list
65593338|NCT03251170|Analgesics|analgesics|mesh-ancestor
65593339|NCT03251170|Sensory System Agents|sensory system agents|mesh-ancestor
65593340|NCT03251170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593341|NCT03251170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593342|NCT03251170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65593343|NCT03251170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65593344|NCT03251170|Anesthetics, General|anesthetics, general|mesh-ancestor
65593345|NCT03251170|Anesthetics|anesthetics|mesh-ancestor
65593346|NCT03251170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65593347|NCT03251170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65593348|NCT03251170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65593349|NCT03251170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65593350|NCT03251170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593351|NCT03251170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65593352|NCT03251170|Narcotics|narcotics|mesh-ancestor
65593353|NCT03251170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65593354|NCT03251170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65593355|NCT03251170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65593356|NCT03251170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65593357|NCT03251170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65593358|NCT03251170|GABA Modulators|gaba modulators|mesh-ancestor
65593359|NCT03251170|GABA Agents|gaba agents|mesh-ancestor
65593360|NCT03539601|Hydrocortisone|hydrocortisone|mesh-list
65593361|NCT03539601|Pimecrolimus|pimecrolimus|mesh-list
65593362|NCT03539601|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
65593363|NCT03539601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65593364|NCT03539601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65593365|NCT03539601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65593366|NCT03539601|Analgesics|analgesics|mesh-ancestor
65593367|NCT03539601|Sensory System Agents|sensory system agents|mesh-ancestor
65593368|NCT03539601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593369|NCT03539601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593370|NCT03539601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65593371|NCT03539601|Dermatologic Agents|dermatologic agents|mesh-ancestor
65593372|NCT03539601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65593373|NCT03539601|Immunologic Factors|immunologic factors|mesh-ancestor
65593374|NCT03539601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65593375|NCT03539601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593376|NCT03539601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593377|NCT02455180|Ascorbic Acid|ascorbic acid|mesh-list
65593378|NCT02455180|Vitamins|vitamins|mesh-ancestor
65593379|NCT02455180|Micronutrients|micronutrients|mesh-ancestor
65593380|NCT02455180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593381|NCT02455180|Antioxidants|antioxidants|mesh-ancestor
65593382|NCT02455180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593383|NCT02455180|Protective Agents|protective agents|mesh-ancestor
65593384|NCT03514719|Avelumab|avelumab|mesh-list
65593385|NCT03514719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65593386|NCT03514719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65593387|NCT03514719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593388|NCT03514719|Immunologic Factors|immunologic factors|mesh-ancestor
65593389|NCT03514719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593390|NCT01349439|Propranolol|propranolol|mesh-list
65593391|NCT01349439|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65593392|NCT01349439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65593393|NCT01349439|Adrenergic Agents|adrenergic agents|mesh-ancestor
65593394|NCT01349439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65593395|NCT01349439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593396|NCT01349439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593397|NCT01349439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65593398|NCT01349439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65593399|NCT01349439|Vasodilator Agents|vasodilator agents|mesh-ancestor
65593400|NCT03245554|Propranolol|propranolol|mesh-list
65593401|NCT03245554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65593402|NCT03245554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65593403|NCT03245554|Adrenergic Agents|adrenergic agents|mesh-ancestor
65593404|NCT03245554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65390842|NCT00715871|Nicotine|nicotine|mesh-list
65593405|NCT03245554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593406|NCT03245554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593407|NCT03245554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65593408|NCT03245554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65593409|NCT03245554|Vasodilator Agents|vasodilator agents|mesh-ancestor
65593410|NCT01346007|Vaccines|vaccines|mesh-list
65593411|NCT01346007|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65593412|NCT01346007|Immunologic Factors|immunologic factors|mesh-ancestor
65593413|NCT01346007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593414|NCT01349751|Levobupivacaine|levobupivacaine|mesh-list
65593415|NCT01349751|Anesthetics, Local|anesthetics, local|mesh-ancestor
65593416|NCT01349751|Anesthetics|anesthetics|mesh-ancestor
65593417|NCT01349751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65593418|NCT01349751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593419|NCT01349751|Sensory System Agents|sensory system agents|mesh-ancestor
65593420|NCT01349751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593421|NCT03004131|Fluticasone|fluticasone|mesh-list
65593422|NCT03004131|Xhance|xhance|mesh-list
65593423|NCT03004131|Loratadine|loratadine|mesh-list
65593424|NCT03004131|Azelastine|azelastine|mesh-list
65593425|NCT03004131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65593426|NCT03004131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65593427|NCT03004131|Autonomic Agents|autonomic agents|mesh-ancestor
65593428|NCT03004131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593429|NCT03004131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593430|NCT03004131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65593431|NCT03004131|Respiratory System Agents|respiratory system agents|mesh-ancestor
65593432|NCT03004131|Dermatologic Agents|dermatologic agents|mesh-ancestor
65593433|NCT03004131|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65593434|NCT03004131|Antipruritics|antipruritics|mesh-ancestor
65593435|NCT03004131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65593436|NCT03004131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65593437|NCT03004131|Histamine Antagonists|histamine antagonists|mesh-ancestor
65593438|NCT03004131|Histamine Agents|histamine agents|mesh-ancestor
65593439|NCT03004131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65593440|NCT03004131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593441|NCT03004131|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65593442|NCT03004131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593443|NCT01350063|Troclosene|troclosene|mesh-list
65593444|NCT01350063|Antifungal Agents|antifungal agents|mesh-ancestor
65593445|NCT01350063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65593446|NCT01350063|Antiviral Agents|antiviral agents|mesh-ancestor
65593447|NCT01350063|Disinfectants|disinfectants|mesh-ancestor
65593448|NCT03421041|Dexamethasone|dexamethasone|mesh-list
65593449|NCT03421041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65593450|NCT03421041|Antiemetics|antiemetics|mesh-ancestor
65593451|NCT03421041|Autonomic Agents|autonomic agents|mesh-ancestor
65593452|NCT03421041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593453|NCT03421041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593454|NCT03421041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65593455|NCT03421041|Glucocorticoids|glucocorticoids|mesh-ancestor
65593456|NCT03421041|Hormones|hormones|mesh-ancestor
65593457|NCT03421041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65593458|NCT03421041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65593459|NCT03421041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593460|NCT03244774|Paclitaxel|paclitaxel|mesh-list
65593461|NCT03244774|Fluorouracil|fluorouracil|mesh-list
65593462|NCT03244774|Oxaliplatin|oxaliplatin|mesh-list
65593463|NCT03244774|Apatinib|apatinib|mesh-list
65593464|NCT03244774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65593465|NCT03244774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593466|NCT03244774|Tubulin Modulators|tubulin modulators|mesh-ancestor
65593467|NCT03244774|Antimitotic Agents|antimitotic agents|mesh-ancestor
65593468|NCT03244774|Mitosis Modulators|mitosis modulators|mesh-ancestor
65248399|NCT02832726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593469|NCT03244774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593470|NCT03244774|Antimetabolites|antimetabolites|mesh-ancestor
65593471|NCT03244774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65593472|NCT03244774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65593473|NCT03244774|Immunologic Factors|immunologic factors|mesh-ancestor
65593474|NCT03244774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593475|NCT03244774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65593476|NCT03244774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593477|NCT02903823|Baclofen|baclofen|mesh-list
65593478|NCT02903823|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65593479|NCT02903823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593480|NCT02903823|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65593481|NCT02903823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593482|NCT02903823|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65593483|NCT02903823|GABA Agonists|gaba agonists|mesh-ancestor
65593484|NCT02903823|GABA Agents|gaba agents|mesh-ancestor
65593485|NCT02903823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65593486|NCT02903823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593487|NCT03244930|Plerixafor|plerixafor|mesh-list
65593488|NCT03244930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65593489|NCT03244930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65593490|NCT03244930|Antiviral Agents|antiviral agents|mesh-ancestor
65593491|NCT03244930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65593492|NCT02855697|Olaparib|olaparib|mesh-list
65593493|NCT02855697|Cediranib|cediranib|mesh-list
65593494|NCT02855697|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65593495|NCT02855697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593496|NCT02855697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593497|NCT02855697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593498|NCT02855697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65593499|NCT03894501|Methadone|methadone|mesh-list
65593500|NCT03894501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65593501|NCT03894501|Narcotics|narcotics|mesh-ancestor
65593502|NCT03894501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65593503|NCT03894501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593504|NCT03894501|Analgesics|analgesics|mesh-ancestor
65593505|NCT03894501|Sensory System Agents|sensory system agents|mesh-ancestor
65593506|NCT03894501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593507|NCT03894501|Antitussive Agents|antitussive agents|mesh-ancestor
65593508|NCT03894501|Respiratory System Agents|respiratory system agents|mesh-ancestor
65593509|NCT01346865|Cilostazol|cilostazol|mesh-list
65593510|NCT01346865|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65593511|NCT01346865|Autonomic Agents|autonomic agents|mesh-ancestor
65593512|NCT01346865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593513|NCT01346865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593514|NCT01346865|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65593515|NCT01346865|Respiratory System Agents|respiratory system agents|mesh-ancestor
65593516|NCT01346865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65593517|NCT01346865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65593518|NCT01346865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593519|NCT01346865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65593520|NCT01346865|Vasodilator Agents|vasodilator agents|mesh-ancestor
65593521|NCT01346865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65593522|NCT01346865|Protective Agents|protective agents|mesh-ancestor
65593523|NCT01346865|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65593524|NCT01346865|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65593525|NCT01346865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593526|NCT03244462|Methotrexate|methotrexate|mesh-list
65593527|NCT03244462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65593528|NCT03244462|Abortifacient Agents|abortifacient agents|mesh-ancestor
65593529|NCT03244462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65593530|NCT03244462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593531|NCT03244462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65593532|NCT03244462|Antimetabolites|antimetabolites|mesh-ancestor
65593533|NCT03244462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593534|NCT03244462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593535|NCT03244462|Dermatologic Agents|dermatologic agents|mesh-ancestor
65593536|NCT03244462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593537|NCT03244462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65593538|NCT03244462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65593539|NCT03244462|Immunologic Factors|immunologic factors|mesh-ancestor
65593540|NCT03244462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65593541|NCT03244462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65593542|NCT01350609|Candesartan|candesartan|mesh-list
65593543|NCT01350609|Candesartan cilexetil|candesartan cilexetil|mesh-list
65593544|NCT01350609|Nifedipine|nifedipine|mesh-list
65593545|NCT01350609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65593546|NCT01350609|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65593547|NCT01350609|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65593548|NCT01350609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593549|NCT01350609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65593550|NCT01350609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65593551|NCT01350609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65593552|NCT01350609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593553|NCT01350609|Vasodilator Agents|vasodilator agents|mesh-ancestor
65593554|NCT01350609|Tocolytic Agents|tocolytic agents|mesh-ancestor
65593555|NCT01350609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65593556|NCT03244540|Acetaminophen|acetaminophen|mesh-list
65390987|NCT00721331|Loratadine|loratadine|mesh-list
65593558|NCT03244540|Ketoprofen|ketoprofen|mesh-list
65593559|NCT03244540|Bupivacaine|bupivacaine|mesh-list
65593560|NCT03244540|Ropivacaine|ropivacaine|mesh-list
65593561|NCT03244540|Anesthetics, Local|anesthetics, local|mesh-ancestor
65593562|NCT03244540|Anesthetics|anesthetics|mesh-ancestor
65593563|NCT03244540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65593564|NCT03244540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593565|NCT03244540|Sensory System Agents|sensory system agents|mesh-ancestor
65593566|NCT03244540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593567|NCT03244540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65593568|NCT03244540|Analgesics|analgesics|mesh-ancestor
65593569|NCT03244540|Antipyretics|antipyretics|mesh-ancestor
65593570|NCT03244540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65593571|NCT03244540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65593572|NCT03244540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65593573|NCT03244540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65593574|NCT03244540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593575|NCT03244540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593576|NCT03249298|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65593577|NCT03249298|Plasma Substitutes|plasma substitutes|mesh-ancestor
65593578|NCT03249298|Blood Substitutes|blood substitutes|mesh-ancestor
65593579|NCT03853317|Avelumab|avelumab|mesh-list
65593580|NCT03853317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65593581|NCT03853317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593582|NCT02454868|Remifentanil|remifentanil|mesh-list
65593583|NCT02454868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65593584|NCT02454868|Narcotics|narcotics|mesh-ancestor
65593585|NCT02454868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65593586|NCT02454868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593587|NCT02454868|Analgesics|analgesics|mesh-ancestor
65593588|NCT02454868|Sensory System Agents|sensory system agents|mesh-ancestor
65593589|NCT02454868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593590|NCT03753087|Empagliflozin|empagliflozin|mesh-list
65593591|NCT03753087|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65593592|NCT03753087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593593|NCT03753087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65593594|NCT03753087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593595|NCT02454712|Naltrexone|naltrexone|mesh-list
65593596|NCT02454712|Oxycodone|oxycodone|mesh-list
65593597|NCT02454712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65593598|NCT02454712|Narcotics|narcotics|mesh-ancestor
65593599|NCT02454712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65593600|NCT02454712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593601|NCT02454712|Analgesics|analgesics|mesh-ancestor
65593602|NCT02454712|Sensory System Agents|sensory system agents|mesh-ancestor
65593603|NCT02454712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593604|NCT02454712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65593605|NCT02454712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65593606|NCT00832455|Montelukast|montelukast|mesh-list
65593607|NCT00832455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65593608|NCT00832455|Respiratory System Agents|respiratory system agents|mesh-ancestor
65593609|NCT00832455|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65593610|NCT00832455|Hormone Antagonists|hormone antagonists|mesh-ancestor
65593611|NCT00832455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65593612|NCT00832455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593613|NCT00832455|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65593614|NCT00832455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65593615|NCT00832455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593616|NCT00687531|Mometasone Furoate|mometasone furoate|mesh-list
65593617|NCT00687531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65593618|NCT00687531|Dermatologic Agents|dermatologic agents|mesh-ancestor
65593619|NCT00687531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65593620|NCT04487392|Estrogens|estrogens|mesh-list
65593621|NCT04487392|Hormones|hormones|mesh-ancestor
65593622|NCT04487392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65593623|NCT04487392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593624|NCT01350921|Ticagrelor|ticagrelor|mesh-list
65593625|NCT01350921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65593626|NCT01350921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65593627|NCT01350921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65593628|NCT01350921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65593629|NCT01350921|Purinergic Agents|purinergic agents|mesh-ancestor
65593630|NCT01350921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65593631|NCT01350921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593632|NCT01350921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593633|NCT00423579|Simvastatin|simvastatin|mesh-list
65593634|NCT00423579|Ezetimibe|ezetimibe|mesh-list
65593635|NCT00423579|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
65593636|NCT00423579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65593637|NCT00423579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65593638|NCT00423579|Antimetabolites|antimetabolites|mesh-ancestor
65593639|NCT00423579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593640|NCT00423579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65593641|NCT00423579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65593642|NCT00423579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593643|NCT03243604|Hormones|hormones|mesh-list
65593644|NCT03243604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65593645|NCT03243604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593646|NCT04520685|Cannabidiol|cannabidiol|mesh-list
65593647|NCT04520685|Anticonvulsants|anticonvulsants|mesh-ancestor
65593648|NCT02454556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65593649|NCT02454556|Hormones|hormones|mesh-ancestor
65593650|NCT02454556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65593651|NCT02454556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593652|NCT01352559|Milnacipran|milnacipran|mesh-list
65593653|NCT01352559|Mirtazapine|mirtazapine|mesh-list
65593654|NCT01352559|Sertraline|sertraline|mesh-list
65593655|NCT01352559|Fluoxetine|fluoxetine|mesh-list
65593656|NCT01352559|Paroxetine|paroxetine|mesh-list
65593657|NCT01352559|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65593658|NCT01352559|Nortriptyline|nortriptyline|mesh-list
65593659|NCT01352559|Antidepressive Agents|antidepressive agents|mesh-ancestor
65593660|NCT01352559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65593661|NCT01352559|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65593662|NCT01352559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65593663|NCT01352559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65593664|NCT01352559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593665|NCT01352559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65593666|NCT01352559|Serotonin Agents|serotonin agents|mesh-ancestor
65593667|NCT01352559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593668|NCT01352559|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65593669|NCT01352559|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65593670|NCT01352559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65593671|NCT01352559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593672|NCT01352559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65593673|NCT01352559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65593674|NCT01352559|Histamine Antagonists|histamine antagonists|mesh-ancestor
65593675|NCT01352559|Histamine Agents|histamine agents|mesh-ancestor
65593676|NCT01352559|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65593677|NCT01352559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65593678|NCT01352559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65593679|NCT01352559|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65593680|NCT01352559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65593681|NCT01352559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65593682|NCT01352559|Adrenergic Agents|adrenergic agents|mesh-ancestor
65593683|NCT01352559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65593684|NCT01352559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65593685|NCT01352559|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65593686|NCT01352559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65593687|NCT01352559|Analgesics|analgesics|mesh-ancestor
65593688|NCT01352559|Sensory System Agents|sensory system agents|mesh-ancestor
65593689|NCT01352559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593690|NCT01352559|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65593691|NCT01352559|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65593692|NCT03247972|Evolocumab|evolocumab|mesh-list
65593693|NCT03247972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65593694|NCT03247972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65593695|NCT03247972|Antimetabolites|antimetabolites|mesh-ancestor
65593696|NCT03247972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593697|NCT03247972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65593698|NCT03269409|Coal Tar|coal tar|mesh-list
65593699|NCT03269409|Keratolytic Agents|keratolytic agents|mesh-ancestor
65593700|NCT03269409|Dermatologic Agents|dermatologic agents|mesh-ancestor
65593701|NCT03242278|Rivaroxaban|rivaroxaban|mesh-list
65593702|NCT03242278|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65593703|NCT03242278|Antithrombins|antithrombins|mesh-ancestor
65391136|NCT02539706|Rocuronium|rocuronium|mesh-list
65593704|NCT03242278|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65593706|NCT03242278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593707|NCT03242278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593708|NCT03242278|Anticoagulants|anticoagulants|mesh-ancestor
65593709|NCT03778372|Methadone|methadone|mesh-list
65593710|NCT03778372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65593711|NCT03778372|Narcotics|narcotics|mesh-ancestor
65593712|NCT03778372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65593713|NCT03778372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593714|NCT03778372|Analgesics|analgesics|mesh-ancestor
65593715|NCT03778372|Sensory System Agents|sensory system agents|mesh-ancestor
65593716|NCT03778372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593717|NCT03778372|Antitussive Agents|antitussive agents|mesh-ancestor
65593718|NCT03778372|Respiratory System Agents|respiratory system agents|mesh-ancestor
65593719|NCT03246880|Tadalafil|tadalafil|mesh-list
65593720|NCT03246880|Tamsulosin|tamsulosin|mesh-list
65593721|NCT03246880|Vasodilator Agents|vasodilator agents|mesh-ancestor
65593722|NCT03246880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65593723|NCT03246880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65593724|NCT03246880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593725|NCT03246880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593726|NCT03246880|Urological Agents|urological agents|mesh-ancestor
65593727|NCT03246880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65593728|NCT03246880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65593729|NCT03246880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65593730|NCT03246880|Adrenergic Agents|adrenergic agents|mesh-ancestor
65593731|NCT03246880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65593732|NCT03246880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593733|NCT03257722|Pembrolizumab|pembrolizumab|mesh-list
65593734|NCT03257722|Idelalisib|idelalisib|mesh-list
65593735|NCT03257722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65593736|NCT03257722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593737|NCT03257722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593738|NCT03257722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593739|NCT03268005|Insulin|insulin|mesh-list
65593740|NCT03268005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65593741|NCT03268005|Metformin|metformin|mesh-list
65593742|NCT03268005|Insulin Aspart|insulin aspart|mesh-list
65593743|NCT03268005|Insulin, Long-Acting|insulin, long-acting|mesh-list
65593744|NCT03268005|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65593745|NCT03268005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65593746|NCT03268005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593747|NCT03239314|Dexamethasone|dexamethasone|mesh-list
65593748|NCT03239314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65593749|NCT03239314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65593750|NCT03239314|Antiemetics|antiemetics|mesh-ancestor
65593751|NCT03239314|Autonomic Agents|autonomic agents|mesh-ancestor
65593752|NCT03239314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593753|NCT03239314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593754|NCT03239314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65593755|NCT03239314|Glucocorticoids|glucocorticoids|mesh-ancestor
65593756|NCT03239314|Hormones|hormones|mesh-ancestor
65593757|NCT03239314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65593758|NCT03239314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65593759|NCT03239314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593760|NCT03241888|Megestrol|megestrol|mesh-list
65593761|NCT03241888|Megestrol Acetate|megestrol acetate|mesh-list
65593762|NCT03241888|Levonorgestrel|levonorgestrel|mesh-list
65593763|NCT03241888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65593764|NCT03241888|Contraceptive Agents|contraceptive agents|mesh-ancestor
65593765|NCT03241888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65593766|NCT03241888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593767|NCT03241888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65593768|NCT03241888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65593769|NCT03241888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65593770|NCT03241888|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65593771|NCT03241888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65593772|NCT03241888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593773|NCT03241888|Appetite Stimulants|appetite stimulants|mesh-ancestor
65593774|NCT03241888|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65593775|NCT02454088|Calcium, Dietary|calcium, dietary|mesh-list
65593776|NCT02454088|Triamcinolone|triamcinolone|mesh-list
65593777|NCT02454088|Calcium|calcium|mesh-list
65593778|NCT02454088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65593779|NCT02454088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593780|NCT02454088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65593781|NCT02454088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65593782|NCT02454088|Glucocorticoids|glucocorticoids|mesh-ancestor
65593783|NCT02454088|Hormones|hormones|mesh-ancestor
65593784|NCT02454088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65593785|NCT02456116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65593786|NCT02456116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65593787|NCT02456116|Analgesics|analgesics|mesh-ancestor
65593788|NCT02456116|Sensory System Agents|sensory system agents|mesh-ancestor
65593789|NCT02456116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593790|NCT02456116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593791|NCT02456116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65593792|NCT02456116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65593793|NCT03239236|Anesthetics|anesthetics|mesh-list
65593794|NCT03239236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65593795|NCT03239236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593796|NCT03257800|Ketamine|ketamine|mesh-list
65593797|NCT03257800|Nitrous Oxide|nitrous oxide|mesh-list
65593798|NCT03257800|Sevoflurane|sevoflurane|mesh-list
65593799|NCT03257800|Analgesics|analgesics|mesh-ancestor
65593800|NCT03257800|Sensory System Agents|sensory system agents|mesh-ancestor
65593801|NCT03257800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593802|NCT03257800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593803|NCT03257800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65593804|NCT03257800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65593805|NCT03257800|Anesthetics, General|anesthetics, general|mesh-ancestor
65593806|NCT03257800|Anesthetics|anesthetics|mesh-ancestor
65593807|NCT03257800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65593808|NCT03257800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65593809|NCT03257800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65593810|NCT03257800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65593811|NCT03257800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593812|NCT03257800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65593813|NCT03257800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65593814|NCT03257800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65593815|NCT01353339|Levofloxacin|levofloxacin|mesh-list
65593816|NCT01353339|Ofloxacin|ofloxacin|mesh-list
65593817|NCT01353339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65593818|NCT01353339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65593819|NCT01353339|Renal Agents|renal agents|mesh-ancestor
65593820|NCT01353339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65593821|NCT01353339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65593822|NCT01353339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65593823|NCT01353339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593824|NCT01353339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593825|NCT01353339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593826|NCT01353339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65593827|NCT01353339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65593828|NCT03239080|Denosumab|denosumab|mesh-list
65593829|NCT03239080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65593830|NCT03239080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593831|NCT03149055|Isavuconazole|isavuconazole|mesh-list
65593832|NCT03149055|Antifungal Agents|antifungal agents|mesh-ancestor
65593833|NCT03149055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65593834|NCT01352091|Goserelin|goserelin|mesh-list
65593835|NCT01352091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65593836|NCT01352091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593837|NCT02954523|Dasatinib|dasatinib|mesh-list
65593838|NCT02954523|Osimertinib|osimertinib|mesh-list
65593839|NCT02954523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593840|NCT02954523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65593841|NCT02954523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593842|NCT02954523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593843|NCT04486612|Anesthetics|anesthetics|mesh-list
65593844|NCT04486612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65593845|NCT04486612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593846|NCT01353729|Moxifloxacin|moxifloxacin|mesh-list
65593847|NCT01353729|Zanamivir|zanamivir|mesh-list
65593848|NCT01353729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65593849|NCT01353729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65593850|NCT01353729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65593851|NCT01353729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65593852|NCT01353729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65593853|NCT01353729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593854|NCT01353729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593855|NCT01353729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593856|NCT01353729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65593857|NCT01353729|Contraceptive Agents|contraceptive agents|mesh-ancestor
65593858|NCT01353729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65593859|NCT01353729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593860|NCT01353729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65593861|NCT01353729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65593862|NCT01353729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65593863|NCT01353729|Antiviral Agents|antiviral agents|mesh-ancestor
65593864|NCT01357317|Calcium, Dietary|calcium, dietary|mesh-list
65593865|NCT01357317|Calcium|calcium|mesh-list
65593866|NCT01357317|Calcium acetate|calcium acetate|mesh-list
65593867|NCT01357317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65593868|NCT01357317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593869|NCT01357317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65593870|NCT01357317|Chelating Agents|chelating agents|mesh-ancestor
65593871|NCT01357317|Sequestering Agents|sequestering agents|mesh-ancestor
65593872|NCT01357317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593873|NCT03238612|Clarithromycin|clarithromycin|mesh-list
65593874|NCT03238612|Oseltamivir|oseltamivir|mesh-list
65593875|NCT03238612|Antiviral Agents|antiviral agents|mesh-list
65593876|NCT03238612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65593877|NCT03238612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65593878|NCT03238612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65593879|NCT03238612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593880|NCT03238612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593881|NCT03238612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65248400|NCT02832726|Vitamin B Complex|vitamin b complex|mesh-ancestor
65593882|NCT03238612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65593883|NCT03137121|Olanzapine|olanzapine|mesh-list
65593884|NCT03137121|Antiemetics|antiemetics|mesh-ancestor
65593885|NCT03137121|Autonomic Agents|autonomic agents|mesh-ancestor
65593886|NCT03137121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593887|NCT03137121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593888|NCT03137121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65593889|NCT03137121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65593890|NCT03137121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65593891|NCT03137121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65593892|NCT03137121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65593893|NCT03137121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65593894|NCT03137121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65593895|NCT03137121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65593896|NCT03137121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593897|NCT03137121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65593898|NCT03137121|Serotonin Agents|serotonin agents|mesh-ancestor
65593899|NCT02453776|Infliximab|infliximab|mesh-list
65593900|NCT02453776|Dermatologic Agents|dermatologic agents|mesh-ancestor
65593901|NCT02453776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65593902|NCT02453776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65593903|NCT03256864|Everolimus|everolimus|mesh-list
65593904|NCT03256864|Tacrolimus|tacrolimus|mesh-list
65593905|NCT03256864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65593906|NCT03256864|Immunologic Factors|immunologic factors|mesh-ancestor
65593907|NCT03256864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593908|NCT03256864|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65593909|NCT03256864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593910|NCT03256864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593911|NCT03256864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593912|NCT01317849|Vitamins|vitamins|mesh-list
65593913|NCT01317849|Folic Acid|folic acid|mesh-list
65593914|NCT01317849|Vitamin B 12|vitamin b 12|mesh-list
65593915|NCT01317849|Pyridoxine|pyridoxine|mesh-list
65593916|NCT01317849|Pyridoxal|pyridoxal|mesh-list
65593917|NCT01317849|Vitamin B 6|vitamin b 6|mesh-list
65593918|NCT01317849|Vitamin B Complex|vitamin b complex|mesh-list
65593919|NCT01317849|Micronutrients|micronutrients|mesh-ancestor
65593920|NCT01317849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593921|NCT01317849|Hematinics|hematinics|mesh-ancestor
65593922|NCT01317927|Belinostat|belinostat|mesh-list
65593923|NCT01317927|Warfarin|warfarin|mesh-list
65593924|NCT01317927|Anticoagulants|anticoagulants|mesh-ancestor
65593925|NCT01317927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593926|NCT01317927|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65593927|NCT01317927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593928|NCT01317927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593929|NCT04251585|Insulin|insulin|mesh-list
65593931|NCT04251585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593932|NCT04418427|Aflibercept|aflibercept|mesh-list
65593933|NCT04418427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65593934|NCT04418427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65593935|NCT04418427|Growth Substances|growth substances|mesh-ancestor
65593936|NCT04418427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593937|NCT04418427|Growth Inhibitors|growth inhibitors|mesh-ancestor
65593938|NCT04418427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593939|NCT02901483|Cisplatin|cisplatin|mesh-list
65593940|NCT02901483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593941|NCT02874651|Apatinib|apatinib|mesh-list
65593942|NCT02874651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593943|NCT02874651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65593944|NCT02874651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593945|NCT02874651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593946|NCT02453932|Donepezil|donepezil|mesh-list
65593947|NCT02453932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65593948|NCT02453932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593949|NCT02453932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593950|NCT02453932|Cholinergic Agents|cholinergic agents|mesh-ancestor
65593951|NCT02453932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65593952|NCT02453932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593953|NCT02453932|Nootropic Agents|nootropic agents|mesh-ancestor
65593954|NCT04385433|Pravastatin|pravastatin|mesh-list
65593955|NCT04385433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65593956|NCT04385433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65593957|NCT04385433|Antimetabolites|antimetabolites|mesh-ancestor
65593958|NCT04385433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593959|NCT04385433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65593960|NCT04385433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65593961|NCT04385433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65593962|NCT00700570|Bevacizumab|bevacizumab|mesh-list
65593963|NCT00700570|Capecitabine|capecitabine|mesh-list
65593964|NCT00700570|Oxaliplatin|oxaliplatin|mesh-list
65593965|NCT00700570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65593966|NCT00700570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65593967|NCT00700570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65593968|NCT00700570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65593969|NCT00700570|Growth Substances|growth substances|mesh-ancestor
65593970|NCT00700570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593971|NCT00700570|Growth Inhibitors|growth inhibitors|mesh-ancestor
65593972|NCT00700570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65593973|NCT00700570|Antimetabolites|antimetabolites|mesh-ancestor
65593974|NCT00700570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593975|NCT02453698|Methylphenidate|methylphenidate|mesh-list
65593976|NCT02453698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65593977|NCT02453698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593978|NCT02453698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65593979|NCT02453698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65593980|NCT02453698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65593981|NCT02453698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65593982|NCT02453698|Dopamine Agents|dopamine agents|mesh-ancestor
65593983|NCT02453698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65593984|NCT01354275|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65593985|NCT01354275|Hormones|hormones|mesh-ancestor
65593986|NCT01354275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65593987|NCT01354275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593988|NCT01318161|Morphine|morphine|mesh-list
65593989|NCT01318161|Ropivacaine|ropivacaine|mesh-list
65593990|NCT01318161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65593991|NCT01318161|Narcotics|narcotics|mesh-ancestor
65593992|NCT01318161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65593993|NCT01318161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65593994|NCT01318161|Analgesics|analgesics|mesh-ancestor
65593995|NCT01318161|Sensory System Agents|sensory system agents|mesh-ancestor
65593996|NCT01318161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65593997|NCT01318161|Anesthetics, Local|anesthetics, local|mesh-ancestor
65593998|NCT01318161|Anesthetics|anesthetics|mesh-ancestor
65593999|NCT03255226|Tolvaptan|tolvaptan|mesh-list
65594000|NCT03255226|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65594001|NCT03255226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594002|NCT03255226|Natriuretic Agents|natriuretic agents|mesh-ancestor
65594003|NCT03255226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594004|NCT02455726|Pregabalin|pregabalin|mesh-list
65594005|NCT02455726|Oxycodone|oxycodone|mesh-list
65594006|NCT02455726|Magnesium Oxide|magnesium oxide|mesh-list
65594007|NCT02455726|Analgesics|analgesics|mesh-ancestor
65594008|NCT02455726|Sensory System Agents|sensory system agents|mesh-ancestor
65594009|NCT02455726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65594010|NCT02455726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594011|NCT02455726|Anticonvulsants|anticonvulsants|mesh-ancestor
65594012|NCT02455726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65594013|NCT02455726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65594014|NCT02455726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594015|NCT02455726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65594016|NCT02455726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65594017|NCT02455726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65594018|NCT02455726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65594019|NCT02455726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65594020|NCT02455726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65594021|NCT02455726|Narcotics|narcotics|mesh-ancestor
65594022|NCT02455726|Antacids|antacids|mesh-ancestor
65594023|NCT02455726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65594024|NCT04488172|Vitamins|vitamins|mesh-list
65594025|NCT04488172|Micronutrients|micronutrients|mesh-ancestor
65594026|NCT04488172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594027|NCT03239860|Antibodies|antibodies|mesh-list
65594028|NCT03239860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65594029|NCT03239860|Immunologic Factors|immunologic factors|mesh-ancestor
65594030|NCT03239860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594031|NCT04486690|Ketamine|ketamine|mesh-list
65594032|NCT04486690|Propofol|propofol|mesh-list
65594033|NCT04486690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65594034|NCT04486690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65594035|NCT04486690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594036|NCT04486690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65594037|NCT04486690|Anesthetics, General|anesthetics, general|mesh-ancestor
65594038|NCT04486690|Anesthetics|anesthetics|mesh-ancestor
65594039|NCT04486690|Analgesics|analgesics|mesh-ancestor
65594040|NCT04486690|Sensory System Agents|sensory system agents|mesh-ancestor
65594041|NCT04486690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65594042|NCT04486690|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65594043|NCT04486690|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65594044|NCT04486690|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65594045|NCT04486690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65594046|NCT04486690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594047|NCT03255148|Oxytocin|oxytocin|mesh-list
65594048|NCT03255148|Oxytocics|oxytocics|mesh-ancestor
65594049|NCT03255148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65594050|NCT03255148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594051|NCT04427501|Bamlanivimab|bamlanivimab|mesh-list
65594052|NCT04427501|Antiviral Agents|antiviral agents|mesh-ancestor
65594053|NCT04427501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594054|NCT03236818|Bosentan|bosentan|mesh-list
65594055|NCT03236818|Sildenafil Citrate|sildenafil citrate|mesh-list
65594056|NCT03236818|Tadalafil|tadalafil|mesh-list
65594057|NCT03236818|Macitentan|macitentan|mesh-list
65594058|NCT03236818|Vasodilator Agents|vasodilator agents|mesh-ancestor
65594059|NCT03236818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65594060|NCT03236818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65594061|NCT03236818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594062|NCT03236818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594063|NCT03236818|Urological Agents|urological agents|mesh-ancestor
65594064|NCT03236818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65594065|NCT03236818|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65594066|NCT03236818|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65594067|NCT03236818|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65594068|NCT03236974|Fulvestrant|fulvestrant|mesh-list
65594069|NCT03236974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65594070|NCT03236974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594071|NCT03236974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65594072|NCT03236974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65594073|NCT03236974|Hormone Antagonists|hormone antagonists|mesh-ancestor
65594074|NCT03236974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65594075|NCT03236974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594076|NCT03748043|Lactoferrin|lactoferrin|mesh-list
65594077|NCT03748043|Teferrol|teferrol|mesh-list
65594078|NCT03748043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594079|NCT03748043|Hematinics|hematinics|mesh-ancestor
65594080|NCT03750773|Gabapentin|gabapentin|mesh-list
65594081|NCT03750773|Analgesics|analgesics|mesh-ancestor
65594082|NCT03750773|Sensory System Agents|sensory system agents|mesh-ancestor
65594083|NCT03750773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65594084|NCT03750773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594085|NCT03750773|Anticonvulsants|anticonvulsants|mesh-ancestor
65594086|NCT03750773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65594087|NCT03750773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65594088|NCT03750773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65594089|NCT03750773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65594090|NCT03750773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65594091|NCT03750773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65594092|NCT03750773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65594093|NCT03750773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594094|NCT03750773|Antimanic Agents|antimanic agents|mesh-ancestor
65594095|NCT02874924|Sirolimus|sirolimus|mesh-list
65594096|NCT02874924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65594097|NCT02874924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594098|NCT02874924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65594099|NCT02874924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594100|NCT02874924|Antifungal Agents|antifungal agents|mesh-ancestor
65594101|NCT02874924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65594102|NCT02874924|Immunologic Factors|immunologic factors|mesh-ancestor
65594103|NCT02874924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594104|NCT04425863|Aspirin|aspirin|mesh-list
65594105|NCT04425863|Ivermectin|ivermectin|mesh-list
65594106|NCT04425863|Dexamethasone|dexamethasone|mesh-list
65594107|NCT04425863|Dexamethasone acetate|dexamethasone acetate|mesh-list
65594108|NCT04425863|Enoxaparin|enoxaparin|mesh-list
65594109|NCT04425863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65594110|NCT04425863|BB 1101|bb 1101|mesh-list
65594111|NCT04425863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65594112|NCT04425863|Antiemetics|antiemetics|mesh-ancestor
65594113|NCT04425863|Autonomic Agents|autonomic agents|mesh-ancestor
65594114|NCT04425863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65594115|NCT04425863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594116|NCT04425863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65594117|NCT04425863|Glucocorticoids|glucocorticoids|mesh-ancestor
65594118|NCT04425863|Hormones|hormones|mesh-ancestor
65594119|NCT04425863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65594120|NCT04425863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65594121|NCT04425863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594122|NCT04425863|Protease Inhibitors|protease inhibitors|mesh-ancestor
65594123|NCT04425863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594124|NCT04425863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594125|NCT04425863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65594126|NCT04425863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65594127|NCT04425863|Analgesics|analgesics|mesh-ancestor
65594128|NCT04425863|Sensory System Agents|sensory system agents|mesh-ancestor
65594129|NCT04425863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65594130|NCT04425863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65594131|NCT04425863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65594132|NCT04425863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65594133|NCT04425863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65594134|NCT04425863|Antipyretics|antipyretics|mesh-ancestor
65594135|NCT04425863|Anticoagulants|anticoagulants|mesh-ancestor
65594136|NCT04425863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65594137|NCT04425863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594138|NCT01370772|Cyclophosphamide|cyclophosphamide|mesh-list
65594139|NCT01370772|Rituximab|rituximab|mesh-list
65594140|NCT01370772|Fludarabine|fludarabine|mesh-list
65594141|NCT01370772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65594142|NCT01370772|Immunologic Factors|immunologic factors|mesh-ancestor
65594143|NCT01370772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594144|NCT01370772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65594145|NCT01370772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65594146|NCT01370772|Alkylating Agents|alkylating agents|mesh-ancestor
65594147|NCT01370772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594148|NCT01370772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594149|NCT01370772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65594150|NCT01370772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65594151|NCT01842282|Amlexanox|amlexanox|mesh-list
65594152|NCT01842282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65594153|NCT03234244|Cholecalciferol|cholecalciferol|mesh-list
65594154|NCT03234244|Vitamin D|vitamin d|mesh-list
65594155|NCT03234244|Bazedoxifene|bazedoxifene|mesh-list
65594156|NCT03234244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65594157|NCT03234244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594158|NCT03234244|Vitamins|vitamins|mesh-ancestor
65594159|NCT03234244|Micronutrients|micronutrients|mesh-ancestor
65594160|NCT03234244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65594161|NCT03234244|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65594162|NCT03234244|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65594163|NCT03234244|Hormone Antagonists|hormone antagonists|mesh-ancestor
65594164|NCT03234244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65594165|NCT03234400|Dapivirine|dapivirine|mesh-list
65594166|NCT03234400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65594167|NCT03234400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65594168|NCT03234400|Antiviral Agents|antiviral agents|mesh-ancestor
65594169|NCT03234400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594170|NCT03254368|ZGN-1061|zgn-1061|mesh-list
65594171|NCT03254368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594172|NCT03254368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594173|NCT03254368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65594174|NCT03236740|Metformin|metformin|mesh-list
65594175|NCT03236740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65594176|NCT03236740|Estradiol|estradiol|mesh-list
65594177|NCT03236740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65594178|NCT03236740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594179|NCT03236740|Estrogens|estrogens|mesh-ancestor
65594180|NCT03236740|Hormones|hormones|mesh-ancestor
65594181|NCT03236740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65594182|NCT03236740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65594183|NCT03236740|Contraceptive Agents|contraceptive agents|mesh-ancestor
65594184|NCT03236740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65594185|NCT03236740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65594186|NCT03236740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65594187|NCT03236740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65594188|NCT02453464|Leucovorin|leucovorin|mesh-list
65594189|NCT02453464|Irinotecan|irinotecan|mesh-list
65594190|NCT02453464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65594191|NCT02453464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65594192|NCT02453464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594193|NCT02453464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594194|NCT02453464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594195|NCT02453464|Antidotes|antidotes|mesh-ancestor
65594196|NCT02453464|Protective Agents|protective agents|mesh-ancestor
65594197|NCT02453464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594198|NCT02453464|Vitamin B Complex|vitamin b complex|mesh-ancestor
65594199|NCT02453464|Vitamins|vitamins|mesh-ancestor
65594200|NCT02453464|Micronutrients|micronutrients|mesh-ancestor
65594201|NCT03233932|Leuprolide|leuprolide|mesh-list
65594202|NCT03233932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65594203|NCT03233932|Fertility Agents|fertility agents|mesh-ancestor
65594204|NCT03233932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65594205|NCT03233932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594206|NCT03233932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65594207|NCT03233932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594208|NCT03236584|Tenofovir|tenofovir|mesh-list
65594209|NCT03236584|Lamivudine|lamivudine|mesh-list
65594210|NCT03236584|Adefovir|adefovir|mesh-list
65594211|NCT03236584|Antiviral Agents|antiviral agents|mesh-ancestor
65594212|NCT03236584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594213|NCT03236584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65594214|NCT03236584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65594215|NCT03236584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594216|NCT03236584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594217|NCT03236584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65594218|NCT03236584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65594219|NCT01164228|Gemcitabine|gemcitabine|mesh-list
65594220|NCT01164228|Sunitinib|sunitinib|mesh-list
65594221|NCT01164228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65594222|NCT01164228|Antimetabolites|antimetabolites|mesh-ancestor
65594223|NCT01164228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594224|NCT01164228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594225|NCT01164228|Antiviral Agents|antiviral agents|mesh-ancestor
65594226|NCT01164228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594227|NCT01164228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594228|NCT01164228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65594229|NCT01164228|Immunologic Factors|immunologic factors|mesh-ancestor
65594230|NCT01164228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594231|NCT01164228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65594232|NCT01164228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65594233|NCT01164228|Growth Substances|growth substances|mesh-ancestor
65594234|NCT01164228|Growth Inhibitors|growth inhibitors|mesh-ancestor
65594235|NCT01164228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65594236|NCT03233776|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65594237|NCT03233776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65594238|NCT04614168|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65594239|NCT04614168|Glycerol|glycerol|mesh-list
65594240|NCT04614168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594241|NCT04614168|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65594242|NCT04614168|Protective Agents|protective agents|mesh-ancestor
65594243|NCT01365312|Ethanol|ethanol|mesh-list
65594244|NCT01365312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65594245|NCT01365312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594246|NCT01365312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65594247|NCT01365312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594248|NCT04495283|Acetaminophen|acetaminophen|mesh-list
65594249|NCT04495283|Pregabalin|pregabalin|mesh-list
65594250|NCT04495283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65594251|NCT04495283|Analgesics|analgesics|mesh-ancestor
65594252|NCT04495283|Sensory System Agents|sensory system agents|mesh-ancestor
65594253|NCT04495283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65594254|NCT04495283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594255|NCT04495283|Antipyretics|antipyretics|mesh-ancestor
65594256|NCT04495283|Anticonvulsants|anticonvulsants|mesh-ancestor
65594257|NCT04495283|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65594258|NCT04495283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65594259|NCT04495283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594260|NCT04495283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65594261|NCT04495283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65594262|NCT04495283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65594263|NCT04495283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65594264|NCT04495283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65594265|NCT03634020|Sirolimus|sirolimus|mesh-list
65594266|NCT03634020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65594267|NCT03634020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594268|NCT03634020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65594269|NCT03634020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594270|NCT03634020|Antifungal Agents|antifungal agents|mesh-ancestor
65594271|NCT03634020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65594272|NCT03634020|Immunologic Factors|immunologic factors|mesh-ancestor
65594273|NCT03634020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594274|NCT03253276|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
65594275|NCT03253276|Cathartics|cathartics|mesh-ancestor
65594276|NCT03253276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65594277|NCT01372644|Pasireotide|pasireotide|mesh-list
65594278|NCT01372644|Hormones|hormones|mesh-ancestor
65594279|NCT01372644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65594280|NCT01372644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594281|NCT03253198|Bupivacaine|bupivacaine|mesh-list
65594282|NCT03253198|Anesthetics, Local|anesthetics, local|mesh-ancestor
65594283|NCT03253198|Anesthetics|anesthetics|mesh-ancestor
65594284|NCT03253198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65594285|NCT03253198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594286|NCT03253198|Sensory System Agents|sensory system agents|mesh-ancestor
65594287|NCT03253198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65594288|NCT04285086|Anagrelide|anagrelide|mesh-list
65594289|NCT04285086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65594290|NCT04285086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65594291|NCT04285086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594292|NCT04285086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65594293|NCT04485988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65594294|NCT04485988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65594295|NCT04485988|Adrenergic Agents|adrenergic agents|mesh-ancestor
65594296|NCT04485988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65594297|NCT04485988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594298|NCT04485988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594299|NCT04234464|Budesonide|budesonide|mesh-list
65594300|NCT04234464|Albuterol|albuterol|mesh-list
65594301|NCT04234464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65594302|NCT04234464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65594303|NCT04234464|Autonomic Agents|autonomic agents|mesh-ancestor
65594304|NCT04234464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65594305|NCT04234464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594306|NCT04234464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65594307|NCT04234464|Respiratory System Agents|respiratory system agents|mesh-ancestor
65391745|NCT02539316|SMOFlipid|smoflipid|mesh-list
65594309|NCT04234464|Hormones|hormones|mesh-ancestor
65594310|NCT04234464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65594311|NCT04234464|Tocolytic Agents|tocolytic agents|mesh-ancestor
65594312|NCT04234464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65594313|NCT04234464|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65594314|NCT04234464|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65594315|NCT04234464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65594316|NCT04234464|Adrenergic Agents|adrenergic agents|mesh-ancestor
65594317|NCT04234464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65594318|NCT04234464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594319|NCT03233152|Nivolumab|nivolumab|mesh-list
65594320|NCT03233152|Ipilimumab|ipilimumab|mesh-list
65594321|NCT03233152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65594322|NCT03233152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65594323|NCT03233152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594324|NCT03233152|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65594325|NCT03233152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594326|NCT03229096|Apatinib|apatinib|mesh-list
65594327|NCT03229096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594328|NCT03229096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65594329|NCT03229096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594330|NCT03229096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594331|NCT03123588|Anagrelide|anagrelide|mesh-list
65594332|NCT03123588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65594333|NCT03123588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65594334|NCT03123588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594335|NCT03123588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65594336|NCT02452918|Oritavancin|oritavancin|mesh-list
65594337|NCT02452918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65594338|NCT02452918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594339|NCT02821026|Mycophenolic Acid|mycophenolic acid|mesh-list
65594340|NCT02821026|Sirolimus|sirolimus|mesh-list
65594341|NCT02821026|Etanercept|etanercept|mesh-list
65594342|NCT02821026|Tacrolimus|tacrolimus|mesh-list
65594343|NCT02821026|Thymoglobulin|thymoglobulin|mesh-list
65594344|NCT02821026|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65594345|NCT02821026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65594346|NCT02821026|Immunologic Factors|immunologic factors|mesh-ancestor
65594347|NCT02821026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594348|NCT02821026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65594349|NCT02821026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594350|NCT02821026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594351|NCT02821026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65594352|NCT02821026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594353|NCT02821026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65594354|NCT02821026|Antitubercular Agents|antitubercular agents|mesh-ancestor
65594355|NCT02821026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65594356|NCT02821026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594357|NCT02821026|Antifungal Agents|antifungal agents|mesh-ancestor
65594358|NCT02821026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65594359|NCT02821026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65594360|NCT02821026|Analgesics|analgesics|mesh-ancestor
65594361|NCT02821026|Sensory System Agents|sensory system agents|mesh-ancestor
65594362|NCT02821026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65594363|NCT02821026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65594364|NCT02821026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65594365|NCT02821026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65594366|NCT03228628|Nitrous Oxide|nitrous oxide|mesh-list
65594367|NCT03228628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65594368|NCT03228628|Anesthetics, General|anesthetics, general|mesh-ancestor
65594369|NCT03228628|Anesthetics|anesthetics|mesh-ancestor
65594370|NCT03228628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65594371|NCT03228628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594372|NCT03228628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65594373|NCT03228628|Analgesics|analgesics|mesh-ancestor
65594374|NCT03228628|Sensory System Agents|sensory system agents|mesh-ancestor
65594375|NCT03228628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65594376|NCT03232450|Aspirin|aspirin|mesh-list
65594377|NCT03232450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65594378|NCT03232450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65594379|NCT03232450|Analgesics|analgesics|mesh-ancestor
65594380|NCT03232450|Sensory System Agents|sensory system agents|mesh-ancestor
65594381|NCT03232450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391820|NCT00114127|Analgesics|analgesics|mesh-ancestor
65594382|NCT03232450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594383|NCT03232450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65594384|NCT03232450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65594385|NCT03232450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65594386|NCT03232450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65594387|NCT03232450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594388|NCT03232450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65594389|NCT03232450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65594390|NCT03232450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594391|NCT03232450|Antipyretics|antipyretics|mesh-ancestor
65594392|NCT04411667|gamma-Globulins|gamma-globulins|mesh-list
65594393|NCT04411667|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65594394|NCT04411667|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65594395|NCT04411667|Immunologic Factors|immunologic factors|mesh-ancestor
65594396|NCT04411667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594397|NCT05359211|Cyclophosphamide|cyclophosphamide|mesh-list
65594398|NCT05359211|Fludarabine|fludarabine|mesh-list
65594399|NCT05359211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65594400|NCT05359211|Immunologic Factors|immunologic factors|mesh-ancestor
65594401|NCT05359211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594402|NCT05359211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65594403|NCT05359211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65594404|NCT05359211|Alkylating Agents|alkylating agents|mesh-ancestor
65594405|NCT05359211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594406|NCT05359211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594407|NCT05359211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65594408|NCT04948697|Bevacizumab|bevacizumab|mesh-list
65594409|NCT04948697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65594410|NCT04948697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594411|NCT04948697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65594412|NCT04948697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65594413|NCT04948697|Growth Substances|growth substances|mesh-ancestor
65594414|NCT04948697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594415|NCT04948697|Growth Inhibitors|growth inhibitors|mesh-ancestor
65594416|NCT04358549|Favipiravir|favipiravir|mesh-list
65594417|NCT04358549|Antiviral Agents|antiviral agents|mesh-ancestor
65594418|NCT04358549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594419|NCT01562483|Dronabinol|dronabinol|mesh-list
65594420|NCT01562483|Hallucinogens|hallucinogens|mesh-ancestor
65594421|NCT01562483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594422|NCT01562483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65594423|NCT01562483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65594424|NCT01562483|Analgesics|analgesics|mesh-ancestor
65594425|NCT01562483|Sensory System Agents|sensory system agents|mesh-ancestor
65594426|NCT01562483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65594427|NCT01562483|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65594428|NCT01562483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65594429|NCT01562483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65594430|NCT01562483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594431|NCT01562483|Hormones|hormones|mesh-ancestor
65594432|NCT01562483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65594433|NCT00700180|Bevacizumab|bevacizumab|mesh-list
65594434|NCT00700180|Carboplatin|carboplatin|mesh-list
65594435|NCT00700180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65594436|NCT00700180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594437|NCT00700180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65594438|NCT00700180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65594439|NCT00700180|Growth Substances|growth substances|mesh-ancestor
65594440|NCT00700180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594441|NCT00700180|Growth Inhibitors|growth inhibitors|mesh-ancestor
65594442|NCT03222544|Methylene Blue|methylene blue|mesh-list
65594443|NCT03222544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594444|NCT03222544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594445|NCT03228862|Ergocalciferols|ergocalciferols|mesh-list
65594446|NCT03228862|Vitamin D|vitamin d|mesh-list
65594447|NCT03228862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65594448|NCT03228862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594449|NCT03228862|Vitamins|vitamins|mesh-ancestor
65594450|NCT03228862|Micronutrients|micronutrients|mesh-ancestor
65594451|NCT03228862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65594452|NCT03228238|Vitamins|vitamins|mesh-list
65594453|NCT03228238|Ascorbic Acid|ascorbic acid|mesh-list
65594454|NCT03228238|Vitamin E|vitamin e|mesh-list
65594455|NCT03228238|Tocopherols|tocopherols|mesh-list
65594456|NCT03228238|Calcium Channel Blockers|calcium channel blockers|mesh-list
65594457|NCT03228238|Atorvastatin|atorvastatin|mesh-list
65594458|NCT03228238|Micronutrients|micronutrients|mesh-ancestor
65594459|NCT03228238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594460|NCT03228238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65594461|NCT03228238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65594462|NCT03228238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65594463|NCT03228238|Antimetabolites|antimetabolites|mesh-ancestor
65594464|NCT03228238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594465|NCT03228238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65594466|NCT03228238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65594467|NCT03228238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594468|NCT03228238|Antioxidants|antioxidants|mesh-ancestor
65594469|NCT03228238|Protective Agents|protective agents|mesh-ancestor
65594470|NCT03228238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65594471|NCT03232216|Vitamin D|vitamin d|mesh-list
65594472|NCT03232216|Cholecalciferol|cholecalciferol|mesh-list
65594473|NCT03232216|Vitamins|vitamins|mesh-ancestor
65594474|NCT03232216|Micronutrients|micronutrients|mesh-ancestor
65594475|NCT03232216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594476|NCT03232216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65594477|NCT03232216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65594478|NCT03231982|Amlodipine|amlodipine|mesh-list
65594479|NCT03231982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65594480|NCT03231982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65594481|NCT03231982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65594482|NCT03231982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594483|NCT03231982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65594484|NCT03231982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594485|NCT03231982|Vasodilator Agents|vasodilator agents|mesh-ancestor
65594486|NCT03222310|Itraconazole|itraconazole|mesh-list
65594487|NCT03222310|Antifungal Agents|antifungal agents|mesh-ancestor
65594488|NCT03222310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594489|NCT03222310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65594490|NCT03222310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65594491|NCT03222310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594492|NCT03222310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594493|NCT03222310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65594494|NCT03222310|Hormone Antagonists|hormone antagonists|mesh-ancestor
65594495|NCT03222310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65594496|NCT03222310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594497|NCT03222310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65594498|NCT04485520|Chlorhexidine|chlorhexidine|mesh-list
65594499|NCT04485520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65594500|NCT04485520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594501|NCT04485520|Disinfectants|disinfectants|mesh-ancestor
65594502|NCT03231436|Bupivacaine|bupivacaine|mesh-list
65594503|NCT03231436|Anesthetics, Local|anesthetics, local|mesh-ancestor
65594504|NCT03231436|Anesthetics|anesthetics|mesh-ancestor
65594505|NCT03231436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65594506|NCT03231436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594507|NCT03231436|Sensory System Agents|sensory system agents|mesh-ancestor
65594508|NCT03231436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65594509|NCT02452450|Acetaminophen|acetaminophen|mesh-list
65594510|NCT02452450|Ibuprofen|ibuprofen|mesh-list
65594511|NCT02452450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65594512|NCT02452450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65594513|NCT02452450|Analgesics|analgesics|mesh-ancestor
65594514|NCT02452450|Sensory System Agents|sensory system agents|mesh-ancestor
65594515|NCT02452450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65594516|NCT02452450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594517|NCT02452450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65594518|NCT02452450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65594519|NCT02452450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65594520|NCT02452450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594521|NCT02452450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594522|NCT02452450|Antipyretics|antipyretics|mesh-ancestor
65594523|NCT01204684|Poly ICLC|poly iclc|mesh-list
65594524|NCT01204684|Interferon Inducers|interferon inducers|mesh-ancestor
65594525|NCT01204684|Immunologic Factors|immunologic factors|mesh-ancestor
65594526|NCT01204684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594527|NCT00594334|Risedronic Acid|risedronic acid|mesh-list
65594528|NCT00594334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65594529|NCT00594334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65594530|NCT00594334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594531|NCT00594334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65594532|NCT00594334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594533|NCT00594334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65594534|NCT00238420|Paclitaxel|paclitaxel|mesh-list
65594535|NCT00238420|Trastuzumab|trastuzumab|mesh-list
65594536|NCT00238420|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65594537|NCT00238420|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
65594538|NCT00238420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65594539|NCT00238420|Antibodies|antibodies|mesh-list
65594540|NCT00238420|Immunoglobulins|immunoglobulins|mesh-list
65594541|NCT00238420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65594542|NCT00238420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65594543|NCT00238420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594544|NCT00238420|Tubulin Modulators|tubulin modulators|mesh-ancestor
65594545|NCT00238420|Antimitotic Agents|antimitotic agents|mesh-ancestor
65594546|NCT00238420|Mitosis Modulators|mitosis modulators|mesh-ancestor
65594547|NCT00238420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594548|NCT00238420|Immunologic Factors|immunologic factors|mesh-ancestor
65594549|NCT00238420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594550|NCT03221998|Acetaminophen|acetaminophen|mesh-list
65594551|NCT03221998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65594552|NCT03221998|Analgesics|analgesics|mesh-ancestor
65594553|NCT03221998|Sensory System Agents|sensory system agents|mesh-ancestor
65594554|NCT03221998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65594555|NCT03221998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594556|NCT03221998|Antipyretics|antipyretics|mesh-ancestor
65594557|NCT04492475|Interferons|interferons|mesh-list
65594558|NCT04492475|Interferon-beta|interferon-beta|mesh-list
65594559|NCT04492475|Interferon beta-1a|interferon beta-1a|mesh-list
65594560|NCT04492475|Remdesivir|remdesivir|mesh-list
65594561|NCT04492475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594562|NCT04492475|Antiviral Agents|antiviral agents|mesh-ancestor
65594563|NCT04492475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594564|NCT04492475|Immunologic Factors|immunologic factors|mesh-ancestor
65594565|NCT04492475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594566|NCT04492475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65594567|NCT04492475|Antimetabolites|antimetabolites|mesh-ancestor
65594568|NCT04492475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594569|NCT04936763|Hyaluronic Acid|hyaluronic acid|mesh-list
65594570|NCT04936763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65594571|NCT04936763|Immunologic Factors|immunologic factors|mesh-ancestor
65594572|NCT04936763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594573|NCT04936763|Viscosupplements|viscosupplements|mesh-ancestor
65594574|NCT04936763|Protective Agents|protective agents|mesh-ancestor
65594575|NCT03230734|Docetaxel|docetaxel|mesh-list
65594576|NCT03230734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594577|NCT03230734|Tubulin Modulators|tubulin modulators|mesh-ancestor
65594578|NCT03230734|Antimitotic Agents|antimitotic agents|mesh-ancestor
65594579|NCT03230734|Mitosis Modulators|mitosis modulators|mesh-ancestor
65594580|NCT03230734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594581|NCT03226522|Bupropion|bupropion|mesh-list
65594582|NCT03226522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65594583|NCT03226522|Antidepressive Agents|antidepressive agents|mesh-ancestor
65594584|NCT03226522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65594585|NCT03226522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65594586|NCT03226522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65594587|NCT03226522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65594588|NCT03226522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594589|NCT03226522|Dopamine Agents|dopamine agents|mesh-ancestor
65594590|NCT03226522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65594591|NCT03226522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594592|NCT03226522|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65594593|NCT03226522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65594594|NCT03226522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594595|NCT03752333|Pembrolizumab|pembrolizumab|mesh-list
65594596|NCT03752333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65594597|NCT03752333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594598|NCT03750383|Cyclosporine|cyclosporine|mesh-list
65594599|NCT03750383|Prednisone|prednisone|mesh-list
65594600|NCT03750383|Cyclosporins|cyclosporins|mesh-list
65594601|NCT03750383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65594602|NCT03750383|Glucocorticoids|glucocorticoids|mesh-ancestor
65594603|NCT03750383|Hormones|hormones|mesh-ancestor
65594604|NCT03750383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65594605|NCT03750383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392043|NCT00449956|Timolol|timolol|mesh-list
65594606|NCT03750383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65594607|NCT03750383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594608|NCT03750383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594609|NCT03750383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594610|NCT03750383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65594611|NCT03750383|Immunologic Factors|immunologic factors|mesh-ancestor
65594612|NCT03750383|Antifungal Agents|antifungal agents|mesh-ancestor
65594613|NCT03750383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594614|NCT03750383|Dermatologic Agents|dermatologic agents|mesh-ancestor
65594615|NCT03750383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65594616|NCT03750383|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65594617|NCT03226210|Insulin|insulin|mesh-list
65594618|NCT03226210|Insulin Aspart|insulin aspart|mesh-list
65594619|NCT03226210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65594620|NCT03226210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594621|NCT05351489|Dexmedetomidine|dexmedetomidine|mesh-list
65594622|NCT05351489|Bupivacaine|bupivacaine|mesh-list
65594623|NCT05351489|Anesthetics, Local|anesthetics, local|mesh-ancestor
65594624|NCT05351489|Anesthetics|anesthetics|mesh-ancestor
65594625|NCT05351489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65594626|NCT05351489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594627|NCT05351489|Sensory System Agents|sensory system agents|mesh-ancestor
65594628|NCT05351489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65594629|NCT05351489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65594630|NCT05351489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65594631|NCT05351489|Analgesics|analgesics|mesh-ancestor
65594632|NCT05351489|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65594633|NCT05351489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65594634|NCT05351489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65594635|NCT05351489|Adrenergic Agents|adrenergic agents|mesh-ancestor
65594636|NCT05351489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65594637|NCT05351489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594638|NCT03229954|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65594639|NCT03229954|Hematinics|hematinics|mesh-ancestor
65594640|NCT03220126|Mirikizumab|mirikizumab|mesh-list
65594641|NCT03220126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65594642|NCT03220126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65594643|NCT03220126|Analgesics|analgesics|mesh-ancestor
65594644|NCT03220126|Sensory System Agents|sensory system agents|mesh-ancestor
65594645|NCT03220126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65594646|NCT03220126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594647|NCT03220126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65594648|NCT03220126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65594649|NCT03220126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65594650|NCT03220126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65594651|NCT02452684|Eszopiclone|eszopiclone|mesh-list
65594652|NCT02452684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65594653|NCT02452684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65594654|NCT02452684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594655|NCT03119428|Nivolumab|nivolumab|mesh-list
65594656|NCT03119428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65594657|NCT03119428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594658|NCT03119428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65594659|NCT03119428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594660|NCT04345367|Abrocitinib|abrocitinib|mesh-list
65594661|NCT04345367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65594662|NCT04345367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594663|NCT04345367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594664|NCT02452606|Levodopa|levodopa|mesh-list
65594665|NCT02452606|Carbidopa|carbidopa|mesh-list
65594666|NCT02452606|Entacapone|entacapone|mesh-list
65594667|NCT02452606|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65594668|NCT02452606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65594669|NCT02452606|Dopamine Agents|dopamine agents|mesh-ancestor
65594670|NCT02452606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65594671|NCT02452606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594672|NCT02452606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594673|NCT02452606|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65594674|NCT02452606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594675|NCT02452606|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65594676|NCT03225352|Aspirin|aspirin|mesh-list
65594677|NCT03225352|Ibuprofen|ibuprofen|mesh-list
65594678|NCT03225352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65594679|NCT03225352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65392113|NCT02538302|Autonomic Agents|autonomic agents|mesh-ancestor
65594680|NCT03225352|Analgesics|analgesics|mesh-ancestor
65594681|NCT03225352|Sensory System Agents|sensory system agents|mesh-ancestor
65594682|NCT03225352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65594683|NCT03225352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594684|NCT03225352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65594685|NCT03225352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65594686|NCT03225352|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65594687|NCT03225352|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65594688|NCT03225352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594689|NCT03225352|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65594690|NCT03225352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65594691|NCT03225352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594692|NCT03225352|Antipyretics|antipyretics|mesh-ancestor
65594693|NCT03208270|Antithrombins|antithrombins|mesh-list
65594694|NCT03208270|Antithrombin III|antithrombin iii|mesh-list
65594695|NCT03208270|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65594696|NCT03208270|Protease Inhibitors|protease inhibitors|mesh-ancestor
65594697|NCT03208270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594698|NCT03208270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594699|NCT03208270|Anticoagulants|anticoagulants|mesh-ancestor
65594700|NCT03208426|Amoxicillin|amoxicillin|mesh-list
65594701|NCT03208426|Metronidazole|metronidazole|mesh-list
65594702|NCT03208426|Clarithromycin|clarithromycin|mesh-list
65594703|NCT03208426|Tetracycline|tetracycline|mesh-list
65594704|NCT03208426|Esomeprazole|esomeprazole|mesh-list
65594705|NCT03208426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65594706|NCT03208426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594707|NCT03208426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65594708|NCT03208426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65594709|NCT03208426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65594710|NCT03208426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65594711|NCT03208426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65594712|NCT03208426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594713|NCT03208426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594714|NCT03208426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65594715|NCT03208426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65594716|NCT03208426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65594717|NCT03216070|Dasatinib|dasatinib|mesh-list
65594718|NCT03216070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594719|NCT03216070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65594720|NCT03216070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594721|NCT03216070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594722|NCT03215602|Pyrantel|pyrantel|mesh-list
65594723|NCT03215602|Pyrantel Pamoate|pyrantel pamoate|mesh-list
65594724|NCT03215602|Antinematodal Agents|antinematodal agents|mesh-ancestor
65594725|NCT03215602|Anthelmintics|anthelmintics|mesh-ancestor
65594726|NCT03215602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65594727|NCT03215602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594728|NCT03215602|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
65594729|NCT03215602|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65594730|NCT03215602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65594731|NCT03215602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65594732|NCT03215602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594733|NCT02450968|Dexamethasone|dexamethasone|mesh-list
65594734|NCT02450968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65594735|NCT02450968|Antiemetics|antiemetics|mesh-ancestor
65594736|NCT02450968|Autonomic Agents|autonomic agents|mesh-ancestor
65594737|NCT02450968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65594738|NCT02450968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594739|NCT02450968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65594740|NCT02450968|Glucocorticoids|glucocorticoids|mesh-ancestor
65594741|NCT02450968|Hormones|hormones|mesh-ancestor
65594742|NCT02450968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65594743|NCT02450968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65594744|NCT02450968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594745|NCT03749915|Tetracaine|tetracaine|mesh-list
65594746|NCT03749915|Anesthetics, Local|anesthetics, local|mesh-ancestor
65594747|NCT03749915|Anesthetics|anesthetics|mesh-ancestor
65594748|NCT03749915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65594749|NCT03749915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594750|NCT03749915|Sensory System Agents|sensory system agents|mesh-ancestor
65594751|NCT03749915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65594752|NCT03119116|Rivaroxaban|rivaroxaban|mesh-list
65594753|NCT03119116|Apixaban|apixaban|mesh-list
65594754|NCT03119116|Dabigatran|dabigatran|mesh-list
65594755|NCT03119116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65594756|NCT03119116|Antithrombins|antithrombins|mesh-ancestor
65594757|NCT03119116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65594758|NCT03119116|Protease Inhibitors|protease inhibitors|mesh-ancestor
65594759|NCT03119116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594760|NCT03119116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594761|NCT03119116|Anticoagulants|anticoagulants|mesh-ancestor
65594762|NCT04329923|Hydroxychloroquine|hydroxychloroquine|mesh-list
65594763|NCT04329923|Antimalarials|antimalarials|mesh-ancestor
65594764|NCT04329923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65594765|NCT04329923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65594766|NCT04329923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594767|NCT04329923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594768|NCT04329923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594769|NCT04329923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65594770|NCT04403399|Varenicline|varenicline|mesh-list
65594771|NCT04403399|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65594772|NCT04403399|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65594773|NCT04403399|Cholinergic Agents|cholinergic agents|mesh-ancestor
65594774|NCT04403399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65594775|NCT04403399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594776|NCT04403399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594777|NCT03224572|Ascorbic Acid|ascorbic acid|mesh-list
65594778|NCT03224572|Vitamins|vitamins|mesh-ancestor
65594779|NCT03224572|Micronutrients|micronutrients|mesh-ancestor
65594780|NCT03224572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594781|NCT03224572|Antioxidants|antioxidants|mesh-ancestor
65594782|NCT03224572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594783|NCT03224572|Protective Agents|protective agents|mesh-ancestor
65594784|NCT02452216|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65594785|NCT02452216|Hematinics|hematinics|mesh-ancestor
65594786|NCT02452216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65594787|NCT02452216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65594788|NCT03207334|Cytarabine|cytarabine|mesh-list
65594789|NCT03207334|Midostaurin|midostaurin|mesh-list
65594790|NCT03207334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65594791|NCT03207334|Antimetabolites|antimetabolites|mesh-ancestor
65594792|NCT03207334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594793|NCT03207334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594794|NCT03207334|Antiviral Agents|antiviral agents|mesh-ancestor
65594795|NCT03207334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594796|NCT03207334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65594797|NCT03207334|Immunologic Factors|immunologic factors|mesh-ancestor
65594798|NCT03207334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594799|NCT03207334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65594800|NCT03207334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594801|NCT03212950|Insulin|insulin|mesh-list
65594802|NCT03212950|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65594803|NCT03212950|Insulin Aspart|insulin aspart|mesh-list
65594804|NCT03212950|Insulin, Long-Acting|insulin, long-acting|mesh-list
65594805|NCT03212950|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65594806|NCT03212950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65594807|NCT03212950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594808|NCT03207100|Antihypertensive Agents|antihypertensive agents|mesh-list
65594809|NCT01561937|Warfarin|warfarin|mesh-list
65594810|NCT01561937|Anticoagulants|anticoagulants|mesh-ancestor
65594811|NCT03210766|Nabilone|nabilone|mesh-list
65594812|NCT03210766|Antiemetics|antiemetics|mesh-ancestor
65594813|NCT03210766|Autonomic Agents|autonomic agents|mesh-ancestor
65594814|NCT03210766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65594815|NCT03210766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594816|NCT03210766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65594817|NCT03210766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65594818|NCT03210766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65594819|NCT03210766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65594820|NCT03210766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65594821|NCT03747341|Fentanyl|fentanyl|mesh-list
65594822|NCT03747341|Oxycodone|oxycodone|mesh-list
65594823|NCT03747341|Buprenorphine|buprenorphine|mesh-list
65594824|NCT03747341|Ondansetron|ondansetron|mesh-list
65594825|NCT03747341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65594826|NCT03747341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65594827|NCT03747341|Narcotics|narcotics|mesh-ancestor
65594828|NCT03747341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65594829|NCT03747341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594830|NCT03747341|Analgesics|analgesics|mesh-ancestor
65392283|NCT00927290|Pioglitazone|pioglitazone|mesh-list
65594831|NCT03747341|Sensory System Agents|sensory system agents|mesh-ancestor
65594832|NCT03747341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65594833|NCT03747341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65594834|NCT03747341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65594835|NCT03747341|Anesthetics, General|anesthetics, general|mesh-ancestor
65594836|NCT03747341|Anesthetics|anesthetics|mesh-ancestor
65594837|NCT03747341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65594838|NCT03747341|Antiemetics|antiemetics|mesh-ancestor
65594839|NCT03747341|Autonomic Agents|autonomic agents|mesh-ancestor
65594840|NCT03747341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65594841|NCT03747341|Antipruritics|antipruritics|mesh-ancestor
65594842|NCT03747341|Dermatologic Agents|dermatologic agents|mesh-ancestor
65594843|NCT03747341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65594844|NCT03747341|Serotonin Agents|serotonin agents|mesh-ancestor
65594845|NCT03747341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65594846|NCT03747341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594847|NCT03747341|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65594848|NCT03747341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65594849|NCT03747341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65594850|NCT03747341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65594851|NCT04401293|Heparin|heparin|mesh-list
65594852|NCT04401293|Enoxaparin|enoxaparin|mesh-list
65594853|NCT04401293|Calcium heparin|calcium heparin|mesh-list
65594854|NCT04401293|Dalteparin|dalteparin|mesh-list
65594855|NCT04401293|Enoxaparin sodium|enoxaparin sodium|mesh-list
65594856|NCT04401293|Anticoagulants|anticoagulants|mesh-ancestor
65594857|NCT04401293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65594858|NCT04401293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65594859|NCT04401293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594860|NCT03209908|Tenofovir|tenofovir|mesh-list
65594861|NCT03209908|Antiviral Agents|antiviral agents|mesh-ancestor
65594862|NCT03209908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594863|NCT03209908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65594864|NCT03209908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65594865|NCT03209908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594866|NCT03209908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594867|NCT03209908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65594868|NCT03209908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65594869|NCT04319159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65594870|NCT04319159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65594871|NCT04319159|Dermatologic Agents|dermatologic agents|mesh-ancestor
65594872|NCT03224338|Dolutegravir|dolutegravir|mesh-list
65594873|NCT03224338|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65594874|NCT03224338|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65594875|NCT03224338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594876|NCT03224338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594877|NCT03224338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65594878|NCT03224338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65594879|NCT03224338|Antiviral Agents|antiviral agents|mesh-ancestor
65594880|NCT03224338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594881|NCT04318535|Griseofulvin|griseofulvin|mesh-list
65594882|NCT04318535|Antifungal Agents|antifungal agents|mesh-ancestor
65594883|NCT04318535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594884|NCT02451826|Ulipristal acetate|ulipristal acetate|mesh-list
65594885|NCT02451826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65594886|NCT02451826|Contraceptive Agents|contraceptive agents|mesh-ancestor
65594887|NCT02451826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65594888|NCT02451826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594889|NCT02451826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65594890|NCT03224416|Ethanol|ethanol|mesh-list
65594891|NCT03224416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65594892|NCT03224416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594893|NCT03224416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65594894|NCT03224416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594895|NCT01562561|Repaglinide|repaglinide|mesh-list
65594896|NCT01562561|Isophane Insulin, Human|isophane insulin, human|mesh-list
65594897|NCT01562561|Insulin, Isophane|insulin, isophane|mesh-list
65594898|NCT01562561|Isophane insulin, beef|isophane insulin, beef|mesh-list
65594899|NCT01562561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65594900|NCT01562561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594901|NCT03206944|Aspirin|aspirin|mesh-list
65594902|NCT03206944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65594903|NCT03206944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65594904|NCT03206944|Analgesics|analgesics|mesh-ancestor
65594905|NCT03206944|Sensory System Agents|sensory system agents|mesh-ancestor
65594906|NCT03206944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65594907|NCT03206944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594908|NCT03206944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65594909|NCT03206944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65594910|NCT03206944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65594911|NCT03206944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65594912|NCT03206944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594913|NCT03206944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65594914|NCT03206944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65594915|NCT03206944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594916|NCT03206944|Antipyretics|antipyretics|mesh-ancestor
65594917|NCT04454567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
65594918|NCT04454567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65594919|NCT04454567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594920|NCT04454567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594921|NCT04454567|Antiviral Agents|antiviral agents|mesh-ancestor
65594922|NCT04454567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594923|NCT03206554|Ropivacaine|ropivacaine|mesh-list
65594924|NCT03206554|Anesthetics, Local|anesthetics, local|mesh-ancestor
65594925|NCT03206554|Anesthetics|anesthetics|mesh-ancestor
65594926|NCT03206554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65594927|NCT03206554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594928|NCT03206554|Sensory System Agents|sensory system agents|mesh-ancestor
65594929|NCT03206554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65594930|NCT03209206|Docetaxel|docetaxel|mesh-list
65594931|NCT03209206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594932|NCT03209206|Tubulin Modulators|tubulin modulators|mesh-ancestor
65594933|NCT03209206|Antimitotic Agents|antimitotic agents|mesh-ancestor
65594934|NCT03209206|Mitosis Modulators|mitosis modulators|mesh-ancestor
65594935|NCT03209206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594936|NCT03223402|Lamivudine|lamivudine|mesh-list
65594937|NCT03223402|Nevirapine|nevirapine|mesh-list
65594938|NCT03223402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65594939|NCT03223402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65594940|NCT03223402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594941|NCT03223402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594942|NCT03223402|Antiviral Agents|antiviral agents|mesh-ancestor
65594943|NCT03223402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594944|NCT03223402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65594945|NCT03223402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65594946|NCT03223402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65594947|NCT03223402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65594948|NCT03208972|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65594949|NCT03208972|Menotropins|menotropins|mesh-list
65594950|NCT03208972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65594951|NCT03208972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594952|NCT03208972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65594953|NCT03208972|Fertility Agents|fertility agents|mesh-ancestor
65594954|NCT03206866|Antibodies|antibodies|mesh-list
65594955|NCT03206866|Immunologic Factors|immunologic factors|mesh-ancestor
65594956|NCT03206866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594957|NCT02451748|Hydroxychloroquine|hydroxychloroquine|mesh-list
65594958|NCT02451748|Sulfasalazine|sulfasalazine|mesh-list
65594959|NCT02451748|Prednisone|prednisone|mesh-list
65594960|NCT02451748|Triamcinolone|triamcinolone|mesh-list
65594961|NCT02451748|Naproxen|naproxen|mesh-list
65594962|NCT02451748|Methotrexate|methotrexate|mesh-list
65594963|NCT02451748|Certolizumab Pegol|certolizumab pegol|mesh-list
65594964|NCT02451748|Leflunomide|leflunomide|mesh-list
65594965|NCT02451748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65594966|NCT02451748|Glucocorticoids|glucocorticoids|mesh-ancestor
65594967|NCT02451748|Hormones|hormones|mesh-ancestor
65594968|NCT02451748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65594969|NCT02451748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65594970|NCT02451748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65594971|NCT02451748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65594972|NCT02451748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65594973|NCT02451748|Abortifacient Agents|abortifacient agents|mesh-ancestor
65594974|NCT02451748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65594975|NCT02451748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65594976|NCT02451748|Antimetabolites|antimetabolites|mesh-ancestor
65594977|NCT02451748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65594978|NCT02451748|Dermatologic Agents|dermatologic agents|mesh-ancestor
65594979|NCT02451748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65594980|NCT02451748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65594981|NCT02451748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65594982|NCT02451748|Immunologic Factors|immunologic factors|mesh-ancestor
65594983|NCT02451748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65594984|NCT02451748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65594985|NCT02451748|Antimalarials|antimalarials|mesh-ancestor
65594986|NCT02451748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65594987|NCT02451748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65594988|NCT02451748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65594989|NCT02451748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65594990|NCT02451748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65594991|NCT02451748|Analgesics|analgesics|mesh-ancestor
65594992|NCT02451748|Sensory System Agents|sensory system agents|mesh-ancestor
65594993|NCT02451748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65594994|NCT02451748|Gout Suppressants|gout suppressants|mesh-ancestor
65594995|NCT02451748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65594996|NCT02451748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65594997|NCT03208894|Furosemide|furosemide|mesh-list
65594998|NCT03208894|Diuretics|diuretics|mesh-ancestor
65594999|NCT03208894|Natriuretic Agents|natriuretic agents|mesh-ancestor
65595000|NCT03208894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595001|NCT03208894|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65595002|NCT03208894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65595003|NCT03208894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595004|NCT02450656|Docetaxel|docetaxel|mesh-list
65595005|NCT02450656|Afatinib|afatinib|mesh-list
65595006|NCT02450656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65595007|NCT02450656|Tubulin Modulators|tubulin modulators|mesh-ancestor
65595008|NCT02450656|Antimitotic Agents|antimitotic agents|mesh-ancestor
65595009|NCT02450656|Mitosis Modulators|mitosis modulators|mesh-ancestor
65595010|NCT02450656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595011|NCT02450656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65595012|NCT02450656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65595013|NCT03206320|Lidocaine|lidocaine|mesh-list
65595014|NCT03206320|Anesthetics, Local|anesthetics, local|mesh-ancestor
65595015|NCT03206320|Anesthetics|anesthetics|mesh-ancestor
65595016|NCT03206320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65595017|NCT03206320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595018|NCT03206320|Sensory System Agents|sensory system agents|mesh-ancestor
65595019|NCT03206320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595020|NCT03206320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65595021|NCT03206320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65595022|NCT03206320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65595023|NCT03206320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65595024|NCT03206320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595025|NCT04448561|Morphine|morphine|mesh-list
65595026|NCT04448561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65595027|NCT04448561|Narcotics|narcotics|mesh-ancestor
65595028|NCT04448561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65595029|NCT04448561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595030|NCT04448561|Analgesics|analgesics|mesh-ancestor
65595031|NCT04448561|Sensory System Agents|sensory system agents|mesh-ancestor
65595032|NCT04448561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595033|NCT03206008|Magnesium Sulfate|magnesium sulfate|mesh-list
65595034|NCT03206008|Analgesics|analgesics|mesh-ancestor
65595035|NCT03206008|Sensory System Agents|sensory system agents|mesh-ancestor
65595036|NCT03206008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595037|NCT03206008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595038|NCT03206008|Anesthetics|anesthetics|mesh-ancestor
65595039|NCT03206008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65595040|NCT03206008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65595041|NCT03206008|Anticonvulsants|anticonvulsants|mesh-ancestor
65595042|NCT03206008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65595043|NCT03206008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65595044|NCT03206008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595045|NCT03206008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65595046|NCT03206008|Tocolytic Agents|tocolytic agents|mesh-ancestor
65595047|NCT03206008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65595048|NCT04978259|Remdesivir|remdesivir|mesh-list
65595049|NCT04978259|Antimetabolites|antimetabolites|mesh-ancestor
65595050|NCT04978259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595051|NCT04978259|Antiviral Agents|antiviral agents|mesh-ancestor
65595052|NCT04978259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65595053|NCT03208582|Risedronic Acid|risedronic acid|mesh-list
65595054|NCT03208582|Diphosphonates|diphosphonates|mesh-list
65595055|NCT03208582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65595056|NCT03208582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65595057|NCT03208582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595058|NCT03208582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65595059|NCT03208582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392489|NCT00568178|Losartan|losartan|mesh-list
65595060|NCT03208582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65595061|NCT03200938|Zinc|zinc|mesh-list
65595062|NCT03200938|Zinc Oxide|zinc oxide|mesh-list
65595063|NCT03200938|Trace Elements|trace elements|mesh-ancestor
65595064|NCT03200938|Micronutrients|micronutrients|mesh-ancestor
65595065|NCT03200938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595066|NCT03200938|Dermatologic Agents|dermatologic agents|mesh-ancestor
65595067|NCT03200938|Sunscreening Agents|sunscreening agents|mesh-ancestor
65595068|NCT03200938|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65595069|NCT03200938|Protective Agents|protective agents|mesh-ancestor
65595070|NCT04297241|Isosorbide|isosorbide|mesh-list
65595071|NCT04297241|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65595072|NCT04297241|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65595073|NCT04297241|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65595074|NCT04297241|Diuretics|diuretics|mesh-ancestor
65595075|NCT04297241|Natriuretic Agents|natriuretic agents|mesh-ancestor
65595076|NCT04297241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595077|NCT04297241|Vasodilator Agents|vasodilator agents|mesh-ancestor
65595078|NCT04297241|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65595079|NCT04297241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595080|NCT04292171|Gabapentin|gabapentin|mesh-list
65595081|NCT04292171|Analgesics|analgesics|mesh-ancestor
65595082|NCT04292171|Sensory System Agents|sensory system agents|mesh-ancestor
65595083|NCT04292171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595084|NCT04292171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595085|NCT04292171|Anticonvulsants|anticonvulsants|mesh-ancestor
65595086|NCT04292171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65595087|NCT04292171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65595088|NCT04292171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65595089|NCT04292171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65595090|NCT04292171|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65595091|NCT04292171|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65595092|NCT04292171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65595093|NCT04292171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595094|NCT04292171|Antimanic Agents|antimanic agents|mesh-ancestor
65595095|NCT03200782|Empagliflozin|empagliflozin|mesh-list
65595096|NCT03200782|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65595097|NCT03200782|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65595098|NCT03200782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595099|NCT03200782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65595100|NCT03200782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595101|NCT03200782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65595102|NCT02449954|Ketorolac|ketorolac|mesh-list
65595103|NCT02449954|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65595104|NCT02449954|Morphine|morphine|mesh-list
65595105|NCT02449954|Tramadol|tramadol|mesh-list
65595106|NCT02449954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65595107|NCT02449954|Narcotics|narcotics|mesh-ancestor
65595108|NCT02449954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65595109|NCT02449954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595110|NCT02449954|Analgesics|analgesics|mesh-ancestor
65595111|NCT02449954|Sensory System Agents|sensory system agents|mesh-ancestor
65595112|NCT02449954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595113|NCT02449954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65595114|NCT02449954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65595115|NCT02449954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65595116|NCT02449954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65595117|NCT02449954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65595118|NCT02449954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65595119|NCT02449954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595120|NCT04393493|Chlorthalidone|chlorthalidone|mesh-list
65595121|NCT04393493|Furosemide|furosemide|mesh-list
65595122|NCT04393493|Spironolactone|spironolactone|mesh-list
65595123|NCT04393493|Diuretics|diuretics|mesh-ancestor
65595124|NCT04393493|Natriuretic Agents|natriuretic agents|mesh-ancestor
65595125|NCT04393493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595126|NCT04393493|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65595127|NCT04393493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65595128|NCT04393493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595129|NCT04393493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65595130|NCT04393493|Hormone Antagonists|hormone antagonists|mesh-ancestor
65595131|NCT04393493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65595132|NCT04393493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65392579|NCT00731861|Paclitaxel|paclitaxel|mesh-list
65595133|NCT04393493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65595134|NCT04393493|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65595135|NCT02448082|Ichthammol|ichthammol|mesh-list
65595136|NCT02448082|Dermatologic Agents|dermatologic agents|mesh-ancestor
65595137|NCT03205228|Flupenthixol|flupenthixol|mesh-list
65595138|NCT03205228|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
65595139|NCT03205228|Omeprazole|omeprazole|mesh-list
65595140|NCT03205228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65595141|NCT03205228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65595142|NCT03205228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65595143|NCT03205228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65595144|NCT03205228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595145|NCT03205228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65595146|NCT03205228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65595147|NCT03205228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65595148|NCT03205228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595149|NCT03205228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65595150|NCT03205228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65595151|NCT03205228|Dopamine Agents|dopamine agents|mesh-ancestor
65595152|NCT03205228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65595153|NCT03195946|Midazolam|midazolam|mesh-list
65595154|NCT03195946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65595155|NCT03195946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65595156|NCT03195946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65595157|NCT03195946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595158|NCT03195946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65595159|NCT03195946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65595160|NCT03195946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65595161|NCT03195946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65595162|NCT03195946|Anesthetics, General|anesthetics, general|mesh-ancestor
65595163|NCT03195946|Anesthetics|anesthetics|mesh-ancestor
65595164|NCT03195946|GABA Modulators|gaba modulators|mesh-ancestor
65595165|NCT03195946|GABA Agents|gaba agents|mesh-ancestor
65595166|NCT03195946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65595167|NCT03195946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595168|NCT03204760|Dexamethasone|dexamethasone|mesh-list
65595169|NCT03204760|Prednisolone|prednisolone|mesh-list
65595170|NCT03204760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65595171|NCT03204760|Antiemetics|antiemetics|mesh-ancestor
65595172|NCT03204760|Autonomic Agents|autonomic agents|mesh-ancestor
65595173|NCT03204760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595174|NCT03204760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595175|NCT03204760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65595176|NCT03204760|Glucocorticoids|glucocorticoids|mesh-ancestor
65595177|NCT03204760|Hormones|hormones|mesh-ancestor
65595178|NCT03204760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65595179|NCT03204760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65595180|NCT03204760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65595181|NCT03200392|Chromium|chromium|mesh-list
65595182|NCT03200392|Trace Elements|trace elements|mesh-ancestor
65595183|NCT03200392|Micronutrients|micronutrients|mesh-ancestor
65595184|NCT03200392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595185|NCT03200080|Amphetamine|amphetamine|mesh-list
65595186|NCT03200080|Dextroamphetamine|dextroamphetamine|mesh-list
65595187|NCT03200080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65595188|NCT03200080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595189|NCT03200080|Sympathomimetics|sympathomimetics|mesh-ancestor
65595190|NCT03200080|Autonomic Agents|autonomic agents|mesh-ancestor
65595191|NCT03200080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595192|NCT03200080|Dopamine Agents|dopamine agents|mesh-ancestor
65595193|NCT03200080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65595194|NCT03200080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595195|NCT03200080|Adrenergic Agents|adrenergic agents|mesh-ancestor
65595196|NCT03200080|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65595197|NCT03200080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65595198|NCT03200080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65595199|NCT03200080|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65595200|NCT03200236|Nicotine|nicotine|mesh-list
65595201|NCT03200236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65595202|NCT03200236|Autonomic Agents|autonomic agents|mesh-ancestor
65595203|NCT03200236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595204|NCT03200236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595205|NCT03200236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65595206|NCT03200236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65595207|NCT03200236|Cholinergic Agents|cholinergic agents|mesh-ancestor
65595208|NCT03200236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65595209|NCT03200236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595210|NCT03200002|Mycophenolic Acid|mycophenolic acid|mesh-list
65595211|NCT03200002|Cyclophosphamide|cyclophosphamide|mesh-list
65595212|NCT03200002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65595213|NCT03200002|Immunologic Factors|immunologic factors|mesh-ancestor
65595214|NCT03200002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595215|NCT03200002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65595216|NCT03200002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65595217|NCT03200002|Alkylating Agents|alkylating agents|mesh-ancestor
65595218|NCT03200002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595219|NCT03200002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65595220|NCT03200002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65595221|NCT03200002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65595222|NCT03200002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65595223|NCT03200002|Antitubercular Agents|antitubercular agents|mesh-ancestor
65595224|NCT03200002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65595225|NCT03200002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65595226|NCT03200002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65595227|NCT02447380|Docetaxel|docetaxel|mesh-list
65595228|NCT02447380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65595229|NCT02447380|Tubulin Modulators|tubulin modulators|mesh-ancestor
65595230|NCT02447380|Antimitotic Agents|antimitotic agents|mesh-ancestor
65595231|NCT02447380|Mitosis Modulators|mitosis modulators|mesh-ancestor
65595232|NCT02447380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595233|NCT02447224|Metronidazole|metronidazole|mesh-list
65595234|NCT02447224|Ertapenem|ertapenem|mesh-list
65595235|NCT02447224|Cefdinir|cefdinir|mesh-list
65595236|NCT02447224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65595237|NCT02447224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65595238|NCT02447224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65595239|NCT02447224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65595240|NCT03199690|Rifampin|rifampin|mesh-list
65595241|NCT03199690|Dolutegravir|dolutegravir|mesh-list
65595242|NCT03199690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65595243|NCT03199690|Antitubercular Agents|antitubercular agents|mesh-ancestor
65595244|NCT03199690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65595245|NCT03199690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65595246|NCT03199690|Leprostatic Agents|leprostatic agents|mesh-ancestor
65595247|NCT03199690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65595248|NCT03199690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65595249|NCT03199690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595250|NCT03199690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65595251|NCT03199690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65595252|NCT03199690|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65595253|NCT03199690|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65595254|NCT03199690|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65595255|NCT03199690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65595256|NCT03199690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65595257|NCT03199690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65595258|NCT03199690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65595259|NCT03199690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65595260|NCT03199690|Antiviral Agents|antiviral agents|mesh-ancestor
65595261|NCT03204058|Metformin|metformin|mesh-list
65595262|NCT03204058|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65595263|NCT03204058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65595264|NCT03204058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595265|NCT03204058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65595266|NCT03204058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65595267|NCT03204058|Antimetabolites|antimetabolites|mesh-ancestor
65595268|NCT03204058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595269|NCT03204058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65595270|NCT03204058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65595271|NCT03204058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65595272|NCT03203746|Lycopene|lycopene|mesh-list
65595273|NCT03203746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65595274|NCT03203746|Antioxidants|antioxidants|mesh-ancestor
65595275|NCT03203746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595276|NCT03203746|Protective Agents|protective agents|mesh-ancestor
65595277|NCT03203746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595278|NCT03203746|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65595279|NCT03203746|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65595280|NCT03203746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65595281|NCT03203668|Choline|choline|mesh-list
65595282|NCT03203668|Lipotropic Agents|lipotropic agents|mesh-ancestor
65595283|NCT03203668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65392715|NCT01013103|Antimetabolites|antimetabolites|mesh-ancestor
65595284|NCT03203668|Antimetabolites|antimetabolites|mesh-ancestor
65595285|NCT03203668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595287|NCT03203668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65595288|NCT03203668|Nootropic Agents|nootropic agents|mesh-ancestor
65595289|NCT03199534|Botulinum Toxins|botulinum toxins|mesh-list
65595290|NCT03199534|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65595291|NCT03199534|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65595292|NCT03199534|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65595293|NCT03199534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65595294|NCT03199534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595295|NCT03199534|Cholinergic Agents|cholinergic agents|mesh-ancestor
65595296|NCT03199534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65595297|NCT03199534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595298|NCT03199534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65595299|NCT03199534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595300|NCT03203356|Hormones|hormones|mesh-list
65595301|NCT03203356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65595302|NCT03203356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595303|NCT04280705|Remdesivir|remdesivir|mesh-list
65595304|NCT04280705|Antimetabolites|antimetabolites|mesh-ancestor
65595305|NCT04280705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595306|NCT04280705|Antiviral Agents|antiviral agents|mesh-ancestor
65595307|NCT04280705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65595308|NCT03203590|Carboplatin|carboplatin|mesh-list
65595309|NCT03203590|Vinorelbine|vinorelbine|mesh-list
65595310|NCT03203590|Gefitinib|gefitinib|mesh-list
65595311|NCT03203590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65595312|NCT03203590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65595313|NCT03203590|Tubulin Modulators|tubulin modulators|mesh-ancestor
65595314|NCT03203590|Antimitotic Agents|antimitotic agents|mesh-ancestor
65595315|NCT03203590|Mitosis Modulators|mitosis modulators|mesh-ancestor
65595316|NCT03203590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595317|NCT03203590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65595318|NCT03203590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65595319|NCT02077166|Rituximab|rituximab|mesh-list
65595320|NCT02077166|Lenalidomide|lenalidomide|mesh-list
65595321|NCT02077166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65595322|NCT02077166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65595323|NCT02077166|Immunologic Factors|immunologic factors|mesh-ancestor
65595324|NCT02077166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595325|NCT02077166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65595326|NCT02077166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65595327|NCT02077166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65595328|NCT02077166|Growth Substances|growth substances|mesh-ancestor
65595329|NCT02077166|Growth Inhibitors|growth inhibitors|mesh-ancestor
65595330|NCT02450188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65595331|NCT02450188|Vasodilator Agents|vasodilator agents|mesh-ancestor
65595332|NCT02450188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65595333|NCT02450188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65595334|NCT02450188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65595335|NCT02450188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595336|NCT02450188|Urological Agents|urological agents|mesh-ancestor
65595337|NCT03198676|Poly I-C|poly i-c|mesh-list
65595338|NCT03198676|Antiviral Agents|antiviral agents|mesh-ancestor
65595339|NCT03198676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65595340|NCT03198676|Interferon Inducers|interferon inducers|mesh-ancestor
65595341|NCT03198676|Immunologic Factors|immunologic factors|mesh-ancestor
65595342|NCT03198676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595343|NCT04484506|Prednisone|prednisone|mesh-list
65595344|NCT04484506|Cyclophosphamide|cyclophosphamide|mesh-list
65595345|NCT04484506|Etoposide|etoposide|mesh-list
65595346|NCT04484506|Vincristine|vincristine|mesh-list
65595347|NCT04484506|Pegaspargase|pegaspargase|mesh-list
65595348|NCT04484506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65595349|NCT04484506|Immunologic Factors|immunologic factors|mesh-ancestor
65595350|NCT04484506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595351|NCT04484506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65595352|NCT04484506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65595353|NCT04484506|Alkylating Agents|alkylating agents|mesh-ancestor
65595354|NCT04484506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595355|NCT04484506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65595356|NCT04484506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65595357|NCT04484506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65595358|NCT04484506|Glucocorticoids|glucocorticoids|mesh-ancestor
65595359|NCT04484506|Hormones|hormones|mesh-ancestor
65595360|NCT04484506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65595361|NCT04484506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65595362|NCT04484506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65595363|NCT04484506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65595364|NCT04484506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65595365|NCT04484506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65595366|NCT04484506|Tubulin Modulators|tubulin modulators|mesh-ancestor
65595367|NCT04484506|Antimitotic Agents|antimitotic agents|mesh-ancestor
65595368|NCT04484506|Mitosis Modulators|mitosis modulators|mesh-ancestor
65595369|NCT04332653|Pembrolizumab|pembrolizumab|mesh-list
65595370|NCT04332653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65595371|NCT04332653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65595372|NCT02449564|Sirolimus|sirolimus|mesh-list
65595373|NCT02449564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65595374|NCT02449564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65595375|NCT02449564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65595376|NCT02449564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65595377|NCT02449564|Antifungal Agents|antifungal agents|mesh-ancestor
65595378|NCT02449564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65595379|NCT02449564|Immunologic Factors|immunologic factors|mesh-ancestor
65595380|NCT02449564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595381|NCT02449720|Ropivacaine|ropivacaine|mesh-list
65595382|NCT02449720|Anesthetics, Local|anesthetics, local|mesh-ancestor
65595383|NCT02449720|Anesthetics|anesthetics|mesh-ancestor
65595384|NCT02449720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65595385|NCT02449720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595386|NCT02449720|Sensory System Agents|sensory system agents|mesh-ancestor
65595387|NCT02449720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595388|NCT03194620|Proanthocyanidin|proanthocyanidin|mesh-list
65595389|NCT03194620|Epicatechin gallate|epicatechin gallate|mesh-list
65595390|NCT03194620|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65595391|NCT03194620|Procyanidin|procyanidin|mesh-list
65595392|NCT03194620|Theaflavin|theaflavin|mesh-list
65595393|NCT03194620|Antioxidants|antioxidants|mesh-ancestor
65595394|NCT03194620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595395|NCT03194620|Protective Agents|protective agents|mesh-ancestor
65595396|NCT03194620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595397|NCT03194620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65595398|NCT03194620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65595399|NCT03194620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65595400|NCT03194620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65595401|NCT03194620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65595402|NCT03194620|Protease Inhibitors|protease inhibitors|mesh-ancestor
65595403|NCT03194620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65595404|NCT03194620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65595405|NCT03194620|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65595406|NCT03194620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65595407|NCT03194620|Chelating Agents|chelating agents|mesh-ancestor
65595408|NCT03194620|Sequestering Agents|sequestering agents|mesh-ancestor
65595409|NCT02445976|Seviteronel|seviteronel|mesh-list
65595410|NCT02445976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65595411|NCT02445976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65595412|NCT02445976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65595413|NCT02445976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595414|NCT03198442|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65595415|NCT03198442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65595416|NCT03198442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595417|NCT03198208|Fentanyl|fentanyl|mesh-list
65595418|NCT03198208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65595419|NCT03198208|Narcotics|narcotics|mesh-ancestor
65595420|NCT03198208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65595421|NCT03198208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595422|NCT03198208|Analgesics|analgesics|mesh-ancestor
65595423|NCT03198208|Sensory System Agents|sensory system agents|mesh-ancestor
65595424|NCT03198208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595425|NCT03198208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65595426|NCT03198208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65595427|NCT03198208|Anesthetics, General|anesthetics, general|mesh-ancestor
65595428|NCT03198208|Anesthetics|anesthetics|mesh-ancestor
65595429|NCT01044056|Contraceptive Agents|contraceptive agents|mesh-list
65595430|NCT01044056|Levonorgestrel|levonorgestrel|mesh-list
65595431|NCT01044056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65595432|NCT01044056|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65595433|NCT01044056|NuvaRing|nuvaring|mesh-list
65392859|NCT00113269|Alemtuzumab|alemtuzumab|mesh-list
65595434|NCT01044056|Contraceptives, Oral|contraceptives, oral|mesh-list
65595435|NCT01044056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65595436|NCT01044056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595437|NCT01044056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65595438|NCT01044056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65595439|NCT01044056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65595440|NCT01044056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65595441|NCT01044056|Estrogens|estrogens|mesh-ancestor
65595442|NCT01044056|Hormones|hormones|mesh-ancestor
65595443|NCT01044056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65595444|NCT01044056|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65595445|NCT01005056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65595446|NCT01005056|Desogestrel|desogestrel|mesh-list
65595447|NCT01005056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65595448|NCT01005056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65595449|NCT01005056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65595450|NCT01005056|Contraceptive Agents|contraceptive agents|mesh-ancestor
65595451|NCT01005056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65595452|NCT01005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595453|NCT01005056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65595454|NCT01005056|Estrogens|estrogens|mesh-ancestor
65595455|NCT01005056|Hormones|hormones|mesh-ancestor
65595456|NCT01005056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65595457|NCT01005056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65595458|NCT01005056|Progestins|progestins|mesh-ancestor
65595459|NCT04796714|Aspirin|aspirin|mesh-list
65595460|NCT04796714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65595461|NCT04796714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65595462|NCT04796714|Analgesics|analgesics|mesh-ancestor
65595463|NCT04796714|Sensory System Agents|sensory system agents|mesh-ancestor
65595464|NCT04796714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595465|NCT04796714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595466|NCT04796714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65595467|NCT04796714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65595468|NCT04796714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65595469|NCT04796714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65595470|NCT04796714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595471|NCT04796714|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65595472|NCT04796714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65595473|NCT04796714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65595474|NCT04796714|Antipyretics|antipyretics|mesh-ancestor
65595475|NCT02445898|Methylprednisolone|methylprednisolone|mesh-list
65595476|NCT02445898|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65595477|NCT02445898|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65595478|NCT02445898|Prednisolone|prednisolone|mesh-list
65595479|NCT02445898|Prednisolone acetate|prednisolone acetate|mesh-list
65595480|NCT02445898|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65595481|NCT02445898|Prednisolone phosphate|prednisolone phosphate|mesh-list
65595482|NCT02445898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65595483|NCT02445898|Antiemetics|antiemetics|mesh-ancestor
65595484|NCT02445898|Autonomic Agents|autonomic agents|mesh-ancestor
65595485|NCT02445898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595486|NCT02445898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595487|NCT02445898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65595488|NCT02445898|Glucocorticoids|glucocorticoids|mesh-ancestor
65595489|NCT02445898|Hormones|hormones|mesh-ancestor
65595490|NCT02445898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65595491|NCT02445898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65595492|NCT02445898|Protective Agents|protective agents|mesh-ancestor
65595493|NCT02445898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65595494|NCT02445898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65595495|NCT02445820|Plasma-lyte 148|plasma-lyte 148|mesh-list
65595496|NCT02445820|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65595497|NCT02445820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65595498|NCT03198130|Cemiplimab|cemiplimab|mesh-list
65595499|NCT03198130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65595500|NCT03198130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65595501|NCT04238780|Fentanyl|fentanyl|mesh-list
65595502|NCT04238780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65595503|NCT04238780|Narcotics|narcotics|mesh-ancestor
65595504|NCT04238780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65595505|NCT04238780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595506|NCT04238780|Analgesics|analgesics|mesh-ancestor
65595507|NCT04238780|Sensory System Agents|sensory system agents|mesh-ancestor
65595508|NCT04238780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595509|NCT04238780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65595510|NCT04238780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65595511|NCT04238780|Anesthetics, General|anesthetics, general|mesh-ancestor
65595512|NCT04238780|Anesthetics|anesthetics|mesh-ancestor
65595513|NCT00944216|Emollients|emollients|mesh-list
65595514|NCT00944216|Dermatologic Agents|dermatologic agents|mesh-ancestor
65595515|NCT04238663|Bevacizumab|bevacizumab|mesh-list
65595516|NCT04238663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65595517|NCT04238663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65595518|NCT04238663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65595519|NCT04238663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65595520|NCT04238663|Growth Substances|growth substances|mesh-ancestor
65595521|NCT04238663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595522|NCT04238663|Growth Inhibitors|growth inhibitors|mesh-ancestor
65595523|NCT00878462|Asenapine|asenapine|mesh-list
65595524|NCT00878462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65595525|NCT00878462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65595526|NCT00878462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65595527|NCT00878462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595528|NCT00878462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65595529|NCT03197818|Budesonide|budesonide|mesh-list
65595530|NCT03197818|Formoterol Fumarate|formoterol fumarate|mesh-list
65595531|NCT03197818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65595532|NCT03197818|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65595533|NCT03197818|Autonomic Agents|autonomic agents|mesh-ancestor
65595534|NCT03197818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595535|NCT03197818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595536|NCT03197818|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65595537|NCT03197818|Respiratory System Agents|respiratory system agents|mesh-ancestor
65595538|NCT03197818|Glucocorticoids|glucocorticoids|mesh-ancestor
65595539|NCT03197818|Hormones|hormones|mesh-ancestor
65595540|NCT03197818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65595541|NCT03197818|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65595542|NCT03197818|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65595543|NCT03197818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65595544|NCT03197818|Adrenergic Agents|adrenergic agents|mesh-ancestor
65595545|NCT03197818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65595546|NCT03197818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595547|NCT03442088|Apremilast|apremilast|mesh-list
65595548|NCT03442088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65595549|NCT03442088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65595550|NCT03442088|Analgesics|analgesics|mesh-ancestor
65595551|NCT03442088|Sensory System Agents|sensory system agents|mesh-ancestor
65595552|NCT03442088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595553|NCT03442088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595554|NCT03442088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65595555|NCT03442088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65595556|NCT03442088|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65595557|NCT03442088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65595558|NCT03442088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65595559|NCT03442088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595560|NCT01562405|Dexamethasone|dexamethasone|mesh-list
65595561|NCT01562405|Lenalidomide|lenalidomide|mesh-list
65595562|NCT01562405|Pomalidomide|pomalidomide|mesh-list
65595563|NCT01562405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65595564|NCT01562405|Antiemetics|antiemetics|mesh-ancestor
65595565|NCT01562405|Autonomic Agents|autonomic agents|mesh-ancestor
65595566|NCT01562405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595567|NCT01562405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595568|NCT01562405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65595569|NCT01562405|Glucocorticoids|glucocorticoids|mesh-ancestor
65595570|NCT01562405|Hormones|hormones|mesh-ancestor
65595571|NCT01562405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65595572|NCT01562405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65595573|NCT01562405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65595574|NCT01562405|Immunologic Factors|immunologic factors|mesh-ancestor
65595575|NCT01562405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65595576|NCT01562405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65595577|NCT01562405|Growth Substances|growth substances|mesh-ancestor
65595578|NCT01562405|Growth Inhibitors|growth inhibitors|mesh-ancestor
65595579|NCT03119194|Opicapone|opicapone|mesh-list
65595580|NCT03119194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65595581|NCT03119194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65595582|NCT03119194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595583|NCT03119194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65393010|NCT00735761|Hydrocortisone|hydrocortisone|mesh-list
65595584|NCT03119194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65595585|NCT03107338|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65595586|NCT03107338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65595587|NCT03107338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65595589|NCT03107338|Sensory System Agents|sensory system agents|mesh-ancestor
65595590|NCT03107338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595591|NCT03107338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595592|NCT03107338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65595593|NCT03107338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65595594|NCT05581940|Bupivacaine|bupivacaine|mesh-list
65595595|NCT05581940|Anesthetics|anesthetics|mesh-list
65595596|NCT05581940|Anesthetics, Local|anesthetics, local|mesh-ancestor
65595597|NCT05581940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65595598|NCT05581940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595599|NCT05581940|Sensory System Agents|sensory system agents|mesh-ancestor
65595600|NCT05581940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595601|NCT02445508|Cholecystokinin|cholecystokinin|mesh-list
65595602|NCT02445508|Sevelamer|sevelamer|mesh-list
65595603|NCT02445508|Chelating Agents|chelating agents|mesh-ancestor
65595604|NCT02445508|Sequestering Agents|sequestering agents|mesh-ancestor
65595605|NCT02445508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595606|NCT02445508|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65595607|NCT02445508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65595608|NCT03197584|Leucovorin|leucovorin|mesh-list
64774277|NCT01644396|Adalimumab|adalimumab|mesh-list
65595609|NCT03197584|Cyclophosphamide|cyclophosphamide|mesh-list
65595610|NCT03197584|Bevacizumab|bevacizumab|mesh-list
65595611|NCT03197584|Fluorouracil|fluorouracil|mesh-list
65595612|NCT03197584|Capecitabine|capecitabine|mesh-list
65595613|NCT03197584|Oxaliplatin|oxaliplatin|mesh-list
65595614|NCT03197584|Fulvestrant|fulvestrant|mesh-list
65595615|NCT03197584|Avelumab|avelumab|mesh-list
65595616|NCT03197584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65595617|NCT03197584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595618|NCT03197584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65595619|NCT03197584|Immunologic Factors|immunologic factors|mesh-ancestor
65595620|NCT03197584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595621|NCT03197584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65595622|NCT03197584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65595623|NCT03197584|Alkylating Agents|alkylating agents|mesh-ancestor
65595624|NCT03197584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65595625|NCT03197584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65595626|NCT03197584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65595627|NCT03197584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65595628|NCT03197584|Growth Substances|growth substances|mesh-ancestor
65595629|NCT03197584|Growth Inhibitors|growth inhibitors|mesh-ancestor
65595630|NCT03197584|Antimetabolites|antimetabolites|mesh-ancestor
65595631|NCT03197584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65595632|NCT03197584|Antidotes|antidotes|mesh-ancestor
65595633|NCT03197584|Protective Agents|protective agents|mesh-ancestor
65595634|NCT03197584|Vitamin B Complex|vitamin b complex|mesh-ancestor
65595635|NCT03197584|Vitamins|vitamins|mesh-ancestor
65595636|NCT03197584|Micronutrients|micronutrients|mesh-ancestor
65595637|NCT03197584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65595638|NCT03197584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65595639|NCT03197584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65595640|NCT03197584|Hormone Antagonists|hormone antagonists|mesh-ancestor
65595641|NCT03197584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65595642|NCT03722576|Calcium|calcium|mesh-list
65595643|NCT03722576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65595644|NCT03722576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595645|NCT03416348|Ethanol|ethanol|mesh-list
65595646|NCT03416348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65595647|NCT03416348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65595648|NCT03416348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65595649|NCT03416348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595650|NCT03236012|Botulinum Toxins|botulinum toxins|mesh-list
65595651|NCT03236012|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65595652|NCT03236012|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65595653|NCT03236012|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65595654|NCT03236012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65595655|NCT03236012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595656|NCT03236012|Cholinergic Agents|cholinergic agents|mesh-ancestor
65595657|NCT03236012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65393086|NCT00515073|Antimitotic Agents|antimitotic agents|mesh-ancestor
65595658|NCT03236012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595659|NCT03236012|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65595660|NCT03236012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595661|NCT02449486|Ropivacaine|ropivacaine|mesh-list
65595662|NCT02449486|Anesthetics, Local|anesthetics, local|mesh-ancestor
65595663|NCT02449486|Anesthetics|anesthetics|mesh-ancestor
65595664|NCT02449486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65595665|NCT02449486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595666|NCT02449486|Sensory System Agents|sensory system agents|mesh-ancestor
65595667|NCT02449486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595668|NCT03202186|Progesterone|progesterone|mesh-list
65595669|NCT03202186|Progestins|progestins|mesh-ancestor
65595670|NCT03202186|Hormones|hormones|mesh-ancestor
65595671|NCT03202186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65595672|NCT03202186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595673|NCT03625076|Lidocaine|lidocaine|mesh-list
65595674|NCT03625076|Propofol|propofol|mesh-list
65595675|NCT03625076|Etomidate|etomidate|mesh-list
65595676|NCT03625076|Anesthetics, Local|anesthetics, local|mesh-ancestor
65595677|NCT03625076|Anesthetics|anesthetics|mesh-ancestor
65595678|NCT03625076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65595679|NCT03625076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595680|NCT03625076|Sensory System Agents|sensory system agents|mesh-ancestor
65595681|NCT03625076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595682|NCT03625076|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65595683|NCT03625076|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65595684|NCT03625076|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65595685|NCT03625076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65595686|NCT03625076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595687|NCT03625076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65595688|NCT03625076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65595689|NCT03625076|Anesthetics, General|anesthetics, general|mesh-ancestor
65595690|NCT02445352|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65595691|NCT02445352|Ezetimibe|ezetimibe|mesh-list
65595692|NCT02445352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65595693|NCT02445352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65595694|NCT02445352|Antimetabolites|antimetabolites|mesh-ancestor
65595695|NCT02445352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595696|NCT02445352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65595697|NCT02445352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65595698|NCT02445352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65595699|NCT03693989|Fluprednisolone|fluprednisolone|mesh-list
65595700|NCT03693989|Difluprednate|difluprednate|mesh-list
65595701|NCT03693989|Glucocorticoids|glucocorticoids|mesh-ancestor
65595702|NCT03693989|Hormones|hormones|mesh-ancestor
65595703|NCT03693989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65595704|NCT03693989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595705|NCT03693989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65595706|NCT04944212|Vitamin D|vitamin d|mesh-list
65595707|NCT04944212|Vitamins|vitamins|mesh-ancestor
65595708|NCT04944212|Micronutrients|micronutrients|mesh-ancestor
65595709|NCT04944212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595710|NCT04944212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65595711|NCT03197740|Donepezil|donepezil|mesh-list
65595712|NCT03197740|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65595713|NCT03197740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65595714|NCT03197740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595715|NCT03197740|Cholinergic Agents|cholinergic agents|mesh-ancestor
65595716|NCT03197740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65595717|NCT03197740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595718|NCT03197740|Nootropic Agents|nootropic agents|mesh-ancestor
65595719|NCT03201796|Levofloxacin|levofloxacin|mesh-list
65595720|NCT03201796|Ofloxacin|ofloxacin|mesh-list
65595721|NCT03201796|Prulifloxacin|prulifloxacin|mesh-list
65595722|NCT03201796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65595723|NCT03201796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65595724|NCT03201796|Renal Agents|renal agents|mesh-ancestor
65595725|NCT03201796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65595726|NCT03201796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65595727|NCT03201796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65595728|NCT03201796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65595729|NCT03201796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595730|NCT03201796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65595731|NCT03201796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65595732|NCT03201796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65595734|NCT02727998|Ketamine|ketamine|mesh-list
65595735|NCT02727998|Analgesics|analgesics|mesh-ancestor
65595736|NCT02727998|Sensory System Agents|sensory system agents|mesh-ancestor
65595737|NCT02727998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595738|NCT02727998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595739|NCT02727998|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65595740|NCT02727998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65595741|NCT02727998|Anesthetics, General|anesthetics, general|mesh-ancestor
65595742|NCT02727998|Anesthetics|anesthetics|mesh-ancestor
65595743|NCT02727998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65595744|NCT02727998|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65595745|NCT02727998|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65595746|NCT02727998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65595747|NCT02727998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595748|NCT02727998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65595749|NCT02727998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65595750|NCT02727998|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65595751|NCT02727998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65595752|NCT02727998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65595753|NCT02727998|GABA Modulators|gaba modulators|mesh-ancestor
65595754|NCT02727998|GABA Agents|gaba agents|mesh-ancestor
65595755|NCT02636270|Mecasermin|mecasermin|mesh-list
65595756|NCT02636270|Growth Substances|growth substances|mesh-ancestor
65595757|NCT02636270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595758|NCT02108990|Acetaminophen|acetaminophen|mesh-list
65595759|NCT02108990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65595760|NCT02108990|Analgesics|analgesics|mesh-ancestor
65595761|NCT02108990|Sensory System Agents|sensory system agents|mesh-ancestor
65595762|NCT02108990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595763|NCT02108990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595764|NCT02108990|Antipyretics|antipyretics|mesh-ancestor
65595765|NCT03194074|Propofol|propofol|mesh-list
65595766|NCT03194074|Desflurane|desflurane|mesh-list
65595767|NCT03194074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65595768|NCT03194074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65595769|NCT03194074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595770|NCT03194074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65595771|NCT03194074|Anesthetics, General|anesthetics, general|mesh-ancestor
65595772|NCT03194074|Anesthetics|anesthetics|mesh-ancestor
65595773|NCT03194074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65595774|NCT03201952|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65595775|NCT03201952|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65595776|NCT03201952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65595777|NCT04179461|Vitamin D|vitamin d|mesh-list
65595778|NCT04179461|Cholecalciferol|cholecalciferol|mesh-list
65595779|NCT04179461|Fluticasone|fluticasone|mesh-list
65595780|NCT04179461|Xhance|xhance|mesh-list
65595781|NCT04179461|Mometasone Furoate|mometasone furoate|mesh-list
65595782|NCT04179461|Cetirizine|cetirizine|mesh-list
65595783|NCT04179461|Loratadine|loratadine|mesh-list
65595784|NCT04179461|Azithromycin|azithromycin|mesh-list
65595785|NCT04179461|Budesonide|budesonide|mesh-list
65595786|NCT04179461|Beclomethasone|beclomethasone|mesh-list
65595787|NCT04179461|Emollients|emollients|mesh-list
65595788|NCT04179461|Formoterol Fumarate|formoterol fumarate|mesh-list
65595789|NCT04179461|Tiotropium Bromide|tiotropium bromide|mesh-list
65595790|NCT04179461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65595791|NCT04179461|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65595792|NCT04179461|Histamine Antagonists|histamine antagonists|mesh-list
65595793|NCT04179461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
65595794|NCT04179461|Vitamins|vitamins|mesh-ancestor
65595795|NCT04179461|Micronutrients|micronutrients|mesh-ancestor
65595796|NCT04179461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595797|NCT04179461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65595798|NCT04179461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65595799|NCT04179461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65595800|NCT04179461|Autonomic Agents|autonomic agents|mesh-ancestor
65595801|NCT04179461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595802|NCT04179461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65595803|NCT04179461|Respiratory System Agents|respiratory system agents|mesh-ancestor
65595804|NCT04179461|Dermatologic Agents|dermatologic agents|mesh-ancestor
65595805|NCT04179461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65595806|NCT04179461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65595807|NCT04179461|Glucocorticoids|glucocorticoids|mesh-ancestor
65595808|NCT04179461|Hormones|hormones|mesh-ancestor
65595809|NCT04179461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65595810|NCT04179461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65595811|NCT04179461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65595812|NCT04179461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65595813|NCT04179461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65595814|NCT04179461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65595815|NCT04179461|Adrenergic Agents|adrenergic agents|mesh-ancestor
65595816|NCT04179461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65595817|NCT04179461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595818|NCT04179461|Parasympatholytics|parasympatholytics|mesh-ancestor
65595819|NCT04179461|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65595820|NCT04179461|Cholinergic Agents|cholinergic agents|mesh-ancestor
65595821|NCT04179461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65595822|NCT04179461|Histamine Agents|histamine agents|mesh-ancestor
65595823|NCT04179461|Antipruritics|antipruritics|mesh-ancestor
65595824|NCT04179461|Sympathomimetics|sympathomimetics|mesh-ancestor
65595825|NCT04844528|Niacinamide|niacinamide|mesh-list
65595826|NCT04844528|Niacin|niacin|mesh-list
65595827|NCT04844528|Nicotinic Acids|nicotinic acids|mesh-list
65595828|NCT04844528|Vitamin B Complex|vitamin b complex|mesh-ancestor
65595829|NCT04844528|Vitamins|vitamins|mesh-ancestor
65595830|NCT04844528|Micronutrients|micronutrients|mesh-ancestor
65595831|NCT04844528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595832|NCT04844528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65595833|NCT04844528|Antimetabolites|antimetabolites|mesh-ancestor
65595834|NCT04844528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595835|NCT04844528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65595836|NCT04844528|Vasodilator Agents|vasodilator agents|mesh-ancestor
65595837|NCT03196882|Iron|iron|mesh-list
65595838|NCT03196882|Trace Elements|trace elements|mesh-ancestor
65595839|NCT03196882|Micronutrients|micronutrients|mesh-ancestor
65595840|NCT03196882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595841|NCT04172831|Cyclobenzaprine|cyclobenzaprine|mesh-list
65595842|NCT04172831|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65595843|NCT04172831|Antidepressive Agents|antidepressive agents|mesh-ancestor
65595844|NCT04172831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65595845|NCT04172831|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65595846|NCT04172831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595847|NCT04172831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65595848|NCT04172831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595849|NCT04172831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65595850|NCT04172831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65595851|NCT01562717|Ibuprofen|ibuprofen|mesh-list
65595852|NCT01562717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65595853|NCT01562717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65595854|NCT01562717|Analgesics|analgesics|mesh-ancestor
65595855|NCT01562717|Sensory System Agents|sensory system agents|mesh-ancestor
65595856|NCT01562717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595857|NCT01562717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595858|NCT01562717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65595859|NCT01562717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65595860|NCT01562717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65595861|NCT01562717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65595862|NCT01562717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595863|NCT03196648|Fluorides|fluorides|mesh-list
65595864|NCT03196648|Antioxidants|antioxidants|mesh-list
65595865|NCT03196648|Cariostatic Agents|cariostatic agents|mesh-ancestor
65595866|NCT03196648|Protective Agents|protective agents|mesh-ancestor
65595867|NCT03196648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595868|NCT03196648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595869|NCT03625310|Listerine|listerine|mesh-list
65595870|NCT03625310|Fluorides|fluorides|mesh-list
65595871|NCT03625310|Sodium Fluoride|sodium fluoride|mesh-list
65595872|NCT03625310|Cariostatic Agents|cariostatic agents|mesh-ancestor
65595873|NCT03625310|Protective Agents|protective agents|mesh-ancestor
65595874|NCT03625310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595875|NCT03625310|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65595876|NCT03625310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65595877|NCT05058404|Prednisone|prednisone|mesh-list
65595878|NCT05058404|Rituximab|rituximab|mesh-list
65595879|NCT05058404|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65595880|NCT05058404|Cyclophosphamide|cyclophosphamide|mesh-list
65595881|NCT05058404|Vincristine|vincristine|mesh-list
65595882|NCT05058404|Doxorubicin|doxorubicin|mesh-list
65595883|NCT05058404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65595884|NCT05058404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65595885|NCT05058404|Immunologic Factors|immunologic factors|mesh-ancestor
65595886|NCT05058404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595887|NCT05058404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65595888|NCT05058404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65595889|NCT05058404|Alkylating Agents|alkylating agents|mesh-ancestor
65595890|NCT05058404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595891|NCT05058404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65595892|NCT05058404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65595893|NCT05058404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65595894|NCT05058404|Glucocorticoids|glucocorticoids|mesh-ancestor
65595895|NCT05058404|Hormones|hormones|mesh-ancestor
65595896|NCT05058404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65595897|NCT05058404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65595898|NCT05058404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65595899|NCT05058404|Tubulin Modulators|tubulin modulators|mesh-ancestor
65595900|NCT05058404|Antimitotic Agents|antimitotic agents|mesh-ancestor
65595901|NCT05058404|Mitosis Modulators|mitosis modulators|mesh-ancestor
65595902|NCT05058404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65595903|NCT05058404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65595904|NCT05058404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65595905|NCT05058404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65595906|NCT03118336|Empagliflozin|empagliflozin|mesh-list
65595907|NCT03118336|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65595908|NCT03118336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595909|NCT03118336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65595910|NCT03118336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595911|NCT02444572|Enoxaparin|enoxaparin|mesh-list
65595912|NCT02444572|Anticoagulants|anticoagulants|mesh-ancestor
65595913|NCT02444572|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65595914|NCT02444572|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65595915|NCT02444572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595916|NCT04165031|Docetaxel|docetaxel|mesh-list
65595917|NCT04165031|Cetuximab|cetuximab|mesh-list
65595918|NCT04165031|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65595919|NCT04165031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65595920|NCT04165031|Tubulin Modulators|tubulin modulators|mesh-ancestor
65595921|NCT04165031|Antimitotic Agents|antimitotic agents|mesh-ancestor
65595922|NCT04165031|Mitosis Modulators|mitosis modulators|mesh-ancestor
65595923|NCT04165031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595924|NCT04165031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65595925|NCT04165031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65595926|NCT04165031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65595927|NCT05480150|Dexetimide|dexetimide|mesh-list
65595928|NCT05480150|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65595929|NCT05480150|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65595930|NCT05480150|Citalopram|citalopram|mesh-list
65595931|NCT05480150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65595932|NCT05480150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65595933|NCT05480150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65595934|NCT05480150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595935|NCT05480150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65595936|NCT05480150|Serotonin Agents|serotonin agents|mesh-ancestor
65595937|NCT05480150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595938|NCT05480150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65595939|NCT05480150|Antidepressive Agents|antidepressive agents|mesh-ancestor
65595940|NCT05480150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65595941|NCT05480150|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65595942|NCT05480150|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65595943|NCT05480150|Parasympatholytics|parasympatholytics|mesh-ancestor
65595944|NCT05480150|Autonomic Agents|autonomic agents|mesh-ancestor
65595945|NCT05480150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65595946|NCT05480150|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65595947|NCT05480150|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65595948|NCT05480150|Cholinergic Agents|cholinergic agents|mesh-ancestor
65595949|NCT05480150|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65595950|NCT05480150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65595951|NCT05480150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65595952|NCT05480150|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65595953|NCT05480150|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65595954|NCT05480150|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65595955|NCT05480150|Adrenergic Agents|adrenergic agents|mesh-ancestor
65595956|NCT05480150|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65595957|NCT05480150|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65595958|NCT05480150|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65595959|NCT05480150|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65595960|NCT05480150|Dopamine Agents|dopamine agents|mesh-ancestor
65595961|NCT05464628|Atorvastatin|atorvastatin|mesh-list
65595962|NCT05464628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65595963|NCT05464628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65595964|NCT05464628|Antimetabolites|antimetabolites|mesh-ancestor
65595965|NCT05464628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595966|NCT05464628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65595967|NCT05464628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65595968|NCT05464628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65595969|NCT02449252|Prednisone|prednisone|mesh-list
65595970|NCT02449252|Cyclophosphamide|cyclophosphamide|mesh-list
65595971|NCT02449252|Doxorubicin|doxorubicin|mesh-list
65595972|NCT02449252|Vincristine|vincristine|mesh-list
65595973|NCT02449252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65595974|NCT02449252|Immunologic Factors|immunologic factors|mesh-ancestor
65595975|NCT02449252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65595976|NCT02449252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65595977|NCT02449252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65595978|NCT02449252|Alkylating Agents|alkylating agents|mesh-ancestor
65595979|NCT02449252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65595980|NCT02449252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65595981|NCT02449252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65595982|NCT02449252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65595983|NCT02449252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65595984|NCT02449252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65595985|NCT02449252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65595986|NCT02449252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65595987|NCT02449252|Glucocorticoids|glucocorticoids|mesh-ancestor
65595988|NCT02449252|Hormones|hormones|mesh-ancestor
65595989|NCT02449252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65595990|NCT02449252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65595991|NCT02449252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65595992|NCT02449252|Tubulin Modulators|tubulin modulators|mesh-ancestor
65595993|NCT02449252|Antimitotic Agents|antimitotic agents|mesh-ancestor
65595994|NCT02449252|Mitosis Modulators|mitosis modulators|mesh-ancestor
65595995|NCT03193918|Paclitaxel|paclitaxel|mesh-list
65595996|NCT03193918|Ramucirumab|ramucirumab|mesh-list
65595997|NCT03193918|Crenolanib|crenolanib|mesh-list
65595998|NCT03193918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65595999|NCT03193918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65596000|NCT03193918|Tubulin Modulators|tubulin modulators|mesh-ancestor
65596001|NCT03193918|Antimitotic Agents|antimitotic agents|mesh-ancestor
65596002|NCT03193918|Mitosis Modulators|mitosis modulators|mesh-ancestor
65596003|NCT03193918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596004|NCT03117790|Dexmedetomidine|dexmedetomidine|mesh-list
65596005|NCT03117790|Morphine|morphine|mesh-list
65596006|NCT03117790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65596007|NCT03117790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65596008|NCT03117790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596009|NCT03117790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65596010|NCT03117790|Analgesics|analgesics|mesh-ancestor
65596011|NCT03117790|Sensory System Agents|sensory system agents|mesh-ancestor
65596012|NCT03117790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65596013|NCT03117790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65596014|NCT03117790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65596015|NCT03117790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65596016|NCT03117790|Adrenergic Agents|adrenergic agents|mesh-ancestor
65596017|NCT03117790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65596018|NCT03117790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596019|NCT03117790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65596020|NCT03117790|Narcotics|narcotics|mesh-ancestor
65596021|NCT03193372|Azelaic acid|azelaic acid|mesh-list
65596022|NCT03193372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65596023|NCT03193372|Dermatologic Agents|dermatologic agents|mesh-ancestor
65596024|NCT03034772|Timolol|timolol|mesh-list
65596025|NCT03034772|Dorzolamide|dorzolamide|mesh-list
65596026|NCT03034772|Lubricant Eye Drops|lubricant eye drops|mesh-list
65596027|NCT03034772|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65596028|NCT03034772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65596029|NCT03034772|Adrenergic Agents|adrenergic agents|mesh-ancestor
65596030|NCT03034772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65596031|NCT03034772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596032|NCT03034772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596033|NCT03034772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65596034|NCT03034772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65596035|NCT03034772|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65596036|NCT03034772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65596037|NCT03034772|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65596038|NCT03034772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596040|NCT05358548|Carboplatin|carboplatin|mesh-list
65596041|NCT05358548|Pembrolizumab|pembrolizumab|mesh-list
65596042|NCT05358548|Fluorouracil|fluorouracil|mesh-list
65596043|NCT05358548|Pemetrexed|pemetrexed|mesh-list
65596044|NCT05358548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65596045|NCT05358548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65596046|NCT05358548|Tubulin Modulators|tubulin modulators|mesh-ancestor
65596047|NCT05358548|Antimitotic Agents|antimitotic agents|mesh-ancestor
65596048|NCT05358548|Mitosis Modulators|mitosis modulators|mesh-ancestor
65596049|NCT05358548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596050|NCT05358548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65596051|NCT05358548|Antimetabolites|antimetabolites|mesh-ancestor
65596052|NCT05358548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65596053|NCT05358548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65596054|NCT05358548|Immunologic Factors|immunologic factors|mesh-ancestor
65596055|NCT05358548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596056|NCT05358548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596057|NCT05358548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65596058|NCT05358548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65596059|NCT03193606|Fluorides|fluorides|mesh-list
65596060|NCT03193606|Cariostatic Agents|cariostatic agents|mesh-ancestor
65596061|NCT03193606|Protective Agents|protective agents|mesh-ancestor
65596062|NCT03193606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596063|NCT02448784|Donepezil|donepezil|mesh-list
65596064|NCT02448784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65596065|NCT02448784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596066|NCT02448784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596067|NCT02448784|Cholinergic Agents|cholinergic agents|mesh-ancestor
65596068|NCT02448784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65596069|NCT02448784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596070|NCT02448784|Nootropic Agents|nootropic agents|mesh-ancestor
65596071|NCT04050488|Zinc Sulfate|zinc sulfate|mesh-list
65596072|NCT04050488|Astringents|astringents|mesh-ancestor
65596073|NCT04050488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596074|NCT04050488|Dermatologic Agents|dermatologic agents|mesh-ancestor
65596075|NCT02584478|Paclitaxel|paclitaxel|mesh-list
65596076|NCT02584478|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65596077|NCT02584478|Carboplatin|carboplatin|mesh-list
65596078|NCT02584478|Doxorubicin|doxorubicin|mesh-list
65596079|NCT02584478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65596080|NCT02584478|Topotecan|topotecan|mesh-list
65596081|NCT02584478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65596082|NCT02584478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65596083|NCT02584478|Tubulin Modulators|tubulin modulators|mesh-ancestor
65596084|NCT02584478|Antimitotic Agents|antimitotic agents|mesh-ancestor
65596085|NCT02584478|Mitosis Modulators|mitosis modulators|mesh-ancestor
65596086|NCT02584478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596087|NCT02584478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65596088|NCT02584478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65596089|NCT02584478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65596090|NCT02584478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596091|NCT02584478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65596092|NCT03365908|Ropivacaine|ropivacaine|mesh-list
65596093|NCT03365908|Anesthetics, Local|anesthetics, local|mesh-ancestor
65596094|NCT03365908|Anesthetics|anesthetics|mesh-ancestor
65596095|NCT03365908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65596096|NCT03365908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596097|NCT03365908|Sensory System Agents|sensory system agents|mesh-ancestor
65596098|NCT03365908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65596099|NCT04779554|Mitomycins|mitomycins|mesh-list
65596100|NCT04779554|Mitomycin|mitomycin|mesh-list
65596101|NCT04779554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65596102|NCT04779554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65596103|NCT04779554|Alkylating Agents|alkylating agents|mesh-ancestor
65596104|NCT04779554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596105|NCT04779554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65596106|NCT04779554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596107|NCT02444260|Lidocaine|lidocaine|mesh-list
65596108|NCT02444260|Midazolam|midazolam|mesh-list
65596109|NCT02444260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65596110|NCT02444260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65596111|NCT02444260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65393541|NCT00931580|Vitamin D|vitamin d|mesh-list
65596112|NCT02444260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596113|NCT02444260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65596114|NCT02444260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65596115|NCT02444260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65596116|NCT02444260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65596117|NCT02444260|Anesthetics, General|anesthetics, general|mesh-ancestor
65596118|NCT02444260|Anesthetics|anesthetics|mesh-ancestor
65596119|NCT02444260|GABA Modulators|gaba modulators|mesh-ancestor
65596120|NCT02444260|GABA Agents|gaba agents|mesh-ancestor
65596121|NCT02444260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65596122|NCT02444260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596123|NCT02444260|Anesthetics, Local|anesthetics, local|mesh-ancestor
65596124|NCT02444260|Sensory System Agents|sensory system agents|mesh-ancestor
65596125|NCT02444260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65596126|NCT02444260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65596127|NCT02444260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65596128|NCT02444260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65596129|NCT02444260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65596130|NCT03195634|Carvedilol|carvedilol|mesh-list
65596131|NCT03195634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65596132|NCT03195634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65596133|NCT03195634|Adrenergic Agents|adrenergic agents|mesh-ancestor
65596134|NCT03195634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65596135|NCT03195634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596136|NCT03195634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596137|NCT03195634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65596138|NCT03195634|Antioxidants|antioxidants|mesh-ancestor
65596139|NCT03195634|Protective Agents|protective agents|mesh-ancestor
65596140|NCT03195634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65596141|NCT03195634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65596142|NCT03195634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65596143|NCT03195634|Vasodilator Agents|vasodilator agents|mesh-ancestor
65596144|NCT03195634|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65596145|NCT03195634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65596146|NCT02448550|Heparin|heparin|mesh-list
65596147|NCT02448550|Calcium heparin|calcium heparin|mesh-list
65596148|NCT02448550|Bivalirudin|bivalirudin|mesh-list
65596149|NCT02448550|Anticoagulants|anticoagulants|mesh-ancestor
65596150|NCT02448550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65596151|NCT02448550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65596152|NCT02448550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596153|NCT02448550|Antithrombins|antithrombins|mesh-ancestor
65596154|NCT02448550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65596155|NCT02448550|Protease Inhibitors|protease inhibitors|mesh-ancestor
65596156|NCT02448550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596157|NCT03701750|Heparin|heparin|mesh-list
65596158|NCT03701750|Enoxaparin|enoxaparin|mesh-list
65596159|NCT03701750|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65596160|NCT03701750|Tinzaparin|tinzaparin|mesh-list
65596161|NCT03701750|Dalteparin|dalteparin|mesh-list
65596162|NCT03701750|Enoxaparin sodium|enoxaparin sodium|mesh-list
65596163|NCT03701750|Anticoagulants|anticoagulants|mesh-ancestor
65596164|NCT03701750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65596165|NCT03701750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65596166|NCT03701750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596167|NCT03704246|Antibodies|antibodies|mesh-list
65596168|NCT03704246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65596169|NCT03704246|Immunologic Factors|immunologic factors|mesh-ancestor
65596170|NCT03704246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596171|NCT05239910|Tenalisib|tenalisib|mesh-list
65596172|NCT05239910|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
65596173|NCT05239910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596174|NCT05239910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596175|NCT03701672|Analgesics, Opioid|analgesics, opioid|mesh-list
65596176|NCT03701672|Analgesics|analgesics|mesh-list
65596177|NCT03701672|Narcotics|narcotics|mesh-ancestor
65596178|NCT03701672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65596179|NCT03701672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596180|NCT03701672|Sensory System Agents|sensory system agents|mesh-ancestor
65596181|NCT03701672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65596182|NCT03746327|Tedizolid phosphate|tedizolid phosphate|mesh-list
65596183|NCT03746327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65596184|NCT03746327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65596185|NCT03746249|Lenvatinib|lenvatinib|mesh-list
65596186|NCT03746249|Antibodies|antibodies|mesh-list
65596187|NCT03746249|Immunoglobulins|immunoglobulins|mesh-list
65596188|NCT03746249|Immunologic Factors|immunologic factors|mesh-ancestor
65596189|NCT03746249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596190|NCT03746249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65596191|NCT03746249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65596192|NCT03746249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596193|NCT03746249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596195|NCT03698474|Magnesium Sulfate|magnesium sulfate|mesh-list
65596196|NCT03698474|Picosulfate sodium|picosulfate sodium|mesh-list
65596197|NCT03698474|Magnesium citrate|magnesium citrate|mesh-list
65596198|NCT03698474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596199|NCT03698474|Analgesics|analgesics|mesh-ancestor
65596200|NCT03698474|Sensory System Agents|sensory system agents|mesh-ancestor
65596201|NCT03698474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65596202|NCT03698474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596203|NCT03698474|Anesthetics|anesthetics|mesh-ancestor
65596204|NCT03698474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65596205|NCT03698474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65596206|NCT03698474|Anticonvulsants|anticonvulsants|mesh-ancestor
65596207|NCT03698474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65596208|NCT03698474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65596209|NCT03698474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65596210|NCT03698474|Tocolytic Agents|tocolytic agents|mesh-ancestor
65596211|NCT03698474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65596212|NCT03698474|Antioxidants|antioxidants|mesh-ancestor
65596213|NCT03698474|Protective Agents|protective agents|mesh-ancestor
65596214|NCT03698474|Vitamins|vitamins|mesh-ancestor
65596215|NCT03698474|Micronutrients|micronutrients|mesh-ancestor
65596216|NCT03698474|Cathartics|cathartics|mesh-ancestor
65596217|NCT03698474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65596218|NCT04710368|Evolocumab|evolocumab|mesh-list
65596219|NCT04710368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65596220|NCT04710368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65596221|NCT04710368|Antimetabolites|antimetabolites|mesh-ancestor
65596222|NCT04710368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596223|NCT04710368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65596224|NCT04709276|Carboplatin|carboplatin|mesh-list
65596225|NCT04709276|Nivolumab|nivolumab|mesh-list
65596226|NCT04709276|Ipilimumab|ipilimumab|mesh-list
65596227|NCT04709276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65596228|NCT04709276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65596229|NCT04709276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65596230|NCT04709276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596231|NCT01194622|Fluticasone|fluticasone|mesh-list
65596232|NCT01194622|Xhance|xhance|mesh-list
65596233|NCT01194622|Azelastine|azelastine|mesh-list
65596234|NCT01194622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65596235|NCT01194622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65596236|NCT01194622|Autonomic Agents|autonomic agents|mesh-ancestor
65596237|NCT01194622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65596238|NCT01194622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596239|NCT01194622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65596240|NCT01194622|Respiratory System Agents|respiratory system agents|mesh-ancestor
65596241|NCT01194622|Dermatologic Agents|dermatologic agents|mesh-ancestor
65596242|NCT01194622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65596243|NCT01194622|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65596244|NCT01194622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596245|NCT01194622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596246|NCT01194622|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65596247|NCT01194622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65596248|NCT01194622|Histamine Antagonists|histamine antagonists|mesh-ancestor
65596249|NCT01194622|Histamine Agents|histamine agents|mesh-ancestor
65596250|NCT01194622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65596251|NCT02448316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65596252|NCT02448316|Methylprednisolone|methylprednisolone|mesh-list
65596253|NCT02448316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65596254|NCT02448316|Prednisolone|prednisolone|mesh-list
65596255|NCT02448316|Prednisolone acetate|prednisolone acetate|mesh-list
65596256|NCT02448316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65596257|NCT02448316|Prednisolone phosphate|prednisolone phosphate|mesh-list
65596258|NCT02448316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65596259|NCT02448316|Antiemetics|antiemetics|mesh-ancestor
65596260|NCT02448316|Autonomic Agents|autonomic agents|mesh-ancestor
65596261|NCT02448316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65596262|NCT02448316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596263|NCT02448316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65596264|NCT02448316|Glucocorticoids|glucocorticoids|mesh-ancestor
65596265|NCT02448316|Hormones|hormones|mesh-ancestor
65596266|NCT02448316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65596267|NCT02448316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65596268|NCT02448316|Protective Agents|protective agents|mesh-ancestor
65596269|NCT02448316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65596270|NCT02448316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65596271|NCT04564898|Trifluridine|trifluridine|mesh-list
65596272|NCT04564898|Bevacizumab|bevacizumab|mesh-list
65596273|NCT04564898|Capecitabine|capecitabine|mesh-list
65596274|NCT04564898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65596275|NCT04564898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65596276|NCT04564898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65596277|NCT04564898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65596278|NCT04564898|Growth Substances|growth substances|mesh-ancestor
65596279|NCT04564898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596280|NCT04564898|Growth Inhibitors|growth inhibitors|mesh-ancestor
65596281|NCT04564898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65596282|NCT04564898|Antimetabolites|antimetabolites|mesh-ancestor
65596283|NCT04564898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596284|NCT04564898|Antiviral Agents|antiviral agents|mesh-ancestor
65596285|NCT04564898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65596286|NCT02443714|Insulin|insulin|mesh-list
65596287|NCT02443714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65596288|NCT02443714|Insulin Lispro|insulin lispro|mesh-list
65596289|NCT02443714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65596290|NCT02443714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596291|NCT03703310|Veratrum Alkaloids|veratrum alkaloids|mesh-list
65596292|NCT03703310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65596293|NCT03703154|Tacrolimus|tacrolimus|mesh-list
65596294|NCT03703154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65596295|NCT03703154|Immunologic Factors|immunologic factors|mesh-ancestor
65596296|NCT03703154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596297|NCT03703154|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65596298|NCT03703154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596299|NCT03703154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596300|NCT02434276|Hemagglutinins|hemagglutinins|mesh-list
65596301|NCT02434276|Immunologic Factors|immunologic factors|mesh-ancestor
65596302|NCT02434276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596303|NCT02434276|Agglutinins|agglutinins|mesh-ancestor
65596304|NCT03190642|Methylprednisolone|methylprednisolone|mesh-list
65596305|NCT03190642|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65596306|NCT03190642|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65596307|NCT03190642|Prednisolone|prednisolone|mesh-list
65596308|NCT03190642|Prednisolone acetate|prednisolone acetate|mesh-list
65596309|NCT03190642|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65596310|NCT03190642|Prednisolone phosphate|prednisolone phosphate|mesh-list
65596311|NCT03190642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65596312|NCT03190642|Antiemetics|antiemetics|mesh-ancestor
65596313|NCT03190642|Autonomic Agents|autonomic agents|mesh-ancestor
65596314|NCT03190642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65596315|NCT03190642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596316|NCT03190642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65596317|NCT03190642|Glucocorticoids|glucocorticoids|mesh-ancestor
65596318|NCT03190642|Hormones|hormones|mesh-ancestor
65596319|NCT03190642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65596320|NCT03190642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65596321|NCT03190642|Protective Agents|protective agents|mesh-ancestor
65596322|NCT03190642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65596323|NCT03190642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65596324|NCT03702530|Albendazole|albendazole|mesh-list
65596325|NCT03702530|Anthelmintics|anthelmintics|mesh-ancestor
65596326|NCT03702530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65596327|NCT03702530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65596328|NCT03702530|Anticestodal Agents|anticestodal agents|mesh-ancestor
65596329|NCT03702530|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65596330|NCT03702530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65596331|NCT03702530|Tubulin Modulators|tubulin modulators|mesh-ancestor
65596332|NCT03702530|Antimitotic Agents|antimitotic agents|mesh-ancestor
65596333|NCT03702530|Mitosis Modulators|mitosis modulators|mesh-ancestor
65596334|NCT03702530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596335|NCT03702530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65596336|NCT02443246|Vitamin D|vitamin d|mesh-list
65596337|NCT02443246|Cholecalciferol|cholecalciferol|mesh-list
65596338|NCT02443246|Vitamins|vitamins|mesh-ancestor
65596339|NCT02443246|Micronutrients|micronutrients|mesh-ancestor
65393764|NCT00926900|Cycloserine|cycloserine|mesh-list
65596340|NCT02443246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596341|NCT02443246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65596342|NCT02443246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65596343|NCT03031496|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65596345|NCT03031496|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
65596346|NCT03031496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65596347|NCT03031496|Diuretics|diuretics|mesh-ancestor
65596348|NCT03031496|Natriuretic Agents|natriuretic agents|mesh-ancestor
65596349|NCT03031496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596350|NCT03031496|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65596351|NCT03031496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65596352|NCT03031496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596353|NCT03031496|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65596354|NCT03031496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65596355|NCT03031496|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65596356|NCT03031496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65596357|NCT03187912|Riboflavin|riboflavin|mesh-list
65596358|NCT03187912|Vitamin B Complex|vitamin b complex|mesh-ancestor
65596359|NCT03187912|Vitamins|vitamins|mesh-ancestor
65596360|NCT03187912|Micronutrients|micronutrients|mesh-ancestor
65596361|NCT03187912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596362|NCT03187912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65596363|NCT03187912|Dermatologic Agents|dermatologic agents|mesh-ancestor
65596364|NCT03702218|Antiviral Agents|antiviral agents|mesh-list
65596365|NCT03702218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65596366|NCT02443012|Nepafenac|nepafenac|mesh-list
65596367|NCT02443012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64597240|NCT00628589|Dopamine Agents|dopamine agents|mesh-ancestor
65596368|NCT02443012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65596369|NCT02443012|Analgesics|analgesics|mesh-ancestor
65596370|NCT02443012|Sensory System Agents|sensory system agents|mesh-ancestor
65596371|NCT02443012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65596372|NCT02443012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596373|NCT02443012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65596374|NCT02443012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65596375|NCT04670432|Troxerutin|troxerutin|mesh-list
65596376|NCT04670432|Anticoagulants|anticoagulants|mesh-ancestor
65596377|NCT03701126|Bupivacaine|bupivacaine|mesh-list
65596378|NCT03701126|Anesthetics, Local|anesthetics, local|mesh-ancestor
65596379|NCT03701126|Anesthetics|anesthetics|mesh-ancestor
65596380|NCT03701126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65596381|NCT03701126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596382|NCT03701126|Sensory System Agents|sensory system agents|mesh-ancestor
65596383|NCT03701126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65596384|NCT04370054|Factor VIII|factor viii|mesh-list
65596385|NCT04370054|Coagulants|coagulants|mesh-ancestor
65596386|NCT03702140|Teriparatide|teriparatide|mesh-list
65596387|NCT03702140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65596388|NCT03702140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596389|NCT03702140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65596390|NCT03700814|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65596391|NCT03700814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65596392|NCT03700814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65596393|NCT03700814|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65596394|NCT03700814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596395|NCT03700814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596396|NCT02433808|Neostigmine|neostigmine|mesh-list
65596397|NCT02433808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65596398|NCT02433808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596399|NCT02433808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596400|NCT02433808|Cholinergic Agents|cholinergic agents|mesh-ancestor
65596401|NCT02433808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65596402|NCT02433808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596403|NCT02433808|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65596404|NCT02433808|Autonomic Agents|autonomic agents|mesh-ancestor
65596405|NCT02433808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65596406|NCT03701984|Lidocaine|lidocaine|mesh-list
65596407|NCT03701984|Tramadol|tramadol|mesh-list
65596408|NCT03701984|Anesthetics, Local|anesthetics, local|mesh-ancestor
65596409|NCT03701984|Anesthetics|anesthetics|mesh-ancestor
65596410|NCT03701984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65596411|NCT03701984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596412|NCT03701984|Sensory System Agents|sensory system agents|mesh-ancestor
65596413|NCT03701984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65596414|NCT03701984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65596415|NCT03701984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65596416|NCT03701984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65596417|NCT03701984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65596418|NCT03701984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596419|NCT03701984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65596420|NCT03701984|Narcotics|narcotics|mesh-ancestor
65596421|NCT03701984|Analgesics|analgesics|mesh-ancestor
65596422|NCT04651400|Antithrombins|antithrombins|mesh-list
65596423|NCT04651400|Antithrombin III|antithrombin iii|mesh-list
65596424|NCT04651400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65596425|NCT04651400|Protease Inhibitors|protease inhibitors|mesh-ancestor
65596426|NCT04651400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596427|NCT04651400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596428|NCT04651400|Anticoagulants|anticoagulants|mesh-ancestor
65596429|NCT02439190|Aspirin|aspirin|mesh-list
65596430|NCT02439190|Clopidogrel|clopidogrel|mesh-list
65596431|NCT02439190|BMS-986120|bms-986120|mesh-list
65596432|NCT02439190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65596433|NCT02439190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65596434|NCT02439190|Analgesics|analgesics|mesh-ancestor
65596435|NCT02439190|Sensory System Agents|sensory system agents|mesh-ancestor
65596436|NCT02439190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65596437|NCT02439190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596438|NCT02439190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65596439|NCT02439190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65596440|NCT02439190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65596441|NCT02439190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65596442|NCT02439190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596443|NCT02439190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65596444|NCT02439190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65596445|NCT02439190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596446|NCT02439190|Antipyretics|antipyretics|mesh-ancestor
65596447|NCT02439190|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65596448|NCT02439190|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65596449|NCT02439190|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65596450|NCT02439190|Purinergic Agents|purinergic agents|mesh-ancestor
65596451|NCT02439190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65596452|NCT02442466|BQ 788|bq 788|mesh-list
65596453|NCT02442466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65596454|NCT02442466|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65596455|NCT02442466|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65596456|NCT02442466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596457|NCT04336982|Azacitidine|azacitidine|mesh-list
65596458|NCT04336982|Venetoclax|venetoclax|mesh-list
65596459|NCT04336982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65596460|NCT04336982|Antimetabolites|antimetabolites|mesh-ancestor
65596461|NCT04336982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596462|NCT04336982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65596463|NCT04336982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596464|NCT02439034|Acetaminophen|acetaminophen|mesh-list
65596465|NCT02439034|Ketoprofen|ketoprofen|mesh-list
65596466|NCT02439034|Codeine|codeine|mesh-list
65596467|NCT02439034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65596468|NCT02439034|Analgesics|analgesics|mesh-ancestor
65596469|NCT02439034|Sensory System Agents|sensory system agents|mesh-ancestor
65596470|NCT02439034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65596471|NCT02439034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596472|NCT02439034|Antipyretics|antipyretics|mesh-ancestor
65596473|NCT02439034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65596474|NCT02439034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65596475|NCT02439034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65596476|NCT02439034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65596477|NCT02439034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596478|NCT02439034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596479|NCT02439034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65596480|NCT02439034|Narcotics|narcotics|mesh-ancestor
65596481|NCT02439034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65596482|NCT02439034|Antitussive Agents|antitussive agents|mesh-ancestor
65596483|NCT02439034|Respiratory System Agents|respiratory system agents|mesh-ancestor
65596484|NCT04239092|Cyclophosphamide|cyclophosphamide|mesh-list
65596485|NCT04239092|Temozolomide|temozolomide|mesh-list
65596486|NCT04239092|Irinotecan|irinotecan|mesh-list
65596487|NCT04239092|Topotecan|topotecan|mesh-list
65596488|NCT04239092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65596489|NCT04239092|Immunologic Factors|immunologic factors|mesh-ancestor
65596490|NCT04239092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596491|NCT04239092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65596492|NCT04239092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65596493|NCT04239092|Alkylating Agents|alkylating agents|mesh-ancestor
65596494|NCT04239092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596495|NCT04239092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65596496|NCT04239092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65596497|NCT04239092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65596498|NCT04239092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65596499|NCT04239092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596501|NCT04483492|Caffeine citrate|caffeine citrate|mesh-list
65596502|NCT04483492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596503|NCT04483492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65596504|NCT04483492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596505|NCT04483492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65596506|NCT04483492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596507|NCT04483492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65596508|NCT04483492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65596509|NCT04483492|Purinergic Agents|purinergic agents|mesh-ancestor
65596510|NCT04483492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65596511|NCT03186742|Eplerenone|eplerenone|mesh-list
65596512|NCT03186742|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65596513|NCT03186742|Hormone Antagonists|hormone antagonists|mesh-ancestor
65596514|NCT03186742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65596515|NCT03186742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596516|NCT03186742|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65596517|NCT03186742|Diuretics|diuretics|mesh-ancestor
65596518|NCT03186742|Natriuretic Agents|natriuretic agents|mesh-ancestor
65596519|NCT03186742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65596520|NCT03186664|Nabiximols|nabiximols|mesh-list
65596521|NCT03186664|Analgesics|analgesics|mesh-ancestor
65596522|NCT03186664|Sensory System Agents|sensory system agents|mesh-ancestor
65596523|NCT03186664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65596524|NCT03186664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596525|NCT02441842|Atenolol|atenolol|mesh-list
65596526|NCT02441842|Lisinopril|lisinopril|mesh-list
65596527|NCT02441842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65596528|NCT02441842|Protease Inhibitors|protease inhibitors|mesh-ancestor
65596529|NCT02441842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596530|NCT02441842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596531|NCT02441842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65596532|NCT02441842|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65596533|NCT02441842|Protective Agents|protective agents|mesh-ancestor
65596534|NCT02441842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596535|NCT02441842|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65596536|NCT02441842|Sympatholytics|sympatholytics|mesh-ancestor
65596537|NCT02441842|Autonomic Agents|autonomic agents|mesh-ancestor
65596538|NCT02441842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65596539|NCT02441842|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65596540|NCT02441842|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65596541|NCT02441842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65596542|NCT02441842|Adrenergic Agents|adrenergic agents|mesh-ancestor
65596543|NCT02441842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65596544|NCT02438566|Tranexamic Acid|tranexamic acid|mesh-list
65596545|NCT02438566|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65596546|NCT02438566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65596547|NCT02438566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596548|NCT02438566|Hemostatics|hemostatics|mesh-ancestor
65596549|NCT02438566|Coagulants|coagulants|mesh-ancestor
65596550|NCT02433652|Vaccines|vaccines|mesh-list
65596551|NCT02433652|Immunologic Factors|immunologic factors|mesh-ancestor
65596552|NCT02433652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596553|NCT03186586|Ulipristal acetate|ulipristal acetate|mesh-list
65596554|NCT03186586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65596555|NCT03186586|Contraceptive Agents|contraceptive agents|mesh-ancestor
65596556|NCT03186586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65596557|NCT03186586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596558|NCT03186586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65596559|NCT02433418|Diclofenac|diclofenac|mesh-list
65596560|NCT02433418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65596561|NCT02433418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65596562|NCT02433418|Analgesics|analgesics|mesh-ancestor
65596563|NCT02433418|Sensory System Agents|sensory system agents|mesh-ancestor
65596564|NCT02433418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65596565|NCT02433418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393992|NCT00446992|Olanzapine|olanzapine|mesh-list
65596566|NCT02433418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65596567|NCT02433418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65596568|NCT02433418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65596569|NCT02433418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596570|NCT02433418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596572|NCT02433730|Androgens|androgens|mesh-ancestor
65596573|NCT02433730|Hormones|hormones|mesh-ancestor
65596574|NCT02433730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65596575|NCT02433730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596576|NCT02438098|Rivaroxaban|rivaroxaban|mesh-list
65596577|NCT02438098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65596578|NCT02438098|Antithrombins|antithrombins|mesh-ancestor
65596579|NCT02438098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65596580|NCT02438098|Protease Inhibitors|protease inhibitors|mesh-ancestor
65596581|NCT02438098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596582|NCT02438098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596583|NCT02438098|Anticoagulants|anticoagulants|mesh-ancestor
65596584|NCT02441530|Vitamin D|vitamin d|mesh-list
65596585|NCT02441530|Vitamins|vitamins|mesh-list
65596586|NCT02441530|Vitamin E|vitamin e|mesh-list
65596587|NCT02441530|Ibuprofen|ibuprofen|mesh-list
65596588|NCT02441530|Micronutrients|micronutrients|mesh-ancestor
65596589|NCT02441530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596590|NCT02441530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65596591|NCT02441530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65596592|NCT02441530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65596593|NCT02441530|Analgesics|analgesics|mesh-ancestor
65596594|NCT02441530|Sensory System Agents|sensory system agents|mesh-ancestor
65596595|NCT02441530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65596596|NCT02441530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65596597|NCT02441530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65596598|NCT02441530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65596599|NCT02441530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596600|NCT02441530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596601|NCT02441530|Antioxidants|antioxidants|mesh-ancestor
65596602|NCT02441530|Protective Agents|protective agents|mesh-ancestor
65596603|NCT02433184|Hydroxychloroquine|hydroxychloroquine|mesh-list
65596604|NCT02433184|Sulfasalazine|sulfasalazine|mesh-list
65596605|NCT02433184|Etanercept|etanercept|mesh-list
65596606|NCT02433184|Methotrexate|methotrexate|mesh-list
65596607|NCT02433184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65596608|NCT02433184|Abortifacient Agents|abortifacient agents|mesh-ancestor
65596609|NCT02433184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65596610|NCT02433184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596611|NCT02433184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65596612|NCT02433184|Antimetabolites|antimetabolites|mesh-ancestor
65596613|NCT02433184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596614|NCT02433184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65596615|NCT02433184|Dermatologic Agents|dermatologic agents|mesh-ancestor
65596616|NCT02433184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596617|NCT02433184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65596618|NCT02433184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65596619|NCT02433184|Immunologic Factors|immunologic factors|mesh-ancestor
65596620|NCT02433184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65596621|NCT02433184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65596622|NCT02433184|Antimalarials|antimalarials|mesh-ancestor
65596623|NCT02433184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65596624|NCT02433184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65596625|NCT02433184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65596626|NCT02433184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65596627|NCT02433184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65596628|NCT02433184|Analgesics|analgesics|mesh-ancestor
65596629|NCT02433184|Sensory System Agents|sensory system agents|mesh-ancestor
65596630|NCT02433184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65596631|NCT02433184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65596632|NCT02433184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65596633|NCT02438020|Metformin|metformin|mesh-list
65596634|NCT02438020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65596635|NCT02438020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596636|NCT02440750|Dienogest|dienogest|mesh-list
65596637|NCT02440750|Ulipristal acetate|ulipristal acetate|mesh-list
65596638|NCT02440750|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65596639|NCT02440750|Contraceptive Agents|contraceptive agents|mesh-ancestor
65596640|NCT02440750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65596641|NCT02440750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596642|NCT02440750|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65596643|NCT02440750|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65596644|NCT02440750|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65596645|NCT02440750|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65596646|NCT02440750|Hormone Antagonists|hormone antagonists|mesh-ancestor
65596647|NCT02440750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65596648|NCT02440750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65596649|NCT02440750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65596650|NCT03186352|Anti-Infective Agents|anti-infective agents|mesh-list
65596651|NCT03186352|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65596652|NCT02432872|Cytarabine|cytarabine|mesh-list
65596653|NCT02432872|Daunorubicin|daunorubicin|mesh-list
65596654|NCT02432872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65596655|NCT02432872|Antimetabolites|antimetabolites|mesh-ancestor
65596656|NCT02432872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596657|NCT02432872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65596658|NCT02432872|Antiviral Agents|antiviral agents|mesh-ancestor
65596659|NCT02432872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65596660|NCT02432872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65596661|NCT02432872|Immunologic Factors|immunologic factors|mesh-ancestor
65596662|NCT02432872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596663|NCT02432872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65596664|NCT02432872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65596665|NCT02432872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65596666|NCT02432872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596667|NCT02432248|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65596668|NCT02432248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65596669|NCT02432248|Immunologic Factors|immunologic factors|mesh-ancestor
65596670|NCT02432248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596671|NCT02436928|Vaccines|vaccines|mesh-list
65596672|NCT02436928|Immunologic Factors|immunologic factors|mesh-ancestor
65596673|NCT02436928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596674|NCT02436538|Hormones|hormones|mesh-list
65596675|NCT02436538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65596676|NCT02436538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596677|NCT02436694|Dexamethasone|dexamethasone|mesh-list
65596678|NCT02436694|Dexamethasone acetate|dexamethasone acetate|mesh-list
65596679|NCT02436694|Ropivacaine|ropivacaine|mesh-list
65596680|NCT02436694|Anesthetics, Local|anesthetics, local|mesh-list
65596681|NCT02436694|Anesthetics|anesthetics|mesh-list
65596682|NCT02436694|BB 1101|bb 1101|mesh-list
65596683|NCT02436694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65596684|NCT02436694|Antiemetics|antiemetics|mesh-ancestor
65596685|NCT02436694|Autonomic Agents|autonomic agents|mesh-ancestor
65596686|NCT02436694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65596687|NCT02436694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596688|NCT02436694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65596689|NCT02436694|Glucocorticoids|glucocorticoids|mesh-ancestor
65596690|NCT02436694|Hormones|hormones|mesh-ancestor
65596691|NCT02436694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65596692|NCT02436694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65596693|NCT02436694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65596694|NCT02436694|Protease Inhibitors|protease inhibitors|mesh-ancestor
65596695|NCT02436694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596696|NCT02436694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596697|NCT02436694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65596698|NCT02436694|Sensory System Agents|sensory system agents|mesh-ancestor
65596699|NCT03186040|Lacosamide|lacosamide|mesh-list
65596700|NCT03186040|Anticonvulsants|anticonvulsants|mesh-ancestor
65596701|NCT03186040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65596702|NCT03186040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65596703|NCT03186040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65596704|NCT03186040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596705|NCT02659020|Gemcitabine|gemcitabine|mesh-list
65596706|NCT02659020|Docetaxel|docetaxel|mesh-list
65596707|NCT02659020|Olaratumab|olaratumab|mesh-list
65596708|NCT02659020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65596709|NCT02659020|Antimetabolites|antimetabolites|mesh-ancestor
65596710|NCT02659020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596711|NCT02659020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65596712|NCT02659020|Antiviral Agents|antiviral agents|mesh-ancestor
65596713|NCT02659020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65596714|NCT02659020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596715|NCT02659020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65394141|NCT00502671|Capecitabine|capecitabine|mesh-list
65596716|NCT02659020|Immunologic Factors|immunologic factors|mesh-ancestor
65596717|NCT02659020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596718|NCT02659020|Tubulin Modulators|tubulin modulators|mesh-ancestor
65596719|NCT02659020|Antimitotic Agents|antimitotic agents|mesh-ancestor
65596720|NCT02659020|Mitosis Modulators|mitosis modulators|mesh-ancestor
65596721|NCT03482011|Mirikizumab|mirikizumab|mesh-list
65596722|NCT03482011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65596723|NCT03482011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65596724|NCT03482011|Analgesics|analgesics|mesh-ancestor
65596725|NCT03482011|Sensory System Agents|sensory system agents|mesh-ancestor
65596726|NCT03482011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65596727|NCT03482011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596728|NCT03482011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65596729|NCT03482011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65596730|NCT03482011|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65596731|NCT03482011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65596732|NCT02436226|Citric Acid|citric acid|mesh-list
65596733|NCT02436226|Sodium Citrate|sodium citrate|mesh-list
65596734|NCT02436226|Clomiphene|clomiphene|mesh-list
65596735|NCT02436226|Enclomiphene|enclomiphene|mesh-list
65596736|NCT02436226|Zuclomiphene|zuclomiphene|mesh-list
65596737|NCT02436226|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65596738|NCT02436226|Anticoagulants|anticoagulants|mesh-ancestor
65596739|NCT02436226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65596740|NCT02436226|Chelating Agents|chelating agents|mesh-ancestor
65596741|NCT02436226|Sequestering Agents|sequestering agents|mesh-ancestor
65596742|NCT02436226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596743|NCT02436226|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65596744|NCT02436226|Hormone Antagonists|hormone antagonists|mesh-ancestor
65596745|NCT02436226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65596746|NCT02436226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596747|NCT02436226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65596748|NCT02436226|Fertility Agents|fertility agents|mesh-ancestor
65596749|NCT02436226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65596750|NCT02436226|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65596751|NCT02436226|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65596752|NCT01374126|Azithromycin|azithromycin|mesh-list
65596753|NCT01374126|Artesunate|artesunate|mesh-list
65596754|NCT01374126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65596755|NCT01374126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65596756|NCT01374126|Antimalarials|antimalarials|mesh-ancestor
65596757|NCT01374126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65596758|NCT01374126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65596759|NCT01374126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65596760|NCT01374126|Antiviral Agents|antiviral agents|mesh-ancestor
65596761|NCT01374126|Schistosomicides|schistosomicides|mesh-ancestor
65596762|NCT01374126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65596763|NCT01374126|Anthelmintics|anthelmintics|mesh-ancestor
65596764|NCT02584920|Rituximab|rituximab|mesh-list
65596765|NCT02584920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65596766|NCT02584920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65596767|NCT02584920|Immunologic Factors|immunologic factors|mesh-ancestor
65596768|NCT02584920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596769|NCT02584920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65596770|NCT02431936|Prazosin|prazosin|mesh-list
65596771|NCT02431936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65596772|NCT02431936|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65596773|NCT02431936|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65596774|NCT02431936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65596775|NCT02431936|Adrenergic Agents|adrenergic agents|mesh-ancestor
65596776|NCT02431936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65596777|NCT02431936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596778|NCT02431936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596779|NCT02440828|Tobramycin|tobramycin|mesh-list
65596780|NCT02440828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65596781|NCT02440828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65596782|NCT01311037|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65596783|NCT01311037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65596784|NCT01311037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596785|NCT01311037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596786|NCT01311037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65596787|NCT01311037|Hormone Antagonists|hormone antagonists|mesh-ancestor
65596788|NCT01311037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65596789|NCT01311037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596790|NCT03789318|Acetaminophen|acetaminophen|mesh-list
65596791|NCT03789318|Fentanyl|fentanyl|mesh-list
65596792|NCT03789318|Oxycodone|oxycodone|mesh-list
65596793|NCT03789318|Hydromorphone|hydromorphone|mesh-list
65596794|NCT03789318|Bupivacaine|bupivacaine|mesh-list
65596795|NCT03789318|Anesthetics, Local|anesthetics, local|mesh-ancestor
65596796|NCT03789318|Anesthetics|anesthetics|mesh-ancestor
65596797|NCT03789318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65596798|NCT03789318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596799|NCT03789318|Sensory System Agents|sensory system agents|mesh-ancestor
65596800|NCT03789318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65596801|NCT03789318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65596802|NCT03789318|Narcotics|narcotics|mesh-ancestor
65596803|NCT03789318|Analgesics|analgesics|mesh-ancestor
65596804|NCT03789318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65596805|NCT03789318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65596806|NCT03789318|Anesthetics, General|anesthetics, general|mesh-ancestor
65596807|NCT03789318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65596808|NCT03789318|Antipyretics|antipyretics|mesh-ancestor
65596809|NCT04518410|Bamlanivimab|bamlanivimab|mesh-list
65596810|NCT04518410|Gabexate|gabexate|mesh-list
65596811|NCT04518410|Immunoglobulins|immunoglobulins|mesh-list
65596812|NCT04518410|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65596813|NCT04518410|Antibodies|antibodies|mesh-list
65596814|NCT04518410|Camostat|camostat|mesh-list
65596815|NCT04518410|Immunologic Factors|immunologic factors|mesh-ancestor
65596816|NCT04518410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596817|NCT04518410|Protease Inhibitors|protease inhibitors|mesh-ancestor
65596818|NCT04518410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596819|NCT04518410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596820|NCT04518410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65596821|NCT04518410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65596822|NCT04518410|Anticoagulants|anticoagulants|mesh-ancestor
65596823|NCT04518410|Antiviral Agents|antiviral agents|mesh-ancestor
65596824|NCT04518410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65596825|NCT02435368|Mycophenolic Acid|mycophenolic acid|mesh-list
65596826|NCT02435368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65596827|NCT02435368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65596828|NCT02435368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65596829|NCT02435368|Antitubercular Agents|antitubercular agents|mesh-ancestor
65596830|NCT02435368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65596831|NCT02435368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65596832|NCT02435368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596833|NCT02435368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596834|NCT05160090|Bupropion|bupropion|mesh-list
65596835|NCT05160090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65596836|NCT05160090|Antidepressive Agents|antidepressive agents|mesh-ancestor
65596837|NCT05160090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65596838|NCT05160090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65596839|NCT05160090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65596840|NCT05160090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65596841|NCT05160090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596842|NCT05160090|Dopamine Agents|dopamine agents|mesh-ancestor
65596843|NCT05160090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65596844|NCT05160090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596845|NCT05160090|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65596846|NCT05160090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65596847|NCT05160090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596848|NCT00695214|Propofol|propofol|mesh-list
65596849|NCT00695214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65596850|NCT00695214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65596851|NCT00695214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596852|NCT00695214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65596853|NCT00695214|Anesthetics, General|anesthetics, general|mesh-ancestor
65596854|NCT00695214|Anesthetics|anesthetics|mesh-ancestor
65596855|NCT04516616|Paclitaxel|paclitaxel|mesh-list
65596856|NCT04516616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65596857|NCT04516616|Cisplatin|cisplatin|mesh-list
65596858|NCT04516616|Antibodies|antibodies|mesh-list
65596859|NCT04516616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65596860|NCT04516616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65596861|NCT04516616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65596862|NCT04516616|Tubulin Modulators|tubulin modulators|mesh-ancestor
65596863|NCT04516616|Antimitotic Agents|antimitotic agents|mesh-ancestor
65596864|NCT04516616|Mitosis Modulators|mitosis modulators|mesh-ancestor
65596865|NCT04516616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596866|NCT04516616|Immunologic Factors|immunologic factors|mesh-ancestor
65596867|NCT04516616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596868|NCT00511134|Eszopiclone|eszopiclone|mesh-list
65596869|NCT00511134|Bupropion|bupropion|mesh-list
65596870|NCT00511134|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65596871|NCT00511134|Antidepressive Agents|antidepressive agents|mesh-ancestor
65596872|NCT00511134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65596873|NCT00511134|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65596874|NCT00511134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65596875|NCT00511134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65596876|NCT00511134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596877|NCT00511134|Dopamine Agents|dopamine agents|mesh-ancestor
65596878|NCT00511134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65596879|NCT00511134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596880|NCT00511134|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65596881|NCT00511134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65596882|NCT00511134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596883|NCT00511134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65596884|NCT00511134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65596885|NCT05103228|Menotropins|menotropins|mesh-list
65596886|NCT05103228|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65596887|NCT05103228|Hormones|hormones|mesh-ancestor
65596888|NCT05103228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65596889|NCT05103228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596890|NCT05103228|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65596891|NCT05103228|Fertility Agents|fertility agents|mesh-ancestor
65596892|NCT05103228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65596893|NCT01372384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65596894|NCT01372384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65596895|NCT01372384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65596896|NCT01372384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596897|NCT01372384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596898|NCT05082480|Hyaluronic Acid|hyaluronic acid|mesh-list
65596899|NCT05082480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65596900|NCT05082480|Immunologic Factors|immunologic factors|mesh-ancestor
65596901|NCT05082480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596902|NCT05082480|Viscosupplements|viscosupplements|mesh-ancestor
65596903|NCT05082480|Protective Agents|protective agents|mesh-ancestor
65596904|NCT03190798|Canagliflozin|canagliflozin|mesh-list
65596905|NCT03190798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65596906|NCT03190798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596907|NCT03190798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65596908|NCT03190798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596909|NCT03696290|Aztreonam|aztreonam|mesh-list
65596910|NCT03696290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65596911|NCT03696290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65596912|NCT03696212|Pembrolizumab|pembrolizumab|mesh-list
65596913|NCT03696212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65596914|NCT03696212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65596915|NCT03692546|Bupivacaine|bupivacaine|mesh-list
65596916|NCT03692546|Anesthetics, Local|anesthetics, local|mesh-ancestor
65596917|NCT03692546|Anesthetics|anesthetics|mesh-ancestor
65596918|NCT03692546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65596919|NCT03692546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596920|NCT03692546|Sensory System Agents|sensory system agents|mesh-ancestor
65596921|NCT03692546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65596922|NCT03480763|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65596923|NCT03480763|Immunologic Factors|immunologic factors|mesh-ancestor
65596924|NCT03480763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596925|NCT02434822|Vaccines|vaccines|mesh-list
65596926|NCT02434822|Immunologic Factors|immunologic factors|mesh-ancestor
65596927|NCT02434822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596928|NCT01371474|Paroxetine|paroxetine|mesh-list
65596929|NCT01371474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65596930|NCT01371474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65596931|NCT01371474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65596932|NCT01371474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596933|NCT01371474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65596934|NCT01371474|Serotonin Agents|serotonin agents|mesh-ancestor
65596935|NCT01371474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596936|NCT01371474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65596937|NCT01371474|Antidepressive Agents|antidepressive agents|mesh-ancestor
65596938|NCT01371474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65596939|NCT01371474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65394370|NCT00699335|Fentanyl|fentanyl|mesh-list
65596940|NCT01371474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65596941|NCT01371474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596942|NCT03185104|Fluorides|fluorides|mesh-list
65596943|NCT03185104|Cariostatic Agents|cariostatic agents|mesh-ancestor
65596944|NCT03185104|Protective Agents|protective agents|mesh-ancestor
65596945|NCT03185104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596946|NCT01319994|Metformin|metformin|mesh-list
65596947|NCT01319994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65596948|NCT01319994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596949|NCT02430298|Melatonin|melatonin|mesh-list
65596950|NCT02430298|Antioxidants|antioxidants|mesh-ancestor
65596951|NCT02430298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596952|NCT02430298|Protective Agents|protective agents|mesh-ancestor
65596953|NCT02430298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596954|NCT02430298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65596955|NCT03626376|Valacyclovir|valacyclovir|mesh-list
65596956|NCT03626376|Acyclovir|acyclovir|mesh-list
65596957|NCT03626376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65596958|NCT03626376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65596959|NCT03626376|Antiviral Agents|antiviral agents|mesh-ancestor
65596960|NCT03626376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65596961|NCT05007522|Ketotifen|ketotifen|mesh-list
65596962|NCT05007522|Indomethacin|indomethacin|mesh-list
65596963|NCT05007522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65596964|NCT05007522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65596965|NCT05007522|Analgesics|analgesics|mesh-ancestor
65596966|NCT05007522|Sensory System Agents|sensory system agents|mesh-ancestor
65596967|NCT05007522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65596968|NCT05007522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596969|NCT05007522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65596970|NCT05007522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65596971|NCT05007522|Gout Suppressants|gout suppressants|mesh-ancestor
65596972|NCT05007522|Tocolytic Agents|tocolytic agents|mesh-ancestor
65596973|NCT05007522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65596974|NCT05007522|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65596975|NCT05007522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65596976|NCT05007522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596977|NCT05007522|Antipruritics|antipruritics|mesh-ancestor
65596978|NCT05007522|Dermatologic Agents|dermatologic agents|mesh-ancestor
65596979|NCT05007522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65596980|NCT05007522|Histamine Antagonists|histamine antagonists|mesh-ancestor
65596981|NCT05007522|Histamine Agents|histamine agents|mesh-ancestor
65596982|NCT05007522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65596983|NCT05007522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65596984|NCT03695822|Mirabegron|mirabegron|mesh-list
65596985|NCT03695822|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65596986|NCT03695822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65596987|NCT03695822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65596988|NCT03695822|Adrenergic Agents|adrenergic agents|mesh-ancestor
65596989|NCT03695822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65596990|NCT03695822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65596991|NCT03695822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596992|NCT03695822|Urological Agents|urological agents|mesh-ancestor
65596993|NCT03718507|Atropine|atropine|mesh-list
65596994|NCT03718507|Fentanyl|fentanyl|mesh-list
65596995|NCT03718507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65596996|NCT03718507|Narcotics|narcotics|mesh-ancestor
65596997|NCT03718507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65596998|NCT03718507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65596999|NCT03718507|Analgesics|analgesics|mesh-ancestor
65597000|NCT03718507|Sensory System Agents|sensory system agents|mesh-ancestor
65597001|NCT03718507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597002|NCT03718507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65597003|NCT03718507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65597004|NCT03718507|Anesthetics, General|anesthetics, general|mesh-ancestor
65597005|NCT03718507|Anesthetics|anesthetics|mesh-ancestor
65597006|NCT03718507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65597007|NCT03718507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65597008|NCT03718507|Autonomic Agents|autonomic agents|mesh-ancestor
65597009|NCT03718507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65597010|NCT03718507|Respiratory System Agents|respiratory system agents|mesh-ancestor
65597011|NCT03718507|Mydriatics|mydriatics|mesh-ancestor
65597012|NCT03718507|Parasympatholytics|parasympatholytics|mesh-ancestor
65597013|NCT03718507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65597014|NCT03718507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65597015|NCT03718507|Cholinergic Agents|cholinergic agents|mesh-ancestor
65597016|NCT03718507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65394440|NCT00935558|Interleukin-2|interleukin-2|mesh-list
65597017|NCT03718507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597018|NCT03695744|Dexamethasone|dexamethasone|mesh-list
65597019|NCT03695744|Bortezomib|bortezomib|mesh-list
65597020|NCT03695744|Daratumumab|daratumumab|mesh-list
65597021|NCT03695744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65597022|NCT03695744|Antiemetics|antiemetics|mesh-ancestor
65597023|NCT03695744|Autonomic Agents|autonomic agents|mesh-ancestor
65597024|NCT03695744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597025|NCT03695744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597026|NCT03695744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65597027|NCT03695744|Glucocorticoids|glucocorticoids|mesh-ancestor
65597028|NCT03695744|Hormones|hormones|mesh-ancestor
65597029|NCT03695744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65597030|NCT03695744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65597031|NCT03695744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597032|NCT01374282|Penicillamine|penicillamine|mesh-list
65597033|NCT01374282|Antidotes|antidotes|mesh-ancestor
65597034|NCT01374282|Protective Agents|protective agents|mesh-ancestor
65597035|NCT01374282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597036|NCT01374282|Chelating Agents|chelating agents|mesh-ancestor
65597037|NCT01374282|Sequestering Agents|sequestering agents|mesh-ancestor
65597038|NCT01374282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597039|NCT01374282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65597040|NCT03691922|Epinephrine|epinephrine|mesh-list
65597041|NCT03691922|Racepinephrine|racepinephrine|mesh-list
65597042|NCT03691922|Bupivacaine|bupivacaine|mesh-list
65597043|NCT03691922|Epinephryl borate|epinephryl borate|mesh-list
65597044|NCT03691922|Anesthetics, Local|anesthetics, local|mesh-ancestor
65597045|NCT03691922|Anesthetics|anesthetics|mesh-ancestor
65597046|NCT03691922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65597047|NCT03691922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597048|NCT03691922|Sensory System Agents|sensory system agents|mesh-ancestor
65597049|NCT03691922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597050|NCT03691922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65597051|NCT03691922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65597052|NCT03691922|Adrenergic Agents|adrenergic agents|mesh-ancestor
65597053|NCT03691922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65597054|NCT03691922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597055|NCT03691922|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65597056|NCT03691922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65597057|NCT03691922|Autonomic Agents|autonomic agents|mesh-ancestor
65597058|NCT03691922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65597059|NCT03691922|Respiratory System Agents|respiratory system agents|mesh-ancestor
65597060|NCT03691922|Mydriatics|mydriatics|mesh-ancestor
65597061|NCT03691922|Sympathomimetics|sympathomimetics|mesh-ancestor
65597062|NCT03691922|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65597063|NCT03453151|Anesthetics|anesthetics|mesh-list
65597064|NCT03453151|Anesthetics, Local|anesthetics, local|mesh-list
65597065|NCT03453151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65597066|NCT03453151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597067|NCT03453151|Sensory System Agents|sensory system agents|mesh-ancestor
65597068|NCT03453151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597069|NCT03433248|Empagliflozin|empagliflozin|mesh-list
65597070|NCT03433248|Gliclazide|gliclazide|mesh-list
65597071|NCT03433248|Linagliptin|linagliptin|mesh-list
65597072|NCT03433248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65597073|NCT03433248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597074|NCT03433248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65597075|NCT03433248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597076|NCT03433248|Incretins|incretins|mesh-ancestor
65597077|NCT03433248|Hormones|hormones|mesh-ancestor
65597078|NCT03433248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65597079|NCT03433248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65597080|NCT03433248|Protease Inhibitors|protease inhibitors|mesh-ancestor
65597081|NCT03433248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597082|NCT03691688|Aspirin|aspirin|mesh-list
65597083|NCT03691688|Clopidogrel|clopidogrel|mesh-list
65597084|NCT03691688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65597085|NCT03691688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65597086|NCT03691688|Analgesics|analgesics|mesh-ancestor
65597087|NCT03691688|Sensory System Agents|sensory system agents|mesh-ancestor
65597088|NCT03691688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597089|NCT03691688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394521|NCT00936260|Alendronate|alendronate|mesh-list
65597090|NCT03691688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65597091|NCT03691688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65597092|NCT03691688|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65597093|NCT03691688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65597094|NCT03691688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597095|NCT03691688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65597096|NCT03691688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65597097|NCT03691688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597099|NCT03691688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65597100|NCT03691688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65597101|NCT03691688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65597102|NCT03691688|Purinergic Agents|purinergic agents|mesh-ancestor
65597103|NCT03691688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65597104|NCT02887248|Gemcitabine|gemcitabine|mesh-list
65597105|NCT02887248|Paclitaxel|paclitaxel|mesh-list
65597106|NCT02887248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65597107|NCT02887248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597108|NCT02887248|Tubulin Modulators|tubulin modulators|mesh-ancestor
65597109|NCT02887248|Antimitotic Agents|antimitotic agents|mesh-ancestor
65597110|NCT02887248|Mitosis Modulators|mitosis modulators|mesh-ancestor
65597111|NCT02887248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597112|NCT02887248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65597113|NCT02887248|Antimetabolites|antimetabolites|mesh-ancestor
65597114|NCT02887248|Antiviral Agents|antiviral agents|mesh-ancestor
65597115|NCT02887248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65597116|NCT02887248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597117|NCT02887248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65597118|NCT02887248|Immunologic Factors|immunologic factors|mesh-ancestor
65597119|NCT02887248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597120|NCT02425462|Dienogest|dienogest|mesh-list
65597121|NCT02425462|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65597122|NCT02425462|Contraceptive Agents|contraceptive agents|mesh-ancestor
65597123|NCT02425462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65597124|NCT02425462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597125|NCT02425462|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65597126|NCT02425462|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65597127|NCT02425462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65597128|NCT02425462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65597129|NCT02425462|Hormone Antagonists|hormone antagonists|mesh-ancestor
65597130|NCT02425462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65597131|NCT02425462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65597132|NCT02425462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597133|NCT03452527|Aflibercept|aflibercept|mesh-list
65597134|NCT03452527|Immunoconjugates|immunoconjugates|mesh-list
65597135|NCT03452527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65597136|NCT03452527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65597137|NCT03452527|Growth Substances|growth substances|mesh-ancestor
65597138|NCT03452527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597139|NCT03452527|Growth Inhibitors|growth inhibitors|mesh-ancestor
65597140|NCT03452527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597141|NCT03452527|Immunologic Factors|immunologic factors|mesh-ancestor
65597142|NCT04878510|Dexmedetomidine|dexmedetomidine|mesh-list
65597143|NCT04878510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65597144|NCT04878510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65597145|NCT04878510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597146|NCT04878510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65597147|NCT04878510|Analgesics|analgesics|mesh-ancestor
65597148|NCT04878510|Sensory System Agents|sensory system agents|mesh-ancestor
65597149|NCT04878510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597150|NCT04878510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65597151|NCT04878510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65597152|NCT04878510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65597153|NCT04878510|Adrenergic Agents|adrenergic agents|mesh-ancestor
65597154|NCT04878510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65597155|NCT04878510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597156|NCT03028142|Tiotropium Bromide|tiotropium bromide|mesh-list
65597157|NCT03028142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65597158|NCT03028142|Autonomic Agents|autonomic agents|mesh-ancestor
65597159|NCT03028142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597160|NCT03028142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597161|NCT03028142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65597162|NCT03028142|Respiratory System Agents|respiratory system agents|mesh-ancestor
65597163|NCT03028142|Parasympatholytics|parasympatholytics|mesh-ancestor
65597164|NCT03028142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65597165|NCT03028142|Cholinergic Agents|cholinergic agents|mesh-ancestor
65597166|NCT03028142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65597167|NCT03028142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597168|NCT02800824|Budesonide|budesonide|mesh-list
65597169|NCT02800824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65597170|NCT02800824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65597171|NCT02800824|Autonomic Agents|autonomic agents|mesh-ancestor
65597172|NCT02800824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597173|NCT02800824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597174|NCT02800824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65597175|NCT02800824|Respiratory System Agents|respiratory system agents|mesh-ancestor
65597176|NCT02800824|Glucocorticoids|glucocorticoids|mesh-ancestor
65597177|NCT02800824|Hormones|hormones|mesh-ancestor
65597178|NCT02800824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65597179|NCT03715777|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65597180|NCT03715777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65597181|NCT03715777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597182|NCT03715777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597183|NCT03715777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65597184|NCT03715777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65597185|NCT03715777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597186|NCT03715777|Cholinergic Agents|cholinergic agents|mesh-ancestor
65597187|NCT03715777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65597188|NCT03122886|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65597189|NCT03122886|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
65597190|NCT03122886|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65597191|NCT03122886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65597192|NCT03715699|Prednisone|prednisone|mesh-list
65597193|NCT03715699|Leflunomide|leflunomide|mesh-list
65597194|NCT03715699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65597195|NCT03715699|Glucocorticoids|glucocorticoids|mesh-ancestor
65597196|NCT03715699|Hormones|hormones|mesh-ancestor
65597197|NCT03715699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65597198|NCT03715699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597199|NCT03715699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65597200|NCT03715699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597201|NCT03715699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597202|NCT03715699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597203|NCT03715699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65597204|NCT03715699|Immunologic Factors|immunologic factors|mesh-ancestor
65597205|NCT04776408|Nitric Oxide|nitric oxide|mesh-list
65597206|NCT04776408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65597207|NCT04776408|Autonomic Agents|autonomic agents|mesh-ancestor
65597208|NCT04776408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597209|NCT04776408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597210|NCT04776408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65597211|NCT04776408|Respiratory System Agents|respiratory system agents|mesh-ancestor
65597212|NCT04776408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65597213|NCT04776408|Antioxidants|antioxidants|mesh-ancestor
65597214|NCT04776408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597215|NCT04776408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65597216|NCT04776408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65597217|NCT04776408|Vasodilator Agents|vasodilator agents|mesh-ancestor
65597218|NCT04776408|Gasotransmitters|gasotransmitters|mesh-ancestor
65597219|NCT04776408|Protective Agents|protective agents|mesh-ancestor
65597220|NCT02429596|Lamotrigine|lamotrigine|mesh-list
65597221|NCT02429596|Carbamazepine|carbamazepine|mesh-list
65597222|NCT02429596|Anticonvulsants|anticonvulsants|mesh-ancestor
65597223|NCT02429596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65597224|NCT02429596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65597225|NCT02429596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597226|NCT02429596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65597227|NCT02429596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597228|NCT02429596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65597229|NCT02429596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65597230|NCT02429596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65597231|NCT02429596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65597232|NCT02429596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65597233|NCT02429596|Antimanic Agents|antimanic agents|mesh-ancestor
65597234|NCT02429596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65597235|NCT02429596|Analgesics|analgesics|mesh-ancestor
65597236|NCT02429596|Sensory System Agents|sensory system agents|mesh-ancestor
65597237|NCT02429596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597238|NCT02429596|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65597239|NCT02429596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65597240|NCT03418675|Brexpiprazole|brexpiprazole|mesh-list
65597241|NCT03418675|Serotonin Agents|serotonin agents|mesh-ancestor
65597242|NCT03418675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65597243|NCT03418675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597244|NCT03418675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597245|NCT03418675|Dopamine Agonists|dopamine agonists|mesh-ancestor
65597246|NCT03418675|Dopamine Agents|dopamine agents|mesh-ancestor
65597247|NCT02653092|Heparin|heparin|mesh-list
65597248|NCT02653092|Anticoagulants|anticoagulants|mesh-list
65597249|NCT02653092|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65597250|NCT02653092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65597251|NCT02653092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65597252|NCT02653092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597253|NCT02653092|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65597254|NCT02653092|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65597255|NCT02653092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65597256|NCT03691454|Docetaxel|docetaxel|mesh-list
65597257|NCT03691454|Oxaliplatin|oxaliplatin|mesh-list
65597258|NCT03691454|Trastuzumab|trastuzumab|mesh-list
64598118|NCT03028701|Glucocorticoids|glucocorticoids|mesh-ancestor
65597259|NCT03691454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597260|NCT03691454|Tubulin Modulators|tubulin modulators|mesh-ancestor
65597261|NCT03691454|Antimitotic Agents|antimitotic agents|mesh-ancestor
65597262|NCT03691454|Mitosis Modulators|mitosis modulators|mesh-ancestor
65597263|NCT03691454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597264|NCT03691454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65597265|NCT03718273|Digoxin|digoxin|mesh-list
65597266|NCT03718273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65597267|NCT03718273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65597268|NCT03718273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597269|NCT03718273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597270|NCT03718273|Protective Agents|protective agents|mesh-ancestor
65597271|NCT03718273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597272|NCT02421640|Cisplatin|cisplatin|mesh-list
65597273|NCT02421640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597274|NCT03715387|Bacitracin|bacitracin|mesh-list
65597275|NCT03715387|Polymyxin B|polymyxin b|mesh-list
65597276|NCT03715387|Tacrolimus|tacrolimus|mesh-list
65597277|NCT03715387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65597278|NCT03715387|Immunologic Factors|immunologic factors|mesh-ancestor
65597279|NCT03715387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597280|NCT03715387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65597281|NCT03715387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597282|NCT03715387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597283|NCT03715387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65597284|NCT03715387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65597285|NCT03715387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65597286|NCT03715309|Lenalidomide|lenalidomide|mesh-list
65597287|NCT03715309|Immunologic Factors|immunologic factors|mesh-ancestor
65597288|NCT03715309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597289|NCT03715309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65597290|NCT03715309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65597291|NCT03715309|Growth Substances|growth substances|mesh-ancestor
65597292|NCT03715309|Growth Inhibitors|growth inhibitors|mesh-ancestor
65597293|NCT03715309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597294|NCT03179254|Metformin|metformin|mesh-list
65597295|NCT03179254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65597296|NCT03179254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597297|NCT04147715|Dolutegravir|dolutegravir|mesh-list
65597298|NCT04147715|Midazolam|midazolam|mesh-list
65597299|NCT04147715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65597300|NCT04147715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65597301|NCT04147715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65597302|NCT04147715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597303|NCT04147715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65597304|NCT04147715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65597305|NCT04147715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65597306|NCT04147715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65597307|NCT04147715|Anesthetics, General|anesthetics, general|mesh-ancestor
65597308|NCT04147715|Anesthetics|anesthetics|mesh-ancestor
65597309|NCT04147715|GABA Modulators|gaba modulators|mesh-ancestor
65597310|NCT04147715|GABA Agents|gaba agents|mesh-ancestor
65597311|NCT04147715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65597312|NCT04147715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597313|NCT04147715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65394739|NCT00696137|Anesthetics|anesthetics|mesh-ancestor
65597314|NCT04147715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65597315|NCT04147715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597317|NCT04147715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65597318|NCT04147715|Antiviral Agents|antiviral agents|mesh-ancestor
65597319|NCT04147715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65597320|NCT02420938|Rituximab|rituximab|mesh-list
65597321|NCT02420938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65597322|NCT02420938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597323|NCT02420938|Immunologic Factors|immunologic factors|mesh-ancestor
65597324|NCT02420938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597325|NCT02420938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65597326|NCT02429440|Molgramostim|molgramostim|mesh-list
65597327|NCT02429440|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65597328|NCT02429440|Sargramostim|sargramostim|mesh-list
65597329|NCT02429440|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65597330|NCT02429440|Immunologic Factors|immunologic factors|mesh-ancestor
65597331|NCT02429440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597332|NCT02429440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597333|NCT02429518|Miltefosine|miltefosine|mesh-list
65597334|NCT02429518|Antifungal Agents|antifungal agents|mesh-ancestor
65597335|NCT02429518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65597336|NCT02429518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597337|NCT02429518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65597338|NCT02429518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65597339|NCT00708526|Anesthetics|anesthetics|mesh-list
65597340|NCT00708526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65597341|NCT00708526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597342|NCT03712735|Fentanyl|fentanyl|mesh-list
65597343|NCT03712735|Bupivacaine|bupivacaine|mesh-list
65597344|NCT03712735|Anesthetics, Local|anesthetics, local|mesh-ancestor
65597345|NCT03712735|Anesthetics|anesthetics|mesh-ancestor
65597346|NCT03712735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65597347|NCT03712735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597348|NCT03712735|Sensory System Agents|sensory system agents|mesh-ancestor
65597349|NCT03712735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597350|NCT03712735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65597351|NCT03712735|Narcotics|narcotics|mesh-ancestor
65597352|NCT03712735|Analgesics|analgesics|mesh-ancestor
65597353|NCT03712735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65597354|NCT03712735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65597355|NCT03712735|Anesthetics, General|anesthetics, general|mesh-ancestor
65597356|NCT03182218|Heparin|heparin|mesh-list
65597357|NCT03182218|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65597358|NCT03182218|Tinzaparin|tinzaparin|mesh-list
65597359|NCT03182218|Dalteparin|dalteparin|mesh-list
65597360|NCT03182218|Anticoagulants|anticoagulants|mesh-list
65597361|NCT03182218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65597362|NCT03182218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65597363|NCT03182218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597364|NCT02452554|Maytansine|maytansine|mesh-list
65597365|NCT02452554|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
65597366|NCT02452554|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65597367|NCT02452554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65597368|NCT02452554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597369|NCT02452554|Tubulin Modulators|tubulin modulators|mesh-ancestor
65597370|NCT02452554|Antimitotic Agents|antimitotic agents|mesh-ancestor
65597371|NCT02452554|Mitosis Modulators|mitosis modulators|mesh-ancestor
65597372|NCT02452554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597373|NCT02452554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65597374|NCT03182296|Exenatide|exenatide|mesh-list
65597375|NCT03182296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65597376|NCT03182296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597377|NCT03182296|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65597378|NCT03182296|Incretins|incretins|mesh-ancestor
65597379|NCT03182296|Hormones|hormones|mesh-ancestor
65597380|NCT03182296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65597381|NCT03182374|Hylan|hylan|mesh-list
65597382|NCT03182374|Viscosupplements|viscosupplements|mesh-ancestor
65597383|NCT03182374|Protective Agents|protective agents|mesh-ancestor
65597384|NCT03182374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597385|NCT03718039|Aprepitant|aprepitant|mesh-list
65597386|NCT03718039|Antiemetics|antiemetics|mesh-ancestor
65597387|NCT03718039|Autonomic Agents|autonomic agents|mesh-ancestor
65597388|NCT03718039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597389|NCT03718039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597390|NCT03718039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65597391|NCT03718039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65597392|NCT03718039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65597393|NCT03718039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597394|NCT01319682|Lidocaine|lidocaine|mesh-list
65597395|NCT01319682|Anesthetics, Local|anesthetics, local|mesh-ancestor
65597396|NCT01319682|Anesthetics|anesthetics|mesh-ancestor
65597397|NCT01319682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65597398|NCT01319682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597399|NCT01319682|Sensory System Agents|sensory system agents|mesh-ancestor
65597400|NCT01319682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597401|NCT01319682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65597402|NCT01319682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65597403|NCT01319682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65597404|NCT01319682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65597405|NCT01319682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597406|NCT04009577|Lemborexant|lemborexant|mesh-list
65597407|NCT04009577|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65597408|NCT04009577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65597409|NCT04009577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597410|NCT04009577|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65597411|NCT04009577|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65597412|NCT04009577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65597413|NCT04009577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597414|NCT02176668|Esomeprazole|esomeprazole|mesh-list
65597415|NCT02176668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65597416|NCT02176668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65597417|NCT02176668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65597418|NCT02176668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597419|NCT02176668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597420|NCT03712423|Docetaxel|docetaxel|mesh-list
65597421|NCT03712423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597422|NCT03712423|Tubulin Modulators|tubulin modulators|mesh-ancestor
65597423|NCT03712423|Antimitotic Agents|antimitotic agents|mesh-ancestor
65597424|NCT03712423|Mitosis Modulators|mitosis modulators|mesh-ancestor
65597425|NCT03712423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597426|NCT04620252|Calcium, Dietary|calcium, dietary|mesh-list
65597427|NCT04620252|Calcium Carbonate|calcium carbonate|mesh-list
65597428|NCT04620252|Citric Acid|citric acid|mesh-list
65597429|NCT04620252|Sodium Citrate|sodium citrate|mesh-list
65597430|NCT04620252|Calcium|calcium|mesh-list
65597431|NCT04620252|Fluorides|fluorides|mesh-list
65597432|NCT04620252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65597433|NCT04620252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597434|NCT04620252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65597435|NCT04620252|Anticoagulants|anticoagulants|mesh-ancestor
65597436|NCT04620252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65597437|NCT04620252|Chelating Agents|chelating agents|mesh-ancestor
65597438|NCT04620252|Sequestering Agents|sequestering agents|mesh-ancestor
65597439|NCT04620252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597440|NCT04620252|Cariostatic Agents|cariostatic agents|mesh-ancestor
65597441|NCT04620252|Protective Agents|protective agents|mesh-ancestor
65597442|NCT04620252|Antacids|antacids|mesh-ancestor
65597443|NCT04620252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65597444|NCT03694886|Caffeine|caffeine|mesh-list
65597445|NCT03694886|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65597446|NCT03694886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597447|NCT03694886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65597448|NCT03694886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597449|NCT03694886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597450|NCT03694886|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65597451|NCT03694886|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65597452|NCT03694886|Purinergic Agents|purinergic agents|mesh-ancestor
65597453|NCT03694886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65597454|NCT05602675|Repaglinide|repaglinide|mesh-list
65597455|NCT05602675|Methotrexate|methotrexate|mesh-list
65597456|NCT05602675|Midazolam|midazolam|mesh-list
65597457|NCT05602675|Dextromethorphan|dextromethorphan|mesh-list
65597458|NCT05602675|Warfarin|warfarin|mesh-list
65597459|NCT05602675|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65597460|NCT05602675|Abortifacient Agents|abortifacient agents|mesh-ancestor
65597461|NCT05602675|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65597462|NCT05602675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597463|NCT05602675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65597464|NCT05602675|Antimetabolites|antimetabolites|mesh-ancestor
65597465|NCT05602675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597466|NCT05602675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597467|NCT05602675|Dermatologic Agents|dermatologic agents|mesh-ancestor
65597468|NCT05602675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597469|NCT05602675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65597470|NCT05602675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65597471|NCT05602675|Immunologic Factors|immunologic factors|mesh-ancestor
65597472|NCT05602675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65597473|NCT05602675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65597474|NCT05602675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65597475|NCT05602675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65597476|NCT05602675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65597477|NCT05602675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65597478|NCT05602675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65597479|NCT05602675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65597480|NCT05602675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65597481|NCT05602675|Anesthetics, General|anesthetics, general|mesh-ancestor
65597482|NCT05602675|Anesthetics|anesthetics|mesh-ancestor
65597483|NCT05602675|GABA Modulators|gaba modulators|mesh-ancestor
65597484|NCT05602675|GABA Agents|gaba agents|mesh-ancestor
65597485|NCT05602675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65597486|NCT05602675|Anticoagulants|anticoagulants|mesh-ancestor
65597487|NCT05602675|Antitussive Agents|antitussive agents|mesh-ancestor
65248401|NCT02832726|Hematinics|hematinics|mesh-ancestor
65597488|NCT05602675|Respiratory System Agents|respiratory system agents|mesh-ancestor
65597489|NCT05602675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65597490|NCT05602675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65597491|NCT05602675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65597492|NCT03714685|Firibastat|firibastat|mesh-list
65597493|NCT03714685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65597494|NCT02705716|Fluorides|fluorides|mesh-list
65597495|NCT02705716|Tin Fluorides|tin fluorides|mesh-list
65597496|NCT02705716|Fluorophosphate|fluorophosphate|mesh-list
65597497|NCT02705716|Cariostatic Agents|cariostatic agents|mesh-ancestor
65597498|NCT02705716|Protective Agents|protective agents|mesh-ancestor
65597499|NCT02705716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597500|NCT02429050|Morphine|morphine|mesh-list
65597501|NCT02429050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65597502|NCT02429050|Narcotics|narcotics|mesh-ancestor
65597503|NCT02429050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65597504|NCT02429050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597505|NCT02429050|Analgesics|analgesics|mesh-ancestor
65597506|NCT02429050|Sensory System Agents|sensory system agents|mesh-ancestor
65597507|NCT02429050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597508|NCT02417142|Exenatide|exenatide|mesh-list
65597509|NCT02417142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65597510|NCT02417142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597511|NCT02417142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65597512|NCT02417142|Incretins|incretins|mesh-ancestor
65597513|NCT02417142|Hormones|hormones|mesh-ancestor
65597514|NCT02417142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65597515|NCT04135937|Bupropion|bupropion|mesh-list
65597516|NCT04135937|Nicotine|nicotine|mesh-list
65597517|NCT04135937|Varenicline|varenicline|mesh-list
65597518|NCT04135937|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65597519|NCT04135937|Autonomic Agents|autonomic agents|mesh-ancestor
65597520|NCT04135937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597521|NCT04135937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597522|NCT04135937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65597523|NCT04135937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65597524|NCT04135937|Cholinergic Agents|cholinergic agents|mesh-ancestor
65597525|NCT04135937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65597526|NCT04135937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597527|NCT04135937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65597528|NCT04135937|Antidepressive Agents|antidepressive agents|mesh-ancestor
65597529|NCT04135937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65597530|NCT04135937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65597531|NCT04135937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65597532|NCT04135937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65597533|NCT04135937|Dopamine Agents|dopamine agents|mesh-ancestor
65597534|NCT04135937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65597535|NCT04135937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65597536|NCT04135937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597537|NCT01374750|Cyclosporine|cyclosporine|mesh-list
65597538|NCT01374750|Sirolimus|sirolimus|mesh-list
65597539|NCT01374750|Tacrolimus|tacrolimus|mesh-list
65597540|NCT01374750|Cyclosporins|cyclosporins|mesh-list
65597541|NCT01374750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65597542|NCT01374750|Immunologic Factors|immunologic factors|mesh-ancestor
65597543|NCT01374750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597544|NCT01374750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65597545|NCT01374750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597546|NCT01374750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597547|NCT01374750|Antifungal Agents|antifungal agents|mesh-ancestor
65597548|NCT01374750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65597549|NCT01374750|Dermatologic Agents|dermatologic agents|mesh-ancestor
65597550|NCT01374750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65597551|NCT01374750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65597552|NCT01374750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65597553|NCT01374750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597555|NCT03182140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65597556|NCT03182140|Contraceptive Agents|contraceptive agents|mesh-ancestor
65597557|NCT03182140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65597558|NCT03182140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597559|NCT03182140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65597560|NCT03182140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65597561|NCT03182140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65597562|NCT01374828|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65597563|NCT01374828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65597564|NCT01374828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65597565|NCT01374828|Analgesics|analgesics|mesh-ancestor
65597566|NCT01374828|Sensory System Agents|sensory system agents|mesh-ancestor
65597567|NCT01374828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597568|NCT01374828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597569|NCT01374828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65597570|NCT01374828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65597571|NCT01374828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65597572|NCT01374828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597573|NCT01374828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597574|NCT03634332|Pembrolizumab|pembrolizumab|mesh-list
65597575|NCT03634332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65597576|NCT03634332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597577|NCT03744767|Spironolactone|spironolactone|mesh-list
65597578|NCT03744767|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65597579|NCT03744767|Hormone Antagonists|hormone antagonists|mesh-ancestor
65597580|NCT03744767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65597581|NCT03744767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597582|NCT03744767|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65597583|NCT03744767|Diuretics|diuretics|mesh-ancestor
65597584|NCT03744767|Natriuretic Agents|natriuretic agents|mesh-ancestor
65597585|NCT02428972|Propofol|propofol|mesh-list
65597586|NCT02428972|Sevoflurane|sevoflurane|mesh-list
65597587|NCT02428972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65597588|NCT02428972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65597589|NCT02428972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597590|NCT02428972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65597591|NCT02428972|Anesthetics, General|anesthetics, general|mesh-ancestor
65597592|NCT02428972|Anesthetics|anesthetics|mesh-ancestor
65597593|NCT02428972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65597594|NCT02428972|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65597595|NCT03699332|Labetuzumab|labetuzumab|mesh-list
65597596|NCT03699332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65597597|NCT03699332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597598|NCT03389893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65597599|NCT03389893|Immunologic Factors|immunologic factors|mesh-ancestor
65597600|NCT03389893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597601|NCT03178708|Amantadine|amantadine|mesh-list
65597602|NCT03178708|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65597603|NCT03178708|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65597604|NCT03178708|Antiviral Agents|antiviral agents|mesh-ancestor
65597605|NCT03178708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65597606|NCT03178708|Dopamine Agents|dopamine agents|mesh-ancestor
65597607|NCT03178708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65597608|NCT03178708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597609|NCT03178708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597610|NCT03178708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65597611|NCT03178708|Analgesics|analgesics|mesh-ancestor
65597612|NCT03178708|Sensory System Agents|sensory system agents|mesh-ancestor
65597613|NCT03178708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597614|NCT00787176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65597615|NCT00787176|Oxytocin|oxytocin|mesh-list
65597616|NCT00787176|Oxytocics|oxytocics|mesh-ancestor
65597617|NCT00787176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65597618|NCT00787176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597619|NCT03744689|Bupivacaine|bupivacaine|mesh-list
65597620|NCT03744689|Anesthetics, Local|anesthetics, local|mesh-ancestor
65597621|NCT03744689|Anesthetics|anesthetics|mesh-ancestor
65597622|NCT03744689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65597623|NCT03744689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597624|NCT03744689|Sensory System Agents|sensory system agents|mesh-ancestor
65597625|NCT03744689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597626|NCT02424214|Ionophores|ionophores|mesh-list
65597627|NCT02424214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65597628|NCT02424214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597629|NCT03712111|Norepinephrine|norepinephrine|mesh-list
65597630|NCT03712111|Bupivacaine|bupivacaine|mesh-list
65597631|NCT03712111|Anesthetics, Local|anesthetics, local|mesh-ancestor
65597632|NCT03712111|Anesthetics|anesthetics|mesh-ancestor
65597633|NCT03712111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65597634|NCT03712111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597635|NCT03712111|Sensory System Agents|sensory system agents|mesh-ancestor
65597636|NCT03712111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597637|NCT03712111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65597638|NCT03712111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65597639|NCT03712111|Adrenergic Agents|adrenergic agents|mesh-ancestor
65597640|NCT03712111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65597641|NCT03712111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597642|NCT03712111|Sympathomimetics|sympathomimetics|mesh-ancestor
65597643|NCT03712111|Autonomic Agents|autonomic agents|mesh-ancestor
65597644|NCT03712111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65597645|NCT02925494|Norethindrone|norethindrone|mesh-list
65597646|NCT02925494|Norethindrone Acetate|norethindrone acetate|mesh-list
65597647|NCT02925494|Estradiol|estradiol|mesh-list
65597648|NCT02925494|Estrogens|estrogens|mesh-ancestor
65597649|NCT02925494|Hormones|hormones|mesh-ancestor
65597650|NCT02925494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65597651|NCT02925494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597652|NCT02925494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65597653|NCT02925494|Contraceptive Agents|contraceptive agents|mesh-ancestor
65597654|NCT02925494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65597655|NCT02925494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65597656|NCT02925494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65597657|NCT02925494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65597658|NCT02925494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65597659|NCT03717415|Carboplatin|carboplatin|mesh-list
65597660|NCT03717415|Rebastinib|rebastinib|mesh-list
65597661|NCT03717415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597662|NCT03717415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65597663|NCT03717415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597664|NCT03717415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597665|NCT03689894|Rituximab|rituximab|mesh-list
65597666|NCT03689894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65597667|NCT03689894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597668|NCT03689894|Immunologic Factors|immunologic factors|mesh-ancestor
65597669|NCT03689894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597670|NCT03689894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65597671|NCT04126343|Moxifloxacin|moxifloxacin|mesh-list
65597672|NCT04126343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65597673|NCT04126343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65597674|NCT04126343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65597675|NCT04126343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65597676|NCT04126343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597677|NCT04126343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597678|NCT04126343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597679|NCT04207710|Ethyl Chloride|ethyl chloride|mesh-list
65597680|NCT04207710|Anesthetics, Local|anesthetics, local|mesh-ancestor
65597681|NCT04207710|Anesthetics|anesthetics|mesh-ancestor
65597682|NCT04207710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65597683|NCT04207710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597684|NCT04207710|Sensory System Agents|sensory system agents|mesh-ancestor
65597685|NCT04207710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597686|NCT03119610|Oxytocin|oxytocin|mesh-list
65597687|NCT03119610|Oxytocics|oxytocics|mesh-ancestor
65597688|NCT03119610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65597689|NCT03119610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597690|NCT01373736|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65597691|NCT01373736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597692|NCT01373736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597693|NCT01373736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597694|NCT01373736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65597695|NCT03401749|Chlorhexidine|chlorhexidine|mesh-list
65597696|NCT03401749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65597697|NCT03401749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65597698|NCT03401749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65597699|NCT03401749|Disinfectants|disinfectants|mesh-ancestor
65597700|NCT03401749|Dermatologic Agents|dermatologic agents|mesh-ancestor
65597701|NCT03689114|Topiramate|topiramate|mesh-list
65597702|NCT03689114|Lamotrigine|lamotrigine|mesh-list
65597703|NCT03689114|Zonisamide|zonisamide|mesh-list
65597704|NCT03689114|Carbamazepine|carbamazepine|mesh-list
65597705|NCT03689114|Oxcarbazepine|oxcarbazepine|mesh-list
65597706|NCT03689114|Gabapentin|gabapentin|mesh-list
65597707|NCT03689114|Levetiracetam|levetiracetam|mesh-list
65597708|NCT03689114|Anticonvulsants|anticonvulsants|mesh-list
65597709|NCT03689114|Valproic Acid|valproic acid|mesh-list
65597710|NCT03689114|Analgesics|analgesics|mesh-ancestor
65597711|NCT03689114|Sensory System Agents|sensory system agents|mesh-ancestor
65597712|NCT03689114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597713|NCT03689114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597714|NCT03689114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65597715|NCT03689114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65597716|NCT03689114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65597717|NCT03689114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65597718|NCT03689114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65597719|NCT03689114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65597720|NCT03689114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65597721|NCT03689114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597722|NCT03689114|Antimanic Agents|antimanic agents|mesh-ancestor
65597723|NCT03689114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65597724|NCT03689114|Nootropic Agents|nootropic agents|mesh-ancestor
65597725|NCT03689114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65597726|NCT03689114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65597727|NCT03689114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65597728|NCT03689114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65597729|NCT03689114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65597730|NCT03689114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597731|NCT03689114|GABA Agents|gaba agents|mesh-ancestor
65597732|NCT03689114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65597733|NCT03689114|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65597734|NCT03689114|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65597735|NCT03689114|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65597736|NCT04040946|Choline|choline|mesh-list
65597737|NCT04040946|Lipotropic Agents|lipotropic agents|mesh-ancestor
65597738|NCT04040946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65597739|NCT04040946|Antimetabolites|antimetabolites|mesh-ancestor
65597740|NCT04040946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597741|NCT04040946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65597742|NCT04040946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65597743|NCT04040946|Nootropic Agents|nootropic agents|mesh-ancestor
65597744|NCT02952001|Triamcinolone|triamcinolone|mesh-list
65597745|NCT02952001|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65597746|NCT02952001|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65597747|NCT02952001|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65597748|NCT02952001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65597749|NCT02952001|Glucocorticoids|glucocorticoids|mesh-ancestor
65597750|NCT02952001|Hormones|hormones|mesh-ancestor
65597751|NCT02952001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65597752|NCT02952001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597753|NCT02952001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65597754|NCT02952001|Immunologic Factors|immunologic factors|mesh-ancestor
65597755|NCT02952001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597756|NCT02952001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597757|NCT04050176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65597758|NCT04050176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65597759|NCT04050176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597760|NCT01311739|Vitamin B 12|vitamin b 12|mesh-list
65597761|NCT01311739|Hydroxocobalamin|hydroxocobalamin|mesh-list
65597762|NCT01311739|Vitamin B Complex|vitamin b complex|mesh-ancestor
65597763|NCT01311739|Vitamins|vitamins|mesh-ancestor
65597764|NCT01311739|Micronutrients|micronutrients|mesh-ancestor
65597765|NCT01311739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597766|NCT01311739|Hematinics|hematinics|mesh-ancestor
65395204|NCT01030120|Etanercept|etanercept|mesh-list
65597767|NCT05507359|Benzocaine|benzocaine|mesh-list
65597768|NCT05507359|Anesthetics, Local|anesthetics, local|mesh-ancestor
65597769|NCT05507359|Anesthetics|anesthetics|mesh-ancestor
65597770|NCT05507359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65597771|NCT05507359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597772|NCT05507359|Sensory System Agents|sensory system agents|mesh-ancestor
65597773|NCT05507359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597774|NCT04123067|Pioglitazone|pioglitazone|mesh-list
65597775|NCT04123067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65597776|NCT04123067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597777|NCT03703050|Nivolumab|nivolumab|mesh-list
65597778|NCT03703050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65597779|NCT03703050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597780|NCT03703050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65597781|NCT03703050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597782|NCT03688958|Iodine|iodine|mesh-list
65597783|NCT03688958|Cadexomer iodine|cadexomer iodine|mesh-list
65597784|NCT03688958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65597785|NCT03688958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65597786|NCT03688958|Trace Elements|trace elements|mesh-ancestor
65597787|NCT03688958|Micronutrients|micronutrients|mesh-ancestor
65597788|NCT03688958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597789|NCT04117607|Rezafungin|rezafungin|mesh-list
65597790|NCT04117607|Antifungal Agents|antifungal agents|mesh-ancestor
65597791|NCT04117607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65597792|NCT03688568|Imatinib Mesylate|imatinib mesylate|mesh-list
65597793|NCT03688568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597794|NCT03688568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65597795|NCT03688568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597796|NCT03688568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597797|NCT05192304|Maleic acid|maleic acid|mesh-list
65597798|NCT05192304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597799|NCT05192304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597800|NCT03693872|Dopamine|dopamine|mesh-list
65597801|NCT03693872|Apomorphine|apomorphine|mesh-list
65597802|NCT03693872|Dopamine Agonists|dopamine agonists|mesh-list
65597803|NCT03693872|Emetics|emetics|mesh-ancestor
65597804|NCT03693872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597805|NCT03693872|Autonomic Agents|autonomic agents|mesh-ancestor
65597806|NCT03693872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597807|NCT03693872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65597808|NCT03693872|Dopamine Agents|dopamine agents|mesh-ancestor
65597809|NCT03693872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65597810|NCT03693872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597811|NCT03693872|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65597812|NCT03693872|Sympathomimetics|sympathomimetics|mesh-ancestor
65597813|NCT03693872|Protective Agents|protective agents|mesh-ancestor
65597814|NCT03693638|Fentanyl|fentanyl|mesh-list
65597815|NCT03693638|Bupivacaine|bupivacaine|mesh-list
65597816|NCT03693638|Anesthetics, Local|anesthetics, local|mesh-ancestor
65597817|NCT03693638|Anesthetics|anesthetics|mesh-ancestor
65597818|NCT03693638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65597819|NCT03693638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597820|NCT03693638|Sensory System Agents|sensory system agents|mesh-ancestor
65597821|NCT03693638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597822|NCT03693638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65597823|NCT03693638|Narcotics|narcotics|mesh-ancestor
65597824|NCT03693638|Analgesics|analgesics|mesh-ancestor
65597825|NCT03693638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65597826|NCT03693638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65597827|NCT03693638|Anesthetics, General|anesthetics, general|mesh-ancestor
65597828|NCT04112303|Sofosbuvir|sofosbuvir|mesh-list
65597829|NCT04112303|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65597830|NCT04112303|Antiviral Agents|antiviral agents|mesh-ancestor
65597831|NCT04112303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65597832|NCT01319838|Isotretinoin|isotretinoin|mesh-list
65597833|NCT01319838|Dermatologic Agents|dermatologic agents|mesh-ancestor
65597834|NCT03693560|Metformin|metformin|mesh-list
65597835|NCT03693560|Glimepiride|glimepiride|mesh-list
65597836|NCT03693560|Vildagliptin|vildagliptin|mesh-list
65597837|NCT03693560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65597838|NCT03693560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597839|NCT03693560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65597840|NCT03693560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65597841|NCT03693560|Immunologic Factors|immunologic factors|mesh-ancestor
65597842|NCT03693560|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65395290|NCT00952094|Cinacalcet|cinacalcet|mesh-list
65597843|NCT03693560|Protease Inhibitors|protease inhibitors|mesh-ancestor
65597844|NCT03693560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597845|NCT03693560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597846|NCT05191914|Fulvestrant|fulvestrant|mesh-list
65597847|NCT05191914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65597848|NCT05191914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597849|NCT05191914|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65597850|NCT05191914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65597851|NCT05191914|Hormone Antagonists|hormone antagonists|mesh-ancestor
65597852|NCT05191914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65597853|NCT05191914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597854|NCT04060394|Prednisone|prednisone|mesh-list
65597855|NCT04060394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65597856|NCT04060394|Glucocorticoids|glucocorticoids|mesh-ancestor
65597857|NCT04060394|Hormones|hormones|mesh-ancestor
65597858|NCT04060394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65597859|NCT04060394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597860|NCT04060394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65597861|NCT04060394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597862|NCT04099277|Pembrolizumab|pembrolizumab|mesh-list
65597863|NCT04099277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65597864|NCT04099277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597865|NCT03743987|Pemetrexed|pemetrexed|mesh-list
65597866|NCT03743987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597867|NCT03743987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597868|NCT03743987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597869|NCT03743987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65597870|NCT03743987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65597871|NCT03693326|Spartalizumab|spartalizumab|mesh-list
65597872|NCT03693326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65597873|NCT03693326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597874|NCT03693326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597875|NCT03988907|Midazolam|midazolam|mesh-list
65597876|NCT03988907|Risdiplam|risdiplam|mesh-list
65597877|NCT03988907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65597878|NCT03988907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65597879|NCT03988907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65597880|NCT03988907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597881|NCT03988907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65597882|NCT03988907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65597883|NCT03988907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65597884|NCT03988907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65597885|NCT03988907|Anesthetics, General|anesthetics, general|mesh-ancestor
65597886|NCT03988907|Anesthetics|anesthetics|mesh-ancestor
65597887|NCT03988907|GABA Modulators|gaba modulators|mesh-ancestor
65597888|NCT03988907|GABA Agents|gaba agents|mesh-ancestor
65597889|NCT03988907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65597890|NCT03988907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597891|NCT03988907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65597892|NCT03988907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597893|NCT03693248|Paclitaxel|paclitaxel|mesh-list
65597894|NCT03693248|Carboplatin|carboplatin|mesh-list
65597895|NCT03693248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65597896|NCT03693248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597897|NCT03693248|Tubulin Modulators|tubulin modulators|mesh-ancestor
65597898|NCT03693248|Antimitotic Agents|antimitotic agents|mesh-ancestor
65597899|NCT03693248|Mitosis Modulators|mitosis modulators|mesh-ancestor
65597900|NCT03693248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597901|NCT03987191|Insulin|insulin|mesh-list
65597902|NCT03987191|Insulin Aspart|insulin aspart|mesh-list
65597903|NCT03987191|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65597904|NCT03987191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65597905|NCT03987191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597906|NCT01373970|Pantoprazole|pantoprazole|mesh-list
65597907|NCT01373970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65597908|NCT01373970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65597909|NCT01373970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65597910|NCT01373970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597911|NCT01373970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597912|NCT04050098|Metformin|metformin|mesh-list
65597913|NCT04050098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65597914|NCT04050098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597915|NCT03745625|Propofol|propofol|mesh-list
65597916|NCT03745625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65597917|NCT03745625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65597918|NCT03745625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597919|NCT03745625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65597920|NCT03745625|Anesthetics, General|anesthetics, general|mesh-ancestor
65597921|NCT03745625|Anesthetics|anesthetics|mesh-ancestor
65597922|NCT03698630|Dexamethasone|dexamethasone|mesh-list
65597923|NCT03698630|Prednisolone|prednisolone|mesh-list
65597924|NCT03698630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65597925|NCT03698630|Methylprednisolone|methylprednisolone|mesh-list
65597926|NCT03698630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65597927|NCT03698630|Prednisolone acetate|prednisolone acetate|mesh-list
65597928|NCT03698630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65597929|NCT03698630|Prednisolone phosphate|prednisolone phosphate|mesh-list
65597930|NCT03698630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65597931|NCT03698630|Antiemetics|antiemetics|mesh-ancestor
65597932|NCT03698630|Autonomic Agents|autonomic agents|mesh-ancestor
65597933|NCT03698630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65597934|NCT03698630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597935|NCT03698630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65597936|NCT03698630|Glucocorticoids|glucocorticoids|mesh-ancestor
65597938|NCT03698630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65597939|NCT03698630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65597940|NCT03698630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597941|NCT03698630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65597942|NCT03698630|Protective Agents|protective agents|mesh-ancestor
65597943|NCT01375452|Letrozole|letrozole|mesh-list
65597944|NCT01375452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65597945|NCT01375452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65597946|NCT01375452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65597947|NCT01375452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597948|NCT01375452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597949|NCT01375452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65597950|NCT01375452|Hormone Antagonists|hormone antagonists|mesh-ancestor
65597951|NCT01375452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65597952|NCT01375452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597953|NCT03046836|Oxytocin|oxytocin|mesh-list
65597954|NCT03046836|Oxytocics|oxytocics|mesh-ancestor
65597955|NCT03046836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65597956|NCT03046836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597957|NCT03400033|Epoetin Alfa|epoetin alfa|mesh-list
65597958|NCT03400033|Hematinics|hematinics|mesh-ancestor
65597959|NCT05123820|Midazolam|midazolam|mesh-list
65597960|NCT05123820|Omeprazole|omeprazole|mesh-list
65597961|NCT05123820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65597962|NCT05123820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65597963|NCT05123820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65597964|NCT05123820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597965|NCT05123820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65597966|NCT05123820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65597967|NCT05123820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65597968|NCT05123820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65597969|NCT05123820|Anesthetics, General|anesthetics, general|mesh-ancestor
65597970|NCT05123820|Anesthetics|anesthetics|mesh-ancestor
65597971|NCT05123820|GABA Modulators|gaba modulators|mesh-ancestor
65597972|NCT05123820|GABA Agents|gaba agents|mesh-ancestor
65597973|NCT05123820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65597974|NCT05123820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597975|NCT05123820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65597976|NCT05123820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65597977|NCT05123820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65597978|NCT05123820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597979|NCT03118518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
65597980|NCT02876835|Darbepoetin alfa|darbepoetin alfa|mesh-list
65597981|NCT02876835|Hematinics|hematinics|mesh-ancestor
65597982|NCT03503318|Risperidone|risperidone|mesh-list
65597983|NCT03503318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65597984|NCT03503318|Serotonin Agents|serotonin agents|mesh-ancestor
65597985|NCT03503318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65597986|NCT03503318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597987|NCT03503318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65597988|NCT03503318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65597989|NCT03503318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65597990|NCT03503318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65597991|NCT03503318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65597992|NCT03503318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65597993|NCT03503318|Dopamine Agents|dopamine agents|mesh-ancestor
65597994|NCT01375920|Metyrapone|metyrapone|mesh-list
65597995|NCT01375920|Antimetabolites|antimetabolites|mesh-ancestor
65597996|NCT01375920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65597997|NCT01375920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65597998|NCT03683108|Resveratrol|resveratrol|mesh-list
65597999|NCT03683108|Antioxidants|antioxidants|mesh-ancestor
65598000|NCT03683108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598001|NCT03683108|Protective Agents|protective agents|mesh-ancestor
65598002|NCT03683108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598003|NCT03683108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598004|NCT03683108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65598006|NCT05137860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598007|NCT03682952|Alprostadil|alprostadil|mesh-list
65598008|NCT03682952|Beraprost|beraprost|mesh-list
65598009|NCT03682952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65598010|NCT03682952|Vasodilator Agents|vasodilator agents|mesh-ancestor
65598011|NCT03682952|Urological Agents|urological agents|mesh-ancestor
65598012|NCT03682718|Misoprostol|misoprostol|mesh-list
65598013|NCT03682718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65598014|NCT03682718|Abortifacient Agents|abortifacient agents|mesh-ancestor
65598015|NCT03682718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65598016|NCT03682718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598017|NCT03682718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65598018|NCT03682718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65598019|NCT03682718|Oxytocics|oxytocics|mesh-ancestor
65598020|NCT03682640|Insulin|insulin|mesh-list
65598021|NCT03682640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65598022|NCT03682640|Insulin Lispro|insulin lispro|mesh-list
65598023|NCT03682640|Azithromycin|azithromycin|mesh-list
65598024|NCT03682640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65598025|NCT03682640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598026|NCT03682640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65598027|NCT03682640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65598028|NCT04084769|Vaccines|vaccines|mesh-list
65598029|NCT04084769|Immunologic Factors|immunologic factors|mesh-ancestor
65598030|NCT04084769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598031|NCT01376076|Moxifloxacin|moxifloxacin|mesh-list
65598032|NCT01376076|Risperidone|risperidone|mesh-list
65598033|NCT01376076|Cariprazine|cariprazine|mesh-list
65598034|NCT01376076|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65598035|NCT01376076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65598036|NCT01376076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65598037|NCT01376076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65598038|NCT01376076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65598039|NCT01376076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598040|NCT01376076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598041|NCT01376076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598042|NCT01376076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65598043|NCT01376076|Contraceptive Agents|contraceptive agents|mesh-ancestor
65598044|NCT01376076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65598045|NCT01376076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598046|NCT01376076|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65598047|NCT01376076|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65598048|NCT01376076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65598049|NCT01376076|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65598050|NCT01376076|Serotonin Agents|serotonin agents|mesh-ancestor
65598051|NCT01376076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65598052|NCT01376076|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65598053|NCT01376076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65598054|NCT01376076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65598055|NCT01376076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65598056|NCT01376076|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65598057|NCT01376076|Dopamine Agents|dopamine agents|mesh-ancestor
65598058|NCT03395353|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65598059|NCT03395353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65598060|NCT03395353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65598061|NCT03395353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65598062|NCT03395353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598063|NCT03395353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65598064|NCT03395353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598065|NCT03395353|Analgesics|analgesics|mesh-ancestor
65598066|NCT03395353|Sensory System Agents|sensory system agents|mesh-ancestor
65598067|NCT03395353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65598068|NCT03395353|Antidepressive Agents|antidepressive agents|mesh-ancestor
65598069|NCT03395353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65598070|NCT03395353|Dopamine Agents|dopamine agents|mesh-ancestor
65598071|NCT01376154|Lamivudine|lamivudine|mesh-list
65598072|NCT01376154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65598073|NCT01376154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65598075|NCT01376154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598076|NCT01376154|Antiviral Agents|antiviral agents|mesh-ancestor
65598077|NCT01376154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65598078|NCT01376154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65598079|NCT01376154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65598080|NCT01562951|Adalimumab|adalimumab|mesh-list
65598081|NCT01562951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65598082|NCT01562951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65598083|NCT01375842|Atezolizumab|atezolizumab|mesh-list
65598084|NCT01375842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598085|NCT03682367|Gabapentin|gabapentin|mesh-list
65598086|NCT03682367|Analgesics|analgesics|mesh-ancestor
65598087|NCT03682367|Sensory System Agents|sensory system agents|mesh-ancestor
65598088|NCT03682367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65598089|NCT03682367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598090|NCT03682367|Anticonvulsants|anticonvulsants|mesh-ancestor
65598091|NCT03682367|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65598092|NCT03682367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65598093|NCT03682367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65598094|NCT03682367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65598095|NCT03682367|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65598096|NCT03682367|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65598097|NCT03682367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65598098|NCT03682367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598099|NCT03682367|Antimanic Agents|antimanic agents|mesh-ancestor
65598100|NCT05170464|Caffeine|caffeine|mesh-list
65598101|NCT05170464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65598102|NCT05170464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598103|NCT05170464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65598104|NCT05170464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598105|NCT05170464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598106|NCT05170464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65598107|NCT05170464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65598108|NCT05170464|Purinergic Agents|purinergic agents|mesh-ancestor
65598109|NCT05170464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65598110|NCT03677492|Cytochalasin D|cytochalasin d|mesh-list
65598111|NCT03677492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65598112|NCT03677492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598113|NCT03677492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598114|NCT03394885|Paclitaxel|paclitaxel|mesh-list
65598115|NCT03394885|Bevacizumab|bevacizumab|mesh-list
65598116|NCT03394885|Carboplatin|carboplatin|mesh-list
65598117|NCT03394885|Atezolizumab|atezolizumab|mesh-list
65598118|NCT03394885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65598119|NCT03394885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598120|NCT03394885|Tubulin Modulators|tubulin modulators|mesh-ancestor
65598121|NCT03394885|Antimitotic Agents|antimitotic agents|mesh-ancestor
65598122|NCT03394885|Mitosis Modulators|mitosis modulators|mesh-ancestor
65598123|NCT03394885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598124|NCT03394885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65598125|NCT03394885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65598126|NCT03394885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65598127|NCT03394885|Growth Substances|growth substances|mesh-ancestor
65598128|NCT03394885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598129|NCT03394885|Growth Inhibitors|growth inhibitors|mesh-ancestor
65598130|NCT01361373|Levodopa|levodopa|mesh-list
65598131|NCT01361373|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65598132|NCT01361373|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65598133|NCT01361373|Dopamine Agents|dopamine agents|mesh-ancestor
65598134|NCT01361373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65598135|NCT01361373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598136|NCT01361373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598137|NCT03677336|Progesterone|progesterone|mesh-list
65598138|NCT03677336|Dydrogesterone|dydrogesterone|mesh-list
65598139|NCT03677336|Progestins|progestins|mesh-ancestor
65598140|NCT03677336|Hormones|hormones|mesh-ancestor
65598141|NCT03677336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65598142|NCT03677336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598143|NCT03793478|Cytarabine|cytarabine|mesh-list
65598144|NCT03793478|Fludarabine|fludarabine|mesh-list
65598145|NCT03793478|Etoposide|etoposide|mesh-list
65598146|NCT03793478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598147|NCT03793478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65598148|NCT03793478|Antimetabolites|antimetabolites|mesh-ancestor
65598149|NCT03793478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598150|NCT03793478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65598151|NCT03793478|Immunologic Factors|immunologic factors|mesh-ancestor
65598152|NCT03793478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598153|NCT03793478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65598154|NCT03793478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65598155|NCT03793478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65598156|NCT03793478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598157|NCT03793478|Antiviral Agents|antiviral agents|mesh-ancestor
65598158|NCT03793478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65598160|NCT02877927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65598161|NCT02877927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65598162|NCT02877927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65598163|NCT02877927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598164|NCT02877927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598165|NCT02706886|Lumasiran|lumasiran|mesh-list
65598166|NCT02706886|Renal Agents|renal agents|mesh-ancestor
65598167|NCT02809131|Levofloxacin|levofloxacin|mesh-list
65598168|NCT02809131|Ofloxacin|ofloxacin|mesh-list
65598169|NCT02809131|Clindamycin|clindamycin|mesh-list
65598170|NCT02809131|Clindamycin palmitate|clindamycin palmitate|mesh-list
65598171|NCT02809131|Clindamycin phosphate|clindamycin phosphate|mesh-list
65598172|NCT02809131|Cephalexin|cephalexin|mesh-list
65598173|NCT02809131|Polymyxins|polymyxins|mesh-list
65598174|NCT02809131|Bacitracin|bacitracin|mesh-list
65598175|NCT02809131|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65598176|NCT02809131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65598177|NCT02809131|Renal Agents|renal agents|mesh-ancestor
65598178|NCT02809131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65598179|NCT02809131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65598180|NCT02809131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65598181|NCT02809131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598182|NCT02809131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598183|NCT02809131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598184|NCT02809131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65598185|NCT02809131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65598186|NCT02809131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65598187|NCT02809131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65598188|NCT05032950|Ritonavir|ritonavir|mesh-list
65598189|NCT05032950|Midazolam|midazolam|mesh-list
65598190|NCT05032950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65598191|NCT05032950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65598192|NCT05032950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65598193|NCT05032950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598194|NCT05032950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65598195|NCT05032950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65598196|NCT05032950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65598197|NCT05032950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65598198|NCT05032950|Anesthetics, General|anesthetics, general|mesh-ancestor
65598199|NCT05032950|Anesthetics|anesthetics|mesh-ancestor
65598200|NCT05032950|GABA Modulators|gaba modulators|mesh-ancestor
65598201|NCT05032950|GABA Agents|gaba agents|mesh-ancestor
65598202|NCT05032950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65598203|NCT05032950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598204|NCT05032950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65598205|NCT05032950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65598206|NCT05032950|Protease Inhibitors|protease inhibitors|mesh-ancestor
65598207|NCT05032950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598208|NCT05032950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65598209|NCT05032950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65598210|NCT05032950|Antiviral Agents|antiviral agents|mesh-ancestor
65598211|NCT05032950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65598212|NCT05032950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65598213|NCT05032950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65598214|NCT04074161|Liraglutide|liraglutide|mesh-list
65598215|NCT04074161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65598216|NCT04074161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598217|NCT04074161|Incretins|incretins|mesh-ancestor
65598218|NCT04074161|Hormones|hormones|mesh-ancestor
65598219|NCT04074161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65598220|NCT01442649|Leucovorin|leucovorin|mesh-list
65598221|NCT01442649|Folic Acid|folic acid|mesh-list
65598222|NCT01442649|Bevacizumab|bevacizumab|mesh-list
65598223|NCT01442649|Cetuximab|cetuximab|mesh-list
65598224|NCT01442649|Oxaliplatin|oxaliplatin|mesh-list
65598225|NCT01442649|Irinotecan|irinotecan|mesh-list
65598226|NCT01442649|Fluorouracil|fluorouracil|mesh-list
65598227|NCT01442649|Levoleucovorin|levoleucovorin|mesh-list
65598228|NCT01442649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65598229|NCT01442649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598230|NCT01442649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65598231|NCT01442649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65598232|NCT01442649|Growth Substances|growth substances|mesh-ancestor
65598233|NCT01442649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598234|NCT01442649|Growth Inhibitors|growth inhibitors|mesh-ancestor
65598235|NCT01442649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65598236|NCT01442649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65598237|NCT01442649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598238|NCT01442649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598239|NCT01442649|Antidotes|antidotes|mesh-ancestor
65598240|NCT01442649|Protective Agents|protective agents|mesh-ancestor
65598241|NCT01442649|Vitamin B Complex|vitamin b complex|mesh-ancestor
65598243|NCT01442649|Micronutrients|micronutrients|mesh-ancestor
65598244|NCT01442649|Hematinics|hematinics|mesh-ancestor
65598245|NCT01442649|Antimetabolites|antimetabolites|mesh-ancestor
65598246|NCT01442649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65598247|NCT01442649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65598248|NCT01442649|Immunologic Factors|immunologic factors|mesh-ancestor
65598249|NCT04995120|Paclitaxel|paclitaxel|mesh-list
65598250|NCT04995120|Cisplatin|cisplatin|mesh-list
65598251|NCT04995120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65598252|NCT04995120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598253|NCT04995120|Tubulin Modulators|tubulin modulators|mesh-ancestor
65598254|NCT04995120|Antimitotic Agents|antimitotic agents|mesh-ancestor
65598255|NCT04995120|Mitosis Modulators|mitosis modulators|mesh-ancestor
65598256|NCT04995120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598257|NCT01376232|Gemfibrozil|gemfibrozil|mesh-list
65598258|NCT01376232|Glycine|glycine|mesh-list
65598259|NCT01376232|Glycine Agents|glycine agents|mesh-ancestor
65598260|NCT01376232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65598261|NCT01376232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598262|NCT01376232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598263|NCT01376232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65598264|NCT01376232|Antimetabolites|antimetabolites|mesh-ancestor
65598265|NCT01376232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65598266|NCT01376232|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65598267|NCT01376232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65598268|NCT01376232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598269|NCT01354665|Interferons|interferons|mesh-list
65598270|NCT01354665|Interferon-beta|interferon-beta|mesh-list
65598271|NCT01354665|Interferon beta-1b|interferon beta-1b|mesh-list
65598272|NCT01354665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598273|NCT01354665|Antiviral Agents|antiviral agents|mesh-ancestor
65598274|NCT01354665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65598275|NCT01354665|Immunologic Factors|immunologic factors|mesh-ancestor
65598276|NCT01354665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598277|NCT01354665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65598278|NCT01354743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65598279|NCT01354743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65598280|NCT01354743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65598281|NCT01354743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598282|NCT01354743|Cholinergic Agents|cholinergic agents|mesh-ancestor
65598283|NCT01354743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65598284|NCT01354743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598285|NCT05008575|Fludarabine|fludarabine|mesh-list
65598286|NCT05008575|Cyclophosphamide|cyclophosphamide|mesh-list
65598287|NCT05008575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598288|NCT05008575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598289|NCT05008575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65598290|NCT05008575|Immunologic Factors|immunologic factors|mesh-ancestor
65598291|NCT05008575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598292|NCT05008575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65598293|NCT05008575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65598294|NCT05008575|Alkylating Agents|alkylating agents|mesh-ancestor
65598295|NCT05008575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65598296|NCT01319487|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65598297|NCT01319487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65598298|NCT03111108|Grazoprevir|grazoprevir|mesh-list
65598299|NCT03111108|Antiviral Agents|antiviral agents|mesh-ancestor
65598300|NCT03111108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65598301|NCT00702520|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65598302|NCT00702520|Hormones|hormones|mesh-list
65598303|NCT00702520|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65598304|NCT00702520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65598305|NCT00702520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598306|NCT00702520|Luteolytic Agents|luteolytic agents|mesh-ancestor
65598307|NCT00702520|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65598308|NCT00702520|Contraceptive Agents|contraceptive agents|mesh-ancestor
65598309|NCT00702520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65598310|NCT00702520|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65598311|NCT00702520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65598312|NCT00702520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598313|NCT05198856|Thalidomide|thalidomide|mesh-list
65598314|NCT05198856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65598315|NCT05198856|Immunologic Factors|immunologic factors|mesh-ancestor
65598316|NCT05198856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598317|NCT05198856|Leprostatic Agents|leprostatic agents|mesh-ancestor
65598318|NCT05198856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65598319|NCT05198856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65598320|NCT05198856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65598321|NCT05198856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65598322|NCT05198856|Growth Substances|growth substances|mesh-ancestor
65598323|NCT05198856|Growth Inhibitors|growth inhibitors|mesh-ancestor
65598324|NCT05198856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598325|NCT02876601|Defibrotide|defibrotide|mesh-list
65598326|NCT02876601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65598327|NCT02876601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65598328|NCT02876601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598329|NCT02876601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65598331|NCT04059536|Heparin|heparin|mesh-list
65598332|NCT04059536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65598333|NCT04059536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65598334|NCT04059536|Analgesics|analgesics|mesh-ancestor
65598335|NCT04059536|Sensory System Agents|sensory system agents|mesh-ancestor
65598336|NCT04059536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65598337|NCT04059536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598338|NCT04059536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65598339|NCT04059536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65598340|NCT04059536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65598341|NCT04059536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65598342|NCT04059536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598343|NCT04059536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65598344|NCT04059536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65598345|NCT04059536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598346|NCT04059536|Antipyretics|antipyretics|mesh-ancestor
65598347|NCT04059536|Anticoagulants|anticoagulants|mesh-ancestor
65598348|NCT05711628|Gemcitabine|gemcitabine|mesh-list
65598349|NCT05711628|Carboplatin|carboplatin|mesh-list
65598350|NCT05711628|Doxorubicin|doxorubicin|mesh-list
65598351|NCT05711628|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65598352|NCT05711628|Pembrolizumab|pembrolizumab|mesh-list
65598353|NCT05711628|Etoposide|etoposide|mesh-list
65598354|NCT05711628|Etoposide phosphate|etoposide phosphate|mesh-list
65598355|NCT05711628|Vinorelbine|vinorelbine|mesh-list
65598356|NCT05711628|Ifosfamide|ifosfamide|mesh-list
65598357|NCT05711628|Isophosphamide mustard|isophosphamide mustard|mesh-list
65598358|NCT05711628|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65598359|NCT05711628|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65598360|NCT05711628|Podophyllotoxin|podophyllotoxin|mesh-list
65598361|NCT05711628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65598362|NCT05711628|Antibodies|antibodies|mesh-list
65598363|NCT05711628|Immunoglobulins|immunoglobulins|mesh-list
65598364|NCT05711628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65598365|NCT05711628|Immunoconjugates|immunoconjugates|mesh-list
65598366|NCT05711628|Immunologic Factors|immunologic factors|mesh-ancestor
65598367|NCT05711628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598368|NCT05711628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598369|NCT05711628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65598370|NCT05711628|Antimetabolites|antimetabolites|mesh-ancestor
65598371|NCT05711628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598372|NCT05711628|Antiviral Agents|antiviral agents|mesh-ancestor
65598373|NCT05711628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65598374|NCT05711628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598375|NCT05711628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65598376|NCT05711628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65598377|NCT05711628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65598378|NCT05711628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65598379|NCT05711628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65598380|NCT05711628|Tubulin Modulators|tubulin modulators|mesh-ancestor
65598381|NCT05711628|Antimitotic Agents|antimitotic agents|mesh-ancestor
65598382|NCT05711628|Mitosis Modulators|mitosis modulators|mesh-ancestor
65598383|NCT05711628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65598384|NCT05711628|Alkylating Agents|alkylating agents|mesh-ancestor
65598385|NCT05711628|Keratolytic Agents|keratolytic agents|mesh-ancestor
65598386|NCT05711628|Dermatologic Agents|dermatologic agents|mesh-ancestor
65598387|NCT03178396|Melatonin|melatonin|mesh-list
65598388|NCT03178396|Antioxidants|antioxidants|mesh-ancestor
65598389|NCT03178396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598390|NCT03178396|Protective Agents|protective agents|mesh-ancestor
65598391|NCT03178396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598392|NCT03178396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65598393|NCT03677258|Hyaluronic Acid|hyaluronic acid|mesh-list
65598394|NCT03677258|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65598395|NCT03677258|Immunologic Factors|immunologic factors|mesh-ancestor
65598396|NCT03677258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598397|NCT03677258|Viscosupplements|viscosupplements|mesh-ancestor
65598398|NCT03677258|Protective Agents|protective agents|mesh-ancestor
65598399|NCT01361763|Dabigatran|dabigatran|mesh-list
65598400|NCT01361763|Antithrombins|antithrombins|mesh-ancestor
65598401|NCT01361763|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65598402|NCT01361763|Protease Inhibitors|protease inhibitors|mesh-ancestor
65598403|NCT01361763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598404|NCT01361763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598405|NCT01361763|Anticoagulants|anticoagulants|mesh-ancestor
65598406|NCT02420782|Itraconazole|itraconazole|mesh-list
65598407|NCT02420782|Midazolam|midazolam|mesh-list
65598408|NCT02420782|Pilocarpine|pilocarpine|mesh-list
65598409|NCT02420782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65598410|NCT02420782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65598411|NCT02420782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65598412|NCT02420782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598413|NCT02420782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65598414|NCT02420782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65598415|NCT02420782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65598416|NCT02420782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65598417|NCT02420782|Anesthetics, General|anesthetics, general|mesh-ancestor
65598418|NCT02420782|Anesthetics|anesthetics|mesh-ancestor
65598419|NCT02420782|GABA Modulators|gaba modulators|mesh-ancestor
65598420|NCT02420782|GABA Agents|gaba agents|mesh-ancestor
65598421|NCT02420782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65598422|NCT02420782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598423|NCT02420782|Antifungal Agents|antifungal agents|mesh-ancestor
65598424|NCT02420782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65598425|NCT02420782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65598426|NCT02420782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65598427|NCT02420782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598428|NCT02420782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65598429|NCT02420782|Hormone Antagonists|hormone antagonists|mesh-ancestor
65598430|NCT02420782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65598431|NCT02420782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65598432|NCT02420782|Miotics|miotics|mesh-ancestor
65598433|NCT02420782|Autonomic Agents|autonomic agents|mesh-ancestor
65598434|NCT02420782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65598435|NCT02420782|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65598436|NCT02420782|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65598437|NCT02420782|Cholinergic Agents|cholinergic agents|mesh-ancestor
65598438|NCT04054193|Dexamethasone|dexamethasone|mesh-list
65598439|NCT04054193|Fosaprepitant|fosaprepitant|mesh-list
65598440|NCT04054193|Aprepitant|aprepitant|mesh-list
65598441|NCT04054193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
65598442|NCT04054193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65598443|NCT04054193|Antiemetics|antiemetics|mesh-ancestor
65598444|NCT04054193|Autonomic Agents|autonomic agents|mesh-ancestor
65598445|NCT04054193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65598446|NCT04054193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598447|NCT04054193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65598448|NCT04054193|Glucocorticoids|glucocorticoids|mesh-ancestor
65598449|NCT04054193|Hormones|hormones|mesh-ancestor
65598450|NCT04054193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65598451|NCT04054193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65598452|NCT04054193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598453|NCT04054193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65598454|NCT04054193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65598455|NCT04054193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598456|NCT04054193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65598458|NCT03394027|TIC10 compound|tic10 compound|mesh-list
65598459|NCT03394027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598460|NCT03682172|Glucagon|glucagon|mesh-list
65598461|NCT03682172|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65598462|NCT03682172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65598463|NCT03682172|Hormones|hormones|mesh-ancestor
65598464|NCT03682172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65598465|NCT03682172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598466|NCT03682172|Incretins|incretins|mesh-ancestor
65598467|NCT03184480|Fluticasone|fluticasone|mesh-list
65598468|NCT03184480|Xhance|xhance|mesh-list
65598469|NCT03184480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65598470|NCT03184480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65598471|NCT03184480|Autonomic Agents|autonomic agents|mesh-ancestor
65598472|NCT03184480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65598473|NCT03184480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598474|NCT03184480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65598475|NCT03184480|Respiratory System Agents|respiratory system agents|mesh-ancestor
65598476|NCT03184480|Dermatologic Agents|dermatologic agents|mesh-ancestor
65598477|NCT03184480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65598478|NCT03136107|Sunscreening Agents|sunscreening agents|mesh-list
65598479|NCT03136107|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65598480|NCT03136107|Protective Agents|protective agents|mesh-ancestor
65598481|NCT03136107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598482|NCT03136107|Dermatologic Agents|dermatologic agents|mesh-ancestor
65598483|NCT03686774|Memantine|memantine|mesh-list
65598484|NCT03686774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65598485|NCT03686774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65598486|NCT03686774|Dopamine Agents|dopamine agents|mesh-ancestor
65598487|NCT03686774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65598488|NCT03686774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598489|NCT03686774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598490|NCT03686774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65598491|NCT03686774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65598492|NCT02420392|Dapagliflozin|dapagliflozin|mesh-list
65598493|NCT02420392|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65598494|NCT02420392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598495|NCT02420392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65598496|NCT02420392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598497|NCT01562795|Fluorometholone|fluorometholone|mesh-list
65598498|NCT01562795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65598499|NCT01562795|Lubricant Eye Drops|lubricant eye drops|mesh-list
65598500|NCT01562795|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65598501|NCT01562795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65598502|NCT01562795|Glucocorticoids|glucocorticoids|mesh-ancestor
65598503|NCT01562795|Hormones|hormones|mesh-ancestor
65598504|NCT01562795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65598505|NCT01562795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598506|NCT01562795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65598507|NCT02424136|Nitric Oxide|nitric oxide|mesh-list
65598508|NCT02424136|Immunoglobulins|immunoglobulins|mesh-list
65598509|NCT02424136|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65598510|NCT02424136|Antibodies|antibodies|mesh-list
65598511|NCT02424136|Immunologic Factors|immunologic factors|mesh-ancestor
65598512|NCT02424136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598513|NCT02424136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65598514|NCT02424136|Autonomic Agents|autonomic agents|mesh-ancestor
65598515|NCT02424136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65598516|NCT02424136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65598517|NCT02424136|Respiratory System Agents|respiratory system agents|mesh-ancestor
65598518|NCT02424136|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65598519|NCT02424136|Antioxidants|antioxidants|mesh-ancestor
65598520|NCT02424136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598521|NCT02424136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65598522|NCT02424136|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65598523|NCT02424136|Vasodilator Agents|vasodilator agents|mesh-ancestor
65598524|NCT02424136|Gasotransmitters|gasotransmitters|mesh-ancestor
65598525|NCT02424136|Protective Agents|protective agents|mesh-ancestor
65598526|NCT03770676|Selenium|selenium|mesh-list
65395955|NCT04619082|Tenofovir|tenofovir|mesh-list
65598527|NCT03770676|Antioxidants|antioxidants|mesh-ancestor
65598528|NCT03770676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598529|NCT03770676|Protective Agents|protective agents|mesh-ancestor
65598530|NCT03770676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598531|NCT03770676|Trace Elements|trace elements|mesh-ancestor
65598532|NCT03770676|Micronutrients|micronutrients|mesh-ancestor
65598533|NCT01361841|Bimatoprost|bimatoprost|mesh-list
65598534|NCT01361841|Travoprost|travoprost|mesh-list
65598535|NCT01361841|Latanoprost|latanoprost|mesh-list
65598536|NCT01361841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65598537|NCT01361841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65598538|NCT01361841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65598539|NCT02583789|Treprostinil|treprostinil|mesh-list
65598540|NCT02583789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65598541|NCT01355367|Nifedipine|nifedipine|mesh-list
65598542|NCT01355367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65598543|NCT01355367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65598544|NCT01355367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598545|NCT01355367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65598546|NCT01355367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598547|NCT01355367|Vasodilator Agents|vasodilator agents|mesh-ancestor
65598548|NCT01355367|Tocolytic Agents|tocolytic agents|mesh-ancestor
65598549|NCT01355367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65598550|NCT05759520|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65598551|NCT05759520|Immunologic Factors|immunologic factors|mesh-ancestor
65598552|NCT05759520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598553|NCT02427880|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65598554|NCT02427880|Furosemide|furosemide|mesh-list
65598555|NCT02427880|Acetazolamide|acetazolamide|mesh-list
65598556|NCT02427880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65598557|NCT02427880|Diuretics|diuretics|mesh-ancestor
65598558|NCT02427880|Natriuretic Agents|natriuretic agents|mesh-ancestor
65598559|NCT02427880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598560|NCT02427880|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65598561|NCT02427880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65598562|NCT02427880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598563|NCT02427880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65598564|NCT02427880|Anticonvulsants|anticonvulsants|mesh-ancestor
65598565|NCT02427880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65598566|NCT02427880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598567|NCT01355445|Irinotecan|irinotecan|mesh-list
65598568|NCT01355445|Vincristine|vincristine|mesh-list
65598569|NCT01355445|Temozolomide|temozolomide|mesh-list
65598570|NCT01355445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65598571|NCT01355445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65598572|NCT01355445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598573|NCT01355445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598574|NCT01355445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598575|NCT01355445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65598576|NCT01355445|Tubulin Modulators|tubulin modulators|mesh-ancestor
65598577|NCT01355445|Antimitotic Agents|antimitotic agents|mesh-ancestor
65598578|NCT01355445|Mitosis Modulators|mitosis modulators|mesh-ancestor
65598579|NCT01355445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65598580|NCT01355445|Alkylating Agents|alkylating agents|mesh-ancestor
65598581|NCT05759442|Metformin|metformin|mesh-list
65598582|NCT05759442|Acetic Acid|acetic acid|mesh-list
65598583|NCT05759442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65598584|NCT05759442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598585|NCT05759442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65598586|NCT05759442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65598587|NCT02420080|Brincidofovir|brincidofovir|mesh-list
65598588|NCT02420080|Antiviral Agents|antiviral agents|mesh-ancestor
65598589|NCT02420080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65598590|NCT04483258|Sevoflurane|sevoflurane|mesh-list
65598591|NCT04483258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65598592|NCT04483258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65598593|NCT04483258|Anesthetics, General|anesthetics, general|mesh-ancestor
65598594|NCT04483258|Anesthetics|anesthetics|mesh-ancestor
65598595|NCT04483258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65598596|NCT04483258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598597|NCT02532231|Nivolumab|nivolumab|mesh-list
65598598|NCT02532231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65598599|NCT02532231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598600|NCT02532231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65598601|NCT02532231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598602|NCT01355757|Anesthetics|anesthetics|mesh-list
65598603|NCT01355757|Anesthetics, Local|anesthetics, local|mesh-list
65396023|NCT00110149|Rituximab|rituximab|mesh-list
65598604|NCT01355757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65598605|NCT01355757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598606|NCT01355757|Sensory System Agents|sensory system agents|mesh-ancestor
65598607|NCT01355757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65598608|NCT02507505|Anesthetics|anesthetics|mesh-list
65598609|NCT02507505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65598610|NCT02507505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598611|NCT03181360|Tenecteplase|tenecteplase|mesh-list
65598612|NCT03181360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65598613|NCT03181360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65598614|NCT03181360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598615|NCT05759364|Papaverine|papaverine|mesh-list
65598616|NCT05759364|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65598617|NCT05759364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598618|NCT05759364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598619|NCT05759364|Vasodilator Agents|vasodilator agents|mesh-ancestor
65598620|NCT05759364|Urological Agents|urological agents|mesh-ancestor
65598621|NCT04275531|Anesthetics|anesthetics|mesh-list
65598622|NCT04275531|Propofol|propofol|mesh-list
65598623|NCT04275531|Sevoflurane|sevoflurane|mesh-list
65598624|NCT04275531|Isoflurane|isoflurane|mesh-list
65598625|NCT04275531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65598626|NCT04275531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598627|NCT04275531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65598628|NCT04275531|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65598629|NCT04275531|Anesthetics, General|anesthetics, general|mesh-ancestor
65598630|NCT04275531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65598631|NCT04275531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65598632|NCT03689712|Manganese|manganese|mesh-list
65598633|NCT03689712|Avasopasem manganese|avasopasem manganese|mesh-list
65598634|NCT03689712|Trace Elements|trace elements|mesh-ancestor
65598635|NCT03689712|Micronutrients|micronutrients|mesh-ancestor
65598636|NCT03689712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598637|NCT03689712|Antioxidants|antioxidants|mesh-ancestor
65598638|NCT03689712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598639|NCT03689712|Protective Agents|protective agents|mesh-ancestor
65598640|NCT01361997|Ethanol|ethanol|mesh-list
65598641|NCT01361997|Chlorhexidine|chlorhexidine|mesh-list
65598642|NCT01361997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65598643|NCT01361997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65598644|NCT01361997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65598645|NCT01361997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598646|NCT01361997|Disinfectants|disinfectants|mesh-ancestor
65598647|NCT04750824|Afatinib|afatinib|mesh-list
65598648|NCT04750824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598649|NCT04750824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65598650|NCT04750824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598651|NCT04750824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598652|NCT03180970|Lugol's solution|lugol's solution|mesh-list
65598653|NCT03180970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65598654|NCT03180970|Hemostatics|hemostatics|mesh-ancestor
65598655|NCT03180970|Coagulants|coagulants|mesh-ancestor
65598656|NCT03631446|Picosulfate sodium|picosulfate sodium|mesh-list
65598657|NCT03631446|Magnesium Oxide|magnesium oxide|mesh-list
65598658|NCT03631446|Citric Acid|citric acid|mesh-list
65598659|NCT03631446|Sodium Citrate|sodium citrate|mesh-list
65598660|NCT03631446|Cathartics|cathartics|mesh-ancestor
65598661|NCT03631446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65598662|NCT03631446|Anticoagulants|anticoagulants|mesh-ancestor
65598663|NCT03631446|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65598664|NCT03631446|Chelating Agents|chelating agents|mesh-ancestor
65598665|NCT03631446|Sequestering Agents|sequestering agents|mesh-ancestor
65598666|NCT03631446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598667|NCT03631446|Antacids|antacids|mesh-ancestor
65598668|NCT01362153|Golimumab|golimumab|mesh-list
65598669|NCT01362153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65598670|NCT01362153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65598671|NCT01362153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65598672|NCT01362153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65598673|NCT01362153|Immunologic Factors|immunologic factors|mesh-ancestor
65598674|NCT01362153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598675|NCT03184324|Esomeprazole|esomeprazole|mesh-list
65598676|NCT03184324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65598677|NCT03184324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65598678|NCT03184324|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65598679|NCT03184324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598680|NCT03184324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598681|NCT02427334|Dienogest|dienogest|mesh-list
65598683|NCT02427334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65598684|NCT02427334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65598685|NCT02427334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65598686|NCT02427334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598687|NCT02427334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65598688|NCT02427334|Serotonin Agents|serotonin agents|mesh-ancestor
65598689|NCT02427334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598690|NCT02427334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65598691|NCT02427334|Antidepressive Agents|antidepressive agents|mesh-ancestor
65598692|NCT02427334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65598693|NCT02427334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65598694|NCT02427334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65598695|NCT02427334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598696|NCT02427334|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65598697|NCT02427334|Contraceptive Agents|contraceptive agents|mesh-ancestor
65598698|NCT02427334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65598699|NCT02427334|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65598700|NCT02427334|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65598701|NCT02427334|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65598702|NCT02427334|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65598703|NCT02427334|Hormone Antagonists|hormone antagonists|mesh-ancestor
65598704|NCT02427334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65598705|NCT02427334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65598706|NCT02427334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598707|NCT03620253|Modafinil|modafinil|mesh-list
65598708|NCT03620253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65598709|NCT03620253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598710|NCT03620253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65598711|NCT03620253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65598712|NCT03620253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65598713|NCT03620253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598714|NCT01355991|Tiotropium Bromide|tiotropium bromide|mesh-list
65598715|NCT01355991|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65598716|NCT01355991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65598717|NCT01355991|Autonomic Agents|autonomic agents|mesh-ancestor
65598718|NCT01355991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65598719|NCT01355991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598720|NCT01355991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65598721|NCT01355991|Respiratory System Agents|respiratory system agents|mesh-ancestor
65598722|NCT01355991|Parasympatholytics|parasympatholytics|mesh-ancestor
65598723|NCT01355991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65598724|NCT01355991|Cholinergic Agents|cholinergic agents|mesh-ancestor
65598725|NCT01355991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65598726|NCT01355991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598727|NCT01355991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65598728|NCT01355991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65598729|NCT01355991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65598730|NCT01355991|Adrenergic Agents|adrenergic agents|mesh-ancestor
65598731|NCT01358253|Cytarabine|cytarabine|mesh-list
65598732|NCT01358253|Dexamethasone|dexamethasone|mesh-list
65598733|NCT01358253|Prednisone|prednisone|mesh-list
65598734|NCT01358253|Cyclophosphamide|cyclophosphamide|mesh-list
65598735|NCT01358253|Rituximab|rituximab|mesh-list
65598736|NCT01358253|Doxorubicin|doxorubicin|mesh-list
65598737|NCT01358253|Methotrexate|methotrexate|mesh-list
65598738|NCT01358253|Vincristine|vincristine|mesh-list
65598739|NCT01358253|Asparaginase|asparaginase|mesh-list
65598740|NCT01358253|Mercaptopurine|mercaptopurine|mesh-list
65598741|NCT01358253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65598742|NCT01358253|Immunologic Factors|immunologic factors|mesh-ancestor
65598743|NCT01358253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598744|NCT01358253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65598745|NCT01358253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65598746|NCT01358253|Alkylating Agents|alkylating agents|mesh-ancestor
65598747|NCT01358253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598748|NCT01358253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598749|NCT01358253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65598750|NCT01358253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65598751|NCT01358253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65598752|NCT01358253|Antiemetics|antiemetics|mesh-ancestor
65598753|NCT01358253|Autonomic Agents|autonomic agents|mesh-ancestor
65598754|NCT01358253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65598755|NCT01358253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65598756|NCT01358253|Glucocorticoids|glucocorticoids|mesh-ancestor
65598758|NCT01358253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65598759|NCT01358253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65598760|NCT01358253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65598761|NCT01358253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65598762|NCT01358253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65598763|NCT01358253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598764|NCT01358253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65598765|NCT01358253|Abortifacient Agents|abortifacient agents|mesh-ancestor
65598766|NCT01358253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65598767|NCT01358253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65598768|NCT01358253|Antimetabolites|antimetabolites|mesh-ancestor
65598769|NCT01358253|Dermatologic Agents|dermatologic agents|mesh-ancestor
65598770|NCT01358253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65598771|NCT01358253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65598772|NCT01358253|Antiviral Agents|antiviral agents|mesh-ancestor
65598773|NCT01358253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65598774|NCT01358253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65598775|NCT01358253|Tubulin Modulators|tubulin modulators|mesh-ancestor
65598776|NCT01358253|Antimitotic Agents|antimitotic agents|mesh-ancestor
65598777|NCT01358253|Mitosis Modulators|mitosis modulators|mesh-ancestor
65598778|NCT03548064|Vaccines|vaccines|mesh-list
65598779|NCT03548064|Immunologic Factors|immunologic factors|mesh-ancestor
65598780|NCT03548064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598781|NCT03180346|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65598782|NCT03180346|Laxatives|laxatives|mesh-ancestor
65598783|NCT03180346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65598784|NCT01356225|Ketorolac|ketorolac|mesh-list
65598785|NCT01356225|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65598786|NCT01356225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65598787|NCT01356225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65598788|NCT01356225|Analgesics|analgesics|mesh-ancestor
65598789|NCT01356225|Sensory System Agents|sensory system agents|mesh-ancestor
65598790|NCT01356225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65598791|NCT01356225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598792|NCT01356225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65598793|NCT01356225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65598794|NCT01356225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65598795|NCT01356225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598796|NCT01356225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598797|NCT02427412|Tranexamic Acid|tranexamic acid|mesh-list
65598798|NCT02427412|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65598799|NCT02427412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65598800|NCT02427412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598801|NCT02427412|Hemostatics|hemostatics|mesh-ancestor
65598802|NCT02427412|Coagulants|coagulants|mesh-ancestor
65598803|NCT01356303|Docetaxel|docetaxel|mesh-list
65598804|NCT01356303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598805|NCT01356303|Tubulin Modulators|tubulin modulators|mesh-ancestor
65598806|NCT01356303|Antimitotic Agents|antimitotic agents|mesh-ancestor
65598807|NCT01356303|Mitosis Modulators|mitosis modulators|mesh-ancestor
65598808|NCT01356303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598809|NCT02220309|Pramipexole|pramipexole|mesh-list
65598810|NCT02220309|Antioxidants|antioxidants|mesh-ancestor
65598811|NCT02220309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598812|NCT02220309|Protective Agents|protective agents|mesh-ancestor
65598813|NCT02220309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598814|NCT02220309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65598815|NCT02220309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65598816|NCT02220309|Dopamine Agonists|dopamine agonists|mesh-ancestor
65598817|NCT02220309|Dopamine Agents|dopamine agents|mesh-ancestor
65598818|NCT02220309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65598819|NCT02419534|Diltiazem|diltiazem|mesh-list
65598820|NCT02419534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65598821|NCT02419534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65598822|NCT02419534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65598823|NCT02419534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598824|NCT02419534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65598825|NCT02419534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598826|NCT02419534|Vasodilator Agents|vasodilator agents|mesh-ancestor
65598827|NCT03527316|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65598828|NCT03527316|Hallucinogens|hallucinogens|mesh-ancestor
65598829|NCT03527316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598830|NCT03527316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65598831|NCT03527316|Serotonin Agents|serotonin agents|mesh-ancestor
65598832|NCT03527316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65598833|NCT03527316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598834|NCT03527316|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65598835|NCT03527316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65598836|NCT03527316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65598837|NCT03527316|Adrenergic Agents|adrenergic agents|mesh-ancestor
65598838|NCT01358409|Nebivolol|nebivolol|mesh-list
65598839|NCT01358409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65598840|NCT01358409|Vasodilator Agents|vasodilator agents|mesh-ancestor
65598841|NCT01358409|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65598842|NCT01358409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65598843|NCT01358409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65598844|NCT01358409|Adrenergic Agents|adrenergic agents|mesh-ancestor
65598845|NCT01358409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65598846|NCT01358409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598847|NCT01358409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598848|NCT02423590|Gemcitabine|gemcitabine|mesh-list
65598849|NCT02423590|Carboplatin|carboplatin|mesh-list
65598850|NCT02423590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598851|NCT02423590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65598852|NCT02423590|Antimetabolites|antimetabolites|mesh-ancestor
65598853|NCT02423590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598854|NCT02423590|Antiviral Agents|antiviral agents|mesh-ancestor
65598855|NCT02423590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65598856|NCT02423590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598857|NCT02423590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65598858|NCT02423590|Immunologic Factors|immunologic factors|mesh-ancestor
65598859|NCT02423590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598860|NCT01362309|Cycloserine|cycloserine|mesh-list
65598861|NCT01362309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65598862|NCT01362309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65598863|NCT01362309|Renal Agents|renal agents|mesh-ancestor
65598864|NCT01362309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65598865|NCT01362309|Antitubercular Agents|antitubercular agents|mesh-ancestor
65598866|NCT01362309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65598867|NCT01362309|Antimetabolites|antimetabolites|mesh-ancestor
65598868|NCT01362309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598869|NCT03710863|Vorolanib|vorolanib|mesh-list
65598870|NCT03710863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65598871|NCT03710863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598872|NCT03710863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598873|NCT03178084|Lamivudine|lamivudine|mesh-list
65598874|NCT03178084|Zidovudine|zidovudine|mesh-list
65598875|NCT03178084|Efavirenz|efavirenz|mesh-list
65598876|NCT03178084|Maraviroc|maraviroc|mesh-list
65598877|NCT03178084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65598878|NCT03178084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65598879|NCT03178084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598880|NCT03178084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598881|NCT03178084|Antiviral Agents|antiviral agents|mesh-ancestor
65598882|NCT03178084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65598883|NCT03178084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65598884|NCT03178084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65598885|NCT03178084|Antimetabolites|antimetabolites|mesh-ancestor
65598886|NCT03178084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65598887|NCT03178084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65598888|NCT03178084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65598889|NCT03178084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65598890|NCT03178084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65598891|NCT03178084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65598892|NCT03178084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65598893|NCT03178084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65598894|NCT03178084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65598895|NCT01356381|Vildagliptin|vildagliptin|mesh-list
65598896|NCT01356381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65598897|NCT01356381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598898|NCT01356381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65598899|NCT01356381|Protease Inhibitors|protease inhibitors|mesh-ancestor
65598900|NCT01356381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598901|NCT01356381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598902|NCT03117166|Lidocaine|lidocaine|mesh-list
65598903|NCT03117166|Anesthetics, Local|anesthetics, local|mesh-ancestor
65598904|NCT03117166|Anesthetics|anesthetics|mesh-ancestor
65598905|NCT03117166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65598906|NCT03117166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598907|NCT03117166|Sensory System Agents|sensory system agents|mesh-ancestor
65598908|NCT03117166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65598909|NCT03117166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65598910|NCT03117166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65598911|NCT03117166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65598912|NCT03117166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65598913|NCT03117166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598914|NCT03302286|Mannitol|mannitol|mesh-list
65598915|NCT03302286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65598916|NCT03302286|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65598917|NCT03302286|Diuretics|diuretics|mesh-ancestor
65598918|NCT03302286|Natriuretic Agents|natriuretic agents|mesh-ancestor
65598919|NCT03302286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598920|NCT05669664|Leuprolide|leuprolide|mesh-list
65598921|NCT05669664|Androgen Antagonists|androgen antagonists|mesh-list
65598922|NCT05669664|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65598923|NCT05669664|Fertility Agents|fertility agents|mesh-ancestor
65598924|NCT05669664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65598925|NCT05669664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598926|NCT05669664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65598927|NCT05669664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598928|NCT05669664|Hormone Antagonists|hormone antagonists|mesh-ancestor
65598929|NCT05669664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65598930|NCT01356615|Heparin|heparin|mesh-list
65598931|NCT01356615|Calcium heparin|calcium heparin|mesh-list
65598932|NCT01356615|Enoxaparin|enoxaparin|mesh-list
65598933|NCT01356615|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65598934|NCT01356615|Tinzaparin|tinzaparin|mesh-list
65598935|NCT01356615|Dalteparin|dalteparin|mesh-list
65598936|NCT01356615|Enoxaparin sodium|enoxaparin sodium|mesh-list
65598937|NCT01356615|Anticoagulants|anticoagulants|mesh-ancestor
65598938|NCT01356615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65598939|NCT01356615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65598940|NCT01356615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598941|NCT04591002|Osimertinib|osimertinib|mesh-list
65598942|NCT04591002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598943|NCT04591002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65598944|NCT04591002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598945|NCT04591002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598946|NCT03180190|Hydroxychloroquine|hydroxychloroquine|mesh-list
65598947|NCT03180190|Antimalarials|antimalarials|mesh-ancestor
65598948|NCT03180190|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65598949|NCT03180190|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65598950|NCT03180190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65598951|NCT03180190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598952|NCT03180190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598953|NCT03180190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65598954|NCT04583592|Gabexate|gabexate|mesh-list
65598955|NCT04583592|Camostat|camostat|mesh-list
65598956|NCT04583592|Protease Inhibitors|protease inhibitors|mesh-ancestor
65598957|NCT04583592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598958|NCT04583592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598959|NCT04583592|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65598960|NCT04583592|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65598961|NCT04583592|Anticoagulants|anticoagulants|mesh-ancestor
65598962|NCT02418988|Chlorotrianisene|chlorotrianisene|mesh-list
65598963|NCT02418988|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65598964|NCT02418988|Estrogens|estrogens|mesh-ancestor
65598965|NCT02418988|Hormones|hormones|mesh-ancestor
65598966|NCT02418988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65598967|NCT02418988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598968|NCT02418988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65598969|NCT02418988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598970|NCT05005182|Hydroxyurea|hydroxyurea|mesh-list
65598971|NCT05005182|Luspatercept|luspatercept|mesh-list
65598972|NCT05005182|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
65598973|NCT05005182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598974|NCT05005182|Antisickling Agents|antisickling agents|mesh-ancestor
65598975|NCT05005182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65598976|NCT05005182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65598977|NCT05005182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65598978|NCT05005182|Hematinics|hematinics|mesh-ancestor
65598979|NCT05005182|Immunologic Factors|immunologic factors|mesh-ancestor
65598980|NCT05005182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598981|NCT01356927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65598982|NCT01356927|Etonogestrel|etonogestrel|mesh-list
65598983|NCT01356927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65598984|NCT01356927|Contraceptive Agents|contraceptive agents|mesh-ancestor
65598985|NCT01356927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65598986|NCT01356927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598987|NCT01356927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65598988|NCT01356927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65598989|NCT01356927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65598990|NCT01356927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598991|NCT03439670|Prednisone|prednisone|mesh-list
65598992|NCT03439670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65598993|NCT03439670|Glucocorticoids|glucocorticoids|mesh-ancestor
65598994|NCT03439670|Hormones|hormones|mesh-ancestor
65598995|NCT03439670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65598996|NCT03439670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65598997|NCT03439670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65598998|NCT03439670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65598999|NCT02930343|Folic Acid|folic acid|mesh-list
65599000|NCT02930343|Hydroxychloroquine|hydroxychloroquine|mesh-list
65599001|NCT02930343|Sulfasalazine|sulfasalazine|mesh-list
65599002|NCT02930343|Prednisolone|prednisolone|mesh-list
65599003|NCT02930343|Methotrexate|methotrexate|mesh-list
65599004|NCT02930343|Leflunomide|leflunomide|mesh-list
65599005|NCT02930343|Glucocorticoids|glucocorticoids|mesh-list
65599006|NCT02930343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65599007|NCT02930343|Abortifacient Agents|abortifacient agents|mesh-ancestor
65599008|NCT02930343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65599009|NCT02930343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599010|NCT02930343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65599011|NCT02930343|Antimetabolites|antimetabolites|mesh-ancestor
65599012|NCT02930343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599013|NCT02930343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599014|NCT02930343|Dermatologic Agents|dermatologic agents|mesh-ancestor
65599015|NCT02930343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599016|NCT02930343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65599017|NCT02930343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65599018|NCT02930343|Immunologic Factors|immunologic factors|mesh-ancestor
65599019|NCT02930343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65599020|NCT02930343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65599021|NCT02930343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65599022|NCT02930343|Hormones|hormones|mesh-ancestor
65599023|NCT02930343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65599024|NCT02930343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65599025|NCT02930343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65599026|NCT02930343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65599027|NCT02930343|Antimalarials|antimalarials|mesh-ancestor
65599028|NCT02930343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65599029|NCT02930343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65599030|NCT02930343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65599031|NCT02930343|Hematinics|hematinics|mesh-ancestor
65599032|NCT02930343|Vitamin B Complex|vitamin b complex|mesh-ancestor
65599033|NCT02930343|Vitamins|vitamins|mesh-ancestor
65599034|NCT02930343|Micronutrients|micronutrients|mesh-ancestor
65599035|NCT02930343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65599036|NCT02930343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65599037|NCT02930343|Analgesics|analgesics|mesh-ancestor
65599038|NCT02930343|Sensory System Agents|sensory system agents|mesh-ancestor
65599039|NCT03686618|Secretin|secretin|mesh-list
65599040|NCT03686618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65599041|NCT03686618|Hormones|hormones|mesh-ancestor
65599042|NCT03686618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65599043|NCT03686618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599044|NCT02426866|Efavirenz|efavirenz|mesh-list
65599045|NCT02426866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65599046|NCT02426866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65599047|NCT02426866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599048|NCT02426866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599049|NCT02426866|Antiviral Agents|antiviral agents|mesh-ancestor
65599050|NCT02426866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65599051|NCT02426866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65599052|NCT02426866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65396478|NCT03024684|Atorvastatin|atorvastatin|mesh-list
65599053|NCT02426866|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65599054|NCT02426866|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65599055|NCT02426866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65599056|NCT02426866|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65599057|NCT02423824|Liraglutide|liraglutide|mesh-list
65599058|NCT02423824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65599059|NCT02423824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599060|NCT02423824|Incretins|incretins|mesh-ancestor
65599061|NCT02423824|Hormones|hormones|mesh-ancestor
65599062|NCT02423824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65599063|NCT01012167|Galantamine|galantamine|mesh-list
65599064|NCT01012167|Oxytocin|oxytocin|mesh-list
65599065|NCT01012167|Oxytocics|oxytocics|mesh-ancestor
65599066|NCT01012167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65599067|NCT01012167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599068|NCT01012167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65599069|NCT01012167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599070|NCT01012167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599071|NCT01012167|Cholinergic Agents|cholinergic agents|mesh-ancestor
65599072|NCT01012167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65599073|NCT01012167|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65599074|NCT01012167|Autonomic Agents|autonomic agents|mesh-ancestor
65599075|NCT01012167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65599076|NCT01012167|Nootropic Agents|nootropic agents|mesh-ancestor
65599077|NCT02423278|Oxaliplatin|oxaliplatin|mesh-list
65599078|NCT02423278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599079|NCT05189067|Paclitaxel|paclitaxel|mesh-list
65599080|NCT05189067|Docetaxel|docetaxel|mesh-list
65599081|NCT05189067|Trastuzumab|trastuzumab|mesh-list
65599082|NCT05189067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65599083|NCT05189067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599084|NCT05189067|Tubulin Modulators|tubulin modulators|mesh-ancestor
65599085|NCT05189067|Antimitotic Agents|antimitotic agents|mesh-ancestor
65599086|NCT05189067|Mitosis Modulators|mitosis modulators|mesh-ancestor
65599087|NCT05189067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599088|NCT05189067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65599089|NCT03133767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65599090|NCT02422966|Acetaminophen|acetaminophen|mesh-list
65599091|NCT02422966|Ibuprofen|ibuprofen|mesh-list
65599092|NCT02422966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65599093|NCT02422966|Analgesics|analgesics|mesh-ancestor
65599094|NCT02422966|Sensory System Agents|sensory system agents|mesh-ancestor
65599095|NCT02422966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65599096|NCT02422966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599097|NCT02422966|Antipyretics|antipyretics|mesh-ancestor
65599098|NCT02422966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65599099|NCT02422966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65599100|NCT02422966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65599101|NCT02422966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65599102|NCT02422966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599103|NCT02422966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599104|NCT05647122|Osimertinib|osimertinib|mesh-list
65599105|NCT05647122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599106|NCT05647122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65599107|NCT05647122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599108|NCT05647122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599109|NCT02422888|Ticagrelor|ticagrelor|mesh-list
65599110|NCT02422888|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65599111|NCT02422888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65599112|NCT02422888|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65599113|NCT02422888|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65599114|NCT02422888|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65599115|NCT02422888|Purinergic Agents|purinergic agents|mesh-ancestor
65599116|NCT02422888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65599117|NCT02422888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599118|NCT02422888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599119|NCT03633552|Temozolomide|temozolomide|mesh-list
65599120|NCT03633552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65599121|NCT03633552|Alkylating Agents|alkylating agents|mesh-ancestor
65599122|NCT03633552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599123|NCT03633552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599124|NCT05760456|Metformin|metformin|mesh-list
65599125|NCT05760456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65599126|NCT05760456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599127|NCT02418130|Inositol|inositol|mesh-list
65599128|NCT02418130|Thiamine|thiamine|mesh-list
65599129|NCT02418130|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65599130|NCT02418130|Vitamin B Complex|vitamin b complex|mesh-ancestor
65599131|NCT02418130|Vitamins|vitamins|mesh-ancestor
65599132|NCT02418130|Micronutrients|micronutrients|mesh-ancestor
65599133|NCT02418130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599134|NCT02418130|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65599135|NCT02418130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65599136|NCT03391765|Tilavonemab|tilavonemab|mesh-list
65599137|NCT03391765|Nootropic Agents|nootropic agents|mesh-ancestor
65599138|NCT02802228|Ifetroban|ifetroban|mesh-list
65599139|NCT02802228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65599140|NCT02801448|Sulforaphane|sulforaphane|mesh-list
65599141|NCT02801448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65599142|NCT02801448|Protective Agents|protective agents|mesh-ancestor
65599143|NCT02801448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599144|NCT02801448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599145|NCT03179332|Insulin Lispro|insulin lispro|mesh-list
65599146|NCT03179332|Insulin Aspart|insulin aspart|mesh-list
65599147|NCT03179332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65599148|NCT03179332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599149|NCT03674177|Vaccines|vaccines|mesh-list
65599150|NCT03674177|Immunologic Factors|immunologic factors|mesh-ancestor
65599151|NCT03674177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599152|NCT02675790|Hydroxyurea|hydroxyurea|mesh-list
65599153|NCT02675790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599154|NCT02675790|Antisickling Agents|antisickling agents|mesh-ancestor
65599155|NCT02675790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599156|NCT02675790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599157|NCT02675790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65599158|NCT02417896|Spironolactone|spironolactone|mesh-list
65599159|NCT02417896|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65599160|NCT02417896|Hormone Antagonists|hormone antagonists|mesh-ancestor
65599161|NCT02417896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65599162|NCT02417896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599163|NCT02417896|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65599164|NCT02417896|Diuretics|diuretics|mesh-ancestor
65599165|NCT02417896|Natriuretic Agents|natriuretic agents|mesh-ancestor
65599166|NCT03183544|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65599167|NCT03183544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65599168|NCT03183544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599169|NCT04380090|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
65599170|NCT04380090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65599171|NCT04380090|Antidiarrheals|antidiarrheals|mesh-ancestor
65599172|NCT03116776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65599173|NCT03116776|Hyaluronic Acid|hyaluronic acid|mesh-list
65599174|NCT03116776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65599175|NCT03116776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65599176|NCT03116776|Immunologic Factors|immunologic factors|mesh-ancestor
65599177|NCT03116776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599178|NCT03116776|Viscosupplements|viscosupplements|mesh-ancestor
65599179|NCT03116776|Protective Agents|protective agents|mesh-ancestor
65599180|NCT02505204|Clonidine|clonidine|mesh-list
65599181|NCT02505204|Analgesics|analgesics|mesh-ancestor
65599182|NCT02505204|Sensory System Agents|sensory system agents|mesh-ancestor
65599183|NCT02505204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65599184|NCT02505204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599185|NCT02505204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65599186|NCT02505204|Sympatholytics|sympatholytics|mesh-ancestor
65599187|NCT02505204|Autonomic Agents|autonomic agents|mesh-ancestor
65599188|NCT02505204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65599189|NCT02505204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65599190|NCT02505204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65599191|NCT02505204|Adrenergic Agents|adrenergic agents|mesh-ancestor
65599192|NCT02505204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65599193|NCT02505204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599194|NCT04351698|Montelukast|montelukast|mesh-list
65599195|NCT04351698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65599196|NCT04351698|Respiratory System Agents|respiratory system agents|mesh-ancestor
65599197|NCT04351698|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65599198|NCT04351698|Hormone Antagonists|hormone antagonists|mesh-ancestor
65599199|NCT04351698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65599200|NCT04351698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599201|NCT04351698|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65599202|NCT04351698|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65599203|NCT04351698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599204|NCT01359423|Cilostazol|cilostazol|mesh-list
65599205|NCT01359423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65599206|NCT01359423|Autonomic Agents|autonomic agents|mesh-ancestor
65599207|NCT01359423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65599208|NCT01359423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599209|NCT01359423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65599210|NCT01359423|Respiratory System Agents|respiratory system agents|mesh-ancestor
65599211|NCT01359423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65599212|NCT01359423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65599213|NCT01359423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599214|NCT01359423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65599215|NCT01359423|Vasodilator Agents|vasodilator agents|mesh-ancestor
65599216|NCT01359423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65599217|NCT01359423|Protective Agents|protective agents|mesh-ancestor
65599218|NCT01359423|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65599219|NCT01359423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65599220|NCT01359423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599221|NCT01363089|Ketorolac|ketorolac|mesh-list
65599222|NCT01363089|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65599223|NCT01363089|Phenylephrine|phenylephrine|mesh-list
65599224|NCT01363089|Oxymetazoline|oxymetazoline|mesh-list
65599225|NCT01363089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65599226|NCT01363089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65599227|NCT01363089|Analgesics|analgesics|mesh-ancestor
65599228|NCT01363089|Sensory System Agents|sensory system agents|mesh-ancestor
65599229|NCT01363089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65599230|NCT01363089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599231|NCT01363089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65599232|NCT01363089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65599233|NCT01363089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65599234|NCT01363089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599235|NCT01363089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599236|NCT01363089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65599237|NCT01363089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65599238|NCT01363089|Adrenergic Agents|adrenergic agents|mesh-ancestor
65599239|NCT01363089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65599240|NCT01363089|Sympathomimetics|sympathomimetics|mesh-ancestor
65599241|NCT01363089|Autonomic Agents|autonomic agents|mesh-ancestor
65599242|NCT01363089|Nasal Decongestants|nasal decongestants|mesh-ancestor
65599243|NCT01363089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65599244|NCT01363089|Respiratory System Agents|respiratory system agents|mesh-ancestor
65599245|NCT01363089|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65599246|NCT01363089|Mydriatics|mydriatics|mesh-ancestor
65599247|NCT01363089|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65599248|NCT01363089|Protective Agents|protective agents|mesh-ancestor
65599249|NCT01365741|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65599250|NCT01365741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65599251|NCT03681548|Doxorubicin|doxorubicin|mesh-list
65599252|NCT03681548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65599253|NCT03681548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65599254|NCT03681548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599255|NCT03681548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65599256|NCT03681548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65599257|NCT03681548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599258|NCT03681548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599259|NCT02417506|Ibuprofen|ibuprofen|mesh-list
65599260|NCT02417506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65599261|NCT02417506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65599262|NCT02417506|Analgesics|analgesics|mesh-ancestor
65599263|NCT02417506|Sensory System Agents|sensory system agents|mesh-ancestor
65599264|NCT02417506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65599265|NCT02417506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599266|NCT02417506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65599267|NCT02417506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65599268|NCT02417506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65599269|NCT02417506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599270|NCT02417506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599271|NCT05188911|Prednisone|prednisone|mesh-list
65599272|NCT05188911|Androgens|androgens|mesh-list
65599273|NCT05188911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65599274|NCT05188911|Glucocorticoids|glucocorticoids|mesh-ancestor
65599275|NCT05188911|Hormones|hormones|mesh-ancestor
65396697|NCT03040778|Vasodilator Agents|vasodilator agents|mesh-ancestor
65599276|NCT05188911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65599277|NCT05188911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599278|NCT05188911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65599279|NCT05188911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599280|NCT03676946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65599281|NCT03676946|Antibodies|antibodies|mesh-list
65599282|NCT03676946|Immunoglobulins|immunoglobulins|mesh-list
65599283|NCT03676946|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65599284|NCT03676946|Immunologic Factors|immunologic factors|mesh-ancestor
65599285|NCT03676946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599286|NCT03676946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599287|NCT01363167|Vitamin D|vitamin d|mesh-list
65599288|NCT01363167|Cholecalciferol|cholecalciferol|mesh-list
65599289|NCT01363167|Vitamins|vitamins|mesh-ancestor
65599290|NCT01363167|Micronutrients|micronutrients|mesh-ancestor
65599291|NCT01363167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599292|NCT01363167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65599293|NCT01363167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65599294|NCT01359579|Varespladib methyl|varespladib methyl|mesh-list
65599295|NCT01359579|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
65599296|NCT01359579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599297|NCT01359579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599298|NCT02422654|Eliglustat|eliglustat|mesh-list
65599299|NCT02422654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599300|NCT02422654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599301|NCT05188833|Paroxetine|paroxetine|mesh-list
65599302|NCT05188833|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65599303|NCT05188833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65599304|NCT05188833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65599305|NCT05188833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599306|NCT05188833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65599307|NCT05188833|Serotonin Agents|serotonin agents|mesh-ancestor
65599308|NCT05188833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599309|NCT05188833|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65599310|NCT05188833|Antidepressive Agents|antidepressive agents|mesh-ancestor
65599311|NCT05188833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65599312|NCT05188833|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65599313|NCT05188833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65599314|NCT05188833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599315|NCT02426164|Methylprednisolone|methylprednisolone|mesh-list
65599316|NCT02426164|Epinephrine|epinephrine|mesh-list
65599317|NCT02426164|Morphine|morphine|mesh-list
65599318|NCT02426164|Bupivacaine|bupivacaine|mesh-list
65599319|NCT02426164|Anesthetics, Local|anesthetics, local|mesh-ancestor
65599320|NCT02426164|Anesthetics|anesthetics|mesh-ancestor
65599321|NCT02426164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65599322|NCT02426164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599323|NCT02426164|Sensory System Agents|sensory system agents|mesh-ancestor
65599324|NCT02426164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65599325|NCT02426164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65599326|NCT02426164|Narcotics|narcotics|mesh-ancestor
65599327|NCT02426164|Analgesics|analgesics|mesh-ancestor
65599328|NCT02426164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65599329|NCT02426164|Antiemetics|antiemetics|mesh-ancestor
65599330|NCT02426164|Autonomic Agents|autonomic agents|mesh-ancestor
65599331|NCT02426164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65599332|NCT02426164|Glucocorticoids|glucocorticoids|mesh-ancestor
65599333|NCT02426164|Hormones|hormones|mesh-ancestor
65599334|NCT02426164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65599335|NCT02426164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65599336|NCT02426164|Protective Agents|protective agents|mesh-ancestor
65599337|NCT02426164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65599338|NCT02426164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65599339|NCT02426164|Adrenergic Agents|adrenergic agents|mesh-ancestor
65599340|NCT02426164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65599341|NCT02426164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599342|NCT02426164|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65599343|NCT02426164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65599344|NCT02426164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65599345|NCT02426164|Respiratory System Agents|respiratory system agents|mesh-ancestor
65599346|NCT02426164|Mydriatics|mydriatics|mesh-ancestor
65599347|NCT02426164|Sympathomimetics|sympathomimetics|mesh-ancestor
65599348|NCT02426164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65599349|NCT03745157|Insulin|insulin|mesh-list
65599350|NCT03745157|Insulin Aspart|insulin aspart|mesh-list
65599351|NCT03745157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65599352|NCT03745157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599353|NCT02426008|Mitogens|mitogens|mesh-list
65599354|NCT02426008|Mitosis Modulators|mitosis modulators|mesh-ancestor
65599355|NCT02426008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599356|NCT02425852|Prednisolone|prednisolone|mesh-list
65599357|NCT02425852|Hydrocortisone|hydrocortisone|mesh-list
65599358|NCT02425852|Azathioprine|azathioprine|mesh-list
65599359|NCT02425852|Infliximab|infliximab|mesh-list
65599360|NCT02425852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65599361|NCT02425852|Glucocorticoids|glucocorticoids|mesh-ancestor
65599362|NCT02425852|Hormones|hormones|mesh-ancestor
65599363|NCT02425852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65599364|NCT02425852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599365|NCT02425852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65599366|NCT02425852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599367|NCT02425852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65599368|NCT02425852|Dermatologic Agents|dermatologic agents|mesh-ancestor
65599369|NCT02425852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65599370|NCT02425852|Antimetabolites|antimetabolites|mesh-ancestor
65599371|NCT02425852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599372|NCT02425852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65599373|NCT02425852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65599374|NCT02425852|Immunologic Factors|immunologic factors|mesh-ancestor
65599375|NCT04050371|Tenofovir|tenofovir|mesh-list
65599376|NCT04050371|Emtricitabine|emtricitabine|mesh-list
65599377|NCT04050371|Antiviral Agents|antiviral agents|mesh-ancestor
65599378|NCT04050371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65599379|NCT04050371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65599380|NCT04050371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65599381|NCT04050371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599382|NCT04050371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599383|NCT04050371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65599384|NCT04050371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65599385|NCT04447287|Buprenorphine|buprenorphine|mesh-list
65599386|NCT04447287|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65599387|NCT04447287|ASP8062|asp8062|mesh-list
65599388|NCT04447287|Naloxone|naloxone|mesh-list
65599389|NCT04447287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65599390|NCT04447287|Narcotics|narcotics|mesh-ancestor
65599391|NCT04447287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65599392|NCT04447287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599393|NCT04447287|Analgesics|analgesics|mesh-ancestor
65599394|NCT04447287|Sensory System Agents|sensory system agents|mesh-ancestor
65599395|NCT04447287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65599396|NCT04447287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65599397|NCT04447287|GABA Modulators|gaba modulators|mesh-ancestor
65599398|NCT04447287|GABA Agents|gaba agents|mesh-ancestor
65599399|NCT04447287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65599400|NCT04447287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599401|NCT01879319|Evolocumab|evolocumab|mesh-list
65599402|NCT01879319|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65599403|NCT01879319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65599404|NCT01879319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65599405|NCT01879319|Antimetabolites|antimetabolites|mesh-ancestor
65599406|NCT01879319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599407|NCT01879319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65599408|NCT01879319|Immunologic Factors|immunologic factors|mesh-ancestor
65599409|NCT01879319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599410|NCT04165122|Valacyclovir|valacyclovir|mesh-list
65599411|NCT04165122|Antiviral Agents|antiviral agents|mesh-ancestor
65599412|NCT04165122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65599413|NCT02422030|Atorvastatin|atorvastatin|mesh-list
65599414|NCT02422030|Fenofibric acid|fenofibric acid|mesh-list
65599415|NCT02422030|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65599416|NCT02422030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65599417|NCT02422030|Antimetabolites|antimetabolites|mesh-ancestor
65599418|NCT02422030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599419|NCT02422030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65599420|NCT02422030|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65599421|NCT02422030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599422|NCT02425930|Oxaliplatin|oxaliplatin|mesh-list
65599423|NCT02425930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599424|NCT01365897|Modafinil|modafinil|mesh-list
65396844|NCT01079767|Sirolimus|sirolimus|mesh-list
65599425|NCT01365897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65599426|NCT01365897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599427|NCT01365897|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65599428|NCT01365897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65599429|NCT01365897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65599430|NCT01365897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599432|NCT02422108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65599433|NCT02422108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599434|NCT01359657|Dexamethasone|dexamethasone|mesh-list
65599435|NCT01359657|Dexamethasone acetate|dexamethasone acetate|mesh-list
65599436|NCT01359657|Lenalidomide|lenalidomide|mesh-list
65599437|NCT01359657|Bortezomib|bortezomib|mesh-list
65599438|NCT01359657|BB 1101|bb 1101|mesh-list
65599439|NCT01359657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65599440|NCT01359657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65599441|NCT01359657|Antiemetics|antiemetics|mesh-ancestor
65599442|NCT01359657|Autonomic Agents|autonomic agents|mesh-ancestor
65599443|NCT01359657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65599444|NCT01359657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599445|NCT01359657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65599446|NCT01359657|Glucocorticoids|glucocorticoids|mesh-ancestor
65599447|NCT01359657|Hormones|hormones|mesh-ancestor
65599448|NCT01359657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65599449|NCT01359657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65599450|NCT01359657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599451|NCT01359657|Protease Inhibitors|protease inhibitors|mesh-ancestor
65599452|NCT01359657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599453|NCT01359657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599454|NCT01359657|Immunologic Factors|immunologic factors|mesh-ancestor
65599455|NCT01359657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65599456|NCT01359657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65599457|NCT01359657|Growth Substances|growth substances|mesh-ancestor
65599458|NCT01359657|Growth Inhibitors|growth inhibitors|mesh-ancestor
65599459|NCT02417116|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65599460|NCT02417116|Hyaluronic Acid|hyaluronic acid|mesh-list
65599461|NCT02417116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65599462|NCT02417116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65599463|NCT02417116|Immunologic Factors|immunologic factors|mesh-ancestor
65599464|NCT02417116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599465|NCT02417116|Viscosupplements|viscosupplements|mesh-ancestor
65599466|NCT02417116|Protective Agents|protective agents|mesh-ancestor
65599467|NCT03183310|Chlorpromazine|chlorpromazine|mesh-list
65599468|NCT03183310|Antiemetics|antiemetics|mesh-ancestor
65599469|NCT03183310|Autonomic Agents|autonomic agents|mesh-ancestor
65599470|NCT03183310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65599471|NCT03183310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599472|NCT03183310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65599473|NCT03183310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65599474|NCT03183310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65599475|NCT03183310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65599476|NCT03183310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65599477|NCT03183310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65599478|NCT03183310|Dopamine Agents|dopamine agents|mesh-ancestor
65599479|NCT03183310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65599480|NCT03183310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599481|NCT03177850|Acetazolamide|acetazolamide|mesh-list
65599482|NCT03177850|Anticonvulsants|anticonvulsants|mesh-ancestor
65599483|NCT03177850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65599484|NCT03177850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599485|NCT03177850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599486|NCT03177850|Diuretics|diuretics|mesh-ancestor
65599487|NCT03177850|Natriuretic Agents|natriuretic agents|mesh-ancestor
65599488|NCT03177850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599489|NCT03102918|Cannabidiol|cannabidiol|mesh-list
65599490|NCT03102918|Anticonvulsants|anticonvulsants|mesh-ancestor
65599491|NCT03102762|Botulinum Toxins|botulinum toxins|mesh-list
65599492|NCT03102762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65599493|NCT03102762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65599494|NCT03102762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65599495|NCT03102762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65599496|NCT03102762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599497|NCT03102762|Cholinergic Agents|cholinergic agents|mesh-ancestor
65599498|NCT03102762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65599499|NCT03102762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599500|NCT03102762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65599501|NCT03102762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65599502|NCT03684824|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65599503|NCT03684824|Luteolytic Agents|luteolytic agents|mesh-ancestor
65599504|NCT03684824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65599505|NCT03684824|Contraceptive Agents|contraceptive agents|mesh-ancestor
65599506|NCT03684824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65599507|NCT03684824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599508|NCT03684824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65599509|NCT03684824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65599510|NCT03684824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599511|NCT03177538|Menotropins|menotropins|mesh-list
65599512|NCT03177538|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65599513|NCT03177538|Hormones|hormones|mesh-ancestor
65599514|NCT03177538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65599515|NCT03177538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599516|NCT03177538|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65599517|NCT03177538|Fertility Agents|fertility agents|mesh-ancestor
65599518|NCT03177538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65599519|NCT01363323|Moxifloxacin|moxifloxacin|mesh-list
65599520|NCT01363323|Naltrexone|naltrexone|mesh-list
65599521|NCT01363323|Methylnaltrexone|methylnaltrexone|mesh-list
65599522|NCT01363323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65599523|NCT01363323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65599524|NCT01363323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65599525|NCT01363323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65599526|NCT01363323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599527|NCT01363323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599528|NCT01363323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599529|NCT01363323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599530|NCT01363323|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65599531|NCT01363323|Sensory System Agents|sensory system agents|mesh-ancestor
65599532|NCT01363323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65599533|NCT01363323|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65599534|NCT03183076|Anticonvulsants|anticonvulsants|mesh-list
65599535|NCT03106948|Ascorbic Acid|ascorbic acid|mesh-list
65599536|NCT03106948|Penicillamine|penicillamine|mesh-list
65599537|NCT03106948|Antioxidants|antioxidants|mesh-ancestor
65599538|NCT03106948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599539|NCT03106948|Protective Agents|protective agents|mesh-ancestor
65599540|NCT03106948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599541|NCT03106948|Vitamins|vitamins|mesh-ancestor
65599542|NCT03106948|Micronutrients|micronutrients|mesh-ancestor
65599543|NCT03106948|Antidotes|antidotes|mesh-ancestor
65599544|NCT03106948|Chelating Agents|chelating agents|mesh-ancestor
65599545|NCT03106948|Sequestering Agents|sequestering agents|mesh-ancestor
65599546|NCT03106948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65599547|NCT01366365|Methylnaltrexone|methylnaltrexone|mesh-list
65599548|NCT01366365|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65599549|NCT01366365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599550|NCT01366365|Sensory System Agents|sensory system agents|mesh-ancestor
65599551|NCT01366365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65599552|NCT01881048|Celecoxib|celecoxib|mesh-list
65599553|NCT01881048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65599554|NCT01881048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65599555|NCT01881048|Analgesics|analgesics|mesh-ancestor
65599556|NCT01881048|Sensory System Agents|sensory system agents|mesh-ancestor
65599557|NCT01881048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65599558|NCT01881048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599559|NCT01881048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65599560|NCT01881048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65599561|NCT01881048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65599562|NCT01881048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65599563|NCT01881048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599564|NCT01881048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599565|NCT01363557|Gefitinib|gefitinib|mesh-list
65599566|NCT01363557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599567|NCT01363557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65599568|NCT01363557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599569|NCT01363557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599570|NCT01346475|Valacyclovir|valacyclovir|mesh-list
65599571|NCT01346475|Antiviral Agents|antiviral agents|mesh-ancestor
65599572|NCT01346475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65599573|NCT05415228|Edetic Acid|edetic acid|mesh-list
65599574|NCT05415228|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65599575|NCT05415228|Chelating Agents|chelating agents|mesh-ancestor
65599576|NCT05415228|Sequestering Agents|sequestering agents|mesh-ancestor
65599577|NCT05415228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599578|NCT05415228|Anticoagulants|anticoagulants|mesh-ancestor
65599579|NCT05415228|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65599580|NCT05415228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65599581|NCT01338636|Ambrisentan|ambrisentan|mesh-list
65599582|NCT01338636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65599583|NCT05753670|Tamsulosin|tamsulosin|mesh-list
65599584|NCT05753670|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65599585|NCT05753670|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65599586|NCT05753670|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65599587|NCT05753670|Adrenergic Agents|adrenergic agents|mesh-ancestor
65599588|NCT05753670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65599589|NCT05753670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599590|NCT05753670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599591|NCT05753670|Urological Agents|urological agents|mesh-ancestor
65599592|NCT02416258|Betamethasone|betamethasone|mesh-list
65599593|NCT02416258|Betamethasone Valerate|betamethasone valerate|mesh-list
65599594|NCT02416258|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65599595|NCT02416258|Betamethasone benzoate|betamethasone benzoate|mesh-list
65599596|NCT02416258|Calcipotriene|calcipotriene|mesh-list
65599597|NCT02416258|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65599598|NCT02416258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65599599|NCT02416258|Glucocorticoids|glucocorticoids|mesh-ancestor
65599600|NCT02416258|Hormones|hormones|mesh-ancestor
65599601|NCT02416258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65599602|NCT02416258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599603|NCT02416258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65599604|NCT02416258|Respiratory System Agents|respiratory system agents|mesh-ancestor
65599605|NCT02416258|Dermatologic Agents|dermatologic agents|mesh-ancestor
65599606|NCT02410720|Picosulfate sodium|picosulfate sodium|mesh-list
65599607|NCT02410720|Cathartics|cathartics|mesh-ancestor
65599608|NCT02410720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65599609|NCT02416570|Clarithromycin|clarithromycin|mesh-list
65599610|NCT02416570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65599611|NCT02416570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65599612|NCT02416570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65599613|NCT02416570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599614|NCT02416570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599615|NCT02416570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65599616|NCT02416570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65599617|NCT05328336|Paclitaxel|paclitaxel|mesh-list
65599618|NCT05328336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65599619|NCT05328336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599620|NCT05328336|Tubulin Modulators|tubulin modulators|mesh-ancestor
65599621|NCT05328336|Antimitotic Agents|antimitotic agents|mesh-ancestor
65599622|NCT05328336|Mitosis Modulators|mitosis modulators|mesh-ancestor
65599623|NCT05328336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599624|NCT02873754|Bupropion|bupropion|mesh-list
65599625|NCT02873754|Nicotine|nicotine|mesh-list
65599626|NCT02873754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65599627|NCT02873754|Autonomic Agents|autonomic agents|mesh-ancestor
65599628|NCT02873754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65599629|NCT02873754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599630|NCT02873754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65599631|NCT02873754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65599632|NCT02873754|Cholinergic Agents|cholinergic agents|mesh-ancestor
65599633|NCT02873754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65599634|NCT02873754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599635|NCT02873754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65599636|NCT02873754|Antidepressive Agents|antidepressive agents|mesh-ancestor
65599637|NCT02873754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65599638|NCT02873754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65599639|NCT02873754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65599640|NCT02873754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65599641|NCT02873754|Dopamine Agents|dopamine agents|mesh-ancestor
65599642|NCT02873754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65599643|NCT02873754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65599644|NCT02873754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599645|NCT03669614|Gallium citrate|gallium citrate|mesh-list
65599646|NCT03669614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599647|NCT03669614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65599648|NCT05200260|Niraparib|niraparib|mesh-list
65599649|NCT05200260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65599650|NCT05200260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599651|NCT05200260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599652|NCT05200260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599653|NCT02416804|Buprenorphine|buprenorphine|mesh-list
65599654|NCT02416804|Tramadol|tramadol|mesh-list
65599655|NCT02416804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65599656|NCT02416804|Narcotics|narcotics|mesh-ancestor
65599657|NCT02416804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65599658|NCT02416804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599659|NCT02416804|Analgesics|analgesics|mesh-ancestor
65599660|NCT02416804|Sensory System Agents|sensory system agents|mesh-ancestor
65599661|NCT02416804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65599662|NCT02416804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65599663|NCT04792320|Charcoal|charcoal|mesh-list
65599664|NCT04792320|Antidotes|antidotes|mesh-ancestor
65599665|NCT04792320|Protective Agents|protective agents|mesh-ancestor
65599666|NCT04792320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599667|NCT03176758|Anesthetics|anesthetics|mesh-list
65599668|NCT03176758|Anesthetics, General|anesthetics, general|mesh-list
65599669|NCT03176758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65599670|NCT03176758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599671|NCT03177070|Methylene Blue|methylene blue|mesh-list
65599672|NCT03177070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599673|NCT03177070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599674|NCT03680612|Cefepime|cefepime|mesh-list
65599675|NCT03680612|Enmetazobactam|enmetazobactam|mesh-list
65599676|NCT03680612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65599677|NCT03680612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65599678|NCT03680612|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65599679|NCT03680612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599680|NCT03680612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599681|NCT02410096|Methacholine Chloride|methacholine chloride|mesh-list
65599682|NCT02410096|Miotics|miotics|mesh-ancestor
65599683|NCT02410096|Autonomic Agents|autonomic agents|mesh-ancestor
65599684|NCT02410096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65599685|NCT02410096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599686|NCT02410096|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65599687|NCT02410096|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
65599688|NCT02410096|Respiratory System Agents|respiratory system agents|mesh-ancestor
65599689|NCT02410096|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65599690|NCT02410096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65599691|NCT02410096|Cholinergic Agents|cholinergic agents|mesh-ancestor
65599692|NCT02410096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65599693|NCT02410096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599694|NCT04046939|Pramipexole|pramipexole|mesh-list
65599695|NCT04046939|Antioxidants|antioxidants|mesh-ancestor
65599696|NCT04046939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599697|NCT04046939|Protective Agents|protective agents|mesh-ancestor
65599698|NCT04046939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599699|NCT04046939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65599700|NCT04046939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65599701|NCT04046939|Dopamine Agonists|dopamine agonists|mesh-ancestor
65599702|NCT04046939|Dopamine Agents|dopamine agents|mesh-ancestor
65599703|NCT04046939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65599704|NCT05188131|Diclofenac|diclofenac|mesh-list
65599705|NCT05188131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65599706|NCT05188131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65599707|NCT05188131|Analgesics|analgesics|mesh-ancestor
65599708|NCT05188131|Sensory System Agents|sensory system agents|mesh-ancestor
65599709|NCT05188131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65599710|NCT05188131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599711|NCT05188131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65599712|NCT05188131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65599713|NCT05188131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65599714|NCT05188131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599715|NCT05188131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599716|NCT03651206|Niraparib|niraparib|mesh-list
65599717|NCT03651206|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65599718|NCT03651206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599719|NCT03651206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599720|NCT03651206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599721|NCT01360437|Ticagrelor|ticagrelor|mesh-list
65599722|NCT01360437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65599723|NCT01360437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65599724|NCT01360437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65599725|NCT01360437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65599726|NCT01360437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65599727|NCT01360437|Purinergic Agents|purinergic agents|mesh-ancestor
65599728|NCT01360437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65599729|NCT01360437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599730|NCT01360437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599732|NCT02409862|Oxytocics|oxytocics|mesh-ancestor
65599733|NCT02409862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65599734|NCT02409862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599735|NCT01360671|Sildenafil Citrate|sildenafil citrate|mesh-list
65599736|NCT01360671|Vasodilator Agents|vasodilator agents|mesh-ancestor
65599737|NCT01360671|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65599738|NCT01360671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65599739|NCT01360671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599740|NCT01360671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599741|NCT01360671|Urological Agents|urological agents|mesh-ancestor
65599742|NCT04927884|Cyclophosphamide|cyclophosphamide|mesh-list
65599743|NCT04927884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65599744|NCT04927884|Immunologic Factors|immunologic factors|mesh-ancestor
65599745|NCT04927884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599746|NCT04927884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65599747|NCT04927884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65599748|NCT04927884|Alkylating Agents|alkylating agents|mesh-ancestor
65599749|NCT04927884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599750|NCT04927884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599751|NCT04927884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65599752|NCT02955797|Vaccines|vaccines|mesh-list
65599753|NCT02955797|Immunologic Factors|immunologic factors|mesh-ancestor
65599754|NCT02955797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599755|NCT03680378|Cefepime|cefepime|mesh-list
65599756|NCT03680378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65599757|NCT03680378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65599758|NCT01319331|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65599759|NCT01319331|Protein C Inhibitor|protein c inhibitor|mesh-list
65599760|NCT01319331|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65599761|NCT01319331|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65599762|NCT01319331|Protease Inhibitors|protease inhibitors|mesh-ancestor
65599763|NCT01319331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599764|NCT01319331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599765|NCT05418348|Nimodipine|nimodipine|mesh-list
65599766|NCT05418348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65599767|NCT05418348|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65599768|NCT05418348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65599769|NCT05418348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599770|NCT05418348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65599771|NCT05418348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599772|NCT05418348|Vasodilator Agents|vasodilator agents|mesh-ancestor
65599773|NCT03010176|Pembrolizumab|pembrolizumab|mesh-list
65599774|NCT03010176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65599775|NCT03010176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599776|NCT04885530|Fluticasone|fluticasone|mesh-list
65599777|NCT04885530|Xhance|xhance|mesh-list
65599778|NCT04885530|Ivermectin|ivermectin|mesh-list
65599779|NCT04885530|Fluvoxamine|fluvoxamine|mesh-list
65599780|NCT04885530|Montelukast|montelukast|mesh-list
65599781|NCT04885530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65599782|NCT04885530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65599783|NCT04885530|Autonomic Agents|autonomic agents|mesh-ancestor
65599784|NCT04885530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65599785|NCT04885530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599786|NCT04885530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65599787|NCT04885530|Respiratory System Agents|respiratory system agents|mesh-ancestor
65599788|NCT04885530|Dermatologic Agents|dermatologic agents|mesh-ancestor
65599789|NCT04885530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65599790|NCT04885530|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65599791|NCT04885530|Hormone Antagonists|hormone antagonists|mesh-ancestor
65599792|NCT04885530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65599793|NCT04885530|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65599794|NCT04885530|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65599795|NCT04885530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599796|NCT04885530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599797|NCT04885530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65599798|NCT04885530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65599799|NCT04885530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65397218|NCT00749723|Temozolomide|temozolomide|mesh-list
65599801|NCT04885530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65599802|NCT04885530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65599803|NCT04885530|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65599804|NCT04885530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65599805|NCT04885530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65599806|NCT04885530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65599807|NCT04885530|Serotonin Agents|serotonin agents|mesh-ancestor
65599808|NCT04885530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65599809|NCT04885530|Antidepressive Agents|antidepressive agents|mesh-ancestor
65599810|NCT04885530|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65599811|NCT04885530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65599812|NCT04885530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65599813|NCT02414776|Hydroxychloroquine|hydroxychloroquine|mesh-list
65599814|NCT02414776|Antimalarials|antimalarials|mesh-ancestor
65599815|NCT02414776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65599816|NCT02414776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65599817|NCT02414776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65599818|NCT02414776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599819|NCT02414776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599820|NCT02414776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65599821|NCT03176524|Glucagon|glucagon|mesh-list
65599822|NCT03176524|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65599823|NCT03176524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65599824|NCT03176524|Hormones|hormones|mesh-ancestor
65599825|NCT03176524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65599826|NCT03176524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599827|NCT03176524|Incretins|incretins|mesh-ancestor
65599828|NCT03676088|Mitogens|mitogens|mesh-list
65599829|NCT03676088|Mitosis Modulators|mitosis modulators|mesh-ancestor
65599830|NCT03676088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599831|NCT02414464|Calcium, Dietary|calcium, dietary|mesh-list
65599832|NCT02414464|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65599833|NCT02414464|Calcium|calcium|mesh-list
65599834|NCT02414464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65599835|NCT02414464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599836|NCT02414464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65599837|NCT02414464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65599838|NCT02414464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65599839|NCT03226418|Cytarabine|cytarabine|mesh-list
65599840|NCT03226418|Azacitidine|azacitidine|mesh-list
65599841|NCT03226418|Decitabine|decitabine|mesh-list
65599842|NCT03226418|Daunorubicin|daunorubicin|mesh-list
65599843|NCT03226418|Venetoclax|venetoclax|mesh-list
65599844|NCT03226418|Idarubicin|idarubicin|mesh-list
65599845|NCT03226418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65599846|NCT03226418|Antimetabolites|antimetabolites|mesh-ancestor
65599847|NCT03226418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599848|NCT03226418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599849|NCT03226418|Antiviral Agents|antiviral agents|mesh-ancestor
65599850|NCT03226418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65599851|NCT03226418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65599852|NCT03226418|Immunologic Factors|immunologic factors|mesh-ancestor
65599853|NCT03226418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599854|NCT03226418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65599855|NCT03226418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65599856|NCT03226418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65599857|NCT03226418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65599858|NCT04039503|Tirzepatide|tirzepatide|mesh-list
65599859|NCT04039503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65599860|NCT04039503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599861|NCT04039503|Incretins|incretins|mesh-ancestor
65599862|NCT04039503|Hormones|hormones|mesh-ancestor
65599863|NCT04039503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65599864|NCT05418114|Magnesium Sulfate|magnesium sulfate|mesh-list
65599865|NCT05418114|Analgesics|analgesics|mesh-ancestor
65599866|NCT05418114|Sensory System Agents|sensory system agents|mesh-ancestor
65599867|NCT05418114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65599868|NCT05418114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599869|NCT05418114|Anesthetics|anesthetics|mesh-ancestor
65599870|NCT05418114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65599871|NCT05418114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65599872|NCT05418114|Anticonvulsants|anticonvulsants|mesh-ancestor
65599873|NCT05418114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65397294|NCT00964704|Antimetabolites|antimetabolites|mesh-ancestor
65599874|NCT05418114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65599875|NCT05418114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599876|NCT05418114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65599877|NCT05418114|Tocolytic Agents|tocolytic agents|mesh-ancestor
65599878|NCT05418114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65599879|NCT05528952|Bevacizumab|bevacizumab|mesh-list
65599880|NCT05528952|Atezolizumab|atezolizumab|mesh-list
65599881|NCT05528952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65599882|NCT05528952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599883|NCT05528952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65599884|NCT05528952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65599885|NCT05528952|Growth Substances|growth substances|mesh-ancestor
65599886|NCT05528952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599887|NCT05528952|Growth Inhibitors|growth inhibitors|mesh-ancestor
65599888|NCT05189769|Levonorgestrel|levonorgestrel|mesh-list
65599889|NCT05189769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65599890|NCT05189769|Contraceptive Agents|contraceptive agents|mesh-ancestor
65599891|NCT05189769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65599892|NCT05189769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599893|NCT05189769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65599894|NCT05189769|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65599895|NCT05189769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65599896|NCT03672812|Liraglutide|liraglutide|mesh-list
65599897|NCT03672812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65599898|NCT03672812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599899|NCT03672812|Incretins|incretins|mesh-ancestor
65599900|NCT03672812|Hormones|hormones|mesh-ancestor
65599901|NCT03672812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65599902|NCT05417880|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65599903|NCT05417880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599904|NCT05029726|Clonidine|clonidine|mesh-list
65599905|NCT05029726|Epinephrine|epinephrine|mesh-list
65599906|NCT05029726|Bupivacaine|bupivacaine|mesh-list
65599907|NCT05029726|Anesthetics, Local|anesthetics, local|mesh-ancestor
65599908|NCT05029726|Anesthetics|anesthetics|mesh-ancestor
65599909|NCT05029726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65599910|NCT05029726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599911|NCT05029726|Sensory System Agents|sensory system agents|mesh-ancestor
65599912|NCT05029726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65599913|NCT05029726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65599914|NCT05029726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65599915|NCT05029726|Adrenergic Agents|adrenergic agents|mesh-ancestor
65599916|NCT05029726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65599917|NCT05029726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599918|NCT05029726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65599919|NCT05029726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65599920|NCT05029726|Autonomic Agents|autonomic agents|mesh-ancestor
65599921|NCT05029726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65599922|NCT05029726|Respiratory System Agents|respiratory system agents|mesh-ancestor
65599923|NCT05029726|Mydriatics|mydriatics|mesh-ancestor
65599924|NCT05029726|Sympathomimetics|sympathomimetics|mesh-ancestor
65599925|NCT05029726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65599926|NCT05029726|Analgesics|analgesics|mesh-ancestor
65599927|NCT05029726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65599928|NCT05029726|Sympatholytics|sympatholytics|mesh-ancestor
65599929|NCT05029726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65599930|NCT05186883|Parathyroid Hormone|parathyroid hormone|mesh-list
65599931|NCT05186883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65599932|NCT05186883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599933|NCT05007652|Plerixafor|plerixafor|mesh-list
65599934|NCT05007652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65599935|NCT05007652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65599936|NCT05007652|Antiviral Agents|antiviral agents|mesh-ancestor
65599937|NCT05007652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65599938|NCT03632772|Solifenacin Succinate|solifenacin succinate|mesh-list
65599939|NCT03632772|Mirabegron|mirabegron|mesh-list
65599940|NCT03632772|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65599941|NCT03632772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65599942|NCT03632772|Cholinergic Agents|cholinergic agents|mesh-ancestor
65599943|NCT03632772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65599944|NCT03632772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599945|NCT03632772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599946|NCT03632772|Urological Agents|urological agents|mesh-ancestor
65599947|NCT03632772|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65599948|NCT03632772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65599949|NCT03632772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65599950|NCT03632772|Adrenergic Agents|adrenergic agents|mesh-ancestor
65599951|NCT01360749|Lidocaine|lidocaine|mesh-list
65599952|NCT01360749|Anesthetics, Local|anesthetics, local|mesh-ancestor
65599953|NCT01360749|Anesthetics|anesthetics|mesh-ancestor
65599954|NCT01360749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65599955|NCT01360749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599956|NCT01360749|Sensory System Agents|sensory system agents|mesh-ancestor
65599957|NCT01360749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65599958|NCT01360749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65599959|NCT01360749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65599960|NCT01360749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65599961|NCT01360749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65248402|NCT00202904|Ezetimibe|ezetimibe|mesh-list
65599962|NCT01360749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599963|NCT01367223|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
65599964|NCT01367223|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65599965|NCT01367223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65599966|NCT01367301|Paclitaxel|paclitaxel|mesh-list
65599967|NCT01367301|Carboplatin|carboplatin|mesh-list
65599968|NCT01367301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65599969|NCT01367301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599970|NCT01367301|Tubulin Modulators|tubulin modulators|mesh-ancestor
65599971|NCT01367301|Antimitotic Agents|antimitotic agents|mesh-ancestor
65599972|NCT01367301|Mitosis Modulators|mitosis modulators|mesh-ancestor
65599973|NCT01367301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599974|NCT03675854|Cefazolin|cefazolin|mesh-list
65599975|NCT03675854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65599976|NCT03675854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65599977|NCT01360827|Cisplatin|cisplatin|mesh-list
65599978|NCT01360827|Fluorouracil|fluorouracil|mesh-list
65599979|NCT01360827|Cetuximab|cetuximab|mesh-list
65599980|NCT01360827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65599981|NCT01360827|Antimetabolites|antimetabolites|mesh-ancestor
65599982|NCT01360827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65599983|NCT01360827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65599984|NCT01360827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65599985|NCT01360827|Immunologic Factors|immunologic factors|mesh-ancestor
65599986|NCT01360827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599987|NCT01360827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65599988|NCT03171610|Fentanyl|fentanyl|mesh-list
65599989|NCT03171610|Sufentanil|sufentanil|mesh-list
65599990|NCT03171610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65599991|NCT03171610|Narcotics|narcotics|mesh-ancestor
65599992|NCT03171610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65599993|NCT03171610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65599994|NCT03171610|Analgesics|analgesics|mesh-ancestor
65599995|NCT03171610|Sensory System Agents|sensory system agents|mesh-ancestor
65599996|NCT03171610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65599997|NCT03171610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65599998|NCT03171610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65599999|NCT03171610|Anesthetics, General|anesthetics, general|mesh-ancestor
65600000|NCT03171610|Anesthetics|anesthetics|mesh-ancestor
65600001|NCT01364181|Udenafil|udenafil|mesh-list
65600002|NCT01364181|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65600003|NCT01364181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65600004|NCT01364181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65600005|NCT01364181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600006|NCT03679442|Acetylcysteine|acetylcysteine|mesh-list
65600007|NCT03679442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65600008|NCT03679442|Antidotes|antidotes|mesh-list
65600009|NCT03679442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600010|NCT03679442|Antiviral Agents|antiviral agents|mesh-ancestor
65600011|NCT03679442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65600012|NCT03679442|Expectorants|expectorants|mesh-ancestor
65600013|NCT03679442|Respiratory System Agents|respiratory system agents|mesh-ancestor
65600014|NCT03679442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65600015|NCT03679442|Antioxidants|antioxidants|mesh-ancestor
65600016|NCT03679442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600017|NCT03679442|Protective Agents|protective agents|mesh-ancestor
65600018|NCT01367535|Naltrexone|naltrexone|mesh-list
65600019|NCT01367535|Methylnaltrexone|methylnaltrexone|mesh-list
65600020|NCT01367535|Paroxetine|paroxetine|mesh-list
65600021|NCT01367535|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65600022|NCT01367535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65600023|NCT01367535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65397455|NCT00960284|Epirubicin|epirubicin|mesh-list
65600024|NCT01367535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600026|NCT01367535|Serotonin Agents|serotonin agents|mesh-ancestor
65600027|NCT01367535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600028|NCT01367535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65600029|NCT01367535|Antidepressive Agents|antidepressive agents|mesh-ancestor
65600030|NCT01367535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65600031|NCT01367535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65600032|NCT01367535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65600033|NCT01367535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65600034|NCT01367535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65600035|NCT01367535|Sensory System Agents|sensory system agents|mesh-ancestor
65600036|NCT01367535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600037|NCT01367535|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65600038|NCT05187663|Chlorhexidine|chlorhexidine|mesh-list
65600039|NCT05187663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65600040|NCT05187663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65600041|NCT05187663|Disinfectants|disinfectants|mesh-ancestor
65600042|NCT04482712|Sirolimus|sirolimus|mesh-list
65600043|NCT04482712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65600044|NCT04482712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65600045|NCT04482712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65600046|NCT04482712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600047|NCT04482712|Antifungal Agents|antifungal agents|mesh-ancestor
65600048|NCT04482712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65600049|NCT04482712|Immunologic Factors|immunologic factors|mesh-ancestor
65600050|NCT04482712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600051|NCT02409004|Rifampin|rifampin|mesh-list
65600052|NCT02409004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65600053|NCT02409004|Antitubercular Agents|antitubercular agents|mesh-ancestor
65600054|NCT02409004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65600055|NCT02409004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65600056|NCT02409004|Leprostatic Agents|leprostatic agents|mesh-ancestor
65600057|NCT02409004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65600058|NCT02409004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65600059|NCT02409004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600060|NCT02409004|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65600061|NCT02409004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65600062|NCT02409004|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65600063|NCT02409004|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65600064|NCT02409004|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65600065|NCT02409004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65600066|NCT03131895|Dexlansoprazole|dexlansoprazole|mesh-list
65600067|NCT03131895|Lansoprazole|lansoprazole|mesh-list
65600068|NCT03131895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65600069|NCT03131895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65600070|NCT03131895|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65600071|NCT03131895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65600072|NCT03131895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600073|NCT01367613|Methylnaltrexone|methylnaltrexone|mesh-list
65600074|NCT01367613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65600075|NCT01367613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600076|NCT01367613|Sensory System Agents|sensory system agents|mesh-ancestor
65600077|NCT01367613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600078|NCT02405104|Chlorzoxazone|chlorzoxazone|mesh-list
65600079|NCT02405104|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65600080|NCT02405104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600081|NCT02405104|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65600082|NCT02405104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600083|NCT01364415|Pasireotide|pasireotide|mesh-list
65600084|NCT01364415|Hormones|hormones|mesh-ancestor
65600085|NCT01364415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65600086|NCT01364415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600087|NCT03176446|Anesthetics|anesthetics|mesh-list
65600088|NCT03176446|Anesthetics, Local|anesthetics, local|mesh-list
65600089|NCT03176446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65600090|NCT03176446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600091|NCT03176446|Sensory System Agents|sensory system agents|mesh-ancestor
65600092|NCT03176446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600093|NCT03176212|Milk fat globule|milk fat globule|mesh-list
65600094|NCT03176212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65600095|NCT04035473|Paclitaxel|paclitaxel|mesh-list
65397531|NCT03962803|Vaccines|vaccines|mesh-list
65600096|NCT04035473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65600097|NCT04035473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600098|NCT04035473|Tubulin Modulators|tubulin modulators|mesh-ancestor
65600099|NCT04035473|Antimitotic Agents|antimitotic agents|mesh-ancestor
65600100|NCT04035473|Mitosis Modulators|mitosis modulators|mesh-ancestor
65600101|NCT04035473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600103|NCT02408926|Immunologic Factors|immunologic factors|mesh-ancestor
65600104|NCT02408926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600105|NCT00704158|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
65600106|NCT00704158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65600107|NCT00704158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600108|NCT03738527|Tranexamic Acid|tranexamic acid|mesh-list
65600109|NCT03738527|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65600110|NCT03738527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65600111|NCT03738527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600112|NCT03738527|Hemostatics|hemostatics|mesh-ancestor
65600113|NCT03738527|Coagulants|coagulants|mesh-ancestor
65600114|NCT02915978|Fentanyl|fentanyl|mesh-list
65600115|NCT02915978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65600116|NCT02915978|Narcotics|narcotics|mesh-ancestor
65600117|NCT02915978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65600118|NCT02915978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600119|NCT02915978|Analgesics|analgesics|mesh-ancestor
65600120|NCT02915978|Sensory System Agents|sensory system agents|mesh-ancestor
65600121|NCT02915978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600122|NCT02915978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65600123|NCT02915978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65600124|NCT02915978|Anesthetics, General|anesthetics, general|mesh-ancestor
65600125|NCT02915978|Anesthetics|anesthetics|mesh-ancestor
65600126|NCT02412904|Menotropins|menotropins|mesh-list
65600127|NCT02412904|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65600128|NCT02412904|Fertility Agents|fertility agents|mesh-ancestor
65600129|NCT02412904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65600130|NCT02412904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600131|NCT02408302|Midazolam|midazolam|mesh-list
65600132|NCT02408302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65600133|NCT02408302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65600134|NCT02408302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65600135|NCT02408302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600136|NCT02408302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65600137|NCT02408302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65600138|NCT02408302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65600139|NCT02408302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65600140|NCT02408302|Anesthetics, General|anesthetics, general|mesh-ancestor
65600141|NCT02408302|Anesthetics|anesthetics|mesh-ancestor
65600142|NCT02408302|GABA Modulators|gaba modulators|mesh-ancestor
65600143|NCT02408302|GABA Agents|gaba agents|mesh-ancestor
65600144|NCT02408302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65600145|NCT02408302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600146|NCT02408146|Celecoxib|celecoxib|mesh-list
65600147|NCT02408146|Parecoxib|parecoxib|mesh-list
65600148|NCT02408146|Fentanyl|fentanyl|mesh-list
65600149|NCT02408146|Ondansetron|ondansetron|mesh-list
65600150|NCT02408146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65600151|NCT02408146|Narcotics|narcotics|mesh-ancestor
65600152|NCT02408146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65600153|NCT02408146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600154|NCT02408146|Analgesics|analgesics|mesh-ancestor
65600155|NCT02408146|Sensory System Agents|sensory system agents|mesh-ancestor
65600156|NCT02408146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600157|NCT02408146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65600158|NCT02408146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65600159|NCT02408146|Anesthetics, General|anesthetics, general|mesh-ancestor
65600160|NCT02408146|Anesthetics|anesthetics|mesh-ancestor
65600161|NCT02408146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600162|NCT02408146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65600163|NCT02408146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65600164|NCT02408146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65600165|NCT02408146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65600166|NCT02408146|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65600167|NCT02408146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65600168|NCT02408146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65600169|NCT02408146|Antiemetics|antiemetics|mesh-ancestor
65600170|NCT02408146|Autonomic Agents|autonomic agents|mesh-ancestor
65600171|NCT02408146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65600172|NCT02408146|Antipruritics|antipruritics|mesh-ancestor
65600174|NCT02408146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65600175|NCT02408146|Serotonin Agents|serotonin agents|mesh-ancestor
65600176|NCT02408146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65600177|NCT02408146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65600178|NCT02408146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65600179|NCT02408146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65600180|NCT02408146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65600181|NCT03175666|Leucovorin|leucovorin|mesh-list
65600182|NCT03175666|Paclitaxel|paclitaxel|mesh-list
65600183|NCT03175666|Cyclophosphamide|cyclophosphamide|mesh-list
65600184|NCT03175666|Bevacizumab|bevacizumab|mesh-list
65600185|NCT03175666|Fluorouracil|fluorouracil|mesh-list
65600186|NCT03175666|Capecitabine|capecitabine|mesh-list
65600187|NCT03175666|Avelumab|avelumab|mesh-list
65600188|NCT03175666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65600189|NCT03175666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600190|NCT03175666|Tubulin Modulators|tubulin modulators|mesh-ancestor
65600191|NCT03175666|Antimitotic Agents|antimitotic agents|mesh-ancestor
65600192|NCT03175666|Mitosis Modulators|mitosis modulators|mesh-ancestor
65600193|NCT03175666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600194|NCT03175666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65600195|NCT03175666|Immunologic Factors|immunologic factors|mesh-ancestor
65600196|NCT03175666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600197|NCT03175666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65600198|NCT03175666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65600199|NCT03175666|Alkylating Agents|alkylating agents|mesh-ancestor
65600200|NCT03175666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65600201|NCT03175666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65600202|NCT03175666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65600203|NCT03175666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65600204|NCT03175666|Growth Substances|growth substances|mesh-ancestor
65600205|NCT03175666|Growth Inhibitors|growth inhibitors|mesh-ancestor
65600206|NCT03175666|Antimetabolites|antimetabolites|mesh-ancestor
65600207|NCT03175666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65600208|NCT03175666|Antidotes|antidotes|mesh-ancestor
65600209|NCT03175666|Protective Agents|protective agents|mesh-ancestor
65600210|NCT03175666|Vitamin B Complex|vitamin b complex|mesh-ancestor
65600211|NCT03175666|Vitamins|vitamins|mesh-ancestor
65600212|NCT03175666|Micronutrients|micronutrients|mesh-ancestor
65600213|NCT03101358|Paclitaxel|paclitaxel|mesh-list
65600214|NCT03101358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65600215|NCT03101358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65600216|NCT03101358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600217|NCT03101358|Tubulin Modulators|tubulin modulators|mesh-ancestor
65600218|NCT03101358|Antimitotic Agents|antimitotic agents|mesh-ancestor
65600219|NCT03101358|Mitosis Modulators|mitosis modulators|mesh-ancestor
65600220|NCT03101358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600221|NCT03171220|Cyclophosphamide|cyclophosphamide|mesh-list
65600222|NCT03171220|Fludarabine|fludarabine|mesh-list
65600223|NCT03171220|Interleukin-2|interleukin-2|mesh-list
65600224|NCT03171220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65600225|NCT03171220|Immunologic Factors|immunologic factors|mesh-ancestor
65600226|NCT03171220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600227|NCT03171220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65600228|NCT03171220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65600229|NCT03171220|Alkylating Agents|alkylating agents|mesh-ancestor
65600230|NCT03171220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600231|NCT03171220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600232|NCT03171220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65600233|NCT03171220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65600234|NCT03171220|Analgesics|analgesics|mesh-ancestor
65600235|NCT03171220|Sensory System Agents|sensory system agents|mesh-ancestor
65600236|NCT03171220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600237|NCT04853004|Antibodies|antibodies|mesh-list
65600238|NCT04853004|Immunologic Factors|immunologic factors|mesh-ancestor
65600239|NCT04853004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600240|NCT03116542|Alovudine|alovudine|mesh-list
65600241|NCT03116542|Antiviral Agents|antiviral agents|mesh-ancestor
65600242|NCT03116542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65600243|NCT03170596|Tazarotene|tazarotene|mesh-list
65600244|NCT03170596|Dermatologic Agents|dermatologic agents|mesh-ancestor
65600245|NCT03170596|Keratolytic Agents|keratolytic agents|mesh-ancestor
65600246|NCT05183412|Methamphetamine|methamphetamine|mesh-list
65600247|NCT05183412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65600248|NCT05183412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600249|NCT05183412|Sympathomimetics|sympathomimetics|mesh-ancestor
65600250|NCT05183412|Autonomic Agents|autonomic agents|mesh-ancestor
65600251|NCT05183412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600252|NCT05183412|Dopamine Agents|dopamine agents|mesh-ancestor
65600253|NCT05183412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65600254|NCT05183412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600255|NCT05183412|Adrenergic Agents|adrenergic agents|mesh-ancestor
65600256|NCT05183412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65600257|NCT05183412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65600258|NCT05183412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65600259|NCT05183412|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65600260|NCT03173326|Anesthetics|anesthetics|mesh-list
65600261|NCT03173326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65600262|NCT03173326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600263|NCT03172858|Oxytocin|oxytocin|mesh-list
65600264|NCT03172858|Oxytocics|oxytocics|mesh-ancestor
65600265|NCT03172858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65600266|NCT03172858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600267|NCT02403856|Methylprednisolone|methylprednisolone|mesh-list
65600268|NCT02403856|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65600269|NCT02403856|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65600270|NCT02403856|Prednisolone|prednisolone|mesh-list
65600271|NCT02403856|Prednisolone acetate|prednisolone acetate|mesh-list
65600272|NCT02403856|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65600273|NCT02403856|Prednisolone phosphate|prednisolone phosphate|mesh-list
65600274|NCT02403856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65600275|NCT02403856|Antiemetics|antiemetics|mesh-ancestor
65600276|NCT02403856|Autonomic Agents|autonomic agents|mesh-ancestor
65600277|NCT02403856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600278|NCT02403856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600279|NCT02403856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65600280|NCT02403856|Glucocorticoids|glucocorticoids|mesh-ancestor
65600281|NCT02403856|Hormones|hormones|mesh-ancestor
65600282|NCT02403856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65600283|NCT02403856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65600284|NCT02403856|Protective Agents|protective agents|mesh-ancestor
65600285|NCT02403856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65600286|NCT02403856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600287|NCT03170284|Bevacizumab|bevacizumab|mesh-list
65600288|NCT03170284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65600289|NCT03170284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600290|NCT03170284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65600291|NCT03170284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65600292|NCT03170284|Growth Substances|growth substances|mesh-ancestor
65600293|NCT03170284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600294|NCT03170284|Growth Inhibitors|growth inhibitors|mesh-ancestor
65600295|NCT02407912|Cisplatin|cisplatin|mesh-list
65600296|NCT02407912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600297|NCT03170050|Lidocaine|lidocaine|mesh-list
65600298|NCT03170050|Anesthetics, Local|anesthetics, local|mesh-ancestor
65600299|NCT03170050|Anesthetics|anesthetics|mesh-ancestor
65600300|NCT03170050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65600301|NCT03170050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600302|NCT03170050|Sensory System Agents|sensory system agents|mesh-ancestor
65600303|NCT03170050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600304|NCT03170050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65600305|NCT03170050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65600306|NCT03170050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65600307|NCT03170050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65600308|NCT03170050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600309|NCT02407834|Sodium Hypochlorite|sodium hypochlorite|mesh-list
65600311|NCT02407834|Disinfectants|disinfectants|mesh-ancestor
65600312|NCT02407834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65600313|NCT03169738|Leucovorin|leucovorin|mesh-list
65600314|NCT03169738|Cyclophosphamide|cyclophosphamide|mesh-list
65600315|NCT03169738|Bevacizumab|bevacizumab|mesh-list
65600316|NCT03169738|Fluorouracil|fluorouracil|mesh-list
65600317|NCT03169738|Capecitabine|capecitabine|mesh-list
65600318|NCT03169738|Oxaliplatin|oxaliplatin|mesh-list
65600319|NCT03169738|Nivolumab|nivolumab|mesh-list
65600320|NCT03169738|Fulvestrant|fulvestrant|mesh-list
65600321|NCT03169738|Avelumab|avelumab|mesh-list
65600322|NCT03169738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600323|NCT03169738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600324|NCT03169738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65600325|NCT03169738|Immunologic Factors|immunologic factors|mesh-ancestor
65600326|NCT03169738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600327|NCT03169738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65600328|NCT03169738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65600329|NCT03169738|Alkylating Agents|alkylating agents|mesh-ancestor
65600330|NCT03169738|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65600331|NCT03169738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65600332|NCT03169738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65600333|NCT03169738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65600334|NCT03169738|Growth Substances|growth substances|mesh-ancestor
65600335|NCT03169738|Growth Inhibitors|growth inhibitors|mesh-ancestor
65600336|NCT03169738|Antimetabolites|antimetabolites|mesh-ancestor
65600337|NCT03169738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65600338|NCT03169738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65600339|NCT03169738|Antidotes|antidotes|mesh-ancestor
65600340|NCT03169738|Protective Agents|protective agents|mesh-ancestor
65600341|NCT03169738|Vitamin B Complex|vitamin b complex|mesh-ancestor
65600342|NCT03169738|Vitamins|vitamins|mesh-ancestor
65600343|NCT03169738|Micronutrients|micronutrients|mesh-ancestor
65600344|NCT03169738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65600345|NCT03169738|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65600346|NCT03169738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65600347|NCT03169738|Hormone Antagonists|hormone antagonists|mesh-ancestor
65600348|NCT03169738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65600349|NCT02407600|Aprepitant|aprepitant|mesh-list
65600350|NCT02407600|Fosaprepitant|fosaprepitant|mesh-list
65600351|NCT02407600|Antiemetics|antiemetics|mesh-ancestor
65600352|NCT02407600|Autonomic Agents|autonomic agents|mesh-ancestor
65600353|NCT02407600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600354|NCT02407600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600355|NCT02407600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65600356|NCT02407600|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65600357|NCT02407600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65600358|NCT02407600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600359|NCT02403544|Capecitabine|capecitabine|mesh-list
65600360|NCT02403544|Oxaliplatin|oxaliplatin|mesh-list
65600361|NCT02403544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65600362|NCT02403544|Antimetabolites|antimetabolites|mesh-ancestor
65600363|NCT02403544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600364|NCT02403544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600365|NCT02411344|Pertuzumab|pertuzumab|mesh-list
65600366|NCT02411344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65600367|NCT02411344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600368|NCT03657095|Beraprost|beraprost|mesh-list
65600369|NCT03657095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65600370|NCT03657095|Vasodilator Agents|vasodilator agents|mesh-ancestor
65600371|NCT02407366|Carboplatin|carboplatin|mesh-list
65600372|NCT02407366|Pemetrexed|pemetrexed|mesh-list
65600373|NCT02407366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600374|NCT02407366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65600375|NCT02407366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600376|NCT02407366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65600377|NCT02407366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65600378|NCT03738137|Lidocaine|lidocaine|mesh-list
65600379|NCT03738137|Midazolam|midazolam|mesh-list
65600380|NCT03738137|Sufentanil|sufentanil|mesh-list
65600381|NCT03738137|Anesthetics, Local|anesthetics, local|mesh-ancestor
65600382|NCT03738137|Anesthetics|anesthetics|mesh-ancestor
65600383|NCT03738137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65600384|NCT03738137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600385|NCT03738137|Sensory System Agents|sensory system agents|mesh-ancestor
65600386|NCT03738137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600387|NCT03738137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65600388|NCT03738137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65600389|NCT03738137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65600390|NCT03738137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65600391|NCT03738137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600392|NCT03738137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65600393|NCT03738137|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65600394|NCT03738137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65600395|NCT03738137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65600396|NCT03738137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65600397|NCT03738137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65600398|NCT03738137|Anesthetics, General|anesthetics, general|mesh-ancestor
65600399|NCT03738137|GABA Modulators|gaba modulators|mesh-ancestor
65600400|NCT03738137|GABA Agents|gaba agents|mesh-ancestor
65600401|NCT03738137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65600402|NCT03738137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65600403|NCT03738137|Narcotics|narcotics|mesh-ancestor
65600404|NCT03738137|Analgesics|analgesics|mesh-ancestor
65600405|NCT02407210|Olmesartan|olmesartan|mesh-list
65600406|NCT02407210|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65600407|NCT02407210|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65600408|NCT02407210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65600409|NCT02407210|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65600410|NCT02407210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65600411|NCT02407210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600412|NCT03737201|Chlorhexidine|chlorhexidine|mesh-list
65600413|NCT03737201|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65600414|NCT03737201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65600415|NCT03737201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65600416|NCT03737201|Disinfectants|disinfectants|mesh-ancestor
65600417|NCT03737201|Dermatologic Agents|dermatologic agents|mesh-ancestor
65600418|NCT03175042|Chrysarobin|chrysarobin|mesh-list
65600419|NCT03175042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65600420|NCT03175042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65600421|NCT03175042|Analgesics|analgesics|mesh-ancestor
65600422|NCT03175042|Sensory System Agents|sensory system agents|mesh-ancestor
65600423|NCT03175042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600424|NCT03175042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600425|NCT03175042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65600426|NCT03175042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65600427|NCT03738059|Dexmedetomidine|dexmedetomidine|mesh-list
65600428|NCT03738059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65600429|NCT03738059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65600430|NCT03738059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600431|NCT03738059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65600432|NCT03738059|Analgesics|analgesics|mesh-ancestor
65600433|NCT03738059|Sensory System Agents|sensory system agents|mesh-ancestor
65600434|NCT03738059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600435|NCT03738059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65600436|NCT03738059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65600437|NCT03738059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65600438|NCT03738059|Adrenergic Agents|adrenergic agents|mesh-ancestor
65600439|NCT03738059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65600440|NCT03738059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600441|NCT05233462|Bupivacaine|bupivacaine|mesh-list
65600442|NCT05233462|Anesthetics, Local|anesthetics, local|mesh-ancestor
65600443|NCT05233462|Anesthetics|anesthetics|mesh-ancestor
65600444|NCT05233462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65600445|NCT05233462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600446|NCT05233462|Sensory System Agents|sensory system agents|mesh-ancestor
65600447|NCT05233462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600448|NCT02700412|Cannabidiol|cannabidiol|mesh-list
65600449|NCT02700412|Anticonvulsants|anticonvulsants|mesh-ancestor
65600450|NCT02351544|Botulinum Toxins|botulinum toxins|mesh-list
65600451|NCT02351544|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65600452|NCT02351544|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65600453|NCT02351544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65600454|NCT02351544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65600455|NCT02351544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600456|NCT02351544|Cholinergic Agents|cholinergic agents|mesh-ancestor
65600457|NCT02351544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65600458|NCT02351544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600459|NCT02351544|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65600460|NCT02351544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600461|NCT02288832|Azithromycin|azithromycin|mesh-list
65600462|NCT02288832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65600463|NCT02288832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65600464|NCT03116308|Opicapone|opicapone|mesh-list
65600465|NCT03116308|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65600466|NCT03116308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65600467|NCT03116308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600468|NCT03116308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65600469|NCT03116308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65600470|NCT03665441|Leucovorin|leucovorin|mesh-list
65600471|NCT03665441|Gemcitabine|gemcitabine|mesh-list
65600472|NCT03665441|Paclitaxel|paclitaxel|mesh-list
65600473|NCT03665441|Irinotecan|irinotecan|mesh-list
65600474|NCT03665441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65600475|NCT03665441|Asparaginase|asparaginase|mesh-list
65600476|NCT03665441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65600477|NCT03665441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600478|NCT03665441|Tubulin Modulators|tubulin modulators|mesh-ancestor
65600479|NCT03665441|Antimitotic Agents|antimitotic agents|mesh-ancestor
65600480|NCT03665441|Mitosis Modulators|mitosis modulators|mesh-ancestor
65600481|NCT03665441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600482|NCT03665441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65600483|NCT03665441|Antimetabolites|antimetabolites|mesh-ancestor
65600484|NCT03665441|Antiviral Agents|antiviral agents|mesh-ancestor
65600485|NCT03665441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65600486|NCT03665441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65600487|NCT03665441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65600488|NCT03665441|Immunologic Factors|immunologic factors|mesh-ancestor
65600489|NCT03665441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600490|NCT03665441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65600491|NCT03665441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65600492|NCT03665441|Antidotes|antidotes|mesh-ancestor
65600493|NCT03665441|Protective Agents|protective agents|mesh-ancestor
65600494|NCT03665441|Vitamin B Complex|vitamin b complex|mesh-ancestor
65600495|NCT03665441|Vitamins|vitamins|mesh-ancestor
65600496|NCT03665441|Micronutrients|micronutrients|mesh-ancestor
65600497|NCT03169660|Aflibercept|aflibercept|mesh-list
65600498|NCT03169660|Mitogens|mitogens|mesh-list
65600499|NCT03169660|Endothelial Growth Factors|endothelial growth factors|mesh-list
65600500|NCT03169660|Mitosis Modulators|mitosis modulators|mesh-ancestor
65600501|NCT03169660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600502|NCT03169660|Growth Substances|growth substances|mesh-ancestor
65600503|NCT03169660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600504|NCT03169660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65600505|NCT03169660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65600506|NCT03169660|Growth Inhibitors|growth inhibitors|mesh-ancestor
65600507|NCT03169660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600508|NCT02401828|Dolutegravir|dolutegravir|mesh-list
65600509|NCT02401828|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65600510|NCT02401828|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65600511|NCT02401828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65600512|NCT02401828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600513|NCT02401828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65600514|NCT02401828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65600515|NCT02401828|Antiviral Agents|antiviral agents|mesh-ancestor
65600516|NCT02401828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65600517|NCT02401594|Enoxaparin|enoxaparin|mesh-list
65600518|NCT02401594|Rivaroxaban|rivaroxaban|mesh-list
65600519|NCT02401594|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65600520|NCT02401594|Antithrombins|antithrombins|mesh-ancestor
65600521|NCT02401594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65600522|NCT02401594|Protease Inhibitors|protease inhibitors|mesh-ancestor
65600523|NCT02401594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65600524|NCT02401594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600525|NCT02401594|Anticoagulants|anticoagulants|mesh-ancestor
65600526|NCT02401594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65600527|NCT02401594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65600528|NCT02406508|Sorafenib|sorafenib|mesh-list
65600529|NCT02406508|Melphalan|melphalan|mesh-list
65600530|NCT02406508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600531|NCT02406508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65600532|NCT02406508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65600533|NCT02406508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600534|NCT02406508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65600535|NCT02406508|Alkylating Agents|alkylating agents|mesh-ancestor
65600536|NCT02406508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65600537|NCT02406508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65600538|NCT02406508|Immunologic Factors|immunologic factors|mesh-ancestor
65600539|NCT02406508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600540|NCT03662789|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65600541|NCT03662789|Hematinics|hematinics|mesh-ancestor
65600542|NCT04481932|Trastuzumab|trastuzumab|mesh-list
65600543|NCT04481932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65600544|NCT04481932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600545|NCT03169582|Sildenafil Citrate|sildenafil citrate|mesh-list
65600546|NCT03169582|Vasodilator Agents|vasodilator agents|mesh-ancestor
65600547|NCT03169582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65600548|NCT03169582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65600549|NCT03169582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65600550|NCT03169582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600551|NCT03169582|Urological Agents|urological agents|mesh-ancestor
65600552|NCT03655691|Botulinum Toxins|botulinum toxins|mesh-list
65600553|NCT03655691|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65600554|NCT03655691|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65600555|NCT03655691|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65600556|NCT03655691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65600557|NCT03655691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600558|NCT03655691|Cholinergic Agents|cholinergic agents|mesh-ancestor
65600559|NCT03655691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65600560|NCT03655691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600561|NCT03655691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65600562|NCT03655691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600563|NCT03169504|Fluticasone|fluticasone|mesh-list
65600565|NCT03169504|Bromides|bromides|mesh-list
65600566|NCT03169504|Tiotropium Bromide|tiotropium bromide|mesh-list
65600567|NCT03169504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65600568|NCT03169504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65600569|NCT03169504|Autonomic Agents|autonomic agents|mesh-ancestor
65600570|NCT03169504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600571|NCT03169504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600572|NCT03169504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65600573|NCT03169504|Respiratory System Agents|respiratory system agents|mesh-ancestor
65600574|NCT03169504|Dermatologic Agents|dermatologic agents|mesh-ancestor
65600575|NCT03169504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65600576|NCT03169504|Parasympatholytics|parasympatholytics|mesh-ancestor
65600577|NCT03169504|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65600578|NCT03169504|Cholinergic Agents|cholinergic agents|mesh-ancestor
65600579|NCT03169504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65600580|NCT03169504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600581|NCT03169504|Anticonvulsants|anticonvulsants|mesh-ancestor
65600582|NCT03169426|Carvedilol|carvedilol|mesh-list
65600583|NCT03169426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65600584|NCT03169426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65600585|NCT03169426|Adrenergic Agents|adrenergic agents|mesh-ancestor
65600586|NCT03169426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65600587|NCT03169426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600588|NCT03169426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600589|NCT03169426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65600590|NCT03169426|Antioxidants|antioxidants|mesh-ancestor
65600591|NCT03169426|Protective Agents|protective agents|mesh-ancestor
65600592|NCT03169426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65600593|NCT03169426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65600594|NCT03169426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65600595|NCT03169426|Vasodilator Agents|vasodilator agents|mesh-ancestor
65600596|NCT03169426|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65600597|NCT03169426|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65600598|NCT03580928|Venetoclax|venetoclax|mesh-list
65600599|NCT03580928|Obinutuzumab|obinutuzumab|mesh-list
65600600|NCT03580928|Acalabrutinib|acalabrutinib|mesh-list
65600601|NCT03580928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600602|NCT03580928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65600603|NCT03169348|Sofosbuvir|sofosbuvir|mesh-list
65600604|NCT03169348|Ledipasvir|ledipasvir|mesh-list
65600605|NCT03169348|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
65600606|NCT03169348|Antiviral Agents|antiviral agents|mesh-ancestor
65600607|NCT03169348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65600608|NCT03631355|Tranexamic Acid|tranexamic acid|mesh-list
65600609|NCT03631355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65600610|NCT03631355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65600611|NCT03631355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600612|NCT03631355|Hemostatics|hemostatics|mesh-ancestor
65600613|NCT03631355|Coagulants|coagulants|mesh-ancestor
65600614|NCT03571568|Rituximab|rituximab|mesh-list
65600615|NCT03571568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65600616|NCT03571568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600617|NCT03571568|Immunologic Factors|immunologic factors|mesh-ancestor
65600618|NCT03571568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600619|NCT03571568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65600620|NCT03169192|Zoledronic Acid|zoledronic acid|mesh-list
65600621|NCT03169192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65600622|NCT03169192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600623|NCT03679052|Clonidine|clonidine|mesh-list
65600624|NCT03679052|Mirtazapine|mirtazapine|mesh-list
65600625|NCT03679052|Analgesics|analgesics|mesh-ancestor
65600626|NCT03679052|Sensory System Agents|sensory system agents|mesh-ancestor
65600627|NCT03679052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600628|NCT03679052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600629|NCT03679052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65600630|NCT03679052|Sympatholytics|sympatholytics|mesh-ancestor
65600631|NCT03679052|Autonomic Agents|autonomic agents|mesh-ancestor
65600632|NCT03679052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65600633|NCT03679052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65600634|NCT03679052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65600635|NCT03679052|Adrenergic Agents|adrenergic agents|mesh-ancestor
65600636|NCT03679052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65600637|NCT03679052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600638|NCT03679052|Antidepressive Agents|antidepressive agents|mesh-ancestor
65600639|NCT03679052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65600640|NCT03679052|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65600641|NCT03679052|Histamine Antagonists|histamine antagonists|mesh-ancestor
65600642|NCT03679052|Histamine Agents|histamine agents|mesh-ancestor
65600643|NCT03679052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65600644|NCT03679052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65600645|NCT03679052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65600646|NCT03679052|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65495907|NCT01256268|Mitosis Modulators|mitosis modulators|mesh-ancestor
65600647|NCT03679052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65600648|NCT03679052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65600649|NCT03679052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65600650|NCT03679052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65600651|NCT03679052|Serotonin Agents|serotonin agents|mesh-ancestor
65600652|NCT03679052|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65600653|NCT03540914|Acetazolamide|acetazolamide|mesh-list
65600654|NCT03540914|Anticonvulsants|anticonvulsants|mesh-ancestor
65600655|NCT03540914|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65600656|NCT03540914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65600657|NCT03540914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600658|NCT03540914|Diuretics|diuretics|mesh-ancestor
65600659|NCT03540914|Natriuretic Agents|natriuretic agents|mesh-ancestor
65600660|NCT03540914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600661|NCT03629249|Indoleacetic Acids|indoleacetic acids|mesh-list
65600662|NCT03629249|Plant Growth Regulators|plant growth regulators|mesh-ancestor
65600663|NCT03629249|Growth Substances|growth substances|mesh-ancestor
65600664|NCT03629249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600665|NCT03671174|Aspirin|aspirin|mesh-list
65600666|NCT03671174|Hydroxychloroquine|hydroxychloroquine|mesh-list
65600667|NCT03671174|Prednisone|prednisone|mesh-list
65600668|NCT03671174|Heparin|heparin|mesh-list
65600669|NCT03671174|Enoxaparin|enoxaparin|mesh-list
65600670|NCT03671174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65600671|NCT03671174|Tinzaparin|tinzaparin|mesh-list
65600672|NCT03671174|Dalteparin|dalteparin|mesh-list
65600673|NCT03671174|Nadroparin|nadroparin|mesh-list
65600674|NCT03671174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65600675|NCT03671174|Glucocorticoids|glucocorticoids|mesh-ancestor
65600676|NCT03671174|Hormones|hormones|mesh-ancestor
65600677|NCT03671174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65600678|NCT03671174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600679|NCT03671174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65600680|NCT03671174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600681|NCT03671174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65600682|NCT03671174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65600683|NCT03671174|Analgesics|analgesics|mesh-ancestor
65600684|NCT03671174|Sensory System Agents|sensory system agents|mesh-ancestor
65600685|NCT03671174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600686|NCT03671174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65600687|NCT03671174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65600688|NCT03671174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65600689|NCT03671174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600690|NCT03671174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65600691|NCT03671174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65600692|NCT03671174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65600693|NCT03671174|Antipyretics|antipyretics|mesh-ancestor
65600694|NCT03671174|Anticoagulants|anticoagulants|mesh-ancestor
65600695|NCT03671174|Antimalarials|antimalarials|mesh-ancestor
65600696|NCT03671174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65600697|NCT03671174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65600698|NCT03671174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65600699|NCT03172234|Amantadine|amantadine|mesh-list
65600700|NCT03172234|Gabapentin|gabapentin|mesh-list
65600701|NCT03172234|Analgesics|analgesics|mesh-ancestor
65600702|NCT03172234|Sensory System Agents|sensory system agents|mesh-ancestor
65600703|NCT03172234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600704|NCT03172234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600705|NCT03172234|Anticonvulsants|anticonvulsants|mesh-ancestor
65600706|NCT03172234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65398116|NCT00966576|Timolol|timolol|mesh-list
65600707|NCT03172234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65600708|NCT03172234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65600709|NCT03172234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65600710|NCT03172234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65600711|NCT03172234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65600712|NCT03172234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65600713|NCT03172234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600714|NCT03172234|Antimanic Agents|antimanic agents|mesh-ancestor
65600715|NCT03172234|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65600716|NCT03172234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65600717|NCT03172234|Antiviral Agents|antiviral agents|mesh-ancestor
65600718|NCT03172234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65600719|NCT03172234|Dopamine Agents|dopamine agents|mesh-ancestor
65600720|NCT03172234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65600721|NCT03709849|Citric Acid|citric acid|mesh-list
65600722|NCT03709849|Sodium Citrate|sodium citrate|mesh-list
65600723|NCT03709849|Clomiphene|clomiphene|mesh-list
65600724|NCT03709849|Enclomiphene|enclomiphene|mesh-list
65600725|NCT03709849|Zuclomiphene|zuclomiphene|mesh-list
65600726|NCT03709849|Anticoagulants|anticoagulants|mesh-ancestor
65600727|NCT03709849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65600728|NCT03709849|Chelating Agents|chelating agents|mesh-ancestor
65600729|NCT03709849|Sequestering Agents|sequestering agents|mesh-ancestor
65600730|NCT03709849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600731|NCT03709849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65600732|NCT03709849|Hormone Antagonists|hormone antagonists|mesh-ancestor
65600733|NCT03709849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65600734|NCT03709849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600735|NCT03709849|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65600736|NCT03709849|Fertility Agents|fertility agents|mesh-ancestor
65600737|NCT03709849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65600738|NCT03709849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65600739|NCT03709849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65600740|NCT05343325|Paclitaxel|paclitaxel|mesh-list
65600741|NCT05343325|Cisplatin|cisplatin|mesh-list
65600742|NCT05343325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65600743|NCT05343325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65600744|NCT05343325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600745|NCT05343325|Tubulin Modulators|tubulin modulators|mesh-ancestor
65600746|NCT05343325|Antimitotic Agents|antimitotic agents|mesh-ancestor
65600747|NCT05343325|Mitosis Modulators|mitosis modulators|mesh-ancestor
65600748|NCT05343325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600749|NCT03349333|Folic Acid|folic acid|mesh-list
65600750|NCT03349333|Vitamin B 12|vitamin b 12|mesh-list
65600751|NCT03349333|Hydroxocobalamin|hydroxocobalamin|mesh-list
65600752|NCT03349333|Vitamins|vitamins|mesh-ancestor
65600753|NCT03349333|Micronutrients|micronutrients|mesh-ancestor
65600754|NCT03349333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600755|NCT03349333|Hematinics|hematinics|mesh-ancestor
65600756|NCT03349333|Vitamin B Complex|vitamin b complex|mesh-ancestor
65600757|NCT03365791|Spartalizumab|spartalizumab|mesh-list
65600758|NCT03365791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65600759|NCT03365791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600760|NCT03365791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600761|NCT03365011|Nitrous Oxide|nitrous oxide|mesh-list
65600762|NCT03365011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65600763|NCT03365011|Anesthetics, General|anesthetics, general|mesh-ancestor
65600764|NCT03365011|Anesthetics|anesthetics|mesh-ancestor
65600765|NCT03365011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65600766|NCT03365011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600767|NCT03365011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65600768|NCT03365011|Analgesics|analgesics|mesh-ancestor
65600769|NCT03365011|Sensory System Agents|sensory system agents|mesh-ancestor
65600770|NCT03365011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600771|NCT03627767|Abrocitinib|abrocitinib|mesh-list
65600772|NCT03627767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65600773|NCT03627767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65600774|NCT03627767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600775|NCT03732365|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65600776|NCT03732365|Cefazolin|cefazolin|mesh-list
65600777|NCT03732365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65600778|NCT03732287|Anesthetics|anesthetics|mesh-list
65600779|NCT03732287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65600780|NCT03732287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600781|NCT02142738|Gemcitabine|gemcitabine|mesh-list
65600782|NCT02142738|Paclitaxel|paclitaxel|mesh-list
65600783|NCT02142738|Carboplatin|carboplatin|mesh-list
65600784|NCT02142738|Pembrolizumab|pembrolizumab|mesh-list
65600785|NCT02142738|Pemetrexed|pemetrexed|mesh-list
65600786|NCT02142738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65600787|NCT02142738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600788|NCT02142738|Tubulin Modulators|tubulin modulators|mesh-ancestor
65600789|NCT02142738|Antimitotic Agents|antimitotic agents|mesh-ancestor
65600790|NCT02142738|Mitosis Modulators|mitosis modulators|mesh-ancestor
65600791|NCT02142738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600792|NCT02142738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65600793|NCT02142738|Antimetabolites|antimetabolites|mesh-ancestor
65600794|NCT02142738|Antiviral Agents|antiviral agents|mesh-ancestor
65600795|NCT02142738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65600796|NCT02142738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65600797|NCT02142738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65600798|NCT02142738|Immunologic Factors|immunologic factors|mesh-ancestor
65600799|NCT02142738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600800|NCT02142738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65600801|NCT02142738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65600802|NCT02142738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65600803|NCT03617861|Secretin|secretin|mesh-list
65600804|NCT03617861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65600805|NCT03617861|Hormones|hormones|mesh-ancestor
65600806|NCT03617861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65600807|NCT03617861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600808|NCT03614975|Vaccines|vaccines|mesh-list
65600809|NCT03614975|Immunologic Factors|immunologic factors|mesh-ancestor
65600810|NCT03614975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600811|NCT03613649|Moxifloxacin|moxifloxacin|mesh-list
65600812|NCT03613649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65600813|NCT03613649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65600814|NCT03613649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65600815|NCT03613649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65600816|NCT03613649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65600817|NCT03613649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600818|NCT03613649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600819|NCT03096288|Evolocumab|evolocumab|mesh-list
65600820|NCT03096288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65600821|NCT03096288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65600822|NCT03096288|Antimetabolites|antimetabolites|mesh-ancestor
65600823|NCT03096288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600824|NCT03096288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65600825|NCT03731897|Lidocaine|lidocaine|mesh-list
65600826|NCT03731897|Anesthetics, Local|anesthetics, local|mesh-ancestor
65600827|NCT03731897|Anesthetics|anesthetics|mesh-ancestor
65600828|NCT03731897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65600829|NCT03731897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600830|NCT03731897|Sensory System Agents|sensory system agents|mesh-ancestor
65600831|NCT03731897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600832|NCT03731897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65600833|NCT03731897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65600834|NCT03731897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65600835|NCT03731897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65600836|NCT03731897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600837|NCT02072148|Cisplatin|cisplatin|mesh-list
65600838|NCT02072148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600839|NCT04456608|Aspirin|aspirin|mesh-list
65600840|NCT04456608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65600841|NCT04456608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65600842|NCT04456608|Analgesics|analgesics|mesh-ancestor
65600843|NCT04456608|Sensory System Agents|sensory system agents|mesh-ancestor
65600844|NCT04456608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600845|NCT04456608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600846|NCT04456608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65600847|NCT04456608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65600848|NCT04456608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65600849|NCT04456608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65600850|NCT04456608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600851|NCT04456608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65600852|NCT04456608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65600853|NCT04456608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65600854|NCT04456608|Antipyretics|antipyretics|mesh-ancestor
65600855|NCT04450212|Vitamin K|vitamin k|mesh-list
65600856|NCT04450212|Vitamins|vitamins|mesh-ancestor
65600857|NCT04450212|Micronutrients|micronutrients|mesh-ancestor
65600858|NCT04450212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600859|NCT04450212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65600860|NCT04450212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65600861|NCT04450212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600862|NCT04450212|Hemostatics|hemostatics|mesh-ancestor
65600863|NCT04450212|Coagulants|coagulants|mesh-ancestor
65600865|NCT05074290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600866|NCT03095508|Menthol|menthol|mesh-list
65600867|NCT03095508|Antipruritics|antipruritics|mesh-ancestor
65600868|NCT03095508|Dermatologic Agents|dermatologic agents|mesh-ancestor
65600869|NCT03632538|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65600870|NCT03632538|Protein C Inhibitor|protein c inhibitor|mesh-list
65600871|NCT03632538|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65600872|NCT03632538|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65600873|NCT03632538|Protease Inhibitors|protease inhibitors|mesh-ancestor
65600874|NCT03632538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65600875|NCT03632538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600876|NCT03731741|Pentoxifylline|pentoxifylline|mesh-list
65600877|NCT03731741|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65600878|NCT03731741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65600879|NCT03731741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600880|NCT03731741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65600881|NCT03731741|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65600882|NCT03731741|Protective Agents|protective agents|mesh-ancestor
65600883|NCT03731741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600884|NCT03731741|Vasodilator Agents|vasodilator agents|mesh-ancestor
65600885|NCT03731741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65600886|NCT03731741|Antioxidants|antioxidants|mesh-ancestor
65600887|NCT03736187|Metronidazole|metronidazole|mesh-list
65600888|NCT03736187|Cephalexin|cephalexin|mesh-list
65600889|NCT03736187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65600890|NCT03736187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65600891|NCT03736187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65600892|NCT03736187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65600893|NCT03731429|Lidocaine|lidocaine|mesh-list
65600894|NCT03731429|Anesthetics, Local|anesthetics, local|mesh-ancestor
65600895|NCT03731429|Anesthetics|anesthetics|mesh-ancestor
65600896|NCT03731429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65600897|NCT03731429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600898|NCT03731429|Sensory System Agents|sensory system agents|mesh-ancestor
65600899|NCT03731429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600900|NCT03731429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65600901|NCT03731429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65600902|NCT03731429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65600903|NCT03731429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65600904|NCT03731429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600905|NCT03735563|Fentanyl|fentanyl|mesh-list
65600906|NCT03735563|Ketamine|ketamine|mesh-list
65600907|NCT03735563|Analgesics|analgesics|mesh-ancestor
65600908|NCT03735563|Sensory System Agents|sensory system agents|mesh-ancestor
65600909|NCT03735563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600910|NCT03735563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600911|NCT03735563|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65600912|NCT03735563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65600913|NCT03735563|Anesthetics, General|anesthetics, general|mesh-ancestor
65600914|NCT03735563|Anesthetics|anesthetics|mesh-ancestor
65600915|NCT03735563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65600916|NCT03735563|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65600917|NCT03735563|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65600918|NCT03735563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65600919|NCT03735563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600920|NCT03735563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65600921|NCT03735563|Narcotics|narcotics|mesh-ancestor
65600922|NCT03735563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65600923|NCT03602339|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
65600924|NCT03602339|Chelating Agents|chelating agents|mesh-ancestor
65600925|NCT03602339|Sequestering Agents|sequestering agents|mesh-ancestor
65600926|NCT03602339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600927|NCT03653429|Tranexamic Acid|tranexamic acid|mesh-list
65600928|NCT03653429|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65600929|NCT03653429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65600930|NCT03653429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600931|NCT03653429|Hemostatics|hemostatics|mesh-ancestor
65600932|NCT03653429|Coagulants|coagulants|mesh-ancestor
65600933|NCT03731117|Furosemide|furosemide|mesh-list
65600934|NCT03731117|Diuretics|diuretics|mesh-ancestor
65600936|NCT03731117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600937|NCT03731117|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65600938|NCT03731117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65600939|NCT03731117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600940|NCT03735251|Metoprolol|metoprolol|mesh-list
65600941|NCT03735251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65600942|NCT03735251|Diuretics|diuretics|mesh-list
65600943|NCT03735251|Natriuretic Agents|natriuretic agents|mesh-ancestor
65600944|NCT03735251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600945|NCT03735251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65600946|NCT03735251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65600947|NCT03735251|Sympatholytics|sympatholytics|mesh-ancestor
65600948|NCT03735251|Autonomic Agents|autonomic agents|mesh-ancestor
65600949|NCT03735251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600950|NCT03735251|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65600951|NCT03735251|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65600952|NCT03735251|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65600953|NCT03735251|Adrenergic Agents|adrenergic agents|mesh-ancestor
65600954|NCT03735251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65600955|NCT03735251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600956|NCT03098550|Nivolumab|nivolumab|mesh-list
65600957|NCT03098550|Daratumumab|daratumumab|mesh-list
65600958|NCT03098550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65600959|NCT03098550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600960|NCT03098550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65600961|NCT03098550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65600962|NCT03095118|Daratumumab|daratumumab|mesh-list
65600963|NCT03095118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600964|NCT04224480|Pembrolizumab|pembrolizumab|mesh-list
65600965|NCT04224480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65600966|NCT04224480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600967|NCT05013216|Poly ICLC|poly iclc|mesh-list
65600968|NCT05013216|Interferon Inducers|interferon inducers|mesh-ancestor
65600969|NCT05013216|Immunologic Factors|immunologic factors|mesh-ancestor
65600970|NCT05013216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600971|NCT03169114|Amikacin|amikacin|mesh-list
65600972|NCT03169114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65600973|NCT03169114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65600974|NCT03115762|Bevacizumab|bevacizumab|mesh-list
65600975|NCT03115762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65600976|NCT03115762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65600977|NCT03115762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65600978|NCT03115762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65600979|NCT03115762|Growth Substances|growth substances|mesh-ancestor
65600980|NCT03115762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600981|NCT03115762|Growth Inhibitors|growth inhibitors|mesh-ancestor
65600982|NCT03168958|Methadone|methadone|mesh-list
65600983|NCT03168958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65600984|NCT03168958|Narcotics|narcotics|mesh-ancestor
65600985|NCT03168958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65600986|NCT03168958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600987|NCT03168958|Analgesics|analgesics|mesh-ancestor
65600988|NCT03168958|Sensory System Agents|sensory system agents|mesh-ancestor
65600989|NCT03168958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65600990|NCT03168958|Antitussive Agents|antitussive agents|mesh-ancestor
65600991|NCT03168958|Respiratory System Agents|respiratory system agents|mesh-ancestor
65600992|NCT03632460|Dexmedetomidine|dexmedetomidine|mesh-list
65600993|NCT03632460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65600994|NCT03632460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65600995|NCT03632460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65600996|NCT03632460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65600997|NCT03632460|Analgesics|analgesics|mesh-ancestor
65600998|NCT03632460|Sensory System Agents|sensory system agents|mesh-ancestor
65600999|NCT03632460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65601000|NCT03632460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65601001|NCT03632460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65601002|NCT03632460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65601003|NCT03632460|Adrenergic Agents|adrenergic agents|mesh-ancestor
65601004|NCT03632460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65601005|NCT03632460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601006|NCT05418660|Pembrolizumab|pembrolizumab|mesh-list
65601007|NCT05418660|Nivolumab|nivolumab|mesh-list
65601008|NCT05418660|Atezolizumab|atezolizumab|mesh-list
65601009|NCT05418660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65601010|NCT05418660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601011|NCT05418660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65601012|NCT05418660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601013|NCT03364309|Ixekizumab|ixekizumab|mesh-list
65601014|NCT03364309|Dermatologic Agents|dermatologic agents|mesh-ancestor
65601015|NCT03168178|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65601016|NCT03168178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65601017|NCT03168178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65601018|NCT03168178|Antitubercular Agents|antitubercular agents|mesh-ancestor
65601019|NCT05166096|Aspirin|aspirin|mesh-list
65601020|NCT05166096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65601021|NCT05166096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65601022|NCT05166096|Analgesics|analgesics|mesh-ancestor
65601023|NCT05166096|Sensory System Agents|sensory system agents|mesh-ancestor
65601024|NCT05166096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496277|NCT01149954|Ibuprofen|ibuprofen|mesh-list
65601025|NCT05166096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601026|NCT05166096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65601027|NCT05166096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65601028|NCT05166096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65601029|NCT05166096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65601030|NCT05166096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601031|NCT05166096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65601032|NCT05166096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65601033|NCT05166096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601034|NCT05166096|Antipyretics|antipyretics|mesh-ancestor
65601035|NCT04544202|Trametinib|trametinib|mesh-list
65601036|NCT04544202|Dabrafenib|dabrafenib|mesh-list
65601037|NCT04544202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601038|NCT04544202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65601039|NCT04544202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601040|NCT04544202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601041|NCT03168412|Vaccines|vaccines|mesh-list
65601042|NCT03168412|Immunologic Factors|immunologic factors|mesh-ancestor
65601043|NCT03168412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601044|NCT05110638|Luliconazole|luliconazole|mesh-list
65601045|NCT05110638|Antifungal Agents|antifungal agents|mesh-ancestor
65601046|NCT05110638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65601047|NCT03700788|Chlorhexidine|chlorhexidine|mesh-list
65601048|NCT03700788|Calcium|calcium|mesh-list
65601049|NCT03700788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65601050|NCT03700788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601051|NCT03700788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65601052|NCT03700788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65601053|NCT03700788|Disinfectants|disinfectants|mesh-ancestor
65601054|NCT03334903|Gabapentin|gabapentin|mesh-list
65601055|NCT03334903|Analgesics|analgesics|mesh-ancestor
65601056|NCT03334903|Sensory System Agents|sensory system agents|mesh-ancestor
65601057|NCT03334903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65601058|NCT03334903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601059|NCT03334903|Anticonvulsants|anticonvulsants|mesh-ancestor
65601060|NCT03334903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65601061|NCT03334903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65601062|NCT03334903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65601063|NCT03334903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65601064|NCT03334903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65601065|NCT03334903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65601066|NCT03334903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65601067|NCT03334903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601068|NCT03334903|Antimanic Agents|antimanic agents|mesh-ancestor
65601069|NCT03168100|Dexamethasone|dexamethasone|mesh-list
65601070|NCT03168100|Lenalidomide|lenalidomide|mesh-list
65601071|NCT03168100|Bortezomib|bortezomib|mesh-list
65601072|NCT03168100|Elotuzumab|elotuzumab|mesh-list
65601073|NCT03168100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65601074|NCT03168100|Antiemetics|antiemetics|mesh-ancestor
65601075|NCT03168100|Autonomic Agents|autonomic agents|mesh-ancestor
65601076|NCT03168100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65601077|NCT03168100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601078|NCT03168100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65601079|NCT03168100|Glucocorticoids|glucocorticoids|mesh-ancestor
65601080|NCT03168100|Hormones|hormones|mesh-ancestor
65601081|NCT03168100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65601082|NCT03168100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65601083|NCT03168100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601084|NCT03168100|Immunologic Factors|immunologic factors|mesh-ancestor
65601085|NCT03168100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65601086|NCT03168100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65601087|NCT03168100|Growth Substances|growth substances|mesh-ancestor
65601088|NCT03168100|Growth Inhibitors|growth inhibitors|mesh-ancestor
65601089|NCT03709381|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65601090|NCT03709381|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
65601091|NCT03709381|Cosyntropin|cosyntropin|mesh-list
65601092|NCT03709381|beta-Endorphin|beta-endorphin|mesh-list
65601093|NCT03709381|Hormones|hormones|mesh-ancestor
65601094|NCT03709381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65601095|NCT03709381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601096|NCT03709381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65601097|NCT03709381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601098|NCT01353664|Romidepsin|romidepsin|mesh-list
65601099|NCT01353664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65601100|NCT01353664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601101|NCT02395744|Paclitaxel|paclitaxel|mesh-list
65601102|NCT02395744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65601103|NCT02395744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601104|NCT02395744|Tubulin Modulators|tubulin modulators|mesh-ancestor
65601105|NCT02395744|Antimitotic Agents|antimitotic agents|mesh-ancestor
65601106|NCT02395744|Mitosis Modulators|mitosis modulators|mesh-ancestor
65601107|NCT02395744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601108|NCT02400268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65601109|NCT02400268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65601110|NCT02400268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65601111|NCT02400268|Antitubercular Agents|antitubercular agents|mesh-ancestor
65601112|NCT03168568|Valsartan|valsartan|mesh-list
65601113|NCT03168568|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65601114|NCT03168568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65601115|NCT03168568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65601116|NCT03168568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65601117|NCT03168568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601118|NCT02400112|Vancomycin|vancomycin|mesh-list
65601119|NCT02400112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65601120|NCT02400112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65601121|NCT02694328|Olanzapine|olanzapine|mesh-list
65601122|NCT02694328|Antiemetics|antiemetics|mesh-ancestor
65601123|NCT02694328|Autonomic Agents|autonomic agents|mesh-ancestor
65601124|NCT02694328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65601125|NCT02694328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601126|NCT02694328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65601127|NCT02694328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65601128|NCT02694328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65601129|NCT02694328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65601130|NCT02694328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65601131|NCT02694328|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65601132|NCT02694328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65601133|NCT02694328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65601134|NCT02694328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601135|NCT02694328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65601136|NCT02694328|Serotonin Agents|serotonin agents|mesh-ancestor
65601137|NCT02395510|Vortioxetine|vortioxetine|mesh-list
65601138|NCT02395510|Antidepressive Agents|antidepressive agents|mesh-ancestor
65601139|NCT02395510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65601140|NCT02395510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65601141|NCT02395510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65601142|NCT02395510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65601143|NCT02395510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601144|NCT02395510|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65601145|NCT02395510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65601146|NCT02395510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65601147|NCT02395510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601148|NCT02395510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65601149|NCT02395510|Serotonin Agents|serotonin agents|mesh-ancestor
65601150|NCT02395510|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65601151|NCT02395510|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65601152|NCT02395510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65601153|NCT02395510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65601154|NCT02399800|Triamcinolone|triamcinolone|mesh-list
65601155|NCT02399800|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65601156|NCT02399800|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65601157|NCT02399800|Bupivacaine|bupivacaine|mesh-list
65601159|NCT02399800|Anesthetics, Local|anesthetics, local|mesh-ancestor
65601160|NCT02399800|Anesthetics|anesthetics|mesh-ancestor
65601161|NCT02399800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65601162|NCT02399800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601163|NCT02399800|Sensory System Agents|sensory system agents|mesh-ancestor
65601164|NCT02399800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65601165|NCT02399800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65601166|NCT02399800|Glucocorticoids|glucocorticoids|mesh-ancestor
65601167|NCT02399800|Hormones|hormones|mesh-ancestor
65601168|NCT02399800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65601169|NCT02399800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65601170|NCT02399800|Immunologic Factors|immunologic factors|mesh-ancestor
65601171|NCT02399800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601172|NCT02399800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601173|NCT02399566|Pemetrexed|pemetrexed|mesh-list
65601174|NCT02399566|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65601175|NCT02399566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601176|NCT02399566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601177|NCT02399566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601178|NCT02399566|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65601179|NCT02399566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65601180|NCT02399566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65601181|NCT03167164|Leucovorin|leucovorin|mesh-list
65601182|NCT03167164|Paclitaxel|paclitaxel|mesh-list
65601183|NCT03167164|Cyclophosphamide|cyclophosphamide|mesh-list
65601184|NCT03167164|Bevacizumab|bevacizumab|mesh-list
65601185|NCT03167164|Fluorouracil|fluorouracil|mesh-list
65601186|NCT03167164|Capecitabine|capecitabine|mesh-list
65601187|NCT03167164|Avelumab|avelumab|mesh-list
65601188|NCT03167164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65601189|NCT03167164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601190|NCT03167164|Tubulin Modulators|tubulin modulators|mesh-ancestor
65601191|NCT03167164|Antimitotic Agents|antimitotic agents|mesh-ancestor
65601192|NCT03167164|Mitosis Modulators|mitosis modulators|mesh-ancestor
65601193|NCT03167164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601194|NCT03167164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65601195|NCT03167164|Immunologic Factors|immunologic factors|mesh-ancestor
65601196|NCT03167164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601197|NCT03167164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65601198|NCT03167164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65601199|NCT03167164|Alkylating Agents|alkylating agents|mesh-ancestor
65601200|NCT03167164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65601201|NCT03167164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65601202|NCT03167164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65601203|NCT03167164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65601204|NCT03167164|Growth Substances|growth substances|mesh-ancestor
65601205|NCT03167164|Growth Inhibitors|growth inhibitors|mesh-ancestor
65601206|NCT03167164|Antimetabolites|antimetabolites|mesh-ancestor
65601207|NCT03167164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65601208|NCT03167164|Antidotes|antidotes|mesh-ancestor
65601209|NCT03167164|Protective Agents|protective agents|mesh-ancestor
65601210|NCT03167164|Vitamin B Complex|vitamin b complex|mesh-ancestor
65601211|NCT03167164|Vitamins|vitamins|mesh-ancestor
65601212|NCT03167164|Micronutrients|micronutrients|mesh-ancestor
65601213|NCT03334747|Lumefantrine|lumefantrine|mesh-list
65601214|NCT03334747|Artemether|artemether|mesh-list
65601215|NCT03334747|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65601216|NCT03334747|Antimalarials|antimalarials|mesh-ancestor
65601217|NCT03334747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65601218|NCT03334747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65601219|NCT03334747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65601220|NCT02394652|Metformin|metformin|mesh-list
65601221|NCT02394652|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
65601222|NCT02394652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65601223|NCT02394652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601224|NCT02394652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65601225|NCT02394652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601226|NCT02394496|Fulvestrant|fulvestrant|mesh-list
65601227|NCT02394496|Lapatinib|lapatinib|mesh-list
65601228|NCT02394496|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65601229|NCT02394496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65601230|NCT02394496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601231|NCT02394496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65601232|NCT02394496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65601233|NCT02394496|Hormone Antagonists|hormone antagonists|mesh-ancestor
65601234|NCT02394496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65601235|NCT02394496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601236|NCT02394496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65601237|NCT02394496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601238|NCT02394496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601239|NCT02394496|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65601240|NCT02394418|Dexmedetomidine|dexmedetomidine|mesh-list
65601241|NCT02394418|Propofol|propofol|mesh-list
65601242|NCT02394418|Sevoflurane|sevoflurane|mesh-list
65601243|NCT02394418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65601244|NCT02394418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65601245|NCT02394418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601246|NCT02394418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65601247|NCT02394418|Anesthetics, General|anesthetics, general|mesh-ancestor
65601248|NCT02394418|Anesthetics|anesthetics|mesh-ancestor
65601249|NCT02394418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65601250|NCT02394418|Analgesics|analgesics|mesh-ancestor
65601251|NCT02394418|Sensory System Agents|sensory system agents|mesh-ancestor
65601252|NCT02394418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65601253|NCT02394418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65601254|NCT02394418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65601255|NCT02394418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65601256|NCT02394418|Adrenergic Agents|adrenergic agents|mesh-ancestor
65601257|NCT02394418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65601258|NCT02394418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601259|NCT02394418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65601260|NCT02394418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65601261|NCT02693002|Norethindrone|norethindrone|mesh-list
65601262|NCT02693002|Norethindrone Acetate|norethindrone acetate|mesh-list
65601263|NCT02693002|Estradiol|estradiol|mesh-list
65601264|NCT02693002|Estrogens|estrogens|mesh-ancestor
65601265|NCT02693002|Hormones|hormones|mesh-ancestor
65601266|NCT02693002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65601267|NCT02693002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601268|NCT02693002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65601269|NCT02693002|Contraceptive Agents|contraceptive agents|mesh-ancestor
65601270|NCT02693002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65601271|NCT02693002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65601272|NCT02693002|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65601273|NCT02693002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65601274|NCT02693002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65601275|NCT05408923|Chlorhexidine|chlorhexidine|mesh-list
65601276|NCT05408923|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65601277|NCT05408923|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65601278|NCT05408923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65601279|NCT05408923|Disinfectants|disinfectants|mesh-ancestor
65601280|NCT05408923|Dermatologic Agents|dermatologic agents|mesh-ancestor
65601281|NCT03707509|Gemcitabine|gemcitabine|mesh-list
65601282|NCT03707509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601283|NCT03707509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65601284|NCT03707509|Antimetabolites|antimetabolites|mesh-ancestor
65601285|NCT03707509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601286|NCT03707509|Antiviral Agents|antiviral agents|mesh-ancestor
65601287|NCT03707509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65601288|NCT03707509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601289|NCT03707509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65601290|NCT03707509|Immunologic Factors|immunologic factors|mesh-ancestor
65601291|NCT03707509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601292|NCT03710395|Nifedipine|nifedipine|mesh-list
65601293|NCT03710395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65601294|NCT03710395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65601295|NCT03710395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601296|NCT03710395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65601297|NCT03710395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601298|NCT03710395|Vasodilator Agents|vasodilator agents|mesh-ancestor
65601299|NCT03710395|Tocolytic Agents|tocolytic agents|mesh-ancestor
65601300|NCT03710395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65601301|NCT03093870|Capecitabine|capecitabine|mesh-list
65601302|NCT03093870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65601303|NCT03093870|Antimetabolites|antimetabolites|mesh-ancestor
65601304|NCT03093870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601305|NCT03093870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601306|NCT05744908|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
65601307|NCT05744908|Anticoagulants|anticoagulants|mesh-ancestor
65601308|NCT02394106|Ofatumumab|ofatumumab|mesh-list
65601309|NCT02394106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601310|NCT04793646|Acetylcysteine|acetylcysteine|mesh-list
65601311|NCT04793646|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65601312|NCT04793646|Antiviral Agents|antiviral agents|mesh-ancestor
65601313|NCT04793646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65601314|NCT04793646|Expectorants|expectorants|mesh-ancestor
65601315|NCT04793646|Respiratory System Agents|respiratory system agents|mesh-ancestor
65601316|NCT04793646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65601317|NCT04793646|Antioxidants|antioxidants|mesh-ancestor
65601318|NCT04793646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601319|NCT04793646|Protective Agents|protective agents|mesh-ancestor
65601320|NCT04793646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601321|NCT04793646|Antidotes|antidotes|mesh-ancestor
65601322|NCT03607890|Nivolumab|nivolumab|mesh-list
65601323|NCT03607890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65601324|NCT03607890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601325|NCT03607890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65601326|NCT03607890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601327|NCT02393482|Cholecalciferol|cholecalciferol|mesh-list
65601328|NCT02393482|Vitamin D|vitamin d|mesh-list
65601329|NCT02393482|Leuprolide|leuprolide|mesh-list
65601330|NCT02393482|Tibolone|tibolone|mesh-list
65601331|NCT02393482|Calcium Carbonate|calcium carbonate|mesh-list
65601332|NCT02393482|Hormones|hormones|mesh-list
65601333|NCT02393482|Estradiol|estradiol|mesh-list
65601334|NCT02393482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65601335|NCT02393482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601336|NCT02393482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65601337|NCT02393482|Estrogens|estrogens|mesh-ancestor
65601338|NCT02393482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65601339|NCT02393482|Antacids|antacids|mesh-ancestor
65601340|NCT02393482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601341|NCT02393482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65601342|NCT02393482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65601343|NCT02393482|Fertility Agents|fertility agents|mesh-ancestor
65601344|NCT02393482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65601345|NCT02393482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601346|NCT02393482|Androgen Antagonists|androgen antagonists|mesh-ancestor
65601347|NCT02393482|Hormone Antagonists|hormone antagonists|mesh-ancestor
65601348|NCT02393482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65601349|NCT02393482|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65601350|NCT02393482|Anabolic Agents|anabolic agents|mesh-ancestor
65601351|NCT02393482|Vitamins|vitamins|mesh-ancestor
65601352|NCT02393482|Micronutrients|micronutrients|mesh-ancestor
65601353|NCT02393482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65601354|NCT03528642|Temozolomide|temozolomide|mesh-list
65601355|NCT03528642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65601356|NCT03528642|Alkylating Agents|alkylating agents|mesh-ancestor
65601357|NCT03528642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601358|NCT03528642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601359|NCT03346057|Glycopyrrolate|glycopyrrolate|mesh-list
65601360|NCT03346057|Rocuronium|rocuronium|mesh-list
65601361|NCT03346057|Vecuronium Bromide|vecuronium bromide|mesh-list
65601362|NCT03346057|Neostigmine|neostigmine|mesh-list
65601363|NCT03346057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65601364|NCT03346057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65601365|NCT03346057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65601366|NCT03346057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65601367|NCT03346057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601368|NCT03346057|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65601369|NCT03346057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601370|NCT03346057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601371|NCT03346057|Cholinergic Agents|cholinergic agents|mesh-ancestor
65601372|NCT03346057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65601373|NCT03346057|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65601374|NCT03346057|Autonomic Agents|autonomic agents|mesh-ancestor
65601375|NCT03346057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65601376|NCT03346057|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65601377|NCT03346057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65601378|NCT03346057|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65601379|NCT03166306|Bevacizumab|bevacizumab|mesh-list
65601380|NCT03166306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65601381|NCT03166306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601382|NCT03166306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65398787|NCT00977028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65601383|NCT03166306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65601384|NCT03166306|Growth Substances|growth substances|mesh-ancestor
65601385|NCT03166306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601386|NCT03166306|Growth Inhibitors|growth inhibitors|mesh-ancestor
65601387|NCT02398630|Hormones|hormones|mesh-list
65601388|NCT02398630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65601389|NCT02398630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601390|NCT02398552|Sunitinib|sunitinib|mesh-list
65601391|NCT02398552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601392|NCT02398552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65601393|NCT02398552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65601394|NCT02398552|Growth Substances|growth substances|mesh-ancestor
65601395|NCT02398552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601396|NCT02398552|Growth Inhibitors|growth inhibitors|mesh-ancestor
65601397|NCT02398552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65601398|NCT02398552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601399|NCT02398552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601400|NCT03345979|Aripiprazole|aripiprazole|mesh-list
65601401|NCT03345979|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65601402|NCT03345979|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
65601403|NCT03345979|Antidepressive Agents|antidepressive agents|mesh-ancestor
65601404|NCT03345979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65601405|NCT03345979|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65601406|NCT03345979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65601407|NCT03345979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65601408|NCT03345979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601409|NCT03345979|Dopamine Agonists|dopamine agonists|mesh-ancestor
65601410|NCT03345979|Dopamine Agents|dopamine agents|mesh-ancestor
65601411|NCT03345979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65601412|NCT03345979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601413|NCT03345979|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65601414|NCT03345979|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65601415|NCT03345979|Serotonin Agents|serotonin agents|mesh-ancestor
65601416|NCT03345979|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65601417|NCT03345979|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65601418|NCT03345979|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65601419|NCT03345979|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65601420|NCT02696434|Naltrexone|naltrexone|mesh-list
65601421|NCT02696434|Buprenorphine|buprenorphine|mesh-list
65601422|NCT02696434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65601423|NCT02696434|Narcotics|narcotics|mesh-ancestor
65601424|NCT02696434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65601425|NCT02696434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601426|NCT02696434|Analgesics|analgesics|mesh-ancestor
65601427|NCT02696434|Sensory System Agents|sensory system agents|mesh-ancestor
65601428|NCT02696434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65601429|NCT02696434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65601430|NCT02696434|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65601431|NCT03709147|Metformin|metformin|mesh-list
65601432|NCT03709147|Carboplatin|carboplatin|mesh-list
65601433|NCT03709147|Pembrolizumab|pembrolizumab|mesh-list
65601434|NCT03709147|Pemetrexed|pemetrexed|mesh-list
65601435|NCT03709147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601436|NCT03709147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65601437|NCT03709147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601438|NCT03709147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65601439|NCT03709147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601440|NCT03709147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601441|NCT03709147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65601442|NCT03709147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65601443|NCT02398474|Ropivacaine|ropivacaine|mesh-list
65601444|NCT02398474|Anesthetics, Local|anesthetics, local|mesh-ancestor
65601445|NCT02398474|Anesthetics|anesthetics|mesh-ancestor
65601446|NCT02398474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65601447|NCT02398474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601448|NCT02398474|Sensory System Agents|sensory system agents|mesh-ancestor
65601449|NCT02398474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65601450|NCT03710317|Misoprostol|misoprostol|mesh-list
65601451|NCT03710317|Tranexamic Acid|tranexamic acid|mesh-list
65601452|NCT03710317|Carbetocin|carbetocin|mesh-list
65601453|NCT03710317|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65601454|NCT03710317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65601455|NCT03710317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601456|NCT03710317|Hemostatics|hemostatics|mesh-ancestor
65398866|NCT00545298|Antioxidants|antioxidants|mesh-ancestor
65601457|NCT03710317|Coagulants|coagulants|mesh-ancestor
65601458|NCT03710317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65601459|NCT03710317|Abortifacient Agents|abortifacient agents|mesh-ancestor
65601460|NCT03710317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65601461|NCT03710317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601462|NCT03710317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65601463|NCT03710317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65601464|NCT03710317|Oxytocics|oxytocics|mesh-ancestor
65601465|NCT02392780|Methylprednisolone|methylprednisolone|mesh-list
65601466|NCT02392780|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65601467|NCT02392780|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65601468|NCT02392780|Prednisolone|prednisolone|mesh-list
65601469|NCT02392780|Prednisolone acetate|prednisolone acetate|mesh-list
65601470|NCT02392780|Cannabidiol|cannabidiol|mesh-list
65601471|NCT02392780|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65601472|NCT02392780|Prednisolone phosphate|prednisolone phosphate|mesh-list
65601473|NCT02392780|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
65601474|NCT02392780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65601475|NCT02392780|Antiemetics|antiemetics|mesh-ancestor
65601476|NCT02392780|Autonomic Agents|autonomic agents|mesh-ancestor
65601477|NCT02392780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65601478|NCT02392780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601479|NCT02392780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65601480|NCT02392780|Glucocorticoids|glucocorticoids|mesh-ancestor
65601481|NCT02392780|Hormones|hormones|mesh-ancestor
65601482|NCT02392780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65601483|NCT02392780|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65601484|NCT02392780|Protective Agents|protective agents|mesh-ancestor
65601485|NCT02392780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65601486|NCT02392780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601487|NCT02392780|Anticonvulsants|anticonvulsants|mesh-ancestor
65601488|NCT02392780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601489|NCT02392780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601490|NCT04053478|Phenylephrine|phenylephrine|mesh-list
65601491|NCT04053478|Vasopressins|vasopressins|mesh-list
65601492|NCT04053478|Arginine Vasopressin|arginine vasopressin|mesh-list
65601493|NCT04053478|Oxymetazoline|oxymetazoline|mesh-list
65601494|NCT04053478|Norepinephrine|norepinephrine|mesh-list
65601495|NCT04053478|Ephedrine|ephedrine|mesh-list
65601496|NCT04053478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65601497|NCT04053478|Mydriatics|mydriatics|mesh-ancestor
65601498|NCT04053478|Autonomic Agents|autonomic agents|mesh-ancestor
65601499|NCT04053478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65601500|NCT04053478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601501|NCT04053478|Sympathomimetics|sympathomimetics|mesh-ancestor
65601502|NCT04053478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65601503|NCT04053478|Nasal Decongestants|nasal decongestants|mesh-ancestor
65601504|NCT04053478|Respiratory System Agents|respiratory system agents|mesh-ancestor
65601505|NCT04053478|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65601506|NCT04053478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65601507|NCT04053478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65601508|NCT04053478|Adrenergic Agents|adrenergic agents|mesh-ancestor
65601509|NCT04053478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65601510|NCT04053478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601511|NCT04053478|Protective Agents|protective agents|mesh-ancestor
65601512|NCT04053478|Hemostatics|hemostatics|mesh-ancestor
65601513|NCT04053478|Coagulants|coagulants|mesh-ancestor
65601514|NCT04053478|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65601515|NCT04053478|Natriuretic Agents|natriuretic agents|mesh-ancestor
65601516|NCT04053478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65601517|NCT02392390|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65601518|NCT02392390|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65601519|NCT02392390|Dermatologic Agents|dermatologic agents|mesh-ancestor
65601520|NCT04468776|Zolpidem|zolpidem|mesh-list
65601521|NCT04468776|Trazodone|trazodone|mesh-list
65601522|NCT04468776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65601523|NCT04468776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65601524|NCT04468776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65601525|NCT04468776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601526|NCT04468776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65601527|NCT04468776|GABA Agonists|gaba agonists|mesh-ancestor
65601528|NCT04468776|GABA Agents|gaba agents|mesh-ancestor
65601529|NCT04468776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65601530|NCT04468776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601531|NCT04468776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65601532|NCT04468776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65601533|NCT04468776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65601534|NCT04468776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65601535|NCT04468776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65601536|NCT04468776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65601537|NCT04468776|Serotonin Agents|serotonin agents|mesh-ancestor
65601538|NCT04468776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65601539|NCT04468776|Antidepressive Agents|antidepressive agents|mesh-ancestor
65601540|NCT03593915|Azacitidine|azacitidine|mesh-list
65601541|NCT03593915|Decitabine|decitabine|mesh-list
65601542|NCT03593915|Alvocidib|alvocidib|mesh-list
65601543|NCT03593915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65601544|NCT03593915|Antimetabolites|antimetabolites|mesh-ancestor
65601545|NCT03593915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601546|NCT03593915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601547|NCT03593915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601548|NCT03593915|Growth Inhibitors|growth inhibitors|mesh-ancestor
65601549|NCT03593915|Growth Substances|growth substances|mesh-ancestor
65601550|NCT03593915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601551|NCT03593915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65601552|NCT02392702|Ivacaftor|ivacaftor|mesh-list
65601553|NCT02392702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65601554|NCT02392702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65601555|NCT02392702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601556|NCT02392468|BI 409306|bi 409306|mesh-list
65601557|NCT02392468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65601558|NCT02392468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601559|NCT02392468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601560|NCT02397928|Carboplatin|carboplatin|mesh-list
65601561|NCT02397928|Pemetrexed|pemetrexed|mesh-list
65601562|NCT02397928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601563|NCT02397928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601564|NCT02397928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601565|NCT02397928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65601566|NCT02397928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65601567|NCT03734627|Acetaminophen|acetaminophen|mesh-list
65601568|NCT03734627|Sulfasalazine|sulfasalazine|mesh-list
65601569|NCT03734627|Octreotide|octreotide|mesh-list
65601570|NCT03734627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65601571|NCT03734627|Analgesics|analgesics|mesh-ancestor
65601572|NCT03734627|Sensory System Agents|sensory system agents|mesh-ancestor
65601573|NCT03734627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65601574|NCT03734627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601575|NCT03734627|Antipyretics|antipyretics|mesh-ancestor
65601576|NCT03734627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65601577|NCT03734627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65601578|NCT03734627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601579|NCT03734627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65601580|NCT03734627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65601581|NCT03734627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65601582|NCT03734627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65601583|NCT02397772|Albendazole|albendazole|mesh-list
65601584|NCT02397772|Anthelmintics|anthelmintics|mesh-ancestor
65601585|NCT02397772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65601586|NCT02397772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65601587|NCT02397772|Anticestodal Agents|anticestodal agents|mesh-ancestor
65601588|NCT02397772|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65601589|NCT02397772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65601590|NCT02397772|Tubulin Modulators|tubulin modulators|mesh-ancestor
65601591|NCT02397772|Antimitotic Agents|antimitotic agents|mesh-ancestor
65601592|NCT02397772|Mitosis Modulators|mitosis modulators|mesh-ancestor
65601593|NCT02397772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601594|NCT02397772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601595|NCT03592277|Vitamins|vitamins|mesh-list
65601596|NCT03592277|Ascorbic Acid|ascorbic acid|mesh-list
65601597|NCT03592277|Thiamine|thiamine|mesh-list
65601598|NCT03592277|Micronutrients|micronutrients|mesh-ancestor
65601599|NCT03592277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601600|NCT03592277|Antioxidants|antioxidants|mesh-ancestor
65601601|NCT03592277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601602|NCT03592277|Protective Agents|protective agents|mesh-ancestor
65601603|NCT03592277|Vitamin B Complex|vitamin b complex|mesh-ancestor
65601604|NCT03106402|Bromfenac|bromfenac|mesh-list
65601605|NCT03106402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65601606|NCT03106402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65601607|NCT03106402|Analgesics|analgesics|mesh-ancestor
65601608|NCT03106402|Sensory System Agents|sensory system agents|mesh-ancestor
65601609|NCT03106402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65601610|NCT03106402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601611|NCT03106402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65601612|NCT03106402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65601613|NCT03734159|Ropivacaine|ropivacaine|mesh-list
65601614|NCT03734159|Anesthetics, Local|anesthetics, local|mesh-ancestor
65601615|NCT03734159|Anesthetics|anesthetics|mesh-ancestor
65601616|NCT03734159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65601617|NCT03734159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601618|NCT03734159|Sensory System Agents|sensory system agents|mesh-ancestor
65601619|NCT03734159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65601620|NCT02397382|Midazolam|midazolam|mesh-list
65601621|NCT02397382|Dextromethorphan|dextromethorphan|mesh-list
65601622|NCT02397382|Caffeine|caffeine|mesh-list
65601623|NCT02397382|Omeprazole|omeprazole|mesh-list
65601624|NCT02397382|Warfarin|warfarin|mesh-list
65601625|NCT02397382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65601626|NCT02397382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65601627|NCT02397382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65601628|NCT02397382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601629|NCT02397382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65601630|NCT02397382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65601631|NCT02397382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65601632|NCT02397382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65601633|NCT02397382|Anesthetics, General|anesthetics, general|mesh-ancestor
65601634|NCT02397382|Anesthetics|anesthetics|mesh-ancestor
65601635|NCT02397382|GABA Modulators|gaba modulators|mesh-ancestor
65601636|NCT02397382|GABA Agents|gaba agents|mesh-ancestor
65601637|NCT02397382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65601638|NCT02397382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601639|NCT02397382|Anticoagulants|anticoagulants|mesh-ancestor
65601640|NCT02397382|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65601641|NCT02397382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65601642|NCT02397382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601643|NCT02397382|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65601644|NCT02397382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65601645|NCT02397382|Purinergic Agents|purinergic agents|mesh-ancestor
65601646|NCT02397382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65601647|NCT02397382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65601648|NCT02397382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65601649|NCT02397382|Antitussive Agents|antitussive agents|mesh-ancestor
65601650|NCT02397382|Respiratory System Agents|respiratory system agents|mesh-ancestor
65601651|NCT02397382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65601652|NCT02397382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65601653|NCT02697916|Aspirin|aspirin|mesh-list
65601654|NCT02697916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65601655|NCT02697916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65601656|NCT02697916|Analgesics|analgesics|mesh-ancestor
65601657|NCT02697916|Sensory System Agents|sensory system agents|mesh-ancestor
65601658|NCT02697916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65601659|NCT02697916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601660|NCT02697916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65601661|NCT02697916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65601662|NCT02697916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65601663|NCT02697916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65601664|NCT02697916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601665|NCT02697916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65601666|NCT02697916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65601667|NCT02697916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601668|NCT02697916|Antipyretics|antipyretics|mesh-ancestor
65601669|NCT04762680|Vaccines|vaccines|mesh-list
65601670|NCT04762680|Immunologic Factors|immunologic factors|mesh-ancestor
65601671|NCT04762680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601672|NCT03650387|Lidocaine|lidocaine|mesh-list
65601673|NCT03650387|Anesthetics, Local|anesthetics, local|mesh-ancestor
65601674|NCT03650387|Anesthetics|anesthetics|mesh-ancestor
65601675|NCT03650387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65601676|NCT03650387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601677|NCT03650387|Sensory System Agents|sensory system agents|mesh-ancestor
65601678|NCT03650387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65601679|NCT03650387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65601680|NCT03650387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65601681|NCT03650387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65601682|NCT03650387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65601683|NCT03650387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601684|NCT02392156|Factor VIII|factor viii|mesh-list
65601685|NCT02392156|Coagulants|coagulants|mesh-ancestor
65399091|NCT00092677|Simvastatin|simvastatin|mesh-list
65601686|NCT03115060|Plasma-lyte 148|plasma-lyte 148|mesh-list
65601687|NCT03115060|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65601688|NCT03115060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65601689|NCT03359473|GSK2881078|gsk2881078|mesh-list
65601690|NCT03359473|Anabolic Agents|anabolic agents|mesh-ancestor
65601691|NCT03359473|Hormones|hormones|mesh-ancestor
65601692|NCT03359473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65601693|NCT03359473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601694|NCT03632304|Anesthetics|anesthetics|mesh-list
65601695|NCT03632304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65601696|NCT03632304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601697|NCT02397538|Amlodipine|amlodipine|mesh-list
65601698|NCT02397538|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65601699|NCT02397538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65601700|NCT02397538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65601701|NCT02397538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65601702|NCT02397538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601703|NCT02397538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65601704|NCT02397538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601705|NCT02397538|Vasodilator Agents|vasodilator agents|mesh-ancestor
65601706|NCT02397538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65601707|NCT02397538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65601708|NCT02397538|Antimetabolites|antimetabolites|mesh-ancestor
65601709|NCT02397538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65601710|NCT02397538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65601711|NCT02397538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601712|NCT04806100|Carbon Fiber|carbon fiber|mesh-list
65601713|NCT04806100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65601714|NCT04806100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65601715|NCT03589469|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
65601716|NCT03589469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65601717|NCT03589469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601718|NCT03359395|Alfentanil|alfentanil|mesh-list
65601719|NCT03359395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65601720|NCT03359395|Narcotics|narcotics|mesh-ancestor
65601721|NCT03359395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65601722|NCT03359395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601723|NCT03359395|Analgesics|analgesics|mesh-ancestor
65601724|NCT03359395|Sensory System Agents|sensory system agents|mesh-ancestor
65601725|NCT03359395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65601726|NCT03359395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65601727|NCT03359395|Anesthetics, General|anesthetics, general|mesh-ancestor
65601728|NCT03359395|Anesthetics|anesthetics|mesh-ancestor
65601729|NCT03733691|Lenalidomide|lenalidomide|mesh-list
65601730|NCT03733691|Ixazomib|ixazomib|mesh-list
65601731|NCT03733691|Immunologic Factors|immunologic factors|mesh-ancestor
65601732|NCT03733691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601733|NCT03733691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65601734|NCT03733691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65601735|NCT03733691|Growth Substances|growth substances|mesh-ancestor
65601736|NCT03733691|Growth Inhibitors|growth inhibitors|mesh-ancestor
65601737|NCT03733691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601738|NCT03733691|Protease Inhibitors|protease inhibitors|mesh-ancestor
65601739|NCT03733691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601740|NCT03733691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601741|NCT03358147|Tiotropium Bromide|tiotropium bromide|mesh-list
65601742|NCT03358147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65601743|NCT03358147|Autonomic Agents|autonomic agents|mesh-ancestor
65601744|NCT03358147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65601745|NCT03358147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601746|NCT03358147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65601747|NCT03358147|Respiratory System Agents|respiratory system agents|mesh-ancestor
65601748|NCT03358147|Parasympatholytics|parasympatholytics|mesh-ancestor
65601749|NCT03358147|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65601750|NCT03358147|Cholinergic Agents|cholinergic agents|mesh-ancestor
65601751|NCT03358147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65601752|NCT03358147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601753|NCT05741632|Moxifloxacin|moxifloxacin|mesh-list
65601754|NCT05741632|Levofloxacin|levofloxacin|mesh-list
65601755|NCT05741632|Ofloxacin|ofloxacin|mesh-list
65601756|NCT05741632|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65601757|NCT05741632|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65601758|NCT05741632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65601759|NCT05741632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65601760|NCT05741632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65601761|NCT05741632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65601763|NCT05741632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601764|NCT05741632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601765|NCT05741632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65601766|NCT05741632|Renal Agents|renal agents|mesh-ancestor
65601767|NCT05741632|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65601768|NCT05741632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65601769|NCT03093402|Dronabinol|dronabinol|mesh-list
65601770|NCT03093402|Lenabasum|lenabasum|mesh-list
65601771|NCT03093402|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65601772|NCT03093402|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65601773|NCT03093402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65601774|NCT03093402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601775|NCT03093402|Hormones|hormones|mesh-ancestor
65497003|NCT03880968|Etanercept|etanercept|mesh-list
65601776|NCT03093402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65601777|NCT03093402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601778|NCT03093402|Hallucinogens|hallucinogens|mesh-ancestor
65601779|NCT03093402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65601780|NCT03093402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65601781|NCT03093402|Analgesics|analgesics|mesh-ancestor
65601782|NCT03093402|Sensory System Agents|sensory system agents|mesh-ancestor
65601783|NCT03093402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65601784|NCT02397070|Salicylic Acid|salicylic acid|mesh-list
65601785|NCT02397070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65601786|NCT02397070|Antifungal Agents|antifungal agents|mesh-ancestor
65601787|NCT02397070|Keratolytic Agents|keratolytic agents|mesh-ancestor
65601788|NCT02397070|Dermatologic Agents|dermatologic agents|mesh-ancestor
65601789|NCT03733379|Amoxicillin|amoxicillin|mesh-list
65601790|NCT03733379|Metronidazole|metronidazole|mesh-list
65601791|NCT03733379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65601792|NCT03733379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65601793|NCT03733379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65601794|NCT03733379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65601795|NCT05733676|Calcium|calcium|mesh-list
65601796|NCT05733676|Fluorides|fluorides|mesh-list
65601797|NCT05733676|Caseins|caseins|mesh-list
65601798|NCT05733676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65601799|NCT05733676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601800|NCT05733676|Cariostatic Agents|cariostatic agents|mesh-ancestor
65601801|NCT05733676|Protective Agents|protective agents|mesh-ancestor
65601802|NCT05733676|Chelating Agents|chelating agents|mesh-ancestor
65601803|NCT05733676|Sequestering Agents|sequestering agents|mesh-ancestor
65601804|NCT05733676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601805|NCT03343639|Serlopitant|serlopitant|mesh-list
65601806|NCT03343639|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65601807|NCT03343639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65601808|NCT03343639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601809|NCT03343639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601810|NCT04479748|Dexamethasone|dexamethasone|mesh-list
65601811|NCT04479748|Prednisolone|prednisolone|mesh-list
65601812|NCT04479748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65601813|NCT04479748|Methylprednisolone|methylprednisolone|mesh-list
65601814|NCT04479748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65601815|NCT04479748|Prednisolone acetate|prednisolone acetate|mesh-list
65601816|NCT04479748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65601817|NCT04479748|Prednisolone phosphate|prednisolone phosphate|mesh-list
65601818|NCT04479748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65601819|NCT04479748|Antiemetics|antiemetics|mesh-ancestor
65601820|NCT04479748|Autonomic Agents|autonomic agents|mesh-ancestor
65601821|NCT04479748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65601822|NCT04479748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601823|NCT04479748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65601824|NCT04479748|Glucocorticoids|glucocorticoids|mesh-ancestor
65601825|NCT04479748|Hormones|hormones|mesh-ancestor
65601826|NCT04479748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65601827|NCT04479748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65601828|NCT04479748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601829|NCT04479748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65601830|NCT04479748|Protective Agents|protective agents|mesh-ancestor
65601831|NCT02690974|Valsartan|valsartan|mesh-list
65601832|NCT02690974|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65601833|NCT02690974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65601834|NCT02690974|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65601835|NCT02690974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65601836|NCT02690974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601837|NCT03093324|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65601838|NCT03093324|Dermatologic Agents|dermatologic agents|mesh-ancestor
65601839|NCT03093324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65601840|NCT03093324|Immunologic Factors|immunologic factors|mesh-ancestor
65601841|NCT03093324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601842|NCT03584009|Venetoclax|venetoclax|mesh-list
65601843|NCT03584009|Fulvestrant|fulvestrant|mesh-list
65601844|NCT03584009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601845|NCT03584009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65601846|NCT03584009|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65601847|NCT03584009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65601848|NCT03584009|Hormone Antagonists|hormone antagonists|mesh-ancestor
65601849|NCT03584009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65601850|NCT03584009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601851|NCT03709927|Moxifloxacin|moxifloxacin|mesh-list
65601852|NCT03709927|Fosfomycin|fosfomycin|mesh-list
65601853|NCT03709927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65601854|NCT03709927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65601855|NCT03709927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65601856|NCT03709927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65601857|NCT03709927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601858|NCT03709927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601859|NCT03709927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601860|NCT05193019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65601861|NCT03730181|Isoniazid|isoniazid|mesh-list
65601862|NCT03730181|Rifapentine|rifapentine|mesh-list
65601863|NCT03730181|Antitubercular Agents|antitubercular agents|mesh-ancestor
65601864|NCT03730181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65601865|NCT03730181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65601866|NCT03730181|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65601867|NCT03730181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65601868|NCT03730181|Antimetabolites|antimetabolites|mesh-ancestor
65601869|NCT03730181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601870|NCT03730181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65601871|NCT03730181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65601872|NCT03730181|Leprostatic Agents|leprostatic agents|mesh-ancestor
65601873|NCT04167462|BMS-986165|bms-986165|mesh-list
65601874|NCT04167462|Dermatologic Agents|dermatologic agents|mesh-ancestor
65601875|NCT04167462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65601876|NCT04167462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601877|NCT04167462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601878|NCT04160520|Morphine|morphine|mesh-list
65601879|NCT04160520|Pramipexole|pramipexole|mesh-list
65601880|NCT04160520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65601881|NCT04160520|Narcotics|narcotics|mesh-ancestor
65601882|NCT04160520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65601883|NCT04160520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601884|NCT04160520|Analgesics|analgesics|mesh-ancestor
65601885|NCT04160520|Sensory System Agents|sensory system agents|mesh-ancestor
65601886|NCT04160520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65601887|NCT04160520|Antioxidants|antioxidants|mesh-ancestor
65601888|NCT04160520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601889|NCT04160520|Protective Agents|protective agents|mesh-ancestor
65601890|NCT04160520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65601891|NCT04160520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65601892|NCT04160520|Dopamine Agonists|dopamine agonists|mesh-ancestor
65601893|NCT04160520|Dopamine Agents|dopamine agents|mesh-ancestor
65601894|NCT04160520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65601895|NCT03583385|Metformin|metformin|mesh-list
65601896|NCT03583385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65601897|NCT03583385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601898|NCT05288335|Methamphetamine|methamphetamine|mesh-list
65601899|NCT05288335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65601900|NCT05288335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601901|NCT05288335|Sympathomimetics|sympathomimetics|mesh-ancestor
65601902|NCT05288335|Autonomic Agents|autonomic agents|mesh-ancestor
65601903|NCT05288335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65601904|NCT05288335|Dopamine Agents|dopamine agents|mesh-ancestor
65601905|NCT05288335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65601906|NCT05288335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601907|NCT05288335|Adrenergic Agents|adrenergic agents|mesh-ancestor
65601908|NCT05288335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65601909|NCT05288335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65601910|NCT05288335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65601911|NCT05288335|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65601913|NCT04792801|Lipotropic Agents|lipotropic agents|mesh-ancestor
65601914|NCT04792801|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65601915|NCT04792801|Antimetabolites|antimetabolites|mesh-ancestor
65601916|NCT04792801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601917|NCT04792801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65601918|NCT04792801|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65601919|NCT04792801|Nootropic Agents|nootropic agents|mesh-ancestor
65601920|NCT05420922|Lenvatinib|lenvatinib|mesh-list
65601921|NCT05420922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65601922|NCT05420922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601923|NCT05420922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65601924|NCT05420922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601925|NCT05420922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601926|NCT03582215|Salicylates|salicylates|mesh-list
65601927|NCT03582215|Avobenzone|avobenzone|mesh-list
65601928|NCT03582215|Homosalate|homosalate|mesh-list
65601929|NCT03582215|Oxybenzone|oxybenzone|mesh-list
65601930|NCT03582215|2-ethylhexyl salicylate|2-ethylhexyl salicylate|mesh-list
65601931|NCT03582215|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
65601932|NCT03582215|Sunscreening Agents|sunscreening agents|mesh-ancestor
65601933|NCT03582215|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65601934|NCT03582215|Protective Agents|protective agents|mesh-ancestor
65601935|NCT03582215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601936|NCT03582215|Dermatologic Agents|dermatologic agents|mesh-ancestor
65601937|NCT03582215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65601938|NCT03582215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65601939|NCT03582215|Analgesics|analgesics|mesh-ancestor
65601940|NCT03582215|Sensory System Agents|sensory system agents|mesh-ancestor
65601941|NCT03582215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65601942|NCT03582215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65601943|NCT03582215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65601944|NCT03582215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65601945|NCT03582215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601946|NCT03582215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601947|NCT05175703|Paclitaxel|paclitaxel|mesh-list
65601948|NCT05175703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65601949|NCT05175703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601950|NCT05175703|Tubulin Modulators|tubulin modulators|mesh-ancestor
65601951|NCT05175703|Antimitotic Agents|antimitotic agents|mesh-ancestor
65601952|NCT05175703|Mitosis Modulators|mitosis modulators|mesh-ancestor
65601953|NCT05175703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601954|NCT04102800|Benralizumab|benralizumab|mesh-list
65601955|NCT04102800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65601956|NCT04102800|Respiratory System Agents|respiratory system agents|mesh-ancestor
65601957|NCT03323346|Disulfiram|disulfiram|mesh-list
65601958|NCT03323346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65601959|NCT03323346|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65601960|NCT03323346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601961|NCT03323346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601962|NCT05628571|Fluorides|fluorides|mesh-list
65601963|NCT05628571|Cariostatic Agents|cariostatic agents|mesh-ancestor
65601964|NCT05628571|Protective Agents|protective agents|mesh-ancestor
65601965|NCT05628571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601966|NCT05255016|Riboflavin|riboflavin|mesh-list
65601967|NCT05255016|Lubricant Eye Drops|lubricant eye drops|mesh-list
65601968|NCT05255016|Vitamin B Complex|vitamin b complex|mesh-ancestor
65601969|NCT05255016|Vitamins|vitamins|mesh-ancestor
65601970|NCT05255016|Micronutrients|micronutrients|mesh-ancestor
65601971|NCT05255016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601972|NCT05255016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65601973|NCT05255016|Dermatologic Agents|dermatologic agents|mesh-ancestor
65601974|NCT05255016|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65601975|NCT05255016|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65601976|NCT05178888|Palbociclib|palbociclib|mesh-list
65601977|NCT05178888|Adagrasib|adagrasib|mesh-list
65601978|NCT05178888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65601979|NCT05178888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65601980|NCT05178888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601981|NCT05178888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65601982|NCT03267888|Pembrolizumab|pembrolizumab|mesh-list
65601983|NCT03267888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65601984|NCT03267888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399401|NCT00098839|Antidotes|antidotes|mesh-ancestor
65601985|NCT03342001|Calcitonin|calcitonin|mesh-list
65601986|NCT03342001|Salmon calcitonin|salmon calcitonin|mesh-list
65601987|NCT03342001|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
65601988|NCT03342001|Katacalcin|katacalcin|mesh-list
65601989|NCT03342001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65601990|NCT03342001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65601991|NCT03342001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65601992|NCT03342001|Vasodilator Agents|vasodilator agents|mesh-ancestor
65601993|NCT03579719|Itraconazole|itraconazole|mesh-list
65601994|NCT03579719|Antifungal Agents|antifungal agents|mesh-ancestor
65601995|NCT03579719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65601996|NCT03579719|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65601997|NCT03579719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65601998|NCT03579719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65601999|NCT03579719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602000|NCT03579719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65602001|NCT03579719|Hormone Antagonists|hormone antagonists|mesh-ancestor
65497219|NCT01162824|Adenosine|adenosine|mesh-list
65602002|NCT03579719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65602003|NCT03579719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602004|NCT03579719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65602005|NCT03631602|Antifungal Agents|antifungal agents|mesh-list
65602006|NCT03631602|Clotrimazole|clotrimazole|mesh-list
65602007|NCT03631602|Miconazole|miconazole|mesh-list
65602008|NCT03631602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65602009|NCT03631602|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65602010|NCT03631602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65602011|NCT03631602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65602012|NCT03631602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602013|NCT03631602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602014|NCT03631602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65602015|NCT03631602|Hormone Antagonists|hormone antagonists|mesh-ancestor
65602016|NCT03631602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65602017|NCT03631602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602018|NCT03631602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65602019|NCT03631602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65602020|NCT02688088|Midazolam|midazolam|mesh-list
65602021|NCT02688088|Dextromethorphan|dextromethorphan|mesh-list
65602022|NCT02688088|Caffeine|caffeine|mesh-list
65602023|NCT02688088|Warfarin|warfarin|mesh-list
65602024|NCT02688088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65602025|NCT02688088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65602026|NCT02688088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65602027|NCT02688088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602028|NCT02688088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65602029|NCT02688088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65602030|NCT02688088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65602031|NCT02688088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65602032|NCT02688088|Anesthetics, General|anesthetics, general|mesh-ancestor
65602033|NCT02688088|Anesthetics|anesthetics|mesh-ancestor
65602034|NCT02688088|GABA Modulators|gaba modulators|mesh-ancestor
65602035|NCT02688088|GABA Agents|gaba agents|mesh-ancestor
65602036|NCT02688088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65602037|NCT02688088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602038|NCT02688088|Anticoagulants|anticoagulants|mesh-ancestor
65602039|NCT02688088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65602040|NCT02688088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65602041|NCT02688088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602042|NCT02688088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65602043|NCT02688088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65602044|NCT02688088|Purinergic Agents|purinergic agents|mesh-ancestor
65602045|NCT02688088|Antitussive Agents|antitussive agents|mesh-ancestor
65602046|NCT02688088|Respiratory System Agents|respiratory system agents|mesh-ancestor
65602047|NCT02688088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65602048|NCT02688088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65602049|NCT03641651|Frovatriptan|frovatriptan|mesh-list
65602050|NCT03641651|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65602051|NCT03641651|Serotonin Agents|serotonin agents|mesh-ancestor
65602052|NCT03641651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65602053|NCT03641651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602054|NCT03641651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602055|NCT03341299|Insulin Lispro|insulin lispro|mesh-list
65602056|NCT03341299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65602057|NCT03341299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602058|NCT05666219|Aminophylline|aminophylline|mesh-list
65602059|NCT05666219|Theophylline|theophylline|mesh-list
65602060|NCT05666219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65602061|NCT05666219|Autonomic Agents|autonomic agents|mesh-ancestor
65602062|NCT05666219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65602063|NCT05666219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602064|NCT05666219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65602065|NCT05666219|Respiratory System Agents|respiratory system agents|mesh-ancestor
65602066|NCT05666219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65602067|NCT05666219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602068|NCT05666219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602069|NCT05666219|Vasodilator Agents|vasodilator agents|mesh-ancestor
65602070|NCT05666219|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65602071|NCT05666219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65602072|NCT05666219|Purinergic Agents|purinergic agents|mesh-ancestor
65602073|NCT05666219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65497303|NCT01268670|Ibuprofen|ibuprofen|mesh-list
65602074|NCT05666219|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65602075|NCT05666219|Protective Agents|protective agents|mesh-ancestor
65602077|NCT02949271|Ropivacaine|ropivacaine|mesh-list
65602078|NCT02949271|Anesthetics, Local|anesthetics, local|mesh-ancestor
65602079|NCT02949271|Anesthetics|anesthetics|mesh-ancestor
65602080|NCT02949271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65602081|NCT02949271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602082|NCT02949271|Sensory System Agents|sensory system agents|mesh-ancestor
65602083|NCT02949271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65602084|NCT02949271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65602085|NCT02949271|Narcotics|narcotics|mesh-ancestor
65602086|NCT02949271|Analgesics|analgesics|mesh-ancestor
65602087|NCT02949271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65602088|NCT02949271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65602089|NCT02949271|Anesthetics, General|anesthetics, general|mesh-ancestor
65602090|NCT03339583|Zopiclone|zopiclone|mesh-list
65602091|NCT03339583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65602092|NCT03339583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65602093|NCT03339583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602094|NCT03639779|Sodium thiosulfate|sodium thiosulfate|mesh-list
65602095|NCT03639779|Antidotes|antidotes|mesh-ancestor
65602096|NCT03639779|Protective Agents|protective agents|mesh-ancestor
65602097|NCT03639779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602098|NCT03639779|Antioxidants|antioxidants|mesh-ancestor
65602099|NCT03639779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602100|NCT03639779|Antitubercular Agents|antitubercular agents|mesh-ancestor
65602101|NCT03639779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65602102|NCT03639779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65602103|NCT03639779|Chelating Agents|chelating agents|mesh-ancestor
65602104|NCT03639779|Sequestering Agents|sequestering agents|mesh-ancestor
65602105|NCT05583721|Regadenoson|regadenoson|mesh-list
65602106|NCT05583721|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65602107|NCT05583721|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65602108|NCT05583721|Purinergic Agonists|purinergic agonists|mesh-ancestor
65602109|NCT05583721|Purinergic Agents|purinergic agents|mesh-ancestor
65602110|NCT05583721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65602111|NCT05583721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602112|NCT05583721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602113|NCT05682547|Lubricant Eye Drops|lubricant eye drops|mesh-list
65602114|NCT05682547|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65602115|NCT05682547|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65602116|NCT05173441|Immunoglobulins|immunoglobulins|mesh-list
65602117|NCT05173441|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65602118|NCT05173441|Antibodies|antibodies|mesh-list
65602119|NCT05173441|Immunologic Factors|immunologic factors|mesh-ancestor
65602120|NCT05173441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602121|NCT03708133|Nifurtimox|nifurtimox|mesh-list
65602122|NCT03708133|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65602123|NCT03708133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65602124|NCT03708133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65602125|NCT03708133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65602126|NCT05075161|Pirfenidone|pirfenidone|mesh-list
65602127|NCT05075161|Analgesics|analgesics|mesh-ancestor
65602128|NCT05075161|Sensory System Agents|sensory system agents|mesh-ancestor
65602129|NCT05075161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65602130|NCT05075161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602131|NCT05075161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65602132|NCT05075161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65602133|NCT05075161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65602134|NCT05075161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65399536|NCT00685763|Gemcitabine|gemcitabine|mesh-list
65602135|NCT05075161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602136|NCT05518903|FAPI-46|fapi-46|mesh-list
65602137|NCT05518903|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65602138|NCT05518903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602139|NCT05065957|Capecitabine|capecitabine|mesh-list
65602140|NCT05065957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65602141|NCT05065957|Antimetabolites|antimetabolites|mesh-ancestor
65602142|NCT05065957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602143|NCT05065957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602144|NCT05095831|Pancrelipase|pancrelipase|mesh-list
65602145|NCT05095831|Pancreatin|pancreatin|mesh-list
65602146|NCT05095831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65602147|NCT03638869|Methadone|methadone|mesh-list
65602148|NCT03638869|D-methadone|d-methadone|mesh-list
65602149|NCT03638869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65602150|NCT03638869|Narcotics|narcotics|mesh-ancestor
65602151|NCT03638869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65602152|NCT03638869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602153|NCT03638869|Analgesics|analgesics|mesh-ancestor
65602154|NCT03638869|Sensory System Agents|sensory system agents|mesh-ancestor
65602155|NCT03638869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65602156|NCT03638869|Antitussive Agents|antitussive agents|mesh-ancestor
65602157|NCT03638869|Respiratory System Agents|respiratory system agents|mesh-ancestor
65602158|NCT03638869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65602159|NCT03091920|Praliciguat|praliciguat|mesh-list
65602160|NCT03091920|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65602161|NCT03091920|Enzyme Activators|enzyme activators|mesh-ancestor
65602162|NCT03091920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602163|NCT03091920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65602164|NCT03338569|Ascorbic Acid|ascorbic acid|mesh-list
65602165|NCT03338569|Vitamins|vitamins|mesh-ancestor
65602166|NCT03338569|Micronutrients|micronutrients|mesh-ancestor
65602167|NCT03338569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602168|NCT03338569|Antioxidants|antioxidants|mesh-ancestor
65602169|NCT03338569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602170|NCT03338569|Protective Agents|protective agents|mesh-ancestor
65602171|NCT03338023|Insulin Lispro|insulin lispro|mesh-list
65602172|NCT03338023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65602173|NCT03338023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602174|NCT05053633|Anesthetics|anesthetics|mesh-list
65602175|NCT05053633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65602176|NCT05053633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602177|NCT03337477|Insulin|insulin|mesh-list
65602178|NCT03337477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65602179|NCT03337477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65602180|NCT03337477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602181|NCT03707899|Amlodipine|amlodipine|mesh-list
65602182|NCT03707899|Telmisartan|telmisartan|mesh-list
65602183|NCT03707899|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
65602184|NCT03707899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65602185|NCT03707899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65602186|NCT03707899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65602187|NCT03707899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65602188|NCT03707899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602189|NCT03707899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65602190|NCT03707899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602191|NCT03707899|Vasodilator Agents|vasodilator agents|mesh-ancestor
65602192|NCT03707899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65602193|NCT03707899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65602194|NCT03707899|Antimetabolites|antimetabolites|mesh-ancestor
65602195|NCT03707899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65602196|NCT03707899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65602197|NCT03707899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602198|NCT03707899|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65602199|NCT03707899|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65602200|NCT05490511|Cannabidiol|cannabidiol|mesh-list
65602201|NCT05490511|Tacrolimus|tacrolimus|mesh-list
65602202|NCT05490511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65602203|NCT05490511|Immunologic Factors|immunologic factors|mesh-ancestor
65602204|NCT05490511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602205|NCT05490511|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65602206|NCT05490511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602207|NCT05490511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602208|NCT05490511|Anticonvulsants|anticonvulsants|mesh-ancestor
65602209|NCT03336619|Nitazoxanide|nitazoxanide|mesh-list
65602210|NCT03336619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65602211|NCT03336619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65602212|NCT03114904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65602213|NCT03114904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65602214|NCT03114904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602215|NCT03706339|Tranexamic Acid|tranexamic acid|mesh-list
65602216|NCT03706339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65602217|NCT03706339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65602218|NCT03706339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602219|NCT03706339|Hemostatics|hemostatics|mesh-ancestor
65602220|NCT03706339|Coagulants|coagulants|mesh-ancestor
65602221|NCT03739476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65602222|NCT03739476|Antidepressive Agents|antidepressive agents|mesh-ancestor
65602223|NCT03739476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65602224|NCT03739476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65602225|NCT03739476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65602226|NCT03739476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65602227|NCT03739476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602228|NCT03639558|Promethazine|promethazine|mesh-list
65602229|NCT03639558|Diphenhydramine|diphenhydramine|mesh-list
65602230|NCT03639558|Haloperidol|haloperidol|mesh-list
65602231|NCT03639558|Chlorpromazine|chlorpromazine|mesh-list
65602232|NCT03639558|Haloperidol decanoate|haloperidol decanoate|mesh-list
65602233|NCT03639558|Antiemetics|antiemetics|mesh-ancestor
65602234|NCT03639558|Autonomic Agents|autonomic agents|mesh-ancestor
65602235|NCT03639558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65602236|NCT03639558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602237|NCT03639558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65602238|NCT03639558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65602239|NCT03639558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65602240|NCT03639558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65602241|NCT03639558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65602242|NCT03639558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65602243|NCT03639558|Dopamine Agents|dopamine agents|mesh-ancestor
65602244|NCT03639558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65602245|NCT03639558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602246|NCT03639558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65602247|NCT03639558|Antipruritics|antipruritics|mesh-ancestor
65602248|NCT03639558|Dermatologic Agents|dermatologic agents|mesh-ancestor
65602249|NCT03639558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65602250|NCT03639558|Histamine Antagonists|histamine antagonists|mesh-ancestor
65602251|NCT03639558|Histamine Agents|histamine agents|mesh-ancestor
65602252|NCT03639558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65602253|NCT03639558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65602254|NCT03639558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65602255|NCT03639558|Anesthetics, Local|anesthetics, local|mesh-ancestor
65602256|NCT03639558|Anesthetics|anesthetics|mesh-ancestor
65602257|NCT03639558|Sensory System Agents|sensory system agents|mesh-ancestor
65602258|NCT01353508|Valsartan|valsartan|mesh-list
65602259|NCT01353508|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65602260|NCT01353508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65602261|NCT01353508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65602262|NCT01353508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65602263|NCT01353508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602264|NCT01568268|Palonosetron|palonosetron|mesh-list
65602265|NCT01568268|Antiemetics|antiemetics|mesh-ancestor
65602266|NCT01568268|Autonomic Agents|autonomic agents|mesh-ancestor
65602267|NCT01568268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65602268|NCT01568268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602269|NCT01568268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65602270|NCT01568268|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65602271|NCT01568268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65602272|NCT01568268|Serotonin Agents|serotonin agents|mesh-ancestor
65602273|NCT01568268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65602274|NCT01568268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602275|NCT04911361|Dexamethasone|dexamethasone|mesh-list
65602276|NCT04911361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65602277|NCT04911361|Antiemetics|antiemetics|mesh-ancestor
65602278|NCT04911361|Autonomic Agents|autonomic agents|mesh-ancestor
65602279|NCT04911361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65602280|NCT04911361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602281|NCT04911361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65602282|NCT04911361|Glucocorticoids|glucocorticoids|mesh-ancestor
65602283|NCT04911361|Hormones|hormones|mesh-ancestor
65602284|NCT04911361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65602285|NCT04911361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65602286|NCT04911361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602287|NCT04475731|Ponatinib|ponatinib|mesh-list
65602288|NCT04475731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602289|NCT04475731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65602290|NCT04475731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602291|NCT04475731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602292|NCT03087786|Nicotine|nicotine|mesh-list
65602293|NCT03087786|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65602294|NCT03087786|Autonomic Agents|autonomic agents|mesh-ancestor
65602295|NCT03087786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65602296|NCT03087786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602297|NCT03087786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65602298|NCT03087786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65602299|NCT03087786|Cholinergic Agents|cholinergic agents|mesh-ancestor
65602300|NCT03087786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65602301|NCT03087786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602302|NCT03635957|Folic Acid|folic acid|mesh-list
65602303|NCT03635957|Methotrexate|methotrexate|mesh-list
65602304|NCT03635957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65602305|NCT03635957|Abortifacient Agents|abortifacient agents|mesh-ancestor
65602306|NCT03635957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65602307|NCT03635957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602308|NCT03635957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65602309|NCT03635957|Antimetabolites|antimetabolites|mesh-ancestor
65602310|NCT03635957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602311|NCT03635957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602312|NCT03635957|Dermatologic Agents|dermatologic agents|mesh-ancestor
65602313|NCT03635957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602314|NCT03635957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65602315|NCT03635957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65602316|NCT03635957|Immunologic Factors|immunologic factors|mesh-ancestor
65602317|NCT03635957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65602318|NCT03635957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65602319|NCT03635957|Hematinics|hematinics|mesh-ancestor
65602320|NCT03635957|Vitamin B Complex|vitamin b complex|mesh-ancestor
65602321|NCT03635957|Vitamins|vitamins|mesh-ancestor
65602322|NCT03635957|Micronutrients|micronutrients|mesh-ancestor
65602323|NCT05005507|Tenofovir|tenofovir|mesh-list
65602324|NCT05005507|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65602325|NCT05005507|Antiviral Agents|antiviral agents|mesh-ancestor
65602326|NCT05005507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65602327|NCT05005507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65602328|NCT05005507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65602329|NCT05005507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602330|NCT05005507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602331|NCT05005507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65602332|NCT05005507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65602333|NCT04739358|Tepotinib|tepotinib|mesh-list
65602334|NCT04739358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602335|NCT04893343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65602336|NCT04893343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65602337|NCT04893343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65602338|NCT04893343|Antitubercular Agents|antitubercular agents|mesh-ancestor
65602339|NCT05399641|Ibrexafungerp|ibrexafungerp|mesh-list
65602340|NCT05399641|Antifungal Agents|antifungal agents|mesh-ancestor
65602341|NCT05399641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65602342|NCT05593666|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65602343|NCT05593666|Antifungal Agents|antifungal agents|mesh-ancestor
65602344|NCT05593666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65602345|NCT05593666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65602346|NCT05593666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65602347|NCT05390359|Oxymetazoline|oxymetazoline|mesh-list
65602348|NCT05390359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65602349|NCT05390359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65602350|NCT05390359|Adrenergic Agents|adrenergic agents|mesh-ancestor
65602351|NCT05390359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65602352|NCT05390359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602353|NCT05390359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602354|NCT05390359|Sympathomimetics|sympathomimetics|mesh-ancestor
65602355|NCT05390359|Autonomic Agents|autonomic agents|mesh-ancestor
65602356|NCT05390359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65602357|NCT05390359|Nasal Decongestants|nasal decongestants|mesh-ancestor
65602358|NCT05390359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65602359|NCT05390359|Respiratory System Agents|respiratory system agents|mesh-ancestor
65602360|NCT02684344|Tamsulosin|tamsulosin|mesh-list
65602361|NCT02684344|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65602362|NCT02684344|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65602363|NCT02684344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65602364|NCT02684344|Adrenergic Agents|adrenergic agents|mesh-ancestor
65602365|NCT02684344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65602366|NCT02684344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602367|NCT02684344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602368|NCT02684344|Urological Agents|urological agents|mesh-ancestor
65602370|NCT05199571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602371|NCT03974100|Denosumab|denosumab|mesh-list
65602372|NCT03974100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65602373|NCT03974100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602374|NCT02689804|Contraceptive Agents|contraceptive agents|mesh-list
65602375|NCT02689804|Levonorgestrel|levonorgestrel|mesh-list
65602376|NCT02689804|Ulipristal acetate|ulipristal acetate|mesh-list
65602377|NCT02689804|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
65602378|NCT02689804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65602379|NCT02689804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602380|NCT02689804|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65602381|NCT02689804|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65602382|NCT02689804|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65602383|NCT02689804|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65602384|NCT05029999|Doxorubicin|doxorubicin|mesh-list
65602385|NCT05029999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65602386|NCT05029999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65602387|NCT05029999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602388|NCT05029999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65602389|NCT05029999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65602390|NCT05029999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602391|NCT05029999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602392|NCT04353271|Hydroxychloroquine|hydroxychloroquine|mesh-list
65602393|NCT04353271|Antimalarials|antimalarials|mesh-ancestor
65602394|NCT04353271|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65602395|NCT04353271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65602396|NCT04353271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65602397|NCT04353271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602398|NCT04353271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602399|NCT04353271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65602400|NCT03417882|Pembrolizumab|pembrolizumab|mesh-list
65602401|NCT03417882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65602402|NCT03417882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602403|NCT01374568|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65602404|NCT01374568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65602405|NCT01374568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602406|NCT01374568|Incretins|incretins|mesh-ancestor
65602407|NCT01374568|Hormones|hormones|mesh-ancestor
65602408|NCT01374568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65602409|NCT01374568|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65602410|NCT01374568|Protease Inhibitors|protease inhibitors|mesh-ancestor
65602411|NCT01374568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602412|NCT01374568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602413|NCT02991456|Ondansetron|ondansetron|mesh-list
65602414|NCT02991456|Rolapitant|rolapitant|mesh-list
65602415|NCT02991456|Antiemetics|antiemetics|mesh-ancestor
65602416|NCT02991456|Autonomic Agents|autonomic agents|mesh-ancestor
65602417|NCT02991456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65602418|NCT02991456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602419|NCT02991456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65602420|NCT02991456|Antipruritics|antipruritics|mesh-ancestor
65602421|NCT02991456|Dermatologic Agents|dermatologic agents|mesh-ancestor
65602422|NCT02991456|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65602423|NCT02991456|Serotonin Agents|serotonin agents|mesh-ancestor
65602424|NCT02991456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65602425|NCT02991456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602426|NCT02991456|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65602427|NCT02991456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65602428|NCT02991456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65602429|NCT02991456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65602430|NCT02991456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65602431|NCT02991456|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65602432|NCT01312363|Rivastigmine|rivastigmine|mesh-list
65602433|NCT01312363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65602434|NCT01312363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602435|NCT01312363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602436|NCT01312363|Cholinergic Agents|cholinergic agents|mesh-ancestor
65602437|NCT01312363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65602438|NCT01312363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602439|NCT01312363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65602440|NCT01312363|Protective Agents|protective agents|mesh-ancestor
65602442|NCT01312441|Vitamin D|vitamin d|mesh-list
65602443|NCT01312441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65602444|NCT01312441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602445|NCT01312441|Vitamins|vitamins|mesh-ancestor
65602446|NCT01312441|Micronutrients|micronutrients|mesh-ancestor
65602447|NCT01312441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65602448|NCT02682784|Oxytocin|oxytocin|mesh-list
65602449|NCT02682784|Oxytocics|oxytocics|mesh-ancestor
65602450|NCT02682784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65602451|NCT02682784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602452|NCT02946463|Eculizumab|eculizumab|mesh-list
65602453|NCT02946463|Ravulizumab|ravulizumab|mesh-list
65602454|NCT02946463|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65602455|NCT02946463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65602456|NCT02946463|Immunologic Factors|immunologic factors|mesh-ancestor
65602457|NCT02946463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602458|NCT03705949|Lubricant Eye Drops|lubricant eye drops|mesh-list
65602459|NCT03705949|Hyaluronic Acid|hyaluronic acid|mesh-list
65602460|NCT03705949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65602461|NCT03705949|Immunologic Factors|immunologic factors|mesh-ancestor
65602462|NCT03705949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602463|NCT03705949|Viscosupplements|viscosupplements|mesh-ancestor
65602464|NCT03705949|Protective Agents|protective agents|mesh-ancestor
65602465|NCT03705949|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65602466|NCT03705949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65602467|NCT03162562|Oregovomab|oregovomab|mesh-list
65602468|NCT03162562|Poly ICLC|poly iclc|mesh-list
65602469|NCT03162562|Interferon Inducers|interferon inducers|mesh-ancestor
65602470|NCT03162562|Immunologic Factors|immunologic factors|mesh-ancestor
65602471|NCT03162562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602472|NCT03162562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65602473|NCT03162562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602474|NCT03164590|Dexmedetomidine|dexmedetomidine|mesh-list
65602475|NCT03164590|Ketamine|ketamine|mesh-list
65602476|NCT03164590|Bupivacaine|bupivacaine|mesh-list
65602477|NCT03164590|Anesthetics, Local|anesthetics, local|mesh-ancestor
65602478|NCT03164590|Anesthetics|anesthetics|mesh-ancestor
65602479|NCT03164590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65602480|NCT03164590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602481|NCT03164590|Sensory System Agents|sensory system agents|mesh-ancestor
65602482|NCT03164590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65602483|NCT03164590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65602484|NCT03164590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65602485|NCT03164590|Analgesics|analgesics|mesh-ancestor
65602486|NCT03164590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65602487|NCT03164590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65602488|NCT03164590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65602489|NCT03164590|Adrenergic Agents|adrenergic agents|mesh-ancestor
65602490|NCT03164590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65602491|NCT03164590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602492|NCT03164590|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65602493|NCT03164590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65602494|NCT03164590|Anesthetics, General|anesthetics, general|mesh-ancestor
65602495|NCT03164590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65602496|NCT03164590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65602497|NCT05119075|Dopamine|dopamine|mesh-list
65602498|NCT05119075|Dopamine Agonists|dopamine agonists|mesh-list
65602499|NCT05119075|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65602500|NCT05119075|Sympathomimetics|sympathomimetics|mesh-ancestor
65602501|NCT05119075|Autonomic Agents|autonomic agents|mesh-ancestor
65602502|NCT05119075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65602503|NCT05119075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602504|NCT05119075|Dopamine Agents|dopamine agents|mesh-ancestor
65602505|NCT05119075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65602506|NCT05119075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602507|NCT05119075|Protective Agents|protective agents|mesh-ancestor
65602508|NCT03387852|Fluticasone|fluticasone|mesh-list
65602509|NCT03387852|Xhance|xhance|mesh-list
65602510|NCT03387852|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65602511|NCT03387852|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65602512|NCT03387852|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65602513|NCT03387852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65602514|NCT03387852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65602515|NCT03387852|Autonomic Agents|autonomic agents|mesh-ancestor
65602516|NCT03387852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65602517|NCT03387852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602518|NCT03387852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65602519|NCT03387852|Respiratory System Agents|respiratory system agents|mesh-ancestor
65602520|NCT03387852|Dermatologic Agents|dermatologic agents|mesh-ancestor
65602521|NCT03387852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65602522|NCT03387852|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65602523|NCT03387852|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65602524|NCT03387852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65602525|NCT03387852|Adrenergic Agents|adrenergic agents|mesh-ancestor
65602526|NCT03387852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65497735|NCT01281696|Growth Substances|growth substances|mesh-ancestor
65602527|NCT03387852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602528|NCT03387852|Immunologic Factors|immunologic factors|mesh-ancestor
65602529|NCT03387852|Glucocorticoids|glucocorticoids|mesh-ancestor
65602530|NCT03387852|Hormones|hormones|mesh-ancestor
65602531|NCT03387852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65602532|NCT03387852|Sympathomimetics|sympathomimetics|mesh-ancestor
65602533|NCT02679274|Methyltestosterone|methyltestosterone|mesh-list
65602534|NCT02679274|Testosterone|testosterone|mesh-list
65602535|NCT02679274|Testosterone undecanoate|testosterone undecanoate|mesh-list
65602536|NCT02679274|Testosterone enanthate|testosterone enanthate|mesh-list
65602537|NCT02679274|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65602538|NCT02679274|Androgens|androgens|mesh-ancestor
65602539|NCT02679274|Hormones|hormones|mesh-ancestor
65602540|NCT02679274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65602541|NCT02679274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602542|NCT02679274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65602543|NCT02679274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602544|NCT02679274|Anabolic Agents|anabolic agents|mesh-ancestor
65602545|NCT03620929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65602546|NCT03620929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65602547|NCT03620929|Estradiol|estradiol|mesh-list
65602548|NCT03620929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65602549|NCT03620929|Dydrogesterone|dydrogesterone|mesh-list
65602550|NCT03620929|Estrogens|estrogens|mesh-ancestor
65602551|NCT03620929|Hormones|hormones|mesh-ancestor
65602552|NCT03620929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65602553|NCT03620929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602554|NCT03620929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65602555|NCT03620929|Contraceptive Agents|contraceptive agents|mesh-ancestor
65602556|NCT03620929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65602557|NCT03620929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65602558|NCT03620929|Progestins|progestins|mesh-ancestor
65602559|NCT04969861|Pembrolizumab|pembrolizumab|mesh-list
65602560|NCT04969861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65602561|NCT04969861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602562|NCT05308849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65602563|NCT05308849|beta-Lactams|beta-lactams|mesh-list
65602564|NCT05308849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65602565|NCT02678416|Acetaminophen|acetaminophen|mesh-list
65602566|NCT02678416|Morphine|morphine|mesh-list
65602567|NCT02678416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65602568|NCT02678416|Narcotics|narcotics|mesh-ancestor
65602569|NCT02678416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65602570|NCT02678416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602571|NCT02678416|Analgesics|analgesics|mesh-ancestor
65602572|NCT02678416|Sensory System Agents|sensory system agents|mesh-ancestor
65602573|NCT02678416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65602574|NCT02678416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65602575|NCT02678416|Antipyretics|antipyretics|mesh-ancestor
65602576|NCT03164668|Menthol|menthol|mesh-list
65602577|NCT03164668|Antipruritics|antipruritics|mesh-ancestor
65602578|NCT03164668|Dermatologic Agents|dermatologic agents|mesh-ancestor
65602579|NCT03164512|Cannabidiol|cannabidiol|mesh-list
65602580|NCT03164512|Anticonvulsants|anticonvulsants|mesh-ancestor
65602581|NCT02677922|Azacitidine|azacitidine|mesh-list
65602582|NCT02677922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65602583|NCT02677922|Antimetabolites|antimetabolites|mesh-ancestor
65602584|NCT02677922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602585|NCT02677922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602586|NCT02677922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602587|NCT02680756|Ferric maltol|ferric maltol|mesh-list
65602588|NCT02680756|Hematinics|hematinics|mesh-ancestor
65602589|NCT03631836|Bevacizumab|bevacizumab|mesh-list
65602590|NCT03631836|Antibodies|antibodies|mesh-list
65602591|NCT03631836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65602592|NCT03631836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65602593|NCT03631836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602594|NCT03631836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65602595|NCT03631836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65602596|NCT03631836|Growth Substances|growth substances|mesh-ancestor
65602597|NCT03631836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602598|NCT03631836|Growth Inhibitors|growth inhibitors|mesh-ancestor
65602599|NCT03631836|Immunologic Factors|immunologic factors|mesh-ancestor
65602600|NCT03162094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65602601|NCT03162094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65602602|NCT05431582|Bevacizumab|bevacizumab|mesh-list
65602603|NCT05431582|Pembrolizumab|pembrolizumab|mesh-list
65602604|NCT05431582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65602605|NCT05431582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602606|NCT05431582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65602607|NCT05431582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65602608|NCT05431582|Growth Substances|growth substances|mesh-ancestor
65602609|NCT05431582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602610|NCT05431582|Growth Inhibitors|growth inhibitors|mesh-ancestor
65602611|NCT03086460|Formoterol Fumarate|formoterol fumarate|mesh-list
65602612|NCT03086460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65602613|NCT03086460|Autonomic Agents|autonomic agents|mesh-ancestor
65602614|NCT03086460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65602615|NCT03086460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602616|NCT03086460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65602617|NCT03086460|Respiratory System Agents|respiratory system agents|mesh-ancestor
65602618|NCT03086460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65602619|NCT03086460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65602620|NCT03086460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65602621|NCT03086460|Adrenergic Agents|adrenergic agents|mesh-ancestor
65602622|NCT03086460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65602623|NCT03086460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602624|NCT05422066|Prednisone|prednisone|mesh-list
65602625|NCT05422066|Cyclophosphamide|cyclophosphamide|mesh-list
65602626|NCT05422066|Rituximab|rituximab|mesh-list
65602627|NCT05422066|Doxorubicin|doxorubicin|mesh-list
65602628|NCT05422066|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65602629|NCT05422066|Vincristine|vincristine|mesh-list
65602630|NCT05422066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65602631|NCT05422066|Immunologic Factors|immunologic factors|mesh-ancestor
65602632|NCT05422066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602633|NCT05422066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65602634|NCT05422066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65602635|NCT05422066|Alkylating Agents|alkylating agents|mesh-ancestor
65602636|NCT05422066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602637|NCT05422066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602638|NCT05422066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65602639|NCT05422066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65602640|NCT05422066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65602641|NCT05422066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65602642|NCT05422066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65602643|NCT05422066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602644|NCT05422066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65602645|NCT05422066|Glucocorticoids|glucocorticoids|mesh-ancestor
65602646|NCT05422066|Hormones|hormones|mesh-ancestor
65602647|NCT05422066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65602648|NCT05422066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65602649|NCT05422066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65602650|NCT05422066|Tubulin Modulators|tubulin modulators|mesh-ancestor
65602651|NCT05422066|Antimitotic Agents|antimitotic agents|mesh-ancestor
65602652|NCT05422066|Mitosis Modulators|mitosis modulators|mesh-ancestor
65602653|NCT03670706|Analgesics|analgesics|mesh-list
65602654|NCT03670706|Sensory System Agents|sensory system agents|mesh-ancestor
65602655|NCT03670706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65602656|NCT03670706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602657|NCT03114280|Carboplatin|carboplatin|mesh-list
65602658|NCT03114280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602659|NCT03161678|Clopidogrel|clopidogrel|mesh-list
65602660|NCT03161678|Ticagrelor|ticagrelor|mesh-list
65602661|NCT03161678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65602662|NCT03161678|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65602663|NCT03161678|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65602664|NCT03161678|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65602665|NCT03161678|Purinergic Agents|purinergic agents|mesh-ancestor
65602666|NCT03161678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65602667|NCT03161678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602668|NCT03161678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602670|NCT05597280|Bedaquiline|bedaquiline|mesh-list
65602671|NCT05597280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65602672|NCT05597280|Antitubercular Agents|antitubercular agents|mesh-ancestor
65602673|NCT05597280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65602674|NCT05597280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65602675|NCT05597280|Leprostatic Agents|leprostatic agents|mesh-ancestor
65602676|NCT05597280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65602677|NCT05597280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602678|NCT05597280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602679|NCT05597280|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65602680|NCT05597280|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65602681|NCT05597280|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65602682|NCT05597280|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65602683|NCT05597280|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65602684|NCT05597280|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65602685|NCT03674606|Aspirin|aspirin|mesh-list
65602686|NCT03674606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65602687|NCT03674606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65602688|NCT03674606|Analgesics|analgesics|mesh-ancestor
65602689|NCT03674606|Sensory System Agents|sensory system agents|mesh-ancestor
65602690|NCT03674606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65602691|NCT03674606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602692|NCT03674606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65602693|NCT03674606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65602694|NCT03674606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65602695|NCT03674606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65602696|NCT03674606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602697|NCT03674606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65602698|NCT03674606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65602699|NCT03674606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602700|NCT03674606|Antipyretics|antipyretics|mesh-ancestor
65602701|NCT02677324|Venetoclax|venetoclax|mesh-list
65602702|NCT02677324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602703|NCT03108846|Citalopram|citalopram|mesh-list
65602704|NCT03108846|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65602705|NCT03108846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65602706|NCT03108846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65602707|NCT03108846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602708|NCT03108846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65602709|NCT03108846|Serotonin Agents|serotonin agents|mesh-ancestor
65602710|NCT03108846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602711|NCT03108846|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65602712|NCT03108846|Antidepressive Agents|antidepressive agents|mesh-ancestor
65602713|NCT03108846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65602714|NCT03163966|Methotrexate|methotrexate|mesh-list
65602715|NCT03163966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65602716|NCT03163966|Abortifacient Agents|abortifacient agents|mesh-ancestor
65602717|NCT03163966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65602718|NCT03163966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602719|NCT03163966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65602720|NCT03163966|Antimetabolites|antimetabolites|mesh-ancestor
65602721|NCT03163966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602722|NCT03163966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602723|NCT03163966|Dermatologic Agents|dermatologic agents|mesh-ancestor
65602724|NCT03163966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602725|NCT03163966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65602726|NCT03163966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65602727|NCT03163966|Immunologic Factors|immunologic factors|mesh-ancestor
65602728|NCT03163966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65602729|NCT03163966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65602730|NCT03678116|Caffeine|caffeine|mesh-list
65602731|NCT03678116|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65602732|NCT03678116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602733|NCT03678116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65602734|NCT03678116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602735|NCT03678116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602736|NCT03678116|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65602737|NCT03678116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65602738|NCT03678116|Purinergic Agents|purinergic agents|mesh-ancestor
65602739|NCT03678116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65602740|NCT03678038|Triamcinolone|triamcinolone|mesh-list
65602741|NCT03678038|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65602742|NCT03678038|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65602743|NCT03678038|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65602744|NCT03678038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65602745|NCT03678038|Glucocorticoids|glucocorticoids|mesh-ancestor
65602746|NCT03678038|Hormones|hormones|mesh-ancestor
65602747|NCT03678038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65602748|NCT03678038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602749|NCT03678038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65602750|NCT03678038|Immunologic Factors|immunologic factors|mesh-ancestor
65602751|NCT03678038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602752|NCT03678038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602753|NCT03163420|Diclofenac|diclofenac|mesh-list
65602754|NCT03163420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65602755|NCT03163420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65602756|NCT03163420|Analgesics|analgesics|mesh-ancestor
65602757|NCT03163420|Sensory System Agents|sensory system agents|mesh-ancestor
65602758|NCT03163420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65602759|NCT03163420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602760|NCT03163420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65602761|NCT03163420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65602762|NCT03163420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65602763|NCT03163420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602764|NCT03163420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602765|NCT04440436|Cyclophosphamide|cyclophosphamide|mesh-list
65602766|NCT04440436|Fludarabine|fludarabine|mesh-list
65602767|NCT04440436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65602768|NCT04440436|Immunologic Factors|immunologic factors|mesh-ancestor
65602769|NCT04440436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602770|NCT04440436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65602771|NCT04440436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65602772|NCT04440436|Alkylating Agents|alkylating agents|mesh-ancestor
65602773|NCT04440436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602774|NCT04440436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602775|NCT04440436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65602776|NCT05405686|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65602777|NCT05405686|Hormones|hormones|mesh-ancestor
65602778|NCT05405686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65602779|NCT05405686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602780|NCT04711122|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65602781|NCT04711122|Cephalosporins|cephalosporins|mesh-list
65602782|NCT04711122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65602783|NCT05272696|Paclitaxel|paclitaxel|mesh-list
65602784|NCT05272696|Pembrolizumab|pembrolizumab|mesh-list
65602785|NCT05272696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65602786|NCT05272696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602787|NCT05272696|Tubulin Modulators|tubulin modulators|mesh-ancestor
65602788|NCT05272696|Antimitotic Agents|antimitotic agents|mesh-ancestor
65602789|NCT05272696|Mitosis Modulators|mitosis modulators|mesh-ancestor
65602790|NCT05272696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602791|NCT05272696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65602792|NCT05563116|Calcium|calcium|mesh-list
65602793|NCT05563116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65602794|NCT05563116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602795|NCT03520946|Ramucirumab|ramucirumab|mesh-list
65602796|NCT03520946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602797|NCT03709758|Cytarabine|cytarabine|mesh-list
65602798|NCT03709758|Daunorubicin|daunorubicin|mesh-list
65602799|NCT03709758|Venetoclax|venetoclax|mesh-list
65602800|NCT03709758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65602801|NCT03709758|Antimetabolites|antimetabolites|mesh-ancestor
65602802|NCT03709758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602803|NCT03709758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602804|NCT03709758|Antiviral Agents|antiviral agents|mesh-ancestor
65602805|NCT03709758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65602806|NCT03709758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65602807|NCT03709758|Immunologic Factors|immunologic factors|mesh-ancestor
65602808|NCT03709758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602809|NCT03709758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65602810|NCT03709758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65602811|NCT03709758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65602812|NCT03709758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602813|NCT03674060|Sorafenib|sorafenib|mesh-list
65602814|NCT03674060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602815|NCT03674060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65602816|NCT03674060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602817|NCT03674060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602818|NCT03163576|Niacin|niacin|mesh-list
65602819|NCT03163576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65602820|NCT03163576|Antimetabolites|antimetabolites|mesh-ancestor
65602821|NCT03163576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602822|NCT03163576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65602823|NCT03163576|Vasodilator Agents|vasodilator agents|mesh-ancestor
65602824|NCT03163576|Vitamin B Complex|vitamin b complex|mesh-ancestor
65602825|NCT03163576|Vitamins|vitamins|mesh-ancestor
65602826|NCT03163576|Micronutrients|micronutrients|mesh-ancestor
65602827|NCT03163576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602828|NCT01374178|Insulin Glargine|insulin glargine|mesh-list
65602829|NCT01374178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65602830|NCT01374178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602831|NCT01104350|Gemcitabine|gemcitabine|mesh-list
65602832|NCT01104350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65602833|NCT01104350|Antimetabolites|antimetabolites|mesh-ancestor
65602834|NCT01104350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602835|NCT01104350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602836|NCT01104350|Antiviral Agents|antiviral agents|mesh-ancestor
65602837|NCT01104350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65602838|NCT01104350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602839|NCT01104350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65602840|NCT01104350|Immunologic Factors|immunologic factors|mesh-ancestor
65602841|NCT01104350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602842|NCT03673280|Morphine|morphine|mesh-list
65602843|NCT03673280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65602844|NCT03673280|Narcotics|narcotics|mesh-ancestor
65602845|NCT03673280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65602846|NCT03673280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602847|NCT03673280|Analgesics|analgesics|mesh-ancestor
65602848|NCT03673280|Sensory System Agents|sensory system agents|mesh-ancestor
65602849|NCT03673280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65602850|NCT05420220|Axitinib|axitinib|mesh-list
65602851|NCT05420220|Antibodies|antibodies|mesh-list
65602852|NCT05420220|Immunologic Factors|immunologic factors|mesh-ancestor
65602853|NCT05420220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602854|NCT05420220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602855|NCT05420220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65602856|NCT05420220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602857|NCT05420220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602858|NCT05383560|Vaccines|vaccines|mesh-list
65602859|NCT05383560|Immunologic Factors|immunologic factors|mesh-ancestor
65602860|NCT05383560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602861|NCT01382004|Azithromycin|azithromycin|mesh-list
65602862|NCT01382004|Penicillins|penicillins|mesh-list
65602863|NCT01382004|Penicillin G|penicillin g|mesh-list
65602864|NCT01382004|Penicillin G Benzathine|penicillin g benzathine|mesh-list
65602865|NCT01382004|Penicillin G Procaine|penicillin g procaine|mesh-list
65602866|NCT01382004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65602867|NCT01382004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65602868|NCT03669224|Chlorhexidine|chlorhexidine|mesh-list
65602869|NCT03669224|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65602870|NCT03669224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65602871|NCT03669224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65602872|NCT03669224|Disinfectants|disinfectants|mesh-ancestor
65602873|NCT03669224|Dermatologic Agents|dermatologic agents|mesh-ancestor
65602874|NCT01381848|Doripenem|doripenem|mesh-list
65602875|NCT01381848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65602876|NCT01381848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65602877|NCT04546620|Prednisolone|prednisolone|mesh-list
65602878|NCT04546620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65602879|NCT04546620|Methylprednisolone|methylprednisolone|mesh-list
65602880|NCT04546620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65602881|NCT04546620|Prednisolone acetate|prednisolone acetate|mesh-list
65602882|NCT04546620|Prednisone|prednisone|mesh-list
65602883|NCT04546620|Cyclophosphamide|cyclophosphamide|mesh-list
65602884|NCT04546620|Rituximab|rituximab|mesh-list
65602885|NCT04546620|Doxorubicin|doxorubicin|mesh-list
65602886|NCT04546620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65602887|NCT04546620|Vincristine|vincristine|mesh-list
65602888|NCT04546620|Acalabrutinib|acalabrutinib|mesh-list
65602889|NCT04546620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65602890|NCT04546620|Prednisolone phosphate|prednisolone phosphate|mesh-list
65602891|NCT04546620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65602892|NCT04546620|Immunologic Factors|immunologic factors|mesh-ancestor
65602893|NCT04546620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602894|NCT04546620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65602895|NCT04546620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65602896|NCT04546620|Alkylating Agents|alkylating agents|mesh-ancestor
65602897|NCT04546620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602898|NCT04546620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602899|NCT04546620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65602900|NCT04546620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65602901|NCT04546620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65602902|NCT04546620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65602903|NCT04546620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65602904|NCT04546620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602905|NCT04546620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65602906|NCT04546620|Tubulin Modulators|tubulin modulators|mesh-ancestor
65602907|NCT04546620|Antimitotic Agents|antimitotic agents|mesh-ancestor
65602908|NCT04546620|Mitosis Modulators|mitosis modulators|mesh-ancestor
65602909|NCT04546620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65602910|NCT04546620|Glucocorticoids|glucocorticoids|mesh-ancestor
65602911|NCT04546620|Hormones|hormones|mesh-ancestor
65602912|NCT04546620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65602913|NCT04546620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65602914|NCT04546620|Antiemetics|antiemetics|mesh-ancestor
65602915|NCT04546620|Autonomic Agents|autonomic agents|mesh-ancestor
65602916|NCT04546620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65602917|NCT04546620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65602918|NCT04546620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65602919|NCT04546620|Protective Agents|protective agents|mesh-ancestor
65602920|NCT04058210|Ivacaftor|ivacaftor|mesh-list
65602921|NCT04058210|Elexacaftor|elexacaftor|mesh-list
65602922|NCT04058210|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65602923|NCT04058210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65602924|NCT04058210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602925|NCT02250300|Ixazomib|ixazomib|mesh-list
65602926|NCT02250300|Glycine|glycine|mesh-list
65602927|NCT02250300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602928|NCT02250300|Protease Inhibitors|protease inhibitors|mesh-ancestor
65602929|NCT02250300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602930|NCT02250300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602931|NCT02250300|Glycine Agents|glycine agents|mesh-ancestor
65602932|NCT02250300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65602933|NCT02250300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602934|NCT03020966|Acetaminophen|acetaminophen|mesh-list
65602935|NCT03020966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65602936|NCT03020966|Analgesics|analgesics|mesh-ancestor
65602937|NCT03020966|Sensory System Agents|sensory system agents|mesh-ancestor
65602938|NCT03020966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65602939|NCT03020966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602940|NCT03020966|Antipyretics|antipyretics|mesh-ancestor
65602941|NCT04051268|Vaccines|vaccines|mesh-list
65602942|NCT04051268|Immunologic Factors|immunologic factors|mesh-ancestor
65602943|NCT04051268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602944|NCT04595786|Tranexamic Acid|tranexamic acid|mesh-list
65602945|NCT04595786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65602946|NCT04595786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65602947|NCT04595786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602948|NCT04595786|Hemostatics|hemostatics|mesh-ancestor
65602949|NCT04595786|Coagulants|coagulants|mesh-ancestor
65602950|NCT02108652|Atezolizumab|atezolizumab|mesh-list
65602951|NCT02108652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602952|NCT01381614|Bevacizumab|bevacizumab|mesh-list
65602953|NCT01381614|Sunitinib|sunitinib|mesh-list
65602954|NCT01381614|Sorafenib|sorafenib|mesh-list
65602955|NCT01381614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65602956|NCT01381614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602957|NCT01381614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65602958|NCT01381614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65602959|NCT01381614|Growth Substances|growth substances|mesh-ancestor
65602960|NCT01381614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602961|NCT01381614|Growth Inhibitors|growth inhibitors|mesh-ancestor
65602962|NCT01381614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65602963|NCT01381614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65602964|NCT01381614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602965|NCT01381536|Belimumab|belimumab|mesh-list
65602966|NCT01381536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65602967|NCT01381536|Immunologic Factors|immunologic factors|mesh-ancestor
65602968|NCT01381536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602969|NCT01950390|Bevacizumab|bevacizumab|mesh-list
65602970|NCT01950390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65602971|NCT01950390|Ipilimumab|ipilimumab|mesh-list
65602972|NCT01950390|Endothelial Growth Factors|endothelial growth factors|mesh-list
65602973|NCT01950390|Antibodies|antibodies|mesh-list
65602974|NCT01950390|Immunoglobulins|immunoglobulins|mesh-list
65602975|NCT01950390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65602976|NCT01950390|Immunoglobulin G|immunoglobulin g|mesh-list
65602977|NCT01950390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65602978|NCT01950390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65602979|NCT01950390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65602980|NCT01950390|Growth Substances|growth substances|mesh-ancestor
65602981|NCT01950390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602982|NCT01950390|Growth Inhibitors|growth inhibitors|mesh-ancestor
65602983|NCT01950390|Immunologic Factors|immunologic factors|mesh-ancestor
65602984|NCT01950390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65602985|NCT01950390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65602986|NCT03162406|Vitamin D|vitamin d|mesh-list
65602987|NCT03162406|Cholecalciferol|cholecalciferol|mesh-list
65602988|NCT03162406|Vitamins|vitamins|mesh-ancestor
65602989|NCT03162406|Micronutrients|micronutrients|mesh-ancestor
65602990|NCT03162406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602991|NCT03162406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65602992|NCT03162406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65602993|NCT02946385|Vaccines|vaccines|mesh-list
65602994|NCT02946385|Immunologic Factors|immunologic factors|mesh-ancestor
65602995|NCT02946385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65602996|NCT02694718|Capecitabine|capecitabine|mesh-list
65602997|NCT02694718|Oxaliplatin|oxaliplatin|mesh-list
65602998|NCT02694718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65602999|NCT02694718|Antimetabolites|antimetabolites|mesh-ancestor
65603000|NCT02694718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603001|NCT02694718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603002|NCT05681299|Liraglutide|liraglutide|mesh-list
65603003|NCT05681299|Hormones|hormones|mesh-list
65603004|NCT05681299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65603005|NCT05681299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603006|NCT05681299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65603007|NCT05681299|Incretins|incretins|mesh-ancestor
65603008|NCT03161080|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65603009|NCT03161080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65603010|NCT04908787|Paclitaxel|paclitaxel|mesh-list
65603011|NCT04908787|Doxorubicin|doxorubicin|mesh-list
65603012|NCT04908787|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65603013|NCT04908787|Topotecan|topotecan|mesh-list
65603014|NCT04908787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65603015|NCT04908787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603016|NCT04908787|Tubulin Modulators|tubulin modulators|mesh-ancestor
65603017|NCT04908787|Antimitotic Agents|antimitotic agents|mesh-ancestor
65603018|NCT04908787|Mitosis Modulators|mitosis modulators|mesh-ancestor
65603019|NCT04908787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603020|NCT04908787|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65603021|NCT04908787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65603022|NCT04908787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65603023|NCT04908787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603024|NCT04908787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65603025|NCT04923139|Rivaroxaban|rivaroxaban|mesh-list
65603026|NCT04923139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65603027|NCT04923139|Antithrombins|antithrombins|mesh-ancestor
65603028|NCT04923139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65603029|NCT04923139|Protease Inhibitors|protease inhibitors|mesh-ancestor
65603030|NCT04923139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603031|NCT04923139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603032|NCT04923139|Anticoagulants|anticoagulants|mesh-ancestor
65603033|NCT05681221|Calcium|calcium|mesh-list
65603034|NCT05681221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65603035|NCT05681221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603036|NCT04303507|Hydroxychloroquine|hydroxychloroquine|mesh-list
65603037|NCT04303507|Chloroquine|chloroquine|mesh-list
65603038|NCT04303507|Antimalarials|antimalarials|mesh-ancestor
65603039|NCT04303507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65603040|NCT04303507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65603041|NCT04303507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65603042|NCT04303507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603043|NCT04303507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603045|NCT04303507|Amebicides|amebicides|mesh-ancestor
65603046|NCT03202537|Dexlansoprazole|dexlansoprazole|mesh-list
65603047|NCT03202537|Lansoprazole|lansoprazole|mesh-list
65603048|NCT03202537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65603049|NCT03202537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65603050|NCT03202537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65603051|NCT03202537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603052|NCT03202537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603053|NCT03179761|Vaccines|vaccines|mesh-list
65603054|NCT03179761|Immunologic Factors|immunologic factors|mesh-ancestor
65603055|NCT03179761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603056|NCT01772472|Trastuzumab|trastuzumab|mesh-list
65603057|NCT01772472|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65603058|NCT01772472|Maytansine|maytansine|mesh-list
65603059|NCT01772472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65603060|NCT01772472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603061|NCT01772472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65603062|NCT01772472|Tubulin Modulators|tubulin modulators|mesh-ancestor
65603063|NCT01772472|Antimitotic Agents|antimitotic agents|mesh-ancestor
65603064|NCT01772472|Mitosis Modulators|mitosis modulators|mesh-ancestor
65603065|NCT01772472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603066|NCT03631134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65603067|NCT03631134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603068|NCT03631134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65603069|NCT03631134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603070|NCT04788667|Erenumab|erenumab|mesh-list
65603071|NCT04788667|Botulinum Toxins|botulinum toxins|mesh-list
65603072|NCT04788667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65603073|NCT04788667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65603074|NCT04788667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603075|NCT04788667|Cholinergic Agents|cholinergic agents|mesh-ancestor
65603076|NCT04788667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65603077|NCT04788667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603078|NCT04788667|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65603079|NCT04788667|Analgesics|analgesics|mesh-ancestor
65603080|NCT04788667|Sensory System Agents|sensory system agents|mesh-ancestor
65603081|NCT04788667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65603082|NCT04138615|Morphine|morphine|mesh-list
65603083|NCT04138615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65603084|NCT04138615|Narcotics|narcotics|mesh-ancestor
65603085|NCT04138615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65603086|NCT04138615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603087|NCT04138615|Analgesics|analgesics|mesh-ancestor
65603088|NCT04138615|Sensory System Agents|sensory system agents|mesh-ancestor
65603089|NCT04138615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65603090|NCT01383330|Megestrol Acetate|megestrol acetate|mesh-list
65603091|NCT01383330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65603092|NCT01383330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603093|NCT01383330|Appetite Stimulants|appetite stimulants|mesh-ancestor
65603094|NCT01383330|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65603095|NCT01383330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603096|NCT03018938|Insulin|insulin|mesh-list
65603097|NCT03018938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65603098|NCT03018938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65603099|NCT03018938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603100|NCT04776499|Perphenazine|perphenazine|mesh-list
65603101|NCT04776499|Riociguat|riociguat|mesh-list
65603102|NCT04776499|Propylthiouracil|propylthiouracil|mesh-list
65603103|NCT04776499|Enzyme Activators|enzyme activators|mesh-ancestor
65603104|NCT04776499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603105|NCT04776499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65603106|NCT04776499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65603107|NCT04776499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65603108|NCT04776499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603109|NCT04776499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65603110|NCT04776499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65603111|NCT04776499|Dopamine Agents|dopamine agents|mesh-ancestor
65603112|NCT04776499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65603113|NCT04776499|Antimetabolites|antimetabolites|mesh-ancestor
65603114|NCT04776499|Antithyroid Agents|antithyroid agents|mesh-ancestor
65603115|NCT04776499|Hormone Antagonists|hormone antagonists|mesh-ancestor
65603116|NCT04776499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65603117|NCT03668054|Bevacizumab|bevacizumab|mesh-list
65603118|NCT03668054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65603120|NCT03668054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65603121|NCT03668054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65603122|NCT03668054|Growth Substances|growth substances|mesh-ancestor
65603123|NCT03668054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603124|NCT03668054|Growth Inhibitors|growth inhibitors|mesh-ancestor
65603125|NCT04698187|Nivolumab|nivolumab|mesh-list
65603126|NCT04698187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65603127|NCT04698187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603128|NCT04698187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65603129|NCT04698187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603130|NCT03623048|Chlorhexidine|chlorhexidine|mesh-list
65603131|NCT03623048|Propolis|propolis|mesh-list
65498321|NCT05650879|Maytansine|maytansine|mesh-list
65603132|NCT03623048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65603133|NCT03623048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65603134|NCT03623048|Disinfectants|disinfectants|mesh-ancestor
65603135|NCT03016598|Oxytocin|oxytocin|mesh-list
65603136|NCT03016598|Oxytocics|oxytocics|mesh-ancestor
65603137|NCT03016598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65603138|NCT03016598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603139|NCT02947087|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65603140|NCT02947087|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65603141|NCT02947087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65603142|NCT02947087|Protease Inhibitors|protease inhibitors|mesh-ancestor
65603143|NCT02947087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603144|NCT02947087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603145|NCT03017846|Cantharidin|cantharidin|mesh-list
65603146|NCT03017846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603147|NCT03017846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603148|NCT03638401|Morphine|morphine|mesh-list
65603149|NCT03638401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65603150|NCT03638401|Narcotics|narcotics|mesh-ancestor
65603151|NCT03638401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65603152|NCT03638401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603153|NCT03638401|Analgesics|analgesics|mesh-ancestor
65603154|NCT03638401|Sensory System Agents|sensory system agents|mesh-ancestor
65603155|NCT03638401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65603156|NCT03666650|Edoxaban|edoxaban|mesh-list
65603157|NCT03666650|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65603158|NCT03666650|Antithrombins|antithrombins|mesh-ancestor
65603159|NCT03666650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65603160|NCT03666650|Protease Inhibitors|protease inhibitors|mesh-ancestor
65603161|NCT03666650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603162|NCT03666650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603163|NCT03666650|Anticoagulants|anticoagulants|mesh-ancestor
65603164|NCT04672291|Poly I-C|poly i-c|mesh-list
65603165|NCT04672291|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65603166|NCT04672291|Poly ICLC|poly iclc|mesh-list
65603167|NCT04672291|Interferon Inducers|interferon inducers|mesh-ancestor
65603168|NCT04672291|Immunologic Factors|immunologic factors|mesh-ancestor
65603169|NCT04672291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603170|NCT04672291|Laxatives|laxatives|mesh-ancestor
65603171|NCT04672291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65603172|NCT04672291|Antiviral Agents|antiviral agents|mesh-ancestor
65603173|NCT04672291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65603174|NCT02942485|Metronidazole|metronidazole|mesh-list
65603175|NCT02942485|Tinidazole|tinidazole|mesh-list
65603176|NCT02942485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65603177|NCT02942485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65603178|NCT02942485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65603179|NCT02942485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65603180|NCT02942485|Alkylating Agents|alkylating agents|mesh-ancestor
65603181|NCT02942485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603182|NCT02942485|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65603183|NCT03666494|Fentanyl|fentanyl|mesh-list
65603184|NCT03666494|Ketamine|ketamine|mesh-list
65603185|NCT03666494|Propofol|propofol|mesh-list
65603186|NCT03666494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65603187|NCT03666494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65603188|NCT03666494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603189|NCT03666494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65603190|NCT03666494|Anesthetics, General|anesthetics, general|mesh-ancestor
65603191|NCT03666494|Anesthetics|anesthetics|mesh-ancestor
65603192|NCT03666494|Analgesics|analgesics|mesh-ancestor
65603193|NCT03666494|Sensory System Agents|sensory system agents|mesh-ancestor
65603194|NCT03666494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65603195|NCT03666494|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65603196|NCT03666494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65603197|NCT03666494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65603198|NCT03666494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65603199|NCT03666494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603200|NCT03666494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65603201|NCT03666494|Narcotics|narcotics|mesh-ancestor
65603202|NCT03666494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65603203|NCT03666884|Cyclosporine|cyclosporine|mesh-list
65603204|NCT03666884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65603205|NCT03666884|Cyclosporins|cyclosporins|mesh-list
65603206|NCT03666884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65603207|NCT03666884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603208|NCT03666884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603209|NCT03666884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65603210|NCT03666884|Immunologic Factors|immunologic factors|mesh-ancestor
65603211|NCT03666884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603212|NCT03666884|Antifungal Agents|antifungal agents|mesh-ancestor
65603213|NCT03666884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65603214|NCT03666884|Dermatologic Agents|dermatologic agents|mesh-ancestor
65603215|NCT03666884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65603216|NCT03666884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65603217|NCT02942407|Warfarin|warfarin|mesh-list
65603218|NCT02942407|Apixaban|apixaban|mesh-list
65603219|NCT02942407|Anticoagulants|anticoagulants|mesh-ancestor
65603220|NCT02942407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65603221|NCT02942407|Antithrombins|antithrombins|mesh-ancestor
65603222|NCT02942407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65603223|NCT02942407|Protease Inhibitors|protease inhibitors|mesh-ancestor
65603224|NCT02942407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603225|NCT02942407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603226|NCT02921035|Interferons|interferons|mesh-list
65603227|NCT02921035|Interferon-beta|interferon-beta|mesh-list
65603228|NCT02921035|Interferon beta-1a|interferon beta-1a|mesh-list
65603229|NCT02921035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603230|NCT02921035|Antiviral Agents|antiviral agents|mesh-ancestor
65603231|NCT02921035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65603232|NCT02921035|Immunologic Factors|immunologic factors|mesh-ancestor
65603233|NCT02921035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603234|NCT02921035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65603235|NCT04621981|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65603236|NCT03006848|Avelumab|avelumab|mesh-list
65603237|NCT03006848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65603238|NCT03006848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603239|NCT03667352|Fentanyl|fentanyl|mesh-list
65603240|NCT03667352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65603241|NCT03667352|Narcotics|narcotics|mesh-ancestor
65603242|NCT03667352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65603243|NCT03667352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603244|NCT03667352|Analgesics|analgesics|mesh-ancestor
65603245|NCT03667352|Sensory System Agents|sensory system agents|mesh-ancestor
65603246|NCT03667352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65603247|NCT03667352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65603248|NCT03667352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65603249|NCT03667352|Anesthetics, General|anesthetics, general|mesh-ancestor
65603250|NCT03667352|Anesthetics|anesthetics|mesh-ancestor
65603251|NCT03320941|Licogliflozin|licogliflozin|mesh-list
65603252|NCT03320941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65603253|NCT03320941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603254|NCT03320941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65603255|NCT03320941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603256|NCT04730947|Dapagliflozin|dapagliflozin|mesh-list
65603257|NCT04730947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65603258|NCT04730947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603259|NCT04730947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65603260|NCT04730947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603262|NCT03557281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65603263|NCT03557281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65603264|NCT02573233|Fluticasone|fluticasone|mesh-list
65603265|NCT02573233|Xhance|xhance|mesh-list
65603266|NCT02573233|Mometasone Furoate|mometasone furoate|mesh-list
65603267|NCT02573233|Budesonide|budesonide|mesh-list
65603268|NCT02573233|Formoterol Fumarate|formoterol fumarate|mesh-list
65603269|NCT02573233|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65603270|NCT02573233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65603271|NCT02573233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65603272|NCT02573233|Autonomic Agents|autonomic agents|mesh-ancestor
65603273|NCT02573233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65603274|NCT02573233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603275|NCT02573233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65603276|NCT02573233|Respiratory System Agents|respiratory system agents|mesh-ancestor
65603277|NCT02573233|Dermatologic Agents|dermatologic agents|mesh-ancestor
65603278|NCT02573233|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65603279|NCT02573233|Glucocorticoids|glucocorticoids|mesh-ancestor
65603280|NCT02573233|Hormones|hormones|mesh-ancestor
65603281|NCT02573233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65603282|NCT02573233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65603283|NCT02573233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65603284|NCT02573233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65603285|NCT02573233|Adrenergic Agents|adrenergic agents|mesh-ancestor
65603286|NCT02573233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65603287|NCT02573233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603288|NCT03867487|Empagliflozin|empagliflozin|mesh-list
65603289|NCT03867487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65603290|NCT03867487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603291|NCT03867487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65603292|NCT03867487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603293|NCT01569048|Dexmedetomidine|dexmedetomidine|mesh-list
65603294|NCT01569048|Remifentanil|remifentanil|mesh-list
65603295|NCT01569048|Propofol|propofol|mesh-list
65603296|NCT01569048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65603297|NCT01569048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65603298|NCT01569048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603299|NCT01569048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65603300|NCT01569048|Anesthetics, General|anesthetics, general|mesh-ancestor
65603301|NCT01569048|Anesthetics|anesthetics|mesh-ancestor
65603302|NCT01569048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65603303|NCT01569048|Analgesics|analgesics|mesh-ancestor
65603304|NCT01569048|Sensory System Agents|sensory system agents|mesh-ancestor
65603305|NCT01569048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65603306|NCT01569048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65603307|NCT01569048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65603308|NCT01569048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65603309|NCT01569048|Adrenergic Agents|adrenergic agents|mesh-ancestor
65603310|NCT01569048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65603311|NCT01569048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603312|NCT01569048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65603313|NCT01569048|Narcotics|narcotics|mesh-ancestor
65603314|NCT01380912|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65603315|NCT01380912|Methylprednisolone|methylprednisolone|mesh-list
65603316|NCT01380912|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65603317|NCT01380912|Prednisolone|prednisolone|mesh-list
65603318|NCT01380912|Prednisolone acetate|prednisolone acetate|mesh-list
65603319|NCT01380912|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65603320|NCT01380912|Prednisolone phosphate|prednisolone phosphate|mesh-list
65603321|NCT01380912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65603322|NCT01380912|Antiemetics|antiemetics|mesh-ancestor
65603323|NCT01380912|Autonomic Agents|autonomic agents|mesh-ancestor
65603324|NCT01380912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65603325|NCT01380912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603326|NCT01380912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65603327|NCT01380912|Glucocorticoids|glucocorticoids|mesh-ancestor
65603328|NCT01380912|Hormones|hormones|mesh-ancestor
65603329|NCT01380912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65603330|NCT01380912|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65603331|NCT01380912|Protective Agents|protective agents|mesh-ancestor
65603332|NCT01380912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65603333|NCT01380912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603334|NCT03315793|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65603335|NCT03315793|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65603336|NCT03315793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65603337|NCT03315793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65603338|NCT03315793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603339|NCT03315793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65603340|NCT03315793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603341|NCT03315793|Analgesics|analgesics|mesh-ancestor
65603342|NCT03315793|Sensory System Agents|sensory system agents|mesh-ancestor
65603343|NCT03315793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65603344|NCT03315793|Antidepressive Agents|antidepressive agents|mesh-ancestor
65603345|NCT03315793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65603346|NCT03315793|Dopamine Agents|dopamine agents|mesh-ancestor
65603347|NCT01569204|Dexamethasone|dexamethasone|mesh-list
65603348|NCT01569204|Prednisone|prednisone|mesh-list
65603349|NCT01569204|Cyclophosphamide|cyclophosphamide|mesh-list
65603350|NCT01569204|Dacarbazine|dacarbazine|mesh-list
65603351|NCT01569204|Doxorubicin|doxorubicin|mesh-list
65603352|NCT01569204|Etoposide|etoposide|mesh-list
65603353|NCT01569204|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65603354|NCT01569204|Procarbazine|procarbazine|mesh-list
65603355|NCT01569204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65603356|NCT01569204|Immunologic Factors|immunologic factors|mesh-ancestor
65603357|NCT01569204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603358|NCT01569204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65603359|NCT01569204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65603360|NCT01569204|Alkylating Agents|alkylating agents|mesh-ancestor
65603361|NCT01569204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603362|NCT01569204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603363|NCT01569204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65603364|NCT01569204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65603365|NCT01569204|Antiemetics|antiemetics|mesh-ancestor
65603366|NCT01569204|Autonomic Agents|autonomic agents|mesh-ancestor
65603367|NCT01569204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65603368|NCT01569204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65603369|NCT01569204|Glucocorticoids|glucocorticoids|mesh-ancestor
65603370|NCT01569204|Hormones|hormones|mesh-ancestor
65603371|NCT01569204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65603372|NCT01569204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65603373|NCT01569204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65603374|NCT01569204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65603375|NCT01569204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65603376|NCT01569204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603377|NCT01569204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65603378|NCT01569204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65603379|NCT02676466|Losartan|losartan|mesh-list
65603380|NCT02676466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65603381|NCT02676466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65603382|NCT02676466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65603383|NCT02676466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65603384|NCT02676466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603385|NCT04439890|Carboplatin|carboplatin|mesh-list
65603386|NCT04439890|Pemetrexed|pemetrexed|mesh-list
65603387|NCT04439890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603388|NCT04439890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603389|NCT04439890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603390|NCT04439890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65603391|NCT04439890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65603392|NCT03635892|Nivolumab|nivolumab|mesh-list
65603393|NCT03635892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65603394|NCT03635892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603395|NCT03635892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65603396|NCT03635892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603397|NCT02324725|Naltrexone|naltrexone|mesh-list
65603398|NCT02324725|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65603399|NCT02324725|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65603400|NCT02324725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603401|NCT02324725|Sensory System Agents|sensory system agents|mesh-ancestor
65603402|NCT02324725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65603403|NCT01380678|Bevacizumab|bevacizumab|mesh-list
65603404|NCT01380678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65603405|NCT01380678|Histamine Antagonists|histamine antagonists|mesh-list
65603406|NCT01380678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
65603407|NCT01380678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65603408|NCT01380678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603409|NCT01380678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65603410|NCT01380678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65603411|NCT01380678|Growth Substances|growth substances|mesh-ancestor
65603412|NCT01380678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603413|NCT01380678|Growth Inhibitors|growth inhibitors|mesh-ancestor
65603414|NCT01380678|Histamine Agents|histamine agents|mesh-ancestor
65603415|NCT01380678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65603416|NCT01380678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603417|NCT01380600|Molgramostim|molgramostim|mesh-list
65603418|NCT01380600|Sargramostim|sargramostim|mesh-list
65400809|NCT04221438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65603419|NCT01380600|Immunologic Factors|immunologic factors|mesh-ancestor
65603420|NCT01380600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603421|NCT01380600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603422|NCT03264118|Tolonium Chloride|tolonium chloride|mesh-list
65603423|NCT03264118|Hemostatics|hemostatics|mesh-ancestor
65603424|NCT03264118|Coagulants|coagulants|mesh-ancestor
65603425|NCT03264118|Heparin Antagonists|heparin antagonists|mesh-ancestor
65603426|NCT03264118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603427|NCT02674204|Atorvastatin|atorvastatin|mesh-list
65603428|NCT02674204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65603429|NCT02674204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65603430|NCT02674204|Antimetabolites|antimetabolites|mesh-ancestor
65603431|NCT02674204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603432|NCT02674204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65603433|NCT02674204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65603434|NCT02674204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603435|NCT05675644|Drospirenone|drospirenone|mesh-list
65603436|NCT05675644|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65603437|NCT05675644|Hormone Antagonists|hormone antagonists|mesh-ancestor
65603438|NCT05675644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65603439|NCT05675644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603440|NCT05675644|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65603441|NCT05675644|Diuretics|diuretics|mesh-ancestor
65603442|NCT05675644|Natriuretic Agents|natriuretic agents|mesh-ancestor
65603443|NCT05010772|Decitabine|decitabine|mesh-list
65603444|NCT05010772|Venetoclax|venetoclax|mesh-list
65603445|NCT05010772|Ivosidenib|ivosidenib|mesh-list
65603446|NCT05010772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65603447|NCT05010772|Antimetabolites|antimetabolites|mesh-ancestor
65603448|NCT05010772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603449|NCT05010772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603450|NCT05010772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603451|NCT02579044|Everolimus|everolimus|mesh-list
65603452|NCT02579044|Lonafarnib|lonafarnib|mesh-list
65603453|NCT02579044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603454|NCT02579044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65603455|NCT02579044|Immunologic Factors|immunologic factors|mesh-ancestor
65603456|NCT02579044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603457|NCT02579044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603458|NCT02579044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603459|NCT02464696|Methylprednisolone|methylprednisolone|mesh-list
65603460|NCT02464696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65603461|NCT02464696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65603462|NCT02464696|Prednisolone|prednisolone|mesh-list
65603463|NCT02464696|Prednisolone acetate|prednisolone acetate|mesh-list
65603464|NCT02464696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65603465|NCT02464696|Prednisolone phosphate|prednisolone phosphate|mesh-list
65603466|NCT02464696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65603467|NCT02464696|Antiemetics|antiemetics|mesh-ancestor
65603468|NCT02464696|Autonomic Agents|autonomic agents|mesh-ancestor
65603469|NCT02464696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65603470|NCT02464696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603471|NCT02464696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65603472|NCT02464696|Glucocorticoids|glucocorticoids|mesh-ancestor
65603473|NCT02464696|Hormones|hormones|mesh-ancestor
65603474|NCT02464696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65603475|NCT02464696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65603476|NCT02464696|Protective Agents|protective agents|mesh-ancestor
65603477|NCT02464696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65603478|NCT02464696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603479|NCT04503694|Nivolumab|nivolumab|mesh-list
65603480|NCT04503694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65603481|NCT04503694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603482|NCT04503694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65603483|NCT04503694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603484|NCT03525379|Resveratrol|resveratrol|mesh-list
65603485|NCT03525379|Antioxidants|antioxidants|mesh-ancestor
65603486|NCT03525379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603487|NCT03525379|Protective Agents|protective agents|mesh-ancestor
65603488|NCT03525379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603489|NCT03525379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603490|NCT03525379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65603491|NCT03476551|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65603492|NCT03476551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65400886|NCT00681863|Protective Agents|protective agents|mesh-ancestor
65603494|NCT03476551|Natriuretic Agents|natriuretic agents|mesh-ancestor
65603495|NCT03476551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603496|NCT03476551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65603497|NCT03476551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65603498|NCT03476551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603499|NCT04702789|Timolol|timolol|mesh-list
65603500|NCT04702789|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65603501|NCT04702789|Dorzolamide|dorzolamide|mesh-list
65603502|NCT04702789|Latanoprost|latanoprost|mesh-list
65603503|NCT04702789|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65603504|NCT04702789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65603505|NCT04702789|Adrenergic Agents|adrenergic agents|mesh-ancestor
65603506|NCT04702789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65603507|NCT04702789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603508|NCT04702789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603509|NCT04702789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65603510|NCT04702789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65603511|NCT04702789|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65603512|NCT04702789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65603513|NCT04702789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65603514|NCT04702789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65603515|NCT04702789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65603516|NCT04702789|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65603517|NCT04702789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603518|NCT03521934|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65603519|NCT03521934|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65603520|NCT03521934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603521|NCT03521934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65603522|NCT03521934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603523|NCT03374137|Obinutuzumab|obinutuzumab|mesh-list
65603524|NCT03374137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65603525|NCT03374137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603526|NCT01380522|Metronidazole|metronidazole|mesh-list
65603527|NCT01380522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65603528|NCT01380522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65603529|NCT01380522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65603530|NCT01380522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65603531|NCT02913326|Warfarin|warfarin|mesh-list
65603532|NCT02913326|Dabigatran|dabigatran|mesh-list
65603533|NCT02913326|Anticoagulants|anticoagulants|mesh-ancestor
65603534|NCT02913326|Antithrombins|antithrombins|mesh-ancestor
65603535|NCT02913326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65603536|NCT02913326|Protease Inhibitors|protease inhibitors|mesh-ancestor
65603537|NCT02913326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603538|NCT02913326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603539|NCT03434028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65603540|NCT03725891|Aspirin|aspirin|mesh-list
65603541|NCT03725891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65603542|NCT03725891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65603543|NCT03725891|Analgesics|analgesics|mesh-ancestor
65603544|NCT03725891|Sensory System Agents|sensory system agents|mesh-ancestor
65603545|NCT03725891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65603546|NCT03725891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603547|NCT03725891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65603548|NCT03725891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65603549|NCT03725891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65603550|NCT03725891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65603551|NCT03725891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603552|NCT03725891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65603553|NCT03725891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65603554|NCT03725891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603555|NCT03725891|Antipyretics|antipyretics|mesh-ancestor
65603556|NCT03751163|Sunscreening Agents|sunscreening agents|mesh-list
65603557|NCT03751163|Tranexamic Acid|tranexamic acid|mesh-list
65603558|NCT03751163|Hydroquinone|hydroquinone|mesh-list
65603559|NCT03751163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65603560|NCT03751163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65603561|NCT03751163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603562|NCT03751163|Hemostatics|hemostatics|mesh-ancestor
65603563|NCT03751163|Coagulants|coagulants|mesh-ancestor
65603564|NCT03751163|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65603565|NCT03751163|Protective Agents|protective agents|mesh-ancestor
65603566|NCT03751163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603567|NCT03751163|Dermatologic Agents|dermatologic agents|mesh-ancestor
65603569|NCT03639545|Metformin|metformin|mesh-list
65603570|NCT03639545|Empagliflozin|empagliflozin|mesh-list
65603571|NCT03639545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65603572|NCT03639545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603573|NCT03639545|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65603574|NCT03639545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603575|NCT03181386|Warfarin|warfarin|mesh-list
65603576|NCT03181386|Rivaroxaban|rivaroxaban|mesh-list
65603577|NCT03181386|Dabigatran|dabigatran|mesh-list
65603578|NCT03181386|Apixaban|apixaban|mesh-list
65603579|NCT03181386|Anticoagulants|anticoagulants|mesh-ancestor
65603580|NCT03181386|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65603581|NCT03181386|Antithrombins|antithrombins|mesh-ancestor
65603582|NCT03181386|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65603583|NCT03181386|Protease Inhibitors|protease inhibitors|mesh-ancestor
65603584|NCT03181386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603585|NCT03181386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603586|NCT02912468|Mometasone Furoate|mometasone furoate|mesh-list
65603587|NCT02912468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65603588|NCT02912468|Dermatologic Agents|dermatologic agents|mesh-ancestor
65603589|NCT02912468|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65603590|NCT03639467|Gemcitabine|gemcitabine|mesh-list
65603591|NCT03639467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603592|NCT03639467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65603593|NCT03639467|Antimetabolites|antimetabolites|mesh-ancestor
65603594|NCT03639467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603595|NCT03639467|Antiviral Agents|antiviral agents|mesh-ancestor
65603596|NCT03639467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65603597|NCT03639467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603598|NCT03639467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65603599|NCT03639467|Immunologic Factors|immunologic factors|mesh-ancestor
65603600|NCT03639467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603601|NCT01382706|Docetaxel|docetaxel|mesh-list
65603602|NCT01382706|Lapatinib|lapatinib|mesh-list
65603603|NCT01382706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603604|NCT01382706|Tubulin Modulators|tubulin modulators|mesh-ancestor
65603605|NCT01382706|Antimitotic Agents|antimitotic agents|mesh-ancestor
65603606|NCT01382706|Mitosis Modulators|mitosis modulators|mesh-ancestor
65603607|NCT01382706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603608|NCT01382706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65603609|NCT01382706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603610|NCT03665402|Isoniazid|isoniazid|mesh-list
65603611|NCT03665402|Antitubercular Agents|antitubercular agents|mesh-ancestor
65603612|NCT03665402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65603613|NCT03665402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65603614|NCT03665402|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65603615|NCT03665402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65603616|NCT03665402|Antimetabolites|antimetabolites|mesh-ancestor
65603617|NCT03665402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603618|NCT03665402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65603619|NCT01380288|Rivastigmine|rivastigmine|mesh-list
65603620|NCT01380288|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65603621|NCT01380288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603622|NCT01380288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603623|NCT01380288|Cholinergic Agents|cholinergic agents|mesh-ancestor
65603624|NCT01380288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65603625|NCT01380288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603626|NCT01380288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65603627|NCT01380288|Protective Agents|protective agents|mesh-ancestor
65603628|NCT03110484|Pemetrexed|pemetrexed|mesh-list
65603629|NCT03110484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65603630|NCT03110484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603631|NCT03110484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603632|NCT03110484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603633|NCT03110484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65603634|NCT03110484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65603635|NCT03110484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65603636|NCT03110328|Pembrolizumab|pembrolizumab|mesh-list
65603637|NCT03110328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65603638|NCT03110328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603639|NCT00002874|Bicalutamide|bicalutamide|mesh-list
65603640|NCT00002874|Androgen Antagonists|androgen antagonists|mesh-ancestor
65603641|NCT00002874|Hormone Antagonists|hormone antagonists|mesh-ancestor
65603642|NCT00002874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65603643|NCT00002874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603644|NCT00002874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603645|NCT03001076|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
65603647|NCT03001076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65603648|NCT03001076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65603649|NCT03001076|Antimetabolites|antimetabolites|mesh-ancestor
65603650|NCT03001076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603651|NCT03001076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65603652|NCT03001076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603653|NCT03001076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65603654|NCT03001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603655|NCT03555305|Insulin|insulin|mesh-list
65603656|NCT03555305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65603657|NCT03555305|Insulin Glargine|insulin glargine|mesh-list
65603658|NCT03555305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65603659|NCT03555305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603660|NCT03018834|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65603661|NCT03018834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65603662|NCT05422716|Baclofen|baclofen|mesh-list
65603663|NCT05422716|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65603664|NCT05422716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603665|NCT05422716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65603666|NCT05422716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65603667|NCT05422716|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65603668|NCT05422716|GABA Agonists|gaba agonists|mesh-ancestor
65603669|NCT05422716|GABA Agents|gaba agents|mesh-ancestor
65603670|NCT05422716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65603671|NCT05422716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603672|NCT03728777|Resveratrol|resveratrol|mesh-list
65603673|NCT03728777|Antioxidants|antioxidants|mesh-ancestor
65603674|NCT03728777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603675|NCT03728777|Protective Agents|protective agents|mesh-ancestor
65603676|NCT03728777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603677|NCT03728777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603678|NCT03728777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65603679|NCT05421936|Osimertinib|osimertinib|mesh-list
65603680|NCT05421936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603681|NCT05421936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65603682|NCT05421936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603683|NCT05421936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603684|NCT01382472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65603685|NCT01382472|Simvastatin|simvastatin|mesh-list
65603686|NCT01382472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65603687|NCT01382472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65603688|NCT01382472|Antimetabolites|antimetabolites|mesh-ancestor
65603689|NCT01382472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603690|NCT01382472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65603691|NCT01382472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65603692|NCT01382472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603693|NCT03725423|Apatinib|apatinib|mesh-list
65603694|NCT03725423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603695|NCT03725423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65603696|NCT03725423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603697|NCT03725423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603698|NCT03521141|Nicotine|nicotine|mesh-list
65603699|NCT03521141|Varenicline|varenicline|mesh-list
65603700|NCT03521141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65603701|NCT03521141|Autonomic Agents|autonomic agents|mesh-ancestor
65603702|NCT03521141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65603703|NCT03521141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603704|NCT03521141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65603705|NCT03521141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65603706|NCT03521141|Cholinergic Agents|cholinergic agents|mesh-ancestor
65603707|NCT03521141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65603708|NCT03521141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603709|NCT03725267|Melatonin|melatonin|mesh-list
65603710|NCT03725267|Antioxidants|antioxidants|mesh-ancestor
65603711|NCT03725267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603712|NCT03725267|Protective Agents|protective agents|mesh-ancestor
65603713|NCT03725267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603714|NCT03725267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65603715|NCT02997176|Talazoparib|talazoparib|mesh-list
65603716|NCT02997176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65603717|NCT02997176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603718|NCT02997176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603719|NCT02997176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603720|NCT03000452|Durvalumab|durvalumab|mesh-list
65603721|NCT03000452|Daratumumab|daratumumab|mesh-list
65603722|NCT03000452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65603723|NCT03000452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603724|NCT03664388|Clopidogrel|clopidogrel|mesh-list
65603725|NCT03664388|Ticagrelor|ticagrelor|mesh-list
65603726|NCT03664388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65603727|NCT03664388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65603728|NCT03664388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65603729|NCT03664388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65603730|NCT03664388|Purinergic Agents|purinergic agents|mesh-ancestor
65603731|NCT03664388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65603732|NCT03664388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603733|NCT03664388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603734|NCT01373164|Gemcitabine|gemcitabine|mesh-list
65603735|NCT01373164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65603736|NCT01373164|Antimetabolites|antimetabolites|mesh-ancestor
65603737|NCT01373164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603738|NCT01373164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603739|NCT01373164|Antiviral Agents|antiviral agents|mesh-ancestor
65603740|NCT01373164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65603741|NCT01373164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603742|NCT01373164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65603743|NCT01373164|Immunologic Factors|immunologic factors|mesh-ancestor
65603744|NCT01373164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603745|NCT02999984|Busulfan|busulfan|mesh-list
65603746|NCT02999984|Alkylating Agents|alkylating agents|mesh-ancestor
65603747|NCT02999984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603748|NCT02999984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65603749|NCT02999984|Immunologic Factors|immunologic factors|mesh-ancestor
65603750|NCT02999984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603751|NCT02999984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65603752|NCT02999984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603753|NCT02999984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65603754|NCT03550313|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65603755|NCT03550313|Immunologic Factors|immunologic factors|mesh-ancestor
65603756|NCT03550313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603757|NCT03312907|Rituximab|rituximab|mesh-list
65603758|NCT03312907|Belimumab|belimumab|mesh-list
65603759|NCT03312907|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65603760|NCT03312907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65603761|NCT03312907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603762|NCT03312907|Immunologic Factors|immunologic factors|mesh-ancestor
65603763|NCT03312907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603764|NCT03312907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65603765|NCT02999672|Trastuzumab|trastuzumab|mesh-list
65603766|NCT02999672|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65603767|NCT02999672|Maytansine|maytansine|mesh-list
65603768|NCT02999672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65603769|NCT02999672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603770|NCT02999672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65603771|NCT02999672|Tubulin Modulators|tubulin modulators|mesh-ancestor
65603772|NCT02999672|Antimitotic Agents|antimitotic agents|mesh-ancestor
65603773|NCT02999672|Mitosis Modulators|mitosis modulators|mesh-ancestor
65603774|NCT02999672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603775|NCT03664622|Ketamine|ketamine|mesh-list
65603776|NCT03664622|Morphine|morphine|mesh-list
65603777|NCT03664622|Analgesics|analgesics|mesh-ancestor
65603778|NCT03664622|Sensory System Agents|sensory system agents|mesh-ancestor
65603779|NCT03664622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65603780|NCT03664622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603781|NCT03664622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65603782|NCT03664622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65603783|NCT03664622|Anesthetics, General|anesthetics, general|mesh-ancestor
65603784|NCT03664622|Anesthetics|anesthetics|mesh-ancestor
65603785|NCT03664622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65603786|NCT03664622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65603787|NCT03664622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65603788|NCT03664622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65603789|NCT03664622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603790|NCT03664622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65603791|NCT03664622|Narcotics|narcotics|mesh-ancestor
65603792|NCT04056182|Lofexidine|lofexidine|mesh-list
65603793|NCT04056182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65603794|NCT04056182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65603795|NCT04056182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603796|NCT04056182|Sensory System Agents|sensory system agents|mesh-ancestor
65603797|NCT04056182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65603798|NCT04056182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65603799|NCT04056182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65603800|NCT04056182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65603801|NCT04056182|Adrenergic Agents|adrenergic agents|mesh-ancestor
65603802|NCT04056182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65603803|NCT04056182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603804|NCT03573323|Ixekizumab|ixekizumab|mesh-list
65603805|NCT03573323|Dermatologic Agents|dermatologic agents|mesh-ancestor
65603806|NCT04058054|Histamine|histamine|mesh-list
65603807|NCT04058054|Histamine Agonists|histamine agonists|mesh-ancestor
65603808|NCT04058054|Histamine Agents|histamine agents|mesh-ancestor
65603809|NCT04058054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65603810|NCT04058054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603811|NCT04058054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603812|NCT04498286|Antibodies|antibodies|mesh-list
65603813|NCT04498286|Immunologic Factors|immunologic factors|mesh-ancestor
65603814|NCT04498286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603815|NCT01069172|Dipivefrin|dipivefrin|mesh-list
65603816|NCT01069172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65603817|NCT01069172|Adrenergic Agents|adrenergic agents|mesh-ancestor
65603818|NCT01069172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65603819|NCT01069172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603820|NCT01069172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603821|NCT04245280|Ropivacaine|ropivacaine|mesh-list
65603822|NCT04245280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65603823|NCT04245280|Anesthetics, Local|anesthetics, local|mesh-ancestor
65603824|NCT04245280|Anesthetics|anesthetics|mesh-ancestor
65603825|NCT04245280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65603826|NCT04245280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603827|NCT04245280|Sensory System Agents|sensory system agents|mesh-ancestor
65603828|NCT04245280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65603829|NCT03724955|Estradiol|estradiol|mesh-list
65603830|NCT03724955|Estrogens|estrogens|mesh-ancestor
65603831|NCT03724955|Hormones|hormones|mesh-ancestor
65603832|NCT03724955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65603833|NCT03724955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603834|NCT04220008|Gemcitabine|gemcitabine|mesh-list
65603835|NCT04220008|Mycophenolic Acid|mycophenolic acid|mesh-list
65603836|NCT04220008|Cyclophosphamide|cyclophosphamide|mesh-list
65603837|NCT04220008|Busulfan|busulfan|mesh-list
65603838|NCT04220008|Rituximab|rituximab|mesh-list
65603839|NCT04220008|Vorinostat|vorinostat|mesh-list
65603840|NCT04220008|Clofarabine|clofarabine|mesh-list
65603841|NCT04220008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65603842|NCT04220008|Tacrolimus|tacrolimus|mesh-list
65603843|NCT04220008|Antibodies|antibodies|mesh-list
65603844|NCT04220008|Immunoglobulins|immunoglobulins|mesh-list
65603845|NCT04220008|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65603846|NCT04220008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65603847|NCT04220008|Immunologic Factors|immunologic factors|mesh-ancestor
65603848|NCT04220008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603849|NCT04220008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65603850|NCT04220008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65603851|NCT04220008|Alkylating Agents|alkylating agents|mesh-ancestor
65603852|NCT04220008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603853|NCT04220008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603854|NCT04220008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65603855|NCT04220008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65603856|NCT04220008|Antimetabolites|antimetabolites|mesh-ancestor
65603857|NCT04220008|Antiviral Agents|antiviral agents|mesh-ancestor
65603858|NCT04220008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65603859|NCT04220008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401266|NCT05271071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65603860|NCT04220008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65603861|NCT04220008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65603862|NCT04220008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65603863|NCT04220008|Antitubercular Agents|antitubercular agents|mesh-ancestor
65603864|NCT04220008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65603865|NCT04220008|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65603866|NCT03721991|Butyric Acid|butyric acid|mesh-list
65603867|NCT03721991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65603868|NCT03721991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603869|NCT03721991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603870|NCT03721991|Histamine Antagonists|histamine antagonists|mesh-ancestor
65603871|NCT03721991|Histamine Agents|histamine agents|mesh-ancestor
65603872|NCT02911688|Vitamin E|vitamin e|mesh-list
65603873|NCT02911688|Tocopherols|tocopherols|mesh-list
65603874|NCT02911688|Tocotrienols|tocotrienols|mesh-list
65603875|NCT02911688|alpha-Tocopherol|alpha-tocopherol|mesh-list
65603876|NCT02911688|gamma-Tocopherol|gamma-tocopherol|mesh-list
65603877|NCT02911688|Vitamins|vitamins|mesh-ancestor
65603878|NCT02911688|Micronutrients|micronutrients|mesh-ancestor
65603879|NCT02911688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603880|NCT02911688|Antioxidants|antioxidants|mesh-ancestor
65603881|NCT02911688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603882|NCT02911688|Protective Agents|protective agents|mesh-ancestor
65603883|NCT03435458|Misoprostol|misoprostol|mesh-list
65603884|NCT03435458|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65603885|NCT03435458|Abortifacient Agents|abortifacient agents|mesh-ancestor
65603886|NCT03435458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65603887|NCT03435458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603888|NCT03435458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65603889|NCT03435458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65603890|NCT03435458|Oxytocics|oxytocics|mesh-ancestor
65603891|NCT05580250|Metformin|metformin|mesh-list
65603892|NCT05580250|Simvastatin|simvastatin|mesh-list
65603893|NCT05580250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65603894|NCT05580250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603895|NCT05580250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65603896|NCT05580250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65603897|NCT05580250|Antimetabolites|antimetabolites|mesh-ancestor
65603898|NCT05580250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603899|NCT05580250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65603900|NCT05580250|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65603901|NCT05580250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603902|NCT03431948|Nivolumab|nivolumab|mesh-list
65603903|NCT03431948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65603904|NCT03431948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603905|NCT03431948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65603906|NCT03431948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603907|NCT03662516|Levonorgestrel|levonorgestrel|mesh-list
65603908|NCT03662516|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65603909|NCT03662516|Contraceptive Agents|contraceptive agents|mesh-list
65603910|NCT03662516|Contraceptives, Oral|contraceptives, oral|mesh-list
65603911|NCT03662516|Estradiol|estradiol|mesh-list
65603912|NCT03662516|Abrocitinib|abrocitinib|mesh-list
65603913|NCT03662516|Estrogens|estrogens|mesh-ancestor
65603914|NCT03662516|Hormones|hormones|mesh-ancestor
65603915|NCT03662516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65603916|NCT03662516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603917|NCT03662516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65603918|NCT03662516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65603919|NCT03662516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65603920|NCT03662516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65603921|NCT03662516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65603922|NCT03662516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65603923|NCT03662516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603924|NCT03662516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603925|NCT03728465|Nivolumab|nivolumab|mesh-list
65603926|NCT03728465|Ipilimumab|ipilimumab|mesh-list
65603927|NCT03728465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65603928|NCT03728465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65603929|NCT03728465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65603930|NCT03728465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603931|NCT03662984|Ciprofibrate|ciprofibrate|mesh-list
65603932|NCT03662984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65603933|NCT03662984|Antimetabolites|antimetabolites|mesh-ancestor
65603934|NCT03662984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603935|NCT03662984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65603936|NCT02994056|Sofosbuvir|sofosbuvir|mesh-list
65603937|NCT02994056|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65603938|NCT02994056|Velpatasvir|velpatasvir|mesh-list
65603939|NCT02994056|Antiviral Agents|antiviral agents|mesh-ancestor
65603940|NCT02994056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65603941|NCT03728153|Fluoxetine|fluoxetine|mesh-list
65603942|NCT03728153|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65603943|NCT03728153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65603944|NCT03728153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65603945|NCT03728153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603946|NCT03728153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65603947|NCT03728153|Serotonin Agents|serotonin agents|mesh-ancestor
65603948|NCT03728153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603949|NCT03728153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65603950|NCT03728153|Antidepressive Agents|antidepressive agents|mesh-ancestor
65603951|NCT03728153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65603952|NCT03728153|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65499150|NCT04708782|Treprostinil|treprostinil|mesh-list
65603953|NCT03728153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65603954|NCT03728153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603955|NCT04056806|Ceftriaxone|ceftriaxone|mesh-list
65603956|NCT04056806|Terlipressin|terlipressin|mesh-list
65603957|NCT04056806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65603958|NCT04056806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65603959|NCT04056806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65603960|NCT04056806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65603961|NCT03305575|Bupivacaine|bupivacaine|mesh-list
65603962|NCT03305575|Chloroprocaine|chloroprocaine|mesh-list
65603963|NCT03305575|Anesthetics, Local|anesthetics, local|mesh-ancestor
65603964|NCT03305575|Anesthetics|anesthetics|mesh-ancestor
65603965|NCT03305575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65603966|NCT03305575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603967|NCT03305575|Sensory System Agents|sensory system agents|mesh-ancestor
65603968|NCT03305575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65603969|NCT02993822|Maleic acid|maleic acid|mesh-list
65603970|NCT02993822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65603971|NCT02993822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65603972|NCT02391844|Oxycodone|oxycodone|mesh-list
65603973|NCT02391844|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65603974|NCT02391844|Narcotics|narcotics|mesh-ancestor
65603975|NCT02391844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65603976|NCT02391844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603977|NCT02391844|Analgesics|analgesics|mesh-ancestor
65603978|NCT02391844|Sensory System Agents|sensory system agents|mesh-ancestor
65603979|NCT02391844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65603980|NCT02391688|Fexofenadine|fexofenadine|mesh-list
65603981|NCT02391688|Flurbiprofen|flurbiprofen|mesh-list
65603982|NCT02391688|Midazolam|midazolam|mesh-list
65603983|NCT02391688|Dextromethorphan|dextromethorphan|mesh-list
65603984|NCT02391688|Caffeine|caffeine|mesh-list
65603985|NCT02391688|Bupropion|bupropion|mesh-list
65603986|NCT02391688|Omeprazole|omeprazole|mesh-list
65603987|NCT02391688|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65603988|NCT02391688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65603989|NCT02391688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65603990|NCT02391688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65603991|NCT02391688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65603992|NCT02391688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65603993|NCT02391688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65603994|NCT02391688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65603995|NCT02391688|Anesthetics, General|anesthetics, general|mesh-ancestor
65603996|NCT02391688|Anesthetics|anesthetics|mesh-ancestor
65603997|NCT02391688|GABA Modulators|gaba modulators|mesh-ancestor
65603998|NCT02391688|GABA Agents|gaba agents|mesh-ancestor
65603999|NCT02391688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65604000|NCT02391688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604001|NCT02391688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65604002|NCT02391688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65604003|NCT02391688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604004|NCT02391688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65604005|NCT02391688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65604006|NCT02391688|Purinergic Agents|purinergic agents|mesh-ancestor
65604007|NCT02391688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65604008|NCT02391688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65604009|NCT02391688|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65604010|NCT02391688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65604011|NCT02391688|Antidepressive Agents|antidepressive agents|mesh-ancestor
65604012|NCT02391688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65604013|NCT02391688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65604014|NCT02391688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65604015|NCT02391688|Dopamine Agents|dopamine agents|mesh-ancestor
65604016|NCT02391688|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65604017|NCT02391688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65604018|NCT02391688|Antitussive Agents|antitussive agents|mesh-ancestor
65604019|NCT02391688|Respiratory System Agents|respiratory system agents|mesh-ancestor
65604020|NCT02391688|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65604021|NCT02391688|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65604022|NCT02391688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65604023|NCT02391688|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65604024|NCT02391688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65604025|NCT02391688|Histamine Antagonists|histamine antagonists|mesh-ancestor
65604026|NCT02391688|Histamine Agents|histamine agents|mesh-ancestor
65604027|NCT02391688|Analgesics|analgesics|mesh-ancestor
65604028|NCT02391688|Sensory System Agents|sensory system agents|mesh-ancestor
65604029|NCT02391688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65604030|NCT02391688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65604031|NCT02391688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65604032|NCT02391688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65604033|NCT02391688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65604034|NCT02391688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65604035|NCT01068860|Insulin|insulin|mesh-list
65604036|NCT01068860|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65604037|NCT01068860|Metformin|metformin|mesh-list
65604038|NCT01068860|Glimepiride|glimepiride|mesh-list
65604039|NCT01068860|Insulin Lispro|insulin lispro|mesh-list
65604040|NCT01068860|Insulin, Isophane|insulin, isophane|mesh-list
65604041|NCT01068860|Glyburide|glyburide|mesh-list
65604042|NCT01068860|Glipizide|glipizide|mesh-list
65604043|NCT01068860|Troglitazone|troglitazone|mesh-list
65604044|NCT01068860|Tolbutamide|tolbutamide|mesh-list
65604045|NCT01068860|Acetohexamide|acetohexamide|mesh-list
65604046|NCT01068860|Chlorpropamide|chlorpropamide|mesh-list
65604047|NCT01068860|Tolazamide|tolazamide|mesh-list
65604048|NCT01068860|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
65604049|NCT01068860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65604050|NCT01068860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65604051|NCT01068860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604052|NCT01068860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65604053|NCT01068860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65604054|NCT01068860|Immunologic Factors|immunologic factors|mesh-ancestor
65604055|NCT04056650|Caffeine|caffeine|mesh-list
65604056|NCT04056650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65604057|NCT04056650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604058|NCT04056650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65604059|NCT04056650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604060|NCT04056650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604061|NCT04056650|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65604062|NCT04056650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65604063|NCT04056650|Purinergic Agents|purinergic agents|mesh-ancestor
65604064|NCT04056650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65604065|NCT04055480|Insulin|insulin|mesh-list
65604066|NCT04055480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65604067|NCT04055480|Insulin Aspart|insulin aspart|mesh-list
65604068|NCT04055480|Insulin, Short-Acting|insulin, short-acting|mesh-list
65604069|NCT04055480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65604070|NCT04055480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604071|NCT03158090|Lanreotide|lanreotide|mesh-list
65604072|NCT03158090|Octreotide|octreotide|mesh-list
65604073|NCT03158090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604074|NCT03158090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65604075|NCT03158090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65604076|NCT02670538|Cariprazine|cariprazine|mesh-list
65604077|NCT02670538|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65604078|NCT02670538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65604079|NCT02670538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65604080|NCT02670538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604081|NCT02670538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65604082|NCT04056910|Nivolumab|nivolumab|mesh-list
65604083|NCT04056910|Ivosidenib|ivosidenib|mesh-list
65604084|NCT04056910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65604085|NCT04056910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604086|NCT04056910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65604087|NCT04056910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604088|NCT04056910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604089|NCT03727763|Cetuximab|cetuximab|mesh-list
65604090|NCT03727763|Vemurafenib|vemurafenib|mesh-list
65604091|NCT03727763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65604092|NCT03727763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604093|NCT03727763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65604094|NCT03727763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604095|NCT03727763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604096|NCT01310621|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65604097|NCT01310621|Respiratory System Agents|respiratory system agents|mesh-ancestor
65604098|NCT02991482|Gemcitabine|gemcitabine|mesh-list
65604099|NCT02991482|Pembrolizumab|pembrolizumab|mesh-list
65604100|NCT02991482|Vinorelbine|vinorelbine|mesh-list
65604101|NCT02991482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65604102|NCT02991482|Antimetabolites|antimetabolites|mesh-ancestor
65604103|NCT02991482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604104|NCT02991482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604105|NCT02991482|Antiviral Agents|antiviral agents|mesh-ancestor
65604106|NCT02991482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65604107|NCT02991482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604108|NCT02991482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65604109|NCT02991482|Immunologic Factors|immunologic factors|mesh-ancestor
65604110|NCT02991482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604111|NCT02991482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65604112|NCT02991482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65604113|NCT02991482|Tubulin Modulators|tubulin modulators|mesh-ancestor
65604114|NCT02991482|Antimitotic Agents|antimitotic agents|mesh-ancestor
65604115|NCT02991482|Mitosis Modulators|mitosis modulators|mesh-ancestor
65604116|NCT02391142|Lidocaine|lidocaine|mesh-list
65604117|NCT02391142|Ropivacaine|ropivacaine|mesh-list
65604118|NCT02391142|Anesthetics, Local|anesthetics, local|mesh-ancestor
65604119|NCT02391142|Anesthetics|anesthetics|mesh-ancestor
65604120|NCT02391142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65604121|NCT02391142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604122|NCT02391142|Sensory System Agents|sensory system agents|mesh-ancestor
65604123|NCT02391142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65604124|NCT02391142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65604125|NCT02391142|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65604126|NCT02391142|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65604127|NCT02391142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65604128|NCT02391142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604129|NCT02987972|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65604130|NCT02987972|Immunologic Factors|immunologic factors|mesh-ancestor
65604131|NCT02987972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604132|NCT04479202|Bentonite|bentonite|mesh-list
65604133|NCT04479202|Antidotes|antidotes|mesh-ancestor
65604134|NCT04479202|Protective Agents|protective agents|mesh-ancestor
65604135|NCT04479202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604136|NCT01372618|Pasireotide|pasireotide|mesh-list
65604137|NCT01372618|Hormones|hormones|mesh-ancestor
65604138|NCT01372618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65604139|NCT01372618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604140|NCT03304873|Retapamulin|retapamulin|mesh-list
65604141|NCT03304873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65604142|NCT03304873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65604143|NCT04526509|Cyclophosphamide|cyclophosphamide|mesh-list
65604144|NCT04526509|Fludarabine|fludarabine|mesh-list
65604145|NCT04526509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65604146|NCT04526509|Immunologic Factors|immunologic factors|mesh-ancestor
65604147|NCT04526509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604148|NCT04526509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65604149|NCT04526509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65604150|NCT04526509|Alkylating Agents|alkylating agents|mesh-ancestor
65604151|NCT04526509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604152|NCT04526509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604153|NCT04526509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65604154|NCT03660020|Anesthetics|anesthetics|mesh-list
65604155|NCT03660020|Anesthetics, Local|anesthetics, local|mesh-list
65604156|NCT03660020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65604157|NCT03660020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604158|NCT03660020|Sensory System Agents|sensory system agents|mesh-ancestor
65604159|NCT03660020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65604160|NCT03661892|Dronabinol|dronabinol|mesh-list
65604161|NCT03661892|Hallucinogens|hallucinogens|mesh-ancestor
65604162|NCT03661892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604163|NCT03661892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65604164|NCT03661892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65604165|NCT03661892|Analgesics|analgesics|mesh-ancestor
65604166|NCT03661892|Sensory System Agents|sensory system agents|mesh-ancestor
65401567|NCT02797548|Aspirin|aspirin|mesh-list
65604167|NCT03661892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65604168|NCT03661892|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65604169|NCT03661892|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65604170|NCT03661892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65604171|NCT03661892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604172|NCT03661892|Hormones|hormones|mesh-ancestor
65604173|NCT03661892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65604174|NCT03658850|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65604175|NCT03658850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65604176|NCT03658850|Diuretics|diuretics|mesh-ancestor
65604177|NCT03658850|Natriuretic Agents|natriuretic agents|mesh-ancestor
65604178|NCT03658850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604179|NCT03658850|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65604180|NCT03658850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65604181|NCT03658850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604182|NCT03659162|Antifungal Agents|antifungal agents|mesh-list
65604183|NCT03659162|Clotrimazole|clotrimazole|mesh-list
65604184|NCT03659162|Miconazole|miconazole|mesh-list
65604185|NCT03659162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65604186|NCT03659162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65604187|NCT03659162|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65604188|NCT03659162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65604189|NCT03659162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604190|NCT03659162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604191|NCT03659162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65604192|NCT03659162|Hormone Antagonists|hormone antagonists|mesh-ancestor
65604193|NCT03659162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65604194|NCT03659162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604195|NCT03659162|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65604196|NCT03659162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65604197|NCT03659084|Deferasirox|deferasirox|mesh-list
65604198|NCT03659084|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65604199|NCT03659084|Chelating Agents|chelating agents|mesh-ancestor
65604200|NCT03659084|Sequestering Agents|sequestering agents|mesh-ancestor
65604201|NCT03659084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604202|NCT01068626|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65604203|NCT01068626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65604204|NCT01068626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65604205|NCT01068626|Antimetabolites|antimetabolites|mesh-ancestor
65604206|NCT01068626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604207|NCT01068626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65604208|NCT01068626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65604209|NCT01068626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604210|NCT02921750|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65604211|NCT02921750|Laxatives|laxatives|mesh-ancestor
65604212|NCT02921750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65604213|NCT03657836|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65604214|NCT03657836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65604215|NCT03622502|Dexmedetomidine|dexmedetomidine|mesh-list
65604216|NCT03622502|Remifentanil|remifentanil|mesh-list
65604217|NCT03622502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65604218|NCT03622502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65604219|NCT03622502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604220|NCT03622502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65604221|NCT03622502|Analgesics|analgesics|mesh-ancestor
65604222|NCT03622502|Sensory System Agents|sensory system agents|mesh-ancestor
65604223|NCT03622502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65604224|NCT03622502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65604225|NCT03622502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65604226|NCT03622502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65604227|NCT03622502|Adrenergic Agents|adrenergic agents|mesh-ancestor
65604228|NCT03622502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65604229|NCT03622502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604230|NCT03622502|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65604231|NCT03622502|Narcotics|narcotics|mesh-ancestor
65604232|NCT04397354|Dexamethasone|dexamethasone|mesh-list
65604233|NCT04397354|Dexamethasone acetate|dexamethasone acetate|mesh-list
65604234|NCT04397354|BB 1101|bb 1101|mesh-list
65604235|NCT04397354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65604236|NCT04397354|Antiemetics|antiemetics|mesh-ancestor
65604237|NCT04397354|Autonomic Agents|autonomic agents|mesh-ancestor
65604238|NCT04397354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65604239|NCT04397354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604240|NCT04397354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65604241|NCT04397354|Glucocorticoids|glucocorticoids|mesh-ancestor
65604243|NCT04397354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65604244|NCT04397354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65604245|NCT04397354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604246|NCT04397354|Protease Inhibitors|protease inhibitors|mesh-ancestor
65604247|NCT04397354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604248|NCT04397354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604249|NCT03657758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65604250|NCT03657758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65604251|NCT03657758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65604252|NCT03657758|Antimetabolites|antimetabolites|mesh-ancestor
65248403|NCT00202904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65604253|NCT03657758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604254|NCT03657758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65604255|NCT03657758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65604256|NCT03657758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604257|NCT01068158|Ivermectin|ivermectin|mesh-list
65604258|NCT01068158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65604259|NCT01068158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65604260|NCT03303079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65604261|NCT03303079|Immunologic Factors|immunologic factors|mesh-ancestor
65604262|NCT03303079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604263|NCT01067846|Cycloserine|cycloserine|mesh-list
65604264|NCT01067846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65604265|NCT01067846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65604266|NCT01067846|Renal Agents|renal agents|mesh-ancestor
65604267|NCT01067846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65604268|NCT01067846|Antitubercular Agents|antitubercular agents|mesh-ancestor
65604269|NCT01067846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65604270|NCT01067846|Antimetabolites|antimetabolites|mesh-ancestor
65604271|NCT01067846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604272|NCT03874234|GSK3186899|gsk3186899|mesh-list
65604273|NCT03874234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65604274|NCT03874234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604275|NCT03874234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604276|NCT03657446|Moxifloxacin|moxifloxacin|mesh-list
65604277|NCT03657446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65604278|NCT03657446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65604279|NCT03657446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65604280|NCT03657446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65604281|NCT03657446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604282|NCT03657446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604283|NCT03657446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604284|NCT05276323|Hydrocortisone|hydrocortisone|mesh-list
65604285|NCT05276323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65604286|NCT05275777|Paclitaxel|paclitaxel|mesh-list
65604287|NCT05275777|Cyclophosphamide|cyclophosphamide|mesh-list
65604288|NCT05275777|Doxorubicin|doxorubicin|mesh-list
65604289|NCT05275777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65604290|NCT05275777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604291|NCT05275777|Tubulin Modulators|tubulin modulators|mesh-ancestor
65604292|NCT05275777|Antimitotic Agents|antimitotic agents|mesh-ancestor
65604293|NCT05275777|Mitosis Modulators|mitosis modulators|mesh-ancestor
65604294|NCT05275777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604295|NCT05275777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65604296|NCT05275777|Immunologic Factors|immunologic factors|mesh-ancestor
65604297|NCT05275777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604298|NCT05275777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65604299|NCT05275777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65604300|NCT05275777|Alkylating Agents|alkylating agents|mesh-ancestor
65604301|NCT05275777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65604302|NCT05275777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65604303|NCT05275777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65604304|NCT05275777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65604305|NCT05275777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604306|NCT05275699|Glycine|glycine|mesh-list
65604307|NCT05275699|Glycine Agents|glycine agents|mesh-ancestor
65604308|NCT05275699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65604309|NCT05275699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604310|NCT05275699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604311|NCT05672212|Sufentanil|sufentanil|mesh-list
65604312|NCT05672212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65604313|NCT05672212|Narcotics|narcotics|mesh-ancestor
65604314|NCT05672212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65401714|NCT00090259|Losartan|losartan|mesh-list
65604315|NCT05672212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604316|NCT05672212|Analgesics|analgesics|mesh-ancestor
65604317|NCT05672212|Sensory System Agents|sensory system agents|mesh-ancestor
65604318|NCT05672212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65604319|NCT05672212|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65604320|NCT05672212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65604321|NCT05672212|Anesthetics, General|anesthetics, general|mesh-ancestor
65604322|NCT05672212|Anesthetics|anesthetics|mesh-ancestor
65604323|NCT02390674|Cyclosporine|cyclosporine|mesh-list
65604324|NCT02390674|Cyclosporins|cyclosporins|mesh-list
65604325|NCT02390674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604326|NCT02390674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604327|NCT02390674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65604328|NCT02390674|Immunologic Factors|immunologic factors|mesh-ancestor
65604329|NCT02390674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604330|NCT02390674|Antifungal Agents|antifungal agents|mesh-ancestor
65604331|NCT02390674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65604332|NCT02390674|Dermatologic Agents|dermatologic agents|mesh-ancestor
65604333|NCT02390674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65604334|NCT02390674|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65604335|NCT02390596|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65604336|NCT02390596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65604337|NCT04438382|Prednisone|prednisone|mesh-list
65604338|NCT04438382|Cortisone|cortisone|mesh-list
65604339|NCT04438382|Infliximab|infliximab|mesh-list
65604340|NCT04438382|Immunoglobulins|immunoglobulins|mesh-list
65604341|NCT04438382|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65604342|NCT04438382|Antibodies|antibodies|mesh-list
65604343|NCT04438382|gamma-Globulins|gamma-globulins|mesh-list
65604344|NCT04438382|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65604345|NCT04438382|Immunoglobulin G|immunoglobulin g|mesh-list
65604346|NCT04438382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65604347|NCT04438382|Glucocorticoids|glucocorticoids|mesh-ancestor
65604348|NCT04438382|Hormones|hormones|mesh-ancestor
65604349|NCT04438382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65604350|NCT04438382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604351|NCT04438382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65604352|NCT04438382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604353|NCT04438382|Immunologic Factors|immunologic factors|mesh-ancestor
65604354|NCT04438382|Dermatologic Agents|dermatologic agents|mesh-ancestor
65604355|NCT04438382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65604356|NCT04438382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65604357|NCT02663674|Fluconazole|fluconazole|mesh-list
65604358|NCT02663674|Antifungal Agents|antifungal agents|mesh-ancestor
65604359|NCT02663674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65604360|NCT02663674|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65604361|NCT02663674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65604362|NCT02663674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604363|NCT02663674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604364|NCT02663674|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65604365|NCT02663674|Hormone Antagonists|hormone antagonists|mesh-ancestor
65604366|NCT02663674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65604367|NCT02663674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604368|NCT02663674|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65604369|NCT02663674|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65604370|NCT01005745|Aldesleukin|aldesleukin|mesh-list
65604371|NCT01005745|Interleukin-2|interleukin-2|mesh-list
65604372|NCT01005745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604373|NCT01005745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65604374|NCT01005745|Analgesics|analgesics|mesh-ancestor
65604375|NCT01005745|Sensory System Agents|sensory system agents|mesh-ancestor
65604376|NCT01005745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65604377|NCT01005745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604378|NCT01005745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65604379|NCT01005745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65604380|NCT01005745|Antiviral Agents|antiviral agents|mesh-ancestor
65604381|NCT01005745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65604382|NCT03657212|Zolpidem|zolpidem|mesh-list
65604383|NCT03657212|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65604384|NCT03657212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65604385|NCT03657212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65604386|NCT03657212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604387|NCT03657212|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65604388|NCT03657212|GABA Agonists|gaba agonists|mesh-ancestor
65604389|NCT03657212|GABA Agents|gaba agents|mesh-ancestor
65604390|NCT03657212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65604391|NCT03657212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604392|NCT03310411|Sumatriptan|sumatriptan|mesh-list
65604393|NCT03310411|Lasmiditan|lasmiditan|mesh-list
65604394|NCT03310411|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65604395|NCT03310411|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65604396|NCT03310411|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65604397|NCT03310411|Serotonin Agents|serotonin agents|mesh-ancestor
65604398|NCT03310411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65604399|NCT03310411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604400|NCT03310411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604401|NCT02909504|Lithium Carbonate|lithium carbonate|mesh-list
65604402|NCT02909504|Antidepressive Agents|antidepressive agents|mesh-ancestor
65604403|NCT02909504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65604404|NCT02909504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604405|NCT02909504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604406|NCT02909504|Antimanic Agents|antimanic agents|mesh-ancestor
65604407|NCT02909504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65604408|NCT02909504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65604409|NCT02909504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604410|NCT02390440|Bupivacaine|bupivacaine|mesh-list
65604411|NCT02390440|Anesthetics, Local|anesthetics, local|mesh-ancestor
65604412|NCT02390440|Anesthetics|anesthetics|mesh-ancestor
65604413|NCT02390440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65604414|NCT02390440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604415|NCT02390440|Sensory System Agents|sensory system agents|mesh-ancestor
65604416|NCT02390440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65604417|NCT03677830|Acetaminophen|acetaminophen|mesh-list
65604418|NCT03677830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65604419|NCT03677830|Analgesics|analgesics|mesh-ancestor
65604420|NCT03677830|Sensory System Agents|sensory system agents|mesh-ancestor
65604421|NCT03677830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65604422|NCT03677830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604423|NCT03677830|Antipyretics|antipyretics|mesh-ancestor
65604424|NCT02199691|Vaccines|vaccines|mesh-list
65604425|NCT02199691|Immunologic Factors|immunologic factors|mesh-ancestor
65604426|NCT02199691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604427|NCT05671510|Docetaxel|docetaxel|mesh-list
65604428|NCT05671510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604429|NCT05671510|Tubulin Modulators|tubulin modulators|mesh-ancestor
65604430|NCT05671510|Antimitotic Agents|antimitotic agents|mesh-ancestor
65604431|NCT05671510|Mitosis Modulators|mitosis modulators|mesh-ancestor
65604432|NCT05671510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604433|NCT05667454|Atropine|atropine|mesh-list
65604434|NCT05667454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65604435|NCT05667454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65604436|NCT05667454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65604437|NCT05667454|Autonomic Agents|autonomic agents|mesh-ancestor
65604438|NCT05667454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65604439|NCT05667454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604440|NCT05667454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65604441|NCT05667454|Respiratory System Agents|respiratory system agents|mesh-ancestor
65604442|NCT05667454|Mydriatics|mydriatics|mesh-ancestor
65604443|NCT05667454|Parasympatholytics|parasympatholytics|mesh-ancestor
65604444|NCT05667454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65604445|NCT05667454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65604446|NCT05667454|Cholinergic Agents|cholinergic agents|mesh-ancestor
65604447|NCT05667454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65604448|NCT05667454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604449|NCT02389972|Dasatinib|dasatinib|mesh-list
65604450|NCT02389972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604451|NCT02389972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65604452|NCT02389972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604453|NCT02389972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604454|NCT03502330|Nivolumab|nivolumab|mesh-list
65604455|NCT03502330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65604456|NCT03502330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604457|NCT03502330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65604458|NCT03502330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604459|NCT03495232|Cimetidine|cimetidine|mesh-list
65604460|NCT03495232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65604461|NCT03495232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65604462|NCT03495232|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65604463|NCT03495232|Histamine Antagonists|histamine antagonists|mesh-ancestor
65604464|NCT03495232|Histamine Agents|histamine agents|mesh-ancestor
65604465|NCT03495232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65604466|NCT03495232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604467|NCT03495232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604468|NCT03495232|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65604469|NCT03495232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65604470|NCT03495232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604472|NCT02389582|Dabigatran|dabigatran|mesh-list
65604473|NCT02389582|Anticoagulants|anticoagulants|mesh-ancestor
65604474|NCT02389582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65604475|NCT02389582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65604476|NCT02389582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604477|NCT02389582|Antithrombins|antithrombins|mesh-ancestor
65604478|NCT02389582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65604479|NCT02389582|Protease Inhibitors|protease inhibitors|mesh-ancestor
65604480|NCT02389582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604481|NCT02389426|Bosentan|bosentan|mesh-list
65604482|NCT02389426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65604483|NCT02389426|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65604484|NCT02389426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604485|NCT02389348|Artefenomel|artefenomel|mesh-list
65604486|NCT02389348|Antimalarials|antimalarials|mesh-ancestor
65604487|NCT02389348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65604488|NCT02389348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65604489|NCT02389348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65604490|NCT02387242|Rifampin|rifampin|mesh-list
65604491|NCT02387242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65604492|NCT02387242|Antitubercular Agents|antitubercular agents|mesh-ancestor
65604493|NCT02387242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65604494|NCT02387242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65604495|NCT02387242|Leprostatic Agents|leprostatic agents|mesh-ancestor
65604496|NCT02387242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65604497|NCT02387242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604498|NCT02387242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604499|NCT02387242|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65604500|NCT02387242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65604501|NCT02387242|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65604502|NCT02387242|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65604503|NCT02387242|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65604504|NCT02387242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65604505|NCT03656588|Iodine|iodine|mesh-list
65604506|NCT03656588|Chlorhexidine|chlorhexidine|mesh-list
65604507|NCT03656588|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65604508|NCT03656588|Cadexomer iodine|cadexomer iodine|mesh-list
65604509|NCT03656588|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65604510|NCT03656588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65604511|NCT03656588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65604512|NCT03656588|Disinfectants|disinfectants|mesh-ancestor
65604513|NCT03656588|Dermatologic Agents|dermatologic agents|mesh-ancestor
65604514|NCT03656588|Trace Elements|trace elements|mesh-ancestor
65604515|NCT03656588|Micronutrients|micronutrients|mesh-ancestor
65604516|NCT03656588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604517|NCT02387086|Aspirin|aspirin|mesh-list
65604518|NCT02387086|Thalidomide|thalidomide|mesh-list
65604519|NCT02387086|Gefitinib|gefitinib|mesh-list
65604520|NCT02387086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65604521|NCT02387086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65604522|NCT02387086|Analgesics|analgesics|mesh-ancestor
65604523|NCT02387086|Sensory System Agents|sensory system agents|mesh-ancestor
65604524|NCT02387086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65604525|NCT02387086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604526|NCT02387086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65604527|NCT02387086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65604528|NCT02387086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65604529|NCT02387086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65604530|NCT02387086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604531|NCT02387086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65604532|NCT02387086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65604533|NCT02387086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604534|NCT02387086|Antipyretics|antipyretics|mesh-ancestor
65604535|NCT02387086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65604536|NCT02387086|Immunologic Factors|immunologic factors|mesh-ancestor
65604537|NCT02387086|Leprostatic Agents|leprostatic agents|mesh-ancestor
65604538|NCT02387086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65604539|NCT02387086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65604540|NCT02387086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65604541|NCT02387086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65604543|NCT02387086|Growth Inhibitors|growth inhibitors|mesh-ancestor
65604544|NCT02387086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604545|NCT02387086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65604546|NCT02383030|Fulvestrant|fulvestrant|mesh-list
65604547|NCT02383030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65604548|NCT02383030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604549|NCT02383030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65604550|NCT02383030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65604551|NCT02383030|Hormone Antagonists|hormone antagonists|mesh-ancestor
65604552|NCT02383030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65604553|NCT02383030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604554|NCT02388802|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65604555|NCT02388802|Immunologic Factors|immunologic factors|mesh-ancestor
65604556|NCT02388802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604557|NCT02983604|Fulvestrant|fulvestrant|mesh-list
65604558|NCT02983604|Exemestane|exemestane|mesh-list
65604559|NCT02983604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65604560|NCT02983604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604561|NCT02983604|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65604562|NCT02983604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65604563|NCT02983604|Hormone Antagonists|hormone antagonists|mesh-ancestor
65604564|NCT02983604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65604565|NCT02983604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604566|NCT02983604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65604567|NCT02983604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65604568|NCT02983604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604569|NCT02983604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604570|NCT03656432|Fluorides|fluorides|mesh-list
65604571|NCT03656432|Cariostatic Agents|cariostatic agents|mesh-ancestor
65604572|NCT03656432|Protective Agents|protective agents|mesh-ancestor
65604573|NCT03656432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604574|NCT02386462|Dexmedetomidine|dexmedetomidine|mesh-list
65604575|NCT02386462|Propofol|propofol|mesh-list
65604576|NCT02386462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65604577|NCT02386462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65604578|NCT02386462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604579|NCT02386462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65604580|NCT02386462|Anesthetics, General|anesthetics, general|mesh-ancestor
65604581|NCT02386462|Anesthetics|anesthetics|mesh-ancestor
65604582|NCT02386462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65604583|NCT02386462|Analgesics|analgesics|mesh-ancestor
65604584|NCT02386462|Sensory System Agents|sensory system agents|mesh-ancestor
65604585|NCT02386462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65604586|NCT02386462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65604587|NCT02386462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65604588|NCT02386462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65604589|NCT02386462|Adrenergic Agents|adrenergic agents|mesh-ancestor
65604590|NCT02386462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65604591|NCT02386462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604592|NCT02382328|Thioctic Acid|thioctic acid|mesh-list
65604593|NCT02382328|Antioxidants|antioxidants|mesh-ancestor
65604594|NCT02382328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604595|NCT02382328|Protective Agents|protective agents|mesh-ancestor
65604596|NCT02382328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604597|NCT02382328|Vitamin B Complex|vitamin b complex|mesh-ancestor
65604598|NCT02382328|Vitamins|vitamins|mesh-ancestor
65604599|NCT02382328|Micronutrients|micronutrients|mesh-ancestor
65604600|NCT02388490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65604601|NCT02388490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65604602|NCT02388490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604603|NCT02382094|Bicalutamide|bicalutamide|mesh-list
65604604|NCT02382094|Androgen Antagonists|androgen antagonists|mesh-ancestor
65604605|NCT02382094|Hormone Antagonists|hormone antagonists|mesh-ancestor
65604606|NCT02382094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65604607|NCT02382094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604608|NCT02382094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604609|NCT02386150|Vaccines|vaccines|mesh-list
65604610|NCT02386150|Immunologic Factors|immunologic factors|mesh-ancestor
65604611|NCT02386150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604612|NCT02377180|Anesthetics|anesthetics|mesh-list
65604613|NCT02377180|Anesthetics, Local|anesthetics, local|mesh-list
65604614|NCT02377180|Capsaicin|capsaicin|mesh-list
65604615|NCT02377180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65604616|NCT02377180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604617|NCT02377180|Sensory System Agents|sensory system agents|mesh-ancestor
65604618|NCT02377180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65604619|NCT02377180|Antipruritics|antipruritics|mesh-ancestor
65604620|NCT02377180|Dermatologic Agents|dermatologic agents|mesh-ancestor
65604621|NCT04364048|Cisplatin|cisplatin|mesh-list
65604622|NCT04364048|Carboplatin|carboplatin|mesh-list
65604623|NCT04364048|Etoposide|etoposide|mesh-list
65604624|NCT04364048|Pemetrexed|pemetrexed|mesh-list
65604625|NCT04364048|Durvalumab|durvalumab|mesh-list
65604626|NCT04364048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65604627|NCT04364048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604628|NCT04364048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65604629|NCT04364048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65604630|NCT04364048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65604631|NCT04364048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604632|NCT04364048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604633|NCT04364048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65604634|NCT04364048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65604635|NCT04364048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65604636|NCT04364048|Immunologic Factors|immunologic factors|mesh-ancestor
65604637|NCT04364048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604638|NCT03656042|Lenograstim|lenograstim|mesh-list
65604639|NCT03656042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65604640|NCT03656042|Immunologic Factors|immunologic factors|mesh-ancestor
65604641|NCT03656042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604642|NCT03655964|Olmesartan|olmesartan|mesh-list
65604643|NCT03655964|Nebivolol|nebivolol|mesh-list
65604644|NCT03655964|Antihypertensive Agents|antihypertensive agents|mesh-list
65604645|NCT03655964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65604646|NCT03655964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65604647|NCT03655964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604648|NCT03655964|Vasodilator Agents|vasodilator agents|mesh-ancestor
65604649|NCT03655964|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65604650|NCT03655964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65604651|NCT03655964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65604652|NCT03655964|Adrenergic Agents|adrenergic agents|mesh-ancestor
65604653|NCT03655964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65604654|NCT03655964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604655|NCT02982590|Warfarin|warfarin|mesh-list
65604656|NCT02982590|Apixaban|apixaban|mesh-list
65604657|NCT02982590|Anticoagulants|anticoagulants|mesh-ancestor
65604658|NCT02982590|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65604659|NCT02982590|Antithrombins|antithrombins|mesh-ancestor
65604660|NCT02982590|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65604661|NCT02982590|Protease Inhibitors|protease inhibitors|mesh-ancestor
65604662|NCT02982590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604663|NCT02982590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604664|NCT02381548|Belinostat|belinostat|mesh-list
65604665|NCT02381548|Adavosertib|adavosertib|mesh-list
65604666|NCT02381548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604667|NCT02381548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604668|NCT02381548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604669|NCT02381548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65604670|NCT02381314|Ipilimumab|ipilimumab|mesh-list
65604671|NCT02381314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65604672|NCT02381314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604673|NCT02381314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65604674|NCT02381314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604675|NCT04282018|Zanubrutinib|zanubrutinib|mesh-list
65604676|NCT04282018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604677|NCT04282018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65604678|NCT04282018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604679|NCT04282018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604680|NCT02386072|Mirabegron|mirabegron|mesh-list
65604681|NCT02386072|Oxybutynin|oxybutynin|mesh-list
65604682|NCT02386072|Muscarinic Antagonists|muscarinic antagonists|mesh-list
65604683|NCT02386072|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65604684|NCT02386072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65604685|NCT02386072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65402086|NCT00979160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604686|NCT02386072|Adrenergic Agents|adrenergic agents|mesh-ancestor
65604687|NCT02386072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65604688|NCT02386072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604689|NCT02386072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604690|NCT02386072|Urological Agents|urological agents|mesh-ancestor
65604691|NCT02386072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65604692|NCT02386072|Cholinergic Agents|cholinergic agents|mesh-ancestor
65604693|NCT02386072|Parasympatholytics|parasympatholytics|mesh-ancestor
65604694|NCT02386072|Autonomic Agents|autonomic agents|mesh-ancestor
65604695|NCT02386072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65604696|NCT03655730|Psychotropic Drugs|psychotropic drugs|mesh-list
65604697|NCT02381470|Amoxicillin|amoxicillin|mesh-list
65604698|NCT02381470|Rifampin|rifampin|mesh-list
65604699|NCT02381470|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65604700|NCT02381470|Clavulanic Acids|clavulanic acids|mesh-list
65604701|NCT02381470|Clavulanic Acid|clavulanic acid|mesh-list
65604702|NCT02381470|Cefadroxil|cefadroxil|mesh-list
65604703|NCT02381470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65604704|NCT02381470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65604705|NCT02381470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65604706|NCT02381470|Antitubercular Agents|antitubercular agents|mesh-ancestor
65604707|NCT02381470|Leprostatic Agents|leprostatic agents|mesh-ancestor
65604708|NCT02381470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65604709|NCT02381470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604710|NCT02381470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604711|NCT02381470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65604712|NCT02381470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65604713|NCT02381470|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65604714|NCT02381470|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65604715|NCT02381470|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65604716|NCT02381470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65604717|NCT02381470|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65604718|NCT02381158|Beclomethasone|beclomethasone|mesh-list
65604719|NCT02381158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65604720|NCT02381158|Glucocorticoids|glucocorticoids|mesh-ancestor
65604721|NCT02381158|Hormones|hormones|mesh-ancestor
65604722|NCT02381158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65604723|NCT02381158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604724|NCT02381158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65604725|NCT02381158|Respiratory System Agents|respiratory system agents|mesh-ancestor
65604726|NCT04190056|Tamoxifen|tamoxifen|mesh-list
65604727|NCT04190056|Pembrolizumab|pembrolizumab|mesh-list
65604728|NCT04190056|Vorinostat|vorinostat|mesh-list
65604729|NCT04190056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65604730|NCT04190056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604731|NCT04190056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65604732|NCT04190056|Hormone Antagonists|hormone antagonists|mesh-ancestor
65604733|NCT04190056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65604734|NCT04190056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604735|NCT04190056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65604736|NCT04190056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65604737|NCT04190056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65604738|NCT04190056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65604739|NCT04190056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65604740|NCT04190056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604741|NCT04190056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604742|NCT02381080|Voriconazole|voriconazole|mesh-list
65604743|NCT02381080|Erythromycin|erythromycin|mesh-list
65604744|NCT02381080|Erythromycin Estolate|erythromycin estolate|mesh-list
65604745|NCT02381080|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65604746|NCT02381080|Erythromycin stearate|erythromycin stearate|mesh-list
65604747|NCT02381080|Antifungal Agents|antifungal agents|mesh-ancestor
65604748|NCT02381080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65604749|NCT02381080|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65604750|NCT02381080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65604751|NCT02381080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604752|NCT02381080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604753|NCT02381080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65604754|NCT02381080|Hormone Antagonists|hormone antagonists|mesh-ancestor
65604755|NCT02381080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65604756|NCT02381080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604757|NCT02381080|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65604758|NCT02381080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65604759|NCT02381080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65402155|NCT00984386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65604760|NCT02381080|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65604761|NCT04694248|Aspirin|aspirin|mesh-list
65604762|NCT04694248|Rivaroxaban|rivaroxaban|mesh-list
65604763|NCT04694248|Anticoagulants|anticoagulants|mesh-list
65604764|NCT04694248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65604765|NCT04694248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65604766|NCT04694248|Analgesics|analgesics|mesh-ancestor
65604767|NCT04694248|Sensory System Agents|sensory system agents|mesh-ancestor
65604768|NCT04694248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65604769|NCT04694248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604770|NCT04694248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65604771|NCT04694248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65604772|NCT04694248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65248404|NCT00202904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65604773|NCT04694248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65604774|NCT04694248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604775|NCT04694248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65604776|NCT04694248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65604777|NCT04694248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604778|NCT04694248|Antipyretics|antipyretics|mesh-ancestor
65604779|NCT04694248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65604780|NCT04694248|Antithrombins|antithrombins|mesh-ancestor
65604781|NCT04694248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65604782|NCT04694248|Protease Inhibitors|protease inhibitors|mesh-ancestor
65604783|NCT02376478|Folic Acid|folic acid|mesh-list
65604784|NCT02376478|Sulfasalazine|sulfasalazine|mesh-list
65604785|NCT02376478|Adalimumab|adalimumab|mesh-list
65604786|NCT02376478|Etanercept|etanercept|mesh-list
65604787|NCT02376478|Methotrexate|methotrexate|mesh-list
65604788|NCT02376478|Mercaptopurine|mercaptopurine|mesh-list
65604789|NCT02376478|Infliximab|infliximab|mesh-list
65604790|NCT02376478|Folic Acid Antagonists|folic acid antagonists|mesh-list
65604791|NCT02376478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65604792|NCT02376478|Abortifacient Agents|abortifacient agents|mesh-ancestor
65604793|NCT02376478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65604794|NCT02376478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604795|NCT02376478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65604796|NCT02376478|Antimetabolites|antimetabolites|mesh-ancestor
65604797|NCT02376478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604798|NCT02376478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604799|NCT02376478|Dermatologic Agents|dermatologic agents|mesh-ancestor
65604800|NCT02376478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604801|NCT02376478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65604802|NCT02376478|Immunologic Factors|immunologic factors|mesh-ancestor
65604803|NCT02376478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65604804|NCT02376478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65604805|NCT02376478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65604806|NCT02376478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65604807|NCT02376478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65604808|NCT02376478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65604809|NCT02376478|Analgesics|analgesics|mesh-ancestor
65604810|NCT02376478|Sensory System Agents|sensory system agents|mesh-ancestor
65604811|NCT02376478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65604812|NCT02376478|Hematinics|hematinics|mesh-ancestor
65604813|NCT02376478|Vitamin B Complex|vitamin b complex|mesh-ancestor
65604814|NCT02376478|Vitamins|vitamins|mesh-ancestor
65604815|NCT02376478|Micronutrients|micronutrients|mesh-ancestor
65604816|NCT02376478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65604817|NCT02385448|Dienogest|dienogest|mesh-list
65604818|NCT02385448|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
65604819|NCT02385448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65604820|NCT02385448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65604821|NCT02385448|Contraceptive Agents|contraceptive agents|mesh-ancestor
65604822|NCT02385448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65604823|NCT02385448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604824|NCT02385448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65604825|NCT02385448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65604826|NCT02385448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65604827|NCT02385448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65604828|NCT02385448|Hormone Antagonists|hormone antagonists|mesh-ancestor
65604829|NCT02385448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65604830|NCT02385448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65604831|NCT02385448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604832|NCT02385448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65604833|NCT02385448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65604834|NCT02385448|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
65604835|NCT02385448|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65604836|NCT02385448|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65604837|NCT02385058|Mebendazole|mebendazole|mesh-list
65604838|NCT02385058|Piperazine|piperazine|mesh-list
65604839|NCT02385058|Piperazine citrate|piperazine citrate|mesh-list
65604840|NCT02385058|DMP 777|dmp 777|mesh-list
65604841|NCT02385058|Antinematodal Agents|antinematodal agents|mesh-ancestor
65604842|NCT02385058|Anthelmintics|anthelmintics|mesh-ancestor
65604843|NCT02385058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65604844|NCT02385058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65604845|NCT02385058|Tubulin Modulators|tubulin modulators|mesh-ancestor
65604846|NCT02385058|Antimitotic Agents|antimitotic agents|mesh-ancestor
65604847|NCT02385058|Mitosis Modulators|mitosis modulators|mesh-ancestor
65248405|NCT00202904|Antimetabolites|antimetabolites|mesh-ancestor
65604848|NCT02385058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604849|NCT02385058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604850|NCT02385058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604851|NCT02376088|Methimazole|methimazole|mesh-list
65604852|NCT02376088|Antithyroid Agents|antithyroid agents|mesh-ancestor
65604853|NCT02376088|Hormone Antagonists|hormone antagonists|mesh-ancestor
65604854|NCT02376088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65604855|NCT02376088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604856|NCT03310021|Rivaroxaban|rivaroxaban|mesh-list
65604857|NCT03310021|Apixaban|apixaban|mesh-list
65604858|NCT03310021|Edoxaban|edoxaban|mesh-list
65604859|NCT03310021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65604860|NCT03310021|Antithrombins|antithrombins|mesh-ancestor
65604861|NCT03310021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65604862|NCT03310021|Protease Inhibitors|protease inhibitors|mesh-ancestor
65604863|NCT03310021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604864|NCT03310021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604865|NCT03310021|Anticoagulants|anticoagulants|mesh-ancestor
65604866|NCT03333109|Erenumab|erenumab|mesh-list
65604867|NCT03333109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65604868|NCT03333109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604869|NCT03333109|Analgesics|analgesics|mesh-ancestor
65604870|NCT03333109|Sensory System Agents|sensory system agents|mesh-ancestor
65604871|NCT03333109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65604872|NCT03333109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604873|NCT02940223|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
65604874|NCT02940223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65604875|NCT02940223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65604876|NCT01312831|Vitamin B 12|vitamin b 12|mesh-list
65604877|NCT01312831|Hydroxocobalamin|hydroxocobalamin|mesh-list
65604878|NCT01312831|Vitamins|vitamins|mesh-ancestor
65604879|NCT01312831|Micronutrients|micronutrients|mesh-ancestor
65604880|NCT01312831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604881|NCT01312831|Vitamin B Complex|vitamin b complex|mesh-ancestor
65604882|NCT01312831|Hematinics|hematinics|mesh-ancestor
65604883|NCT03296527|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65604884|NCT03296527|Hormones|hormones|mesh-ancestor
65604885|NCT03296527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65604886|NCT03296527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604887|NCT04431193|Oxytocin|oxytocin|mesh-list
65604888|NCT04431193|Oxytocics|oxytocics|mesh-ancestor
65604889|NCT04431193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65604890|NCT04431193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604891|NCT03293485|Imipenem|imipenem|mesh-list
65604892|NCT03293485|Relebactam|relebactam|mesh-list
65604893|NCT03293485|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
65604894|NCT03293485|Cilastatin|cilastatin|mesh-list
65604895|NCT03293485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65604896|NCT03293485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65604897|NCT03293485|Protease Inhibitors|protease inhibitors|mesh-ancestor
65604898|NCT03293485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604899|NCT03293485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604900|NCT03293485|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65604901|NCT03309943|Propranolol|propranolol|mesh-list
65604902|NCT03309943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65604903|NCT03309943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65604904|NCT03309943|Adrenergic Agents|adrenergic agents|mesh-ancestor
65604905|NCT03309943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65604906|NCT03309943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604907|NCT03309943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604908|NCT03309943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65604909|NCT03309943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65604910|NCT03309943|Vasodilator Agents|vasodilator agents|mesh-ancestor
65604911|NCT01732627|Vaccines|vaccines|mesh-list
65604912|NCT01732627|Immunologic Factors|immunologic factors|mesh-ancestor
65604913|NCT01732627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604914|NCT04296799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65604915|NCT03331315|Celecoxib|celecoxib|mesh-list
65604916|NCT03331315|Ketorolac|ketorolac|mesh-list
65604917|NCT03331315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65604918|NCT03331315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65604919|NCT03331315|Analgesics|analgesics|mesh-ancestor
65604920|NCT03331315|Sensory System Agents|sensory system agents|mesh-ancestor
65604921|NCT03331315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65604922|NCT03331315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604923|NCT03331315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65604924|NCT03331315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65604925|NCT03331315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65604926|NCT03331315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65604927|NCT03331315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604928|NCT03331315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604929|NCT03287869|Brexpiprazole|brexpiprazole|mesh-list
65604930|NCT03287869|Serotonin Agents|serotonin agents|mesh-ancestor
65604931|NCT03287869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65604932|NCT03287869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604933|NCT03287869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604934|NCT03287869|Dopamine Agonists|dopamine agonists|mesh-ancestor
65604935|NCT03287869|Dopamine Agents|dopamine agents|mesh-ancestor
65604936|NCT02661490|Vaccines|vaccines|mesh-list
65604937|NCT02661490|Immunologic Factors|immunologic factors|mesh-ancestor
65604938|NCT02661490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604939|NCT03287791|Azelaic acid|azelaic acid|mesh-list
65604940|NCT03287791|Sunscreening Agents|sunscreening agents|mesh-list
65604941|NCT03287791|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65604942|NCT03287791|Protective Agents|protective agents|mesh-ancestor
65604943|NCT03287791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604944|NCT03287791|Dermatologic Agents|dermatologic agents|mesh-ancestor
65604945|NCT03287791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604946|NCT03287635|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65604947|NCT03287635|Hormones|hormones|mesh-ancestor
65604948|NCT03287635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65604949|NCT03287635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604950|NCT03287089|Nitrofurantoin|nitrofurantoin|mesh-list
65604951|NCT03287089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65604952|NCT03287089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65604953|NCT03287089|Renal Agents|renal agents|mesh-ancestor
65604954|NCT03287089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65604955|NCT02380768|Chlorhexidine|chlorhexidine|mesh-list
65604956|NCT02380768|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65604957|NCT02380768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65604958|NCT02380768|Disinfectants|disinfectants|mesh-ancestor
65604959|NCT02385136|Temozolomide|temozolomide|mesh-list
65604960|NCT02385136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65604961|NCT02385136|Alkylating Agents|alkylating agents|mesh-ancestor
65604962|NCT02385136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604963|NCT02385136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604964|NCT04927780|Leucovorin|leucovorin|mesh-list
65604965|NCT04927780|Fluorouracil|fluorouracil|mesh-list
65604966|NCT04927780|Oxaliplatin|oxaliplatin|mesh-list
65604967|NCT04927780|Irinotecan|irinotecan|mesh-list
65604968|NCT04927780|Calcium|calcium|mesh-list
65604969|NCT04927780|Levoleucovorin|levoleucovorin|mesh-list
65604970|NCT04927780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65604971|NCT04927780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65604972|NCT04927780|Antimetabolites|antimetabolites|mesh-ancestor
65604973|NCT04927780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65604974|NCT04927780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65604975|NCT04927780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65604976|NCT04927780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65604977|NCT04927780|Immunologic Factors|immunologic factors|mesh-ancestor
65604978|NCT04927780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65604979|NCT04927780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65604980|NCT04927780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65604981|NCT04927780|Antidotes|antidotes|mesh-ancestor
65604982|NCT04927780|Protective Agents|protective agents|mesh-ancestor
65604983|NCT04927780|Vitamin B Complex|vitamin b complex|mesh-ancestor
65604984|NCT04927780|Vitamins|vitamins|mesh-ancestor
65604985|NCT04927780|Micronutrients|micronutrients|mesh-ancestor
65604986|NCT02940691|Grazoprevir|grazoprevir|mesh-list
65604987|NCT02940691|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65604988|NCT02940691|Antiviral Agents|antiviral agents|mesh-ancestor
65604989|NCT02940691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65604991|NCT04949269|Famotidine|famotidine|mesh-list
65604992|NCT04949269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65604993|NCT04949269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65604994|NCT04949269|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65604995|NCT04949269|Histamine Antagonists|histamine antagonists|mesh-ancestor
65604996|NCT04949269|Histamine Agents|histamine agents|mesh-ancestor
65604997|NCT04949269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65604998|NCT04949269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500187|NCT02613169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65604999|NCT04949269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605000|NCT04949269|Dermatologic Agents|dermatologic agents|mesh-ancestor
65605001|NCT04949269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65605002|NCT04949269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605003|NCT02379754|Gentamicins|gentamicins|mesh-list
65605004|NCT02379754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65605005|NCT02379754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605006|NCT02379754|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65605007|NCT02379754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605008|NCT02379754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605009|NCT04914793|Anti-Infective Agents|anti-infective agents|mesh-list
65605010|NCT04914793|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65605011|NCT01313377|Gemcitabine|gemcitabine|mesh-list
65605012|NCT01313377|Oxaliplatin|oxaliplatin|mesh-list
65605013|NCT01313377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65605014|NCT01313377|Antimetabolites|antimetabolites|mesh-ancestor
65605015|NCT01313377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605016|NCT01313377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605017|NCT01313377|Antiviral Agents|antiviral agents|mesh-ancestor
65605018|NCT01313377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605019|NCT01313377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605020|NCT01313377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65605021|NCT01313377|Immunologic Factors|immunologic factors|mesh-ancestor
65605022|NCT01313377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605023|NCT02384746|Fulvestrant|fulvestrant|mesh-list
65605024|NCT02384746|Ixazomib|ixazomib|mesh-list
65605025|NCT02384746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65605026|NCT02384746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605027|NCT02384746|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65605028|NCT02384746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65605029|NCT02384746|Hormone Antagonists|hormone antagonists|mesh-ancestor
65605030|NCT02384746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65605031|NCT02384746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605032|NCT02384746|Protease Inhibitors|protease inhibitors|mesh-ancestor
65605033|NCT02384746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605034|NCT02384746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605035|NCT02375464|Octreotide|octreotide|mesh-list
65605036|NCT02375464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65605037|NCT02375464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65605038|NCT02375464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605039|NCT03113344|Amoxicillin|amoxicillin|mesh-list
65605040|NCT03113344|Azithromycin|azithromycin|mesh-list
65605041|NCT03113344|Meropenem|meropenem|mesh-list
65605042|NCT03113344|Ceftriaxone|ceftriaxone|mesh-list
65605043|NCT03113344|Penicillins|penicillins|mesh-list
65605044|NCT03113344|Imipenem|imipenem|mesh-list
65605045|NCT03113344|Erythromycin|erythromycin|mesh-list
65605046|NCT03113344|Ceftazidime|ceftazidime|mesh-list
65605047|NCT03113344|Ampicillin|ampicillin|mesh-list
65605048|NCT03113344|Cephalosporins|cephalosporins|mesh-list
65605049|NCT03113344|Acyclovir|acyclovir|mesh-list
65605050|NCT03113344|Ganciclovir|ganciclovir|mesh-list
65605051|NCT03113344|Antiviral Agents|antiviral agents|mesh-list
65605052|NCT03113344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65605053|NCT03113344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605054|NCT03113344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605055|NCT03113344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605056|NCT03113344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65605057|NCT03113344|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65605058|NCT03113266|Antibodies|antibodies|mesh-list
65605059|NCT03113266|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65605060|NCT03113266|Immunologic Factors|immunologic factors|mesh-ancestor
65605061|NCT03113266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605062|NCT02379676|Clopidogrel|clopidogrel|mesh-list
65605063|NCT02379676|Ticagrelor|ticagrelor|mesh-list
65605064|NCT02379676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65605065|NCT02379676|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65605066|NCT02379676|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65605067|NCT02379676|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65605068|NCT02379676|Purinergic Agents|purinergic agents|mesh-ancestor
65605069|NCT02379676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65605070|NCT02379676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605071|NCT02379676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605072|NCT04715230|Lorazepam|lorazepam|mesh-list
65605073|NCT04715230|Haloperidol|haloperidol|mesh-list
65605074|NCT04715230|Haloperidol decanoate|haloperidol decanoate|mesh-list
65605075|NCT04715230|Antiemetics|antiemetics|mesh-ancestor
65605076|NCT04715230|Autonomic Agents|autonomic agents|mesh-ancestor
65605077|NCT04715230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65605078|NCT04715230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605079|NCT04715230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65605080|NCT04715230|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65605081|NCT04715230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65605082|NCT04715230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65605083|NCT04715230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65605084|NCT04715230|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65605085|NCT04715230|Dopamine Agents|dopamine agents|mesh-ancestor
65605086|NCT04715230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65605087|NCT04715230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605088|NCT04715230|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65605089|NCT04715230|Anticonvulsants|anticonvulsants|mesh-ancestor
65605090|NCT04715230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65605091|NCT04715230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65605092|NCT04715230|GABA Modulators|gaba modulators|mesh-ancestor
65605093|NCT04715230|GABA Agents|gaba agents|mesh-ancestor
65605094|NCT02384122|Octreotide|octreotide|mesh-list
65605095|NCT02384122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65605096|NCT02384122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65605097|NCT02384122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605098|NCT02378740|Ketamine|ketamine|mesh-list
65605099|NCT02378740|Analgesics|analgesics|mesh-ancestor
65605100|NCT02378740|Sensory System Agents|sensory system agents|mesh-ancestor
65605101|NCT02378740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65605102|NCT02378740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605103|NCT02378740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65605104|NCT02378740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65605105|NCT02378740|Anesthetics, General|anesthetics, general|mesh-ancestor
65605106|NCT02378740|Anesthetics|anesthetics|mesh-ancestor
65605107|NCT02378740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65605108|NCT02378740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65605109|NCT02378740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65605110|NCT02378740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65605111|NCT02378740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605112|NCT01411267|Cytarabine|cytarabine|mesh-list
65605113|NCT01411267|Methotrexate|methotrexate|mesh-list
65605114|NCT01411267|Etoposide|etoposide|mesh-list
65605115|NCT01411267|Etoposide phosphate|etoposide phosphate|mesh-list
65605116|NCT01411267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65605117|NCT01411267|Abortifacient Agents|abortifacient agents|mesh-ancestor
65605118|NCT01411267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65605119|NCT01411267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605120|NCT01411267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65605121|NCT01411267|Antimetabolites|antimetabolites|mesh-ancestor
65605122|NCT01411267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605123|NCT01411267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605124|NCT01411267|Dermatologic Agents|dermatologic agents|mesh-ancestor
65605125|NCT01411267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605126|NCT01411267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65605127|NCT01411267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65605128|NCT01411267|Immunologic Factors|immunologic factors|mesh-ancestor
65605129|NCT01411267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65605130|NCT01411267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65605131|NCT01411267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65605132|NCT01411267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65605133|NCT01411267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65605134|NCT01411267|Antiviral Agents|antiviral agents|mesh-ancestor
65605135|NCT01411267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605136|NCT03113110|Empagliflozin|empagliflozin|mesh-list
65605137|NCT03113110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65605138|NCT03113110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605139|NCT03113110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65402530|NCT00748787|Psyllium|psyllium|mesh-list
65605140|NCT03113110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605141|NCT04828486|Pembrolizumab|pembrolizumab|mesh-list
65605142|NCT04828486|Futibatinib|futibatinib|mesh-list
65605143|NCT04828486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65605144|NCT04828486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605145|NCT02378428|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65605146|NCT02378428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605147|NCT02378428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605148|NCT02378428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605149|NCT02378428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65605150|NCT02383888|BI 425809|bi 425809|mesh-list
65605151|NCT02383888|Nootropic Agents|nootropic agents|mesh-ancestor
65605152|NCT02377960|Antihypertensive Agents|antihypertensive agents|mesh-list
65605153|NCT03130959|Nivolumab|nivolumab|mesh-list
65605154|NCT03130959|Ipilimumab|ipilimumab|mesh-list
65605155|NCT03130959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65605156|NCT03130959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605157|NCT03130959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65605158|NCT03130959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605159|NCT04553692|Leucovorin|leucovorin|mesh-list
65605160|NCT04553692|Gemcitabine|gemcitabine|mesh-list
65605161|NCT04553692|Bevacizumab|bevacizumab|mesh-list
65605162|NCT04553692|Docetaxel|docetaxel|mesh-list
65605163|NCT04553692|Fluorouracil|fluorouracil|mesh-list
65605164|NCT04553692|Irinotecan|irinotecan|mesh-list
65605165|NCT04553692|Azacitidine|azacitidine|mesh-list
65605166|NCT04553692|Venetoclax|venetoclax|mesh-list
65605167|NCT04553692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65605168|NCT04553692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605169|NCT04553692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65605170|NCT04553692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65605171|NCT04553692|Growth Substances|growth substances|mesh-ancestor
65605172|NCT04553692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605173|NCT04553692|Growth Inhibitors|growth inhibitors|mesh-ancestor
65605174|NCT04553692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65605175|NCT04553692|Antimetabolites|antimetabolites|mesh-ancestor
65605176|NCT04553692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605177|NCT04553692|Antiviral Agents|antiviral agents|mesh-ancestor
65605178|NCT04553692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605179|NCT04553692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605180|NCT04553692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65605181|NCT04553692|Immunologic Factors|immunologic factors|mesh-ancestor
65605182|NCT04553692|Tubulin Modulators|tubulin modulators|mesh-ancestor
65605183|NCT04553692|Antimitotic Agents|antimitotic agents|mesh-ancestor
65605184|NCT04553692|Mitosis Modulators|mitosis modulators|mesh-ancestor
65605185|NCT04553692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65605186|NCT04553692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65605187|NCT04553692|Antidotes|antidotes|mesh-ancestor
65605188|NCT04553692|Protective Agents|protective agents|mesh-ancestor
65605189|NCT04553692|Vitamin B Complex|vitamin b complex|mesh-ancestor
65605190|NCT04553692|Vitamins|vitamins|mesh-ancestor
65605191|NCT04553692|Micronutrients|micronutrients|mesh-ancestor
65605192|NCT01370031|Charcoal|charcoal|mesh-list
65605193|NCT01370031|Antidotes|antidotes|mesh-ancestor
65605194|NCT01370031|Protective Agents|protective agents|mesh-ancestor
65605195|NCT01370031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605196|NCT02373514|Acetaminophen|acetaminophen|mesh-list
65605197|NCT02373514|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65605198|NCT02373514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65605199|NCT02373514|Analgesics|analgesics|mesh-ancestor
65605200|NCT02373514|Sensory System Agents|sensory system agents|mesh-ancestor
65605201|NCT02373514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65605202|NCT02373514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605203|NCT02373514|Antipyretics|antipyretics|mesh-ancestor
65605204|NCT02373514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65605205|NCT02373514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65605206|NCT02373514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65605207|NCT01364493|Capecitabine|capecitabine|mesh-list
65605208|NCT01364493|Oxaliplatin|oxaliplatin|mesh-list
65605209|NCT01364493|Trastuzumab|trastuzumab|mesh-list
65605210|NCT01364493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65605211|NCT01364493|Antimetabolites|antimetabolites|mesh-ancestor
65605212|NCT01364493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605213|NCT01364493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605214|NCT01364493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65605215|NCT01370187|Montelukast|montelukast|mesh-list
65605216|NCT01370187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65605217|NCT01370187|Respiratory System Agents|respiratory system agents|mesh-ancestor
65605218|NCT01370187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65605219|NCT01370187|Hormone Antagonists|hormone antagonists|mesh-ancestor
65605220|NCT01370187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65605221|NCT01370187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605222|NCT01370187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65605223|NCT01370187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65605224|NCT01370187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605226|NCT04483960|Enoxaparin|enoxaparin|mesh-list
65605227|NCT04483960|Dalteparin|dalteparin|mesh-list
65605228|NCT04483960|Tinzaparin|tinzaparin|mesh-list
65605229|NCT04483960|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65605230|NCT04483960|Anticoagulants|anticoagulants|mesh-ancestor
65605231|NCT04483960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65605232|NCT04483960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65605233|NCT04483960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605234|NCT04483960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65605235|NCT04483960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65605236|NCT04483960|Analgesics|analgesics|mesh-ancestor
65605237|NCT04483960|Sensory System Agents|sensory system agents|mesh-ancestor
65605238|NCT04483960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65605239|NCT04483960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605240|NCT04483960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65605241|NCT04483960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65605242|NCT04483960|Protease Inhibitors|protease inhibitors|mesh-ancestor
65605243|NCT04483960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605244|NCT04483960|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65605245|NCT04483960|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65605246|NCT04483960|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65605247|NCT04483960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65605248|NCT04483960|Immunologic Factors|immunologic factors|mesh-ancestor
65605249|NCT01370343|Nicotinic Acids|nicotinic acids|mesh-list
65605250|NCT01370343|Cyclosporine|cyclosporine|mesh-list
65605251|NCT01370343|Cyclosporins|cyclosporins|mesh-list
65605252|NCT01370343|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
65605253|NCT01370343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605254|NCT01370343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605255|NCT01370343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65605256|NCT01370343|Immunologic Factors|immunologic factors|mesh-ancestor
65605257|NCT01370343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605258|NCT01370343|Antifungal Agents|antifungal agents|mesh-ancestor
65605259|NCT01370343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605260|NCT01370343|Dermatologic Agents|dermatologic agents|mesh-ancestor
65605261|NCT01370343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65605262|NCT01370343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65605263|NCT01370343|Vitamin B Complex|vitamin b complex|mesh-ancestor
65605264|NCT01370343|Vitamins|vitamins|mesh-ancestor
65605265|NCT01370343|Micronutrients|micronutrients|mesh-ancestor
65605266|NCT01368003|Dutasteride|dutasteride|mesh-list
65605267|NCT01368003|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65605268|NCT01368003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65605269|NCT01368003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605270|NCT01368003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605271|NCT01368003|Hormone Antagonists|hormone antagonists|mesh-ancestor
65605272|NCT01368003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65605273|NCT01368003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605274|NCT01364571|Vaccines|vaccines|mesh-list
65605275|NCT01364571|Immunologic Factors|immunologic factors|mesh-ancestor
65605276|NCT01364571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605277|NCT04222257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65605278|NCT04222257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65605279|NCT04222257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605280|NCT04222257|Antitubercular Agents|antitubercular agents|mesh-ancestor
65605281|NCT03933904|Sirolimus|sirolimus|mesh-list
65605282|NCT03933904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65605283|NCT03933904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605284|NCT03933904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65605285|NCT03933904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605286|NCT03933904|Antifungal Agents|antifungal agents|mesh-ancestor
65605287|NCT03933904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65605288|NCT03933904|Immunologic Factors|immunologic factors|mesh-ancestor
65605289|NCT03933904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605290|NCT02377648|Everolimus|everolimus|mesh-list
65605291|NCT02377648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402711|NCT01004874|Topotecan|topotecan|mesh-list
65605292|NCT02377648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65605293|NCT02377648|Immunologic Factors|immunologic factors|mesh-ancestor
65605294|NCT02377648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605295|NCT02371408|Ribavirin|ribavirin|mesh-list
65605296|NCT02371408|Sofosbuvir|sofosbuvir|mesh-list
65605297|NCT02371408|Antimetabolites|antimetabolites|mesh-ancestor
65605298|NCT02371408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605299|NCT02371408|Antiviral Agents|antiviral agents|mesh-ancestor
65605300|NCT02371408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605301|NCT01364805|Ascorbic Acid|ascorbic acid|mesh-list
65605302|NCT01364805|Gemcitabine|gemcitabine|mesh-list
65605303|NCT01364805|Vitamins|vitamins|mesh-ancestor
65605304|NCT01364805|Micronutrients|micronutrients|mesh-ancestor
65605305|NCT01364805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605306|NCT01364805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65605307|NCT01364805|Antimetabolites|antimetabolites|mesh-ancestor
65605308|NCT01364805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605309|NCT01364805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605310|NCT01364805|Antiviral Agents|antiviral agents|mesh-ancestor
65605311|NCT01364805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605312|NCT01364805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605313|NCT01364805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65605314|NCT01364805|Immunologic Factors|immunologic factors|mesh-ancestor
65605315|NCT01364805|Antioxidants|antioxidants|mesh-ancestor
65605316|NCT01364805|Protective Agents|protective agents|mesh-ancestor
65605317|NCT01370889|Resveratrol|resveratrol|mesh-list
65605318|NCT01370889|Antioxidants|antioxidants|mesh-ancestor
65605319|NCT01370889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605320|NCT01370889|Protective Agents|protective agents|mesh-ancestor
65605321|NCT01370889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605322|NCT01370889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605323|NCT01370889|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65605324|NCT02373046|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65605325|NCT02373046|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65605326|NCT02373046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605327|NCT02373046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65605328|NCT02373046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605329|NCT04382404|Sofosbuvir|sofosbuvir|mesh-list
65605330|NCT04382404|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65605331|NCT04382404|Velpatasvir|velpatasvir|mesh-list
65605332|NCT04382404|Antiviral Agents|antiviral agents|mesh-ancestor
65605333|NCT04382404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605334|NCT02371096|Rituximab|rituximab|mesh-list
65605335|NCT02371096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65605336|NCT02371096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605337|NCT02371096|Immunologic Factors|immunologic factors|mesh-ancestor
65605338|NCT02371096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605339|NCT02371096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65605340|NCT04420455|Enoximone|enoximone|mesh-list
65605341|NCT04420455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65605342|NCT04420455|Vasodilator Agents|vasodilator agents|mesh-ancestor
65605343|NCT04420455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65605344|NCT04420455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65605345|NCT04420455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605346|NCT04420455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605347|NCT04420455|Protective Agents|protective agents|mesh-ancestor
65605348|NCT04420455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605349|NCT04381936|Aspirin|aspirin|mesh-list
65605350|NCT04381936|Empagliflozin|empagliflozin|mesh-list
65605351|NCT04381936|Ritonavir|ritonavir|mesh-list
65605352|NCT04381936|Lopinavir|lopinavir|mesh-list
65605353|NCT04381936|Azithromycin|azithromycin|mesh-list
65605354|NCT04381936|Hydroxychloroquine|hydroxychloroquine|mesh-list
65605355|NCT04381936|Colchicine|colchicine|mesh-list
65605356|NCT04381936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65605357|NCT04381936|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65605358|NCT04381936|Antibodies|antibodies|mesh-list
65605359|NCT04381936|Immunoglobulins|immunoglobulins|mesh-list
65605360|NCT04381936|Immunologic Factors|immunologic factors|mesh-ancestor
65605361|NCT04381936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605362|NCT04381936|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65605363|NCT04381936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65605364|NCT04381936|Analgesics|analgesics|mesh-ancestor
65605365|NCT04381936|Sensory System Agents|sensory system agents|mesh-ancestor
65605366|NCT04381936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65605367|NCT04381936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65605368|NCT04381936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65605369|NCT04381936|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65605370|NCT04381936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65605371|NCT04381936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605372|NCT04381936|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65605373|NCT04381936|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65605374|NCT04381936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605375|NCT04381936|Antipyretics|antipyretics|mesh-ancestor
65605376|NCT04381936|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65605377|NCT04381936|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65605378|NCT04381936|Protease Inhibitors|protease inhibitors|mesh-ancestor
65605379|NCT04381936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65605380|NCT04381936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65605381|NCT04381936|Antiviral Agents|antiviral agents|mesh-ancestor
65605382|NCT04381936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605383|NCT04381936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65605384|NCT04381936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65605385|NCT04381936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65605386|NCT04381936|Antimalarials|antimalarials|mesh-ancestor
65605387|NCT04381936|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65605388|NCT04381936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65605389|NCT04381936|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65605390|NCT04381936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65605391|NCT04381936|Gout Suppressants|gout suppressants|mesh-ancestor
65605392|NCT04381936|Tubulin Modulators|tubulin modulators|mesh-ancestor
65605393|NCT04381936|Antimitotic Agents|antimitotic agents|mesh-ancestor
65605394|NCT04381936|Mitosis Modulators|mitosis modulators|mesh-ancestor
65605395|NCT04381936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605396|NCT04381936|Dermatologic Agents|dermatologic agents|mesh-ancestor
65605397|NCT04381936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65605398|NCT03124407|Capsaicin|capsaicin|mesh-list
65605399|NCT03124407|Antipruritics|antipruritics|mesh-ancestor
65605400|NCT03124407|Dermatologic Agents|dermatologic agents|mesh-ancestor
65605401|NCT03124407|Sensory System Agents|sensory system agents|mesh-ancestor
65605402|NCT03124407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65605403|NCT03124407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605404|NCT01364961|Resveratrol|resveratrol|mesh-list
65605405|NCT01364961|Antioxidants|antioxidants|mesh-ancestor
65605406|NCT01364961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605407|NCT01364961|Protective Agents|protective agents|mesh-ancestor
65605408|NCT01364961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605409|NCT01364961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605410|NCT01364961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65605411|NCT02370862|Glycopyrrolate|glycopyrrolate|mesh-list
65605412|NCT02370862|Neostigmine|neostigmine|mesh-list
65605413|NCT02370862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65605414|NCT02370862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605415|NCT02370862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605416|NCT02370862|Cholinergic Agents|cholinergic agents|mesh-ancestor
65605417|NCT02370862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65605418|NCT02370862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605419|NCT02370862|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65605420|NCT02370862|Autonomic Agents|autonomic agents|mesh-ancestor
65262764|NCT00928889|Acarbose|acarbose|mesh-list
65605421|NCT02370862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65605422|NCT02370862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65605423|NCT02370862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65605424|NCT02370862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65605425|NCT03620578|Nivolumab|nivolumab|mesh-list
65605426|NCT03620578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65263037|NCT01192698|Interferons|interferons|mesh-list
65605427|NCT03620578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605428|NCT03620578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65263104|NCT02799758|Pitavastatin|pitavastatin|mesh-list
65605429|NCT03620578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605430|NCT02373280|Amoxicillin|amoxicillin|mesh-list
65605431|NCT02373280|Moxifloxacin|moxifloxacin|mesh-list
65605432|NCT02373280|Metronidazole|metronidazole|mesh-list
65605433|NCT02373280|Clarithromycin|clarithromycin|mesh-list
65605434|NCT02373280|Esomeprazole|esomeprazole|mesh-list
65605435|NCT02373280|Bismuth|bismuth|mesh-list
65605436|NCT02373280|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65605437|NCT02373280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65605438|NCT02373280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605439|NCT02373280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65605440|NCT02373280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65402831|NCT01088815|Antimetabolites|antimetabolites|mesh-ancestor
65605441|NCT02373280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605442|NCT02373280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605443|NCT02373280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605444|NCT02373280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65605445|NCT02373280|Contraceptive Agents|contraceptive agents|mesh-ancestor
65605446|NCT02373280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65263529|NCT04260581|Analgesics|analgesics|mesh-ancestor
65605447|NCT02373280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263608|NCT00637988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65605448|NCT02373280|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65263683|NCT00945373|Calcium|calcium|mesh-list
65605449|NCT02373280|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65605450|NCT02373280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65605451|NCT02373280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65605452|NCT02373280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65605453|NCT02373280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65605454|NCT02373280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65605455|NCT02373280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65605456|NCT02373280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65605457|NCT02373280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65605458|NCT02373280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65605459|NCT02373280|Antacids|antacids|mesh-ancestor
65605460|NCT02370550|Cyclosporine|cyclosporine|mesh-list
65605461|NCT02370550|Prednisone|prednisone|mesh-list
65605462|NCT02370550|Calcium Carbonate|calcium carbonate|mesh-list
65605463|NCT02370550|Calcium|calcium|mesh-list
65605464|NCT02370550|Cyclosporins|cyclosporins|mesh-list
65605465|NCT02370550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65605466|NCT02370550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605467|NCT02370550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65264132|NCT02787746|Donepezil|donepezil|mesh-list
65605468|NCT02370550|Glucocorticoids|glucocorticoids|mesh-ancestor
65605469|NCT02370550|Hormones|hormones|mesh-ancestor
65264265|NCT04232150|GABA Modulators|gaba modulators|mesh-ancestor
65264272|NCT02336750|Aprepitant|aprepitant|mesh-list
65605470|NCT02370550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65605471|NCT02370550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65605472|NCT02370550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605473|NCT02370550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605474|NCT02370550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605475|NCT02370550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65605476|NCT02370550|Immunologic Factors|immunologic factors|mesh-ancestor
65605477|NCT02370550|Antifungal Agents|antifungal agents|mesh-ancestor
65605478|NCT02370550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605479|NCT02370550|Dermatologic Agents|dermatologic agents|mesh-ancestor
65605480|NCT02370550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65605481|NCT02370550|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65605482|NCT02370550|Antacids|antacids|mesh-ancestor
65264704|NCT00923273|Folic Acid|folic acid|mesh-list
65605483|NCT02370550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65605484|NCT02365402|Entecavir|entecavir|mesh-list
65605485|NCT02365402|Antiviral Agents|antiviral agents|mesh-ancestor
65264780|NCT02721888|Incretins|incretins|mesh-ancestor
65264849|NCT02598687|Paclitaxel|paclitaxel|mesh-list
65605486|NCT02365402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605487|NCT02364934|Propofol|propofol|mesh-list
65605488|NCT02364934|Sevoflurane|sevoflurane|mesh-list
65605489|NCT02364934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65605490|NCT02364934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65605491|NCT02364934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605492|NCT02364934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65605493|NCT02364934|Anesthetics, General|anesthetics, general|mesh-ancestor
65605494|NCT02364934|Anesthetics|anesthetics|mesh-ancestor
65605495|NCT02364934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65605496|NCT02364934|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65605497|NCT02372656|Metformin|metformin|mesh-list
65605498|NCT02372656|Simvastatin|simvastatin|mesh-list
65605499|NCT02372656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65605500|NCT02372656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605501|NCT02372656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65605502|NCT02372656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65605503|NCT02372656|Antimetabolites|antimetabolites|mesh-ancestor
65605504|NCT02372656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265209|NCT00940693|Analgesics|analgesics|mesh-ancestor
65605505|NCT02372656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65265426|NCT00948493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605506|NCT02372656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65605507|NCT02372656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605508|NCT01368627|Sirolimus|sirolimus|mesh-list
65605509|NCT01368627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65605510|NCT01368627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605511|NCT01368627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65605512|NCT01368627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605513|NCT01368627|Antifungal Agents|antifungal agents|mesh-ancestor
65605514|NCT01368627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65605515|NCT01368627|Immunologic Factors|immunologic factors|mesh-ancestor
65605516|NCT01368627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402908|NCT04004234|Manganese|manganese|mesh-list
65605517|NCT02358681|Ketorolac|ketorolac|mesh-list
65605518|NCT02358681|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65605519|NCT02358681|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65605520|NCT02358681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65605521|NCT02358681|Analgesics|analgesics|mesh-ancestor
65605522|NCT02358681|Sensory System Agents|sensory system agents|mesh-ancestor
65605523|NCT02358681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65605524|NCT02358681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265803|NCT04688814|Morphine|morphine|mesh-list
65605525|NCT02358681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65265866|NCT02693574|Levofloxacin|levofloxacin|mesh-list
65605526|NCT02358681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65605527|NCT02358681|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65605528|NCT02358681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605529|NCT02358681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605530|NCT03123861|Gabapentin|gabapentin|mesh-list
65605531|NCT03123861|Analgesics|analgesics|mesh-ancestor
65605532|NCT03123861|Sensory System Agents|sensory system agents|mesh-ancestor
65605533|NCT03123861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65605534|NCT03123861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605535|NCT03123861|Anticonvulsants|anticonvulsants|mesh-ancestor
65605536|NCT03123861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65605537|NCT03123861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65605538|NCT03123861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65605539|NCT03123861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65605540|NCT03123861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65605541|NCT03123861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65605542|NCT03123861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65605543|NCT03123861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605544|NCT03123861|Antimanic Agents|antimanic agents|mesh-ancestor
65605545|NCT01368783|Ritonavir|ritonavir|mesh-list
65605546|NCT01368783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65605547|NCT01368783|Tenofovir|tenofovir|mesh-list
65605548|NCT01368783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65605549|NCT01368783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65605550|NCT01368783|Protease Inhibitors|protease inhibitors|mesh-ancestor
65605551|NCT01368783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605552|NCT01368783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605553|NCT01368783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65605554|NCT01368783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65605555|NCT01368783|Antiviral Agents|antiviral agents|mesh-ancestor
65605556|NCT01368783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605557|NCT01368783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65605558|NCT01368783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65605559|NCT01368783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65605560|NCT01368783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65605561|NCT01509339|Vancomycin|vancomycin|mesh-list
65605562|NCT01509339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65605563|NCT01509339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605564|NCT03123471|Apremilast|apremilast|mesh-list
65605565|NCT03123471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65605566|NCT03123471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65605567|NCT03123471|Analgesics|analgesics|mesh-ancestor
65605568|NCT03123471|Sensory System Agents|sensory system agents|mesh-ancestor
65605569|NCT03123471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65605570|NCT03123471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605571|NCT03123471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65605572|NCT03123471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65605573|NCT03123471|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65605574|NCT03123471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65605575|NCT03123471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605576|NCT03123471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605577|NCT02661178|Emodepside|emodepside|mesh-list
65605578|NCT02661178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65605579|NCT02661178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605580|NCT01365117|Insulin|insulin|mesh-list
65605581|NCT01365117|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65605582|NCT01365117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65605583|NCT01365117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605584|NCT02372812|Dexamethasone|dexamethasone|mesh-list
65605585|NCT02372812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65605586|NCT02372812|Antiemetics|antiemetics|mesh-ancestor
65605587|NCT02372812|Autonomic Agents|autonomic agents|mesh-ancestor
65605588|NCT02372812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65605589|NCT02372812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605590|NCT02372812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65605591|NCT02372812|Glucocorticoids|glucocorticoids|mesh-ancestor
65605592|NCT02372812|Hormones|hormones|mesh-ancestor
65605593|NCT02372812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65605594|NCT02372812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65605595|NCT02372812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605596|NCT02365012|Midodrine|midodrine|mesh-list
65605597|NCT02365012|Sympathomimetics|sympathomimetics|mesh-ancestor
65605598|NCT02365012|Autonomic Agents|autonomic agents|mesh-ancestor
65605599|NCT02365012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65605600|NCT02365012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605601|NCT02365012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65605602|NCT02365012|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65605603|NCT02365012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65605604|NCT02365012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65605605|NCT02365012|Adrenergic Agents|adrenergic agents|mesh-ancestor
65605606|NCT02365012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65605607|NCT02365012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605608|NCT01369017|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65605609|NCT01369017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65605610|NCT01365351|Hormones|hormones|mesh-list
65605611|NCT01365351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65605612|NCT01365351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605613|NCT04562896|Carbon Fiber|carbon fiber|mesh-list
65605614|NCT04562896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65605615|NCT04562896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605616|NCT01372449|Memantine|memantine|mesh-list
65605617|NCT01372449|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65605618|NCT01372449|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65605619|NCT01372449|Dopamine Agents|dopamine agents|mesh-ancestor
65605620|NCT01372449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65605621|NCT01372449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605622|NCT01372449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605623|NCT01372449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65605624|NCT01372449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65605625|NCT04666389|Atorvastatin|atorvastatin|mesh-list
65605626|NCT04666389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65605627|NCT04666389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65605628|NCT04666389|Antimetabolites|antimetabolites|mesh-ancestor
65605629|NCT04666389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605630|NCT04666389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65605631|NCT04666389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65605632|NCT04666389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605633|NCT02372110|Caffeine|caffeine|mesh-list
65605634|NCT02372110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65605635|NCT02372110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605636|NCT02372110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65605637|NCT02372110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605638|NCT02372110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605639|NCT02372110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65605640|NCT02372110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65605641|NCT02372110|Purinergic Agents|purinergic agents|mesh-ancestor
65605642|NCT02372110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65605643|NCT02372188|Caffeine|caffeine|mesh-list
65605644|NCT02372188|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65605645|NCT02372188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605646|NCT02372188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65605647|NCT02372188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605648|NCT02372188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605649|NCT02372188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65605650|NCT02372188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65605651|NCT02372188|Purinergic Agents|purinergic agents|mesh-ancestor
65605652|NCT02372188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65605653|NCT01371435|Paroxetine|paroxetine|mesh-list
65605654|NCT01371435|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65605655|NCT01371435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65605656|NCT01371435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65605657|NCT01371435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605658|NCT01371435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65605659|NCT01371435|Serotonin Agents|serotonin agents|mesh-ancestor
65605660|NCT01371435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605661|NCT01371435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65605662|NCT01371435|Antidepressive Agents|antidepressive agents|mesh-ancestor
65605663|NCT01371435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65605664|NCT01371435|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65605665|NCT01371435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65605666|NCT01371435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605667|NCT01369719|Deferasirox|deferasirox|mesh-list
65605668|NCT01369719|Deferoxamine|deferoxamine|mesh-list
65605669|NCT01369719|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65605670|NCT01369719|Chelating Agents|chelating agents|mesh-ancestor
65605671|NCT01369719|Sequestering Agents|sequestering agents|mesh-ancestor
65605672|NCT01369719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605673|NCT01369719|Siderophores|siderophores|mesh-ancestor
65605674|NCT02369380|Hyaluronic Acid|hyaluronic acid|mesh-list
65605675|NCT02369380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65605676|NCT02369380|Immunologic Factors|immunologic factors|mesh-ancestor
65605677|NCT02369380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605678|NCT02369380|Viscosupplements|viscosupplements|mesh-ancestor
65605679|NCT02369380|Protective Agents|protective agents|mesh-ancestor
65605680|NCT02038816|Azacitidine|azacitidine|mesh-list
65605681|NCT02038816|Deferasirox|deferasirox|mesh-list
65605682|NCT02038816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65605683|NCT02038816|Antimetabolites|antimetabolites|mesh-ancestor
65605684|NCT02038816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605685|NCT02038816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605686|NCT02038816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605687|NCT02038816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65605688|NCT02038816|Chelating Agents|chelating agents|mesh-ancestor
65605689|NCT02038816|Sequestering Agents|sequestering agents|mesh-ancestor
65605690|NCT04809831|Chlorhexidine|chlorhexidine|mesh-list
65605691|NCT04809831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65605692|NCT04809831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605693|NCT04809831|Disinfectants|disinfectants|mesh-ancestor
65605694|NCT02358850|Acetaminophen|acetaminophen|mesh-list
65605696|NCT02358850|Hydromorphone|hydromorphone|mesh-list
65605697|NCT02358850|Hydrocodone|hydrocodone|mesh-list
65605698|NCT02358850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65605699|NCT02358850|Analgesics|analgesics|mesh-ancestor
65605700|NCT02358850|Sensory System Agents|sensory system agents|mesh-ancestor
65605701|NCT02358850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65605702|NCT02358850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605703|NCT02358850|Antipyretics|antipyretics|mesh-ancestor
65605704|NCT02358850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65605705|NCT02358850|Narcotics|narcotics|mesh-ancestor
65605706|NCT02358850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65605707|NCT02358850|Antitussive Agents|antitussive agents|mesh-ancestor
65605708|NCT02358850|Respiratory System Agents|respiratory system agents|mesh-ancestor
65605709|NCT02359162|Gemcitabine|gemcitabine|mesh-list
65605710|NCT02359162|Prednisone|prednisone|mesh-list
65605711|NCT02359162|Cyclophosphamide|cyclophosphamide|mesh-list
65605712|NCT02359162|Doxorubicin|doxorubicin|mesh-list
65605713|NCT02359162|Oxaliplatin|oxaliplatin|mesh-list
65605714|NCT02359162|Etoposide|etoposide|mesh-list
65605715|NCT02359162|Vincristine|vincristine|mesh-list
65605716|NCT02359162|Pegaspargase|pegaspargase|mesh-list
65605717|NCT02359162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65605718|NCT02359162|Immunologic Factors|immunologic factors|mesh-ancestor
65605719|NCT02359162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605720|NCT02359162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65605721|NCT02359162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65605722|NCT02359162|Alkylating Agents|alkylating agents|mesh-ancestor
65605723|NCT02359162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605724|NCT02359162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605725|NCT02359162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65605726|NCT02359162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65605727|NCT02359162|Antimetabolites|antimetabolites|mesh-ancestor
65605728|NCT02359162|Antiviral Agents|antiviral agents|mesh-ancestor
65605729|NCT02359162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605730|NCT02359162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605731|NCT02359162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65605732|NCT02359162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65605733|NCT02359162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65605734|NCT02359162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65605735|NCT02359162|Glucocorticoids|glucocorticoids|mesh-ancestor
65605736|NCT02359162|Hormones|hormones|mesh-ancestor
65605737|NCT02359162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65605738|NCT02359162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65605739|NCT02359162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65605740|NCT02359162|Tubulin Modulators|tubulin modulators|mesh-ancestor
65605741|NCT02359162|Antimitotic Agents|antimitotic agents|mesh-ancestor
65605742|NCT02359162|Mitosis Modulators|mitosis modulators|mesh-ancestor
65605743|NCT03634605|Tetracycline|tetracycline|mesh-list
65605744|NCT03634605|Lidocaine|lidocaine|mesh-list
65605745|NCT03634605|Anesthetics, Local|anesthetics, local|mesh-ancestor
65605746|NCT03634605|Anesthetics|anesthetics|mesh-ancestor
65605747|NCT03634605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65605748|NCT03634605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605749|NCT03634605|Sensory System Agents|sensory system agents|mesh-ancestor
65605750|NCT03634605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65605751|NCT03634605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65605752|NCT03634605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65605753|NCT03634605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65605754|NCT03634605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65605755|NCT03634605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605756|NCT03634605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65605757|NCT03634605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605758|NCT03634605|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65605759|NCT03634605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605760|NCT02363764|Dimercaprol|dimercaprol|mesh-list
65605761|NCT02363764|Chelating Agents|chelating agents|mesh-ancestor
65605762|NCT02363764|Sequestering Agents|sequestering agents|mesh-ancestor
65605763|NCT02363764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605764|NCT03654794|Tacrolimus|tacrolimus|mesh-list
65605765|NCT03654794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65605766|NCT03654794|Immunologic Factors|immunologic factors|mesh-ancestor
65605767|NCT03654794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605768|NCT03654794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65605769|NCT03654794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605770|NCT03654794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605771|NCT03654170|BI 425809|bi 425809|mesh-list
65605772|NCT03654170|Nootropic Agents|nootropic agents|mesh-ancestor
65605773|NCT02369146|UB-421|ub-421|mesh-list
65605774|NCT02369146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65605775|NCT02369146|Antiviral Agents|antiviral agents|mesh-ancestor
65605776|NCT02369146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605777|NCT02363452|Lamivudine|lamivudine|mesh-list
65605778|NCT02363452|Zidovudine|zidovudine|mesh-list
65605779|NCT02363452|Abacavir|abacavir|mesh-list
65605780|NCT02363452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
65605781|NCT02363452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65605782|NCT02363452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605783|NCT02363452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605784|NCT02363452|Antiviral Agents|antiviral agents|mesh-ancestor
65605785|NCT02363452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605786|NCT02363452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65605787|NCT02363452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65605788|NCT02363452|Antimetabolites|antimetabolites|mesh-ancestor
65605789|NCT03634137|Afamelanotide|afamelanotide|mesh-list
65605790|NCT03634137|alpha-MSH|alpha-msh|mesh-list
65605791|NCT03634137|Dermatologic Agents|dermatologic agents|mesh-ancestor
65605792|NCT03634137|Hormones|hormones|mesh-ancestor
65605793|NCT03634137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65605794|NCT03634137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605795|NCT02358694|Immunoglobulins|immunoglobulins|mesh-list
65605796|NCT02358694|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65605797|NCT02358694|Antibodies|antibodies|mesh-list
65605798|NCT02358694|Immunologic Factors|immunologic factors|mesh-ancestor
65605799|NCT02358694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605800|NCT04473807|Sotalol|sotalol|mesh-list
65605801|NCT04473807|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65605802|NCT04473807|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65605803|NCT04473807|Adrenergic Agents|adrenergic agents|mesh-ancestor
65605804|NCT04473807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65605805|NCT04473807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605806|NCT04473807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605807|NCT04473807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65605808|NCT04473807|Sympatholytics|sympatholytics|mesh-ancestor
65605809|NCT04473807|Autonomic Agents|autonomic agents|mesh-ancestor
65605810|NCT04473807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65605811|NCT02323659|Interferons|interferons|mesh-list
65605812|NCT02323659|Interferon-alpha|interferon-alpha|mesh-list
65605813|NCT02323659|Interferon alpha-2|interferon alpha-2|mesh-list
65605814|NCT02323659|Methotrexate|methotrexate|mesh-list
65605815|NCT02323659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65605816|NCT02323659|Abortifacient Agents|abortifacient agents|mesh-ancestor
65605817|NCT02323659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65605818|NCT02323659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605819|NCT02323659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65605820|NCT02323659|Antimetabolites|antimetabolites|mesh-ancestor
65605821|NCT02323659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605822|NCT02323659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605823|NCT02323659|Dermatologic Agents|dermatologic agents|mesh-ancestor
65605824|NCT02323659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605825|NCT02323659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65605826|NCT02323659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65605827|NCT02323659|Immunologic Factors|immunologic factors|mesh-ancestor
65605828|NCT02323659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65605829|NCT02323659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65605830|NCT02323659|Antiviral Agents|antiviral agents|mesh-ancestor
65605831|NCT02323659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605832|NCT03634059|Apatinib|apatinib|mesh-list
65605833|NCT03634059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605834|NCT03634059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65605835|NCT03634059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605836|NCT03634059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605837|NCT02358304|Calcitonin|calcitonin|mesh-list
65605838|NCT02358304|Salmon calcitonin|salmon calcitonin|mesh-list
65605839|NCT02358304|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
65605840|NCT02358304|Katacalcin|katacalcin|mesh-list
65605841|NCT02358304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65605842|NCT02358304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605843|NCT02358304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65605844|NCT02358304|Vasodilator Agents|vasodilator agents|mesh-ancestor
65605845|NCT02363530|Ethyl cellulose|ethyl cellulose|mesh-list
65605846|NCT02363530|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65605847|NCT02363530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65605848|NCT01316523|Rituximab|rituximab|mesh-list
65605849|NCT01316523|Lenalidomide|lenalidomide|mesh-list
65605850|NCT01316523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65605851|NCT01316523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605852|NCT01316523|Immunologic Factors|immunologic factors|mesh-ancestor
65605853|NCT01316523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605854|NCT01316523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65605855|NCT01316523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65605856|NCT01316523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65605857|NCT01316523|Growth Substances|growth substances|mesh-ancestor
65605858|NCT01316523|Growth Inhibitors|growth inhibitors|mesh-ancestor
65605859|NCT02362906|Azithromycin|azithromycin|mesh-list
65605860|NCT02362906|Erythromycin|erythromycin|mesh-list
65605861|NCT02362906|Erythromycin Estolate|erythromycin estolate|mesh-list
65605862|NCT02362906|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65605863|NCT02362906|Erythromycin stearate|erythromycin stearate|mesh-list
65605864|NCT02362906|Cephalosporins|cephalosporins|mesh-list
65605865|NCT02362906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65605866|NCT02362906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605867|NCT02362906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65605868|NCT02362906|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65605869|NCT02362906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605870|NCT02362906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605871|NCT04469530|Sirolimus|sirolimus|mesh-list
65605872|NCT04469530|Celecoxib|celecoxib|mesh-list
65605873|NCT04469530|Cyclophosphamide|cyclophosphamide|mesh-list
65605874|NCT04469530|Etoposide|etoposide|mesh-list
65605875|NCT04469530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65605876|NCT04469530|Immunologic Factors|immunologic factors|mesh-ancestor
65605877|NCT04469530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605878|NCT04469530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65605879|NCT04469530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65605880|NCT04469530|Alkylating Agents|alkylating agents|mesh-ancestor
65605881|NCT04469530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605882|NCT04469530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605883|NCT04469530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65605884|NCT04469530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65605885|NCT04469530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65605886|NCT04469530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65605887|NCT04469530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605888|NCT04469530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65605889|NCT04469530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605890|NCT04469530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65605891|NCT04469530|Antifungal Agents|antifungal agents|mesh-ancestor
65605892|NCT04469530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65605893|NCT04469530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65605894|NCT04469530|Analgesics|analgesics|mesh-ancestor
65605895|NCT04469530|Sensory System Agents|sensory system agents|mesh-ancestor
65605896|NCT04469530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65605897|NCT04469530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65605898|NCT04469530|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65605899|NCT04469530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65605901|NCT03085914|Gemcitabine|gemcitabine|mesh-list
65605902|NCT03085914|Paclitaxel|paclitaxel|mesh-list
65605903|NCT03085914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65605904|NCT03085914|Cyclophosphamide|cyclophosphamide|mesh-list
65605905|NCT03085914|Carboplatin|carboplatin|mesh-list
65605906|NCT03085914|Pembrolizumab|pembrolizumab|mesh-list
65605907|NCT03085914|Fluorouracil|fluorouracil|mesh-list
65605908|NCT03085914|Oxaliplatin|oxaliplatin|mesh-list
65605909|NCT03085914|Pemetrexed|pemetrexed|mesh-list
65605910|NCT03085914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65605911|NCT03085914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65605912|NCT03085914|Tubulin Modulators|tubulin modulators|mesh-ancestor
65605913|NCT03085914|Antimitotic Agents|antimitotic agents|mesh-ancestor
65605914|NCT03085914|Mitosis Modulators|mitosis modulators|mesh-ancestor
65605915|NCT03085914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605916|NCT03085914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65605917|NCT03085914|Immunologic Factors|immunologic factors|mesh-ancestor
65605918|NCT03085914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605919|NCT03085914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65605920|NCT03085914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65605921|NCT03085914|Alkylating Agents|alkylating agents|mesh-ancestor
65605922|NCT03085914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65605923|NCT03085914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65605924|NCT03085914|Antimetabolites|antimetabolites|mesh-ancestor
65605925|NCT03085914|Antiviral Agents|antiviral agents|mesh-ancestor
65605926|NCT03085914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605927|NCT03085914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605928|NCT03085914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65605929|NCT03085914|Antidotes|antidotes|mesh-ancestor
65605930|NCT03085914|Protective Agents|protective agents|mesh-ancestor
65605931|NCT03085914|Vitamin B Complex|vitamin b complex|mesh-ancestor
65605932|NCT03085914|Vitamins|vitamins|mesh-ancestor
65605933|NCT03085914|Micronutrients|micronutrients|mesh-ancestor
65605934|NCT03085914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65605935|NCT03085914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65605936|NCT02467608|Isoniazid|isoniazid|mesh-list
65605937|NCT02467608|Antitubercular Agents|antitubercular agents|mesh-ancestor
65605938|NCT02467608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65605939|NCT02467608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605940|NCT02467608|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65605941|NCT02467608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65605942|NCT02467608|Antimetabolites|antimetabolites|mesh-ancestor
65605943|NCT02467608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605944|NCT02467608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65605945|NCT02368288|Entecavir|entecavir|mesh-list
65605946|NCT02368288|Antiviral Agents|antiviral agents|mesh-ancestor
65605947|NCT02368288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605948|NCT02357524|Oritavancin|oritavancin|mesh-list
65605949|NCT02357524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65605950|NCT02357524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605951|NCT02368054|Epinephrine|epinephrine|mesh-list
65605952|NCT02368054|Racepinephrine|racepinephrine|mesh-list
65605953|NCT02368054|Bupivacaine|bupivacaine|mesh-list
65605954|NCT02368054|Epinephryl borate|epinephryl borate|mesh-list
65605955|NCT02368054|Anesthetics, Local|anesthetics, local|mesh-ancestor
65605956|NCT02368054|Anesthetics|anesthetics|mesh-ancestor
65605957|NCT02368054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65605958|NCT02368054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65605959|NCT02368054|Sensory System Agents|sensory system agents|mesh-ancestor
65605960|NCT02368054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65605961|NCT02368054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65605962|NCT02368054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65605963|NCT02368054|Adrenergic Agents|adrenergic agents|mesh-ancestor
65605964|NCT02368054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65605965|NCT02368054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605966|NCT02368054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65605967|NCT02368054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65605968|NCT02368054|Autonomic Agents|autonomic agents|mesh-ancestor
65605969|NCT02368054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65605970|NCT02368054|Respiratory System Agents|respiratory system agents|mesh-ancestor
65605971|NCT02368054|Mydriatics|mydriatics|mesh-ancestor
65605972|NCT02368054|Sympathomimetics|sympathomimetics|mesh-ancestor
65605973|NCT02368054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65605974|NCT02357602|Tenofovir|tenofovir|mesh-list
65605975|NCT02357602|Antiviral Agents|antiviral agents|mesh-ancestor
65605976|NCT02357602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605977|NCT02357602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65605978|NCT02357602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65605979|NCT02357602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605980|NCT02357602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605981|NCT02357602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65605982|NCT02357602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65605983|NCT01379196|Azithromycin|azithromycin|mesh-list
65605984|NCT01379196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65605985|NCT01379196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605986|NCT01382238|Dolutegravir|dolutegravir|mesh-list
65605987|NCT01382238|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65605988|NCT01382238|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65605989|NCT01382238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65605990|NCT01382238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65605991|NCT01382238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65605992|NCT01382238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65605993|NCT01382238|Antiviral Agents|antiviral agents|mesh-ancestor
65605994|NCT01382238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65605995|NCT03112564|Fentanyl|fentanyl|mesh-list
65605996|NCT03112564|Sevoflurane|sevoflurane|mesh-list
65605997|NCT03112564|Rocuronium|rocuronium|mesh-list
65605998|NCT03112564|Cisatracurium|cisatracurium|mesh-list
65605999|NCT03112564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65606000|NCT03112564|Narcotics|narcotics|mesh-ancestor
65606001|NCT03112564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65606002|NCT03112564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606003|NCT03112564|Analgesics|analgesics|mesh-ancestor
65606004|NCT03112564|Sensory System Agents|sensory system agents|mesh-ancestor
65606005|NCT03112564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65606006|NCT03112564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65606007|NCT03112564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65606008|NCT03112564|Anesthetics, General|anesthetics, general|mesh-ancestor
65606009|NCT03112564|Anesthetics|anesthetics|mesh-ancestor
65606010|NCT03112564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65606011|NCT03112564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65606012|NCT03112564|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65606013|NCT03112564|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65606014|NCT03112564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65606015|NCT01379976|Acetylcarnitine|acetylcarnitine|mesh-list
65606016|NCT01379976|Vitamin B Complex|vitamin b complex|mesh-ancestor
65606017|NCT01379976|Vitamins|vitamins|mesh-ancestor
65606018|NCT01379976|Micronutrients|micronutrients|mesh-ancestor
65606019|NCT01379976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606020|NCT01379976|Nootropic Agents|nootropic agents|mesh-ancestor
65606021|NCT01379898|Doxazosin|doxazosin|mesh-list
65606022|NCT01379898|Phenoxybenzamine|phenoxybenzamine|mesh-list
65606023|NCT01379898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65606024|NCT01379898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65606025|NCT01379898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65606026|NCT01379898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65606027|NCT01379898|Adrenergic Agents|adrenergic agents|mesh-ancestor
65606028|NCT01379898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65606029|NCT01379898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606030|NCT01379898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606031|NCT01379898|Vasodilator Agents|vasodilator agents|mesh-ancestor
65606032|NCT02362516|BI 425809|bi 425809|mesh-list
65606033|NCT02362516|Nootropic Agents|nootropic agents|mesh-ancestor
65606034|NCT02367664|Vaccines|vaccines|mesh-list
65606035|NCT02367664|Immunologic Factors|immunologic factors|mesh-ancestor
65606036|NCT02367664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606037|NCT05421000|Anesthetics|anesthetics|mesh-list
65606038|NCT05421000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65606039|NCT05421000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606040|NCT05419362|Avelumab|avelumab|mesh-list
65606041|NCT05419362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65606042|NCT05419362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606043|NCT02357212|Adenosine|adenosine|mesh-list
65606044|NCT02357212|Analgesics|analgesics|mesh-ancestor
65606045|NCT02357212|Sensory System Agents|sensory system agents|mesh-ancestor
65606046|NCT02357212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65606047|NCT02357212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606048|NCT02357212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65403444|NCT00767117|Ritonavir|ritonavir|mesh-list
65606049|NCT02357212|Vasodilator Agents|vasodilator agents|mesh-ancestor
65606050|NCT02357212|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65606051|NCT02357212|Purinergic Agonists|purinergic agonists|mesh-ancestor
65606052|NCT02357212|Purinergic Agents|purinergic agents|mesh-ancestor
65606053|NCT02357212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65606054|NCT02357212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606055|NCT01382160|Adalimumab|adalimumab|mesh-list
65606056|NCT01382160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65606057|NCT01382160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65606058|NCT00735748|Tramadol|tramadol|mesh-list
65606059|NCT00735748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65606060|NCT00735748|Narcotics|narcotics|mesh-ancestor
65606061|NCT00735748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65606062|NCT00735748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606063|NCT00735748|Analgesics|analgesics|mesh-ancestor
65606064|NCT00735748|Sensory System Agents|sensory system agents|mesh-ancestor
65606065|NCT00735748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65606066|NCT02367196|Rituximab|rituximab|mesh-list
65606067|NCT02367196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65606068|NCT02367196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606069|NCT02367196|Immunologic Factors|immunologic factors|mesh-ancestor
65606070|NCT02367196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606071|NCT02367196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65606072|NCT05418504|Anesthetics|anesthetics|mesh-list
65606073|NCT05418504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65606074|NCT05418504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606075|NCT03408886|Vancomycin|vancomycin|mesh-list
65606076|NCT03408886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65606077|NCT03408886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65606078|NCT03323476|Mycophenolic Acid|mycophenolic acid|mesh-list
65606079|NCT03323476|Prednisone|prednisone|mesh-list
65606080|NCT03323476|Rituximab|rituximab|mesh-list
65606081|NCT03323476|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65606082|NCT03323476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65606083|NCT03323476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606084|NCT03323476|Immunologic Factors|immunologic factors|mesh-ancestor
65606085|NCT03323476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606086|NCT03323476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65606087|NCT03323476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65606088|NCT03323476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65606089|NCT03323476|Antitubercular Agents|antitubercular agents|mesh-ancestor
65606090|NCT03323476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65606091|NCT03323476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65606092|NCT03323476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606093|NCT03323476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606094|NCT03323476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65606095|NCT03323476|Glucocorticoids|glucocorticoids|mesh-ancestor
65606096|NCT03323476|Hormones|hormones|mesh-ancestor
65606097|NCT03323476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65606098|NCT03323476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65606099|NCT02361892|Ulipristal acetate|ulipristal acetate|mesh-list
65606100|NCT02361892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65606101|NCT02361892|Contraceptive Agents|contraceptive agents|mesh-ancestor
65606102|NCT02361892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65606103|NCT02361892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606104|NCT02361892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65606105|NCT04013334|Nivolumab|nivolumab|mesh-list
65606106|NCT04013334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65606107|NCT04013334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606108|NCT04013334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65606109|NCT04013334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606110|NCT02366884|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65606111|NCT02366884|Antifungal Agents|antifungal agents|mesh-list
65606112|NCT02366884|Clotrimazole|clotrimazole|mesh-list
65606113|NCT02366884|Miconazole|miconazole|mesh-list
65606114|NCT02366884|Antiprotozoal Agents|antiprotozoal agents|mesh-list
65606115|NCT02366884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65606116|NCT02366884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65606117|NCT02366884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65606118|NCT02366884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65606119|NCT02366884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266021|NCT02774876|Insulin|insulin|mesh-list
65606120|NCT02366884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606121|NCT02366884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65606122|NCT02366884|Hormone Antagonists|hormone antagonists|mesh-ancestor
65606123|NCT02366884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65606124|NCT02366884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606125|NCT02366884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65606126|NCT02366884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65606127|NCT02366884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65606129|NCT02361502|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65606130|NCT02361502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65606131|NCT02361502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65606132|NCT02361502|Adrenergic Agents|adrenergic agents|mesh-ancestor
65606133|NCT02361502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65606134|NCT02361502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606135|NCT02361502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606136|NCT02361502|Urological Agents|urological agents|mesh-ancestor
65606137|NCT02367118|Prednisone|prednisone|mesh-list
65606138|NCT02367118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65606139|NCT02367118|Glucocorticoids|glucocorticoids|mesh-ancestor
65606140|NCT02367118|Hormones|hormones|mesh-ancestor
65606141|NCT02367118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65606142|NCT02367118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606143|NCT02367118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65606144|NCT02367118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606145|NCT00979212|Paclitaxel|paclitaxel|mesh-list
65606146|NCT00979212|Carboplatin|carboplatin|mesh-list
65606147|NCT00979212|Panitumumab|panitumumab|mesh-list
65606148|NCT00979212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65606149|NCT00979212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606150|NCT00979212|Tubulin Modulators|tubulin modulators|mesh-ancestor
65606151|NCT00979212|Antimitotic Agents|antimitotic agents|mesh-ancestor
65606152|NCT00979212|Mitosis Modulators|mitosis modulators|mesh-ancestor
65606153|NCT00979212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606154|NCT00979212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65606155|NCT02361190|Methyltestosterone|methyltestosterone|mesh-list
65606156|NCT02361190|Testosterone|testosterone|mesh-list
65606157|NCT02361190|Testosterone undecanoate|testosterone undecanoate|mesh-list
65606158|NCT02361190|Testosterone enanthate|testosterone enanthate|mesh-list
65606159|NCT02361190|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65606160|NCT02361190|Androgens|androgens|mesh-ancestor
65606161|NCT02361190|Hormones|hormones|mesh-ancestor
65606162|NCT02361190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65606163|NCT02361190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606164|NCT02361190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65606165|NCT02361190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606166|NCT02361190|Anabolic Agents|anabolic agents|mesh-ancestor
65606167|NCT02361112|Capecitabine|capecitabine|mesh-list
65606168|NCT02361112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65606169|NCT02361112|Antimetabolites|antimetabolites|mesh-ancestor
65606170|NCT02361112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606171|NCT02361112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606172|NCT02360956|Olmesartan|olmesartan|mesh-list
65606173|NCT02360956|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65606174|NCT02360956|Antihypertensive Agents|antihypertensive agents|mesh-list
65606175|NCT02360956|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65606176|NCT02360956|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65606177|NCT02360956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606178|NCT02360800|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65606179|NCT02360800|Hemostatics|hemostatics|mesh-list
65606180|NCT02360800|Coagulants|coagulants|mesh-ancestor
65606181|NCT03501966|Acetazolamide|acetazolamide|mesh-list
65606182|NCT03501966|Diuretics|diuretics|mesh-list
65606183|NCT03501966|Natriuretic Agents|natriuretic agents|mesh-ancestor
65606184|NCT03501966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606185|NCT03501966|Anticonvulsants|anticonvulsants|mesh-ancestor
65606186|NCT03501966|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65606187|NCT03501966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606188|NCT03501966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606189|NCT02355184|Leronlimab|leronlimab|mesh-list
65606190|NCT02355184|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65606191|NCT02355184|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65606192|NCT02355184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606193|NCT02355184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65606194|NCT02355184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65606195|NCT02355184|Antiviral Agents|antiviral agents|mesh-ancestor
65606196|NCT02355184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65606197|NCT03477630|Hyaluronic Acid|hyaluronic acid|mesh-list
65606198|NCT03477630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65606199|NCT03477630|Immunologic Factors|immunologic factors|mesh-ancestor
65606200|NCT03477630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606201|NCT03477630|Viscosupplements|viscosupplements|mesh-ancestor
65606202|NCT03477630|Protective Agents|protective agents|mesh-ancestor
65606204|NCT02981342|Capecitabine|capecitabine|mesh-list
65606205|NCT02981342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65606206|NCT02981342|Antimetabolites|antimetabolites|mesh-ancestor
65606207|NCT02981342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606208|NCT02981342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606209|NCT02981342|Antiviral Agents|antiviral agents|mesh-ancestor
65606210|NCT02981342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65606211|NCT02981342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606212|NCT02981342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65606213|NCT02981342|Immunologic Factors|immunologic factors|mesh-ancestor
65606214|NCT02981342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606215|NCT02639026|Durvalumab|durvalumab|mesh-list
65606216|NCT02639026|Tremelimumab|tremelimumab|mesh-list
65606217|NCT02639026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65606218|NCT02639026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606219|NCT02360644|Vitamin D|vitamin d|mesh-list
65606220|NCT02360644|Cholecalciferol|cholecalciferol|mesh-list
65606221|NCT02360644|Vitamins|vitamins|mesh-ancestor
65606222|NCT02360644|Micronutrients|micronutrients|mesh-ancestor
65606223|NCT02360644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606224|NCT02360644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65606225|NCT02360644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65606226|NCT02365948|Certolizumab Pegol|certolizumab pegol|mesh-list
65606227|NCT02365948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65606228|NCT02365948|Immunologic Factors|immunologic factors|mesh-ancestor
65606229|NCT02365948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606230|NCT02365948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65606231|NCT02354950|Cabotegravir|cabotegravir|mesh-list
65606232|NCT02354950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65606233|NCT02354950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65606234|NCT02354950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606235|NCT02354950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606236|NCT02354950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65606237|NCT02354950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65606238|NCT02354950|Antiviral Agents|antiviral agents|mesh-ancestor
65606239|NCT02354950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65606240|NCT02980874|Triamcinolone|triamcinolone|mesh-list
65606241|NCT02980874|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65606242|NCT02980874|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65606243|NCT02980874|Aflibercept|aflibercept|mesh-list
65606244|NCT02980874|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65606245|NCT02980874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65606246|NCT02980874|Glucocorticoids|glucocorticoids|mesh-ancestor
65606247|NCT02980874|Hormones|hormones|mesh-ancestor
65606248|NCT02980874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65606249|NCT02980874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606250|NCT02980874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65606251|NCT02980874|Immunologic Factors|immunologic factors|mesh-ancestor
65606252|NCT02980874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606253|NCT02980874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606254|NCT02980874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65606255|NCT02980874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65606256|NCT02980874|Growth Substances|growth substances|mesh-ancestor
65606257|NCT02980874|Growth Inhibitors|growth inhibitors|mesh-ancestor
65606258|NCT02980874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606259|NCT02354872|Nicotine|nicotine|mesh-list
65606260|NCT02354872|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65606261|NCT02354872|Autonomic Agents|autonomic agents|mesh-ancestor
65606262|NCT02354872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65606263|NCT02354872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606264|NCT02354872|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65606265|NCT02354872|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65606266|NCT02354872|Cholinergic Agents|cholinergic agents|mesh-ancestor
65606267|NCT02354872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65606268|NCT02354872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606269|NCT02354638|Nicotine|nicotine|mesh-list
65606270|NCT02354638|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65606271|NCT02354638|Autonomic Agents|autonomic agents|mesh-ancestor
65606272|NCT02354638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65606273|NCT02354638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606274|NCT02354638|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65606275|NCT02354638|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65606276|NCT02354638|Cholinergic Agents|cholinergic agents|mesh-ancestor
65606277|NCT02354638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65606278|NCT02354638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606279|NCT02360254|Insulin|insulin|mesh-list
65606280|NCT02360254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65606281|NCT02360254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606282|NCT03121014|Methotrexate|methotrexate|mesh-list
65606283|NCT03121014|Fludarabine|fludarabine|mesh-list
65606284|NCT03121014|Busulfan|busulfan|mesh-list
65606285|NCT03121014|Tacrolimus|tacrolimus|mesh-list
65606286|NCT03121014|Thymoglobulin|thymoglobulin|mesh-list
65606287|NCT03121014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65606288|NCT03121014|Abortifacient Agents|abortifacient agents|mesh-ancestor
65606289|NCT03121014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65606290|NCT03121014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606291|NCT03121014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65606292|NCT03121014|Antimetabolites|antimetabolites|mesh-ancestor
65606293|NCT03121014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606294|NCT03121014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606295|NCT03121014|Dermatologic Agents|dermatologic agents|mesh-ancestor
65606296|NCT03121014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606297|NCT03121014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65606298|NCT03121014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65606299|NCT03121014|Immunologic Factors|immunologic factors|mesh-ancestor
65606300|NCT03121014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65606301|NCT03121014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65606302|NCT03121014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65606303|NCT03121014|Alkylating Agents|alkylating agents|mesh-ancestor
65606304|NCT03121014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65606305|NCT03121014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65606306|NCT03112642|Anesthetics|anesthetics|mesh-list
65606307|NCT03112642|Bupivacaine|bupivacaine|mesh-list
65606308|NCT03112642|Anesthetics, Local|anesthetics, local|mesh-list
65606309|NCT03112642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65606310|NCT03112642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606311|NCT03112642|Sensory System Agents|sensory system agents|mesh-ancestor
65606312|NCT03112642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65606313|NCT01377324|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65606314|NCT01377324|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65606315|NCT01377324|Estradiol|estradiol|mesh-list
65606316|NCT01377324|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65606317|NCT01377324|Estrogens|estrogens|mesh-ancestor
65606318|NCT01377324|Hormones|hormones|mesh-ancestor
65606319|NCT01377324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65606320|NCT01377324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606321|NCT01377324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65606322|NCT01377324|Contraceptive Agents|contraceptive agents|mesh-ancestor
65606323|NCT01377324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65606324|NCT01377324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65606325|NCT02359942|Citric Acid|citric acid|mesh-list
65606326|NCT02359942|Sodium Citrate|sodium citrate|mesh-list
65606327|NCT02359942|Anticoagulants|anticoagulants|mesh-ancestor
65606328|NCT02359942|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65606329|NCT02359942|Chelating Agents|chelating agents|mesh-ancestor
65606330|NCT02359942|Sequestering Agents|sequestering agents|mesh-ancestor
65606331|NCT02359942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606332|NCT02354560|Erythromycin|erythromycin|mesh-list
65606333|NCT02354560|Erythromycin Estolate|erythromycin estolate|mesh-list
65606334|NCT02354560|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65606335|NCT02354560|Erythromycin stearate|erythromycin stearate|mesh-list
65606336|NCT02354560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65606337|NCT02354560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65606338|NCT02354560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65606339|NCT02354560|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65606340|NCT02354560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606341|NCT02354560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606342|NCT01378884|Domperidone|domperidone|mesh-list
65606343|NCT01378884|Antiemetics|antiemetics|mesh-ancestor
65606344|NCT01378884|Autonomic Agents|autonomic agents|mesh-ancestor
65606345|NCT01378884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65606346|NCT01378884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606347|NCT01378884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65606348|NCT01378884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65606349|NCT01378884|Dopamine Agents|dopamine agents|mesh-ancestor
65606351|NCT01378884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606352|NCT02039050|Tiotropium Bromide|tiotropium bromide|mesh-list
65606353|NCT02039050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65606354|NCT02039050|Autonomic Agents|autonomic agents|mesh-ancestor
65606355|NCT02039050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65606356|NCT02039050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606357|NCT02039050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65606358|NCT02039050|Respiratory System Agents|respiratory system agents|mesh-ancestor
65606359|NCT02039050|Parasympatholytics|parasympatholytics|mesh-ancestor
65606360|NCT02039050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65606361|NCT02039050|Cholinergic Agents|cholinergic agents|mesh-ancestor
65606362|NCT02039050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65606363|NCT02039050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606364|NCT05383482|Paclitaxel|paclitaxel|mesh-list
65606365|NCT05383482|Docetaxel|docetaxel|mesh-list
65606366|NCT05383482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65606367|NCT05383482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606368|NCT05383482|Tubulin Modulators|tubulin modulators|mesh-ancestor
65606369|NCT05383482|Antimitotic Agents|antimitotic agents|mesh-ancestor
65606370|NCT05383482|Mitosis Modulators|mitosis modulators|mesh-ancestor
65606371|NCT05383482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606372|NCT02354170|Mifepristone|mifepristone|mesh-list
65606373|NCT02354170|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65606374|NCT02354170|Abortifacient Agents|abortifacient agents|mesh-ancestor
65606375|NCT02354170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65606376|NCT02354170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606377|NCT02354170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65606378|NCT02354170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65606379|NCT02354170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65606380|NCT02354170|Contraceptive Agents|contraceptive agents|mesh-ancestor
65606381|NCT02354170|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65606382|NCT02354170|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65606383|NCT02354170|Hormone Antagonists|hormone antagonists|mesh-ancestor
65606384|NCT02354170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65606385|NCT02354170|Luteolytic Agents|luteolytic agents|mesh-ancestor
65606386|NCT02354170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65606387|NCT02354170|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65606388|NCT01377246|Octreotide|octreotide|mesh-list
65606389|NCT01377246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65606390|NCT01377246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65606391|NCT01377246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606392|NCT02353936|Afatinib|afatinib|mesh-list
65606393|NCT02353936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606394|NCT02353936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65606395|NCT02353936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606396|NCT02353936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606397|NCT02353858|Fluorouracil|fluorouracil|mesh-list
65606398|NCT02353858|Antimetabolites|antimetabolites|mesh-ancestor
65606399|NCT02353858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606400|NCT02353858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65606401|NCT02353858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606402|NCT02353858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65606403|NCT02353858|Immunologic Factors|immunologic factors|mesh-ancestor
65606404|NCT02353858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606405|NCT02353702|Ropivacaine|ropivacaine|mesh-list
65606406|NCT02353702|Anesthetics, Local|anesthetics, local|mesh-ancestor
65606407|NCT02353702|Anesthetics|anesthetics|mesh-ancestor
65606408|NCT02353702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65606409|NCT02353702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606410|NCT02353702|Sensory System Agents|sensory system agents|mesh-ancestor
65606411|NCT02353702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65606412|NCT02532660|Dexetimide|dexetimide|mesh-list
65606413|NCT02532660|Citalopram|citalopram|mesh-list
65606414|NCT02532660|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65606415|NCT02532660|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65606416|NCT02532660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65606417|NCT02532660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606418|NCT02532660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65606419|NCT02532660|Serotonin Agents|serotonin agents|mesh-ancestor
65606420|NCT02532660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403813|NCT00069121|Leucovorin|leucovorin|mesh-list
65606421|NCT02532660|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65606422|NCT02532660|Antidepressive Agents|antidepressive agents|mesh-ancestor
65606423|NCT02532660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65606424|NCT02532660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65606425|NCT02532660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65606426|NCT02532660|Parasympatholytics|parasympatholytics|mesh-ancestor
65606427|NCT02532660|Autonomic Agents|autonomic agents|mesh-ancestor
65606428|NCT02532660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65606429|NCT02532660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65606430|NCT02532660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65606431|NCT02532660|Cholinergic Agents|cholinergic agents|mesh-ancestor
65606432|NCT01377168|Naltrexone|naltrexone|mesh-list
65606433|NCT01377168|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65606434|NCT01377168|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65606435|NCT01377168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606436|NCT01377168|Sensory System Agents|sensory system agents|mesh-ancestor
65606437|NCT01377168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65606438|NCT02892149|Darbepoetin alfa|darbepoetin alfa|mesh-list
65606439|NCT02892149|Hematinics|hematinics|mesh-ancestor
65606440|NCT05335356|Ustekinumab|ustekinumab|mesh-list
65606441|NCT05335356|Dermatologic Agents|dermatologic agents|mesh-ancestor
65606442|NCT02348398|Topotecan|topotecan|mesh-list
65606443|NCT02348398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65606444|NCT02348398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65606445|NCT02348398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606446|NCT02348398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606447|NCT02348398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606448|NCT05278338|Denosumab|denosumab|mesh-list
65606449|NCT05278338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65606450|NCT05278338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606451|NCT03721757|Nivolumab|nivolumab|mesh-list
65606452|NCT03721757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65606453|NCT03721757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606454|NCT03721757|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65606455|NCT03721757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606456|NCT03727607|Propofol|propofol|mesh-list
65606457|NCT03727607|Desflurane|desflurane|mesh-list
65606458|NCT03727607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65606459|NCT03727607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65606460|NCT03727607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606461|NCT03727607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65606462|NCT03727607|Anesthetics, General|anesthetics, general|mesh-ancestor
65606463|NCT03727607|Anesthetics|anesthetics|mesh-ancestor
65606464|NCT03727607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65606465|NCT02348242|Lubricant Eye Drops|lubricant eye drops|mesh-list
65606466|NCT02348242|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65606467|NCT02348242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65606468|NCT03157804|Plerixafor|plerixafor|mesh-list
65606469|NCT03157804|Lenograstim|lenograstim|mesh-list
65606470|NCT03157804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65606471|NCT03157804|Immunologic Factors|immunologic factors|mesh-ancestor
65606472|NCT03157804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606473|NCT03157804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65606474|NCT03157804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65606475|NCT03157804|Antiviral Agents|antiviral agents|mesh-ancestor
65606476|NCT03157804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65606477|NCT03157414|Empagliflozin|empagliflozin|mesh-list
65606478|NCT03157414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65606479|NCT03157414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606480|NCT03157414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65606481|NCT03157414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606482|NCT03147196|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65606483|NCT03147196|Bicalutamide|bicalutamide|mesh-list
65606484|NCT03147196|Androgen Antagonists|androgen antagonists|mesh-ancestor
65606485|NCT03147196|Hormone Antagonists|hormone antagonists|mesh-ancestor
65606486|NCT03147196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65606487|NCT03147196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606488|NCT03147196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606489|NCT03147196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65606490|NCT03147196|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65606491|NCT03147196|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65606492|NCT03147196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65606493|NCT03153436|Inositol|inositol|mesh-list
65606494|NCT03153436|Vitamin B Complex|vitamin b complex|mesh-ancestor
65606495|NCT03153436|Vitamins|vitamins|mesh-ancestor
65606496|NCT03153436|Micronutrients|micronutrients|mesh-ancestor
65606497|NCT03153436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606498|NCT03544229|Maleic acid|maleic acid|mesh-list
65606499|NCT03544229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606500|NCT03544229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606502|NCT02351908|Raltegravir Potassium|raltegravir potassium|mesh-list
65606503|NCT02351908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65606504|NCT02351908|Dolutegravir|dolutegravir|mesh-list
65606505|NCT02351908|Cobicistat|cobicistat|mesh-list
65606506|NCT02351908|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65606507|NCT02351908|Elvitegravir|elvitegravir|mesh-list
65606508|NCT02351908|Antiviral Agents|antiviral agents|mesh-ancestor
65606509|NCT02351908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65606510|NCT02351908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65606511|NCT02351908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65606512|NCT02351908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606513|NCT02351908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606514|NCT02351908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65606515|NCT02351908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65606516|NCT02351908|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65606517|NCT02351908|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65606518|NCT02351908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65606519|NCT02351908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65606520|NCT01371240|Secretin|secretin|mesh-list
65606521|NCT01371240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65606522|NCT01371240|Hormones|hormones|mesh-ancestor
65606523|NCT01371240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65606524|NCT01371240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606525|NCT02352064|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65606526|NCT02352064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65606527|NCT02352064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606528|NCT03723941|Etoposide|etoposide|mesh-list
65606529|NCT03723941|Mitotane|mitotane|mesh-list
65606530|NCT03723941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606531|NCT03723941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65606532|NCT03723941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65606533|NCT03723941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65606534|NCT03723941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606535|NCT03723941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606536|NCT03723941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65606537|NCT00775476|Acetylcysteine|acetylcysteine|mesh-list
65606538|NCT00775476|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65606539|NCT00775476|Antiviral Agents|antiviral agents|mesh-ancestor
65606540|NCT00775476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65606541|NCT00775476|Expectorants|expectorants|mesh-ancestor
65606542|NCT00775476|Respiratory System Agents|respiratory system agents|mesh-ancestor
65606543|NCT00775476|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65606544|NCT00775476|Antioxidants|antioxidants|mesh-ancestor
65266050|NCT00613470|Citalopram|citalopram|mesh-list
65606545|NCT00775476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606546|NCT00775476|Protective Agents|protective agents|mesh-ancestor
65606547|NCT00775476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606548|NCT00775476|Antidotes|antidotes|mesh-ancestor
65606549|NCT03721679|Pembrolizumab|pembrolizumab|mesh-list
65606550|NCT03721679|Nivolumab|nivolumab|mesh-list
65606551|NCT03721679|Durvalumab|durvalumab|mesh-list
65606552|NCT03721679|Atezolizumab|atezolizumab|mesh-list
65606553|NCT03721679|Poly ICLC|poly iclc|mesh-list
65606554|NCT03721679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65606555|NCT03721679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606556|NCT03721679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65606557|NCT03721679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606558|NCT03721679|Interferon Inducers|interferon inducers|mesh-ancestor
65606559|NCT03721679|Immunologic Factors|immunologic factors|mesh-ancestor
65606560|NCT03721679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606561|NCT03639948|Carboplatin|carboplatin|mesh-list
65606562|NCT03639948|Docetaxel|docetaxel|mesh-list
65606563|NCT03639948|Pembrolizumab|pembrolizumab|mesh-list
65606564|NCT03639948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606565|NCT03639948|Tubulin Modulators|tubulin modulators|mesh-ancestor
65606566|NCT03639948|Antimitotic Agents|antimitotic agents|mesh-ancestor
65606567|NCT03639948|Mitosis Modulators|mitosis modulators|mesh-ancestor
65606568|NCT03639948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606569|NCT03639948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65606570|NCT03968406|Talazoparib|talazoparib|mesh-list
65606571|NCT03968406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65606572|NCT03968406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606573|NCT03968406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606574|NCT03968406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606575|NCT03510455|Infigratinib|infigratinib|mesh-list
65606576|NCT03510455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606577|NCT03509675|Ibuprofen|ibuprofen|mesh-list
65606578|NCT03509675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65606579|NCT03509675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65606580|NCT03509675|Analgesics|analgesics|mesh-ancestor
65606581|NCT03509675|Sensory System Agents|sensory system agents|mesh-ancestor
65606582|NCT03509675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65606583|NCT03509675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606584|NCT03509675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65606585|NCT03509675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65606586|NCT03509675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65606587|NCT03509675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606588|NCT03509675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606589|NCT02351752|Hydroxychloroquine|hydroxychloroquine|mesh-list
65606590|NCT02351752|Antimalarials|antimalarials|mesh-ancestor
65606591|NCT02351752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65606592|NCT02351752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65606593|NCT02351752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65606594|NCT02351752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606595|NCT02351752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606596|NCT02351752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65606597|NCT04852224|Leuprolide|leuprolide|mesh-list
65606598|NCT04852224|Goserelin|goserelin|mesh-list
65606599|NCT04852224|Androgens|androgens|mesh-list
65606600|NCT04852224|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65606601|NCT04852224|Fertility Agents|fertility agents|mesh-ancestor
65606602|NCT04852224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65606603|NCT04852224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606604|NCT04852224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65606605|NCT04852224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606606|NCT04852224|Hormones|hormones|mesh-ancestor
65606607|NCT04852224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65606608|NCT02353078|Sucralfate|sucralfate|mesh-list
65606609|NCT02353078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65606610|NCT02353078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65606611|NCT03509207|Vorinostat|vorinostat|mesh-list
65606612|NCT03509207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606613|NCT03509207|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65606614|NCT03509207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606615|NCT03509207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606616|NCT04808778|Hydroxyurea|hydroxyurea|mesh-list
65606617|NCT04808778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606618|NCT04808778|Antisickling Agents|antisickling agents|mesh-ancestor
65606619|NCT04808778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606620|NCT04808778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606621|NCT04808778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65606622|NCT03727295|Idebenone|idebenone|mesh-list
65606623|NCT03727295|Antioxidants|antioxidants|mesh-ancestor
65606624|NCT03727295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606625|NCT03727295|Protective Agents|protective agents|mesh-ancestor
65606626|NCT03727295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606627|NCT01378650|Cilostazol|cilostazol|mesh-list
65606628|NCT01378650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65606629|NCT01378650|Autonomic Agents|autonomic agents|mesh-ancestor
65606630|NCT01378650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65606631|NCT01378650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606632|NCT01378650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65606633|NCT01378650|Respiratory System Agents|respiratory system agents|mesh-ancestor
65606634|NCT01378650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65606635|NCT01378650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65606636|NCT01378650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606637|NCT01378650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65606638|NCT01378650|Vasodilator Agents|vasodilator agents|mesh-ancestor
65606639|NCT01378650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65606640|NCT01378650|Protective Agents|protective agents|mesh-ancestor
65606641|NCT01378650|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65606642|NCT01378650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65606643|NCT01378650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606644|NCT04796922|Rituximab|rituximab|mesh-list
65606645|NCT04796922|Obinutuzumab|obinutuzumab|mesh-list
65606646|NCT04796922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65606647|NCT04796922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606648|NCT04796922|Immunologic Factors|immunologic factors|mesh-ancestor
65606649|NCT04796922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606650|NCT04796922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65606651|NCT03723785|Insulin|insulin|mesh-list
65606652|NCT03723785|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65606653|NCT03723785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65606654|NCT03723785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606655|NCT03543137|Nicotine|nicotine|mesh-list
65606656|NCT03543137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65606657|NCT03543137|Autonomic Agents|autonomic agents|mesh-ancestor
65606658|NCT03543137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65606659|NCT03543137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606660|NCT03543137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65606661|NCT03543137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65606662|NCT03543137|Cholinergic Agents|cholinergic agents|mesh-ancestor
65606663|NCT03543137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65606664|NCT03543137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606665|NCT03146650|Nivolumab|nivolumab|mesh-list
65606666|NCT03146650|Ipilimumab|ipilimumab|mesh-list
65606667|NCT03146650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65606668|NCT03146650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606669|NCT03146650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65606670|NCT03146650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606671|NCT02343484|Ethanol|ethanol|mesh-list
65606672|NCT02343484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65606673|NCT02343484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65606674|NCT02343484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65606675|NCT02343484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606676|NCT03630042|Rituximab|rituximab|mesh-list
65606677|NCT03630042|Pembrolizumab|pembrolizumab|mesh-list
65606678|NCT03630042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65606679|NCT03630042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606680|NCT03630042|Immunologic Factors|immunologic factors|mesh-ancestor
65606681|NCT03630042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606682|NCT03630042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65606683|NCT03073980|Acetaminophen|acetaminophen|mesh-list
65606684|NCT03073980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65606685|NCT03073980|Analgesics|analgesics|mesh-ancestor
65606686|NCT03073980|Sensory System Agents|sensory system agents|mesh-ancestor
65606687|NCT03073980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65606688|NCT03073980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606689|NCT03073980|Antipyretics|antipyretics|mesh-ancestor
65606690|NCT04117932|Ustekinumab|ustekinumab|mesh-list
65606691|NCT04117932|Dermatologic Agents|dermatologic agents|mesh-ancestor
65606692|NCT03930186|Apremilast|apremilast|mesh-list
65606693|NCT03930186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65606694|NCT03930186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65606695|NCT03930186|Analgesics|analgesics|mesh-ancestor
65606696|NCT03930186|Sensory System Agents|sensory system agents|mesh-ancestor
65606697|NCT03930186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65606698|NCT03930186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606699|NCT03930186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65606700|NCT03930186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65606701|NCT03930186|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65606702|NCT03930186|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65606703|NCT03930186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606704|NCT03930186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606705|NCT02351440|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65606706|NCT02351440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65606707|NCT02351440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65606708|NCT02351440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65606709|NCT02351440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606710|NCT02351440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65606711|NCT02351440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606712|NCT02351440|Analgesics|analgesics|mesh-ancestor
65606713|NCT02351440|Sensory System Agents|sensory system agents|mesh-ancestor
65606714|NCT02351440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65606715|NCT02351440|Antidepressive Agents|antidepressive agents|mesh-ancestor
65606716|NCT02351440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65606717|NCT02351440|Dopamine Agents|dopamine agents|mesh-ancestor
65606718|NCT02351128|Lanreotide|lanreotide|mesh-list
65606719|NCT02351128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606720|NCT02343250|Valsartan|valsartan|mesh-list
65606721|NCT02343250|Cilnidipine|cilnidipine|mesh-list
65606722|NCT02343250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65606723|NCT02343250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65606724|NCT02343250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65606725|NCT02343250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606726|NCT02343250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65606727|NCT02343250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65606728|NCT02343250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65606729|NCT02343250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606730|NCT03781440|Lidocaine|lidocaine|mesh-list
65606731|NCT03781440|Anesthetics, Local|anesthetics, local|mesh-ancestor
65606732|NCT03781440|Anesthetics|anesthetics|mesh-ancestor
65606733|NCT03781440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65606734|NCT03781440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606735|NCT03781440|Sensory System Agents|sensory system agents|mesh-ancestor
65606736|NCT03781440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65606737|NCT03781440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65606738|NCT03781440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65606739|NCT03781440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65606740|NCT03781440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65606741|NCT03781440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606742|NCT03565211|Progesterone|progesterone|mesh-list
65606743|NCT03565211|Progestins|progestins|mesh-ancestor
65606744|NCT03565211|Hormones|hormones|mesh-ancestor
65606745|NCT03565211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65606746|NCT03565211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606747|NCT03740100|Sirolimus|sirolimus|mesh-list
65606748|NCT03740100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65606749|NCT03740100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65606750|NCT03740100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65606751|NCT03740100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606752|NCT03740100|Antifungal Agents|antifungal agents|mesh-ancestor
65606753|NCT03740100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65606754|NCT03740100|Immunologic Factors|immunologic factors|mesh-ancestor
65606755|NCT03740100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606756|NCT03723395|Repaglinide|repaglinide|mesh-list
65606757|NCT03723395|Tolbutamide|tolbutamide|mesh-list
65606758|NCT03723395|Itraconazole|itraconazole|mesh-list
65606759|NCT03723395|Rifampin|rifampin|mesh-list
65606760|NCT03723395|Tucatinib|tucatinib|mesh-list
65606761|NCT03723395|Digoxin|digoxin|mesh-list
65606762|NCT03723395|Midazolam|midazolam|mesh-list
65606763|NCT03723395|Gemfibrozil|gemfibrozil|mesh-list
65606764|NCT03723395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65606765|NCT03723395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65606766|NCT03723395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65606767|NCT03723395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606768|NCT03723395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65606769|NCT03723395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65606770|NCT03723395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65606771|NCT03723395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65606772|NCT03723395|Anesthetics, General|anesthetics, general|mesh-ancestor
65606773|NCT03723395|Anesthetics|anesthetics|mesh-ancestor
65606774|NCT03723395|GABA Modulators|gaba modulators|mesh-ancestor
65606775|NCT03723395|GABA Agents|gaba agents|mesh-ancestor
65606776|NCT03723395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65606777|NCT03723395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606778|NCT03723395|Antifungal Agents|antifungal agents|mesh-ancestor
65606779|NCT03723395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65606780|NCT03723395|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65606781|NCT03723395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65606782|NCT03723395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606783|NCT03723395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65606784|NCT03723395|Hormone Antagonists|hormone antagonists|mesh-ancestor
65606785|NCT03723395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65606786|NCT03723395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65606787|NCT03723395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65606788|NCT03723395|Antitubercular Agents|antitubercular agents|mesh-ancestor
65606789|NCT03723395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65606790|NCT03723395|Leprostatic Agents|leprostatic agents|mesh-ancestor
65606791|NCT03723395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65606792|NCT03723395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65606793|NCT03723395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65606794|NCT03723395|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65606795|NCT03723395|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65606796|NCT03723395|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65606797|NCT03723395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65606798|NCT03723395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65606799|NCT03723395|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65606800|NCT03723395|Protective Agents|protective agents|mesh-ancestor
65606801|NCT03723395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65606802|NCT03723395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606803|NCT03723395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65606804|NCT03723395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65606805|NCT03723395|Antimetabolites|antimetabolites|mesh-ancestor
65606806|NCT03723395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65606807|NCT03723395|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65606808|NCT03531905|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
65606809|NCT03531905|Ezetimibe|ezetimibe|mesh-list
65606810|NCT03531905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65606811|NCT03531905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65606812|NCT03531905|Antimetabolites|antimetabolites|mesh-ancestor
65606813|NCT03531905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606814|NCT03531905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65606815|NCT03531905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606816|NCT03531905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65606817|NCT03531905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606818|NCT02350426|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65606819|NCT02350426|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65606820|NCT02350426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606821|NCT02346682|Clonazepam|clonazepam|mesh-list
65606822|NCT02346682|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65606823|NCT02346682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65606824|NCT02346682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65606825|NCT02346682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65606826|NCT02346682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606827|NCT02346682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65606828|NCT02346682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606829|NCT02346682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65606830|NCT02346682|Antidepressive Agents|antidepressive agents|mesh-ancestor
65606831|NCT02346682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65606832|NCT02346682|Anticonvulsants|anticonvulsants|mesh-ancestor
65606833|NCT02346682|GABA Modulators|gaba modulators|mesh-ancestor
65606834|NCT02346682|GABA Agents|gaba agents|mesh-ancestor
65606835|NCT04300296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65606836|NCT04300296|Immunologic Factors|immunologic factors|mesh-ancestor
65606837|NCT04300296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606838|NCT05764590|Sevelamer|sevelamer|mesh-list
65606839|NCT05764590|Chelating Agents|chelating agents|mesh-ancestor
65606840|NCT05764590|Sequestering Agents|sequestering agents|mesh-ancestor
65606841|NCT05764590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606842|NCT05764512|Endorphins|endorphins|mesh-list
65606843|NCT05764512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65606844|NCT05764512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606845|NCT05764512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606846|NCT02342392|Ranibizumab|ranibizumab|mesh-list
65606847|NCT02342392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65606848|NCT02342392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65606849|NCT02342392|Growth Substances|growth substances|mesh-ancestor
65606850|NCT02342392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606851|NCT02342392|Growth Inhibitors|growth inhibitors|mesh-ancestor
65606852|NCT02342392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606853|NCT02342002|Misoprostol|misoprostol|mesh-list
65606854|NCT02342002|Mifepristone|mifepristone|mesh-list
65606855|NCT02342002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65606856|NCT02342002|Abortifacient Agents|abortifacient agents|mesh-ancestor
65606857|NCT02342002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65606858|NCT02342002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606859|NCT02342002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65606860|NCT02342002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65606861|NCT02342002|Oxytocics|oxytocics|mesh-ancestor
65606862|NCT02342002|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65606863|NCT02342002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65606864|NCT02342002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65606865|NCT02342002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65606866|NCT02342002|Contraceptive Agents|contraceptive agents|mesh-ancestor
65606867|NCT02342002|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65606868|NCT02342002|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65606869|NCT02342002|Hormone Antagonists|hormone antagonists|mesh-ancestor
65606870|NCT02342002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65606871|NCT02342002|Luteolytic Agents|luteolytic agents|mesh-ancestor
65606872|NCT02342002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65606873|NCT02342002|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65606874|NCT03657264|Moxifloxacin|moxifloxacin|mesh-list
65606875|NCT03657264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65606876|NCT03657264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65606877|NCT03657264|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65606878|NCT03657264|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65606879|NCT03657264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606880|NCT03657264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606881|NCT03657264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606882|NCT02345902|Haloperidol|haloperidol|mesh-list
65606883|NCT02345902|Haloperidol decanoate|haloperidol decanoate|mesh-list
65606884|NCT02345902|Antiemetics|antiemetics|mesh-ancestor
65606885|NCT02345902|Autonomic Agents|autonomic agents|mesh-ancestor
65606886|NCT02345902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65606887|NCT02345902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606888|NCT02345902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65606889|NCT02345902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65606890|NCT02345902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65606891|NCT02345902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65606892|NCT02345902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65606893|NCT02345902|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65606894|NCT02345902|Dopamine Agents|dopamine agents|mesh-ancestor
65606895|NCT02345902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65606896|NCT02345902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606897|NCT02345902|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65606898|NCT03601806|Thalidomide|thalidomide|mesh-list
65606899|NCT03601806|Pomalidomide|pomalidomide|mesh-list
65606900|NCT03601806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65606901|NCT03601806|Immunologic Factors|immunologic factors|mesh-ancestor
65606902|NCT03601806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606903|NCT03601806|Leprostatic Agents|leprostatic agents|mesh-ancestor
65606904|NCT03601806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65606905|NCT03601806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65606906|NCT03601806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65606907|NCT03601806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65606908|NCT03601806|Growth Substances|growth substances|mesh-ancestor
65606909|NCT03601806|Growth Inhibitors|growth inhibitors|mesh-ancestor
65606910|NCT03601806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606911|NCT02345980|Sildenafil Citrate|sildenafil citrate|mesh-list
65606912|NCT02345980|Vasodilator Agents|vasodilator agents|mesh-ancestor
65606913|NCT02345980|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65606914|NCT02345980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65606915|NCT02345980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606916|NCT02345980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606917|NCT02345980|Urological Agents|urological agents|mesh-ancestor
65606918|NCT02345746|Leucovorin|leucovorin|mesh-list
65606919|NCT02345746|Folic Acid|folic acid|mesh-list
65606920|NCT02345746|Fluorouracil|fluorouracil|mesh-list
65606921|NCT02345746|Oxaliplatin|oxaliplatin|mesh-list
65606922|NCT02345746|Levoleucovorin|levoleucovorin|mesh-list
65606923|NCT02345746|Antimetabolites|antimetabolites|mesh-ancestor
65606924|NCT02345746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606925|NCT02345746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65606926|NCT02345746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606927|NCT02345746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65606928|NCT02345746|Immunologic Factors|immunologic factors|mesh-ancestor
65606929|NCT02345746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606930|NCT02345746|Antidotes|antidotes|mesh-ancestor
65606931|NCT02345746|Protective Agents|protective agents|mesh-ancestor
65606932|NCT02345746|Vitamin B Complex|vitamin b complex|mesh-ancestor
65606933|NCT02345746|Vitamins|vitamins|mesh-ancestor
65606934|NCT02345746|Micronutrients|micronutrients|mesh-ancestor
65606935|NCT02345746|Hematinics|hematinics|mesh-ancestor
65606936|NCT03794778|Paclitaxel|paclitaxel|mesh-list
65606937|NCT03794778|Carboplatin|carboplatin|mesh-list
65606938|NCT03794778|Doxorubicin|doxorubicin|mesh-list
65606939|NCT03794778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65606940|NCT03794778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65606941|NCT03794778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606942|NCT03794778|Tubulin Modulators|tubulin modulators|mesh-ancestor
65606943|NCT03794778|Antimitotic Agents|antimitotic agents|mesh-ancestor
65606944|NCT03794778|Mitosis Modulators|mitosis modulators|mesh-ancestor
65606945|NCT03794778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606946|NCT03794778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65606947|NCT03794778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65606948|NCT03794778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65606949|NCT03794778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606950|NCT02341300|Iron|iron|mesh-list
65606951|NCT02341300|Trace Elements|trace elements|mesh-ancestor
65606952|NCT02341300|Micronutrients|micronutrients|mesh-ancestor
65606953|NCT02341300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606954|NCT05462496|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65606955|NCT05462496|Metronidazole|metronidazole|mesh-list
65606956|NCT05462496|Ciprofloxacin|ciprofloxacin|mesh-list
65606957|NCT05462496|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65606958|NCT05462496|Pembrolizumab|pembrolizumab|mesh-list
65606959|NCT05462496|Folfirinox|folfirinox|mesh-list
65606960|NCT05462496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65606961|NCT05462496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65606962|NCT05462496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65606963|NCT05462496|Antitubercular Agents|antitubercular agents|mesh-ancestor
65606964|NCT05462496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65606965|NCT05462496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65606966|NCT05462496|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65606967|NCT05462496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65606968|NCT05462496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65606969|NCT05462496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606970|NCT05462496|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65606971|NCT05462496|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65606972|NCT03785340|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65606973|NCT03785340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65606974|NCT03785340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65606975|NCT03785340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65606976|NCT03785340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65606977|NCT03785340|Adrenergic Agents|adrenergic agents|mesh-ancestor
65606978|NCT03785340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65606979|NCT03785340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65606980|NCT03785340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606981|NCT02345590|Eplerenone|eplerenone|mesh-list
65606982|NCT02345590|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65606983|NCT02345590|Hormone Antagonists|hormone antagonists|mesh-ancestor
65606984|NCT02345590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65606985|NCT02345590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606986|NCT02345590|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65606987|NCT02345590|Diuretics|diuretics|mesh-ancestor
65606988|NCT02345590|Natriuretic Agents|natriuretic agents|mesh-ancestor
65606989|NCT02345590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65606990|NCT03723083|Thalidomide|thalidomide|mesh-list
65606991|NCT03723083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65606992|NCT03723083|Immunologic Factors|immunologic factors|mesh-ancestor
65606993|NCT03723083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65606994|NCT03723083|Leprostatic Agents|leprostatic agents|mesh-ancestor
65606995|NCT03723083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65606996|NCT03723083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65606997|NCT03723083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65606998|NCT03723083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65606999|NCT03723083|Growth Substances|growth substances|mesh-ancestor
65607000|NCT03723083|Growth Inhibitors|growth inhibitors|mesh-ancestor
65607001|NCT03723083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607002|NCT03774810|Zolpidem|zolpidem|mesh-list
65607003|NCT03774810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65607004|NCT03774810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65607005|NCT03774810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65607006|NCT03774810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607007|NCT03774810|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65607008|NCT03774810|GABA Agonists|gaba agonists|mesh-ancestor
65607009|NCT03774810|GABA Agents|gaba agents|mesh-ancestor
65607010|NCT03774810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65607011|NCT03774810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607012|NCT03562481|Lidocaine|lidocaine|mesh-list
65607013|NCT03562481|Epinephrine|epinephrine|mesh-list
65607014|NCT03562481|Racepinephrine|racepinephrine|mesh-list
65607015|NCT03562481|Epinephryl borate|epinephryl borate|mesh-list
65607016|NCT03562481|Anesthetics, Local|anesthetics, local|mesh-ancestor
65607017|NCT03562481|Anesthetics|anesthetics|mesh-ancestor
65607018|NCT03562481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65607019|NCT03562481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607020|NCT03562481|Sensory System Agents|sensory system agents|mesh-ancestor
65607021|NCT03562481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65607022|NCT03562481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65607023|NCT03562481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65607024|NCT03562481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65607025|NCT03562481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65607026|NCT03562481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607027|NCT03562481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65607028|NCT03562481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65607029|NCT03562481|Adrenergic Agents|adrenergic agents|mesh-ancestor
65607030|NCT03562481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65607031|NCT03562481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65607032|NCT03562481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65607033|NCT03562481|Autonomic Agents|autonomic agents|mesh-ancestor
65607034|NCT03562481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65607035|NCT03562481|Respiratory System Agents|respiratory system agents|mesh-ancestor
65607036|NCT03562481|Mydriatics|mydriatics|mesh-ancestor
65607037|NCT03562481|Sympathomimetics|sympathomimetics|mesh-ancestor
65607038|NCT03562481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65607039|NCT03726593|Artesunate|artesunate|mesh-list
65607040|NCT03726593|Mefloquine|mefloquine|mesh-list
65607041|NCT03726593|Atovaquone|atovaquone|mesh-list
65607042|NCT03726593|Pyronaridine|pyronaridine|mesh-list
65607043|NCT03726593|Proguanil|proguanil|mesh-list
65607044|NCT03726593|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
65607045|NCT03726593|Antimalarials|antimalarials|mesh-ancestor
65607046|NCT03726593|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65607047|NCT03726593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65607048|NCT03726593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65607049|NCT03726593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607050|NCT03726593|Antiviral Agents|antiviral agents|mesh-ancestor
65607051|NCT03726593|Schistosomicides|schistosomicides|mesh-ancestor
65607052|NCT03726593|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65607053|NCT03726593|Anthelmintics|anthelmintics|mesh-ancestor
65607054|NCT03726593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607055|NCT03726593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607056|NCT03726593|Antimetabolites|antimetabolites|mesh-ancestor
65607057|NCT04007224|Oxytocin|oxytocin|mesh-list
65607058|NCT04007224|Oxytocics|oxytocics|mesh-ancestor
65607059|NCT04007224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65607060|NCT04007224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607061|NCT03197064|Fosaprepitant|fosaprepitant|mesh-list
65607062|NCT03197064|Aprepitant|aprepitant|mesh-list
65607063|NCT03197064|Antiemetics|antiemetics|mesh-ancestor
65607064|NCT03197064|Autonomic Agents|autonomic agents|mesh-ancestor
65607065|NCT03197064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65607066|NCT03197064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607067|NCT03197064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65607068|NCT03197064|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65607069|NCT03197064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65607070|NCT03197064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607071|NCT02345044|Eplerenone|eplerenone|mesh-list
65607072|NCT02345044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65607073|NCT02345044|Hormone Antagonists|hormone antagonists|mesh-ancestor
65607074|NCT02345044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65607075|NCT02345044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607076|NCT02345044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65607077|NCT02345044|Diuretics|diuretics|mesh-ancestor
65607078|NCT02345044|Natriuretic Agents|natriuretic agents|mesh-ancestor
65607079|NCT02345044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65607080|NCT02349802|Exenatide|exenatide|mesh-list
65607081|NCT02349802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65607082|NCT02349802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607083|NCT02349802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65607084|NCT02349802|Incretins|incretins|mesh-ancestor
65607085|NCT02349802|Hormones|hormones|mesh-ancestor
65607086|NCT02349802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65607087|NCT03120624|Iodine|iodine|mesh-list
65607088|NCT03120624|Interferons|interferons|mesh-list
65607089|NCT03120624|Interferon-beta|interferon-beta|mesh-list
65607090|NCT03120624|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
65607091|NCT03120624|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
65607092|NCT03120624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607093|NCT03120624|Antiviral Agents|antiviral agents|mesh-ancestor
65607094|NCT03120624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65607095|NCT03120624|Immunologic Factors|immunologic factors|mesh-ancestor
65607096|NCT03120624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607097|NCT03120624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65607098|NCT03120624|Trace Elements|trace elements|mesh-ancestor
65607099|NCT03120624|Micronutrients|micronutrients|mesh-ancestor
65607100|NCT03120624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65607101|NCT03120624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607102|NCT03120624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607103|NCT03120624|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65607104|NCT03145714|Dexmedetomidine|dexmedetomidine|mesh-list
65607105|NCT03145714|Anesthetics|anesthetics|mesh-list
65607106|NCT03145714|Propofol|propofol|mesh-list
65607107|NCT03145714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65607108|NCT03145714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607109|NCT03145714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65607110|NCT03145714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65607111|NCT03145714|Anesthetics, General|anesthetics, general|mesh-ancestor
65607112|NCT03145714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65607113|NCT03145714|Analgesics|analgesics|mesh-ancestor
65607114|NCT03145714|Sensory System Agents|sensory system agents|mesh-ancestor
65607115|NCT03145714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65607116|NCT03145714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65607117|NCT03145714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65607118|NCT03145714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65607119|NCT03145714|Adrenergic Agents|adrenergic agents|mesh-ancestor
65607120|NCT03145714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65607121|NCT03145714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607122|NCT02349958|Doxorubicin|doxorubicin|mesh-list
65607123|NCT02349958|Cisplatin|cisplatin|mesh-list
65607124|NCT02349958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65607125|NCT02349958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607126|NCT02349958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65607127|NCT02349958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65607128|NCT02349958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607129|NCT02349958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607130|NCT04872426|Insulin|insulin|mesh-list
65607131|NCT04872426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65607132|NCT04872426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607133|NCT02344888|Folic Acid|folic acid|mesh-list
65607134|NCT02344888|Vitamin B Complex|vitamin b complex|mesh-list
65607135|NCT02344888|Prednisolone|prednisolone|mesh-list
65607136|NCT02344888|Citric Acid|citric acid|mesh-list
65607137|NCT02344888|Sodium Citrate|sodium citrate|mesh-list
65607138|NCT02344888|Clomiphene|clomiphene|mesh-list
65607139|NCT02344888|Enclomiphene|enclomiphene|mesh-list
65607140|NCT02344888|Zuclomiphene|zuclomiphene|mesh-list
65607141|NCT02344888|Anticoagulants|anticoagulants|mesh-ancestor
65607142|NCT02344888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65607143|NCT02344888|Chelating Agents|chelating agents|mesh-ancestor
65607144|NCT02344888|Sequestering Agents|sequestering agents|mesh-ancestor
65607145|NCT02344888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607146|NCT02344888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65607147|NCT02344888|Glucocorticoids|glucocorticoids|mesh-ancestor
65607148|NCT02344888|Hormones|hormones|mesh-ancestor
65607149|NCT02344888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65607150|NCT02344888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607151|NCT02344888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65607152|NCT02344888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607153|NCT02344888|Hematinics|hematinics|mesh-ancestor
65607154|NCT02344888|Vitamins|vitamins|mesh-ancestor
65607155|NCT02344888|Micronutrients|micronutrients|mesh-ancestor
65607156|NCT02344888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65607157|NCT02344888|Hormone Antagonists|hormone antagonists|mesh-ancestor
65607158|NCT02344888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65607159|NCT02344888|Fertility Agents|fertility agents|mesh-ancestor
65607160|NCT02344888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65607161|NCT02344888|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65607162|NCT02344888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65607163|NCT02921022|Gemcitabine|gemcitabine|mesh-list
65607164|NCT02921022|Paclitaxel|paclitaxel|mesh-list
65607165|NCT02921022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65607166|NCT02921022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607167|NCT02921022|Tubulin Modulators|tubulin modulators|mesh-ancestor
65607168|NCT02921022|Antimitotic Agents|antimitotic agents|mesh-ancestor
65607169|NCT02921022|Mitosis Modulators|mitosis modulators|mesh-ancestor
65607170|NCT02921022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607171|NCT02921022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65607172|NCT02921022|Antimetabolites|antimetabolites|mesh-ancestor
65607173|NCT02921022|Antiviral Agents|antiviral agents|mesh-ancestor
65607174|NCT02921022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65607175|NCT02921022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607176|NCT02921022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65607177|NCT02921022|Immunologic Factors|immunologic factors|mesh-ancestor
65607178|NCT02921022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607179|NCT03497429|Niraparib|niraparib|mesh-list
65607180|NCT03497429|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65607181|NCT03497429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607182|NCT03497429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607183|NCT03497429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607184|NCT03146104|Propofol|propofol|mesh-list
65607185|NCT03146104|Isoflurane|isoflurane|mesh-list
65607186|NCT03146104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65607187|NCT03146104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65607188|NCT03146104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607189|NCT03146104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65607190|NCT03146104|Anesthetics, General|anesthetics, general|mesh-ancestor
65607191|NCT03146104|Anesthetics|anesthetics|mesh-ancestor
65607192|NCT03146104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65607193|NCT03497039|Diclofenac|diclofenac|mesh-list
65607194|NCT03497039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65607195|NCT03497039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65607196|NCT03497039|Analgesics|analgesics|mesh-ancestor
65607197|NCT03497039|Sensory System Agents|sensory system agents|mesh-ancestor
65607198|NCT03497039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65607199|NCT03497039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607200|NCT03497039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65607201|NCT03497039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65607202|NCT03497039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65607203|NCT03497039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607204|NCT03497039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607205|NCT02340910|Oxymetazoline|oxymetazoline|mesh-list
65607206|NCT02340910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65607207|NCT02340910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65607208|NCT02340910|Adrenergic Agents|adrenergic agents|mesh-ancestor
65607209|NCT02340910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65607210|NCT02340910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607211|NCT02340910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607212|NCT02340910|Sympathomimetics|sympathomimetics|mesh-ancestor
65607213|NCT02340910|Autonomic Agents|autonomic agents|mesh-ancestor
65607214|NCT02340910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65607215|NCT02340910|Nasal Decongestants|nasal decongestants|mesh-ancestor
65607216|NCT02340910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65607217|NCT02340910|Respiratory System Agents|respiratory system agents|mesh-ancestor
65607218|NCT02349490|Hemostatics|hemostatics|mesh-list
65607219|NCT02349490|Coagulants|coagulants|mesh-ancestor
65607220|NCT03720899|Nicotine|nicotine|mesh-list
65607221|NCT03720899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65607222|NCT03720899|Autonomic Agents|autonomic agents|mesh-ancestor
65607223|NCT03720899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65607224|NCT03720899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607225|NCT03720899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65607226|NCT03720899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65607227|NCT03720899|Cholinergic Agents|cholinergic agents|mesh-ancestor
65607228|NCT03720899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65607229|NCT03720899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607230|NCT02340988|Oritavancin|oritavancin|mesh-list
65607231|NCT02340988|Warfarin|warfarin|mesh-list
65607232|NCT02340988|Anticoagulants|anticoagulants|mesh-ancestor
65607233|NCT02340988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65607234|NCT02340988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65607235|NCT03145480|Obinutuzumab|obinutuzumab|mesh-list
65607236|NCT03145480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65607237|NCT03145480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607238|NCT03726515|Pembrolizumab|pembrolizumab|mesh-list
65607239|NCT03726515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65607240|NCT03726515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607241|NCT05665283|Ensartinib|ensartinib|mesh-list
65607242|NCT05665283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607243|NCT05665283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65607244|NCT05665283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607245|NCT05665283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607246|NCT02344810|Leucovorin|leucovorin|mesh-list
65607247|NCT02344810|Fluorouracil|fluorouracil|mesh-list
65607248|NCT02344810|Oxaliplatin|oxaliplatin|mesh-list
65607249|NCT02344810|Calcium|calcium|mesh-list
65607250|NCT02344810|Levoleucovorin|levoleucovorin|mesh-list
65607251|NCT02344810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65607252|NCT02344810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607253|NCT02344810|Antimetabolites|antimetabolites|mesh-ancestor
65607254|NCT02344810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607255|NCT02344810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65607256|NCT02344810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607257|NCT02344810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65607258|NCT02344810|Immunologic Factors|immunologic factors|mesh-ancestor
65607259|NCT02344810|Antidotes|antidotes|mesh-ancestor
65607260|NCT02344810|Protective Agents|protective agents|mesh-ancestor
65607261|NCT02344810|Vitamin B Complex|vitamin b complex|mesh-ancestor
65607262|NCT02344810|Vitamins|vitamins|mesh-ancestor
65607263|NCT02344810|Micronutrients|micronutrients|mesh-ancestor
65607264|NCT03071094|Nivolumab|nivolumab|mesh-list
65607265|NCT03071094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65607266|NCT03071094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607267|NCT03071094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65607268|NCT03071094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607269|NCT03148990|Vaccines|vaccines|mesh-list
65607270|NCT03148990|Immunologic Factors|immunologic factors|mesh-ancestor
65607271|NCT03148990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607272|NCT04477642|Abatacept|abatacept|mesh-list
65607273|NCT04477642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65607274|NCT04477642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607275|NCT04477642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607276|NCT04477642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65607277|NCT04477642|Immunologic Factors|immunologic factors|mesh-ancestor
65607278|NCT04477642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607279|NCT04477642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65607280|NCT02344732|Polymyxins|polymyxins|mesh-list
65607281|NCT02344732|Neomycin|neomycin|mesh-list
65607282|NCT02344732|Polymyxin B|polymyxin b|mesh-list
65607283|NCT02344732|Dexamethasone|dexamethasone|mesh-list
65607284|NCT02344732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65607285|NCT02344732|Homatropine|homatropine|mesh-list
65607286|NCT02344732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65607287|NCT02344732|Antiemetics|antiemetics|mesh-ancestor
65607288|NCT02344732|Autonomic Agents|autonomic agents|mesh-ancestor
65607289|NCT02344732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65607290|NCT02344732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607291|NCT02344732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65607292|NCT02344732|Glucocorticoids|glucocorticoids|mesh-ancestor
65607293|NCT02344732|Hormones|hormones|mesh-ancestor
65607294|NCT02344732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65607295|NCT02344732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65607296|NCT02344732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607297|NCT02344732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65607298|NCT02344732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65607299|NCT02344732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65607300|NCT02344732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65607301|NCT02344732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607302|NCT02344732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607303|NCT02344732|Parasympatholytics|parasympatholytics|mesh-ancestor
65607304|NCT03720665|Caffeine|caffeine|mesh-list
65607305|NCT03720665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65607306|NCT03720665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607307|NCT03720665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65607308|NCT03720665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607309|NCT03720665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607310|NCT03720665|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65607311|NCT03720665|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65607312|NCT03720665|Purinergic Agents|purinergic agents|mesh-ancestor
65607313|NCT03720665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65607314|NCT03726281|Nivolumab|nivolumab|mesh-list
65607315|NCT03726281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65607316|NCT03726281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607317|NCT03726281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65607318|NCT03726281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607319|NCT02344264|Ropivacaine|ropivacaine|mesh-list
65607320|NCT02344264|Anesthetics, Local|anesthetics, local|mesh-ancestor
65607321|NCT02344264|Anesthetics|anesthetics|mesh-ancestor
65607322|NCT02344264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65607323|NCT02344264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607324|NCT02344264|Sensory System Agents|sensory system agents|mesh-ancestor
65404714|NCT00057811|Doxorubicin|doxorubicin|mesh-list
65607325|NCT02344264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65607326|NCT02344030|Pyrithione zinc|pyrithione zinc|mesh-list
65607327|NCT02344030|Keratolytic Agents|keratolytic agents|mesh-ancestor
65607328|NCT02344030|Dermatologic Agents|dermatologic agents|mesh-ancestor
65607329|NCT02339662|Gabapentin|gabapentin|mesh-list
65607330|NCT02339662|Amitriptyline|amitriptyline|mesh-list
65607331|NCT02339662|Analgesics|analgesics|mesh-ancestor
65607332|NCT02339662|Sensory System Agents|sensory system agents|mesh-ancestor
65607333|NCT02339662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65607334|NCT02339662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607335|NCT02339662|Anticonvulsants|anticonvulsants|mesh-ancestor
65607336|NCT02339662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65607337|NCT02339662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65607338|NCT02339662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65607339|NCT02339662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65607340|NCT02339662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65607341|NCT02339662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65607342|NCT02339662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65607343|NCT02339662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607344|NCT02339662|Antimanic Agents|antimanic agents|mesh-ancestor
65607345|NCT02339662|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65607346|NCT02339662|Antidepressive Agents|antidepressive agents|mesh-ancestor
65607347|NCT02339662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65607348|NCT02339662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65607349|NCT02339662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65607350|NCT02339662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65607351|NCT02339662|Adrenergic Agents|adrenergic agents|mesh-ancestor
65607352|NCT02343718|Sirolimus|sirolimus|mesh-list
65607353|NCT02343718|Vinblastine|vinblastine|mesh-list
65607354|NCT02343718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65607355|NCT02343718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65607356|NCT02343718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65607357|NCT02343718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607358|NCT02343718|Antifungal Agents|antifungal agents|mesh-ancestor
65607359|NCT02343718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65607360|NCT02343718|Immunologic Factors|immunologic factors|mesh-ancestor
65607361|NCT02343718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607362|NCT02343718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65607363|NCT02343718|Tubulin Modulators|tubulin modulators|mesh-ancestor
65607364|NCT02343718|Antimitotic Agents|antimitotic agents|mesh-ancestor
65607365|NCT02343718|Mitosis Modulators|mitosis modulators|mesh-ancestor
65607366|NCT02343718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607367|NCT03148522|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65607368|NCT03148522|Mirtazapine|mirtazapine|mesh-list
65607369|NCT03148522|Citalopram|citalopram|mesh-list
65607370|NCT03148522|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65607371|NCT03148522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65607372|NCT03148522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65607373|NCT03148522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607374|NCT03148522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65607375|NCT03148522|Serotonin Agents|serotonin agents|mesh-ancestor
65607376|NCT03148522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607377|NCT03148522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65607378|NCT03148522|Antidepressive Agents|antidepressive agents|mesh-ancestor
65607379|NCT03148522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65607380|NCT03148522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65607381|NCT03148522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65607382|NCT03148522|Analgesics|analgesics|mesh-ancestor
65607383|NCT03148522|Sensory System Agents|sensory system agents|mesh-ancestor
65607384|NCT03148522|Dopamine Agents|dopamine agents|mesh-ancestor
65607385|NCT03148522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65607386|NCT03148522|Histamine Antagonists|histamine antagonists|mesh-ancestor
65607387|NCT03148522|Histamine Agents|histamine agents|mesh-ancestor
65607388|NCT03148522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65607389|NCT03148522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65607390|NCT03148522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65607391|NCT03148522|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65607392|NCT03148522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65607393|NCT03148522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65607394|NCT03148522|Adrenergic Agents|adrenergic agents|mesh-ancestor
65607395|NCT03148522|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65607396|NCT03148522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65607397|NCT03148522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65607398|NCT03148444|Cephalexin|cephalexin|mesh-list
65607399|NCT03148444|Roxithromycin|roxithromycin|mesh-list
65607400|NCT03148444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65607401|NCT03148444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65607402|NCT03148132|Bevacizumab|bevacizumab|mesh-list
65607403|NCT03148132|Ranibizumab|ranibizumab|mesh-list
65607404|NCT03148132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65607405|NCT03148132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607406|NCT03148132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65607407|NCT03148132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65607408|NCT03148132|Growth Substances|growth substances|mesh-ancestor
65607409|NCT03148132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607410|NCT03148132|Growth Inhibitors|growth inhibitors|mesh-ancestor
65607411|NCT02339350|Methotrexate|methotrexate|mesh-list
65607412|NCT02339350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65607413|NCT02339350|Abortifacient Agents|abortifacient agents|mesh-ancestor
65607414|NCT02339350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65607415|NCT02339350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607416|NCT02339350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65607417|NCT02339350|Antimetabolites|antimetabolites|mesh-ancestor
65607418|NCT02339350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607419|NCT02339350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607420|NCT02339350|Dermatologic Agents|dermatologic agents|mesh-ancestor
65607421|NCT02339350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607422|NCT02339350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65607423|NCT02339350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65607424|NCT02339350|Immunologic Factors|immunologic factors|mesh-ancestor
65607425|NCT02339350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65607426|NCT02339350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65607427|NCT05166304|Rebamipide|rebamipide|mesh-list
65607428|NCT05166304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65607429|NCT05166304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65607430|NCT05166304|Antioxidants|antioxidants|mesh-ancestor
65607431|NCT05166304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607432|NCT05166304|Protective Agents|protective agents|mesh-ancestor
65607433|NCT05166304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607434|NCT05166304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607435|NCT02339428|Diclofenac|diclofenac|mesh-list
65607436|NCT02339428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65607437|NCT02339428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65607438|NCT02339428|Analgesics|analgesics|mesh-ancestor
65607439|NCT02339428|Sensory System Agents|sensory system agents|mesh-ancestor
65607440|NCT02339428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65607441|NCT02339428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607442|NCT02339428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65607443|NCT02339428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65607444|NCT02339428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65607445|NCT02339428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607446|NCT02339428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607447|NCT02337322|Ritonavir|ritonavir|mesh-list
65607448|NCT02337322|Darunavir|darunavir|mesh-list
65607449|NCT02337322|Dolutegravir|dolutegravir|mesh-list
65607450|NCT02337322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65607451|NCT02337322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65607452|NCT02337322|Protease Inhibitors|protease inhibitors|mesh-ancestor
65607453|NCT02337322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607454|NCT02337322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607455|NCT02337322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65266115|NCT02677155|Pembrolizumab|pembrolizumab|mesh-list
65607456|NCT02337322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65607457|NCT02337322|Antiviral Agents|antiviral agents|mesh-ancestor
65607458|NCT02337322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65607459|NCT02337322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65607460|NCT02337322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65607461|NCT02337322|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65607462|NCT02337322|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65607463|NCT02337166|Hyaluronic Acid|hyaluronic acid|mesh-list
65607464|NCT02337166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65607465|NCT02337166|Immunologic Factors|immunologic factors|mesh-ancestor
65607466|NCT02337166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607467|NCT02337166|Viscosupplements|viscosupplements|mesh-ancestor
65607468|NCT02337166|Protective Agents|protective agents|mesh-ancestor
65607469|NCT03148288|Vitamin D|vitamin d|mesh-list
65607470|NCT03148288|Vitamins|vitamins|mesh-ancestor
65607471|NCT03148288|Micronutrients|micronutrients|mesh-ancestor
65607472|NCT03148288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607473|NCT03148288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65607474|NCT02039362|Tenofovir|tenofovir|mesh-list
65607476|NCT02039362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65607477|NCT02039362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65607478|NCT02039362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65607479|NCT02039362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607480|NCT02039362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607481|NCT02039362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65607482|NCT02039362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65607483|NCT02339116|Bevacizumab|bevacizumab|mesh-list
65607484|NCT02339116|Oxaliplatin|oxaliplatin|mesh-list
65607485|NCT02339116|Irinotecan|irinotecan|mesh-list
65607486|NCT02339116|Fluorouracil|fluorouracil|mesh-list
65607487|NCT02339116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65607488|NCT02339116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607489|NCT02339116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65607490|NCT02339116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65607491|NCT02339116|Growth Substances|growth substances|mesh-ancestor
65607492|NCT02339116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607493|NCT02339116|Growth Inhibitors|growth inhibitors|mesh-ancestor
65607494|NCT02339116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65607495|NCT02339116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65607496|NCT02339116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607497|NCT02339116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607498|NCT02339116|Antimetabolites|antimetabolites|mesh-ancestor
65607499|NCT02339116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65607500|NCT02339116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65607501|NCT02339116|Immunologic Factors|immunologic factors|mesh-ancestor
65607502|NCT04824274|Fentanyl|fentanyl|mesh-list
65607503|NCT04824274|Morphine|morphine|mesh-list
65607504|NCT04824274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65607505|NCT04824274|Narcotics|narcotics|mesh-ancestor
65607506|NCT04824274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65607507|NCT04824274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607508|NCT04824274|Analgesics|analgesics|mesh-ancestor
65607509|NCT04824274|Sensory System Agents|sensory system agents|mesh-ancestor
65607510|NCT04824274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65607511|NCT04824274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65607512|NCT04824274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65607513|NCT04824274|Anesthetics, General|anesthetics, general|mesh-ancestor
65607514|NCT04824274|Anesthetics|anesthetics|mesh-ancestor
65607515|NCT02348788|Chloroquine|chloroquine|mesh-list
65607516|NCT02348788|Lumefantrine|lumefantrine|mesh-list
65607517|NCT02348788|Artemether|artemether|mesh-list
65607518|NCT02348788|Primaquine|primaquine|mesh-list
65607519|NCT02348788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65607520|NCT02348788|Amebicides|amebicides|mesh-ancestor
65607521|NCT02348788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65607522|NCT02348788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65607523|NCT02348788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65607524|NCT02348788|Antimalarials|antimalarials|mesh-ancestor
65607525|NCT02348788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65607526|NCT02337010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65607527|NCT02338570|Everolimus|everolimus|mesh-list
65607528|NCT02338570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607529|NCT02338570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65607530|NCT02338570|Immunologic Factors|immunologic factors|mesh-ancestor
65070395|NCT00324831|Hormones|hormones|mesh-ancestor
65607531|NCT02338570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607532|NCT02336854|Tacrolimus|tacrolimus|mesh-list
65607533|NCT02336854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65607534|NCT02336854|Immunologic Factors|immunologic factors|mesh-ancestor
65607535|NCT02336854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607536|NCT02336854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65607537|NCT02336854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607538|NCT02336854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607539|NCT02338024|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65607540|NCT02338024|Antiviral Agents|antiviral agents|mesh-ancestor
65607541|NCT02338024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65607542|NCT02332174|Rufinamide|rufinamide|mesh-list
65607543|NCT02332174|Anticonvulsants|anticonvulsants|mesh-ancestor
65607544|NCT02332174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65607545|NCT02332174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65607546|NCT02332174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65607547|NCT02332174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607548|NCT03726125|Insulin|insulin|mesh-list
65607549|NCT03726125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65607550|NCT03726125|Insulin, Long-Acting|insulin, long-acting|mesh-list
65607551|NCT03726125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65607552|NCT03726125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607553|NCT02336308|Ketamine|ketamine|mesh-list
65607554|NCT02336308|Analgesics|analgesics|mesh-ancestor
65607555|NCT02336308|Sensory System Agents|sensory system agents|mesh-ancestor
65607556|NCT02336308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65607557|NCT02336308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607558|NCT02336308|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65607559|NCT02336308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65607560|NCT02336308|Anesthetics, General|anesthetics, general|mesh-ancestor
65607561|NCT02336308|Anesthetics|anesthetics|mesh-ancestor
65607562|NCT02336308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65607563|NCT02336308|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65607564|NCT02336308|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65607565|NCT02336308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65607566|NCT02336308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607567|NCT02336386|Dexamethasone|dexamethasone|mesh-list
65607568|NCT02336386|Cyclophosphamide|cyclophosphamide|mesh-list
65607569|NCT02336386|Doxorubicin|doxorubicin|mesh-list
65607570|NCT02336386|Bortezomib|bortezomib|mesh-list
65607571|NCT02336386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65607572|NCT02336386|Immunologic Factors|immunologic factors|mesh-ancestor
65607573|NCT02336386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607574|NCT02336386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65607575|NCT02336386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65607576|NCT02336386|Alkylating Agents|alkylating agents|mesh-ancestor
65607577|NCT02336386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607578|NCT02336386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607579|NCT02336386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65607580|NCT02336386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65607581|NCT02336386|Antiemetics|antiemetics|mesh-ancestor
65607582|NCT02336386|Autonomic Agents|autonomic agents|mesh-ancestor
65607583|NCT02336386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65607584|NCT02336386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65607585|NCT02336386|Glucocorticoids|glucocorticoids|mesh-ancestor
65607586|NCT02336386|Hormones|hormones|mesh-ancestor
65607587|NCT02336386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65607588|NCT02336386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65607589|NCT02336386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607590|NCT02336386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65607591|NCT02336386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65607592|NCT02336386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65607593|NCT02337712|Etoposide|etoposide|mesh-list
65607594|NCT02337712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607595|NCT02337712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65607596|NCT02337712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65607597|NCT02337712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65607598|NCT02337712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607599|NCT02337712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607600|NCT03049540|Tadalafil|tadalafil|mesh-list
65607601|NCT03049540|Vasodilator Agents|vasodilator agents|mesh-ancestor
65607602|NCT03049540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65607603|NCT03049540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65607604|NCT03049540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607605|NCT03049540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607606|NCT03049540|Urological Agents|urological agents|mesh-ancestor
65607607|NCT03492281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65607608|NCT03492281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65607609|NCT03492281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65607610|NCT03492281|Cholinergic Agents|cholinergic agents|mesh-ancestor
65607611|NCT03492281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65607612|NCT03492281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607613|NCT03492281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607614|NCT03492281|Urological Agents|urological agents|mesh-ancestor
65607615|NCT02336152|Anesthetics|anesthetics|mesh-list
65607616|NCT02336152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65607617|NCT02336152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607618|NCT02331862|Methylprednisolone|methylprednisolone|mesh-list
65607619|NCT02331862|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65607620|NCT02331862|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65607621|NCT02331862|Prednisolone|prednisolone|mesh-list
65607622|NCT02331862|Prednisolone acetate|prednisolone acetate|mesh-list
65607623|NCT02331862|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65607624|NCT02331862|Prednisolone phosphate|prednisolone phosphate|mesh-list
65607625|NCT02331862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65607626|NCT02331862|Antiemetics|antiemetics|mesh-ancestor
65607627|NCT02331862|Autonomic Agents|autonomic agents|mesh-ancestor
65607628|NCT02331862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65607629|NCT02331862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607630|NCT02331862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65607631|NCT02331862|Glucocorticoids|glucocorticoids|mesh-ancestor
65607632|NCT02331862|Hormones|hormones|mesh-ancestor
65607633|NCT02331862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65607634|NCT02331862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65607635|NCT02331862|Protective Agents|protective agents|mesh-ancestor
65607636|NCT02331862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65607637|NCT02331862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607638|NCT03525119|Vaccines|vaccines|mesh-list
65607639|NCT03525119|Immunologic Factors|immunologic factors|mesh-ancestor
65607640|NCT03525119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607641|NCT05230654|Fosaprepitant|fosaprepitant|mesh-list
65607642|NCT05230654|Aprepitant|aprepitant|mesh-list
65607643|NCT05230654|Antiemetics|antiemetics|mesh-ancestor
65607644|NCT05230654|Autonomic Agents|autonomic agents|mesh-ancestor
65607645|NCT05230654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65607646|NCT05230654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607647|NCT05230654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65607648|NCT05230654|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65607649|NCT05230654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65607650|NCT05230654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607651|NCT02039518|Gemcitabine|gemcitabine|mesh-list
65607652|NCT02039518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65607653|NCT02039518|Antimetabolites|antimetabolites|mesh-ancestor
65607654|NCT02039518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607655|NCT02039518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607656|NCT02039518|Antiviral Agents|antiviral agents|mesh-ancestor
65607657|NCT02039518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65607658|NCT02039518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607659|NCT02039518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65607660|NCT02039518|Immunologic Factors|immunologic factors|mesh-ancestor
65607661|NCT02039518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607662|NCT03722381|Amlodipine|amlodipine|mesh-list
65607663|NCT03722381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65607664|NCT03722381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65607665|NCT03722381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65607666|NCT03722381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607667|NCT03722381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65607668|NCT03722381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607669|NCT03722381|Vasodilator Agents|vasodilator agents|mesh-ancestor
65607670|NCT04352608|Vaccines|vaccines|mesh-list
65607671|NCT04352608|Immunologic Factors|immunologic factors|mesh-ancestor
65607672|NCT04352608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607673|NCT03722303|Cortisone|cortisone|mesh-list
65607674|NCT03722303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65607675|NCT03558503|Mitomycins|mitomycins|mesh-list
65607676|NCT03558503|Mitomycin|mitomycin|mesh-list
65607677|NCT03558503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65607678|NCT03558503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607679|NCT03558503|Alkylating Agents|alkylating agents|mesh-ancestor
65607680|NCT03558503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607681|NCT03558503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65607682|NCT03558503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607683|NCT02331706|Interferons|interferons|mesh-list
65607684|NCT02331706|Interferon-alpha|interferon-alpha|mesh-list
65607685|NCT02331706|Interferon alpha-2|interferon alpha-2|mesh-list
65607686|NCT02331706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607687|NCT02331706|Antiviral Agents|antiviral agents|mesh-ancestor
65607688|NCT02331706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65607689|NCT02331706|Immunologic Factors|immunologic factors|mesh-ancestor
65607690|NCT02331706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607691|NCT04400838|Vaccines|vaccines|mesh-list
65607692|NCT04400838|Immunologic Factors|immunologic factors|mesh-ancestor
65607693|NCT04400838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607694|NCT03489863|Ticagrelor|ticagrelor|mesh-list
65607695|NCT03489863|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65607696|NCT03489863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65607697|NCT03489863|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65607698|NCT03489863|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65607699|NCT03489863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65607700|NCT03489863|Purinergic Agents|purinergic agents|mesh-ancestor
65607701|NCT03489863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65607702|NCT03489863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607703|NCT03489863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607705|NCT04344444|Hydroxychloroquine|hydroxychloroquine|mesh-list
65607706|NCT04344444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65607707|NCT04344444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65607708|NCT04344444|Antimalarials|antimalarials|mesh-ancestor
65607709|NCT04344444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65607710|NCT04344444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65607711|NCT04344444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607712|NCT04344444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607713|NCT04344444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65607714|NCT03489551|Haloperidol|haloperidol|mesh-list
65607715|NCT03489551|Antiemetics|antiemetics|mesh-ancestor
65607716|NCT03489551|Autonomic Agents|autonomic agents|mesh-ancestor
65607717|NCT03489551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65607718|NCT03489551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607719|NCT03489551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65607720|NCT03489551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65607721|NCT03489551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65607722|NCT03489551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65607723|NCT03489551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65607724|NCT03489551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65607725|NCT03489551|Dopamine Agents|dopamine agents|mesh-ancestor
65607726|NCT03489551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65266124|NCT02537691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65607727|NCT03489551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607728|NCT03489551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65607729|NCT05762952|Dapagliflozin|dapagliflozin|mesh-list
65607730|NCT05762952|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65607731|NCT05762952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607732|NCT05762952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65607733|NCT05762952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607734|NCT02335684|Methamphetamine|methamphetamine|mesh-list
65607735|NCT02335684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65607736|NCT02335684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607737|NCT02335684|Sympathomimetics|sympathomimetics|mesh-ancestor
65607738|NCT02335684|Autonomic Agents|autonomic agents|mesh-ancestor
65607739|NCT02335684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65607740|NCT02335684|Dopamine Agents|dopamine agents|mesh-ancestor
65607741|NCT02335684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65607742|NCT02335684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607743|NCT02335684|Adrenergic Agents|adrenergic agents|mesh-ancestor
65607744|NCT02335684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65607745|NCT02335684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65607746|NCT02335684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65607747|NCT02335684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65607748|NCT05198388|Endorphins|endorphins|mesh-list
65607749|NCT05198388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65607750|NCT05198388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607751|NCT05198388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607752|NCT04210180|Varenicline|varenicline|mesh-list
65607753|NCT04210180|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65607754|NCT04210180|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65607755|NCT04210180|Cholinergic Agents|cholinergic agents|mesh-ancestor
65607756|NCT04210180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65607757|NCT04210180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607758|NCT04210180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607759|NCT03523715|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
65607760|NCT03523715|Antidiarrheals|antidiarrheals|mesh-ancestor
65607761|NCT03523715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65607762|NCT03523091|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65607763|NCT03523091|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65607764|NCT03523091|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65607765|NCT03523091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65607766|NCT03523091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607767|NCT03523091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65607768|NCT03523091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65607769|NCT03523091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607770|NCT03523091|Cholinergic Agents|cholinergic agents|mesh-ancestor
65607771|NCT03523091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65607772|NCT03105310|Interferons|interferons|mesh-list
65607773|NCT03105310|Interferon-alpha|interferon-alpha|mesh-list
65607774|NCT03105310|Ezetimibe|ezetimibe|mesh-list
65607775|NCT03105310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607776|NCT03105310|Antiviral Agents|antiviral agents|mesh-ancestor
65607777|NCT03105310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65607778|NCT03105310|Immunologic Factors|immunologic factors|mesh-ancestor
65607779|NCT03105310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607780|NCT03105310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65607781|NCT03105310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65607782|NCT03105310|Antimetabolites|antimetabolites|mesh-ancestor
65607783|NCT03105310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607784|NCT03105310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65607785|NCT03144466|Pembrolizumab|pembrolizumab|mesh-list
65607786|NCT03144466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65607787|NCT03144466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607788|NCT03105466|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
65607789|NCT03105466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65607790|NCT03105466|Tacrolimus|tacrolimus|mesh-list
65607791|NCT03105466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65607792|NCT03105466|Immunologic Factors|immunologic factors|mesh-ancestor
65607793|NCT03105466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607794|NCT03105466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65607795|NCT03105466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607796|NCT03105466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607797|NCT03105466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65607798|NCT03105466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65607799|NCT03105466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65607800|NCT03105466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65607801|NCT03105466|Glucocorticoids|glucocorticoids|mesh-ancestor
65607802|NCT03105466|Hormones|hormones|mesh-ancestor
65607803|NCT03105466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65607804|NCT02335372|Acetic Acid|acetic acid|mesh-list
65607805|NCT02335372|Proflavine|proflavine|mesh-list
65607806|NCT02335372|Retinol acetate|retinol acetate|mesh-list
65607807|NCT02335372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65607808|NCT02335372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65607809|NCT02335372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65607810|NCT02335372|Immunologic Factors|immunologic factors|mesh-ancestor
65607811|NCT02335372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607812|NCT02335372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65607813|NCT02335372|Protective Agents|protective agents|mesh-ancestor
65607814|NCT02335372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607815|NCT02335372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65607816|NCT03488225|Calcium, Dietary|calcium, dietary|mesh-list
65607817|NCT03488225|Leucovorin|leucovorin|mesh-list
65607818|NCT03488225|Folic Acid|folic acid|mesh-list
65607819|NCT03488225|Cytarabine|cytarabine|mesh-list
65607820|NCT03488225|Dexamethasone|dexamethasone|mesh-list
65607821|NCT03488225|Prednisone|prednisone|mesh-list
65607822|NCT03488225|Dexamethasone acetate|dexamethasone acetate|mesh-list
65607823|NCT03488225|Cortisone|cortisone|mesh-list
65607824|NCT03488225|Cyclophosphamide|cyclophosphamide|mesh-list
65607825|NCT03488225|Rituximab|rituximab|mesh-list
65607826|NCT03488225|Doxorubicin|doxorubicin|mesh-list
65607827|NCT03488225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65607828|NCT03488225|Methotrexate|methotrexate|mesh-list
65607829|NCT03488225|Vincristine|vincristine|mesh-list
65607830|NCT03488225|Mercaptopurine|mercaptopurine|mesh-list
65607831|NCT03488225|Ofatumumab|ofatumumab|mesh-list
65607832|NCT03488225|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65607833|NCT03488225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65607834|NCT03488225|Antibodies|antibodies|mesh-list
65607835|NCT03488225|Immunoglobulins|immunoglobulins|mesh-list
65607836|NCT03488225|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65607837|NCT03488225|BB 1101|bb 1101|mesh-list
65607838|NCT03488225|Calcium|calcium|mesh-list
65607839|NCT03488225|Levoleucovorin|levoleucovorin|mesh-list
65607840|NCT03488225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65607841|NCT03488225|Immunologic Factors|immunologic factors|mesh-ancestor
65607842|NCT03488225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607843|NCT03488225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65607844|NCT03488225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65607845|NCT03488225|Alkylating Agents|alkylating agents|mesh-ancestor
65607846|NCT03488225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607847|NCT03488225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607848|NCT03488225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65607849|NCT03488225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65607850|NCT03488225|Antiemetics|antiemetics|mesh-ancestor
65607851|NCT03488225|Autonomic Agents|autonomic agents|mesh-ancestor
65607852|NCT03488225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65607853|NCT03488225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65607854|NCT03488225|Glucocorticoids|glucocorticoids|mesh-ancestor
65607855|NCT03488225|Hormones|hormones|mesh-ancestor
65607856|NCT03488225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65607857|NCT03488225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65607858|NCT03488225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65607859|NCT03488225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65607860|NCT03488225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65607861|NCT03488225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607862|NCT03488225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65607863|NCT03488225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65607864|NCT03488225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65607865|NCT03488225|Abortifacient Agents|abortifacient agents|mesh-ancestor
65607866|NCT03488225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65607867|NCT03488225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65607868|NCT03488225|Antimetabolites|antimetabolites|mesh-ancestor
65607869|NCT03488225|Dermatologic Agents|dermatologic agents|mesh-ancestor
65607870|NCT03488225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65607871|NCT03488225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65607872|NCT03488225|Antiviral Agents|antiviral agents|mesh-ancestor
65607873|NCT03488225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65607874|NCT03488225|Antidotes|antidotes|mesh-ancestor
65607875|NCT03488225|Protective Agents|protective agents|mesh-ancestor
65607876|NCT03488225|Vitamin B Complex|vitamin b complex|mesh-ancestor
65607877|NCT03488225|Vitamins|vitamins|mesh-ancestor
65607878|NCT03488225|Micronutrients|micronutrients|mesh-ancestor
65607879|NCT03488225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65607880|NCT03488225|Tubulin Modulators|tubulin modulators|mesh-ancestor
65607881|NCT03488225|Antimitotic Agents|antimitotic agents|mesh-ancestor
65607882|NCT03488225|Mitosis Modulators|mitosis modulators|mesh-ancestor
65607883|NCT03488225|Hematinics|hematinics|mesh-ancestor
65607884|NCT03488225|Protease Inhibitors|protease inhibitors|mesh-ancestor
65607885|NCT02334904|Risperidone|risperidone|mesh-list
65607886|NCT02334904|Aripiprazole|aripiprazole|mesh-list
65607887|NCT02334904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65607888|NCT02334904|Serotonin Agents|serotonin agents|mesh-ancestor
65607889|NCT02334904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65607890|NCT02334904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607891|NCT02334904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607892|NCT02334904|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65607893|NCT02334904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65607894|NCT02334904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65607895|NCT02334904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65607896|NCT02334904|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65607897|NCT02334904|Dopamine Agents|dopamine agents|mesh-ancestor
65607898|NCT02334904|Antidepressive Agents|antidepressive agents|mesh-ancestor
65607899|NCT02334904|Dopamine Agonists|dopamine agonists|mesh-ancestor
65607900|NCT02334904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65607901|NCT02334904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65607902|NCT02334904|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65607903|NCT02334904|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65607904|NCT02326090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65607905|NCT02326090|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65607906|NCT03437447|Praziquantel|praziquantel|mesh-list
65607907|NCT03437447|Anthelmintics|anthelmintics|mesh-ancestor
65607908|NCT03437447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65607909|NCT03437447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65607910|NCT03720041|Dexamethasone|dexamethasone|mesh-list
65607911|NCT03720041|Dexamethasone acetate|dexamethasone acetate|mesh-list
65607912|NCT03720041|Lenalidomide|lenalidomide|mesh-list
65607913|NCT03720041|Ixazomib|ixazomib|mesh-list
65607914|NCT03720041|BB 1101|bb 1101|mesh-list
65607915|NCT03720041|Glycine|glycine|mesh-list
65607916|NCT03720041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65607917|NCT03720041|Antiemetics|antiemetics|mesh-ancestor
65607918|NCT03720041|Autonomic Agents|autonomic agents|mesh-ancestor
65607919|NCT03720041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65607920|NCT03720041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607921|NCT03720041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65607922|NCT03720041|Glucocorticoids|glucocorticoids|mesh-ancestor
65607923|NCT03720041|Hormones|hormones|mesh-ancestor
65607924|NCT03720041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65607925|NCT03720041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65607926|NCT03720041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607927|NCT03720041|Protease Inhibitors|protease inhibitors|mesh-ancestor
65607928|NCT03720041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607929|NCT03720041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607930|NCT03720041|Immunologic Factors|immunologic factors|mesh-ancestor
65607931|NCT03720041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65607932|NCT03720041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65607933|NCT03720041|Growth Substances|growth substances|mesh-ancestor
65607934|NCT03720041|Growth Inhibitors|growth inhibitors|mesh-ancestor
65607935|NCT03720041|Glycine Agents|glycine agents|mesh-ancestor
65607936|NCT03720041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65607937|NCT02326168|BCG Vaccine|bcg vaccine|mesh-list
65607938|NCT02326168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65607939|NCT02326168|Immunologic Factors|immunologic factors|mesh-ancestor
65607940|NCT02326168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607941|NCT02334670|Fluconazole|fluconazole|mesh-list
65607942|NCT02334670|Antifungal Agents|antifungal agents|mesh-ancestor
65607943|NCT02334670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65607944|NCT02334670|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65607945|NCT02334670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65607946|NCT02334670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607947|NCT02334670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607948|NCT02334670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65607949|NCT02334670|Hormone Antagonists|hormone antagonists|mesh-ancestor
65607950|NCT02334670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65607951|NCT02334670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607952|NCT02334670|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65607953|NCT02334670|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65607954|NCT02974868|PF-06700841|pf-06700841|mesh-list
65607955|NCT02974868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65607956|NCT02974868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65607957|NCT02974868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65607958|NCT02330770|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65607959|NCT02330770|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65607960|NCT02330770|Luteolytic Agents|luteolytic agents|mesh-ancestor
65607961|NCT02330770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65607962|NCT02330770|Contraceptive Agents|contraceptive agents|mesh-ancestor
65607963|NCT02330770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65607964|NCT02330770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607965|NCT02330770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65607966|NCT02330770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65607967|NCT02330770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65607968|NCT05076526|Hyaluronic Acid|hyaluronic acid|mesh-list
65607969|NCT05076526|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65607970|NCT05076526|Immunologic Factors|immunologic factors|mesh-ancestor
65607971|NCT05076526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607972|NCT05076526|Viscosupplements|viscosupplements|mesh-ancestor
65607973|NCT05076526|Protective Agents|protective agents|mesh-ancestor
65607974|NCT02330614|Carbamide Peroxide|carbamide peroxide|mesh-list
65607975|NCT02330614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65607976|NCT02330614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65607977|NCT03143998|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65607978|NCT03143998|Grazoprevir|grazoprevir|mesh-list
65607979|NCT03143998|Antiviral Agents|antiviral agents|mesh-ancestor
65607980|NCT03143998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65607981|NCT02334046|Remifentanil|remifentanil|mesh-list
65607982|NCT02334046|Sevoflurane|sevoflurane|mesh-list
65607983|NCT02334046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65607984|NCT02334046|Narcotics|narcotics|mesh-ancestor
65607985|NCT02334046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65607986|NCT02334046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65607987|NCT02334046|Analgesics|analgesics|mesh-ancestor
65607988|NCT02334046|Sensory System Agents|sensory system agents|mesh-ancestor
65607989|NCT02334046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65607990|NCT02334046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65607991|NCT02334046|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65607992|NCT02334046|Anesthetics, General|anesthetics, general|mesh-ancestor
65607993|NCT02334046|Anesthetics|anesthetics|mesh-ancestor
65607994|NCT02330380|Adalimumab|adalimumab|mesh-list
65607995|NCT02330380|Etanercept|etanercept|mesh-list
65607996|NCT02330380|Methotrexate|methotrexate|mesh-list
65607997|NCT02330380|Ustekinumab|ustekinumab|mesh-list
65607998|NCT02330380|Acitretin|acitretin|mesh-list
65607999|NCT02330380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65608000|NCT02330380|Abortifacient Agents|abortifacient agents|mesh-ancestor
65608001|NCT02330380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65608002|NCT02330380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608003|NCT02330380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65608004|NCT02330380|Antimetabolites|antimetabolites|mesh-ancestor
65608005|NCT02330380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608006|NCT02330380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608007|NCT02330380|Dermatologic Agents|dermatologic agents|mesh-ancestor
65608008|NCT02330380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608009|NCT02330380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65608010|NCT02330380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65608011|NCT02330380|Immunologic Factors|immunologic factors|mesh-ancestor
65608012|NCT02330380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65608013|NCT02330380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65608014|NCT02330380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65608015|NCT02330380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65608016|NCT02330380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65608017|NCT02330380|Analgesics|analgesics|mesh-ancestor
65608018|NCT02330380|Sensory System Agents|sensory system agents|mesh-ancestor
65608019|NCT02330380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65608020|NCT02330380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65608021|NCT02330380|Keratolytic Agents|keratolytic agents|mesh-ancestor
65608022|NCT04278404|Metformin|metformin|mesh-list
65608023|NCT04278404|Interferons|interferons|mesh-list
65608024|NCT04278404|Ritonavir|ritonavir|mesh-list
65608025|NCT04278404|Ribavirin|ribavirin|mesh-list
65608026|NCT04278404|Lopinavir|lopinavir|mesh-list
65608027|NCT04278404|Oseltamivir|oseltamivir|mesh-list
65608028|NCT04278404|Remdesivir|remdesivir|mesh-list
65608029|NCT04278404|Azithromycin|azithromycin|mesh-list
65608030|NCT04278404|Clindamycin|clindamycin|mesh-list
65608031|NCT04278404|Meropenem|meropenem|mesh-list
65608032|NCT04278404|Voriconazole|voriconazole|mesh-list
65608033|NCT04278404|Ceftazidime|ceftazidime|mesh-list
65608034|NCT04278404|Fosfomycin|fosfomycin|mesh-list
65608035|NCT04278404|Cefepime|cefepime|mesh-list
65608036|NCT04278404|Cefdinir|cefdinir|mesh-list
65608037|NCT04278404|Dexamethasone|dexamethasone|mesh-list
65608038|NCT04278404|Budesonide|budesonide|mesh-list
65608039|NCT04278404|Hydrocortisone|hydrocortisone|mesh-list
65608040|NCT04278404|Colchicine|colchicine|mesh-list
65608041|NCT04278404|Amiodarone|amiodarone|mesh-list
65608042|NCT04278404|Bosentan|bosentan|mesh-list
65608043|NCT04278404|Guanfacine|guanfacine|mesh-list
65608044|NCT04278404|Labetalol|labetalol|mesh-list
65608045|NCT04278404|Nicardipine|nicardipine|mesh-list
65608046|NCT04278404|Nifedipine|nifedipine|mesh-list
65608047|NCT04278404|Milrinone|milrinone|mesh-list
65608048|NCT04278404|Furosemide|furosemide|mesh-list
65608049|NCT04278404|Spironolactone|spironolactone|mesh-list
65608050|NCT04278404|Dexmedetomidine|dexmedetomidine|mesh-list
65608051|NCT04278404|Oxycodone|oxycodone|mesh-list
65608052|NCT04278404|Gabapentin|gabapentin|mesh-list
65608053|NCT04278404|Nalbuphine|nalbuphine|mesh-list
65608054|NCT04278404|Clobazam|clobazam|mesh-list
65608055|NCT04278404|Zolpidem|zolpidem|mesh-list
65608056|NCT04278404|Risperidone|risperidone|mesh-list
65608057|NCT04278404|Amphetamine|amphetamine|mesh-list
65608058|NCT04278404|Dextroamphetamine|dextroamphetamine|mesh-list
65608059|NCT04278404|Sertraline|sertraline|mesh-list
65608060|NCT04278404|Tranexamic Acid|tranexamic acid|mesh-list
65608061|NCT04278404|Aminocaproic Acid|aminocaproic acid|mesh-list
65608062|NCT04278404|Terbutaline|terbutaline|mesh-list
65608063|NCT04278404|Sevelamer|sevelamer|mesh-list
65608064|NCT04278404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65608065|NCT04278404|Antiemetics|antiemetics|mesh-ancestor
65608066|NCT04278404|Autonomic Agents|autonomic agents|mesh-ancestor
65608067|NCT04278404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65608068|NCT04278404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608069|NCT04278404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65608070|NCT04278404|Glucocorticoids|glucocorticoids|mesh-ancestor
65608071|NCT04278404|Hormones|hormones|mesh-ancestor
65608072|NCT04278404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65608073|NCT04278404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65608074|NCT04278404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608075|NCT04278404|Protease Inhibitors|protease inhibitors|mesh-ancestor
65608076|NCT04278404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608077|NCT04278404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608078|NCT04278404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65608079|NCT04278404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65608080|NCT04278404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65608081|NCT04278404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65608082|NCT04278404|Analgesics|analgesics|mesh-ancestor
65608083|NCT04278404|Sensory System Agents|sensory system agents|mesh-ancestor
65608084|NCT04278404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65608085|NCT04278404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65608086|NCT04278404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65608087|NCT04278404|Adrenergic Agents|adrenergic agents|mesh-ancestor
65608088|NCT04278404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65608089|NCT04278404|Antiviral Agents|antiviral agents|mesh-ancestor
65608090|NCT04278404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65608091|NCT04278404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65608092|NCT04278404|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65608093|NCT04278404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65608094|NCT04278404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65608095|NCT04278404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65608096|NCT04278404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65608097|NCT04278404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65608098|NCT04278404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65608099|NCT04278404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65608100|NCT04278404|Antimetabolites|antimetabolites|mesh-ancestor
65608101|NCT04278404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65608102|NCT04278404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65608103|NCT04278404|Respiratory System Agents|respiratory system agents|mesh-ancestor
65608104|NCT04278404|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65608105|NCT04278404|Hemostatics|hemostatics|mesh-ancestor
65608106|NCT04278404|Coagulants|coagulants|mesh-ancestor
65608107|NCT04278404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65608108|NCT04278404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65608109|NCT04278404|Narcotics|narcotics|mesh-ancestor
65608110|NCT04278404|Anticonvulsants|anticonvulsants|mesh-ancestor
65608111|NCT04278404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65608112|NCT04278404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65608113|NCT04278404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65608114|NCT04278404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65608115|NCT04278404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65608116|NCT04278404|Antimanic Agents|antimanic agents|mesh-ancestor
65608117|NCT04278404|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65608118|NCT04278404|Serotonin Agents|serotonin agents|mesh-ancestor
65608119|NCT04278404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65608120|NCT04278404|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65608121|NCT04278404|Dopamine Agents|dopamine agents|mesh-ancestor
65608122|NCT04278404|Antidepressive Agents|antidepressive agents|mesh-ancestor
65608123|NCT04278404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65608124|NCT04278404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65608125|NCT04278404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65608126|NCT04278404|Diuretics|diuretics|mesh-ancestor
65608127|NCT04278404|Natriuretic Agents|natriuretic agents|mesh-ancestor
65608128|NCT04278404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65608129|NCT04278404|Gout Suppressants|gout suppressants|mesh-ancestor
65608130|NCT04278404|Tubulin Modulators|tubulin modulators|mesh-ancestor
65608131|NCT04278404|Antimitotic Agents|antimitotic agents|mesh-ancestor
65608132|NCT04278404|Mitosis Modulators|mitosis modulators|mesh-ancestor
65608133|NCT04278404|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65608134|NCT04278404|Hormone Antagonists|hormone antagonists|mesh-ancestor
65608135|NCT04278404|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65608136|NCT04278404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65608137|NCT04278404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65608138|NCT04278404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65608139|NCT04278404|Vasodilator Agents|vasodilator agents|mesh-ancestor
65608140|NCT04278404|Tocolytic Agents|tocolytic agents|mesh-ancestor
65608141|NCT04278404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65608142|NCT04278404|Antifungal Agents|antifungal agents|mesh-ancestor
65608143|NCT04278404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65608144|NCT04278404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65608145|NCT04278404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65608146|NCT04278404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65608147|NCT04278404|GABA Agonists|gaba agonists|mesh-ancestor
65608148|NCT04278404|GABA Agents|gaba agents|mesh-ancestor
65608149|NCT04278404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65608150|NCT04278404|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65608151|NCT04278404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65608152|NCT04278404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65608153|NCT04278404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65608154|NCT04278404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65608155|NCT04278404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65608156|NCT04278404|Sympathomimetics|sympathomimetics|mesh-ancestor
65608157|NCT04278404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65608158|NCT04278404|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65608159|NCT04278404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65608160|NCT04278404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65608161|NCT04278404|Chelating Agents|chelating agents|mesh-ancestor
65608162|NCT04278404|Sequestering Agents|sequestering agents|mesh-ancestor
65608163|NCT04278404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65405551|NCT00783653|Sunitinib|sunitinib|mesh-list
65608164|NCT04278404|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65608165|NCT04278404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65608166|NCT04278404|Protective Agents|protective agents|mesh-ancestor
65608167|NCT04278404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65608168|NCT04278404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65608169|NCT04278404|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65608170|NCT04278404|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65608171|NCT04278404|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65608172|NCT04278404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65608173|NCT02333890|Chloroquine|chloroquine|mesh-list
65608174|NCT02333890|Amebicides|amebicides|mesh-ancestor
65608175|NCT02333890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65608176|NCT02333890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65608177|NCT02333890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65608178|NCT02333890|Antimalarials|antimalarials|mesh-ancestor
65608179|NCT02333890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65608180|NCT02330302|Ropivacaine|ropivacaine|mesh-list
65608181|NCT02330302|Anesthetics, Local|anesthetics, local|mesh-ancestor
65608182|NCT02330302|Anesthetics|anesthetics|mesh-ancestor
65608183|NCT02330302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65608184|NCT02330302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608185|NCT02330302|Sensory System Agents|sensory system agents|mesh-ancestor
65608186|NCT02330302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65608187|NCT03143530|Ropivacaine|ropivacaine|mesh-list
65608188|NCT03143530|Anesthetics, Local|anesthetics, local|mesh-ancestor
65608189|NCT03143530|Anesthetics|anesthetics|mesh-ancestor
65608190|NCT03143530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65608191|NCT03143530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608192|NCT03143530|Sensory System Agents|sensory system agents|mesh-ancestor
65608193|NCT03143530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65608194|NCT01065818|Telbivudine|telbivudine|mesh-list
65608195|NCT01065818|Antiviral Agents|antiviral agents|mesh-ancestor
65608196|NCT01065818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65608197|NCT01065818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65608198|NCT01065818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608199|NCT01065818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608201|NCT03697408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608202|NCT03697408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65608203|NCT03697408|Immunologic Factors|immunologic factors|mesh-ancestor
65608204|NCT03697408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608205|NCT02318277|Durvalumab|durvalumab|mesh-list
65608206|NCT02318277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65608207|NCT02318277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608208|NCT03143452|Lidocaine|lidocaine|mesh-list
65608209|NCT03143452|Tetracaine|tetracaine|mesh-list
65608210|NCT03143452|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65608211|NCT03143452|Anesthetics, Local|anesthetics, local|mesh-ancestor
65608212|NCT03143452|Anesthetics|anesthetics|mesh-ancestor
65608213|NCT03143452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65608214|NCT03143452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608215|NCT03143452|Sensory System Agents|sensory system agents|mesh-ancestor
65608216|NCT03143452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65608217|NCT03143452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65608218|NCT03143452|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65608219|NCT03143452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65608220|NCT03143452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65608221|NCT03143452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608222|NCT03143452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65608223|NCT01063868|Oxycodone|oxycodone|mesh-list
65608224|NCT01063868|Tapentadol|tapentadol|mesh-list
65608225|NCT01063868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65608226|NCT01063868|Narcotics|narcotics|mesh-ancestor
65608227|NCT01063868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65608228|NCT01063868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608229|NCT01063868|Analgesics|analgesics|mesh-ancestor
65608230|NCT01063868|Sensory System Agents|sensory system agents|mesh-ancestor
65608231|NCT01063868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65608232|NCT01063868|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65608233|NCT01063868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65608234|NCT01063868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65608235|NCT01063868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608236|NCT01063868|Adrenergic Agents|adrenergic agents|mesh-ancestor
65608237|NCT01063868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65608238|NCT04993924|Cetrorelix|cetrorelix|mesh-list
65608239|NCT04993924|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65608240|NCT04993924|Fertility Agents|fertility agents|mesh-ancestor
65608241|NCT04993924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65608242|NCT04993924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608243|NCT04993924|Hormone Antagonists|hormone antagonists|mesh-ancestor
65608244|NCT04993924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65608245|NCT02330068|Citalopram|citalopram|mesh-list
65608246|NCT02330068|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65608247|NCT02330068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65608248|NCT02330068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65608249|NCT02330068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608250|NCT02330068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65608251|NCT02330068|Serotonin Agents|serotonin agents|mesh-ancestor
65608252|NCT02330068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608253|NCT02330068|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65608254|NCT02330068|Antidepressive Agents|antidepressive agents|mesh-ancestor
65608255|NCT02330068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65608256|NCT02333344|Zoledronic Acid|zoledronic acid|mesh-list
65608257|NCT02333344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65608258|NCT02333344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608259|NCT01312857|Panitumumab|panitumumab|mesh-list
65608260|NCT01312857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65608261|NCT01312857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608262|NCT02974010|Cycloserine|cycloserine|mesh-list
65608263|NCT02974010|Ketamine|ketamine|mesh-list
65608264|NCT02974010|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65608265|NCT02974010|Analgesics|analgesics|mesh-ancestor
65608266|NCT02974010|Sensory System Agents|sensory system agents|mesh-ancestor
65608267|NCT02974010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65608268|NCT02974010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608269|NCT02974010|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65608270|NCT02974010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65608271|NCT02974010|Anesthetics, General|anesthetics, general|mesh-ancestor
65608272|NCT02974010|Anesthetics|anesthetics|mesh-ancestor
65608273|NCT02974010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65608274|NCT02974010|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65608275|NCT02974010|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65608276|NCT02974010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65608277|NCT02974010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608278|NCT02974010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65608279|NCT02974010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65608280|NCT02974010|Renal Agents|renal agents|mesh-ancestor
65608281|NCT02974010|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65608282|NCT02974010|Antitubercular Agents|antitubercular agents|mesh-ancestor
65608283|NCT02974010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65608284|NCT02974010|Antimetabolites|antimetabolites|mesh-ancestor
65608285|NCT02974010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65608286|NCT02974010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65608287|NCT02974010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65608288|NCT02974010|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65608289|NCT02974010|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65608290|NCT02974010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65608291|NCT02974010|Adrenergic Agents|adrenergic agents|mesh-ancestor
65608292|NCT02974010|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65608293|NCT02974010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65608294|NCT02974010|Serotonin Agents|serotonin agents|mesh-ancestor
65608295|NCT02974010|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65608296|NCT02974010|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65608297|NCT02974010|Dopamine Agents|dopamine agents|mesh-ancestor
65608298|NCT01061606|Sirolimus|sirolimus|mesh-list
65608299|NCT01061606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65608300|NCT01061606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65608301|NCT01061606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65608302|NCT01061606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608303|NCT01061606|Antifungal Agents|antifungal agents|mesh-ancestor
65608304|NCT01061606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65608305|NCT01061606|Immunologic Factors|immunologic factors|mesh-ancestor
65608306|NCT01061606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608307|NCT04696822|Epinephrine|epinephrine|mesh-list
65608308|NCT04696822|Racepinephrine|racepinephrine|mesh-list
65608309|NCT04696822|Epinephryl borate|epinephryl borate|mesh-list
65608310|NCT04696822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65608311|NCT04696822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65608312|NCT04696822|Adrenergic Agents|adrenergic agents|mesh-ancestor
65608313|NCT04696822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65608314|NCT04696822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608315|NCT04696822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608316|NCT04696822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65608317|NCT04696822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65608318|NCT04696822|Autonomic Agents|autonomic agents|mesh-ancestor
65608319|NCT04696822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65608320|NCT04696822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65608321|NCT04696822|Respiratory System Agents|respiratory system agents|mesh-ancestor
65608322|NCT04696822|Mydriatics|mydriatics|mesh-ancestor
65608323|NCT04696822|Sympathomimetics|sympathomimetics|mesh-ancestor
65608324|NCT04696822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65608325|NCT02329756|Tranexamic Acid|tranexamic acid|mesh-list
65608326|NCT02329756|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65608327|NCT02329756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65608328|NCT02329756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608329|NCT02329756|Hemostatics|hemostatics|mesh-ancestor
65608330|NCT02329756|Coagulants|coagulants|mesh-ancestor
65608331|NCT02329288|Triamcinolone|triamcinolone|mesh-list
65608332|NCT02329288|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65608333|NCT02329288|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65608334|NCT02329288|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65608335|NCT02329288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65608336|NCT02329288|Glucocorticoids|glucocorticoids|mesh-ancestor
65608337|NCT02329288|Hormones|hormones|mesh-ancestor
65608338|NCT02329288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65608339|NCT02329288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608340|NCT02329288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65608341|NCT02329288|Immunologic Factors|immunologic factors|mesh-ancestor
65608342|NCT02329288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608343|NCT02329288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608344|NCT02333188|Leucovorin|leucovorin|mesh-list
65608345|NCT02333188|Paclitaxel|paclitaxel|mesh-list
65608346|NCT02333188|Fluorouracil|fluorouracil|mesh-list
65608347|NCT02333188|Irinotecan|irinotecan|mesh-list
65608348|NCT02333188|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65608349|NCT02333188|Calcium|calcium|mesh-list
65608350|NCT02333188|Levoleucovorin|levoleucovorin|mesh-list
65608351|NCT02333188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65608352|NCT02333188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608353|NCT02333188|Tubulin Modulators|tubulin modulators|mesh-ancestor
65608354|NCT02333188|Antimitotic Agents|antimitotic agents|mesh-ancestor
65608355|NCT02333188|Mitosis Modulators|mitosis modulators|mesh-ancestor
65608356|NCT02333188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608357|NCT02333188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65608358|NCT02333188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608359|NCT02333188|Antimetabolites|antimetabolites|mesh-ancestor
65608360|NCT02333188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65608361|NCT02333188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65608362|NCT02333188|Immunologic Factors|immunologic factors|mesh-ancestor
65608363|NCT02333188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65608364|NCT02333188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65608365|NCT02333188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608366|NCT02333188|Antidotes|antidotes|mesh-ancestor
65608367|NCT02333188|Protective Agents|protective agents|mesh-ancestor
65608368|NCT02333188|Vitamin B Complex|vitamin b complex|mesh-ancestor
65608369|NCT02333188|Vitamins|vitamins|mesh-ancestor
65608370|NCT02333188|Micronutrients|micronutrients|mesh-ancestor
65608371|NCT02329054|Favipiravir|favipiravir|mesh-list
65608372|NCT02329054|Antiviral Agents|antiviral agents|mesh-ancestor
65608373|NCT02329054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65608374|NCT03122457|C 1027|c 1027|mesh-list
65608375|NCT03122457|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65608376|NCT03122457|Dermatologic Agents|dermatologic agents|mesh-ancestor
65608377|NCT03122457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65608378|NCT03122457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608379|NCT04407988|Letrozole|letrozole|mesh-list
65608380|NCT04407988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608381|NCT04407988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65608382|NCT04407988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65608383|NCT04407988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608384|NCT04407988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608385|NCT04407988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65608386|NCT04407988|Hormone Antagonists|hormone antagonists|mesh-ancestor
65608387|NCT04407988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65608388|NCT04407988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608389|NCT02329132|Ranibizumab|ranibizumab|mesh-list
65608390|NCT02329132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65608391|NCT02329132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65608392|NCT02329132|Growth Substances|growth substances|mesh-ancestor
65608393|NCT02329132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608394|NCT02329132|Growth Inhibitors|growth inhibitors|mesh-ancestor
65608395|NCT02329132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608396|NCT04342078|Vitamin D|vitamin d|mesh-list
65608397|NCT04342078|Vitamins|vitamins|mesh-ancestor
65608398|NCT04342078|Micronutrients|micronutrients|mesh-ancestor
65608399|NCT04342078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608400|NCT04342078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65608401|NCT02332954|Vortioxetine|vortioxetine|mesh-list
65608402|NCT02332954|Antidepressive Agents|antidepressive agents|mesh-ancestor
65608403|NCT02332954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65608404|NCT02332954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65608405|NCT02332954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65608406|NCT02332954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65266234|NCT02773550|Hormones|hormones|mesh-ancestor
65608407|NCT02332954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608408|NCT02332954|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65608409|NCT02332954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65608410|NCT02332954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65608411|NCT02332954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608412|NCT02332954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65608413|NCT02332954|Serotonin Agents|serotonin agents|mesh-ancestor
65608414|NCT02332954|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65608415|NCT02332954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65608416|NCT02332954|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65608417|NCT02332954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65608418|NCT01372761|CKD732|ckd732|mesh-list
65608419|NCT01372761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65608420|NCT01372761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65608421|NCT01372761|Growth Substances|growth substances|mesh-ancestor
65608422|NCT01372761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608423|NCT01372761|Growth Inhibitors|growth inhibitors|mesh-ancestor
65608424|NCT01372761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608425|NCT03873675|Hormones|hormones|mesh-list
65608426|NCT03873675|Parathyroid Hormone|parathyroid hormone|mesh-list
65608427|NCT03873675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65608428|NCT03873675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608429|NCT03873675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65608430|NCT05173857|Paclitaxel|paclitaxel|mesh-list
65608431|NCT05173857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65608432|NCT05173857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608433|NCT05173857|Tubulin Modulators|tubulin modulators|mesh-ancestor
65608434|NCT05173857|Antimitotic Agents|antimitotic agents|mesh-ancestor
65608435|NCT05173857|Mitosis Modulators|mitosis modulators|mesh-ancestor
65608436|NCT05173857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608437|NCT05133297|Tofacitinib|tofacitinib|mesh-list
65608438|NCT05133297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65608439|NCT05133297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608440|NCT05133297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608441|NCT03417999|Dexmedetomidine|dexmedetomidine|mesh-list
65608442|NCT03417999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65608443|NCT03417999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65608444|NCT03417999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608445|NCT03417999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65608446|NCT03417999|Analgesics|analgesics|mesh-ancestor
65608447|NCT03417999|Sensory System Agents|sensory system agents|mesh-ancestor
65608448|NCT03417999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65608449|NCT03417999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65608450|NCT03417999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65608451|NCT03417999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65608452|NCT03417999|Adrenergic Agents|adrenergic agents|mesh-ancestor
65608453|NCT03417999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65608454|NCT03417999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608455|NCT03142516|Leucovorin|leucovorin|mesh-list
65608456|NCT03142516|Folic Acid|folic acid|mesh-list
65608457|NCT03142516|Fluorouracil|fluorouracil|mesh-list
65608458|NCT03142516|Irinotecan|irinotecan|mesh-list
65608459|NCT03142516|Panitumumab|panitumumab|mesh-list
65608460|NCT03142516|Levoleucovorin|levoleucovorin|mesh-list
65608461|NCT03142516|Antimetabolites|antimetabolites|mesh-ancestor
65608462|NCT03142516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608463|NCT03142516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65608464|NCT03142516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608465|NCT03142516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65608466|NCT03142516|Immunologic Factors|immunologic factors|mesh-ancestor
65608467|NCT03142516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608468|NCT03142516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65608469|NCT03142516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65608470|NCT03142516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608471|NCT03142516|Antidotes|antidotes|mesh-ancestor
65608472|NCT03142516|Protective Agents|protective agents|mesh-ancestor
65608473|NCT03142516|Vitamin B Complex|vitamin b complex|mesh-ancestor
65608474|NCT03142516|Vitamins|vitamins|mesh-ancestor
65608475|NCT03142516|Micronutrients|micronutrients|mesh-ancestor
65608476|NCT03142516|Hematinics|hematinics|mesh-ancestor
65608477|NCT03142516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65608478|NCT03719729|Rifaximin|rifaximin|mesh-list
65608479|NCT03719729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65608480|NCT03719729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65608481|NCT03719729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65608482|NCT05077462|Cryptophycin 52|cryptophycin 52|mesh-list
65608483|NCT05077462|Antimitotic Agents|antimitotic agents|mesh-ancestor
65608484|NCT05077462|Mitosis Modulators|mitosis modulators|mesh-ancestor
65608485|NCT05077462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608486|NCT05077462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608487|NCT03714113|Antibodies|antibodies|mesh-list
65608488|NCT03714113|Immunologic Factors|immunologic factors|mesh-ancestor
65608489|NCT03714113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608490|NCT03472547|Diacetylrhein|diacetylrhein|mesh-list
65608491|NCT03472547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65608492|NCT00799396|Aspirin|aspirin|mesh-list
65608493|NCT00799396|Clopidogrel|clopidogrel|mesh-list
65608494|NCT00799396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65608495|NCT00799396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65608496|NCT00799396|Analgesics|analgesics|mesh-ancestor
65608497|NCT00799396|Sensory System Agents|sensory system agents|mesh-ancestor
65608498|NCT00799396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65608499|NCT00799396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608500|NCT00799396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65608501|NCT00799396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65608502|NCT00799396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65608503|NCT00799396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65608504|NCT00799396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608505|NCT00799396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65608506|NCT00799396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65608507|NCT00799396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608508|NCT00799396|Antipyretics|antipyretics|mesh-ancestor
65608509|NCT00799396|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65608510|NCT00799396|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65608511|NCT00799396|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65608512|NCT00799396|Purinergic Agents|purinergic agents|mesh-ancestor
65608513|NCT00799396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65608514|NCT02624128|Cetuximab|cetuximab|mesh-list
65608515|NCT02624128|Valproic Acid|valproic acid|mesh-list
65608516|NCT02624128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608517|NCT02624128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65608518|NCT02624128|Anticonvulsants|anticonvulsants|mesh-ancestor
65608519|NCT02624128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608520|NCT02624128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608521|NCT02624128|GABA Agents|gaba agents|mesh-ancestor
65608522|NCT02624128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65608523|NCT02624128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608524|NCT02624128|Antimanic Agents|antimanic agents|mesh-ancestor
65608525|NCT02624128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65608526|NCT02624128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65608527|NCT02624128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65608528|NCT03469349|Actovegin|actovegin|mesh-list
65608529|NCT03469349|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65608530|NCT03469349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608531|NCT03469349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65608532|NCT03469349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65608533|NCT03469349|Antioxidants|antioxidants|mesh-ancestor
65608534|NCT03469349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608535|NCT03469349|Protective Agents|protective agents|mesh-ancestor
65608536|NCT03469349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65608537|NCT03467945|Metformin|metformin|mesh-list
65608538|NCT03467945|Gliclazide|gliclazide|mesh-list
65608539|NCT03467945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65608540|NCT03467945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608541|NCT03719261|Sodium Hypochlorite|sodium hypochlorite|mesh-list
65608542|NCT03719261|Eusol|eusol|mesh-list
65608543|NCT03719261|Chitosan|chitosan|mesh-list
65608544|NCT03719261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65608545|NCT03719261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65608546|NCT03719261|Antimetabolites|antimetabolites|mesh-ancestor
65608547|NCT03719261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608548|NCT03719261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65608549|NCT03719261|Chelating Agents|chelating agents|mesh-ancestor
65608550|NCT03719261|Sequestering Agents|sequestering agents|mesh-ancestor
65608551|NCT03719261|Hemostatics|hemostatics|mesh-ancestor
65608552|NCT03719261|Coagulants|coagulants|mesh-ancestor
65608553|NCT03719261|Disinfectants|disinfectants|mesh-ancestor
65608554|NCT03719261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65608555|NCT00069238|Prednisone|prednisone|mesh-list
65608556|NCT00069238|Cyclophosphamide|cyclophosphamide|mesh-list
65608557|NCT00069238|Doxorubicin|doxorubicin|mesh-list
65608558|NCT00069238|Etoposide|etoposide|mesh-list
65608559|NCT00069238|Vincristine|vincristine|mesh-list
65608560|NCT00069238|Alemtuzumab|alemtuzumab|mesh-list
65608561|NCT00069238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65608562|NCT00069238|Immunologic Factors|immunologic factors|mesh-ancestor
65608563|NCT00069238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608564|NCT00069238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65608565|NCT00069238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65608566|NCT00069238|Alkylating Agents|alkylating agents|mesh-ancestor
65608567|NCT00069238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608568|NCT00069238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608569|NCT00069238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65608570|NCT00069238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65608571|NCT00069238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65608572|NCT00069238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65608573|NCT00069238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608574|NCT00069238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65608575|NCT00069238|Glucocorticoids|glucocorticoids|mesh-ancestor
65608576|NCT00069238|Hormones|hormones|mesh-ancestor
65608577|NCT00069238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65608578|NCT00069238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65608579|NCT00069238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65608580|NCT00069238|Tubulin Modulators|tubulin modulators|mesh-ancestor
65608581|NCT00069238|Antimitotic Agents|antimitotic agents|mesh-ancestor
65608582|NCT00069238|Mitosis Modulators|mitosis modulators|mesh-ancestor
65608583|NCT00069238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65608584|NCT03639155|Glycine|glycine|mesh-list
65608585|NCT03639155|Glycine Agents|glycine agents|mesh-ancestor
65608586|NCT03639155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65608587|NCT03639155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608588|NCT03639155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608589|NCT05080348|Ropivacaine|ropivacaine|mesh-list
65608590|NCT05080348|Anesthetics, Local|anesthetics, local|mesh-ancestor
65608591|NCT05080348|Anesthetics|anesthetics|mesh-ancestor
65608592|NCT05080348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65608593|NCT05080348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608594|NCT05080348|Sensory System Agents|sensory system agents|mesh-ancestor
65608595|NCT05080348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65608596|NCT03073200|Etanercept|etanercept|mesh-list
65608597|NCT03073200|Ixekizumab|ixekizumab|mesh-list
65608598|NCT03073200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65608599|NCT03073200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65608600|NCT03073200|Analgesics|analgesics|mesh-ancestor
65608601|NCT03073200|Sensory System Agents|sensory system agents|mesh-ancestor
65608602|NCT03073200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65608603|NCT03073200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608604|NCT03073200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65608605|NCT03073200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65608606|NCT03073200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65608607|NCT03073200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65608608|NCT03073200|Immunologic Factors|immunologic factors|mesh-ancestor
65608609|NCT03073200|Dermatologic Agents|dermatologic agents|mesh-ancestor
65608610|NCT02030860|Gemcitabine|gemcitabine|mesh-list
65608611|NCT02030860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65608612|NCT02030860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65608613|NCT02030860|Antimetabolites|antimetabolites|mesh-ancestor
65608614|NCT02030860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608615|NCT02030860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608616|NCT02030860|Antiviral Agents|antiviral agents|mesh-ancestor
65608617|NCT02030860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65608618|NCT02030860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608619|NCT02030860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65608620|NCT02030860|Immunologic Factors|immunologic factors|mesh-ancestor
65608621|NCT02030860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608622|NCT01569984|Bevacizumab|bevacizumab|mesh-list
65608623|NCT01569984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65608624|NCT01569984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608625|NCT01569984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65608626|NCT01569984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65608627|NCT01569984|Growth Substances|growth substances|mesh-ancestor
65608628|NCT01569984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608629|NCT01569984|Growth Inhibitors|growth inhibitors|mesh-ancestor
65608630|NCT02328118|Triamcinolone|triamcinolone|mesh-list
65608631|NCT02328118|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65608632|NCT02328118|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65608633|NCT02328118|Ranibizumab|ranibizumab|mesh-list
65608634|NCT02328118|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65608635|NCT02328118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65608636|NCT02328118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65608637|NCT02328118|Growth Substances|growth substances|mesh-ancestor
65608638|NCT02328118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608639|NCT02328118|Growth Inhibitors|growth inhibitors|mesh-ancestor
65608640|NCT02328118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608641|NCT02328118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65608642|NCT02328118|Glucocorticoids|glucocorticoids|mesh-ancestor
65608643|NCT02328118|Hormones|hormones|mesh-ancestor
65608644|NCT02328118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65608645|NCT02328118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65608646|NCT02328118|Immunologic Factors|immunologic factors|mesh-ancestor
65608647|NCT02328118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608648|NCT02328118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608649|NCT02602314|Imatinib Mesylate|imatinib mesylate|mesh-list
65608650|NCT02602314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608651|NCT02602314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65608652|NCT02602314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608653|NCT02602314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608654|NCT05079880|Caffeine|caffeine|mesh-list
65608655|NCT05079880|Caffeine citrate|caffeine citrate|mesh-list
65608656|NCT05079880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608657|NCT05079880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65608658|NCT05079880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608659|NCT05079880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65608660|NCT05079880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608661|NCT05079880|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65608662|NCT05079880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65608663|NCT05079880|Purinergic Agents|purinergic agents|mesh-ancestor
65608664|NCT05079880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65608665|NCT03716765|Vitamin D|vitamin d|mesh-list
65608666|NCT03716765|Vitamins|vitamins|mesh-ancestor
65608667|NCT03716765|Micronutrients|micronutrients|mesh-ancestor
65608668|NCT03716765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608669|NCT03716765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65608670|NCT03629418|Phenylephrine|phenylephrine|mesh-list
65608671|NCT03629418|Norepinephrine|norepinephrine|mesh-list
65608672|NCT03629418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65608673|NCT03629418|Mydriatics|mydriatics|mesh-ancestor
65608674|NCT03629418|Autonomic Agents|autonomic agents|mesh-ancestor
65608675|NCT03629418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65608676|NCT03629418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608677|NCT03629418|Sympathomimetics|sympathomimetics|mesh-ancestor
65608678|NCT03629418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65608679|NCT03629418|Nasal Decongestants|nasal decongestants|mesh-ancestor
65608680|NCT03629418|Respiratory System Agents|respiratory system agents|mesh-ancestor
65608681|NCT03629418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65608682|NCT03629418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65608683|NCT03629418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65608684|NCT03629418|Adrenergic Agents|adrenergic agents|mesh-ancestor
65608685|NCT03629418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65608686|NCT03629418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608687|NCT03629418|Protective Agents|protective agents|mesh-ancestor
65608688|NCT03070002|Denosumab|denosumab|mesh-list
65608689|NCT03070002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65608690|NCT03070002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608691|NCT02327728|Botulinum Toxins|botulinum toxins|mesh-list
65608692|NCT02327728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65608693|NCT02327728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65608694|NCT02327728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65608695|NCT02327728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65608696|NCT02327728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608698|NCT02327728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65608699|NCT02327728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608700|NCT02327728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65608701|NCT02327728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65608702|NCT02918318|Esketamine|esketamine|mesh-list
65608703|NCT02918318|Antidepressive Agents|antidepressive agents|mesh-ancestor
65608704|NCT02918318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65608705|NCT04926454|Dexmedetomidine|dexmedetomidine|mesh-list
65608706|NCT04926454|Bupivacaine|bupivacaine|mesh-list
65608707|NCT04926454|Anesthetics, Local|anesthetics, local|mesh-ancestor
65608708|NCT04926454|Anesthetics|anesthetics|mesh-ancestor
65608709|NCT04926454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65608710|NCT04926454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608711|NCT04926454|Sensory System Agents|sensory system agents|mesh-ancestor
65608712|NCT04926454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65608713|NCT04926454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65608714|NCT04926454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65608715|NCT04926454|Analgesics|analgesics|mesh-ancestor
65608716|NCT04926454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65608717|NCT04926454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65608718|NCT04926454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65608719|NCT04926454|Adrenergic Agents|adrenergic agents|mesh-ancestor
65608720|NCT04926454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65608721|NCT04926454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608722|NCT03652376|Benralizumab|benralizumab|mesh-list
65608723|NCT03652376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65608724|NCT03652376|Respiratory System Agents|respiratory system agents|mesh-ancestor
65608725|NCT05200143|Nivolumab|nivolumab|mesh-list
65608726|NCT05200143|Ipilimumab|ipilimumab|mesh-list
65608727|NCT05200143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65608728|NCT05200143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608729|NCT05200143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65608730|NCT05200143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608731|NCT03142828|Chlorhexidine|chlorhexidine|mesh-list
65608732|NCT03142828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65608733|NCT03142828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65608734|NCT03142828|Disinfectants|disinfectants|mesh-ancestor
65608735|NCT01372839|Atorvastatin|atorvastatin|mesh-list
65608736|NCT01372839|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65608737|NCT01372839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65608738|NCT01372839|Antimetabolites|antimetabolites|mesh-ancestor
65608739|NCT01372839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608740|NCT01372839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65608741|NCT01372839|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65608742|NCT01372839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608743|NCT01065350|Ketamine|ketamine|mesh-list
65608744|NCT01065350|Propofol|propofol|mesh-list
65608745|NCT01065350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65608746|NCT01065350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65608747|NCT01065350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608748|NCT01065350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65608749|NCT01065350|Anesthetics, General|anesthetics, general|mesh-ancestor
65608750|NCT01065350|Anesthetics|anesthetics|mesh-ancestor
65608751|NCT01065350|Analgesics|analgesics|mesh-ancestor
65608752|NCT01065350|Sensory System Agents|sensory system agents|mesh-ancestor
65608753|NCT01065350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65608754|NCT01065350|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65608755|NCT01065350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65608756|NCT01065350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65608757|NCT01065350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65608758|NCT01065350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608759|NCT02914977|Daunorubicin|daunorubicin|mesh-list
65608760|NCT02914977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65608761|NCT02914977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608762|NCT02914977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65608763|NCT02914977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65608764|NCT02914977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608765|NCT02914977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608766|NCT03718715|Metformin|metformin|mesh-list
65608767|NCT03718715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65406155|NCT00066469|Hormones|hormones|mesh-ancestor
65608768|NCT03718715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608769|NCT05079022|Aflutinib|aflutinib|mesh-list
65608770|NCT05079022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65608771|NCT05079022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608772|NCT05079022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608773|NCT05078788|Triamcinolone|triamcinolone|mesh-list
65608774|NCT05078788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65608775|NCT05078788|Glucocorticoids|glucocorticoids|mesh-ancestor
65608776|NCT05078788|Hormones|hormones|mesh-ancestor
65608777|NCT05078788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65608778|NCT05078788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608779|NCT02032654|Floxacillin|floxacillin|mesh-list
65608780|NCT02032654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65608781|NCT02032654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65608782|NCT04734886|Vitamin D|vitamin d|mesh-list
65608783|NCT04734886|Ergocalciferols|ergocalciferols|mesh-list
65608784|NCT04734886|Cholecalciferol|cholecalciferol|mesh-list
65608785|NCT04734886|Vitamins|vitamins|mesh-list
65608786|NCT04734886|Micronutrients|micronutrients|mesh-ancestor
65608787|NCT04734886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608788|NCT04734886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65608789|NCT04734886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65608790|NCT03114969|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65608791|NCT03114969|Tiotropium Bromide|tiotropium bromide|mesh-list
65608792|NCT03114969|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65608793|NCT03114969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65608794|NCT03114969|Respiratory System Agents|respiratory system agents|mesh-ancestor
65608795|NCT03114969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65608796|NCT03114969|Autonomic Agents|autonomic agents|mesh-ancestor
65608797|NCT03114969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65608798|NCT03114969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608799|NCT03114969|Parasympatholytics|parasympatholytics|mesh-ancestor
65608800|NCT03114969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65608801|NCT03114969|Cholinergic Agents|cholinergic agents|mesh-ancestor
65608802|NCT03114969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65608803|NCT03114969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608804|NCT03114969|Glucocorticoids|glucocorticoids|mesh-ancestor
65608805|NCT03114969|Hormones|hormones|mesh-ancestor
65608806|NCT03114969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65608807|NCT03114969|Sympathomimetics|sympathomimetics|mesh-ancestor
65608808|NCT05078710|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65608809|NCT05078710|Immunologic Factors|immunologic factors|mesh-ancestor
65608810|NCT05078710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608811|NCT03144778|Durvalumab|durvalumab|mesh-list
65608812|NCT03144778|Ipilimumab|ipilimumab|mesh-list
65608813|NCT03144778|Tremelimumab|tremelimumab|mesh-list
65608814|NCT03144778|Immunoglobulins|immunoglobulins|mesh-list
65608815|NCT03144778|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65608816|NCT03144778|Immunoglobulin G|immunoglobulin g|mesh-list
65608817|NCT03144778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65608818|NCT03144778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608819|NCT03144778|Immunologic Factors|immunologic factors|mesh-ancestor
65608820|NCT03144778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608821|NCT03144778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65608822|NCT03144778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608823|NCT03142360|Beraprost|beraprost|mesh-list
65608824|NCT03142360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65608825|NCT03142360|Vasodilator Agents|vasodilator agents|mesh-ancestor
65608826|NCT05124678|Isoniazid|isoniazid|mesh-list
65608827|NCT05124678|Antitubercular Agents|antitubercular agents|mesh-ancestor
65608828|NCT05124678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65608829|NCT05124678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65608830|NCT05124678|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65608831|NCT05124678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65608832|NCT05124678|Antimetabolites|antimetabolites|mesh-ancestor
65608833|NCT05124678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608834|NCT05124678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65608835|NCT05761860|Oxycodone|oxycodone|mesh-list
65608836|NCT05761860|Oxytocin|oxytocin|mesh-list
65608837|NCT05761860|Oxytocics|oxytocics|mesh-ancestor
65608838|NCT05761860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65608839|NCT05761860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608840|NCT05761860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65608841|NCT05761860|Narcotics|narcotics|mesh-ancestor
65608842|NCT05761860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65608843|NCT05761860|Analgesics|analgesics|mesh-ancestor
65608844|NCT05761860|Sensory System Agents|sensory system agents|mesh-ancestor
65608845|NCT05761860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65608847|NCT03122145|Antipruritics|antipruritics|mesh-ancestor
65608848|NCT03122145|Dermatologic Agents|dermatologic agents|mesh-ancestor
65608849|NCT03122145|Sensory System Agents|sensory system agents|mesh-ancestor
65608850|NCT03122145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65608851|NCT03122145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608852|NCT05081674|Pembrolizumab|pembrolizumab|mesh-list
65608853|NCT05081674|Nivolumab|nivolumab|mesh-list
65608854|NCT05081674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65608855|NCT05081674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65608856|NCT05081674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608857|NCT05081674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65608858|NCT05081674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608859|NCT05081674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65608860|NCT05081674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608861|NCT05003076|Methamphetamine|methamphetamine|mesh-list
65608862|NCT05003076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65608863|NCT05003076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608864|NCT05003076|Sympathomimetics|sympathomimetics|mesh-ancestor
65608865|NCT05003076|Autonomic Agents|autonomic agents|mesh-ancestor
65608866|NCT05003076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65608867|NCT05003076|Dopamine Agents|dopamine agents|mesh-ancestor
65608868|NCT05003076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65608869|NCT05003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608870|NCT05003076|Adrenergic Agents|adrenergic agents|mesh-ancestor
65608871|NCT05003076|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65608872|NCT05003076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65608873|NCT05003076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65608874|NCT05003076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65608875|NCT03144856|Apatinib|apatinib|mesh-list
65608876|NCT03144856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608877|NCT03144856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65608878|NCT03144856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608879|NCT03144856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608880|NCT03141970|Prednisone|prednisone|mesh-list
65608881|NCT03141970|Prednisolone|prednisolone|mesh-list
65608882|NCT03141970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65608883|NCT03141970|Glucocorticoids|glucocorticoids|mesh-ancestor
65608884|NCT03141970|Hormones|hormones|mesh-ancestor
65608885|NCT03141970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65608886|NCT03141970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608887|NCT03141970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65608888|NCT03141970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608889|NCT04949022|Insulin|insulin|mesh-list
65608890|NCT04949022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65608891|NCT04949022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608892|NCT02327338|Ibuprofen|ibuprofen|mesh-list
65608893|NCT02327338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65608894|NCT02327338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65608895|NCT02327338|Analgesics|analgesics|mesh-ancestor
65608896|NCT02327338|Sensory System Agents|sensory system agents|mesh-ancestor
65608897|NCT02327338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65608898|NCT02327338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608899|NCT02327338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65608900|NCT02327338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65608901|NCT02327338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65608902|NCT02327338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608903|NCT02327338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608904|NCT02327416|Entecavir|entecavir|mesh-list
65608905|NCT02327416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65608906|NCT02327416|Interferon-alpha|interferon-alpha|mesh-list
65608907|NCT02327416|Adefovir|adefovir|mesh-list
65608908|NCT02327416|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65608909|NCT02327416|Molgramostim|molgramostim|mesh-list
65608910|NCT02327416|Sargramostim|sargramostim|mesh-list
65608911|NCT02327416|Antiviral Agents|antiviral agents|mesh-ancestor
65608912|NCT02327416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65608913|NCT02327416|Immunologic Factors|immunologic factors|mesh-ancestor
65608914|NCT02327416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608915|NCT02327416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65608916|NCT02327416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65406294|NCT00787553|Imidazole|imidazole|mesh-list
65608917|NCT02327416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608918|NCT02327416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608919|NCT02327416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608920|NCT02926950|Metformin|metformin|mesh-list
65608921|NCT02926950|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65608922|NCT02926950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65608923|NCT02926950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608924|NCT02926950|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65608925|NCT02926950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608926|NCT01064414|Canagliflozin|canagliflozin|mesh-list
65608927|NCT01064414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65608928|NCT01064414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608929|NCT01064414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65608930|NCT01064414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608931|NCT01372293|Contraceptive Agents|contraceptive agents|mesh-list
65608932|NCT01372293|Contraceptives, Oral|contraceptives, oral|mesh-list
65608933|NCT01372293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65608934|NCT01372293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65608935|NCT01372293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608936|NCT01372293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65608937|NCT03433703|Lenvatinib|lenvatinib|mesh-list
65608938|NCT03433703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608939|NCT03433703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65608940|NCT03433703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608941|NCT03433703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608942|NCT01374633|Sevoflurane|sevoflurane|mesh-list
65608943|NCT01374633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65608944|NCT01374633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65608945|NCT01374633|Anesthetics, General|anesthetics, general|mesh-ancestor
65608946|NCT01374633|Anesthetics|anesthetics|mesh-ancestor
65608947|NCT01374633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65608948|NCT01374633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608949|NCT01178814|Lenalidomide|lenalidomide|mesh-list
65608950|NCT01178814|Immunologic Factors|immunologic factors|mesh-ancestor
65608951|NCT01178814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608952|NCT01178814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65608953|NCT01178814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65608954|NCT01178814|Growth Substances|growth substances|mesh-ancestor
65608955|NCT01178814|Growth Inhibitors|growth inhibitors|mesh-ancestor
65608956|NCT01178814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65608957|NCT05202288|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
65608958|NCT05202288|Antiviral Agents|antiviral agents|mesh-ancestor
65608959|NCT05202288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65608960|NCT05762484|Clindamycin|clindamycin|mesh-list
65608961|NCT05762484|Clindamycin palmitate|clindamycin palmitate|mesh-list
65608962|NCT05762484|Clindamycin phosphate|clindamycin phosphate|mesh-list
65608963|NCT05762484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65608964|NCT05762484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65608965|NCT05762484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65608966|NCT05762484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608967|NCT05762484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608968|NCT03462641|Flumazenil|flumazenil|mesh-list
65608969|NCT03462641|Antidotes|antidotes|mesh-ancestor
65608970|NCT03462641|Protective Agents|protective agents|mesh-ancestor
65608971|NCT03462641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608972|NCT03462641|GABA Modulators|gaba modulators|mesh-ancestor
65608973|NCT03462641|GABA Agents|gaba agents|mesh-ancestor
65608974|NCT03462641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65608975|NCT03462641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608976|NCT05201352|Trifluridine|trifluridine|mesh-list
65608977|NCT05201352|Antimetabolites|antimetabolites|mesh-ancestor
65608978|NCT05201352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608979|NCT05201352|Antiviral Agents|antiviral agents|mesh-ancestor
65608980|NCT05201352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65608981|NCT04128956|Aspirin|aspirin|mesh-list
65608982|NCT04128956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65608983|NCT04128956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65608984|NCT04128956|Analgesics|analgesics|mesh-ancestor
65608985|NCT04128956|Sensory System Agents|sensory system agents|mesh-ancestor
65608986|NCT04128956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65608987|NCT04128956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65608988|NCT04128956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65608989|NCT04128956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65608990|NCT04128956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65608991|NCT04128956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65608992|NCT04128956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65608993|NCT04128956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65608994|NCT04128956|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65608995|NCT04128956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65608996|NCT04128956|Antipyretics|antipyretics|mesh-ancestor
65608997|NCT05761704|Anticoagulants|anticoagulants|mesh-list
65608998|NCT03652142|Nivolumab|nivolumab|mesh-list
65608999|NCT03652142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65609000|NCT03652142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609001|NCT03652142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65609002|NCT03652142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609003|NCT05762328|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65609004|NCT05762328|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65609005|NCT05762328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65609006|NCT05762328|Antitubercular Agents|antitubercular agents|mesh-ancestor
65609007|NCT04629378|Amoxicillin|amoxicillin|mesh-list
65609008|NCT04629378|Meropenem|meropenem|mesh-list
65609009|NCT04629378|Clavulanic Acid|clavulanic acid|mesh-list
65609010|NCT04629378|Clavulanic Acids|clavulanic acids|mesh-list
65609011|NCT04629378|Pyrazinamide|pyrazinamide|mesh-list
65609012|NCT04629378|Bedaquiline|bedaquiline|mesh-list
65609013|NCT04629378|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65609014|NCT04629378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65609015|NCT04629378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65609016|NCT04629378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65609017|NCT04629378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609018|NCT04629378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609019|NCT04629378|Antitubercular Agents|antitubercular agents|mesh-ancestor
65609020|NCT03651674|Olanzapine|olanzapine|mesh-list
65609021|NCT03651674|Clozapine|clozapine|mesh-list
65609022|NCT03651674|Antiemetics|antiemetics|mesh-ancestor
65609023|NCT03651674|Autonomic Agents|autonomic agents|mesh-ancestor
65609024|NCT03651674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65609025|NCT03651674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609026|NCT03651674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65609027|NCT03651674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65609028|NCT03651674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65609029|NCT03651674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609030|NCT03651674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65609031|NCT03651674|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65609032|NCT03651674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65609033|NCT03651674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65609034|NCT03651674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609035|NCT03651674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65609036|NCT03651674|Serotonin Agents|serotonin agents|mesh-ancestor
65609037|NCT03651674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65609038|NCT03651674|GABA Antagonists|gaba antagonists|mesh-ancestor
65609039|NCT03651674|GABA Agents|gaba agents|mesh-ancestor
65609040|NCT01061840|Molgramostim|molgramostim|mesh-list
65609041|NCT01061840|Modafinil|modafinil|mesh-list
65609042|NCT01061840|Vaccines|vaccines|mesh-list
65609043|NCT01061840|Sargramostim|sargramostim|mesh-list
65609044|NCT01061840|Immunologic Factors|immunologic factors|mesh-ancestor
65609045|NCT01061840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609046|NCT01061840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609047|NCT01061840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65609048|NCT01061840|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65609049|NCT01061840|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65609050|NCT01061840|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65609051|NCT01061840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609052|NCT02926638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65609053|NCT02926638|Rilotumumab|rilotumumab|mesh-list
65609054|NCT02926638|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65609055|NCT02926638|Antibodies|antibodies|mesh-list
65609056|NCT02926638|Immunoglobulins|immunoglobulins|mesh-list
65609057|NCT02926638|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65609058|NCT02926638|Immunologic Factors|immunologic factors|mesh-ancestor
65609059|NCT02926638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609060|NCT02926638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609061|NCT02926638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65609062|NCT02926638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609063|NCT02926638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609064|NCT03650582|Glucagon|glucagon|mesh-list
65609065|NCT03650582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65609066|NCT03650582|Hormones|hormones|mesh-ancestor
65609067|NCT03650582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65609068|NCT03650582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609069|NCT02903030|Silicon|silicon|mesh-list
65609070|NCT02903030|Trace Elements|trace elements|mesh-ancestor
65609071|NCT02903030|Micronutrients|micronutrients|mesh-ancestor
65609072|NCT02903030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609073|NCT02969408|Albuterol|albuterol|mesh-list
65609074|NCT02969408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65609075|NCT02969408|Autonomic Agents|autonomic agents|mesh-ancestor
65609076|NCT02969408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65609077|NCT02969408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609078|NCT02969408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65609079|NCT02969408|Respiratory System Agents|respiratory system agents|mesh-ancestor
65609080|NCT02969408|Tocolytic Agents|tocolytic agents|mesh-ancestor
65609081|NCT02969408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65609082|NCT02969408|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65609083|NCT02969408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65609084|NCT02969408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65609085|NCT02969408|Adrenergic Agents|adrenergic agents|mesh-ancestor
65609086|NCT02969408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65609087|NCT02969408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609088|NCT04528134|Listerine|listerine|mesh-list
65609089|NCT04528134|Fluorides|fluorides|mesh-list
65609090|NCT04528134|Sodium Fluoride|sodium fluoride|mesh-list
65609091|NCT04528134|Fluorides, Topical|fluorides, topical|mesh-list
65609092|NCT04528134|Cariostatic Agents|cariostatic agents|mesh-ancestor
65609093|NCT04528134|Protective Agents|protective agents|mesh-ancestor
65609094|NCT04528134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609095|NCT04528134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65609096|NCT04528134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65609097|NCT05180214|Ketorolac|ketorolac|mesh-list
65609098|NCT05180214|Bupivacaine|bupivacaine|mesh-list
65609099|NCT05180214|Anesthetics, Local|anesthetics, local|mesh-ancestor
65609100|NCT05180214|Anesthetics|anesthetics|mesh-ancestor
65609101|NCT05180214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609102|NCT05180214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609103|NCT05180214|Sensory System Agents|sensory system agents|mesh-ancestor
65609104|NCT05180214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65609105|NCT05180214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65609106|NCT05180214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65609107|NCT05180214|Analgesics|analgesics|mesh-ancestor
65609108|NCT05180214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65609109|NCT05180214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65609110|NCT05180214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65609111|NCT05180214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609112|NCT05180214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609113|NCT01060124|Fentanyl|fentanyl|mesh-list
65609114|NCT01060124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65609115|NCT01060124|Narcotics|narcotics|mesh-ancestor
65609116|NCT01060124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609117|NCT01060124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609118|NCT01060124|Analgesics|analgesics|mesh-ancestor
65609119|NCT01060124|Sensory System Agents|sensory system agents|mesh-ancestor
65609120|NCT01060124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65609121|NCT01060124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65609122|NCT01060124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65609123|NCT01060124|Anesthetics, General|anesthetics, general|mesh-ancestor
65609124|NCT01060124|Anesthetics|anesthetics|mesh-ancestor
65609125|NCT03461003|Losartan|losartan|mesh-list
65609126|NCT03461003|Amlodipine|amlodipine|mesh-list
65609127|NCT03461003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65609128|NCT03461003|Lisinopril|lisinopril|mesh-list
65609129|NCT03461003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65609130|NCT03461003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65609131|NCT03461003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65609132|NCT03461003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609133|NCT03461003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65609134|NCT03461003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609135|NCT03461003|Vasodilator Agents|vasodilator agents|mesh-ancestor
65609136|NCT03461003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65609137|NCT03461003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65609138|NCT03461003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65609139|NCT03461003|Diuretics|diuretics|mesh-ancestor
65609140|NCT03461003|Natriuretic Agents|natriuretic agents|mesh-ancestor
65609141|NCT03461003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65609142|NCT03461003|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65609143|NCT03461003|Protease Inhibitors|protease inhibitors|mesh-ancestor
65609144|NCT03461003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609145|NCT03461003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65609146|NCT03461003|Protective Agents|protective agents|mesh-ancestor
65609147|NCT03650348|Atezolizumab|atezolizumab|mesh-list
65609148|NCT03650348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609150|NCT05761470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65609151|NCT05761470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609152|NCT05761470|Tubulin Modulators|tubulin modulators|mesh-ancestor
65609153|NCT05761470|Antimitotic Agents|antimitotic agents|mesh-ancestor
65609154|NCT05761470|Mitosis Modulators|mitosis modulators|mesh-ancestor
65609155|NCT05761470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609156|NCT02904902|Adalimumab|adalimumab|mesh-list
65609157|NCT02904902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65609158|NCT02904902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65609159|NCT03650270|Phenytoin|phenytoin|mesh-list
65609160|NCT03650270|Midazolam|midazolam|mesh-list
65609161|NCT03650270|Phenobarbital|phenobarbital|mesh-list
65609162|NCT03650270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65609163|NCT03650270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65609164|NCT03650270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609165|NCT03650270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609166|NCT03650270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65609167|NCT03650270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65609168|NCT03650270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65609169|NCT03650270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65609170|NCT03650270|Anesthetics, General|anesthetics, general|mesh-ancestor
65609171|NCT03650270|Anesthetics|anesthetics|mesh-ancestor
65609172|NCT03650270|GABA Modulators|gaba modulators|mesh-ancestor
65609173|NCT03650270|GABA Agents|gaba agents|mesh-ancestor
65609174|NCT03650270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65609175|NCT03650270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609176|NCT03650270|Anticonvulsants|anticonvulsants|mesh-ancestor
65609177|NCT03650270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65609178|NCT03650270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65609179|NCT03650270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65609180|NCT03650270|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65609181|NCT03650270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65609182|NCT03650270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65609183|NCT03650270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65609184|NCT03650270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65609185|NCT03650270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65609186|NCT05285228|Fluorides|fluorides|mesh-list
65609187|NCT05285228|Fluorides, Topical|fluorides, topical|mesh-list
65609188|NCT05285228|Cariostatic Agents|cariostatic agents|mesh-ancestor
65609189|NCT05285228|Protective Agents|protective agents|mesh-ancestor
65609190|NCT05285228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609191|NCT04075526|Vancomycin|vancomycin|mesh-list
65609192|NCT04075526|Povidone-Iodine|povidone-iodine|mesh-list
65609193|NCT04075526|Povidone|povidone|mesh-list
65609194|NCT04075526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65609195|NCT04075526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65609196|NCT04075526|Plasma Substitutes|plasma substitutes|mesh-ancestor
65609197|NCT04075526|Blood Substitutes|blood substitutes|mesh-ancestor
65609198|NCT04075526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65609199|NCT05204628|Crizotinib|crizotinib|mesh-list
65609200|NCT05204628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609201|NCT05204628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65609202|NCT05204628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609203|NCT05204628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609204|NCT03650738|Paclitaxel|paclitaxel|mesh-list
65609205|NCT03650738|Carboplatin|carboplatin|mesh-list
65609206|NCT03650738|Apatinib|apatinib|mesh-list
65609207|NCT03650738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65609208|NCT03650738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609209|NCT03650738|Tubulin Modulators|tubulin modulators|mesh-ancestor
65609210|NCT03650738|Antimitotic Agents|antimitotic agents|mesh-ancestor
65609211|NCT03650738|Mitosis Modulators|mitosis modulators|mesh-ancestor
65609212|NCT03650738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609213|NCT03650738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65609214|NCT03650738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609215|NCT02904200|Silicon|silicon|mesh-list
65609216|NCT02904200|Trace Elements|trace elements|mesh-ancestor
65609217|NCT02904200|Micronutrients|micronutrients|mesh-ancestor
65609218|NCT02904200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609219|NCT03432533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65609220|NCT03432533|Immunologic Factors|immunologic factors|mesh-ancestor
65609221|NCT03432533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609222|NCT03621800|Menthol|menthol|mesh-list
65609223|NCT03621800|Antipruritics|antipruritics|mesh-ancestor
65609224|NCT03621800|Dermatologic Agents|dermatologic agents|mesh-ancestor
65609225|NCT03649334|Ketorolac|ketorolac|mesh-list
65609226|NCT03649334|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65609227|NCT03649334|Fentanyl|fentanyl|mesh-list
65609228|NCT03649334|Ketamine|ketamine|mesh-list
65609229|NCT03649334|Analgesics|analgesics|mesh-ancestor
65609230|NCT03649334|Sensory System Agents|sensory system agents|mesh-ancestor
65609231|NCT03649334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65609232|NCT03649334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609233|NCT03649334|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65609234|NCT03649334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65609235|NCT03649334|Anesthetics, General|anesthetics, general|mesh-ancestor
65609236|NCT03649334|Anesthetics|anesthetics|mesh-ancestor
65609237|NCT03649334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609238|NCT03649334|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65609239|NCT03649334|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65609240|NCT03649334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65609241|NCT03649334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609242|NCT03649334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65609243|NCT03649334|Narcotics|narcotics|mesh-ancestor
65609244|NCT03649334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65609245|NCT03649334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65609246|NCT03649334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65609247|NCT03649334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65609248|NCT03649334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65609249|NCT03649334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65609250|NCT03649334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609251|NCT02901548|Durvalumab|durvalumab|mesh-list
65609252|NCT02901548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65609253|NCT02901548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609254|NCT03457727|Omeprazole|omeprazole|mesh-list
65609255|NCT03457727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65609256|NCT03457727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65609257|NCT03457727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65609258|NCT03457727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609259|NCT03457727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609260|NCT05285384|Myeloma Proteins|myeloma proteins|mesh-list
65609261|NCT05285384|Paraproteins|paraproteins|mesh-list
65609262|NCT05285384|Immunologic Factors|immunologic factors|mesh-ancestor
65609263|NCT05285384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609264|NCT03648554|Dulaglutide|dulaglutide|mesh-list
65609265|NCT03648554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65609266|NCT03648554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609267|NCT05284994|Osimertinib|osimertinib|mesh-list
65609268|NCT05284994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609269|NCT05284994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65609270|NCT05284994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609271|NCT05284994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609272|NCT03068754|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65609273|NCT03068754|Hormones|hormones|mesh-ancestor
65609274|NCT03068754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65609275|NCT03068754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609276|NCT02965820|Contact Lens Solutions|contact lens solutions|mesh-list
65609277|NCT02965820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65609278|NCT02965820|Disinfectants|disinfectants|mesh-ancestor
65609279|NCT02965820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65609280|NCT03430895|Durvalumab|durvalumab|mesh-list
65609281|NCT03430895|Tremelimumab|tremelimumab|mesh-list
65609282|NCT03430895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65609283|NCT03430895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609284|NCT05745480|Analgesics, Opioid|analgesics, opioid|mesh-list
65609285|NCT05745480|Narcotics|narcotics|mesh-ancestor
65609286|NCT05745480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609287|NCT05745480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609288|NCT05745480|Analgesics|analgesics|mesh-ancestor
65609289|NCT05745480|Sensory System Agents|sensory system agents|mesh-ancestor
65609290|NCT05745480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65609291|NCT03452189|Vancomycin|vancomycin|mesh-list
65609292|NCT03452189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65609293|NCT03452189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65609294|NCT00603954|Fludarabine|fludarabine|mesh-list
65609295|NCT00603954|Fludarabine phosphate|fludarabine phosphate|mesh-list
65609296|NCT00603954|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65609297|NCT00603954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609298|NCT00603954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65609299|NCT00603954|Antimetabolites|antimetabolites|mesh-ancestor
65609300|NCT00603954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609301|NCT00603954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65609302|NCT00603954|Immunologic Factors|immunologic factors|mesh-ancestor
65609303|NCT00603954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609304|NCT03427619|Picibanil|picibanil|mesh-list
65609305|NCT03427619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609306|NCT03712475|Pregabalin|pregabalin|mesh-list
65609307|NCT03712475|Analgesics|analgesics|mesh-ancestor
65609308|NCT03712475|Sensory System Agents|sensory system agents|mesh-ancestor
65609309|NCT03712475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65609310|NCT03712475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609311|NCT03712475|Anticonvulsants|anticonvulsants|mesh-ancestor
65609312|NCT03712475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65609313|NCT03712475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65609314|NCT03712475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609315|NCT03712475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65609316|NCT03712475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65609317|NCT03712475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65609318|NCT03712475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609319|NCT03712475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65609320|NCT02435433|Ramucirumab|ramucirumab|mesh-list
65609321|NCT02435433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609322|NCT01372371|Vancomycin|vancomycin|mesh-list
65609323|NCT01372371|Gentamicins|gentamicins|mesh-list
65609324|NCT01372371|Cefuroxime|cefuroxime|mesh-list
65609325|NCT01372371|Cefuroxime axetil|cefuroxime axetil|mesh-list
65609326|NCT01372371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65609327|NCT01372371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65609328|NCT01372371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65609329|NCT01372371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609330|NCT01372371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609331|NCT03120351|Lidocaine|lidocaine|mesh-list
65609332|NCT03120351|Anesthetics, Local|anesthetics, local|mesh-ancestor
65609333|NCT03120351|Anesthetics|anesthetics|mesh-ancestor
65609334|NCT03120351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609335|NCT03120351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609336|NCT03120351|Sensory System Agents|sensory system agents|mesh-ancestor
65609337|NCT03120351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65609338|NCT03120351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65609339|NCT03120351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65609340|NCT03120351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65609341|NCT03120351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65609342|NCT03120351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609343|NCT01374789|Panitumumab|panitumumab|mesh-list
65609344|NCT01374789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65609345|NCT01374789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609346|NCT02354703|Ondansetron|ondansetron|mesh-list
65609347|NCT02354703|Antiemetics|antiemetics|mesh-ancestor
65609348|NCT02354703|Autonomic Agents|autonomic agents|mesh-ancestor
65609349|NCT02354703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65609350|NCT02354703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609351|NCT02354703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65609352|NCT02354703|Antipruritics|antipruritics|mesh-ancestor
65609353|NCT02354703|Dermatologic Agents|dermatologic agents|mesh-ancestor
65609354|NCT02354703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65609355|NCT02354703|Serotonin Agents|serotonin agents|mesh-ancestor
65609356|NCT02354703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65609357|NCT02354703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609358|NCT02354703|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65609359|NCT02354703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65609360|NCT02354703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609361|NCT02354703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65609362|NCT02354703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65609363|NCT05008887|Fluorouracil|fluorouracil|mesh-list
65609364|NCT05008887|Methotrexate|methotrexate|mesh-list
65609365|NCT05008887|Antimetabolites|antimetabolites|mesh-ancestor
65609366|NCT05008887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609367|NCT05008887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65609368|NCT05008887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609369|NCT05008887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65406745|NCT00798083|Analgesics|analgesics|mesh-ancestor
65609370|NCT05008887|Immunologic Factors|immunologic factors|mesh-ancestor
65609371|NCT05008887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609372|NCT05008887|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65609373|NCT05008887|Abortifacient Agents|abortifacient agents|mesh-ancestor
65609374|NCT05008887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65609375|NCT05008887|Dermatologic Agents|dermatologic agents|mesh-ancestor
65609376|NCT05008887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609377|NCT05008887|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65609378|NCT05008887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65609379|NCT05008887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65609380|NCT01376193|Naratriptan|naratriptan|mesh-list
65609381|NCT01376193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65609382|NCT01376193|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65609383|NCT01376193|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65609384|NCT01376193|Serotonin Agents|serotonin agents|mesh-ancestor
65609385|NCT01376193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65609386|NCT01376193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609387|NCT01376193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609388|NCT04944771|Rabeprazole|rabeprazole|mesh-list
65609389|NCT04944771|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65609390|NCT04944771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65609391|NCT04944771|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65609392|NCT04944771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609393|NCT04944771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609394|NCT01375023|Thymoglobulin|thymoglobulin|mesh-list
65609395|NCT01375023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65609396|NCT01375023|Immunologic Factors|immunologic factors|mesh-ancestor
65609397|NCT01375023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609398|NCT01375023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65609400|NCT05197101|Oxytocics|oxytocics|mesh-ancestor
65609401|NCT05197101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65609402|NCT05197101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609403|NCT01375101|Quercetin|quercetin|mesh-list
65609404|NCT01375101|Antioxidants|antioxidants|mesh-ancestor
65609405|NCT01375101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609406|NCT01375101|Protective Agents|protective agents|mesh-ancestor
65609407|NCT01375101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609408|NCT04865289|Paclitaxel|paclitaxel|mesh-list
65609409|NCT04865289|Carboplatin|carboplatin|mesh-list
65609410|NCT04865289|Pembrolizumab|pembrolizumab|mesh-list
65609411|NCT04865289|Lenvatinib|lenvatinib|mesh-list
65609412|NCT04865289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65609413|NCT04865289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609414|NCT04865289|Tubulin Modulators|tubulin modulators|mesh-ancestor
65609415|NCT04865289|Antimitotic Agents|antimitotic agents|mesh-ancestor
65609416|NCT04865289|Mitosis Modulators|mitosis modulators|mesh-ancestor
65609417|NCT04865289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609418|NCT04865289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65609419|NCT04865289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65609420|NCT04865289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609421|NCT03633591|Tolcapone|tolcapone|mesh-list
65609422|NCT03633591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65609423|NCT03633591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65609424|NCT03633591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65609425|NCT03633591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609426|NCT03633591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609427|NCT01376271|Paroxetine|paroxetine|mesh-list
65609428|NCT01376271|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65609429|NCT01376271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65609430|NCT01376271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65609431|NCT01376271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609432|NCT01376271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65609433|NCT01376271|Serotonin Agents|serotonin agents|mesh-ancestor
65609434|NCT01376271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609435|NCT01376271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65609436|NCT01376271|Antidepressive Agents|antidepressive agents|mesh-ancestor
65609437|NCT01376271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65609438|NCT01376271|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65609439|NCT01376271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65609440|NCT01376271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609441|NCT04885881|Lidocaine|lidocaine|mesh-list
65609442|NCT04885881|Anesthetics, Local|anesthetics, local|mesh-ancestor
65609443|NCT04885881|Anesthetics|anesthetics|mesh-ancestor
65609444|NCT04885881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609445|NCT04885881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609446|NCT04885881|Sensory System Agents|sensory system agents|mesh-ancestor
65609447|NCT04885881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65609448|NCT04885881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65609449|NCT04885881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65609450|NCT04885881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65609451|NCT04885881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65609452|NCT04885881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609453|NCT04820205|Dexmedetomidine|dexmedetomidine|mesh-list
65609454|NCT04820205|Ketamine|ketamine|mesh-list
65609455|NCT04820205|Chloral Hydrate|chloral hydrate|mesh-list
65609456|NCT04820205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65609457|NCT04820205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609458|NCT04820205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609459|NCT04820205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65609460|NCT04820205|Analgesics|analgesics|mesh-ancestor
65609461|NCT04820205|Sensory System Agents|sensory system agents|mesh-ancestor
65609462|NCT04820205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65609463|NCT04820205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65609464|NCT04820205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65609465|NCT04820205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65609466|NCT04820205|Adrenergic Agents|adrenergic agents|mesh-ancestor
65609467|NCT04820205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65609468|NCT04820205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609469|NCT04820205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65609470|NCT04820205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65609471|NCT04820205|Anesthetics, General|anesthetics, general|mesh-ancestor
65609472|NCT04820205|Anesthetics|anesthetics|mesh-ancestor
65609473|NCT04820205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65609474|NCT04820205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65609475|NCT01375257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65609476|NCT01375257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65609477|NCT01375257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65609478|NCT01375257|Antitubercular Agents|antitubercular agents|mesh-ancestor
65609479|NCT05195619|Cyclophosphamide|cyclophosphamide|mesh-list
65609480|NCT05195619|Vaccines|vaccines|mesh-list
65609481|NCT05195619|Immunologic Factors|immunologic factors|mesh-ancestor
65609482|NCT05195619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609483|NCT05195619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65609484|NCT05195619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65609485|NCT05195619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65609486|NCT05195619|Alkylating Agents|alkylating agents|mesh-ancestor
65609487|NCT05195619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609488|NCT05195619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609489|NCT05195619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65609490|NCT01375335|Dobutamine|dobutamine|mesh-list
65609491|NCT01375335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65609492|NCT01375335|Sympathomimetics|sympathomimetics|mesh-ancestor
65609493|NCT01375335|Autonomic Agents|autonomic agents|mesh-ancestor
65609494|NCT01375335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65609495|NCT01375335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609496|NCT01375335|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65609497|NCT01375335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65609498|NCT01375335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65609499|NCT01375335|Adrenergic Agents|adrenergic agents|mesh-ancestor
65609500|NCT01375335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65609501|NCT01375335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609502|NCT01375335|Protective Agents|protective agents|mesh-ancestor
65609503|NCT01373463|Carboplatin|carboplatin|mesh-list
65609504|NCT01373463|Pemetrexed|pemetrexed|mesh-list
65609505|NCT01373463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609506|NCT01373463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609507|NCT01373463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609508|NCT01373463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65609509|NCT01373463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65609510|NCT04585893|Rituximab|rituximab|mesh-list
65609511|NCT04585893|Etoposide|etoposide|mesh-list
65609512|NCT04585893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65609513|NCT04585893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609514|NCT04585893|Immunologic Factors|immunologic factors|mesh-ancestor
65609515|NCT04585893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609516|NCT04585893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65406940|NCT00803465|Xhance|xhance|mesh-list
65609518|NCT04585893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65609519|NCT04585893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65609520|NCT04585893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609521|NCT04585893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609522|NCT04573647|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65609523|NCT04573647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65609524|NCT03113409|Naltrexone|naltrexone|mesh-list
65609525|NCT03113409|Buprenorphine|buprenorphine|mesh-list
65609526|NCT03113409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65609527|NCT03113409|Narcotics|narcotics|mesh-ancestor
65609528|NCT03113409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609529|NCT03113409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609530|NCT03113409|Analgesics|analgesics|mesh-ancestor
65609531|NCT03113409|Sensory System Agents|sensory system agents|mesh-ancestor
65609532|NCT03113409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65609533|NCT03113409|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65609534|NCT03113409|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65609535|NCT05193747|Anesthetics|anesthetics|mesh-list
65609536|NCT05193747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609537|NCT05193747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609538|NCT01373541|Palmitic Acid|palmitic acid|mesh-list
65609539|NCT01373541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609540|NCT01373541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609541|NCT03633747|Propranolol|propranolol|mesh-list
65609542|NCT03633747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65609543|NCT03633747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65609544|NCT03633747|Adrenergic Agents|adrenergic agents|mesh-ancestor
65609545|NCT03633747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65609546|NCT03633747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609547|NCT03633747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609548|NCT03633747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65609549|NCT03633747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65609550|NCT03633747|Vasodilator Agents|vasodilator agents|mesh-ancestor
65609551|NCT01376817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65609552|NCT01376817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65609553|NCT01376817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65609554|NCT01376817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65609555|NCT01373697|Ibuprofen|ibuprofen|mesh-list
65609556|NCT01373697|Ketoprofen|ketoprofen|mesh-list
65609557|NCT01373697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65609558|NCT01373697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65609559|NCT01373697|Analgesics|analgesics|mesh-ancestor
65609560|NCT01373697|Sensory System Agents|sensory system agents|mesh-ancestor
65609561|NCT01373697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65609562|NCT01373697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609563|NCT01373697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65609564|NCT01373697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65609565|NCT01373697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65609566|NCT01373697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609567|NCT01373697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609568|NCT01375881|Ritonavir|ritonavir|mesh-list
65609569|NCT01375881|Darunavir|darunavir|mesh-list
65609570|NCT01375881|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65609571|NCT01375881|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65609572|NCT01375881|Protease Inhibitors|protease inhibitors|mesh-ancestor
65609573|NCT01375881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609574|NCT01375881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609575|NCT01375881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65609576|NCT01375881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65609577|NCT01375881|Antiviral Agents|antiviral agents|mesh-ancestor
65609578|NCT01375881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65609579|NCT01375881|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65609580|NCT01375881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65609581|NCT04690023|Ropivacaine|ropivacaine|mesh-list
65609582|NCT04690023|Anesthetics, Local|anesthetics, local|mesh-ancestor
65609583|NCT04690023|Anesthetics|anesthetics|mesh-ancestor
65609584|NCT04690023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609585|NCT04690023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609586|NCT04690023|Sensory System Agents|sensory system agents|mesh-ancestor
65609587|NCT04690023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65609588|NCT03066804|Valsartan|valsartan|mesh-list
65609589|NCT03066804|Enalapril|enalapril|mesh-list
65609590|NCT03066804|Enalaprilat|enalaprilat|mesh-list
65609591|NCT03066804|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65609592|NCT03066804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65609593|NCT03066804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65609594|NCT03066804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65609595|NCT03066804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609596|NCT03066804|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65609597|NCT03066804|Protease Inhibitors|protease inhibitors|mesh-ancestor
65609598|NCT03066804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609599|NCT04269213|Cytarabine|cytarabine|mesh-list
65609600|NCT04269213|Daunorubicin|daunorubicin|mesh-list
65609601|NCT04269213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65609602|NCT04269213|Antimetabolites|antimetabolites|mesh-ancestor
65609603|NCT04269213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609604|NCT04269213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609605|NCT04269213|Antiviral Agents|antiviral agents|mesh-ancestor
65609606|NCT04269213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65609607|NCT04269213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65609608|NCT04269213|Immunologic Factors|immunologic factors|mesh-ancestor
65609609|NCT04269213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609610|NCT04269213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65609611|NCT04269213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65609612|NCT04269213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65609613|NCT04269213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609614|NCT03629262|Sufentanil|sufentanil|mesh-list
65609615|NCT03629262|Dexmedetomidine|dexmedetomidine|mesh-list
65609616|NCT03629262|Dsuvia|dsuvia|mesh-list
65609617|NCT03629262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65609618|NCT03629262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609619|NCT03629262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609620|NCT03629262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65609621|NCT03629262|Analgesics|analgesics|mesh-ancestor
65609622|NCT03629262|Sensory System Agents|sensory system agents|mesh-ancestor
65609623|NCT03629262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65609624|NCT03629262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65609625|NCT03629262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65609626|NCT03629262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65609627|NCT03629262|Adrenergic Agents|adrenergic agents|mesh-ancestor
65609628|NCT03629262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65609629|NCT03629262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609630|NCT03629262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65609631|NCT03629262|Narcotics|narcotics|mesh-ancestor
65609632|NCT03629262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65609633|NCT03629262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65609634|NCT03629262|Anesthetics, General|anesthetics, general|mesh-ancestor
65609635|NCT03629262|Anesthetics|anesthetics|mesh-ancestor
65609636|NCT05208294|Sulpiride|sulpiride|mesh-list
65609637|NCT05208294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65609638|NCT05208294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65609639|NCT05208294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609640|NCT05208294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609641|NCT05208294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65609642|NCT05208294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65609643|NCT05208294|Dopamine Agents|dopamine agents|mesh-ancestor
65609644|NCT05208294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65609645|NCT05208294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609646|NCT05208294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65609647|NCT05208294|Antidepressive Agents|antidepressive agents|mesh-ancestor
65609648|NCT05213988|Clofibric Acid|clofibric acid|mesh-list
65609649|NCT05213988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65609650|NCT05213988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65609651|NCT05213988|Antimetabolites|antimetabolites|mesh-ancestor
65609652|NCT05213988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609653|NCT05213988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65609654|NCT05207904|Paclitaxel|paclitaxel|mesh-list
65609655|NCT05207904|Carboplatin|carboplatin|mesh-list
65609656|NCT05207904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65609657|NCT05207904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609658|NCT05207904|Tubulin Modulators|tubulin modulators|mesh-ancestor
65609659|NCT05207904|Antimitotic Agents|antimitotic agents|mesh-ancestor
65609660|NCT05207904|Mitosis Modulators|mitosis modulators|mesh-ancestor
65609661|NCT05207904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609662|NCT05207514|Ethanol|ethanol|mesh-list
65609663|NCT05207514|Cyclophosphamide|cyclophosphamide|mesh-list
65609664|NCT05207514|Docetaxel|docetaxel|mesh-list
65609665|NCT05207514|Doxorubicin|doxorubicin|mesh-list
65609666|NCT05207514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65609667|NCT05207514|Immunologic Factors|immunologic factors|mesh-ancestor
65609668|NCT05207514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609669|NCT05207514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65609670|NCT05207514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65609671|NCT05207514|Alkylating Agents|alkylating agents|mesh-ancestor
65609672|NCT05207514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609673|NCT05207514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609674|NCT05207514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65609675|NCT05207514|Tubulin Modulators|tubulin modulators|mesh-ancestor
65609676|NCT05207514|Antimitotic Agents|antimitotic agents|mesh-ancestor
65609677|NCT05207514|Mitosis Modulators|mitosis modulators|mesh-ancestor
65609678|NCT05207514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65609679|NCT05207514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65609680|NCT05207514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65609681|NCT05207514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609682|NCT05207514|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65609683|NCT05207514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65609684|NCT05207514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609685|NCT05213676|Nitric Oxide|nitric oxide|mesh-list
65609686|NCT05213676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65609687|NCT05213676|Autonomic Agents|autonomic agents|mesh-ancestor
65609688|NCT05213676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65609689|NCT05213676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609690|NCT05213676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65609691|NCT05213676|Respiratory System Agents|respiratory system agents|mesh-ancestor
65609692|NCT05213676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65609693|NCT05213676|Antioxidants|antioxidants|mesh-ancestor
65609694|NCT05213676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609695|NCT05213676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65609696|NCT05213676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65609697|NCT05213676|Vasodilator Agents|vasodilator agents|mesh-ancestor
65609698|NCT05213676|Gasotransmitters|gasotransmitters|mesh-ancestor
65609699|NCT05213676|Protective Agents|protective agents|mesh-ancestor
65609700|NCT05207436|Oxytocin|oxytocin|mesh-list
65609701|NCT05207436|Oxytocics|oxytocics|mesh-ancestor
65609702|NCT05207436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65609703|NCT05207436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609704|NCT05760807|Oxytocin|oxytocin|mesh-list
65609705|NCT05760807|Oxytocics|oxytocics|mesh-ancestor
65609706|NCT05760807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65609707|NCT05760807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609708|NCT03118947|Pimavanserin|pimavanserin|mesh-list
65609709|NCT03118947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65609710|NCT03118947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65609711|NCT03118947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65609712|NCT03118947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65609713|NCT03118947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609714|NCT03118947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609715|NCT03118947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65609716|NCT03118947|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65609717|NCT03118947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65609718|NCT03118947|Serotonin Agents|serotonin agents|mesh-ancestor
65609719|NCT03118947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65609720|NCT03118947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609721|NCT03998319|Tenecteplase|tenecteplase|mesh-list
65609722|NCT03998319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65609723|NCT03998319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65609724|NCT03998319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609725|NCT03953079|Sunitinib|sunitinib|mesh-list
65609726|NCT03953079|Aflibercept|aflibercept|mesh-list
65609727|NCT03953079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609728|NCT03953079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65609729|NCT03953079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65609730|NCT03953079|Growth Substances|growth substances|mesh-ancestor
65609731|NCT03953079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609732|NCT03953079|Growth Inhibitors|growth inhibitors|mesh-ancestor
65609733|NCT03953079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65609734|NCT03953079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609735|NCT03953079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609736|NCT03794427|Anesthetics|anesthetics|mesh-list
65609737|NCT03794427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609738|NCT03794427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407129|NCT00806741|Phenylephrine|phenylephrine|mesh-list
65609739|NCT05759481|Propofol|propofol|mesh-list
65609740|NCT05759481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65609741|NCT05759481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609742|NCT05759481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609743|NCT05759481|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65609744|NCT05759481|Anesthetics, General|anesthetics, general|mesh-ancestor
65609745|NCT05759481|Anesthetics|anesthetics|mesh-ancestor
65609746|NCT03410901|Antibodies|antibodies|mesh-list
65609747|NCT03410901|Immunologic Factors|immunologic factors|mesh-ancestor
65609748|NCT03410901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609749|NCT03357939|Adalimumab|adalimumab|mesh-list
65609750|NCT03357939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65609751|NCT03357939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65609752|NCT03567057|Amantadine|amantadine|mesh-list
65609753|NCT03567057|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65609754|NCT03567057|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65609755|NCT03567057|Antiviral Agents|antiviral agents|mesh-ancestor
65609756|NCT03567057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65609757|NCT03567057|Dopamine Agents|dopamine agents|mesh-ancestor
65609758|NCT03567057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65609759|NCT03567057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609760|NCT03567057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609761|NCT03567057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65609762|NCT03567057|Analgesics|analgesics|mesh-ancestor
65609763|NCT03567057|Sensory System Agents|sensory system agents|mesh-ancestor
65609764|NCT03567057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65609765|NCT03057600|Paclitaxel|paclitaxel|mesh-list
65609766|NCT03057600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65609767|NCT03057600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609768|NCT03057600|Tubulin Modulators|tubulin modulators|mesh-ancestor
65609769|NCT03057600|Antimitotic Agents|antimitotic agents|mesh-ancestor
65609770|NCT03057600|Mitosis Modulators|mitosis modulators|mesh-ancestor
65609771|NCT03057600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609772|NCT04382937|Ribavirin|ribavirin|mesh-list
65609773|NCT04382937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65609774|NCT04382937|Antimetabolites|antimetabolites|mesh-ancestor
65609775|NCT04382937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609776|NCT04382937|Antiviral Agents|antiviral agents|mesh-ancestor
65609777|NCT04382937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65609778|NCT05212662|Cysteamine|cysteamine|mesh-list
65609779|NCT05212662|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
65609780|NCT05212662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609781|NCT02966301|Arsenic Trioxide|arsenic trioxide|mesh-list
65609782|NCT02966301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609783|NCT03107091|Terlipressin|terlipressin|mesh-list
65609784|NCT03107091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65609785|NCT03107091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65609786|NCT03849768|Gefitinib|gefitinib|mesh-list
65609787|NCT03849768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609788|NCT03849768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65609789|NCT03849768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609790|NCT03849768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609791|NCT05760261|Midazolam|midazolam|mesh-list
65609792|NCT05760261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65609793|NCT05760261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65609794|NCT05760261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609795|NCT05760261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609796|NCT05760261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65609797|NCT05760261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65609798|NCT05760261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65609799|NCT05760261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65609800|NCT05760261|Anesthetics, General|anesthetics, general|mesh-ancestor
65609801|NCT05760261|Anesthetics|anesthetics|mesh-ancestor
65609802|NCT05760261|GABA Modulators|gaba modulators|mesh-ancestor
65609803|NCT05760261|GABA Agents|gaba agents|mesh-ancestor
65609804|NCT05760261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65609805|NCT05760261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609806|NCT03189693|Anesthetics|anesthetics|mesh-list
65609807|NCT03189693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609808|NCT03189693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609809|NCT03065400|Pembrolizumab|pembrolizumab|mesh-list
65609810|NCT03065400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65609811|NCT03065400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609812|NCT03824808|Lidocaine|lidocaine|mesh-list
65609813|NCT03824808|Anesthetics, Local|anesthetics, local|mesh-ancestor
65609814|NCT03824808|Anesthetics|anesthetics|mesh-ancestor
65609815|NCT03824808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609816|NCT03824808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609817|NCT03824808|Sensory System Agents|sensory system agents|mesh-ancestor
65609818|NCT03824808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65609819|NCT03824808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65609820|NCT03824808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65609821|NCT03824808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65609822|NCT03824808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65609823|NCT03824808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609824|NCT05734716|Epoetin Alfa|epoetin alfa|mesh-list
65609825|NCT05734716|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65609826|NCT05734716|Hematinics|hematinics|mesh-ancestor
65609827|NCT05733000|Thioctic Acid|thioctic acid|mesh-list
65609828|NCT05733000|Gemcitabine|gemcitabine|mesh-list
65609829|NCT05733000|Hydroxychloroquine|hydroxychloroquine|mesh-list
65609830|NCT05733000|Fluorouracil|fluorouracil|mesh-list
65609831|NCT05733000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65609832|NCT05733000|Antimetabolites|antimetabolites|mesh-ancestor
65609833|NCT05733000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609834|NCT05733000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609835|NCT05733000|Antiviral Agents|antiviral agents|mesh-ancestor
65609836|NCT05733000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65609837|NCT05733000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609838|NCT05733000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65609839|NCT05733000|Immunologic Factors|immunologic factors|mesh-ancestor
65609840|NCT05733000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609841|NCT05733000|Antimalarials|antimalarials|mesh-ancestor
65609842|NCT05733000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65609843|NCT05733000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65609844|NCT05733000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65609845|NCT05733000|Antioxidants|antioxidants|mesh-ancestor
65609846|NCT05733000|Protective Agents|protective agents|mesh-ancestor
65609847|NCT05733000|Vitamin B Complex|vitamin b complex|mesh-ancestor
65609848|NCT05733000|Vitamins|vitamins|mesh-ancestor
65609849|NCT05733000|Micronutrients|micronutrients|mesh-ancestor
65609850|NCT04879368|Trifluridine|trifluridine|mesh-list
65609851|NCT04879368|Paclitaxel|paclitaxel|mesh-list
65609852|NCT04879368|Docetaxel|docetaxel|mesh-list
65609853|NCT04879368|Nivolumab|nivolumab|mesh-list
65609854|NCT04879368|Irinotecan|irinotecan|mesh-list
65609855|NCT04879368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65609856|NCT04879368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609857|NCT04879368|Tubulin Modulators|tubulin modulators|mesh-ancestor
65609858|NCT04879368|Antimitotic Agents|antimitotic agents|mesh-ancestor
65609859|NCT04879368|Mitosis Modulators|mitosis modulators|mesh-ancestor
65609860|NCT04879368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609861|NCT04879368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65609862|NCT04879368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65609863|NCT04879368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65609864|NCT04879368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65609865|NCT04879368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609866|NCT04879368|Antimetabolites|antimetabolites|mesh-ancestor
65609867|NCT04879368|Antiviral Agents|antiviral agents|mesh-ancestor
65609868|NCT04879368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65609869|NCT03417180|Remifentanil|remifentanil|mesh-list
65609870|NCT03417180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65609871|NCT03417180|Narcotics|narcotics|mesh-ancestor
65609872|NCT03417180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609873|NCT03417180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609874|NCT03417180|Analgesics|analgesics|mesh-ancestor
65609875|NCT03417180|Sensory System Agents|sensory system agents|mesh-ancestor
65609876|NCT03417180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65609877|NCT03085095|Leuprolide|leuprolide|mesh-list
65609878|NCT03085095|Relugolix|relugolix|mesh-list
65609879|NCT03085095|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65609880|NCT03085095|Fertility Agents|fertility agents|mesh-ancestor
65609881|NCT03085095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65609882|NCT03085095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609883|NCT03085095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65609884|NCT03085095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609885|NCT03085095|Androgen Antagonists|androgen antagonists|mesh-ancestor
65609886|NCT03085095|Hormone Antagonists|hormone antagonists|mesh-ancestor
65609887|NCT03085095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65609888|NCT02891811|Thalidomide|thalidomide|mesh-list
65609889|NCT02891811|Dexamethasone|dexamethasone|mesh-list
65609890|NCT02891811|Lenalidomide|lenalidomide|mesh-list
65407275|NCT00800423|Timolol|timolol|mesh-list
65609891|NCT02891811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65609892|NCT02891811|Antiemetics|antiemetics|mesh-ancestor
65609893|NCT02891811|Autonomic Agents|autonomic agents|mesh-ancestor
65609894|NCT02891811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65609895|NCT02891811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609896|NCT02891811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65609897|NCT02891811|Glucocorticoids|glucocorticoids|mesh-ancestor
65609898|NCT02891811|Hormones|hormones|mesh-ancestor
65609899|NCT02891811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65609900|NCT02891811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65609901|NCT02891811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609902|NCT02891811|Immunologic Factors|immunologic factors|mesh-ancestor
65609903|NCT02891811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65609904|NCT02891811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65609905|NCT02891811|Growth Substances|growth substances|mesh-ancestor
65609906|NCT02891811|Growth Inhibitors|growth inhibitors|mesh-ancestor
65609907|NCT02891811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65609908|NCT02891811|Leprostatic Agents|leprostatic agents|mesh-ancestor
65609909|NCT02891811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65609910|NCT02891811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65609911|NCT02811783|Naloxone|naloxone|mesh-list
65609912|NCT02811783|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65609913|NCT02811783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609914|NCT02811783|Sensory System Agents|sensory system agents|mesh-ancestor
65609915|NCT02811783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65609916|NCT02649855|Docetaxel|docetaxel|mesh-list
65609917|NCT02649855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609918|NCT02649855|Tubulin Modulators|tubulin modulators|mesh-ancestor
65609919|NCT02649855|Antimitotic Agents|antimitotic agents|mesh-ancestor
65609920|NCT02649855|Mitosis Modulators|mitosis modulators|mesh-ancestor
65609921|NCT02649855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609922|NCT05720715|Cyclosporine|cyclosporine|mesh-list
65609923|NCT05720715|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65609924|NCT05720715|Cyclosporins|cyclosporins|mesh-list
65609925|NCT05720715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609926|NCT05720715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609927|NCT05720715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65609928|NCT05720715|Immunologic Factors|immunologic factors|mesh-ancestor
65609929|NCT05720715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609930|NCT05720715|Antifungal Agents|antifungal agents|mesh-ancestor
65609931|NCT05720715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65609932|NCT05720715|Dermatologic Agents|dermatologic agents|mesh-ancestor
65609933|NCT05720715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65609934|NCT05720715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65609935|NCT05720715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65609936|NCT02310867|Abatacept|abatacept|mesh-list
65609937|NCT02310867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65609938|NCT02310867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609939|NCT02310867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609940|NCT02310867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65609941|NCT02310867|Immunologic Factors|immunologic factors|mesh-ancestor
65609942|NCT02310867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609943|NCT02310867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65609944|NCT03106077|Maytansine|maytansine|mesh-list
65609945|NCT03106077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65609946|NCT03106077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609947|NCT03106077|Tubulin Modulators|tubulin modulators|mesh-ancestor
65609948|NCT03106077|Antimitotic Agents|antimitotic agents|mesh-ancestor
65609949|NCT03106077|Mitosis Modulators|mitosis modulators|mesh-ancestor
65609950|NCT03106077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609951|NCT03648008|Morphine|morphine|mesh-list
65609952|NCT03648008|Hydromorphone|hydromorphone|mesh-list
65609953|NCT03648008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65609954|NCT03648008|Narcotics|narcotics|mesh-ancestor
65609955|NCT03648008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65609956|NCT03648008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609957|NCT03648008|Analgesics|analgesics|mesh-ancestor
65609958|NCT03648008|Sensory System Agents|sensory system agents|mesh-ancestor
65609959|NCT03648008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65609960|NCT05702541|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65609961|NCT05702541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65609962|NCT05702541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65609963|NCT05701527|Pembrolizumab|pembrolizumab|mesh-list
65609964|NCT05701527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65609965|NCT05701527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609966|NCT05253495|Cytarabine|cytarabine|mesh-list
65609967|NCT05253495|Etoposide|etoposide|mesh-list
65609968|NCT05253495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65407351|NCT00810563|Bupivacaine|bupivacaine|mesh-list
65609969|NCT05253495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609970|NCT05253495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65609971|NCT05253495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65609972|NCT05253495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609973|NCT05253495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609974|NCT05253495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65609975|NCT05253495|Antimetabolites|antimetabolites|mesh-ancestor
65609976|NCT05253495|Antiviral Agents|antiviral agents|mesh-ancestor
65609977|NCT05253495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65609978|NCT05253495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65609979|NCT05253495|Immunologic Factors|immunologic factors|mesh-ancestor
65609980|NCT05253495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609981|NCT05054751|Fulvestrant|fulvestrant|mesh-list
65609982|NCT05054751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65609983|NCT05054751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609984|NCT05054751|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65609985|NCT05054751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65609986|NCT05054751|Hormone Antagonists|hormone antagonists|mesh-ancestor
65609987|NCT05054751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65609988|NCT05054751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65609989|NCT00604617|Interferons|interferons|mesh-list
65609990|NCT00604617|Interferon-gamma|interferon-gamma|mesh-list
65072828|NCT00306020|Morphine|morphine|mesh-list
65609991|NCT00604617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65609992|NCT00604617|Antiviral Agents|antiviral agents|mesh-ancestor
65609993|NCT00604617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65609994|NCT03426995|Cantharidin|cantharidin|mesh-list
65609995|NCT03426995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65609996|NCT03426995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65609997|NCT05200299|Leucovorin|leucovorin|mesh-list
65609998|NCT05200299|Fluorouracil|fluorouracil|mesh-list
65609999|NCT05200299|Capecitabine|capecitabine|mesh-list
65610000|NCT05200299|Oxaliplatin|oxaliplatin|mesh-list
65610001|NCT05200299|Irinotecan|irinotecan|mesh-list
65610002|NCT05200299|Levoleucovorin|levoleucovorin|mesh-list
65610003|NCT05200299|Antimetabolites|antimetabolites|mesh-ancestor
65610004|NCT05200299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610005|NCT05200299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65610006|NCT05200299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610007|NCT05200299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65610008|NCT05200299|Immunologic Factors|immunologic factors|mesh-ancestor
65610009|NCT05200299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610010|NCT05200299|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65610011|NCT05200299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65610012|NCT05200299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610013|NCT05200299|Antidotes|antidotes|mesh-ancestor
65610014|NCT05200299|Protective Agents|protective agents|mesh-ancestor
65610015|NCT05200299|Vitamin B Complex|vitamin b complex|mesh-ancestor
65610016|NCT05200299|Vitamins|vitamins|mesh-ancestor
65610017|NCT05200299|Micronutrients|micronutrients|mesh-ancestor
65610018|NCT03322566|Pembrolizumab|pembrolizumab|mesh-list
65610019|NCT03322566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65610020|NCT03322566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610021|NCT03822975|Heparin|heparin|mesh-list
65610022|NCT03822975|Calcium heparin|calcium heparin|mesh-list
65610023|NCT03822975|Bivalirudin|bivalirudin|mesh-list
65610024|NCT03822975|Anticoagulants|anticoagulants|mesh-ancestor
65610025|NCT03822975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65610026|NCT03822975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65610027|NCT03822975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610028|NCT03822975|Antithrombins|antithrombins|mesh-ancestor
65610029|NCT03822975|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65610030|NCT03822975|Protease Inhibitors|protease inhibitors|mesh-ancestor
65610031|NCT03822975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610032|NCT05732532|Dexamethasone|dexamethasone|mesh-list
65610033|NCT05732532|Lidocaine|lidocaine|mesh-list
65610034|NCT05732532|Bupivacaine|bupivacaine|mesh-list
65610035|NCT05732532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65610036|NCT05732532|Antiemetics|antiemetics|mesh-ancestor
65610037|NCT05732532|Autonomic Agents|autonomic agents|mesh-ancestor
65610038|NCT05732532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610039|NCT05732532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610040|NCT05732532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65610041|NCT05732532|Glucocorticoids|glucocorticoids|mesh-ancestor
65610042|NCT05732532|Hormones|hormones|mesh-ancestor
65610043|NCT05732532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65610044|NCT05732532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65610045|NCT05732532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610046|NCT05732532|Anesthetics, Local|anesthetics, local|mesh-ancestor
65610047|NCT05732532|Anesthetics|anesthetics|mesh-ancestor
65610048|NCT05732532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65610049|NCT05732532|Sensory System Agents|sensory system agents|mesh-ancestor
65610050|NCT05732532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65610051|NCT05732532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65610052|NCT05732532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65610053|NCT05732532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65610054|NCT05732532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610055|NCT05178225|Ubiquinone|ubiquinone|mesh-list
65610056|NCT05178225|Coenzyme Q10|coenzyme q10|mesh-list
65610057|NCT05178225|Anticoagulants|anticoagulants|mesh-list
65610058|NCT05178225|Micronutrients|micronutrients|mesh-ancestor
65610059|NCT05178225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610060|NCT05178225|Vitamins|vitamins|mesh-ancestor
65610061|NCT02969018|PF-06700841|pf-06700841|mesh-list
65610062|NCT02969018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65610063|NCT02969018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610064|NCT02969018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610065|NCT03255096|Rituximab|rituximab|mesh-list
65610066|NCT03255096|Venetoclax|venetoclax|mesh-list
65266304|NCT02776748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610067|NCT03255096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65610068|NCT03255096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610069|NCT03255096|Immunologic Factors|immunologic factors|mesh-ancestor
65610070|NCT03255096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610071|NCT03255096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65610072|NCT01319721|Mitomycins|mitomycins|mesh-list
65610073|NCT01319721|Mitomycin|mitomycin|mesh-list
65610074|NCT01319721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65610075|NCT01319721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610076|NCT01319721|Alkylating Agents|alkylating agents|mesh-ancestor
65610077|NCT01319721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610078|NCT01319721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65610079|NCT01319721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610080|NCT05210166|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
65610081|NCT05210166|Antioxidants|antioxidants|mesh-ancestor
65610082|NCT05210166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610083|NCT05210166|Protective Agents|protective agents|mesh-ancestor
65610084|NCT05210166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610085|NCT05210166|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65610086|NCT05210166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610087|NCT05542407|Atezolizumab|atezolizumab|mesh-list
65610088|NCT05542407|TIC10 compound|tic10 compound|mesh-list
65610089|NCT05542407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610090|NCT03792867|Doxorubicin|doxorubicin|mesh-list
65610091|NCT03792867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65610092|NCT03792867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610093|NCT03792867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65610094|NCT03792867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65610095|NCT03792867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610096|NCT03792867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610097|NCT03015324|Hydroxychloroquine|hydroxychloroquine|mesh-list
65610098|NCT03015324|Antimalarials|antimalarials|mesh-ancestor
65610099|NCT03015324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65610100|NCT03015324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65610101|NCT03015324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65610102|NCT03015324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610103|NCT03015324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610104|NCT03015324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65610105|NCT05139849|Methylprednisolone|methylprednisolone|mesh-list
65610106|NCT05139849|Hydrocortisone|hydrocortisone|mesh-list
65610107|NCT05139849|Vasopressins|vasopressins|mesh-list
65610108|NCT05139849|Arginine Vasopressin|arginine vasopressin|mesh-list
65610109|NCT05139849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65610110|NCT05139849|Antiemetics|antiemetics|mesh-ancestor
65610111|NCT05139849|Autonomic Agents|autonomic agents|mesh-ancestor
65610112|NCT05139849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610113|NCT05139849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610114|NCT05139849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65610115|NCT05139849|Glucocorticoids|glucocorticoids|mesh-ancestor
65610116|NCT05139849|Hormones|hormones|mesh-ancestor
65610117|NCT05139849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65610118|NCT05139849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65610119|NCT05139849|Protective Agents|protective agents|mesh-ancestor
65610120|NCT05139849|Hemostatics|hemostatics|mesh-ancestor
65610121|NCT05139849|Coagulants|coagulants|mesh-ancestor
65610122|NCT05139849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65407499|NCT00812123|Prednisone|prednisone|mesh-list
65610123|NCT05139849|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65610124|NCT05139849|Natriuretic Agents|natriuretic agents|mesh-ancestor
65610125|NCT05327361|Sunscreening Agents|sunscreening agents|mesh-list
65610126|NCT05327361|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65610127|NCT05327361|Protective Agents|protective agents|mesh-ancestor
65610128|NCT05327361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610129|NCT05327361|Dermatologic Agents|dermatologic agents|mesh-ancestor
65610130|NCT03315741|Pirfenidone|pirfenidone|mesh-list
65610131|NCT03315741|Analgesics|analgesics|mesh-ancestor
65610132|NCT03315741|Sensory System Agents|sensory system agents|mesh-ancestor
65610133|NCT03315741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610134|NCT03315741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610135|NCT03315741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65610136|NCT03315741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65610137|NCT03315741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65610138|NCT03315741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65610139|NCT03315741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072990|NCT00451373|Vancomycin|vancomycin|mesh-list
65610140|NCT05077449|Fulvestrant|fulvestrant|mesh-list
65610141|NCT05077449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65610142|NCT05077449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610143|NCT05077449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65610144|NCT05077449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65610145|NCT05077449|Hormone Antagonists|hormone antagonists|mesh-ancestor
65610146|NCT05077449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65610147|NCT05077449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610148|NCT03632733|Tetracycline|tetracycline|mesh-list
65610149|NCT03632733|Clotrimazole|clotrimazole|mesh-list
65610150|NCT03632733|Miconazole|miconazole|mesh-list
65610151|NCT03632733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65610152|NCT03632733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65610153|NCT03632733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65610154|NCT03632733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610155|NCT03632733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610156|NCT03632733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65610157|NCT03632733|Antifungal Agents|antifungal agents|mesh-ancestor
65610158|NCT03632733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65610159|NCT03632733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65610160|NCT03632733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65610161|NCT03632733|Hormone Antagonists|hormone antagonists|mesh-ancestor
65610162|NCT03632733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65610163|NCT03632733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610164|NCT03632733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65610165|NCT03632733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65610166|NCT05074485|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65610167|NCT05074485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65610168|NCT05305287|Pioglitazone|pioglitazone|mesh-list
65610169|NCT05305287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65610170|NCT05305287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610171|NCT03259425|Nivolumab|nivolumab|mesh-list
65610172|NCT03259425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65610173|NCT03259425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610174|NCT03259425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65610175|NCT03259425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610176|NCT03061188|Nivolumab|nivolumab|mesh-list
65610177|NCT03061188|Veliparib|veliparib|mesh-list
65610178|NCT03061188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65610179|NCT03061188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610180|NCT03061188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65610181|NCT03061188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610182|NCT03061188|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65610183|NCT03061188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610184|NCT05588453|Temozolomide|temozolomide|mesh-list
65610185|NCT05588453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65610186|NCT05588453|Alkylating Agents|alkylating agents|mesh-ancestor
65610187|NCT05588453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610188|NCT05588453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610189|NCT05188326|Azacitidine|azacitidine|mesh-list
65610190|NCT05188326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65610191|NCT05188326|Antimetabolites|antimetabolites|mesh-ancestor
65610192|NCT05188326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610193|NCT05188326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610194|NCT05188326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610195|NCT05186454|Dexamethasone|dexamethasone|mesh-list
65610196|NCT05186454|Midazolam|midazolam|mesh-list
65610197|NCT05186454|Morphine|morphine|mesh-list
65610198|NCT05186454|Bupivacaine|bupivacaine|mesh-list
65610199|NCT05186454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65610200|NCT05186454|Antiemetics|antiemetics|mesh-ancestor
65610201|NCT05186454|Autonomic Agents|autonomic agents|mesh-ancestor
65610202|NCT05186454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610203|NCT05186454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610204|NCT05186454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65610205|NCT05186454|Glucocorticoids|glucocorticoids|mesh-ancestor
65610206|NCT05186454|Hormones|hormones|mesh-ancestor
65610207|NCT05186454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65610208|NCT05186454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65610209|NCT05186454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610210|NCT05186454|Anesthetics, Local|anesthetics, local|mesh-ancestor
65610211|NCT05186454|Anesthetics|anesthetics|mesh-ancestor
65610212|NCT05186454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65610213|NCT05186454|Sensory System Agents|sensory system agents|mesh-ancestor
65610214|NCT05186454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65610215|NCT05186454|Narcotics|narcotics|mesh-ancestor
65610216|NCT05186454|Analgesics|analgesics|mesh-ancestor
65610217|NCT05186454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65610218|NCT05186454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65610219|NCT05186454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65610220|NCT05186454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65610221|NCT05186454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65610222|NCT05186454|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65610223|NCT05186454|Anesthetics, General|anesthetics, general|mesh-ancestor
65610224|NCT05186454|GABA Modulators|gaba modulators|mesh-ancestor
65610225|NCT05186454|GABA Agents|gaba agents|mesh-ancestor
65610226|NCT05186454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65610227|NCT05186454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610228|NCT02113878|Cisplatin|cisplatin|mesh-list
65610229|NCT02113878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610230|NCT05176080|Fulvestrant|fulvestrant|mesh-list
65610231|NCT05176080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65610232|NCT05176080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610233|NCT05176080|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65610234|NCT05176080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65610235|NCT05176080|Hormone Antagonists|hormone antagonists|mesh-ancestor
65610236|NCT05176080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65610237|NCT05176080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610238|NCT05162898|Lenvatinib|lenvatinib|mesh-list
65610239|NCT05162898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610240|NCT05162898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65610241|NCT05162898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610242|NCT05162898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610243|NCT05113290|Sorafenib|sorafenib|mesh-list
65610244|NCT05113290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610245|NCT05113290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65610246|NCT05113290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610247|NCT05113290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610248|NCT03477162|Metformin|metformin|mesh-list
65610249|NCT03477162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65610250|NCT03477162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610251|NCT03461952|Nivolumab|nivolumab|mesh-list
65610252|NCT03461952|Ipilimumab|ipilimumab|mesh-list
65610253|NCT03461952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65610254|NCT03461952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610255|NCT03461952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65610256|NCT03461952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610257|NCT03619824|Gemcitabine|gemcitabine|mesh-list
65610258|NCT03619824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610259|NCT03619824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65610260|NCT03619824|Antimetabolites|antimetabolites|mesh-ancestor
65610261|NCT03619824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610262|NCT03619824|Antiviral Agents|antiviral agents|mesh-ancestor
65610263|NCT03619824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65610264|NCT03619824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610265|NCT03619824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65610266|NCT03619824|Immunologic Factors|immunologic factors|mesh-ancestor
65610267|NCT03619824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610268|NCT01759836|Atorvastatin|atorvastatin|mesh-list
65610269|NCT01759836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65610270|NCT01759836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65610271|NCT01759836|Antimetabolites|antimetabolites|mesh-ancestor
65610272|NCT01759836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610274|NCT01759836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65610275|NCT01759836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610276|NCT03447821|Rifamycins|rifamycins|mesh-list
65610277|NCT03447821|Rifamycin SV|rifamycin sv|mesh-list
65610278|NCT03447821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65610279|NCT03447821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65610280|NCT03447821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65610281|NCT05630339|Vitamin D|vitamin d|mesh-list
65610282|NCT05630339|Cholecalciferol|cholecalciferol|mesh-list
65610283|NCT05630339|Vitamins|vitamins|mesh-ancestor
65610284|NCT05630339|Micronutrients|micronutrients|mesh-ancestor
65610285|NCT05630339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610286|NCT05630339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65610287|NCT05630339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65610288|NCT04968366|Temozolomide|temozolomide|mesh-list
65610289|NCT04968366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65610290|NCT04968366|Alkylating Agents|alkylating agents|mesh-ancestor
65610291|NCT04968366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610292|NCT04968366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610293|NCT03447353|Acetaminophen|acetaminophen|mesh-list
65610294|NCT03447353|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65610295|NCT03447353|Hydrocodone|hydrocodone|mesh-list
65610296|NCT03447353|Alprazolam|alprazolam|mesh-list
65610297|NCT03447353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65610298|NCT03447353|Analgesics|analgesics|mesh-ancestor
65610299|NCT03447353|Sensory System Agents|sensory system agents|mesh-ancestor
65610300|NCT03447353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610301|NCT03447353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610302|NCT03447353|Antipyretics|antipyretics|mesh-ancestor
65610303|NCT03447353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65610304|NCT03447353|Narcotics|narcotics|mesh-ancestor
65610305|NCT03447353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65610306|NCT03447353|Antitussive Agents|antitussive agents|mesh-ancestor
65610307|NCT03447353|Respiratory System Agents|respiratory system agents|mesh-ancestor
65610308|NCT03447353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65610309|NCT03447353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65610310|NCT03447353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65610311|NCT03447353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65610312|NCT03447353|GABA Modulators|gaba modulators|mesh-ancestor
65610313|NCT03447353|GABA Agents|gaba agents|mesh-ancestor
65610314|NCT03447353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65610315|NCT03447353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610316|NCT03447353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65610317|NCT03447353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65610318|NCT03447353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65610319|NCT03446885|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65610320|NCT03446885|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65610321|NCT03446885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610322|NCT03446885|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65610323|NCT03446885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65610324|NCT03446885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65610325|NCT03446885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610326|NCT03446885|Dopamine Agents|dopamine agents|mesh-ancestor
65610327|NCT03446885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65610328|NCT00710970|Tamoxifen|tamoxifen|mesh-list
65610329|NCT00710970|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65610330|NCT00710970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65610331|NCT00710970|Hormone Antagonists|hormone antagonists|mesh-ancestor
65610332|NCT00710970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65610333|NCT00710970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610334|NCT00710970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65610335|NCT00710970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610336|NCT00710970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65610337|NCT00710970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65610338|NCT00710970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65610339|NCT03422159|Ascorbic Acid|ascorbic acid|mesh-list
65610340|NCT03422159|Thiamine|thiamine|mesh-list
65610341|NCT03422159|Hydrocortisone|hydrocortisone|mesh-list
65610342|NCT03422159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65610343|NCT03422159|Vitamins|vitamins|mesh-ancestor
65610344|NCT03422159|Micronutrients|micronutrients|mesh-ancestor
65407727|NCT01045954|Insulin|insulin|mesh-list
65610345|NCT03422159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610346|NCT03422159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65610347|NCT03422159|Antioxidants|antioxidants|mesh-ancestor
65610348|NCT03422159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610349|NCT03422159|Protective Agents|protective agents|mesh-ancestor
65610350|NCT03422159|Vitamin B Complex|vitamin b complex|mesh-ancestor
65610351|NCT03421379|Glucagon|glucagon|mesh-list
65610352|NCT03421379|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65610353|NCT03421379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65610354|NCT03421379|Hormones|hormones|mesh-ancestor
65610355|NCT03421379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65610356|NCT03421379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610357|NCT03421379|Incretins|incretins|mesh-ancestor
65610358|NCT03712241|Indomethacin|indomethacin|mesh-list
65610359|NCT03712241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65610360|NCT03712241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65610361|NCT03712241|Analgesics|analgesics|mesh-ancestor
65610362|NCT03712241|Sensory System Agents|sensory system agents|mesh-ancestor
65610363|NCT03712241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610364|NCT03712241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610365|NCT03712241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65610366|NCT03712241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65610367|NCT03712241|Gout Suppressants|gout suppressants|mesh-ancestor
65610368|NCT03712241|Tocolytic Agents|tocolytic agents|mesh-ancestor
65610369|NCT03712241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65610370|NCT03712241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65610371|NCT03712241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610372|NCT03712241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610373|NCT02675946|Pembrolizumab|pembrolizumab|mesh-list
65610374|NCT02675946|Cetuximab|cetuximab|mesh-list
65610375|NCT02675946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65610376|NCT02675946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610377|NCT02900378|Valsartan|valsartan|mesh-list
65610378|NCT02900378|Enalapril|enalapril|mesh-list
65610379|NCT02900378|Enalaprilat|enalaprilat|mesh-list
65610380|NCT02900378|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65610381|NCT02900378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65610382|NCT02900378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65610383|NCT02900378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65610384|NCT02900378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610385|NCT02900378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65610386|NCT02900378|Protease Inhibitors|protease inhibitors|mesh-ancestor
65610387|NCT02900378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610388|NCT03058692|Vaccines|vaccines|mesh-list
65610389|NCT03058692|Immunologic Factors|immunologic factors|mesh-ancestor
65610390|NCT03058692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610391|NCT03647150|Amoxicillin|amoxicillin|mesh-list
65610392|NCT03647150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65610393|NCT03647150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65610394|NCT03056352|Diphenhydramine|diphenhydramine|mesh-list
65610395|NCT03056352|Promethazine|promethazine|mesh-list
65610396|NCT03056352|Metoclopramide|metoclopramide|mesh-list
65610397|NCT03056352|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65610398|NCT03056352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65610399|NCT03056352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65610400|NCT03056352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610401|NCT03056352|Anesthetics, Local|anesthetics, local|mesh-ancestor
65610402|NCT03056352|Anesthetics|anesthetics|mesh-ancestor
65610403|NCT03056352|Sensory System Agents|sensory system agents|mesh-ancestor
65610404|NCT03056352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610405|NCT03056352|Antiemetics|antiemetics|mesh-ancestor
65610406|NCT03056352|Autonomic Agents|autonomic agents|mesh-ancestor
65610407|NCT03056352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65610408|NCT03056352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65610409|NCT03056352|Histamine Antagonists|histamine antagonists|mesh-ancestor
65610410|NCT03056352|Histamine Agents|histamine agents|mesh-ancestor
65610411|NCT03056352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65610412|NCT03056352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610413|NCT03056352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65610414|NCT03056352|Antipruritics|antipruritics|mesh-ancestor
65610415|NCT03056352|Dermatologic Agents|dermatologic agents|mesh-ancestor
65610416|NCT03056352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65610417|NCT03056352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65610418|NCT03056352|Dopamine Agents|dopamine agents|mesh-ancestor
65610419|NCT04360980|Colchicine|colchicine|mesh-list
65407806|NCT01098019|Cholinergic Agents|cholinergic agents|mesh-ancestor
65610421|NCT04360980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65610422|NCT04360980|Tubulin Modulators|tubulin modulators|mesh-ancestor
65610423|NCT04360980|Antimitotic Agents|antimitotic agents|mesh-ancestor
65610424|NCT04360980|Mitosis Modulators|mitosis modulators|mesh-ancestor
65610425|NCT04360980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610426|NCT04360980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610427|NCT03647072|Famotidine|famotidine|mesh-list
65610428|NCT03647072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65610429|NCT03647072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65610430|NCT03647072|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65610431|NCT03647072|Histamine Antagonists|histamine antagonists|mesh-ancestor
65610432|NCT03647072|Histamine Agents|histamine agents|mesh-ancestor
65610433|NCT03647072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65610434|NCT03647072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610435|NCT03647072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610436|NCT05284136|Prednisolone|prednisolone|mesh-list
65610437|NCT05284136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65610438|NCT05284136|Glucocorticoids|glucocorticoids|mesh-ancestor
65610439|NCT05284136|Hormones|hormones|mesh-ancestor
65610440|NCT05284136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65610441|NCT05284136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610442|NCT05284136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65610443|NCT05284136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610444|NCT03875690|Methylprednisolone|methylprednisolone|mesh-list
65610445|NCT03875690|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65610446|NCT03875690|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65610447|NCT03875690|Prednisolone|prednisolone|mesh-list
65610448|NCT03875690|Prednisolone acetate|prednisolone acetate|mesh-list
65610449|NCT03875690|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65610450|NCT03875690|Prednisolone phosphate|prednisolone phosphate|mesh-list
65610451|NCT03875690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65610452|NCT03875690|Antiemetics|antiemetics|mesh-ancestor
65610453|NCT03875690|Autonomic Agents|autonomic agents|mesh-ancestor
65610454|NCT03875690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610455|NCT03875690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610456|NCT03875690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65610457|NCT03875690|Glucocorticoids|glucocorticoids|mesh-ancestor
65610458|NCT03875690|Hormones|hormones|mesh-ancestor
65610459|NCT03875690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65610460|NCT03875690|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65610461|NCT03875690|Protective Agents|protective agents|mesh-ancestor
65610462|NCT03875690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65610463|NCT03875690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610464|NCT03646916|Dexamethasone|dexamethasone|mesh-list
65610465|NCT03646916|Dexamethasone acetate|dexamethasone acetate|mesh-list
65610466|NCT03646916|BB 1101|bb 1101|mesh-list
65610467|NCT03646916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65610468|NCT03646916|Antiemetics|antiemetics|mesh-ancestor
65610469|NCT03646916|Autonomic Agents|autonomic agents|mesh-ancestor
65610470|NCT03646916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610471|NCT03646916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610472|NCT03646916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65610473|NCT03646916|Glucocorticoids|glucocorticoids|mesh-ancestor
65610474|NCT03646916|Hormones|hormones|mesh-ancestor
65610475|NCT03646916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65610476|NCT03646916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65610477|NCT03646916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610478|NCT03646916|Protease Inhibitors|protease inhibitors|mesh-ancestor
65610479|NCT03646916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610480|NCT03646916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610481|NCT04305756|Enoxaparin|enoxaparin|mesh-list
65610482|NCT04305756|Anticoagulants|anticoagulants|mesh-ancestor
65610483|NCT04305756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65610484|NCT04305756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65610485|NCT04305756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610486|NCT05283980|Bupivacaine|bupivacaine|mesh-list
65610487|NCT05283980|Anesthetics, Local|anesthetics, local|mesh-ancestor
65610488|NCT05283980|Anesthetics|anesthetics|mesh-ancestor
65610489|NCT05283980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65610490|NCT05283980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610491|NCT05283980|Sensory System Agents|sensory system agents|mesh-ancestor
65610492|NCT05283980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610493|NCT03645980|Sorafenib|sorafenib|mesh-list
65610494|NCT03645980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610495|NCT03645980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65610496|NCT03645980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266322|NCT02676297|Autonomic Agents|autonomic agents|mesh-ancestor
65610497|NCT03645980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610499|NCT04315038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65610500|NCT04315038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610501|NCT03645200|Apatinib|apatinib|mesh-list
65610502|NCT03645200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610503|NCT03645200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65610504|NCT03645200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610505|NCT03645200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610506|NCT03055338|Risperidone|risperidone|mesh-list
65610507|NCT03055338|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65610508|NCT03055338|Serotonin Agents|serotonin agents|mesh-ancestor
65610509|NCT03055338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65610510|NCT03055338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610511|NCT03055338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610512|NCT03055338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65610513|NCT03055338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65610514|NCT03055338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65610515|NCT03055338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65610516|NCT03055338|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65610517|NCT03055338|Dopamine Agents|dopamine agents|mesh-ancestor
65610518|NCT03645668|Meropenem|meropenem|mesh-list
65610519|NCT03645668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65610520|NCT03645668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65610521|NCT04186494|Liraglutide|liraglutide|mesh-list
65610522|NCT04186494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65610523|NCT04186494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610524|NCT04186494|Incretins|incretins|mesh-ancestor
65610525|NCT04186494|Hormones|hormones|mesh-ancestor
65610526|NCT04186494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65610527|NCT03712163|Ketotifen|ketotifen|mesh-list
65610528|NCT03712163|Antipruritics|antipruritics|mesh-ancestor
65610529|NCT03712163|Dermatologic Agents|dermatologic agents|mesh-ancestor
65610530|NCT03712163|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65610531|NCT03712163|Histamine Antagonists|histamine antagonists|mesh-ancestor
65610532|NCT03712163|Histamine Agents|histamine agents|mesh-ancestor
65610533|NCT03712163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65610534|NCT03712163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610535|NCT03712163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610536|NCT03712163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65610537|NCT01311167|Dexamethasone|dexamethasone|mesh-list
65610538|NCT01311167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65610539|NCT01311167|Antiemetics|antiemetics|mesh-ancestor
65610540|NCT01311167|Autonomic Agents|autonomic agents|mesh-ancestor
65610541|NCT01311167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610542|NCT01311167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610543|NCT01311167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65610544|NCT01311167|Glucocorticoids|glucocorticoids|mesh-ancestor
65610545|NCT01311167|Hormones|hormones|mesh-ancestor
65610546|NCT01311167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65610547|NCT01311167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65610548|NCT01311167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610549|NCT04233840|Nivolumab|nivolumab|mesh-list
65610550|NCT04233840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65610551|NCT04233840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610552|NCT04233840|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65610553|NCT04233840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610554|NCT02896400|Nicotine|nicotine|mesh-list
65610555|NCT02896400|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65610556|NCT02896400|Autonomic Agents|autonomic agents|mesh-ancestor
65610557|NCT02896400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610558|NCT02896400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610559|NCT02896400|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65610560|NCT02896400|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65610561|NCT02896400|Cholinergic Agents|cholinergic agents|mesh-ancestor
65610562|NCT02896400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65610563|NCT02896400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610564|NCT03404843|Fasudil|fasudil|mesh-list
65610565|NCT03404843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65610566|NCT03404843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65266323|NCT02676297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610567|NCT03404843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407953|NCT01093807|Lercanidipine|lercanidipine|mesh-list
65610568|NCT03404843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65610569|NCT03404843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610570|NCT03404843|Vasodilator Agents|vasodilator agents|mesh-ancestor
65610571|NCT03404843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65610572|NCT03404843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610573|NCT05284448|Pentoxifylline|pentoxifylline|mesh-list
65610574|NCT05284448|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65610575|NCT05284448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610576|NCT05284448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610577|NCT05284448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65610578|NCT05284448|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65610579|NCT05284448|Protective Agents|protective agents|mesh-ancestor
65610580|NCT05284448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610581|NCT05284448|Vasodilator Agents|vasodilator agents|mesh-ancestor
65610582|NCT05284448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65610583|NCT05284448|Antioxidants|antioxidants|mesh-ancestor
65610584|NCT03032250|Hydrocortisone|hydrocortisone|mesh-list
65610585|NCT03032250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65610586|NCT03444155|Folic Acid|folic acid|mesh-list
65610587|NCT03444155|Vitamin B Complex|vitamin b complex|mesh-list
65610588|NCT03444155|Vitamins|vitamins|mesh-ancestor
65610589|NCT03444155|Micronutrients|micronutrients|mesh-ancestor
65610590|NCT03444155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610591|NCT03444155|Hematinics|hematinics|mesh-ancestor
65610592|NCT02898116|Durvalumab|durvalumab|mesh-list
65610593|NCT02898116|Ensartinib|ensartinib|mesh-list
65610594|NCT02898116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65610595|NCT02898116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610596|NCT02898116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65610597|NCT02898116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610598|NCT02898116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610599|NCT03717701|Metformin|metformin|mesh-list
65610600|NCT03717701|Esomeprazole|esomeprazole|mesh-list
65610601|NCT03717701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65610602|NCT03717701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610603|NCT03717701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65610604|NCT03717701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65610605|NCT03717701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65610606|NCT03717701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610607|NCT03717701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610608|NCT03658304|Mitomycins|mitomycins|mesh-list
65610609|NCT03658304|Mitomycin|mitomycin|mesh-list
65610610|NCT03658304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65610611|NCT03658304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610612|NCT03658304|Alkylating Agents|alkylating agents|mesh-ancestor
65610613|NCT03658304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610614|NCT03658304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65610615|NCT03658304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610616|NCT04538040|Tenofovir|tenofovir|mesh-list
65610617|NCT04538040|Emtricitabine|emtricitabine|mesh-list
65610618|NCT04538040|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65610619|NCT04538040|Antiviral Agents|antiviral agents|mesh-ancestor
65610620|NCT04538040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65610621|NCT04538040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65610622|NCT04538040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65610623|NCT04538040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610624|NCT04538040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610625|NCT04538040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65610626|NCT04538040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65610627|NCT02297412|Minocycline|minocycline|mesh-list
65610628|NCT02297412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65610629|NCT02297412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65610630|NCT03644576|Pseudoephedrine|pseudoephedrine|mesh-list
65610631|NCT03644576|Ephedrine|ephedrine|mesh-list
65610632|NCT03644576|Ozanimod|ozanimod|mesh-list
65610633|NCT03644576|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65610634|NCT03644576|Autonomic Agents|autonomic agents|mesh-ancestor
65610635|NCT03644576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610636|NCT03644576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610637|NCT03644576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65610638|NCT03644576|Respiratory System Agents|respiratory system agents|mesh-ancestor
65610639|NCT03644576|Nasal Decongestants|nasal decongestants|mesh-ancestor
65610640|NCT03644576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65408031|NCT01020357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610641|NCT03644576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65610642|NCT03644576|Sympathomimetics|sympathomimetics|mesh-ancestor
65610643|NCT03644576|Adrenergic Agents|adrenergic agents|mesh-ancestor
65610644|NCT03644576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65610645|NCT03644576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610646|NCT03644576|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65610647|NCT03644576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65610648|NCT03644576|Immunologic Factors|immunologic factors|mesh-ancestor
65610649|NCT03418727|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65610650|NCT03418727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65610651|NCT03418727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65610652|NCT03418727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65610653|NCT03418727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65610654|NCT03418727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65610655|NCT03418727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65610656|NCT03418727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65610657|NCT03418727|Adrenergic Agents|adrenergic agents|mesh-ancestor
65610658|NCT03418727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65610659|NCT03418727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610660|NCT03418727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610661|NCT03418727|Laxatives|laxatives|mesh-ancestor
65610662|NCT03418727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65610663|NCT01180374|Dronabinol|dronabinol|mesh-list
65610664|NCT01180374|Cannabidiol|cannabidiol|mesh-list
65610665|NCT01180374|Anticonvulsants|anticonvulsants|mesh-ancestor
65610666|NCT01180374|Hallucinogens|hallucinogens|mesh-ancestor
65610667|NCT01180374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610668|NCT01180374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65610669|NCT01180374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65610670|NCT01180374|Analgesics|analgesics|mesh-ancestor
65610671|NCT01180374|Sensory System Agents|sensory system agents|mesh-ancestor
65610672|NCT01180374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610673|NCT01180374|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65610674|NCT01180374|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65610675|NCT01180374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65610676|NCT01180374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610677|NCT01180374|Hormones|hormones|mesh-ancestor
65610678|NCT01180374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65610679|NCT03418571|Gontivimab|gontivimab|mesh-list
65610680|NCT03418571|Antiviral Agents|antiviral agents|mesh-ancestor
65610681|NCT03418571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65610682|NCT03715517|Morphine|morphine|mesh-list
65610683|NCT03715517|Hydromorphone|hydromorphone|mesh-list
65610684|NCT03715517|Bupivacaine|bupivacaine|mesh-list
65610685|NCT03715517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65610686|NCT03715517|Anesthetics, Local|anesthetics, local|mesh-ancestor
65610687|NCT03715517|Anesthetics|anesthetics|mesh-ancestor
65610688|NCT03715517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65610689|NCT03715517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610690|NCT03715517|Sensory System Agents|sensory system agents|mesh-ancestor
65610691|NCT03715517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610692|NCT03715517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65610693|NCT03715517|Narcotics|narcotics|mesh-ancestor
65610694|NCT03715517|Analgesics|analgesics|mesh-ancestor
65610695|NCT03717467|Magnesium Sulfate|magnesium sulfate|mesh-list
65610696|NCT03717467|Analgesics|analgesics|mesh-ancestor
65610697|NCT03717467|Sensory System Agents|sensory system agents|mesh-ancestor
65610698|NCT03717467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610699|NCT03717467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610700|NCT03717467|Anesthetics|anesthetics|mesh-ancestor
65610701|NCT03717467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65610702|NCT03717467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65610703|NCT03717467|Anticonvulsants|anticonvulsants|mesh-ancestor
65610704|NCT03717467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65610705|NCT03717467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65610706|NCT03717467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610707|NCT03717467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65610708|NCT03717467|Tocolytic Agents|tocolytic agents|mesh-ancestor
65610709|NCT03717467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65610710|NCT01318122|Pioglitazone|pioglitazone|mesh-list
65610711|NCT01318122|Alogliptin|alogliptin|mesh-list
65610712|NCT01318122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65610713|NCT01318122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610714|NCT01318122|Incretins|incretins|mesh-ancestor
65610715|NCT01318122|Hormones|hormones|mesh-ancestor
65610716|NCT01318122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65610717|NCT01318122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65610718|NCT01318122|Protease Inhibitors|protease inhibitors|mesh-ancestor
65610719|NCT01318122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610720|NCT01318122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610721|NCT02954159|Vedolizumab|vedolizumab|mesh-list
65610722|NCT02954159|Tacrolimus|tacrolimus|mesh-list
65610723|NCT02954159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65610724|NCT02954159|Immunologic Factors|immunologic factors|mesh-ancestor
65610725|NCT02954159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610726|NCT02954159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65610727|NCT02954159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610728|NCT02954159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610729|NCT02954159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65610730|NCT03737136|Bortezomib|bortezomib|mesh-list
65610731|NCT03737136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610732|NCT03763422|Temozolomide|temozolomide|mesh-list
65610733|NCT03763422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65610734|NCT03763422|Alkylating Agents|alkylating agents|mesh-ancestor
65610735|NCT03763422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610736|NCT03763422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610737|NCT03667716|Nivolumab|nivolumab|mesh-list
65610738|NCT03667716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65610739|NCT03667716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610740|NCT03667716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65610741|NCT03667716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610742|NCT03740334|Dexamethasone|dexamethasone|mesh-list
65610743|NCT03740334|Everolimus|everolimus|mesh-list
65610744|NCT03740334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65610745|NCT03740334|Antiemetics|antiemetics|mesh-ancestor
65610746|NCT03740334|Autonomic Agents|autonomic agents|mesh-ancestor
65610747|NCT03740334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610748|NCT03740334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610749|NCT03740334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65610750|NCT03740334|Glucocorticoids|glucocorticoids|mesh-ancestor
65610751|NCT03740334|Hormones|hormones|mesh-ancestor
65610752|NCT03740334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65610753|NCT03740334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65610754|NCT03740334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610755|NCT03740334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65610756|NCT03740334|Immunologic Factors|immunologic factors|mesh-ancestor
65610757|NCT03440411|Dexamethasone|dexamethasone|mesh-list
65610758|NCT03440411|Cyclophosphamide|cyclophosphamide|mesh-list
65610759|NCT03440411|Pomalidomide|pomalidomide|mesh-list
65610760|NCT03440411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65610761|NCT03440411|Immunologic Factors|immunologic factors|mesh-ancestor
65610762|NCT03440411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610763|NCT03440411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65610764|NCT03440411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65610765|NCT03440411|Alkylating Agents|alkylating agents|mesh-ancestor
65610766|NCT03440411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610767|NCT03440411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610768|NCT03440411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65610769|NCT03440411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65610770|NCT03440411|Antiemetics|antiemetics|mesh-ancestor
65610771|NCT03440411|Autonomic Agents|autonomic agents|mesh-ancestor
65610772|NCT03440411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610773|NCT03440411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65610774|NCT03440411|Glucocorticoids|glucocorticoids|mesh-ancestor
65610775|NCT03440411|Hormones|hormones|mesh-ancestor
65610776|NCT03440411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65610777|NCT03440411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65610778|NCT03440411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65610779|NCT03440411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65610780|NCT03440411|Growth Substances|growth substances|mesh-ancestor
65610781|NCT03440411|Growth Inhibitors|growth inhibitors|mesh-ancestor
65610782|NCT03714737|Vaccines|vaccines|mesh-list
65610783|NCT03714737|Immunologic Factors|immunologic factors|mesh-ancestor
65266332|NCT02696720|Lidocaine|lidocaine|mesh-list
65610784|NCT03714737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610785|NCT03389555|Vitamins|vitamins|mesh-list
65610786|NCT03389555|Ascorbic Acid|ascorbic acid|mesh-list
65610787|NCT03389555|Thiamine|thiamine|mesh-list
65610788|NCT03389555|Hydrocortisone|hydrocortisone|mesh-list
65610789|NCT03389555|Micronutrients|micronutrients|mesh-ancestor
65610790|NCT03389555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610791|NCT03389555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65610792|NCT03389555|Antioxidants|antioxidants|mesh-ancestor
65610793|NCT03389555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610794|NCT03389555|Protective Agents|protective agents|mesh-ancestor
65610795|NCT03389555|Vitamin B Complex|vitamin b complex|mesh-ancestor
65610796|NCT03505710|Trastuzumab|trastuzumab|mesh-list
65610797|NCT03505710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65610798|NCT03505710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610799|NCT03395639|Heparin|heparin|mesh-list
65610800|NCT03395639|Enoxaparin|enoxaparin|mesh-list
65610801|NCT03395639|Warfarin|warfarin|mesh-list
65610802|NCT03395639|Edoxaban|edoxaban|mesh-list
65610803|NCT03395639|Anticoagulants|anticoagulants|mesh-ancestor
65610804|NCT03395639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65610805|NCT03395639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65610806|NCT03395639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610807|NCT03395639|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65610808|NCT03395639|Antithrombins|antithrombins|mesh-ancestor
65610809|NCT03395639|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65610810|NCT03395639|Protease Inhibitors|protease inhibitors|mesh-ancestor
65610811|NCT03395639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610812|NCT03353922|Cyclobenzaprine|cyclobenzaprine|mesh-list
65610813|NCT03353922|Tolperisone|tolperisone|mesh-list
65610814|NCT03353922|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65610815|NCT03353922|Antidepressive Agents|antidepressive agents|mesh-ancestor
65610816|NCT03353922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65610817|NCT03353922|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65610818|NCT03353922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610819|NCT03353922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65610820|NCT03353922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610821|NCT03353922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65610822|NCT03353922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65610823|NCT03395405|Nitazoxanide|nitazoxanide|mesh-list
65610824|NCT03395405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65610825|NCT03395405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65610826|NCT03387683|Dapagliflozin|dapagliflozin|mesh-list
65610827|NCT03387683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65610828|NCT03387683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610829|NCT03387683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65610830|NCT03387683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610831|NCT05467553|Tenofovir|tenofovir|mesh-list
65610832|NCT05467553|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65610833|NCT05467553|Antiviral Agents|antiviral agents|mesh-ancestor
65610834|NCT05467553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65610835|NCT05467553|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65610836|NCT05467553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65610837|NCT05467553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610838|NCT05467553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610839|NCT05467553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65610840|NCT05467553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65610841|NCT05467553|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65610842|NCT05467553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65610843|NCT02942004|Pregnanolone|pregnanolone|mesh-list
65610844|NCT02942004|Brexanolone|brexanolone|mesh-list
65610845|NCT02942004|Neurosteroids|neurosteroids|mesh-ancestor
65610846|NCT02942004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65610847|NCT02942004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610848|NCT02942004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610849|NCT02942004|GABA Modulators|gaba modulators|mesh-ancestor
65610850|NCT02942004|GABA Agents|gaba agents|mesh-ancestor
65610851|NCT02942004|Anesthetics|anesthetics|mesh-ancestor
65610852|NCT02942004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65610853|NCT03414983|Leucovorin|leucovorin|mesh-list
65610854|NCT03414983|Bevacizumab|bevacizumab|mesh-list
65610855|NCT03414983|Nivolumab|nivolumab|mesh-list
65610856|NCT03414983|Fluorouracil|fluorouracil|mesh-list
65610857|NCT03414983|Oxaliplatin|oxaliplatin|mesh-list
65610858|NCT03414983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65610859|NCT03414983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610860|NCT03414983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65610861|NCT03414983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65610862|NCT03414983|Growth Substances|growth substances|mesh-ancestor
65610863|NCT03414983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610864|NCT03414983|Growth Inhibitors|growth inhibitors|mesh-ancestor
65610865|NCT03414983|Antimetabolites|antimetabolites|mesh-ancestor
65610866|NCT03414983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610867|NCT03414983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65610868|NCT03414983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65610869|NCT03414983|Immunologic Factors|immunologic factors|mesh-ancestor
65610870|NCT03414983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65610871|NCT03414983|Antidotes|antidotes|mesh-ancestor
65610873|NCT03414983|Vitamin B Complex|vitamin b complex|mesh-ancestor
65610874|NCT03414983|Vitamins|vitamins|mesh-ancestor
65610875|NCT03414983|Micronutrients|micronutrients|mesh-ancestor
65610876|NCT03414359|Lidocaine|lidocaine|mesh-list
65610877|NCT03414359|Chloroprocaine|chloroprocaine|mesh-list
65610878|NCT03414359|Anesthetics, Local|anesthetics, local|mesh-ancestor
65610879|NCT03414359|Anesthetics|anesthetics|mesh-ancestor
65610880|NCT03414359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65610881|NCT03414359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610882|NCT03414359|Sensory System Agents|sensory system agents|mesh-ancestor
65610883|NCT03414359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610884|NCT03414359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65610885|NCT03414359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65610886|NCT03414359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65610887|NCT03414359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65610888|NCT03414359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610889|NCT03285295|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
65610890|NCT03285295|Immunologic Factors|immunologic factors|mesh-ancestor
65610891|NCT03285295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610892|NCT02583048|Dolutegravir|dolutegravir|mesh-list
65610893|NCT02583048|Bedaquiline|bedaquiline|mesh-list
65610894|NCT02583048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65610895|NCT02583048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65610896|NCT02583048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610897|NCT02583048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610898|NCT02583048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65610899|NCT02583048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65610900|NCT02583048|Antiviral Agents|antiviral agents|mesh-ancestor
65610901|NCT02583048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65610902|NCT02583048|Antitubercular Agents|antitubercular agents|mesh-ancestor
65610903|NCT02583048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65610904|NCT04661137|Dexamethasone|dexamethasone|mesh-list
65610905|NCT04661137|Daratumumab|daratumumab|mesh-list
65610906|NCT04661137|Pomalidomide|pomalidomide|mesh-list
65610907|NCT04661137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65610908|NCT04661137|Antiemetics|antiemetics|mesh-ancestor
65610909|NCT04661137|Autonomic Agents|autonomic agents|mesh-ancestor
65610910|NCT04661137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610911|NCT04661137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610912|NCT04661137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65610913|NCT04661137|Glucocorticoids|glucocorticoids|mesh-ancestor
65610914|NCT04661137|Hormones|hormones|mesh-ancestor
65610915|NCT04661137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65610916|NCT04661137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65610917|NCT04661137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610918|NCT04661137|Immunologic Factors|immunologic factors|mesh-ancestor
65610919|NCT04661137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65610920|NCT04661137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65610921|NCT04661137|Growth Substances|growth substances|mesh-ancestor
65610922|NCT04661137|Growth Inhibitors|growth inhibitors|mesh-ancestor
65610923|NCT03274687|Androgens|androgens|mesh-list
65610924|NCT03274687|Hormones|hormones|mesh-ancestor
65610925|NCT03274687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65610926|NCT03274687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610927|NCT02542956|Bupivacaine|bupivacaine|mesh-list
65610928|NCT02542956|Anesthetics, Local|anesthetics, local|mesh-ancestor
65610929|NCT02542956|Anesthetics|anesthetics|mesh-ancestor
65610930|NCT02542956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65610931|NCT02542956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610932|NCT02542956|Sensory System Agents|sensory system agents|mesh-ancestor
65610933|NCT02542956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610934|NCT03274453|Ketamine|ketamine|mesh-list
65610935|NCT03274453|Analgesics|analgesics|mesh-ancestor
65610936|NCT03274453|Sensory System Agents|sensory system agents|mesh-ancestor
65610937|NCT03274453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610938|NCT03274453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610939|NCT03274453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65610940|NCT03274453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65610941|NCT03274453|Anesthetics, General|anesthetics, general|mesh-ancestor
65610942|NCT03274453|Anesthetics|anesthetics|mesh-ancestor
65610943|NCT03274453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65610944|NCT03274453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65610945|NCT03274453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65610946|NCT03274453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65610947|NCT03274453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610948|NCT02313870|Clobetasol|clobetasol|mesh-list
65610949|NCT02313870|Methotrexate|methotrexate|mesh-list
65610950|NCT02313870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65610951|NCT02313870|Abortifacient Agents|abortifacient agents|mesh-ancestor
65610952|NCT02313870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65610953|NCT02313870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610954|NCT02313870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65610955|NCT02313870|Antimetabolites|antimetabolites|mesh-ancestor
65610956|NCT02313870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610957|NCT02313870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65610958|NCT02313870|Dermatologic Agents|dermatologic agents|mesh-ancestor
65610959|NCT02313870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610960|NCT02313870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65610961|NCT02313870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65610962|NCT02313870|Immunologic Factors|immunologic factors|mesh-ancestor
65610963|NCT02313870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65610964|NCT02313870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65610965|NCT02313870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65610966|NCT02313870|Glucocorticoids|glucocorticoids|mesh-ancestor
65610967|NCT02313870|Hormones|hormones|mesh-ancestor
65610968|NCT02313870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65610969|NCT01942122|Mefenamic Acid|mefenamic acid|mesh-list
65610970|NCT01942122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65610971|NCT01942122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65610972|NCT01942122|Analgesics|analgesics|mesh-ancestor
65610973|NCT01942122|Sensory System Agents|sensory system agents|mesh-ancestor
65610974|NCT01942122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610975|NCT01942122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610976|NCT01942122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65610977|NCT01942122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65610978|NCT01942122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65610979|NCT01942122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610980|NCT01942122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610981|NCT04327999|Lubricant Eye Drops|lubricant eye drops|mesh-list
65610982|NCT04327999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65610983|NCT04327999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65610984|NCT02236806|Ramipril|ramipril|mesh-list
65610985|NCT02236806|Bisoprolol|bisoprolol|mesh-list
65610986|NCT02236806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65610987|NCT02236806|Protease Inhibitors|protease inhibitors|mesh-ancestor
65610988|NCT02236806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65610989|NCT02236806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65610990|NCT02236806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65610991|NCT02236806|Sympatholytics|sympatholytics|mesh-ancestor
65610992|NCT02236806|Autonomic Agents|autonomic agents|mesh-ancestor
65610993|NCT02236806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65610994|NCT02236806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65610995|NCT02236806|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65610996|NCT02236806|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65610997|NCT02236806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65610998|NCT02236806|Adrenergic Agents|adrenergic agents|mesh-ancestor
65610999|NCT02236806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65611000|NCT01578954|Lenalidomide|lenalidomide|mesh-list
65611001|NCT01578954|Immunologic Factors|immunologic factors|mesh-ancestor
65611002|NCT01578954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611003|NCT01578954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65611004|NCT01578954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65611005|NCT01578954|Growth Substances|growth substances|mesh-ancestor
65611006|NCT01578954|Growth Inhibitors|growth inhibitors|mesh-ancestor
65611007|NCT01578954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611008|NCT00659646|Levofloxacin|levofloxacin|mesh-list
65611009|NCT00659646|Ofloxacin|ofloxacin|mesh-list
65611010|NCT00659646|Gentamicins|gentamicins|mesh-list
65611011|NCT00659646|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65611012|NCT00659646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65611013|NCT00659646|Renal Agents|renal agents|mesh-ancestor
65611014|NCT00659646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65611015|NCT00659646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65611016|NCT00659646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65611017|NCT00659646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611018|NCT00659646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611019|NCT00659646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611020|NCT00659646|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65611021|NCT00659646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65611022|NCT00659646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65611023|NCT02236572|Everolimus|everolimus|mesh-list
65611024|NCT02236572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611025|NCT02236572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65611026|NCT02236572|Immunologic Factors|immunologic factors|mesh-ancestor
65611027|NCT02236572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611029|NCT03054870|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65611030|NCT03054870|Anesthetics, General|anesthetics, general|mesh-ancestor
65611031|NCT03054870|Anesthetics|anesthetics|mesh-ancestor
65611032|NCT03054870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65611033|NCT03054870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611034|NCT05448677|Bevacizumab|bevacizumab|mesh-list
65611035|NCT05448677|Atezolizumab|atezolizumab|mesh-list
65611036|NCT05448677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65611037|NCT05448677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611038|NCT05448677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65611039|NCT05448677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65611040|NCT05448677|Growth Substances|growth substances|mesh-ancestor
65611041|NCT05448677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611042|NCT05448677|Growth Inhibitors|growth inhibitors|mesh-ancestor
65611043|NCT05222646|Metoclopramide|metoclopramide|mesh-list
65611044|NCT05222646|Antiemetics|antiemetics|mesh-ancestor
65611045|NCT05222646|Autonomic Agents|autonomic agents|mesh-ancestor
65611046|NCT05222646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611047|NCT05222646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611048|NCT05222646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65611049|NCT05222646|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65611050|NCT05222646|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65611051|NCT05222646|Dopamine Agents|dopamine agents|mesh-ancestor
65611052|NCT05222646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65611053|NCT05222646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611054|NCT05222334|Bupivacaine|bupivacaine|mesh-list
65611055|NCT05222334|Anesthetics, Local|anesthetics, local|mesh-ancestor
65611056|NCT05222334|Anesthetics|anesthetics|mesh-ancestor
65611057|NCT05222334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65611058|NCT05222334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611059|NCT05222334|Sensory System Agents|sensory system agents|mesh-ancestor
65611060|NCT05222334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611061|NCT04465266|Tolperisone|tolperisone|mesh-list
65611062|NCT04465266|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65611063|NCT04465266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611064|NCT04465266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65611065|NCT04465266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611066|NCT04434300|Daptomycin|daptomycin|mesh-list
65611067|NCT04434300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65611068|NCT04434300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65611069|NCT04315896|Hydroxychloroquine|hydroxychloroquine|mesh-list
65611070|NCT04315896|Antimalarials|antimalarials|mesh-ancestor
65611071|NCT04315896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65073909|NCT00308165|Topotecan|topotecan|mesh-list
65611072|NCT04315896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65611073|NCT04315896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65611074|NCT04315896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611075|NCT04315896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611076|NCT04315896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65611077|NCT04108962|Benralizumab|benralizumab|mesh-list
65611078|NCT04108962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65611079|NCT04108962|Respiratory System Agents|respiratory system agents|mesh-ancestor
65611080|NCT04865796|Lactoferrin|lactoferrin|mesh-list
65611081|NCT04865796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65611082|NCT04811118|Docetaxel|docetaxel|mesh-list
65611083|NCT04811118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611084|NCT04811118|Tubulin Modulators|tubulin modulators|mesh-ancestor
65611085|NCT04811118|Antimitotic Agents|antimitotic agents|mesh-ancestor
65611086|NCT04811118|Mitosis Modulators|mitosis modulators|mesh-ancestor
65611087|NCT04811118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611088|NCT05221164|Aspirin|aspirin|mesh-list
65611089|NCT05221164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65611090|NCT05221164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65611091|NCT05221164|Analgesics|analgesics|mesh-ancestor
65611092|NCT05221164|Sensory System Agents|sensory system agents|mesh-ancestor
65611093|NCT05221164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611094|NCT05221164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611095|NCT05221164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65611096|NCT05221164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65611097|NCT05221164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65611098|NCT05221164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65611099|NCT05221164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611100|NCT05221164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65611101|NCT05221164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65611102|NCT05221164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611103|NCT05221164|Antipyretics|antipyretics|mesh-ancestor
65611104|NCT04647084|Lidocaine|lidocaine|mesh-list
65611105|NCT04647084|Anesthetics, Local|anesthetics, local|mesh-ancestor
65611106|NCT04647084|Anesthetics|anesthetics|mesh-ancestor
65611107|NCT04647084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65611108|NCT04647084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611109|NCT04647084|Sensory System Agents|sensory system agents|mesh-ancestor
65611110|NCT04647084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611111|NCT04647084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65611112|NCT04647084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65611113|NCT04647084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65611114|NCT04647084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65611115|NCT04647084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611116|NCT03627546|Sofosbuvir|sofosbuvir|mesh-list
65611117|NCT03627546|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65611118|NCT03627546|Velpatasvir|velpatasvir|mesh-list
65611119|NCT03627546|Antiviral Agents|antiviral agents|mesh-ancestor
65611120|NCT03627546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65611121|NCT04620798|Antibodies|antibodies|mesh-list
65611122|NCT04620798|Immunologic Factors|immunologic factors|mesh-ancestor
65611123|NCT04620798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611124|NCT05220228|Prucalopride|prucalopride|mesh-list
65611125|NCT05220228|Laxatives|laxatives|mesh-ancestor
65611126|NCT05220228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65611127|NCT05220228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65611128|NCT05220228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65611129|NCT05220228|Serotonin Agents|serotonin agents|mesh-ancestor
65611130|NCT05220228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65611131|NCT05220228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611132|NCT05220228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611133|NCT03822780|Hydroxychloroquine|hydroxychloroquine|mesh-list
65611134|NCT03822780|Antimalarials|antimalarials|mesh-ancestor
65611135|NCT03822780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65611136|NCT03822780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65611137|NCT03822780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65611138|NCT03822780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611139|NCT03822780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611140|NCT03822780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65611141|NCT04765644|Celecoxib|celecoxib|mesh-list
65611142|NCT04765644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65611143|NCT04765644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65611144|NCT04765644|Analgesics|analgesics|mesh-ancestor
65611145|NCT04765644|Sensory System Agents|sensory system agents|mesh-ancestor
65611146|NCT04765644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611147|NCT04765644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611148|NCT04765644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65611149|NCT04765644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65611150|NCT04765644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65611151|NCT04765644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65611152|NCT04765644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611153|NCT04765644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611154|NCT03052764|Botulinum Toxins|botulinum toxins|mesh-list
65611155|NCT03052764|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65611156|NCT03052764|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65611157|NCT03052764|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65611158|NCT03052764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65611159|NCT03052764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611160|NCT03052764|Cholinergic Agents|cholinergic agents|mesh-ancestor
65611161|NCT03052764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65611162|NCT03052764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611163|NCT03052764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65611164|NCT03052764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611165|NCT05197374|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65611166|NCT05197374|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65611167|NCT05197374|Estradiol|estradiol|mesh-list
65611168|NCT05197374|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65611169|NCT05197374|Estrogens|estrogens|mesh-ancestor
65408558|NCT00819065|Botulinum Toxins|botulinum toxins|mesh-list
65611170|NCT05197374|Hormones|hormones|mesh-ancestor
65611171|NCT05197374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65611172|NCT05197374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611173|NCT05197374|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65611174|NCT05197374|Contraceptive Agents|contraceptive agents|mesh-ancestor
65611175|NCT05197374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65611176|NCT05197374|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65611177|NCT02951819|Dexamethasone|dexamethasone|mesh-list
65611178|NCT02951819|Cyclophosphamide|cyclophosphamide|mesh-list
65611179|NCT02951819|Bortezomib|bortezomib|mesh-list
65611180|NCT02951819|Daratumumab|daratumumab|mesh-list
65611181|NCT02951819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65611182|NCT02951819|Immunologic Factors|immunologic factors|mesh-ancestor
65611183|NCT02951819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611184|NCT02951819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65611185|NCT02951819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65611186|NCT02951819|Alkylating Agents|alkylating agents|mesh-ancestor
65611187|NCT02951819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611188|NCT02951819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611189|NCT02951819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65611190|NCT02951819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65611191|NCT02951819|Antiemetics|antiemetics|mesh-ancestor
65611192|NCT02951819|Autonomic Agents|autonomic agents|mesh-ancestor
65611193|NCT02951819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611194|NCT02951819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65611195|NCT02951819|Glucocorticoids|glucocorticoids|mesh-ancestor
65611196|NCT02951819|Hormones|hormones|mesh-ancestor
65611197|NCT02951819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65611198|NCT02951819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65611199|NCT05191290|Heparin|heparin|mesh-list
65611200|NCT05191290|Calcium heparin|calcium heparin|mesh-list
65611201|NCT05191290|Citric Acid|citric acid|mesh-list
65611202|NCT05191290|Sodium Citrate|sodium citrate|mesh-list
65611203|NCT05191290|Anticoagulants|anticoagulants|mesh-ancestor
65611204|NCT05191290|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65611205|NCT05191290|Chelating Agents|chelating agents|mesh-ancestor
65611206|NCT05191290|Sequestering Agents|sequestering agents|mesh-ancestor
65611207|NCT05191290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611208|NCT05191290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65611209|NCT05191290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65611210|NCT05627544|Anesthetics|anesthetics|mesh-list
65611211|NCT05627544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65611212|NCT05627544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611213|NCT05189028|Gemcitabine|gemcitabine|mesh-list
65611214|NCT05189028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611215|NCT05189028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65611216|NCT05189028|Antimetabolites|antimetabolites|mesh-ancestor
65611217|NCT05189028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611218|NCT05189028|Antiviral Agents|antiviral agents|mesh-ancestor
65611219|NCT05189028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65611220|NCT05189028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611221|NCT05189028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65611222|NCT05189028|Immunologic Factors|immunologic factors|mesh-ancestor
65611223|NCT05189028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611224|NCT05706870|Clobetasol|clobetasol|mesh-list
65611225|NCT05706870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65611226|NCT05706870|Glucocorticoids|glucocorticoids|mesh-ancestor
65611227|NCT05706870|Hormones|hormones|mesh-ancestor
65611228|NCT05706870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65611229|NCT05706870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611230|NCT03383783|Listerine|listerine|mesh-list
65611231|NCT03383783|Fluorides|fluorides|mesh-list
65611232|NCT03383783|Sodium Fluoride|sodium fluoride|mesh-list
65611233|NCT03383783|Cariostatic Agents|cariostatic agents|mesh-ancestor
65611234|NCT03383783|Protective Agents|protective agents|mesh-ancestor
65611235|NCT03383783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611236|NCT03383783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65611237|NCT03383783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65611238|NCT03627390|Molybdenum|molybdenum|mesh-list
65611239|NCT03627390|Trace Elements|trace elements|mesh-ancestor
65611240|NCT03627390|Micronutrients|micronutrients|mesh-ancestor
65611241|NCT03627390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611242|NCT03709745|Ranibizumab|ranibizumab|mesh-list
65408637|NCT00469209|Alkylating Agents|alkylating agents|mesh-ancestor
65611243|NCT03709745|Aflibercept|aflibercept|mesh-list
65611244|NCT03709745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65611245|NCT03709745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65611246|NCT03709745|Growth Substances|growth substances|mesh-ancestor
65611247|NCT03709745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611248|NCT03709745|Growth Inhibitors|growth inhibitors|mesh-ancestor
65611249|NCT03709745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611250|NCT05570526|Melatonin|melatonin|mesh-list
65611251|NCT05570526|Antioxidants|antioxidants|mesh-ancestor
65611252|NCT05570526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611253|NCT05570526|Protective Agents|protective agents|mesh-ancestor
65611254|NCT05570526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611255|NCT05570526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65611256|NCT03707639|Apatinib|apatinib|mesh-list
65611257|NCT03707639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611258|NCT03707639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65611259|NCT03707639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611260|NCT03707639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611261|NCT03334721|Gabapentin|gabapentin|mesh-list
65611262|NCT03334721|Analgesics|analgesics|mesh-ancestor
65611263|NCT03334721|Sensory System Agents|sensory system agents|mesh-ancestor
65611264|NCT03334721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611265|NCT03334721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611266|NCT03334721|Anticonvulsants|anticonvulsants|mesh-ancestor
65611267|NCT03334721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65611268|NCT03334721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65611269|NCT03334721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65611270|NCT03334721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65611271|NCT03334721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65611272|NCT03334721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65611273|NCT03334721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65611274|NCT03334721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611275|NCT03334721|Antimanic Agents|antimanic agents|mesh-ancestor
65611276|NCT05706402|Acetylcysteine|acetylcysteine|mesh-list
65611277|NCT05706402|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65611278|NCT05706402|Antiviral Agents|antiviral agents|mesh-ancestor
65611279|NCT05706402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65611280|NCT05706402|Expectorants|expectorants|mesh-ancestor
65611281|NCT05706402|Respiratory System Agents|respiratory system agents|mesh-ancestor
65611282|NCT05706402|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65611283|NCT05706402|Antioxidants|antioxidants|mesh-ancestor
65611284|NCT05706402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611285|NCT05706402|Protective Agents|protective agents|mesh-ancestor
65611286|NCT05706402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611287|NCT05706402|Antidotes|antidotes|mesh-ancestor
65611288|NCT05706090|Fentanyl|fentanyl|mesh-list
65611289|NCT05706090|Anesthetics|anesthetics|mesh-ancestor
65611290|NCT05706090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65611291|NCT05706090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611292|NCT05706090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65611293|NCT05706090|Narcotics|narcotics|mesh-ancestor
65611294|NCT05706090|Analgesics|analgesics|mesh-ancestor
65611295|NCT05706090|Sensory System Agents|sensory system agents|mesh-ancestor
65611296|NCT05706090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611297|NCT05706090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65611298|NCT05706090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65611299|NCT05706090|Anesthetics, General|anesthetics, general|mesh-ancestor
65611300|NCT03380429|Albuterol|albuterol|mesh-list
65611301|NCT03380429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65611302|NCT03380429|Autonomic Agents|autonomic agents|mesh-ancestor
65611303|NCT03380429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611304|NCT03380429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611305|NCT03380429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65611306|NCT03380429|Respiratory System Agents|respiratory system agents|mesh-ancestor
65611307|NCT03380429|Tocolytic Agents|tocolytic agents|mesh-ancestor
65611308|NCT03380429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65611309|NCT03380429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65611310|NCT03380429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65611311|NCT03380429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65611312|NCT03380429|Adrenergic Agents|adrenergic agents|mesh-ancestor
65611313|NCT03380429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65611314|NCT03380429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611315|NCT05096442|Paclitaxel|paclitaxel|mesh-list
65611316|NCT05096442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65611317|NCT05096442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65611318|NCT05096442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611319|NCT05096442|Tubulin Modulators|tubulin modulators|mesh-ancestor
65611320|NCT05096442|Antimitotic Agents|antimitotic agents|mesh-ancestor
65611321|NCT05096442|Mitosis Modulators|mitosis modulators|mesh-ancestor
65611322|NCT05096442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611324|NCT01313143|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65611325|NCT01313143|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65611326|NCT01313143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65611327|NCT01313143|Adrenergic Agents|adrenergic agents|mesh-ancestor
65611328|NCT01313143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65611329|NCT01313143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611330|NCT01313143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611331|NCT05705856|Ustekinumab|ustekinumab|mesh-list
65611332|NCT05705856|Dermatologic Agents|dermatologic agents|mesh-ancestor
65611333|NCT05071794|Propofol|propofol|mesh-list
65611334|NCT05071794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65611335|NCT05071794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65611336|NCT05071794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611337|NCT05071794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65611338|NCT05071794|Anesthetics, General|anesthetics, general|mesh-ancestor
65611339|NCT05071794|Anesthetics|anesthetics|mesh-ancestor
65611340|NCT03280537|Omalizumab|omalizumab|mesh-list
65611341|NCT03280537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65611342|NCT03280537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65611343|NCT03280537|Respiratory System Agents|respiratory system agents|mesh-ancestor
65611344|NCT05618730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65611345|NCT05618730|Lubricant Eye Drops|lubricant eye drops|mesh-list
65611346|NCT05618730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65611347|NCT05029050|Clonidine|clonidine|mesh-list
65611348|NCT05029050|Dexmedetomidine|dexmedetomidine|mesh-list
65611349|NCT05029050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65611350|NCT05029050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65611351|NCT05029050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611352|NCT05029050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65611353|NCT05029050|Analgesics|analgesics|mesh-ancestor
65611354|NCT05029050|Sensory System Agents|sensory system agents|mesh-ancestor
65611355|NCT05029050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611356|NCT05029050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65611357|NCT05029050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65611358|NCT05029050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65611359|NCT05029050|Adrenergic Agents|adrenergic agents|mesh-ancestor
65611360|NCT05029050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65611361|NCT05029050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611362|NCT05029050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65611363|NCT05029050|Sympatholytics|sympatholytics|mesh-ancestor
65611364|NCT05029050|Autonomic Agents|autonomic agents|mesh-ancestor
65611365|NCT05553366|Acetaminophen|acetaminophen|mesh-list
65611366|NCT05553366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65611367|NCT05553366|Analgesics|analgesics|mesh-ancestor
65611368|NCT05553366|Sensory System Agents|sensory system agents|mesh-ancestor
65611369|NCT05553366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611370|NCT05553366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611371|NCT05553366|Antipyretics|antipyretics|mesh-ancestor
65611372|NCT04690231|Etoposide|etoposide|mesh-list
65611373|NCT04690231|Etoposide phosphate|etoposide phosphate|mesh-list
65611374|NCT04690231|Apatinib|apatinib|mesh-list
65611375|NCT04690231|Ifosfamide|ifosfamide|mesh-list
65611376|NCT04690231|Isophosphamide mustard|isophosphamide mustard|mesh-list
65611377|NCT04690231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65611378|NCT04690231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611379|NCT04690231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65611380|NCT04690231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65611381|NCT04690231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611382|NCT04690231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611383|NCT04690231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65611384|NCT04690231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65611385|NCT04690231|Alkylating Agents|alkylating agents|mesh-ancestor
65611386|NCT03270085|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65611387|NCT03270085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65611388|NCT03270085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65611389|NCT03270085|Antimetabolites|antimetabolites|mesh-ancestor
65611390|NCT03270085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611391|NCT03270085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65611392|NCT04998006|Ethanol|ethanol|mesh-list
65611393|NCT04998006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65611394|NCT04998006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65611395|NCT04998006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65408784|NCT00450801|Protective Agents|protective agents|mesh-ancestor
65611396|NCT04998006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611397|NCT04234945|Doxycycline|doxycycline|mesh-list
65611398|NCT04234945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65611399|NCT04234945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65611400|NCT04234945|Antimalarials|antimalarials|mesh-ancestor
65611401|NCT04234945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65611402|NCT04234945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65611403|NCT03316807|Vaccines|vaccines|mesh-list
65611404|NCT03316807|Immunologic Factors|immunologic factors|mesh-ancestor
65611405|NCT03316807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611406|NCT03328897|Omalizumab|omalizumab|mesh-list
65611407|NCT03328897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65611408|NCT03328897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65611409|NCT03328897|Respiratory System Agents|respiratory system agents|mesh-ancestor
65611410|NCT04918758|Sucralfate|sucralfate|mesh-list
65611411|NCT04918758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65611412|NCT04918758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65611413|NCT04892472|Pembrolizumab|pembrolizumab|mesh-list
65611414|NCT04892472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65611415|NCT04892472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611416|NCT03378635|Glucagon|glucagon|mesh-list
65611417|NCT03378635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65611418|NCT03378635|Hormones|hormones|mesh-ancestor
65611419|NCT03378635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65611420|NCT03378635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611421|NCT01182727|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
65611422|NCT01182727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65611423|NCT01182727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65611424|NCT01182727|Analgesics|analgesics|mesh-ancestor
65611425|NCT01182727|Sensory System Agents|sensory system agents|mesh-ancestor
65611426|NCT01182727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611427|NCT01182727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611428|NCT01182727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65611429|NCT01182727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65611430|NCT05550714|Anesthetics|anesthetics|mesh-list
65611431|NCT05550714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65611432|NCT05550714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611433|NCT03334409|Vitamins|vitamins|mesh-list
65611434|NCT03334409|Ascorbic Acid|ascorbic acid|mesh-list
65611435|NCT03334409|Micronutrients|micronutrients|mesh-ancestor
65611436|NCT03334409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611437|NCT03334409|Antioxidants|antioxidants|mesh-ancestor
65611438|NCT03334409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611439|NCT03334409|Protective Agents|protective agents|mesh-ancestor
65611440|NCT02891915|Amoxicillin|amoxicillin|mesh-list
65611441|NCT02891915|Clavulanic Acid|clavulanic acid|mesh-list
65611442|NCT02891915|Clavulanic Acids|clavulanic acids|mesh-list
65611443|NCT02891915|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65611444|NCT02891915|Cefdinir|cefdinir|mesh-list
65611445|NCT02891915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65611446|NCT02891915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65611447|NCT02891915|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65611448|NCT02891915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611449|NCT02891915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611450|NCT05233566|Ketamine|ketamine|mesh-list
65611451|NCT05233566|Analgesics|analgesics|mesh-ancestor
65611452|NCT05233566|Sensory System Agents|sensory system agents|mesh-ancestor
65611453|NCT05233566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611454|NCT05233566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611455|NCT05233566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65611456|NCT05233566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65611457|NCT05233566|Anesthetics, General|anesthetics, general|mesh-ancestor
65611458|NCT05233566|Anesthetics|anesthetics|mesh-ancestor
65611459|NCT05233566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65611460|NCT05233566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65611461|NCT05233566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65611462|NCT05233566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65611463|NCT05233566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611464|NCT05230368|Decitabine|decitabine|mesh-list
65611465|NCT05230368|Romidepsin|romidepsin|mesh-list
65611466|NCT05230368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65611467|NCT05230368|Antimetabolites|antimetabolites|mesh-ancestor
65611468|NCT05230368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611469|NCT05230368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611470|NCT05230368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611471|NCT05230368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65611473|NCT03046446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65611474|NCT03046446|Glucocorticoids|glucocorticoids|mesh-ancestor
65611475|NCT03046446|Hormones|hormones|mesh-ancestor
65611476|NCT03046446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65611477|NCT03046446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611478|NCT03046446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65611479|NCT03046446|Immunologic Factors|immunologic factors|mesh-ancestor
65611480|NCT03051217|Certolizumab Pegol|certolizumab pegol|mesh-list
65611481|NCT03051217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65611482|NCT03051217|Immunologic Factors|immunologic factors|mesh-ancestor
65611483|NCT03051217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611484|NCT03051217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65611485|NCT05035303|Epinephrine|epinephrine|mesh-list
65611486|NCT05035303|Norepinephrine|norepinephrine|mesh-list
65611487|NCT05035303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65611488|NCT05035303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65611489|NCT05035303|Adrenergic Agents|adrenergic agents|mesh-ancestor
65611490|NCT05035303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65611491|NCT05035303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611492|NCT05035303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611493|NCT05035303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65611494|NCT05035303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65611495|NCT05035303|Autonomic Agents|autonomic agents|mesh-ancestor
65611496|NCT05035303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611497|NCT05035303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65611498|NCT05035303|Respiratory System Agents|respiratory system agents|mesh-ancestor
65611499|NCT05035303|Mydriatics|mydriatics|mesh-ancestor
65611500|NCT05035303|Sympathomimetics|sympathomimetics|mesh-ancestor
65611501|NCT05035303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65611502|NCT03347279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65611503|NCT03347279|Immunologic Factors|immunologic factors|mesh-ancestor
65611504|NCT03347279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611505|NCT03806166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65611506|NCT03806166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65611507|NCT03262441|Mycophenolic Acid|mycophenolic acid|mesh-list
65611508|NCT03262441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65611509|NCT03262441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611510|NCT03262441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65611511|NCT03262441|Antitubercular Agents|antitubercular agents|mesh-ancestor
65611512|NCT03262441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65611513|NCT03262441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65611514|NCT03262441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266355|NCT02767310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65611515|NCT03262441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611516|NCT04580394|Oxybutynin|oxybutynin|mesh-list
65611517|NCT04580394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65611518|NCT04580394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65611519|NCT04580394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65611520|NCT04580394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65611521|NCT04580394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611522|NCT04580394|Adrenergic Agents|adrenergic agents|mesh-ancestor
65611523|NCT04580394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65611524|NCT04580394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611525|NCT04580394|Parasympatholytics|parasympatholytics|mesh-ancestor
65611526|NCT04580394|Autonomic Agents|autonomic agents|mesh-ancestor
65611527|NCT04580394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611528|NCT04580394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65611529|NCT04580394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65611530|NCT04580394|Cholinergic Agents|cholinergic agents|mesh-ancestor
65611531|NCT04580394|Urological Agents|urological agents|mesh-ancestor
65611532|NCT03713580|Venetoclax|venetoclax|mesh-list
65611533|NCT03713580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611534|NCT01343082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65611535|NCT01343082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65611536|NCT04385173|Temozolomide|temozolomide|mesh-list
65611537|NCT04385173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65611538|NCT04385173|Alkylating Agents|alkylating agents|mesh-ancestor
65611539|NCT04385173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611540|NCT04385173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611541|NCT03707249|Ferric Compounds|ferric compounds|mesh-list
65611542|NCT03707249|Hematinics|hematinics|mesh-ancestor
65611543|NCT05682911|Simvastatin|simvastatin|mesh-list
65611544|NCT05682911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65611545|NCT05682911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65611546|NCT05682911|Antimetabolites|antimetabolites|mesh-ancestor
65611547|NCT05682911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611548|NCT05682911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65611549|NCT05682911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65611550|NCT05682911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611551|NCT04625088|Atropine|atropine|mesh-list
65611552|NCT04625088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65611553|NCT04625088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65611554|NCT04625088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65611555|NCT04625088|Autonomic Agents|autonomic agents|mesh-ancestor
65611556|NCT04625088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611557|NCT04625088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611558|NCT04625088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65611559|NCT04625088|Respiratory System Agents|respiratory system agents|mesh-ancestor
65611560|NCT04625088|Mydriatics|mydriatics|mesh-ancestor
65611561|NCT04625088|Parasympatholytics|parasympatholytics|mesh-ancestor
65611562|NCT04625088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65611563|NCT04625088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65611564|NCT04625088|Cholinergic Agents|cholinergic agents|mesh-ancestor
65611565|NCT04625088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65611566|NCT04625088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611567|NCT03568422|Paclitaxel|paclitaxel|mesh-list
65611568|NCT03568422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65611569|NCT03568422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611570|NCT03568422|Tubulin Modulators|tubulin modulators|mesh-ancestor
65611571|NCT03568422|Antimitotic Agents|antimitotic agents|mesh-ancestor
65611572|NCT03568422|Mitosis Modulators|mitosis modulators|mesh-ancestor
65611573|NCT03568422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611574|NCT03535350|Temozolomide|temozolomide|mesh-list
65611575|NCT03535350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65611576|NCT03535350|Alkylating Agents|alkylating agents|mesh-ancestor
65611577|NCT03535350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611578|NCT03535350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611579|NCT02547493|Abatacept|abatacept|mesh-list
65611580|NCT02547493|Vaccines|vaccines|mesh-list
65611581|NCT02547493|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65611582|NCT02547493|Immunologic Factors|immunologic factors|mesh-ancestor
65611583|NCT02547493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611584|NCT02547493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65611585|NCT02547493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611586|NCT02547493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611587|NCT02547493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65611588|NCT02547493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65611589|NCT03259789|Bexagliflozin|bexagliflozin|mesh-list
65611590|NCT03259789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65611591|NCT03259789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611592|NCT03259555|Brexpiprazole|brexpiprazole|mesh-list
65611593|NCT03259555|Serotonin Agents|serotonin agents|mesh-ancestor
65611594|NCT03259555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65611595|NCT03259555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611596|NCT03259555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611597|NCT03259555|Dopamine Agonists|dopamine agonists|mesh-ancestor
65611598|NCT03259555|Dopamine Agents|dopamine agents|mesh-ancestor
65611599|NCT03257995|Maleic acid|maleic acid|mesh-list
65611600|NCT03257995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611601|NCT03257995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611602|NCT03049488|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65611603|NCT03049488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65611604|NCT03049488|Immunologic Factors|immunologic factors|mesh-ancestor
65611605|NCT03049488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611606|NCT03049488|Antacids|antacids|mesh-ancestor
65611607|NCT03049488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611608|NCT03049488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65611609|NCT04484922|Dexmedetomidine|dexmedetomidine|mesh-list
65611610|NCT04484922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65611611|NCT04484922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65611612|NCT04484922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611613|NCT04484922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65611614|NCT04484922|Analgesics|analgesics|mesh-ancestor
65611615|NCT04484922|Sensory System Agents|sensory system agents|mesh-ancestor
65611616|NCT04484922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611617|NCT04484922|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65611618|NCT04484922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65611619|NCT04484922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65611620|NCT04484922|Adrenergic Agents|adrenergic agents|mesh-ancestor
65611621|NCT04484922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65611622|NCT04484922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611623|NCT04446390|Listerine|listerine|mesh-list
65611624|NCT04446390|Sodium Fluoride|sodium fluoride|mesh-list
65611625|NCT04446390|Cariostatic Agents|cariostatic agents|mesh-ancestor
65611626|NCT04446390|Protective Agents|protective agents|mesh-ancestor
65611627|NCT04446390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611628|NCT04446390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65611629|NCT04446390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65611630|NCT02338921|Metformin|metformin|mesh-list
65611631|NCT02338921|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65611632|NCT02338921|Dapagliflozin|dapagliflozin|mesh-list
65611633|NCT02338921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65611634|NCT02338921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611635|NCT02338921|Incretins|incretins|mesh-ancestor
65611636|NCT02338921|Hormones|hormones|mesh-ancestor
65611637|NCT02338921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65611638|NCT02338921|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65611639|NCT02338921|Protease Inhibitors|protease inhibitors|mesh-ancestor
65611640|NCT02338921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611641|NCT02338921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611642|NCT02338921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65611643|NCT01313845|Amantadine|amantadine|mesh-list
65611644|NCT01313845|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65611645|NCT01313845|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65611646|NCT01313845|Antiviral Agents|antiviral agents|mesh-ancestor
65611647|NCT01313845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65611648|NCT01313845|Dopamine Agents|dopamine agents|mesh-ancestor
65611649|NCT01313845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65611650|NCT01313845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611651|NCT01313845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611652|NCT01313845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65611653|NCT01313845|Analgesics|analgesics|mesh-ancestor
65611654|NCT01313845|Sensory System Agents|sensory system agents|mesh-ancestor
65611655|NCT01313845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611656|NCT04400058|gamma-Globulins|gamma-globulins|mesh-list
65611657|NCT04400058|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65611658|NCT04400058|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65611659|NCT04400058|Immunologic Factors|immunologic factors|mesh-ancestor
65611660|NCT04400058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611661|NCT04745845|Norepinephrine|norepinephrine|mesh-list
65611662|NCT04745845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65611663|NCT04745845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65611664|NCT04745845|Adrenergic Agents|adrenergic agents|mesh-ancestor
65611665|NCT04745845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65611666|NCT04745845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611667|NCT04745845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611668|NCT04745845|Sympathomimetics|sympathomimetics|mesh-ancestor
65611669|NCT04745845|Autonomic Agents|autonomic agents|mesh-ancestor
65611670|NCT04745845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611671|NCT04745845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65611672|NCT04173247|Mineral Oil|mineral oil|mesh-list
65611673|NCT04173247|Emollients|emollients|mesh-ancestor
65611674|NCT04173247|Dermatologic Agents|dermatologic agents|mesh-ancestor
65611675|NCT03196986|Bevacizumab|bevacizumab|mesh-list
65611676|NCT03196986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65611677|NCT03196986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611678|NCT03196986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65611679|NCT03196986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65611680|NCT03196986|Growth Substances|growth substances|mesh-ancestor
65611681|NCT03196986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611682|NCT03196986|Growth Inhibitors|growth inhibitors|mesh-ancestor
65611683|NCT04051632|Insulin|insulin|mesh-list
65611684|NCT04051632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65611685|NCT04051632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611686|NCT04507555|Antidepressive Agents|antidepressive agents|mesh-list
65611687|NCT04507555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65611688|NCT04423237|Deferasirox|deferasirox|mesh-list
65611689|NCT04423237|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65611690|NCT04423237|Chelating Agents|chelating agents|mesh-ancestor
65611691|NCT04423237|Sequestering Agents|sequestering agents|mesh-ancestor
65611692|NCT04423237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611693|NCT03107988|Cyclophosphamide|cyclophosphamide|mesh-list
65611694|NCT03107988|Topotecan|topotecan|mesh-list
65611695|NCT03107988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65611696|NCT03107988|Immunologic Factors|immunologic factors|mesh-ancestor
65611697|NCT03107988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611698|NCT03107988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65611699|NCT03107988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65611700|NCT03107988|Alkylating Agents|alkylating agents|mesh-ancestor
65611701|NCT03107988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611702|NCT03107988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611703|NCT03107988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65611704|NCT03107988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65611705|NCT03107988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65611706|NCT03107988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611708|NCT03043560|Anticonvulsants|anticonvulsants|mesh-ancestor
65611709|NCT03043560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65611710|NCT03043560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611711|NCT02145403|Tacrolimus|tacrolimus|mesh-list
65611712|NCT02145403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65611713|NCT02145403|Immunologic Factors|immunologic factors|mesh-ancestor
65611714|NCT02145403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611715|NCT02145403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65611716|NCT02145403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611717|NCT02145403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611718|NCT02899988|Mirikizumab|mirikizumab|mesh-list
65611719|NCT02899988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65611720|NCT02899988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65611721|NCT02899988|Analgesics|analgesics|mesh-ancestor
65611722|NCT02899988|Sensory System Agents|sensory system agents|mesh-ancestor
65611723|NCT02899988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611724|NCT02899988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611725|NCT02899988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65611726|NCT02899988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65611727|NCT02899988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65611728|NCT02899988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65611729|NCT03646526|Amitriptyline|amitriptyline|mesh-list
65611730|NCT03646526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65611731|NCT03646526|Antidepressive Agents|antidepressive agents|mesh-ancestor
65611732|NCT03646526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65611733|NCT03646526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65611734|NCT03646526|Analgesics|analgesics|mesh-ancestor
65611735|NCT03646526|Sensory System Agents|sensory system agents|mesh-ancestor
65611736|NCT03646526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611737|NCT03646526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611738|NCT03646526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65611739|NCT03646526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65611740|NCT03646526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65611741|NCT03646526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611742|NCT03646526|Adrenergic Agents|adrenergic agents|mesh-ancestor
65611743|NCT03646526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65611744|NCT03646370|Tenofovir|tenofovir|mesh-list
65611745|NCT03646370|Antiviral Agents|antiviral agents|mesh-ancestor
65611746|NCT03646370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65611747|NCT03646370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65611748|NCT03646370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65611749|NCT03646370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611750|NCT03646370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611751|NCT03646370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65611752|NCT03646370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65611753|NCT03646292|Pioglitazone|pioglitazone|mesh-list
65611754|NCT03646292|Empagliflozin|empagliflozin|mesh-list
65611755|NCT03646292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65611756|NCT03646292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611757|NCT03646292|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65611758|NCT03646292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611759|NCT03345407|Albuterol|albuterol|mesh-list
65611760|NCT03345407|Nemiralisib|nemiralisib|mesh-list
65611761|NCT03345407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65611762|NCT03345407|Autonomic Agents|autonomic agents|mesh-ancestor
65611763|NCT03345407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611764|NCT03345407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611765|NCT03345407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65611766|NCT03345407|Respiratory System Agents|respiratory system agents|mesh-ancestor
65611767|NCT03345407|Tocolytic Agents|tocolytic agents|mesh-ancestor
65409162|NCT00449163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65611768|NCT03345407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65611769|NCT03345407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65611770|NCT03345407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65611771|NCT03345407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65611772|NCT03345407|Adrenergic Agents|adrenergic agents|mesh-ancestor
65611773|NCT03345407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65611774|NCT03345407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611775|NCT03345407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65611776|NCT03345407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611777|NCT02537418|Durvalumab|durvalumab|mesh-list
65611778|NCT02537418|Tremelimumab|tremelimumab|mesh-list
65611779|NCT02537418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65611780|NCT02537418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611781|NCT03626298|Niacinamide|niacinamide|mesh-list
65611782|NCT03626298|Niacin|niacin|mesh-list
65611783|NCT03626298|Nicotinic Acids|nicotinic acids|mesh-list
65611784|NCT03626298|Adapalene|adapalene|mesh-list
65611785|NCT03626298|Vitamin B Complex|vitamin b complex|mesh-ancestor
65611786|NCT03626298|Vitamins|vitamins|mesh-ancestor
65611787|NCT03626298|Micronutrients|micronutrients|mesh-ancestor
65611788|NCT03626298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611789|NCT03626298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65611790|NCT03626298|Antimetabolites|antimetabolites|mesh-ancestor
65611791|NCT03626298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611792|NCT03626298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65611793|NCT03626298|Vasodilator Agents|vasodilator agents|mesh-ancestor
65611794|NCT03626298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65611795|NCT03626298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65611796|NCT03626298|Analgesics|analgesics|mesh-ancestor
65611797|NCT03626298|Sensory System Agents|sensory system agents|mesh-ancestor
65611798|NCT03626298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611799|NCT03626298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65611800|NCT03626298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65611801|NCT03626298|Dermatologic Agents|dermatologic agents|mesh-ancestor
65611802|NCT03644264|Sevelamer|sevelamer|mesh-list
65611803|NCT03644264|Chelating Agents|chelating agents|mesh-ancestor
65611804|NCT03644264|Sequestering Agents|sequestering agents|mesh-ancestor
65611805|NCT03644264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611806|NCT02298348|Cyclophosphamide|cyclophosphamide|mesh-list
65611807|NCT02298348|Sorafenib|sorafenib|mesh-list
65611808|NCT02298348|Topotecan|topotecan|mesh-list
65611809|NCT02298348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65611810|NCT02298348|Immunologic Factors|immunologic factors|mesh-ancestor
65611811|NCT02298348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611812|NCT02298348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65611813|NCT02298348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65611814|NCT02298348|Alkylating Agents|alkylating agents|mesh-ancestor
65611815|NCT02298348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611816|NCT02298348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611817|NCT02298348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65611818|NCT02298348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65611819|NCT02298348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611820|NCT02298348|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65611821|NCT02298348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65611822|NCT03641456|Dexamethasone|dexamethasone|mesh-list
65611823|NCT03641456|Dexamethasone acetate|dexamethasone acetate|mesh-list
65611824|NCT03641456|Lenalidomide|lenalidomide|mesh-list
65611825|NCT03641456|Bortezomib|bortezomib|mesh-list
65611826|NCT03641456|BB 1101|bb 1101|mesh-list
65611827|NCT03641456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65611828|NCT03641456|Antiemetics|antiemetics|mesh-ancestor
65611829|NCT03641456|Autonomic Agents|autonomic agents|mesh-ancestor
65611830|NCT03641456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611831|NCT03641456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611832|NCT03641456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65611833|NCT03641456|Glucocorticoids|glucocorticoids|mesh-ancestor
65611834|NCT03641456|Hormones|hormones|mesh-ancestor
65611835|NCT03641456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65611836|NCT03641456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65611837|NCT03641456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611838|NCT03641456|Protease Inhibitors|protease inhibitors|mesh-ancestor
65611839|NCT03641456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611840|NCT03641456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611841|NCT03641456|Immunologic Factors|immunologic factors|mesh-ancestor
65409237|NCT01024413|Gefitinib|gefitinib|mesh-list
65611842|NCT03641456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65611843|NCT03641456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65611844|NCT03641456|Growth Substances|growth substances|mesh-ancestor
65611845|NCT03641456|Growth Inhibitors|growth inhibitors|mesh-ancestor
65611847|NCT03240133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611848|NCT03240133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611849|NCT03814356|Methylphenidate|methylphenidate|mesh-list
65611850|NCT03814356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65611851|NCT03814356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611852|NCT03814356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65611853|NCT03814356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65611854|NCT03814356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65611855|NCT03814356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611856|NCT03814356|Dopamine Agents|dopamine agents|mesh-ancestor
65611857|NCT03814356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65611858|NCT03707171|Liraglutide|liraglutide|mesh-list
65611859|NCT03707171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65611860|NCT03707171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611861|NCT03707171|Incretins|incretins|mesh-ancestor
65611862|NCT03707171|Hormones|hormones|mesh-ancestor
65611863|NCT03707171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65611864|NCT02101944|Dexamethasone|dexamethasone|mesh-list
65611865|NCT02101944|Dexamethasone acetate|dexamethasone acetate|mesh-list
65611866|NCT02101944|Ichthammol|ichthammol|mesh-list
65611867|NCT02101944|BB 1101|bb 1101|mesh-list
65611868|NCT02101944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65611869|NCT02101944|Antiemetics|antiemetics|mesh-ancestor
65611870|NCT02101944|Autonomic Agents|autonomic agents|mesh-ancestor
65611871|NCT02101944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611872|NCT02101944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611873|NCT02101944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65611874|NCT02101944|Glucocorticoids|glucocorticoids|mesh-ancestor
65611875|NCT02101944|Hormones|hormones|mesh-ancestor
65611876|NCT02101944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65611877|NCT02101944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65611878|NCT02101944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611879|NCT02101944|Protease Inhibitors|protease inhibitors|mesh-ancestor
65611880|NCT02101944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611881|NCT02101944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611882|NCT02101944|Dermatologic Agents|dermatologic agents|mesh-ancestor
65611883|NCT02030964|Eflornithine|eflornithine|mesh-list
65611884|NCT02030964|Celecoxib|celecoxib|mesh-list
65611885|NCT02030964|Cyclophosphamide|cyclophosphamide|mesh-list
65611886|NCT02030964|Topotecan|topotecan|mesh-list
65611887|NCT02030964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65611888|NCT02030964|Immunologic Factors|immunologic factors|mesh-ancestor
65611889|NCT02030964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611890|NCT02030964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65611891|NCT02030964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65611892|NCT02030964|Alkylating Agents|alkylating agents|mesh-ancestor
65611893|NCT02030964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611894|NCT02030964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611895|NCT02030964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65611896|NCT02030964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65611897|NCT02030964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65611898|NCT02030964|Analgesics|analgesics|mesh-ancestor
65611899|NCT02030964|Sensory System Agents|sensory system agents|mesh-ancestor
65611900|NCT02030964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611901|NCT02030964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65611902|NCT02030964|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65611903|NCT02030964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65611904|NCT02030964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611905|NCT02030964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65611906|NCT02030964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65611907|NCT02030964|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65611908|NCT02030964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65611909|NCT02030964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65611910|NCT02030964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65611911|NCT02030964|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
65611912|NCT03372083|Deferasirox|deferasirox|mesh-list
65611913|NCT03372083|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65611914|NCT03372083|Chelating Agents|chelating agents|mesh-ancestor
65611915|NCT03372083|Sequestering Agents|sequestering agents|mesh-ancestor
65611916|NCT03372083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611917|NCT03044886|Vitamin D|vitamin d|mesh-list
65611918|NCT03044886|Vitamins|vitamins|mesh-ancestor
65611919|NCT03044886|Micronutrients|micronutrients|mesh-ancestor
65611920|NCT03044886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611921|NCT03044886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65611922|NCT02961764|Dalbavancin|dalbavancin|mesh-list
65611923|NCT02961764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65611924|NCT02961764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65611925|NCT03371459|Albuterol|albuterol|mesh-list
65611926|NCT03371459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65611927|NCT03371459|Autonomic Agents|autonomic agents|mesh-ancestor
65611928|NCT03371459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65611929|NCT03371459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611930|NCT03371459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65611931|NCT03371459|Respiratory System Agents|respiratory system agents|mesh-ancestor
65611932|NCT03371459|Tocolytic Agents|tocolytic agents|mesh-ancestor
65611933|NCT03371459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65611934|NCT03371459|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65611935|NCT03371459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65611936|NCT03371459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65611937|NCT03371459|Adrenergic Agents|adrenergic agents|mesh-ancestor
65611938|NCT03371459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65611939|NCT03371459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611940|NCT03371381|Nivolumab|nivolumab|mesh-list
65611941|NCT03371381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65611942|NCT03371381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611943|NCT03371381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65611944|NCT03371381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611945|NCT03044730|Pembrolizumab|pembrolizumab|mesh-list
65611946|NCT03044730|Capecitabine|capecitabine|mesh-list
65611947|NCT03044730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65611948|NCT03044730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611949|NCT03044730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65611950|NCT03044730|Antimetabolites|antimetabolites|mesh-ancestor
65611951|NCT03044730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611952|NCT05326997|Tranexamic Acid|tranexamic acid|mesh-list
65611953|NCT05326997|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65611954|NCT05326997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65611955|NCT05326997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611956|NCT05326997|Hemostatics|hemostatics|mesh-ancestor
65611957|NCT05326997|Coagulants|coagulants|mesh-ancestor
65611958|NCT03738852|Insulin|insulin|mesh-list
65611959|NCT03738852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65611960|NCT03738852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611961|NCT02961374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65611962|NCT02961374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611963|NCT02961374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65611964|NCT02961374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611965|NCT02961374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611966|NCT04783233|Chitosan|chitosan|mesh-list
65611967|NCT04783233|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
65611968|NCT04783233|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65611969|NCT04783233|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65611970|NCT04783233|Antimetabolites|antimetabolites|mesh-ancestor
65611971|NCT04783233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611972|NCT04783233|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65611973|NCT04783233|Chelating Agents|chelating agents|mesh-ancestor
65611974|NCT04783233|Sequestering Agents|sequestering agents|mesh-ancestor
65611975|NCT04783233|Hemostatics|hemostatics|mesh-ancestor
65611976|NCT04783233|Coagulants|coagulants|mesh-ancestor
65611977|NCT05251233|Pantoprazole|pantoprazole|mesh-list
65611978|NCT05251233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65611979|NCT05251233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65611980|NCT05251233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65611981|NCT05251233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611982|NCT05251233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611983|NCT04777539|Natalizumab|natalizumab|mesh-list
65611984|NCT04777539|Immunologic Factors|immunologic factors|mesh-ancestor
65611985|NCT04777539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65611986|NCT04664829|Capecitabine|capecitabine|mesh-list
65611987|NCT04664829|Bexarotene|bexarotene|mesh-list
65611988|NCT04664829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65611989|NCT04664829|Antimetabolites|antimetabolites|mesh-ancestor
65611990|NCT04664829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611991|NCT04664829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65611992|NCT02951429|Pirfenidone|pirfenidone|mesh-list
65611993|NCT02951429|Sildenafil Citrate|sildenafil citrate|mesh-list
65409403|NCT00443703|Ritonavir|ritonavir|mesh-list
65611994|NCT02951429|Vasodilator Agents|vasodilator agents|mesh-ancestor
65611995|NCT02951429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65611996|NCT02951429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65611997|NCT02951429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65611998|NCT02951429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65611999|NCT02951429|Urological Agents|urological agents|mesh-ancestor
65612000|NCT02951429|Analgesics|analgesics|mesh-ancestor
65612001|NCT02951429|Sensory System Agents|sensory system agents|mesh-ancestor
65612002|NCT02951429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65612003|NCT02951429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612004|NCT02951429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65612005|NCT02951429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65612006|NCT02951429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65612007|NCT02951429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65612008|NCT02951429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612009|NCT04622709|Furosemide|furosemide|mesh-list
65612010|NCT04622709|Diuretics|diuretics|mesh-list
65612011|NCT04622709|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
65612012|NCT04622709|Natriuretic Agents|natriuretic agents|mesh-ancestor
65612013|NCT04622709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612014|NCT04622709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65612015|NCT04622709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612016|NCT05423379|Everolimus|everolimus|mesh-list
65612017|NCT05423379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612018|NCT05423379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65612019|NCT05423379|Immunologic Factors|immunologic factors|mesh-ancestor
65612020|NCT05423379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612021|NCT05214807|Chitosan|chitosan|mesh-list
65612022|NCT05214807|Hylan|hylan|mesh-list
65612023|NCT05214807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65612024|NCT05214807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65612025|NCT05214807|Antimetabolites|antimetabolites|mesh-ancestor
65612026|NCT05214807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612027|NCT05214807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65612028|NCT05214807|Chelating Agents|chelating agents|mesh-ancestor
65612029|NCT05214807|Sequestering Agents|sequestering agents|mesh-ancestor
65612030|NCT05214807|Hemostatics|hemostatics|mesh-ancestor
65612031|NCT05214807|Coagulants|coagulants|mesh-ancestor
65612032|NCT05214807|Viscosupplements|viscosupplements|mesh-ancestor
65612033|NCT05214807|Protective Agents|protective agents|mesh-ancestor
65612034|NCT05214807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612035|NCT02454855|Melatonin|melatonin|mesh-list
65612036|NCT02454855|Antioxidants|antioxidants|mesh-ancestor
65612037|NCT02454855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612038|NCT02454855|Protective Agents|protective agents|mesh-ancestor
65612039|NCT02454855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612040|NCT02454855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65612041|NCT03343067|Norethindrone|norethindrone|mesh-list
65612042|NCT03343067|Norethindrone Acetate|norethindrone acetate|mesh-list
65612043|NCT03343067|Estradiol|estradiol|mesh-list
65612044|NCT03343067|Estrogens|estrogens|mesh-ancestor
65612045|NCT03343067|Hormones|hormones|mesh-ancestor
65612046|NCT03343067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65612047|NCT03343067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612048|NCT03343067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65612049|NCT03343067|Contraceptive Agents|contraceptive agents|mesh-ancestor
65612050|NCT03343067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65612051|NCT03343067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65612052|NCT03343067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65612053|NCT03343067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65612054|NCT03343067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65612055|NCT05205525|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65612056|NCT05205525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65612057|NCT05205525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65612058|NCT05205525|Antitubercular Agents|antitubercular agents|mesh-ancestor
65612059|NCT04707183|Lidocaine|lidocaine|mesh-list
65612060|NCT04707183|Anesthetics, Local|anesthetics, local|mesh-ancestor
65612061|NCT04707183|Anesthetics|anesthetics|mesh-ancestor
65612062|NCT04707183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65612063|NCT04707183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612064|NCT04707183|Sensory System Agents|sensory system agents|mesh-ancestor
65612065|NCT04707183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65612066|NCT04707183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65612067|NCT04707183|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65409477|NCT04400994|Rituximab|rituximab|mesh-list
65612068|NCT04707183|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65612069|NCT04707183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65612070|NCT04707183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612071|NCT04703205|Ivermectin|ivermectin|mesh-list
65612072|NCT04703205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65612073|NCT04703205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65612074|NCT03706781|Cetylpyridinium|cetylpyridinium|mesh-list
65612075|NCT03706781|Benzydamine|benzydamine|mesh-list
65612076|NCT03706781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65612077|NCT03706781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65612078|NCT03706781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65612079|NCT03706703|Carboplatin|carboplatin|mesh-list
65612080|NCT03706703|Docetaxel|docetaxel|mesh-list
65612081|NCT03706703|Pemetrexed|pemetrexed|mesh-list
65612082|NCT03706703|Endostar protein|endostar protein|mesh-list
65612083|NCT03706703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612084|NCT03706703|Tubulin Modulators|tubulin modulators|mesh-ancestor
65612085|NCT03706703|Antimitotic Agents|antimitotic agents|mesh-ancestor
65612086|NCT03706703|Mitosis Modulators|mitosis modulators|mesh-ancestor
65612087|NCT03706703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612088|NCT03706703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612089|NCT03706703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65612090|NCT03706703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65612091|NCT03706703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65612092|NCT03706703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65612093|NCT03706703|Growth Substances|growth substances|mesh-ancestor
65612094|NCT03706703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612095|NCT03706703|Growth Inhibitors|growth inhibitors|mesh-ancestor
65612096|NCT05642403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65612097|NCT03706547|Cyclophosphamide|cyclophosphamide|mesh-list
65612098|NCT03706547|Fludarabine|fludarabine|mesh-list
65612099|NCT03706547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65612100|NCT03706547|Immunologic Factors|immunologic factors|mesh-ancestor
65612101|NCT03706547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612102|NCT03706547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65612103|NCT03706547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65612104|NCT03706547|Alkylating Agents|alkylating agents|mesh-ancestor
65612105|NCT03706547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612106|NCT03706547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612107|NCT03706547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65612108|NCT05682209|Octreotide|octreotide|mesh-list
65612109|NCT05682209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65612110|NCT05682209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65612111|NCT05682209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612112|NCT03708497|Misoprostol|misoprostol|mesh-list
65612113|NCT03708497|Tranexamic Acid|tranexamic acid|mesh-list
65612114|NCT03708497|Carbetocin|carbetocin|mesh-list
65612115|NCT03708497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65612116|NCT03708497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65612117|NCT03708497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612118|NCT03708497|Hemostatics|hemostatics|mesh-ancestor
65612119|NCT03708497|Coagulants|coagulants|mesh-ancestor
65612120|NCT03708497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65612121|NCT03708497|Abortifacient Agents|abortifacient agents|mesh-ancestor
65612122|NCT03708497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65612123|NCT03708497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612124|NCT03708497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65612125|NCT03708497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65612126|NCT03708497|Oxytocics|oxytocics|mesh-ancestor
65612127|NCT04608903|Sulforaphane|sulforaphane|mesh-list
65612128|NCT04608903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65612129|NCT04608903|Protective Agents|protective agents|mesh-ancestor
65612130|NCT04608903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612131|NCT04608903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612132|NCT05681975|Antibodies|antibodies|mesh-list
65612133|NCT05681975|Immunoglobulins|immunoglobulins|mesh-list
65612134|NCT05681975|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65612135|NCT05681975|Immunoglobulin G|immunoglobulin g|mesh-list
65612136|NCT05681975|Immunologic Factors|immunologic factors|mesh-ancestor
65612137|NCT05681975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612138|NCT05216744|Doxycycline|doxycycline|mesh-list
65612139|NCT05216744|Ceftriaxone|ceftriaxone|mesh-list
65612140|NCT05216744|Cefixime|cefixime|mesh-list
65612141|NCT05216744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65612142|NCT05216744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65612143|NCT05216744|Antimalarials|antimalarials|mesh-ancestor
65612144|NCT05216744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65612145|NCT05216744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65612146|NCT05681897|Minoxidil|minoxidil|mesh-list
65612147|NCT05681897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65612148|NCT05681897|Vasodilator Agents|vasodilator agents|mesh-ancestor
65612149|NCT03341273|Azithromycin|azithromycin|mesh-list
65612150|NCT03341273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65612151|NCT03341273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65612152|NCT01345058|Lacosamide|lacosamide|mesh-list
65612153|NCT01345058|Levetiracetam|levetiracetam|mesh-list
65612154|NCT01345058|Anticonvulsants|anticonvulsants|mesh-ancestor
65612155|NCT01345058|Nootropic Agents|nootropic agents|mesh-ancestor
65612156|NCT01345058|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65612157|NCT01345058|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65612158|NCT01345058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65612159|NCT01345058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612160|NCT01345292|Listerine|listerine|mesh-list
65612161|NCT01345292|Fluorides|fluorides|mesh-list
65612162|NCT01345292|Sodium Fluoride|sodium fluoride|mesh-list
65612163|NCT01345292|Cariostatic Agents|cariostatic agents|mesh-ancestor
65612164|NCT01345292|Protective Agents|protective agents|mesh-ancestor
65612165|NCT01345292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612166|NCT01345292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65612167|NCT01345292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65612168|NCT03340961|Doxycycline|doxycycline|mesh-list
65612169|NCT03340961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65612170|NCT03340961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65612171|NCT03340961|Antimalarials|antimalarials|mesh-ancestor
65612172|NCT03340961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65612173|NCT03340961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65612174|NCT05372367|Rifampin|rifampin|mesh-list
65612175|NCT05372367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65612176|NCT05372367|Antitubercular Agents|antitubercular agents|mesh-ancestor
65612177|NCT05372367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65612178|NCT05372367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65612179|NCT05372367|Leprostatic Agents|leprostatic agents|mesh-ancestor
65612180|NCT05372367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65612181|NCT05372367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612182|NCT05372367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612183|NCT05372367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65612184|NCT05372367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65612185|NCT05372367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65612186|NCT05372367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65612187|NCT05372367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65612188|NCT05372367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65612189|NCT03708341|Melatonin|melatonin|mesh-list
65612190|NCT03708341|Antioxidants|antioxidants|mesh-ancestor
65612191|NCT03708341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612192|NCT03708341|Protective Agents|protective agents|mesh-ancestor
65612193|NCT03708341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612194|NCT03708341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65612195|NCT03643874|Albuterol|albuterol|mesh-list
65612196|NCT03643874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65612197|NCT03643874|Autonomic Agents|autonomic agents|mesh-ancestor
65612198|NCT03643874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65612199|NCT03643874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612200|NCT03643874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65612201|NCT03643874|Respiratory System Agents|respiratory system agents|mesh-ancestor
65612202|NCT03643874|Tocolytic Agents|tocolytic agents|mesh-ancestor
65612203|NCT03643874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65612204|NCT03643874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65612205|NCT03643874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65612206|NCT03643874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65612207|NCT03643874|Adrenergic Agents|adrenergic agents|mesh-ancestor
65612208|NCT03643874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65612209|NCT03643874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612210|NCT03254485|Praliciguat|praliciguat|mesh-list
65612211|NCT03254485|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65612212|NCT03254485|Enzyme Activators|enzyme activators|mesh-ancestor
65612213|NCT03254485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612214|NCT03254485|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65612215|NCT03641690|Anti-Infective Agents|anti-infective agents|mesh-list
65612216|NCT03641690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65612217|NCT00769327|Imatinib Mesylate|imatinib mesylate|mesh-list
65612218|NCT00769327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612219|NCT00769327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65409613|NCT00992082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65612220|NCT00769327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612221|NCT00769327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612222|NCT01068704|Letrozole|letrozole|mesh-list
65612223|NCT01068704|Lapatinib|lapatinib|mesh-list
65612224|NCT01068704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612225|NCT01068704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65612226|NCT01068704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65612227|NCT01068704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612228|NCT01068704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612229|NCT01068704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65612230|NCT01068704|Hormone Antagonists|hormone antagonists|mesh-ancestor
65612231|NCT01068704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65612232|NCT01068704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612233|NCT01068704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65612234|NCT03339401|Brincidofovir|brincidofovir|mesh-list
65612235|NCT03339401|Antiviral Agents|antiviral agents|mesh-ancestor
65612236|NCT03339401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65612237|NCT05179525|Risperidone|risperidone|mesh-list
65612238|NCT05179525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65612239|NCT05179525|Serotonin Agents|serotonin agents|mesh-ancestor
65612240|NCT05179525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65612241|NCT05179525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612242|NCT05179525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612243|NCT05179525|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65612244|NCT05179525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65612245|NCT05179525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65612246|NCT05179525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65266370|NCT00643149|Amoxicillin|amoxicillin|mesh-list
65612247|NCT05179525|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65612248|NCT05179525|Dopamine Agents|dopamine agents|mesh-ancestor
65612249|NCT03370289|Vaccines|vaccines|mesh-list
65612250|NCT03370289|Immunologic Factors|immunologic factors|mesh-ancestor
65612251|NCT03370289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612252|NCT01344824|Bevacizumab|bevacizumab|mesh-list
65612253|NCT01344824|Carboplatin|carboplatin|mesh-list
65612254|NCT01344824|Pemetrexed|pemetrexed|mesh-list
65612255|NCT01344824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65612256|NCT01344824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65612257|NCT01344824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612258|NCT01344824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65612259|NCT01344824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65612260|NCT01344824|Growth Substances|growth substances|mesh-ancestor
65612261|NCT01344824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612262|NCT01344824|Growth Inhibitors|growth inhibitors|mesh-ancestor
65612263|NCT01344824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612264|NCT01344824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612265|NCT01344824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65612266|NCT01344824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65612267|NCT01344824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65612268|NCT05507580|Upadacitinib|upadacitinib|mesh-list
65612269|NCT05507580|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65612270|NCT05507580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65612271|NCT05507580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612272|NCT05507580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612273|NCT05507580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65612274|NCT01311947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65612275|NCT01311947|Antiviral Agents|antiviral agents|mesh-ancestor
65612276|NCT01311947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65612277|NCT05137496|Methylprednisolone|methylprednisolone|mesh-list
65612278|NCT05137496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65612279|NCT05137496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65612280|NCT05137496|Prednisolone|prednisolone|mesh-list
65612281|NCT05137496|Prednisolone acetate|prednisolone acetate|mesh-list
65612282|NCT05137496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65612283|NCT05137496|Prednisolone phosphate|prednisolone phosphate|mesh-list
65612284|NCT05137496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65612285|NCT05137496|Antiemetics|antiemetics|mesh-ancestor
65612286|NCT05137496|Autonomic Agents|autonomic agents|mesh-ancestor
65612287|NCT05137496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65612288|NCT05137496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612289|NCT05137496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65612290|NCT05137496|Glucocorticoids|glucocorticoids|mesh-ancestor
65612291|NCT05137496|Hormones|hormones|mesh-ancestor
65612292|NCT05137496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65612293|NCT05137496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65612294|NCT05137496|Protective Agents|protective agents|mesh-ancestor
65612295|NCT05137496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65612296|NCT05137496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612297|NCT04025359|Dronabinol|dronabinol|mesh-list
65612298|NCT04025359|Hallucinogens|hallucinogens|mesh-ancestor
65612299|NCT04025359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612300|NCT04025359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65612301|NCT04025359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65612302|NCT04025359|Analgesics|analgesics|mesh-ancestor
65612303|NCT04025359|Sensory System Agents|sensory system agents|mesh-ancestor
65612304|NCT04025359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65612305|NCT04025359|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65612306|NCT04025359|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65612307|NCT04025359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65612308|NCT04025359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612309|NCT04025359|Hormones|hormones|mesh-ancestor
65612310|NCT04025359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65612311|NCT03339245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65612312|NCT02959892|Amphetamine|amphetamine|mesh-list
65612313|NCT02959892|Naxagolide|naxagolide|mesh-list
65612314|NCT02959892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65612315|NCT02959892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612316|NCT02959892|Sympathomimetics|sympathomimetics|mesh-ancestor
65612317|NCT02959892|Autonomic Agents|autonomic agents|mesh-ancestor
65612318|NCT02959892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65612319|NCT02959892|Dopamine Agents|dopamine agents|mesh-ancestor
65612320|NCT02959892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65612321|NCT02959892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612322|NCT02959892|Adrenergic Agents|adrenergic agents|mesh-ancestor
65612323|NCT02959892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65612324|NCT02959892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65612325|NCT02959892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65612326|NCT02959892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65612327|NCT02959892|Dopamine Agonists|dopamine agonists|mesh-ancestor
65612328|NCT01661400|Thalidomide|thalidomide|mesh-list
65612329|NCT01661400|Cyclophosphamide|cyclophosphamide|mesh-list
65612330|NCT01661400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65612331|NCT01661400|Immunologic Factors|immunologic factors|mesh-ancestor
65612332|NCT01661400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612333|NCT01661400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65612334|NCT01661400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65612335|NCT01661400|Alkylating Agents|alkylating agents|mesh-ancestor
65612336|NCT01661400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612337|NCT01661400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612338|NCT01661400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65612339|NCT01661400|Leprostatic Agents|leprostatic agents|mesh-ancestor
65612340|NCT01661400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65612341|NCT01661400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65612342|NCT01661400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65612343|NCT01661400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65612344|NCT01661400|Growth Substances|growth substances|mesh-ancestor
65612345|NCT01661400|Growth Inhibitors|growth inhibitors|mesh-ancestor
65612346|NCT05158166|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65612347|NCT05158166|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65612348|NCT05158166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65612349|NCT05158166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65612350|NCT05158166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612351|NCT05158166|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65612352|NCT05158166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65612353|NCT05158166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612354|NCT05158166|Cholinergic Agents|cholinergic agents|mesh-ancestor
65612355|NCT05158166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65612356|NCT03368807|Insulin Lispro|insulin lispro|mesh-list
65612357|NCT03368807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65612358|NCT03368807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612359|NCT05179213|Azacitidine|azacitidine|mesh-list
65612360|NCT05179213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65612361|NCT05179213|Antimetabolites|antimetabolites|mesh-ancestor
65612362|NCT05179213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612363|NCT05179213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612364|NCT05179213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612365|NCT03338855|Dapagliflozin|dapagliflozin|mesh-list
65612366|NCT03338855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65409765|NCT04001712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65612367|NCT03338855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612368|NCT03338855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65612369|NCT03338855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612370|NCT03367793|Metronidazole|metronidazole|mesh-list
65612371|NCT03367793|Methamphetamine|methamphetamine|mesh-list
65612372|NCT03367793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65612373|NCT03367793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612374|NCT03367793|Sympathomimetics|sympathomimetics|mesh-ancestor
65612375|NCT03367793|Autonomic Agents|autonomic agents|mesh-ancestor
65612376|NCT03367793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65612377|NCT03367793|Dopamine Agents|dopamine agents|mesh-ancestor
65612378|NCT03367793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65612379|NCT03367793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612380|NCT03367793|Adrenergic Agents|adrenergic agents|mesh-ancestor
65612381|NCT03367793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65612382|NCT03367793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65612383|NCT03367793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65612384|NCT03367793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65612385|NCT03367793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65612386|NCT03367793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65612387|NCT03367793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65612388|NCT03367793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65612389|NCT05178745|Fluorouracil|fluorouracil|mesh-list
65612390|NCT05178745|Irinotecan|irinotecan|mesh-list
65612391|NCT05178745|Aflibercept|aflibercept|mesh-list
65612392|NCT05178745|Antimetabolites|antimetabolites|mesh-ancestor
65612393|NCT05178745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612394|NCT05178745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65612395|NCT05178745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612396|NCT05178745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65612397|NCT05178745|Immunologic Factors|immunologic factors|mesh-ancestor
65612398|NCT05178745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612399|NCT05178745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65612400|NCT05178745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65612401|NCT05178745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612402|NCT05178745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65612403|NCT05178745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65612404|NCT05178745|Growth Substances|growth substances|mesh-ancestor
65612405|NCT05178745|Growth Inhibitors|growth inhibitors|mesh-ancestor
65612406|NCT05178511|Ensartinib|ensartinib|mesh-list
65612407|NCT05178511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612408|NCT05178511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65612409|NCT05178511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612410|NCT05178511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612411|NCT03995641|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65612412|NCT03995641|Bupivacaine|bupivacaine|mesh-list
65612413|NCT03995641|Anesthetics, Local|anesthetics, local|mesh-ancestor
65612414|NCT03995641|Anesthetics|anesthetics|mesh-ancestor
65612415|NCT03995641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65612416|NCT03995641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612417|NCT03995641|Sensory System Agents|sensory system agents|mesh-ancestor
65612418|NCT03995641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65612419|NCT03995641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65612420|NCT03995641|Glucocorticoids|glucocorticoids|mesh-ancestor
65612421|NCT03995641|Hormones|hormones|mesh-ancestor
65612422|NCT03995641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65612423|NCT03995641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65612424|NCT03995641|Immunologic Factors|immunologic factors|mesh-ancestor
65612425|NCT04105231|Cannabidiol|cannabidiol|mesh-list
65612426|NCT04105231|Risperidone|risperidone|mesh-list
65612427|NCT04105231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65612428|NCT04105231|Serotonin Agents|serotonin agents|mesh-ancestor
65612429|NCT04105231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65612430|NCT04105231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612431|NCT04105231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612432|NCT04105231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65612433|NCT04105231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65612434|NCT04105231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65612435|NCT04105231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65612436|NCT04105231|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65612437|NCT04105231|Dopamine Agents|dopamine agents|mesh-ancestor
65612438|NCT04105231|Anticonvulsants|anticonvulsants|mesh-ancestor
65612439|NCT03557749|Dimercaprol|dimercaprol|mesh-list
65612440|NCT03557749|Chelating Agents|chelating agents|mesh-ancestor
65612441|NCT03557749|Sequestering Agents|sequestering agents|mesh-ancestor
65612442|NCT03557749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612444|NCT03532555|Trace Elements|trace elements|mesh-ancestor
65612445|NCT03532555|Micronutrients|micronutrients|mesh-ancestor
65612446|NCT03532555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612447|NCT03993457|Citalopram|citalopram|mesh-list
65612448|NCT03993457|Bupropion|bupropion|mesh-list
65612449|NCT03993457|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65612450|NCT03993457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65612451|NCT03993457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65612452|NCT03993457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612453|NCT03993457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65612454|NCT03993457|Serotonin Agents|serotonin agents|mesh-ancestor
65612455|NCT03993457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612456|NCT03993457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65612457|NCT03993457|Antidepressive Agents|antidepressive agents|mesh-ancestor
65612458|NCT03993457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65612459|NCT03993457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65612460|NCT03993457|Dopamine Agents|dopamine agents|mesh-ancestor
65612461|NCT03993457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65612462|NCT03993457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65612463|NCT03993457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612464|NCT04677439|HH-GV-678|hh-gv-678|mesh-list
65612465|NCT04677439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65612466|NCT04677439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612467|NCT04677439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612468|NCT03399175|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65612469|NCT03399175|Immunologic Factors|immunologic factors|mesh-ancestor
65612470|NCT03399175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612471|NCT05689710|Inositol|inositol|mesh-list
65612472|NCT05689710|Vitamin B Complex|vitamin b complex|mesh-ancestor
65612473|NCT05689710|Vitamins|vitamins|mesh-ancestor
65612474|NCT05689710|Micronutrients|micronutrients|mesh-ancestor
65612475|NCT05689710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612476|NCT02777424|Thrombin|thrombin|mesh-list
65612477|NCT02777424|Hemostatics|hemostatics|mesh-ancestor
65612478|NCT02777424|Coagulants|coagulants|mesh-ancestor
65612479|NCT01347073|Glycerol|glycerol|mesh-list
65612480|NCT01347073|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65612481|NCT01347073|Protective Agents|protective agents|mesh-ancestor
65612482|NCT01347073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612483|NCT01315236|Amikacin|amikacin|mesh-list
65612484|NCT01315236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65612485|NCT01315236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65612486|NCT03730051|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
65612487|NCT03730051|Chelating Agents|chelating agents|mesh-ancestor
65612488|NCT03730051|Sequestering Agents|sequestering agents|mesh-ancestor
65612489|NCT03730051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612490|NCT05627466|Magrolimab|magrolimab|mesh-list
65612491|NCT05627466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65612492|NCT05627466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612493|NCT05620914|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
65612494|NCT05620914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65612495|NCT05620914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612496|NCT05572255|Cenobamate|cenobamate|mesh-list
65612497|NCT05572255|Anticonvulsants|anticonvulsants|mesh-ancestor
65612498|NCT03364049|Pembrolizumab|pembrolizumab|mesh-list
65612499|NCT03364049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65612500|NCT03364049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612501|NCT05343078|Dapagliflozin|dapagliflozin|mesh-list
65612502|NCT05343078|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65612503|NCT05343078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612504|NCT05343078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65612505|NCT05343078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612506|NCT05199311|Dexamethasone|dexamethasone|mesh-list
65612507|NCT05199311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65612508|NCT05199311|Antiemetics|antiemetics|mesh-ancestor
65612509|NCT05199311|Autonomic Agents|autonomic agents|mesh-ancestor
65612510|NCT05199311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65612511|NCT05199311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612512|NCT05199311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65612513|NCT05199311|Glucocorticoids|glucocorticoids|mesh-ancestor
65612514|NCT05199311|Hormones|hormones|mesh-ancestor
65612515|NCT05199311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65409912|NCT03994107|Paclitaxel|paclitaxel|mesh-list
65612516|NCT05199311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65612517|NCT05199311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612518|NCT03710369|Sildenafil Citrate|sildenafil citrate|mesh-list
65612519|NCT03710369|Vasodilator Agents|vasodilator agents|mesh-ancestor
65612520|NCT03710369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65612521|NCT03710369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65612522|NCT03710369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612523|NCT03710369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612524|NCT03710369|Urological Agents|urological agents|mesh-ancestor
65612526|NCT03706157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65612527|NCT03706157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65612528|NCT03706157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612529|NCT03706157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65612530|NCT03706157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65612531|NCT03706157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612532|NCT03706157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612533|NCT03707795|Betamethasone|betamethasone|mesh-list
65612534|NCT03707795|Betamethasone Valerate|betamethasone valerate|mesh-list
65612535|NCT03707795|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65612536|NCT03707795|Betamethasone benzoate|betamethasone benzoate|mesh-list
65612537|NCT03707795|Betamethasone acetate|betamethasone acetate|mesh-list
65266376|NCT05141682|Antimetabolites|antimetabolites|mesh-ancestor
65612538|NCT03707795|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
65612539|NCT03707795|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65612540|NCT03707795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65612541|NCT03707795|Glucocorticoids|glucocorticoids|mesh-ancestor
65612542|NCT03707795|Hormones|hormones|mesh-ancestor
65612543|NCT03707795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65612544|NCT03707795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612545|NCT03707795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65612546|NCT03707795|Respiratory System Agents|respiratory system agents|mesh-ancestor
65612547|NCT03707795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65612548|NCT03707795|Autonomic Agents|autonomic agents|mesh-ancestor
65612549|NCT03707795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65612550|NCT03042312|177Lu-PSMA-617|177lu-psma-617|mesh-list
65612551|NCT03042312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65612552|NCT03042312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612553|NCT05171231|Hemostatics|hemostatics|mesh-list
65612554|NCT05171231|Coagulants|coagulants|mesh-ancestor
65612555|NCT05692986|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65612556|NCT05692986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65612557|NCT03360071|Immunologic Factors|immunologic factors|mesh-list
65612558|NCT03360071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612559|NCT05058924|Aspirin|aspirin|mesh-list
65612560|NCT05058924|Heparin|heparin|mesh-list
65612561|NCT05058924|Calcium heparin|calcium heparin|mesh-list
65612562|NCT05058924|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65612563|NCT05058924|Tinzaparin|tinzaparin|mesh-list
65612564|NCT05058924|Dalteparin|dalteparin|mesh-list
65612565|NCT05058924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65612566|NCT05058924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65612567|NCT05058924|Analgesics|analgesics|mesh-ancestor
65612568|NCT05058924|Sensory System Agents|sensory system agents|mesh-ancestor
65612569|NCT05058924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65612570|NCT05058924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612571|NCT05058924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65612572|NCT05058924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65612573|NCT05058924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65612574|NCT05058924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65612575|NCT05058924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612576|NCT05058924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65612577|NCT05058924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65612578|NCT05058924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612579|NCT05058924|Antipyretics|antipyretics|mesh-ancestor
65612580|NCT05058924|Anticoagulants|anticoagulants|mesh-ancestor
65612581|NCT05681429|Acetaminophen|acetaminophen|mesh-list
65612582|NCT05681429|Parecoxib|parecoxib|mesh-list
65612583|NCT05681429|Lidocaine|lidocaine|mesh-list
65612584|NCT05681429|Dexmedetomidine|dexmedetomidine|mesh-list
65612585|NCT05681429|Sevoflurane|sevoflurane|mesh-list
65612586|NCT05681429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65612587|NCT05681429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65612588|NCT05681429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612589|NCT05681429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65612590|NCT05681429|Analgesics|analgesics|mesh-ancestor
65612591|NCT05681429|Sensory System Agents|sensory system agents|mesh-ancestor
65612592|NCT05681429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65612593|NCT05681429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65612594|NCT05681429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65612595|NCT05681429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65612596|NCT05681429|Adrenergic Agents|adrenergic agents|mesh-ancestor
65612597|NCT05681429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65612598|NCT05681429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612599|NCT05681429|Antipyretics|antipyretics|mesh-ancestor
65612600|NCT05681429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65612601|NCT05681429|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65612602|NCT05681429|Anesthetics, General|anesthetics, general|mesh-ancestor
65612603|NCT05681429|Anesthetics|anesthetics|mesh-ancestor
65612604|NCT05681429|Anesthetics, Local|anesthetics, local|mesh-ancestor
65612605|NCT05681429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65612606|NCT05681429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65612607|NCT05681429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65612608|NCT05681429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65612609|NCT05681429|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65612610|NCT05681429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65612611|NCT05681429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612612|NCT05681429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65612613|NCT05681429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65612614|NCT05681429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65612615|NCT05024760|Chlorhexidine|chlorhexidine|mesh-list
65612616|NCT05024760|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65612617|NCT05024760|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65612618|NCT05024760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65612619|NCT05024760|Disinfectants|disinfectants|mesh-ancestor
65612620|NCT05020860|Paclitaxel|paclitaxel|mesh-list
65612621|NCT05020860|Cyclophosphamide|cyclophosphamide|mesh-list
65612622|NCT05020860|Carboplatin|carboplatin|mesh-list
65612623|NCT05020860|Doxorubicin|doxorubicin|mesh-list
65612624|NCT05020860|Pembrolizumab|pembrolizumab|mesh-list
65612625|NCT05020860|Trastuzumab|trastuzumab|mesh-list
65612626|NCT05020860|Pertuzumab|pertuzumab|mesh-list
65612627|NCT05020860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65612628|NCT05020860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612629|NCT05020860|Tubulin Modulators|tubulin modulators|mesh-ancestor
65612630|NCT05020860|Antimitotic Agents|antimitotic agents|mesh-ancestor
65612631|NCT05020860|Mitosis Modulators|mitosis modulators|mesh-ancestor
65612632|NCT05020860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612633|NCT05020860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65612634|NCT05020860|Immunologic Factors|immunologic factors|mesh-ancestor
65612635|NCT05020860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612636|NCT05020860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65612637|NCT05020860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65612638|NCT05020860|Alkylating Agents|alkylating agents|mesh-ancestor
65612639|NCT05020860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65612640|NCT05020860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65612641|NCT05020860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65612642|NCT05020860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65612643|NCT05020860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612644|NCT05020860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65612645|NCT04999020|Ravulizumab|ravulizumab|mesh-list
65612646|NCT04999020|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65612647|NCT04999020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65612648|NCT04999020|Immunologic Factors|immunologic factors|mesh-ancestor
65612649|NCT04999020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612650|NCT02949011|Oseltamivir|oseltamivir|mesh-list
65612651|NCT02949011|Baloxavir|baloxavir|mesh-list
65612652|NCT02949011|Antiviral Agents|antiviral agents|mesh-ancestor
65612653|NCT02949011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65612654|NCT02949011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612655|NCT02949011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612656|NCT05409066|Rituximab|rituximab|mesh-list
65612657|NCT05409066|Lenalidomide|lenalidomide|mesh-list
65612658|NCT05409066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65612659|NCT05409066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612660|NCT05409066|Immunologic Factors|immunologic factors|mesh-ancestor
65612661|NCT05409066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612662|NCT05409066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65612663|NCT05409066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65612664|NCT05409066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65612665|NCT05409066|Growth Substances|growth substances|mesh-ancestor
65612666|NCT05409066|Growth Inhibitors|growth inhibitors|mesh-ancestor
65612667|NCT03705533|Telmisartan|telmisartan|mesh-list
65612668|NCT03705533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65612669|NCT03705533|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65612670|NCT03705533|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65612671|NCT03705533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612672|NCT03357731|Nitroglycerin|nitroglycerin|mesh-list
65612673|NCT03357731|Vasodilator Agents|vasodilator agents|mesh-ancestor
65612674|NCT03357341|Albuterol|albuterol|mesh-list
65612675|NCT03357341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65612676|NCT03357341|Autonomic Agents|autonomic agents|mesh-ancestor
65612677|NCT03357341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65612678|NCT03357341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612679|NCT03357341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65612680|NCT03357341|Respiratory System Agents|respiratory system agents|mesh-ancestor
65612681|NCT03357341|Tocolytic Agents|tocolytic agents|mesh-ancestor
65612682|NCT03357341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65612683|NCT03357341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65612684|NCT03357341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65612685|NCT03357341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65612686|NCT03357341|Adrenergic Agents|adrenergic agents|mesh-ancestor
65612687|NCT03357341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65612688|NCT03357341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612689|NCT05177237|Endostar protein|endostar protein|mesh-list
65612690|NCT05177237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65612691|NCT05177237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65612692|NCT05177237|Growth Substances|growth substances|mesh-ancestor
65612693|NCT05177237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612694|NCT05177237|Growth Inhibitors|growth inhibitors|mesh-ancestor
65612695|NCT05177237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612696|NCT05681273|Empagliflozin|empagliflozin|mesh-list
65612697|NCT05681273|Valsartan|valsartan|mesh-list
65612698|NCT05681273|Atorvastatin|atorvastatin|mesh-list
65612699|NCT05681273|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65612700|NCT05681273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65612701|NCT05681273|Antimetabolites|antimetabolites|mesh-ancestor
65612702|NCT05681273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612703|NCT05681273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65612704|NCT05681273|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65612705|NCT05681273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612706|NCT05681273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65612707|NCT05681273|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65612708|NCT05681273|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65612709|NCT05681273|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65612710|NCT05681273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65612711|NCT05681273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612712|NCT05147376|Curcumin|curcumin|mesh-list
65612713|NCT05147376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65612714|NCT05147376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65612715|NCT05147376|Analgesics|analgesics|mesh-ancestor
65612716|NCT05147376|Sensory System Agents|sensory system agents|mesh-ancestor
65612717|NCT05147376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65612718|NCT05147376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612719|NCT05147376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65612720|NCT05147376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65612721|NCT05147376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612722|NCT05147376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612723|NCT05147376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612724|NCT05175131|Mebeverine|mebeverine|mesh-list
65612725|NCT05175131|Simethicone|simethicone|mesh-list
65612726|NCT05175131|Alverine|alverine|mesh-list
65612727|NCT05175131|Antifoaming Agents|antifoaming agents|mesh-ancestor
65612728|NCT05175131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612729|NCT05175131|Emollients|emollients|mesh-ancestor
65612730|NCT05175131|Dermatologic Agents|dermatologic agents|mesh-ancestor
65612731|NCT05175131|Anticonvulsants|anticonvulsants|mesh-ancestor
65612732|NCT05175131|Parasympatholytics|parasympatholytics|mesh-ancestor
65612733|NCT05175131|Autonomic Agents|autonomic agents|mesh-ancestor
65612734|NCT05175131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65612735|NCT05175131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612736|NCT04507373|Simvastatin|simvastatin|mesh-list
65612737|NCT04507373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65612738|NCT04507373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65612739|NCT04507373|Antimetabolites|antimetabolites|mesh-ancestor
65612740|NCT04507373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612741|NCT04507373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65612742|NCT04507373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65612743|NCT04507373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612744|NCT01312337|Gefitinib|gefitinib|mesh-list
65612745|NCT01312337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612746|NCT01312337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65612747|NCT01312337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612748|NCT01312337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612749|NCT05229653|Ketamine|ketamine|mesh-list
65612750|NCT05229653|Analgesics|analgesics|mesh-ancestor
65612751|NCT05229653|Sensory System Agents|sensory system agents|mesh-ancestor
65612752|NCT05229653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65612753|NCT05229653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612754|NCT05229653|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65612755|NCT05229653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65612756|NCT05229653|Anesthetics, General|anesthetics, general|mesh-ancestor
65612757|NCT05229653|Anesthetics|anesthetics|mesh-ancestor
65612758|NCT05229653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65612759|NCT05229653|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65612760|NCT05229653|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65612761|NCT05229653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65612762|NCT05229653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612763|NCT05418582|Carbamazepine|carbamazepine|mesh-list
65612764|NCT05418582|Anticonvulsants|anticonvulsants|mesh-ancestor
65612765|NCT05418582|Antimanic Agents|antimanic agents|mesh-ancestor
65612766|NCT05418582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65612767|NCT05418582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65612768|NCT05418582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612769|NCT05418582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65612770|NCT05418582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65612771|NCT05418582|Analgesics|analgesics|mesh-ancestor
65612772|NCT05418582|Sensory System Agents|sensory system agents|mesh-ancestor
65612773|NCT05418582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65612774|NCT05418582|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65612775|NCT05418582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65612776|NCT05418582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612777|NCT05418582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65612778|NCT05418582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65612779|NCT05551949|Estradiol|estradiol|mesh-list
65612780|NCT05551949|Estrogens|estrogens|mesh-ancestor
65612781|NCT05551949|Hormones|hormones|mesh-ancestor
65612782|NCT05551949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65612783|NCT05551949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612784|NCT05541497|Varenicline|varenicline|mesh-list
65612785|NCT05541497|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65612786|NCT05541497|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65612787|NCT05541497|Cholinergic Agents|cholinergic agents|mesh-ancestor
65612788|NCT05541497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65612789|NCT05541497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612790|NCT05541497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612791|NCT05283954|Ivermectin|ivermectin|mesh-list
65612792|NCT05283954|Albendazole|albendazole|mesh-list
65612793|NCT05283954|Prednisolone|prednisolone|mesh-list
65612794|NCT05283954|Fluoxetine|fluoxetine|mesh-list
65612795|NCT05283954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612796|NCT05283954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65612797|NCT05283954|Glucocorticoids|glucocorticoids|mesh-ancestor
65612798|NCT05283954|Hormones|hormones|mesh-ancestor
65612799|NCT05283954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65612800|NCT05283954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65612801|NCT05283954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612802|NCT05283954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612803|NCT05283954|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65612804|NCT05283954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65612805|NCT05283954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65612806|NCT05283954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65612807|NCT05283954|Serotonin Agents|serotonin agents|mesh-ancestor
65612808|NCT05283954|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65612809|NCT05283954|Antidepressive Agents|antidepressive agents|mesh-ancestor
65612810|NCT05283954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65612811|NCT05283954|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65612812|NCT05283954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65612813|NCT05283954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410211|NCT05162196|Niraparib|niraparib|mesh-list
65612815|NCT05283954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65612816|NCT05283954|Anthelmintics|anthelmintics|mesh-ancestor
65612817|NCT05283954|Anticestodal Agents|anticestodal agents|mesh-ancestor
65612818|NCT05283954|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65612819|NCT05283954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65612820|NCT05283954|Tubulin Modulators|tubulin modulators|mesh-ancestor
65612821|NCT05283954|Antimitotic Agents|antimitotic agents|mesh-ancestor
65612822|NCT05283954|Mitosis Modulators|mitosis modulators|mesh-ancestor
65612823|NCT01312415|Morphine|morphine|mesh-list
65612824|NCT01312415|Levobupivacaine|levobupivacaine|mesh-list
65612825|NCT01312415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65612826|NCT01312415|Narcotics|narcotics|mesh-ancestor
65612827|NCT01312415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65612828|NCT01312415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612829|NCT01312415|Analgesics|analgesics|mesh-ancestor
65612830|NCT01312415|Sensory System Agents|sensory system agents|mesh-ancestor
65266380|NCT00643227|Azithromycin|azithromycin|mesh-list
65612831|NCT01312415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65612832|NCT01312415|Anesthetics, Local|anesthetics, local|mesh-ancestor
65612833|NCT01312415|Anesthetics|anesthetics|mesh-ancestor
65612834|NCT03036852|Sofosbuvir|sofosbuvir|mesh-list
65612835|NCT03036852|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65612836|NCT03036852|Velpatasvir|velpatasvir|mesh-list
65612837|NCT03036852|Antiviral Agents|antiviral agents|mesh-ancestor
65612838|NCT03036852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65612839|NCT01312493|Panitumumab|panitumumab|mesh-list
65612840|NCT01312493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65612841|NCT01312493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612842|NCT05323656|Pembrolizumab|pembrolizumab|mesh-list
65612843|NCT05323656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65612844|NCT05323656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612845|NCT04313244|Vaccines|vaccines|mesh-list
65612846|NCT04313244|Immunologic Factors|immunologic factors|mesh-ancestor
65612847|NCT04313244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612848|NCT05279898|Dexmedetomidine|dexmedetomidine|mesh-list
65612849|NCT05279898|Ketamine|ketamine|mesh-list
65612850|NCT05279898|Remifentanil|remifentanil|mesh-list
65612851|NCT05279898|Propofol|propofol|mesh-list
65612852|NCT05279898|Ropivacaine|ropivacaine|mesh-list
65612853|NCT05279898|Rocuronium|rocuronium|mesh-list
65612854|NCT05279898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65612855|NCT05279898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65612856|NCT05279898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612857|NCT05279898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65612858|NCT05279898|Anesthetics, General|anesthetics, general|mesh-ancestor
65612859|NCT05279898|Anesthetics|anesthetics|mesh-ancestor
65612860|NCT05279898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65612861|NCT05279898|Analgesics|analgesics|mesh-ancestor
65612862|NCT05279898|Sensory System Agents|sensory system agents|mesh-ancestor
65612863|NCT05279898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65612864|NCT05279898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65612865|NCT05279898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65612866|NCT05279898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65612867|NCT05279898|Adrenergic Agents|adrenergic agents|mesh-ancestor
65612868|NCT05279898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65612869|NCT05279898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612870|NCT05279898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65612871|NCT05279898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65612872|NCT05279898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65612873|NCT05279898|Anesthetics, Local|anesthetics, local|mesh-ancestor
65612874|NCT05279898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65612875|NCT05279898|Narcotics|narcotics|mesh-ancestor
65612876|NCT05279898|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65612877|NCT05279898|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65612878|NCT05279898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65612879|NCT05309694|Copper|copper|mesh-list
65612880|NCT05309694|Contraceptive Agents|contraceptive agents|mesh-list
65612881|NCT05309694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65612882|NCT05309694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612883|NCT05309694|Trace Elements|trace elements|mesh-ancestor
65612884|NCT05309694|Micronutrients|micronutrients|mesh-ancestor
65612885|NCT05268510|Pembrolizumab|pembrolizumab|mesh-list
65612886|NCT05268510|Olaparib|olaparib|mesh-list
65612887|NCT05268510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65612888|NCT05268510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612889|NCT05268510|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65612890|NCT05268510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410287|NCT01001364|Hormones|hormones|mesh-ancestor
65612891|NCT05268510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612893|NCT05030441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612894|NCT05030441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612895|NCT05030441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612896|NCT04952753|Leucovorin|leucovorin|mesh-list
65612897|NCT04952753|Bevacizumab|bevacizumab|mesh-list
65612898|NCT04952753|Oxaliplatin|oxaliplatin|mesh-list
65612899|NCT04952753|Irinotecan|irinotecan|mesh-list
65612900|NCT04952753|Levoleucovorin|levoleucovorin|mesh-list
65612901|NCT04952753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65612902|NCT04952753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612903|NCT04952753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65612904|NCT04952753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65612905|NCT04952753|Growth Substances|growth substances|mesh-ancestor
65612906|NCT04952753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612907|NCT04952753|Growth Inhibitors|growth inhibitors|mesh-ancestor
65612908|NCT04952753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65612909|NCT04952753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65612910|NCT04952753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612911|NCT04952753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612912|NCT04952753|Antidotes|antidotes|mesh-ancestor
65612913|NCT04952753|Protective Agents|protective agents|mesh-ancestor
65612914|NCT04952753|Vitamin B Complex|vitamin b complex|mesh-ancestor
65612915|NCT04952753|Vitamins|vitamins|mesh-ancestor
65612916|NCT04952753|Micronutrients|micronutrients|mesh-ancestor
65612917|NCT05438303|Celecoxib|celecoxib|mesh-list
65612918|NCT05438303|Midazolam|midazolam|mesh-list
65612919|NCT05438303|Omeprazole|omeprazole|mesh-list
65612920|NCT05438303|Dabigatran|dabigatran|mesh-list
65612921|NCT05438303|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65612922|NCT05438303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65612923|NCT05438303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65612924|NCT05438303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612925|NCT05438303|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65612926|NCT05438303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65612927|NCT05438303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65612928|NCT05438303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65612929|NCT05438303|Anesthetics, General|anesthetics, general|mesh-ancestor
65612930|NCT05438303|Anesthetics|anesthetics|mesh-ancestor
65612931|NCT05438303|GABA Modulators|gaba modulators|mesh-ancestor
65612932|NCT05438303|GABA Agents|gaba agents|mesh-ancestor
65612933|NCT05438303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65612934|NCT05438303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612935|NCT05438303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65612936|NCT05438303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65612937|NCT05438303|Analgesics|analgesics|mesh-ancestor
65612938|NCT05438303|Sensory System Agents|sensory system agents|mesh-ancestor
65612939|NCT05438303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65612940|NCT05438303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65612941|NCT05438303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65612942|NCT05438303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65612943|NCT05438303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65612944|NCT05438303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612945|NCT05438303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65612946|NCT05438303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65612947|NCT05438303|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65612948|NCT05438303|Antithrombins|antithrombins|mesh-ancestor
65612949|NCT05438303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65612950|NCT05438303|Protease Inhibitors|protease inhibitors|mesh-ancestor
65612951|NCT05438303|Anticoagulants|anticoagulants|mesh-ancestor
65612952|NCT05432141|Vaccines|vaccines|mesh-list
65612953|NCT05432141|Immunologic Factors|immunologic factors|mesh-ancestor
65612954|NCT05432141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612955|NCT04956809|Dapagliflozin|dapagliflozin|mesh-list
65612956|NCT04956809|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65612957|NCT04956809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612958|NCT04956809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65612959|NCT04956809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612960|NCT04735913|Abiraterone Acetate|abiraterone acetate|mesh-list
65612961|NCT04735913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65612962|NCT04735913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65612963|NCT04735913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65612964|NCT04735913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410371|NCT00424593|Analgesics|analgesics|mesh-ancestor
65612965|NCT04735913|Hormone Antagonists|hormone antagonists|mesh-ancestor
65612966|NCT04735913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65612967|NCT04735913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612968|NCT04735913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65612969|NCT04906889|Lidocaine|lidocaine|mesh-list
65612970|NCT04906889|Dexmedetomidine|dexmedetomidine|mesh-list
65612971|NCT04906889|Remifentanil|remifentanil|mesh-list
65612972|NCT04906889|Anesthetics, Local|anesthetics, local|mesh-ancestor
65612973|NCT04906889|Anesthetics|anesthetics|mesh-ancestor
65612974|NCT04906889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65612975|NCT04906889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65612976|NCT04906889|Sensory System Agents|sensory system agents|mesh-ancestor
65612977|NCT04906889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65612978|NCT04906889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65612979|NCT04906889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65612980|NCT04906889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65612981|NCT04906889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65612982|NCT04906889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612983|NCT04906889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65612984|NCT04906889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65612985|NCT04906889|Analgesics|analgesics|mesh-ancestor
65612986|NCT04906889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65612987|NCT04906889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65612988|NCT04906889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65612989|NCT04906889|Adrenergic Agents|adrenergic agents|mesh-ancestor
65612990|NCT04906889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65612991|NCT04906889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65612992|NCT04906889|Narcotics|narcotics|mesh-ancestor
65612993|NCT02948777|Evolocumab|evolocumab|mesh-list
65612994|NCT02948777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65612995|NCT02948777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65612996|NCT02948777|Antimetabolites|antimetabolites|mesh-ancestor
65612997|NCT02948777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65612998|NCT02948777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65612999|NCT04868747|Lidocaine|lidocaine|mesh-list
65613000|NCT04868747|Anesthetics, Local|anesthetics, local|mesh-ancestor
65613001|NCT04868747|Anesthetics|anesthetics|mesh-ancestor
65613002|NCT04868747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65613003|NCT04868747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613004|NCT04868747|Sensory System Agents|sensory system agents|mesh-ancestor
65613005|NCT04868747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65613006|NCT04868747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65613007|NCT04868747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65613008|NCT04868747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65613009|NCT04868747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65613010|NCT04868747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613011|NCT05330273|Efavirenz|efavirenz|mesh-list
65613012|NCT05330273|Lumefantrine|lumefantrine|mesh-list
65613013|NCT05330273|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65613014|NCT05330273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65613015|NCT05330273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613016|NCT05330273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613017|NCT05330273|Antiviral Agents|antiviral agents|mesh-ancestor
65613018|NCT05330273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65613019|NCT05330273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65613020|NCT05330273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65613021|NCT05330273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65613022|NCT05330273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65613023|NCT05330273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65613024|NCT05330273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65613025|NCT05330273|Antimalarials|antimalarials|mesh-ancestor
65613026|NCT05330273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65613027|NCT05330273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65613028|NCT05329259|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65613029|NCT05329259|Immunologic Factors|immunologic factors|mesh-ancestor
65613030|NCT05329259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613031|NCT04533737|Brodalumab|brodalumab|mesh-list
65613032|NCT04533737|Dermatologic Agents|dermatologic agents|mesh-ancestor
65613033|NCT05254847|Capecitabine|capecitabine|mesh-list
65613034|NCT05254847|Lenvatinib|lenvatinib|mesh-list
65613035|NCT05254847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65613036|NCT05254847|Antimetabolites|antimetabolites|mesh-ancestor
65613037|NCT05254847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613038|NCT05254847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613039|NCT05254847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65613040|NCT05254847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613041|NCT05249699|Isoniazid|isoniazid|mesh-list
65613042|NCT05249699|Antitubercular Agents|antitubercular agents|mesh-list
65613043|NCT05249699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65613044|NCT05249699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65613045|NCT05249699|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65613046|NCT05249699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65613047|NCT05249699|Antimetabolites|antimetabolites|mesh-ancestor
65613048|NCT05249699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613049|NCT05249699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65613050|NCT04751669|Trace Elements|trace elements|mesh-list
65613051|NCT04751669|Micronutrients|micronutrients|mesh-list
65613052|NCT04751669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613053|NCT04731233|Triamcinolone|triamcinolone|mesh-list
65613054|NCT04731233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65613055|NCT04731233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65613056|NCT04731233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65613057|NCT04731233|Mitogens|mitogens|mesh-list
65613058|NCT04731233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65613059|NCT04731233|Glucocorticoids|glucocorticoids|mesh-ancestor
65613060|NCT04731233|Hormones|hormones|mesh-ancestor
65613061|NCT04731233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65613062|NCT04731233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613063|NCT04731233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65613064|NCT04731233|Immunologic Factors|immunologic factors|mesh-ancestor
65613065|NCT04731233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613066|NCT04731233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613067|NCT04731233|Mitosis Modulators|mitosis modulators|mesh-ancestor
65613068|NCT04417517|Azacitidine|azacitidine|mesh-list
65613069|NCT04417517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65613070|NCT04417517|Antimetabolites|antimetabolites|mesh-ancestor
65613071|NCT04417517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613072|NCT04417517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613073|NCT04417517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613074|NCT04695977|Nivolumab|nivolumab|mesh-list
65613075|NCT04695977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65613076|NCT04695977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613077|NCT04695977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65613078|NCT04695977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613079|NCT03093155|Bevacizumab|bevacizumab|mesh-list
65613080|NCT03093155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65613081|NCT03093155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613082|NCT03093155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65613083|NCT03093155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65613084|NCT03093155|Growth Substances|growth substances|mesh-ancestor
65613085|NCT03093155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613086|NCT03093155|Growth Inhibitors|growth inhibitors|mesh-ancestor
65613087|NCT03324581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65613088|NCT03324581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65613089|NCT03324581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65613090|NCT03324581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65613091|NCT03324581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613092|NCT03324581|Adrenergic Agents|adrenergic agents|mesh-ancestor
65613093|NCT03324581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65613094|NCT03324581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613095|NCT03629873|Cytarabine|cytarabine|mesh-list
65613096|NCT03629873|Cyclophosphamide|cyclophosphamide|mesh-list
65613097|NCT03629873|Carmustine|carmustine|mesh-list
65613098|NCT03629873|Etoposide|etoposide|mesh-list
65613099|NCT03629873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65613100|NCT03629873|Immunologic Factors|immunologic factors|mesh-ancestor
65613101|NCT03629873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613102|NCT03629873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65613103|NCT03629873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65613104|NCT03629873|Alkylating Agents|alkylating agents|mesh-ancestor
65613105|NCT03629873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613106|NCT03629873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613107|NCT03629873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65613108|NCT03629873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65613109|NCT03629873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65613110|NCT03629873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65613111|NCT03629873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613112|NCT03629873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65613114|NCT03629873|Antiviral Agents|antiviral agents|mesh-ancestor
65613115|NCT03629873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65613116|NCT04294043|Gallium nitrate|gallium nitrate|mesh-list
65613117|NCT04294043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65613118|NCT04294043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613119|NCT04294043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613120|NCT02899793|Pembrolizumab|pembrolizumab|mesh-list
65613121|NCT02899793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65613122|NCT02899793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613123|NCT04981145|Hydroxychloroquine|hydroxychloroquine|mesh-list
65613124|NCT04981145|Antimalarials|antimalarials|mesh-ancestor
65613125|NCT04981145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65613126|NCT04981145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65613127|NCT04981145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65613128|NCT04981145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613129|NCT04981145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613130|NCT04981145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65613131|NCT02864147|Imiquimod|imiquimod|mesh-list
65613132|NCT02864147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65613133|NCT02864147|Immunologic Factors|immunologic factors|mesh-ancestor
65613134|NCT02864147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613135|NCT02864147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613136|NCT02864147|Interferon Inducers|interferon inducers|mesh-ancestor
65613137|NCT04258631|Hydromorphone|hydromorphone|mesh-list
65613138|NCT04258631|Bupivacaine|bupivacaine|mesh-list
65613139|NCT04258631|Anesthetics, Local|anesthetics, local|mesh-ancestor
65613140|NCT04258631|Anesthetics|anesthetics|mesh-ancestor
65613141|NCT04258631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65613142|NCT04258631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613143|NCT04258631|Sensory System Agents|sensory system agents|mesh-ancestor
65613144|NCT04258631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65613145|NCT04258631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65613146|NCT04258631|Narcotics|narcotics|mesh-ancestor
65613147|NCT04258631|Analgesics|analgesics|mesh-ancestor
65613148|NCT02931695|Hormones|hormones|mesh-list
65613149|NCT02931695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65613150|NCT02931695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613151|NCT03638063|Adenosine|adenosine|mesh-list
65613152|NCT03638063|Capsaicin|capsaicin|mesh-list
65613153|NCT03638063|Antipruritics|antipruritics|mesh-ancestor
65613154|NCT03638063|Dermatologic Agents|dermatologic agents|mesh-ancestor
65613155|NCT03638063|Sensory System Agents|sensory system agents|mesh-ancestor
65613156|NCT03638063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65613157|NCT03638063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613158|NCT03638063|Analgesics|analgesics|mesh-ancestor
65613159|NCT03638063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65613160|NCT03638063|Vasodilator Agents|vasodilator agents|mesh-ancestor
65613161|NCT03638063|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65613162|NCT03638063|Purinergic Agonists|purinergic agonists|mesh-ancestor
65613163|NCT03638063|Purinergic Agents|purinergic agents|mesh-ancestor
65613164|NCT03638063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65613165|NCT03638063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613166|NCT04869371|Prednisone|prednisone|mesh-list
65613167|NCT04869371|Docetaxel|docetaxel|mesh-list
65613168|NCT04869371|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65613169|NCT04869371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613170|NCT04869371|Tubulin Modulators|tubulin modulators|mesh-ancestor
65613171|NCT04869371|Antimitotic Agents|antimitotic agents|mesh-ancestor
65613172|NCT04869371|Mitosis Modulators|mitosis modulators|mesh-ancestor
65613173|NCT04869371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613174|NCT04869371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65613175|NCT04869371|Glucocorticoids|glucocorticoids|mesh-ancestor
65613176|NCT04869371|Hormones|hormones|mesh-ancestor
65613177|NCT04869371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65613178|NCT04869371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613179|NCT04869371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65613180|NCT04869371|Luteolytic Agents|luteolytic agents|mesh-ancestor
65613181|NCT04869371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65613182|NCT04869371|Contraceptive Agents|contraceptive agents|mesh-ancestor
65613183|NCT04869371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65613184|NCT04869371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65613185|NCT02710331|Ethanol|ethanol|mesh-list
65613186|NCT02710331|Dronabinol|dronabinol|mesh-list
65613187|NCT02710331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65613188|NCT02710331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65613189|NCT02710331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65613190|NCT02710331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613191|NCT02710331|Hallucinogens|hallucinogens|mesh-ancestor
65613192|NCT02710331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65613193|NCT02710331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65613194|NCT02710331|Analgesics|analgesics|mesh-ancestor
65613195|NCT02710331|Sensory System Agents|sensory system agents|mesh-ancestor
65613196|NCT02710331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65613197|NCT02710331|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65613198|NCT02710331|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65613199|NCT02710331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65613200|NCT02710331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613202|NCT02710331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65613203|NCT02885753|Leucovorin|leucovorin|mesh-list
65613204|NCT02885753|Folic Acid|folic acid|mesh-list
65613205|NCT02885753|Bevacizumab|bevacizumab|mesh-list
65613206|NCT02885753|Panitumumab|panitumumab|mesh-list
65613207|NCT02885753|Oxaliplatin|oxaliplatin|mesh-list
65613208|NCT02885753|Irinotecan|irinotecan|mesh-list
65613209|NCT02885753|Fluorouracil|fluorouracil|mesh-list
65613210|NCT02885753|Levoleucovorin|levoleucovorin|mesh-list
65613211|NCT02885753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65613212|NCT02885753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613213|NCT02885753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65613214|NCT02885753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65613215|NCT02885753|Growth Substances|growth substances|mesh-ancestor
65613216|NCT02885753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613217|NCT02885753|Growth Inhibitors|growth inhibitors|mesh-ancestor
65613218|NCT02885753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65613219|NCT02885753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65613220|NCT02885753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613221|NCT02885753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613222|NCT02885753|Antimetabolites|antimetabolites|mesh-ancestor
65613223|NCT02885753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65613224|NCT02885753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65613225|NCT02885753|Immunologic Factors|immunologic factors|mesh-ancestor
65613226|NCT02885753|Antidotes|antidotes|mesh-ancestor
65613227|NCT02885753|Protective Agents|protective agents|mesh-ancestor
65613228|NCT02885753|Vitamin B Complex|vitamin b complex|mesh-ancestor
65613229|NCT02885753|Vitamins|vitamins|mesh-ancestor
65613230|NCT02885753|Micronutrients|micronutrients|mesh-ancestor
65613231|NCT02885753|Hematinics|hematinics|mesh-ancestor
65613232|NCT03320057|Mifepristone|mifepristone|mesh-list
65613233|NCT03320057|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65613234|NCT03320057|Abortifacient Agents|abortifacient agents|mesh-ancestor
65613235|NCT03320057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65613236|NCT03320057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613237|NCT03320057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65613238|NCT03320057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65613239|NCT03320057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65613240|NCT03320057|Contraceptive Agents|contraceptive agents|mesh-ancestor
65613241|NCT03320057|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65613242|NCT03320057|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65613243|NCT03320057|Hormone Antagonists|hormone antagonists|mesh-ancestor
65613244|NCT03320057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65613245|NCT03320057|Luteolytic Agents|luteolytic agents|mesh-ancestor
65076097|NCT00351507|Vildagliptin|vildagliptin|mesh-list
65613246|NCT03320057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65613247|NCT03320057|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65613248|NCT04741139|Acetaminophen|acetaminophen|mesh-list
65613249|NCT04741139|Diphenhydramine|diphenhydramine|mesh-list
65613250|NCT04741139|Promethazine|promethazine|mesh-list
65613251|NCT04741139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65613252|NCT04741139|Analgesics|analgesics|mesh-ancestor
65613253|NCT04741139|Sensory System Agents|sensory system agents|mesh-ancestor
65613254|NCT04741139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65613255|NCT04741139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613256|NCT04741139|Antipyretics|antipyretics|mesh-ancestor
65613257|NCT04741139|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65613258|NCT04741139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65613259|NCT04741139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65613260|NCT04741139|Anesthetics, Local|anesthetics, local|mesh-ancestor
65613261|NCT04741139|Anesthetics|anesthetics|mesh-ancestor
65613262|NCT04741139|Antiemetics|antiemetics|mesh-ancestor
65613263|NCT04741139|Autonomic Agents|autonomic agents|mesh-ancestor
65613264|NCT04741139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65613265|NCT04741139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65613266|NCT04741139|Histamine Antagonists|histamine antagonists|mesh-ancestor
65613267|NCT04741139|Histamine Agents|histamine agents|mesh-ancestor
65613268|NCT04741139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65613269|NCT04741139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613270|NCT04741139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65613271|NCT04741139|Antipruritics|antipruritics|mesh-ancestor
65613272|NCT04741139|Dermatologic Agents|dermatologic agents|mesh-ancestor
65613273|NCT02227199|Carboplatin|carboplatin|mesh-list
65613274|NCT02227199|Etoposide|etoposide|mesh-list
65613275|NCT02227199|Etoposide phosphate|etoposide phosphate|mesh-list
65613276|NCT02227199|Ifosfamide|ifosfamide|mesh-list
65613277|NCT02227199|Isophosphamide mustard|isophosphamide mustard|mesh-list
65613278|NCT02227199|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65613279|NCT02227199|Podophyllotoxin|podophyllotoxin|mesh-list
65613280|NCT02227199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65613281|NCT02227199|Antibodies|antibodies|mesh-list
65613282|NCT02227199|Immunoglobulins|immunoglobulins|mesh-list
65613283|NCT02227199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65613284|NCT02227199|Immunoconjugates|immunoconjugates|mesh-list
65613285|NCT02227199|Immunologic Factors|immunologic factors|mesh-ancestor
65613286|NCT02227199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613287|NCT02227199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613288|NCT02227199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65613289|NCT02227199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65613290|NCT02227199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65613291|NCT02227199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613292|NCT02227199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613293|NCT02227199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65613294|NCT02227199|Alkylating Agents|alkylating agents|mesh-ancestor
65613295|NCT02227199|Keratolytic Agents|keratolytic agents|mesh-ancestor
65613296|NCT02227199|Dermatologic Agents|dermatologic agents|mesh-ancestor
65613297|NCT02227199|Tubulin Modulators|tubulin modulators|mesh-ancestor
65613298|NCT02227199|Antimitotic Agents|antimitotic agents|mesh-ancestor
65613299|NCT02227199|Mitosis Modulators|mitosis modulators|mesh-ancestor
65613300|NCT04853147|Dexamethasone|dexamethasone|mesh-list
65613301|NCT04853147|Dexamethasone acetate|dexamethasone acetate|mesh-list
65613302|NCT04853147|Palonosetron|palonosetron|mesh-list
65613303|NCT04853147|Fosaprepitant|fosaprepitant|mesh-list
65613304|NCT04853147|Aprepitant|aprepitant|mesh-list
65613305|NCT04853147|BB 1101|bb 1101|mesh-list
65613306|NCT04853147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65613307|NCT04853147|Antiemetics|antiemetics|mesh-ancestor
65613308|NCT04853147|Autonomic Agents|autonomic agents|mesh-ancestor
65613309|NCT04853147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65613310|NCT04853147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613311|NCT04853147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65613312|NCT04853147|Glucocorticoids|glucocorticoids|mesh-ancestor
65613313|NCT04853147|Hormones|hormones|mesh-ancestor
65613314|NCT04853147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65613315|NCT04853147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65613316|NCT04853147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613317|NCT04853147|Protease Inhibitors|protease inhibitors|mesh-ancestor
65613318|NCT04853147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613319|NCT04853147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613320|NCT04853147|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65613321|NCT04853147|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65613322|NCT04853147|Serotonin Agents|serotonin agents|mesh-ancestor
65613323|NCT04853147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65613324|NCT04853147|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65613325|NCT03473561|Racecadotril|racecadotril|mesh-list
65613326|NCT03473561|Antidiarrheals|antidiarrheals|mesh-ancestor
65613327|NCT03473561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65613328|NCT03473561|Protease Inhibitors|protease inhibitors|mesh-ancestor
65613329|NCT03473561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613330|NCT03473561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613331|NCT04689347|Leucovorin|leucovorin|mesh-list
65613332|NCT04689347|Bevacizumab|bevacizumab|mesh-list
65613333|NCT04689347|Fluorouracil|fluorouracil|mesh-list
65613334|NCT04689347|Irinotecan|irinotecan|mesh-list
65613335|NCT04689347|Temozolomide|temozolomide|mesh-list
65613336|NCT04689347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65613337|NCT04689347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410736|NCT01002690|Etoricoxib|etoricoxib|mesh-list
65613338|NCT04689347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65613339|NCT04689347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65613340|NCT04689347|Growth Substances|growth substances|mesh-ancestor
65613341|NCT04689347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613343|NCT04689347|Antimetabolites|antimetabolites|mesh-ancestor
65613344|NCT04689347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613345|NCT04689347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65613346|NCT04689347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65613347|NCT04689347|Immunologic Factors|immunologic factors|mesh-ancestor
65613348|NCT04689347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65613349|NCT04689347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65613350|NCT04689347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613351|NCT04689347|Antidotes|antidotes|mesh-ancestor
65613352|NCT04689347|Protective Agents|protective agents|mesh-ancestor
65613353|NCT04689347|Vitamin B Complex|vitamin b complex|mesh-ancestor
65613354|NCT04689347|Vitamins|vitamins|mesh-ancestor
65613355|NCT04689347|Micronutrients|micronutrients|mesh-ancestor
65613356|NCT04689347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65613357|NCT04689347|Alkylating Agents|alkylating agents|mesh-ancestor
65613358|NCT03313037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65613359|NCT03313037|Immunologic Factors|immunologic factors|mesh-ancestor
65613360|NCT03313037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613361|NCT01268579|Ribavirin|ribavirin|mesh-list
65613362|NCT01268579|Antimetabolites|antimetabolites|mesh-ancestor
65613363|NCT01268579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613364|NCT01268579|Antiviral Agents|antiviral agents|mesh-ancestor
65613365|NCT01268579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65613366|NCT02420795|TIC10 compound|tic10 compound|mesh-list
65613367|NCT02420795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613368|NCT02384759|Aflibercept|aflibercept|mesh-list
65613369|NCT02384759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65613370|NCT02384759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65613371|NCT02384759|Growth Substances|growth substances|mesh-ancestor
65613372|NCT02384759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613373|NCT02384759|Growth Inhibitors|growth inhibitors|mesh-ancestor
65613374|NCT02384759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613375|NCT05276687|Vancomycin|vancomycin|mesh-list
65613376|NCT05276687|Povidone-Iodine|povidone-iodine|mesh-list
65613377|NCT05276687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65613378|NCT05276687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65613379|NCT05276687|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65613380|NCT03036150|Dapagliflozin|dapagliflozin|mesh-list
65613381|NCT03036150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65613382|NCT03036150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613383|NCT03036150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65613384|NCT03036150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613385|NCT03332771|Metformin|metformin|mesh-list
65613386|NCT03332771|Glimepiride|glimepiride|mesh-list
65613387|NCT03332771|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65613388|NCT03332771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65613389|NCT03332771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613390|NCT03332771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65613391|NCT03332771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65613392|NCT03332771|Immunologic Factors|immunologic factors|mesh-ancestor
65613393|NCT03332771|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65613394|NCT03332771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613395|NCT03625830|Paclitaxel|paclitaxel|mesh-list
65613396|NCT03625830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65613397|NCT03625830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613398|NCT03625830|Tubulin Modulators|tubulin modulators|mesh-ancestor
65613399|NCT03625830|Antimitotic Agents|antimitotic agents|mesh-ancestor
65613400|NCT03625830|Mitosis Modulators|mitosis modulators|mesh-ancestor
65613401|NCT03625830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613402|NCT04108104|Cyproheptadine|cyproheptadine|mesh-list
65613403|NCT04108104|Prazosin|prazosin|mesh-list
65613404|NCT04108104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65613405|NCT04108104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65613406|NCT04108104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65613407|NCT04108104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65613408|NCT04108104|Adrenergic Agents|adrenergic agents|mesh-ancestor
65613409|NCT04108104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65613410|NCT04108104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613411|NCT04108104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613412|NCT04108104|Antipruritics|antipruritics|mesh-ancestor
65613413|NCT04108104|Dermatologic Agents|dermatologic agents|mesh-ancestor
65613414|NCT04108104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65613416|NCT04108104|Histamine Antagonists|histamine antagonists|mesh-ancestor
65613417|NCT04108104|Histamine Agents|histamine agents|mesh-ancestor
65613418|NCT04108104|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65613419|NCT04108104|Serotonin Agents|serotonin agents|mesh-ancestor
65613420|NCT04108104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65613421|NCT05304468|Cisplatin|cisplatin|mesh-list
65613422|NCT05304468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613423|NCT04731480|Propofol|propofol|mesh-list
65613424|NCT04731480|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65613425|NCT04731480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65613426|NCT04731480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613427|NCT04731480|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65613428|NCT04731480|Anesthetics, General|anesthetics, general|mesh-ancestor
65613429|NCT04731480|Anesthetics|anesthetics|mesh-ancestor
65613430|NCT03039192|Esketamine|esketamine|mesh-list
65613431|NCT03039192|Antidepressive Agents|antidepressive agents|mesh-ancestor
65613432|NCT03039192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65613433|NCT03698279|Vaccines|vaccines|mesh-list
65613434|NCT03698279|Immunologic Factors|immunologic factors|mesh-ancestor
65613435|NCT03698279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613436|NCT03038880|Ranibizumab|ranibizumab|mesh-list
65613437|NCT03038880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65613438|NCT03038880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65613439|NCT03038880|Growth Substances|growth substances|mesh-ancestor
65613440|NCT03038880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613441|NCT03038880|Growth Inhibitors|growth inhibitors|mesh-ancestor
65613442|NCT03038880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613443|NCT05211336|Prednisone|prednisone|mesh-list
65613444|NCT05211336|Lenalidomide|lenalidomide|mesh-list
65613445|NCT05211336|Venetoclax|venetoclax|mesh-list
65613446|NCT05211336|Obinutuzumab|obinutuzumab|mesh-list
65613447|NCT05211336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65613448|NCT05211336|Glucocorticoids|glucocorticoids|mesh-ancestor
65613449|NCT05211336|Hormones|hormones|mesh-ancestor
65613450|NCT05211336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65613451|NCT05211336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613452|NCT05211336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65613453|NCT05211336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613454|NCT05211336|Immunologic Factors|immunologic factors|mesh-ancestor
65613455|NCT05211336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65613456|NCT05211336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65613457|NCT05211336|Growth Substances|growth substances|mesh-ancestor
65613458|NCT05211336|Growth Inhibitors|growth inhibitors|mesh-ancestor
65613459|NCT05211336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65613460|NCT03035916|Anesthetics|anesthetics|mesh-list
65613461|NCT03035916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65613462|NCT03035916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613463|NCT01702571|Trastuzumab|trastuzumab|mesh-list
65613464|NCT01702571|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65613465|NCT01702571|Maytansine|maytansine|mesh-list
65613466|NCT01702571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65613467|NCT01702571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613468|NCT01702571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65613469|NCT01702571|Tubulin Modulators|tubulin modulators|mesh-ancestor
65613470|NCT01702571|Antimitotic Agents|antimitotic agents|mesh-ancestor
65613471|NCT01702571|Mitosis Modulators|mitosis modulators|mesh-ancestor
65613472|NCT01702571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613473|NCT01578239|Octreotide|octreotide|mesh-list
65613474|NCT01578239|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65613475|NCT01578239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65613476|NCT01578239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65613477|NCT01578239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613478|NCT01578239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65613479|NCT01578239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613480|NCT05274893|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65613481|NCT05274893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613482|NCT03231709|Alogliptin|alogliptin|mesh-list
65613483|NCT03231709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65613484|NCT03231709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613485|NCT03231709|Incretins|incretins|mesh-ancestor
65613486|NCT03231709|Hormones|hormones|mesh-ancestor
65613487|NCT03231709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65613488|NCT03231709|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65613489|NCT03231709|Protease Inhibitors|protease inhibitors|mesh-ancestor
65613490|NCT03231709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613491|NCT03231709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613492|NCT01220531|Cyclosporine|cyclosporine|mesh-list
65613493|NCT01220531|Mycophenolic Acid|mycophenolic acid|mesh-list
65613494|NCT01220531|Methylprednisolone|methylprednisolone|mesh-list
65613495|NCT01220531|Prednisolone|prednisolone|mesh-list
65613496|NCT01220531|Tacrolimus|tacrolimus|mesh-list
65613497|NCT01220531|Cyclosporins|cyclosporins|mesh-list
65613498|NCT01220531|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65613499|NCT01220531|Thymoglobulin|thymoglobulin|mesh-list
65613500|NCT01220531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65613501|NCT01220531|Immunologic Factors|immunologic factors|mesh-ancestor
65613502|NCT01220531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613503|NCT01220531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65613504|NCT01220531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613505|NCT01220531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613506|NCT01220531|Antifungal Agents|antifungal agents|mesh-ancestor
65613507|NCT01220531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65613508|NCT01220531|Dermatologic Agents|dermatologic agents|mesh-ancestor
65613509|NCT01220531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65613510|NCT01220531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65613511|NCT01220531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613512|NCT01220531|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65613513|NCT01220531|Antitubercular Agents|antitubercular agents|mesh-ancestor
65613514|NCT01220531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65613515|NCT01220531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65613516|NCT01220531|Antiemetics|antiemetics|mesh-ancestor
65613517|NCT01220531|Autonomic Agents|autonomic agents|mesh-ancestor
65613518|NCT01220531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65613519|NCT01220531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65613520|NCT01220531|Glucocorticoids|glucocorticoids|mesh-ancestor
65613521|NCT01220531|Hormones|hormones|mesh-ancestor
65613522|NCT01220531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65613523|NCT01220531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65613524|NCT01220531|Protective Agents|protective agents|mesh-ancestor
65613525|NCT01220531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65613526|NCT05255471|Olaparib|olaparib|mesh-list
65613527|NCT05255471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65613528|NCT05255471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613529|NCT05255471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613530|NCT05255471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613531|NCT03241927|Pembrolizumab|pembrolizumab|mesh-list
65613532|NCT03241927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65613533|NCT03241927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613534|NCT02941523|Carboplatin|carboplatin|mesh-list
65613535|NCT02941523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613536|NCT00360425|Moxifloxacin|moxifloxacin|mesh-list
65613537|NCT00360425|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65613538|NCT00360425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65613539|NCT00360425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65613540|NCT00360425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65613541|NCT00360425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65613542|NCT00360425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613543|NCT00360425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613544|NCT00360425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613545|NCT00360425|Hematinics|hematinics|mesh-ancestor
65613546|NCT00360425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65613547|NCT00360425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65613548|NCT02938585|Factor VIII|factor viii|mesh-list
65613549|NCT02938585|Coagulants|coagulants|mesh-ancestor
65613550|NCT00233597|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65613551|NCT00233597|Hematinics|hematinics|mesh-ancestor
65613552|NCT00233597|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65613553|NCT00233597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65613554|NCT04282811|Venetoclax|venetoclax|mesh-list
65613555|NCT04282811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613556|NCT03229759|Octenidine|octenidine|mesh-list
65613557|NCT03229759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65613558|NCT03229759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65613559|NCT03476681|Pembrolizumab|pembrolizumab|mesh-list
65613560|NCT03476681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65613561|NCT03476681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613562|NCT03620825|Indomethacin|indomethacin|mesh-list
65613563|NCT03620825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65613564|NCT03620825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65613565|NCT03620825|Analgesics|analgesics|mesh-ancestor
65613566|NCT03620825|Sensory System Agents|sensory system agents|mesh-ancestor
65613567|NCT03620825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65613568|NCT03620825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613569|NCT03620825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65613570|NCT03620825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65613571|NCT03620825|Gout Suppressants|gout suppressants|mesh-ancestor
65613572|NCT03620825|Tocolytic Agents|tocolytic agents|mesh-ancestor
65613573|NCT03620825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65613574|NCT03620825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65613575|NCT03620825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613576|NCT03620825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613577|NCT03527537|Insulin|insulin|mesh-list
65613578|NCT03527537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65613579|NCT03527537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613580|NCT01496118|Panobinostat|panobinostat|mesh-list
65613581|NCT01496118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613582|NCT01496118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65613583|NCT01496118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613584|NCT01496118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613585|NCT04544280|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65613586|NCT04544280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65613587|NCT04544280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65613588|NCT04544280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613589|NCT04544280|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65613590|NCT04544280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65613591|NCT04544280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613592|NCT04544280|Cholinergic Agents|cholinergic agents|mesh-ancestor
65613593|NCT04544280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65613594|NCT05014776|Pembrolizumab|pembrolizumab|mesh-list
65613595|NCT05014776|Ipilimumab|ipilimumab|mesh-list
65613596|NCT05014776|Tadalafil|tadalafil|mesh-list
65613597|NCT05014776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65613598|NCT05014776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613599|NCT05014776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65613600|NCT05014776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613601|NCT05014776|Vasodilator Agents|vasodilator agents|mesh-ancestor
65613602|NCT05014776|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65613603|NCT05014776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65613604|NCT05014776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613605|NCT05014776|Urological Agents|urological agents|mesh-ancestor
65613606|NCT03329573|Paroxetine|paroxetine|mesh-list
65613607|NCT03329573|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65613608|NCT03329573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65613609|NCT03329573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65613610|NCT03329573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613611|NCT03329573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65613612|NCT03329573|Serotonin Agents|serotonin agents|mesh-ancestor
65613613|NCT03329573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613614|NCT03329573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65613615|NCT03329573|Antidepressive Agents|antidepressive agents|mesh-ancestor
65613616|NCT03329573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65613617|NCT03329573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65613618|NCT03329573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65613619|NCT03329573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613620|NCT00492349|Varenicline|varenicline|mesh-list
65613621|NCT00492349|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65613622|NCT00492349|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65613623|NCT00492349|Cholinergic Agents|cholinergic agents|mesh-ancestor
65613624|NCT00492349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65613625|NCT00492349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613626|NCT00492349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613627|NCT03924193|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65613628|NCT03924193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65613629|NCT03924193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613630|NCT03924193|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65613631|NCT03924193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65613632|NCT03924193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65613633|NCT03924193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613634|NCT03924193|Dopamine Agents|dopamine agents|mesh-ancestor
65613635|NCT03924193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65613636|NCT03308825|Vaccines|vaccines|mesh-list
65613637|NCT03308825|Immunologic Factors|immunologic factors|mesh-ancestor
65613638|NCT03308825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613639|NCT04235855|Liver Extracts|liver extracts|mesh-list
65613640|NCT04235855|Hematinics|hematinics|mesh-ancestor
65613641|NCT03328325|Vaccines|vaccines|mesh-list
65613642|NCT03328325|Immunologic Factors|immunologic factors|mesh-ancestor
65613643|NCT03328325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613644|NCT03476603|Irbesartan|irbesartan|mesh-list
65613645|NCT03476603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65613646|NCT03476603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65613647|NCT03476603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65613648|NCT03476603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613649|NCT03476525|Fluoxetine|fluoxetine|mesh-list
65613650|NCT03476525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65613651|NCT03476525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65613652|NCT03476525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65613653|NCT03476525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613654|NCT03476525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65613655|NCT03476525|Serotonin Agents|serotonin agents|mesh-ancestor
65613656|NCT03476525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613657|NCT03476525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65613658|NCT03476525|Antidepressive Agents|antidepressive agents|mesh-ancestor
65613659|NCT03476525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65613660|NCT03476525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65613661|NCT03476525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65613662|NCT03476525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613663|NCT05039489|Antipsychotic Agents|antipsychotic agents|mesh-list
65613664|NCT05039489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65613665|NCT05039489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65613666|NCT05039489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613667|NCT05039489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65613668|NCT03226249|Deoxyglucose|deoxyglucose|mesh-list
65613669|NCT03226249|Doxorubicin|doxorubicin|mesh-list
65613670|NCT03226249|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65613671|NCT03226249|Pembrolizumab|pembrolizumab|mesh-list
65613672|NCT03226249|Dacarbazine|dacarbazine|mesh-list
65613673|NCT03226249|Vinblastine|vinblastine|mesh-list
65613674|NCT03226249|Imidazole|imidazole|mesh-list
65613675|NCT03226249|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65613676|NCT03226249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65613677|NCT03226249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613678|NCT03226249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65613679|NCT03226249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65613680|NCT03226249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613681|NCT03226249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613682|NCT03226249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65613683|NCT03226249|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65613684|NCT03226249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65266428|NCT02766764|Hormones|hormones|mesh-list
65613685|NCT03226249|Alkylating Agents|alkylating agents|mesh-ancestor
65613686|NCT03226249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65613687|NCT03226249|Tubulin Modulators|tubulin modulators|mesh-ancestor
65613688|NCT03226249|Antimitotic Agents|antimitotic agents|mesh-ancestor
65613689|NCT03226249|Mitosis Modulators|mitosis modulators|mesh-ancestor
65613690|NCT03226249|Antimetabolites|antimetabolites|mesh-ancestor
65613691|NCT03226249|Antiviral Agents|antiviral agents|mesh-ancestor
65613692|NCT03226249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65613693|NCT03665545|Poly I-C|poly i-c|mesh-list
65613694|NCT03665545|Pembrolizumab|pembrolizumab|mesh-list
65613695|NCT03665545|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65613696|NCT03665545|Poly ICLC|poly iclc|mesh-list
65613697|NCT03665545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65613698|NCT03665545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613699|NCT03665545|Interferon Inducers|interferon inducers|mesh-ancestor
65613700|NCT03665545|Immunologic Factors|immunologic factors|mesh-ancestor
65613701|NCT03665545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613702|NCT03665545|Laxatives|laxatives|mesh-ancestor
65613703|NCT03665545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65613704|NCT03665545|Antiviral Agents|antiviral agents|mesh-ancestor
65613705|NCT03665545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65613706|NCT03305081|Copper|copper|mesh-list
65613707|NCT03305081|Levonorgestrel|levonorgestrel|mesh-list
65613708|NCT03305081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65613709|NCT03305081|Contraceptive Agents|contraceptive agents|mesh-ancestor
65613710|NCT03305081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65613711|NCT03305081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613712|NCT03305081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65613713|NCT03305081|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65613714|NCT03305081|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65411112|NCT00423735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613715|NCT03305081|Trace Elements|trace elements|mesh-ancestor
65613716|NCT03305081|Micronutrients|micronutrients|mesh-ancestor
65613717|NCT04079881|Insulin|insulin|mesh-list
65613718|NCT04079881|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65613719|NCT04079881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65613720|NCT04079881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613721|NCT03223909|Hyaluronic Acid|hyaluronic acid|mesh-list
65613722|NCT03223909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65613723|NCT03223909|Immunologic Factors|immunologic factors|mesh-ancestor
65613724|NCT03223909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613725|NCT03223909|Viscosupplements|viscosupplements|mesh-ancestor
65613726|NCT03223909|Protective Agents|protective agents|mesh-ancestor
65613727|NCT03733925|Golimumab|golimumab|mesh-list
65613728|NCT03733925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65613729|NCT03733925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65613730|NCT03733925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65613731|NCT03733925|Immunologic Factors|immunologic factors|mesh-ancestor
65613732|NCT03733925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613733|NCT03649711|Aspirin|aspirin|mesh-list
65613734|NCT03649711|Clopidogrel|clopidogrel|mesh-list
65613735|NCT03649711|Ticagrelor|ticagrelor|mesh-list
65613736|NCT03649711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65613737|NCT03649711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65613738|NCT03649711|Analgesics|analgesics|mesh-ancestor
65613739|NCT03649711|Sensory System Agents|sensory system agents|mesh-ancestor
65613740|NCT03649711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65613741|NCT03649711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613742|NCT03649711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65613743|NCT03649711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65613744|NCT03649711|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65613745|NCT03649711|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65613746|NCT03649711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613747|NCT03649711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65613748|NCT03649711|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65613749|NCT03649711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613750|NCT03649711|Antipyretics|antipyretics|mesh-ancestor
65613751|NCT03649711|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65613752|NCT03649711|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65613753|NCT03649711|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65613754|NCT03649711|Purinergic Agents|purinergic agents|mesh-ancestor
65613755|NCT03649711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65613756|NCT03897673|Iron|iron|mesh-list
65613757|NCT03897673|Trace Elements|trace elements|mesh-ancestor
65613758|NCT03897673|Micronutrients|micronutrients|mesh-ancestor
65613759|NCT03897673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613760|NCT03273257|Riociguat|riociguat|mesh-list
65613761|NCT03273257|Enzyme Activators|enzyme activators|mesh-ancestor
65613762|NCT03273257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613763|NCT02553473|Doxycycline|doxycycline|mesh-list
65613764|NCT02553473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65613765|NCT02553473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65613766|NCT02553473|Antimalarials|antimalarials|mesh-ancestor
65613767|NCT02553473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65613768|NCT02553473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65613769|NCT04270877|Naltrexone|naltrexone|mesh-list
65613770|NCT04270877|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65613771|NCT04270877|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65613772|NCT04270877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613773|NCT04270877|Sensory System Agents|sensory system agents|mesh-ancestor
65613774|NCT04270877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65613775|NCT03271151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65613776|NCT03271151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65613777|NCT03271151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65613778|NCT03271151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65613779|NCT03271151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613780|NCT03271151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65613781|NCT03271151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613782|NCT03271151|Analgesics|analgesics|mesh-ancestor
65613783|NCT03271151|Sensory System Agents|sensory system agents|mesh-ancestor
65613784|NCT03271151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65613785|NCT03271151|Antidepressive Agents|antidepressive agents|mesh-ancestor
65613786|NCT03271151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65613787|NCT03271151|Dopamine Agents|dopamine agents|mesh-ancestor
65613788|NCT04237649|Spartalizumab|spartalizumab|mesh-list
65613789|NCT04237649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65613790|NCT04237649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613791|NCT04237649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613792|NCT03301649|Ivermectin|ivermectin|mesh-list
65613793|NCT03301649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65613794|NCT03301649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65613795|NCT01144416|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65613796|NCT01144416|Hormones|hormones|mesh-ancestor
65613797|NCT01144416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65613798|NCT01144416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613799|NCT00335777|Dihydroergotamine|dihydroergotamine|mesh-list
65613800|NCT00335777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65613801|NCT00335777|Dopamine Agonists|dopamine agonists|mesh-ancestor
65613802|NCT00335777|Dopamine Agents|dopamine agents|mesh-ancestor
65613803|NCT00335777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65613804|NCT00335777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613805|NCT00335777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613806|NCT00335777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65613807|NCT00335777|Analgesics|analgesics|mesh-ancestor
65613808|NCT00335777|Sensory System Agents|sensory system agents|mesh-ancestor
65613809|NCT00335777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65613810|NCT03764137|Panitumumab|panitumumab|mesh-list
65613811|NCT03764137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65613812|NCT03764137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613813|NCT02889809|Fluticasone|fluticasone|mesh-list
65613814|NCT02889809|Xhance|xhance|mesh-list
65613815|NCT02889809|Montelukast|montelukast|mesh-list
65613816|NCT02889809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65613817|NCT02889809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65613818|NCT02889809|Autonomic Agents|autonomic agents|mesh-ancestor
65613819|NCT02889809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65613820|NCT02889809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613821|NCT02889809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65613822|NCT02889809|Respiratory System Agents|respiratory system agents|mesh-ancestor
65613823|NCT02889809|Dermatologic Agents|dermatologic agents|mesh-ancestor
65613824|NCT02889809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65613825|NCT02889809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65613826|NCT02889809|Hormone Antagonists|hormone antagonists|mesh-ancestor
65613827|NCT02889809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65613828|NCT02889809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65613829|NCT02889809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65613830|NCT02889809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613831|NCT03625518|Oxytocin|oxytocin|mesh-list
65613832|NCT03625518|Dinoprostone|dinoprostone|mesh-list
65613833|NCT03625518|Oxytocics|oxytocics|mesh-ancestor
65613834|NCT03625518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65613835|NCT03625518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613836|NCT00972738|Loratadine|loratadine|mesh-list
65613837|NCT00972738|Montelukast|montelukast|mesh-list
65613838|NCT00972738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65613839|NCT00972738|Respiratory System Agents|respiratory system agents|mesh-ancestor
65613840|NCT00972738|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65613841|NCT00972738|Hormone Antagonists|hormone antagonists|mesh-ancestor
65613842|NCT00972738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65613843|NCT00972738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613844|NCT00972738|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65613845|NCT00972738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65613846|NCT00972738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613847|NCT00972738|Antipruritics|antipruritics|mesh-ancestor
65613848|NCT00972738|Dermatologic Agents|dermatologic agents|mesh-ancestor
65613849|NCT00972738|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65613850|NCT00972738|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65613851|NCT00972738|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65613852|NCT00972738|Histamine Antagonists|histamine antagonists|mesh-ancestor
65613853|NCT00972738|Histamine Agents|histamine agents|mesh-ancestor
65613854|NCT00972738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65613855|NCT03452839|Meropenem|meropenem|mesh-list
65613856|NCT03452839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65613857|NCT03452839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65613858|NCT04701281|Capecitabine|capecitabine|mesh-list
65613859|NCT04701281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65613860|NCT04701281|Antimetabolites|antimetabolites|mesh-ancestor
65613861|NCT04701281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613862|NCT04701281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613863|NCT03882918|Gaboxadol|gaboxadol|mesh-list
65613864|NCT03882918|Analgesics|analgesics|mesh-ancestor
65411279|NCT03742336|Dabigatran|dabigatran|mesh-list
65613865|NCT03882918|Sensory System Agents|sensory system agents|mesh-ancestor
65613866|NCT03882918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65613867|NCT03882918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613868|NCT03882918|Anticonvulsants|anticonvulsants|mesh-ancestor
65613869|NCT03882918|GABA Agonists|gaba agonists|mesh-ancestor
65613870|NCT03882918|GABA Agents|gaba agents|mesh-ancestor
65613871|NCT03882918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65613872|NCT03882918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613873|NCT04180397|Furosemide|furosemide|mesh-list
65613874|NCT04180397|Diuretics|diuretics|mesh-ancestor
65613875|NCT04180397|Natriuretic Agents|natriuretic agents|mesh-ancestor
65613876|NCT04180397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613877|NCT04180397|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65613878|NCT04180397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65613879|NCT04180397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613880|NCT04174859|Rivaroxaban|rivaroxaban|mesh-list
65613881|NCT04174859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65613882|NCT04174859|Antithrombins|antithrombins|mesh-ancestor
65613883|NCT04174859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65613884|NCT04174859|Protease Inhibitors|protease inhibitors|mesh-ancestor
65613885|NCT04174859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613886|NCT04174859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613887|NCT04174859|Anticoagulants|anticoagulants|mesh-ancestor
65613888|NCT03295721|Bupivacaine|bupivacaine|mesh-list
65613889|NCT03295721|Anesthetics, Local|anesthetics, local|mesh-ancestor
65613890|NCT03295721|Anesthetics|anesthetics|mesh-ancestor
65613891|NCT03295721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65613892|NCT03295721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613893|NCT03295721|Sensory System Agents|sensory system agents|mesh-ancestor
65613894|NCT03295721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65613895|NCT00803790|Vitamin D|vitamin d|mesh-list
65613896|NCT00803790|Ergocalciferols|ergocalciferols|mesh-list
65613897|NCT00803790|Cholecalciferol|cholecalciferol|mesh-list
65613898|NCT00803790|Alendronate|alendronate|mesh-list
65613899|NCT00803790|Vitamins|vitamins|mesh-list
65613900|NCT00803790|Micronutrients|micronutrients|mesh-ancestor
65613901|NCT00803790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613902|NCT00803790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65613903|NCT00803790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65613904|NCT00442338|Aminophylline|aminophylline|mesh-list
65613905|NCT00442338|Theophylline|theophylline|mesh-list
65613906|NCT00442338|Montelukast|montelukast|mesh-list
65613907|NCT00442338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65613908|NCT00442338|Respiratory System Agents|respiratory system agents|mesh-ancestor
65613909|NCT00442338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65613910|NCT00442338|Hormone Antagonists|hormone antagonists|mesh-ancestor
65613911|NCT00442338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65613912|NCT00442338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613913|NCT00442338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65613914|NCT00442338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65613915|NCT00442338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613916|NCT00442338|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65613917|NCT00442338|Autonomic Agents|autonomic agents|mesh-ancestor
65613918|NCT00442338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65613919|NCT00442338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65613920|NCT00442338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65613921|NCT00442338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613922|NCT00442338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65613923|NCT00442338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65613924|NCT00442338|Purinergic Agents|purinergic agents|mesh-ancestor
65613925|NCT00442338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65613926|NCT00442338|Protective Agents|protective agents|mesh-ancestor
65613927|NCT00442338|Vasodilator Agents|vasodilator agents|mesh-ancestor
65613928|NCT03506412|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65613929|NCT03506412|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65613930|NCT03506412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613931|NCT02316834|Talazoparib|talazoparib|mesh-list
65613932|NCT02316834|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65613933|NCT02316834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613934|NCT02316834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613935|NCT02316834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613936|NCT02975934|Docetaxel|docetaxel|mesh-list
65613937|NCT02975934|Abiraterone Acetate|abiraterone acetate|mesh-list
65613938|NCT02975934|Rucaparib|rucaparib|mesh-list
65613939|NCT02975934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613940|NCT02975934|Tubulin Modulators|tubulin modulators|mesh-ancestor
65613941|NCT02975934|Antimitotic Agents|antimitotic agents|mesh-ancestor
65613942|NCT02975934|Mitosis Modulators|mitosis modulators|mesh-ancestor
65613943|NCT02975934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613944|NCT02975934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65613945|NCT02975934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613946|NCT02975934|Hormone Antagonists|hormone antagonists|mesh-ancestor
65613947|NCT02975934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65613948|NCT02975934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613949|NCT02975934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65613950|NCT02975934|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65613951|NCT02879136|Methylphenidate|methylphenidate|mesh-list
65613952|NCT02879136|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65613953|NCT02879136|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65613954|NCT02879136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613955|NCT02879136|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65613956|NCT02879136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65613957|NCT02879136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65613958|NCT02879136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613959|NCT02879136|Dopamine Agents|dopamine agents|mesh-ancestor
65613960|NCT02879136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65613961|NCT02879136|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65613962|NCT02879136|Adrenergic Agents|adrenergic agents|mesh-ancestor
65613963|NCT00250458|Rizatriptan|rizatriptan|mesh-list
65613964|NCT00250458|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65613965|NCT00250458|Serotonin Agents|serotonin agents|mesh-ancestor
65613966|NCT00250458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65613967|NCT00250458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613968|NCT00250458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613969|NCT01965132|Adalimumab|adalimumab|mesh-list
65613970|NCT01965132|Etanercept|etanercept|mesh-list
65613971|NCT01965132|Golimumab|golimumab|mesh-list
65613972|NCT01965132|Abatacept|abatacept|mesh-list
65613973|NCT01965132|Infliximab|infliximab|mesh-list
65613974|NCT01965132|Upadacitinib|upadacitinib|mesh-list
65613975|NCT01965132|Ustekinumab|ustekinumab|mesh-list
65613976|NCT01965132|Ixekizumab|ixekizumab|mesh-list
65613977|NCT01965132|Tofacitinib|tofacitinib|mesh-list
65613978|NCT01965132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613979|NCT01965132|Immunologic Factors|immunologic factors|mesh-ancestor
65613980|NCT01965132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65613981|NCT01965132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65613982|NCT01965132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65613983|NCT01965132|Dermatologic Agents|dermatologic agents|mesh-ancestor
65613984|NCT01965132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65613985|NCT01965132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65613986|NCT01965132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65613987|NCT01965132|Analgesics|analgesics|mesh-ancestor
65613988|NCT01965132|Sensory System Agents|sensory system agents|mesh-ancestor
65613989|NCT01965132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65613990|NCT01965132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65613991|NCT01965132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65613992|NCT01965132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65613993|NCT01965132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65613994|NCT01965132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65613995|NCT01965132|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65613996|NCT01965132|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65613997|NCT01667133|Ponatinib|ponatinib|mesh-list
65613998|NCT01667133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65613999|NCT01667133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65614000|NCT01667133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614001|NCT01667133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614002|NCT01891344|Rucaparib|rucaparib|mesh-list
65614003|NCT01891344|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65614004|NCT01891344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614005|NCT01891344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614006|NCT01891344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614007|NCT01498770|Olanzapine|olanzapine|mesh-list
65614008|NCT01498770|Risperidone|risperidone|mesh-list
65614009|NCT01498770|Aripiprazole|aripiprazole|mesh-list
65614010|NCT01498770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65614011|NCT01498770|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65614012|NCT01498770|Ziprasidone|ziprasidone|mesh-list
65614013|NCT01498770|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65614015|NCT01498770|Asenapine|asenapine|mesh-list
65614016|NCT01498770|Amisulpride|amisulpride|mesh-list
65614017|NCT01498770|Iloperidone|iloperidone|mesh-list
65614018|NCT01498770|Sertindole|sertindole|mesh-list
65614019|NCT01498770|Zotepine|zotepine|mesh-list
65614020|NCT01498770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65614021|NCT01498770|Serotonin Agents|serotonin agents|mesh-ancestor
65614022|NCT01498770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65614023|NCT01498770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614024|NCT01498770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614025|NCT01498770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65614026|NCT01498770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65614027|NCT01498770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65614028|NCT01498770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65614029|NCT01498770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65614030|NCT01498770|Dopamine Agents|dopamine agents|mesh-ancestor
65614031|NCT01498770|Antiemetics|antiemetics|mesh-ancestor
65614032|NCT01498770|Autonomic Agents|autonomic agents|mesh-ancestor
65614033|NCT01498770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614034|NCT01498770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65614035|NCT01498770|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65614036|NCT01498770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65614037|NCT01498770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65614038|NCT01498770|Antidepressive Agents|antidepressive agents|mesh-ancestor
65614039|NCT01498770|Dopamine Agonists|dopamine agonists|mesh-ancestor
65614040|NCT01498770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65614041|NCT01498770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65614042|NCT01498770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65614043|NCT01498770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65614044|NCT01498770|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65614045|NCT01498770|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65614046|NCT01498770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65614047|NCT01498770|Adrenergic Agents|adrenergic agents|mesh-ancestor
65614048|NCT01498770|GABA Antagonists|gaba antagonists|mesh-ancestor
65614049|NCT01498770|GABA Agents|gaba agents|mesh-ancestor
65614050|NCT01498770|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65614051|NCT00140946|Montelukast|montelukast|mesh-list
65614052|NCT00140946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614053|NCT00140946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614054|NCT00140946|Respiratory System Agents|respiratory system agents|mesh-ancestor
65614055|NCT00140946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65614056|NCT00140946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65614057|NCT00140946|Hormone Antagonists|hormone antagonists|mesh-ancestor
65614058|NCT00140946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65614059|NCT00140946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65614060|NCT00140946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65614061|NCT01267812|Rituximab|rituximab|mesh-list
65614062|NCT01267812|Bortezomib|bortezomib|mesh-list
65614063|NCT01267812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65614064|NCT01267812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614065|NCT01267812|Immunologic Factors|immunologic factors|mesh-ancestor
65614066|NCT01267812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614067|NCT01267812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65614068|NCT00095004|Rizatriptan|rizatriptan|mesh-list
65614069|NCT00095004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65614070|NCT00095004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614071|NCT00095004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614072|NCT00095004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65614073|NCT00095004|Serotonin Agents|serotonin agents|mesh-ancestor
65614074|NCT00967746|Etonogestrel|etonogestrel|mesh-list
65614075|NCT00967746|Desogestrel|desogestrel|mesh-list
65614076|NCT00967746|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65614077|NCT00967746|Contraceptive Agents|contraceptive agents|mesh-ancestor
65614078|NCT00967746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65614079|NCT00967746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614080|NCT00967746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65614081|NCT00967746|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65614082|NCT00967746|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65614083|NCT00967746|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65614084|NCT00967746|Progestins|progestins|mesh-ancestor
65614085|NCT00967746|Hormones|hormones|mesh-ancestor
65614086|NCT00967746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65614087|NCT00092118|Montelukast|montelukast|mesh-list
65614088|NCT00092118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65614089|NCT00092118|Respiratory System Agents|respiratory system agents|mesh-ancestor
65614090|NCT00092118|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65614091|NCT00092118|Hormone Antagonists|hormone antagonists|mesh-ancestor
65614092|NCT00092118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65614093|NCT00092118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614094|NCT00092118|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65614095|NCT00092118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65614096|NCT00092118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614097|NCT00920634|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65614098|NCT00920634|Hormones|hormones|mesh-ancestor
65614099|NCT00920634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65614100|NCT00920634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614101|NCT00092040|Alendronate|alendronate|mesh-list
65614102|NCT00092040|Risedronic Acid|risedronic acid|mesh-list
65614103|NCT00092040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614104|NCT00092040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614105|NCT00092040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65614106|NCT00092040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65614107|NCT00092040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65614108|NCT00092040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65614109|NCT05224128|Imatinib Mesylate|imatinib mesylate|mesh-list
65614110|NCT05224128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614111|NCT05224128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65614112|NCT05224128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614113|NCT05224128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614114|NCT05416827|Dexamethasone|dexamethasone|mesh-list
65614115|NCT05416827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65614116|NCT05416827|Antiemetics|antiemetics|mesh-ancestor
65614117|NCT05416827|Autonomic Agents|autonomic agents|mesh-ancestor
65614118|NCT05416827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614119|NCT05416827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614120|NCT05416827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65614121|NCT05416827|Glucocorticoids|glucocorticoids|mesh-ancestor
65614122|NCT05416827|Hormones|hormones|mesh-ancestor
65614123|NCT05416827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65614124|NCT05416827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65614125|NCT05416827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614126|NCT05472792|Tamoxifen|tamoxifen|mesh-list
65614127|NCT05472792|Toremifene|toremifene|mesh-list
65614128|NCT05472792|Letrozole|letrozole|mesh-list
65614129|NCT05472792|Fulvestrant|fulvestrant|mesh-list
65614130|NCT05472792|Anastrozole|anastrozole|mesh-list
65614131|NCT05472792|Exemestane|exemestane|mesh-list
65614132|NCT05472792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614133|NCT05472792|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65614134|NCT05472792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65614135|NCT05472792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614136|NCT05472792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614137|NCT05472792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65614138|NCT05472792|Hormone Antagonists|hormone antagonists|mesh-ancestor
65614139|NCT05472792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65614140|NCT05472792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614141|NCT05472792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65614142|NCT05472792|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65614143|NCT05472792|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65614144|NCT05472792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65614145|NCT05472792|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65614146|NCT04961619|Trametinib|trametinib|mesh-list
65614147|NCT04961619|Dabrafenib|dabrafenib|mesh-list
65614148|NCT04961619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614149|NCT04961619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65614150|NCT04961619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614151|NCT04961619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614152|NCT05076513|Niraparib|niraparib|mesh-list
65614153|NCT05076513|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65614154|NCT05076513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614155|NCT05076513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614156|NCT05076513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614157|NCT04979910|Ixekizumab|ixekizumab|mesh-list
65614158|NCT04979910|Dermatologic Agents|dermatologic agents|mesh-ancestor
65614159|NCT05418465|Dapagliflozin|dapagliflozin|mesh-list
65411592|NCT00624065|Carvedilol|carvedilol|mesh-list
65614160|NCT05418465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65614161|NCT05418465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614162|NCT05418465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65614163|NCT05418465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614165|NCT03261167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65614166|NCT03261167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65614167|NCT03261167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65614168|NCT03261167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65614169|NCT03261167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614170|NCT03261167|Cholinergic Agents|cholinergic agents|mesh-ancestor
65614171|NCT03261167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65614172|NCT03261167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614173|NCT03261167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65614174|NCT03261167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614175|NCT05391126|Irinotecan|irinotecan|mesh-list
65614176|NCT05391126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65614177|NCT05391126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65614178|NCT05391126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614179|NCT05391126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614180|NCT05391126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614181|NCT05418309|Paclitaxel|paclitaxel|mesh-list
65614182|NCT05418309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65614183|NCT05418309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614184|NCT05418309|Tubulin Modulators|tubulin modulators|mesh-ancestor
65614185|NCT05418309|Antimitotic Agents|antimitotic agents|mesh-ancestor
65614186|NCT05418309|Mitosis Modulators|mitosis modulators|mesh-ancestor
65614187|NCT05418309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614188|NCT05137548|Tenofovir|tenofovir|mesh-list
65614189|NCT05137548|Antiviral Agents|antiviral agents|mesh-ancestor
65614190|NCT05137548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65614191|NCT05137548|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65266437|NCT04891068|Azacitidine|azacitidine|mesh-list
65614192|NCT05137548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65614193|NCT05137548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614194|NCT05137548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614195|NCT05137548|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65614196|NCT05137548|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65614197|NCT05044611|Amiloride|amiloride|mesh-list
65614198|NCT05044611|Diuretics|diuretics|mesh-ancestor
65614199|NCT05044611|Natriuretic Agents|natriuretic agents|mesh-ancestor
65614200|NCT05044611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614201|NCT05044611|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65614202|NCT05044611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65614203|NCT05044611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65614204|NCT05044611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614205|NCT05044611|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65614206|NCT05044611|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65614207|NCT05091294|Anesthetics|anesthetics|mesh-list
65614208|NCT05091294|Anesthetics, Local|anesthetics, local|mesh-list
65614209|NCT05091294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65614210|NCT05091294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614211|NCT05091294|Sensory System Agents|sensory system agents|mesh-ancestor
65614212|NCT05091294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614213|NCT04520178|Carbidopa|carbidopa|mesh-list
65614214|NCT04520178|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
65614215|NCT04520178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65614216|NCT04520178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65614217|NCT04520178|Dopamine Agents|dopamine agents|mesh-ancestor
65614218|NCT04520178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65614219|NCT04520178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614220|NCT04520178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614221|NCT04520178|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65614222|NCT04520178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614223|NCT04520178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65614224|NCT04520178|Antidepressive Agents|antidepressive agents|mesh-ancestor
65614225|NCT04520178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65614226|NCT05320926|Aspirin|aspirin|mesh-list
65614227|NCT05320926|Clopidogrel|clopidogrel|mesh-list
65614228|NCT05320926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65614229|NCT05320926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65614230|NCT05320926|Analgesics|analgesics|mesh-ancestor
65411634|NCT00360334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65614231|NCT05320926|Sensory System Agents|sensory system agents|mesh-ancestor
65614232|NCT05320926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614233|NCT05320926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614234|NCT05320926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65614235|NCT05320926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65614236|NCT05320926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65614237|NCT05320926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65614238|NCT05320926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614239|NCT05320926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65614240|NCT05320926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65614241|NCT05320926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614242|NCT05320926|Antipyretics|antipyretics|mesh-ancestor
65614243|NCT05320926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65614244|NCT05320926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65614245|NCT05320926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65614246|NCT05320926|Purinergic Agents|purinergic agents|mesh-ancestor
65614247|NCT05320926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65614248|NCT05296512|Pembrolizumab|pembrolizumab|mesh-list
65614249|NCT05296512|Lenvatinib|lenvatinib|mesh-list
65614250|NCT05296512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65614251|NCT05296512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614252|NCT05296512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65614253|NCT05296512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614254|NCT05296512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614255|NCT05417997|Clarithromycin|clarithromycin|mesh-list
65614256|NCT05417997|Ceftriaxone|ceftriaxone|mesh-list
65614257|NCT05417997|Favipiravir|favipiravir|mesh-list
65614258|NCT05417997|Methylprednisolone|methylprednisolone|mesh-list
65614259|NCT05417997|Enoxaparin|enoxaparin|mesh-list
65614260|NCT05417997|Lansoprazole|lansoprazole|mesh-list
65614261|NCT05417997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65614262|NCT05417997|Antiemetics|antiemetics|mesh-ancestor
65614263|NCT05417997|Autonomic Agents|autonomic agents|mesh-ancestor
65614264|NCT05417997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614265|NCT05417997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614266|NCT05417997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65614267|NCT05417997|Glucocorticoids|glucocorticoids|mesh-ancestor
65614268|NCT05417997|Hormones|hormones|mesh-ancestor
65614269|NCT05417997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65614270|NCT05417997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65614271|NCT05417997|Protective Agents|protective agents|mesh-ancestor
65614272|NCT05417997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65614273|NCT05417997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65614274|NCT05417997|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65614275|NCT05417997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614276|NCT05417997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614277|NCT05417997|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65614278|NCT05417997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65614279|NCT05417997|Anticoagulants|anticoagulants|mesh-ancestor
65614280|NCT05417997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65614281|NCT05417997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65614282|NCT05417997|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65614283|NCT05417997|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65614284|NCT05417997|Antiviral Agents|antiviral agents|mesh-ancestor
65614285|NCT03856788|Bupivacaine|bupivacaine|mesh-list
65614286|NCT03856788|Anesthetics, Local|anesthetics, local|mesh-ancestor
65614287|NCT03856788|Anesthetics|anesthetics|mesh-ancestor
65614288|NCT03856788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65614289|NCT03856788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614290|NCT03856788|Sensory System Agents|sensory system agents|mesh-ancestor
65614291|NCT03856788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614292|NCT03242759|Pirfenidone|pirfenidone|mesh-list
65614293|NCT03242759|Nintedanib|nintedanib|mesh-list
65614294|NCT03242759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614295|NCT03242759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65614296|NCT03242759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614297|NCT03242759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614298|NCT03242759|Analgesics|analgesics|mesh-ancestor
65614299|NCT03242759|Sensory System Agents|sensory system agents|mesh-ancestor
65614300|NCT03242759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614301|NCT03242759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614302|NCT03242759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65614303|NCT03242759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65614304|NCT03242759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65411710|NCT00833963|Pertuzumab|pertuzumab|mesh-list
65614305|NCT03242759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65614306|NCT03243552|Levodopa|levodopa|mesh-list
65614307|NCT03243552|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65614308|NCT03243552|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65614309|NCT03243552|Dopamine Agents|dopamine agents|mesh-ancestor
65614310|NCT03243552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65614311|NCT03243552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614312|NCT03243552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614313|NCT03625050|Celecoxib|celecoxib|mesh-list
65614314|NCT03625050|Esomeprazole|esomeprazole|mesh-list
65614315|NCT03625050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65614316|NCT03625050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65614317|NCT03625050|Analgesics|analgesics|mesh-ancestor
65614318|NCT03625050|Sensory System Agents|sensory system agents|mesh-ancestor
65614319|NCT03625050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614320|NCT03625050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614321|NCT03625050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65614322|NCT03625050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65614323|NCT03625050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65614324|NCT03625050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65614325|NCT03625050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614326|NCT03625050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614327|NCT03625050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65614328|NCT03625050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65614329|NCT03625050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65614330|NCT03257813|Timolol|timolol|mesh-list
65614331|NCT03257813|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65614332|NCT03257813|Dorzolamide|dorzolamide|mesh-list
65614333|NCT03257813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65614334|NCT03257813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65614335|NCT03257813|Adrenergic Agents|adrenergic agents|mesh-ancestor
65614336|NCT03257813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65614337|NCT03257813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614338|NCT03257813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614339|NCT03257813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65614340|NCT03257813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65614341|NCT03257813|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65614342|NCT03257813|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65614343|NCT03257813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65614344|NCT03257813|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65614345|NCT03257813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614346|NCT03210259|Adalimumab|adalimumab|mesh-list
65614347|NCT03210259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65614348|NCT03210259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65614349|NCT04319757|Cyclophosphamide|cyclophosphamide|mesh-list
65614350|NCT04319757|Fludarabine|fludarabine|mesh-list
65614351|NCT04319757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65614352|NCT04319757|Immunologic Factors|immunologic factors|mesh-ancestor
65614353|NCT04319757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614354|NCT04319757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65614355|NCT04319757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65614356|NCT04319757|Alkylating Agents|alkylating agents|mesh-ancestor
65614357|NCT04319757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614358|NCT04319757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614359|NCT04319757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65614360|NCT05180461|Ivermectin|ivermectin|mesh-list
65614361|NCT05180461|Emodepside|emodepside|mesh-list
65614362|NCT05180461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65614363|NCT05180461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65614364|NCT02496611|Exenatide|exenatide|mesh-list
65614365|NCT02496611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65614366|NCT02496611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614367|NCT02496611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65614368|NCT02496611|Incretins|incretins|mesh-ancestor
65614369|NCT02496611|Hormones|hormones|mesh-ancestor
65614370|NCT02496611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65614371|NCT03636295|Warfarin|warfarin|mesh-list
65614372|NCT03636295|Anticoagulants|anticoagulants|mesh-ancestor
65614373|NCT03237481|Bupivacaine|bupivacaine|mesh-list
65614374|NCT03237481|Anesthetics, Local|anesthetics, local|mesh-ancestor
65614375|NCT03237481|Anesthetics|anesthetics|mesh-ancestor
65614376|NCT03237481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65614377|NCT03237481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614378|NCT03237481|Sensory System Agents|sensory system agents|mesh-ancestor
65614379|NCT03237481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614380|NCT03704220|Warfarin|warfarin|mesh-list
65614381|NCT03704220|Anticoagulants|anticoagulants|mesh-ancestor
65614382|NCT03222349|Diazepam|diazepam|mesh-list
65614383|NCT03222349|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65614384|NCT03222349|Anticonvulsants|anticonvulsants|mesh-ancestor
65614385|NCT03222349|Antiemetics|antiemetics|mesh-ancestor
65614386|NCT03222349|Autonomic Agents|autonomic agents|mesh-ancestor
65614387|NCT03222349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614388|NCT03222349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614389|NCT03222349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65614390|NCT03222349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65614391|NCT03222349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65614392|NCT03222349|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65614393|NCT03222349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65614394|NCT03222349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65614395|NCT03222349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65614396|NCT03222349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65614397|NCT03222349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65614398|NCT03222349|Anesthetics, General|anesthetics, general|mesh-ancestor
65614399|NCT03222349|Anesthetics|anesthetics|mesh-ancestor
65614400|NCT03222349|GABA Modulators|gaba modulators|mesh-ancestor
65614401|NCT03222349|GABA Agents|gaba agents|mesh-ancestor
65614402|NCT03222349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65614403|NCT03222349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614404|NCT02927925|Daratumumab|daratumumab|mesh-list
65614405|NCT02927925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614406|NCT03208933|Pirfenidone|pirfenidone|mesh-list
65614407|NCT03208933|Analgesics|analgesics|mesh-ancestor
65614408|NCT03208933|Sensory System Agents|sensory system agents|mesh-ancestor
65614409|NCT03208933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614410|NCT03208933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614411|NCT03208933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65614412|NCT03208933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65614413|NCT03208933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65614414|NCT03208933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65614415|NCT03208933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614416|NCT02499120|Cetuximab|cetuximab|mesh-list
65614417|NCT02499120|Palbociclib|palbociclib|mesh-list
65614418|NCT02499120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65614419|NCT02499120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614420|NCT02499120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65614421|NCT02499120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614422|NCT02499120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614423|NCT01568307|Antidepressive Agents|antidepressive agents|mesh-list
65614424|NCT01568307|Serotonin|serotonin|mesh-list
65614425|NCT01568307|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65614426|NCT01568307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65614427|NCT01568307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65614428|NCT01568307|Serotonin Agents|serotonin agents|mesh-ancestor
65614429|NCT01568307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65614430|NCT01568307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614431|NCT01568307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614432|NCT01568307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65614433|NCT01568307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65614434|NCT02415036|Melphalan|melphalan|mesh-list
65614435|NCT02415036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65614436|NCT02415036|Alkylating Agents|alkylating agents|mesh-ancestor
65614437|NCT02415036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614438|NCT02415036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614439|NCT02415036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65614440|NCT02415036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65614441|NCT02415036|Immunologic Factors|immunologic factors|mesh-ancestor
65614442|NCT02415036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614443|NCT04752267|Clevudine|clevudine|mesh-list
65614444|NCT04752267|Antiviral Agents|antiviral agents|mesh-ancestor
65614445|NCT04752267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65614446|NCT02117700|Acetylcysteine|acetylcysteine|mesh-list
65614447|NCT02117700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65614448|NCT02117700|Antiviral Agents|antiviral agents|mesh-ancestor
65614449|NCT02117700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65614450|NCT02117700|Expectorants|expectorants|mesh-ancestor
65614451|NCT02117700|Respiratory System Agents|respiratory system agents|mesh-ancestor
65614452|NCT02117700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65614453|NCT02117700|Antioxidants|antioxidants|mesh-ancestor
65614454|NCT02117700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614455|NCT02117700|Protective Agents|protective agents|mesh-ancestor
65614456|NCT02117700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614457|NCT02117700|Antidotes|antidotes|mesh-ancestor
65614458|NCT03257267|Cemiplimab|cemiplimab|mesh-list
65614459|NCT03257267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65614460|NCT03257267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614461|NCT02932579|Acetaminophen|acetaminophen|mesh-list
65614462|NCT02932579|Ibuprofen|ibuprofen|mesh-list
65614463|NCT02932579|Oxycodone|oxycodone|mesh-list
65614464|NCT02932579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65614465|NCT02932579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65614466|NCT02932579|Analgesics|analgesics|mesh-ancestor
65614467|NCT02932579|Sensory System Agents|sensory system agents|mesh-ancestor
65614468|NCT02932579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614469|NCT02932579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614470|NCT02932579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65614471|NCT02932579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65614472|NCT02932579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65614473|NCT02932579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614474|NCT02932579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614475|NCT02932579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65614476|NCT02932579|Narcotics|narcotics|mesh-ancestor
65614477|NCT02932579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65614478|NCT02932579|Antipyretics|antipyretics|mesh-ancestor
65614479|NCT04748757|Annexin A5|annexin a5|mesh-list
65614480|NCT04748757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614481|NCT04748757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614482|NCT03207451|Aspirin|aspirin|mesh-list
65614483|NCT03207451|Clopidogrel|clopidogrel|mesh-list
65614484|NCT03207451|Vorapaxar|vorapaxar|mesh-list
65266441|NCT04891068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614485|NCT03207451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65614486|NCT03207451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65614487|NCT03207451|Analgesics|analgesics|mesh-ancestor
65614488|NCT03207451|Sensory System Agents|sensory system agents|mesh-ancestor
65614489|NCT03207451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614490|NCT03207451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614491|NCT03207451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65614492|NCT03207451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65614493|NCT03207451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65614494|NCT03207451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65614495|NCT03207451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614496|NCT03207451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65614497|NCT03207451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65614498|NCT03207451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614499|NCT03207451|Antipyretics|antipyretics|mesh-ancestor
65614500|NCT03207451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65614501|NCT03207451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65614502|NCT03207451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65614503|NCT03207451|Purinergic Agents|purinergic agents|mesh-ancestor
65614504|NCT03207451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65614505|NCT02476097|Esomeprazole|esomeprazole|mesh-list
65614506|NCT02476097|Omeprazole|omeprazole|mesh-list
65614507|NCT02476097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65614508|NCT02476097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65614509|NCT02476097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65614510|NCT02476097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614511|NCT02476097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614512|NCT05089123|Vaccines|vaccines|mesh-list
65614513|NCT05089123|Immunologic Factors|immunologic factors|mesh-ancestor
65614514|NCT05089123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614515|NCT02666547|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65614516|NCT02666547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65614517|NCT02666547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614518|NCT02361125|Methylphenidate|methylphenidate|mesh-list
65614519|NCT02361125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65614520|NCT02361125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614521|NCT02361125|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65614522|NCT02361125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65614523|NCT02361125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65614524|NCT02361125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614525|NCT02361125|Dopamine Agents|dopamine agents|mesh-ancestor
65614526|NCT02361125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65614527|NCT03701256|Atracurium|atracurium|mesh-list
65614528|NCT03701256|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65614529|NCT03701256|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65614530|NCT03701256|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65614531|NCT03701256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65411942|NCT05416476|Anisodine|anisodine|mesh-list
65614532|NCT03701256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614533|NCT03701256|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65614534|NCT03701256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65614535|NCT03701256|Cholinergic Agents|cholinergic agents|mesh-ancestor
65614536|NCT03701256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65614537|NCT03701256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614538|NCT04780581|Dexamethasone|dexamethasone|mesh-list
65614539|NCT04780581|Methylprednisolone|methylprednisolone|mesh-list
65614540|NCT04780581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65614541|NCT04780581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65614542|NCT04780581|Prednisolone|prednisolone|mesh-list
65614543|NCT04780581|Prednisolone acetate|prednisolone acetate|mesh-list
65614544|NCT04780581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65614545|NCT04780581|Prednisolone phosphate|prednisolone phosphate|mesh-list
65614546|NCT04780581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65614547|NCT04780581|Antiemetics|antiemetics|mesh-ancestor
65614548|NCT04780581|Autonomic Agents|autonomic agents|mesh-ancestor
65614549|NCT04780581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614550|NCT04780581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614551|NCT04780581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65614552|NCT04780581|Glucocorticoids|glucocorticoids|mesh-ancestor
65614553|NCT04780581|Hormones|hormones|mesh-ancestor
65614554|NCT04780581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65614555|NCT04780581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65614556|NCT04780581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614557|NCT04780581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65614558|NCT04780581|Protective Agents|protective agents|mesh-ancestor
65614559|NCT01526135|Gemcitabine|gemcitabine|mesh-list
65614560|NCT01526135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65614561|NCT01526135|Antimetabolites|antimetabolites|mesh-ancestor
65614562|NCT01526135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614563|NCT01526135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614564|NCT01526135|Antiviral Agents|antiviral agents|mesh-ancestor
65614565|NCT01526135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65614566|NCT01526135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614567|NCT01526135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65614568|NCT01526135|Immunologic Factors|immunologic factors|mesh-ancestor
65614569|NCT01526135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614570|NCT03701022|Apatinib|apatinib|mesh-list
65614571|NCT03701022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614572|NCT03701022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65614573|NCT03701022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614574|NCT03701022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614575|NCT04221165|Analgesics, Opioid|analgesics, opioid|mesh-list
65614576|NCT04221165|Narcotics|narcotics|mesh-ancestor
65614577|NCT04221165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65614578|NCT04221165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614579|NCT04221165|Analgesics|analgesics|mesh-ancestor
65614580|NCT04221165|Sensory System Agents|sensory system agents|mesh-ancestor
65614581|NCT04221165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614582|NCT03255629|Glucagon|glucagon|mesh-list
65614583|NCT03255629|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65614584|NCT03255629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65614585|NCT03255629|Hormones|hormones|mesh-ancestor
65614586|NCT03255629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65614587|NCT03255629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614588|NCT03255629|Incretins|incretins|mesh-ancestor
65614589|NCT01143779|Telbivudine|telbivudine|mesh-list
65614590|NCT01143779|Antiviral Agents|antiviral agents|mesh-ancestor
65614591|NCT01143779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65614592|NCT01143779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65614593|NCT01143779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614594|NCT01143779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614595|NCT03703596|Docetaxel|docetaxel|mesh-list
65614596|NCT03703596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614597|NCT03703596|Tubulin Modulators|tubulin modulators|mesh-ancestor
65614598|NCT03703596|Antimitotic Agents|antimitotic agents|mesh-ancestor
65614599|NCT03703596|Mitosis Modulators|mitosis modulators|mesh-ancestor
65614600|NCT03703596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614601|NCT01137773|Insulin|insulin|mesh-list
65614602|NCT01137773|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65614603|NCT01137773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65614604|NCT01137773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614605|NCT03698292|Metoclopramide|metoclopramide|mesh-list
65614606|NCT03698292|Antiemetics|antiemetics|mesh-ancestor
65614607|NCT03698292|Autonomic Agents|autonomic agents|mesh-ancestor
65614608|NCT03698292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614609|NCT03698292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614610|NCT03698292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65614611|NCT03698292|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65614612|NCT03698292|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65614613|NCT03698292|Dopamine Agents|dopamine agents|mesh-ancestor
65614614|NCT03698292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65614615|NCT03698292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614616|NCT04614909|Temozolomide|temozolomide|mesh-list
65614617|NCT04614909|Olaparib|olaparib|mesh-list
65614618|NCT04614909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65614619|NCT04614909|Alkylating Agents|alkylating agents|mesh-ancestor
65614620|NCT04614909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614621|NCT04614909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614622|NCT04614909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65614623|NCT04614909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614624|NCT04613271|Azithromycin|azithromycin|mesh-list
65614625|NCT04613271|Favipiravir|favipiravir|mesh-list
65614626|NCT04613271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65614627|NCT04613271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65614628|NCT04613271|Antiviral Agents|antiviral agents|mesh-ancestor
65614629|NCT03094611|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65614630|NCT03094611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65614631|NCT03094611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614632|NCT03094611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65614633|NCT03631953|Trametinib|trametinib|mesh-list
65614634|NCT03631953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614635|NCT03631953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65614636|NCT03631953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614637|NCT03631953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614638|NCT01030575|Inositol|inositol|mesh-list
65614639|NCT01030575|Vitamin B Complex|vitamin b complex|mesh-ancestor
65614640|NCT01030575|Vitamins|vitamins|mesh-ancestor
65614641|NCT01030575|Micronutrients|micronutrients|mesh-ancestor
65614642|NCT01030575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614643|NCT04352205|Thalidomide|thalidomide|mesh-list
65614644|NCT04352205|Dexamethasone|dexamethasone|mesh-list
65614645|NCT04352205|Dexamethasone acetate|dexamethasone acetate|mesh-list
65614646|NCT04352205|Lenalidomide|lenalidomide|mesh-list
65614647|NCT04352205|Bortezomib|bortezomib|mesh-list
65614648|NCT04352205|Daratumumab|daratumumab|mesh-list
65614649|NCT04352205|Ichthammol|ichthammol|mesh-list
65614650|NCT04352205|BB 1101|bb 1101|mesh-list
65614651|NCT04352205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65614652|NCT04352205|Antiemetics|antiemetics|mesh-ancestor
65614653|NCT04352205|Autonomic Agents|autonomic agents|mesh-ancestor
65614654|NCT04352205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614655|NCT04352205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614656|NCT04352205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65614657|NCT04352205|Glucocorticoids|glucocorticoids|mesh-ancestor
65614658|NCT04352205|Hormones|hormones|mesh-ancestor
65614659|NCT04352205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65614660|NCT04352205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65614661|NCT04352205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614662|NCT04352205|Protease Inhibitors|protease inhibitors|mesh-ancestor
65614663|NCT04352205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614664|NCT04352205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614665|NCT04352205|Immunologic Factors|immunologic factors|mesh-ancestor
65614666|NCT04352205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65614667|NCT04352205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65614668|NCT04352205|Growth Substances|growth substances|mesh-ancestor
65614669|NCT04352205|Growth Inhibitors|growth inhibitors|mesh-ancestor
65614670|NCT04352205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65614671|NCT04352205|Leprostatic Agents|leprostatic agents|mesh-ancestor
65614672|NCT04352205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65614673|NCT04352205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65614674|NCT04352205|Dermatologic Agents|dermatologic agents|mesh-ancestor
65614675|NCT04215471|Antibodies|antibodies|mesh-list
65614676|NCT04215471|Immunoglobulins|immunoglobulins|mesh-list
65614677|NCT04215471|Immunologic Factors|immunologic factors|mesh-ancestor
65614678|NCT04215471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614679|NCT04066023|Zolmitriptan|zolmitriptan|mesh-list
65614680|NCT04066023|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65614681|NCT04066023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65412085|NCT00839501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614682|NCT04066023|Serotonin Agents|serotonin agents|mesh-ancestor
65614683|NCT04066023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65614684|NCT04066023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614685|NCT04066023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614686|NCT03106987|Olaparib|olaparib|mesh-list
65614687|NCT03106987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65614688|NCT03106987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614689|NCT03106987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614690|NCT03106987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614691|NCT05040217|Mitogens|mitogens|mesh-list
65614692|NCT05040217|Mitosis Modulators|mitosis modulators|mesh-ancestor
65614693|NCT05040217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614694|NCT02932267|Adapalene|adapalene|mesh-list
65614695|NCT02932267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65614696|NCT02932267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65614697|NCT02932267|Analgesics|analgesics|mesh-ancestor
65614698|NCT02932267|Sensory System Agents|sensory system agents|mesh-ancestor
65614699|NCT02932267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614700|NCT02932267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614701|NCT02932267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65614702|NCT02932267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65614703|NCT02932267|Dermatologic Agents|dermatologic agents|mesh-ancestor
65614704|NCT03217591|Praliciguat|praliciguat|mesh-list
65614705|NCT03217591|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65614706|NCT03217591|Enzyme Activators|enzyme activators|mesh-ancestor
65614707|NCT03217591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614708|NCT03217591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65614709|NCT03697824|Cyclophosphamide|cyclophosphamide|mesh-list
65614710|NCT03697824|Pembrolizumab|pembrolizumab|mesh-list
65614711|NCT03697824|Fludarabine|fludarabine|mesh-list
65614712|NCT03697824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65614713|NCT03697824|Immunologic Factors|immunologic factors|mesh-ancestor
65614714|NCT03697824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614715|NCT03697824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65614716|NCT03697824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65614717|NCT03697824|Alkylating Agents|alkylating agents|mesh-ancestor
65614718|NCT03697824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614719|NCT03697824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614720|NCT03697824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65614721|NCT03697824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65614722|NCT03702894|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65614723|NCT03702894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65614724|NCT03702894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65614725|NCT03702894|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65614726|NCT03702894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614727|NCT03702894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614728|NCT03697746|Acetaminophen|acetaminophen|mesh-list
65614729|NCT03697746|Ibuprofen|ibuprofen|mesh-list
65614730|NCT03697746|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65614731|NCT03697746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65614732|NCT03697746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65614733|NCT03697746|Analgesics|analgesics|mesh-ancestor
65614734|NCT03697746|Sensory System Agents|sensory system agents|mesh-ancestor
65614735|NCT03697746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614736|NCT03697746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614737|NCT03697746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65614738|NCT03697746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65614739|NCT03697746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65614740|NCT03697746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614741|NCT03697746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614742|NCT03697746|Antipyretics|antipyretics|mesh-ancestor
65614743|NCT03697668|Piperaquine|piperaquine|mesh-list
65614744|NCT03697668|Artenimol|artenimol|mesh-list
65614745|NCT03697668|Imatinib Mesylate|imatinib mesylate|mesh-list
65614746|NCT03697668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614747|NCT03697668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65614748|NCT03697668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614749|NCT03697668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614750|NCT03697668|Antimalarials|antimalarials|mesh-ancestor
65614751|NCT03697668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65614752|NCT03697668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65614753|NCT03697668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65614754|NCT03702738|Acetylcysteine|acetylcysteine|mesh-list
65614755|NCT03702738|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65614756|NCT03702738|Antiviral Agents|antiviral agents|mesh-ancestor
65614757|NCT03702738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65614758|NCT03702738|Expectorants|expectorants|mesh-ancestor
65614759|NCT03702738|Respiratory System Agents|respiratory system agents|mesh-ancestor
65614760|NCT03702738|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65614761|NCT03702738|Antioxidants|antioxidants|mesh-ancestor
65614762|NCT03702738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614763|NCT03702738|Protective Agents|protective agents|mesh-ancestor
65614764|NCT03702738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614765|NCT03702738|Antidotes|antidotes|mesh-ancestor
65614766|NCT03702582|Warfarin|warfarin|mesh-list
65614767|NCT03702582|Rivaroxaban|rivaroxaban|mesh-list
65614768|NCT03702582|Anticoagulants|anticoagulants|mesh-ancestor
65614769|NCT03702582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65614770|NCT03702582|Antithrombins|antithrombins|mesh-ancestor
65614771|NCT03702582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65614772|NCT03702582|Protease Inhibitors|protease inhibitors|mesh-ancestor
65614773|NCT03702582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614774|NCT03702582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614775|NCT03697044|Irinotecan|irinotecan|mesh-list
65614776|NCT03697044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65614777|NCT03697044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65614778|NCT03697044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614779|NCT03697044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614780|NCT03697044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614781|NCT03699774|Firuglipel|firuglipel|mesh-list
65614782|NCT03699774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65614783|NCT03699774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65614784|NCT03699774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65614785|NCT03699774|Antimetabolites|antimetabolites|mesh-ancestor
65614786|NCT03699774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614787|NCT03699774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65614788|NCT03699774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65614789|NCT03699774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614790|NCT03699774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65614791|NCT03699774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614792|NCT03699696|Propofol|propofol|mesh-list
65614793|NCT03699696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65614794|NCT03699696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65614795|NCT03699696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614796|NCT03699696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65614797|NCT03699696|Anesthetics, General|anesthetics, general|mesh-ancestor
65614798|NCT03699696|Anesthetics|anesthetics|mesh-ancestor
65614799|NCT03702426|Norfloxacin|norfloxacin|mesh-list
65614800|NCT03702426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65614801|NCT03702426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65614802|NCT03702426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65614803|NCT03702426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65614804|NCT03702426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614805|NCT03702426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614806|NCT03702426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614807|NCT03702426|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65614808|NCT03702426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65614809|NCT00265941|Cetuximab|cetuximab|mesh-list
65614810|NCT00265941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614811|NCT00265941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65614812|NCT03377361|Nivolumab|nivolumab|mesh-list
65614813|NCT03377361|Ipilimumab|ipilimumab|mesh-list
65614814|NCT03377361|Trametinib|trametinib|mesh-list
65614815|NCT03377361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65614816|NCT03377361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614817|NCT03377361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65614818|NCT03377361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614819|NCT03377361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65614820|NCT03377361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614821|NCT03699384|Azacitidine|azacitidine|mesh-list
65614822|NCT03699384|Avelumab|avelumab|mesh-list
65614823|NCT03699384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65614824|NCT03699384|Antimetabolites|antimetabolites|mesh-ancestor
65614825|NCT03699384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614826|NCT03699384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614827|NCT03699384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614828|NCT03699384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65614829|NCT04546425|Vaccines|vaccines|mesh-list
65614830|NCT04546425|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65614831|NCT04546425|Immunologic Factors|immunologic factors|mesh-ancestor
65614832|NCT04546425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614834|NCT05378763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614835|NCT05378763|Tubulin Modulators|tubulin modulators|mesh-ancestor
65614836|NCT05378763|Antimitotic Agents|antimitotic agents|mesh-ancestor
65614837|NCT05378763|Mitosis Modulators|mitosis modulators|mesh-ancestor
65614838|NCT05378763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614839|NCT03203473|Nivolumab|nivolumab|mesh-list
65614840|NCT03203473|Ipilimumab|ipilimumab|mesh-list
65614841|NCT03203473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65614842|NCT03203473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614843|NCT03203473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65614844|NCT03203473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614845|NCT02937571|Dexamethasone|dexamethasone|mesh-list
65614846|NCT02937571|Lenalidomide|lenalidomide|mesh-list
65614847|NCT02937571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65614848|NCT02937571|Antiemetics|antiemetics|mesh-ancestor
65614849|NCT02937571|Autonomic Agents|autonomic agents|mesh-ancestor
65614850|NCT02937571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614851|NCT02937571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614852|NCT02937571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65614853|NCT02937571|Glucocorticoids|glucocorticoids|mesh-ancestor
65614854|NCT02937571|Hormones|hormones|mesh-ancestor
65614855|NCT02937571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65614856|NCT02937571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65614857|NCT02937571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614858|NCT02937571|Immunologic Factors|immunologic factors|mesh-ancestor
65614859|NCT02937571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65614860|NCT02937571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65614861|NCT02937571|Growth Substances|growth substances|mesh-ancestor
65614862|NCT02937571|Growth Inhibitors|growth inhibitors|mesh-ancestor
65614863|NCT03201211|Vaccines|vaccines|mesh-list
65614864|NCT03201211|Immunologic Factors|immunologic factors|mesh-ancestor
65614865|NCT03201211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614866|NCT04624945|Thromboplastin|thromboplastin|mesh-list
65614867|NCT04624945|Hemostatics|hemostatics|mesh-ancestor
65614868|NCT04624945|Coagulants|coagulants|mesh-ancestor
65614869|NCT03566511|Diazoxide|diazoxide|mesh-list
65614870|NCT03566511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65614871|NCT03566511|Vasodilator Agents|vasodilator agents|mesh-ancestor
65614872|NCT04472949|Carboplatin|carboplatin|mesh-list
65614873|NCT04472949|Etoposide|etoposide|mesh-list
65614874|NCT04472949|Durvalumab|durvalumab|mesh-list
65614875|NCT04472949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614876|NCT04472949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65614877|NCT04472949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65614878|NCT04472949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65614879|NCT04472949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614880|NCT04472949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614881|NCT04472949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65614882|NCT03696186|Phenobarbital|phenobarbital|mesh-list
65614883|NCT03696186|Anticonvulsants|anticonvulsants|mesh-ancestor
65614884|NCT03696186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65614885|NCT03696186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65614886|NCT03696186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614887|NCT03696186|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65614888|NCT03696186|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65614889|NCT03696186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65614890|NCT03696186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614891|NCT03696186|GABA Modulators|gaba modulators|mesh-ancestor
65614892|NCT03696186|GABA Agents|gaba agents|mesh-ancestor
65614893|NCT03696186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65614894|NCT03696186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65614895|NCT03696186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65614896|NCT03698916|Celecoxib|celecoxib|mesh-list
65614897|NCT03698916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65614898|NCT03698916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65614899|NCT03698916|Analgesics|analgesics|mesh-ancestor
65614900|NCT03698916|Sensory System Agents|sensory system agents|mesh-ancestor
65614901|NCT03698916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614902|NCT03698916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614903|NCT03698916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65614904|NCT03698916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65614905|NCT03698916|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65614906|NCT03698916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65614907|NCT03698916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614908|NCT03698916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614910|NCT03336333|Venetoclax|venetoclax|mesh-list
65614911|NCT03336333|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65614912|NCT03336333|Zanubrutinib|zanubrutinib|mesh-list
65614913|NCT03336333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65614914|NCT03336333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614915|NCT03336333|Immunologic Factors|immunologic factors|mesh-ancestor
65614916|NCT03336333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614917|NCT03336333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65614918|NCT03336333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65614919|NCT03336333|Alkylating Agents|alkylating agents|mesh-ancestor
65614920|NCT03336333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614921|NCT03336333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65614922|NCT03336333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614923|NCT03695952|Pembrolizumab|pembrolizumab|mesh-list
65614924|NCT03695952|Nivolumab|nivolumab|mesh-list
65614925|NCT03695952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65614926|NCT03695952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65614927|NCT03695952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614928|NCT03695952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614929|NCT03695640|Magnesium Sulfate|magnesium sulfate|mesh-list
65614930|NCT03695640|Analgesics|analgesics|mesh-ancestor
65614931|NCT03695640|Sensory System Agents|sensory system agents|mesh-ancestor
65614932|NCT03695640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614933|NCT03695640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614934|NCT03695640|Anesthetics|anesthetics|mesh-ancestor
65614935|NCT03695640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65614936|NCT03695640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65614937|NCT03695640|Anticonvulsants|anticonvulsants|mesh-ancestor
65614938|NCT03695640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65614939|NCT03695640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65614940|NCT03695640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614941|NCT03695640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65614942|NCT03695640|Tocolytic Agents|tocolytic agents|mesh-ancestor
65614943|NCT03695640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65614944|NCT03698682|Levofloxacin|levofloxacin|mesh-list
65614945|NCT03698682|Ofloxacin|ofloxacin|mesh-list
65614946|NCT03698682|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65614947|NCT03698682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65614948|NCT03698682|Renal Agents|renal agents|mesh-ancestor
65614949|NCT03698682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65614950|NCT03698682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65614951|NCT03698682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65614952|NCT03698682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65614953|NCT03698682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614954|NCT03698682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614955|NCT03698682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65614956|NCT03698682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65614957|NCT03029832|Atezolizumab|atezolizumab|mesh-list
65614958|NCT03029832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614959|NCT05598567|Anesthetics|anesthetics|mesh-list
65614960|NCT05598567|Sevoflurane|sevoflurane|mesh-list
65614961|NCT05598567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65614962|NCT05598567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614963|NCT05598567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65614964|NCT05598567|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65614965|NCT05598567|Anesthetics, General|anesthetics, general|mesh-ancestor
65614966|NCT03701880|Bisoprolol|bisoprolol|mesh-list
65614967|NCT03701880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65614968|NCT03701880|Sympatholytics|sympatholytics|mesh-ancestor
65614969|NCT03701880|Autonomic Agents|autonomic agents|mesh-ancestor
65614970|NCT03701880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614971|NCT03701880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614972|NCT03701880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65614973|NCT03701880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65614974|NCT03701880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65614975|NCT03701880|Adrenergic Agents|adrenergic agents|mesh-ancestor
65614976|NCT03701880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65614977|NCT03701880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614978|NCT03692754|Calcium, Dietary|calcium, dietary|mesh-list
65614979|NCT03692754|Dexamethasone|dexamethasone|mesh-list
65614980|NCT03692754|Atorvastatin|atorvastatin|mesh-list
65614981|NCT03692754|Calcium|calcium|mesh-list
65614983|NCT03692754|Antiemetics|antiemetics|mesh-ancestor
65614984|NCT03692754|Autonomic Agents|autonomic agents|mesh-ancestor
65614985|NCT03692754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65614986|NCT03692754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65614987|NCT03692754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65614988|NCT03692754|Glucocorticoids|glucocorticoids|mesh-ancestor
65614989|NCT03692754|Hormones|hormones|mesh-ancestor
65614990|NCT03692754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65614991|NCT03692754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65614992|NCT03692754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65614993|NCT03692754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65614994|NCT03692754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65614995|NCT03692754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65614996|NCT03692754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65614997|NCT03692754|Antimetabolites|antimetabolites|mesh-ancestor
65614998|NCT03692754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65614999|NCT03692754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65615000|NCT03692754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65615001|NCT03692754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615002|NCT04224558|Acetaminophen|acetaminophen|mesh-list
65615003|NCT04224558|Diphenhydramine|diphenhydramine|mesh-list
65615004|NCT04224558|Promethazine|promethazine|mesh-list
65615005|NCT04224558|Methylprednisolone|methylprednisolone|mesh-list
65615006|NCT04224558|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65615007|NCT04224558|Cyclophosphamide|cyclophosphamide|mesh-list
65615008|NCT04224558|Fludarabine|fludarabine|mesh-list
65615009|NCT04224558|Thymoglobulin|thymoglobulin|mesh-list
65615010|NCT04224558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65615011|NCT04224558|Immunoglobulins|immunoglobulins|mesh-list
65615012|NCT04224558|Antibodies|antibodies|mesh-list
65615013|NCT04224558|gamma-Globulins|gamma-globulins|mesh-list
65615014|NCT04224558|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65615015|NCT04224558|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65615016|NCT04224558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65615017|NCT04224558|Immunologic Factors|immunologic factors|mesh-ancestor
65615018|NCT04224558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615019|NCT04224558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65615020|NCT04224558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65615021|NCT04224558|Alkylating Agents|alkylating agents|mesh-ancestor
65615022|NCT04224558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615023|NCT04224558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615024|NCT04224558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65615025|NCT04224558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65615026|NCT04224558|Analgesics|analgesics|mesh-ancestor
65615027|NCT04224558|Sensory System Agents|sensory system agents|mesh-ancestor
65615028|NCT04224558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615029|NCT04224558|Antipyretics|antipyretics|mesh-ancestor
65615030|NCT04224558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65615031|NCT04224558|Antiemetics|antiemetics|mesh-ancestor
65615032|NCT04224558|Autonomic Agents|autonomic agents|mesh-ancestor
65615033|NCT04224558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65615034|NCT04224558|Glucocorticoids|glucocorticoids|mesh-ancestor
65615035|NCT04224558|Hormones|hormones|mesh-ancestor
65615036|NCT04224558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65615037|NCT04224558|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65615038|NCT04224558|Protective Agents|protective agents|mesh-ancestor
65615039|NCT04224558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65615040|NCT04224558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65615041|NCT04224558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65615042|NCT04224558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65615043|NCT04224558|Anesthetics, Local|anesthetics, local|mesh-ancestor
65615044|NCT04224558|Anesthetics|anesthetics|mesh-ancestor
65615045|NCT04224558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65615046|NCT04224558|Histamine Antagonists|histamine antagonists|mesh-ancestor
65615047|NCT04224558|Histamine Agents|histamine agents|mesh-ancestor
65615048|NCT04224558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65615049|NCT04224558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65615050|NCT04224558|Antipruritics|antipruritics|mesh-ancestor
65615051|NCT04224558|Dermatologic Agents|dermatologic agents|mesh-ancestor
65615052|NCT05598411|Methylprednisolone|methylprednisolone|mesh-list
65615053|NCT05598411|Glucocorticoids|glucocorticoids|mesh-list
65412463|NCT01564680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615054|NCT05598411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65615055|NCT05598411|Antiemetics|antiemetics|mesh-ancestor
65615056|NCT05598411|Autonomic Agents|autonomic agents|mesh-ancestor
65615057|NCT05598411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615058|NCT05598411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615059|NCT05598411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65615061|NCT05598411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65615062|NCT05598411|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65615063|NCT05598411|Protective Agents|protective agents|mesh-ancestor
65615064|NCT03688230|Cetuximab|cetuximab|mesh-list
65615065|NCT03688230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65615066|NCT03688230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615067|NCT03694236|Durvalumab|durvalumab|mesh-list
65615068|NCT03694236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65615069|NCT03694236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615070|NCT03692286|Calcium, Dietary|calcium, dietary|mesh-list
65615071|NCT03692286|Calcium|calcium|mesh-list
65615072|NCT03692286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65615073|NCT03692286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615074|NCT03692286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65615075|NCT03694080|Calcium|calcium|mesh-list
65615076|NCT03694080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65615077|NCT03694080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615078|NCT04207944|Sulindac|sulindac|mesh-list
65615079|NCT04207944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65615080|NCT04207944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65615081|NCT04207944|Analgesics|analgesics|mesh-ancestor
65615082|NCT04207944|Sensory System Agents|sensory system agents|mesh-ancestor
65615083|NCT04207944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615084|NCT04207944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615085|NCT04207944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65615086|NCT04207944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65615087|NCT04207944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615088|NCT04207944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65615089|NCT04207944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615090|NCT04207944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615091|NCT04203498|Nabiximols|nabiximols|mesh-list
65615092|NCT04203498|Analgesics|analgesics|mesh-ancestor
65615093|NCT04203498|Sensory System Agents|sensory system agents|mesh-ancestor
65615094|NCT04203498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615095|NCT04203498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615096|NCT03691896|Cholecalciferol|cholecalciferol|mesh-list
65615097|NCT03691896|Vitamin D|vitamin d|mesh-list
65615098|NCT03691896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65615099|NCT03691896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615100|NCT03691896|Vitamins|vitamins|mesh-ancestor
65615101|NCT03691896|Micronutrients|micronutrients|mesh-ancestor
65615102|NCT03691896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65615103|NCT03691818|Ibuprofen|ibuprofen|mesh-list
65615104|NCT03691818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65615105|NCT03691818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65615106|NCT03691818|Analgesics|analgesics|mesh-ancestor
65615107|NCT03691818|Sensory System Agents|sensory system agents|mesh-ancestor
65615108|NCT03691818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615109|NCT03691818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615110|NCT03691818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65615111|NCT03691818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65615112|NCT03691818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65615113|NCT03691818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615114|NCT03691818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615115|NCT03687606|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65615116|NCT03687606|Menotropins|menotropins|mesh-list
65615117|NCT03687606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65615118|NCT03687606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615119|NCT03687606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65615120|NCT03687606|Fertility Agents|fertility agents|mesh-ancestor
65615121|NCT03691662|Timolol|timolol|mesh-list
65615122|NCT03691662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65615123|NCT03691662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65615124|NCT03691662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615125|NCT03691662|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65615126|NCT03691662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65615127|NCT03691662|Adrenergic Agents|adrenergic agents|mesh-ancestor
65615128|NCT03691662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65615129|NCT03691662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412545|NCT00849095|Hormones|hormones|mesh-ancestor
65615130|NCT03691662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65615131|NCT03691662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65615132|NCT04059978|Remifentanil|remifentanil|mesh-list
65615133|NCT04059978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65615134|NCT04059978|Narcotics|narcotics|mesh-ancestor
65615135|NCT04059978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65615136|NCT04059978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615137|NCT04059978|Analgesics|analgesics|mesh-ancestor
65615138|NCT04059978|Sensory System Agents|sensory system agents|mesh-ancestor
65615139|NCT04059978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615140|NCT03199963|Tamoxifen|tamoxifen|mesh-list
65615141|NCT03199963|Afimoxifene|afimoxifene|mesh-list
65615142|NCT03199963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65615143|NCT03199963|Hormone Antagonists|hormone antagonists|mesh-ancestor
65615144|NCT03199963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65615145|NCT03199963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615146|NCT03199963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65615147|NCT03199963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615148|NCT03199963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65615149|NCT03199963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65615150|NCT03199963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65615151|NCT03636685|Paclitaxel|paclitaxel|mesh-list
65615152|NCT03636685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65615153|NCT03636685|Carboplatin|carboplatin|mesh-list
65615154|NCT03636685|Pemetrexed|pemetrexed|mesh-list
65615155|NCT03636685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65615156|NCT03636685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615157|NCT03636685|Tubulin Modulators|tubulin modulators|mesh-ancestor
65615158|NCT03636685|Antimitotic Agents|antimitotic agents|mesh-ancestor
65615159|NCT03636685|Mitosis Modulators|mitosis modulators|mesh-ancestor
65615160|NCT03636685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615161|NCT03636685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615162|NCT03636685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65615163|NCT03636685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65615164|NCT03257631|Thalidomide|thalidomide|mesh-list
65615165|NCT03257631|Pomalidomide|pomalidomide|mesh-list
65615166|NCT03257631|Immunologic Factors|immunologic factors|mesh-ancestor
65615167|NCT03257631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615168|NCT03257631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65615169|NCT03257631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65615170|NCT03257631|Growth Substances|growth substances|mesh-ancestor
65615171|NCT03257631|Growth Inhibitors|growth inhibitors|mesh-ancestor
65615172|NCT03257631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615173|NCT03257631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65615174|NCT03257631|Leprostatic Agents|leprostatic agents|mesh-ancestor
65615175|NCT03257631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65615176|NCT03257631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65615177|NCT03883581|Quinidine|quinidine|mesh-list
65615178|NCT03883581|Quinidine gluconate|quinidine gluconate|mesh-list
65615179|NCT03883581|Dextromethorphan|dextromethorphan|mesh-list
65615180|NCT03883581|Antitussive Agents|antitussive agents|mesh-ancestor
65615181|NCT03883581|Respiratory System Agents|respiratory system agents|mesh-ancestor
65615182|NCT03883581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65615183|NCT03883581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65615184|NCT03883581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65615185|NCT03883581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615186|NCT03883581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615187|NCT03883581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65615188|NCT03883581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65615189|NCT03883581|Adrenergic Agents|adrenergic agents|mesh-ancestor
65615190|NCT03883581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65615191|NCT03883581|Antimalarials|antimalarials|mesh-ancestor
65615192|NCT03883581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65615193|NCT03883581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65615194|NCT03883581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65615195|NCT03883581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615196|NCT03883581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65615197|NCT03883581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65615198|NCT03883581|Cholinergic Agents|cholinergic agents|mesh-ancestor
65615199|NCT03883581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65615200|NCT03883581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65615201|NCT03883581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65615202|NCT03883581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65615203|NCT03883581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65615204|NCT03824535|Deoxyglucose|deoxyglucose|mesh-list
65615205|NCT03824535|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65615206|NCT03824535|Fluorides|fluorides|mesh-list
65615207|NCT03824535|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65615208|NCT03824535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615209|NCT03824535|Cariostatic Agents|cariostatic agents|mesh-ancestor
65615210|NCT03824535|Protective Agents|protective agents|mesh-ancestor
65615211|NCT03824535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615212|NCT03824535|Antimetabolites|antimetabolites|mesh-ancestor
65615213|NCT03824535|Antiviral Agents|antiviral agents|mesh-ancestor
65615214|NCT03824535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65615215|NCT03113643|Azacitidine|azacitidine|mesh-list
65615216|NCT03113643|Venetoclax|venetoclax|mesh-list
65615217|NCT03113643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65615218|NCT03113643|Antimetabolites|antimetabolites|mesh-ancestor
65615219|NCT03113643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615220|NCT03113643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615221|NCT03113643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615222|NCT03091491|Nivolumab|nivolumab|mesh-list
65615223|NCT03091491|Ipilimumab|ipilimumab|mesh-list
65615224|NCT03091491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65615225|NCT03091491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615226|NCT03091491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65615227|NCT03091491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615228|NCT05598255|Dexamethasone|dexamethasone|mesh-list
65615229|NCT05598255|Levobupivacaine|levobupivacaine|mesh-list
65615230|NCT05598255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65615231|NCT05598255|Antiemetics|antiemetics|mesh-ancestor
65615232|NCT05598255|Autonomic Agents|autonomic agents|mesh-ancestor
65615233|NCT05598255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615234|NCT05598255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615235|NCT05598255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65615236|NCT05598255|Glucocorticoids|glucocorticoids|mesh-ancestor
65615237|NCT05598255|Hormones|hormones|mesh-ancestor
65615238|NCT05598255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65615239|NCT05598255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65615240|NCT05598255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615241|NCT05598255|Anesthetics, Local|anesthetics, local|mesh-ancestor
65615242|NCT05598255|Anesthetics|anesthetics|mesh-ancestor
65615243|NCT05598255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65615244|NCT05598255|Sensory System Agents|sensory system agents|mesh-ancestor
65615245|NCT04733235|Progesterone|progesterone|mesh-list
65615246|NCT04733235|Hormones|hormones|mesh-ancestor
65615247|NCT04733235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65615248|NCT04733235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615249|NCT04733235|Progestins|progestins|mesh-ancestor
65615250|NCT05598177|Dexmedetomidine|dexmedetomidine|mesh-list
65615251|NCT05598177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65615252|NCT05598177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65615253|NCT05598177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615254|NCT05598177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65615255|NCT05598177|Analgesics|analgesics|mesh-ancestor
65615256|NCT05598177|Sensory System Agents|sensory system agents|mesh-ancestor
65615257|NCT05598177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615258|NCT05598177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65615259|NCT05598177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65615260|NCT05598177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65615261|NCT05598177|Adrenergic Agents|adrenergic agents|mesh-ancestor
65615262|NCT05598177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65615263|NCT05598177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615264|NCT03740529|Rituximab|rituximab|mesh-list
65615265|NCT03740529|Venetoclax|venetoclax|mesh-list
65615266|NCT03740529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65615267|NCT03740529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615268|NCT03740529|Immunologic Factors|immunologic factors|mesh-ancestor
65615269|NCT03740529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615270|NCT03740529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65615271|NCT03029208|Darbepoetin alfa|darbepoetin alfa|mesh-list
65615272|NCT03029208|Hematinics|hematinics|mesh-ancestor
65615273|NCT05212623|Vaccines|vaccines|mesh-list
65615274|NCT05212623|Immunologic Factors|immunologic factors|mesh-ancestor
65615275|NCT05212623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615276|NCT03228537|Cisplatin|cisplatin|mesh-list
65615277|NCT03228537|Pemetrexed|pemetrexed|mesh-list
65615278|NCT03228537|Atezolizumab|atezolizumab|mesh-list
65412685|NCT00856037|Doxorubicin|doxorubicin|mesh-list
65615279|NCT03228537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65615280|NCT03228537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615281|NCT03228537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615282|NCT03228537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615283|NCT03228537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65266469|NCT02770430|Infliximab|infliximab|mesh-list
65615284|NCT03228537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65615285|NCT03228537|Immunologic Factors|immunologic factors|mesh-ancestor
65615286|NCT03228537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615287|NCT03693222|Morphine|morphine|mesh-list
65615288|NCT03693222|Tramadol|tramadol|mesh-list
65615289|NCT03693222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65615290|NCT03693222|Narcotics|narcotics|mesh-ancestor
65615291|NCT03693222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65615292|NCT03693222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615293|NCT03693222|Analgesics|analgesics|mesh-ancestor
65615294|NCT03693222|Sensory System Agents|sensory system agents|mesh-ancestor
65615295|NCT03693222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615296|NCT03215511|Selitrectinib|selitrectinib|mesh-list
65615297|NCT03215511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615298|NCT03215511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615299|NCT03693066|Chlorhexidine|chlorhexidine|mesh-list
65615300|NCT03693066|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65615301|NCT03693066|Disinfectants|disinfectants|mesh-list
65615302|NCT03693066|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65615303|NCT03693066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65615304|NCT03693066|Dermatologic Agents|dermatologic agents|mesh-ancestor
65615305|NCT03631641|Nivolumab|nivolumab|mesh-list
65615306|NCT03631641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65615307|NCT03631641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615308|NCT03631641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65615309|NCT03631641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615310|NCT03631875|Ketamine|ketamine|mesh-list
65615311|NCT03631875|Propofol|propofol|mesh-list
65615312|NCT03631875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65615313|NCT03631875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65615314|NCT03631875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615315|NCT03631875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65615316|NCT03631875|Anesthetics, General|anesthetics, general|mesh-ancestor
65615317|NCT03631875|Anesthetics|anesthetics|mesh-ancestor
65615318|NCT03631875|Analgesics|analgesics|mesh-ancestor
65615319|NCT03631875|Sensory System Agents|sensory system agents|mesh-ancestor
65615320|NCT03631875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615321|NCT03631875|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65615322|NCT03631875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65615323|NCT03631875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65615324|NCT03631875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65615325|NCT03631875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615326|NCT03631563|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65615327|NCT03631563|Immunologic Factors|immunologic factors|mesh-ancestor
65615328|NCT03631563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615329|NCT03158805|Liraglutide|liraglutide|mesh-list
65615330|NCT03158805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65615331|NCT03158805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615332|NCT03158805|Incretins|incretins|mesh-ancestor
65615333|NCT03158805|Hormones|hormones|mesh-ancestor
65615334|NCT03158805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65615335|NCT03197935|Paclitaxel|paclitaxel|mesh-list
65615336|NCT03197935|Cyclophosphamide|cyclophosphamide|mesh-list
65615337|NCT03197935|Doxorubicin|doxorubicin|mesh-list
65615338|NCT03197935|Atezolizumab|atezolizumab|mesh-list
65615339|NCT03197935|Antibodies|antibodies|mesh-list
65615340|NCT03197935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65615341|NCT03197935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615342|NCT03197935|Tubulin Modulators|tubulin modulators|mesh-ancestor
65615343|NCT03197935|Antimitotic Agents|antimitotic agents|mesh-ancestor
65615344|NCT03197935|Mitosis Modulators|mitosis modulators|mesh-ancestor
65615345|NCT03197935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615346|NCT03197935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65615347|NCT03197935|Immunologic Factors|immunologic factors|mesh-ancestor
65615348|NCT03197935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615349|NCT03197935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65615350|NCT03197935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65615351|NCT03197935|Alkylating Agents|alkylating agents|mesh-ancestor
65615352|NCT03197935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65615353|NCT03197935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65615354|NCT03197935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65615355|NCT03197935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65615357|NCT04941261|Vaccines|vaccines|mesh-list
65615358|NCT04941261|Immunologic Factors|immunologic factors|mesh-ancestor
65266470|NCT02770430|Basiliximab|basiliximab|mesh-list
65615359|NCT04941261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615360|NCT05597709|Insulin|insulin|mesh-list
65615361|NCT05597709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65615362|NCT05597709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615363|NCT04863885|Nivolumab|nivolumab|mesh-list
65615364|NCT04863885|Ipilimumab|ipilimumab|mesh-list
65615365|NCT04863885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65615366|NCT04863885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615367|NCT04863885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65615368|NCT04863885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615369|NCT02917629|Pioglitazone|pioglitazone|mesh-list
65615370|NCT02917629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65615371|NCT02917629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615372|NCT05417841|Insulin|insulin|mesh-list
65615373|NCT05417841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65615374|NCT05417841|Insulin Aspart|insulin aspart|mesh-list
65615375|NCT05417841|Insulin, Long-Acting|insulin, long-acting|mesh-list
65615376|NCT05417841|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65615377|NCT05417841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65615378|NCT05417841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615379|NCT03691038|Pregabalin|pregabalin|mesh-list
65615380|NCT03691038|Analgesics|analgesics|mesh-ancestor
65615381|NCT03691038|Sensory System Agents|sensory system agents|mesh-ancestor
65615382|NCT03691038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615383|NCT03691038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615384|NCT03691038|Anticonvulsants|anticonvulsants|mesh-ancestor
65615385|NCT03691038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65615386|NCT03691038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65615387|NCT03691038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615388|NCT03691038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65615389|NCT03691038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65615390|NCT03691038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65615391|NCT03691038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65615392|NCT03691038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65615393|NCT02927847|Nicotine|nicotine|mesh-list
65615394|NCT02927847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65615395|NCT02927847|Autonomic Agents|autonomic agents|mesh-ancestor
65615396|NCT02927847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615397|NCT02927847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615398|NCT02927847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65615399|NCT02927847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65615400|NCT02927847|Cholinergic Agents|cholinergic agents|mesh-ancestor
65615401|NCT02927847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65615402|NCT02927847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615403|NCT03682692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65615404|NCT03682692|Protease Inhibitors|protease inhibitors|mesh-ancestor
65615405|NCT03682692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615406|NCT03682692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615407|NCT02886585|Pembrolizumab|pembrolizumab|mesh-list
65615408|NCT02886585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65615409|NCT02886585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615410|NCT01568853|Norepinephrine|norepinephrine|mesh-list
65615411|NCT01568853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65615412|NCT01568853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65615413|NCT01568853|Adrenergic Agents|adrenergic agents|mesh-ancestor
65615414|NCT01568853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65615415|NCT01568853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615416|NCT01568853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615417|NCT01568853|Sympathomimetics|sympathomimetics|mesh-ancestor
65615418|NCT01568853|Autonomic Agents|autonomic agents|mesh-ancestor
65615419|NCT01568853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615420|NCT01568853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65615421|NCT02960438|Quetmolimab|quetmolimab|mesh-list
65615422|NCT02960438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65615423|NCT03926052|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65615424|NCT03926052|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65615425|NCT03926052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615426|NCT03926052|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65615427|NCT03926052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65615428|NCT03926052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65615429|NCT03926052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615430|NCT03926052|Dopamine Agents|dopamine agents|mesh-ancestor
65615431|NCT03926052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65615432|NCT05411991|Chlorthalidone|chlorthalidone|mesh-list
65615433|NCT05411991|Acetazolamide|acetazolamide|mesh-list
65615434|NCT05411991|Bumetanide|bumetanide|mesh-list
65615435|NCT05411991|Diuretics|diuretics|mesh-list
65615436|NCT05411991|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
65615437|NCT05411991|Natriuretic Agents|natriuretic agents|mesh-ancestor
65615438|NCT05411991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615439|NCT05411991|Anticonvulsants|anticonvulsants|mesh-ancestor
65615440|NCT05411991|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65615441|NCT05411991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615442|NCT05411991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615443|NCT05411991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65615444|NCT05411991|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65615445|NCT05411991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65615446|NCT03690414|Atropine|atropine|mesh-list
65615447|NCT03690414|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65615448|NCT03690414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65615449|NCT03690414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65615450|NCT03690414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65615451|NCT03690414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65615452|NCT03690414|Autonomic Agents|autonomic agents|mesh-ancestor
65615453|NCT03690414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615454|NCT03690414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615455|NCT03690414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65615456|NCT03690414|Respiratory System Agents|respiratory system agents|mesh-ancestor
65615457|NCT03690414|Mydriatics|mydriatics|mesh-ancestor
65615458|NCT03690414|Parasympatholytics|parasympatholytics|mesh-ancestor
65615459|NCT03690414|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65615460|NCT03690414|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65615461|NCT03690414|Cholinergic Agents|cholinergic agents|mesh-ancestor
65615462|NCT03690414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65615463|NCT03690414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615464|NCT02959970|Dapsone|dapsone|mesh-list
65615465|NCT02959970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65615466|NCT02959970|Antimalarials|antimalarials|mesh-ancestor
65615467|NCT02959970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65615468|NCT02959970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65615469|NCT02959970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65615470|NCT02959970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615471|NCT02959970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615472|NCT02959970|Leprostatic Agents|leprostatic agents|mesh-ancestor
65615473|NCT02959970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65615474|NCT03779334|Risdiplam|risdiplam|mesh-list
65615475|NCT03779334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65615476|NCT03779334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615477|NCT03779334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615478|NCT02740335|Protein C|protein c|mesh-list
65615479|NCT02740335|Protein S|protein s|mesh-list
65615480|NCT02740335|Thrombin|thrombin|mesh-list
65615481|NCT02740335|Hemostatics|hemostatics|mesh-ancestor
65615482|NCT02740335|Coagulants|coagulants|mesh-ancestor
65615483|NCT02740335|Anticoagulants|anticoagulants|mesh-ancestor
65615484|NCT02740335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65615485|NCT02740335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65615486|NCT02740335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615487|NCT03580369|Omalizumab|omalizumab|mesh-list
65615488|NCT03580369|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65615489|NCT03580369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65615490|NCT03580369|Respiratory System Agents|respiratory system agents|mesh-ancestor
65615491|NCT05351151|Lidocaine|lidocaine|mesh-list
65615492|NCT05351151|Anesthetics, Local|anesthetics, local|mesh-ancestor
65615493|NCT05351151|Anesthetics|anesthetics|mesh-ancestor
65615494|NCT05351151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65615495|NCT05351151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615496|NCT05351151|Sensory System Agents|sensory system agents|mesh-ancestor
65615497|NCT05351151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615498|NCT05351151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65615499|NCT05351151|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65615500|NCT05351151|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65615501|NCT05351151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65615502|NCT05351151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615503|NCT01568931|Coal Tar|coal tar|mesh-list
65615504|NCT01568931|Keratolytic Agents|keratolytic agents|mesh-ancestor
65615505|NCT01568931|Dermatologic Agents|dermatologic agents|mesh-ancestor
65615506|NCT04800367|Denosumab|denosumab|mesh-list
65615507|NCT04800367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65615508|NCT04800367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615509|NCT05523609|Vitamin D|vitamin d|mesh-list
65615510|NCT05523609|Letrozole|letrozole|mesh-list
65615511|NCT05523609|Vitamins|vitamins|mesh-ancestor
65615512|NCT05523609|Micronutrients|micronutrients|mesh-ancestor
65615513|NCT05523609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615514|NCT05523609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65615515|NCT05523609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615516|NCT05523609|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65615517|NCT05523609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65615518|NCT05523609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615519|NCT05523609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615520|NCT05523609|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65615521|NCT05523609|Hormone Antagonists|hormone antagonists|mesh-ancestor
65615522|NCT05523609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65615523|NCT03713658|Risperidone|risperidone|mesh-list
65615524|NCT03713658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65615525|NCT03713658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65615526|NCT03713658|Serotonin Agents|serotonin agents|mesh-ancestor
65615527|NCT03713658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65615528|NCT03713658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615529|NCT03713658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615530|NCT03713658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65615531|NCT03713658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65615532|NCT03713658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65615533|NCT03713658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65615534|NCT03713658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65615535|NCT03713658|Dopamine Agents|dopamine agents|mesh-ancestor
65615536|NCT03713658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65615537|NCT03713658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65615538|NCT04603365|Temozolomide|temozolomide|mesh-list
65615539|NCT04603365|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65615540|NCT04603365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65615541|NCT04603365|Alkylating Agents|alkylating agents|mesh-ancestor
65615542|NCT04603365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615543|NCT04603365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615544|NCT04603365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615545|NCT05475717|Alprostadil|alprostadil|mesh-list
65615546|NCT05475717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65615547|NCT05475717|Vasodilator Agents|vasodilator agents|mesh-ancestor
65615548|NCT05475717|Urological Agents|urological agents|mesh-ancestor
65615549|NCT05133687|Bupivacaine|bupivacaine|mesh-list
65615550|NCT05133687|Anesthetics, Local|anesthetics, local|mesh-ancestor
65615551|NCT05133687|Anesthetics|anesthetics|mesh-ancestor
65615552|NCT05133687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65615553|NCT05133687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615554|NCT05133687|Sensory System Agents|sensory system agents|mesh-ancestor
65615555|NCT05133687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615556|NCT03685032|Dexamethasone|dexamethasone|mesh-list
65615557|NCT03685032|Ondansetron|ondansetron|mesh-list
65615558|NCT03685032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65615559|NCT03685032|Antiemetics|antiemetics|mesh-ancestor
65615560|NCT03685032|Autonomic Agents|autonomic agents|mesh-ancestor
65615561|NCT03685032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615562|NCT03685032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615563|NCT03685032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65615564|NCT03685032|Glucocorticoids|glucocorticoids|mesh-ancestor
65615565|NCT03685032|Hormones|hormones|mesh-ancestor
65615566|NCT03685032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65615567|NCT03685032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65615568|NCT03685032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615569|NCT03685032|Antipruritics|antipruritics|mesh-ancestor
65615570|NCT03685032|Dermatologic Agents|dermatologic agents|mesh-ancestor
65615571|NCT03685032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65615572|NCT03685032|Serotonin Agents|serotonin agents|mesh-ancestor
65615573|NCT03685032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65266478|NCT00918203|Carboplatin|carboplatin|mesh-list
65615574|NCT03685032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615575|NCT03685032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65615576|NCT03685032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65615577|NCT03685032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65615578|NCT03685032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65412987|NCT00854711|Autonomic Agents|autonomic agents|mesh-ancestor
65615579|NCT03685032|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65615580|NCT02451111|Rituximab|rituximab|mesh-list
65615581|NCT02451111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65615582|NCT02451111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615583|NCT02451111|Immunologic Factors|immunologic factors|mesh-ancestor
65615584|NCT02451111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615585|NCT02451111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65615586|NCT03689010|Azelaic acid|azelaic acid|mesh-list
65615587|NCT03689010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615588|NCT03689010|Dermatologic Agents|dermatologic agents|mesh-ancestor
65615589|NCT03710772|Cytarabine|cytarabine|mesh-list
65615590|NCT03710772|Dexamethasone|dexamethasone|mesh-list
65615591|NCT03710772|Dexamethasone acetate|dexamethasone acetate|mesh-list
65615592|NCT03710772|Cyclophosphamide|cyclophosphamide|mesh-list
65615593|NCT03710772|Rituximab|rituximab|mesh-list
65615594|NCT03710772|Doxorubicin|doxorubicin|mesh-list
65615595|NCT03710772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65615596|NCT03710772|Methotrexate|methotrexate|mesh-list
65615597|NCT03710772|Vincristine|vincristine|mesh-list
65615598|NCT03710772|Venetoclax|venetoclax|mesh-list
65615599|NCT03710772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65615600|NCT03710772|Antibodies|antibodies|mesh-list
65615601|NCT03710772|Immunoglobulins|immunoglobulins|mesh-list
65615602|NCT03710772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65615603|NCT03710772|BB 1101|bb 1101|mesh-list
65615604|NCT03710772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65615605|NCT03710772|Immunologic Factors|immunologic factors|mesh-ancestor
65615606|NCT03710772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615607|NCT03710772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65615608|NCT03710772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65615609|NCT03710772|Alkylating Agents|alkylating agents|mesh-ancestor
65615610|NCT03710772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615611|NCT03710772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615612|NCT03710772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65615613|NCT03710772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65615614|NCT03710772|Antiemetics|antiemetics|mesh-ancestor
65615615|NCT03710772|Autonomic Agents|autonomic agents|mesh-ancestor
65615616|NCT03710772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615617|NCT03710772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65615618|NCT03710772|Glucocorticoids|glucocorticoids|mesh-ancestor
65615619|NCT03710772|Hormones|hormones|mesh-ancestor
65615620|NCT03710772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65615621|NCT03710772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65615622|NCT03710772|Protease Inhibitors|protease inhibitors|mesh-ancestor
65615623|NCT03710772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615624|NCT03710772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65615625|NCT03710772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65615626|NCT03710772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65615627|NCT03710772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65615628|NCT03710772|Abortifacient Agents|abortifacient agents|mesh-ancestor
65615629|NCT03710772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65615630|NCT03710772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65615631|NCT03710772|Antimetabolites|antimetabolites|mesh-ancestor
65615632|NCT03710772|Dermatologic Agents|dermatologic agents|mesh-ancestor
65615633|NCT03710772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65615634|NCT03710772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65615635|NCT03710772|Antiviral Agents|antiviral agents|mesh-ancestor
65615636|NCT03710772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65615637|NCT03710772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65615638|NCT03710772|Tubulin Modulators|tubulin modulators|mesh-ancestor
65615639|NCT03710772|Antimitotic Agents|antimitotic agents|mesh-ancestor
65615640|NCT03710772|Mitosis Modulators|mitosis modulators|mesh-ancestor
65615641|NCT05451771|Dexamethasone|dexamethasone|mesh-list
65615642|NCT05451771|Dexamethasone acetate|dexamethasone acetate|mesh-list
65615643|NCT05451771|Venetoclax|venetoclax|mesh-list
65615644|NCT05451771|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65615645|NCT05451771|Daratumumab|daratumumab|mesh-list
65615646|NCT05451771|Pomalidomide|pomalidomide|mesh-list
65615647|NCT05451771|Ixazomib|ixazomib|mesh-list
65615648|NCT05451771|BB 1101|bb 1101|mesh-list
65615649|NCT05451771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65615650|NCT05451771|Antiemetics|antiemetics|mesh-ancestor
65615651|NCT05451771|Autonomic Agents|autonomic agents|mesh-ancestor
65615652|NCT05451771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615653|NCT05451771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615654|NCT05451771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65615655|NCT05451771|Glucocorticoids|glucocorticoids|mesh-ancestor
65615656|NCT05451771|Hormones|hormones|mesh-ancestor
65615657|NCT05451771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65615658|NCT05451771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65615659|NCT05451771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615660|NCT05451771|Protease Inhibitors|protease inhibitors|mesh-ancestor
65615661|NCT05451771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615662|NCT05451771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615663|NCT05451771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65615664|NCT05451771|Alkylating Agents|alkylating agents|mesh-ancestor
65615665|NCT05451771|Immunologic Factors|immunologic factors|mesh-ancestor
65615666|NCT05451771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65615667|NCT05451771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65615668|NCT05451771|Growth Substances|growth substances|mesh-ancestor
65615669|NCT05451771|Growth Inhibitors|growth inhibitors|mesh-ancestor
65615671|NCT03680976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65615672|NCT03684876|Diuretics|diuretics|mesh-list
65615673|NCT03684876|Natriuretic Agents|natriuretic agents|mesh-ancestor
65615674|NCT03684876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615675|NCT05387343|Vaccines|vaccines|mesh-list
65615676|NCT05387343|Immunologic Factors|immunologic factors|mesh-ancestor
65615677|NCT05387343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615678|NCT04220775|Atezolizumab|atezolizumab|mesh-list
65615679|NCT04220775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615680|NCT01381887|Canagliflozin|canagliflozin|mesh-list
65615681|NCT01381887|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65615682|NCT01381887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615683|NCT01381887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65615684|NCT01381887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615685|NCT04877379|Ceftibuten|ceftibuten|mesh-list
65615686|NCT04877379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65615687|NCT04877379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65615688|NCT01382745|Nimotuzumab|nimotuzumab|mesh-list
65615689|NCT01382745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65615690|NCT01382745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615691|NCT03684330|Vitamin D|vitamin d|mesh-list
65615692|NCT03684330|Vitamins|vitamins|mesh-ancestor
65615693|NCT03684330|Micronutrients|micronutrients|mesh-ancestor
65615694|NCT03684330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615695|NCT03684330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65615696|NCT03688464|Diphenhydramine|diphenhydramine|mesh-list
65615697|NCT03688464|Promethazine|promethazine|mesh-list
65615698|NCT03688464|Melatonin|melatonin|mesh-list
65615699|NCT03688464|Antioxidants|antioxidants|mesh-ancestor
65615700|NCT03688464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615701|NCT03688464|Protective Agents|protective agents|mesh-ancestor
65615702|NCT03688464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615703|NCT03688464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65615704|NCT03688464|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65615705|NCT03688464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65615706|NCT03688464|Anesthetics, Local|anesthetics, local|mesh-ancestor
65615707|NCT03688464|Anesthetics|anesthetics|mesh-ancestor
65615708|NCT03688464|Sensory System Agents|sensory system agents|mesh-ancestor
65615709|NCT03688464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615710|NCT03688464|Antiemetics|antiemetics|mesh-ancestor
65615711|NCT03688464|Autonomic Agents|autonomic agents|mesh-ancestor
65615712|NCT03688464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65615713|NCT03688464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65615714|NCT03688464|Histamine Antagonists|histamine antagonists|mesh-ancestor
65615715|NCT03688464|Histamine Agents|histamine agents|mesh-ancestor
65615716|NCT03688464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65615717|NCT03688464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65615718|NCT03688464|Antipruritics|antipruritics|mesh-ancestor
65615719|NCT03688464|Dermatologic Agents|dermatologic agents|mesh-ancestor
65615720|NCT03503370|Chlorhexidine|chlorhexidine|mesh-list
65615721|NCT03503370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65615722|NCT03503370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65615723|NCT03503370|Disinfectants|disinfectants|mesh-ancestor
65615724|NCT01381809|Epoetin Alfa|epoetin alfa|mesh-list
65615725|NCT01381809|Hematinics|hematinics|mesh-ancestor
65615726|NCT03677466|Tenecteplase|tenecteplase|mesh-list
65615727|NCT03677466|Streptokinase|streptokinase|mesh-list
65615728|NCT03677466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65615729|NCT03677466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65615730|NCT03677466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615731|NCT03447132|Fulvestrant|fulvestrant|mesh-list
65615732|NCT03447132|Goserelin|goserelin|mesh-list
65615733|NCT03447132|Palbociclib|palbociclib|mesh-list
65615734|NCT03447132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65615735|NCT03447132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615736|NCT03447132|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65615737|NCT03447132|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65615738|NCT03447132|Hormone Antagonists|hormone antagonists|mesh-ancestor
65615739|NCT03447132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65615740|NCT03447132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615741|NCT03447132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65615742|NCT03447132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615743|NCT03447132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615744|NCT04133623|Ibuprofen|ibuprofen|mesh-list
65615745|NCT04133623|Ketorolac|ketorolac|mesh-list
65615746|NCT04133623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65615747|NCT04133623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65615748|NCT04133623|Analgesics|analgesics|mesh-ancestor
65615749|NCT04133623|Sensory System Agents|sensory system agents|mesh-ancestor
65615750|NCT04133623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615751|NCT04133623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615752|NCT04133623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65615753|NCT04133623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65615754|NCT04133623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65615755|NCT04133623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615756|NCT04133623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615757|NCT03425838|Letrozole|letrozole|mesh-list
65615758|NCT03425838|Fulvestrant|fulvestrant|mesh-list
65615759|NCT03425838|Palbociclib|palbociclib|mesh-list
65615760|NCT03425838|Anastrozole|anastrozole|mesh-list
65615761|NCT03425838|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65615762|NCT03425838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615763|NCT03425838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65615764|NCT03425838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615765|NCT03425838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615766|NCT03425838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65615767|NCT03425838|Hormone Antagonists|hormone antagonists|mesh-ancestor
65615768|NCT03425838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65615769|NCT03425838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615770|NCT03425838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65615771|NCT03425838|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65615772|NCT03425838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65615773|NCT03398148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65615774|NCT03398148|Immunologic Factors|immunologic factors|mesh-ancestor
65615775|NCT03398148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615776|NCT03188185|Naltrexone|naltrexone|mesh-list
65615777|NCT03188185|Buprenorphine|buprenorphine|mesh-list
65615778|NCT03188185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65615779|NCT03188185|Narcotics|narcotics|mesh-ancestor
65615780|NCT03188185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65615781|NCT03188185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615782|NCT03188185|Analgesics|analgesics|mesh-ancestor
65615783|NCT03188185|Sensory System Agents|sensory system agents|mesh-ancestor
65615784|NCT03188185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615785|NCT03188185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65615786|NCT03188185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65615787|NCT03679182|Olanzapine|olanzapine|mesh-list
65615788|NCT03679182|Antiemetics|antiemetics|mesh-ancestor
65615789|NCT03679182|Autonomic Agents|autonomic agents|mesh-ancestor
65615790|NCT03679182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615791|NCT03679182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615792|NCT03679182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65615793|NCT03679182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65615794|NCT03679182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65615795|NCT03679182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65615796|NCT03679182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65615797|NCT03679182|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65615798|NCT03679182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65615799|NCT03679182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65615800|NCT03679182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615801|NCT03679182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65615802|NCT03679182|Serotonin Agents|serotonin agents|mesh-ancestor
65615803|NCT03184987|Albuterol|albuterol|mesh-list
65615804|NCT03184987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65615805|NCT03184987|Autonomic Agents|autonomic agents|mesh-ancestor
65615806|NCT03184987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615807|NCT03184987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615808|NCT03184987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65615809|NCT03184987|Respiratory System Agents|respiratory system agents|mesh-ancestor
65615810|NCT03184987|Tocolytic Agents|tocolytic agents|mesh-ancestor
65615811|NCT03184987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65615812|NCT03184987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65615813|NCT03184987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65615814|NCT03184987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65615815|NCT03184987|Adrenergic Agents|adrenergic agents|mesh-ancestor
65615816|NCT03184987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65615817|NCT03184987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615818|NCT03193333|Timolol|timolol|mesh-list
65615819|NCT03193333|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65615820|NCT03193333|Dorzolamide|dorzolamide|mesh-list
65615821|NCT03193333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65615822|NCT03193333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65615823|NCT03193333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65615824|NCT03193333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65615825|NCT03193333|Adrenergic Agents|adrenergic agents|mesh-ancestor
65615826|NCT03193333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65615827|NCT03193333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615828|NCT03193333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615829|NCT03193333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65615830|NCT03193333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65615831|NCT03193333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65615832|NCT03193333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65615833|NCT03193333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65615834|NCT03193333|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65615835|NCT03193333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615836|NCT03026166|Nivolumab|nivolumab|mesh-list
65615837|NCT03026166|Ipilimumab|ipilimumab|mesh-list
65615838|NCT03026166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65615839|NCT03026166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615840|NCT03026166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65615841|NCT03026166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615842|NCT03345576|Methyltestosterone|methyltestosterone|mesh-list
65615843|NCT03345576|Testosterone|testosterone|mesh-list
65615844|NCT03345576|Testosterone undecanoate|testosterone undecanoate|mesh-list
65615845|NCT03345576|Testosterone enanthate|testosterone enanthate|mesh-list
65615846|NCT03345576|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65615847|NCT03345576|Androgens|androgens|mesh-ancestor
65615848|NCT03345576|Hormones|hormones|mesh-ancestor
65615849|NCT03345576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65615850|NCT03345576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615851|NCT03345576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65615852|NCT03345576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615853|NCT03345576|Anabolic Agents|anabolic agents|mesh-ancestor
65615854|NCT03573648|Palbociclib|palbociclib|mesh-list
65615855|NCT03573648|Avelumab|avelumab|mesh-list
65615856|NCT03573648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615857|NCT03573648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65615858|NCT03573648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615859|NCT03573648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615860|NCT03573648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65615861|NCT03026088|Bisoprolol|bisoprolol|mesh-list
65615862|NCT03026088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65615863|NCT03026088|Sympatholytics|sympatholytics|mesh-ancestor
65615864|NCT03026088|Autonomic Agents|autonomic agents|mesh-ancestor
65615865|NCT03026088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615866|NCT03026088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615867|NCT03026088|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65615868|NCT03026088|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65615869|NCT03026088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65615870|NCT03026088|Adrenergic Agents|adrenergic agents|mesh-ancestor
65615871|NCT03026088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65615872|NCT03026088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615873|NCT03328884|Irinotecan|irinotecan|mesh-list
65615874|NCT03328884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65615875|NCT03328884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65615876|NCT03328884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615877|NCT03328884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615878|NCT03328884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615879|NCT03678792|Morphine|morphine|mesh-list
65615880|NCT03678792|Buprenorphine|buprenorphine|mesh-list
65615881|NCT03678792|Tramadol|tramadol|mesh-list
65615882|NCT03678792|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65615883|NCT03678792|Naloxone|naloxone|mesh-list
65413288|NCT00523848|Immunologic Factors|immunologic factors|mesh-ancestor
65615885|NCT03678792|Narcotics|narcotics|mesh-ancestor
65615886|NCT03678792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65615887|NCT03678792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615888|NCT03678792|Analgesics|analgesics|mesh-ancestor
65615889|NCT03678792|Sensory System Agents|sensory system agents|mesh-ancestor
65615890|NCT03678792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65615891|NCT03678792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65615892|NCT03678480|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65615893|NCT03678480|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65615894|NCT03678480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65615895|NCT03181789|Interleukin-12|interleukin-12|mesh-list
65615896|NCT03181789|Vaccines|vaccines|mesh-list
65615897|NCT03181789|Immunologic Factors|immunologic factors|mesh-ancestor
65615898|NCT03181789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615899|NCT03181789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65615900|NCT03181789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65615901|NCT03181789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65615902|NCT03181789|Growth Substances|growth substances|mesh-ancestor
65615903|NCT03181789|Growth Inhibitors|growth inhibitors|mesh-ancestor
65615904|NCT03181789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615905|NCT03678090|Plasminogen|plasminogen|mesh-list
65615906|NCT03678090|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65615907|NCT03678090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65615908|NCT03678090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65615909|NCT03678090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615910|NCT03678012|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65615911|NCT03678012|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65615912|NCT03678012|Hematinics|hematinics|mesh-ancestor
65615913|NCT03678012|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65615914|NCT03678012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65615915|NCT03678012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65615916|NCT03678012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65615917|NCT03259074|Adalimumab|adalimumab|mesh-list
65615918|NCT03259074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65615919|NCT03259074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65615920|NCT03676374|Prucalopride|prucalopride|mesh-list
65615921|NCT03676374|Laxatives|laxatives|mesh-ancestor
65615922|NCT03676374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65615923|NCT03676374|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65615924|NCT03676374|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65615925|NCT03676374|Serotonin Agents|serotonin agents|mesh-ancestor
65615926|NCT03676374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65615927|NCT03676374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615928|NCT03676374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615929|NCT03676296|Puerarin|puerarin|mesh-list
65615930|NCT03676296|Vasodilator Agents|vasodilator agents|mesh-ancestor
65615931|NCT03676140|Azithromycin|azithromycin|mesh-list
65615932|NCT03676140|Ivermectin|ivermectin|mesh-list
65615933|NCT03676140|Albendazole|albendazole|mesh-list
65615934|NCT03676140|Diethylcarbamazine|diethylcarbamazine|mesh-list
65615935|NCT03676140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65615936|NCT03676140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65615937|NCT03676140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65615938|NCT03676140|Anthelmintics|anthelmintics|mesh-ancestor
65615939|NCT03676140|Anticestodal Agents|anticestodal agents|mesh-ancestor
65615940|NCT03676140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65615941|NCT03676140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65615942|NCT03676140|Tubulin Modulators|tubulin modulators|mesh-ancestor
65615943|NCT03676140|Antimitotic Agents|antimitotic agents|mesh-ancestor
65615944|NCT03676140|Mitosis Modulators|mitosis modulators|mesh-ancestor
65615945|NCT03676140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615946|NCT03676140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615947|NCT03676140|Filaricides|filaricides|mesh-ancestor
65615948|NCT03676140|Antinematodal Agents|antinematodal agents|mesh-ancestor
65615949|NCT03676140|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65615950|NCT03676140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615951|NCT04059198|Tenofovir|tenofovir|mesh-list
65615952|NCT04059198|Antiviral Agents|antiviral agents|mesh-ancestor
65615953|NCT04059198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65615954|NCT04059198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65615955|NCT04059198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65615956|NCT04059198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615957|NCT04059198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615958|NCT04059198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65615959|NCT04059198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65615960|NCT04058964|Pembrolizumab|pembrolizumab|mesh-list
65615961|NCT04058964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65615962|NCT04058964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615963|NCT03246906|Cyclosporine|cyclosporine|mesh-list
65615964|NCT03246906|Sirolimus|sirolimus|mesh-list
65615965|NCT03246906|Mycophenolic Acid|mycophenolic acid|mesh-list
65615966|NCT03246906|Cyclophosphamide|cyclophosphamide|mesh-list
65615967|NCT03246906|Cyclosporins|cyclosporins|mesh-list
65615968|NCT03246906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65615969|NCT03246906|Immunologic Factors|immunologic factors|mesh-ancestor
65615970|NCT03246906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615971|NCT03246906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65615972|NCT03246906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65615973|NCT03246906|Alkylating Agents|alkylating agents|mesh-ancestor
65615974|NCT03246906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65615975|NCT03246906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65615976|NCT03246906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65615977|NCT03246906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65615978|NCT03246906|Antifungal Agents|antifungal agents|mesh-ancestor
65615979|NCT03246906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65615980|NCT03246906|Dermatologic Agents|dermatologic agents|mesh-ancestor
65615981|NCT03246906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65615982|NCT03246906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65615983|NCT03246906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65615984|NCT03246906|Antitubercular Agents|antitubercular agents|mesh-ancestor
65615985|NCT03246906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65615986|NCT02875314|Cyclophosphamide|cyclophosphamide|mesh-list
65615987|NCT02875314|Thiotepa|thiotepa|mesh-list
65615988|NCT02875314|Cisplatin|cisplatin|mesh-list
65615989|NCT02875314|Carboplatin|carboplatin|mesh-list
65615990|NCT02875314|Methotrexate|methotrexate|mesh-list
65615991|NCT02875314|Etoposide|etoposide|mesh-list
65615992|NCT02875314|Etoposide phosphate|etoposide phosphate|mesh-list
65615993|NCT02875314|Vincristine|vincristine|mesh-list
65615994|NCT02875314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65615995|NCT02875314|Immunologic Factors|immunologic factors|mesh-ancestor
65615996|NCT02875314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65615997|NCT02875314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65615998|NCT02875314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65615999|NCT02875314|Alkylating Agents|alkylating agents|mesh-ancestor
65616000|NCT02875314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616001|NCT02875314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616002|NCT02875314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65616003|NCT02875314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65616004|NCT02875314|Abortifacient Agents|abortifacient agents|mesh-ancestor
65616005|NCT02875314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65616006|NCT02875314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65616007|NCT02875314|Antimetabolites|antimetabolites|mesh-ancestor
65616008|NCT02875314|Dermatologic Agents|dermatologic agents|mesh-ancestor
65616009|NCT02875314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616010|NCT02875314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65616011|NCT02875314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65616012|NCT02875314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65616013|NCT02875314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65616014|NCT02875314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65616015|NCT02875314|Tubulin Modulators|tubulin modulators|mesh-ancestor
65616016|NCT02875314|Antimitotic Agents|antimitotic agents|mesh-ancestor
65616017|NCT02875314|Mitosis Modulators|mitosis modulators|mesh-ancestor
65616018|NCT03675594|Cobalt|cobalt|mesh-list
65616019|NCT03675594|Chromium|chromium|mesh-list
65616020|NCT03675594|Trace Elements|trace elements|mesh-ancestor
65616021|NCT03675594|Micronutrients|micronutrients|mesh-ancestor
65616022|NCT03675594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616023|NCT03671538|Pemetrexed|pemetrexed|mesh-list
65616024|NCT03671538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616025|NCT03671538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616026|NCT03671538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616027|NCT03671538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65616028|NCT03671538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65616029|NCT05420467|Paclitaxel|paclitaxel|mesh-list
65616030|NCT05420467|Docetaxel|docetaxel|mesh-list
65616031|NCT05420467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65616032|NCT05420467|Cyclophosphamide|cyclophosphamide|mesh-list
65616033|NCT05420467|Carboplatin|carboplatin|mesh-list
65413440|NCT01009944|Atenolol|atenolol|mesh-list
65616034|NCT05420467|Trastuzumab|trastuzumab|mesh-list
65616035|NCT05420467|Epirubicin|epirubicin|mesh-list
65616036|NCT05420467|Pertuzumab|pertuzumab|mesh-list
65616037|NCT05420467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65616038|NCT05420467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616040|NCT05420467|Antimitotic Agents|antimitotic agents|mesh-ancestor
65616041|NCT05420467|Mitosis Modulators|mitosis modulators|mesh-ancestor
65616042|NCT05420467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616043|NCT05420467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65616044|NCT05420467|Immunologic Factors|immunologic factors|mesh-ancestor
65616045|NCT05420467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616046|NCT05420467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65616047|NCT05420467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65616048|NCT05420467|Alkylating Agents|alkylating agents|mesh-ancestor
65616049|NCT05420467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65616050|NCT05420467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65616051|NCT05420467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65616052|NCT05420467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65616053|NCT05420467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65616054|NCT05420467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616055|NCT03022578|Lomustine|lomustine|mesh-list
65616056|NCT03022578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65616057|NCT03022578|Alkylating Agents|alkylating agents|mesh-ancestor
65616058|NCT03022578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616059|NCT03022578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616060|NCT03671070|Epinephrine|epinephrine|mesh-list
65616061|NCT03671070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65616062|NCT03671070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65616063|NCT03671070|Adrenergic Agents|adrenergic agents|mesh-ancestor
65616064|NCT03671070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65616065|NCT03671070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616066|NCT03671070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616067|NCT03671070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65616068|NCT03671070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65616069|NCT03671070|Autonomic Agents|autonomic agents|mesh-ancestor
65616070|NCT03671070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65616071|NCT03671070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65616072|NCT03671070|Respiratory System Agents|respiratory system agents|mesh-ancestor
65616073|NCT03671070|Mydriatics|mydriatics|mesh-ancestor
65616074|NCT03671070|Sympathomimetics|sympathomimetics|mesh-ancestor
65616075|NCT03671070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65616076|NCT03670758|Protein S|protein s|mesh-list
65616077|NCT03670758|Anticoagulants|anticoagulants|mesh-ancestor
65616078|NCT03674658|Propafenone|propafenone|mesh-list
65616079|NCT03674658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65616080|NCT03674658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65616081|NCT03674658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65616082|NCT03674658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65616083|NCT03674658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616084|NCT03623256|Fentanyl|fentanyl|mesh-list
65616085|NCT03623256|Bupivacaine|bupivacaine|mesh-list
65616086|NCT03623256|Anesthetics, Local|anesthetics, local|mesh-ancestor
65616087|NCT03623256|Anesthetics|anesthetics|mesh-ancestor
65616088|NCT03623256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65616089|NCT03623256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616090|NCT03623256|Sensory System Agents|sensory system agents|mesh-ancestor
65616091|NCT03623256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65616092|NCT03623256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65616093|NCT03623256|Narcotics|narcotics|mesh-ancestor
65616094|NCT03623256|Analgesics|analgesics|mesh-ancestor
65616095|NCT03623256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65616096|NCT03623256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65616097|NCT03623256|Anesthetics, General|anesthetics, general|mesh-ancestor
65616098|NCT03082014|Losartan|losartan|mesh-list
65616099|NCT03082014|Atenolol|atenolol|mesh-list
65616100|NCT03082014|Amlodipine|amlodipine|mesh-list
65616101|NCT03082014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65616102|NCT03082014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65616103|NCT03082014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65616104|NCT03082014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616105|NCT03082014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65616106|NCT03082014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616107|NCT03082014|Vasodilator Agents|vasodilator agents|mesh-ancestor
65616108|NCT03082014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65616109|NCT03082014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65616110|NCT03082014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65616111|NCT03082014|Sympatholytics|sympatholytics|mesh-ancestor
65616112|NCT03082014|Autonomic Agents|autonomic agents|mesh-ancestor
65616113|NCT03082014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65616114|NCT03082014|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65616115|NCT03082014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65616116|NCT03082014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65616117|NCT03082014|Adrenergic Agents|adrenergic agents|mesh-ancestor
65616118|NCT03082014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65616120|NCT03670212|Yohimbine|yohimbine|mesh-list
65616121|NCT03670212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65616122|NCT03670212|Mydriatics|mydriatics|mesh-ancestor
65616123|NCT03670212|Autonomic Agents|autonomic agents|mesh-ancestor
65616124|NCT03670212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65616125|NCT03670212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616126|NCT03670212|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65616127|NCT03670212|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65616128|NCT03670212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65616129|NCT03670212|Adrenergic Agents|adrenergic agents|mesh-ancestor
65616130|NCT03670212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65616131|NCT03670212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616132|NCT03670212|Urological Agents|urological agents|mesh-ancestor
65616133|NCT03165955|Paclitaxel|paclitaxel|mesh-list
65616134|NCT03165955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65616135|NCT03165955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616136|NCT03165955|Tubulin Modulators|tubulin modulators|mesh-ancestor
65616137|NCT03165955|Antimitotic Agents|antimitotic agents|mesh-ancestor
65616138|NCT03165955|Mitosis Modulators|mitosis modulators|mesh-ancestor
65616139|NCT03165955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616140|NCT05263921|Ritonavir|ritonavir|mesh-list
65616141|NCT05263921|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65616142|NCT05263921|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65616143|NCT05263921|Protease Inhibitors|protease inhibitors|mesh-ancestor
65616144|NCT05263921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616145|NCT05263921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616146|NCT05263921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65616147|NCT05263921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65616148|NCT05263921|Antiviral Agents|antiviral agents|mesh-ancestor
65616149|NCT05263921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65616150|NCT05263921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65616151|NCT05263921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65616152|NCT03673332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65616153|NCT03673332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616154|NCT03673332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616155|NCT02400216|Cholic Acids|cholic acids|mesh-list
65616156|NCT02400216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65616157|NCT03048084|Levetiracetam|levetiracetam|mesh-list
65616158|NCT03048084|Valproic Acid|valproic acid|mesh-list
65616159|NCT03048084|Anticonvulsants|anticonvulsants|mesh-ancestor
65616160|NCT03048084|Nootropic Agents|nootropic agents|mesh-ancestor
65616161|NCT03048084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616162|NCT03048084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616163|NCT03048084|GABA Agents|gaba agents|mesh-ancestor
65616164|NCT03048084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65616165|NCT03048084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616166|NCT03048084|Antimanic Agents|antimanic agents|mesh-ancestor
65616167|NCT03048084|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65616168|NCT03048084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65616169|NCT03048084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65616170|NCT02329860|Apatinib|apatinib|mesh-list
65616171|NCT02329860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65266492|NCT00644319|Analgesics|analgesics|mesh-ancestor
65616172|NCT02329860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65616173|NCT02329860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616174|NCT02329860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616175|NCT02251548|Cyclophosphamide|cyclophosphamide|mesh-list
65616176|NCT02251548|Rituximab|rituximab|mesh-list
65616177|NCT02251548|Fludarabine|fludarabine|mesh-list
65616178|NCT02251548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65616179|NCT02251548|Immunologic Factors|immunologic factors|mesh-ancestor
65616180|NCT02251548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616181|NCT02251548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65616182|NCT02251548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65616183|NCT02251548|Alkylating Agents|alkylating agents|mesh-ancestor
65616184|NCT02251548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616185|NCT02251548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616186|NCT02251548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65616187|NCT02251548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65616188|NCT03165721|Guadecitabine|guadecitabine|mesh-list
65616189|NCT03165721|Azacitidine|azacitidine|mesh-list
65616190|NCT03165721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616191|NCT03165721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65616192|NCT03165721|Antimetabolites|antimetabolites|mesh-ancestor
65616193|NCT03165721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616194|NCT03165721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616195|NCT02224872|Mycophenolic Acid|mycophenolic acid|mesh-list
65616196|NCT02224872|Cyclophosphamide|cyclophosphamide|mesh-list
65616197|NCT02224872|Fludarabine|fludarabine|mesh-list
65616198|NCT02224872|Tacrolimus|tacrolimus|mesh-list
65616199|NCT02224872|Thymoglobulin|thymoglobulin|mesh-list
65616200|NCT02224872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65616201|NCT02224872|Immunologic Factors|immunologic factors|mesh-ancestor
65616202|NCT02224872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616203|NCT02224872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65616204|NCT02224872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65616205|NCT02224872|Alkylating Agents|alkylating agents|mesh-ancestor
65616206|NCT02224872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616207|NCT02224872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616208|NCT02224872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65616209|NCT02224872|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65616210|NCT02224872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616211|NCT02224872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65616212|NCT02224872|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65616213|NCT02224872|Antitubercular Agents|antitubercular agents|mesh-ancestor
65616214|NCT02224872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65616215|NCT02224872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65616216|NCT02187198|Buprenorphine|buprenorphine|mesh-list
65616217|NCT02187198|Naloxone|naloxone|mesh-list
65616218|NCT02187198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65616219|NCT02187198|Narcotics|narcotics|mesh-ancestor
65616220|NCT02187198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65616221|NCT02187198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616222|NCT02187198|Analgesics|analgesics|mesh-ancestor
65616223|NCT02187198|Sensory System Agents|sensory system agents|mesh-ancestor
65616224|NCT02187198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65616225|NCT02187198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65616226|NCT03735121|Atezolizumab|atezolizumab|mesh-list
65616227|NCT03735121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616228|NCT04969705|Dexmedetomidine|dexmedetomidine|mesh-list
65616229|NCT04969705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65616230|NCT04969705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65616231|NCT04969705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616232|NCT04969705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65616233|NCT04969705|Analgesics|analgesics|mesh-ancestor
65616234|NCT04969705|Sensory System Agents|sensory system agents|mesh-ancestor
65616235|NCT04969705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65616236|NCT04969705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65616237|NCT04969705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65616238|NCT04969705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65616239|NCT04969705|Adrenergic Agents|adrenergic agents|mesh-ancestor
65616240|NCT04969705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65616241|NCT04969705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616242|NCT02085408|Cytarabine|cytarabine|mesh-list
65616243|NCT02085408|Decitabine|decitabine|mesh-list
65616244|NCT02085408|Clofarabine|clofarabine|mesh-list
65616245|NCT02085408|Azacitidine|azacitidine|mesh-list
65616246|NCT02085408|Daunorubicin|daunorubicin|mesh-list
65616247|NCT02085408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65616248|NCT02085408|Antimetabolites|antimetabolites|mesh-ancestor
65616249|NCT02085408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616250|NCT02085408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616251|NCT02085408|Antiviral Agents|antiviral agents|mesh-ancestor
65616252|NCT02085408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65616253|NCT02085408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65616254|NCT02085408|Immunologic Factors|immunologic factors|mesh-ancestor
65616255|NCT02085408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616256|NCT02085408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65616257|NCT02085408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65616258|NCT02085408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65616259|NCT02085408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616260|NCT01829958|Prednisone|prednisone|mesh-list
65616261|NCT01829958|Rituximab|rituximab|mesh-list
65616262|NCT01829958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65616263|NCT01829958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616264|NCT01829958|Immunologic Factors|immunologic factors|mesh-ancestor
65616265|NCT01829958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616266|NCT01829958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65616267|NCT01829958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65616268|NCT01829958|Glucocorticoids|glucocorticoids|mesh-ancestor
65616269|NCT01829958|Hormones|hormones|mesh-ancestor
65616270|NCT01829958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65616271|NCT01829958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65616272|NCT03021642|Tepotinib|tepotinib|mesh-list
65616273|NCT03021642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616274|NCT01374984|Immunoglobulins|immunoglobulins|mesh-list
65616275|NCT01374984|gamma-Globulins|gamma-globulins|mesh-list
65616276|NCT01374984|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65616277|NCT01374984|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65616278|NCT01374984|Immunologic Factors|immunologic factors|mesh-ancestor
65616279|NCT01374984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616280|NCT00867048|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65616281|NCT00867048|Antiviral Agents|antiviral agents|mesh-ancestor
65616282|NCT00867048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65616283|NCT03023046|Prednisone|prednisone|mesh-list
65616284|NCT03023046|Cortisone|cortisone|mesh-list
65616285|NCT03023046|Cyclophosphamide|cyclophosphamide|mesh-list
65616286|NCT03023046|Rituximab|rituximab|mesh-list
65616287|NCT03023046|Doxorubicin|doxorubicin|mesh-list
65616288|NCT03023046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65616289|NCT03023046|Etoposide|etoposide|mesh-list
65616290|NCT03023046|Vincristine|vincristine|mesh-list
65616291|NCT03023046|Etoposide phosphate|etoposide phosphate|mesh-list
65616292|NCT03023046|Imatinib Mesylate|imatinib mesylate|mesh-list
65616293|NCT03023046|Daunorubicin|daunorubicin|mesh-list
65616294|NCT03023046|Dasatinib|dasatinib|mesh-list
65616295|NCT03023046|Podophyllotoxin|podophyllotoxin|mesh-list
65616296|NCT03023046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65616297|NCT03023046|Antibodies|antibodies|mesh-list
65616298|NCT03023046|Immunoglobulins|immunoglobulins|mesh-list
65616299|NCT03023046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65616300|NCT03023046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65616301|NCT03023046|Immunologic Factors|immunologic factors|mesh-ancestor
65616302|NCT03023046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616303|NCT03023046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65616304|NCT03023046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65616305|NCT03023046|Alkylating Agents|alkylating agents|mesh-ancestor
65616306|NCT03023046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616307|NCT03023046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616308|NCT03023046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65616309|NCT03023046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65616310|NCT03023046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65616311|NCT03023046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65616312|NCT03023046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616313|NCT03023046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65616314|NCT03023046|Glucocorticoids|glucocorticoids|mesh-ancestor
65616315|NCT03023046|Hormones|hormones|mesh-ancestor
65616316|NCT03023046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65616317|NCT03023046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65616318|NCT03023046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65616319|NCT03023046|Tubulin Modulators|tubulin modulators|mesh-ancestor
65616320|NCT03023046|Antimitotic Agents|antimitotic agents|mesh-ancestor
65616321|NCT03023046|Mitosis Modulators|mitosis modulators|mesh-ancestor
65616322|NCT03023046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65616323|NCT03023046|Keratolytic Agents|keratolytic agents|mesh-ancestor
65616324|NCT03023046|Dermatologic Agents|dermatologic agents|mesh-ancestor
65616325|NCT03668262|Atracurium|atracurium|mesh-list
65616326|NCT03668262|Cisatracurium|cisatracurium|mesh-list
65616327|NCT03668262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65616328|NCT03668262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65616329|NCT03668262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65616330|NCT03668262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65616331|NCT03668262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616332|NCT03668262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65616333|NCT03668262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65616334|NCT03668262|Cholinergic Agents|cholinergic agents|mesh-ancestor
65616335|NCT03668262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65616336|NCT03668262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616337|NCT03668964|Vitamin D|vitamin d|mesh-list
65616338|NCT03668964|Cholecalciferol|cholecalciferol|mesh-list
65413733|NCT00872651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65616339|NCT03668964|Vitamins|vitamins|mesh-list
65616340|NCT03668964|Vitamin E|vitamin e|mesh-list
65616341|NCT03668964|Tocopherols|tocopherols|mesh-list
65616342|NCT03668964|alpha-Tocopherol|alpha-tocopherol|mesh-list
65616343|NCT03668964|Vitamin A|vitamin a|mesh-list
65616344|NCT03668964|Riboflavin|riboflavin|mesh-list
65616345|NCT03668964|Vitamin B Complex|vitamin b complex|mesh-list
65616346|NCT03668964|Micronutrients|micronutrients|mesh-ancestor
65616347|NCT03668964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616348|NCT03668964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65616349|NCT03668964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65616350|NCT03668964|Antioxidants|antioxidants|mesh-ancestor
65616351|NCT03668964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616352|NCT03668964|Protective Agents|protective agents|mesh-ancestor
65616353|NCT03668964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65616354|NCT03668964|Dermatologic Agents|dermatologic agents|mesh-ancestor
65616355|NCT03668730|Paclitaxel|paclitaxel|mesh-list
65616356|NCT03668730|Fluorouracil|fluorouracil|mesh-list
65616357|NCT03668730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65616358|NCT03668730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616359|NCT03668730|Tubulin Modulators|tubulin modulators|mesh-ancestor
65616360|NCT03668730|Antimitotic Agents|antimitotic agents|mesh-ancestor
65616361|NCT03668730|Mitosis Modulators|mitosis modulators|mesh-ancestor
65616362|NCT03668730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616363|NCT03668730|Antimetabolites|antimetabolites|mesh-ancestor
65616364|NCT03668730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65616365|NCT03668730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65616366|NCT03668730|Immunologic Factors|immunologic factors|mesh-ancestor
65616367|NCT03668730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616368|NCT03021018|Lorazepam|lorazepam|mesh-list
65616369|NCT03021018|Brivaracetam|brivaracetam|mesh-list
65616370|NCT03021018|Anticonvulsants|anticonvulsants|mesh-ancestor
65616371|NCT03021018|Antiemetics|antiemetics|mesh-ancestor
65616372|NCT03021018|Autonomic Agents|autonomic agents|mesh-ancestor
65616373|NCT03021018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65616374|NCT03021018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616375|NCT03021018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65616376|NCT03021018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65616377|NCT03021018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65616378|NCT03021018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65616379|NCT03021018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65616380|NCT03021018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65616381|NCT03021018|GABA Modulators|gaba modulators|mesh-ancestor
65616382|NCT03021018|GABA Agents|gaba agents|mesh-ancestor
65616383|NCT03021018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65616384|NCT03021018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616385|NCT02509507|Pembrolizumab|pembrolizumab|mesh-list
65616386|NCT02509507|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
65616387|NCT02509507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65616388|NCT02509507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616389|NCT03175549|Apremilast|apremilast|mesh-list
65616390|NCT03175549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65616391|NCT03175549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65616392|NCT03175549|Analgesics|analgesics|mesh-ancestor
65616393|NCT03175549|Sensory System Agents|sensory system agents|mesh-ancestor
65616394|NCT03175549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65616395|NCT03175549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616396|NCT03175549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65616397|NCT03175549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65616398|NCT03175549|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65616399|NCT03175549|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65616400|NCT03175549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616401|NCT03175549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616402|NCT01314937|Mebendazole|mebendazole|mesh-list
65616403|NCT01314937|Piperazine|piperazine|mesh-list
65616404|NCT01314937|Piperazine citrate|piperazine citrate|mesh-list
65616405|NCT01314937|DMP 777|dmp 777|mesh-list
65616406|NCT01314937|Antinematodal Agents|antinematodal agents|mesh-ancestor
65616407|NCT01314937|Anthelmintics|anthelmintics|mesh-ancestor
65616408|NCT01314937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65616409|NCT01314937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65616410|NCT01314937|Tubulin Modulators|tubulin modulators|mesh-ancestor
65616411|NCT01314937|Antimitotic Agents|antimitotic agents|mesh-ancestor
65616412|NCT01314937|Mitosis Modulators|mitosis modulators|mesh-ancestor
65616413|NCT01314937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616414|NCT01314937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616415|NCT01314937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616416|NCT04718155|Atorvastatin|atorvastatin|mesh-list
65616417|NCT04718155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65616418|NCT04718155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65616419|NCT04718155|Antimetabolites|antimetabolites|mesh-ancestor
65616420|NCT04718155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616421|NCT04718155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65616422|NCT04718155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65616423|NCT04718155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616424|NCT04668859|Midodrine|midodrine|mesh-list
65616425|NCT04668859|Sympathomimetics|sympathomimetics|mesh-ancestor
65616426|NCT04668859|Autonomic Agents|autonomic agents|mesh-ancestor
65616427|NCT04668859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65616428|NCT04668859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616429|NCT04668859|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65616430|NCT04668859|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65616431|NCT04668859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65616432|NCT04668859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65616433|NCT04668859|Adrenergic Agents|adrenergic agents|mesh-ancestor
65616434|NCT04668859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65616435|NCT04668859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616436|NCT04648969|Hormones|hormones|mesh-list
65616437|NCT04648969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65616438|NCT04648969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616439|NCT02924688|Fluticasone|fluticasone|mesh-list
65616440|NCT02924688|Albuterol|albuterol|mesh-list
65616441|NCT02924688|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65616442|NCT02924688|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65616443|NCT02924688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65616444|NCT02924688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65616445|NCT02924688|Autonomic Agents|autonomic agents|mesh-ancestor
65616446|NCT02924688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65616447|NCT02924688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616448|NCT02924688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65616449|NCT02924688|Respiratory System Agents|respiratory system agents|mesh-ancestor
65616450|NCT02924688|Dermatologic Agents|dermatologic agents|mesh-ancestor
65616451|NCT02924688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65616452|NCT02924688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65616453|NCT02924688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65616454|NCT02924688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65616455|NCT02924688|Adrenergic Agents|adrenergic agents|mesh-ancestor
65616456|NCT02924688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65616457|NCT02924688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616458|NCT02924688|Tocolytic Agents|tocolytic agents|mesh-ancestor
65616459|NCT02924688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65616460|NCT02924688|Glucocorticoids|glucocorticoids|mesh-ancestor
65616461|NCT02924688|Hormones|hormones|mesh-ancestor
65616462|NCT02924688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65616463|NCT02924688|Sympathomimetics|sympathomimetics|mesh-ancestor
65616464|NCT03668418|Gemcitabine|gemcitabine|mesh-list
65616465|NCT03668418|Camptothecin|camptothecin|mesh-list
65616466|NCT03668418|Docetaxel|docetaxel|mesh-list
65616467|NCT03668418|Fluorouracil|fluorouracil|mesh-list
65616468|NCT03668418|Oxaliplatin|oxaliplatin|mesh-list
65616469|NCT03668418|Irinotecan|irinotecan|mesh-list
65616470|NCT03668418|Epirubicin|epirubicin|mesh-list
65616471|NCT03668418|Taxane|taxane|mesh-list
65616472|NCT03668418|Antimetabolites|antimetabolites|mesh-list
65616473|NCT03668418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65616474|NCT03668418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616475|NCT03668418|Tubulin Modulators|tubulin modulators|mesh-ancestor
65616476|NCT03668418|Antimitotic Agents|antimitotic agents|mesh-ancestor
65616477|NCT03668418|Mitosis Modulators|mitosis modulators|mesh-ancestor
65616478|NCT03668418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616479|NCT03668418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65616480|NCT03668418|Antiviral Agents|antiviral agents|mesh-ancestor
65616481|NCT03668418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65616482|NCT03668418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616483|NCT03668418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65616484|NCT03668418|Immunologic Factors|immunologic factors|mesh-ancestor
65616485|NCT03668418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616486|NCT03668418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65616487|NCT03668418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65616488|NCT03668418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65616489|NCT03668418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65616490|NCT02177695|Gemcitabine|gemcitabine|mesh-list
65616491|NCT02177695|Doxorubicin|doxorubicin|mesh-list
65616492|NCT02177695|Methotrexate|methotrexate|mesh-list
65616493|NCT02177695|Vinblastine|vinblastine|mesh-list
65616494|NCT02177695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616495|NCT02177695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65616496|NCT02177695|Antimetabolites|antimetabolites|mesh-ancestor
65616497|NCT02177695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616498|NCT02177695|Antiviral Agents|antiviral agents|mesh-ancestor
65616499|NCT02177695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65616500|NCT02177695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616501|NCT02177695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65616502|NCT02177695|Immunologic Factors|immunologic factors|mesh-ancestor
65616503|NCT02177695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616504|NCT02177695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65616505|NCT02177695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65616506|NCT02177695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65616507|NCT02177695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65616508|NCT02177695|Abortifacient Agents|abortifacient agents|mesh-ancestor
65616509|NCT02177695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65616510|NCT02177695|Dermatologic Agents|dermatologic agents|mesh-ancestor
65616511|NCT02177695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65616512|NCT02177695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65616513|NCT02177695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65616514|NCT02177695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65616515|NCT02177695|Tubulin Modulators|tubulin modulators|mesh-ancestor
65616516|NCT02177695|Antimitotic Agents|antimitotic agents|mesh-ancestor
65616517|NCT02177695|Mitosis Modulators|mitosis modulators|mesh-ancestor
65616518|NCT03011892|Triamcinolone|triamcinolone|mesh-list
65616519|NCT03011892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65616520|NCT03011892|Glucocorticoids|glucocorticoids|mesh-ancestor
65616521|NCT03011892|Hormones|hormones|mesh-ancestor
65616522|NCT03011892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65616523|NCT03011892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616524|NCT02125513|Paclitaxel|paclitaxel|mesh-list
65616525|NCT02125513|Carboplatin|carboplatin|mesh-list
65616526|NCT02125513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65616527|NCT02125513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616528|NCT02125513|Tubulin Modulators|tubulin modulators|mesh-ancestor
65616529|NCT02125513|Antimitotic Agents|antimitotic agents|mesh-ancestor
65616530|NCT02125513|Mitosis Modulators|mitosis modulators|mesh-ancestor
65616531|NCT02125513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616532|NCT04575948|Chlorhexidine|chlorhexidine|mesh-list
65616533|NCT04575948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65616534|NCT04575948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65616535|NCT04575948|Disinfectants|disinfectants|mesh-ancestor
65616536|NCT03666546|Methamphetamine|methamphetamine|mesh-list
65616537|NCT03666546|Lactulose|lactulose|mesh-list
65616538|NCT03666546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65616539|NCT03666546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65616540|NCT03666546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616541|NCT03666546|Sympathomimetics|sympathomimetics|mesh-ancestor
65616542|NCT03666546|Autonomic Agents|autonomic agents|mesh-ancestor
65616543|NCT03666546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65616544|NCT03666546|Dopamine Agents|dopamine agents|mesh-ancestor
65616545|NCT03666546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65616546|NCT03666546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616547|NCT03666546|Adrenergic Agents|adrenergic agents|mesh-ancestor
65616548|NCT03666546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65616549|NCT03666546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65616550|NCT03666546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65616551|NCT03666546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65616552|NCT03012828|Moxidectin|moxidectin|mesh-list
65616553|NCT03012828|Anthelmintics|anthelmintics|mesh-ancestor
65616554|NCT03012828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65616555|NCT03012828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65616556|NCT03012828|Antinematodal Agents|antinematodal agents|mesh-ancestor
65616557|NCT03666390|Midazolam|midazolam|mesh-list
65616558|NCT03666390|Ketamine|ketamine|mesh-list
65616559|NCT03666390|Analgesics|analgesics|mesh-ancestor
65616560|NCT03666390|Sensory System Agents|sensory system agents|mesh-ancestor
65616561|NCT03666390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65616562|NCT03666390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616563|NCT03666390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65616564|NCT03666390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65616565|NCT03666390|Anesthetics, General|anesthetics, general|mesh-ancestor
65413956|NCT00874523|Antiviral Agents|antiviral agents|mesh-ancestor
65616566|NCT03666390|Anesthetics|anesthetics|mesh-ancestor
65616567|NCT03666390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65616568|NCT03666390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65616569|NCT03666390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65616570|NCT03666390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65616571|NCT03666390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616572|NCT03666390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65616573|NCT03666390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65616574|NCT03666390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65616575|NCT03666390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65616576|NCT03666390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65616577|NCT03666390|GABA Modulators|gaba modulators|mesh-ancestor
65616578|NCT03666390|GABA Agents|gaba agents|mesh-ancestor
65616579|NCT03003390|Enoxaparin|enoxaparin|mesh-list
65616580|NCT03003390|Anticoagulants|anticoagulants|mesh-ancestor
65616581|NCT03003390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65616582|NCT03003390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65616583|NCT03003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616584|NCT03003000|Ibuprofen|ibuprofen|mesh-list
65616585|NCT03003000|Caffeine|caffeine|mesh-list
65616586|NCT03003000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65616587|NCT03003000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65616588|NCT03003000|Analgesics|analgesics|mesh-ancestor
65616589|NCT03003000|Sensory System Agents|sensory system agents|mesh-ancestor
65616590|NCT03003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65616591|NCT03003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616592|NCT03003000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65616593|NCT03003000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65616594|NCT03003000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65616595|NCT03003000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616596|NCT03003000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616597|NCT03003000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65616598|NCT03003000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65616599|NCT03003000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65616600|NCT03003000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65616601|NCT03003000|Purinergic Agents|purinergic agents|mesh-ancestor
65616602|NCT03003000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65616603|NCT03665766|Cycloserine|cycloserine|mesh-list
65616604|NCT03665766|Tacrolimus|tacrolimus|mesh-list
65616605|NCT03665766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65616606|NCT03665766|Immunologic Factors|immunologic factors|mesh-ancestor
65616607|NCT03665766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616608|NCT03665766|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65616609|NCT03665766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616610|NCT03665766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616611|NCT03665766|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65616612|NCT03665766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65616613|NCT03665766|Renal Agents|renal agents|mesh-ancestor
65616614|NCT03665766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65616615|NCT03665766|Antitubercular Agents|antitubercular agents|mesh-ancestor
65616616|NCT03665766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65616617|NCT03665766|Antimetabolites|antimetabolites|mesh-ancestor
65616618|NCT03546894|Ceritinib|ceritinib|mesh-list
65616619|NCT03546894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616620|NCT03546894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65616621|NCT03546894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616622|NCT03546894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616623|NCT03637361|Methadone|methadone|mesh-list
65616624|NCT03637361|D-methadone|d-methadone|mesh-list
65616625|NCT03637361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65616626|NCT03637361|Narcotics|narcotics|mesh-ancestor
65616627|NCT03637361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65616628|NCT03637361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616629|NCT03637361|Analgesics|analgesics|mesh-ancestor
65616630|NCT03637361|Sensory System Agents|sensory system agents|mesh-ancestor
65616631|NCT03637361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65616632|NCT03637361|Antitussive Agents|antitussive agents|mesh-ancestor
65616633|NCT03637361|Respiratory System Agents|respiratory system agents|mesh-ancestor
65616634|NCT03637361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65616635|NCT04083599|Gemcitabine|gemcitabine|mesh-list
65616636|NCT04083599|Paclitaxel|paclitaxel|mesh-list
65616637|NCT04083599|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65616638|NCT04083599|Carboplatin|carboplatin|mesh-list
65616639|NCT04083599|Pembrolizumab|pembrolizumab|mesh-list
65616640|NCT04083599|Pemetrexed|pemetrexed|mesh-list
65616641|NCT04083599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65616642|NCT04083599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616643|NCT04083599|Tubulin Modulators|tubulin modulators|mesh-ancestor
65616644|NCT04083599|Antimitotic Agents|antimitotic agents|mesh-ancestor
65616645|NCT04083599|Mitosis Modulators|mitosis modulators|mesh-ancestor
65616646|NCT04083599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616647|NCT04083599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65616648|NCT04083599|Antimetabolites|antimetabolites|mesh-ancestor
65616649|NCT04083599|Antiviral Agents|antiviral agents|mesh-ancestor
65616650|NCT04083599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65616651|NCT04083599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616652|NCT04083599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65616653|NCT04083599|Immunologic Factors|immunologic factors|mesh-ancestor
65616654|NCT04083599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616655|NCT04083599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65616656|NCT04083599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65616657|NCT04083599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65616658|NCT00038675|Imatinib Mesylate|imatinib mesylate|mesh-list
65616659|NCT00038675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616660|NCT00038675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65616661|NCT00038675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616662|NCT00038675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616663|NCT03254459|Morphine|morphine|mesh-list
65616664|NCT03254459|Oxycodone|oxycodone|mesh-list
65616665|NCT03254459|Buprenorphine|buprenorphine|mesh-list
65616666|NCT03254459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65616667|NCT03254459|Narcotics|narcotics|mesh-ancestor
65616668|NCT03254459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65616669|NCT03254459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616670|NCT03254459|Analgesics|analgesics|mesh-ancestor
65616671|NCT03254459|Sensory System Agents|sensory system agents|mesh-ancestor
65616672|NCT03254459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65616673|NCT03254459|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65616674|NCT03620591|Lidocaine|lidocaine|mesh-list
65616675|NCT03620591|Anesthetics, Local|anesthetics, local|mesh-ancestor
65616676|NCT03620591|Anesthetics|anesthetics|mesh-ancestor
65616677|NCT03620591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65616678|NCT03620591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616679|NCT03620591|Sensory System Agents|sensory system agents|mesh-ancestor
65616680|NCT03620591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65616681|NCT03620591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65616682|NCT03620591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65616683|NCT03620591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65616684|NCT03620591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65616685|NCT03620591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616686|NCT02903381|Dexamethasone|dexamethasone|mesh-list
65616687|NCT02903381|Nivolumab|nivolumab|mesh-list
65616688|NCT02903381|Lenalidomide|lenalidomide|mesh-list
65616689|NCT02903381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65616690|NCT02903381|Antiemetics|antiemetics|mesh-ancestor
65616691|NCT02903381|Autonomic Agents|autonomic agents|mesh-ancestor
65616692|NCT02903381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65616693|NCT02903381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616694|NCT02903381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65616695|NCT02903381|Glucocorticoids|glucocorticoids|mesh-ancestor
65616696|NCT02903381|Hormones|hormones|mesh-ancestor
65616697|NCT02903381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65616698|NCT02903381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65616699|NCT02903381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616700|NCT02903381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65616701|NCT02903381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65616702|NCT02903381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616703|NCT02903381|Immunologic Factors|immunologic factors|mesh-ancestor
65616704|NCT02903381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65616705|NCT02903381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65616706|NCT02903381|Growth Substances|growth substances|mesh-ancestor
65616707|NCT02903381|Growth Inhibitors|growth inhibitors|mesh-ancestor
65616708|NCT05178953|Zinc|zinc|mesh-list
65616709|NCT05178953|Pentoxifylline|pentoxifylline|mesh-list
65616710|NCT05178953|Zinc Sulfate|zinc sulfate|mesh-list
65616711|NCT05178953|Trace Elements|trace elements|mesh-ancestor
65616712|NCT05178953|Micronutrients|micronutrients|mesh-ancestor
65616713|NCT05178953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616714|NCT05178953|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65616715|NCT05178953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616716|NCT05178953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616717|NCT05178953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65616718|NCT05178953|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65616719|NCT05178953|Protective Agents|protective agents|mesh-ancestor
65414148|NCT00875927|Zinc|zinc|mesh-list
65616720|NCT05178953|Vasodilator Agents|vasodilator agents|mesh-ancestor
65616721|NCT05178953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65616722|NCT05178953|Antioxidants|antioxidants|mesh-ancestor
65616723|NCT05178953|Astringents|astringents|mesh-ancestor
65616724|NCT05178953|Dermatologic Agents|dermatologic agents|mesh-ancestor
65616725|NCT02736617|Obinutuzumab|obinutuzumab|mesh-list
65616726|NCT02736617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65616727|NCT02736617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616728|NCT03251963|Enoxaparin|enoxaparin|mesh-list
65616729|NCT03251963|Enoxaparin sodium|enoxaparin sodium|mesh-list
65616730|NCT03251963|Anticoagulants|anticoagulants|mesh-ancestor
65616731|NCT03251963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65616732|NCT03251963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65616733|NCT03251963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616734|NCT03287219|Methylene Blue|methylene blue|mesh-list
65616735|NCT03287219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616736|NCT03287219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616737|NCT03286751|Insulin Lispro|insulin lispro|mesh-list
65616738|NCT03286751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65616739|NCT03286751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616740|NCT05572229|Lenalidomide|lenalidomide|mesh-list
65616741|NCT05572229|Daratumumab|daratumumab|mesh-list
65616742|NCT05572229|Immunologic Factors|immunologic factors|mesh-ancestor
65616743|NCT05572229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616744|NCT05572229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65616745|NCT05572229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65616746|NCT05572229|Growth Substances|growth substances|mesh-ancestor
65616747|NCT05572229|Growth Inhibitors|growth inhibitors|mesh-ancestor
65616748|NCT05572229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616749|NCT03249935|Azithromycin|azithromycin|mesh-list
65616750|NCT03249935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65616751|NCT03249935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65616752|NCT03622073|Misoprostol|misoprostol|mesh-list
65616753|NCT03622073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65616754|NCT03622073|Abortifacient Agents|abortifacient agents|mesh-ancestor
65616755|NCT03622073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65616756|NCT03622073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616757|NCT03622073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65616758|NCT03622073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65616759|NCT03622073|Oxytocics|oxytocics|mesh-ancestor
65616760|NCT03000348|Cysteamine|cysteamine|mesh-list
65616761|NCT03000348|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
65266507|NCT04224116|Coagulants|coagulants|mesh-ancestor
65616762|NCT03000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616763|NCT03664986|Bupivacaine|bupivacaine|mesh-list
65616764|NCT03664986|Anesthetics, Local|anesthetics, local|mesh-ancestor
65616765|NCT03664986|Anesthetics|anesthetics|mesh-ancestor
65616766|NCT03664986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65616767|NCT03664986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616768|NCT03664986|Sensory System Agents|sensory system agents|mesh-ancestor
65616769|NCT03664986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65616770|NCT03492918|Pembrolizumab|pembrolizumab|mesh-list
65616771|NCT03492918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65616772|NCT03492918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616773|NCT03247673|Bevacizumab|bevacizumab|mesh-list
65616774|NCT03247673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65616775|NCT03247673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616776|NCT03247673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65616777|NCT03247673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65616778|NCT03247673|Growth Substances|growth substances|mesh-ancestor
65616779|NCT03247673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616780|NCT03247673|Growth Inhibitors|growth inhibitors|mesh-ancestor
65616781|NCT03665610|Ozanimod|ozanimod|mesh-list
65616782|NCT03665610|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65616783|NCT03665610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616784|NCT03665610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65616785|NCT03665610|Immunologic Factors|immunologic factors|mesh-ancestor
65616786|NCT03665610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616787|NCT03664908|Antibodies|antibodies|mesh-list
65616788|NCT03664908|Immunologic Factors|immunologic factors|mesh-ancestor
65616789|NCT03664908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616790|NCT03665454|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65616791|NCT03665454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65616792|NCT03665454|Immunologic Factors|immunologic factors|mesh-ancestor
65616793|NCT03665454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616794|NCT03665454|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65616795|NCT03665454|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65616796|NCT03665454|Dopamine Agonists|dopamine agonists|mesh-ancestor
65616797|NCT03665454|Dopamine Agents|dopamine agents|mesh-ancestor
65616798|NCT03665454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65616799|NCT03665454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616800|NCT03664440|Nevirapine|nevirapine|mesh-list
65616801|NCT03664440|Rilpivirine|rilpivirine|mesh-list
65616802|NCT03664440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65616803|NCT03664440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65616804|NCT03664440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616805|NCT03664440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616806|NCT03664440|Antiviral Agents|antiviral agents|mesh-ancestor
65616807|NCT03664440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65616808|NCT03664440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65616809|NCT03664440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65616810|NCT03664440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65616811|NCT03664440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65616812|NCT03664596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65616813|NCT03664596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65616814|NCT03664596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65616815|NCT03282227|Oxazolidinones|oxazolidinones|mesh-list
65616816|NCT03282227|Zolmitriptan|zolmitriptan|mesh-list
65616817|NCT03282227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65616818|NCT03282227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65616819|NCT03282227|Serotonin Agents|serotonin agents|mesh-ancestor
65616820|NCT03282227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65616821|NCT03282227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616822|NCT03282227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616823|NCT03282227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65616824|NCT03282227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65616825|NCT03282227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616826|NCT03240575|Fluticasone|fluticasone|mesh-list
65616827|NCT03240575|Xhance|xhance|mesh-list
65616828|NCT03240575|Tiotropium Bromide|tiotropium bromide|mesh-list
65616829|NCT03240575|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65616830|NCT03240575|Olodaterol|olodaterol|mesh-list
65616831|NCT03240575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65616832|NCT03240575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65616833|NCT03240575|Autonomic Agents|autonomic agents|mesh-ancestor
65616834|NCT03240575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65616835|NCT03240575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616836|NCT03240575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65616837|NCT03240575|Respiratory System Agents|respiratory system agents|mesh-ancestor
65616838|NCT03240575|Dermatologic Agents|dermatologic agents|mesh-ancestor
65616839|NCT03240575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65616840|NCT03240575|Parasympatholytics|parasympatholytics|mesh-ancestor
65616841|NCT03240575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65616842|NCT03240575|Cholinergic Agents|cholinergic agents|mesh-ancestor
65616843|NCT03240575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65616844|NCT03240575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616845|NCT03240575|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65616846|NCT03240575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65616847|NCT03240575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65616848|NCT03240575|Adrenergic Agents|adrenergic agents|mesh-ancestor
65616849|NCT04034225|Pembrolizumab|pembrolizumab|mesh-list
65616850|NCT04034225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65616851|NCT04034225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616852|NCT03690947|Ranibizumab|ranibizumab|mesh-list
65616853|NCT03690947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65616854|NCT03690947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65616855|NCT03690947|Growth Substances|growth substances|mesh-ancestor
65616856|NCT03690947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616857|NCT03690947|Growth Inhibitors|growth inhibitors|mesh-ancestor
65616858|NCT03690947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616859|NCT03268499|Cisplatin|cisplatin|mesh-list
65616860|NCT03268499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616861|NCT02999178|Nintedanib|nintedanib|mesh-list
65616862|NCT02999178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616863|NCT02999178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65616864|NCT02999178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616865|NCT02999178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616866|NCT02999100|Oxytocin|oxytocin|mesh-list
65616867|NCT02999100|Oxytocics|oxytocics|mesh-ancestor
65616868|NCT02999100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65616869|NCT02999100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616870|NCT02749370|Etanercept|etanercept|mesh-list
65616871|NCT02749370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65616872|NCT02749370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65616873|NCT02749370|Analgesics|analgesics|mesh-ancestor
65616874|NCT02749370|Sensory System Agents|sensory system agents|mesh-ancestor
65616875|NCT02749370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65616876|NCT02749370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616877|NCT02749370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65616878|NCT02749370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65616879|NCT02749370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65616880|NCT02749370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65616881|NCT02749370|Immunologic Factors|immunologic factors|mesh-ancestor
65616882|NCT03618758|Paclitaxel|paclitaxel|mesh-list
65616883|NCT03618758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65616884|NCT03618758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616885|NCT03618758|Tubulin Modulators|tubulin modulators|mesh-ancestor
65616886|NCT03618758|Antimitotic Agents|antimitotic agents|mesh-ancestor
65616887|NCT03618758|Mitosis Modulators|mitosis modulators|mesh-ancestor
65616888|NCT03618758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616889|NCT03617900|Acetaminophen|acetaminophen|mesh-list
65616890|NCT03617900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65616891|NCT03617900|Analgesics|analgesics|mesh-ancestor
65616892|NCT03617900|Sensory System Agents|sensory system agents|mesh-ancestor
65616893|NCT03617900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65616894|NCT03617900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616895|NCT03617900|Antipyretics|antipyretics|mesh-ancestor
65616896|NCT05384366|Paclitaxel|paclitaxel|mesh-list
65616897|NCT05384366|Carboplatin|carboplatin|mesh-list
65616898|NCT05384366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65616899|NCT05384366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616900|NCT05384366|Tubulin Modulators|tubulin modulators|mesh-ancestor
65616901|NCT05384366|Antimitotic Agents|antimitotic agents|mesh-ancestor
65616902|NCT05384366|Mitosis Modulators|mitosis modulators|mesh-ancestor
65616903|NCT05384366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616904|NCT03616808|Hemostatics|hemostatics|mesh-list
65616905|NCT03616808|Coagulants|coagulants|mesh-ancestor
65616906|NCT03617510|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
65616907|NCT03617510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65616908|NCT03617510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65616909|NCT03617510|Analgesics|analgesics|mesh-ancestor
65616910|NCT03617510|Sensory System Agents|sensory system agents|mesh-ancestor
65616911|NCT03617510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65616912|NCT03617510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616913|NCT03617510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65616914|NCT03617510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65616915|NCT03617432|Prednisone|prednisone|mesh-list
65616916|NCT03617432|Cyclophosphamide|cyclophosphamide|mesh-list
65616917|NCT03617432|Doxorubicin|doxorubicin|mesh-list
65616918|NCT03617432|Etoposide|etoposide|mesh-list
65616919|NCT03617432|Vincristine|vincristine|mesh-list
65616920|NCT03617432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65616921|NCT03617432|Immunologic Factors|immunologic factors|mesh-ancestor
65616922|NCT03617432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616923|NCT03617432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65616924|NCT03617432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65616925|NCT03617432|Alkylating Agents|alkylating agents|mesh-ancestor
65616926|NCT03617432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616927|NCT03617432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616928|NCT03617432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65616929|NCT03617432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65616930|NCT03617432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65616931|NCT03617432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65616932|NCT03617432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616933|NCT03617432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65616934|NCT03617432|Glucocorticoids|glucocorticoids|mesh-ancestor
65616935|NCT03617432|Hormones|hormones|mesh-ancestor
65616936|NCT03617432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65616937|NCT03617432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65616938|NCT03617432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65616939|NCT03617432|Tubulin Modulators|tubulin modulators|mesh-ancestor
65616940|NCT03617432|Antimitotic Agents|antimitotic agents|mesh-ancestor
65616941|NCT03617432|Mitosis Modulators|mitosis modulators|mesh-ancestor
65616942|NCT02996682|Ribavirin|ribavirin|mesh-list
65616943|NCT02996682|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65616944|NCT02996682|Antimetabolites|antimetabolites|mesh-ancestor
65616945|NCT02996682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616946|NCT02996682|Antiviral Agents|antiviral agents|mesh-ancestor
65616947|NCT02996682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65616948|NCT02873702|Lansoprazole|lansoprazole|mesh-list
65616949|NCT02873702|Dexlansoprazole|dexlansoprazole|mesh-list
65616950|NCT02873702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65616951|NCT02873702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65616952|NCT02873702|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65616953|NCT02873702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616954|NCT02873702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616955|NCT03616262|Lidocaine|lidocaine|mesh-list
65616956|NCT03616262|Anesthetics, Local|anesthetics, local|mesh-ancestor
65616957|NCT03616262|Anesthetics|anesthetics|mesh-ancestor
65616958|NCT03616262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65616959|NCT03616262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616960|NCT03616262|Sensory System Agents|sensory system agents|mesh-ancestor
65616961|NCT03616262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65616962|NCT03616262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65616963|NCT03616262|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65616964|NCT03616262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65616965|NCT03616262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65616966|NCT03616262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616967|NCT03615950|Vitamin D|vitamin d|mesh-list
65616968|NCT03615950|Vitamins|vitamins|mesh-ancestor
65616969|NCT03615950|Micronutrients|micronutrients|mesh-ancestor
65616970|NCT03615950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616971|NCT03615950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65616972|NCT02911116|Ustekinumab|ustekinumab|mesh-list
65616973|NCT02911116|Dermatologic Agents|dermatologic agents|mesh-ancestor
65616974|NCT03664050|Letrozole|letrozole|mesh-list
65616975|NCT03664050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616976|NCT03664050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65616977|NCT03664050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65616978|NCT03664050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616979|NCT03664050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616980|NCT03664050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65616981|NCT03664050|Hormone Antagonists|hormone antagonists|mesh-ancestor
65616982|NCT03664050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65616983|NCT03664050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616984|NCT04055844|Decitabine|decitabine|mesh-list
65616985|NCT04055844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65616986|NCT04055844|Antimetabolites|antimetabolites|mesh-ancestor
65616987|NCT04055844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65616988|NCT04055844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616989|NCT04055844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65616990|NCT04055688|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65616991|NCT04055688|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65616992|NCT04055688|Dermatologic Agents|dermatologic agents|mesh-ancestor
65616993|NCT04054284|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65616994|NCT04054284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65616995|NCT04494438|Rituximab|rituximab|mesh-list
65616996|NCT04494438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65616997|NCT04494438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65616998|NCT04494438|Immunologic Factors|immunologic factors|mesh-ancestor
65616999|NCT04494438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617000|NCT04494438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65617001|NCT04057482|Dequalinium|dequalinium|mesh-list
65617002|NCT04057482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65617003|NCT04057482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617004|NCT03662412|Sirolimus|sirolimus|mesh-list
65617005|NCT03662412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65617006|NCT03662412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617007|NCT03662412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65617008|NCT03662412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617009|NCT03662412|Antifungal Agents|antifungal agents|mesh-ancestor
65617010|NCT03662412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65617011|NCT03662412|Immunologic Factors|immunologic factors|mesh-ancestor
65617012|NCT03662412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617013|NCT02870972|Berotralstat|berotralstat|mesh-list
65617014|NCT02870972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617015|NCT02870972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617016|NCT03214367|Insulin|insulin|mesh-list
65617017|NCT03214367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65617018|NCT03214367|Insulin Glargine|insulin glargine|mesh-list
65617019|NCT03214367|Insulin Lispro|insulin lispro|mesh-list
65617020|NCT03214367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65617021|NCT03214367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617022|NCT03662958|Leuprolide|leuprolide|mesh-list
65617023|NCT03662958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65617024|NCT03662958|Fertility Agents|fertility agents|mesh-ancestor
65617025|NCT03662958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65617026|NCT03662958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617027|NCT03662958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65617028|NCT03662958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617030|NCT03231371|Analgesics|analgesics|mesh-ancestor
65617031|NCT03231371|Sensory System Agents|sensory system agents|mesh-ancestor
65617032|NCT03231371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65617033|NCT03231371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617034|NCT03231371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65617035|NCT03231371|Vasodilator Agents|vasodilator agents|mesh-ancestor
65617036|NCT03231371|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65617037|NCT03231371|Purinergic Agonists|purinergic agonists|mesh-ancestor
65617038|NCT03231371|Purinergic Agents|purinergic agents|mesh-ancestor
65617039|NCT03231371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65617040|NCT03231371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617041|NCT03663114|Lenvatinib|lenvatinib|mesh-list
65266520|NCT02770274|Analgesics|analgesics|mesh-ancestor
65617042|NCT03663114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617043|NCT03663114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65617044|NCT03663114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617045|NCT03663114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617046|NCT03526679|Lenvatinib|lenvatinib|mesh-list
65617047|NCT03526679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617048|NCT03526679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65617049|NCT03526679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617050|NCT03526679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617051|NCT04057326|Pancreatin|pancreatin|mesh-list
65617052|NCT04057326|Pancrelipase|pancrelipase|mesh-list
65617053|NCT04057326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65617054|NCT02870348|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65617055|NCT02870348|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65617056|NCT02870348|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65617057|NCT02870348|Protease Inhibitors|protease inhibitors|mesh-ancestor
65617058|NCT02870348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617059|NCT02870348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617060|NCT05384210|Gabapentin|gabapentin|mesh-list
65617061|NCT05384210|Milnacipran|milnacipran|mesh-list
65617062|NCT05384210|Levomilnacipran|levomilnacipran|mesh-list
65617063|NCT05384210|Analgesics|analgesics|mesh-ancestor
65617064|NCT05384210|Sensory System Agents|sensory system agents|mesh-ancestor
65617065|NCT05384210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65617066|NCT05384210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617067|NCT05384210|Anticonvulsants|anticonvulsants|mesh-ancestor
65617068|NCT05384210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65617069|NCT05384210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65617070|NCT05384210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65617071|NCT05384210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65617072|NCT05384210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65617073|NCT05384210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65617074|NCT05384210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65617075|NCT05384210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617076|NCT05384210|Antimanic Agents|antimanic agents|mesh-ancestor
65617077|NCT05384210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65617078|NCT05384210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65617079|NCT05384210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65617080|NCT05384210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65617081|NCT05384210|Antidepressive Agents|antidepressive agents|mesh-ancestor
65617082|NCT02032394|Chlorhexidine|chlorhexidine|mesh-list
65617083|NCT02032394|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65617084|NCT02032394|Povidone-Iodine|povidone-iodine|mesh-list
65617085|NCT02032394|Povidone|povidone|mesh-list
65617086|NCT02032394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65617087|NCT02032394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617088|NCT02032394|Disinfectants|disinfectants|mesh-ancestor
65617089|NCT02032394|Dermatologic Agents|dermatologic agents|mesh-ancestor
65617090|NCT02032394|Plasma Substitutes|plasma substitutes|mesh-ancestor
65617091|NCT02032394|Blood Substitutes|blood substitutes|mesh-ancestor
65617092|NCT03239483|Dapivirine|dapivirine|mesh-list
65617093|NCT03239483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65617094|NCT03239483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65617095|NCT03239483|Antiviral Agents|antiviral agents|mesh-ancestor
65617096|NCT03239483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617097|NCT01068912|Favipiravir|favipiravir|mesh-list
65414482|NCT00880373|Analgesics|analgesics|mesh-ancestor
65617098|NCT01068912|Antiviral Agents|antiviral agents|mesh-ancestor
65617099|NCT01068912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617100|NCT04056702|Ivacaftor|ivacaftor|mesh-list
65617101|NCT04056702|Elexacaftor|elexacaftor|mesh-list
65617102|NCT04056702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65617103|NCT04056702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65617104|NCT04056702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617105|NCT03662100|Mirikizumab|mirikizumab|mesh-list
65617106|NCT03662100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65617107|NCT03662100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65617108|NCT03662100|Analgesics|analgesics|mesh-ancestor
65617109|NCT03662100|Sensory System Agents|sensory system agents|mesh-ancestor
65617110|NCT03662100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65617111|NCT03662100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617112|NCT03662100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65617113|NCT03662100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65617114|NCT03662100|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65617115|NCT03662100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65617116|NCT03612440|Dexmedetomidine|dexmedetomidine|mesh-list
65617117|NCT03612440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65617118|NCT03612440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65617119|NCT03612440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617120|NCT03612440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65617121|NCT03612440|Analgesics|analgesics|mesh-ancestor
65617122|NCT03612440|Sensory System Agents|sensory system agents|mesh-ancestor
65617123|NCT03612440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65617124|NCT03612440|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65617125|NCT03612440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65617126|NCT03612440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65617127|NCT03612440|Adrenergic Agents|adrenergic agents|mesh-ancestor
65617128|NCT03612440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65617129|NCT03612440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617130|NCT03662724|Venetoclax|venetoclax|mesh-list
65617131|NCT03662724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617132|NCT03662568|Ritonavir|ritonavir|mesh-list
65617133|NCT03662568|Tenofovir|tenofovir|mesh-list
65617134|NCT03662568|Entecavir|entecavir|mesh-list
65617135|NCT03662568|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65617136|NCT03662568|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65617137|NCT03662568|Protease Inhibitors|protease inhibitors|mesh-ancestor
65617138|NCT03662568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617139|NCT03662568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617140|NCT03662568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65617141|NCT03662568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65617142|NCT03662568|Antiviral Agents|antiviral agents|mesh-ancestor
65617143|NCT03662568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617144|NCT03662568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65617145|NCT03662568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65617146|NCT03662568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65617147|NCT03662568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65617148|NCT03031730|Dexamethasone|dexamethasone|mesh-list
65617149|NCT03031730|Dexamethasone acetate|dexamethasone acetate|mesh-list
65617150|NCT03031730|Lenalidomide|lenalidomide|mesh-list
65617151|NCT03031730|Ichthammol|ichthammol|mesh-list
65617152|NCT03031730|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65617153|NCT03031730|BB 1101|bb 1101|mesh-list
65617154|NCT03031730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65617155|NCT03031730|Antiemetics|antiemetics|mesh-ancestor
65617156|NCT03031730|Autonomic Agents|autonomic agents|mesh-ancestor
65617157|NCT03031730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65617158|NCT03031730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617159|NCT03031730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65617160|NCT03031730|Glucocorticoids|glucocorticoids|mesh-ancestor
65617161|NCT03031730|Hormones|hormones|mesh-ancestor
65617162|NCT03031730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65617163|NCT03031730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65617164|NCT03031730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617165|NCT03031730|Protease Inhibitors|protease inhibitors|mesh-ancestor
65617166|NCT03031730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617167|NCT03031730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617168|NCT03031730|Immunologic Factors|immunologic factors|mesh-ancestor
65617169|NCT03031730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65617170|NCT03031730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65617171|NCT03031730|Growth Substances|growth substances|mesh-ancestor
65617172|NCT03031730|Growth Inhibitors|growth inhibitors|mesh-ancestor
65617173|NCT03031730|Dermatologic Agents|dermatologic agents|mesh-ancestor
65617174|NCT02993250|Simeprevir|simeprevir|mesh-list
65617175|NCT02993250|Odalasvir|odalasvir|mesh-list
65617176|NCT02993250|Antiviral Agents|antiviral agents|mesh-ancestor
65617177|NCT02993250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617178|NCT02993250|Protease Inhibitors|protease inhibitors|mesh-ancestor
65617179|NCT02993250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617180|NCT02993250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617181|NCT03661788|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65617182|NCT03661788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65617183|NCT03661788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65617184|NCT03661788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65617185|NCT03661788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617186|NCT03661788|Adrenergic Agents|adrenergic agents|mesh-ancestor
65617187|NCT03661788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65617188|NCT03661788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617189|NCT05383820|Ketorolac|ketorolac|mesh-list
65617190|NCT05383820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65617191|NCT05383820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65617192|NCT05383820|Analgesics|analgesics|mesh-ancestor
65617193|NCT05383820|Sensory System Agents|sensory system agents|mesh-ancestor
65617194|NCT05383820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65617195|NCT05383820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617196|NCT05383820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65617197|NCT05383820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65617198|NCT05383820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65617199|NCT05383820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617200|NCT05383820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617201|NCT03611504|Hemostatics|hemostatics|mesh-list
65617202|NCT03611504|Coagulants|coagulants|mesh-ancestor
65617203|NCT02954510|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65617204|NCT02954510|Hematinics|hematinics|mesh-ancestor
65617205|NCT02954510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65617206|NCT02954510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65617207|NCT02032784|Octreotide|octreotide|mesh-list
65617208|NCT02032784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65617209|NCT02032784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65617210|NCT02032784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617211|NCT03611426|Thrombin|thrombin|mesh-list
65617212|NCT03611426|Hemostatics|hemostatics|mesh-ancestor
65617213|NCT03611426|Coagulants|coagulants|mesh-ancestor
65617214|NCT03658746|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65617215|NCT03658746|Amoxicillin|amoxicillin|mesh-list
65617216|NCT03658746|Metronidazole|metronidazole|mesh-list
65617217|NCT03658746|Clarithromycin|clarithromycin|mesh-list
65617218|NCT03658746|Levofloxacin|levofloxacin|mesh-list
65617219|NCT03658746|Ofloxacin|ofloxacin|mesh-list
65617220|NCT03658746|Tetracycline|tetracycline|mesh-list
65617221|NCT03658746|Tinidazole|tinidazole|mesh-list
65617222|NCT03658746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65617223|NCT03658746|Furazolidone|furazolidone|mesh-list
65617224|NCT03658746|Bismuth|bismuth|mesh-list
65617225|NCT03658746|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65617226|NCT03658746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617227|NCT03658746|Antitubercular Agents|antitubercular agents|mesh-ancestor
65617228|NCT03658746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65617229|NCT03658746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65617230|NCT03658746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65617231|NCT03658746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617232|NCT03658746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617233|NCT03658746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65617234|NCT03658746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65617235|NCT03658746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65617236|NCT03658746|Renal Agents|renal agents|mesh-ancestor
65617237|NCT03658746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65617238|NCT03658746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65617239|NCT03658746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617240|NCT03658746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65617241|NCT03658746|Antacids|antacids|mesh-ancestor
65617242|NCT03658746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65617243|NCT03658746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65617244|NCT03658746|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65617245|NCT03658746|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65617246|NCT03658746|Alkylating Agents|alkylating agents|mesh-ancestor
65617247|NCT02990910|Analgesics, Opioid|analgesics, opioid|mesh-list
65617248|NCT02990910|Narcotics|narcotics|mesh-ancestor
65617249|NCT02990910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65617250|NCT02990910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617251|NCT02990910|Analgesics|analgesics|mesh-ancestor
65617252|NCT02990910|Sensory System Agents|sensory system agents|mesh-ancestor
65617253|NCT02990910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65617254|NCT04056000|Caffeine|caffeine|mesh-list
65617255|NCT04056000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65617256|NCT04056000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617257|NCT04056000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65617258|NCT04056000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617259|NCT04056000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617260|NCT04056000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65617261|NCT04056000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65617262|NCT04056000|Purinergic Agents|purinergic agents|mesh-ancestor
65617263|NCT04056000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65617264|NCT03611348|Latanoprost|latanoprost|mesh-list
65080095|NCT00338624|Oxybutynin|oxybutynin|mesh-list
65617265|NCT03611348|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65617266|NCT03611348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65617267|NCT02033018|Aflibercept|aflibercept|mesh-list
65617268|NCT02033018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65617269|NCT02033018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65617270|NCT02033018|Growth Substances|growth substances|mesh-ancestor
65617271|NCT02033018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617272|NCT02033018|Growth Inhibitors|growth inhibitors|mesh-ancestor
65617273|NCT02033018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617274|NCT03155100|Dexamethasone|dexamethasone|mesh-list
65617275|NCT03155100|Elotuzumab|elotuzumab|mesh-list
65617276|NCT03155100|Proteasome Inhibitors|proteasome inhibitors|mesh-list
65617277|NCT03155100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65617278|NCT03155100|Antiemetics|antiemetics|mesh-ancestor
65617279|NCT03155100|Autonomic Agents|autonomic agents|mesh-ancestor
65617280|NCT03155100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65617281|NCT03155100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617282|NCT03155100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65617283|NCT03155100|Glucocorticoids|glucocorticoids|mesh-ancestor
65617284|NCT03155100|Hormones|hormones|mesh-ancestor
65617285|NCT03155100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65617286|NCT03155100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65617287|NCT03155100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617288|NCT03155100|Protease Inhibitors|protease inhibitors|mesh-ancestor
65617289|NCT03155100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617290|NCT03155100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617291|NCT02033096|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
65617292|NCT02033096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617293|NCT02033096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617294|NCT03658590|Dexamethasone|dexamethasone|mesh-list
65617295|NCT03658590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65617296|NCT03658590|Antiemetics|antiemetics|mesh-ancestor
65617297|NCT03658590|Autonomic Agents|autonomic agents|mesh-ancestor
65617298|NCT03658590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65617299|NCT03658590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617300|NCT03658590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65617301|NCT03658590|Glucocorticoids|glucocorticoids|mesh-ancestor
65617302|NCT03658590|Hormones|hormones|mesh-ancestor
65617303|NCT03658590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65617304|NCT03658590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65617305|NCT03658590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617306|NCT03428945|Hydroxychloroquine|hydroxychloroquine|mesh-list
65617307|NCT03428945|Antimalarials|antimalarials|mesh-ancestor
65617308|NCT03428945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65617309|NCT03428945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65617310|NCT03428945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617311|NCT03428945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617312|NCT03428945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617313|NCT03428945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65617314|NCT03208127|Antiviral Agents|antiviral agents|mesh-list
65617315|NCT03208127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617316|NCT02728388|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65617317|NCT02728388|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65617318|NCT02728388|Dermatologic Agents|dermatologic agents|mesh-ancestor
65617319|NCT03941093|Leucovorin|leucovorin|mesh-list
65617320|NCT03941093|Gemcitabine|gemcitabine|mesh-list
65617321|NCT03941093|Paclitaxel|paclitaxel|mesh-list
65617322|NCT03941093|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65617323|NCT03941093|Irinotecan|irinotecan|mesh-list
65617324|NCT03941093|Fluorouracil|fluorouracil|mesh-list
65617325|NCT03941093|Folfirinox|folfirinox|mesh-list
65617326|NCT03941093|Levoleucovorin|levoleucovorin|mesh-list
65617327|NCT03941093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65617328|NCT03941093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617329|NCT03941093|Tubulin Modulators|tubulin modulators|mesh-ancestor
65617330|NCT03941093|Antimitotic Agents|antimitotic agents|mesh-ancestor
65617331|NCT03941093|Mitosis Modulators|mitosis modulators|mesh-ancestor
65617332|NCT03941093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617333|NCT03941093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65617334|NCT03941093|Antimetabolites|antimetabolites|mesh-ancestor
65617335|NCT03941093|Antiviral Agents|antiviral agents|mesh-ancestor
65617336|NCT03941093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617337|NCT03941093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617338|NCT03941093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65617339|NCT03941093|Immunologic Factors|immunologic factors|mesh-ancestor
65617340|NCT03941093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617341|NCT03941093|Antidotes|antidotes|mesh-ancestor
65617342|NCT03941093|Protective Agents|protective agents|mesh-ancestor
65617343|NCT03941093|Vitamin B Complex|vitamin b complex|mesh-ancestor
65617344|NCT03941093|Vitamins|vitamins|mesh-ancestor
65617345|NCT03941093|Micronutrients|micronutrients|mesh-ancestor
65617346|NCT03941093|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65617347|NCT03941093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65617348|NCT03917381|Docetaxel|docetaxel|mesh-list
65617349|NCT03917381|Pembrolizumab|pembrolizumab|mesh-list
65617350|NCT03917381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617351|NCT03917381|Tubulin Modulators|tubulin modulators|mesh-ancestor
65617352|NCT03917381|Antimitotic Agents|antimitotic agents|mesh-ancestor
65617353|NCT03917381|Mitosis Modulators|mitosis modulators|mesh-ancestor
65617354|NCT03917381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617355|NCT03917381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65617356|NCT02033408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65617357|NCT02033408|Amoxicillin|amoxicillin|mesh-list
65617358|NCT02033408|Metronidazole|metronidazole|mesh-list
65617359|NCT02033408|Vancomycin|vancomycin|mesh-list
65617360|NCT02033408|Doxycycline|doxycycline|mesh-list
65617361|NCT02033408|Ciprofloxacin|ciprofloxacin|mesh-list
65617362|NCT02033408|Gentamicins|gentamicins|mesh-list
65617363|NCT02033408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617364|NCT02033408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65617365|NCT02033408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65617366|NCT02033408|Antimalarials|antimalarials|mesh-ancestor
65617367|NCT02033408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65617368|NCT02033408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65617369|NCT02033408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617370|NCT02033408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617371|NCT02033408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617372|NCT02033408|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65617373|NCT02033408|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65617374|NCT02033408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65617375|NCT03610880|Yimitasvir|yimitasvir|mesh-list
65617376|NCT03610880|Antiviral Agents|antiviral agents|mesh-ancestor
65617377|NCT03610880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617378|NCT02097121|Botulinum Toxins|botulinum toxins|mesh-list
65617379|NCT02097121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65617380|NCT02097121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65617381|NCT02097121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65617382|NCT02097121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65617383|NCT02097121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617384|NCT02097121|Cholinergic Agents|cholinergic agents|mesh-ancestor
65617385|NCT02097121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65617386|NCT02097121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617387|NCT02097121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65617388|NCT02097121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65617389|NCT02075671|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65617390|NCT02075671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65617391|NCT02075671|Dermatologic Agents|dermatologic agents|mesh-ancestor
65617392|NCT02560298|Paclitaxel|paclitaxel|mesh-list
65617393|NCT02560298|Cisplatin|cisplatin|mesh-list
65617394|NCT02560298|Carboplatin|carboplatin|mesh-list
65617395|NCT02560298|Fluorouracil|fluorouracil|mesh-list
65617396|NCT02560298|Capecitabine|capecitabine|mesh-list
65617397|NCT02560298|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65617398|NCT02560298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65617399|NCT02560298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617400|NCT02560298|Tubulin Modulators|tubulin modulators|mesh-ancestor
65617401|NCT02560298|Antimitotic Agents|antimitotic agents|mesh-ancestor
65617402|NCT02560298|Mitosis Modulators|mitosis modulators|mesh-ancestor
65617403|NCT02560298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617404|NCT02560298|Antimetabolites|antimetabolites|mesh-ancestor
65617405|NCT02560298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65617406|NCT02560298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65617407|NCT02560298|Immunologic Factors|immunologic factors|mesh-ancestor
65617408|NCT02560298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617409|NCT01330615|Lidocaine|lidocaine|mesh-list
65617410|NCT01330615|Prilocaine|prilocaine|mesh-list
65617411|NCT01330615|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65617412|NCT01330615|Anesthetics, Local|anesthetics, local|mesh-ancestor
65617413|NCT01330615|Anesthetics|anesthetics|mesh-ancestor
65617414|NCT01330615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65617415|NCT01330615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617416|NCT01330615|Sensory System Agents|sensory system agents|mesh-ancestor
65617417|NCT01330615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65617418|NCT01330615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65617419|NCT01330615|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65617420|NCT01330615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65617421|NCT01330615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65617422|NCT01330615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617423|NCT01330615|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65617424|NCT05034029|Metformin|metformin|mesh-list
65617425|NCT05034029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65617426|NCT05034029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617427|NCT03237065|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65617428|NCT03237065|Hematinics|hematinics|mesh-ancestor
65617429|NCT03620461|Gemcitabine|gemcitabine|mesh-list
65617430|NCT03620461|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65617431|NCT03620461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65617432|NCT03620461|Antimetabolites|antimetabolites|mesh-ancestor
65617433|NCT03620461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617434|NCT03620461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617435|NCT03620461|Antiviral Agents|antiviral agents|mesh-ancestor
65617436|NCT03620461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617437|NCT03620461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617438|NCT03620461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65617439|NCT03620461|Immunologic Factors|immunologic factors|mesh-ancestor
65617440|NCT03620461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617441|NCT01314781|Solifenacin Succinate|solifenacin succinate|mesh-list
65617442|NCT01314781|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65617443|NCT01314781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65617444|NCT01314781|Cholinergic Agents|cholinergic agents|mesh-ancestor
65617445|NCT01314781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65617446|NCT01314781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617447|NCT01314781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617448|NCT01314781|Urological Agents|urological agents|mesh-ancestor
65617449|NCT01330693|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65617450|NCT01330693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65617451|NCT01330693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65617452|NCT01330693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65617453|NCT01330693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617454|NCT01330693|Adrenergic Agents|adrenergic agents|mesh-ancestor
65617455|NCT01330693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65617456|NCT01330693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617457|NCT04377451|Metformin|metformin|mesh-list
65617458|NCT04377451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65617459|NCT04377451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617460|NCT02863328|Empagliflozin|empagliflozin|mesh-list
65617461|NCT02863328|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65617462|NCT02863328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617463|NCT02863328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65617464|NCT02863328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617465|NCT03040141|Oseltamivir|oseltamivir|mesh-list
65617466|NCT03040141|Antiviral Agents|antiviral agents|mesh-ancestor
65617467|NCT03040141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617468|NCT03040141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617469|NCT03040141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617470|NCT02937701|Infliximab|infliximab|mesh-list
65617471|NCT02937701|Dermatologic Agents|dermatologic agents|mesh-ancestor
65617472|NCT02937701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65617473|NCT02937701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65617474|NCT05186623|Ustekinumab|ustekinumab|mesh-list
65617475|NCT05186623|Vedolizumab|vedolizumab|mesh-list
65617476|NCT05186623|Tofacitinib|tofacitinib|mesh-list
65617477|NCT05186623|Dermatologic Agents|dermatologic agents|mesh-ancestor
65617478|NCT05186623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65617479|NCT05186623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617480|NCT05186623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617481|NCT05186623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65617482|NCT04602845|Flurbiprofen|flurbiprofen|mesh-list
65617483|NCT04602845|Fentanyl|fentanyl|mesh-list
65617484|NCT04602845|Midazolam|midazolam|mesh-list
65617485|NCT04602845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65617486|NCT04602845|Narcotics|narcotics|mesh-ancestor
65617487|NCT04602845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65617488|NCT04602845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617489|NCT04602845|Analgesics|analgesics|mesh-ancestor
65617490|NCT04602845|Sensory System Agents|sensory system agents|mesh-ancestor
65617491|NCT04602845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65617492|NCT04602845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65617493|NCT04602845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65617494|NCT04602845|Anesthetics, General|anesthetics, general|mesh-ancestor
65617495|NCT04602845|Anesthetics|anesthetics|mesh-ancestor
65617496|NCT04602845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65617497|NCT04602845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65617498|NCT04602845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65617499|NCT04602845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65617500|NCT04602845|GABA Modulators|gaba modulators|mesh-ancestor
65617501|NCT04602845|GABA Agents|gaba agents|mesh-ancestor
65617502|NCT04602845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65617503|NCT04602845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617504|NCT04602845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65617505|NCT04602845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65617506|NCT04602845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65617507|NCT04602845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65617508|NCT04602845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65617509|NCT04602845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617510|NCT04966325|Moxifloxacin|moxifloxacin|mesh-list
65617511|NCT04966325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65617512|NCT04966325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617513|NCT04966325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65617514|NCT04966325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65617515|NCT04966325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617516|NCT04966325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617517|NCT04966325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617518|NCT03168919|Temozolomide|temozolomide|mesh-list
65617519|NCT03168919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65617520|NCT03168919|Alkylating Agents|alkylating agents|mesh-ancestor
65617521|NCT03168919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617522|NCT03168919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617523|NCT03205163|Factor VIII|factor viii|mesh-list
65617524|NCT03205163|Coagulants|coagulants|mesh-ancestor
65617525|NCT03638947|Povidone-Iodine|povidone-iodine|mesh-list
65617526|NCT03638947|Povidone|povidone|mesh-list
65617527|NCT03638947|Plasma Substitutes|plasma substitutes|mesh-ancestor
65617528|NCT03638947|Blood Substitutes|blood substitutes|mesh-ancestor
65617529|NCT03638947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65617530|NCT03638947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617531|NCT03502681|Avelumab|avelumab|mesh-list
65617532|NCT03502681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65617533|NCT03502681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617534|NCT04938817|Pembrolizumab|pembrolizumab|mesh-list
65617535|NCT04938817|Lenvatinib|lenvatinib|mesh-list
65617536|NCT04938817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65617537|NCT04938817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617538|NCT04938817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65617539|NCT04938817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617540|NCT04938817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617541|NCT00788671|Levonorgestrel|levonorgestrel|mesh-list
65617542|NCT00788671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65617543|NCT00788671|Contraceptive Agents|contraceptive agents|mesh-ancestor
65617544|NCT00788671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65617545|NCT00788671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617546|NCT00788671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65617547|NCT00788671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65617548|NCT00788671|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65617549|NCT03636373|Triamcinolone|triamcinolone|mesh-list
65617550|NCT03636373|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65617551|NCT03636373|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65617552|NCT03636373|Etanercept|etanercept|mesh-list
65617553|NCT03636373|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65617554|NCT03636373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65617555|NCT03636373|Glucocorticoids|glucocorticoids|mesh-ancestor
65617556|NCT03636373|Hormones|hormones|mesh-ancestor
65617557|NCT03636373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65617558|NCT03636373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617559|NCT03636373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65617560|NCT03636373|Immunologic Factors|immunologic factors|mesh-ancestor
65617561|NCT03636373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617562|NCT03636373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617563|NCT03636373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65617564|NCT03636373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65617565|NCT03636373|Analgesics|analgesics|mesh-ancestor
65617566|NCT03636373|Sensory System Agents|sensory system agents|mesh-ancestor
65617567|NCT03636373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65617568|NCT03636373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65617569|NCT03636373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65617570|NCT04485325|Etanercept|etanercept|mesh-list
65617571|NCT04485325|Tofacitinib|tofacitinib|mesh-list
65617572|NCT04485325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65617573|NCT04485325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65617574|NCT04485325|Analgesics|analgesics|mesh-ancestor
65617575|NCT04485325|Sensory System Agents|sensory system agents|mesh-ancestor
65617576|NCT04485325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65617577|NCT04485325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617578|NCT04485325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65617579|NCT04485325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65617580|NCT04485325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65617581|NCT04485325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65617582|NCT04485325|Immunologic Factors|immunologic factors|mesh-ancestor
65617583|NCT04485325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65617584|NCT04485325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617585|NCT04485325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617586|NCT03610178|Insulin|insulin|mesh-list
65617587|NCT03610178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65617588|NCT03610178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65617589|NCT03610178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617590|NCT02033798|Tamsulosin|tamsulosin|mesh-list
65617591|NCT02033798|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65617592|NCT02033798|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65617593|NCT02033798|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65617594|NCT02033798|Adrenergic Agents|adrenergic agents|mesh-ancestor
65617595|NCT02033798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65617596|NCT02033798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617597|NCT02033798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617598|NCT02033798|Urological Agents|urological agents|mesh-ancestor
65617599|NCT02887183|Valsartan|valsartan|mesh-list
65617600|NCT02887183|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65617601|NCT02887183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65617602|NCT02887183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65617603|NCT02887183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65617604|NCT02887183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617605|NCT03660306|Analgesics, Opioid|analgesics, opioid|mesh-list
65617606|NCT03660306|Anesthetics|anesthetics|mesh-list
65617607|NCT03660306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65617608|NCT03660306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617609|NCT03660306|Narcotics|narcotics|mesh-ancestor
65617610|NCT03660306|Analgesics|analgesics|mesh-ancestor
65617611|NCT03660306|Sensory System Agents|sensory system agents|mesh-ancestor
65617612|NCT03660306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65617613|NCT01067352|Hormones|hormones|mesh-list
65617614|NCT01067352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65617615|NCT01067352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617616|NCT02920242|Rifaximin|rifaximin|mesh-list
65617617|NCT02920242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65617618|NCT02920242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617619|NCT02920242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65617620|NCT02985996|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65617621|NCT02985996|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65617622|NCT02985996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65617623|NCT02985996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65617624|NCT02985996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617625|NCT02985996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617626|NCT02985996|Antiviral Agents|antiviral agents|mesh-ancestor
65617627|NCT02985996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65415013|NCT00888797|Analgesics|analgesics|mesh-ancestor
65617628|NCT02985996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65617629|NCT02985996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65617630|NCT03203447|Triamcinolone|triamcinolone|mesh-list
65617631|NCT03203447|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65617632|NCT03203447|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65617633|NCT03203447|Bevacizumab|bevacizumab|mesh-list
65617634|NCT03203447|Ranibizumab|ranibizumab|mesh-list
65617635|NCT03203447|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65617636|NCT03203447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65617637|NCT03203447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617638|NCT03203447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65617639|NCT03203447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65617640|NCT03203447|Growth Substances|growth substances|mesh-ancestor
65617641|NCT03203447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617642|NCT03203447|Growth Inhibitors|growth inhibitors|mesh-ancestor
65617643|NCT03203447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65617644|NCT03203447|Glucocorticoids|glucocorticoids|mesh-ancestor
65617646|NCT03203447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65617647|NCT03203447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65617648|NCT03203447|Immunologic Factors|immunologic factors|mesh-ancestor
65617649|NCT03203447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617650|NCT03203447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617651|NCT01068678|Insulin|insulin|mesh-list
65617652|NCT01068678|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65617653|NCT01068678|Insulin Glargine|insulin glargine|mesh-list
65617654|NCT01068678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65617655|NCT01068678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617656|NCT03202511|Tenofovir|tenofovir|mesh-list
65617657|NCT03202511|Emtricitabine|emtricitabine|mesh-list
65617658|NCT03202511|Probenecid|probenecid|mesh-list
65617659|NCT03202511|Antiviral Agents|antiviral agents|mesh-ancestor
65617660|NCT03202511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617661|NCT03202511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65617662|NCT03202511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65617663|NCT03202511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617664|NCT03202511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617665|NCT03202511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65617666|NCT03202511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65617667|NCT03202511|Uricosuric Agents|uricosuric agents|mesh-ancestor
65617668|NCT03202511|Gout Suppressants|gout suppressants|mesh-ancestor
65617669|NCT03202511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65617670|NCT03202511|Renal Agents|renal agents|mesh-ancestor
65617671|NCT03637049|Midazolam|midazolam|mesh-list
65617672|NCT03637049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65617673|NCT03637049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65617674|NCT03637049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65617675|NCT03637049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617676|NCT03637049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65617677|NCT03637049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65617678|NCT03637049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65617679|NCT03637049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65617680|NCT03637049|Anesthetics, General|anesthetics, general|mesh-ancestor
65617681|NCT03637049|Anesthetics|anesthetics|mesh-ancestor
65617682|NCT03637049|GABA Modulators|gaba modulators|mesh-ancestor
65617683|NCT03637049|GABA Agents|gaba agents|mesh-ancestor
65617684|NCT03637049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65617685|NCT03637049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617686|NCT03636971|Mannitol|mannitol|mesh-list
65617687|NCT03636971|Sorbitol|sorbitol|mesh-list
65617688|NCT03636971|Hyaluronic Acid|hyaluronic acid|mesh-list
65617689|NCT03636971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65617690|NCT03636971|Immunologic Factors|immunologic factors|mesh-ancestor
65617691|NCT03636971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617692|NCT03636971|Viscosupplements|viscosupplements|mesh-ancestor
65617693|NCT03636971|Protective Agents|protective agents|mesh-ancestor
65617694|NCT03636971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65617695|NCT03636971|Diuretics|diuretics|mesh-ancestor
65617696|NCT03636971|Natriuretic Agents|natriuretic agents|mesh-ancestor
65617697|NCT03636971|Cathartics|cathartics|mesh-ancestor
65617698|NCT03636971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65617699|NCT03610100|Gemcitabine|gemcitabine|mesh-list
65617700|NCT03610100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65617701|NCT03610100|Antimetabolites|antimetabolites|mesh-ancestor
65617702|NCT03610100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617703|NCT03610100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415088|NCT00611975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617704|NCT03610100|Antiviral Agents|antiviral agents|mesh-ancestor
65617705|NCT03610100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617706|NCT03610100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617707|NCT03610100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65617708|NCT03610100|Immunologic Factors|immunologic factors|mesh-ancestor
65617709|NCT03610100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617710|NCT03657966|Gemcitabine|gemcitabine|mesh-list
65617711|NCT03657966|Paclitaxel|paclitaxel|mesh-list
65617712|NCT03657966|Carboplatin|carboplatin|mesh-list
65617713|NCT03657966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65617714|NCT03657966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617715|NCT03657966|Tubulin Modulators|tubulin modulators|mesh-ancestor
65617716|NCT03657966|Antimitotic Agents|antimitotic agents|mesh-ancestor
65617717|NCT03657966|Mitosis Modulators|mitosis modulators|mesh-ancestor
65617718|NCT03657966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617719|NCT03657966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65617720|NCT03657966|Antimetabolites|antimetabolites|mesh-ancestor
65617721|NCT03657966|Antiviral Agents|antiviral agents|mesh-ancestor
65617722|NCT03657966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617723|NCT03657966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617724|NCT03657966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65617725|NCT03657966|Immunologic Factors|immunologic factors|mesh-ancestor
65617726|NCT03657966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617727|NCT03659292|Anesthetics|anesthetics|mesh-list
65617728|NCT03659292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65617729|NCT03659292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617730|NCT03659058|Colchicine|colchicine|mesh-list
65617731|NCT03659058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65617732|NCT03659058|Antioxidants|antioxidants|mesh-list
65617733|NCT03659058|Silymarin|silymarin|mesh-list
65617734|NCT03659058|Gout Suppressants|gout suppressants|mesh-ancestor
65617735|NCT03659058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65617736|NCT03659058|Tubulin Modulators|tubulin modulators|mesh-ancestor
65617737|NCT03659058|Antimitotic Agents|antimitotic agents|mesh-ancestor
65617738|NCT03659058|Mitosis Modulators|mitosis modulators|mesh-ancestor
65617739|NCT03659058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617740|NCT03659058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617741|NCT03659058|Protective Agents|protective agents|mesh-ancestor
65617742|NCT03659058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617743|NCT03659058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65617744|NCT03659058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65617745|NCT03635905|Gabapentin|gabapentin|mesh-list
65617746|NCT03635905|Analgesics|analgesics|mesh-ancestor
65617747|NCT03635905|Sensory System Agents|sensory system agents|mesh-ancestor
65617748|NCT03635905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65617749|NCT03635905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617750|NCT03635905|Anticonvulsants|anticonvulsants|mesh-ancestor
65617751|NCT03635905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65617752|NCT03635905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65617753|NCT03635905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65617754|NCT03635905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65617755|NCT03635905|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65617756|NCT03635905|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65617757|NCT03635905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65617758|NCT03635905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617759|NCT03635905|Antimanic Agents|antimanic agents|mesh-ancestor
65617760|NCT02960113|Scopolamine|scopolamine|mesh-list
65617761|NCT02960113|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65617762|NCT02960113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65617763|NCT02960113|Antiemetics|antiemetics|mesh-ancestor
65617764|NCT02960113|Autonomic Agents|autonomic agents|mesh-ancestor
65617765|NCT02960113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65617766|NCT02960113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617767|NCT02960113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65617768|NCT02960113|Mydriatics|mydriatics|mesh-ancestor
65617769|NCT02960113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65617770|NCT02960113|Cholinergic Agents|cholinergic agents|mesh-ancestor
65617771|NCT02960113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65617772|NCT02960113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617773|NCT02960113|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65617774|NCT02960113|Parasympatholytics|parasympatholytics|mesh-ancestor
65617775|NCT04458324|Buspirone|buspirone|mesh-list
65617776|NCT04458324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65617777|NCT04458324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65617778|NCT04458324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65617779|NCT04458324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617780|NCT04458324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65617781|NCT04458324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65617782|NCT04458324|Serotonin Agents|serotonin agents|mesh-ancestor
65617783|NCT04458324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65617784|NCT04458324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617785|NCT03657420|Dexamethasone|dexamethasone|mesh-list
65617786|NCT03657420|Pomalidomide|pomalidomide|mesh-list
65617787|NCT03657420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65617788|NCT03657420|Antiemetics|antiemetics|mesh-ancestor
65617789|NCT03657420|Autonomic Agents|autonomic agents|mesh-ancestor
65617790|NCT03657420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65617791|NCT03657420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617792|NCT03657420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65617793|NCT03657420|Glucocorticoids|glucocorticoids|mesh-ancestor
65617794|NCT03657420|Hormones|hormones|mesh-ancestor
65617795|NCT03657420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65617796|NCT03657420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65617797|NCT03657420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617798|NCT03657420|Immunologic Factors|immunologic factors|mesh-ancestor
65617799|NCT03657420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65617800|NCT03657420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65617801|NCT03657420|Growth Substances|growth substances|mesh-ancestor
65617802|NCT03657420|Growth Inhibitors|growth inhibitors|mesh-ancestor
65617803|NCT02984982|Anticoagulants|anticoagulants|mesh-list
65617804|NCT02984982|Atorvastatin|atorvastatin|mesh-list
65617805|NCT02984982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65617806|NCT02984982|Ezetimibe|ezetimibe|mesh-list
65617807|NCT02984982|Fenofibrate|fenofibrate|mesh-list
65617808|NCT02984982|Bezafibrate|bezafibrate|mesh-list
65617809|NCT02984982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65617810|NCT02984982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65617811|NCT02984982|Antimetabolites|antimetabolites|mesh-ancestor
65617812|NCT02984982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617813|NCT02984982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65617814|NCT02984982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65617815|NCT02984982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617816|NCT03656484|Metronidazole|metronidazole|mesh-list
65617817|NCT03656484|Tetracycline|tetracycline|mesh-list
65617818|NCT03656484|Melatonin|melatonin|mesh-list
65617819|NCT03656484|Hyaluronic Acid|hyaluronic acid|mesh-list
65617820|NCT03656484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617821|NCT03656484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65617822|NCT03656484|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65617823|NCT03656484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65617824|NCT03656484|Antioxidants|antioxidants|mesh-ancestor
65617825|NCT03656484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617826|NCT03656484|Protective Agents|protective agents|mesh-ancestor
65617827|NCT03656484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617828|NCT03656484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65617829|NCT03656484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65617830|NCT03656484|Immunologic Factors|immunologic factors|mesh-ancestor
65617831|NCT03656484|Viscosupplements|viscosupplements|mesh-ancestor
65617832|NCT03656484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65617833|NCT03656484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617834|NCT04309578|Capecitabine|capecitabine|mesh-list
65617835|NCT04309578|Trastuzumab|trastuzumab|mesh-list
65617836|NCT04309578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617837|NCT04309578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65617838|NCT04309578|Antimetabolites|antimetabolites|mesh-ancestor
65617839|NCT04309578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617840|NCT04309578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65617841|NCT03656952|Moxifloxacin|moxifloxacin|mesh-list
65617842|NCT03656952|PF-06700841|pf-06700841|mesh-list
65617843|NCT03656952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65617844|NCT03656952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617845|NCT03656952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65617846|NCT03656952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65617847|NCT03656952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617848|NCT03656952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617849|NCT03656952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617850|NCT03656952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65617851|NCT02981472|Vitamin K|vitamin k|mesh-list
65617852|NCT02981472|Heparin|heparin|mesh-list
65617853|NCT02981472|Enoxaparin|enoxaparin|mesh-list
65617854|NCT02981472|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65617855|NCT02981472|Tinzaparin|tinzaparin|mesh-list
65617856|NCT02981472|Dalteparin|dalteparin|mesh-list
65617857|NCT02981472|Warfarin|warfarin|mesh-list
65617858|NCT02981472|Apixaban|apixaban|mesh-list
65617859|NCT02981472|Vitamins|vitamins|mesh-ancestor
65617860|NCT02981472|Micronutrients|micronutrients|mesh-ancestor
65617861|NCT02981472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617862|NCT02981472|Anticoagulants|anticoagulants|mesh-ancestor
65617863|NCT02981472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65617864|NCT02981472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65617865|NCT02981472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617866|NCT02981472|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65617867|NCT02981472|Antithrombins|antithrombins|mesh-ancestor
65617868|NCT02981472|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65617869|NCT02981472|Protease Inhibitors|protease inhibitors|mesh-ancestor
65617870|NCT02981472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617871|NCT02981472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65617872|NCT02981472|Hemostatics|hemostatics|mesh-ancestor
65617873|NCT02981472|Coagulants|coagulants|mesh-ancestor
65617874|NCT03656172|Chrysarobin|chrysarobin|mesh-list
65617875|NCT03656172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65617876|NCT03656172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65617877|NCT03656172|Analgesics|analgesics|mesh-ancestor
65617878|NCT03656172|Sensory System Agents|sensory system agents|mesh-ancestor
65617879|NCT03656172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65617880|NCT03656172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617881|NCT03656172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65617882|NCT03656172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65617883|NCT03656094|Docetaxel|docetaxel|mesh-list
65617884|NCT03656094|Pembrolizumab|pembrolizumab|mesh-list
65617885|NCT03656094|Pemetrexed|pemetrexed|mesh-list
65617886|NCT03656094|Vinorelbine|vinorelbine|mesh-list
65617887|NCT03656094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617888|NCT03656094|Tubulin Modulators|tubulin modulators|mesh-ancestor
65617889|NCT03656094|Antimitotic Agents|antimitotic agents|mesh-ancestor
65617890|NCT03656094|Mitosis Modulators|mitosis modulators|mesh-ancestor
65617891|NCT03656094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617892|NCT03656094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65617893|NCT03656094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617894|NCT03656094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65617895|NCT03656094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65617896|NCT03656094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65617897|NCT04298034|Labetalol|labetalol|mesh-list
65617898|NCT04298034|Nifedipine|nifedipine|mesh-list
65617899|NCT04298034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65617900|NCT04298034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65617901|NCT04298034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617902|NCT04298034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65617903|NCT04298034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617904|NCT04298034|Vasodilator Agents|vasodilator agents|mesh-ancestor
65617905|NCT04298034|Tocolytic Agents|tocolytic agents|mesh-ancestor
65617906|NCT04298034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65617907|NCT04298034|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65617908|NCT04298034|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65617909|NCT04298034|Adrenergic Agents|adrenergic agents|mesh-ancestor
65617910|NCT04298034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65617911|NCT04298034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65617912|NCT04298034|Sympathomimetics|sympathomimetics|mesh-ancestor
65617913|NCT04298034|Autonomic Agents|autonomic agents|mesh-ancestor
65617914|NCT04298034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65617915|NCT04298034|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65617916|NCT04298034|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65617917|NCT02982720|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65617918|NCT02982720|Pembrolizumab|pembrolizumab|mesh-list
65617919|NCT02982720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65617920|NCT02982720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617921|NCT02982720|Antiviral Agents|antiviral agents|mesh-ancestor
65617922|NCT02982720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617923|NCT00849667|Carboplatin|carboplatin|mesh-list
65617924|NCT00849667|Taxane|taxane|mesh-list
65617925|NCT00849667|Farletuzumab|farletuzumab|mesh-list
65617926|NCT00849667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617927|NCT03201419|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65617928|NCT03201419|Hemostatics|hemostatics|mesh-ancestor
65617929|NCT03201419|Coagulants|coagulants|mesh-ancestor
65617930|NCT03201419|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65617931|NCT03201419|Natriuretic Agents|natriuretic agents|mesh-ancestor
65617932|NCT03201419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617933|NCT01764633|Evolocumab|evolocumab|mesh-list
65617934|NCT01764633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65415325|NCT02541383|Bortezomib|bortezomib|mesh-list
65617935|NCT01764633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65617937|NCT01764633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617938|NCT01764633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65617939|NCT02924389|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65617940|NCT02924389|Dolutegravir|dolutegravir|mesh-list
65617941|NCT02924389|Triumeq|triumeq|mesh-list
65617942|NCT02924389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65617943|NCT02924389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65617944|NCT02924389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65617945|NCT02924389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617946|NCT02924389|Antiviral Agents|antiviral agents|mesh-ancestor
65617947|NCT02924389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65617948|NCT02924389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65617949|NCT02924389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65617950|NCT02924389|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65617951|NCT02924389|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65617952|NCT01315093|Heparin|heparin|mesh-list
65617953|NCT01315093|Calcium heparin|calcium heparin|mesh-list
65617954|NCT01315093|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65617955|NCT01315093|Tinzaparin|tinzaparin|mesh-list
65617956|NCT01315093|Dalteparin|dalteparin|mesh-list
65617957|NCT01315093|Anticoagulants|anticoagulants|mesh-ancestor
65617958|NCT01315093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65617959|NCT01315093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65617960|NCT01315093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617961|NCT01331707|Everolimus|everolimus|mesh-list
65617962|NCT01331707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617963|NCT01331707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65617964|NCT01331707|Immunologic Factors|immunologic factors|mesh-ancestor
65617965|NCT01331707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617966|NCT02956447|Hormones|hormones|mesh-list
65617967|NCT02956447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65617968|NCT02956447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617969|NCT03953807|Dexamethasone|dexamethasone|mesh-list
65617970|NCT03953807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65617971|NCT03953807|Antiemetics|antiemetics|mesh-ancestor
65617972|NCT03953807|Autonomic Agents|autonomic agents|mesh-ancestor
65617973|NCT03953807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65617974|NCT03953807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617975|NCT03953807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65617976|NCT03953807|Glucocorticoids|glucocorticoids|mesh-ancestor
65617977|NCT03953807|Hormones|hormones|mesh-ancestor
65617978|NCT03953807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65617979|NCT03953807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65617980|NCT03953807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617981|NCT03662711|Bronchodilator Agents|bronchodilator agents|mesh-list
65617982|NCT03662711|Olodaterol|olodaterol|mesh-list
65617983|NCT03662711|Autonomic Agents|autonomic agents|mesh-ancestor
65617984|NCT03662711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65617985|NCT03662711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65617986|NCT03662711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65617987|NCT03662711|Respiratory System Agents|respiratory system agents|mesh-ancestor
65617988|NCT02923531|Nivolumab|nivolumab|mesh-list
65617989|NCT02923531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65617990|NCT02923531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617991|NCT02923531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65617992|NCT02923531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65617993|NCT02934503|Carboplatin|carboplatin|mesh-list
65617994|NCT02934503|Pembrolizumab|pembrolizumab|mesh-list
65617995|NCT02934503|Etoposide|etoposide|mesh-list
65617996|NCT02934503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65617997|NCT02934503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65617998|NCT02934503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65617999|NCT02934503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65618000|NCT02934503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65618001|NCT02934503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618002|NCT02934503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618003|NCT04563247|Antibodies|antibodies|mesh-list
65618004|NCT04563247|Immunologic Factors|immunologic factors|mesh-ancestor
65618005|NCT04563247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618006|NCT01314209|Dexmedetomidine|dexmedetomidine|mesh-list
65618007|NCT01314209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65618008|NCT01314209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65618009|NCT01314209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618010|NCT01314209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65618011|NCT01314209|Analgesics|analgesics|mesh-ancestor
65618012|NCT01314209|Sensory System Agents|sensory system agents|mesh-ancestor
65618013|NCT01314209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65618014|NCT01314209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65618015|NCT01314209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65618016|NCT01314209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65618017|NCT01314209|Adrenergic Agents|adrenergic agents|mesh-ancestor
65618018|NCT01314209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65618019|NCT01314209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618020|NCT05431075|Amoxicillin|amoxicillin|mesh-list
65618021|NCT05431075|Tetracycline|tetracycline|mesh-list
65618022|NCT05431075|Potassium Citrate|potassium citrate|mesh-list
65618023|NCT05431075|Esomeprazole|esomeprazole|mesh-list
65618024|NCT05431075|Bismuth|bismuth|mesh-list
65618025|NCT05431075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618026|NCT05431075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65618027|NCT05431075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65618028|NCT05431075|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65618029|NCT05431075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65618030|NCT05431075|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65618031|NCT05431075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618032|NCT05431075|Antacids|antacids|mesh-ancestor
65618033|NCT05431075|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65618034|NCT05431075|Diuretics|diuretics|mesh-ancestor
65618035|NCT05431075|Natriuretic Agents|natriuretic agents|mesh-ancestor
65618036|NCT05431075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618037|NCT05431075|Expectorants|expectorants|mesh-ancestor
65618038|NCT05431075|Respiratory System Agents|respiratory system agents|mesh-ancestor
65618039|NCT03636659|Amphotericin B|amphotericin b|mesh-list
65618040|NCT03636659|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65618041|NCT03636659|Amebicides|amebicides|mesh-ancestor
65618042|NCT03636659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65618043|NCT03636659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65618044|NCT03636659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65618045|NCT03636659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65618046|NCT03636659|Antifungal Agents|antifungal agents|mesh-ancestor
65618047|NCT04892173|Cetuximab|cetuximab|mesh-list
65618048|NCT04892173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65618049|NCT04892173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618050|NCT03198767|Licogliflozin|licogliflozin|mesh-list
65618051|NCT03198767|Calcium Carbonate|calcium carbonate|mesh-list
65618052|NCT03198767|Psyllium|psyllium|mesh-list
65618053|NCT03198767|Calcium|calcium|mesh-list
65618054|NCT03198767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65618055|NCT03198767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618056|NCT03198767|Antacids|antacids|mesh-ancestor
65618057|NCT03198767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618058|NCT03198767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65618059|NCT03198767|Cathartics|cathartics|mesh-ancestor
65618060|NCT03198767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65618061|NCT03198767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65618062|NCT03162055|Glycopyrrolate|glycopyrrolate|mesh-list
65618063|NCT03162055|Formoterol Fumarate|formoterol fumarate|mesh-list
65618064|NCT03162055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65618065|NCT03162055|Autonomic Agents|autonomic agents|mesh-ancestor
65618066|NCT03162055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65618067|NCT03162055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618068|NCT03162055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65618069|NCT03162055|Respiratory System Agents|respiratory system agents|mesh-ancestor
65618070|NCT03162055|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65618071|NCT03162055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65618072|NCT03162055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65618073|NCT03162055|Adrenergic Agents|adrenergic agents|mesh-ancestor
65618074|NCT03162055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65618075|NCT03162055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618076|NCT03162055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65618077|NCT03162055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65618078|NCT03162055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65618079|NCT03162055|Cholinergic Agents|cholinergic agents|mesh-ancestor
65618080|NCT01331785|Midodrine|midodrine|mesh-list
65618081|NCT01331785|Sympathomimetics|sympathomimetics|mesh-ancestor
65618082|NCT01331785|Autonomic Agents|autonomic agents|mesh-ancestor
65618083|NCT01331785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65618084|NCT01331785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618085|NCT01331785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65618086|NCT01331785|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65618087|NCT01331785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65618088|NCT01331785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65618089|NCT01331785|Adrenergic Agents|adrenergic agents|mesh-ancestor
65618090|NCT01331785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65618091|NCT01331785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618092|NCT01382589|Afamelanotide|afamelanotide|mesh-list
65618093|NCT01382589|Dermatologic Agents|dermatologic agents|mesh-ancestor
65618094|NCT03671759|Caffeine|caffeine|mesh-list
65618095|NCT03671759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65618096|NCT03671759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618097|NCT03671759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65618098|NCT03671759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618099|NCT03671759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618100|NCT03671759|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65618101|NCT03671759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65618102|NCT03671759|Purinergic Agents|purinergic agents|mesh-ancestor
65618103|NCT03671759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65618104|NCT01384227|Proflavine|proflavine|mesh-list
65618105|NCT01384227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65618106|NCT01384227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65618107|NCT01382511|Simvastatin|simvastatin|mesh-list
65618108|NCT01382511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65618109|NCT01382511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65618110|NCT01382511|Antimetabolites|antimetabolites|mesh-ancestor
65618111|NCT01382511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618112|NCT01382511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65618113|NCT01382511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65618114|NCT01382511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618115|NCT04916197|Dexmedetomidine|dexmedetomidine|mesh-list
65618116|NCT04916197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65618117|NCT04916197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65618118|NCT04916197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618119|NCT04916197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65618120|NCT04916197|Analgesics|analgesics|mesh-ancestor
65618121|NCT04916197|Sensory System Agents|sensory system agents|mesh-ancestor
65618122|NCT04916197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65618123|NCT04916197|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65618124|NCT04916197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65618125|NCT04916197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65618126|NCT04916197|Adrenergic Agents|adrenergic agents|mesh-ancestor
65618127|NCT04916197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65618128|NCT04916197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618129|NCT03684447|Propofol|propofol|mesh-list
65618130|NCT03684447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65618131|NCT03684447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65618132|NCT03684447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618133|NCT03684447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65618134|NCT03684447|Anesthetics, General|anesthetics, general|mesh-ancestor
65618135|NCT03684447|Anesthetics|anesthetics|mesh-ancestor
65618136|NCT04505059|Anesthetics|anesthetics|mesh-list
65618137|NCT04505059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65618138|NCT04505059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618139|NCT01314599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65618140|NCT04217135|Hydralazine|hydralazine|mesh-list
65618141|NCT04217135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65618142|NCT04217135|Vasodilator Agents|vasodilator agents|mesh-ancestor
65618143|NCT01337401|Cediranib|cediranib|mesh-list
65618144|NCT01337401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618145|NCT01337401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65618146|NCT01337401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266554|NCT04657562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65618147|NCT01337401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618148|NCT04178603|Insulin|insulin|mesh-list
65618149|NCT04178603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65618150|NCT04178603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618151|NCT01333891|Nitroprusside|nitroprusside|mesh-list
65618152|NCT01333891|Phenylephrine|phenylephrine|mesh-list
65618153|NCT01333891|Oxymetazoline|oxymetazoline|mesh-list
65618154|NCT01333891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65618155|NCT01333891|Mydriatics|mydriatics|mesh-ancestor
65618156|NCT01333891|Autonomic Agents|autonomic agents|mesh-ancestor
65618157|NCT01333891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65618158|NCT01333891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618159|NCT01333891|Sympathomimetics|sympathomimetics|mesh-ancestor
65618160|NCT01333891|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65618161|NCT01333891|Nasal Decongestants|nasal decongestants|mesh-ancestor
65618162|NCT01333891|Respiratory System Agents|respiratory system agents|mesh-ancestor
65618163|NCT01333891|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65618164|NCT01333891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65618165|NCT01333891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65618166|NCT01333891|Adrenergic Agents|adrenergic agents|mesh-ancestor
65618167|NCT01333891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65618168|NCT01333891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618169|NCT01333891|Protective Agents|protective agents|mesh-ancestor
65618170|NCT01333891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65618171|NCT01333891|Vasodilator Agents|vasodilator agents|mesh-ancestor
65618172|NCT01333891|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65618173|NCT04853875|Amoxicillin|amoxicillin|mesh-list
65618174|NCT04853875|Metronidazole|metronidazole|mesh-list
65618175|NCT04853875|Clarithromycin|clarithromycin|mesh-list
65618176|NCT04853875|Tetracycline|tetracycline|mesh-list
65618177|NCT04853875|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
65618178|NCT04853875|Bismuth|bismuth|mesh-list
65618179|NCT04853875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65618180|NCT04853875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65618181|NCT04853875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65618182|NCT04853875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65618183|NCT04853875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65618184|NCT04853875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618185|NCT04853875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618186|NCT04853875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65618187|NCT04853875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65618188|NCT04853875|Antacids|antacids|mesh-ancestor
65618189|NCT04853875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65618190|NCT04853875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65618191|NCT03196973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65618192|NCT03196973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65618193|NCT03196973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65618194|NCT03196973|Antitubercular Agents|antitubercular agents|mesh-ancestor
65618195|NCT03196505|Bupivacaine|bupivacaine|mesh-list
65618196|NCT03196505|Anesthetics, Local|anesthetics, local|mesh-ancestor
65618197|NCT03196505|Anesthetics|anesthetics|mesh-ancestor
65618198|NCT03196505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65618199|NCT03196505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618200|NCT03196505|Sensory System Agents|sensory system agents|mesh-ancestor
65618201|NCT03196505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65618202|NCT01334047|Vaccines|vaccines|mesh-list
65618203|NCT01334047|Immunologic Factors|immunologic factors|mesh-ancestor
65618204|NCT01334047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618205|NCT01337557|Bepotastine besilate|bepotastine besilate|mesh-list
65618206|NCT01337557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65618207|NCT03196349|Warfarin|warfarin|mesh-list
65618208|NCT03196349|Rivaroxaban|rivaroxaban|mesh-list
65618209|NCT03196349|Apixaban|apixaban|mesh-list
65618210|NCT03196349|Anticoagulants|anticoagulants|mesh-ancestor
65618211|NCT03196349|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65618212|NCT03196349|Antithrombins|antithrombins|mesh-ancestor
65618213|NCT03196349|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65618214|NCT03196349|Protease Inhibitors|protease inhibitors|mesh-ancestor
65618215|NCT03196349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618216|NCT03196349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618217|NCT01331941|Paclitaxel|paclitaxel|mesh-list
65618218|NCT01331941|Trebananib|trebananib|mesh-list
65618219|NCT01331941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65618220|NCT01331941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618221|NCT01331941|Tubulin Modulators|tubulin modulators|mesh-ancestor
65618222|NCT01331941|Antimitotic Agents|antimitotic agents|mesh-ancestor
65618223|NCT01331941|Mitosis Modulators|mitosis modulators|mesh-ancestor
65618224|NCT01331941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618225|NCT01331941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65618226|NCT01331941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65618227|NCT01331941|Growth Substances|growth substances|mesh-ancestor
65618228|NCT01331941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618229|NCT01331941|Growth Inhibitors|growth inhibitors|mesh-ancestor
65618230|NCT02886715|Nicotinic Acids|nicotinic acids|mesh-list
65618231|NCT02886715|Tazarotene|tazarotene|mesh-list
65618232|NCT02886715|Dermatologic Agents|dermatologic agents|mesh-ancestor
65618233|NCT02886715|Keratolytic Agents|keratolytic agents|mesh-ancestor
65618234|NCT02886715|Vitamin B Complex|vitamin b complex|mesh-ancestor
65618235|NCT02886715|Vitamins|vitamins|mesh-ancestor
65618236|NCT02886715|Micronutrients|micronutrients|mesh-ancestor
65618237|NCT02886715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618238|NCT01337791|Telbivudine|telbivudine|mesh-list
65618239|NCT01337791|Antiviral Agents|antiviral agents|mesh-ancestor
65618240|NCT01337791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65618241|NCT01337791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65618242|NCT01337791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618243|NCT01337791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618244|NCT01334203|Ranolazine|ranolazine|mesh-list
65618245|NCT01334203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65618246|NCT01334203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65618247|NCT01334203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618248|NCT03085797|Mometasone Furoate|mometasone furoate|mesh-list
65618249|NCT03085797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65618250|NCT03085797|Dermatologic Agents|dermatologic agents|mesh-ancestor
65618251|NCT03085797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65618252|NCT01569165|Fluorides|fluorides|mesh-list
65618253|NCT01569165|Fluorides, Topical|fluorides, topical|mesh-list
65618254|NCT01569165|Cariostatic Agents|cariostatic agents|mesh-ancestor
65618255|NCT01569165|Protective Agents|protective agents|mesh-ancestor
65618256|NCT01569165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618257|NCT04259749|Menthol|menthol|mesh-list
65618258|NCT04259749|Antipruritics|antipruritics|mesh-ancestor
65618259|NCT04259749|Dermatologic Agents|dermatologic agents|mesh-ancestor
65618260|NCT03575793|Nivolumab|nivolumab|mesh-list
65618261|NCT03575793|Ipilimumab|ipilimumab|mesh-list
65618262|NCT03575793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65618263|NCT03575793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618264|NCT03575793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65618265|NCT03575793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618266|NCT02535091|Cenobamate|cenobamate|mesh-list
65618267|NCT02535091|Anticonvulsants|anticonvulsants|mesh-ancestor
65618268|NCT01382277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65618269|NCT01382277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65618270|NCT01382277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65618271|NCT01382277|Antimetabolites|antimetabolites|mesh-ancestor
65618272|NCT01382277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618273|NCT01382277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65618274|NCT01382277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65618275|NCT01382277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618276|NCT01382199|Lactoferrin|lactoferrin|mesh-list
65618277|NCT01382199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65618278|NCT01381497|Naproxen|naproxen|mesh-list
65618279|NCT01381497|Sumatriptan|sumatriptan|mesh-list
65618280|NCT01381497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65618281|NCT01381497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65618282|NCT01381497|Analgesics|analgesics|mesh-ancestor
65618283|NCT01381497|Sensory System Agents|sensory system agents|mesh-ancestor
65618284|NCT01381497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65618285|NCT01381497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618286|NCT01381497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65618287|NCT01381497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65618288|NCT01381497|Gout Suppressants|gout suppressants|mesh-ancestor
65618289|NCT01381497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65618290|NCT01381497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618291|NCT01381497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618292|NCT01381497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65618293|NCT01381497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65618294|NCT01381497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65618295|NCT01381497|Serotonin Agents|serotonin agents|mesh-ancestor
65618296|NCT01381497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65618297|NCT04221997|Sertraline|sertraline|mesh-list
65618298|NCT04221997|Antidepressive Agents|antidepressive agents|mesh-ancestor
65618299|NCT04221997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65618300|NCT04221997|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65618301|NCT04221997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65618302|NCT04221997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65618303|NCT04221997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618304|NCT04221997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65618305|NCT04221997|Serotonin Agents|serotonin agents|mesh-ancestor
65618306|NCT04221997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618307|NCT03635827|Xenon|xenon|mesh-list
65618308|NCT03635827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65618309|NCT03635827|Anesthetics, General|anesthetics, general|mesh-ancestor
65618310|NCT03635827|Anesthetics|anesthetics|mesh-ancestor
65618311|NCT03635827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65618312|NCT03635827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618313|NCT01338103|Rituximab|rituximab|mesh-list
65618314|NCT01338103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65618315|NCT01338103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618316|NCT01338103|Immunologic Factors|immunologic factors|mesh-ancestor
65618317|NCT01338103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618318|NCT01338103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65618319|NCT03369665|Cladribine|cladribine|mesh-list
65618320|NCT03369665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618321|NCT03369665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65618322|NCT03369665|Immunologic Factors|immunologic factors|mesh-ancestor
65618323|NCT03369665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618324|NCT03621761|Modafinil|modafinil|mesh-list
65618325|NCT03621761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65618326|NCT03621761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618327|NCT03621761|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65618328|NCT03621761|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65618329|NCT03621761|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65618330|NCT03621761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618331|NCT03318861|Cyclophosphamide|cyclophosphamide|mesh-list
65618332|NCT03318861|Fludarabine|fludarabine|mesh-list
65618333|NCT03318861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65618334|NCT03318861|Immunologic Factors|immunologic factors|mesh-ancestor
65618335|NCT03318861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618336|NCT03318861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65618337|NCT03318861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65618338|NCT03318861|Alkylating Agents|alkylating agents|mesh-ancestor
65618339|NCT03318861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618340|NCT03318861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618341|NCT03318861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65618342|NCT03084315|Nicotine|nicotine|mesh-list
65618343|NCT03084315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65618344|NCT03084315|Autonomic Agents|autonomic agents|mesh-ancestor
65618345|NCT03084315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65618346|NCT03084315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618347|NCT03084315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65618348|NCT03084315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65618349|NCT03084315|Cholinergic Agents|cholinergic agents|mesh-ancestor
65618350|NCT03084315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65618351|NCT03084315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618352|NCT03187301|Moxifloxacin|moxifloxacin|mesh-list
65618353|NCT03187301|Apomorphine|apomorphine|mesh-list
65618354|NCT03187301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65618355|NCT03187301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65618356|NCT03187301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65618357|NCT03187301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65618358|NCT03187301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618359|NCT03187301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618360|NCT03187301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618361|NCT03187301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618362|NCT03187301|Emetics|emetics|mesh-ancestor
65618363|NCT03187301|Autonomic Agents|autonomic agents|mesh-ancestor
65618364|NCT03187301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65618365|NCT03187301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65618366|NCT03187301|Dopamine Agonists|dopamine agonists|mesh-ancestor
65618367|NCT03187301|Dopamine Agents|dopamine agents|mesh-ancestor
65618368|NCT03187301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65618369|NCT01381185|Aspirin|aspirin|mesh-list
65618370|NCT01381185|Clopidogrel|clopidogrel|mesh-list
65618371|NCT01381185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65618372|NCT01381185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65618373|NCT01381185|Analgesics|analgesics|mesh-ancestor
65618374|NCT01381185|Sensory System Agents|sensory system agents|mesh-ancestor
65618375|NCT01381185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65618376|NCT01381185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618377|NCT01381185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65618378|NCT01381185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65618379|NCT01381185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65618380|NCT01381185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65618381|NCT01381185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618382|NCT01381185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65618383|NCT01381185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65618384|NCT01381185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618385|NCT01381185|Antipyretics|antipyretics|mesh-ancestor
65618386|NCT01381185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65618387|NCT01381185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65618388|NCT01381185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65618389|NCT01381185|Purinergic Agents|purinergic agents|mesh-ancestor
65618390|NCT01381185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65618391|NCT02946047|Ixazomib|ixazomib|mesh-list
65618392|NCT02946047|Glycine|glycine|mesh-list
65618393|NCT02946047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618394|NCT02946047|Protease Inhibitors|protease inhibitors|mesh-ancestor
65618395|NCT02946047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618396|NCT02946047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618397|NCT02946047|Glycine Agents|glycine agents|mesh-ancestor
65618398|NCT02946047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65618399|NCT02946047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618400|NCT05422131|Clozapine|clozapine|mesh-list
65618401|NCT05422131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65618402|NCT05422131|Serotonin Agents|serotonin agents|mesh-ancestor
65618403|NCT05422131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65618404|NCT05422131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618405|NCT05422131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618406|NCT05422131|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65618407|NCT05422131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65618408|NCT05422131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65618409|NCT05422131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65618410|NCT05422131|GABA Antagonists|gaba antagonists|mesh-ancestor
65618411|NCT05422131|GABA Agents|gaba agents|mesh-ancestor
65618412|NCT05421897|Cyclophosphamide|cyclophosphamide|mesh-list
65618413|NCT05421897|Temozolomide|temozolomide|mesh-list
65618414|NCT05421897|Irinotecan|irinotecan|mesh-list
65618415|NCT05421897|Topotecan|topotecan|mesh-list
65618416|NCT05421897|Dinutuximab|dinutuximab|mesh-list
65618417|NCT05421897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65618418|NCT05421897|Immunologic Factors|immunologic factors|mesh-ancestor
65618419|NCT05421897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618420|NCT05421897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65618421|NCT05421897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65618422|NCT05421897|Alkylating Agents|alkylating agents|mesh-ancestor
65618423|NCT05421897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618424|NCT05421897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618425|NCT05421897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65618426|NCT05421897|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65618427|NCT05421897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65618428|NCT05421897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618429|NCT03077919|Ropivacaine|ropivacaine|mesh-list
65618430|NCT03077919|Anesthetics, Local|anesthetics, local|mesh-ancestor
65618431|NCT03077919|Anesthetics|anesthetics|mesh-ancestor
65618432|NCT03077919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65618433|NCT03077919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618434|NCT03077919|Sensory System Agents|sensory system agents|mesh-ancestor
65618435|NCT03077919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65618436|NCT01380951|Telbivudine|telbivudine|mesh-list
65618437|NCT01380951|Antiviral Agents|antiviral agents|mesh-ancestor
65618438|NCT01380951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65618439|NCT01380951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65618440|NCT01380951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618441|NCT01380951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618442|NCT01377597|Ranibizumab|ranibizumab|mesh-list
65618443|NCT01377597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65618444|NCT01377597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65618445|NCT01377597|Growth Substances|growth substances|mesh-ancestor
65618446|NCT01377597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618447|NCT01377597|Growth Inhibitors|growth inhibitors|mesh-ancestor
65618448|NCT01377597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618449|NCT03287375|Cisplatin|cisplatin|mesh-list
65618450|NCT03287375|Doxorubicin|doxorubicin|mesh-list
65618451|NCT03287375|Oxaliplatin|oxaliplatin|mesh-list
65618452|NCT03287375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618453|NCT03287375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65618454|NCT03287375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65618455|NCT03287375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65618456|NCT03287375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618457|NCT03287375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618458|NCT03881059|Ustekinumab|ustekinumab|mesh-list
65618459|NCT03881059|BMS-986165|bms-986165|mesh-list
65618460|NCT03881059|Dermatologic Agents|dermatologic agents|mesh-ancestor
65618461|NCT03881059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65415843|NCT01056874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65618462|NCT03881059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618463|NCT03881059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618464|NCT01338337|Azacitidine|azacitidine|mesh-list
65618465|NCT01338337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65618466|NCT01338337|Antimetabolites|antimetabolites|mesh-ancestor
65618467|NCT01338337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618468|NCT01338337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618469|NCT01338337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618470|NCT03083847|Chloroquine|chloroquine|mesh-list
65618471|NCT03083847|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65618472|NCT03083847|Pyrimethamine|pyrimethamine|mesh-list
65618473|NCT03083847|Amebicides|amebicides|mesh-ancestor
65618474|NCT03083847|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65618475|NCT03083847|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65618476|NCT03083847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65618477|NCT03083847|Antimalarials|antimalarials|mesh-ancestor
65618478|NCT03083847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65618479|NCT03083847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65618480|NCT03083847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65618481|NCT03083847|Analgesics|analgesics|mesh-ancestor
65618482|NCT03083847|Sensory System Agents|sensory system agents|mesh-ancestor
65618483|NCT03083847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65618484|NCT03083847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618485|NCT03083847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65618486|NCT03083847|Filaricides|filaricides|mesh-ancestor
65618487|NCT03083847|Antinematodal Agents|antinematodal agents|mesh-ancestor
65618488|NCT03083847|Anthelmintics|anthelmintics|mesh-ancestor
65618489|NCT03083847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65618490|NCT03083847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618491|NCT03083847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618493|NCT03082677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618494|NCT03082677|Protease Inhibitors|protease inhibitors|mesh-ancestor
65618495|NCT03082677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618496|NCT03082677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618497|NCT03136055|Paclitaxel|paclitaxel|mesh-list
65618498|NCT03136055|Pembrolizumab|pembrolizumab|mesh-list
65618499|NCT03136055|Irinotecan|irinotecan|mesh-list
65618500|NCT03136055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65618501|NCT03136055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618502|NCT03136055|Tubulin Modulators|tubulin modulators|mesh-ancestor
65618503|NCT03136055|Antimitotic Agents|antimitotic agents|mesh-ancestor
65618504|NCT03136055|Mitosis Modulators|mitosis modulators|mesh-ancestor
65618505|NCT03136055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618506|NCT03136055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65618507|NCT03136055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65618508|NCT03136055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65618509|NCT03136055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618510|NCT03221309|Analgesics, Opioid|analgesics, opioid|mesh-list
65618511|NCT03221309|Narcotics|narcotics|mesh-ancestor
65618512|NCT03221309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65618513|NCT03221309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618514|NCT03221309|Analgesics|analgesics|mesh-ancestor
65618515|NCT03221309|Sensory System Agents|sensory system agents|mesh-ancestor
65618516|NCT03221309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65618517|NCT05353829|Methotrexate|methotrexate|mesh-list
65618518|NCT05353829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65618519|NCT05353829|Abortifacient Agents|abortifacient agents|mesh-ancestor
65618520|NCT05353829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65618521|NCT05353829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618522|NCT05353829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65618523|NCT05353829|Antimetabolites|antimetabolites|mesh-ancestor
65618524|NCT05353829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618525|NCT05353829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618526|NCT05353829|Dermatologic Agents|dermatologic agents|mesh-ancestor
65618527|NCT05353829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618528|NCT05353829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65618529|NCT05353829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65618530|NCT05353829|Immunologic Factors|immunologic factors|mesh-ancestor
65618531|NCT05353829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65618532|NCT05353829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65618533|NCT03426657|Durvalumab|durvalumab|mesh-list
65618534|NCT03426657|Tremelimumab|tremelimumab|mesh-list
65618535|NCT03426657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65618536|NCT03426657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618537|NCT02858180|Sofosbuvir|sofosbuvir|mesh-list
65618538|NCT02858180|Ledipasvir|ledipasvir|mesh-list
65618539|NCT02858180|Antiviral Agents|antiviral agents|mesh-ancestor
65618540|NCT02858180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65618541|NCT02285192|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65618542|NCT02285192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65618543|NCT02285192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618545|NCT03609086|Antioxidants|antioxidants|mesh-ancestor
65618546|NCT03609086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618547|NCT03609086|Protective Agents|protective agents|mesh-ancestor
65618548|NCT03609086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618549|NCT03609086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65618550|NCT00730717|Adalimumab|adalimumab|mesh-list
65618551|NCT00730717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65618552|NCT00730717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65618553|NCT01332409|Fluticasone|fluticasone|mesh-list
65618554|NCT01332409|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65618555|NCT01332409|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65618556|NCT01332409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65618557|NCT01332409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65618558|NCT01332409|Autonomic Agents|autonomic agents|mesh-ancestor
65618559|NCT01332409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65618560|NCT01332409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618561|NCT01332409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65618562|NCT01332409|Respiratory System Agents|respiratory system agents|mesh-ancestor
65618563|NCT01332409|Dermatologic Agents|dermatologic agents|mesh-ancestor
65618564|NCT01332409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65618565|NCT01332409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65618566|NCT01332409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65618567|NCT01332409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65618568|NCT01332409|Adrenergic Agents|adrenergic agents|mesh-ancestor
65618569|NCT01332409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65618570|NCT01332409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618571|NCT01332409|Glucocorticoids|glucocorticoids|mesh-ancestor
65618572|NCT01332409|Hormones|hormones|mesh-ancestor
65618573|NCT01332409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65618574|NCT01332409|Sympathomimetics|sympathomimetics|mesh-ancestor
65618575|NCT03181451|Ferric maltol|ferric maltol|mesh-list
65618576|NCT03181451|Hematinics|hematinics|mesh-ancestor
65618577|NCT03495973|Ustekinumab|ustekinumab|mesh-list
65618578|NCT03495973|Dermatologic Agents|dermatologic agents|mesh-ancestor
65618579|NCT00480805|Losartan|losartan|mesh-list
65618580|NCT00480805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65618581|NCT00480805|Ramipril|ramipril|mesh-list
65618582|NCT00480805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65618583|NCT00480805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65618584|NCT00480805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65618585|NCT00480805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65618586|NCT00480805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618587|NCT00480805|Diuretics|diuretics|mesh-ancestor
65618588|NCT00480805|Natriuretic Agents|natriuretic agents|mesh-ancestor
65618589|NCT00480805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618590|NCT00480805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65618591|NCT00480805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65618592|NCT00480805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65618593|NCT00480805|Protease Inhibitors|protease inhibitors|mesh-ancestor
65618594|NCT00480805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618595|NCT00406783|Desloratadine|desloratadine|mesh-list
65618596|NCT00406783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65618597|NCT00406783|Cholinergic Agents|cholinergic agents|mesh-ancestor
65618598|NCT00406783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65618599|NCT00406783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618600|NCT00406783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618601|NCT00406783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65618602|NCT00406783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65618603|NCT00406783|Histamine Antagonists|histamine antagonists|mesh-ancestor
65618604|NCT00406783|Histamine Agents|histamine agents|mesh-ancestor
65618605|NCT03179891|Diazepam|diazepam|mesh-list
65618606|NCT03179891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65618607|NCT03179891|Anticonvulsants|anticonvulsants|mesh-ancestor
65618608|NCT03179891|Antiemetics|antiemetics|mesh-ancestor
65618609|NCT03179891|Autonomic Agents|autonomic agents|mesh-ancestor
65618610|NCT03179891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65618611|NCT03179891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618612|NCT03179891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65618613|NCT03179891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65618614|NCT03179891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65618615|NCT03179891|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65618617|NCT03179891|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65618618|NCT03179891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65618619|NCT03179891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65618620|NCT03179891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65618621|NCT03179891|Anesthetics, General|anesthetics, general|mesh-ancestor
65618622|NCT03179891|Anesthetics|anesthetics|mesh-ancestor
65618623|NCT03179891|GABA Modulators|gaba modulators|mesh-ancestor
65618624|NCT03179891|GABA Agents|gaba agents|mesh-ancestor
65618625|NCT03179891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65618626|NCT03179891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618627|NCT01334671|Atorvastatin|atorvastatin|mesh-list
65618628|NCT01334671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65618629|NCT01334671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65618630|NCT01334671|Antimetabolites|antimetabolites|mesh-ancestor
65618631|NCT01334671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618632|NCT01334671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65618633|NCT01334671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65618634|NCT01334671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618635|NCT01332565|Dolutegravir|dolutegravir|mesh-list
65618636|NCT01332565|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65618637|NCT01332565|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65618638|NCT01332565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618639|NCT01332565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618640|NCT01332565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65618641|NCT01332565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65618642|NCT01332565|Antiviral Agents|antiviral agents|mesh-ancestor
65618643|NCT01332565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65618644|NCT02861417|Vidarabine|vidarabine|mesh-list
65618645|NCT02861417|Mycophenolic Acid|mycophenolic acid|mesh-list
65618646|NCT02861417|Cyclophosphamide|cyclophosphamide|mesh-list
65618647|NCT02861417|Busulfan|busulfan|mesh-list
65618648|NCT02861417|Thiotepa|thiotepa|mesh-list
65618649|NCT02861417|Fludarabine|fludarabine|mesh-list
65618650|NCT02861417|Fludarabine phosphate|fludarabine phosphate|mesh-list
65618651|NCT02861417|Tacrolimus|tacrolimus|mesh-list
65618652|NCT02861417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65618653|NCT02861417|Immunologic Factors|immunologic factors|mesh-ancestor
65618654|NCT02861417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618655|NCT02861417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65618656|NCT02861417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65618657|NCT02861417|Alkylating Agents|alkylating agents|mesh-ancestor
65618658|NCT02861417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618659|NCT02861417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618660|NCT02861417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65618661|NCT02861417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65618662|NCT02861417|Antimetabolites|antimetabolites|mesh-ancestor
65618663|NCT02861417|Antiviral Agents|antiviral agents|mesh-ancestor
65618664|NCT02861417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65618665|NCT02861417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65618666|NCT02861417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618667|NCT02861417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65618668|NCT02861417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65618669|NCT02861417|Antitubercular Agents|antitubercular agents|mesh-ancestor
65618670|NCT02861417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65618671|NCT01314677|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65618672|NCT01314677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65618673|NCT01314677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618674|NCT02736227|Everolimus|everolimus|mesh-list
65618675|NCT02736227|Tacrolimus|tacrolimus|mesh-list
65618676|NCT02736227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65618677|NCT02736227|Immunologic Factors|immunologic factors|mesh-ancestor
65618678|NCT02736227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618679|NCT02736227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65618680|NCT02736227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618681|NCT02736227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618682|NCT02736227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618683|NCT01334905|Mirabegron|mirabegron|mesh-list
65618684|NCT01334905|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65618685|NCT01334905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65618686|NCT01334905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65618687|NCT01334905|Adrenergic Agents|adrenergic agents|mesh-ancestor
65618688|NCT01334905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65618689|NCT01334905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416077|NCT00516386|Mecasermin|mecasermin|mesh-list
65618691|NCT01334905|Urological Agents|urological agents|mesh-ancestor
65618692|NCT01335139|Immunologic Factors|immunologic factors|mesh-list
65618693|NCT01335139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618694|NCT05030129|Vitamin B 6|vitamin b 6|mesh-list
65618695|NCT05030129|Pyridoxal|pyridoxal|mesh-list
65618696|NCT05030129|Pyridoxine|pyridoxine|mesh-list
65618697|NCT05030129|Ergoloid Mesylates|ergoloid mesylates|mesh-list
65618698|NCT05030129|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
65618699|NCT05030129|Dihydroergotoxine|dihydroergotoxine|mesh-list
65618700|NCT05030129|Vitamins|vitamins|mesh-ancestor
65618701|NCT05030129|Micronutrients|micronutrients|mesh-ancestor
65618702|NCT05030129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618703|NCT05030129|Vitamin B Complex|vitamin b complex|mesh-ancestor
65618704|NCT05030129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65618705|NCT05030129|Antidepressive Agents|antidepressive agents|mesh-ancestor
65618706|NCT05030129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65618707|NCT05030129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65618708|NCT05030129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65618709|NCT05030129|Adrenergic Agents|adrenergic agents|mesh-ancestor
65618710|NCT05030129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65618711|NCT05030129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618712|NCT05030129|Vasodilator Agents|vasodilator agents|mesh-ancestor
65618713|NCT05030129|Nootropic Agents|nootropic agents|mesh-ancestor
65618714|NCT05030129|Dopamine Agonists|dopamine agonists|mesh-ancestor
65618715|NCT05030129|Dopamine Agents|dopamine agents|mesh-ancestor
65618716|NCT05017025|Osimertinib|osimertinib|mesh-list
65618717|NCT05017025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618718|NCT05017025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65618719|NCT05017025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618720|NCT05017025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618721|NCT03260023|Avelumab|avelumab|mesh-list
65618722|NCT03260023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65618723|NCT03260023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618724|NCT01339039|Plerixafor|plerixafor|mesh-list
65618725|NCT01339039|Bevacizumab|bevacizumab|mesh-list
65618726|NCT01339039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65618727|NCT01339039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618728|NCT01339039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65618729|NCT01339039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65618730|NCT01339039|Growth Substances|growth substances|mesh-ancestor
65618731|NCT01339039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618732|NCT01339039|Growth Inhibitors|growth inhibitors|mesh-ancestor
65618733|NCT01339039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65618734|NCT01339039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65618735|NCT01339039|Antiviral Agents|antiviral agents|mesh-ancestor
65618736|NCT01339039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65618737|NCT03176459|Bupivacaine|bupivacaine|mesh-list
65618738|NCT03176459|Anesthetics, Local|anesthetics, local|mesh-ancestor
65618739|NCT03176459|Anesthetics|anesthetics|mesh-ancestor
65618740|NCT03176459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65618741|NCT03176459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618742|NCT03176459|Sensory System Agents|sensory system agents|mesh-ancestor
65618743|NCT03176459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65618744|NCT01332955|Ribavirin|ribavirin|mesh-list
65618745|NCT01332955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65618746|NCT01332955|Antimetabolites|antimetabolites|mesh-ancestor
65618747|NCT01332955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618748|NCT01332955|Antiviral Agents|antiviral agents|mesh-ancestor
65618749|NCT01332955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65618750|NCT05224895|Anesthetics|anesthetics|mesh-list
65618751|NCT05224895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65618752|NCT05224895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618753|NCT01335373|Metronidazole|metronidazole|mesh-list
65618754|NCT01335373|Miconazole|miconazole|mesh-list
65618755|NCT01335373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65618756|NCT01335373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65618757|NCT01335373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65618758|NCT01335373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65618759|NCT01335373|Antifungal Agents|antifungal agents|mesh-ancestor
65618760|NCT01335373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65618761|NCT01335373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65618762|NCT01335373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618763|NCT01335373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618764|NCT01335373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65618765|NCT01335373|Hormone Antagonists|hormone antagonists|mesh-ancestor
65618766|NCT01335373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65618767|NCT01335373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618768|NCT01335373|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65618769|NCT01335373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65618771|NCT01333267|Testosterone Congeners|testosterone congeners|mesh-list
65618772|NCT01333267|Parathyroid Hormone|parathyroid hormone|mesh-list
65618773|NCT01333267|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
65618774|NCT01333267|Anabolic Agents|anabolic agents|mesh-list
65618775|NCT01333267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65618776|NCT01333267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618777|NCT01333267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65618778|NCT01335529|Interferons|interferons|mesh-list
65618779|NCT01335529|Ribavirin|ribavirin|mesh-list
65618780|NCT01335529|Interferon-alpha|interferon-alpha|mesh-list
65618781|NCT01335529|Interferon alpha-2|interferon alpha-2|mesh-list
65618782|NCT01335529|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65618783|NCT01335529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618784|NCT01335529|Antiviral Agents|antiviral agents|mesh-ancestor
65618785|NCT01335529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65618786|NCT01335529|Antimetabolites|antimetabolites|mesh-ancestor
65618787|NCT01335529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618788|NCT01335529|Immunologic Factors|immunologic factors|mesh-ancestor
65618789|NCT01335529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618790|NCT00308347|Losartan|losartan|mesh-list
65618791|NCT00308347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65618792|NCT00308347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65618793|NCT00308347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65618794|NCT00308347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65618795|NCT00308347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618796|NCT02186834|Dexamethasone|dexamethasone|mesh-list
65618797|NCT02186834|Doxorubicin|doxorubicin|mesh-list
65618798|NCT02186834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65618799|NCT02186834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65618800|NCT02186834|Antiemetics|antiemetics|mesh-ancestor
65618801|NCT02186834|Autonomic Agents|autonomic agents|mesh-ancestor
65618802|NCT02186834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65618803|NCT02186834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618804|NCT02186834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65618805|NCT02186834|Glucocorticoids|glucocorticoids|mesh-ancestor
65618806|NCT02186834|Hormones|hormones|mesh-ancestor
65618807|NCT02186834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65618808|NCT02186834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65618809|NCT02186834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618810|NCT02186834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65618811|NCT02186834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65618812|NCT02186834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65618813|NCT02186834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618814|NCT02186834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618815|NCT04335890|Vaccines|vaccines|mesh-list
65618816|NCT04335890|Immunologic Factors|immunologic factors|mesh-ancestor
65618817|NCT04335890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618818|NCT01379157|Imipenem|imipenem|mesh-list
65618819|NCT01379157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65618820|NCT01379157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65618821|NCT01538966|Octreotide|octreotide|mesh-list
65618822|NCT01538966|Lanreotide|lanreotide|mesh-list
65618823|NCT01538966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65618824|NCT01538966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65618825|NCT01538966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618826|NCT01377285|Pentoxifylline|pentoxifylline|mesh-list
65618827|NCT01377285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65618828|NCT01377285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65618829|NCT01377285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618830|NCT01377285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618831|NCT01377285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65618832|NCT01377285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65618833|NCT01377285|Protective Agents|protective agents|mesh-ancestor
65618834|NCT01377285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618835|NCT01377285|Vasodilator Agents|vasodilator agents|mesh-ancestor
65618836|NCT01377285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65618837|NCT01377285|Antioxidants|antioxidants|mesh-ancestor
65618838|NCT02905266|Nivolumab|nivolumab|mesh-list
65618839|NCT02905266|Ipilimumab|ipilimumab|mesh-list
65618840|NCT02905266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65618841|NCT02905266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618842|NCT02905266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65618843|NCT02905266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618844|NCT01380717|Calcium Channel Blockers|calcium channel blockers|mesh-list
65618845|NCT01380717|Calcium|calcium|mesh-list
65618846|NCT01380717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65618847|NCT01380717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65618848|NCT01380717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65618849|NCT01380717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618850|NCT01380717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65618851|NCT01380717|Adrenergic Agents|adrenergic agents|mesh-ancestor
65618852|NCT01380717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65618853|NCT01380717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618854|NCT01380717|Protease Inhibitors|protease inhibitors|mesh-ancestor
65618855|NCT01380717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618856|NCT01380717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65618857|NCT03080493|Acetaminophen|acetaminophen|mesh-list
65618858|NCT03080493|Ibuprofen|ibuprofen|mesh-list
65618859|NCT03080493|Gabapentin|gabapentin|mesh-list
65618860|NCT03080493|Codeine|codeine|mesh-list
65618861|NCT03080493|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65618862|NCT03080493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65618863|NCT03080493|Analgesics|analgesics|mesh-ancestor
65618864|NCT03080493|Sensory System Agents|sensory system agents|mesh-ancestor
65618865|NCT03080493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65618866|NCT03080493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618867|NCT03080493|Antipyretics|antipyretics|mesh-ancestor
65618868|NCT03080493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65618869|NCT03080493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65618870|NCT03080493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65618871|NCT03080493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65618872|NCT03080493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618873|NCT03080493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618874|NCT03080493|Anticonvulsants|anticonvulsants|mesh-ancestor
65618875|NCT03080493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65618876|NCT03080493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65618877|NCT03080493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65618878|NCT03080493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65618879|NCT03080493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65618880|NCT03080493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65618881|NCT03080493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65618882|NCT03080493|Antimanic Agents|antimanic agents|mesh-ancestor
65618883|NCT03080493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65618884|NCT03080493|Narcotics|narcotics|mesh-ancestor
65618885|NCT03080493|Antitussive Agents|antitussive agents|mesh-ancestor
65618886|NCT03080493|Respiratory System Agents|respiratory system agents|mesh-ancestor
65618887|NCT03080493|Laxatives|laxatives|mesh-ancestor
65618888|NCT03080493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65618889|NCT02906007|Bedaquiline|bedaquiline|mesh-list
65618890|NCT02906007|Antitubercular Agents|antitubercular agents|mesh-ancestor
65618891|NCT02906007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65618892|NCT02906007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65618893|NCT01339910|Vidarabine|vidarabine|mesh-list
65618894|NCT01339910|Cyclophosphamide|cyclophosphamide|mesh-list
65618895|NCT01339910|Melphalan|melphalan|mesh-list
65618896|NCT01339910|Busulfan|busulfan|mesh-list
65618897|NCT01339910|Fludarabine|fludarabine|mesh-list
65618898|NCT01339910|Fludarabine phosphate|fludarabine phosphate|mesh-list
65618899|NCT01339910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65618900|NCT01339910|Immunologic Factors|immunologic factors|mesh-ancestor
65618901|NCT01339910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618902|NCT01339910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65618903|NCT01339910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65618904|NCT01339910|Alkylating Agents|alkylating agents|mesh-ancestor
65618905|NCT01339910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618906|NCT01339910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618907|NCT01339910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65618908|NCT01339910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65618909|NCT01339910|Antimetabolites|antimetabolites|mesh-ancestor
65618910|NCT01339910|Antiviral Agents|antiviral agents|mesh-ancestor
65618911|NCT01339910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65618912|NCT02647827|Metformin|metformin|mesh-list
65618913|NCT02647827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65618914|NCT02647827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618915|NCT03655392|Nitric Oxide|nitric oxide|mesh-list
65618916|NCT03655392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65618917|NCT03655392|Autonomic Agents|autonomic agents|mesh-ancestor
65618918|NCT03655392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65618919|NCT03655392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618920|NCT03655392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65618921|NCT03655392|Respiratory System Agents|respiratory system agents|mesh-ancestor
65618922|NCT03655392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65618924|NCT03655392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618925|NCT03655392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65618926|NCT03655392|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65618927|NCT03655392|Vasodilator Agents|vasodilator agents|mesh-ancestor
65618928|NCT03655392|Gasotransmitters|gasotransmitters|mesh-ancestor
65618929|NCT03655392|Protective Agents|protective agents|mesh-ancestor
65618930|NCT01430390|Cyclophosphamide|cyclophosphamide|mesh-list
65618931|NCT01430390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65618932|NCT01430390|Immunologic Factors|immunologic factors|mesh-ancestor
65618933|NCT01430390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618934|NCT01430390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65618935|NCT01430390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65618936|NCT01430390|Alkylating Agents|alkylating agents|mesh-ancestor
65618937|NCT01430390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618938|NCT01430390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618939|NCT01430390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65618940|NCT03608618|Cyclophosphamide|cyclophosphamide|mesh-list
65618941|NCT03608618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65618942|NCT03608618|Immunologic Factors|immunologic factors|mesh-ancestor
65618943|NCT03608618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618944|NCT03608618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65618945|NCT03608618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65618946|NCT03608618|Alkylating Agents|alkylating agents|mesh-ancestor
65618947|NCT03608618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618948|NCT03608618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618949|NCT03608618|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65618950|NCT04203290|Bupivacaine|bupivacaine|mesh-list
65618951|NCT04203290|Sevoflurane|sevoflurane|mesh-list
65618952|NCT04203290|Anesthetics, Local|anesthetics, local|mesh-ancestor
65618953|NCT04203290|Anesthetics|anesthetics|mesh-ancestor
65618954|NCT04203290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65618955|NCT04203290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618956|NCT04203290|Sensory System Agents|sensory system agents|mesh-ancestor
65618957|NCT04203290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65618958|NCT04203290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65618959|NCT04203290|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65618960|NCT04203290|Anesthetics, General|anesthetics, general|mesh-ancestor
65618961|NCT02981082|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65618962|NCT02981082|Dermatologic Agents|dermatologic agents|mesh-ancestor
65618963|NCT02981082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65618964|NCT02981082|Immunologic Factors|immunologic factors|mesh-ancestor
65618965|NCT02981082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618966|NCT03654612|Apatinib|apatinib|mesh-list
65618967|NCT03654612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65618968|NCT03654612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65618969|NCT03654612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65618970|NCT03654612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618971|NCT01066104|Omalizumab|omalizumab|mesh-list
65618972|NCT01066104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65618973|NCT01066104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65618974|NCT01066104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65618975|NCT01066104|Respiratory System Agents|respiratory system agents|mesh-ancestor
65618976|NCT01066104|Immunologic Factors|immunologic factors|mesh-ancestor
65618977|NCT01066104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618978|NCT02736968|Auranofin|auranofin|mesh-list
65618979|NCT02736968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65618980|NCT03608306|Methamphetamine|methamphetamine|mesh-list
65618981|NCT03608306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65618982|NCT03608306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65618983|NCT03608306|Sympathomimetics|sympathomimetics|mesh-ancestor
65618984|NCT03608306|Autonomic Agents|autonomic agents|mesh-ancestor
65618985|NCT03608306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65618986|NCT03608306|Dopamine Agents|dopamine agents|mesh-ancestor
65618987|NCT03608306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65618988|NCT03608306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65618989|NCT03608306|Adrenergic Agents|adrenergic agents|mesh-ancestor
65618990|NCT03608306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65618991|NCT03608306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65618992|NCT03608306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65618993|NCT03608306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65618994|NCT03654144|Dienogest|dienogest|mesh-list
65618995|NCT03654144|Contraceptive Agents|contraceptive agents|mesh-list
65618996|NCT03654144|Contraceptives, Oral|contraceptives, oral|mesh-list
65618997|NCT03654144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65618998|NCT03654144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65618999|NCT03654144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619000|NCT03654144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65619001|NCT03654144|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65619002|NCT03654144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65619003|NCT03654144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65619004|NCT03654144|Hormone Antagonists|hormone antagonists|mesh-ancestor
65619005|NCT03654144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65619006|NCT03654144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65619007|NCT03654144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619008|NCT02591615|Paclitaxel|paclitaxel|mesh-list
65619009|NCT02591615|Carboplatin|carboplatin|mesh-list
65619010|NCT02591615|Pembrolizumab|pembrolizumab|mesh-list
65619011|NCT02591615|Pemetrexed|pemetrexed|mesh-list
65619012|NCT02591615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65619013|NCT02591615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619014|NCT02591615|Tubulin Modulators|tubulin modulators|mesh-ancestor
65619015|NCT02591615|Antimitotic Agents|antimitotic agents|mesh-ancestor
65619016|NCT02591615|Mitosis Modulators|mitosis modulators|mesh-ancestor
65619017|NCT02591615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619018|NCT02591615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65619019|NCT02591615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619020|NCT02591615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65619021|NCT02591615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65619022|NCT03077607|Itraconazole|itraconazole|mesh-list
65619023|NCT03077607|Rifampin|rifampin|mesh-list
65619024|NCT03077607|Talazoparib|talazoparib|mesh-list
65619025|NCT03077607|Antifungal Agents|antifungal agents|mesh-ancestor
65619026|NCT03077607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65619027|NCT03077607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65619028|NCT03077607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65619029|NCT03077607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619030|NCT03077607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619031|NCT03077607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65619032|NCT03077607|Hormone Antagonists|hormone antagonists|mesh-ancestor
65619033|NCT03077607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65619034|NCT03077607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619035|NCT03077607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65619036|NCT03077607|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65619037|NCT03077607|Antitubercular Agents|antitubercular agents|mesh-ancestor
65619038|NCT03077607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65619039|NCT03077607|Leprostatic Agents|leprostatic agents|mesh-ancestor
65619040|NCT03077607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65619041|NCT03077607|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65619042|NCT03077607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65619043|NCT03077607|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65619044|NCT03077607|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65619045|NCT03077607|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65619046|NCT03077607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65619047|NCT03077607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65619048|NCT03077607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619049|NCT04215588|Hemostatics|hemostatics|mesh-list
65619050|NCT04215588|Coagulants|coagulants|mesh-ancestor
65619051|NCT01377051|Maleic acid|maleic acid|mesh-list
65619052|NCT01377051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619053|NCT01377051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619054|NCT03217175|Glucagon|glucagon|mesh-list
65619055|NCT03217175|Pancrelipase|pancrelipase|mesh-list
65619056|NCT03217175|Pancreatin|pancreatin|mesh-list
65619057|NCT03217175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619058|NCT03217175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65619059|NCT03217175|Hormones|hormones|mesh-ancestor
65619060|NCT03217175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65619061|NCT01379079|Aspirin|aspirin|mesh-list
65619062|NCT01379079|Calcium, Dietary|calcium, dietary|mesh-list
65619063|NCT01379079|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
65619064|NCT01379079|Carbaspirin calcium|carbaspirin calcium|mesh-list
65619065|NCT01379079|Calcium|calcium|mesh-list
65619066|NCT01379079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65619067|NCT01379079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619068|NCT01379079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65619069|NCT01379079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65619070|NCT01379079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65619071|NCT01379079|Analgesics|analgesics|mesh-ancestor
65619072|NCT01379079|Sensory System Agents|sensory system agents|mesh-ancestor
65619073|NCT01379079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65619074|NCT01379079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65619075|NCT01379079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65619076|NCT01379079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65619077|NCT01379079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65619078|NCT01379079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619079|NCT01379079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65619080|NCT01379079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65619081|NCT01379079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619082|NCT01379079|Antipyretics|antipyretics|mesh-ancestor
65619083|NCT02034968|Nimotuzumab|nimotuzumab|mesh-list
65619084|NCT02034968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65619085|NCT02034968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619086|NCT01379001|Scopolamine|scopolamine|mesh-list
65619087|NCT01379001|Donepezil|donepezil|mesh-list
65619088|NCT01379001|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65619089|NCT01379001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65619090|NCT01379001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619091|NCT01379001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619092|NCT01379001|Cholinergic Agents|cholinergic agents|mesh-ancestor
65619093|NCT01379001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65619094|NCT01379001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619095|NCT01379001|Nootropic Agents|nootropic agents|mesh-ancestor
65619096|NCT01379001|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65619097|NCT01379001|Antiemetics|antiemetics|mesh-ancestor
65619098|NCT01379001|Autonomic Agents|autonomic agents|mesh-ancestor
65619099|NCT01379001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65619100|NCT01379001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65619101|NCT01379001|Mydriatics|mydriatics|mesh-ancestor
65619102|NCT01379001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65619103|NCT01379001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65619104|NCT01379001|Parasympatholytics|parasympatholytics|mesh-ancestor
65619105|NCT03172325|Folic Acid|folic acid|mesh-list
65619106|NCT03172325|Prednisolone|prednisolone|mesh-list
65619107|NCT03172325|Adalimumab|adalimumab|mesh-list
65619108|NCT03172325|Methotrexate|methotrexate|mesh-list
65619109|NCT03172325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65619110|NCT03172325|Abortifacient Agents|abortifacient agents|mesh-ancestor
65619111|NCT03172325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65619112|NCT03172325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619113|NCT03172325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65619114|NCT03172325|Antimetabolites|antimetabolites|mesh-ancestor
65619115|NCT03172325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619116|NCT03172325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619117|NCT03172325|Dermatologic Agents|dermatologic agents|mesh-ancestor
65619118|NCT03172325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619119|NCT03172325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65619120|NCT03172325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65619121|NCT03172325|Immunologic Factors|immunologic factors|mesh-ancestor
65619122|NCT03172325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65619123|NCT03172325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65619124|NCT03172325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65619125|NCT03172325|Glucocorticoids|glucocorticoids|mesh-ancestor
65619126|NCT03172325|Hormones|hormones|mesh-ancestor
65619127|NCT03172325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65619128|NCT03172325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65619129|NCT03172325|Hematinics|hematinics|mesh-ancestor
65619130|NCT03172325|Vitamin B Complex|vitamin b complex|mesh-ancestor
65619131|NCT03172325|Vitamins|vitamins|mesh-ancestor
65619132|NCT03172325|Micronutrients|micronutrients|mesh-ancestor
65619133|NCT03653520|Diazepam|diazepam|mesh-list
65619134|NCT03653520|Tramadol|tramadol|mesh-list
65619135|NCT03653520|Ondansetron|ondansetron|mesh-list
65619136|NCT03653520|Antiemetics|antiemetics|mesh-ancestor
65619137|NCT03653520|Autonomic Agents|autonomic agents|mesh-ancestor
65619138|NCT03653520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65619139|NCT03653520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619141|NCT03653520|Antipruritics|antipruritics|mesh-ancestor
65619142|NCT03653520|Dermatologic Agents|dermatologic agents|mesh-ancestor
65619143|NCT03653520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65619144|NCT03653520|Serotonin Agents|serotonin agents|mesh-ancestor
65619145|NCT03653520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65619146|NCT03653520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619147|NCT03653520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65619148|NCT03653520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65266603|NCT00917579|Atorvastatin|atorvastatin|mesh-list
65619149|NCT03653520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65619150|NCT03653520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65619151|NCT03653520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65619152|NCT03653520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65619153|NCT03653520|Narcotics|narcotics|mesh-ancestor
65619154|NCT03653520|Analgesics|analgesics|mesh-ancestor
65619155|NCT03653520|Sensory System Agents|sensory system agents|mesh-ancestor
65619156|NCT03653520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65619157|NCT03653520|Anticonvulsants|anticonvulsants|mesh-ancestor
65619158|NCT03653520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65619159|NCT03653520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65619160|NCT03653520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65619161|NCT03653520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65619162|NCT03653520|Anesthetics, General|anesthetics, general|mesh-ancestor
65619163|NCT03653520|Anesthetics|anesthetics|mesh-ancestor
65619164|NCT03653520|GABA Modulators|gaba modulators|mesh-ancestor
65619165|NCT03653520|GABA Agents|gaba agents|mesh-ancestor
65619166|NCT01208090|Ponesimod|ponesimod|mesh-list
65619167|NCT01208090|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65619168|NCT01208090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619169|NCT01208090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65619170|NCT01208090|Immunologic Factors|immunologic factors|mesh-ancestor
65619171|NCT01208090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619172|NCT01380483|Doxycycline|doxycycline|mesh-list
65619173|NCT01380483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65619174|NCT01380483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65619175|NCT01380483|Antimalarials|antimalarials|mesh-ancestor
65619176|NCT01380483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65619177|NCT01380483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65619178|NCT02745392|Zolmitriptan|zolmitriptan|mesh-list
65619179|NCT02745392|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65619180|NCT02745392|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65619181|NCT02745392|Serotonin Agents|serotonin agents|mesh-ancestor
65619182|NCT02745392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65619183|NCT02745392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619184|NCT02745392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619185|NCT01378845|Bosentan|bosentan|mesh-list
65619186|NCT01378845|Alprostadil|alprostadil|mesh-list
65619187|NCT01378845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65619188|NCT01378845|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65619189|NCT01378845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619190|NCT01378845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65619191|NCT01378845|Vasodilator Agents|vasodilator agents|mesh-ancestor
65619192|NCT01378845|Urological Agents|urological agents|mesh-ancestor
65619193|NCT04884399|Ranibizumab|ranibizumab|mesh-list
65619194|NCT04884399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65619195|NCT04884399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65619196|NCT04884399|Growth Substances|growth substances|mesh-ancestor
65619197|NCT04884399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619198|NCT04884399|Growth Inhibitors|growth inhibitors|mesh-ancestor
65619199|NCT04884399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619200|NCT03264404|Pembrolizumab|pembrolizumab|mesh-list
65619201|NCT03264404|Azacitidine|azacitidine|mesh-list
65619202|NCT03264404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65619203|NCT03264404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619204|NCT03264404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65619205|NCT03264404|Antimetabolites|antimetabolites|mesh-ancestor
65619206|NCT03264404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619207|NCT03264404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619208|NCT04904549|Vaccines|vaccines|mesh-list
65619209|NCT04904549|Immunologic Factors|immunologic factors|mesh-ancestor
65619210|NCT04904549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619211|NCT03607916|Morphine|morphine|mesh-list
65619212|NCT03607916|Prilocaine|prilocaine|mesh-list
65619213|NCT03607916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65619214|NCT03607916|Narcotics|narcotics|mesh-ancestor
65619215|NCT03607916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65619216|NCT03607916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619217|NCT03607916|Analgesics|analgesics|mesh-ancestor
65619218|NCT03607916|Sensory System Agents|sensory system agents|mesh-ancestor
65619219|NCT03607916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65619220|NCT03607916|Anesthetics, Local|anesthetics, local|mesh-ancestor
65619221|NCT03607916|Anesthetics|anesthetics|mesh-ancestor
65619222|NCT01141712|Cytarabine|cytarabine|mesh-list
65619223|NCT01141712|Etoposide|etoposide|mesh-list
65619224|NCT01141712|Melphalan|melphalan|mesh-list
65619225|NCT01141712|Carmustine|carmustine|mesh-list
65619226|NCT01141712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65619227|NCT01141712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619228|NCT01141712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65619229|NCT01141712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65619230|NCT01141712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619231|NCT01141712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619232|NCT01141712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65619233|NCT01141712|Antimetabolites|antimetabolites|mesh-ancestor
65619234|NCT01141712|Antiviral Agents|antiviral agents|mesh-ancestor
65619235|NCT01141712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65619236|NCT01141712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65619237|NCT01141712|Immunologic Factors|immunologic factors|mesh-ancestor
65619238|NCT01141712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619239|NCT01141712|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65619240|NCT01141712|Alkylating Agents|alkylating agents|mesh-ancestor
65619241|NCT01141712|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65619242|NCT02034890|Hyaluronic Acid|hyaluronic acid|mesh-list
65619243|NCT02034890|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65619244|NCT02034890|Immunologic Factors|immunologic factors|mesh-ancestor
65619245|NCT02034890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619246|NCT02034890|Viscosupplements|viscosupplements|mesh-ancestor
65619247|NCT02034890|Protective Agents|protective agents|mesh-ancestor
65619248|NCT02015351|Bevacizumab|bevacizumab|mesh-list
65619249|NCT02015351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65619250|NCT02015351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619251|NCT02015351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65619252|NCT02015351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65619253|NCT02015351|Growth Substances|growth substances|mesh-ancestor
65619254|NCT02015351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619255|NCT02015351|Growth Inhibitors|growth inhibitors|mesh-ancestor
65619256|NCT03604796|Acetaminophen|acetaminophen|mesh-list
65619257|NCT03604796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65619258|NCT03604796|Analgesics|analgesics|mesh-ancestor
65619259|NCT03604796|Sensory System Agents|sensory system agents|mesh-ancestor
65619260|NCT03604796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65619261|NCT03604796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619262|NCT03604796|Antipyretics|antipyretics|mesh-ancestor
65619263|NCT02237534|Calcium Carbonate|calcium carbonate|mesh-list
65619264|NCT02237534|Calcium|calcium|mesh-list
65619265|NCT02237534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65619266|NCT02237534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619267|NCT02237534|Antacids|antacids|mesh-ancestor
65619268|NCT02237534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619269|NCT02237534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65619270|NCT03606902|Fentanyl|fentanyl|mesh-list
65619271|NCT03606902|Bupivacaine|bupivacaine|mesh-list
65619272|NCT03606902|Anesthetics, Local|anesthetics, local|mesh-ancestor
65619273|NCT03606902|Anesthetics|anesthetics|mesh-ancestor
65619274|NCT03606902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65619275|NCT03606902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619276|NCT03606902|Sensory System Agents|sensory system agents|mesh-ancestor
65619277|NCT03606902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65619278|NCT03606902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65619279|NCT03606902|Narcotics|narcotics|mesh-ancestor
65619280|NCT03606902|Analgesics|analgesics|mesh-ancestor
65619281|NCT03606902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65619282|NCT03606902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65619283|NCT03606902|Anesthetics, General|anesthetics, general|mesh-ancestor
65619284|NCT03602378|Hydrocortisone|hydrocortisone|mesh-list
65619285|NCT03602378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65619286|NCT03606824|Pitavastatin|pitavastatin|mesh-list
65619287|NCT03606824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65619288|NCT03606824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65619289|NCT03606824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65619290|NCT03606824|Antimetabolites|antimetabolites|mesh-ancestor
65619291|NCT03606824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619292|NCT03606824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619293|NCT03606824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65619294|NCT03604016|Tenofovir|tenofovir|mesh-list
65619295|NCT03604016|Antiviral Agents|antiviral agents|mesh-ancestor
65619296|NCT03604016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65619297|NCT03604016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65619298|NCT03604016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65619299|NCT03604016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619300|NCT03604016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619301|NCT03604016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65619302|NCT03604016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65619303|NCT01064622|Gemcitabine|gemcitabine|mesh-list
65619304|NCT01064622|Hydrocortisone|hydrocortisone|mesh-list
65619305|NCT01064622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65619306|NCT01064622|Antimetabolites|antimetabolites|mesh-ancestor
65619307|NCT01064622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619308|NCT01064622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619309|NCT01064622|Antiviral Agents|antiviral agents|mesh-ancestor
65619310|NCT01064622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65619311|NCT01064622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619312|NCT01064622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65619313|NCT01064622|Immunologic Factors|immunologic factors|mesh-ancestor
65619314|NCT01064622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619315|NCT01064622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65619316|NCT01063764|Levetiracetam|levetiracetam|mesh-list
65619317|NCT01063764|Anticonvulsants|anticonvulsants|mesh-ancestor
65619318|NCT01063764|Nootropic Agents|nootropic agents|mesh-ancestor
65619319|NCT04053972|Lenvatinib|lenvatinib|mesh-list
65619320|NCT04053972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619321|NCT04053972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65619322|NCT04053972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619323|NCT04053972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619324|NCT01380249|Bromides|bromides|mesh-list
65619325|NCT01380249|Anticonvulsants|anticonvulsants|mesh-ancestor
65619326|NCT04054518|Durvalumab|durvalumab|mesh-list
65619327|NCT04054518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65619328|NCT04054518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619329|NCT03652896|Liver Extracts|liver extracts|mesh-list
65619330|NCT03652896|Hematinics|hematinics|mesh-ancestor
65619331|NCT04565847|Albuterol|albuterol|mesh-list
65619332|NCT04565847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65619333|NCT04565847|Autonomic Agents|autonomic agents|mesh-ancestor
65619334|NCT04565847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65619335|NCT04565847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619336|NCT04565847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65619337|NCT04565847|Respiratory System Agents|respiratory system agents|mesh-ancestor
65619338|NCT04565847|Tocolytic Agents|tocolytic agents|mesh-ancestor
65619339|NCT04565847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65619340|NCT04565847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65619341|NCT04565847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65619342|NCT04565847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65619343|NCT04565847|Adrenergic Agents|adrenergic agents|mesh-ancestor
65619344|NCT04565847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65619345|NCT04565847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619346|NCT03075891|Doxycycline|doxycycline|mesh-list
65619347|NCT03075891|Ivermectin|ivermectin|mesh-list
65619348|NCT03075891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65619349|NCT03075891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65619350|NCT03075891|Antimalarials|antimalarials|mesh-ancestor
65619351|NCT03075891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65619352|NCT03075891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65619353|NCT02013167|Blinatumomab|blinatumomab|mesh-list
65619354|NCT02013167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619355|NCT01378533|Paclitaxel|paclitaxel|mesh-list
65619356|NCT01378533|Cyclophosphamide|cyclophosphamide|mesh-list
65619357|NCT01378533|Carboplatin|carboplatin|mesh-list
65619358|NCT01378533|Epirubicin|epirubicin|mesh-list
65619359|NCT01378533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65619360|NCT01378533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619361|NCT01378533|Tubulin Modulators|tubulin modulators|mesh-ancestor
65619362|NCT01378533|Antimitotic Agents|antimitotic agents|mesh-ancestor
65266619|NCT02766140|Docetaxel|docetaxel|mesh-list
65619363|NCT01378533|Mitosis Modulators|mitosis modulators|mesh-ancestor
65619364|NCT01378533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619365|NCT01378533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65619366|NCT01378533|Immunologic Factors|immunologic factors|mesh-ancestor
65619367|NCT01378533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619368|NCT01378533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65619369|NCT01378533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65619370|NCT01378533|Alkylating Agents|alkylating agents|mesh-ancestor
65619371|NCT01378533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65619372|NCT01378533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65619373|NCT01378533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65619374|NCT01378533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65619375|NCT01378533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619376|NCT02630199|Paclitaxel|paclitaxel|mesh-list
65619377|NCT02630199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65619378|NCT02630199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619379|NCT02630199|Tubulin Modulators|tubulin modulators|mesh-ancestor
65619380|NCT02630199|Antimitotic Agents|antimitotic agents|mesh-ancestor
65619381|NCT02630199|Mitosis Modulators|mitosis modulators|mesh-ancestor
65619382|NCT02630199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619383|NCT02588781|Pemetrexed|pemetrexed|mesh-list
65619384|NCT02588781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619385|NCT02588781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619386|NCT02588781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619387|NCT02588781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65619388|NCT02588781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65619389|NCT01063062|Methotrexate|methotrexate|mesh-list
65619390|NCT01063062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65619391|NCT01063062|Abortifacient Agents|abortifacient agents|mesh-ancestor
65619392|NCT01063062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65619393|NCT01063062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619394|NCT01063062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65619395|NCT01063062|Antimetabolites|antimetabolites|mesh-ancestor
65619396|NCT01063062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619397|NCT01063062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619398|NCT01063062|Dermatologic Agents|dermatologic agents|mesh-ancestor
65619399|NCT01063062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619400|NCT01063062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65619401|NCT01063062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65619402|NCT01063062|Immunologic Factors|immunologic factors|mesh-ancestor
65619403|NCT01063062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65619404|NCT01063062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65619405|NCT01314989|Cyproheptadine|cyproheptadine|mesh-list
65619406|NCT01314989|Antipruritics|antipruritics|mesh-ancestor
65619407|NCT01314989|Dermatologic Agents|dermatologic agents|mesh-ancestor
65619408|NCT01314989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65619409|NCT01314989|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65619410|NCT01314989|Histamine Antagonists|histamine antagonists|mesh-ancestor
65619411|NCT01314989|Histamine Agents|histamine agents|mesh-ancestor
65619412|NCT01314989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65619413|NCT01314989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619414|NCT01314989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619415|NCT01314989|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65619416|NCT01314989|Serotonin Agents|serotonin agents|mesh-ancestor
65619417|NCT01314989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65619418|NCT04483115|Tadalafil|tadalafil|mesh-list
65619419|NCT04483115|Vasodilator Agents|vasodilator agents|mesh-ancestor
65619420|NCT04483115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65619421|NCT04483115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65619422|NCT04483115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619423|NCT04483115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619424|NCT04483115|Urological Agents|urological agents|mesh-ancestor
65619425|NCT04054362|Gemcitabine|gemcitabine|mesh-list
65619426|NCT04054362|Paclitaxel|paclitaxel|mesh-list
65619427|NCT04054362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65619428|NCT04054362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65619429|NCT04054362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619430|NCT04054362|Tubulin Modulators|tubulin modulators|mesh-ancestor
65619431|NCT04054362|Antimitotic Agents|antimitotic agents|mesh-ancestor
65619432|NCT04054362|Mitosis Modulators|mitosis modulators|mesh-ancestor
65619433|NCT04054362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619434|NCT04054362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65619435|NCT04054362|Antimetabolites|antimetabolites|mesh-ancestor
65619436|NCT04054362|Antiviral Agents|antiviral agents|mesh-ancestor
65619437|NCT04054362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65619438|NCT04054362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619439|NCT04054362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65619440|NCT04054362|Immunologic Factors|immunologic factors|mesh-ancestor
65619441|NCT04054362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619442|NCT04467281|Daratumumab|daratumumab|mesh-list
65619443|NCT04467281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619444|NCT01378143|Pentamidine|pentamidine|mesh-list
65416834|NCT03560531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65619445|NCT01378143|Antifungal Agents|antifungal agents|mesh-ancestor
65619446|NCT01378143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65619447|NCT01378143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65619448|NCT01378143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65619449|NCT01378143|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65619450|NCT02973048|Bupivacaine|bupivacaine|mesh-list
65619451|NCT02973048|Prilocaine|prilocaine|mesh-list
65619452|NCT02973048|Anesthetics, Local|anesthetics, local|mesh-ancestor
65619453|NCT02973048|Anesthetics|anesthetics|mesh-ancestor
65619454|NCT02973048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65619455|NCT02973048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619456|NCT02973048|Sensory System Agents|sensory system agents|mesh-ancestor
65619457|NCT02973048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65619458|NCT03342027|Bupropion|bupropion|mesh-list
65619459|NCT03342027|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65619460|NCT03342027|Antidepressive Agents|antidepressive agents|mesh-ancestor
65619461|NCT03342027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65619462|NCT03342027|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65619463|NCT03342027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65619464|NCT03342027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65619465|NCT03342027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619466|NCT03342027|Dopamine Agents|dopamine agents|mesh-ancestor
65619467|NCT03342027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65619468|NCT03342027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619469|NCT03342027|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65619470|NCT03342027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65619471|NCT03342027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619472|NCT04054206|Ibudilast|ibudilast|mesh-list
65619473|NCT04054206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65619474|NCT04054206|Autonomic Agents|autonomic agents|mesh-ancestor
65619475|NCT04054206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65619476|NCT04054206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619477|NCT04054206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65619478|NCT04054206|Respiratory System Agents|respiratory system agents|mesh-ancestor
65619479|NCT04054206|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65619480|NCT04054206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619481|NCT04054206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619482|NCT04054206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65619483|NCT04054206|Vasodilator Agents|vasodilator agents|mesh-ancestor
65619484|NCT03603938|Losartan|losartan|mesh-list
65619485|NCT03603938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65619486|NCT03603938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65619487|NCT03603938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65619488|NCT03603938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65619489|NCT03603938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619490|NCT03652116|Meperidine|meperidine|mesh-list
65619491|NCT03652116|Bupivacaine|bupivacaine|mesh-list
65619492|NCT03652116|Anesthetics, Local|anesthetics, local|mesh-ancestor
65619493|NCT03652116|Anesthetics|anesthetics|mesh-ancestor
65619494|NCT03652116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65619495|NCT03652116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619496|NCT03652116|Sensory System Agents|sensory system agents|mesh-ancestor
65619497|NCT03652116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65619498|NCT03652116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65619499|NCT03652116|Narcotics|narcotics|mesh-ancestor
65619500|NCT03652116|Analgesics|analgesics|mesh-ancestor
65619501|NCT03652116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65619502|NCT04428671|Cemiplimab|cemiplimab|mesh-list
65619503|NCT04428671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65619504|NCT04428671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619505|NCT02232087|Fluticasone|fluticasone|mesh-list
65619506|NCT02232087|Xhance|xhance|mesh-list
65619507|NCT02232087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65619508|NCT02232087|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65619509|NCT02232087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65619510|NCT02232087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65619511|NCT02232087|Autonomic Agents|autonomic agents|mesh-ancestor
65619512|NCT02232087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65619513|NCT02232087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619514|NCT02232087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65619515|NCT02232087|Respiratory System Agents|respiratory system agents|mesh-ancestor
65619516|NCT02232087|Dermatologic Agents|dermatologic agents|mesh-ancestor
65619517|NCT02232087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65619518|NCT02232087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65416946|NCT00896519|Prednisone|prednisone|mesh-list
65619519|NCT02232087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65619520|NCT02232087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65619521|NCT02232087|Adrenergic Agents|adrenergic agents|mesh-ancestor
65619522|NCT02232087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65619523|NCT02232087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619524|NCT02232087|Glucocorticoids|glucocorticoids|mesh-ancestor
65619525|NCT02232087|Hormones|hormones|mesh-ancestor
65619526|NCT02232087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65619527|NCT02232087|Sympathomimetics|sympathomimetics|mesh-ancestor
65619528|NCT01380015|Rosmarinic acid|rosmarinic acid|mesh-list
65619529|NCT01380015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65619530|NCT01380015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65619531|NCT01380015|Analgesics|analgesics|mesh-ancestor
65619532|NCT01380015|Sensory System Agents|sensory system agents|mesh-ancestor
65619533|NCT01380015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65619534|NCT01380015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619535|NCT01380015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65619536|NCT01380015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65619537|NCT01380015|Antioxidants|antioxidants|mesh-ancestor
65619538|NCT01380015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619539|NCT01380015|Protective Agents|protective agents|mesh-ancestor
65619540|NCT01380015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65619541|NCT01380015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65619542|NCT01380015|Protease Inhibitors|protease inhibitors|mesh-ancestor
65619543|NCT01380015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619544|NCT03603626|Pregabalin|pregabalin|mesh-list
65619545|NCT03603626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619546|NCT03603626|Analgesics|analgesics|mesh-ancestor
65619547|NCT03603626|Sensory System Agents|sensory system agents|mesh-ancestor
65619548|NCT03603626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65619549|NCT03603626|Anticonvulsants|anticonvulsants|mesh-ancestor
65619550|NCT03603626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65619551|NCT03603626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65619552|NCT03603626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619553|NCT03603626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65619554|NCT03603626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65619555|NCT03603626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65619556|NCT03603626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65619557|NCT03603626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65619558|NCT01765218|Topiramate|topiramate|mesh-list
65619559|NCT01765218|Anticonvulsants|anticonvulsants|mesh-ancestor
65619560|NCT01765218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65619561|NCT01765218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619562|NCT03651882|Oxytocin|oxytocin|mesh-list
65619563|NCT03651882|Carbetocin|carbetocin|mesh-list
65619564|NCT03651882|Oxytocics|oxytocics|mesh-ancestor
65619565|NCT03651882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65619566|NCT03651882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619567|NCT02972502|Diphenhydramine|diphenhydramine|mesh-list
65619568|NCT02972502|Promethazine|promethazine|mesh-list
65619569|NCT02972502|Haloperidol|haloperidol|mesh-list
65619570|NCT02972502|Metoclopramide|metoclopramide|mesh-list
65619571|NCT02972502|Haloperidol decanoate|haloperidol decanoate|mesh-list
65619572|NCT02972502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65619573|NCT02972502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65619574|NCT02972502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65619575|NCT02972502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619576|NCT02972502|Anesthetics, Local|anesthetics, local|mesh-ancestor
65619577|NCT02972502|Anesthetics|anesthetics|mesh-ancestor
65619578|NCT02972502|Sensory System Agents|sensory system agents|mesh-ancestor
65619579|NCT02972502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65619580|NCT02972502|Antiemetics|antiemetics|mesh-ancestor
65619581|NCT02972502|Autonomic Agents|autonomic agents|mesh-ancestor
65619582|NCT02972502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65619583|NCT02972502|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65619584|NCT02972502|Histamine Antagonists|histamine antagonists|mesh-ancestor
65619585|NCT02972502|Histamine Agents|histamine agents|mesh-ancestor
65619586|NCT02972502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65619587|NCT02972502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619588|NCT02972502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65619589|NCT02972502|Antipruritics|antipruritics|mesh-ancestor
65619590|NCT02972502|Dermatologic Agents|dermatologic agents|mesh-ancestor
65619591|NCT02972502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65619592|NCT02972502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65619593|NCT02972502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65619594|NCT02972502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65619595|NCT02972502|Dopamine Agents|dopamine agents|mesh-ancestor
65619596|NCT02972502|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65619597|NCT02972502|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65619599|NCT03606590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619600|NCT03606590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65619601|NCT03606590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619602|NCT03606590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619603|NCT03163667|Everolimus|everolimus|mesh-list
65619604|NCT03163667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619605|NCT03163667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65619606|NCT03163667|Immunologic Factors|immunologic factors|mesh-ancestor
65619607|NCT03163667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619608|NCT03603548|Tacrolimus|tacrolimus|mesh-list
65619609|NCT03603548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65619610|NCT03603548|Immunologic Factors|immunologic factors|mesh-ancestor
65619611|NCT03603548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619612|NCT03603548|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65619613|NCT03603548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619614|NCT03603548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619615|NCT03954782|Nintedanib|nintedanib|mesh-list
65619616|NCT03954782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619617|NCT03954782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65619618|NCT03954782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619619|NCT03954782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619620|NCT03651726|Palmidrol|palmidrol|mesh-list
65619621|NCT03651726|Dronabinol|dronabinol|mesh-list
65619622|NCT03651726|Hallucinogens|hallucinogens|mesh-ancestor
65619623|NCT03651726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619624|NCT03651726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65619625|NCT03651726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65619626|NCT03651726|Analgesics|analgesics|mesh-ancestor
65619627|NCT03651726|Sensory System Agents|sensory system agents|mesh-ancestor
65619628|NCT03651726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65619629|NCT03651726|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65619630|NCT03651726|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65619631|NCT03651726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65619632|NCT03651726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619633|NCT03651726|Hormones|hormones|mesh-ancestor
65619634|NCT03651726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65266644|NCT04178109|Narcotics|narcotics|mesh-ancestor
65619635|NCT03651726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65619636|NCT03651726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65619637|NCT03651726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65619638|NCT03651726|Antiviral Agents|antiviral agents|mesh-ancestor
65619639|NCT03651726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65619640|NCT00107250|Paclitaxel|paclitaxel|mesh-list
65619641|NCT00107250|Carboplatin|carboplatin|mesh-list
65619642|NCT00107250|Capecitabine|capecitabine|mesh-list
65619643|NCT00107250|Cediranib|cediranib|mesh-list
65619644|NCT00107250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65619645|NCT00107250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619646|NCT00107250|Tubulin Modulators|tubulin modulators|mesh-ancestor
65619647|NCT00107250|Antimitotic Agents|antimitotic agents|mesh-ancestor
65619648|NCT00107250|Mitosis Modulators|mitosis modulators|mesh-ancestor
65619649|NCT00107250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619650|NCT00107250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65619651|NCT00107250|Antimetabolites|antimetabolites|mesh-ancestor
65619652|NCT00107250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619653|NCT00107250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65619654|NCT03167411|Exenatide|exenatide|mesh-list
65619655|NCT03167411|Bexagliflozin|bexagliflozin|mesh-list
65619656|NCT03167411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65619657|NCT03167411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619658|NCT03167411|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65619659|NCT03167411|Incretins|incretins|mesh-ancestor
65619660|NCT03167411|Hormones|hormones|mesh-ancestor
65619661|NCT03167411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65619662|NCT02237768|Dirithromycin|dirithromycin|mesh-list
65619663|NCT02237768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65619664|NCT02237768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65619665|NCT05461833|Octylonium|octylonium|mesh-list
65619666|NCT05461833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65619667|NCT05461833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65619668|NCT05461833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619669|NCT05461833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65619670|NCT05461833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619671|NCT05461833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65619672|NCT05461833|Parasympatholytics|parasympatholytics|mesh-ancestor
65619673|NCT05461833|Autonomic Agents|autonomic agents|mesh-ancestor
65619674|NCT05461833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65619675|NCT05461833|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65619676|NCT05461833|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65619677|NCT05461833|Cholinergic Agents|cholinergic agents|mesh-ancestor
65619678|NCT05461833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65619679|NCT01560585|Isotretinoin|isotretinoin|mesh-list
65619680|NCT01560585|Dermatologic Agents|dermatologic agents|mesh-ancestor
65619681|NCT01376427|Dexamethasone|dexamethasone|mesh-list
65619682|NCT01376427|Methotrexate|methotrexate|mesh-list
65619683|NCT01376427|Vincristine|vincristine|mesh-list
65619684|NCT01376427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65619685|NCT01376427|Antiemetics|antiemetics|mesh-ancestor
65619686|NCT01376427|Autonomic Agents|autonomic agents|mesh-ancestor
65619687|NCT01376427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65619688|NCT01376427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619689|NCT01376427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65619690|NCT01376427|Glucocorticoids|glucocorticoids|mesh-ancestor
65619691|NCT01376427|Hormones|hormones|mesh-ancestor
65619692|NCT01376427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65619693|NCT01376427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65619694|NCT01376427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619695|NCT01376427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65619696|NCT01376427|Abortifacient Agents|abortifacient agents|mesh-ancestor
65619697|NCT01376427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65619698|NCT01376427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65619699|NCT01376427|Antimetabolites|antimetabolites|mesh-ancestor
65619700|NCT01376427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619701|NCT01376427|Dermatologic Agents|dermatologic agents|mesh-ancestor
65619702|NCT01376427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619703|NCT01376427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65619704|NCT01376427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65619705|NCT01376427|Immunologic Factors|immunologic factors|mesh-ancestor
65619706|NCT01376427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65619707|NCT01376427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65619708|NCT01376427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65619709|NCT01376427|Tubulin Modulators|tubulin modulators|mesh-ancestor
65619710|NCT01376427|Antimitotic Agents|antimitotic agents|mesh-ancestor
65619711|NCT01376427|Mitosis Modulators|mitosis modulators|mesh-ancestor
65619712|NCT05764395|Pembrolizumab|pembrolizumab|mesh-list
65619713|NCT05764395|ON 01910|on 01910|mesh-list
65619714|NCT05764395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65619715|NCT05764395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619716|NCT05764395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65619717|NCT05764395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619718|NCT05764395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619719|NCT03075501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65619720|NCT03075501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619721|NCT03075501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65619722|NCT05462535|Losartan|losartan|mesh-list
65619723|NCT05462535|Amlodipine|amlodipine|mesh-list
65619724|NCT05462535|Chlorthalidone|chlorthalidone|mesh-list
65619725|NCT05462535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65619726|NCT05462535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65619727|NCT05462535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65619728|NCT05462535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619729|NCT05462535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65619730|NCT05462535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619731|NCT05462535|Vasodilator Agents|vasodilator agents|mesh-ancestor
65619732|NCT05462535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65619733|NCT05462535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65619734|NCT05462535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65619735|NCT05462535|Diuretics|diuretics|mesh-ancestor
65619736|NCT05462535|Natriuretic Agents|natriuretic agents|mesh-ancestor
65619737|NCT05462535|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65619738|NCT05764317|Amlodipine|amlodipine|mesh-list
65619739|NCT05764317|Perindopril|perindopril|mesh-list
65619740|NCT05764317|Atorvastatin|atorvastatin|mesh-list
65619741|NCT05764317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65619742|NCT05764317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65619743|NCT05764317|Antimetabolites|antimetabolites|mesh-ancestor
65619744|NCT05764317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619745|NCT05764317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65619746|NCT05764317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65619747|NCT05764317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619748|NCT05764317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65619749|NCT05764317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65619750|NCT05764317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65619751|NCT05764317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65619752|NCT05764317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619753|NCT05764317|Vasodilator Agents|vasodilator agents|mesh-ancestor
65619754|NCT05764317|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65619755|NCT05764317|Protease Inhibitors|protease inhibitors|mesh-ancestor
65619757|NCT05461365|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65619758|NCT05461365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65619759|NCT05461365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619760|NCT03602846|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65619761|NCT03602846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619762|NCT02317991|Paclitaxel|paclitaxel|mesh-list
65619763|NCT02317991|Ramucirumab|ramucirumab|mesh-list
65619764|NCT02317991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65619765|NCT02317991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619766|NCT02317991|Tubulin Modulators|tubulin modulators|mesh-ancestor
65619767|NCT02317991|Antimitotic Agents|antimitotic agents|mesh-ancestor
65619768|NCT02317991|Mitosis Modulators|mitosis modulators|mesh-ancestor
65619769|NCT02317991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619770|NCT03602690|Ritonavir|ritonavir|mesh-list
65619771|NCT03602690|Darunavir|darunavir|mesh-list
65619772|NCT03602690|Dolutegravir|dolutegravir|mesh-list
65619773|NCT03602690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65619774|NCT03602690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65619775|NCT03602690|Protease Inhibitors|protease inhibitors|mesh-ancestor
65619776|NCT03602690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619777|NCT03602690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619778|NCT03602690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65619779|NCT03602690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65619780|NCT03602690|Antiviral Agents|antiviral agents|mesh-ancestor
65619781|NCT03602690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65619782|NCT03602690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65619783|NCT03602690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65619784|NCT03602690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65619785|NCT03602690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65619786|NCT01379547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65619787|NCT01379547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65619788|NCT02978495|Paclitaxel|paclitaxel|mesh-list
65619789|NCT02978495|Cyclophosphamide|cyclophosphamide|mesh-list
65619790|NCT02978495|Carboplatin|carboplatin|mesh-list
65619791|NCT02978495|Doxorubicin|doxorubicin|mesh-list
65619792|NCT02978495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65619793|NCT02978495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619794|NCT02978495|Tubulin Modulators|tubulin modulators|mesh-ancestor
65619795|NCT02978495|Antimitotic Agents|antimitotic agents|mesh-ancestor
65619796|NCT02978495|Mitosis Modulators|mitosis modulators|mesh-ancestor
65619797|NCT02978495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619798|NCT02978495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65619799|NCT02978495|Immunologic Factors|immunologic factors|mesh-ancestor
65619800|NCT02978495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619801|NCT02978495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65619802|NCT02978495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65619803|NCT02978495|Alkylating Agents|alkylating agents|mesh-ancestor
65619804|NCT02978495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65619805|NCT02978495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65619806|NCT02978495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65619807|NCT02978495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65619808|NCT02978495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619809|NCT02237690|Doxorubicin|doxorubicin|mesh-list
65619810|NCT02237690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65619811|NCT02237690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65619812|NCT02237690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619813|NCT02237690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65619814|NCT02237690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65619815|NCT02237690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619816|NCT02237690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619817|NCT04788017|Ziresovir|ziresovir|mesh-list
65619818|NCT04788017|Antiviral Agents|antiviral agents|mesh-ancestor
65417212|NCT00895115|Vitamin E|vitamin e|mesh-list
65619819|NCT04788017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65619821|NCT03600974|Citalopram|citalopram|mesh-list
65619822|NCT03600974|Esomeprazole|esomeprazole|mesh-list
65619823|NCT03600974|Omeprazole|omeprazole|mesh-list
65619824|NCT03600974|Rabeprazole|rabeprazole|mesh-list
65619825|NCT03600974|Pantoprazole|pantoprazole|mesh-list
65619826|NCT03600974|Lansoprazole|lansoprazole|mesh-list
65619827|NCT03600974|Mosapride|mosapride|mesh-list
65619828|NCT03600974|Neurotransmitter Agents|neurotransmitter agents|mesh-list
65619829|NCT03600974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65619830|NCT03600974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65619831|NCT03600974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65619832|NCT03600974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619833|NCT03600974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619834|NCT03600974|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65619835|NCT03600974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65619836|NCT03600974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65619837|NCT03600974|Serotonin Agents|serotonin agents|mesh-ancestor
65619838|NCT03600974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619839|NCT03600974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65619840|NCT03600974|Antidepressive Agents|antidepressive agents|mesh-ancestor
65619841|NCT03600974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65619842|NCT03600974|Autonomic Agents|autonomic agents|mesh-ancestor
65619843|NCT03600974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65619844|NCT03600974|Antiemetics|antiemetics|mesh-ancestor
65619845|NCT03600974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65619846|NCT03600974|Dopamine Agents|dopamine agents|mesh-ancestor
65619847|NCT03600974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65619848|NCT03075267|Budesonide|budesonide|mesh-list
65619849|NCT03075267|Glycopyrrolate|glycopyrrolate|mesh-list
65619850|NCT03075267|Formoterol Fumarate|formoterol fumarate|mesh-list
65619851|NCT03075267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65619852|NCT03075267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65619853|NCT03075267|Autonomic Agents|autonomic agents|mesh-ancestor
65619854|NCT03075267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65619855|NCT03075267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619856|NCT03075267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65619857|NCT03075267|Respiratory System Agents|respiratory system agents|mesh-ancestor
65619858|NCT03075267|Glucocorticoids|glucocorticoids|mesh-ancestor
65619859|NCT03075267|Hormones|hormones|mesh-ancestor
65619860|NCT03075267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65619861|NCT03075267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65619862|NCT03075267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65619863|NCT03075267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65619864|NCT03075267|Adrenergic Agents|adrenergic agents|mesh-ancestor
65619865|NCT03075267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65619866|NCT03075267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619867|NCT03075267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65619868|NCT03075267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65619869|NCT03075267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65619870|NCT03075267|Cholinergic Agents|cholinergic agents|mesh-ancestor
65619871|NCT03600506|Dexmedetomidine|dexmedetomidine|mesh-list
65619872|NCT03600506|Sympatholytics|sympatholytics|mesh-list
65619873|NCT03600506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65619874|NCT03600506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65619875|NCT03600506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619876|NCT03600506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65619877|NCT03600506|Analgesics|analgesics|mesh-ancestor
65619878|NCT03600506|Sensory System Agents|sensory system agents|mesh-ancestor
65619879|NCT03600506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65619880|NCT03600506|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65619881|NCT03600506|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65619882|NCT03600506|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65619883|NCT03600506|Adrenergic Agents|adrenergic agents|mesh-ancestor
65619884|NCT03600506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65619885|NCT03600506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619886|NCT03600506|Autonomic Agents|autonomic agents|mesh-ancestor
65619887|NCT03074331|Sofosbuvir|sofosbuvir|mesh-list
65619888|NCT03074331|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65619889|NCT03074331|Velpatasvir|velpatasvir|mesh-list
65619890|NCT03074331|Antiviral Agents|antiviral agents|mesh-ancestor
65619891|NCT03074331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65619892|NCT02237924|Endostar protein|endostar protein|mesh-list
65619893|NCT02237924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65619894|NCT02237924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65619896|NCT02237924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619897|NCT02237924|Growth Inhibitors|growth inhibitors|mesh-ancestor
65619898|NCT02237924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619899|NCT03825302|Mannitol|mannitol|mesh-list
65619900|NCT03825302|Methacholine Chloride|methacholine chloride|mesh-list
65619901|NCT03825302|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65619902|NCT03825302|Diuretics|diuretics|mesh-ancestor
65619903|NCT03825302|Natriuretic Agents|natriuretic agents|mesh-ancestor
65619904|NCT03825302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619905|NCT03825302|Miotics|miotics|mesh-ancestor
65619906|NCT03825302|Autonomic Agents|autonomic agents|mesh-ancestor
65619907|NCT03825302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65619908|NCT03825302|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65619909|NCT03825302|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
65619910|NCT03825302|Respiratory System Agents|respiratory system agents|mesh-ancestor
65619911|NCT03825302|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65619912|NCT03825302|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65619913|NCT03825302|Cholinergic Agents|cholinergic agents|mesh-ancestor
65619914|NCT03825302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65619915|NCT03825302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619916|NCT02238392|Adenosine|adenosine|mesh-list
65619917|NCT02238392|Analgesics|analgesics|mesh-ancestor
65619918|NCT02238392|Sensory System Agents|sensory system agents|mesh-ancestor
65619919|NCT02238392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65619920|NCT02238392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619921|NCT02238392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65619922|NCT02238392|Vasodilator Agents|vasodilator agents|mesh-ancestor
65619923|NCT02238392|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65619924|NCT02238392|Purinergic Agonists|purinergic agonists|mesh-ancestor
65619925|NCT02238392|Purinergic Agents|purinergic agents|mesh-ancestor
65619926|NCT02238392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65619927|NCT02238392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619928|NCT02260193|Glycine|glycine|mesh-list
65619929|NCT02260193|Glycine Agents|glycine agents|mesh-ancestor
65619930|NCT02260193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65619931|NCT02260193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619932|NCT02260193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619933|NCT02849678|Lidocaine|lidocaine|mesh-list
65619934|NCT02849678|Ropivacaine|ropivacaine|mesh-list
65619935|NCT02849678|Anesthetics, Local|anesthetics, local|mesh-ancestor
65619936|NCT02849678|Anesthetics|anesthetics|mesh-ancestor
65619937|NCT02849678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65619938|NCT02849678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619939|NCT02849678|Sensory System Agents|sensory system agents|mesh-ancestor
65619940|NCT02849678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65619941|NCT02849678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65619942|NCT02849678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65619943|NCT02849678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65619944|NCT02849678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65619945|NCT02849678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619946|NCT04295577|Niraparib|niraparib|mesh-list
65619947|NCT04295577|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65619948|NCT04295577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619949|NCT04295577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619950|NCT04295577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65619951|NCT02238158|Ipratropium|ipratropium|mesh-list
65619952|NCT02238158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65619953|NCT02238158|Autonomic Agents|autonomic agents|mesh-ancestor
65619954|NCT02238158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65619955|NCT02238158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65619956|NCT02238158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65619957|NCT02238158|Respiratory System Agents|respiratory system agents|mesh-ancestor
65619958|NCT02238158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65619959|NCT02238158|Cholinergic Agents|cholinergic agents|mesh-ancestor
65619960|NCT02238158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65619961|NCT02238158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619962|NCT02238314|Ritonavir|ritonavir|mesh-list
65619963|NCT02238314|Tipranavir|tipranavir|mesh-list
65619964|NCT02238314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
65619965|NCT02238314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65619966|NCT02238314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65619967|NCT02238314|Protease Inhibitors|protease inhibitors|mesh-ancestor
65619968|NCT02238314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619969|NCT02238314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619970|NCT02238314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65619971|NCT02238314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65619972|NCT02238314|Antiviral Agents|antiviral agents|mesh-ancestor
65619973|NCT02238314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65619974|NCT02238314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65619975|NCT02238314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65619976|NCT02238314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65619977|NCT02238470|Warfarin|warfarin|mesh-list
65619978|NCT02238470|Rivaroxaban|rivaroxaban|mesh-list
65619979|NCT02238470|Dabigatran|dabigatran|mesh-list
65619980|NCT02238470|Apixaban|apixaban|mesh-list
65619981|NCT02238470|Anticoagulants|anticoagulants|mesh-list
65619982|NCT02238470|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65619983|NCT02238470|Antithrombins|antithrombins|mesh-ancestor
65619984|NCT02238470|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65619985|NCT02238470|Protease Inhibitors|protease inhibitors|mesh-ancestor
65619986|NCT02238470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65619987|NCT02238470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65619988|NCT03586934|Acetaminophen|acetaminophen|mesh-list
65619989|NCT03586934|Celecoxib|celecoxib|mesh-list
65619990|NCT03586934|Ketorolac|ketorolac|mesh-list
65619991|NCT03586934|Meloxicam|meloxicam|mesh-list
65619992|NCT03586934|Morphine|morphine|mesh-list
65619993|NCT03586934|Oxycodone|oxycodone|mesh-list
65619994|NCT03586934|Tramadol|tramadol|mesh-list
65619995|NCT03586934|Hydrocodone|hydrocodone|mesh-list
65619996|NCT03586934|Ropivacaine|ropivacaine|mesh-list
65619997|NCT03586934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65619998|NCT03586934|Narcotics|narcotics|mesh-ancestor
65619999|NCT03586934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65620000|NCT03586934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620001|NCT03586934|Analgesics|analgesics|mesh-ancestor
65620002|NCT03586934|Sensory System Agents|sensory system agents|mesh-ancestor
65620003|NCT03586934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620004|NCT03586934|Anesthetics, Local|anesthetics, local|mesh-ancestor
65620005|NCT03586934|Anesthetics|anesthetics|mesh-ancestor
65620006|NCT03586934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65620007|NCT03586934|Antipyretics|antipyretics|mesh-ancestor
65620008|NCT03586934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65620009|NCT03586934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65620010|NCT03586934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65620011|NCT03586934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65620012|NCT03586934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65620013|NCT03586934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620014|NCT03586934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620015|NCT03586934|Antitussive Agents|antitussive agents|mesh-ancestor
65620016|NCT03586934|Respiratory System Agents|respiratory system agents|mesh-ancestor
65620017|NCT03586154|Ketamine|ketamine|mesh-list
65620018|NCT03586154|Bupivacaine|bupivacaine|mesh-list
65620019|NCT03586154|Anesthetics, Local|anesthetics, local|mesh-ancestor
65620020|NCT03586154|Anesthetics|anesthetics|mesh-ancestor
65620021|NCT03586154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65620022|NCT03586154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620023|NCT03586154|Sensory System Agents|sensory system agents|mesh-ancestor
65620024|NCT03586154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620025|NCT03586154|Analgesics|analgesics|mesh-ancestor
65620026|NCT03586154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65620027|NCT03586154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65620028|NCT03586154|Anesthetics, General|anesthetics, general|mesh-ancestor
65620029|NCT03586154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65620030|NCT03586154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65620031|NCT03586154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65620032|NCT03586154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620033|NCT03629847|Everolimus|everolimus|mesh-list
65620034|NCT03629847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620035|NCT03629847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65620036|NCT03629847|Immunologic Factors|immunologic factors|mesh-ancestor
65620037|NCT03629847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620038|NCT01314833|Paclitaxel|paclitaxel|mesh-list
65417439|NCT00903851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65620039|NCT01314833|Docetaxel|docetaxel|mesh-list
65620040|NCT01314833|Cyclophosphamide|cyclophosphamide|mesh-list
65620041|NCT01314833|Fluorouracil|fluorouracil|mesh-list
65620042|NCT01314833|Epirubicin|epirubicin|mesh-list
65620043|NCT01314833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65620044|NCT01314833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620045|NCT01314833|Tubulin Modulators|tubulin modulators|mesh-ancestor
65620046|NCT01314833|Antimitotic Agents|antimitotic agents|mesh-ancestor
65620047|NCT01314833|Mitosis Modulators|mitosis modulators|mesh-ancestor
65620048|NCT01314833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620049|NCT01314833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65620050|NCT01314833|Immunologic Factors|immunologic factors|mesh-ancestor
65620051|NCT01314833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620052|NCT01314833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65620053|NCT01314833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65620054|NCT01314833|Alkylating Agents|alkylating agents|mesh-ancestor
65620055|NCT01314833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65620056|NCT01314833|Antimetabolites|antimetabolites|mesh-ancestor
65620057|NCT01314833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65620058|NCT01314833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65620059|NCT01314833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65620060|NCT01314833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65620061|NCT01314833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620062|NCT03579836|Gemcitabine|gemcitabine|mesh-list
65620063|NCT03579836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65620064|NCT03579836|Antimetabolites|antimetabolites|mesh-ancestor
65620065|NCT03579836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620066|NCT03579836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620067|NCT03579836|Antiviral Agents|antiviral agents|mesh-ancestor
65620068|NCT03579836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65620069|NCT03579836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620070|NCT03579836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65620071|NCT03579836|Immunologic Factors|immunologic factors|mesh-ancestor
65620072|NCT03579836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620073|NCT02737826|Buprenorphine|buprenorphine|mesh-list
65620074|NCT02737826|Gabapentin|gabapentin|mesh-list
65620075|NCT02737826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65620076|NCT02737826|Narcotics|narcotics|mesh-ancestor
65620077|NCT02737826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65620078|NCT02737826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620079|NCT02737826|Analgesics|analgesics|mesh-ancestor
65620080|NCT02737826|Sensory System Agents|sensory system agents|mesh-ancestor
65620081|NCT02737826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620082|NCT02737826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65620083|NCT02737826|Anticonvulsants|anticonvulsants|mesh-ancestor
65620084|NCT02737826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65620085|NCT02737826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65620086|NCT02737826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65620087|NCT02737826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65620088|NCT02737826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65620089|NCT02737826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65620090|NCT02737826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620091|NCT02737826|Antimanic Agents|antimanic agents|mesh-ancestor
65620092|NCT03367715|Nivolumab|nivolumab|mesh-list
65620093|NCT03367715|Ipilimumab|ipilimumab|mesh-list
65620094|NCT03367715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65620095|NCT03367715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620096|NCT03367715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65620097|NCT03367715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620098|NCT04064931|Niacin|niacin|mesh-list
65620099|NCT04064931|Vitamins|vitamins|mesh-ancestor
65620100|NCT04064931|Micronutrients|micronutrients|mesh-ancestor
65620101|NCT04064931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620102|NCT04064931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65620103|NCT04064931|Antimetabolites|antimetabolites|mesh-ancestor
65620104|NCT04064931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620105|NCT04064931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65620106|NCT04064931|Vasodilator Agents|vasodilator agents|mesh-ancestor
65620107|NCT04064931|Vitamin B Complex|vitamin b complex|mesh-ancestor
65620108|NCT03577652|Ticagrelor|ticagrelor|mesh-list
65620109|NCT03577652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65620110|NCT03577652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65620111|NCT03577652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65620112|NCT03577652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65620113|NCT03577652|Purinergic Agents|purinergic agents|mesh-ancestor
65620114|NCT03577652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65620115|NCT03577652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620116|NCT03577652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620117|NCT03620513|Lidocaine|lidocaine|mesh-list
65620118|NCT03620513|Phenylephrine|phenylephrine|mesh-list
65620119|NCT03620513|Oxymetazoline|oxymetazoline|mesh-list
65620120|NCT03620513|Nasal Decongestants|nasal decongestants|mesh-list
65620121|NCT03620513|Pseudoephedrine|pseudoephedrine|mesh-list
65620122|NCT03620513|Ephedrine|ephedrine|mesh-list
65620123|NCT03620513|Anesthetics|anesthetics|mesh-list
65620124|NCT03620513|Anesthetics, Local|anesthetics, local|mesh-ancestor
65620125|NCT03620513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65620126|NCT03620513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620127|NCT03620513|Sensory System Agents|sensory system agents|mesh-ancestor
65620128|NCT03620513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620129|NCT03620513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65620130|NCT03620513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65620131|NCT03620513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65620132|NCT03620513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65620133|NCT03620513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620134|NCT03620513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65620135|NCT03620513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65620136|NCT03620513|Adrenergic Agents|adrenergic agents|mesh-ancestor
65620137|NCT03620513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65620138|NCT03620513|Sympathomimetics|sympathomimetics|mesh-ancestor
65620139|NCT03620513|Autonomic Agents|autonomic agents|mesh-ancestor
65620140|NCT03620513|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65620141|NCT03620513|Respiratory System Agents|respiratory system agents|mesh-ancestor
65620142|NCT03620513|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65620143|NCT03620513|Mydriatics|mydriatics|mesh-ancestor
65620144|NCT03620513|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65620145|NCT03620513|Protective Agents|protective agents|mesh-ancestor
65620146|NCT03620513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65620147|NCT03620513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65620148|NCT03620513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65620149|NCT03585062|Paclitaxel|paclitaxel|mesh-list
65620150|NCT03585062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65620151|NCT03585062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620152|NCT03585062|Tubulin Modulators|tubulin modulators|mesh-ancestor
65620153|NCT03585062|Antimitotic Agents|antimitotic agents|mesh-ancestor
65620154|NCT03585062|Mitosis Modulators|mitosis modulators|mesh-ancestor
65620155|NCT03585062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620156|NCT03584360|Calcitriol|calcitriol|mesh-list
65620157|NCT03584360|Betamethasone|betamethasone|mesh-list
65620158|NCT03584360|Betamethasone Valerate|betamethasone valerate|mesh-list
65620159|NCT03584360|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65620160|NCT03584360|Betamethasone benzoate|betamethasone benzoate|mesh-list
65620161|NCT03584360|Calcipotriene|calcipotriene|mesh-list
65620162|NCT03584360|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65620163|NCT03584360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65620164|NCT03584360|Glucocorticoids|glucocorticoids|mesh-ancestor
65620165|NCT03584360|Hormones|hormones|mesh-ancestor
65620166|NCT03584360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65620167|NCT03584360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620168|NCT03584360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65620169|NCT03584360|Respiratory System Agents|respiratory system agents|mesh-ancestor
65620170|NCT03584360|Dermatologic Agents|dermatologic agents|mesh-ancestor
65620171|NCT03584360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65620172|NCT03584360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65620173|NCT03584360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65620174|NCT03584360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620175|NCT03584360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65620176|NCT03584360|Vitamins|vitamins|mesh-ancestor
65620177|NCT03584360|Micronutrients|micronutrients|mesh-ancestor
65620178|NCT03584360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65620179|NCT05763771|Nicotine|nicotine|mesh-list
65620180|NCT05763771|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65620181|NCT05763771|Autonomic Agents|autonomic agents|mesh-ancestor
65620182|NCT05763771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620183|NCT05763771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620184|NCT05763771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65620185|NCT05763771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65620186|NCT05763771|Cholinergic Agents|cholinergic agents|mesh-ancestor
65620187|NCT05763771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65620188|NCT05763771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620189|NCT03579758|Gemcitabine|gemcitabine|mesh-list
65620190|NCT03579758|Capecitabine|capecitabine|mesh-list
65620191|NCT03579758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620192|NCT03579758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65620193|NCT03579758|Antimetabolites|antimetabolites|mesh-ancestor
65620194|NCT03579758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620195|NCT03579758|Antiviral Agents|antiviral agents|mesh-ancestor
65620196|NCT03579758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65620197|NCT03579758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620198|NCT03579758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65620199|NCT03579758|Immunologic Factors|immunologic factors|mesh-ancestor
65620200|NCT03579758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620201|NCT03577574|Anesthetics|anesthetics|mesh-list
65620202|NCT03577574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65620203|NCT03577574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620204|NCT01130519|Bevacizumab|bevacizumab|mesh-list
65620205|NCT01130519|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65620206|NCT01130519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65620207|NCT01130519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620208|NCT01130519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65620209|NCT01130519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65620210|NCT01130519|Growth Substances|growth substances|mesh-ancestor
65620211|NCT01130519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620212|NCT01130519|Growth Inhibitors|growth inhibitors|mesh-ancestor
65620213|NCT01130519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65620214|NCT01130519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620215|NCT01130519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620216|NCT01330901|Ustekinumab|ustekinumab|mesh-list
65620217|NCT01330901|Dermatologic Agents|dermatologic agents|mesh-ancestor
65620218|NCT02428647|Zinc|zinc|mesh-list
65620219|NCT02428647|Trace Elements|trace elements|mesh-ancestor
65620220|NCT02428647|Micronutrients|micronutrients|mesh-ancestor
65620221|NCT02428647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620222|NCT01071395|Amantadine|amantadine|mesh-list
65620223|NCT01071395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65620224|NCT01071395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65620225|NCT01071395|Antiviral Agents|antiviral agents|mesh-ancestor
65620226|NCT01071395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65620227|NCT01071395|Dopamine Agents|dopamine agents|mesh-ancestor
65620228|NCT01071395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65620229|NCT01071395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620230|NCT01071395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620231|NCT01071395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65620232|NCT01071395|Analgesics|analgesics|mesh-ancestor
65620233|NCT01071395|Sensory System Agents|sensory system agents|mesh-ancestor
65620234|NCT01071395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620235|NCT00335816|Leucovorin|leucovorin|mesh-list
65620236|NCT00335816|Fluorouracil|fluorouracil|mesh-list
65620237|NCT00335816|Oxaliplatin|oxaliplatin|mesh-list
65620238|NCT00335816|Calcium|calcium|mesh-list
65620239|NCT00335816|Levoleucovorin|levoleucovorin|mesh-list
65620240|NCT00335816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65620241|NCT00335816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620242|NCT00335816|Antimetabolites|antimetabolites|mesh-ancestor
65620243|NCT00335816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620244|NCT00335816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65620245|NCT00335816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620246|NCT00335816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65620247|NCT00335816|Immunologic Factors|immunologic factors|mesh-ancestor
65620248|NCT00335816|Antidotes|antidotes|mesh-ancestor
65620249|NCT00335816|Protective Agents|protective agents|mesh-ancestor
65620250|NCT00335816|Vitamin B Complex|vitamin b complex|mesh-ancestor
65620251|NCT00335816|Vitamins|vitamins|mesh-ancestor
65620252|NCT00335816|Micronutrients|micronutrients|mesh-ancestor
65620253|NCT03577496|Peppermint oil|peppermint oil|mesh-list
65620254|NCT03577496|Antiemetics|antiemetics|mesh-ancestor
65620255|NCT03577496|Autonomic Agents|autonomic agents|mesh-ancestor
65620256|NCT03577496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620257|NCT03577496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620258|NCT03577496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65620259|NCT03577496|Parasympatholytics|parasympatholytics|mesh-ancestor
65620260|NCT03582878|Mycophenolic Acid|mycophenolic acid|mesh-list
65620261|NCT03582878|Sirolimus|sirolimus|mesh-list
65620262|NCT03582878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65620263|NCT03582878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620264|NCT03582878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65620265|NCT03582878|Antitubercular Agents|antitubercular agents|mesh-ancestor
65620266|NCT03582878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65620267|NCT03582878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65620268|NCT03582878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620269|NCT03582878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620270|NCT03582878|Antifungal Agents|antifungal agents|mesh-ancestor
65620271|NCT03582878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65620272|NCT03582878|Immunologic Factors|immunologic factors|mesh-ancestor
65620273|NCT03582878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620274|NCT05763693|Azithromycin|azithromycin|mesh-list
65620275|NCT05763693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65620276|NCT05763693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65620277|NCT02238704|Calcium, Dietary|calcium, dietary|mesh-list
65620278|NCT02238704|Iron|iron|mesh-list
65620279|NCT02238704|Folic Acid|folic acid|mesh-list
65620280|NCT02238704|Vitamin B Complex|vitamin b complex|mesh-list
65620281|NCT02238704|Calcium|calcium|mesh-list
65620282|NCT02238704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65620283|NCT02238704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620284|NCT02238704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65620285|NCT02238704|Trace Elements|trace elements|mesh-ancestor
65620286|NCT02238704|Micronutrients|micronutrients|mesh-ancestor
65620287|NCT02238704|Hematinics|hematinics|mesh-ancestor
65620288|NCT02238704|Vitamins|vitamins|mesh-ancestor
65620289|NCT01331135|Sirolimus|sirolimus|mesh-list
65620290|NCT01331135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65620291|NCT01331135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65620292|NCT01331135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65620293|NCT01331135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620294|NCT01331135|Antifungal Agents|antifungal agents|mesh-ancestor
65620295|NCT01331135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65620296|NCT01331135|Immunologic Factors|immunologic factors|mesh-ancestor
65620297|NCT01331135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620298|NCT03577184|Metformin|metformin|mesh-list
65620299|NCT03577184|Vildagliptin|vildagliptin|mesh-list
65620300|NCT03577184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65620301|NCT03577184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620302|NCT03577184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65620303|NCT03577184|Protease Inhibitors|protease inhibitors|mesh-ancestor
65620304|NCT03577184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620305|NCT03577184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620306|NCT02849171|Choline|choline|mesh-list
65620307|NCT02849171|Lipotropic Agents|lipotropic agents|mesh-ancestor
65620308|NCT02849171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65620309|NCT02849171|Antimetabolites|antimetabolites|mesh-ancestor
65620310|NCT02849171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620311|NCT02849171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65620312|NCT02849171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65620313|NCT02849171|Nootropic Agents|nootropic agents|mesh-ancestor
65620314|NCT02238860|Tenofovir|tenofovir|mesh-list
65620315|NCT02238860|Antiviral Agents|antiviral agents|mesh-ancestor
65620316|NCT02238860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65620317|NCT02238860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65620318|NCT02238860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65620319|NCT02238860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620320|NCT02238860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620321|NCT02238860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65620322|NCT02238860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65620323|NCT01333709|Folfirinox|folfirinox|mesh-list
65620324|NCT01333709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620325|NCT04869137|Pembrolizumab|pembrolizumab|mesh-list
65620326|NCT04869137|Lenvatinib|lenvatinib|mesh-list
65620327|NCT04869137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65620328|NCT04869137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620329|NCT04869137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65620330|NCT04869137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620331|NCT04869137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620332|NCT00364637|Anesthetics|anesthetics|mesh-list
65620333|NCT00364637|Sevoflurane|sevoflurane|mesh-list
65620334|NCT00364637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65620335|NCT00364637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620336|NCT00364637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65620337|NCT00364637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65620338|NCT00364637|Anesthetics, General|anesthetics, general|mesh-ancestor
65620339|NCT00493961|Hormones|hormones|mesh-list
65620340|NCT00493961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65620341|NCT00493961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620342|NCT02903238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65266700|NCT00915473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65620343|NCT02903238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65620344|NCT02903238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65620345|NCT02903238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65620346|NCT02903238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620347|NCT02903238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65620348|NCT02903238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620349|NCT02903238|Analgesics|analgesics|mesh-ancestor
65620350|NCT02903238|Sensory System Agents|sensory system agents|mesh-ancestor
65620351|NCT02903238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620352|NCT02903238|Antidepressive Agents|antidepressive agents|mesh-ancestor
65620353|NCT02903238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65620355|NCT01329809|Molgramostim|molgramostim|mesh-list
65620356|NCT01329809|Sargramostim|sargramostim|mesh-list
65620357|NCT01329809|Immunologic Factors|immunologic factors|mesh-ancestor
65620358|NCT01329809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620359|NCT01329809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620360|NCT02847260|Treprostinil|treprostinil|mesh-list
65620361|NCT02847260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65620362|NCT01331447|Exemestane|exemestane|mesh-list
65620363|NCT01331447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620364|NCT01331447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65620365|NCT01331447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65620366|NCT01331447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620367|NCT01331447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620368|NCT01331447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65620369|NCT01331447|Hormone Antagonists|hormone antagonists|mesh-ancestor
65620370|NCT01331447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65620371|NCT01331447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620372|NCT02968563|Obinutuzumab|obinutuzumab|mesh-list
65620373|NCT02968563|Idelalisib|idelalisib|mesh-list
65620374|NCT02968563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65620375|NCT02968563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620376|NCT02968563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620377|NCT02968563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620378|NCT01329887|Ketanserin|ketanserin|mesh-list
65620379|NCT01329887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65620380|NCT01329887|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65620381|NCT01329887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65620382|NCT01329887|Serotonin Agents|serotonin agents|mesh-ancestor
65620383|NCT01329887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65620384|NCT01329887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620385|NCT01329887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620386|NCT01334099|Tremelimumab|tremelimumab|mesh-list
65620387|NCT01334099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620388|NCT01331525|Ipilimumab|ipilimumab|mesh-list
65620389|NCT01331525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65620390|NCT01331525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620391|NCT01331525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65620392|NCT01331525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620393|NCT01334177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65620394|NCT01334177|Cetuximab|cetuximab|mesh-list
65620395|NCT01334177|Antibodies|antibodies|mesh-list
65620396|NCT01334177|Immunoglobulins|immunoglobulins|mesh-list
65620397|NCT01334177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65620398|NCT01334177|Immunologic Factors|immunologic factors|mesh-ancestor
65620399|NCT01334177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620400|NCT01334177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620401|NCT04098393|Fludarabine|fludarabine|mesh-list
65620402|NCT04098393|Melphalan|melphalan|mesh-list
65620403|NCT04098393|Busulfan|busulfan|mesh-list
65620404|NCT04098393|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65620405|NCT04098393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620406|NCT04098393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620407|NCT04098393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65620408|NCT04098393|Immunologic Factors|immunologic factors|mesh-ancestor
65620409|NCT04098393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620410|NCT04098393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65620411|NCT04098393|Alkylating Agents|alkylating agents|mesh-ancestor
65620412|NCT04098393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65620413|NCT03649230|Palonosetron|palonosetron|mesh-list
65620414|NCT03649230|Antiemetics|antiemetics|mesh-ancestor
65620415|NCT03649230|Autonomic Agents|autonomic agents|mesh-ancestor
65620416|NCT03649230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620417|NCT03649230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620418|NCT03649230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65620419|NCT03649230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65620420|NCT03649230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65620421|NCT03649230|Serotonin Agents|serotonin agents|mesh-ancestor
65620422|NCT03649230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65620423|NCT03649230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620424|NCT05762523|Vaccines|vaccines|mesh-list
65620425|NCT05762523|Immunologic Factors|immunologic factors|mesh-ancestor
65620426|NCT05762523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620427|NCT02796261|Eflornithine|eflornithine|mesh-list
65620428|NCT02796261|Lomustine|lomustine|mesh-list
65620429|NCT02796261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65620430|NCT02796261|Alkylating Agents|alkylating agents|mesh-ancestor
65620431|NCT02796261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620432|NCT02796261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620433|NCT02796261|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65620434|NCT02796261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65620435|NCT02796261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65620436|NCT02796261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65620437|NCT02796261|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
65620438|NCT02796261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620439|NCT02904096|Lidocaine|lidocaine|mesh-list
65620440|NCT02904096|Anesthetics, Local|anesthetics, local|mesh-ancestor
65620441|NCT02904096|Anesthetics|anesthetics|mesh-ancestor
65620442|NCT02904096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65620443|NCT02904096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620444|NCT02904096|Sensory System Agents|sensory system agents|mesh-ancestor
65620445|NCT02904096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620446|NCT02904096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65620447|NCT02904096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65620448|NCT02904096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65620449|NCT02904096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65620450|NCT02904096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620451|NCT04079712|Nivolumab|nivolumab|mesh-list
65620452|NCT04079712|Ipilimumab|ipilimumab|mesh-list
65620453|NCT04079712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65620454|NCT04079712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620455|NCT04079712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65620456|NCT04079712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620457|NCT02586675|Tamoxifen|tamoxifen|mesh-list
65620458|NCT02586675|Goserelin|goserelin|mesh-list
65620459|NCT02586675|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65620460|NCT02586675|Hormone Antagonists|hormone antagonists|mesh-ancestor
65620461|NCT02586675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65620462|NCT02586675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620463|NCT02586675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65620464|NCT02586675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620465|NCT02586675|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65620466|NCT02586675|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65620467|NCT02586675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65620468|NCT03648528|Cholecalciferol|cholecalciferol|mesh-list
65620469|NCT03648528|Vitamin D|vitamin d|mesh-list
65620470|NCT03648528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65620471|NCT03648528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620472|NCT03648528|Vitamins|vitamins|mesh-ancestor
65620473|NCT03648528|Micronutrients|micronutrients|mesh-ancestor
65620474|NCT03648528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65620475|NCT03161405|Itraconazole|itraconazole|mesh-list
65620476|NCT03161405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620477|NCT03161405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620478|NCT03161405|Antifungal Agents|antifungal agents|mesh-ancestor
65620479|NCT03161405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65620480|NCT03161405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65620481|NCT03161405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65620482|NCT03161405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65620483|NCT03161405|Hormone Antagonists|hormone antagonists|mesh-ancestor
65620484|NCT03161405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65620485|NCT03161405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620486|NCT03161405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65620487|NCT01813929|Metformin|metformin|mesh-list
65620488|NCT01813929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65620489|NCT01813929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620490|NCT01502085|Dexamethasone|dexamethasone|mesh-list
65620491|NCT01502085|Vorinostat|vorinostat|mesh-list
65620492|NCT01502085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65620493|NCT01502085|Antiemetics|antiemetics|mesh-ancestor
65620494|NCT01502085|Autonomic Agents|autonomic agents|mesh-ancestor
65620495|NCT01502085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620496|NCT01502085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417882|NCT00338728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65620497|NCT01502085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65620498|NCT01502085|Glucocorticoids|glucocorticoids|mesh-ancestor
65620499|NCT01502085|Hormones|hormones|mesh-ancestor
65620500|NCT01502085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65620501|NCT01502085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65620502|NCT01502085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620503|NCT01502085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65620504|NCT01502085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620505|NCT01502085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620506|NCT04052880|Dexamethasone|dexamethasone|mesh-list
65620507|NCT04052880|Lenalidomide|lenalidomide|mesh-list
65620508|NCT04052880|Bortezomib|bortezomib|mesh-list
65620509|NCT04052880|Daratumumab|daratumumab|mesh-list
65620510|NCT04052880|Ixazomib|ixazomib|mesh-list
65620511|NCT04052880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65620512|NCT04052880|Antiemetics|antiemetics|mesh-ancestor
65620513|NCT04052880|Autonomic Agents|autonomic agents|mesh-ancestor
65620514|NCT04052880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620515|NCT04052880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620516|NCT04052880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65620517|NCT04052880|Glucocorticoids|glucocorticoids|mesh-ancestor
65620518|NCT04052880|Hormones|hormones|mesh-ancestor
65620519|NCT04052880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65620520|NCT04052880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65620521|NCT04052880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620522|NCT04052880|Immunologic Factors|immunologic factors|mesh-ancestor
65620523|NCT04052880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65620524|NCT04052880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65620525|NCT04052880|Growth Substances|growth substances|mesh-ancestor
65620526|NCT04052880|Growth Inhibitors|growth inhibitors|mesh-ancestor
65620527|NCT04052880|Protease Inhibitors|protease inhibitors|mesh-ancestor
65620528|NCT04052880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620529|NCT04052880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620530|NCT03648684|Caffeine|caffeine|mesh-list
65620531|NCT03648684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65620532|NCT03648684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620533|NCT03648684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65620534|NCT03648684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620535|NCT03648684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620536|NCT03648684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65620537|NCT03648684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65620538|NCT03648684|Purinergic Agents|purinergic agents|mesh-ancestor
65620539|NCT03648684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65620540|NCT03647982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65620541|NCT03647982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65620542|NCT03647982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620543|NCT03647982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620544|NCT03647982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65620545|NCT03647982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65620546|NCT03647982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620547|NCT03647982|Cholinergic Agents|cholinergic agents|mesh-ancestor
65620548|NCT03647982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65620549|NCT02901054|Ondansetron|ondansetron|mesh-list
65620550|NCT02901054|Antiemetics|antiemetics|mesh-ancestor
65620551|NCT02901054|Autonomic Agents|autonomic agents|mesh-ancestor
65620552|NCT02901054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620553|NCT02901054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620554|NCT02901054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65620555|NCT02901054|Antipruritics|antipruritics|mesh-ancestor
65620556|NCT02901054|Dermatologic Agents|dermatologic agents|mesh-ancestor
65620557|NCT02901054|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65620558|NCT02901054|Serotonin Agents|serotonin agents|mesh-ancestor
65620559|NCT02901054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65620560|NCT02901054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620561|NCT02901054|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65620562|NCT02901054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65620563|NCT02901054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65620564|NCT02901054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65620565|NCT02901054|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65620566|NCT03647670|Midazolam|midazolam|mesh-list
65620567|NCT03647670|Abrocitinib|abrocitinib|mesh-list
65620568|NCT03647670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65620569|NCT03647670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65620570|NCT03647670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65620571|NCT03647670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620573|NCT03647670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65620574|NCT03647670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65620575|NCT03647670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65620576|NCT03647670|Anesthetics, General|anesthetics, general|mesh-ancestor
65620577|NCT03647670|Anesthetics|anesthetics|mesh-ancestor
65620578|NCT03647670|GABA Modulators|gaba modulators|mesh-ancestor
65620579|NCT03647670|GABA Agents|gaba agents|mesh-ancestor
65620580|NCT03647670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65620581|NCT03647670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620582|NCT03647670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65620583|NCT03647670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620584|NCT02966340|Prazosin|prazosin|mesh-list
65620585|NCT02966340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65620586|NCT02966340|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65620587|NCT02966340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65620588|NCT02966340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65620589|NCT02966340|Adrenergic Agents|adrenergic agents|mesh-ancestor
65620590|NCT02966340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65620591|NCT02966340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620592|NCT02966340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620593|NCT05284734|Anesthetics|anesthetics|mesh-list
65620594|NCT05284734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65620595|NCT05284734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620596|NCT05170893|Ubiquinone|ubiquinone|mesh-list
65620597|NCT05170893|Coenzyme Q10|coenzyme q10|mesh-list
65620598|NCT05170893|Micronutrients|micronutrients|mesh-ancestor
65620599|NCT05170893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620600|NCT05170893|Vitamins|vitamins|mesh-ancestor
65620601|NCT05761041|Listerine|listerine|mesh-list
65620602|NCT05761041|Fluorides|fluorides|mesh-list
65620603|NCT05761041|Sodium Fluoride|sodium fluoride|mesh-list
65620604|NCT05761041|Fluorides, Topical|fluorides, topical|mesh-list
65620605|NCT05761041|Cariostatic Agents|cariostatic agents|mesh-ancestor
65620606|NCT05761041|Protective Agents|protective agents|mesh-ancestor
65620607|NCT05761041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620608|NCT05761041|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65620609|NCT05761041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65620610|NCT03629379|Ustekinumab|ustekinumab|mesh-list
65620611|NCT03629379|Vedolizumab|vedolizumab|mesh-list
65620612|NCT03629379|Dermatologic Agents|dermatologic agents|mesh-ancestor
65620613|NCT03629379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65620614|NCT05055999|Atezolizumab|atezolizumab|mesh-list
65620615|NCT05055999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620616|NCT05205837|Letrozole|letrozole|mesh-list
65620617|NCT05205837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620618|NCT05205837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65620619|NCT05205837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65620620|NCT05205837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620621|NCT05205837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620622|NCT05205837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65620623|NCT05205837|Hormone Antagonists|hormone antagonists|mesh-ancestor
65620624|NCT05205837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65620625|NCT05205837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620626|NCT05205603|Mesalamine|mesalamine|mesh-list
65620627|NCT05205603|Infliximab|infliximab|mesh-list
65620628|NCT05205603|Vedolizumab|vedolizumab|mesh-list
65620629|NCT05205603|Dermatologic Agents|dermatologic agents|mesh-ancestor
65620630|NCT05205603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65620631|NCT05205603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65620632|NCT05205603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65620633|NCT05205603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65620634|NCT05205603|Analgesics|analgesics|mesh-ancestor
65620635|NCT05205603|Sensory System Agents|sensory system agents|mesh-ancestor
65620636|NCT05205603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620637|NCT05205603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620638|NCT05205603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65620639|NCT03578900|Citric Acid|citric acid|mesh-list
65620640|NCT03578900|Sodium Citrate|sodium citrate|mesh-list
65620641|NCT03578900|Anticoagulants|anticoagulants|mesh-ancestor
65620642|NCT03578900|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65620643|NCT03578900|Chelating Agents|chelating agents|mesh-ancestor
65620644|NCT03578900|Sequestering Agents|sequestering agents|mesh-ancestor
65620645|NCT03578900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620646|NCT02550002|Aflibercept|aflibercept|mesh-list
65620647|NCT02550002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65620648|NCT02550002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65620649|NCT02550002|Growth Substances|growth substances|mesh-ancestor
65620650|NCT02550002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620651|NCT02550002|Growth Inhibitors|growth inhibitors|mesh-ancestor
65620652|NCT02550002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620653|NCT03574376|Bupivacaine|bupivacaine|mesh-list
65620654|NCT03574376|Anesthetics, Local|anesthetics, local|mesh-ancestor
65620655|NCT03574376|Anesthetics|anesthetics|mesh-ancestor
65620656|NCT03574376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65620657|NCT03574376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620658|NCT03574376|Sensory System Agents|sensory system agents|mesh-ancestor
65620659|NCT03574376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620660|NCT03576794|Prednisolone|prednisolone|mesh-list
65620661|NCT03576794|Leflunomide|leflunomide|mesh-list
65620662|NCT03576794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65620663|NCT03576794|Glucocorticoids|glucocorticoids|mesh-ancestor
65620664|NCT03576794|Hormones|hormones|mesh-ancestor
65620665|NCT03576794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65620666|NCT03576794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620667|NCT03576794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65620668|NCT03576794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620669|NCT03576794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620670|NCT03576794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620671|NCT03576794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65620672|NCT03576794|Immunologic Factors|immunologic factors|mesh-ancestor
65620673|NCT03578822|Aspirin|aspirin|mesh-list
65620674|NCT03578822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65620675|NCT03578822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65620676|NCT03578822|Analgesics|analgesics|mesh-ancestor
65620677|NCT03578822|Sensory System Agents|sensory system agents|mesh-ancestor
65620678|NCT03578822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620679|NCT03578822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620680|NCT03578822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65620681|NCT03578822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65620682|NCT03578822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65620683|NCT03578822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65620684|NCT03578822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620685|NCT03578822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65620686|NCT03578822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65620687|NCT03578822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620688|NCT03578822|Antipyretics|antipyretics|mesh-ancestor
65620689|NCT03576638|Levodopa|levodopa|mesh-list
65620690|NCT03576638|Carbidopa|carbidopa|mesh-list
65620691|NCT03576638|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65620692|NCT03576638|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65620693|NCT03576638|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65620694|NCT03576638|Dopamine Agents|dopamine agents|mesh-ancestor
65620695|NCT03576638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65620696|NCT03576638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620697|NCT03576638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620698|NCT03576638|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65620699|NCT03576638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620700|NCT03576638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65620701|NCT03576638|Immunologic Factors|immunologic factors|mesh-ancestor
65620702|NCT03576638|Dopamine Agonists|dopamine agonists|mesh-ancestor
65620703|NCT04284657|Citric Acid|citric acid|mesh-list
65620704|NCT04284657|Sodium Citrate|sodium citrate|mesh-list
65620705|NCT04284657|Pravastatin|pravastatin|mesh-list
65620706|NCT04284657|Anticoagulants|anticoagulants|mesh-ancestor
65620707|NCT04284657|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65620708|NCT04284657|Chelating Agents|chelating agents|mesh-ancestor
65620709|NCT04284657|Sequestering Agents|sequestering agents|mesh-ancestor
65620710|NCT04284657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620711|NCT04284657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65620712|NCT04284657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65620713|NCT04284657|Antimetabolites|antimetabolites|mesh-ancestor
65620714|NCT04284657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65620715|NCT04284657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65620716|NCT04284657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620717|NCT01569945|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65620718|NCT01569945|Clomiphene|clomiphene|mesh-list
65620719|NCT01569945|Menotropins|menotropins|mesh-list
65620720|NCT01569945|Estradiol|estradiol|mesh-list
65620721|NCT01569945|Estrogens|estrogens|mesh-ancestor
65620722|NCT01569945|Hormones|hormones|mesh-ancestor
65620723|NCT01569945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65620724|NCT01569945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620725|NCT01569945|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65620726|NCT01569945|Contraceptive Agents|contraceptive agents|mesh-ancestor
65620727|NCT01569945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65620728|NCT01569945|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65620729|NCT01569945|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65620730|NCT01569945|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65620731|NCT01569945|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65620732|NCT01569945|Hormone Antagonists|hormone antagonists|mesh-ancestor
65620733|NCT01569945|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65620734|NCT01569945|Fertility Agents|fertility agents|mesh-ancestor
65620735|NCT01569945|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65620736|NCT01569945|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65620737|NCT03574220|Pembrolizumab|pembrolizumab|mesh-list
65620738|NCT03574220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65620739|NCT03574220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620740|NCT04876677|Beclomethasone|beclomethasone|mesh-list
65620741|NCT04876677|Glycopyrrolate|glycopyrrolate|mesh-list
65620742|NCT04876677|Formoterol Fumarate|formoterol fumarate|mesh-list
65620743|NCT04876677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65620744|NCT04876677|Autonomic Agents|autonomic agents|mesh-ancestor
65620745|NCT04876677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620746|NCT04876677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620747|NCT04876677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65620748|NCT04876677|Respiratory System Agents|respiratory system agents|mesh-ancestor
65620749|NCT04876677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65620750|NCT04876677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65620751|NCT04876677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65620752|NCT04876677|Adrenergic Agents|adrenergic agents|mesh-ancestor
65620753|NCT04876677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65620754|NCT04876677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620755|NCT04876677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65620756|NCT04876677|Glucocorticoids|glucocorticoids|mesh-ancestor
65620757|NCT04876677|Hormones|hormones|mesh-ancestor
65620758|NCT04876677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65620759|NCT04876677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65620760|NCT04876677|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65620761|NCT04876677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65620762|NCT04876677|Cholinergic Agents|cholinergic agents|mesh-ancestor
65620763|NCT03578432|Everolimus|everolimus|mesh-list
65620764|NCT03578432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620765|NCT03578432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65620766|NCT03578432|Immunologic Factors|immunologic factors|mesh-ancestor
65620767|NCT03578432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620768|NCT03578354|Atenolol|atenolol|mesh-list
65620769|NCT03578354|4-Aminopyridine|4-aminopyridine|mesh-list
65620770|NCT03578354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65620771|NCT03578354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65620772|NCT03578354|Sympatholytics|sympatholytics|mesh-ancestor
65620773|NCT03578354|Autonomic Agents|autonomic agents|mesh-ancestor
65620774|NCT03578354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620775|NCT03578354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620776|NCT03578354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65620777|NCT03578354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65620778|NCT03578354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65620779|NCT03578354|Adrenergic Agents|adrenergic agents|mesh-ancestor
65620780|NCT03578354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65620781|NCT03578354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620782|NCT03578354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65620783|NCT03578354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65620784|NCT05204979|Misoprostol|misoprostol|mesh-list
65620785|NCT05204979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65620786|NCT05204979|Abortifacient Agents|abortifacient agents|mesh-ancestor
65620787|NCT05204979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65620788|NCT05204979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620789|NCT05204979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65620790|NCT05204979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65620791|NCT05204979|Oxytocics|oxytocics|mesh-ancestor
65620792|NCT03647514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65620793|NCT03647514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620794|NCT02239952|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65620795|NCT02239952|Sunitinib|sunitinib|mesh-list
65620796|NCT02239952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418181|NCT00934193|Gabapentin|gabapentin|mesh-list
65620797|NCT02239952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65620798|NCT02239952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620799|NCT02239952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620800|NCT02239952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65620801|NCT02239952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65620802|NCT02239952|Growth Substances|growth substances|mesh-ancestor
65620803|NCT02239952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620804|NCT02239952|Growth Inhibitors|growth inhibitors|mesh-ancestor
65620805|NCT03647280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65620807|NCT03647280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620808|NCT03647280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620809|NCT03647280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65620810|NCT03647280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65620811|NCT03647280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65620812|NCT03647280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620813|NCT03578042|Losartan|losartan|mesh-list
65620814|NCT03578042|Amlodipine|amlodipine|mesh-list
65620815|NCT03578042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65620816|NCT03578042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65620817|NCT03578042|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65620818|NCT03578042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65620819|NCT03578042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620820|NCT03578042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65620821|NCT03578042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620822|NCT03578042|Vasodilator Agents|vasodilator agents|mesh-ancestor
65620823|NCT03578042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65620824|NCT03578042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65620825|NCT03578042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65620826|NCT03578042|Diuretics|diuretics|mesh-ancestor
65620827|NCT03578042|Natriuretic Agents|natriuretic agents|mesh-ancestor
65620828|NCT03578042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65620829|NCT03646500|Remifentanil|remifentanil|mesh-list
65620830|NCT03646500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65620831|NCT03646500|Narcotics|narcotics|mesh-ancestor
65620832|NCT03646500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65620833|NCT03646500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620834|NCT03646500|Analgesics|analgesics|mesh-ancestor
65620835|NCT03646500|Sensory System Agents|sensory system agents|mesh-ancestor
65620836|NCT03646500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620837|NCT03574064|Glucagon|glucagon|mesh-list
65620838|NCT03574064|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
65620839|NCT03574064|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65620840|NCT03574064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65620841|NCT03574064|Hormones|hormones|mesh-ancestor
65620842|NCT03574064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65620843|NCT03574064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620844|NCT03574064|Incretins|incretins|mesh-ancestor
65620845|NCT03573986|Bevacizumab|bevacizumab|mesh-list
65620846|NCT03573986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65620847|NCT03573986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620848|NCT03573986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65620849|NCT03573986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65620850|NCT03573986|Growth Substances|growth substances|mesh-ancestor
65620851|NCT03573986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620852|NCT03573986|Growth Inhibitors|growth inhibitors|mesh-ancestor
65620853|NCT03959592|Carotenoids|carotenoids|mesh-list
65620854|NCT03959592|Antioxidants|antioxidants|mesh-ancestor
65620855|NCT03959592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620856|NCT03959592|Protective Agents|protective agents|mesh-ancestor
65620857|NCT03959592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620858|NCT04087395|Lidocaine|lidocaine|mesh-list
65620859|NCT04087395|Anesthetics|anesthetics|mesh-list
65620860|NCT04087395|Anesthetics, Local|anesthetics, local|mesh-ancestor
65620861|NCT04087395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65620862|NCT04087395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620863|NCT04087395|Sensory System Agents|sensory system agents|mesh-ancestor
65620864|NCT04087395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620865|NCT04087395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65620866|NCT04087395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65620867|NCT04087395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65620868|NCT04087395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65620869|NCT04087395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620870|NCT03573596|Dasatinib|dasatinib|mesh-list
65620871|NCT03573596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620872|NCT03573596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65620873|NCT03573596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620874|NCT03573596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620875|NCT03621618|Dobutamine|dobutamine|mesh-list
65620876|NCT03621618|Norepinephrine|norepinephrine|mesh-list
65620877|NCT03621618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65620878|NCT03621618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65620879|NCT03621618|Adrenergic Agents|adrenergic agents|mesh-ancestor
65620880|NCT03621618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65620881|NCT03621618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620882|NCT03621618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620883|NCT03621618|Sympathomimetics|sympathomimetics|mesh-ancestor
65620884|NCT03621618|Autonomic Agents|autonomic agents|mesh-ancestor
65620885|NCT03621618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620886|NCT03621618|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65620887|NCT03621618|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65620888|NCT03621618|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65620889|NCT03621618|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65620890|NCT03621618|Protective Agents|protective agents|mesh-ancestor
65620891|NCT03944304|Paclitaxel|paclitaxel|mesh-list
65620892|NCT03944304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65620893|NCT03944304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620894|NCT03944304|Tubulin Modulators|tubulin modulators|mesh-ancestor
65620895|NCT03944304|Antimitotic Agents|antimitotic agents|mesh-ancestor
65620896|NCT03944304|Mitosis Modulators|mitosis modulators|mesh-ancestor
65620897|NCT03944304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620898|NCT05204121|Elsulfavirine|elsulfavirine|mesh-list
65620899|NCT05204121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65620900|NCT05204121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65620901|NCT05204121|Antiviral Agents|antiviral agents|mesh-ancestor
65620902|NCT05204121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65620903|NCT04671615|Palbociclib|palbociclib|mesh-list
65620904|NCT04671615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620905|NCT04671615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65620906|NCT04671615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620907|NCT04671615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620908|NCT03645876|Capecitabine|capecitabine|mesh-list
65620909|NCT03645876|Oxaliplatin|oxaliplatin|mesh-list
65620910|NCT03645876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65620911|NCT03645876|Antimetabolites|antimetabolites|mesh-ancestor
65620912|NCT03645876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620913|NCT03645876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620914|NCT05284344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65620915|NCT05284344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620916|NCT02899728|Cisplatin|cisplatin|mesh-list
65620917|NCT02899728|Carboplatin|carboplatin|mesh-list
65620918|NCT02899728|Etoposide|etoposide|mesh-list
65620919|NCT02899728|Etoposide phosphate|etoposide phosphate|mesh-list
65620920|NCT02899728|Olaparib|olaparib|mesh-list
65620921|NCT02899728|Podophyllotoxin|podophyllotoxin|mesh-list
65620922|NCT02899728|Cediranib|cediranib|mesh-list
65620923|NCT02899728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65620924|NCT02899728|Maleic acid|maleic acid|mesh-list
65620925|NCT02899728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65620926|NCT02899728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65620927|NCT02899728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65620928|NCT02899728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65620929|NCT02899728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620930|NCT02899728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620931|NCT02899728|Keratolytic Agents|keratolytic agents|mesh-ancestor
65620932|NCT02899728|Dermatologic Agents|dermatologic agents|mesh-ancestor
65620933|NCT02899728|Tubulin Modulators|tubulin modulators|mesh-ancestor
65620934|NCT02899728|Antimitotic Agents|antimitotic agents|mesh-ancestor
65620935|NCT02899728|Mitosis Modulators|mitosis modulators|mesh-ancestor
65620936|NCT02899728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65620937|NCT03646266|Bromides|bromides|mesh-list
65620938|NCT03646266|Rocuronium|rocuronium|mesh-list
65620939|NCT03646266|Anticonvulsants|anticonvulsants|mesh-ancestor
65620940|NCT03646266|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65620941|NCT03646266|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65620942|NCT03646266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65620943|NCT03646266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620944|NCT03646266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620945|NCT04052178|Capsaicin|capsaicin|mesh-list
65620946|NCT04052178|Antipruritics|antipruritics|mesh-ancestor
65620947|NCT04052178|Dermatologic Agents|dermatologic agents|mesh-ancestor
65620948|NCT04052178|Sensory System Agents|sensory system agents|mesh-ancestor
65620949|NCT04052178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620950|NCT04052178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620951|NCT03645642|Midodrine|midodrine|mesh-list
65620952|NCT03645642|Diuretics|diuretics|mesh-list
65620953|NCT03645642|Natriuretic Agents|natriuretic agents|mesh-ancestor
65620954|NCT03645642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620955|NCT03645642|Sympathomimetics|sympathomimetics|mesh-ancestor
65620956|NCT03645642|Autonomic Agents|autonomic agents|mesh-ancestor
65620957|NCT03645642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620958|NCT03645642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65620959|NCT03645642|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65620960|NCT03645642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65620961|NCT03645642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65620962|NCT03645642|Adrenergic Agents|adrenergic agents|mesh-ancestor
65620963|NCT03645642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65620964|NCT03645642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620965|NCT03066609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65620966|NCT03066609|Immunologic Factors|immunologic factors|mesh-ancestor
65620967|NCT03066609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620968|NCT03768492|Caffeine|caffeine|mesh-list
65620969|NCT03768492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65620970|NCT03768492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620971|NCT03768492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65620972|NCT03768492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620973|NCT03768492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620974|NCT03768492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65620975|NCT03768492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65620976|NCT03768492|Purinergic Agents|purinergic agents|mesh-ancestor
65620977|NCT03768492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65620978|NCT01345188|Ranolazine|ranolazine|mesh-list
65620979|NCT01345188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65620980|NCT01345188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65620981|NCT01345188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620982|NCT03852459|Ibuprofen|ibuprofen|mesh-list
65620983|NCT03852459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65620984|NCT03852459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65620985|NCT03852459|Analgesics|analgesics|mesh-ancestor
65620986|NCT03852459|Sensory System Agents|sensory system agents|mesh-ancestor
65620987|NCT03852459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65620988|NCT03852459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65620989|NCT03852459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65620990|NCT03852459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65620991|NCT03852459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65620992|NCT03852459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65620993|NCT03852459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65620994|NCT03580902|Buprenorphine|buprenorphine|mesh-list
65620995|NCT03580902|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65620996|NCT03580902|Naloxone|naloxone|mesh-list
65620997|NCT03580902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65620998|NCT03580902|Narcotics|narcotics|mesh-ancestor
65620999|NCT03580902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65266712|NCT04691726|Lidocaine|lidocaine|mesh-list
65621000|NCT03580902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621001|NCT03580902|Analgesics|analgesics|mesh-ancestor
65621002|NCT03580902|Sensory System Agents|sensory system agents|mesh-ancestor
65621003|NCT03580902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65621004|NCT03580902|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65621005|NCT02896296|Buprenorphine|buprenorphine|mesh-list
65621006|NCT02896296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65621007|NCT02896296|Narcotics|narcotics|mesh-ancestor
65621008|NCT02896296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65621009|NCT02896296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621010|NCT02896296|Analgesics|analgesics|mesh-ancestor
65621011|NCT02896296|Sensory System Agents|sensory system agents|mesh-ancestor
65621012|NCT02896296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65621013|NCT02896296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65621014|NCT03644706|Potassium Citrate|potassium citrate|mesh-list
65621015|NCT03644706|Diuretics|diuretics|mesh-ancestor
65621016|NCT03644706|Natriuretic Agents|natriuretic agents|mesh-ancestor
65621017|NCT03644706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621018|NCT03644706|Expectorants|expectorants|mesh-ancestor
65621019|NCT03644706|Respiratory System Agents|respiratory system agents|mesh-ancestor
65621020|NCT03740919|Insulin|insulin|mesh-list
65621021|NCT03740919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65621022|NCT03740919|Insulin Glargine|insulin glargine|mesh-list
65621023|NCT03740919|Insulin Lispro|insulin lispro|mesh-list
65621024|NCT03740919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65621025|NCT03740919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621026|NCT01335685|Prednisone|prednisone|mesh-list
65621027|NCT01335685|Melphalan|melphalan|mesh-list
65621028|NCT01335685|Ixazomib|ixazomib|mesh-list
65621029|NCT01335685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65621030|NCT01335685|Glucocorticoids|glucocorticoids|mesh-ancestor
65621031|NCT01335685|Hormones|hormones|mesh-ancestor
65621032|NCT01335685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65621033|NCT01335685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621034|NCT01335685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65621035|NCT01335685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621036|NCT01335685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65621037|NCT01335685|Alkylating Agents|alkylating agents|mesh-ancestor
65621038|NCT01335685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621039|NCT01335685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65621040|NCT01335685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65621041|NCT01335685|Immunologic Factors|immunologic factors|mesh-ancestor
65621042|NCT01335685|Protease Inhibitors|protease inhibitors|mesh-ancestor
65621043|NCT01335685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621044|NCT01335763|Insulin Glargine|insulin glargine|mesh-list
65621045|NCT01335763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65621046|NCT01335763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621047|NCT04462965|Temozolomide|temozolomide|mesh-list
65621048|NCT04462965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65621049|NCT04462965|Alkylating Agents|alkylating agents|mesh-ancestor
65621050|NCT04462965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621051|NCT04462965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621052|NCT01339663|Aldesleukin|aldesleukin|mesh-list
65621053|NCT01339663|Cyclophosphamide|cyclophosphamide|mesh-list
65621054|NCT01339663|Interleukin-2|interleukin-2|mesh-list
65621055|NCT01339663|Vaccines|vaccines|mesh-list
65621056|NCT01339663|Immunologic Factors|immunologic factors|mesh-ancestor
65621057|NCT01339663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621058|NCT01339663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65621059|NCT01339663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65621060|NCT01339663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65621061|NCT01339663|Alkylating Agents|alkylating agents|mesh-ancestor
65621062|NCT01339663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621063|NCT01339663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621064|NCT01339663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65621065|NCT01339663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65621066|NCT01339663|Analgesics|analgesics|mesh-ancestor
65621067|NCT01339663|Sensory System Agents|sensory system agents|mesh-ancestor
65621068|NCT01339663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65621069|NCT01339663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65621070|NCT01339663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65621071|NCT01339663|Antiviral Agents|antiviral agents|mesh-ancestor
65621072|NCT01339663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65621073|NCT00092599|Ezetimibe|ezetimibe|mesh-list
65621074|NCT00092599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65621075|NCT00092599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65621076|NCT00092599|Antimetabolites|antimetabolites|mesh-ancestor
65621077|NCT00092599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621078|NCT00092599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65621079|NCT03737565|Tryptophan|tryptophan|mesh-list
65621080|NCT03737565|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65621081|NCT03737565|Antidepressive Agents|antidepressive agents|mesh-ancestor
65621082|NCT03737565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65621083|NCT02889133|Iron|iron|mesh-list
65621084|NCT02889133|Dextrans|dextrans|mesh-list
65621085|NCT02889133|Iron-Dextran Complex|iron-dextran complex|mesh-list
65621086|NCT02889133|Trace Elements|trace elements|mesh-ancestor
65621087|NCT02889133|Micronutrients|micronutrients|mesh-ancestor
65621088|NCT02889133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621089|NCT02889133|Anticoagulants|anticoagulants|mesh-ancestor
65621090|NCT02889133|Plasma Substitutes|plasma substitutes|mesh-ancestor
65621091|NCT02889133|Blood Substitutes|blood substitutes|mesh-ancestor
65621092|NCT02889133|Hematinics|hematinics|mesh-ancestor
65621093|NCT01333423|Roscovitine|roscovitine|mesh-list
65621094|NCT01333423|Doxorubicin|doxorubicin|mesh-list
65621095|NCT01333423|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65621096|NCT01333423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65621097|NCT01333423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621098|NCT01333423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65621099|NCT01333423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65621100|NCT01333423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621101|NCT01333423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621103|NCT01333423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65621104|NCT01333423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65621105|NCT00092209|Losartan|losartan|mesh-list
65621106|NCT00092209|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65621107|NCT00092209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65621108|NCT00092209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65621109|NCT00092209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65621110|NCT00092209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65621111|NCT00092209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621112|NCT00092209|Diuretics|diuretics|mesh-ancestor
65621113|NCT00092209|Natriuretic Agents|natriuretic agents|mesh-ancestor
65621114|NCT00092209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621115|NCT00092209|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65621116|NCT00092209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65621117|NCT01339741|Vitamin D|vitamin d|mesh-list
65621118|NCT01339741|Cholecalciferol|cholecalciferol|mesh-list
65621119|NCT01339741|Vitamins|vitamins|mesh-ancestor
65621120|NCT01339741|Micronutrients|micronutrients|mesh-ancestor
65621121|NCT01339741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621122|NCT01339741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65621123|NCT01339741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65621124|NCT00003777|Fluorouracil|fluorouracil|mesh-list
65621125|NCT00003777|Amifostine|amifostine|mesh-list
65621126|NCT00003777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621127|NCT00003777|Antimetabolites|antimetabolites|mesh-ancestor
65621128|NCT00003777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621129|NCT00003777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65621130|NCT00003777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65621131|NCT00003777|Immunologic Factors|immunologic factors|mesh-ancestor
65621132|NCT00003777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621133|NCT00003777|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65621134|NCT00003777|Protective Agents|protective agents|mesh-ancestor
65621135|NCT01339819|Dabigatran|dabigatran|mesh-list
65621136|NCT01339819|Phenprocoumon|phenprocoumon|mesh-list
65621137|NCT01339819|Antithrombins|antithrombins|mesh-ancestor
65621138|NCT01339819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65621139|NCT01339819|Protease Inhibitors|protease inhibitors|mesh-ancestor
65621140|NCT01339819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621141|NCT01339819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621142|NCT01339819|Anticoagulants|anticoagulants|mesh-ancestor
65621143|NCT02963922|Liraglutide|liraglutide|mesh-list
65621144|NCT02963922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65621145|NCT02963922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621146|NCT02963922|Incretins|incretins|mesh-ancestor
65621147|NCT02963922|Hormones|hormones|mesh-ancestor
65621148|NCT02963922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65621149|NCT00090181|Diclofenac|diclofenac|mesh-list
65621150|NCT00090181|Etoricoxib|etoricoxib|mesh-list
65621151|NCT00090181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65621152|NCT00090181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65621153|NCT00090181|Analgesics|analgesics|mesh-ancestor
65621154|NCT00090181|Sensory System Agents|sensory system agents|mesh-ancestor
65621155|NCT00090181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65621156|NCT00090181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621157|NCT00090181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65621158|NCT00090181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65621159|NCT00090181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65621160|NCT00090181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621161|NCT00090181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621162|NCT00090181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65621163|NCT03619785|Acetaminophen|acetaminophen|mesh-list
65621164|NCT03619785|Ibuprofen|ibuprofen|mesh-list
65621165|NCT03619785|Ketorolac|ketorolac|mesh-list
65621166|NCT03619785|Fentanyl|fentanyl|mesh-list
65621167|NCT03619785|Ketamine|ketamine|mesh-list
65621168|NCT03619785|Morphine|morphine|mesh-list
65621169|NCT03619785|Gabapentin|gabapentin|mesh-list
65621170|NCT03619785|Hydromorphone|hydromorphone|mesh-list
65621171|NCT03619785|Hydrocodone|hydrocodone|mesh-list
65621172|NCT03619785|Bupivacaine|bupivacaine|mesh-list
65621173|NCT03619785|Anesthetics, Local|anesthetics, local|mesh-ancestor
65621174|NCT03619785|Anesthetics|anesthetics|mesh-ancestor
65621175|NCT03619785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65418554|NCT01018914|Mycophenolic Acid|mycophenolic acid|mesh-list
65621176|NCT03619785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621178|NCT03619785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65621179|NCT03619785|Analgesics|analgesics|mesh-ancestor
65621180|NCT03619785|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65621181|NCT03619785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65621182|NCT03619785|Anesthetics, General|anesthetics, general|mesh-ancestor
65621183|NCT03619785|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65621184|NCT03619785|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65621185|NCT03619785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65621186|NCT03619785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621187|NCT03619785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65621188|NCT03619785|Narcotics|narcotics|mesh-ancestor
65621189|NCT03619785|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65621190|NCT03619785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65621191|NCT03619785|Antipyretics|antipyretics|mesh-ancestor
65621192|NCT03619785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65621193|NCT03619785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65621194|NCT03619785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65621195|NCT03619785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65621196|NCT03619785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621197|NCT03619785|Anticonvulsants|anticonvulsants|mesh-ancestor
65621198|NCT03619785|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65621199|NCT03619785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65621200|NCT03619785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65621201|NCT03619785|Antimanic Agents|antimanic agents|mesh-ancestor
65621202|NCT03619785|Antitussive Agents|antitussive agents|mesh-ancestor
65621203|NCT03619785|Respiratory System Agents|respiratory system agents|mesh-ancestor
65621204|NCT02881567|Daclizumab|daclizumab|mesh-list
65621205|NCT02881567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65621206|NCT02881567|Immunologic Factors|immunologic factors|mesh-ancestor
65621207|NCT02881567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621208|NCT05184517|Cyclosporine|cyclosporine|mesh-list
65621209|NCT05184517|Cyclosporins|cyclosporins|mesh-list
65621210|NCT05184517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621211|NCT05184517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621212|NCT05184517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65621213|NCT05184517|Immunologic Factors|immunologic factors|mesh-ancestor
65621214|NCT05184517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621215|NCT05184517|Antifungal Agents|antifungal agents|mesh-ancestor
65621216|NCT05184517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65621217|NCT05184517|Dermatologic Agents|dermatologic agents|mesh-ancestor
65621218|NCT05184517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65621219|NCT05184517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65621220|NCT03184155|Nicardipine|nicardipine|mesh-list
65621221|NCT03184155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65621222|NCT03184155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65621223|NCT03184155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65621224|NCT03184155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621225|NCT03184155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65621226|NCT03184155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621227|NCT03184155|Vasodilator Agents|vasodilator agents|mesh-ancestor
65621228|NCT02962284|Methylprednisolone|methylprednisolone|mesh-list
65621229|NCT02962284|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65621230|NCT02962284|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65621231|NCT02962284|Prednisolone|prednisolone|mesh-list
65621232|NCT02962284|Prednisolone acetate|prednisolone acetate|mesh-list
65621233|NCT02962284|Abiraterone Acetate|abiraterone acetate|mesh-list
65621234|NCT02962284|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65621235|NCT02962284|Prednisolone phosphate|prednisolone phosphate|mesh-list
65621236|NCT02962284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65621237|NCT02962284|Antiemetics|antiemetics|mesh-ancestor
65621238|NCT02962284|Autonomic Agents|autonomic agents|mesh-ancestor
65621239|NCT02962284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65621240|NCT02962284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621241|NCT02962284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65621242|NCT02962284|Glucocorticoids|glucocorticoids|mesh-ancestor
65621243|NCT02962284|Hormones|hormones|mesh-ancestor
65621244|NCT02962284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65621245|NCT02962284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65621246|NCT02962284|Protective Agents|protective agents|mesh-ancestor
65621247|NCT02962284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65621248|NCT02962284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621249|NCT02962284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65621250|NCT02962284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418632|NCT02567825|Renal Agents|renal agents|mesh-ancestor
65621251|NCT02962284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621252|NCT02962284|Hormone Antagonists|hormone antagonists|mesh-ancestor
65621253|NCT02962284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65621254|NCT03642600|Folic Acid|folic acid|mesh-list
65621255|NCT03642600|Inositol|inositol|mesh-list
65621256|NCT03642600|Liraglutide|liraglutide|mesh-list
65621257|NCT03642600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65621258|NCT03642600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621259|NCT03642600|Incretins|incretins|mesh-ancestor
65621260|NCT03642600|Hormones|hormones|mesh-ancestor
65621261|NCT03642600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65621262|NCT03642600|Hematinics|hematinics|mesh-ancestor
65621263|NCT03642600|Vitamin B Complex|vitamin b complex|mesh-ancestor
65621264|NCT03642600|Vitamins|vitamins|mesh-ancestor
65621265|NCT03642600|Micronutrients|micronutrients|mesh-ancestor
65621266|NCT01069692|Ferric Compounds|ferric compounds|mesh-list
65621267|NCT01069692|Hematinics|hematinics|mesh-ancestor
65621268|NCT05183178|Ticagrelor|ticagrelor|mesh-list
65621269|NCT05183178|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65621270|NCT05183178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65621271|NCT05183178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65621272|NCT05183178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65621273|NCT05183178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65621274|NCT05183178|Purinergic Agents|purinergic agents|mesh-ancestor
65621275|NCT05183178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65621276|NCT05183178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621277|NCT05183178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621278|NCT00026312|Vitamin A|vitamin a|mesh-list
65621279|NCT00026312|Aldesleukin|aldesleukin|mesh-list
65621280|NCT00026312|Interleukin-2|interleukin-2|mesh-list
65621281|NCT00026312|Tretinoin|tretinoin|mesh-list
65621282|NCT00026312|Dinutuximab|dinutuximab|mesh-list
65621283|NCT00026312|Isotretinoin|isotretinoin|mesh-list
65621284|NCT00026312|Sargramostim|sargramostim|mesh-list
65621285|NCT00026312|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65621286|NCT00026312|Vitamins|vitamins|mesh-ancestor
65621287|NCT00026312|Micronutrients|micronutrients|mesh-ancestor
65621288|NCT00026312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621289|NCT00026312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621290|NCT00026312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65621291|NCT00026312|Analgesics|analgesics|mesh-ancestor
65621292|NCT00026312|Sensory System Agents|sensory system agents|mesh-ancestor
65621293|NCT00026312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65621294|NCT00026312|Immunologic Factors|immunologic factors|mesh-ancestor
65621295|NCT00026312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65621296|NCT00026312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65621297|NCT00026312|Antiviral Agents|antiviral agents|mesh-ancestor
65621298|NCT00026312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65621299|NCT00026312|Keratolytic Agents|keratolytic agents|mesh-ancestor
65621300|NCT00026312|Dermatologic Agents|dermatologic agents|mesh-ancestor
65621301|NCT03161093|Naproxen|naproxen|mesh-list
65621302|NCT03161093|Fasinumab|fasinumab|mesh-list
65621303|NCT03161093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65621304|NCT03161093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65621305|NCT03161093|Analgesics|analgesics|mesh-ancestor
65621306|NCT03161093|Sensory System Agents|sensory system agents|mesh-ancestor
65621307|NCT03161093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65621308|NCT03161093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621309|NCT03161093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65621310|NCT03161093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65621311|NCT03161093|Gout Suppressants|gout suppressants|mesh-ancestor
65621312|NCT03161093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65621313|NCT03161093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621314|NCT03161093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621315|NCT03573284|Nitric Oxide|nitric oxide|mesh-list
65621316|NCT03573284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65621317|NCT03573284|Autonomic Agents|autonomic agents|mesh-ancestor
65621318|NCT03573284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65621319|NCT03573284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621320|NCT03573284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65621321|NCT03573284|Respiratory System Agents|respiratory system agents|mesh-ancestor
65621322|NCT03573284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65621323|NCT03573284|Antioxidants|antioxidants|mesh-ancestor
65621324|NCT03573284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418701|NCT00936533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65621325|NCT03573284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65621326|NCT03573284|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65621327|NCT03573284|Vasodilator Agents|vasodilator agents|mesh-ancestor
65621328|NCT03573284|Gasotransmitters|gasotransmitters|mesh-ancestor
65621329|NCT03573284|Protective Agents|protective agents|mesh-ancestor
65621331|NCT03575780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621332|NCT03575780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621333|NCT01334333|Tacrolimus|tacrolimus|mesh-list
65621334|NCT01334333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65621335|NCT01334333|Immunologic Factors|immunologic factors|mesh-ancestor
65621336|NCT01334333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621337|NCT01334333|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65621338|NCT01334333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621339|NCT01334333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621340|NCT03573050|Rivastigmine|rivastigmine|mesh-list
65621341|NCT03573050|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65621342|NCT03573050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621343|NCT03573050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621344|NCT03573050|Cholinergic Agents|cholinergic agents|mesh-ancestor
65621345|NCT03573050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65621346|NCT03573050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621347|NCT03573050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65621348|NCT03573050|Protective Agents|protective agents|mesh-ancestor
65621349|NCT03575312|Enrofloxacin|enrofloxacin|mesh-list
65621350|NCT03575312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65621351|NCT03575312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65621352|NCT02847494|Dexamethasone|dexamethasone|mesh-list
65621353|NCT02847494|Methylprednisolone|methylprednisolone|mesh-list
65621354|NCT02847494|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65621355|NCT02847494|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65621356|NCT02847494|Prednisolone|prednisolone|mesh-list
65621357|NCT02847494|Prednisolone acetate|prednisolone acetate|mesh-list
65621358|NCT02847494|Metoclopramide|metoclopramide|mesh-list
65621359|NCT02847494|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65621360|NCT02847494|Prednisolone phosphate|prednisolone phosphate|mesh-list
65621361|NCT02847494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65621362|NCT02847494|Antiemetics|antiemetics|mesh-ancestor
65621363|NCT02847494|Autonomic Agents|autonomic agents|mesh-ancestor
65621364|NCT02847494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65621365|NCT02847494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621366|NCT02847494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65621367|NCT02847494|Glucocorticoids|glucocorticoids|mesh-ancestor
65621368|NCT02847494|Hormones|hormones|mesh-ancestor
65621369|NCT02847494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65621370|NCT02847494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65621371|NCT02847494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621372|NCT02847494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65621373|NCT02847494|Protective Agents|protective agents|mesh-ancestor
65621374|NCT02847494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65084154|NCT01050530|Tolvaptan|tolvaptan|mesh-list
65621375|NCT02847494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65621376|NCT02847494|Dopamine Agents|dopamine agents|mesh-ancestor
65621377|NCT02847494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65621378|NCT02847494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621379|NCT02554253|Ketamine|ketamine|mesh-list
65621380|NCT02554253|Propofol|propofol|mesh-list
65621381|NCT02554253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65621382|NCT02554253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65621383|NCT02554253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621384|NCT02554253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65621385|NCT02554253|Anesthetics, General|anesthetics, general|mesh-ancestor
65621386|NCT02554253|Anesthetics|anesthetics|mesh-ancestor
65621387|NCT02554253|Analgesics|analgesics|mesh-ancestor
65621388|NCT02554253|Sensory System Agents|sensory system agents|mesh-ancestor
65621389|NCT02554253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65621390|NCT02554253|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65621391|NCT02554253|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65621392|NCT02554253|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65621393|NCT02554253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65621394|NCT02554253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621395|NCT02239484|Tadalafil|tadalafil|mesh-list
65621396|NCT02239484|Tamsulosin|tamsulosin|mesh-list
65621397|NCT02239484|Vasodilator Agents|vasodilator agents|mesh-ancestor
65621398|NCT02239484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65621399|NCT02239484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65621400|NCT02239484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621401|NCT02239484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621402|NCT02239484|Urological Agents|urological agents|mesh-ancestor
65621403|NCT02239484|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65621404|NCT02239484|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65621405|NCT02239484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65621406|NCT02239484|Adrenergic Agents|adrenergic agents|mesh-ancestor
65621407|NCT02239484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65621408|NCT02239484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621410|NCT03575234|Nivolumab|nivolumab|mesh-list
65621411|NCT03575234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65621412|NCT03575234|Immunologic Factors|immunologic factors|mesh-ancestor
65621413|NCT03575234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621414|NCT03575234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65621415|NCT03575234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65621416|NCT03575234|Alkylating Agents|alkylating agents|mesh-ancestor
65621417|NCT03575234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621418|NCT03575234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621419|NCT03575234|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65621420|NCT03575234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65621421|NCT03575234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65621422|NCT04508855|Heparin|heparin|mesh-list
65621423|NCT04508855|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65621424|NCT04508855|Tinzaparin|tinzaparin|mesh-list
65621425|NCT04508855|Dalteparin|dalteparin|mesh-list
65621426|NCT04508855|Anticoagulants|anticoagulants|mesh-ancestor
65621427|NCT04508855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65621428|NCT04508855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65621429|NCT04508855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621430|NCT03575078|Olaparib|olaparib|mesh-list
65621431|NCT03575078|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65621432|NCT03575078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621433|NCT03575078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621434|NCT03575078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621435|NCT03157583|Sunscreening Agents|sunscreening agents|mesh-list
65621436|NCT03157583|Glycerol|glycerol|mesh-list
65621437|NCT03157583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65621438|NCT03157583|Protective Agents|protective agents|mesh-ancestor
65621439|NCT03157583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621440|NCT03157583|Dermatologic Agents|dermatologic agents|mesh-ancestor
65621441|NCT03157583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65621442|NCT03570710|Tranexamic Acid|tranexamic acid|mesh-list
65621443|NCT03570710|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65621444|NCT03570710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65621445|NCT03570710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621446|NCT03570710|Hemostatics|hemostatics|mesh-ancestor
65621447|NCT03570710|Coagulants|coagulants|mesh-ancestor
65621448|NCT01337765|Dactolisib|dactolisib|mesh-list
65621449|NCT01337765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621450|NCT01307033|Losartan|losartan|mesh-list
65621451|NCT01307033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65621452|NCT01307033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65621453|NCT01307033|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65621454|NCT01307033|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65621455|NCT01307033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621456|NCT04475705|Propofol|propofol|mesh-list
65621457|NCT04475705|Sevoflurane|sevoflurane|mesh-list
65621458|NCT04475705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65621459|NCT04475705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65621460|NCT04475705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621461|NCT04475705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65621462|NCT04475705|Anesthetics, General|anesthetics, general|mesh-ancestor
65621463|NCT04475705|Anesthetics|anesthetics|mesh-ancestor
65621464|NCT04475705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65621465|NCT04475705|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65621466|NCT03158311|Fluticasone|fluticasone|mesh-list
65621467|NCT03158311|Tiotropium Bromide|tiotropium bromide|mesh-list
65621468|NCT03158311|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65621469|NCT03158311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65621470|NCT03158311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65621471|NCT03158311|Autonomic Agents|autonomic agents|mesh-ancestor
65621472|NCT03158311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65621473|NCT03158311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621474|NCT03158311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65621475|NCT03158311|Respiratory System Agents|respiratory system agents|mesh-ancestor
65621476|NCT03158311|Dermatologic Agents|dermatologic agents|mesh-ancestor
65418848|NCT01019772|Vaccines|vaccines|mesh-list
65621477|NCT03158311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65621478|NCT03158311|Parasympatholytics|parasympatholytics|mesh-ancestor
65621479|NCT03158311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65621480|NCT03158311|Cholinergic Agents|cholinergic agents|mesh-ancestor
65621481|NCT03158311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65621482|NCT03158311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621483|NCT03158311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65621484|NCT03158311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65621485|NCT03158311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65621486|NCT03158311|Adrenergic Agents|adrenergic agents|mesh-ancestor
65621487|NCT02244866|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65621488|NCT02244866|Hormones|hormones|mesh-ancestor
65621489|NCT02244866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65621490|NCT02244866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621491|NCT01334567|Tenofovir|tenofovir|mesh-list
65621492|NCT01334567|Antiviral Agents|antiviral agents|mesh-ancestor
65621493|NCT01334567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65621494|NCT01334567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65621495|NCT01334567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65621496|NCT01334567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621497|NCT01334567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621498|NCT01334567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65621499|NCT01334567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65621500|NCT04398329|Bupivacaine|bupivacaine|mesh-list
65621501|NCT04398329|Anesthetics, Local|anesthetics, local|mesh-ancestor
65621502|NCT04398329|Anesthetics|anesthetics|mesh-ancestor
65621503|NCT04398329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65621504|NCT04398329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621505|NCT04398329|Sensory System Agents|sensory system agents|mesh-ancestor
65621506|NCT04398329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65621507|NCT00449111|Losartan|losartan|mesh-list
65621508|NCT00449111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65621509|NCT00449111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65621510|NCT00449111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65621511|NCT00449111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65621512|NCT00449111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621513|NCT03568916|Rivaroxaban|rivaroxaban|mesh-list
65621514|NCT03568916|Apixaban|apixaban|mesh-list
65621515|NCT03568916|Dabigatran|dabigatran|mesh-list
65621516|NCT03568916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65621517|NCT03568916|Antithrombins|antithrombins|mesh-ancestor
65621518|NCT03568916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65621519|NCT03568916|Protease Inhibitors|protease inhibitors|mesh-ancestor
65621520|NCT03568916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621521|NCT03568916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621522|NCT03568916|Anticoagulants|anticoagulants|mesh-ancestor
65621523|NCT01334645|Arginine Vasopressin|arginine vasopressin|mesh-list
65621524|NCT01334645|Hemostatics|hemostatics|mesh-ancestor
65621525|NCT01334645|Coagulants|coagulants|mesh-ancestor
65621526|NCT01334645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65621527|NCT01334645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65621528|NCT01334645|Natriuretic Agents|natriuretic agents|mesh-ancestor
65621529|NCT01334645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621530|NCT03571490|Ropivacaine|ropivacaine|mesh-list
65621531|NCT03571490|Anesthetics, Local|anesthetics, local|mesh-ancestor
65621532|NCT03571490|Anesthetics|anesthetics|mesh-ancestor
65621533|NCT03571490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65621534|NCT03571490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621535|NCT03571490|Sensory System Agents|sensory system agents|mesh-ancestor
65621536|NCT03571490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65621537|NCT01331993|Naproxen|naproxen|mesh-list
65621538|NCT01331993|Esomeprazole|esomeprazole|mesh-list
65621539|NCT01331993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65621540|NCT01331993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65621541|NCT01331993|Analgesics|analgesics|mesh-ancestor
65621542|NCT01331993|Sensory System Agents|sensory system agents|mesh-ancestor
65621543|NCT01331993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65621544|NCT01331993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621545|NCT01331993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65621546|NCT01331993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65621547|NCT01331993|Gout Suppressants|gout suppressants|mesh-ancestor
65621548|NCT01331993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65621549|NCT01331993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621550|NCT01331993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418925|NCT00941057|Calcium, Dietary|calcium, dietary|mesh-list
65621551|NCT01331993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65621552|NCT01331993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65621553|NCT01331993|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65621554|NCT01338077|Omeprazole|omeprazole|mesh-list
65621555|NCT01338077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65621556|NCT01338077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65621557|NCT01338077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65621558|NCT01338077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621559|NCT01338077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621560|NCT03570320|Analgesics, Opioid|analgesics, opioid|mesh-list
65621561|NCT03570320|Narcotics|narcotics|mesh-ancestor
65621562|NCT03570320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65621563|NCT03570320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621564|NCT03570320|Analgesics|analgesics|mesh-ancestor
65621565|NCT03570320|Sensory System Agents|sensory system agents|mesh-ancestor
65621566|NCT03570320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65621567|NCT04266665|Dexmedetomidine|dexmedetomidine|mesh-list
65621568|NCT04266665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65621569|NCT04266665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65621570|NCT04266665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621571|NCT04266665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65621572|NCT04266665|Analgesics|analgesics|mesh-ancestor
65621573|NCT04266665|Sensory System Agents|sensory system agents|mesh-ancestor
65621574|NCT04266665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65621575|NCT04266665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65621576|NCT04266665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65621577|NCT04266665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65621578|NCT04266665|Adrenergic Agents|adrenergic agents|mesh-ancestor
65621579|NCT04266665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65621580|NCT04266665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621581|NCT03571100|Chlorhexidine|chlorhexidine|mesh-list
65621582|NCT03571100|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65621583|NCT03571100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65621584|NCT03571100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65621585|NCT03571100|Disinfectants|disinfectants|mesh-ancestor
65621586|NCT03571100|Dermatologic Agents|dermatologic agents|mesh-ancestor
65621587|NCT01338311|Albuterol|albuterol|mesh-list
65621588|NCT01338311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65621589|NCT01338311|Autonomic Agents|autonomic agents|mesh-ancestor
65621590|NCT01338311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65621591|NCT01338311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621592|NCT01338311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65621593|NCT01338311|Respiratory System Agents|respiratory system agents|mesh-ancestor
65621594|NCT01338311|Tocolytic Agents|tocolytic agents|mesh-ancestor
65621595|NCT01338311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65621596|NCT01338311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65621597|NCT01338311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65621598|NCT01338311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65621599|NCT01338311|Adrenergic Agents|adrenergic agents|mesh-ancestor
65621600|NCT01338311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65621601|NCT01338311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621602|NCT01334879|Ranibizumab|ranibizumab|mesh-list
65621603|NCT01334879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65621604|NCT01334879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65621605|NCT01334879|Growth Substances|growth substances|mesh-ancestor
65621606|NCT01334879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621607|NCT01334879|Growth Inhibitors|growth inhibitors|mesh-ancestor
65621608|NCT01334879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621609|NCT01315795|Lanreotide|lanreotide|mesh-list
65621610|NCT01315795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621611|NCT03570164|Sevoflurane|sevoflurane|mesh-list
65621612|NCT03570164|Desflurane|desflurane|mesh-list
65621613|NCT03570164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65621614|NCT03570164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65621615|NCT03570164|Anesthetics, General|anesthetics, general|mesh-ancestor
65621616|NCT03570164|Anesthetics|anesthetics|mesh-ancestor
65621617|NCT03570164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65621618|NCT03570164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621619|NCT01315951|Petrolatum|petrolatum|mesh-list
65621620|NCT01315951|Emollients|emollients|mesh-ancestor
65621621|NCT01315951|Dermatologic Agents|dermatologic agents|mesh-ancestor
65621622|NCT05184049|Vitamin B 12|vitamin b 12|mesh-list
65621623|NCT05184049|Epalrestat|epalrestat|mesh-list
65621624|NCT05184049|Vitamin B Complex|vitamin b complex|mesh-ancestor
65621625|NCT05184049|Vitamins|vitamins|mesh-ancestor
65621626|NCT05184049|Micronutrients|micronutrients|mesh-ancestor
65621627|NCT05184049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621628|NCT05184049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621629|NCT05184049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621630|NCT01336543|Gemcitabine|gemcitabine|mesh-list
65621632|NCT01336543|Etoposide|etoposide|mesh-list
65621633|NCT01336543|Pemetrexed|pemetrexed|mesh-list
65621634|NCT01336543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621635|NCT01336543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65621636|NCT01336543|Antimetabolites|antimetabolites|mesh-ancestor
65621637|NCT01336543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621638|NCT01336543|Antiviral Agents|antiviral agents|mesh-ancestor
65621639|NCT01336543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65621640|NCT01336543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621641|NCT01336543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65621642|NCT01336543|Immunologic Factors|immunologic factors|mesh-ancestor
65621643|NCT01336543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621644|NCT01336543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65621645|NCT01336543|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65621646|NCT01336543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65621647|NCT01336543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65621648|NCT01336543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65621649|NCT03568136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65621650|NCT03568136|Immunologic Factors|immunologic factors|mesh-ancestor
65621651|NCT03568136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621652|NCT01336621|Ezogabine|ezogabine|mesh-list
65621653|NCT01336621|Anticonvulsants|anticonvulsants|mesh-ancestor
65621654|NCT01336621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65621655|NCT01336621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621656|NCT00383435|Mometasone Furoate|mometasone furoate|mesh-list
65621657|NCT00383435|Formoterol Fumarate|formoterol fumarate|mesh-list
65621658|NCT00383435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65621659|NCT00383435|Autonomic Agents|autonomic agents|mesh-ancestor
65621660|NCT00383435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65621661|NCT00383435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621662|NCT00383435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65621663|NCT00383435|Respiratory System Agents|respiratory system agents|mesh-ancestor
65621664|NCT00383435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65621665|NCT00383435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65621666|NCT00383435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65621667|NCT00383435|Adrenergic Agents|adrenergic agents|mesh-ancestor
65621668|NCT00383435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65621669|NCT00383435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621670|NCT00383435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65621671|NCT00383435|Dermatologic Agents|dermatologic agents|mesh-ancestor
65621672|NCT00383435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65621673|NCT01340521|Clomiphene|clomiphene|mesh-list
65621674|NCT01340521|Enclomiphene|enclomiphene|mesh-list
65621675|NCT01340521|Zuclomiphene|zuclomiphene|mesh-list
65621676|NCT01340521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65621677|NCT01340521|Hormone Antagonists|hormone antagonists|mesh-ancestor
65621678|NCT01340521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65621679|NCT01340521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621680|NCT01340521|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65621681|NCT01340521|Fertility Agents|fertility agents|mesh-ancestor
65621682|NCT01340521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65621683|NCT01340521|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65621684|NCT01340521|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65621685|NCT01340599|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65621686|NCT01340599|Antioxidants|antioxidants|mesh-ancestor
65621687|NCT01340599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621688|NCT01340599|Protective Agents|protective agents|mesh-ancestor
65621689|NCT01340599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621690|NCT01340599|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65621691|NCT01340599|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65621692|NCT01340599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621693|NCT01340599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65621694|NCT01335035|Deferasirox|deferasirox|mesh-list
65621695|NCT01335035|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65621696|NCT01335035|Chelating Agents|chelating agents|mesh-ancestor
65621697|NCT01335035|Sequestering Agents|sequestering agents|mesh-ancestor
65621698|NCT01335035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621699|NCT01340677|Canagliflozin|canagliflozin|mesh-list
65621700|NCT01340677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65419077|NCT01012544|Clopidogrel|clopidogrel|mesh-list
65621701|NCT01340677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621702|NCT01340677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65621703|NCT01340677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621705|NCT05163535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65621706|NCT05163535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65621707|NCT05163535|Antiviral Agents|antiviral agents|mesh-ancestor
65621708|NCT05163535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65621709|NCT01338389|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
65621710|NCT01338389|Nootropic Agents|nootropic agents|mesh-ancestor
65621711|NCT01340833|Dabrafenib|dabrafenib|mesh-list
65621712|NCT01340833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621713|NCT01340833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65621714|NCT01340833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621715|NCT01340833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621716|NCT01332383|Naratriptan|naratriptan|mesh-list
65621717|NCT01332383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65621718|NCT01332383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65621719|NCT01332383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65621720|NCT01332383|Serotonin Agents|serotonin agents|mesh-ancestor
65621721|NCT01332383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65621722|NCT01332383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621723|NCT01332383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621724|NCT01342237|Carboplatin|carboplatin|mesh-list
65621725|NCT01342237|Etoposide|etoposide|mesh-list
65621726|NCT01342237|Melphalan|melphalan|mesh-list
65621727|NCT01342237|Topotecan|topotecan|mesh-list
65621728|NCT01342237|Thiotepa|thiotepa|mesh-list
65621729|NCT01342237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621730|NCT01342237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65621731|NCT01342237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65621732|NCT01342237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65621733|NCT01342237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621734|NCT01342237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621735|NCT01342237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65621736|NCT01342237|Alkylating Agents|alkylating agents|mesh-ancestor
65621737|NCT01342237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65621738|NCT01342237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65621739|NCT01342237|Immunologic Factors|immunologic factors|mesh-ancestor
65621740|NCT01342237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621741|NCT01342237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65621742|NCT01337323|Fluticasone|fluticasone|mesh-list
65621743|NCT01337323|Xhance|xhance|mesh-list
65621744|NCT01337323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65621745|NCT01337323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65621746|NCT01337323|Autonomic Agents|autonomic agents|mesh-ancestor
65621747|NCT01337323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65621748|NCT01337323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621749|NCT01337323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65621750|NCT01337323|Respiratory System Agents|respiratory system agents|mesh-ancestor
65621751|NCT01337323|Dermatologic Agents|dermatologic agents|mesh-ancestor
65621752|NCT01337323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65621753|NCT03157037|Immunoglobulins|immunoglobulins|mesh-list
65621754|NCT03157037|Immunoglobulin G|immunoglobulin g|mesh-list
65621755|NCT03157037|Immunologic Factors|immunologic factors|mesh-ancestor
65621756|NCT03157037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621757|NCT04830943|Cerebrolysin|cerebrolysin|mesh-list
65621758|NCT04830943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65621759|NCT04830943|Protective Agents|protective agents|mesh-ancestor
65621760|NCT04830943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621761|NCT04830943|Nootropic Agents|nootropic agents|mesh-ancestor
65621762|NCT04429321|Nivolumab|nivolumab|mesh-list
65621763|NCT04429321|Ipilimumab|ipilimumab|mesh-list
65621764|NCT04429321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65621765|NCT04429321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621766|NCT04429321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65621767|NCT04429321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621768|NCT03067610|Paclitaxel|paclitaxel|mesh-list
65621769|NCT03067610|Cisplatin|cisplatin|mesh-list
65621770|NCT03067610|Carboplatin|carboplatin|mesh-list
65621771|NCT03067610|Cetuximab|cetuximab|mesh-list
65621772|NCT03067610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65621773|NCT03067610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621774|NCT03067610|Tubulin Modulators|tubulin modulators|mesh-ancestor
65621775|NCT03067610|Antimitotic Agents|antimitotic agents|mesh-ancestor
65419155|NCT00482274|Docetaxel|docetaxel|mesh-list
65621776|NCT03067610|Mitosis Modulators|mitosis modulators|mesh-ancestor
65621777|NCT03067610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621778|NCT03067610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65621779|NCT00381485|Mometasone Furoate|mometasone furoate|mesh-list
65621780|NCT00381485|Formoterol Fumarate|formoterol fumarate|mesh-list
65621781|NCT00381485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65621782|NCT00381485|Autonomic Agents|autonomic agents|mesh-ancestor
65621783|NCT00381485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65621784|NCT00381485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621785|NCT00381485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65621786|NCT00381485|Respiratory System Agents|respiratory system agents|mesh-ancestor
65621787|NCT00381485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65621788|NCT00381485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65621789|NCT00381485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65621790|NCT00381485|Adrenergic Agents|adrenergic agents|mesh-ancestor
65621791|NCT00381485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65621792|NCT00381485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621793|NCT00381485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65621794|NCT00381485|Dermatologic Agents|dermatologic agents|mesh-ancestor
65621795|NCT00381485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65621796|NCT05182957|Lenalidomide|lenalidomide|mesh-list
65621797|NCT05182957|Azacitidine|azacitidine|mesh-list
65621798|NCT05182957|Antibodies|antibodies|mesh-list
65621799|NCT05182957|Immunoglobulins|immunoglobulins|mesh-list
65621800|NCT05182957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65621801|NCT05182957|Immunologic Factors|immunologic factors|mesh-list
65621802|NCT05182957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621803|NCT05182957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65621804|NCT05182957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65621805|NCT05182957|Growth Substances|growth substances|mesh-ancestor
65621806|NCT05182957|Growth Inhibitors|growth inhibitors|mesh-ancestor
65621807|NCT05182957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621808|NCT05182957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65621809|NCT05182957|Antimetabolites|antimetabolites|mesh-ancestor
65621810|NCT05182957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621811|NCT05182957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621812|NCT00092651|Simvastatin|simvastatin|mesh-list
65621813|NCT00092651|Ezetimibe|ezetimibe|mesh-list
65621814|NCT00092651|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
65621815|NCT00092651|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65621816|NCT00092651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65621817|NCT00092651|Antimetabolites|antimetabolites|mesh-ancestor
65621818|NCT00092651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621819|NCT00092651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65621820|NCT00092651|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65621821|NCT00092651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621822|NCT04889599|Docetaxel|docetaxel|mesh-list
65621823|NCT04889599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621824|NCT04889599|Tubulin Modulators|tubulin modulators|mesh-ancestor
65621825|NCT04889599|Antimitotic Agents|antimitotic agents|mesh-ancestor
65621826|NCT04889599|Mitosis Modulators|mitosis modulators|mesh-ancestor
65621827|NCT04889599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621828|NCT01342627|Sorafenib|sorafenib|mesh-list
65621829|NCT01342627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621830|NCT01342627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65621831|NCT01342627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621832|NCT01342627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621833|NCT03160703|Fluorides|fluorides|mesh-list
65621834|NCT03160703|Tin Fluorides|tin fluorides|mesh-list
65621835|NCT03160703|Fluorophosphate|fluorophosphate|mesh-list
65621836|NCT03160703|Cariostatic Agents|cariostatic agents|mesh-ancestor
65621837|NCT03160703|Protective Agents|protective agents|mesh-ancestor
65621838|NCT03160703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621839|NCT01332617|Zoledronic Acid|zoledronic acid|mesh-list
65621840|NCT01332617|Methylprednisolone|methylprednisolone|mesh-list
65621841|NCT01332617|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65621842|NCT01332617|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65621843|NCT01332617|Prednisolone|prednisolone|mesh-list
65621844|NCT01332617|Prednisolone acetate|prednisolone acetate|mesh-list
65621845|NCT01332617|Diclofenac|diclofenac|mesh-list
65621846|NCT01332617|Bortezomib|bortezomib|mesh-list
65621847|NCT01332617|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65621848|NCT01332617|Simvastatin|simvastatin|mesh-list
65621849|NCT01332617|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65621850|NCT01332617|Prednisolone phosphate|prednisolone phosphate|mesh-list
65621851|NCT01332617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621852|NCT01332617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65621853|NCT01332617|Antiemetics|antiemetics|mesh-ancestor
65621854|NCT01332617|Autonomic Agents|autonomic agents|mesh-ancestor
65621855|NCT01332617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65621856|NCT01332617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621857|NCT01332617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65621858|NCT01332617|Glucocorticoids|glucocorticoids|mesh-ancestor
65621859|NCT01332617|Hormones|hormones|mesh-ancestor
65621860|NCT01332617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65621861|NCT01332617|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65621862|NCT01332617|Protective Agents|protective agents|mesh-ancestor
65621863|NCT01332617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65621864|NCT01332617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65621865|NCT01332617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65621866|NCT01332617|Antimetabolites|antimetabolites|mesh-ancestor
65621867|NCT01332617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621868|NCT01332617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65621869|NCT01332617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65621870|NCT01332617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621871|NCT01332617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65621872|NCT01332617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65621873|NCT01332617|Analgesics|analgesics|mesh-ancestor
65621874|NCT01332617|Sensory System Agents|sensory system agents|mesh-ancestor
65621875|NCT01332617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65621876|NCT01332617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65621877|NCT01332617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65621878|NCT01332617|Alkylating Agents|alkylating agents|mesh-ancestor
65621879|NCT01332617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65621880|NCT03569696|Nivolumab|nivolumab|mesh-list
65621881|NCT03569696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65621882|NCT03569696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621883|NCT03569696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65621884|NCT03569696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621885|NCT00092573|Ezetimibe|ezetimibe|mesh-list
65621886|NCT00092573|Fenofibrate|fenofibrate|mesh-list
65621887|NCT00092573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65266733|NCT00614328|Naltrexone|naltrexone|mesh-list
65621888|NCT00092573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65621889|NCT00092573|Antimetabolites|antimetabolites|mesh-ancestor
65621890|NCT00092573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621891|NCT00092573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65621892|NCT01342939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65621893|NCT01342939|Incretins|incretins|mesh-list
65621894|NCT01342939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65621895|NCT01342939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621896|NCT01342939|Hormones|hormones|mesh-ancestor
65621897|NCT01342939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65621898|NCT01342939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65621899|NCT01342939|Protease Inhibitors|protease inhibitors|mesh-ancestor
65621900|NCT01342939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621901|NCT01342939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621902|NCT03569540|Glyburide|glyburide|mesh-list
65621903|NCT03569540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65621904|NCT03569540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621905|NCT05708690|Tranexamic Acid|tranexamic acid|mesh-list
65621906|NCT05708690|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65621907|NCT05708690|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65621908|NCT05708690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621909|NCT05708690|Hemostatics|hemostatics|mesh-ancestor
65621910|NCT05708690|Coagulants|coagulants|mesh-ancestor
65621911|NCT04851821|Quercetin|quercetin|mesh-list
65621912|NCT04851821|Antioxidants|antioxidants|mesh-ancestor
65621913|NCT04851821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621914|NCT04851821|Protective Agents|protective agents|mesh-ancestor
65621915|NCT04851821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621916|NCT03379727|Midostaurin|midostaurin|mesh-list
65621917|NCT03379727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621918|NCT03379727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65621919|NCT03379727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621920|NCT03379727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621921|NCT02247128|Aspirin|aspirin|mesh-list
65621922|NCT02247128|Clopidogrel|clopidogrel|mesh-list
65621923|NCT02247128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65621924|NCT02247128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65621925|NCT02247128|Analgesics|analgesics|mesh-ancestor
65621926|NCT02247128|Sensory System Agents|sensory system agents|mesh-ancestor
65621927|NCT02247128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65621928|NCT02247128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621929|NCT02247128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65621930|NCT02247128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65621931|NCT02247128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65621932|NCT02247128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65621933|NCT02247128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621934|NCT02247128|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65621935|NCT02247128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65621936|NCT02247128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621937|NCT02247128|Antipyretics|antipyretics|mesh-ancestor
65621938|NCT02247128|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65621939|NCT02247128|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65621940|NCT02247128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65621941|NCT02247128|Purinergic Agents|purinergic agents|mesh-ancestor
65621942|NCT02247128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65621944|NCT01339481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65621945|NCT01339481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621946|NCT01339481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621947|NCT01339481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65621948|NCT01339481|Immunologic Factors|immunologic factors|mesh-ancestor
65621949|NCT01339481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621950|NCT01339481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65621951|NCT01344031|Fulvestrant|fulvestrant|mesh-list
65621952|NCT01344031|Anastrozole|anastrozole|mesh-list
65621953|NCT01344031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65621954|NCT01344031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621955|NCT01344031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65621956|NCT01344031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65621957|NCT01344031|Hormone Antagonists|hormone antagonists|mesh-ancestor
65621958|NCT01344031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65621959|NCT01344031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621960|NCT01344031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65621961|NCT01344031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65621962|NCT01344031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65621963|NCT01344031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621964|NCT01332929|Bevacizumab|bevacizumab|mesh-list
65621965|NCT01332929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65621966|NCT01332929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621967|NCT01332929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65621968|NCT01332929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65621969|NCT01332929|Growth Substances|growth substances|mesh-ancestor
65621970|NCT01332929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621971|NCT01332929|Growth Inhibitors|growth inhibitors|mesh-ancestor
65621972|NCT03566966|Antiviral Agents|antiviral agents|mesh-list
65621973|NCT03566966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65621974|NCT02247986|Methylphenidate|methylphenidate|mesh-list
65621975|NCT02247986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65621976|NCT02247986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621977|NCT02247986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65621978|NCT02247986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65621979|NCT02247986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65621980|NCT02247986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621981|NCT02247986|Dopamine Agents|dopamine agents|mesh-ancestor
65621982|NCT02247986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65621983|NCT03567434|Ethanol|ethanol|mesh-list
65621984|NCT03567434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65621985|NCT03567434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65621986|NCT03567434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65621987|NCT03567434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621988|NCT05708534|Abatacept|abatacept|mesh-list
65621989|NCT05708534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65621990|NCT05708534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65621991|NCT05708534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65621992|NCT05708534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65621993|NCT05708534|Immunologic Factors|immunologic factors|mesh-ancestor
65621994|NCT05708534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65621995|NCT05708534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65621996|NCT03000374|Leucovorin|leucovorin|mesh-list
65621997|NCT03000374|Fluorouracil|fluorouracil|mesh-list
65419378|NCT00307684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65621999|NCT03000374|Panitumumab|panitumumab|mesh-list
65622000|NCT03000374|Antimetabolites|antimetabolites|mesh-ancestor
65622001|NCT03000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622002|NCT03000374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65622003|NCT03000374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622004|NCT03000374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65622005|NCT03000374|Immunologic Factors|immunologic factors|mesh-ancestor
65622006|NCT03000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622007|NCT03000374|Antidotes|antidotes|mesh-ancestor
65622008|NCT03000374|Protective Agents|protective agents|mesh-ancestor
65622009|NCT03000374|Vitamin B Complex|vitamin b complex|mesh-ancestor
65622010|NCT03000374|Vitamins|vitamins|mesh-ancestor
65622011|NCT03000374|Micronutrients|micronutrients|mesh-ancestor
65622012|NCT03000374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65622013|NCT03566576|Docetaxel|docetaxel|mesh-list
65622014|NCT03566576|Pemetrexed|pemetrexed|mesh-list
65622015|NCT03566576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622016|NCT03566576|Tubulin Modulators|tubulin modulators|mesh-ancestor
65622017|NCT03566576|Antimitotic Agents|antimitotic agents|mesh-ancestor
65622018|NCT03566576|Mitosis Modulators|mitosis modulators|mesh-ancestor
65622019|NCT03566576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622020|NCT03566576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622021|NCT03566576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65622022|NCT03566576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65622023|NCT04377997|Heparin|heparin|mesh-list
65622024|NCT04377997|Calcium heparin|calcium heparin|mesh-list
65622025|NCT04377997|Enoxaparin|enoxaparin|mesh-list
65622026|NCT04377997|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65622027|NCT04377997|Tinzaparin|tinzaparin|mesh-list
65622028|NCT04377997|Dalteparin|dalteparin|mesh-list
65622029|NCT04377997|Anticoagulants|anticoagulants|mesh-ancestor
65622030|NCT04377997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65622031|NCT04377997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65622032|NCT04377997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622033|NCT01336049|Nimotuzumab|nimotuzumab|mesh-list
65622034|NCT01336049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65622035|NCT01336049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622036|NCT04758949|Nivolumab|nivolumab|mesh-list
65622037|NCT04758949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65622038|NCT04758949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622039|NCT04758949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65622040|NCT04758949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622041|NCT05099107|Albuterol|albuterol|mesh-list
65622042|NCT05099107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65622043|NCT05099107|Autonomic Agents|autonomic agents|mesh-ancestor
65622044|NCT05099107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622045|NCT05099107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622046|NCT05099107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65622047|NCT05099107|Respiratory System Agents|respiratory system agents|mesh-ancestor
65622048|NCT05099107|Tocolytic Agents|tocolytic agents|mesh-ancestor
65622049|NCT05099107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65622050|NCT05099107|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65622051|NCT05099107|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65622052|NCT05099107|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65622053|NCT05099107|Adrenergic Agents|adrenergic agents|mesh-ancestor
65622054|NCT05099107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65622055|NCT05099107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622056|NCT03566030|Tenofovir|tenofovir|mesh-list
65622057|NCT03566030|Antiviral Agents|antiviral agents|mesh-ancestor
65622058|NCT03566030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65622059|NCT03566030|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65622060|NCT03566030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65622061|NCT03566030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622062|NCT03566030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622063|NCT03566030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65622064|NCT03566030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65622065|NCT01333085|Paclitaxel|paclitaxel|mesh-list
65622066|NCT01333085|Carboplatin|carboplatin|mesh-list
65622067|NCT01333085|Everolimus|everolimus|mesh-list
65622068|NCT01333085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65622069|NCT01333085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622070|NCT01333085|Tubulin Modulators|tubulin modulators|mesh-ancestor
65622071|NCT01333085|Antimitotic Agents|antimitotic agents|mesh-ancestor
65622072|NCT01333085|Mitosis Modulators|mitosis modulators|mesh-ancestor
65622073|NCT01333085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622074|NCT01333085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65622075|NCT01333085|Immunologic Factors|immunologic factors|mesh-ancestor
65622076|NCT01333085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622077|NCT01344655|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65622078|NCT01344655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65622079|NCT01344655|Autonomic Agents|autonomic agents|mesh-ancestor
65622080|NCT01344655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622081|NCT01344655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622082|NCT01344655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65622083|NCT01344655|Respiratory System Agents|respiratory system agents|mesh-ancestor
65622084|NCT01344655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65622085|NCT01344655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65622086|NCT01344655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65622087|NCT01344655|Adrenergic Agents|adrenergic agents|mesh-ancestor
65622088|NCT01344655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65622089|NCT01344655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622090|NCT04734535|Thrombin|thrombin|mesh-list
65622091|NCT04734535|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
65622092|NCT04734535|Hemostatics|hemostatics|mesh-ancestor
65622093|NCT04734535|Coagulants|coagulants|mesh-ancestor
65622094|NCT03565406|Nivolumab|nivolumab|mesh-list
65622095|NCT03565406|Ipilimumab|ipilimumab|mesh-list
65622096|NCT03565406|Mocetinostat|mocetinostat|mesh-list
65622097|NCT03565406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65622098|NCT03565406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622099|NCT03565406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65622100|NCT03565406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622101|NCT03565406|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65622102|NCT03565406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622103|NCT04734379|Fasudil|fasudil|mesh-list
65622104|NCT04734379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65622105|NCT04734379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65622106|NCT04734379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622107|NCT04734379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65622108|NCT04734379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622109|NCT04734379|Vasodilator Agents|vasodilator agents|mesh-ancestor
65622110|NCT04734379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65622111|NCT04734379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622112|NCT01339871|Vorinostat|vorinostat|mesh-list
65622113|NCT01339871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622114|NCT01339871|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65622115|NCT01339871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622116|NCT01339871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622117|NCT04693429|Bepotastine besilate|bepotastine besilate|mesh-list
65622118|NCT04693429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65622119|NCT03564704|Cytarabine|cytarabine|mesh-list
65622120|NCT03564704|Dexamethasone|dexamethasone|mesh-list
65622121|NCT03564704|Cyclophosphamide|cyclophosphamide|mesh-list
65622122|NCT03564704|Methotrexate|methotrexate|mesh-list
65622123|NCT03564704|Etoposide|etoposide|mesh-list
65622124|NCT03564704|Vincristine|vincristine|mesh-list
65622125|NCT03564704|Doxorubicin|doxorubicin|mesh-list
65622126|NCT03564704|Mercaptopurine|mercaptopurine|mesh-list
65622127|NCT03564704|Idarubicin|idarubicin|mesh-list
65622128|NCT03564704|Pegaspargase|pegaspargase|mesh-list
65622129|NCT03564704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65622130|NCT03564704|Immunologic Factors|immunologic factors|mesh-ancestor
65622131|NCT03564704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622132|NCT03564704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65622133|NCT03564704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65622134|NCT03564704|Alkylating Agents|alkylating agents|mesh-ancestor
65622135|NCT03564704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622136|NCT03564704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622137|NCT03564704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65622138|NCT03564704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65622139|NCT03564704|Antiemetics|antiemetics|mesh-ancestor
65622140|NCT03564704|Autonomic Agents|autonomic agents|mesh-ancestor
65622141|NCT03564704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622142|NCT03564704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65622143|NCT03564704|Glucocorticoids|glucocorticoids|mesh-ancestor
65622144|NCT03564704|Hormones|hormones|mesh-ancestor
65622145|NCT03564704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65622146|NCT03564704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65622147|NCT03564704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65622148|NCT03564704|Abortifacient Agents|abortifacient agents|mesh-ancestor
65419529|NCT00492284|Dermatologic Agents|dermatologic agents|mesh-ancestor
65622149|NCT03564704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65622150|NCT03564704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65622151|NCT03564704|Antimetabolites|antimetabolites|mesh-ancestor
65622152|NCT03564704|Dermatologic Agents|dermatologic agents|mesh-ancestor
65622153|NCT03564704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622154|NCT03564704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65622155|NCT03564704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65622156|NCT03564704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65622157|NCT03564704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65622158|NCT03564704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65622159|NCT03564704|Antiviral Agents|antiviral agents|mesh-ancestor
65622160|NCT03564704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65622161|NCT03564704|Tubulin Modulators|tubulin modulators|mesh-ancestor
65622162|NCT03564704|Antimitotic Agents|antimitotic agents|mesh-ancestor
65622163|NCT03564704|Mitosis Modulators|mitosis modulators|mesh-ancestor
65622164|NCT03564704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65622165|NCT03564548|Morphine|morphine|mesh-list
65622166|NCT03564548|Oxycodone|oxycodone|mesh-list
65622167|NCT03564548|Hydromorphone|hydromorphone|mesh-list
65622168|NCT03564548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65622169|NCT03564548|Narcotics|narcotics|mesh-ancestor
65622170|NCT03564548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65622171|NCT03564548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622172|NCT03564548|Analgesics|analgesics|mesh-ancestor
65622173|NCT03564548|Sensory System Agents|sensory system agents|mesh-ancestor
65622174|NCT03564548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622175|NCT05353010|Tacrolimus|tacrolimus|mesh-list
65622176|NCT05353010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65622177|NCT05353010|Immunologic Factors|immunologic factors|mesh-ancestor
65622178|NCT05353010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622179|NCT05353010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65622180|NCT05353010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622181|NCT05353010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622182|NCT05352854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65622183|NCT05352854|Pilocarpine|pilocarpine|mesh-list
65622184|NCT05352854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65622185|NCT05352854|Miotics|miotics|mesh-ancestor
65622186|NCT05352854|Autonomic Agents|autonomic agents|mesh-ancestor
65622187|NCT05352854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622188|NCT05352854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622189|NCT05352854|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65622190|NCT05352854|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65622191|NCT05352854|Cholinergic Agents|cholinergic agents|mesh-ancestor
65622192|NCT05352854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65622193|NCT05352854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622194|NCT01841177|Milrinone|milrinone|mesh-list
65622195|NCT01841177|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65622196|NCT01841177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65622197|NCT01841177|Vasodilator Agents|vasodilator agents|mesh-ancestor
65622198|NCT01841177|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65622199|NCT01841177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65622200|NCT01841177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622201|NCT01841177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622202|NCT01841177|Protective Agents|protective agents|mesh-ancestor
65622203|NCT01841177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622204|NCT02838134|Rocuronium|rocuronium|mesh-list
65622205|NCT02838134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65622206|NCT02838134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65622207|NCT02838134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65622208|NCT02838134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622209|NCT02838134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622210|NCT03150589|Ranibizumab|ranibizumab|mesh-list
65622211|NCT03150589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65622212|NCT03150589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65622213|NCT03150589|Growth Substances|growth substances|mesh-ancestor
65622214|NCT03150589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622215|NCT03150589|Growth Inhibitors|growth inhibitors|mesh-ancestor
65622216|NCT03150589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622217|NCT05708300|Vaccines|vaccines|mesh-list
65622218|NCT05708300|Immunologic Factors|immunologic factors|mesh-ancestor
65622219|NCT05708300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622220|NCT05340452|Clarithromycin|clarithromycin|mesh-list
65622221|NCT05340452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65622222|NCT05340452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65622223|NCT05340452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65622224|NCT05340452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622225|NCT05340452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622226|NCT05340452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65622227|NCT05340452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65622228|NCT03145207|Lidocaine|lidocaine|mesh-list
65622229|NCT03145207|Anesthetics, Local|anesthetics, local|mesh-ancestor
65622230|NCT03145207|Anesthetics|anesthetics|mesh-ancestor
65622231|NCT03145207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65622232|NCT03145207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622233|NCT03145207|Sensory System Agents|sensory system agents|mesh-ancestor
65622234|NCT03145207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622235|NCT03145207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65622236|NCT03145207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65622237|NCT03145207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65622238|NCT03145207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65622239|NCT03145207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622240|NCT02836652|Aspirin|aspirin|mesh-list
65622241|NCT02836652|Warfarin|warfarin|mesh-list
65622242|NCT02836652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65622243|NCT02836652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65622244|NCT02836652|Analgesics|analgesics|mesh-ancestor
65622245|NCT02836652|Sensory System Agents|sensory system agents|mesh-ancestor
65622246|NCT02836652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622247|NCT02836652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622248|NCT02836652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65622249|NCT02836652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65622250|NCT02836652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65622251|NCT02836652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65622252|NCT02836652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622253|NCT02836652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65622254|NCT02836652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65622255|NCT02836652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622256|NCT02836652|Antipyretics|antipyretics|mesh-ancestor
65622257|NCT02836652|Anticoagulants|anticoagulants|mesh-ancestor
65622258|NCT02836496|Prednisone|prednisone|mesh-list
65622259|NCT02836496|Prednisolone|prednisolone|mesh-list
65622260|NCT02836496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65622261|NCT02836496|Glucocorticoids|glucocorticoids|mesh-ancestor
65622262|NCT02836496|Hormones|hormones|mesh-ancestor
65622263|NCT02836496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65622264|NCT02836496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622265|NCT02836496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65622266|NCT02836496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622267|NCT01344967|Zoledronic Acid|zoledronic acid|mesh-list
65622268|NCT01344967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65622269|NCT01344967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622270|NCT05250661|Propolis|propolis|mesh-list
65622271|NCT05250661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65622272|NCT01345279|Paclitaxel|paclitaxel|mesh-list
65622273|NCT01345279|Topotecan|topotecan|mesh-list
65622274|NCT01345279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65622275|NCT01345279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622276|NCT01345279|Tubulin Modulators|tubulin modulators|mesh-ancestor
65622277|NCT01345279|Antimitotic Agents|antimitotic agents|mesh-ancestor
65622278|NCT01345279|Mitosis Modulators|mitosis modulators|mesh-ancestor
65622279|NCT01345279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622280|NCT01345279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65622281|NCT01345279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65622282|NCT01345279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622283|NCT02833844|Evolocumab|evolocumab|mesh-list
65622284|NCT02833844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65622285|NCT02833844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65622286|NCT02833844|Antimetabolites|antimetabolites|mesh-ancestor
65622287|NCT02833844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622288|NCT02833844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65622289|NCT01345357|Gemcitabine|gemcitabine|mesh-list
65622290|NCT01345357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622291|NCT01345357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65622292|NCT01345357|Antimetabolites|antimetabolites|mesh-ancestor
65622293|NCT01345357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622294|NCT01345357|Antiviral Agents|antiviral agents|mesh-ancestor
65622295|NCT01345357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65622296|NCT01345357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622297|NCT01345357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65622298|NCT01345357|Immunologic Factors|immunologic factors|mesh-ancestor
65622299|NCT01345357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622300|NCT01333631|Valproic Acid|valproic acid|mesh-list
65622301|NCT01333631|Anticonvulsants|anticonvulsants|mesh-ancestor
65622302|NCT01333631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622303|NCT01333631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622304|NCT01333631|GABA Agents|gaba agents|mesh-ancestor
65622305|NCT01333631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65622306|NCT01333631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622307|NCT01333631|Antimanic Agents|antimanic agents|mesh-ancestor
65622308|NCT01333631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65622309|NCT01333631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65622310|NCT01333631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65622311|NCT04611763|Flurbiprofen|flurbiprofen|mesh-list
65622312|NCT04611763|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
65622313|NCT04611763|Analgesics|analgesics|mesh-ancestor
65622314|NCT04611763|Sensory System Agents|sensory system agents|mesh-ancestor
65622315|NCT04611763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622316|NCT04611763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622317|NCT04611763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65622318|NCT04611763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65622319|NCT04611763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65622320|NCT04611763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65622321|NCT04611763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65622322|NCT04611763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622323|NCT04611763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622324|NCT01341782|Ergocalciferols|ergocalciferols|mesh-list
65622325|NCT01341782|Calcitriol|calcitriol|mesh-list
65622326|NCT01341782|Maxacalcitol|maxacalcitol|mesh-list
65622327|NCT01341782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65622328|NCT01341782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622329|NCT01341782|Vitamins|vitamins|mesh-ancestor
65622330|NCT01341782|Micronutrients|micronutrients|mesh-ancestor
65622331|NCT01341782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65622332|NCT01341782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622333|NCT01341782|Dermatologic Agents|dermatologic agents|mesh-ancestor
65622334|NCT01341782|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65622335|NCT01341782|Protective Agents|protective agents|mesh-ancestor
65622336|NCT01341782|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65622337|NCT01341782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65622338|NCT01341782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622339|NCT01341782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65622340|NCT02607319|Bemiparin|bemiparin|mesh-list
65622341|NCT02607319|Anticoagulants|anticoagulants|mesh-ancestor
65622342|NCT02250157|Irinotecan|irinotecan|mesh-list
65622343|NCT02250157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65622344|NCT02250157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65622345|NCT02250157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622346|NCT02250157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622347|NCT02250157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622348|NCT05063149|Broncho-Vaxom|broncho-vaxom|mesh-list
65622349|NCT05063149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65622350|NCT05063149|Immunologic Factors|immunologic factors|mesh-ancestor
65622351|NCT05063149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622352|NCT03564158|Moxifloxacin|moxifloxacin|mesh-list
65622353|NCT03564158|Meropenem|meropenem|mesh-list
65622354|NCT03564158|Vaborbactam|vaborbactam|mesh-list
65622355|NCT03564158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65622356|NCT03564158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65622357|NCT03564158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65622358|NCT03564158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65622359|NCT03564158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622360|NCT03564158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622361|NCT03564158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622362|NCT03564158|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65622363|NCT02677298|Botulinum Toxins|botulinum toxins|mesh-list
65622364|NCT02677298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65622365|NCT02677298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65622366|NCT02677298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65622367|NCT02677298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65622368|NCT02677298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622369|NCT02677298|Cholinergic Agents|cholinergic agents|mesh-ancestor
65622370|NCT02677298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65622371|NCT02677298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622372|NCT02677298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65622373|NCT02677298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622374|NCT01345981|Lidocaine|lidocaine|mesh-list
65622375|NCT01345981|Anesthetics, Local|anesthetics, local|mesh-ancestor
65622376|NCT01345981|Anesthetics|anesthetics|mesh-ancestor
65622377|NCT01345981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65622378|NCT01345981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622379|NCT01345981|Sensory System Agents|sensory system agents|mesh-ancestor
65622380|NCT01345981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622381|NCT01345981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65622382|NCT01345981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65622383|NCT01345981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65622384|NCT01345981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65622385|NCT01345981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622386|NCT04541797|Empagliflozin|empagliflozin|mesh-list
65622387|NCT04541797|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65622388|NCT04541797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622389|NCT04541797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65622390|NCT04541797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622391|NCT00871351|Atorvastatin|atorvastatin|mesh-list
65622392|NCT00871351|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65622393|NCT00871351|Ezetimibe|ezetimibe|mesh-list
65622394|NCT00871351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65622395|NCT00871351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65622396|NCT00871351|Antimetabolites|antimetabolites|mesh-ancestor
65622397|NCT00871351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622398|NCT00871351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65622399|NCT00871351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65622400|NCT00871351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622401|NCT04920331|Erenumab|erenumab|mesh-list
65622402|NCT04920331|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65622403|NCT04920331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622404|NCT04920331|Analgesics|analgesics|mesh-ancestor
65622405|NCT04920331|Sensory System Agents|sensory system agents|mesh-ancestor
65622406|NCT04920331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622407|NCT04920331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622408|NCT02745080|Adalimumab|adalimumab|mesh-list
65622409|NCT02745080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65622410|NCT02745080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65622411|NCT01346137|Meloxicam|meloxicam|mesh-list
65622412|NCT01346137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65622413|NCT01346137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65622414|NCT01346137|Analgesics|analgesics|mesh-ancestor
65622415|NCT01346137|Sensory System Agents|sensory system agents|mesh-ancestor
65622416|NCT01346137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622417|NCT01346137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622418|NCT01346137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65622419|NCT01346137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65622420|NCT01346137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65622421|NCT01346137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65622422|NCT01346137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622423|NCT01346137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622424|NCT00521599|Mometasone Furoate|mometasone furoate|mesh-list
65622425|NCT00521599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65622426|NCT00521599|Dermatologic Agents|dermatologic agents|mesh-ancestor
65622427|NCT00521599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65622428|NCT00442897|Atorvastatin|atorvastatin|mesh-list
65622429|NCT00442897|Simvastatin|simvastatin|mesh-list
65622430|NCT00442897|Ezetimibe|ezetimibe|mesh-list
65622431|NCT00442897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65622432|NCT00442897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65622433|NCT00442897|Antimetabolites|antimetabolites|mesh-ancestor
65622434|NCT00442897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622435|NCT00442897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65622436|NCT00442897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65622437|NCT00442897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622438|NCT01346215|Heparin|heparin|mesh-list
65622439|NCT01346215|Calcium heparin|calcium heparin|mesh-list
65622440|NCT01346215|Anticoagulants|anticoagulants|mesh-ancestor
65622441|NCT01346215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65622442|NCT01346215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65622443|NCT01346215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622444|NCT02834390|Cytarabine|cytarabine|mesh-list
65622445|NCT02834390|Daunorubicin|daunorubicin|mesh-list
65622446|NCT02834390|Idarubicin|idarubicin|mesh-list
65622447|NCT02834390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65622448|NCT02834390|Antimetabolites|antimetabolites|mesh-ancestor
65622449|NCT02834390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622450|NCT02834390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622451|NCT02834390|Antiviral Agents|antiviral agents|mesh-ancestor
65622452|NCT02834390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65622453|NCT02834390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65622454|NCT02834390|Immunologic Factors|immunologic factors|mesh-ancestor
65622455|NCT02834390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622456|NCT02834390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65622457|NCT02834390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65622458|NCT02834390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65622459|NCT02834390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622460|NCT01317433|Doxycycline|doxycycline|mesh-list
65622462|NCT01317433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65622463|NCT01317433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622464|NCT01317433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65622465|NCT01317433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65622466|NCT01317433|Antimalarials|antimalarials|mesh-ancestor
65622467|NCT01317433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65622468|NCT01317433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65622469|NCT01317511|Caseins|caseins|mesh-list
65622470|NCT01317511|Chelating Agents|chelating agents|mesh-ancestor
65622471|NCT01317511|Sequestering Agents|sequestering agents|mesh-ancestor
65622472|NCT01317511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622473|NCT01356602|Triamcinolone|triamcinolone|mesh-list
65622474|NCT01356602|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65622475|NCT01356602|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65622476|NCT01356602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65622477|NCT01356602|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65622478|NCT01356602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65622479|NCT01356602|Glucocorticoids|glucocorticoids|mesh-ancestor
65622480|NCT01356602|Hormones|hormones|mesh-ancestor
65622481|NCT01356602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65622482|NCT01356602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622483|NCT01356602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65622484|NCT01356602|Immunologic Factors|immunologic factors|mesh-ancestor
65622485|NCT01356602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622486|NCT01356602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622487|NCT01347853|Ketorolac|ketorolac|mesh-list
65622488|NCT01347853|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65622489|NCT01347853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65622490|NCT01347853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65622491|NCT01347853|Analgesics|analgesics|mesh-ancestor
65622492|NCT01347853|Sensory System Agents|sensory system agents|mesh-ancestor
65622493|NCT01347853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622494|NCT01347853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622495|NCT01347853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65622496|NCT01347853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65622497|NCT01347853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65622498|NCT01347853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622499|NCT01347853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622500|NCT01346917|Lidocaine|lidocaine|mesh-list
65622501|NCT01346917|Anesthetics, Local|anesthetics, local|mesh-ancestor
65622502|NCT01346917|Anesthetics|anesthetics|mesh-ancestor
65622503|NCT01346917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65622504|NCT01346917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622505|NCT01346917|Sensory System Agents|sensory system agents|mesh-ancestor
65622506|NCT01346917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622507|NCT01346917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65622508|NCT01346917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65622509|NCT01346917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65622510|NCT01346917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65622511|NCT01346917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622512|NCT01348009|Cisplatin|cisplatin|mesh-list
65622513|NCT01348009|Capecitabine|capecitabine|mesh-list
65622514|NCT01348009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622515|NCT01348009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65622516|NCT01348009|Antimetabolites|antimetabolites|mesh-ancestor
65622517|NCT01348009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622518|NCT01343173|Imatinib Mesylate|imatinib mesylate|mesh-list
65622519|NCT01343173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622520|NCT01343173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65622521|NCT01343173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622522|NCT01343173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622524|NCT01348243|Lidocaine|lidocaine|mesh-list
65622525|NCT01348243|Anesthetics, Local|anesthetics, local|mesh-ancestor
65622526|NCT01348243|Anesthetics|anesthetics|mesh-ancestor
65622527|NCT01348243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65622528|NCT01348243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622529|NCT01348243|Sensory System Agents|sensory system agents|mesh-ancestor
65622530|NCT01348243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622531|NCT01348243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65622532|NCT01348243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65622533|NCT01348243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65622534|NCT01348243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65622535|NCT01348243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622536|NCT01348243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65622537|NCT01348321|Levamisole|levamisole|mesh-list
65622538|NCT01348321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65622539|NCT01348321|Immunologic Factors|immunologic factors|mesh-ancestor
65622540|NCT01348321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622541|NCT01348321|Antinematodal Agents|antinematodal agents|mesh-ancestor
65622542|NCT01348321|Anthelmintics|anthelmintics|mesh-ancestor
65622543|NCT01348321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65622544|NCT01348321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65622545|NCT01348321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65622546|NCT03772951|Clozapine|clozapine|mesh-list
65622547|NCT03772951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65622548|NCT03772951|Serotonin Agents|serotonin agents|mesh-ancestor
65622549|NCT03772951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65622550|NCT03772951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622551|NCT03772951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622552|NCT03772951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65622553|NCT03772951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65622554|NCT03772951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65622555|NCT03772951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65622556|NCT03772951|GABA Antagonists|gaba antagonists|mesh-ancestor
65622557|NCT03772951|GABA Agents|gaba agents|mesh-ancestor
65622558|NCT01343329|Propranolol|propranolol|mesh-list
65622559|NCT01343329|Esmolol|esmolol|mesh-list
65622560|NCT01343329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65622561|NCT01343329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65622562|NCT01343329|Adrenergic Agents|adrenergic agents|mesh-ancestor
65622563|NCT01343329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65622564|NCT01343329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622565|NCT01343329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622566|NCT01343329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65622567|NCT01343329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65622568|NCT01343329|Vasodilator Agents|vasodilator agents|mesh-ancestor
65622569|NCT01343329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65622570|NCT01317589|Fentanyl|fentanyl|mesh-list
65622571|NCT01317589|Methadone|methadone|mesh-list
65622572|NCT01317589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65622573|NCT01317589|Narcotics|narcotics|mesh-ancestor
65622574|NCT01317589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65622575|NCT01317589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622576|NCT01317589|Analgesics|analgesics|mesh-ancestor
65622577|NCT01317589|Sensory System Agents|sensory system agents|mesh-ancestor
65622578|NCT01317589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622579|NCT01317589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65622580|NCT01317589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65622581|NCT01317589|Anesthetics, General|anesthetics, general|mesh-ancestor
65622582|NCT01317589|Anesthetics|anesthetics|mesh-ancestor
65622583|NCT01317589|Antitussive Agents|antitussive agents|mesh-ancestor
65622584|NCT01317589|Respiratory System Agents|respiratory system agents|mesh-ancestor
65622585|NCT02825420|Trabectedin|trabectedin|mesh-list
65622586|NCT02825420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65622587|NCT02825420|Alkylating Agents|alkylating agents|mesh-ancestor
65622588|NCT02825420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622589|NCT02825420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622590|NCT03715153|Bumetanide|bumetanide|mesh-list
65622591|NCT03715153|Diuretics|diuretics|mesh-ancestor
65622592|NCT03715153|Natriuretic Agents|natriuretic agents|mesh-ancestor
65622593|NCT03715153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622594|NCT03715153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65622595|NCT03715153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65622596|NCT03715153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622597|NCT02829944|Ketorolac|ketorolac|mesh-list
65622598|NCT02829944|Ropivacaine|ropivacaine|mesh-list
65622599|NCT02829944|Anesthetics, Local|anesthetics, local|mesh-ancestor
65622600|NCT02829944|Anesthetics|anesthetics|mesh-ancestor
65266748|NCT04177173|Simvastatin|simvastatin|mesh-list
65622601|NCT02829944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65622602|NCT02829944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622603|NCT02829944|Sensory System Agents|sensory system agents|mesh-ancestor
65622604|NCT02829944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622605|NCT02829944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65622606|NCT02829944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65622607|NCT02829944|Analgesics|analgesics|mesh-ancestor
65622608|NCT02829944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65622609|NCT02829944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65622610|NCT02829944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65622611|NCT02829944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622612|NCT02829944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622613|NCT04014530|Pembrolizumab|pembrolizumab|mesh-list
65622614|NCT04014530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65622615|NCT04014530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622616|NCT03563534|Fluorides|fluorides|mesh-list
65622617|NCT03563534|Cariostatic Agents|cariostatic agents|mesh-ancestor
65622618|NCT03563534|Protective Agents|protective agents|mesh-ancestor
65622619|NCT03563534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622620|NCT03563144|Leucovorin|leucovorin|mesh-list
65622621|NCT03563144|Gemcitabine|gemcitabine|mesh-list
65622622|NCT03563144|Paclitaxel|paclitaxel|mesh-list
65622623|NCT03563144|Cyclophosphamide|cyclophosphamide|mesh-list
65622624|NCT03563144|Bevacizumab|bevacizumab|mesh-list
65622625|NCT03563144|Fluorouracil|fluorouracil|mesh-list
65622626|NCT03563144|Capecitabine|capecitabine|mesh-list
65622627|NCT03563144|Oxaliplatin|oxaliplatin|mesh-list
65622628|NCT03563144|Avelumab|avelumab|mesh-list
65622629|NCT03563144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65622630|NCT03563144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622631|NCT03563144|Tubulin Modulators|tubulin modulators|mesh-ancestor
65622632|NCT03563144|Antimitotic Agents|antimitotic agents|mesh-ancestor
65622633|NCT03563144|Mitosis Modulators|mitosis modulators|mesh-ancestor
65622634|NCT03563144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622635|NCT03563144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65622636|NCT03563144|Immunologic Factors|immunologic factors|mesh-ancestor
65622637|NCT03563144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622638|NCT03563144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65622639|NCT03563144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65622640|NCT03563144|Alkylating Agents|alkylating agents|mesh-ancestor
65622641|NCT03563144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65622642|NCT03563144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65622643|NCT03563144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65622644|NCT03563144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65622645|NCT03563144|Growth Substances|growth substances|mesh-ancestor
65622646|NCT03563144|Growth Inhibitors|growth inhibitors|mesh-ancestor
65622647|NCT03563144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65622648|NCT03563144|Antimetabolites|antimetabolites|mesh-ancestor
65622649|NCT03563144|Antiviral Agents|antiviral agents|mesh-ancestor
65622650|NCT03563144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65622651|NCT03563144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622652|NCT03563144|Antidotes|antidotes|mesh-ancestor
65622653|NCT03563144|Protective Agents|protective agents|mesh-ancestor
65622654|NCT03563144|Vitamin B Complex|vitamin b complex|mesh-ancestor
65622655|NCT03563144|Vitamins|vitamins|mesh-ancestor
65622656|NCT03563144|Micronutrients|micronutrients|mesh-ancestor
65622657|NCT01338818|Methylphenidate|methylphenidate|mesh-list
65622658|NCT01338818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65622659|NCT01338818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622660|NCT01338818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65622661|NCT01338818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65622662|NCT01338818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65622663|NCT01338818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622664|NCT01338818|Dopamine Agents|dopamine agents|mesh-ancestor
65622665|NCT01338818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65622666|NCT05310110|Lidocaine|lidocaine|mesh-list
65622667|NCT05310110|Propofol|propofol|mesh-list
65622668|NCT05310110|Cisatracurium|cisatracurium|mesh-list
65622669|NCT05310110|Atracurium|atracurium|mesh-list
65622670|NCT05310110|Anesthetics, Local|anesthetics, local|mesh-ancestor
65622671|NCT05310110|Anesthetics|anesthetics|mesh-ancestor
65420066|NCT00488982|Docetaxel|docetaxel|mesh-list
65622672|NCT05310110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65622673|NCT05310110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622674|NCT05310110|Sensory System Agents|sensory system agents|mesh-ancestor
65622675|NCT05310110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622676|NCT05310110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65622677|NCT05310110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65622678|NCT05310110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65622679|NCT05310110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65622680|NCT05310110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622681|NCT05310110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65622682|NCT05310110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65622683|NCT05310110|Anesthetics, General|anesthetics, general|mesh-ancestor
65622684|NCT05310110|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65622685|NCT05310110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65622686|NCT05310110|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65622687|NCT05310110|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65622688|NCT05310110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65622689|NCT05310110|Cholinergic Agents|cholinergic agents|mesh-ancestor
65622690|NCT05310110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65622692|NCT02823470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65622693|NCT02823470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65622694|NCT02823470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622695|NCT05294588|Ciprofloxacin|ciprofloxacin|mesh-list
65622696|NCT05294588|Ceftriaxone|ceftriaxone|mesh-list
65622697|NCT05294588|Cefixime|cefixime|mesh-list
65622698|NCT05294588|Vaccines|vaccines|mesh-list
65622699|NCT05294588|Immunologic Factors|immunologic factors|mesh-ancestor
65622700|NCT05294588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622701|NCT05294588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65622702|NCT05294588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65622703|NCT05294588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65622704|NCT05294588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65622705|NCT05294588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622706|NCT05294588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622707|NCT05294588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622708|NCT05294588|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65622709|NCT05294588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65622710|NCT04697576|Pembrolizumab|pembrolizumab|mesh-list
65622711|NCT04697576|Nivolumab|nivolumab|mesh-list
65622712|NCT04697576|Ipilimumab|ipilimumab|mesh-list
65622713|NCT04697576|Vaccines|vaccines|mesh-list
65622714|NCT04697576|Immunologic Factors|immunologic factors|mesh-ancestor
65622715|NCT04697576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622716|NCT04697576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65622717|NCT04697576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622718|NCT04697576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65622719|NCT04697576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622720|NCT03562754|Heparin|heparin|mesh-list
65622721|NCT03562754|Anticoagulants|anticoagulants|mesh-ancestor
65622722|NCT03562754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622723|NCT03562754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65622724|NCT03562754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65622725|NCT02259920|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
65622726|NCT02259920|Mydriatics|mydriatics|mesh-ancestor
65622727|NCT02259920|Autonomic Agents|autonomic agents|mesh-ancestor
65622728|NCT02259920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622729|NCT02259920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622730|NCT02259920|Sympathomimetics|sympathomimetics|mesh-ancestor
65622731|NCT01371656|Levofloxacin|levofloxacin|mesh-list
65622732|NCT01371656|Ofloxacin|ofloxacin|mesh-list
65622733|NCT01371656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65622734|NCT01371656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65622735|NCT01371656|Renal Agents|renal agents|mesh-ancestor
65622736|NCT01371656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65622737|NCT01371656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65622738|NCT01371656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65622739|NCT01371656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622740|NCT01371656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622741|NCT01371656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622742|NCT01371656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65622743|NCT01371656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65622744|NCT04541888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65622745|NCT04541888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65622746|NCT01354964|Vitamin D|vitamin d|mesh-list
65622747|NCT01354964|Ergocalciferols|ergocalciferols|mesh-list
65622748|NCT01354964|Cholecalciferol|cholecalciferol|mesh-list
65622749|NCT01354964|Vitamins|vitamins|mesh-list
65622750|NCT01354964|Micronutrients|micronutrients|mesh-ancestor
65622751|NCT01354964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622752|NCT01354964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65622753|NCT01354964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65622754|NCT02259998|Dipyridamole|dipyridamole|mesh-list
65622755|NCT02259998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65622756|NCT02259998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622757|NCT02259998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622758|NCT02259998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65622759|NCT02259998|Vasodilator Agents|vasodilator agents|mesh-ancestor
65622760|NCT02035904|Morphine|morphine|mesh-list
65622761|NCT02035904|Levobupivacaine|levobupivacaine|mesh-list
65622762|NCT02035904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65622763|NCT02035904|Narcotics|narcotics|mesh-ancestor
65622764|NCT02035904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65622765|NCT02035904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622766|NCT02035904|Analgesics|analgesics|mesh-ancestor
65622767|NCT02035904|Sensory System Agents|sensory system agents|mesh-ancestor
65622768|NCT02035904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622769|NCT02035904|Anesthetics, Local|anesthetics, local|mesh-ancestor
65622770|NCT02035904|Anesthetics|anesthetics|mesh-ancestor
65622771|NCT04110080|Anesthetics|anesthetics|mesh-list
65622772|NCT04110080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65622773|NCT04110080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622774|NCT02035982|Rivastigmine|rivastigmine|mesh-list
65622775|NCT02035982|Donepezil|donepezil|mesh-list
65622776|NCT02035982|Galantamine|galantamine|mesh-list
65622777|NCT02035982|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
65622778|NCT02035982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622779|NCT02035982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622780|NCT02035982|Cholinergic Agents|cholinergic agents|mesh-ancestor
65622781|NCT02035982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65622782|NCT02035982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622783|NCT02035982|Nootropic Agents|nootropic agents|mesh-ancestor
65622784|NCT02035982|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65622785|NCT02035982|Autonomic Agents|autonomic agents|mesh-ancestor
65622786|NCT02035982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622787|NCT02035982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65622788|NCT02035982|Protective Agents|protective agents|mesh-ancestor
65622789|NCT05707832|Amphotericin B|amphotericin b|mesh-list
65622790|NCT05707832|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65622791|NCT05707832|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
65622792|NCT05707832|Amebicides|amebicides|mesh-ancestor
65622793|NCT05707832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65622794|NCT05707832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65622795|NCT05707832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65622796|NCT05707832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65622797|NCT05707832|Antifungal Agents|antifungal agents|mesh-ancestor
65622798|NCT05707832|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65622799|NCT05707832|Protease Inhibitors|protease inhibitors|mesh-ancestor
65622800|NCT05707832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622801|NCT05707832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622802|NCT05707832|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65622803|NCT05707832|Protective Agents|protective agents|mesh-ancestor
65622804|NCT05707832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622805|NCT05707832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622806|NCT02822222|Magnesium citrate|magnesium citrate|mesh-list
65622807|NCT02822222|Cathartics|cathartics|mesh-ancestor
65622808|NCT02822222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65622809|NCT05707754|Bupivacaine|bupivacaine|mesh-list
65622810|NCT05707754|Anesthetics, Local|anesthetics, local|mesh-ancestor
65622811|NCT05707754|Anesthetics|anesthetics|mesh-ancestor
65622812|NCT05707754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65622813|NCT05707754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622814|NCT05707754|Sensory System Agents|sensory system agents|mesh-ancestor
65622815|NCT05707754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622816|NCT02821910|Metformin|metformin|mesh-list
65622817|NCT02821910|Empagliflozin|empagliflozin|mesh-list
65622818|NCT02821910|Linagliptin|linagliptin|mesh-list
65622819|NCT02821910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65622820|NCT02821910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622821|NCT02821910|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65622822|NCT02821910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622823|NCT02821910|Incretins|incretins|mesh-ancestor
65622824|NCT02821910|Hormones|hormones|mesh-ancestor
65622825|NCT02821910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65622826|NCT02821910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65622827|NCT02821910|Protease Inhibitors|protease inhibitors|mesh-ancestor
65622828|NCT02821910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622829|NCT03819452|Vitamin D|vitamin d|mesh-list
65622830|NCT03819452|Vitamins|vitamins|mesh-ancestor
65622831|NCT03819452|Micronutrients|micronutrients|mesh-ancestor
65622832|NCT03819452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622833|NCT03819452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65622834|NCT03138655|Vedolizumab|vedolizumab|mesh-list
65622835|NCT03138655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65622836|NCT05707520|Mycophenolic Acid|mycophenolic acid|mesh-list
65622837|NCT05707520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65622838|NCT05707520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622839|NCT05707520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65622840|NCT05707520|Antitubercular Agents|antitubercular agents|mesh-ancestor
65622841|NCT05707520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65622842|NCT05707520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65622843|NCT05707520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622844|NCT05707520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622845|NCT04412785|Cyclosporine|cyclosporine|mesh-list
65622846|NCT04412785|Cyclosporins|cyclosporins|mesh-list
65622847|NCT04412785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622848|NCT04412785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622849|NCT04412785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65622850|NCT04412785|Immunologic Factors|immunologic factors|mesh-ancestor
65622851|NCT04412785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622852|NCT04412785|Antifungal Agents|antifungal agents|mesh-ancestor
65622853|NCT04412785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65622854|NCT04412785|Dermatologic Agents|dermatologic agents|mesh-ancestor
65622855|NCT04412785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65622856|NCT04412785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65622857|NCT01352611|Baclofen|baclofen|mesh-list
65622858|NCT01352611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65622859|NCT01352611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622860|NCT01352611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65622861|NCT01352611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622862|NCT01352611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65622863|NCT01352611|GABA Agonists|gaba agonists|mesh-ancestor
65622864|NCT01352611|GABA Agents|gaba agents|mesh-ancestor
65622865|NCT01352611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65622866|NCT01352611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622867|NCT02819804|Nivolumab|nivolumab|mesh-list
65622868|NCT02819804|Dasatinib|dasatinib|mesh-list
65622869|NCT02819804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65622870|NCT02819804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622871|NCT02819804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65622872|NCT02819804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622873|NCT02819804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65622874|NCT02819804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622875|NCT02819726|Rituximab|rituximab|mesh-list
65622876|NCT02819726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65622877|NCT02819726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622878|NCT02819726|Immunologic Factors|immunologic factors|mesh-ancestor
65622879|NCT02819726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622880|NCT02819726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65622881|NCT02816138|Nicotine|nicotine|mesh-list
65622882|NCT02816138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65622883|NCT02816138|Autonomic Agents|autonomic agents|mesh-ancestor
65622884|NCT02816138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622885|NCT02816138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622886|NCT02816138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65622887|NCT02816138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65622888|NCT02816138|Cholinergic Agents|cholinergic agents|mesh-ancestor
65622889|NCT02816138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65622890|NCT02816138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622891|NCT02036060|Prednisone|prednisone|mesh-list
65622892|NCT02036060|Docetaxel|docetaxel|mesh-list
65622893|NCT02036060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622894|NCT02036060|Tubulin Modulators|tubulin modulators|mesh-ancestor
65622895|NCT02036060|Antimitotic Agents|antimitotic agents|mesh-ancestor
65622896|NCT02036060|Mitosis Modulators|mitosis modulators|mesh-ancestor
65622897|NCT02036060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420291|NCT00474786|Sirolimus|sirolimus|mesh-list
65622898|NCT02036060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65622899|NCT02036060|Glucocorticoids|glucocorticoids|mesh-ancestor
65622901|NCT02036060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65622902|NCT02036060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622903|NCT02036060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65622904|NCT02036372|Insulin|insulin|mesh-list
65622905|NCT02036372|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65622906|NCT02036372|Liraglutide|liraglutide|mesh-list
65622907|NCT02036372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65622908|NCT02036372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622909|NCT02036372|Incretins|incretins|mesh-ancestor
65622910|NCT02036372|Hormones|hormones|mesh-ancestor
65622911|NCT02036372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65622912|NCT02036528|Doxycycline|doxycycline|mesh-list
65622913|NCT02036528|Ciprofloxacin|ciprofloxacin|mesh-list
65622914|NCT02036528|Gentamicins|gentamicins|mesh-list
65622915|NCT02036528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65622916|NCT02036528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65622917|NCT02036528|Antimalarials|antimalarials|mesh-ancestor
65622918|NCT02036528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65622919|NCT02036528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65622920|NCT02036528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65622921|NCT02036528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65622922|NCT02036528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65622923|NCT02036528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622924|NCT02036528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622925|NCT02036528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65622926|NCT02036528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65622927|NCT02036528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65622928|NCT02880865|Vaccines|vaccines|mesh-list
65622929|NCT02880865|Immunologic Factors|immunologic factors|mesh-ancestor
65622930|NCT02880865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622931|NCT03635125|Metoprolol|metoprolol|mesh-list
65622932|NCT03635125|Nebivolol|nebivolol|mesh-list
65622933|NCT03635125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65622934|NCT03635125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65622935|NCT03635125|Sympatholytics|sympatholytics|mesh-ancestor
65622936|NCT03635125|Autonomic Agents|autonomic agents|mesh-ancestor
65622937|NCT03635125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622938|NCT03635125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622939|NCT03635125|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65622940|NCT03635125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65622941|NCT03635125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65622942|NCT03635125|Adrenergic Agents|adrenergic agents|mesh-ancestor
65622943|NCT03635125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65622944|NCT03635125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622945|NCT03635125|Vasodilator Agents|vasodilator agents|mesh-ancestor
65622946|NCT03635125|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65622947|NCT03635125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65622948|NCT03635125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65622949|NCT01854385|Sumatriptan|sumatriptan|mesh-list
65622950|NCT01854385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65622951|NCT01854385|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65622952|NCT01854385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65622953|NCT01854385|Serotonin Agents|serotonin agents|mesh-ancestor
65622954|NCT01854385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65622955|NCT01854385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622956|NCT01854385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622957|NCT02047838|Hormones|hormones|mesh-list
65622958|NCT02047838|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65622959|NCT02047838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65622960|NCT02047838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622961|NCT01318681|Fluticasone|fluticasone|mesh-list
65622962|NCT01318681|Xhance|xhance|mesh-list
65622963|NCT01318681|Cetirizine|cetirizine|mesh-list
65622964|NCT01318681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65622965|NCT01318681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65622966|NCT01318681|Autonomic Agents|autonomic agents|mesh-ancestor
65622967|NCT01318681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622968|NCT01318681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622969|NCT01318681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65622970|NCT01318681|Respiratory System Agents|respiratory system agents|mesh-ancestor
65622971|NCT01318681|Dermatologic Agents|dermatologic agents|mesh-ancestor
65622972|NCT01318681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65420372|NCT00403455|Paroxetine|paroxetine|mesh-list
65622973|NCT01318681|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65622974|NCT01318681|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65622975|NCT01318681|Histamine Antagonists|histamine antagonists|mesh-ancestor
65622976|NCT01318681|Histamine Agents|histamine agents|mesh-ancestor
65622977|NCT01318681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65622978|NCT01318681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65622979|NCT03604159|Buprenorphine|buprenorphine|mesh-list
65622980|NCT03604159|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65622981|NCT03604159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65622982|NCT03604159|Narcotics|narcotics|mesh-ancestor
65622983|NCT03604159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65622984|NCT03604159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622985|NCT03604159|Analgesics|analgesics|mesh-ancestor
65622986|NCT03604159|Sensory System Agents|sensory system agents|mesh-ancestor
65622987|NCT03604159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65622988|NCT03604159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65622989|NCT03686930|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65622990|NCT01353235|Prednisolone|prednisolone|mesh-list
65622991|NCT01353235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65622992|NCT01353235|Glucocorticoids|glucocorticoids|mesh-ancestor
65622994|NCT01353235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65622995|NCT01353235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65622996|NCT01353235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65622997|NCT01353235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65622998|NCT02048228|Clopidogrel|clopidogrel|mesh-list
65622999|NCT02048228|Ticagrelor|ticagrelor|mesh-list
65623000|NCT02048228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65623001|NCT02048228|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65623002|NCT02048228|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65623003|NCT02048228|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65623004|NCT02048228|Purinergic Agents|purinergic agents|mesh-ancestor
65623005|NCT02048228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65623006|NCT02048228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623007|NCT02048228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623008|NCT03046927|Vitamin D|vitamin d|mesh-list
65623009|NCT03046927|Ergocalciferols|ergocalciferols|mesh-list
65623010|NCT03046927|Vitamins|vitamins|mesh-ancestor
65623011|NCT03046927|Micronutrients|micronutrients|mesh-ancestor
65623012|NCT03046927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623013|NCT03046927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65623014|NCT03046927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65623015|NCT01349257|Formoterol Fumarate|formoterol fumarate|mesh-list
65623016|NCT01349257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65623017|NCT01349257|Autonomic Agents|autonomic agents|mesh-ancestor
65623018|NCT01349257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65623019|NCT01349257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623020|NCT01349257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65623021|NCT01349257|Respiratory System Agents|respiratory system agents|mesh-ancestor
65623022|NCT01349257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65623023|NCT01349257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65623024|NCT01349257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65623025|NCT01349257|Adrenergic Agents|adrenergic agents|mesh-ancestor
65623026|NCT01349257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65623027|NCT01349257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623028|NCT03589105|Ocrelizumab|ocrelizumab|mesh-list
65623029|NCT03589105|Immunologic Factors|immunologic factors|mesh-ancestor
65623030|NCT03589105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623031|NCT02048384|Metformin|metformin|mesh-list
65623032|NCT02048384|Sirolimus|sirolimus|mesh-list
65623033|NCT02048384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65623034|NCT02048384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623035|NCT02048384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65623036|NCT02048384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65623037|NCT02048384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65623038|NCT02048384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623039|NCT02048384|Antifungal Agents|antifungal agents|mesh-ancestor
65623040|NCT02048384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65623041|NCT02048384|Immunologic Factors|immunologic factors|mesh-ancestor
65623042|NCT01353391|Metformin|metformin|mesh-list
65623043|NCT01353391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65623044|NCT01353391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623045|NCT01349335|Tolvaptan|tolvaptan|mesh-list
65623046|NCT01349335|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65623047|NCT01349335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623048|NCT01349335|Natriuretic Agents|natriuretic agents|mesh-ancestor
65623049|NCT01349335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623050|NCT03009487|Amlodipine|amlodipine|mesh-list
65623051|NCT03009487|Olmesartan|olmesartan|mesh-list
65623052|NCT03009487|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65623053|NCT03009487|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
65623054|NCT03009487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65623055|NCT03009487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65623056|NCT03009487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65623057|NCT03009487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65623058|NCT03009487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623059|NCT03009487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65623060|NCT03009487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623061|NCT03009487|Vasodilator Agents|vasodilator agents|mesh-ancestor
65623062|NCT03009487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65623063|NCT03009487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65623064|NCT03009487|Antimetabolites|antimetabolites|mesh-ancestor
65623065|NCT03009487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65623066|NCT03009487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65623067|NCT03009487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623068|NCT03009487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65623069|NCT03009487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65623070|NCT02048540|Bevacizumab|bevacizumab|mesh-list
65623071|NCT02048540|Docetaxel|docetaxel|mesh-list
65623072|NCT02048540|Oxaliplatin|oxaliplatin|mesh-list
65623073|NCT02048540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65623074|NCT02048540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623075|NCT02048540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65623076|NCT02048540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65623077|NCT02048540|Growth Substances|growth substances|mesh-ancestor
65623078|NCT02048540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623079|NCT02048540|Growth Inhibitors|growth inhibitors|mesh-ancestor
65623080|NCT02048540|Tubulin Modulators|tubulin modulators|mesh-ancestor
65623081|NCT02048540|Antimitotic Agents|antimitotic agents|mesh-ancestor
65623082|NCT02048540|Mitosis Modulators|mitosis modulators|mesh-ancestor
65623083|NCT02048540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623084|NCT01353469|Insulin|insulin|mesh-list
65623085|NCT01353469|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65623086|NCT01353469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65623087|NCT01353469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623088|NCT03562130|Teduglutide|teduglutide|mesh-list
65623089|NCT03562130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65623090|NCT03562130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65623091|NCT03562130|Protective Agents|protective agents|mesh-ancestor
65623092|NCT03562130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623093|NCT02050178|Gemcitabine|gemcitabine|mesh-list
65623094|NCT02050178|Paclitaxel|paclitaxel|mesh-list
65623095|NCT02050178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65623096|NCT02050178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623097|NCT02050178|Tubulin Modulators|tubulin modulators|mesh-ancestor
65623098|NCT02050178|Antimitotic Agents|antimitotic agents|mesh-ancestor
65623099|NCT02050178|Mitosis Modulators|mitosis modulators|mesh-ancestor
65623100|NCT02050178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623101|NCT02050178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65623102|NCT02050178|Antimetabolites|antimetabolites|mesh-ancestor
65623103|NCT02050178|Antiviral Agents|antiviral agents|mesh-ancestor
65623104|NCT02050178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65623105|NCT02050178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623106|NCT02050178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65623107|NCT02050178|Immunologic Factors|immunologic factors|mesh-ancestor
65623108|NCT02050178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623109|NCT02048852|Menthol|menthol|mesh-list
65623110|NCT02048852|Nicotine|nicotine|mesh-list
65623111|NCT02048852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65623112|NCT02048852|Autonomic Agents|autonomic agents|mesh-ancestor
65623113|NCT02048852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65623114|NCT02048852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623115|NCT02048852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65623116|NCT02048852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65623117|NCT02048852|Cholinergic Agents|cholinergic agents|mesh-ancestor
65623118|NCT02048852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65623119|NCT02048852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623120|NCT02048852|Antipruritics|antipruritics|mesh-ancestor
65420518|NCT01020708|Mesalamine|mesalamine|mesh-list
65623121|NCT02048852|Dermatologic Agents|dermatologic agents|mesh-ancestor
65623122|NCT02048930|Budesonide|budesonide|mesh-list
65623123|NCT02048930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65623124|NCT02048930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65623125|NCT02048930|Autonomic Agents|autonomic agents|mesh-ancestor
65623126|NCT02048930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65623127|NCT02048930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623128|NCT02048930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65623129|NCT02048930|Respiratory System Agents|respiratory system agents|mesh-ancestor
65623130|NCT02048930|Glucocorticoids|glucocorticoids|mesh-ancestor
65623131|NCT02048930|Hormones|hormones|mesh-ancestor
65623132|NCT02048930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65623133|NCT02049320|Remifentanil|remifentanil|mesh-list
65623134|NCT02049320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65623135|NCT02049320|Narcotics|narcotics|mesh-ancestor
65623136|NCT02049320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65623137|NCT02049320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623138|NCT02049320|Analgesics|analgesics|mesh-ancestor
65623139|NCT02049320|Sensory System Agents|sensory system agents|mesh-ancestor
65623140|NCT02049320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65623141|NCT02050724|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
65623142|NCT02050724|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65623143|NCT02050724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623144|NCT02050802|Moxifloxacin|moxifloxacin|mesh-list
65623145|NCT02050802|Macitentan|macitentan|mesh-list
65623146|NCT02050802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65623147|NCT02050802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65623148|NCT02050802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65623149|NCT02050802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65623150|NCT02050802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623151|NCT02050802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623152|NCT02050802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623153|NCT02050802|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65623154|NCT02050802|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65623155|NCT02050802|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65623156|NCT02051738|Mebendazole|mebendazole|mesh-list
65623157|NCT02051738|Piperazine|piperazine|mesh-list
65623158|NCT02051738|Piperazine citrate|piperazine citrate|mesh-list
65623159|NCT02051738|DMP 777|dmp 777|mesh-list
65623160|NCT02051738|Antinematodal Agents|antinematodal agents|mesh-ancestor
65623161|NCT02051738|Anthelmintics|anthelmintics|mesh-ancestor
65623162|NCT02051738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65623163|NCT02051738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65623164|NCT02051738|Tubulin Modulators|tubulin modulators|mesh-ancestor
65623165|NCT02051738|Antimitotic Agents|antimitotic agents|mesh-ancestor
65623166|NCT02051738|Mitosis Modulators|mitosis modulators|mesh-ancestor
65623167|NCT02051738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623168|NCT02051738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623169|NCT02051738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623170|NCT02050958|Ibuprofen|ibuprofen|mesh-list
65623171|NCT02050958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65623172|NCT02050958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65623173|NCT02050958|Analgesics|analgesics|mesh-ancestor
65623174|NCT02050958|Sensory System Agents|sensory system agents|mesh-ancestor
65266790|NCT00917267|Exenatide|exenatide|mesh-list
65623175|NCT02050958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65623176|NCT02050958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623177|NCT02050958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65623178|NCT02050958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65623179|NCT02050958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65623180|NCT02050958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623181|NCT02050958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623182|NCT02037464|Capsaicin|capsaicin|mesh-list
65623183|NCT02037464|Antipruritics|antipruritics|mesh-ancestor
65623184|NCT02037464|Dermatologic Agents|dermatologic agents|mesh-ancestor
65623185|NCT02037464|Sensory System Agents|sensory system agents|mesh-ancestor
65623186|NCT02037464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65623187|NCT02037464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623188|NCT01357603|Insulin Glargine|insulin glargine|mesh-list
65623189|NCT01357603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65623190|NCT01357603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623191|NCT02051894|Dobutamine|dobutamine|mesh-list
65623192|NCT02051894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65623193|NCT02051894|Sympathomimetics|sympathomimetics|mesh-ancestor
65420597|NCT00496470|Budesonide|budesonide|mesh-list
65623194|NCT02051894|Autonomic Agents|autonomic agents|mesh-ancestor
65623195|NCT02051894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65623196|NCT02051894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623197|NCT02051894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65623198|NCT02051894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65623199|NCT02051894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65623200|NCT02051894|Adrenergic Agents|adrenergic agents|mesh-ancestor
65623201|NCT02051894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65623202|NCT02051894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623203|NCT02051894|Protective Agents|protective agents|mesh-ancestor
65623204|NCT01357681|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65623205|NCT01357681|Antioxidants|antioxidants|mesh-ancestor
65623206|NCT01357681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623207|NCT01357681|Protective Agents|protective agents|mesh-ancestor
65623208|NCT01357681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623209|NCT01357681|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65623210|NCT01357681|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65623211|NCT01357681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623212|NCT01357681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65623213|NCT01543633|Propofol|propofol|mesh-list
65623214|NCT01543633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65623215|NCT01543633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65623216|NCT01543633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623217|NCT01543633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65623218|NCT01543633|Anesthetics, General|anesthetics, general|mesh-ancestor
65623219|NCT01543633|Anesthetics|anesthetics|mesh-ancestor
65623220|NCT03561740|Capecitabine|capecitabine|mesh-list
65623221|NCT03561740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65623222|NCT03561740|Antimetabolites|antimetabolites|mesh-ancestor
65623223|NCT03561740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623224|NCT03561740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623225|NCT01357759|Gimsilumab|gimsilumab|mesh-list
65623226|NCT01357759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65623227|NCT01357759|Antiviral Agents|antiviral agents|mesh-ancestor
65623228|NCT01357759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65623229|NCT02052128|Onapristone|onapristone|mesh-list
65623230|NCT02052128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623231|NCT02052128|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65623232|NCT02052128|Fertility Agents|fertility agents|mesh-ancestor
65623233|NCT02052128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65623234|NCT02052128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623235|NCT02052128|Hormone Antagonists|hormone antagonists|mesh-ancestor
65623236|NCT02052128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65623237|NCT01349413|Esomeprazole|esomeprazole|mesh-list
65623238|NCT01349413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65623239|NCT01349413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65623240|NCT01349413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65623241|NCT01349413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623242|NCT01349413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623243|NCT01349647|Vaccines|vaccines|mesh-list
65623244|NCT01349647|Immunologic Factors|immunologic factors|mesh-ancestor
65623245|NCT01349647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623246|NCT02806232|Praziquantel|praziquantel|mesh-list
65623247|NCT02806232|Anthelmintics|anthelmintics|mesh-ancestor
65623248|NCT02806232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65623249|NCT02806232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65623250|NCT02908087|Liraglutide|liraglutide|mesh-list
65623251|NCT02908087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65623252|NCT02908087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623253|NCT02908087|Incretins|incretins|mesh-ancestor
65623254|NCT02908087|Hormones|hormones|mesh-ancestor
65623255|NCT02908087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65623256|NCT02053766|Dexmedetomidine|dexmedetomidine|mesh-list
65623257|NCT02053766|Propofol|propofol|mesh-list
65623258|NCT02053766|Sevoflurane|sevoflurane|mesh-list
65623259|NCT02053766|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65623260|NCT02053766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65623261|NCT02053766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623262|NCT02053766|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65623263|NCT02053766|Anesthetics, General|anesthetics, general|mesh-ancestor
65623264|NCT02053766|Anesthetics|anesthetics|mesh-ancestor
65623265|NCT02053766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65623266|NCT02053766|Analgesics|analgesics|mesh-ancestor
65623267|NCT02053766|Sensory System Agents|sensory system agents|mesh-ancestor
65623268|NCT02053766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65623269|NCT02053766|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65623270|NCT02053766|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65623271|NCT02053766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65623272|NCT02053766|Adrenergic Agents|adrenergic agents|mesh-ancestor
65623273|NCT02053766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65623274|NCT02053766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623275|NCT02053766|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65623276|NCT02053766|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65623277|NCT02053922|Misoprostol|misoprostol|mesh-list
65623278|NCT02053922|Oxytocin|oxytocin|mesh-list
65623279|NCT02053922|Carbetocin|carbetocin|mesh-list
65623280|NCT02053922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65623281|NCT02053922|Abortifacient Agents|abortifacient agents|mesh-ancestor
65623282|NCT02053922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65623283|NCT02053922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623284|NCT02053922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65623285|NCT02053922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65623286|NCT02053922|Oxytocics|oxytocics|mesh-ancestor
65623287|NCT02054000|Tirofiban|tirofiban|mesh-list
65623288|NCT02054000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65623289|NCT02054000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65623290|NCT02054000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623291|NCT02054000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65623292|NCT02054078|Bevacizumab|bevacizumab|mesh-list
65623293|NCT02054078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65623294|NCT02054078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623295|NCT02054078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65623296|NCT02054078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65623297|NCT02054078|Growth Substances|growth substances|mesh-ancestor
65623298|NCT02054078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623299|NCT02054078|Growth Inhibitors|growth inhibitors|mesh-ancestor
65623300|NCT00392327|Vitamin A|vitamin a|mesh-list
65623301|NCT00392327|Cyclophosphamide|cyclophosphamide|mesh-list
65623302|NCT00392327|Cisplatin|cisplatin|mesh-list
65623303|NCT00392327|Carboplatin|carboplatin|mesh-list
65623304|NCT00392327|Vincristine|vincristine|mesh-list
65623305|NCT00392327|Tretinoin|tretinoin|mesh-list
65623306|NCT00392327|Isotretinoin|isotretinoin|mesh-list
65623307|NCT00392327|Lenograstim|lenograstim|mesh-list
65623308|NCT00392327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65623309|NCT00392327|Immunologic Factors|immunologic factors|mesh-ancestor
65623310|NCT00392327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623311|NCT00392327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65623312|NCT00392327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65623313|NCT00392327|Alkylating Agents|alkylating agents|mesh-ancestor
65623314|NCT00392327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623315|NCT00392327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623316|NCT00392327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65623317|NCT00392327|Vitamins|vitamins|mesh-ancestor
65623318|NCT00392327|Micronutrients|micronutrients|mesh-ancestor
65623319|NCT00392327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65623320|NCT00392327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65623321|NCT00392327|Tubulin Modulators|tubulin modulators|mesh-ancestor
65623322|NCT00392327|Antimitotic Agents|antimitotic agents|mesh-ancestor
65623323|NCT00392327|Mitosis Modulators|mitosis modulators|mesh-ancestor
65623324|NCT00392327|Keratolytic Agents|keratolytic agents|mesh-ancestor
65623325|NCT00392327|Dermatologic Agents|dermatologic agents|mesh-ancestor
65623326|NCT01336439|Botulinum Toxins|botulinum toxins|mesh-list
65623327|NCT01336439|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65623328|NCT01336439|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65623329|NCT01336439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65623330|NCT01336439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65623331|NCT01336439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623332|NCT01336439|Cholinergic Agents|cholinergic agents|mesh-ancestor
65623333|NCT01336439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65623334|NCT01336439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623335|NCT01336439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65623336|NCT01336439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65623337|NCT01336595|Cobalt|cobalt|mesh-list
65623338|NCT01336595|Triamcinolone|triamcinolone|mesh-list
65623339|NCT01336595|Trace Elements|trace elements|mesh-ancestor
65623340|NCT01336595|Micronutrients|micronutrients|mesh-ancestor
65623341|NCT01336595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623342|NCT01336595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65623343|NCT01336595|Glucocorticoids|glucocorticoids|mesh-ancestor
65623344|NCT01336595|Hormones|hormones|mesh-ancestor
65623345|NCT01336595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65623346|NCT01336751|Insulin|insulin|mesh-list
65623347|NCT01336751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65623348|NCT01336751|Insulin Glargine|insulin glargine|mesh-list
65623349|NCT01336751|Insulin Lispro|insulin lispro|mesh-list
65623350|NCT01336751|Protamines|protamines|mesh-list
65623351|NCT01336751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65623352|NCT01336751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623353|NCT01336751|Heparin Antagonists|heparin antagonists|mesh-ancestor
65623354|NCT01336751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623355|NCT01336751|Coagulants|coagulants|mesh-ancestor
65623356|NCT01336829|Rilpivirine|rilpivirine|mesh-list
65623357|NCT01336829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65623358|NCT01336829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65623359|NCT01336829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623360|NCT01336829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623361|NCT01336829|Antiviral Agents|antiviral agents|mesh-ancestor
65623362|NCT01336829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65623363|NCT01336829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65623364|NCT01336829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65623365|NCT02960490|Quetmolimab|quetmolimab|mesh-list
65623366|NCT02960490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65623367|NCT05184179|Olmesartan|olmesartan|mesh-list
65623368|NCT05184179|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65623369|NCT05184179|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65623370|NCT05184179|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65623371|NCT05184179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65623372|NCT05184179|Antimetabolites|antimetabolites|mesh-ancestor
65623373|NCT05184179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623374|NCT05184179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65623375|NCT05184179|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65623376|NCT05184179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623377|NCT05184179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65623378|NCT05184179|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65623379|NCT05184179|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65623380|NCT05163834|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65623381|NCT05163834|Immunologic Factors|immunologic factors|mesh-ancestor
65623382|NCT05163834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623383|NCT01065012|Udenafil|udenafil|mesh-list
65623384|NCT01065012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65623385|NCT01065012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65623386|NCT01065012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623387|NCT01065012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623388|NCT01315691|Amikacin|amikacin|mesh-list
65623389|NCT01315691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65623390|NCT01315691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65623391|NCT05654090|Sulbactam|sulbactam|mesh-list
65623392|NCT05654090|Cefoperazone|cefoperazone|mesh-list
65623393|NCT05654090|Sulperazone|sulperazone|mesh-list
65623394|NCT05654090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65623395|NCT05654090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65623396|NCT05654090|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65623397|NCT05654090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623398|NCT05654090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623399|NCT05654090|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65623400|NCT05654090|Renal Agents|renal agents|mesh-ancestor
65623401|NCT02054468|Remifentanil|remifentanil|mesh-list
65623402|NCT02054468|Propofol|propofol|mesh-list
65623403|NCT02054468|Rocuronium|rocuronium|mesh-list
65623404|NCT02054468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65623405|NCT02054468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65623406|NCT02054468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623407|NCT02054468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65623408|NCT02054468|Anesthetics, General|anesthetics, general|mesh-ancestor
65623409|NCT02054468|Anesthetics|anesthetics|mesh-ancestor
65623410|NCT02054468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65623411|NCT02054468|Narcotics|narcotics|mesh-ancestor
65623412|NCT02054468|Analgesics|analgesics|mesh-ancestor
65623413|NCT02054468|Sensory System Agents|sensory system agents|mesh-ancestor
65623414|NCT02054468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65623415|NCT02054468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65623416|NCT02054468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65623417|NCT02054468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65623418|NCT03640650|Triamcinolone|triamcinolone|mesh-list
65623419|NCT03640650|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65623420|NCT03640650|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65623421|NCT03640650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65623422|NCT03640650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65623423|NCT03640650|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65623424|NCT03640650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65623425|NCT03640650|Glucocorticoids|glucocorticoids|mesh-ancestor
65623427|NCT03640650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65623428|NCT03640650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623429|NCT03640650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65623430|NCT03640650|Immunologic Factors|immunologic factors|mesh-ancestor
65623431|NCT03640650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623432|NCT03640650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623433|NCT05183555|Edotreotide|edotreotide|mesh-list
65623434|NCT05183555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65623435|NCT05183555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623436|NCT02052908|Naproxen|naproxen|mesh-list
65623437|NCT02052908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65623438|NCT02052908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65623439|NCT02052908|Analgesics|analgesics|mesh-ancestor
65623440|NCT02052908|Sensory System Agents|sensory system agents|mesh-ancestor
65623441|NCT02052908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65623442|NCT02052908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623443|NCT02052908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65623444|NCT02052908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65623445|NCT02052908|Gout Suppressants|gout suppressants|mesh-ancestor
65623446|NCT02052908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65623447|NCT02052908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623448|NCT02052908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623449|NCT01336985|Irinotecan|irinotecan|mesh-list
65623450|NCT01336985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65623451|NCT01336985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65623452|NCT01336985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623453|NCT01336985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623454|NCT01336985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623455|NCT01337219|Tobramycin|tobramycin|mesh-list
65623456|NCT01337219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65623457|NCT01337219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65623458|NCT01337375|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65623459|NCT01337375|Interferon-alpha|interferon-alpha|mesh-list
65623460|NCT01337375|Antiviral Agents|antiviral agents|mesh-ancestor
65623461|NCT01337375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65623462|NCT01337375|Immunologic Factors|immunologic factors|mesh-ancestor
65623463|NCT01337375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623464|NCT03635411|Niacinamide|niacinamide|mesh-list
65623465|NCT03635411|Niacin|niacin|mesh-list
65623466|NCT03635411|Nicotinic Acids|nicotinic acids|mesh-list
65623467|NCT03635411|Vitamin B Complex|vitamin b complex|mesh-ancestor
65623468|NCT03635411|Vitamins|vitamins|mesh-ancestor
65623469|NCT03635411|Micronutrients|micronutrients|mesh-ancestor
65623470|NCT03635411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623471|NCT03635411|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65086250|NCT00479895|HBOC 201|hboc 201|mesh-list
65623472|NCT03635411|Antimetabolites|antimetabolites|mesh-ancestor
65623473|NCT03635411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623474|NCT03635411|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65623475|NCT03635411|Vasodilator Agents|vasodilator agents|mesh-ancestor
65623476|NCT02748512|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
65623477|NCT02748512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65623478|NCT02748512|Glucocorticoids|glucocorticoids|mesh-ancestor
65623479|NCT02748512|Hormones|hormones|mesh-ancestor
65623480|NCT02748512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65623481|NCT02748512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623482|NCT01341041|Chlorine dioxide|chlorine dioxide|mesh-list
65623483|NCT01341041|Dental Disinfectants|dental disinfectants|mesh-ancestor
65623484|NCT01341041|Disinfectants|disinfectants|mesh-ancestor
65623485|NCT01341041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65623486|NCT02053142|Acyclovir|acyclovir|mesh-list
65623487|NCT02053142|Antiviral Agents|antiviral agents|mesh-ancestor
65623488|NCT02053142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65623489|NCT01316549|Fludarabine|fludarabine|mesh-list
65623490|NCT01316549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623491|NCT03439657|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65623492|NCT03439657|Immunologic Factors|immunologic factors|mesh-ancestor
65623493|NCT03439657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623494|NCT01341743|Entecavir|entecavir|mesh-list
65623495|NCT01341743|Adefovir|adefovir|mesh-list
65623496|NCT01341743|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65623497|NCT01341743|Antiviral Agents|antiviral agents|mesh-ancestor
65623498|NCT01341743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65623499|NCT01341743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65623500|NCT01341743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65623501|NCT01341743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623502|NCT01341743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623503|NCT01341275|Vaccines|vaccines|mesh-list
65623504|NCT01341275|Immunologic Factors|immunologic factors|mesh-ancestor
65623505|NCT01341275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623506|NCT01353937|Plerixafor|plerixafor|mesh-list
65623507|NCT01353937|Becaplermin|becaplermin|mesh-list
65623508|NCT01353937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65623509|NCT01353937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65623510|NCT01353937|Antiviral Agents|antiviral agents|mesh-ancestor
65623511|NCT01353937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65623512|NCT01353937|Anticoagulants|anticoagulants|mesh-ancestor
65623513|NCT01353937|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
65623514|NCT01353937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65623515|NCT01353937|Growth Substances|growth substances|mesh-ancestor
65623516|NCT01353937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623517|NCT04705883|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65623518|NCT04705883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65623519|NCT04705883|Immunologic Factors|immunologic factors|mesh-ancestor
65623520|NCT04705883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623521|NCT02053298|Timolol|timolol|mesh-list
65623522|NCT02053298|Dorzolamide|dorzolamide|mesh-list
65623523|NCT02053298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65623524|NCT02053298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65623525|NCT02053298|Adrenergic Agents|adrenergic agents|mesh-ancestor
65623526|NCT02053298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65623527|NCT02053298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623528|NCT02053298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623529|NCT02053298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65623530|NCT02053298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65623531|NCT02053298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65623532|NCT02053298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623533|NCT02054936|Warfarin|warfarin|mesh-list
65623534|NCT02054936|Rivaroxaban|rivaroxaban|mesh-list
65623535|NCT02054936|Anticoagulants|anticoagulants|mesh-ancestor
65623536|NCT02054936|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65623537|NCT02054936|Antithrombins|antithrombins|mesh-ancestor
65623538|NCT02054936|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65623539|NCT02054936|Protease Inhibitors|protease inhibitors|mesh-ancestor
65623540|NCT02054936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623541|NCT02054936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623542|NCT04782791|Nivolumab|nivolumab|mesh-list
65266804|NCT00644943|Amoxicillin|amoxicillin|mesh-list
65623543|NCT04782791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65623544|NCT04782791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623545|NCT04782791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65623546|NCT04782791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623547|NCT01341353|Amiodarone|amiodarone|mesh-list
65623548|NCT01341353|Calcium Channel Blockers|calcium channel blockers|mesh-list
65623549|NCT01341353|Calcium|calcium|mesh-list
65623550|NCT01341353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65623551|NCT01341353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623552|NCT01341353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65623553|NCT01341353|Vasodilator Agents|vasodilator agents|mesh-ancestor
65623554|NCT01341353|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65623555|NCT01341353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65623556|NCT01341353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623557|NCT01341353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65623558|NCT01341353|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65623559|NCT01341353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65623560|NCT01341353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623561|NCT01341353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65623562|NCT01341353|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65623563|NCT01341353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65623564|NCT05170139|Caffeine|caffeine|mesh-list
65623565|NCT05170139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65623566|NCT05170139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623567|NCT05170139|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65623568|NCT05170139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623569|NCT05170139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623570|NCT05170139|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65623571|NCT05170139|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65623572|NCT05170139|Purinergic Agents|purinergic agents|mesh-ancestor
65623573|NCT05170139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65623574|NCT02056106|Antidepressive Agents|antidepressive agents|mesh-list
65623575|NCT02056106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65623576|NCT02056184|Adalimumab|adalimumab|mesh-list
65623577|NCT02056184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65623578|NCT02056184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65623579|NCT02800928|Aticaprant|aticaprant|mesh-list
65623580|NCT02800928|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65623581|NCT02800928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623582|NCT02800928|Sensory System Agents|sensory system agents|mesh-ancestor
65623583|NCT02800928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65623584|NCT02056418|Prednisone|prednisone|mesh-list
65623585|NCT02056418|Hydrocortisone|hydrocortisone|mesh-list
65623586|NCT02056418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65623587|NCT02056418|Glucocorticoids|glucocorticoids|mesh-ancestor
65623588|NCT02056418|Hormones|hormones|mesh-ancestor
65623589|NCT02056418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65623590|NCT02056418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623591|NCT02056418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65623592|NCT02056418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623593|NCT02055014|Liraglutide|liraglutide|mesh-list
65623594|NCT02055014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65623595|NCT02055014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623596|NCT02055014|Incretins|incretins|mesh-ancestor
65623597|NCT02055014|Hormones|hormones|mesh-ancestor
65623598|NCT02055014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65623599|NCT02055170|Finasteride|finasteride|mesh-list
65623600|NCT02055170|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65623601|NCT02055170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65623602|NCT02055170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623603|NCT02055170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623604|NCT02055170|Hormone Antagonists|hormone antagonists|mesh-ancestor
65623605|NCT02055170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65623606|NCT02055170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623607|NCT02055170|Urological Agents|urological agents|mesh-ancestor
65623608|NCT04490993|Epirubicin|epirubicin|mesh-list
65623609|NCT04490993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65623610|NCT04490993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623611|NCT04490993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65623612|NCT04490993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65623613|NCT04490993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623614|NCT04490993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623615|NCT02055482|Darbepoetin alfa|darbepoetin alfa|mesh-list
65623616|NCT02055482|Hematinics|hematinics|mesh-ancestor
65623617|NCT02059460|Terlipressin|terlipressin|mesh-list
65623618|NCT02059460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65623619|NCT02059460|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65623620|NCT02055716|Sulforaphane|sulforaphane|mesh-list
65623621|NCT02055716|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65623622|NCT02055716|Protective Agents|protective agents|mesh-ancestor
65623623|NCT02055716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623624|NCT02055716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623625|NCT04739735|Anesthetics|anesthetics|mesh-list
65623626|NCT04739735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65623627|NCT04739735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623628|NCT02059616|Amlodipine|amlodipine|mesh-list
65623629|NCT02059616|Candesartan|candesartan|mesh-list
65623630|NCT02059616|Candesartan cilexetil|candesartan cilexetil|mesh-list
65623631|NCT02059616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65623632|NCT02059616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65623633|NCT02059616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65623634|NCT02059616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623635|NCT02059616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65623636|NCT02059616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623637|NCT02059616|Vasodilator Agents|vasodilator agents|mesh-ancestor
65623638|NCT02059616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65623639|NCT02059616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65623640|NCT04356209|Pravastatin|pravastatin|mesh-list
65623641|NCT04356209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65623642|NCT04356209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65623643|NCT04356209|Antimetabolites|antimetabolites|mesh-ancestor
65623644|NCT04356209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623645|NCT04356209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65623646|NCT04356209|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65623647|NCT04356209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623648|NCT02059694|Lidocaine|lidocaine|mesh-list
65623649|NCT02059694|Epinephrine|epinephrine|mesh-list
65623650|NCT02059694|Racepinephrine|racepinephrine|mesh-list
65623651|NCT02059694|Epinephryl borate|epinephryl borate|mesh-list
65623652|NCT02059694|Anesthetics, Local|anesthetics, local|mesh-ancestor
65623653|NCT02059694|Anesthetics|anesthetics|mesh-ancestor
65623654|NCT02059694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65623655|NCT02059694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623656|NCT02059694|Sensory System Agents|sensory system agents|mesh-ancestor
65623657|NCT02059694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65623658|NCT02059694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65623659|NCT02059694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65623660|NCT02059694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65623661|NCT02059694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65623662|NCT02059694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623663|NCT02059694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65623664|NCT02059694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65623665|NCT02059694|Adrenergic Agents|adrenergic agents|mesh-ancestor
65623666|NCT02059694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65623667|NCT02059694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65623668|NCT02059694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65623669|NCT02059694|Autonomic Agents|autonomic agents|mesh-ancestor
65623670|NCT02059694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65623671|NCT02059694|Respiratory System Agents|respiratory system agents|mesh-ancestor
65623672|NCT02059694|Mydriatics|mydriatics|mesh-ancestor
65623673|NCT02059694|Sympathomimetics|sympathomimetics|mesh-ancestor
65623674|NCT02059694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65623675|NCT03146741|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65623676|NCT03146741|Antiviral Agents|antiviral agents|mesh-ancestor
65623677|NCT03146741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65623678|NCT02056730|Calcium|calcium|mesh-list
65623679|NCT02056730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65623680|NCT02056730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623681|NCT05162573|177Lu-PSMA-617|177lu-psma-617|mesh-list
65623682|NCT05162573|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65623683|NCT05162573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623684|NCT03560804|Olmesartan|olmesartan|mesh-list
65623685|NCT03560804|Chlorthalidone|chlorthalidone|mesh-list
65623686|NCT03560804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65623687|NCT03560804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65623688|NCT03560804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65623689|NCT03560804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623690|NCT03560804|Diuretics|diuretics|mesh-ancestor
65623691|NCT03560804|Natriuretic Agents|natriuretic agents|mesh-ancestor
65623692|NCT03560804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623693|NCT03560804|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65623694|NCT03560804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65623695|NCT03150719|Ivacaftor|ivacaftor|mesh-list
65623696|NCT03150719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65623697|NCT03150719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65623698|NCT03150719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623699|NCT02059772|Ranibizumab|ranibizumab|mesh-list
65623700|NCT02059772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65623701|NCT02059772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65623702|NCT02059772|Growth Substances|growth substances|mesh-ancestor
65623703|NCT02059772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623704|NCT02059772|Growth Inhibitors|growth inhibitors|mesh-ancestor
65623705|NCT02059772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623706|NCT01344083|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
65623707|NCT01344083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65623708|NCT01344083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65623709|NCT01344083|Analgesics|analgesics|mesh-ancestor
65623710|NCT01344083|Sensory System Agents|sensory system agents|mesh-ancestor
65623711|NCT01344083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65623712|NCT01344083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623713|NCT01344083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65623714|NCT01344083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65623715|NCT01344083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65623716|NCT01344083|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65623717|NCT01344083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65623718|NCT01344083|Histamine Antagonists|histamine antagonists|mesh-ancestor
65623719|NCT01344083|Histamine Agents|histamine agents|mesh-ancestor
65623720|NCT01344083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65623721|NCT01344083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623722|NCT02059850|Cyclophosphamide|cyclophosphamide|mesh-list
65623723|NCT02059850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65623724|NCT02059850|Immunologic Factors|immunologic factors|mesh-ancestor
65623725|NCT02059850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623726|NCT02059850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65623727|NCT02059850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65623728|NCT02059850|Alkylating Agents|alkylating agents|mesh-ancestor
65623729|NCT02059850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623730|NCT02059850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623731|NCT02059850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65623732|NCT00982111|Pemetrexed|pemetrexed|mesh-list
65623733|NCT00982111|Necitumumab|necitumumab|mesh-list
65623734|NCT00982111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623735|NCT00982111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623736|NCT00982111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623737|NCT00982111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65623738|NCT00982111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65623739|NCT00982111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65623740|NCT03057951|Empagliflozin|empagliflozin|mesh-list
65623741|NCT03057951|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65623742|NCT03057951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623743|NCT03057951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65623744|NCT03057951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623745|NCT02060318|Infliximab|infliximab|mesh-list
65623746|NCT02060318|Dermatologic Agents|dermatologic agents|mesh-ancestor
65623747|NCT02060318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65623748|NCT02060318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65623749|NCT01318837|Solifenacin Succinate|solifenacin succinate|mesh-list
65623750|NCT01318837|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65623751|NCT01318837|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65623752|NCT01318837|Cholinergic Agents|cholinergic agents|mesh-ancestor
65623753|NCT01318837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65623754|NCT01318837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623755|NCT01318837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623756|NCT01318837|Urological Agents|urological agents|mesh-ancestor
65623757|NCT01350037|Remifentanil|remifentanil|mesh-list
65623758|NCT01350037|Alfentanil|alfentanil|mesh-list
65623759|NCT01350037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65623760|NCT01350037|Narcotics|narcotics|mesh-ancestor
65623761|NCT01350037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65623762|NCT01350037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623763|NCT01350037|Analgesics|analgesics|mesh-ancestor
65623764|NCT01350037|Sensory System Agents|sensory system agents|mesh-ancestor
65623765|NCT01350037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65623766|NCT01350037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65623767|NCT01350037|Anesthetics, General|anesthetics, general|mesh-ancestor
65623768|NCT01350037|Anesthetics|anesthetics|mesh-ancestor
65623769|NCT02060006|Meloxicam|meloxicam|mesh-list
65623770|NCT02060006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
65623771|NCT02060006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65623772|NCT02060006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65623773|NCT02060006|Analgesics|analgesics|mesh-ancestor
65623774|NCT02060006|Sensory System Agents|sensory system agents|mesh-ancestor
65623775|NCT02060006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65623776|NCT02060006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623777|NCT02060006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65623778|NCT02060006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65623779|NCT02060006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65623780|NCT02060006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623781|NCT02060006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623782|NCT03620435|Atezolizumab|atezolizumab|mesh-list
65623783|NCT03620435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623784|NCT03497156|Lercanidipine|lercanidipine|mesh-list
65623785|NCT03497156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65623786|NCT03497156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65623787|NCT03497156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65623788|NCT03497156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623789|NCT03497156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65623790|NCT03497156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623791|NCT01317017|Interferon-gamma|interferon-gamma|mesh-list
65623792|NCT01317017|Antiviral Agents|antiviral agents|mesh-ancestor
65623793|NCT01317017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65623794|NCT04686773|Vaccines|vaccines|mesh-list
65623795|NCT04686773|Immunologic Factors|immunologic factors|mesh-ancestor
65623796|NCT04686773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623797|NCT02956278|Allopurinol|allopurinol|mesh-list
65623798|NCT02956278|Antimetabolites|antimetabolites|mesh-ancestor
65623799|NCT02956278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623800|NCT02956278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623801|NCT02956278|Gout Suppressants|gout suppressants|mesh-ancestor
65623802|NCT02956278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65623803|NCT02956278|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65623804|NCT02956278|Antioxidants|antioxidants|mesh-ancestor
65623805|NCT02956278|Protective Agents|protective agents|mesh-ancestor
65623806|NCT02956278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623807|NCT02060396|Aspirin|aspirin|mesh-list
65623808|NCT02060396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65623809|NCT02060396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65623810|NCT02060396|Analgesics|analgesics|mesh-ancestor
65623811|NCT02060396|Sensory System Agents|sensory system agents|mesh-ancestor
65623812|NCT02060396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65623813|NCT02060396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623814|NCT02060396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65623815|NCT02060396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65623816|NCT02060396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65623817|NCT02060396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65623818|NCT02060396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623819|NCT02060396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65623820|NCT02060396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65623821|NCT02060396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623822|NCT02060396|Antipyretics|antipyretics|mesh-ancestor
65623823|NCT01358071|Doxorubicin|doxorubicin|mesh-list
65623824|NCT01358071|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65623825|NCT01358071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65623826|NCT01358071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623827|NCT01358071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65623828|NCT01358071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65623829|NCT01358071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266812|NCT02769884|Pancrelipase|pancrelipase|mesh-list
65623830|NCT01358071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623831|NCT02058212|Vitamin E|vitamin e|mesh-list
65623832|NCT02058212|Selenium|selenium|mesh-list
65623833|NCT02058212|Vitamins|vitamins|mesh-ancestor
65623834|NCT02058212|Micronutrients|micronutrients|mesh-ancestor
65623835|NCT02058212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623836|NCT02058212|Antioxidants|antioxidants|mesh-ancestor
65623837|NCT02058212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623838|NCT02058212|Protective Agents|protective agents|mesh-ancestor
65623839|NCT02058212|Trace Elements|trace elements|mesh-ancestor
65623840|NCT02058446|Amlodipine|amlodipine|mesh-list
65623841|NCT02058446|Valsartan|valsartan|mesh-list
65623842|NCT02058446|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
65623843|NCT02058446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65623844|NCT02058446|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65623845|NCT02058446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65623846|NCT02058446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623847|NCT02058446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65623848|NCT02058446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623849|NCT02058446|Vasodilator Agents|vasodilator agents|mesh-ancestor
65623850|NCT02058446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65623851|NCT02058446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65623852|NCT02842827|Tretinoin|tretinoin|mesh-list
65623853|NCT02842827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623854|NCT02842827|Keratolytic Agents|keratolytic agents|mesh-ancestor
65623855|NCT02842827|Dermatologic Agents|dermatologic agents|mesh-ancestor
65623856|NCT01354405|Lanreotide|lanreotide|mesh-list
65623857|NCT01354405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623858|NCT03363035|Enoxaparin|enoxaparin|mesh-list
65623859|NCT03363035|Rivaroxaban|rivaroxaban|mesh-list
65623860|NCT03363035|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65623861|NCT03363035|Antithrombins|antithrombins|mesh-ancestor
65623862|NCT03363035|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65623863|NCT03363035|Protease Inhibitors|protease inhibitors|mesh-ancestor
65623864|NCT03363035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623865|NCT03363035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623866|NCT03363035|Anticoagulants|anticoagulants|mesh-ancestor
65623867|NCT03363035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65421271|NCT00330460|Denosumab|denosumab|mesh-list
65623868|NCT03363035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65623869|NCT02582775|Mycophenolic Acid|mycophenolic acid|mesh-list
65623870|NCT02582775|Cyclophosphamide|cyclophosphamide|mesh-list
65623871|NCT02582775|Busulfan|busulfan|mesh-list
65623872|NCT02582775|Fludarabine|fludarabine|mesh-list
65623873|NCT02582775|Fludarabine phosphate|fludarabine phosphate|mesh-list
65623874|NCT02582775|Tacrolimus|tacrolimus|mesh-list
65623875|NCT02582775|Thymoglobulin|thymoglobulin|mesh-list
65623876|NCT02582775|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65623877|NCT02582775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65623878|NCT02582775|Immunologic Factors|immunologic factors|mesh-ancestor
65623879|NCT02582775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623880|NCT02582775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65623881|NCT02582775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65623882|NCT02582775|Alkylating Agents|alkylating agents|mesh-ancestor
65623883|NCT02582775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623884|NCT02582775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623885|NCT02582775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65623886|NCT02582775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65623887|NCT02582775|Antimetabolites|antimetabolites|mesh-ancestor
65623888|NCT02582775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65623889|NCT02582775|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65623890|NCT02582775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623891|NCT02582775|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65623892|NCT02582775|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65623893|NCT02582775|Antitubercular Agents|antitubercular agents|mesh-ancestor
65623894|NCT02582775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65266814|NCT05213507|Amikacin|amikacin|mesh-list
65623895|NCT02060552|Diacetylrhein|diacetylrhein|mesh-list
65623896|NCT02060552|Colchicine|colchicine|mesh-list
65623897|NCT02060552|Febuxostat|febuxostat|mesh-list
65623898|NCT02060552|Gout Suppressants|gout suppressants|mesh-ancestor
65623899|NCT02060552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65623900|NCT02060552|Tubulin Modulators|tubulin modulators|mesh-ancestor
65623901|NCT02060552|Antimitotic Agents|antimitotic agents|mesh-ancestor
65623902|NCT02060552|Mitosis Modulators|mitosis modulators|mesh-ancestor
65623903|NCT02060552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623904|NCT02060552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623905|NCT02060552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65623906|NCT05384574|Cholecalciferol|cholecalciferol|mesh-list
65623907|NCT05384574|Vitamin D|vitamin d|mesh-list
65623908|NCT05384574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65623909|NCT05384574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623910|NCT05384574|Vitamins|vitamins|mesh-ancestor
65623911|NCT05384574|Micronutrients|micronutrients|mesh-ancestor
65623912|NCT05384574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65623913|NCT04355585|Colchicine|colchicine|mesh-list
65623914|NCT04355585|Gout Suppressants|gout suppressants|mesh-ancestor
65623915|NCT04355585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65623916|NCT04355585|Tubulin Modulators|tubulin modulators|mesh-ancestor
65623917|NCT04355585|Antimitotic Agents|antimitotic agents|mesh-ancestor
65623918|NCT04355585|Mitosis Modulators|mitosis modulators|mesh-ancestor
65623919|NCT04355585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623920|NCT04355585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623921|NCT02031744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65623922|NCT02031744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623923|NCT02031744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65623924|NCT02031744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623925|NCT02031744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623926|NCT01344395|Ketorolac|ketorolac|mesh-list
65623927|NCT01344395|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65623928|NCT01344395|Ropivacaine|ropivacaine|mesh-list
65623929|NCT01344395|Anesthetics, Local|anesthetics, local|mesh-ancestor
65623930|NCT01344395|Anesthetics|anesthetics|mesh-ancestor
65623931|NCT01344395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65623932|NCT01344395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623933|NCT01344395|Sensory System Agents|sensory system agents|mesh-ancestor
65623934|NCT01344395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65623935|NCT01344395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65623936|NCT01344395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65623937|NCT01344395|Analgesics|analgesics|mesh-ancestor
65623938|NCT01344395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65623939|NCT01344395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65623940|NCT01344395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65623941|NCT01344395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623942|NCT01344395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623943|NCT02291445|Peppermint oil|peppermint oil|mesh-list
65623944|NCT02291445|Antiemetics|antiemetics|mesh-ancestor
65623945|NCT02291445|Autonomic Agents|autonomic agents|mesh-ancestor
65623946|NCT02291445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65623947|NCT02291445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623948|NCT02291445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65623949|NCT02291445|Parasympatholytics|parasympatholytics|mesh-ancestor
65623951|NCT02062112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65623952|NCT01342289|Mycophenolic Acid|mycophenolic acid|mesh-list
65623953|NCT01342289|Cyclophosphamide|cyclophosphamide|mesh-list
65623954|NCT01342289|Fludarabine|fludarabine|mesh-list
65623955|NCT01342289|Tacrolimus|tacrolimus|mesh-list
65623956|NCT01342289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65623957|NCT01342289|Immunologic Factors|immunologic factors|mesh-ancestor
65623958|NCT01342289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623959|NCT01342289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65623960|NCT01342289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65623961|NCT01342289|Alkylating Agents|alkylating agents|mesh-ancestor
65623962|NCT01342289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623963|NCT01342289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65266825|NCT04253873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623964|NCT01342289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65623965|NCT01342289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65623966|NCT01342289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623967|NCT01342289|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65623968|NCT01342289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65623969|NCT01342289|Antitubercular Agents|antitubercular agents|mesh-ancestor
65623970|NCT01342289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65623971|NCT01342289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65623972|NCT02062190|Resveratrol|resveratrol|mesh-list
65623973|NCT02062190|Antioxidants|antioxidants|mesh-ancestor
65623974|NCT02062190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623975|NCT02062190|Protective Agents|protective agents|mesh-ancestor
65623976|NCT02062190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623977|NCT02062190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65623978|NCT02062190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65623979|NCT05601752|Nivolumab|nivolumab|mesh-list
65623980|NCT05601752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65623981|NCT05601752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65623982|NCT05601752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65623983|NCT05601752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65623984|NCT01354483|Methylprednisolone|methylprednisolone|mesh-list
65623985|NCT01354483|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65623986|NCT01354483|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65623987|NCT01354483|Prednisolone|prednisolone|mesh-list
65623988|NCT01354483|Prednisolone acetate|prednisolone acetate|mesh-list
65623989|NCT01354483|Lithium Carbonate|lithium carbonate|mesh-list
65623990|NCT01354483|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65623991|NCT01354483|Prednisolone phosphate|prednisolone phosphate|mesh-list
65623992|NCT01354483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65623993|NCT01354483|Antiemetics|antiemetics|mesh-ancestor
65623994|NCT01354483|Autonomic Agents|autonomic agents|mesh-ancestor
65623995|NCT01354483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65623996|NCT01354483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65623997|NCT01354483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65623998|NCT01354483|Glucocorticoids|glucocorticoids|mesh-ancestor
65623999|NCT01354483|Hormones|hormones|mesh-ancestor
65624000|NCT01354483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65624001|NCT01354483|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65624002|NCT01354483|Protective Agents|protective agents|mesh-ancestor
65624003|NCT01354483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65624004|NCT01354483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624005|NCT01354483|Antidepressive Agents|antidepressive agents|mesh-ancestor
65624006|NCT01354483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65624007|NCT01354483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65624008|NCT01354483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624009|NCT01354483|Antimanic Agents|antimanic agents|mesh-ancestor
65624010|NCT01354483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65624011|NCT01354483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65624012|NCT03618264|Dexamethasone|dexamethasone|mesh-list
65624013|NCT03618264|Ropivacaine|ropivacaine|mesh-list
65624014|NCT03618264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65624015|NCT03618264|Antiemetics|antiemetics|mesh-ancestor
65624016|NCT03618264|Autonomic Agents|autonomic agents|mesh-ancestor
65624017|NCT03618264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624018|NCT03618264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624019|NCT03618264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65624020|NCT03618264|Glucocorticoids|glucocorticoids|mesh-ancestor
65624021|NCT03618264|Hormones|hormones|mesh-ancestor
65624022|NCT03618264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65624023|NCT03618264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65421415|NCT01039155|Antimetabolites|antimetabolites|mesh-ancestor
65624024|NCT03618264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624025|NCT03618264|Anesthetics, Local|anesthetics, local|mesh-ancestor
65624026|NCT03618264|Anesthetics|anesthetics|mesh-ancestor
65624027|NCT03618264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65624028|NCT03618264|Sensory System Agents|sensory system agents|mesh-ancestor
65624029|NCT03617016|Domperidone|domperidone|mesh-list
65624030|NCT03617016|Antiemetics|antiemetics|mesh-ancestor
65624031|NCT03617016|Autonomic Agents|autonomic agents|mesh-ancestor
65624032|NCT03617016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624033|NCT03617016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624034|NCT03617016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65624035|NCT03617016|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65624036|NCT03617016|Dopamine Agents|dopamine agents|mesh-ancestor
65624037|NCT03617016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65624038|NCT03617016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624039|NCT02060786|Clopidogrel|clopidogrel|mesh-list
65624040|NCT02060786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65624041|NCT02060786|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65624042|NCT02060786|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65624043|NCT02060786|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65624044|NCT02060786|Purinergic Agents|purinergic agents|mesh-ancestor
65624045|NCT02060786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65624046|NCT02060786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624047|NCT02060786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624048|NCT03153137|Macitentan|macitentan|mesh-list
65624049|NCT03153137|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65624050|NCT03153137|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65624051|NCT03153137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624052|NCT03153137|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65624053|NCT03617484|Bortezomib|bortezomib|mesh-list
65624054|NCT03617484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624055|NCT01344473|Caseins|caseins|mesh-list
65624056|NCT01344473|Chelating Agents|chelating agents|mesh-ancestor
65624057|NCT01344473|Sequestering Agents|sequestering agents|mesh-ancestor
65624058|NCT01344473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624059|NCT03618108|Azithromycin|azithromycin|mesh-list
65624060|NCT03618108|Doxycycline|doxycycline|mesh-list
65624061|NCT03618108|Rifabutin|rifabutin|mesh-list
65624062|NCT03618108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65624063|NCT03618108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65624064|NCT03618108|Antimalarials|antimalarials|mesh-ancestor
65624065|NCT03618108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65624066|NCT03618108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65624067|NCT03618108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65624068|NCT03618108|Antitubercular Agents|antitubercular agents|mesh-ancestor
65624069|NCT01342601|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65624070|NCT01342601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65624071|NCT02236728|Pramipexole|pramipexole|mesh-list
65624072|NCT02236728|Antioxidants|antioxidants|mesh-ancestor
65624073|NCT02236728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624074|NCT02236728|Protective Agents|protective agents|mesh-ancestor
65624075|NCT02236728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624076|NCT02236728|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65624077|NCT02236728|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65624078|NCT02236728|Dopamine Agonists|dopamine agonists|mesh-ancestor
65624079|NCT02236728|Dopamine Agents|dopamine agents|mesh-ancestor
65624080|NCT02236728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65624081|NCT03136861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65624082|NCT03136861|Immunologic Factors|immunologic factors|mesh-ancestor
65624083|NCT03136861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624084|NCT01342679|Dasatinib|dasatinib|mesh-list
65624085|NCT01342679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624086|NCT01342679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65624087|NCT01342679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65624088|NCT01342679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624089|NCT01342835|Propofol|propofol|mesh-list
65624090|NCT01342835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65624091|NCT01342835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65624092|NCT01342835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624093|NCT01342835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65624094|NCT01342835|Anesthetics, General|anesthetics, general|mesh-ancestor
65624095|NCT01342835|Anesthetics|anesthetics|mesh-ancestor
65624096|NCT01344863|Trastuzumab|trastuzumab|mesh-list
65624097|NCT01344863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65624098|NCT01344863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624099|NCT03139279|Dexmedetomidine|dexmedetomidine|mesh-list
65624100|NCT03139279|Propofol|propofol|mesh-list
65624101|NCT03139279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65624102|NCT03139279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65624103|NCT03139279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624104|NCT03139279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65624105|NCT03139279|Anesthetics, General|anesthetics, general|mesh-ancestor
65624106|NCT03139279|Anesthetics|anesthetics|mesh-ancestor
65624107|NCT03139279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65624108|NCT03139279|Analgesics|analgesics|mesh-ancestor
65624109|NCT03139279|Sensory System Agents|sensory system agents|mesh-ancestor
65624110|NCT03139279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624111|NCT03139279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65624112|NCT03139279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65624113|NCT03139279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65624114|NCT03139279|Adrenergic Agents|adrenergic agents|mesh-ancestor
65624115|NCT03139279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65624116|NCT03139279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624117|NCT02562599|Raltitrexed|raltitrexed|mesh-list
65624118|NCT02562599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624119|NCT02562599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65624120|NCT02562599|Antimetabolites|antimetabolites|mesh-ancestor
65624121|NCT02562599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624122|NCT02562599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65624123|NCT02562599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65624124|NCT03311958|Nivolumab|nivolumab|mesh-list
65624125|NCT03311958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65624126|NCT03311958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624127|NCT03311958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65624128|NCT03311958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624129|NCT02225405|Cisplatin|cisplatin|mesh-list
65624130|NCT02225405|Docetaxel|docetaxel|mesh-list
65624131|NCT02225405|Nintedanib|nintedanib|mesh-list
65624132|NCT02225405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624133|NCT02225405|Tubulin Modulators|tubulin modulators|mesh-ancestor
65624134|NCT02225405|Antimitotic Agents|antimitotic agents|mesh-ancestor
65624135|NCT02225405|Mitosis Modulators|mitosis modulators|mesh-ancestor
65624136|NCT02225405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624137|NCT02225405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65624138|NCT02225405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65624139|NCT01370642|Ribavirin|ribavirin|mesh-list
65624140|NCT01370642|Antimetabolites|antimetabolites|mesh-ancestor
65624141|NCT01370642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624142|NCT01370642|Antiviral Agents|antiviral agents|mesh-ancestor
65624143|NCT01370642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65624144|NCT03138967|Glycopyrrolate|glycopyrrolate|mesh-list
65624145|NCT03138967|Bromides|bromides|mesh-list
65624146|NCT03138967|Rocuronium|rocuronium|mesh-list
65624147|NCT03138967|Neostigmine|neostigmine|mesh-list
65624148|NCT03138967|Anticonvulsants|anticonvulsants|mesh-ancestor
65624149|NCT03138967|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65624150|NCT03138967|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65624151|NCT03138967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65624152|NCT03138967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624153|NCT03138967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624154|NCT03138967|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65624155|NCT03138967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65624156|NCT03138967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624157|NCT03138967|Cholinergic Agents|cholinergic agents|mesh-ancestor
65624158|NCT03138967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65624159|NCT03138967|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65624160|NCT03138967|Autonomic Agents|autonomic agents|mesh-ancestor
65624161|NCT03138967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65624162|NCT03138967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65624163|NCT03138967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65624164|NCT01547117|Carbon Monoxide|carbon monoxide|mesh-list
65624165|NCT01547117|Antimetabolites|antimetabolites|mesh-ancestor
65624166|NCT01547117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624167|NCT01547117|Gasotransmitters|gasotransmitters|mesh-ancestor
65624168|NCT01547117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65624169|NCT01547117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624170|NCT01358383|Naproxen|naproxen|mesh-list
65624171|NCT01358383|Esomeprazole|esomeprazole|mesh-list
65624172|NCT01358383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65624173|NCT01358383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65624174|NCT01358383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65421563|NCT00941369|Insulin|insulin|mesh-list
65624175|NCT01358383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65624176|NCT01358383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624177|NCT01358383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65624178|NCT01358383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65624179|NCT01358383|Analgesics|analgesics|mesh-ancestor
65624180|NCT01358383|Sensory System Agents|sensory system agents|mesh-ancestor
65624181|NCT01358383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624182|NCT01358383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624183|NCT01358383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65624184|NCT01358383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65624185|NCT01358383|Gout Suppressants|gout suppressants|mesh-ancestor
65624186|NCT01358383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65624187|NCT03560336|Liraglutide|liraglutide|mesh-list
65624188|NCT03560336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65624189|NCT03560336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624190|NCT03560336|Incretins|incretins|mesh-ancestor
65624191|NCT03560336|Hormones|hormones|mesh-ancestor
65624192|NCT03560336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65624193|NCT03136159|Anti-Infective Agents|anti-infective agents|mesh-list
65624194|NCT03136159|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65624195|NCT03615768|Clindamycin|clindamycin|mesh-list
65624196|NCT03615768|Clindamycin palmitate|clindamycin palmitate|mesh-list
65624197|NCT03615768|Clindamycin phosphate|clindamycin phosphate|mesh-list
65624198|NCT03615768|Adapalene|adapalene|mesh-list
65624199|NCT03615768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65624200|NCT03615768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65624201|NCT03615768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65624202|NCT03615768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65624203|NCT03615768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624204|NCT03615768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65624205|NCT03615768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65624206|NCT03615768|Analgesics|analgesics|mesh-ancestor
65624207|NCT03615768|Sensory System Agents|sensory system agents|mesh-ancestor
65624208|NCT03615768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624209|NCT03615768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624210|NCT03615768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65624211|NCT03615768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65624212|NCT03615768|Dermatologic Agents|dermatologic agents|mesh-ancestor
65624213|NCT02061644|Anesthetics|anesthetics|mesh-list
65624214|NCT02061644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65624215|NCT02061644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624216|NCT03793400|Bevacizumab|bevacizumab|mesh-list
65624217|NCT03793400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65624218|NCT03793400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624219|NCT03793400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65624220|NCT03793400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65624221|NCT03793400|Growth Substances|growth substances|mesh-ancestor
65624222|NCT03793400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624223|NCT03793400|Growth Inhibitors|growth inhibitors|mesh-ancestor
65624224|NCT01318369|Diazepam|diazepam|mesh-list
65624225|NCT01318369|Dronabinol|dronabinol|mesh-list
65624226|NCT01318369|Hallucinogens|hallucinogens|mesh-ancestor
65624227|NCT01318369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624228|NCT01318369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65624229|NCT01318369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65624230|NCT01318369|Analgesics|analgesics|mesh-ancestor
65624231|NCT01318369|Sensory System Agents|sensory system agents|mesh-ancestor
65624232|NCT01318369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624233|NCT01318369|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65624234|NCT01318369|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65624235|NCT01318369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65624236|NCT01318369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624237|NCT01318369|Hormones|hormones|mesh-ancestor
65624238|NCT01318369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65624239|NCT01318369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65624240|NCT01318369|Anticonvulsants|anticonvulsants|mesh-ancestor
65624241|NCT01318369|Antiemetics|antiemetics|mesh-ancestor
65624242|NCT01318369|Autonomic Agents|autonomic agents|mesh-ancestor
65624243|NCT01318369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65624244|NCT01318369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65624245|NCT01318369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65624246|NCT01318369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65624247|NCT01318369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65624248|NCT01318369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65624249|NCT01318369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65624250|NCT01318369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65624251|NCT01318369|Anesthetics, General|anesthetics, general|mesh-ancestor
65624252|NCT01318369|Anesthetics|anesthetics|mesh-ancestor
65624253|NCT01318369|GABA Modulators|gaba modulators|mesh-ancestor
65624254|NCT01318369|GABA Agents|gaba agents|mesh-ancestor
65624255|NCT03479684|Warfarin|warfarin|mesh-list
65624256|NCT03479684|Anticoagulants|anticoagulants|mesh-ancestor
65624257|NCT03614052|Tamsulosin|tamsulosin|mesh-list
65624258|NCT03614052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65624259|NCT03614052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65624260|NCT03614052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65624261|NCT03614052|Adrenergic Agents|adrenergic agents|mesh-ancestor
65624262|NCT03614052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65624263|NCT03614052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624264|NCT03614052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624265|NCT03614052|Urological Agents|urological agents|mesh-ancestor
65624266|NCT02062892|Sirolimus|sirolimus|mesh-list
65624267|NCT02062892|Everolimus|everolimus|mesh-list
65624268|NCT02062892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624269|NCT02062892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65624270|NCT02062892|Immunologic Factors|immunologic factors|mesh-ancestor
65624271|NCT02062892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624272|NCT02062892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65624273|NCT02062892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65624274|NCT02062892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65624275|NCT02062892|Antifungal Agents|antifungal agents|mesh-ancestor
65624276|NCT02063360|Ritonavir|ritonavir|mesh-list
65624277|NCT02063360|Darunavir|darunavir|mesh-list
65624278|NCT02063360|Fostemsavir|fostemsavir|mesh-list
65624279|NCT02063360|Etravirine|etravirine|mesh-list
65624280|NCT02063360|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65624281|NCT02063360|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65624282|NCT02063360|Protease Inhibitors|protease inhibitors|mesh-ancestor
65624283|NCT02063360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65624284|NCT02063360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624285|NCT02063360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65624286|NCT02063360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65624287|NCT02063360|Antiviral Agents|antiviral agents|mesh-ancestor
65624288|NCT02063360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65624289|NCT02063360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65624290|NCT02063360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65624291|NCT02063360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65624292|NCT02063360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65624293|NCT02063360|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65624294|NCT02063360|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65624295|NCT03614832|Clopidogrel|clopidogrel|mesh-list
65624296|NCT03614832|Ticagrelor|ticagrelor|mesh-list
65624297|NCT03614832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65624298|NCT03614832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65624299|NCT03614832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65624300|NCT03614832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65624301|NCT03614832|Purinergic Agents|purinergic agents|mesh-ancestor
65624302|NCT03614832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65624303|NCT03614832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624304|NCT03614832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624305|NCT05210595|Clopidogrel|clopidogrel|mesh-list
65624306|NCT05210595|Ticagrelor|ticagrelor|mesh-list
65624307|NCT05210595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65624308|NCT05210595|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65624309|NCT05210595|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65624310|NCT05210595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65624311|NCT05210595|Purinergic Agents|purinergic agents|mesh-ancestor
65624312|NCT05210595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65624313|NCT05210595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624314|NCT05210595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624315|NCT05210517|Empagliflozin|empagliflozin|mesh-list
65624316|NCT05210517|Benzbromarone|benzbromarone|mesh-list
65624317|NCT05210517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65624318|NCT05210517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624319|NCT05210517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65624320|NCT05210517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624321|NCT05210517|Uricosuric Agents|uricosuric agents|mesh-ancestor
65421713|NCT00507728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65624322|NCT05210517|Gout Suppressants|gout suppressants|mesh-ancestor
65624323|NCT05210517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65624324|NCT05210517|Renal Agents|renal agents|mesh-ancestor
65624325|NCT02061800|Methylprednisolone|methylprednisolone|mesh-list
65624326|NCT02061800|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65624327|NCT02061800|Cyclophosphamide|cyclophosphamide|mesh-list
65624328|NCT02061800|Melphalan|melphalan|mesh-list
65624329|NCT02061800|Busulfan|busulfan|mesh-list
65624330|NCT02061800|Thiotepa|thiotepa|mesh-list
65624331|NCT02061800|Fludarabine|fludarabine|mesh-list
65624332|NCT02061800|Alemtuzumab|alemtuzumab|mesh-list
65624333|NCT02061800|Tacrolimus|tacrolimus|mesh-list
65624334|NCT02061800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65624335|NCT02061800|Immunologic Factors|immunologic factors|mesh-ancestor
65624336|NCT02061800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624337|NCT02061800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65624338|NCT02061800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65624339|NCT02061800|Alkylating Agents|alkylating agents|mesh-ancestor
65624340|NCT02061800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624341|NCT02061800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624342|NCT02061800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65624343|NCT02061800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65624344|NCT02061800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65624345|NCT02061800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65624346|NCT02061800|Antiemetics|antiemetics|mesh-ancestor
65624347|NCT02061800|Autonomic Agents|autonomic agents|mesh-ancestor
65624348|NCT02061800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624349|NCT02061800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65624350|NCT02061800|Glucocorticoids|glucocorticoids|mesh-ancestor
65624351|NCT02061800|Hormones|hormones|mesh-ancestor
65624352|NCT02061800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65624353|NCT02061800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65624354|NCT02061800|Protective Agents|protective agents|mesh-ancestor
65624355|NCT02061800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65624356|NCT02061800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65624357|NCT01350817|Docetaxel|docetaxel|mesh-list
65624358|NCT01350817|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65624359|NCT01350817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624360|NCT01350817|Tubulin Modulators|tubulin modulators|mesh-ancestor
65624361|NCT01350817|Antimitotic Agents|antimitotic agents|mesh-ancestor
65624362|NCT01350817|Mitosis Modulators|mitosis modulators|mesh-ancestor
65624363|NCT01350817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624364|NCT01350817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65624365|NCT01350817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65624366|NCT01986075|Amphetamine|amphetamine|mesh-list
65624367|NCT01986075|Adderall|adderall|mesh-list
65624368|NCT01986075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65624369|NCT01986075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624370|NCT01986075|Sympathomimetics|sympathomimetics|mesh-ancestor
65624371|NCT01986075|Autonomic Agents|autonomic agents|mesh-ancestor
65624372|NCT01986075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624373|NCT01986075|Dopamine Agents|dopamine agents|mesh-ancestor
65624374|NCT01986075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65624375|NCT01986075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624376|NCT01986075|Adrenergic Agents|adrenergic agents|mesh-ancestor
65624377|NCT01986075|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65624378|NCT01986075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65624379|NCT01986075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65624380|NCT01986075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65624381|NCT02061878|Bexarotene|bexarotene|mesh-list
65624382|NCT02061878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624383|NCT00394355|Fluticasone|fluticasone|mesh-list
65624384|NCT00394355|Xhance|xhance|mesh-list
65624385|NCT00394355|Mometasone Furoate|mometasone furoate|mesh-list
65624386|NCT00394355|Montelukast|montelukast|mesh-list
65624387|NCT00394355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65624388|NCT00394355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65624389|NCT00394355|Autonomic Agents|autonomic agents|mesh-ancestor
65624390|NCT00394355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624391|NCT00394355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624392|NCT00394355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65624393|NCT00394355|Respiratory System Agents|respiratory system agents|mesh-ancestor
65624394|NCT00394355|Dermatologic Agents|dermatologic agents|mesh-ancestor
65624395|NCT00394355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65624396|NCT00394355|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65421789|NCT00490490|Iodine|iodine|mesh-list
65624397|NCT00394355|Hormone Antagonists|hormone antagonists|mesh-ancestor
65624398|NCT00394355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65624399|NCT00394355|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65624400|NCT00394355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65624401|NCT00394355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624402|NCT02797808|Sertraline|sertraline|mesh-list
65624403|NCT02797808|Antidepressive Agents|antidepressive agents|mesh-ancestor
65624404|NCT02797808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65624405|NCT02797808|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65624406|NCT02797808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65624407|NCT02797808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65624408|NCT02797808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624409|NCT02797808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65624410|NCT02797808|Serotonin Agents|serotonin agents|mesh-ancestor
65624411|NCT02797808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624412|NCT02796560|Travoprost|travoprost|mesh-list
65624413|NCT02796560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65624414|NCT01316081|Vitamins|vitamins|mesh-list
65624415|NCT01316081|Ascorbic Acid|ascorbic acid|mesh-list
65624416|NCT01316081|Vitamin E|vitamin e|mesh-list
65624417|NCT01316081|Tocopherols|tocopherols|mesh-list
65624418|NCT01316081|Tocotrienols|tocotrienols|mesh-list
65624419|NCT01316081|alpha-Tocopherol|alpha-tocopherol|mesh-list
65624420|NCT01316081|Micronutrients|micronutrients|mesh-ancestor
65624421|NCT01316081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624422|NCT01316081|Antioxidants|antioxidants|mesh-ancestor
65624423|NCT01316081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624424|NCT01316081|Protective Agents|protective agents|mesh-ancestor
65624425|NCT00958737|Leucovorin|leucovorin|mesh-list
65624426|NCT00958737|Fluorouracil|fluorouracil|mesh-list
65624427|NCT00958737|Capecitabine|capecitabine|mesh-list
65624428|NCT00958737|Oxaliplatin|oxaliplatin|mesh-list
65624429|NCT00958737|Calcium|calcium|mesh-list
65624430|NCT00958737|Levoleucovorin|levoleucovorin|mesh-list
65624431|NCT00958737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65624432|NCT00958737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624433|NCT00958737|Antimetabolites|antimetabolites|mesh-ancestor
65624434|NCT00958737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624435|NCT00958737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65624436|NCT00958737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624437|NCT00958737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65624438|NCT00958737|Immunologic Factors|immunologic factors|mesh-ancestor
65624439|NCT00958737|Antidotes|antidotes|mesh-ancestor
65624440|NCT00958737|Protective Agents|protective agents|mesh-ancestor
65624441|NCT00958737|Vitamin B Complex|vitamin b complex|mesh-ancestor
65624442|NCT00958737|Vitamins|vitamins|mesh-ancestor
65624443|NCT00958737|Micronutrients|micronutrients|mesh-ancestor
65624444|NCT02062034|Vitamins|vitamins|mesh-list
65624445|NCT02062034|Vitamin E|vitamin e|mesh-list
65624446|NCT02062034|Coenzyme Q10|coenzyme q10|mesh-list
65624447|NCT02062034|Ubiquinone|ubiquinone|mesh-list
65624448|NCT02062034|Antioxidants|antioxidants|mesh-list
65624449|NCT02062034|Micronutrients|micronutrients|mesh-ancestor
65624450|NCT02062034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624451|NCT02062034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624452|NCT02062034|Protective Agents|protective agents|mesh-ancestor
65624453|NCT00344487|Ritonavir|ritonavir|mesh-list
65624454|NCT00344487|Lopinavir|lopinavir|mesh-list
65624455|NCT00344487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65624456|NCT00344487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65624457|NCT00344487|Protease Inhibitors|protease inhibitors|mesh-ancestor
65624458|NCT00344487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65624459|NCT00344487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624460|NCT00344487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65624461|NCT00344487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65624462|NCT00344487|Antiviral Agents|antiviral agents|mesh-ancestor
65624463|NCT00344487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65624464|NCT00344487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65624465|NCT00344487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65624466|NCT03789968|Tenofovir|tenofovir|mesh-list
65624467|NCT03789968|Emtricitabine|emtricitabine|mesh-list
65624468|NCT03789968|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65624469|NCT03789968|Antiviral Agents|antiviral agents|mesh-ancestor
65624470|NCT03789968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65624471|NCT03789968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65087237|NCT00495846|Octreotide|octreotide|mesh-list
65624472|NCT03789968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65624473|NCT03789968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65624474|NCT03789968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624475|NCT03789968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65624476|NCT03789968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65624477|NCT05089643|Capecitabine|capecitabine|mesh-list
65624478|NCT05089643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65624479|NCT05089643|Antimetabolites|antimetabolites|mesh-ancestor
65624480|NCT05089643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624481|NCT05089643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624482|NCT02871492|Acyclovir|acyclovir|mesh-list
65624483|NCT02871492|Pritelivir|pritelivir|mesh-list
65624484|NCT02871492|Antiviral Agents|antiviral agents|mesh-ancestor
65624485|NCT02871492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65624486|NCT02871492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65624487|NCT02871492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624488|NCT03613974|Lidocaine|lidocaine|mesh-list
65624489|NCT03613974|Anesthetics, Local|anesthetics, local|mesh-ancestor
65624490|NCT03613974|Anesthetics|anesthetics|mesh-ancestor
65624491|NCT03613974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65624492|NCT03613974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624493|NCT03613974|Sensory System Agents|sensory system agents|mesh-ancestor
65624494|NCT03613974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624495|NCT03613974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65624496|NCT03613974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65624497|NCT03613974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65624498|NCT03613974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65624499|NCT03613974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624500|NCT01343225|Ritonavir|ritonavir|mesh-list
65624501|NCT01343225|Darunavir|darunavir|mesh-list
65624502|NCT01343225|Raltegravir Potassium|raltegravir potassium|mesh-list
65624503|NCT01343225|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65624504|NCT01343225|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65624505|NCT01343225|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65624506|NCT01343225|Protease Inhibitors|protease inhibitors|mesh-ancestor
65624507|NCT01343225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65624508|NCT01343225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624509|NCT01343225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65624510|NCT01343225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65624511|NCT01343225|Antiviral Agents|antiviral agents|mesh-ancestor
65624512|NCT01343225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65624513|NCT01343225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65624514|NCT01343225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65624515|NCT01343225|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65624516|NCT01343225|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65624517|NCT01343225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65624518|NCT01343225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65624519|NCT05208879|Carotenoids|carotenoids|mesh-list
65624520|NCT05208879|Antioxidants|antioxidants|mesh-ancestor
65624521|NCT05208879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624522|NCT05208879|Protective Agents|protective agents|mesh-ancestor
65624523|NCT05208879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624524|NCT04739865|Psilocybin|psilocybin|mesh-list
65624525|NCT04739865|Hallucinogens|hallucinogens|mesh-ancestor
65624526|NCT04739865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624527|NCT04739865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65624528|NCT01370408|Dexamethasone|dexamethasone|mesh-list
65624529|NCT01370408|Ondansetron|ondansetron|mesh-list
65624530|NCT01370408|Palonosetron|palonosetron|mesh-list
65624531|NCT01370408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65624532|NCT01370408|Antiemetics|antiemetics|mesh-ancestor
65624533|NCT01370408|Autonomic Agents|autonomic agents|mesh-ancestor
65624534|NCT01370408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624535|NCT01370408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624536|NCT01370408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65624537|NCT01370408|Glucocorticoids|glucocorticoids|mesh-ancestor
65624538|NCT01370408|Hormones|hormones|mesh-ancestor
65624539|NCT01370408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65624540|NCT01370408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65624541|NCT01370408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624542|NCT01370408|Antipruritics|antipruritics|mesh-ancestor
65624543|NCT01370408|Dermatologic Agents|dermatologic agents|mesh-ancestor
65624544|NCT01370408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65087313|NCT00591604|Vitamin D|vitamin d|mesh-list
65624545|NCT01370408|Serotonin Agents|serotonin agents|mesh-ancestor
65624546|NCT01370408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65624547|NCT01370408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624548|NCT01370408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65624549|NCT01370408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65624550|NCT01370408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65421934|NCT00950105|Semapimod|semapimod|mesh-list
65624551|NCT01370408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65624552|NCT01370408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65624553|NCT01370408|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65624554|NCT04769388|Carboplatin|carboplatin|mesh-list
65624555|NCT04769388|Pemetrexed|pemetrexed|mesh-list
65624556|NCT04769388|Osimertinib|osimertinib|mesh-list
65624557|NCT04769388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624558|NCT04769388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65624559|NCT04769388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624560|NCT04769388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65624561|NCT04769388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65624562|NCT04769388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65624563|NCT03294109|Bupivacaine|bupivacaine|mesh-list
65624564|NCT03294109|Anesthetics, Local|anesthetics, local|mesh-ancestor
65624565|NCT03294109|Anesthetics|anesthetics|mesh-ancestor
65624566|NCT03294109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65624567|NCT03294109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624568|NCT03294109|Sensory System Agents|sensory system agents|mesh-ancestor
65624569|NCT03294109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624570|NCT01345643|Chrysarobin|chrysarobin|mesh-list
65624571|NCT01345643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65624572|NCT01345643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65624573|NCT01345643|Analgesics|analgesics|mesh-ancestor
65624574|NCT01345643|Sensory System Agents|sensory system agents|mesh-ancestor
65624575|NCT01345643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624576|NCT01345643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624577|NCT01345643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65624578|NCT01345643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65624579|NCT02065466|Paclitaxel|paclitaxel|mesh-list
65624580|NCT02065466|Bevacizumab|bevacizumab|mesh-list
65624581|NCT02065466|Temozolomide|temozolomide|mesh-list
65624582|NCT02065466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65624583|NCT02065466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624584|NCT02065466|Tubulin Modulators|tubulin modulators|mesh-ancestor
65624585|NCT02065466|Antimitotic Agents|antimitotic agents|mesh-ancestor
65624586|NCT02065466|Mitosis Modulators|mitosis modulators|mesh-ancestor
65624587|NCT02065466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624588|NCT02065466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65624589|NCT02065466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65624590|NCT02065466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65624591|NCT02065466|Growth Substances|growth substances|mesh-ancestor
65624592|NCT02065466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624593|NCT02065466|Growth Inhibitors|growth inhibitors|mesh-ancestor
65624594|NCT02065466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65624595|NCT02065466|Alkylating Agents|alkylating agents|mesh-ancestor
65624596|NCT03446040|Nivolumab|nivolumab|mesh-list
65624597|NCT03446040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65624598|NCT03446040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624599|NCT03446040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65624600|NCT03446040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624601|NCT05208801|Morphine|morphine|mesh-list
65624602|NCT05208801|Bupivacaine|bupivacaine|mesh-list
65624603|NCT05208801|Anesthetics, Local|anesthetics, local|mesh-ancestor
65624604|NCT05208801|Anesthetics|anesthetics|mesh-ancestor
65624605|NCT05208801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65624606|NCT05208801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624607|NCT05208801|Sensory System Agents|sensory system agents|mesh-ancestor
65624608|NCT05208801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624609|NCT05208801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65624610|NCT05208801|Narcotics|narcotics|mesh-ancestor
65624611|NCT05208801|Analgesics|analgesics|mesh-ancestor
65624612|NCT02064140|Rocuronium|rocuronium|mesh-list
65624613|NCT02064140|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65624614|NCT02064140|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65624615|NCT02064140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65624616|NCT02064140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624617|NCT02064140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624618|NCT05190627|Loratadine|loratadine|mesh-list
65624619|NCT05190627|Sirolimus|sirolimus|mesh-list
65624620|NCT05190627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65624621|NCT05190627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65624622|NCT05190627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65624623|NCT05190627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624624|NCT05190627|Antifungal Agents|antifungal agents|mesh-ancestor
65624625|NCT05190627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65624626|NCT05190627|Immunologic Factors|immunologic factors|mesh-ancestor
65624627|NCT05190627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624629|NCT05190627|Dermatologic Agents|dermatologic agents|mesh-ancestor
65624630|NCT05190627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65624631|NCT05190627|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65624632|NCT05190627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65624633|NCT05190627|Histamine Antagonists|histamine antagonists|mesh-ancestor
65624634|NCT05190627|Histamine Agents|histamine agents|mesh-ancestor
65624635|NCT05190627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65624636|NCT05190627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624637|NCT02064218|Antihypertensive Agents|antihypertensive agents|mesh-list
65624638|NCT01343303|Naproxen|naproxen|mesh-list
65624639|NCT01343303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65624640|NCT01343303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65624641|NCT01343303|Analgesics|analgesics|mesh-ancestor
65624642|NCT01343303|Sensory System Agents|sensory system agents|mesh-ancestor
65624643|NCT01343303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624644|NCT01343303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624645|NCT01343303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65624646|NCT01343303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65624647|NCT01343303|Gout Suppressants|gout suppressants|mesh-ancestor
65624648|NCT01343303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65624649|NCT01343303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65624650|NCT01343303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624651|NCT01343381|Heparin|heparin|mesh-list
65624652|NCT01343381|Calcium heparin|calcium heparin|mesh-list
65624653|NCT01343381|Anticoagulants|anticoagulants|mesh-ancestor
65624654|NCT01343381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65624655|NCT01343381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65624656|NCT01343381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624657|NCT03620149|Denosumab|denosumab|mesh-list
65624658|NCT03620149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65624659|NCT03620149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624660|NCT02064374|Metformin|metformin|mesh-list
65624661|NCT02064374|Dolutegravir|dolutegravir|mesh-list
65624662|NCT02064374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65624663|NCT02064374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624664|NCT02064374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65624665|NCT02064374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65624666|NCT02064374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65624667|NCT02064374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624668|NCT02064374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65624669|NCT02064374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65624670|NCT02064374|Antiviral Agents|antiviral agents|mesh-ancestor
65624671|NCT02064374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65624672|NCT01355263|Vitamin A|vitamin a|mesh-list
65624673|NCT01355263|Vitamins|vitamins|mesh-ancestor
65624674|NCT01355263|Micronutrients|micronutrients|mesh-ancestor
65624675|NCT01355263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624676|NCT03613428|Prednisone|prednisone|mesh-list
65624677|NCT03613428|Vincristine|vincristine|mesh-list
65624678|NCT03613428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65624679|NCT03613428|Glucocorticoids|glucocorticoids|mesh-ancestor
65624680|NCT03613428|Hormones|hormones|mesh-ancestor
65624681|NCT03613428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65624682|NCT03613428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624683|NCT03613428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65624684|NCT03613428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624685|NCT03613428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65624686|NCT03613428|Tubulin Modulators|tubulin modulators|mesh-ancestor
65624687|NCT03613428|Antimitotic Agents|antimitotic agents|mesh-ancestor
65624688|NCT03613428|Mitosis Modulators|mitosis modulators|mesh-ancestor
65624689|NCT03613428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624690|NCT02064530|Dexmedetomidine|dexmedetomidine|mesh-list
65624691|NCT02064530|Bupivacaine|bupivacaine|mesh-list
65624692|NCT02064530|Anesthetics, Local|anesthetics, local|mesh-ancestor
65624693|NCT02064530|Anesthetics|anesthetics|mesh-ancestor
65624694|NCT02064530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65624695|NCT02064530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624696|NCT02064530|Sensory System Agents|sensory system agents|mesh-ancestor
65624697|NCT02064530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624698|NCT02064530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65624699|NCT02064530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65624700|NCT02064530|Analgesics|analgesics|mesh-ancestor
65624701|NCT02064530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65624702|NCT02064530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65624703|NCT02064530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65624704|NCT02064530|Adrenergic Agents|adrenergic agents|mesh-ancestor
65624705|NCT02064530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65624706|NCT02064530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624708|NCT01359085|Analgesics|analgesics|mesh-ancestor
65624709|NCT01359085|Sensory System Agents|sensory system agents|mesh-ancestor
65624710|NCT01359085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624711|NCT01359085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624712|NCT01359085|Anticonvulsants|anticonvulsants|mesh-ancestor
65624713|NCT01359085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65624714|NCT01359085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65624715|NCT01359085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624716|NCT01359085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65624717|NCT01359085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65624718|NCT01359085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65624719|NCT01359085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65624720|NCT01359085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65624721|NCT04322357|Prednisone|prednisone|mesh-list
65624722|NCT04322357|Glucocorticoids|glucocorticoids|mesh-list
65624723|NCT04322357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65624724|NCT04322357|Hormones|hormones|mesh-ancestor
65624725|NCT04322357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65624726|NCT04322357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624727|NCT04322357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65624728|NCT04322357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624729|NCT01351285|Remifentanil|remifentanil|mesh-list
65624730|NCT01351285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65624731|NCT01351285|Narcotics|narcotics|mesh-ancestor
65624732|NCT01351285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65624733|NCT01351285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624734|NCT01351285|Analgesics|analgesics|mesh-ancestor
65624735|NCT01351285|Sensory System Agents|sensory system agents|mesh-ancestor
65624736|NCT01351285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624737|NCT02032290|Clopidogrel|clopidogrel|mesh-list
65624738|NCT02032290|Ticagrelor|ticagrelor|mesh-list
65624739|NCT02032290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65624740|NCT02032290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65624741|NCT02032290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65624742|NCT02032290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65624743|NCT02032290|Purinergic Agents|purinergic agents|mesh-ancestor
65624744|NCT02032290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65624745|NCT02032290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624746|NCT02032290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624747|NCT03379428|Trastuzumab|trastuzumab|mesh-list
65624748|NCT03379428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65624749|NCT03379428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624750|NCT03628131|Carboplatin|carboplatin|mesh-list
65624751|NCT03628131|Etoposide|etoposide|mesh-list
65624752|NCT03628131|Ifosfamide|ifosfamide|mesh-list
65624753|NCT03628131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624754|NCT03628131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65624755|NCT03628131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65624756|NCT03628131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65624757|NCT03628131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65624758|NCT03628131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624759|NCT03628131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65624760|NCT03628131|Alkylating Agents|alkylating agents|mesh-ancestor
65624761|NCT03560024|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
65624762|NCT03560024|Growth Substances|growth substances|mesh-ancestor
65266852|NCT00920699|Coenzyme Q10|coenzyme q10|mesh-list
65624763|NCT03560024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624764|NCT03560024|Vasodilator Agents|vasodilator agents|mesh-ancestor
65624765|NCT03560024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65624766|NCT03560024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624767|NCT05095857|Ketamine|ketamine|mesh-list
65624768|NCT05095857|Esketamine|esketamine|mesh-list
65624769|NCT05095857|Analgesics|analgesics|mesh-ancestor
65624770|NCT05095857|Sensory System Agents|sensory system agents|mesh-ancestor
65624771|NCT05095857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624772|NCT05095857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624773|NCT05095857|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65624774|NCT05095857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65624775|NCT05095857|Anesthetics, General|anesthetics, general|mesh-ancestor
65624776|NCT05095857|Anesthetics|anesthetics|mesh-ancestor
65624777|NCT05095857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65624778|NCT05095857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65624779|NCT05095857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65624780|NCT05095857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65624781|NCT05095857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624782|NCT05095857|Antidepressive Agents|antidepressive agents|mesh-ancestor
65624783|NCT05095857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65624784|NCT01351519|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65624785|NCT01351519|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65624786|NCT01351519|Dermatologic Agents|dermatologic agents|mesh-ancestor
65624787|NCT03612492|Lidocaine|lidocaine|mesh-list
65624788|NCT03612492|Anesthetics, Local|anesthetics, local|mesh-list
65624789|NCT03612492|Anesthetics|anesthetics|mesh-list
65624790|NCT03612492|Esmolol|esmolol|mesh-list
65624791|NCT03612492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65624792|NCT03612492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624793|NCT03612492|Sensory System Agents|sensory system agents|mesh-ancestor
65624794|NCT03612492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624795|NCT03612492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65624796|NCT03612492|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65624797|NCT03612492|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65624798|NCT03612492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65624799|NCT03612492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624800|NCT03612492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65624801|NCT03612492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65624802|NCT03612492|Adrenergic Agents|adrenergic agents|mesh-ancestor
65624803|NCT03612492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65624804|NCT03612492|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65624805|NCT01359163|Ethynodiol Diacetate|ethynodiol diacetate|mesh-list
65624806|NCT01359163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65624807|NCT01359163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65624808|NCT01359163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65624809|NCT01359163|Contraceptive Agents|contraceptive agents|mesh-ancestor
65624810|NCT01359163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65624811|NCT01359163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624812|NCT01359163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65624813|NCT01359163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65624814|NCT03730337|Nivolumab|nivolumab|mesh-list
65624815|NCT03730337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65624816|NCT03730337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624817|NCT03730337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65624818|NCT03730337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624819|NCT01351597|Docetaxel|docetaxel|mesh-list
65624820|NCT01351597|Oxaliplatin|oxaliplatin|mesh-list
65624821|NCT01351597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624822|NCT01351597|Tubulin Modulators|tubulin modulators|mesh-ancestor
65624823|NCT01351597|Antimitotic Agents|antimitotic agents|mesh-ancestor
65624824|NCT01351597|Mitosis Modulators|mitosis modulators|mesh-ancestor
65624825|NCT01351597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624826|NCT02793128|Mitomycins|mitomycins|mesh-list
65624827|NCT02793128|Mitomycin|mitomycin|mesh-list
65624828|NCT02793128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65624829|NCT02793128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624830|NCT02793128|Alkylating Agents|alkylating agents|mesh-ancestor
65624831|NCT02793128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624832|NCT02793128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65624833|NCT02793128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65624834|NCT03612180|Metoprolol|metoprolol|mesh-list
65624835|NCT03612180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65624836|NCT03612180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65624837|NCT03612180|Sympatholytics|sympatholytics|mesh-ancestor
65624838|NCT03612180|Autonomic Agents|autonomic agents|mesh-ancestor
65624839|NCT03612180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624840|NCT03612180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624841|NCT03612180|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65624842|NCT03612180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65624843|NCT03612180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65624844|NCT03612180|Adrenergic Agents|adrenergic agents|mesh-ancestor
65624845|NCT03612180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65624846|NCT03612180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624847|NCT04400799|Enoxaparin|enoxaparin|mesh-list
65624848|NCT04400799|Anticoagulants|anticoagulants|mesh-ancestor
65624849|NCT04400799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65624850|NCT04400799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65624851|NCT04400799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624852|NCT01359241|Insulin|insulin|mesh-list
65624853|NCT01359241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65624854|NCT01359241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624855|NCT02068196|Ipilimumab|ipilimumab|mesh-list
65624856|NCT02068196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65624857|NCT02068196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624858|NCT02068196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65624859|NCT02068196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624860|NCT03142451|Minocycline|minocycline|mesh-list
65624861|NCT03142451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65624862|NCT03142451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65624863|NCT04065789|Dexamethasone|dexamethasone|mesh-list
65624864|NCT04065789|Lenalidomide|lenalidomide|mesh-list
65624865|NCT04065789|Daratumumab|daratumumab|mesh-list
65624866|NCT04065789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65624867|NCT04065789|Antiemetics|antiemetics|mesh-ancestor
65624868|NCT04065789|Autonomic Agents|autonomic agents|mesh-ancestor
65624869|NCT04065789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624870|NCT04065789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624871|NCT04065789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65624872|NCT04065789|Glucocorticoids|glucocorticoids|mesh-ancestor
65624873|NCT04065789|Hormones|hormones|mesh-ancestor
65624874|NCT04065789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65624875|NCT04065789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65624876|NCT04065789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624877|NCT04065789|Immunologic Factors|immunologic factors|mesh-ancestor
65624878|NCT04065789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65624879|NCT04065789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65624880|NCT04065789|Growth Substances|growth substances|mesh-ancestor
65624881|NCT04065789|Growth Inhibitors|growth inhibitors|mesh-ancestor
65624882|NCT02066558|Carbon Monoxide|carbon monoxide|mesh-list
65624883|NCT02066558|Antimetabolites|antimetabolites|mesh-ancestor
65624884|NCT02066558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624885|NCT02066558|Gasotransmitters|gasotransmitters|mesh-ancestor
65624886|NCT02066558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65624887|NCT02066558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624888|NCT02064842|Ritonavir|ritonavir|mesh-list
65624889|NCT02064842|Simeprevir|simeprevir|mesh-list
65624890|NCT02064842|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65624891|NCT02064842|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65624892|NCT02064842|Protease Inhibitors|protease inhibitors|mesh-ancestor
65624893|NCT02064842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65624894|NCT02064842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624895|NCT02064842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65624896|NCT02064842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65624897|NCT02064842|Antiviral Agents|antiviral agents|mesh-ancestor
65624898|NCT02064842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65624899|NCT02064842|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65624900|NCT02064842|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65624901|NCT04192266|Estradiol|estradiol|mesh-list
65624902|NCT04192266|Estrogens|estrogens|mesh-ancestor
65624903|NCT04192266|Hormones|hormones|mesh-ancestor
65624904|NCT04192266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65624905|NCT04192266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624906|NCT01370018|Protease Inhibitors|protease inhibitors|mesh-list
65624907|NCT01370018|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65624908|NCT01370018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65624909|NCT01370018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624910|NCT01370018|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65624911|NCT01370018|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65624912|NCT01359397|Bevacizumab|bevacizumab|mesh-list
65624913|NCT01359397|Trastuzumab|trastuzumab|mesh-list
65624914|NCT01359397|Docetaxel|docetaxel|mesh-list
65624915|NCT01359397|Oxaliplatin|oxaliplatin|mesh-list
65624916|NCT01359397|Capecitabine|capecitabine|mesh-list
65624917|NCT01359397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65624918|NCT01359397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624919|NCT01359397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65624920|NCT01359397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65624921|NCT01359397|Growth Substances|growth substances|mesh-ancestor
65624922|NCT01359397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624923|NCT01359397|Growth Inhibitors|growth inhibitors|mesh-ancestor
65624924|NCT01359397|Tubulin Modulators|tubulin modulators|mesh-ancestor
65624925|NCT01359397|Antimitotic Agents|antimitotic agents|mesh-ancestor
65624926|NCT01359397|Mitosis Modulators|mitosis modulators|mesh-ancestor
65624927|NCT01359397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624928|NCT01359397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65624929|NCT01359397|Antimetabolites|antimetabolites|mesh-ancestor
65624930|NCT05250245|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65624931|NCT05250245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65624932|NCT05250245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65624933|NCT05250245|Cholinergic Agents|cholinergic agents|mesh-ancestor
65624934|NCT05250245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65624935|NCT05250245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624936|NCT05250245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624937|NCT05250245|Urological Agents|urological agents|mesh-ancestor
65624938|NCT01347983|Methotrexate|methotrexate|mesh-list
65624939|NCT01347983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65624940|NCT01347983|Abortifacient Agents|abortifacient agents|mesh-ancestor
65624941|NCT01347983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65624942|NCT01347983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624943|NCT01347983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65624944|NCT01347983|Antimetabolites|antimetabolites|mesh-ancestor
65624945|NCT01347983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624946|NCT01347983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624947|NCT01347983|Dermatologic Agents|dermatologic agents|mesh-ancestor
65624948|NCT01347983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65624949|NCT01347983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65624950|NCT01347983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65624951|NCT01347983|Immunologic Factors|immunologic factors|mesh-ancestor
65624952|NCT01347983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65624953|NCT01347983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65624955|NCT05249933|Anesthetics, Local|anesthetics, local|mesh-ancestor
65624956|NCT05249933|Anesthetics|anesthetics|mesh-ancestor
65624957|NCT05249933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65624958|NCT05249933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624959|NCT05249933|Sensory System Agents|sensory system agents|mesh-ancestor
65624960|NCT05249933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624961|NCT02032836|Iloprost|iloprost|mesh-list
65624962|NCT02032836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65624963|NCT02032836|Vasodilator Agents|vasodilator agents|mesh-ancestor
65624964|NCT02065076|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
65624965|NCT02065076|Chelating Agents|chelating agents|mesh-ancestor
65624966|NCT02065076|Sequestering Agents|sequestering agents|mesh-ancestor
65624967|NCT02065076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624968|NCT02465593|Fluorouracil|fluorouracil|mesh-list
65624969|NCT02465593|Capecitabine|capecitabine|mesh-list
65624970|NCT02465593|Antimetabolites|antimetabolites|mesh-ancestor
65624971|NCT02465593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65624972|NCT02465593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65624973|NCT02465593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624974|NCT02465593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65624975|NCT02465593|Immunologic Factors|immunologic factors|mesh-ancestor
65624976|NCT02465593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624977|NCT02424019|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
65624978|NCT02424019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65624979|NCT02424019|Glucocorticoids|glucocorticoids|mesh-ancestor
65624980|NCT02424019|Hormones|hormones|mesh-ancestor
65624981|NCT02424019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65624982|NCT02424019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624983|NCT02066870|Arsenic Trioxide|arsenic trioxide|mesh-list
65624984|NCT02066870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65624985|NCT03611244|Benzocaine|benzocaine|mesh-list
65624986|NCT03611244|Anesthetics, Local|anesthetics, local|mesh-ancestor
65624987|NCT03611244|Anesthetics|anesthetics|mesh-ancestor
65624988|NCT03611244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65624989|NCT03611244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624990|NCT03611244|Sensory System Agents|sensory system agents|mesh-ancestor
65624991|NCT03611244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624992|NCT01359709|Nicotine|nicotine|mesh-list
65624993|NCT01359709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65624994|NCT01359709|Autonomic Agents|autonomic agents|mesh-ancestor
65624995|NCT01359709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65624996|NCT01359709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65624997|NCT01359709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65624998|NCT01359709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65624999|NCT01359709|Cholinergic Agents|cholinergic agents|mesh-ancestor
65625000|NCT01359709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65625001|NCT01359709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625002|NCT02826486|Leucovorin|leucovorin|mesh-list
65625003|NCT02826486|Pembrolizumab|pembrolizumab|mesh-list
65625004|NCT02826486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65625005|NCT02826486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625006|NCT02826486|Antidotes|antidotes|mesh-ancestor
65625007|NCT02826486|Protective Agents|protective agents|mesh-ancestor
65625008|NCT02826486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625009|NCT02826486|Vitamin B Complex|vitamin b complex|mesh-ancestor
65625010|NCT02826486|Vitamins|vitamins|mesh-ancestor
65625011|NCT02826486|Micronutrients|micronutrients|mesh-ancestor
65625012|NCT02825940|Gemcitabine|gemcitabine|mesh-list
65625013|NCT02825940|Atezolizumab|atezolizumab|mesh-list
65625014|NCT02825940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625015|NCT02825940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65625016|NCT02825940|Antimetabolites|antimetabolites|mesh-ancestor
65625017|NCT02825940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625018|NCT02825940|Antiviral Agents|antiviral agents|mesh-ancestor
65625019|NCT02825940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65625020|NCT02825940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625021|NCT02825940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65625022|NCT02825940|Immunologic Factors|immunologic factors|mesh-ancestor
65625023|NCT02825940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625024|NCT02304991|Glycerol|glycerol|mesh-list
65625025|NCT02304991|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65625026|NCT02304991|Protective Agents|protective agents|mesh-ancestor
65625027|NCT02304991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625028|NCT02069132|Warfarin|warfarin|mesh-list
65625029|NCT02069132|Anticoagulants|anticoagulants|mesh-ancestor
65625030|NCT01352065|Bosentan|bosentan|mesh-list
65625031|NCT01352065|Ambrisentan|ambrisentan|mesh-list
65625032|NCT01352065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65625033|NCT01352065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65625034|NCT01352065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625035|NCT01356043|Niacin|niacin|mesh-list
65625036|NCT01356043|Amlodipine|amlodipine|mesh-list
65625037|NCT01356043|Telmisartan|telmisartan|mesh-list
65625038|NCT01356043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65625039|NCT01356043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65625040|NCT01356043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65625041|NCT01356043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625042|NCT01356043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65625043|NCT01356043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625044|NCT01356043|Vasodilator Agents|vasodilator agents|mesh-ancestor
65625045|NCT01356043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65625046|NCT01356043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65625047|NCT01356043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65625048|NCT01356043|Antimetabolites|antimetabolites|mesh-ancestor
65625049|NCT01356043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65625050|NCT01356043|Vitamin B Complex|vitamin b complex|mesh-ancestor
65625051|NCT01356043|Vitamins|vitamins|mesh-ancestor
65625052|NCT01356043|Micronutrients|micronutrients|mesh-ancestor
65625053|NCT02065388|Warfarin|warfarin|mesh-list
65625054|NCT02065388|Anticoagulants|anticoagulants|mesh-ancestor
65625055|NCT01317563|Vitamin A|vitamin a|mesh-list
65625056|NCT01317563|Selenium|selenium|mesh-list
65625057|NCT01317563|Vitamins|vitamins|mesh-ancestor
65625058|NCT01317563|Micronutrients|micronutrients|mesh-ancestor
65625059|NCT01317563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625060|NCT01317563|Antioxidants|antioxidants|mesh-ancestor
65625061|NCT01317563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625062|NCT01317563|Protective Agents|protective agents|mesh-ancestor
65625063|NCT01317563|Trace Elements|trace elements|mesh-ancestor
65625064|NCT02067338|Morphine|morphine|mesh-list
65625065|NCT02067338|Cellulose, Oxidized|cellulose, oxidized|mesh-list
65625066|NCT02067338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65625067|NCT02067338|Narcotics|narcotics|mesh-ancestor
65625068|NCT02067338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65625069|NCT02067338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625070|NCT02067338|Analgesics|analgesics|mesh-ancestor
65625071|NCT02067338|Sensory System Agents|sensory system agents|mesh-ancestor
65625072|NCT02067338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625073|NCT02067338|Hemostatics|hemostatics|mesh-ancestor
65625074|NCT02067338|Coagulants|coagulants|mesh-ancestor
65625075|NCT01352143|Thrombin|thrombin|mesh-list
65625076|NCT01352143|Hemostatics|hemostatics|mesh-ancestor
65625077|NCT01352143|Coagulants|coagulants|mesh-ancestor
65625079|NCT03911661|Anticoagulants|anticoagulants|mesh-ancestor
65625080|NCT01352299|Pyrithione zinc|pyrithione zinc|mesh-list
65625081|NCT01352299|Keratolytic Agents|keratolytic agents|mesh-ancestor
65625082|NCT01352299|Dermatologic Agents|dermatologic agents|mesh-ancestor
65625083|NCT05188495|Trastuzumab|trastuzumab|mesh-list
65625084|NCT05188495|Pertuzumab|pertuzumab|mesh-list
65625085|NCT05188495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65625086|NCT05188495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625087|NCT02069288|Fludrocortisone|fludrocortisone|mesh-list
65625088|NCT02069288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65625089|NCT01356121|Midazolam|midazolam|mesh-list
65625090|NCT01356121|Propofol|propofol|mesh-list
65625091|NCT01356121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65625092|NCT01356121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65625093|NCT01356121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625094|NCT01356121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65625095|NCT01356121|Anesthetics, General|anesthetics, general|mesh-ancestor
65625096|NCT01356121|Anesthetics|anesthetics|mesh-ancestor
65625097|NCT01356121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65625098|NCT01356121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65625099|NCT01356121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65625100|NCT01356121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65625101|NCT01356121|GABA Modulators|gaba modulators|mesh-ancestor
65625102|NCT01356121|GABA Agents|gaba agents|mesh-ancestor
65625103|NCT01356121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65625104|NCT01356121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625105|NCT01336608|Fluticasone|fluticasone|mesh-list
65625106|NCT01336608|Xhance|xhance|mesh-list
65625107|NCT01336608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65625108|NCT01336608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65625109|NCT01336608|Autonomic Agents|autonomic agents|mesh-ancestor
65625110|NCT01336608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625111|NCT01336608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625112|NCT01336608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65625113|NCT01336608|Respiratory System Agents|respiratory system agents|mesh-ancestor
65625114|NCT01336608|Dermatologic Agents|dermatologic agents|mesh-ancestor
65625115|NCT01336608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65625116|NCT03628521|Gemcitabine|gemcitabine|mesh-list
65625117|NCT03628521|Carboplatin|carboplatin|mesh-list
65625118|NCT03628521|Pemetrexed|pemetrexed|mesh-list
65625119|NCT03628521|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65625120|NCT03628521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625121|NCT03628521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65625122|NCT03628521|Antimetabolites|antimetabolites|mesh-ancestor
65625123|NCT03628521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625124|NCT03628521|Antiviral Agents|antiviral agents|mesh-ancestor
65625125|NCT03628521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65625126|NCT03628521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625127|NCT03628521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65625128|NCT03628521|Immunologic Factors|immunologic factors|mesh-ancestor
65625129|NCT03628521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625130|NCT03628521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65625131|NCT03628521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65625132|NCT03628521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65625133|NCT05697003|Fluticasone|fluticasone|mesh-list
65625134|NCT05697003|Xhance|xhance|mesh-list
65625135|NCT05697003|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65625136|NCT05697003|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65625137|NCT05697003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65625138|NCT05697003|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65625139|NCT05697003|Autonomic Agents|autonomic agents|mesh-ancestor
65625140|NCT05697003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625141|NCT05697003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625142|NCT05697003|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65625143|NCT05697003|Respiratory System Agents|respiratory system agents|mesh-ancestor
65625144|NCT05697003|Dermatologic Agents|dermatologic agents|mesh-ancestor
65625145|NCT05697003|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65625146|NCT05697003|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65625147|NCT05697003|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65625148|NCT05697003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65625149|NCT05697003|Adrenergic Agents|adrenergic agents|mesh-ancestor
65625150|NCT05697003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65625151|NCT05697003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625152|NCT05697003|Glucocorticoids|glucocorticoids|mesh-ancestor
65625153|NCT05697003|Hormones|hormones|mesh-ancestor
65625154|NCT05697003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65625155|NCT05697003|Sympathomimetics|sympathomimetics|mesh-ancestor
65625156|NCT02069522|Carotenoids|carotenoids|mesh-list
65625157|NCT02069522|Antioxidants|antioxidants|mesh-ancestor
65625158|NCT02069522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625159|NCT02069522|Protective Agents|protective agents|mesh-ancestor
65625160|NCT02069522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625161|NCT01361425|Methyldopa|methyldopa|mesh-list
65625162|NCT01361425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65625163|NCT01361425|Sympatholytics|sympatholytics|mesh-ancestor
65625164|NCT01361425|Autonomic Agents|autonomic agents|mesh-ancestor
65625165|NCT01361425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625166|NCT01361425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625167|NCT01361425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65625168|NCT01361425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65625169|NCT01361425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65625170|NCT01361425|Adrenergic Agents|adrenergic agents|mesh-ancestor
65625171|NCT01361425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65625172|NCT01361425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625173|NCT01356355|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65625174|NCT01356355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65625175|NCT01356355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65625176|NCT01356355|Cholinergic Agents|cholinergic agents|mesh-ancestor
65625177|NCT01356355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65625178|NCT01356355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625179|NCT01356355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625180|NCT01356355|Urological Agents|urological agents|mesh-ancestor
65625181|NCT01356433|Vitamins|vitamins|mesh-list
65625182|NCT01356433|Ascorbic Acid|ascorbic acid|mesh-list
65625183|NCT01356433|Micronutrients|micronutrients|mesh-ancestor
65625184|NCT01356433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625185|NCT01356433|Antioxidants|antioxidants|mesh-ancestor
65625186|NCT01356433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625187|NCT01356433|Protective Agents|protective agents|mesh-ancestor
65625188|NCT03691727|Tirofiban|tirofiban|mesh-list
65625189|NCT03691727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65625190|NCT03691727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65625191|NCT03691727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625192|NCT03691727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65625193|NCT01346371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65625194|NCT01346371|Lubricant Eye Drops|lubricant eye drops|mesh-list
65625195|NCT01346371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65625196|NCT01356511|Dexamethasone|dexamethasone|mesh-list
65625197|NCT01356511|Prednisone|prednisone|mesh-list
65625198|NCT01356511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65625199|NCT01356511|Antiemetics|antiemetics|mesh-ancestor
65625200|NCT01356511|Autonomic Agents|autonomic agents|mesh-ancestor
65625201|NCT01356511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625202|NCT01356511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625203|NCT01356511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65625204|NCT01356511|Glucocorticoids|glucocorticoids|mesh-ancestor
65625205|NCT01356511|Hormones|hormones|mesh-ancestor
65625206|NCT01356511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65625207|NCT01356511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65625208|NCT01356511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625209|NCT02069990|Cholecalciferol|cholecalciferol|mesh-list
65625210|NCT02069990|Vitamin D|vitamin d|mesh-list
65625211|NCT02069990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65625212|NCT02069990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625213|NCT02069990|Vitamins|vitamins|mesh-ancestor
65625214|NCT02069990|Micronutrients|micronutrients|mesh-ancestor
65625215|NCT02069990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65625216|NCT05076409|Fluconazole|fluconazole|mesh-list
65625217|NCT05076409|BI 425809|bi 425809|mesh-list
65625218|NCT05076409|Antifungal Agents|antifungal agents|mesh-ancestor
65625219|NCT05076409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65625220|NCT05076409|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65625221|NCT05076409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65625222|NCT05076409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625223|NCT05076409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625224|NCT05076409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65625225|NCT05076409|Hormone Antagonists|hormone antagonists|mesh-ancestor
65625226|NCT05076409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65625227|NCT05076409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422602|NCT00949247|Trastuzumab|trastuzumab|mesh-list
65625228|NCT05076409|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65625229|NCT05076409|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65625230|NCT05076409|Nootropic Agents|nootropic agents|mesh-ancestor
65625231|NCT02076386|Dolutegravir|dolutegravir|mesh-list
65625232|NCT02076386|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65625233|NCT02076386|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65625234|NCT02076386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625235|NCT02076386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625236|NCT02076386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65625237|NCT02076386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65625238|NCT02076386|Antiviral Agents|antiviral agents|mesh-ancestor
65625239|NCT02076386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65625240|NCT01347593|Ceftizoxime|ceftizoxime|mesh-list
65625241|NCT01347593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65625242|NCT01347593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65625243|NCT02072330|Amlodipine|amlodipine|mesh-list
65625244|NCT02072330|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65625245|NCT02072330|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65625246|NCT02072330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65625247|NCT02072330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65625248|NCT02072330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65625249|NCT02072330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625250|NCT02072330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65625251|NCT02072330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625252|NCT02072330|Vasodilator Agents|vasodilator agents|mesh-ancestor
65625253|NCT02072330|Diuretics|diuretics|mesh-ancestor
65625254|NCT02072330|Natriuretic Agents|natriuretic agents|mesh-ancestor
65625255|NCT02072330|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65625256|NCT02072330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65625257|NCT02072330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65625258|NCT02072408|Aflibercept|aflibercept|mesh-list
65625259|NCT02072408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65625260|NCT02072408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65625261|NCT02072408|Growth Substances|growth substances|mesh-ancestor
65625262|NCT02072408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625263|NCT02072408|Growth Inhibitors|growth inhibitors|mesh-ancestor
65625264|NCT02072408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625265|NCT02070458|Cytarabine|cytarabine|mesh-list
65625266|NCT02070458|Etoposide|etoposide|mesh-list
65625267|NCT02070458|Mitoxantrone|mitoxantrone|mesh-list
65625268|NCT02070458|Etoposide phosphate|etoposide phosphate|mesh-list
65625269|NCT02070458|Ixazomib|ixazomib|mesh-list
65625270|NCT02070458|Glycine|glycine|mesh-list
65625271|NCT02070458|Proteasome Inhibitors|proteasome inhibitors|mesh-list
65625272|NCT02070458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65625273|NCT02070458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625274|NCT02070458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65625275|NCT02070458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65625276|NCT02070458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625277|NCT02070458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625278|NCT02070458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65625279|NCT02070458|Antimetabolites|antimetabolites|mesh-ancestor
65625280|NCT02070458|Antiviral Agents|antiviral agents|mesh-ancestor
65625281|NCT02070458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65625282|NCT02070458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65625283|NCT02070458|Immunologic Factors|immunologic factors|mesh-ancestor
65625284|NCT02070458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625285|NCT02070458|Analgesics|analgesics|mesh-ancestor
65625286|NCT02070458|Sensory System Agents|sensory system agents|mesh-ancestor
65625287|NCT02070458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625288|NCT02070458|Protease Inhibitors|protease inhibitors|mesh-ancestor
65625289|NCT02070458|Glycine Agents|glycine agents|mesh-ancestor
65625290|NCT02070458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65625291|NCT03131479|Licogliflozin|licogliflozin|mesh-list
65625292|NCT03131479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65625293|NCT03131479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625294|NCT03131479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65625295|NCT03131479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625296|NCT04984369|Cetuximab|cetuximab|mesh-list
65625297|NCT04984369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65625298|NCT04984369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625299|NCT02077010|Milrinone|milrinone|mesh-list
65625300|NCT02077010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65625301|NCT02077010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65625302|NCT02077010|Vasodilator Agents|vasodilator agents|mesh-ancestor
65625303|NCT02077010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65625304|NCT02077010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65625305|NCT02077010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625306|NCT02077010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625307|NCT02077010|Protective Agents|protective agents|mesh-ancestor
65625308|NCT02077010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625309|NCT01319461|Hyaluronic Acid|hyaluronic acid|mesh-list
65625310|NCT01319461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65625311|NCT01319461|Immunologic Factors|immunologic factors|mesh-ancestor
65625312|NCT01319461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625313|NCT01319461|Viscosupplements|viscosupplements|mesh-ancestor
65625314|NCT01319461|Protective Agents|protective agents|mesh-ancestor
65625315|NCT02072720|Bevacizumab|bevacizumab|mesh-list
65625316|NCT02072720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65625317|NCT02072720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625318|NCT02072720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65625319|NCT02072720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65625320|NCT02072720|Growth Substances|growth substances|mesh-ancestor
65625321|NCT02072720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625322|NCT02072720|Growth Inhibitors|growth inhibitors|mesh-ancestor
65625323|NCT01356745|Nitrous Oxide|nitrous oxide|mesh-list
65625324|NCT01356745|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65625325|NCT01356745|Anesthetics, General|anesthetics, general|mesh-ancestor
65625326|NCT01356745|Anesthetics|anesthetics|mesh-ancestor
65625327|NCT01356745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65625328|NCT01356745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625329|NCT01356745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65625330|NCT01356745|Analgesics|analgesics|mesh-ancestor
65625331|NCT01356745|Sensory System Agents|sensory system agents|mesh-ancestor
65625332|NCT01356745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625333|NCT02072798|Cefuroxime|cefuroxime|mesh-list
65625334|NCT02072798|Cefuroxime axetil|cefuroxime axetil|mesh-list
65625335|NCT02072798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65625336|NCT02072798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65625337|NCT04943549|Bupivacaine|bupivacaine|mesh-list
65625338|NCT04943549|Anesthetics, Local|anesthetics, local|mesh-ancestor
65625339|NCT04943549|Anesthetics|anesthetics|mesh-ancestor
65625340|NCT04943549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65625341|NCT04943549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625342|NCT04943549|Sensory System Agents|sensory system agents|mesh-ancestor
65625343|NCT04943549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625344|NCT03578081|Dexamethasone|dexamethasone|mesh-list
65625345|NCT03578081|Ondansetron|ondansetron|mesh-list
65625346|NCT03578081|Olanzapine|olanzapine|mesh-list
65625347|NCT03578081|Palonosetron|palonosetron|mesh-list
65625348|NCT03578081|Fosaprepitant|fosaprepitant|mesh-list
65625349|NCT03578081|Aprepitant|aprepitant|mesh-list
65625350|NCT03578081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65625351|NCT03578081|Antiemetics|antiemetics|mesh-ancestor
65625352|NCT03578081|Autonomic Agents|autonomic agents|mesh-ancestor
65625353|NCT03578081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625354|NCT03578081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625355|NCT03578081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65625356|NCT03578081|Glucocorticoids|glucocorticoids|mesh-ancestor
65625357|NCT03578081|Hormones|hormones|mesh-ancestor
65266864|NCT02769494|Riboflavin|riboflavin|mesh-list
65625358|NCT03578081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65625359|NCT03578081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65625360|NCT03578081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625361|NCT03578081|Antipruritics|antipruritics|mesh-ancestor
65625362|NCT03578081|Dermatologic Agents|dermatologic agents|mesh-ancestor
65625363|NCT03578081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65625364|NCT03578081|Serotonin Agents|serotonin agents|mesh-ancestor
65625365|NCT03578081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65625366|NCT03578081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625367|NCT03578081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65625368|NCT03578081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65625369|NCT03578081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65625370|NCT03578081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65625371|NCT03578081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65625372|NCT03578081|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65625373|NCT03578081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65625374|NCT03578081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65625375|NCT03578081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65625376|NCT03578081|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65625377|NCT04252105|Antioxidants|antioxidants|mesh-list
65625378|NCT04252105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625379|NCT04252105|Protective Agents|protective agents|mesh-ancestor
65422766|NCT00953303|Prednisone|prednisone|mesh-list
65625380|NCT04252105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625381|NCT02077322|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
65625382|NCT02077322|Hemostatics|hemostatics|mesh-ancestor
65625383|NCT02077322|Coagulants|coagulants|mesh-ancestor
65625384|NCT02077400|Cefazolin|cefazolin|mesh-list
65625385|NCT02077400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65625386|NCT02077400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65625387|NCT02077478|Remifentanil|remifentanil|mesh-list
65625388|NCT02077478|Propofol|propofol|mesh-list
65625389|NCT02077478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65625390|NCT02077478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65625391|NCT02077478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625392|NCT02077478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65625393|NCT02077478|Anesthetics, General|anesthetics, general|mesh-ancestor
65625394|NCT02077478|Anesthetics|anesthetics|mesh-ancestor
65625395|NCT02077478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65625396|NCT02077478|Narcotics|narcotics|mesh-ancestor
65625397|NCT02077478|Analgesics|analgesics|mesh-ancestor
65625398|NCT02077478|Sensory System Agents|sensory system agents|mesh-ancestor
65625399|NCT02077478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625400|NCT02077556|Mycophenolic Acid|mycophenolic acid|mesh-list
65625401|NCT02077556|Methylprednisolone|methylprednisolone|mesh-list
65625402|NCT02077556|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65625403|NCT02077556|Prednisolone|prednisolone|mesh-list
65625404|NCT02077556|Everolimus|everolimus|mesh-list
65625405|NCT02077556|Tacrolimus|tacrolimus|mesh-list
65625406|NCT02077556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65625407|NCT02077556|Immunologic Factors|immunologic factors|mesh-ancestor
65625408|NCT02077556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625409|NCT02077556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65625410|NCT02077556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625411|NCT02077556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625412|NCT02077556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625413|NCT02077556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65625414|NCT02077556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65625415|NCT02077556|Antitubercular Agents|antitubercular agents|mesh-ancestor
65625416|NCT02077556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65625417|NCT02077556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65625418|NCT02077556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65625419|NCT02077556|Antiemetics|antiemetics|mesh-ancestor
65625420|NCT02077556|Autonomic Agents|autonomic agents|mesh-ancestor
65625421|NCT02077556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625422|NCT02077556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65625423|NCT02077556|Glucocorticoids|glucocorticoids|mesh-ancestor
65625424|NCT02077556|Hormones|hormones|mesh-ancestor
65625425|NCT02077556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65625426|NCT02077556|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65625427|NCT02077556|Protective Agents|protective agents|mesh-ancestor
65625428|NCT02077556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65625429|NCT02930941|Tranexamic Acid|tranexamic acid|mesh-list
65625430|NCT02930941|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65625431|NCT02930941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65625432|NCT02930941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625433|NCT02930941|Hemostatics|hemostatics|mesh-ancestor
65625434|NCT02930941|Coagulants|coagulants|mesh-ancestor
65625435|NCT02077634|Prednisone|prednisone|mesh-list
65625436|NCT02077634|Abiraterone Acetate|abiraterone acetate|mesh-list
65625437|NCT02077634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65625438|NCT02077634|Glucocorticoids|glucocorticoids|mesh-ancestor
65625439|NCT02077634|Hormones|hormones|mesh-ancestor
65625440|NCT02077634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65625441|NCT02077634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625442|NCT02077634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65625443|NCT02077634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625444|NCT02077634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65625445|NCT02077634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625446|NCT02077634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625447|NCT02077634|Hormone Antagonists|hormone antagonists|mesh-ancestor
65625448|NCT02077634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65625449|NCT01365403|Carbamazepine|carbamazepine|mesh-list
65625450|NCT01365403|Anticonvulsants|anticonvulsants|mesh-ancestor
65625451|NCT01365403|Antimanic Agents|antimanic agents|mesh-ancestor
65625452|NCT01365403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65625453|NCT01365403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65625454|NCT01365403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625455|NCT01365403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65422857|NCT00548249|Iron|iron|mesh-list
65625456|NCT01365403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65625457|NCT01365403|Analgesics|analgesics|mesh-ancestor
65625458|NCT01365403|Sensory System Agents|sensory system agents|mesh-ancestor
65625459|NCT01365403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625460|NCT01365403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65625461|NCT01365403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65625462|NCT01365403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625463|NCT01365403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65625464|NCT01365403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65625465|NCT01352663|Insulin|insulin|mesh-list
65625466|NCT01352663|Insulin Glargine|insulin glargine|mesh-list
65625467|NCT01352663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65625468|NCT01352663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625469|NCT01362361|Nintedanib|nintedanib|mesh-list
65625470|NCT01362361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625471|NCT01362361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65625472|NCT01362361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625473|NCT01362361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625474|NCT02077712|Dexmedetomidine|dexmedetomidine|mesh-list
65625475|NCT02077712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65625476|NCT02077712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65625477|NCT02077712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625478|NCT02077712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65625479|NCT02077712|Analgesics|analgesics|mesh-ancestor
65625480|NCT02077712|Sensory System Agents|sensory system agents|mesh-ancestor
65625481|NCT02077712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625482|NCT02077712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65625483|NCT02077712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65625484|NCT02077712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65625485|NCT02077712|Adrenergic Agents|adrenergic agents|mesh-ancestor
65625486|NCT02077712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65625487|NCT02077712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625488|NCT02073734|Dexamethasone|dexamethasone|mesh-list
65625489|NCT02073734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65625490|NCT02073734|Antiemetics|antiemetics|mesh-ancestor
65625491|NCT02073734|Autonomic Agents|autonomic agents|mesh-ancestor
65625492|NCT02073734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625493|NCT02073734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625494|NCT02073734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65625495|NCT02073734|Glucocorticoids|glucocorticoids|mesh-ancestor
65625496|NCT02073734|Hormones|hormones|mesh-ancestor
65625497|NCT02073734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65625498|NCT02073734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65625499|NCT02073734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625500|NCT02071004|Aspirin|aspirin|mesh-list
65625501|NCT02071004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65625502|NCT02071004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65625503|NCT02071004|Analgesics|analgesics|mesh-ancestor
65625504|NCT02071004|Sensory System Agents|sensory system agents|mesh-ancestor
65625505|NCT02071004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625506|NCT02071004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625507|NCT02071004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65625508|NCT02071004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65625509|NCT02071004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65625510|NCT02071004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65625511|NCT02071004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625512|NCT02071004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65625513|NCT02071004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65625514|NCT02071004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625515|NCT02071004|Antipyretics|antipyretics|mesh-ancestor
65625516|NCT02071160|Melatonin|melatonin|mesh-list
65625517|NCT02071160|Antioxidants|antioxidants|mesh-ancestor
65625518|NCT02071160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625519|NCT02071160|Protective Agents|protective agents|mesh-ancestor
65625520|NCT02071160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625521|NCT02071160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65625522|NCT03131713|Acetaminophen|acetaminophen|mesh-list
65625523|NCT03131713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65625524|NCT03131713|Analgesics|analgesics|mesh-ancestor
65625525|NCT03131713|Sensory System Agents|sensory system agents|mesh-ancestor
65625526|NCT03131713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625527|NCT03131713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625528|NCT03131713|Antipyretics|antipyretics|mesh-ancestor
65625529|NCT03514121|Pembrolizumab|pembrolizumab|mesh-list
65625530|NCT03514121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65625531|NCT03514121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625532|NCT02930005|Meclofenamic Acid|meclofenamic acid|mesh-list
65625533|NCT02930005|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
65625534|NCT02930005|Anticoagulants|anticoagulants|mesh-ancestor
65625535|NCT02930005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65625536|NCT02930005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65625537|NCT02930005|Analgesics|analgesics|mesh-ancestor
65625538|NCT02930005|Sensory System Agents|sensory system agents|mesh-ancestor
65625539|NCT02930005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625540|NCT02930005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625541|NCT02930005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65625542|NCT02930005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65625543|NCT02930005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65625544|NCT02930005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625545|NCT02930005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625546|NCT01349387|Metformin|metformin|mesh-list
65625547|NCT01349387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65625548|NCT01349387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625549|NCT04905173|Amyl Nitrite|amyl nitrite|mesh-list
65625550|NCT04905173|Vasodilator Agents|vasodilator agents|mesh-ancestor
65625551|NCT01361269|Clindamycin|clindamycin|mesh-list
65625552|NCT01361269|Clindamycin palmitate|clindamycin palmitate|mesh-list
65625553|NCT01361269|Clindamycin phosphate|clindamycin phosphate|mesh-list
65625554|NCT01361269|Fosmidomycin|fosmidomycin|mesh-list
65625555|NCT01361269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65625556|NCT01361269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65625557|NCT01361269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65625558|NCT01361269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625559|NCT01361269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625560|NCT01353209|Letrozole|letrozole|mesh-list
65625561|NCT01353209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625562|NCT01353209|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65625563|NCT01353209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65625564|NCT01353209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625565|NCT01353209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625566|NCT01353209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65625567|NCT01353209|Hormone Antagonists|hormone antagonists|mesh-ancestor
65625568|NCT01353209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65625569|NCT01353209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625570|NCT03637491|Avelumab|avelumab|mesh-list
65625571|NCT03637491|Talazoparib|talazoparib|mesh-list
65625572|NCT03637491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65625573|NCT03637491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625574|NCT03637491|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65625575|NCT03637491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625576|NCT03637491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625577|NCT01363063|Ketorolac|ketorolac|mesh-list
65625578|NCT01363063|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65625579|NCT01363063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65625580|NCT01363063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65625581|NCT01363063|Analgesics|analgesics|mesh-ancestor
65625582|NCT01363063|Sensory System Agents|sensory system agents|mesh-ancestor
65625583|NCT01363063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625584|NCT01363063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625585|NCT01363063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65625586|NCT01363063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65625587|NCT01363063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65625588|NCT01363063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625589|NCT01363063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625590|NCT04550455|Cladribine|cladribine|mesh-list
65625591|NCT04550455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625592|NCT04550455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65625593|NCT04550455|Immunologic Factors|immunologic factors|mesh-ancestor
65625594|NCT04550455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625595|NCT01349699|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65625596|NCT01349699|Deferasirox|deferasirox|mesh-list
65625597|NCT01349699|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65625598|NCT01349699|Chelating Agents|chelating agents|mesh-ancestor
65625599|NCT01349699|Sequestering Agents|sequestering agents|mesh-ancestor
65625600|NCT01349699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625601|NCT01349699|Hematinics|hematinics|mesh-ancestor
65625602|NCT01370161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65422984|NCT01025778|Antimetabolites|antimetabolites|mesh-ancestor
65625603|NCT01370161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65625604|NCT01370161|Adrenergic Agents|adrenergic agents|mesh-ancestor
65625605|NCT01370161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65625606|NCT01370161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625607|NCT01370161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625609|NCT03628443|Mitosis Modulators|mitosis modulators|mesh-ancestor
65625610|NCT03628443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625611|NCT01365871|Anesthetics|anesthetics|mesh-list
65625612|NCT01365871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65625613|NCT01365871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625614|NCT01349777|Clopidogrel|clopidogrel|mesh-list
65625615|NCT01349777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65625616|NCT01349777|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65625617|NCT01349777|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65625618|NCT01349777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65625619|NCT01349777|Purinergic Agents|purinergic agents|mesh-ancestor
65625620|NCT01349777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65625621|NCT01349777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625622|NCT01349777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625623|NCT03446157|Cetuximab|cetuximab|mesh-list
65625624|NCT03446157|Palbociclib|palbociclib|mesh-list
65625625|NCT03446157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65625626|NCT03446157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625627|NCT03446157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65625628|NCT03446157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625629|NCT03446157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625630|NCT04700007|Diphenhydramine|diphenhydramine|mesh-list
65625631|NCT04700007|Promethazine|promethazine|mesh-list
65625632|NCT04700007|Morphine|morphine|mesh-list
65625633|NCT04700007|Capsaicin|capsaicin|mesh-list
65625634|NCT04700007|Histamine|histamine|mesh-list
65625635|NCT04700007|Histamine Antagonists|histamine antagonists|mesh-list
65625636|NCT04700007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65625637|NCT04700007|Narcotics|narcotics|mesh-ancestor
65625638|NCT04700007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65625639|NCT04700007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625640|NCT04700007|Analgesics|analgesics|mesh-ancestor
65625641|NCT04700007|Sensory System Agents|sensory system agents|mesh-ancestor
65625642|NCT04700007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625643|NCT04700007|Antipruritics|antipruritics|mesh-ancestor
65625644|NCT04700007|Dermatologic Agents|dermatologic agents|mesh-ancestor
65625645|NCT04700007|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65625646|NCT04700007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65625647|NCT04700007|Anesthetics, Local|anesthetics, local|mesh-ancestor
65625648|NCT04700007|Anesthetics|anesthetics|mesh-ancestor
65625649|NCT04700007|Antiemetics|antiemetics|mesh-ancestor
65625650|NCT04700007|Autonomic Agents|autonomic agents|mesh-ancestor
65625651|NCT04700007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65625652|NCT04700007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65625653|NCT04700007|Histamine Agents|histamine agents|mesh-ancestor
65625654|NCT04700007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65625655|NCT04700007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625656|NCT04700007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65625657|NCT04700007|Histamine Agonists|histamine agonists|mesh-ancestor
65625658|NCT01349855|Insulin Glargine|insulin glargine|mesh-list
65625659|NCT01349855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65625660|NCT01349855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625661|NCT01318655|Naloxegol|naloxegol|mesh-list
65625662|NCT01318655|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65625663|NCT01318655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625664|NCT01318655|Sensory System Agents|sensory system agents|mesh-ancestor
65625665|NCT01318655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625666|NCT01353599|Mometasone Furoate|mometasone furoate|mesh-list
65625667|NCT01353599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65625668|NCT01353599|Dermatologic Agents|dermatologic agents|mesh-ancestor
65625669|NCT01353599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65625670|NCT02961881|Blinatumomab|blinatumomab|mesh-list
65625671|NCT02961881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625672|NCT03334539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65625673|NCT03334539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65625674|NCT01350089|Ethanol|ethanol|mesh-list
65625675|NCT01350089|Caffeine|caffeine|mesh-list
65625676|NCT01350089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65625677|NCT01350089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65625678|NCT01350089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65625679|NCT01350089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625680|NCT01350089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65625681|NCT01350089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65625682|NCT01350089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625683|NCT01350089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625684|NCT01350089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65625685|NCT01350089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65625686|NCT01350089|Purinergic Agents|purinergic agents|mesh-ancestor
65625687|NCT01350089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65625688|NCT03137303|Albuterol|albuterol|mesh-list
65625689|NCT03137303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65625690|NCT03137303|Autonomic Agents|autonomic agents|mesh-ancestor
65625691|NCT03137303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625692|NCT03137303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625693|NCT03137303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65625694|NCT03137303|Respiratory System Agents|respiratory system agents|mesh-ancestor
65625695|NCT03137303|Tocolytic Agents|tocolytic agents|mesh-ancestor
65625696|NCT03137303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65625697|NCT03137303|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65625698|NCT03137303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65625699|NCT03137303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65625700|NCT03137303|Adrenergic Agents|adrenergic agents|mesh-ancestor
65625701|NCT03137303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65625702|NCT03137303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625703|NCT03296553|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65625704|NCT03296553|Valganciclovir|valganciclovir|mesh-list
65625705|NCT03296553|Antiviral Agents|antiviral agents|mesh-ancestor
65625706|NCT03296553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65625707|NCT01363375|Carbon Fiber|carbon fiber|mesh-list
65625708|NCT01363375|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65625709|NCT01363375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65625710|NCT01370707|Metformin|metformin|mesh-list
65625711|NCT01370707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65625712|NCT01370707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625713|NCT01363531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65625714|NCT01363531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65625715|NCT01363609|Insulin Glargine|insulin glargine|mesh-list
65625716|NCT01363609|Liraglutide|liraglutide|mesh-list
65625717|NCT01363609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65625718|NCT01363609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625719|NCT01363609|Incretins|incretins|mesh-ancestor
65625720|NCT01363609|Hormones|hormones|mesh-ancestor
65266874|NCT02769494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65625721|NCT01363609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65625722|NCT03060447|Vesatolimod|vesatolimod|mesh-list
65625723|NCT03060447|Antiviral Agents|antiviral agents|mesh-ancestor
65625724|NCT03060447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65625725|NCT04623567|Metformin|metformin|mesh-list
65625726|NCT04623567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65625727|NCT04623567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625728|NCT01712789|Dexamethasone|dexamethasone|mesh-list
65625729|NCT01712789|Pomalidomide|pomalidomide|mesh-list
65625730|NCT01712789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65625731|NCT01712789|Antiemetics|antiemetics|mesh-ancestor
65625732|NCT01712789|Autonomic Agents|autonomic agents|mesh-ancestor
65625733|NCT01712789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625734|NCT01712789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625735|NCT01712789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65625736|NCT01712789|Glucocorticoids|glucocorticoids|mesh-ancestor
65625737|NCT01712789|Hormones|hormones|mesh-ancestor
65625738|NCT01712789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65625739|NCT01712789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65625740|NCT01712789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625741|NCT01712789|Immunologic Factors|immunologic factors|mesh-ancestor
65625742|NCT01712789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65625743|NCT01712789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65625744|NCT01712789|Growth Substances|growth substances|mesh-ancestor
65625745|NCT01712789|Growth Inhibitors|growth inhibitors|mesh-ancestor
65625746|NCT01350323|Bevacizumab|bevacizumab|mesh-list
65625747|NCT01350323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65625748|NCT01350323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625749|NCT01350323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65625750|NCT01350323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65625751|NCT01350323|Growth Substances|growth substances|mesh-ancestor
65625752|NCT01350323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625753|NCT01350323|Growth Inhibitors|growth inhibitors|mesh-ancestor
65625754|NCT01357811|Digoxin|digoxin|mesh-list
65625755|NCT01357811|Eliglustat|eliglustat|mesh-list
65625756|NCT01357811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65625757|NCT01357811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65625758|NCT01357811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625759|NCT01357811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625760|NCT01357811|Protective Agents|protective agents|mesh-ancestor
65625761|NCT01357811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625762|NCT03074318|Avelumab|avelumab|mesh-list
65625763|NCT03074318|Trabectedin|trabectedin|mesh-list
65625764|NCT03074318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65625765|NCT03074318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65625766|NCT03074318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625767|NCT03074318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65625768|NCT03074318|Alkylating Agents|alkylating agents|mesh-ancestor
65625769|NCT03074318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625770|NCT03074318|Immunologic Factors|immunologic factors|mesh-ancestor
65625771|NCT03074318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625772|NCT02071316|Esomeprazole|esomeprazole|mesh-list
65625773|NCT02071316|Tranexamic Acid|tranexamic acid|mesh-list
65625774|NCT02071316|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65625775|NCT02071316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65625776|NCT02071316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625777|NCT02071316|Hemostatics|hemostatics|mesh-ancestor
65625778|NCT02071316|Coagulants|coagulants|mesh-ancestor
65625779|NCT02071316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65625780|NCT02071316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65625781|NCT02071316|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65625782|NCT02071316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625783|NCT02074202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65625784|NCT02074202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65625785|NCT02074202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625786|NCT02074280|Rifaximin|rifaximin|mesh-list
65625787|NCT02074280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65625788|NCT02074280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65625789|NCT02074280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65625790|NCT02077946|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65625791|NCT02077946|Liraglutide|liraglutide|mesh-list
65625792|NCT02077946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65625793|NCT02077946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625794|NCT02077946|Incretins|incretins|mesh-ancestor
65625795|NCT02077946|Hormones|hormones|mesh-ancestor
65625796|NCT02077946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65625797|NCT02077946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65625798|NCT02077946|Protease Inhibitors|protease inhibitors|mesh-ancestor
65625799|NCT02077946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625800|NCT02077946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625801|NCT03559790|Tenofovir|tenofovir|mesh-list
65625802|NCT03559790|Antiviral Agents|antiviral agents|mesh-ancestor
65625803|NCT03559790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65625804|NCT03559790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65625805|NCT03559790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65625806|NCT03559790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625807|NCT03559790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625808|NCT03559790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65625809|NCT03559790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65625810|NCT02079974|Pravastatin|pravastatin|mesh-list
65625811|NCT02079974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65625812|NCT02079974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65625813|NCT02079974|Antimetabolites|antimetabolites|mesh-ancestor
65625814|NCT02079974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625815|NCT02079974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65625816|NCT02079974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65625817|NCT02079974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625818|NCT01317953|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65625819|NCT01317953|Antioxidants|antioxidants|mesh-ancestor
65625820|NCT01317953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625821|NCT01317953|Protective Agents|protective agents|mesh-ancestor
65625822|NCT01317953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625823|NCT01317953|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65625824|NCT01317953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65625825|NCT01317953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625826|NCT01317953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65625827|NCT02078336|Atropine|atropine|mesh-list
65625828|NCT02078336|Midazolam|midazolam|mesh-list
65625829|NCT02078336|Droperidol|droperidol|mesh-list
65625830|NCT02078336|Lorazepam|lorazepam|mesh-list
65625831|NCT02078336|Biperiden|biperiden|mesh-list
65625832|NCT02078336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65625833|NCT02078336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65625834|NCT02078336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65625835|NCT02078336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625836|NCT02078336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65625837|NCT02078336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65625838|NCT02078336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65625839|NCT02078336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65625840|NCT02078336|Anesthetics, General|anesthetics, general|mesh-ancestor
65625841|NCT02078336|Anesthetics|anesthetics|mesh-ancestor
65625842|NCT02078336|GABA Modulators|gaba modulators|mesh-ancestor
65625843|NCT02078336|GABA Agents|gaba agents|mesh-ancestor
65625844|NCT02078336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65625845|NCT02078336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625846|NCT02078336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65625847|NCT02078336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65625848|NCT02078336|Autonomic Agents|autonomic agents|mesh-ancestor
65625849|NCT02078336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625850|NCT02078336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65625851|NCT02078336|Respiratory System Agents|respiratory system agents|mesh-ancestor
65625852|NCT02078336|Mydriatics|mydriatics|mesh-ancestor
65625853|NCT02078336|Parasympatholytics|parasympatholytics|mesh-ancestor
65625854|NCT02078336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65625855|NCT02078336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65625856|NCT02078336|Cholinergic Agents|cholinergic agents|mesh-ancestor
65625857|NCT02078336|Anticonvulsants|anticonvulsants|mesh-ancestor
65625858|NCT02078336|Antiemetics|antiemetics|mesh-ancestor
65625859|NCT02078336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65625860|NCT02078336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65625861|NCT02078336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65625862|NCT02078336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65625863|NCT02078336|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65625864|NCT02078336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65625865|NCT02078336|Dopamine Agents|dopamine agents|mesh-ancestor
65625866|NCT01353833|Aldesleukin|aldesleukin|mesh-list
65625867|NCT01353833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625868|NCT01353833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65625869|NCT01353833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65625870|NCT01353833|Antiviral Agents|antiviral agents|mesh-ancestor
65625871|NCT01353833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65625872|NCT03353675|Nivolumab|nivolumab|mesh-list
65625873|NCT03353675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65625874|NCT03353675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625875|NCT03353675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65625876|NCT03353675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625877|NCT01350713|Povidone-Iodine|povidone-iodine|mesh-list
65625878|NCT01350713|Povidone|povidone|mesh-list
65625879|NCT01350713|Plasma Substitutes|plasma substitutes|mesh-ancestor
65625880|NCT01350713|Blood Substitutes|blood substitutes|mesh-ancestor
65625881|NCT01350713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65625882|NCT01350713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65625883|NCT02075294|Entecavir|entecavir|mesh-list
65625884|NCT02075294|Adefovir|adefovir|mesh-list
65625885|NCT02075294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65625886|NCT02075294|Antiviral Agents|antiviral agents|mesh-ancestor
65625887|NCT02075294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65625888|NCT02075294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65625889|NCT02075294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65625890|NCT02075294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625891|NCT02075294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625892|NCT01357967|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65625893|NCT01357967|Antidepressive Agents|antidepressive agents|mesh-ancestor
65625894|NCT01357967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65625895|NCT01357967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65625896|NCT01357967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65625897|NCT01357967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65625898|NCT01357967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625899|NCT02075528|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65625900|NCT02075528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65625901|NCT02075528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65625902|NCT02075528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65625903|NCT02075528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625904|NCT02075528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65625905|NCT02075528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65625906|NCT02075528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65625907|NCT02075528|Serotonin Agents|serotonin agents|mesh-ancestor
65625908|NCT02075528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65625909|NCT02075528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625910|NCT02075528|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65625911|NCT02075528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65625912|NCT02075528|Dopamine Agents|dopamine agents|mesh-ancestor
65625913|NCT02078648|Poly I-C|poly i-c|mesh-list
65625914|NCT02078648|Bevacizumab|bevacizumab|mesh-list
65625915|NCT02078648|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65625916|NCT02078648|Poly ICLC|poly iclc|mesh-list
65625917|NCT02078648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65625918|NCT02078648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625919|NCT02078648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65625920|NCT02078648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65625921|NCT02078648|Growth Substances|growth substances|mesh-ancestor
65625922|NCT02078648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625923|NCT02078648|Growth Inhibitors|growth inhibitors|mesh-ancestor
65625924|NCT02078648|Interferon Inducers|interferon inducers|mesh-ancestor
65625925|NCT02078648|Immunologic Factors|immunologic factors|mesh-ancestor
65625926|NCT02078648|Antiviral Agents|antiviral agents|mesh-ancestor
65625927|NCT02078648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65625928|NCT02078648|Laxatives|laxatives|mesh-ancestor
65625929|NCT02078648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65625930|NCT01358045|Calcitriol|calcitriol|mesh-list
65625931|NCT01358045|Diclofenac|diclofenac|mesh-list
65625932|NCT01358045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65625933|NCT01358045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65625934|NCT01358045|Analgesics|analgesics|mesh-ancestor
65625935|NCT01358045|Sensory System Agents|sensory system agents|mesh-ancestor
65625936|NCT01358045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625937|NCT01358045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625938|NCT01358045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65625939|NCT01358045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65625940|NCT01358045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65625941|NCT01358045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625942|NCT01358045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625943|NCT01358045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65625944|NCT01358045|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65625945|NCT01358045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65625946|NCT01358045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65625947|NCT01358045|Vitamins|vitamins|mesh-ancestor
65625948|NCT01358045|Micronutrients|micronutrients|mesh-ancestor
65625949|NCT01358045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65625950|NCT02076230|Phosphoramide Mustards|phosphoramide mustards|mesh-list
65625951|NCT02076230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65625952|NCT02076230|Alkylating Agents|alkylating agents|mesh-ancestor
65625953|NCT02076230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625954|NCT02076230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65625955|NCT04300985|Magnesium Sulfate|magnesium sulfate|mesh-list
65625956|NCT04300985|Dexmedetomidine|dexmedetomidine|mesh-list
65625957|NCT04300985|Anesthetics|anesthetics|mesh-list
65625958|NCT04300985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65625959|NCT04300985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625960|NCT04300985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65625961|NCT04300985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65625962|NCT04300985|Analgesics|analgesics|mesh-ancestor
65625963|NCT04300985|Sensory System Agents|sensory system agents|mesh-ancestor
65625964|NCT04300985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625965|NCT04300985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65625966|NCT04300985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65625967|NCT04300985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65625968|NCT04300985|Adrenergic Agents|adrenergic agents|mesh-ancestor
65625969|NCT04300985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65625970|NCT04300985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625971|NCT04300985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65625972|NCT04300985|Anticonvulsants|anticonvulsants|mesh-ancestor
65625973|NCT04300985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65625974|NCT04300985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65625975|NCT04300985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65625976|NCT04300985|Tocolytic Agents|tocolytic agents|mesh-ancestor
65625977|NCT04300985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65625978|NCT02079194|Aspirin|aspirin|mesh-list
65625979|NCT02079194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65625980|NCT02079194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65625981|NCT02079194|Analgesics|analgesics|mesh-ancestor
65625982|NCT02079194|Sensory System Agents|sensory system agents|mesh-ancestor
65625983|NCT02079194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625984|NCT02079194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625985|NCT02079194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65625986|NCT02079194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65625987|NCT02079194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65625988|NCT02079194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65625989|NCT02079194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65625990|NCT02079194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65625991|NCT02079194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65625992|NCT02079194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65625993|NCT02079194|Antipyretics|antipyretics|mesh-ancestor
65625994|NCT01351493|Nitric Oxide|nitric oxide|mesh-list
65625995|NCT01351493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65625996|NCT01351493|Autonomic Agents|autonomic agents|mesh-ancestor
65625997|NCT01351493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65625998|NCT01351493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65625999|NCT01351493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65626000|NCT01351493|Respiratory System Agents|respiratory system agents|mesh-ancestor
65626001|NCT01351493|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65626002|NCT01351493|Antioxidants|antioxidants|mesh-ancestor
65626003|NCT01351493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626004|NCT01351493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65626005|NCT01351493|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65626006|NCT01351493|Vasodilator Agents|vasodilator agents|mesh-ancestor
65626007|NCT01351493|Gasotransmitters|gasotransmitters|mesh-ancestor
65626008|NCT01351493|Protective Agents|protective agents|mesh-ancestor
65626009|NCT01318187|Acetaminophen|acetaminophen|mesh-list
65626010|NCT01318187|Morphine|morphine|mesh-list
65626011|NCT01318187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65626012|NCT01318187|Narcotics|narcotics|mesh-ancestor
65626013|NCT01318187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65626014|NCT01318187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626015|NCT01318187|Analgesics|analgesics|mesh-ancestor
65088784|NCT00473915|Xhance|xhance|mesh-list
65626016|NCT01318187|Sensory System Agents|sensory system agents|mesh-ancestor
65626017|NCT01318187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626018|NCT01318187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65626019|NCT01318187|Antipyretics|antipyretics|mesh-ancestor
65626020|NCT01358435|Insulin|insulin|mesh-list
65626021|NCT01358435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65626022|NCT01358435|Insulin, Isophane|insulin, isophane|mesh-list
65626023|NCT01358435|Isophane Insulin, Human|isophane insulin, human|mesh-list
65626024|NCT01358435|Isophane insulin, beef|isophane insulin, beef|mesh-list
65626025|NCT01358435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65626026|NCT01358435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626027|NCT01318265|Ketoconazole|ketoconazole|mesh-list
65626028|NCT01318265|Antifungal Agents|antifungal agents|mesh-ancestor
65626029|NCT01318265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65626030|NCT01318265|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65626031|NCT01318265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65626032|NCT01318265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626033|NCT01318265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626034|NCT01318265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65626035|NCT01318265|Hormone Antagonists|hormone antagonists|mesh-ancestor
65626036|NCT01318265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65626037|NCT01318265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626038|NCT01318265|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65626039|NCT01354457|Epratuzumab|epratuzumab|mesh-list
65626040|NCT01354457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65626041|NCT01354457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626042|NCT02079350|Polygeline|polygeline|mesh-list
65626043|NCT02079350|Plasma Substitutes|plasma substitutes|mesh-ancestor
65626044|NCT02079350|Blood Substitutes|blood substitutes|mesh-ancestor
65626045|NCT03062540|Cyclobenzaprine|cyclobenzaprine|mesh-list
65626046|NCT03062540|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65626047|NCT03062540|Antidepressive Agents|antidepressive agents|mesh-ancestor
65626048|NCT03062540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65626049|NCT03062540|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65626050|NCT03062540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626051|NCT03062540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65626052|NCT03062540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626053|NCT03062540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65626054|NCT03062540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65626055|NCT03060980|Empagliflozin|empagliflozin|mesh-list
65626056|NCT03060980|Glimepiride|glimepiride|mesh-list
65626057|NCT03060980|Exenatide|exenatide|mesh-list
65626058|NCT03060980|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65626059|NCT03060980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626060|NCT03060980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65626061|NCT03060980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626062|NCT03060980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65626063|NCT03060980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65626064|NCT03060980|Immunologic Factors|immunologic factors|mesh-ancestor
65626065|NCT03060980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65626066|NCT03060980|Incretins|incretins|mesh-ancestor
65626067|NCT03060980|Hormones|hormones|mesh-ancestor
65626068|NCT03060980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65626069|NCT01358591|Calcium Carbonate|calcium carbonate|mesh-list
65626070|NCT01358591|Calcium|calcium|mesh-list
65626071|NCT01358591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65626072|NCT01358591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626073|NCT01358591|Antacids|antacids|mesh-ancestor
65626074|NCT01358591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626075|NCT01358591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65626076|NCT02081144|Nicotine|nicotine|mesh-list
65626077|NCT02081144|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65626078|NCT02081144|Autonomic Agents|autonomic agents|mesh-ancestor
65626079|NCT02081144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626080|NCT02081144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626081|NCT02081144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65626082|NCT02081144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65626083|NCT02081144|Cholinergic Agents|cholinergic agents|mesh-ancestor
65626084|NCT02081144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65626085|NCT02081144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626086|NCT02083328|Mannitol|mannitol|mesh-list
65626087|NCT02083328|Caffeine|caffeine|mesh-list
65626088|NCT02083328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65626089|NCT02083328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626090|NCT02083328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65626091|NCT02083328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626092|NCT02083328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626093|NCT02083328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65626094|NCT02083328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65626095|NCT02083328|Purinergic Agents|purinergic agents|mesh-ancestor
65626096|NCT02083328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65626097|NCT02083328|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65626098|NCT02083328|Diuretics|diuretics|mesh-ancestor
65626099|NCT02083328|Natriuretic Agents|natriuretic agents|mesh-ancestor
65626100|NCT02079506|Candesartan|candesartan|mesh-list
65626101|NCT02079506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65626102|NCT02079506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65626103|NCT02079506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65626104|NCT02079506|Antimetabolites|antimetabolites|mesh-ancestor
65626105|NCT02079506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626106|NCT02079506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65626107|NCT02079506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65626108|NCT02079506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626109|NCT02079506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65626110|NCT02079506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65626111|NCT02079506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65626112|NCT02940548|Amlodipine|amlodipine|mesh-list
65626113|NCT02940548|Nifedipine|nifedipine|mesh-list
65626114|NCT02940548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65626115|NCT02940548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65626116|NCT02940548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65626117|NCT02940548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626118|NCT02940548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65626119|NCT02940548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626120|NCT02940548|Vasodilator Agents|vasodilator agents|mesh-ancestor
65626121|NCT02940548|Tocolytic Agents|tocolytic agents|mesh-ancestor
65626122|NCT02940548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65626123|NCT01366183|Paclitaxel|paclitaxel|mesh-list
65626124|NCT01366183|Carboplatin|carboplatin|mesh-list
65626125|NCT01366183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65626126|NCT01366183|Lenograstim|lenograstim|mesh-list
65626127|NCT01366183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65626128|NCT01366183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626129|NCT01366183|Tubulin Modulators|tubulin modulators|mesh-ancestor
65626130|NCT01366183|Antimitotic Agents|antimitotic agents|mesh-ancestor
65626131|NCT01366183|Mitosis Modulators|mitosis modulators|mesh-ancestor
65626132|NCT01366183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626133|NCT01366183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65626134|NCT01366183|Immunologic Factors|immunologic factors|mesh-ancestor
65626135|NCT01366183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626136|NCT03134183|Misoprostol|misoprostol|mesh-list
65626137|NCT03134183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65626138|NCT03134183|Abortifacient Agents|abortifacient agents|mesh-ancestor
65626139|NCT03134183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65626140|NCT03134183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626141|NCT03134183|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65626142|NCT03134183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65626143|NCT03134183|Oxytocics|oxytocics|mesh-ancestor
65626144|NCT02083484|Pembrolizumab|pembrolizumab|mesh-list
65626145|NCT02083484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65626146|NCT02083484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626147|NCT01354613|Amlodipine|amlodipine|mesh-list
65626148|NCT01354613|Dobutamine|dobutamine|mesh-list
65626149|NCT01354613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65626150|NCT01354613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65626151|NCT01354613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65626152|NCT01354613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626153|NCT01354613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65626154|NCT01354613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626155|NCT01354613|Vasodilator Agents|vasodilator agents|mesh-ancestor
65626156|NCT01354613|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65626157|NCT01354613|Sympathomimetics|sympathomimetics|mesh-ancestor
65626158|NCT01354613|Autonomic Agents|autonomic agents|mesh-ancestor
65626159|NCT01354613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626160|NCT01354613|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65626161|NCT01354613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65626162|NCT01354613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65626163|NCT01354613|Adrenergic Agents|adrenergic agents|mesh-ancestor
65626164|NCT01354613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65626165|NCT01354613|Protective Agents|protective agents|mesh-ancestor
65626166|NCT02083640|Palbociclib|palbociclib|mesh-list
65626167|NCT02083640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626168|NCT02083640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65626169|NCT02083640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626170|NCT02083640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626171|NCT01352039|Heparin|heparin|mesh-list
65626172|NCT01352039|Calcium heparin|calcium heparin|mesh-list
65626173|NCT01352039|Anticoagulants|anticoagulants|mesh-ancestor
65626174|NCT01352039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65626175|NCT01352039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65626176|NCT01352039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626177|NCT04419337|Metformin|metformin|mesh-list
65626178|NCT04419337|Pioglitazone|pioglitazone|mesh-list
65626179|NCT04419337|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65626180|NCT04419337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65626181|NCT04419337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626182|NCT04419337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626183|NCT01359059|Pregabalin|pregabalin|mesh-list
65626184|NCT01359059|Analgesics|analgesics|mesh-ancestor
65626185|NCT01359059|Sensory System Agents|sensory system agents|mesh-ancestor
65626186|NCT01359059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626187|NCT01359059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626188|NCT01359059|Anticonvulsants|anticonvulsants|mesh-ancestor
65626189|NCT01359059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65626190|NCT01359059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65626191|NCT01359059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626192|NCT01359059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65626193|NCT01359059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65626194|NCT01359059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65626195|NCT01359059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65626196|NCT01359059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65626197|NCT02576574|Gemcitabine|gemcitabine|mesh-list
65626198|NCT02576574|Paclitaxel|paclitaxel|mesh-list
65626199|NCT02576574|Carboplatin|carboplatin|mesh-list
65626200|NCT02576574|Pemetrexed|pemetrexed|mesh-list
65626201|NCT02576574|Avelumab|avelumab|mesh-list
65626202|NCT02576574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65626203|NCT02576574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65626204|NCT02576574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626205|NCT02576574|Tubulin Modulators|tubulin modulators|mesh-ancestor
65626206|NCT02576574|Antimitotic Agents|antimitotic agents|mesh-ancestor
65626207|NCT02576574|Mitosis Modulators|mitosis modulators|mesh-ancestor
65626208|NCT02576574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626209|NCT02576574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65626210|NCT02576574|Antimetabolites|antimetabolites|mesh-ancestor
65626211|NCT02576574|Antiviral Agents|antiviral agents|mesh-ancestor
65626212|NCT02576574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65626213|NCT02576574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626214|NCT02576574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65626215|NCT02576574|Immunologic Factors|immunologic factors|mesh-ancestor
65626216|NCT02576574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626217|NCT02576574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65626218|NCT02576574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65626219|NCT02576574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65626220|NCT05189093|Antibodies|antibodies|mesh-list
65626221|NCT05189093|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65626222|NCT05189093|Immunologic Factors|immunologic factors|mesh-ancestor
65626223|NCT05189093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626224|NCT01371331|Tacrolimus|tacrolimus|mesh-list
65626225|NCT01371331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65626226|NCT01371331|Immunologic Factors|immunologic factors|mesh-ancestor
65626227|NCT01371331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626228|NCT01371331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65626229|NCT01371331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626230|NCT01371331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626231|NCT01366339|Methylnaltrexone|methylnaltrexone|mesh-list
65626232|NCT01366339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65626233|NCT01366339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626234|NCT01366339|Sensory System Agents|sensory system agents|mesh-ancestor
65626235|NCT01366339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626236|NCT03133793|Coenzyme Q10|coenzyme q10|mesh-list
65626237|NCT03133793|Vitamins|vitamins|mesh-ancestor
65626238|NCT03133793|Micronutrients|micronutrients|mesh-ancestor
65626239|NCT03133793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626240|NCT03133481|Ropivacaine|ropivacaine|mesh-list
65626241|NCT03133481|Anesthetics, Local|anesthetics, local|mesh-ancestor
65626242|NCT03133481|Anesthetics|anesthetics|mesh-ancestor
65626243|NCT03133481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65626244|NCT03133481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626245|NCT03133481|Sensory System Agents|sensory system agents|mesh-ancestor
65626246|NCT03133481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626247|NCT01366651|Doripenem|doripenem|mesh-list
65626248|NCT01366651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65626249|NCT01366651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65626250|NCT05124509|Vaccines|vaccines|mesh-list
65626251|NCT05124509|Immunologic Factors|immunologic factors|mesh-ancestor
65626252|NCT05124509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626253|NCT02864316|Nivolumab|nivolumab|mesh-list
65626254|NCT02864316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65626255|NCT02864316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626256|NCT02864316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65626257|NCT02864316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626258|NCT03941509|Anti-Infective Agents|anti-infective agents|mesh-list
65626259|NCT03941509|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65626260|NCT01361399|Aspirin|aspirin|mesh-list
65626261|NCT01361399|Lidocaine|lidocaine|mesh-list
65626262|NCT01361399|Anesthetics, Local|anesthetics, local|mesh-ancestor
65626263|NCT01361399|Anesthetics|anesthetics|mesh-ancestor
65626264|NCT01361399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65626265|NCT01361399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626266|NCT01361399|Sensory System Agents|sensory system agents|mesh-ancestor
65626267|NCT01361399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626268|NCT01361399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65626269|NCT01361399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65626270|NCT01361399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65626271|NCT01361399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65626272|NCT01361399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626273|NCT01361399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65626274|NCT01361399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65626275|NCT01361399|Analgesics|analgesics|mesh-ancestor
65626276|NCT01361399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65626277|NCT01361399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65626278|NCT01361399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65626279|NCT01361399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65423651|NCT00407511|Pregabalin|pregabalin|mesh-list
65626280|NCT01361399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65626281|NCT01361399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65626282|NCT01361399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626283|NCT01361399|Antipyretics|antipyretics|mesh-ancestor
65626284|NCT02862600|Perhexiline|perhexiline|mesh-list
65626285|NCT02862600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65626286|NCT02862600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65626287|NCT02862600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626288|NCT02862600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65626289|NCT02862600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626290|NCT02862600|Vasodilator Agents|vasodilator agents|mesh-ancestor
65626291|NCT01354925|Insulin|insulin|mesh-list
65626292|NCT01354925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65626293|NCT01354925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626294|NCT03556345|Trastuzumab|trastuzumab|mesh-list
65626295|NCT03556345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65626296|NCT03556345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626297|NCT03610230|Iron|iron|mesh-list
65626298|NCT03610230|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65626299|NCT03610230|Ferric Compounds|ferric compounds|mesh-list
65626300|NCT03610230|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65626301|NCT03610230|Trace Elements|trace elements|mesh-ancestor
65626302|NCT03610230|Micronutrients|micronutrients|mesh-ancestor
65626303|NCT03610230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626304|NCT03610230|Hematinics|hematinics|mesh-ancestor
65626305|NCT01359605|Varespladib methyl|varespladib methyl|mesh-list
65626306|NCT01359605|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
65626307|NCT01359605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089075|NCT00469586|Insulin|insulin|mesh-list
65626308|NCT01359605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626309|NCT05188859|Pemetrexed|pemetrexed|mesh-list
65626310|NCT05188859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626311|NCT05188859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626312|NCT05188859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626313|NCT05188859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65626314|NCT05188859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65626315|NCT02033538|Paclitaxel|paclitaxel|mesh-list
65626316|NCT02033538|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65626317|NCT02033538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65626318|NCT02033538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626319|NCT02033538|Tubulin Modulators|tubulin modulators|mesh-ancestor
65626320|NCT02033538|Antimitotic Agents|antimitotic agents|mesh-ancestor
65626321|NCT02033538|Mitosis Modulators|mitosis modulators|mesh-ancestor
65626322|NCT02033538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626323|NCT02792192|Atezolizumab|atezolizumab|mesh-list
65626324|NCT02792192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626325|NCT03609996|Ranibizumab|ranibizumab|mesh-list
65626326|NCT03609996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65626327|NCT03609996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65626328|NCT03609996|Growth Substances|growth substances|mesh-ancestor
65626329|NCT03609996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626330|NCT03609996|Growth Inhibitors|growth inhibitors|mesh-ancestor
65626331|NCT03609996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626332|NCT02088008|Valsartan|valsartan|mesh-list
65626333|NCT02088008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65626334|NCT02088008|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65626335|NCT02088008|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65626336|NCT02088008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626337|NCT01361789|Dexamethasone|dexamethasone|mesh-list
65626338|NCT01361789|Dexamethasone acetate|dexamethasone acetate|mesh-list
65626339|NCT01361789|Etoricoxib|etoricoxib|mesh-list
65626340|NCT01361789|Parecoxib|parecoxib|mesh-list
65626341|NCT01361789|Valdecoxib|valdecoxib|mesh-list
65626342|NCT01361789|BB 1101|bb 1101|mesh-list
65626343|NCT01361789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65626344|NCT01361789|Antiemetics|antiemetics|mesh-ancestor
65626345|NCT01361789|Autonomic Agents|autonomic agents|mesh-ancestor
65626346|NCT01361789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626347|NCT01361789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626348|NCT01361789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65626349|NCT01361789|Glucocorticoids|glucocorticoids|mesh-ancestor
65626350|NCT01361789|Hormones|hormones|mesh-ancestor
65626351|NCT01361789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65626352|NCT01361789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65626353|NCT01361789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626354|NCT01361789|Protease Inhibitors|protease inhibitors|mesh-ancestor
65626355|NCT01361789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626356|NCT01361789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626357|NCT01361789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65626358|NCT01361789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65626359|NCT01361789|Analgesics|analgesics|mesh-ancestor
65626360|NCT01361789|Sensory System Agents|sensory system agents|mesh-ancestor
65626361|NCT01361789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65626362|NCT01361789|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65626363|NCT01361789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65626364|NCT02964507|Fulvestrant|fulvestrant|mesh-list
65626365|NCT02964507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65626366|NCT02964507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626367|NCT02964507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65626368|NCT02964507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65626369|NCT02964507|Hormone Antagonists|hormone antagonists|mesh-ancestor
65626370|NCT02964507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65626371|NCT02964507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626372|NCT02083874|Cannabidiol|cannabidiol|mesh-list
65626373|NCT02083874|Anticonvulsants|anticonvulsants|mesh-ancestor
65626374|NCT05188781|Pembrolizumab|pembrolizumab|mesh-list
65626375|NCT05188781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65626376|NCT05188781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626377|NCT03634735|Thiamine|thiamine|mesh-list
65626378|NCT03634735|Vitamins|vitamins|mesh-ancestor
65626379|NCT03634735|Micronutrients|micronutrients|mesh-ancestor
65626380|NCT03634735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626381|NCT03634735|Vitamin B Complex|vitamin b complex|mesh-ancestor
65626382|NCT02084342|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65626383|NCT02084342|Tranexamic Acid|tranexamic acid|mesh-list
65626384|NCT02084342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65626385|NCT02084342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65626386|NCT02084342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626387|NCT02084342|Hemostatics|hemostatics|mesh-ancestor
65626388|NCT02084342|Coagulants|coagulants|mesh-ancestor
65626389|NCT02084342|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65626390|NCT02084342|Natriuretic Agents|natriuretic agents|mesh-ancestor
65626391|NCT02084342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626392|NCT01371487|Trametinib|trametinib|mesh-list
65626393|NCT01371487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626394|NCT01371487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65626395|NCT01371487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626396|NCT01371487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626397|NCT02084420|Pantoprazole|pantoprazole|mesh-list
65626398|NCT02084420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65626399|NCT02084420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65626400|NCT02084420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65626401|NCT02084420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626402|NCT02084420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626403|NCT01367431|Xanthohumol|xanthohumol|mesh-list
65626404|NCT01367431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626405|NCT01367431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65626406|NCT01367431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65626407|NCT01367431|Growth Substances|growth substances|mesh-ancestor
65626408|NCT01367431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626409|NCT01367431|Growth Inhibitors|growth inhibitors|mesh-ancestor
65626410|NCT01367509|Methylnaltrexone|methylnaltrexone|mesh-list
65626411|NCT01367509|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65626412|NCT01367509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626413|NCT01367509|Sensory System Agents|sensory system agents|mesh-ancestor
65626414|NCT01367509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626415|NCT01364701|Sildenafil Citrate|sildenafil citrate|mesh-list
65626416|NCT01364701|Tadalafil|tadalafil|mesh-list
65626417|NCT01364701|Vasodilator Agents|vasodilator agents|mesh-ancestor
65626418|NCT01364701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65626419|NCT01364701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65626420|NCT01364701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626421|NCT01364701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626422|NCT01364701|Urological Agents|urological agents|mesh-ancestor
65626423|NCT02440464|Fludarabine|fludarabine|mesh-list
65626424|NCT02440464|Bortezomib|bortezomib|mesh-list
65626425|NCT02440464|Melphalan|melphalan|mesh-list
65626426|NCT02440464|Ixazomib|ixazomib|mesh-list
65626427|NCT02440464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626428|NCT02440464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626429|NCT02440464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65423824|NCT04720547|Zolpidem|zolpidem|mesh-list
65626430|NCT02440464|Immunologic Factors|immunologic factors|mesh-ancestor
65626431|NCT02440464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626432|NCT02440464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65626433|NCT02440464|Alkylating Agents|alkylating agents|mesh-ancestor
65626434|NCT02440464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65626435|NCT02440464|Protease Inhibitors|protease inhibitors|mesh-ancestor
65626436|NCT02440464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626437|NCT01367587|Methylnaltrexone|methylnaltrexone|mesh-list
65626438|NCT01367587|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65626439|NCT01367587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626440|NCT01367587|Sensory System Agents|sensory system agents|mesh-ancestor
65626441|NCT01367587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626442|NCT02088398|Ricolinostat|ricolinostat|mesh-list
65626443|NCT02088398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626444|NCT02088398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65626445|NCT02088398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626446|NCT02088398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626447|NCT02084576|Ketorolac|ketorolac|mesh-list
65626448|NCT02084576|Nepafenac|nepafenac|mesh-list
65626449|NCT02084576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65626450|NCT02084576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65626451|NCT02084576|Analgesics|analgesics|mesh-ancestor
65626452|NCT02084576|Sensory System Agents|sensory system agents|mesh-ancestor
65626453|NCT02084576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626454|NCT02084576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626455|NCT02084576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65626456|NCT02084576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65626457|NCT02084576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65626458|NCT02084576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626459|NCT02084576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626460|NCT03131453|CNP520|cnp520|mesh-list
65626461|NCT03131453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626462|NCT03131453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626463|NCT01364857|GTPase-Activating Proteins|gtpase-activating proteins|mesh-list
65626464|NCT01364857|GTP Phosphohydrolase Activators|gtp phosphohydrolase activators|mesh-ancestor
65626465|NCT01364857|Enzyme Activators|enzyme activators|mesh-ancestor
65626466|NCT01364857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626467|NCT02084654|Exenatide|exenatide|mesh-list
65626468|NCT02084654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65626469|NCT02084654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626470|NCT02084654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65626471|NCT02084654|Incretins|incretins|mesh-ancestor
65626472|NCT02084654|Hormones|hormones|mesh-ancestor
65626473|NCT02084654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65626474|NCT01367743|Epinephrine|epinephrine|mesh-list
65626475|NCT01367743|Norepinephrine|norepinephrine|mesh-list
65626476|NCT01367743|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65626477|NCT01367743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65626478|NCT01367743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65626479|NCT01367743|Adrenergic Agents|adrenergic agents|mesh-ancestor
65626480|NCT01367743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65626481|NCT01367743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626482|NCT01367743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626483|NCT01367743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65626484|NCT01367743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65626485|NCT01367743|Autonomic Agents|autonomic agents|mesh-ancestor
65626486|NCT01367743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626487|NCT01367743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65626488|NCT01367743|Respiratory System Agents|respiratory system agents|mesh-ancestor
65626489|NCT01367743|Mydriatics|mydriatics|mesh-ancestor
65626490|NCT01367743|Sympathomimetics|sympathomimetics|mesh-ancestor
65626491|NCT02084732|Sorafenib|sorafenib|mesh-list
65626492|NCT02084732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626493|NCT02084732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65626494|NCT02084732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626495|NCT02084732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626496|NCT02780401|Vaccines|vaccines|mesh-list
65626497|NCT02780401|Sargramostim|sargramostim|mesh-list
65626498|NCT02780401|Immunologic Factors|immunologic factors|mesh-ancestor
65626499|NCT02780401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626500|NCT02533232|Minocycline|minocycline|mesh-list
65626501|NCT02533232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65626502|NCT02533232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65626503|NCT02673151|Edetic Acid|edetic acid|mesh-list
65626504|NCT02673151|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65626505|NCT02673151|Chelating Agents|chelating agents|mesh-ancestor
65626506|NCT02673151|Sequestering Agents|sequestering agents|mesh-ancestor
65626507|NCT02673151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626508|NCT02673151|Anticoagulants|anticoagulants|mesh-ancestor
65626509|NCT02673151|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65626510|NCT02673151|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65626511|NCT02942277|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65626512|NCT02942277|Antimalarials|antimalarials|mesh-ancestor
65626513|NCT02942277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65626514|NCT02942277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65626515|NCT02942277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65626516|NCT05042947|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65626517|NCT05042947|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
65626518|NCT05042947|beta-Endorphin|beta-endorphin|mesh-list
65626519|NCT05042947|Hormones|hormones|mesh-ancestor
65626520|NCT05042947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65626521|NCT05042947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626522|NCT05042947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65626523|NCT05042947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626524|NCT02082236|Sufentanil|sufentanil|mesh-list
65626525|NCT02082236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65626526|NCT02082236|Narcotics|narcotics|mesh-ancestor
65626527|NCT02082236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65626528|NCT02082236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626529|NCT02082236|Analgesics|analgesics|mesh-ancestor
65626530|NCT02082236|Sensory System Agents|sensory system agents|mesh-ancestor
65626531|NCT02082236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626532|NCT02082236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65626533|NCT02082236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65626534|NCT02082236|Anesthetics, General|anesthetics, general|mesh-ancestor
65626535|NCT02082236|Anesthetics|anesthetics|mesh-ancestor
65626536|NCT03557996|Listerine|listerine|mesh-list
65626537|NCT03557996|Fluorides|fluorides|mesh-list
65626538|NCT03557996|Sodium Fluoride|sodium fluoride|mesh-list
65626539|NCT03557996|Fluorides, Topical|fluorides, topical|mesh-list
65626540|NCT03557996|Cariostatic Agents|cariostatic agents|mesh-ancestor
65626541|NCT03557996|Protective Agents|protective agents|mesh-ancestor
65626542|NCT03557996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626543|NCT03557996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65626544|NCT03557996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65626545|NCT03131219|Ravulizumab|ravulizumab|mesh-list
65626546|NCT03131219|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65626547|NCT03131219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65626548|NCT03131219|Immunologic Factors|immunologic factors|mesh-ancestor
65626549|NCT03131219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626550|NCT02296801|Letrozole|letrozole|mesh-list
65626551|NCT02296801|Palbociclib|palbociclib|mesh-list
65626552|NCT02296801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626553|NCT02296801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65626554|NCT02296801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65626555|NCT02296801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626556|NCT02296801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626557|NCT02296801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65626558|NCT02296801|Hormone Antagonists|hormone antagonists|mesh-ancestor
65626559|NCT02296801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65626560|NCT02296801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626561|NCT02296801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65626562|NCT02859324|Nivolumab|nivolumab|mesh-list
65626563|NCT02859324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65626564|NCT02859324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626565|NCT02859324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65626566|NCT02859324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626567|NCT02085590|Vaccines|vaccines|mesh-list
65626568|NCT02085590|BCG Vaccine|bcg vaccine|mesh-list
65626569|NCT02085590|Immunologic Factors|immunologic factors|mesh-ancestor
65626570|NCT02085590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626571|NCT02085590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65626572|NCT02143063|Cocaine|cocaine|mesh-list
65626573|NCT02143063|Anesthetics, Local|anesthetics, local|mesh-ancestor
65626574|NCT02143063|Anesthetics|anesthetics|mesh-ancestor
65626575|NCT02143063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65626576|NCT02143063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626577|NCT02143063|Sensory System Agents|sensory system agents|mesh-ancestor
65626578|NCT02143063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626579|NCT02143063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65626580|NCT02143063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65626581|NCT02143063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65626582|NCT02143063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65626583|NCT02143063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626584|NCT02143063|Dopamine Agents|dopamine agents|mesh-ancestor
65626585|NCT02143063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65626586|NCT02088866|Lidocaine|lidocaine|mesh-list
65626587|NCT02088866|Anesthetics, Local|anesthetics, local|mesh-ancestor
65626588|NCT02088866|Anesthetics|anesthetics|mesh-ancestor
65626589|NCT02088866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65626590|NCT02088866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626591|NCT02088866|Sensory System Agents|sensory system agents|mesh-ancestor
65626592|NCT02088866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626593|NCT02088866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65626594|NCT02088866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65626595|NCT02088866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65626596|NCT02088866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65626597|NCT02088866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626598|NCT02859246|Guaifenesin|guaifenesin|mesh-list
65626599|NCT02859246|Expectorants|expectorants|mesh-ancestor
65626600|NCT02859246|Respiratory System Agents|respiratory system agents|mesh-ancestor
65626601|NCT02088944|Infliximab|infliximab|mesh-list
65626602|NCT02088944|Dermatologic Agents|dermatologic agents|mesh-ancestor
65626603|NCT02088944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65626604|NCT02088944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65626605|NCT02073097|Acyclovir|acyclovir|mesh-list
65626606|NCT02073097|Prednisone|prednisone|mesh-list
65626607|NCT02073097|Cyclophosphamide|cyclophosphamide|mesh-list
65626608|NCT02073097|Rituximab|rituximab|mesh-list
65626609|NCT02073097|Doxorubicin|doxorubicin|mesh-list
65626610|NCT02073097|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65626611|NCT02073097|Vincristine|vincristine|mesh-list
65626612|NCT02073097|Lenograstim|lenograstim|mesh-list
65626613|NCT02073097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65626614|NCT02073097|Immunologic Factors|immunologic factors|mesh-ancestor
65626615|NCT02073097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626616|NCT02073097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65626617|NCT02073097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65626618|NCT02073097|Alkylating Agents|alkylating agents|mesh-ancestor
65626619|NCT02073097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626620|NCT02073097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626621|NCT02073097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65626622|NCT02073097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65626623|NCT02073097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65626624|NCT02073097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65626625|NCT02073097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65626626|NCT02073097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626627|NCT02073097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65626628|NCT02073097|Glucocorticoids|glucocorticoids|mesh-ancestor
65626629|NCT02073097|Hormones|hormones|mesh-ancestor
65626630|NCT02073097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65626631|NCT02073097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65626632|NCT02073097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65626633|NCT02073097|Tubulin Modulators|tubulin modulators|mesh-ancestor
65626634|NCT02073097|Antimitotic Agents|antimitotic agents|mesh-ancestor
65626635|NCT02073097|Mitosis Modulators|mitosis modulators|mesh-ancestor
65626636|NCT02073097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65626637|NCT02073097|Antiviral Agents|antiviral agents|mesh-ancestor
65626638|NCT02073097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65626639|NCT02921997|Vaccines|vaccines|mesh-list
65626640|NCT02921997|Immunologic Factors|immunologic factors|mesh-ancestor
65626641|NCT02921997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626642|NCT04989829|Omeprazole|omeprazole|mesh-list
65626643|NCT04989829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65626644|NCT04989829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65626645|NCT04989829|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65626646|NCT04989829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626647|NCT04989829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626648|NCT02791490|Metformin|metformin|mesh-list
65626649|NCT02791490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65626650|NCT02791490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65626651|NCT02791490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626652|NCT02791490|Incretins|incretins|mesh-ancestor
65626653|NCT02791490|Hormones|hormones|mesh-ancestor
65626654|NCT02791490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65626655|NCT02791490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65626656|NCT02791490|Protease Inhibitors|protease inhibitors|mesh-ancestor
65626657|NCT02791490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626658|NCT02791490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626659|NCT04635631|Talazoparib|talazoparib|mesh-list
65626660|NCT04635631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65626661|NCT04635631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626662|NCT04635631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626663|NCT04635631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626664|NCT02085824|Enoxaparin|enoxaparin|mesh-list
65626665|NCT02085824|Rivaroxaban|rivaroxaban|mesh-list
65626666|NCT02085824|Dabigatran|dabigatran|mesh-list
65626667|NCT02085824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65626668|NCT02085824|Antithrombins|antithrombins|mesh-ancestor
65626669|NCT02085824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65626670|NCT02085824|Protease Inhibitors|protease inhibitors|mesh-ancestor
65626671|NCT02085824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626672|NCT02085824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626673|NCT02085824|Anticoagulants|anticoagulants|mesh-ancestor
65626674|NCT02085824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65626675|NCT02085824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65626676|NCT01368445|Azelastine|azelastine|mesh-list
65626677|NCT01368445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65626678|NCT01368445|Autonomic Agents|autonomic agents|mesh-ancestor
65626679|NCT01368445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626680|NCT01368445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626681|NCT01368445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65626682|NCT01368445|Respiratory System Agents|respiratory system agents|mesh-ancestor
65626683|NCT01368445|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65626684|NCT01368445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626685|NCT01368445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626686|NCT01368445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65626687|NCT01368445|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65626688|NCT01368445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65626689|NCT01368445|Histamine Antagonists|histamine antagonists|mesh-ancestor
65626690|NCT01368445|Histamine Agents|histamine agents|mesh-ancestor
65626691|NCT01368445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65626692|NCT02085902|Ropivacaine|ropivacaine|mesh-list
65626693|NCT02085902|Anesthetics, Local|anesthetics, local|mesh-ancestor
65626694|NCT02085902|Anesthetics|anesthetics|mesh-ancestor
65626695|NCT02085902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65626696|NCT02085902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626697|NCT02085902|Sensory System Agents|sensory system agents|mesh-ancestor
65626698|NCT02085902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626699|NCT01368757|Lenalidomide|lenalidomide|mesh-list
65626700|NCT01368757|Immunologic Factors|immunologic factors|mesh-ancestor
65626701|NCT01368757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626702|NCT01368757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65626703|NCT01368757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65626704|NCT01368757|Growth Substances|growth substances|mesh-ancestor
65626705|NCT01368757|Growth Inhibitors|growth inhibitors|mesh-ancestor
65626706|NCT01368757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626707|NCT02086292|Lidocaine|lidocaine|mesh-list
65626708|NCT02086292|Anesthetics, Local|anesthetics, local|mesh-ancestor
65626709|NCT02086292|Anesthetics|anesthetics|mesh-ancestor
65626710|NCT02086292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65626711|NCT02086292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626712|NCT02086292|Sensory System Agents|sensory system agents|mesh-ancestor
65626713|NCT02086292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626714|NCT02086292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65626715|NCT02086292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65626716|NCT02086292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65626717|NCT02086292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65626718|NCT02086292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626719|NCT04431375|Tenofovir|tenofovir|mesh-list
65626720|NCT04431375|Antiviral Agents|antiviral agents|mesh-ancestor
65626721|NCT04431375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65626722|NCT04431375|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65626723|NCT04431375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65626724|NCT04431375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626725|NCT04431375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626726|NCT04431375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65626727|NCT04431375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65626728|NCT02425644|Teriflunomide|teriflunomide|mesh-list
65626729|NCT02425644|Ponesimod|ponesimod|mesh-list
65626730|NCT02425644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65626731|NCT02425644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65626732|NCT02425644|Analgesics|analgesics|mesh-ancestor
65626733|NCT02425644|Sensory System Agents|sensory system agents|mesh-ancestor
65626734|NCT02425644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626735|NCT02425644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626736|NCT02425644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65626737|NCT02425644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65626738|NCT02425644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65626739|NCT02425644|Immunologic Factors|immunologic factors|mesh-ancestor
65626740|NCT02425644|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65626741|NCT02425644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626742|NCT02184741|Immunoglobulins|immunoglobulins|mesh-list
65626743|NCT02184741|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65626744|NCT02184741|gamma-Globulins|gamma-globulins|mesh-list
65626745|NCT02184741|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65626746|NCT02184741|Immunologic Factors|immunologic factors|mesh-ancestor
65626747|NCT02184741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626748|NCT02086526|Metformin|metformin|mesh-list
65626749|NCT02086526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65626750|NCT02086526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626751|NCT04180995|Axitinib|axitinib|mesh-list
65626752|NCT04180995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626753|NCT04180995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65626754|NCT04180995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626755|NCT04180995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626756|NCT02089178|Remifentanil|remifentanil|mesh-list
65626757|NCT02089178|Anesthetics|anesthetics|mesh-list
65626758|NCT02089178|Propofol|propofol|mesh-list
65626759|NCT02089178|Sevoflurane|sevoflurane|mesh-list
65626760|NCT02089178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65626761|NCT02089178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626762|NCT02089178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65626763|NCT02089178|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65626764|NCT02089178|Anesthetics, General|anesthetics, general|mesh-ancestor
65626765|NCT02089178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65626766|NCT02089178|Narcotics|narcotics|mesh-ancestor
65626767|NCT02089178|Analgesics|analgesics|mesh-ancestor
65626768|NCT02089178|Sensory System Agents|sensory system agents|mesh-ancestor
65626769|NCT02089178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626770|NCT02089178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65626771|NCT02089178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65626772|NCT02089256|Liraglutide|liraglutide|mesh-list
65626773|NCT02089256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65626774|NCT02089256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626775|NCT02089256|Incretins|incretins|mesh-ancestor
65626776|NCT02089256|Hormones|hormones|mesh-ancestor
65626777|NCT02089256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65626778|NCT02861664|Fluorides|fluorides|mesh-list
65626779|NCT02861664|Tin Fluorides|tin fluorides|mesh-list
65626780|NCT02861664|Fluorophosphate|fluorophosphate|mesh-list
65626781|NCT02861664|Cariostatic Agents|cariostatic agents|mesh-ancestor
65626782|NCT02861664|Protective Agents|protective agents|mesh-ancestor
65626783|NCT02861664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626784|NCT02086838|Dextrans|dextrans|mesh-list
65626785|NCT02086838|Iron-Dextran Complex|iron-dextran complex|mesh-list
65626786|NCT02086838|Hematinics|hematinics|mesh-list
65626787|NCT02086838|Anticoagulants|anticoagulants|mesh-ancestor
65626788|NCT02086838|Plasma Substitutes|plasma substitutes|mesh-ancestor
65626789|NCT02086838|Blood Substitutes|blood substitutes|mesh-ancestor
65626790|NCT02236962|Pioglitazone|pioglitazone|mesh-list
65626791|NCT02236962|Ephedrine|ephedrine|mesh-list
65626792|NCT02236962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65626793|NCT02236962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626794|NCT02236962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65626795|NCT02236962|Sympathomimetics|sympathomimetics|mesh-ancestor
65626796|NCT02236962|Autonomic Agents|autonomic agents|mesh-ancestor
65626797|NCT02236962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626798|NCT02236962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65626799|NCT02236962|Adrenergic Agents|adrenergic agents|mesh-ancestor
65626800|NCT02236962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65626801|NCT02236962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626802|NCT02086994|Misoprostol|misoprostol|mesh-list
65626803|NCT02086994|Carbetocin|carbetocin|mesh-list
65626804|NCT02086994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65626805|NCT02086994|Abortifacient Agents|abortifacient agents|mesh-ancestor
65626806|NCT02086994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65626807|NCT02086994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626808|NCT02086994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65626809|NCT02086994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65626811|NCT05664711|Bupivacaine|bupivacaine|mesh-list
65626812|NCT05664711|Anesthetics, Local|anesthetics, local|mesh-ancestor
65626813|NCT05664711|Anesthetics|anesthetics|mesh-ancestor
65626814|NCT05664711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65626815|NCT05664711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626816|NCT05664711|Sensory System Agents|sensory system agents|mesh-ancestor
65626817|NCT05664711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626818|NCT02089568|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65626819|NCT02089568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65626820|NCT02089568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65626821|NCT02089568|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65626822|NCT02089568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626823|NCT02089568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626824|NCT03284853|Latanoprost|latanoprost|mesh-list
65626825|NCT03284853|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65626826|NCT03284853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65626827|NCT02087384|Vaccines|vaccines|mesh-list
65626828|NCT02087384|Immunologic Factors|immunologic factors|mesh-ancestor
65626829|NCT02087384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626830|NCT02087462|Vitamins|vitamins|mesh-list
65626831|NCT02087462|Thiamine|thiamine|mesh-list
65626832|NCT02087462|Vitamin B Complex|vitamin b complex|mesh-list
65626833|NCT02087462|Diclofenac|diclofenac|mesh-list
65626834|NCT02087462|Micronutrients|micronutrients|mesh-ancestor
65626835|NCT02087462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626836|NCT02087462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65626837|NCT02087462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65626838|NCT02087462|Analgesics|analgesics|mesh-ancestor
65626839|NCT02087462|Sensory System Agents|sensory system agents|mesh-ancestor
65626840|NCT02087462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626841|NCT02087462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65626842|NCT02087462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65626843|NCT02087462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65626844|NCT02087462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626845|NCT02087462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626846|NCT02087540|Telmisartan|telmisartan|mesh-list
65626847|NCT02087540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65626848|NCT02087540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65626849|NCT02087540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65626850|NCT02087540|Antimetabolites|antimetabolites|mesh-ancestor
65626851|NCT02087540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626852|NCT02087540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65626853|NCT02087540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65626854|NCT02087540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626855|NCT02087540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65626856|NCT02087540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65626857|NCT02087540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65626858|NCT03055221|Treprostinil|treprostinil|mesh-list
65626859|NCT03055221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65626860|NCT03206463|Dronabinol|dronabinol|mesh-list
65626861|NCT03206463|Hallucinogens|hallucinogens|mesh-ancestor
65626862|NCT03206463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626863|NCT03206463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65626864|NCT03206463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65626865|NCT03206463|Analgesics|analgesics|mesh-ancestor
65626866|NCT03206463|Sensory System Agents|sensory system agents|mesh-ancestor
65626867|NCT03206463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626868|NCT03206463|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65626869|NCT03206463|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65626870|NCT03206463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65626871|NCT03206463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626872|NCT03206463|Hormones|hormones|mesh-ancestor
65626873|NCT03206463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65626874|NCT02091674|Hyaluronic Acid|hyaluronic acid|mesh-list
65626875|NCT02091674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65626876|NCT02091674|Immunologic Factors|immunologic factors|mesh-ancestor
65626877|NCT02091674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626878|NCT02091674|Viscosupplements|viscosupplements|mesh-ancestor
65626879|NCT02091674|Protective Agents|protective agents|mesh-ancestor
65626880|NCT01218555|Lenalidomide|lenalidomide|mesh-list
65626881|NCT01218555|Everolimus|everolimus|mesh-list
65626882|NCT01218555|Immunologic Factors|immunologic factors|mesh-ancestor
65424252|NCT00967031|Capecitabine|capecitabine|mesh-list
65626883|NCT01218555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626884|NCT01218555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65626885|NCT01218555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65626886|NCT01218555|Growth Substances|growth substances|mesh-ancestor
65626887|NCT01218555|Growth Inhibitors|growth inhibitors|mesh-ancestor
65626888|NCT01218555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626889|NCT01218555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65626890|NCT02091830|Acetaminophen|acetaminophen|mesh-list
65626891|NCT02091830|Cortisone|cortisone|mesh-list
65626892|NCT02091830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65626893|NCT02091830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65626894|NCT02091830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65626895|NCT02091830|Analgesics|analgesics|mesh-ancestor
65626896|NCT02091830|Sensory System Agents|sensory system agents|mesh-ancestor
65626897|NCT02091830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626898|NCT02091830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626899|NCT02091830|Antipyretics|antipyretics|mesh-ancestor
65626900|NCT02091830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65626901|NCT01111305|Diethylcarbamazine|diethylcarbamazine|mesh-list
65626902|NCT01111305|Reslizumab|reslizumab|mesh-list
65626903|NCT01111305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65626904|NCT01111305|Respiratory System Agents|respiratory system agents|mesh-ancestor
65626905|NCT01111305|Filaricides|filaricides|mesh-ancestor
65626906|NCT01111305|Antinematodal Agents|antinematodal agents|mesh-ancestor
65626907|NCT01111305|Anthelmintics|anthelmintics|mesh-ancestor
65626908|NCT01111305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65626909|NCT01111305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65626910|NCT01111305|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65626911|NCT01111305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626912|NCT01111305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626913|NCT03752307|Prednisone|prednisone|mesh-list
65626914|NCT03752307|Methylprednisolone|methylprednisolone|mesh-list
65626915|NCT03752307|Isoxsuprine|isoxsuprine|mesh-list
65626916|NCT03752307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65626917|NCT03752307|Glucocorticoids|glucocorticoids|mesh-ancestor
65626918|NCT03752307|Hormones|hormones|mesh-ancestor
65626919|NCT03752307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65626920|NCT03752307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626921|NCT03752307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65626922|NCT03752307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626923|NCT03752307|Antiemetics|antiemetics|mesh-ancestor
65626924|NCT03752307|Autonomic Agents|autonomic agents|mesh-ancestor
65626925|NCT03752307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626926|NCT03752307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65626927|NCT03752307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65626928|NCT03752307|Protective Agents|protective agents|mesh-ancestor
65626929|NCT03752307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65626930|NCT03752307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65626931|NCT03752307|Adrenergic Agents|adrenergic agents|mesh-ancestor
65626932|NCT03752307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65626933|NCT03752307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626934|NCT03752307|Sympathomimetics|sympathomimetics|mesh-ancestor
65626935|NCT03752307|Vasodilator Agents|vasodilator agents|mesh-ancestor
65626936|NCT03752307|Tocolytic Agents|tocolytic agents|mesh-ancestor
65626937|NCT03752307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65626938|NCT00792831|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
65626939|NCT00792831|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65626940|NCT00792831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626941|NCT00792831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626942|NCT00496431|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
65626943|NCT00496431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65626944|NCT00496431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65626945|NCT00496431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626946|NCT02091908|Lactitol|lactitol|mesh-list
65626947|NCT02091908|Vaccines|vaccines|mesh-list
65626948|NCT02091908|Immunologic Factors|immunologic factors|mesh-ancestor
65626949|NCT02091908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626950|NCT02091908|Cathartics|cathartics|mesh-ancestor
65626951|NCT02091908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65626952|NCT03627897|Bupivacaine|bupivacaine|mesh-list
65626953|NCT03627897|Anesthetics, Local|anesthetics, local|mesh-ancestor
65626954|NCT03627897|Anesthetics|anesthetics|mesh-ancestor
65626955|NCT03627897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65626956|NCT03627897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626957|NCT03627897|Sensory System Agents|sensory system agents|mesh-ancestor
65626958|NCT03627897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65424323|NCT00971165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65626959|NCT01372111|Cisplatin|cisplatin|mesh-list
65626960|NCT01372111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626961|NCT03125941|Dexamethasone|dexamethasone|mesh-list
65626962|NCT03125941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65626963|NCT03125941|Antiemetics|antiemetics|mesh-ancestor
65626964|NCT03125941|Autonomic Agents|autonomic agents|mesh-ancestor
65626965|NCT03125941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65626966|NCT03125941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626967|NCT03125941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65626968|NCT03125941|Glucocorticoids|glucocorticoids|mesh-ancestor
65626970|NCT03125941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65626971|NCT03125941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65626972|NCT03125941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626973|NCT02092142|Vaccines|vaccines|mesh-list
65626974|NCT02092142|Immunologic Factors|immunologic factors|mesh-ancestor
65626975|NCT02092142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626976|NCT02095886|BMS-955176|bms-955176|mesh-list
65626977|NCT02095886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65626978|NCT02095886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65626979|NCT02095886|Antiviral Agents|antiviral agents|mesh-ancestor
65626980|NCT02095886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65626981|NCT01372579|Carboplatin|carboplatin|mesh-list
65626982|NCT01372579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65626983|NCT02090036|Lumefantrine|lumefantrine|mesh-list
65626984|NCT02090036|Artemether|artemether|mesh-list
65626985|NCT02090036|Primaquine|primaquine|mesh-list
65626986|NCT02090036|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65626987|NCT02090036|Antimalarials|antimalarials|mesh-ancestor
65626988|NCT02090036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65626989|NCT02090036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65626990|NCT02090036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65626991|NCT03125629|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65626992|NCT03125629|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65626993|NCT03125629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65626994|NCT02092376|Cholecalciferol|cholecalciferol|mesh-list
65626995|NCT02092376|Vitamin D|vitamin d|mesh-list
65626996|NCT02092376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65626997|NCT02092376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65626998|NCT02092376|Vitamins|vitamins|mesh-ancestor
65626999|NCT02092376|Micronutrients|micronutrients|mesh-ancestor
65627000|NCT02092376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65627001|NCT05452928|Valacyclovir|valacyclovir|mesh-list
65627002|NCT05452928|Acyclovir|acyclovir|mesh-list
65627003|NCT05452928|Antiviral Agents|antiviral agents|mesh-ancestor
65627004|NCT05452928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65627005|NCT03125395|Ivacaftor|ivacaftor|mesh-list
65627006|NCT03125395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65627007|NCT03125395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65627008|NCT03125395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627009|NCT01369303|Tenofovir|tenofovir|mesh-list
65627010|NCT01369303|Antiviral Agents|antiviral agents|mesh-ancestor
65627011|NCT01369303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65627012|NCT01369303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65627013|NCT01369303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65627014|NCT01369303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65627015|NCT01369303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627016|NCT01369303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65627017|NCT01369303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65627018|NCT02092532|Aflibercept|aflibercept|mesh-list
65627019|NCT02092532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65627020|NCT02092532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65627021|NCT02092532|Growth Substances|growth substances|mesh-ancestor
65627022|NCT02092532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627023|NCT02092532|Growth Inhibitors|growth inhibitors|mesh-ancestor
65627024|NCT02092532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65627025|NCT02092766|Artesunate|artesunate|mesh-list
65627026|NCT02092766|Quinine|quinine|mesh-list
65627027|NCT02092766|Antimalarials|antimalarials|mesh-ancestor
65627028|NCT02092766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65627029|NCT02092766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65627030|NCT02092766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65627031|NCT02092766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65627032|NCT02092766|Antiviral Agents|antiviral agents|mesh-ancestor
65627033|NCT02092766|Schistosomicides|schistosomicides|mesh-ancestor
65627034|NCT02092766|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65627035|NCT02092766|Anthelmintics|anthelmintics|mesh-ancestor
65627036|NCT02092766|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65627037|NCT02092766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627038|NCT02092766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65627039|NCT02092766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65627040|NCT02092766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65627041|NCT02092766|Analgesics|analgesics|mesh-ancestor
65627042|NCT02092766|Sensory System Agents|sensory system agents|mesh-ancestor
65627043|NCT02090348|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65627044|NCT02090348|Dermatologic Agents|dermatologic agents|mesh-ancestor
65627045|NCT02090348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65627046|NCT02090348|Immunologic Factors|immunologic factors|mesh-ancestor
65627047|NCT02090348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627048|NCT02721069|Diazepam|diazepam|mesh-list
65627049|NCT02721069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65627050|NCT02721069|Anticonvulsants|anticonvulsants|mesh-ancestor
65627051|NCT02721069|Antiemetics|antiemetics|mesh-ancestor
65627052|NCT02721069|Autonomic Agents|autonomic agents|mesh-ancestor
65627053|NCT02721069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65627054|NCT02721069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627055|NCT02721069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65627056|NCT02721069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65627057|NCT02721069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65627058|NCT02721069|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65627059|NCT02721069|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65627060|NCT02721069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65627061|NCT02721069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65627062|NCT02721069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65627063|NCT02721069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65627064|NCT02721069|Anesthetics, General|anesthetics, general|mesh-ancestor
65627065|NCT02721069|Anesthetics|anesthetics|mesh-ancestor
65627066|NCT02721069|GABA Modulators|gaba modulators|mesh-ancestor
65627067|NCT02721069|GABA Agents|gaba agents|mesh-ancestor
65627068|NCT02721069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65627069|NCT02721069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627070|NCT02093000|Bevacizumab|bevacizumab|mesh-list
65627071|NCT02093000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65627072|NCT02093000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65627073|NCT02093000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65627074|NCT02093000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65627075|NCT02093000|Growth Substances|growth substances|mesh-ancestor
65627076|NCT02093000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627077|NCT02093000|Growth Inhibitors|growth inhibitors|mesh-ancestor
65627078|NCT00261807|Daptomycin|daptomycin|mesh-list
65627079|NCT00261807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65627080|NCT00261807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65627081|NCT02090504|Sodium Oxybate|sodium oxybate|mesh-list
65627082|NCT02090504|Oxazepam|oxazepam|mesh-list
65627083|NCT02090504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65627084|NCT02090504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65627085|NCT02090504|Anesthetics, General|anesthetics, general|mesh-ancestor
65627086|NCT02090504|Anesthetics|anesthetics|mesh-ancestor
65627087|NCT02090504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65627088|NCT02090504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627089|NCT02090504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65627090|NCT02090504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65627091|NCT02090504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65627092|NCT02090504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65627093|NCT02090504|GABA Modulators|gaba modulators|mesh-ancestor
65627094|NCT02090504|GABA Agents|gaba agents|mesh-ancestor
65627095|NCT02090504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65627096|NCT02090504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627097|NCT01567059|Cytarabine|cytarabine|mesh-list
65627098|NCT01567059|Decitabine|decitabine|mesh-list
65627099|NCT01567059|Azacitidine|azacitidine|mesh-list
65627100|NCT01567059|Tosedostat|tosedostat|mesh-list
65627101|NCT01567059|Glycine|glycine|mesh-list
65627102|NCT01567059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65627103|NCT01567059|Antimetabolites|antimetabolites|mesh-ancestor
65627104|NCT01567059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627105|NCT01567059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089855|NCT00475553|Progestins|progestins|mesh-ancestor
65627106|NCT01567059|Antiviral Agents|antiviral agents|mesh-ancestor
65627107|NCT01567059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65627108|NCT01567059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65627109|NCT01567059|Immunologic Factors|immunologic factors|mesh-ancestor
65627110|NCT01567059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627111|NCT01567059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65627112|NCT01567059|Glycine Agents|glycine agents|mesh-ancestor
65424475|NCT00310804|Vaccines|vaccines|mesh-list
65627113|NCT01567059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65627114|NCT02090738|Amoxicillin|amoxicillin|mesh-list
65627115|NCT02090738|Clarithromycin|clarithromycin|mesh-list
65627116|NCT02090738|Acetazolamide|acetazolamide|mesh-list
65627117|NCT02090738|Esomeprazole|esomeprazole|mesh-list
65627118|NCT02090738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65627119|NCT02090738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65627120|NCT02090738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65627121|NCT02090738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65627122|NCT02090738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65627123|NCT02090738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65627124|NCT02090738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627125|NCT02090738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65627126|NCT02090738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65627127|NCT02090738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65627128|NCT02090738|Anticonvulsants|anticonvulsants|mesh-ancestor
65627129|NCT02090738|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65627130|NCT02090738|Diuretics|diuretics|mesh-ancestor
65627131|NCT02090738|Natriuretic Agents|natriuretic agents|mesh-ancestor
65627132|NCT02090738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627133|NCT02096510|Hydrocortisone|hydrocortisone|mesh-list
65627134|NCT02096510|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65627135|NCT02096510|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65627136|NCT02096510|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65627137|NCT02096510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65627138|NCT03441555|Venetoclax|venetoclax|mesh-list
65627139|NCT03441555|Alvocidib|alvocidib|mesh-list
65627140|NCT03441555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65627141|NCT03441555|Growth Inhibitors|growth inhibitors|mesh-ancestor
65627142|NCT03441555|Growth Substances|growth substances|mesh-ancestor
65627143|NCT03441555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627144|NCT03441555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65627145|NCT03441555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65627146|NCT03441555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627147|NCT02093780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65627148|NCT03346239|Citalopram|citalopram|mesh-list
65627149|NCT03346239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65627150|NCT03346239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65627151|NCT03346239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65627152|NCT03346239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627153|NCT03346239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65627154|NCT03346239|Serotonin Agents|serotonin agents|mesh-ancestor
65627155|NCT03346239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627156|NCT03346239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65627157|NCT03346239|Antidepressive Agents|antidepressive agents|mesh-ancestor
65627158|NCT03346239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65627159|NCT05218161|Dexmedetomidine|dexmedetomidine|mesh-list
65627160|NCT05218161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65627161|NCT05218161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65627162|NCT05218161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627163|NCT05218161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65627164|NCT05218161|Analgesics|analgesics|mesh-ancestor
65627165|NCT05218161|Sensory System Agents|sensory system agents|mesh-ancestor
65627166|NCT05218161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65627167|NCT05218161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65627168|NCT05218161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65627169|NCT05218161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65627170|NCT05218161|Adrenergic Agents|adrenergic agents|mesh-ancestor
65627171|NCT05218161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65627172|NCT05218161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627173|NCT02861586|Vaccines|vaccines|mesh-list
65627174|NCT02861586|Immunologic Factors|immunologic factors|mesh-ancestor
65627175|NCT02861586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627176|NCT02099240|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65627177|NCT02099240|Amoxicillin|amoxicillin|mesh-list
65627178|NCT02099240|Azithromycin|azithromycin|mesh-list
65627179|NCT02099240|Moxifloxacin|moxifloxacin|mesh-list
65627180|NCT02099240|Vancomycin|vancomycin|mesh-list
65627181|NCT02099240|Clarithromycin|clarithromycin|mesh-list
65627182|NCT02099240|Doxycycline|doxycycline|mesh-list
65627183|NCT02099240|Ciprofloxacin|ciprofloxacin|mesh-list
65627184|NCT02099240|Levofloxacin|levofloxacin|mesh-list
65627185|NCT02099240|Ofloxacin|ofloxacin|mesh-list
65627186|NCT02099240|Minocycline|minocycline|mesh-list
65627187|NCT02099240|Rifampin|rifampin|mesh-list
65627188|NCT02099240|Clindamycin|clindamycin|mesh-list
65627189|NCT02099240|Clindamycin palmitate|clindamycin palmitate|mesh-list
65627190|NCT02099240|Clindamycin phosphate|clindamycin phosphate|mesh-list
65627191|NCT02099240|Gentamicins|gentamicins|mesh-list
65627192|NCT02099240|Isoniazid|isoniazid|mesh-list
65627193|NCT02099240|Meropenem|meropenem|mesh-list
65627194|NCT02099240|Ceftriaxone|ceftriaxone|mesh-list
65627195|NCT02099240|Tazobactam|tazobactam|mesh-list
65627196|NCT02099240|Linezolid|linezolid|mesh-list
65627197|NCT02099240|Cycloserine|cycloserine|mesh-list
65627198|NCT02099240|Piperacillin|piperacillin|mesh-list
65627199|NCT02099240|Metronidazole|metronidazole|mesh-list
65627200|NCT02099240|Penicillins|penicillins|mesh-list
65627201|NCT02099240|Imipenem|imipenem|mesh-list
65627202|NCT02099240|Amikacin|amikacin|mesh-list
65627203|NCT02099240|Pyrazinamide|pyrazinamide|mesh-list
65627204|NCT02099240|Erythromycin|erythromycin|mesh-list
65627205|NCT02099240|Erythromycin Estolate|erythromycin estolate|mesh-list
65627206|NCT02099240|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65627207|NCT02099240|Erythromycin stearate|erythromycin stearate|mesh-list
65627208|NCT02099240|Ceftazidime|ceftazidime|mesh-list
65627209|NCT02099240|Colistin|colistin|mesh-list
65627210|NCT02099240|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65627211|NCT02099240|Clavulanic Acids|clavulanic acids|mesh-list
65627212|NCT02099240|Clavulanic Acid|clavulanic acid|mesh-list
65627213|NCT02099240|Rifabutin|rifabutin|mesh-list
65627214|NCT02099240|Ampicillin|ampicillin|mesh-list
65627215|NCT02099240|Rifapentine|rifapentine|mesh-list
65627216|NCT02099240|Cefuroxime|cefuroxime|mesh-list
65627217|NCT02099240|Cefuroxime axetil|cefuroxime axetil|mesh-list
65627218|NCT02099240|Fosfomycin|fosfomycin|mesh-list
65627219|NCT02099240|Mupirocin|mupirocin|mesh-list
65627220|NCT02099240|Cefepime|cefepime|mesh-list
65627221|NCT02099240|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65627222|NCT02099240|Paromomycin|paromomycin|mesh-list
65627223|NCT02099240|Nitrofurantoin|nitrofurantoin|mesh-list
65627224|NCT02099240|Polymyxins|polymyxins|mesh-list
65627225|NCT02099240|Aztreonam|aztreonam|mesh-list
65627226|NCT02099240|Neomycin|neomycin|mesh-list
65627227|NCT02099240|Bacitracin|bacitracin|mesh-list
65627228|NCT02099240|Cefotaxime|cefotaxime|mesh-list
65627229|NCT02099240|Cefoxitin|cefoxitin|mesh-list
65627230|NCT02099240|Gatifloxacin|gatifloxacin|mesh-list
65627231|NCT02099240|Sulbactam|sulbactam|mesh-list
65627232|NCT02099240|Cefixime|cefixime|mesh-list
65627233|NCT02099240|Polymyxin B|polymyxin b|mesh-list
65627234|NCT02099240|Sulfadiazine|sulfadiazine|mesh-list
65627235|NCT02099240|Cefdinir|cefdinir|mesh-list
65627236|NCT02099240|Penicillin G|penicillin g|mesh-list
65627237|NCT02099240|Penicillin G Benzathine|penicillin g benzathine|mesh-list
65627238|NCT02099240|Penicillin G Procaine|penicillin g procaine|mesh-list
65627239|NCT02099240|Cloxacillin|cloxacillin|mesh-list
65627240|NCT02099240|Norfloxacin|norfloxacin|mesh-list
65627241|NCT02099240|Cefprozil|cefprozil|mesh-list
65627242|NCT02099240|Cephalosporins|cephalosporins|mesh-list
65627243|NCT02099240|Oxacillin|oxacillin|mesh-list
65627244|NCT02099240|Nafcillin|nafcillin|mesh-list
65627245|NCT02099240|Streptomycin|streptomycin|mesh-list
65627246|NCT02099240|Ticarcillin|ticarcillin|mesh-list
65627247|NCT02099240|Methenamine hippurate|methenamine hippurate|mesh-list
65627248|NCT02099240|Methenamine mandelate|methenamine mandelate|mesh-list
65627249|NCT02099240|Dicloxacillin|dicloxacillin|mesh-list
65627250|NCT02099240|Ethionamide|ethionamide|mesh-list
65627251|NCT02099240|Sultamicillin|sultamicillin|mesh-list
65627252|NCT02099240|Cefpodoxime|cefpodoxime|mesh-list
65627253|NCT02099240|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
65627254|NCT02099240|Ceftizoxime|ceftizoxime|mesh-list
65627255|NCT02099240|Kanamycin|kanamycin|mesh-list
65627256|NCT02099240|Cefoperazone|cefoperazone|mesh-list
65627257|NCT02099240|Penicillin V|penicillin v|mesh-list
65627258|NCT02099240|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
65627259|NCT02099240|Ceftibuten|ceftibuten|mesh-list
65627260|NCT02099240|Lincomycin|lincomycin|mesh-list
65627261|NCT02099240|Dirithromycin|dirithromycin|mesh-list
65627262|NCT02099240|Demeclocycline|demeclocycline|mesh-list
65627263|NCT02099240|Cefotetan|cefotetan|mesh-list
65627264|NCT02099240|Cefaclor|cefaclor|mesh-list
65627265|NCT02099240|Capreomycin|capreomycin|mesh-list
65627266|NCT02099240|Mafenide|mafenide|mesh-list
65627267|NCT02099240|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
65627268|NCT02099240|Chloramphenicol|chloramphenicol|mesh-list
65627269|NCT02099240|Chloramphenicol succinate|chloramphenicol succinate|mesh-list
65627270|NCT02099240|Tobramycin|tobramycin|mesh-list
65627271|NCT02099240|Oxytetracycline|oxytetracycline|mesh-list
65627272|NCT02099240|Netilmicin|netilmicin|mesh-list
65627273|NCT02099240|Enoxacin|enoxacin|mesh-list
65627274|NCT02099240|Novobiocin|novobiocin|mesh-list
65627275|NCT02099240|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
65627276|NCT02099240|Virginiamycin|virginiamycin|mesh-list
65627277|NCT02099240|Methicillin|methicillin|mesh-list
65627278|NCT02099240|Sulfacetamide|sulfacetamide|mesh-list
65627279|NCT02099240|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65627280|NCT02099240|Bacampicillin|bacampicillin|mesh-list
65627281|NCT02099240|Carbenicillin|carbenicillin|mesh-list
65627282|NCT02099240|Carbenicillin indanyl|carbenicillin indanyl|mesh-list
65627283|NCT02099240|Mezlocillin|mezlocillin|mesh-list
65627284|NCT02099240|Benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|mesh-list
65627285|NCT02099240|Cefamandole|cefamandole|mesh-list
65627286|NCT02099240|Cefamandole nafate|cefamandole nafate|mesh-list
65627287|NCT02099240|Cefonicid|cefonicid|mesh-list
65627288|NCT02099240|Cefmetazole|cefmetazole|mesh-list
65627289|NCT02099240|Loracarbef|loracarbef|mesh-list
65627290|NCT02099240|Grepafloxacin|grepafloxacin|mesh-list
65627291|NCT02099240|Fluoroquinolones|fluoroquinolones|mesh-list
65627292|NCT02099240|Lomefloxacin|lomefloxacin|mesh-list
65627293|NCT02099240|Nalidixic Acid|nalidixic acid|mesh-list
65627294|NCT02099240|Sparfloxacin|sparfloxacin|mesh-list
65627295|NCT02099240|Methacycline|methacycline|mesh-list
65627296|NCT02099240|Tetracycline|tetracycline|mesh-list
65627297|NCT02099240|Chlortetracycline|chlortetracycline|mesh-list
65627298|NCT02099240|Dalfopristin|dalfopristin|mesh-list
65627299|NCT02099240|Spectinomycin|spectinomycin|mesh-list
65627300|NCT02099240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65627301|NCT02099240|Sulfamethoxazole|sulfamethoxazole|mesh-list
65627302|NCT02099240|Sulfasalazine|sulfasalazine|mesh-list
65627303|NCT02099240|Silver Sulfadiazine|silver sulfadiazine|mesh-list
65627304|NCT02099240|Methenamine|methenamine|mesh-list
65627305|NCT02099240|Sulperazone|sulperazone|mesh-list
65627306|NCT02099240|Sulfisoxazole|sulfisoxazole|mesh-list
65627307|NCT02099240|Cinoxacin|cinoxacin|mesh-list
65627308|NCT02099240|Nitrofurazone|nitrofurazone|mesh-list
65627309|NCT02099240|Trimethoprim|trimethoprim|mesh-list
65627310|NCT02099240|Sulfamethizole|sulfamethizole|mesh-list
65627311|NCT02099240|Procaine|procaine|mesh-list
65627312|NCT02099240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65627313|NCT02099240|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65627314|NCT02099240|Cilastatin|cilastatin|mesh-list
65627315|NCT02099240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65627316|NCT02099240|Antitubercular Agents|antitubercular agents|mesh-ancestor
65627317|NCT02099240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65627318|NCT02099240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65627319|NCT02099240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65627320|NCT02099240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627321|NCT02099240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65627322|NCT02099240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65627323|NCT02099240|Contraceptive Agents|contraceptive agents|mesh-ancestor
65627324|NCT02099240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65627325|NCT02099240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627326|NCT02099240|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65627327|NCT02099240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65627328|NCT02099240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65627329|NCT02099240|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65627330|NCT02099240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65627331|NCT02099240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65627332|NCT02099240|Antimalarials|antimalarials|mesh-ancestor
65627333|NCT02099240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65627334|NCT02099240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65627335|NCT02099240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65627336|NCT02099240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65627337|NCT02099240|Renal Agents|renal agents|mesh-ancestor
65627338|NCT02099240|Leprostatic Agents|leprostatic agents|mesh-ancestor
65627339|NCT02099240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65627340|NCT02099240|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65627341|NCT02099240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65627342|NCT02099240|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65627343|NCT02099240|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65627344|NCT02099240|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65627345|NCT02099240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65627346|NCT02099240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65627347|NCT02099240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65627348|NCT02099240|Antimetabolites|antimetabolites|mesh-ancestor
65627349|NCT02099240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65627350|NCT02099240|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65627351|NCT02099240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65627352|NCT02099240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65627353|NCT02099240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65627354|NCT02099240|Analgesics|analgesics|mesh-ancestor
65627355|NCT02099240|Sensory System Agents|sensory system agents|mesh-ancestor
65627356|NCT02099240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65627357|NCT02099240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65627358|NCT02099240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65627359|NCT02099240|Protease Inhibitors|protease inhibitors|mesh-ancestor
65627360|NCT02099240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65627361|NCT02099240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65627362|NCT02099240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65627363|NCT02099240|Coccidiostats|coccidiostats|mesh-ancestor
65627364|NCT02099240|Anesthetics, Local|anesthetics, local|mesh-ancestor
65627366|NCT02099240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65627367|NCT02099240|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65627368|NCT02099240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65627369|NCT02099240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65627370|NCT02099240|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65627371|NCT02099240|Dermatologic Agents|dermatologic agents|mesh-ancestor
65627372|NCT02245230|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
65627373|NCT02245230|Trimethaphan|trimethaphan|mesh-list
65627374|NCT02245230|Phenylephrine|phenylephrine|mesh-list
65627375|NCT02245230|Oxymetazoline|oxymetazoline|mesh-list
65627376|NCT02245230|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
65627377|NCT02245230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65627378|NCT02245230|Mydriatics|mydriatics|mesh-ancestor
65627379|NCT02245230|Autonomic Agents|autonomic agents|mesh-ancestor
65627380|NCT02245230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65627381|NCT02245230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627382|NCT02245230|Sympathomimetics|sympathomimetics|mesh-ancestor
65627383|NCT02245230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65627384|NCT02245230|Nasal Decongestants|nasal decongestants|mesh-ancestor
65627385|NCT02245230|Respiratory System Agents|respiratory system agents|mesh-ancestor
65627386|NCT02245230|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65627387|NCT02245230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65627388|NCT02245230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65627389|NCT02245230|Adrenergic Agents|adrenergic agents|mesh-ancestor
65627390|NCT02245230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65627391|NCT02245230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627392|NCT02245230|Protective Agents|protective agents|mesh-ancestor
65627393|NCT02245230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65627394|NCT02245230|Vasodilator Agents|vasodilator agents|mesh-ancestor
65627395|NCT02245230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65627396|NCT02245230|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
65627397|NCT02245230|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65627398|NCT02245230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65627399|NCT02245230|Cholinergic Agents|cholinergic agents|mesh-ancestor
65627400|NCT05215743|Acetylcysteine|acetylcysteine|mesh-list
65627401|NCT05215743|Antioxidants|antioxidants|mesh-list
65627402|NCT05215743|Deferoxamine|deferoxamine|mesh-list
65627403|NCT05215743|Antiviral Agents|antiviral agents|mesh-ancestor
65627404|NCT05215743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65627405|NCT05215743|Expectorants|expectorants|mesh-ancestor
65627406|NCT05215743|Respiratory System Agents|respiratory system agents|mesh-ancestor
65627407|NCT05215743|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65627408|NCT05215743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627409|NCT05215743|Protective Agents|protective agents|mesh-ancestor
65627410|NCT05215743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627411|NCT05215743|Siderophores|siderophores|mesh-ancestor
65627412|NCT05215743|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65627413|NCT05215743|Chelating Agents|chelating agents|mesh-ancestor
65627414|NCT05215743|Sequestering Agents|sequestering agents|mesh-ancestor
65627415|NCT02099396|Gemcitabine|gemcitabine|mesh-list
65627416|NCT02099396|Docetaxel|docetaxel|mesh-list
65627417|NCT02099396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65627418|NCT02099396|Antimetabolites|antimetabolites|mesh-ancestor
65627419|NCT02099396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627420|NCT02099396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65627421|NCT02099396|Antiviral Agents|antiviral agents|mesh-ancestor
65627422|NCT02099396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65627423|NCT02099396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65627424|NCT02099396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65627425|NCT02099396|Immunologic Factors|immunologic factors|mesh-ancestor
65627426|NCT02099396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627427|NCT02099396|Tubulin Modulators|tubulin modulators|mesh-ancestor
65627428|NCT02099396|Antimitotic Agents|antimitotic agents|mesh-ancestor
65627429|NCT02099396|Mitosis Modulators|mitosis modulators|mesh-ancestor
65627430|NCT05215665|Lenvatinib|lenvatinib|mesh-list
65627431|NCT05215665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65627432|NCT05215665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65627433|NCT05215665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65627434|NCT05215665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627435|NCT02099474|Raltegravir Potassium|raltegravir potassium|mesh-list
65627436|NCT02099474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65627437|NCT02099474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65627438|NCT02099474|Antiviral Agents|antiviral agents|mesh-ancestor
65627439|NCT02099474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65627440|NCT02099474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65627441|NCT02099474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65627442|NCT02099474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65627443|NCT02099474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627444|NCT05217069|Leucovorin|leucovorin|mesh-list
65627445|NCT05217069|Folic Acid|folic acid|mesh-list
65627446|NCT05217069|Irinotecan|irinotecan|mesh-list
65627447|NCT05217069|Cetuximab|cetuximab|mesh-list
65627448|NCT05217069|Avelumab|avelumab|mesh-list
65627449|NCT05217069|Levoleucovorin|levoleucovorin|mesh-list
65627450|NCT05217069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65627451|NCT05217069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65627452|NCT05217069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65627453|NCT05217069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627454|NCT05217069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65627455|NCT05217069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65627456|NCT05217069|Antidotes|antidotes|mesh-ancestor
65627457|NCT05217069|Protective Agents|protective agents|mesh-ancestor
65627458|NCT05217069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627459|NCT05217069|Vitamin B Complex|vitamin b complex|mesh-ancestor
65627460|NCT05217069|Vitamins|vitamins|mesh-ancestor
65627461|NCT05217069|Micronutrients|micronutrients|mesh-ancestor
65627462|NCT05217069|Hematinics|hematinics|mesh-ancestor
65627463|NCT02065635|Propofol|propofol|mesh-list
65627464|NCT02065635|Sevoflurane|sevoflurane|mesh-list
65627465|NCT02065635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65627466|NCT02065635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65627467|NCT02065635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627468|NCT02065635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65627469|NCT02065635|Anesthetics, General|anesthetics, general|mesh-ancestor
65627470|NCT02065635|Anesthetics|anesthetics|mesh-ancestor
65627471|NCT02065635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65627472|NCT02065635|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65627473|NCT03628053|Blinatumomab|blinatumomab|mesh-list
65627474|NCT03628053|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65627475|NCT03628053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65627476|NCT03628053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65627477|NCT03628053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65627478|NCT02100176|Dopamine|dopamine|mesh-list
65627479|NCT02100176|Rotigotine|rotigotine|mesh-list
65627480|NCT02100176|Dopamine Agonists|dopamine agonists|mesh-list
65627481|NCT02100176|Dopamine Agents|dopamine agents|mesh-ancestor
65627482|NCT02100176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65627483|NCT02100176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627484|NCT02100176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627485|NCT02100176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65627486|NCT02100176|Sympathomimetics|sympathomimetics|mesh-ancestor
65627487|NCT02100176|Autonomic Agents|autonomic agents|mesh-ancestor
65627488|NCT02100176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65627489|NCT02100176|Protective Agents|protective agents|mesh-ancestor
65627490|NCT02250482|Factor VIII|factor viii|mesh-list
65627491|NCT02250482|Coagulants|coagulants|mesh-ancestor
65627492|NCT05189145|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65627493|NCT05189145|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65627494|NCT05189145|Hormones|hormones|mesh-list
65627495|NCT05189145|Estradiol|estradiol|mesh-list
65627496|NCT05189145|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65627497|NCT05189145|Progesterone|progesterone|mesh-list
65627498|NCT05189145|Dydrogesterone|dydrogesterone|mesh-list
65266928|NCT02765204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627499|NCT05189145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65627500|NCT05189145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627501|NCT05189145|Estrogens|estrogens|mesh-ancestor
65627502|NCT05189145|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65627503|NCT05189145|Contraceptive Agents|contraceptive agents|mesh-ancestor
65627504|NCT05189145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65627505|NCT05189145|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65627506|NCT05189145|Progestins|progestins|mesh-ancestor
65627507|NCT04967079|Trametinib|trametinib|mesh-list
65627508|NCT04967079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65627509|NCT04967079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65627510|NCT04967079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65627511|NCT04967079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627512|NCT03556592|Metoprolol|metoprolol|mesh-list
65627513|NCT03556592|Midazolam|midazolam|mesh-list
65627514|NCT03556592|Caffeine|caffeine|mesh-list
65627515|NCT03556592|Omeprazole|omeprazole|mesh-list
65627516|NCT03556592|Warfarin|warfarin|mesh-list
65627517|NCT03556592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65627518|NCT03556592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65627519|NCT03556592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65627520|NCT03556592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627521|NCT03556592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65627522|NCT03556592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65627523|NCT03556592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65627524|NCT03556592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65627525|NCT03556592|Anesthetics, General|anesthetics, general|mesh-ancestor
65627526|NCT03556592|Anesthetics|anesthetics|mesh-ancestor
65627527|NCT03556592|GABA Modulators|gaba modulators|mesh-ancestor
65627528|NCT03556592|GABA Agents|gaba agents|mesh-ancestor
65627529|NCT03556592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65627530|NCT03556592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627531|NCT03556592|Anticoagulants|anticoagulants|mesh-ancestor
65627532|NCT03556592|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65627533|NCT03556592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65627534|NCT03556592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65627535|NCT03556592|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65627536|NCT03556592|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65627537|NCT03556592|Purinergic Agents|purinergic agents|mesh-ancestor
65627538|NCT03556592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65627539|NCT03556592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65627540|NCT03556592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65627541|NCT03556592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65627542|NCT03556592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65627543|NCT03556592|Sympatholytics|sympatholytics|mesh-ancestor
65627544|NCT03556592|Autonomic Agents|autonomic agents|mesh-ancestor
65627545|NCT03556592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65627546|NCT03556592|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65627547|NCT03556592|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65627548|NCT03556592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65627549|NCT03556592|Adrenergic Agents|adrenergic agents|mesh-ancestor
65627550|NCT04964193|Cyproterone Acetate|cyproterone acetate|mesh-list
65627551|NCT04964193|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65627552|NCT04964193|Cyproterone|cyproterone|mesh-list
65627553|NCT04964193|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
65627554|NCT04964193|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65627555|NCT04964193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65627556|NCT04964193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65627557|NCT04964193|Contraceptive Agents|contraceptive agents|mesh-ancestor
65627558|NCT04964193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65627559|NCT04964193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627560|NCT04964193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65627561|NCT04964193|Estrogens|estrogens|mesh-ancestor
65627562|NCT04964193|Hormones|hormones|mesh-ancestor
65627563|NCT04964193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65627564|NCT04964193|Androgen Antagonists|androgen antagonists|mesh-ancestor
65627565|NCT04964193|Hormone Antagonists|hormone antagonists|mesh-ancestor
65627566|NCT04964193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65627567|NCT04964193|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65627568|NCT02100488|Insulin|insulin|mesh-list
65627569|NCT02100488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65627570|NCT02100488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65627571|NCT02100488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627572|NCT02095418|Mycophenolic Acid|mycophenolic acid|mesh-list
65627573|NCT02095418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65627574|NCT02095418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65627575|NCT02095418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65627576|NCT02095418|Antitubercular Agents|antitubercular agents|mesh-ancestor
65627577|NCT02095418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65627578|NCT02095418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65627579|NCT02095418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65627580|NCT02095418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627581|NCT04865497|Vaccines|vaccines|mesh-list
65627582|NCT04865497|Immunologic Factors|immunologic factors|mesh-ancestor
65627583|NCT04865497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627584|NCT05665725|Siltuximab|siltuximab|mesh-list
65627585|NCT05665725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65627586|NCT05665725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65627587|NCT05665725|Immunologic Factors|immunologic factors|mesh-ancestor
65627588|NCT05665725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627589|NCT02098148|Xenon|xenon|mesh-list
65627590|NCT02098148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65627591|NCT02098148|Anesthetics, General|anesthetics, general|mesh-ancestor
65627592|NCT02098148|Anesthetics|anesthetics|mesh-ancestor
65627593|NCT02098148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65627594|NCT02098148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627595|NCT05222607|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65627596|NCT05222607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65627597|NCT05222607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65627598|NCT05222607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627599|NCT05222607|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65627600|NCT05222607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65627601|NCT05222607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627602|NCT05222607|Cholinergic Agents|cholinergic agents|mesh-ancestor
65627603|NCT05222607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65627604|NCT05168527|Gemcitabine|gemcitabine|mesh-list
65627606|NCT05168527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65627607|NCT05168527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65627608|NCT05168527|Tubulin Modulators|tubulin modulators|mesh-ancestor
65627609|NCT05168527|Antimitotic Agents|antimitotic agents|mesh-ancestor
65627610|NCT05168527|Mitosis Modulators|mitosis modulators|mesh-ancestor
65627611|NCT05168527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627612|NCT05168527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65627613|NCT05168527|Antimetabolites|antimetabolites|mesh-ancestor
65627614|NCT05168527|Antiviral Agents|antiviral agents|mesh-ancestor
65627615|NCT05168527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65627616|NCT05168527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65627617|NCT05168527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65627618|NCT05168527|Immunologic Factors|immunologic factors|mesh-ancestor
65627619|NCT05168527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627620|NCT02098460|Cilostazol|cilostazol|mesh-list
65627621|NCT02098460|Atorvastatin|atorvastatin|mesh-list
65627622|NCT02098460|Probucol|probucol|mesh-list
65627623|NCT02098460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65627624|NCT02098460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65627625|NCT02098460|Antimetabolites|antimetabolites|mesh-ancestor
65627626|NCT02098460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627627|NCT02098460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65627628|NCT02098460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65627629|NCT02098460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65627630|NCT02098460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65627631|NCT02098460|Autonomic Agents|autonomic agents|mesh-ancestor
65627632|NCT02098460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65627633|NCT02098460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627634|NCT02098460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65627635|NCT02098460|Respiratory System Agents|respiratory system agents|mesh-ancestor
65627636|NCT02098460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65627637|NCT02098460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65627638|NCT02098460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65627639|NCT02098460|Vasodilator Agents|vasodilator agents|mesh-ancestor
65627640|NCT02098460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65627641|NCT02098460|Protective Agents|protective agents|mesh-ancestor
65627642|NCT02098460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65627643|NCT02098460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65627644|NCT02098460|Antioxidants|antioxidants|mesh-ancestor
65627645|NCT02095574|Venetoclax|venetoclax|mesh-list
65627646|NCT02095574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65627647|NCT04230265|Cyclophosphamide|cyclophosphamide|mesh-list
65627648|NCT04230265|Fludarabine|fludarabine|mesh-list
65627649|NCT04230265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65627650|NCT04230265|Immunologic Factors|immunologic factors|mesh-ancestor
65627651|NCT04230265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627652|NCT04230265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65627653|NCT04230265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65627654|NCT04230265|Alkylating Agents|alkylating agents|mesh-ancestor
65627655|NCT04230265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627656|NCT04230265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65627657|NCT04230265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65627658|NCT04856319|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65627659|NCT04856319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65627660|NCT02095730|Vitamins|vitamins|mesh-list
65627661|NCT02095730|Riboflavin|riboflavin|mesh-list
65627662|NCT02095730|Vitamin B Complex|vitamin b complex|mesh-list
65627663|NCT02095730|Micronutrients|micronutrients|mesh-ancestor
65627664|NCT02095730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627665|NCT02095730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65627666|NCT02095730|Dermatologic Agents|dermatologic agents|mesh-ancestor
65627667|NCT02102438|Paclitaxel|paclitaxel|mesh-list
65627668|NCT02102438|Carboplatin|carboplatin|mesh-list
65627669|NCT02102438|Trastuzumab|trastuzumab|mesh-list
65627670|NCT02102438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65627671|NCT02102438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424998|NCT00981851|Albuterol|albuterol|mesh-list
65627672|NCT02102438|Tubulin Modulators|tubulin modulators|mesh-ancestor
65627673|NCT02102438|Antimitotic Agents|antimitotic agents|mesh-ancestor
65627674|NCT02102438|Mitosis Modulators|mitosis modulators|mesh-ancestor
65627675|NCT02102438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627676|NCT02102438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65627677|NCT02098616|Asunaprevir|asunaprevir|mesh-list
65627678|NCT02098616|Protease Inhibitors|protease inhibitors|mesh-ancestor
65627679|NCT02098616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65627680|NCT02098616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627681|NCT02102516|Ketorolac|ketorolac|mesh-list
65627682|NCT02102516|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65627683|NCT02102516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65627684|NCT02102516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65627685|NCT02102516|Analgesics|analgesics|mesh-ancestor
65627686|NCT02102516|Sensory System Agents|sensory system agents|mesh-ancestor
65627687|NCT02102516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65627688|NCT02102516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627689|NCT02102516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65627690|NCT02102516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65627691|NCT02102516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65627692|NCT02102516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65627693|NCT02102516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627694|NCT02106182|Silodosin|silodosin|mesh-list
65627695|NCT02106182|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65627696|NCT02106182|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65627697|NCT02106182|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65627698|NCT02106182|Adrenergic Agents|adrenergic agents|mesh-ancestor
65627699|NCT02106182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65627700|NCT02106182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627701|NCT02106182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627702|NCT02106182|Urological Agents|urological agents|mesh-ancestor
65627703|NCT01369693|Lobeline|lobeline|mesh-list
65627704|NCT01369693|Nicotine|nicotine|mesh-list
65627705|NCT01369693|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65627706|NCT01369693|Autonomic Agents|autonomic agents|mesh-ancestor
65627707|NCT01369693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65627708|NCT01369693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627709|NCT01369693|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65627710|NCT01369693|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65627711|NCT01369693|Cholinergic Agents|cholinergic agents|mesh-ancestor
65627712|NCT01369693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65627713|NCT01369693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627714|NCT01369693|Respiratory System Agents|respiratory system agents|mesh-ancestor
65627715|NCT02102594|Bortezomib|bortezomib|mesh-list
65627716|NCT02102594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65627717|NCT02102672|Trimetazidine|trimetazidine|mesh-list
65627718|NCT02102672|Vasodilator Agents|vasodilator agents|mesh-ancestor
65627719|NCT03121261|Clonidine|clonidine|mesh-list
65627720|NCT03121261|Levobupivacaine|levobupivacaine|mesh-list
65627721|NCT03121261|Analgesics|analgesics|mesh-ancestor
65627722|NCT03121261|Sensory System Agents|sensory system agents|mesh-ancestor
65627723|NCT03121261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65627724|NCT03121261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627725|NCT03121261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65627726|NCT03121261|Sympatholytics|sympatholytics|mesh-ancestor
65627727|NCT03121261|Autonomic Agents|autonomic agents|mesh-ancestor
65627728|NCT03121261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65627729|NCT03121261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65627730|NCT03121261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65627731|NCT03121261|Adrenergic Agents|adrenergic agents|mesh-ancestor
65627732|NCT03121261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65627733|NCT03121261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627734|NCT03121261|Anesthetics, Local|anesthetics, local|mesh-ancestor
65627735|NCT03121261|Anesthetics|anesthetics|mesh-ancestor
65627736|NCT03121261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65627737|NCT04249323|Prednisone|prednisone|mesh-list
65627738|NCT04249323|Cortisone|cortisone|mesh-list
65627739|NCT04249323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65627740|NCT04249323|Glucocorticoids|glucocorticoids|mesh-ancestor
65627741|NCT04249323|Hormones|hormones|mesh-ancestor
65627742|NCT04249323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65627743|NCT04249323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627744|NCT04249323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65627745|NCT04249323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65627746|NCT04227327|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65627747|NCT04227327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65627748|NCT04227327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65627749|NCT04227327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627750|NCT04227327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65627751|NCT04227327|Hormone Antagonists|hormone antagonists|mesh-ancestor
65627752|NCT04227327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65627753|NCT04227327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627755|NCT02102828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65627756|NCT02102828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65627757|NCT02102828|Analgesics|analgesics|mesh-ancestor
65627758|NCT02102828|Sensory System Agents|sensory system agents|mesh-ancestor
65627759|NCT02102828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65627760|NCT02102828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627761|NCT02102828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65627762|NCT02102828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65627763|NCT02102828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65627764|NCT02102828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65627765|NCT02102828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627766|NCT02102828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65627767|NCT02102828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65627768|NCT02102828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65627769|NCT02102828|Antipyretics|antipyretics|mesh-ancestor
65627770|NCT01372423|Lubiprostone|lubiprostone|mesh-list
65627771|NCT01372423|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65627772|NCT01372423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65627773|NCT01372423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627774|NCT04218357|Probenecid|probenecid|mesh-list
65627775|NCT04218357|Uricosuric Agents|uricosuric agents|mesh-ancestor
65627776|NCT04218357|Gout Suppressants|gout suppressants|mesh-ancestor
65627777|NCT04218357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65627778|NCT04218357|Renal Agents|renal agents|mesh-ancestor
65627779|NCT02106650|Leucovorin|leucovorin|mesh-list
65627780|NCT02106650|Folic Acid|folic acid|mesh-list
65627781|NCT02106650|Vitamin B 12|vitamin b 12|mesh-list
65627782|NCT02106650|Hydroxocobalamin|hydroxocobalamin|mesh-list
65627783|NCT02106650|Vitamins|vitamins|mesh-ancestor
65627784|NCT02106650|Micronutrients|micronutrients|mesh-ancestor
65627785|NCT02106650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627786|NCT02106650|Antidotes|antidotes|mesh-ancestor
65627787|NCT02106650|Protective Agents|protective agents|mesh-ancestor
65627788|NCT02106650|Vitamin B Complex|vitamin b complex|mesh-ancestor
65627789|NCT02106650|Hematinics|hematinics|mesh-ancestor
65627790|NCT05221437|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65627791|NCT05221437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65627792|NCT01376011|Quercetin|quercetin|mesh-list
65627793|NCT01376011|Antioxidants|antioxidants|mesh-ancestor
65627794|NCT01376011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627795|NCT01376011|Protective Agents|protective agents|mesh-ancestor
65627796|NCT01376011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627797|NCT04033107|Ascorbic Acid|ascorbic acid|mesh-list
65627798|NCT04033107|Metformin|metformin|mesh-list
65627799|NCT04033107|Vitamins|vitamins|mesh-ancestor
65627800|NCT04033107|Micronutrients|micronutrients|mesh-ancestor
65627801|NCT04033107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627802|NCT04033107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65627803|NCT04033107|Antioxidants|antioxidants|mesh-ancestor
65627804|NCT04033107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627805|NCT04033107|Protective Agents|protective agents|mesh-ancestor
65627806|NCT02106806|Zinc|zinc|mesh-list
65627807|NCT02106806|Zinc Sulfate|zinc sulfate|mesh-list
65627808|NCT02106806|Trace Elements|trace elements|mesh-ancestor
65627809|NCT02106806|Micronutrients|micronutrients|mesh-ancestor
65627810|NCT02106806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627811|NCT02106806|Astringents|astringents|mesh-ancestor
65627812|NCT02106806|Dermatologic Agents|dermatologic agents|mesh-ancestor
65627813|NCT02966119|Aspirin|aspirin|mesh-list
65627814|NCT02966119|Clopidogrel|clopidogrel|mesh-list
65627815|NCT02966119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65627816|NCT02966119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65627817|NCT02966119|Analgesics|analgesics|mesh-ancestor
65627818|NCT02966119|Sensory System Agents|sensory system agents|mesh-ancestor
65627819|NCT02966119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65627820|NCT02966119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425149|NCT00364533|Oxycodone|oxycodone|mesh-list
65627821|NCT02966119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65627822|NCT02966119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65627823|NCT02966119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65627824|NCT02966119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65627825|NCT02966119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627826|NCT02966119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65627827|NCT02966119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65627828|NCT02966119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65627829|NCT02966119|Antipyretics|antipyretics|mesh-ancestor
65627830|NCT02966119|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65627831|NCT02966119|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65627832|NCT02966119|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65627833|NCT02966119|Purinergic Agents|purinergic agents|mesh-ancestor
65627834|NCT02966119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65627835|NCT02101892|Amitriptyline|amitriptyline|mesh-list
65627836|NCT02101892|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65627837|NCT02101892|Antidepressive Agents|antidepressive agents|mesh-ancestor
65627838|NCT02101892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65627839|NCT02101892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65627840|NCT02101892|Analgesics|analgesics|mesh-ancestor
65627841|NCT02101892|Sensory System Agents|sensory system agents|mesh-ancestor
65627842|NCT02101892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65627843|NCT02101892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627844|NCT02101892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65627845|NCT02101892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65627846|NCT02101892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65627847|NCT02101892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627848|NCT02101892|Adrenergic Agents|adrenergic agents|mesh-ancestor
65627849|NCT02101892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65627850|NCT03634111|Morphine|morphine|mesh-list
65627851|NCT03634111|Ropivacaine|ropivacaine|mesh-list
65627852|NCT03634111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65627853|NCT03634111|Narcotics|narcotics|mesh-ancestor
65627854|NCT03634111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65627855|NCT03634111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627856|NCT03634111|Analgesics|analgesics|mesh-ancestor
65627857|NCT03634111|Sensory System Agents|sensory system agents|mesh-ancestor
65627858|NCT03634111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65627859|NCT03634111|Anesthetics, Local|anesthetics, local|mesh-ancestor
65627860|NCT03634111|Anesthetics|anesthetics|mesh-ancestor
65627861|NCT02102048|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65627862|NCT02102048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65627863|NCT02102048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65627864|NCT02102048|Protease Inhibitors|protease inhibitors|mesh-ancestor
65627865|NCT02102048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65627866|NCT02102048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627867|NCT02102048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65627868|NCT02102048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65627869|NCT02102048|Antiviral Agents|antiviral agents|mesh-ancestor
65627870|NCT02102048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65627871|NCT03118297|Ulipristal acetate|ulipristal acetate|mesh-list
65627872|NCT03118297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65627873|NCT03118297|Contraceptive Agents|contraceptive agents|mesh-ancestor
65627874|NCT03118297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65627875|NCT03118297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627876|NCT03118297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65627877|NCT02250794|Insulin|insulin|mesh-list
65627878|NCT02250794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65627879|NCT02250794|Metformin|metformin|mesh-list
65627880|NCT02250794|Insulin Glargine|insulin glargine|mesh-list
65627881|NCT02250794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65627882|NCT02250794|Insulin Lispro|insulin lispro|mesh-list
65627883|NCT02250794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65627884|NCT02250794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627885|NCT02250794|Incretins|incretins|mesh-ancestor
65627886|NCT02250794|Hormones|hormones|mesh-ancestor
65627887|NCT02250794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65627888|NCT02250794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65627889|NCT02250794|Protease Inhibitors|protease inhibitors|mesh-ancestor
65627890|NCT02250794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65627891|NCT02250794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627892|NCT02103374|Terbutaline|terbutaline|mesh-list
65627893|NCT02103374|Ipratropium|ipratropium|mesh-list
65627894|NCT02103374|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65627895|NCT02103374|Autonomic Agents|autonomic agents|mesh-ancestor
65627896|NCT02103374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65627897|NCT02103374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627898|NCT02103374|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65627899|NCT02103374|Respiratory System Agents|respiratory system agents|mesh-ancestor
65627900|NCT02103374|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65627901|NCT02103374|Cholinergic Agents|cholinergic agents|mesh-ancestor
65627902|NCT02103374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65627903|NCT02103374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627904|NCT02103374|Sympathomimetics|sympathomimetics|mesh-ancestor
65627905|NCT02103374|Tocolytic Agents|tocolytic agents|mesh-ancestor
65627906|NCT02103374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65627907|NCT02103374|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65627908|NCT02103374|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65627909|NCT02103374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65627910|NCT02103374|Adrenergic Agents|adrenergic agents|mesh-ancestor
65627911|NCT03555188|Ondansetron|ondansetron|mesh-list
65627912|NCT03555188|Antiemetics|antiemetics|mesh-ancestor
65627913|NCT03555188|Autonomic Agents|autonomic agents|mesh-ancestor
65627914|NCT03555188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65627915|NCT03555188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627916|NCT03555188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65627917|NCT03555188|Antipruritics|antipruritics|mesh-ancestor
65627918|NCT03555188|Dermatologic Agents|dermatologic agents|mesh-ancestor
65627919|NCT03555188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65627920|NCT03555188|Serotonin Agents|serotonin agents|mesh-ancestor
65627921|NCT03555188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65627922|NCT03555188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627923|NCT03555188|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65627924|NCT03555188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65627925|NCT03555188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65627926|NCT03555188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65627927|NCT03555188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65627928|NCT05707221|Chlorhexidine|chlorhexidine|mesh-list
65627929|NCT05707221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65627930|NCT05707221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65627931|NCT05707221|Disinfectants|disinfectants|mesh-ancestor
65627932|NCT03117361|Dexamethasone|dexamethasone|mesh-list
65627933|NCT03117361|Bortezomib|bortezomib|mesh-list
65627934|NCT03117361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65627935|NCT03117361|Antiemetics|antiemetics|mesh-ancestor
65627936|NCT03117361|Autonomic Agents|autonomic agents|mesh-ancestor
65627937|NCT03117361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65627938|NCT03117361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627939|NCT03117361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65627940|NCT03117361|Glucocorticoids|glucocorticoids|mesh-ancestor
65627941|NCT03117361|Hormones|hormones|mesh-ancestor
65627942|NCT03117361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65627943|NCT03117361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65627944|NCT03117361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65627945|NCT03840291|Edoxaban|edoxaban|mesh-list
65627946|NCT03840291|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65627947|NCT03840291|Antithrombins|antithrombins|mesh-ancestor
65627948|NCT03840291|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65627949|NCT03840291|Protease Inhibitors|protease inhibitors|mesh-ancestor
65627950|NCT03840291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65627951|NCT03840291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627952|NCT03840291|Anticoagulants|anticoagulants|mesh-ancestor
65627953|NCT03053427|Gabapentin|gabapentin|mesh-list
65627954|NCT03053427|Analgesics|analgesics|mesh-ancestor
65627955|NCT03053427|Sensory System Agents|sensory system agents|mesh-ancestor
65627956|NCT03053427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65627957|NCT03053427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627958|NCT03053427|Anticonvulsants|anticonvulsants|mesh-ancestor
65627959|NCT03053427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65627960|NCT03053427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65627961|NCT03053427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65627962|NCT03053427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65627963|NCT03053427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65627964|NCT03053427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65627965|NCT03053427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65627966|NCT03053427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627967|NCT03053427|Antimanic Agents|antimanic agents|mesh-ancestor
65627968|NCT02107118|Complement Factor H|complement factor h|mesh-list
65627969|NCT02107118|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65627970|NCT02107118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65627971|NCT02107118|Immunologic Factors|immunologic factors|mesh-ancestor
65627972|NCT02107118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65627973|NCT05081089|Lumefantrine|lumefantrine|mesh-list
65627974|NCT05081089|Artemether|artemether|mesh-list
65627976|NCT05081089|Primaquine|primaquine|mesh-list
65627977|NCT05081089|Sulfadoxine|sulfadoxine|mesh-list
65627978|NCT05081089|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65627979|NCT05081089|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65627980|NCT05081089|Amodiaquine|amodiaquine|mesh-list
65627981|NCT05081089|Tafenoquine|tafenoquine|mesh-list
65627982|NCT05081089|Antimalarials|antimalarials|mesh-ancestor
65627983|NCT05081089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65627984|NCT05081089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65627985|NCT05081089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65627986|NCT05081089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65627987|NCT05081089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65627988|NCT05081089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65627989|NCT05081089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65627990|NCT05081089|Renal Agents|renal agents|mesh-ancestor
65627991|NCT03555032|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
65627992|NCT03555032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65627993|NCT03555032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65627994|NCT03554408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65627995|NCT03554408|Antibodies|antibodies|mesh-list
65627996|NCT03554408|Immunoglobulins|immunoglobulins|mesh-list
65627997|NCT03554408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65627998|NCT03554408|Immunologic Factors|immunologic factors|mesh-ancestor
65627999|NCT03554408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628000|NCT03554408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628001|NCT02103686|Pregabalin|pregabalin|mesh-list
65628002|NCT02103686|Analgesics|analgesics|mesh-ancestor
65628003|NCT02103686|Sensory System Agents|sensory system agents|mesh-ancestor
65628004|NCT02103686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65628005|NCT02103686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628006|NCT02103686|Anticonvulsants|anticonvulsants|mesh-ancestor
65628007|NCT02103686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65628008|NCT02103686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65628009|NCT02103686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628010|NCT02103686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65628011|NCT02103686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65628012|NCT02103686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65628013|NCT02103686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65628014|NCT02103686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65628015|NCT02110082|Cetuximab|cetuximab|mesh-list
65628016|NCT02110082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65628017|NCT02110082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628018|NCT02103764|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65628019|NCT02103764|Medroxyprogesterone|medroxyprogesterone|mesh-list
65628020|NCT02103764|Desogestrel|desogestrel|mesh-list
65628021|NCT02103764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65628022|NCT02103764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65628023|NCT02103764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65628024|NCT02103764|Contraceptive Agents|contraceptive agents|mesh-ancestor
65628025|NCT02103764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65628026|NCT02103764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628027|NCT02103764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65628028|NCT02103764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65628029|NCT02103764|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65628030|NCT02103764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65628031|NCT02103764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628032|NCT02103764|Progestins|progestins|mesh-ancestor
65628033|NCT02103764|Hormones|hormones|mesh-ancestor
65628034|NCT02103764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65628035|NCT02110316|Voriconazole|voriconazole|mesh-list
65628036|NCT02110316|Antifungal Agents|antifungal agents|mesh-ancestor
65628037|NCT02110316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65628038|NCT02110316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65628039|NCT02110316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65628040|NCT02110316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628041|NCT02110316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628042|NCT02110316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65628043|NCT02110316|Hormone Antagonists|hormone antagonists|mesh-ancestor
65628044|NCT02110316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65628045|NCT02110316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628046|NCT02110316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65628047|NCT05625087|Fulvestrant|fulvestrant|mesh-list
65628048|NCT05625087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65628049|NCT05625087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628050|NCT05625087|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65628051|NCT05625087|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65628052|NCT05625087|Hormone Antagonists|hormone antagonists|mesh-ancestor
65628053|NCT05625087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65628054|NCT05625087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628055|NCT02110394|Rituximab|rituximab|mesh-list
65628056|NCT02110394|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65628057|NCT02110394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65628058|NCT02110394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628059|NCT02110394|Immunologic Factors|immunologic factors|mesh-ancestor
65628060|NCT02110394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628061|NCT02110394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65628062|NCT02110394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65628063|NCT02110394|Alkylating Agents|alkylating agents|mesh-ancestor
65628064|NCT02110394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628065|NCT02373241|Losartan|losartan|mesh-list
65628066|NCT02373241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65628067|NCT02373241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65628068|NCT02373241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65628069|NCT02373241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65628070|NCT02373241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628071|NCT02103998|Iodine|iodine|mesh-list
65628072|NCT02103998|Hormones|hormones|mesh-list
65628073|NCT02103998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65628074|NCT02103998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628075|NCT02103998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65628076|NCT02103998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65628077|NCT02103998|Trace Elements|trace elements|mesh-ancestor
65628078|NCT02103998|Micronutrients|micronutrients|mesh-ancestor
65628079|NCT01941589|Methylprednisolone|methylprednisolone|mesh-list
65628080|NCT01941589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65628081|NCT01941589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65628082|NCT01941589|Prednisolone|prednisolone|mesh-list
65628083|NCT01941589|Prednisolone acetate|prednisolone acetate|mesh-list
65628084|NCT01941589|Hydrocortisone|hydrocortisone|mesh-list
65628085|NCT01941589|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65628086|NCT01941589|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65628087|NCT01941589|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65628088|NCT01941589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65628089|NCT01941589|Prednisolone phosphate|prednisolone phosphate|mesh-list
65628090|NCT01941589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65628091|NCT01941589|Antiemetics|antiemetics|mesh-ancestor
65628092|NCT01941589|Autonomic Agents|autonomic agents|mesh-ancestor
65628093|NCT01941589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65628094|NCT01941589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628095|NCT01941589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65628096|NCT01941589|Glucocorticoids|glucocorticoids|mesh-ancestor
65628097|NCT01941589|Hormones|hormones|mesh-ancestor
65628098|NCT01941589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65628099|NCT01941589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65628100|NCT01941589|Protective Agents|protective agents|mesh-ancestor
65628101|NCT01941589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65628102|NCT01941589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628103|NCT01845649|Estradiol|estradiol|mesh-list
65628104|NCT01845649|Estrogens|estrogens|mesh-ancestor
65628105|NCT01845649|Hormones|hormones|mesh-ancestor
65628106|NCT01845649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65628107|NCT01845649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628108|NCT01345929|Levofloxacin|levofloxacin|mesh-list
65628109|NCT01345929|Ofloxacin|ofloxacin|mesh-list
65628110|NCT01345929|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65628111|NCT01345929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65628112|NCT01345929|Renal Agents|renal agents|mesh-ancestor
65628113|NCT01345929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65628114|NCT01345929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65628115|NCT01345929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65628116|NCT01345929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628117|NCT01345929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628118|NCT01345929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628119|NCT01345929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65628120|NCT01345929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65628121|NCT02107742|Lidocaine|lidocaine|mesh-list
65628122|NCT02107742|Anesthetics, Local|anesthetics, local|mesh-ancestor
65628123|NCT02107742|Anesthetics|anesthetics|mesh-ancestor
65628124|NCT02107742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65628125|NCT02107742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628126|NCT02107742|Sensory System Agents|sensory system agents|mesh-ancestor
65628127|NCT02107742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65628128|NCT02107742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65628129|NCT02107742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65628130|NCT02107742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65628131|NCT02107742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65628132|NCT02107742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628133|NCT02250872|Cisplatin|cisplatin|mesh-list
65628134|NCT02250872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628135|NCT02110784|Piperaquine|piperaquine|mesh-list
65628136|NCT02110784|Artenimol|artenimol|mesh-list
65628137|NCT02110784|Antimalarials|antimalarials|mesh-ancestor
65628138|NCT02110784|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65628139|NCT02110784|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65628140|NCT02110784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65628141|NCT04988425|Methylprednisolone|methylprednisolone|mesh-list
65628142|NCT04988425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65628143|NCT04988425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65628144|NCT04988425|Prednisolone|prednisolone|mesh-list
65628145|NCT04988425|Prednisolone acetate|prednisolone acetate|mesh-list
65628146|NCT04988425|Antibodies|antibodies|mesh-list
65628147|NCT04988425|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65628148|NCT04988425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65628149|NCT04988425|Prednisolone phosphate|prednisolone phosphate|mesh-list
65628150|NCT04988425|Immunologic Factors|immunologic factors|mesh-ancestor
65628151|NCT04988425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090877|NCT02891161|Durvalumab|durvalumab|mesh-list
65628152|NCT04988425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65628153|NCT04988425|Antiemetics|antiemetics|mesh-ancestor
65628154|NCT04988425|Autonomic Agents|autonomic agents|mesh-ancestor
65628155|NCT04988425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65628156|NCT04988425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65628157|NCT04988425|Glucocorticoids|glucocorticoids|mesh-ancestor
65628158|NCT04988425|Hormones|hormones|mesh-ancestor
65628159|NCT04988425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65628160|NCT04988425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65628161|NCT04988425|Protective Agents|protective agents|mesh-ancestor
65628162|NCT04988425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65628163|NCT04988425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628164|NCT01343901|Bevacizumab|bevacizumab|mesh-list
65628165|NCT01343901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65628166|NCT01343901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628167|NCT01343901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65628168|NCT01343901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65628169|NCT01343901|Growth Substances|growth substances|mesh-ancestor
65628170|NCT01343901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628171|NCT01343901|Growth Inhibitors|growth inhibitors|mesh-ancestor
65628172|NCT05617521|Caffeine|caffeine|mesh-list
65628173|NCT05617521|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65628174|NCT05617521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628175|NCT05617521|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65628176|NCT05617521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628177|NCT05617521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628178|NCT05617521|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65628179|NCT05617521|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65628180|NCT05617521|Purinergic Agents|purinergic agents|mesh-ancestor
65628181|NCT05617521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65628182|NCT02108210|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65628183|NCT02108210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65628184|NCT02104700|Tenofovir|tenofovir|mesh-list
65628185|NCT02104700|Emtricitabine|emtricitabine|mesh-list
65628186|NCT02104700|Rilpivirine|rilpivirine|mesh-list
65628187|NCT02104700|Antiviral Agents|antiviral agents|mesh-ancestor
65628188|NCT02104700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65628189|NCT02104700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65628190|NCT02104700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65628191|NCT02104700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628192|NCT02104700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628193|NCT02104700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65628194|NCT02104700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65628195|NCT02104778|Dexamethasone|dexamethasone|mesh-list
65628196|NCT02104778|Epinephrine|epinephrine|mesh-list
65628197|NCT02104778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65628199|NCT02104778|Autonomic Agents|autonomic agents|mesh-ancestor
65628200|NCT02104778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65628201|NCT02104778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628202|NCT02104778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65628203|NCT02104778|Glucocorticoids|glucocorticoids|mesh-ancestor
65628204|NCT02104778|Hormones|hormones|mesh-ancestor
65628205|NCT02104778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65628206|NCT02104778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65628207|NCT02104778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628208|NCT02104778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65628209|NCT02104778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65628210|NCT02104778|Adrenergic Agents|adrenergic agents|mesh-ancestor
65628211|NCT02104778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65628212|NCT02104778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628213|NCT02104778|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65628214|NCT02104778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65628215|NCT02104778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65628216|NCT02104778|Respiratory System Agents|respiratory system agents|mesh-ancestor
65628217|NCT02104778|Mydriatics|mydriatics|mesh-ancestor
65628218|NCT02104778|Sympathomimetics|sympathomimetics|mesh-ancestor
65628219|NCT02104778|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65628220|NCT02108366|Oseltamivir|oseltamivir|mesh-list
65628221|NCT02108366|Celecoxib|celecoxib|mesh-list
65628222|NCT02108366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65628223|NCT02108366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65628224|NCT02108366|Analgesics|analgesics|mesh-ancestor
65628225|NCT02108366|Sensory System Agents|sensory system agents|mesh-ancestor
65628226|NCT02108366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65628227|NCT02108366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628228|NCT02108366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65628229|NCT02108366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65628230|NCT02108366|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65628231|NCT02108366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65628232|NCT02108366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628233|NCT02108366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628234|NCT02108366|Antiviral Agents|antiviral agents|mesh-ancestor
65628235|NCT02108366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65628236|NCT05706207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65628237|NCT05706207|Antibodies|antibodies|mesh-list
65628238|NCT05706207|Immunoglobulins|immunoglobulins|mesh-list
65628239|NCT05706207|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65628240|NCT05706207|Immunologic Factors|immunologic factors|mesh-ancestor
65628241|NCT05706207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628242|NCT05706207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628243|NCT02105090|Anesthetics|anesthetics|mesh-list
65628244|NCT02105090|Anesthetics, Local|anesthetics, local|mesh-list
65628245|NCT02105090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65628246|NCT02105090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628247|NCT02105090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65628248|NCT02105090|Sensory System Agents|sensory system agents|mesh-ancestor
65628249|NCT03553628|Chlorhexidine|chlorhexidine|mesh-list
65628250|NCT03553628|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65628251|NCT03553628|Propolis|propolis|mesh-list
65628252|NCT03553628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65628253|NCT03553628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65628254|NCT03553628|Disinfectants|disinfectants|mesh-ancestor
65628255|NCT03553628|Dermatologic Agents|dermatologic agents|mesh-ancestor
65628256|NCT02112032|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65628257|NCT02112032|Pembrolizumab|pembrolizumab|mesh-list
65628258|NCT02112032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65628259|NCT02112032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628260|NCT02112032|Antiviral Agents|antiviral agents|mesh-ancestor
65628261|NCT02112032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65628262|NCT01343823|Ecallantide|ecallantide|mesh-list
65628263|NCT01343823|Analgesics|analgesics|mesh-ancestor
65628264|NCT01343823|Sensory System Agents|sensory system agents|mesh-ancestor
65628265|NCT01343823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65628266|NCT01343823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628267|NCT01343823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65628268|NCT01343823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65628269|NCT01343823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65628270|NCT01343823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65628271|NCT02251184|Aspirin|aspirin|mesh-list
65628272|NCT02251184|Dipyridamole|dipyridamole|mesh-list
65628273|NCT02251184|Lansoprazole|lansoprazole|mesh-list
65628274|NCT02251184|Dexlansoprazole|dexlansoprazole|mesh-list
65628275|NCT02251184|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
65628276|NCT02251184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65628277|NCT02251184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65628278|NCT02251184|Analgesics|analgesics|mesh-ancestor
65628279|NCT02251184|Sensory System Agents|sensory system agents|mesh-ancestor
65628280|NCT02251184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65628281|NCT02251184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628282|NCT02251184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65628283|NCT02251184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65628284|NCT02251184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65628285|NCT02251184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65628286|NCT02251184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628287|NCT02251184|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65628288|NCT02251184|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65628289|NCT02251184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628290|NCT02251184|Antipyretics|antipyretics|mesh-ancestor
65628291|NCT02251184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65628292|NCT02251184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65628293|NCT02251184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65628294|NCT02251184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65628295|NCT02251184|Vasodilator Agents|vasodilator agents|mesh-ancestor
65628296|NCT02108756|Pantoprazole|pantoprazole|mesh-list
65628297|NCT02108756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65628298|NCT02108756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65628299|NCT02108756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65628300|NCT02108756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628301|NCT02108756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628302|NCT05547399|Zanubrutinib|zanubrutinib|mesh-list
65628303|NCT05547399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628304|NCT05547399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65628305|NCT05547399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628306|NCT05547399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628307|NCT01318083|Glimepiride|glimepiride|mesh-list
65628308|NCT01318083|Alogliptin|alogliptin|mesh-list
65628309|NCT01318083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65628310|NCT01318083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65628311|NCT01318083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628312|NCT01318083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65628313|NCT01318083|Immunologic Factors|immunologic factors|mesh-ancestor
65628314|NCT01318083|Incretins|incretins|mesh-ancestor
65628315|NCT01318083|Hormones|hormones|mesh-ancestor
65628316|NCT01318083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65628317|NCT01318083|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65628318|NCT01318083|Protease Inhibitors|protease inhibitors|mesh-ancestor
65628319|NCT01318083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628320|NCT01318083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628321|NCT05545137|Fosfomycin|fosfomycin|mesh-list
65628322|NCT05545137|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
65628323|NCT05545137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65628324|NCT05545137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65628325|NCT05545137|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65628326|NCT05545137|Renal Agents|renal agents|mesh-ancestor
65628327|NCT02105714|Formaldehyde|formaldehyde|mesh-list
65628328|NCT02105714|Disinfectants|disinfectants|mesh-ancestor
65628329|NCT02105714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65628330|NCT02105792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65628331|NCT02105792|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65628332|NCT02105792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628333|NCT02105792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65628334|NCT02105792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628335|NCT02105792|Protease Inhibitors|protease inhibitors|mesh-ancestor
65628336|NCT02105792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628337|NCT03817515|Sirolimus|sirolimus|mesh-list
65628338|NCT03817515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65628339|NCT03817515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65628340|NCT03817515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65628341|NCT03817515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628342|NCT03817515|Antifungal Agents|antifungal agents|mesh-ancestor
65628343|NCT03817515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65628344|NCT03817515|Immunologic Factors|immunologic factors|mesh-ancestor
65628345|NCT03817515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628346|NCT02105870|Abciximab|abciximab|mesh-list
65628347|NCT02105870|Anticoagulants|anticoagulants|mesh-ancestor
65425685|NCT01011920|Cytarabine|cytarabine|mesh-list
65628348|NCT02105870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65628349|NCT02112422|Dexamethasone|dexamethasone|mesh-list
65628350|NCT02112422|Dexamethasone acetate|dexamethasone acetate|mesh-list
65628351|NCT02112422|BB 1101|bb 1101|mesh-list
65628352|NCT02112422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65628353|NCT02112422|Antiemetics|antiemetics|mesh-ancestor
65628354|NCT02112422|Autonomic Agents|autonomic agents|mesh-ancestor
65628355|NCT02112422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65628356|NCT02112422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628357|NCT02112422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65628358|NCT02112422|Glucocorticoids|glucocorticoids|mesh-ancestor
65628359|NCT02112422|Hormones|hormones|mesh-ancestor
65628360|NCT02112422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65628361|NCT02112422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65628362|NCT02112422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628363|NCT02112422|Protease Inhibitors|protease inhibitors|mesh-ancestor
65628364|NCT02112422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628365|NCT02112422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628366|NCT02109614|Niacin|niacin|mesh-list
65628367|NCT02109614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65628368|NCT02109614|Antimetabolites|antimetabolites|mesh-ancestor
65628369|NCT02109614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628370|NCT02109614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65628371|NCT02109614|Vasodilator Agents|vasodilator agents|mesh-ancestor
65628372|NCT02109614|Vitamin B Complex|vitamin b complex|mesh-ancestor
65628373|NCT02109614|Vitamins|vitamins|mesh-ancestor
65628374|NCT02109614|Micronutrients|micronutrients|mesh-ancestor
65628375|NCT02109614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628376|NCT02106104|Glimepiride|glimepiride|mesh-list
65628377|NCT02106104|Linagliptin|linagliptin|mesh-list
65628378|NCT02106104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65628379|NCT02106104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65628380|NCT02106104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628381|NCT02106104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65628382|NCT02106104|Immunologic Factors|immunologic factors|mesh-ancestor
65628383|NCT02106104|Incretins|incretins|mesh-ancestor
65628384|NCT02106104|Hormones|hormones|mesh-ancestor
65628385|NCT02106104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65628386|NCT02106104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65628387|NCT02106104|Protease Inhibitors|protease inhibitors|mesh-ancestor
65628388|NCT02106104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628389|NCT02106104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628390|NCT01376323|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65628391|NCT01376323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65628392|NCT01376323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628393|NCT01376323|Incretins|incretins|mesh-ancestor
65628394|NCT01376323|Hormones|hormones|mesh-ancestor
65628395|NCT01376323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65628396|NCT01376323|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65628397|NCT01376323|Protease Inhibitors|protease inhibitors|mesh-ancestor
65628398|NCT01376323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628399|NCT01376323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628400|NCT02113904|Adalimumab|adalimumab|mesh-list
65628401|NCT02113904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65628402|NCT02113904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65628403|NCT05613777|BI 425809|bi 425809|mesh-list
65628404|NCT05613777|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65628405|NCT05613777|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
65628406|NCT05613777|Nootropic Agents|nootropic agents|mesh-ancestor
65628407|NCT05613777|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65628408|NCT05613777|Contraceptive Agents|contraceptive agents|mesh-ancestor
65628409|NCT05613777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65628410|NCT05613777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628411|NCT05613777|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65628412|NCT05613777|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65628413|NCT05613777|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65628414|NCT05613777|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65628415|NCT05613777|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65628416|NCT05613777|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
65628417|NCT05613777|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65628418|NCT05613777|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65628419|NCT05438979|Calcium|calcium|mesh-list
65628420|NCT05438979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65425751|NCT01067950|Pancrelipase|pancrelipase|mesh-list
65628421|NCT05438979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628423|NCT05432115|Tetracycline|tetracycline|mesh-list
65628424|NCT05432115|Esomeprazole|esomeprazole|mesh-list
65628425|NCT05432115|Bismuth|bismuth|mesh-list
65628426|NCT05432115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65628427|NCT05432115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65628428|NCT05432115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65628429|NCT05432115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65628430|NCT05432115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65628431|NCT05432115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628432|NCT05432115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628433|NCT05432115|Antacids|antacids|mesh-ancestor
65628434|NCT05432115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65628435|NCT02114528|Amiodarone|amiodarone|mesh-list
65628436|NCT02114528|Sotalol|sotalol|mesh-list
65628437|NCT02114528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
65628438|NCT02114528|Mexiletine|mexiletine|mesh-list
65628439|NCT02114528|Procainamide|procainamide|mesh-list
65628440|NCT02114528|Vasodilator Agents|vasodilator agents|mesh-ancestor
65628441|NCT02114528|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65628442|NCT02114528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65628443|NCT02114528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628444|NCT02114528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65628445|NCT02114528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65628446|NCT02114528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65628447|NCT02114528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628448|NCT02114528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65628449|NCT02114528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65628450|NCT02114528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65628451|NCT02114528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65628452|NCT02114528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65628453|NCT02114528|Adrenergic Agents|adrenergic agents|mesh-ancestor
65628454|NCT02114528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65628455|NCT02114528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628456|NCT02114528|Sympatholytics|sympatholytics|mesh-ancestor
65628457|NCT02114528|Autonomic Agents|autonomic agents|mesh-ancestor
65628458|NCT02114528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65628459|NCT02114528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65628460|NCT02113202|Bevacizumab|bevacizumab|mesh-list
65628461|NCT02113202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65628462|NCT02113202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628463|NCT02113202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65628464|NCT02113202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65628465|NCT02113202|Growth Substances|growth substances|mesh-ancestor
65628466|NCT02113202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628467|NCT02113202|Growth Inhibitors|growth inhibitors|mesh-ancestor
65628468|NCT01376401|Prednisone|prednisone|mesh-list
65628469|NCT01376401|Bortezomib|bortezomib|mesh-list
65628470|NCT01376401|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65628471|NCT01376401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65628472|NCT01376401|Glucocorticoids|glucocorticoids|mesh-ancestor
65628473|NCT01376401|Hormones|hormones|mesh-ancestor
65628474|NCT01376401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65628475|NCT01376401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628476|NCT01376401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65628477|NCT01376401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628478|NCT01376401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65628479|NCT01376401|Alkylating Agents|alkylating agents|mesh-ancestor
65628480|NCT01376401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628481|NCT02119520|Atorvastatin|atorvastatin|mesh-list
65628482|NCT02119520|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65628483|NCT02119520|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65628484|NCT02119520|Antimetabolites|antimetabolites|mesh-ancestor
65628485|NCT02119520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628486|NCT02119520|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65628487|NCT02119520|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65628488|NCT02119520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628489|NCT03961789|Analgesics, Opioid|analgesics, opioid|mesh-list
65628490|NCT03961789|Narcotics|narcotics|mesh-ancestor
65628491|NCT03961789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65628492|NCT03961789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628493|NCT03961789|Analgesics|analgesics|mesh-ancestor
65628494|NCT03961789|Sensory System Agents|sensory system agents|mesh-ancestor
65628495|NCT03961789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65628496|NCT04854343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
65628497|NCT04854343|Protease Inhibitors|protease inhibitors|mesh-list
65628498|NCT04854343|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
65628499|NCT04854343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628500|NCT04854343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628501|NCT04854343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65628502|NCT04854343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65628503|NCT04854343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65628504|NCT04854343|Antiviral Agents|antiviral agents|mesh-ancestor
65628505|NCT04854343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65628506|NCT04854343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65628507|NCT01376713|Dacarbazine|dacarbazine|mesh-list
65628508|NCT01376713|Ofatumumab|ofatumumab|mesh-list
65628509|NCT01376713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65628510|NCT01376713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65628511|NCT01376713|Alkylating Agents|alkylating agents|mesh-ancestor
65628512|NCT01376713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628513|NCT01376713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628514|NCT01376713|Immunologic Factors|immunologic factors|mesh-ancestor
65628515|NCT01376713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628516|NCT03728179|Aspirin|aspirin|mesh-list
65628517|NCT03728179|Celecoxib|celecoxib|mesh-list
65628518|NCT03728179|Cyclophosphamide|cyclophosphamide|mesh-list
65628519|NCT03728179|Nivolumab|nivolumab|mesh-list
65628520|NCT03728179|Ipilimumab|ipilimumab|mesh-list
65628521|NCT03728179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65628522|NCT03728179|Immunologic Factors|immunologic factors|mesh-ancestor
65628523|NCT03728179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628524|NCT03728179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65628525|NCT03728179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65628526|NCT03728179|Alkylating Agents|alkylating agents|mesh-ancestor
65628527|NCT03728179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628528|NCT03728179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628529|NCT03728179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65628530|NCT03728179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65628531|NCT03728179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65628532|NCT03728179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65628533|NCT03728179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65628534|NCT03728179|Analgesics|analgesics|mesh-ancestor
65628535|NCT03728179|Sensory System Agents|sensory system agents|mesh-ancestor
65628536|NCT03728179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65628537|NCT03728179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65628538|NCT03728179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65628539|NCT03728179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65628540|NCT03728179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65628541|NCT03728179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65628542|NCT03728179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628543|NCT03728179|Antipyretics|antipyretics|mesh-ancestor
65628544|NCT03728179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65628545|NCT01368536|Amlodipine|amlodipine|mesh-list
65628546|NCT01368536|Chlorthalidone|chlorthalidone|mesh-list
65628547|NCT01368536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65628548|NCT01368536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65628549|NCT01368536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65628550|NCT01368536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628551|NCT01368536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65628552|NCT01368536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628553|NCT01368536|Vasodilator Agents|vasodilator agents|mesh-ancestor
65628554|NCT01368536|Diuretics|diuretics|mesh-ancestor
65628555|NCT01368536|Natriuretic Agents|natriuretic agents|mesh-ancestor
65628556|NCT01368536|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65628557|NCT05103735|Dexmedetomidine|dexmedetomidine|mesh-list
65628558|NCT05103735|Remifentanil|remifentanil|mesh-list
65628559|NCT05103735|Propofol|propofol|mesh-list
65628560|NCT05103735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65628561|NCT05103735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65628562|NCT05103735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628563|NCT05103735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65628564|NCT05103735|Anesthetics, General|anesthetics, general|mesh-ancestor
65628565|NCT05103735|Anesthetics|anesthetics|mesh-ancestor
65628566|NCT05103735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65628567|NCT05103735|Analgesics|analgesics|mesh-ancestor
65628568|NCT05103735|Sensory System Agents|sensory system agents|mesh-ancestor
65628569|NCT05103735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65628570|NCT05103735|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65628571|NCT05103735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65628572|NCT05103735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65628573|NCT05103735|Adrenergic Agents|adrenergic agents|mesh-ancestor
65628574|NCT05103735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65628575|NCT05103735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628576|NCT05103735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65628577|NCT05103735|Narcotics|narcotics|mesh-ancestor
65628578|NCT01319929|CB2 receptor agonist LY2828360|cb2 receptor agonist ly2828360|mesh-list
65628579|NCT01319929|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65628580|NCT01319929|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65628581|NCT01319929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65628582|NCT01319929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628583|NCT01319929|Hormones|hormones|mesh-ancestor
65628584|NCT01319929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65628585|NCT01319929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628586|NCT03633565|Prednisolone|prednisolone|mesh-list
65628587|NCT03633565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65628588|NCT03633565|Methylprednisolone|methylprednisolone|mesh-list
65628589|NCT03633565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65628590|NCT03633565|Prednisolone acetate|prednisolone acetate|mesh-list
65628591|NCT03633565|Sildenafil Citrate|sildenafil citrate|mesh-list
65628592|NCT03633565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65628593|NCT03633565|Prednisolone phosphate|prednisolone phosphate|mesh-list
65628594|NCT03633565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
65628595|NCT03633565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65628596|NCT03633565|Glucocorticoids|glucocorticoids|mesh-ancestor
65628597|NCT03633565|Hormones|hormones|mesh-ancestor
65628598|NCT03633565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65628599|NCT03633565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628600|NCT03633565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65628601|NCT03633565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628602|NCT03633565|Antiemetics|antiemetics|mesh-ancestor
65628603|NCT03633565|Autonomic Agents|autonomic agents|mesh-ancestor
65628604|NCT03633565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65628605|NCT03633565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65628606|NCT03633565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65628607|NCT03633565|Protective Agents|protective agents|mesh-ancestor
65628608|NCT03633565|Vasodilator Agents|vasodilator agents|mesh-ancestor
65628609|NCT03633565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65628610|NCT03633565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628611|NCT03633565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628612|NCT03633565|Urological Agents|urological agents|mesh-ancestor
65628613|NCT02120066|Plasminogen|plasminogen|mesh-list
65628614|NCT02120066|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65628615|NCT02120066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65628616|NCT02120066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65628617|NCT02120066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628618|NCT01373359|Misoprostol|misoprostol|mesh-list
65628619|NCT01373359|Oxytocin|oxytocin|mesh-list
65628620|NCT01373359|Oxytocics|oxytocics|mesh-ancestor
65628621|NCT01373359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65628622|NCT01373359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628623|NCT01373359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65628624|NCT01373359|Abortifacient Agents|abortifacient agents|mesh-ancestor
65628625|NCT01373359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65628626|NCT01373359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65628627|NCT02123264|Zoledronic Acid|zoledronic acid|mesh-list
65628628|NCT02123264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65628629|NCT02123264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628630|NCT02251964|Rituximab|rituximab|mesh-list
65628631|NCT02251964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65628632|NCT02251964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628633|NCT02251964|Immunologic Factors|immunologic factors|mesh-ancestor
65628634|NCT02251964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628635|NCT02251964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65628636|NCT04739995|Naltrexone|naltrexone|mesh-list
65628637|NCT04739995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65628638|NCT04739995|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65628639|NCT04739995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628640|NCT04739995|Sensory System Agents|sensory system agents|mesh-ancestor
65628641|NCT04739995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65628642|NCT02120612|Naloxone|naloxone|mesh-list
65425976|NCT00488774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65628643|NCT02120612|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65628644|NCT02120612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628645|NCT02120612|Sensory System Agents|sensory system agents|mesh-ancestor
65628646|NCT02120612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65628647|NCT02115152|Cyclophosphamide|cyclophosphamide|mesh-list
65628648|NCT02115152|Fluorouracil|fluorouracil|mesh-list
65628649|NCT02115152|Capecitabine|capecitabine|mesh-list
65628650|NCT02115152|Epirubicin|epirubicin|mesh-list
65628651|NCT02115152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65628652|NCT02115152|Immunologic Factors|immunologic factors|mesh-ancestor
65628653|NCT02115152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628654|NCT02115152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65628655|NCT02115152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65628656|NCT02115152|Alkylating Agents|alkylating agents|mesh-ancestor
65628657|NCT02115152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628658|NCT02115152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628659|NCT02115152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65628660|NCT02115152|Antimetabolites|antimetabolites|mesh-ancestor
65628661|NCT02115152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65628662|NCT02115152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65628663|NCT02115152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65628664|NCT02115152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65628665|NCT02115152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628666|NCT02115464|Metformin|metformin|mesh-list
65628667|NCT02115464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65628668|NCT02115464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628669|NCT02858076|Aflibercept|aflibercept|mesh-list
65628670|NCT02858076|Endothelial Growth Factors|endothelial growth factors|mesh-list
65628671|NCT02858076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65628672|NCT02858076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65628673|NCT02858076|Growth Substances|growth substances|mesh-ancestor
65628674|NCT02858076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628675|NCT02858076|Growth Inhibitors|growth inhibitors|mesh-ancestor
65628676|NCT02858076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628677|NCT01319695|Hormones|hormones|mesh-list
65628678|NCT01319695|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65628679|NCT01319695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65628680|NCT01319695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628681|NCT04594759|Isotretinoin|isotretinoin|mesh-list
65628682|NCT04594759|Dermatologic Agents|dermatologic agents|mesh-ancestor
65628683|NCT02123498|Omeprazole|omeprazole|mesh-list
65628684|NCT02123498|Pantoprazole|pantoprazole|mesh-list
65628685|NCT02123498|Ranitidine|ranitidine|mesh-list
65628686|NCT02123498|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65628687|NCT02123498|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65628688|NCT02123498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65628689|NCT02123498|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65628690|NCT02123498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628691|NCT02123498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628692|NCT02123498|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65628693|NCT02123498|Histamine Antagonists|histamine antagonists|mesh-ancestor
65628694|NCT02123498|Histamine Agents|histamine agents|mesh-ancestor
65628695|NCT02123498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65628696|NCT02123498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628697|NCT02115776|Amoxicillin|amoxicillin|mesh-list
65628698|NCT02115776|Clavulanic Acid|clavulanic acid|mesh-list
65628699|NCT02115776|Clavulanic Acids|clavulanic acids|mesh-list
65628700|NCT02115776|Chlorhexidine|chlorhexidine|mesh-list
65628701|NCT02115776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65628702|NCT02115776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65628703|NCT02115776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65628704|NCT02115776|Disinfectants|disinfectants|mesh-ancestor
65628705|NCT02115776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65628706|NCT02115776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628707|NCT02115776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628708|NCT02123654|Asunaprevir|asunaprevir|mesh-list
65628709|NCT02123654|Protease Inhibitors|protease inhibitors|mesh-ancestor
65628710|NCT02123654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628711|NCT02123654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628712|NCT02116010|Sulfadiazine|sulfadiazine|mesh-list
65628713|NCT02116010|Silver Sulfadiazine|silver sulfadiazine|mesh-list
65426050|NCT00445770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65628714|NCT02116010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65628715|NCT02116010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65628716|NCT02116010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65628717|NCT02116010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65628718|NCT02116010|Coccidiostats|coccidiostats|mesh-ancestor
65628719|NCT02116010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65628720|NCT03609294|Linagliptin|linagliptin|mesh-list
65628721|NCT03609294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65628722|NCT03609294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628723|NCT03609294|Incretins|incretins|mesh-ancestor
65628724|NCT03609294|Hormones|hormones|mesh-ancestor
65628725|NCT03609294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65628726|NCT03609294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65628727|NCT03609294|Protease Inhibitors|protease inhibitors|mesh-ancestor
65628728|NCT03609294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628729|NCT03609294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628730|NCT01917552|Capecitabine|capecitabine|mesh-list
65628731|NCT01917552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65628732|NCT01917552|Antimetabolites|antimetabolites|mesh-ancestor
65628733|NCT01917552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628734|NCT01917552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628735|NCT01873326|Paclitaxel|paclitaxel|mesh-list
65628736|NCT01873326|Etoposide|etoposide|mesh-list
65628737|NCT01873326|Ifosfamide|ifosfamide|mesh-list
65628738|NCT01873326|Bleomycin|bleomycin|mesh-list
65628739|NCT01873326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65628740|NCT01873326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628741|NCT01873326|Tubulin Modulators|tubulin modulators|mesh-ancestor
65628742|NCT01873326|Antimitotic Agents|antimitotic agents|mesh-ancestor
65628743|NCT01873326|Mitosis Modulators|mitosis modulators|mesh-ancestor
65628744|NCT01873326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628745|NCT01873326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65628746|NCT01873326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65628747|NCT01873326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628748|NCT01873326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65628749|NCT01873326|Alkylating Agents|alkylating agents|mesh-ancestor
65628750|NCT01873326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65628751|NCT01261728|Gemcitabine|gemcitabine|mesh-list
65628752|NCT01261728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628753|NCT01261728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65628754|NCT01261728|Antimetabolites|antimetabolites|mesh-ancestor
65628755|NCT01261728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628756|NCT01261728|Antiviral Agents|antiviral agents|mesh-ancestor
65628757|NCT01261728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65628758|NCT01261728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628759|NCT01261728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65628760|NCT01261728|Immunologic Factors|immunologic factors|mesh-ancestor
65628761|NCT01261728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628762|NCT02116400|Lithium Carbonate|lithium carbonate|mesh-list
65628763|NCT02116400|Antidepressive Agents|antidepressive agents|mesh-ancestor
65628764|NCT02116400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65628765|NCT02116400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628766|NCT02116400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628767|NCT02116400|Antimanic Agents|antimanic agents|mesh-ancestor
65628768|NCT02116400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65628769|NCT02116400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65628770|NCT02116400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628771|NCT03119701|Interferons|interferons|mesh-list
65628772|NCT03119701|Interferon-beta|interferon-beta|mesh-list
65628773|NCT03119701|Interferon beta-1a|interferon beta-1a|mesh-list
65628774|NCT03119701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628775|NCT03119701|Antiviral Agents|antiviral agents|mesh-ancestor
65628776|NCT03119701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65628777|NCT03119701|Immunologic Factors|immunologic factors|mesh-ancestor
65628778|NCT03119701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628779|NCT03119701|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65628780|NCT03717129|Tenofovir|tenofovir|mesh-list
65628781|NCT03717129|Emtricitabine|emtricitabine|mesh-list
65628782|NCT03717129|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65628783|NCT03717129|Cobicistat|cobicistat|mesh-list
65628784|NCT03717129|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65628785|NCT03717129|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65628786|NCT03717129|Elvitegravir|elvitegravir|mesh-list
65628787|NCT03717129|Antiviral Agents|antiviral agents|mesh-ancestor
65628788|NCT03717129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65628789|NCT03717129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65628790|NCT03717129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65628791|NCT03717129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628792|NCT03717129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628793|NCT03717129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65628794|NCT03717129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65628795|NCT03717129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65628796|NCT03717129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65628797|NCT03717129|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65628798|NCT03627039|Metformin|metformin|mesh-list
65628799|NCT03627039|Dapagliflozin|dapagliflozin|mesh-list
65628800|NCT03627039|Empagliflozin|empagliflozin|mesh-list
65628801|NCT03627039|Canagliflozin|canagliflozin|mesh-list
65628802|NCT03627039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65628803|NCT03627039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628804|NCT03627039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65628805|NCT03627039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628806|NCT01374373|Epoetin Alfa|epoetin alfa|mesh-list
65628807|NCT01374373|Hematinics|hematinics|mesh-ancestor
65628808|NCT02116556|Rifaximin|rifaximin|mesh-list
65628809|NCT02116556|Prednisone|prednisone|mesh-list
65628810|NCT02116556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65628811|NCT02116556|Glucocorticoids|glucocorticoids|mesh-ancestor
65628812|NCT02116556|Hormones|hormones|mesh-ancestor
65266966|NCT04666649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628813|NCT02116556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65628814|NCT02116556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628815|NCT02116556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65628816|NCT02116556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628817|NCT02116556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65628818|NCT02116556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65628819|NCT02116556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65628820|NCT03634345|Fluconazole|fluconazole|mesh-list
65628821|NCT03634345|Fluvoxamine|fluvoxamine|mesh-list
65628822|NCT03634345|Abrocitinib|abrocitinib|mesh-list
65628823|NCT03634345|Antifungal Agents|antifungal agents|mesh-ancestor
65628824|NCT03634345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65628825|NCT03634345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65628826|NCT03634345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65628827|NCT03634345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628828|NCT03634345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628829|NCT03634345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65628830|NCT03634345|Hormone Antagonists|hormone antagonists|mesh-ancestor
65628831|NCT03634345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65628832|NCT03634345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628833|NCT03634345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65628834|NCT03634345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65628835|NCT03634345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65628836|NCT03634345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65628837|NCT03634345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65628838|NCT03634345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65628839|NCT03634345|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65628840|NCT03634345|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65628841|NCT03634345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65628842|NCT03634345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65628843|NCT03634345|Serotonin Agents|serotonin agents|mesh-ancestor
65628844|NCT03634345|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65628845|NCT03634345|Antidepressive Agents|antidepressive agents|mesh-ancestor
65628846|NCT03634345|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65628847|NCT03634345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65628848|NCT03553238|Cytarabine|cytarabine|mesh-list
65628849|NCT03553238|Dexamethasone|dexamethasone|mesh-list
65628850|NCT03553238|Cyclophosphamide|cyclophosphamide|mesh-list
65628851|NCT03553238|Methotrexate|methotrexate|mesh-list
65628852|NCT03553238|Etoposide|etoposide|mesh-list
65628853|NCT03553238|Vincristine|vincristine|mesh-list
65628854|NCT03553238|Doxorubicin|doxorubicin|mesh-list
65628855|NCT03553238|Mercaptopurine|mercaptopurine|mesh-list
65628856|NCT03553238|Idarubicin|idarubicin|mesh-list
65628857|NCT03553238|Pegaspargase|pegaspargase|mesh-list
65628858|NCT03553238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65628859|NCT03553238|Immunologic Factors|immunologic factors|mesh-ancestor
65628860|NCT03553238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628861|NCT03553238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65628862|NCT03553238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65628863|NCT03553238|Alkylating Agents|alkylating agents|mesh-ancestor
65628864|NCT03553238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628865|NCT03553238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628866|NCT03553238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65628867|NCT03553238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65628868|NCT03553238|Antiemetics|antiemetics|mesh-ancestor
65628869|NCT03553238|Autonomic Agents|autonomic agents|mesh-ancestor
65628870|NCT03553238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65628871|NCT03553238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65628872|NCT03553238|Glucocorticoids|glucocorticoids|mesh-ancestor
65628873|NCT03553238|Hormones|hormones|mesh-ancestor
65628874|NCT03553238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65628875|NCT03553238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65628876|NCT03553238|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65628877|NCT03553238|Abortifacient Agents|abortifacient agents|mesh-ancestor
65628878|NCT03553238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65628879|NCT03553238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65628880|NCT03553238|Antimetabolites|antimetabolites|mesh-ancestor
65628881|NCT03553238|Dermatologic Agents|dermatologic agents|mesh-ancestor
65628882|NCT03553238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628883|NCT03553238|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65628884|NCT03553238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65628885|NCT03553238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65628886|NCT03553238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65628887|NCT03553238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65628888|NCT03553238|Antiviral Agents|antiviral agents|mesh-ancestor
65628889|NCT03553238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65628890|NCT03553238|Tubulin Modulators|tubulin modulators|mesh-ancestor
65628891|NCT03553238|Antimitotic Agents|antimitotic agents|mesh-ancestor
65628892|NCT03553238|Mitosis Modulators|mitosis modulators|mesh-ancestor
65628893|NCT03553238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65628894|NCT04980027|Insulin Glargine|insulin glargine|mesh-list
65628895|NCT04980027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65628896|NCT04980027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628897|NCT01373593|Lidocaine|lidocaine|mesh-list
65628898|NCT01373593|Anesthetics, Local|anesthetics, local|mesh-ancestor
65628899|NCT01373593|Anesthetics|anesthetics|mesh-ancestor
65628900|NCT01373593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65628901|NCT01373593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628902|NCT01373593|Sensory System Agents|sensory system agents|mesh-ancestor
65628903|NCT01373593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65628904|NCT01373593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65628905|NCT01373593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65628906|NCT01373593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65628907|NCT01373593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65628908|NCT01373593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628909|NCT02116712|Saracatinib|saracatinib|mesh-list
65628910|NCT02116712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65628911|NCT02116712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628912|NCT02116712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628913|NCT02116790|Naproxen|naproxen|mesh-list
65628914|NCT02116790|Levodopa|levodopa|mesh-list
65628915|NCT02116790|Carbidopa|carbidopa|mesh-list
65628916|NCT02116790|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65628917|NCT02116790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65628918|NCT02116790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65628919|NCT02116790|Analgesics|analgesics|mesh-ancestor
65628920|NCT02116790|Sensory System Agents|sensory system agents|mesh-ancestor
65628921|NCT02116790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65628922|NCT02116790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628923|NCT02116790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65628924|NCT02116790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65628925|NCT02116790|Gout Suppressants|gout suppressants|mesh-ancestor
65628926|NCT02116790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65628927|NCT02116790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65628928|NCT02116790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628929|NCT02116790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65628930|NCT02116790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65628931|NCT02116790|Dopamine Agents|dopamine agents|mesh-ancestor
65628932|NCT02116790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65628933|NCT02116790|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65628934|NCT02116790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65628935|NCT02116790|Immunologic Factors|immunologic factors|mesh-ancestor
65628936|NCT02116790|Dopamine Agonists|dopamine agonists|mesh-ancestor
65628937|NCT02859961|Leronlimab|leronlimab|mesh-list
65628938|NCT02859961|HIV Antibodies|hiv antibodies|mesh-list
65628939|NCT02859961|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65628940|NCT02859961|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65628941|NCT02859961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628942|NCT02859961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65628943|NCT02859961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65628944|NCT02859961|Antiviral Agents|antiviral agents|mesh-ancestor
65628945|NCT02859961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65628946|NCT02859961|Immunologic Factors|immunologic factors|mesh-ancestor
65628947|NCT02859961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628948|NCT02124200|Nicotine|nicotine|mesh-list
65628949|NCT02124200|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65628950|NCT02124200|Autonomic Agents|autonomic agents|mesh-ancestor
65628951|NCT02124200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65628952|NCT02124200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628953|NCT02124200|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65628954|NCT02124200|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65628955|NCT02124200|Cholinergic Agents|cholinergic agents|mesh-ancestor
65628956|NCT02124200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65628957|NCT02124200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628958|NCT02124278|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
65628959|NCT02124278|Respiratory System Agents|respiratory system agents|mesh-ancestor
65628960|NCT04503993|Antibodies|antibodies|mesh-list
65628961|NCT04503993|Immunoglobulins|immunoglobulins|mesh-list
65628962|NCT04503993|Immunologic Factors|immunologic factors|mesh-ancestor
65628963|NCT04503993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628964|NCT02116868|Antihypertensive Agents|antihypertensive agents|mesh-list
65628965|NCT02116868|Nicardipine|nicardipine|mesh-list
65628966|NCT02116868|Urapidil|urapidil|mesh-list
65628967|NCT02116868|Remifentanil|remifentanil|mesh-list
65628968|NCT02116868|Esmolol|esmolol|mesh-list
65628969|NCT02116868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65628970|NCT02116868|Narcotics|narcotics|mesh-ancestor
65628971|NCT02116868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65628972|NCT02116868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628973|NCT02116868|Analgesics|analgesics|mesh-ancestor
65628974|NCT02116868|Sensory System Agents|sensory system agents|mesh-ancestor
65628975|NCT02116868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65628976|NCT02116868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65628977|NCT02116868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65628978|NCT02116868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65628979|NCT02116868|Adrenergic Agents|adrenergic agents|mesh-ancestor
65628980|NCT02116868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65628981|NCT02116868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65628982|NCT02116868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65628983|NCT02116868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65628984|NCT02116868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65628985|NCT02116868|Vasodilator Agents|vasodilator agents|mesh-ancestor
65628986|NCT02116868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65628987|NCT02116868|Serotonin Agents|serotonin agents|mesh-ancestor
65628988|NCT02116868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65628989|NCT02116868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65628990|NCT02679781|Midazolam|midazolam|mesh-list
65628991|NCT02679781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65628992|NCT02679781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65628993|NCT02679781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65628994|NCT02679781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65628995|NCT02679781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65628996|NCT02679781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65628997|NCT02679781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65628998|NCT02679781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65628999|NCT02679781|Anesthetics, General|anesthetics, general|mesh-ancestor
65629000|NCT02679781|Anesthetics|anesthetics|mesh-ancestor
65629001|NCT02679781|GABA Modulators|gaba modulators|mesh-ancestor
65629002|NCT02679781|GABA Agents|gaba agents|mesh-ancestor
65629003|NCT02679781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65629004|NCT02679781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629005|NCT04373031|Pembrolizumab|pembrolizumab|mesh-list
65629006|NCT04373031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65629007|NCT04373031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629008|NCT02624869|Evolocumab|evolocumab|mesh-list
65629009|NCT02624869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65629010|NCT02624869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65629011|NCT02624869|Antimetabolites|antimetabolites|mesh-ancestor
65629012|NCT02624869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629013|NCT02624869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65629014|NCT02121782|Vaccines|vaccines|mesh-list
65629015|NCT02121782|Immunologic Factors|immunologic factors|mesh-ancestor
65426355|NCT05003258|Autonomic Agents|autonomic agents|mesh-ancestor
65629016|NCT02121782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629017|NCT04877457|Ocrelizumab|ocrelizumab|mesh-list
65629018|NCT04877457|Immunologic Factors|immunologic factors|mesh-ancestor
65629019|NCT04877457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629020|NCT03553082|Propofol|propofol|mesh-list
65629021|NCT03553082|Sevoflurane|sevoflurane|mesh-list
65629022|NCT03553082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65629023|NCT03553082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65629024|NCT03553082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629025|NCT03553082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65629026|NCT03553082|Anesthetics, General|anesthetics, general|mesh-ancestor
65629027|NCT03553082|Anesthetics|anesthetics|mesh-ancestor
65629028|NCT03553082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65629029|NCT03553082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65629030|NCT03318393|Heparin|heparin|mesh-list
65629031|NCT03318393|Calcium heparin|calcium heparin|mesh-list
65629032|NCT03318393|Bivalirudin|bivalirudin|mesh-list
65629033|NCT03318393|Anticoagulants|anticoagulants|mesh-ancestor
65629034|NCT03318393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65629035|NCT03318393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65629036|NCT03318393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629037|NCT03318393|Antithrombins|antithrombins|mesh-ancestor
65629038|NCT03318393|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65629039|NCT03318393|Protease Inhibitors|protease inhibitors|mesh-ancestor
65629040|NCT03318393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629041|NCT03110029|Efinaconazole|efinaconazole|mesh-list
65629042|NCT03110029|Antifungal Agents|antifungal agents|mesh-ancestor
65629043|NCT03110029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65629044|NCT03552146|Dexmedetomidine|dexmedetomidine|mesh-list
65629045|NCT03552146|Propofol|propofol|mesh-list
65629046|NCT03552146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65629047|NCT03552146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65629048|NCT03552146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629049|NCT03552146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65629050|NCT03552146|Anesthetics, General|anesthetics, general|mesh-ancestor
65629051|NCT03552146|Anesthetics|anesthetics|mesh-ancestor
65629052|NCT03552146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65629053|NCT03552146|Analgesics|analgesics|mesh-ancestor
65629054|NCT03552146|Sensory System Agents|sensory system agents|mesh-ancestor
65629055|NCT03552146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65629056|NCT03552146|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65629057|NCT03552146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65629058|NCT03552146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65629059|NCT03552146|Adrenergic Agents|adrenergic agents|mesh-ancestor
65629060|NCT03552146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65629061|NCT03552146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629062|NCT01374763|Oxycodone|oxycodone|mesh-list
65629063|NCT01374763|Naloxone|naloxone|mesh-list
65629064|NCT01374763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65629065|NCT01374763|Narcotics|narcotics|mesh-ancestor
65629066|NCT01374763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65629067|NCT01374763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629068|NCT01374763|Analgesics|analgesics|mesh-ancestor
65629069|NCT01374763|Sensory System Agents|sensory system agents|mesh-ancestor
65629070|NCT01374763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65629071|NCT01374763|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65629072|NCT02747004|Tamoxifen|tamoxifen|mesh-list
65629073|NCT02747004|Loperamide|loperamide|mesh-list
65629074|NCT02747004|Antidiarrheals|antidiarrheals|mesh-list
65629075|NCT02747004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65629076|NCT02747004|Hormone Antagonists|hormone antagonists|mesh-ancestor
65629077|NCT02747004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65629078|NCT02747004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629079|NCT02747004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65629080|NCT02747004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629081|NCT02747004|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65629082|NCT02747004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65629083|NCT02747004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65629084|NCT02747004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65629085|NCT04454515|Dexmedetomidine|dexmedetomidine|mesh-list
65629086|NCT04454515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65629087|NCT04454515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65629088|NCT04454515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629089|NCT04454515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65629090|NCT04454515|Analgesics|analgesics|mesh-ancestor
65629091|NCT04454515|Sensory System Agents|sensory system agents|mesh-ancestor
65629092|NCT04454515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65629093|NCT04454515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65629094|NCT04454515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65629095|NCT04454515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65629096|NCT04454515|Adrenergic Agents|adrenergic agents|mesh-ancestor
65629097|NCT04454515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65629098|NCT04454515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629099|NCT03608514|Terlipressin|terlipressin|mesh-list
65629100|NCT03608514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65629101|NCT03608514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65629102|NCT01374841|Cyclophosphamide|cyclophosphamide|mesh-list
65629103|NCT01374841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65629104|NCT01374841|Immunologic Factors|immunologic factors|mesh-ancestor
65629105|NCT01374841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629106|NCT01374841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65629107|NCT01374841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65629108|NCT01374841|Alkylating Agents|alkylating agents|mesh-ancestor
65629109|NCT01374841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629110|NCT01374841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629111|NCT01374841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65629112|NCT02117726|Midazolam|midazolam|mesh-list
65629113|NCT02117726|Dexmedetomidine|dexmedetomidine|mesh-list
65629114|NCT02117726|Propofol|propofol|mesh-list
65629115|NCT02117726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65629116|NCT02117726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65629117|NCT02117726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629118|NCT02117726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65629119|NCT02117726|Anesthetics, General|anesthetics, general|mesh-ancestor
65629120|NCT02117726|Anesthetics|anesthetics|mesh-ancestor
65629121|NCT02117726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65629122|NCT02117726|Analgesics|analgesics|mesh-ancestor
65629123|NCT02117726|Sensory System Agents|sensory system agents|mesh-ancestor
65629124|NCT02117726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65629125|NCT02117726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65629126|NCT02117726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65629127|NCT02117726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65629128|NCT02117726|Adrenergic Agents|adrenergic agents|mesh-ancestor
65629129|NCT02117726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65629130|NCT02117726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629131|NCT02117726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65629132|NCT02117726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65629133|NCT02117726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65629134|NCT02117726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65629135|NCT02117726|GABA Modulators|gaba modulators|mesh-ancestor
65629136|NCT02117726|GABA Agents|gaba agents|mesh-ancestor
65629137|NCT02733432|Fluconazole|fluconazole|mesh-list
65629138|NCT02733432|Rezafungin|rezafungin|mesh-list
65629139|NCT02733432|Antifungal Agents|antifungal agents|mesh-ancestor
65629140|NCT02733432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65629141|NCT02733432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65629142|NCT02733432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65629143|NCT02733432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629144|NCT02733432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629145|NCT02733432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65629146|NCT02733432|Hormone Antagonists|hormone antagonists|mesh-ancestor
65629147|NCT02733432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65629148|NCT02733432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629149|NCT02733432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65629150|NCT02733432|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65629151|NCT03634189|Cannabidiol|cannabidiol|mesh-list
65629152|NCT03634189|Anticonvulsants|anticonvulsants|mesh-ancestor
65629153|NCT03608046|Irinotecan|irinotecan|mesh-list
65629154|NCT03608046|Cetuximab|cetuximab|mesh-list
65629155|NCT03608046|Avelumab|avelumab|mesh-list
65629156|NCT03608046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65629157|NCT03608046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65629158|NCT03608046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629159|NCT03608046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629160|NCT03608046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629161|NCT03608046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65629162|NCT02122484|Colchicine|colchicine|mesh-list
65629163|NCT02122484|Gout Suppressants|gout suppressants|mesh-ancestor
65629164|NCT02122484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65629165|NCT02122484|Tubulin Modulators|tubulin modulators|mesh-ancestor
65629166|NCT02122484|Antimitotic Agents|antimitotic agents|mesh-ancestor
65629167|NCT02122484|Mitosis Modulators|mitosis modulators|mesh-ancestor
65629168|NCT02122484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629169|NCT02122484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629170|NCT04106856|Losartan|losartan|mesh-list
65629171|NCT04106856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65629172|NCT04106856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65629173|NCT04106856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65629174|NCT04106856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65629175|NCT04106856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629176|NCT03606018|Insulin|insulin|mesh-list
65629177|NCT03606018|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65629178|NCT03606018|Insulin Lispro|insulin lispro|mesh-list
65629179|NCT03606018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65629180|NCT03606018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629181|NCT01373749|Sildenafil Citrate|sildenafil citrate|mesh-list
65629182|NCT01373749|Vasodilator Agents|vasodilator agents|mesh-ancestor
65629183|NCT01373749|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65629184|NCT01373749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65629185|NCT01373749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629186|NCT01373749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629187|NCT01373749|Urological Agents|urological agents|mesh-ancestor
65629188|NCT04045795|Dexamethasone|dexamethasone|mesh-list
65629189|NCT04045795|Pomalidomide|pomalidomide|mesh-list
65629190|NCT04045795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65629191|NCT04045795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65629192|NCT04045795|Antiemetics|antiemetics|mesh-ancestor
65629193|NCT04045795|Autonomic Agents|autonomic agents|mesh-ancestor
65629194|NCT04045795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65629195|NCT04045795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629196|NCT04045795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65629197|NCT04045795|Glucocorticoids|glucocorticoids|mesh-ancestor
65629198|NCT04045795|Hormones|hormones|mesh-ancestor
65629199|NCT04045795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65629200|NCT04045795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65629201|NCT04045795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629202|NCT04045795|Immunologic Factors|immunologic factors|mesh-ancestor
65629203|NCT04045795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65629204|NCT04045795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65629205|NCT04045795|Growth Substances|growth substances|mesh-ancestor
65629206|NCT04045795|Growth Inhibitors|growth inhibitors|mesh-ancestor
65629207|NCT03605940|Methoxsalen|methoxsalen|mesh-list
65629208|NCT03605940|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65629209|NCT03605940|Dermatologic Agents|dermatologic agents|mesh-ancestor
65629210|NCT03607734|Amoxicillin|amoxicillin|mesh-list
65629211|NCT03607734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65629212|NCT03607734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65629213|NCT02035488|Tobramycin|tobramycin|mesh-list
65629214|NCT02035488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65629215|NCT02035488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65629216|NCT03602430|Vitamin D|vitamin d|mesh-list
65629217|NCT03602430|Cholecalciferol|cholecalciferol|mesh-list
65629218|NCT03602430|Vitamins|vitamins|mesh-ancestor
65629219|NCT03602430|Micronutrients|micronutrients|mesh-ancestor
65629220|NCT03602430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629221|NCT03602430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65629222|NCT03602430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65629223|NCT02260544|Doxorubicin|doxorubicin|mesh-list
65629224|NCT02260544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65629225|NCT02260544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65629226|NCT02260544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629227|NCT02260544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65629228|NCT02260544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65629229|NCT02260544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629230|NCT02260544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629231|NCT05470647|Interleukin-4|interleukin-4|mesh-list
65629232|NCT05470647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65629233|NCT05470647|Immunologic Factors|immunologic factors|mesh-ancestor
65629234|NCT05470647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629235|NCT05470647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629236|NCT05470647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65629237|NCT04409665|Ketamine|ketamine|mesh-list
65629238|NCT04409665|Analgesics|analgesics|mesh-ancestor
65629239|NCT04409665|Sensory System Agents|sensory system agents|mesh-ancestor
65629240|NCT04409665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65629241|NCT04409665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629242|NCT04409665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65629243|NCT04409665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65629244|NCT04409665|Anesthetics, General|anesthetics, general|mesh-ancestor
65629245|NCT04409665|Anesthetics|anesthetics|mesh-ancestor
65629246|NCT04409665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65629247|NCT04409665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65629248|NCT04409665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65091962|NCT04515732|Analgesics|analgesics|mesh-ancestor
65629249|NCT04409665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65629250|NCT04409665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629251|NCT02854800|Varenicline|varenicline|mesh-list
65629252|NCT02854800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65629253|NCT02854800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65629254|NCT02854800|Cholinergic Agents|cholinergic agents|mesh-ancestor
65629255|NCT02854800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65629256|NCT02854800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629257|NCT02854800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629258|NCT03552770|Bevacizumab|bevacizumab|mesh-list
65629259|NCT03552770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65629260|NCT03552770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629261|NCT03552770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65629262|NCT03552770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65629263|NCT03552770|Growth Substances|growth substances|mesh-ancestor
65629264|NCT03552770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629265|NCT03552770|Growth Inhibitors|growth inhibitors|mesh-ancestor
65629266|NCT02127164|Sodium Hypochlorite|sodium hypochlorite|mesh-list
65629267|NCT02127164|Eusol|eusol|mesh-list
65629268|NCT02127164|Disinfectants|disinfectants|mesh-ancestor
65629269|NCT02127164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65629270|NCT02931539|Valganciclovir|valganciclovir|mesh-list
65629271|NCT02931539|Ganciclovir|ganciclovir|mesh-list
65629272|NCT02931539|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65629273|NCT02931539|Cidofovir|cidofovir|mesh-list
65629274|NCT02931539|Foscarnet|foscarnet|mesh-list
65629275|NCT02931539|Maribavir|maribavir|mesh-list
65629276|NCT02931539|Antiviral Agents|antiviral agents|mesh-ancestor
65629277|NCT02931539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65629278|NCT02931539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65629279|NCT02931539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629280|NCT02931539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629281|NCT02931539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65629282|NCT03602118|Phenobarbital|phenobarbital|mesh-list
65629283|NCT03602118|Anticonvulsants|anticonvulsants|mesh-ancestor
65629284|NCT03602118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65629285|NCT03602118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65629286|NCT03602118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629287|NCT03602118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65629288|NCT03602118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65629289|NCT03602118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65629290|NCT03602118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629291|NCT03602118|GABA Modulators|gaba modulators|mesh-ancestor
65629292|NCT03602118|GABA Agents|gaba agents|mesh-ancestor
65629293|NCT03602118|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65629294|NCT03602118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65629295|NCT03602118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65629296|NCT02125682|Atorvastatin|atorvastatin|mesh-list
65629297|NCT02125682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65629298|NCT02125682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65629299|NCT02125682|Antimetabolites|antimetabolites|mesh-ancestor
65629300|NCT02125682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629301|NCT02125682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65629302|NCT02125682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65629303|NCT02125682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629304|NCT03610711|Nivolumab|nivolumab|mesh-list
65629305|NCT03610711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65629306|NCT03610711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629307|NCT03610711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65629308|NCT03610711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629309|NCT02546999|Botulinum Toxins|botulinum toxins|mesh-list
65629310|NCT02546999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65629311|NCT02546999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65629312|NCT02546999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65629313|NCT02546999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629314|NCT02546999|Cholinergic Agents|cholinergic agents|mesh-ancestor
65629315|NCT02546999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65629316|NCT02546999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629317|NCT02546999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65629318|NCT02546999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65629319|NCT02131220|Tirofiban|tirofiban|mesh-list
65629320|NCT02131220|Saruplase|saruplase|mesh-list
65629321|NCT02131220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65629322|NCT02131220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65629323|NCT02131220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629324|NCT02131220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65629325|NCT04042077|Vancomycin|vancomycin|mesh-list
65629326|NCT04042077|Tazobactam|tazobactam|mesh-list
65629327|NCT04042077|Linezolid|linezolid|mesh-list
65629328|NCT04042077|Piperacillin|piperacillin|mesh-list
65629329|NCT04042077|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65629330|NCT04042077|Tigecycline|tigecycline|mesh-list
65629331|NCT04042077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65629332|NCT04042077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65629333|NCT04042077|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65629334|NCT04042077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629335|NCT04042077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629336|NCT04042077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65629337|NCT03557359|Nivolumab|nivolumab|mesh-list
65629338|NCT03557359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65629339|NCT03557359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629340|NCT03557359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65629341|NCT03557359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629342|NCT05760313|Linaclotide|linaclotide|mesh-list
65629343|NCT05760313|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65629344|NCT05760313|Enzyme Activators|enzyme activators|mesh-ancestor
65629345|NCT05760313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629346|NCT05760313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65629347|NCT02127320|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65629348|NCT02127320|Ezetimibe|ezetimibe|mesh-list
65629349|NCT02127320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65629350|NCT02127320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65629351|NCT02127320|Antimetabolites|antimetabolites|mesh-ancestor
65629352|NCT02127320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629353|NCT02127320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65629354|NCT02127320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65629355|NCT02127320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629356|NCT03522415|Methotrexate|methotrexate|mesh-list
65629357|NCT03522415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65629358|NCT03522415|Abortifacient Agents|abortifacient agents|mesh-ancestor
65629359|NCT03522415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65629360|NCT03522415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629361|NCT03522415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65629362|NCT03522415|Antimetabolites|antimetabolites|mesh-ancestor
65629363|NCT03522415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629364|NCT03522415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629365|NCT03522415|Dermatologic Agents|dermatologic agents|mesh-ancestor
65629366|NCT03522415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629367|NCT03522415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65629368|NCT03522415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65629369|NCT03522415|Immunologic Factors|immunologic factors|mesh-ancestor
65629370|NCT03522415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65629371|NCT03522415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65629372|NCT04226833|Entrectinib|entrectinib|mesh-list
65629373|NCT04226833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65629374|NCT04226833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629375|NCT04226833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629376|NCT02131298|Itraconazole|itraconazole|mesh-list
65629377|NCT02131298|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
65629378|NCT02131298|Palbociclib|palbociclib|mesh-list
65629379|NCT02131298|Antifungal Agents|antifungal agents|mesh-ancestor
65629380|NCT02131298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65629381|NCT02131298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65629382|NCT02131298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65629383|NCT02131298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629384|NCT02131298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629385|NCT02131298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65629386|NCT02131298|Hormone Antagonists|hormone antagonists|mesh-ancestor
65629387|NCT02131298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65629388|NCT02131298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629389|NCT02131298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65629390|NCT02131298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629391|NCT02131298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65629392|NCT01375387|Lacosamide|lacosamide|mesh-list
65629393|NCT01375387|Anticonvulsants|anticonvulsants|mesh-ancestor
65629394|NCT01375387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65629395|NCT01375387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65629396|NCT01375387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65629397|NCT01375387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629398|NCT02853318|Cyclophosphamide|cyclophosphamide|mesh-list
65629399|NCT02853318|Bevacizumab|bevacizumab|mesh-list
65629400|NCT02853318|Pembrolizumab|pembrolizumab|mesh-list
65629401|NCT02853318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65629402|NCT02853318|Antibodies|antibodies|mesh-list
65629403|NCT02853318|Immunoglobulins|immunoglobulins|mesh-list
65629404|NCT02853318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65629405|NCT02853318|Immunoglobulin G|immunoglobulin g|mesh-list
65629406|NCT02853318|Endothelial Growth Factors|endothelial growth factors|mesh-list
65629407|NCT02853318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65629408|NCT02853318|Immunologic Factors|immunologic factors|mesh-ancestor
65629409|NCT02853318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629410|NCT02853318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65629411|NCT02853318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65629412|NCT02853318|Alkylating Agents|alkylating agents|mesh-ancestor
65629413|NCT02853318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629414|NCT02853318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629415|NCT02853318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65629416|NCT02853318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65629417|NCT02853318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65629418|NCT02853318|Growth Substances|growth substances|mesh-ancestor
65629419|NCT02853318|Growth Inhibitors|growth inhibitors|mesh-ancestor
65629420|NCT05541471|Digoxin|digoxin|mesh-list
65629421|NCT05541471|Midazolam|midazolam|mesh-list
65629422|NCT05541471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65629423|NCT05541471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65629424|NCT05541471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65629425|NCT05541471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629426|NCT05541471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65629427|NCT05541471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65629428|NCT05541471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65629429|NCT05541471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65629430|NCT05541471|Anesthetics, General|anesthetics, general|mesh-ancestor
65629431|NCT05541471|Anesthetics|anesthetics|mesh-ancestor
65629432|NCT05541471|GABA Modulators|gaba modulators|mesh-ancestor
65629433|NCT05541471|GABA Agents|gaba agents|mesh-ancestor
65629434|NCT05541471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65629435|NCT05541471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629436|NCT05541471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65629437|NCT05541471|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65629438|NCT05541471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629439|NCT05541471|Protective Agents|protective agents|mesh-ancestor
65629440|NCT03626727|Sodium Oxybate|sodium oxybate|mesh-list
65629441|NCT03626727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65629442|NCT03626727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65629443|NCT03626727|Anesthetics, General|anesthetics, general|mesh-ancestor
65629444|NCT03626727|Anesthetics|anesthetics|mesh-ancestor
65629445|NCT03626727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65629446|NCT03626727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629447|NCT03604224|Canagliflozin|canagliflozin|mesh-list
65629448|NCT03604224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65629449|NCT03604224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629450|NCT03604224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65629451|NCT03604224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629452|NCT02126384|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65629453|NCT02126384|Immunologic Factors|immunologic factors|mesh-ancestor
65629454|NCT02126384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629455|NCT02035410|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65629456|NCT02035410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65629457|NCT02035410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65629458|NCT02404155|Clozapine|clozapine|mesh-list
65629459|NCT02404155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65629460|NCT02404155|Serotonin Agents|serotonin agents|mesh-ancestor
65629461|NCT02404155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65629462|NCT02404155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629463|NCT02404155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629464|NCT02404155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65629465|NCT02404155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65629466|NCT02404155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65629467|NCT02404155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65629468|NCT02404155|GABA Antagonists|gaba antagonists|mesh-ancestor
65629469|NCT02404155|GABA Agents|gaba agents|mesh-ancestor
65629470|NCT02127788|Micafungin|micafungin|mesh-list
65629471|NCT02127788|Antifungal Agents|antifungal agents|mesh-ancestor
65629472|NCT02127788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65629473|NCT02131688|Mitoxantrone|mitoxantrone|mesh-list
65629474|NCT02131688|Analgesics|analgesics|mesh-ancestor
65629475|NCT02131688|Sensory System Agents|sensory system agents|mesh-ancestor
65629476|NCT02131688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65629477|NCT02131688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629478|NCT02131688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629479|NCT02131688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65629480|NCT02131688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65629481|NCT02131688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629482|NCT02131688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629483|NCT02126462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65629484|NCT02126462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65629485|NCT02126462|Immunologic Factors|immunologic factors|mesh-ancestor
65629486|NCT02126462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629487|NCT02126462|Antacids|antacids|mesh-ancestor
65629488|NCT02126462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629489|NCT02126462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65629490|NCT03113071|Decitabine|decitabine|mesh-list
65629491|NCT03113071|Digoxin|digoxin|mesh-list
65629492|NCT03113071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65629493|NCT03113071|Antimetabolites|antimetabolites|mesh-ancestor
65629494|NCT03113071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629495|NCT03113071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629496|NCT03113071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629497|NCT03113071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65629498|NCT03113071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65629499|NCT03113071|Protective Agents|protective agents|mesh-ancestor
65629500|NCT03113071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629501|NCT03050307|Lansoprazole|lansoprazole|mesh-list
65629502|NCT03050307|Dexlansoprazole|dexlansoprazole|mesh-list
65629503|NCT03050307|Bismuth|bismuth|mesh-list
65629504|NCT03050307|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65629505|NCT03050307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65629506|NCT03050307|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65629507|NCT03050307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629508|NCT03050307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629509|NCT03050307|Antacids|antacids|mesh-ancestor
65629510|NCT02127866|Beclomethasone|beclomethasone|mesh-list
65629511|NCT02127866|Glycopyrrolate|glycopyrrolate|mesh-list
65629512|NCT02127866|Formoterol Fumarate|formoterol fumarate|mesh-list
65629513|NCT02127866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65629514|NCT02127866|Autonomic Agents|autonomic agents|mesh-ancestor
65629515|NCT02127866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65629516|NCT02127866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629517|NCT02127866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65629518|NCT02127866|Respiratory System Agents|respiratory system agents|mesh-ancestor
65629519|NCT02127866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65629520|NCT02127866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65629521|NCT02127866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65629522|NCT02127866|Adrenergic Agents|adrenergic agents|mesh-ancestor
65629523|NCT02127866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65629524|NCT02127866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629525|NCT02127866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65629526|NCT02127866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65629527|NCT02127866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65629528|NCT02127866|Cholinergic Agents|cholinergic agents|mesh-ancestor
65629529|NCT02127866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65629530|NCT02127866|Glucocorticoids|glucocorticoids|mesh-ancestor
65629531|NCT02127866|Hormones|hormones|mesh-ancestor
65629532|NCT02127866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65629533|NCT03550508|Antibodies|antibodies|mesh-list
65629534|NCT03550508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65629535|NCT03550508|Immunologic Factors|immunologic factors|mesh-ancestor
65629536|NCT03550508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629537|NCT03607578|Sunscreening Agents|sunscreening agents|mesh-list
65629538|NCT03607578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65629539|NCT03607578|Protective Agents|protective agents|mesh-ancestor
65629540|NCT03607578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426889|NCT01050699|Narcotics|narcotics|mesh-ancestor
65629541|NCT03607578|Dermatologic Agents|dermatologic agents|mesh-ancestor
65629542|NCT05461131|Azithromycin|azithromycin|mesh-list
65629544|NCT05461131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65629545|NCT05760079|Lactoferrin|lactoferrin|mesh-list
65629546|NCT05760079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65629547|NCT03603834|Leucovorin|leucovorin|mesh-list
65629548|NCT03603834|Fluorouracil|fluorouracil|mesh-list
65629549|NCT03603834|Oxaliplatin|oxaliplatin|mesh-list
65629550|NCT03603834|Irinotecan|irinotecan|mesh-list
65629551|NCT03603834|Antimetabolites|antimetabolites|mesh-ancestor
65629552|NCT03603834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629553|NCT03603834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65629554|NCT03603834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629555|NCT03603834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65629556|NCT03603834|Immunologic Factors|immunologic factors|mesh-ancestor
65629557|NCT03603834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629558|NCT03603834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65629559|NCT03603834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65629560|NCT03603834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629561|NCT03603834|Antidotes|antidotes|mesh-ancestor
65629562|NCT03603834|Protective Agents|protective agents|mesh-ancestor
65629563|NCT03603834|Vitamin B Complex|vitamin b complex|mesh-ancestor
65629564|NCT03603834|Vitamins|vitamins|mesh-ancestor
65629565|NCT03603834|Micronutrients|micronutrients|mesh-ancestor
65629566|NCT03601338|Bemiparin|bemiparin|mesh-list
65629567|NCT03601338|Anticoagulants|anticoagulants|mesh-ancestor
65629568|NCT02128022|Glyburide|glyburide|mesh-list
65629569|NCT02128022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65629570|NCT02128022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629571|NCT03256045|Dexamethasone|dexamethasone|mesh-list
65629572|NCT03256045|Dexamethasone acetate|dexamethasone acetate|mesh-list
65629573|NCT03256045|Panobinostat|panobinostat|mesh-list
65629574|NCT03256045|Ichthammol|ichthammol|mesh-list
65629575|NCT03256045|BB 1101|bb 1101|mesh-list
65629576|NCT03256045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65629577|NCT03256045|Antiemetics|antiemetics|mesh-ancestor
65629578|NCT03256045|Autonomic Agents|autonomic agents|mesh-ancestor
65629579|NCT03256045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65629580|NCT03256045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629581|NCT03256045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65629582|NCT03256045|Glucocorticoids|glucocorticoids|mesh-ancestor
65629583|NCT03256045|Hormones|hormones|mesh-ancestor
65629584|NCT03256045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65629585|NCT03256045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65629586|NCT03256045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629587|NCT03256045|Protease Inhibitors|protease inhibitors|mesh-ancestor
65629588|NCT03256045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629589|NCT03256045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629590|NCT03256045|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65629591|NCT03256045|Dermatologic Agents|dermatologic agents|mesh-ancestor
65629592|NCT03603756|Paclitaxel|paclitaxel|mesh-list
65629593|NCT03603756|Irinotecan|irinotecan|mesh-list
65629594|NCT03603756|Apatinib|apatinib|mesh-list
65629595|NCT03603756|Nedaplatin|nedaplatin|mesh-list
65629596|NCT03603756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65629597|NCT03603756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629598|NCT03603756|Tubulin Modulators|tubulin modulators|mesh-ancestor
65629599|NCT03603756|Antimitotic Agents|antimitotic agents|mesh-ancestor
65629600|NCT03603756|Mitosis Modulators|mitosis modulators|mesh-ancestor
65629601|NCT03603756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629602|NCT03603756|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65629603|NCT03603756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65629604|NCT03603756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629605|NCT03603756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65629606|NCT02372409|Doxorubicin|doxorubicin|mesh-list
65629607|NCT02372409|Etoposide|etoposide|mesh-list
65629608|NCT02372409|Etoposide phosphate|etoposide phosphate|mesh-list
65629609|NCT02372409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65629610|NCT02372409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629611|NCT02372409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65629612|NCT02372409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65629613|NCT02372409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629614|NCT02372409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629615|NCT02372409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65629616|NCT03626259|Losartan|losartan|mesh-list
65629617|NCT03626259|Amlodipine|amlodipine|mesh-list
65629618|NCT03626259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65629619|NCT03626259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65629620|NCT03626259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65629621|NCT03626259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629622|NCT03626259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65629623|NCT03626259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629624|NCT03626259|Vasodilator Agents|vasodilator agents|mesh-ancestor
65629625|NCT03626259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65629626|NCT03626259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65629627|NCT03626259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65629628|NCT03601260|Allopurinol|allopurinol|mesh-list
65629629|NCT03601260|Antimetabolites|antimetabolites|mesh-ancestor
65629630|NCT03601260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629631|NCT03601260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629632|NCT03601260|Gout Suppressants|gout suppressants|mesh-ancestor
65629633|NCT03601260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65629634|NCT03601260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65629635|NCT03601260|Antioxidants|antioxidants|mesh-ancestor
65629636|NCT03601260|Protective Agents|protective agents|mesh-ancestor
65629637|NCT03601260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629638|NCT05193253|Liver Extracts|liver extracts|mesh-list
65629639|NCT05193253|Hematinics|hematinics|mesh-ancestor
65629640|NCT04629651|Captopril|captopril|mesh-list
65629641|NCT04629651|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65629642|NCT04629651|Protease Inhibitors|protease inhibitors|mesh-ancestor
65629643|NCT04629651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629644|NCT04629651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629645|NCT04629651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65629646|NCT02131922|Chlorhexidine|chlorhexidine|mesh-list
65629647|NCT02131922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65629648|NCT02131922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65629649|NCT02131922|Disinfectants|disinfectants|mesh-ancestor
65629650|NCT03600948|Sirolimus|sirolimus|mesh-list
65629651|NCT03600948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65629652|NCT03600948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65629653|NCT03600948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65629654|NCT03600948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629655|NCT03600948|Antifungal Agents|antifungal agents|mesh-ancestor
65629656|NCT03600948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65629657|NCT03600948|Immunologic Factors|immunologic factors|mesh-ancestor
65629658|NCT03600948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629659|NCT02132000|Tamoxifen|tamoxifen|mesh-list
65629660|NCT02132000|Toremifene|toremifene|mesh-list
65629661|NCT02132000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65629662|NCT02132000|Hormone Antagonists|hormone antagonists|mesh-ancestor
65629663|NCT02132000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65629664|NCT02132000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629665|NCT02132000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65629666|NCT02132000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629667|NCT02132000|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65629668|NCT02132000|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65629669|NCT02132000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65629670|NCT03607110|Fentanyl|fentanyl|mesh-list
65629671|NCT03607110|Ketamine|ketamine|mesh-list
65629672|NCT03607110|Analgesics|analgesics|mesh-ancestor
65629673|NCT03607110|Sensory System Agents|sensory system agents|mesh-ancestor
65629674|NCT03607110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65629675|NCT03607110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629676|NCT03607110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65629677|NCT03607110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65629678|NCT03607110|Anesthetics, General|anesthetics, general|mesh-ancestor
65629679|NCT03607110|Anesthetics|anesthetics|mesh-ancestor
65629680|NCT03607110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65629681|NCT03607110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65629682|NCT03607110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65629683|NCT03607110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65629684|NCT03607110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629685|NCT03607110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65629686|NCT03607110|Narcotics|narcotics|mesh-ancestor
65629687|NCT03607110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65629688|NCT03118765|Bromides|bromides|mesh-list
65629689|NCT03118765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65629690|NCT03118765|Tiotropium Bromide|tiotropium bromide|mesh-list
65629691|NCT03118765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65629692|NCT03118765|Autonomic Agents|autonomic agents|mesh-ancestor
65629693|NCT03118765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65629694|NCT03118765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629695|NCT03118765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65629697|NCT03118765|Parasympatholytics|parasympatholytics|mesh-ancestor
65629698|NCT03118765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65629699|NCT03118765|Cholinergic Agents|cholinergic agents|mesh-ancestor
65629700|NCT03118765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65629701|NCT03118765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629702|NCT03118765|Anticonvulsants|anticonvulsants|mesh-ancestor
65629703|NCT02128100|Leucovorin|leucovorin|mesh-list
65629704|NCT02128100|Fluorouracil|fluorouracil|mesh-list
65629705|NCT02128100|Oxaliplatin|oxaliplatin|mesh-list
65629706|NCT02128100|Irinotecan|irinotecan|mesh-list
65629707|NCT02128100|Folfirinox|folfirinox|mesh-list
65629708|NCT02128100|Antimetabolites|antimetabolites|mesh-ancestor
65629709|NCT02128100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629710|NCT02128100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65629711|NCT02128100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629712|NCT02128100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65629713|NCT02128100|Immunologic Factors|immunologic factors|mesh-ancestor
65629714|NCT02128100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629715|NCT02128100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65629716|NCT02128100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65629717|NCT02128100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629718|NCT02128100|Antidotes|antidotes|mesh-ancestor
65629719|NCT02128100|Protective Agents|protective agents|mesh-ancestor
65629720|NCT02128100|Vitamin B Complex|vitamin b complex|mesh-ancestor
65629721|NCT02128100|Vitamins|vitamins|mesh-ancestor
65629722|NCT02128100|Micronutrients|micronutrients|mesh-ancestor
65629723|NCT03603366|Aspirin|aspirin|mesh-list
65629724|NCT03603366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65629725|NCT03603366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65629726|NCT03603366|Analgesics|analgesics|mesh-ancestor
65629727|NCT03603366|Sensory System Agents|sensory system agents|mesh-ancestor
65629728|NCT03603366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65629729|NCT03603366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629730|NCT03603366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65629731|NCT03603366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65629732|NCT03603366|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65629733|NCT03603366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65629734|NCT03603366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629735|NCT03603366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65629736|NCT03603366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65629737|NCT03603366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629738|NCT03603366|Antipyretics|antipyretics|mesh-ancestor
65629739|NCT02128178|Enoxaparin|enoxaparin|mesh-list
65629740|NCT02128178|Enoxaparin sodium|enoxaparin sodium|mesh-list
65629741|NCT02128178|Anticoagulants|anticoagulants|mesh-ancestor
65629742|NCT02128178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65629743|NCT02128178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65629744|NCT02128178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629745|NCT03600870|Midodrine|midodrine|mesh-list
65629746|NCT03600870|Sympathomimetics|sympathomimetics|mesh-ancestor
65629747|NCT03600870|Autonomic Agents|autonomic agents|mesh-ancestor
65629748|NCT03600870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65629749|NCT03600870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629750|NCT03600870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65629751|NCT03600870|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65629752|NCT03600870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65629753|NCT03600870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65629754|NCT03600870|Adrenergic Agents|adrenergic agents|mesh-ancestor
65629755|NCT03600870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65629756|NCT03600870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629757|NCT02128334|Leuprolide|leuprolide|mesh-list
65629758|NCT02128334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65629759|NCT02128334|Fertility Agents|fertility agents|mesh-ancestor
65629760|NCT02128334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65629761|NCT02128334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629762|NCT02128334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65629763|NCT02128334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629764|NCT01375699|Doxorubicin|doxorubicin|mesh-list
65629765|NCT01375699|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65629766|NCT01375699|Sildenafil Citrate|sildenafil citrate|mesh-list
65629767|NCT01375699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65629768|NCT01375699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629769|NCT01375699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65629770|NCT01375699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65629771|NCT01375699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629772|NCT01375699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629773|NCT01375699|Vasodilator Agents|vasodilator agents|mesh-ancestor
65629774|NCT01375699|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65629775|NCT01375699|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65629776|NCT01375699|Urological Agents|urological agents|mesh-ancestor
65629778|NCT01373983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65629779|NCT01373983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65629780|NCT01373983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629781|NCT01373983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65629782|NCT01373983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629783|NCT01373983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65629784|NCT01373983|Protective Agents|protective agents|mesh-ancestor
65629785|NCT01373983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65629786|NCT01373983|Analgesics|analgesics|mesh-ancestor
65629787|NCT01373983|Sensory System Agents|sensory system agents|mesh-ancestor
65629788|NCT01373983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65629789|NCT05173597|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65629790|NCT05173597|Hormones|hormones|mesh-ancestor
65629791|NCT05173597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65629792|NCT05173597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629793|NCT05812612|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65629794|NCT05812612|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65629795|NCT05812612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65629796|NCT05812521|Methylene Blue|methylene blue|mesh-list
65629797|NCT05812521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629798|NCT05812521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629799|NCT05812430|Paclitaxel|paclitaxel|mesh-list
65629800|NCT05812430|Cisplatin|cisplatin|mesh-list
65629801|NCT05812430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65629802|NCT05812430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629803|NCT05812430|Tubulin Modulators|tubulin modulators|mesh-ancestor
65629804|NCT05812430|Antimitotic Agents|antimitotic agents|mesh-ancestor
65629805|NCT05812430|Mitosis Modulators|mitosis modulators|mesh-ancestor
65629806|NCT05812430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629807|NCT05812417|DA-8010|da-8010|mesh-list
65629808|NCT05812417|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65629809|NCT05812417|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65629810|NCT05812417|Cholinergic Agents|cholinergic agents|mesh-ancestor
65629811|NCT05812417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65629812|NCT05812417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629813|NCT05812417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629814|NCT05812300|Hyaluronic Acid|hyaluronic acid|mesh-list
65629815|NCT05812300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65629816|NCT05812300|Immunologic Factors|immunologic factors|mesh-ancestor
65629817|NCT05812300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629818|NCT05812300|Viscosupplements|viscosupplements|mesh-ancestor
65629819|NCT05812300|Protective Agents|protective agents|mesh-ancestor
65629820|NCT05811793|Bevacizumab|bevacizumab|mesh-list
65629821|NCT05811793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65629822|NCT05811793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629823|NCT05811793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65629824|NCT05811793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65629825|NCT05811793|Growth Substances|growth substances|mesh-ancestor
65629826|NCT05811793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629827|NCT05811793|Growth Inhibitors|growth inhibitors|mesh-ancestor
65629828|NCT05811676|Tranexamic Acid|tranexamic acid|mesh-list
65629829|NCT05811676|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65629830|NCT05811676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65629831|NCT05811676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629832|NCT05811676|Hemostatics|hemostatics|mesh-ancestor
65629833|NCT05811676|Coagulants|coagulants|mesh-ancestor
65629834|NCT05811507|Testosterone|testosterone|mesh-list
65629835|NCT05811507|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65629836|NCT05811507|Androgens|androgens|mesh-ancestor
65629837|NCT05811507|Hormones|hormones|mesh-ancestor
65629838|NCT05811507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65629839|NCT05811507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629840|NCT05811507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65629841|NCT05811507|Immunologic Factors|immunologic factors|mesh-ancestor
65629842|NCT05811390|Erythritol|erythritol|mesh-list
65629843|NCT05811390|Vasodilator Agents|vasodilator agents|mesh-ancestor
65629844|NCT05811377|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65629845|NCT05811377|Hematinics|hematinics|mesh-ancestor
65629846|NCT05811377|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65629847|NCT05811377|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65629848|NCT05811351|Prednisone|prednisone|mesh-list
65629849|NCT05811351|Triamcinolone|triamcinolone|mesh-list
65629850|NCT05811351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65629851|NCT05811351|Glucocorticoids|glucocorticoids|mesh-ancestor
65629852|NCT05811351|Hormones|hormones|mesh-ancestor
65629853|NCT05811351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65629854|NCT05811351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629855|NCT05811351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65629856|NCT05811351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629857|NCT05811221|Anesthetics|anesthetics|mesh-list
65629858|NCT05811221|Esketamine|esketamine|mesh-list
65629859|NCT05811221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65629860|NCT05811221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629861|NCT05811221|Antidepressive Agents|antidepressive agents|mesh-ancestor
65629862|NCT05811221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65629863|NCT05811000|Donepezil|donepezil|mesh-list
65629864|NCT05811000|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65629865|NCT05811000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629866|NCT05811000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629867|NCT05811000|Cholinergic Agents|cholinergic agents|mesh-ancestor
65629868|NCT05811000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65629869|NCT05811000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629870|NCT05811000|Nootropic Agents|nootropic agents|mesh-ancestor
65629871|NCT05810909|Calcium Carbonate|calcium carbonate|mesh-list
65629872|NCT05810909|Calcium|calcium|mesh-list
65629873|NCT05810909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65629874|NCT05810909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629875|NCT05810909|Antacids|antacids|mesh-ancestor
65629876|NCT05810909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629877|NCT05810909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65629878|NCT05810350|Pemetrexed|pemetrexed|mesh-list
65629879|NCT05810350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629880|NCT05810350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629881|NCT05810350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629882|NCT05810350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65629883|NCT05810350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65629884|NCT05807360|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65629885|NCT05807360|Hyaluronic Acid|hyaluronic acid|mesh-list
65629886|NCT05807360|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65629887|NCT05807360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65629888|NCT05807360|Immunologic Factors|immunologic factors|mesh-ancestor
65629889|NCT05807360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629890|NCT05807360|Viscosupplements|viscosupplements|mesh-ancestor
65629891|NCT05807360|Protective Agents|protective agents|mesh-ancestor
65629892|NCT05804123|Acetylcysteine|acetylcysteine|mesh-list
65629893|NCT05804123|Ciprofloxacin|ciprofloxacin|mesh-list
65629894|NCT05804123|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65629895|NCT05804123|Cefotaxime|cefotaxime|mesh-list
65629896|NCT05804123|Cefoxitin|cefoxitin|mesh-list
65629897|NCT05804123|Xylometazoline|xylometazoline|mesh-list
65629898|NCT05804123|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65629899|NCT05804123|Antiviral Agents|antiviral agents|mesh-ancestor
65629900|NCT05804123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65629901|NCT05804123|Expectorants|expectorants|mesh-ancestor
65629902|NCT05804123|Respiratory System Agents|respiratory system agents|mesh-ancestor
65629903|NCT05804123|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65629904|NCT05804123|Antioxidants|antioxidants|mesh-ancestor
65629905|NCT05804123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629906|NCT05804123|Protective Agents|protective agents|mesh-ancestor
65629907|NCT05804123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629908|NCT05804123|Antidotes|antidotes|mesh-ancestor
65629909|NCT05804123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65629910|NCT05804123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65629911|NCT05804123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65629912|NCT05804123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629913|NCT05804123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629914|NCT05804123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65629915|NCT05804123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65629916|NCT05804123|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65629917|NCT05804123|Nasal Decongestants|nasal decongestants|mesh-ancestor
65629918|NCT05804123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65629919|NCT05804084|Acetazolamide|acetazolamide|mesh-list
65629920|NCT05804084|Anticonvulsants|anticonvulsants|mesh-ancestor
65629921|NCT05804084|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65629922|NCT05804084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629923|NCT05804084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629924|NCT05804084|Diuretics|diuretics|mesh-ancestor
65629925|NCT05804084|Natriuretic Agents|natriuretic agents|mesh-ancestor
65629926|NCT05804084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629927|NCT05803655|Oxymetazoline|oxymetazoline|mesh-list
65629928|NCT05803655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65629929|NCT05803655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65629930|NCT05803655|Adrenergic Agents|adrenergic agents|mesh-ancestor
65629931|NCT05803655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65629932|NCT05803655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629933|NCT05803655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629934|NCT05803655|Sympathomimetics|sympathomimetics|mesh-ancestor
65629935|NCT05803655|Autonomic Agents|autonomic agents|mesh-ancestor
65629936|NCT05803655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65629937|NCT05803655|Nasal Decongestants|nasal decongestants|mesh-ancestor
65629938|NCT05803655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65629939|NCT05803655|Respiratory System Agents|respiratory system agents|mesh-ancestor
65629940|NCT05801224|Nitric Oxide|nitric oxide|mesh-list
65629941|NCT05801224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65629942|NCT05801224|Autonomic Agents|autonomic agents|mesh-ancestor
65629943|NCT05801224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65629944|NCT05801224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629945|NCT05801224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65629946|NCT05801224|Respiratory System Agents|respiratory system agents|mesh-ancestor
65629947|NCT05801224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65629948|NCT05801224|Antioxidants|antioxidants|mesh-ancestor
65629949|NCT05801224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629950|NCT05801224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65629951|NCT05801224|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65629952|NCT05801224|Vasodilator Agents|vasodilator agents|mesh-ancestor
65629953|NCT05801224|Gasotransmitters|gasotransmitters|mesh-ancestor
65629954|NCT05801224|Protective Agents|protective agents|mesh-ancestor
65629955|NCT05793489|Silybin|silybin|mesh-list
65629956|NCT05793489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65629957|NCT05793489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629958|NCT05793489|Protective Agents|protective agents|mesh-ancestor
65629959|NCT05793489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629960|NCT05761574|Acetaminophen|acetaminophen|mesh-list
65629961|NCT05761574|Naproxen|naproxen|mesh-list
65629962|NCT05761574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65629963|NCT05761574|Analgesics|analgesics|mesh-ancestor
65629964|NCT05761574|Sensory System Agents|sensory system agents|mesh-ancestor
65629965|NCT05761574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65629966|NCT05761574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629967|NCT05761574|Antipyretics|antipyretics|mesh-ancestor
65629968|NCT05761574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65629969|NCT05761574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65629970|NCT05761574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65629971|NCT05761574|Gout Suppressants|gout suppressants|mesh-ancestor
65629972|NCT05761574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65629973|NCT05761574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629974|NCT05761574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629975|NCT05756673|Listerine|listerine|mesh-list
65629976|NCT05756673|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
65629977|NCT05756673|Sodium Fluoride|sodium fluoride|mesh-list
65629978|NCT05756673|Cariostatic Agents|cariostatic agents|mesh-ancestor
65629979|NCT05756673|Protective Agents|protective agents|mesh-ancestor
65629980|NCT05756673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65629981|NCT05756673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65629982|NCT05754853|Gemcitabine|gemcitabine|mesh-list
65629983|NCT05754853|Paclitaxel|paclitaxel|mesh-list
65629984|NCT05754853|Docetaxel|docetaxel|mesh-list
65629985|NCT05754853|Pemetrexed|pemetrexed|mesh-list
65629986|NCT05754853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65629987|NCT05754853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65629988|NCT05754853|Tubulin Modulators|tubulin modulators|mesh-ancestor
65629989|NCT05754853|Antimitotic Agents|antimitotic agents|mesh-ancestor
65629990|NCT05754853|Mitosis Modulators|mitosis modulators|mesh-ancestor
65629991|NCT05754853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65629992|NCT05754853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65629993|NCT05754853|Antimetabolites|antimetabolites|mesh-ancestor
65629994|NCT05754853|Antiviral Agents|antiviral agents|mesh-ancestor
65629995|NCT05754853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65629996|NCT05754853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65629997|NCT05754853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65629998|NCT05754853|Immunologic Factors|immunologic factors|mesh-ancestor
65629999|NCT05754853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630000|NCT05754853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65630001|NCT05754853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65630002|NCT05747625|Panitumumab|panitumumab|mesh-list
65630003|NCT05747625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65630004|NCT05747625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630005|NCT05746520|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65630006|NCT05746520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65630007|NCT05746520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65630008|NCT05746520|Antitubercular Agents|antitubercular agents|mesh-ancestor
65630009|NCT05742347|Protective Agents|protective agents|mesh-list
65630010|NCT05742347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630011|NCT05729932|Analgesics, Opioid|analgesics, opioid|mesh-list
65630012|NCT05729932|Narcotics|narcotics|mesh-ancestor
65630013|NCT05729932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65630014|NCT05729932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630015|NCT05729932|Analgesics|analgesics|mesh-ancestor
65630016|NCT05729932|Sensory System Agents|sensory system agents|mesh-ancestor
65630017|NCT05729932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65630018|NCT05729282|Diazoxide|diazoxide|mesh-list
65630019|NCT05729282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65630020|NCT05729282|Vasodilator Agents|vasodilator agents|mesh-ancestor
65630021|NCT05720325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65630022|NCT05720325|Immunologic Factors|immunologic factors|mesh-ancestor
65630023|NCT05720325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630024|NCT05714345|Cyclophosphamide|cyclophosphamide|mesh-list
65630025|NCT05714345|Fludarabine|fludarabine|mesh-list
65630026|NCT05714345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65630027|NCT05714345|Immunologic Factors|immunologic factors|mesh-ancestor
65630028|NCT05714345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630029|NCT05714345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65630030|NCT05714345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65630031|NCT05714345|Alkylating Agents|alkylating agents|mesh-ancestor
65630032|NCT05714345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630033|NCT05714345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630034|NCT05714345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65630035|NCT05708989|Dexmedetomidine|dexmedetomidine|mesh-list
65630036|NCT05708989|Ropivacaine|ropivacaine|mesh-list
65630037|NCT05708989|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65630038|NCT05708989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65630039|NCT05708989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630040|NCT05708989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65630041|NCT05708989|Analgesics|analgesics|mesh-ancestor
65630042|NCT05708989|Sensory System Agents|sensory system agents|mesh-ancestor
65630043|NCT05708989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65630044|NCT05708989|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65630045|NCT05708989|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65630046|NCT05708989|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65630047|NCT05708989|Adrenergic Agents|adrenergic agents|mesh-ancestor
65630048|NCT05708989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65630049|NCT05708989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630050|NCT05708989|Anesthetics, Local|anesthetics, local|mesh-ancestor
65630051|NCT05708989|Anesthetics|anesthetics|mesh-ancestor
65630052|NCT05706506|Tirzepatide|tirzepatide|mesh-list
65630053|NCT05706506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65630054|NCT05706506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630055|NCT05706506|Incretins|incretins|mesh-ancestor
65630056|NCT05706506|Hormones|hormones|mesh-ancestor
65630057|NCT05706506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65630058|NCT05705505|Letrozole|letrozole|mesh-list
65630059|NCT05705505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630060|NCT05705505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65630061|NCT05705505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65630062|NCT05705505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266994|NCT04679012|Prednisone|prednisone|mesh-list
65630063|NCT05705505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630064|NCT05705505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65630065|NCT05705505|Hormone Antagonists|hormone antagonists|mesh-ancestor
65630066|NCT05705505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65630067|NCT05705505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630068|NCT05705427|Tenofovir|tenofovir|mesh-list
65630069|NCT05705427|Vaccines|vaccines|mesh-list
65630070|NCT05705427|Immunologic Factors|immunologic factors|mesh-ancestor
65630071|NCT05705427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630072|NCT05705427|Antiviral Agents|antiviral agents|mesh-ancestor
65630073|NCT05705427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65630074|NCT05705427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65630075|NCT05705427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65630076|NCT05705427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630077|NCT05705427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630078|NCT05705427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65630079|NCT05705427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65630080|NCT05696847|Tirzepatide|tirzepatide|mesh-list
65630081|NCT05696847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65630082|NCT05696847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630083|NCT05696847|Incretins|incretins|mesh-ancestor
65630084|NCT05696847|Hormones|hormones|mesh-ancestor
65630085|NCT05696847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65630086|NCT05692869|Propranolol|propranolol|mesh-list
65630087|NCT05692869|Pseudoephedrine|pseudoephedrine|mesh-list
65630088|NCT05692869|Ephedrine|ephedrine|mesh-list
65630089|NCT05692869|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65630090|NCT05692869|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65630091|NCT05692869|Adrenergic Agents|adrenergic agents|mesh-ancestor
65630092|NCT05692869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65630093|NCT05692869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630094|NCT05692869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630095|NCT05692869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65630096|NCT05692869|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65630097|NCT05692869|Vasodilator Agents|vasodilator agents|mesh-ancestor
65630098|NCT05692869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65630099|NCT05692869|Autonomic Agents|autonomic agents|mesh-ancestor
65630100|NCT05692869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65630101|NCT05692869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65630102|NCT05692869|Respiratory System Agents|respiratory system agents|mesh-ancestor
65630103|NCT05692869|Nasal Decongestants|nasal decongestants|mesh-ancestor
65630104|NCT05692869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65630105|NCT05692869|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65630106|NCT05692869|Sympathomimetics|sympathomimetics|mesh-ancestor
65630107|NCT05662332|Insulin|insulin|mesh-list
65630108|NCT05662332|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65630109|NCT05662332|Insulin Glargine|insulin glargine|mesh-list
65630110|NCT05662332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65630111|NCT05662332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630112|NCT05655468|Dronedarone|dronedarone|mesh-list
65630113|NCT05655468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65630114|NCT05654454|Paclitaxel|paclitaxel|mesh-list
65630115|NCT05654454|Bevacizumab|bevacizumab|mesh-list
65630116|NCT05654454|Carboplatin|carboplatin|mesh-list
65630117|NCT05654454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65630118|NCT05654454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630119|NCT05654454|Tubulin Modulators|tubulin modulators|mesh-ancestor
65630120|NCT05654454|Antimitotic Agents|antimitotic agents|mesh-ancestor
65630121|NCT05654454|Mitosis Modulators|mitosis modulators|mesh-ancestor
65630122|NCT05654454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630123|NCT05654454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65630124|NCT05654454|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65630125|NCT05654454|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65630126|NCT05654454|Growth Substances|growth substances|mesh-ancestor
65630127|NCT05654454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630128|NCT05654454|Growth Inhibitors|growth inhibitors|mesh-ancestor
65630129|NCT05653271|Cyclophosphamide|cyclophosphamide|mesh-list
65630130|NCT05653271|Fludarabine|fludarabine|mesh-list
65630131|NCT05653271|Obinutuzumab|obinutuzumab|mesh-list
65630132|NCT05653271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65630133|NCT05653271|Immunologic Factors|immunologic factors|mesh-ancestor
65630134|NCT05653271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630135|NCT05653271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65630136|NCT05653271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65630137|NCT05653271|Alkylating Agents|alkylating agents|mesh-ancestor
65630138|NCT05653271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630139|NCT05653271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630140|NCT05653271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65630141|NCT05653271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65630142|NCT05648448|Oseltamivir|oseltamivir|mesh-list
65630143|NCT05648448|Favipiravir|favipiravir|mesh-list
65630144|NCT05648448|Zanamivir|zanamivir|mesh-list
65630145|NCT05648448|Peramivir|peramivir|mesh-list
65630146|NCT05648448|Baloxavir|baloxavir|mesh-list
65630147|NCT05648448|Laninamivir|laninamivir|mesh-list
65630148|NCT05648448|Antiviral Agents|antiviral agents|mesh-ancestor
65630149|NCT05648448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65630150|NCT05648448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630151|NCT05648448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630153|NCT05644665|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65630154|NCT05644665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630155|NCT05644665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65630156|NCT05644665|Immunologic Factors|immunologic factors|mesh-ancestor
65630157|NCT05644665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630158|NCT05644353|Mirikizumab|mirikizumab|mesh-list
65630159|NCT05644353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65630160|NCT05644353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65630161|NCT05644353|Analgesics|analgesics|mesh-ancestor
65630162|NCT05644353|Sensory System Agents|sensory system agents|mesh-ancestor
65630163|NCT05644353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65630164|NCT05644353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630165|NCT05644353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65630166|NCT05644353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65630167|NCT05644353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65630168|NCT05644353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65630169|NCT05643560|Factor VIII|factor viii|mesh-list
65630170|NCT05643560|Coagulants|coagulants|mesh-ancestor
65630171|NCT05640245|Adalimumab|adalimumab|mesh-list
65630172|NCT05640245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65630173|NCT05640245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65630174|NCT05625399|Nivolumab|nivolumab|mesh-list
65630175|NCT05625399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65630176|NCT05625399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630177|NCT05625399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65630178|NCT05625399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630179|NCT05608291|Pembrolizumab|pembrolizumab|mesh-list
65630180|NCT05608291|Cemiplimab|cemiplimab|mesh-list
65630181|NCT05608291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65630182|NCT05608291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630183|NCT05581004|Atezolizumab|atezolizumab|mesh-list
65630184|NCT05581004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630185|NCT05563389|Atorvastatin|atorvastatin|mesh-list
65630186|NCT05563389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65630187|NCT05563389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65630188|NCT05563389|Antimetabolites|antimetabolites|mesh-ancestor
65630189|NCT05563389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630190|NCT05563389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65630191|NCT05563389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65630192|NCT05563389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630193|NCT05557838|Durvalumab|durvalumab|mesh-list
65630194|NCT05557838|Tremelimumab|tremelimumab|mesh-list
65630195|NCT05557838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65630196|NCT05557838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630197|NCT05548660|Analgesics|analgesics|mesh-list
65630198|NCT05548660|Sensory System Agents|sensory system agents|mesh-ancestor
65630199|NCT05548660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65630200|NCT05548660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630201|NCT05539963|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65630202|NCT05539963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65630203|NCT05525273|Trametinib|trametinib|mesh-list
65630204|NCT05525273|Dabrafenib|dabrafenib|mesh-list
65630205|NCT05525273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630206|NCT05525273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65630207|NCT05525273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630208|NCT05525273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630209|NCT05516849|Oxandrolone|oxandrolone|mesh-list
65630210|NCT05516849|Androgens|androgens|mesh-ancestor
65630211|NCT05516849|Hormones|hormones|mesh-ancestor
65630212|NCT05516849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65630213|NCT05516849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630214|NCT05516849|Anabolic Agents|anabolic agents|mesh-ancestor
65630215|NCT05511766|Allopurinol|allopurinol|mesh-list
65630216|NCT05511766|Atorvastatin|atorvastatin|mesh-list
65630217|NCT05511766|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65630218|NCT05511766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65630219|NCT05511766|Antimetabolites|antimetabolites|mesh-ancestor
65630220|NCT05511766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630221|NCT05511766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65630222|NCT05511766|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65630223|NCT05511766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630224|NCT05511766|Gout Suppressants|gout suppressants|mesh-ancestor
65630225|NCT05511766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65630226|NCT05511766|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65630227|NCT05511766|Antioxidants|antioxidants|mesh-ancestor
65630228|NCT05511766|Protective Agents|protective agents|mesh-ancestor
65630229|NCT05511766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630230|NCT05485805|Naproxen|naproxen|mesh-list
65630231|NCT05485805|Caffeine|caffeine|mesh-list
65630232|NCT05485805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65630233|NCT05485805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630234|NCT05485805|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65630235|NCT05485805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630236|NCT05485805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630237|NCT05485805|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65630238|NCT05485805|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65630239|NCT05485805|Purinergic Agents|purinergic agents|mesh-ancestor
65630240|NCT05485805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65630241|NCT05485805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65630242|NCT05485805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65630243|NCT05485805|Analgesics|analgesics|mesh-ancestor
65630244|NCT05485805|Sensory System Agents|sensory system agents|mesh-ancestor
65630245|NCT05485805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65630246|NCT05485805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65630247|NCT05485805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65630248|NCT05485805|Gout Suppressants|gout suppressants|mesh-ancestor
65630249|NCT05485805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65630250|NCT05479916|Caseins|caseins|mesh-list
65630251|NCT05479916|Chelating Agents|chelating agents|mesh-ancestor
65630252|NCT05479916|Sequestering Agents|sequestering agents|mesh-ancestor
65630253|NCT05479916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630254|NCT05476926|Ranibizumab|ranibizumab|mesh-list
65630255|NCT05476926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65630256|NCT05476926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65630257|NCT05476926|Growth Substances|growth substances|mesh-ancestor
65630258|NCT05476926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630259|NCT05476926|Growth Inhibitors|growth inhibitors|mesh-ancestor
65630260|NCT05476926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630261|NCT05476796|Trifluridine|trifluridine|mesh-list
65630262|NCT05476796|Oxaliplatin|oxaliplatin|mesh-list
65630263|NCT05476796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630264|NCT05476796|Antimetabolites|antimetabolites|mesh-ancestor
65630265|NCT05476796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630266|NCT05476796|Antiviral Agents|antiviral agents|mesh-ancestor
65630267|NCT05476796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65630268|NCT05466734|Cilostazol|cilostazol|mesh-list
65630269|NCT05466734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65630270|NCT05466734|Autonomic Agents|autonomic agents|mesh-ancestor
65630271|NCT05466734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65630272|NCT05466734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630273|NCT05466734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65630274|NCT05466734|Respiratory System Agents|respiratory system agents|mesh-ancestor
65630275|NCT05466734|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65630276|NCT05466734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65630277|NCT05466734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630278|NCT05466734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65630279|NCT05466734|Vasodilator Agents|vasodilator agents|mesh-ancestor
65630280|NCT05466734|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65630281|NCT05466734|Protective Agents|protective agents|mesh-ancestor
65630282|NCT05466734|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65630283|NCT05466734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65630284|NCT05466734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630285|NCT05464836|Venetoclax|venetoclax|mesh-list
65630286|NCT05464836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630287|NCT05458401|Trastuzumab|trastuzumab|mesh-list
65630288|NCT05458401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65630289|NCT05458401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630290|NCT05450029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65630291|NCT05450029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630292|NCT05450029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630293|NCT05440786|Irinotecan|irinotecan|mesh-list
65630294|NCT05440786|Temozolomide|temozolomide|mesh-list
65630295|NCT05440786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65630296|NCT05440786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65630297|NCT05440786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630298|NCT05440786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427641|NCT01055691|Metformin|metformin|mesh-list
65630299|NCT05440786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630300|NCT05440786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65630302|NCT05420402|Propofol|propofol|mesh-list
65630303|NCT05420402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65630304|NCT05420402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65630305|NCT05420402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630306|NCT05420402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65630307|NCT05420402|Anesthetics, General|anesthetics, general|mesh-ancestor
65630308|NCT05420402|Anesthetics|anesthetics|mesh-ancestor
65630309|NCT05417646|Empagliflozin|empagliflozin|mesh-list
65630310|NCT05417646|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65630311|NCT05417646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630312|NCT05417646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65630313|NCT05417646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630314|NCT05417087|Vortioxetine|vortioxetine|mesh-list
65630315|NCT05417087|Antidepressive Agents|antidepressive agents|mesh-ancestor
65630316|NCT05417087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65630317|NCT05417087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65630318|NCT05417087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65630319|NCT05417087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65630320|NCT05417087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630321|NCT05417087|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65630322|NCT05417087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65630323|NCT05417087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65630324|NCT05417087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630325|NCT05417087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65630326|NCT05417087|Serotonin Agents|serotonin agents|mesh-ancestor
65630327|NCT05417087|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65630328|NCT05417087|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65630329|NCT05417087|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65630330|NCT05417087|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65630331|NCT05416957|Vortioxetine|vortioxetine|mesh-list
65630332|NCT05416957|Antidepressive Agents|antidepressive agents|mesh-ancestor
65630333|NCT05416957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65630334|NCT05416957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65630335|NCT05416957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65630336|NCT05416957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65630337|NCT05416957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630338|NCT05416957|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65630339|NCT05416957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65630340|NCT05416957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65630341|NCT05416957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630342|NCT05416957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65630343|NCT05416957|Serotonin Agents|serotonin agents|mesh-ancestor
65630344|NCT05416957|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65630345|NCT05416957|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65630346|NCT05416957|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65630347|NCT05416957|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65630348|NCT05416762|Vortioxetine|vortioxetine|mesh-list
65630349|NCT05416762|Antidepressive Agents|antidepressive agents|mesh-ancestor
65630350|NCT05416762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65630351|NCT05416762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65630352|NCT05416762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65630353|NCT05416762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65630354|NCT05416762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630355|NCT05416762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65630356|NCT05416762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65630357|NCT05416762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65630358|NCT05416762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630359|NCT05416762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65630360|NCT05416762|Serotonin Agents|serotonin agents|mesh-ancestor
65630361|NCT05416762|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65630362|NCT05416762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65630363|NCT05416762|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65630364|NCT05416762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65630365|NCT05383742|Rifampin|rifampin|mesh-list
65630366|NCT05383742|Isoniazid|isoniazid|mesh-list
65630367|NCT05383742|Linezolid|linezolid|mesh-list
65630368|NCT05383742|Pyrazinamide|pyrazinamide|mesh-list
65630369|NCT05383742|Ethambutol|ethambutol|mesh-list
65427715|NCT04403165|Sympathomimetics|sympathomimetics|mesh-ancestor
65630370|NCT05383742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65630371|NCT05383742|Antitubercular Agents|antitubercular agents|mesh-ancestor
65630372|NCT05383742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65630373|NCT05383742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65630374|NCT05383742|Leprostatic Agents|leprostatic agents|mesh-ancestor
65630375|NCT05383742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65630376|NCT05383742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630377|NCT05383742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630378|NCT05383742|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65630379|NCT05383742|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65630380|NCT05383742|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65630381|NCT05383742|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65630382|NCT05383742|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65630383|NCT05383742|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65630384|NCT05383742|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65630385|NCT05383742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65630386|NCT05383742|Antimetabolites|antimetabolites|mesh-ancestor
65630387|NCT05383742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65630388|NCT05383742|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65630389|NCT05383352|Leucovorin|leucovorin|mesh-list
65630390|NCT05383352|Folic Acid|folic acid|mesh-list
65630391|NCT05383352|Fluorouracil|fluorouracil|mesh-list
65630392|NCT05383352|Irinotecan|irinotecan|mesh-list
65630393|NCT05383352|Camptothecin|camptothecin|mesh-list
65630394|NCT05383352|Levoleucovorin|levoleucovorin|mesh-list
65630395|NCT05383352|Antimetabolites|antimetabolites|mesh-ancestor
65630396|NCT05383352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630397|NCT05383352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65630398|NCT05383352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630399|NCT05383352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65630400|NCT05383352|Immunologic Factors|immunologic factors|mesh-ancestor
65630401|NCT05383352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630402|NCT05383352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65630403|NCT05383352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65630404|NCT05383352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630405|NCT05383352|Antidotes|antidotes|mesh-ancestor
65630406|NCT05383352|Protective Agents|protective agents|mesh-ancestor
65630407|NCT05383352|Vitamin B Complex|vitamin b complex|mesh-ancestor
65630408|NCT05383352|Vitamins|vitamins|mesh-ancestor
65630409|NCT05383352|Micronutrients|micronutrients|mesh-ancestor
65630410|NCT05383352|Hematinics|hematinics|mesh-ancestor
65630411|NCT05383352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65630412|NCT05365802|FAPI-46|fapi-46|mesh-list
65630413|NCT05365802|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65630414|NCT05365802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630415|NCT05358639|Olaparib|olaparib|mesh-list
65630416|NCT05358639|Navitoclax|navitoclax|mesh-list
65630417|NCT05358639|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65630418|NCT05358639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630419|NCT05358639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630420|NCT05358639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630421|NCT05358249|Cetuximab|cetuximab|mesh-list
65630422|NCT05358249|Trametinib|trametinib|mesh-list
65630423|NCT05358249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65630424|NCT05358249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630425|NCT05358249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65630426|NCT05358249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267003|NCT04679012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65630427|NCT05358249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630428|NCT05347485|Cyclophosphamide|cyclophosphamide|mesh-list
65630429|NCT05347485|Fludarabine|fludarabine|mesh-list
65630430|NCT05347485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65630431|NCT05347485|Immunologic Factors|immunologic factors|mesh-ancestor
65630432|NCT05347485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630433|NCT05347485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65630434|NCT05347485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65630435|NCT05347485|Alkylating Agents|alkylating agents|mesh-ancestor
65630436|NCT05347485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630437|NCT05347485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630438|NCT05347485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65630439|NCT05342636|Paclitaxel|paclitaxel|mesh-list
65630440|NCT05342636|Pembrolizumab|pembrolizumab|mesh-list
65630441|NCT05342636|Irinotecan|irinotecan|mesh-list
65630442|NCT05342636|Lenvatinib|lenvatinib|mesh-list
65630443|NCT05342636|Immunoglobulins|immunoglobulins|mesh-list
65630444|NCT05342636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65630445|NCT05342636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630446|NCT05342636|Tubulin Modulators|tubulin modulators|mesh-ancestor
65630447|NCT05342636|Antimitotic Agents|antimitotic agents|mesh-ancestor
65630448|NCT05342636|Mitosis Modulators|mitosis modulators|mesh-ancestor
65630449|NCT05342636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630450|NCT05342636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65630451|NCT05342636|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65630452|NCT05342636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65630453|NCT05342636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630454|NCT05342636|Immunologic Factors|immunologic factors|mesh-ancestor
65630455|NCT05342636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630456|NCT05342636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65630458|NCT05334004|Lopinavir|lopinavir|mesh-list
65630459|NCT05334004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65630460|NCT05334004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65630461|NCT05334004|Protease Inhibitors|protease inhibitors|mesh-ancestor
65630462|NCT05334004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630463|NCT05334004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630464|NCT05334004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65630465|NCT05334004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65630466|NCT05334004|Antiviral Agents|antiviral agents|mesh-ancestor
65630467|NCT05334004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65630468|NCT05334004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65630469|NCT05334004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65630470|NCT05330871|Vaccines|vaccines|mesh-list
65630471|NCT05330871|Immunologic Factors|immunologic factors|mesh-ancestor
65630472|NCT05330871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630473|NCT05327595|Midazolam|midazolam|mesh-list
65630474|NCT05327595|Atorvastatin|atorvastatin|mesh-list
65630475|NCT05327595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65630476|NCT05327595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65630477|NCT05327595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65630478|NCT05327595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630479|NCT05327595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65630480|NCT05327595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65630481|NCT05327595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65630482|NCT05327595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65630483|NCT05327595|Anesthetics, General|anesthetics, general|mesh-ancestor
65630484|NCT05327595|Anesthetics|anesthetics|mesh-ancestor
65630485|NCT05327595|GABA Modulators|gaba modulators|mesh-ancestor
65630486|NCT05327595|GABA Agents|gaba agents|mesh-ancestor
65630487|NCT05327595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65630488|NCT05327595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630489|NCT05327595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65630490|NCT05327595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65630491|NCT05327595|Antimetabolites|antimetabolites|mesh-ancestor
65630492|NCT05327595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65630493|NCT05327595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65630494|NCT05327595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630495|NCT05319873|Carboplatin|carboplatin|mesh-list
65630496|NCT05319873|Docetaxel|docetaxel|mesh-list
65630497|NCT05319873|Trastuzumab|trastuzumab|mesh-list
65630498|NCT05319873|Fulvestrant|fulvestrant|mesh-list
65630499|NCT05319873|Pertuzumab|pertuzumab|mesh-list
65630500|NCT05319873|Tucatinib|tucatinib|mesh-list
65630501|NCT05319873|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
65267005|NCT04679012|Alkylating Agents|alkylating agents|mesh-ancestor
65630502|NCT05319873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65630503|NCT05319873|Antibodies|antibodies|mesh-list
65630504|NCT05319873|Immunoglobulins|immunoglobulins|mesh-list
65630505|NCT05319873|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65630506|NCT05319873|Immunologic Factors|immunologic factors|mesh-ancestor
65630507|NCT05319873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630508|NCT05319873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630509|NCT05319873|Tubulin Modulators|tubulin modulators|mesh-ancestor
65630510|NCT05319873|Antimitotic Agents|antimitotic agents|mesh-ancestor
65630511|NCT05319873|Mitosis Modulators|mitosis modulators|mesh-ancestor
65630512|NCT05319873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630513|NCT05319873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65630514|NCT05319873|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65630515|NCT05319873|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65630516|NCT05319873|Hormone Antagonists|hormone antagonists|mesh-ancestor
65630517|NCT05319873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65630518|NCT05319873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65630519|NCT05319873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630520|NCT05314153|Brexanolone|brexanolone|mesh-list
65630521|NCT05314153|Neurosteroids|neurosteroids|mesh-ancestor
65630522|NCT05314153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65630523|NCT05314153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630524|NCT05314153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630525|NCT05314153|GABA Modulators|gaba modulators|mesh-ancestor
65630526|NCT05314153|GABA Agents|gaba agents|mesh-ancestor
65630527|NCT05306340|Tamoxifen|tamoxifen|mesh-list
65630528|NCT05306340|Dexamethasone|dexamethasone|mesh-list
65630529|NCT05306340|Fulvestrant|fulvestrant|mesh-list
65630530|NCT05306340|Everolimus|everolimus|mesh-list
65630531|NCT05306340|Exemestane|exemestane|mesh-list
65630532|NCT05306340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65630533|NCT05306340|Antiemetics|antiemetics|mesh-ancestor
65630534|NCT05306340|Autonomic Agents|autonomic agents|mesh-ancestor
65630535|NCT05306340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65630536|NCT05306340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630537|NCT05306340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65630538|NCT05306340|Glucocorticoids|glucocorticoids|mesh-ancestor
65630539|NCT05306340|Hormones|hormones|mesh-ancestor
65630540|NCT05306340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65630541|NCT05306340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65630542|NCT05306340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630543|NCT05306340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65630544|NCT05306340|Immunologic Factors|immunologic factors|mesh-ancestor
65630545|NCT05306340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65630546|NCT05306340|Hormone Antagonists|hormone antagonists|mesh-ancestor
65630547|NCT05306340|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65630548|NCT05306340|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65630549|NCT05306340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65630550|NCT05306340|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65630551|NCT05306340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65630552|NCT05306340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65630553|NCT05306340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630554|NCT05306340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630555|NCT05283408|Dexmedetomidine|dexmedetomidine|mesh-list
65630556|NCT05283408|Esketamine|esketamine|mesh-list
65630557|NCT05283408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65630558|NCT05283408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65630559|NCT05283408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630560|NCT05283408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65630561|NCT05283408|Analgesics|analgesics|mesh-ancestor
65630562|NCT05283408|Sensory System Agents|sensory system agents|mesh-ancestor
65630563|NCT05283408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65630564|NCT05283408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65630565|NCT05283408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65630566|NCT05283408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65630567|NCT05283408|Adrenergic Agents|adrenergic agents|mesh-ancestor
65630568|NCT05283408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65630569|NCT05283408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630570|NCT05283408|Antidepressive Agents|antidepressive agents|mesh-ancestor
65630571|NCT05283408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65630572|NCT05275400|Insulin|insulin|mesh-list
65630573|NCT05275400|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65630574|NCT05275400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65630575|NCT05275400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630576|NCT05244070|Cyclophosphamide|cyclophosphamide|mesh-list
65630577|NCT05244070|Fludarabine|fludarabine|mesh-list
65630578|NCT05244070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65630579|NCT05244070|Immunologic Factors|immunologic factors|mesh-ancestor
65630580|NCT05244070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630581|NCT05244070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65630582|NCT05244070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65630583|NCT05244070|Alkylating Agents|alkylating agents|mesh-ancestor
65630584|NCT05244070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630585|NCT05244070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630586|NCT05244070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65630587|NCT05240755|Cannabidiol|cannabidiol|mesh-list
65630588|NCT05240755|Anticonvulsants|anticonvulsants|mesh-ancestor
65630589|NCT05229315|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65630590|NCT05229315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630591|NCT05229315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630592|NCT05229055|Ketamine|ketamine|mesh-list
65630593|NCT05229055|Analgesics|analgesics|mesh-ancestor
65630594|NCT05229055|Sensory System Agents|sensory system agents|mesh-ancestor
65630595|NCT05229055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65630596|NCT05229055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630597|NCT05229055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65630598|NCT05229055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65630599|NCT05229055|Anesthetics, General|anesthetics, general|mesh-ancestor
65630600|NCT05229055|Anesthetics|anesthetics|mesh-ancestor
65630601|NCT05229055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65630602|NCT05229055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65630603|NCT05229055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65630604|NCT05229055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65630605|NCT05229055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630606|NCT05220722|Pembrolizumab|pembrolizumab|mesh-list
65630607|NCT05220722|Nivolumab|nivolumab|mesh-list
65630608|NCT05220722|Ipilimumab|ipilimumab|mesh-list
65630609|NCT05220722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65630610|NCT05220722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630611|NCT05220722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65630612|NCT05220722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630613|NCT05219513|Obinutuzumab|obinutuzumab|mesh-list
65630614|NCT05219513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65630615|NCT05219513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630616|NCT05213143|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65630617|NCT05213143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65630618|NCT05213143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65630619|NCT05213143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65630620|NCT05213143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630621|NCT05213143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65630622|NCT05213143|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65630623|NCT05213143|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65630624|NCT05213143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65630625|NCT05213143|Adrenergic Agents|adrenergic agents|mesh-ancestor
65630626|NCT05213143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65630627|NCT05213143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630628|NCT05213143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65630629|NCT05213143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65630630|NCT05213143|Serotonin Agents|serotonin agents|mesh-ancestor
65630631|NCT05213143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65630632|NCT05213143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65630633|NCT05213143|Dopamine Agents|dopamine agents|mesh-ancestor
65630634|NCT05208931|Mitogens|mitogens|mesh-list
65630635|NCT05208931|Endothelial Growth Factors|endothelial growth factors|mesh-list
65630636|NCT05208931|Mitosis Modulators|mitosis modulators|mesh-ancestor
65630637|NCT05208931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630638|NCT05208931|Growth Substances|growth substances|mesh-ancestor
65630639|NCT05208931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630640|NCT05191862|Cilostazol|cilostazol|mesh-list
65630641|NCT05191862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65630642|NCT05191862|Autonomic Agents|autonomic agents|mesh-ancestor
65630643|NCT05191862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65630644|NCT05191862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630645|NCT05191862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65630646|NCT05191862|Respiratory System Agents|respiratory system agents|mesh-ancestor
65630647|NCT05191862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65630648|NCT05191862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65630649|NCT05191862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630650|NCT05191862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65630651|NCT05191862|Vasodilator Agents|vasodilator agents|mesh-ancestor
65630652|NCT05191862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65630653|NCT05191862|Protective Agents|protective agents|mesh-ancestor
65630654|NCT05191862|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65630655|NCT05191862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65630656|NCT05191862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630657|NCT05189704|Analgesics, Opioid|analgesics, opioid|mesh-list
65630658|NCT05189704|Narcotics|narcotics|mesh-ancestor
65630659|NCT05189704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65630660|NCT05189704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630661|NCT05189704|Analgesics|analgesics|mesh-ancestor
65630662|NCT05189704|Sensory System Agents|sensory system agents|mesh-ancestor
65630663|NCT05189704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65630664|NCT05179421|Oxytocin|oxytocin|mesh-list
65630665|NCT05179421|Oxytocics|oxytocics|mesh-ancestor
65630666|NCT05179421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65630667|NCT05179421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630668|NCT05178862|Fluconazole|fluconazole|mesh-list
65630669|NCT05178862|Caspofungin|caspofungin|mesh-list
65630670|NCT05178862|Micafungin|micafungin|mesh-list
65630671|NCT05178862|Anidulafungin|anidulafungin|mesh-list
65630672|NCT05178862|Ibrexafungerp|ibrexafungerp|mesh-list
65630673|NCT05178862|Echinocandins|echinocandins|mesh-list
65630674|NCT05178862|Antifungal Agents|antifungal agents|mesh-ancestor
65630675|NCT05178862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65630676|NCT05178862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65630677|NCT05178862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65630678|NCT05178862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630679|NCT05178862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630680|NCT05178862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65630681|NCT05178862|Hormone Antagonists|hormone antagonists|mesh-ancestor
65630682|NCT05178862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65630683|NCT05178862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630684|NCT05178862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65630685|NCT05178862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65630686|NCT05169567|Fulvestrant|fulvestrant|mesh-list
65630687|NCT05169567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65630688|NCT05169567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630689|NCT05169567|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65630690|NCT05169567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65630691|NCT05169567|Hormone Antagonists|hormone antagonists|mesh-ancestor
65630692|NCT05169567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65630693|NCT05169567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630694|NCT05153915|Tacrolimus|tacrolimus|mesh-list
65630695|NCT05153915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65630696|NCT05153915|Immunologic Factors|immunologic factors|mesh-ancestor
65630697|NCT05153915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630698|NCT05153915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65630699|NCT05153915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630700|NCT05153915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630701|NCT05136703|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65630702|NCT05136703|Antiviral Agents|antiviral agents|mesh-ancestor
65630703|NCT05136703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65630704|NCT05123599|Tenofovir|tenofovir|mesh-list
65630705|NCT05123599|Antiviral Agents|antiviral agents|mesh-ancestor
65630706|NCT05123599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65630707|NCT05123599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65630708|NCT05123599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65630709|NCT05123599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630710|NCT05123599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630711|NCT05123599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65630712|NCT05123599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65630713|NCT05100160|Gabapentin|gabapentin|mesh-list
65630714|NCT05100160|Analgesics|analgesics|mesh-ancestor
65630715|NCT05100160|Sensory System Agents|sensory system agents|mesh-ancestor
65630716|NCT05100160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65630717|NCT05100160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630718|NCT05100160|Anticonvulsants|anticonvulsants|mesh-ancestor
65630719|NCT05100160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65630720|NCT05100160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65630721|NCT05100160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65630722|NCT05100160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65630723|NCT05100160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65630724|NCT05100160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65630725|NCT05100160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65630726|NCT05100160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630727|NCT05100160|Antimanic Agents|antimanic agents|mesh-ancestor
65630728|NCT05065970|Felzartamab|felzartamab|mesh-list
65630729|NCT05065970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630730|NCT05065970|Immunologic Factors|immunologic factors|mesh-ancestor
65630731|NCT05065970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630732|NCT05062044|Folic Acid|folic acid|mesh-list
65630733|NCT05062044|Hematinics|hematinics|mesh-ancestor
65630734|NCT05062044|Vitamin B Complex|vitamin b complex|mesh-ancestor
65630735|NCT05062044|Vitamins|vitamins|mesh-ancestor
65630736|NCT05062044|Micronutrients|micronutrients|mesh-ancestor
65630737|NCT05062044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630738|NCT05060822|Pirfenidone|pirfenidone|mesh-list
65630739|NCT05060822|Analgesics|analgesics|mesh-ancestor
65630740|NCT05060822|Sensory System Agents|sensory system agents|mesh-ancestor
65630741|NCT05060822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65630742|NCT05060822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630743|NCT05060822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65630744|NCT05060822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65630745|NCT05060822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65630746|NCT05060822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65630747|NCT05060822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630749|NCT05052931|Oxaliplatin|oxaliplatin|mesh-list
65630750|NCT05052931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65630751|NCT05052931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630752|NCT05052931|Tubulin Modulators|tubulin modulators|mesh-ancestor
65630753|NCT05052931|Antimitotic Agents|antimitotic agents|mesh-ancestor
65630754|NCT05052931|Mitosis Modulators|mitosis modulators|mesh-ancestor
65630755|NCT05052931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630756|NCT05052229|Nitric Oxide|nitric oxide|mesh-list
65630757|NCT05052229|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65630758|NCT05052229|Autonomic Agents|autonomic agents|mesh-ancestor
65630759|NCT05052229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65630760|NCT05052229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630761|NCT05052229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65630762|NCT05052229|Respiratory System Agents|respiratory system agents|mesh-ancestor
65630763|NCT05052229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65630764|NCT05052229|Antioxidants|antioxidants|mesh-ancestor
65630765|NCT05052229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630766|NCT05052229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65630767|NCT05052229|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65630768|NCT05052229|Vasodilator Agents|vasodilator agents|mesh-ancestor
65630769|NCT05052229|Gasotransmitters|gasotransmitters|mesh-ancestor
65630770|NCT05052229|Protective Agents|protective agents|mesh-ancestor
65630771|NCT05050097|Lenalidomide|lenalidomide|mesh-list
65630772|NCT05050097|Pomalidomide|pomalidomide|mesh-list
65630773|NCT05050097|Daratumumab|daratumumab|mesh-list
65630774|NCT05050097|Immunologic Factors|immunologic factors|mesh-ancestor
65630775|NCT05050097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630776|NCT05050097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65630777|NCT05050097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65630778|NCT05050097|Growth Substances|growth substances|mesh-ancestor
65630779|NCT05050097|Growth Inhibitors|growth inhibitors|mesh-ancestor
65630780|NCT05050097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630781|NCT05048212|Nivolumab|nivolumab|mesh-list
65630782|NCT05048212|Ipilimumab|ipilimumab|mesh-list
65630783|NCT05048212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65630784|NCT05048212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630785|NCT05048212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65630786|NCT05048212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630787|NCT05037500|Decitabine|decitabine|mesh-list
65630788|NCT05037500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65630789|NCT05037500|Antimetabolites|antimetabolites|mesh-ancestor
65630790|NCT05037500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630791|NCT05037500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630792|NCT05037500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630793|NCT05029921|Ustekinumab|ustekinumab|mesh-list
65630794|NCT05029921|Dermatologic Agents|dermatologic agents|mesh-ancestor
65630795|NCT05020769|Osimertinib|osimertinib|mesh-list
65630796|NCT05020769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630797|NCT05020769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65630798|NCT05020769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630799|NCT05020769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630800|NCT05007106|Gemcitabine|gemcitabine|mesh-list
65630801|NCT05007106|Docetaxel|docetaxel|mesh-list
65630802|NCT05007106|Bevacizumab|bevacizumab|mesh-list
65630803|NCT05007106|Carboplatin|carboplatin|mesh-list
65630804|NCT05007106|Pembrolizumab|pembrolizumab|mesh-list
65630805|NCT05007106|Fluorouracil|fluorouracil|mesh-list
65630806|NCT05007106|Capecitabine|capecitabine|mesh-list
65630807|NCT05007106|Oxaliplatin|oxaliplatin|mesh-list
65630808|NCT05007106|Lenvatinib|lenvatinib|mesh-list
65630809|NCT05007106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630810|NCT05007106|Tubulin Modulators|tubulin modulators|mesh-ancestor
65630811|NCT05007106|Antimitotic Agents|antimitotic agents|mesh-ancestor
65630812|NCT05007106|Mitosis Modulators|mitosis modulators|mesh-ancestor
65630813|NCT05007106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630814|NCT05007106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65630815|NCT05007106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65630816|NCT05007106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65630817|NCT05007106|Growth Substances|growth substances|mesh-ancestor
65630818|NCT05007106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630819|NCT05007106|Growth Inhibitors|growth inhibitors|mesh-ancestor
65428174|NCT01052259|Gusperimus|gusperimus|mesh-list
65630820|NCT05007106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65630821|NCT05007106|Antimetabolites|antimetabolites|mesh-ancestor
65630822|NCT05007106|Antiviral Agents|antiviral agents|mesh-ancestor
65630823|NCT05007106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65630824|NCT05007106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630825|NCT05007106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65630826|NCT05007106|Immunologic Factors|immunologic factors|mesh-ancestor
65630827|NCT05007106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65630828|NCT05006794|Gemcitabine|gemcitabine|mesh-list
65630829|NCT05006794|Docetaxel|docetaxel|mesh-list
65630830|NCT05006794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65630831|NCT05006794|Antimetabolites|antimetabolites|mesh-ancestor
65630832|NCT05006794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630833|NCT05006794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630834|NCT05006794|Antiviral Agents|antiviral agents|mesh-ancestor
65630835|NCT05006794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65630836|NCT05006794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630837|NCT05006794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65630838|NCT05006794|Immunologic Factors|immunologic factors|mesh-ancestor
65630839|NCT05006794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630840|NCT05006794|Tubulin Modulators|tubulin modulators|mesh-ancestor
65630841|NCT05006794|Antimitotic Agents|antimitotic agents|mesh-ancestor
65630842|NCT05006794|Mitosis Modulators|mitosis modulators|mesh-ancestor
65630843|NCT05002738|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65630844|NCT05002738|Desogestrel|desogestrel|mesh-list
65630845|NCT05002738|Estradiol|estradiol|mesh-list
65630846|NCT05002738|Estrogens|estrogens|mesh-ancestor
65630847|NCT05002738|Hormones|hormones|mesh-ancestor
65630848|NCT05002738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65630849|NCT05002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630850|NCT05002738|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65630851|NCT05002738|Contraceptive Agents|contraceptive agents|mesh-ancestor
65630852|NCT05002738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65630853|NCT05002738|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65630854|NCT05002738|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65630855|NCT05002738|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65630856|NCT05002738|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65630857|NCT05002738|Progestins|progestins|mesh-ancestor
65630858|NCT04990284|Levodopa|levodopa|mesh-list
65630859|NCT04990284|Opicapone|opicapone|mesh-list
65630860|NCT04990284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65630861|NCT04990284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65630862|NCT04990284|Dopamine Agents|dopamine agents|mesh-ancestor
65630863|NCT04990284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65630864|NCT04990284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630865|NCT04990284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630866|NCT04990284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65630867|NCT04990284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630868|NCT04955158|Dexmedetomidine|dexmedetomidine|mesh-list
65630869|NCT04955158|Ketamine|ketamine|mesh-list
65630870|NCT04955158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65630871|NCT04955158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65630872|NCT04955158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630873|NCT04955158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65630874|NCT04955158|Analgesics|analgesics|mesh-ancestor
65630875|NCT04955158|Sensory System Agents|sensory system agents|mesh-ancestor
65630876|NCT04955158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65630877|NCT04955158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65630878|NCT04955158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65630879|NCT04955158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65630880|NCT04955158|Adrenergic Agents|adrenergic agents|mesh-ancestor
65630881|NCT04955158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65630882|NCT04955158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630883|NCT04955158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65630884|NCT04955158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65630885|NCT04955158|Anesthetics, General|anesthetics, general|mesh-ancestor
65630886|NCT04955158|Anesthetics|anesthetics|mesh-ancestor
65630887|NCT04955158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65630888|NCT04955158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65630889|NCT04940039|Risperidone|risperidone|mesh-list
65630890|NCT04940039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65630891|NCT04940039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65630892|NCT04940039|Serotonin Agents|serotonin agents|mesh-ancestor
65630893|NCT04940039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65630894|NCT04940039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630895|NCT04940039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630896|NCT04940039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65630897|NCT04940039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65630898|NCT04940039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65630899|NCT04940039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65630900|NCT04940039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65630901|NCT04940039|Dopamine Agents|dopamine agents|mesh-ancestor
65630902|NCT04940039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65630903|NCT04940039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65630904|NCT04928391|Dexmedetomidine|dexmedetomidine|mesh-list
65630905|NCT04928391|Nalbuphine|nalbuphine|mesh-list
65630906|NCT04928391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65630907|NCT04928391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65630908|NCT04928391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630909|NCT04928391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65630910|NCT04928391|Analgesics|analgesics|mesh-ancestor
65630911|NCT04928391|Sensory System Agents|sensory system agents|mesh-ancestor
65630912|NCT04928391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65630913|NCT04928391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65630914|NCT04928391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65630915|NCT04928391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65630916|NCT04928391|Adrenergic Agents|adrenergic agents|mesh-ancestor
65630917|NCT04928391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65630918|NCT04928391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630919|NCT04928391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65630920|NCT04928391|Narcotics|narcotics|mesh-ancestor
65630921|NCT04928352|Bupivacaine|bupivacaine|mesh-list
65630922|NCT04928352|Anesthetics, Local|anesthetics, local|mesh-ancestor
65630923|NCT04928352|Anesthetics|anesthetics|mesh-ancestor
65630924|NCT04928352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65630925|NCT04928352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630926|NCT04928352|Sensory System Agents|sensory system agents|mesh-ancestor
65630927|NCT04928352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65630928|NCT04928300|Dexmedetomidine|dexmedetomidine|mesh-list
65630929|NCT04928300|Ketamine|ketamine|mesh-list
65630930|NCT04928300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65630931|NCT04928300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65630932|NCT04928300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630933|NCT04928300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65630934|NCT04928300|Analgesics|analgesics|mesh-ancestor
65630935|NCT04928300|Sensory System Agents|sensory system agents|mesh-ancestor
65630936|NCT04928300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65630937|NCT04928300|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65630938|NCT04928300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65630939|NCT04928300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65630940|NCT04928300|Adrenergic Agents|adrenergic agents|mesh-ancestor
65630941|NCT04928300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65630942|NCT04928300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630943|NCT04928300|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65630944|NCT04928300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65630945|NCT04928300|Anesthetics, General|anesthetics, general|mesh-ancestor
65630946|NCT04928300|Anesthetics|anesthetics|mesh-ancestor
65630947|NCT04928300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65630948|NCT04928300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65630949|NCT04920695|Nitric Oxide|nitric oxide|mesh-list
65630950|NCT04920695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65630951|NCT04920695|Autonomic Agents|autonomic agents|mesh-ancestor
65630952|NCT04920695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65630953|NCT04920695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630954|NCT04920695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65630955|NCT04920695|Respiratory System Agents|respiratory system agents|mesh-ancestor
65630956|NCT04920695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65630957|NCT04920695|Antioxidants|antioxidants|mesh-ancestor
65630958|NCT04920695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630959|NCT04920695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65630960|NCT04920695|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65630961|NCT04920695|Vasodilator Agents|vasodilator agents|mesh-ancestor
65630962|NCT04920695|Gasotransmitters|gasotransmitters|mesh-ancestor
65630963|NCT04920695|Protective Agents|protective agents|mesh-ancestor
65630964|NCT04915755|Niraparib|niraparib|mesh-list
65630965|NCT04915755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65630966|NCT04915755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65630967|NCT04915755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630968|NCT04915755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630969|NCT04910464|Tranexamic Acid|tranexamic acid|mesh-list
65630970|NCT04910464|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65630971|NCT04910464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65630972|NCT04910464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630973|NCT04910464|Hemostatics|hemostatics|mesh-ancestor
65630974|NCT04910464|Coagulants|coagulants|mesh-ancestor
65630975|NCT04905901|Tranexamic Acid|tranexamic acid|mesh-list
65630976|NCT04905901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65630977|NCT04905901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65630978|NCT04905901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630979|NCT04905901|Hemostatics|hemostatics|mesh-ancestor
65630980|NCT04905901|Coagulants|coagulants|mesh-ancestor
65630981|NCT04901988|Nivolumab|nivolumab|mesh-list
65630982|NCT04901988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65630983|NCT04901988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65630984|NCT04901988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65630985|NCT04901988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630986|NCT04899687|Dextromethorphan|dextromethorphan|mesh-list
65630987|NCT04899687|Fluoxetine|fluoxetine|mesh-list
65630988|NCT04899687|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65630989|NCT04899687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65630990|NCT04899687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65630991|NCT04899687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65630992|NCT04899687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65630993|NCT04899687|Serotonin Agents|serotonin agents|mesh-ancestor
65630994|NCT04899687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65630995|NCT04899687|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65630996|NCT04899687|Antidepressive Agents|antidepressive agents|mesh-ancestor
65630997|NCT04899687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65630998|NCT04899687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65630999|NCT04899687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65631000|NCT04899687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631001|NCT04899687|Antitussive Agents|antitussive agents|mesh-ancestor
65631002|NCT04899687|Respiratory System Agents|respiratory system agents|mesh-ancestor
65631003|NCT04899687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65631004|NCT04899687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65631005|NCT04882072|Ustekinumab|ustekinumab|mesh-list
65631006|NCT04882072|Dermatologic Agents|dermatologic agents|mesh-ancestor
65631007|NCT04865419|Voriconazole|voriconazole|mesh-list
65631008|NCT04865419|Antifungal Agents|antifungal agents|mesh-ancestor
65631009|NCT04865419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65631010|NCT04865419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65631011|NCT04865419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65631012|NCT04865419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631013|NCT04865419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631014|NCT04865419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65631015|NCT04865419|Hormone Antagonists|hormone antagonists|mesh-ancestor
65631016|NCT04865419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65631017|NCT04865419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631018|NCT04865419|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65631019|NCT04829318|Esketamine|esketamine|mesh-list
65631020|NCT04829318|Antidepressive Agents|antidepressive agents|mesh-ancestor
65631021|NCT04829318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65631022|NCT04823845|Adapalene|adapalene|mesh-list
65631023|NCT04823845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65631024|NCT04823845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65631025|NCT04823845|Analgesics|analgesics|mesh-ancestor
65631026|NCT04823845|Sensory System Agents|sensory system agents|mesh-ancestor
65631027|NCT04823845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65631028|NCT04823845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631029|NCT04823845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65631030|NCT04823845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65631031|NCT04823845|Dermatologic Agents|dermatologic agents|mesh-ancestor
65631032|NCT04792749|Metformin|metformin|mesh-list
65631033|NCT04792749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65631034|NCT04792749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631035|NCT04792190|Dapagliflozin|dapagliflozin|mesh-list
65631036|NCT04792190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65631037|NCT04792190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631038|NCT04792190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65631039|NCT04792190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631040|NCT04789070|Sirolimus|sirolimus|mesh-list
65631041|NCT04789070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65631042|NCT04789070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65428398|NCT02533011|Heparin|heparin|mesh-list
65631043|NCT04789070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65631044|NCT04789070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631046|NCT04789070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65631047|NCT04789070|Immunologic Factors|immunologic factors|mesh-ancestor
65631048|NCT04789070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631049|NCT04756427|Citric Acid|citric acid|mesh-list
65631050|NCT04756427|Sodium Citrate|sodium citrate|mesh-list
65631051|NCT04756427|Anticoagulants|anticoagulants|mesh-list
65631052|NCT04756427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65631053|NCT04756427|Chelating Agents|chelating agents|mesh-ancestor
65631054|NCT04756427|Sequestering Agents|sequestering agents|mesh-ancestor
65631055|NCT04756427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631056|NCT04733040|Felzartamab|felzartamab|mesh-list
65631057|NCT04733040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631058|NCT04733040|Immunologic Factors|immunologic factors|mesh-ancestor
65631059|NCT04733040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631060|NCT04722601|Azacitidine|azacitidine|mesh-list
65631061|NCT04722601|Venetoclax|venetoclax|mesh-list
65631062|NCT04722601|Obinutuzumab|obinutuzumab|mesh-list
65631063|NCT04722601|Cc-486|cc-486|mesh-list
65631064|NCT04722601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65631065|NCT04722601|Antimetabolites|antimetabolites|mesh-ancestor
65631066|NCT04722601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631067|NCT04722601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631068|NCT04722601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631069|NCT04722601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65631070|NCT04722146|Lenalidomide|lenalidomide|mesh-list
65631071|NCT04722146|Pomalidomide|pomalidomide|mesh-list
65631072|NCT04722146|Bortezomib|bortezomib|mesh-list
65631073|NCT04722146|Daratumumab|daratumumab|mesh-list
65631074|NCT04722146|Immunologic Factors|immunologic factors|mesh-ancestor
65631075|NCT04722146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631076|NCT04722146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65631077|NCT04722146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65631078|NCT04722146|Growth Substances|growth substances|mesh-ancestor
65631079|NCT04722146|Growth Inhibitors|growth inhibitors|mesh-ancestor
65631080|NCT04722146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631081|NCT04704934|Paclitaxel|paclitaxel|mesh-list
65631082|NCT04704934|Trastuzumab|trastuzumab|mesh-list
65631083|NCT04704934|Ramucirumab|ramucirumab|mesh-list
65631084|NCT04704934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65631085|NCT04704934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631086|NCT04704934|Tubulin Modulators|tubulin modulators|mesh-ancestor
65631087|NCT04704934|Antimitotic Agents|antimitotic agents|mesh-ancestor
65631088|NCT04704934|Mitosis Modulators|mitosis modulators|mesh-ancestor
65631089|NCT04704934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631090|NCT04704934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65631091|NCT04692844|Propranolol|propranolol|mesh-list
65631092|NCT04692844|Primidone|primidone|mesh-list
65631093|NCT04692844|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65631094|NCT04692844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65631095|NCT04692844|Adrenergic Agents|adrenergic agents|mesh-ancestor
65631096|NCT04692844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65631097|NCT04692844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631098|NCT04692844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631099|NCT04692844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65631100|NCT04692844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65631101|NCT04692844|Vasodilator Agents|vasodilator agents|mesh-ancestor
65631102|NCT04692844|Anticonvulsants|anticonvulsants|mesh-ancestor
65631103|NCT04692844|GABA Modulators|gaba modulators|mesh-ancestor
65631104|NCT04692844|GABA Agents|gaba agents|mesh-ancestor
65631105|NCT04692077|Tenofovir|tenofovir|mesh-list
65631106|NCT04692077|Emtricitabine|emtricitabine|mesh-list
65631107|NCT04692077|Cabotegravir|cabotegravir|mesh-list
65631108|NCT04692077|Antiviral Agents|antiviral agents|mesh-ancestor
65631109|NCT04692077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65631110|NCT04692077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65631111|NCT04692077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65631112|NCT04692077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631113|NCT04692077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631114|NCT04692077|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65631115|NCT04692077|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65631116|NCT04692077|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65428473|NCT01057875|Caffeine|caffeine|mesh-list
65631117|NCT04692077|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65631118|NCT04683029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65631119|NCT04683029|Immunologic Factors|immunologic factors|mesh-ancestor
65631120|NCT04683029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631121|NCT04676646|Spironolactone|spironolactone|mesh-list
65631122|NCT04676646|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65631123|NCT04676646|Hormone Antagonists|hormone antagonists|mesh-ancestor
65631124|NCT04676646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65631125|NCT04676646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631126|NCT04676646|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65631127|NCT04676646|Diuretics|diuretics|mesh-ancestor
65631128|NCT04676646|Natriuretic Agents|natriuretic agents|mesh-ancestor
65631129|NCT04674683|Nivolumab|nivolumab|mesh-list
65631130|NCT04674683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65631131|NCT04674683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631132|NCT04674683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65631133|NCT04674683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631134|NCT04673357|Ustekinumab|ustekinumab|mesh-list
65631135|NCT04673357|Dermatologic Agents|dermatologic agents|mesh-ancestor
65631136|NCT04658862|Gemcitabine|gemcitabine|mesh-list
65631137|NCT04658862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631138|NCT04658862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65631139|NCT04658862|Antimetabolites|antimetabolites|mesh-ancestor
65631140|NCT04658862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631141|NCT04658862|Antiviral Agents|antiviral agents|mesh-ancestor
65631142|NCT04658862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65631143|NCT04658862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631144|NCT04658862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65631145|NCT04658862|Immunologic Factors|immunologic factors|mesh-ancestor
65631146|NCT04658862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631147|NCT04657003|Tirzepatide|tirzepatide|mesh-list
65631148|NCT04657003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65631149|NCT04657003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631150|NCT04657003|Incretins|incretins|mesh-ancestor
65631151|NCT04657003|Hormones|hormones|mesh-ancestor
65631152|NCT04657003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65631153|NCT04640623|Gemcitabine|gemcitabine|mesh-list
65631154|NCT04640623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65631155|NCT04640623|Antimetabolites|antimetabolites|mesh-ancestor
65631156|NCT04640623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631157|NCT04640623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631158|NCT04640623|Antiviral Agents|antiviral agents|mesh-ancestor
65631159|NCT04640623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65631160|NCT04640623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631161|NCT04640623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65631162|NCT04640623|Immunologic Factors|immunologic factors|mesh-ancestor
65631163|NCT04640623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631164|NCT04630145|Clarithromycin|clarithromycin|mesh-list
65631165|NCT04630145|Rifampin|rifampin|mesh-list
65631166|NCT04630145|Ethambutol|ethambutol|mesh-list
65631167|NCT04630145|Rifabutin|rifabutin|mesh-list
65631168|NCT04630145|Bedaquiline|bedaquiline|mesh-list
65631169|NCT04630145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65631170|NCT04630145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65631171|NCT04630145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65631172|NCT04630145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631173|NCT04630145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631174|NCT04630145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65631175|NCT04630145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65631176|NCT04630145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65631177|NCT04630145|Antitubercular Agents|antitubercular agents|mesh-ancestor
65631178|NCT04630145|Leprostatic Agents|leprostatic agents|mesh-ancestor
65631179|NCT04630145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65631180|NCT04630145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65631181|NCT04630145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65631182|NCT04630145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65631183|NCT04630145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65631184|NCT04630145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65631185|NCT04630145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65631186|NCT04630028|Ustekinumab|ustekinumab|mesh-list
65631187|NCT04630028|Dermatologic Agents|dermatologic agents|mesh-ancestor
65631188|NCT04624906|Rituximab|rituximab|mesh-list
65631189|NCT04624906|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65631190|NCT04624906|Acalabrutinib|acalabrutinib|mesh-list
65631191|NCT04624906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65631192|NCT04624906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631193|NCT04624906|Immunologic Factors|immunologic factors|mesh-ancestor
65631194|NCT04624906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631195|NCT04624906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65631196|NCT04624906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65631197|NCT04624906|Alkylating Agents|alkylating agents|mesh-ancestor
65631198|NCT04624906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631199|NCT04622319|Trastuzumab|trastuzumab|mesh-list
65631200|NCT04622319|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65631201|NCT04622319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65631202|NCT04622319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631203|NCT04622319|Tubulin Modulators|tubulin modulators|mesh-ancestor
65631204|NCT04622319|Antimitotic Agents|antimitotic agents|mesh-ancestor
65631205|NCT04622319|Mitosis Modulators|mitosis modulators|mesh-ancestor
65631206|NCT04622319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631207|NCT04610320|Daratumumab|daratumumab|mesh-list
65631208|NCT04610320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631209|NCT04606381|Lazertinib|lazertinib|mesh-list
65631210|NCT04606381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65631211|NCT04606381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631212|NCT04606381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631213|NCT04599855|Esketamine|esketamine|mesh-list
65631214|NCT04599855|Antidepressive Agents|antidepressive agents|mesh-ancestor
65631215|NCT04599855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65631216|NCT04597125|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65631217|NCT04597125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631218|NCT04586426|Daratumumab|daratumumab|mesh-list
65631219|NCT04586426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631220|NCT04585789|Tenofovir|tenofovir|mesh-list
65631221|NCT04585789|Entecavir|entecavir|mesh-list
65631222|NCT04585789|JNJ-56136379|jnj-56136379|mesh-list
65631223|NCT04585789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65631224|NCT04585789|Antiviral Agents|antiviral agents|mesh-ancestor
65631225|NCT04585789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65631226|NCT04585789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65631227|NCT04585789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65631228|NCT04585789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631229|NCT04585789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267020|NCT00910455|SRX246|srx246|mesh-list
65631230|NCT04585789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65631231|NCT04585789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65631232|NCT04577833|Prednisone|prednisone|mesh-list
65631233|NCT04577833|Abiraterone Acetate|abiraterone acetate|mesh-list
65631234|NCT04577833|Niraparib|niraparib|mesh-list
65631235|NCT04577833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65631236|NCT04577833|Glucocorticoids|glucocorticoids|mesh-ancestor
65631237|NCT04577833|Hormones|hormones|mesh-ancestor
65631238|NCT04577833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65631239|NCT04577833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631240|NCT04577833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65631241|NCT04577833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631242|NCT04577833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65631243|NCT04577833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631244|NCT04577833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631245|NCT04577833|Hormone Antagonists|hormone antagonists|mesh-ancestor
65631246|NCT04577833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65631247|NCT04577833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65631248|NCT04565990|Selexipag|selexipag|mesh-list
65631249|NCT04565990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65631250|NCT04546399|Calcium, Dietary|calcium, dietary|mesh-list
65631251|NCT04546399|Leucovorin|leucovorin|mesh-list
65631252|NCT04546399|Folic Acid|folic acid|mesh-list
65631253|NCT04546399|Cytarabine|cytarabine|mesh-list
65631254|NCT04546399|Dexamethasone|dexamethasone|mesh-list
65631255|NCT04546399|Dexamethasone acetate|dexamethasone acetate|mesh-list
65631256|NCT04546399|Hydrocortisone|hydrocortisone|mesh-list
65631257|NCT04546399|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65631258|NCT04546399|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65631259|NCT04546399|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65631260|NCT04546399|Cyclophosphamide|cyclophosphamide|mesh-list
65631261|NCT04546399|Methotrexate|methotrexate|mesh-list
65631262|NCT04546399|Nivolumab|nivolumab|mesh-list
65631263|NCT04546399|Etoposide|etoposide|mesh-list
65631264|NCT04546399|Vincristine|vincristine|mesh-list
65631265|NCT04546399|Etoposide phosphate|etoposide phosphate|mesh-list
65631266|NCT04546399|Asparaginase|asparaginase|mesh-list
65631267|NCT04546399|Mercaptopurine|mercaptopurine|mesh-list
65428626|NCT00992381|Naproxen|naproxen|mesh-list
65631268|NCT04546399|Podophyllotoxin|podophyllotoxin|mesh-list
65631269|NCT04546399|Pegaspargase|pegaspargase|mesh-list
65631270|NCT04546399|Thioguanine|thioguanine|mesh-list
65631271|NCT04546399|Blinatumomab|blinatumomab|mesh-list
65631272|NCT04546399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65631273|NCT04546399|Muromonab-CD3|muromonab-cd3|mesh-list
65631274|NCT04546399|Antibodies|antibodies|mesh-list
65631275|NCT04546399|Immunoglobulins|immunoglobulins|mesh-list
65631276|NCT04546399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65631277|NCT04546399|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65631278|NCT04546399|BB 1101|bb 1101|mesh-list
65631279|NCT04546399|Calcium|calcium|mesh-list
65631280|NCT04546399|2-Aminopurine|2-aminopurine|mesh-list
65631281|NCT04546399|Levoleucovorin|levoleucovorin|mesh-list
65631282|NCT04546399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65631283|NCT04546399|Immunologic Factors|immunologic factors|mesh-ancestor
65631284|NCT04546399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631285|NCT04546399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65631286|NCT04546399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65631287|NCT04546399|Alkylating Agents|alkylating agents|mesh-ancestor
65631288|NCT04546399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631289|NCT04546399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631290|NCT04546399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65631291|NCT04546399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65631292|NCT04546399|Antiemetics|antiemetics|mesh-ancestor
65631293|NCT04546399|Autonomic Agents|autonomic agents|mesh-ancestor
65631294|NCT04546399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65631295|NCT04546399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65631296|NCT04546399|Glucocorticoids|glucocorticoids|mesh-ancestor
65631297|NCT04546399|Hormones|hormones|mesh-ancestor
65631298|NCT04546399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65631299|NCT04546399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65631300|NCT04546399|Protease Inhibitors|protease inhibitors|mesh-ancestor
65631301|NCT04546399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631302|NCT04546399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65631303|NCT04546399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65631304|NCT04546399|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65631305|NCT04546399|Abortifacient Agents|abortifacient agents|mesh-ancestor
65094003|NCT00493727|Antidotes|antidotes|mesh-ancestor
65631306|NCT04546399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65631307|NCT04546399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65631308|NCT04546399|Antimetabolites|antimetabolites|mesh-ancestor
65631309|NCT04546399|Dermatologic Agents|dermatologic agents|mesh-ancestor
65631310|NCT04546399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65631311|NCT04546399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65631312|NCT04546399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65631313|NCT04546399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65631314|NCT04546399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65631315|NCT04546399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65631316|NCT04546399|Antiviral Agents|antiviral agents|mesh-ancestor
65631317|NCT04546399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65631318|NCT04546399|Antidotes|antidotes|mesh-ancestor
65631319|NCT04546399|Protective Agents|protective agents|mesh-ancestor
65631320|NCT04546399|Vitamin B Complex|vitamin b complex|mesh-ancestor
65631321|NCT04546399|Vitamins|vitamins|mesh-ancestor
65631322|NCT04546399|Micronutrients|micronutrients|mesh-ancestor
65631323|NCT04546399|Tubulin Modulators|tubulin modulators|mesh-ancestor
65631324|NCT04546399|Antimitotic Agents|antimitotic agents|mesh-ancestor
65631325|NCT04546399|Mitosis Modulators|mitosis modulators|mesh-ancestor
65631326|NCT04546399|Hematinics|hematinics|mesh-ancestor
65631327|NCT04546399|Keratolytic Agents|keratolytic agents|mesh-ancestor
65631328|NCT04543383|Thrombin|thrombin|mesh-list
65631329|NCT04543383|Hemostatics|hemostatics|mesh-ancestor
65631330|NCT04543383|Coagulants|coagulants|mesh-ancestor
65631331|NCT04540120|Dapansutrile|dapansutrile|mesh-list
65631332|NCT04540120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65631333|NCT04538664|Carboplatin|carboplatin|mesh-list
65631334|NCT04538664|Pemetrexed|pemetrexed|mesh-list
65631335|NCT04538664|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
65631336|NCT04538664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631337|NCT04538664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631338|NCT04538664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631339|NCT04538664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65631340|NCT04538664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65631341|NCT04538664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65631342|NCT04535544|Tenofovir|tenofovir|mesh-list
65631343|NCT04535544|Entecavir|entecavir|mesh-list
65631344|NCT04535544|Antiviral Agents|antiviral agents|mesh-ancestor
65631345|NCT04535544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65631346|NCT04535544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65631347|NCT04535544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65631348|NCT04535544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428695|NCT00993707|Viscosupplements|viscosupplements|mesh-ancestor
65631349|NCT04535544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631351|NCT04535544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65631352|NCT04523207|Relugolix|relugolix|mesh-list
65631353|NCT04523207|Androgen Antagonists|androgen antagonists|mesh-ancestor
65631354|NCT04523207|Hormone Antagonists|hormone antagonists|mesh-ancestor
65631355|NCT04523207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65631356|NCT04523207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631357|NCT04513912|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65631358|NCT04513912|Antidepressive Agents|antidepressive agents|mesh-ancestor
65631359|NCT04513912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65631360|NCT04513912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65631361|NCT04513912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65631362|NCT04513912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65631363|NCT04513912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631364|NCT04497844|Prednisone|prednisone|mesh-list
65631365|NCT04497844|Abiraterone Acetate|abiraterone acetate|mesh-list
65631366|NCT04497844|Niraparib|niraparib|mesh-list
65631367|NCT04497844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65631368|NCT04497844|Glucocorticoids|glucocorticoids|mesh-ancestor
65631369|NCT04497844|Hormones|hormones|mesh-ancestor
65631370|NCT04497844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65631371|NCT04497844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631372|NCT04497844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65631373|NCT04497844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631374|NCT04497844|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65631375|NCT04497844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631376|NCT04497844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631377|NCT04497844|Hormone Antagonists|hormone antagonists|mesh-ancestor
65631378|NCT04497844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65631379|NCT04497844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65631380|NCT04487080|Osimertinib|osimertinib|mesh-list
65631381|NCT04487080|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
65631382|NCT04487080|Lazertinib|lazertinib|mesh-list
65631383|NCT04487080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631384|NCT04487080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65631385|NCT04487080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631386|NCT04487080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631387|NCT04487080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65631388|NCT04480086|Navitoclax|navitoclax|mesh-list
65631389|NCT04480086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631390|NCT04476446|Esketamine|esketamine|mesh-list
65631391|NCT04476446|Antidepressive Agents|antidepressive agents|mesh-ancestor
65631392|NCT04476446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65631393|NCT04476212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65631394|NCT04476212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65631395|NCT04458831|Dexamethasone|dexamethasone|mesh-list
65631396|NCT04458831|Pomalidomide|pomalidomide|mesh-list
65631397|NCT04458831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65631398|NCT04458831|Antiemetics|antiemetics|mesh-ancestor
65631399|NCT04458831|Autonomic Agents|autonomic agents|mesh-ancestor
65631400|NCT04458831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65631401|NCT04458831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631402|NCT04458831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65631403|NCT04458831|Glucocorticoids|glucocorticoids|mesh-ancestor
65631404|NCT04458831|Hormones|hormones|mesh-ancestor
65631405|NCT04458831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65631406|NCT04458831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65631407|NCT04458831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631408|NCT04458831|Immunologic Factors|immunologic factors|mesh-ancestor
65631409|NCT04458831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65631410|NCT04458831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65631411|NCT04458831|Growth Substances|growth substances|mesh-ancestor
65631412|NCT04458831|Growth Inhibitors|growth inhibitors|mesh-ancestor
65631413|NCT04441138|Durvalumab|durvalumab|mesh-list
65631414|NCT04441138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65631415|NCT04441138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631416|NCT04439539|Tenofovir|tenofovir|mesh-list
65631417|NCT04439539|JNJ-56136379|jnj-56136379|mesh-list
65631418|NCT04439539|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65631419|NCT04439539|Antiviral Agents|antiviral agents|mesh-ancestor
65631420|NCT04439539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65631421|NCT04439539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65631422|NCT04439539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65631423|NCT04439539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631424|NCT04439539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631425|NCT04439539|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65631426|NCT04439539|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65631428|NCT04435782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65631429|NCT04432688|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65631430|NCT04432688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65631431|NCT04432688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65631432|NCT04432688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65631433|NCT04432688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631434|NCT04432688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65631435|NCT04432688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65631436|NCT04432688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65267031|NCT00916721|Propranolol|propranolol|mesh-list
65631437|NCT04432688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65631438|NCT04432688|Adrenergic Agents|adrenergic agents|mesh-ancestor
65631439|NCT04432688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65631440|NCT04432688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631441|NCT04432688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65631442|NCT04432688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65631443|NCT04432688|Serotonin Agents|serotonin agents|mesh-ancestor
65631444|NCT04432688|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65631445|NCT04432688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65631446|NCT04432688|Dopamine Agents|dopamine agents|mesh-ancestor
65631447|NCT04432584|Eculizumab|eculizumab|mesh-list
65631448|NCT04432584|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65631449|NCT04432584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65631450|NCT04432584|Immunologic Factors|immunologic factors|mesh-ancestor
65631451|NCT04432584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631452|NCT04426825|Bevacizumab|bevacizumab|mesh-list
65631453|NCT04426825|Atezolizumab|atezolizumab|mesh-list
65631454|NCT04426825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65631455|NCT04426825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631456|NCT04426825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65631457|NCT04426825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65631458|NCT04426825|Growth Substances|growth substances|mesh-ancestor
65631459|NCT04426825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631460|NCT04426825|Growth Inhibitors|growth inhibitors|mesh-ancestor
65631461|NCT04418479|Aspirin|aspirin|mesh-list
65631462|NCT04418479|Clopidogrel|clopidogrel|mesh-list
65631463|NCT04418479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65631464|NCT04418479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65631465|NCT04418479|Analgesics|analgesics|mesh-ancestor
65631466|NCT04418479|Sensory System Agents|sensory system agents|mesh-ancestor
65631467|NCT04418479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65631468|NCT04418479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631469|NCT04418479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65631470|NCT04418479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65631471|NCT04418479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65631472|NCT04418479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65631473|NCT04418479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631474|NCT04418479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65631475|NCT04418479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65631476|NCT04418479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631477|NCT04418479|Antipyretics|antipyretics|mesh-ancestor
65631478|NCT04418479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65631479|NCT04418479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65631480|NCT04418479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65631481|NCT04418479|Purinergic Agents|purinergic agents|mesh-ancestor
65631482|NCT04418479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65631483|NCT04417998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65631484|NCT04417998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65631485|NCT04417998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631486|NCT04408508|Amoxicillin|amoxicillin|mesh-list
65631487|NCT04408508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65631488|NCT04408508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65631489|NCT04372108|Ustekinumab|ustekinumab|mesh-list
65631490|NCT04372108|Dermatologic Agents|dermatologic agents|mesh-ancestor
65631491|NCT04314375|Budesonide|budesonide|mesh-list
65631492|NCT04314375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65631493|NCT04314375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65631494|NCT04314375|Autonomic Agents|autonomic agents|mesh-ancestor
65631495|NCT04314375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65631496|NCT04314375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631497|NCT04314375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65631498|NCT04314375|Respiratory System Agents|respiratory system agents|mesh-ancestor
65631499|NCT04314375|Glucocorticoids|glucocorticoids|mesh-ancestor
65631501|NCT04314375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65631502|NCT04312659|Infliximab|infliximab|mesh-list
65631503|NCT04312659|Dermatologic Agents|dermatologic agents|mesh-ancestor
65631504|NCT04312659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65631505|NCT04312659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65631506|NCT04279847|INCB057643|incb057643|mesh-list
65631507|NCT04279847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631508|NCT04271475|Macitentan|macitentan|mesh-list
65631509|NCT04271475|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65631510|NCT04271475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65631511|NCT04271475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631512|NCT04271475|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65631513|NCT04262206|Atorvastatin|atorvastatin|mesh-list
65631514|NCT04262206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65631515|NCT04262206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65631516|NCT04262206|Antimetabolites|antimetabolites|mesh-ancestor
65631517|NCT04262206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631518|NCT04262206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65631519|NCT04262206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65631520|NCT04262206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631521|NCT04238819|Irinotecan|irinotecan|mesh-list
65631522|NCT04238819|Temozolomide|temozolomide|mesh-list
65631523|NCT04238819|Dinutuximab|dinutuximab|mesh-list
65631524|NCT04238819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65631525|NCT04238819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65631526|NCT04238819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631527|NCT04238819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631528|NCT04238819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631529|NCT04238819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65631530|NCT04238819|Alkylating Agents|alkylating agents|mesh-ancestor
65631531|NCT04227275|Cyclophosphamide|cyclophosphamide|mesh-list
65631532|NCT04227275|Fludarabine|fludarabine|mesh-list
65631533|NCT04227275|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65631534|NCT04227275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65631535|NCT04227275|Immunologic Factors|immunologic factors|mesh-ancestor
65631536|NCT04227275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631537|NCT04227275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65631538|NCT04227275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65631539|NCT04227275|Alkylating Agents|alkylating agents|mesh-ancestor
65631540|NCT04227275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631541|NCT04227275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631542|NCT04227275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65631543|NCT04181827|Dexamethasone|dexamethasone|mesh-list
65631544|NCT04181827|Bortezomib|bortezomib|mesh-list
65631545|NCT04181827|Daratumumab|daratumumab|mesh-list
65631546|NCT04181827|Pomalidomide|pomalidomide|mesh-list
65631547|NCT04181827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65631548|NCT04181827|Antiemetics|antiemetics|mesh-ancestor
65631549|NCT04181827|Autonomic Agents|autonomic agents|mesh-ancestor
65631550|NCT04181827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65631551|NCT04181827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631552|NCT04181827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65631553|NCT04181827|Glucocorticoids|glucocorticoids|mesh-ancestor
65631554|NCT04181827|Hormones|hormones|mesh-ancestor
65631555|NCT04181827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65631556|NCT04181827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65631557|NCT04181827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631558|NCT04181827|Immunologic Factors|immunologic factors|mesh-ancestor
65631559|NCT04181827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65631560|NCT04181827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65631561|NCT04181827|Growth Substances|growth substances|mesh-ancestor
65631562|NCT04181827|Growth Inhibitors|growth inhibitors|mesh-ancestor
65631563|NCT04181515|Hydrocortisone|hydrocortisone|mesh-list
65631564|NCT04181515|Yohimbine|yohimbine|mesh-list
65631565|NCT04181515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65631566|NCT04181515|Mydriatics|mydriatics|mesh-ancestor
65631567|NCT04181515|Autonomic Agents|autonomic agents|mesh-ancestor
65631568|NCT04181515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65631569|NCT04181515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631570|NCT04181515|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65631571|NCT04181515|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65631572|NCT04181515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65631573|NCT04181515|Adrenergic Agents|adrenergic agents|mesh-ancestor
65631574|NCT04181515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65631575|NCT04181515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631576|NCT04181515|Urological Agents|urological agents|mesh-ancestor
65631577|NCT04180969|Hydrocortisone|hydrocortisone|mesh-list
65631578|NCT04180969|Yohimbine|yohimbine|mesh-list
65631579|NCT04180969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65631580|NCT04180969|Mydriatics|mydriatics|mesh-ancestor
65631581|NCT04180969|Autonomic Agents|autonomic agents|mesh-ancestor
65631582|NCT04180969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65631583|NCT04180969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631584|NCT04180969|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65631585|NCT04180969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65631586|NCT04180969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65631587|NCT04180969|Adrenergic Agents|adrenergic agents|mesh-ancestor
65631588|NCT04180969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65631589|NCT04180969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631590|NCT04180969|Urological Agents|urological agents|mesh-ancestor
65631591|NCT04180215|Pembrolizumab|pembrolizumab|mesh-list
65631592|NCT04180215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65631593|NCT04180215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65631594|NCT04180215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631595|NCT04180215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631596|NCT04175600|Selexipag|selexipag|mesh-list
65631597|NCT04175600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65631598|NCT04175431|Prednisone|prednisone|mesh-list
65631599|NCT04175431|Abiraterone Acetate|abiraterone acetate|mesh-list
65631600|NCT04175431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65631601|NCT04175431|Glucocorticoids|glucocorticoids|mesh-ancestor
65631602|NCT04175431|Hormones|hormones|mesh-ancestor
65631603|NCT04175431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65631604|NCT04175431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631605|NCT04175431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65631606|NCT04175431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631607|NCT04175431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65631608|NCT04175431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631609|NCT04175431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631610|NCT04175431|Hormone Antagonists|hormone antagonists|mesh-ancestor
65631611|NCT04175431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65631612|NCT04172675|Gemcitabine|gemcitabine|mesh-list
65631613|NCT04172675|Mitomycins|mitomycins|mesh-list
65631614|NCT04172675|Mitomycin|mitomycin|mesh-list
65631615|NCT04172675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65631616|NCT04172675|Antimetabolites|antimetabolites|mesh-ancestor
65631617|NCT04172675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631618|NCT04172675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631619|NCT04172675|Antiviral Agents|antiviral agents|mesh-ancestor
65631620|NCT04172675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65631621|NCT04172675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631622|NCT04172675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65631623|NCT04172675|Immunologic Factors|immunologic factors|mesh-ancestor
65631624|NCT04172675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631625|NCT04172675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65631626|NCT04172675|Alkylating Agents|alkylating agents|mesh-ancestor
65631627|NCT04172675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65631628|NCT04166773|Tirzepatide|tirzepatide|mesh-list
65631629|NCT04166773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65631630|NCT04166773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631631|NCT04166773|Incretins|incretins|mesh-ancestor
65631632|NCT04166773|Hormones|hormones|mesh-ancestor
65631633|NCT04166773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65631634|NCT04145440|Felzartamab|felzartamab|mesh-list
65631635|NCT04145440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631636|NCT04145440|Immunologic Factors|immunologic factors|mesh-ancestor
65631637|NCT04145440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631638|NCT04133636|Dexamethasone|dexamethasone|mesh-list
65631639|NCT04133636|Lenalidomide|lenalidomide|mesh-list
65631640|NCT04133636|Bortezomib|bortezomib|mesh-list
65631641|NCT04133636|Daratumumab|daratumumab|mesh-list
65631642|NCT04133636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65631643|NCT04133636|Antiemetics|antiemetics|mesh-ancestor
65631644|NCT04133636|Autonomic Agents|autonomic agents|mesh-ancestor
65631645|NCT04133636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65631646|NCT04133636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631647|NCT04133636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65631648|NCT04133636|Glucocorticoids|glucocorticoids|mesh-ancestor
65631649|NCT04133636|Hormones|hormones|mesh-ancestor
65631650|NCT04133636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65631651|NCT04133636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65631652|NCT04133636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631653|NCT04133636|Immunologic Factors|immunologic factors|mesh-ancestor
65631654|NCT04133636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65631655|NCT04133636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65631656|NCT04133636|Growth Substances|growth substances|mesh-ancestor
65631657|NCT04133636|Growth Inhibitors|growth inhibitors|mesh-ancestor
65631658|NCT04126070|Docetaxel|docetaxel|mesh-list
65631659|NCT04126070|Nivolumab|nivolumab|mesh-list
65631660|NCT04126070|Leuprolide|leuprolide|mesh-list
65631661|NCT04126070|Goserelin|goserelin|mesh-list
65631662|NCT04126070|Androgens|androgens|mesh-list
65631663|NCT04126070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631664|NCT04126070|Tubulin Modulators|tubulin modulators|mesh-ancestor
65631665|NCT04126070|Antimitotic Agents|antimitotic agents|mesh-ancestor
65631666|NCT04126070|Mitosis Modulators|mitosis modulators|mesh-ancestor
65631667|NCT04126070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631668|NCT04126070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65631669|NCT04126070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65631670|NCT04126070|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65631671|NCT04126070|Fertility Agents|fertility agents|mesh-ancestor
65631672|NCT04126070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65631673|NCT04126070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631674|NCT04126070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65631675|NCT04126070|Hormones|hormones|mesh-ancestor
65631676|NCT04126070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65631677|NCT04123470|Atezolizumab|atezolizumab|mesh-list
65631678|NCT04123470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631679|NCT04121260|Daratumumab|daratumumab|mesh-list
65631680|NCT04121260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631681|NCT04108208|Androgens|androgens|mesh-list
65631682|NCT04108208|Hormones|hormones|mesh-ancestor
65631683|NCT04108208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65631684|NCT04108208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631685|NCT04108195|Daratumumab|daratumumab|mesh-list
65631686|NCT04108195|Pomalidomide|pomalidomide|mesh-list
65631687|NCT04108195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631688|NCT04108195|Immunologic Factors|immunologic factors|mesh-ancestor
65631689|NCT04108195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631690|NCT04108195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65631691|NCT04108195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65631692|NCT04108195|Growth Substances|growth substances|mesh-ancestor
65631693|NCT04108195|Growth Inhibitors|growth inhibitors|mesh-ancestor
65631694|NCT04091386|Factor VIII|factor viii|mesh-list
65631695|NCT04091386|Coagulants|coagulants|mesh-ancestor
65631696|NCT04083495|Cyclophosphamide|cyclophosphamide|mesh-list
65631697|NCT04083495|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65631698|NCT04083495|Fludarabine|fludarabine|mesh-list
65631699|NCT04083495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65631700|NCT04083495|Immunologic Factors|immunologic factors|mesh-ancestor
65631701|NCT04083495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631702|NCT04083495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65631703|NCT04083495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65631704|NCT04083495|Alkylating Agents|alkylating agents|mesh-ancestor
65631705|NCT04083495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631706|NCT04083495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631707|NCT04083495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65631708|NCT04082442|Evolocumab|evolocumab|mesh-list
65631709|NCT04082442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65631710|NCT04082442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65631711|NCT04082442|Antimetabolites|antimetabolites|mesh-ancestor
65631712|NCT04082442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631713|NCT04082442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65631714|NCT04080518|Dapagliflozin|dapagliflozin|mesh-list
65631715|NCT04080518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65631716|NCT04080518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631717|NCT04080518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65631718|NCT04080518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631719|NCT04071236|Avelumab|avelumab|mesh-list
65631720|NCT04071236|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65631721|NCT04071236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65631722|NCT04071236|Peposertib|peposertib|mesh-list
65631723|NCT04071236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65631724|NCT04071236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631725|NCT04071236|Immunologic Factors|immunologic factors|mesh-ancestor
65631726|NCT04071236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631727|NCT04071236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65631728|NCT04071236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631729|NCT04071236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631730|NCT04069052|Nitric Oxide|nitric oxide|mesh-list
65631731|NCT04069052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65631732|NCT04069052|Autonomic Agents|autonomic agents|mesh-ancestor
65631733|NCT04069052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65631734|NCT04069052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631735|NCT04069052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65631736|NCT04069052|Respiratory System Agents|respiratory system agents|mesh-ancestor
65631737|NCT04069052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65631738|NCT04069052|Antioxidants|antioxidants|mesh-ancestor
65631739|NCT04069052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631740|NCT04069052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65631741|NCT04069052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65631742|NCT04069052|Vasodilator Agents|vasodilator agents|mesh-ancestor
65631743|NCT04069052|Gasotransmitters|gasotransmitters|mesh-ancestor
65631744|NCT04069052|Protective Agents|protective agents|mesh-ancestor
65631745|NCT04060108|Methamphetamine|methamphetamine|mesh-list
65631746|NCT04060108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65631747|NCT04060108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631748|NCT04060108|Sympathomimetics|sympathomimetics|mesh-ancestor
65631749|NCT04060108|Autonomic Agents|autonomic agents|mesh-ancestor
65631750|NCT04060108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65631751|NCT04060108|Dopamine Agents|dopamine agents|mesh-ancestor
65631752|NCT04060108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65631753|NCT04060108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631754|NCT04060108|Adrenergic Agents|adrenergic agents|mesh-ancestor
65631755|NCT04060108|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65631756|NCT04060108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65631757|NCT04060108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65631758|NCT04060108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65631759|NCT04038515|Menthol|menthol|mesh-list
65631760|NCT04038515|Nicotine|nicotine|mesh-list
65631761|NCT04038515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65631762|NCT04038515|Autonomic Agents|autonomic agents|mesh-ancestor
65631763|NCT04038515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65631764|NCT04038515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631765|NCT04038515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65631766|NCT04038515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65631767|NCT04038515|Cholinergic Agents|cholinergic agents|mesh-ancestor
65631768|NCT04038515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65631769|NCT04038515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631770|NCT04038515|Antipruritics|antipruritics|mesh-ancestor
65631771|NCT04038515|Dermatologic Agents|dermatologic agents|mesh-ancestor
65631772|NCT04034095|Prednisolone|prednisolone|mesh-list
65631773|NCT04034095|Docetaxel|docetaxel|mesh-list
65631774|NCT04034095|Bicalutamide|bicalutamide|mesh-list
65631775|NCT04034095|Androgens|androgens|mesh-list
65631776|NCT04034095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631777|NCT04034095|Tubulin Modulators|tubulin modulators|mesh-ancestor
65631778|NCT04034095|Antimitotic Agents|antimitotic agents|mesh-ancestor
65631779|NCT04034095|Mitosis Modulators|mitosis modulators|mesh-ancestor
65631780|NCT04034095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631781|NCT04034095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65631782|NCT04034095|Glucocorticoids|glucocorticoids|mesh-ancestor
65631783|NCT04034095|Hormones|hormones|mesh-ancestor
65631784|NCT04034095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65631785|NCT04034095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631786|NCT04034095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65631787|NCT04034095|Androgen Antagonists|androgen antagonists|mesh-ancestor
65631788|NCT04034095|Hormone Antagonists|hormone antagonists|mesh-ancestor
65631789|NCT04026113|Linaclotide|linaclotide|mesh-list
65631790|NCT04026113|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65631791|NCT04026113|Enzyme Activators|enzyme activators|mesh-ancestor
65631792|NCT04026113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631793|NCT04026113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65631794|NCT04023526|Azacitidine|azacitidine|mesh-list
65631795|NCT04023526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65631796|NCT04023526|Antimetabolites|antimetabolites|mesh-ancestor
65631797|NCT04023526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631798|NCT04023526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631799|NCT04023526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631800|NCT04017598|Iron|iron|mesh-list
65631801|NCT04017598|Trace Elements|trace elements|mesh-ancestor
65631802|NCT04017598|Micronutrients|micronutrients|mesh-ancestor
65631803|NCT04017598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631804|NCT04014803|Aspirin|aspirin|mesh-list
65631805|NCT04014803|Clopidogrel|clopidogrel|mesh-list
65631806|NCT04014803|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65631807|NCT04014803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65631808|NCT04014803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65631809|NCT04014803|Analgesics|analgesics|mesh-ancestor
65631810|NCT04014803|Sensory System Agents|sensory system agents|mesh-ancestor
65631811|NCT04014803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65631812|NCT04014803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631813|NCT04014803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65631814|NCT04014803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65631815|NCT04014803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65631816|NCT04014803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65631817|NCT04014803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631818|NCT04014803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65631819|NCT04014803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65631820|NCT04014803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631821|NCT04014803|Antipyretics|antipyretics|mesh-ancestor
65631822|NCT04014803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65631823|NCT04014803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65631824|NCT04014803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65631825|NCT04014803|Purinergic Agents|purinergic agents|mesh-ancestor
65631826|NCT04014803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65631827|NCT03980184|Guanfacine|guanfacine|mesh-list
65631828|NCT03980184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65631829|NCT03980184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65631830|NCT03980184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65631831|NCT03980184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65631832|NCT03980184|Adrenergic Agents|adrenergic agents|mesh-ancestor
65631833|NCT03980184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65631834|NCT03980184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631835|NCT03980184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631836|NCT03945903|Golimumab|golimumab|mesh-list
65631837|NCT03945903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65631838|NCT03945903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65631839|NCT03945903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65631840|NCT03945903|Immunologic Factors|immunologic factors|mesh-ancestor
65631841|NCT03945903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631842|NCT03944876|Botulinum Toxins|botulinum toxins|mesh-list
65631843|NCT03944876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65631844|NCT03944876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65631845|NCT03944876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65631846|NCT03944876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65631847|NCT03944876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631848|NCT03944876|Cholinergic Agents|cholinergic agents|mesh-ancestor
65631849|NCT03944876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65631850|NCT03944876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631851|NCT03944876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65631852|NCT03944876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65631853|NCT03943589|Immunoglobulins|immunoglobulins|mesh-list
65631854|NCT03943589|Immunoglobulin G|immunoglobulin g|mesh-list
65631855|NCT03943589|Immunologic Factors|immunologic factors|mesh-ancestor
65631856|NCT03943589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631857|NCT03942211|Selexipag|selexipag|mesh-list
65631858|NCT03942211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65631859|NCT03937219|Nivolumab|nivolumab|mesh-list
65631860|NCT03937219|Ipilimumab|ipilimumab|mesh-list
65631861|NCT03937219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65631862|NCT03937219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631863|NCT03937219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65631864|NCT03937219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631865|NCT03934684|Dexamethasone|dexamethasone|mesh-list
65631866|NCT03934684|Dexamethasone acetate|dexamethasone acetate|mesh-list
65631867|NCT03934684|Lenalidomide|lenalidomide|mesh-list
65631868|NCT03934684|BB 1101|bb 1101|mesh-list
65631869|NCT03934684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65631870|NCT03934684|Antiemetics|antiemetics|mesh-ancestor
65631871|NCT03934684|Autonomic Agents|autonomic agents|mesh-ancestor
65631872|NCT03934684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65631873|NCT03934684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631874|NCT03934684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65631875|NCT03934684|Glucocorticoids|glucocorticoids|mesh-ancestor
65631876|NCT03934684|Hormones|hormones|mesh-ancestor
65631877|NCT03934684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65631878|NCT03934684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65631879|NCT03934684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631880|NCT03934684|Protease Inhibitors|protease inhibitors|mesh-ancestor
65631881|NCT03934684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631882|NCT03934684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631883|NCT03934684|Immunologic Factors|immunologic factors|mesh-ancestor
65631884|NCT03934684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65631885|NCT03934684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65631886|NCT03934684|Growth Substances|growth substances|mesh-ancestor
65631887|NCT03934684|Growth Inhibitors|growth inhibitors|mesh-ancestor
65631888|NCT03904693|Tadalafil|tadalafil|mesh-list
65631889|NCT03904693|Macitentan|macitentan|mesh-list
65631890|NCT03904693|Vasodilator Agents|vasodilator agents|mesh-ancestor
65631891|NCT03904693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65631892|NCT03904693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65631893|NCT03904693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631894|NCT03904693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631895|NCT03904693|Urological Agents|urological agents|mesh-ancestor
65631896|NCT03904693|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65631897|NCT03904693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65631898|NCT03904693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65631899|NCT03901963|Lenalidomide|lenalidomide|mesh-list
65631900|NCT03901963|Daratumumab|daratumumab|mesh-list
65631901|NCT03901963|Immunologic Factors|immunologic factors|mesh-ancestor
65631902|NCT03901963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631903|NCT03901963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65631904|NCT03901963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65631905|NCT03901963|Growth Substances|growth substances|mesh-ancestor
65631906|NCT03901963|Growth Inhibitors|growth inhibitors|mesh-ancestor
65631907|NCT03901963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631908|NCT03875235|Durvalumab|durvalumab|mesh-list
65631909|NCT03875235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65631910|NCT03875235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631911|NCT03873805|Vidarabine|vidarabine|mesh-list
65631912|NCT03873805|Cyclophosphamide|cyclophosphamide|mesh-list
65631913|NCT03873805|Fludarabine|fludarabine|mesh-list
65631914|NCT03873805|Fludarabine phosphate|fludarabine phosphate|mesh-list
65631915|NCT03873805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65631916|NCT03873805|Immunologic Factors|immunologic factors|mesh-ancestor
65631917|NCT03873805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631918|NCT03873805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65631919|NCT03873805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65631920|NCT03873805|Alkylating Agents|alkylating agents|mesh-ancestor
65631921|NCT03873805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631922|NCT03873805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631923|NCT03873805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65631924|NCT03873805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65631925|NCT03873805|Antimetabolites|antimetabolites|mesh-ancestor
65631926|NCT03873805|Antiviral Agents|antiviral agents|mesh-ancestor
65631927|NCT03873805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65631928|NCT03869268|Aspirin|aspirin|mesh-list
65631929|NCT03869268|Ticagrelor|ticagrelor|mesh-list
65631930|NCT03869268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65631931|NCT03869268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65631932|NCT03869268|Analgesics|analgesics|mesh-ancestor
65631933|NCT03869268|Sensory System Agents|sensory system agents|mesh-ancestor
65631934|NCT03869268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65631935|NCT03869268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631936|NCT03869268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65631937|NCT03869268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65631938|NCT03869268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65631939|NCT03869268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65631940|NCT03869268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631941|NCT03869268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65631942|NCT03869268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65631943|NCT03869268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65631944|NCT03869268|Antipyretics|antipyretics|mesh-ancestor
65631945|NCT03869268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65631946|NCT03869268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65631947|NCT03869268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65631948|NCT03869268|Purinergic Agents|purinergic agents|mesh-ancestor
65631949|NCT03869268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65631951|NCT03843463|Citalopram|citalopram|mesh-list
65631952|NCT03843463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65631953|NCT03843463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65631954|NCT03843463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65631955|NCT03843463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631956|NCT03843463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65631957|NCT03843463|Serotonin Agents|serotonin agents|mesh-ancestor
65631958|NCT03843463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631959|NCT03843463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65631960|NCT03843463|Antidepressive Agents|antidepressive agents|mesh-ancestor
65631961|NCT03843463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65631962|NCT03843463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65631963|NCT03843463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65631964|NCT03843463|Parasympatholytics|parasympatholytics|mesh-ancestor
65631965|NCT03843463|Autonomic Agents|autonomic agents|mesh-ancestor
65631966|NCT03843463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65631967|NCT03843463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65631968|NCT03843463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65631969|NCT03843463|Cholinergic Agents|cholinergic agents|mesh-ancestor
65631970|NCT03819049|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65631971|NCT03819049|Immunologic Factors|immunologic factors|mesh-ancestor
65631972|NCT03819049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631973|NCT03805932|Rituximab|rituximab|mesh-list
65631974|NCT03805932|Immunotoxin HA22|immunotoxin ha22|mesh-list
65631975|NCT03805932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65631976|NCT03805932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631977|NCT03805932|Immunologic Factors|immunologic factors|mesh-ancestor
65631978|NCT03805932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65631979|NCT03805932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65631980|NCT03782207|Atezolizumab|atezolizumab|mesh-list
65631981|NCT03782207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631982|NCT03775486|Gemcitabine|gemcitabine|mesh-list
65631983|NCT03775486|Paclitaxel|paclitaxel|mesh-list
65631984|NCT03775486|Cisplatin|cisplatin|mesh-list
65631985|NCT03775486|Carboplatin|carboplatin|mesh-list
65631986|NCT03775486|Pemetrexed|pemetrexed|mesh-list
65631987|NCT03775486|Durvalumab|durvalumab|mesh-list
65631988|NCT03775486|Olaparib|olaparib|mesh-list
65631989|NCT03775486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65631990|NCT03775486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65631991|NCT03775486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65631992|NCT03775486|Tubulin Modulators|tubulin modulators|mesh-ancestor
65631993|NCT03775486|Antimitotic Agents|antimitotic agents|mesh-ancestor
65631994|NCT03775486|Mitosis Modulators|mitosis modulators|mesh-ancestor
65631995|NCT03775486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65631996|NCT03775486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65631997|NCT03775486|Antimetabolites|antimetabolites|mesh-ancestor
65631998|NCT03775486|Antiviral Agents|antiviral agents|mesh-ancestor
65631999|NCT03775486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65632000|NCT03775486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632001|NCT03775486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65632002|NCT03775486|Immunologic Factors|immunologic factors|mesh-ancestor
65632003|NCT03775486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632004|NCT03775486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65632005|NCT03775486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65632006|NCT03775486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65632007|NCT03775486|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65632008|NCT03772717|Immunoglobulins|immunoglobulins|mesh-list
65632009|NCT03772717|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65632010|NCT03772717|gamma-Globulins|gamma-globulins|mesh-list
65632011|NCT03772717|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65632012|NCT03772717|Immunologic Factors|immunologic factors|mesh-ancestor
65632013|NCT03772717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632014|NCT03767244|Androgens|androgens|mesh-list
65632015|NCT03767244|Hormones|hormones|mesh-ancestor
65632016|NCT03767244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65632017|NCT03767244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632018|NCT03755791|Sorafenib|sorafenib|mesh-list
65632019|NCT03755791|Atezolizumab|atezolizumab|mesh-list
65632020|NCT03755791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632021|NCT03755791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65632022|NCT03755791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429374|NCT01006187|Lidocaine|lidocaine|mesh-list
65632023|NCT03755791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632024|NCT03729349|Golimumab|golimumab|mesh-list
65632025|NCT03729349|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65632026|NCT03729349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65632027|NCT03729349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65632028|NCT03729349|Immunologic Factors|immunologic factors|mesh-ancestor
65632029|NCT03729349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632030|NCT03706365|Prednisone|prednisone|mesh-list
65632031|NCT03706365|Abiraterone Acetate|abiraterone acetate|mesh-list
65632032|NCT03706365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65632033|NCT03706365|Glucocorticoids|glucocorticoids|mesh-ancestor
65632034|NCT03706365|Hormones|hormones|mesh-ancestor
65632035|NCT03706365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65632036|NCT03706365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632037|NCT03706365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65632038|NCT03706365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632039|NCT03706365|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65632040|NCT03706365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632041|NCT03706365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632042|NCT03706365|Hormone Antagonists|hormone antagonists|mesh-ancestor
65632043|NCT03706365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65632044|NCT03660930|Sirolimus|sirolimus|mesh-list
65632045|NCT03660930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65632046|NCT03660930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65632047|NCT03660930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65632048|NCT03660930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632049|NCT03660930|Antifungal Agents|antifungal agents|mesh-ancestor
65632050|NCT03660930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65632051|NCT03660930|Immunologic Factors|immunologic factors|mesh-ancestor
65632052|NCT03660930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632053|NCT03652064|Dexamethasone|dexamethasone|mesh-list
65632054|NCT03652064|Lenalidomide|lenalidomide|mesh-list
65632055|NCT03652064|Bortezomib|bortezomib|mesh-list
65632056|NCT03652064|Daratumumab|daratumumab|mesh-list
65632057|NCT03652064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65632058|NCT03652064|Antiemetics|antiemetics|mesh-ancestor
65632059|NCT03652064|Autonomic Agents|autonomic agents|mesh-ancestor
65632060|NCT03652064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65632061|NCT03652064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632062|NCT03652064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65632063|NCT03652064|Glucocorticoids|glucocorticoids|mesh-ancestor
65632064|NCT03652064|Hormones|hormones|mesh-ancestor
65632065|NCT03652064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65632066|NCT03652064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65632067|NCT03652064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632068|NCT03652064|Immunologic Factors|immunologic factors|mesh-ancestor
65632069|NCT03652064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65632070|NCT03652064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65632071|NCT03652064|Growth Substances|growth substances|mesh-ancestor
65632072|NCT03652064|Growth Inhibitors|growth inhibitors|mesh-ancestor
65632073|NCT03643796|Dexmedetomidine|dexmedetomidine|mesh-list
65632074|NCT03643796|Ketamine|ketamine|mesh-list
65632075|NCT03643796|Remifentanil|remifentanil|mesh-list
65632076|NCT03643796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65632077|NCT03643796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65632078|NCT03643796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632079|NCT03643796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65632080|NCT03643796|Analgesics|analgesics|mesh-ancestor
65632081|NCT03643796|Sensory System Agents|sensory system agents|mesh-ancestor
65632082|NCT03643796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65632083|NCT03643796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65632084|NCT03643796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65632085|NCT03643796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65632086|NCT03643796|Adrenergic Agents|adrenergic agents|mesh-ancestor
65632087|NCT03643796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65632088|NCT03643796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632089|NCT03643796|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65632090|NCT03643796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65632091|NCT03643796|Anesthetics, General|anesthetics, general|mesh-ancestor
65632092|NCT03643796|Anesthetics|anesthetics|mesh-ancestor
65632093|NCT03643796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65632094|NCT03643796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65632095|NCT03643796|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65632096|NCT03643796|Narcotics|narcotics|mesh-ancestor
65632097|NCT03623854|Nivolumab|nivolumab|mesh-list
65632098|NCT03623854|Immunoglobulins|immunoglobulins|mesh-list
65632099|NCT03623854|Immunoglobulin G|immunoglobulin g|mesh-list
65632100|NCT03623854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65632101|NCT03623854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632102|NCT03623854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65632103|NCT03623854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632105|NCT03623854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632106|NCT03606499|Ustekinumab|ustekinumab|mesh-list
65632107|NCT03606499|Dermatologic Agents|dermatologic agents|mesh-ancestor
65632108|NCT03596645|Golimumab|golimumab|mesh-list
65632109|NCT03596645|Infliximab|infliximab|mesh-list
65632110|NCT03596645|Dermatologic Agents|dermatologic agents|mesh-ancestor
65632111|NCT03596645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65632112|NCT03596645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65632113|NCT03596645|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65632114|NCT03596645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65632115|NCT03596645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65632116|NCT03596645|Immunologic Factors|immunologic factors|mesh-ancestor
65632117|NCT03596645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632118|NCT03584334|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65632119|NCT03584334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65632120|NCT03584334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632121|NCT03573310|JNJ-64619178|jnj-64619178|mesh-list
65632122|NCT03573310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632123|NCT03573310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632124|NCT03530215|Antineoplastic Agents|antineoplastic agents|mesh-list
65632125|NCT03475277|Ketamine|ketamine|mesh-list
65632126|NCT03475277|Analgesics|analgesics|mesh-ancestor
65632127|NCT03475277|Sensory System Agents|sensory system agents|mesh-ancestor
65632128|NCT03475277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65632129|NCT03475277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632130|NCT03475277|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65632131|NCT03475277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65632132|NCT03475277|Anesthetics, General|anesthetics, general|mesh-ancestor
65632133|NCT03475277|Anesthetics|anesthetics|mesh-ancestor
65632134|NCT03475277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65632135|NCT03475277|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65632136|NCT03475277|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65632137|NCT03475277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65632138|NCT03475277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632139|NCT03473743|Carboplatin|carboplatin|mesh-list
65632140|NCT03473743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632141|NCT03472274|Durvalumab|durvalumab|mesh-list
65632142|NCT03472274|Tremelimumab|tremelimumab|mesh-list
65632143|NCT03472274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632144|NCT03472274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65632145|NCT03466411|Ustekinumab|ustekinumab|mesh-list
65632146|NCT03466411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65632147|NCT03466411|Dermatologic Agents|dermatologic agents|mesh-ancestor
65632148|NCT03466411|Immunologic Factors|immunologic factors|mesh-ancestor
65632149|NCT03466411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632150|NCT03451851|Etanercept|etanercept|mesh-list
65632151|NCT03451851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65632152|NCT03451851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65632153|NCT03451851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65632154|NCT03451851|Analgesics|analgesics|mesh-ancestor
65632155|NCT03451851|Sensory System Agents|sensory system agents|mesh-ancestor
65632156|NCT03451851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65632157|NCT03451851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632158|NCT03451851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65632159|NCT03451851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65632160|NCT03451851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65632161|NCT03451851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65632162|NCT03451851|Immunologic Factors|immunologic factors|mesh-ancestor
65632163|NCT03436433|Lacosamide|lacosamide|mesh-list
65632164|NCT03436433|Levetiracetam|levetiracetam|mesh-list
65632165|NCT03436433|Anticonvulsants|anticonvulsants|mesh-ancestor
65632166|NCT03436433|Nootropic Agents|nootropic agents|mesh-ancestor
65632167|NCT03436433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65632168|NCT03436433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65632169|NCT03436433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65632170|NCT03436433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632171|NCT03431350|Prednisone|prednisone|mesh-list
65632172|NCT03431350|Abiraterone Acetate|abiraterone acetate|mesh-list
65632173|NCT03431350|Niraparib|niraparib|mesh-list
65632174|NCT03431350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65632175|NCT03431350|Glucocorticoids|glucocorticoids|mesh-ancestor
65632176|NCT03431350|Hormones|hormones|mesh-ancestor
65632177|NCT03431350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65632178|NCT03431350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632179|NCT03431350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65632180|NCT03431350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632181|NCT03431350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65632182|NCT03431350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632183|NCT03431350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632184|NCT03431350|Hormone Antagonists|hormone antagonists|mesh-ancestor
65632185|NCT03431350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65632186|NCT03431350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65632187|NCT03415854|Gemcitabine|gemcitabine|mesh-list
65632188|NCT03415854|Paclitaxel|paclitaxel|mesh-list
65632189|NCT03415854|Cisplatin|cisplatin|mesh-list
65632190|NCT03415854|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65632191|NCT03415854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65632192|NCT03415854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632193|NCT03415854|Tubulin Modulators|tubulin modulators|mesh-ancestor
65632194|NCT03415854|Antimitotic Agents|antimitotic agents|mesh-ancestor
65632195|NCT03415854|Mitosis Modulators|mitosis modulators|mesh-ancestor
65632196|NCT03415854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632197|NCT03415854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65632198|NCT03415854|Antimetabolites|antimetabolites|mesh-ancestor
65632199|NCT03415854|Antiviral Agents|antiviral agents|mesh-ancestor
65632200|NCT03415854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65632201|NCT03415854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632202|NCT03415854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65632203|NCT03415854|Immunologic Factors|immunologic factors|mesh-ancestor
65632204|NCT03415854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632205|NCT03412565|Dexamethasone|dexamethasone|mesh-list
65632206|NCT03412565|Prednisone|prednisone|mesh-list
65632207|NCT03412565|Lenalidomide|lenalidomide|mesh-list
65632208|NCT03412565|Bortezomib|bortezomib|mesh-list
65632209|NCT03412565|Melphalan|melphalan|mesh-list
65632210|NCT03412565|Daratumumab|daratumumab|mesh-list
65632211|NCT03412565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65632212|NCT03412565|Antiemetics|antiemetics|mesh-ancestor
65632213|NCT03412565|Autonomic Agents|autonomic agents|mesh-ancestor
65632214|NCT03412565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65632215|NCT03412565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632216|NCT03412565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65632217|NCT03412565|Glucocorticoids|glucocorticoids|mesh-ancestor
65632218|NCT03412565|Hormones|hormones|mesh-ancestor
65632219|NCT03412565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65632220|NCT03412565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65632221|NCT03412565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632222|NCT03412565|Immunologic Factors|immunologic factors|mesh-ancestor
65632223|NCT03412565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65632224|NCT03412565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65632225|NCT03412565|Growth Substances|growth substances|mesh-ancestor
65632226|NCT03412565|Growth Inhibitors|growth inhibitors|mesh-ancestor
65632227|NCT03412565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65632228|NCT03412565|Alkylating Agents|alkylating agents|mesh-ancestor
65632229|NCT03412565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632230|NCT03412565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65632231|NCT03412565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65632232|NCT03405090|Fentanyl|fentanyl|mesh-list
65632233|NCT03405090|Bronchodilator Agents|bronchodilator agents|mesh-list
65632234|NCT03405090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65632235|NCT03405090|Narcotics|narcotics|mesh-ancestor
65632236|NCT03405090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65632237|NCT03405090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632238|NCT03405090|Analgesics|analgesics|mesh-ancestor
65632239|NCT03405090|Sensory System Agents|sensory system agents|mesh-ancestor
65632240|NCT03405090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65632241|NCT03405090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65632242|NCT03405090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65632243|NCT03405090|Anesthetics, General|anesthetics, general|mesh-ancestor
65632244|NCT03405090|Anesthetics|anesthetics|mesh-ancestor
65632245|NCT03405090|Autonomic Agents|autonomic agents|mesh-ancestor
65632246|NCT03405090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65632247|NCT03405090|Respiratory System Agents|respiratory system agents|mesh-ancestor
65632248|NCT03384641|Bedaquiline|bedaquiline|mesh-list
65632249|NCT03384641|Antitubercular Agents|antitubercular agents|mesh-ancestor
65632250|NCT03384641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65632251|NCT03384641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65429601|NCT01003613|Tranilast|tranilast|mesh-list
65632252|NCT03334617|Trastuzumab|trastuzumab|mesh-list
65632253|NCT03334617|Durvalumab|durvalumab|mesh-list
65632254|NCT03334617|Olaparib|olaparib|mesh-list
65632255|NCT03334617|Cediranib|cediranib|mesh-list
65632256|NCT03334617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65632257|NCT03334617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632258|NCT03334617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65632259|NCT03334617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632260|NCT03334617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632261|NCT03334617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65632262|NCT03301220|Daratumumab|daratumumab|mesh-list
65632263|NCT03301220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632264|NCT03284307|Midazolam|midazolam|mesh-list
65632265|NCT03284307|Dexmedetomidine|dexmedetomidine|mesh-list
65632266|NCT03284307|Ketamine|ketamine|mesh-list
65632267|NCT03284307|Propofol|propofol|mesh-list
65632268|NCT03284307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65632269|NCT03284307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65632270|NCT03284307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632271|NCT03284307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65632272|NCT03284307|Anesthetics, General|anesthetics, general|mesh-ancestor
65632273|NCT03284307|Anesthetics|anesthetics|mesh-ancestor
65632274|NCT03284307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65632275|NCT03284307|Analgesics|analgesics|mesh-ancestor
65632276|NCT03284307|Sensory System Agents|sensory system agents|mesh-ancestor
65632277|NCT03284307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65632278|NCT03284307|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65632279|NCT03284307|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65632280|NCT03284307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65632281|NCT03284307|Adrenergic Agents|adrenergic agents|mesh-ancestor
65632282|NCT03284307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65632283|NCT03284307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632284|NCT03284307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65632285|NCT03284307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65632286|NCT03284307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65632287|NCT03284307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65632288|NCT03284307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65632289|NCT03284307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65632290|NCT03284307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65632291|NCT03284307|GABA Modulators|gaba modulators|mesh-ancestor
65632292|NCT03284307|GABA Agents|gaba agents|mesh-ancestor
65632293|NCT03281369|Leucovorin|leucovorin|mesh-list
65632294|NCT03281369|Linagliptin|linagliptin|mesh-list
65632295|NCT03281369|Paclitaxel|paclitaxel|mesh-list
65632296|NCT03281369|Fluorouracil|fluorouracil|mesh-list
65632297|NCT03281369|Oxaliplatin|oxaliplatin|mesh-list
65632298|NCT03281369|Atezolizumab|atezolizumab|mesh-list
65632299|NCT03281369|Ramucirumab|ramucirumab|mesh-list
65632300|NCT03281369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65632301|NCT03281369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65632302|NCT03281369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632303|NCT03281369|Tubulin Modulators|tubulin modulators|mesh-ancestor
65632304|NCT03281369|Antimitotic Agents|antimitotic agents|mesh-ancestor
65632305|NCT03281369|Mitosis Modulators|mitosis modulators|mesh-ancestor
65632306|NCT03281369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632307|NCT03281369|Antimetabolites|antimetabolites|mesh-ancestor
65632308|NCT03281369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65632309|NCT03281369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65267070|NCT00646815|Hormones|hormones|mesh-list
65632310|NCT03281369|Immunologic Factors|immunologic factors|mesh-ancestor
65632311|NCT03281369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632312|NCT03281369|Antidotes|antidotes|mesh-ancestor
65632313|NCT03281369|Protective Agents|protective agents|mesh-ancestor
65632314|NCT03281369|Vitamin B Complex|vitamin b complex|mesh-ancestor
65632315|NCT03281369|Vitamins|vitamins|mesh-ancestor
65632316|NCT03281369|Micronutrients|micronutrients|mesh-ancestor
65632317|NCT03281369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65632318|NCT03281369|Incretins|incretins|mesh-ancestor
65632319|NCT03281369|Hormones|hormones|mesh-ancestor
65632320|NCT03281369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65632321|NCT03281369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65632322|NCT03281369|Protease Inhibitors|protease inhibitors|mesh-ancestor
65632323|NCT03281369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632324|NCT03279289|Leucovorin|leucovorin|mesh-list
65632325|NCT03279289|Folic Acid|folic acid|mesh-list
65429682|NCT05538767|Emodepside|emodepside|mesh-list
65632326|NCT03279289|Fluorouracil|fluorouracil|mesh-list
65632327|NCT03279289|Irinotecan|irinotecan|mesh-list
65632328|NCT03279289|Aflibercept|aflibercept|mesh-list
65632329|NCT03279289|Levoleucovorin|levoleucovorin|mesh-list
65632330|NCT03279289|Antimetabolites|antimetabolites|mesh-ancestor
65632331|NCT03279289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632332|NCT03279289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65632333|NCT03279289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632334|NCT03279289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65632335|NCT03279289|Immunologic Factors|immunologic factors|mesh-ancestor
65632336|NCT03279289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632337|NCT03279289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65632338|NCT03279289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65632339|NCT03279289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632340|NCT03279289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65632341|NCT03279289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65632342|NCT03279289|Growth Substances|growth substances|mesh-ancestor
65632343|NCT03279289|Growth Inhibitors|growth inhibitors|mesh-ancestor
65632344|NCT03279289|Antidotes|antidotes|mesh-ancestor
65632345|NCT03279289|Protective Agents|protective agents|mesh-ancestor
65632346|NCT03279289|Vitamin B Complex|vitamin b complex|mesh-ancestor
65632347|NCT03279289|Vitamins|vitamins|mesh-ancestor
65632348|NCT03279289|Micronutrients|micronutrients|mesh-ancestor
65632349|NCT03279289|Hematinics|hematinics|mesh-ancestor
65632350|NCT03255174|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65632351|NCT03255174|Hemostatics|hemostatics|mesh-ancestor
65632352|NCT03255174|Coagulants|coagulants|mesh-ancestor
65632353|NCT03234972|Dexamethasone|dexamethasone|mesh-list
65632354|NCT03234972|Bortezomib|bortezomib|mesh-list
65632355|NCT03234972|Daratumumab|daratumumab|mesh-list
65632356|NCT03234972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65632357|NCT03234972|Antiemetics|antiemetics|mesh-ancestor
65632358|NCT03234972|Autonomic Agents|autonomic agents|mesh-ancestor
65632359|NCT03234972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65632360|NCT03234972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632361|NCT03234972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65632362|NCT03234972|Glucocorticoids|glucocorticoids|mesh-ancestor
65632363|NCT03234972|Hormones|hormones|mesh-ancestor
65632364|NCT03234972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65632365|NCT03234972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65632366|NCT03234972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632367|NCT03232073|Ponesimod|ponesimod|mesh-list
65632368|NCT03232073|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65632369|NCT03232073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632370|NCT03232073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65632371|NCT03232073|Immunologic Factors|immunologic factors|mesh-ancestor
65632372|NCT03232073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632373|NCT03218488|Ustekinumab|ustekinumab|mesh-list
65632374|NCT03218488|Dermatologic Agents|dermatologic agents|mesh-ancestor
65632375|NCT03207867|Spartalizumab|spartalizumab|mesh-list
65632376|NCT03207867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65632377|NCT03207867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632378|NCT03207867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632379|NCT03207529|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
65632380|NCT03207529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632381|NCT03207529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632382|NCT03201965|Dexamethasone|dexamethasone|mesh-list
65632383|NCT03201965|Cyclophosphamide|cyclophosphamide|mesh-list
65632384|NCT03201965|Bortezomib|bortezomib|mesh-list
65632385|NCT03201965|Daratumumab|daratumumab|mesh-list
65632386|NCT03201965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65632387|NCT03201965|Immunologic Factors|immunologic factors|mesh-ancestor
65632388|NCT03201965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632389|NCT03201965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65632390|NCT03201965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65632391|NCT03201965|Alkylating Agents|alkylating agents|mesh-ancestor
65632392|NCT03201965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632393|NCT03201965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632394|NCT03201965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65632395|NCT03201965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65632396|NCT03201965|Antiemetics|antiemetics|mesh-ancestor
65632397|NCT03201965|Autonomic Agents|autonomic agents|mesh-ancestor
65632398|NCT03201965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65632399|NCT03201965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65632400|NCT03201965|Glucocorticoids|glucocorticoids|mesh-ancestor
65632401|NCT03201965|Hormones|hormones|mesh-ancestor
65632402|NCT03201965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65632403|NCT03201965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65429743|NCT05405387|Glucocorticoids|glucocorticoids|mesh-ancestor
65632404|NCT03201939|Lisinopril|lisinopril|mesh-list
65632405|NCT03201939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65632407|NCT03201939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632408|NCT03201939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632409|NCT03201939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65632410|NCT03201939|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65632411|NCT03201939|Protective Agents|protective agents|mesh-ancestor
65632412|NCT03201939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632413|NCT03186456|Aspirin|aspirin|mesh-list
65632414|NCT03186456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65632415|NCT03186456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65632416|NCT03186456|Analgesics|analgesics|mesh-ancestor
65632417|NCT03186456|Sensory System Agents|sensory system agents|mesh-ancestor
65632418|NCT03186456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65632419|NCT03186456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632420|NCT03186456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65632421|NCT03186456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65632422|NCT03186456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65632423|NCT03186456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65632424|NCT03186456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632425|NCT03186456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65632426|NCT03186456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65632427|NCT03186456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632428|NCT03186456|Antipyretics|antipyretics|mesh-ancestor
65632429|NCT03184935|Decitabine|decitabine|mesh-list
65632430|NCT03184935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65632431|NCT03184935|Antimetabolites|antimetabolites|mesh-ancestor
65632432|NCT03184935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632433|NCT03184935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632434|NCT03184935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632435|NCT03176498|Aspirin|aspirin|mesh-list
65632436|NCT03176498|Atorvastatin|atorvastatin|mesh-list
65632437|NCT03176498|Calcium|calcium|mesh-list
65632438|NCT03176498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65632439|NCT03176498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632440|NCT03176498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65632441|NCT03176498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65632442|NCT03176498|Analgesics|analgesics|mesh-ancestor
65632443|NCT03176498|Sensory System Agents|sensory system agents|mesh-ancestor
65632444|NCT03176498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65632445|NCT03176498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65632446|NCT03176498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65632447|NCT03176498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65632448|NCT03176498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65632449|NCT03176498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632450|NCT03176498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65632451|NCT03176498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65632452|NCT03176498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632453|NCT03176498|Antipyretics|antipyretics|mesh-ancestor
65632454|NCT03176498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65632455|NCT03176498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65632456|NCT03176498|Antimetabolites|antimetabolites|mesh-ancestor
65632457|NCT03176498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65632458|NCT03176498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65632459|NCT03170960|Atezolizumab|atezolizumab|mesh-list
65632460|NCT03170960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632461|NCT03170518|Canagliflozin|canagliflozin|mesh-list
65632462|NCT03170518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65632463|NCT03170518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632464|NCT03170518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65632465|NCT03170518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632466|NCT03126591|Pembrolizumab|pembrolizumab|mesh-list
65632467|NCT03126591|Olaratumab|olaratumab|mesh-list
65632468|NCT03126591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65632469|NCT03126591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632470|NCT03122197|Letrozole|letrozole|mesh-list
65632471|NCT03122197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632472|NCT03122197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65632473|NCT03122197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65632474|NCT03122197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632475|NCT03122197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632476|NCT03122197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65632477|NCT03122197|Hormone Antagonists|hormone antagonists|mesh-ancestor
65632478|NCT03122197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65632479|NCT03122197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632480|NCT03091192|Sunitinib|sunitinib|mesh-list
65632481|NCT03091192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632482|NCT03091192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65632483|NCT03091192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65632484|NCT03091192|Growth Substances|growth substances|mesh-ancestor
65632485|NCT03091192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632486|NCT03091192|Growth Inhibitors|growth inhibitors|mesh-ancestor
65632487|NCT03091192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65632488|NCT03091192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632489|NCT03091192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632490|NCT03085004|Gemcitabine|gemcitabine|mesh-list
65632491|NCT03085004|Ethanol|ethanol|mesh-list
65632492|NCT03085004|Paclitaxel|paclitaxel|mesh-list
65632493|NCT03085004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65632494|NCT03085004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632495|NCT03085004|Tubulin Modulators|tubulin modulators|mesh-ancestor
65632496|NCT03085004|Antimitotic Agents|antimitotic agents|mesh-ancestor
65632497|NCT03085004|Mitosis Modulators|mitosis modulators|mesh-ancestor
65632498|NCT03085004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632499|NCT03085004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65632500|NCT03085004|Antimetabolites|antimetabolites|mesh-ancestor
65632501|NCT03085004|Antiviral Agents|antiviral agents|mesh-ancestor
65632502|NCT03085004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65632503|NCT03085004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632504|NCT03085004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65632505|NCT03085004|Immunologic Factors|immunologic factors|mesh-ancestor
65632506|NCT03085004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632507|NCT03085004|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65632508|NCT03085004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65632509|NCT03076554|Avelumab|avelumab|mesh-list
65632510|NCT03076554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65632511|NCT03076554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632512|NCT03073967|Foscarnet|foscarnet|mesh-list
65632513|NCT03073967|Pritelivir|pritelivir|mesh-list
65632514|NCT03073967|Antiviral Agents|antiviral agents|mesh-ancestor
65632515|NCT03073967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65632516|NCT03073967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65632517|NCT03073967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65632518|NCT03073967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632519|NCT03073967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632520|NCT03059862|Tryptophan|tryptophan|mesh-list
65632521|NCT03059862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65632522|NCT03059862|Antidepressive Agents|antidepressive agents|mesh-ancestor
65632523|NCT03059862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65632524|NCT03031821|Metformin|metformin|mesh-list
65632525|NCT03031821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65632526|NCT03031821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632527|NCT03015844|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65632528|NCT03015844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632529|NCT03015844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632530|NCT03015844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632531|NCT03015844|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65632532|NCT02949284|Prednisone|prednisone|mesh-list
65632533|NCT02949284|Cortisone|cortisone|mesh-list
65632534|NCT02949284|Abiraterone Acetate|abiraterone acetate|mesh-list
65632535|NCT02949284|Hormones|hormones|mesh-list
65632536|NCT02949284|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65632537|NCT02949284|Androgens|androgens|mesh-list
65632538|NCT02949284|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
65632539|NCT02949284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65632540|NCT02949284|Glucocorticoids|glucocorticoids|mesh-ancestor
65632541|NCT02949284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65632542|NCT02949284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632543|NCT02949284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65632544|NCT02949284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632545|NCT02949284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65632546|NCT02949284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632547|NCT02949284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632548|NCT02949284|Hormone Antagonists|hormone antagonists|mesh-ancestor
65632549|NCT02949284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65632550|NCT02949284|Androgen Antagonists|androgen antagonists|mesh-ancestor
65632551|NCT02932410|Macitentan|macitentan|mesh-list
65632552|NCT02932410|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65632553|NCT02932410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65632554|NCT02932410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632555|NCT02932410|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65632556|NCT02916862|Calcium, Dietary|calcium, dietary|mesh-list
65632557|NCT02916862|Calcium|calcium|mesh-list
65632558|NCT02916862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65632559|NCT02916862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632560|NCT02916862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65632561|NCT02891447|Cisplatin|cisplatin|mesh-list
65632562|NCT02891447|Mitomycins|mitomycins|mesh-list
65632563|NCT02891447|Mitomycin|mitomycin|mesh-list
65632564|NCT02891447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632565|NCT02891447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65632566|NCT02891447|Alkylating Agents|alkylating agents|mesh-ancestor
65632567|NCT02891447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632568|NCT02891447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65632569|NCT02891447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632570|NCT02885974|Gemcitabine|gemcitabine|mesh-list
65632571|NCT02885974|Celecoxib|celecoxib|mesh-list
65632572|NCT02885974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632573|NCT02885974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65632574|NCT02885974|Antimetabolites|antimetabolites|mesh-ancestor
65632575|NCT02885974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632576|NCT02885974|Antiviral Agents|antiviral agents|mesh-ancestor
65632577|NCT02885974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65632578|NCT02885974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632579|NCT02885974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65632580|NCT02885974|Immunologic Factors|immunologic factors|mesh-ancestor
65632581|NCT02885974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632582|NCT02885974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65632583|NCT02885974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65632584|NCT02885974|Analgesics|analgesics|mesh-ancestor
65632585|NCT02885974|Sensory System Agents|sensory system agents|mesh-ancestor
65632586|NCT02885974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65632587|NCT02885974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65632588|NCT02885974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65632589|NCT02885974|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65632590|NCT02885974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65632591|NCT02867761|Glycopyrrolate|glycopyrrolate|mesh-list
65632592|NCT02867761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65632593|NCT02867761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65632594|NCT02867761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65632595|NCT02867761|Cholinergic Agents|cholinergic agents|mesh-ancestor
65632596|NCT02867761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65632597|NCT02867761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632598|NCT02867761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632599|NCT02854436|Niraparib|niraparib|mesh-list
65632600|NCT02854436|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65632601|NCT02854436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632602|NCT02854436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632603|NCT02854436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632604|NCT02754726|Gemcitabine|gemcitabine|mesh-list
65632605|NCT02754726|Paclitaxel|paclitaxel|mesh-list
65632606|NCT02754726|Nivolumab|nivolumab|mesh-list
65632607|NCT02754726|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65632608|NCT02754726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65632609|NCT02754726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632610|NCT02754726|Tubulin Modulators|tubulin modulators|mesh-ancestor
65632611|NCT02754726|Antimitotic Agents|antimitotic agents|mesh-ancestor
65632612|NCT02754726|Mitosis Modulators|mitosis modulators|mesh-ancestor
65632613|NCT02754726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632614|NCT02754726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65632615|NCT02754726|Antimetabolites|antimetabolites|mesh-ancestor
65632616|NCT02754726|Antiviral Agents|antiviral agents|mesh-ancestor
65632617|NCT02754726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65632618|NCT02754726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632619|NCT02754726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65632620|NCT02754726|Immunologic Factors|immunologic factors|mesh-ancestor
65632621|NCT02754726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632622|NCT02754726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65632623|NCT02754726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65632624|NCT02680626|Magnesium Sulfate|magnesium sulfate|mesh-list
65632625|NCT02680626|Ropivacaine|ropivacaine|mesh-list
65632626|NCT02680626|Anesthetics, Local|anesthetics, local|mesh-ancestor
65632627|NCT02680626|Anesthetics|anesthetics|mesh-ancestor
65632628|NCT02680626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65632629|NCT02680626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632630|NCT02680626|Sensory System Agents|sensory system agents|mesh-ancestor
65632631|NCT02680626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65632632|NCT02680626|Analgesics|analgesics|mesh-ancestor
65632633|NCT02680626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65632634|NCT02680626|Anticonvulsants|anticonvulsants|mesh-ancestor
65632635|NCT02680626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65632636|NCT02680626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65632637|NCT02680626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632638|NCT02680626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65632639|NCT02680626|Tocolytic Agents|tocolytic agents|mesh-ancestor
65632640|NCT02680626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65632641|NCT02609776|Carboplatin|carboplatin|mesh-list
65632642|NCT02609776|Pemetrexed|pemetrexed|mesh-list
65632643|NCT02609776|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
65632644|NCT02609776|Lazertinib|lazertinib|mesh-list
65632645|NCT02609776|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65632646|NCT02609776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632647|NCT02609776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632648|NCT02609776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632649|NCT02609776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65632650|NCT02609776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65632651|NCT02609776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65632652|NCT02609776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65632653|NCT02609776|Immunologic Factors|immunologic factors|mesh-ancestor
65632654|NCT02609776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632655|NCT02531516|Bicalutamide|bicalutamide|mesh-list
65632656|NCT02531516|Androgen Antagonists|androgen antagonists|mesh-ancestor
65632657|NCT02531516|Hormone Antagonists|hormone antagonists|mesh-ancestor
65632658|NCT02531516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65632659|NCT02531516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632660|NCT02531516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632661|NCT02520362|Denosumab|denosumab|mesh-list
65632662|NCT02520362|Diphosphonates|diphosphonates|mesh-list
65632663|NCT02520362|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65632664|NCT02520362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632665|NCT02494583|Pembrolizumab|pembrolizumab|mesh-list
65632666|NCT02494583|Capecitabine|capecitabine|mesh-list
65632667|NCT02494583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632668|NCT02494583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65632669|NCT02494583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65632670|NCT02494583|Antimetabolites|antimetabolites|mesh-ancestor
65632671|NCT02494583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632672|NCT02489318|Androgens|androgens|mesh-list
65632673|NCT02489318|Hormones|hormones|mesh-ancestor
65267085|NCT02696642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65632674|NCT02489318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65632675|NCT02489318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632676|NCT02473042|Promethazine|promethazine|mesh-list
65632677|NCT02473042|Dexamethasone|dexamethasone|mesh-list
65632678|NCT02473042|Ondansetron|ondansetron|mesh-list
65632679|NCT02473042|Famotidine|famotidine|mesh-list
65632680|NCT02473042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65632681|NCT02473042|Antiemetics|antiemetics|mesh-ancestor
65632682|NCT02473042|Autonomic Agents|autonomic agents|mesh-ancestor
65632683|NCT02473042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65632684|NCT02473042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632685|NCT02473042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65632686|NCT02473042|Glucocorticoids|glucocorticoids|mesh-ancestor
65632687|NCT02473042|Hormones|hormones|mesh-ancestor
65632688|NCT02473042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65632689|NCT02473042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65632690|NCT02473042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632691|NCT02473042|Antipruritics|antipruritics|mesh-ancestor
65632692|NCT02473042|Dermatologic Agents|dermatologic agents|mesh-ancestor
65632693|NCT02473042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65632694|NCT02473042|Serotonin Agents|serotonin agents|mesh-ancestor
65632695|NCT02473042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65632696|NCT02473042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632697|NCT02473042|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65632698|NCT02473042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65632699|NCT02473042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65632700|NCT02473042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65632701|NCT02473042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65632702|NCT02473042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65632703|NCT02473042|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65632704|NCT02473042|Histamine Antagonists|histamine antagonists|mesh-ancestor
65632705|NCT02473042|Histamine Agents|histamine agents|mesh-ancestor
65632706|NCT02473042|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65632707|NCT02473042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65632708|NCT02365597|Metformin|metformin|mesh-list
65632709|NCT02365597|Midazolam|midazolam|mesh-list
65632710|NCT02365597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65632711|NCT02365597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632712|NCT02365597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65632713|NCT02365597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65632714|NCT02365597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65632715|NCT02365597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65632716|NCT02365597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65632717|NCT02365597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65632718|NCT02365597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65632719|NCT02365597|Anesthetics, General|anesthetics, general|mesh-ancestor
65632720|NCT02365597|Anesthetics|anesthetics|mesh-ancestor
65632721|NCT02365597|GABA Modulators|gaba modulators|mesh-ancestor
65632722|NCT02365597|GABA Agents|gaba agents|mesh-ancestor
65632723|NCT02365597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65632724|NCT02365597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632725|NCT02359331|Amoxicillin|amoxicillin|mesh-list
65632726|NCT02359331|Moxifloxacin|moxifloxacin|mesh-list
65632727|NCT02359331|Metronidazole|metronidazole|mesh-list
65632728|NCT02359331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65632729|NCT02359331|Tetracycline|tetracycline|mesh-list
65632730|NCT02359331|Anti-Infective Agents|anti-infective agents|mesh-list
65632731|NCT02359331|Bismuth|bismuth|mesh-list
65632732|NCT02359331|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65632733|NCT02359331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65632734|NCT02359331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65632735|NCT02359331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632736|NCT02359331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632737|NCT02359331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632738|NCT02359331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65632739|NCT02359331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65632740|NCT02359331|Antacids|antacids|mesh-ancestor
65632741|NCT02359331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65632742|NCT02359331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65632743|NCT02354014|Bedaquiline|bedaquiline|mesh-list
65632744|NCT02354014|Diarylquinolines|diarylquinolines|mesh-list
65632745|NCT02354014|Antitubercular Agents|antitubercular agents|mesh-ancestor
65632746|NCT02354014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65632747|NCT02354014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65632748|NCT02322814|Paclitaxel|paclitaxel|mesh-list
65632749|NCT02322814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65632750|NCT02322814|Atezolizumab|atezolizumab|mesh-list
65632751|NCT02322814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65632752|NCT02322814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632753|NCT02322814|Tubulin Modulators|tubulin modulators|mesh-ancestor
65632754|NCT02322814|Antimitotic Agents|antimitotic agents|mesh-ancestor
65632755|NCT02322814|Mitosis Modulators|mitosis modulators|mesh-ancestor
65632756|NCT02322814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632757|NCT02316106|Daratumumab|daratumumab|mesh-list
65632758|NCT02316106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65632759|NCT02316106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632760|NCT02316106|Immunologic Factors|immunologic factors|mesh-ancestor
65632761|NCT02316106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632762|NCT02277444|Golimumab|golimumab|mesh-list
65632763|NCT02277444|Methotrexate|methotrexate|mesh-list
65632764|NCT02277444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65632765|NCT02277444|Abortifacient Agents|abortifacient agents|mesh-ancestor
65632766|NCT02277444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65632767|NCT02277444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632768|NCT02277444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65632769|NCT02277444|Antimetabolites|antimetabolites|mesh-ancestor
65632770|NCT02277444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632771|NCT02277444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632772|NCT02277444|Dermatologic Agents|dermatologic agents|mesh-ancestor
65632773|NCT02277444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632774|NCT02277444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65632775|NCT02277444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65632776|NCT02277444|Immunologic Factors|immunologic factors|mesh-ancestor
65632777|NCT02277444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65632778|NCT02277444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65632779|NCT02277444|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65632780|NCT02277444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65632781|NCT02257736|Prednisone|prednisone|mesh-list
65632782|NCT02257736|Abiraterone Acetate|abiraterone acetate|mesh-list
65632783|NCT02257736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65632784|NCT02257736|Glucocorticoids|glucocorticoids|mesh-ancestor
65632785|NCT02257736|Hormones|hormones|mesh-ancestor
65632786|NCT02257736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65632787|NCT02257736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632788|NCT02257736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65632789|NCT02257736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632790|NCT02257736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65632791|NCT02257736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632792|NCT02257736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632793|NCT02257736|Hormone Antagonists|hormone antagonists|mesh-ancestor
65632794|NCT02257736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65632795|NCT02252172|Dexamethasone|dexamethasone|mesh-list
65632796|NCT02252172|Lenalidomide|lenalidomide|mesh-list
65632797|NCT02252172|Daratumumab|daratumumab|mesh-list
65632798|NCT02252172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65632799|NCT02252172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65632800|NCT02252172|Antiemetics|antiemetics|mesh-ancestor
65632801|NCT02252172|Autonomic Agents|autonomic agents|mesh-ancestor
65632802|NCT02252172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65632803|NCT02252172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632804|NCT02252172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65632805|NCT02252172|Glucocorticoids|glucocorticoids|mesh-ancestor
65632806|NCT02252172|Hormones|hormones|mesh-ancestor
65632807|NCT02252172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65632808|NCT02252172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65632809|NCT02252172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632810|NCT02252172|Immunologic Factors|immunologic factors|mesh-ancestor
65632811|NCT02252172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65632812|NCT02252172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65632813|NCT02252172|Growth Substances|growth substances|mesh-ancestor
65632814|NCT02252172|Growth Inhibitors|growth inhibitors|mesh-ancestor
65632815|NCT02195479|Dexamethasone|dexamethasone|mesh-list
65632816|NCT02195479|Prednisone|prednisone|mesh-list
65632817|NCT02195479|Melphalan|melphalan|mesh-list
65632818|NCT02195479|Bortezomib|bortezomib|mesh-list
65632819|NCT02195479|Daratumumab|daratumumab|mesh-list
65632820|NCT02195479|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65632821|NCT02195479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65632822|NCT02195479|Antiemetics|antiemetics|mesh-ancestor
65632823|NCT02195479|Autonomic Agents|autonomic agents|mesh-ancestor
65632824|NCT02195479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65632825|NCT02195479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632826|NCT02195479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65632827|NCT02195479|Glucocorticoids|glucocorticoids|mesh-ancestor
65632828|NCT02195479|Hormones|hormones|mesh-ancestor
65632829|NCT02195479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65632830|NCT02195479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65632831|NCT02195479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632832|NCT02195479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65632833|NCT02195479|Alkylating Agents|alkylating agents|mesh-ancestor
65632834|NCT02195479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632835|NCT02195479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65632836|NCT02195479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65632837|NCT02195479|Immunologic Factors|immunologic factors|mesh-ancestor
65632838|NCT02136134|Dexamethasone|dexamethasone|mesh-list
65632839|NCT02136134|Bortezomib|bortezomib|mesh-list
65632840|NCT02136134|Daratumumab|daratumumab|mesh-list
65632841|NCT02136134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65632842|NCT02136134|Antiemetics|antiemetics|mesh-ancestor
65632843|NCT02136134|Autonomic Agents|autonomic agents|mesh-ancestor
65632844|NCT02136134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65632845|NCT02136134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632846|NCT02136134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65632847|NCT02136134|Glucocorticoids|glucocorticoids|mesh-ancestor
65632848|NCT02136134|Hormones|hormones|mesh-ancestor
65632849|NCT02136134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65632850|NCT02136134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65632851|NCT02136134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632852|NCT02123758|Prednisone|prednisone|mesh-list
65632853|NCT02123758|Abiraterone Acetate|abiraterone acetate|mesh-list
65632854|NCT02123758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65632855|NCT02123758|Glucocorticoids|glucocorticoids|mesh-ancestor
65632856|NCT02123758|Hormones|hormones|mesh-ancestor
65430195|NCT00452348|Xhance|xhance|mesh-list
65632857|NCT02123758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65632858|NCT02123758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632859|NCT02123758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65632860|NCT02123758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632861|NCT02123758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65632862|NCT02123758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632863|NCT02123758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632864|NCT02123758|Hormone Antagonists|hormone antagonists|mesh-ancestor
65632865|NCT02123758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65632866|NCT02108964|Nazartinib|nazartinib|mesh-list
65632867|NCT02108964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632868|NCT02076009|Dexamethasone|dexamethasone|mesh-list
65632869|NCT02076009|Lenalidomide|lenalidomide|mesh-list
65632870|NCT02076009|Daratumumab|daratumumab|mesh-list
65632871|NCT02076009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65632872|NCT02076009|Antiemetics|antiemetics|mesh-ancestor
65632873|NCT02076009|Autonomic Agents|autonomic agents|mesh-ancestor
65632874|NCT02076009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65632875|NCT02076009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632876|NCT02076009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65632877|NCT02076009|Glucocorticoids|glucocorticoids|mesh-ancestor
65632878|NCT02076009|Hormones|hormones|mesh-ancestor
65632879|NCT02076009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65632880|NCT02076009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65632881|NCT02076009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632882|NCT02076009|Immunologic Factors|immunologic factors|mesh-ancestor
65632883|NCT02076009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65632884|NCT02076009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65632885|NCT02076009|Growth Substances|growth substances|mesh-ancestor
65632886|NCT02076009|Growth Inhibitors|growth inhibitors|mesh-ancestor
65632887|NCT02057133|Tamoxifen|tamoxifen|mesh-list
65632888|NCT02057133|Trastuzumab|trastuzumab|mesh-list
65632889|NCT02057133|Pertuzumab|pertuzumab|mesh-list
65632890|NCT02057133|Everolimus|everolimus|mesh-list
65632891|NCT02057133|Letrozole|letrozole|mesh-list
65632892|NCT02057133|Fulvestrant|fulvestrant|mesh-list
65632893|NCT02057133|Anastrozole|anastrozole|mesh-list
65632894|NCT02057133|Exemestane|exemestane|mesh-list
65632895|NCT02057133|Loperamide|loperamide|mesh-list
65632896|NCT02057133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65632897|NCT02057133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632898|NCT02057133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65632899|NCT02057133|Immunologic Factors|immunologic factors|mesh-ancestor
65632900|NCT02057133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632901|NCT02057133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65632902|NCT02057133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65632903|NCT02057133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632904|NCT02057133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632905|NCT02057133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65632906|NCT02057133|Hormone Antagonists|hormone antagonists|mesh-ancestor
65632907|NCT02057133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65632908|NCT02057133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65632909|NCT02057133|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65632910|NCT02057133|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65632911|NCT02057133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65632912|NCT02057133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65632913|NCT02057133|Antidiarrheals|antidiarrheals|mesh-ancestor
65632914|NCT02057133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65632915|NCT01894308|Testosterone|testosterone|mesh-list
65632916|NCT01894308|Androgens|androgens|mesh-ancestor
65632917|NCT01894308|Hormones|hormones|mesh-ancestor
65632918|NCT01894308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65632919|NCT01894308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632920|NCT01837862|Mebendazole|mebendazole|mesh-list
65632921|NCT01837862|Piperazine|piperazine|mesh-list
65632922|NCT01837862|Piperazine citrate|piperazine citrate|mesh-list
65632923|NCT01837862|Bevacizumab|bevacizumab|mesh-list
65632924|NCT01837862|Carboplatin|carboplatin|mesh-list
65632925|NCT01837862|Irinotecan|irinotecan|mesh-list
65632926|NCT01837862|Vincristine|vincristine|mesh-list
65632927|NCT01837862|Temozolomide|temozolomide|mesh-list
65632928|NCT01837862|DMP 777|dmp 777|mesh-list
65632929|NCT01837862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65632930|NCT01837862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632931|NCT01837862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65632932|NCT01837862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65632933|NCT01837862|Growth Substances|growth substances|mesh-ancestor
65632934|NCT01837862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632935|NCT01837862|Growth Inhibitors|growth inhibitors|mesh-ancestor
65632936|NCT01837862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65632937|NCT01837862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65632939|NCT01837862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632940|NCT01837862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65632941|NCT01837862|Tubulin Modulators|tubulin modulators|mesh-ancestor
65632942|NCT01837862|Antimitotic Agents|antimitotic agents|mesh-ancestor
65632943|NCT01837862|Mitosis Modulators|mitosis modulators|mesh-ancestor
65632944|NCT01837862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65632945|NCT01837862|Alkylating Agents|alkylating agents|mesh-ancestor
65632946|NCT01837862|Antinematodal Agents|antinematodal agents|mesh-ancestor
65632947|NCT01837862|Anthelmintics|anthelmintics|mesh-ancestor
65632948|NCT01837862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65632949|NCT01837862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65632950|NCT01792687|Prednisone|prednisone|mesh-list
65632951|NCT01792687|Abiraterone Acetate|abiraterone acetate|mesh-list
65632952|NCT01792687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65632953|NCT01792687|Glucocorticoids|glucocorticoids|mesh-ancestor
65632954|NCT01792687|Hormones|hormones|mesh-ancestor
65632955|NCT01792687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65632956|NCT01792687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632957|NCT01792687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65632958|NCT01792687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632959|NCT01792687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65632960|NCT01792687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632961|NCT01792687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632962|NCT01792687|Hormone Antagonists|hormone antagonists|mesh-ancestor
65632963|NCT01792687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65632964|NCT01776840|Rituximab|rituximab|mesh-list
65632965|NCT01776840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65632966|NCT01776840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65632967|NCT01776840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632968|NCT01776840|Immunologic Factors|immunologic factors|mesh-ancestor
65632969|NCT01776840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632970|NCT01776840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65632971|NCT01776840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65632972|NCT01776840|Alkylating Agents|alkylating agents|mesh-ancestor
65632973|NCT01776840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632974|NCT01675219|Mitomycins|mitomycins|mesh-list
65632975|NCT01675219|Mitomycin|mitomycin|mesh-list
65632976|NCT01675219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65632977|NCT01675219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632978|NCT01675219|Alkylating Agents|alkylating agents|mesh-ancestor
65632979|NCT01675219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65632980|NCT01675219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65632981|NCT01675219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65632982|NCT01615029|Dexamethasone|dexamethasone|mesh-list
65632983|NCT01615029|Lenalidomide|lenalidomide|mesh-list
65632984|NCT01615029|Daratumumab|daratumumab|mesh-list
65632985|NCT01615029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65632986|NCT01615029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65632987|NCT01615029|Antiemetics|antiemetics|mesh-ancestor
65632988|NCT01615029|Autonomic Agents|autonomic agents|mesh-ancestor
65632989|NCT01615029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65632990|NCT01615029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65632991|NCT01615029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65632992|NCT01615029|Glucocorticoids|glucocorticoids|mesh-ancestor
65632993|NCT01615029|Hormones|hormones|mesh-ancestor
65632994|NCT01615029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65632995|NCT01615029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65632996|NCT01615029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65632997|NCT01615029|Immunologic Factors|immunologic factors|mesh-ancestor
65632998|NCT01615029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65632999|NCT01615029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65633000|NCT01615029|Growth Substances|growth substances|mesh-ancestor
65633001|NCT01615029|Growth Inhibitors|growth inhibitors|mesh-ancestor
65633002|NCT01590069|Aldesleukin|aldesleukin|mesh-list
65633003|NCT01590069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633004|NCT01590069|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65633005|NCT01590069|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65633006|NCT01590069|Antiviral Agents|antiviral agents|mesh-ancestor
65633007|NCT01590069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65633008|NCT01529593|Metformin|metformin|mesh-list
65633009|NCT01529593|Sirolimus|sirolimus|mesh-list
65633010|NCT01529593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65633011|NCT01529593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633012|NCT01529593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65633013|NCT01529593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65633014|NCT01529593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65633015|NCT01529593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633016|NCT01529593|Antifungal Agents|antifungal agents|mesh-ancestor
65633017|NCT01529593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65633018|NCT01529593|Immunologic Factors|immunologic factors|mesh-ancestor
65633019|NCT01446133|Rituximab|rituximab|mesh-list
65633020|NCT01446133|Lenalidomide|lenalidomide|mesh-list
65633021|NCT01446133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65633022|NCT01446133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633023|NCT01446133|Immunologic Factors|immunologic factors|mesh-ancestor
65633024|NCT01446133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633025|NCT01446133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65633026|NCT01446133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65633027|NCT01446133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65633028|NCT01446133|Growth Substances|growth substances|mesh-ancestor
65633029|NCT01446133|Growth Inhibitors|growth inhibitors|mesh-ancestor
65633030|NCT01424982|Cytarabine|cytarabine|mesh-list
65633031|NCT01424982|Dexamethasone|dexamethasone|mesh-list
65633032|NCT01424982|Prednisone|prednisone|mesh-list
65633033|NCT01424982|Dexamethasone acetate|dexamethasone acetate|mesh-list
65633034|NCT01424982|Cortisone|cortisone|mesh-list
65633035|NCT01424982|Cyclophosphamide|cyclophosphamide|mesh-list
65633036|NCT01424982|Rituximab|rituximab|mesh-list
65633037|NCT01424982|Doxorubicin|doxorubicin|mesh-list
65633038|NCT01424982|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65633039|NCT01424982|Methotrexate|methotrexate|mesh-list
65633040|NCT01424982|Vincristine|vincristine|mesh-list
65633041|NCT01424982|Daunorubicin|daunorubicin|mesh-list
65633042|NCT01424982|Ponatinib|ponatinib|mesh-list
65633043|NCT01424982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65633044|NCT01424982|Antibodies|antibodies|mesh-list
65633045|NCT01424982|Immunoglobulins|immunoglobulins|mesh-list
65633046|NCT01424982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65633047|NCT01424982|BB 1101|bb 1101|mesh-list
65633048|NCT01424982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65633049|NCT01424982|Immunologic Factors|immunologic factors|mesh-ancestor
65633050|NCT01424982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633051|NCT01424982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65633052|NCT01424982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65633053|NCT01424982|Alkylating Agents|alkylating agents|mesh-ancestor
65633054|NCT01424982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633055|NCT01424982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633056|NCT01424982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65633057|NCT01424982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65633058|NCT01424982|Antiemetics|antiemetics|mesh-ancestor
65633059|NCT01424982|Autonomic Agents|autonomic agents|mesh-ancestor
65633060|NCT01424982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65633061|NCT01424982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65633062|NCT01424982|Glucocorticoids|glucocorticoids|mesh-ancestor
65633063|NCT01424982|Hormones|hormones|mesh-ancestor
65633064|NCT01424982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65633065|NCT01424982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65633066|NCT01424982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65633067|NCT01424982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65633068|NCT01424982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65633069|NCT01424982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633070|NCT01424982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65633071|NCT01424982|Abortifacient Agents|abortifacient agents|mesh-ancestor
65633072|NCT01424982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65633073|NCT01424982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65633074|NCT01424982|Antimetabolites|antimetabolites|mesh-ancestor
65633075|NCT01424982|Dermatologic Agents|dermatologic agents|mesh-ancestor
65633076|NCT01424982|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65633077|NCT01424982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65633078|NCT01424982|Antiviral Agents|antiviral agents|mesh-ancestor
65633079|NCT01424982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65633080|NCT01424982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65633081|NCT01424982|Tubulin Modulators|tubulin modulators|mesh-ancestor
65633082|NCT01424982|Antimitotic Agents|antimitotic agents|mesh-ancestor
65633083|NCT01424982|Mitosis Modulators|mitosis modulators|mesh-ancestor
65633084|NCT01424982|Protease Inhibitors|protease inhibitors|mesh-ancestor
65430421|NCT00420342|Diuretics|diuretics|mesh-ancestor
65633085|NCT01424982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65633086|NCT01333033|Leucovorin|leucovorin|mesh-list
65633087|NCT01333033|Paclitaxel|paclitaxel|mesh-list
65633088|NCT01333033|Carboplatin|carboplatin|mesh-list
65633089|NCT01333033|Fluorouracil|fluorouracil|mesh-list
65633090|NCT01333033|Oxaliplatin|oxaliplatin|mesh-list
65633091|NCT01333033|Calcium|calcium|mesh-list
65633092|NCT01333033|Levoleucovorin|levoleucovorin|mesh-list
65633093|NCT01333033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65633094|NCT01333033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633095|NCT01333033|Tubulin Modulators|tubulin modulators|mesh-ancestor
65633096|NCT01333033|Antimitotic Agents|antimitotic agents|mesh-ancestor
65633097|NCT01333033|Mitosis Modulators|mitosis modulators|mesh-ancestor
65633098|NCT01333033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633099|NCT01333033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65633100|NCT01333033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633101|NCT01333033|Antimetabolites|antimetabolites|mesh-ancestor
65633102|NCT01333033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65633103|NCT01333033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65633104|NCT01333033|Immunologic Factors|immunologic factors|mesh-ancestor
65633105|NCT01333033|Antidotes|antidotes|mesh-ancestor
65633106|NCT01333033|Protective Agents|protective agents|mesh-ancestor
65633107|NCT01333033|Vitamin B Complex|vitamin b complex|mesh-ancestor
65633108|NCT01333033|Vitamins|vitamins|mesh-ancestor
65633109|NCT01333033|Micronutrients|micronutrients|mesh-ancestor
65633110|NCT01314118|Prednisone|prednisone|mesh-list
65633111|NCT01314118|Abiraterone Acetate|abiraterone acetate|mesh-list
65633112|NCT01314118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65633113|NCT01314118|Glucocorticoids|glucocorticoids|mesh-ancestor
65633114|NCT01314118|Hormones|hormones|mesh-ancestor
65633115|NCT01314118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65633116|NCT01314118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633117|NCT01314118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65633118|NCT01314118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633119|NCT01314118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65633120|NCT01314118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633121|NCT01314118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633122|NCT01314118|Hormone Antagonists|hormone antagonists|mesh-ancestor
65633123|NCT01314118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65633124|NCT01187199|Sirolimus|sirolimus|mesh-list
65633125|NCT01187199|Paclitaxel|paclitaxel|mesh-list
65633126|NCT01187199|Bevacizumab|bevacizumab|mesh-list
65633127|NCT01187199|Carboplatin|carboplatin|mesh-list
65633128|NCT01187199|Sorafenib|sorafenib|mesh-list
65633129|NCT01187199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65633130|NCT01187199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633131|NCT01187199|Tubulin Modulators|tubulin modulators|mesh-ancestor
65633132|NCT01187199|Antimitotic Agents|antimitotic agents|mesh-ancestor
65633133|NCT01187199|Mitosis Modulators|mitosis modulators|mesh-ancestor
65633134|NCT01187199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633135|NCT01187199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65633136|NCT01187199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65633137|NCT01187199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65633138|NCT01187199|Growth Substances|growth substances|mesh-ancestor
65633139|NCT01187199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633140|NCT01187199|Growth Inhibitors|growth inhibitors|mesh-ancestor
65633141|NCT01187199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65633142|NCT01187199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633143|NCT01187199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65633144|NCT01187199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65633145|NCT01187199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65633146|NCT01187199|Antifungal Agents|antifungal agents|mesh-ancestor
65633147|NCT01187199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65633148|NCT01187199|Immunologic Factors|immunologic factors|mesh-ancestor
65633149|NCT01093326|Ponesimod|ponesimod|mesh-list
65633150|NCT01093326|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65633151|NCT01093326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633152|NCT01093326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65633153|NCT01093326|Immunologic Factors|immunologic factors|mesh-ancestor
65633154|NCT01093326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633155|NCT00980538|Etravirine|etravirine|mesh-list
65633156|NCT00980538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65633157|NCT00980538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65633158|NCT00980538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633159|NCT00980538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633160|NCT00980538|Antiviral Agents|antiviral agents|mesh-ancestor
65633161|NCT00980538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65430492|NCT01027520|Monensin|monensin|mesh-list
65633162|NCT00778063|Dexmedetomidine|dexmedetomidine|mesh-list
65633163|NCT00778063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65633164|NCT00778063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65633165|NCT00778063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633166|NCT00778063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65633167|NCT00778063|Analgesics|analgesics|mesh-ancestor
65633168|NCT00778063|Sensory System Agents|sensory system agents|mesh-ancestor
65633169|NCT00778063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65633170|NCT00778063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65633171|NCT00778063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65633172|NCT00778063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65633173|NCT00778063|Adrenergic Agents|adrenergic agents|mesh-ancestor
65633174|NCT00778063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65633175|NCT00778063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633176|NCT00606346|Infliximab|infliximab|mesh-list
65633177|NCT00606346|Dermatologic Agents|dermatologic agents|mesh-ancestor
65633178|NCT00606346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65633179|NCT00606346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65633180|NCT00547196|Cyclosporine|cyclosporine|mesh-list
65633181|NCT00547196|Mycophenolic Acid|mycophenolic acid|mesh-list
65633182|NCT00547196|Cyclophosphamide|cyclophosphamide|mesh-list
65633183|NCT00547196|Melphalan|melphalan|mesh-list
65633184|NCT00547196|Busulfan|busulfan|mesh-list
65633185|NCT00547196|Fludarabine|fludarabine|mesh-list
65633186|NCT00547196|Fludarabine phosphate|fludarabine phosphate|mesh-list
65633187|NCT00547196|Cyclosporins|cyclosporins|mesh-list
65633188|NCT00547196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65633189|NCT00547196|Immunologic Factors|immunologic factors|mesh-ancestor
65633190|NCT00547196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633191|NCT00547196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65633192|NCT00547196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65633193|NCT00547196|Alkylating Agents|alkylating agents|mesh-ancestor
65633194|NCT00547196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633195|NCT00547196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633196|NCT00547196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65633197|NCT00547196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65633198|NCT00547196|Antimetabolites|antimetabolites|mesh-ancestor
65633199|NCT00547196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633200|NCT00547196|Antifungal Agents|antifungal agents|mesh-ancestor
65633201|NCT00547196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65633202|NCT00547196|Dermatologic Agents|dermatologic agents|mesh-ancestor
65633203|NCT00547196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65633204|NCT00547196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65633205|NCT00547196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65633206|NCT00547196|Antitubercular Agents|antitubercular agents|mesh-ancestor
65633207|NCT00547196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65633208|NCT00330941|Lidocaine|lidocaine|mesh-list
65633209|NCT00330941|Anesthetics, Local|anesthetics, local|mesh-ancestor
65633210|NCT00330941|Anesthetics|anesthetics|mesh-ancestor
65633211|NCT00330941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65633212|NCT00330941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633213|NCT00330941|Sensory System Agents|sensory system agents|mesh-ancestor
65633214|NCT00330941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65633215|NCT00330941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65633216|NCT00330941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65633217|NCT00330941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65633218|NCT00330941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65633219|NCT00330941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633220|NCT03149107|Acetylcysteine|acetylcysteine|mesh-list
65633221|NCT03149107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65633222|NCT03149107|Antiviral Agents|antiviral agents|mesh-ancestor
65633223|NCT03149107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65633224|NCT03149107|Expectorants|expectorants|mesh-ancestor
65633225|NCT03149107|Respiratory System Agents|respiratory system agents|mesh-ancestor
65633226|NCT03149107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65633227|NCT03149107|Antioxidants|antioxidants|mesh-ancestor
65633228|NCT03149107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633229|NCT03149107|Protective Agents|protective agents|mesh-ancestor
65633230|NCT03149107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633231|NCT03149107|Antidotes|antidotes|mesh-ancestor
65633232|NCT03135301|Metformin|metformin|mesh-list
65633233|NCT03135301|Letrozole|letrozole|mesh-list
65633234|NCT03135301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65633235|NCT03135301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633236|NCT03135301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633237|NCT03135301|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65633238|NCT03135301|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65633239|NCT03135301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633240|NCT03135301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633241|NCT03135301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65633242|NCT03135301|Hormone Antagonists|hormone antagonists|mesh-ancestor
65633243|NCT03135301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65633244|NCT03602898|Cyclosporine|cyclosporine|mesh-list
65633245|NCT03602898|Cyclophosphamide|cyclophosphamide|mesh-list
65633246|NCT03602898|Busulfan|busulfan|mesh-list
65633247|NCT03602898|Methotrexate|methotrexate|mesh-list
65633248|NCT03602898|Fludarabine|fludarabine|mesh-list
65633249|NCT03602898|Fludarabine phosphate|fludarabine phosphate|mesh-list
65633250|NCT03602898|Tacrolimus|tacrolimus|mesh-list
65633251|NCT03602898|Cyclosporins|cyclosporins|mesh-list
65633252|NCT03602898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65633253|NCT03602898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65633254|NCT03602898|Immunologic Factors|immunologic factors|mesh-ancestor
65633255|NCT03602898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633256|NCT03602898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65633257|NCT03602898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65633258|NCT03602898|Alkylating Agents|alkylating agents|mesh-ancestor
65633259|NCT03602898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633260|NCT03602898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633261|NCT03602898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65633262|NCT03602898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65633263|NCT03602898|Abortifacient Agents|abortifacient agents|mesh-ancestor
65633264|NCT03602898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65633265|NCT03602898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65633266|NCT03602898|Antimetabolites|antimetabolites|mesh-ancestor
65633267|NCT03602898|Dermatologic Agents|dermatologic agents|mesh-ancestor
65633268|NCT03602898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633269|NCT03602898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65633270|NCT03602898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65633271|NCT03602898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65633272|NCT03602898|Antifungal Agents|antifungal agents|mesh-ancestor
65633273|NCT03602898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65633274|NCT02983747|Loxoprofen|loxoprofen|mesh-list
65633275|NCT02983747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65633276|NCT02983747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65633277|NCT02983747|Analgesics|analgesics|mesh-ancestor
65633278|NCT02983747|Sensory System Agents|sensory system agents|mesh-ancestor
65633279|NCT02983747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65633280|NCT02983747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633281|NCT02983747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65633282|NCT02983747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65633283|NCT05759845|Topiramate|topiramate|mesh-list
65633284|NCT05759845|Amitriptyline|amitriptyline|mesh-list
65633285|NCT05759845|Anticonvulsants|anticonvulsants|mesh-ancestor
65633286|NCT05759845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65633287|NCT05759845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633288|NCT05759845|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65633289|NCT05759845|Antidepressive Agents|antidepressive agents|mesh-ancestor
65633290|NCT05759845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65633291|NCT05759845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65633292|NCT05759845|Analgesics|analgesics|mesh-ancestor
65633293|NCT05759845|Sensory System Agents|sensory system agents|mesh-ancestor
65633294|NCT05759845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65633295|NCT05759845|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65633296|NCT05759845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65633297|NCT05759845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65633298|NCT05759845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633299|NCT05759845|Adrenergic Agents|adrenergic agents|mesh-ancestor
65633300|NCT05759845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65633301|NCT03931291|Azacitidine|azacitidine|mesh-list
65633302|NCT03931291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65633303|NCT03931291|Antimetabolites|antimetabolites|mesh-ancestor
65633304|NCT03931291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633305|NCT03931291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633306|NCT03931291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633307|NCT00799110|Imiquimod|imiquimod|mesh-list
65633308|NCT00799110|Vaccines|vaccines|mesh-list
65633309|NCT00799110|Immunologic Factors|immunologic factors|mesh-ancestor
65633310|NCT00799110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633311|NCT00799110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65633312|NCT00799110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633313|NCT00799110|Interferon Inducers|interferon inducers|mesh-ancestor
65633314|NCT05199727|Tadalafil|tadalafil|mesh-list
65430638|NCT01323374|Carbidopa|carbidopa|mesh-list
65633315|NCT05199727|Vasodilator Agents|vasodilator agents|mesh-ancestor
65633316|NCT05199727|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65633317|NCT05199727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65633318|NCT05199727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633319|NCT05199727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633320|NCT05199727|Urological Agents|urological agents|mesh-ancestor
65633322|NCT02132234|Etanercept|etanercept|mesh-list
65633323|NCT02132234|Infliximab|infliximab|mesh-list
65633324|NCT02132234|Certolizumab Pegol|certolizumab pegol|mesh-list
65633325|NCT02132234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65633326|NCT02132234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65633327|NCT02132234|Dermatologic Agents|dermatologic agents|mesh-ancestor
65633328|NCT02132234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65633329|NCT02132234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65633330|NCT02132234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65633331|NCT02132234|Analgesics|analgesics|mesh-ancestor
65633332|NCT02132234|Sensory System Agents|sensory system agents|mesh-ancestor
65633333|NCT02132234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65633334|NCT02132234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633335|NCT02132234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65633336|NCT02132234|Immunologic Factors|immunologic factors|mesh-ancestor
65633337|NCT02132390|Toremifene|toremifene|mesh-list
65633338|NCT02132390|Goserelin|goserelin|mesh-list
65633339|NCT02132390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65633340|NCT02132390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633341|NCT02132390|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65633342|NCT02132390|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65633343|NCT02132390|Hormone Antagonists|hormone antagonists|mesh-ancestor
65633344|NCT02132390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65633345|NCT02132390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633346|NCT02132390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65633347|NCT02128646|Ketorolac|ketorolac|mesh-list
65633348|NCT02128646|Bupivacaine|bupivacaine|mesh-list
65633349|NCT02128646|Anesthetics, Local|anesthetics, local|mesh-ancestor
65633350|NCT02128646|Anesthetics|anesthetics|mesh-ancestor
65633351|NCT02128646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65633352|NCT02128646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633353|NCT02128646|Sensory System Agents|sensory system agents|mesh-ancestor
65633354|NCT02128646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65633355|NCT02128646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65633356|NCT02128646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65633357|NCT02128646|Analgesics|analgesics|mesh-ancestor
65633358|NCT02128646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65633359|NCT02128646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65633360|NCT02128646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65633361|NCT02128646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633362|NCT02128646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633363|NCT05199103|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65633364|NCT05199103|Thymoglobulin|thymoglobulin|mesh-list
65633365|NCT05199103|Immunologic Factors|immunologic factors|mesh-ancestor
65633366|NCT05199103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633367|NCT05199103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65633368|NCT02132546|Chlorhexidine|chlorhexidine|mesh-list
65633369|NCT02132546|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65633370|NCT02132546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65633371|NCT02132546|Disinfectants|disinfectants|mesh-ancestor
65633372|NCT05198947|Ivermectin|ivermectin|mesh-list
65633373|NCT05198947|Permethrin|permethrin|mesh-list
65633374|NCT05198947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65633375|NCT05198947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65633376|NCT05198947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633377|NCT05198947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633378|NCT01367834|Hormones|hormones|mesh-list
65633379|NCT01367834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65633380|NCT01367834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633381|NCT03106753|Bupivacaine|bupivacaine|mesh-list
65633382|NCT03106753|Terbutaline|terbutaline|mesh-list
65633383|NCT03106753|Anesthetics, Local|anesthetics, local|mesh-ancestor
65633384|NCT03106753|Anesthetics|anesthetics|mesh-ancestor
65633385|NCT03106753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65633386|NCT03106753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633387|NCT03106753|Sensory System Agents|sensory system agents|mesh-ancestor
65633388|NCT03106753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65633389|NCT03106753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65633390|NCT03106753|Autonomic Agents|autonomic agents|mesh-ancestor
65633391|NCT03106753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65633392|NCT03106753|Respiratory System Agents|respiratory system agents|mesh-ancestor
65633393|NCT03106753|Sympathomimetics|sympathomimetics|mesh-ancestor
65633394|NCT03106753|Tocolytic Agents|tocolytic agents|mesh-ancestor
65633395|NCT03106753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65633396|NCT03106753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65633397|NCT03106753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65633398|NCT03106753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65633399|NCT03106753|Adrenergic Agents|adrenergic agents|mesh-ancestor
65633400|NCT03106753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65633401|NCT03106753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633402|NCT05730205|Etonogestrel|etonogestrel|mesh-list
65633403|NCT05730205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65633404|NCT05730205|Contraceptive Agents|contraceptive agents|mesh-ancestor
65633405|NCT05730205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65633406|NCT05730205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633407|NCT05730205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65633408|NCT02133014|Fluorouracil|fluorouracil|mesh-list
65633409|NCT02133014|Antimetabolites|antimetabolites|mesh-ancestor
65633410|NCT02133014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633411|NCT02133014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65633412|NCT02133014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633413|NCT02133014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65633414|NCT02133014|Immunologic Factors|immunologic factors|mesh-ancestor
65633415|NCT02133014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633416|NCT05759455|Vitamin D|vitamin d|mesh-list
65633417|NCT05759455|Vitamins|vitamins|mesh-ancestor
65633418|NCT05759455|Micronutrients|micronutrients|mesh-ancestor
65633419|NCT05759455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633420|NCT05759455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65633421|NCT02129114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65633422|NCT02129114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65633423|NCT02129114|Estradiol|estradiol|mesh-list
65633424|NCT02129114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65633425|NCT02129114|Estrogens|estrogens|mesh-ancestor
65633426|NCT02129114|Hormones|hormones|mesh-ancestor
65633427|NCT02129114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65633428|NCT02129114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633429|NCT02129114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65633430|NCT02129114|Contraceptive Agents|contraceptive agents|mesh-ancestor
65633431|NCT02129114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65633432|NCT02129114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65633433|NCT02136992|Pirfenidone|pirfenidone|mesh-list
65633434|NCT02136992|Analgesics|analgesics|mesh-ancestor
65633435|NCT02136992|Sensory System Agents|sensory system agents|mesh-ancestor
65633436|NCT02136992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65633437|NCT02136992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633438|NCT02136992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65633439|NCT02136992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65633440|NCT02136992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65633441|NCT02136992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65633442|NCT02136992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633443|NCT02252978|Ciprofloxacin|ciprofloxacin|mesh-list
65633444|NCT02252978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65633445|NCT02252978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65633446|NCT02252978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65633447|NCT02252978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65633448|NCT02252978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633449|NCT02252978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633450|NCT02252978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633451|NCT02252978|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65633452|NCT02252978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65633453|NCT02129270|Lidocaine|lidocaine|mesh-list
65633454|NCT02129270|Anesthetics, Local|anesthetics, local|mesh-ancestor
65633455|NCT02129270|Anesthetics|anesthetics|mesh-ancestor
65633456|NCT02129270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65633457|NCT02129270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633458|NCT02129270|Sensory System Agents|sensory system agents|mesh-ancestor
65633459|NCT02129270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65633460|NCT02129270|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65633461|NCT02129270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65633462|NCT02129270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65633463|NCT02129270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65633464|NCT02129270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633465|NCT05370547|Cyclophosphamide|cyclophosphamide|mesh-list
65633466|NCT05370547|Fludarabine|fludarabine|mesh-list
65633467|NCT05370547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65633468|NCT05370547|Immunologic Factors|immunologic factors|mesh-ancestor
65633469|NCT05370547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633470|NCT05370547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65633471|NCT05370547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65633472|NCT05370547|Alkylating Agents|alkylating agents|mesh-ancestor
65633473|NCT05370547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633474|NCT05370547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633475|NCT05370547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65633476|NCT02133326|Acetaminophen|acetaminophen|mesh-list
65633477|NCT02133326|Ibuprofen|ibuprofen|mesh-list
65633478|NCT02133326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65633479|NCT02133326|Analgesics|analgesics|mesh-ancestor
65633480|NCT02133326|Sensory System Agents|sensory system agents|mesh-ancestor
65633481|NCT02133326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65633482|NCT02133326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633483|NCT02133326|Antipyretics|antipyretics|mesh-ancestor
65633484|NCT02133326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65633485|NCT02133326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65633486|NCT02133326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65633487|NCT02133326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65633488|NCT02133326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633489|NCT02133326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633490|NCT02137616|Olanzapine|olanzapine|mesh-list
65633491|NCT02137616|Risperidone|risperidone|mesh-list
65633492|NCT02137616|Aripiprazole|aripiprazole|mesh-list
65633493|NCT02137616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65633494|NCT02137616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65633495|NCT02137616|Serotonin Agents|serotonin agents|mesh-ancestor
65633496|NCT02137616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65633497|NCT02137616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633498|NCT02137616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633499|NCT02137616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65633500|NCT02137616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65633501|NCT02137616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65633502|NCT02137616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65633503|NCT02137616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65633504|NCT02137616|Dopamine Agents|dopamine agents|mesh-ancestor
65633505|NCT02137616|Antiemetics|antiemetics|mesh-ancestor
65633506|NCT02137616|Autonomic Agents|autonomic agents|mesh-ancestor
65633507|NCT02137616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65633508|NCT02137616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65633509|NCT02137616|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65633510|NCT02137616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65633511|NCT02137616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65633512|NCT02137616|Antidepressive Agents|antidepressive agents|mesh-ancestor
65633513|NCT02137616|Dopamine Agonists|dopamine agonists|mesh-ancestor
65633514|NCT02137616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65633515|NCT02137616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65633516|NCT02137616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65633517|NCT02137616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65633518|NCT02133638|Propofol|propofol|mesh-list
65633519|NCT02133638|Sevoflurane|sevoflurane|mesh-list
65633520|NCT02133638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65633521|NCT02133638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65633522|NCT02133638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633523|NCT02133638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65633524|NCT02133638|Anesthetics, General|anesthetics, general|mesh-ancestor
65633525|NCT02133638|Anesthetics|anesthetics|mesh-ancestor
65633526|NCT02133638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65633527|NCT02133638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65633528|NCT02545283|Cytarabine|cytarabine|mesh-list
65633529|NCT02545283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65633530|NCT02545283|Antimetabolites|antimetabolites|mesh-ancestor
65633531|NCT02545283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633532|NCT02545283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633533|NCT02545283|Antiviral Agents|antiviral agents|mesh-ancestor
65633534|NCT02545283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65633535|NCT02545283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65633536|NCT02545283|Immunologic Factors|immunologic factors|mesh-ancestor
65633537|NCT02545283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633538|NCT02137928|Carboplatin|carboplatin|mesh-list
65633540|NCT02137928|Etoposide phosphate|etoposide phosphate|mesh-list
65633541|NCT02137928|Vincristine|vincristine|mesh-list
65633542|NCT02137928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633543|NCT02137928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65633544|NCT02137928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65633545|NCT02137928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65633546|NCT02137928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633547|NCT02137928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633548|NCT02137928|Tubulin Modulators|tubulin modulators|mesh-ancestor
65633549|NCT02137928|Antimitotic Agents|antimitotic agents|mesh-ancestor
65633550|NCT02137928|Mitosis Modulators|mitosis modulators|mesh-ancestor
65633551|NCT02138084|Ritonavir|ritonavir|mesh-list
65633552|NCT02138084|Fostemsavir|fostemsavir|mesh-list
65633553|NCT02138084|Rifabutin|rifabutin|mesh-list
65633554|NCT02138084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65633555|NCT02138084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65633556|NCT02138084|Protease Inhibitors|protease inhibitors|mesh-ancestor
65633557|NCT02138084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633558|NCT02138084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633559|NCT02138084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65633560|NCT02138084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65633561|NCT02138084|Antiviral Agents|antiviral agents|mesh-ancestor
65633562|NCT02138084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65633563|NCT02138084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65633564|NCT02138084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65633565|NCT02138084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65633566|NCT02138084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65633567|NCT02138084|Antitubercular Agents|antitubercular agents|mesh-ancestor
65633568|NCT02138084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65633569|NCT02138084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65633570|NCT02129582|Methotrexate|methotrexate|mesh-list
65633571|NCT02129582|Fludarabine phosphate|fludarabine phosphate|mesh-list
65633572|NCT02129582|Fludarabine|fludarabine|mesh-list
65633573|NCT02129582|Busulfan|busulfan|mesh-list
65633574|NCT02129582|Tacrolimus|tacrolimus|mesh-list
65633575|NCT02129582|Thymoglobulin|thymoglobulin|mesh-list
65633576|NCT02129582|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65633577|NCT02129582|Immunoglobulins|immunoglobulins|mesh-list
65633578|NCT02129582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65633579|NCT02129582|Abortifacient Agents|abortifacient agents|mesh-ancestor
65633580|NCT02129582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65633581|NCT02129582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633582|NCT02129582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65633583|NCT02129582|Antimetabolites|antimetabolites|mesh-ancestor
65633584|NCT02129582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633585|NCT02129582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633586|NCT02129582|Dermatologic Agents|dermatologic agents|mesh-ancestor
65633587|NCT02129582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633588|NCT02129582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65633589|NCT02129582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65633590|NCT02129582|Immunologic Factors|immunologic factors|mesh-ancestor
65633591|NCT02129582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65633592|NCT02129582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65633593|NCT02129582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65633594|NCT02129582|Alkylating Agents|alkylating agents|mesh-ancestor
65633595|NCT02129582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65633596|NCT02129582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65633597|NCT05037487|Dronabinol|dronabinol|mesh-list
65633598|NCT05037487|Hallucinogens|hallucinogens|mesh-ancestor
65633599|NCT05037487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633600|NCT05037487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65633601|NCT05037487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65633602|NCT05037487|Analgesics|analgesics|mesh-ancestor
65633603|NCT05037487|Sensory System Agents|sensory system agents|mesh-ancestor
65633604|NCT05037487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65633605|NCT05037487|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65633606|NCT05037487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65633607|NCT05037487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65633608|NCT05037487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633609|NCT05037487|Hormones|hormones|mesh-ancestor
65633610|NCT05037487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65633611|NCT05162443|Adagrasib|adagrasib|mesh-list
65633612|NCT05162443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633613|NCT02138396|Fentanyl|fentanyl|mesh-list
65633614|NCT02138396|Naltrexone|naltrexone|mesh-list
65633615|NCT02138396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65633616|NCT02138396|Narcotics|narcotics|mesh-ancestor
65633617|NCT02138396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65633618|NCT02138396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633619|NCT02138396|Analgesics|analgesics|mesh-ancestor
65633620|NCT02138396|Sensory System Agents|sensory system agents|mesh-ancestor
65633621|NCT02138396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65633622|NCT02138396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65633623|NCT02138396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65633624|NCT02138396|Anesthetics, General|anesthetics, general|mesh-ancestor
65633625|NCT02138396|Anesthetics|anesthetics|mesh-ancestor
65633626|NCT02138396|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65633627|NCT02138396|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65633628|NCT04560881|Vaccines|vaccines|mesh-list
65633629|NCT04560881|Immunologic Factors|immunologic factors|mesh-ancestor
65633630|NCT04560881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633631|NCT02828761|Calcium, Dietary|calcium, dietary|mesh-list
65633632|NCT02828761|Calcium|calcium|mesh-list
65633633|NCT02828761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65633634|NCT02828761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633635|NCT02828761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65633636|NCT02875613|Avelumab|avelumab|mesh-list
65633637|NCT02875613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65633638|NCT02875613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633639|NCT02815267|Minocycline|minocycline|mesh-list
65633640|NCT02815267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65633641|NCT02815267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65633642|NCT02130440|Resveratrol|resveratrol|mesh-list
65633643|NCT02130440|Antioxidants|antioxidants|mesh-ancestor
65633644|NCT02130440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633645|NCT02130440|Protective Agents|protective agents|mesh-ancestor
65633646|NCT02130440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633647|NCT02130440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633648|NCT02130440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65633649|NCT02138552|Octenidine|octenidine|mesh-list
65633650|NCT02138552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65633651|NCT02138552|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65633652|NCT02930837|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65633653|NCT02930837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65633654|NCT02930837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65633655|NCT02930837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633656|NCT02138708|Adenosine|adenosine|mesh-list
65633657|NCT02138708|Acetylcholine|acetylcholine|mesh-list
65633658|NCT02138708|Analgesics|analgesics|mesh-ancestor
65633659|NCT02138708|Sensory System Agents|sensory system agents|mesh-ancestor
65633660|NCT02138708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65633661|NCT02138708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633662|NCT02138708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65633663|NCT02138708|Vasodilator Agents|vasodilator agents|mesh-ancestor
65633664|NCT02138708|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65633665|NCT02138708|Purinergic Agonists|purinergic agonists|mesh-ancestor
65633666|NCT02138708|Purinergic Agents|purinergic agents|mesh-ancestor
65633667|NCT02138708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65633668|NCT02138708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633669|NCT02138708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65633670|NCT02138708|Cholinergic Agents|cholinergic agents|mesh-ancestor
65633671|NCT03633175|Progesterone|progesterone|mesh-list
65633672|NCT03633175|Progestins|progestins|mesh-ancestor
65633673|NCT03633175|Hormones|hormones|mesh-ancestor
65633674|NCT03633175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65633675|NCT03633175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633676|NCT02539693|Lidocaine|lidocaine|mesh-list
65633677|NCT02539693|Clonidine|clonidine|mesh-list
65633678|NCT02539693|Anesthetics, Local|anesthetics, local|mesh-ancestor
65633679|NCT02539693|Anesthetics|anesthetics|mesh-ancestor
65633680|NCT02539693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65633681|NCT02539693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633682|NCT02539693|Sensory System Agents|sensory system agents|mesh-ancestor
65633683|NCT02539693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65633684|NCT02539693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65633685|NCT02539693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65633686|NCT02539693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65633687|NCT02539693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65633688|NCT02539693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633689|NCT02539693|Analgesics|analgesics|mesh-ancestor
65431022|NCT00418938|Vitamins|vitamins|mesh-ancestor
65633691|NCT02539693|Sympatholytics|sympatholytics|mesh-ancestor
65633692|NCT02539693|Autonomic Agents|autonomic agents|mesh-ancestor
65633693|NCT02539693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65633694|NCT02539693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65633695|NCT02539693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65633696|NCT02539693|Adrenergic Agents|adrenergic agents|mesh-ancestor
65633697|NCT02539693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65633698|NCT05062135|Progesterone|progesterone|mesh-list
65633699|NCT05062135|Progestins|progestins|mesh-ancestor
65633700|NCT05062135|Hormones|hormones|mesh-ancestor
65633701|NCT05062135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65633702|NCT05062135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633703|NCT02130518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65633704|NCT02134106|Polymyxins|polymyxins|mesh-list
65633705|NCT02134106|Doripenem|doripenem|mesh-list
65633706|NCT02134106|Polymyxin B|polymyxin b|mesh-list
65633707|NCT02134106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65633708|NCT02134106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65633709|NCT01354301|Mycophenolic Acid|mycophenolic acid|mesh-list
65633710|NCT01354301|Everolimus|everolimus|mesh-list
65633711|NCT01354301|Tacrolimus|tacrolimus|mesh-list
65633712|NCT01354301|Thymoglobulin|thymoglobulin|mesh-list
65633713|NCT01354301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65633714|NCT01354301|Immunologic Factors|immunologic factors|mesh-ancestor
65633715|NCT01354301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633716|NCT01354301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65633717|NCT01354301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633718|NCT01354301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633719|NCT01354301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633720|NCT01354301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65633721|NCT01354301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65633722|NCT01354301|Antitubercular Agents|antitubercular agents|mesh-ancestor
65633723|NCT01354301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65633724|NCT01354301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65633725|NCT02134262|Cyclophosphamide|cyclophosphamide|mesh-list
65633726|NCT02134262|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65633727|NCT02134262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65633728|NCT02134262|Immunologic Factors|immunologic factors|mesh-ancestor
65633729|NCT02134262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633730|NCT02134262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65633731|NCT02134262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65633732|NCT02134262|Alkylating Agents|alkylating agents|mesh-ancestor
65633733|NCT02134262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633734|NCT02134262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633735|NCT02134262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65633736|NCT01343277|Dacarbazine|dacarbazine|mesh-list
65633737|NCT01343277|Trabectedin|trabectedin|mesh-list
65633738|NCT01343277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65633739|NCT01343277|Alkylating Agents|alkylating agents|mesh-ancestor
65633740|NCT01343277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633741|NCT01343277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633742|NCT04856293|Crizotinib|crizotinib|mesh-list
65633743|NCT04856293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633744|NCT04856293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65633745|NCT04856293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633746|NCT04856293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633747|NCT02253212|Carboplatin|carboplatin|mesh-list
65633748|NCT02253212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633749|NCT01355939|Zinc Oxide|zinc oxide|mesh-list
65633750|NCT01355939|Dermatologic Agents|dermatologic agents|mesh-ancestor
65633751|NCT01355939|Sunscreening Agents|sunscreening agents|mesh-ancestor
65633752|NCT01355939|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65633753|NCT01355939|Protective Agents|protective agents|mesh-ancestor
65633754|NCT01355939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633755|NCT01356017|Amlodipine|amlodipine|mesh-list
65633756|NCT01356017|Telmisartan|telmisartan|mesh-list
65633757|NCT01356017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65633758|NCT01356017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65633759|NCT01356017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65633760|NCT01356017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633761|NCT01356017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65633762|NCT01356017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633763|NCT01356017|Vasodilator Agents|vasodilator agents|mesh-ancestor
65431094|NCT01039740|Histamine Antagonists|histamine antagonists|mesh-ancestor
65633764|NCT01356017|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65633765|NCT01356017|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65633767|NCT02139098|Zolpidem|zolpidem|mesh-list
65633768|NCT02139098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65633769|NCT02139098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65633770|NCT02139098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65633771|NCT02139098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633772|NCT02139098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65633773|NCT02139098|GABA Agonists|gaba agonists|mesh-ancestor
65633774|NCT02139098|GABA Agents|gaba agents|mesh-ancestor
65633775|NCT02139098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65633776|NCT02139098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633777|NCT02139098|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65633778|NCT02139098|Antidepressive Agents|antidepressive agents|mesh-ancestor
65633779|NCT02139098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65633780|NCT02139098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65633781|NCT02139098|Analgesics|analgesics|mesh-ancestor
65633782|NCT02139098|Sensory System Agents|sensory system agents|mesh-ancestor
65633783|NCT02139098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65633784|NCT02139098|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65633785|NCT02139098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65633786|NCT02139098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65633787|NCT02139098|Adrenergic Agents|adrenergic agents|mesh-ancestor
65633788|NCT04498715|Zoledronic Acid|zoledronic acid|mesh-list
65633789|NCT04498715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65633790|NCT04498715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633791|NCT02487979|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
65633792|NCT02487979|Immunoconjugates|immunoconjugates|mesh-list
65633793|NCT02487979|Immunotoxins|immunotoxins|mesh-list
65633794|NCT02487979|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65633795|NCT02487979|Immunologic Factors|immunologic factors|mesh-ancestor
65633796|NCT02487979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633797|NCT02487979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65633798|NCT02487979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633799|NCT02130830|Lidocaine|lidocaine|mesh-list
65633800|NCT02130830|Prilocaine|prilocaine|mesh-list
65633801|NCT02130830|Anesthetics, Local|anesthetics, local|mesh-ancestor
65633802|NCT02130830|Anesthetics|anesthetics|mesh-ancestor
65633803|NCT02130830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65633804|NCT02130830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633805|NCT02130830|Sensory System Agents|sensory system agents|mesh-ancestor
65633806|NCT02130830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65633807|NCT02130830|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65633808|NCT02130830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65633809|NCT02130830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65633810|NCT02130830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65633811|NCT02130830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633812|NCT04471727|Atezolizumab|atezolizumab|mesh-list
65633813|NCT04471727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633814|NCT01360151|Ranibizumab|ranibizumab|mesh-list
65633815|NCT01360151|Verteporfin|verteporfin|mesh-list
65633816|NCT01360151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65633817|NCT01360151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65633818|NCT01360151|Growth Substances|growth substances|mesh-ancestor
65633819|NCT01360151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633820|NCT01360151|Growth Inhibitors|growth inhibitors|mesh-ancestor
65633821|NCT01360151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633822|NCT01360151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65633823|NCT01360151|Dermatologic Agents|dermatologic agents|mesh-ancestor
65633824|NCT01363037|Maraviroc|maraviroc|mesh-list
65633825|NCT01363037|Dapivirine|dapivirine|mesh-list
65633826|NCT01363037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65633827|NCT01363037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65633828|NCT01363037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633829|NCT01363037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65633830|NCT01363037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65633831|NCT01363037|Antiviral Agents|antiviral agents|mesh-ancestor
65633832|NCT01363037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65633833|NCT01363037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65633834|NCT01363115|Vitamin D|vitamin d|mesh-list
65633835|NCT01363115|Calcium|calcium|mesh-list
65633836|NCT01363115|Vitamins|vitamins|mesh-ancestor
65633837|NCT01363115|Micronutrients|micronutrients|mesh-ancestor
65633838|NCT01363115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633839|NCT01363115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65633840|NCT01363115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65633842|NCT01356329|Enoxaparin|enoxaparin|mesh-list
65633843|NCT01356329|Anticoagulants|anticoagulants|mesh-ancestor
65633844|NCT01356329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65633845|NCT01356329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65633846|NCT01356329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633847|NCT05579522|Hyaluronic Acid|hyaluronic acid|mesh-list
65633848|NCT05579522|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65633849|NCT05579522|Immunologic Factors|immunologic factors|mesh-ancestor
65633850|NCT05579522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633851|NCT05579522|Viscosupplements|viscosupplements|mesh-ancestor
65633852|NCT05579522|Protective Agents|protective agents|mesh-ancestor
65633853|NCT01356485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65633854|NCT01363193|Heparin|heparin|mesh-list
65633855|NCT01363193|Calcium heparin|calcium heparin|mesh-list
65633856|NCT01363193|Anticoagulants|anticoagulants|mesh-ancestor
65633857|NCT01363193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65633858|NCT01363193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65633859|NCT01363193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633860|NCT01319279|Hydrocodone|hydrocodone|mesh-list
65633861|NCT01319279|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65633862|NCT01319279|Narcotics|narcotics|mesh-ancestor
65633863|NCT01319279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65633864|NCT01319279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633865|NCT01319279|Analgesics|analgesics|mesh-ancestor
65633866|NCT01319279|Sensory System Agents|sensory system agents|mesh-ancestor
65633867|NCT01319279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65633868|NCT01319279|Antitussive Agents|antitussive agents|mesh-ancestor
65633869|NCT01319279|Respiratory System Agents|respiratory system agents|mesh-ancestor
65633870|NCT01363271|Vancomycin|vancomycin|mesh-list
65633871|NCT01363271|Linezolid|linezolid|mesh-list
65633872|NCT01363271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65633873|NCT01363271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65633874|NCT01363271|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65633875|NCT01363271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633876|NCT01363271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633877|NCT02134886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65633878|NCT02134886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633879|NCT02134886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65633880|NCT02134886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633881|NCT02134886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633882|NCT01360463|Methadone|methadone|mesh-list
65633883|NCT01360463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65633884|NCT01360463|Narcotics|narcotics|mesh-ancestor
65633885|NCT01360463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65633886|NCT01360463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633887|NCT01360463|Analgesics|analgesics|mesh-ancestor
65633888|NCT01360463|Sensory System Agents|sensory system agents|mesh-ancestor
65633889|NCT01360463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65633890|NCT01360463|Antitussive Agents|antitussive agents|mesh-ancestor
65633891|NCT01360463|Respiratory System Agents|respiratory system agents|mesh-ancestor
65633892|NCT01356641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65633893|NCT01356641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65633894|NCT03103087|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65633895|NCT03103087|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65633896|NCT03103087|Norethindrone|norethindrone|mesh-list
65633897|NCT03103087|Norethindrone Acetate|norethindrone acetate|mesh-list
65633898|NCT03103087|Estradiol|estradiol|mesh-list
65633899|NCT03103087|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65633900|NCT03103087|Relugolix|relugolix|mesh-list
65633901|NCT03103087|Estrogens|estrogens|mesh-ancestor
65633902|NCT03103087|Hormones|hormones|mesh-ancestor
65633903|NCT03103087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65633904|NCT03103087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633905|NCT03103087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65633906|NCT03103087|Contraceptive Agents|contraceptive agents|mesh-ancestor
65633907|NCT03103087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65633908|NCT03103087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65633909|NCT03103087|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65633910|NCT03103087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65633911|NCT03103087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65633912|NCT03103087|Androgen Antagonists|androgen antagonists|mesh-ancestor
65633913|NCT03103087|Hormone Antagonists|hormone antagonists|mesh-ancestor
65633914|NCT05579288|Nitrous Oxide|nitrous oxide|mesh-list
65633915|NCT05579288|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65633916|NCT05579288|Anesthetics, General|anesthetics, general|mesh-ancestor
65633917|NCT05579288|Anesthetics|anesthetics|mesh-ancestor
65633918|NCT05579288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65633919|NCT05579288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633920|NCT05579288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65633921|NCT05579288|Analgesics|analgesics|mesh-ancestor
65633922|NCT05579288|Sensory System Agents|sensory system agents|mesh-ancestor
65633923|NCT05579288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65633924|NCT03132467|Durvalumab|durvalumab|mesh-list
65633925|NCT03132467|Ipilimumab|ipilimumab|mesh-list
65633926|NCT03132467|Tremelimumab|tremelimumab|mesh-list
65633927|NCT03132467|Immunoglobulins|immunoglobulins|mesh-list
65633928|NCT03132467|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65633929|NCT03132467|Immunoglobulin G|immunoglobulin g|mesh-list
65633930|NCT03132467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65633931|NCT03132467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633932|NCT03132467|Immunologic Factors|immunologic factors|mesh-ancestor
65633933|NCT03132467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633934|NCT03132467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65633935|NCT03132467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633936|NCT02134964|Dapansutrile|dapansutrile|mesh-list
65633937|NCT02134964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65633938|NCT01363583|Epoprostenol|epoprostenol|mesh-list
65633939|NCT01363583|Tezosentan|tezosentan|mesh-list
65633940|NCT01363583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65633941|NCT01363583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65633942|NCT01363583|Vasodilator Agents|vasodilator agents|mesh-ancestor
65633943|NCT02135120|Morphine|morphine|mesh-list
65633944|NCT02135120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65633945|NCT02135120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633946|NCT02135120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65633947|NCT02135120|Narcotics|narcotics|mesh-ancestor
65633948|NCT02135120|Analgesics|analgesics|mesh-ancestor
65633949|NCT02135120|Sensory System Agents|sensory system agents|mesh-ancestor
65633950|NCT02135120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65633951|NCT03131999|Imatinib Mesylate|imatinib mesylate|mesh-list
65633952|NCT03131999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633953|NCT03131999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65633954|NCT03131999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633955|NCT03131999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633956|NCT01319357|Saxagliptin|saxagliptin|mesh-list
65633957|NCT01319357|Incretins|incretins|mesh-ancestor
65633958|NCT01319357|Hormones|hormones|mesh-ancestor
65633959|NCT01319357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65633960|NCT01319357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633961|NCT01319357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65633962|NCT01319357|Protease Inhibitors|protease inhibitors|mesh-ancestor
65633963|NCT01319357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633964|NCT01319357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633965|NCT01319357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65633966|NCT02135354|Azithromycin|azithromycin|mesh-list
65633967|NCT02135354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65633968|NCT02135354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65633969|NCT02055053|Bupivacaine|bupivacaine|mesh-list
65633970|NCT02055053|Anesthetics, Local|anesthetics, local|mesh-ancestor
65633971|NCT02055053|Anesthetics|anesthetics|mesh-ancestor
65633972|NCT02055053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65633973|NCT02055053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633974|NCT02055053|Sensory System Agents|sensory system agents|mesh-ancestor
65633975|NCT02055053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65633976|NCT05198804|Niraparib|niraparib|mesh-list
65633977|NCT05198804|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65633978|NCT05198804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633979|NCT05198804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633980|NCT05198804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65633981|NCT02303431|Edoxaban|edoxaban|mesh-list
65633982|NCT02303431|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65633983|NCT02303431|Antithrombins|antithrombins|mesh-ancestor
65633984|NCT02303431|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65633985|NCT02303431|Protease Inhibitors|protease inhibitors|mesh-ancestor
65633986|NCT02303431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65633987|NCT02303431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65633988|NCT02303431|Anticoagulants|anticoagulants|mesh-ancestor
65633989|NCT02135510|Metoclopramide|metoclopramide|mesh-list
65633990|NCT02135510|Palonosetron|palonosetron|mesh-list
65633991|NCT02135510|Antiemetics|antiemetics|mesh-ancestor
65633992|NCT02135510|Autonomic Agents|autonomic agents|mesh-ancestor
65633993|NCT02135510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65633994|NCT02135510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65633995|NCT02135510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65633996|NCT02135510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65633997|NCT02135510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65633998|NCT02135510|Dopamine Agents|dopamine agents|mesh-ancestor
65633999|NCT02135510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65634000|NCT02135510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634001|NCT02135510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65634002|NCT02135510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65634003|NCT02135510|Serotonin Agents|serotonin agents|mesh-ancestor
65634004|NCT02004275|Dexamethasone|dexamethasone|mesh-list
65634005|NCT02004275|Pomalidomide|pomalidomide|mesh-list
65634006|NCT02004275|Ixazomib|ixazomib|mesh-list
65634007|NCT02004275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65634008|NCT02004275|Antiemetics|antiemetics|mesh-ancestor
65634009|NCT02004275|Autonomic Agents|autonomic agents|mesh-ancestor
65634010|NCT02004275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634011|NCT02004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634012|NCT02004275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65634013|NCT02004275|Glucocorticoids|glucocorticoids|mesh-ancestor
65634014|NCT02004275|Hormones|hormones|mesh-ancestor
65634015|NCT02004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65634016|NCT02004275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65634017|NCT02004275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634018|NCT02004275|Immunologic Factors|immunologic factors|mesh-ancestor
65634019|NCT02004275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65634020|NCT02004275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65634021|NCT02004275|Growth Substances|growth substances|mesh-ancestor
65634022|NCT02004275|Growth Inhibitors|growth inhibitors|mesh-ancestor
65634023|NCT02004275|Protease Inhibitors|protease inhibitors|mesh-ancestor
65634024|NCT02004275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634025|NCT02004275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634026|NCT03548714|Ethanol|ethanol|mesh-list
65634027|NCT03548714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65634028|NCT03548714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65634029|NCT03548714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65634030|NCT03548714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634031|NCT02135588|Plasminogen|plasminogen|mesh-list
65634032|NCT02135588|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65634033|NCT02135588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65634034|NCT02135588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65634035|NCT02135588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634036|NCT05578664|Pembrolizumab|pembrolizumab|mesh-list
65634037|NCT05578664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65634038|NCT05578664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634039|NCT01491763|Imatinib Mesylate|imatinib mesylate|mesh-list
65634040|NCT01491763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634041|NCT01491763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65634042|NCT01491763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634043|NCT01491763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634044|NCT01363817|Dexamethasone|dexamethasone|mesh-list
65634045|NCT01363817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65634046|NCT01363817|Antiemetics|antiemetics|mesh-ancestor
65634047|NCT01363817|Autonomic Agents|autonomic agents|mesh-ancestor
65634048|NCT01363817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634049|NCT01363817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634050|NCT01363817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65634051|NCT01363817|Glucocorticoids|glucocorticoids|mesh-ancestor
65634052|NCT01363817|Hormones|hormones|mesh-ancestor
65634053|NCT01363817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65634054|NCT01363817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65634055|NCT01363817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634056|NCT02140268|Midazolam|midazolam|mesh-list
65634057|NCT02140268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65634058|NCT02140268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65634059|NCT02140268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65634060|NCT02140268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634061|NCT02140268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65634062|NCT02140268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65634063|NCT02140268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65634064|NCT02140268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65634065|NCT02140268|Anesthetics, General|anesthetics, general|mesh-ancestor
65634066|NCT02140268|Anesthetics|anesthetics|mesh-ancestor
65634068|NCT02140268|GABA Agents|gaba agents|mesh-ancestor
65634069|NCT02140268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65634070|NCT02140268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634071|NCT05578352|Insulin|insulin|mesh-list
65634072|NCT05578352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65634073|NCT05578352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634074|NCT03602508|Solifenacin Succinate|solifenacin succinate|mesh-list
65634075|NCT03602508|Mirabegron|mirabegron|mesh-list
65634076|NCT03602508|Fesoterodine|fesoterodine|mesh-list
65634077|NCT03602508|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65634078|NCT03602508|Oxybutynin|oxybutynin|mesh-list
65634079|NCT03602508|Darifenacin|darifenacin|mesh-list
65634080|NCT03602508|Propiverine|propiverine|mesh-list
65634081|NCT03602508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65634082|NCT03602508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65634083|NCT03602508|Cholinergic Agents|cholinergic agents|mesh-ancestor
65634084|NCT03602508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65634085|NCT03602508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634086|NCT03602508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634087|NCT03602508|Urological Agents|urological agents|mesh-ancestor
65634088|NCT03602508|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65634089|NCT03602508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65634090|NCT03602508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65634091|NCT03602508|Adrenergic Agents|adrenergic agents|mesh-ancestor
65634092|NCT03602508|Parasympatholytics|parasympatholytics|mesh-ancestor
65634093|NCT03602508|Autonomic Agents|autonomic agents|mesh-ancestor
65634094|NCT03602508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634095|NCT03549728|Lenograstim|lenograstim|mesh-list
65634096|NCT03549728|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65634097|NCT03549728|Immunologic Factors|immunologic factors|mesh-ancestor
65634098|NCT03549728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634099|NCT01356797|Fentanyl|fentanyl|mesh-list
65634100|NCT01356797|Bupivacaine|bupivacaine|mesh-list
65634101|NCT01356797|Levobupivacaine|levobupivacaine|mesh-list
65634102|NCT01356797|Anesthetics, Local|anesthetics, local|mesh-ancestor
65634103|NCT01356797|Anesthetics|anesthetics|mesh-ancestor
65634104|NCT01356797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65634105|NCT01356797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634106|NCT01356797|Sensory System Agents|sensory system agents|mesh-ancestor
65634107|NCT01356797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634108|NCT01356797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65634109|NCT01356797|Narcotics|narcotics|mesh-ancestor
65634110|NCT01356797|Analgesics|analgesics|mesh-ancestor
65634111|NCT01356797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65634112|NCT01356797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65634113|NCT01356797|Anesthetics, General|anesthetics, general|mesh-ancestor
65634114|NCT02238132|Ipratropium|ipratropium|mesh-list
65634115|NCT02238132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65634116|NCT02238132|Autonomic Agents|autonomic agents|mesh-ancestor
65634117|NCT02238132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634118|NCT02238132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634119|NCT02238132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65634120|NCT02238132|Respiratory System Agents|respiratory system agents|mesh-ancestor
65634121|NCT02238132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65634122|NCT02238132|Cholinergic Agents|cholinergic agents|mesh-ancestor
65634123|NCT02238132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65634124|NCT02238132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634125|NCT05200429|Ivacaftor|ivacaftor|mesh-list
65634126|NCT05200429|Elexacaftor|elexacaftor|mesh-list
65634127|NCT05200429|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65634128|NCT05200429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65634129|NCT05200429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634130|NCT05578196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65634131|NCT02135822|Gemcitabine|gemcitabine|mesh-list
65634132|NCT02135822|Paclitaxel|paclitaxel|mesh-list
65634133|NCT02135822|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65634134|NCT02135822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65634135|NCT02135822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634136|NCT02135822|Tubulin Modulators|tubulin modulators|mesh-ancestor
65634137|NCT02135822|Antimitotic Agents|antimitotic agents|mesh-ancestor
65634138|NCT02135822|Mitosis Modulators|mitosis modulators|mesh-ancestor
65634139|NCT02135822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634140|NCT02135822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65634141|NCT02135822|Antimetabolites|antimetabolites|mesh-ancestor
65431478|NCT00455312|Hormones|hormones|mesh-ancestor
65634142|NCT02135822|Antiviral Agents|antiviral agents|mesh-ancestor
65634143|NCT02135822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65634144|NCT02135822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634145|NCT02135822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65634146|NCT02135822|Immunologic Factors|immunologic factors|mesh-ancestor
65634147|NCT02135822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634148|NCT02238210|Ipratropium|ipratropium|mesh-list
65634149|NCT02238210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65634150|NCT02238210|Autonomic Agents|autonomic agents|mesh-ancestor
65634151|NCT02238210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634152|NCT02238210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634153|NCT02238210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65634154|NCT02238210|Respiratory System Agents|respiratory system agents|mesh-ancestor
65634155|NCT02238210|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65634156|NCT02238210|Cholinergic Agents|cholinergic agents|mesh-ancestor
65634157|NCT02238210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65634158|NCT02238210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634159|NCT05739955|Disinfectants|disinfectants|mesh-list
65634160|NCT05739955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65634161|NCT02978456|Sirolimus|sirolimus|mesh-list
65634162|NCT02978456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65634163|NCT02978456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65634164|NCT02978456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65634165|NCT02978456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634166|NCT02978456|Antifungal Agents|antifungal agents|mesh-ancestor
65634167|NCT02978456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65634168|NCT02978456|Immunologic Factors|immunologic factors|mesh-ancestor
65634169|NCT02978456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634170|NCT05736913|Vaccines|vaccines|mesh-list
65634171|NCT05736913|Immunologic Factors|immunologic factors|mesh-ancestor
65634172|NCT05736913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634173|NCT03598452|Ganciclovir|ganciclovir|mesh-list
65634174|NCT03598452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65634175|NCT03598452|Antiviral Agents|antiviral agents|mesh-ancestor
65634176|NCT03598452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65634177|NCT03598452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65634178|NCT03598452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634179|NCT03598452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634180|NCT03549026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65634181|NCT03549026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65634182|NCT03549026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65634183|NCT03549026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65634184|NCT03549026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634185|NCT03549026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65634186|NCT03549026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634187|NCT03549026|Analgesics|analgesics|mesh-ancestor
65634188|NCT03549026|Sensory System Agents|sensory system agents|mesh-ancestor
65634189|NCT03549026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634190|NCT03549026|Antidepressive Agents|antidepressive agents|mesh-ancestor
65634191|NCT03549026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65634192|NCT03549026|Dopamine Agents|dopamine agents|mesh-ancestor
65634193|NCT03101371|Iodine|iodine|mesh-list
65634194|NCT03101371|Povidone-Iodine|povidone-iodine|mesh-list
65634195|NCT03101371|Povidone|povidone|mesh-list
65634196|NCT03101371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65634197|NCT03101371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65634198|NCT03101371|Trace Elements|trace elements|mesh-ancestor
65634199|NCT03101371|Micronutrients|micronutrients|mesh-ancestor
65634200|NCT03101371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634201|NCT03101371|Plasma Substitutes|plasma substitutes|mesh-ancestor
65634202|NCT03101371|Blood Substitutes|blood substitutes|mesh-ancestor
65634203|NCT03588078|Azacitidine|azacitidine|mesh-list
65634204|NCT03588078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65634205|NCT03588078|Antimetabolites|antimetabolites|mesh-ancestor
65634206|NCT03588078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634207|NCT03588078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634208|NCT03588078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634209|NCT02238366|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65634210|NCT02238366|Luteolytic Agents|luteolytic agents|mesh-ancestor
65634211|NCT02238366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65634212|NCT02238366|Contraceptive Agents|contraceptive agents|mesh-ancestor
65634213|NCT02238366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65634214|NCT02238366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634215|NCT02238366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65634216|NCT02238366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65431549|NCT03795194|Clavulanic Acid|clavulanic acid|mesh-list
65634217|NCT02238366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634218|NCT05494190|Docetaxel|docetaxel|mesh-list
65634219|NCT05494190|Capecitabine|capecitabine|mesh-list
65634220|NCT05494190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634221|NCT05494190|Tubulin Modulators|tubulin modulators|mesh-ancestor
65634222|NCT05494190|Antimitotic Agents|antimitotic agents|mesh-ancestor
65634223|NCT05494190|Mitosis Modulators|mitosis modulators|mesh-ancestor
65634224|NCT05494190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634225|NCT05494190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65634226|NCT05494190|Antimetabolites|antimetabolites|mesh-ancestor
65634227|NCT05364073|Aflutinib|aflutinib|mesh-list
65634228|NCT05364073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65634229|NCT05364073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634230|NCT05364073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634231|NCT02850276|Bromides|bromides|mesh-list
65634232|NCT02850276|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
65634233|NCT02850276|Anticonvulsants|anticonvulsants|mesh-ancestor
65634234|NCT02850276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65634235|NCT02850276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634236|NCT02850276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634237|NCT02850276|Cholinergic Agents|cholinergic agents|mesh-ancestor
65634238|NCT02850276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65634239|NCT02850276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634240|NCT04961593|Caspofungin|caspofungin|mesh-list
65634241|NCT04961593|Antifungal Agents|antifungal agents|mesh-ancestor
65634242|NCT04961593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65634243|NCT04961593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634244|NCT04961593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634245|NCT03862170|Ciprofloxacin|ciprofloxacin|mesh-list
65634246|NCT03862170|Cefazolin|cefazolin|mesh-list
65634247|NCT03862170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65634248|NCT03862170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65634249|NCT03862170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65634250|NCT03862170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65634251|NCT03862170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634252|NCT03862170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634253|NCT03862170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634254|NCT03862170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65634255|NCT03862170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65634256|NCT02140580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65634257|NCT02140580|Respiratory System Agents|respiratory system agents|mesh-ancestor
65634258|NCT05577806|Dydrogesterone|dydrogesterone|mesh-list
65634259|NCT05577806|Progestins|progestins|mesh-ancestor
65634260|NCT05577806|Hormones|hormones|mesh-ancestor
65634261|NCT05577806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65634262|NCT05577806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634263|NCT03591276|Antineoplastic Agents|antineoplastic agents|mesh-list
65634264|NCT03548948|Iron|iron|mesh-list
65634265|NCT03548948|Trace Elements|trace elements|mesh-ancestor
65634266|NCT03548948|Micronutrients|micronutrients|mesh-ancestor
65634267|NCT03548948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634268|NCT02238444|Aspirin|aspirin|mesh-list
65634269|NCT02238444|Heparin|heparin|mesh-list
65634270|NCT02238444|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65634271|NCT02238444|Tinzaparin|tinzaparin|mesh-list
65634272|NCT02238444|Dalteparin|dalteparin|mesh-list
65634273|NCT02238444|Dipyridamole|dipyridamole|mesh-list
65634274|NCT02238444|Warfarin|warfarin|mesh-list
65634275|NCT02238444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65634276|NCT02238444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65634277|NCT02238444|Analgesics|analgesics|mesh-ancestor
65634278|NCT02238444|Sensory System Agents|sensory system agents|mesh-ancestor
65634279|NCT02238444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634280|NCT02238444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634281|NCT02238444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65634282|NCT02238444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65634283|NCT02238444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65634284|NCT02238444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65634285|NCT02238444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634286|NCT02238444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65634287|NCT02238444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65634288|NCT02238444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634289|NCT02238444|Antipyretics|antipyretics|mesh-ancestor
65634290|NCT02238444|Anticoagulants|anticoagulants|mesh-ancestor
65634291|NCT02238444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65634292|NCT02238444|Vasodilator Agents|vasodilator agents|mesh-ancestor
65634293|NCT03131687|Dulaglutide|dulaglutide|mesh-list
65634294|NCT03131687|Tirzepatide|tirzepatide|mesh-list
65634295|NCT03131687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65634296|NCT03131687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634297|NCT03131687|Incretins|incretins|mesh-ancestor
65634298|NCT03131687|Hormones|hormones|mesh-ancestor
65267127|NCT02696330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65634299|NCT03131687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65634300|NCT03579888|Cyclophosphamide|cyclophosphamide|mesh-list
65634301|NCT03579888|Fludarabine|fludarabine|mesh-list
65634302|NCT03579888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65634303|NCT03579888|Immunologic Factors|immunologic factors|mesh-ancestor
65634304|NCT03579888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634305|NCT03579888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65634306|NCT03579888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65634307|NCT03579888|Alkylating Agents|alkylating agents|mesh-ancestor
65634308|NCT03579888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634309|NCT03579888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634310|NCT03579888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65634311|NCT05344027|Mitotane|mitotane|mesh-list
65634312|NCT05344027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65634313|NCT05344027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634314|NCT05430698|Antibodies|antibodies|mesh-list
65634315|NCT05430698|Immunologic Factors|immunologic factors|mesh-ancestor
65634316|NCT05430698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634317|NCT03585894|Ketorolac|ketorolac|mesh-list
65634318|NCT03585894|Sumatriptan|sumatriptan|mesh-list
65634319|NCT03585894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65634320|NCT03585894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65634321|NCT03585894|Analgesics|analgesics|mesh-ancestor
65634322|NCT03585894|Sensory System Agents|sensory system agents|mesh-ancestor
65634323|NCT03585894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634324|NCT03585894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634325|NCT03585894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65634326|NCT03585894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65634327|NCT03585894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65634328|NCT03585894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634329|NCT03585894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634330|NCT03585894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65634331|NCT03585894|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65634332|NCT03585894|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65634333|NCT03585894|Serotonin Agents|serotonin agents|mesh-ancestor
65634334|NCT03585894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65634335|NCT04912921|Palmidrol|palmidrol|mesh-list
65634336|NCT04912921|Curcumin|curcumin|mesh-list
65634337|NCT04912921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65634338|NCT04912921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65634339|NCT04912921|Analgesics|analgesics|mesh-ancestor
65634340|NCT04912921|Sensory System Agents|sensory system agents|mesh-ancestor
65634341|NCT04912921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634342|NCT04912921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634343|NCT04912921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65634344|NCT04912921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65634345|NCT04912921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634346|NCT04912921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634347|NCT04912921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634348|NCT04912921|Antiviral Agents|antiviral agents|mesh-ancestor
65634349|NCT04912921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65634350|NCT04912921|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65634351|NCT04912921|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65634352|NCT04912921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65634353|NCT04912921|Hormones|hormones|mesh-ancestor
65634354|NCT04912921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65634355|NCT05418361|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65634356|NCT05418361|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65634357|NCT05418361|Protease Inhibitors|protease inhibitors|mesh-ancestor
65634358|NCT05418361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634359|NCT05418361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634360|NCT05420324|Paclitaxel|paclitaxel|mesh-list
65634361|NCT05420324|Pembrolizumab|pembrolizumab|mesh-list
65634362|NCT05420324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65634363|NCT05420324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634364|NCT05420324|Tubulin Modulators|tubulin modulators|mesh-ancestor
65634365|NCT05420324|Antimitotic Agents|antimitotic agents|mesh-ancestor
65634366|NCT05420324|Mitosis Modulators|mitosis modulators|mesh-ancestor
65634367|NCT05420324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634368|NCT05420324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65634369|NCT02238288|Acetaminophen|acetaminophen|mesh-list
65634370|NCT02238288|Lidocaine|lidocaine|mesh-list
65634371|NCT02238288|Epinephrine|epinephrine|mesh-list
65634372|NCT02238288|Aminocaproic Acid|aminocaproic acid|mesh-list
65634373|NCT02238288|Anesthetics, Local|anesthetics, local|mesh-ancestor
65634374|NCT02238288|Anesthetics|anesthetics|mesh-ancestor
65634375|NCT02238288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65634376|NCT02238288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634377|NCT02238288|Sensory System Agents|sensory system agents|mesh-ancestor
65634378|NCT02238288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634379|NCT02238288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65634380|NCT02238288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65634381|NCT02238288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65634382|NCT02238288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65634383|NCT02238288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634384|NCT02238288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65634385|NCT02238288|Analgesics|analgesics|mesh-ancestor
65634386|NCT02238288|Antipyretics|antipyretics|mesh-ancestor
65634387|NCT02238288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65634388|NCT02238288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65634389|NCT02238288|Adrenergic Agents|adrenergic agents|mesh-ancestor
65634390|NCT02238288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65634391|NCT02238288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65634392|NCT02238288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65634393|NCT02238288|Autonomic Agents|autonomic agents|mesh-ancestor
65634394|NCT02238288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65634395|NCT02238288|Respiratory System Agents|respiratory system agents|mesh-ancestor
65634396|NCT02238288|Mydriatics|mydriatics|mesh-ancestor
65634397|NCT02238288|Sympathomimetics|sympathomimetics|mesh-ancestor
65634398|NCT02238288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65634399|NCT02238288|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65267141|NCT00647127|Fentanyl|fentanyl|mesh-list
65634400|NCT02238288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65634401|NCT02238288|Hemostatics|hemostatics|mesh-ancestor
65634402|NCT02238288|Coagulants|coagulants|mesh-ancestor
65634403|NCT01561040|Vitamin D|vitamin d|mesh-list
65634404|NCT01561040|Vitamin A|vitamin a|mesh-list
65634405|NCT01561040|Vitamins|vitamins|mesh-ancestor
65634406|NCT01561040|Micronutrients|micronutrients|mesh-ancestor
65634407|NCT01561040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634408|NCT01561040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65634409|NCT03590496|Calcium|calcium|mesh-list
65634410|NCT03590496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65634411|NCT03590496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634412|NCT05577260|Dexmedetomidine|dexmedetomidine|mesh-list
65634413|NCT05577260|Bupivacaine|bupivacaine|mesh-list
65634414|NCT05577260|Anesthetics, Local|anesthetics, local|mesh-ancestor
65634415|NCT05577260|Anesthetics|anesthetics|mesh-ancestor
65634416|NCT05577260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65634417|NCT05577260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634418|NCT05577260|Sensory System Agents|sensory system agents|mesh-ancestor
65634419|NCT05577260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634420|NCT05577260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65634421|NCT05577260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65634422|NCT05577260|Analgesics|analgesics|mesh-ancestor
65634423|NCT05577260|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65634424|NCT05577260|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65634425|NCT05577260|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65634426|NCT05577260|Adrenergic Agents|adrenergic agents|mesh-ancestor
65634427|NCT05577260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65634428|NCT05577260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634429|NCT03760562|Glucocorticoids|glucocorticoids|mesh-list
65634430|NCT03760562|Hormones|hormones|mesh-ancestor
65634431|NCT03760562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65634432|NCT03760562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634433|NCT01357031|Amitriptyline|amitriptyline|mesh-list
65634434|NCT01357031|Melatonin|melatonin|mesh-list
65634435|NCT01357031|Antioxidants|antioxidants|mesh-ancestor
65634436|NCT01357031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634437|NCT01357031|Protective Agents|protective agents|mesh-ancestor
65634438|NCT01357031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634439|NCT01357031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65634440|NCT01357031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65634441|NCT01357031|Antidepressive Agents|antidepressive agents|mesh-ancestor
65634442|NCT01357031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65634443|NCT01357031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65634444|NCT01357031|Analgesics|analgesics|mesh-ancestor
65634445|NCT01357031|Sensory System Agents|sensory system agents|mesh-ancestor
65634446|NCT01357031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634447|NCT01357031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65634448|NCT01357031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65634449|NCT01357031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65634450|NCT01357031|Adrenergic Agents|adrenergic agents|mesh-ancestor
65634451|NCT01357031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65634452|NCT01357109|Bosentan|bosentan|mesh-list
65634453|NCT01357109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65634454|NCT01357109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65634455|NCT01357109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634456|NCT04792580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65634457|NCT04792580|Lifitegrast|lifitegrast|mesh-list
65634458|NCT04792580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65634459|NCT02253446|Diclofenac|diclofenac|mesh-list
65634460|NCT02253446|Piroxicam|piroxicam|mesh-list
65634461|NCT02253446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65634462|NCT02253446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65634463|NCT02253446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65634464|NCT02253446|Analgesics|analgesics|mesh-ancestor
65634465|NCT02253446|Sensory System Agents|sensory system agents|mesh-ancestor
65634466|NCT02253446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634467|NCT02253446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634468|NCT02253446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65634469|NCT02253446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65634470|NCT02253446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65634471|NCT02253446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634472|NCT02253446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634473|NCT05417893|Sirolimus|sirolimus|mesh-list
65634474|NCT05417893|Everolimus|everolimus|mesh-list
65634475|NCT05417893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634476|NCT05417893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65634477|NCT05417893|Immunologic Factors|immunologic factors|mesh-ancestor
65634478|NCT05417893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634479|NCT05417893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65634480|NCT05417893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65634481|NCT05417893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65634482|NCT05417893|Antifungal Agents|antifungal agents|mesh-ancestor
65634483|NCT03585348|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
65634484|NCT03585348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65634485|NCT03585348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634486|NCT03585348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634487|NCT03347617|Pembrolizumab|pembrolizumab|mesh-list
65634488|NCT03347617|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65634489|NCT03347617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65634490|NCT03347617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634491|NCT03347617|Hematinics|hematinics|mesh-ancestor
65634492|NCT03347617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65634493|NCT03347617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65634494|NCT05384678|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
65634495|NCT05384678|Hallucinogens|hallucinogens|mesh-ancestor
65634496|NCT05384678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634497|NCT05384678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65634498|NCT05384678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65634499|NCT05384678|Serotonin Agents|serotonin agents|mesh-ancestor
65634500|NCT05384678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65634501|NCT05384678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634502|NCT05384678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65634503|NCT01563224|Baclofen|baclofen|mesh-list
65634504|NCT01563224|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65634505|NCT01563224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634506|NCT01563224|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65634507|NCT01563224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634508|NCT01563224|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65634509|NCT01563224|GABA Agonists|gaba agonists|mesh-ancestor
65634510|NCT01563224|GABA Agents|gaba agents|mesh-ancestor
65634511|NCT01563224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65634512|NCT01563224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634513|NCT01369979|Imidacloprid|imidacloprid|mesh-list
65634514|NCT01369979|Cholinergic Agents|cholinergic agents|mesh-ancestor
65634515|NCT01369979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65634516|NCT01369979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634517|NCT01369979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634518|NCT03577860|Bupivacaine|bupivacaine|mesh-list
65634519|NCT03577860|Anesthetics, Local|anesthetics, local|mesh-ancestor
65634520|NCT03577860|Anesthetics|anesthetics|mesh-ancestor
65634521|NCT03577860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65634522|NCT03577860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634523|NCT03577860|Sensory System Agents|sensory system agents|mesh-ancestor
65634524|NCT03577860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634525|NCT03577782|Vedolizumab|vedolizumab|mesh-list
65634526|NCT03577782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65634527|NCT03432065|Buspirone|buspirone|mesh-list
65634528|NCT03432065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65634529|NCT03432065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65634530|NCT03432065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65634531|NCT03432065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634532|NCT03432065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65634533|NCT03432065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65634534|NCT03432065|Serotonin Agents|serotonin agents|mesh-ancestor
65634535|NCT03432065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65634536|NCT03432065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634537|NCT03577626|Hemay005|hemay005|mesh-list
65634538|NCT03577626|Dermatologic Agents|dermatologic agents|mesh-ancestor
65634539|NCT03577626|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65634540|NCT03577626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65634541|NCT03577626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634542|NCT03577626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634543|NCT03412799|Gemcitabine|gemcitabine|mesh-list
65634544|NCT03412799|Paclitaxel|paclitaxel|mesh-list
65634545|NCT03412799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65634546|NCT03412799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65634547|NCT03412799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634548|NCT03412799|Tubulin Modulators|tubulin modulators|mesh-ancestor
65634549|NCT03412799|Antimitotic Agents|antimitotic agents|mesh-ancestor
65634550|NCT03412799|Mitosis Modulators|mitosis modulators|mesh-ancestor
65634551|NCT03412799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634552|NCT03412799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65634553|NCT03412799|Antimetabolites|antimetabolites|mesh-ancestor
65634554|NCT03412799|Antiviral Agents|antiviral agents|mesh-ancestor
65634555|NCT03412799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65634556|NCT03412799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634557|NCT03412799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65634558|NCT03412799|Immunologic Factors|immunologic factors|mesh-ancestor
65634559|NCT03412799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634560|NCT03579732|Aspirin|aspirin|mesh-list
65634561|NCT03579732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65634562|NCT03579732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65634563|NCT03579732|Analgesics|analgesics|mesh-ancestor
65634564|NCT03579732|Sensory System Agents|sensory system agents|mesh-ancestor
65634565|NCT03579732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634566|NCT03579732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634567|NCT03579732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65634568|NCT03579732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65634569|NCT03579732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65634570|NCT03579732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65634571|NCT03579732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634572|NCT03579732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65634573|NCT03579732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65634574|NCT03579732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634575|NCT03579732|Antipyretics|antipyretics|mesh-ancestor
65634576|NCT02259816|Amlodipine|amlodipine|mesh-list
65634577|NCT02259816|Telmisartan|telmisartan|mesh-list
65634578|NCT02259816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65634579|NCT02259816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65634580|NCT02259816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65634581|NCT02259816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634582|NCT02259816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65634583|NCT02259816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634584|NCT02259816|Vasodilator Agents|vasodilator agents|mesh-ancestor
65634585|NCT02259816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65634586|NCT02259816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65634587|NCT01567735|Simeprevir|simeprevir|mesh-list
65634588|NCT01567735|Antiviral Agents|antiviral agents|mesh-ancestor
65634589|NCT01567735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65634590|NCT01567735|Protease Inhibitors|protease inhibitors|mesh-ancestor
65634591|NCT01567735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634592|NCT01567735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634593|NCT04631471|Ibudilast|ibudilast|mesh-list
65634594|NCT04631471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65634595|NCT04631471|Autonomic Agents|autonomic agents|mesh-ancestor
65634596|NCT04631471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634597|NCT04631471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634598|NCT04631471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65634599|NCT04631471|Respiratory System Agents|respiratory system agents|mesh-ancestor
65634600|NCT04631471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65634601|NCT04631471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634602|NCT04631471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634603|NCT04631471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65634604|NCT04631471|Vasodilator Agents|vasodilator agents|mesh-ancestor
65634605|NCT03577392|Capecitabine|capecitabine|mesh-list
65634606|NCT03577392|Oxaliplatin|oxaliplatin|mesh-list
65634607|NCT03577392|Endostatins|endostatins|mesh-list
65634608|NCT03577392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65634609|NCT03577392|Antimetabolites|antimetabolites|mesh-ancestor
65634610|NCT03577392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634611|NCT03577392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634612|NCT03577392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65634613|NCT03577392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65634614|NCT03577392|Growth Substances|growth substances|mesh-ancestor
65634615|NCT03577392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634616|NCT03577392|Growth Inhibitors|growth inhibitors|mesh-ancestor
65634617|NCT03579576|Ribavirin|ribavirin|mesh-list
65634618|NCT03579576|Sofosbuvir|sofosbuvir|mesh-list
65634619|NCT03579576|Velpatasvir|velpatasvir|mesh-list
65634620|NCT03579576|Antimetabolites|antimetabolites|mesh-ancestor
65634621|NCT03579576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634622|NCT03579576|Antiviral Agents|antiviral agents|mesh-ancestor
65634623|NCT03579576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65634624|NCT01364519|Fluticasone|fluticasone|mesh-list
65634625|NCT01364519|Xhance|xhance|mesh-list
65634626|NCT01364519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65634627|NCT01364519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65634628|NCT01364519|Autonomic Agents|autonomic agents|mesh-ancestor
65634629|NCT01364519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634630|NCT01364519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634631|NCT01364519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65634632|NCT01364519|Respiratory System Agents|respiratory system agents|mesh-ancestor
65634633|NCT01364519|Dermatologic Agents|dermatologic agents|mesh-ancestor
65634634|NCT01364519|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65634635|NCT04721132|Bevacizumab|bevacizumab|mesh-list
65634636|NCT04721132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65634637|NCT04721132|Atezolizumab|atezolizumab|mesh-list
65634638|NCT04721132|Endothelial Growth Factors|endothelial growth factors|mesh-list
65634639|NCT04721132|Antibodies|antibodies|mesh-list
65634640|NCT04721132|Immunoglobulins|immunoglobulins|mesh-list
65634641|NCT04721132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65634642|NCT04721132|Immunoglobulin G|immunoglobulin g|mesh-list
65634643|NCT04721132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634644|NCT04721132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65634645|NCT04721132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65634646|NCT04721132|Growth Substances|growth substances|mesh-ancestor
65634647|NCT04721132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634648|NCT04721132|Growth Inhibitors|growth inhibitors|mesh-ancestor
65634649|NCT04721132|Immunologic Factors|immunologic factors|mesh-ancestor
65634650|NCT03577158|Insulin|insulin|mesh-list
65634651|NCT03577158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65634652|NCT03577158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634653|NCT02253914|Ritonavir|ritonavir|mesh-list
65634654|NCT02253914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65634655|NCT02253914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65634656|NCT02253914|Protease Inhibitors|protease inhibitors|mesh-ancestor
65634657|NCT02253914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634658|NCT02253914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634659|NCT02253914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65634660|NCT02253914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65634661|NCT02253914|Antiviral Agents|antiviral agents|mesh-ancestor
65634662|NCT02253914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65634663|NCT02253914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65634664|NCT02253914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65634665|NCT01364675|Metformin|metformin|mesh-list
65432004|NCT01032434|Sertraline|sertraline|mesh-list
65634666|NCT01364675|Enalapril|enalapril|mesh-list
65634667|NCT01364675|Simvastatin|simvastatin|mesh-list
65634668|NCT01364675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65634669|NCT01364675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634670|NCT01364675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65634671|NCT01364675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65634672|NCT01364675|Antimetabolites|antimetabolites|mesh-ancestor
65634673|NCT01364675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634674|NCT01364675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65634675|NCT01364675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65634676|NCT01364675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634677|NCT01364675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65634678|NCT01364675|Protease Inhibitors|protease inhibitors|mesh-ancestor
65634679|NCT01364675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65634680|NCT02253758|Propofol|propofol|mesh-list
65634681|NCT02253758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65634682|NCT02253758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65634683|NCT02253758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634684|NCT02253758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65634685|NCT02253758|Anesthetics, General|anesthetics, general|mesh-ancestor
65634686|NCT02253758|Anesthetics|anesthetics|mesh-ancestor
65634687|NCT03547232|Indomethacin|indomethacin|mesh-list
65267183|NCT04750070|Protective Agents|protective agents|mesh-ancestor
65634688|NCT03547232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65634689|NCT03547232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65634690|NCT03547232|Analgesics|analgesics|mesh-ancestor
65634691|NCT03547232|Sensory System Agents|sensory system agents|mesh-ancestor
65634692|NCT03547232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634693|NCT03547232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634694|NCT03547232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65634695|NCT03547232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65634696|NCT03547232|Gout Suppressants|gout suppressants|mesh-ancestor
65634697|NCT03547232|Tocolytic Agents|tocolytic agents|mesh-ancestor
65634698|NCT03547232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65634699|NCT03547232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65634700|NCT03547232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634701|NCT03547232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634702|NCT02250534|Nicotine|nicotine|mesh-list
65634703|NCT02250534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65634704|NCT02250534|Autonomic Agents|autonomic agents|mesh-ancestor
65634705|NCT02250534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634706|NCT02250534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634707|NCT02250534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65634708|NCT02250534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65634709|NCT02250534|Cholinergic Agents|cholinergic agents|mesh-ancestor
65634710|NCT02250534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65634711|NCT02250534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634712|NCT01370135|Ranibizumab|ranibizumab|mesh-list
65634713|NCT01370135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65634714|NCT01370135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65634715|NCT01370135|Growth Substances|growth substances|mesh-ancestor
65634716|NCT01370135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634717|NCT01370135|Growth Inhibitors|growth inhibitors|mesh-ancestor
65634718|NCT01370135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634719|NCT05266586|Ezetimibe|ezetimibe|mesh-list
65634720|NCT05266586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65634721|NCT05266586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65634722|NCT05266586|Antimetabolites|antimetabolites|mesh-ancestor
65634723|NCT05266586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634724|NCT05266586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65634725|NCT01370291|Risperidone|risperidone|mesh-list
65634726|NCT01370291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65634727|NCT01370291|Serotonin Agents|serotonin agents|mesh-ancestor
65634728|NCT01370291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65634729|NCT01370291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634730|NCT01370291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634731|NCT01370291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65634732|NCT01370291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65634733|NCT01370291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65634734|NCT01370291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65634735|NCT01370291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65634736|NCT01370291|Dopamine Agents|dopamine agents|mesh-ancestor
65634737|NCT05575544|Morphine|morphine|mesh-list
65634738|NCT05575544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65634739|NCT05575544|Narcotics|narcotics|mesh-ancestor
65634740|NCT05575544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65634741|NCT05575544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634742|NCT05575544|Analgesics|analgesics|mesh-ancestor
65634743|NCT05575544|Sensory System Agents|sensory system agents|mesh-ancestor
65634744|NCT05575544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634745|NCT05179772|Olanzapine|olanzapine|mesh-list
65634746|NCT05179772|Antiemetics|antiemetics|mesh-ancestor
65634747|NCT05179772|Autonomic Agents|autonomic agents|mesh-ancestor
65634748|NCT05179772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634749|NCT05179772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634750|NCT05179772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65634751|NCT05179772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65634752|NCT05179772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65634753|NCT05179772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65634754|NCT05179772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65634755|NCT05179772|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65634756|NCT05179772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65634757|NCT05179772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65634758|NCT05179772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634759|NCT05179772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65634760|NCT05179772|Serotonin Agents|serotonin agents|mesh-ancestor
65634761|NCT04703426|Pembrolizumab|pembrolizumab|mesh-list
65634762|NCT04703426|Sargramostim|sargramostim|mesh-list
65634763|NCT04703426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65634764|NCT04703426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634765|NCT04703426|Immunologic Factors|immunologic factors|mesh-ancestor
65634766|NCT04703426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634767|NCT01364987|Mycophenolic Acid|mycophenolic acid|mesh-list
65634768|NCT01364987|Peficitinib|peficitinib|mesh-list
65634769|NCT01364987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65634770|NCT01364987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634771|NCT01364987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65634772|NCT01364987|Antitubercular Agents|antitubercular agents|mesh-ancestor
65634773|NCT01364987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65634774|NCT01364987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65634775|NCT01364987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634776|NCT01364987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634777|NCT01364987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65634778|NCT01364987|Immunologic Factors|immunologic factors|mesh-ancestor
65634779|NCT01364987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634780|NCT01365923|Dexmedetomidine|dexmedetomidine|mesh-list
65634781|NCT01365923|Remifentanil|remifentanil|mesh-list
65634782|NCT01365923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65634783|NCT01365923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65634784|NCT01365923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634785|NCT01365923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65634786|NCT01365923|Analgesics|analgesics|mesh-ancestor
65634787|NCT01365923|Sensory System Agents|sensory system agents|mesh-ancestor
65634788|NCT01365923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634789|NCT01365923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65634790|NCT01365923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65634791|NCT01365923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65634792|NCT01365923|Adrenergic Agents|adrenergic agents|mesh-ancestor
65634793|NCT01365923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65634794|NCT01365923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634795|NCT01365923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65634796|NCT01365923|Narcotics|narcotics|mesh-ancestor
65634797|NCT05264168|Rivaroxaban|rivaroxaban|mesh-list
65634798|NCT05264168|Apixaban|apixaban|mesh-list
65634799|NCT05264168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65634800|NCT05264168|Antithrombins|antithrombins|mesh-ancestor
65634801|NCT05264168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65634802|NCT05264168|Protease Inhibitors|protease inhibitors|mesh-ancestor
65634803|NCT05264168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634804|NCT05264168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634805|NCT05264168|Anticoagulants|anticoagulants|mesh-ancestor
65634806|NCT01370915|Vitamins|vitamins|mesh-list
65634807|NCT01370915|Pregabalin|pregabalin|mesh-list
65634808|NCT01370915|Micronutrients|micronutrients|mesh-ancestor
65634809|NCT01370915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634810|NCT01370915|Analgesics|analgesics|mesh-ancestor
65634811|NCT01370915|Sensory System Agents|sensory system agents|mesh-ancestor
65634812|NCT01370915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634813|NCT01370915|Anticonvulsants|anticonvulsants|mesh-ancestor
65634814|NCT01370915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65634815|NCT01370915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65634816|NCT01370915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634817|NCT01370915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65634818|NCT01370915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65634819|NCT01370915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65634820|NCT01370915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65634821|NCT01370915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65634822|NCT05574998|Paclitaxel|paclitaxel|mesh-list
65634823|NCT05574998|Cisplatin|cisplatin|mesh-list
65634824|NCT05574998|Carboplatin|carboplatin|mesh-list
65634825|NCT05574998|Pemetrexed|pemetrexed|mesh-list
65634826|NCT05574998|Endostar protein|endostar protein|mesh-list
65634827|NCT05574998|Endostatins|endostatins|mesh-list
65634828|NCT05574998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65634829|NCT05574998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634830|NCT05574998|Tubulin Modulators|tubulin modulators|mesh-ancestor
65634831|NCT05574998|Antimitotic Agents|antimitotic agents|mesh-ancestor
65634832|NCT05574998|Mitosis Modulators|mitosis modulators|mesh-ancestor
65634833|NCT05574998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634834|NCT05574998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634835|NCT05574998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65634836|NCT05574998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65634837|NCT05574998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65634838|NCT05574998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65634839|NCT05574998|Growth Substances|growth substances|mesh-ancestor
65634840|NCT05574998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634841|NCT05574998|Growth Inhibitors|growth inhibitors|mesh-ancestor
65634842|NCT03547778|Misoprostol|misoprostol|mesh-list
65634843|NCT03547778|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65634844|NCT03547778|Abortifacient Agents|abortifacient agents|mesh-ancestor
65634845|NCT03547778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65634846|NCT03547778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634847|NCT03547778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65634848|NCT03547778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65634849|NCT03547778|Oxytocics|oxytocics|mesh-ancestor
65634850|NCT03547700|Ixazomib|ixazomib|mesh-list
65634851|NCT03547700|Romidepsin|romidepsin|mesh-list
65634852|NCT03547700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634853|NCT03547700|Protease Inhibitors|protease inhibitors|mesh-ancestor
65634854|NCT03547700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634855|NCT03547700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634856|NCT03547700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65634857|NCT02239458|Saxagliptin|saxagliptin|mesh-list
65634858|NCT02239458|Incretins|incretins|mesh-ancestor
65634859|NCT02239458|Hormones|hormones|mesh-ancestor
65634860|NCT02239458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65634861|NCT02239458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634862|NCT02239458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65634863|NCT02239458|Protease Inhibitors|protease inhibitors|mesh-ancestor
65634864|NCT02239458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634865|NCT02239458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634866|NCT02239458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65634867|NCT03578874|Capecitabine|capecitabine|mesh-list
65634868|NCT03578874|Oxaliplatin|oxaliplatin|mesh-list
65634869|NCT03578874|Sorafenib|sorafenib|mesh-list
65634870|NCT03578874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65634871|NCT03578874|Antimetabolites|antimetabolites|mesh-ancestor
65634872|NCT03578874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634873|NCT03578874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634874|NCT03578874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65634875|NCT03578874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634876|NCT04586504|Midazolam|midazolam|mesh-list
65634877|NCT04586504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65634878|NCT04586504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65634879|NCT04586504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65634880|NCT04586504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634881|NCT04586504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65634882|NCT04586504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65634883|NCT04586504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65634884|NCT04586504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65634885|NCT04586504|Anesthetics, General|anesthetics, general|mesh-ancestor
65634886|NCT04586504|Anesthetics|anesthetics|mesh-ancestor
65634887|NCT04586504|GABA Modulators|gaba modulators|mesh-ancestor
65634888|NCT04586504|GABA Agents|gaba agents|mesh-ancestor
65634889|NCT04586504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65634890|NCT04586504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634891|NCT01366001|Buprenorphine|buprenorphine|mesh-list
65634892|NCT01366001|ALKS-33|alks-33|mesh-list
65634893|NCT01366001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65634894|NCT01366001|Narcotics|narcotics|mesh-ancestor
65634895|NCT01366001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65432241|NCT01041378|Hormones|hormones|mesh-ancestor
65634896|NCT01366001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634898|NCT01366001|Sensory System Agents|sensory system agents|mesh-ancestor
65634899|NCT01366001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634900|NCT01366001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65634901|NCT01365065|Vorinostat|vorinostat|mesh-list
65634902|NCT01365065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634903|NCT01365065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65634904|NCT01365065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634905|NCT01365065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634906|NCT03576456|Alprazolam|alprazolam|mesh-list
65634907|NCT03576456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65634908|NCT03576456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65634909|NCT03576456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634910|NCT03576456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65634911|NCT03576456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65634912|NCT03576456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65634913|NCT03576456|GABA Modulators|gaba modulators|mesh-ancestor
65634914|NCT03576456|GABA Agents|gaba agents|mesh-ancestor
65634915|NCT03576456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65634916|NCT03576456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634917|NCT03576378|Prednisone|prednisone|mesh-list
65634918|NCT03576378|Cyclophosphamide|cyclophosphamide|mesh-list
65634919|NCT03576378|Etoposide|etoposide|mesh-list
65634920|NCT03576378|Mitoxantrone|mitoxantrone|mesh-list
65634921|NCT03576378|Procarbazine|procarbazine|mesh-list
65634922|NCT03576378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65634923|NCT03576378|Immunologic Factors|immunologic factors|mesh-ancestor
65634924|NCT03576378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634925|NCT03576378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65634926|NCT03576378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65634927|NCT03576378|Alkylating Agents|alkylating agents|mesh-ancestor
65634928|NCT03576378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634929|NCT03576378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634930|NCT03576378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65634931|NCT03576378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65634932|NCT03576378|Glucocorticoids|glucocorticoids|mesh-ancestor
65634933|NCT03576378|Hormones|hormones|mesh-ancestor
65634934|NCT03576378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65634935|NCT03576378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65634936|NCT03576378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65634937|NCT03576378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65634938|NCT03576378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65634939|NCT03576378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634940|NCT03576378|Analgesics|analgesics|mesh-ancestor
65634941|NCT03576378|Sensory System Agents|sensory system agents|mesh-ancestor
65634942|NCT03576378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634943|NCT05572190|Hydrocodone|hydrocodone|mesh-list
65634944|NCT05572190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65634945|NCT05572190|Narcotics|narcotics|mesh-ancestor
65634946|NCT05572190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65634947|NCT05572190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634948|NCT05572190|Analgesics|analgesics|mesh-ancestor
65634949|NCT05572190|Sensory System Agents|sensory system agents|mesh-ancestor
65634950|NCT05572190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634951|NCT05572190|Antitussive Agents|antitussive agents|mesh-ancestor
65634952|NCT05572190|Respiratory System Agents|respiratory system agents|mesh-ancestor
65634953|NCT01365221|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65634954|NCT01365221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65634955|NCT05567588|Pembrolizumab|pembrolizumab|mesh-list
65634956|NCT05567588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65634957|NCT05567588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65634958|NCT03124199|Rifaximin|rifaximin|mesh-list
65634959|NCT03124199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65634960|NCT03124199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65634961|NCT03124199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65634962|NCT03578640|Grazoprevir|grazoprevir|mesh-list
65634963|NCT03578640|Antiviral Agents|antiviral agents|mesh-ancestor
65634964|NCT03578640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65634965|NCT04465916|Tenofovir|tenofovir|mesh-list
65634966|NCT04465916|Entecavir|entecavir|mesh-list
65634967|NCT04465916|Antiviral Agents|antiviral agents|mesh-ancestor
65634968|NCT04465916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65634969|NCT04465916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65634970|NCT04465916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65634971|NCT04465916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65634972|NCT04465916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65634973|NCT04465916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65634974|NCT04465916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65634975|NCT01366235|Chloroquine|chloroquine|mesh-list
65634976|NCT01366235|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65634977|NCT01366235|Amebicides|amebicides|mesh-ancestor
65634978|NCT01366235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65634979|NCT01366235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65634980|NCT01366235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65634981|NCT01366235|Antimalarials|antimalarials|mesh-ancestor
65634982|NCT01366235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65634983|NCT01366235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65634984|NCT01366235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65634985|NCT01366235|Analgesics|analgesics|mesh-ancestor
65634986|NCT01366235|Sensory System Agents|sensory system agents|mesh-ancestor
65634987|NCT01366235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65634988|NCT01366235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634989|NCT01366235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65634990|NCT01366235|Filaricides|filaricides|mesh-ancestor
65634991|NCT01366235|Antinematodal Agents|antinematodal agents|mesh-ancestor
65634992|NCT01366235|Anthelmintics|anthelmintics|mesh-ancestor
65634993|NCT04871165|Immunoglobulins|immunoglobulins|mesh-list
65634994|NCT04871165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65634996|NCT04871165|Immunologic Factors|immunologic factors|mesh-ancestor
65634997|NCT04871165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65634998|NCT04465760|Antibodies|antibodies|mesh-list
65634999|NCT04465760|Immunoglobulins|immunoglobulins|mesh-list
65635000|NCT04465760|Immunologic Factors|immunologic factors|mesh-ancestor
65635001|NCT04465760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635002|NCT04249739|Pembrolizumab|pembrolizumab|mesh-list
65635003|NCT04249739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65635004|NCT04249739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635005|NCT01366313|Acetaminophen|acetaminophen|mesh-list
65635006|NCT01366313|Morphine|morphine|mesh-list
65635007|NCT01366313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65635008|NCT01366313|Narcotics|narcotics|mesh-ancestor
65635009|NCT01366313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65635010|NCT01366313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635011|NCT01366313|Analgesics|analgesics|mesh-ancestor
65635012|NCT01366313|Sensory System Agents|sensory system agents|mesh-ancestor
65635013|NCT01366313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65635014|NCT01366313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65635015|NCT01366313|Antipyretics|antipyretics|mesh-ancestor
65635016|NCT05561738|Niacinamide|niacinamide|mesh-list
65635017|NCT05561738|Niacin|niacin|mesh-list
65635018|NCT05561738|Nicotinic Acids|nicotinic acids|mesh-list
65635019|NCT05561738|Vitamin B Complex|vitamin b complex|mesh-ancestor
65635020|NCT05561738|Vitamins|vitamins|mesh-ancestor
65635021|NCT05561738|Micronutrients|micronutrients|mesh-ancestor
65635022|NCT05561738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635023|NCT05561738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65635024|NCT05561738|Antimetabolites|antimetabolites|mesh-ancestor
65635025|NCT05561738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635026|NCT05561738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65635027|NCT05561738|Vasodilator Agents|vasodilator agents|mesh-ancestor
65635028|NCT02253524|Metoclopramide|metoclopramide|mesh-list
65635029|NCT02253524|Dimenhydrinate|dimenhydrinate|mesh-list
65635030|NCT02253524|Antiemetics|antiemetics|mesh-ancestor
65635031|NCT02253524|Autonomic Agents|autonomic agents|mesh-ancestor
65635032|NCT02253524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65635033|NCT02253524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635034|NCT02253524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65635035|NCT02253524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65635036|NCT02253524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65635037|NCT02253524|Dopamine Agents|dopamine agents|mesh-ancestor
65635038|NCT02253524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65635039|NCT02253524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635040|NCT02253524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65635041|NCT02253524|Histamine Antagonists|histamine antagonists|mesh-ancestor
65635042|NCT02253524|Histamine Agents|histamine agents|mesh-ancestor
65635043|NCT03575598|Nivolumab|nivolumab|mesh-list
65635044|NCT03575598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65635045|NCT03575598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635046|NCT03575598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65635047|NCT03575598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635048|NCT02253602|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65635049|NCT02253602|Hematinics|hematinics|mesh-ancestor
65635050|NCT02253602|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65635051|NCT02253602|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65635052|NCT03575520|Cyclophosphamide|cyclophosphamide|mesh-list
65635053|NCT03575520|Doxorubicin|doxorubicin|mesh-list
65635054|NCT03575520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65635055|NCT03575520|Immunologic Factors|immunologic factors|mesh-ancestor
65635056|NCT03575520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635057|NCT03575520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65635058|NCT03575520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65635059|NCT03575520|Alkylating Agents|alkylating agents|mesh-ancestor
65635060|NCT03575520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635061|NCT03575520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635062|NCT03575520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65635063|NCT03575520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65635064|NCT03575520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65635065|NCT03575520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65635066|NCT03575520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635067|NCT01366391|Metformin|metformin|mesh-list
65635068|NCT01366391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65635069|NCT01366391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635070|NCT04408586|Topiramate|topiramate|mesh-list
65635071|NCT04408586|Phentermine|phentermine|mesh-list
65635072|NCT04408586|Anticonvulsants|anticonvulsants|mesh-ancestor
65635073|NCT04408586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65635074|NCT04408586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635075|NCT04408586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65635076|NCT04408586|Appetite Depressants|appetite depressants|mesh-ancestor
65635077|NCT04408586|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65635078|NCT04408586|Sympathomimetics|sympathomimetics|mesh-ancestor
65635079|NCT04408586|Autonomic Agents|autonomic agents|mesh-ancestor
65635080|NCT04408586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65635081|NCT04408586|Adrenergic Agents|adrenergic agents|mesh-ancestor
65635082|NCT04408586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65635083|NCT04408586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635084|NCT02239614|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65635085|NCT02239614|Aluminum sulfate|aluminum sulfate|mesh-list
65635086|NCT02239614|Immunologic Factors|immunologic factors|mesh-ancestor
65635087|NCT02239614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635088|NCT02239614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65635089|NCT02239614|Antacids|antacids|mesh-ancestor
65635090|NCT02239614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635091|NCT02239614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65635092|NCT03572400|Gemcitabine|gemcitabine|mesh-list
65635093|NCT03572400|Durvalumab|durvalumab|mesh-list
65635094|NCT03572400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65635095|NCT03572400|Antimetabolites|antimetabolites|mesh-ancestor
65635096|NCT03572400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635097|NCT03572400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635098|NCT03572400|Antiviral Agents|antiviral agents|mesh-ancestor
65635099|NCT03572400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65635100|NCT03572400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635101|NCT03572400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65635102|NCT03572400|Immunologic Factors|immunologic factors|mesh-ancestor
65635103|NCT03572400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635104|NCT03572400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65635105|NCT02253836|Ritonavir|ritonavir|mesh-list
65635106|NCT02253836|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65635107|NCT02253836|Tipranavir|tipranavir|mesh-list
65635108|NCT02253836|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65635109|NCT02253836|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65635110|NCT02253836|Protease Inhibitors|protease inhibitors|mesh-ancestor
65635111|NCT02253836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635112|NCT02253836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635113|NCT02253836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65635114|NCT02253836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65635115|NCT02253836|Antiviral Agents|antiviral agents|mesh-ancestor
65635116|NCT02253836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65635117|NCT02253836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65635118|NCT02253836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65635119|NCT03575130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65635120|NCT03575130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65635121|NCT02241018|Antibodies|antibodies|mesh-list
65635122|NCT02241018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65635123|NCT02241018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
65635124|NCT02241018|Immunologic Factors|immunologic factors|mesh-ancestor
65635125|NCT02241018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635127|NCT02241018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635128|NCT04039022|Dextromethorphan|dextromethorphan|mesh-list
65635129|NCT04039022|Bupropion|bupropion|mesh-list
65635130|NCT04039022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65635131|NCT04039022|Antidepressive Agents|antidepressive agents|mesh-ancestor
65635132|NCT04039022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65635133|NCT04039022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65635134|NCT04039022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65635135|NCT04039022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65635136|NCT04039022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635137|NCT04039022|Dopamine Agents|dopamine agents|mesh-ancestor
65635138|NCT04039022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65635139|NCT04039022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635140|NCT04039022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65635141|NCT04039022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65635142|NCT04039022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635143|NCT04039022|Antitussive Agents|antitussive agents|mesh-ancestor
65635144|NCT04039022|Respiratory System Agents|respiratory system agents|mesh-ancestor
65635145|NCT04039022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65635146|NCT04039022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65635147|NCT03572088|Terlipressin|terlipressin|mesh-list
65635148|NCT03572088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65635149|NCT03572088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65635150|NCT00109772|Lenalidomide|lenalidomide|mesh-list
65635151|NCT00109772|Immunologic Factors|immunologic factors|mesh-ancestor
65635152|NCT00109772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635153|NCT00109772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65635154|NCT00109772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65635155|NCT00109772|Growth Substances|growth substances|mesh-ancestor
65635156|NCT00109772|Growth Inhibitors|growth inhibitors|mesh-ancestor
65635157|NCT00109772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635158|NCT03572010|Fesoterodine|fesoterodine|mesh-list
65635159|NCT03572010|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65635160|NCT03572010|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65635161|NCT03572010|Cholinergic Agents|cholinergic agents|mesh-ancestor
65635162|NCT03572010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65635163|NCT03572010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635164|NCT03572010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635165|NCT03572010|Urological Agents|urological agents|mesh-ancestor
65635166|NCT01560104|Paclitaxel|paclitaxel|mesh-list
65635167|NCT01560104|Carboplatin|carboplatin|mesh-list
65635168|NCT01560104|Veliparib|veliparib|mesh-list
65635169|NCT01560104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65635170|NCT01560104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635171|NCT01560104|Tubulin Modulators|tubulin modulators|mesh-ancestor
65635172|NCT01560104|Antimitotic Agents|antimitotic agents|mesh-ancestor
65635173|NCT01560104|Mitosis Modulators|mitosis modulators|mesh-ancestor
65635174|NCT01560104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635175|NCT01560104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65635176|NCT01560104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635177|NCT00101972|Antibodies|antibodies|mesh-list
65635178|NCT00101972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65635179|NCT00101972|Immunologic Factors|immunologic factors|mesh-ancestor
65635180|NCT00101972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635181|NCT02245932|Resveratrol|resveratrol|mesh-list
65635182|NCT02245932|Antioxidants|antioxidants|mesh-ancestor
65635183|NCT02245932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635184|NCT02245932|Protective Agents|protective agents|mesh-ancestor
65635185|NCT02245932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635186|NCT02245932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635187|NCT02245932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65635188|NCT05095922|Valsartan|valsartan|mesh-list
65635189|NCT05095922|Calcium Dobesilate|calcium dobesilate|mesh-list
65635190|NCT05095922|Calcium|calcium|mesh-list
65635191|NCT05095922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65635192|NCT05095922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635193|NCT05095922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65635194|NCT05095922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65635195|NCT05095922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65635196|NCT05095922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635197|NCT05095922|Hemostatics|hemostatics|mesh-ancestor
65635198|NCT05095922|Coagulants|coagulants|mesh-ancestor
65635199|NCT03573102|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65635200|NCT03573102|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65635201|NCT03573102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635202|NCT03573102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635203|NCT03573102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635204|NCT03573102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65635205|NCT03573102|Protease Inhibitors|protease inhibitors|mesh-ancestor
65635206|NCT03865706|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65635207|NCT03865706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65635208|NCT03865706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65635209|NCT03865706|Antitubercular Agents|antitubercular agents|mesh-ancestor
65635210|NCT03756896|Dexamethasone|dexamethasone|mesh-list
65635211|NCT03756896|Pomalidomide|pomalidomide|mesh-list
65635212|NCT03756896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65635213|NCT03756896|Antiemetics|antiemetics|mesh-ancestor
65635214|NCT03756896|Autonomic Agents|autonomic agents|mesh-ancestor
65635215|NCT03756896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65635216|NCT03756896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635217|NCT03756896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65635218|NCT03756896|Glucocorticoids|glucocorticoids|mesh-ancestor
65635220|NCT03756896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65635221|NCT03756896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65635222|NCT03756896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635223|NCT03756896|Immunologic Factors|immunologic factors|mesh-ancestor
65635224|NCT03756896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65635225|NCT03756896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65635226|NCT03756896|Growth Substances|growth substances|mesh-ancestor
65635227|NCT03756896|Growth Inhibitors|growth inhibitors|mesh-ancestor
65635228|NCT04944368|Myeloma Proteins|myeloma proteins|mesh-list
65635229|NCT04944368|Paraproteins|paraproteins|mesh-list
65635230|NCT04944368|Immunologic Factors|immunologic factors|mesh-ancestor
65635231|NCT04944368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635232|NCT04268498|Acetaminophen|acetaminophen|mesh-list
65635233|NCT04268498|Diphenhydramine|diphenhydramine|mesh-list
65635234|NCT04268498|Promethazine|promethazine|mesh-list
65635235|NCT04268498|Dexamethasone|dexamethasone|mesh-list
65635236|NCT04268498|Lenalidomide|lenalidomide|mesh-list
65635237|NCT04268498|Bortezomib|bortezomib|mesh-list
65635238|NCT04268498|Daratumumab|daratumumab|mesh-list
65635239|NCT04268498|Montelukast|montelukast|mesh-list
65635240|NCT04268498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65635241|NCT04268498|Antiemetics|antiemetics|mesh-ancestor
65635242|NCT04268498|Autonomic Agents|autonomic agents|mesh-ancestor
65635243|NCT04268498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65635244|NCT04268498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635245|NCT04268498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65635246|NCT04268498|Glucocorticoids|glucocorticoids|mesh-ancestor
65635247|NCT04268498|Hormones|hormones|mesh-ancestor
65635248|NCT04268498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65635249|NCT04268498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65635250|NCT04268498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635251|NCT04268498|Immunologic Factors|immunologic factors|mesh-ancestor
65635252|NCT04268498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65635253|NCT04268498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65635254|NCT04268498|Growth Substances|growth substances|mesh-ancestor
65635255|NCT04268498|Growth Inhibitors|growth inhibitors|mesh-ancestor
65635256|NCT04268498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65635257|NCT04268498|Analgesics|analgesics|mesh-ancestor
65635258|NCT04268498|Sensory System Agents|sensory system agents|mesh-ancestor
65635259|NCT04268498|Antipyretics|antipyretics|mesh-ancestor
65635260|NCT04268498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65635261|NCT04268498|Respiratory System Agents|respiratory system agents|mesh-ancestor
65635262|NCT04268498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65635263|NCT04268498|Hormone Antagonists|hormone antagonists|mesh-ancestor
65635264|NCT04268498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65635265|NCT04268498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65635266|NCT04268498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635267|NCT04268498|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65635268|NCT04268498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65635269|NCT04268498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65635270|NCT04268498|Anesthetics, Local|anesthetics, local|mesh-ancestor
65635271|NCT04268498|Anesthetics|anesthetics|mesh-ancestor
65635272|NCT04268498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65635273|NCT04268498|Histamine Antagonists|histamine antagonists|mesh-ancestor
65635274|NCT04268498|Histamine Agents|histamine agents|mesh-ancestor
65635275|NCT04268498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65635276|NCT04268498|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65635277|NCT04268498|Antipruritics|antipruritics|mesh-ancestor
65635278|NCT04268498|Dermatologic Agents|dermatologic agents|mesh-ancestor
65635279|NCT04260464|PF-06700841|pf-06700841|mesh-list
65635280|NCT04260464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65635281|NCT04260464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635282|NCT04260464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635283|NCT03651518|Rituximab|rituximab|mesh-list
65635284|NCT03651518|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65635285|NCT03651518|Ustekinumab|ustekinumab|mesh-list
65635286|NCT03651518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65635287|NCT03651518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635288|NCT03651518|Immunologic Factors|immunologic factors|mesh-ancestor
65635289|NCT03651518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635290|NCT03651518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65635291|NCT03651518|Dermatologic Agents|dermatologic agents|mesh-ancestor
65635292|NCT03546530|Interferons|interferons|mesh-list
65635293|NCT03546530|Resveratrol|resveratrol|mesh-list
65635294|NCT03546530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635295|NCT03546530|Antiviral Agents|antiviral agents|mesh-ancestor
65635296|NCT03546530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65635297|NCT03546530|Antioxidants|antioxidants|mesh-ancestor
65635298|NCT03546530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635299|NCT03546530|Protective Agents|protective agents|mesh-ancestor
65635300|NCT03546530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635301|NCT03546530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635302|NCT03546530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65635303|NCT03568994|Cytarabine|cytarabine|mesh-list
65635304|NCT03568994|Atovaquone|atovaquone|mesh-list
65635305|NCT03568994|Etoposide|etoposide|mesh-list
65635306|NCT03568994|Daunorubicin|daunorubicin|mesh-list
65635307|NCT03568994|Gemtuzumab|gemtuzumab|mesh-list
65635308|NCT03568994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65635309|NCT03568994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635310|NCT03568994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65635311|NCT03568994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65635312|NCT03568994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635313|NCT03568994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635314|NCT03568994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65635315|NCT03568994|Antimetabolites|antimetabolites|mesh-ancestor
65635316|NCT03568994|Antiviral Agents|antiviral agents|mesh-ancestor
65635317|NCT03568994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65635318|NCT03568994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65635319|NCT03568994|Immunologic Factors|immunologic factors|mesh-ancestor
65635320|NCT03568994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635321|NCT03568994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65635322|NCT03568994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65635323|NCT03568994|Antimalarials|antimalarials|mesh-ancestor
65635324|NCT03568994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65635325|NCT03568994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65635326|NCT04203056|Aripiprazole|aripiprazole|mesh-list
65635327|NCT04203056|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
65635328|NCT04203056|Antidepressive Agents|antidepressive agents|mesh-ancestor
65635329|NCT04203056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65635330|NCT04203056|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65635331|NCT04203056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65635332|NCT04203056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65635333|NCT04203056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635334|NCT04203056|Dopamine Agonists|dopamine agonists|mesh-ancestor
65635335|NCT04203056|Dopamine Agents|dopamine agents|mesh-ancestor
65635336|NCT04203056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65635337|NCT04203056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635338|NCT04203056|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65635339|NCT04203056|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65635340|NCT04203056|Serotonin Agents|serotonin agents|mesh-ancestor
65635341|NCT04203056|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65635342|NCT04203056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65635343|NCT04203056|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65635344|NCT04203056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65635345|NCT04894994|Ipilimumab|ipilimumab|mesh-list
65635346|NCT04894994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65635347|NCT04894994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635348|NCT04894994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65635349|NCT04894994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635350|NCT01366547|Lamivudine|lamivudine|mesh-list
65635352|NCT01366547|Dideoxynucleosides|dideoxynucleosides|mesh-list
65635353|NCT01366547|Dolutegravir|dolutegravir|mesh-list
65635354|NCT01366547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65635355|NCT01366547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65635356|NCT01366547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635357|NCT01366547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635358|NCT01366547|Antiviral Agents|antiviral agents|mesh-ancestor
65635359|NCT01366547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65635360|NCT01366547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65635361|NCT01366547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65635362|NCT01366547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65635363|NCT01366547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65635364|NCT01366547|Antimetabolites|antimetabolites|mesh-ancestor
65635365|NCT05190341|Ibuprofen|ibuprofen|mesh-list
65635366|NCT05190341|Ketorolac|ketorolac|mesh-list
65635367|NCT05190341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65635368|NCT05190341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65635369|NCT05190341|Analgesics|analgesics|mesh-ancestor
65635370|NCT05190341|Sensory System Agents|sensory system agents|mesh-ancestor
65635371|NCT05190341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65635372|NCT05190341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635373|NCT05190341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65635374|NCT05190341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65635375|NCT05190341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65635376|NCT05190341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635377|NCT05190341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635378|NCT04347239|Leronlimab|leronlimab|mesh-list
65635379|NCT04347239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65635380|NCT04347239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65635381|NCT04347239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635382|NCT04347239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65635383|NCT04347239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65635384|NCT04347239|Antiviral Agents|antiviral agents|mesh-ancestor
65635385|NCT04347239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65635386|NCT00109928|Gemcitabine|gemcitabine|mesh-list
65635387|NCT00109928|Methylprednisolone|methylprednisolone|mesh-list
65635388|NCT00109928|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65635389|NCT00109928|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65635390|NCT00109928|Prednisolone|prednisolone|mesh-list
65635391|NCT00109928|Prednisolone acetate|prednisolone acetate|mesh-list
65635392|NCT00109928|Etoposide|etoposide|mesh-list
65635393|NCT00109928|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65635394|NCT00109928|Prednisolone phosphate|prednisolone phosphate|mesh-list
65635395|NCT00109928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635396|NCT00109928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65635397|NCT00109928|Antimetabolites|antimetabolites|mesh-ancestor
65635398|NCT00109928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635399|NCT00109928|Antiviral Agents|antiviral agents|mesh-ancestor
65635400|NCT00109928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65635401|NCT00109928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635402|NCT00109928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65635403|NCT00109928|Immunologic Factors|immunologic factors|mesh-ancestor
65635404|NCT00109928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635405|NCT00109928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65635406|NCT00109928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65635407|NCT00109928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65635408|NCT00109928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65635409|NCT00109928|Antiemetics|antiemetics|mesh-ancestor
65635410|NCT00109928|Autonomic Agents|autonomic agents|mesh-ancestor
65635411|NCT00109928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65635412|NCT00109928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65635413|NCT00109928|Glucocorticoids|glucocorticoids|mesh-ancestor
65635414|NCT00109928|Hormones|hormones|mesh-ancestor
65635415|NCT00109928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65635416|NCT00109928|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65635417|NCT00109928|Protective Agents|protective agents|mesh-ancestor
65635418|NCT00109928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65635419|NCT02104310|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
65635420|NCT02104310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635421|NCT02104310|Dopamine Agents|dopamine agents|mesh-ancestor
65635422|NCT02104310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65635423|NCT02104310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432766|NCT02532777|Prednisone|prednisone|mesh-list
65635424|NCT00109850|Irinotecan|irinotecan|mesh-list
65635425|NCT00109850|Cetuximab|cetuximab|mesh-list
65635426|NCT00109850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635427|NCT00109850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65635428|NCT00109850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65635429|NCT00109850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635430|NCT00109850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635431|NCT00109850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65635432|NCT03318770|Dasatinib|dasatinib|mesh-list
65635433|NCT03318770|Blinatumomab|blinatumomab|mesh-list
65635434|NCT03318770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635435|NCT03318770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65635436|NCT03318770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635437|NCT03318770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635438|NCT03437421|Vitamin D|vitamin d|mesh-list
65635439|NCT03437421|Cholecalciferol|cholecalciferol|mesh-list
65635440|NCT03437421|Vitamins|vitamins|mesh-ancestor
65635441|NCT03437421|Micronutrients|micronutrients|mesh-ancestor
65635442|NCT03437421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635443|NCT03437421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65635444|NCT03437421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65635445|NCT01065519|Umirolimus|umirolimus|mesh-list
65635446|NCT01065519|Everolimus|everolimus|mesh-list
65635447|NCT01065519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635448|NCT01065519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65635449|NCT01065519|Immunologic Factors|immunologic factors|mesh-ancestor
65635450|NCT01065519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635451|NCT01065519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65635452|NCT05539989|Vaccines|vaccines|mesh-list
65635453|NCT05539989|BCG Vaccine|bcg vaccine|mesh-list
65635454|NCT05539989|Immunologic Factors|immunologic factors|mesh-ancestor
65635455|NCT05539989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635456|NCT05539989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65635457|NCT05493111|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65635458|NCT05493111|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65635459|NCT01810016|Poly I-C|poly i-c|mesh-list
65635460|NCT01810016|Ipilimumab|ipilimumab|mesh-list
65635461|NCT01810016|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65635462|NCT01810016|Vaccines|vaccines|mesh-list
65635463|NCT01810016|Poly ICLC|poly iclc|mesh-list
65635464|NCT01810016|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65635465|NCT01810016|Immunologic Factors|immunologic factors|mesh-ancestor
65635466|NCT01810016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635467|NCT01810016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65635468|NCT01810016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635469|NCT01810016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65635470|NCT01810016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635471|NCT01810016|Interferon Inducers|interferon inducers|mesh-ancestor
65635472|NCT01810016|Laxatives|laxatives|mesh-ancestor
65635473|NCT01810016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65635474|NCT01810016|Antiviral Agents|antiviral agents|mesh-ancestor
65635475|NCT01810016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65635476|NCT01810016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65635477|NCT01722266|Liraglutide|liraglutide|mesh-list
65635478|NCT01722266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65635479|NCT01722266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635480|NCT01722266|Incretins|incretins|mesh-ancestor
65635481|NCT01722266|Hormones|hormones|mesh-ancestor
65635482|NCT01722266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65635483|NCT03545516|Dexmedetomidine|dexmedetomidine|mesh-list
65635484|NCT03545516|Bupivacaine|bupivacaine|mesh-list
65635485|NCT03545516|Anesthetics, Local|anesthetics, local|mesh-ancestor
65635486|NCT03545516|Anesthetics|anesthetics|mesh-ancestor
65635487|NCT03545516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65635488|NCT03545516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635489|NCT03545516|Sensory System Agents|sensory system agents|mesh-ancestor
65635490|NCT03545516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65635491|NCT03545516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65635492|NCT03545516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65635493|NCT03545516|Analgesics|analgesics|mesh-ancestor
65635494|NCT03545516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65635495|NCT03545516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65635496|NCT03545516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65635497|NCT03545516|Adrenergic Agents|adrenergic agents|mesh-ancestor
65635498|NCT03545516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65635499|NCT03545516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635500|NCT02254148|Metoprolol|metoprolol|mesh-list
65432825|NCT01063101|Fucoidan|fucoidan|mesh-list
65635501|NCT02254148|Digoxin|digoxin|mesh-list
65635502|NCT02254148|Midazolam|midazolam|mesh-list
65635504|NCT02254148|Omeprazole|omeprazole|mesh-list
65635505|NCT02254148|Warfarin|warfarin|mesh-list
65635506|NCT02254148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65635507|NCT02254148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65635508|NCT02254148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65635509|NCT02254148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635510|NCT02254148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65635511|NCT02254148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65635512|NCT02254148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65635513|NCT02254148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65635514|NCT02254148|Anesthetics, General|anesthetics, general|mesh-ancestor
65635515|NCT02254148|Anesthetics|anesthetics|mesh-ancestor
65635516|NCT02254148|GABA Modulators|gaba modulators|mesh-ancestor
65635517|NCT02254148|GABA Agents|gaba agents|mesh-ancestor
65635518|NCT02254148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65635519|NCT02254148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635520|NCT02254148|Anticoagulants|anticoagulants|mesh-ancestor
65635521|NCT02254148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65635522|NCT02254148|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65635523|NCT02254148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635524|NCT02254148|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65635525|NCT02254148|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65635526|NCT02254148|Purinergic Agents|purinergic agents|mesh-ancestor
65635527|NCT02254148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65635528|NCT02254148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65635529|NCT02254148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65635530|NCT02254148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65635531|NCT02254148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65635532|NCT02254148|Sympatholytics|sympatholytics|mesh-ancestor
65635533|NCT02254148|Autonomic Agents|autonomic agents|mesh-ancestor
65635534|NCT02254148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65635535|NCT02254148|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65635536|NCT02254148|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65635537|NCT02254148|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65635538|NCT02254148|Adrenergic Agents|adrenergic agents|mesh-ancestor
65635539|NCT02254148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65635540|NCT02254148|Protective Agents|protective agents|mesh-ancestor
65635541|NCT02842866|Vaccines|vaccines|mesh-list
65635542|NCT02842866|Immunologic Factors|immunologic factors|mesh-ancestor
65635543|NCT02842866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635544|NCT01316913|Bromides|bromides|mesh-list
65635545|NCT01316913|Tiotropium Bromide|tiotropium bromide|mesh-list
65635546|NCT01316913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65635547|NCT01316913|Autonomic Agents|autonomic agents|mesh-ancestor
65635548|NCT01316913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65635549|NCT01316913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635550|NCT01316913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65635551|NCT01316913|Respiratory System Agents|respiratory system agents|mesh-ancestor
65635552|NCT01316913|Parasympatholytics|parasympatholytics|mesh-ancestor
65635553|NCT01316913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65635554|NCT01316913|Cholinergic Agents|cholinergic agents|mesh-ancestor
65635555|NCT01316913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65635556|NCT01316913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635557|NCT01316913|Anticonvulsants|anticonvulsants|mesh-ancestor
65635558|NCT02875067|Pembrolizumab|pembrolizumab|mesh-list
65635559|NCT02875067|Lenalidomide|lenalidomide|mesh-list
65635560|NCT02875067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65635561|NCT02875067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635562|NCT02875067|Immunologic Factors|immunologic factors|mesh-ancestor
65635563|NCT02875067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635564|NCT02875067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65635565|NCT02875067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65635566|NCT02875067|Growth Substances|growth substances|mesh-ancestor
65635567|NCT02875067|Growth Inhibitors|growth inhibitors|mesh-ancestor
65635568|NCT03570294|Atosiban|atosiban|mesh-list
65635569|NCT03570294|Hormone Antagonists|hormone antagonists|mesh-ancestor
65635570|NCT03570294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65635571|NCT03570294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635572|NCT03570294|Tocolytic Agents|tocolytic agents|mesh-ancestor
65635573|NCT03570294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65432895|NCT01066767|Histamine Antagonists|histamine antagonists|mesh-ancestor
65635574|NCT02143622|Cetuximab|cetuximab|mesh-list
65635575|NCT02143622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65635576|NCT02143622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635577|NCT02781506|Nivolumab|nivolumab|mesh-list
65267206|NCT00561925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65635578|NCT02781506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65635579|NCT02781506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635580|NCT02781506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65635581|NCT02781506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635582|NCT03571230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65635583|NCT03571230|Amoxicillin|amoxicillin|mesh-list
65635584|NCT03571230|Metronidazole|metronidazole|mesh-list
65635585|NCT03571230|Clarithromycin|clarithromycin|mesh-list
65635586|NCT03571230|Levofloxacin|levofloxacin|mesh-list
65635587|NCT03571230|Tetracycline|tetracycline|mesh-list
65635588|NCT03571230|Tinidazole|tinidazole|mesh-list
65635589|NCT03571230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65635590|NCT03571230|Furazolidone|furazolidone|mesh-list
65635591|NCT03571230|Bismuth|bismuth|mesh-list
65635592|NCT03571230|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65635593|NCT03571230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65635594|NCT03571230|Antitubercular Agents|antitubercular agents|mesh-ancestor
65635595|NCT03571230|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65635596|NCT03571230|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65635597|NCT03571230|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65635598|NCT03571230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635599|NCT03571230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635600|NCT03571230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65635601|NCT03571230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65635602|NCT03571230|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65635603|NCT03571230|Renal Agents|renal agents|mesh-ancestor
65635604|NCT03571230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65635605|NCT03571230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65635606|NCT03571230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635607|NCT03571230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65635608|NCT03571230|Antacids|antacids|mesh-ancestor
65635609|NCT03571230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65635610|NCT03571230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65635611|NCT03571230|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65635612|NCT03571230|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65635613|NCT03571230|Alkylating Agents|alkylating agents|mesh-ancestor
65635614|NCT03368963|Trifluridine|trifluridine|mesh-list
65635615|NCT03368963|Irinotecan|irinotecan|mesh-list
65635616|NCT03368963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65635617|NCT03368963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65635618|NCT03368963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635619|NCT03368963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635620|NCT03368963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635621|NCT03368963|Antimetabolites|antimetabolites|mesh-ancestor
65635622|NCT03368963|Antiviral Agents|antiviral agents|mesh-ancestor
65635623|NCT03368963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65635624|NCT05489211|Leucovorin|leucovorin|mesh-list
65635625|NCT05489211|Bevacizumab|bevacizumab|mesh-list
65635626|NCT05489211|Nivolumab|nivolumab|mesh-list
65635627|NCT05489211|Durvalumab|durvalumab|mesh-list
65635628|NCT05489211|Carboplatin|carboplatin|mesh-list
65635629|NCT05489211|Fluorouracil|fluorouracil|mesh-list
65635630|NCT05489211|Capecitabine|capecitabine|mesh-list
65635631|NCT05489211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65635632|NCT05489211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635633|NCT05489211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65635634|NCT05489211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65635635|NCT05489211|Growth Substances|growth substances|mesh-ancestor
65635636|NCT05489211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635637|NCT05489211|Growth Inhibitors|growth inhibitors|mesh-ancestor
65635638|NCT05489211|Antimetabolites|antimetabolites|mesh-ancestor
65635639|NCT05489211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635640|NCT05489211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65635641|NCT05489211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65635642|NCT05489211|Immunologic Factors|immunologic factors|mesh-ancestor
65635643|NCT05489211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65635644|NCT05489211|Antidotes|antidotes|mesh-ancestor
65635645|NCT05489211|Protective Agents|protective agents|mesh-ancestor
65635646|NCT05489211|Vitamin B Complex|vitamin b complex|mesh-ancestor
65635647|NCT05489211|Vitamins|vitamins|mesh-ancestor
65635648|NCT05489211|Micronutrients|micronutrients|mesh-ancestor
65635649|NCT02254226|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65635650|NCT02254226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65635651|NCT02254226|Autonomic Agents|autonomic agents|mesh-ancestor
65635652|NCT02254226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65635653|NCT02254226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432967|NCT00290745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65635654|NCT02254226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65635655|NCT02254226|Respiratory System Agents|respiratory system agents|mesh-ancestor
65635656|NCT02254226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65635657|NCT02254226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65635658|NCT02254226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65635659|NCT02254226|Adrenergic Agents|adrenergic agents|mesh-ancestor
65635660|NCT02254226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65635661|NCT02254226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635662|NCT02143934|Chloroquine|chloroquine|mesh-list
65635663|NCT02143934|Lumefantrine|lumefantrine|mesh-list
65635664|NCT02143934|Artemether|artemether|mesh-list
65635665|NCT02143934|Primaquine|primaquine|mesh-list
65635666|NCT02143934|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65635667|NCT02143934|Amebicides|amebicides|mesh-ancestor
65635668|NCT02143934|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65635669|NCT02143934|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65635670|NCT02143934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65635671|NCT02143934|Antimalarials|antimalarials|mesh-ancestor
65635672|NCT02143934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65635673|NCT03096847|Letrozole|letrozole|mesh-list
65635674|NCT03096847|Goserelin|goserelin|mesh-list
65635675|NCT03096847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635676|NCT03096847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65635677|NCT03096847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65635678|NCT03096847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635679|NCT03096847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635680|NCT03096847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65635681|NCT03096847|Hormone Antagonists|hormone antagonists|mesh-ancestor
65635682|NCT03096847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65635683|NCT03096847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635684|NCT03096847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65635685|NCT04753879|Gemcitabine|gemcitabine|mesh-list
65635686|NCT04753879|Paclitaxel|paclitaxel|mesh-list
65635687|NCT04753879|Pembrolizumab|pembrolizumab|mesh-list
65635688|NCT04753879|Capecitabine|capecitabine|mesh-list
65635689|NCT04753879|Irinotecan|irinotecan|mesh-list
65635690|NCT04753879|Olaparib|olaparib|mesh-list
65635691|NCT04753879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65635692|NCT04753879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635693|NCT04753879|Tubulin Modulators|tubulin modulators|mesh-ancestor
65635694|NCT04753879|Antimitotic Agents|antimitotic agents|mesh-ancestor
65635695|NCT04753879|Mitosis Modulators|mitosis modulators|mesh-ancestor
65635696|NCT04753879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635697|NCT04753879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65635698|NCT04753879|Antimetabolites|antimetabolites|mesh-ancestor
65635699|NCT04753879|Antiviral Agents|antiviral agents|mesh-ancestor
65635700|NCT04753879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65635701|NCT04753879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635702|NCT04753879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65635703|NCT04753879|Immunologic Factors|immunologic factors|mesh-ancestor
65635704|NCT04753879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635705|NCT04753879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65635706|NCT04753879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65635707|NCT04753879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65635708|NCT04753879|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65635709|NCT02846532|Aspirin|aspirin|mesh-list
65635710|NCT02846532|Rivaroxaban|rivaroxaban|mesh-list
65635711|NCT02846532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65635712|NCT02846532|Antithrombins|antithrombins|mesh-ancestor
65635713|NCT02846532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65635714|NCT02846532|Protease Inhibitors|protease inhibitors|mesh-ancestor
65635715|NCT02846532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635716|NCT02846532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635717|NCT02846532|Anticoagulants|anticoagulants|mesh-ancestor
65635718|NCT02846532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65635719|NCT02846532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65635720|NCT02846532|Analgesics|analgesics|mesh-ancestor
65635721|NCT02846532|Sensory System Agents|sensory system agents|mesh-ancestor
65635722|NCT02846532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65635723|NCT02846532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635724|NCT02846532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65635725|NCT02846532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65635726|NCT02846532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65635727|NCT02846532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65635728|NCT02846532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65635729|NCT02846532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65635730|NCT02846532|Antipyretics|antipyretics|mesh-ancestor
65635731|NCT01371461|Paroxetine|paroxetine|mesh-list
65635732|NCT01371461|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65635733|NCT01371461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65635734|NCT01371461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65635735|NCT01371461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635736|NCT01371461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65635737|NCT01371461|Serotonin Agents|serotonin agents|mesh-ancestor
65635738|NCT01371461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635739|NCT01371461|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65635740|NCT01371461|Antidepressive Agents|antidepressive agents|mesh-ancestor
65635741|NCT01371461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65635742|NCT01371461|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65635743|NCT01371461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65635744|NCT01371461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635745|NCT05324423|Colchicine|colchicine|mesh-list
65635746|NCT05324423|Febuxostat|febuxostat|mesh-list
65635747|NCT05324423|Gout Suppressants|gout suppressants|mesh-ancestor
65635748|NCT05324423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65635749|NCT05324423|Tubulin Modulators|tubulin modulators|mesh-ancestor
65635750|NCT05324423|Antimitotic Agents|antimitotic agents|mesh-ancestor
65635751|NCT05324423|Mitosis Modulators|mitosis modulators|mesh-ancestor
65635752|NCT05324423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635753|NCT05324423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635754|NCT04704219|Pembrolizumab|pembrolizumab|mesh-list
65635755|NCT04704219|Lenvatinib|lenvatinib|mesh-list
65635756|NCT04704219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65635757|NCT04704219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635758|NCT04704219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65635759|NCT04704219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635760|NCT04704219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635761|NCT00842348|Lanreotide|lanreotide|mesh-list
65635762|NCT00842348|Somatostatin|somatostatin|mesh-list
65635763|NCT00842348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635764|NCT00842348|Hormones|hormones|mesh-ancestor
65635765|NCT00842348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65635766|NCT00842348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635767|NCT05443971|Durvalumab|durvalumab|mesh-list
65635768|NCT05443971|Immunoglobulins|immunoglobulins|mesh-list
65635769|NCT05443971|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65635770|NCT05443971|Immunoglobulin G|immunoglobulin g|mesh-list
65635771|NCT05443971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65635772|NCT05443971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635773|NCT05443971|Immunologic Factors|immunologic factors|mesh-ancestor
65635774|NCT05443971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635775|NCT02144246|Moxifloxacin|moxifloxacin|mesh-list
65635776|NCT02144246|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65635777|NCT02144246|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65635778|NCT02144246|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65635779|NCT02144246|Norgestimate|norgestimate|mesh-list
65635780|NCT02144246|Norgestrel|norgestrel|mesh-list
65635781|NCT02144246|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65635782|NCT02144246|Estradiol|estradiol|mesh-list
65635783|NCT02144246|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65635784|NCT02144246|Estrogens|estrogens|mesh-ancestor
65635785|NCT02144246|Hormones|hormones|mesh-ancestor
65635786|NCT02144246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65635787|NCT02144246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635788|NCT02144246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65635789|NCT02144246|Contraceptive Agents|contraceptive agents|mesh-ancestor
65635790|NCT02144246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65635791|NCT02144246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65635792|NCT02144246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65635793|NCT02144246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65635794|NCT02144246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65635795|NCT02144246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65635796|NCT02144246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65635797|NCT02144246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65635798|NCT02144246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65635799|NCT02144246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635800|NCT02144246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635801|NCT02144246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635802|NCT02144246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65635803|NCT03095521|Menthol|menthol|mesh-list
65635804|NCT03095521|Antipruritics|antipruritics|mesh-ancestor
65635805|NCT03095521|Dermatologic Agents|dermatologic agents|mesh-ancestor
65635806|NCT01372865|Mometasone Furoate|mometasone furoate|mesh-list
65635807|NCT01372865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65635808|NCT01372865|Dermatologic Agents|dermatologic agents|mesh-ancestor
65635809|NCT01372865|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65635810|NCT05251909|Benralizumab|benralizumab|mesh-list
65635811|NCT05251909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65635812|NCT05251909|Respiratory System Agents|respiratory system agents|mesh-ancestor
65635813|NCT05242315|Tacrolimus|tacrolimus|mesh-list
65635814|NCT05242315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65635815|NCT05242315|Immunologic Factors|immunologic factors|mesh-ancestor
65635816|NCT05242315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635817|NCT05242315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65635818|NCT05242315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635819|NCT05242315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635820|NCT05132699|Cannabidiol|cannabidiol|mesh-list
65635821|NCT05132699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65635822|NCT05132699|Anticonvulsants|anticonvulsants|mesh-ancestor
65635823|NCT03569046|Antihypertensive Agents|antihypertensive agents|mesh-list
65635824|NCT03569046|Bupivacaine|bupivacaine|mesh-list
65635825|NCT03569046|Anesthetics, Local|anesthetics, local|mesh-list
65635826|NCT03569046|Anesthetics|anesthetics|mesh-list
65635827|NCT03569046|Anesthetics, General|anesthetics, general|mesh-list
65635828|NCT03569046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65635829|NCT03569046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635830|NCT03569046|Sensory System Agents|sensory system agents|mesh-ancestor
65635831|NCT03569046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65635832|NCT02935595|Ketamine|ketamine|mesh-list
65635833|NCT02935595|Analgesics|analgesics|mesh-ancestor
65635834|NCT02935595|Sensory System Agents|sensory system agents|mesh-ancestor
65635835|NCT02935595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65635836|NCT02935595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635837|NCT02935595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65635838|NCT02935595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65635839|NCT02935595|Anesthetics, General|anesthetics, general|mesh-ancestor
65635840|NCT02935595|Anesthetics|anesthetics|mesh-ancestor
65635841|NCT02935595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65635842|NCT02935595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65635843|NCT02935595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65635844|NCT02935595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65635845|NCT02935595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635846|NCT02649673|Topotecan|topotecan|mesh-list
65635847|NCT02649673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65635848|NCT02649673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65635849|NCT02649673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635850|NCT02649673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635851|NCT02649673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635852|NCT03568968|Niacinamide|niacinamide|mesh-list
65635853|NCT03568968|Niacin|niacin|mesh-list
65635854|NCT03568968|Nicotinic Acids|nicotinic acids|mesh-list
65635855|NCT03568968|Vitamin B Complex|vitamin b complex|mesh-ancestor
65635856|NCT03568968|Vitamins|vitamins|mesh-ancestor
65635857|NCT03568968|Micronutrients|micronutrients|mesh-ancestor
65635858|NCT03568968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635859|NCT03568968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65635860|NCT03568968|Antimetabolites|antimetabolites|mesh-ancestor
65635861|NCT03568968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635862|NCT03568968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65635863|NCT03568968|Vasodilator Agents|vasodilator agents|mesh-ancestor
65635864|NCT02817347|Tazobactam|tazobactam|mesh-list
65635865|NCT02817347|Piperacillin|piperacillin|mesh-list
65635866|NCT02817347|Dexamethasone|dexamethasone|mesh-list
65635867|NCT02817347|Dexamethasone acetate|dexamethasone acetate|mesh-list
65635868|NCT02817347|BB 1101|bb 1101|mesh-list
65635869|NCT02817347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65635870|NCT02817347|Antiemetics|antiemetics|mesh-ancestor
65635871|NCT02817347|Autonomic Agents|autonomic agents|mesh-ancestor
65635872|NCT02817347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65635873|NCT02817347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635874|NCT02817347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65635875|NCT02817347|Glucocorticoids|glucocorticoids|mesh-ancestor
65635876|NCT02817347|Hormones|hormones|mesh-ancestor
65635877|NCT02817347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65635878|NCT02817347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65635879|NCT02817347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433198|NCT00288639|Anticonvulsants|anticonvulsants|mesh-ancestor
65635880|NCT02817347|Protease Inhibitors|protease inhibitors|mesh-ancestor
65635881|NCT02817347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635882|NCT02817347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635883|NCT02817347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65635884|NCT02817347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65635885|NCT02817347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65635887|NCT01373021|Dexmedetomidine|dexmedetomidine|mesh-list
65635888|NCT01373021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65635889|NCT01373021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65635890|NCT01373021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635891|NCT01373021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65635892|NCT01373021|Analgesics|analgesics|mesh-ancestor
65635893|NCT01373021|Sensory System Agents|sensory system agents|mesh-ancestor
65635894|NCT01373021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65635895|NCT01373021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65635896|NCT01373021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65635897|NCT01373021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65635898|NCT01373021|Adrenergic Agents|adrenergic agents|mesh-ancestor
65635899|NCT01373021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65635900|NCT01373021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635901|NCT01373021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65635902|NCT01373021|Narcotics|narcotics|mesh-ancestor
65635903|NCT01373021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65635904|NCT01373021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65635905|NCT01373021|Anesthetics, General|anesthetics, general|mesh-ancestor
65635906|NCT01373021|Anesthetics|anesthetics|mesh-ancestor
65635907|NCT02690558|Gemcitabine|gemcitabine|mesh-list
65635908|NCT02690558|Pembrolizumab|pembrolizumab|mesh-list
65635909|NCT02690558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635910|NCT02690558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65635911|NCT02690558|Antimetabolites|antimetabolites|mesh-ancestor
65635912|NCT02690558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635913|NCT02690558|Antiviral Agents|antiviral agents|mesh-ancestor
65635914|NCT02690558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65635915|NCT02690558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635916|NCT02690558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65635917|NCT02690558|Immunologic Factors|immunologic factors|mesh-ancestor
65635918|NCT02690558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635919|NCT02690558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65635920|NCT03568578|Entecavir|entecavir|mesh-list
65635921|NCT03568578|Antiviral Agents|antiviral agents|mesh-ancestor
65635922|NCT03568578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65635923|NCT01367483|Methylnaltrexone|methylnaltrexone|mesh-list
65635924|NCT01367483|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65635925|NCT01367483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635926|NCT01367483|Sensory System Agents|sensory system agents|mesh-ancestor
65635927|NCT01367483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65635928|NCT02140736|Epoetin Alfa|epoetin alfa|mesh-list
65635929|NCT02140736|Hematinics|hematinics|mesh-ancestor
65635930|NCT05417035|Testosterone undecanoate|testosterone undecanoate|mesh-list
65635931|NCT05417035|Androgens|androgens|mesh-ancestor
65635932|NCT05417035|Hormones|hormones|mesh-ancestor
65635933|NCT05417035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65635934|NCT05417035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635935|NCT05708742|Bupivacaine|bupivacaine|mesh-list
65635936|NCT05708742|Anesthetics, Local|anesthetics, local|mesh-list
65635937|NCT05708742|Anesthetics|anesthetics|mesh-list
65635938|NCT05708742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65635939|NCT05708742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635940|NCT05708742|Sensory System Agents|sensory system agents|mesh-ancestor
65635941|NCT05708742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65635942|NCT03095287|Factor VIII|factor viii|mesh-list
65635943|NCT03095287|Coagulants|coagulants|mesh-ancestor
65635944|NCT01335581|Tretinoin|tretinoin|mesh-list
65635945|NCT01335581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65635946|NCT01335581|Keratolytic Agents|keratolytic agents|mesh-ancestor
65635947|NCT01335581|Dermatologic Agents|dermatologic agents|mesh-ancestor
65635948|NCT05204563|Imipenem|imipenem|mesh-list
65635949|NCT05204563|Relebactam|relebactam|mesh-list
65635950|NCT05204563|Cilastatin|cilastatin|mesh-list
65635951|NCT05204563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65635952|NCT05204563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65635953|NCT05204563|Protease Inhibitors|protease inhibitors|mesh-ancestor
65635954|NCT05204563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635955|NCT05204563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635956|NCT05204563|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65635957|NCT02140814|Niacinamide|niacinamide|mesh-list
65635958|NCT02140814|Niacin|niacin|mesh-list
65433268|NCT01045902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635960|NCT02140814|Vitamins|vitamins|mesh-ancestor
65635961|NCT02140814|Micronutrients|micronutrients|mesh-ancestor
65635962|NCT02140814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635963|NCT02140814|Vitamin B Complex|vitamin b complex|mesh-ancestor
65635964|NCT02140814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65635965|NCT02140814|Antimetabolites|antimetabolites|mesh-ancestor
65635966|NCT02140814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635967|NCT02140814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65635968|NCT02140814|Vasodilator Agents|vasodilator agents|mesh-ancestor
65635969|NCT03015090|Theophylline|theophylline|mesh-list
65635970|NCT03015090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65635971|NCT03015090|Autonomic Agents|autonomic agents|mesh-ancestor
65635972|NCT03015090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65635973|NCT03015090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635974|NCT03015090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65635975|NCT03015090|Respiratory System Agents|respiratory system agents|mesh-ancestor
65635976|NCT03015090|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65635977|NCT03015090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65635978|NCT03015090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635979|NCT03015090|Vasodilator Agents|vasodilator agents|mesh-ancestor
65635980|NCT03015090|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65635981|NCT03015090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65635982|NCT03015090|Purinergic Agents|purinergic agents|mesh-ancestor
65635983|NCT03015090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65635984|NCT02620748|Tranexamic Acid|tranexamic acid|mesh-list
65635985|NCT02620748|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65635986|NCT02620748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65635987|NCT02620748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635988|NCT02620748|Hemostatics|hemostatics|mesh-ancestor
65635989|NCT02620748|Coagulants|coagulants|mesh-ancestor
65635990|NCT02144792|Verapamil|verapamil|mesh-list
65635991|NCT02144792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65635992|NCT02144792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65635993|NCT02144792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65635994|NCT02144792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65635995|NCT02144792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65635996|NCT02144792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65635997|NCT02144792|Vasodilator Agents|vasodilator agents|mesh-ancestor
65635998|NCT03566394|Gabapentin|gabapentin|mesh-list
65635999|NCT03566394|Analgesics|analgesics|mesh-ancestor
65636000|NCT03566394|Sensory System Agents|sensory system agents|mesh-ancestor
65636001|NCT03566394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65636002|NCT03566394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636003|NCT03566394|Anticonvulsants|anticonvulsants|mesh-ancestor
65636004|NCT03566394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65636005|NCT03566394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65636006|NCT03566394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65636007|NCT03566394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65636008|NCT03566394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65636009|NCT03566394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65636010|NCT03566394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65636011|NCT03566394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636012|NCT03566394|Antimanic Agents|antimanic agents|mesh-ancestor
65636013|NCT00033293|Prednisone|prednisone|mesh-list
65636014|NCT00033293|Cortisone|cortisone|mesh-list
65636015|NCT00033293|Cyclophosphamide|cyclophosphamide|mesh-list
65636016|NCT00033293|Immunoglobulins|immunoglobulins|mesh-list
65636017|NCT00033293|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65636018|NCT00033293|Antibodies|antibodies|mesh-list
65636019|NCT00033293|gamma-Globulins|gamma-globulins|mesh-list
65636020|NCT00033293|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65636021|NCT00033293|Immunoglobulin G|immunoglobulin g|mesh-list
65636022|NCT00033293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65267218|NCT04172259|Cyclophosphamide|cyclophosphamide|mesh-list
65636023|NCT00033293|Immunologic Factors|immunologic factors|mesh-ancestor
65636024|NCT00033293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636025|NCT00033293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65636026|NCT00033293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65636027|NCT00033293|Alkylating Agents|alkylating agents|mesh-ancestor
65636028|NCT00033293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636029|NCT00033293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636030|NCT00033293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65636031|NCT00033293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65636032|NCT00033293|Glucocorticoids|glucocorticoids|mesh-ancestor
65636033|NCT00033293|Hormones|hormones|mesh-ancestor
65636034|NCT00033293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65636035|NCT00033293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65636036|NCT03566316|Amlodipine|amlodipine|mesh-list
65636037|NCT03566316|Telmisartan|telmisartan|mesh-list
65636038|NCT03566316|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
65636039|NCT03566316|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65636040|NCT03566316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65636041|NCT03566316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65636042|NCT03566316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65636043|NCT03566316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636044|NCT03566316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65636045|NCT03566316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636046|NCT03566316|Vasodilator Agents|vasodilator agents|mesh-ancestor
65636047|NCT03566316|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65636048|NCT03566316|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65636049|NCT03566316|Antimetabolites|antimetabolites|mesh-ancestor
65636050|NCT03566316|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65636051|NCT03566316|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65636052|NCT03566316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636053|NCT03566316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65636054|NCT03566316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65636055|NCT02145104|Valsartan|valsartan|mesh-list
65636056|NCT02145104|Cilnidipine|cilnidipine|mesh-list
65636057|NCT02145104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65636058|NCT02145104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65636059|NCT02145104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65636060|NCT02145104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636061|NCT02145104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65636062|NCT02145104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65636063|NCT02145104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65636064|NCT02145104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636065|NCT02145338|Trimethoprim|trimethoprim|mesh-list
65636066|NCT02145338|Nitrofurantoin|nitrofurantoin|mesh-list
65636067|NCT02145338|Cephalexin|cephalexin|mesh-list
65636068|NCT02145338|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65636069|NCT02145338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65636070|NCT02145338|Renal Agents|renal agents|mesh-ancestor
65636071|NCT02145338|Antimalarials|antimalarials|mesh-ancestor
65636072|NCT02145338|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65636073|NCT02145338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65636074|NCT02145338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65636075|NCT02145338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636076|NCT02145338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636077|NCT02145338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65636078|NCT02145338|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65636079|NCT02145338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65636080|NCT02145338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65636081|NCT01373333|Amifampridine|amifampridine|mesh-list
65636082|NCT01373333|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65636083|NCT01373333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65636084|NCT01373333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636085|NCT01373333|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65636086|NCT01373333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65636087|NCT01373333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636088|NCT03565536|Sorafenib|sorafenib|mesh-list
65636089|NCT03565536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636090|NCT03565536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65636091|NCT03565536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267220|NCT04172259|Doxorubicin|doxorubicin|mesh-list
65636092|NCT03565536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636093|NCT03565458|Dapagliflozin|dapagliflozin|mesh-list
65636094|NCT03565458|Empagliflozin|empagliflozin|mesh-list
65636095|NCT03565458|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65636096|NCT03565458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636097|NCT03565458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65636098|NCT03565458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636099|NCT03565302|Terbutaline|terbutaline|mesh-list
65636100|NCT03565302|Formoterol Fumarate|formoterol fumarate|mesh-list
65636101|NCT03565302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65636102|NCT03565302|Autonomic Agents|autonomic agents|mesh-ancestor
65636103|NCT03565302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65636104|NCT03565302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636105|NCT03565302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65636106|NCT03565302|Respiratory System Agents|respiratory system agents|mesh-ancestor
65636107|NCT03565302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65636108|NCT03565302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65636109|NCT03565302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65636110|NCT03565302|Adrenergic Agents|adrenergic agents|mesh-ancestor
65636111|NCT03565302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65636112|NCT03565302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636113|NCT03565302|Sympathomimetics|sympathomimetics|mesh-ancestor
65636114|NCT03565302|Tocolytic Agents|tocolytic agents|mesh-ancestor
65636115|NCT03565302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65636116|NCT05193227|Lidocaine|lidocaine|mesh-list
65636117|NCT05193227|Bupivacaine|bupivacaine|mesh-list
65636118|NCT05193227|Anesthetics, Local|anesthetics, local|mesh-ancestor
65636119|NCT05193227|Anesthetics|anesthetics|mesh-ancestor
65636120|NCT05193227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65636121|NCT05193227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636122|NCT05193227|Sensory System Agents|sensory system agents|mesh-ancestor
65636123|NCT05193227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65636124|NCT05193227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65636125|NCT05193227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65636126|NCT05193227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65636127|NCT05193227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65636128|NCT05193227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636129|NCT01372007|Lanreotide|lanreotide|mesh-list
65636130|NCT01372007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636131|NCT01373411|Ticagrelor|ticagrelor|mesh-list
65636132|NCT01373411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65636133|NCT01373411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65636134|NCT01373411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65636135|NCT01373411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65636136|NCT01373411|Purinergic Agents|purinergic agents|mesh-ancestor
65636137|NCT01373411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65636138|NCT01373411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636139|NCT01373411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636140|NCT03567408|Bivalirudin|bivalirudin|mesh-list
65636141|NCT03567408|Antithrombins|antithrombins|mesh-ancestor
65636142|NCT03567408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65636143|NCT03567408|Protease Inhibitors|protease inhibitors|mesh-ancestor
65636144|NCT03567408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636145|NCT03567408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636146|NCT03567408|Anticoagulants|anticoagulants|mesh-ancestor
65636147|NCT05354076|Doxorubicin|doxorubicin|mesh-list
65636148|NCT05354076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65636149|NCT05354076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65636150|NCT05354076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636151|NCT05354076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65636152|NCT05354076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65636153|NCT05354076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636154|NCT05354076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636155|NCT05106335|Docetaxel|docetaxel|mesh-list
65636156|NCT05106335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636157|NCT05106335|Tubulin Modulators|tubulin modulators|mesh-ancestor
65636158|NCT05106335|Antimitotic Agents|antimitotic agents|mesh-ancestor
65636159|NCT05106335|Mitosis Modulators|mitosis modulators|mesh-ancestor
65636160|NCT05106335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636161|NCT05192681|Docetaxel|docetaxel|mesh-list
65636162|NCT05192681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636163|NCT05192681|Tubulin Modulators|tubulin modulators|mesh-ancestor
65636164|NCT05192681|Antimitotic Agents|antimitotic agents|mesh-ancestor
65636165|NCT05192681|Mitosis Modulators|mitosis modulators|mesh-ancestor
65636166|NCT05192681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636167|NCT05192213|Thiamine|thiamine|mesh-list
65636168|NCT05192213|Hydrocortisone|hydrocortisone|mesh-list
65636169|NCT05192213|Vitamins|vitamins|mesh-ancestor
65636170|NCT05192213|Micronutrients|micronutrients|mesh-ancestor
65636171|NCT05192213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636172|NCT05192213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65636173|NCT05192213|Vitamin B Complex|vitamin b complex|mesh-ancestor
65636174|NCT02039674|Paclitaxel|paclitaxel|mesh-list
65636175|NCT02039674|Bevacizumab|bevacizumab|mesh-list
65636176|NCT02039674|Carboplatin|carboplatin|mesh-list
65636177|NCT02039674|Pembrolizumab|pembrolizumab|mesh-list
65636178|NCT02039674|Pemetrexed|pemetrexed|mesh-list
65636179|NCT02039674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65636180|NCT02039674|Ipilimumab|ipilimumab|mesh-list
65636181|NCT02039674|Gefitinib|gefitinib|mesh-list
65433500|NCT00429416|Mesna|mesna|mesh-list
65636182|NCT02039674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65636183|NCT02039674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636184|NCT02039674|Tubulin Modulators|tubulin modulators|mesh-ancestor
65636185|NCT02039674|Antimitotic Agents|antimitotic agents|mesh-ancestor
65636186|NCT02039674|Mitosis Modulators|mitosis modulators|mesh-ancestor
65636187|NCT02039674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636188|NCT02039674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65636189|NCT02039674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65636190|NCT02039674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65636191|NCT02039674|Growth Substances|growth substances|mesh-ancestor
65636192|NCT02039674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636193|NCT02039674|Growth Inhibitors|growth inhibitors|mesh-ancestor
65636194|NCT02039674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636195|NCT02039674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65636196|NCT02039674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65636197|NCT02039674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65636198|NCT02039674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65636199|NCT03099187|Pirfenidone|pirfenidone|mesh-list
65636200|NCT03099187|Analgesics|analgesics|mesh-ancestor
65636201|NCT03099187|Sensory System Agents|sensory system agents|mesh-ancestor
65636202|NCT03099187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65636203|NCT03099187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636204|NCT03099187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65636205|NCT03099187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65636206|NCT03099187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65636207|NCT03099187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65636208|NCT03099187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636209|NCT04162756|Cyclophosphamide|cyclophosphamide|mesh-list
65636210|NCT04162756|Fludarabine|fludarabine|mesh-list
65636211|NCT04162756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65636212|NCT04162756|Immunologic Factors|immunologic factors|mesh-ancestor
65636213|NCT04162756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636214|NCT04162756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65636215|NCT04162756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65636216|NCT04162756|Alkylating Agents|alkylating agents|mesh-ancestor
65636217|NCT04162756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636218|NCT04162756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636219|NCT04162756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65636220|NCT04544267|Vaccines|vaccines|mesh-list
65636221|NCT04544267|Immunologic Factors|immunologic factors|mesh-ancestor
65636222|NCT04544267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636223|NCT04895488|Vortioxetine|vortioxetine|mesh-list
65636224|NCT04895488|Antipsychotic Agents|antipsychotic agents|mesh-list
65636225|NCT04895488|Antidepressive Agents|antidepressive agents|mesh-ancestor
65636226|NCT04895488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65636227|NCT04895488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65636228|NCT04895488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65636229|NCT04895488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65636230|NCT04895488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636231|NCT04895488|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65636232|NCT04895488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65636233|NCT04895488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65636234|NCT04895488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636235|NCT04895488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65636236|NCT04895488|Serotonin Agents|serotonin agents|mesh-ancestor
65636237|NCT04895488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65636238|NCT04895488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65636239|NCT04895488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65636240|NCT04895488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65636241|NCT04342715|Paromomycin|paromomycin|mesh-list
65636242|NCT04342715|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
65636243|NCT04342715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65636244|NCT04342715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65636245|NCT04342715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65636246|NCT04342715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65636247|NCT04342715|Schistosomicides|schistosomicides|mesh-ancestor
65636248|NCT04342715|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65636249|NCT04342715|Anthelmintics|anthelmintics|mesh-ancestor
65636250|NCT01368341|Amoxicillin|amoxicillin|mesh-list
65636251|NCT01368341|Doxycycline|doxycycline|mesh-list
65636252|NCT01368341|Penicillin V|penicillin v|mesh-list
65636253|NCT01368341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65636254|NCT01368341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65433570|NCT00301821|Hormones|hormones|mesh-ancestor
65636255|NCT01368341|Antimalarials|antimalarials|mesh-ancestor
65636256|NCT01368341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65636257|NCT01368341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65636258|NCT01368419|Endostar protein|endostar protein|mesh-list
65636259|NCT01368419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65636260|NCT01368419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65636261|NCT01368419|Growth Substances|growth substances|mesh-ancestor
65636262|NCT01368419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636263|NCT01368419|Growth Inhibitors|growth inhibitors|mesh-ancestor
65636264|NCT01368419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636265|NCT04639219|Trastuzumab|trastuzumab|mesh-list
65636266|NCT04639219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65636267|NCT04639219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636268|NCT04455100|Itraconazole|itraconazole|mesh-list
65636269|NCT04455100|Antifungal Agents|antifungal agents|mesh-ancestor
65636270|NCT04455100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65636271|NCT04455100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65636272|NCT04455100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65636273|NCT04455100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636274|NCT04455100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636275|NCT04455100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65636276|NCT04455100|Hormone Antagonists|hormone antagonists|mesh-ancestor
65636277|NCT04455100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65636278|NCT04455100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636279|NCT04455100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65636280|NCT04439578|Rifampin|rifampin|mesh-list
65636281|NCT04439578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65636282|NCT04439578|Antitubercular Agents|antitubercular agents|mesh-ancestor
65636283|NCT04439578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65636284|NCT04439578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65636285|NCT04439578|Leprostatic Agents|leprostatic agents|mesh-ancestor
65636286|NCT04439578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65636287|NCT04439578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636288|NCT04439578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636289|NCT04439578|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65636290|NCT04439578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65636291|NCT04439578|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65636292|NCT04439578|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65636293|NCT04439578|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65636294|NCT04439578|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65636295|NCT03110848|Methylprednisolone|methylprednisolone|mesh-list
65636296|NCT03110848|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65636297|NCT03110848|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65636298|NCT03110848|Prednisolone|prednisolone|mesh-list
65636299|NCT03110848|Prednisolone acetate|prednisolone acetate|mesh-list
65636300|NCT03110848|Atorvastatin|atorvastatin|mesh-list
65636301|NCT03110848|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65636302|NCT03110848|Prednisolone phosphate|prednisolone phosphate|mesh-list
65636303|NCT03110848|Glucocorticoids|glucocorticoids|mesh-list
65636304|NCT03110848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65636305|NCT03110848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65636306|NCT03110848|Antimetabolites|antimetabolites|mesh-ancestor
65636307|NCT03110848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636308|NCT03110848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65636309|NCT03110848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65636310|NCT03110848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636311|NCT03110848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65636312|NCT03110848|Antiemetics|antiemetics|mesh-ancestor
65636313|NCT03110848|Autonomic Agents|autonomic agents|mesh-ancestor
65636314|NCT03110848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65636315|NCT03110848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636316|NCT03110848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65636317|NCT03110848|Hormones|hormones|mesh-ancestor
65636318|NCT03110848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65636319|NCT03110848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65636320|NCT03110848|Protective Agents|protective agents|mesh-ancestor
65636321|NCT03110848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65636322|NCT03110848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636323|NCT03139474|Hormones|hormones|mesh-list
65636324|NCT03139474|Hormone Antagonists|hormone antagonists|mesh-list
65636325|NCT03139474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65636326|NCT03139474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636327|NCT04300231|Hydromorphone|hydromorphone|mesh-list
65636328|NCT04300231|Bupivacaine|bupivacaine|mesh-list
65636329|NCT04300231|Anesthetics, Local|anesthetics, local|mesh-ancestor
65636330|NCT04300231|Anesthetics|anesthetics|mesh-ancestor
65636331|NCT04300231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65636332|NCT04300231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636333|NCT04300231|Sensory System Agents|sensory system agents|mesh-ancestor
65636334|NCT04300231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65636335|NCT04300231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65636336|NCT04300231|Narcotics|narcotics|mesh-ancestor
65636337|NCT04300231|Analgesics|analgesics|mesh-ancestor
65636338|NCT01368887|Niacinamide|niacinamide|mesh-list
65636339|NCT01368887|Niacin|niacin|mesh-list
65636340|NCT01368887|Nicotinic Acids|nicotinic acids|mesh-list
65636341|NCT01368887|Calcipotriene|calcipotriene|mesh-list
65636342|NCT01368887|Vitamin B Complex|vitamin b complex|mesh-ancestor
65636343|NCT01368887|Vitamins|vitamins|mesh-ancestor
65636344|NCT01368887|Micronutrients|micronutrients|mesh-ancestor
65636345|NCT01368887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636346|NCT01368887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65636347|NCT01368887|Antimetabolites|antimetabolites|mesh-ancestor
65636348|NCT01368887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636349|NCT01368887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65636350|NCT01368887|Vasodilator Agents|vasodilator agents|mesh-ancestor
65636351|NCT01368887|Dermatologic Agents|dermatologic agents|mesh-ancestor
65636352|NCT01369043|Vitamins|vitamins|mesh-list
65636353|NCT01369043|Vitamin E|vitamin e|mesh-list
65636354|NCT01369043|Micronutrients|micronutrients|mesh-ancestor
65636355|NCT01369043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636356|NCT01369043|Antioxidants|antioxidants|mesh-ancestor
65267228|NCT04172259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65636357|NCT01369043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636358|NCT01369043|Protective Agents|protective agents|mesh-ancestor
65636359|NCT04477096|Emtricitabine|emtricitabine|mesh-list
65636360|NCT04477096|Antiviral Agents|antiviral agents|mesh-ancestor
65636361|NCT04477096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65636362|NCT04477096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65636363|NCT04477096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65636364|NCT04477096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636365|NCT04477096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636366|NCT04477096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65636367|NCT04477096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65636368|NCT01369121|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
65636369|NCT01369121|Hormones|hormones|mesh-ancestor
65636370|NCT01369121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65636371|NCT01369121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636372|NCT03868150|Amiodarone|amiodarone|mesh-list
65636373|NCT03868150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65636374|NCT03868150|Vasodilator Agents|vasodilator agents|mesh-ancestor
65636375|NCT03868150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65636376|NCT03868150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65636377|NCT03868150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636378|NCT03868150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65636379|NCT03868150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65636380|NCT03868150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65636381|NCT03868150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636382|NCT03868150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65636383|NCT03868150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65636384|NCT03868150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65636385|NCT03521687|Apremilast|apremilast|mesh-list
65636386|NCT03521687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65636387|NCT03521687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65636388|NCT03521687|Analgesics|analgesics|mesh-ancestor
65636389|NCT03521687|Sensory System Agents|sensory system agents|mesh-ancestor
65636390|NCT03521687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65636391|NCT03521687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636392|NCT03521687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65636393|NCT03521687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65636394|NCT03521687|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65636395|NCT03521687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65636396|NCT03521687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636397|NCT03521687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636398|NCT03141658|Ketamine|ketamine|mesh-list
65636399|NCT03141658|Analgesics|analgesics|mesh-ancestor
65636400|NCT03141658|Sensory System Agents|sensory system agents|mesh-ancestor
65433714|NCT00286455|Protease Inhibitors|protease inhibitors|mesh-ancestor
65636401|NCT03141658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65636402|NCT03141658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636403|NCT03141658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65636404|NCT03141658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65636405|NCT03141658|Anesthetics, General|anesthetics, general|mesh-ancestor
65636406|NCT03141658|Anesthetics|anesthetics|mesh-ancestor
65636407|NCT03141658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65636408|NCT03141658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65636409|NCT03141658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65636410|NCT03141658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65636411|NCT03141658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636412|NCT03498131|Melatonin|melatonin|mesh-list
65636413|NCT03498131|Antioxidants|antioxidants|mesh-ancestor
65636414|NCT03498131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636415|NCT03498131|Protective Agents|protective agents|mesh-ancestor
65636416|NCT03498131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636417|NCT03498131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65636418|NCT01319825|Milnacipran|milnacipran|mesh-list
65636419|NCT01319825|Levomilnacipran|levomilnacipran|mesh-list
65636420|NCT01319825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65636421|NCT01319825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65636422|NCT01319825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65636423|NCT01319825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636424|NCT01319825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65636425|NCT01319825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636426|NCT01319825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65636427|NCT01319825|Analgesics|analgesics|mesh-ancestor
65636428|NCT01319825|Sensory System Agents|sensory system agents|mesh-ancestor
65636429|NCT01319825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65636430|NCT01319825|Antidepressive Agents|antidepressive agents|mesh-ancestor
65636431|NCT01319825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65636432|NCT01369277|Nicotinic Acids|nicotinic acids|mesh-list
65636433|NCT01369277|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
65636434|NCT01369277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636435|NCT01369277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636436|NCT01369277|Vitamin B Complex|vitamin b complex|mesh-ancestor
65636437|NCT01369277|Vitamins|vitamins|mesh-ancestor
65636438|NCT01369277|Micronutrients|micronutrients|mesh-ancestor
65636439|NCT01369277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636440|NCT02983006|Nivolumab|nivolumab|mesh-list
65636441|NCT02983006|DS-8273a|ds-8273a|mesh-list
65636442|NCT02983006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65636443|NCT02983006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636444|NCT02983006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65636445|NCT02983006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636446|NCT05046184|Midazolam|midazolam|mesh-list
65636447|NCT05046184|Ketamine|ketamine|mesh-list
65636448|NCT05046184|Analgesics|analgesics|mesh-ancestor
65636449|NCT05046184|Sensory System Agents|sensory system agents|mesh-ancestor
65636450|NCT05046184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65636451|NCT05046184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636452|NCT05046184|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65636453|NCT05046184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65636454|NCT05046184|Anesthetics, General|anesthetics, general|mesh-ancestor
65636455|NCT05046184|Anesthetics|anesthetics|mesh-ancestor
65636456|NCT05046184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65636457|NCT05046184|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65636458|NCT05046184|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65636459|NCT05046184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65636460|NCT05046184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636461|NCT05046184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65636462|NCT05046184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65636463|NCT05046184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65636464|NCT05046184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65636465|NCT05046184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65636466|NCT05046184|GABA Modulators|gaba modulators|mesh-ancestor
65636467|NCT05046184|GABA Agents|gaba agents|mesh-ancestor
65636468|NCT03811756|Coenzyme Q10|coenzyme q10|mesh-list
65636469|NCT03811756|Vitamins|vitamins|mesh-ancestor
65636470|NCT03811756|Micronutrients|micronutrients|mesh-ancestor
65636471|NCT03811756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636472|NCT03141268|Lactulose|lactulose|mesh-list
65636473|NCT03141268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65636474|NCT03316781|Adalimumab|adalimumab|mesh-list
65636475|NCT03316781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65636476|NCT03316781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65636477|NCT01319903|Antibodies|antibodies|mesh-list
65636478|NCT01319903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65636479|NCT01319903|Immunologic Factors|immunologic factors|mesh-ancestor
65636480|NCT01319903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636481|NCT02839200|Zolpidem|zolpidem|mesh-list
65636482|NCT02839200|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65636483|NCT02839200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65636484|NCT02839200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65636485|NCT02839200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636486|NCT02839200|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65636487|NCT02839200|GABA Agonists|gaba agonists|mesh-ancestor
65636488|NCT02839200|GABA Agents|gaba agents|mesh-ancestor
65636489|NCT02839200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65636490|NCT02839200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636491|NCT01369667|Vitamin D|vitamin d|mesh-list
65636492|NCT01369667|Cholecalciferol|cholecalciferol|mesh-list
65636493|NCT01369667|Vitamins|vitamins|mesh-ancestor
65636494|NCT01369667|Micronutrients|micronutrients|mesh-ancestor
65636495|NCT01369667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636496|NCT01369667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65636497|NCT01369667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65636498|NCT03564912|Capecitabine|capecitabine|mesh-list
65636499|NCT03564912|Oxaliplatin|oxaliplatin|mesh-list
65636500|NCT03564912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65636501|NCT03564912|Antimetabolites|antimetabolites|mesh-ancestor
65636502|NCT03564912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636503|NCT03564912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636504|NCT03551626|Trametinib|trametinib|mesh-list
65636505|NCT03551626|Dabrafenib|dabrafenib|mesh-list
65636506|NCT03551626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636507|NCT03551626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65636508|NCT03551626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636509|NCT03551626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636510|NCT05760053|Cisplatin|cisplatin|mesh-list
65636511|NCT05760053|Carboplatin|carboplatin|mesh-list
65636512|NCT05760053|Etoposide|etoposide|mesh-list
65636513|NCT05760053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636514|NCT05760053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65636515|NCT05760053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65636516|NCT05760053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65636517|NCT05760053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636518|NCT05760053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636519|NCT03245008|Fasinumab|fasinumab|mesh-list
65636520|NCT03245008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65636521|NCT03245008|Analgesics|analgesics|mesh-ancestor
65636522|NCT03245008|Sensory System Agents|sensory system agents|mesh-ancestor
65636523|NCT03245008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65636524|NCT03245008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636525|NCT03118739|Febuxostat|febuxostat|mesh-list
65636526|NCT03118739|Verinurad|verinurad|mesh-list
65636527|NCT03118739|Gout Suppressants|gout suppressants|mesh-ancestor
65636528|NCT03118739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65636529|NCT03181126|Venetoclax|venetoclax|mesh-list
65636530|NCT03181126|Navitoclax|navitoclax|mesh-list
65636531|NCT03181126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636532|NCT05139875|Triamcinolone|triamcinolone|mesh-list
65636533|NCT05139875|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65636534|NCT05139875|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65636535|NCT05139875|Betamethasone|betamethasone|mesh-list
65636536|NCT05139875|Betamethasone Valerate|betamethasone valerate|mesh-list
65636537|NCT05139875|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65636538|NCT05139875|Betamethasone benzoate|betamethasone benzoate|mesh-list
65636539|NCT05139875|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
65636540|NCT05139875|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65636541|NCT05139875|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65636542|NCT05139875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65636543|NCT05139875|Glucocorticoids|glucocorticoids|mesh-ancestor
65636544|NCT05139875|Hormones|hormones|mesh-ancestor
65636545|NCT05139875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65636546|NCT05139875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636547|NCT05139875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65636548|NCT05139875|Immunologic Factors|immunologic factors|mesh-ancestor
65636549|NCT05139875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267280|NCT02517918|Antimetabolites|antimetabolites|mesh-ancestor
65636550|NCT05139875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636551|NCT05139875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65636552|NCT05139875|Respiratory System Agents|respiratory system agents|mesh-ancestor
65636553|NCT03140410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65636554|NCT03140410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65636555|NCT01375985|Radavirsen|radavirsen|mesh-list
65636556|NCT01375985|Antiviral Agents|antiviral agents|mesh-ancestor
65636557|NCT01375985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65636558|NCT05384821|Irinotecan|irinotecan|mesh-list
65636559|NCT05384821|Etoposide|etoposide|mesh-list
65636560|NCT05384821|Vincristine|vincristine|mesh-list
65636561|NCT05384821|Temozolomide|temozolomide|mesh-list
65636562|NCT05384821|Tretinoin|tretinoin|mesh-list
65636563|NCT05384821|Isotretinoin|isotretinoin|mesh-list
65636564|NCT05384821|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65636565|NCT05384821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65636566|NCT05384821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636567|NCT05384821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636568|NCT05384821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636569|NCT05384821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65636570|NCT05384821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65636571|NCT05384821|Tubulin Modulators|tubulin modulators|mesh-ancestor
65636572|NCT05384821|Antimitotic Agents|antimitotic agents|mesh-ancestor
65636573|NCT05384821|Mitosis Modulators|mitosis modulators|mesh-ancestor
65636574|NCT05384821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65636575|NCT05384821|Alkylating Agents|alkylating agents|mesh-ancestor
65636576|NCT05384821|Keratolytic Agents|keratolytic agents|mesh-ancestor
65636577|NCT05384821|Dermatologic Agents|dermatologic agents|mesh-ancestor
65636578|NCT02654080|Vaccines|vaccines|mesh-list
65636579|NCT02654080|Immunologic Factors|immunologic factors|mesh-ancestor
65636580|NCT02654080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636581|NCT05375305|Morphine|morphine|mesh-list
65636582|NCT05375305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65636583|NCT05375305|Narcotics|narcotics|mesh-ancestor
65636584|NCT05375305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65636585|NCT05375305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636586|NCT05375305|Analgesics|analgesics|mesh-ancestor
65636587|NCT05375305|Sensory System Agents|sensory system agents|mesh-ancestor
65636588|NCT05375305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65636589|NCT03140332|Sorafenib|sorafenib|mesh-list
65636590|NCT03140332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636591|NCT03140332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65636592|NCT03140332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636593|NCT03140332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636594|NCT02835690|Pembrolizumab|pembrolizumab|mesh-list
65636595|NCT02835690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65636596|NCT02835690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636597|NCT00921115|Fulvestrant|fulvestrant|mesh-list
65636598|NCT00921115|Anastrozole|anastrozole|mesh-list
65636599|NCT00921115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65636600|NCT00921115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636601|NCT00921115|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65636602|NCT00921115|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65636603|NCT00921115|Hormone Antagonists|hormone antagonists|mesh-ancestor
65636604|NCT00921115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65636605|NCT00921115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636606|NCT00921115|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65636607|NCT00921115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65636608|NCT00921115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636609|NCT00921115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636610|NCT05024773|Paclitaxel|paclitaxel|mesh-list
65636611|NCT05024773|Hyaluronic Acid|hyaluronic acid|mesh-list
65636612|NCT05024773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65636613|NCT05024773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636614|NCT05024773|Tubulin Modulators|tubulin modulators|mesh-ancestor
65636615|NCT05024773|Antimitotic Agents|antimitotic agents|mesh-ancestor
65636616|NCT05024773|Mitosis Modulators|mitosis modulators|mesh-ancestor
65636617|NCT05024773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636618|NCT05024773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65636619|NCT05024773|Immunologic Factors|immunologic factors|mesh-ancestor
65636620|NCT05024773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636621|NCT05024773|Viscosupplements|viscosupplements|mesh-ancestor
65636622|NCT05024773|Protective Agents|protective agents|mesh-ancestor
65636623|NCT02832167|Nivolumab|nivolumab|mesh-list
65636624|NCT02832167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65636625|NCT02832167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636626|NCT02832167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65636627|NCT02832167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636628|NCT04941040|Analgesics, Opioid|analgesics, opioid|mesh-list
65636629|NCT04941040|Anesthetics|anesthetics|mesh-list
65636630|NCT04941040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65636631|NCT04941040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636632|NCT04941040|Narcotics|narcotics|mesh-ancestor
65636633|NCT04941040|Analgesics|analgesics|mesh-ancestor
65636634|NCT04941040|Sensory System Agents|sensory system agents|mesh-ancestor
65636635|NCT04941040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65636636|NCT00913705|Carboplatin|carboplatin|mesh-list
65636637|NCT00913705|Paclitaxel|paclitaxel|mesh-list
65636638|NCT00913705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65636639|NCT00913705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636640|NCT00913705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65636641|NCT00913705|Tubulin Modulators|tubulin modulators|mesh-ancestor
65636642|NCT00913705|Antimitotic Agents|antimitotic agents|mesh-ancestor
65636643|NCT00913705|Mitosis Modulators|mitosis modulators|mesh-ancestor
65636644|NCT00913705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636645|NCT04934410|Midazolam|midazolam|mesh-list
65636646|NCT04934410|Etomidate|etomidate|mesh-list
65636647|NCT04934410|Sevoflurane|sevoflurane|mesh-list
65636648|NCT04934410|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65636649|NCT04934410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65636650|NCT04934410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65636651|NCT04934410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636652|NCT04934410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65636653|NCT04934410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65636654|NCT04934410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65636655|NCT04934410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65636656|NCT04934410|Anesthetics, General|anesthetics, general|mesh-ancestor
65636657|NCT04934410|Anesthetics|anesthetics|mesh-ancestor
65636658|NCT04934410|GABA Modulators|gaba modulators|mesh-ancestor
65636659|NCT04934410|GABA Agents|gaba agents|mesh-ancestor
65636660|NCT04934410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65636661|NCT04934410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636662|NCT04934410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65636663|NCT04934410|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65636664|NCT02787239|Rituximab|rituximab|mesh-list
65636665|NCT02787239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65636666|NCT02787239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636667|NCT02787239|Immunologic Factors|immunologic factors|mesh-ancestor
65636668|NCT02787239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636669|NCT02787239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65636670|NCT03140956|Levodopa|levodopa|mesh-list
65636671|NCT03140956|Carbidopa|carbidopa|mesh-list
65636672|NCT03140956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65636673|NCT03140956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65636674|NCT03140956|Dopamine Agents|dopamine agents|mesh-ancestor
65636675|NCT03140956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65636676|NCT03140956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636677|NCT03140956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636678|NCT03140956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65636679|NCT03140956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636680|NCT02681237|Olaparib|olaparib|mesh-list
65636681|NCT02681237|Cediranib|cediranib|mesh-list
65636682|NCT02681237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65636683|NCT02681237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636684|NCT02681237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636685|NCT02681237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636686|NCT02681237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65636687|NCT00089245|Iodine|iodine|mesh-list
65636688|NCT00089245|Cadexomer iodine|cadexomer iodine|mesh-list
65636689|NCT00089245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65636690|NCT00089245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65636691|NCT00089245|Trace Elements|trace elements|mesh-ancestor
65636692|NCT00089245|Micronutrients|micronutrients|mesh-ancestor
65636693|NCT00089245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636694|NCT02674529|Citalopram|citalopram|mesh-list
65636695|NCT02674529|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65636696|NCT02674529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65636697|NCT02674529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65636698|NCT02674529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636699|NCT02674529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65636700|NCT02674529|Serotonin Agents|serotonin agents|mesh-ancestor
65636701|NCT02674529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636702|NCT02674529|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65636703|NCT02674529|Antidepressive Agents|antidepressive agents|mesh-ancestor
65636704|NCT02674529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65636705|NCT05081986|Cycloserine|cycloserine|mesh-list
65636706|NCT05081986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65636707|NCT05081986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65636708|NCT05081986|Renal Agents|renal agents|mesh-ancestor
65636709|NCT05081986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65636710|NCT05081986|Antitubercular Agents|antitubercular agents|mesh-ancestor
65636711|NCT05081986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65636712|NCT05081986|Antimetabolites|antimetabolites|mesh-ancestor
65636713|NCT05081986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636714|NCT05418907|Exenatide|exenatide|mesh-list
65636715|NCT05418907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65636716|NCT05418907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636717|NCT05418907|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65636718|NCT05418907|Incretins|incretins|mesh-ancestor
65636719|NCT05418907|Hormones|hormones|mesh-ancestor
65636720|NCT05418907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65636721|NCT02838420|Crizotinib|crizotinib|mesh-list
65636722|NCT02838420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636723|NCT02838420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65636724|NCT02838420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636725|NCT02838420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636726|NCT02666599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65636727|NCT02666599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65636728|NCT02666599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636729|NCT03632317|Everolimus|everolimus|mesh-list
65636730|NCT03632317|Panobinostat|panobinostat|mesh-list
65636731|NCT03632317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636732|NCT03632317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65636733|NCT03632317|Immunologic Factors|immunologic factors|mesh-ancestor
65636734|NCT03632317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636735|NCT03632317|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65636736|NCT03632317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636737|NCT03632317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636738|NCT02591784|Nimotuzumab|nimotuzumab|mesh-list
65636739|NCT02591784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65636740|NCT02591784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636741|NCT02653963|Triamcinolone|triamcinolone|mesh-list
65636742|NCT02653963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65636743|NCT02653963|Glucocorticoids|glucocorticoids|mesh-ancestor
65636744|NCT02653963|Hormones|hormones|mesh-ancestor
65636745|NCT02653963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65636746|NCT02653963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636747|NCT03097861|Lubiprostone|lubiprostone|mesh-list
65636748|NCT03097861|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65636749|NCT03097861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65636750|NCT03097861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636751|NCT03910673|Fosfomycin|fosfomycin|mesh-list
65636752|NCT03910673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65636753|NCT03910673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65636754|NCT01376141|Sumatriptan|sumatriptan|mesh-list
65636755|NCT01376141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65636756|NCT01376141|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65636757|NCT01376141|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65636758|NCT01376141|Serotonin Agents|serotonin agents|mesh-ancestor
65636759|NCT01376141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65636760|NCT01376141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636761|NCT01376141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636762|NCT03642067|Nivolumab|nivolumab|mesh-list
65636763|NCT03642067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65636764|NCT03642067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636765|NCT03642067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65636766|NCT03642067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636767|NCT01816139|Estradiol|estradiol|mesh-list
65636768|NCT01816139|Estrogens|estrogens|mesh-ancestor
65636769|NCT01816139|Hormones|hormones|mesh-ancestor
65636770|NCT01816139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65636771|NCT01816139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636772|NCT04052776|Levodopa|levodopa|mesh-list
65636773|NCT04052776|Carbidopa|carbidopa|mesh-list
65636774|NCT04052776|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65636775|NCT04052776|Buspirone|buspirone|mesh-list
65636776|NCT04052776|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65636777|NCT04052776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65636778|NCT04052776|Dopamine Agents|dopamine agents|mesh-ancestor
65636779|NCT04052776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65636780|NCT04052776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636781|NCT04052776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636782|NCT04052776|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65636783|NCT04052776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636784|NCT04052776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65636785|NCT04052776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65636786|NCT04052776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65636787|NCT04052776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65636788|NCT04052776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65636789|NCT04052776|Serotonin Agents|serotonin agents|mesh-ancestor
65636790|NCT04052776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65636791|NCT04052776|Immunologic Factors|immunologic factors|mesh-ancestor
65636792|NCT04052776|Dopamine Agonists|dopamine agonists|mesh-ancestor
65636793|NCT01374191|Botulinum Toxins|botulinum toxins|mesh-list
65636794|NCT01374191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65636795|NCT01374191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65636796|NCT01374191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65636797|NCT01374191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65636798|NCT01374191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636799|NCT01374191|Cholinergic Agents|cholinergic agents|mesh-ancestor
65636800|NCT01374191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65636801|NCT01374191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636802|NCT01374191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65636803|NCT01374191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65636804|NCT03764735|Benzalkonium Compounds|benzalkonium compounds|mesh-list
65636805|NCT03764735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65636806|NCT03764735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65636807|NCT05041673|Metformin|metformin|mesh-list
65636808|NCT05041673|Liraglutide|liraglutide|mesh-list
65636809|NCT05041673|Empagliflozin|empagliflozin|mesh-list
65636810|NCT05041673|Vildagliptin|vildagliptin|mesh-list
65636811|NCT05041673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65636812|NCT05041673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636813|NCT05041673|Incretins|incretins|mesh-ancestor
65636814|NCT05041673|Hormones|hormones|mesh-ancestor
65636815|NCT05041673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65636816|NCT05041673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65636817|NCT05041673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636818|NCT05041673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65636819|NCT05041673|Protease Inhibitors|protease inhibitors|mesh-ancestor
65636820|NCT05041673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636821|NCT03907540|Belumosudil|belumosudil|mesh-list
65636822|NCT03907540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65636823|NCT03907540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636824|NCT03907540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636825|NCT05759429|Melatonin|melatonin|mesh-list
65636826|NCT05759429|Antioxidants|antioxidants|mesh-ancestor
65636827|NCT05759429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636828|NCT05759429|Protective Agents|protective agents|mesh-ancestor
65636829|NCT05759429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636830|NCT05759429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65636831|NCT04005209|Ketamine|ketamine|mesh-list
65636832|NCT04005209|Analgesics|analgesics|mesh-ancestor
65636833|NCT04005209|Sensory System Agents|sensory system agents|mesh-ancestor
65636834|NCT04005209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65636835|NCT04005209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636836|NCT04005209|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65636837|NCT04005209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65636838|NCT04005209|Anesthetics, General|anesthetics, general|mesh-ancestor
65636839|NCT04005209|Anesthetics|anesthetics|mesh-ancestor
65636840|NCT04005209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65636841|NCT04005209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65636842|NCT04005209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65636843|NCT04005209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65636844|NCT04005209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636845|NCT03904108|Ramucirumab|ramucirumab|mesh-list
65636846|NCT03904108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636847|NCT02833350|Folic Acid|folic acid|mesh-list
65636848|NCT02833350|Adalimumab|adalimumab|mesh-list
65636849|NCT02833350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65636850|NCT02833350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65636851|NCT02833350|Hematinics|hematinics|mesh-ancestor
65636852|NCT02833350|Vitamin B Complex|vitamin b complex|mesh-ancestor
65636853|NCT02833350|Vitamins|vitamins|mesh-ancestor
65636854|NCT02833350|Micronutrients|micronutrients|mesh-ancestor
65636855|NCT02833350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636856|NCT03137134|Crizotinib|crizotinib|mesh-list
65636857|NCT03137134|Esomeprazole|esomeprazole|mesh-list
65636858|NCT03137134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65636859|NCT03137134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65636860|NCT03137134|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65636861|NCT03137134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636862|NCT03137134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636863|NCT03137134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636864|NCT03137134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65636865|NCT03137368|Tamoxifen|tamoxifen|mesh-list
65636866|NCT03137368|Exemestane|exemestane|mesh-list
65636867|NCT03137368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65636868|NCT03137368|Hormone Antagonists|hormone antagonists|mesh-ancestor
65636869|NCT03137368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65636870|NCT03137368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636871|NCT03137368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65636872|NCT03137368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636873|NCT03137368|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65636874|NCT03137368|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65636875|NCT03137368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65636876|NCT03137368|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65636877|NCT03137368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65636878|NCT03137368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636879|NCT03137368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636880|NCT03138616|Vitamin D|vitamin d|mesh-list
65636881|NCT03138616|Vitamins|vitamins|mesh-ancestor
65636882|NCT03138616|Micronutrients|micronutrients|mesh-ancestor
65636883|NCT03138616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636884|NCT03138616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65636885|NCT03137290|Neostigmine|neostigmine|mesh-list
65636886|NCT03137290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65636887|NCT03137290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636888|NCT03137290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636889|NCT03137290|Cholinergic Agents|cholinergic agents|mesh-ancestor
65636890|NCT03137290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65636891|NCT03137290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636892|NCT03137290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65636893|NCT03137290|Autonomic Agents|autonomic agents|mesh-ancestor
65636894|NCT03137290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65636895|NCT03782818|Olaparib|olaparib|mesh-list
65636896|NCT03782818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65636897|NCT03782818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636898|NCT03782818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636899|NCT03782818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636900|NCT05391724|Brincidofovir|brincidofovir|mesh-list
65636901|NCT05391724|Antiviral Agents|antiviral agents|mesh-ancestor
65636902|NCT05391724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65636903|NCT03355534|Dexmedetomidine|dexmedetomidine|mesh-list
65636904|NCT03355534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65636905|NCT03355534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65636906|NCT03355534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636907|NCT03355534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65636908|NCT03355534|Analgesics|analgesics|mesh-ancestor
65636909|NCT03355534|Sensory System Agents|sensory system agents|mesh-ancestor
65636910|NCT03355534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65636911|NCT03355534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65636912|NCT03355534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65636913|NCT03355534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65636914|NCT03355534|Adrenergic Agents|adrenergic agents|mesh-ancestor
65636915|NCT03355534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65636916|NCT03355534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636917|NCT05385562|Triamcinolone|triamcinolone|mesh-list
65636918|NCT05385562|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65636919|NCT05385562|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65636920|NCT05385562|Hyaluronic Acid|hyaluronic acid|mesh-list
65636921|NCT05385562|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65636922|NCT05385562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65636923|NCT05385562|Glucocorticoids|glucocorticoids|mesh-ancestor
65636924|NCT05385562|Hormones|hormones|mesh-ancestor
65636925|NCT05385562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65636926|NCT05385562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636927|NCT05385562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65434237|NCT01040702|Methylphenidate|methylphenidate|mesh-list
65636928|NCT05385562|Immunologic Factors|immunologic factors|mesh-ancestor
65636929|NCT05385562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65636930|NCT05385562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636931|NCT05385562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65636932|NCT05385562|Viscosupplements|viscosupplements|mesh-ancestor
65636933|NCT05385562|Protective Agents|protective agents|mesh-ancestor
65636934|NCT01343043|Cyclophosphamide|cyclophosphamide|mesh-list
65636936|NCT01343043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65636937|NCT01343043|Immunologic Factors|immunologic factors|mesh-ancestor
65636938|NCT01343043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636939|NCT01343043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65636940|NCT01343043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65636941|NCT01343043|Alkylating Agents|alkylating agents|mesh-ancestor
65636942|NCT01343043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636943|NCT01343043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636944|NCT01343043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65636945|NCT03139708|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65636946|NCT03139708|Phenylephrine|phenylephrine|mesh-list
65636947|NCT03139708|Oxymetazoline|oxymetazoline|mesh-list
65636948|NCT03139708|Tropicamide|tropicamide|mesh-list
65636949|NCT03139708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65636950|NCT03139708|Mydriatics|mydriatics|mesh-ancestor
65636951|NCT03139708|Autonomic Agents|autonomic agents|mesh-ancestor
65636952|NCT03139708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65636953|NCT03139708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636954|NCT03139708|Sympathomimetics|sympathomimetics|mesh-ancestor
65636955|NCT03139708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65636956|NCT03139708|Nasal Decongestants|nasal decongestants|mesh-ancestor
65636957|NCT03139708|Respiratory System Agents|respiratory system agents|mesh-ancestor
65636958|NCT03139708|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65636959|NCT03139708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65636960|NCT03139708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65636961|NCT03139708|Adrenergic Agents|adrenergic agents|mesh-ancestor
65636962|NCT03139708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65636963|NCT03139708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636964|NCT03139708|Protective Agents|protective agents|mesh-ancestor
65636965|NCT03139708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65636966|NCT03139708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65636967|NCT03139708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65636968|NCT03139708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65636969|NCT03139708|Cholinergic Agents|cholinergic agents|mesh-ancestor
65636970|NCT01358760|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65636971|NCT01358760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65636972|NCT01358760|Immunologic Factors|immunologic factors|mesh-ancestor
65636973|NCT01358760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636974|NCT05330364|Cladribine|cladribine|mesh-list
65636975|NCT05330364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65636976|NCT05330364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65636977|NCT05330364|Immunologic Factors|immunologic factors|mesh-ancestor
65636978|NCT05330364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636979|NCT05087368|Vaccines|vaccines|mesh-list
65636980|NCT05087368|Immunologic Factors|immunologic factors|mesh-ancestor
65636981|NCT05087368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636982|NCT01341990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65636983|NCT05087134|Choline|choline|mesh-list
65636984|NCT05087134|Lipotropic Agents|lipotropic agents|mesh-ancestor
65636985|NCT05087134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65636986|NCT05087134|Antimetabolites|antimetabolites|mesh-ancestor
65636987|NCT05087134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636988|NCT05087134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65636989|NCT05087134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65636990|NCT05087134|Nootropic Agents|nootropic agents|mesh-ancestor
65636991|NCT03048747|Tolvaptan|tolvaptan|mesh-list
65099666|NCT05319834|Aspirin|aspirin|mesh-list
65636992|NCT03048747|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65636993|NCT03048747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65636994|NCT03048747|Natriuretic Agents|natriuretic agents|mesh-ancestor
65636995|NCT03048747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65636996|NCT05086822|Irinotecan|irinotecan|mesh-list
65636997|NCT05086822|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65636998|NCT05086822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65636999|NCT05086822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637000|NCT05086822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637001|NCT05086822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637002|NCT05354128|Fibrinolytic Agents|fibrinolytic agents|mesh-list
65637004|NCT05354128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637005|NCT04051827|Midazolam|midazolam|mesh-list
65637006|NCT04051827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65637007|NCT04051827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65637008|NCT04051827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65637009|NCT04051827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637010|NCT04051827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65637011|NCT04051827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65637012|NCT04051827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65637013|NCT04051827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65637014|NCT04051827|Anesthetics, General|anesthetics, general|mesh-ancestor
65637015|NCT04051827|Anesthetics|anesthetics|mesh-ancestor
65637016|NCT04051827|GABA Modulators|gaba modulators|mesh-ancestor
65637017|NCT04051827|GABA Agents|gaba agents|mesh-ancestor
65637018|NCT04051827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65637019|NCT04051827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637020|NCT05346874|Oxaliplatin|oxaliplatin|mesh-list
65637021|NCT05346874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637022|NCT05325502|Mannitol|mannitol|mesh-list
65637023|NCT05325502|Caffeine|caffeine|mesh-list
65637024|NCT05325502|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65637025|NCT05325502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637026|NCT05325502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65637027|NCT05325502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637028|NCT05325502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637029|NCT05325502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65637030|NCT05325502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65637031|NCT05325502|Purinergic Agents|purinergic agents|mesh-ancestor
65637032|NCT05325502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65637033|NCT05325502|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65637034|NCT05325502|Diuretics|diuretics|mesh-ancestor
65637035|NCT05325502|Natriuretic Agents|natriuretic agents|mesh-ancestor
65637036|NCT02123823|Everolimus|everolimus|mesh-list
65637037|NCT02123823|Exemestane|exemestane|mesh-list
65637038|NCT02123823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637039|NCT02123823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65637040|NCT02123823|Immunologic Factors|immunologic factors|mesh-ancestor
65637041|NCT02123823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637042|NCT02123823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65637043|NCT02123823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65637044|NCT02123823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637045|NCT02123823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637046|NCT02123823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65637047|NCT02123823|Hormone Antagonists|hormone antagonists|mesh-ancestor
65637048|NCT02123823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65637049|NCT05085652|Anesthetics|anesthetics|mesh-list
65637050|NCT05085652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65637051|NCT05085652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637052|NCT03136510|Apixaban|apixaban|mesh-list
65637053|NCT03136510|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65637054|NCT03136510|Antithrombins|antithrombins|mesh-ancestor
65637055|NCT03136510|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65637056|NCT03136510|Protease Inhibitors|protease inhibitors|mesh-ancestor
65637057|NCT03136510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637058|NCT03136510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637059|NCT03136510|Anticoagulants|anticoagulants|mesh-ancestor
65637060|NCT05692245|Dexamethasone|dexamethasone|mesh-list
65637061|NCT05692245|Ondansetron|ondansetron|mesh-list
65637062|NCT05692245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65637063|NCT05692245|Antiemetics|antiemetics|mesh-ancestor
65637064|NCT05692245|Autonomic Agents|autonomic agents|mesh-ancestor
65637065|NCT05692245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65637066|NCT05692245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637067|NCT05692245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65637068|NCT05692245|Glucocorticoids|glucocorticoids|mesh-ancestor
65637069|NCT05692245|Hormones|hormones|mesh-ancestor
65637070|NCT05692245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65637071|NCT05692245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65637072|NCT05692245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637073|NCT05692245|Antipruritics|antipruritics|mesh-ancestor
65637074|NCT05692245|Dermatologic Agents|dermatologic agents|mesh-ancestor
65637075|NCT05692245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65637076|NCT05692245|Serotonin Agents|serotonin agents|mesh-ancestor
65637077|NCT05692245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65637078|NCT05692245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637079|NCT05692245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65637080|NCT05692245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65637081|NCT05692245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65637082|NCT05692245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65637083|NCT05692245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65637084|NCT05085106|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
65637085|NCT05085106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65637086|NCT05085106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65637087|NCT05085106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65637088|NCT05085106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65637089|NCT05085106|Analgesics|analgesics|mesh-ancestor
65637090|NCT05085106|Sensory System Agents|sensory system agents|mesh-ancestor
65637091|NCT05085106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65637092|NCT05085106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637093|NCT05085106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65637094|NCT05085106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65637095|NCT05692167|Dexmedetomidine|dexmedetomidine|mesh-list
65637096|NCT05692167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65637097|NCT05692167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65637098|NCT05692167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637099|NCT05692167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65637100|NCT05692167|Analgesics|analgesics|mesh-ancestor
65637101|NCT05692167|Sensory System Agents|sensory system agents|mesh-ancestor
65637102|NCT05692167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65637103|NCT05692167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65637104|NCT05692167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65637105|NCT05692167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65637106|NCT05692167|Adrenergic Agents|adrenergic agents|mesh-ancestor
65637107|NCT05692167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65637108|NCT05692167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637109|NCT05084872|Hydroxychloroquine|hydroxychloroquine|mesh-list
65637110|NCT05084872|Antimalarials|antimalarials|mesh-ancestor
65637111|NCT05084872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65637112|NCT05084872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65637113|NCT05084872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65637114|NCT05084872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637115|NCT05084872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637116|NCT05084872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65637117|NCT00159796|Olanzapine|olanzapine|mesh-list
65637118|NCT00159796|Asenapine|asenapine|mesh-list
65637119|NCT00159796|Antiemetics|antiemetics|mesh-ancestor
65637120|NCT00159796|Autonomic Agents|autonomic agents|mesh-ancestor
65637121|NCT00159796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65637122|NCT00159796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637123|NCT00159796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65637124|NCT00159796|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65637125|NCT00159796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65637126|NCT00159796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65637127|NCT00159796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65637128|NCT00159796|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65637129|NCT00159796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65637130|NCT00159796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65637131|NCT00159796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637132|NCT00159796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65637133|NCT00159796|Serotonin Agents|serotonin agents|mesh-ancestor
65637134|NCT03626571|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65637135|NCT03626571|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65637136|NCT03626571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637137|NCT03327844|Calcium, Dietary|calcium, dietary|mesh-list
65637138|NCT03327844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65637139|NCT03327844|Metronidazole|metronidazole|mesh-list
65637140|NCT03327844|Ciprofloxacin|ciprofloxacin|mesh-list
65637141|NCT03327844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65637142|NCT03327844|Calcium|calcium|mesh-list
65637143|NCT03327844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65637144|NCT03327844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637145|NCT03327844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65637146|NCT03327844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65637147|NCT03327844|Antitubercular Agents|antitubercular agents|mesh-ancestor
65637148|NCT03327844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65637149|NCT03327844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65637150|NCT03327844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65637151|NCT03327844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65637152|NCT03327844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637153|NCT03327844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637154|NCT03327844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637155|NCT03327844|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65637156|NCT03327844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65637157|NCT05691699|Itraconazole|itraconazole|mesh-list
65637158|NCT05691699|Antifungal Agents|antifungal agents|mesh-ancestor
65637159|NCT05691699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65637160|NCT05691699|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65637161|NCT05691699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65637162|NCT05691699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637163|NCT05691699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637164|NCT05691699|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65637165|NCT05691699|Hormone Antagonists|hormone antagonists|mesh-ancestor
65637166|NCT05691699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65637167|NCT05691699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637168|NCT05691699|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65637169|NCT02133196|Aldesleukin|aldesleukin|mesh-list
65637170|NCT02133196|Cyclophosphamide|cyclophosphamide|mesh-list
65637171|NCT02133196|Fludarabine|fludarabine|mesh-list
65637172|NCT02133196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65637173|NCT02133196|Immunologic Factors|immunologic factors|mesh-ancestor
65637174|NCT02133196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637175|NCT02133196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65637176|NCT02133196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65637177|NCT02133196|Alkylating Agents|alkylating agents|mesh-ancestor
65637178|NCT02133196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637179|NCT02133196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637180|NCT02133196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65637181|NCT02133196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65637182|NCT02133196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65637183|NCT02133196|Antiviral Agents|antiviral agents|mesh-ancestor
65637184|NCT02133196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65637185|NCT05008510|Camptothecin|camptothecin|mesh-list
65637186|NCT05008510|Immunoconjugates|immunoconjugates|mesh-list
65637187|NCT05008510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65637188|NCT05008510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637189|NCT05008510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65637190|NCT05008510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65637191|NCT05008510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637192|NCT05008510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637193|NCT05008510|Immunologic Factors|immunologic factors|mesh-ancestor
65637194|NCT05008510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637195|NCT05194995|Cetuximab|cetuximab|mesh-list
65637196|NCT05194995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65637197|NCT05194995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637198|NCT05187039|Anesthetics|anesthetics|mesh-list
65637199|NCT05187039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65637200|NCT05187039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637201|NCT03136666|Candesartan|candesartan|mesh-list
65637202|NCT03136666|Candesartan cilexetil|candesartan cilexetil|mesh-list
65637203|NCT03136666|Nifedipine|nifedipine|mesh-list
65637204|NCT03136666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65637205|NCT03136666|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65637206|NCT03136666|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65637207|NCT03136666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637208|NCT03136666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65637209|NCT03136666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65637210|NCT03136666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65637211|NCT03136666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637212|NCT03136666|Vasodilator Agents|vasodilator agents|mesh-ancestor
65637213|NCT03136666|Tocolytic Agents|tocolytic agents|mesh-ancestor
65637214|NCT03136666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65637215|NCT03255083|Osimertinib|osimertinib|mesh-list
65637216|NCT03255083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637217|NCT03255083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65637218|NCT03255083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637219|NCT03255083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637220|NCT04861558|Fluorouracil|fluorouracil|mesh-list
65637221|NCT04861558|Oxaliplatin|oxaliplatin|mesh-list
65637222|NCT04861558|Irinotecan|irinotecan|mesh-list
65637223|NCT04861558|Antimetabolites|antimetabolites|mesh-ancestor
65434551|NCT00421148|Bromides|bromides|mesh-list
65637224|NCT04861558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637225|NCT04861558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65637226|NCT04861558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637227|NCT04861558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65637228|NCT04861558|Immunologic Factors|immunologic factors|mesh-ancestor
65637229|NCT04861558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637230|NCT04861558|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65637231|NCT04861558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65637232|NCT04861558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637233|NCT03735537|Zoledronic Acid|zoledronic acid|mesh-list
65637234|NCT03735537|Teriparatide|teriparatide|mesh-list
65637235|NCT03735537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65637236|NCT03735537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65637237|NCT03735537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637238|NCT03735537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65637239|NCT04531059|Metronidazole|metronidazole|mesh-list
65637240|NCT04531059|Minocycline|minocycline|mesh-list
65637241|NCT04531059|Tetracycline|tetracycline|mesh-list
65637242|NCT04531059|Potassium Citrate|potassium citrate|mesh-list
65637243|NCT04531059|Esomeprazole|esomeprazole|mesh-list
65637244|NCT04531059|Bismuth|bismuth|mesh-list
65637245|NCT04531059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637246|NCT04531059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65637247|NCT04531059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65637248|NCT04531059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65637249|NCT04531059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65637250|NCT04531059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65637251|NCT04531059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65637252|NCT04531059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65637253|NCT04531059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637254|NCT04531059|Antacids|antacids|mesh-ancestor
65637255|NCT04531059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65637256|NCT04531059|Diuretics|diuretics|mesh-ancestor
65637257|NCT04531059|Natriuretic Agents|natriuretic agents|mesh-ancestor
65637258|NCT04531059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637259|NCT04531059|Expectorants|expectorants|mesh-ancestor
65637260|NCT04531059|Respiratory System Agents|respiratory system agents|mesh-ancestor
65637261|NCT05168163|Atezolizumab|atezolizumab|mesh-list
65637262|NCT05168163|Lenvatinib|lenvatinib|mesh-list
65637263|NCT05168163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65637264|NCT05168163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637265|NCT05168163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65637266|NCT05168163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637267|NCT05168163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637268|NCT05168163|Immunologic Factors|immunologic factors|mesh-ancestor
65637269|NCT05168163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637270|NCT05090176|Povidone|povidone|mesh-list
65637271|NCT05090176|Plasma Substitutes|plasma substitutes|mesh-ancestor
65637272|NCT05090176|Blood Substitutes|blood substitutes|mesh-ancestor
65637273|NCT04530981|Repaglinide|repaglinide|mesh-list
65637274|NCT04530981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65637275|NCT04530981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637276|NCT01316055|4-Aminopyridine|4-aminopyridine|mesh-list
65637277|NCT01316055|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65637278|NCT01316055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65637279|NCT01316055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637280|NCT05669625|Vaccines|vaccines|mesh-list
65637281|NCT05669625|Immunologic Factors|immunologic factors|mesh-ancestor
65637282|NCT05669625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637283|NCT05659563|Tamoxifen|tamoxifen|mesh-list
65637284|NCT05659563|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65637285|NCT05659563|Hormone Antagonists|hormone antagonists|mesh-ancestor
65637286|NCT05659563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65637287|NCT05659563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637288|NCT05659563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65637289|NCT05659563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637290|NCT05659563|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65637291|NCT05659563|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65637292|NCT05659563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65637293|NCT04558294|Ketanserin|ketanserin|mesh-list
65637294|NCT04558294|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
65637295|NCT04558294|Hallucinogens|hallucinogens|mesh-ancestor
65637296|NCT04558294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637297|NCT04558294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65637298|NCT04558294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65637299|NCT04558294|Serotonin Agents|serotonin agents|mesh-ancestor
65637300|NCT04558294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65637301|NCT04558294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637302|NCT04558294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65637303|NCT04558294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65637304|NCT04558294|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65637306|NCT05057247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637307|NCT05057247|Tubulin Modulators|tubulin modulators|mesh-ancestor
65637308|NCT05057247|Antimitotic Agents|antimitotic agents|mesh-ancestor
65637309|NCT05057247|Mitosis Modulators|mitosis modulators|mesh-ancestor
65637310|NCT05057247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637311|NCT05626257|Omalizumab|omalizumab|mesh-list
65637312|NCT05626257|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65637313|NCT05626257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65637314|NCT05626257|Respiratory System Agents|respiratory system agents|mesh-ancestor
65637315|NCT04396821|Gemcitabine|gemcitabine|mesh-list
65637316|NCT04396821|Paclitaxel|paclitaxel|mesh-list
65637317|NCT04396821|Nivolumab|nivolumab|mesh-list
65637318|NCT04396821|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65637319|NCT04396821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65637320|NCT04396821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637321|NCT04396821|Tubulin Modulators|tubulin modulators|mesh-ancestor
65637322|NCT04396821|Antimitotic Agents|antimitotic agents|mesh-ancestor
65637323|NCT04396821|Mitosis Modulators|mitosis modulators|mesh-ancestor
65637324|NCT04396821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637325|NCT04396821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65637326|NCT04396821|Antimetabolites|antimetabolites|mesh-ancestor
65637327|NCT04396821|Antiviral Agents|antiviral agents|mesh-ancestor
65637328|NCT04396821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65637329|NCT04396821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637330|NCT04396821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65637331|NCT04396821|Immunologic Factors|immunologic factors|mesh-ancestor
65637332|NCT04396821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637333|NCT04396821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65637334|NCT04396821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65637335|NCT03378466|Heparin|heparin|mesh-list
65637336|NCT03378466|Calcium heparin|calcium heparin|mesh-list
65637337|NCT03378466|Anticoagulants|anticoagulants|mesh-ancestor
65637338|NCT03378466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65637339|NCT03378466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65637340|NCT03378466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637341|NCT04507438|Donepezil|donepezil|mesh-list
65637342|NCT04507438|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65637343|NCT04507438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637344|NCT04507438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637345|NCT04507438|Cholinergic Agents|cholinergic agents|mesh-ancestor
65637346|NCT04507438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65637347|NCT04507438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637348|NCT04507438|Nootropic Agents|nootropic agents|mesh-ancestor
65637349|NCT05077540|Misoprostol|misoprostol|mesh-list
65637350|NCT05077540|Oxytocin|oxytocin|mesh-list
65637351|NCT05077540|Oxytocics|oxytocics|mesh-ancestor
65637352|NCT05077540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65637353|NCT05077540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637354|NCT05077540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65637355|NCT05077540|Abortifacient Agents|abortifacient agents|mesh-ancestor
65637356|NCT05077540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65637357|NCT05077540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65637358|NCT05413551|Isoniazid|isoniazid|mesh-list
65637359|NCT05413551|Antitubercular Agents|antitubercular agents|mesh-ancestor
65637360|NCT05413551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65637361|NCT05413551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65637362|NCT05413551|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65637363|NCT05413551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65637364|NCT05413551|Antimetabolites|antimetabolites|mesh-ancestor
65637365|NCT05413551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637366|NCT05413551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65637367|NCT04977375|Pembrolizumab|pembrolizumab|mesh-list
65637368|NCT04977375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65637369|NCT04977375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637370|NCT02470585|Paclitaxel|paclitaxel|mesh-list
65637371|NCT02470585|Carboplatin|carboplatin|mesh-list
65637372|NCT02470585|Veliparib|veliparib|mesh-list
65637373|NCT02470585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65637374|NCT02470585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637375|NCT02470585|Tubulin Modulators|tubulin modulators|mesh-ancestor
65637377|NCT02470585|Mitosis Modulators|mitosis modulators|mesh-ancestor
65637378|NCT02470585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637379|NCT02470585|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65637380|NCT02470585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637381|NCT02744898|Paclitaxel|paclitaxel|mesh-list
65637382|NCT02744898|Carboplatin|carboplatin|mesh-list
65637383|NCT02744898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65637384|NCT02744898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65637385|NCT02744898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637386|NCT02744898|Tubulin Modulators|tubulin modulators|mesh-ancestor
65637387|NCT02744898|Antimitotic Agents|antimitotic agents|mesh-ancestor
65637388|NCT02744898|Mitosis Modulators|mitosis modulators|mesh-ancestor
65637389|NCT02744898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637390|NCT03587311|Paclitaxel|paclitaxel|mesh-list
65637391|NCT03587311|Maytansine|maytansine|mesh-list
65637392|NCT03587311|Bevacizumab|bevacizumab|mesh-list
65637393|NCT03587311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65637394|NCT03587311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65637395|NCT03587311|Endothelial Growth Factors|endothelial growth factors|mesh-list
65637396|NCT03587311|Antibodies|antibodies|mesh-list
65637397|NCT03587311|Immunoglobulins|immunoglobulins|mesh-list
65637398|NCT03587311|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65637399|NCT03587311|Immunoglobulin G|immunoglobulin g|mesh-list
65637400|NCT03587311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65637401|NCT03587311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637402|NCT03587311|Tubulin Modulators|tubulin modulators|mesh-ancestor
65637403|NCT03587311|Antimitotic Agents|antimitotic agents|mesh-ancestor
65637404|NCT03587311|Mitosis Modulators|mitosis modulators|mesh-ancestor
65637405|NCT03587311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637406|NCT03587311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65637407|NCT03587311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65637408|NCT03587311|Growth Substances|growth substances|mesh-ancestor
65637409|NCT03587311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637410|NCT03587311|Growth Inhibitors|growth inhibitors|mesh-ancestor
65637411|NCT03587311|Immunologic Factors|immunologic factors|mesh-ancestor
65637412|NCT04040088|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
65637413|NCT04040088|Chelating Agents|chelating agents|mesh-ancestor
65637414|NCT04040088|Sequestering Agents|sequestering agents|mesh-ancestor
65637415|NCT04040088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637416|NCT03097315|Triamcinolone|triamcinolone|mesh-list
65637417|NCT03097315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65637418|NCT03097315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65637419|NCT03097315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65637420|NCT03097315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65637421|NCT03097315|Glucocorticoids|glucocorticoids|mesh-ancestor
65637422|NCT03097315|Hormones|hormones|mesh-ancestor
65637423|NCT03097315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65637424|NCT03097315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637425|NCT03097315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65637426|NCT03097315|Immunologic Factors|immunologic factors|mesh-ancestor
65637427|NCT03097315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637428|NCT03097315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637429|NCT05530707|Niacinamide|niacinamide|mesh-list
65637430|NCT05530707|Niacin|niacin|mesh-list
65637431|NCT05530707|Nicotinic Acids|nicotinic acids|mesh-list
65637432|NCT05530707|Vitamin B Complex|vitamin b complex|mesh-ancestor
65637433|NCT05530707|Vitamins|vitamins|mesh-ancestor
65637434|NCT05530707|Micronutrients|micronutrients|mesh-ancestor
65637435|NCT05530707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637436|NCT05530707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65637437|NCT05530707|Antimetabolites|antimetabolites|mesh-ancestor
65637438|NCT05530707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637439|NCT05530707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65637440|NCT05530707|Vasodilator Agents|vasodilator agents|mesh-ancestor
65637441|NCT02833974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65637442|NCT05515575|Niraparib|niraparib|mesh-list
65637443|NCT05515575|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65637444|NCT05515575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637445|NCT05515575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637446|NCT05515575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434752|NCT00380874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65637447|NCT04827147|Methamphetamine|methamphetamine|mesh-list
65637448|NCT04827147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65637449|NCT04827147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637450|NCT04827147|Sympathomimetics|sympathomimetics|mesh-ancestor
65637451|NCT04827147|Autonomic Agents|autonomic agents|mesh-ancestor
65637452|NCT04827147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65637453|NCT04827147|Dopamine Agents|dopamine agents|mesh-ancestor
65637454|NCT04827147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65637455|NCT04827147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637456|NCT04827147|Adrenergic Agents|adrenergic agents|mesh-ancestor
65637457|NCT04827147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65637458|NCT04827147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65637459|NCT04827147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65637460|NCT04827147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65637461|NCT03093415|Grazoprevir|grazoprevir|mesh-list
65637462|NCT03093415|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65637463|NCT03093415|Antiviral Agents|antiviral agents|mesh-ancestor
65637464|NCT03093415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65637465|NCT01358526|Oxycodone|oxycodone|mesh-list
65637466|NCT01358526|Naloxone|naloxone|mesh-list
65637467|NCT01358526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65637468|NCT01358526|Narcotics|narcotics|mesh-ancestor
65637469|NCT01358526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65637470|NCT01358526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637471|NCT01358526|Analgesics|analgesics|mesh-ancestor
65637472|NCT01358526|Sensory System Agents|sensory system agents|mesh-ancestor
65637473|NCT01358526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65637474|NCT01358526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65637475|NCT05434689|Dexamethasone|dexamethasone|mesh-list
65637476|NCT05434689|Daratumumab|daratumumab|mesh-list
65637477|NCT05434689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65637478|NCT05434689|Antiemetics|antiemetics|mesh-ancestor
65637479|NCT05434689|Autonomic Agents|autonomic agents|mesh-ancestor
65637480|NCT05434689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65637481|NCT05434689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637482|NCT05434689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65637483|NCT05434689|Glucocorticoids|glucocorticoids|mesh-ancestor
65637484|NCT05434689|Hormones|hormones|mesh-ancestor
65637485|NCT05434689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65637486|NCT05434689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65637487|NCT05434689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637488|NCT01310010|Dasatinib|dasatinib|mesh-list
65637489|NCT01310010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637490|NCT01310010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65637491|NCT01310010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637492|NCT01310010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637493|NCT02830776|Bimatoprost|bimatoprost|mesh-list
65637494|NCT02830776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65637495|NCT02830776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65637496|NCT02830776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65637497|NCT03563664|Danazol|danazol|mesh-list
65637498|NCT03563664|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65637499|NCT03563664|Hormone Antagonists|hormone antagonists|mesh-ancestor
65637500|NCT03563664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65637501|NCT03563664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637502|NCT01904136|Mycophenolic Acid|mycophenolic acid|mesh-list
65637503|NCT01904136|Cyclophosphamide|cyclophosphamide|mesh-list
65637504|NCT01904136|Melphalan|melphalan|mesh-list
65637505|NCT01904136|Mechlorethamine|mechlorethamine|mesh-list
65637506|NCT01904136|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65637507|NCT01904136|Fludarabine|fludarabine|mesh-list
65637508|NCT01904136|Tacrolimus|tacrolimus|mesh-list
65637509|NCT01904136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65637510|NCT01904136|Immunologic Factors|immunologic factors|mesh-ancestor
65637511|NCT01904136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637512|NCT01904136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65637513|NCT01904136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65637514|NCT01904136|Alkylating Agents|alkylating agents|mesh-ancestor
65637515|NCT01904136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637516|NCT01904136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637517|NCT01904136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65637518|NCT01904136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65637519|NCT01904136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637520|NCT01904136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65637521|NCT01904136|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65637522|NCT01904136|Antitubercular Agents|antitubercular agents|mesh-ancestor
65637523|NCT01904136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65637524|NCT01904136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65637526|NCT03041181|Docetaxel|docetaxel|mesh-list
65637527|NCT03041181|Nivolumab|nivolumab|mesh-list
65637528|NCT03041181|Pemetrexed|pemetrexed|mesh-list
65637529|NCT03041181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65637530|NCT03041181|Antimetabolites|antimetabolites|mesh-ancestor
65637531|NCT03041181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637532|NCT03041181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637533|NCT03041181|Antiviral Agents|antiviral agents|mesh-ancestor
65637534|NCT03041181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65637535|NCT03041181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637536|NCT03041181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65637537|NCT03041181|Immunologic Factors|immunologic factors|mesh-ancestor
65637538|NCT03041181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637539|NCT03041181|Tubulin Modulators|tubulin modulators|mesh-ancestor
65637540|NCT03041181|Antimitotic Agents|antimitotic agents|mesh-ancestor
65637541|NCT03041181|Mitosis Modulators|mitosis modulators|mesh-ancestor
65637542|NCT03041181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65637543|NCT03041181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65637544|NCT03041181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65637545|NCT03041181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65637546|NCT05351229|Morphine|morphine|mesh-list
65637547|NCT05351229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65637548|NCT05351229|Narcotics|narcotics|mesh-ancestor
65637549|NCT05351229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65637550|NCT05351229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637551|NCT05351229|Analgesics|analgesics|mesh-ancestor
65637552|NCT05351229|Sensory System Agents|sensory system agents|mesh-ancestor
65637553|NCT05351229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65637554|NCT05121909|Listerine|listerine|mesh-list
65637555|NCT05121909|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
65637556|NCT05121909|Sodium Fluoride|sodium fluoride|mesh-list
65637557|NCT05121909|Cariostatic Agents|cariostatic agents|mesh-ancestor
65637558|NCT05121909|Protective Agents|protective agents|mesh-ancestor
65637559|NCT05121909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637560|NCT05121909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65637561|NCT02828124|Nivolumab|nivolumab|mesh-list
65637562|NCT02828124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65637563|NCT02828124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637564|NCT02828124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65637565|NCT02828124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637566|NCT04761393|Xenon|xenon|mesh-list
65637567|NCT04761393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65637568|NCT04761393|Anesthetics, General|anesthetics, general|mesh-ancestor
65637569|NCT04761393|Anesthetics|anesthetics|mesh-ancestor
65637570|NCT04761393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65637571|NCT04761393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637572|NCT05120895|Pravastatin|pravastatin|mesh-list
65637573|NCT05120895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65637574|NCT05120895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65637575|NCT05120895|Antimetabolites|antimetabolites|mesh-ancestor
65637576|NCT05120895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637577|NCT05120895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65637578|NCT05120895|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65637579|NCT05120895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637580|NCT02829996|Latanoprost|latanoprost|mesh-list
65637581|NCT02829996|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65637582|NCT02829996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65637583|NCT05385549|Imatinib Mesylate|imatinib mesylate|mesh-list
65637584|NCT05385549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637585|NCT05385549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65637586|NCT05385549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637587|NCT05385549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637588|NCT03563586|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65637589|NCT03563586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65637590|NCT05197062|Aticaprant|aticaprant|mesh-list
65637591|NCT05197062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65637592|NCT05197062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637593|NCT05197062|Sensory System Agents|sensory system agents|mesh-ancestor
65637594|NCT05197062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65637595|NCT05000736|Fulvestrant|fulvestrant|mesh-list
65637596|NCT05000736|Palbociclib|palbociclib|mesh-list
65637597|NCT05000736|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65434900|NCT00377676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65637598|NCT05000736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65637599|NCT05000736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637600|NCT05000736|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65637601|NCT05000736|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65637602|NCT05000736|Hormone Antagonists|hormone antagonists|mesh-ancestor
65637603|NCT05000736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65637604|NCT05000736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637605|NCT05000736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65637606|NCT05000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637607|NCT05000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637608|NCT05000736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65637609|NCT03828162|Anticoagulants|anticoagulants|mesh-list
65637610|NCT03563040|Methoxsalen|methoxsalen|mesh-list
65637611|NCT03563040|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65637612|NCT03563040|Dermatologic Agents|dermatologic agents|mesh-ancestor
65637613|NCT03094416|Esomeprazole|esomeprazole|mesh-list
65637614|NCT03094416|Omeprazole|omeprazole|mesh-list
65637615|NCT03094416|Rabeprazole|rabeprazole|mesh-list
65637616|NCT03094416|Pantoprazole|pantoprazole|mesh-list
65637617|NCT03094416|Lansoprazole|lansoprazole|mesh-list
65637618|NCT03094416|Dexlansoprazole|dexlansoprazole|mesh-list
65637619|NCT03094416|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65637620|NCT03094416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65637621|NCT03094416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65637622|NCT03094416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637623|NCT03094416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637624|NCT05109429|Analgesics, Opioid|analgesics, opioid|mesh-list
65637625|NCT05109429|Narcotics|narcotics|mesh-ancestor
65637626|NCT05109429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65637627|NCT05109429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637628|NCT05109429|Analgesics|analgesics|mesh-ancestor
65637629|NCT05109429|Sensory System Agents|sensory system agents|mesh-ancestor
65637630|NCT05109429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65637631|NCT01338870|Nicotinic Acids|nicotinic acids|mesh-list
65637632|NCT01338870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65637633|NCT01338870|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
65637634|NCT01338870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65637635|NCT01338870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637636|NCT01338870|Incretins|incretins|mesh-ancestor
65637637|NCT01338870|Hormones|hormones|mesh-ancestor
65637638|NCT01338870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65637639|NCT01338870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65637640|NCT01338870|Protease Inhibitors|protease inhibitors|mesh-ancestor
65637641|NCT01338870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637642|NCT01338870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637643|NCT01338870|Vitamin B Complex|vitamin b complex|mesh-ancestor
65637644|NCT01338870|Vitamins|vitamins|mesh-ancestor
65637645|NCT01338870|Micronutrients|micronutrients|mesh-ancestor
65637646|NCT02824224|Tamoxifen|tamoxifen|mesh-list
65637647|NCT02824224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65637648|NCT02824224|Hormone Antagonists|hormone antagonists|mesh-ancestor
65637649|NCT02824224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65637650|NCT02824224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637651|NCT02824224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65637652|NCT02824224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637653|NCT02824224|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65637654|NCT02824224|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65637655|NCT02824224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65637656|NCT01338792|Oxaliplatin|oxaliplatin|mesh-list
65637657|NCT01338792|Pemetrexed|pemetrexed|mesh-list
65637658|NCT01338792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637659|NCT01338792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637660|NCT01338792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637661|NCT01338792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65637662|NCT01338792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65637663|NCT01314105|Carboplatin|carboplatin|mesh-list
65637664|NCT01314105|Nintedanib|nintedanib|mesh-list
65637665|NCT01314105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637666|NCT01314105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65637667|NCT01314105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637668|NCT01314105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637669|NCT01966471|Maytansine|maytansine|mesh-list
65637670|NCT01966471|Docetaxel|docetaxel|mesh-list
65637671|NCT01966471|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65637672|NCT01966471|Cyclophosphamide|cyclophosphamide|mesh-list
65637673|NCT01966471|Doxorubicin|doxorubicin|mesh-list
65637674|NCT01966471|Fluorouracil|fluorouracil|mesh-list
65637675|NCT01966471|Trastuzumab|trastuzumab|mesh-list
65637676|NCT01966471|Epirubicin|epirubicin|mesh-list
65637677|NCT01966471|Pertuzumab|pertuzumab|mesh-list
65637678|NCT01966471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65637679|NCT01966471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637680|NCT01966471|Tubulin Modulators|tubulin modulators|mesh-ancestor
65637681|NCT01966471|Antimitotic Agents|antimitotic agents|mesh-ancestor
65637682|NCT01966471|Mitosis Modulators|mitosis modulators|mesh-ancestor
65637683|NCT01966471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637684|NCT01966471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65637685|NCT01966471|Immunologic Factors|immunologic factors|mesh-ancestor
65637686|NCT01966471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637687|NCT01966471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65637688|NCT01966471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65637689|NCT01966471|Alkylating Agents|alkylating agents|mesh-ancestor
65637690|NCT01966471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65637691|NCT01966471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65637692|NCT01966471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65637693|NCT01966471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65637694|NCT01966471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637695|NCT01966471|Antimetabolites|antimetabolites|mesh-ancestor
65637696|NCT01966471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65637697|NCT01966471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65637698|NCT04188847|Apatinib|apatinib|mesh-list
65637699|NCT04188847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637700|NCT04188847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65637701|NCT04188847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637702|NCT04188847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637703|NCT05255107|Riboflavin|riboflavin|mesh-list
65637704|NCT05255107|Lubricant Eye Drops|lubricant eye drops|mesh-list
65637705|NCT05255107|Vitamin B Complex|vitamin b complex|mesh-ancestor
65637706|NCT05255107|Vitamins|vitamins|mesh-ancestor
65637707|NCT05255107|Micronutrients|micronutrients|mesh-ancestor
65637708|NCT05255107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637709|NCT05255107|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65637710|NCT05255107|Dermatologic Agents|dermatologic agents|mesh-ancestor
65637711|NCT05255107|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65637712|NCT05255107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65637713|NCT03227471|Ivacaftor|ivacaftor|mesh-list
65637714|NCT03227471|Elexacaftor|elexacaftor|mesh-list
65637715|NCT03227471|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65637716|NCT03227471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65637717|NCT03227471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637718|NCT01354314|Fluconazole|fluconazole|mesh-list
65637719|NCT01354314|Paroxetine|paroxetine|mesh-list
65637720|NCT01354314|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65637721|NCT01354314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65637722|NCT01354314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65637723|NCT01354314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637724|NCT01354314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65637725|NCT01354314|Serotonin Agents|serotonin agents|mesh-ancestor
65637726|NCT01354314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637727|NCT01354314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65637728|NCT01354314|Antidepressive Agents|antidepressive agents|mesh-ancestor
65637729|NCT01354314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65637730|NCT01354314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65637731|NCT01354314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65637732|NCT01354314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637733|NCT01354314|Antifungal Agents|antifungal agents|mesh-ancestor
65637734|NCT01354314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65637735|NCT01354314|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65637736|NCT01354314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65637737|NCT01354314|Hormone Antagonists|hormone antagonists|mesh-ancestor
65637738|NCT01354314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65637739|NCT01354314|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65637740|NCT01354314|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65637741|NCT04509336|Orphenadrine|orphenadrine|mesh-list
65637742|NCT04509336|Baclofen|baclofen|mesh-list
65637743|NCT04509336|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65637744|NCT04509336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637745|NCT04509336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65637746|NCT04509336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65637747|NCT04509336|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65637748|NCT04509336|GABA Agonists|gaba agonists|mesh-ancestor
65637750|NCT04509336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65637751|NCT04509336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637752|NCT04509336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65637753|NCT04509336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65637754|NCT04509336|Parasympatholytics|parasympatholytics|mesh-ancestor
65637755|NCT04509336|Autonomic Agents|autonomic agents|mesh-ancestor
65637756|NCT04509336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65637757|NCT04509336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65637758|NCT04509336|Cholinergic Agents|cholinergic agents|mesh-ancestor
65637759|NCT04509336|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
65637760|NCT04509336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65637761|NCT04509336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637762|NCT03194321|Tacrolimus|tacrolimus|mesh-list
65637763|NCT03194321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65637764|NCT03194321|Immunologic Factors|immunologic factors|mesh-ancestor
65637765|NCT03194321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637766|NCT03194321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65637767|NCT03194321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637768|NCT03194321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637769|NCT05231460|Narcotics|narcotics|mesh-list
65637770|NCT05231460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65637771|NCT05231460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637772|NCT05231460|Analgesics|analgesics|mesh-ancestor
65637773|NCT05231460|Sensory System Agents|sensory system agents|mesh-ancestor
65637774|NCT05231460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65637775|NCT01374581|Artesunate|artesunate|mesh-list
65637776|NCT01374581|Lumefantrine|lumefantrine|mesh-list
65637777|NCT01374581|Artemether|artemether|mesh-list
65637778|NCT01374581|Amodiaquine|amodiaquine|mesh-list
65637779|NCT01374581|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65637780|NCT01374581|Quinine|quinine|mesh-list
65637781|NCT01374581|Clindamycin|clindamycin|mesh-list
65637782|NCT01374581|Clindamycin palmitate|clindamycin palmitate|mesh-list
65637783|NCT01374581|Clindamycin phosphate|clindamycin phosphate|mesh-list
65637784|NCT01374581|Antimalarials|antimalarials|mesh-ancestor
65637785|NCT01374581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65637786|NCT01374581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65637787|NCT01374581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65637788|NCT01374581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637789|NCT01374581|Antiviral Agents|antiviral agents|mesh-ancestor
65637790|NCT01374581|Schistosomicides|schistosomicides|mesh-ancestor
65637791|NCT01374581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65637792|NCT01374581|Anthelmintics|anthelmintics|mesh-ancestor
65017305|NCT00173745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65637793|NCT01374581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65637794|NCT01374581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65637795|NCT01374581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637796|NCT01374581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637797|NCT01374581|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65637798|NCT01374581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637799|NCT01374581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65637800|NCT01374581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65637801|NCT01374581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65637802|NCT01374581|Analgesics|analgesics|mesh-ancestor
65637803|NCT01374581|Sensory System Agents|sensory system agents|mesh-ancestor
65637804|NCT01354938|Clarithromycin|clarithromycin|mesh-list
65637805|NCT01354938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65637806|NCT01354938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65637807|NCT01354938|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65637808|NCT01354938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637809|NCT01354938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637810|NCT01354938|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65637811|NCT01354938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65637812|NCT03065556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65637813|NCT01374737|Dexmedetomidine|dexmedetomidine|mesh-list
65637814|NCT01374737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65637815|NCT01374737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65637816|NCT01374737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637817|NCT01374737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65637818|NCT01374737|Analgesics|analgesics|mesh-ancestor
65637819|NCT01374737|Sensory System Agents|sensory system agents|mesh-ancestor
65637820|NCT01374737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65637821|NCT01374737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65637822|NCT01374737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65637823|NCT01374737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65637824|NCT01374737|Adrenergic Agents|adrenergic agents|mesh-ancestor
65637825|NCT01374737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65637826|NCT01374737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637827|NCT03631615|Antibodies|antibodies|mesh-list
65637828|NCT03631615|Immunologic Factors|immunologic factors|mesh-ancestor
65637829|NCT03631615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637830|NCT01376453|Fluorouracil|fluorouracil|mesh-list
65637831|NCT01376453|Sorafenib|sorafenib|mesh-list
65637832|NCT01376453|Antimetabolites|antimetabolites|mesh-ancestor
65637833|NCT01376453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637834|NCT01376453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65637835|NCT01376453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637836|NCT01376453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65637837|NCT01376453|Immunologic Factors|immunologic factors|mesh-ancestor
65637838|NCT01376453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637839|NCT01376453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65637840|NCT01376453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637841|NCT05107219|Linaclotide|linaclotide|mesh-list
65637842|NCT05107219|Plecanatide|plecanatide|mesh-list
65637843|NCT05107219|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65637844|NCT05107219|Enzyme Activators|enzyme activators|mesh-ancestor
65637845|NCT05107219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637846|NCT05107219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65637847|NCT01568125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65637848|NCT01568125|Incretins|incretins|mesh-list
65637849|NCT01568125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637850|NCT01568125|Hormones|hormones|mesh-ancestor
65637851|NCT01568125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65637852|NCT03360721|Prednisone|prednisone|mesh-list
65637853|NCT03360721|Cortisone|cortisone|mesh-list
65637854|NCT03360721|Abiraterone Acetate|abiraterone acetate|mesh-list
65637855|NCT03360721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65637856|NCT03360721|Glucocorticoids|glucocorticoids|mesh-ancestor
65637857|NCT03360721|Hormones|hormones|mesh-ancestor
65637858|NCT03360721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65637859|NCT03360721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637860|NCT03360721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65637861|NCT03360721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637862|NCT03360721|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65637863|NCT03360721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637864|NCT03360721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267309|NCT04171791|Venetoclax|venetoclax|mesh-list
65637865|NCT03360721|Hormone Antagonists|hormone antagonists|mesh-ancestor
65637866|NCT03360721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65637867|NCT05196347|Dapagliflozin|dapagliflozin|mesh-list
65637868|NCT05196347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65637869|NCT05196347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637870|NCT05196347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65637871|NCT05196347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637872|NCT02288897|Temozolomide|temozolomide|mesh-list
65637873|NCT02288897|Dacarbazine|dacarbazine|mesh-list
65637874|NCT02288897|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
65637875|NCT02288897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65637876|NCT02288897|Alkylating Agents|alkylating agents|mesh-ancestor
65637877|NCT02288897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637878|NCT02288897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637879|NCT02288897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65637880|NCT05707572|Methylprednisolone|methylprednisolone|mesh-list
65637881|NCT05707572|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65637882|NCT05707572|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65637883|NCT05707572|Prednisolone|prednisolone|mesh-list
65637884|NCT05707572|Prednisolone acetate|prednisolone acetate|mesh-list
65637885|NCT05707572|Lidocaine|lidocaine|mesh-list
65637886|NCT05707572|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65637887|NCT05707572|Prednisolone phosphate|prednisolone phosphate|mesh-list
65637888|NCT05707572|Anesthetics, Local|anesthetics, local|mesh-ancestor
65637889|NCT05707572|Anesthetics|anesthetics|mesh-ancestor
65637890|NCT05707572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65637891|NCT05707572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637892|NCT05707572|Sensory System Agents|sensory system agents|mesh-ancestor
65637893|NCT05707572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65637894|NCT05707572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65637895|NCT05707572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65637896|NCT05707572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65637897|NCT05707572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65637898|NCT05707572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637900|NCT05707572|Antiemetics|antiemetics|mesh-ancestor
65637901|NCT05707572|Autonomic Agents|autonomic agents|mesh-ancestor
65637902|NCT05707572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65637903|NCT05707572|Glucocorticoids|glucocorticoids|mesh-ancestor
65637904|NCT05707572|Hormones|hormones|mesh-ancestor
65637905|NCT05707572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65637906|NCT05707572|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65637907|NCT05707572|Protective Agents|protective agents|mesh-ancestor
65637908|NCT05707572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65637909|NCT05707572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637910|NCT04280562|Acetaminophen|acetaminophen|mesh-list
65637911|NCT04280562|Analgesics|analgesics|mesh-list
65637912|NCT04280562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65637913|NCT04280562|Sensory System Agents|sensory system agents|mesh-ancestor
65637914|NCT04280562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65637915|NCT04280562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637916|NCT04280562|Antipyretics|antipyretics|mesh-ancestor
65637917|NCT02035800|Adalimumab|adalimumab|mesh-list
65637918|NCT02035800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65637919|NCT02035800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65637920|NCT03993912|Dexamethasone|dexamethasone|mesh-list
65637921|NCT03993912|Lenalidomide|lenalidomide|mesh-list
65637922|NCT03993912|Daratumumab|daratumumab|mesh-list
65637923|NCT03993912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65637924|NCT03993912|Antiemetics|antiemetics|mesh-ancestor
65637925|NCT03993912|Autonomic Agents|autonomic agents|mesh-ancestor
65637926|NCT03993912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65637927|NCT03993912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637928|NCT03993912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65637929|NCT03993912|Glucocorticoids|glucocorticoids|mesh-ancestor
65637930|NCT03993912|Hormones|hormones|mesh-ancestor
65267310|NCT04171791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637931|NCT03993912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65637932|NCT03993912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65637933|NCT03993912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637934|NCT03993912|Immunologic Factors|immunologic factors|mesh-ancestor
65637935|NCT03993912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65637936|NCT03993912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65637937|NCT03993912|Growth Substances|growth substances|mesh-ancestor
65637938|NCT03993912|Growth Inhibitors|growth inhibitors|mesh-ancestor
65637939|NCT01568749|Acetaminophen|acetaminophen|mesh-list
65637940|NCT01568749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65637941|NCT01568749|Analgesics|analgesics|mesh-ancestor
65637942|NCT01568749|Sensory System Agents|sensory system agents|mesh-ancestor
65637943|NCT01568749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65637944|NCT01568749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637945|NCT01568749|Antipyretics|antipyretics|mesh-ancestor
65637946|NCT02819310|Laxatives|laxatives|mesh-list
65637947|NCT02819310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65637948|NCT01375361|Albuterol|albuterol|mesh-list
65637949|NCT01375361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65637950|NCT01375361|Autonomic Agents|autonomic agents|mesh-ancestor
65637951|NCT01375361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65637952|NCT01375361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637953|NCT01375361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65637954|NCT01375361|Respiratory System Agents|respiratory system agents|mesh-ancestor
65637955|NCT01375361|Tocolytic Agents|tocolytic agents|mesh-ancestor
65637956|NCT01375361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65637957|NCT01375361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65637958|NCT01375361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65637959|NCT01375361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65637960|NCT01375361|Adrenergic Agents|adrenergic agents|mesh-ancestor
65637961|NCT01375361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65637962|NCT01375361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637963|NCT04206787|Afatinib|afatinib|mesh-list
65637964|NCT04206787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65637965|NCT04206787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65637966|NCT04206787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65637967|NCT04206787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637968|NCT01376765|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65637969|NCT01376765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65637970|NCT01376765|Immunologic Factors|immunologic factors|mesh-ancestor
65637971|NCT01376765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637972|NCT01376765|Antacids|antacids|mesh-ancestor
65435273|NCT01045772|Rilonacept|rilonacept|mesh-list
65637973|NCT01376765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637974|NCT01376765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65637976|NCT03278509|Bisoprolol|bisoprolol|mesh-list
65637977|NCT03278509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65637978|NCT03278509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65637979|NCT03278509|Sympatholytics|sympatholytics|mesh-ancestor
65637980|NCT03278509|Autonomic Agents|autonomic agents|mesh-ancestor
65637981|NCT03278509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65637982|NCT03278509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637983|NCT03278509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65637984|NCT03278509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65637985|NCT03278509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65637986|NCT03278509|Adrenergic Agents|adrenergic agents|mesh-ancestor
65637987|NCT03278509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65637988|NCT03278509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65637989|NCT05754593|Hormones|hormones|mesh-list
65637990|NCT05754593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65637991|NCT05754593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65637992|NCT04788563|Antihypertensive Agents|antihypertensive agents|mesh-list
65637993|NCT01358201|Cytarabine|cytarabine|mesh-list
65637994|NCT01358201|Dexamethasone|dexamethasone|mesh-list
65637995|NCT01358201|Methotrexate|methotrexate|mesh-list
65637996|NCT01358201|Vincristine|vincristine|mesh-list
65637997|NCT01358201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65637998|NCT01358201|Antiemetics|antiemetics|mesh-ancestor
65637999|NCT01358201|Autonomic Agents|autonomic agents|mesh-ancestor
65638000|NCT01358201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638001|NCT01358201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638002|NCT01358201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65638003|NCT01358201|Glucocorticoids|glucocorticoids|mesh-ancestor
65638004|NCT01358201|Hormones|hormones|mesh-ancestor
65638005|NCT01358201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65638006|NCT01358201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65638007|NCT01358201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638008|NCT01358201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65638009|NCT01358201|Abortifacient Agents|abortifacient agents|mesh-ancestor
65638010|NCT01358201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65638011|NCT01358201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65638012|NCT01358201|Antimetabolites|antimetabolites|mesh-ancestor
65638013|NCT01358201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638014|NCT01358201|Dermatologic Agents|dermatologic agents|mesh-ancestor
65638015|NCT01358201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638016|NCT01358201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65638017|NCT01358201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65638018|NCT01358201|Immunologic Factors|immunologic factors|mesh-ancestor
65638019|NCT01358201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65638020|NCT01358201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65638021|NCT01358201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65638022|NCT01358201|Tubulin Modulators|tubulin modulators|mesh-ancestor
65638023|NCT01358201|Antimitotic Agents|antimitotic agents|mesh-ancestor
65638024|NCT01358201|Mitosis Modulators|mitosis modulators|mesh-ancestor
65638025|NCT01358201|Antiviral Agents|antiviral agents|mesh-ancestor
65638026|NCT01358201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65638027|NCT02971501|Bevacizumab|bevacizumab|mesh-list
65638028|NCT02971501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65638029|NCT02971501|Osimertinib|osimertinib|mesh-list
65638030|NCT02971501|Endothelial Growth Factors|endothelial growth factors|mesh-list
65638031|NCT02971501|Antibodies|antibodies|mesh-list
65638032|NCT02971501|Immunoglobulins|immunoglobulins|mesh-list
65638033|NCT02971501|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65638034|NCT02971501|Immunoglobulin G|immunoglobulin g|mesh-list
65638035|NCT02971501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638036|NCT02971501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65638037|NCT02971501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65638038|NCT02971501|Growth Substances|growth substances|mesh-ancestor
65638039|NCT02971501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638040|NCT02971501|Growth Inhibitors|growth inhibitors|mesh-ancestor
65638041|NCT02971501|Immunologic Factors|immunologic factors|mesh-ancestor
65267339|NCT00648063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65638042|NCT02971501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638043|NCT02971501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65638044|NCT02971501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638045|NCT02969083|Gemcitabine|gemcitabine|mesh-list
65638046|NCT02969083|Cisplatin|cisplatin|mesh-list
65638047|NCT02969083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638048|NCT02969083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65638049|NCT02969083|Antimetabolites|antimetabolites|mesh-ancestor
65638050|NCT02969083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638051|NCT02969083|Antiviral Agents|antiviral agents|mesh-ancestor
65638052|NCT02969083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65638053|NCT02969083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638054|NCT02969083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65638055|NCT02969083|Immunologic Factors|immunologic factors|mesh-ancestor
65638056|NCT02969083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638057|NCT04726475|Cannabidiol|cannabidiol|mesh-list
65638058|NCT04726475|Anticonvulsants|anticonvulsants|mesh-ancestor
65638059|NCT02951767|Atezolizumab|atezolizumab|mesh-list
65638060|NCT02951767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638061|NCT05170763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65638062|NCT03091777|Metronidazole|metronidazole|mesh-list
65638063|NCT03091777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65638064|NCT03091777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65638065|NCT03091777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65638066|NCT03091777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65638067|NCT05603741|Lidocaine|lidocaine|mesh-list
65638068|NCT05603741|Anesthetics, Local|anesthetics, local|mesh-ancestor
65638069|NCT05603741|Anesthetics|anesthetics|mesh-ancestor
65638070|NCT05603741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65638071|NCT05603741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638072|NCT05603741|Sensory System Agents|sensory system agents|mesh-ancestor
65638073|NCT05603741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638074|NCT05603741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65638075|NCT05603741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65638076|NCT05603741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65638077|NCT05603741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65638078|NCT05603741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638079|NCT05392361|Gabapentin|gabapentin|mesh-list
65638080|NCT05392361|Baclofen|baclofen|mesh-list
65638081|NCT05392361|Analgesics|analgesics|mesh-ancestor
65638082|NCT05392361|Sensory System Agents|sensory system agents|mesh-ancestor
65638083|NCT05392361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638084|NCT05392361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638085|NCT05392361|Anticonvulsants|anticonvulsants|mesh-ancestor
65638086|NCT05392361|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65638087|NCT05392361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65638088|NCT05392361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65638089|NCT05392361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65638090|NCT05392361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65638091|NCT05392361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65638092|NCT05392361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65638093|NCT05392361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638094|NCT05392361|Antimanic Agents|antimanic agents|mesh-ancestor
65638095|NCT05392361|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65638096|NCT05392361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65638097|NCT05392361|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65638098|NCT05392361|GABA Agonists|gaba agonists|mesh-ancestor
65638099|NCT05392361|GABA Agents|gaba agents|mesh-ancestor
65638100|NCT05338541|Etoposide|etoposide|mesh-list
65638101|NCT05338541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65638102|NCT05338541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638103|NCT05338541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65638104|NCT05338541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65638105|NCT05338541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638106|NCT05338541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638107|NCT05335655|Dexmedetomidine|dexmedetomidine|mesh-list
65638108|NCT05335655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65638109|NCT05335655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65638110|NCT05335655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638111|NCT05335655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65638112|NCT05335655|Analgesics|analgesics|mesh-ancestor
65638113|NCT05335655|Sensory System Agents|sensory system agents|mesh-ancestor
65638114|NCT05335655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638115|NCT05335655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65638116|NCT05335655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65638117|NCT05335655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65638118|NCT05335655|Adrenergic Agents|adrenergic agents|mesh-ancestor
65638119|NCT05335655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65638120|NCT05335655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638121|NCT04589351|Ezetimibe|ezetimibe|mesh-list
65435425|NCT00278889|Leucovorin|leucovorin|mesh-list
65638122|NCT04589351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65638123|NCT04589351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65638125|NCT04589351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638126|NCT04589351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65638127|NCT02818998|Aflibercept|aflibercept|mesh-list
65638128|NCT02818998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65638129|NCT02818998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65638130|NCT02818998|Growth Substances|growth substances|mesh-ancestor
65638131|NCT02818998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638132|NCT02818998|Growth Inhibitors|growth inhibitors|mesh-ancestor
65638133|NCT02818998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638134|NCT05760677|Metformin|metformin|mesh-list
65638135|NCT05760677|Pioglitazone|pioglitazone|mesh-list
65638136|NCT05760677|Orlistat|orlistat|mesh-list
65638137|NCT05760677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65638138|NCT05760677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638139|NCT05760677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638140|NCT05760677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638141|NCT05760677|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65638142|NCT05760677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65638143|NCT02821416|Benralizumab|benralizumab|mesh-list
65638144|NCT02821416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65638145|NCT02821416|Respiratory System Agents|respiratory system agents|mesh-ancestor
65638146|NCT03108521|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65638147|NCT03108521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65638148|NCT03108521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638149|NCT03108521|Incretins|incretins|mesh-ancestor
65638150|NCT03108521|Hormones|hormones|mesh-ancestor
65638151|NCT03108521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65638152|NCT03108521|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65638153|NCT03108521|Protease Inhibitors|protease inhibitors|mesh-ancestor
65638154|NCT03108521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638155|NCT03108521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638156|NCT04500509|Diclofenac|diclofenac|mesh-list
65638157|NCT04500509|Dinoprostone|dinoprostone|mesh-list
65638158|NCT04500509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65638159|NCT04500509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65638160|NCT04500509|Analgesics|analgesics|mesh-ancestor
65638161|NCT04500509|Sensory System Agents|sensory system agents|mesh-ancestor
65638162|NCT04500509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638163|NCT04500509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638164|NCT04500509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65638165|NCT04500509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65638166|NCT04500509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65638167|NCT04500509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638168|NCT04500509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638169|NCT04500509|Oxytocics|oxytocics|mesh-ancestor
65638170|NCT04500509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65638171|NCT05760599|Bevacizumab|bevacizumab|mesh-list
65638172|NCT05760599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65638173|NCT05760599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638174|NCT05760599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65638175|NCT05760599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65638176|NCT05760599|Growth Substances|growth substances|mesh-ancestor
65638177|NCT05760599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638178|NCT05760599|Growth Inhibitors|growth inhibitors|mesh-ancestor
65638179|NCT04441073|Lidocaine|lidocaine|mesh-list
65638180|NCT04441073|Anesthetics, Local|anesthetics, local|mesh-ancestor
65638181|NCT04441073|Anesthetics|anesthetics|mesh-ancestor
65638182|NCT04441073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65638183|NCT04441073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638184|NCT04441073|Sensory System Agents|sensory system agents|mesh-ancestor
65638185|NCT04441073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638186|NCT04441073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65638187|NCT04441073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65638188|NCT04441073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65638189|NCT04441073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65638190|NCT04441073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638191|NCT02817828|Drospirenone|drospirenone|mesh-list
65638192|NCT02817828|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65638193|NCT02817828|Hormone Antagonists|hormone antagonists|mesh-ancestor
65638194|NCT02817828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65638195|NCT02817828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638196|NCT02817828|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65638198|NCT02817828|Natriuretic Agents|natriuretic agents|mesh-ancestor
65638199|NCT03632681|Insulin|insulin|mesh-list
65638200|NCT03632681|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65638201|NCT03632681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65638202|NCT03632681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638203|NCT05597995|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
65638204|NCT05597995|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65638205|NCT05597995|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65638206|NCT05597917|Trabectedin|trabectedin|mesh-list
65638207|NCT05597917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65638208|NCT05597917|Alkylating Agents|alkylating agents|mesh-ancestor
65638209|NCT05597917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638210|NCT05597917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638211|NCT03796650|Vancomycin|vancomycin|mesh-list
65638212|NCT03796650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65638213|NCT03796650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65638214|NCT05597527|Apatinib|apatinib|mesh-list
65638215|NCT05597527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638216|NCT05597527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65638217|NCT05597527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638218|NCT05597527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638219|NCT02888743|Durvalumab|durvalumab|mesh-list
65638220|NCT02888743|Ipilimumab|ipilimumab|mesh-list
65638221|NCT02888743|Tremelimumab|tremelimumab|mesh-list
65638222|NCT02888743|Immunoglobulins|immunoglobulins|mesh-list
65638223|NCT02888743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65638224|NCT02888743|Immunoglobulin G|immunoglobulin g|mesh-list
65638225|NCT02888743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65638226|NCT02888743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638227|NCT02888743|Immunologic Factors|immunologic factors|mesh-ancestor
65638228|NCT02888743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638229|NCT02888743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65638230|NCT02888743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638231|NCT02883049|Calcium, Dietary|calcium, dietary|mesh-list
65638232|NCT02883049|Leucovorin|leucovorin|mesh-list
65638233|NCT02883049|Folic Acid|folic acid|mesh-list
65638234|NCT02883049|Cytarabine|cytarabine|mesh-list
65638235|NCT02883049|Dexamethasone|dexamethasone|mesh-list
65638236|NCT02883049|Dexamethasone acetate|dexamethasone acetate|mesh-list
65638237|NCT02883049|Prednisone|prednisone|mesh-list
65638238|NCT02883049|Hydrocortisone|hydrocortisone|mesh-list
65638239|NCT02883049|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65638240|NCT02883049|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65638241|NCT02883049|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65638242|NCT02883049|Cortisone|cortisone|mesh-list
65638243|NCT02883049|Cyclophosphamide|cyclophosphamide|mesh-list
65638244|NCT02883049|Doxorubicin|doxorubicin|mesh-list
65638245|NCT02883049|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65638246|NCT02883049|Methotrexate|methotrexate|mesh-list
65638247|NCT02883049|Etoposide|etoposide|mesh-list
65638248|NCT02883049|Vincristine|vincristine|mesh-list
65638249|NCT02883049|Etoposide phosphate|etoposide phosphate|mesh-list
65638250|NCT02883049|Daunorubicin|daunorubicin|mesh-list
65638251|NCT02883049|Asparaginase|asparaginase|mesh-list
65638252|NCT02883049|Dasatinib|dasatinib|mesh-list
65638253|NCT02883049|Mercaptopurine|mercaptopurine|mesh-list
65638254|NCT02883049|Clofarabine|clofarabine|mesh-list
65638255|NCT02883049|Podophyllotoxin|podophyllotoxin|mesh-list
65638256|NCT02883049|Pegaspargase|pegaspargase|mesh-list
65638257|NCT02883049|Thioguanine|thioguanine|mesh-list
65638258|NCT02883049|BB 1101|bb 1101|mesh-list
65638259|NCT02883049|Calcium|calcium|mesh-list
65638260|NCT02883049|2-Aminopurine|2-aminopurine|mesh-list
65638261|NCT02883049|Levoleucovorin|levoleucovorin|mesh-list
65638262|NCT02883049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65638263|NCT02883049|Immunologic Factors|immunologic factors|mesh-ancestor
65638264|NCT02883049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638265|NCT02883049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65638266|NCT02883049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65638267|NCT02883049|Alkylating Agents|alkylating agents|mesh-ancestor
65638268|NCT02883049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638269|NCT02883049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638270|NCT02883049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65638271|NCT02883049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65638272|NCT02883049|Antiemetics|antiemetics|mesh-ancestor
65638273|NCT02883049|Autonomic Agents|autonomic agents|mesh-ancestor
65638274|NCT02883049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638275|NCT02883049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65638277|NCT02883049|Hormones|hormones|mesh-ancestor
65638278|NCT02883049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65638279|NCT02883049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65638280|NCT02883049|Protease Inhibitors|protease inhibitors|mesh-ancestor
65638281|NCT02883049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638282|NCT02883049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65638283|NCT02883049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65638284|NCT02883049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65638285|NCT02883049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65638286|NCT02883049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65638287|NCT02883049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65638288|NCT02883049|Abortifacient Agents|abortifacient agents|mesh-ancestor
65638289|NCT02883049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65638290|NCT02883049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65638291|NCT02883049|Antimetabolites|antimetabolites|mesh-ancestor
65638292|NCT02883049|Dermatologic Agents|dermatologic agents|mesh-ancestor
65638293|NCT02883049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65638294|NCT02883049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65638295|NCT02883049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65638296|NCT02883049|Antiviral Agents|antiviral agents|mesh-ancestor
65638297|NCT02883049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65638298|NCT02883049|Antidotes|antidotes|mesh-ancestor
65638299|NCT02883049|Protective Agents|protective agents|mesh-ancestor
65638300|NCT02883049|Vitamin B Complex|vitamin b complex|mesh-ancestor
65638301|NCT02883049|Vitamins|vitamins|mesh-ancestor
65638302|NCT02883049|Micronutrients|micronutrients|mesh-ancestor
65638303|NCT02883049|Tubulin Modulators|tubulin modulators|mesh-ancestor
65638304|NCT02883049|Antimitotic Agents|antimitotic agents|mesh-ancestor
65638305|NCT02883049|Mitosis Modulators|mitosis modulators|mesh-ancestor
65638306|NCT02883049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65638307|NCT02883049|Hematinics|hematinics|mesh-ancestor
65638308|NCT02883049|Keratolytic Agents|keratolytic agents|mesh-ancestor
65638309|NCT04721873|Topiramate|topiramate|mesh-list
65638310|NCT04721873|Phentermine|phentermine|mesh-list
65638311|NCT04721873|Anticonvulsants|anticonvulsants|mesh-ancestor
65638312|NCT04721873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65638313|NCT04721873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638314|NCT04721873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65638315|NCT04721873|Appetite Depressants|appetite depressants|mesh-ancestor
65638316|NCT04721873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65638317|NCT04721873|Sympathomimetics|sympathomimetics|mesh-ancestor
65638318|NCT04721873|Autonomic Agents|autonomic agents|mesh-ancestor
65638319|NCT04721873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638320|NCT04721873|Adrenergic Agents|adrenergic agents|mesh-ancestor
65638321|NCT04721873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65638322|NCT04721873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638323|NCT05198609|Apatinib|apatinib|mesh-list
65638324|NCT05198609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638325|NCT05198609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65638326|NCT05198609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638327|NCT05198609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638328|NCT05198141|Letrozole|letrozole|mesh-list
65638329|NCT05198141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638330|NCT05198141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65638331|NCT05198141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65638332|NCT05198141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638333|NCT05198141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638334|NCT05198141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65638335|NCT05198141|Hormone Antagonists|hormone antagonists|mesh-ancestor
65638336|NCT05198141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65638337|NCT05198141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638338|NCT02813694|Moxifloxacin|moxifloxacin|mesh-list
65638339|NCT02813694|Lefamulin|lefamulin|mesh-list
65638340|NCT02813694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65638341|NCT02813694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65638342|NCT02813694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65638343|NCT02813694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65638344|NCT02813694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638345|NCT02813694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638346|NCT02813694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638347|NCT03632161|Dexmedetomidine|dexmedetomidine|mesh-list
65638348|NCT03632161|Bupivacaine|bupivacaine|mesh-list
65638349|NCT03632161|Anesthetics, Local|anesthetics, local|mesh-ancestor
65638350|NCT03632161|Anesthetics|anesthetics|mesh-ancestor
65638351|NCT03632161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65638352|NCT03632161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638353|NCT03632161|Sensory System Agents|sensory system agents|mesh-ancestor
65638354|NCT03632161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638355|NCT03632161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65638356|NCT03632161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65638358|NCT03632161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65638359|NCT03632161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65638360|NCT03632161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65638361|NCT03632161|Adrenergic Agents|adrenergic agents|mesh-ancestor
65638362|NCT03632161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65638363|NCT03632161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638364|NCT03103919|Rotigotine|rotigotine|mesh-list
65638365|NCT03103919|Dopamine Agonists|dopamine agonists|mesh-ancestor
65638366|NCT03103919|Dopamine Agents|dopamine agents|mesh-ancestor
65638367|NCT03103919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65638368|NCT03103919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638369|NCT03103919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638370|NCT04173325|Nivolumab|nivolumab|mesh-list
65638371|NCT04173325|Irinotecan|irinotecan|mesh-list
65638372|NCT04173325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65638373|NCT04173325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638374|NCT04173325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65638375|NCT04173325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638376|NCT04173325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65638377|NCT04173325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65638378|NCT04173325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638379|NCT02810964|Sulforaphane|sulforaphane|mesh-list
65638380|NCT02810964|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65638381|NCT02810964|Protective Agents|protective agents|mesh-ancestor
65638382|NCT02810964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638383|NCT02810964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638384|NCT05571319|Metformin|metformin|mesh-list
65638385|NCT05571319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65638386|NCT05571319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638387|NCT04073147|Venetoclax|venetoclax|mesh-list
65638388|NCT04073147|Obinutuzumab|obinutuzumab|mesh-list
65638389|NCT04073147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638390|NCT04073147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65638391|NCT05676203|Docetaxel|docetaxel|mesh-list
65638392|NCT05676203|Androgens|androgens|mesh-list
65638393|NCT05676203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638394|NCT05676203|Tubulin Modulators|tubulin modulators|mesh-ancestor
65638395|NCT05676203|Antimitotic Agents|antimitotic agents|mesh-ancestor
65638396|NCT05676203|Mitosis Modulators|mitosis modulators|mesh-ancestor
65638397|NCT05676203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638398|NCT05676203|Hormones|hormones|mesh-ancestor
65638399|NCT05676203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65638400|NCT05676203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638401|NCT02707159|Gemcitabine|gemcitabine|mesh-list
65638402|NCT02707159|Paclitaxel|paclitaxel|mesh-list
65638403|NCT02707159|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65638404|NCT02707159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65638405|NCT02707159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638406|NCT02707159|Tubulin Modulators|tubulin modulators|mesh-ancestor
65638407|NCT02707159|Antimitotic Agents|antimitotic agents|mesh-ancestor
65638408|NCT02707159|Mitosis Modulators|mitosis modulators|mesh-ancestor
65638409|NCT02707159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638410|NCT02707159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65638411|NCT02707159|Antimetabolites|antimetabolites|mesh-ancestor
65638412|NCT02707159|Antiviral Agents|antiviral agents|mesh-ancestor
65638413|NCT02707159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65638414|NCT02707159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638415|NCT02707159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65638416|NCT02707159|Immunologic Factors|immunologic factors|mesh-ancestor
65638417|NCT02707159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638418|NCT04113187|Propranolol|propranolol|mesh-list
65638419|NCT04113187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65638420|NCT04113187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65638421|NCT04113187|Adrenergic Agents|adrenergic agents|mesh-ancestor
65638422|NCT04113187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65638423|NCT04113187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638424|NCT04113187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638425|NCT04113187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65638426|NCT04113187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65638427|NCT04113187|Vasodilator Agents|vasodilator agents|mesh-ancestor
65638428|NCT03103763|Warfarin|warfarin|mesh-list
65638429|NCT03103763|Anticoagulants|anticoagulants|mesh-ancestor
65638430|NCT05197517|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65638431|NCT05197517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65638432|NCT05197517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65638433|NCT05197517|Antimetabolites|antimetabolites|mesh-ancestor
65638434|NCT05197517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638435|NCT05197517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65638436|NCT05197517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65638437|NCT05197517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638438|NCT04011475|Tiotropium Bromide|tiotropium bromide|mesh-list
65638439|NCT04011475|Olodaterol|olodaterol|mesh-list
65638440|NCT04011475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65638441|NCT04011475|Autonomic Agents|autonomic agents|mesh-ancestor
65638442|NCT04011475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638443|NCT04011475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638444|NCT04011475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65638445|NCT04011475|Respiratory System Agents|respiratory system agents|mesh-ancestor
65638446|NCT04011475|Parasympatholytics|parasympatholytics|mesh-ancestor
65638447|NCT04011475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65638448|NCT04011475|Cholinergic Agents|cholinergic agents|mesh-ancestor
65638449|NCT04011475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65638450|NCT04011475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638451|NCT05110781|Atezolizumab|atezolizumab|mesh-list
65638452|NCT05110781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65638453|NCT05110781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638454|NCT05110781|Immunologic Factors|immunologic factors|mesh-ancestor
65638455|NCT05110781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638456|NCT05658575|Dapansutrile|dapansutrile|mesh-list
65638457|NCT05658575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65638458|NCT04138277|Miglustat|miglustat|mesh-list
65638459|NCT04138277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638460|NCT04138277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638461|NCT04138277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65638462|NCT04138277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65638463|NCT04138277|Antiviral Agents|antiviral agents|mesh-ancestor
65638464|NCT04138277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65638465|NCT04138277|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65638466|NCT04138277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65638467|NCT04138277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638468|NCT03663335|Tacrolimus|tacrolimus|mesh-list
65638469|NCT03663335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65638470|NCT03663335|Immunologic Factors|immunologic factors|mesh-ancestor
65638471|NCT03663335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638472|NCT03663335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65638473|NCT03663335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638474|NCT03663335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638475|NCT03632915|Lacosamide|lacosamide|mesh-list
65638476|NCT03632915|Phenytoin|phenytoin|mesh-list
65638477|NCT03632915|Ketamine|ketamine|mesh-list
65638478|NCT03632915|Levetiracetam|levetiracetam|mesh-list
65638479|NCT03632915|Valproic Acid|valproic acid|mesh-list
65638480|NCT03632915|Phenobarbital|phenobarbital|mesh-list
65638481|NCT03632915|Analgesics|analgesics|mesh-ancestor
65638482|NCT03632915|Sensory System Agents|sensory system agents|mesh-ancestor
65638483|NCT03632915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638484|NCT03632915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638485|NCT03632915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65638486|NCT03632915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65638487|NCT03632915|Anesthetics, General|anesthetics, general|mesh-ancestor
65638488|NCT03632915|Anesthetics|anesthetics|mesh-ancestor
65638489|NCT03632915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65638490|NCT03632915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65638491|NCT03632915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65638492|NCT03632915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65638493|NCT03632915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638494|NCT03632915|Anticonvulsants|anticonvulsants|mesh-ancestor
65638495|NCT03632915|Nootropic Agents|nootropic agents|mesh-ancestor
65638496|NCT03632915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638497|NCT03632915|GABA Agents|gaba agents|mesh-ancestor
65638498|NCT03632915|Antimanic Agents|antimanic agents|mesh-ancestor
65638499|NCT03632915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65638500|NCT03632915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65638501|NCT03632915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65638502|NCT03632915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65638503|NCT03632915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65638504|NCT03632915|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65638505|NCT03632915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65638506|NCT03632915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65638508|NCT03632915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65638509|NCT03632915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65638510|NCT05649605|Methyltestosterone|methyltestosterone|mesh-list
65638511|NCT05649605|Testosterone|testosterone|mesh-list
65638512|NCT05649605|Testosterone undecanoate|testosterone undecanoate|mesh-list
65638513|NCT05649605|Testosterone enanthate|testosterone enanthate|mesh-list
65638514|NCT05649605|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65638515|NCT05649605|Androgens|androgens|mesh-ancestor
65638516|NCT05649605|Hormones|hormones|mesh-ancestor
65638517|NCT05649605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65638518|NCT05649605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638519|NCT05649605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65638520|NCT05649605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638521|NCT05649605|Anabolic Agents|anabolic agents|mesh-ancestor
65638522|NCT05640479|Pregabalin|pregabalin|mesh-list
65638523|NCT05640479|Dexmedetomidine|dexmedetomidine|mesh-list
65638524|NCT05640479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65638525|NCT05640479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65638526|NCT05640479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638527|NCT05640479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65638528|NCT05640479|Analgesics|analgesics|mesh-ancestor
65638529|NCT05640479|Sensory System Agents|sensory system agents|mesh-ancestor
65638530|NCT05640479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638531|NCT05640479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65638532|NCT05640479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65638533|NCT05640479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65638534|NCT05640479|Adrenergic Agents|adrenergic agents|mesh-ancestor
65638535|NCT05640479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65638536|NCT05640479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638537|NCT05640479|Anticonvulsants|anticonvulsants|mesh-ancestor
65638538|NCT05640479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65638539|NCT05640479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65638540|NCT05640479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65638541|NCT05640479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65638542|NCT05640479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65638543|NCT05640479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65638544|NCT05309525|Tranexamic Acid|tranexamic acid|mesh-list
65638545|NCT05309525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65638546|NCT05309525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65638547|NCT05309525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638548|NCT05309525|Hemostatics|hemostatics|mesh-ancestor
65638549|NCT05309525|Coagulants|coagulants|mesh-ancestor
65638550|NCT04905563|Acetaminophen|acetaminophen|mesh-list
65638551|NCT04905563|Ibuprofen|ibuprofen|mesh-list
65638552|NCT04905563|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65638553|NCT04905563|Hydrocodone|hydrocodone|mesh-list
65638554|NCT04905563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65638555|NCT04905563|Analgesics|analgesics|mesh-ancestor
65638556|NCT04905563|Sensory System Agents|sensory system agents|mesh-ancestor
65638557|NCT04905563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638558|NCT04905563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638559|NCT04905563|Antipyretics|antipyretics|mesh-ancestor
65638560|NCT04905563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65638561|NCT04905563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65638562|NCT04905563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65638563|NCT04905563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65638564|NCT04905563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638565|NCT04905563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638566|NCT04905563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65638567|NCT04905563|Narcotics|narcotics|mesh-ancestor
65267363|NCT00953641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65638568|NCT04905563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65638569|NCT04905563|Antitussive Agents|antitussive agents|mesh-ancestor
65638570|NCT04905563|Respiratory System Agents|respiratory system agents|mesh-ancestor
65638571|NCT05253131|Durvalumab|durvalumab|mesh-list
65638572|NCT05253131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65638573|NCT05253131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638574|NCT02810418|Paclitaxel|paclitaxel|mesh-list
65638575|NCT02810418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65638576|NCT02810418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638577|NCT02810418|Tubulin Modulators|tubulin modulators|mesh-ancestor
65638578|NCT02810418|Antimitotic Agents|antimitotic agents|mesh-ancestor
65638579|NCT02810418|Mitosis Modulators|mitosis modulators|mesh-ancestor
65638580|NCT02810418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638581|NCT02959541|Leucovorin|leucovorin|mesh-list
65638582|NCT02959541|Levoleucovorin|levoleucovorin|mesh-list
65638583|NCT02959541|Antidotes|antidotes|mesh-ancestor
65638584|NCT02959541|Protective Agents|protective agents|mesh-ancestor
65638585|NCT02959541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638586|NCT02959541|Vitamin B Complex|vitamin b complex|mesh-ancestor
65638587|NCT02959541|Vitamins|vitamins|mesh-ancestor
65638588|NCT02959541|Micronutrients|micronutrients|mesh-ancestor
65638589|NCT02675465|Miglustat|miglustat|mesh-list
65638590|NCT02675465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638591|NCT02675465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638592|NCT02675465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65638593|NCT02675465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65638594|NCT02675465|Antiviral Agents|antiviral agents|mesh-ancestor
65638595|NCT02675465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65638596|NCT02675465|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65638597|NCT02675465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65638598|NCT02675465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638599|NCT05705700|Dutasteride|dutasteride|mesh-list
65638600|NCT05705700|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65638601|NCT05705700|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65638602|NCT05705700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638603|NCT05705700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638604|NCT05705700|Hormone Antagonists|hormone antagonists|mesh-ancestor
65638605|NCT05705700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65638606|NCT05705700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638607|NCT02498951|Obinutuzumab|obinutuzumab|mesh-list
65638608|NCT02498951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65638609|NCT02498951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638610|NCT05614739|Pembrolizumab|pembrolizumab|mesh-list
65638611|NCT05614739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65638612|NCT05614739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638613|NCT02260050|Epinastine|epinastine|mesh-list
65638614|NCT02260050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65638615|NCT02260050|Histamine Antagonists|histamine antagonists|mesh-ancestor
65638616|NCT02260050|Histamine Agents|histamine agents|mesh-ancestor
65638617|NCT02260050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65638618|NCT02260050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638619|NCT02260050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638620|NCT02036736|Propofol|propofol|mesh-list
65638621|NCT02036736|Anesthetics|anesthetics|mesh-list
65638622|NCT02036736|Desflurane|desflurane|mesh-list
65638623|NCT02036736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65638624|NCT02036736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65638625|NCT02036736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638626|NCT02036736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65638627|NCT02036736|Anesthetics, General|anesthetics, general|mesh-ancestor
65638628|NCT02036736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65638629|NCT05693688|Atosiban|atosiban|mesh-list
65638630|NCT05693688|Hormone Antagonists|hormone antagonists|mesh-ancestor
65638631|NCT05693688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65638632|NCT05693688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638633|NCT05693688|Tocolytic Agents|tocolytic agents|mesh-ancestor
65638634|NCT05693688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65638635|NCT02047422|Metolazone|metolazone|mesh-list
65638636|NCT02047422|Furosemide|furosemide|mesh-list
65638637|NCT02047422|Spironolactone|spironolactone|mesh-list
65638638|NCT02047422|Diuretics|diuretics|mesh-ancestor
65638639|NCT02047422|Natriuretic Agents|natriuretic agents|mesh-ancestor
65638640|NCT02047422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638641|NCT02047422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65101316|NCT02929095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65638642|NCT02047422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65638643|NCT02047422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638644|NCT02047422|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65638645|NCT02047422|Hormone Antagonists|hormone antagonists|mesh-ancestor
65638646|NCT02047422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65638647|NCT02047422|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65638648|NCT02047422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65638649|NCT02047422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65638650|NCT02048358|Methylprednisolone|methylprednisolone|mesh-list
65638651|NCT02048358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65638652|NCT02048358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65638653|NCT02048358|Prednisolone|prednisolone|mesh-list
65638654|NCT02048358|Prednisolone acetate|prednisolone acetate|mesh-list
65638655|NCT02048358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65638656|NCT02048358|Prednisolone phosphate|prednisolone phosphate|mesh-list
65638657|NCT02048358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65638658|NCT02048358|Antiemetics|antiemetics|mesh-ancestor
65638659|NCT02048358|Autonomic Agents|autonomic agents|mesh-ancestor
65638660|NCT02048358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638661|NCT02048358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638662|NCT02048358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65638663|NCT02048358|Glucocorticoids|glucocorticoids|mesh-ancestor
65638664|NCT02048358|Hormones|hormones|mesh-ancestor
65638665|NCT02048358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65638666|NCT02048358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65638667|NCT02048358|Protective Agents|protective agents|mesh-ancestor
65638668|NCT02048358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65638669|NCT02048358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638670|NCT02928029|Dexamethasone|dexamethasone|mesh-list
65638671|NCT02928029|Bortezomib|bortezomib|mesh-list
65638672|NCT02928029|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65638673|NCT02928029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65638674|NCT02928029|Antiemetics|antiemetics|mesh-ancestor
65638675|NCT02928029|Autonomic Agents|autonomic agents|mesh-ancestor
65638676|NCT02928029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638677|NCT02928029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638678|NCT02928029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65638679|NCT02928029|Glucocorticoids|glucocorticoids|mesh-ancestor
65638680|NCT02928029|Hormones|hormones|mesh-ancestor
65638681|NCT02928029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65638682|NCT02928029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65638683|NCT02928029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638684|NCT02050074|Metformin|metformin|mesh-list
65638685|NCT02050074|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65638686|NCT02050074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65638687|NCT02050074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638688|NCT02050074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65638689|NCT02050074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65638690|NCT02050074|Antimetabolites|antimetabolites|mesh-ancestor
65638691|NCT02050074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638692|NCT02050074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65638693|NCT02050152|Nitrous Oxide|nitrous oxide|mesh-list
65638694|NCT02050152|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65638695|NCT02050152|Anesthetics, General|anesthetics, general|mesh-ancestor
65638696|NCT02050152|Anesthetics|anesthetics|mesh-ancestor
65638697|NCT02050152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65638698|NCT02050152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638699|NCT02050152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65638700|NCT02050152|Analgesics|analgesics|mesh-ancestor
65638701|NCT02050152|Sensory System Agents|sensory system agents|mesh-ancestor
65638702|NCT02050152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638703|NCT02806986|Immunoglobulins|immunoglobulins|mesh-list
65638704|NCT02806986|gamma-Globulins|gamma-globulins|mesh-list
65638705|NCT02806986|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65638706|NCT02806986|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65638707|NCT02806986|Immunologic Factors|immunologic factors|mesh-ancestor
65638708|NCT02806986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638709|NCT03095651|Insulin Glargine|insulin glargine|mesh-list
65638710|NCT03095651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65638711|NCT03095651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638712|NCT04740905|Aflibercept|aflibercept|mesh-list
65638713|NCT04740905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65638714|NCT04740905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65638715|NCT04740905|Growth Substances|growth substances|mesh-ancestor
65638716|NCT04740905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638717|NCT04740905|Growth Inhibitors|growth inhibitors|mesh-ancestor
65638718|NCT04740905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638719|NCT05176223|Edetic Acid|edetic acid|mesh-list
65638720|NCT05176223|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65638721|NCT05176223|Chelating Agents|chelating agents|mesh-ancestor
65638722|NCT05176223|Sequestering Agents|sequestering agents|mesh-ancestor
65638723|NCT05176223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638724|NCT05176223|Anticoagulants|anticoagulants|mesh-ancestor
65638725|NCT05176223|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65436034|NCT01050114|Oxybutynin|oxybutynin|mesh-list
65638726|NCT05176223|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65638727|NCT04717193|Epinephrine|epinephrine|mesh-list
65638728|NCT04717193|Racepinephrine|racepinephrine|mesh-list
65638729|NCT04717193|Bupivacaine|bupivacaine|mesh-list
65638730|NCT04717193|Anesthetics, Local|anesthetics, local|mesh-list
65638731|NCT04717193|Anesthetics|anesthetics|mesh-list
65638732|NCT04717193|Epinephryl borate|epinephryl borate|mesh-list
65638733|NCT04717193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65638734|NCT04717193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638735|NCT04717193|Sensory System Agents|sensory system agents|mesh-ancestor
65638736|NCT04717193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638737|NCT04717193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65638738|NCT04717193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65638739|NCT04717193|Adrenergic Agents|adrenergic agents|mesh-ancestor
65638740|NCT04717193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65638741|NCT04717193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638742|NCT04717193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65638743|NCT04717193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65638744|NCT04717193|Autonomic Agents|autonomic agents|mesh-ancestor
65638745|NCT04717193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65638746|NCT04717193|Respiratory System Agents|respiratory system agents|mesh-ancestor
65638747|NCT04717193|Mydriatics|mydriatics|mesh-ancestor
65638748|NCT04717193|Sympathomimetics|sympathomimetics|mesh-ancestor
65638749|NCT04717193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65638750|NCT05172245|Cisplatin|cisplatin|mesh-list
65638751|NCT05172245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638752|NCT05212025|Gemcitabine|gemcitabine|mesh-list
65638753|NCT05212025|Adavosertib|adavosertib|mesh-list
65638754|NCT05212025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65638755|NCT05212025|Antimetabolites|antimetabolites|mesh-ancestor
65638756|NCT05212025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638757|NCT05212025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638758|NCT05212025|Antiviral Agents|antiviral agents|mesh-ancestor
65638759|NCT05212025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65638760|NCT05212025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638761|NCT05212025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65638762|NCT05212025|Immunologic Factors|immunologic factors|mesh-ancestor
65638763|NCT05212025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638764|NCT02051868|Paclitaxel|paclitaxel|mesh-list
65638765|NCT02051868|Carboplatin|carboplatin|mesh-list
65638766|NCT02051868|Fluorouracil|fluorouracil|mesh-list
65638767|NCT02051868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65638768|NCT02051868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638769|NCT02051868|Tubulin Modulators|tubulin modulators|mesh-ancestor
65638770|NCT02051868|Antimitotic Agents|antimitotic agents|mesh-ancestor
65638771|NCT02051868|Mitosis Modulators|mitosis modulators|mesh-ancestor
65638772|NCT02051868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638773|NCT02051868|Antimetabolites|antimetabolites|mesh-ancestor
65638774|NCT02051868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65638775|NCT02051868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65638776|NCT02051868|Immunologic Factors|immunologic factors|mesh-ancestor
65638777|NCT02051868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638778|NCT04696757|Capecitabine|capecitabine|mesh-list
65638779|NCT04696757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65638780|NCT04696757|Antimetabolites|antimetabolites|mesh-ancestor
65267374|NCT02763098|Sensory System Agents|sensory system agents|mesh-ancestor
65638781|NCT04696757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638782|NCT04696757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638783|NCT02049294|Omalizumab|omalizumab|mesh-list
65638784|NCT02049294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65638785|NCT02049294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65638786|NCT02049294|Respiratory System Agents|respiratory system agents|mesh-ancestor
65638787|NCT02051946|Ethacrynic Acid|ethacrynic acid|mesh-list
65638788|NCT02051946|Diuretics|diuretics|mesh-ancestor
65638789|NCT02051946|Natriuretic Agents|natriuretic agents|mesh-ancestor
65638790|NCT02051946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638791|NCT02051946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638792|NCT02051946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638793|NCT02049606|Nabumetone|nabumetone|mesh-list
65638794|NCT02049606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65638795|NCT02049606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65638796|NCT02049606|Analgesics|analgesics|mesh-ancestor
65638797|NCT02049606|Sensory System Agents|sensory system agents|mesh-ancestor
65638798|NCT02049606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638799|NCT02049606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638800|NCT02049606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65436117|NCT01075438|Vaccines|vaccines|mesh-list
65638801|NCT02049606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65638802|NCT02049606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65638803|NCT02049606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65638804|NCT02049606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638805|NCT02049606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638807|NCT05071703|Etoposide|etoposide|mesh-list
65638808|NCT05071703|Topotecan|topotecan|mesh-list
65638809|NCT05071703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638810|NCT05071703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65638811|NCT05071703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65638812|NCT05071703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65638813|NCT05071703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638814|NCT05071703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638815|NCT05071703|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65638816|NCT02037516|Neostigmine|neostigmine|mesh-list
65638817|NCT02037516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65638818|NCT02037516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638819|NCT02037516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638820|NCT02037516|Cholinergic Agents|cholinergic agents|mesh-ancestor
65638821|NCT02037516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65638822|NCT02037516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638823|NCT02037516|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65638824|NCT02037516|Autonomic Agents|autonomic agents|mesh-ancestor
65638825|NCT02037516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638826|NCT02052024|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
65638827|NCT02052024|Botulinum Toxins|botulinum toxins|mesh-list
65638828|NCT02052024|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65638829|NCT02052024|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65638830|NCT02052024|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65638831|NCT02052024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65638832|NCT02052024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638833|NCT02052024|Cholinergic Agents|cholinergic agents|mesh-ancestor
65638834|NCT02052024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65638835|NCT02052024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638836|NCT02052024|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65638837|NCT02052024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638838|NCT02052024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65638839|NCT02037672|Metformin|metformin|mesh-list
65638840|NCT02037672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65638841|NCT02037672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638842|NCT02049762|Aspirin|aspirin|mesh-list
65638843|NCT02049762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65638844|NCT02049762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65638845|NCT02049762|Analgesics|analgesics|mesh-ancestor
65638846|NCT02049762|Sensory System Agents|sensory system agents|mesh-ancestor
65638847|NCT02049762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638848|NCT02049762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638849|NCT02049762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65638850|NCT02049762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65638851|NCT02049762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65638852|NCT02049762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65638853|NCT02049762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638854|NCT02049762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65638855|NCT02049762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65638856|NCT02049762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638857|NCT02049762|Antipyretics|antipyretics|mesh-ancestor
65638858|NCT03561558|Ibuprofen|ibuprofen|mesh-list
65638859|NCT03561558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65638860|NCT03561558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65638861|NCT03561558|Analgesics|analgesics|mesh-ancestor
65638862|NCT03561558|Sensory System Agents|sensory system agents|mesh-ancestor
65638863|NCT03561558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638864|NCT03561558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638865|NCT03561558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65638866|NCT03561558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65638867|NCT03561558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65638868|NCT03561558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638869|NCT03561558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638870|NCT03099161|Pembrolizumab|pembrolizumab|mesh-list
65638871|NCT03099161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65638872|NCT03099161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638873|NCT04639115|Ozanimod|ozanimod|mesh-list
65638874|NCT04639115|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65638875|NCT04639115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638876|NCT04639115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65638877|NCT04639115|Immunologic Factors|immunologic factors|mesh-ancestor
65638878|NCT04639115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638879|NCT04260659|Lidocaine|lidocaine|mesh-list
65638880|NCT04260659|Magnesium Sulfate|magnesium sulfate|mesh-list
65638881|NCT04260659|Fentanyl|fentanyl|mesh-list
65638882|NCT04260659|Dexmedetomidine|dexmedetomidine|mesh-list
65638883|NCT04260659|Ketamine|ketamine|mesh-list
65638884|NCT04260659|Remifentanil|remifentanil|mesh-list
65638885|NCT04260659|Anesthetics, Local|anesthetics, local|mesh-ancestor
65638886|NCT04260659|Anesthetics|anesthetics|mesh-ancestor
65638887|NCT04260659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65638888|NCT04260659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638889|NCT04260659|Sensory System Agents|sensory system agents|mesh-ancestor
65638890|NCT04260659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638891|NCT04260659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65638892|NCT04260659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65638893|NCT04260659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65638894|NCT04260659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65638895|NCT04260659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638896|NCT04260659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65638897|NCT04260659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65638898|NCT04260659|Analgesics|analgesics|mesh-ancestor
65638899|NCT04260659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65638900|NCT04260659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65638901|NCT04260659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65638902|NCT04260659|Adrenergic Agents|adrenergic agents|mesh-ancestor
65638903|NCT04260659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65638904|NCT04260659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65638905|NCT04260659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65638906|NCT04260659|Anesthetics, General|anesthetics, general|mesh-ancestor
65638907|NCT04260659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65638908|NCT04260659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65638909|NCT04260659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65638910|NCT04260659|Narcotics|narcotics|mesh-ancestor
65638911|NCT04260659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65638912|NCT04260659|Anticonvulsants|anticonvulsants|mesh-ancestor
65638913|NCT04260659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65638914|NCT04260659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65638915|NCT04260659|Tocolytic Agents|tocolytic agents|mesh-ancestor
65638916|NCT04260659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65638917|NCT05102669|Antibodies|antibodies|mesh-list
65638918|NCT05102669|Immunologic Factors|immunologic factors|mesh-ancestor
65638919|NCT05102669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638920|NCT05068661|Fentanyl|fentanyl|mesh-list
65638921|NCT05068661|Bupivacaine|bupivacaine|mesh-list
65638922|NCT05068661|Ropivacaine|ropivacaine|mesh-list
65638923|NCT05068661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65638924|NCT05068661|Anesthetics, Local|anesthetics, local|mesh-ancestor
65638925|NCT05068661|Anesthetics|anesthetics|mesh-ancestor
65638926|NCT05068661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65638927|NCT05068661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638928|NCT05068661|Sensory System Agents|sensory system agents|mesh-ancestor
65638929|NCT05068661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638930|NCT05068661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65638931|NCT05068661|Narcotics|narcotics|mesh-ancestor
65638932|NCT05068661|Analgesics|analgesics|mesh-ancestor
65638933|NCT05068661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65638934|NCT05068661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65638935|NCT05068661|Anesthetics, General|anesthetics, general|mesh-ancestor
65638936|NCT04455815|Gabexate|gabexate|mesh-list
65638937|NCT04455815|Camostat|camostat|mesh-list
65638938|NCT04455815|Protease Inhibitors|protease inhibitors|mesh-ancestor
65638939|NCT04455815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638940|NCT04455815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638941|NCT04455815|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65638942|NCT04455815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65638943|NCT04455815|Anticoagulants|anticoagulants|mesh-ancestor
65638944|NCT04197713|Olaparib|olaparib|mesh-list
65638945|NCT04197713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65638946|NCT04197713|Adavosertib|adavosertib|mesh-list
65638947|NCT04197713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638948|NCT04197713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638949|NCT04197713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638950|NCT04303403|Trametinib|trametinib|mesh-list
65638951|NCT04303403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638952|NCT04303403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65638953|NCT04303403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638954|NCT04303403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638955|NCT04148495|Acetaminophen|acetaminophen|mesh-list
65638956|NCT04148495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65638957|NCT04148495|Analgesics|analgesics|mesh-ancestor
65638958|NCT04148495|Sensory System Agents|sensory system agents|mesh-ancestor
65638959|NCT04148495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638960|NCT04148495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638961|NCT04148495|Antipyretics|antipyretics|mesh-ancestor
65638962|NCT05060003|Atezolizumab|atezolizumab|mesh-list
65638963|NCT05060003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638964|NCT04203641|Doxorubicin|doxorubicin|mesh-list
65638965|NCT04203641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65638966|NCT04203641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65638967|NCT04203641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65638968|NCT04203641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65638969|NCT04203641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65638970|NCT04203641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638971|NCT05051189|Fentanyl|fentanyl|mesh-list
65638972|NCT05051189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65638973|NCT05051189|Narcotics|narcotics|mesh-ancestor
65638974|NCT05051189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65638975|NCT05051189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638976|NCT05051189|Analgesics|analgesics|mesh-ancestor
65638977|NCT05051189|Sensory System Agents|sensory system agents|mesh-ancestor
65638978|NCT05051189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638979|NCT05051189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65638980|NCT05051189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65638981|NCT05051189|Anesthetics, General|anesthetics, general|mesh-ancestor
65638982|NCT05051189|Anesthetics|anesthetics|mesh-ancestor
65638983|NCT04521647|Nicotine|nicotine|mesh-list
65638984|NCT04521647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65638985|NCT04521647|Autonomic Agents|autonomic agents|mesh-ancestor
65638986|NCT04521647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65638987|NCT04521647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65638988|NCT04521647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65638989|NCT04521647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65638990|NCT04521647|Cholinergic Agents|cholinergic agents|mesh-ancestor
65638991|NCT04521647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65638992|NCT04521647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65638993|NCT04172597|Loperamide|loperamide|mesh-list
65638994|NCT04172597|Antidiarrheals|antidiarrheals|mesh-list
65638995|NCT04172597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65638996|NCT04047641|Cytarabine|cytarabine|mesh-list
65638997|NCT04047641|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
65638998|NCT04047641|Idarubicin|idarubicin|mesh-list
65638999|NCT04047641|Cladribine|cladribine|mesh-list
65639000|NCT04047641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65639001|NCT04047641|Antimetabolites|antimetabolites|mesh-ancestor
65639002|NCT04047641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639003|NCT04047641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639004|NCT04047641|Antiviral Agents|antiviral agents|mesh-ancestor
65639005|NCT04047641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65639006|NCT04047641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65639007|NCT04047641|Immunologic Factors|immunologic factors|mesh-ancestor
65639008|NCT04047641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639009|NCT04047641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65639010|NCT04047641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65639011|NCT04047641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65639012|NCT04047641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639013|NCT00446225|Gemcitabine|gemcitabine|mesh-list
65639014|NCT00446225|Carboplatin|carboplatin|mesh-list
65639015|NCT00446225|Docetaxel|docetaxel|mesh-list
65639016|NCT00446225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65639017|NCT00446225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639018|NCT00446225|Tubulin Modulators|tubulin modulators|mesh-ancestor
65639019|NCT00446225|Antimitotic Agents|antimitotic agents|mesh-ancestor
65639020|NCT00446225|Mitosis Modulators|mitosis modulators|mesh-ancestor
65639021|NCT00446225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639022|NCT00446225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65639023|NCT00446225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639024|NCT00446225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65639025|NCT00446225|Antimetabolites|antimetabolites|mesh-ancestor
65639026|NCT00446225|Antiviral Agents|antiviral agents|mesh-ancestor
65639027|NCT00446225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65639028|NCT00446225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65639029|NCT00446225|Immunologic Factors|immunologic factors|mesh-ancestor
65639030|NCT00446225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639031|NCT03080935|Evolocumab|evolocumab|mesh-list
65639032|NCT03080935|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65639033|NCT03080935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65639034|NCT03080935|Antimetabolites|antimetabolites|mesh-ancestor
65639035|NCT03080935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639036|NCT03080935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65639037|NCT04479449|Otaplimastat|otaplimastat|mesh-list
65639038|NCT04479449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65639039|NCT04479449|Protective Agents|protective agents|mesh-ancestor
65639040|NCT04479449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639041|NCT03674567|Pembrolizumab|pembrolizumab|mesh-list
65639042|NCT03674567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65639043|NCT03674567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639044|NCT03148795|Talazoparib|talazoparib|mesh-list
65639045|NCT03148795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65639046|NCT03148795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639047|NCT03148795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639048|NCT03148795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639049|NCT04986605|Methoxsalen|methoxsalen|mesh-list
65639050|NCT04986605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65639051|NCT04986605|Dermatologic Agents|dermatologic agents|mesh-ancestor
65639052|NCT04390399|Leucovorin|leucovorin|mesh-list
65639053|NCT04390399|Gemcitabine|gemcitabine|mesh-list
65639054|NCT04390399|Paclitaxel|paclitaxel|mesh-list
65639055|NCT04390399|Cyclophosphamide|cyclophosphamide|mesh-list
65639056|NCT04390399|Fluorouracil|fluorouracil|mesh-list
65639057|NCT04390399|Irinotecan|irinotecan|mesh-list
65639058|NCT04390399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65639059|NCT04390399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639060|NCT04390399|Tubulin Modulators|tubulin modulators|mesh-ancestor
65639061|NCT04390399|Antimitotic Agents|antimitotic agents|mesh-ancestor
65639062|NCT04390399|Mitosis Modulators|mitosis modulators|mesh-ancestor
65639063|NCT04390399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639064|NCT04390399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65639065|NCT04390399|Immunologic Factors|immunologic factors|mesh-ancestor
65639066|NCT04390399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639067|NCT04390399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65639068|NCT04390399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65639069|NCT04390399|Alkylating Agents|alkylating agents|mesh-ancestor
65639070|NCT04390399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65639071|NCT04390399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65639072|NCT04390399|Antimetabolites|antimetabolites|mesh-ancestor
65639073|NCT04390399|Antiviral Agents|antiviral agents|mesh-ancestor
65639074|NCT04390399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65639075|NCT04390399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639076|NCT04390399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65639077|NCT04390399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65639078|NCT04390399|Antidotes|antidotes|mesh-ancestor
65639079|NCT04390399|Protective Agents|protective agents|mesh-ancestor
65639080|NCT04390399|Vitamin B Complex|vitamin b complex|mesh-ancestor
65639081|NCT04390399|Vitamins|vitamins|mesh-ancestor
65639082|NCT04390399|Micronutrients|micronutrients|mesh-ancestor
65639083|NCT01383655|Magnesium Sulfate|magnesium sulfate|mesh-list
65639084|NCT01383655|Analgesics|analgesics|mesh-ancestor
65639085|NCT01383655|Sensory System Agents|sensory system agents|mesh-ancestor
65639086|NCT01383655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65639087|NCT01383655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639088|NCT01383655|Anesthetics|anesthetics|mesh-ancestor
65639089|NCT01383655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65639090|NCT01383655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65639091|NCT01383655|Anticonvulsants|anticonvulsants|mesh-ancestor
65639092|NCT01383655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65639093|NCT01383655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65639094|NCT01383655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639095|NCT01383655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65639096|NCT01383655|Tocolytic Agents|tocolytic agents|mesh-ancestor
65639097|NCT01383655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65639098|NCT01568281|Anastrozole|anastrozole|mesh-list
65639099|NCT01568281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65639100|NCT01568281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639101|NCT01568281|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65639102|NCT01568281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65639103|NCT01568281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639104|NCT01568281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639105|NCT01568281|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65639106|NCT01568281|Hormone Antagonists|hormone antagonists|mesh-ancestor
65639107|NCT01568281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65639108|NCT01568281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639109|NCT03949855|Rituximab|rituximab|mesh-list
65639110|NCT03949855|Belimumab|belimumab|mesh-list
65639111|NCT03949855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65639112|NCT03949855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639113|NCT03949855|Immunologic Factors|immunologic factors|mesh-ancestor
65639114|NCT03949855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639115|NCT03949855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65639116|NCT03949855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65639117|NCT02921789|Mycophenolic Acid|mycophenolic acid|mesh-list
65639118|NCT02921789|Prednisone|prednisone|mesh-list
65639119|NCT02921789|Tacrolimus|tacrolimus|mesh-list
65639120|NCT02921789|Basiliximab|basiliximab|mesh-list
65639121|NCT02921789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65639122|NCT02921789|Glucocorticoids|glucocorticoids|mesh-ancestor
65639123|NCT02921789|Hormones|hormones|mesh-ancestor
65639124|NCT02921789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65639125|NCT02921789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639126|NCT02921789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65639127|NCT02921789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639128|NCT02921789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65639129|NCT02921789|Immunologic Factors|immunologic factors|mesh-ancestor
65639130|NCT02921789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65639131|NCT02921789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639132|NCT02921789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639133|NCT02921789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65639134|NCT02921789|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65639135|NCT02921789|Antitubercular Agents|antitubercular agents|mesh-ancestor
65639136|NCT02921789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65639137|NCT02921789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65639138|NCT02564900|Camptothecin|camptothecin|mesh-list
65639139|NCT02564900|Immunoconjugates|immunoconjugates|mesh-list
65639140|NCT02564900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65639141|NCT02564900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639142|NCT02564900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65639143|NCT02564900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65639144|NCT02564900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639145|NCT02564900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639146|NCT02564900|Immunologic Factors|immunologic factors|mesh-ancestor
65639147|NCT02564900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639148|NCT01568333|Decitabine|decitabine|mesh-list
65639149|NCT01568333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65639150|NCT01568333|Antimetabolites|antimetabolites|mesh-ancestor
65639151|NCT01568333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639152|NCT01568333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639153|NCT01568333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639154|NCT03437005|Ketoconazole|ketoconazole|mesh-list
65639155|NCT03437005|Desonide|desonide|mesh-list
65639156|NCT03437005|Antifungal Agents|antifungal agents|mesh-ancestor
65639157|NCT03437005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65639158|NCT03437005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65639159|NCT03437005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65639160|NCT03437005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639161|NCT03437005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639162|NCT03437005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65639163|NCT03437005|Hormone Antagonists|hormone antagonists|mesh-ancestor
65639164|NCT03437005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65639165|NCT03437005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639166|NCT03437005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65639167|NCT03437005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65639168|NCT03943823|Estrogens|estrogens|mesh-list
65639169|NCT03943823|Hormones|hormones|mesh-ancestor
65639170|NCT03943823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65639171|NCT03943823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639172|NCT02535338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65639173|NCT02535338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639174|NCT02535338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65639175|NCT02535338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639176|NCT02535338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639177|NCT02484248|Ketotifen|ketotifen|mesh-list
65639178|NCT02484248|Antipruritics|antipruritics|mesh-ancestor
65639179|NCT02484248|Dermatologic Agents|dermatologic agents|mesh-ancestor
65639180|NCT02484248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65639181|NCT02484248|Histamine Antagonists|histamine antagonists|mesh-ancestor
65639182|NCT02484248|Histamine Agents|histamine agents|mesh-ancestor
65639183|NCT02484248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65639184|NCT02484248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639185|NCT02484248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639186|NCT02484248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65639187|NCT02419742|Paclitaxel|paclitaxel|mesh-list
65639188|NCT02419742|Docetaxel|docetaxel|mesh-list
65639189|NCT02419742|Cyclophosphamide|cyclophosphamide|mesh-list
65639190|NCT02419742|Carboplatin|carboplatin|mesh-list
65639191|NCT02419742|Doxorubicin|doxorubicin|mesh-list
65639192|NCT02419742|Trastuzumab|trastuzumab|mesh-list
65639193|NCT02419742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65639194|NCT02419742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639195|NCT02419742|Tubulin Modulators|tubulin modulators|mesh-ancestor
65639196|NCT02419742|Antimitotic Agents|antimitotic agents|mesh-ancestor
65639197|NCT02419742|Mitosis Modulators|mitosis modulators|mesh-ancestor
65639198|NCT02419742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639199|NCT02419742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65639200|NCT02419742|Immunologic Factors|immunologic factors|mesh-ancestor
65639201|NCT02419742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639202|NCT02419742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65639203|NCT02419742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65639204|NCT02419742|Alkylating Agents|alkylating agents|mesh-ancestor
65639205|NCT02419742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65639206|NCT02419742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65639207|NCT02419742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65639208|NCT02419742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65639209|NCT02419742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639210|NCT02419742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65639211|NCT02409290|Moxifloxacin|moxifloxacin|mesh-list
65639212|NCT02409290|Levofloxacin|levofloxacin|mesh-list
65639213|NCT02409290|Isoniazid|isoniazid|mesh-list
65639214|NCT02409290|Pyrazinamide|pyrazinamide|mesh-list
65639215|NCT02409290|Ethambutol|ethambutol|mesh-list
65639216|NCT02409290|Bedaquiline|bedaquiline|mesh-list
65639217|NCT02409290|Clofazimine|clofazimine|mesh-list
65639218|NCT02409290|Kanamycin|kanamycin|mesh-list
65639219|NCT02409290|Prothionamide|prothionamide|mesh-list
65639220|NCT02409290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65639221|NCT02409290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65639222|NCT02409290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65639223|NCT02409290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65639224|NCT02409290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639225|NCT02409290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639226|NCT02409290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639227|NCT02409290|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65639228|NCT02409290|Renal Agents|renal agents|mesh-ancestor
65639229|NCT02409290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65639230|NCT02409290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65639231|NCT02409290|Antitubercular Agents|antitubercular agents|mesh-ancestor
65639232|NCT02409290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65639233|NCT02409290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65639234|NCT02409290|Antimetabolites|antimetabolites|mesh-ancestor
65639235|NCT02409290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65639236|NCT02409290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65639237|NCT02409290|Leprostatic Agents|leprostatic agents|mesh-ancestor
65639238|NCT02409290|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65639239|NCT02898077|Paclitaxel|paclitaxel|mesh-list
65639240|NCT02898077|Ramucirumab|ramucirumab|mesh-list
65639241|NCT02898077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65639242|NCT02898077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639243|NCT02898077|Tubulin Modulators|tubulin modulators|mesh-ancestor
65639244|NCT02898077|Antimitotic Agents|antimitotic agents|mesh-ancestor
65639245|NCT02898077|Mitosis Modulators|mitosis modulators|mesh-ancestor
65639246|NCT02898077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639247|NCT02145884|Timolol|timolol|mesh-list
65639248|NCT02145884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639249|NCT02145884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65639250|NCT02145884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65639251|NCT02145884|Adrenergic Agents|adrenergic agents|mesh-ancestor
65639252|NCT02145884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65639253|NCT02145884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639254|NCT02145884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65639255|NCT02145884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65639256|NCT03544814|Cisplatin|cisplatin|mesh-list
65639257|NCT03544814|Pemetrexed|pemetrexed|mesh-list
65639258|NCT03544814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639259|NCT03544814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639260|NCT03544814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639261|NCT03544814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65639262|NCT03544814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65639263|NCT03097133|Esketamine|esketamine|mesh-list
65639264|NCT03097133|Antidepressive Agents|antidepressive agents|mesh-ancestor
65639265|NCT03097133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65639266|NCT02148380|Carboplatin|carboplatin|mesh-list
65639267|NCT02148380|Pemetrexed|pemetrexed|mesh-list
65639268|NCT02148380|Gefitinib|gefitinib|mesh-list
65639269|NCT02148380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639270|NCT02148380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639271|NCT02148380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639272|NCT02148380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65639273|NCT02148380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65639274|NCT02148380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65639275|NCT02146118|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65639276|NCT02146118|Silybin|silybin|mesh-list
65639277|NCT02146118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639278|NCT02146118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65639279|NCT02146118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639280|NCT02146118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639281|NCT02146118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65639282|NCT02146118|Protective Agents|protective agents|mesh-ancestor
65639283|NCT02146118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639284|NCT02142140|Methylphenidate|methylphenidate|mesh-list
65639285|NCT02142140|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65639286|NCT02142140|Adderall|adderall|mesh-list
65639287|NCT02142140|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
65639288|NCT02142140|Dextroamphetamine|dextroamphetamine|mesh-list
65639289|NCT02142140|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65639290|NCT02142140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639291|NCT02142140|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65101958|NCT02922933|Histamine Agents|histamine agents|mesh-ancestor
65639292|NCT02142140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65639293|NCT02142140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65639294|NCT02142140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639295|NCT02142140|Dopamine Agents|dopamine agents|mesh-ancestor
65639296|NCT02142140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65639297|NCT02142140|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65639298|NCT02142140|Adrenergic Agents|adrenergic agents|mesh-ancestor
65639299|NCT02142218|Nivolumab|nivolumab|mesh-list
65639300|NCT02142218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65639301|NCT02142218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639302|NCT02142218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65639303|NCT02142218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639304|NCT02142296|Aflibercept|aflibercept|mesh-list
65639305|NCT02142296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65639306|NCT02142296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65639307|NCT02142296|Growth Substances|growth substances|mesh-ancestor
65639308|NCT02142296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639309|NCT02142296|Growth Inhibitors|growth inhibitors|mesh-ancestor
65639310|NCT02142296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639311|NCT02142530|Belinostat|belinostat|mesh-list
65639312|NCT02142530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639313|NCT02142530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65639314|NCT02142530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639315|NCT02142530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639316|NCT01383343|Calcium, Dietary|calcium, dietary|mesh-list
65639317|NCT01383343|Leucovorin|leucovorin|mesh-list
65639318|NCT01383343|Folic Acid|folic acid|mesh-list
65639319|NCT01383343|Bevacizumab|bevacizumab|mesh-list
65639320|NCT01383343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65639321|NCT01383343|Fluorouracil|fluorouracil|mesh-list
65639322|NCT01383343|Irinotecan|irinotecan|mesh-list
65639323|NCT01383343|Sorafenib|sorafenib|mesh-list
65639324|NCT01383343|Camptothecin|camptothecin|mesh-list
65639325|NCT01383343|Endothelial Growth Factors|endothelial growth factors|mesh-list
65639326|NCT01383343|Antibodies|antibodies|mesh-list
65639327|NCT01383343|Immunoglobulins|immunoglobulins|mesh-list
65639328|NCT01383343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65639329|NCT01383343|Immunoglobulin G|immunoglobulin g|mesh-list
65639330|NCT01383343|Calcium|calcium|mesh-list
65436634|NCT00354744|Ifosfamide|ifosfamide|mesh-list
65639331|NCT01383343|Levoleucovorin|levoleucovorin|mesh-list
65639332|NCT01383343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639333|NCT01383343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65639334|NCT01383343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65639335|NCT01383343|Growth Substances|growth substances|mesh-ancestor
65639336|NCT01383343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639337|NCT01383343|Growth Inhibitors|growth inhibitors|mesh-ancestor
65639338|NCT01383343|Immunologic Factors|immunologic factors|mesh-ancestor
65639339|NCT01383343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65639340|NCT01383343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65639341|NCT01383343|Antimetabolites|antimetabolites|mesh-ancestor
65639342|NCT01383343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639343|NCT01383343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65639344|NCT01383343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65639345|NCT01383343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65639346|NCT01383343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65639347|NCT01383343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639348|NCT01383343|Antidotes|antidotes|mesh-ancestor
65639349|NCT01383343|Protective Agents|protective agents|mesh-ancestor
65639350|NCT01383343|Vitamin B Complex|vitamin b complex|mesh-ancestor
65639351|NCT01383343|Vitamins|vitamins|mesh-ancestor
65639352|NCT01383343|Micronutrients|micronutrients|mesh-ancestor
65639353|NCT01383343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65639354|NCT01383343|Hematinics|hematinics|mesh-ancestor
65639355|NCT01383343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65639356|NCT03631147|Rifaximin|rifaximin|mesh-list
65639357|NCT03631147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65639358|NCT03631147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65639359|NCT03631147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65639360|NCT02148848|Risedronic Acid|risedronic acid|mesh-list
65639361|NCT02148848|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65639362|NCT02148848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65639363|NCT02148848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639364|NCT02148848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65639365|NCT02148848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639366|NCT02148848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65639367|NCT03265145|Cholinergic Agents|cholinergic agents|mesh-list
65639368|NCT03265145|Muscarinic Antagonists|muscarinic antagonists|mesh-list
65639369|NCT03265145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65639370|NCT03265145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639371|NCT03265145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639372|NCT03265145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65639373|NCT05344495|Midazolam|midazolam|mesh-list
65639374|NCT05344495|Bupivacaine|bupivacaine|mesh-list
65639375|NCT05344495|Anesthetics, Local|anesthetics, local|mesh-ancestor
65639376|NCT05344495|Anesthetics|anesthetics|mesh-ancestor
65639377|NCT05344495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65639378|NCT05344495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639379|NCT05344495|Sensory System Agents|sensory system agents|mesh-ancestor
65639380|NCT05344495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65639381|NCT05344495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65639382|NCT05344495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65639383|NCT05344495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65639384|NCT05344495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65639385|NCT05344495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65639386|NCT05344495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65639387|NCT05344495|Anesthetics, General|anesthetics, general|mesh-ancestor
65639388|NCT05344495|GABA Modulators|gaba modulators|mesh-ancestor
65639389|NCT05344495|GABA Agents|gaba agents|mesh-ancestor
65639390|NCT05344495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65639391|NCT05344495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639392|NCT01593241|Carboplatin|carboplatin|mesh-list
65639393|NCT01593241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639394|NCT03064763|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
65639395|NCT03064763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65639396|NCT03064763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639397|NCT02782676|Hyaluronic Acid|hyaluronic acid|mesh-list
65639398|NCT02782676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65639399|NCT02782676|Immunologic Factors|immunologic factors|mesh-ancestor
65639400|NCT02782676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639401|NCT02782676|Viscosupplements|viscosupplements|mesh-ancestor
65639402|NCT02782676|Protective Agents|protective agents|mesh-ancestor
65639403|NCT03033095|Etanercept|etanercept|mesh-list
65436703|NCT00373256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65639404|NCT03033095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65639406|NCT03033095|Analgesics|analgesics|mesh-ancestor
65639407|NCT03033095|Sensory System Agents|sensory system agents|mesh-ancestor
65639408|NCT03033095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65639409|NCT03033095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639410|NCT03033095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65639411|NCT03033095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65639412|NCT03033095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65639413|NCT03033095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65639414|NCT03033095|Immunologic Factors|immunologic factors|mesh-ancestor
65639415|NCT02142920|Gedatolisib|gedatolisib|mesh-list
65639416|NCT02142920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65639417|NCT02142920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639418|NCT02142920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639419|NCT01383785|Abciximab|abciximab|mesh-list
65639420|NCT01383785|Anticoagulants|anticoagulants|mesh-ancestor
65639421|NCT01383785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65639422|NCT02923739|Paclitaxel|paclitaxel|mesh-list
65639423|NCT02923739|Bevacizumab|bevacizumab|mesh-list
65639424|NCT02923739|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65639425|NCT02923739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65639426|NCT02923739|Endothelial Growth Factors|endothelial growth factors|mesh-list
65639427|NCT02923739|Antibodies|antibodies|mesh-list
65639428|NCT02923739|Immunoglobulins|immunoglobulins|mesh-list
65639429|NCT02923739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65639430|NCT02923739|Immunoglobulin G|immunoglobulin g|mesh-list
65639431|NCT02923739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65639432|NCT02923739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639433|NCT02923739|Tubulin Modulators|tubulin modulators|mesh-ancestor
65639434|NCT02923739|Antimitotic Agents|antimitotic agents|mesh-ancestor
65639435|NCT02923739|Mitosis Modulators|mitosis modulators|mesh-ancestor
65639436|NCT02923739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639437|NCT02923739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65639438|NCT02923739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65639439|NCT02923739|Growth Substances|growth substances|mesh-ancestor
65639440|NCT02923739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639441|NCT02923739|Growth Inhibitors|growth inhibitors|mesh-ancestor
65639442|NCT02923739|Immunologic Factors|immunologic factors|mesh-ancestor
65639443|NCT02146976|Propofol|propofol|mesh-list
65639444|NCT02146976|Sevoflurane|sevoflurane|mesh-list
65639445|NCT02146976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65639446|NCT02146976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65639447|NCT02146976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639448|NCT02146976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65639449|NCT02146976|Anesthetics, General|anesthetics, general|mesh-ancestor
65639450|NCT02146976|Anesthetics|anesthetics|mesh-ancestor
65639451|NCT02146976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65639452|NCT02146976|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65639453|NCT02147054|Rocuronium|rocuronium|mesh-list
65639454|NCT02147054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65639455|NCT02147054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65639456|NCT02147054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65639457|NCT02147054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65639458|NCT02147054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639459|NCT00107978|Vancomycin|vancomycin|mesh-list
65639460|NCT00107978|Telavancin|telavancin|mesh-list
65639461|NCT00107978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65639462|NCT00107978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65639463|NCT02781818|Triamcinolone|triamcinolone|mesh-list
65639464|NCT02781818|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65639465|NCT02781818|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65639466|NCT02781818|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65639467|NCT02781818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65639468|NCT02781818|Glucocorticoids|glucocorticoids|mesh-ancestor
65639469|NCT02781818|Hormones|hormones|mesh-ancestor
65639470|NCT02781818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65639471|NCT02781818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639472|NCT02781818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65639473|NCT02781818|Immunologic Factors|immunologic factors|mesh-ancestor
65639474|NCT02781818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639475|NCT02781818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639476|NCT02149628|Propofol|propofol|mesh-list
65639477|NCT02149628|Desflurane|desflurane|mesh-list
65639478|NCT02149628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65639479|NCT02149628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65436800|NCT01046006|Dexamethasone|dexamethasone|mesh-list
65639480|NCT02149628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639481|NCT02149628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65639482|NCT02149628|Anesthetics, General|anesthetics, general|mesh-ancestor
65639483|NCT02149628|Anesthetics|anesthetics|mesh-ancestor
65639484|NCT02149628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65639485|NCT02927873|Vaccines|vaccines|mesh-list
65639486|NCT02927873|Immunologic Factors|immunologic factors|mesh-ancestor
65639487|NCT02927873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639488|NCT02460419|Capecitabine|capecitabine|mesh-list
65639489|NCT02460419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65639490|NCT02460419|Antimetabolites|antimetabolites|mesh-ancestor
65639491|NCT02460419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639492|NCT02460419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639493|NCT01568411|Itraconazole|itraconazole|mesh-list
65639494|NCT01568411|Antifungal Agents|antifungal agents|mesh-ancestor
65639495|NCT01568411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65639496|NCT01568411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65639497|NCT01568411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65639498|NCT01568411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639499|NCT01568411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639500|NCT01568411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65639501|NCT01568411|Hormone Antagonists|hormone antagonists|mesh-ancestor
65639502|NCT01568411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65639503|NCT01568411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639504|NCT01568411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65639505|NCT00142415|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
65639506|NCT00142415|Chelating Agents|chelating agents|mesh-ancestor
65639507|NCT00142415|Sequestering Agents|sequestering agents|mesh-ancestor
65639508|NCT00142415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639509|NCT03631901|Diazepam|diazepam|mesh-list
65639510|NCT03631901|Melatonin|melatonin|mesh-list
65639511|NCT03631901|Antioxidants|antioxidants|mesh-ancestor
65639512|NCT03631901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639513|NCT03631901|Protective Agents|protective agents|mesh-ancestor
65639514|NCT03631901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639515|NCT03631901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65639516|NCT03631901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65639517|NCT03631901|Anticonvulsants|anticonvulsants|mesh-ancestor
65639518|NCT03631901|Antiemetics|antiemetics|mesh-ancestor
65639519|NCT03631901|Autonomic Agents|autonomic agents|mesh-ancestor
65639520|NCT03631901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65639521|NCT03631901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65639522|NCT03631901|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65639523|NCT03631901|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65639524|NCT03631901|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65639525|NCT03631901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65639526|NCT03631901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65639527|NCT03631901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65639528|NCT03631901|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65639529|NCT03631901|Anesthetics, General|anesthetics, general|mesh-ancestor
65639530|NCT03631901|Anesthetics|anesthetics|mesh-ancestor
65639531|NCT03631901|GABA Modulators|gaba modulators|mesh-ancestor
65639532|NCT03631901|GABA Agents|gaba agents|mesh-ancestor
65639533|NCT03631901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65639534|NCT01383395|Cilostazol|cilostazol|mesh-list
65639535|NCT01383395|Simvastatin|simvastatin|mesh-list
65639536|NCT01383395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65639537|NCT01383395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65639538|NCT01383395|Antimetabolites|antimetabolites|mesh-ancestor
65639539|NCT01383395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639540|NCT01383395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65639541|NCT01383395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65639542|NCT01383395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639543|NCT01383395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65639544|NCT01383395|Autonomic Agents|autonomic agents|mesh-ancestor
65639545|NCT01383395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65639546|NCT01383395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639547|NCT01383395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65639548|NCT01383395|Respiratory System Agents|respiratory system agents|mesh-ancestor
65639549|NCT01383395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65639550|NCT01383395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65639551|NCT01383395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65639552|NCT01383395|Vasodilator Agents|vasodilator agents|mesh-ancestor
65639553|NCT01383395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65639554|NCT01383395|Protective Agents|protective agents|mesh-ancestor
65639555|NCT01383395|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65639556|NCT01383395|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65639557|NCT05084651|Itraconazole|itraconazole|mesh-list
65639558|NCT05084651|Lumefantrine|lumefantrine|mesh-list
65639559|NCT05084651|Antifungal Agents|antifungal agents|mesh-ancestor
65639560|NCT05084651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65639561|NCT05084651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65639562|NCT05084651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65639563|NCT05084651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639564|NCT05084651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639565|NCT05084651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65639566|NCT05084651|Hormone Antagonists|hormone antagonists|mesh-ancestor
65639567|NCT05084651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65639568|NCT05084651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639569|NCT05084651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65639570|NCT05084651|Antimalarials|antimalarials|mesh-ancestor
65639571|NCT05084651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65639572|NCT05084651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65639573|NCT02781584|Firsocostat|firsocostat|mesh-list
65639574|NCT02781584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639575|NCT02781584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639576|NCT02149706|Freund's Adjuvant|freund's adjuvant|mesh-list
65639577|NCT02149706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65639578|NCT02149706|Immunologic Factors|immunologic factors|mesh-ancestor
65639579|NCT02149706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639580|NCT02147678|Remifentanil|remifentanil|mesh-list
65639581|NCT02147678|Propofol|propofol|mesh-list
65639582|NCT02147678|Etomidate|etomidate|mesh-list
65639583|NCT02147678|Anesthetics|anesthetics|mesh-ancestor
65639584|NCT02147678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65639585|NCT02147678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639586|NCT02147678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65639587|NCT02147678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65639588|NCT02147678|Anesthetics, General|anesthetics, general|mesh-ancestor
65639589|NCT02147678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65639590|NCT02147678|Narcotics|narcotics|mesh-ancestor
65639591|NCT02147678|Analgesics|analgesics|mesh-ancestor
65639592|NCT02147678|Sensory System Agents|sensory system agents|mesh-ancestor
65639593|NCT02147678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65639594|NCT02151344|Vaccines|vaccines|mesh-list
65639595|NCT02151344|Immunologic Factors|immunologic factors|mesh-ancestor
65639596|NCT02151344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639597|NCT02155634|Lenalidomide|lenalidomide|mesh-list
65639598|NCT02155634|Immunologic Factors|immunologic factors|mesh-ancestor
65639599|NCT02155634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639600|NCT02155634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65639601|NCT02155634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65639602|NCT02155634|Growth Substances|growth substances|mesh-ancestor
65639603|NCT02155634|Growth Inhibitors|growth inhibitors|mesh-ancestor
65639604|NCT02155634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639605|NCT02151812|Paclitaxel|paclitaxel|mesh-list
65639606|NCT02151812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65639607|NCT02151812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65639608|NCT02151812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639609|NCT02151812|Tubulin Modulators|tubulin modulators|mesh-ancestor
65639610|NCT02151812|Antimitotic Agents|antimitotic agents|mesh-ancestor
65639611|NCT02151812|Mitosis Modulators|mitosis modulators|mesh-ancestor
65639612|NCT02151812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639613|NCT02151968|Anesthetics|anesthetics|mesh-list
65639614|NCT02151968|Anesthetics, Local|anesthetics, local|mesh-list
65639615|NCT02151968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65639616|NCT02151968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639617|NCT02151968|Sensory System Agents|sensory system agents|mesh-ancestor
65639618|NCT02151968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65639619|NCT02776670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65639620|NCT02776670|Lubricant Eye Drops|lubricant eye drops|mesh-list
65639621|NCT02776670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65639622|NCT02255084|Menthol|menthol|mesh-list
65639623|NCT02255084|Antipruritics|antipruritics|mesh-ancestor
65639624|NCT02255084|Dermatologic Agents|dermatologic agents|mesh-ancestor
65639625|NCT02150330|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65639626|NCT02150330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65639627|NCT02150330|Immunologic Factors|immunologic factors|mesh-ancestor
65639628|NCT02150330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436924|NCT01046708|Progestins|progestins|mesh-ancestor
65639629|NCT02255162|Cytarabine|cytarabine|mesh-list
65639630|NCT02255162|Lenalidomide|lenalidomide|mesh-list
65639631|NCT02255162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65639632|NCT02255162|Antimetabolites|antimetabolites|mesh-ancestor
65639633|NCT02255162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639634|NCT02255162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639635|NCT02255162|Antiviral Agents|antiviral agents|mesh-ancestor
65639636|NCT02255162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65639637|NCT02255162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65639638|NCT02255162|Immunologic Factors|immunologic factors|mesh-ancestor
65639639|NCT02255162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639640|NCT02255162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65639641|NCT02255162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65639642|NCT02255162|Growth Substances|growth substances|mesh-ancestor
65639643|NCT02255162|Growth Inhibitors|growth inhibitors|mesh-ancestor
65639644|NCT02152514|Sufentanil|sufentanil|mesh-list
65639645|NCT02152514|Morphine|morphine|mesh-list
65639646|NCT02152514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65639647|NCT02152514|Narcotics|narcotics|mesh-ancestor
65639648|NCT02152514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65639649|NCT02152514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639650|NCT02152514|Analgesics|analgesics|mesh-ancestor
65639651|NCT02152514|Sensory System Agents|sensory system agents|mesh-ancestor
65639652|NCT02152514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65639653|NCT02152514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65639654|NCT02152514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65639655|NCT02152514|Anesthetics, General|anesthetics, general|mesh-ancestor
65639656|NCT02152514|Anesthetics|anesthetics|mesh-ancestor
65639657|NCT02261090|Pramipexole|pramipexole|mesh-list
65639658|NCT02261090|Antioxidants|antioxidants|mesh-ancestor
65639659|NCT02261090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639660|NCT02261090|Protective Agents|protective agents|mesh-ancestor
65639661|NCT02261090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639662|NCT02261090|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65639663|NCT02261090|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65639664|NCT02261090|Dopamine Agonists|dopamine agonists|mesh-ancestor
65639665|NCT02261090|Dopamine Agents|dopamine agents|mesh-ancestor
65639666|NCT02261090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65639667|NCT04849910|Gemtuzumab|gemtuzumab|mesh-list
65639668|NCT04849910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65639669|NCT04849910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639670|NCT01307423|Thalidomide|thalidomide|mesh-list
65639671|NCT01307423|Apremilast|apremilast|mesh-list
65639672|NCT01307423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65639673|NCT01307423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65639674|NCT01307423|Analgesics|analgesics|mesh-ancestor
65639675|NCT01307423|Sensory System Agents|sensory system agents|mesh-ancestor
65639676|NCT01307423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65639677|NCT01307423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639678|NCT01307423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65639679|NCT01307423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65639680|NCT01307423|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65639681|NCT01307423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65639682|NCT01307423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639683|NCT01307423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639684|NCT01307423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65639685|NCT01307423|Immunologic Factors|immunologic factors|mesh-ancestor
65639686|NCT01307423|Leprostatic Agents|leprostatic agents|mesh-ancestor
65639687|NCT01307423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65639688|NCT01307423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65639689|NCT01307423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65639690|NCT01307423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65639691|NCT01307423|Growth Substances|growth substances|mesh-ancestor
65639692|NCT01307423|Growth Inhibitors|growth inhibitors|mesh-ancestor
65639693|NCT01307423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639694|NCT03543254|Botulinum Toxins|botulinum toxins|mesh-list
65639695|NCT03543254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65639696|NCT03543254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65639697|NCT03543254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65639698|NCT03543254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65639699|NCT03543254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639700|NCT03543254|Cholinergic Agents|cholinergic agents|mesh-ancestor
65639701|NCT03543254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65639702|NCT03543254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639703|NCT03543254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65639704|NCT03543254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65639705|NCT02156336|Ranolazine|ranolazine|mesh-list
65639706|NCT02156336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65639707|NCT02156336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65639708|NCT02156336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639709|NCT03542240|Curcumin|curcumin|mesh-list
65639710|NCT03542240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65639711|NCT03542240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65639712|NCT03542240|Analgesics|analgesics|mesh-ancestor
65639713|NCT03542240|Sensory System Agents|sensory system agents|mesh-ancestor
65639714|NCT03542240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65639715|NCT03542240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639716|NCT03542240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65639717|NCT03542240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65639718|NCT03542240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639719|NCT03542240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639720|NCT03542240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639721|NCT00911183|Prednisone|prednisone|mesh-list
65639722|NCT00911183|Cyclophosphamide|cyclophosphamide|mesh-list
65639723|NCT00911183|Rituximab|rituximab|mesh-list
65639724|NCT00911183|Doxorubicin|doxorubicin|mesh-list
65639725|NCT00911183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65639726|NCT00911183|Vincristine|vincristine|mesh-list
65639727|NCT00911183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65639728|NCT00911183|Immunologic Factors|immunologic factors|mesh-ancestor
65639729|NCT00911183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639730|NCT00911183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65639731|NCT00911183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65639732|NCT00911183|Alkylating Agents|alkylating agents|mesh-ancestor
65639733|NCT00911183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639734|NCT00911183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639735|NCT00911183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65639736|NCT00911183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65639737|NCT00911183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65639738|NCT00911183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65639739|NCT00911183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65639740|NCT00911183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639741|NCT00911183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65639742|NCT00911183|Glucocorticoids|glucocorticoids|mesh-ancestor
65639743|NCT00911183|Hormones|hormones|mesh-ancestor
65639744|NCT00911183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65639745|NCT00911183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65639746|NCT00911183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65639747|NCT00911183|Tubulin Modulators|tubulin modulators|mesh-ancestor
65639748|NCT00911183|Antimitotic Agents|antimitotic agents|mesh-ancestor
65639749|NCT00911183|Mitosis Modulators|mitosis modulators|mesh-ancestor
65639750|NCT03631121|Insulin Glargine|insulin glargine|mesh-list
65639751|NCT03631121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65639752|NCT03631121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639753|NCT02768792|Pembrolizumab|pembrolizumab|mesh-list
65639754|NCT02768792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65639755|NCT02768792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639756|NCT05420441|Chitosan|chitosan|mesh-list
65639757|NCT05420441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65639758|NCT05420441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65639759|NCT05420441|Antimetabolites|antimetabolites|mesh-ancestor
65639760|NCT05420441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639761|NCT05420441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65639762|NCT05420441|Chelating Agents|chelating agents|mesh-ancestor
65639763|NCT05420441|Sequestering Agents|sequestering agents|mesh-ancestor
65639764|NCT05420441|Hemostatics|hemostatics|mesh-ancestor
65639765|NCT05420441|Coagulants|coagulants|mesh-ancestor
65639766|NCT05598593|Cytarabine|cytarabine|mesh-list
65639767|NCT05598593|Fludarabine|fludarabine|mesh-list
65639768|NCT05598593|Busulfan|busulfan|mesh-list
65639769|NCT05598593|Thiotepa|thiotepa|mesh-list
65639770|NCT05598593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639771|NCT05598593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65639772|NCT05598593|Antimetabolites|antimetabolites|mesh-ancestor
65639773|NCT05598593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639774|NCT05598593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65639775|NCT05598593|Immunologic Factors|immunologic factors|mesh-ancestor
65639776|NCT05598593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639777|NCT05598593|Antiviral Agents|antiviral agents|mesh-ancestor
65639778|NCT05598593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65639779|NCT05598593|Alkylating Agents|alkylating agents|mesh-ancestor
65639780|NCT05598593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65639781|NCT05598593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65639782|NCT05337449|Fluorides|fluorides|mesh-list
65639783|NCT05337449|Cariostatic Agents|cariostatic agents|mesh-ancestor
65639784|NCT05337449|Protective Agents|protective agents|mesh-ancestor
65639785|NCT05337449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639786|NCT02150720|Tranexamic Acid|tranexamic acid|mesh-list
65639787|NCT02150720|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65639788|NCT02150720|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65639789|NCT02150720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65639790|NCT02150720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639791|NCT02150720|Hemostatics|hemostatics|mesh-ancestor
65639792|NCT02150720|Coagulants|coagulants|mesh-ancestor
65639793|NCT02153060|Dexamethasone|dexamethasone|mesh-list
65639794|NCT02153060|Dexamethasone acetate|dexamethasone acetate|mesh-list
65639795|NCT02153060|BB 1101|bb 1101|mesh-list
65639796|NCT02153060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65639797|NCT02153060|Antiemetics|antiemetics|mesh-ancestor
65639798|NCT02153060|Autonomic Agents|autonomic agents|mesh-ancestor
65639799|NCT02153060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65639800|NCT02153060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639801|NCT02153060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65639802|NCT02153060|Glucocorticoids|glucocorticoids|mesh-ancestor
65639803|NCT02153060|Hormones|hormones|mesh-ancestor
65639804|NCT02153060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65639805|NCT02153060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65639806|NCT02153060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639807|NCT02153060|Protease Inhibitors|protease inhibitors|mesh-ancestor
65639808|NCT02153060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639809|NCT02153060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639810|NCT02156570|Ribavirin|ribavirin|mesh-list
65639811|NCT02156570|Sofosbuvir|sofosbuvir|mesh-list
65639812|NCT02156570|Antimetabolites|antimetabolites|mesh-ancestor
65639813|NCT02156570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639814|NCT02156570|Antiviral Agents|antiviral agents|mesh-ancestor
65639815|NCT02156570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65639816|NCT03087851|Zoledronic Acid|zoledronic acid|mesh-list
65639817|NCT03087851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65639818|NCT03087851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639819|NCT02156726|Cyclophosphamide|cyclophosphamide|mesh-list
65639820|NCT02156726|Fludarabine|fludarabine|mesh-list
65639821|NCT02156726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65639822|NCT02156726|Immunologic Factors|immunologic factors|mesh-ancestor
65639823|NCT02156726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639824|NCT02156726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65639825|NCT02156726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65639826|NCT02156726|Alkylating Agents|alkylating agents|mesh-ancestor
65639827|NCT02156726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639828|NCT02156726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639829|NCT02156726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65639830|NCT02153450|Metformin|metformin|mesh-list
65639831|NCT02153450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65639832|NCT02153450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639833|NCT05598281|Digoxin|digoxin|mesh-list
65639834|NCT05598281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65639835|NCT05598281|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65639836|NCT05598281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639837|NCT05598281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639838|NCT05598281|Protective Agents|protective agents|mesh-ancestor
65639839|NCT05598281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639840|NCT03092375|Ribavirin|ribavirin|mesh-list
65639841|NCT03092375|Antimetabolites|antimetabolites|mesh-ancestor
65639842|NCT03092375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639843|NCT03092375|Antiviral Agents|antiviral agents|mesh-ancestor
65639844|NCT03092375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65639845|NCT01995513|Prednisone|prednisone|mesh-list
65639846|NCT01995513|Prednisolone|prednisolone|mesh-list
65639847|NCT01995513|Abiraterone Acetate|abiraterone acetate|mesh-list
65639848|NCT01995513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65639849|NCT01995513|Glucocorticoids|glucocorticoids|mesh-ancestor
65639850|NCT01995513|Hormones|hormones|mesh-ancestor
65639851|NCT01995513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65639852|NCT01995513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639853|NCT01995513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65639854|NCT01995513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639855|NCT01995513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65437160|NCT00371150|Entecavir|entecavir|mesh-list
65639856|NCT01995513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639857|NCT01995513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639858|NCT01995513|Hormone Antagonists|hormone antagonists|mesh-ancestor
65639859|NCT01995513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65639860|NCT04678401|Cyclophosphamide|cyclophosphamide|mesh-list
65639861|NCT04678401|Thiotepa|thiotepa|mesh-list
65639862|NCT04678401|Fludarabine|fludarabine|mesh-list
65639863|NCT04678401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65639864|NCT04678401|Immunologic Factors|immunologic factors|mesh-ancestor
65639865|NCT04678401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639866|NCT04678401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65639867|NCT04678401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65639868|NCT04678401|Alkylating Agents|alkylating agents|mesh-ancestor
65639869|NCT04678401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639870|NCT04678401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639871|NCT04678401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65639872|NCT04633239|Olaparib|olaparib|mesh-list
65639873|NCT04633239|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65639874|NCT04633239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639875|NCT04633239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639876|NCT04633239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639877|NCT03180359|Vaccines|vaccines|mesh-list
65639878|NCT03180359|Immunologic Factors|immunologic factors|mesh-ancestor
65639879|NCT03180359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639880|NCT03687957|Temozolomide|temozolomide|mesh-list
65639881|NCT03687957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65639882|NCT03687957|Alkylating Agents|alkylating agents|mesh-ancestor
65639883|NCT03687957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639884|NCT03687957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639885|NCT05199285|Nivolumab|nivolumab|mesh-list
65639886|NCT05199285|Ipilimumab|ipilimumab|mesh-list
65639887|NCT05199285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65639888|NCT05199285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639889|NCT05199285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65639890|NCT05199285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639891|NCT01304511|Ganirelix|ganirelix|mesh-list
65639892|NCT01304511|Hormone Antagonists|hormone antagonists|mesh-ancestor
65639893|NCT01304511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65639894|NCT01304511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639895|NCT04808973|Lamivudine|lamivudine|mesh-list
65639896|NCT04808973|Dolutegravir|dolutegravir|mesh-list
65639897|NCT04808973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65639898|NCT04808973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65639899|NCT04808973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639900|NCT04808973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639901|NCT04808973|Antiviral Agents|antiviral agents|mesh-ancestor
65639902|NCT04808973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65639903|NCT04808973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65639904|NCT04808973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65639905|NCT04808973|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65639906|NCT04808973|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65639907|NCT00103610|Plerixafor|plerixafor|mesh-list
65639908|NCT00103610|Lenograstim|lenograstim|mesh-list
65639909|NCT00103610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65639910|NCT00103610|Immunologic Factors|immunologic factors|mesh-ancestor
65639911|NCT00103610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639912|NCT00103610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65639913|NCT00103610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65639914|NCT00103610|Antiviral Agents|antiviral agents|mesh-ancestor
65639915|NCT00103610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65639916|NCT04871321|Gemcitabine|gemcitabine|mesh-list
65639917|NCT04871321|Paclitaxel|paclitaxel|mesh-list
65639918|NCT04871321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65639919|NCT04871321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639920|NCT04871321|Tubulin Modulators|tubulin modulators|mesh-ancestor
65639921|NCT04871321|Antimitotic Agents|antimitotic agents|mesh-ancestor
65639922|NCT04871321|Mitosis Modulators|mitosis modulators|mesh-ancestor
65639923|NCT04871321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639924|NCT04871321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65639925|NCT04871321|Antimetabolites|antimetabolites|mesh-ancestor
65639926|NCT04871321|Antiviral Agents|antiviral agents|mesh-ancestor
65639927|NCT04871321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65639928|NCT04871321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639929|NCT04871321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65639930|NCT04871321|Immunologic Factors|immunologic factors|mesh-ancestor
65639931|NCT04871321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639933|NCT02156960|Teriparatide|teriparatide|mesh-list
65639934|NCT02156960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65639935|NCT02156960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639936|NCT02156960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65639937|NCT02153606|Glycerol|glycerol|mesh-list
65639938|NCT02153606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65639939|NCT02153606|Protective Agents|protective agents|mesh-ancestor
65639940|NCT02153606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639941|NCT02153762|Hydrocortisone|hydrocortisone|mesh-list
65639942|NCT02153762|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65639943|NCT02153762|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65639944|NCT02153762|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65639945|NCT02153762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65639946|NCT04687631|Bevacizumab|bevacizumab|mesh-list
65639947|NCT04687631|Cetuximab|cetuximab|mesh-list
65639948|NCT04687631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65639949|NCT04687631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639950|NCT04687631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65639951|NCT04687631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65639952|NCT04687631|Growth Substances|growth substances|mesh-ancestor
65639953|NCT04687631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639954|NCT04687631|Growth Inhibitors|growth inhibitors|mesh-ancestor
65639955|NCT04833023|Olanzapine|olanzapine|mesh-list
65639956|NCT04833023|Antiemetics|antiemetics|mesh-ancestor
65639957|NCT04833023|Autonomic Agents|autonomic agents|mesh-ancestor
65639958|NCT04833023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65639959|NCT04833023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639960|NCT04833023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65639961|NCT04833023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65639962|NCT04833023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65639963|NCT04833023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65639964|NCT04833023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65639965|NCT04833023|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65639966|NCT04833023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65639967|NCT04833023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65639968|NCT04833023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639969|NCT04833023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65639970|NCT04833023|Serotonin Agents|serotonin agents|mesh-ancestor
65639971|NCT03091439|Dalbavancin|dalbavancin|mesh-list
65639972|NCT03091439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65639973|NCT03091439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65639974|NCT03631823|Temozolomide|temozolomide|mesh-list
65639975|NCT03631823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65639976|NCT03631823|Alkylating Agents|alkylating agents|mesh-ancestor
65639977|NCT03631823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639978|NCT03631823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65639979|NCT02157272|Rivaroxaban|rivaroxaban|mesh-list
65639980|NCT02157272|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65639981|NCT02157272|Antithrombins|antithrombins|mesh-ancestor
65639982|NCT02157272|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65639983|NCT02157272|Protease Inhibitors|protease inhibitors|mesh-ancestor
65639984|NCT02157272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65639985|NCT02157272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65639986|NCT02157272|Anticoagulants|anticoagulants|mesh-ancestor
65639987|NCT02154074|Dexmedetomidine|dexmedetomidine|mesh-list
65639988|NCT02154074|Isoflurane|isoflurane|mesh-list
65639989|NCT02154074|Anesthetics|anesthetics|mesh-ancestor
65639990|NCT02154074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65639991|NCT02154074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65639992|NCT02154074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65639993|NCT02154074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65639994|NCT02154074|Analgesics|analgesics|mesh-ancestor
65639995|NCT02154074|Sensory System Agents|sensory system agents|mesh-ancestor
65639996|NCT02154074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65639997|NCT02154074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65639998|NCT02154074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65639999|NCT02154074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65640000|NCT02154074|Adrenergic Agents|adrenergic agents|mesh-ancestor
65640001|NCT02154074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65640002|NCT02154074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640003|NCT02154074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65640004|NCT02154074|Anesthetics, General|anesthetics, general|mesh-ancestor
65640005|NCT05593055|Eplerenone|eplerenone|mesh-list
65640006|NCT05593055|Chlorthalidone|chlorthalidone|mesh-list
65640007|NCT05593055|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65640008|NCT05593055|Hormone Antagonists|hormone antagonists|mesh-ancestor
65640009|NCT05593055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65640010|NCT05593055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640011|NCT05593055|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65640012|NCT05593055|Diuretics|diuretics|mesh-ancestor
65640013|NCT05593055|Natriuretic Agents|natriuretic agents|mesh-ancestor
65640014|NCT05593055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65640015|NCT05593055|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65640016|NCT05593055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65640017|NCT05593055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640018|NCT05460455|Antibodies|antibodies|mesh-list
65640019|NCT05460455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65640020|NCT05460455|Immunologic Factors|immunologic factors|mesh-ancestor
65640021|NCT05460455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640022|NCT03104413|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65640023|NCT03104413|Immunologic Factors|immunologic factors|mesh-ancestor
65640024|NCT03104413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640025|NCT01382147|Daunorubicin|daunorubicin|mesh-list
65640026|NCT01382147|Mitoxantrone|mitoxantrone|mesh-list
65640027|NCT01382147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65640028|NCT01382147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640029|NCT01382147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65640030|NCT01382147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65640031|NCT01382147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640032|NCT01382147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640033|NCT01382147|Analgesics|analgesics|mesh-ancestor
65640034|NCT01382147|Sensory System Agents|sensory system agents|mesh-ancestor
65640035|NCT01382147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640036|NCT01382147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640037|NCT01381835|Simeprevir|simeprevir|mesh-list
65640038|NCT01381835|Antiviral Agents|antiviral agents|mesh-ancestor
65640039|NCT01381835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65640040|NCT01381835|Protease Inhibitors|protease inhibitors|mesh-ancestor
65640041|NCT01381835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640042|NCT01381835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640043|NCT04429685|Ketamine|ketamine|mesh-list
65640044|NCT04429685|Analgesics|analgesics|mesh-ancestor
65640045|NCT04429685|Sensory System Agents|sensory system agents|mesh-ancestor
65640046|NCT04429685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640047|NCT04429685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640048|NCT04429685|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65640049|NCT04429685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65640050|NCT04429685|Anesthetics, General|anesthetics, general|mesh-ancestor
65640051|NCT04429685|Anesthetics|anesthetics|mesh-ancestor
65640052|NCT04429685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65640053|NCT04429685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65640054|NCT04429685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65640055|NCT04429685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65640056|NCT04429685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640057|NCT01384279|Metformin|metformin|mesh-list
65640058|NCT01384279|Topiramate|topiramate|mesh-list
65640059|NCT01384279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65640060|NCT01384279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640061|NCT01384279|Anticonvulsants|anticonvulsants|mesh-ancestor
65640062|NCT01381601|Bevacizumab|bevacizumab|mesh-list
65640063|NCT01381601|Sunitinib|sunitinib|mesh-list
65640064|NCT01381601|Sorafenib|sorafenib|mesh-list
65640065|NCT01381601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65640066|NCT01381601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640067|NCT01381601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65640068|NCT01381601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65640069|NCT01381601|Growth Substances|growth substances|mesh-ancestor
65640070|NCT01381601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640071|NCT01381601|Growth Inhibitors|growth inhibitors|mesh-ancestor
65640072|NCT01381601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65640073|NCT01381601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640074|NCT01381601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640075|NCT02823353|Fenofibrate|fenofibrate|mesh-list
65640076|NCT02823353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65640077|NCT02823353|Antimetabolites|antimetabolites|mesh-ancestor
65640078|NCT02823353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640079|NCT02823353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65640080|NCT04509193|Warfarin|warfarin|mesh-list
65640081|NCT04509193|Rivaroxaban|rivaroxaban|mesh-list
65640082|NCT04509193|Anticoagulants|anticoagulants|mesh-ancestor
65640083|NCT04509193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65640084|NCT04509193|Antithrombins|antithrombins|mesh-ancestor
65640085|NCT04509193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65640086|NCT04509193|Protease Inhibitors|protease inhibitors|mesh-ancestor
65640087|NCT04509193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640088|NCT04509193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640089|NCT02697383|Dexamethasone|dexamethasone|mesh-list
65640090|NCT02697383|Ixazomib|ixazomib|mesh-list
65640091|NCT02697383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65640092|NCT02697383|Antiemetics|antiemetics|mesh-ancestor
65640093|NCT02697383|Autonomic Agents|autonomic agents|mesh-ancestor
65640094|NCT02697383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65267408|NCT00549445|Azithromycin|azithromycin|mesh-list
65640095|NCT02697383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640096|NCT02697383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65640097|NCT02697383|Glucocorticoids|glucocorticoids|mesh-ancestor
65640098|NCT02697383|Hormones|hormones|mesh-ancestor
65640099|NCT02697383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65640100|NCT02697383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65640101|NCT02697383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640102|NCT02697383|Protease Inhibitors|protease inhibitors|mesh-ancestor
65640103|NCT02697383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640104|NCT02697383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640105|NCT04173949|Ramipril|ramipril|mesh-list
65640106|NCT04173949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65640107|NCT04173949|Protease Inhibitors|protease inhibitors|mesh-ancestor
65640108|NCT04173949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640109|NCT04173949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640110|NCT04173949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65640111|NCT05422001|Ketamine|ketamine|mesh-list
65640112|NCT05422001|Analgesics|analgesics|mesh-ancestor
65640113|NCT05422001|Sensory System Agents|sensory system agents|mesh-ancestor
65640114|NCT05422001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640115|NCT05422001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640116|NCT05422001|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65640117|NCT05422001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65640118|NCT05422001|Anesthetics, General|anesthetics, general|mesh-ancestor
65640119|NCT05422001|Anesthetics|anesthetics|mesh-ancestor
65640120|NCT05422001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65640121|NCT05422001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65640122|NCT05422001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65640123|NCT05422001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65640124|NCT05422001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640125|NCT01382017|Lacosamide|lacosamide|mesh-list
65640126|NCT01382017|Carbamazepine|carbamazepine|mesh-list
65640127|NCT01382017|Anticonvulsants|anticonvulsants|mesh-ancestor
65640128|NCT01382017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65640129|NCT01382017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65640130|NCT01382017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65640131|NCT01382017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640132|NCT01382017|Antimanic Agents|antimanic agents|mesh-ancestor
65640133|NCT01382017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65640134|NCT01382017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65640135|NCT01382017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640136|NCT01382017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65640137|NCT01382017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65640138|NCT01382017|Analgesics|analgesics|mesh-ancestor
65640139|NCT01382017|Sensory System Agents|sensory system agents|mesh-ancestor
65640140|NCT01382017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640141|NCT01382017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65640142|NCT01382017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65640143|NCT01381523|Naproxen|naproxen|mesh-list
65640144|NCT01381523|Sumatriptan|sumatriptan|mesh-list
65640145|NCT01381523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65640146|NCT01381523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65640147|NCT01381523|Analgesics|analgesics|mesh-ancestor
65640148|NCT01381523|Sensory System Agents|sensory system agents|mesh-ancestor
65640149|NCT01381523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640150|NCT01381523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640151|NCT01381523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65640152|NCT01381523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65640153|NCT01381523|Gout Suppressants|gout suppressants|mesh-ancestor
65640154|NCT01381523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65640155|NCT01381523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640156|NCT01381523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640157|NCT01381523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65640158|NCT01381523|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65640159|NCT01381523|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65640160|NCT01381523|Serotonin Agents|serotonin agents|mesh-ancestor
65640161|NCT01381523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65640162|NCT04233047|Fostemsavir|fostemsavir|mesh-list
65640163|NCT04233047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65640164|NCT04233047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65640165|NCT04233047|Antiviral Agents|antiviral agents|mesh-ancestor
65640166|NCT04233047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65640167|NCT04233047|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65640168|NCT04233047|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65640169|NCT04233047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640170|NCT01381445|Clobetasol|clobetasol|mesh-list
65640171|NCT01381445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65640172|NCT01381445|Glucocorticoids|glucocorticoids|mesh-ancestor
65640173|NCT01381445|Hormones|hormones|mesh-ancestor
65640174|NCT01381445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65640175|NCT01381445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640176|NCT03083639|Esomeprazole|esomeprazole|mesh-list
65640177|NCT03083639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65640178|NCT03083639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65640179|NCT03083639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65640180|NCT03083639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640181|NCT03083639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640182|NCT02927431|Oseltamivir|oseltamivir|mesh-list
65640183|NCT02927431|Antiviral Agents|antiviral agents|mesh-ancestor
65640184|NCT02927431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65640185|NCT02927431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640186|NCT02927431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640187|NCT05027893|Moxifloxacin|moxifloxacin|mesh-list
65640188|NCT05027893|Cefixime|cefixime|mesh-list
65640189|NCT05027893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65640190|NCT05027893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65640191|NCT05027893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65640192|NCT05027893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65640193|NCT05027893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640194|NCT05027893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640195|NCT05027893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640196|NCT04113083|Dehydrocholesterols|dehydrocholesterols|mesh-list
65640197|NCT04113083|Provitamins|provitamins|mesh-ancestor
65640198|NCT04113083|Vitamins|vitamins|mesh-ancestor
65640199|NCT04113083|Micronutrients|micronutrients|mesh-ancestor
65640200|NCT04113083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640201|NCT01381367|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65640202|NCT01381367|Immunologic Factors|immunologic factors|mesh-ancestor
65640203|NCT01381367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640204|NCT04989361|Hyaluronic Acid|hyaluronic acid|mesh-list
65640205|NCT04989361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65640206|NCT04989361|Immunologic Factors|immunologic factors|mesh-ancestor
65640207|NCT04989361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640208|NCT04989361|Viscosupplements|viscosupplements|mesh-ancestor
65640209|NCT04989361|Protective Agents|protective agents|mesh-ancestor
65640210|NCT01381289|Ivacaftor|ivacaftor|mesh-list
65640211|NCT01381289|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65640212|NCT01381289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65640213|NCT01381289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640214|NCT04899193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65640215|NCT04899193|Hormones|hormones|mesh-ancestor
65640216|NCT04899193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65640217|NCT04899193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640218|NCT01381705|Rituximab|rituximab|mesh-list
65640219|NCT01381705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65640220|NCT01381705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640221|NCT01381705|Immunologic Factors|immunologic factors|mesh-ancestor
65640222|NCT01381705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640223|NCT01381705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65640224|NCT04401709|Gemcitabine|gemcitabine|mesh-list
65640225|NCT04401709|Capecitabine|capecitabine|mesh-list
65640226|NCT04401709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65640227|NCT04401709|Antimetabolites|antimetabolites|mesh-ancestor
65640228|NCT04401709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640229|NCT04401709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640230|NCT04401709|Antiviral Agents|antiviral agents|mesh-ancestor
65640231|NCT04401709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65640232|NCT04401709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640233|NCT04401709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65640234|NCT04401709|Immunologic Factors|immunologic factors|mesh-ancestor
65640235|NCT04401709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640236|NCT04497987|Bamlanivimab|bamlanivimab|mesh-list
65640237|NCT04497987|Antiviral Agents|antiviral agents|mesh-ancestor
65640238|NCT04497987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65640239|NCT01381627|Dexmedetomidine|dexmedetomidine|mesh-list
65640240|NCT01381627|Remifentanil|remifentanil|mesh-list
65640241|NCT01381627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65640242|NCT01381627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65640243|NCT01381627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640244|NCT01381627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65640245|NCT01381627|Analgesics|analgesics|mesh-ancestor
65640246|NCT01381627|Sensory System Agents|sensory system agents|mesh-ancestor
65640247|NCT01381627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640248|NCT01381627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65640249|NCT01381627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65640250|NCT01381627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65640251|NCT01381627|Adrenergic Agents|adrenergic agents|mesh-ancestor
65640252|NCT01381627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65640253|NCT01381627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640254|NCT01381627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65640255|NCT01381627|Narcotics|narcotics|mesh-ancestor
65640256|NCT00974571|Cetirizine|cetirizine|mesh-list
65640257|NCT00974571|Montelukast|montelukast|mesh-list
65640258|NCT00974571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65640259|NCT00974571|Respiratory System Agents|respiratory system agents|mesh-ancestor
65640260|NCT00974571|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65640261|NCT00974571|Hormone Antagonists|hormone antagonists|mesh-ancestor
65640262|NCT00974571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65640263|NCT00974571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640264|NCT00974571|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65640265|NCT00974571|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65640266|NCT00974571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640267|NCT00974571|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65640268|NCT00974571|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65640269|NCT00974571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65640270|NCT00974571|Histamine Antagonists|histamine antagonists|mesh-ancestor
65640271|NCT00974571|Histamine Agents|histamine agents|mesh-ancestor
65640272|NCT00974571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65640273|NCT02766608|Budesonide|budesonide|mesh-list
65640274|NCT02766608|Formoterol Fumarate|formoterol fumarate|mesh-list
65640275|NCT02766608|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65640276|NCT02766608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65640277|NCT02766608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65640278|NCT02766608|Autonomic Agents|autonomic agents|mesh-ancestor
65640279|NCT02766608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640280|NCT02766608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640281|NCT02766608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65640282|NCT02766608|Respiratory System Agents|respiratory system agents|mesh-ancestor
65640283|NCT02766608|Glucocorticoids|glucocorticoids|mesh-ancestor
65640284|NCT02766608|Hormones|hormones|mesh-ancestor
65640285|NCT02766608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65640286|NCT02766608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65640287|NCT02766608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65640288|NCT02766608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65640289|NCT02766608|Adrenergic Agents|adrenergic agents|mesh-ancestor
65640290|NCT02766608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65640291|NCT02766608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640292|NCT01382407|Cetuximab|cetuximab|mesh-list
65640293|NCT01382407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65640294|NCT01382407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640295|NCT02235857|Dextrans|dextrans|mesh-list
65640296|NCT02235857|Anticoagulants|anticoagulants|mesh-ancestor
65640297|NCT02235857|Plasma Substitutes|plasma substitutes|mesh-ancestor
65640298|NCT02235857|Blood Substitutes|blood substitutes|mesh-ancestor
65640299|NCT05082285|Vaccines|vaccines|mesh-list
65640300|NCT05082285|Immunologic Factors|immunologic factors|mesh-ancestor
65640301|NCT05082285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640302|NCT03317119|Trifluridine|trifluridine|mesh-list
65640303|NCT03317119|Trametinib|trametinib|mesh-list
65640304|NCT03317119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640305|NCT03317119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65640306|NCT03317119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640307|NCT03317119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640308|NCT03317119|Antimetabolites|antimetabolites|mesh-ancestor
65640309|NCT03317119|Antiviral Agents|antiviral agents|mesh-ancestor
65640310|NCT03317119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65640311|NCT04356495|Ciclesonide|ciclesonide|mesh-list
65640312|NCT04356495|Interferons|interferons|mesh-list
65640313|NCT04356495|Interferon-beta|interferon-beta|mesh-list
65640314|NCT04356495|Telmisartan|telmisartan|mesh-list
65640315|NCT04356495|Interferon beta-1b|interferon beta-1b|mesh-list
65640316|NCT04356495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640317|NCT04356495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640318|NCT04356495|Antiviral Agents|antiviral agents|mesh-ancestor
65640319|NCT04356495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65640320|NCT04356495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65640321|NCT04356495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65640322|NCT04356495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65640323|NCT04356495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640324|NCT04356495|Glucocorticoids|glucocorticoids|mesh-ancestor
65640325|NCT04356495|Hormones|hormones|mesh-ancestor
65640326|NCT04356495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65640327|NCT04356495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65640328|NCT04356495|Immunologic Factors|immunologic factors|mesh-ancestor
65640329|NCT04356495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65640330|NCT05345249|Ropivacaine|ropivacaine|mesh-list
65640331|NCT05345249|Anesthetics, Local|anesthetics, local|mesh-ancestor
65640332|NCT05345249|Anesthetics|anesthetics|mesh-ancestor
65640333|NCT05345249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65640334|NCT05345249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640335|NCT05345249|Sensory System Agents|sensory system agents|mesh-ancestor
65640336|NCT05345249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640337|NCT02154230|Calcium|calcium|mesh-list
65640338|NCT02154230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65640339|NCT02154230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640340|NCT04200963|Nivolumab|nivolumab|mesh-list
65640341|NCT04200963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65640342|NCT04200963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640343|NCT04200963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65640344|NCT04200963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640345|NCT02157428|Flumazenil|flumazenil|mesh-list
65640346|NCT02157428|Antidotes|antidotes|mesh-ancestor
65640347|NCT02157428|Protective Agents|protective agents|mesh-ancestor
65640348|NCT02157428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640349|NCT02157428|GABA Modulators|gaba modulators|mesh-ancestor
65640350|NCT02157428|GABA Agents|gaba agents|mesh-ancestor
65640351|NCT02157428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65640352|NCT02157428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640353|NCT00960141|Loratadine|loratadine|mesh-list
65640354|NCT00960141|Montelukast|montelukast|mesh-list
65640355|NCT00960141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65640356|NCT00960141|Respiratory System Agents|respiratory system agents|mesh-ancestor
65640357|NCT00960141|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65640358|NCT00960141|Hormone Antagonists|hormone antagonists|mesh-ancestor
65640359|NCT00960141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65640360|NCT00960141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640361|NCT00960141|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65640362|NCT00960141|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65640363|NCT00960141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640364|NCT00960141|Antipruritics|antipruritics|mesh-ancestor
65640365|NCT00960141|Dermatologic Agents|dermatologic agents|mesh-ancestor
65640366|NCT00960141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65640367|NCT00960141|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65640368|NCT00960141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65640369|NCT00960141|Histamine Antagonists|histamine antagonists|mesh-ancestor
65640370|NCT00960141|Histamine Agents|histamine agents|mesh-ancestor
65640371|NCT00960141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65640372|NCT00759655|Factor VIII|factor viii|mesh-list
65640373|NCT00759655|Coagulants|coagulants|mesh-ancestor
65640374|NCT03918915|Atropine|atropine|mesh-list
65640375|NCT03918915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65640376|NCT03918915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65640377|NCT03918915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65640378|NCT03918915|Autonomic Agents|autonomic agents|mesh-ancestor
65640379|NCT03918915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640380|NCT03918915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640382|NCT03918915|Respiratory System Agents|respiratory system agents|mesh-ancestor
65640383|NCT03918915|Mydriatics|mydriatics|mesh-ancestor
65640384|NCT03918915|Parasympatholytics|parasympatholytics|mesh-ancestor
65640385|NCT03918915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65640386|NCT03918915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65640387|NCT03918915|Cholinergic Agents|cholinergic agents|mesh-ancestor
65640388|NCT03918915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65640389|NCT03918915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640390|NCT02255006|Glyburide|glyburide|mesh-list
65640391|NCT02255006|Celecoxib|celecoxib|mesh-list
65640392|NCT02255006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65640393|NCT02255006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65640394|NCT02255006|Analgesics|analgesics|mesh-ancestor
65640395|NCT02255006|Sensory System Agents|sensory system agents|mesh-ancestor
65640396|NCT02255006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640397|NCT02255006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640398|NCT02255006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65640399|NCT02255006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65640400|NCT02255006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65640401|NCT02255006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65640402|NCT02255006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640403|NCT02255006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640404|NCT02255006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65640405|NCT03396471|Pembrolizumab|pembrolizumab|mesh-list
65640406|NCT03396471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65640407|NCT03396471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640408|NCT00103142|Sargramostim|sargramostim|mesh-list
65640409|NCT00103142|Immunologic Factors|immunologic factors|mesh-ancestor
65640410|NCT00103142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640411|NCT00943683|Montelukast|montelukast|mesh-list
65640412|NCT00943683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65640413|NCT00943683|Respiratory System Agents|respiratory system agents|mesh-ancestor
65640414|NCT00943683|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65640415|NCT00943683|Hormone Antagonists|hormone antagonists|mesh-ancestor
65640416|NCT00943683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65640417|NCT00943683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640418|NCT00943683|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65640419|NCT00943683|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65640420|NCT00943683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640421|NCT03542006|Brinzolamide|brinzolamide|mesh-list
65640422|NCT03542006|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65640423|NCT03542006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640424|NCT03542006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640425|NCT02154464|Acetaminophen|acetaminophen|mesh-list
65640426|NCT02154464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65640427|NCT02154464|Analgesics|analgesics|mesh-ancestor
65640428|NCT02154464|Sensory System Agents|sensory system agents|mesh-ancestor
65640429|NCT02154464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640430|NCT02154464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640431|NCT02154464|Antipyretics|antipyretics|mesh-ancestor
65640432|NCT00911547|Beclomethasone|beclomethasone|mesh-list
65640433|NCT00911547|Montelukast|montelukast|mesh-list
65640434|NCT00911547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65640435|NCT00911547|Respiratory System Agents|respiratory system agents|mesh-ancestor
65640436|NCT00911547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65640437|NCT00911547|Hormone Antagonists|hormone antagonists|mesh-ancestor
65640438|NCT00911547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65640439|NCT00911547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640440|NCT00911547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65640441|NCT00911547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65640442|NCT00911547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640443|NCT00911547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65640444|NCT00911547|Glucocorticoids|glucocorticoids|mesh-ancestor
65640445|NCT00911547|Hormones|hormones|mesh-ancestor
65640446|NCT02159690|Prednisone|prednisone|mesh-list
65640447|NCT02159690|Abiraterone Acetate|abiraterone acetate|mesh-list
65640448|NCT02159690|Dutasteride|dutasteride|mesh-list
65640449|NCT02159690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65640450|NCT02159690|Glucocorticoids|glucocorticoids|mesh-ancestor
65640451|NCT02159690|Hormones|hormones|mesh-ancestor
65640452|NCT02159690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65640453|NCT02159690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640454|NCT02159690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65640455|NCT02159690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640456|NCT02159690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65640458|NCT02159690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640459|NCT02159690|Hormone Antagonists|hormone antagonists|mesh-ancestor
65640460|NCT02159690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65640461|NCT02159690|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65640462|NCT02157818|Midazolam|midazolam|mesh-list
65640463|NCT02157818|Dexmedetomidine|dexmedetomidine|mesh-list
65640464|NCT02157818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65640465|NCT02157818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65640466|NCT02157818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640467|NCT02157818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65640468|NCT02157818|Analgesics|analgesics|mesh-ancestor
65640469|NCT02157818|Sensory System Agents|sensory system agents|mesh-ancestor
65640470|NCT02157818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640471|NCT02157818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65640472|NCT02157818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65640473|NCT02157818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65640474|NCT02157818|Adrenergic Agents|adrenergic agents|mesh-ancestor
65640475|NCT02157818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65640476|NCT02157818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640477|NCT02157818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65640478|NCT02157818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65640479|NCT02157818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65640480|NCT02157818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65640481|NCT02157818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65640482|NCT02157818|Anesthetics, General|anesthetics, general|mesh-ancestor
65640483|NCT02157818|Anesthetics|anesthetics|mesh-ancestor
65640484|NCT02157818|GABA Modulators|gaba modulators|mesh-ancestor
65640485|NCT02157818|GABA Agents|gaba agents|mesh-ancestor
65640486|NCT00899379|Rizatriptan|rizatriptan|mesh-list
65640487|NCT00899379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65640488|NCT00899379|Serotonin Agents|serotonin agents|mesh-ancestor
65640489|NCT00899379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65640490|NCT00899379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640491|NCT00899379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640492|NCT04326439|Cytarabine|cytarabine|mesh-list
65640493|NCT04326439|Etoposide|etoposide|mesh-list
65640494|NCT04326439|Daunorubicin|daunorubicin|mesh-list
65640495|NCT04326439|Sorafenib|sorafenib|mesh-list
65640496|NCT04326439|Asparaginase|asparaginase|mesh-list
65640497|NCT04326439|Gemtuzumab|gemtuzumab|mesh-list
65640498|NCT04326439|Calicheamicins|calicheamicins|mesh-list
65640499|NCT04326439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65640500|NCT04326439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640501|NCT04326439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65640502|NCT04326439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65640503|NCT04326439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640504|NCT04326439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640505|NCT04326439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65640506|NCT04326439|Antimetabolites|antimetabolites|mesh-ancestor
65640507|NCT04326439|Antiviral Agents|antiviral agents|mesh-ancestor
65640508|NCT04326439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65640509|NCT04326439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65640510|NCT04326439|Immunologic Factors|immunologic factors|mesh-ancestor
65640511|NCT04326439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640512|NCT04326439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65640513|NCT04326439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65640514|NCT04326439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65640515|NCT03541928|Valacyclovir|valacyclovir|mesh-list
65640516|NCT03541928|Leuprolide|leuprolide|mesh-list
65640517|NCT03541928|Bicalutamide|bicalutamide|mesh-list
65640518|NCT03541928|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65640519|NCT03541928|Fertility Agents|fertility agents|mesh-ancestor
65640520|NCT03541928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65640521|NCT03541928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640522|NCT03541928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65267426|NCT02758340|Misoprostol|misoprostol|mesh-list
65640523|NCT03541928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640524|NCT03541928|Androgen Antagonists|androgen antagonists|mesh-ancestor
65640525|NCT03541928|Hormone Antagonists|hormone antagonists|mesh-ancestor
65640526|NCT03541928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65640527|NCT03541928|Antiviral Agents|antiviral agents|mesh-ancestor
65640528|NCT03541928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65640529|NCT00145795|Ritonavir|ritonavir|mesh-list
65640530|NCT00145795|Lopinavir|lopinavir|mesh-list
65640531|NCT00145795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65640532|NCT00145795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65640533|NCT00145795|Protease Inhibitors|protease inhibitors|mesh-ancestor
65640534|NCT00145795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640535|NCT00145795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640536|NCT00145795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65640537|NCT00145795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65640538|NCT00145795|Antiviral Agents|antiviral agents|mesh-ancestor
65640539|NCT00145795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65640540|NCT00145795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65640541|NCT00145795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65640542|NCT02771210|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65640543|NCT02771210|Immunologic Factors|immunologic factors|mesh-ancestor
65640544|NCT02771210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640545|NCT00898677|Sumatriptan|sumatriptan|mesh-list
65640546|NCT00898677|Rizatriptan|rizatriptan|mesh-list
65640547|NCT00898677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65640548|NCT00898677|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65640549|NCT00898677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65640550|NCT00898677|Serotonin Agents|serotonin agents|mesh-ancestor
65640551|NCT00898677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65640552|NCT00898677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640553|NCT00898677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640554|NCT01381393|Ibandronic Acid|ibandronic acid|mesh-list
65640555|NCT01381393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65640556|NCT01381393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640557|NCT02154776|Letrozole|letrozole|mesh-list
65640558|NCT02154776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640559|NCT02154776|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65640560|NCT02154776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65640561|NCT02154776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640562|NCT02154776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640563|NCT02154776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65640564|NCT02154776|Hormone Antagonists|hormone antagonists|mesh-ancestor
65640565|NCT02154776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65640566|NCT02154776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640567|NCT04967157|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
65640568|NCT04967157|Nootropic Agents|nootropic agents|mesh-ancestor
65640569|NCT03388749|Annamycin|annamycin|mesh-list
65640570|NCT03388749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65640571|NCT03388749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640572|NCT02770820|Aldesleukin|aldesleukin|mesh-list
65640573|NCT02770820|Interleukin-2|interleukin-2|mesh-list
65640574|NCT02770820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640575|NCT02770820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65640576|NCT02770820|Analgesics|analgesics|mesh-ancestor
65640577|NCT02770820|Sensory System Agents|sensory system agents|mesh-ancestor
65640578|NCT02770820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640579|NCT02770820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640580|NCT02770820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65640581|NCT02770820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65640582|NCT02770820|Antiviral Agents|antiviral agents|mesh-ancestor
65640583|NCT02770820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65640584|NCT02154854|Tacrolimus|tacrolimus|mesh-list
65640585|NCT02154854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65640586|NCT02154854|Immunologic Factors|immunologic factors|mesh-ancestor
65640587|NCT02154854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640588|NCT02154854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65640589|NCT02154854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640590|NCT02154854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640591|NCT03330405|Avelumab|avelumab|mesh-list
65640592|NCT03330405|Talazoparib|talazoparib|mesh-list
65640593|NCT03330405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65640594|NCT03330405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65640595|NCT03330405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640596|NCT03330405|Immunologic Factors|immunologic factors|mesh-ancestor
65640597|NCT03330405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640598|NCT03330405|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65640599|NCT03330405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640600|NCT03330405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640601|NCT02160080|Interferons|interferons|mesh-list
65640602|NCT02160080|Ribavirin|ribavirin|mesh-list
65640603|NCT02160080|Interferon-alpha|interferon-alpha|mesh-list
65640604|NCT02160080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640605|NCT02160080|Antiviral Agents|antiviral agents|mesh-ancestor
65640606|NCT02160080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65640607|NCT02160080|Antimetabolites|antimetabolites|mesh-ancestor
65640608|NCT02160080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640609|NCT02160080|Immunologic Factors|immunologic factors|mesh-ancestor
65640610|NCT02160080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640612|NCT05422183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640613|NCT05422183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65640614|NCT05422183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640615|NCT05422183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640616|NCT02160158|Fesoterodine|fesoterodine|mesh-list
65640617|NCT02160158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65640618|NCT02160158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65640619|NCT02160158|Cholinergic Agents|cholinergic agents|mesh-ancestor
65640620|NCT02160158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65640621|NCT02160158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640622|NCT02160158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640623|NCT02160158|Urological Agents|urological agents|mesh-ancestor
65640624|NCT03283761|Leucovorin|leucovorin|mesh-list
65640625|NCT03283761|Paclitaxel|paclitaxel|mesh-list
65640626|NCT03283761|Fluorouracil|fluorouracil|mesh-list
65640627|NCT03283761|Oxaliplatin|oxaliplatin|mesh-list
65640628|NCT03283761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65640629|NCT03283761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640630|NCT03283761|Tubulin Modulators|tubulin modulators|mesh-ancestor
65640631|NCT03283761|Antimitotic Agents|antimitotic agents|mesh-ancestor
65640632|NCT03283761|Mitosis Modulators|mitosis modulators|mesh-ancestor
65640633|NCT03283761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640634|NCT03283761|Antimetabolites|antimetabolites|mesh-ancestor
65640635|NCT03283761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65640636|NCT03283761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65640637|NCT03283761|Immunologic Factors|immunologic factors|mesh-ancestor
65640638|NCT03283761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640639|NCT03283761|Antidotes|antidotes|mesh-ancestor
65640640|NCT03283761|Protective Agents|protective agents|mesh-ancestor
65640641|NCT03283761|Vitamin B Complex|vitamin b complex|mesh-ancestor
65640642|NCT03283761|Vitamins|vitamins|mesh-ancestor
65640643|NCT03283761|Micronutrients|micronutrients|mesh-ancestor
65640644|NCT02160236|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65640645|NCT02160236|Tenoxicam|tenoxicam|mesh-list
65640646|NCT02160236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65640647|NCT02160236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65640648|NCT02160236|Analgesics|analgesics|mesh-ancestor
65640649|NCT02160236|Sensory System Agents|sensory system agents|mesh-ancestor
65640650|NCT02160236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640651|NCT02160236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640652|NCT02160236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65640653|NCT02160236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65640654|NCT02160236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65640655|NCT02160236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640656|NCT02160236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640657|NCT02154932|Misoprostol|misoprostol|mesh-list
65640658|NCT02154932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65640659|NCT02154932|Abortifacient Agents|abortifacient agents|mesh-ancestor
65640660|NCT02154932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65640661|NCT02154932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640662|NCT02154932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65640663|NCT02154932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65640664|NCT02154932|Oxytocics|oxytocics|mesh-ancestor
65640665|NCT02158286|Acetaminophen|acetaminophen|mesh-list
65640666|NCT02158286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65640667|NCT02158286|Analgesics|analgesics|mesh-ancestor
65640668|NCT02158286|Sensory System Agents|sensory system agents|mesh-ancestor
65640669|NCT02158286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640670|NCT02158286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640671|NCT02158286|Antipyretics|antipyretics|mesh-ancestor
65640672|NCT01377415|Bupivacaine|bupivacaine|mesh-list
65640673|NCT01377415|Anesthetics, Local|anesthetics, local|mesh-ancestor
65640674|NCT01377415|Anesthetics|anesthetics|mesh-ancestor
65640675|NCT01377415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65640676|NCT01377415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437981|NCT00127036|Growth Substances|growth substances|mesh-ancestor
65640677|NCT01377415|Sensory System Agents|sensory system agents|mesh-ancestor
65640678|NCT01377415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640679|NCT02155088|Gemcitabine|gemcitabine|mesh-list
65640680|NCT02155088|Paclitaxel|paclitaxel|mesh-list
65640681|NCT02155088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65640682|NCT02155088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640683|NCT02155088|Tubulin Modulators|tubulin modulators|mesh-ancestor
65640684|NCT02155088|Antimitotic Agents|antimitotic agents|mesh-ancestor
65640685|NCT02155088|Mitosis Modulators|mitosis modulators|mesh-ancestor
65640686|NCT02155088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640687|NCT02155088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65640688|NCT02155088|Antimetabolites|antimetabolites|mesh-ancestor
65640689|NCT02155088|Antiviral Agents|antiviral agents|mesh-ancestor
65640690|NCT02155088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65640691|NCT02155088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640692|NCT02155088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65640693|NCT02155088|Immunologic Factors|immunologic factors|mesh-ancestor
65640694|NCT02155088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640695|NCT02160548|Atropine|atropine|mesh-list
65640696|NCT02160548|Albuterol|albuterol|mesh-list
65640697|NCT02160548|Pralidoxime|pralidoxime|mesh-list
65640698|NCT02160548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65640699|NCT02160548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65640700|NCT02160548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65640701|NCT02160548|Autonomic Agents|autonomic agents|mesh-ancestor
65640702|NCT02160548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640703|NCT02160548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640704|NCT02160548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65640705|NCT02160548|Respiratory System Agents|respiratory system agents|mesh-ancestor
65640706|NCT02160548|Mydriatics|mydriatics|mesh-ancestor
65640707|NCT02160548|Parasympatholytics|parasympatholytics|mesh-ancestor
65640708|NCT02160548|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65640709|NCT02160548|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65640710|NCT02160548|Cholinergic Agents|cholinergic agents|mesh-ancestor
65640711|NCT02160548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65640712|NCT02160548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640713|NCT02160548|Tocolytic Agents|tocolytic agents|mesh-ancestor
65640714|NCT02160548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65640715|NCT02160548|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65640716|NCT02160548|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65640717|NCT02160548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65640718|NCT02160548|Adrenergic Agents|adrenergic agents|mesh-ancestor
65640719|NCT02160548|Antidotes|antidotes|mesh-ancestor
65640720|NCT02160548|Protective Agents|protective agents|mesh-ancestor
65640721|NCT02160548|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
65640722|NCT02160548|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
65640723|NCT02158598|Vitamin D|vitamin d|mesh-list
65640724|NCT02158598|Ergocalciferols|ergocalciferols|mesh-list
65640725|NCT02158598|Cholecalciferol|cholecalciferol|mesh-list
65640726|NCT02158598|Vitamins|vitamins|mesh-list
65640727|NCT02158598|Micronutrients|micronutrients|mesh-ancestor
65640728|NCT02158598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640729|NCT02158598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65640730|NCT02158598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65640731|NCT03082729|Apremilast|apremilast|mesh-list
65640732|NCT03082729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65640733|NCT03082729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65640734|NCT03082729|Analgesics|analgesics|mesh-ancestor
65640735|NCT03082729|Sensory System Agents|sensory system agents|mesh-ancestor
65640736|NCT03082729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640737|NCT03082729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640738|NCT03082729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65640739|NCT03082729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65640740|NCT03082729|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65640741|NCT03082729|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65640742|NCT03082729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640743|NCT03082729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640744|NCT02160704|Enclomiphene|enclomiphene|mesh-list
65640745|NCT02160704|Clomiphene|clomiphene|mesh-list
65640746|NCT02160704|Zuclomiphene|zuclomiphene|mesh-list
65640747|NCT02160704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65640748|NCT02160704|Hormone Antagonists|hormone antagonists|mesh-ancestor
65640749|NCT02160704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65640750|NCT02160704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640751|NCT02160704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65640752|NCT02160704|Fertility Agents|fertility agents|mesh-ancestor
65640753|NCT02160704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65640754|NCT02160704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65640755|NCT02160704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65640756|NCT03542552|Magnesium Sulfate|magnesium sulfate|mesh-list
65640758|NCT03542552|Analgesics|analgesics|mesh-ancestor
65640759|NCT03542552|Sensory System Agents|sensory system agents|mesh-ancestor
65640760|NCT03542552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640761|NCT03542552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640762|NCT03542552|Anesthetics|anesthetics|mesh-ancestor
65640763|NCT03542552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65640764|NCT03542552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65640765|NCT03542552|Anticonvulsants|anticonvulsants|mesh-ancestor
65640766|NCT03542552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65640767|NCT03542552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65640768|NCT03542552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640769|NCT03542552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65640770|NCT03542552|Tocolytic Agents|tocolytic agents|mesh-ancestor
65640771|NCT03542552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65640772|NCT03542552|Vasodilator Agents|vasodilator agents|mesh-ancestor
65640773|NCT02155166|Ibuprofen|ibuprofen|mesh-list
65640774|NCT02155166|Lidocaine|lidocaine|mesh-list
65640775|NCT02155166|Anesthetics, Local|anesthetics, local|mesh-ancestor
65640776|NCT02155166|Anesthetics|anesthetics|mesh-ancestor
65640777|NCT02155166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65640778|NCT02155166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640779|NCT02155166|Sensory System Agents|sensory system agents|mesh-ancestor
65640780|NCT02155166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640781|NCT02155166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65640782|NCT02155166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65640783|NCT02155166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65640784|NCT02155166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65640785|NCT02155166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640786|NCT02155166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65640787|NCT02155166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65640788|NCT02155166|Analgesics|analgesics|mesh-ancestor
65640789|NCT02155166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65640790|NCT02155166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65640791|NCT02155166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65640792|NCT02155166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640793|NCT00398931|Alendronate|alendronate|mesh-list
65640794|NCT00398931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640795|NCT00398931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65640796|NCT00920361|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65640797|NCT00920361|Hormones|hormones|mesh-ancestor
65640798|NCT00920361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65640799|NCT00920361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640800|NCT00651807|Etonogestrel|etonogestrel|mesh-list
65640801|NCT00651807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65640802|NCT00651807|Contraceptive Agents|contraceptive agents|mesh-ancestor
65640803|NCT00651807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65640804|NCT00651807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640805|NCT00651807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65640806|NCT03246529|Lenograstim|lenograstim|mesh-list
65640807|NCT03246529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65640808|NCT03246529|Immunologic Factors|immunologic factors|mesh-ancestor
65640809|NCT03246529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640810|NCT02158910|Donepezil|donepezil|mesh-list
65640811|NCT02158910|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65640812|NCT02158910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640813|NCT02158910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640814|NCT02158910|Cholinergic Agents|cholinergic agents|mesh-ancestor
65640815|NCT02158910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65640816|NCT02158910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640817|NCT02158910|Nootropic Agents|nootropic agents|mesh-ancestor
65640818|NCT03077659|Paclitaxel|paclitaxel|mesh-list
65640819|NCT03077659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65640820|NCT03077659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640821|NCT03077659|Tubulin Modulators|tubulin modulators|mesh-ancestor
65640822|NCT03077659|Antimitotic Agents|antimitotic agents|mesh-ancestor
65640823|NCT03077659|Mitosis Modulators|mitosis modulators|mesh-ancestor
65640824|NCT03077659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640825|NCT05052723|Pembrolizumab|pembrolizumab|mesh-list
65640826|NCT05052723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65640827|NCT05052723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640828|NCT02807883|Blinatumomab|blinatumomab|mesh-list
65640829|NCT02807883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640830|NCT05563155|Dexamethasone|dexamethasone|mesh-list
65640831|NCT05563155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65640832|NCT05563155|Antiemetics|antiemetics|mesh-ancestor
65640833|NCT05563155|Autonomic Agents|autonomic agents|mesh-ancestor
65640834|NCT05563155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640835|NCT05563155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640836|NCT05563155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65640837|NCT05563155|Glucocorticoids|glucocorticoids|mesh-ancestor
65640838|NCT05563155|Hormones|hormones|mesh-ancestor
65640839|NCT05563155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65640840|NCT05563155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65640841|NCT05563155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640842|NCT04051047|Gemcitabine|gemcitabine|mesh-list
65640843|NCT04051047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65640844|NCT04051047|Antimetabolites|antimetabolites|mesh-ancestor
65640845|NCT04051047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640846|NCT04051047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640847|NCT04051047|Antiviral Agents|antiviral agents|mesh-ancestor
65640848|NCT04051047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65640849|NCT04051047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640850|NCT04051047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65640851|NCT04051047|Immunologic Factors|immunologic factors|mesh-ancestor
65640852|NCT04051047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640853|NCT00102440|Allopurinol|allopurinol|mesh-list
65640854|NCT00102440|Febuxostat|febuxostat|mesh-list
65640855|NCT00102440|Antimetabolites|antimetabolites|mesh-ancestor
65640856|NCT00102440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640857|NCT00102440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640858|NCT00102440|Gout Suppressants|gout suppressants|mesh-ancestor
65640859|NCT00102440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65640860|NCT00102440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65640861|NCT00102440|Antioxidants|antioxidants|mesh-ancestor
65640862|NCT00102440|Protective Agents|protective agents|mesh-ancestor
65640863|NCT00102440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640864|NCT03113617|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
65640865|NCT03113617|Bombesin|bombesin|mesh-list
65640866|NCT03113617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640867|NCT03113617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65640868|NCT03113617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640869|NCT03113617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65640870|NCT05224167|Melatonin|melatonin|mesh-list
65640871|NCT05224167|Hydroxyzine|hydroxyzine|mesh-list
65640872|NCT05224167|Antioxidants|antioxidants|mesh-ancestor
65640873|NCT05224167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640874|NCT05224167|Protective Agents|protective agents|mesh-ancestor
65640875|NCT05224167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640876|NCT05224167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65640877|NCT05224167|Antipruritics|antipruritics|mesh-ancestor
65640878|NCT05224167|Dermatologic Agents|dermatologic agents|mesh-ancestor
65640879|NCT05224167|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65640880|NCT05224167|Histamine Antagonists|histamine antagonists|mesh-ancestor
65640881|NCT05224167|Histamine Agents|histamine agents|mesh-ancestor
65640882|NCT05224167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65640883|NCT01377259|Anesthetics|anesthetics|mesh-list
65640884|NCT01377259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65640885|NCT01377259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640886|NCT02884219|Ibuprofen|ibuprofen|mesh-list
65640887|NCT02884219|Indomethacin|indomethacin|mesh-list
65640888|NCT02884219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
65640889|NCT02884219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65640890|NCT02884219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65640891|NCT02884219|Analgesics|analgesics|mesh-ancestor
65640892|NCT02884219|Sensory System Agents|sensory system agents|mesh-ancestor
65640893|NCT02884219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640894|NCT02884219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640895|NCT02884219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65640896|NCT02884219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65640897|NCT02884219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640898|NCT02884219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640899|NCT02884219|Gout Suppressants|gout suppressants|mesh-ancestor
65640900|NCT02884219|Tocolytic Agents|tocolytic agents|mesh-ancestor
65640901|NCT02884219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65640902|NCT04994535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65640903|NCT04994535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65640904|NCT04994535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65640905|NCT04994535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640906|NCT04994535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640907|NCT04994535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65640908|NCT04994535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65640909|NCT04994535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640910|NCT04994535|Cholinergic Agents|cholinergic agents|mesh-ancestor
65640911|NCT04994535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65640912|NCT03909607|Ketamine|ketamine|mesh-list
65640913|NCT03909607|Analgesics|analgesics|mesh-ancestor
65640914|NCT03909607|Sensory System Agents|sensory system agents|mesh-ancestor
65640915|NCT03909607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640916|NCT03909607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640917|NCT03909607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65640918|NCT03909607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65640919|NCT03909607|Anesthetics, General|anesthetics, general|mesh-ancestor
65640920|NCT03909607|Anesthetics|anesthetics|mesh-ancestor
65640921|NCT03909607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65640922|NCT03909607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65640923|NCT03909607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65640924|NCT03909607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65640925|NCT03909607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640926|NCT03902509|Pirfenidone|pirfenidone|mesh-list
65640927|NCT03902509|Analgesics|analgesics|mesh-ancestor
65640928|NCT03902509|Sensory System Agents|sensory system agents|mesh-ancestor
65640929|NCT03902509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640930|NCT03902509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640931|NCT03902509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65640932|NCT03902509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65640933|NCT03902509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65640934|NCT03902509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65640935|NCT03902509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640936|NCT04935177|Antibodies|antibodies|mesh-list
65640937|NCT04935177|Immunoglobulins|immunoglobulins|mesh-list
65640938|NCT04935177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65640939|NCT04935177|gamma-Globulins|gamma-globulins|mesh-list
65640940|NCT04935177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65640941|NCT04935177|Eculizumab|eculizumab|mesh-list
65640942|NCT04935177|Immunologic Factors|immunologic factors|mesh-ancestor
65640943|NCT04935177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640944|NCT04935177|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65640945|NCT04935177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65640946|NCT02166632|Bupivacaine|bupivacaine|mesh-list
65640947|NCT02166632|Anesthetics, Local|anesthetics, local|mesh-ancestor
65640948|NCT02166632|Anesthetics|anesthetics|mesh-ancestor
65640949|NCT02166632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65640950|NCT02166632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640951|NCT02166632|Sensory System Agents|sensory system agents|mesh-ancestor
65640952|NCT02166632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640953|NCT02161952|Pirfenidone|pirfenidone|mesh-list
65640954|NCT02161952|Analgesics|analgesics|mesh-ancestor
65640955|NCT02161952|Sensory System Agents|sensory system agents|mesh-ancestor
65640956|NCT02161952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640957|NCT02161952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640958|NCT02161952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65640959|NCT02161952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65640960|NCT02161952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65640961|NCT02161952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65640962|NCT02161952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640963|NCT04993677|Carboplatin|carboplatin|mesh-list
65640964|NCT04993677|Pembrolizumab|pembrolizumab|mesh-list
65640965|NCT04993677|Pemetrexed|pemetrexed|mesh-list
65640966|NCT04993677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640967|NCT04993677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65640968|NCT04993677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65640969|NCT04993677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65640970|NCT04993677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65640971|NCT04993677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65640972|NCT05047731|Antihypertensive Agents|antihypertensive agents|mesh-list
65640973|NCT04795869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65640974|NCT04795869|Pembrolizumab|pembrolizumab|mesh-list
65640975|NCT04795869|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65640976|NCT04795869|Antibodies|antibodies|mesh-list
65640977|NCT04795869|Immunoglobulins|immunoglobulins|mesh-list
65640978|NCT04795869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65640979|NCT04795869|Immunoconjugates|immunoconjugates|mesh-list
65640980|NCT04795869|Immunologic Factors|immunologic factors|mesh-ancestor
65640981|NCT04795869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640982|NCT04795869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65640983|NCT04050735|Ethanol|ethanol|mesh-list
65640984|NCT04050735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65640985|NCT04050735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65640986|NCT04050735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65640987|NCT04050735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640988|NCT04784559|Remdesivir|remdesivir|mesh-list
65640989|NCT04784559|Favipiravir|favipiravir|mesh-list
65640990|NCT04784559|Dexamethasone|dexamethasone|mesh-list
65640991|NCT04784559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65640992|NCT04784559|Antiemetics|antiemetics|mesh-ancestor
65640993|NCT04784559|Autonomic Agents|autonomic agents|mesh-ancestor
65640994|NCT04784559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65640995|NCT04784559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65640996|NCT04784559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65640997|NCT04784559|Glucocorticoids|glucocorticoids|mesh-ancestor
65640998|NCT04784559|Hormones|hormones|mesh-ancestor
65640999|NCT04784559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65641000|NCT04784559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65641001|NCT04784559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641002|NCT04784559|Antimetabolites|antimetabolites|mesh-ancestor
65641003|NCT04784559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641004|NCT04784559|Antiviral Agents|antiviral agents|mesh-ancestor
65641005|NCT04784559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65641006|NCT03704181|Colchicine|colchicine|mesh-list
65641007|NCT03704181|Gout Suppressants|gout suppressants|mesh-ancestor
65641008|NCT03704181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65641009|NCT03704181|Tubulin Modulators|tubulin modulators|mesh-ancestor
65641010|NCT03704181|Antimitotic Agents|antimitotic agents|mesh-ancestor
65641011|NCT03704181|Mitosis Modulators|mitosis modulators|mesh-ancestor
65641012|NCT03704181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641013|NCT03704181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641014|NCT03625011|Gabapentin|gabapentin|mesh-list
65641015|NCT03625011|Analgesics|analgesics|mesh-ancestor
65641016|NCT03625011|Sensory System Agents|sensory system agents|mesh-ancestor
65641017|NCT03625011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641018|NCT03625011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641019|NCT03625011|Anticonvulsants|anticonvulsants|mesh-ancestor
65641020|NCT03625011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65641021|NCT03625011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65641022|NCT03625011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65641023|NCT03625011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65641024|NCT03625011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65641025|NCT03625011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65641026|NCT03625011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65641027|NCT03625011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267450|NCT04701476|Pembrolizumab|pembrolizumab|mesh-list
65641028|NCT03625011|Antimanic Agents|antimanic agents|mesh-ancestor
65641029|NCT03625167|Petrolatum|petrolatum|mesh-list
65641030|NCT03625167|Emollients|emollients|mesh-ancestor
65641031|NCT03625167|Dermatologic Agents|dermatologic agents|mesh-ancestor
65641032|NCT04576455|Fulvestrant|fulvestrant|mesh-list
65641033|NCT04576455|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65641034|NCT04576455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65641035|NCT04576455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641036|NCT04576455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65641037|NCT04576455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65641038|NCT04576455|Hormone Antagonists|hormone antagonists|mesh-ancestor
65641039|NCT04576455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65641040|NCT04576455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641041|NCT04576455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65641042|NCT04576455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641043|NCT04576455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641044|NCT04892277|Cyclophosphamide|cyclophosphamide|mesh-list
65641045|NCT04892277|Fludarabine|fludarabine|mesh-list
65641046|NCT04892277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65641047|NCT04892277|Immunologic Factors|immunologic factors|mesh-ancestor
65641048|NCT04892277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641049|NCT04892277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65641050|NCT04892277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65641051|NCT04892277|Alkylating Agents|alkylating agents|mesh-ancestor
65641052|NCT04892277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641053|NCT04892277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641054|NCT04892277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65641055|NCT04718727|Olanzapine|olanzapine|mesh-list
65641056|NCT04718727|Antiemetics|antiemetics|mesh-ancestor
65641057|NCT04718727|Autonomic Agents|autonomic agents|mesh-ancestor
65641058|NCT04718727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641059|NCT04718727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641060|NCT04718727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65641061|NCT04718727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65641062|NCT04718727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65641063|NCT04718727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65641064|NCT04718727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65641065|NCT04718727|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65641066|NCT04718727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65641067|NCT04718727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65641068|NCT04718727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641069|NCT04718727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65641070|NCT04718727|Serotonin Agents|serotonin agents|mesh-ancestor
65641071|NCT03701529|Anesthetics|anesthetics|mesh-list
65641072|NCT03701529|Propofol|propofol|mesh-list
65641073|NCT03701529|Sevoflurane|sevoflurane|mesh-list
65641074|NCT03701529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65641075|NCT03701529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641076|NCT03701529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65641077|NCT03701529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65641078|NCT03701529|Anesthetics, General|anesthetics, general|mesh-ancestor
65641079|NCT03701529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65641080|NCT03701529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65641081|NCT04535271|Gemcitabine|gemcitabine|mesh-list
65641082|NCT04535271|Dacarbazine|dacarbazine|mesh-list
65641083|NCT04535271|Trabectedin|trabectedin|mesh-list
65641084|NCT04535271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65641085|NCT04535271|Antimetabolites|antimetabolites|mesh-ancestor
65641086|NCT04535271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641087|NCT04535271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641088|NCT04535271|Antiviral Agents|antiviral agents|mesh-ancestor
65641089|NCT04535271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65641090|NCT04535271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641091|NCT04535271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65641092|NCT04535271|Immunologic Factors|immunologic factors|mesh-ancestor
65641093|NCT04535271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641094|NCT04535271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65641095|NCT04535271|Alkylating Agents|alkylating agents|mesh-ancestor
65641096|NCT04553133|Letrozole|letrozole|mesh-list
65641097|NCT04553133|Fulvestrant|fulvestrant|mesh-list
65641098|NCT04553133|Palbociclib|palbociclib|mesh-list
65641099|NCT04553133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641100|NCT04553133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65641101|NCT04553133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65641102|NCT04553133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641103|NCT04553133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641104|NCT04553133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65641105|NCT04553133|Hormone Antagonists|hormone antagonists|mesh-ancestor
65641106|NCT04553133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65641107|NCT04553133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641108|NCT04553133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65641109|NCT04553133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65641110|NCT04553133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65641111|NCT03701451|Decitabine|decitabine|mesh-list
65641112|NCT03701451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65641113|NCT03701451|Antimetabolites|antimetabolites|mesh-ancestor
65641114|NCT03701451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641115|NCT03701451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641116|NCT03701451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641117|NCT03703089|Gemcitabine|gemcitabine|mesh-list
65641118|NCT03703089|Paclitaxel|paclitaxel|mesh-list
65641119|NCT03703089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65641120|NCT03703089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641121|NCT03703089|Tubulin Modulators|tubulin modulators|mesh-ancestor
65641122|NCT03703089|Antimitotic Agents|antimitotic agents|mesh-ancestor
65641123|NCT03703089|Mitosis Modulators|mitosis modulators|mesh-ancestor
65641124|NCT03703089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641125|NCT03703089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65641126|NCT03703089|Antimetabolites|antimetabolites|mesh-ancestor
65641127|NCT03703089|Antiviral Agents|antiviral agents|mesh-ancestor
65641128|NCT03703089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65641129|NCT03703089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641130|NCT03703089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65641131|NCT03703089|Immunologic Factors|immunologic factors|mesh-ancestor
65641132|NCT03703089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641133|NCT02807844|Spartalizumab|spartalizumab|mesh-list
65641134|NCT02807844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65641135|NCT02807844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641136|NCT02807844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641137|NCT02763566|Letrozole|letrozole|mesh-list
65641138|NCT02763566|Fulvestrant|fulvestrant|mesh-list
65641139|NCT02763566|Anastrozole|anastrozole|mesh-list
65641140|NCT02763566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641141|NCT02763566|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65641142|NCT02763566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65641143|NCT02763566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641144|NCT02763566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641145|NCT02763566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65641146|NCT02763566|Hormone Antagonists|hormone antagonists|mesh-ancestor
65641147|NCT02763566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65641148|NCT02763566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641149|NCT02763566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65641150|NCT02763566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65641151|NCT03702855|Tetrabenazine|tetrabenazine|mesh-list
65641152|NCT03702855|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65641153|NCT03702855|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65641154|NCT03702855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65641155|NCT03702855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641156|NCT03702855|Adrenergic Agents|adrenergic agents|mesh-ancestor
65641157|NCT03702855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65641158|NCT03702855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641159|NCT02052180|Bupivacaine|bupivacaine|mesh-list
65641160|NCT02052180|Anesthetics, Local|anesthetics, local|mesh-ancestor
65641161|NCT02052180|Anesthetics|anesthetics|mesh-ancestor
65641162|NCT02052180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65641163|NCT02052180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641164|NCT02052180|Sensory System Agents|sensory system agents|mesh-ancestor
65641165|NCT02052180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641166|NCT03561402|Teriflunomide|teriflunomide|mesh-list
65641167|NCT03561402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65641168|NCT03561402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65641169|NCT03561402|Analgesics|analgesics|mesh-ancestor
65641170|NCT03561402|Sensory System Agents|sensory system agents|mesh-ancestor
65641171|NCT03561402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641172|NCT03561402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641173|NCT03561402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65641174|NCT03561402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65641175|NCT03561402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65641176|NCT03561402|Immunologic Factors|immunologic factors|mesh-ancestor
65641177|NCT04542135|Sulindac|sulindac|mesh-list
65641178|NCT04542135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65641179|NCT04542135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65641180|NCT04542135|Analgesics|analgesics|mesh-ancestor
65641181|NCT04542135|Sensory System Agents|sensory system agents|mesh-ancestor
65641182|NCT04542135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641183|NCT04542135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641184|NCT04542135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65641185|NCT04542135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65641186|NCT04542135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641187|NCT04542135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65641188|NCT04542135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641189|NCT04542135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641190|NCT04694781|Pembrolizumab|pembrolizumab|mesh-list
65641191|NCT04694781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65641192|NCT04694781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641193|NCT02805972|Naloxone|naloxone|mesh-list
65641194|NCT02805972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65641195|NCT02805972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641196|NCT02805972|Sensory System Agents|sensory system agents|mesh-ancestor
65641197|NCT02805972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641198|NCT03702621|Bupivacaine|bupivacaine|mesh-list
65641199|NCT03702621|Anesthetics, Local|anesthetics, local|mesh-ancestor
65641200|NCT03702621|Anesthetics|anesthetics|mesh-ancestor
65641201|NCT03702621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65641202|NCT03702621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641203|NCT03702621|Sensory System Agents|sensory system agents|mesh-ancestor
65641204|NCT03702621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641205|NCT02052258|Oxytocin|oxytocin|mesh-list
65641206|NCT02052258|Oxytocics|oxytocics|mesh-ancestor
65641207|NCT02052258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65641208|NCT02052258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641209|NCT02053818|Sufentanil|sufentanil|mesh-list
65641210|NCT02053818|Remifentanil|remifentanil|mesh-list
65641211|NCT02053818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65641212|NCT02053818|Narcotics|narcotics|mesh-ancestor
65641213|NCT02053818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65641214|NCT02053818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641215|NCT02053818|Analgesics|analgesics|mesh-ancestor
65641216|NCT02053818|Sensory System Agents|sensory system agents|mesh-ancestor
65641217|NCT02053818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641218|NCT02053818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65641219|NCT02053818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65641220|NCT02053818|Anesthetics, General|anesthetics, general|mesh-ancestor
65641221|NCT02053818|Anesthetics|anesthetics|mesh-ancestor
65641222|NCT03702387|Anesthetics|anesthetics|mesh-list
65641223|NCT03702387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65641224|NCT03702387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641225|NCT03031899|Tolonium Chloride|tolonium chloride|mesh-list
65641226|NCT03031899|Hemostatics|hemostatics|mesh-ancestor
65641227|NCT03031899|Coagulants|coagulants|mesh-ancestor
65641228|NCT03031899|Heparin Antagonists|heparin antagonists|mesh-ancestor
65641229|NCT03031899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641230|NCT03700905|Nivolumab|nivolumab|mesh-list
65641231|NCT03700905|Ipilimumab|ipilimumab|mesh-list
65641232|NCT03700905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65641233|NCT03700905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641234|NCT03700905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65641235|NCT03700905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641236|NCT03700749|Iodine|iodine|mesh-list
65641237|NCT03700749|Chlorhexidine|chlorhexidine|mesh-list
65641238|NCT03700749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65641239|NCT03700749|Cadexomer iodine|cadexomer iodine|mesh-list
65641240|NCT03700749|Povidone-Iodine|povidone-iodine|mesh-list
65641241|NCT03700749|Povidone|povidone|mesh-list
65641242|NCT03700749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65641243|NCT03700749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65641244|NCT03700749|Disinfectants|disinfectants|mesh-ancestor
65641245|NCT03700749|Dermatologic Agents|dermatologic agents|mesh-ancestor
65267475|NCT05343546|Levonorgestrel|levonorgestrel|mesh-list
65641246|NCT03700749|Trace Elements|trace elements|mesh-ancestor
65641247|NCT03700749|Micronutrients|micronutrients|mesh-ancestor
65641248|NCT03700749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641249|NCT03700749|Plasma Substitutes|plasma substitutes|mesh-ancestor
65641250|NCT03700749|Blood Substitutes|blood substitutes|mesh-ancestor
65641251|NCT03086369|Gemcitabine|gemcitabine|mesh-list
65641252|NCT03086369|Paclitaxel|paclitaxel|mesh-list
65641253|NCT03086369|Olaratumab|olaratumab|mesh-list
65641254|NCT03086369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65641255|NCT03086369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641256|NCT03086369|Tubulin Modulators|tubulin modulators|mesh-ancestor
65641257|NCT03086369|Antimitotic Agents|antimitotic agents|mesh-ancestor
65641258|NCT03086369|Mitosis Modulators|mitosis modulators|mesh-ancestor
65641259|NCT03086369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641260|NCT03086369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65641261|NCT03086369|Antimetabolites|antimetabolites|mesh-ancestor
65641262|NCT03086369|Antiviral Agents|antiviral agents|mesh-ancestor
65641263|NCT03086369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65641264|NCT03086369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641265|NCT03086369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65641266|NCT03086369|Immunologic Factors|immunologic factors|mesh-ancestor
65641267|NCT03086369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641268|NCT00101582|Cisplatin|cisplatin|mesh-list
65641269|NCT00101582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641270|NCT05326373|Fluorides|fluorides|mesh-list
65641271|NCT05326373|Tin Fluorides|tin fluorides|mesh-list
65641272|NCT05326373|Cariostatic Agents|cariostatic agents|mesh-ancestor
65641273|NCT05326373|Protective Agents|protective agents|mesh-ancestor
65641274|NCT05326373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641275|NCT02166944|Tamoxifen|tamoxifen|mesh-list
65641276|NCT02166944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65641277|NCT02166944|Hormone Antagonists|hormone antagonists|mesh-ancestor
65641278|NCT02166944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65641279|NCT02166944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438590|NCT01044992|Levodopa|levodopa|mesh-list
65641280|NCT02166944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65641281|NCT02166944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641282|NCT02166944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65641283|NCT02166944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65641284|NCT02166944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65641285|NCT04665843|Atezolizumab|atezolizumab|mesh-list
65641286|NCT04665843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641287|NCT03540836|Cortisone|cortisone|mesh-list
65641288|NCT03540836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65641289|NCT03198351|Teriflunomide|teriflunomide|mesh-list
65641290|NCT03198351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65641291|NCT03198351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65641292|NCT03198351|Analgesics|analgesics|mesh-ancestor
65641293|NCT03198351|Sensory System Agents|sensory system agents|mesh-ancestor
65641294|NCT03198351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641295|NCT03198351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641296|NCT03198351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65641297|NCT03198351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65641298|NCT03198351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65641299|NCT03198351|Immunologic Factors|immunologic factors|mesh-ancestor
65641300|NCT04211675|Irinotecan|irinotecan|mesh-list
65641301|NCT04211675|Temozolomide|temozolomide|mesh-list
65641302|NCT04211675|Dinutuximab|dinutuximab|mesh-list
65641303|NCT04211675|Sargramostim|sargramostim|mesh-list
65641304|NCT04211675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65641305|NCT04211675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65641306|NCT04211675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641307|NCT04211675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641308|NCT04211675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641309|NCT04211675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65641310|NCT04211675|Alkylating Agents|alkylating agents|mesh-ancestor
65641311|NCT04211675|Immunologic Factors|immunologic factors|mesh-ancestor
65641312|NCT04211675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641313|NCT02162264|Donepezil|donepezil|mesh-list
65641314|NCT02162264|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65641315|NCT02162264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641316|NCT02162264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641317|NCT02162264|Cholinergic Agents|cholinergic agents|mesh-ancestor
65641318|NCT02162264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65641319|NCT02162264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641320|NCT02162264|Nootropic Agents|nootropic agents|mesh-ancestor
65641321|NCT03700515|Epoetin Alfa|epoetin alfa|mesh-list
65641322|NCT03700515|Hematinics|hematinics|mesh-ancestor
65641323|NCT04740008|Nicotine|nicotine|mesh-list
65641324|NCT04740008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65641325|NCT04740008|Autonomic Agents|autonomic agents|mesh-ancestor
65641326|NCT04740008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641327|NCT04740008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641328|NCT04740008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65641329|NCT04740008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65641330|NCT04740008|Cholinergic Agents|cholinergic agents|mesh-ancestor
65641331|NCT04740008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65641332|NCT04740008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641333|NCT03700359|Etoposide|etoposide|mesh-list
65641334|NCT03700359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65641335|NCT03700359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641336|NCT03700359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65641337|NCT03700359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65641338|NCT03700359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641339|NCT03700359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641340|NCT02167178|Polygeline|polygeline|mesh-list
65641341|NCT02167178|Plasma Substitutes|plasma substitutes|mesh-ancestor
65641342|NCT02167178|Blood Substitutes|blood substitutes|mesh-ancestor
65641343|NCT03625089|Atorvastatin|atorvastatin|mesh-list
65641344|NCT03625089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65641345|NCT03625089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65641346|NCT03625089|Antimetabolites|antimetabolites|mesh-ancestor
65641347|NCT03625089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641348|NCT03625089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65641349|NCT03625089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65641350|NCT03625089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641351|NCT01378949|Morphine|morphine|mesh-list
65641352|NCT01378949|Bupivacaine|bupivacaine|mesh-list
65641353|NCT01378949|Anesthetics, Local|anesthetics, local|mesh-ancestor
65641354|NCT01378949|Anesthetics|anesthetics|mesh-ancestor
65641355|NCT01378949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65641356|NCT01378949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641357|NCT01378949|Sensory System Agents|sensory system agents|mesh-ancestor
65641358|NCT01378949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641359|NCT01378949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65641360|NCT01378949|Narcotics|narcotics|mesh-ancestor
65641361|NCT01378949|Analgesics|analgesics|mesh-ancestor
65641362|NCT01381055|Pentoxifylline|pentoxifylline|mesh-list
65641363|NCT01381055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65641364|NCT01381055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641365|NCT01381055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641366|NCT01381055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65641367|NCT01381055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65641368|NCT01381055|Protective Agents|protective agents|mesh-ancestor
65641369|NCT01381055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641370|NCT01381055|Vasodilator Agents|vasodilator agents|mesh-ancestor
65641371|NCT01381055|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65641372|NCT01381055|Antioxidants|antioxidants|mesh-ancestor
65641374|NCT04649229|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65641375|NCT04649229|Antiemetics|antiemetics|mesh-ancestor
65641376|NCT04649229|Autonomic Agents|autonomic agents|mesh-ancestor
65641377|NCT04649229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641378|NCT04649229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641379|NCT04649229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65641380|NCT04649229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65641381|NCT04649229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65641382|NCT04649229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641383|NCT04649229|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65641384|NCT03122613|Curcumin|curcumin|mesh-list
65641385|NCT03122613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65641386|NCT03122613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65641387|NCT03122613|Analgesics|analgesics|mesh-ancestor
65641388|NCT03122613|Sensory System Agents|sensory system agents|mesh-ancestor
65641389|NCT03122613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641390|NCT03122613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641391|NCT03122613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65641392|NCT03122613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65641393|NCT03122613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641394|NCT03122613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641395|NCT03122613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641396|NCT03540368|Tranexamic Acid|tranexamic acid|mesh-list
65641397|NCT03540368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65641398|NCT03540368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65641399|NCT03540368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641400|NCT03540368|Hemostatics|hemostatics|mesh-ancestor
65641401|NCT03540368|Coagulants|coagulants|mesh-ancestor
65641402|NCT04631601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65641403|NCT04631601|Androgens|androgens|mesh-list
65641404|NCT04631601|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
65641405|NCT04631601|Hormones|hormones|mesh-ancestor
65641406|NCT04631601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65641407|NCT04631601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641408|NCT04631601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641409|NCT04631601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641410|NCT04631601|Androgen Antagonists|androgen antagonists|mesh-ancestor
65641411|NCT04631601|Hormone Antagonists|hormone antagonists|mesh-ancestor
65641412|NCT02255396|Estradiol|estradiol|mesh-list
65641413|NCT02255396|Estrogens|estrogens|mesh-ancestor
65641414|NCT02255396|Hormones|hormones|mesh-ancestor
65641415|NCT02255396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65641416|NCT02255396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641417|NCT02163980|Dexmedetomidine|dexmedetomidine|mesh-list
65641418|NCT02163980|Ropivacaine|ropivacaine|mesh-list
65641419|NCT02163980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65641420|NCT02163980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65641421|NCT02163980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641422|NCT02163980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65641423|NCT02163980|Analgesics|analgesics|mesh-ancestor
65641424|NCT02163980|Sensory System Agents|sensory system agents|mesh-ancestor
65641425|NCT02163980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641426|NCT02163980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65641427|NCT02163980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65641428|NCT02163980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65641429|NCT02163980|Adrenergic Agents|adrenergic agents|mesh-ancestor
65641430|NCT02163980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65641431|NCT02163980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641432|NCT02163980|Anesthetics, Local|anesthetics, local|mesh-ancestor
65641434|NCT02162888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65641435|NCT02162888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65641436|NCT02162888|Alkylating Agents|alkylating agents|mesh-ancestor
65641437|NCT02162888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641438|NCT02162888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641439|NCT01569035|Warfarin|warfarin|mesh-list
65641440|NCT01569035|Anticoagulants|anticoagulants|mesh-ancestor
65641441|NCT03841565|Dexamethasone|dexamethasone|mesh-list
65641442|NCT03841565|Dexamethasone acetate|dexamethasone acetate|mesh-list
65641443|NCT03841565|Daratumumab|daratumumab|mesh-list
65641444|NCT03841565|Pomalidomide|pomalidomide|mesh-list
65641445|NCT03841565|Ichthammol|ichthammol|mesh-list
65641446|NCT03841565|BB 1101|bb 1101|mesh-list
65641447|NCT03841565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65641448|NCT03841565|Antiemetics|antiemetics|mesh-ancestor
65641449|NCT03841565|Autonomic Agents|autonomic agents|mesh-ancestor
65641450|NCT03841565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641451|NCT03841565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641452|NCT03841565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65641453|NCT03841565|Glucocorticoids|glucocorticoids|mesh-ancestor
65641454|NCT03841565|Hormones|hormones|mesh-ancestor
65641455|NCT03841565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65641456|NCT03841565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65641457|NCT03841565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641458|NCT03841565|Protease Inhibitors|protease inhibitors|mesh-ancestor
65641459|NCT03841565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641460|NCT03841565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641461|NCT03841565|Immunologic Factors|immunologic factors|mesh-ancestor
65641462|NCT03841565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65641463|NCT03841565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65641464|NCT03841565|Growth Substances|growth substances|mesh-ancestor
65641465|NCT03841565|Growth Inhibitors|growth inhibitors|mesh-ancestor
65641466|NCT03841565|Dermatologic Agents|dermatologic agents|mesh-ancestor
65641467|NCT02162966|Colistin|colistin|mesh-list
65641468|NCT02162966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65641469|NCT02162966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65641470|NCT01595321|Leucovorin|leucovorin|mesh-list
65641471|NCT01595321|Cyclophosphamide|cyclophosphamide|mesh-list
65641472|NCT01595321|Fluorouracil|fluorouracil|mesh-list
65641473|NCT01595321|Oxaliplatin|oxaliplatin|mesh-list
65641474|NCT01595321|Irinotecan|irinotecan|mesh-list
65641475|NCT01595321|Folfirinox|folfirinox|mesh-list
65641476|NCT01595321|Vaccines|vaccines|mesh-list
65641477|NCT01595321|Immunologic Factors|immunologic factors|mesh-ancestor
65641478|NCT01595321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641479|NCT01595321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65641480|NCT01595321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65641481|NCT01595321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65641482|NCT01595321|Alkylating Agents|alkylating agents|mesh-ancestor
65641483|NCT01595321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641484|NCT01595321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641485|NCT01595321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65641486|NCT01595321|Antimetabolites|antimetabolites|mesh-ancestor
65641487|NCT01595321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65641488|NCT01595321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65641489|NCT01595321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65641490|NCT01595321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641491|NCT01595321|Antidotes|antidotes|mesh-ancestor
65641492|NCT01595321|Protective Agents|protective agents|mesh-ancestor
65641493|NCT01595321|Vitamin B Complex|vitamin b complex|mesh-ancestor
65641494|NCT01595321|Vitamins|vitamins|mesh-ancestor
65641495|NCT01595321|Micronutrients|micronutrients|mesh-ancestor
65641496|NCT02164214|Etanercept|etanercept|mesh-list
65641497|NCT02164214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65641498|NCT02164214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65641499|NCT02164214|Analgesics|analgesics|mesh-ancestor
65641500|NCT02164214|Sensory System Agents|sensory system agents|mesh-ancestor
65641501|NCT02164214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641502|NCT02164214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438820|NCT00345540|Carboplatin|carboplatin|mesh-list
65641503|NCT02164214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65641504|NCT02164214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65641505|NCT02164214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65641506|NCT02164214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65641507|NCT02164214|Immunologic Factors|immunologic factors|mesh-ancestor
65641508|NCT03722849|Adenosine|adenosine|mesh-list
65641509|NCT03722849|Capsaicin|capsaicin|mesh-list
65641510|NCT03722849|Antipruritics|antipruritics|mesh-ancestor
65641511|NCT03722849|Dermatologic Agents|dermatologic agents|mesh-ancestor
65641512|NCT03722849|Sensory System Agents|sensory system agents|mesh-ancestor
65641513|NCT03722849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641514|NCT03722849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641515|NCT03722849|Analgesics|analgesics|mesh-ancestor
65641516|NCT03722849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65641517|NCT03722849|Vasodilator Agents|vasodilator agents|mesh-ancestor
65641518|NCT03722849|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65641519|NCT03722849|Purinergic Agonists|purinergic agonists|mesh-ancestor
65641520|NCT03722849|Purinergic Agents|purinergic agents|mesh-ancestor
65641521|NCT03722849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65641522|NCT03722849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641523|NCT02170844|Dabigatran|dabigatran|mesh-list
65641524|NCT02170844|Antithrombins|antithrombins|mesh-ancestor
65641525|NCT02170844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65641526|NCT02170844|Protease Inhibitors|protease inhibitors|mesh-ancestor
65641527|NCT02170844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641528|NCT02170844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641529|NCT02170844|Anticoagulants|anticoagulants|mesh-ancestor
65641530|NCT02170922|Dabigatran|dabigatran|mesh-list
65641531|NCT02170922|Antithrombins|antithrombins|mesh-ancestor
65641532|NCT02170922|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65641533|NCT02170922|Protease Inhibitors|protease inhibitors|mesh-ancestor
65641534|NCT02170922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641535|NCT02170922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641536|NCT02170922|Anticoagulants|anticoagulants|mesh-ancestor
65641537|NCT02167958|Cyclophosphamide|cyclophosphamide|mesh-list
65641538|NCT02167958|Fludarabine|fludarabine|mesh-list
65641539|NCT02167958|Tacrolimus|tacrolimus|mesh-list
65641540|NCT02167958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65641541|NCT02167958|Immunologic Factors|immunologic factors|mesh-ancestor
65641542|NCT02167958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641543|NCT02167958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65641544|NCT02167958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65641545|NCT02167958|Alkylating Agents|alkylating agents|mesh-ancestor
65641546|NCT02167958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641547|NCT02167958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641548|NCT02167958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65641549|NCT02167958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65641550|NCT02167958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641551|NCT01384331|NuvaRing|nuvaring|mesh-list
65641552|NCT01384331|Desogestrel|desogestrel|mesh-list
65641553|NCT01384331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65641554|NCT01384331|Contraceptive Agents|contraceptive agents|mesh-ancestor
65641555|NCT01384331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65641556|NCT01384331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641557|NCT01384331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65641558|NCT01384331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65641559|NCT01384331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65641560|NCT01384331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65641561|NCT01384331|Progestins|progestins|mesh-ancestor
65641562|NCT01384331|Hormones|hormones|mesh-ancestor
65641563|NCT01384331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65641564|NCT03699423|Atropine|atropine|mesh-list
65641565|NCT03699423|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65641566|NCT03699423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65641567|NCT03699423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65641568|NCT03699423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65641569|NCT03699423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65641570|NCT03699423|Autonomic Agents|autonomic agents|mesh-ancestor
65641571|NCT03699423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641572|NCT03699423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641573|NCT03699423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65641574|NCT03699423|Respiratory System Agents|respiratory system agents|mesh-ancestor
65641575|NCT03699423|Mydriatics|mydriatics|mesh-ancestor
65641576|NCT03699423|Parasympatholytics|parasympatholytics|mesh-ancestor
65641577|NCT03699423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65641578|NCT03699423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65641579|NCT03699423|Cholinergic Agents|cholinergic agents|mesh-ancestor
65641580|NCT03699423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65641581|NCT03699423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641583|NCT02164448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65641584|NCT02164448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65641585|NCT02164448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641586|NCT02164448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65641587|NCT02164448|Analgesics|analgesics|mesh-ancestor
65641588|NCT02164448|Sensory System Agents|sensory system agents|mesh-ancestor
65641589|NCT02164448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641590|NCT02164448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65641591|NCT02164448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65641592|NCT02164448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65641593|NCT02164448|Adrenergic Agents|adrenergic agents|mesh-ancestor
65641594|NCT02164448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65641595|NCT02164448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641596|NCT03612713|Oxycodone|oxycodone|mesh-list
65641597|NCT03612713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65641598|NCT03612713|Narcotics|narcotics|mesh-ancestor
65641599|NCT03612713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65641600|NCT03612713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641601|NCT03612713|Analgesics|analgesics|mesh-ancestor
65641602|NCT03612713|Sensory System Agents|sensory system agents|mesh-ancestor
65641603|NCT03612713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641604|NCT01380509|Metronidazole|metronidazole|mesh-list
65641605|NCT01380509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65641606|NCT01380509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65641607|NCT01380509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65641608|NCT01380509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65641609|NCT01378715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65641610|NCT01378715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65641611|NCT01378715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65641612|NCT01378715|Antimetabolites|antimetabolites|mesh-ancestor
65641613|NCT01378715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641614|NCT01378715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65641615|NCT01378715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65641616|NCT01378715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641617|NCT04853043|Cetuximab|cetuximab|mesh-list
65641618|NCT04853043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65641619|NCT04853043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641620|NCT00976131|Ubiquinone|ubiquinone|mesh-list
65641621|NCT00976131|Coenzyme Q10|coenzyme q10|mesh-list
65641622|NCT00976131|Cyclophosphamide|cyclophosphamide|mesh-list
65641623|NCT00976131|Doxorubicin|doxorubicin|mesh-list
65641624|NCT00976131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65641625|NCT00976131|Immunologic Factors|immunologic factors|mesh-ancestor
65641626|NCT00976131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641627|NCT00976131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65641628|NCT00976131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65641629|NCT00976131|Alkylating Agents|alkylating agents|mesh-ancestor
65641630|NCT00976131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641631|NCT00976131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641632|NCT00976131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65641633|NCT00976131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65641634|NCT00976131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65641635|NCT00976131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65641636|NCT00976131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641637|NCT00976131|Micronutrients|micronutrients|mesh-ancestor
65641638|NCT00976131|Vitamins|vitamins|mesh-ancestor
65641639|NCT01384253|Trastuzumab|trastuzumab|mesh-list
65641640|NCT01384253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65641641|NCT01384253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641642|NCT03631277|Calcium|calcium|mesh-list
65641643|NCT03631277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65641644|NCT03631277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641645|NCT02171000|Dabigatran|dabigatran|mesh-list
65641646|NCT02171000|Antithrombins|antithrombins|mesh-ancestor
65641647|NCT02171000|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65641648|NCT02171000|Protease Inhibitors|protease inhibitors|mesh-ancestor
65641649|NCT02171000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641650|NCT02171000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641651|NCT02171000|Anticoagulants|anticoagulants|mesh-ancestor
65641652|NCT04841265|Vitamin D|vitamin d|mesh-list
65641653|NCT04841265|Cholecalciferol|cholecalciferol|mesh-list
65641654|NCT04841265|Vitamins|vitamins|mesh-ancestor
65641655|NCT04841265|Micronutrients|micronutrients|mesh-ancestor
65641656|NCT04841265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438974|NCT02531451|Aspirin|aspirin|mesh-list
65641657|NCT04841265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65641658|NCT04841265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65641659|NCT02164604|Ranibizumab|ranibizumab|mesh-list
65641660|NCT02164604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65641661|NCT02164604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65641662|NCT02164604|Growth Substances|growth substances|mesh-ancestor
65641663|NCT02164604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641664|NCT02164604|Growth Inhibitors|growth inhibitors|mesh-ancestor
65641665|NCT02164604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641666|NCT04380831|Cyclophosphamide|cyclophosphamide|mesh-list
65641667|NCT04380831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65641668|NCT04380831|Immunologic Factors|immunologic factors|mesh-ancestor
65641669|NCT04380831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641670|NCT04380831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65641671|NCT04380831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65641672|NCT04380831|Alkylating Agents|alkylating agents|mesh-ancestor
65641673|NCT04380831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641674|NCT04380831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641675|NCT04380831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65641676|NCT04571645|Heparin|heparin|mesh-list
65641677|NCT04571645|Anticoagulants|anticoagulants|mesh-ancestor
65641678|NCT04571645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65641679|NCT04571645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65641680|NCT04571645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641681|NCT04050267|Nitrous Oxide|nitrous oxide|mesh-list
65641682|NCT04050267|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65641683|NCT04050267|Anesthetics, General|anesthetics, general|mesh-ancestor
65641684|NCT04050267|Anesthetics|anesthetics|mesh-ancestor
65641685|NCT04050267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65641686|NCT04050267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641687|NCT04050267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65641688|NCT04050267|Analgesics|analgesics|mesh-ancestor
65641689|NCT04050267|Sensory System Agents|sensory system agents|mesh-ancestor
65641690|NCT04050267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641691|NCT02759120|Doxycycline|doxycycline|mesh-list
65641692|NCT02759120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65641693|NCT02759120|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65641694|NCT02759120|Anti-Infective Agents|anti-infective agents|mesh-list
65641695|NCT02759120|Antimalarials|antimalarials|mesh-ancestor
65641696|NCT02759120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65641697|NCT02759120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65641698|NCT02759120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65641699|NCT02759120|Renal Agents|renal agents|mesh-ancestor
65641700|NCT01569113|Levonorgestrel|levonorgestrel|mesh-list
65641701|NCT01569113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65641702|NCT01569113|Ulipristal acetate|ulipristal acetate|mesh-list
65641703|NCT01569113|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65641704|NCT01569113|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
65641705|NCT01569113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65641706|NCT01569113|Contraceptive Agents|contraceptive agents|mesh-ancestor
65641707|NCT01569113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65641708|NCT01569113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641709|NCT01569113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65641710|NCT01569113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65641711|NCT01569113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65641712|NCT01569113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65641713|NCT01569113|Estrogens|estrogens|mesh-ancestor
65641714|NCT01569113|Hormones|hormones|mesh-ancestor
65641715|NCT01569113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65641716|NCT01569113|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65641717|NCT01569113|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
65641718|NCT01569113|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65641719|NCT01569113|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65641720|NCT03699033|Paclitaxel|paclitaxel|mesh-list
65641721|NCT03699033|Carboplatin|carboplatin|mesh-list
65641722|NCT03699033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65641723|NCT03699033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641724|NCT03699033|Tubulin Modulators|tubulin modulators|mesh-ancestor
65641725|NCT03699033|Antimitotic Agents|antimitotic agents|mesh-ancestor
65641726|NCT03699033|Mitosis Modulators|mitosis modulators|mesh-ancestor
65641727|NCT03699033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641728|NCT03697239|Ascorbic Acid|ascorbic acid|mesh-list
65641729|NCT03697239|Gemcitabine|gemcitabine|mesh-list
65641730|NCT03697239|Paclitaxel|paclitaxel|mesh-list
65641731|NCT03697239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65641732|NCT03697239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65641733|NCT03697239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641734|NCT03697239|Tubulin Modulators|tubulin modulators|mesh-ancestor
65641735|NCT03697239|Antimitotic Agents|antimitotic agents|mesh-ancestor
65641736|NCT03697239|Mitosis Modulators|mitosis modulators|mesh-ancestor
65641737|NCT03697239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641738|NCT03697239|Vitamins|vitamins|mesh-ancestor
65641739|NCT03697239|Micronutrients|micronutrients|mesh-ancestor
65641740|NCT03697239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641741|NCT03697239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65641742|NCT03697239|Antimetabolites|antimetabolites|mesh-ancestor
65641743|NCT03697239|Antiviral Agents|antiviral agents|mesh-ancestor
65641744|NCT03697239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65641745|NCT03697239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641746|NCT03697239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65641747|NCT03697239|Immunologic Factors|immunologic factors|mesh-ancestor
65641748|NCT03697239|Antioxidants|antioxidants|mesh-ancestor
65641749|NCT03697239|Protective Agents|protective agents|mesh-ancestor
65641750|NCT01380431|Lisinopril|lisinopril|mesh-list
65641751|NCT01380431|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65641752|NCT01380431|Protease Inhibitors|protease inhibitors|mesh-ancestor
65641753|NCT01380431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641754|NCT01380431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641755|NCT01380431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65641756|NCT01380431|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65641757|NCT01380431|Protective Agents|protective agents|mesh-ancestor
65641758|NCT01380431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641759|NCT03697161|Gaboxadol|gaboxadol|mesh-list
65641760|NCT03697161|Analgesics|analgesics|mesh-ancestor
65641761|NCT03697161|Sensory System Agents|sensory system agents|mesh-ancestor
65641762|NCT03697161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641763|NCT03697161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641764|NCT03697161|Anticonvulsants|anticonvulsants|mesh-ancestor
65641765|NCT03697161|GABA Agonists|gaba agonists|mesh-ancestor
65641766|NCT03697161|GABA Agents|gaba agents|mesh-ancestor
65641767|NCT03697161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65641768|NCT03697161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641769|NCT03164993|Cyclophosphamide|cyclophosphamide|mesh-list
65641770|NCT03164993|Doxorubicin|doxorubicin|mesh-list
65641771|NCT03164993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65641772|NCT03164993|Atezolizumab|atezolizumab|mesh-list
65641773|NCT03164993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65641774|NCT03164993|Immunologic Factors|immunologic factors|mesh-ancestor
65641775|NCT03164993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641776|NCT03164993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65641777|NCT03164993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65641778|NCT03164993|Alkylating Agents|alkylating agents|mesh-ancestor
65641779|NCT03164993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641780|NCT03164993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641781|NCT03164993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65641782|NCT03164993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65641783|NCT03164993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65641784|NCT03164993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65641785|NCT03164993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641786|NCT02171156|Nintedanib|nintedanib|mesh-list
65641787|NCT02171156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641788|NCT02171156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65641789|NCT02171156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641790|NCT02171156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641791|NCT01380353|Diclofenac|diclofenac|mesh-list
65641792|NCT01380353|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
65641793|NCT01380353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65641794|NCT01380353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65641795|NCT01380353|Analgesics|analgesics|mesh-ancestor
65641796|NCT01380353|Sensory System Agents|sensory system agents|mesh-ancestor
65641797|NCT01380353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641798|NCT01380353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641799|NCT01380353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65641800|NCT01380353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65641801|NCT01380353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65641802|NCT01380353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641803|NCT01380353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641804|NCT02168426|Hyaluronic Acid|hyaluronic acid|mesh-list
65439119|NCT03677141|Doxorubicin|doxorubicin|mesh-list
65641805|NCT02168426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65641806|NCT02168426|Immunologic Factors|immunologic factors|mesh-ancestor
65641807|NCT02168426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641808|NCT02168426|Viscosupplements|viscosupplements|mesh-ancestor
65641809|NCT02168426|Protective Agents|protective agents|mesh-ancestor
65641810|NCT01380275|Docetaxel|docetaxel|mesh-list
65641811|NCT01380275|Irinotecan|irinotecan|mesh-list
65641812|NCT01380275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641813|NCT01380275|Tubulin Modulators|tubulin modulators|mesh-ancestor
65641814|NCT01380275|Antimitotic Agents|antimitotic agents|mesh-ancestor
65641815|NCT01380275|Mitosis Modulators|mitosis modulators|mesh-ancestor
65641816|NCT01380275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641817|NCT01380275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65641818|NCT01380275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65641819|NCT01380275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641820|NCT02171390|Methyltestosterone|methyltestosterone|mesh-list
65641821|NCT02171390|Testosterone|testosterone|mesh-list
65641822|NCT02171390|Testosterone undecanoate|testosterone undecanoate|mesh-list
65641823|NCT02171390|Testosterone enanthate|testosterone enanthate|mesh-list
65641824|NCT02171390|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65641825|NCT02171390|Androgens|androgens|mesh-ancestor
65641826|NCT02171390|Hormones|hormones|mesh-ancestor
65641827|NCT02171390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65641828|NCT02171390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641829|NCT02171390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65641830|NCT02171390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641831|NCT02171390|Anabolic Agents|anabolic agents|mesh-ancestor
65641832|NCT01378481|Vorinostat|vorinostat|mesh-list
65641833|NCT01378481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641834|NCT01378481|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65641835|NCT01378481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641836|NCT01378481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641837|NCT02171468|Dabigatran|dabigatran|mesh-list
65641838|NCT02171468|Antithrombins|antithrombins|mesh-ancestor
65641839|NCT02171468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65641840|NCT02171468|Protease Inhibitors|protease inhibitors|mesh-ancestor
65641841|NCT02171468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641842|NCT02171468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641843|NCT02171468|Anticoagulants|anticoagulants|mesh-ancestor
65641844|NCT03502031|Losartan|losartan|mesh-list
65641845|NCT03502031|Valsartan|valsartan|mesh-list
65641846|NCT03502031|Enalapril|enalapril|mesh-list
65641847|NCT03502031|Enalaprilat|enalaprilat|mesh-list
65641848|NCT03502031|Lisinopril|lisinopril|mesh-list
65641849|NCT03502031|Perindopril|perindopril|mesh-list
65641850|NCT03502031|Spironolactone|spironolactone|mesh-list
65641851|NCT03502031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65641852|NCT03502031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65641853|NCT03502031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65641854|NCT03502031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641855|NCT03502031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65641856|NCT03502031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65641857|NCT03502031|Hormone Antagonists|hormone antagonists|mesh-ancestor
65641858|NCT03502031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65641859|NCT03502031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641860|NCT03502031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65641861|NCT03502031|Diuretics|diuretics|mesh-ancestor
65641862|NCT03502031|Natriuretic Agents|natriuretic agents|mesh-ancestor
65641863|NCT03502031|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65641864|NCT03502031|Protease Inhibitors|protease inhibitors|mesh-ancestor
65641865|NCT03502031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641866|NCT03502031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65641867|NCT03502031|Protective Agents|protective agents|mesh-ancestor
65641868|NCT02171546|Fexofenadine|fexofenadine|mesh-list
65641869|NCT02171546|Quinidine|quinidine|mesh-list
65641870|NCT02171546|Quinidine gluconate|quinidine gluconate|mesh-list
65641871|NCT02171546|Dabigatran|dabigatran|mesh-list
65641872|NCT02171546|Antithrombins|antithrombins|mesh-ancestor
65641873|NCT02171546|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65641874|NCT02171546|Protease Inhibitors|protease inhibitors|mesh-ancestor
65641875|NCT02171546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641876|NCT02171546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641877|NCT02171546|Anticoagulants|anticoagulants|mesh-ancestor
65641878|NCT02171546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65641879|NCT02171546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65641880|NCT02171546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65641881|NCT02171546|Histamine Antagonists|histamine antagonists|mesh-ancestor
65641882|NCT02171546|Histamine Agents|histamine agents|mesh-ancestor
65641883|NCT02171546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65641884|NCT02171546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641885|NCT02171546|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65641886|NCT02171546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65641887|NCT02171546|Adrenergic Agents|adrenergic agents|mesh-ancestor
65641888|NCT02171546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65641889|NCT02171546|Antimalarials|antimalarials|mesh-ancestor
65641890|NCT02171546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65641891|NCT02171546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65641892|NCT02171546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65641893|NCT02171546|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65641894|NCT02171546|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65641895|NCT02171546|Cholinergic Agents|cholinergic agents|mesh-ancestor
65641896|NCT02171546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65641897|NCT02171546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65641898|NCT02171546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65641899|NCT02171546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65641900|NCT02171546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65641901|NCT02171624|Quinidine|quinidine|mesh-list
65641902|NCT02171624|Dabigatran|dabigatran|mesh-list
65641903|NCT02171624|Antithrombins|antithrombins|mesh-ancestor
65641904|NCT02171624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65641905|NCT02171624|Protease Inhibitors|protease inhibitors|mesh-ancestor
65641906|NCT02171624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641907|NCT02171624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641908|NCT02171624|Anticoagulants|anticoagulants|mesh-ancestor
65641909|NCT02171624|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65641910|NCT02171624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65641911|NCT02171624|Adrenergic Agents|adrenergic agents|mesh-ancestor
65641912|NCT02171624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65641913|NCT02171624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641914|NCT02171624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65641915|NCT02171624|Antimalarials|antimalarials|mesh-ancestor
65641916|NCT02171624|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65641917|NCT02171624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65641918|NCT02171624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65641919|NCT02171624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65641920|NCT02171624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65641921|NCT02171624|Cholinergic Agents|cholinergic agents|mesh-ancestor
65641922|NCT02171624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65641923|NCT02171624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65641924|NCT02171624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65641925|NCT02171624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65641926|NCT02171624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65641927|NCT03705351|Temozolomide|temozolomide|mesh-list
65641928|NCT03705351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65641929|NCT03705351|Alkylating Agents|alkylating agents|mesh-ancestor
65641930|NCT03705351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641931|NCT03705351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641932|NCT03705195|Gliclazide|gliclazide|mesh-list
65641933|NCT03705195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65641934|NCT03705195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641935|NCT00101192|Cetuximab|cetuximab|mesh-list
65641936|NCT00101192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641937|NCT00101192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65641938|NCT03688269|Dexamethasone|dexamethasone|mesh-list
65641939|NCT03688269|Ropivacaine|ropivacaine|mesh-list
65641940|NCT03688269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65641941|NCT03688269|Antiemetics|antiemetics|mesh-ancestor
65641942|NCT03688269|Autonomic Agents|autonomic agents|mesh-ancestor
65641943|NCT03688269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641944|NCT03688269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641945|NCT03688269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65641946|NCT03688269|Glucocorticoids|glucocorticoids|mesh-ancestor
65641947|NCT03688269|Hormones|hormones|mesh-ancestor
65641948|NCT03688269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65641949|NCT03688269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65641950|NCT03688269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641951|NCT03688269|Anesthetics, Local|anesthetics, local|mesh-ancestor
65641952|NCT03688269|Anesthetics|anesthetics|mesh-ancestor
65641953|NCT03688269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65641954|NCT03688269|Sensory System Agents|sensory system agents|mesh-ancestor
65641955|NCT03688191|Sirolimus|sirolimus|mesh-list
65641956|NCT03688191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65641957|NCT03688191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65641958|NCT03688191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65641959|NCT03688191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641960|NCT03688191|Antifungal Agents|antifungal agents|mesh-ancestor
65641961|NCT03688191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65641962|NCT03688191|Immunologic Factors|immunologic factors|mesh-ancestor
65641963|NCT03688191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641965|NCT02164838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641966|NCT02164838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65641967|NCT02164838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641968|NCT02164838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641969|NCT02171702|Afatinib|afatinib|mesh-list
65641970|NCT02171702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65641971|NCT02171702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65641972|NCT02171702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65641973|NCT02171702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65641974|NCT02171780|Olodaterol|olodaterol|mesh-list
65641975|NCT02171780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65641976|NCT02171780|Autonomic Agents|autonomic agents|mesh-ancestor
65641977|NCT02171780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641978|NCT02171780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641979|NCT02171780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65641980|NCT02171780|Respiratory System Agents|respiratory system agents|mesh-ancestor
65641981|NCT02172014|Fentanyl|fentanyl|mesh-list
65641982|NCT02172014|Midazolam|midazolam|mesh-list
65641983|NCT02172014|Citric Acid|citric acid|mesh-list
65641984|NCT02172014|Sodium Citrate|sodium citrate|mesh-list
65641985|NCT02172014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65641986|NCT02172014|Narcotics|narcotics|mesh-ancestor
65641987|NCT02172014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65641988|NCT02172014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65641989|NCT02172014|Analgesics|analgesics|mesh-ancestor
65641990|NCT02172014|Sensory System Agents|sensory system agents|mesh-ancestor
65641991|NCT02172014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65641992|NCT02172014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65641993|NCT02172014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65641994|NCT02172014|Anesthetics, General|anesthetics, general|mesh-ancestor
65641995|NCT02172014|Anesthetics|anesthetics|mesh-ancestor
65641996|NCT02172014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65641997|NCT02172014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65641998|NCT02172014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65641999|NCT02172014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65642000|NCT02172014|GABA Modulators|gaba modulators|mesh-ancestor
65642001|NCT02172014|GABA Agents|gaba agents|mesh-ancestor
65642002|NCT02172014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65642003|NCT02172014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642004|NCT02172014|Anticoagulants|anticoagulants|mesh-ancestor
65642005|NCT02172014|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65642006|NCT02172014|Chelating Agents|chelating agents|mesh-ancestor
65642007|NCT02172014|Sequestering Agents|sequestering agents|mesh-ancestor
65642008|NCT04627922|Acetylcysteine|acetylcysteine|mesh-list
65642009|NCT04627922|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65642010|NCT04627922|Antiviral Agents|antiviral agents|mesh-ancestor
65642011|NCT04627922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65642012|NCT04627922|Expectorants|expectorants|mesh-ancestor
65642013|NCT04627922|Respiratory System Agents|respiratory system agents|mesh-ancestor
65642014|NCT04627922|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65642015|NCT04627922|Antioxidants|antioxidants|mesh-ancestor
65642016|NCT04627922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642017|NCT04627922|Protective Agents|protective agents|mesh-ancestor
65642018|NCT04627922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642019|NCT04627922|Antidotes|antidotes|mesh-ancestor
65642020|NCT02172170|Empagliflozin|empagliflozin|mesh-list
65642021|NCT02172170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65642022|NCT02172170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642023|NCT02172170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65642024|NCT02172170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642025|NCT02255942|Zinc|zinc|mesh-list
65642026|NCT02255942|Iron|iron|mesh-list
65642027|NCT02255942|Zinc Sulfate|zinc sulfate|mesh-list
65642028|NCT02255942|Zinc Oxide|zinc oxide|mesh-list
65642029|NCT02255942|Trace Elements|trace elements|mesh-ancestor
65642030|NCT02255942|Micronutrients|micronutrients|mesh-ancestor
65642031|NCT02255942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642032|NCT02255942|Astringents|astringents|mesh-ancestor
65642033|NCT02255942|Dermatologic Agents|dermatologic agents|mesh-ancestor
65642034|NCT02255942|Sunscreening Agents|sunscreening agents|mesh-ancestor
65642035|NCT02255942|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65642037|NCT03029247|Epoetin Alfa|epoetin alfa|mesh-list
65642038|NCT03029247|Hematinics|hematinics|mesh-ancestor
65642039|NCT03696459|Moxifloxacin|moxifloxacin|mesh-list
65642040|NCT03696459|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65642041|NCT03696459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65642042|NCT03696459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65642043|NCT03696459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65642044|NCT03696459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65642045|NCT03696459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642046|NCT03696459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642047|NCT03696459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65642048|NCT03696459|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65642049|NCT03696459|Contraceptive Agents|contraceptive agents|mesh-ancestor
65642050|NCT03696459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65642051|NCT03696459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642052|NCT03696459|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65642053|NCT03696459|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65642054|NCT03696459|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65642055|NCT03624309|Docetaxel|docetaxel|mesh-list
65642056|NCT03624309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65642057|NCT03624309|Tubulin Modulators|tubulin modulators|mesh-ancestor
65642058|NCT03624309|Antimitotic Agents|antimitotic agents|mesh-ancestor
65642059|NCT03624309|Mitosis Modulators|mitosis modulators|mesh-ancestor
65642060|NCT03624309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642061|NCT04327791|Baloxavir|baloxavir|mesh-list
65642062|NCT04327791|Antiviral Agents|antiviral agents|mesh-ancestor
65642063|NCT04327791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65642064|NCT04327791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642065|NCT04327791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642066|NCT03624231|Durvalumab|durvalumab|mesh-list
65642067|NCT03624231|Tremelimumab|tremelimumab|mesh-list
65642068|NCT03624231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65642069|NCT03624231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65642070|NCT03692013|Losartan|losartan|mesh-list
65642071|NCT03692013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65642072|NCT03692013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65642073|NCT03692013|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65642074|NCT03692013|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65642075|NCT03692013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642076|NCT03695835|Sargramostim|sargramostim|mesh-list
65642077|NCT03695835|Immunologic Factors|immunologic factors|mesh-ancestor
65642078|NCT03695835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642079|NCT03687255|Tazobactam|tazobactam|mesh-list
65642080|NCT03687255|Piperacillin|piperacillin|mesh-list
65642081|NCT03687255|Cefepime|cefepime|mesh-list
65642082|NCT03687255|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65642083|NCT03687255|Enmetazobactam|enmetazobactam|mesh-list
65642084|NCT03687255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65642085|NCT03687255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65642086|NCT03687255|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65642087|NCT03687255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642088|NCT03687255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642089|NCT03691467|Hyaluronic Acid|hyaluronic acid|mesh-list
65642090|NCT03691467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65642091|NCT03691467|Immunologic Factors|immunologic factors|mesh-ancestor
65642092|NCT03691467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642093|NCT03691467|Viscosupplements|viscosupplements|mesh-ancestor
65642094|NCT03691467|Protective Agents|protective agents|mesh-ancestor
65642095|NCT02165774|Neurotransmitter Agents|neurotransmitter agents|mesh-list
65642096|NCT02165774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642097|NCT02165774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642098|NCT02165930|Naltrexone|naltrexone|mesh-list
65642099|NCT02165930|Oxycodone|oxycodone|mesh-list
65642100|NCT02165930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65642101|NCT02165930|Narcotics|narcotics|mesh-ancestor
65642102|NCT02165930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65642103|NCT02165930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642104|NCT02165930|Analgesics|analgesics|mesh-ancestor
65642105|NCT02165930|Sensory System Agents|sensory system agents|mesh-ancestor
65642106|NCT02165930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65642107|NCT02165930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65642108|NCT02165930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65642109|NCT03694977|Spartalizumab|spartalizumab|mesh-list
65642110|NCT03694977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65642111|NCT03694977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642112|NCT03694977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65642113|NCT02172248|Metformin|metformin|mesh-list
65642114|NCT02172248|Empagliflozin|empagliflozin|mesh-list
65642115|NCT02172248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65642116|NCT02172248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642117|NCT02172248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65642118|NCT02172248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642119|NCT02172326|Tiotropium Bromide|tiotropium bromide|mesh-list
65642120|NCT02172326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65642121|NCT02172326|Autonomic Agents|autonomic agents|mesh-ancestor
65642122|NCT02172326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65642123|NCT02172326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642124|NCT02172326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65642125|NCT02172326|Respiratory System Agents|respiratory system agents|mesh-ancestor
65642126|NCT02172326|Parasympatholytics|parasympatholytics|mesh-ancestor
65642127|NCT02172326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65642128|NCT02172326|Cholinergic Agents|cholinergic agents|mesh-ancestor
65642129|NCT02172326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65642130|NCT02172326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642131|NCT02169596|Ticagrelor|ticagrelor|mesh-list
65642132|NCT02169596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65642133|NCT02169596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65642134|NCT02169596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65642135|NCT02169596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65642136|NCT02169596|Purinergic Agents|purinergic agents|mesh-ancestor
65642137|NCT02169596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65642138|NCT02169596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642139|NCT02169596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642140|NCT03937635|Dexamethasone|dexamethasone|mesh-list
65642141|NCT03937635|Dexamethasone acetate|dexamethasone acetate|mesh-list
65642142|NCT03937635|Lenalidomide|lenalidomide|mesh-list
65642143|NCT03937635|Daratumumab|daratumumab|mesh-list
65642144|NCT03937635|Ichthammol|ichthammol|mesh-list
65642145|NCT03937635|BB 1101|bb 1101|mesh-list
65642146|NCT03937635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65642147|NCT03937635|Antiemetics|antiemetics|mesh-ancestor
65642148|NCT03937635|Autonomic Agents|autonomic agents|mesh-ancestor
65642149|NCT03937635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65642150|NCT03937635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642151|NCT03937635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65642152|NCT03937635|Glucocorticoids|glucocorticoids|mesh-ancestor
65642153|NCT03937635|Hormones|hormones|mesh-ancestor
65642154|NCT03937635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65642155|NCT03937635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65642156|NCT03937635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65642157|NCT03937635|Immunologic Factors|immunologic factors|mesh-ancestor
65642158|NCT03937635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65642159|NCT03937635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65642160|NCT03937635|Growth Substances|growth substances|mesh-ancestor
65642161|NCT03937635|Growth Inhibitors|growth inhibitors|mesh-ancestor
65642162|NCT03937635|Protease Inhibitors|protease inhibitors|mesh-ancestor
65642163|NCT03937635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642164|NCT03937635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642165|NCT03937635|Dermatologic Agents|dermatologic agents|mesh-ancestor
65642166|NCT02169752|Ambrisentan|ambrisentan|mesh-list
65642167|NCT02169752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65642168|NCT02172404|Ipratropium|ipratropium|mesh-list
65642169|NCT02172404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65642170|NCT02172404|Autonomic Agents|autonomic agents|mesh-ancestor
65642171|NCT02172404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65642172|NCT02172404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642173|NCT02172404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65642174|NCT02172404|Respiratory System Agents|respiratory system agents|mesh-ancestor
65642175|NCT02172404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65642176|NCT02172404|Cholinergic Agents|cholinergic agents|mesh-ancestor
65642177|NCT02172404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65642178|NCT02172404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642179|NCT00109538|Lonafarnib|lonafarnib|mesh-list
65642180|NCT00109538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642181|NCT00109538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642182|NCT02172482|Bromides|bromides|mesh-list
65642183|NCT02172482|Tiotropium Bromide|tiotropium bromide|mesh-list
65439516|NCT01060488|Hormones|hormones|mesh-ancestor
65642184|NCT02172482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65642185|NCT02172482|Autonomic Agents|autonomic agents|mesh-ancestor
65642186|NCT02172482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65642187|NCT02172482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642188|NCT02172482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65642189|NCT02172482|Respiratory System Agents|respiratory system agents|mesh-ancestor
65642190|NCT02172482|Parasympatholytics|parasympatholytics|mesh-ancestor
65642191|NCT02172482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65642192|NCT02172482|Cholinergic Agents|cholinergic agents|mesh-ancestor
65642193|NCT02172482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65642194|NCT02172482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642195|NCT02172482|Anticonvulsants|anticonvulsants|mesh-ancestor
65642196|NCT02172560|Tiotropium Bromide|tiotropium bromide|mesh-list
65642197|NCT02172560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65642198|NCT02172560|Autonomic Agents|autonomic agents|mesh-ancestor
65642199|NCT02172560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65642200|NCT02172560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642201|NCT02172560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65642202|NCT02172560|Respiratory System Agents|respiratory system agents|mesh-ancestor
65642203|NCT02172560|Parasympatholytics|parasympatholytics|mesh-ancestor
65642204|NCT02172560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65642205|NCT02172560|Cholinergic Agents|cholinergic agents|mesh-ancestor
65642206|NCT02172560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65642207|NCT02172560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642209|NCT00106808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65642210|NCT00106808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642211|NCT02166554|Hyaluronic Acid|hyaluronic acid|mesh-list
65642212|NCT02166554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65642213|NCT02166554|Immunologic Factors|immunologic factors|mesh-ancestor
65642214|NCT02166554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642215|NCT02166554|Viscosupplements|viscosupplements|mesh-ancestor
65642216|NCT02166554|Protective Agents|protective agents|mesh-ancestor
65642217|NCT02174666|Vitamin D|vitamin d|mesh-list
65642218|NCT02174666|Ergocalciferols|ergocalciferols|mesh-list
65642219|NCT02174666|Cholecalciferol|cholecalciferol|mesh-list
65642220|NCT02174666|Vitamins|vitamins|mesh-list
65642221|NCT02174666|Genistein|genistein|mesh-list
65642222|NCT02174666|Biochanin A|biochanin a|mesh-list
65642223|NCT02174666|Daidzein|daidzein|mesh-list
65642224|NCT02174666|Formononetin|formononetin|mesh-list
65642225|NCT02174666|Micronutrients|micronutrients|mesh-ancestor
65642226|NCT02174666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642227|NCT02174666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65642228|NCT02174666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65642229|NCT02174666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65642230|NCT02174666|Protective Agents|protective agents|mesh-ancestor
65642231|NCT02174666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65642232|NCT02174666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65642233|NCT02174666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642234|NCT02174666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642235|NCT02174666|Phytoestrogens|phytoestrogens|mesh-ancestor
65642236|NCT02174666|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65642237|NCT02174666|Estrogens|estrogens|mesh-ancestor
65642238|NCT02174666|Hormones|hormones|mesh-ancestor
65642239|NCT02174666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65642240|NCT03687021|Progesterone|progesterone|mesh-list
65642241|NCT03687021|Progestins|progestins|mesh-ancestor
65642242|NCT03687021|Hormones|hormones|mesh-ancestor
65642243|NCT03687021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65642244|NCT03687021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642245|NCT03691077|Ocrelizumab|ocrelizumab|mesh-list
65642246|NCT03691077|Immunologic Factors|immunologic factors|mesh-ancestor
65642247|NCT03691077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642248|NCT02172794|Tiotropium Bromide|tiotropium bromide|mesh-list
65642249|NCT02172794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65642250|NCT02172794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65642251|NCT02172794|Autonomic Agents|autonomic agents|mesh-ancestor
65642252|NCT02172794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65642253|NCT02172794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642254|NCT02172794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65642255|NCT02172794|Respiratory System Agents|respiratory system agents|mesh-ancestor
65439569|NCT01045304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65642256|NCT02172794|Parasympatholytics|parasympatholytics|mesh-ancestor
65642257|NCT02172794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65642258|NCT02172794|Cholinergic Agents|cholinergic agents|mesh-ancestor
65642259|NCT02172794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65642260|NCT02172794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642261|NCT02172794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65642262|NCT02172794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65642263|NCT02172794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65642264|NCT02172794|Adrenergic Agents|adrenergic agents|mesh-ancestor
65642266|NCT04305327|Brodalumab|brodalumab|mesh-list
65642267|NCT04305327|Dermatologic Agents|dermatologic agents|mesh-ancestor
65642268|NCT02174900|Lumefantrine|lumefantrine|mesh-list
65642269|NCT02174900|Artemether|artemether|mesh-list
65642270|NCT02174900|Primaquine|primaquine|mesh-list
65642271|NCT02174900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65642272|NCT02174900|Antimalarials|antimalarials|mesh-ancestor
65642273|NCT02174900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65642274|NCT02174900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65642275|NCT02174900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65642276|NCT02170610|Pantoprazole|pantoprazole|mesh-list
65642277|NCT02170610|Dabigatran|dabigatran|mesh-list
65642278|NCT02170610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65642279|NCT02170610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65642280|NCT02170610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65642281|NCT02170610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642282|NCT02170610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642283|NCT02170610|Antithrombins|antithrombins|mesh-ancestor
65642284|NCT02170610|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65642285|NCT02170610|Protease Inhibitors|protease inhibitors|mesh-ancestor
65642286|NCT02170610|Anticoagulants|anticoagulants|mesh-ancestor
65642287|NCT02173106|Cyclosporine|cyclosporine|mesh-list
65642288|NCT02173106|Cyclosporins|cyclosporins|mesh-list
65642289|NCT02173106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642290|NCT02173106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642291|NCT02173106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65642292|NCT02173106|Immunologic Factors|immunologic factors|mesh-ancestor
65642293|NCT02173106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642294|NCT02173106|Antifungal Agents|antifungal agents|mesh-ancestor
65642295|NCT02173106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65642296|NCT02173106|Dermatologic Agents|dermatologic agents|mesh-ancestor
65642297|NCT02173106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65642298|NCT02173106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65642299|NCT03932721|Evolocumab|evolocumab|mesh-list
65642300|NCT03932721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65642301|NCT03932721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65642302|NCT03932721|Antimetabolites|antimetabolites|mesh-ancestor
65642303|NCT03932721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642304|NCT03932721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65642305|NCT00106340|Metformin|metformin|mesh-list
65642306|NCT00106340|Glimepiride|glimepiride|mesh-list
65642307|NCT00106340|Vildagliptin|vildagliptin|mesh-list
65642308|NCT00106340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65642309|NCT00106340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642310|NCT00106340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65642311|NCT00106340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65642312|NCT00106340|Immunologic Factors|immunologic factors|mesh-ancestor
65642313|NCT00106340|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65642314|NCT00106340|Protease Inhibitors|protease inhibitors|mesh-ancestor
65642315|NCT00106340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642316|NCT00106340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642317|NCT03538496|Bupivacaine|bupivacaine|mesh-list
65642318|NCT03538496|Anesthetics, Local|anesthetics, local|mesh-ancestor
65642319|NCT03538496|Anesthetics|anesthetics|mesh-ancestor
65642320|NCT03538496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65642321|NCT03538496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642322|NCT03538496|Sensory System Agents|sensory system agents|mesh-ancestor
65642323|NCT03538496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65642324|NCT03686787|Tranexamic Acid|tranexamic acid|mesh-list
65642325|NCT03686787|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65642326|NCT03686787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65642327|NCT03686787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642328|NCT03686787|Hemostatics|hemostatics|mesh-ancestor
65642329|NCT03686787|Coagulants|coagulants|mesh-ancestor
65642330|NCT03694587|Ibuprofen|ibuprofen|mesh-list
65642331|NCT03694587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65642332|NCT03694587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65642333|NCT03694587|Analgesics|analgesics|mesh-ancestor
65642334|NCT03694587|Sensory System Agents|sensory system agents|mesh-ancestor
65642335|NCT03694587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65642336|NCT03694587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642338|NCT03694587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65642339|NCT03694587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65642340|NCT03694587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642341|NCT03694587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642342|NCT02175056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65642343|NCT02175056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65642344|NCT02170766|Pantoprazole|pantoprazole|mesh-list
65642345|NCT02170766|Dabigatran|dabigatran|mesh-list
65642346|NCT02170766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65642347|NCT02170766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65642348|NCT02170766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65642349|NCT02170766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642350|NCT02170766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642351|NCT02170766|Antithrombins|antithrombins|mesh-ancestor
65642352|NCT02170766|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65642353|NCT02170766|Protease Inhibitors|protease inhibitors|mesh-ancestor
65642354|NCT02170766|Anticoagulants|anticoagulants|mesh-ancestor
65642355|NCT03694119|Phenelzine|phenelzine|mesh-list
65642356|NCT03694119|Ozanimod|ozanimod|mesh-list
65642357|NCT03694119|Tyramine|tyramine|mesh-list
65642358|NCT03694119|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65642359|NCT03694119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642360|NCT03694119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65642361|NCT03694119|Immunologic Factors|immunologic factors|mesh-ancestor
65642362|NCT03694119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642363|NCT03694119|Antidepressive Agents|antidepressive agents|mesh-ancestor
65642364|NCT03694119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65642365|NCT03694119|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65642366|NCT03694119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642367|NCT03694119|Sympathomimetics|sympathomimetics|mesh-ancestor
65642368|NCT03694119|Autonomic Agents|autonomic agents|mesh-ancestor
65642369|NCT03694119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65642370|NCT03694119|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65642371|NCT03694119|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65642372|NCT03694119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65642373|NCT03694119|Adrenergic Agents|adrenergic agents|mesh-ancestor
65642374|NCT03694119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65642375|NCT02178254|Fosfomycin|fosfomycin|mesh-list
65642376|NCT02178254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65642377|NCT02178254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65642378|NCT02173262|Ciprofloxacin|ciprofloxacin|mesh-list
65642379|NCT02173262|Lenograstim|lenograstim|mesh-list
65642380|NCT02173262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65642381|NCT02173262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65642382|NCT02173262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65642383|NCT02173262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65642384|NCT02173262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642385|NCT02173262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642386|NCT02173262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65642387|NCT02173262|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65642388|NCT02173262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65642389|NCT02173262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65642390|NCT02173262|Immunologic Factors|immunologic factors|mesh-ancestor
65642391|NCT02173262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642392|NCT02173418|Ropivacaine|ropivacaine|mesh-list
65642393|NCT02173418|Anesthetics, Local|anesthetics, local|mesh-ancestor
65642394|NCT02173418|Anesthetics|anesthetics|mesh-ancestor
65642395|NCT02173418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65642396|NCT02173418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642397|NCT02173418|Sensory System Agents|sensory system agents|mesh-ancestor
65642398|NCT02173418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65642399|NCT03932331|Acalabrutinib|acalabrutinib|mesh-list
65642400|NCT03932331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65642401|NCT02178488|Cholecalciferol|cholecalciferol|mesh-list
65642402|NCT02178488|Vitamin D|vitamin d|mesh-list
65642403|NCT02178488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65642404|NCT02178488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642405|NCT02178488|Vitamins|vitamins|mesh-ancestor
65642406|NCT02178488|Micronutrients|micronutrients|mesh-ancestor
65642407|NCT02178488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65642408|NCT02173652|Linagliptin|linagliptin|mesh-list
65642409|NCT02173652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65439720|NCT01082926|Aldesleukin|aldesleukin|mesh-list
65642410|NCT02173652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642412|NCT02173652|Hormones|hormones|mesh-ancestor
65642413|NCT02173652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65642414|NCT02173652|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65642415|NCT02173652|Protease Inhibitors|protease inhibitors|mesh-ancestor
65642416|NCT02173652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642417|NCT02173652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642418|NCT02173730|Pantoprazole|pantoprazole|mesh-list
65642419|NCT02173730|Dabigatran|dabigatran|mesh-list
65642420|NCT02173730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65642421|NCT02173730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65642422|NCT02173730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65105119|NCT04687449|Curcumin|curcumin|mesh-list
65642423|NCT02173730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642424|NCT02173730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642425|NCT02173730|Antithrombins|antithrombins|mesh-ancestor
65642426|NCT02173730|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65642427|NCT02173730|Protease Inhibitors|protease inhibitors|mesh-ancestor
65642428|NCT02173730|Anticoagulants|anticoagulants|mesh-ancestor
65642429|NCT02175446|Bevacizumab|bevacizumab|mesh-list
65642430|NCT02175446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65642431|NCT02175446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65642432|NCT02175446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65642433|NCT02175446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65642434|NCT02175446|Growth Substances|growth substances|mesh-ancestor
65642435|NCT02175446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642436|NCT02175446|Growth Inhibitors|growth inhibitors|mesh-ancestor
65642437|NCT02178644|Capecitabine|capecitabine|mesh-list
65642438|NCT02178644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65642439|NCT02178644|Antimetabolites|antimetabolites|mesh-ancestor
65642440|NCT02178644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642441|NCT02178644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65642442|NCT03686163|Mitogens|mitogens|mesh-list
65642443|NCT03686163|Mitosis Modulators|mitosis modulators|mesh-ancestor
65642444|NCT03686163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642445|NCT02173808|Levonorgestrel|levonorgestrel|mesh-list
65642446|NCT02173808|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
65642447|NCT02173808|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65642448|NCT02173808|Contraceptive Agents|contraceptive agents|mesh-ancestor
65642449|NCT02173808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65642450|NCT02173808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642451|NCT02173808|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65642452|NCT02173808|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65642453|NCT02173808|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65642454|NCT02173808|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65642455|NCT02173886|Bupropion|bupropion|mesh-list
65642456|NCT02173886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65642457|NCT02173886|Antidepressive Agents|antidepressive agents|mesh-ancestor
65642458|NCT02173886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65642459|NCT02173886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65642460|NCT02173886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65642461|NCT02173886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65642462|NCT02173886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642463|NCT02173886|Dopamine Agents|dopamine agents|mesh-ancestor
65642464|NCT02173886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65642465|NCT02173886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642466|NCT02173886|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65642467|NCT02173886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65642468|NCT02173886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642469|NCT02173964|Pinaverium|pinaverium|mesh-list
65642470|NCT02173964|Bromides|bromides|mesh-list
65642471|NCT02173964|Anticonvulsants|anticonvulsants|mesh-ancestor
65642472|NCT02173964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65642473|NCT02173964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65642474|NCT02173964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642475|NCT02173964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65642476|NCT02173964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642477|NCT02173964|Parasympatholytics|parasympatholytics|mesh-ancestor
65642478|NCT02173964|Autonomic Agents|autonomic agents|mesh-ancestor
65642479|NCT02173964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65642480|NCT02175602|Citalopram|citalopram|mesh-list
65642481|NCT02175602|Sertraline|sertraline|mesh-list
65439793|NCT00514943|Cetuximab|cetuximab|mesh-list
65642482|NCT02175602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65642483|NCT02175602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65642484|NCT02175602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65642485|NCT02175602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642486|NCT02175602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65642488|NCT02175602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642489|NCT02175602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65642490|NCT02175602|Antidepressive Agents|antidepressive agents|mesh-ancestor
65642491|NCT02175602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65642492|NCT03686085|Dinoprostone|dinoprostone|mesh-list
65642493|NCT03686085|Oxytocics|oxytocics|mesh-ancestor
65642494|NCT03686085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65642495|NCT03686085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642496|NCT03693885|Oxytocin|oxytocin|mesh-list
65642497|NCT03693885|Oxytocics|oxytocics|mesh-ancestor
65642498|NCT03693885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65642499|NCT03693885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642500|NCT02174120|Propofol|propofol|mesh-list
65642501|NCT02174120|Etomidate|etomidate|mesh-list
65642502|NCT02174120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65642503|NCT02174120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65642504|NCT02174120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642505|NCT02174120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65642506|NCT02174120|Anesthetics, General|anesthetics, general|mesh-ancestor
65642507|NCT02174120|Anesthetics|anesthetics|mesh-ancestor
65642508|NCT02175914|Erythromycin|erythromycin|mesh-list
65642509|NCT02175914|Erythromycin Estolate|erythromycin estolate|mesh-list
65642510|NCT02175914|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65642511|NCT02175914|Erythromycin stearate|erythromycin stearate|mesh-list
65642512|NCT02175914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65642513|NCT02175914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65642514|NCT02175914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65642515|NCT02175914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65642516|NCT02175914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642517|NCT02175914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642518|NCT02753816|Tranexamic Acid|tranexamic acid|mesh-list
65642519|NCT02753816|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65642520|NCT02753816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65642521|NCT02753816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642522|NCT02753816|Hemostatics|hemostatics|mesh-ancestor
65642523|NCT02753816|Coagulants|coagulants|mesh-ancestor
65642524|NCT02179034|Menthol|menthol|mesh-list
65642525|NCT02179034|Nicotine|nicotine|mesh-list
65642526|NCT02179034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65642527|NCT02179034|Autonomic Agents|autonomic agents|mesh-ancestor
65642528|NCT02179034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65642529|NCT02179034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642530|NCT02179034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65642531|NCT02179034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65642532|NCT02179034|Cholinergic Agents|cholinergic agents|mesh-ancestor
65642533|NCT02179034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65642534|NCT02179034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642535|NCT02179034|Antipruritics|antipruritics|mesh-ancestor
65642536|NCT02179034|Dermatologic Agents|dermatologic agents|mesh-ancestor
65642537|NCT02174588|Midazolam|midazolam|mesh-list
65642538|NCT02174588|Propofol|propofol|mesh-list
65642539|NCT02174588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65642540|NCT02174588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65642541|NCT02174588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642542|NCT02174588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65642543|NCT02174588|Anesthetics, General|anesthetics, general|mesh-ancestor
65642544|NCT02174588|Anesthetics|anesthetics|mesh-ancestor
65642545|NCT02174588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65642546|NCT02174588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65642547|NCT02174588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65642548|NCT02174588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65642549|NCT02174588|GABA Modulators|gaba modulators|mesh-ancestor
65642550|NCT02174588|GABA Agents|gaba agents|mesh-ancestor
65642551|NCT02174588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65642552|NCT02174588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642553|NCT03693573|Bevacizumab|bevacizumab|mesh-list
65642554|NCT03693573|Atezolizumab|atezolizumab|mesh-list
65642555|NCT03693573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65642556|NCT03693573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65642557|NCT03693573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65642558|NCT03693573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65642559|NCT03693573|Growth Substances|growth substances|mesh-ancestor
65642560|NCT03693573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642561|NCT03693573|Growth Inhibitors|growth inhibitors|mesh-ancestor
65642562|NCT02176304|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65642563|NCT02176304|Methylprednisolone|methylprednisolone|mesh-list
65642564|NCT02176304|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65642565|NCT02176304|Prednisolone|prednisolone|mesh-list
65642566|NCT02176304|Prednisolone acetate|prednisolone acetate|mesh-list
65642567|NCT02176304|Lidocaine|lidocaine|mesh-list
65642568|NCT02176304|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65642569|NCT02176304|Prednisolone phosphate|prednisolone phosphate|mesh-list
65642570|NCT02176304|Anesthetics, Local|anesthetics, local|mesh-ancestor
65642571|NCT02176304|Anesthetics|anesthetics|mesh-ancestor
65642572|NCT02176304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65642573|NCT02176304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642574|NCT02176304|Sensory System Agents|sensory system agents|mesh-ancestor
65642575|NCT02176304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65642576|NCT02176304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65642577|NCT02176304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65642578|NCT02176304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65642579|NCT02176304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65642580|NCT02176304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642581|NCT02176304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65642582|NCT02176304|Antiemetics|antiemetics|mesh-ancestor
65642583|NCT02176304|Autonomic Agents|autonomic agents|mesh-ancestor
65642584|NCT02176304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65642585|NCT02176304|Glucocorticoids|glucocorticoids|mesh-ancestor
65642586|NCT02176304|Hormones|hormones|mesh-ancestor
65642587|NCT02176304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65642588|NCT02176304|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65642589|NCT02176304|Protective Agents|protective agents|mesh-ancestor
65642590|NCT02176304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65642591|NCT02176304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65642592|NCT02176460|Colchicine|colchicine|mesh-list
65642593|NCT02176460|Gout Suppressants|gout suppressants|mesh-ancestor
65642594|NCT02176460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65642595|NCT02176460|Tubulin Modulators|tubulin modulators|mesh-ancestor
65642596|NCT02176460|Antimitotic Agents|antimitotic agents|mesh-ancestor
65642597|NCT02176460|Mitosis Modulators|mitosis modulators|mesh-ancestor
65642598|NCT02176460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642599|NCT02176460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65642600|NCT02256254|Simvastatin|simvastatin|mesh-list
65642601|NCT02256254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65642602|NCT02256254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65642603|NCT02256254|Antimetabolites|antimetabolites|mesh-ancestor
65642604|NCT02256254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642605|NCT02256254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65642606|NCT02256254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65642607|NCT02256254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642608|NCT02182076|Nintedanib|nintedanib|mesh-list
65642609|NCT02182076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65642610|NCT02182076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65642611|NCT02182076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642612|NCT02182076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642613|NCT02179268|Sertraline|sertraline|mesh-list
65642614|NCT02179268|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65642615|NCT02179268|Citalopram|citalopram|mesh-list
65642616|NCT02179268|Reboxetine|reboxetine|mesh-list
65642617|NCT02179268|Antidepressive Agents|antidepressive agents|mesh-ancestor
65642618|NCT02179268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65642619|NCT02179268|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65642620|NCT02179268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65642621|NCT02179268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65642622|NCT02179268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642623|NCT02179268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65642624|NCT02179268|Serotonin Agents|serotonin agents|mesh-ancestor
65642625|NCT02179268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642626|NCT02179268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65642627|NCT02179268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65642628|NCT02179268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65642629|NCT02179268|Adrenergic Agents|adrenergic agents|mesh-ancestor
65642630|NCT02182154|Nintedanib|nintedanib|mesh-list
65642631|NCT02182154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65642632|NCT02182154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65642633|NCT02182154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642634|NCT02182154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642635|NCT04115631|Cytarabine|cytarabine|mesh-list
65642636|NCT04115631|Rituximab|rituximab|mesh-list
65642637|NCT04115631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65642638|NCT04115631|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65642639|NCT04115631|Acalabrutinib|acalabrutinib|mesh-list
65642640|NCT04115631|Antibodies|antibodies|mesh-list
65642641|NCT04115631|Immunoglobulins|immunoglobulins|mesh-list
65642642|NCT04115631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65642643|NCT04115631|Immunologic Factors|immunologic factors|mesh-ancestor
65642644|NCT04115631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642645|NCT04115631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65642646|NCT04115631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65642647|NCT04115631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65642648|NCT04115631|Antimetabolites|antimetabolites|mesh-ancestor
65642649|NCT04115631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642650|NCT04115631|Antiviral Agents|antiviral agents|mesh-ancestor
65642651|NCT04115631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65642652|NCT04115631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65642653|NCT04115631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65642654|NCT04115631|Alkylating Agents|alkylating agents|mesh-ancestor
65642655|NCT02182232|Paclitaxel|paclitaxel|mesh-list
65642656|NCT02182232|Carboplatin|carboplatin|mesh-list
65642657|NCT02182232|Nintedanib|nintedanib|mesh-list
65642658|NCT02182232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65642659|NCT02182232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65642660|NCT02182232|Tubulin Modulators|tubulin modulators|mesh-ancestor
65642661|NCT02182232|Antimitotic Agents|antimitotic agents|mesh-ancestor
65642662|NCT02182232|Mitosis Modulators|mitosis modulators|mesh-ancestor
65642663|NCT02182232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642664|NCT02182232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65642665|NCT02182232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642666|NCT02182310|Moxifloxacin|moxifloxacin|mesh-list
65642667|NCT02182310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65642668|NCT02182310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65642669|NCT02182310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65642670|NCT02182310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65642671|NCT02182310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642672|NCT02182310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642673|NCT02182310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65642674|NCT02176850|Telmisartan|telmisartan|mesh-list
65642675|NCT02176850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65642676|NCT02176850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65642677|NCT02176850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65642678|NCT02176850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642679|NCT03537326|Budesonide|budesonide|mesh-list
65642680|NCT03537326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65642681|NCT03537326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65642682|NCT03537326|Autonomic Agents|autonomic agents|mesh-ancestor
65642683|NCT03537326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65642684|NCT03537326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642685|NCT03537326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65642686|NCT03537326|Respiratory System Agents|respiratory system agents|mesh-ancestor
65642687|NCT03537326|Glucocorticoids|glucocorticoids|mesh-ancestor
65642688|NCT03537326|Hormones|hormones|mesh-ancestor
65642689|NCT03537326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65642690|NCT02182544|Ketotifen|ketotifen|mesh-list
65642691|NCT02182544|Epinastine|epinastine|mesh-list
65642692|NCT02182544|Antipruritics|antipruritics|mesh-ancestor
65642693|NCT02182544|Dermatologic Agents|dermatologic agents|mesh-ancestor
65642694|NCT02182544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65642695|NCT02182544|Histamine Antagonists|histamine antagonists|mesh-ancestor
65642696|NCT02182544|Histamine Agents|histamine agents|mesh-ancestor
65642697|NCT02182544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65642698|NCT02182544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642699|NCT02182544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642700|NCT02182544|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65642701|NCT02179658|Vancomycin|vancomycin|mesh-list
65642702|NCT02179658|Fidaxomicin|fidaxomicin|mesh-list
65642703|NCT02179658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65642704|NCT02179658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65642705|NCT02177318|Bromides|bromides|mesh-list
65642706|NCT02177318|Tiotropium Bromide|tiotropium bromide|mesh-list
65642707|NCT02177318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65642708|NCT02177318|Autonomic Agents|autonomic agents|mesh-ancestor
65642709|NCT02177318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65642710|NCT02177318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642711|NCT02177318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65642712|NCT02177318|Respiratory System Agents|respiratory system agents|mesh-ancestor
65642713|NCT02177318|Parasympatholytics|parasympatholytics|mesh-ancestor
65642714|NCT02177318|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65642715|NCT02177318|Cholinergic Agents|cholinergic agents|mesh-ancestor
65642716|NCT02177318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65642717|NCT02177318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642718|NCT02177318|Anticonvulsants|anticonvulsants|mesh-ancestor
65642719|NCT02177396|Valsartan|valsartan|mesh-list
65642720|NCT02177396|Telmisartan|telmisartan|mesh-list
65642721|NCT02177396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65642722|NCT02177396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65642723|NCT02177396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65642724|NCT02177396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642725|NCT02030054|Atorvastatin|atorvastatin|mesh-list
65642726|NCT02030054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65642727|NCT02030054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65642728|NCT02030054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65642729|NCT02030054|Antimetabolites|antimetabolites|mesh-ancestor
65642730|NCT02030054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642731|NCT02030054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65642732|NCT02030054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65642733|NCT02030054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642734|NCT02182622|Prednisone|prednisone|mesh-list
65642735|NCT02182622|Docetaxel|docetaxel|mesh-list
65642736|NCT02182622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65642737|NCT02182622|Tubulin Modulators|tubulin modulators|mesh-ancestor
65642738|NCT02182622|Antimitotic Agents|antimitotic agents|mesh-ancestor
65642739|NCT02182622|Mitosis Modulators|mitosis modulators|mesh-ancestor
65642740|NCT02182622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642741|NCT02182622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65642742|NCT02182622|Glucocorticoids|glucocorticoids|mesh-ancestor
65642743|NCT02182622|Hormones|hormones|mesh-ancestor
65642744|NCT02182622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65642745|NCT02182622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642746|NCT02182622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65642747|NCT03693183|Ketorolac|ketorolac|mesh-list
65642748|NCT03693183|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65642749|NCT03693183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65642750|NCT03693183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65642751|NCT03693183|Analgesics|analgesics|mesh-ancestor
65642752|NCT03693183|Sensory System Agents|sensory system agents|mesh-ancestor
65642753|NCT03693183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65642754|NCT03693183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642755|NCT03693183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65642756|NCT03693183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65642757|NCT03693183|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65642758|NCT03693183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642759|NCT03693183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642760|NCT02182700|Bromides|bromides|mesh-list
65642761|NCT02182700|Albuterol|albuterol|mesh-list
65642762|NCT02182700|Ipratropium|ipratropium|mesh-list
65642763|NCT02182700|Anticonvulsants|anticonvulsants|mesh-ancestor
65642764|NCT02182700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65642765|NCT02182700|Autonomic Agents|autonomic agents|mesh-ancestor
65642766|NCT02182700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65642767|NCT02182700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642768|NCT02182700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65642769|NCT02182700|Respiratory System Agents|respiratory system agents|mesh-ancestor
65642770|NCT02182700|Tocolytic Agents|tocolytic agents|mesh-ancestor
65642771|NCT02182700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65267547|NCT00649233|Metoprolol|metoprolol|mesh-list
65642772|NCT02182700|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65642773|NCT02182700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65642774|NCT02182700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65642775|NCT02182700|Adrenergic Agents|adrenergic agents|mesh-ancestor
65642776|NCT02182700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65642777|NCT02182700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642778|NCT02182700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65642779|NCT02182700|Cholinergic Agents|cholinergic agents|mesh-ancestor
65642780|NCT02182778|Gemcitabine|gemcitabine|mesh-list
65440089|NCT00510887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65642781|NCT02182778|Cisplatin|cisplatin|mesh-list
65642782|NCT02182778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65642783|NCT02182778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65642784|NCT02182778|Antimetabolites|antimetabolites|mesh-ancestor
65642785|NCT02182778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642786|NCT02182778|Antiviral Agents|antiviral agents|mesh-ancestor
65642787|NCT02182778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65642788|NCT02182778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642789|NCT02182778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65642790|NCT02182778|Immunologic Factors|immunologic factors|mesh-ancestor
65642791|NCT02182778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642792|NCT03688971|Ketoconazole|ketoconazole|mesh-list
65642793|NCT03688971|Antifungal Agents|antifungal agents|mesh-ancestor
65642794|NCT03688971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65642795|NCT03688971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65642796|NCT03688971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65642797|NCT03688971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642798|NCT03688971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642799|NCT03688971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65642800|NCT03688971|Hormone Antagonists|hormone antagonists|mesh-ancestor
65642801|NCT03688971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65642802|NCT03688971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642803|NCT03688971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65642804|NCT02179814|Diphenhydramine|diphenhydramine|mesh-list
65642805|NCT02179814|Promethazine|promethazine|mesh-list
65642806|NCT02179814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65642807|NCT02179814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65642808|NCT02179814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65642809|NCT02179814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642810|NCT02179814|Anesthetics, Local|anesthetics, local|mesh-ancestor
65642811|NCT02179814|Anesthetics|anesthetics|mesh-ancestor
65642812|NCT02179814|Sensory System Agents|sensory system agents|mesh-ancestor
65642813|NCT02179814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65642814|NCT02179814|Antiemetics|antiemetics|mesh-ancestor
65642815|NCT02179814|Autonomic Agents|autonomic agents|mesh-ancestor
65642816|NCT02179814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65642817|NCT02179814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65642818|NCT02179814|Histamine Antagonists|histamine antagonists|mesh-ancestor
65642819|NCT02179814|Histamine Agents|histamine agents|mesh-ancestor
65642820|NCT02179814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65642821|NCT02179814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642822|NCT02179814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65642823|NCT02179814|Antipruritics|antipruritics|mesh-ancestor
65642824|NCT02179814|Dermatologic Agents|dermatologic agents|mesh-ancestor
65642825|NCT02179970|Plerixafor|plerixafor|mesh-list
65642826|NCT02179970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65642827|NCT02179970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65642828|NCT02179970|Antiviral Agents|antiviral agents|mesh-ancestor
65642829|NCT02179970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65642830|NCT03537950|Cannabidiol|cannabidiol|mesh-list
65642831|NCT03537950|Anticonvulsants|anticonvulsants|mesh-ancestor
65642832|NCT02182856|Bromides|bromides|mesh-list
65642833|NCT02182856|Albuterol|albuterol|mesh-list
65642834|NCT02182856|Ipratropium|ipratropium|mesh-list
65642835|NCT02182856|Anticonvulsants|anticonvulsants|mesh-ancestor
65642836|NCT02182856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65642837|NCT02182856|Autonomic Agents|autonomic agents|mesh-ancestor
65642838|NCT02182856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65642839|NCT02182856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642840|NCT02182856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65642841|NCT02182856|Respiratory System Agents|respiratory system agents|mesh-ancestor
65642842|NCT02182856|Tocolytic Agents|tocolytic agents|mesh-ancestor
65642843|NCT02182856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65642844|NCT02182856|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65642845|NCT02182856|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65642846|NCT02182856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65642847|NCT02182856|Adrenergic Agents|adrenergic agents|mesh-ancestor
65642848|NCT02182856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65642849|NCT02182856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642850|NCT02182856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65642851|NCT02182856|Cholinergic Agents|cholinergic agents|mesh-ancestor
65642852|NCT02183012|Ibuprofen|ibuprofen|mesh-list
65642853|NCT02183012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65642854|NCT02183012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65642855|NCT02183012|Analgesics|analgesics|mesh-ancestor
65642856|NCT02183012|Sensory System Agents|sensory system agents|mesh-ancestor
65642857|NCT02183012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65642858|NCT02183012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642859|NCT02183012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65642860|NCT02183012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65642861|NCT02183012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65642862|NCT02183012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642863|NCT02183012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642864|NCT02180048|Caffeine|caffeine|mesh-list
65642865|NCT02180048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65642866|NCT02180048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642867|NCT02180048|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65642868|NCT02180048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642869|NCT02180048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642870|NCT02180048|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65642871|NCT02180048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65642872|NCT02180048|Purinergic Agents|purinergic agents|mesh-ancestor
65642873|NCT02180048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65642874|NCT03688659|Vancomycin|vancomycin|mesh-list
65642875|NCT03688659|Gentamicins|gentamicins|mesh-list
65642876|NCT03688659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65642877|NCT03688659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65642878|NCT03688659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65642879|NCT03688659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642880|NCT03688659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642881|NCT03683043|Leuprolide|leuprolide|mesh-list
65642882|NCT03683043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65642883|NCT03683043|Fertility Agents|fertility agents|mesh-ancestor
65642884|NCT03683043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65642885|NCT03683043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642886|NCT03683043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65642887|NCT03683043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65642888|NCT02180204|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65642889|NCT02180204|Tenecteplase|tenecteplase|mesh-list
65642890|NCT02180204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65642891|NCT02180204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65642892|NCT02180204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642893|NCT02183090|Meloxicam|meloxicam|mesh-list
65642894|NCT02183090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65642895|NCT02183090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65642896|NCT02183090|Analgesics|analgesics|mesh-ancestor
65642897|NCT02183090|Sensory System Agents|sensory system agents|mesh-ancestor
65642898|NCT02183090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65642899|NCT02183090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642900|NCT02183090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65642901|NCT02183090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65642902|NCT02183090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65642903|NCT02183090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65642904|NCT02183090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642905|NCT02183090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642906|NCT02177552|Carboplatin|carboplatin|mesh-list
65642907|NCT02177552|Docetaxel|docetaxel|mesh-list
65642908|NCT02177552|Capecitabine|capecitabine|mesh-list
65642909|NCT02177552|Oxaliplatin|oxaliplatin|mesh-list
65642910|NCT02177552|Epirubicin|epirubicin|mesh-list
65642911|NCT02177552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65642912|NCT02177552|Tubulin Modulators|tubulin modulators|mesh-ancestor
65642913|NCT02177552|Antimitotic Agents|antimitotic agents|mesh-ancestor
65105645|NCT04885686|Thymol|thymol|mesh-list
65642914|NCT02177552|Mitosis Modulators|mitosis modulators|mesh-ancestor
65642915|NCT02177552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642916|NCT02177552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65642917|NCT02177552|Antimetabolites|antimetabolites|mesh-ancestor
65642918|NCT02177552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65642919|NCT02177552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65642920|NCT02177552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65642921|NCT02177552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642922|NCT03682653|Azithromycin|azithromycin|mesh-list
65642923|NCT03682653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65642924|NCT03682653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65642925|NCT03684993|Chlorhexidine|chlorhexidine|mesh-list
65642926|NCT03684993|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65642927|NCT03684993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65642928|NCT03684993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65642929|NCT03684993|Disinfectants|disinfectants|mesh-ancestor
65642930|NCT03684993|Dermatologic Agents|dermatologic agents|mesh-ancestor
65642931|NCT04062279|Autoantibodies|autoantibodies|mesh-list
65642933|NCT04062279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642934|NCT02183168|Indomethacin|indomethacin|mesh-list
65642935|NCT02183168|Meloxicam|meloxicam|mesh-list
65642936|NCT02183168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65642937|NCT02183168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65642938|NCT02183168|Analgesics|analgesics|mesh-ancestor
65642939|NCT02183168|Sensory System Agents|sensory system agents|mesh-ancestor
65642940|NCT02183168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65642941|NCT02183168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642942|NCT02183168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65642943|NCT02183168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65642944|NCT02183168|Gout Suppressants|gout suppressants|mesh-ancestor
65642945|NCT02183168|Tocolytic Agents|tocolytic agents|mesh-ancestor
65642946|NCT02183168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65642947|NCT02183168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65642948|NCT02183168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642949|NCT02183168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642950|NCT02183168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65642951|NCT02183246|Porfiromycin|porfiromycin|mesh-list
65642952|NCT02183246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65642953|NCT02183246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65642954|NCT02183324|Linagliptin|linagliptin|mesh-list
65642955|NCT02183324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65642956|NCT02183324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642957|NCT02183324|Incretins|incretins|mesh-ancestor
65642958|NCT02183324|Hormones|hormones|mesh-ancestor
65642959|NCT02183324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65642960|NCT02183324|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65642961|NCT02183324|Protease Inhibitors|protease inhibitors|mesh-ancestor
65642962|NCT02183324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642963|NCT02183324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642964|NCT02183402|Linagliptin|linagliptin|mesh-list
65642965|NCT02183402|Digoxin|digoxin|mesh-list
65642966|NCT02183402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65642967|NCT02183402|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65642968|NCT02183402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642969|NCT02183402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642970|NCT02183402|Protective Agents|protective agents|mesh-ancestor
65642971|NCT02183402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642972|NCT02183402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65642973|NCT02183402|Incretins|incretins|mesh-ancestor
65642974|NCT02183402|Hormones|hormones|mesh-ancestor
65642975|NCT02183402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65642976|NCT02183402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65642977|NCT02183402|Protease Inhibitors|protease inhibitors|mesh-ancestor
65642978|NCT02183480|Linagliptin|linagliptin|mesh-list
65642979|NCT02183480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65642980|NCT02183480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642981|NCT02183480|Incretins|incretins|mesh-ancestor
65642982|NCT02183480|Hormones|hormones|mesh-ancestor
65642983|NCT02183480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65642984|NCT02183480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65642985|NCT02183480|Protease Inhibitors|protease inhibitors|mesh-ancestor
65642986|NCT02183480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65642987|NCT02183480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65642988|NCT05141864|Lidocaine|lidocaine|mesh-list
65642989|NCT05141864|Anesthetics, Local|anesthetics, local|mesh-ancestor
65642990|NCT05141864|Anesthetics|anesthetics|mesh-ancestor
65642991|NCT05141864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65642992|NCT05141864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65642993|NCT05141864|Sensory System Agents|sensory system agents|mesh-ancestor
65642994|NCT05141864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65642995|NCT05141864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65642996|NCT05141864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65642997|NCT05141864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65642998|NCT05141864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65642999|NCT05141864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643000|NCT02180516|Meloxicam|meloxicam|mesh-list
65643001|NCT02180516|Etodolac|etodolac|mesh-list
65643002|NCT02180516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65643003|NCT02180516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65440312|NCT01052792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643004|NCT02180516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65643005|NCT02180516|Analgesics|analgesics|mesh-ancestor
65643006|NCT02180516|Sensory System Agents|sensory system agents|mesh-ancestor
65643007|NCT02180516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643008|NCT02180516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643009|NCT02180516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65643010|NCT02180516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65643011|NCT02180516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65643012|NCT02180516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643013|NCT02180516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643014|NCT02183636|Pioglitazone|pioglitazone|mesh-list
65643015|NCT02183636|Linagliptin|linagliptin|mesh-list
65643016|NCT02183636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65643017|NCT02183636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643018|NCT02183636|Incretins|incretins|mesh-ancestor
65643019|NCT02183636|Hormones|hormones|mesh-ancestor
65643020|NCT02183636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65643021|NCT02183636|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65643022|NCT02183636|Protease Inhibitors|protease inhibitors|mesh-ancestor
65643023|NCT02183636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643024|NCT02183636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643025|NCT02183948|Oxytocin|oxytocin|mesh-list
65643026|NCT02183948|Oxytocics|oxytocics|mesh-ancestor
65643027|NCT02183948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65643028|NCT02183948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643029|NCT02184104|Caffeine|caffeine|mesh-list
65643030|NCT02184104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65643031|NCT02184104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643032|NCT02184104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65643033|NCT02184104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643034|NCT02184104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643035|NCT02184104|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65643036|NCT02184104|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65643037|NCT02184104|Purinergic Agents|purinergic agents|mesh-ancestor
65643038|NCT02184104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65643039|NCT02184260|Dipyrone|dipyrone|mesh-list
65643040|NCT02184260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65643041|NCT02184260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65643042|NCT02184260|Analgesics|analgesics|mesh-ancestor
65643043|NCT02184260|Sensory System Agents|sensory system agents|mesh-ancestor
65643044|NCT02184260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643045|NCT02184260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643046|NCT02184260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65643047|NCT02184260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65643048|NCT02184260|Antipyretics|antipyretics|mesh-ancestor
65643049|NCT03813147|Cytarabine|cytarabine|mesh-list
65643050|NCT03813147|Hydrocortisone|hydrocortisone|mesh-list
65643051|NCT03813147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65643052|NCT03813147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65643053|NCT03813147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65643054|NCT03813147|Methotrexate|methotrexate|mesh-list
65643055|NCT03813147|Fludarabine phosphate|fludarabine phosphate|mesh-list
65643056|NCT03813147|Azacitidine|azacitidine|mesh-list
65643057|NCT03813147|Fludarabine|fludarabine|mesh-list
65643058|NCT03813147|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65643059|NCT03813147|Pevonedistat|pevonedistat|mesh-list
65643060|NCT03813147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65643061|NCT03813147|Abortifacient Agents|abortifacient agents|mesh-ancestor
65643062|NCT03813147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65643063|NCT03813147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643064|NCT03813147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65643065|NCT03813147|Antimetabolites|antimetabolites|mesh-ancestor
65643066|NCT03813147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643067|NCT03813147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65643068|NCT03813147|Dermatologic Agents|dermatologic agents|mesh-ancestor
65643069|NCT03813147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65643070|NCT03813147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65643071|NCT03813147|Immunologic Factors|immunologic factors|mesh-ancestor
65643072|NCT03813147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65643073|NCT03813147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65643074|NCT03813147|Antiviral Agents|antiviral agents|mesh-ancestor
65643075|NCT03813147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65643076|NCT03813147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65643077|NCT03684837|Vitamin D|vitamin d|mesh-list
65643078|NCT03684837|Vitamins|vitamins|mesh-ancestor
65643079|NCT03684837|Micronutrients|micronutrients|mesh-ancestor
65643080|NCT03684837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643081|NCT03684837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65643082|NCT03810417|Digoxin|digoxin|mesh-list
65643083|NCT03810417|Antibodies|antibodies|mesh-list
65643084|NCT03810417|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
65643085|NCT03810417|Immunologic Factors|immunologic factors|mesh-ancestor
65643086|NCT03810417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643087|NCT03810417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65643088|NCT03810417|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65643089|NCT03810417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643090|NCT03810417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643091|NCT03810417|Protective Agents|protective agents|mesh-ancestor
65643092|NCT03808155|Tamsulosin|tamsulosin|mesh-list
65643093|NCT03808155|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65643094|NCT03808155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65643095|NCT03808155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65643096|NCT03808155|Adrenergic Agents|adrenergic agents|mesh-ancestor
65643097|NCT03808155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65643098|NCT03808155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643099|NCT03808155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643100|NCT03808155|Urological Agents|urological agents|mesh-ancestor
65643101|NCT02752958|Fluorides|fluorides|mesh-list
65643102|NCT02752958|Tin Fluorides|tin fluorides|mesh-list
65643103|NCT02752958|Cariostatic Agents|cariostatic agents|mesh-ancestor
65643104|NCT02752958|Protective Agents|protective agents|mesh-ancestor
65643105|NCT02752958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643106|NCT02181218|Gemcitabine|gemcitabine|mesh-list
65643107|NCT02181218|Dexamethasone|dexamethasone|mesh-list
65643108|NCT02181218|Dexamethasone acetate|dexamethasone acetate|mesh-list
65643109|NCT02181218|Oxaliplatin|oxaliplatin|mesh-list
65643110|NCT02181218|Romidepsin|romidepsin|mesh-list
65643111|NCT02181218|BB 1101|bb 1101|mesh-list
65643112|NCT02181218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65643113|NCT02181218|Antiemetics|antiemetics|mesh-ancestor
65643114|NCT02181218|Autonomic Agents|autonomic agents|mesh-ancestor
65643115|NCT02181218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643116|NCT02181218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643117|NCT02181218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65643118|NCT02181218|Glucocorticoids|glucocorticoids|mesh-ancestor
65643119|NCT02181218|Hormones|hormones|mesh-ancestor
65643120|NCT02181218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65643121|NCT02181218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65643122|NCT02181218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65643123|NCT02181218|Protease Inhibitors|protease inhibitors|mesh-ancestor
65643124|NCT02181218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643125|NCT02181218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643126|NCT02181218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65643127|NCT02181218|Antimetabolites|antimetabolites|mesh-ancestor
65643128|NCT02181218|Antiviral Agents|antiviral agents|mesh-ancestor
65643129|NCT02181218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65643130|NCT02181218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65643131|NCT02181218|Immunologic Factors|immunologic factors|mesh-ancestor
65643132|NCT02181218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65643133|NCT03536234|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65643134|NCT03536234|Luteolytic Agents|luteolytic agents|mesh-ancestor
65643135|NCT03536234|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65643136|NCT03536234|Contraceptive Agents|contraceptive agents|mesh-ancestor
65643137|NCT03536234|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65643138|NCT03536234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643139|NCT03536234|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65643140|NCT03536234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65643141|NCT03536234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65643142|NCT03682497|Spironolactone|spironolactone|mesh-list
65643143|NCT03682497|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65643144|NCT03682497|Hormone Antagonists|hormone antagonists|mesh-ancestor
65643145|NCT03682497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65643146|NCT03682497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643147|NCT03682497|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65643148|NCT03682497|Diuretics|diuretics|mesh-ancestor
65643149|NCT03682497|Natriuretic Agents|natriuretic agents|mesh-ancestor
65643150|NCT02185898|Menthol|menthol|mesh-list
65643151|NCT02185898|Nicotine|nicotine|mesh-list
65643152|NCT02185898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65643153|NCT02185898|Autonomic Agents|autonomic agents|mesh-ancestor
65643154|NCT02185898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65440461|NCT00098020|Isotretinoin|isotretinoin|mesh-list
65643155|NCT02185898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643156|NCT02185898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65643157|NCT02185898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65643158|NCT02185898|Cholinergic Agents|cholinergic agents|mesh-ancestor
65643159|NCT02185898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65643160|NCT02185898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643161|NCT02185898|Antipruritics|antipruritics|mesh-ancestor
65643162|NCT02185898|Dermatologic Agents|dermatologic agents|mesh-ancestor
65643163|NCT02805660|Durvalumab|durvalumab|mesh-list
65643164|NCT02805660|Mocetinostat|mocetinostat|mesh-list
65643165|NCT02805660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65643166|NCT02805660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65643167|NCT02805660|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65643168|NCT02805660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643169|NCT02805660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643170|NCT02186132|Atropine|atropine|mesh-list
65643171|NCT02186132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65643172|NCT02186132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65643173|NCT02186132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65643174|NCT02186132|Autonomic Agents|autonomic agents|mesh-ancestor
65643175|NCT02186132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643176|NCT02186132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643177|NCT02186132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65643178|NCT02186132|Respiratory System Agents|respiratory system agents|mesh-ancestor
65643179|NCT02186132|Mydriatics|mydriatics|mesh-ancestor
65643180|NCT02186132|Parasympatholytics|parasympatholytics|mesh-ancestor
65643181|NCT02186132|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65643182|NCT02186132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65643183|NCT02186132|Cholinergic Agents|cholinergic agents|mesh-ancestor
65643184|NCT02186132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65643185|NCT02186132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643186|NCT03536780|Gemcitabine|gemcitabine|mesh-list
65643187|NCT03536780|Avelumab|avelumab|mesh-list
65643188|NCT03536780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65643189|NCT03536780|Antimetabolites|antimetabolites|mesh-ancestor
65643190|NCT03536780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643191|NCT03536780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65643192|NCT03536780|Antiviral Agents|antiviral agents|mesh-ancestor
65643193|NCT03536780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65643194|NCT03536780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643195|NCT03536780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65643196|NCT03536780|Immunologic Factors|immunologic factors|mesh-ancestor
65643197|NCT03536780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643198|NCT03536780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65643199|NCT02052336|Clarithromycin|clarithromycin|mesh-list
65643200|NCT02052336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65643201|NCT02052336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65643202|NCT02052336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65643203|NCT02052336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267563|NCT00649233|Adrenergic Agents|adrenergic agents|mesh-ancestor
65643204|NCT02052336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643205|NCT02052336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65643206|NCT02052336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65643207|NCT02181920|Dipyrone|dipyrone|mesh-list
65643208|NCT02181920|Diclofenac|diclofenac|mesh-list
65643209|NCT02181920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65643210|NCT02181920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65643211|NCT02181920|Analgesics|analgesics|mesh-ancestor
65643212|NCT02181920|Sensory System Agents|sensory system agents|mesh-ancestor
65643213|NCT02181920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643214|NCT02181920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643215|NCT02181920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65643216|NCT02181920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65643217|NCT02181920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65643218|NCT02181920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643219|NCT02181920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643220|NCT02181920|Antipyretics|antipyretics|mesh-ancestor
65643221|NCT02185118|Sevoflurane|sevoflurane|mesh-list
65643222|NCT02185118|Isoflurane|isoflurane|mesh-list
65643223|NCT02185118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65643224|NCT02185118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65643225|NCT02185118|Anesthetics, General|anesthetics, general|mesh-ancestor
65643226|NCT02185118|Anesthetics|anesthetics|mesh-ancestor
65643227|NCT02185118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65643228|NCT02185118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643229|NCT02186366|Buspirone|buspirone|mesh-list
65643230|NCT02186366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65643231|NCT02186366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65643232|NCT02186366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65643233|NCT02186366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643234|NCT02186366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65643235|NCT02186366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65643236|NCT02186366|Serotonin Agents|serotonin agents|mesh-ancestor
65643237|NCT02186366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65643238|NCT02186366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643239|NCT02053974|Spironolactone|spironolactone|mesh-list
65643240|NCT02053974|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65643241|NCT02053974|Hormone Antagonists|hormone antagonists|mesh-ancestor
65643242|NCT02053974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65643243|NCT02053974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643244|NCT02053974|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65643245|NCT02053974|Diuretics|diuretics|mesh-ancestor
65643246|NCT02053974|Natriuretic Agents|natriuretic agents|mesh-ancestor
65643247|NCT02185196|Vitamin D|vitamin d|mesh-list
65643248|NCT02185196|Cholecalciferol|cholecalciferol|mesh-list
65643249|NCT02185196|Vitamins|vitamins|mesh-ancestor
65643250|NCT02185196|Micronutrients|micronutrients|mesh-ancestor
65643251|NCT02185196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643252|NCT02185196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65643253|NCT02185196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65643254|NCT02052492|Vitamin D|vitamin d|mesh-list
65643255|NCT02052492|Vitamins|vitamins|mesh-ancestor
65643256|NCT02052492|Micronutrients|micronutrients|mesh-ancestor
65643257|NCT02052492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643258|NCT02052492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65643259|NCT02181998|Heparin|heparin|mesh-list
65643260|NCT02181998|Enoxaparin|enoxaparin|mesh-list
65643261|NCT02181998|Tenecteplase|tenecteplase|mesh-list
65643262|NCT02181998|Anticoagulants|anticoagulants|mesh-ancestor
65643263|NCT02181998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65643264|NCT02181998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65643265|NCT02181998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643266|NCT02054052|Bevacizumab|bevacizumab|mesh-list
65643267|NCT02054052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65643268|NCT02054052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65643269|NCT02054052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65643270|NCT02054052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65643271|NCT02054052|Growth Substances|growth substances|mesh-ancestor
65643272|NCT02054052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643273|NCT02054052|Growth Inhibitors|growth inhibitors|mesh-ancestor
65643274|NCT02185352|Cisplatin|cisplatin|mesh-list
65643275|NCT02185352|Etoposide|etoposide|mesh-list
65643276|NCT02185352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65643277|NCT02185352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65643278|NCT02185352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65643279|NCT02185352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65643280|NCT02185352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643281|NCT02185352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643282|NCT02186600|Vitamin D|vitamin d|mesh-list
65643283|NCT02186600|Cholecalciferol|cholecalciferol|mesh-list
65643284|NCT02186600|Risedronic Acid|risedronic acid|mesh-list
65643285|NCT02186600|Calcium Carbonate|calcium carbonate|mesh-list
65643286|NCT02186600|Calcium|calcium|mesh-list
65643287|NCT02186600|Vitamins|vitamins|mesh-ancestor
65643288|NCT02186600|Micronutrients|micronutrients|mesh-ancestor
65643289|NCT02186600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643290|NCT02186600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65643291|NCT02186600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65643292|NCT02186600|Antacids|antacids|mesh-ancestor
65643293|NCT02186600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643294|NCT02186600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65643295|NCT02186600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65643296|NCT02186600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65643297|NCT02052726|Vaccines|vaccines|mesh-list
65643298|NCT02052726|Immunologic Factors|immunologic factors|mesh-ancestor
65643299|NCT02052726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643300|NCT02185430|Dexmedetomidine|dexmedetomidine|mesh-list
65643301|NCT02185430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65643302|NCT02185430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65643303|NCT02185430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643304|NCT02185430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65440616|NCT00227721|Tubulin Modulators|tubulin modulators|mesh-ancestor
65643306|NCT02185430|Sensory System Agents|sensory system agents|mesh-ancestor
65643307|NCT02185430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643308|NCT02185430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65643309|NCT02185430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65643310|NCT02185430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65643311|NCT02185430|Adrenergic Agents|adrenergic agents|mesh-ancestor
65643312|NCT02185430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65643313|NCT02185430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643314|NCT03536390|Methylphenidate|methylphenidate|mesh-list
65643315|NCT03536390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65643316|NCT03536390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643317|NCT03536390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65643318|NCT03536390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65643319|NCT03536390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65643320|NCT03536390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643321|NCT03536390|Dopamine Agents|dopamine agents|mesh-ancestor
65643322|NCT03536390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65643323|NCT03561870|Olaparib|olaparib|mesh-list
65643324|NCT03561870|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65643325|NCT03561870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643326|NCT03561870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643327|NCT03561870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65643328|NCT02186990|Propofol|propofol|mesh-list
65643329|NCT02186990|Etomidate|etomidate|mesh-list
65643330|NCT02186990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65643331|NCT02186990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65643332|NCT02186990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643333|NCT02186990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65643334|NCT02186990|Anesthetics, General|anesthetics, general|mesh-ancestor
65643335|NCT02186990|Anesthetics|anesthetics|mesh-ancestor
65643336|NCT05657028|Lidocaine|lidocaine|mesh-list
65643337|NCT05657028|Dexmedetomidine|dexmedetomidine|mesh-list
65643338|NCT05657028|Anesthetics, Local|anesthetics, local|mesh-ancestor
65643339|NCT05657028|Anesthetics|anesthetics|mesh-ancestor
65643340|NCT05657028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65643341|NCT05657028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643342|NCT05657028|Sensory System Agents|sensory system agents|mesh-ancestor
65643343|NCT05657028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643344|NCT05657028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65643345|NCT05657028|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65643346|NCT05657028|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65643347|NCT05657028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65643348|NCT05657028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643349|NCT05657028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65643350|NCT05657028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65643351|NCT05657028|Analgesics|analgesics|mesh-ancestor
65643352|NCT05657028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65643353|NCT05657028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65643354|NCT05657028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65643355|NCT05657028|Adrenergic Agents|adrenergic agents|mesh-ancestor
65643356|NCT05657028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65643357|NCT02187068|Dexmedetomidine|dexmedetomidine|mesh-list
65643358|NCT02187068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65643359|NCT02187068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65643360|NCT02187068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643361|NCT02187068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65643362|NCT02187068|Analgesics|analgesics|mesh-ancestor
65643363|NCT02187068|Sensory System Agents|sensory system agents|mesh-ancestor
65643364|NCT02187068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643365|NCT02187068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65643366|NCT02187068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65643367|NCT02187068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65643368|NCT02187068|Adrenergic Agents|adrenergic agents|mesh-ancestor
65643369|NCT02187068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65643370|NCT02187068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643371|NCT02054442|Methotrexate|methotrexate|mesh-list
65643372|NCT02054442|Cetuximab|cetuximab|mesh-list
65643373|NCT02054442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65643374|NCT02054442|Abortifacient Agents|abortifacient agents|mesh-ancestor
65643375|NCT02054442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65643376|NCT02054442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643377|NCT02054442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65643378|NCT02054442|Antimetabolites|antimetabolites|mesh-ancestor
65643379|NCT02054442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643380|NCT02054442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65643381|NCT02054442|Dermatologic Agents|dermatologic agents|mesh-ancestor
65643382|NCT02054442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643383|NCT02054442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65643384|NCT02054442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65643385|NCT02054442|Immunologic Factors|immunologic factors|mesh-ancestor
65643386|NCT02054442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65643387|NCT02054442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65643388|NCT02054442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65643389|NCT02054676|Ibuprofen|ibuprofen|mesh-list
65643390|NCT02054676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65643391|NCT02054676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65643392|NCT02054676|Analgesics|analgesics|mesh-ancestor
65643393|NCT02054676|Sensory System Agents|sensory system agents|mesh-ancestor
65643394|NCT02054676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643395|NCT02054676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643396|NCT02054676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65643397|NCT02054676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65643398|NCT02054676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65643399|NCT02054676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643400|NCT02054676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643401|NCT02256956|Amitriptyline|amitriptyline|mesh-list
65643402|NCT02256956|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65643403|NCT02256956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65643404|NCT02256956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65643405|NCT02256956|Cholinergic Agents|cholinergic agents|mesh-ancestor
65643406|NCT02256956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65643407|NCT02256956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643408|NCT02256956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643409|NCT02256956|Urological Agents|urological agents|mesh-ancestor
65643410|NCT02256956|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65643411|NCT02256956|Antidepressive Agents|antidepressive agents|mesh-ancestor
65643412|NCT02256956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65643413|NCT02256956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65643414|NCT02256956|Analgesics|analgesics|mesh-ancestor
65643415|NCT02256956|Sensory System Agents|sensory system agents|mesh-ancestor
65643416|NCT02256956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643417|NCT02256956|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65643418|NCT02256956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65643419|NCT02256956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65643420|NCT02256956|Adrenergic Agents|adrenergic agents|mesh-ancestor
65643421|NCT02187536|Telmisartan|telmisartan|mesh-list
65643422|NCT02187536|Simvastatin|simvastatin|mesh-list
65643423|NCT02187536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65643424|NCT02187536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65643425|NCT02187536|Antimetabolites|antimetabolites|mesh-ancestor
65643426|NCT02187536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643427|NCT02187536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65643428|NCT02187536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65643429|NCT02187536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643430|NCT02187536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65643431|NCT02187536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65643432|NCT02187536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65643433|NCT02256722|Propranolol|propranolol|mesh-list
65643434|NCT02256722|Bisoprolol|bisoprolol|mesh-list
65643435|NCT02256722|Acipimox|acipimox|mesh-list
65643436|NCT02256722|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65643437|NCT02256722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65643438|NCT02256722|Autonomic Agents|autonomic agents|mesh-ancestor
65643439|NCT02256722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643440|NCT02256722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643441|NCT02256722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65643442|NCT02256722|Respiratory System Agents|respiratory system agents|mesh-ancestor
65643443|NCT02256722|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65643444|NCT02256722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65643445|NCT02256722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65643446|NCT02256722|Adrenergic Agents|adrenergic agents|mesh-ancestor
65643447|NCT02256722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65643448|NCT02256722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643449|NCT02256722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65643450|NCT02256722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65643451|NCT02256722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65643452|NCT02256722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65643453|NCT02256722|Vasodilator Agents|vasodilator agents|mesh-ancestor
65643454|NCT02256722|Sympatholytics|sympatholytics|mesh-ancestor
65643455|NCT02256722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65643456|NCT02256722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65643457|NCT02256722|Antimetabolites|antimetabolites|mesh-ancestor
65643458|NCT02256722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65643459|NCT02193620|Nalbuphine|nalbuphine|mesh-list
65643460|NCT02193620|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65643461|NCT02193620|Narcotics|narcotics|mesh-ancestor
65643462|NCT02193620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65643463|NCT02193620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643464|NCT02193620|Analgesics|analgesics|mesh-ancestor
65643465|NCT02193620|Sensory System Agents|sensory system agents|mesh-ancestor
65643466|NCT02193620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643467|NCT05624268|Psilocybin|psilocybin|mesh-list
65643468|NCT05624268|Hallucinogens|hallucinogens|mesh-ancestor
65643469|NCT05624268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643470|NCT05624268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65643471|NCT02187614|Acetaminophen|acetaminophen|mesh-list
65643472|NCT02187614|Diclofenac|diclofenac|mesh-list
65643473|NCT02187614|Morphine|morphine|mesh-list
65643474|NCT02187614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65643475|NCT02187614|Narcotics|narcotics|mesh-ancestor
65643476|NCT02187614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65643477|NCT02187614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643478|NCT02187614|Analgesics|analgesics|mesh-ancestor
65643479|NCT02187614|Sensory System Agents|sensory system agents|mesh-ancestor
65643480|NCT02187614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643481|NCT02187614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65643482|NCT02187614|Antipyretics|antipyretics|mesh-ancestor
65643483|NCT02187614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65643484|NCT02187614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65643485|NCT02187614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65643486|NCT02187614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65643487|NCT02187614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643488|NCT02187614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643489|NCT02030678|Irinotecan|irinotecan|mesh-list
65643490|NCT02030678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65643491|NCT02030678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65643492|NCT02030678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643493|NCT02030678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643494|NCT02030678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65643495|NCT02054988|Caffeine|caffeine|mesh-list
65643496|NCT02054988|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65643497|NCT02054988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643498|NCT02054988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65643499|NCT02054988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643500|NCT02054988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643501|NCT02054988|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65643502|NCT02054988|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65643503|NCT02054988|Purinergic Agents|purinergic agents|mesh-ancestor
65643504|NCT02054988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65643505|NCT02191124|Mirtazapine|mirtazapine|mesh-list
65643506|NCT02191124|Paroxetine|paroxetine|mesh-list
65643507|NCT02191124|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65643508|NCT02191124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65643509|NCT02191124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65643510|NCT02191124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643511|NCT02191124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65643512|NCT02191124|Serotonin Agents|serotonin agents|mesh-ancestor
65643513|NCT02191124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643514|NCT02191124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65643515|NCT02191124|Antidepressive Agents|antidepressive agents|mesh-ancestor
65643516|NCT02191124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65643517|NCT02191124|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65643518|NCT02191124|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65643519|NCT02191124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643520|NCT02191124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65643521|NCT02191124|Histamine Antagonists|histamine antagonists|mesh-ancestor
65643522|NCT02191124|Histamine Agents|histamine agents|mesh-ancestor
65643523|NCT02191124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65643524|NCT02191124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65643525|NCT02191124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65643526|NCT02191124|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65643527|NCT02191124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65643528|NCT02191124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65643529|NCT02191124|Adrenergic Agents|adrenergic agents|mesh-ancestor
65643530|NCT02191124|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65643531|NCT02191124|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65643532|NCT02191124|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65643533|NCT02193698|Dexamethasone|dexamethasone|mesh-list
65643534|NCT02193698|Lenalidomide|lenalidomide|mesh-list
65643535|NCT02193698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65643536|NCT02193698|Antiemetics|antiemetics|mesh-ancestor
65643537|NCT02193698|Autonomic Agents|autonomic agents|mesh-ancestor
65643538|NCT02193698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643539|NCT02193698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643540|NCT02193698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65643541|NCT02193698|Glucocorticoids|glucocorticoids|mesh-ancestor
65643542|NCT02193698|Hormones|hormones|mesh-ancestor
65267592|NCT02692248|Rituximab|rituximab|mesh-list
65643543|NCT02193698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65643544|NCT02193698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65643545|NCT02193698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65643546|NCT02193698|Immunologic Factors|immunologic factors|mesh-ancestor
65643547|NCT02193698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65643548|NCT02193698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65643549|NCT02193698|Growth Substances|growth substances|mesh-ancestor
65643550|NCT02193698|Growth Inhibitors|growth inhibitors|mesh-ancestor
65643551|NCT02191202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
65643552|NCT02191202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65643553|NCT02191202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643554|NCT02191202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643555|NCT02191202|Antiviral Agents|antiviral agents|mesh-ancestor
65643556|NCT02191202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65643557|NCT02055300|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65643558|NCT02055300|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65643559|NCT02055300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65643560|NCT02055300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65643561|NCT02055300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643562|NCT02055300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65643563|NCT02055300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643564|NCT02055300|Antidepressive Agents|antidepressive agents|mesh-ancestor
65643565|NCT02055300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65643566|NCT02191280|Quercetin|quercetin|mesh-list
65643567|NCT02191280|Antioxidants|antioxidants|mesh-ancestor
65643568|NCT02191280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643569|NCT02191280|Protective Agents|protective agents|mesh-ancestor
65643570|NCT02191280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643571|NCT02055378|Atropine|atropine|mesh-list
65643572|NCT02055378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65643573|NCT02055378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65643574|NCT02055378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65643575|NCT02055378|Autonomic Agents|autonomic agents|mesh-ancestor
65643576|NCT02055378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643577|NCT02055378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643578|NCT02055378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65643579|NCT02055378|Respiratory System Agents|respiratory system agents|mesh-ancestor
65643580|NCT02055378|Mydriatics|mydriatics|mesh-ancestor
65643581|NCT02055378|Parasympatholytics|parasympatholytics|mesh-ancestor
65643582|NCT02055378|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65643583|NCT02055378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65643584|NCT02055378|Cholinergic Agents|cholinergic agents|mesh-ancestor
65643585|NCT02055378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65643586|NCT02055378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643587|NCT04558190|Ubiquinone|ubiquinone|mesh-list
65643588|NCT04558190|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65643589|NCT04558190|Albuterol|albuterol|mesh-list
65643590|NCT04558190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65643591|NCT04558190|Autonomic Agents|autonomic agents|mesh-ancestor
65643592|NCT04558190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643593|NCT04558190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643594|NCT04558190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65643595|NCT04558190|Respiratory System Agents|respiratory system agents|mesh-ancestor
65643596|NCT04558190|Tocolytic Agents|tocolytic agents|mesh-ancestor
65440921|NCT01015391|Azathioprine|azathioprine|mesh-list
65643597|NCT04558190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65643598|NCT04558190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65643599|NCT04558190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65643600|NCT04558190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65643601|NCT04558190|Adrenergic Agents|adrenergic agents|mesh-ancestor
65643602|NCT04558190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65643603|NCT04558190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643604|NCT04558190|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65643605|NCT04558190|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65643606|NCT04558190|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65643607|NCT04558190|Micronutrients|micronutrients|mesh-ancestor
65643608|NCT02055456|Nandrolone Decanoate|nandrolone decanoate|mesh-list
65643609|NCT02055456|Nandrolone|nandrolone|mesh-list
65643610|NCT02055456|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
65643611|NCT02055456|Androgens|androgens|mesh-ancestor
65643612|NCT02055456|Hormones|hormones|mesh-ancestor
65643613|NCT02055456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65643614|NCT02055456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643615|NCT02055456|Anabolic Agents|anabolic agents|mesh-ancestor
65643616|NCT02055456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65643617|NCT03676959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65643618|NCT03676959|Antibodies|antibodies|mesh-list
65643619|NCT03676959|Immunoglobulins|immunoglobulins|mesh-list
65643620|NCT03676959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65643621|NCT03676959|Immunologic Factors|immunologic factors|mesh-ancestor
65643622|NCT03676959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643623|NCT03676959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65643624|NCT03755973|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65643625|NCT03755973|Hormones|hormones|mesh-ancestor
65643626|NCT03755973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65643627|NCT03755973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643628|NCT02056938|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65643629|NCT02056938|Basiliximab|basiliximab|mesh-list
65643630|NCT02056938|Immunologic Factors|immunologic factors|mesh-ancestor
65643631|NCT02056938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643632|NCT02056938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65643633|NCT02191670|Tenecteplase|tenecteplase|mesh-list
65643634|NCT02191670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65643635|NCT02191670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65643636|NCT02191670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643637|NCT02057094|Caseins|caseins|mesh-list
65643638|NCT02057094|Chelating Agents|chelating agents|mesh-ancestor
65643639|NCT02057094|Sequestering Agents|sequestering agents|mesh-ancestor
65643640|NCT02057094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643641|NCT02917941|Dexamethasone|dexamethasone|mesh-list
65643642|NCT02917941|Lenalidomide|lenalidomide|mesh-list
65643643|NCT02917941|Ixazomib|ixazomib|mesh-list
65643644|NCT02917941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65643645|NCT02917941|Antiemetics|antiemetics|mesh-ancestor
65643646|NCT02917941|Autonomic Agents|autonomic agents|mesh-ancestor
65643647|NCT02917941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643648|NCT02917941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643649|NCT02917941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65643650|NCT02917941|Glucocorticoids|glucocorticoids|mesh-ancestor
65643651|NCT02917941|Hormones|hormones|mesh-ancestor
65643652|NCT02917941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65643653|NCT02917941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65643654|NCT02917941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65643655|NCT02917941|Immunologic Factors|immunologic factors|mesh-ancestor
65643656|NCT02917941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65643657|NCT02917941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65643658|NCT02917941|Growth Substances|growth substances|mesh-ancestor
65643659|NCT02917941|Growth Inhibitors|growth inhibitors|mesh-ancestor
65643660|NCT02917941|Protease Inhibitors|protease inhibitors|mesh-ancestor
65643661|NCT02917941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643662|NCT02917941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643663|NCT02055690|Fosbretabulin|fosbretabulin|mesh-list
65643664|NCT02055690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65643665|NCT02055690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65643666|NCT02191748|Triamcinolone|triamcinolone|mesh-list
65643667|NCT02191748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65643668|NCT02191748|Glucocorticoids|glucocorticoids|mesh-ancestor
65643669|NCT02191748|Hormones|hormones|mesh-ancestor
65643670|NCT02191748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65440998|NCT01015547|Analgesics|analgesics|mesh-ancestor
65643671|NCT02191748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643672|NCT02191826|Tolcapone|tolcapone|mesh-list
65643673|NCT02191826|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65643674|NCT02191826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65643675|NCT02191826|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65643676|NCT02191826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643677|NCT02191826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643678|NCT01333956|Pregabalin|pregabalin|mesh-list
65643679|NCT01333956|Analgesics|analgesics|mesh-ancestor
65643680|NCT01333956|Sensory System Agents|sensory system agents|mesh-ancestor
65643681|NCT01333956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643682|NCT01333956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643683|NCT01333956|Anticonvulsants|anticonvulsants|mesh-ancestor
65643684|NCT01333956|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65643685|NCT01333956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65643686|NCT01333956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643687|NCT01333956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65643688|NCT01333956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65643689|NCT01333956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65643690|NCT01333956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65643691|NCT01333956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65643692|NCT02057328|Telmisartan|telmisartan|mesh-list
65643693|NCT02057328|Nebivolol|nebivolol|mesh-list
65643694|NCT02057328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65643695|NCT02057328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65643696|NCT02057328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65643697|NCT02057328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643698|NCT02057328|Vasodilator Agents|vasodilator agents|mesh-ancestor
65643699|NCT02057328|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65643700|NCT02057328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65643701|NCT02057328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65643702|NCT02057328|Adrenergic Agents|adrenergic agents|mesh-ancestor
65643703|NCT02057328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65643704|NCT02057328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643705|NCT02057484|Tacrolimus|tacrolimus|mesh-list
65643706|NCT02057484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65643707|NCT02057484|Immunologic Factors|immunologic factors|mesh-ancestor
65643708|NCT02057484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643709|NCT02057484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65643710|NCT02057484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643711|NCT02057484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643712|NCT02192060|Triclosan|triclosan|mesh-list
65643713|NCT02192060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65643714|NCT02192060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65643715|NCT02192060|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65643716|NCT02192060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65643717|NCT02192060|Antimetabolites|antimetabolites|mesh-ancestor
65643718|NCT02192060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643719|NCT02192060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65643720|NCT02188394|Bupivacaine|bupivacaine|mesh-list
65643721|NCT02188394|Anesthetics|anesthetics|mesh-list
65643722|NCT02188394|Anesthetics, Local|anesthetics, local|mesh-ancestor
65643723|NCT02188394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65643724|NCT02188394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643725|NCT02188394|Sensory System Agents|sensory system agents|mesh-ancestor
65643726|NCT02188394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643727|NCT01333722|Acetaminophen|acetaminophen|mesh-list
65643728|NCT01333722|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65643729|NCT01333722|Hydrocodone|hydrocodone|mesh-list
65643730|NCT01333722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65643731|NCT01333722|Analgesics|analgesics|mesh-ancestor
65643732|NCT01333722|Sensory System Agents|sensory system agents|mesh-ancestor
65643733|NCT01333722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643734|NCT01333722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643735|NCT01333722|Antipyretics|antipyretics|mesh-ancestor
65643736|NCT01333722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65643737|NCT01333722|Narcotics|narcotics|mesh-ancestor
65643738|NCT01333722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65643739|NCT01333722|Antitussive Agents|antitussive agents|mesh-ancestor
65643740|NCT01333722|Respiratory System Agents|respiratory system agents|mesh-ancestor
65643741|NCT01333722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65643742|NCT01333722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65643743|NCT01333722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65643744|NCT02188472|Trimethoprim|trimethoprim|mesh-list
65643745|NCT02188472|Penicillins|penicillins|mesh-list
65643746|NCT02188472|Penicillin V|penicillin v|mesh-list
65643747|NCT02188472|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65643748|NCT02188472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65643749|NCT02188472|Renal Agents|renal agents|mesh-ancestor
65643750|NCT02188472|Antimalarials|antimalarials|mesh-ancestor
65643751|NCT02188472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65643752|NCT02188472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65643753|NCT02188472|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65643754|NCT02188472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643755|NCT02188472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643756|NCT02188472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65643757|NCT02188472|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65643758|NCT02188472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65643759|NCT02188472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65643760|NCT02188550|Everolimus|everolimus|mesh-list
65643761|NCT02188550|Letrozole|letrozole|mesh-list
65643762|NCT02188550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65643763|NCT02188550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65643764|NCT02188550|Immunologic Factors|immunologic factors|mesh-ancestor
65643765|NCT02188550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643766|NCT02188550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65643767|NCT02188550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65643768|NCT02188550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643769|NCT02188550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643770|NCT02188550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65643771|NCT02188550|Hormone Antagonists|hormone antagonists|mesh-ancestor
65643772|NCT02188550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65643773|NCT02059590|Isavuconazole|isavuconazole|mesh-list
65643774|NCT02059590|Antifungal Agents|antifungal agents|mesh-ancestor
65643775|NCT02059590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65643776|NCT02057796|Efavirenz|efavirenz|mesh-list
65643777|NCT02057796|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65643778|NCT02057796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65643779|NCT02057796|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
65643780|NCT02057796|Rifampin|rifampin|mesh-list
65643781|NCT02057796|Isoniazid|isoniazid|mesh-list
65643782|NCT02057796|Pyrazinamide|pyrazinamide|mesh-list
65643783|NCT02057796|Ethambutol|ethambutol|mesh-list
65643784|NCT02057796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65643785|NCT02057796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65643786|NCT02057796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643787|NCT02057796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643788|NCT02057796|Antiviral Agents|antiviral agents|mesh-ancestor
65643789|NCT02057796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65643790|NCT02057796|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65643791|NCT02057796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65643792|NCT02057796|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65643793|NCT02057796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65643794|NCT02057796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65643795|NCT02057796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65643796|NCT02057796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65643797|NCT02057796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65643798|NCT02057796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65643799|NCT02057796|Antitubercular Agents|antitubercular agents|mesh-ancestor
65643800|NCT02057796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65643801|NCT02057796|Leprostatic Agents|leprostatic agents|mesh-ancestor
65643802|NCT02057796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65643803|NCT02057796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65643804|NCT02057796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65643805|NCT02057796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65643806|NCT02057796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65643807|NCT02057796|Antimetabolites|antimetabolites|mesh-ancestor
65643808|NCT02057796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65643809|NCT02192450|Insulin|insulin|mesh-list
65643810|NCT02192450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65643811|NCT02192450|Insulin Aspart|insulin aspart|mesh-list
65643812|NCT02192450|Insulin, Long-Acting|insulin, long-acting|mesh-list
65643813|NCT02192450|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65643814|NCT02192450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65643815|NCT02192450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643816|NCT03284385|Adavosertib|adavosertib|mesh-list
65643817|NCT03284385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643818|NCT03284385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643819|NCT03560856|Fulvestrant|fulvestrant|mesh-list
65643820|NCT03560856|Palbociclib|palbociclib|mesh-list
65643821|NCT03560856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65643822|NCT03560856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65643823|NCT03560856|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65643824|NCT03560856|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65643825|NCT03560856|Hormone Antagonists|hormone antagonists|mesh-ancestor
65643826|NCT03560856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65643827|NCT03560856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643828|NCT03560856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65643829|NCT03560856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643830|NCT03560856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643831|NCT03676413|Fluticasone|fluticasone|mesh-list
65643832|NCT03676413|Xhance|xhance|mesh-list
65643833|NCT03676413|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65643834|NCT03676413|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65643835|NCT03676413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65643836|NCT03676413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65643837|NCT03676413|Autonomic Agents|autonomic agents|mesh-ancestor
65643838|NCT03676413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643839|NCT03676413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643840|NCT03676413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65643841|NCT03676413|Respiratory System Agents|respiratory system agents|mesh-ancestor
65643842|NCT03676413|Dermatologic Agents|dermatologic agents|mesh-ancestor
65643843|NCT03676413|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65643844|NCT03676413|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65643845|NCT03676413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65643846|NCT03676413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65643847|NCT03676413|Adrenergic Agents|adrenergic agents|mesh-ancestor
65643848|NCT03676413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65643849|NCT03676413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643850|NCT03676413|Glucocorticoids|glucocorticoids|mesh-ancestor
65643851|NCT03676413|Hormones|hormones|mesh-ancestor
65643852|NCT03676413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65643853|NCT03676413|Sympathomimetics|sympathomimetics|mesh-ancestor
65643854|NCT03676335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65643855|NCT03676335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65643856|NCT01370694|Prednisolone|prednisolone|mesh-list
65643857|NCT01370694|Cyclophosphamide|cyclophosphamide|mesh-list
65643858|NCT01370694|Vincristine|vincristine|mesh-list
65643859|NCT01370694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65643860|NCT01370694|Immunologic Factors|immunologic factors|mesh-ancestor
65643861|NCT01370694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643862|NCT01370694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65643863|NCT01370694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65643864|NCT01370694|Alkylating Agents|alkylating agents|mesh-ancestor
65643865|NCT01370694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643866|NCT01370694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65643867|NCT01370694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65643868|NCT01370694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65643869|NCT01370694|Tubulin Modulators|tubulin modulators|mesh-ancestor
65643870|NCT01370694|Antimitotic Agents|antimitotic agents|mesh-ancestor
65643871|NCT01370694|Mitosis Modulators|mitosis modulators|mesh-ancestor
65643872|NCT01370694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65643873|NCT01370694|Glucocorticoids|glucocorticoids|mesh-ancestor
65643874|NCT01370694|Hormones|hormones|mesh-ancestor
65643875|NCT01370694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65643876|NCT01370694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65643877|NCT02256878|Amitriptyline|amitriptyline|mesh-list
65643878|NCT02256878|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65643879|NCT02256878|Antidepressive Agents|antidepressive agents|mesh-ancestor
65643880|NCT02256878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65643881|NCT02256878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65643882|NCT02256878|Analgesics|analgesics|mesh-ancestor
65643883|NCT02256878|Sensory System Agents|sensory system agents|mesh-ancestor
65643884|NCT02256878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643885|NCT02256878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643886|NCT02256878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65643887|NCT02256878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65643888|NCT02256878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65643889|NCT02256878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441219|NCT01054118|Incretins|incretins|mesh-ancestor
65643890|NCT02256878|Adrenergic Agents|adrenergic agents|mesh-ancestor
65643891|NCT02256878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65643892|NCT02058186|Vitamin D|vitamin d|mesh-list
65643893|NCT02058186|Vitamins|vitamins|mesh-ancestor
65643894|NCT02058186|Micronutrients|micronutrients|mesh-ancestor
65643895|NCT02058186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643896|NCT02058186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65643897|NCT03676023|Tranexamic Acid|tranexamic acid|mesh-list
65643898|NCT03676023|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65643899|NCT03676023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65643900|NCT03676023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643901|NCT03676023|Hemostatics|hemostatics|mesh-ancestor
65643902|NCT03676023|Coagulants|coagulants|mesh-ancestor
65643903|NCT02260206|Colchicine|colchicine|mesh-list
65643904|NCT02260206|Gout Suppressants|gout suppressants|mesh-ancestor
65643905|NCT02260206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65643906|NCT02260206|Tubulin Modulators|tubulin modulators|mesh-ancestor
65643907|NCT02260206|Antimitotic Agents|antimitotic agents|mesh-ancestor
65643908|NCT02260206|Mitosis Modulators|mitosis modulators|mesh-ancestor
65643909|NCT02260206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643910|NCT02260206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65643911|NCT02661282|Temozolomide|temozolomide|mesh-list
65643912|NCT02661282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65643913|NCT02661282|Alkylating Agents|alkylating agents|mesh-ancestor
65643914|NCT02661282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643915|NCT02661282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65643916|NCT02058576|Tamsulosin|tamsulosin|mesh-list
65643917|NCT02058576|Dutasteride|dutasteride|mesh-list
65643918|NCT02058576|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65643919|NCT02058576|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65643920|NCT02058576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65643921|NCT02058576|Adrenergic Agents|adrenergic agents|mesh-ancestor
65643922|NCT02058576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65643923|NCT02058576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643924|NCT02058576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643925|NCT02058576|Urological Agents|urological agents|mesh-ancestor
65643926|NCT02058576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65643927|NCT02058576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65643928|NCT02058576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643929|NCT02058576|Hormone Antagonists|hormone antagonists|mesh-ancestor
65643930|NCT02058576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65643931|NCT03535220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
65643932|NCT03535220|Protease Inhibitors|protease inhibitors|mesh-list
65643933|NCT03535220|Proteasome Inhibitors|proteasome inhibitors|mesh-list
65643934|NCT03535220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65643935|NCT03535220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643936|NCT03535220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65643937|NCT03535220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65643938|NCT03535220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65643939|NCT03535220|Antiviral Agents|antiviral agents|mesh-ancestor
65643940|NCT03535220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65643941|NCT02189720|Amifampridine|amifampridine|mesh-list
65643942|NCT02189720|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65643943|NCT02189720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643944|NCT02189720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643945|NCT02189720|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65643946|NCT02189720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65643947|NCT02189720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643948|NCT03675555|Dexamethasone|dexamethasone|mesh-list
65643949|NCT03675555|Mirtazapine|mirtazapine|mesh-list
65643950|NCT03675555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65643951|NCT03675555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65643952|NCT03675555|Antiemetics|antiemetics|mesh-ancestor
65643953|NCT03675555|Autonomic Agents|autonomic agents|mesh-ancestor
65643954|NCT03675555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643955|NCT03675555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643956|NCT03675555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65643957|NCT03675555|Glucocorticoids|glucocorticoids|mesh-ancestor
65643958|NCT03675555|Hormones|hormones|mesh-ancestor
65643959|NCT03675555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65643960|NCT03675555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65643961|NCT03675555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65643962|NCT03675555|Antidepressive Agents|antidepressive agents|mesh-ancestor
65441295|NCT00376688|Sirolimus|sirolimus|mesh-list
65643963|NCT03675555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65643964|NCT03675555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65643965|NCT03675555|Histamine Antagonists|histamine antagonists|mesh-ancestor
65643966|NCT03675555|Histamine Agents|histamine agents|mesh-ancestor
65643967|NCT03675555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65643968|NCT03675555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643969|NCT03675555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65643970|NCT03675555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65643971|NCT03675555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65643972|NCT03675555|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65643973|NCT03675555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65643974|NCT03675555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65643975|NCT03675555|Adrenergic Agents|adrenergic agents|mesh-ancestor
65643976|NCT03675555|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65643977|NCT03675555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65643978|NCT03675555|Serotonin Agents|serotonin agents|mesh-ancestor
65643979|NCT03675555|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65643980|NCT02194166|Paclitaxel|paclitaxel|mesh-list
65643981|NCT02194166|Docetaxel|docetaxel|mesh-list
65643982|NCT02194166|Trastuzumab|trastuzumab|mesh-list
65643983|NCT02194166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65643984|NCT02194166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65643985|NCT02194166|Tubulin Modulators|tubulin modulators|mesh-ancestor
65643986|NCT02194166|Antimitotic Agents|antimitotic agents|mesh-ancestor
65643987|NCT02194166|Mitosis Modulators|mitosis modulators|mesh-ancestor
65643988|NCT02194166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65643989|NCT02194166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65643990|NCT03683277|Dexamethasone|dexamethasone|mesh-list
65643991|NCT03683277|Pomalidomide|pomalidomide|mesh-list
65643992|NCT03683277|Ixazomib|ixazomib|mesh-list
65643993|NCT03683277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65643994|NCT03683277|Antiemetics|antiemetics|mesh-ancestor
65643995|NCT03683277|Autonomic Agents|autonomic agents|mesh-ancestor
65643996|NCT03683277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65643997|NCT03683277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65643998|NCT03683277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65643999|NCT03683277|Glucocorticoids|glucocorticoids|mesh-ancestor
65644000|NCT03683277|Hormones|hormones|mesh-ancestor
65644001|NCT03683277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65644002|NCT03683277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65644003|NCT03683277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644004|NCT03683277|Immunologic Factors|immunologic factors|mesh-ancestor
65644005|NCT03683277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65644006|NCT03683277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65644007|NCT03683277|Growth Substances|growth substances|mesh-ancestor
65644008|NCT03683277|Growth Inhibitors|growth inhibitors|mesh-ancestor
65644009|NCT03683277|Protease Inhibitors|protease inhibitors|mesh-ancestor
65644010|NCT03683277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644011|NCT03683277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644012|NCT02193308|Amlodipine|amlodipine|mesh-list
65644013|NCT02193308|Telmisartan|telmisartan|mesh-list
65644014|NCT02193308|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
65644015|NCT02193308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65644016|NCT02193308|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65644017|NCT02193308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65644018|NCT02193308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644019|NCT02193308|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65644020|NCT02193308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644021|NCT02193308|Vasodilator Agents|vasodilator agents|mesh-ancestor
65644022|NCT02193308|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65644023|NCT02193308|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65644024|NCT02060604|Ketorolac|ketorolac|mesh-list
65644025|NCT02060604|Ranibizumab|ranibizumab|mesh-list
65644026|NCT02060604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65644027|NCT02060604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65644028|NCT02060604|Growth Substances|growth substances|mesh-ancestor
65644029|NCT02060604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644030|NCT02060604|Growth Inhibitors|growth inhibitors|mesh-ancestor
65644031|NCT02060604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644032|NCT02060604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65644033|NCT02060604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65644034|NCT02060604|Analgesics|analgesics|mesh-ancestor
65644035|NCT02060604|Sensory System Agents|sensory system agents|mesh-ancestor
65644036|NCT02060604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65644037|NCT02060604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65644038|NCT02060604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65644039|NCT02060604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65644040|NCT02060604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644041|NCT02060604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644043|NCT03679455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65644044|NCT03679455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644045|NCT03315143|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65644046|NCT03315143|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65644047|NCT03315143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644048|NCT03315143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65644049|NCT03315143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644050|NCT02194556|Gemcitabine|gemcitabine|mesh-list
65644051|NCT02194556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65644052|NCT02194556|Antimetabolites|antimetabolites|mesh-ancestor
65644053|NCT02194556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644054|NCT02194556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644055|NCT02194556|Antiviral Agents|antiviral agents|mesh-ancestor
65644056|NCT02194556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65644057|NCT02194556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644058|NCT02194556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65644059|NCT02194556|Immunologic Factors|immunologic factors|mesh-ancestor
65644060|NCT02194556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644061|NCT02030912|Amoxicillin|amoxicillin|mesh-list
65644062|NCT02030912|Minocycline|minocycline|mesh-list
65644063|NCT02030912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65644064|NCT02030912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65644065|NCT02060916|PAZ320|paz320|mesh-list
65644066|NCT02060916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65644067|NCT02060916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644068|NCT04649060|Dexamethasone|dexamethasone|mesh-list
65644069|NCT04649060|Melphalan|melphalan|mesh-list
65644070|NCT04649060|Daratumumab|daratumumab|mesh-list
65644071|NCT04649060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65644072|NCT04649060|Antiemetics|antiemetics|mesh-ancestor
65644073|NCT04649060|Autonomic Agents|autonomic agents|mesh-ancestor
65644074|NCT04649060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65644075|NCT04649060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644076|NCT04649060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65644077|NCT04649060|Glucocorticoids|glucocorticoids|mesh-ancestor
65644078|NCT04649060|Hormones|hormones|mesh-ancestor
65644079|NCT04649060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65644080|NCT04649060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65644081|NCT04649060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644082|NCT04649060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65644083|NCT04649060|Alkylating Agents|alkylating agents|mesh-ancestor
65644084|NCT04649060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644085|NCT04649060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65644086|NCT04649060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65644087|NCT04649060|Immunologic Factors|immunologic factors|mesh-ancestor
65644088|NCT02797080|Interferons|interferons|mesh-list
65644089|NCT02797080|Interferon-gamma|interferon-gamma|mesh-list
65644090|NCT02797080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644091|NCT02797080|Antiviral Agents|antiviral agents|mesh-ancestor
65644092|NCT02797080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65644093|NCT02196194|Tiotropium Bromide|tiotropium bromide|mesh-list
65644094|NCT02196194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65644095|NCT02196194|Autonomic Agents|autonomic agents|mesh-ancestor
65644096|NCT02196194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65644097|NCT02196194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644098|NCT02196194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65644099|NCT02196194|Respiratory System Agents|respiratory system agents|mesh-ancestor
65644100|NCT02196194|Parasympatholytics|parasympatholytics|mesh-ancestor
65644101|NCT02196194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65644102|NCT02196194|Cholinergic Agents|cholinergic agents|mesh-ancestor
65644103|NCT02196194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65644104|NCT02196194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644105|NCT02915835|Riociguat|riociguat|mesh-list
65644106|NCT02915835|Enzyme Activators|enzyme activators|mesh-ancestor
65644107|NCT02915835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644108|NCT01370616|Amoxicillin|amoxicillin|mesh-list
65644109|NCT01370616|Tazobactam|tazobactam|mesh-list
65644110|NCT01370616|Piperacillin|piperacillin|mesh-list
65644111|NCT01370616|Ertapenem|ertapenem|mesh-list
65644112|NCT01370616|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65644113|NCT01370616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65644114|NCT01370616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65644115|NCT01370616|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65644116|NCT01370616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644117|NCT01370616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644118|NCT02688881|Sirolimus|sirolimus|mesh-list
65644119|NCT02688881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65644120|NCT02688881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65644121|NCT02688881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65644122|NCT02688881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644123|NCT02688881|Antifungal Agents|antifungal agents|mesh-ancestor
65644124|NCT02688881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65644125|NCT02688881|Immunologic Factors|immunologic factors|mesh-ancestor
65644126|NCT02688881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644127|NCT03560310|Ticagrelor|ticagrelor|mesh-list
65644128|NCT03560310|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65644129|NCT03560310|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65644130|NCT03560310|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65644131|NCT03560310|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65644132|NCT03560310|Purinergic Agents|purinergic agents|mesh-ancestor
65644133|NCT03560310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65644134|NCT03560310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644135|NCT03560310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644136|NCT02197286|Vitamin D|vitamin d|mesh-list
65644137|NCT02197286|Ergocalciferols|ergocalciferols|mesh-list
65644138|NCT02197286|Cholecalciferol|cholecalciferol|mesh-list
65644139|NCT02197286|Vitamins|vitamins|mesh-list
65644140|NCT02197286|Micronutrients|micronutrients|mesh-ancestor
65644141|NCT02197286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644142|NCT02197286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65644143|NCT02197286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65644144|NCT02197442|Valsartan|valsartan|mesh-list
65644145|NCT02197442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65644146|NCT02197442|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65644147|NCT02197442|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65644148|NCT02197442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644149|NCT03534674|Vitamin D|vitamin d|mesh-list
65644150|NCT03534674|Cholecalciferol|cholecalciferol|mesh-list
65644151|NCT03534674|Vitamins|vitamins|mesh-ancestor
65644152|NCT03534674|Micronutrients|micronutrients|mesh-ancestor
65644153|NCT03534674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644154|NCT03534674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65644155|NCT03534674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65644156|NCT02063334|Vitamin D|vitamin d|mesh-list
65644157|NCT02063334|Cholecalciferol|cholecalciferol|mesh-list
65644158|NCT02063334|Vitamins|vitamins|mesh-ancestor
65644159|NCT02063334|Micronutrients|micronutrients|mesh-ancestor
65644160|NCT02063334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644161|NCT02063334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65644162|NCT02063334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65644163|NCT02916927|Ketamine|ketamine|mesh-list
65644164|NCT02916927|Analgesics|analgesics|mesh-ancestor
65644165|NCT02916927|Sensory System Agents|sensory system agents|mesh-ancestor
65644166|NCT02916927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65644167|NCT02916927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644168|NCT02916927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65644169|NCT02916927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65644170|NCT02916927|Anesthetics, General|anesthetics, general|mesh-ancestor
65644171|NCT02916927|Anesthetics|anesthetics|mesh-ancestor
65644172|NCT02916927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65644173|NCT02916927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65644174|NCT02916927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65644175|NCT02916927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65644176|NCT02916927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644177|NCT02197598|Nalmefene|nalmefene|mesh-list
65644178|NCT02197598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65644179|NCT02197598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644180|NCT02197598|Sensory System Agents|sensory system agents|mesh-ancestor
65644181|NCT02197598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65644182|NCT02196662|Mesalamine|mesalamine|mesh-list
65644183|NCT02196662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65644184|NCT02196662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65644185|NCT02196662|Analgesics|analgesics|mesh-ancestor
65644186|NCT02196662|Sensory System Agents|sensory system agents|mesh-ancestor
65644187|NCT02196662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65644188|NCT02196662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644189|NCT02196662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65644190|NCT02196662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65644192|NCT02195180|Gemcitabine|gemcitabine|mesh-list
65644193|NCT02195180|Fluorouracil|fluorouracil|mesh-list
65644194|NCT02195180|Oxaliplatin|oxaliplatin|mesh-list
65644195|NCT02195180|Asparaginase|asparaginase|mesh-list
65644196|NCT02195180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65644197|NCT02195180|Antimetabolites|antimetabolites|mesh-ancestor
65644198|NCT02195180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644199|NCT02195180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644200|NCT02195180|Antiviral Agents|antiviral agents|mesh-ancestor
65644201|NCT02195180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65644202|NCT02195180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644203|NCT02195180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65644204|NCT02195180|Immunologic Factors|immunologic factors|mesh-ancestor
65644205|NCT02195180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644206|NCT02195180|Antidotes|antidotes|mesh-ancestor
65644207|NCT02195180|Protective Agents|protective agents|mesh-ancestor
65644208|NCT02195180|Vitamin B Complex|vitamin b complex|mesh-ancestor
65644209|NCT02195180|Vitamins|vitamins|mesh-ancestor
65644210|NCT02195180|Micronutrients|micronutrients|mesh-ancestor
65644211|NCT03623529|Angiotensin II|angiotensin ii|mesh-list
65644212|NCT03623529|Giapreza|giapreza|mesh-list
65644213|NCT03623529|Angiotensinogen|angiotensinogen|mesh-list
65644214|NCT03623529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65644215|NCT03623529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65644216|NCT03623529|Protease Inhibitors|protease inhibitors|mesh-ancestor
65644217|NCT03623529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644218|NCT03623529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644219|NCT03161379|Cyclophosphamide|cyclophosphamide|mesh-list
65644220|NCT03161379|Nivolumab|nivolumab|mesh-list
65644221|NCT03161379|Pancrelipase|pancrelipase|mesh-list
65644222|NCT03161379|Vaccines|vaccines|mesh-list
65644223|NCT03161379|Immunologic Factors|immunologic factors|mesh-ancestor
65644224|NCT03161379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644225|NCT03161379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65644226|NCT03161379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65644227|NCT03161379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65644228|NCT03161379|Alkylating Agents|alkylating agents|mesh-ancestor
65644229|NCT03161379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644230|NCT03161379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644231|NCT03161379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65644232|NCT03161379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65644233|NCT03161379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65644234|NCT03161379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65644235|NCT02197676|Guadecitabine|guadecitabine|mesh-list
65644236|NCT02197676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644237|NCT02916693|Mirabegron|mirabegron|mesh-list
65644238|NCT02916693|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65644239|NCT02916693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65644240|NCT02916693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65644241|NCT02916693|Adrenergic Agents|adrenergic agents|mesh-ancestor
65644242|NCT02916693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65644243|NCT02916693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644244|NCT02916693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644245|NCT02916693|Urological Agents|urological agents|mesh-ancestor
65644246|NCT02195336|Paclitaxel|paclitaxel|mesh-list
65644247|NCT02195336|Bevacizumab|bevacizumab|mesh-list
65644248|NCT02195336|Carboplatin|carboplatin|mesh-list
65644249|NCT02195336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65644250|NCT02195336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644251|NCT02195336|Tubulin Modulators|tubulin modulators|mesh-ancestor
65644252|NCT02195336|Antimitotic Agents|antimitotic agents|mesh-ancestor
65644253|NCT02195336|Mitosis Modulators|mitosis modulators|mesh-ancestor
65644254|NCT02195336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644255|NCT02195336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65644256|NCT02195336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65644257|NCT02195336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65644258|NCT02195336|Growth Substances|growth substances|mesh-ancestor
65644259|NCT02195336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644260|NCT02195336|Growth Inhibitors|growth inhibitors|mesh-ancestor
65644261|NCT03679065|Acetaminophen|acetaminophen|mesh-list
65644262|NCT03679065|Dexamethasone|dexamethasone|mesh-list
65644263|NCT03679065|Dexamethasone acetate|dexamethasone acetate|mesh-list
65644264|NCT03679065|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65644265|NCT03679065|BB 1101|bb 1101|mesh-list
65644266|NCT03679065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65644267|NCT03679065|Antiemetics|antiemetics|mesh-ancestor
65644268|NCT03679065|Autonomic Agents|autonomic agents|mesh-ancestor
65644269|NCT03679065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65644270|NCT03679065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644271|NCT03679065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65644272|NCT03679065|Glucocorticoids|glucocorticoids|mesh-ancestor
65644273|NCT03679065|Hormones|hormones|mesh-ancestor
65644274|NCT03679065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65644275|NCT03679065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65644276|NCT03679065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644277|NCT03679065|Protease Inhibitors|protease inhibitors|mesh-ancestor
65644278|NCT03679065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644279|NCT03679065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644280|NCT03679065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65644281|NCT03679065|Analgesics|analgesics|mesh-ancestor
65644282|NCT03679065|Sensory System Agents|sensory system agents|mesh-ancestor
65644283|NCT03679065|Antipyretics|antipyretics|mesh-ancestor
65644284|NCT02196740|Metronidazole|metronidazole|mesh-list
65644285|NCT02196740|Ciprofloxacin|ciprofloxacin|mesh-list
65644286|NCT02196740|Clindamycin|clindamycin|mesh-list
65644287|NCT02196740|Clindamycin palmitate|clindamycin palmitate|mesh-list
65644288|NCT02196740|Clindamycin phosphate|clindamycin phosphate|mesh-list
65644289|NCT02196740|Gatifloxacin|gatifloxacin|mesh-list
65644290|NCT02196740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65644291|NCT02196740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65644292|NCT02196740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65644293|NCT02196740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65644294|NCT02196740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65644295|NCT02196740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65644296|NCT02196740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644297|NCT02196740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644298|NCT02196740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644299|NCT02196740|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65644300|NCT02196740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65644301|NCT02196740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65644302|NCT02196740|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65644303|NCT02196740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65644304|NCT02195492|Hylan|hylan|mesh-list
65644305|NCT02195492|Viscosupplements|viscosupplements|mesh-ancestor
65644306|NCT02195492|Protective Agents|protective agents|mesh-ancestor
65644307|NCT02195492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644308|NCT03678987|Mycophenolic Acid|mycophenolic acid|mesh-list
65644309|NCT03678987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65644310|NCT03678987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644311|NCT03678987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65644312|NCT03678987|Antitubercular Agents|antitubercular agents|mesh-ancestor
65644313|NCT03678987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65644314|NCT03678987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65644315|NCT03678987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644316|NCT03678987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644317|NCT02919345|Dapagliflozin|dapagliflozin|mesh-list
65644318|NCT02919345|Glyburide|glyburide|mesh-list
65644319|NCT02919345|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65644320|NCT02919345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644321|NCT02919345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65644322|NCT02919345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644323|NCT02195804|Ranitidine|ranitidine|mesh-list
65644324|NCT02195804|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65644325|NCT02195804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65644326|NCT02195804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65644327|NCT02195804|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65644328|NCT02195804|Histamine Antagonists|histamine antagonists|mesh-ancestor
65644329|NCT02195804|Histamine Agents|histamine agents|mesh-ancestor
65644330|NCT02195804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65644331|NCT02195804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644332|NCT02195804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644333|NCT03672435|Proxymetacaine|proxymetacaine|mesh-list
65644334|NCT03672435|Anesthetics, Local|anesthetics, local|mesh-ancestor
65644335|NCT03672435|Anesthetics|anesthetics|mesh-ancestor
65644336|NCT03672435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65441670|NCT00490061|Lapatinib|lapatinib|mesh-list
65644337|NCT03672435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644338|NCT03672435|Sensory System Agents|sensory system agents|mesh-ancestor
65644339|NCT03672435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65644340|NCT03674385|Vitamin E|vitamin e|mesh-list
65644341|NCT03674385|Metformin|metformin|mesh-list
65644342|NCT03674385|Clomiphene|clomiphene|mesh-list
65644343|NCT03674385|Enclomiphene|enclomiphene|mesh-list
65644344|NCT03674385|Zuclomiphene|zuclomiphene|mesh-list
65644345|NCT03674385|Vitamins|vitamins|mesh-ancestor
65644346|NCT03674385|Micronutrients|micronutrients|mesh-ancestor
65644347|NCT03674385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644348|NCT03674385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65644349|NCT03674385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644350|NCT03674385|Antioxidants|antioxidants|mesh-ancestor
65644351|NCT03674385|Protective Agents|protective agents|mesh-ancestor
65644352|NCT03674385|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65644353|NCT03674385|Hormone Antagonists|hormone antagonists|mesh-ancestor
65644354|NCT03674385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65644355|NCT03674385|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65644356|NCT03674385|Fertility Agents|fertility agents|mesh-ancestor
65644357|NCT03674385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65644358|NCT03674385|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65644359|NCT03674385|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65644360|NCT02574455|Gemcitabine|gemcitabine|mesh-list
65644361|NCT02574455|Capecitabine|capecitabine|mesh-list
65644362|NCT02574455|Vinorelbine|vinorelbine|mesh-list
65644363|NCT02574455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65644364|NCT02574455|Antimetabolites|antimetabolites|mesh-ancestor
65644365|NCT02574455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644366|NCT02574455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644367|NCT02574455|Antiviral Agents|antiviral agents|mesh-ancestor
65644368|NCT02574455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65644369|NCT02574455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644370|NCT02574455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65644371|NCT02574455|Immunologic Factors|immunologic factors|mesh-ancestor
65644372|NCT02574455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644373|NCT02574455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65644374|NCT02574455|Tubulin Modulators|tubulin modulators|mesh-ancestor
65644375|NCT02574455|Antimitotic Agents|antimitotic agents|mesh-ancestor
65644376|NCT02574455|Mitosis Modulators|mitosis modulators|mesh-ancestor
65644377|NCT02197988|Fentanyl|fentanyl|mesh-list
65644378|NCT02197988|Bupivacaine|bupivacaine|mesh-list
65644379|NCT02197988|Anesthetics, Local|anesthetics, local|mesh-ancestor
65644380|NCT02197988|Anesthetics|anesthetics|mesh-ancestor
65644381|NCT02197988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65644382|NCT02197988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644383|NCT02197988|Sensory System Agents|sensory system agents|mesh-ancestor
65644384|NCT02197988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65644385|NCT02197988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65644386|NCT02197988|Narcotics|narcotics|mesh-ancestor
65644387|NCT02197988|Analgesics|analgesics|mesh-ancestor
65644388|NCT02197988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65644389|NCT02197988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65644390|NCT02197988|Anesthetics, General|anesthetics, general|mesh-ancestor
65644391|NCT03672357|Liver Extracts|liver extracts|mesh-list
65644392|NCT03672357|Hematinics|hematinics|mesh-ancestor
65644393|NCT02201030|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65644394|NCT02201030|Immunologic Factors|immunologic factors|mesh-ancestor
65644395|NCT02201030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644396|NCT03674073|Vaccines|vaccines|mesh-list
65644397|NCT03674073|Immunologic Factors|immunologic factors|mesh-ancestor
65644398|NCT03674073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644399|NCT03440190|Methylphenidate|methylphenidate|mesh-list
65644400|NCT03440190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65644401|NCT03440190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644402|NCT03440190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65644403|NCT03440190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65644404|NCT03440190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65267615|NCT04370509|Pembrolizumab|pembrolizumab|mesh-list
65644405|NCT03440190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644406|NCT03440190|Dopamine Agents|dopamine agents|mesh-ancestor
65644407|NCT03440190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65644408|NCT03673995|Inositol|inositol|mesh-list
65644409|NCT03673995|Vitamin B Complex|vitamin b complex|mesh-ancestor
65644410|NCT03673995|Vitamins|vitamins|mesh-ancestor
65644411|NCT03673995|Micronutrients|micronutrients|mesh-ancestor
65644412|NCT03673995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644413|NCT01378091|Prednisone|prednisone|mesh-list
65644414|NCT01378091|Docetaxel|docetaxel|mesh-list
65644415|NCT01378091|Lenalidomide|lenalidomide|mesh-list
65644416|NCT01378091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644417|NCT01378091|Tubulin Modulators|tubulin modulators|mesh-ancestor
65644418|NCT01378091|Antimitotic Agents|antimitotic agents|mesh-ancestor
65644419|NCT01378091|Mitosis Modulators|mitosis modulators|mesh-ancestor
65644420|NCT01378091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644421|NCT01378091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65644422|NCT01378091|Glucocorticoids|glucocorticoids|mesh-ancestor
65644423|NCT01378091|Hormones|hormones|mesh-ancestor
65644424|NCT01378091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65644425|NCT01378091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644426|NCT01378091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65644427|NCT01378091|Immunologic Factors|immunologic factors|mesh-ancestor
65644428|NCT01378091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65644429|NCT01378091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65644430|NCT01378091|Growth Substances|growth substances|mesh-ancestor
65644431|NCT01378091|Growth Inhibitors|growth inhibitors|mesh-ancestor
65644432|NCT02794974|Anesthetics|anesthetics|mesh-list
65644433|NCT02794974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65644434|NCT02794974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644435|NCT02063568|Oxytocin|oxytocin|mesh-list
65644436|NCT02063568|Oxytocics|oxytocics|mesh-ancestor
65644437|NCT02063568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65644438|NCT02063568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644439|NCT02257502|Aflibercept|aflibercept|mesh-list
65644440|NCT02257502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65644441|NCT02257502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65644442|NCT02257502|Growth Substances|growth substances|mesh-ancestor
65644443|NCT02257502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644444|NCT02257502|Growth Inhibitors|growth inhibitors|mesh-ancestor
65644445|NCT02257502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644446|NCT02907099|Pembrolizumab|pembrolizumab|mesh-list
65644447|NCT02907099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65644448|NCT02907099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644449|NCT02450123|Sunitinib|sunitinib|mesh-list
65644450|NCT02450123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644451|NCT02450123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65644452|NCT02450123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65644453|NCT02450123|Growth Substances|growth substances|mesh-ancestor
65644454|NCT02450123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644455|NCT02450123|Growth Inhibitors|growth inhibitors|mesh-ancestor
65644456|NCT02450123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65644457|NCT02450123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644458|NCT02450123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644459|NCT02063802|Metformin|metformin|mesh-list
65644460|NCT02063802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65644461|NCT02063802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644462|NCT03672045|Carbetocin|carbetocin|mesh-list
65644463|NCT03672045|Oxytocics|oxytocics|mesh-ancestor
65644464|NCT03672045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65644465|NCT03672045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644466|NCT02198300|Clopidogrel|clopidogrel|mesh-list
65644467|NCT02198300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65644468|NCT02198300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65644469|NCT02198300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65644470|NCT02198300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65644471|NCT02198300|Purinergic Agents|purinergic agents|mesh-ancestor
65644472|NCT02198300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65644473|NCT02198300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644474|NCT02198300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644475|NCT03560232|Clindamycin|clindamycin|mesh-list
65644476|NCT03560232|Gentamicins|gentamicins|mesh-list
65644477|NCT03560232|Ceftriaxone|ceftriaxone|mesh-list
65644478|NCT03560232|Cefazolin|cefazolin|mesh-list
65644479|NCT03560232|Tazobactam|tazobactam|mesh-list
65644480|NCT03560232|Piperacillin|piperacillin|mesh-list
65644481|NCT03560232|Ampicillin|ampicillin|mesh-list
65644482|NCT03560232|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65644483|NCT03560232|Sulbactam|sulbactam|mesh-list
65644484|NCT03560232|Sultamicillin|sultamicillin|mesh-list
65644485|NCT03560232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65644486|NCT03560232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65644487|NCT03560232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65644488|NCT03560232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644489|NCT03560232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644490|NCT03560232|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65441816|NCT00319020|Bosentan|bosentan|mesh-list
65644491|NCT02201342|Udenafil|udenafil|mesh-list
65644492|NCT02201342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65644493|NCT02201342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65644494|NCT02201342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644495|NCT02201342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644496|NCT02201576|Bortezomib|bortezomib|mesh-list
65644497|NCT02201576|Immunoglobulins|immunoglobulins|mesh-list
65644498|NCT02201576|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65644499|NCT02201576|Antibodies|antibodies|mesh-list
65644500|NCT02201576|gamma-Globulins|gamma-globulins|mesh-list
65644501|NCT02201576|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65644502|NCT02201576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644503|NCT02201576|Immunologic Factors|immunologic factors|mesh-ancestor
65644504|NCT02201576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644505|NCT02198378|Acetaminophen|acetaminophen|mesh-list
65644506|NCT02198378|Morphine|morphine|mesh-list
65644507|NCT02198378|Entonox|entonox|mesh-list
65644508|NCT02198378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65644509|NCT02198378|Narcotics|narcotics|mesh-ancestor
65644510|NCT02198378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65644511|NCT02198378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644512|NCT02198378|Analgesics|analgesics|mesh-ancestor
65644513|NCT02198378|Sensory System Agents|sensory system agents|mesh-ancestor
65644514|NCT02198378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65644515|NCT02198378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65644516|NCT02198378|Antipyretics|antipyretics|mesh-ancestor
65644517|NCT02198378|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65644518|NCT02198378|Anesthetics|anesthetics|mesh-ancestor
65644519|NCT02063100|Losartan|losartan|mesh-list
65644520|NCT02063100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65644521|NCT02063100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65644522|NCT02063100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65644523|NCT02063100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65644524|NCT02063100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644525|NCT02198846|Insulin|insulin|mesh-list
65644526|NCT02198846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65644527|NCT02198846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644528|NCT02198924|Celecoxib|celecoxib|mesh-list
65644529|NCT02198924|Parecoxib|parecoxib|mesh-list
65644530|NCT02198924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65644531|NCT02198924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65644532|NCT02198924|Analgesics|analgesics|mesh-ancestor
65644533|NCT02198924|Sensory System Agents|sensory system agents|mesh-ancestor
65644534|NCT02198924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65644535|NCT02198924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644536|NCT02198924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65644537|NCT02198924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65644538|NCT02198924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65644539|NCT02198924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65644540|NCT02198924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644541|NCT02198924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644542|NCT05462093|Liver Extracts|liver extracts|mesh-list
65644543|NCT05462093|Hematinics|hematinics|mesh-ancestor
65644544|NCT02064348|Moxifloxacin|moxifloxacin|mesh-list
65644545|NCT02064348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65644546|NCT02064348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65644547|NCT02064348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65644548|NCT02064348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65644549|NCT02064348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644550|NCT02064348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644551|NCT02064348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644552|NCT02202200|Palbociclib|palbociclib|mesh-list
65644553|NCT02202200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644554|NCT02202200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65644555|NCT02202200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644556|NCT02202200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644557|NCT02064504|Fluticasone|fluticasone|mesh-list
65644558|NCT02064504|Xhance|xhance|mesh-list
65644559|NCT02064504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65644560|NCT02064504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65644561|NCT02064504|Autonomic Agents|autonomic agents|mesh-ancestor
65644562|NCT02064504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65644563|NCT02064504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644564|NCT02064504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65441887|NCT01325298|Micronutrients|micronutrients|mesh-ancestor
65644565|NCT02064504|Respiratory System Agents|respiratory system agents|mesh-ancestor
65644566|NCT02064504|Dermatologic Agents|dermatologic agents|mesh-ancestor
65644567|NCT02064504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65644568|NCT02067936|Remifentanil|remifentanil|mesh-list
65644569|NCT02067936|Propofol|propofol|mesh-list
65644570|NCT02067936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65644571|NCT02067936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65644572|NCT02067936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644573|NCT02067936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65644574|NCT02067936|Anesthetics, General|anesthetics, general|mesh-ancestor
65644575|NCT02067936|Anesthetics|anesthetics|mesh-ancestor
65644576|NCT02067936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65644577|NCT02067936|Narcotics|narcotics|mesh-ancestor
65644578|NCT02067936|Analgesics|analgesics|mesh-ancestor
65644579|NCT02067936|Sensory System Agents|sensory system agents|mesh-ancestor
65644580|NCT02067936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65644581|NCT01377545|Anesthetics|anesthetics|mesh-list
65644582|NCT01377545|Anesthetics, Local|anesthetics, local|mesh-list
65644583|NCT01377545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65644584|NCT01377545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644585|NCT01377545|Sensory System Agents|sensory system agents|mesh-ancestor
65644586|NCT01377545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65644587|NCT01379807|Docetaxel|docetaxel|mesh-list
65644588|NCT01379807|Panitumumab|panitumumab|mesh-list
65644589|NCT01379807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644590|NCT01379807|Tubulin Modulators|tubulin modulators|mesh-ancestor
65644591|NCT01379807|Antimitotic Agents|antimitotic agents|mesh-ancestor
65644592|NCT01379807|Mitosis Modulators|mitosis modulators|mesh-ancestor
65644593|NCT01379807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644594|NCT01379807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65644595|NCT02202512|Naproxen|naproxen|mesh-list
65644596|NCT02202512|Cimetidine|cimetidine|mesh-list
65644597|NCT02202512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65644598|NCT02202512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65644599|NCT02202512|Analgesics|analgesics|mesh-ancestor
65644600|NCT02202512|Sensory System Agents|sensory system agents|mesh-ancestor
65644601|NCT02202512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65644602|NCT02202512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644603|NCT02202512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65644604|NCT02202512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65644605|NCT02202512|Gout Suppressants|gout suppressants|mesh-ancestor
65644606|NCT02202512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65644607|NCT02202512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644608|NCT02202512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644609|NCT02202512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65644610|NCT02202512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65644611|NCT02202512|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65644612|NCT02202512|Histamine Antagonists|histamine antagonists|mesh-ancestor
65644613|NCT02202512|Histamine Agents|histamine agents|mesh-ancestor
65644614|NCT02202512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65644615|NCT02202512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65644616|NCT02202512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65644617|NCT02065752|Metformin|metformin|mesh-list
65644618|NCT02065752|Canagliflozin|canagliflozin|mesh-list
65644619|NCT02065752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65644620|NCT02065752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644621|NCT02065752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65644622|NCT02065752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644623|NCT03492671|Gemcitabine|gemcitabine|mesh-list
65644624|NCT03492671|Paclitaxel|paclitaxel|mesh-list
65644625|NCT03492671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65644626|NCT03492671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644627|NCT03492671|Tubulin Modulators|tubulin modulators|mesh-ancestor
65644628|NCT03492671|Antimitotic Agents|antimitotic agents|mesh-ancestor
65644629|NCT03492671|Mitosis Modulators|mitosis modulators|mesh-ancestor
65644630|NCT03492671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644631|NCT03492671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65644632|NCT03492671|Antimetabolites|antimetabolites|mesh-ancestor
65644633|NCT03492671|Antiviral Agents|antiviral agents|mesh-ancestor
65644634|NCT03492671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65644635|NCT03492671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644636|NCT03492671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65644637|NCT03492671|Immunologic Factors|immunologic factors|mesh-ancestor
65644638|NCT03492671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644639|NCT02206490|Naltrexone|naltrexone|mesh-list
65644640|NCT02206490|Dextromethorphan|dextromethorphan|mesh-list
65644641|NCT02206490|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65644642|NCT02206490|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65644643|NCT02206490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644644|NCT02206490|Sensory System Agents|sensory system agents|mesh-ancestor
65644645|NCT02206490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65644646|NCT02206490|Antitussive Agents|antitussive agents|mesh-ancestor
65644647|NCT02206490|Respiratory System Agents|respiratory system agents|mesh-ancestor
65644648|NCT02206490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65644649|NCT02206490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65644650|NCT02206490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65644651|NCT02206490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644653|NCT02068170|Moxifloxacin|moxifloxacin|mesh-list
65644654|NCT02068170|Clarithromycin|clarithromycin|mesh-list
65644655|NCT02068170|Levofloxacin|levofloxacin|mesh-list
65644656|NCT02068170|Erythromycin|erythromycin|mesh-list
65644657|NCT02068170|Erythromycin Estolate|erythromycin estolate|mesh-list
65644658|NCT02068170|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65644659|NCT02068170|Erythromycin stearate|erythromycin stearate|mesh-list
65644660|NCT02068170|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65644661|NCT02068170|Itraconazole|itraconazole|mesh-list
65644662|NCT02068170|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
65644663|NCT02068170|Fluconazole|fluconazole|mesh-list
65644664|NCT02068170|Ketoconazole|ketoconazole|mesh-list
65644665|NCT02068170|Voriconazole|voriconazole|mesh-list
65644666|NCT02068170|Sunitinib|sunitinib|mesh-list
65644667|NCT02068170|Methadone|methadone|mesh-list
65644668|NCT02068170|Haloperidol|haloperidol|mesh-list
65644669|NCT02068170|Haloperidol decanoate|haloperidol decanoate|mesh-list
65644670|NCT02068170|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65644671|NCT02068170|Tacrolimus|tacrolimus|mesh-list
65644672|NCT02068170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65644673|NCT02068170|Immunologic Factors|immunologic factors|mesh-ancestor
65644674|NCT02068170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644675|NCT02068170|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65644676|NCT02068170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644677|NCT02068170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644678|NCT02068170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65644679|NCT02068170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65644680|NCT02068170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65644681|NCT02068170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65644682|NCT02068170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644683|NCT02068170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65644684|NCT02068170|Contraceptive Agents|contraceptive agents|mesh-ancestor
65644685|NCT02068170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65644686|NCT02068170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65644687|NCT02068170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65644688|NCT02068170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65644689|NCT02068170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65644690|NCT02068170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65644691|NCT02068170|Growth Substances|growth substances|mesh-ancestor
65644692|NCT02068170|Growth Inhibitors|growth inhibitors|mesh-ancestor
65644693|NCT02068170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65644694|NCT02068170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65644695|NCT02068170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65644696|NCT02068170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65644697|NCT02068170|Antifungal Agents|antifungal agents|mesh-ancestor
65644698|NCT02068170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65644699|NCT02068170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65644700|NCT02068170|Hormone Antagonists|hormone antagonists|mesh-ancestor
65644701|NCT02068170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65644702|NCT02068170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65644703|NCT02068170|Renal Agents|renal agents|mesh-ancestor
65644704|NCT02068170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65644705|NCT02068170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65644706|NCT02068170|Narcotics|narcotics|mesh-ancestor
65644707|NCT02068170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65644708|NCT02068170|Analgesics|analgesics|mesh-ancestor
65644709|NCT02068170|Sensory System Agents|sensory system agents|mesh-ancestor
65644710|NCT02068170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65644711|NCT02068170|Antitussive Agents|antitussive agents|mesh-ancestor
65644712|NCT02068170|Respiratory System Agents|respiratory system agents|mesh-ancestor
65644713|NCT02068170|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65644714|NCT02068170|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65644715|NCT02068170|Antiemetics|antiemetics|mesh-ancestor
65644716|NCT02068170|Autonomic Agents|autonomic agents|mesh-ancestor
65644717|NCT02068170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65644718|NCT02068170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65644719|NCT02068170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65644720|NCT02068170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65644721|NCT02068170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65644722|NCT02068170|Dopamine Agents|dopamine agents|mesh-ancestor
65644723|NCT02068170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65644724|NCT02068170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65644725|NCT02068170|Antimalarials|antimalarials|mesh-ancestor
65644726|NCT02068170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65644727|NCT02068170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65644728|NCT05545020|Chromium|chromium|mesh-list
65644729|NCT05545020|Trace Elements|trace elements|mesh-ancestor
65644730|NCT05545020|Micronutrients|micronutrients|mesh-ancestor
65644731|NCT05545020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644732|NCT02206568|Insulin Lispro|insulin lispro|mesh-list
65644733|NCT02206568|Insulin, Short-Acting|insulin, short-acting|mesh-list
65644734|NCT02206568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65644735|NCT02206568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644736|NCT02206646|Tenecteplase|tenecteplase|mesh-list
65644737|NCT02206646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65644738|NCT02206646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65644739|NCT02206646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644740|NCT02419417|Nivolumab|nivolumab|mesh-list
65644741|NCT02419417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65644742|NCT02419417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644743|NCT02419417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65644744|NCT02419417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644745|NCT02068404|Nifedipine|nifedipine|mesh-list
65644746|NCT02068404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65644747|NCT02068404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65644748|NCT02068404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644749|NCT02068404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65644750|NCT02068404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644751|NCT02068404|Vasodilator Agents|vasodilator agents|mesh-ancestor
65644752|NCT02068404|Tocolytic Agents|tocolytic agents|mesh-ancestor
65644753|NCT02068404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65644754|NCT02068482|Rifaximin|rifaximin|mesh-list
65644755|NCT02068482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65644756|NCT02068482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65644757|NCT02068482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65644758|NCT02206802|Minoxidil|minoxidil|mesh-list
65644759|NCT02206802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65644760|NCT02206802|Vasodilator Agents|vasodilator agents|mesh-ancestor
65644761|NCT02065986|Tenofovir|tenofovir|mesh-list
65644762|NCT02065986|Emtricitabine|emtricitabine|mesh-list
65644763|NCT02065986|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65644764|NCT02065986|Antiviral Agents|antiviral agents|mesh-ancestor
65644765|NCT02065986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65644766|NCT02065986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65644767|NCT02065986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65644768|NCT02065986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644769|NCT02065986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644770|NCT02065986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65644771|NCT02065986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65644772|NCT02068560|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65644773|NCT02068560|Hemostatics|hemostatics|mesh-ancestor
65644774|NCT02068560|Coagulants|coagulants|mesh-ancestor
65644775|NCT02068560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65644776|NCT02068560|Natriuretic Agents|natriuretic agents|mesh-ancestor
65644777|NCT02068560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644778|NCT01377103|Testosterone|testosterone|mesh-list
65644779|NCT01377103|Androgens|androgens|mesh-ancestor
65644780|NCT01377103|Hormones|hormones|mesh-ancestor
65644781|NCT01377103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65644782|NCT01377103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644783|NCT01377025|Sorafenib|sorafenib|mesh-list
65644784|NCT01377025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644785|NCT01377025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65644786|NCT01377025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644787|NCT01377025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644788|NCT02203604|Aldesleukin|aldesleukin|mesh-list
65644789|NCT02203604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65644790|NCT02203604|Ipilimumab|ipilimumab|mesh-list
65644791|NCT02203604|Interleukin-2|interleukin-2|mesh-list
65442113|NCT01059110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65644792|NCT02203604|Antibodies|antibodies|mesh-list
65644793|NCT02203604|Immunoglobulins|immunoglobulins|mesh-list
65644794|NCT02203604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65644795|NCT02203604|Immunologic Factors|immunologic factors|mesh-ancestor
65644796|NCT02203604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644797|NCT02203604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644798|NCT02203604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65644799|NCT02203604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644800|NCT02203604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65644801|NCT02203604|Analgesics|analgesics|mesh-ancestor
65644802|NCT02203604|Sensory System Agents|sensory system agents|mesh-ancestor
65644803|NCT02203604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65644804|NCT02203604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65644805|NCT02203604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65644806|NCT02203604|Antiviral Agents|antiviral agents|mesh-ancestor
65644807|NCT02203604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65644808|NCT02342275|Propranolol|propranolol|mesh-list
65644809|NCT02342275|Atenolol|atenolol|mesh-list
65644810|NCT02342275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65644811|NCT02342275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65644812|NCT02342275|Adrenergic Agents|adrenergic agents|mesh-ancestor
65644813|NCT02342275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65644814|NCT02342275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644815|NCT02342275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644816|NCT02342275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65644817|NCT02342275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65644818|NCT02342275|Vasodilator Agents|vasodilator agents|mesh-ancestor
65644819|NCT02342275|Sympatholytics|sympatholytics|mesh-ancestor
65644820|NCT02342275|Autonomic Agents|autonomic agents|mesh-ancestor
65644821|NCT02342275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65644822|NCT02342275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65644824|NCT01827553|Folfirinox|folfirinox|mesh-list
65644825|NCT01827553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65644826|NCT01827553|Antimetabolites|antimetabolites|mesh-ancestor
65644827|NCT01827553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644828|NCT01827553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644829|NCT01827553|Antiviral Agents|antiviral agents|mesh-ancestor
65644830|NCT01827553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65644831|NCT01827553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644832|NCT01827553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65644833|NCT01827553|Immunologic Factors|immunologic factors|mesh-ancestor
65644834|NCT01827553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644835|NCT02207348|Liraglutide|liraglutide|mesh-list
65644836|NCT02207348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65644837|NCT02207348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644838|NCT02207348|Incretins|incretins|mesh-ancestor
65644839|NCT02207348|Hormones|hormones|mesh-ancestor
65644840|NCT02207348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65644841|NCT02066454|Apixaban|apixaban|mesh-list
65644842|NCT02066454|Anticoagulants|anticoagulants|mesh-list
65644843|NCT02066454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65644844|NCT02066454|Antithrombins|antithrombins|mesh-ancestor
65644845|NCT02066454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65644846|NCT02066454|Protease Inhibitors|protease inhibitors|mesh-ancestor
65644847|NCT02066454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644848|NCT02066454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644849|NCT00979693|Psilocybin|psilocybin|mesh-list
65644850|NCT00979693|Hallucinogens|hallucinogens|mesh-ancestor
65644851|NCT00979693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644852|NCT00979693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65644853|NCT02207426|Tobramycin|tobramycin|mesh-list
65644854|NCT02207426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65644855|NCT02207426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65644856|NCT00777491|Gemcitabine|gemcitabine|mesh-list
65644857|NCT00777491|Cisplatin|cisplatin|mesh-list
65644858|NCT00777491|Fluorouracil|fluorouracil|mesh-list
65644859|NCT00777491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644860|NCT00777491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65644861|NCT00777491|Antimetabolites|antimetabolites|mesh-ancestor
65644862|NCT00777491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644863|NCT00777491|Antiviral Agents|antiviral agents|mesh-ancestor
65644864|NCT00777491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65644865|NCT00777491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644866|NCT00777491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65644867|NCT00777491|Immunologic Factors|immunologic factors|mesh-ancestor
65644868|NCT00777491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644869|NCT02199392|Lenvatinib|lenvatinib|mesh-list
65644870|NCT02199392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644871|NCT02199392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65644872|NCT02199392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644873|NCT02199392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644874|NCT05320627|Edoxaban|edoxaban|mesh-list
65644875|NCT05320627|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65644876|NCT05320627|Antithrombins|antithrombins|mesh-ancestor
65644877|NCT05320627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65644878|NCT05320627|Protease Inhibitors|protease inhibitors|mesh-ancestor
65644879|NCT05320627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644880|NCT05320627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644881|NCT05320627|Anticoagulants|anticoagulants|mesh-ancestor
65644882|NCT03559920|Propofol|propofol|mesh-list
65644883|NCT03559920|Anesthetics|anesthetics|mesh-list
65644884|NCT03559920|Sevoflurane|sevoflurane|mesh-list
65644885|NCT03559920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65644886|NCT03559920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65644887|NCT03559920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644888|NCT03559920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65644889|NCT03559920|Anesthetics, General|anesthetics, general|mesh-ancestor
65644890|NCT03559920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65644891|NCT03559920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65644892|NCT02203760|Gemcitabine|gemcitabine|mesh-list
65644893|NCT02203760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65644894|NCT02203760|Antimetabolites|antimetabolites|mesh-ancestor
65644895|NCT02203760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644896|NCT02203760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644897|NCT02203760|Antiviral Agents|antiviral agents|mesh-ancestor
65644898|NCT02203760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65644899|NCT02203760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644900|NCT02203760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65644901|NCT02203760|Immunologic Factors|immunologic factors|mesh-ancestor
65644902|NCT02203760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644903|NCT03703271|Methotrexate|methotrexate|mesh-list
65644904|NCT03703271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65644905|NCT03703271|Abortifacient Agents|abortifacient agents|mesh-ancestor
65644906|NCT03703271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65644907|NCT03703271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644908|NCT03703271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65644909|NCT03703271|Antimetabolites|antimetabolites|mesh-ancestor
65644910|NCT03703271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644911|NCT03703271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644912|NCT03703271|Dermatologic Agents|dermatologic agents|mesh-ancestor
65644913|NCT03703271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65644914|NCT03703271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65644915|NCT03703271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65644916|NCT03703271|Immunologic Factors|immunologic factors|mesh-ancestor
65644917|NCT03703271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65644918|NCT03703271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65644919|NCT03532802|Metoprolol|metoprolol|mesh-list
65644920|NCT03532802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65644921|NCT03532802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65644922|NCT03532802|Sympatholytics|sympatholytics|mesh-ancestor
65644923|NCT03532802|Autonomic Agents|autonomic agents|mesh-ancestor
65644924|NCT03532802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65644925|NCT03532802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644926|NCT03532802|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65644927|NCT03532802|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65644928|NCT03532802|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65644929|NCT03532802|Adrenergic Agents|adrenergic agents|mesh-ancestor
65644930|NCT03532802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65644931|NCT03532802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644932|NCT03430531|Lidocaine|lidocaine|mesh-list
65644933|NCT03430531|Anesthetics, Local|anesthetics, local|mesh-ancestor
65644934|NCT03430531|Anesthetics|anesthetics|mesh-ancestor
65644935|NCT03430531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65644936|NCT03430531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644937|NCT03430531|Sensory System Agents|sensory system agents|mesh-ancestor
65644938|NCT03430531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65644939|NCT03430531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65644940|NCT03430531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65644941|NCT03430531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65644942|NCT03430531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65644943|NCT03430531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644944|NCT02066532|Trastuzumab|trastuzumab|mesh-list
65644945|NCT02066532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65644946|NCT02066532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644947|NCT05763329|Lemborexant|lemborexant|mesh-list
65644948|NCT05763329|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65644949|NCT05763329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65644950|NCT05763329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644951|NCT05763329|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65644952|NCT05763329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65644953|NCT05763329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65644954|NCT05763329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644955|NCT04088513|Aspirin|aspirin|mesh-list
65644956|NCT04088513|Clopidogrel|clopidogrel|mesh-list
65644957|NCT04088513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65644958|NCT04088513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65644959|NCT04088513|Analgesics|analgesics|mesh-ancestor
65644960|NCT04088513|Sensory System Agents|sensory system agents|mesh-ancestor
65644961|NCT04088513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65644962|NCT04088513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644963|NCT04088513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65644964|NCT04088513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65644965|NCT04088513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65644966|NCT04088513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65644967|NCT04088513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644968|NCT04088513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65644969|NCT04088513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65644970|NCT04088513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442337|NCT02533544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65644971|NCT04088513|Antipyretics|antipyretics|mesh-ancestor
65644972|NCT04088513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65644973|NCT04088513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65644974|NCT04088513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65644975|NCT04088513|Purinergic Agents|purinergic agents|mesh-ancestor
65644976|NCT04088513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65644977|NCT02207660|Fluorouracil|fluorouracil|mesh-list
65644978|NCT02207660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644979|NCT02207660|Antimetabolites|antimetabolites|mesh-ancestor
65644980|NCT02207660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644981|NCT02207660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65644982|NCT02207660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65644983|NCT02207660|Immunologic Factors|immunologic factors|mesh-ancestor
65644984|NCT02207660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644985|NCT02069340|Zoledronic Acid|zoledronic acid|mesh-list
65644986|NCT02069340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65644987|NCT02069340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65644988|NCT02069418|Alovudine|alovudine|mesh-list
65644989|NCT02069418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65644990|NCT02069418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65644991|NCT02069418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65644992|NCT02069418|Antiviral Agents|antiviral agents|mesh-ancestor
65644993|NCT02069418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65644994|NCT03386357|Pembrolizumab|pembrolizumab|mesh-list
65644995|NCT03386357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65644996|NCT03386357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65644997|NCT02208128|Bevacizumab|bevacizumab|mesh-list
65644998|NCT02208128|Sunitinib|sunitinib|mesh-list
65644999|NCT02208128|Everolimus|everolimus|mesh-list
65645000|NCT02208128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65645001|NCT02208128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645002|NCT02208128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65645003|NCT02208128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65645004|NCT02208128|Growth Substances|growth substances|mesh-ancestor
65645005|NCT02208128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645006|NCT02208128|Growth Inhibitors|growth inhibitors|mesh-ancestor
65645007|NCT02208128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65645008|NCT02208128|Immunologic Factors|immunologic factors|mesh-ancestor
65645009|NCT02208128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65645010|NCT02208128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645011|NCT02208128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645012|NCT02066610|Selenium|selenium|mesh-list
65645013|NCT02066610|Selenious Acid|selenious acid|mesh-list
65645014|NCT02066610|Sodium Selenite|sodium selenite|mesh-list
65645015|NCT02066610|Selenic Acid|selenic acid|mesh-list
65645016|NCT02066610|Antioxidants|antioxidants|mesh-ancestor
65645017|NCT02066610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645018|NCT02066610|Protective Agents|protective agents|mesh-ancestor
65645019|NCT02066610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645020|NCT02066610|Trace Elements|trace elements|mesh-ancestor
65645021|NCT02066610|Micronutrients|micronutrients|mesh-ancestor
65645022|NCT03077711|Trimethoprim|trimethoprim|mesh-list
65645023|NCT03077711|Methenamine|methenamine|mesh-list
65645024|NCT03077711|Methenamine hippurate|methenamine hippurate|mesh-list
65645025|NCT03077711|Methenamine mandelate|methenamine mandelate|mesh-list
65645026|NCT03077711|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65645027|NCT03077711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65645028|NCT03077711|Renal Agents|renal agents|mesh-ancestor
65645029|NCT03077711|Antimalarials|antimalarials|mesh-ancestor
65645030|NCT03077711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65645031|NCT03077711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65645032|NCT03077711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65645033|NCT03077711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645034|NCT03077711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645035|NCT03077711|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65645036|NCT03077711|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65645037|NCT03077711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65645038|NCT03077711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65645039|NCT04374019|Artesunate|artesunate|mesh-list
65645040|NCT04374019|Ivermectin|ivermectin|mesh-list
65645041|NCT04374019|Camostat|camostat|mesh-list
65645042|NCT04374019|Antimalarials|antimalarials|mesh-ancestor
65645043|NCT04374019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65645044|NCT04374019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65645045|NCT04374019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65645046|NCT04374019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645047|NCT04374019|Antiviral Agents|antiviral agents|mesh-ancestor
65645048|NCT04374019|Schistosomicides|schistosomicides|mesh-ancestor
65645049|NCT04374019|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65645050|NCT04374019|Anthelmintics|anthelmintics|mesh-ancestor
65645051|NCT04374019|Protease Inhibitors|protease inhibitors|mesh-ancestor
65645052|NCT04374019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645053|NCT04374019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645054|NCT04374019|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65645055|NCT04374019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65645056|NCT02069808|Leuprolide|leuprolide|mesh-list
65645057|NCT02069808|Menotropins|menotropins|mesh-list
65645058|NCT02069808|Ganirelix|ganirelix|mesh-list
65645059|NCT02069808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65645060|NCT02069808|Fertility Agents|fertility agents|mesh-ancestor
65645061|NCT02069808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65645062|NCT02069808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645063|NCT02069808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65645064|NCT02069808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645065|NCT02069808|Hormone Antagonists|hormone antagonists|mesh-ancestor
65645066|NCT02069808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65645067|NCT03673605|Warfarin|warfarin|mesh-list
65645068|NCT03673605|Rivaroxaban|rivaroxaban|mesh-list
65645069|NCT03673605|Anticoagulants|anticoagulants|mesh-ancestor
65645070|NCT03673605|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65645071|NCT03673605|Antithrombins|antithrombins|mesh-ancestor
65645072|NCT03673605|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65645073|NCT03673605|Protease Inhibitors|protease inhibitors|mesh-ancestor
65645074|NCT03673605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645075|NCT03673605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645076|NCT02069886|Deferasirox|deferasirox|mesh-list
65645077|NCT02069886|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65645078|NCT02069886|Chelating Agents|chelating agents|mesh-ancestor
65645079|NCT02069886|Sequestering Agents|sequestering agents|mesh-ancestor
65645080|NCT02069886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645081|NCT04311463|Paroxetine|paroxetine|mesh-list
65645082|NCT04311463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65645083|NCT04311463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65645084|NCT04311463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65645085|NCT04311463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645086|NCT04311463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65645087|NCT04311463|Serotonin Agents|serotonin agents|mesh-ancestor
65645088|NCT04311463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645089|NCT04311463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65645090|NCT04311463|Antidepressive Agents|antidepressive agents|mesh-ancestor
65645091|NCT04311463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65645092|NCT04311463|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65645093|NCT04311463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65645094|NCT04311463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645095|NCT05553834|Cemiplimab|cemiplimab|mesh-list
65645096|NCT05553834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65645097|NCT05553834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645098|NCT02065128|Capsaicin|capsaicin|mesh-list
65645099|NCT02065128|Antipruritics|antipruritics|mesh-ancestor
65645100|NCT02065128|Dermatologic Agents|dermatologic agents|mesh-ancestor
65645101|NCT02065128|Sensory System Agents|sensory system agents|mesh-ancestor
65645102|NCT02065128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65645103|NCT02065128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645104|NCT03677895|Hyaluronic Acid|hyaluronic acid|mesh-list
65645105|NCT03677895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65645106|NCT03677895|Immunologic Factors|immunologic factors|mesh-ancestor
65645107|NCT03677895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645108|NCT03677895|Viscosupplements|viscosupplements|mesh-ancestor
65645109|NCT03677895|Protective Agents|protective agents|mesh-ancestor
65645110|NCT04295005|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65645111|NCT04295005|Empagliflozin|empagliflozin|mesh-list
65645112|NCT04295005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65645113|NCT04295005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645114|NCT04295005|Incretins|incretins|mesh-ancestor
65645115|NCT04295005|Hormones|hormones|mesh-ancestor
65645116|NCT04295005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65645117|NCT04295005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65645118|NCT04295005|Protease Inhibitors|protease inhibitors|mesh-ancestor
65645119|NCT04295005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645120|NCT04295005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645121|NCT04295005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65645122|NCT03174353|Lanreotide|lanreotide|mesh-list
65645123|NCT03174353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645124|NCT05214235|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65645125|NCT05214235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645127|NCT03054363|Palbociclib|palbociclib|mesh-list
65645128|NCT03054363|Tucatinib|tucatinib|mesh-list
65645129|NCT03054363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645130|NCT03054363|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65645131|NCT03054363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65645132|NCT03054363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645133|NCT03054363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645134|NCT03054363|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65645135|NCT03054363|Hormone Antagonists|hormone antagonists|mesh-ancestor
65645136|NCT03054363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65645137|NCT03054363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645138|NCT03054363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65645139|NCT04080947|Montelukast|montelukast|mesh-list
65645140|NCT04080947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65645141|NCT04080947|Respiratory System Agents|respiratory system agents|mesh-ancestor
65645142|NCT04080947|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65645143|NCT04080947|Hormone Antagonists|hormone antagonists|mesh-ancestor
65645144|NCT04080947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65645145|NCT04080947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645146|NCT04080947|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65645147|NCT04080947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65645148|NCT04080947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645149|NCT02066688|Calcium, Dietary|calcium, dietary|mesh-list
65645150|NCT02066688|Vitamin D|vitamin d|mesh-list
65645151|NCT02066688|Folic Acid|folic acid|mesh-list
65645152|NCT02066688|Vitamin B Complex|vitamin b complex|mesh-list
65645153|NCT02066688|Calcium|calcium|mesh-list
65645154|NCT02066688|Vitamins|vitamins|mesh-ancestor
65645155|NCT02066688|Micronutrients|micronutrients|mesh-ancestor
65645156|NCT02066688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645157|NCT02066688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65645158|NCT02066688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65645159|NCT02066688|Hematinics|hematinics|mesh-ancestor
65645160|NCT03671733|Liraglutide|liraglutide|mesh-list
65645161|NCT03671733|Exenatide|exenatide|mesh-list
65645162|NCT03671733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65645163|NCT03671733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645164|NCT03671733|Incretins|incretins|mesh-ancestor
65645165|NCT03671733|Hormones|hormones|mesh-ancestor
65645166|NCT03671733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65645167|NCT03671733|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65645168|NCT03119363|Methamphetamine|methamphetamine|mesh-list
65645169|NCT03119363|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65645170|NCT03119363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645171|NCT03119363|Sympathomimetics|sympathomimetics|mesh-ancestor
65645172|NCT03119363|Autonomic Agents|autonomic agents|mesh-ancestor
65645173|NCT03119363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65645174|NCT03119363|Dopamine Agents|dopamine agents|mesh-ancestor
65645175|NCT03119363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65645176|NCT03119363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645177|NCT03119363|Adrenergic Agents|adrenergic agents|mesh-ancestor
65645178|NCT03119363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65645179|NCT03119363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65645180|NCT03119363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65645181|NCT03119363|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65645182|NCT04059081|Obinutuzumab|obinutuzumab|mesh-list
65645183|NCT04059081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65645184|NCT04059081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645185|NCT03671655|Paclitaxel|paclitaxel|mesh-list
65645186|NCT03671655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65645187|NCT03671655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645188|NCT03671655|Tubulin Modulators|tubulin modulators|mesh-ancestor
65645189|NCT03671655|Antimitotic Agents|antimitotic agents|mesh-ancestor
65645190|NCT03671655|Mitosis Modulators|mitosis modulators|mesh-ancestor
65645191|NCT03671655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645192|NCT02200094|Telmisartan|telmisartan|mesh-list
65645193|NCT02200094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65645194|NCT02200094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65442562|NCT00159861|Sildenafil Citrate|sildenafil citrate|mesh-list
65645195|NCT02200094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65645196|NCT02200094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645197|NCT01370538|Esomeprazole|esomeprazole|mesh-list
65645198|NCT01370538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65645199|NCT01370538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65645200|NCT01370538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65645201|NCT01370538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645202|NCT01370538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645203|NCT03248297|Amoxicillin|amoxicillin|mesh-list
65645204|NCT03248297|Azithromycin|azithromycin|mesh-list
65645205|NCT03248297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65645206|NCT03248297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65645207|NCT02208596|Pentazocine|pentazocine|mesh-list
65645208|NCT02208596|Propofol|propofol|mesh-list
65645209|NCT02208596|Etomidate|etomidate|mesh-list
65645210|NCT02208596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65645211|NCT02208596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65645212|NCT02208596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645213|NCT02208596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65645214|NCT02208596|Anesthetics, General|anesthetics, general|mesh-ancestor
65645215|NCT02208596|Anesthetics|anesthetics|mesh-ancestor
65645216|NCT02208596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65645217|NCT02208596|Narcotics|narcotics|mesh-ancestor
65645218|NCT02208596|Analgesics|analgesics|mesh-ancestor
65645219|NCT02208596|Sensory System Agents|sensory system agents|mesh-ancestor
65645220|NCT02208596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65645221|NCT02208596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65645222|NCT02208596|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65645223|NCT02070120|Mitomycins|mitomycins|mesh-list
65645224|NCT02070120|Mitomycin|mitomycin|mesh-list
65645225|NCT02070120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65645226|NCT02070120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645227|NCT02070120|Alkylating Agents|alkylating agents|mesh-ancestor
65645228|NCT02070120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645229|NCT02070120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65645230|NCT02070120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645231|NCT02200172|Melatonin|melatonin|mesh-list
65645232|NCT02200172|Antioxidants|antioxidants|mesh-ancestor
65645233|NCT02200172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645234|NCT02200172|Protective Agents|protective agents|mesh-ancestor
65645235|NCT02200172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645236|NCT02200172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65645237|NCT03673137|Gemcitabine|gemcitabine|mesh-list
65645238|NCT03673137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65645239|NCT03673137|Antimetabolites|antimetabolites|mesh-ancestor
65645240|NCT03673137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645241|NCT03673137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645242|NCT03673137|Antiviral Agents|antiviral agents|mesh-ancestor
65645243|NCT03673137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65645244|NCT03673137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645245|NCT03673137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65645246|NCT03673137|Immunologic Factors|immunologic factors|mesh-ancestor
65645247|NCT03673137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645248|NCT02066844|Betamethasone|betamethasone|mesh-list
65645249|NCT02066844|Betamethasone Valerate|betamethasone valerate|mesh-list
65645250|NCT02066844|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65645251|NCT02066844|Betamethasone benzoate|betamethasone benzoate|mesh-list
65645252|NCT02066844|Lidocaine|lidocaine|mesh-list
65645253|NCT02066844|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65645254|NCT02066844|Anesthetics, Local|anesthetics, local|mesh-ancestor
65645255|NCT02066844|Anesthetics|anesthetics|mesh-ancestor
65645256|NCT02066844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65645257|NCT02066844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645258|NCT02066844|Sensory System Agents|sensory system agents|mesh-ancestor
65645259|NCT02066844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65645260|NCT02066844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65645261|NCT02066844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65645262|NCT02066844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65645263|NCT02066844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65645264|NCT02066844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645265|NCT02066844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65645266|NCT02066844|Glucocorticoids|glucocorticoids|mesh-ancestor
65645267|NCT02066844|Hormones|hormones|mesh-ancestor
65645268|NCT02066844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65645269|NCT02066844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65645270|NCT02066844|Respiratory System Agents|respiratory system agents|mesh-ancestor
65645272|NCT03669783|Carboplatin|carboplatin|mesh-list
65645273|NCT03669783|Doxorubicin|doxorubicin|mesh-list
65645274|NCT03669783|Etoposide|etoposide|mesh-list
65645275|NCT03669783|Vincristine|vincristine|mesh-list
65645276|NCT03669783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645277|NCT03669783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65645278|NCT03669783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65645279|NCT03669783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65645280|NCT03669783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645281|NCT03669783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645282|NCT03669783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65645283|NCT03669783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65645284|NCT03669783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65645285|NCT03669783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65645286|NCT03669783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65645287|NCT03669783|Tubulin Modulators|tubulin modulators|mesh-ancestor
65645288|NCT03669783|Antimitotic Agents|antimitotic agents|mesh-ancestor
65645289|NCT03669783|Mitosis Modulators|mitosis modulators|mesh-ancestor
65645290|NCT02067078|Dexamethasone|dexamethasone|mesh-list
65645291|NCT02067078|Dexamethasone acetate|dexamethasone acetate|mesh-list
65645292|NCT02067078|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65645293|NCT02067078|Clonidine|clonidine|mesh-list
65645294|NCT02067078|Epinephrine|epinephrine|mesh-list
65645295|NCT02067078|Racepinephrine|racepinephrine|mesh-list
65645296|NCT02067078|Ropivacaine|ropivacaine|mesh-list
65645297|NCT02067078|Bupivacaine|bupivacaine|mesh-list
65645298|NCT02067078|Epinephryl borate|epinephryl borate|mesh-list
65645299|NCT02067078|BB 1101|bb 1101|mesh-list
65645300|NCT02067078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65645301|NCT02067078|Antiemetics|antiemetics|mesh-ancestor
65645302|NCT02067078|Autonomic Agents|autonomic agents|mesh-ancestor
65645303|NCT02067078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65645304|NCT02067078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645305|NCT02067078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65645306|NCT02067078|Glucocorticoids|glucocorticoids|mesh-ancestor
65645307|NCT02067078|Hormones|hormones|mesh-ancestor
65645308|NCT02067078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65645309|NCT02067078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65645310|NCT02067078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645311|NCT02067078|Protease Inhibitors|protease inhibitors|mesh-ancestor
65645312|NCT02067078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645313|NCT02067078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645314|NCT02067078|Anesthetics, Local|anesthetics, local|mesh-ancestor
65645315|NCT02067078|Anesthetics|anesthetics|mesh-ancestor
65645316|NCT02067078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65645317|NCT02067078|Sensory System Agents|sensory system agents|mesh-ancestor
65645318|NCT02067078|Analgesics|analgesics|mesh-ancestor
65645319|NCT02067078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65645320|NCT02067078|Sympatholytics|sympatholytics|mesh-ancestor
65645321|NCT02067078|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65645322|NCT02067078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65645323|NCT02067078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65645324|NCT02067078|Adrenergic Agents|adrenergic agents|mesh-ancestor
65645325|NCT02067078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65645326|NCT02067078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65645327|NCT02067078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65645328|NCT02067078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65645329|NCT02067078|Respiratory System Agents|respiratory system agents|mesh-ancestor
65645330|NCT02067078|Mydriatics|mydriatics|mesh-ancestor
65645331|NCT02067078|Sympathomimetics|sympathomimetics|mesh-ancestor
65645332|NCT02067078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65645333|NCT02067078|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65645334|NCT02067078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65645335|NCT02067078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65645336|NCT02067078|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65645337|NCT05461235|Pembrolizumab|pembrolizumab|mesh-list
65645338|NCT05461235|Nivolumab|nivolumab|mesh-list
65645339|NCT05461235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65645340|NCT05461235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645341|NCT05461235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65645342|NCT05461235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645343|NCT02070198|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65645344|NCT02070198|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65645345|NCT02070198|Hormones|hormones|mesh-ancestor
65645346|NCT02070198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65645347|NCT02070198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645348|NCT02070198|Luteolytic Agents|luteolytic agents|mesh-ancestor
65645349|NCT02070198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65645350|NCT02070198|Contraceptive Agents|contraceptive agents|mesh-ancestor
65645351|NCT02070198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65645352|NCT02070198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65645353|NCT02070198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65645354|NCT02070198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645355|NCT02918201|Tranexamic Acid|tranexamic acid|mesh-list
65645356|NCT02918201|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65645357|NCT02918201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65645358|NCT02918201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645359|NCT02918201|Hemostatics|hemostatics|mesh-ancestor
65645360|NCT02918201|Coagulants|coagulants|mesh-ancestor
65645361|NCT02200406|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65645362|NCT02200406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65645363|NCT02200406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65645364|NCT02200406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65645365|NCT02200406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645366|NCT02200406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65645367|NCT02200406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645368|NCT02200406|Antidepressive Agents|antidepressive agents|mesh-ancestor
65645369|NCT02200406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65645370|NCT02204852|Iloprost|iloprost|mesh-list
65645371|NCT02204852|Eptifibatide|eptifibatide|mesh-list
65645372|NCT02204852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65645373|NCT02204852|Vasodilator Agents|vasodilator agents|mesh-ancestor
65645374|NCT02070510|Lisinopril|lisinopril|mesh-list
65645375|NCT02070510|Warfarin|warfarin|mesh-list
65645376|NCT02070510|Anticoagulants|anticoagulants|mesh-ancestor
65645377|NCT02070510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65645378|NCT02070510|Protease Inhibitors|protease inhibitors|mesh-ancestor
65645379|NCT02070510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645380|NCT02070510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645381|NCT02070510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65645382|NCT02070510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65645383|NCT02070510|Protective Agents|protective agents|mesh-ancestor
65645384|NCT02070510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645385|NCT02200562|Ipilimumab|ipilimumab|mesh-list
65645386|NCT02200562|Dabrafenib|dabrafenib|mesh-list
65645387|NCT02200562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65645388|NCT02200562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645389|NCT02200562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65645390|NCT02200562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645391|NCT02200562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65645392|NCT02200562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645393|NCT02200640|Losartan|losartan|mesh-list
65645394|NCT02200640|Telmisartan|telmisartan|mesh-list
65645395|NCT02200640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65645396|NCT02200640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65645397|NCT02200640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65645398|NCT02200640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65645399|NCT02200640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645400|NCT02200718|Freund's Adjuvant|freund's adjuvant|mesh-list
65645401|NCT02200718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65645402|NCT02200718|Immunologic Factors|immunologic factors|mesh-ancestor
65645403|NCT02200718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645404|NCT02208986|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65645405|NCT02208986|Luteolytic Agents|luteolytic agents|mesh-ancestor
65645406|NCT02208986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65645407|NCT02208986|Contraceptive Agents|contraceptive agents|mesh-ancestor
65645408|NCT02208986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65645409|NCT02208986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645410|NCT02208986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65645411|NCT02208986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65645412|NCT02208986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645413|NCT02067780|Levofloxacin|levofloxacin|mesh-list
65645414|NCT02067780|Ofloxacin|ofloxacin|mesh-list
65645415|NCT02067780|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65645416|NCT02067780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65645417|NCT02067780|Renal Agents|renal agents|mesh-ancestor
65645418|NCT02067780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65645419|NCT02067780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65442803|NCT00305604|Hormones|hormones|mesh-ancestor
65645420|NCT02067780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65645421|NCT02067780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645422|NCT02067780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645423|NCT02067780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645424|NCT02067780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65645425|NCT02067780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65645426|NCT02205164|Aprepitant|aprepitant|mesh-list
65645427|NCT02205164|Palonosetron|palonosetron|mesh-list
65645428|NCT02205164|Antiemetics|antiemetics|mesh-ancestor
65645429|NCT02205164|Autonomic Agents|autonomic agents|mesh-ancestor
65645430|NCT02205164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65645431|NCT02205164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645432|NCT02205164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65645433|NCT02205164|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65645434|NCT02205164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65645435|NCT02205164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645436|NCT02205164|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65645437|NCT02205164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65645438|NCT02205164|Serotonin Agents|serotonin agents|mesh-ancestor
65645439|NCT02071212|Ticagrelor|ticagrelor|mesh-list
65645440|NCT02071212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65645441|NCT02071212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65645442|NCT02071212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65645443|NCT02071212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65645444|NCT02071212|Purinergic Agents|purinergic agents|mesh-ancestor
65645445|NCT02071212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65645446|NCT02071212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645447|NCT02071212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645448|NCT02072382|Metformin|metformin|mesh-list
65645449|NCT02072382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65645450|NCT02072382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645451|NCT02205242|Azithromycin|azithromycin|mesh-list
65645452|NCT02205242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65645453|NCT02205242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65645454|NCT02071368|Metformin|metformin|mesh-list
65645455|NCT02071368|Canagliflozin|canagliflozin|mesh-list
65645456|NCT02071368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65645457|NCT02071368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645458|NCT02071368|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65645459|NCT02071368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645460|NCT03402841|Olaparib|olaparib|mesh-list
65645461|NCT03402841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65645462|NCT03402841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645463|NCT03402841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645464|NCT03402841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645465|NCT02205398|Cetuximab|cetuximab|mesh-list
65645466|NCT02205398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65645467|NCT02205398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645468|NCT04130659|Omeprazole|omeprazole|mesh-list
65645469|NCT04130659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65645470|NCT04130659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65645471|NCT04130659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65645472|NCT04130659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108187|NCT05541484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65645473|NCT04130659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645474|NCT02220608|Bortezomib|bortezomib|mesh-list
65645475|NCT02220608|Lenograstim|lenograstim|mesh-list
65645476|NCT02220608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65645477|NCT02220608|Immunologic Factors|immunologic factors|mesh-ancestor
65645478|NCT02220608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645479|NCT02220608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645480|NCT03630367|Dexamethasone|dexamethasone|mesh-list
65645481|NCT03630367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65645482|NCT03630367|Antiemetics|antiemetics|mesh-ancestor
65645483|NCT03630367|Autonomic Agents|autonomic agents|mesh-ancestor
65645484|NCT03630367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65645485|NCT03630367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645486|NCT03630367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65645487|NCT03630367|Glucocorticoids|glucocorticoids|mesh-ancestor
65645488|NCT03630367|Hormones|hormones|mesh-ancestor
65645489|NCT03630367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65645490|NCT03630367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65645491|NCT03630367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645492|NCT02258282|Etanercept|etanercept|mesh-list
65645493|NCT02258282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65645494|NCT02258282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65645495|NCT02258282|Analgesics|analgesics|mesh-ancestor
65645496|NCT02258282|Sensory System Agents|sensory system agents|mesh-ancestor
65645497|NCT02258282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65645498|NCT02258282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645499|NCT02258282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65645500|NCT02258282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65645501|NCT02258282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65645502|NCT02258282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65645503|NCT02258282|Immunologic Factors|immunologic factors|mesh-ancestor
65645504|NCT02076594|Docetaxel|docetaxel|mesh-list
65645505|NCT02076594|Capecitabine|capecitabine|mesh-list
65645506|NCT02076594|Oxaliplatin|oxaliplatin|mesh-list
65645507|NCT02076594|Epirubicin|epirubicin|mesh-list
65645508|NCT02076594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645509|NCT02076594|Tubulin Modulators|tubulin modulators|mesh-ancestor
65645510|NCT02076594|Antimitotic Agents|antimitotic agents|mesh-ancestor
65645511|NCT02076594|Mitosis Modulators|mitosis modulators|mesh-ancestor
65645512|NCT02076594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645513|NCT02076594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65645514|NCT02076594|Antimetabolites|antimetabolites|mesh-ancestor
65645515|NCT02076594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65645516|NCT02076594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65645517|NCT02076594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65645518|NCT02076594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645519|NCT04175509|Acetaminophen|acetaminophen|mesh-list
65645520|NCT04175509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65645521|NCT04175509|Analgesics|analgesics|mesh-ancestor
65645522|NCT04175509|Sensory System Agents|sensory system agents|mesh-ancestor
65645523|NCT04175509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65645524|NCT04175509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645525|NCT04175509|Antipyretics|antipyretics|mesh-ancestor
65645526|NCT02220842|Atezolizumab|atezolizumab|mesh-list
65645527|NCT02220842|Obinutuzumab|obinutuzumab|mesh-list
65645528|NCT02220842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645529|NCT02220842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65645530|NCT02205554|Tramadol|tramadol|mesh-list
65645531|NCT02205554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65645532|NCT02205554|Narcotics|narcotics|mesh-ancestor
65645533|NCT02205554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65645534|NCT02205554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645535|NCT02205554|Analgesics|analgesics|mesh-ancestor
65645536|NCT02205554|Sensory System Agents|sensory system agents|mesh-ancestor
65645537|NCT02205554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65645538|NCT02076750|Vitamin D|vitamin d|mesh-list
65645539|NCT02076750|Cholecalciferol|cholecalciferol|mesh-list
65645540|NCT02076750|Vitamins|vitamins|mesh-ancestor
65645541|NCT02076750|Micronutrients|micronutrients|mesh-ancestor
65645542|NCT02076750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645543|NCT02076750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65645544|NCT02076750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65645545|NCT05262608|Olaparib|olaparib|mesh-list
65645546|NCT05262608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65645547|NCT05262608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645548|NCT05262608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645549|NCT05262608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645550|NCT01380457|Dronabinol|dronabinol|mesh-list
65645551|NCT01380457|Hallucinogens|hallucinogens|mesh-ancestor
65645552|NCT01380457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645553|NCT01380457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65645554|NCT01380457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65645555|NCT01380457|Analgesics|analgesics|mesh-ancestor
65645556|NCT01380457|Sensory System Agents|sensory system agents|mesh-ancestor
65645557|NCT01380457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65645558|NCT01380457|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65645559|NCT01380457|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65645560|NCT01380457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65645561|NCT01380457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645562|NCT01380457|Hormones|hormones|mesh-ancestor
65645563|NCT01380457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65645564|NCT02071680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65645565|NCT02071680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645566|NCT02071680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645567|NCT02071680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645568|NCT02071680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65645569|NCT01380301|Miltefosine|miltefosine|mesh-list
65645570|NCT01380301|Antifungal Agents|antifungal agents|mesh-ancestor
65645571|NCT01380301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65645572|NCT01380301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645573|NCT01380301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65645574|NCT01380301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65645576|NCT02076828|Glycine|glycine|mesh-list
65645577|NCT02076828|Trace Elements|trace elements|mesh-ancestor
65645578|NCT02076828|Micronutrients|micronutrients|mesh-ancestor
65645579|NCT02076828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645580|NCT02076828|Glycine Agents|glycine agents|mesh-ancestor
65645581|NCT02076828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65645582|NCT02076828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645583|NCT02221154|Folic Acid|folic acid|mesh-list
65645584|NCT02221154|Hematinics|hematinics|mesh-ancestor
65645585|NCT02221154|Vitamin B Complex|vitamin b complex|mesh-ancestor
65645586|NCT02221154|Vitamins|vitamins|mesh-ancestor
65645587|NCT02221154|Micronutrients|micronutrients|mesh-ancestor
65645588|NCT02221154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645589|NCT02073084|Moxifloxacin|moxifloxacin|mesh-list
65645590|NCT02073084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65645591|NCT02073084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65645592|NCT02073084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65645593|NCT02073084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65645594|NCT02073084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645595|NCT02073084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645596|NCT02073084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645597|NCT03787849|Anesthetics|anesthetics|mesh-list
65645598|NCT03787849|Propofol|propofol|mesh-list
65645599|NCT03787849|Sevoflurane|sevoflurane|mesh-list
65645600|NCT03787849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65645601|NCT03787849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645602|NCT03787849|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65645603|NCT03787849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65645604|NCT03787849|Anesthetics, General|anesthetics, general|mesh-ancestor
65645605|NCT03787849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65645606|NCT03787849|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65645607|NCT03777319|Prednisolone|prednisolone|mesh-list
65645608|NCT03777319|Spironolactone|spironolactone|mesh-list
65645609|NCT03777319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65645610|NCT03777319|Glucocorticoids|glucocorticoids|mesh-ancestor
65645611|NCT03777319|Hormones|hormones|mesh-ancestor
65645612|NCT03777319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65645613|NCT03777319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645614|NCT03777319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65645615|NCT03777319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645616|NCT03777319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65645617|NCT03777319|Hormone Antagonists|hormone antagonists|mesh-ancestor
65645618|NCT03777319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65645619|NCT03777319|Diuretics|diuretics|mesh-ancestor
65645620|NCT03777319|Natriuretic Agents|natriuretic agents|mesh-ancestor
65645621|NCT03671265|Apatinib|apatinib|mesh-list
65645622|NCT03671265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645623|NCT03671265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65645624|NCT03671265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645625|NCT03671265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645626|NCT02881957|Vitamin D|vitamin d|mesh-list
65645627|NCT02881957|Cholecalciferol|cholecalciferol|mesh-list
65645628|NCT02881957|Vitamins|vitamins|mesh-ancestor
65645629|NCT02881957|Micronutrients|micronutrients|mesh-ancestor
65645630|NCT02881957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645631|NCT02881957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65645632|NCT02881957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65645633|NCT02206022|Remifentanil|remifentanil|mesh-list
65645634|NCT02206022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65645635|NCT02206022|Narcotics|narcotics|mesh-ancestor
65645636|NCT02206022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65645637|NCT02206022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645638|NCT02206022|Analgesics|analgesics|mesh-ancestor
65645639|NCT02206022|Sensory System Agents|sensory system agents|mesh-ancestor
65645640|NCT02206022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65645641|NCT02073552|Ascorbic Acid|ascorbic acid|mesh-list
65645642|NCT02073552|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65645643|NCT02073552|Antioxidants|antioxidants|mesh-ancestor
65645644|NCT02073552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645645|NCT02073552|Protective Agents|protective agents|mesh-ancestor
65645646|NCT02073552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645648|NCT02073552|Micronutrients|micronutrients|mesh-ancestor
65645649|NCT02073552|Laxatives|laxatives|mesh-ancestor
65645650|NCT02073552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65645651|NCT02210156|Micronutrients|micronutrients|mesh-list
65645652|NCT02210156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645653|NCT02080026|Chloroquine|chloroquine|mesh-list
65645654|NCT02080026|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65645655|NCT02080026|Atovaquone|atovaquone|mesh-list
65645656|NCT02080026|Proguanil|proguanil|mesh-list
65645657|NCT02080026|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
65645658|NCT02080026|Amebicides|amebicides|mesh-ancestor
65645659|NCT02080026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65645660|NCT02080026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65645661|NCT02080026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65645662|NCT02080026|Antimalarials|antimalarials|mesh-ancestor
65645663|NCT02080026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65645664|NCT02080026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65645665|NCT02080026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65645666|NCT02080026|Analgesics|analgesics|mesh-ancestor
65645667|NCT02080026|Sensory System Agents|sensory system agents|mesh-ancestor
65645668|NCT02080026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65645669|NCT02080026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645670|NCT02080026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65645671|NCT02080026|Filaricides|filaricides|mesh-ancestor
65645672|NCT02080026|Antinematodal Agents|antinematodal agents|mesh-ancestor
65645673|NCT02080026|Anthelmintics|anthelmintics|mesh-ancestor
65645674|NCT02080026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645675|NCT02080026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645676|NCT02080026|Antimetabolites|antimetabolites|mesh-ancestor
65645677|NCT02206178|Acetaminophen|acetaminophen|mesh-list
65645678|NCT02206178|Acetylcysteine|acetylcysteine|mesh-list
65645679|NCT02206178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65645680|NCT02206178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65645681|NCT02206178|Analgesics|analgesics|mesh-ancestor
65645682|NCT02206178|Sensory System Agents|sensory system agents|mesh-ancestor
65645683|NCT02206178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65645684|NCT02206178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645685|NCT02206178|Antipyretics|antipyretics|mesh-ancestor
65645686|NCT02206178|Antiviral Agents|antiviral agents|mesh-ancestor
65645687|NCT02206178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65645688|NCT02206178|Expectorants|expectorants|mesh-ancestor
65645689|NCT02206178|Respiratory System Agents|respiratory system agents|mesh-ancestor
65645690|NCT02206178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65645691|NCT02206178|Antioxidants|antioxidants|mesh-ancestor
65645692|NCT02206178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645693|NCT02206178|Protective Agents|protective agents|mesh-ancestor
65645694|NCT02206178|Antidotes|antidotes|mesh-ancestor
65645695|NCT02080104|Oxytocin|oxytocin|mesh-list
65645696|NCT02080104|Oxytocics|oxytocics|mesh-ancestor
65645697|NCT02080104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65645698|NCT02080104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645699|NCT03463057|Atezolizumab|atezolizumab|mesh-list
65645700|NCT03463057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645701|NCT02211326|Warfarin|warfarin|mesh-list
65645702|NCT02211326|Anticoagulants|anticoagulants|mesh-ancestor
65645703|NCT02691793|Sunitinib|sunitinib|mesh-list
65645704|NCT02691793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645705|NCT02691793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65645706|NCT02691793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65645707|NCT02691793|Growth Substances|growth substances|mesh-ancestor
65645708|NCT02691793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645709|NCT02691793|Growth Inhibitors|growth inhibitors|mesh-ancestor
65645710|NCT02691793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65645711|NCT02691793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645712|NCT02691793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645713|NCT02221622|Pregnanolone|pregnanolone|mesh-list
65645714|NCT02221622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65645715|NCT02221622|Anesthetics|anesthetics|mesh-ancestor
65645716|NCT02221622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65645717|NCT02221622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645718|NCT02080182|Acetylcysteine|acetylcysteine|mesh-list
65645719|NCT02080182|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65645720|NCT02080182|Antiviral Agents|antiviral agents|mesh-ancestor
65645721|NCT02080182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65645722|NCT02080182|Expectorants|expectorants|mesh-ancestor
65645723|NCT02080182|Respiratory System Agents|respiratory system agents|mesh-ancestor
65645724|NCT02080182|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65645725|NCT02080182|Antioxidants|antioxidants|mesh-ancestor
65645726|NCT02080182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645727|NCT02080182|Protective Agents|protective agents|mesh-ancestor
65645728|NCT02080182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645729|NCT02080182|Antidotes|antidotes|mesh-ancestor
65645730|NCT02750930|rGLP-1 protein|rglp-1 protein|mesh-list
65645731|NCT02750930|Incretins|incretins|mesh-ancestor
65645732|NCT02750930|Hormones|hormones|mesh-ancestor
65645733|NCT02750930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65645734|NCT02750930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645735|NCT02080416|Nelfinavir|nelfinavir|mesh-list
65645736|NCT02080416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65645737|NCT02080416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65645738|NCT02080416|Protease Inhibitors|protease inhibitors|mesh-ancestor
65645739|NCT02080416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645740|NCT02080416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645741|NCT02080416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65645742|NCT02080416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65645743|NCT02080416|Antiviral Agents|antiviral agents|mesh-ancestor
65645744|NCT02080416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65645745|NCT02080494|Tranexamic Acid|tranexamic acid|mesh-list
65645746|NCT02080494|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65645747|NCT02080494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65645748|NCT02080494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645749|NCT02080494|Hemostatics|hemostatics|mesh-ancestor
65645750|NCT02080494|Coagulants|coagulants|mesh-ancestor
65645751|NCT02213744|Gemcitabine|gemcitabine|mesh-list
65645752|NCT02213744|Capecitabine|capecitabine|mesh-list
65645753|NCT02213744|Trastuzumab|trastuzumab|mesh-list
65645754|NCT02213744|Vinorelbine|vinorelbine|mesh-list
65645755|NCT02213744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65645756|NCT02213744|Antimetabolites|antimetabolites|mesh-ancestor
65645757|NCT02213744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645758|NCT02213744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645759|NCT02213744|Antiviral Agents|antiviral agents|mesh-ancestor
65645760|NCT02213744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65645761|NCT02213744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645762|NCT02213744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65645763|NCT02213744|Immunologic Factors|immunologic factors|mesh-ancestor
65645764|NCT02213744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645765|NCT02213744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65645766|NCT02213744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65645767|NCT02213744|Tubulin Modulators|tubulin modulators|mesh-ancestor
65645768|NCT02213744|Antimitotic Agents|antimitotic agents|mesh-ancestor
65645769|NCT02213744|Mitosis Modulators|mitosis modulators|mesh-ancestor
65645770|NCT01378741|Dexmedetomidine|dexmedetomidine|mesh-list
65645771|NCT01378741|Propofol|propofol|mesh-list
65645772|NCT01378741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65645773|NCT01378741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65645774|NCT01378741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645775|NCT01378741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65645776|NCT01378741|Anesthetics, General|anesthetics, general|mesh-ancestor
65645777|NCT01378741|Anesthetics|anesthetics|mesh-ancestor
65645778|NCT01378741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65645779|NCT01378741|Analgesics|analgesics|mesh-ancestor
65645780|NCT01378741|Sensory System Agents|sensory system agents|mesh-ancestor
65645781|NCT01378741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65645782|NCT01378741|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65645783|NCT01378741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65645784|NCT01378741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65645785|NCT01378741|Adrenergic Agents|adrenergic agents|mesh-ancestor
65645786|NCT01378741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65645787|NCT01378741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645788|NCT04850599|Pomalidomide|pomalidomide|mesh-list
65645789|NCT04850599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65645790|NCT04850599|Immunologic Factors|immunologic factors|mesh-ancestor
65645791|NCT04850599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645792|NCT04850599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65645793|NCT04850599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65645794|NCT04850599|Growth Substances|growth substances|mesh-ancestor
65645795|NCT04850599|Growth Inhibitors|growth inhibitors|mesh-ancestor
65645796|NCT04850599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645797|NCT02461849|Imatinib Mesylate|imatinib mesylate|mesh-list
65645798|NCT02461849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645799|NCT02461849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65645800|NCT02461849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443165|NCT03981770|Anesthetics|anesthetics|mesh-list
65645801|NCT02461849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645802|NCT02225054|Dexmedetomidine|dexmedetomidine|mesh-list
65645803|NCT02225054|Ropivacaine|ropivacaine|mesh-list
65645804|NCT02225054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65645805|NCT02225054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65645806|NCT02225054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645807|NCT02225054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65645808|NCT02225054|Analgesics|analgesics|mesh-ancestor
65645809|NCT02225054|Sensory System Agents|sensory system agents|mesh-ancestor
65645810|NCT02225054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65645811|NCT02225054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65645812|NCT02225054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65645813|NCT02225054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65645814|NCT02225054|Adrenergic Agents|adrenergic agents|mesh-ancestor
65645815|NCT02225054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65645816|NCT02225054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645817|NCT02225054|Anesthetics, Local|anesthetics, local|mesh-ancestor
65645818|NCT02225054|Anesthetics|anesthetics|mesh-ancestor
65645819|NCT02080728|Ropivacaine|ropivacaine|mesh-list
65645820|NCT02080728|Anesthetics, Local|anesthetics, local|mesh-ancestor
65645821|NCT02080728|Anesthetics|anesthetics|mesh-ancestor
65645822|NCT02080728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65645823|NCT02080728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645824|NCT02080728|Sensory System Agents|sensory system agents|mesh-ancestor
65645825|NCT02080728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65645826|NCT03078907|Selexipag|selexipag|mesh-list
65645827|NCT03078907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65645828|NCT02225210|Fentanyl|fentanyl|mesh-list
65645829|NCT02225210|Midazolam|midazolam|mesh-list
65645830|NCT02225210|Dexmedetomidine|dexmedetomidine|mesh-list
65645831|NCT02225210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65645832|NCT02225210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65645833|NCT02225210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645834|NCT02225210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65645835|NCT02225210|Analgesics|analgesics|mesh-ancestor
65645836|NCT02225210|Sensory System Agents|sensory system agents|mesh-ancestor
65645837|NCT02225210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65645838|NCT02225210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65645839|NCT02225210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65645840|NCT02225210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65645841|NCT02225210|Adrenergic Agents|adrenergic agents|mesh-ancestor
65645842|NCT02225210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65645843|NCT02225210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645844|NCT02225210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65645845|NCT02225210|Narcotics|narcotics|mesh-ancestor
65645846|NCT02225210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65645847|NCT02225210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65645848|NCT02225210|Anesthetics, General|anesthetics, general|mesh-ancestor
65645849|NCT02225210|Anesthetics|anesthetics|mesh-ancestor
65645850|NCT02225210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65645851|NCT02225210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65645852|NCT02225210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65645853|NCT02225210|GABA Modulators|gaba modulators|mesh-ancestor
65645854|NCT02225210|GABA Agents|gaba agents|mesh-ancestor
65645855|NCT02217020|Oxaliplatin|oxaliplatin|mesh-list
65645856|NCT02217020|Irinotecan|irinotecan|mesh-list
65645857|NCT02217020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645858|NCT02217020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65645859|NCT02217020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65645860|NCT02217020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645861|NCT02217020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645862|NCT03249714|Ofatumumab|ofatumumab|mesh-list
65645863|NCT03249714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65645864|NCT03249714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645865|NCT03249714|Immunologic Factors|immunologic factors|mesh-ancestor
65645866|NCT03249714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645867|NCT02222168|BI 409306|bi 409306|mesh-list
65645868|NCT02222168|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65645869|NCT02222168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645870|NCT02222168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645871|NCT02925117|Upadacitinib|upadacitinib|mesh-list
65645872|NCT02925117|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65645873|NCT02925117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65645874|NCT02925117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645875|NCT02925117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645876|NCT02925117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65645877|NCT02077920|Chlorhexidine|chlorhexidine|mesh-list
65645878|NCT02077920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65645879|NCT02077920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65645880|NCT02077920|Disinfectants|disinfectants|mesh-ancestor
65645881|NCT02225756|Cyclosporine|cyclosporine|mesh-list
65645882|NCT02225756|Cyclosporins|cyclosporins|mesh-list
65645883|NCT02225756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645884|NCT02225756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645885|NCT02225756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65645886|NCT02225756|Immunologic Factors|immunologic factors|mesh-ancestor
65645887|NCT02225756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645888|NCT02225756|Antifungal Agents|antifungal agents|mesh-ancestor
65645889|NCT02225756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65645890|NCT02225756|Dermatologic Agents|dermatologic agents|mesh-ancestor
65645891|NCT02225756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65645892|NCT02225756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65645893|NCT02225834|Atorvastatin|atorvastatin|mesh-list
65645894|NCT02225834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65645895|NCT02225834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65645896|NCT02225834|Antimetabolites|antimetabolites|mesh-ancestor
65645897|NCT02225834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645898|NCT02225834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65645899|NCT02225834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65645900|NCT02225834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645901|NCT02077998|Oxaliplatin|oxaliplatin|mesh-list
65645902|NCT02077998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645903|NCT02222324|Moxifloxacin|moxifloxacin|mesh-list
65645904|NCT02222324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65645905|NCT02222324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65645906|NCT02222324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65645907|NCT02222324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65645908|NCT02222324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645909|NCT02222324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645910|NCT02222324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645911|NCT02074800|Siltuximab|siltuximab|mesh-list
65645912|NCT02074800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65645913|NCT02074800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645914|NCT02074800|Immunologic Factors|immunologic factors|mesh-ancestor
65645915|NCT02074800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645916|NCT04504045|Metformin|metformin|mesh-list
65645917|NCT04504045|Efavirenz|efavirenz|mesh-list
65645918|NCT04504045|Losartan|losartan|mesh-list
65645919|NCT04504045|Metoprolol|metoprolol|mesh-list
65645920|NCT04504045|Midazolam|midazolam|mesh-list
65645921|NCT04504045|Caffeine|caffeine|mesh-list
65645922|NCT04504045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65645923|NCT04504045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645924|NCT04504045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65645925|NCT04504045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65645926|NCT04504045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65645927|NCT04504045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65645928|NCT04504045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65645929|NCT04504045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65645930|NCT04504045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65645931|NCT04504045|Anesthetics, General|anesthetics, general|mesh-ancestor
65645932|NCT04504045|Anesthetics|anesthetics|mesh-ancestor
65645933|NCT04504045|GABA Modulators|gaba modulators|mesh-ancestor
65645934|NCT04504045|GABA Agents|gaba agents|mesh-ancestor
65645935|NCT04504045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65645936|NCT04504045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645937|NCT04504045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65645938|NCT04504045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65645939|NCT04504045|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65645940|NCT04504045|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65645941|NCT04504045|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65645942|NCT04504045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65645943|NCT04504045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65645944|NCT04504045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65645945|NCT04504045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65645946|NCT04504045|Purinergic Agents|purinergic agents|mesh-ancestor
65645947|NCT04504045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65645948|NCT04504045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65645949|NCT04504045|Antiviral Agents|antiviral agents|mesh-ancestor
65645950|NCT04504045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65645951|NCT04504045|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65645952|NCT04504045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65645953|NCT04504045|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65645954|NCT04504045|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65645955|NCT04504045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65645956|NCT04504045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65645957|NCT04504045|Sympatholytics|sympatholytics|mesh-ancestor
65645958|NCT04504045|Autonomic Agents|autonomic agents|mesh-ancestor
65645959|NCT04504045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65645960|NCT04504045|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65645961|NCT04504045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65645962|NCT04504045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65645963|NCT04504045|Adrenergic Agents|adrenergic agents|mesh-ancestor
65645964|NCT03283488|Megestrol|megestrol|mesh-list
65645965|NCT03283488|Megestrol Acetate|megestrol acetate|mesh-list
65645966|NCT03283488|Mirtazapine|mirtazapine|mesh-list
65645967|NCT03283488|Antidepressive Agents|antidepressive agents|mesh-ancestor
65645968|NCT03283488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65645969|NCT03283488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65645970|NCT03283488|Histamine Antagonists|histamine antagonists|mesh-ancestor
65645971|NCT03283488|Histamine Agents|histamine agents|mesh-ancestor
65645972|NCT03283488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65645973|NCT03283488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65645974|NCT03283488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65645975|NCT03283488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65645976|NCT03283488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65645977|NCT03283488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65645978|NCT03283488|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65645979|NCT03283488|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65645980|NCT03283488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65645981|NCT03283488|Adrenergic Agents|adrenergic agents|mesh-ancestor
65645982|NCT03283488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65645983|NCT03283488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65645984|NCT03283488|Serotonin Agents|serotonin agents|mesh-ancestor
65645985|NCT03283488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65645986|NCT03283488|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65645987|NCT03283488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65645988|NCT03283488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65645989|NCT03283488|Contraceptive Agents|contraceptive agents|mesh-ancestor
65645990|NCT03283488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65645991|NCT03283488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65645992|NCT03283488|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65645993|NCT03283488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65645994|NCT03283488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65645995|NCT03283488|Appetite Stimulants|appetite stimulants|mesh-ancestor
65645996|NCT03283488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65645997|NCT02258204|Ketamine|ketamine|mesh-list
65645998|NCT02258204|Analgesics|analgesics|mesh-ancestor
65645999|NCT02258204|Sensory System Agents|sensory system agents|mesh-ancestor
65646000|NCT02258204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65646001|NCT02258204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646002|NCT02258204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65646003|NCT02258204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65646004|NCT02258204|Anesthetics, General|anesthetics, general|mesh-ancestor
65646005|NCT02258204|Anesthetics|anesthetics|mesh-ancestor
65646006|NCT02258204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65646007|NCT02258204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65646008|NCT02258204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65646009|NCT02258204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65646010|NCT02258204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646011|NCT02226068|Cyclosporine|cyclosporine|mesh-list
65646012|NCT02226068|Cyclosporins|cyclosporins|mesh-list
65646013|NCT02226068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646014|NCT02226068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646015|NCT02226068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65646016|NCT02226068|Immunologic Factors|immunologic factors|mesh-ancestor
65646017|NCT02226068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646018|NCT02226068|Antifungal Agents|antifungal agents|mesh-ancestor
65646019|NCT02226068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65646020|NCT02226068|Dermatologic Agents|dermatologic agents|mesh-ancestor
65646021|NCT02226068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65646022|NCT02226068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65646023|NCT02220218|Metformin|metformin|mesh-list
65646024|NCT02220218|Canagliflozin|canagliflozin|mesh-list
65646025|NCT02220218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65443391|NCT03981068|Nimorazole|nimorazole|mesh-list
65646026|NCT02220218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646027|NCT02220218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65646028|NCT02220218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646030|NCT02222480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65646031|NCT02222480|Diuretics|diuretics|mesh-ancestor
65646032|NCT02222480|Natriuretic Agents|natriuretic agents|mesh-ancestor
65646033|NCT02222480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267708|NCT00649311|Diuretics|diuretics|mesh-ancestor
65646034|NCT02222480|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65646035|NCT02222480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65646036|NCT02222480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646037|NCT03670875|Curcumin|curcumin|mesh-list
65646038|NCT03670875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65646039|NCT03670875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65646040|NCT03670875|Analgesics|analgesics|mesh-ancestor
65646041|NCT03670875|Sensory System Agents|sensory system agents|mesh-ancestor
65646042|NCT03670875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65646043|NCT03670875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646044|NCT03670875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65646045|NCT03670875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65646046|NCT03670875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646047|NCT03670875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646048|NCT03670875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646049|NCT01379677|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
65646050|NCT01379677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65646051|NCT01379677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646052|NCT02220296|Insulin|insulin|mesh-list
65646053|NCT02220296|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65646054|NCT02220296|Insulin Glargine|insulin glargine|mesh-list
65646055|NCT02220296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65646056|NCT02220296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646057|NCT02074878|Sunitinib|sunitinib|mesh-list
65646058|NCT02074878|Crizotinib|crizotinib|mesh-list
65646059|NCT02074878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646060|NCT02074878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65646061|NCT02074878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65646062|NCT02074878|Growth Substances|growth substances|mesh-ancestor
65646063|NCT02074878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646064|NCT02074878|Growth Inhibitors|growth inhibitors|mesh-ancestor
65646065|NCT02074878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65646066|NCT02074878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646067|NCT02074878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646068|NCT03075163|Ondansetron|ondansetron|mesh-list
65646069|NCT03075163|Antiemetics|antiemetics|mesh-ancestor
65646070|NCT03075163|Autonomic Agents|autonomic agents|mesh-ancestor
65646071|NCT03075163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65646072|NCT03075163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646073|NCT03075163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65646074|NCT03075163|Antipruritics|antipruritics|mesh-ancestor
65646075|NCT03075163|Dermatologic Agents|dermatologic agents|mesh-ancestor
65646076|NCT03075163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65646077|NCT03075163|Serotonin Agents|serotonin agents|mesh-ancestor
65646078|NCT03075163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65646079|NCT03075163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646080|NCT03075163|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65646081|NCT03075163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65646082|NCT03075163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65646083|NCT03075163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65646084|NCT03075163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65646085|NCT02628405|Rituximab|rituximab|mesh-list
65646086|NCT02628405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65646087|NCT02628405|Carboplatin|carboplatin|mesh-list
65646088|NCT02628405|Etoposide|etoposide|mesh-list
65646089|NCT02628405|Lenalidomide|lenalidomide|mesh-list
65646090|NCT02628405|Etoposide phosphate|etoposide phosphate|mesh-list
65646091|NCT02628405|Ifosfamide|ifosfamide|mesh-list
65646092|NCT02628405|Isophosphamide mustard|isophosphamide mustard|mesh-list
65646093|NCT02628405|Podophyllotoxin|podophyllotoxin|mesh-list
65646094|NCT02628405|Antibodies|antibodies|mesh-list
65646095|NCT02628405|Immunoglobulins|immunoglobulins|mesh-list
65646096|NCT02628405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65646097|NCT02628405|Immunologic Factors|immunologic factors|mesh-ancestor
65646098|NCT02628405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646099|NCT02628405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646100|NCT02628405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65646101|NCT02628405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65646102|NCT02628405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65646103|NCT02628405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65646104|NCT02628405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646105|NCT02628405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646106|NCT02628405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65646107|NCT02628405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65646108|NCT02628405|Growth Substances|growth substances|mesh-ancestor
65646109|NCT02628405|Growth Inhibitors|growth inhibitors|mesh-ancestor
65646110|NCT02628405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65646111|NCT02628405|Alkylating Agents|alkylating agents|mesh-ancestor
65646112|NCT02628405|Keratolytic Agents|keratolytic agents|mesh-ancestor
65646113|NCT02628405|Dermatologic Agents|dermatologic agents|mesh-ancestor
65646114|NCT02628405|Tubulin Modulators|tubulin modulators|mesh-ancestor
65646115|NCT02628405|Antimitotic Agents|antimitotic agents|mesh-ancestor
65646116|NCT02628405|Mitosis Modulators|mitosis modulators|mesh-ancestor
65646118|NCT02220530|Midazolam|midazolam|mesh-list
65646119|NCT02220530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65646120|NCT02220530|Narcotics|narcotics|mesh-ancestor
65646121|NCT02220530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65646122|NCT02220530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646123|NCT02220530|Analgesics|analgesics|mesh-ancestor
65646124|NCT02220530|Sensory System Agents|sensory system agents|mesh-ancestor
65646125|NCT02220530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65646126|NCT02220530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65646127|NCT02220530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65646128|NCT02220530|Anesthetics, General|anesthetics, general|mesh-ancestor
65646129|NCT02220530|Anesthetics|anesthetics|mesh-ancestor
65646130|NCT02220530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65646131|NCT02220530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65646132|NCT02220530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65646133|NCT02220530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65646134|NCT02220530|GABA Modulators|gaba modulators|mesh-ancestor
65646135|NCT02220530|GABA Agents|gaba agents|mesh-ancestor
65646136|NCT02220530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65646137|NCT02220530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646138|NCT02078232|Pancrelipase|pancrelipase|mesh-list
65646139|NCT02078232|Pancreatin|pancreatin|mesh-list
65646140|NCT02078232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65646141|NCT02075034|ON 01910|on 01910|mesh-list
65646142|NCT02075034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646143|NCT02075034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65646144|NCT02075034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646145|NCT02075034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646146|NCT02567175|Domperidone|domperidone|mesh-list
65646147|NCT02567175|Antiemetics|antiemetics|mesh-ancestor
65646148|NCT02567175|Autonomic Agents|autonomic agents|mesh-ancestor
65646149|NCT02567175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65646150|NCT02567175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646151|NCT02567175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65646152|NCT02567175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65646153|NCT02567175|Dopamine Agents|dopamine agents|mesh-ancestor
65646154|NCT02567175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65646155|NCT02567175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646156|NCT02078388|Doxorubicin|doxorubicin|mesh-list
65646157|NCT02078388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65646158|NCT02078388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646159|NCT02078388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65646160|NCT02078388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65646161|NCT02078388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646162|NCT02078388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646163|NCT02222636|Fentanyl|fentanyl|mesh-list
65646164|NCT02222636|Dexmedetomidine|dexmedetomidine|mesh-list
65646165|NCT02222636|Anesthetics|anesthetics|mesh-list
65646166|NCT02222636|Sevoflurane|sevoflurane|mesh-list
65646167|NCT02222636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65646168|NCT02222636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646169|NCT02222636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65646170|NCT02222636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65646171|NCT02222636|Analgesics|analgesics|mesh-ancestor
65646172|NCT02222636|Sensory System Agents|sensory system agents|mesh-ancestor
65646173|NCT02222636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65443538|NCT03978234|Cholinergic Agents|cholinergic agents|mesh-ancestor
65646174|NCT02222636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65646175|NCT02222636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65646176|NCT02222636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65646177|NCT02222636|Adrenergic Agents|adrenergic agents|mesh-ancestor
65646178|NCT02222636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65646179|NCT02222636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646180|NCT02222636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65646181|NCT02222636|Narcotics|narcotics|mesh-ancestor
65646182|NCT02222636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65646183|NCT02222636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65646184|NCT02222636|Anesthetics, General|anesthetics, general|mesh-ancestor
65646185|NCT02222636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65646186|NCT02222636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65646187|NCT04058145|Plerixafor|plerixafor|mesh-list
65646188|NCT04058145|Pembrolizumab|pembrolizumab|mesh-list
65646189|NCT04058145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65646190|NCT04058145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646191|NCT04058145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65646192|NCT04058145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65646193|NCT04058145|Antiviral Agents|antiviral agents|mesh-ancestor
65646194|NCT04058145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65646195|NCT02230982|Nintedanib|nintedanib|mesh-list
65646196|NCT02230982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646197|NCT02230982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65646198|NCT02230982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646199|NCT02230982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646200|NCT02075112|Genistein|genistein|mesh-list
65646201|NCT02075112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646202|NCT02075112|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65646203|NCT02075112|Protective Agents|protective agents|mesh-ancestor
65646204|NCT02075112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646205|NCT02075112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65646206|NCT02075112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646207|NCT02075112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646208|NCT02075112|Phytoestrogens|phytoestrogens|mesh-ancestor
65646209|NCT02075112|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65646210|NCT02075112|Estrogens|estrogens|mesh-ancestor
65646211|NCT02075112|Hormones|hormones|mesh-ancestor
65646212|NCT02075112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65646213|NCT02223026|Metformin|metformin|mesh-list
65646214|NCT02223026|Linagliptin|linagliptin|mesh-list
65646215|NCT02223026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65646216|NCT02223026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646217|NCT02223026|Incretins|incretins|mesh-ancestor
65646218|NCT02223026|Hormones|hormones|mesh-ancestor
65646219|NCT02223026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65646220|NCT02223026|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65646221|NCT02223026|Protease Inhibitors|protease inhibitors|mesh-ancestor
65646222|NCT02223026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646223|NCT02223026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646224|NCT02075268|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65646225|NCT02075268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65646226|NCT02477384|Propranolol|propranolol|mesh-list
65646227|NCT02477384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65646228|NCT02477384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65646229|NCT02477384|Adrenergic Agents|adrenergic agents|mesh-ancestor
65646230|NCT02477384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65646231|NCT02477384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646232|NCT02477384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646233|NCT02477384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65646234|NCT02477384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65646235|NCT02477384|Vasodilator Agents|vasodilator agents|mesh-ancestor
65646236|NCT02231294|Pramipexole|pramipexole|mesh-list
65646237|NCT02231294|Antioxidants|antioxidants|mesh-ancestor
65646238|NCT02231294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646239|NCT02231294|Protective Agents|protective agents|mesh-ancestor
65646240|NCT02231294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646241|NCT02231294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65646242|NCT02231294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65646243|NCT02231294|Dopamine Agonists|dopamine agonists|mesh-ancestor
65646244|NCT02231294|Dopamine Agents|dopamine agents|mesh-ancestor
65646245|NCT02231294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65646246|NCT02223416|Teriparatide|teriparatide|mesh-list
65646247|NCT02223416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65646248|NCT02223416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646249|NCT02223416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65646250|NCT02082054|Chlorpheniramine|chlorpheniramine|mesh-list
65646251|NCT02082054|Atropine|atropine|mesh-list
65646252|NCT02082054|Pseudoephedrine|pseudoephedrine|mesh-list
65646253|NCT02082054|Ephedrine|ephedrine|mesh-list
65646254|NCT02082054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65646255|NCT02082054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65646256|NCT02082054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65646257|NCT02082054|Autonomic Agents|autonomic agents|mesh-ancestor
65646258|NCT02082054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65646259|NCT02082054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646260|NCT02082054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65646261|NCT02082054|Respiratory System Agents|respiratory system agents|mesh-ancestor
65646262|NCT02082054|Mydriatics|mydriatics|mesh-ancestor
65646263|NCT02082054|Parasympatholytics|parasympatholytics|mesh-ancestor
65646264|NCT02082054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65646265|NCT02082054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65646266|NCT02082054|Cholinergic Agents|cholinergic agents|mesh-ancestor
65646267|NCT02082054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65646268|NCT02082054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646269|NCT02082054|Nasal Decongestants|nasal decongestants|mesh-ancestor
65646270|NCT02082054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65646271|NCT02082054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65646272|NCT02082054|Sympathomimetics|sympathomimetics|mesh-ancestor
65646273|NCT02082054|Adrenergic Agents|adrenergic agents|mesh-ancestor
65646274|NCT02082054|Antipruritics|antipruritics|mesh-ancestor
65646275|NCT02082054|Dermatologic Agents|dermatologic agents|mesh-ancestor
65646276|NCT02082054|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65646277|NCT02082054|Histamine Antagonists|histamine antagonists|mesh-ancestor
65646278|NCT02082054|Histamine Agents|histamine agents|mesh-ancestor
65646279|NCT02082054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65646280|NCT02231372|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
65646281|NCT02231372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65646282|NCT02231372|Autonomic Agents|autonomic agents|mesh-ancestor
65646283|NCT02231372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65646284|NCT02231372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646285|NCT02231372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65646286|NCT02231372|Respiratory System Agents|respiratory system agents|mesh-ancestor
65646287|NCT02884544|Dextroamphetamine|dextroamphetamine|mesh-list
65646288|NCT02884544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65646289|NCT02884544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646290|NCT02884544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65646291|NCT02884544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65646292|NCT02884544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65646293|NCT02884544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646294|NCT02884544|Dopamine Agents|dopamine agents|mesh-ancestor
65646295|NCT02884544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65646296|NCT02226926|Aspirin|aspirin|mesh-list
65646297|NCT02226926|Dipyridamole|dipyridamole|mesh-list
65646298|NCT02226926|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
65646299|NCT02226926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65646300|NCT02226926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65646301|NCT02226926|Analgesics|analgesics|mesh-ancestor
65646302|NCT02226926|Sensory System Agents|sensory system agents|mesh-ancestor
65646303|NCT02226926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65646304|NCT02226926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646305|NCT02226926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65646306|NCT02226926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65646307|NCT02226926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65646308|NCT02226926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65646309|NCT02226926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646310|NCT02226926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65646311|NCT02226926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65646312|NCT02226926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646313|NCT02226926|Antipyretics|antipyretics|mesh-ancestor
65646314|NCT02226926|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65646315|NCT02226926|Vasodilator Agents|vasodilator agents|mesh-ancestor
65646316|NCT02924883|Trastuzumab|trastuzumab|mesh-list
65646317|NCT02924883|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65646318|NCT02924883|Atezolizumab|atezolizumab|mesh-list
65646319|NCT02924883|Maytansine|maytansine|mesh-list
65646320|NCT02924883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65646321|NCT02924883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646322|NCT02924883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65646323|NCT02924883|Tubulin Modulators|tubulin modulators|mesh-ancestor
65646324|NCT02924883|Antimitotic Agents|antimitotic agents|mesh-ancestor
65646325|NCT02924883|Mitosis Modulators|mitosis modulators|mesh-ancestor
65646326|NCT02924883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646327|NCT02075970|Epoetin Alfa|epoetin alfa|mesh-list
65646328|NCT02075970|Hematinics|hematinics|mesh-ancestor
65646329|NCT05764057|Dapagliflozin|dapagliflozin|mesh-list
65646330|NCT05764057|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65646331|NCT05764057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646332|NCT05764057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65646333|NCT05764057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646334|NCT02227082|Olaparib|olaparib|mesh-list
65646335|NCT02227082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65646336|NCT02227082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646337|NCT02227082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646338|NCT02227082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646339|NCT01369680|Ketamine|ketamine|mesh-list
65646340|NCT01369680|Analgesics|analgesics|mesh-ancestor
65646341|NCT01369680|Sensory System Agents|sensory system agents|mesh-ancestor
65646342|NCT01369680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65646343|NCT01369680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646344|NCT01369680|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65646345|NCT01369680|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65646346|NCT01369680|Anesthetics, General|anesthetics, general|mesh-ancestor
65646347|NCT01369680|Anesthetics|anesthetics|mesh-ancestor
65646348|NCT01369680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65646349|NCT01369680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65646350|NCT01369680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65646351|NCT01369680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65646352|NCT01369680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646353|NCT04780321|Antibodies|antibodies|mesh-list
65646354|NCT04780321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65646355|NCT04780321|Immunologic Factors|immunologic factors|mesh-ancestor
65646356|NCT04780321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646357|NCT03670095|Memantine|memantine|mesh-list
65646358|NCT03670095|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65646359|NCT03670095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65646360|NCT03670095|Dopamine Agents|dopamine agents|mesh-ancestor
65646361|NCT03670095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65646362|NCT03670095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646363|NCT03670095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646364|NCT03670095|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65646365|NCT03670095|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65646366|NCT01378039|Budesonide|budesonide|mesh-list
65646367|NCT01378039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65646368|NCT01378039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65646369|NCT01378039|Autonomic Agents|autonomic agents|mesh-ancestor
65646370|NCT01378039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65646371|NCT01378039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646372|NCT01378039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65646373|NCT01378039|Respiratory System Agents|respiratory system agents|mesh-ancestor
65646374|NCT01378039|Glucocorticoids|glucocorticoids|mesh-ancestor
65646375|NCT01378039|Hormones|hormones|mesh-ancestor
65646376|NCT01378039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65646377|NCT01377961|Lycopene|lycopene|mesh-list
65646378|NCT01377961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65646379|NCT01377961|Antioxidants|antioxidants|mesh-ancestor
65646380|NCT01377961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646381|NCT01377961|Protective Agents|protective agents|mesh-ancestor
65646382|NCT01377961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646383|NCT01377961|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65646384|NCT01377961|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65646385|NCT01377961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646386|NCT03558750|Rituximab|rituximab|mesh-list
65646387|NCT03558750|Nivolumab|nivolumab|mesh-list
65646388|NCT03558750|Lenalidomide|lenalidomide|mesh-list
65646389|NCT03558750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65646390|NCT03558750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646391|NCT03558750|Immunologic Factors|immunologic factors|mesh-ancestor
65646392|NCT03558750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646393|NCT03558750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65646394|NCT03558750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65646395|NCT03558750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646396|NCT03558750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65646397|NCT03558750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65646398|NCT03558750|Growth Substances|growth substances|mesh-ancestor
65646399|NCT03558750|Growth Inhibitors|growth inhibitors|mesh-ancestor
65646400|NCT03559140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65646402|NCT02751320|Sodium Citrate|sodium citrate|mesh-list
65646403|NCT02751320|Anticoagulants|anticoagulants|mesh-ancestor
65646404|NCT02751320|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65646405|NCT02751320|Chelating Agents|chelating agents|mesh-ancestor
65646406|NCT02751320|Sequestering Agents|sequestering agents|mesh-ancestor
65646407|NCT02751320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646408|NCT04093219|Acetaminophen|acetaminophen|mesh-list
65646409|NCT04093219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65646410|NCT04093219|Analgesics|analgesics|mesh-ancestor
65646411|NCT04093219|Sensory System Agents|sensory system agents|mesh-ancestor
65646412|NCT04093219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65646413|NCT04093219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646414|NCT04093219|Antipyretics|antipyretics|mesh-ancestor
65646415|NCT04931641|Ferrous fumarate|ferrous fumarate|mesh-list
65646416|NCT04931641|Trace Elements|trace elements|mesh-ancestor
65646417|NCT04931641|Micronutrients|micronutrients|mesh-ancestor
65646418|NCT04931641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646419|NCT02083536|Docetaxel|docetaxel|mesh-list
65646420|NCT02083536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646421|NCT02083536|Tubulin Modulators|tubulin modulators|mesh-ancestor
65646422|NCT02083536|Antimitotic Agents|antimitotic agents|mesh-ancestor
65646423|NCT02083536|Mitosis Modulators|mitosis modulators|mesh-ancestor
65646424|NCT02083536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646425|NCT02231606|Methamphetamine|methamphetamine|mesh-list
65646426|NCT02231606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65646427|NCT02231606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646428|NCT02231606|Sympathomimetics|sympathomimetics|mesh-ancestor
65646429|NCT02231606|Autonomic Agents|autonomic agents|mesh-ancestor
65646430|NCT02231606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65646431|NCT02231606|Dopamine Agents|dopamine agents|mesh-ancestor
65646432|NCT02231606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65646433|NCT02231606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646434|NCT02231606|Adrenergic Agents|adrenergic agents|mesh-ancestor
65646435|NCT02231606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65646436|NCT02231606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65646437|NCT02231606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65646438|NCT02231606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65646439|NCT02275533|Nivolumab|nivolumab|mesh-list
65646440|NCT02275533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65646441|NCT02275533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646442|NCT02275533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65646443|NCT02275533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646444|NCT02083692|Metformin|metformin|mesh-list
65646445|NCT02083692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65646446|NCT02083692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646447|NCT02227550|Vitamin K|vitamin k|mesh-list
65646448|NCT02227550|Warfarin|warfarin|mesh-list
65646449|NCT02227550|Apixaban|apixaban|mesh-list
65646450|NCT02227550|Phenprocoumon|phenprocoumon|mesh-list
65646451|NCT02227550|Fluindione|fluindione|mesh-list
65646452|NCT02227550|Vitamins|vitamins|mesh-ancestor
65646453|NCT02227550|Micronutrients|micronutrients|mesh-ancestor
65646454|NCT02227550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646455|NCT02227550|Anticoagulants|anticoagulants|mesh-ancestor
65646456|NCT02227550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65646457|NCT02227550|Antithrombins|antithrombins|mesh-ancestor
65646458|NCT02227550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65646459|NCT02227550|Protease Inhibitors|protease inhibitors|mesh-ancestor
65646460|NCT02227550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646461|NCT02227550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646462|NCT02227550|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65646463|NCT02227550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65646464|NCT02227550|Hemostatics|hemostatics|mesh-ancestor
65646465|NCT02227550|Coagulants|coagulants|mesh-ancestor
65646466|NCT02206035|Methotrexate|methotrexate|mesh-list
65646467|NCT02206035|Tacrolimus|tacrolimus|mesh-list
65646468|NCT02206035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65646469|NCT02206035|Abortifacient Agents|abortifacient agents|mesh-ancestor
65646470|NCT02206035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65646471|NCT02206035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646472|NCT02206035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65646473|NCT02206035|Antimetabolites|antimetabolites|mesh-ancestor
65443833|NCT03979976|Ramipril|ramipril|mesh-list
65646474|NCT02206035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646475|NCT02206035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646476|NCT02206035|Dermatologic Agents|dermatologic agents|mesh-ancestor
65646477|NCT02206035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646478|NCT02206035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65646479|NCT02206035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65646480|NCT02206035|Immunologic Factors|immunologic factors|mesh-ancestor
65646481|NCT02206035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65646482|NCT02206035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65646483|NCT02206035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65646485|NCT02258828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65646486|NCT02258828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65646487|NCT02258828|Dopamine Agents|dopamine agents|mesh-ancestor
65646488|NCT02258828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65646489|NCT02258828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646490|NCT02258828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646491|NCT02258828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65646492|NCT02258828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65646493|NCT02083068|Vaccines|vaccines|mesh-list
65646494|NCT02083068|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65646495|NCT02083068|Immunologic Factors|immunologic factors|mesh-ancestor
65646496|NCT02083068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646497|NCT02083068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65646498|NCT02228252|Caseins|caseins|mesh-list
65646499|NCT02228252|Chelating Agents|chelating agents|mesh-ancestor
65646500|NCT02228252|Sequestering Agents|sequestering agents|mesh-ancestor
65646501|NCT02228252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646502|NCT02070549|Trametinib|trametinib|mesh-list
65646503|NCT02070549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646504|NCT02070549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65646505|NCT02070549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646506|NCT02070549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646507|NCT02591953|Methylprednisolone|methylprednisolone|mesh-list
65646508|NCT02591953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65646509|NCT02591953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65646510|NCT02591953|Prednisolone|prednisolone|mesh-list
65646511|NCT02591953|Prednisolone acetate|prednisolone acetate|mesh-list
65646512|NCT02591953|Lidocaine|lidocaine|mesh-list
65646513|NCT02591953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65646514|NCT02591953|Prednisolone phosphate|prednisolone phosphate|mesh-list
65646515|NCT02591953|Anesthetics, Local|anesthetics, local|mesh-ancestor
65646516|NCT02591953|Anesthetics|anesthetics|mesh-ancestor
65646517|NCT02591953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65646518|NCT02591953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646519|NCT02591953|Sensory System Agents|sensory system agents|mesh-ancestor
65646520|NCT02591953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65646521|NCT02591953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65646522|NCT02591953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65646523|NCT02591953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65646524|NCT02591953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65646525|NCT02591953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646526|NCT02591953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65646527|NCT02591953|Antiemetics|antiemetics|mesh-ancestor
65646528|NCT02591953|Autonomic Agents|autonomic agents|mesh-ancestor
65646529|NCT02591953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65646530|NCT02591953|Glucocorticoids|glucocorticoids|mesh-ancestor
65646531|NCT02591953|Hormones|hormones|mesh-ancestor
65646532|NCT02591953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65646533|NCT02591953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65646534|NCT02591953|Protective Agents|protective agents|mesh-ancestor
65646535|NCT02591953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65646536|NCT02591953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646537|NCT02223884|Carboplatin|carboplatin|mesh-list
65646538|NCT02223884|Docetaxel|docetaxel|mesh-list
65646539|NCT02223884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646540|NCT02223884|Tubulin Modulators|tubulin modulators|mesh-ancestor
65646541|NCT02223884|Antimitotic Agents|antimitotic agents|mesh-ancestor
65646542|NCT02223884|Mitosis Modulators|mitosis modulators|mesh-ancestor
65646543|NCT02223884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646544|NCT02079480|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
65109278|NCT00551850|MP 412|mp 412|mesh-list
65646545|NCT02079480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65646546|NCT02079480|Immunologic Factors|immunologic factors|mesh-ancestor
65646547|NCT02079480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646548|NCT02569489|Paclitaxel|paclitaxel|mesh-list
65646549|NCT02569489|Trastuzumab|trastuzumab|mesh-list
65646550|NCT02569489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65646551|NCT02569489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646552|NCT02569489|Tubulin Modulators|tubulin modulators|mesh-ancestor
65646553|NCT02569489|Antimitotic Agents|antimitotic agents|mesh-ancestor
65646554|NCT02569489|Mitosis Modulators|mitosis modulators|mesh-ancestor
65646555|NCT02569489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646556|NCT02569489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65646558|NCT02079558|Carbetocin|carbetocin|mesh-list
65646559|NCT02079558|Oxytocics|oxytocics|mesh-ancestor
65646560|NCT02079558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65646561|NCT02079558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646562|NCT04057755|Botulinum Toxins|botulinum toxins|mesh-list
65646563|NCT04057755|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65646564|NCT04057755|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65646565|NCT04057755|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65646566|NCT04057755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65646567|NCT04057755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646568|NCT04057755|Cholinergic Agents|cholinergic agents|mesh-ancestor
65646569|NCT04057755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65646570|NCT04057755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646571|NCT04057755|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65646572|NCT04057755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65646573|NCT03669003|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
65646574|NCT03669003|Hemostatics|hemostatics|mesh-ancestor
65646575|NCT03669003|Coagulants|coagulants|mesh-ancestor
65646576|NCT04313959|Dexamethasone|dexamethasone|mesh-list
65646577|NCT04313959|Ropivacaine|ropivacaine|mesh-list
65646578|NCT04313959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65646579|NCT04313959|Antiemetics|antiemetics|mesh-ancestor
65646580|NCT04313959|Autonomic Agents|autonomic agents|mesh-ancestor
65646581|NCT04313959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65646582|NCT04313959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646583|NCT04313959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65646584|NCT04313959|Glucocorticoids|glucocorticoids|mesh-ancestor
65646585|NCT04313959|Hormones|hormones|mesh-ancestor
65646586|NCT04313959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65646587|NCT04313959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65646588|NCT04313959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646589|NCT04313959|Anesthetics, Local|anesthetics, local|mesh-ancestor
65646590|NCT04313959|Anesthetics|anesthetics|mesh-ancestor
65646591|NCT04313959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65646592|NCT04313959|Sensory System Agents|sensory system agents|mesh-ancestor
65646593|NCT03073213|Ixekizumab|ixekizumab|mesh-list
65646594|NCT03073213|Dermatologic Agents|dermatologic agents|mesh-ancestor
65646595|NCT03070483|Vitamin D|vitamin d|mesh-list
65646596|NCT03070483|Cholecalciferol|cholecalciferol|mesh-list
65646597|NCT03070483|Vitamins|vitamins|mesh-ancestor
65646598|NCT03070483|Micronutrients|micronutrients|mesh-ancestor
65646599|NCT03070483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646600|NCT03070483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65646601|NCT03070483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65646602|NCT05763667|Bupivacaine|bupivacaine|mesh-list
65646603|NCT05763667|Anesthetics, Local|anesthetics, local|mesh-ancestor
65646604|NCT05763667|Anesthetics|anesthetics|mesh-ancestor
65646605|NCT05763667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65646606|NCT05763667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646607|NCT05763667|Sensory System Agents|sensory system agents|mesh-ancestor
65646608|NCT05763667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65646609|NCT01704859|Vitamin D|vitamin d|mesh-list
65646610|NCT01704859|Ergocalciferols|ergocalciferols|mesh-list
65646611|NCT01704859|Cholecalciferol|cholecalciferol|mesh-list
65646612|NCT01704859|Vitamins|vitamins|mesh-list
65646613|NCT01704859|Micronutrients|micronutrients|mesh-ancestor
65646614|NCT01704859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646615|NCT01704859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65646616|NCT01704859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65646617|NCT04107727|Cytarabine|cytarabine|mesh-list
65646618|NCT04107727|Idarubicin|idarubicin|mesh-list
65646619|NCT04107727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65646620|NCT04107727|Antimetabolites|antimetabolites|mesh-ancestor
65646621|NCT04107727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646622|NCT04107727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646623|NCT04107727|Antiviral Agents|antiviral agents|mesh-ancestor
65646624|NCT04107727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65646625|NCT04107727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65443991|NCT00298272|Adalimumab|adalimumab|mesh-list
65646626|NCT04107727|Immunologic Factors|immunologic factors|mesh-ancestor
65646627|NCT04107727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646628|NCT04107727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65646629|NCT04107727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65646630|NCT04107727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65646631|NCT04107727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646632|NCT01074151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65646633|NCT01074151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65646634|NCT01074151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65646635|NCT01074151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65646636|NCT01074151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646637|NCT01074151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65646638|NCT01074151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646639|NCT01074151|Analgesics|analgesics|mesh-ancestor
65646640|NCT01074151|Sensory System Agents|sensory system agents|mesh-ancestor
65646641|NCT01074151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65646642|NCT01074151|Antidepressive Agents|antidepressive agents|mesh-ancestor
65646643|NCT01074151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65646644|NCT01074151|Dopamine Agents|dopamine agents|mesh-ancestor
65646645|NCT05761405|Ceftriaxone|ceftriaxone|mesh-list
65646646|NCT05761405|Amikacin|amikacin|mesh-list
65646647|NCT05761405|Mannitol|mannitol|mesh-list
65646648|NCT05761405|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65646649|NCT05761405|Diuretics|diuretics|mesh-ancestor
65646650|NCT05761405|Natriuretic Agents|natriuretic agents|mesh-ancestor
65646651|NCT05761405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646652|NCT05761405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65646653|NCT05761405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65646654|NCT03979885|Nicotine|nicotine|mesh-list
65646655|NCT03979885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65646656|NCT03979885|Autonomic Agents|autonomic agents|mesh-ancestor
65646657|NCT03979885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65646658|NCT03979885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646659|NCT03979885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65646660|NCT03979885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65646661|NCT03979885|Cholinergic Agents|cholinergic agents|mesh-ancestor
65646662|NCT03979885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65646663|NCT03979885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646664|NCT02786329|Lidocaine|lidocaine|mesh-list
65646665|NCT02786329|Sevoflurane|sevoflurane|mesh-list
65646666|NCT02786329|Anesthetics, Local|anesthetics, local|mesh-ancestor
65646667|NCT02786329|Anesthetics|anesthetics|mesh-ancestor
65646668|NCT02786329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65646669|NCT02786329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646670|NCT02786329|Sensory System Agents|sensory system agents|mesh-ancestor
65646671|NCT02786329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65646672|NCT02786329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65646673|NCT02786329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65646674|NCT02786329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65646675|NCT02786329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65646676|NCT02786329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646677|NCT02786329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65646678|NCT02786329|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65646679|NCT02786329|Anesthetics, General|anesthetics, general|mesh-ancestor
65646680|NCT05761951|Pembrolizumab|pembrolizumab|mesh-list
65646681|NCT05761951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65646682|NCT05761951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646683|NCT05761327|Curcumin|curcumin|mesh-list
65646684|NCT05761327|Resveratrol|resveratrol|mesh-list
65646685|NCT05761327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65646686|NCT05761327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65646687|NCT05761327|Analgesics|analgesics|mesh-ancestor
65646688|NCT05761327|Sensory System Agents|sensory system agents|mesh-ancestor
65646689|NCT05761327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65646690|NCT05761327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646691|NCT05761327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65646692|NCT05761327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65646693|NCT05761327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646694|NCT05761327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646695|NCT05761327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646696|NCT05761327|Antioxidants|antioxidants|mesh-ancestor
65646697|NCT05761327|Protective Agents|protective agents|mesh-ancestor
65646698|NCT05761327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65646699|NCT01757535|Azacitidine|azacitidine|mesh-list
65646700|NCT01757535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65646701|NCT01757535|Antimetabolites|antimetabolites|mesh-ancestor
65646702|NCT01757535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646703|NCT01757535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646704|NCT01757535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646705|NCT02231762|Temozolomide|temozolomide|mesh-list
65646706|NCT02231762|Lanreotide|lanreotide|mesh-list
65646707|NCT02231762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65646708|NCT02231762|Alkylating Agents|alkylating agents|mesh-ancestor
65646709|NCT02231762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646710|NCT02231762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646711|NCT04507178|Nadroparin|nadroparin|mesh-list
65646712|NCT04507178|Anticoagulants|anticoagulants|mesh-ancestor
65646713|NCT04507178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65646714|NCT04507178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65646715|NCT04507178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646716|NCT01191957|Cyclophosphamide|cyclophosphamide|mesh-list
65646717|NCT01191957|Busulfan|busulfan|mesh-list
65646718|NCT01191957|Fludarabine|fludarabine|mesh-list
65646719|NCT01191957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65646720|NCT01191957|Immunologic Factors|immunologic factors|mesh-ancestor
65646721|NCT01191957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646722|NCT01191957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65646723|NCT01191957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65646724|NCT01191957|Alkylating Agents|alkylating agents|mesh-ancestor
65646725|NCT01191957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646726|NCT01191957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646727|NCT01191957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65646728|NCT01050855|Busulfan|busulfan|mesh-list
65646729|NCT01050855|Alemtuzumab|alemtuzumab|mesh-list
65646730|NCT01050855|Alkylating Agents|alkylating agents|mesh-ancestor
65646731|NCT01050855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646732|NCT01050855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65646733|NCT01050855|Immunologic Factors|immunologic factors|mesh-ancestor
65646734|NCT01050855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646735|NCT01050855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65646736|NCT01050855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646737|NCT01050855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65646738|NCT01050855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65646739|NCT04459286|Ritonavir|ritonavir|mesh-list
65646740|NCT04459286|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65646741|NCT04459286|Nitazoxanide|nitazoxanide|mesh-list
65646742|NCT04459286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65646743|NCT04459286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65646744|NCT04459286|Protease Inhibitors|protease inhibitors|mesh-ancestor
65646745|NCT04459286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646746|NCT04459286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646747|NCT04459286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65646748|NCT04459286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65646749|NCT04459286|Antiviral Agents|antiviral agents|mesh-ancestor
65646750|NCT04459286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65646751|NCT04459286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65646752|NCT04459286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65646753|NCT04459286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65646754|NCT00744081|Topotecan|topotecan|mesh-list
65646755|NCT00744081|Mitoxantrone|mitoxantrone|mesh-list
65646756|NCT00744081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65646757|NCT00744081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65646758|NCT00744081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646759|NCT00744081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646760|NCT00744081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646761|NCT00744081|Analgesics|analgesics|mesh-ancestor
65646762|NCT00744081|Sensory System Agents|sensory system agents|mesh-ancestor
65646763|NCT00744081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65646764|NCT00744081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646765|NCT00744081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65646766|NCT02229266|Cytarabine|cytarabine|mesh-list
65646767|NCT02229266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65646768|NCT02229266|Antimetabolites|antimetabolites|mesh-ancestor
65646769|NCT02229266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646770|NCT02229266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646771|NCT02229266|Antiviral Agents|antiviral agents|mesh-ancestor
65646772|NCT02229266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65646773|NCT02229266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65646774|NCT02229266|Immunologic Factors|immunologic factors|mesh-ancestor
65646775|NCT02229266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646776|NCT02224040|Azithromycin|azithromycin|mesh-list
65646777|NCT02224040|Ceftriaxone|ceftriaxone|mesh-list
65646778|NCT02224040|Cefixime|cefixime|mesh-list
65646779|NCT02224040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65646780|NCT02224040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65646781|NCT04448834|Vincristine|vincristine|mesh-list
65646782|NCT04448834|Blinatumomab|blinatumomab|mesh-list
65646783|NCT04448834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65646784|NCT04448834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646785|NCT04448834|Tubulin Modulators|tubulin modulators|mesh-ancestor
65646786|NCT04448834|Antimitotic Agents|antimitotic agents|mesh-ancestor
65646787|NCT04448834|Mitosis Modulators|mitosis modulators|mesh-ancestor
65646788|NCT04448834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646789|NCT02229422|Obinutuzumab|obinutuzumab|mesh-list
65646790|NCT02229422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65646791|NCT02229422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646792|NCT02232308|Lisinopril|lisinopril|mesh-list
65646793|NCT02232308|Nizatidine|nizatidine|mesh-list
65646794|NCT02232308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65646795|NCT02232308|Protease Inhibitors|protease inhibitors|mesh-ancestor
65646796|NCT02232308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646797|NCT02232308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646798|NCT02232308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65646799|NCT02232308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65646800|NCT02232308|Protective Agents|protective agents|mesh-ancestor
65646801|NCT02232308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646802|NCT02232308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65646803|NCT02232308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65646804|NCT02232308|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65646805|NCT02232308|Histamine Antagonists|histamine antagonists|mesh-ancestor
65646806|NCT02232308|Histamine Agents|histamine agents|mesh-ancestor
65646807|NCT02232308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65646808|NCT02232386|Rituximab|rituximab|mesh-list
65646809|NCT02232386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65646810|NCT02232386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646811|NCT02232386|Immunologic Factors|immunologic factors|mesh-ancestor
65646812|NCT02232386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646813|NCT02232386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65646814|NCT02229734|Androgens|androgens|mesh-list
65646815|NCT02229734|Hormones|hormones|mesh-ancestor
65646816|NCT02229734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65646817|NCT02229734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646818|NCT04333160|Hylan|hylan|mesh-list
65646819|NCT04333160|Viscosupplements|viscosupplements|mesh-ancestor
65646820|NCT04333160|Protective Agents|protective agents|mesh-ancestor
65646821|NCT04333160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646822|NCT02258906|Urinastatin|urinastatin|mesh-list
65646823|NCT02258906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65646824|NCT02258906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65646825|NCT02258906|Protease Inhibitors|protease inhibitors|mesh-ancestor
65646826|NCT02258906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646827|NCT02258906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646828|NCT02229812|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65646829|NCT02229812|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65646830|NCT02229812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65646831|NCT02229812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646832|NCT04222712|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65646833|NCT04222712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65646834|NCT02229890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65646835|NCT02229890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65646836|NCT02229890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65646837|NCT02229890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646838|NCT02230046|Abiraterone Acetate|abiraterone acetate|mesh-list
65646839|NCT02230046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646840|NCT02230046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65646841|NCT02230046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646842|NCT02230046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646843|NCT02230046|Hormone Antagonists|hormone antagonists|mesh-ancestor
65646844|NCT02230046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65646845|NCT02230046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646846|NCT02230046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65646847|NCT03068455|Nivolumab|nivolumab|mesh-list
65646848|NCT03068455|Ipilimumab|ipilimumab|mesh-list
65646849|NCT03068455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65646850|NCT03068455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646851|NCT03068455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65646852|NCT03068455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646854|NCT03646994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646855|NCT03646994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65646856|NCT03646994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646857|NCT03646994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646858|NCT02810444|Immunoglobulins|immunoglobulins|mesh-list
65646859|NCT02810444|gamma-Globulins|gamma-globulins|mesh-list
65646860|NCT02810444|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65646861|NCT02810444|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65646862|NCT02810444|Immunologic Factors|immunologic factors|mesh-ancestor
65646863|NCT02810444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646864|NCT04209296|Ketamine|ketamine|mesh-list
65646865|NCT04209296|Analgesics|analgesics|mesh-ancestor
65646866|NCT04209296|Sensory System Agents|sensory system agents|mesh-ancestor
65646867|NCT04209296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65646868|NCT04209296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646869|NCT04209296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65646870|NCT04209296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65646871|NCT04209296|Anesthetics, General|anesthetics, general|mesh-ancestor
65646872|NCT04209296|Anesthetics|anesthetics|mesh-ancestor
65646873|NCT04209296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65646874|NCT04209296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65646875|NCT04209296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65646876|NCT04209296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65646877|NCT04209296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646878|NCT04207736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65646879|NCT04207736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65646880|NCT02232932|Capecitabine|capecitabine|mesh-list
65646881|NCT02232932|Liver Extracts|liver extracts|mesh-list
65646882|NCT02232932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65646883|NCT02232932|Antimetabolites|antimetabolites|mesh-ancestor
65646884|NCT02232932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646885|NCT02232932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646886|NCT02232932|Hematinics|hematinics|mesh-ancestor
65646887|NCT02230358|Anesthetics|anesthetics|mesh-list
65646888|NCT02230358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65646889|NCT02230358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646890|NCT04214288|Fulvestrant|fulvestrant|mesh-list
65646891|NCT04214288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65646892|NCT04214288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646893|NCT04214288|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65646894|NCT04214288|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65646895|NCT04214288|Hormone Antagonists|hormone antagonists|mesh-ancestor
65646896|NCT04214288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65646897|NCT04214288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646898|NCT03494504|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65646899|NCT03494504|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65646900|NCT04049864|Lenalidomide|lenalidomide|mesh-list
65646901|NCT04049864|Vaccines|vaccines|mesh-list
65646902|NCT04049864|Immunologic Factors|immunologic factors|mesh-ancestor
65646903|NCT04049864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646904|NCT04049864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65646905|NCT04049864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65646906|NCT04049864|Growth Substances|growth substances|mesh-ancestor
65646907|NCT04049864|Growth Inhibitors|growth inhibitors|mesh-ancestor
65646908|NCT04049864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646909|NCT03475706|Solabegron|solabegron|mesh-list
65646910|NCT03475706|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65646911|NCT03475706|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65646912|NCT03475706|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65646913|NCT03475706|Adrenergic Agents|adrenergic agents|mesh-ancestor
65646914|NCT03475706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65646915|NCT03475706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646916|NCT03475706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646917|NCT02234492|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65646918|NCT02234492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65646919|NCT02234492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65646920|NCT02234492|Antimetabolites|antimetabolites|mesh-ancestor
65646921|NCT02234492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646922|NCT02234492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65646923|NCT02234492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65646924|NCT02234492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646925|NCT03928184|Lorecivivint|lorecivivint|mesh-list
65646926|NCT03928184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65646927|NCT02259374|Ropivacaine|ropivacaine|mesh-list
65646928|NCT02259374|Anesthetics, Local|anesthetics, local|mesh-ancestor
65646929|NCT02259374|Anesthetics|anesthetics|mesh-ancestor
65646930|NCT02259374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65646931|NCT02259374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646932|NCT02259374|Sensory System Agents|sensory system agents|mesh-ancestor
65646933|NCT02259374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65646934|NCT03198728|Testosterone|testosterone|mesh-list
65646935|NCT03198728|Androgens|androgens|mesh-ancestor
65646936|NCT03198728|Hormones|hormones|mesh-ancestor
65646937|NCT03198728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65646938|NCT03198728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646939|NCT04921982|Propranolol|propranolol|mesh-list
65646940|NCT04921982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65646941|NCT04921982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65646942|NCT04921982|Adrenergic Agents|adrenergic agents|mesh-ancestor
65646943|NCT04921982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65646944|NCT04921982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646945|NCT04921982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646946|NCT04921982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65646947|NCT04921982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65646948|NCT04921982|Vasodilator Agents|vasodilator agents|mesh-ancestor
65646949|NCT04866056|Azacitidine|azacitidine|mesh-list
65646950|NCT04866056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65646951|NCT04866056|Antimetabolites|antimetabolites|mesh-ancestor
65646952|NCT04866056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646953|NCT04866056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65646954|NCT04866056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646955|NCT03911102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65646956|NCT03911102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65646957|NCT03911102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65646958|NCT03911102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65646959|NCT03911102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646960|NCT03911102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65646961|NCT03911102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65646962|NCT03911102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646963|NCT03911102|Cholinergic Agents|cholinergic agents|mesh-ancestor
65646964|NCT03911102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65646965|NCT04789148|Oxytocin|oxytocin|mesh-list
65646966|NCT04789148|Oxytocics|oxytocics|mesh-ancestor
65646967|NCT04789148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65646968|NCT04789148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646969|NCT03172910|Rivaroxaban|rivaroxaban|mesh-list
65646970|NCT03172910|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65646971|NCT03172910|Antithrombins|antithrombins|mesh-ancestor
65646972|NCT03172910|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65646973|NCT03172910|Protease Inhibitors|protease inhibitors|mesh-ancestor
65646974|NCT03172910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65646975|NCT03172910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646976|NCT03172910|Anticoagulants|anticoagulants|mesh-ancestor
65646977|NCT03881852|Reboxetine|reboxetine|mesh-list
65646978|NCT03881852|Antidepressive Agents|antidepressive agents|mesh-ancestor
65646979|NCT03881852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65646980|NCT03881852|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65646981|NCT03881852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65646982|NCT03881852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65646983|NCT03881852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65646984|NCT03881852|Adrenergic Agents|adrenergic agents|mesh-ancestor
65646985|NCT03881852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65646986|NCT03881852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646987|NCT03818828|Iodine|iodine|mesh-list
65646988|NCT03818828|Cadexomer iodine|cadexomer iodine|mesh-list
65646989|NCT03818828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65646990|NCT03818828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65646991|NCT03818828|Trace Elements|trace elements|mesh-ancestor
65646992|NCT03818828|Micronutrients|micronutrients|mesh-ancestor
65646993|NCT03818828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646994|NCT02804282|Furosemide|furosemide|mesh-list
65646995|NCT02804282|Diuretics|diuretics|mesh-ancestor
65646996|NCT02804282|Natriuretic Agents|natriuretic agents|mesh-ancestor
65646997|NCT02804282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65646998|NCT02804282|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65646999|NCT02804282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65647000|NCT02804282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647002|NCT02233244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65647003|NCT02233244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65647004|NCT02233244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65647005|NCT02233244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647006|NCT02233244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65647007|NCT02233244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65647008|NCT02233244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65647009|NCT02233244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65647010|NCT02233244|Anesthetics, General|anesthetics, general|mesh-ancestor
65647011|NCT02233244|Anesthetics|anesthetics|mesh-ancestor
65647012|NCT02233244|GABA Modulators|gaba modulators|mesh-ancestor
65647013|NCT02233244|GABA Agents|gaba agents|mesh-ancestor
65647014|NCT02233244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65647015|NCT02233244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647016|NCT02259530|Psychotropic Drugs|psychotropic drugs|mesh-list
65647017|NCT02234882|Fostemsavir|fostemsavir|mesh-list
65647018|NCT02234882|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65647019|NCT02234882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65647020|NCT02234882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65647021|NCT02234882|Antimetabolites|antimetabolites|mesh-ancestor
65647022|NCT02234882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647023|NCT02234882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65647024|NCT02234882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65647025|NCT02234882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647026|NCT02234882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65647027|NCT02234882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65647028|NCT02234882|Antiviral Agents|antiviral agents|mesh-ancestor
65647029|NCT02234882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65647030|NCT02234882|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65647031|NCT02234882|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65647032|NCT03729362|Miglustat|miglustat|mesh-list
65647033|NCT03729362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647034|NCT03729362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647035|NCT03729362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65647036|NCT03729362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65647037|NCT03729362|Antiviral Agents|antiviral agents|mesh-ancestor
65647038|NCT03729362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65647039|NCT03729362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65647040|NCT03729362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65647041|NCT03729362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647042|NCT03727022|Lorecivivint|lorecivivint|mesh-list
65647043|NCT03727022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65647044|NCT02233322|Ferrous gluconate|ferrous gluconate|mesh-list
65647045|NCT02233322|Hematinics|hematinics|mesh-ancestor
65647046|NCT02233400|Acetaminophen|acetaminophen|mesh-list
65647047|NCT02233400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65647048|NCT02233400|Analgesics|analgesics|mesh-ancestor
65647049|NCT02233400|Sensory System Agents|sensory system agents|mesh-ancestor
65647050|NCT02233400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65647051|NCT02233400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647052|NCT02233400|Antipyretics|antipyretics|mesh-ancestor
65647053|NCT03067441|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
65647054|NCT03067441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65647055|NCT03067441|Antimetabolites|antimetabolites|mesh-ancestor
65647056|NCT03067441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647057|NCT03067441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65647058|NCT03067441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647059|NCT03067441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65647060|NCT03067441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647061|NCT02235194|Chromium|chromium|mesh-list
65647062|NCT02235194|Picolinic acid|picolinic acid|mesh-list
65647063|NCT02235194|Trace Elements|trace elements|mesh-ancestor
65647064|NCT02235194|Micronutrients|micronutrients|mesh-ancestor
65647065|NCT02235194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647066|NCT02235194|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65647067|NCT02235194|Chelating Agents|chelating agents|mesh-ancestor
65647068|NCT02235194|Sequestering Agents|sequestering agents|mesh-ancestor
65647069|NCT02235194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647070|NCT03684278|Infliximab|infliximab|mesh-list
65647071|NCT03684278|Dermatologic Agents|dermatologic agents|mesh-ancestor
65647072|NCT03684278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65647073|NCT03684278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65647074|NCT02726659|Celecoxib|celecoxib|mesh-list
65647075|NCT02726659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65647077|NCT02726659|Analgesics|analgesics|mesh-ancestor
65647078|NCT02726659|Sensory System Agents|sensory system agents|mesh-ancestor
65647079|NCT02726659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65647080|NCT02726659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647081|NCT02726659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65647082|NCT02726659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65647083|NCT02726659|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65647084|NCT02726659|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65647085|NCT02726659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647086|NCT02726659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647087|NCT03660878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65647088|NCT03660878|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65647089|NCT04446962|Lenalidomide|lenalidomide|mesh-list
65647090|NCT04446962|Immunologic Factors|immunologic factors|mesh-ancestor
65647091|NCT04446962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647092|NCT04446962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65647093|NCT04446962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65647094|NCT04446962|Growth Substances|growth substances|mesh-ancestor
65647095|NCT04446962|Growth Inhibitors|growth inhibitors|mesh-ancestor
65647096|NCT04446962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647097|NCT03951961|Midostaurin|midostaurin|mesh-list
65647098|NCT03951961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647099|NCT03951961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65647100|NCT03951961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647101|NCT03951961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647102|NCT02232542|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65647103|NCT02232542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65647104|NCT02232542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65647105|NCT02232542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65647106|NCT02232542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647107|NCT02232542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65647108|NCT02232542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647109|NCT02232542|Analgesics|analgesics|mesh-ancestor
65647110|NCT02232542|Sensory System Agents|sensory system agents|mesh-ancestor
65647111|NCT02232542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65647112|NCT02232542|Antidepressive Agents|antidepressive agents|mesh-ancestor
65647113|NCT02232542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65647114|NCT02232542|Dopamine Agents|dopamine agents|mesh-ancestor
65647115|NCT02600923|Letrozole|letrozole|mesh-list
65647116|NCT02600923|Palbociclib|palbociclib|mesh-list
65647117|NCT02600923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647118|NCT02600923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65647119|NCT02600923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65647120|NCT02600923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647121|NCT02600923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647122|NCT02600923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65647123|NCT02600923|Hormone Antagonists|hormone antagonists|mesh-ancestor
65267750|NCT02658435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65647124|NCT02600923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65647125|NCT02600923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647126|NCT02600923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65647127|NCT05761171|Cytarabine|cytarabine|mesh-list
65647128|NCT05761171|Prednisone|prednisone|mesh-list
65647129|NCT05761171|Prednisolone|prednisolone|mesh-list
65647130|NCT05761171|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65647131|NCT05761171|Methylprednisolone|methylprednisolone|mesh-list
65647132|NCT05761171|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65647133|NCT05761171|Prednisolone acetate|prednisolone acetate|mesh-list
65647134|NCT05761171|Hydrocortisone|hydrocortisone|mesh-list
65647135|NCT05761171|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65647136|NCT05761171|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65647137|NCT05761171|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65647138|NCT05761171|Cortisone|cortisone|mesh-list
65647139|NCT05761171|Methotrexate|methotrexate|mesh-list
65647140|NCT05761171|Fludarabine|fludarabine|mesh-list
65647141|NCT05761171|Fludarabine phosphate|fludarabine phosphate|mesh-list
65647142|NCT05761171|Vincristine|vincristine|mesh-list
65647143|NCT05761171|Asparaginase|asparaginase|mesh-list
65647144|NCT05761171|Pegaspargase|pegaspargase|mesh-list
65647145|NCT05761171|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65647146|NCT05761171|Prednisolone phosphate|prednisolone phosphate|mesh-list
65647147|NCT05761171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65647148|NCT05761171|Glucocorticoids|glucocorticoids|mesh-ancestor
65647149|NCT05761171|Hormones|hormones|mesh-ancestor
65647150|NCT05761171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65647151|NCT05761171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647152|NCT05761171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65647153|NCT05761171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647154|NCT05761171|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65647155|NCT05761171|Abortifacient Agents|abortifacient agents|mesh-ancestor
65647156|NCT05761171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65647157|NCT05761171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65647158|NCT05761171|Antimetabolites|antimetabolites|mesh-ancestor
65647159|NCT05761171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647160|NCT05761171|Dermatologic Agents|dermatologic agents|mesh-ancestor
65647161|NCT05761171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647162|NCT05761171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65647163|NCT05761171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65647164|NCT05761171|Immunologic Factors|immunologic factors|mesh-ancestor
65647165|NCT05761171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65647166|NCT05761171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65647167|NCT05761171|Antiviral Agents|antiviral agents|mesh-ancestor
65647168|NCT05761171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65647169|NCT05761171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65647170|NCT05761171|Tubulin Modulators|tubulin modulators|mesh-ancestor
65647171|NCT05761171|Antimitotic Agents|antimitotic agents|mesh-ancestor
65647172|NCT05761171|Mitosis Modulators|mitosis modulators|mesh-ancestor
65647173|NCT05761171|Antiemetics|antiemetics|mesh-ancestor
65647174|NCT05761171|Autonomic Agents|autonomic agents|mesh-ancestor
65647175|NCT05761171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65647176|NCT05761171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65647177|NCT05761171|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65647178|NCT05761171|Protective Agents|protective agents|mesh-ancestor
65647179|NCT02232776|Losartan|losartan|mesh-list
65647180|NCT02232776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65647181|NCT02232776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65647182|NCT02232776|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65647183|NCT02232776|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65647184|NCT02232776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647185|NCT03847519|Pembrolizumab|pembrolizumab|mesh-list
65267755|NCT02756546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65647186|NCT03847519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65647187|NCT03847519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647188|NCT02235428|Bromides|bromides|mesh-list
65647189|NCT02235428|Albuterol|albuterol|mesh-list
65647190|NCT02235428|Ipratropium|ipratropium|mesh-list
65647191|NCT02235428|Anticonvulsants|anticonvulsants|mesh-ancestor
65647192|NCT02235428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65647193|NCT02235428|Autonomic Agents|autonomic agents|mesh-ancestor
65647194|NCT02235428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65647195|NCT02235428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647196|NCT02235428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65647197|NCT02235428|Respiratory System Agents|respiratory system agents|mesh-ancestor
65647198|NCT02235428|Tocolytic Agents|tocolytic agents|mesh-ancestor
65647199|NCT02235428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65647200|NCT02235428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65647201|NCT02235428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65647202|NCT02235428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65647203|NCT02235428|Adrenergic Agents|adrenergic agents|mesh-ancestor
65647204|NCT02235428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65647205|NCT02235428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647206|NCT02235428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65647207|NCT02235428|Cholinergic Agents|cholinergic agents|mesh-ancestor
65647208|NCT03781219|Vemurafenib|vemurafenib|mesh-list
65647209|NCT03781219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647210|NCT03781219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65647211|NCT03781219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647212|NCT03781219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647213|NCT03070171|Dabigatran|dabigatran|mesh-list
65647214|NCT03070171|Antithrombins|antithrombins|mesh-ancestor
65647215|NCT03070171|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65647216|NCT03070171|Protease Inhibitors|protease inhibitors|mesh-ancestor
65647217|NCT03070171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647218|NCT03070171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647219|NCT03070171|Anticoagulants|anticoagulants|mesh-ancestor
65647220|NCT02262572|Telmisartan|telmisartan|mesh-list
65647221|NCT02262572|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65647222|NCT02262572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65647223|NCT02262572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65647224|NCT02262572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65647225|NCT02262572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647226|NCT02262572|Diuretics|diuretics|mesh-ancestor
65647227|NCT02262572|Natriuretic Agents|natriuretic agents|mesh-ancestor
65647228|NCT02262572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647229|NCT02262572|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65647230|NCT02262572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65647231|NCT02235584|Dexamethasone|dexamethasone|mesh-list
65647232|NCT02235584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65647233|NCT02235584|Antiemetics|antiemetics|mesh-ancestor
65647234|NCT02235584|Autonomic Agents|autonomic agents|mesh-ancestor
65647235|NCT02235584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65647236|NCT02235584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647237|NCT02235584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65647238|NCT02235584|Glucocorticoids|glucocorticoids|mesh-ancestor
65647239|NCT02235584|Hormones|hormones|mesh-ancestor
65647240|NCT02235584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65647241|NCT02235584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65647242|NCT02235584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647243|NCT02235662|Tenofovir|tenofovir|mesh-list
65647244|NCT02235662|Levonorgestrel|levonorgestrel|mesh-list
65647245|NCT02235662|Antiviral Agents|antiviral agents|mesh-ancestor
65647246|NCT02235662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65647247|NCT02235662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65647248|NCT02235662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65647249|NCT02235662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647250|NCT02235662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647251|NCT02235662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65647252|NCT02235662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65647253|NCT02235662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65647254|NCT02235662|Contraceptive Agents|contraceptive agents|mesh-ancestor
65647255|NCT02235662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65647256|NCT02235662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647257|NCT02235662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65647258|NCT02235662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65647259|NCT02235662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65647260|NCT02262650|Telmisartan|telmisartan|mesh-list
65647261|NCT02262650|Clopidogrel|clopidogrel|mesh-list
65647262|NCT02262650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65647263|NCT02262650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65647264|NCT02262650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65647265|NCT02262650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65647266|NCT02262650|Purinergic Agents|purinergic agents|mesh-ancestor
65647267|NCT02262650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65647268|NCT02262650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647269|NCT02262650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647270|NCT02262650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65647271|NCT02262650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65647272|NCT02262650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65647273|NCT01084252|Dexamethasone|dexamethasone|mesh-list
65647274|NCT01084252|Dexamethasone acetate|dexamethasone acetate|mesh-list
65647275|NCT01084252|BB 1101|bb 1101|mesh-list
65647276|NCT01084252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65647277|NCT01084252|Antiemetics|antiemetics|mesh-ancestor
65647278|NCT01084252|Autonomic Agents|autonomic agents|mesh-ancestor
65647279|NCT01084252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65647280|NCT01084252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647281|NCT01084252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65647282|NCT01084252|Glucocorticoids|glucocorticoids|mesh-ancestor
65647283|NCT01084252|Hormones|hormones|mesh-ancestor
65647284|NCT01084252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65647285|NCT01084252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65647286|NCT01084252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647287|NCT01084252|Protease Inhibitors|protease inhibitors|mesh-ancestor
65647288|NCT01084252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647289|NCT01084252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647290|NCT04106414|Nivolumab|nivolumab|mesh-list
65647291|NCT04106414|Linrodostat|linrodostat|mesh-list
65647292|NCT04106414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65647293|NCT04106414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647294|NCT04106414|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65647295|NCT04106414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647296|NCT04106414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647297|NCT02784002|Fidaxomicin|fidaxomicin|mesh-list
65647298|NCT02784002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65647299|NCT02784002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65647300|NCT02233556|Memantine|memantine|mesh-list
65647301|NCT02233556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65647302|NCT02233556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65647303|NCT02233556|Dopamine Agents|dopamine agents|mesh-ancestor
65647304|NCT02233556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65647305|NCT02233556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647306|NCT02233556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647307|NCT02233556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65647308|NCT02233556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65647309|NCT04240288|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65647310|NCT04240288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65647311|NCT04240288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65647312|NCT04240288|Antitubercular Agents|antitubercular agents|mesh-ancestor
65647313|NCT02236052|Vaccines|vaccines|mesh-list
65647314|NCT02236052|Immunologic Factors|immunologic factors|mesh-ancestor
65647315|NCT02236052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647316|NCT04122196|Pregabalin|pregabalin|mesh-list
65647317|NCT04122196|Analgesics|analgesics|mesh-ancestor
65647318|NCT04122196|Sensory System Agents|sensory system agents|mesh-ancestor
65647319|NCT04122196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65647320|NCT04122196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647321|NCT04122196|Anticonvulsants|anticonvulsants|mesh-ancestor
65647322|NCT04122196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65647323|NCT04122196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65647324|NCT04122196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647325|NCT04122196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65647326|NCT04122196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65647327|NCT04122196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65647328|NCT04122196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65647329|NCT04122196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65647330|NCT04908592|Dexamethasone|dexamethasone|mesh-list
65647331|NCT04908592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65647332|NCT04908592|Antiemetics|antiemetics|mesh-ancestor
65647333|NCT04908592|Autonomic Agents|autonomic agents|mesh-ancestor
65647334|NCT04908592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65647335|NCT04908592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647336|NCT04908592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65647337|NCT04908592|Glucocorticoids|glucocorticoids|mesh-ancestor
65647338|NCT04908592|Hormones|hormones|mesh-ancestor
65647339|NCT04908592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65647340|NCT04908592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65647341|NCT04908592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647342|NCT04788550|Listerine|listerine|mesh-list
65647343|NCT04788550|Fluorides|fluorides|mesh-list
65647344|NCT04788550|Sodium Fluoride|sodium fluoride|mesh-list
65647345|NCT04788550|Fluorides, Topical|fluorides, topical|mesh-list
65647346|NCT04788550|Cariostatic Agents|cariostatic agents|mesh-ancestor
65647347|NCT04788550|Protective Agents|protective agents|mesh-ancestor
65647348|NCT04788550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647349|NCT04788550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65647350|NCT04788550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65647351|NCT04016714|Vaccines|vaccines|mesh-list
65647352|NCT04016714|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65647353|NCT04016714|Immunologic Factors|immunologic factors|mesh-ancestor
65647354|NCT04016714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647355|NCT04759768|Naltrexone|naltrexone|mesh-list
65647356|NCT04759768|Nalmefene|nalmefene|mesh-list
65647357|NCT04759768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65647358|NCT04759768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647359|NCT04759768|Sensory System Agents|sensory system agents|mesh-ancestor
65647360|NCT04759768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65647361|NCT04759768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65647362|NCT02564744|Rituximab|rituximab|mesh-list
65647363|NCT02564744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65647364|NCT02564744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647365|NCT02564744|Immunologic Factors|immunologic factors|mesh-ancestor
65647366|NCT02564744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647367|NCT02564744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65647368|NCT05759767|Tamsulosin|tamsulosin|mesh-list
65647369|NCT05759767|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65647370|NCT05759767|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65647371|NCT05759767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65647372|NCT05759767|Adrenergic Agents|adrenergic agents|mesh-ancestor
65647373|NCT05759767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65647374|NCT05759767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647375|NCT05759767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647376|NCT05759767|Urological Agents|urological agents|mesh-ancestor
65647377|NCT02750306|Suvorexant|suvorexant|mesh-list
65647378|NCT02750306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65647379|NCT02750306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65647380|NCT02750306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65647381|NCT02750306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647382|NCT02750306|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65647383|NCT02750306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65647384|NCT02750306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647385|NCT03845140|Praziquantel|praziquantel|mesh-list
65647386|NCT03845140|Anthelmintics|anthelmintics|mesh-ancestor
65647387|NCT03845140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65647388|NCT03845140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65647389|NCT01816165|Acipimox|acipimox|mesh-list
65647390|NCT01816165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65647391|NCT01816165|Antimetabolites|antimetabolites|mesh-ancestor
65647392|NCT01816165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647393|NCT01816165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65647394|NCT04476680|Vitamin D|vitamin d|mesh-list
65647395|NCT04476680|Vitamins|vitamins|mesh-ancestor
65647396|NCT04476680|Micronutrients|micronutrients|mesh-ancestor
65647397|NCT04476680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647398|NCT04476680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65647399|NCT04952350|Atorvastatin|atorvastatin|mesh-list
65647400|NCT04952350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65647401|NCT04952350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65647402|NCT04952350|Antimetabolites|antimetabolites|mesh-ancestor
65647403|NCT04952350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647404|NCT04952350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65647405|NCT04952350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65647406|NCT04952350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647407|NCT05376202|Cetuximab|cetuximab|mesh-list
65647408|NCT05376202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65647409|NCT05376202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647410|NCT04812808|Bazedoxifene|bazedoxifene|mesh-list
65647411|NCT04812808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65647412|NCT04812808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65647413|NCT04812808|Hormone Antagonists|hormone antagonists|mesh-ancestor
65647414|NCT04812808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65647415|NCT04812808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647416|NCT04812808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65647417|NCT01677988|Folfirinox|folfirinox|mesh-list
65647418|NCT01677988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647419|NCT02233790|Clopidogrel|clopidogrel|mesh-list
65647420|NCT02233790|Ticagrelor|ticagrelor|mesh-list
65647421|NCT02233790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65647422|NCT02233790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65647423|NCT02233790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65647424|NCT02233790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65647425|NCT02233790|Purinergic Agents|purinergic agents|mesh-ancestor
65647426|NCT02233790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65647427|NCT02233790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647428|NCT02233790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647429|NCT02547818|Ibuprofen|ibuprofen|mesh-list
65647430|NCT02547818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65647431|NCT02547818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65647432|NCT02547818|Analgesics|analgesics|mesh-ancestor
65647433|NCT02547818|Sensory System Agents|sensory system agents|mesh-ancestor
65647434|NCT02547818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65647435|NCT02547818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647436|NCT02547818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65647437|NCT02547818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65647438|NCT02547818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65647439|NCT02547818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647440|NCT02547818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647441|NCT04539808|Calcium, Dietary|calcium, dietary|mesh-list
65647442|NCT04539808|Leucovorin|leucovorin|mesh-list
65647443|NCT04539808|Folic Acid|folic acid|mesh-list
65647444|NCT04539808|Fluorouracil|fluorouracil|mesh-list
65647445|NCT04539808|Capecitabine|capecitabine|mesh-list
65647446|NCT04539808|Oxaliplatin|oxaliplatin|mesh-list
65647447|NCT04539808|Irinotecan|irinotecan|mesh-list
65647448|NCT04539808|Camptothecin|camptothecin|mesh-list
65647450|NCT04539808|Calcium|calcium|mesh-list
65647451|NCT04539808|Levoleucovorin|levoleucovorin|mesh-list
65647452|NCT04539808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65647453|NCT04539808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647454|NCT04539808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65647455|NCT04539808|Antimetabolites|antimetabolites|mesh-ancestor
65647456|NCT04539808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647457|NCT04539808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65647458|NCT04539808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647459|NCT04539808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65647460|NCT04539808|Immunologic Factors|immunologic factors|mesh-ancestor
65647461|NCT04539808|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65647462|NCT04539808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65647463|NCT04539808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647464|NCT04539808|Antidotes|antidotes|mesh-ancestor
65647465|NCT04539808|Protective Agents|protective agents|mesh-ancestor
65647466|NCT04539808|Vitamin B Complex|vitamin b complex|mesh-ancestor
65647467|NCT04539808|Vitamins|vitamins|mesh-ancestor
65647468|NCT04539808|Micronutrients|micronutrients|mesh-ancestor
65647469|NCT04539808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65647470|NCT04539808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65267776|NCT02752724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65647471|NCT04539808|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65647472|NCT04539808|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65647473|NCT04539808|Hematinics|hematinics|mesh-ancestor
65647474|NCT04539808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65647475|NCT02520076|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65647476|NCT02520076|Protein C Inhibitor|protein c inhibitor|mesh-list
65647477|NCT02520076|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65647478|NCT02520076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65647479|NCT02520076|Protease Inhibitors|protease inhibitors|mesh-ancestor
65647480|NCT02520076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647481|NCT02520076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647482|NCT03752918|Niacin|niacin|mesh-list
65647483|NCT03752918|Nicotinic Acids|nicotinic acids|mesh-list
65647484|NCT03752918|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65647485|NCT03752918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65647486|NCT03752918|Antimetabolites|antimetabolites|mesh-ancestor
65647487|NCT03752918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647488|NCT03752918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65647489|NCT03752918|Vasodilator Agents|vasodilator agents|mesh-ancestor
65647490|NCT03752918|Vitamin B Complex|vitamin b complex|mesh-ancestor
65647491|NCT03752918|Vitamins|vitamins|mesh-ancestor
65647492|NCT03752918|Micronutrients|micronutrients|mesh-ancestor
65647493|NCT03752918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647494|NCT03752918|Hallucinogens|hallucinogens|mesh-ancestor
65647495|NCT03752918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65647496|NCT03752918|Serotonin Agents|serotonin agents|mesh-ancestor
65647497|NCT03752918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65647498|NCT03752918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65647499|NCT03752918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65647500|NCT03752918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65647501|NCT03752918|Adrenergic Agents|adrenergic agents|mesh-ancestor
65647502|NCT04259320|Propolis|propolis|mesh-list
65647503|NCT04259320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65647504|NCT04058158|Eculizumab|eculizumab|mesh-list
65647505|NCT04058158|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65647506|NCT04058158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65647507|NCT04058158|Immunologic Factors|immunologic factors|mesh-ancestor
65647508|NCT04058158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647509|NCT02263196|Ethanol|ethanol|mesh-list
65647510|NCT02263196|Povidone-Iodine|povidone-iodine|mesh-list
65647511|NCT02263196|Povidone|povidone|mesh-list
65647512|NCT02263196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65647513|NCT02263196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65647514|NCT02263196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65647515|NCT02263196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647516|NCT02263196|Plasma Substitutes|plasma substitutes|mesh-ancestor
65647517|NCT02263196|Blood Substitutes|blood substitutes|mesh-ancestor
65647518|NCT05160506|Hydrocortisone|hydrocortisone|mesh-list
65647519|NCT05160506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65647520|NCT02926573|Gabapentin|gabapentin|mesh-list
65647521|NCT02926573|Analgesics|analgesics|mesh-ancestor
65647522|NCT02926573|Sensory System Agents|sensory system agents|mesh-ancestor
65647523|NCT02926573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65647524|NCT02926573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647525|NCT02926573|Anticonvulsants|anticonvulsants|mesh-ancestor
65647526|NCT02926573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65647527|NCT02926573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65647528|NCT02926573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65647529|NCT02926573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65647530|NCT02926573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65647531|NCT02926573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65647532|NCT02926573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65647533|NCT02926573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647534|NCT02926573|Antimanic Agents|antimanic agents|mesh-ancestor
65647536|NCT04477018|Chelating Agents|chelating agents|mesh-list
65647537|NCT04477018|Micronutrients|micronutrients|mesh-ancestor
65647538|NCT04477018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647539|NCT04477018|Trace Elements|trace elements|mesh-ancestor
65647540|NCT04477018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647541|NCT04477018|Sequestering Agents|sequestering agents|mesh-ancestor
65647542|NCT05113940|Midazolam|midazolam|mesh-list
65647543|NCT05113940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65647544|NCT05113940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65647545|NCT05113940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65647546|NCT05113940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647547|NCT05113940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65647548|NCT05113940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65647549|NCT05113940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65647550|NCT05113940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65647551|NCT05113940|Anesthetics, General|anesthetics, general|mesh-ancestor
65647552|NCT05113940|Anesthetics|anesthetics|mesh-ancestor
65647553|NCT05113940|GABA Modulators|gaba modulators|mesh-ancestor
65647554|NCT05113940|GABA Agents|gaba agents|mesh-ancestor
65647555|NCT05113940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65647556|NCT05113940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647557|NCT00158860|Valacyclovir|valacyclovir|mesh-list
65647558|NCT00158860|Antiviral Agents|antiviral agents|mesh-ancestor
65647559|NCT00158860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65647560|NCT02490488|Gemcitabine|gemcitabine|mesh-list
65647561|NCT02490488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65647562|NCT02490488|Antimetabolites|antimetabolites|mesh-ancestor
65647563|NCT02490488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647564|NCT02490488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647565|NCT02490488|Antiviral Agents|antiviral agents|mesh-ancestor
65647566|NCT02490488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65647567|NCT02490488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647568|NCT02490488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65647569|NCT02490488|Immunologic Factors|immunologic factors|mesh-ancestor
65647570|NCT02490488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647571|NCT02654990|Dexamethasone|dexamethasone|mesh-list
65647572|NCT02654990|Bortezomib|bortezomib|mesh-list
65647573|NCT02654990|Panobinostat|panobinostat|mesh-list
65647574|NCT02654990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65647575|NCT02654990|Antiemetics|antiemetics|mesh-ancestor
65647576|NCT02654990|Autonomic Agents|autonomic agents|mesh-ancestor
65647577|NCT02654990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65647578|NCT02654990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647579|NCT02654990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65647580|NCT02654990|Glucocorticoids|glucocorticoids|mesh-ancestor
65647581|NCT02654990|Hormones|hormones|mesh-ancestor
65647582|NCT02654990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65647583|NCT02654990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65647584|NCT02654990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647585|NCT02654990|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65647586|NCT02654990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647587|NCT02654990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647588|NCT02471222|Amantadine|amantadine|mesh-list
65647589|NCT02471222|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65647590|NCT02471222|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65647591|NCT02471222|Antiviral Agents|antiviral agents|mesh-ancestor
65647592|NCT02471222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65647593|NCT02471222|Dopamine Agents|dopamine agents|mesh-ancestor
65647594|NCT02471222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65647595|NCT02471222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647596|NCT02471222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647597|NCT02471222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65444962|NCT01066988|Emollients|emollients|mesh-list
65647598|NCT02471222|Analgesics|analgesics|mesh-ancestor
65647599|NCT02471222|Sensory System Agents|sensory system agents|mesh-ancestor
65647600|NCT02471222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65647602|NCT02636582|Vaccines|vaccines|mesh-list
65647603|NCT02636582|Sargramostim|sargramostim|mesh-list
65647604|NCT02636582|Immunologic Factors|immunologic factors|mesh-ancestor
65647605|NCT02636582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647606|NCT02636582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647607|NCT03136120|Bromides|bromides|mesh-list
65647608|NCT03136120|Ipratropium|ipratropium|mesh-list
65647609|NCT03136120|Anticonvulsants|anticonvulsants|mesh-ancestor
65647610|NCT03136120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65647611|NCT03136120|Autonomic Agents|autonomic agents|mesh-ancestor
65647612|NCT03136120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65647613|NCT03136120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647614|NCT03136120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65647615|NCT03136120|Respiratory System Agents|respiratory system agents|mesh-ancestor
65647616|NCT03136120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65647617|NCT03136120|Cholinergic Agents|cholinergic agents|mesh-ancestor
65647618|NCT03136120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65647619|NCT03136120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647620|NCT01625234|Ensartinib|ensartinib|mesh-list
65647621|NCT01625234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647622|NCT01625234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65647623|NCT01625234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647624|NCT01625234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647625|NCT02264834|Sufentanil|sufentanil|mesh-list
65647626|NCT02264834|Dsuvia|dsuvia|mesh-list
65647627|NCT02264834|Levobupivacaine|levobupivacaine|mesh-list
65647628|NCT02264834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65647629|NCT02264834|Narcotics|narcotics|mesh-ancestor
65647630|NCT02264834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65647631|NCT02264834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647632|NCT02264834|Analgesics|analgesics|mesh-ancestor
65647633|NCT02264834|Sensory System Agents|sensory system agents|mesh-ancestor
65647634|NCT02264834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65647635|NCT02264834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65647636|NCT02264834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65647637|NCT02264834|Anesthetics, General|anesthetics, general|mesh-ancestor
65647638|NCT02264834|Anesthetics|anesthetics|mesh-ancestor
65647639|NCT02264834|Anesthetics, Local|anesthetics, local|mesh-ancestor
65647640|NCT05762419|Etoposide|etoposide|mesh-list
65647641|NCT05762419|Etoposide phosphate|etoposide phosphate|mesh-list
65647642|NCT05762419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65647643|NCT05762419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647644|NCT05762419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65647645|NCT05762419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65647646|NCT05762419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647647|NCT05762419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647648|NCT02264912|Clopidogrel|clopidogrel|mesh-list
65647649|NCT02264912|Ticagrelor|ticagrelor|mesh-list
65647650|NCT02264912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65647651|NCT02264912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65647652|NCT02264912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65647653|NCT02264912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65647654|NCT02264912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65647655|NCT02264912|Purinergic Agents|purinergic agents|mesh-ancestor
65647656|NCT02264912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65647657|NCT02264912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647658|NCT02264912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647659|NCT02263352|Carotenoids|carotenoids|mesh-list
65647660|NCT02263352|Antioxidants|antioxidants|mesh-ancestor
65647661|NCT02263352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647662|NCT02263352|Protective Agents|protective agents|mesh-ancestor
65647663|NCT02263352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647664|NCT01435226|Ribavirin|ribavirin|mesh-list
65647665|NCT01435226|Ledipasvir|ledipasvir|mesh-list
65647666|NCT01435226|Antimetabolites|antimetabolites|mesh-ancestor
65647667|NCT01435226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647668|NCT01435226|Antiviral Agents|antiviral agents|mesh-ancestor
65647669|NCT01435226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65647670|NCT01679002|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
65647671|NCT01679002|Oxcarbazepine|oxcarbazepine|mesh-list
65647672|NCT01679002|Anticonvulsants|anticonvulsants|mesh-ancestor
65647673|NCT01679002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65647674|NCT01679002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65445036|NCT00117676|Antiviral Agents|antiviral agents|mesh-ancestor
65647675|NCT01679002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65647676|NCT01679002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647677|NCT01679002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65647678|NCT01679002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65647679|NCT04409509|Antibodies|antibodies|mesh-list
65647680|NCT04409509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65647681|NCT04409509|Immunologic Factors|immunologic factors|mesh-ancestor
65647682|NCT04409509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647683|NCT04401865|Riboflavin|riboflavin|mesh-list
65647684|NCT04401865|Vitamin B Complex|vitamin b complex|mesh-ancestor
65647685|NCT04401865|Vitamins|vitamins|mesh-ancestor
65647686|NCT04401865|Micronutrients|micronutrients|mesh-ancestor
65647687|NCT04401865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647688|NCT04401865|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65647689|NCT04401865|Dermatologic Agents|dermatologic agents|mesh-ancestor
65647690|NCT02609048|Seladelpar|seladelpar|mesh-list
65647691|NCT02609048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65647692|NCT02609048|Antimetabolites|antimetabolites|mesh-ancestor
65647693|NCT02609048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647694|NCT02609048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65647695|NCT02265068|Ticagrelor|ticagrelor|mesh-list
65647696|NCT02265068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65647697|NCT02265068|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65647698|NCT02265068|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65647699|NCT02265068|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65647700|NCT02265068|Purinergic Agents|purinergic agents|mesh-ancestor
65647701|NCT02265068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65647702|NCT02265068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647703|NCT02265068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647704|NCT02262416|Leuprolide|leuprolide|mesh-list
65647705|NCT02262416|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65647706|NCT02262416|Fertility Agents|fertility agents|mesh-ancestor
65647707|NCT02262416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65647708|NCT02262416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647709|NCT02262416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65647710|NCT02262416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647711|NCT01577654|Folic Acid|folic acid|mesh-list
65647712|NCT01577654|Docetaxel|docetaxel|mesh-list
65647713|NCT01577654|Vinca Alkaloids|vinca alkaloids|mesh-list
65647714|NCT01577654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647715|NCT01577654|Tubulin Modulators|tubulin modulators|mesh-ancestor
65647716|NCT01577654|Antimitotic Agents|antimitotic agents|mesh-ancestor
65647717|NCT01577654|Mitosis Modulators|mitosis modulators|mesh-ancestor
65647718|NCT01577654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647719|NCT01577654|Hematinics|hematinics|mesh-ancestor
65647720|NCT01577654|Vitamin B Complex|vitamin b complex|mesh-ancestor
65647721|NCT01577654|Vitamins|vitamins|mesh-ancestor
65647722|NCT01577654|Micronutrients|micronutrients|mesh-ancestor
65647723|NCT01577654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647724|NCT05736952|Topotecan|topotecan|mesh-list
65647725|NCT05736952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65647726|NCT05736952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65647727|NCT05736952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647728|NCT05736952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647729|NCT05736952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647730|NCT01423058|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
65647731|NCT01423058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65647732|NCT01423058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647733|NCT01423058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647734|NCT04413292|BIRC5 protein, human|birc5 protein, human|mesh-list
65647735|NCT04413292|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65647736|NCT04413292|Protease Inhibitors|protease inhibitors|mesh-ancestor
65647737|NCT04413292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647738|NCT04413292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647739|NCT01418222|Leucovorin|leucovorin|mesh-list
65647740|NCT01418222|Bevacizumab|bevacizumab|mesh-list
65647741|NCT01418222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65647742|NCT01418222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647743|NCT01418222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65647744|NCT01418222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65647745|NCT01418222|Growth Substances|growth substances|mesh-ancestor
65647746|NCT01418222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647747|NCT01418222|Growth Inhibitors|growth inhibitors|mesh-ancestor
65647748|NCT01418222|Antidotes|antidotes|mesh-ancestor
65647749|NCT01418222|Protective Agents|protective agents|mesh-ancestor
65647750|NCT01418222|Vitamin B Complex|vitamin b complex|mesh-ancestor
65647752|NCT01418222|Micronutrients|micronutrients|mesh-ancestor
65647753|NCT05377606|Temazepam|temazepam|mesh-list
65647754|NCT05377606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65647755|NCT05377606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65647756|NCT05377606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647757|NCT05377606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65647758|NCT05377606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65647759|NCT05377606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65647760|NCT05377606|GABA Modulators|gaba modulators|mesh-ancestor
65647761|NCT05377606|GABA Agents|gaba agents|mesh-ancestor
65647762|NCT05377606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65647763|NCT05377606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647764|NCT01256762|Paclitaxel|paclitaxel|mesh-list
65647765|NCT01256762|Bevacizumab|bevacizumab|mesh-list
65647766|NCT01256762|Imetelstat|imetelstat|mesh-list
65647767|NCT01256762|Motesanib diphosphate|motesanib diphosphate|mesh-list
65647768|NCT01256762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65647769|NCT01256762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647770|NCT01256762|Tubulin Modulators|tubulin modulators|mesh-ancestor
65647771|NCT01256762|Antimitotic Agents|antimitotic agents|mesh-ancestor
65647772|NCT01256762|Mitosis Modulators|mitosis modulators|mesh-ancestor
65647773|NCT01256762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647774|NCT01256762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65647775|NCT01256762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65647776|NCT01256762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65647777|NCT01256762|Growth Substances|growth substances|mesh-ancestor
65647778|NCT01256762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647779|NCT01256762|Growth Inhibitors|growth inhibitors|mesh-ancestor
65647780|NCT01256762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647781|NCT01256762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65647782|NCT01252628|Cetuximab|cetuximab|mesh-list
65647783|NCT01252628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65647784|NCT01252628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647785|NCT01236638|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
65647786|NCT01236638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65647787|NCT01236638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647788|NCT01236638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647789|NCT04349371|Chloroquine|chloroquine|mesh-list
65647790|NCT04349371|Amebicides|amebicides|mesh-ancestor
65647791|NCT04349371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65647792|NCT04349371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65647793|NCT04349371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65647794|NCT04349371|Antimalarials|antimalarials|mesh-ancestor
65647795|NCT04349371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65647796|NCT01410188|Latanoprost|latanoprost|mesh-list
65647797|NCT01410188|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65647798|NCT01410188|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65647799|NCT01408082|Azithromycin|azithromycin|mesh-list
65647800|NCT01408082|Dexamethasone|dexamethasone|mesh-list
65647801|NCT01408082|Dexamethasone acetate|dexamethasone acetate|mesh-list
65647802|NCT01408082|BB 1101|bb 1101|mesh-list
65647803|NCT01408082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65647804|NCT01408082|Antiemetics|antiemetics|mesh-ancestor
65647805|NCT01408082|Autonomic Agents|autonomic agents|mesh-ancestor
65647806|NCT01408082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65647807|NCT01408082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647808|NCT01408082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65647809|NCT01408082|Glucocorticoids|glucocorticoids|mesh-ancestor
65647810|NCT01408082|Hormones|hormones|mesh-ancestor
65647811|NCT01408082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65647812|NCT01408082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65647813|NCT01408082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647814|NCT01408082|Protease Inhibitors|protease inhibitors|mesh-ancestor
65647815|NCT01408082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647816|NCT01408082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647817|NCT01408082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65647818|NCT01408082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65647819|NCT03071263|Spironolactone|spironolactone|mesh-list
65647820|NCT03071263|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65647821|NCT03071263|Hormone Antagonists|hormone antagonists|mesh-ancestor
65647822|NCT03071263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65647823|NCT03071263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647824|NCT03071263|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65647825|NCT03071263|Diuretics|diuretics|mesh-ancestor
65647826|NCT03071263|Natriuretic Agents|natriuretic agents|mesh-ancestor
65647828|NCT05200663|Vitamin E|vitamin e|mesh-list
65647829|NCT05200663|Vitamins|vitamins|mesh-ancestor
65647830|NCT05200663|Micronutrients|micronutrients|mesh-ancestor
65647831|NCT05200663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647832|NCT05200663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65647833|NCT05200663|Hormone Antagonists|hormone antagonists|mesh-ancestor
65647834|NCT05200663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65647835|NCT05200663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65647836|NCT05200663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647837|NCT05200663|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65647838|NCT05200663|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65647839|NCT05200663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65647840|NCT05200663|Antioxidants|antioxidants|mesh-ancestor
65647841|NCT05200663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647842|NCT05200663|Protective Agents|protective agents|mesh-ancestor
65647843|NCT02268422|Buprenorphine|buprenorphine|mesh-list
65647844|NCT02268422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65647845|NCT02268422|Narcotics|narcotics|mesh-ancestor
65647846|NCT02268422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65647847|NCT02268422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647848|NCT02268422|Analgesics|analgesics|mesh-ancestor
65647849|NCT02268422|Sensory System Agents|sensory system agents|mesh-ancestor
65647850|NCT02268422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65647851|NCT02268422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65647852|NCT01522196|Varespladib methyl|varespladib methyl|mesh-list
65647853|NCT01522196|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
65647854|NCT01522196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647855|NCT01522196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647856|NCT05049343|Ketamine|ketamine|mesh-list
65647857|NCT05049343|Analgesics|analgesics|mesh-ancestor
65647858|NCT05049343|Sensory System Agents|sensory system agents|mesh-ancestor
65647859|NCT05049343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65647860|NCT05049343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647861|NCT05049343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65647862|NCT05049343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65647863|NCT05049343|Anesthetics, General|anesthetics, general|mesh-ancestor
65647864|NCT05049343|Anesthetics|anesthetics|mesh-ancestor
65647865|NCT05049343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65647866|NCT05049343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65647867|NCT05049343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65647868|NCT05049343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65647869|NCT05049343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647870|NCT01569919|Folic Acid|folic acid|mesh-list
65647871|NCT01569919|Vitamin B 12|vitamin b 12|mesh-list
65647872|NCT01569919|Dexamethasone|dexamethasone|mesh-list
65647873|NCT01569919|Pemetrexed|pemetrexed|mesh-list
65647874|NCT01569919|Vitamins|vitamins|mesh-ancestor
65647875|NCT01569919|Micronutrients|micronutrients|mesh-ancestor
65647876|NCT01569919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647877|NCT01569919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65647878|NCT01569919|Antiemetics|antiemetics|mesh-ancestor
65647879|NCT01569919|Autonomic Agents|autonomic agents|mesh-ancestor
65647880|NCT01569919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65647881|NCT01569919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65647882|NCT01569919|Glucocorticoids|glucocorticoids|mesh-ancestor
65647883|NCT01569919|Hormones|hormones|mesh-ancestor
65647884|NCT01569919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65647885|NCT01569919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65647886|NCT01569919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647887|NCT01569919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647888|NCT01569919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647889|NCT01569919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65647890|NCT01569919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65647891|NCT01569919|Hematinics|hematinics|mesh-ancestor
65647892|NCT01569919|Vitamin B Complex|vitamin b complex|mesh-ancestor
65647893|NCT01399580|Atrasentan|atrasentan|mesh-list
65647894|NCT01399580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647895|NCT01399580|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65647896|NCT01399580|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65647897|NCT01399580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647898|NCT04069585|Lidocaine|lidocaine|mesh-list
65647899|NCT04069585|Anesthetics|anesthetics|mesh-list
65647900|NCT04069585|Anesthetics, Local|anesthetics, local|mesh-ancestor
65647901|NCT04069585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65647902|NCT04069585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647903|NCT04069585|Sensory System Agents|sensory system agents|mesh-ancestor
65647904|NCT04069585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65647905|NCT04069585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65267787|NCT00649623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65647906|NCT04069585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65647907|NCT04069585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65647908|NCT04069585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65647909|NCT04069585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647910|NCT00157196|Cyclophosphamide|cyclophosphamide|mesh-list
65647911|NCT00157196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65647912|NCT00157196|Immunologic Factors|immunologic factors|mesh-ancestor
65647913|NCT00157196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647914|NCT00157196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65647915|NCT00157196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65647916|NCT00157196|Alkylating Agents|alkylating agents|mesh-ancestor
65647917|NCT00157196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647918|NCT00157196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647919|NCT00157196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65647920|NCT02265770|Cyclophosphamide|cyclophosphamide|mesh-list
65647921|NCT02265770|Cisplatin|cisplatin|mesh-list
65647922|NCT02265770|Carboplatin|carboplatin|mesh-list
65647923|NCT02265770|Methotrexate|methotrexate|mesh-list
65647924|NCT02265770|Etoposide|etoposide|mesh-list
65647925|NCT02265770|Etoposide phosphate|etoposide phosphate|mesh-list
65647926|NCT02265770|Vincristine|vincristine|mesh-list
65647927|NCT02265770|Valproic Acid|valproic acid|mesh-list
65647928|NCT02265770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65647929|NCT02265770|Immunologic Factors|immunologic factors|mesh-ancestor
65647930|NCT02265770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647931|NCT02265770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65647932|NCT02265770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65647933|NCT02265770|Alkylating Agents|alkylating agents|mesh-ancestor
65647934|NCT02265770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647935|NCT02265770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65647936|NCT02265770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65647937|NCT02265770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65647938|NCT02265770|Abortifacient Agents|abortifacient agents|mesh-ancestor
65647939|NCT02265770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65647940|NCT02265770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65647941|NCT02265770|Antimetabolites|antimetabolites|mesh-ancestor
65647942|NCT02265770|Dermatologic Agents|dermatologic agents|mesh-ancestor
65647943|NCT02265770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65647944|NCT02265770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65647945|NCT02265770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65647946|NCT02265770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65647947|NCT02265770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65647948|NCT02265770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65647949|NCT02265770|Tubulin Modulators|tubulin modulators|mesh-ancestor
65647950|NCT02265770|Antimitotic Agents|antimitotic agents|mesh-ancestor
65647951|NCT02265770|Mitosis Modulators|mitosis modulators|mesh-ancestor
65647952|NCT02265770|Anticonvulsants|anticonvulsants|mesh-ancestor
65647953|NCT02265770|GABA Agents|gaba agents|mesh-ancestor
65647954|NCT02265770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65647955|NCT02265770|Antimanic Agents|antimanic agents|mesh-ancestor
65647956|NCT02265770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65647957|NCT02265770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65647958|NCT02265770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65647959|NCT03066193|Palmidrol|palmidrol|mesh-list
65647960|NCT03066193|Dronabinol|dronabinol|mesh-list
65647961|NCT03066193|Hallucinogens|hallucinogens|mesh-ancestor
65647962|NCT03066193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647963|NCT03066193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65647964|NCT03066193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65647965|NCT03066193|Analgesics|analgesics|mesh-ancestor
65647966|NCT03066193|Sensory System Agents|sensory system agents|mesh-ancestor
65647967|NCT03066193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65647968|NCT03066193|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65647969|NCT03066193|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65647970|NCT03066193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65647971|NCT03066193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647972|NCT03066193|Hormones|hormones|mesh-ancestor
65647973|NCT03066193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65647974|NCT03066193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65647975|NCT03066193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65647976|NCT03066193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65647977|NCT03066193|Antiviral Agents|antiviral agents|mesh-ancestor
65647978|NCT03066193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65647980|NCT02263976|Tiotropium Bromide|tiotropium bromide|mesh-list
65647981|NCT02263976|Methacholine Chloride|methacholine chloride|mesh-list
65647982|NCT02263976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65647983|NCT02263976|Autonomic Agents|autonomic agents|mesh-ancestor
65647984|NCT02263976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65647985|NCT02263976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65647986|NCT02263976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65647987|NCT02263976|Respiratory System Agents|respiratory system agents|mesh-ancestor
65647988|NCT02263976|Parasympatholytics|parasympatholytics|mesh-ancestor
65647989|NCT02263976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65647990|NCT02263976|Cholinergic Agents|cholinergic agents|mesh-ancestor
65647991|NCT02263976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65647992|NCT02263976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65647993|NCT02263976|Anticonvulsants|anticonvulsants|mesh-ancestor
65647994|NCT02263976|Miotics|miotics|mesh-ancestor
65647995|NCT02263976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65647996|NCT02263976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
65647997|NCT02263976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65647998|NCT02263976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65647999|NCT01382654|Azelastine|azelastine|mesh-list
65648000|NCT01382654|Epinastine|epinastine|mesh-list
65648001|NCT01382654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65648002|NCT01382654|Autonomic Agents|autonomic agents|mesh-ancestor
65648003|NCT01382654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65648004|NCT01382654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648005|NCT01382654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65648006|NCT01382654|Respiratory System Agents|respiratory system agents|mesh-ancestor
65648007|NCT01382654|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65648008|NCT01382654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648009|NCT01382654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648010|NCT01382654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65648011|NCT01382654|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65648012|NCT01382654|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65648013|NCT01382654|Histamine Antagonists|histamine antagonists|mesh-ancestor
65648014|NCT01382654|Histamine Agents|histamine agents|mesh-ancestor
65648015|NCT01382654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65648016|NCT01378676|Riluzole|riluzole|mesh-list
65648017|NCT01378676|Anticonvulsants|anticonvulsants|mesh-ancestor
65648018|NCT01378676|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65648019|NCT01378676|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65648020|NCT01378676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65648021|NCT01378676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648022|NCT01378676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648023|NCT01378676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65648024|NCT01378676|Protective Agents|protective agents|mesh-ancestor
65648025|NCT01377662|Methylphenidate|methylphenidate|mesh-list
65648026|NCT01377662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65648027|NCT01377662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648028|NCT01377662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65648029|NCT01377662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65648030|NCT01377662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65648031|NCT01377662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648032|NCT01377662|Dopamine Agents|dopamine agents|mesh-ancestor
65648033|NCT01377662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65648034|NCT01371578|Ribavirin|ribavirin|mesh-list
65648035|NCT01371578|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65648036|NCT01371578|Ledipasvir|ledipasvir|mesh-list
65648037|NCT01371578|Antimetabolites|antimetabolites|mesh-ancestor
65648038|NCT01371578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648039|NCT01371578|Antiviral Agents|antiviral agents|mesh-ancestor
65648040|NCT01371578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65648041|NCT01225640|Oxazolidinones|oxazolidinones|mesh-list
65648042|NCT01225640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65648043|NCT01225640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65648044|NCT01225640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648045|NCT01225640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648046|NCT01205048|Lidocaine|lidocaine|mesh-list
65648047|NCT01205048|Anesthetics, Local|anesthetics, local|mesh-ancestor
65648048|NCT01205048|Anesthetics|anesthetics|mesh-ancestor
65648049|NCT01205048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65648050|NCT01205048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648051|NCT01205048|Sensory System Agents|sensory system agents|mesh-ancestor
65648052|NCT01205048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65648053|NCT01205048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65648054|NCT01205048|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65648055|NCT01205048|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65648056|NCT01205048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65648057|NCT01205048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648058|NCT01498328|Bevacizumab|bevacizumab|mesh-list
65648059|NCT01498328|Rindopepimut|rindopepimut|mesh-list
65648060|NCT01498328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65648061|NCT01498328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648062|NCT01498328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65648063|NCT01498328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65648064|NCT01498328|Growth Substances|growth substances|mesh-ancestor
65648065|NCT01498328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648066|NCT01498328|Growth Inhibitors|growth inhibitors|mesh-ancestor
65648067|NCT01497704|Apatinib|apatinib|mesh-list
65648068|NCT01497704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648069|NCT01497704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65648070|NCT01497704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648071|NCT01497704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648072|NCT02266160|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65648073|NCT02266160|Anesthetics, Local|anesthetics, local|mesh-ancestor
65648074|NCT02266160|Anesthetics|anesthetics|mesh-ancestor
65648075|NCT02266160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65648076|NCT02266160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648077|NCT02266160|Sensory System Agents|sensory system agents|mesh-ancestor
65648078|NCT02266160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65648079|NCT02266160|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65648080|NCT03911713|Ivacaftor|ivacaftor|mesh-list
65648081|NCT03911713|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65648082|NCT03911713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65648083|NCT03911713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648084|NCT02264132|Pramipexole|pramipexole|mesh-list
65648085|NCT02264132|Antioxidants|antioxidants|mesh-ancestor
65648086|NCT02264132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648087|NCT02264132|Protective Agents|protective agents|mesh-ancestor
65648088|NCT02264132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648089|NCT02264132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65648090|NCT02264132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65648091|NCT02264132|Dopamine Agonists|dopamine agonists|mesh-ancestor
65648092|NCT02264132|Dopamine Agents|dopamine agents|mesh-ancestor
65648093|NCT02264132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65648094|NCT01192880|Antipsychotic Agents|antipsychotic agents|mesh-list
65648095|NCT01192880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65648096|NCT01192880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65648097|NCT01192880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648098|NCT01192880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65648099|NCT04540744|Tadalafil|tadalafil|mesh-list
65648100|NCT04540744|Macitentan|macitentan|mesh-list
65648101|NCT04540744|Vasodilator Agents|vasodilator agents|mesh-ancestor
65648102|NCT04540744|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65648103|NCT04540744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65648104|NCT04540744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648105|NCT04540744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648106|NCT04540744|Urological Agents|urological agents|mesh-ancestor
65648107|NCT04540744|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65648108|NCT04540744|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65648109|NCT04540744|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65648110|NCT01489046|Tenofovir|tenofovir|mesh-list
65648111|NCT01489046|Lamivudine|lamivudine|mesh-list
65648112|NCT01489046|Efavirenz|efavirenz|mesh-list
65648113|NCT01489046|Antiviral Agents|antiviral agents|mesh-ancestor
65648114|NCT01489046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65648115|NCT01489046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65648116|NCT01489046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65648117|NCT01489046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648118|NCT01489046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445487|NCT01072578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65648119|NCT01489046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65648120|NCT01489046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65648121|NCT01489046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65648122|NCT01489046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65648123|NCT01489046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65648124|NCT01489046|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65648125|NCT01489046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65648126|NCT01489046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65648127|NCT01180634|Levofloxacin|levofloxacin|mesh-list
65648128|NCT01180634|Ofloxacin|ofloxacin|mesh-list
65648129|NCT01180634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65648130|NCT01180634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65648131|NCT01180634|Renal Agents|renal agents|mesh-ancestor
65648132|NCT01180634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65648133|NCT01180634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65648134|NCT01180634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65648135|NCT01180634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648136|NCT01180634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648137|NCT01180634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648138|NCT01180634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65648139|NCT01180634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65648140|NCT02268890|Bortezomib|bortezomib|mesh-list
65648141|NCT02268890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648142|NCT02268968|Lidocaine|lidocaine|mesh-list
65648143|NCT02268968|Anesthetics, Local|anesthetics, local|mesh-ancestor
65648144|NCT02268968|Anesthetics|anesthetics|mesh-ancestor
65648145|NCT02268968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65648146|NCT02268968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648147|NCT02268968|Sensory System Agents|sensory system agents|mesh-ancestor
65648148|NCT02268968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65648149|NCT02268968|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65648150|NCT02268968|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65648151|NCT02268968|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65648152|NCT02268968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65648153|NCT02268968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648154|NCT01359566|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
65648155|NCT01359566|Baclofen|baclofen|mesh-list
65648156|NCT01359566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65648157|NCT01359566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648158|NCT01359566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65648159|NCT01359566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65648160|NCT01359566|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65648161|NCT01359566|GABA Agonists|gaba agonists|mesh-ancestor
65648162|NCT01359566|GABA Agents|gaba agents|mesh-ancestor
65648163|NCT01359566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65648164|NCT01359566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648165|NCT04885816|Sirolimus|sirolimus|mesh-list
65648166|NCT04885816|Everolimus|everolimus|mesh-list
65648167|NCT04885816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648168|NCT04885816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65648169|NCT04885816|Immunologic Factors|immunologic factors|mesh-ancestor
65648170|NCT04885816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648171|NCT04885816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65648172|NCT04885816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65648173|NCT04885816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65648174|NCT04885816|Antifungal Agents|antifungal agents|mesh-ancestor
65648175|NCT04865614|Sevoflurane|sevoflurane|mesh-list
65648176|NCT04865614|Etomidate|etomidate|mesh-list
65648177|NCT04865614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65648178|NCT04865614|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65648179|NCT04865614|Anesthetics, General|anesthetics, general|mesh-ancestor
65648180|NCT04865614|Anesthetics|anesthetics|mesh-ancestor
65648181|NCT04865614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65648182|NCT04865614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648183|NCT04865614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65648184|NCT04865614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65648185|NCT02269046|Simvastatin|simvastatin|mesh-list
65648186|NCT02269046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65648187|NCT02269046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65648188|NCT02269046|Antimetabolites|antimetabolites|mesh-ancestor
65648189|NCT02269046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648190|NCT02269046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65648191|NCT02269046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65445568|NCT00084136|Tenofovir|tenofovir|mesh-list
65648192|NCT02269046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648193|NCT04770454|Buspirone|buspirone|mesh-list
65648194|NCT04770454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65648195|NCT04770454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65648196|NCT04770454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65648197|NCT04770454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648198|NCT04770454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65648199|NCT04770454|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65648200|NCT04770454|Serotonin Agents|serotonin agents|mesh-ancestor
65648201|NCT04770454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65648202|NCT04770454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648203|NCT01483742|Ritonavir|ritonavir|mesh-list
65648204|NCT01483742|Ribavirin|ribavirin|mesh-list
65648205|NCT01483742|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65648206|NCT01483742|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65648207|NCT01483742|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65648208|NCT01483742|Protease Inhibitors|protease inhibitors|mesh-ancestor
65648209|NCT01483742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648210|NCT01483742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648211|NCT01483742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65648212|NCT01483742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65648213|NCT01483742|Antiviral Agents|antiviral agents|mesh-ancestor
65648214|NCT01483742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65648215|NCT01483742|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65648216|NCT01483742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65648217|NCT01483742|Antimetabolites|antimetabolites|mesh-ancestor
65648218|NCT04691128|Anesthetics|anesthetics|mesh-list
65648219|NCT04691128|Propofol|propofol|mesh-list
65648220|NCT04691128|Desflurane|desflurane|mesh-list
65648221|NCT04691128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65648222|NCT04691128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648223|NCT04691128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65648224|NCT04691128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65648225|NCT04691128|Anesthetics, General|anesthetics, general|mesh-ancestor
65648226|NCT04691128|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65648227|NCT04207918|Nimotuzumab|nimotuzumab|mesh-list
65648228|NCT04207918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65648229|NCT04207918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648230|NCT02269202|Midazolam|midazolam|mesh-list
65648231|NCT02269202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65648232|NCT02269202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65648233|NCT02269202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65648234|NCT02269202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648235|NCT02269202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65648236|NCT02269202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65648237|NCT02269202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65648238|NCT02269202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65648239|NCT02269202|Anesthetics, General|anesthetics, general|mesh-ancestor
65648240|NCT02269202|Anesthetics|anesthetics|mesh-ancestor
65648241|NCT02269202|GABA Modulators|gaba modulators|mesh-ancestor
65648242|NCT02269202|GABA Agents|gaba agents|mesh-ancestor
65648243|NCT02269202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65648244|NCT02269202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648245|NCT03614923|Mometasone Furoate|mometasone furoate|mesh-list
65648246|NCT03614923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65648247|NCT03614923|Dermatologic Agents|dermatologic agents|mesh-ancestor
65648248|NCT03614923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65648249|NCT01353248|Ribavirin|ribavirin|mesh-list
65648250|NCT01353248|Ledipasvir|ledipasvir|mesh-list
65648251|NCT01353248|Antimetabolites|antimetabolites|mesh-ancestor
65648252|NCT01353248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648253|NCT01353248|Antiviral Agents|antiviral agents|mesh-ancestor
65648254|NCT01353248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65648255|NCT05095636|Apatinib|apatinib|mesh-list
65648256|NCT05095636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648257|NCT05095636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65648258|NCT05095636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648259|NCT05095636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648260|NCT01343966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65648261|NCT01343966|Immunologic Factors|immunologic factors|mesh-ancestor
65648262|NCT01343966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648263|NCT05095480|Red yeast rice|red yeast rice|mesh-list
65648264|NCT05095480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65648265|NCT05095480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65648266|NCT05095480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65648267|NCT05095480|Antimetabolites|antimetabolites|mesh-ancestor
65648268|NCT05095480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110984|NCT04662866|Hormones|hormones|mesh-ancestor
65648269|NCT05095480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648270|NCT05095480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65648271|NCT02915016|Vaccines|vaccines|mesh-list
65648272|NCT02915016|MF59 oil emulsion|mf59 oil emulsion|mesh-list
65648273|NCT02915016|Immunologic Factors|immunologic factors|mesh-ancestor
65648274|NCT02915016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648275|NCT02915016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65648276|NCT02269280|Azacitidine|azacitidine|mesh-list
65648277|NCT02269280|Decitabine|decitabine|mesh-list
65648278|NCT02269280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65648279|NCT02269280|Antimetabolites|antimetabolites|mesh-ancestor
65648280|NCT02269280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648281|NCT02269280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648282|NCT02269280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648283|NCT01170650|Doxorubicin|doxorubicin|mesh-list
65648284|NCT01170650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65648285|NCT01170650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65648286|NCT01170650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648287|NCT01170650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65648288|NCT01170650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65648289|NCT01170650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648290|NCT01170650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648291|NCT04533646|Insulin|insulin|mesh-list
65648292|NCT04533646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65648293|NCT04533646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648294|NCT01168310|Fluticasone|fluticasone|mesh-list
65648295|NCT01168310|Xhance|xhance|mesh-list
65648296|NCT01168310|Formoterol Fumarate|formoterol fumarate|mesh-list
65648297|NCT01168310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65648298|NCT01168310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65648299|NCT01168310|Autonomic Agents|autonomic agents|mesh-ancestor
65648300|NCT01168310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65648301|NCT01168310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648302|NCT01168310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65648303|NCT01168310|Respiratory System Agents|respiratory system agents|mesh-ancestor
65648304|NCT01168310|Dermatologic Agents|dermatologic agents|mesh-ancestor
65648305|NCT01168310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65648306|NCT01168310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65648307|NCT01168310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65648308|NCT01168310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65648309|NCT01168310|Adrenergic Agents|adrenergic agents|mesh-ancestor
65648310|NCT01168310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65648311|NCT01168310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648312|NCT01472198|Gemcitabine|gemcitabine|mesh-list
65648313|NCT01472198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65648314|NCT01472198|Antimetabolites|antimetabolites|mesh-ancestor
65648315|NCT01472198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648316|NCT01472198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648317|NCT01472198|Antiviral Agents|antiviral agents|mesh-ancestor
65648318|NCT01472198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65648319|NCT01472198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648320|NCT01472198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65648321|NCT01472198|Immunologic Factors|immunologic factors|mesh-ancestor
65648322|NCT01472198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648323|NCT04444492|Ranibizumab|ranibizumab|mesh-list
65648324|NCT04444492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65648325|NCT04444492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65648326|NCT04444492|Growth Substances|growth substances|mesh-ancestor
65648327|NCT04444492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648328|NCT04444492|Growth Inhibitors|growth inhibitors|mesh-ancestor
65648329|NCT04444492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648330|NCT02269358|Methotrexate|methotrexate|mesh-list
65648331|NCT02269358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65648332|NCT02269358|Abortifacient Agents|abortifacient agents|mesh-ancestor
65648333|NCT02269358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65648334|NCT02269358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648335|NCT02269358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65648336|NCT02269358|Antimetabolites|antimetabolites|mesh-ancestor
65648337|NCT02269358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648338|NCT02269358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648339|NCT02269358|Dermatologic Agents|dermatologic agents|mesh-ancestor
65267794|NCT02657187|Rocuronium|rocuronium|mesh-list
65648340|NCT02269358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648341|NCT02269358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65648342|NCT02269358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65648343|NCT02269358|Immunologic Factors|immunologic factors|mesh-ancestor
65648344|NCT02269358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65648345|NCT02269358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65648346|NCT04504240|Famotidine|famotidine|mesh-list
65648347|NCT04504240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65648348|NCT04504240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65648349|NCT04504240|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65648350|NCT04504240|Histamine Antagonists|histamine antagonists|mesh-ancestor
65648351|NCT04504240|Histamine Agents|histamine agents|mesh-ancestor
65648352|NCT04504240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65648353|NCT04504240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648354|NCT04504240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648355|NCT02088060|Cannabidiol|cannabidiol|mesh-list
65648356|NCT02088060|Olanzapine|olanzapine|mesh-list
65648357|NCT02088060|Antiemetics|antiemetics|mesh-ancestor
65648358|NCT02088060|Autonomic Agents|autonomic agents|mesh-ancestor
65648359|NCT02088060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65648360|NCT02088060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648361|NCT02088060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65648362|NCT02088060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65648363|NCT02088060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65648364|NCT02088060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65648365|NCT02088060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65648366|NCT02088060|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65648367|NCT02088060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65648368|NCT02088060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65648369|NCT02088060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648370|NCT02088060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65648371|NCT02088060|Serotonin Agents|serotonin agents|mesh-ancestor
65648372|NCT02088060|Anticonvulsants|anticonvulsants|mesh-ancestor
65648373|NCT02264522|Dialysis Solutions|dialysis solutions|mesh-list
65648374|NCT02264522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65648375|NCT02269514|Nicotine|nicotine|mesh-list
65648376|NCT02269514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65648377|NCT02269514|Autonomic Agents|autonomic agents|mesh-ancestor
65648378|NCT02269514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65648379|NCT02269514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648380|NCT02269514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65648381|NCT02269514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65648382|NCT02269514|Cholinergic Agents|cholinergic agents|mesh-ancestor
65648383|NCT02269514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65648384|NCT02269514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648385|NCT01332812|Dexamethasone|dexamethasone|mesh-list
65648386|NCT01332812|Dexamethasone acetate|dexamethasone acetate|mesh-list
65648387|NCT01332812|BB 1101|bb 1101|mesh-list
65648388|NCT01332812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65648389|NCT01332812|Antiemetics|antiemetics|mesh-ancestor
65648390|NCT01332812|Autonomic Agents|autonomic agents|mesh-ancestor
65648391|NCT01332812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65648392|NCT01332812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648393|NCT01332812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65648394|NCT01332812|Glucocorticoids|glucocorticoids|mesh-ancestor
65648395|NCT01332812|Hormones|hormones|mesh-ancestor
65648396|NCT01332812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65648397|NCT01332812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65648398|NCT01332812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648399|NCT01332812|Protease Inhibitors|protease inhibitors|mesh-ancestor
65648400|NCT01332812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648401|NCT01332812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648402|NCT03408652|Zoledronic Acid|zoledronic acid|mesh-list
65648403|NCT03408652|Denosumab|denosumab|mesh-list
65648404|NCT03408652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65648405|NCT03408652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648406|NCT01332656|Paclitaxel|paclitaxel|mesh-list
65648407|NCT01332656|Carboplatin|carboplatin|mesh-list
65648408|NCT01332656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65648409|NCT01332656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648410|NCT01332656|Tubulin Modulators|tubulin modulators|mesh-ancestor
65648411|NCT01332656|Antimitotic Agents|antimitotic agents|mesh-ancestor
65648412|NCT01332656|Mitosis Modulators|mitosis modulators|mesh-ancestor
65648413|NCT01332656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648414|NCT02084472|Petrolatum|petrolatum|mesh-list
65648415|NCT02084472|Glycerol|glycerol|mesh-list
65648416|NCT02084472|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65648417|NCT02084472|Protective Agents|protective agents|mesh-ancestor
65648418|NCT02084472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648419|NCT02084472|Emollients|emollients|mesh-ancestor
65648420|NCT02084472|Dermatologic Agents|dermatologic agents|mesh-ancestor
65648421|NCT02266784|Nicotine|nicotine|mesh-list
65648422|NCT02266784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65648423|NCT02266784|Autonomic Agents|autonomic agents|mesh-ancestor
65648424|NCT02266784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65648425|NCT02266784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648426|NCT02266784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65648427|NCT02266784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65648428|NCT02266784|Cholinergic Agents|cholinergic agents|mesh-ancestor
65648429|NCT02266784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65648430|NCT02266784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648431|NCT02090790|Dexamethasone|dexamethasone|mesh-list
65648432|NCT02090790|Dexamethasone acetate|dexamethasone acetate|mesh-list
65648433|NCT02090790|BB 1101|bb 1101|mesh-list
65648434|NCT02090790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65648435|NCT02090790|Antiemetics|antiemetics|mesh-ancestor
65648436|NCT02090790|Autonomic Agents|autonomic agents|mesh-ancestor
65648437|NCT02090790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65648438|NCT02090790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648439|NCT02090790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65648440|NCT02090790|Glucocorticoids|glucocorticoids|mesh-ancestor
65648441|NCT02090790|Hormones|hormones|mesh-ancestor
65648442|NCT02090790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65648443|NCT02090790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65648444|NCT02090790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648445|NCT02090790|Protease Inhibitors|protease inhibitors|mesh-ancestor
65648446|NCT02090790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648447|NCT02090790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648448|NCT02084550|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
65648449|NCT02084550|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65648450|NCT02084550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65648451|NCT01443728|Vitamin D|vitamin d|mesh-list
65648452|NCT01443728|Ergocalciferols|ergocalciferols|mesh-list
65648453|NCT01443728|Cholecalciferol|cholecalciferol|mesh-list
65648454|NCT01443728|Vitamins|vitamins|mesh-list
65648455|NCT01443728|Micronutrients|micronutrients|mesh-ancestor
65648456|NCT01443728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648457|NCT01443728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65648458|NCT01443728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65648459|NCT01324466|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
65648460|NCT01324466|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
65648461|NCT01324466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648462|NCT01324466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648463|NCT01312454|Travoprost|travoprost|mesh-list
65648464|NCT01312454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65648465|NCT01312454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65648466|NCT02084784|Methylene Blue|methylene blue|mesh-list
65648467|NCT02084784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648468|NCT02084784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648469|NCT03267589|Durvalumab|durvalumab|mesh-list
65648470|NCT03267589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65648471|NCT03267589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648472|NCT02091180|Mannitol|mannitol|mesh-list
65648473|NCT02091180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65648474|NCT02091180|Diuretics|diuretics|mesh-ancestor
65648475|NCT02091180|Natriuretic Agents|natriuretic agents|mesh-ancestor
65648476|NCT02091180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648477|NCT02269748|Analgesics|analgesics|mesh-list
65648478|NCT02269748|Sensory System Agents|sensory system agents|mesh-ancestor
65648479|NCT02269748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65648480|NCT02269748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648481|NCT03149809|Solifenacin Succinate|solifenacin succinate|mesh-list
65648482|NCT03149809|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65648483|NCT03149809|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65648484|NCT03149809|Cholinergic Agents|cholinergic agents|mesh-ancestor
65648485|NCT03149809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65267800|NCT00649779|Albuterol|albuterol|mesh-list
65648486|NCT03149809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648487|NCT03149809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648488|NCT03149809|Urological Agents|urological agents|mesh-ancestor
65648489|NCT04533880|Calcium|calcium|mesh-list
65648490|NCT04533880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65648491|NCT04533880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648492|NCT02269904|Fluorouracil|fluorouracil|mesh-list
65648493|NCT02269904|Antimetabolites|antimetabolites|mesh-ancestor
65648494|NCT02269904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648495|NCT02269904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65648496|NCT02269904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648497|NCT02269904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65648498|NCT02269904|Immunologic Factors|immunologic factors|mesh-ancestor
65648499|NCT02269904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648500|NCT03557112|Nimotuzumab|nimotuzumab|mesh-list
65648501|NCT03557112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648502|NCT03557112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65648503|NCT01300208|CC-11050|cc-11050|mesh-list
65648504|NCT01300208|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65648505|NCT01300208|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65648506|NCT01300208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648507|NCT01300208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648508|NCT02085018|Omeprazole|omeprazole|mesh-list
65648509|NCT02085018|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65648510|NCT02085018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65648511|NCT02085018|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65648512|NCT02085018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648513|NCT02085018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648514|NCT02091336|Metformin|metformin|mesh-list
65648515|NCT02091336|Glyburide|glyburide|mesh-list
65648516|NCT02091336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65648517|NCT02091336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648518|NCT01442090|Everolimus|everolimus|mesh-list
65648519|NCT01442090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648520|NCT01442090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65648521|NCT01442090|Immunologic Factors|immunologic factors|mesh-ancestor
65648522|NCT01442090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648523|NCT04475042|Dapagliflozin|dapagliflozin|mesh-list
65648524|NCT04475042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65648525|NCT04475042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648526|NCT04475042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65648527|NCT04475042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648528|NCT02088450|Nitrendipine|nitrendipine|mesh-list
65648529|NCT02088450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65648530|NCT02088450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65648531|NCT02088450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65648532|NCT02088450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648533|NCT02088450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65648534|NCT02088450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648535|NCT02088450|Vasodilator Agents|vasodilator agents|mesh-ancestor
65648536|NCT03688828|Amoxicillin|amoxicillin|mesh-list
65648537|NCT03688828|Clarithromycin|clarithromycin|mesh-list
65648538|NCT03688828|Potassium Citrate|potassium citrate|mesh-list
65648539|NCT03688828|Esomeprazole|esomeprazole|mesh-list
65648540|NCT03688828|Bismuth|bismuth|mesh-list
65648541|NCT03688828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648542|NCT03688828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65648543|NCT03688828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65648544|NCT03688828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65648545|NCT03688828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65648546|NCT03688828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65648547|NCT03688828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648548|NCT03688828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65648549|NCT03688828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65648550|NCT03688828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65648551|NCT03688828|Antacids|antacids|mesh-ancestor
65648552|NCT03688828|Diuretics|diuretics|mesh-ancestor
65648553|NCT03688828|Natriuretic Agents|natriuretic agents|mesh-ancestor
65648554|NCT03688828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648555|NCT03688828|Expectorants|expectorants|mesh-ancestor
65648556|NCT03688828|Respiratory System Agents|respiratory system agents|mesh-ancestor
65648557|NCT02091492|Teriparatide|teriparatide|mesh-list
65267801|NCT00649779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65648558|NCT02091492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65648559|NCT02091492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648560|NCT02091492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65648561|NCT02266940|DS-1971a|ds-1971a|mesh-list
65648562|NCT02266940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65648563|NCT02266940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65648564|NCT02266940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65648565|NCT02266940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648566|NCT03981952|Vaccines|vaccines|mesh-list
65648567|NCT03981952|Immunologic Factors|immunologic factors|mesh-ancestor
65648568|NCT03981952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648570|NCT04475120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65648571|NCT02088528|Mitomycins|mitomycins|mesh-list
65648572|NCT02088528|Mitomycin|mitomycin|mesh-list
65648573|NCT02088528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65648574|NCT02088528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648575|NCT02088528|Alkylating Agents|alkylating agents|mesh-ancestor
65648576|NCT02088528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648577|NCT02088528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65648578|NCT02088528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648579|NCT03634150|Doxorubicin|doxorubicin|mesh-list
65648580|NCT03634150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65648581|NCT03634150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648582|NCT03634150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65648583|NCT03634150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65648584|NCT03634150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648585|NCT03634150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648586|NCT02092038|Temozolomide|temozolomide|mesh-list
65648587|NCT02092038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65648588|NCT02092038|Alkylating Agents|alkylating agents|mesh-ancestor
65648589|NCT02092038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648590|NCT02092038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648591|NCT02272166|Propofol|propofol|mesh-list
65648592|NCT02272166|Sevoflurane|sevoflurane|mesh-list
65648593|NCT02272166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65648594|NCT02272166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65648595|NCT02272166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648596|NCT02272166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65648597|NCT02272166|Anesthetics, General|anesthetics, general|mesh-ancestor
65648598|NCT02272166|Anesthetics|anesthetics|mesh-ancestor
65648599|NCT02272166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65648600|NCT02272166|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65648601|NCT02088684|Fulvestrant|fulvestrant|mesh-list
65648602|NCT02088684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65648603|NCT02088684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648604|NCT02088684|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65648605|NCT02088684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65648606|NCT02088684|Hormone Antagonists|hormone antagonists|mesh-ancestor
65648607|NCT02088684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65648608|NCT02088684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648609|NCT01137968|Bevacizumab|bevacizumab|mesh-list
65648610|NCT01137968|Imetelstat|imetelstat|mesh-list
65648611|NCT01137968|Motesanib diphosphate|motesanib diphosphate|mesh-list
65648612|NCT01137968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65648613|NCT01137968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648614|NCT01137968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65648615|NCT01137968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65648616|NCT01137968|Growth Substances|growth substances|mesh-ancestor
65648617|NCT01137968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648618|NCT01137968|Growth Inhibitors|growth inhibitors|mesh-ancestor
65648619|NCT01137968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648620|NCT01137968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648621|NCT01137968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65648622|NCT01133990|Leucovorin|leucovorin|mesh-list
65648623|NCT01133990|Bevacizumab|bevacizumab|mesh-list
65648624|NCT01133990|Fluorouracil|fluorouracil|mesh-list
65648625|NCT01133990|Irinotecan|irinotecan|mesh-list
65648626|NCT01133990|Calcium|calcium|mesh-list
65648627|NCT01133990|Levoleucovorin|levoleucovorin|mesh-list
65648628|NCT01133990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65648629|NCT01133990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648630|NCT01133990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65648631|NCT01133990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65648632|NCT01133990|Growth Substances|growth substances|mesh-ancestor
65648633|NCT01133990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648634|NCT01133990|Growth Inhibitors|growth inhibitors|mesh-ancestor
65648635|NCT01133990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65648636|NCT01133990|Antimetabolites|antimetabolites|mesh-ancestor
65648637|NCT01133990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648638|NCT01133990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65648639|NCT01133990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65648640|NCT01133990|Immunologic Factors|immunologic factors|mesh-ancestor
65648641|NCT01133990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65648642|NCT01133990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65648643|NCT01133990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648644|NCT01133990|Antidotes|antidotes|mesh-ancestor
65648645|NCT01133990|Protective Agents|protective agents|mesh-ancestor
65648646|NCT01133990|Vitamin B Complex|vitamin b complex|mesh-ancestor
65648647|NCT01133990|Vitamins|vitamins|mesh-ancestor
65648648|NCT01133990|Micronutrients|micronutrients|mesh-ancestor
65648649|NCT02249910|Metformin|metformin|mesh-list
65648650|NCT02249910|Digoxin|digoxin|mesh-list
65648651|NCT02249910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65648652|NCT02249910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648653|NCT02249910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65648654|NCT02249910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65648655|NCT02249910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648656|NCT02249910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648657|NCT02249910|Protective Agents|protective agents|mesh-ancestor
65648658|NCT02936596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65648659|NCT02936596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65648660|NCT02936596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65648661|NCT02936596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65648662|NCT02936596|Immunologic Factors|immunologic factors|mesh-ancestor
65648663|NCT02936596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648664|NCT02398396|Lactitol|lactitol|mesh-list
65648665|NCT02398396|Cathartics|cathartics|mesh-ancestor
65648666|NCT02398396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65648667|NCT05628584|Metformin|metformin|mesh-list
65648668|NCT05628584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65648669|NCT05628584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648670|NCT02088918|Metformin|metformin|mesh-list
65648671|NCT02088918|Nateglinide|nateglinide|mesh-list
65648672|NCT02088918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65648673|NCT02088918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648674|NCT02419378|Alemtuzumab|alemtuzumab|mesh-list
65648675|NCT02419378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65648676|NCT02419378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648677|NCT02092428|Adenosine|adenosine|mesh-list
65648678|NCT02092428|Regadenoson|regadenoson|mesh-list
65648679|NCT02092428|Analgesics|analgesics|mesh-ancestor
65648680|NCT02092428|Sensory System Agents|sensory system agents|mesh-ancestor
65648681|NCT02092428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65648682|NCT02092428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648683|NCT02092428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65648684|NCT02092428|Vasodilator Agents|vasodilator agents|mesh-ancestor
65648685|NCT02092428|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65648686|NCT02092428|Purinergic Agonists|purinergic agonists|mesh-ancestor
65648687|NCT02092428|Purinergic Agents|purinergic agents|mesh-ancestor
65648688|NCT02092428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65648689|NCT02092428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648690|NCT02092428|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65648691|NCT02783404|Amoxicillin|amoxicillin|mesh-list
65648692|NCT02783404|Clavulanic Acid|clavulanic acid|mesh-list
65648693|NCT02783404|Clavulanic Acids|clavulanic acids|mesh-list
65648694|NCT02783404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65648695|NCT02783404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65648696|NCT02783404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65648697|NCT02783404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648698|NCT02783404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648699|NCT01097018|Capecitabine|capecitabine|mesh-list
65648700|NCT01097018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65648701|NCT01097018|Antimetabolites|antimetabolites|mesh-ancestor
65648702|NCT01097018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648703|NCT01097018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648704|NCT01096862|Peficitinib|peficitinib|mesh-list
65648705|NCT01096862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648706|NCT01096862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648707|NCT01096862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65648708|NCT01096862|Immunologic Factors|immunologic factors|mesh-ancestor
65648709|NCT01096862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648710|NCT02092506|Amoxicillin|amoxicillin|mesh-list
65648711|NCT02092506|Metronidazole|metronidazole|mesh-list
65648712|NCT02092506|Clarithromycin|clarithromycin|mesh-list
65648713|NCT02092506|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65648714|NCT02092506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65648715|NCT02092506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65446092|NCT01070030|Vasodilator Agents|vasodilator agents|mesh-ancestor
65648716|NCT02092506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65648717|NCT02092506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65648718|NCT02092506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65648719|NCT02092506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648720|NCT02092506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648721|NCT02092506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65648722|NCT02092506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65648723|NCT01092104|Cenicriviroc|cenicriviroc|mesh-list
65648724|NCT01092104|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65648725|NCT01092104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648726|NCT01092104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65648727|NCT01092104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65648728|NCT01092104|Antiviral Agents|antiviral agents|mesh-ancestor
65648729|NCT01092104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65648730|NCT01128530|Linezolid|linezolid|mesh-list
65648731|NCT01128530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65648732|NCT01128530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65648733|NCT01128530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65648734|NCT01128530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648735|NCT01128530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648736|NCT02086032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65648737|NCT02086032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65648738|NCT02086032|Estradiol|estradiol|mesh-list
65648739|NCT02086032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65648740|NCT02086032|Estrogens|estrogens|mesh-list
65648741|NCT02086032|Progesterone|progesterone|mesh-list
65648742|NCT02086032|Dydrogesterone|dydrogesterone|mesh-list
65648743|NCT02086032|Hormones|hormones|mesh-ancestor
65648744|NCT02086032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65648745|NCT02086032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648746|NCT02086032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65648747|NCT02086032|Contraceptive Agents|contraceptive agents|mesh-ancestor
65648748|NCT02086032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65648749|NCT02086032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65648750|NCT02086032|Progestins|progestins|mesh-ancestor
65648751|NCT02092818|Riociguat|riociguat|mesh-list
65648752|NCT02092818|Enzyme Activators|enzyme activators|mesh-ancestor
65648753|NCT02092818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648754|NCT02086188|Mirabegron|mirabegron|mesh-list
65648755|NCT02086188|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65648756|NCT02086188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65648757|NCT02086188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65648758|NCT02086188|Adrenergic Agents|adrenergic agents|mesh-ancestor
65648759|NCT02086188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65648760|NCT02086188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648761|NCT02086188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648762|NCT02086188|Urological Agents|urological agents|mesh-ancestor
65648763|NCT02267408|Warfarin|warfarin|mesh-list
65648764|NCT02267408|Anticoagulants|anticoagulants|mesh-ancestor
65648765|NCT02092896|Liraglutide|liraglutide|mesh-list
65648766|NCT02092896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65648767|NCT02092896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648768|NCT02092896|Incretins|incretins|mesh-ancestor
65648769|NCT02092896|Hormones|hormones|mesh-ancestor
65648770|NCT02092896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65648771|NCT02092974|Citalopram|citalopram|mesh-list
65648772|NCT02092974|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65648773|NCT02092974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65648774|NCT02092974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65648775|NCT02092974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648776|NCT02092974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65648777|NCT02092974|Serotonin Agents|serotonin agents|mesh-ancestor
65648778|NCT02092974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648779|NCT02092974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65648780|NCT02092974|Antidepressive Agents|antidepressive agents|mesh-ancestor
65648781|NCT02092974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65648782|NCT05097508|Bromides|bromides|mesh-list
65648783|NCT05097508|Rocuronium|rocuronium|mesh-list
65648784|NCT05097508|Atracurium|atracurium|mesh-list
65648785|NCT05097508|Anticonvulsants|anticonvulsants|mesh-ancestor
65648786|NCT05097508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65648787|NCT05097508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65648788|NCT05097508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65648789|NCT05097508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65648790|NCT05097508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648791|NCT05097508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65648792|NCT05097508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65446164|NCT01062932|Antimetabolites|antimetabolites|mesh-ancestor
65648793|NCT05097508|Cholinergic Agents|cholinergic agents|mesh-ancestor
65648794|NCT05097508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65648795|NCT05097508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648796|NCT02089308|Nicotine|nicotine|mesh-list
65648797|NCT02089308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65648798|NCT02089308|Autonomic Agents|autonomic agents|mesh-ancestor
65648799|NCT02089308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65648800|NCT02089308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648801|NCT02089308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65648802|NCT02089308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65648803|NCT02089308|Cholinergic Agents|cholinergic agents|mesh-ancestor
65648804|NCT02089308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65648805|NCT02089308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648806|NCT00153920|Bortezomib|bortezomib|mesh-list
65648807|NCT00153920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648808|NCT05095714|Liver Extracts|liver extracts|mesh-list
65648809|NCT05095714|Hematinics|hematinics|mesh-ancestor
65648810|NCT02660242|Glucagon|glucagon|mesh-list
65648811|NCT02660242|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65648812|NCT02660242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648813|NCT02660242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65648814|NCT02660242|Hormones|hormones|mesh-ancestor
65648815|NCT02660242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65648816|NCT02660242|Incretins|incretins|mesh-ancestor
65648817|NCT02089386|Tamoxifen|tamoxifen|mesh-list
65648818|NCT02089386|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65648819|NCT02089386|Hormone Antagonists|hormone antagonists|mesh-ancestor
65648820|NCT02089386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65648821|NCT02089386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648822|NCT02089386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65648823|NCT02089386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648824|NCT02089386|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65648825|NCT02089386|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65648826|NCT02089386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65648827|NCT05628038|Capecitabine|capecitabine|mesh-list
65648828|NCT05628038|Oxaliplatin|oxaliplatin|mesh-list
65648829|NCT05628038|Antibodies|antibodies|mesh-list
65648830|NCT05628038|Immunologic Factors|immunologic factors|mesh-ancestor
65648831|NCT05628038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648832|NCT05628038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65648833|NCT05628038|Antimetabolites|antimetabolites|mesh-ancestor
65648834|NCT05628038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648835|NCT05628038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648836|NCT03557580|Isosorbide|isosorbide|mesh-list
65648837|NCT03557580|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65648838|NCT03557580|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65648839|NCT03557580|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65648840|NCT03557580|Diuretics|diuretics|mesh-ancestor
65648841|NCT03557580|Natriuretic Agents|natriuretic agents|mesh-ancestor
65648842|NCT03557580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648843|NCT03557580|Vasodilator Agents|vasodilator agents|mesh-ancestor
65648844|NCT03557580|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65648845|NCT03557580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648846|NCT02089542|Methylene Blue|methylene blue|mesh-list
65648847|NCT02089542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648848|NCT02089542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648849|NCT01295060|Octreotide|octreotide|mesh-list
65648850|NCT01295060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65648851|NCT01295060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65648852|NCT01295060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648853|NCT02086656|Bevacizumab|bevacizumab|mesh-list
65648854|NCT02086656|Capecitabine|capecitabine|mesh-list
65648855|NCT02086656|Oxaliplatin|oxaliplatin|mesh-list
65648856|NCT02086656|Irinotecan|irinotecan|mesh-list
65648857|NCT02086656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65648858|NCT02086656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648859|NCT02086656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65648860|NCT02086656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65648861|NCT02086656|Growth Substances|growth substances|mesh-ancestor
65648862|NCT02086656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648863|NCT02086656|Growth Inhibitors|growth inhibitors|mesh-ancestor
65648864|NCT02086656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65648865|NCT02086656|Antimetabolites|antimetabolites|mesh-ancestor
65648866|NCT02086656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648867|NCT02086656|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65648868|NCT02086656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65648869|NCT02086656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648870|NCT01294202|Imatinib Mesylate|imatinib mesylate|mesh-list
65648871|NCT01294202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648872|NCT01294202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65648873|NCT01294202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648874|NCT01294202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648875|NCT01071902|Moxifloxacin|moxifloxacin|mesh-list
65648876|NCT01071902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65648877|NCT01071902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65648878|NCT01071902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65648879|NCT01071902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65648880|NCT01071902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65648881|NCT01071902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648882|NCT01071902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648883|NCT01071902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648884|NCT01126970|Orlistat|orlistat|mesh-list
65648885|NCT01126970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648886|NCT01126970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648887|NCT01126970|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65648888|NCT01126970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65648889|NCT03557424|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
65648890|NCT03557424|Cathartics|cathartics|mesh-ancestor
65648891|NCT03557424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65648892|NCT05057572|Carvedilol|carvedilol|mesh-list
65648893|NCT05057572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65648894|NCT05057572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65648895|NCT05057572|Adrenergic Agents|adrenergic agents|mesh-ancestor
65648896|NCT05057572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65648897|NCT05057572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648898|NCT05057572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648899|NCT05057572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65648900|NCT05057572|Antioxidants|antioxidants|mesh-ancestor
65648901|NCT05057572|Protective Agents|protective agents|mesh-ancestor
65648902|NCT05057572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65648903|NCT05057572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65648904|NCT05057572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65648905|NCT05057572|Vasodilator Agents|vasodilator agents|mesh-ancestor
65648906|NCT05057572|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65648907|NCT05057572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65648908|NCT02093598|Sirolimus|sirolimus|mesh-list
65648909|NCT02093598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65648910|NCT02093598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65648911|NCT02093598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65648912|NCT02093598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648913|NCT02093598|Antifungal Agents|antifungal agents|mesh-ancestor
65648914|NCT02093598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65648915|NCT02093598|Immunologic Factors|immunologic factors|mesh-ancestor
65648916|NCT02093598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648917|NCT01124552|Botulinum Toxins|botulinum toxins|mesh-list
65648918|NCT01124552|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65648919|NCT01124552|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65648920|NCT01124552|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65648921|NCT01124552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65648922|NCT01124552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648923|NCT01124552|Cholinergic Agents|cholinergic agents|mesh-ancestor
65648924|NCT01124552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65648925|NCT01124552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648926|NCT01124552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65648927|NCT01124552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65648928|NCT02621944|Melatonin|melatonin|mesh-list
65648929|NCT02621944|Antioxidants|antioxidants|mesh-ancestor
65648930|NCT02621944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648931|NCT02621944|Protective Agents|protective agents|mesh-ancestor
65648932|NCT02621944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648933|NCT02621944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65648934|NCT02087202|Magnesium Sulfate|magnesium sulfate|mesh-list
65648935|NCT02087202|Ketamine|ketamine|mesh-list
65648936|NCT02087202|Analgesics|analgesics|mesh-ancestor
65648937|NCT02087202|Sensory System Agents|sensory system agents|mesh-ancestor
65648938|NCT02087202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65648939|NCT02087202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648940|NCT02087202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65648941|NCT02087202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65648942|NCT02087202|Anesthetics, General|anesthetics, general|mesh-ancestor
65648943|NCT02087202|Anesthetics|anesthetics|mesh-ancestor
65648944|NCT02087202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65648945|NCT02087202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65648946|NCT02087202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65648947|NCT02087202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65648948|NCT02087202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648949|NCT02087202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65648950|NCT02087202|Anticonvulsants|anticonvulsants|mesh-ancestor
65648951|NCT02087202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65648952|NCT02087202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65648953|NCT02087202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65648954|NCT02087202|Tocolytic Agents|tocolytic agents|mesh-ancestor
65648955|NCT02087202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65648956|NCT01283594|Levodopa|levodopa|mesh-list
65648957|NCT01283594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65648958|NCT01283594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65648959|NCT01283594|Dopamine Agents|dopamine agents|mesh-ancestor
65648960|NCT01283594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65648961|NCT01283594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648962|NCT01283594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648963|NCT01281254|Trebananib|trebananib|mesh-list
65648964|NCT01281254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65648965|NCT01281254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65648966|NCT01281254|Growth Substances|growth substances|mesh-ancestor
65648967|NCT01281254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648968|NCT01281254|Growth Inhibitors|growth inhibitors|mesh-ancestor
65648969|NCT01281254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648970|NCT05104138|Eplerenone|eplerenone|mesh-list
65648971|NCT05104138|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65648972|NCT05104138|Hormone Antagonists|hormone antagonists|mesh-ancestor
65648973|NCT05104138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65648974|NCT05104138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648975|NCT05104138|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65648976|NCT05104138|Diuretics|diuretics|mesh-ancestor
65648977|NCT05104138|Natriuretic Agents|natriuretic agents|mesh-ancestor
65648978|NCT05104138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65648979|NCT03072043|Azacitidine|azacitidine|mesh-list
65648980|NCT03072043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65648981|NCT03072043|Antimetabolites|antimetabolites|mesh-ancestor
65648982|NCT03072043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648983|NCT03072043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65648984|NCT03072043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648985|NCT05626010|Acetaminophen|acetaminophen|mesh-list
65648986|NCT05626010|Ibuprofen|ibuprofen|mesh-list
65648987|NCT05626010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65648988|NCT05626010|Analgesics|analgesics|mesh-ancestor
65648989|NCT05626010|Sensory System Agents|sensory system agents|mesh-ancestor
65648990|NCT05626010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65648991|NCT05626010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65648992|NCT05626010|Antipyretics|antipyretics|mesh-ancestor
65648993|NCT05626010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65648994|NCT05626010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65648995|NCT05626010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65648996|NCT05626010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65648997|NCT05626010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65648998|NCT05626010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65648999|NCT02089854|Toremifene|toremifene|mesh-list
65649000|NCT02089854|Anastrozole|anastrozole|mesh-list
65649001|NCT02089854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65649002|NCT02089854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649003|NCT02089854|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65649004|NCT02089854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65649005|NCT02089854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65649006|NCT02089854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649007|NCT02089854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65649008|NCT02089854|Hormone Antagonists|hormone antagonists|mesh-ancestor
65649009|NCT02089854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65649010|NCT02089854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649011|NCT02089854|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65649012|NCT02089854|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65649013|NCT02089854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65649014|NCT05624840|Ritonavir|ritonavir|mesh-list
65649015|NCT05624840|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65649016|NCT05624840|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65649017|NCT05624840|Protease Inhibitors|protease inhibitors|mesh-ancestor
65649018|NCT05624840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65649019|NCT05624840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649020|NCT05624840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65649021|NCT05624840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65649022|NCT05624840|Antiviral Agents|antiviral agents|mesh-ancestor
65649023|NCT05624840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65649024|NCT05624840|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65649025|NCT05624840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65649026|NCT02093910|Dexamethasone|dexamethasone|mesh-list
65649027|NCT02093910|Bortezomib|bortezomib|mesh-list
65649028|NCT02093910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65649029|NCT02093910|Antiemetics|antiemetics|mesh-ancestor
65649030|NCT02093910|Autonomic Agents|autonomic agents|mesh-ancestor
65649031|NCT02093910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65649032|NCT02093910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649033|NCT02093910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65649034|NCT02093910|Glucocorticoids|glucocorticoids|mesh-ancestor
65649035|NCT02093910|Hormones|hormones|mesh-ancestor
65649036|NCT02093910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65649037|NCT02093910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65649038|NCT02093910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649039|NCT04437160|Cyclophosphamide|cyclophosphamide|mesh-list
65649040|NCT04437160|Epirubicin|epirubicin|mesh-list
65649041|NCT04437160|Pirarubicin|pirarubicin|mesh-list
65649042|NCT04437160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65649043|NCT04437160|Immunologic Factors|immunologic factors|mesh-ancestor
65649044|NCT04437160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649045|NCT04437160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65649046|NCT04437160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65649047|NCT04437160|Alkylating Agents|alkylating agents|mesh-ancestor
65649048|NCT04437160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649049|NCT04437160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649050|NCT04437160|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65649051|NCT04437160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65649052|NCT04437160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65649053|NCT04437160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65649054|NCT04437160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65649055|NCT02089932|Dexmedetomidine|dexmedetomidine|mesh-list
65649056|NCT02089932|Bupivacaine|bupivacaine|mesh-list
65649057|NCT02089932|Anesthetics, Local|anesthetics, local|mesh-ancestor
65649058|NCT02089932|Anesthetics|anesthetics|mesh-ancestor
65649059|NCT02089932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65649060|NCT02089932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649061|NCT02089932|Sensory System Agents|sensory system agents|mesh-ancestor
65649062|NCT02089932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65649063|NCT02089932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65649064|NCT02089932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65649065|NCT02089932|Analgesics|analgesics|mesh-ancestor
65649066|NCT02089932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65649067|NCT02089932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65649068|NCT02089932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65649069|NCT02089932|Adrenergic Agents|adrenergic agents|mesh-ancestor
65649070|NCT02089932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65649071|NCT02089932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649072|NCT01037036|Latanoprost|latanoprost|mesh-list
65649073|NCT01037036|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65649074|NCT01037036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65649075|NCT05204641|Rifaximin|rifaximin|mesh-list
65649076|NCT05204641|Levodopa|levodopa|mesh-list
65649077|NCT05204641|Benserazide|benserazide|mesh-list
65649078|NCT05204641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65649079|NCT05204641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65649080|NCT05204641|Dopamine Agents|dopamine agents|mesh-ancestor
65649081|NCT05204641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65649082|NCT05204641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649083|NCT05204641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649084|NCT05204641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65649085|NCT05204641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65649086|NCT05204641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65649087|NCT05204641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446479|NCT00459953|Nicotine|nicotine|mesh-list
65649088|NCT03069313|Vitamin B 12|vitamin b 12|mesh-list
65649089|NCT03069313|Hydroxocobalamin|hydroxocobalamin|mesh-list
65649090|NCT03069313|Vitamins|vitamins|mesh-ancestor
65649091|NCT03069313|Micronutrients|micronutrients|mesh-ancestor
65649092|NCT03069313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649093|NCT03069313|Vitamin B Complex|vitamin b complex|mesh-ancestor
65649094|NCT03069313|Hematinics|hematinics|mesh-ancestor
65649095|NCT02094066|Tranexamic Acid|tranexamic acid|mesh-list
65649096|NCT02094066|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65649097|NCT02094066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65649098|NCT02094066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649099|NCT02094066|Hemostatics|hemostatics|mesh-ancestor
65649100|NCT02094066|Coagulants|coagulants|mesh-ancestor
65649101|NCT01033292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65649102|NCT01033292|Iniparib|iniparib|mesh-list
65649103|NCT01033292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65649104|NCT01033292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649105|NCT01033292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649106|NCT03068767|Vitamin D|vitamin d|mesh-list
65649107|NCT03068767|Vitamins|vitamins|mesh-ancestor
65649108|NCT03068767|Micronutrients|micronutrients|mesh-ancestor
65649109|NCT03068767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649110|NCT03068767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65649111|NCT02267720|Salicylic Acid|salicylic acid|mesh-list
65649112|NCT02267720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65649113|NCT02267720|Antifungal Agents|antifungal agents|mesh-ancestor
65649114|NCT02267720|Keratolytic Agents|keratolytic agents|mesh-ancestor
65649115|NCT02267720|Dermatologic Agents|dermatologic agents|mesh-ancestor
65649116|NCT05204329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65649117|NCT05204329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65649118|NCT01110902|S 20098|s 20098|mesh-list
65649119|NCT01110902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65649120|NCT01110902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65649121|NCT01110902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649122|NCT05204173|Paclitaxel|paclitaxel|mesh-list
65649123|NCT05204173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65649124|NCT05204173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649125|NCT05204173|Tubulin Modulators|tubulin modulators|mesh-ancestor
65649126|NCT05204173|Antimitotic Agents|antimitotic agents|mesh-ancestor
65649127|NCT05204173|Mitosis Modulators|mitosis modulators|mesh-ancestor
65649128|NCT05204173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649129|NCT01025648|Epinephrine|epinephrine|mesh-list
65649130|NCT01025648|Racepinephrine|racepinephrine|mesh-list
65649131|NCT01025648|Epinephryl borate|epinephryl borate|mesh-list
65649132|NCT01025648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65649133|NCT01025648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65649134|NCT01025648|Adrenergic Agents|adrenergic agents|mesh-ancestor
65649135|NCT01025648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65649136|NCT01025648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649137|NCT01025648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649138|NCT01025648|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65649139|NCT01025648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65649140|NCT01025648|Autonomic Agents|autonomic agents|mesh-ancestor
65649141|NCT01025648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65649142|NCT01025648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65649143|NCT01025648|Respiratory System Agents|respiratory system agents|mesh-ancestor
65649144|NCT01025648|Mydriatics|mydriatics|mesh-ancestor
65649145|NCT01025648|Sympathomimetics|sympathomimetics|mesh-ancestor
65649146|NCT01025648|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65649147|NCT01110746|Insulin|insulin|mesh-list
65649148|NCT01110746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65649149|NCT01110746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65649150|NCT01110746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649151|NCT05622968|Dinoprostone|dinoprostone|mesh-list
65649152|NCT05622968|Oxytocics|oxytocics|mesh-ancestor
65649153|NCT05622968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65649154|NCT05622968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649155|NCT02268032|Androgens|androgens|mesh-list
65649156|NCT02268032|Hormones|hormones|mesh-ancestor
65649157|NCT02268032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65649158|NCT02268032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649159|NCT03019965|Meropenem|meropenem|mesh-list
65649160|NCT03019965|Tazobactam|tazobactam|mesh-list
65649161|NCT03019965|Piperacillin|piperacillin|mesh-list
65649162|NCT03019965|Imipenem|imipenem|mesh-list
65649163|NCT03019965|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65649164|NCT03019965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65446546|NCT00065182|Docetaxel|docetaxel|mesh-list
65649165|NCT03019965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65649166|NCT03019965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65649167|NCT03019965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65649168|NCT03019965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649170|NCT01468831|Bevacizumab|bevacizumab|mesh-list
65649171|NCT01468831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65649172|NCT01468831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649173|NCT01468831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65649174|NCT01468831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65649175|NCT01468831|Growth Substances|growth substances|mesh-ancestor
65649176|NCT01468831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649177|NCT01468831|Growth Inhibitors|growth inhibitors|mesh-ancestor
65649178|NCT01468831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65649179|NCT01468831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65649180|NCT04475276|Thioctic Acid|thioctic acid|mesh-list
65649181|NCT04475276|Antioxidants|antioxidants|mesh-ancestor
65649182|NCT04475276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649183|NCT04475276|Protective Agents|protective agents|mesh-ancestor
65649184|NCT04475276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649185|NCT04475276|Vitamin B Complex|vitamin b complex|mesh-ancestor
65649186|NCT04475276|Vitamins|vitamins|mesh-ancestor
65649187|NCT04475276|Micronutrients|micronutrients|mesh-ancestor
65649188|NCT05627414|Paclitaxel|paclitaxel|mesh-list
65649189|NCT05627414|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65649190|NCT05627414|Tegafur|tegafur|mesh-list
65649191|NCT05627414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65649192|NCT05627414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649193|NCT05627414|Tubulin Modulators|tubulin modulators|mesh-ancestor
65649194|NCT05627414|Antimitotic Agents|antimitotic agents|mesh-ancestor
65649195|NCT05627414|Mitosis Modulators|mitosis modulators|mesh-ancestor
65649196|NCT05627414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649197|NCT05627414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65649198|NCT05627414|Antimetabolites|antimetabolites|mesh-ancestor
65649199|NCT05617508|Niacinamide|niacinamide|mesh-list
65649200|NCT05617508|Niacin|niacin|mesh-list
65649201|NCT05617508|Nicotinic Acids|nicotinic acids|mesh-list
65649202|NCT05617508|Vitamin B Complex|vitamin b complex|mesh-ancestor
65649203|NCT05617508|Vitamins|vitamins|mesh-ancestor
65649204|NCT05617508|Micronutrients|micronutrients|mesh-ancestor
65649205|NCT05617508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649206|NCT05617508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65649207|NCT05617508|Antimetabolites|antimetabolites|mesh-ancestor
65267823|NCT02536911|Eliglustat|eliglustat|mesh-list
65649208|NCT05617508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649209|NCT05617508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65649210|NCT05617508|Vasodilator Agents|vasodilator agents|mesh-ancestor
65649211|NCT03018249|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65649212|NCT03018249|Entinostat|entinostat|mesh-list
65649213|NCT03018249|Medroxyprogesterone|medroxyprogesterone|mesh-list
65649214|NCT03018249|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65649215|NCT03018249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65649216|NCT03018249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65649217|NCT03018249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65649218|NCT03018249|Contraceptive Agents|contraceptive agents|mesh-ancestor
65649219|NCT03018249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65649220|NCT03018249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649221|NCT03018249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65649222|NCT03018249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65649223|NCT03018249|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65649224|NCT03018249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65649225|NCT03018249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649226|NCT03018249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65649227|NCT03018249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649228|NCT05380154|Botulinum Toxins|botulinum toxins|mesh-list
65649229|NCT05380154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65649230|NCT05380154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65649231|NCT05380154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65649232|NCT05380154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65649233|NCT05380154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649234|NCT05380154|Cholinergic Agents|cholinergic agents|mesh-ancestor
65649235|NCT05380154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65649236|NCT05380154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649237|NCT05380154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65649238|NCT05380154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65649239|NCT05374252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65649240|NCT05374252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649241|NCT05374252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649242|NCT04602975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65649243|NCT04602975|Vaccines|vaccines|mesh-list
65649244|NCT04602975|Immunologic Factors|immunologic factors|mesh-ancestor
65649245|NCT04602975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649246|NCT04602975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65649247|NCT04602975|Antacids|antacids|mesh-ancestor
65649248|NCT04602975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649249|NCT04602975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65649250|NCT00905606|Topiramate|topiramate|mesh-list
65649251|NCT00905606|Anticonvulsants|anticonvulsants|mesh-ancestor
65649252|NCT00905606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65649253|NCT00905606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649254|NCT03017235|Picosulfate sodium|picosulfate sodium|mesh-list
65649255|NCT03017235|Magnesium Oxide|magnesium oxide|mesh-list
65649256|NCT03017235|Sodium Citrate|sodium citrate|mesh-list
65649257|NCT03017235|Citric Acid|citric acid|mesh-list
65649258|NCT03017235|Anticoagulants|anticoagulants|mesh-ancestor
65649259|NCT03017235|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65649260|NCT03017235|Chelating Agents|chelating agents|mesh-ancestor
65649261|NCT03017235|Sequestering Agents|sequestering agents|mesh-ancestor
65649262|NCT03017235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649263|NCT03017235|Cathartics|cathartics|mesh-ancestor
65649264|NCT03017235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65649265|NCT03017235|Antacids|antacids|mesh-ancestor
65649266|NCT05191784|Bevacizumab|bevacizumab|mesh-list
65649267|NCT05191784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65649268|NCT05191784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649269|NCT05191784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65649270|NCT05191784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65649271|NCT05191784|Growth Substances|growth substances|mesh-ancestor
65649272|NCT05191784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649273|NCT05191784|Growth Inhibitors|growth inhibitors|mesh-ancestor
65649274|NCT05048134|Trametinib|trametinib|mesh-list
65649275|NCT05048134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649276|NCT05048134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65649277|NCT05048134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65649278|NCT05048134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649279|NCT04438928|Micronutrients|micronutrients|mesh-list
65649280|NCT04438928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649281|NCT03667677|Amlodipine|amlodipine|mesh-list
65649282|NCT03667677|Tandospirone|tandospirone|mesh-list
65649283|NCT03667677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65649284|NCT03667677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65649285|NCT03667677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65649286|NCT03667677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649287|NCT03667677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65649288|NCT03667677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649289|NCT03667677|Vasodilator Agents|vasodilator agents|mesh-ancestor
65649290|NCT03667677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65649291|NCT03667677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65649292|NCT03667677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65649293|NCT03667677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65649294|NCT03667677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65649295|NCT03667677|Serotonin Agents|serotonin agents|mesh-ancestor
65649296|NCT03667677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65649297|NCT04588545|Trastuzumab|trastuzumab|mesh-list
65649298|NCT04588545|Pertuzumab|pertuzumab|mesh-list
65649299|NCT04588545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65649300|NCT04588545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649301|NCT04176718|Dexamethasone|dexamethasone|mesh-list
65649302|NCT04176718|Daratumumab|daratumumab|mesh-list
65649303|NCT04176718|Pomalidomide|pomalidomide|mesh-list
65649304|NCT04176718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65649305|NCT04176718|Antiemetics|antiemetics|mesh-ancestor
65649306|NCT04176718|Autonomic Agents|autonomic agents|mesh-ancestor
65649307|NCT04176718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65649308|NCT04176718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649309|NCT04176718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65649310|NCT04176718|Glucocorticoids|glucocorticoids|mesh-ancestor
65649311|NCT04176718|Hormones|hormones|mesh-ancestor
65649312|NCT04176718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65649313|NCT04176718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65649314|NCT04176718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649315|NCT04176718|Immunologic Factors|immunologic factors|mesh-ancestor
65649316|NCT04176718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65649317|NCT04176718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65649318|NCT04176718|Growth Substances|growth substances|mesh-ancestor
65649319|NCT04176718|Growth Inhibitors|growth inhibitors|mesh-ancestor
65649321|NCT02880371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65649322|NCT02880371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649323|NCT00813956|Gemcitabine|gemcitabine|mesh-list
65649324|NCT00813956|Carboplatin|carboplatin|mesh-list
65649325|NCT00813956|Iniparib|iniparib|mesh-list
65649326|NCT00813956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649327|NCT00813956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65649328|NCT00813956|Antimetabolites|antimetabolites|mesh-ancestor
65649329|NCT00813956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649330|NCT00813956|Antiviral Agents|antiviral agents|mesh-ancestor
65649331|NCT00813956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65649332|NCT00813956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65649333|NCT00813956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65649334|NCT00813956|Immunologic Factors|immunologic factors|mesh-ancestor
65649335|NCT00813956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649336|NCT00813956|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65649337|NCT01002248|Dexamethasone|dexamethasone|mesh-list
65649338|NCT01002248|Bortezomib|bortezomib|mesh-list
65649339|NCT01002248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65649340|NCT01002248|Antiemetics|antiemetics|mesh-ancestor
65649341|NCT01002248|Autonomic Agents|autonomic agents|mesh-ancestor
65649342|NCT01002248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65649343|NCT01002248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649344|NCT01002248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65649345|NCT01002248|Glucocorticoids|glucocorticoids|mesh-ancestor
65649346|NCT01002248|Hormones|hormones|mesh-ancestor
65649347|NCT01002248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65649348|NCT01002248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65649349|NCT01002248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649350|NCT02837029|Nivolumab|nivolumab|mesh-list
65649351|NCT02837029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65649352|NCT02837029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649353|NCT02837029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65649354|NCT02837029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649355|NCT03667131|Enalapril|enalapril|mesh-list
65649356|NCT03667131|Enalaprilat|enalaprilat|mesh-list
65649357|NCT03667131|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65649358|NCT03667131|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65649359|NCT03667131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649360|NCT03667131|Protease Inhibitors|protease inhibitors|mesh-ancestor
65649361|NCT03667131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65649362|NCT04532710|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65649363|NCT04532710|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65649364|NCT02642965|Cytarabine|cytarabine|mesh-list
65649365|NCT02642965|Fludarabine|fludarabine|mesh-list
65649366|NCT02642965|Fludarabine phosphate|fludarabine phosphate|mesh-list
65649367|NCT02642965|Daunorubicin|daunorubicin|mesh-list
65649368|NCT02642965|Lenograstim|lenograstim|mesh-list
65649369|NCT02642965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649370|NCT02642965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65649371|NCT02642965|Antimetabolites|antimetabolites|mesh-ancestor
65649372|NCT02642965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649373|NCT02642965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65649374|NCT02642965|Immunologic Factors|immunologic factors|mesh-ancestor
65649375|NCT02642965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649376|NCT02642965|Antiviral Agents|antiviral agents|mesh-ancestor
65649377|NCT02642965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65649378|NCT02642965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65649379|NCT02642965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65649380|NCT02642965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65649381|NCT02642965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65649382|NCT02642965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65649383|NCT01377155|Insulin Detemir|insulin detemir|mesh-list
65649384|NCT01377155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65649385|NCT01377155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649386|NCT04976374|Dexmedetomidine|dexmedetomidine|mesh-list
65649387|NCT04976374|Gabapentin|gabapentin|mesh-list
65649388|NCT04976374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65649389|NCT04976374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65649390|NCT04976374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649391|NCT04976374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65649392|NCT04976374|Analgesics|analgesics|mesh-ancestor
65649393|NCT04976374|Sensory System Agents|sensory system agents|mesh-ancestor
65649394|NCT04976374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65649395|NCT04976374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65649396|NCT04976374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65649397|NCT04976374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65649398|NCT04976374|Adrenergic Agents|adrenergic agents|mesh-ancestor
65649399|NCT04976374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65649400|NCT04976374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649401|NCT04976374|Anticonvulsants|anticonvulsants|mesh-ancestor
65649402|NCT04976374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65649403|NCT04976374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65649404|NCT04976374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65649405|NCT04976374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65649406|NCT04976374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65649407|NCT04976374|Antimanic Agents|antimanic agents|mesh-ancestor
65649408|NCT02764541|Tamoxifen|tamoxifen|mesh-list
65649409|NCT02764541|Letrozole|letrozole|mesh-list
65649410|NCT02764541|Palbociclib|palbociclib|mesh-list
65649411|NCT02764541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649412|NCT02764541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65649413|NCT02764541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65649414|NCT02764541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65649415|NCT02764541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649416|NCT02764541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65649417|NCT02764541|Hormone Antagonists|hormone antagonists|mesh-ancestor
65649418|NCT02764541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65649419|NCT02764541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649420|NCT02764541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65649421|NCT02764541|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65649422|NCT02764541|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65649423|NCT02764541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65649424|NCT02764541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65649425|NCT00894530|Azithromycin|azithromycin|mesh-list
65649426|NCT00894530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65649427|NCT00894530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65649428|NCT00894530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65649429|NCT00894530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65649430|NCT01376999|Hormones|hormones|mesh-list
65649431|NCT01376999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65649432|NCT01376999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649433|NCT00892970|Azithromycin|azithromycin|mesh-list
65649434|NCT00892970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65649435|NCT00892970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65649436|NCT00892970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65649437|NCT00892970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65649438|NCT05340257|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65649439|NCT05340257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65649440|NCT05340257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65649441|NCT05340257|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65649442|NCT05340257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65649443|NCT05340257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649444|NCT02201381|Metformin|metformin|mesh-list
65649445|NCT02201381|Doxycycline|doxycycline|mesh-list
65649446|NCT02201381|Mebendazole|mebendazole|mesh-list
65649447|NCT02201381|Atorvastatin|atorvastatin|mesh-list
65649448|NCT02201381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65649449|NCT02201381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649450|NCT02201381|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65649451|NCT02201381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65649452|NCT02201381|Antimetabolites|antimetabolites|mesh-ancestor
65649453|NCT02201381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649454|NCT02201381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65649455|NCT02201381|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65649456|NCT02201381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65649457|NCT02201381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65649458|NCT02201381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65649459|NCT02201381|Antimalarials|antimalarials|mesh-ancestor
65649460|NCT02201381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65649461|NCT02201381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65649462|NCT02201381|Antinematodal Agents|antinematodal agents|mesh-ancestor
65649463|NCT02201381|Anthelmintics|anthelmintics|mesh-ancestor
65649464|NCT02201381|Tubulin Modulators|tubulin modulators|mesh-ancestor
65649465|NCT02201381|Antimitotic Agents|antimitotic agents|mesh-ancestor
65649466|NCT02201381|Mitosis Modulators|mitosis modulators|mesh-ancestor
65649467|NCT02201381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649468|NCT00803114|Morphine|morphine|mesh-list
65649469|NCT00803114|Narcotics|narcotics|mesh-list
65649470|NCT00803114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65649471|NCT00803114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65649472|NCT00803114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649473|NCT00803114|Analgesics|analgesics|mesh-ancestor
65649474|NCT00803114|Sensory System Agents|sensory system agents|mesh-ancestor
65649475|NCT00803114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65649476|NCT02059499|Fluorouracil|fluorouracil|mesh-list
65649477|NCT02059499|Imiquimod|imiquimod|mesh-list
65649478|NCT02059499|Antimetabolites|antimetabolites|mesh-ancestor
65649479|NCT02059499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649480|NCT02059499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65649481|NCT02059499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649482|NCT02059499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65649483|NCT02059499|Immunologic Factors|immunologic factors|mesh-ancestor
65649484|NCT02059499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649485|NCT02059499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65649486|NCT02059499|Interferon Inducers|interferon inducers|mesh-ancestor
65649487|NCT05519384|Cyclophosphamide|cyclophosphamide|mesh-list
65649488|NCT05519384|Fludarabine|fludarabine|mesh-list
65649489|NCT05519384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65649490|NCT05519384|Immunologic Factors|immunologic factors|mesh-ancestor
65649491|NCT05519384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649492|NCT05519384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65649493|NCT05519384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65649494|NCT05519384|Alkylating Agents|alkylating agents|mesh-ancestor
65649495|NCT05519384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649496|NCT05519384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649497|NCT05519384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65649498|NCT05302271|Prednisone|prednisone|mesh-list
65649499|NCT05302271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65649500|NCT05302271|Glucocorticoids|glucocorticoids|mesh-ancestor
65649501|NCT05302271|Hormones|hormones|mesh-ancestor
65649502|NCT05302271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65649503|NCT05302271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649504|NCT05302271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65649505|NCT05302271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649506|NCT00799292|Vasopressins|vasopressins|mesh-list
65649507|NCT00799292|Arginine Vasopressin|arginine vasopressin|mesh-list
65649508|NCT00799292|Hemostatics|hemostatics|mesh-ancestor
65649509|NCT00799292|Coagulants|coagulants|mesh-ancestor
65649510|NCT00799292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65649511|NCT00799292|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65649512|NCT00799292|Natriuretic Agents|natriuretic agents|mesh-ancestor
65649513|NCT00799292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649514|NCT02162849|Nicotine|nicotine|mesh-list
65649515|NCT02162849|Varenicline|varenicline|mesh-list
65649516|NCT02162849|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65649517|NCT02162849|Autonomic Agents|autonomic agents|mesh-ancestor
65649518|NCT02162849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65649519|NCT02162849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649520|NCT02162849|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65649521|NCT02162849|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65649522|NCT02162849|Cholinergic Agents|cholinergic agents|mesh-ancestor
65649523|NCT02162849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65649524|NCT02162849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649525|NCT05371600|Midazolam|midazolam|mesh-list
65649526|NCT05371600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65649527|NCT05371600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65649528|NCT05371600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65649529|NCT05371600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649530|NCT05371600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65649531|NCT05371600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65649532|NCT05371600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65649533|NCT05371600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65649534|NCT05371600|Anesthetics, General|anesthetics, general|mesh-ancestor
65649535|NCT05371600|Anesthetics|anesthetics|mesh-ancestor
65649536|NCT05371600|GABA Modulators|gaba modulators|mesh-ancestor
65649537|NCT05371600|GABA Agents|gaba agents|mesh-ancestor
65649538|NCT05371600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65649539|NCT05371600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649540|NCT02914275|Vaccines|vaccines|mesh-list
65446915|NCT00446849|Analgesics|analgesics|mesh-ancestor
65649541|NCT02914275|Immunologic Factors|immunologic factors|mesh-ancestor
65649542|NCT02914275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649543|NCT01941875|Progesterone|progesterone|mesh-list
65649544|NCT01941875|Progestins|progestins|mesh-ancestor
65649545|NCT01941875|Hormones|hormones|mesh-ancestor
65649546|NCT01941875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65649547|NCT01941875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649548|NCT04287062|Suvorexant|suvorexant|mesh-list
65649549|NCT04287062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65649550|NCT04287062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65649551|NCT04287062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65649552|NCT04287062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649553|NCT04287062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65649554|NCT04287062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65649555|NCT04287062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649556|NCT05508074|Riluzole|riluzole|mesh-list
65649557|NCT05508074|Anticonvulsants|anticonvulsants|mesh-ancestor
65649558|NCT05508074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65649559|NCT05508074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65649560|NCT05508074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65649561|NCT05508074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649562|NCT05508074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649563|NCT05508074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65649564|NCT05508074|Protective Agents|protective agents|mesh-ancestor
65649565|NCT01814657|Lidocaine|lidocaine|mesh-list
65649566|NCT01814657|Anesthetics, Local|anesthetics, local|mesh-ancestor
65649567|NCT01814657|Anesthetics|anesthetics|mesh-ancestor
65649568|NCT01814657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65649569|NCT01814657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649570|NCT01814657|Sensory System Agents|sensory system agents|mesh-ancestor
65649571|NCT01814657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65649572|NCT01814657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65649573|NCT01814657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65649574|NCT01814657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65649575|NCT01814657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65649576|NCT01814657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649577|NCT01773395|Methotrexate|methotrexate|mesh-list
65649578|NCT01773395|Fludarabine|fludarabine|mesh-list
65649579|NCT01773395|Busulfan|busulfan|mesh-list
65649580|NCT01773395|Tacrolimus|tacrolimus|mesh-list
65649581|NCT01773395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65649582|NCT01773395|Abortifacient Agents|abortifacient agents|mesh-ancestor
65649583|NCT01773395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65649584|NCT01773395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649585|NCT01773395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65649586|NCT01773395|Antimetabolites|antimetabolites|mesh-ancestor
65649587|NCT01773395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649588|NCT01773395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649589|NCT01773395|Dermatologic Agents|dermatologic agents|mesh-ancestor
65649590|NCT01773395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65649591|NCT01773395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65649592|NCT01773395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65649593|NCT01773395|Immunologic Factors|immunologic factors|mesh-ancestor
65649594|NCT01773395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65649595|NCT01773395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65649596|NCT01773395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65649597|NCT01773395|Alkylating Agents|alkylating agents|mesh-ancestor
65649598|NCT01773395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65649599|NCT01773395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65649600|NCT01000922|Insulin|insulin|mesh-list
65649601|NCT01000922|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65649602|NCT01000922|Insulin Glargine|insulin glargine|mesh-list
65649603|NCT01000922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65649604|NCT01000922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649605|NCT04559217|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
65649606|NCT04559217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649607|NCT03666195|Titanium dioxide|titanium dioxide|mesh-list
65649608|NCT03666195|Sunscreening Agents|sunscreening agents|mesh-ancestor
65649609|NCT03666195|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65649610|NCT03666195|Protective Agents|protective agents|mesh-ancestor
65649611|NCT03666195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649612|NCT03666195|Dermatologic Agents|dermatologic agents|mesh-ancestor
65649613|NCT03666195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65649614|NCT00889382|Paclitaxel|paclitaxel|mesh-list
65649615|NCT00889382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65649616|NCT00889382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649617|NCT00889382|Tubulin Modulators|tubulin modulators|mesh-ancestor
65649618|NCT00889382|Antimitotic Agents|antimitotic agents|mesh-ancestor
65649619|NCT00889382|Mitosis Modulators|mitosis modulators|mesh-ancestor
65649620|NCT00889382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649621|NCT04059003|Taxane|taxane|mesh-list
65649622|NCT04059003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649623|NCT05375188|Dexmedetomidine|dexmedetomidine|mesh-list
65649624|NCT05375188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65649625|NCT05375188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65649626|NCT05375188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649627|NCT05375188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65649628|NCT05375188|Analgesics|analgesics|mesh-ancestor
65649629|NCT05375188|Sensory System Agents|sensory system agents|mesh-ancestor
65649630|NCT05375188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65649631|NCT05375188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65649632|NCT05375188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65649633|NCT05375188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65649634|NCT05375188|Adrenergic Agents|adrenergic agents|mesh-ancestor
65649635|NCT05375188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65649636|NCT05375188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649637|NCT00994292|Darexaban|darexaban|mesh-list
65649638|NCT00994292|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65649639|NCT00994292|Antithrombins|antithrombins|mesh-ancestor
65649640|NCT00994292|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65649641|NCT00994292|Protease Inhibitors|protease inhibitors|mesh-ancestor
65649642|NCT00994292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267835|NCT02756000|Sympathomimetics|sympathomimetics|mesh-ancestor
65649643|NCT00994292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649644|NCT00994292|Anticoagulants|anticoagulants|mesh-ancestor
65649645|NCT02604433|Luspatercept|luspatercept|mesh-list
65649646|NCT02604433|Hematinics|hematinics|mesh-ancestor
65649647|NCT04437004|Fenfluramine|fenfluramine|mesh-list
65649648|NCT04437004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65649649|NCT04437004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65649650|NCT04437004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65649651|NCT04437004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649652|NCT04437004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65649653|NCT04437004|Serotonin Agents|serotonin agents|mesh-ancestor
65649654|NCT04437004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649655|NCT00992732|Valganciclovir|valganciclovir|mesh-list
65649656|NCT00992732|Ganciclovir|ganciclovir|mesh-list
65649657|NCT00992732|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65649658|NCT00992732|Arginine butyrate|arginine butyrate|mesh-list
65649659|NCT00992732|Antiviral Agents|antiviral agents|mesh-ancestor
65649660|NCT00992732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65649661|NCT00992732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65649662|NCT00992732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65649663|NCT00992732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649664|NCT00992732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649665|NCT00884234|Botulinum Toxins|botulinum toxins|mesh-list
65649666|NCT00884234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65649667|NCT00884234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65649668|NCT00884234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65649669|NCT00884234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65649670|NCT00884234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649671|NCT00884234|Cholinergic Agents|cholinergic agents|mesh-ancestor
65649672|NCT00884234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65649673|NCT00884234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649674|NCT00884234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65649675|NCT00884234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65649676|NCT03006393|Infliximab|infliximab|mesh-list
65649677|NCT03006393|Dermatologic Agents|dermatologic agents|mesh-ancestor
65649678|NCT03006393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65649679|NCT03006393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65649680|NCT00991172|Fasinumab|fasinumab|mesh-list
65649681|NCT00991172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65649682|NCT00991172|Analgesics|analgesics|mesh-ancestor
65649683|NCT00991172|Sensory System Agents|sensory system agents|mesh-ancestor
65649684|NCT00991172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65649685|NCT00991172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649686|NCT01383109|Pyronaridine|pyronaridine|mesh-list
65649687|NCT01383109|Antimalarials|antimalarials|mesh-ancestor
65649688|NCT01383109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65649689|NCT01383109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65649690|NCT01383109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65649691|NCT00882440|Losartan|losartan|mesh-list
65649692|NCT00882440|Enalapril|enalapril|mesh-list
65649693|NCT00882440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65649694|NCT00882440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65649695|NCT00882440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65649696|NCT00882440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65649697|NCT00882440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649698|NCT00882440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65649699|NCT00882440|Protease Inhibitors|protease inhibitors|mesh-ancestor
65649700|NCT00882440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65649701|NCT05214391|Zanubrutinib|zanubrutinib|mesh-list
65649702|NCT05214391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649703|NCT05214391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65649704|NCT05214391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65649705|NCT05214391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649706|NCT00880490|Formoterol Fumarate|formoterol fumarate|mesh-list
65649707|NCT00880490|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65649708|NCT00880490|Autonomic Agents|autonomic agents|mesh-ancestor
65649709|NCT00880490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65649710|NCT00880490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649711|NCT00880490|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65649712|NCT00880490|Respiratory System Agents|respiratory system agents|mesh-ancestor
65649713|NCT00880490|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65649714|NCT00880490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65649715|NCT00880490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65649716|NCT00880490|Adrenergic Agents|adrenergic agents|mesh-ancestor
65649717|NCT00880490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65649718|NCT00880490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649719|NCT05214157|Bupivacaine|bupivacaine|mesh-list
65649720|NCT05214157|Anesthetics, Local|anesthetics, local|mesh-ancestor
65649721|NCT05214157|Anesthetics|anesthetics|mesh-ancestor
65649722|NCT05214157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65649723|NCT05214157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649724|NCT05214157|Sensory System Agents|sensory system agents|mesh-ancestor
65649725|NCT05214157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65649726|NCT04549467|Tenofovir|tenofovir|mesh-list
65649727|NCT04549467|Lamivudine|lamivudine|mesh-list
65649728|NCT04549467|Emtricitabine|emtricitabine|mesh-list
65649729|NCT04549467|Dolutegravir|dolutegravir|mesh-list
65649730|NCT04549467|Antiviral Agents|antiviral agents|mesh-ancestor
65649731|NCT04549467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65649732|NCT04549467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65649733|NCT04549467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65649734|NCT04549467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65649735|NCT04549467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649736|NCT04549467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65649737|NCT04549467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65649738|NCT04549467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65649739|NCT04549467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65649740|NCT03630341|Clomiphene|clomiphene|mesh-list
65649741|NCT03630341|Enclomiphene|enclomiphene|mesh-list
65649742|NCT03630341|Zuclomiphene|zuclomiphene|mesh-list
65649743|NCT03630341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65649744|NCT03630341|Hormone Antagonists|hormone antagonists|mesh-ancestor
65649745|NCT03630341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65649746|NCT03630341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649747|NCT03630341|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65649748|NCT03630341|Fertility Agents|fertility agents|mesh-ancestor
65649749|NCT03630341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65649750|NCT03630341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65649751|NCT03630341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65649752|NCT02632396|Rituximab|rituximab|mesh-list
65649753|NCT02632396|Ixazomib|ixazomib|mesh-list
65649754|NCT02632396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65649755|NCT02632396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649756|NCT02632396|Immunologic Factors|immunologic factors|mesh-ancestor
65649757|NCT02632396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649758|NCT02632396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65649759|NCT02632396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649760|NCT02632396|Protease Inhibitors|protease inhibitors|mesh-ancestor
65649761|NCT02632396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65649762|NCT05474846|Melatonin|melatonin|mesh-list
65649763|NCT05474846|Methylphenidate|methylphenidate|mesh-list
65649764|NCT05474846|Antioxidants|antioxidants|mesh-ancestor
65649765|NCT05474846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649766|NCT05474846|Protective Agents|protective agents|mesh-ancestor
65649767|NCT05474846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649768|NCT05474846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65649769|NCT05474846|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65649770|NCT05474846|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65649771|NCT05474846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65649772|NCT05474846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65649773|NCT05474846|Dopamine Agents|dopamine agents|mesh-ancestor
65649774|NCT05474846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65649775|NCT05102422|Propofol|propofol|mesh-list
65649776|NCT05102422|Sevoflurane|sevoflurane|mesh-list
65649777|NCT05102422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65649778|NCT05102422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65649779|NCT05102422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649780|NCT05102422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65649781|NCT05102422|Anesthetics, General|anesthetics, general|mesh-ancestor
65649782|NCT05102422|Anesthetics|anesthetics|mesh-ancestor
65649783|NCT05102422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65649784|NCT05102422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65649785|NCT01088789|Cyclophosphamide|cyclophosphamide|mesh-list
65649786|NCT01088789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65649787|NCT01088789|Immunologic Factors|immunologic factors|mesh-ancestor
65649788|NCT01088789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649789|NCT01088789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65649790|NCT01088789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65649791|NCT01088789|Alkylating Agents|alkylating agents|mesh-ancestor
65649792|NCT01088789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649793|NCT01088789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649794|NCT01088789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65649795|NCT03665181|Bismuth|bismuth|mesh-list
65649796|NCT03665181|Antacids|antacids|mesh-ancestor
65649797|NCT03665181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649798|NCT03665181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65649799|NCT05326906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65649800|NCT05326906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649801|NCT05326906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649802|NCT05101954|Mitogens|mitogens|mesh-list
65649803|NCT05101954|Mitosis Modulators|mitosis modulators|mesh-ancestor
65649804|NCT05101954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649805|NCT00875108|Insulin|insulin|mesh-list
65649806|NCT00875108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65649807|NCT00875108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65649808|NCT00875108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649809|NCT04044209|Nivolumab|nivolumab|mesh-list
65649810|NCT04044209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65649811|NCT04044209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649812|NCT04044209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65649813|NCT04044209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649814|NCT00001481|Estradiol|estradiol|mesh-list
65649815|NCT00001481|Progesterone|progesterone|mesh-list
65649816|NCT00001481|Estrogens|estrogens|mesh-ancestor
65649817|NCT00001481|Hormones|hormones|mesh-ancestor
65649818|NCT00001481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65649819|NCT00001481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649820|NCT00001481|Progestins|progestins|mesh-ancestor
65649821|NCT04724759|Lidocaine|lidocaine|mesh-list
65649822|NCT04724759|Dexmedetomidine|dexmedetomidine|mesh-list
65649823|NCT04724759|Ketamine|ketamine|mesh-list
65649824|NCT04724759|Anesthetics, Local|anesthetics, local|mesh-ancestor
65649825|NCT04724759|Anesthetics|anesthetics|mesh-ancestor
65649826|NCT04724759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65649827|NCT04724759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649828|NCT04724759|Sensory System Agents|sensory system agents|mesh-ancestor
65649829|NCT04724759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65649830|NCT04724759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65649831|NCT04724759|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65649832|NCT04724759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65649833|NCT04724759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65649834|NCT04724759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649835|NCT04724759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65649836|NCT04724759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65649837|NCT04724759|Analgesics|analgesics|mesh-ancestor
65649838|NCT04724759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65649839|NCT04724759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65649840|NCT04724759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65447219|NCT01095640|Adapalene|adapalene|mesh-list
65649841|NCT04724759|Adrenergic Agents|adrenergic agents|mesh-ancestor
65649842|NCT04724759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65649843|NCT04724759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65649844|NCT04724759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65649845|NCT04724759|Anesthetics, General|anesthetics, general|mesh-ancestor
65649846|NCT04724759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65649847|NCT04724759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65649848|NCT03817463|Empagliflozin|empagliflozin|mesh-list
65649849|NCT03817463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65649850|NCT03817463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65649851|NCT03817463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649852|NCT03817463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65649853|NCT03817463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649854|NCT03817463|Protease Inhibitors|protease inhibitors|mesh-ancestor
65649855|NCT03817463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65649856|NCT05207683|Antibodies|antibodies|mesh-list
65649857|NCT05207683|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
65649858|NCT05207683|Immunologic Factors|immunologic factors|mesh-ancestor
65649859|NCT05207683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649860|NCT03000075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65649861|NCT03000075|Immunologic Factors|immunologic factors|mesh-ancestor
65649862|NCT03000075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649863|NCT05213065|Bupivacaine|bupivacaine|mesh-list
65649864|NCT05213065|Anesthetics, Local|anesthetics, local|mesh-ancestor
65649865|NCT05213065|Anesthetics|anesthetics|mesh-ancestor
65649866|NCT05213065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65649867|NCT05213065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649868|NCT05213065|Sensory System Agents|sensory system agents|mesh-ancestor
65649869|NCT05213065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65649870|NCT04578938|Ketamine|ketamine|mesh-list
65649871|NCT04578938|Analgesics|analgesics|mesh-ancestor
65649872|NCT04578938|Sensory System Agents|sensory system agents|mesh-ancestor
65649873|NCT04578938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65649874|NCT04578938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649875|NCT04578938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65649876|NCT04578938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65649877|NCT04578938|Anesthetics, General|anesthetics, general|mesh-ancestor
65649878|NCT04578938|Anesthetics|anesthetics|mesh-ancestor
65649879|NCT04578938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65649880|NCT04578938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65649881|NCT04578938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65649882|NCT04578938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65649883|NCT04578938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649884|NCT00969722|Tretinoin|tretinoin|mesh-list
65649885|NCT00969722|Molgramostim|molgramostim|mesh-list
65649886|NCT00969722|Isotretinoin|isotretinoin|mesh-list
65649887|NCT00969722|Sargramostim|sargramostim|mesh-list
65649888|NCT00969722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649889|NCT00969722|Keratolytic Agents|keratolytic agents|mesh-ancestor
65649890|NCT00969722|Dermatologic Agents|dermatologic agents|mesh-ancestor
65649891|NCT00969722|Immunologic Factors|immunologic factors|mesh-ancestor
65649892|NCT00969722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649893|NCT05099614|Naloxone|naloxone|mesh-list
65649894|NCT05099614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65649895|NCT05099614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649896|NCT05099614|Sensory System Agents|sensory system agents|mesh-ancestor
65649897|NCT05099614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65649898|NCT00968942|Botulinum Toxins|botulinum toxins|mesh-list
65649899|NCT00968942|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65649900|NCT00968942|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65649901|NCT00968942|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65649902|NCT00968942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65649903|NCT00968942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649904|NCT00968942|Cholinergic Agents|cholinergic agents|mesh-ancestor
65649905|NCT00968942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65649906|NCT00968942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649907|NCT00968942|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65649908|NCT00968942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65649909|NCT05283382|Cannabidiol|cannabidiol|mesh-list
65649910|NCT05283382|Anticonvulsants|anticonvulsants|mesh-ancestor
65649911|NCT00869336|Luliconazole|luliconazole|mesh-list
65649912|NCT00869336|Antifungal Agents|antifungal agents|mesh-ancestor
65649913|NCT00869336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65649914|NCT02371889|Topiramate|topiramate|mesh-list
65649915|NCT02371889|Anticonvulsants|anticonvulsants|mesh-ancestor
65649916|NCT02371889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65649917|NCT02371889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649918|NCT00860288|Metformin|metformin|mesh-list
65649919|NCT00860288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65649920|NCT00860288|Vildagliptin|vildagliptin|mesh-list
65649921|NCT00860288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65649922|NCT00860288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649923|NCT00860288|Incretins|incretins|mesh-ancestor
65649924|NCT00860288|Hormones|hormones|mesh-ancestor
65649925|NCT00860288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65649926|NCT00860288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65649927|NCT00860288|Protease Inhibitors|protease inhibitors|mesh-ancestor
65649928|NCT00860288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65649929|NCT00860288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649930|NCT03630029|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65649931|NCT03630029|Hematinics|hematinics|mesh-ancestor
65649932|NCT05763953|Etripamil|etripamil|mesh-list
65649933|NCT05763953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65649934|NCT05763953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65649935|NCT05763953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649936|NCT05763953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65649937|NCT05763953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649938|NCT05212597|Losartan|losartan|mesh-list
65649939|NCT05212597|Amlodipine|amlodipine|mesh-list
65649940|NCT05212597|Valsartan|valsartan|mesh-list
65649941|NCT05212597|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65649942|NCT05212597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65649943|NCT05212597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65649944|NCT05212597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65649945|NCT05212597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649946|NCT05212597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65649947|NCT05212597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649948|NCT05212597|Vasodilator Agents|vasodilator agents|mesh-ancestor
65649949|NCT05212597|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65649950|NCT05212597|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65649951|NCT05212597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65649952|NCT02450812|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65649953|NCT02450812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649954|NCT03629717|Vitamin D|vitamin d|mesh-list
65649955|NCT03629717|Denosumab|denosumab|mesh-list
65649956|NCT03629717|Calcium|calcium|mesh-list
65649957|NCT03629717|Vitamins|vitamins|mesh-ancestor
65649958|NCT03629717|Micronutrients|micronutrients|mesh-ancestor
65649959|NCT03629717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649960|NCT03629717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65649961|NCT03629717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65649962|NCT05108350|Metformin|metformin|mesh-list
65649963|NCT05108350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65649964|NCT05108350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649965|NCT00859430|Levetiracetam|levetiracetam|mesh-list
65649966|NCT00859430|Anticonvulsants|anticonvulsants|mesh-ancestor
65649967|NCT00859430|Nootropic Agents|nootropic agents|mesh-ancestor
65649968|NCT00855764|Paclitaxel|paclitaxel|mesh-list
65649969|NCT00855764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65649970|NCT00855764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649971|NCT00855764|Tubulin Modulators|tubulin modulators|mesh-ancestor
65649972|NCT00855764|Antimitotic Agents|antimitotic agents|mesh-ancestor
65649973|NCT00855764|Mitosis Modulators|mitosis modulators|mesh-ancestor
65649974|NCT00855764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649975|NCT00959036|Methotrexate|methotrexate|mesh-list
65649976|NCT00959036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65649977|NCT00959036|Abortifacient Agents|abortifacient agents|mesh-ancestor
65649978|NCT00959036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65649979|NCT00959036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649980|NCT00959036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65649981|NCT00959036|Antimetabolites|antimetabolites|mesh-ancestor
65649982|NCT00959036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65649983|NCT00959036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65649984|NCT00959036|Dermatologic Agents|dermatologic agents|mesh-ancestor
65649985|NCT00959036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65649986|NCT00959036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65649987|NCT00959036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65649988|NCT00959036|Immunologic Factors|immunologic factors|mesh-ancestor
65649989|NCT00959036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65649990|NCT00959036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65649991|NCT04129723|Tin Fluorides|tin fluorides|mesh-list
65649992|NCT04129723|Cariostatic Agents|cariostatic agents|mesh-ancestor
65649993|NCT04129723|Protective Agents|protective agents|mesh-ancestor
65649994|NCT04129723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65649995|NCT04474262|Midodrine|midodrine|mesh-list
65649996|NCT04474262|Sympathomimetics|sympathomimetics|mesh-ancestor
65649997|NCT04474262|Autonomic Agents|autonomic agents|mesh-ancestor
65649998|NCT04474262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65649999|NCT04474262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650000|NCT04474262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65650001|NCT04474262|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65650002|NCT04474262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65650003|NCT04474262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65650004|NCT04474262|Adrenergic Agents|adrenergic agents|mesh-ancestor
65650005|NCT04474262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650006|NCT04474262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650007|NCT05211583|Progesterone|progesterone|mesh-list
65650008|NCT05211583|Progestins|progestins|mesh-ancestor
65650009|NCT05211583|Hormones|hormones|mesh-ancestor
65650010|NCT05211583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65650011|NCT05211583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650012|NCT04031599|Hormones|hormones|mesh-list
65650013|NCT04031599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650014|NCT04031599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65650015|NCT04019821|Insulin|insulin|mesh-list
65650016|NCT04019821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65650017|NCT04019821|Insulin Aspart|insulin aspart|mesh-list
65650018|NCT04019821|Insulin Lispro|insulin lispro|mesh-list
65650019|NCT04019821|Insulin glulisine|insulin glulisine|mesh-list
65650020|NCT04019821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65650021|NCT04019821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650022|NCT05186467|Magnesium Sulfate|magnesium sulfate|mesh-list
65650023|NCT05186467|Analgesics|analgesics|mesh-ancestor
65650024|NCT05186467|Sensory System Agents|sensory system agents|mesh-ancestor
65650025|NCT05186467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650026|NCT05186467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650027|NCT05186467|Anesthetics|anesthetics|mesh-ancestor
65650028|NCT05186467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65650029|NCT05186467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65650030|NCT05186467|Anticonvulsants|anticonvulsants|mesh-ancestor
65650031|NCT05186467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65650032|NCT05186467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65650033|NCT05186467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650034|NCT05186467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65650035|NCT05186467|Tocolytic Agents|tocolytic agents|mesh-ancestor
65650036|NCT05186467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65650037|NCT00771134|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65650038|NCT00771134|Antidepressive Agents|antidepressive agents|mesh-ancestor
65650039|NCT00771134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65650040|NCT00771134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65650041|NCT00771134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65650042|NCT00771134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65650043|NCT00771134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650044|NCT00768482|Buprenorphine|buprenorphine|mesh-list
65650045|NCT00768482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65650046|NCT00768482|Narcotics|narcotics|mesh-ancestor
65650047|NCT00768482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65650048|NCT00768482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650049|NCT00768482|Analgesics|analgesics|mesh-ancestor
65650050|NCT00768482|Sensory System Agents|sensory system agents|mesh-ancestor
65650051|NCT00768482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650052|NCT00768482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65650053|NCT00840866|Cefprozil|cefprozil|mesh-list
65650054|NCT00840866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65650055|NCT00840866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65650056|NCT05043116|Vitamin D|vitamin d|mesh-list
65650057|NCT05043116|Cholecalciferol|cholecalciferol|mesh-list
65650058|NCT05043116|Vitamins|vitamins|mesh-ancestor
65650059|NCT05043116|Micronutrients|micronutrients|mesh-ancestor
65650060|NCT05043116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650061|NCT05043116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65650062|NCT05043116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65650063|NCT00840632|Trandolapril|trandolapril|mesh-list
65650064|NCT00840632|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65447436|NCT00250718|Hormones|hormones|mesh-ancestor
65650065|NCT00840632|Protease Inhibitors|protease inhibitors|mesh-ancestor
65650066|NCT00840632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650067|NCT00840632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650068|NCT00840632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65650069|NCT00840476|Meloxicam|meloxicam|mesh-list
65650070|NCT00840476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65650071|NCT00840476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65650072|NCT00840476|Analgesics|analgesics|mesh-ancestor
65650073|NCT00840476|Sensory System Agents|sensory system agents|mesh-ancestor
65650074|NCT00840476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650075|NCT00840476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650076|NCT00840476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65650077|NCT00840476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65650078|NCT00840476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65650079|NCT00840476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65650080|NCT00840476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650081|NCT00840476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650082|NCT00765830|Vildagliptin|vildagliptin|mesh-list
65650083|NCT00765830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65650084|NCT00765830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650085|NCT00765830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65650086|NCT00765830|Protease Inhibitors|protease inhibitors|mesh-ancestor
65650087|NCT00765830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650088|NCT00765830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650089|NCT03664869|Mitomycins|mitomycins|mesh-list
65650090|NCT03664869|Mitomycin|mitomycin|mesh-list
65650091|NCT03664869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65650092|NCT03664869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65650093|NCT03664869|Alkylating Agents|alkylating agents|mesh-ancestor
65650094|NCT03664869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650095|NCT03664869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65650096|NCT03664869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650097|NCT00953420|Dexamethasone|dexamethasone|mesh-list
65650098|NCT00953420|Carboplatin|carboplatin|mesh-list
65650099|NCT00953420|Docetaxel|docetaxel|mesh-list
65650100|NCT00953420|Lenograstim|lenograstim|mesh-list
65650101|NCT00953420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65650102|NCT00953420|Antiemetics|antiemetics|mesh-ancestor
65650103|NCT00953420|Autonomic Agents|autonomic agents|mesh-ancestor
65650104|NCT00953420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650105|NCT00953420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650106|NCT00953420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65650107|NCT00953420|Glucocorticoids|glucocorticoids|mesh-ancestor
65650108|NCT00953420|Hormones|hormones|mesh-ancestor
65650109|NCT00953420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65650110|NCT00953420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65650111|NCT00953420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65650112|NCT00953420|Tubulin Modulators|tubulin modulators|mesh-ancestor
65650113|NCT00953420|Antimitotic Agents|antimitotic agents|mesh-ancestor
65650114|NCT00953420|Mitosis Modulators|mitosis modulators|mesh-ancestor
65650115|NCT00953420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650116|NCT00953420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65650117|NCT00953420|Immunologic Factors|immunologic factors|mesh-ancestor
65650118|NCT01602562|Valacyclovir|valacyclovir|mesh-list
65650119|NCT01602562|Antiviral Agents|antiviral agents|mesh-ancestor
65650120|NCT01602562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65650121|NCT01945775|Talazoparib|talazoparib|mesh-list
65650122|NCT01945775|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65650123|NCT01945775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650124|NCT01945775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650125|NCT01945775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65650126|NCT00839930|Cilostazol|cilostazol|mesh-list
65650127|NCT00839930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65650128|NCT00839930|Autonomic Agents|autonomic agents|mesh-ancestor
65650129|NCT00839930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650130|NCT00839930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650131|NCT00839930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65650132|NCT00839930|Respiratory System Agents|respiratory system agents|mesh-ancestor
65650133|NCT00839930|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65650134|NCT00839930|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65650135|NCT00839930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650136|NCT00839930|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65650137|NCT00839930|Vasodilator Agents|vasodilator agents|mesh-ancestor
65650138|NCT00839930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65650139|NCT00839930|Protective Agents|protective agents|mesh-ancestor
65650140|NCT00839930|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65650141|NCT00839930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65650142|NCT00839930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650143|NCT00838136|Lamotrigine|lamotrigine|mesh-list
65650144|NCT00838136|Anticonvulsants|anticonvulsants|mesh-ancestor
65650145|NCT00838136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65650146|NCT00838136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65650147|NCT00838136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650148|NCT00838136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65650149|NCT00838136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650150|NCT00838136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65650151|NCT00838136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65650152|NCT00838136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65650153|NCT00838136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65650154|NCT00838136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65650155|NCT00944294|Adenosine|adenosine|mesh-list
65650156|NCT00944294|Binodenoson|binodenoson|mesh-list
65650157|NCT00944294|Analgesics|analgesics|mesh-ancestor
65650158|NCT00944294|Sensory System Agents|sensory system agents|mesh-ancestor
65650159|NCT00944294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650160|NCT00944294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650161|NCT00944294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65650162|NCT00944294|Vasodilator Agents|vasodilator agents|mesh-ancestor
65650163|NCT00944294|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65650164|NCT00944294|Purinergic Agonists|purinergic agonists|mesh-ancestor
65650165|NCT00944294|Purinergic Agents|purinergic agents|mesh-ancestor
65650166|NCT00944294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650167|NCT00944294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650168|NCT00758966|Naltrexone|naltrexone|mesh-list
65650169|NCT00758966|Fluoxetine|fluoxetine|mesh-list
65650170|NCT00758966|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65650171|NCT00758966|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65650172|NCT00758966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650173|NCT00758966|Sensory System Agents|sensory system agents|mesh-ancestor
65650174|NCT00758966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650175|NCT00758966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65650176|NCT00758966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65650177|NCT00758966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65650178|NCT00758966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650179|NCT00758966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650180|NCT00758966|Serotonin Agents|serotonin agents|mesh-ancestor
65650181|NCT00758966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65650182|NCT00758966|Antidepressive Agents|antidepressive agents|mesh-ancestor
65650183|NCT00758966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65650184|NCT00758966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65650185|NCT00758966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65650186|NCT00758966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650187|NCT03072719|Fluorides|fluorides|mesh-list
65650188|NCT03072719|Tin Fluorides|tin fluorides|mesh-list
65650189|NCT03072719|Fluorophosphate|fluorophosphate|mesh-list
65650190|NCT03072719|Cariostatic Agents|cariostatic agents|mesh-ancestor
65650191|NCT03072719|Protective Agents|protective agents|mesh-ancestor
65650192|NCT03072719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650193|NCT03617731|Dexamethasone|dexamethasone|mesh-list
65650194|NCT03617731|Lenalidomide|lenalidomide|mesh-list
65650195|NCT03617731|Bortezomib|bortezomib|mesh-list
65650196|NCT03617731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65650197|NCT03617731|Antiemetics|antiemetics|mesh-ancestor
65650198|NCT03617731|Autonomic Agents|autonomic agents|mesh-ancestor
65650199|NCT03617731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650200|NCT03617731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650201|NCT03617731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65650202|NCT03617731|Glucocorticoids|glucocorticoids|mesh-ancestor
65650203|NCT03617731|Hormones|hormones|mesh-ancestor
65650204|NCT03617731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65650205|NCT03617731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65650206|NCT03617731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65650207|NCT03617731|Immunologic Factors|immunologic factors|mesh-ancestor
65650208|NCT03617731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65650209|NCT03617731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65650210|NCT03617731|Growth Substances|growth substances|mesh-ancestor
65650211|NCT03617731|Growth Inhibitors|growth inhibitors|mesh-ancestor
65650212|NCT05106400|Lidocaine|lidocaine|mesh-list
65650213|NCT05106400|Menthol|menthol|mesh-list
65650214|NCT05106400|Anesthetics, Local|anesthetics, local|mesh-ancestor
65650215|NCT05106400|Anesthetics|anesthetics|mesh-ancestor
65267845|NCT02756000|Protective Agents|protective agents|mesh-ancestor
65650216|NCT05106400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65650217|NCT05106400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650219|NCT05106400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650220|NCT05106400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65650221|NCT05106400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65650222|NCT05106400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65650223|NCT05106400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65650224|NCT05106400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650225|NCT05106400|Antipruritics|antipruritics|mesh-ancestor
65650226|NCT05106400|Dermatologic Agents|dermatologic agents|mesh-ancestor
65650227|NCT00754988|Metformin|metformin|mesh-list
65650228|NCT00754988|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65650229|NCT00754988|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65650230|NCT00754988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65650231|NCT00754988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650232|NCT00754988|Incretins|incretins|mesh-ancestor
65650233|NCT00754988|Hormones|hormones|mesh-ancestor
65650234|NCT00754988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65650235|NCT00754988|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65650236|NCT00754988|Protease Inhibitors|protease inhibitors|mesh-ancestor
65650237|NCT00754988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650238|NCT00754988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650239|NCT01416935|Amiodarone|amiodarone|mesh-list
65650240|NCT01416935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65650241|NCT01416935|Vasodilator Agents|vasodilator agents|mesh-ancestor
65650242|NCT01416935|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65650243|NCT01416935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65650244|NCT01416935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650245|NCT01416935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65650246|NCT01416935|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65650247|NCT01416935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65650248|NCT01416935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650249|NCT01416935|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65650250|NCT01416935|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65650251|NCT01416935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65650252|NCT05012566|Botulinum Toxins|botulinum toxins|mesh-list
65650253|NCT05012566|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65650254|NCT05012566|Hyaluronic Acid|hyaluronic acid|mesh-list
65650255|NCT05012566|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65650256|NCT05012566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65650257|NCT05012566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650258|NCT05012566|Cholinergic Agents|cholinergic agents|mesh-ancestor
65650259|NCT05012566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650260|NCT05012566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650261|NCT05012566|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65650262|NCT05012566|Immunologic Factors|immunologic factors|mesh-ancestor
65650263|NCT05012566|Viscosupplements|viscosupplements|mesh-ancestor
65650264|NCT05012566|Protective Agents|protective agents|mesh-ancestor
65650265|NCT05012566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65650266|NCT05012566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650267|NCT05202665|Fluorides|fluorides|mesh-list
65650268|NCT05202665|Fluorides, Topical|fluorides, topical|mesh-list
65650269|NCT05202665|Cariostatic Agents|cariostatic agents|mesh-ancestor
65650270|NCT05202665|Protective Agents|protective agents|mesh-ancestor
65650271|NCT05202665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650272|NCT04438772|Anesthetics|anesthetics|mesh-list
65650273|NCT04438772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65650274|NCT04438772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650275|NCT04560634|Norepinephrine|norepinephrine|mesh-list
65650276|NCT04560634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65650277|NCT04560634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65650278|NCT04560634|Adrenergic Agents|adrenergic agents|mesh-ancestor
65650279|NCT04560634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650280|NCT04560634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650281|NCT04560634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650282|NCT04560634|Sympathomimetics|sympathomimetics|mesh-ancestor
65650283|NCT04560634|Autonomic Agents|autonomic agents|mesh-ancestor
65650284|NCT04560634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650285|NCT04560634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65650286|NCT00927914|Ranirestat|ranirestat|mesh-list
65650287|NCT00927914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650288|NCT00927914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650290|NCT05261464|Diltiazem|diltiazem|mesh-list
65650291|NCT05261464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65650292|NCT05261464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65650293|NCT05261464|Sympatholytics|sympatholytics|mesh-ancestor
65650294|NCT05261464|Autonomic Agents|autonomic agents|mesh-ancestor
65650295|NCT05261464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650296|NCT05261464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650297|NCT05261464|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65650298|NCT05261464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65650299|NCT05261464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65650300|NCT05261464|Adrenergic Agents|adrenergic agents|mesh-ancestor
65650301|NCT05261464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650302|NCT05261464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650303|NCT05261464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65650304|NCT05261464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65650305|NCT05261464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65650306|NCT05261464|Vasodilator Agents|vasodilator agents|mesh-ancestor
65650307|NCT05681377|Flumazenil|flumazenil|mesh-list
65650308|NCT05681377|Antidotes|antidotes|mesh-ancestor
65650309|NCT05681377|Protective Agents|protective agents|mesh-ancestor
65650310|NCT05681377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650311|NCT05681377|GABA Modulators|gaba modulators|mesh-ancestor
65650312|NCT05681377|GABA Agents|gaba agents|mesh-ancestor
65650313|NCT05681377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650314|NCT05681377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650315|NCT05047939|Propofol|propofol|mesh-list
65650316|NCT05047939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65650317|NCT05047939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65650318|NCT05047939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650319|NCT05047939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65650320|NCT05047939|Anesthetics, General|anesthetics, general|mesh-ancestor
65650321|NCT05047939|Anesthetics|anesthetics|mesh-ancestor
65650322|NCT00835796|Finasteride|finasteride|mesh-list
65650323|NCT00835796|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65650324|NCT00835796|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65650325|NCT00835796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650326|NCT00835796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650327|NCT00835796|Hormone Antagonists|hormone antagonists|mesh-ancestor
65650328|NCT00835796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65650329|NCT00835796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650330|NCT00835796|Urological Agents|urological agents|mesh-ancestor
65650331|NCT05106712|Vitamin D|vitamin d|mesh-list
65650332|NCT05106712|Cholecalciferol|cholecalciferol|mesh-list
65650333|NCT05106712|Letrozole|letrozole|mesh-list
65650334|NCT05106712|Clomiphene|clomiphene|mesh-list
65650335|NCT05106712|Enclomiphene|enclomiphene|mesh-list
65650336|NCT05106712|Zuclomiphene|zuclomiphene|mesh-list
65650337|NCT05106712|Vitamins|vitamins|mesh-ancestor
65650338|NCT05106712|Micronutrients|micronutrients|mesh-ancestor
65650339|NCT05106712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650340|NCT05106712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65650341|NCT05106712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650342|NCT05106712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65650343|NCT05106712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65650344|NCT05106712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65650345|NCT05106712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65650346|NCT05106712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650347|NCT05106712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65650348|NCT05106712|Hormone Antagonists|hormone antagonists|mesh-ancestor
65650349|NCT05106712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65650350|NCT05106712|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65650351|NCT05106712|Fertility Agents|fertility agents|mesh-ancestor
65650352|NCT05106712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65650353|NCT05106712|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65650354|NCT05106712|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65650355|NCT05105698|Dapagliflozin|dapagliflozin|mesh-list
65650356|NCT05105698|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65650357|NCT05105698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65650358|NCT05105698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650359|NCT05105698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65650360|NCT05105698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650361|NCT05105698|Protease Inhibitors|protease inhibitors|mesh-ancestor
65650362|NCT05105698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650364|NCT00835640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65650365|NCT00835640|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65650366|NCT00835640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65650367|NCT00835640|Histamine Antagonists|histamine antagonists|mesh-ancestor
65650368|NCT00835640|Histamine Agents|histamine agents|mesh-ancestor
65650369|NCT00835640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650370|NCT00835640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650371|NCT00835640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650372|NCT00752570|Trebananib|trebananib|mesh-list
65650373|NCT00752570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65650374|NCT00752570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65650375|NCT00752570|Growth Substances|growth substances|mesh-ancestor
65650376|NCT00752570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650377|NCT00752570|Growth Inhibitors|growth inhibitors|mesh-ancestor
65650378|NCT00752570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65650379|NCT05083000|Topotecan|topotecan|mesh-list
65650380|NCT05083000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65650381|NCT05083000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65650382|NCT05083000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650383|NCT05083000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650384|NCT05083000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65650385|NCT00752258|Botulinum Toxins|botulinum toxins|mesh-list
65650386|NCT00752258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65650387|NCT00752258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65650388|NCT00752258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65650389|NCT00752258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65650390|NCT00752258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650391|NCT00752258|Cholinergic Agents|cholinergic agents|mesh-ancestor
65650392|NCT00752258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650393|NCT00752258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650394|NCT00752258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65650395|NCT00752258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650396|NCT02942017|Brexanolone|brexanolone|mesh-list
65650397|NCT02942017|Neurosteroids|neurosteroids|mesh-ancestor
65650398|NCT02942017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650399|NCT02942017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650400|NCT02942017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650401|NCT02942017|GABA Modulators|gaba modulators|mesh-ancestor
65650402|NCT02942017|GABA Agents|gaba agents|mesh-ancestor
65650403|NCT04447781|Citric Acid|citric acid|mesh-list
65650404|NCT04447781|Sodium Citrate|sodium citrate|mesh-list
65650405|NCT04447781|Anticoagulants|anticoagulants|mesh-ancestor
65650406|NCT04447781|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65650407|NCT04447781|Chelating Agents|chelating agents|mesh-ancestor
65650408|NCT04447781|Sequestering Agents|sequestering agents|mesh-ancestor
65650409|NCT04447781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650410|NCT04364776|Durvalumab|durvalumab|mesh-list
65650411|NCT04364776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65650412|NCT04364776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65650413|NCT00835484|Cefdinir|cefdinir|mesh-list
65650414|NCT00835484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65650415|NCT00835484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65650416|NCT00835406|Alendronate|alendronate|mesh-list
65650417|NCT00835406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65650418|NCT00835406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650419|NCT05202275|Olanzapine|olanzapine|mesh-list
65650420|NCT05202275|Aprepitant|aprepitant|mesh-list
65650421|NCT05202275|Palonosetron|palonosetron|mesh-list
65650422|NCT05202275|Antiemetics|antiemetics|mesh-ancestor
65650423|NCT05202275|Autonomic Agents|autonomic agents|mesh-ancestor
65650424|NCT05202275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650425|NCT05202275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650426|NCT05202275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65650427|NCT05202275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65650428|NCT05202275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65650429|NCT05202275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65650430|NCT05202275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65650431|NCT05202275|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65650432|NCT05202275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65267860|NCT02759510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65650433|NCT05202275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65650434|NCT05202275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447824|NCT01072604|Aspirin|aspirin|mesh-list
65650435|NCT05202275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650436|NCT05202275|Serotonin Agents|serotonin agents|mesh-ancestor
65650437|NCT05202275|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65650438|NCT05202275|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65650439|NCT05202275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65650441|NCT04369937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65650442|NCT04369937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65650443|NCT00745316|Adenosine|adenosine|mesh-list
65650444|NCT00745316|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-list
65650445|NCT00745316|Analgesics|analgesics|mesh-ancestor
65650446|NCT00745316|Sensory System Agents|sensory system agents|mesh-ancestor
65650447|NCT00745316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650448|NCT00745316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650449|NCT00745316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65650450|NCT00745316|Vasodilator Agents|vasodilator agents|mesh-ancestor
65650451|NCT00745316|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65650452|NCT00745316|Purinergic Agonists|purinergic agonists|mesh-ancestor
65650453|NCT00745316|Purinergic Agents|purinergic agents|mesh-ancestor
65650454|NCT00745316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650455|NCT00745316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650456|NCT00745316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65650457|NCT00745316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65650458|NCT00744926|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65650459|NCT00744926|Incretins|incretins|mesh-ancestor
65650460|NCT00744926|Hormones|hormones|mesh-ancestor
65650461|NCT00744926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65650462|NCT00744926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650463|NCT03838744|Olaparib|olaparib|mesh-list
65650464|NCT03838744|Trabectedin|trabectedin|mesh-list
65650465|NCT03838744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65650466|NCT03838744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650467|NCT03838744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650468|NCT03838744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65650469|NCT03838744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65650470|NCT03838744|Alkylating Agents|alkylating agents|mesh-ancestor
65650471|NCT05327348|Ascorbic Acid|ascorbic acid|mesh-list
65650472|NCT05327348|Antioxidants|antioxidants|mesh-ancestor
65650473|NCT05327348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650474|NCT05327348|Protective Agents|protective agents|mesh-ancestor
65650475|NCT05327348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650476|NCT05327348|Vitamins|vitamins|mesh-ancestor
65650477|NCT05327348|Micronutrients|micronutrients|mesh-ancestor
65650478|NCT04695106|Aspirin|aspirin|mesh-list
65650479|NCT04695106|Dabigatran|dabigatran|mesh-list
65650480|NCT04695106|Clopidogrel|clopidogrel|mesh-list
65650481|NCT04695106|Ticagrelor|ticagrelor|mesh-list
65650482|NCT04695106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65650483|NCT04695106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65650484|NCT04695106|Analgesics|analgesics|mesh-ancestor
65650485|NCT04695106|Sensory System Agents|sensory system agents|mesh-ancestor
65650486|NCT04695106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650487|NCT04695106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650488|NCT04695106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65650489|NCT04695106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65650490|NCT04695106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65650491|NCT04695106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65650492|NCT04695106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650493|NCT04695106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65650494|NCT04695106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65650495|NCT04695106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650496|NCT04695106|Antipyretics|antipyretics|mesh-ancestor
65650497|NCT04695106|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65650498|NCT04695106|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65650499|NCT04695106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65650500|NCT04695106|Purinergic Agents|purinergic agents|mesh-ancestor
65650501|NCT04695106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650502|NCT04695106|Antithrombins|antithrombins|mesh-ancestor
65650503|NCT04695106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65650504|NCT04695106|Protease Inhibitors|protease inhibitors|mesh-ancestor
65650505|NCT04695106|Anticoagulants|anticoagulants|mesh-ancestor
65650506|NCT04032665|Rivaroxaban|rivaroxaban|mesh-list
65650507|NCT04032665|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65447894|NCT01581788|Valproic Acid|valproic acid|mesh-list
65650508|NCT04032665|Antithrombins|antithrombins|mesh-ancestor
65650509|NCT04032665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65650510|NCT04032665|Protease Inhibitors|protease inhibitors|mesh-ancestor
65650511|NCT04032665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650512|NCT04032665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650513|NCT04032665|Anticoagulants|anticoagulants|mesh-ancestor
65650514|NCT03629639|Metformin|metformin|mesh-list
65650515|NCT03629639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65650516|NCT03629639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650517|NCT00835172|Glimepiride|glimepiride|mesh-list
65650518|NCT00835172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65650519|NCT00835172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65650520|NCT00835172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650521|NCT00835172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65650522|NCT00835172|Immunologic Factors|immunologic factors|mesh-ancestor
65650523|NCT04941755|Famotidine|famotidine|mesh-list
65650524|NCT04941755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65650525|NCT04941755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65650526|NCT04941755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65650527|NCT04941755|Histamine Antagonists|histamine antagonists|mesh-ancestor
65650528|NCT04941755|Histamine Agents|histamine agents|mesh-ancestor
65650529|NCT04941755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650530|NCT04941755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650531|NCT04941755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650532|NCT04921735|Cisatracurium|cisatracurium|mesh-list
65650533|NCT04921735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65650534|NCT04921735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65650535|NCT04921735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650536|NCT04921735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650537|NCT01676116|Liraglutide|liraglutide|mesh-list
65650538|NCT01676116|Exenatide|exenatide|mesh-list
65650539|NCT01676116|Xultophy|xultophy|mesh-list
65650540|NCT01676116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65650541|NCT01676116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650542|NCT01676116|Incretins|incretins|mesh-ancestor
65650543|NCT01676116|Hormones|hormones|mesh-ancestor
65650544|NCT01676116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65650545|NCT01676116|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65650546|NCT05200793|Metformin|metformin|mesh-list
65650547|NCT05200793|Empagliflozin|empagliflozin|mesh-list
65650548|NCT05200793|Linagliptin|linagliptin|mesh-list
65650549|NCT05200793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65650550|NCT05200793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650551|NCT05200793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65650552|NCT05200793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650553|NCT05200793|Incretins|incretins|mesh-ancestor
65650554|NCT05200793|Hormones|hormones|mesh-ancestor
65650555|NCT05200793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65650556|NCT05200793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65650557|NCT05200793|Protease Inhibitors|protease inhibitors|mesh-ancestor
65650558|NCT05200793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650559|NCT03383224|Nicotine|nicotine|mesh-list
65650560|NCT03383224|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65650561|NCT03383224|Autonomic Agents|autonomic agents|mesh-ancestor
65650562|NCT03383224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650563|NCT03383224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650564|NCT03383224|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65650565|NCT03383224|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65650566|NCT03383224|Cholinergic Agents|cholinergic agents|mesh-ancestor
65650567|NCT03383224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650568|NCT03383224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650569|NCT04699357|Atropine|atropine|mesh-list
65650570|NCT04699357|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65650571|NCT04699357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65650572|NCT04699357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65650573|NCT04699357|Autonomic Agents|autonomic agents|mesh-ancestor
65650574|NCT04699357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650575|NCT04699357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650576|NCT04699357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65113318|NCT01227889|Dabrafenib|dabrafenib|mesh-list
65650577|NCT04699357|Respiratory System Agents|respiratory system agents|mesh-ancestor
65650578|NCT04699357|Mydriatics|mydriatics|mesh-ancestor
65650579|NCT04699357|Parasympatholytics|parasympatholytics|mesh-ancestor
65650580|NCT04699357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65650581|NCT04699357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65650582|NCT04699357|Cholinergic Agents|cholinergic agents|mesh-ancestor
65650583|NCT04699357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650584|NCT04699357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650585|NCT03030118|Hydroxychloroquine|hydroxychloroquine|mesh-list
65650586|NCT03030118|Antimalarials|antimalarials|mesh-ancestor
65650587|NCT03030118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65650588|NCT03030118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65650589|NCT03030118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65650590|NCT03030118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650591|NCT03030118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650592|NCT03030118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65650593|NCT05198531|Gemcitabine|gemcitabine|mesh-list
65650594|NCT05198531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65650595|NCT05198531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65650596|NCT05198531|Antimetabolites|antimetabolites|mesh-ancestor
65650597|NCT05198531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650598|NCT05198531|Antiviral Agents|antiviral agents|mesh-ancestor
65650599|NCT05198531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65650600|NCT05198531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650601|NCT05198531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65650602|NCT05198531|Immunologic Factors|immunologic factors|mesh-ancestor
65650603|NCT05198531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650604|NCT04177706|Ketamine|ketamine|mesh-list
65650605|NCT04177706|Analgesics|analgesics|mesh-ancestor
65650606|NCT04177706|Sensory System Agents|sensory system agents|mesh-ancestor
65650607|NCT04177706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650608|NCT04177706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650609|NCT04177706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65650610|NCT04177706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65650611|NCT04177706|Anesthetics, General|anesthetics, general|mesh-ancestor
65650612|NCT04177706|Anesthetics|anesthetics|mesh-ancestor
65650613|NCT04177706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65650614|NCT04177706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65650615|NCT04177706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65650616|NCT04177706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650617|NCT04177706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650618|NCT01869829|Antifungal Agents|antifungal agents|mesh-list
65650619|NCT01869829|Clotrimazole|clotrimazole|mesh-list
65650620|NCT01869829|Miconazole|miconazole|mesh-list
65650621|NCT01869829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65650622|NCT01869829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65650623|NCT01869829|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65650624|NCT01869829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65650625|NCT01869829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650626|NCT01869829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650627|NCT01869829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65650628|NCT01869829|Hormone Antagonists|hormone antagonists|mesh-ancestor
65650629|NCT01869829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65650630|NCT01869829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650631|NCT01869829|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65650632|NCT01869829|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65650633|NCT02683018|Dronabinol|dronabinol|mesh-list
65650634|NCT02683018|Hallucinogens|hallucinogens|mesh-ancestor
65650635|NCT02683018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650636|NCT02683018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65650637|NCT02683018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65650638|NCT02683018|Analgesics|analgesics|mesh-ancestor
65650639|NCT02683018|Sensory System Agents|sensory system agents|mesh-ancestor
65650640|NCT02683018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650641|NCT02683018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65650642|NCT02683018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65650643|NCT02683018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650644|NCT02683018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650645|NCT02683018|Hormones|hormones|mesh-ancestor
65650646|NCT02683018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65650647|NCT03982576|Nicotine|nicotine|mesh-list
65650648|NCT03982576|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65650649|NCT03982576|Autonomic Agents|autonomic agents|mesh-ancestor
65650650|NCT03982576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650651|NCT03982576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650652|NCT03982576|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65650653|NCT03982576|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65650654|NCT03982576|Cholinergic Agents|cholinergic agents|mesh-ancestor
65650655|NCT03982576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650656|NCT03982576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650657|NCT04172246|Zanubrutinib|zanubrutinib|mesh-list
65650658|NCT04172246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65650659|NCT04172246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65650660|NCT04172246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650661|NCT04172246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650662|NCT02675842|Dronabinol|dronabinol|mesh-list
65650663|NCT02675842|Hallucinogens|hallucinogens|mesh-ancestor
65650664|NCT02675842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650665|NCT02675842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65650666|NCT02675842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65650667|NCT02675842|Analgesics|analgesics|mesh-ancestor
65650668|NCT02675842|Sensory System Agents|sensory system agents|mesh-ancestor
65650669|NCT02675842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650670|NCT02675842|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65650671|NCT02675842|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65650672|NCT02675842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650673|NCT02675842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650674|NCT02675842|Hormones|hormones|mesh-ancestor
65650675|NCT02675842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65650676|NCT04528108|Hemostatics|hemostatics|mesh-list
65650677|NCT04528108|Coagulants|coagulants|mesh-ancestor
65650678|NCT05074121|Acetylcysteine|acetylcysteine|mesh-list
65650679|NCT05074121|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65650680|NCT05074121|Antiviral Agents|antiviral agents|mesh-ancestor
65650681|NCT05074121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65650682|NCT05074121|Expectorants|expectorants|mesh-ancestor
65650683|NCT05074121|Respiratory System Agents|respiratory system agents|mesh-ancestor
65650684|NCT05074121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65650685|NCT05074121|Antioxidants|antioxidants|mesh-ancestor
65650686|NCT05074121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650687|NCT05074121|Protective Agents|protective agents|mesh-ancestor
65650688|NCT05074121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650689|NCT05074121|Antidotes|antidotes|mesh-ancestor
65650690|NCT04251689|Mannitol|mannitol|mesh-list
65650691|NCT04251689|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65650692|NCT04251689|Diuretics|diuretics|mesh-ancestor
65650693|NCT04251689|Natriuretic Agents|natriuretic agents|mesh-ancestor
65650694|NCT04251689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650695|NCT04232423|Olanzapine|olanzapine|mesh-list
65650696|NCT04232423|Antiemetics|antiemetics|mesh-ancestor
65650697|NCT04232423|Autonomic Agents|autonomic agents|mesh-ancestor
65650698|NCT04232423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650699|NCT04232423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650700|NCT04232423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65650701|NCT04232423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65650702|NCT04232423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65650703|NCT04232423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65650704|NCT04232423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65650705|NCT04232423|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65650706|NCT04232423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65650707|NCT04232423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65650708|NCT04232423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650709|NCT04232423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650710|NCT04232423|Serotonin Agents|serotonin agents|mesh-ancestor
65650711|NCT05669833|Golimumab|golimumab|mesh-list
65650712|NCT05669833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65650713|NCT05669833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65650714|NCT05669833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65650715|NCT05669833|Immunologic Factors|immunologic factors|mesh-ancestor
65650716|NCT05669833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650717|NCT04178993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65650718|NCT04178993|Methylphenidate|methylphenidate|mesh-list
65650719|NCT04178993|Methamphetamine|methamphetamine|mesh-list
65650720|NCT04178993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65650721|NCT04178993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650722|NCT04178993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65650723|NCT04178993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65650724|NCT04178993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65650725|NCT04178993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650726|NCT04178993|Dopamine Agents|dopamine agents|mesh-ancestor
65650727|NCT04178993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650728|NCT04178993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65650729|NCT04178993|Analgesics|analgesics|mesh-ancestor
65650730|NCT04178993|Sensory System Agents|sensory system agents|mesh-ancestor
65650731|NCT04178993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650732|NCT04178993|Antidepressive Agents|antidepressive agents|mesh-ancestor
65650733|NCT04178993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65650734|NCT04178993|Sympathomimetics|sympathomimetics|mesh-ancestor
65650735|NCT04178993|Autonomic Agents|autonomic agents|mesh-ancestor
65650736|NCT04178993|Adrenergic Agents|adrenergic agents|mesh-ancestor
65650737|NCT04178993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65650738|NCT04436536|Methamphetamine|methamphetamine|mesh-list
65650739|NCT04436536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65650740|NCT04436536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650741|NCT04436536|Sympathomimetics|sympathomimetics|mesh-ancestor
65650742|NCT04436536|Autonomic Agents|autonomic agents|mesh-ancestor
65650743|NCT04436536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650744|NCT04436536|Dopamine Agents|dopamine agents|mesh-ancestor
65650745|NCT04436536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650746|NCT04436536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650747|NCT04436536|Adrenergic Agents|adrenergic agents|mesh-ancestor
65650748|NCT04436536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65650749|NCT04436536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65650750|NCT04436536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65650751|NCT04436536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65650752|NCT03997097|Sildenafil Citrate|sildenafil citrate|mesh-list
65650753|NCT03997097|Vasodilator Agents|vasodilator agents|mesh-ancestor
65650754|NCT03997097|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65650755|NCT03997097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65650756|NCT03997097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650757|NCT03997097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650758|NCT03997097|Urological Agents|urological agents|mesh-ancestor
65650759|NCT05762003|Interferons|interferons|mesh-list
65650760|NCT05762003|Teriflunomide|teriflunomide|mesh-list
65650761|NCT05762003|Rituximab|rituximab|mesh-list
65650762|NCT05762003|Alemtuzumab|alemtuzumab|mesh-list
65650763|NCT05762003|Ofatumumab|ofatumumab|mesh-list
65650764|NCT05762003|Cladribine|cladribine|mesh-list
65650765|NCT05762003|Glatiramer Acetate|glatiramer acetate|mesh-list
65650766|NCT05762003|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65650767|NCT05762003|Ocrelizumab|ocrelizumab|mesh-list
65650768|NCT05762003|Natalizumab|natalizumab|mesh-list
65650769|NCT05762003|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65650770|NCT05762003|(T,G)-A-L|(t,g)-a-l|mesh-list
65650771|NCT05762003|Ponesimod|ponesimod|mesh-list
65650772|NCT05762003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65650773|NCT05762003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65650774|NCT05762003|Immunologic Factors|immunologic factors|mesh-ancestor
65650775|NCT05762003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650776|NCT05762003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65650777|NCT05762003|Antiviral Agents|antiviral agents|mesh-ancestor
65650778|NCT05762003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65650779|NCT05762003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65650780|NCT05762003|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65650781|NCT05762003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650782|NCT05762003|Dermatologic Agents|dermatologic agents|mesh-ancestor
65650783|NCT05762003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65650784|NCT05762003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65650785|NCT05762003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65650786|NCT05762003|Analgesics|analgesics|mesh-ancestor
65650787|NCT05762003|Sensory System Agents|sensory system agents|mesh-ancestor
65650788|NCT05762003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650789|NCT05762003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65650790|NCT04094012|Isoniazid|isoniazid|mesh-list
65650791|NCT04094012|Rifapentine|rifapentine|mesh-list
65650792|NCT04094012|Antitubercular Agents|antitubercular agents|mesh-ancestor
65650793|NCT04094012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65650794|NCT04094012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65650795|NCT04094012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65650796|NCT04094012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65650797|NCT04094012|Antimetabolites|antimetabolites|mesh-ancestor
65650798|NCT04094012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650799|NCT04094012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65650800|NCT04094012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65650801|NCT04094012|Leprostatic Agents|leprostatic agents|mesh-ancestor
65650802|NCT04644016|Cyclosporine|cyclosporine|mesh-list
65650803|NCT04644016|Mycophenolic Acid|mycophenolic acid|mesh-list
65650804|NCT04644016|Fludarabine|fludarabine|mesh-list
65650805|NCT04644016|Busulfan|busulfan|mesh-list
65650806|NCT04644016|Clofarabine|clofarabine|mesh-list
65448229|NCT00006916|Bleomycin|bleomycin|mesh-list
65650807|NCT04644016|Cyclosporins|cyclosporins|mesh-list
65650808|NCT04644016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65650809|NCT04644016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65650810|NCT04644016|Antimetabolites|antimetabolites|mesh-ancestor
65650811|NCT04644016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650812|NCT04644016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65650813|NCT04644016|Immunologic Factors|immunologic factors|mesh-ancestor
65650814|NCT04644016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650815|NCT04644016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650816|NCT04644016|Antifungal Agents|antifungal agents|mesh-ancestor
65650817|NCT04644016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65650818|NCT04644016|Dermatologic Agents|dermatologic agents|mesh-ancestor
65650819|NCT04644016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65650820|NCT04644016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65650821|NCT04644016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65650822|NCT04644016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65650823|NCT04644016|Antitubercular Agents|antitubercular agents|mesh-ancestor
65650824|NCT04644016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65650825|NCT04644016|Alkylating Agents|alkylating agents|mesh-ancestor
65650826|NCT04644016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65650827|NCT04644016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65650828|NCT03679676|Omalizumab|omalizumab|mesh-list
65650829|NCT03679676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65650830|NCT03679676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65650831|NCT03679676|Respiratory System Agents|respiratory system agents|mesh-ancestor
65650832|NCT03001557|Lemborexant|lemborexant|mesh-list
65650833|NCT03001557|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65650834|NCT03001557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650835|NCT03001557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650836|NCT03001557|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65650837|NCT03001557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65650838|NCT03001557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65650839|NCT03001557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650840|NCT03134612|Lidocaine|lidocaine|mesh-list
65650841|NCT03134612|Ondansetron|ondansetron|mesh-list
65650842|NCT03134612|Anesthetics, Local|anesthetics, local|mesh-ancestor
65650843|NCT03134612|Anesthetics|anesthetics|mesh-ancestor
65650844|NCT03134612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65650845|NCT03134612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650846|NCT03134612|Sensory System Agents|sensory system agents|mesh-ancestor
65650847|NCT03134612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650848|NCT03134612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65650849|NCT03134612|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65650850|NCT03134612|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65650851|NCT03134612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65650852|NCT03134612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650853|NCT03134612|Antiemetics|antiemetics|mesh-ancestor
65650854|NCT03134612|Autonomic Agents|autonomic agents|mesh-ancestor
65650855|NCT03134612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65650856|NCT03134612|Antipruritics|antipruritics|mesh-ancestor
65650857|NCT03134612|Dermatologic Agents|dermatologic agents|mesh-ancestor
65650858|NCT03134612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65650859|NCT03134612|Serotonin Agents|serotonin agents|mesh-ancestor
65650860|NCT03134612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650861|NCT03134612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65650862|NCT03134612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65650863|NCT03134612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65650864|NCT03134612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65650865|NCT00831662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65650866|NCT00831662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65650867|NCT04365985|Naltrexone|naltrexone|mesh-list
65650868|NCT04365985|Ketamine|ketamine|mesh-list
65650869|NCT04365985|Analgesics|analgesics|mesh-ancestor
65650870|NCT04365985|Sensory System Agents|sensory system agents|mesh-ancestor
65650871|NCT04365985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650872|NCT04365985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650873|NCT04365985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65650874|NCT04365985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65650875|NCT04365985|Anesthetics, General|anesthetics, general|mesh-ancestor
65650876|NCT04365985|Anesthetics|anesthetics|mesh-ancestor
65650877|NCT04365985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65650878|NCT04365985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65650879|NCT04365985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65650880|NCT04365985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650881|NCT04365985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650882|NCT04365985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65650883|NCT04365985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65650884|NCT05111860|Bevacizumab|bevacizumab|mesh-list
65650885|NCT05111860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65650886|NCT05111860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65650887|NCT05111860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65650888|NCT05111860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65650889|NCT05111860|Growth Substances|growth substances|mesh-ancestor
65650890|NCT05111860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650891|NCT05111860|Growth Inhibitors|growth inhibitors|mesh-ancestor
65650892|NCT00830336|Azithromycin|azithromycin|mesh-list
65650893|NCT00830336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65650894|NCT00830336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65650895|NCT00830258|Pravastatin|pravastatin|mesh-list
65650896|NCT00830258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65650897|NCT00830258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65650898|NCT00830258|Antimetabolites|antimetabolites|mesh-ancestor
65650899|NCT00830258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650900|NCT00830258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65650901|NCT00830258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65650902|NCT00830258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65650903|NCT00830102|Fluticasone|fluticasone|mesh-list
65650904|NCT00830102|Xhance|xhance|mesh-list
65650905|NCT00830102|Formoterol Fumarate|formoterol fumarate|mesh-list
65650906|NCT00830102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65650907|NCT00830102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65650908|NCT00830102|Autonomic Agents|autonomic agents|mesh-ancestor
65650909|NCT00830102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65650910|NCT00830102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650911|NCT00830102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65650912|NCT00830102|Respiratory System Agents|respiratory system agents|mesh-ancestor
65650913|NCT00830102|Dermatologic Agents|dermatologic agents|mesh-ancestor
65650914|NCT00830102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65650915|NCT00830102|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65650916|NCT00830102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65650917|NCT00830102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65650918|NCT00830102|Adrenergic Agents|adrenergic agents|mesh-ancestor
65650919|NCT00830102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650920|NCT00830102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650921|NCT03349775|Metformin|metformin|mesh-list
65650922|NCT03349775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65650923|NCT03349775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650924|NCT00830024|Alprazolam|alprazolam|mesh-list
65650925|NCT00830024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65650926|NCT00830024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65650927|NCT00830024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650928|NCT00830024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65650929|NCT00830024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65650930|NCT00830024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65650931|NCT00830024|GABA Modulators|gaba modulators|mesh-ancestor
65650932|NCT00830024|GABA Agents|gaba agents|mesh-ancestor
65113675|NCT05657704|Tramadol|tramadol|mesh-list
65650933|NCT00830024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650934|NCT00830024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650935|NCT00829868|Zaleplon|zaleplon|mesh-list
65650936|NCT00829868|Anticonvulsants|anticonvulsants|mesh-ancestor
65650937|NCT00829868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65650938|NCT00829868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65650939|NCT00829868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650940|NCT00829868|GABA Modulators|gaba modulators|mesh-ancestor
65650941|NCT00829868|GABA Agents|gaba agents|mesh-ancestor
65650942|NCT00829868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650943|NCT00829868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650944|NCT00721760|Enoxaparin|enoxaparin|mesh-list
65650945|NCT00721760|Semuloparin|semuloparin|mesh-list
65650946|NCT00721760|Enoxaparin sodium|enoxaparin sodium|mesh-list
65650947|NCT00721760|Anticoagulants|anticoagulants|mesh-ancestor
65650948|NCT00721760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65650949|NCT00721760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65650950|NCT00721760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650951|NCT00829790|Doxycycline|doxycycline|mesh-list
65650952|NCT00829790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65650953|NCT00829790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65650954|NCT00829790|Antimalarials|antimalarials|mesh-ancestor
65650955|NCT00829790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65650956|NCT00829790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65650957|NCT03207815|Prednisone|prednisone|mesh-list
65650958|NCT03207815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65650959|NCT03207815|Glucocorticoids|glucocorticoids|mesh-ancestor
65650960|NCT03207815|Hormones|hormones|mesh-ancestor
65650961|NCT03207815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65650962|NCT03207815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650963|NCT03207815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65650964|NCT03207815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65650966|NCT02911935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65650967|NCT02911935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65650968|NCT05193487|Anesthetics|anesthetics|mesh-list
65650969|NCT05193487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65650970|NCT05193487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650971|NCT03479762|Liraglutide|liraglutide|mesh-list
65650972|NCT03479762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65650973|NCT03479762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650974|NCT03479762|Incretins|incretins|mesh-ancestor
65650975|NCT03479762|Hormones|hormones|mesh-ancestor
65650976|NCT03479762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65650977|NCT00829712|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
65650978|NCT00829712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65650979|NCT00829712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65650980|NCT00829712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65650981|NCT00829712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65650982|NCT00829712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65650983|NCT00829712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650984|NCT00829712|Dopamine Agents|dopamine agents|mesh-ancestor
65650985|NCT00829712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65650986|NCT05079802|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65650987|NCT05079802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65650988|NCT05079802|Chitosan|chitosan|mesh-list
65650989|NCT05079802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65650990|NCT05079802|Antitubercular Agents|antitubercular agents|mesh-ancestor
65650991|NCT05079802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65650992|NCT05079802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65650993|NCT05079802|Antimetabolites|antimetabolites|mesh-ancestor
65650994|NCT05079802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65650995|NCT05079802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65650996|NCT05079802|Chelating Agents|chelating agents|mesh-ancestor
65650997|NCT05079802|Sequestering Agents|sequestering agents|mesh-ancestor
65650998|NCT05079802|Hemostatics|hemostatics|mesh-ancestor
65650999|NCT05079802|Coagulants|coagulants|mesh-ancestor
65651000|NCT05203055|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65651001|NCT05203055|Interferon-alpha|interferon-alpha|mesh-list
65651002|NCT05203055|Antiviral Agents|antiviral agents|mesh-ancestor
65651003|NCT05203055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65651004|NCT05203055|Immunologic Factors|immunologic factors|mesh-ancestor
65651005|NCT05203055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651006|NCT03899636|Folfirinox|folfirinox|mesh-list
65651007|NCT03899636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651008|NCT05761223|Pembrolizumab|pembrolizumab|mesh-list
65651009|NCT05761223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65651010|NCT05761223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651011|NCT03386942|Farletuzumab|farletuzumab|mesh-list
65651012|NCT03386942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651013|NCT04910230|Niacinamide|niacinamide|mesh-list
65651014|NCT04910230|Niacin|niacin|mesh-list
65651015|NCT04910230|Nicotinic Acids|nicotinic acids|mesh-list
65651016|NCT04910230|Vitamin B Complex|vitamin b complex|mesh-ancestor
65651017|NCT04910230|Vitamins|vitamins|mesh-ancestor
65651018|NCT04910230|Micronutrients|micronutrients|mesh-ancestor
65651019|NCT04910230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651020|NCT04910230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65651021|NCT04910230|Antimetabolites|antimetabolites|mesh-ancestor
65651022|NCT04910230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651023|NCT04910230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65651024|NCT04910230|Vasodilator Agents|vasodilator agents|mesh-ancestor
65651025|NCT04995094|Pembrolizumab|pembrolizumab|mesh-list
65651026|NCT04995094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65651027|NCT04995094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651028|NCT05202821|Fluorides|fluorides|mesh-list
65651029|NCT05202821|Fluorides, Topical|fluorides, topical|mesh-list
65651030|NCT05202821|Cariostatic Agents|cariostatic agents|mesh-ancestor
65651031|NCT05202821|Protective Agents|protective agents|mesh-ancestor
65651032|NCT05202821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651033|NCT02560805|Losartan|losartan|mesh-list
65651034|NCT02560805|Atenolol|atenolol|mesh-list
65651035|NCT02560805|Nitroprusside|nitroprusside|mesh-list
65651036|NCT02560805|Phenylephrine|phenylephrine|mesh-list
65651037|NCT02560805|Oxymetazoline|oxymetazoline|mesh-list
65651038|NCT02560805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65651039|NCT02560805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65651040|NCT02560805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65651041|NCT02560805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65651042|NCT02560805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651043|NCT02560805|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65651044|NCT02560805|Mydriatics|mydriatics|mesh-ancestor
65651045|NCT02560805|Autonomic Agents|autonomic agents|mesh-ancestor
65651046|NCT02560805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65651047|NCT02560805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651048|NCT02560805|Sympathomimetics|sympathomimetics|mesh-ancestor
65651049|NCT02560805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65651050|NCT02560805|Nasal Decongestants|nasal decongestants|mesh-ancestor
65651051|NCT02560805|Respiratory System Agents|respiratory system agents|mesh-ancestor
65651052|NCT02560805|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65651053|NCT02560805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65651054|NCT02560805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65651055|NCT02560805|Adrenergic Agents|adrenergic agents|mesh-ancestor
65651056|NCT02560805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65651057|NCT02560805|Protective Agents|protective agents|mesh-ancestor
65651058|NCT02560805|Sympatholytics|sympatholytics|mesh-ancestor
65651059|NCT02560805|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65651060|NCT02560805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65651061|NCT02560805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65651062|NCT02560805|Vasodilator Agents|vasodilator agents|mesh-ancestor
65651063|NCT02560805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65651064|NCT04615936|Methylene Blue|methylene blue|mesh-list
65651065|NCT04615936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651066|NCT04615936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651067|NCT03797222|Vitamin E|vitamin e|mesh-list
65651068|NCT03797222|Tocopherols|tocopherols|mesh-list
65651069|NCT03797222|alpha-Tocopherol|alpha-tocopherol|mesh-list
65651070|NCT03797222|Vitamins|vitamins|mesh-ancestor
65651071|NCT03797222|Micronutrients|micronutrients|mesh-ancestor
65651072|NCT03797222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651073|NCT03797222|Antioxidants|antioxidants|mesh-ancestor
65651074|NCT03797222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651075|NCT03797222|Protective Agents|protective agents|mesh-ancestor
65651076|NCT03755102|Osimertinib|osimertinib|mesh-list
65651077|NCT03755102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651078|NCT03755102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65651079|NCT03755102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651080|NCT03755102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651081|NCT04471675|Docetaxel|docetaxel|mesh-list
65651082|NCT04471675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651083|NCT04471675|Tubulin Modulators|tubulin modulators|mesh-ancestor
65651084|NCT04471675|Antimitotic Agents|antimitotic agents|mesh-ancestor
65651085|NCT04471675|Mitosis Modulators|mitosis modulators|mesh-ancestor
65651086|NCT04471675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651087|NCT04461028|Dexamethasone|dexamethasone|mesh-list
65651088|NCT04461028|Bupivacaine|bupivacaine|mesh-list
65651089|NCT04461028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65651090|NCT04461028|Antiemetics|antiemetics|mesh-ancestor
65651091|NCT04461028|Autonomic Agents|autonomic agents|mesh-ancestor
65651092|NCT04461028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65651093|NCT04461028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651094|NCT04461028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65651095|NCT04461028|Glucocorticoids|glucocorticoids|mesh-ancestor
65651096|NCT04461028|Hormones|hormones|mesh-ancestor
65651097|NCT04461028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65651098|NCT04461028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65651099|NCT04461028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651100|NCT04461028|Anesthetics, Local|anesthetics, local|mesh-ancestor
65651101|NCT04461028|Anesthetics|anesthetics|mesh-ancestor
65651102|NCT04461028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65651103|NCT04461028|Sensory System Agents|sensory system agents|mesh-ancestor
65651104|NCT00716534|Paclitaxel|paclitaxel|mesh-list
65651105|NCT00716534|Carboplatin|carboplatin|mesh-list
65651106|NCT00716534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65651107|NCT00716534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651108|NCT00716534|Tubulin Modulators|tubulin modulators|mesh-ancestor
65651109|NCT00716534|Antimitotic Agents|antimitotic agents|mesh-ancestor
65651110|NCT00716534|Mitosis Modulators|mitosis modulators|mesh-ancestor
65651111|NCT00716534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651112|NCT04335058|Iron|iron|mesh-list
65651113|NCT04335058|Lactoferrin|lactoferrin|mesh-list
65651114|NCT04335058|Trace Elements|trace elements|mesh-ancestor
65651115|NCT04335058|Micronutrients|micronutrients|mesh-ancestor
65651116|NCT04335058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651117|NCT04335058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65651118|NCT02283476|Gemcitabine|gemcitabine|mesh-list
65651119|NCT02283476|Endostar protein|endostar protein|mesh-list
65651120|NCT02283476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651121|NCT02283476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65651122|NCT02283476|Antimetabolites|antimetabolites|mesh-ancestor
65651123|NCT02283476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651124|NCT02283476|Antiviral Agents|antiviral agents|mesh-ancestor
65651125|NCT02283476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65651126|NCT02283476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651127|NCT02283476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65651128|NCT02283476|Immunologic Factors|immunologic factors|mesh-ancestor
65651129|NCT02283476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651130|NCT02283476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65651131|NCT02283476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65651132|NCT02283476|Growth Substances|growth substances|mesh-ancestor
65651133|NCT02283476|Growth Inhibitors|growth inhibitors|mesh-ancestor
65651135|NCT05156879|Drospirenone|drospirenone|mesh-list
65651136|NCT05156879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65651137|NCT05156879|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65651138|NCT05156879|Estradiol|estradiol|mesh-list
65651139|NCT05156879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65651140|NCT05156879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65651141|NCT05156879|Analgesics|analgesics|mesh-ancestor
65651142|NCT05156879|Sensory System Agents|sensory system agents|mesh-ancestor
65651143|NCT05156879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65651144|NCT05156879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651145|NCT05156879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65651146|NCT05156879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65651147|NCT05156879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65651148|NCT05156879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65651149|NCT05156879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651150|NCT05156879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65651151|NCT05156879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65651152|NCT05156879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651153|NCT05156879|Antipyretics|antipyretics|mesh-ancestor
65651154|NCT05156879|Estrogens|estrogens|mesh-ancestor
65651155|NCT05156879|Hormones|hormones|mesh-ancestor
65651156|NCT05156879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65651157|NCT05156879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65651158|NCT05156879|Contraceptive Agents|contraceptive agents|mesh-ancestor
65651159|NCT05156879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65651160|NCT05156879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65651161|NCT05156879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65651162|NCT05156879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65651163|NCT05156879|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65651164|NCT05156879|Hormone Antagonists|hormone antagonists|mesh-ancestor
65651165|NCT05156879|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65651166|NCT05156879|Diuretics|diuretics|mesh-ancestor
65651167|NCT05156879|Natriuretic Agents|natriuretic agents|mesh-ancestor
65651168|NCT02283554|Metformin|metformin|mesh-list
65651169|NCT02283554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65651170|NCT02283554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651171|NCT00641732|Enoxaparin|enoxaparin|mesh-list
65651172|NCT00641732|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
65651173|NCT00641732|Anticoagulants|anticoagulants|mesh-ancestor
65651174|NCT00641732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65651175|NCT00641732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65651176|NCT00641732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651177|NCT00641732|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65651178|NCT00641732|Antithrombins|antithrombins|mesh-ancestor
65651179|NCT00641732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65651180|NCT00641732|Protease Inhibitors|protease inhibitors|mesh-ancestor
65651181|NCT00641732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651182|NCT00790829|Nicotine|nicotine|mesh-list
65651183|NCT00790829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65651184|NCT00790829|Autonomic Agents|autonomic agents|mesh-ancestor
65651185|NCT00790829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65651186|NCT00790829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651187|NCT00790829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65651188|NCT00790829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65651189|NCT00790829|Cholinergic Agents|cholinergic agents|mesh-ancestor
65651190|NCT00790829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65651191|NCT00790829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651192|NCT00640484|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65651193|NCT00640484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65651194|NCT00640484|Autonomic Agents|autonomic agents|mesh-ancestor
65651195|NCT00640484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65651196|NCT00640484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651197|NCT00640484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65651198|NCT00640484|Respiratory System Agents|respiratory system agents|mesh-ancestor
65651199|NCT00640484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65651200|NCT00640484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65651201|NCT00640484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65651202|NCT00640484|Adrenergic Agents|adrenergic agents|mesh-ancestor
65651203|NCT00640484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65651204|NCT00640484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651205|NCT03065933|Clonidine|clonidine|mesh-list
65651206|NCT03065933|Analgesics|analgesics|mesh-ancestor
65651207|NCT03065933|Sensory System Agents|sensory system agents|mesh-ancestor
65651208|NCT03065933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65651209|NCT03065933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651210|NCT03065933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65651211|NCT03065933|Sympatholytics|sympatholytics|mesh-ancestor
65651212|NCT03065933|Autonomic Agents|autonomic agents|mesh-ancestor
65651213|NCT03065933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65651214|NCT03065933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65651215|NCT03065933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65651216|NCT03065933|Adrenergic Agents|adrenergic agents|mesh-ancestor
65651217|NCT03065933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65651218|NCT03065933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651219|NCT00630656|Talactoferrin alfa|talactoferrin alfa|mesh-list
65651220|NCT00630656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651221|NCT04256629|Allopurinol|allopurinol|mesh-list
65651222|NCT04256629|Verinurad|verinurad|mesh-list
65651223|NCT04256629|Antimetabolites|antimetabolites|mesh-ancestor
65651224|NCT04256629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651225|NCT04256629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651226|NCT04256629|Gout Suppressants|gout suppressants|mesh-ancestor
65651227|NCT04256629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65651228|NCT04256629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65651229|NCT04256629|Antioxidants|antioxidants|mesh-ancestor
65651230|NCT04256629|Protective Agents|protective agents|mesh-ancestor
65651231|NCT04256629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651232|NCT05206721|Chlorhexidine|chlorhexidine|mesh-list
65651233|NCT05206721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65651234|NCT05206721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65651235|NCT05206721|Disinfectants|disinfectants|mesh-ancestor
65651236|NCT00696332|alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid|mesh-list
65651237|NCT00696332|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
65651238|NCT00696332|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65651239|NCT00696332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65651240|NCT00696332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651241|NCT00696332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651242|NCT05125523|Sirolimus|sirolimus|mesh-list
65651243|NCT05125523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65651244|NCT05125523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65651245|NCT05125523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65651246|NCT05125523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651247|NCT05125523|Antifungal Agents|antifungal agents|mesh-ancestor
65651248|NCT05125523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65651249|NCT05125523|Immunologic Factors|immunologic factors|mesh-ancestor
65651250|NCT05125523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651251|NCT00625664|Gemcitabine|gemcitabine|mesh-list
65651252|NCT00625664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651253|NCT00625664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65651254|NCT00625664|Antimetabolites|antimetabolites|mesh-ancestor
65651255|NCT00625664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651256|NCT00625664|Antiviral Agents|antiviral agents|mesh-ancestor
65651257|NCT00625664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65651258|NCT00625664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651259|NCT00625664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65651260|NCT00625664|Immunologic Factors|immunologic factors|mesh-ancestor
65651261|NCT00625664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651263|NCT02947165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65651264|NCT02947165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651265|NCT02947165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651266|NCT03629093|Anesthetics|anesthetics|mesh-list
65651267|NCT03629093|Anesthetics, General|anesthetics, general|mesh-list
65651268|NCT03629093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65651269|NCT03629093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651270|NCT02283710|Pentoxifylline|pentoxifylline|mesh-list
65651271|NCT02283710|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65651272|NCT02283710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651273|NCT02283710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651274|NCT02283710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65651275|NCT02283710|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65651276|NCT02283710|Protective Agents|protective agents|mesh-ancestor
65651277|NCT02283710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651278|NCT02283710|Vasodilator Agents|vasodilator agents|mesh-ancestor
65114041|NCT05424393|Etanercept|etanercept|mesh-list
65651279|NCT02283710|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65651280|NCT02283710|Antioxidants|antioxidants|mesh-ancestor
65651281|NCT05055947|Atezolizumab|atezolizumab|mesh-list
65651282|NCT05055947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651283|NCT03943342|Venetoclax|venetoclax|mesh-list
65651284|NCT03943342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651285|NCT00357565|Cyclosporine|cyclosporine|mesh-list
65651286|NCT00357565|Mycophenolic Acid|mycophenolic acid|mesh-list
65651287|NCT00357565|Fludarabine|fludarabine|mesh-list
65651288|NCT00357565|Fludarabine phosphate|fludarabine phosphate|mesh-list
65651289|NCT00357565|Melphalan|melphalan|mesh-list
65651290|NCT00357565|Busulfan|busulfan|mesh-list
65651291|NCT00357565|Cyclosporins|cyclosporins|mesh-list
65651292|NCT00357565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651293|NCT00357565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65651294|NCT00357565|Antimetabolites|antimetabolites|mesh-ancestor
65651295|NCT00357565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651296|NCT00357565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65651297|NCT00357565|Immunologic Factors|immunologic factors|mesh-ancestor
65651298|NCT00357565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651299|NCT00357565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651300|NCT00357565|Antifungal Agents|antifungal agents|mesh-ancestor
65651301|NCT00357565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65651302|NCT00357565|Dermatologic Agents|dermatologic agents|mesh-ancestor
65651303|NCT00357565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65651304|NCT00357565|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65651305|NCT00357565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65651306|NCT00357565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65651307|NCT00357565|Antitubercular Agents|antitubercular agents|mesh-ancestor
65651308|NCT00357565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65651309|NCT00357565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65651310|NCT00357565|Alkylating Agents|alkylating agents|mesh-ancestor
65651311|NCT00357565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65651312|NCT00694928|Clindamycin|clindamycin|mesh-list
65651313|NCT00694928|Clindamycin palmitate|clindamycin palmitate|mesh-list
65651314|NCT00694928|Clindamycin phosphate|clindamycin phosphate|mesh-list
65651315|NCT00694928|Butoconazole|butoconazole|mesh-list
65651316|NCT00694928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65651317|NCT00694928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65651318|NCT00694928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65651319|NCT00694928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651320|NCT00694928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651321|NCT00694928|Antifungal Agents|antifungal agents|mesh-ancestor
65651322|NCT03272464|Trametinib|trametinib|mesh-list
65651323|NCT03272464|Dabrafenib|dabrafenib|mesh-list
65651324|NCT03272464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651325|NCT03272464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65651326|NCT03272464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651327|NCT03272464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651328|NCT00694382|Semuloparin|semuloparin|mesh-list
65651329|NCT00694382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65651330|NCT00694382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65651331|NCT00694382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65651332|NCT00694382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651333|NCT00694382|Anticoagulants|anticoagulants|mesh-ancestor
65651334|NCT05116228|Rituximab|rituximab|mesh-list
65651335|NCT05116228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65651336|NCT05116228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651337|NCT05116228|Immunologic Factors|immunologic factors|mesh-ancestor
65651338|NCT05116228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651340|NCT05116150|Grape Seed Extract|grape seed extract|mesh-list
65651341|NCT05116150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65651342|NCT05116150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651343|NCT05116150|Antioxidants|antioxidants|mesh-ancestor
65651344|NCT05116150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651345|NCT05116150|Protective Agents|protective agents|mesh-ancestor
65651346|NCT05116150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651347|NCT00136903|Cyclosporine|cyclosporine|mesh-list
65651348|NCT00136903|Mycophenolic Acid|mycophenolic acid|mesh-list
65651349|NCT00136903|Remestemcel-l|remestemcel-l|mesh-list
65651350|NCT00136903|Prednisone|prednisone|mesh-list
65651351|NCT00136903|Methylprednisolone|methylprednisolone|mesh-list
65651352|NCT00136903|Tacrolimus|tacrolimus|mesh-list
65651353|NCT00136903|Cyclosporins|cyclosporins|mesh-list
65651354|NCT00136903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65651355|NCT00136903|Glucocorticoids|glucocorticoids|mesh-ancestor
65651356|NCT00136903|Hormones|hormones|mesh-ancestor
65651357|NCT00136903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65651358|NCT00136903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651359|NCT00136903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65651360|NCT00136903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651361|NCT00136903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65651362|NCT00136903|Immunologic Factors|immunologic factors|mesh-ancestor
65651363|NCT00136903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65651364|NCT00136903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651365|NCT00136903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651366|NCT00136903|Antifungal Agents|antifungal agents|mesh-ancestor
65651367|NCT00136903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65651368|NCT00136903|Dermatologic Agents|dermatologic agents|mesh-ancestor
65651369|NCT00136903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65651370|NCT00136903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65651371|NCT00136903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65651372|NCT00136903|Antitubercular Agents|antitubercular agents|mesh-ancestor
65651373|NCT00136903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65651374|NCT00136903|Antiemetics|antiemetics|mesh-ancestor
65651375|NCT00136903|Autonomic Agents|autonomic agents|mesh-ancestor
65651376|NCT00136903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65651377|NCT00136903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65651378|NCT00136903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65651379|NCT00136903|Protective Agents|protective agents|mesh-ancestor
65651380|NCT00136903|Antiviral Agents|antiviral agents|mesh-ancestor
65651381|NCT04917029|Dexmedetomidine|dexmedetomidine|mesh-list
65651382|NCT04917029|Bupivacaine|bupivacaine|mesh-list
65651383|NCT04917029|Anesthetics, Local|anesthetics, local|mesh-ancestor
65651384|NCT04917029|Anesthetics|anesthetics|mesh-ancestor
65651385|NCT04917029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65651386|NCT04917029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651387|NCT04917029|Sensory System Agents|sensory system agents|mesh-ancestor
65651388|NCT04917029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65651389|NCT04917029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65651390|NCT04917029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65651391|NCT04917029|Analgesics|analgesics|mesh-ancestor
65651392|NCT04917029|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65651393|NCT04917029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65651394|NCT04917029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65651395|NCT04917029|Adrenergic Agents|adrenergic agents|mesh-ancestor
65651396|NCT04917029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65651397|NCT04917029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651398|NCT04189510|Pancrelipase|pancrelipase|mesh-list
65651399|NCT04189510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65651400|NCT03632759|Liraglutide|liraglutide|mesh-list
65651401|NCT03632759|Golimumab|golimumab|mesh-list
65651402|NCT03632759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65651403|NCT03632759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651404|NCT03632759|Incretins|incretins|mesh-ancestor
65651405|NCT03632759|Hormones|hormones|mesh-ancestor
65651406|NCT03632759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65651407|NCT03632759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65651408|NCT03632759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65651409|NCT03632759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65651410|NCT03632759|Immunologic Factors|immunologic factors|mesh-ancestor
65651411|NCT02953093|Acarbose|acarbose|mesh-list
65651412|NCT02953093|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65651413|NCT02953093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651414|NCT02953093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651415|NCT02953093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65651416|NCT02953093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651417|NCT04518280|Capecitabine|capecitabine|mesh-list
65651418|NCT04518280|Oxaliplatin|oxaliplatin|mesh-list
65651419|NCT04518280|Antibodies|antibodies|mesh-list
65651420|NCT04518280|Immunologic Factors|immunologic factors|mesh-ancestor
65651421|NCT04518280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651422|NCT04518280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65651423|NCT04518280|Antimetabolites|antimetabolites|mesh-ancestor
65651424|NCT04518280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651425|NCT04518280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651426|NCT00498836|Sorafenib|sorafenib|mesh-list
65651427|NCT00498836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651428|NCT00498836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65651429|NCT00498836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651430|NCT00498836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651431|NCT02283866|Desflurane|desflurane|mesh-list
65651432|NCT02283866|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65651433|NCT02283866|Anesthetics, General|anesthetics, general|mesh-ancestor
65651434|NCT02283866|Anesthetics|anesthetics|mesh-ancestor
65651435|NCT02283866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65651436|NCT02283866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651437|NCT04517110|Pregabalin|pregabalin|mesh-list
65651438|NCT04517110|Analgesics|analgesics|mesh-ancestor
65651439|NCT04517110|Sensory System Agents|sensory system agents|mesh-ancestor
65651440|NCT04517110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65651441|NCT04517110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651442|NCT04517110|Anticonvulsants|anticonvulsants|mesh-ancestor
65651443|NCT04517110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65651444|NCT04517110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65651445|NCT04517110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651446|NCT04517110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65651447|NCT04517110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65651448|NCT04517110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65651449|NCT04517110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65651450|NCT04517110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65651451|NCT00498212|1018 oligonucleotide|1018 oligonucleotide|mesh-list
65651452|NCT00498212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65651453|NCT00498212|Immunologic Factors|immunologic factors|mesh-ancestor
65651454|NCT00498212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651455|NCT02281058|Abatacept|abatacept|mesh-list
65651456|NCT02281058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65651457|NCT02281058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651458|NCT02281058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651459|NCT02281058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65651460|NCT02281058|Immunologic Factors|immunologic factors|mesh-ancestor
65651461|NCT02281058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651462|NCT02281058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65651463|NCT02784262|Botulinum Toxins|botulinum toxins|mesh-list
65651464|NCT02784262|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65651465|NCT02784262|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65651466|NCT02784262|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65651467|NCT02784262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65651468|NCT02784262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651469|NCT02784262|Cholinergic Agents|cholinergic agents|mesh-ancestor
65651470|NCT02784262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65651471|NCT02784262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651472|NCT02784262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65651473|NCT02784262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65651474|NCT05205317|Metformin|metformin|mesh-list
65651475|NCT05205317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65651476|NCT05205317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651477|NCT00691964|Etanercept|etanercept|mesh-list
65651478|NCT00691964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65651479|NCT00691964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65651480|NCT00691964|Analgesics|analgesics|mesh-ancestor
65651481|NCT00691964|Sensory System Agents|sensory system agents|mesh-ancestor
65651482|NCT00691964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65651483|NCT00691964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651484|NCT00691964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65651485|NCT00691964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65651486|NCT00691964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65651487|NCT00691964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65651488|NCT00691964|Immunologic Factors|immunologic factors|mesh-ancestor
65651489|NCT04470908|Rifabutin|rifabutin|mesh-list
65651490|NCT04470908|Zanubrutinib|zanubrutinib|mesh-list
65651491|NCT04470908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651492|NCT04470908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65651493|NCT04470908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651494|NCT04470908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651495|NCT04470908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65651496|NCT04470908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65651497|NCT04470908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65651498|NCT04470908|Antitubercular Agents|antitubercular agents|mesh-ancestor
65651499|NCT02281292|Ranibizumab|ranibizumab|mesh-list
65651500|NCT02281292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65651501|NCT02281292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65651502|NCT02281292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65651503|NCT02281292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65651504|NCT02281292|Growth Substances|growth substances|mesh-ancestor
65651505|NCT02281292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651506|NCT02281292|Growth Inhibitors|growth inhibitors|mesh-ancestor
65651507|NCT02281292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651508|NCT03723772|Insulin|insulin|mesh-list
65651509|NCT03723772|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65651510|NCT03723772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65651511|NCT03723772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651512|NCT03292133|Gefitinib|gefitinib|mesh-list
65651513|NCT03292133|Nazartinib|nazartinib|mesh-list
65651514|NCT03292133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651515|NCT03292133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65651516|NCT03292133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651517|NCT03292133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651518|NCT02660827|Insulin|insulin|mesh-list
65651519|NCT02660827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65651520|NCT02660827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651521|NCT00491738|Bevacizumab|bevacizumab|mesh-list
65651522|NCT00491738|Sunitinib|sunitinib|mesh-list
65651523|NCT00491738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65651524|NCT00491738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651525|NCT00491738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65651526|NCT00491738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65651527|NCT00491738|Growth Substances|growth substances|mesh-ancestor
65651528|NCT00491738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651529|NCT00491738|Growth Inhibitors|growth inhibitors|mesh-ancestor
65651530|NCT00491738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65651531|NCT00491738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651532|NCT00491738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651533|NCT04318678|Cyclophosphamide|cyclophosphamide|mesh-list
65651534|NCT04318678|Rituximab|rituximab|mesh-list
65651535|NCT04318678|Fludarabine|fludarabine|mesh-list
65651536|NCT04318678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65651537|NCT04318678|Immunologic Factors|immunologic factors|mesh-ancestor
65651538|NCT04318678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651539|NCT04318678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65651540|NCT04318678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65651541|NCT04318678|Alkylating Agents|alkylating agents|mesh-ancestor
65651542|NCT04318678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651543|NCT04318678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651544|NCT04318678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65651545|NCT04318678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65651546|NCT02281370|Cyclosporine|cyclosporine|mesh-list
65651547|NCT02281370|Cyclosporins|cyclosporins|mesh-list
65651548|NCT02281370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651549|NCT02281370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651550|NCT02281370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65651551|NCT02281370|Immunologic Factors|immunologic factors|mesh-ancestor
65651552|NCT02281370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651553|NCT02281370|Antifungal Agents|antifungal agents|mesh-ancestor
65651554|NCT02281370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65651555|NCT02281370|Dermatologic Agents|dermatologic agents|mesh-ancestor
65651556|NCT02281370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65651557|NCT02281370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65651558|NCT00680342|Silymarin|silymarin|mesh-list
65651559|NCT00680342|Antioxidants|antioxidants|mesh-ancestor
65651560|NCT00680342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651561|NCT00680342|Protective Agents|protective agents|mesh-ancestor
65651562|NCT00680342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651563|NCT04057365|Nivolumab|nivolumab|mesh-list
65651564|NCT04057365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65651565|NCT04057365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651566|NCT04057365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65651567|NCT04057365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651568|NCT00616148|Cenobamate|cenobamate|mesh-list
65651569|NCT00616148|Anticonvulsants|anticonvulsants|mesh-ancestor
65651570|NCT03622827|Endostar protein|endostar protein|mesh-list
65651571|NCT03622827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65651572|NCT03622827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65651573|NCT03622827|Growth Substances|growth substances|mesh-ancestor
65651574|NCT03622827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651575|NCT03622827|Growth Inhibitors|growth inhibitors|mesh-ancestor
65651576|NCT03622827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651577|NCT00486512|Aspirin|aspirin|mesh-list
65651578|NCT00486512|Calcium, Dietary|calcium, dietary|mesh-list
65651579|NCT00486512|Calcitriol|calcitriol|mesh-list
65651580|NCT00486512|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
65651581|NCT00486512|Calcium Carbonate|calcium carbonate|mesh-list
65651582|NCT00486512|Calcium|calcium|mesh-list
65651583|NCT00486512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65651584|NCT00486512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651585|NCT00486512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65651586|NCT00486512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65651587|NCT00486512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65651588|NCT00486512|Analgesics|analgesics|mesh-ancestor
65651589|NCT00486512|Sensory System Agents|sensory system agents|mesh-ancestor
65651590|NCT00486512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65651591|NCT00486512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65651592|NCT00486512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65651593|NCT00486512|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65651594|NCT00486512|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65651595|NCT00486512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651596|NCT00486512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65651597|NCT00486512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65651598|NCT00486512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651599|NCT00486512|Antipyretics|antipyretics|mesh-ancestor
65651600|NCT00486512|Antacids|antacids|mesh-ancestor
65651601|NCT00486512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65651602|NCT00486512|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65651603|NCT00486512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65651604|NCT00486512|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65651605|NCT00486512|Vitamins|vitamins|mesh-ancestor
65651606|NCT00486512|Micronutrients|micronutrients|mesh-ancestor
65651607|NCT04057989|Ketamine|ketamine|mesh-list
65651608|NCT04057989|Analgesics|analgesics|mesh-ancestor
65651609|NCT04057989|Sensory System Agents|sensory system agents|mesh-ancestor
65651610|NCT04057989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65651611|NCT04057989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651612|NCT04057989|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65651613|NCT04057989|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65651614|NCT04057989|Anesthetics, General|anesthetics, general|mesh-ancestor
65651615|NCT04057989|Anesthetics|anesthetics|mesh-ancestor
65651616|NCT04057989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65651617|NCT04057989|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65651618|NCT04057989|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65651619|NCT04057989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65651620|NCT04057989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651621|NCT00486200|Valacyclovir|valacyclovir|mesh-list
65651622|NCT00486200|Antiviral Agents|antiviral agents|mesh-ancestor
65651623|NCT00486200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65651624|NCT03463408|Nivolumab|nivolumab|mesh-list
65651625|NCT03463408|Ipilimumab|ipilimumab|mesh-list
65651626|NCT03463408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65651627|NCT03463408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651628|NCT03463408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65651629|NCT03463408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651630|NCT00479258|Insulin|insulin|mesh-list
65651631|NCT00479258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65651632|NCT00479258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65651633|NCT00479258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651634|NCT00612170|Reboxetine|reboxetine|mesh-list
65651635|NCT00612170|Antidepressive Agents|antidepressive agents|mesh-ancestor
65651636|NCT00612170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65651637|NCT00612170|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65651638|NCT00612170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65651639|NCT00612170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65651640|NCT00612170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651641|NCT00612170|Adrenergic Agents|adrenergic agents|mesh-ancestor
65651642|NCT00612170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65651643|NCT00612170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651645|NCT05068336|Sevoflurane|sevoflurane|mesh-list
65651646|NCT05068336|Desflurane|desflurane|mesh-list
65651647|NCT05068336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65651648|NCT05068336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651649|NCT05068336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65651650|NCT05068336|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65651651|NCT05068336|Anesthetics, General|anesthetics, general|mesh-ancestor
65651652|NCT00607256|Reboxetine|reboxetine|mesh-list
65651653|NCT00607256|Antidepressive Agents|antidepressive agents|mesh-ancestor
65651654|NCT00607256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65651655|NCT00607256|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65651656|NCT00607256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65651657|NCT00607256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65651658|NCT00607256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651659|NCT00607256|Adrenergic Agents|adrenergic agents|mesh-ancestor
65651660|NCT00607256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65651661|NCT00607256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651662|NCT02774590|Timolol|timolol|mesh-list
65651663|NCT02774590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65651664|NCT02774590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65651665|NCT02774590|Adrenergic Agents|adrenergic agents|mesh-ancestor
65651666|NCT02774590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65651667|NCT02774590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651668|NCT02774590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651669|NCT02774590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65651670|NCT02774590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65651671|NCT01069341|Ranibizumab|ranibizumab|mesh-list
65651672|NCT01069341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65651673|NCT01069341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65651674|NCT01069341|Growth Substances|growth substances|mesh-ancestor
65651675|NCT01069341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651676|NCT01069341|Growth Inhibitors|growth inhibitors|mesh-ancestor
65651677|NCT01069341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651678|NCT00676832|Prednisolone|prednisolone|mesh-list
65651679|NCT00676832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65651680|NCT00676832|Methylprednisolone|methylprednisolone|mesh-list
65651681|NCT00676832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65651682|NCT00676832|Prednisolone acetate|prednisolone acetate|mesh-list
65651683|NCT00676832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65651684|NCT00676832|Prednisolone phosphate|prednisolone phosphate|mesh-list
65651685|NCT00676832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65651686|NCT00676832|Glucocorticoids|glucocorticoids|mesh-ancestor
65651687|NCT00676832|Hormones|hormones|mesh-ancestor
65651688|NCT00676832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65651689|NCT00676832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651690|NCT00676832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65651691|NCT00676832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651692|NCT00676832|Antiemetics|antiemetics|mesh-ancestor
65651693|NCT00676832|Autonomic Agents|autonomic agents|mesh-ancestor
65651694|NCT00676832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65651695|NCT00676832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65651696|NCT00676832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65651697|NCT00676832|Protective Agents|protective agents|mesh-ancestor
65651698|NCT01909414|Vaccines|vaccines|mesh-list
65651699|NCT01909414|Immunologic Factors|immunologic factors|mesh-ancestor
65651700|NCT01909414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651701|NCT00467402|S 20098|s 20098|mesh-list
65651702|NCT00467402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65651703|NCT00467402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65651704|NCT00467402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651705|NCT02996097|Triamcinolone|triamcinolone|mesh-list
65651706|NCT02996097|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65651707|NCT02996097|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65651708|NCT02996097|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65651709|NCT02996097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65651710|NCT02996097|Glucocorticoids|glucocorticoids|mesh-ancestor
65651711|NCT02996097|Hormones|hormones|mesh-ancestor
65651712|NCT02996097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65651713|NCT02996097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651714|NCT02996097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65651715|NCT02996097|Immunologic Factors|immunologic factors|mesh-ancestor
65651716|NCT02996097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651717|NCT02996097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651718|NCT04054713|Acetic Acid|acetic acid|mesh-list
65651719|NCT04054713|Retinol acetate|retinol acetate|mesh-list
65651720|NCT04054713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65651721|NCT04054713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65651722|NCT04054713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65651723|NCT04054713|Immunologic Factors|immunologic factors|mesh-ancestor
65651724|NCT04054713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651725|NCT04054713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65651726|NCT04054713|Protective Agents|protective agents|mesh-ancestor
65651727|NCT04054713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651728|NCT02568124|Tranexamic Acid|tranexamic acid|mesh-list
65651729|NCT02568124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65651730|NCT02568124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65651731|NCT02568124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651732|NCT02568124|Hemostatics|hemostatics|mesh-ancestor
65651733|NCT02568124|Coagulants|coagulants|mesh-ancestor
65651734|NCT03314181|Dexamethasone|dexamethasone|mesh-list
65651735|NCT03314181|Bortezomib|bortezomib|mesh-list
65651736|NCT03314181|Venetoclax|venetoclax|mesh-list
65651737|NCT03314181|Daratumumab|daratumumab|mesh-list
65651738|NCT03314181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65651739|NCT03314181|Antiemetics|antiemetics|mesh-ancestor
65651740|NCT03314181|Autonomic Agents|autonomic agents|mesh-ancestor
65651741|NCT03314181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65651742|NCT03314181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651743|NCT03314181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65651744|NCT03314181|Glucocorticoids|glucocorticoids|mesh-ancestor
65651745|NCT03314181|Hormones|hormones|mesh-ancestor
65651746|NCT03314181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65651747|NCT03314181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65651748|NCT03314181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651749|NCT03133832|Praziquantel|praziquantel|mesh-list
65651750|NCT03133832|Anthelmintics|anthelmintics|mesh-ancestor
65651751|NCT03133832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65651752|NCT03133832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65651753|NCT03663465|Antipsychotic Agents|antipsychotic agents|mesh-list
65651754|NCT03663465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65651755|NCT03663465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65651756|NCT03663465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651757|NCT03663465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65651758|NCT04161430|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65651759|NCT04161430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65651760|NCT04161430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651761|NCT04161430|Incretins|incretins|mesh-ancestor
65651762|NCT04161430|Hormones|hormones|mesh-ancestor
65651763|NCT04161430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65651764|NCT04161430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65651765|NCT04161430|Protease Inhibitors|protease inhibitors|mesh-ancestor
65651766|NCT04161430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651767|NCT04161430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651768|NCT00673478|Tiotropium Bromide|tiotropium bromide|mesh-list
65651769|NCT00673478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65651770|NCT00673478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65651771|NCT00673478|Autonomic Agents|autonomic agents|mesh-ancestor
65651772|NCT00673478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65651773|NCT00673478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651774|NCT00673478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65651775|NCT00673478|Respiratory System Agents|respiratory system agents|mesh-ancestor
65651776|NCT00673478|Parasympatholytics|parasympatholytics|mesh-ancestor
65651777|NCT00673478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65651778|NCT00673478|Cholinergic Agents|cholinergic agents|mesh-ancestor
65651779|NCT00673478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65651780|NCT00673478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651781|NCT00673478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65651782|NCT00673478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65651783|NCT00673478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65651784|NCT00673478|Adrenergic Agents|adrenergic agents|mesh-ancestor
65651785|NCT02203474|Tiotropium Bromide|tiotropium bromide|mesh-list
65651786|NCT02203474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65651787|NCT02203474|Autonomic Agents|autonomic agents|mesh-ancestor
65651788|NCT02203474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65651789|NCT02203474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651790|NCT02203474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65651791|NCT02203474|Respiratory System Agents|respiratory system agents|mesh-ancestor
65651792|NCT02203474|Parasympatholytics|parasympatholytics|mesh-ancestor
65651793|NCT02203474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65651794|NCT02203474|Cholinergic Agents|cholinergic agents|mesh-ancestor
65651795|NCT02203474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65651796|NCT02203474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651797|NCT04053699|Factor VIII|factor viii|mesh-list
65651798|NCT04053699|Coagulants|coagulants|mesh-ancestor
65651799|NCT04303000|Analgesics, Opioid|analgesics, opioid|mesh-list
65651800|NCT04303000|Naloxone|naloxone|mesh-list
65651801|NCT04303000|Narcotics|narcotics|mesh-ancestor
65651802|NCT04303000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65651803|NCT04303000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651804|NCT04303000|Analgesics|analgesics|mesh-ancestor
65651805|NCT04303000|Sensory System Agents|sensory system agents|mesh-ancestor
65651806|NCT04303000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65651807|NCT04303000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65651808|NCT00672386|Metformin|metformin|mesh-list
65651809|NCT00672386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65651810|NCT00672386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651811|NCT04056897|Teriflunomide|teriflunomide|mesh-list
65651812|NCT04056897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65651813|NCT04056897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65651814|NCT04056897|Analgesics|analgesics|mesh-ancestor
65651815|NCT04056897|Sensory System Agents|sensory system agents|mesh-ancestor
65651816|NCT04056897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65651817|NCT04056897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651818|NCT04056897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65651819|NCT04056897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65651820|NCT04056897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65651821|NCT04056897|Immunologic Factors|immunologic factors|mesh-ancestor
65651822|NCT02281682|Fluorouracil|fluorouracil|mesh-list
65651823|NCT02281682|Imiquimod|imiquimod|mesh-list
65651824|NCT02281682|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65651825|NCT02281682|Antimetabolites|antimetabolites|mesh-ancestor
65651826|NCT02281682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651827|NCT02281682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65651828|NCT02281682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651829|NCT02281682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65651830|NCT02281682|Immunologic Factors|immunologic factors|mesh-ancestor
65651831|NCT02281682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651832|NCT02281682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65651833|NCT02281682|Interferon Inducers|interferon inducers|mesh-ancestor
65651834|NCT02281682|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65651835|NCT02281682|Dermatologic Agents|dermatologic agents|mesh-ancestor
65651836|NCT04057053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65651837|NCT04057053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65651838|NCT04056975|Antibodies|antibodies|mesh-list
65651839|NCT04056975|Immunologic Factors|immunologic factors|mesh-ancestor
65651840|NCT04056975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651841|NCT03662763|Guanfacine|guanfacine|mesh-list
65651842|NCT03662763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65651843|NCT03662763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65651844|NCT03662763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65651845|NCT03662763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65651846|NCT03662763|Adrenergic Agents|adrenergic agents|mesh-ancestor
65651847|NCT03662763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65651848|NCT03662763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651849|NCT03662763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651850|NCT00458978|Cediranib|cediranib|mesh-list
65651851|NCT00458978|Maleic acid|maleic acid|mesh-list
65651852|NCT00458978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651853|NCT00458978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651854|NCT00458978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651855|NCT00458978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65651856|NCT00458276|Tezosentan|tezosentan|mesh-list
65651857|NCT00458276|Vasodilator Agents|vasodilator agents|mesh-ancestor
65651858|NCT04520074|Cyclophosphamide|cyclophosphamide|mesh-list
65651859|NCT04520074|Carboplatin|carboplatin|mesh-list
65651860|NCT04520074|Etoposide|etoposide|mesh-list
65651861|NCT04520074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65651862|NCT04520074|Immunologic Factors|immunologic factors|mesh-ancestor
65651863|NCT04520074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651864|NCT04520074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65651865|NCT04520074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65651866|NCT04520074|Alkylating Agents|alkylating agents|mesh-ancestor
65651867|NCT04520074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651868|NCT04520074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651869|NCT04520074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65651870|NCT04520074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65651871|NCT04520074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65651872|NCT04520074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65651873|NCT04520074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651874|NCT00455156|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65651875|NCT00455156|ST 1435|st 1435|mesh-list
65651876|NCT00455156|Estradiol|estradiol|mesh-list
65651877|NCT00455156|Estrogens|estrogens|mesh-ancestor
65651878|NCT00455156|Hormones|hormones|mesh-ancestor
65651879|NCT00455156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65651880|NCT00455156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651881|NCT00455156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65651882|NCT00455156|Contraceptive Agents|contraceptive agents|mesh-ancestor
65651883|NCT00455156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65651884|NCT00455156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65651885|NCT00455156|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65651886|NCT00455156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65651887|NCT03661515|Cytarabine|cytarabine|mesh-list
65651888|NCT03661515|Fludarabine|fludarabine|mesh-list
65651889|NCT03661515|Idarubicin|idarubicin|mesh-list
65651890|NCT03661515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651891|NCT03661515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65651892|NCT03661515|Antimetabolites|antimetabolites|mesh-ancestor
65651893|NCT03661515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651894|NCT03661515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65651895|NCT03661515|Immunologic Factors|immunologic factors|mesh-ancestor
65651896|NCT03661515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651897|NCT03661515|Antiviral Agents|antiviral agents|mesh-ancestor
65651898|NCT03661515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65651899|NCT03661515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65651900|NCT03661515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65651901|NCT03661515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65651902|NCT03661515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651903|NCT01624480|Modafinil|modafinil|mesh-list
65651904|NCT01624480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65651905|NCT01624480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651906|NCT01624480|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65651907|NCT01624480|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65651908|NCT01624480|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65651909|NCT01624480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651910|NCT00448058|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65651911|NCT00448058|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65651912|NCT00448058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65651913|NCT00448058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65651914|NCT00448058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651915|NCT00448058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65651916|NCT00448058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651917|NCT00448058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65651918|NCT00448058|Antidepressive Agents|antidepressive agents|mesh-ancestor
65651919|NCT00448058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65651920|NCT05073172|Sulfadiazine|sulfadiazine|mesh-list
65651921|NCT05073172|Silver Sulfadiazine|silver sulfadiazine|mesh-list
65651922|NCT05073172|Petrolatum|petrolatum|mesh-list
65651923|NCT05073172|Mineral Oil|mineral oil|mesh-list
65651924|NCT05073172|Emollients|emollients|mesh-ancestor
65651925|NCT05073172|Dermatologic Agents|dermatologic agents|mesh-ancestor
65651926|NCT05073172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65651927|NCT05073172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65651928|NCT05073172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65651929|NCT05073172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65651930|NCT05073172|Coccidiostats|coccidiostats|mesh-ancestor
65651931|NCT05073172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65651932|NCT02284412|Neostigmine|neostigmine|mesh-list
65651933|NCT02284412|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65651934|NCT02284412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651935|NCT02284412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651936|NCT02284412|Cholinergic Agents|cholinergic agents|mesh-ancestor
65651937|NCT02284412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65651938|NCT02284412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651939|NCT02284412|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65651940|NCT02284412|Autonomic Agents|autonomic agents|mesh-ancestor
65651941|NCT02284412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65651942|NCT02789020|Rasagiline|rasagiline|mesh-list
65267932|NCT04220606|Nitroglycerin|nitroglycerin|mesh-list
65651943|NCT02789020|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65651944|NCT02789020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651945|NCT02789020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651946|NCT02789020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65651947|NCT02789020|Protective Agents|protective agents|mesh-ancestor
65651948|NCT02789020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651949|NCT02284490|Pemetrexed|pemetrexed|mesh-list
65651950|NCT02284490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651951|NCT02284490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651952|NCT02284490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651953|NCT02284490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65651954|NCT02284490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65651955|NCT02273570|Vitamin D|vitamin d|mesh-list
65651956|NCT02273570|Calcium|calcium|mesh-list
65651957|NCT02273570|Vitamins|vitamins|mesh-ancestor
65651958|NCT02273570|Micronutrients|micronutrients|mesh-ancestor
65651959|NCT02273570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651960|NCT02273570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65651961|NCT02273570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65651962|NCT02282150|Hydrocortisone|hydrocortisone|mesh-list
65651963|NCT02282150|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65651964|NCT02282150|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65651965|NCT02282150|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65651966|NCT02282150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65651967|NCT00579020|Moxifloxacin|moxifloxacin|mesh-list
65651968|NCT00579020|Dexamethasone|dexamethasone|mesh-list
65651969|NCT00579020|Dexamethasone acetate|dexamethasone acetate|mesh-list
65651970|NCT00579020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65651971|NCT00579020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65651972|NCT00579020|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65651973|NCT00579020|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65651974|NCT00579020|BB 1101|bb 1101|mesh-list
65651975|NCT00579020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65651976|NCT00579020|Antiemetics|antiemetics|mesh-ancestor
65651977|NCT00579020|Autonomic Agents|autonomic agents|mesh-ancestor
65651978|NCT00579020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65651979|NCT00579020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65651980|NCT00579020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65651981|NCT00579020|Glucocorticoids|glucocorticoids|mesh-ancestor
65651982|NCT00579020|Hormones|hormones|mesh-ancestor
65651983|NCT00579020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65651984|NCT00579020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65651985|NCT00579020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65651986|NCT00579020|Protease Inhibitors|protease inhibitors|mesh-ancestor
65651987|NCT00579020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65651988|NCT00579020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65651989|NCT00579020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65651990|NCT00579020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65651991|NCT00579020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65651992|NCT00579020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65651993|NCT00579020|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65651994|NCT00579020|Contraceptive Agents|contraceptive agents|mesh-ancestor
65651995|NCT00579020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65651996|NCT00579020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65651997|NCT00579020|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65651998|NCT00579020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65651999|NCT04530604|Defibrotide|defibrotide|mesh-list
65652000|NCT04530604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65652001|NCT04530604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65652002|NCT04530604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652003|NCT04530604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65652004|NCT04169698|Denosumab|denosumab|mesh-list
65652005|NCT04169698|Alendronate|alendronate|mesh-list
65652006|NCT04169698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65652007|NCT04169698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652008|NCT04470752|Capsaicin|capsaicin|mesh-list
65652009|NCT04470752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65652010|NCT04470752|Antipruritics|antipruritics|mesh-ancestor
65652011|NCT04470752|Dermatologic Agents|dermatologic agents|mesh-ancestor
65652012|NCT04470752|Sensory System Agents|sensory system agents|mesh-ancestor
65652013|NCT04470752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65652014|NCT04470752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652015|NCT02273804|Topiramate|topiramate|mesh-list
65652017|NCT02273804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65652018|NCT02273804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652019|NCT00578474|Ofloxacin|ofloxacin|mesh-list
65652020|NCT00578474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65652021|NCT00578474|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65652022|NCT00578474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65652023|NCT00578474|Renal Agents|renal agents|mesh-ancestor
65652024|NCT00578474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65652025|NCT00578474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65652026|NCT00578474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65652027|NCT00578474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652028|NCT00578474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652029|NCT00578474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652030|NCT00578474|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65652031|NCT00578474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65652032|NCT00577148|Rimonabant|rimonabant|mesh-list
65652033|NCT00577148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65652034|NCT00577148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65652035|NCT00577148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65652036|NCT00577148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65652037|NCT00577148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652038|NCT00577148|Hormones|hormones|mesh-ancestor
65652039|NCT00577148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65652040|NCT00577148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652041|NCT03673228|Nicotine|nicotine|mesh-list
65652042|NCT03673228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65652043|NCT03673228|Autonomic Agents|autonomic agents|mesh-ancestor
65652044|NCT03673228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65652045|NCT03673228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652046|NCT03673228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65652047|NCT03673228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65652048|NCT03673228|Cholinergic Agents|cholinergic agents|mesh-ancestor
65652049|NCT03673228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65652050|NCT03673228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652051|NCT00441896|Ganaxolone|ganaxolone|mesh-list
65652052|NCT00441896|Neurosteroids|neurosteroids|mesh-ancestor
65652053|NCT00441896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65652054|NCT00441896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652055|NCT00441896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652056|NCT00441896|GABA Modulators|gaba modulators|mesh-ancestor
65652057|NCT00441896|GABA Agents|gaba agents|mesh-ancestor
65652058|NCT05116462|Gemcitabine|gemcitabine|mesh-list
65652059|NCT05116462|Paclitaxel|paclitaxel|mesh-list
65652060|NCT05116462|Docetaxel|docetaxel|mesh-list
65652061|NCT05116462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65652062|NCT05116462|Carboplatin|carboplatin|mesh-list
65652063|NCT05116462|Pemetrexed|pemetrexed|mesh-list
65652064|NCT05116462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65652065|NCT05116462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652066|NCT05116462|Tubulin Modulators|tubulin modulators|mesh-ancestor
65652067|NCT05116462|Antimitotic Agents|antimitotic agents|mesh-ancestor
65652068|NCT05116462|Mitosis Modulators|mitosis modulators|mesh-ancestor
65652069|NCT05116462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652070|NCT05116462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65652071|NCT05116462|Antimetabolites|antimetabolites|mesh-ancestor
65652072|NCT05116462|Antiviral Agents|antiviral agents|mesh-ancestor
65652073|NCT05116462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65652074|NCT05116462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652075|NCT05116462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65652076|NCT05116462|Immunologic Factors|immunologic factors|mesh-ancestor
65652077|NCT05116462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652078|NCT05116462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65652079|NCT05116462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65652080|NCT05116306|Hyaluronic Acid|hyaluronic acid|mesh-list
65652081|NCT05116306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65652082|NCT05116306|Immunologic Factors|immunologic factors|mesh-ancestor
65652083|NCT05116306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652084|NCT05116306|Viscosupplements|viscosupplements|mesh-ancestor
65652085|NCT05116306|Protective Agents|protective agents|mesh-ancestor
65652086|NCT00570986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65652087|NCT00570986|Immunologic Factors|immunologic factors|mesh-ancestor
65652088|NCT00570986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652089|NCT00570752|Atorvastatin|atorvastatin|mesh-list
65652090|NCT00570752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65652091|NCT00570752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65652092|NCT00570752|Antimetabolites|antimetabolites|mesh-ancestor
65652093|NCT00570752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652094|NCT00570752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65652095|NCT00570752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65652096|NCT00570752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652097|NCT02282384|Oseltamivir|oseltamivir|mesh-list
65652098|NCT02282384|Calcium Carbonate|calcium carbonate|mesh-list
65652099|NCT02282384|Antacids|antacids|mesh-ancestor
65652100|NCT02282384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652101|NCT02282384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65652102|NCT02282384|Antiviral Agents|antiviral agents|mesh-ancestor
65652103|NCT02282384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65652104|NCT02282384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652105|NCT02989389|Itraconazole|itraconazole|mesh-list
65652106|NCT02989389|Antifungal Agents|antifungal agents|mesh-ancestor
65652107|NCT02989389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65652108|NCT02989389|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65652109|NCT02989389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65652110|NCT02989389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652111|NCT02989389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652112|NCT02989389|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65652113|NCT02989389|Hormone Antagonists|hormone antagonists|mesh-ancestor
65652114|NCT02989389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65652115|NCT02989389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652116|NCT02989389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65652117|NCT02653300|Insulin|insulin|mesh-list
65652118|NCT02653300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65652119|NCT02653300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652120|NCT00436670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65652121|NCT00436670|Immunologic Factors|immunologic factors|mesh-ancestor
65652122|NCT00436670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652123|NCT03187509|Torsemide|torsemide|mesh-list
65652124|NCT03187509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65652125|NCT03187509|Diuretics|diuretics|mesh-ancestor
65652126|NCT03187509|Natriuretic Agents|natriuretic agents|mesh-ancestor
65652127|NCT03187509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652128|NCT03187509|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65652129|NCT03187509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65652130|NCT03187509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652131|NCT00430508|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65652132|NCT00430508|Olmesartan|olmesartan|mesh-list
65652133|NCT00430508|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65652134|NCT00430508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65652135|NCT00430508|Diuretics|diuretics|mesh-ancestor
65652136|NCT00430508|Natriuretic Agents|natriuretic agents|mesh-ancestor
65652137|NCT00430508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652138|NCT00430508|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65652139|NCT00430508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65652140|NCT00430508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652141|NCT00430508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65652142|NCT00430508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65652143|NCT04221880|Lidocaine|lidocaine|mesh-list
65652144|NCT04221880|Bupivacaine|bupivacaine|mesh-list
65652145|NCT04221880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65652146|NCT04221880|Anesthetics, Local|anesthetics, local|mesh-ancestor
65652147|NCT04221880|Anesthetics|anesthetics|mesh-ancestor
65652148|NCT04221880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65652149|NCT04221880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652150|NCT04221880|Sensory System Agents|sensory system agents|mesh-ancestor
65652151|NCT04221880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65652152|NCT04221880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65652153|NCT04221880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65652154|NCT04221880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65652155|NCT04221880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65652156|NCT04221880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652157|NCT04055415|Bronchodilator Agents|bronchodilator agents|mesh-list
65652158|NCT04055415|Expectorants|expectorants|mesh-list
65652159|NCT04055415|Autonomic Agents|autonomic agents|mesh-ancestor
65652160|NCT04055415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65652161|NCT04055415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652162|NCT04055415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65652163|NCT04055415|Respiratory System Agents|respiratory system agents|mesh-ancestor
65652164|NCT00427856|Rituximab|rituximab|mesh-list
65652165|NCT00427856|Obatoclax|obatoclax|mesh-list
65652166|NCT00427856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65652167|NCT00427856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652168|NCT00427856|Immunologic Factors|immunologic factors|mesh-ancestor
65652169|NCT00427856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652170|NCT00427856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65652171|NCT00427856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652172|NCT00427856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652173|NCT00427154|Insulin|insulin|mesh-list
65652174|NCT00427154|Metformin|metformin|mesh-list
65652175|NCT00427154|Glimepiride|glimepiride|mesh-list
65652176|NCT00427154|Rosiglitazone|rosiglitazone|mesh-list
65652177|NCT00427154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65652178|NCT00427154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65652179|NCT00427154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652180|NCT00427154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65652181|NCT00427154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65652182|NCT00427154|Immunologic Factors|immunologic factors|mesh-ancestor
65652183|NCT02988219|Epinephrine|epinephrine|mesh-list
65652184|NCT02988219|Fentanyl|fentanyl|mesh-list
65652185|NCT02988219|Bupivacaine|bupivacaine|mesh-list
65652186|NCT02988219|Anesthetics|anesthetics|mesh-list
65652187|NCT02988219|Anesthetics, Local|anesthetics, local|mesh-ancestor
65652188|NCT02988219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65652189|NCT02988219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652190|NCT02988219|Sensory System Agents|sensory system agents|mesh-ancestor
65652191|NCT02988219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65652192|NCT02988219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65652193|NCT02988219|Narcotics|narcotics|mesh-ancestor
65652194|NCT02988219|Analgesics|analgesics|mesh-ancestor
65652195|NCT02988219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65652196|NCT02988219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65652197|NCT02988219|Anesthetics, General|anesthetics, general|mesh-ancestor
65652198|NCT02988219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65652199|NCT02988219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65652200|NCT02988219|Adrenergic Agents|adrenergic agents|mesh-ancestor
65652201|NCT02988219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65652202|NCT02988219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652203|NCT02988219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65652204|NCT02988219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65652205|NCT02988219|Autonomic Agents|autonomic agents|mesh-ancestor
65652206|NCT02988219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65652207|NCT02988219|Respiratory System Agents|respiratory system agents|mesh-ancestor
65652208|NCT02988219|Mydriatics|mydriatics|mesh-ancestor
65652209|NCT02988219|Sympathomimetics|sympathomimetics|mesh-ancestor
65652210|NCT02988219|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65652211|NCT01346059|Vancomycin|vancomycin|mesh-list
65652212|NCT01346059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65652213|NCT01346059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65652214|NCT05204069|Cyclopentolate|cyclopentolate|mesh-list
65652215|NCT05204069|Mydriatics|mydriatics|mesh-ancestor
65652216|NCT05204069|Autonomic Agents|autonomic agents|mesh-ancestor
65652217|NCT05204069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65652218|NCT05204069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652219|NCT05204069|Parasympatholytics|parasympatholytics|mesh-ancestor
65652220|NCT05204069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65652221|NCT05204069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65652222|NCT05204069|Cholinergic Agents|cholinergic agents|mesh-ancestor
65652223|NCT05204069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65652224|NCT05204069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652225|NCT04548973|Esketamine|esketamine|mesh-list
65652226|NCT04548973|Antidepressive Agents|antidepressive agents|mesh-ancestor
65652227|NCT04548973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65652228|NCT02277938|Amantadine|amantadine|mesh-list
65652229|NCT02277938|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65267945|NCT00003042|Tamoxifen|tamoxifen|mesh-list
65652230|NCT02277938|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65652231|NCT02277938|Antiviral Agents|antiviral agents|mesh-ancestor
65652232|NCT02277938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65652233|NCT02277938|Dopamine Agents|dopamine agents|mesh-ancestor
65652234|NCT02277938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65652235|NCT02277938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652236|NCT02277938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652237|NCT02277938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65652238|NCT02277938|Analgesics|analgesics|mesh-ancestor
65652239|NCT02277938|Sensory System Agents|sensory system agents|mesh-ancestor
65652240|NCT02277938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65652241|NCT00415142|Citalopram|citalopram|mesh-list
65652242|NCT00415142|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65652243|NCT00415142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65652244|NCT00415142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65652245|NCT00415142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652246|NCT00415142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65652247|NCT00415142|Serotonin Agents|serotonin agents|mesh-ancestor
65652248|NCT00415142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652249|NCT00415142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65652250|NCT00415142|Antidepressive Agents|antidepressive agents|mesh-ancestor
65652251|NCT00415142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65652252|NCT04708145|Aflibercept|aflibercept|mesh-list
65652253|NCT04708145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65652254|NCT04708145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65652255|NCT04708145|Growth Substances|growth substances|mesh-ancestor
65652256|NCT04708145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652257|NCT04708145|Growth Inhibitors|growth inhibitors|mesh-ancestor
65652258|NCT04708145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652259|NCT03661125|Saracatinib|saracatinib|mesh-list
65652260|NCT03661125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652261|NCT03661125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652262|NCT03661125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652263|NCT00413114|Obatoclax|obatoclax|mesh-list
65652264|NCT00413114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652265|NCT00413114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652266|NCT03016013|Methotrexate|methotrexate|mesh-list
65652267|NCT03016013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65652268|NCT03016013|Abortifacient Agents|abortifacient agents|mesh-ancestor
65652269|NCT03016013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65652270|NCT03016013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652271|NCT03016013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65652272|NCT03016013|Antimetabolites|antimetabolites|mesh-ancestor
65652273|NCT03016013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652274|NCT03016013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652275|NCT03016013|Dermatologic Agents|dermatologic agents|mesh-ancestor
65652276|NCT03016013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652277|NCT03016013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65652278|NCT03016013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65652279|NCT03016013|Immunologic Factors|immunologic factors|mesh-ancestor
65652280|NCT03016013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65652281|NCT03016013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65652282|NCT01318915|Mycophenolic Acid|mycophenolic acid|mesh-list
65652283|NCT01318915|Sirolimus|sirolimus|mesh-list
65652284|NCT01318915|Rituximab|rituximab|mesh-list
65652285|NCT01318915|Tacrolimus|tacrolimus|mesh-list
65652286|NCT01318915|Thymoglobulin|thymoglobulin|mesh-list
65652287|NCT01318915|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65652288|NCT01318915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65652289|NCT01318915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652290|NCT01318915|Immunologic Factors|immunologic factors|mesh-ancestor
65652291|NCT01318915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652292|NCT01318915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65652293|NCT01318915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65652294|NCT01318915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65652295|NCT01318915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652296|NCT01318915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652297|NCT01318915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65652298|NCT01318915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65652299|NCT01318915|Antitubercular Agents|antitubercular agents|mesh-ancestor
65652300|NCT01318915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65652301|NCT01318915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65652302|NCT01318915|Antifungal Agents|antifungal agents|mesh-ancestor
65652303|NCT04688177|Nicotine|nicotine|mesh-list
65652304|NCT04688177|Carbon Monoxide|carbon monoxide|mesh-list
65652305|NCT04688177|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65652306|NCT04688177|Autonomic Agents|autonomic agents|mesh-ancestor
65652307|NCT04688177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65652308|NCT04688177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652309|NCT04688177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65652310|NCT04688177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65652311|NCT04688177|Cholinergic Agents|cholinergic agents|mesh-ancestor
65652312|NCT04688177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65652313|NCT04688177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652314|NCT04688177|Antimetabolites|antimetabolites|mesh-ancestor
65449709|NCT00184028|Oxaliplatin|oxaliplatin|mesh-list
65652315|NCT04688177|Gasotransmitters|gasotransmitters|mesh-ancestor
65652316|NCT04675294|Pembrolizumab|pembrolizumab|mesh-list
65652317|NCT04675294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65652318|NCT04675294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652319|NCT00411242|S 20098|s 20098|mesh-list
65652320|NCT00411242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65652321|NCT00411242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65652322|NCT00411242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652323|NCT04668365|Prednisone|prednisone|mesh-list
65652324|NCT04668365|Cyclophosphamide|cyclophosphamide|mesh-list
65652325|NCT04668365|Rituximab|rituximab|mesh-list
65652326|NCT04668365|Vincristine|vincristine|mesh-list
65652327|NCT04668365|Epirubicin|epirubicin|mesh-list
65652328|NCT04668365|Zanubrutinib|zanubrutinib|mesh-list
65652329|NCT04668365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65652330|NCT04668365|Immunologic Factors|immunologic factors|mesh-ancestor
65652331|NCT04668365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652332|NCT04668365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65652333|NCT04668365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65652334|NCT04668365|Alkylating Agents|alkylating agents|mesh-ancestor
65652335|NCT04668365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652336|NCT04668365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652337|NCT04668365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65652338|NCT04668365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65652339|NCT04668365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65652340|NCT04668365|Glucocorticoids|glucocorticoids|mesh-ancestor
65652341|NCT04668365|Hormones|hormones|mesh-ancestor
65652342|NCT04668365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65652343|NCT04668365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65652344|NCT04668365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65652345|NCT04668365|Tubulin Modulators|tubulin modulators|mesh-ancestor
65652346|NCT04668365|Antimitotic Agents|antimitotic agents|mesh-ancestor
65652347|NCT04668365|Mitosis Modulators|mitosis modulators|mesh-ancestor
65652348|NCT04668365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65652349|NCT04668365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65652350|NCT04668365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65652351|NCT04668365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652352|NCT04668365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65652353|NCT05203913|Paclitaxel|paclitaxel|mesh-list
65652354|NCT05203913|Nivolumab|nivolumab|mesh-list
65652355|NCT05203913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65652356|NCT05203913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652357|NCT05203913|Tubulin Modulators|tubulin modulators|mesh-ancestor
65652358|NCT05203913|Antimitotic Agents|antimitotic agents|mesh-ancestor
65652359|NCT05203913|Mitosis Modulators|mitosis modulators|mesh-ancestor
65652360|NCT05203913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652361|NCT05203913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65652362|NCT05203913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65652363|NCT00402428|Interferons|interferons|mesh-list
65652364|NCT00402428|Ribavirin|ribavirin|mesh-list
65652365|NCT00402428|Interferon-alpha|interferon-alpha|mesh-list
65652366|NCT00402428|Interferon alpha-2|interferon alpha-2|mesh-list
65652367|NCT00402428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65652368|NCT00402428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652369|NCT00402428|Antiviral Agents|antiviral agents|mesh-ancestor
65652370|NCT00402428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65652371|NCT00402428|Antimetabolites|antimetabolites|mesh-ancestor
65652372|NCT00402428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652373|NCT00402428|Immunologic Factors|immunologic factors|mesh-ancestor
65652374|NCT00402428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652375|NCT05120206|Chlorhexidine|chlorhexidine|mesh-list
65652376|NCT05120206|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65652377|NCT05120206|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65652378|NCT05120206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65652379|NCT05120206|Disinfectants|disinfectants|mesh-ancestor
65652380|NCT05120206|Dermatologic Agents|dermatologic agents|mesh-ancestor
65652381|NCT03660267|Caffeine|caffeine|mesh-list
65652382|NCT03660267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65652383|NCT03660267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652384|NCT03660267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65652385|NCT03660267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652386|NCT03660267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652387|NCT03660267|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65652388|NCT03660267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65652389|NCT03660267|Purinergic Agents|purinergic agents|mesh-ancestor
65652390|NCT03660267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65652392|NCT03950245|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65652393|NCT03950245|Incretins|incretins|mesh-ancestor
65652394|NCT03950245|Hormones|hormones|mesh-ancestor
65652395|NCT03950245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65652396|NCT03950245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652397|NCT03950245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65652398|NCT03889249|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65652399|NCT03889249|Tenecteplase|tenecteplase|mesh-list
65652400|NCT03889249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65652401|NCT03889249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65652402|NCT03889249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652403|NCT00401570|Gemcitabine|gemcitabine|mesh-list
65652404|NCT00401570|Volociximab|volociximab|mesh-list
65652405|NCT00401570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65652406|NCT00401570|Antimetabolites|antimetabolites|mesh-ancestor
65652407|NCT00401570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652408|NCT00401570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652409|NCT00401570|Antiviral Agents|antiviral agents|mesh-ancestor
65652410|NCT00401570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65652411|NCT00401570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652412|NCT00401570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65652413|NCT00401570|Immunologic Factors|immunologic factors|mesh-ancestor
65652414|NCT00401570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652415|NCT00401570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65652416|NCT00401570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65652417|NCT00401570|Growth Substances|growth substances|mesh-ancestor
65652418|NCT00401570|Growth Inhibitors|growth inhibitors|mesh-ancestor
65652419|NCT04056741|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65652420|NCT04056741|Respiratory System Agents|respiratory system agents|mesh-ancestor
65652421|NCT05193565|Mycophenolic Acid|mycophenolic acid|mesh-list
65652422|NCT05193565|Sirolimus|sirolimus|mesh-list
65652423|NCT05193565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65652424|NCT05193565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652425|NCT05193565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65652426|NCT05193565|Antitubercular Agents|antitubercular agents|mesh-ancestor
65652427|NCT05193565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65652428|NCT05193565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65652429|NCT05193565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652430|NCT05193565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652431|NCT05193565|Antifungal Agents|antifungal agents|mesh-ancestor
65652432|NCT05193565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65652433|NCT05193565|Immunologic Factors|immunologic factors|mesh-ancestor
65652434|NCT05193565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652435|NCT04471922|Rabeprazole|rabeprazole|mesh-list
65652436|NCT04471922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65652437|NCT04471922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65652438|NCT04471922|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65652439|NCT04471922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652440|NCT04471922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652441|NCT04368364|Morphine|morphine|mesh-list
65652442|NCT04368364|Bupivacaine|bupivacaine|mesh-list
65652443|NCT04368364|Ropivacaine|ropivacaine|mesh-list
65652444|NCT04368364|Anesthetics, Local|anesthetics, local|mesh-ancestor
65652445|NCT04368364|Anesthetics|anesthetics|mesh-ancestor
65652446|NCT04368364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65115202|NCT04688723|Dabigatran|dabigatran|mesh-list
65652447|NCT04368364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652448|NCT04368364|Sensory System Agents|sensory system agents|mesh-ancestor
65652449|NCT04368364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65652450|NCT04368364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65652451|NCT04368364|Narcotics|narcotics|mesh-ancestor
65652452|NCT04368364|Analgesics|analgesics|mesh-ancestor
65652453|NCT05186779|Progestins|progestins|mesh-list
65652454|NCT05186779|Hormones|hormones|mesh-ancestor
65652455|NCT05186779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65652456|NCT05186779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652457|NCT02285036|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65652458|NCT02285036|Immunologic Factors|immunologic factors|mesh-ancestor
65652459|NCT02285036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652460|NCT00543374|Remestemcel-l|remestemcel-l|mesh-list
65652461|NCT00543374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65652462|NCT00543374|Antiviral Agents|antiviral agents|mesh-ancestor
65652463|NCT00543374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65652464|NCT02926937|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65652465|NCT02926937|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65652466|NCT02926937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652467|NCT02926937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65652468|NCT02926937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652469|NCT05229796|Empagliflozin|empagliflozin|mesh-list
65652470|NCT05229796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65652471|NCT05229796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652472|NCT05229796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65652473|NCT05229796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652474|NCT04189588|Diphenhydramine|diphenhydramine|mesh-list
65652475|NCT04189588|Promethazine|promethazine|mesh-list
65652476|NCT04189588|Cetirizine|cetirizine|mesh-list
65652477|NCT04189588|Paclitaxel|paclitaxel|mesh-list
65652478|NCT04189588|Rituximab|rituximab|mesh-list
65652479|NCT04189588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65652480|NCT04189588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652481|NCT04189588|Tubulin Modulators|tubulin modulators|mesh-ancestor
65652482|NCT04189588|Antimitotic Agents|antimitotic agents|mesh-ancestor
65652483|NCT04189588|Mitosis Modulators|mitosis modulators|mesh-ancestor
65652484|NCT04189588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652485|NCT04189588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65652486|NCT04189588|Immunologic Factors|immunologic factors|mesh-ancestor
65652487|NCT04189588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652488|NCT04189588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65652489|NCT04189588|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65652490|NCT04189588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65652491|NCT04189588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65652492|NCT04189588|Anesthetics, Local|anesthetics, local|mesh-ancestor
65652493|NCT04189588|Anesthetics|anesthetics|mesh-ancestor
65652494|NCT04189588|Sensory System Agents|sensory system agents|mesh-ancestor
65652495|NCT04189588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65652496|NCT04189588|Antiemetics|antiemetics|mesh-ancestor
65652497|NCT04189588|Autonomic Agents|autonomic agents|mesh-ancestor
65652498|NCT04189588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65652499|NCT04189588|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65652500|NCT04189588|Histamine Antagonists|histamine antagonists|mesh-ancestor
65652501|NCT04189588|Histamine Agents|histamine agents|mesh-ancestor
65652502|NCT04189588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65652503|NCT04189588|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65652504|NCT04189588|Antipruritics|antipruritics|mesh-ancestor
65652505|NCT04189588|Dermatologic Agents|dermatologic agents|mesh-ancestor
65652506|NCT04189588|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65652507|NCT00151892|Mesalamine|mesalamine|mesh-list
65652508|NCT00151892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65652509|NCT00151892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65652510|NCT00151892|Analgesics|analgesics|mesh-ancestor
65652511|NCT00151892|Sensory System Agents|sensory system agents|mesh-ancestor
65652512|NCT00151892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65652513|NCT00151892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652514|NCT00151892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65652515|NCT00151892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65652516|NCT04175470|Tocotrienols|tocotrienols|mesh-list
65652517|NCT04175470|Vitamin E|vitamin e|mesh-list
65652518|NCT04175470|Tocopherols|tocopherols|mesh-list
65652519|NCT04175470|Bevacizumab|bevacizumab|mesh-list
65652520|NCT04175470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65652521|NCT04175470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652522|NCT04175470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65652523|NCT04175470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65652524|NCT04175470|Growth Substances|growth substances|mesh-ancestor
65652525|NCT04175470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652526|NCT04175470|Growth Inhibitors|growth inhibitors|mesh-ancestor
65652527|NCT04175470|Antioxidants|antioxidants|mesh-ancestor
65652528|NCT04175470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652529|NCT04175470|Protective Agents|protective agents|mesh-ancestor
65652530|NCT04175470|Vitamins|vitamins|mesh-ancestor
65652531|NCT04175470|Micronutrients|micronutrients|mesh-ancestor
65652532|NCT02740127|Dexamethasone|dexamethasone|mesh-list
65652533|NCT02740127|Clonidine|clonidine|mesh-list
65652534|NCT02740127|Epinephrine|epinephrine|mesh-list
65652535|NCT02740127|Propofol|propofol|mesh-list
65652536|NCT02740127|Ropivacaine|ropivacaine|mesh-list
65652537|NCT02740127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65652538|NCT02740127|Antiemetics|antiemetics|mesh-ancestor
65652539|NCT02740127|Autonomic Agents|autonomic agents|mesh-ancestor
65652540|NCT02740127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65652541|NCT02740127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652542|NCT02740127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65652543|NCT02740127|Glucocorticoids|glucocorticoids|mesh-ancestor
65652544|NCT02740127|Hormones|hormones|mesh-ancestor
65652545|NCT02740127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65652546|NCT02740127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65652547|NCT02740127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652548|NCT02740127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652549|NCT02740127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65652550|NCT02740127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65652551|NCT02740127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65652552|NCT02740127|Anesthetics, General|anesthetics, general|mesh-ancestor
65652553|NCT02740127|Anesthetics|anesthetics|mesh-ancestor
65652554|NCT02740127|Anesthetics, Local|anesthetics, local|mesh-ancestor
65652555|NCT02740127|Sensory System Agents|sensory system agents|mesh-ancestor
65652556|NCT02740127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65652557|NCT02740127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65652558|NCT02740127|Adrenergic Agents|adrenergic agents|mesh-ancestor
65652559|NCT02740127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65652560|NCT02740127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65652561|NCT02740127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65652562|NCT02740127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65652563|NCT02740127|Respiratory System Agents|respiratory system agents|mesh-ancestor
65652564|NCT02740127|Mydriatics|mydriatics|mesh-ancestor
65652565|NCT02740127|Sympathomimetics|sympathomimetics|mesh-ancestor
65652566|NCT02740127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65652567|NCT02740127|Analgesics|analgesics|mesh-ancestor
65652568|NCT02740127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65652569|NCT02740127|Sympatholytics|sympatholytics|mesh-ancestor
65652570|NCT02740127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65652571|NCT05008783|Capecitabine|capecitabine|mesh-list
65652572|NCT05008783|Oxaliplatin|oxaliplatin|mesh-list
65652573|NCT05008783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65652574|NCT05008783|Antimetabolites|antimetabolites|mesh-ancestor
65652575|NCT05008783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652576|NCT05008783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652577|NCT04450498|Vaccines|vaccines|mesh-list
65652578|NCT04450498|Immunologic Factors|immunologic factors|mesh-ancestor
65652579|NCT04450498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652580|NCT00654992|Epoetin Alfa|epoetin alfa|mesh-list
65652581|NCT00654992|Hematinics|hematinics|mesh-ancestor
65652582|NCT02921919|Talazoparib|talazoparib|mesh-list
65652583|NCT02921919|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65652584|NCT02921919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652585|NCT02921919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652586|NCT02921919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652587|NCT00393068|Paclitaxel|paclitaxel|mesh-list
65652588|NCT00393068|Bevacizumab|bevacizumab|mesh-list
65652589|NCT00393068|Carboplatin|carboplatin|mesh-list
65652590|NCT00393068|Fluorouracil|fluorouracil|mesh-list
65652591|NCT00393068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65652592|NCT00393068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65652593|NCT00393068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652594|NCT00393068|Tubulin Modulators|tubulin modulators|mesh-ancestor
65652595|NCT00393068|Antimitotic Agents|antimitotic agents|mesh-ancestor
65652596|NCT00393068|Mitosis Modulators|mitosis modulators|mesh-ancestor
65652597|NCT00393068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652598|NCT00393068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65652599|NCT00393068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65652600|NCT00393068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65652601|NCT00393068|Growth Substances|growth substances|mesh-ancestor
65652602|NCT00393068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652603|NCT00393068|Growth Inhibitors|growth inhibitors|mesh-ancestor
65652604|NCT00393068|Antimetabolites|antimetabolites|mesh-ancestor
65652605|NCT00393068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65652606|NCT00393068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65652607|NCT00393068|Immunologic Factors|immunologic factors|mesh-ancestor
65652608|NCT00393068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65652609|NCT00393068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652610|NCT04930315|Apatinib|apatinib|mesh-list
65652611|NCT04930315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652612|NCT04930315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65652613|NCT04930315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652614|NCT04930315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652615|NCT04769401|Progesterone|progesterone|mesh-list
65652616|NCT04769401|Progestins|progestins|mesh-ancestor
65450045|NCT00168818|Enoxaparin|enoxaparin|mesh-list
65652617|NCT04769401|Hormones|hormones|mesh-ancestor
65652618|NCT04769401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65652619|NCT04769401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652620|NCT02094222|Glycerol|glycerol|mesh-list
65652621|NCT02094222|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65652622|NCT02094222|Protective Agents|protective agents|mesh-ancestor
65652623|NCT02094222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652624|NCT02280590|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65652625|NCT02280590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65652626|NCT02280590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65652627|NCT02280590|Antimetabolites|antimetabolites|mesh-ancestor
65652628|NCT02280590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652629|NCT02280590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65652630|NCT02280590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65652631|NCT02280590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652632|NCT02090244|Teriparatide|teriparatide|mesh-list
65652633|NCT02090244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65652634|NCT02090244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652635|NCT02090244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65652636|NCT02282774|Lidocaine|lidocaine|mesh-list
65652637|NCT02282774|Bupivacaine|bupivacaine|mesh-list
65652638|NCT02282774|Anesthetics, Local|anesthetics, local|mesh-ancestor
65652639|NCT02282774|Anesthetics|anesthetics|mesh-ancestor
65652640|NCT02282774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65652641|NCT02282774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652642|NCT02282774|Sensory System Agents|sensory system agents|mesh-ancestor
65652643|NCT02282774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65652644|NCT02282774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65652645|NCT02282774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65652646|NCT02282774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65652647|NCT02282774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65652648|NCT02282774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652649|NCT02090322|Bevacizumab|bevacizumab|mesh-list
65652650|NCT02090322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65652651|NCT02090322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652652|NCT02090322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65652653|NCT02090322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65652654|NCT02090322|Growth Substances|growth substances|mesh-ancestor
65652655|NCT02090322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652656|NCT02090322|Growth Inhibitors|growth inhibitors|mesh-ancestor
65652657|NCT03658785|Aldesleukin|aldesleukin|mesh-list
65652658|NCT03658785|Cyclophosphamide|cyclophosphamide|mesh-list
65652659|NCT03658785|Fludarabine|fludarabine|mesh-list
65652660|NCT03658785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65652661|NCT03658785|Immunologic Factors|immunologic factors|mesh-ancestor
65652662|NCT03658785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652663|NCT03658785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65652664|NCT03658785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65652665|NCT03658785|Alkylating Agents|alkylating agents|mesh-ancestor
65652666|NCT03658785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652667|NCT03658785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652668|NCT03658785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65652669|NCT03658785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65652670|NCT03658785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65652671|NCT03658785|Antiviral Agents|antiviral agents|mesh-ancestor
65652672|NCT03658785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65652673|NCT02095782|Paclitaxel|paclitaxel|mesh-list
65652674|NCT02095782|Carboplatin|carboplatin|mesh-list
65652675|NCT02095782|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65652676|NCT02095782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65652677|NCT02095782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652678|NCT02095782|Tubulin Modulators|tubulin modulators|mesh-ancestor
65652679|NCT02095782|Antimitotic Agents|antimitotic agents|mesh-ancestor
65652680|NCT02095782|Mitosis Modulators|mitosis modulators|mesh-ancestor
65652681|NCT02095782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652682|NCT02095782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65652683|NCT02095782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652684|NCT02094378|Esketamine|esketamine|mesh-list
65652685|NCT02094378|Antidepressive Agents|antidepressive agents|mesh-ancestor
65652686|NCT02094378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65652687|NCT02285738|Aspirin|aspirin|mesh-list
65652688|NCT02285738|Simvastatin|simvastatin|mesh-list
65652689|NCT02285738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65450079|NCT00166712|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65652690|NCT02285738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65652691|NCT02285738|Analgesics|analgesics|mesh-ancestor
65652692|NCT02285738|Sensory System Agents|sensory system agents|mesh-ancestor
65652693|NCT02285738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65652694|NCT02285738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652695|NCT02285738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65652696|NCT02285738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65652697|NCT02285738|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65652698|NCT02285738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65652699|NCT02285738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652700|NCT02285738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65652701|NCT02285738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65652702|NCT02285738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652703|NCT02285738|Antipyretics|antipyretics|mesh-ancestor
65652704|NCT02285738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65652705|NCT02285738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65652706|NCT02285738|Antimetabolites|antimetabolites|mesh-ancestor
65652707|NCT02285738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65652708|NCT02285738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65652709|NCT00650702|Latanoprost|latanoprost|mesh-list
65652710|NCT00650702|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65652711|NCT00650702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65652712|NCT02090400|Bazedoxifene|bazedoxifene|mesh-list
65652713|NCT02090400|Calcium|calcium|mesh-list
65652714|NCT02090400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65652715|NCT02090400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652716|NCT02090400|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65652717|NCT02090400|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65652718|NCT02090400|Hormone Antagonists|hormone antagonists|mesh-ancestor
65652719|NCT02090400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65652720|NCT02090400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65652721|NCT03134846|Cetuximab|cetuximab|mesh-list
65652722|NCT03134846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65652723|NCT03134846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652724|NCT01068717|Metformin|metformin|mesh-list
65652725|NCT01068717|Saxagliptin|saxagliptin|mesh-list
65652726|NCT01068717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65652727|NCT01068717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652728|NCT01068717|Incretins|incretins|mesh-ancestor
65652729|NCT01068717|Hormones|hormones|mesh-ancestor
65652730|NCT01068717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65652731|NCT01068717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65652732|NCT01068717|Protease Inhibitors|protease inhibitors|mesh-ancestor
65652733|NCT01068717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652734|NCT01068717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652735|NCT02095938|Amisulpride|amisulpride|mesh-list
65652736|NCT02095938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65652737|NCT02095938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65652738|NCT02095938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65652739|NCT02095938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652740|NCT02095938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65652741|NCT02095938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65652742|NCT02095938|Dopamine Agents|dopamine agents|mesh-ancestor
65652743|NCT02095938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65652744|NCT02095938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652745|NCT02095938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65652746|NCT02095938|Antidepressive Agents|antidepressive agents|mesh-ancestor
65652747|NCT02285972|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65652748|NCT02285972|Tenoxicam|tenoxicam|mesh-list
65652749|NCT02285972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65652750|NCT02285972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65652751|NCT02285972|Analgesics|analgesics|mesh-ancestor
65652752|NCT02285972|Sensory System Agents|sensory system agents|mesh-ancestor
65652753|NCT02285972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65652754|NCT02285972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652755|NCT02285972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65652756|NCT02285972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65652757|NCT02285972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65652758|NCT02285972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652759|NCT02285972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652760|NCT02096094|Chlorhexidine|chlorhexidine|mesh-list
65652761|NCT02096094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65652762|NCT02096094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65652763|NCT02096094|Disinfectants|disinfectants|mesh-ancestor
65652764|NCT02921763|Dydrogesterone|dydrogesterone|mesh-list
65652765|NCT02921763|Progestins|progestins|mesh-ancestor
65652767|NCT02921763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65652768|NCT02921763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652769|NCT03658473|Naproxen|naproxen|mesh-list
65652770|NCT03658473|Rabeprazole|rabeprazole|mesh-list
65652771|NCT03658473|Rebamipide|rebamipide|mesh-list
65652772|NCT03658473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65652773|NCT03658473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65652774|NCT03658473|Analgesics|analgesics|mesh-ancestor
65652775|NCT03658473|Sensory System Agents|sensory system agents|mesh-ancestor
65652776|NCT03658473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65652777|NCT03658473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652778|NCT03658473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65652779|NCT03658473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65652780|NCT03658473|Gout Suppressants|gout suppressants|mesh-ancestor
65652781|NCT03658473|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65652782|NCT03658473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652783|NCT03658473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652784|NCT03658473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65652785|NCT03658473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65652786|NCT03658473|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65652787|NCT03658473|Antioxidants|antioxidants|mesh-ancestor
65652788|NCT03658473|Protective Agents|protective agents|mesh-ancestor
65652789|NCT02096250|Ferrous fumarate|ferrous fumarate|mesh-list
65652790|NCT02096250|Edetic Acid|edetic acid|mesh-list
65652791|NCT02096250|Ferric Compounds|ferric compounds|mesh-list
65652792|NCT02096250|Fe(III)-EDTA|fe(iii)-edta|mesh-list
65652793|NCT02096250|Trace Elements|trace elements|mesh-ancestor
65652794|NCT02096250|Micronutrients|micronutrients|mesh-ancestor
65652795|NCT02096250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652796|NCT02096250|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65652797|NCT02096250|Chelating Agents|chelating agents|mesh-ancestor
65652798|NCT02096250|Sequestering Agents|sequestering agents|mesh-ancestor
65652799|NCT02096250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652800|NCT02096250|Anticoagulants|anticoagulants|mesh-ancestor
65652801|NCT02096250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65652802|NCT02096250|Hematinics|hematinics|mesh-ancestor
65652803|NCT02096328|Murepavadin|murepavadin|mesh-list
65652804|NCT02096328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65652805|NCT02096328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65652806|NCT01318135|Metformin|metformin|mesh-list
65652807|NCT01318135|Glimepiride|glimepiride|mesh-list
65652808|NCT01318135|Alogliptin|alogliptin|mesh-list
65652809|NCT01318135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65652810|NCT01318135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652811|NCT01318135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65652812|NCT01318135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65652813|NCT01318135|Immunologic Factors|immunologic factors|mesh-ancestor
65652814|NCT01318135|Incretins|incretins|mesh-ancestor
65652815|NCT01318135|Hormones|hormones|mesh-ancestor
65115553|NCT02044341|Benzocaine|benzocaine|mesh-list
65652816|NCT01318135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65652817|NCT01318135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65652818|NCT01318135|Protease Inhibitors|protease inhibitors|mesh-ancestor
65652819|NCT01318135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652820|NCT01318135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652821|NCT02094924|Candesartan|candesartan|mesh-list
65652822|NCT02094924|Candesartan cilexetil|candesartan cilexetil|mesh-list
65652823|NCT02094924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65652824|NCT02094924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65652825|NCT02094924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65652826|NCT02094924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652827|NCT02286206|Clozapine|clozapine|mesh-list
65652828|NCT02286206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65652829|NCT02286206|Serotonin Agents|serotonin agents|mesh-ancestor
65652830|NCT02286206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65652831|NCT02286206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652832|NCT02286206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652833|NCT02286206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65652834|NCT02286206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65652835|NCT02286206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65652836|NCT02286206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65652837|NCT02286206|GABA Antagonists|gaba antagonists|mesh-ancestor
65652838|NCT02286206|GABA Agents|gaba agents|mesh-ancestor
65652839|NCT03104283|Apatinib|apatinib|mesh-list
65652840|NCT03104283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652841|NCT03104283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65652842|NCT03104283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652843|NCT03104283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652844|NCT00529178|Pravastatin|pravastatin|mesh-list
65652845|NCT00529178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65652846|NCT00529178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65652847|NCT00529178|Antimetabolites|antimetabolites|mesh-ancestor
65652848|NCT00529178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652849|NCT00529178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65652850|NCT00529178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65652851|NCT00529178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652852|NCT00382460|Pravastatin|pravastatin|mesh-list
65652853|NCT00382460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65652854|NCT00382460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65652855|NCT00382460|Antimetabolites|antimetabolites|mesh-ancestor
65652856|NCT00382460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652857|NCT00382460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65652858|NCT00382460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65652859|NCT00382460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652860|NCT00523250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65652861|NCT00523250|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65652862|NCT02286596|Heparin|heparin|mesh-list
65652863|NCT02286596|Dextrans|dextrans|mesh-list
65652864|NCT02286596|Anticoagulants|anticoagulants|mesh-ancestor
65652865|NCT02286596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65652866|NCT02286596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65652867|NCT02286596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652868|NCT02286596|Plasma Substitutes|plasma substitutes|mesh-ancestor
65652869|NCT02286596|Blood Substitutes|blood substitutes|mesh-ancestor
65652870|NCT02098824|Methylphenidate|methylphenidate|mesh-list
65652871|NCT02098824|Galantamine|galantamine|mesh-list
65652872|NCT02098824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65652873|NCT02098824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652874|NCT02098824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65652875|NCT02098824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65652876|NCT02098824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65652877|NCT02098824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652878|NCT02098824|Dopamine Agents|dopamine agents|mesh-ancestor
65652879|NCT02098824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65652880|NCT02098824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65652881|NCT02098824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652882|NCT02098824|Cholinergic Agents|cholinergic agents|mesh-ancestor
65652883|NCT02098824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65652884|NCT02098824|Autonomic Agents|autonomic agents|mesh-ancestor
65652885|NCT02098824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65652886|NCT02098824|Nootropic Agents|nootropic agents|mesh-ancestor
65652887|NCT03658317|Uric Acid|uric acid|mesh-list
65652888|NCT03658317|Antioxidants|antioxidants|mesh-ancestor
65652889|NCT03658317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652890|NCT03658317|Protective Agents|protective agents|mesh-ancestor
65652891|NCT03658317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652892|NCT02286752|Neostigmine|neostigmine|mesh-list
65652893|NCT02286752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65652894|NCT02286752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652895|NCT02286752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652896|NCT02286752|Cholinergic Agents|cholinergic agents|mesh-ancestor
65652897|NCT02286752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65652898|NCT02286752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652899|NCT02286752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65652900|NCT02286752|Autonomic Agents|autonomic agents|mesh-ancestor
65652901|NCT02286752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65652902|NCT04470050|Dexmedetomidine|dexmedetomidine|mesh-list
65652903|NCT04470050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65652904|NCT04470050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65652905|NCT04470050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652906|NCT04470050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65652907|NCT04470050|Analgesics|analgesics|mesh-ancestor
65652908|NCT04470050|Sensory System Agents|sensory system agents|mesh-ancestor
65652909|NCT04470050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65652910|NCT04470050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65652911|NCT04470050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65652912|NCT04470050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65652913|NCT04470050|Adrenergic Agents|adrenergic agents|mesh-ancestor
65652914|NCT04470050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65652915|NCT04470050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652916|NCT02095314|Vaccines|vaccines|mesh-list
65652917|NCT02095314|Immunologic Factors|immunologic factors|mesh-ancestor
65652918|NCT02095314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652919|NCT02098980|Vitamin D|vitamin d|mesh-list
65652920|NCT02098980|Vitamins|vitamins|mesh-ancestor
65652921|NCT02098980|Micronutrients|micronutrients|mesh-ancestor
65652922|NCT02098980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652923|NCT02098980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65652924|NCT04431700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65652925|NCT00372944|Capecitabine|capecitabine|mesh-list
65652926|NCT00372944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65652927|NCT00372944|Antimetabolites|antimetabolites|mesh-ancestor
65652928|NCT00372944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652929|NCT00372944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652930|NCT02099136|Celecoxib|celecoxib|mesh-list
65652931|NCT02099136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65652932|NCT02099136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65652933|NCT02099136|Analgesics|analgesics|mesh-ancestor
65652934|NCT02099136|Sensory System Agents|sensory system agents|mesh-ancestor
65652935|NCT02099136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65652936|NCT02099136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652937|NCT02099136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65652938|NCT02099136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65652939|NCT02099136|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65652940|NCT02099136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65652941|NCT02099136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652942|NCT02099136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652943|NCT00117650|Etoposide|etoposide|mesh-list
65652944|NCT00117650|Etoposide phosphate|etoposide phosphate|mesh-list
65652945|NCT00117650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65652946|NCT00117650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652947|NCT00117650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65652948|NCT00117650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65652949|NCT00117650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652950|NCT00117650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652951|NCT02095548|Lorecivivint|lorecivivint|mesh-list
65652952|NCT02095548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65652953|NCT00113438|Paclitaxel|paclitaxel|mesh-list
65652954|NCT00113438|Fosbretabulin|fosbretabulin|mesh-list
65652955|NCT00113438|Combretastatin|combretastatin|mesh-list
65652956|NCT00113438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65652957|NCT00113438|Carboplatin|carboplatin|mesh-list
65652958|NCT00113438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65652959|NCT00113438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652960|NCT00113438|Tubulin Modulators|tubulin modulators|mesh-ancestor
65652961|NCT00113438|Antimitotic Agents|antimitotic agents|mesh-ancestor
65652962|NCT00113438|Mitosis Modulators|mitosis modulators|mesh-ancestor
65652963|NCT00113438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652964|NCT04087408|Hormones|hormones|mesh-list
65652965|NCT04087408|Progesterone|progesterone|mesh-list
65652966|NCT04087408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65652967|NCT04087408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652968|NCT04087408|Progestins|progestins|mesh-ancestor
65652969|NCT02099292|Rituximab|rituximab|mesh-list
65652970|NCT02099292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65652971|NCT02099292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652972|NCT02099292|Immunologic Factors|immunologic factors|mesh-ancestor
65652973|NCT02099292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652974|NCT02099292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65652975|NCT02283242|Galantamine|galantamine|mesh-list
65652976|NCT02283242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65652977|NCT02283242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65652978|NCT02283242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652979|NCT02283242|Cholinergic Agents|cholinergic agents|mesh-ancestor
65652980|NCT02283242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65652981|NCT02283242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652982|NCT02283242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65652983|NCT02283242|Autonomic Agents|autonomic agents|mesh-ancestor
65652984|NCT02283242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65652985|NCT02283242|Nootropic Agents|nootropic agents|mesh-ancestor
65652986|NCT02283320|Docetaxel|docetaxel|mesh-list
65652987|NCT02283320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65652988|NCT02283320|Tubulin Modulators|tubulin modulators|mesh-ancestor
65652989|NCT02283320|Antimitotic Agents|antimitotic agents|mesh-ancestor
65652990|NCT02283320|Mitosis Modulators|mitosis modulators|mesh-ancestor
65652991|NCT02283320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65652992|NCT03556098|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
65652993|NCT03556098|Hormones|hormones|mesh-list
65652994|NCT03556098|Incretins|incretins|mesh-list
65652995|NCT03556098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65652996|NCT03556098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65652997|NCT03556098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65652998|NCT02286986|Cannabidiol|cannabidiol|mesh-list
65652999|NCT02286986|Anticonvulsants|anticonvulsants|mesh-ancestor
65653000|NCT04995874|Micronutrients|micronutrients|mesh-list
65653001|NCT04995874|Trace Elements|trace elements|mesh-list
65653002|NCT04995874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653003|NCT02287064|Immunoglobulins|immunoglobulins|mesh-list
65653004|NCT02287064|Antibodies|antibodies|mesh-list
65653005|NCT02287064|gamma-Globulins|gamma-globulins|mesh-list
65653006|NCT02287064|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65653007|NCT02287064|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65653008|NCT02287064|Immunologic Factors|immunologic factors|mesh-ancestor
65653009|NCT02287064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653010|NCT02095704|Acetaminophen|acetaminophen|mesh-list
65653011|NCT02095704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65653012|NCT02095704|Analgesics|analgesics|mesh-ancestor
65653013|NCT02095704|Sensory System Agents|sensory system agents|mesh-ancestor
65653014|NCT02095704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65653015|NCT02095704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653016|NCT02095704|Antipyretics|antipyretics|mesh-ancestor
65653017|NCT02099604|Vitamin D|vitamin d|mesh-list
65653018|NCT02099604|Interferons|interferons|mesh-list
65653019|NCT02099604|Ribavirin|ribavirin|mesh-list
65653020|NCT02099604|Interferon-alpha|interferon-alpha|mesh-list
65653021|NCT02099604|Interferon alpha-2|interferon alpha-2|mesh-list
65653022|NCT02099604|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65653023|NCT02099604|Vitamins|vitamins|mesh-ancestor
65653024|NCT02099604|Micronutrients|micronutrients|mesh-ancestor
65653025|NCT02099604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653026|NCT02099604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65653027|NCT02099604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653028|NCT02099604|Antiviral Agents|antiviral agents|mesh-ancestor
65653029|NCT02099604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65653030|NCT02099604|Antimetabolites|antimetabolites|mesh-ancestor
65653031|NCT02099604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653032|NCT02099604|Immunologic Factors|immunologic factors|mesh-ancestor
65653033|NCT02099916|Menotropins|menotropins|mesh-list
65653034|NCT02099916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653035|NCT02099916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65653036|NCT02099916|Fertility Agents|fertility agents|mesh-ancestor
65653037|NCT02099916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65653038|NCT02102646|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65653039|NCT02102646|Luteolytic Agents|luteolytic agents|mesh-ancestor
65653040|NCT02102646|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65653041|NCT02102646|Contraceptive Agents|contraceptive agents|mesh-ancestor
65653042|NCT02102646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65653043|NCT02102646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653044|NCT02102646|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65653045|NCT02102646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65653046|NCT02102646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653047|NCT00366704|Risperidone|risperidone|mesh-list
65653048|NCT00366704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65653049|NCT00366704|Serotonin Agents|serotonin agents|mesh-ancestor
65653050|NCT00366704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65653051|NCT00366704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653052|NCT00366704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653053|NCT00366704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65653054|NCT00366704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65653055|NCT00366704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65653056|NCT00366704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65653057|NCT00366704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65653058|NCT00366704|Dopamine Agents|dopamine agents|mesh-ancestor
65653059|NCT02097264|Adalimumab|adalimumab|mesh-list
65653060|NCT02097264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65653061|NCT02097264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65653062|NCT04572100|Paclitaxel|paclitaxel|mesh-list
65653063|NCT04572100|Carboplatin|carboplatin|mesh-list
65653064|NCT04572100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65653065|NCT04572100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653066|NCT04572100|Tubulin Modulators|tubulin modulators|mesh-ancestor
65653067|NCT04572100|Antimitotic Agents|antimitotic agents|mesh-ancestor
65653068|NCT04572100|Mitosis Modulators|mitosis modulators|mesh-ancestor
65653069|NCT04572100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653070|NCT02097342|Linagliptin|linagliptin|mesh-list
65653072|NCT02097342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65653073|NCT02097342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653074|NCT02097342|Incretins|incretins|mesh-ancestor
65653075|NCT02097342|Hormones|hormones|mesh-ancestor
65653076|NCT02097342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65653077|NCT02097342|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65653078|NCT02097342|Protease Inhibitors|protease inhibitors|mesh-ancestor
65653079|NCT02097342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653080|NCT02097342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653081|NCT02097342|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65653082|NCT04294498|Entecavir|entecavir|mesh-list
65653083|NCT04294498|Durvalumab|durvalumab|mesh-list
65653084|NCT04294498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65653085|NCT04294498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653086|NCT04294498|Antiviral Agents|antiviral agents|mesh-ancestor
65653087|NCT04294498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65653088|NCT04059172|Ibuprofen|ibuprofen|mesh-list
65653089|NCT04059172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65653090|NCT04059172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65653091|NCT04059172|Analgesics|analgesics|mesh-ancestor
65653092|NCT04059172|Sensory System Agents|sensory system agents|mesh-ancestor
65653093|NCT04059172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65653094|NCT04059172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653095|NCT04059172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65653096|NCT04059172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65653097|NCT04059172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65653098|NCT04059172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653099|NCT04059172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653100|NCT00359450|Taxane|taxane|mesh-list
65653101|NCT00359450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653102|NCT03530462|Methylprednisolone|methylprednisolone|mesh-list
65653103|NCT03530462|Cyclophosphamide|cyclophosphamide|mesh-list
65653104|NCT03530462|Rituximab|rituximab|mesh-list
65653105|NCT03530462|Immunoglobulins|immunoglobulins|mesh-list
65653106|NCT03530462|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65653107|NCT03530462|Antibodies|antibodies|mesh-list
65653108|NCT03530462|gamma-Globulins|gamma-globulins|mesh-list
65653109|NCT03530462|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65653110|NCT03530462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65653111|NCT03530462|Immunologic Factors|immunologic factors|mesh-ancestor
65653112|NCT03530462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653113|NCT03530462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65653114|NCT03530462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65653115|NCT03530462|Alkylating Agents|alkylating agents|mesh-ancestor
65653116|NCT03530462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653117|NCT03530462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653118|NCT03530462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65653119|NCT03530462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65653120|NCT03530462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65653121|NCT03530462|Antiemetics|antiemetics|mesh-ancestor
65653122|NCT03530462|Autonomic Agents|autonomic agents|mesh-ancestor
65653123|NCT03530462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65653124|NCT03530462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65653125|NCT03530462|Glucocorticoids|glucocorticoids|mesh-ancestor
65653126|NCT03530462|Hormones|hormones|mesh-ancestor
65653127|NCT03530462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65653128|NCT03530462|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65653129|NCT03530462|Protective Agents|protective agents|mesh-ancestor
65653130|NCT02103192|Antioxidants|antioxidants|mesh-list
65653131|NCT02103192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653132|NCT02103192|Protective Agents|protective agents|mesh-ancestor
65653133|NCT02103192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653134|NCT02097810|Entrectinib|entrectinib|mesh-list
65653135|NCT02097810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65653136|NCT02097810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653137|NCT02097810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653138|NCT02100462|Aspirin|aspirin|mesh-list
65653139|NCT02100462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65653140|NCT02100462|Chlorthalidone|chlorthalidone|mesh-list
65653141|NCT02100462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65653142|NCT02100462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65653143|NCT02100462|Analgesics|analgesics|mesh-ancestor
65653144|NCT02100462|Sensory System Agents|sensory system agents|mesh-ancestor
65653145|NCT02100462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65653146|NCT02100462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653147|NCT02100462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65653148|NCT02100462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65653149|NCT02100462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65653150|NCT02100462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65653151|NCT02100462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653152|NCT02100462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65653153|NCT02100462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65653154|NCT02100462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653155|NCT02100462|Antipyretics|antipyretics|mesh-ancestor
65653156|NCT02100462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65653157|NCT02100462|Diuretics|diuretics|mesh-ancestor
65653158|NCT02100462|Natriuretic Agents|natriuretic agents|mesh-ancestor
65653159|NCT02100462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65653160|NCT02100462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65653161|NCT04507126|BCG Vaccine|bcg vaccine|mesh-list
65653162|NCT04507126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65653163|NCT04507126|Immunologic Factors|immunologic factors|mesh-ancestor
65653164|NCT04507126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653165|NCT00150176|Asenapine|asenapine|mesh-list
65653166|NCT00150176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65653167|NCT00150176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65653168|NCT00150176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65653169|NCT00150176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653170|NCT00150176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65653171|NCT00961792|Diphenhydramine|diphenhydramine|mesh-list
65653172|NCT00961792|Promethazine|promethazine|mesh-list
65653173|NCT00961792|Ethanol|ethanol|mesh-list
65653174|NCT00961792|Caffeine|caffeine|mesh-list
65653175|NCT00961792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65653176|NCT00961792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653177|NCT00961792|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65653178|NCT00961792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653179|NCT00961792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653180|NCT00961792|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65653181|NCT00961792|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65653182|NCT00961792|Purinergic Agents|purinergic agents|mesh-ancestor
65653183|NCT00961792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65653184|NCT00961792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65653185|NCT00961792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65653186|NCT00961792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65653187|NCT00961792|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65653188|NCT00961792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65653189|NCT00961792|Anesthetics, Local|anesthetics, local|mesh-ancestor
65653190|NCT00961792|Anesthetics|anesthetics|mesh-ancestor
65653191|NCT00961792|Sensory System Agents|sensory system agents|mesh-ancestor
65653192|NCT00961792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65653193|NCT00961792|Antiemetics|antiemetics|mesh-ancestor
65653194|NCT00961792|Autonomic Agents|autonomic agents|mesh-ancestor
65653195|NCT00961792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65653196|NCT00961792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65653197|NCT00961792|Histamine Antagonists|histamine antagonists|mesh-ancestor
65653198|NCT00961792|Histamine Agents|histamine agents|mesh-ancestor
65653199|NCT00961792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65653200|NCT00961792|Antipruritics|antipruritics|mesh-ancestor
65653201|NCT00961792|Dermatologic Agents|dermatologic agents|mesh-ancestor
65653202|NCT04435912|Hydrocortisone|hydrocortisone|mesh-list
65653203|NCT04435912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65653204|NCT02100852|Obinutuzumab|obinutuzumab|mesh-list
65653205|NCT02100852|Chlorambucil|chlorambucil|mesh-list
65653206|NCT02100852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65653207|NCT02100852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653208|NCT02100852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65653209|NCT02100852|Alkylating Agents|alkylating agents|mesh-ancestor
65653210|NCT02100852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653211|NCT00057980|Celecoxib|celecoxib|mesh-list
65653212|NCT00057980|Epirubicin|epirubicin|mesh-list
65653213|NCT00057980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65653214|NCT00057980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65653215|NCT00057980|Analgesics|analgesics|mesh-ancestor
65653216|NCT00057980|Sensory System Agents|sensory system agents|mesh-ancestor
65653217|NCT00057980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65653218|NCT00057980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653219|NCT00057980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65653220|NCT00057980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65653221|NCT00057980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65653222|NCT00057980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65653223|NCT00057980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653224|NCT00057980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653225|NCT00057980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65653226|NCT00057980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653227|NCT00057980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65653228|NCT00057980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65653229|NCT02985879|Tilavonemab|tilavonemab|mesh-list
65653230|NCT02985879|Nootropic Agents|nootropic agents|mesh-ancestor
65653231|NCT02097966|Ribavirin|ribavirin|mesh-list
65653232|NCT02097966|Sofosbuvir|sofosbuvir|mesh-list
65653233|NCT02097966|Antimetabolites|antimetabolites|mesh-ancestor
65653234|NCT02097966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653235|NCT02097966|Antiviral Agents|antiviral agents|mesh-ancestor
65653236|NCT02097966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65653237|NCT00052598|Aldesleukin|aldesleukin|mesh-list
65653238|NCT00052598|Interleukin-2|interleukin-2|mesh-list
65653239|NCT00052598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653240|NCT00052598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65653241|NCT00052598|Analgesics|analgesics|mesh-ancestor
65653242|NCT00052598|Sensory System Agents|sensory system agents|mesh-ancestor
65653243|NCT00052598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65653244|NCT00052598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653245|NCT00052598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65653246|NCT00052598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65653247|NCT00052598|Antiviral Agents|antiviral agents|mesh-ancestor
65653248|NCT00052598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65653249|NCT05037994|Prednisolone|prednisolone|mesh-list
65653250|NCT05037994|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65653251|NCT05037994|Methylprednisolone|methylprednisolone|mesh-list
65653252|NCT05037994|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65653253|NCT05037994|Prednisolone acetate|prednisolone acetate|mesh-list
65653254|NCT05037994|Gabapentin|gabapentin|mesh-list
65653255|NCT05037994|Bupivacaine|bupivacaine|mesh-list
65653256|NCT05037994|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65653257|NCT05037994|Prednisolone phosphate|prednisolone phosphate|mesh-list
65653258|NCT05037994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65653259|NCT05037994|Glucocorticoids|glucocorticoids|mesh-ancestor
65653260|NCT05037994|Hormones|hormones|mesh-ancestor
65653261|NCT05037994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65653262|NCT05037994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653263|NCT05037994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65653264|NCT05037994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653265|NCT05037994|Antiemetics|antiemetics|mesh-ancestor
65653266|NCT05037994|Autonomic Agents|autonomic agents|mesh-ancestor
65653267|NCT05037994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65653268|NCT05037994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65653269|NCT05037994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65653270|NCT05037994|Protective Agents|protective agents|mesh-ancestor
65653271|NCT05037994|Analgesics|analgesics|mesh-ancestor
65653272|NCT05037994|Sensory System Agents|sensory system agents|mesh-ancestor
65653273|NCT05037994|Anticonvulsants|anticonvulsants|mesh-ancestor
65653274|NCT05037994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65653275|NCT05037994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65653276|NCT05037994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65653277|NCT05037994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65653278|NCT05037994|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65653279|NCT05037994|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65653280|NCT05037994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65653281|NCT05037994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653282|NCT05037994|Antimanic Agents|antimanic agents|mesh-ancestor
65653283|NCT05037994|Anesthetics, Local|anesthetics, local|mesh-ancestor
65653284|NCT05037994|Anesthetics|anesthetics|mesh-ancestor
65653285|NCT00052520|Aldesleukin|aldesleukin|mesh-list
65653286|NCT00052520|Interleukin-2|interleukin-2|mesh-list
65653287|NCT00052520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653288|NCT00052520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65653289|NCT00052520|Analgesics|analgesics|mesh-ancestor
65653290|NCT00052520|Sensory System Agents|sensory system agents|mesh-ancestor
65653291|NCT00052520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65653292|NCT00052520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653293|NCT00052520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65653294|NCT00052520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65653295|NCT00052520|Antiviral Agents|antiviral agents|mesh-ancestor
65653296|NCT00052520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65653298|NCT05036434|Lenvatinib|lenvatinib|mesh-list
65653299|NCT05036434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65653300|NCT05036434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653301|NCT05036434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65653302|NCT05036434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653303|NCT05036434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653304|NCT00051038|Entecavir|entecavir|mesh-list
65653305|NCT00051038|Antiviral Agents|antiviral agents|mesh-ancestor
65653306|NCT00051038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65653307|NCT05035186|Amoxicillin|amoxicillin|mesh-list
65653308|NCT05035186|Clarithromycin|clarithromycin|mesh-list
65653309|NCT05035186|Levofloxacin|levofloxacin|mesh-list
65653310|NCT05035186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65653311|NCT05035186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65653312|NCT05035186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65653313|NCT05035186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653314|NCT05035186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653315|NCT05035186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65653316|NCT05035186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65653317|NCT05035186|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65653318|NCT05035186|Renal Agents|renal agents|mesh-ancestor
65653319|NCT05035186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65653320|NCT05035186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65653321|NCT05035186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653322|NCT05035186|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65653323|NCT01067469|Bevacizumab|bevacizumab|mesh-list
65653324|NCT01067469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65653325|NCT01067469|Lomustine|lomustine|mesh-list
65653326|NCT01067469|Antibodies|antibodies|mesh-list
65653327|NCT01067469|Immunoglobulins|immunoglobulins|mesh-list
65653328|NCT01067469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65653329|NCT01067469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653330|NCT01067469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65653331|NCT01067469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65653332|NCT01067469|Growth Substances|growth substances|mesh-ancestor
65653333|NCT01067469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653334|NCT01067469|Growth Inhibitors|growth inhibitors|mesh-ancestor
65653335|NCT01067469|Immunologic Factors|immunologic factors|mesh-ancestor
65653336|NCT01067469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65653337|NCT01067469|Alkylating Agents|alkylating agents|mesh-ancestor
65653338|NCT01067469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653339|NCT00050102|Ipilimumab|ipilimumab|mesh-list
65653340|NCT00050102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65653341|NCT00050102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653342|NCT00050102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65653343|NCT00050102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653344|NCT02103660|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65653345|NCT02103660|Contraceptive Agents|contraceptive agents|mesh-list
65653346|NCT02103660|Medroxyprogesterone|medroxyprogesterone|mesh-list
65653347|NCT02103660|Progestins|progestins|mesh-list
65653348|NCT02103660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65653349|NCT02103660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653350|NCT02103660|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65653351|NCT02103660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65653352|NCT02103660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65653353|NCT02103660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65653354|NCT02103660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65653355|NCT02103660|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65653356|NCT02103660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65653357|NCT02103660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653358|NCT02103660|Hormones|hormones|mesh-ancestor
65653359|NCT02103660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65653360|NCT02788773|Durvalumab|durvalumab|mesh-list
65653361|NCT02788773|Tremelimumab|tremelimumab|mesh-list
65653362|NCT02788773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65653363|NCT02788773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653364|NCT00358982|Mocetinostat|mocetinostat|mesh-list
65653365|NCT00358982|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65653366|NCT00358982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653367|NCT00358982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653368|NCT02101164|Denosumab|denosumab|mesh-list
65653369|NCT02101164|Pamidronate|pamidronate|mesh-list
65450771|NCT01212406|Vitamin D|vitamin d|mesh-list
65653370|NCT02101164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65653371|NCT02101164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653373|NCT00036608|Antiviral Agents|antiviral agents|mesh-ancestor
65653374|NCT00036608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65653375|NCT02103738|Ranibizumab|ranibizumab|mesh-list
65653376|NCT02103738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65653377|NCT02103738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65653378|NCT02103738|Growth Substances|growth substances|mesh-ancestor
65653379|NCT02103738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653380|NCT02103738|Growth Inhibitors|growth inhibitors|mesh-ancestor
65653381|NCT02103738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653382|NCT02985021|Carboplatin|carboplatin|mesh-list
65653383|NCT02985021|Docetaxel|docetaxel|mesh-list
65653384|NCT02985021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653385|NCT02985021|Tubulin Modulators|tubulin modulators|mesh-ancestor
65653386|NCT02985021|Antimitotic Agents|antimitotic agents|mesh-ancestor
65653387|NCT02985021|Mitosis Modulators|mitosis modulators|mesh-ancestor
65653388|NCT02985021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653389|NCT05714540|Magnesium Sulfate|magnesium sulfate|mesh-list
65653390|NCT05714540|Ketamine|ketamine|mesh-list
65653391|NCT05714540|Analgesics|analgesics|mesh-ancestor
65653392|NCT05714540|Sensory System Agents|sensory system agents|mesh-ancestor
65653393|NCT05714540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65653394|NCT05714540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653395|NCT05714540|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65653396|NCT05714540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65653397|NCT05714540|Anesthetics, General|anesthetics, general|mesh-ancestor
65653398|NCT05714540|Anesthetics|anesthetics|mesh-ancestor
65653399|NCT05714540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65653400|NCT05714540|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65653401|NCT05714540|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65653402|NCT05714540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65653403|NCT05714540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653404|NCT05714540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65653405|NCT05714540|Anticonvulsants|anticonvulsants|mesh-ancestor
65653406|NCT05714540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65653407|NCT05714540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65653408|NCT05714540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65653409|NCT05714540|Tocolytic Agents|tocolytic agents|mesh-ancestor
65653410|NCT05714540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65653411|NCT04385667|Levonorgestrel|levonorgestrel|mesh-list
65653412|NCT04385667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65653413|NCT04385667|Contraceptive Agents|contraceptive agents|mesh-ancestor
65653414|NCT04385667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65653415|NCT04385667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653416|NCT04385667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65653417|NCT04385667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65653418|NCT04385667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65653419|NCT04441424|Azithromycin|azithromycin|mesh-list
65653420|NCT04441424|Hydroxychloroquine|hydroxychloroquine|mesh-list
65653421|NCT04441424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65653422|NCT04441424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65653423|NCT04441424|Antimalarials|antimalarials|mesh-ancestor
65653424|NCT04441424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65653425|NCT04441424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65653426|NCT04441424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653427|NCT04441424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653428|NCT04441424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65653429|NCT03530228|Esomeprazole|esomeprazole|mesh-list
65653430|NCT03530228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65653431|NCT03530228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65653432|NCT03530228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65653433|NCT03530228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653434|NCT03530228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653435|NCT01066923|Aspirin|aspirin|mesh-list
65653436|NCT01066923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65653437|NCT01066923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65653438|NCT01066923|Analgesics|analgesics|mesh-ancestor
65653439|NCT01066923|Sensory System Agents|sensory system agents|mesh-ancestor
65653440|NCT01066923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65653441|NCT01066923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653442|NCT01066923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65653443|NCT01066923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65653444|NCT01066923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65653445|NCT01066923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65653446|NCT01066923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653447|NCT01066923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65653448|NCT01066923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65653449|NCT01066923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653450|NCT01066923|Antipyretics|antipyretics|mesh-ancestor
65653451|NCT03530150|Pirfenidone|pirfenidone|mesh-list
65653452|NCT03530150|Analgesics|analgesics|mesh-ancestor
65653453|NCT03530150|Sensory System Agents|sensory system agents|mesh-ancestor
65653454|NCT03530150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65653455|NCT03530150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653456|NCT03530150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65653457|NCT03530150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65653458|NCT03530150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65653459|NCT03530150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65653460|NCT03530150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653461|NCT02098590|Chloroquine|chloroquine|mesh-list
65653462|NCT02098590|Atovaquone|atovaquone|mesh-list
65653463|NCT02098590|Proguanil|proguanil|mesh-list
65653464|NCT02098590|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
65653465|NCT02098590|Amebicides|amebicides|mesh-ancestor
65653466|NCT02098590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65653467|NCT02098590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65653468|NCT02098590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65653469|NCT02098590|Antimalarials|antimalarials|mesh-ancestor
65653470|NCT02098590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65653471|NCT02098590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653472|NCT02098590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653473|NCT02098590|Antimetabolites|antimetabolites|mesh-ancestor
65653474|NCT03657381|Antibodies|antibodies|mesh-list
65653475|NCT03657381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65653476|NCT03657381|Immunologic Factors|immunologic factors|mesh-ancestor
65653477|NCT03657381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653478|NCT00005918|Lamivudine|lamivudine|mesh-list
65653479|NCT00005918|Efavirenz|efavirenz|mesh-list
65653480|NCT00005918|Stavudine|stavudine|mesh-list
65653481|NCT00005918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65653482|NCT00005918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65653483|NCT00005918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653484|NCT00005918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653485|NCT00005918|Antiviral Agents|antiviral agents|mesh-ancestor
65653486|NCT00005918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65653487|NCT00005918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65653488|NCT00005918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65653489|NCT00005918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65653490|NCT00005918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65653491|NCT00005918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65653492|NCT00005918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65653493|NCT00005918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65653494|NCT00005918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65653495|NCT00005918|Antimetabolites|antimetabolites|mesh-ancestor
65653496|NCT02656797|Amphotericin B|amphotericin b|mesh-list
65653497|NCT02656797|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65653498|NCT02656797|Amebicides|amebicides|mesh-ancestor
65653499|NCT02656797|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65653500|NCT02656797|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65653501|NCT02656797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65653502|NCT02656797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65653503|NCT02656797|Antifungal Agents|antifungal agents|mesh-ancestor
65653504|NCT04443244|Botulinum Toxins|botulinum toxins|mesh-list
65653505|NCT04443244|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65653506|NCT04443244|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65653507|NCT04443244|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65653508|NCT04443244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65653509|NCT04443244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653510|NCT04443244|Cholinergic Agents|cholinergic agents|mesh-ancestor
65653511|NCT04443244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65653512|NCT04443244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653513|NCT04443244|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65653514|NCT04443244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65653515|NCT02101476|Acetaminophen|acetaminophen|mesh-list
65653516|NCT02101476|Oxycodone|oxycodone|mesh-list
65653517|NCT02101476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65653518|NCT02101476|Analgesics|analgesics|mesh-ancestor
65653519|NCT02101476|Sensory System Agents|sensory system agents|mesh-ancestor
65653520|NCT02101476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65653521|NCT02101476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653522|NCT02101476|Antipyretics|antipyretics|mesh-ancestor
65653523|NCT02101476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65653524|NCT02101476|Narcotics|narcotics|mesh-ancestor
65653525|NCT02101476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65653527|NCT02104128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65653528|NCT02104128|Antidepressive Agents|antidepressive agents|mesh-ancestor
65653529|NCT02104128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65653530|NCT02104128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65653531|NCT02104128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65653532|NCT02104128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65653533|NCT02104128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653534|NCT02104128|Dopamine Agents|dopamine agents|mesh-ancestor
65653535|NCT02104128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65653536|NCT02104128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653537|NCT02104128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65653538|NCT02104128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65653539|NCT02104128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653540|NCT00004916|Paclitaxel|paclitaxel|mesh-list
65653541|NCT00004916|Ifosfamide|ifosfamide|mesh-list
65653542|NCT00004916|Teniposide|teniposide|mesh-list
65653543|NCT00004916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65653544|NCT00004916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653545|NCT00004916|Tubulin Modulators|tubulin modulators|mesh-ancestor
65653546|NCT00004916|Antimitotic Agents|antimitotic agents|mesh-ancestor
65653547|NCT00004916|Mitosis Modulators|mitosis modulators|mesh-ancestor
65653548|NCT00004916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653549|NCT00004916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65653550|NCT00004916|Alkylating Agents|alkylating agents|mesh-ancestor
65653551|NCT00004916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65653552|NCT00004916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65653553|NCT00004916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653554|NCT02101632|Petrolatum|petrolatum|mesh-list
65653555|NCT02101632|Emollients|emollients|mesh-ancestor
65653556|NCT02101632|Dermatologic Agents|dermatologic agents|mesh-ancestor
65653557|NCT02101710|Isosorbide|isosorbide|mesh-list
65653558|NCT02101710|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65653559|NCT02101710|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65653560|NCT02101710|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65653561|NCT02101710|Diuretics|diuretics|mesh-ancestor
65653562|NCT02101710|Natriuretic Agents|natriuretic agents|mesh-ancestor
65653563|NCT02101710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653564|NCT02101710|Vasodilator Agents|vasodilator agents|mesh-ancestor
65653565|NCT02101710|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65653566|NCT02101710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653567|NCT03878368|Sulforaphane|sulforaphane|mesh-list
65653568|NCT03878368|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65653569|NCT03878368|Protective Agents|protective agents|mesh-ancestor
65653570|NCT03878368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653571|NCT03878368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653572|NCT02910063|Blinatumomab|blinatumomab|mesh-list
65653573|NCT02910063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653574|NCT04441762|Ketorolac|ketorolac|mesh-list
65653575|NCT04441762|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65653576|NCT04441762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65653577|NCT04441762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65653578|NCT04441762|Analgesics|analgesics|mesh-ancestor
65653579|NCT04441762|Sensory System Agents|sensory system agents|mesh-ancestor
65653580|NCT04441762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65653581|NCT04441762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653582|NCT04441762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65653583|NCT04441762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65653584|NCT04441762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65653585|NCT04441762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653586|NCT04441762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653587|NCT02104284|Mannitol|mannitol|mesh-list
65653588|NCT02104284|Methacholine Chloride|methacholine chloride|mesh-list
65653589|NCT02104284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65653590|NCT02104284|Diuretics|diuretics|mesh-ancestor
65653591|NCT02104284|Natriuretic Agents|natriuretic agents|mesh-ancestor
65653592|NCT02104284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653593|NCT02104284|Miotics|miotics|mesh-ancestor
65653594|NCT02104284|Autonomic Agents|autonomic agents|mesh-ancestor
65653595|NCT02104284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65653596|NCT02104284|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65653597|NCT02104284|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
65653598|NCT02104284|Respiratory System Agents|respiratory system agents|mesh-ancestor
65653599|NCT02104284|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65653600|NCT02104284|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65653601|NCT02104284|Cholinergic Agents|cholinergic agents|mesh-ancestor
65653602|NCT02104284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65653603|NCT02104284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653604|NCT00337532|Paclitaxel|paclitaxel|mesh-list
65653605|NCT00337532|Cisplatin|cisplatin|mesh-list
65653606|NCT00337532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65653607|NCT00337532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653608|NCT00337532|Tubulin Modulators|tubulin modulators|mesh-ancestor
65653609|NCT00337532|Antimitotic Agents|antimitotic agents|mesh-ancestor
65653610|NCT00337532|Mitosis Modulators|mitosis modulators|mesh-ancestor
65653611|NCT00337532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653612|NCT02625441|Trastuzumab|trastuzumab|mesh-list
65653613|NCT02625441|Pertuzumab|pertuzumab|mesh-list
65653614|NCT02625441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65653615|NCT02625441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653616|NCT04209868|Bupivacaine|bupivacaine|mesh-list
65653617|NCT04209868|Levobupivacaine|levobupivacaine|mesh-list
65653618|NCT04209868|Anesthetics, Local|anesthetics, local|mesh-ancestor
65653619|NCT04209868|Anesthetics|anesthetics|mesh-ancestor
65653620|NCT04209868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65653621|NCT04209868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653622|NCT04209868|Sensory System Agents|sensory system agents|mesh-ancestor
65653623|NCT04209868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65653624|NCT02361801|Dobutamine|dobutamine|mesh-list
65653625|NCT02361801|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65653626|NCT02361801|Sympathomimetics|sympathomimetics|mesh-ancestor
65653627|NCT02361801|Autonomic Agents|autonomic agents|mesh-ancestor
65653628|NCT02361801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65653629|NCT02361801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653630|NCT02361801|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65653631|NCT02361801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65653632|NCT02361801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65653633|NCT02361801|Adrenergic Agents|adrenergic agents|mesh-ancestor
65653634|NCT02361801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65653635|NCT02361801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653636|NCT02361801|Protective Agents|protective agents|mesh-ancestor
65653637|NCT03965728|Methotrexate|methotrexate|mesh-list
65653638|NCT03965728|Midazolam|midazolam|mesh-list
65653639|NCT03965728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65653640|NCT03965728|Abortifacient Agents|abortifacient agents|mesh-ancestor
65653641|NCT03965728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65653642|NCT03965728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653643|NCT03965728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65653644|NCT03965728|Antimetabolites|antimetabolites|mesh-ancestor
65653645|NCT03965728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653646|NCT03965728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653647|NCT03965728|Dermatologic Agents|dermatologic agents|mesh-ancestor
65653648|NCT03965728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653649|NCT03965728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65653650|NCT03965728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65653651|NCT03965728|Immunologic Factors|immunologic factors|mesh-ancestor
65653652|NCT03965728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65653653|NCT03965728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65653654|NCT03965728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65653655|NCT03965728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65653656|NCT03965728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65653657|NCT03965728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65653658|NCT03965728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65653659|NCT03965728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65653660|NCT03965728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65653661|NCT03965728|Anesthetics, General|anesthetics, general|mesh-ancestor
65653662|NCT03965728|Anesthetics|anesthetics|mesh-ancestor
65653663|NCT03965728|GABA Modulators|gaba modulators|mesh-ancestor
65653664|NCT03965728|GABA Agents|gaba agents|mesh-ancestor
65653665|NCT03965728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65653666|NCT00337454|Dasatinib|dasatinib|mesh-list
65653667|NCT00337454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653668|NCT00337454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65653669|NCT00337454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653670|NCT00337454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653671|NCT02909907|Botulinum Toxins|botulinum toxins|mesh-list
65653672|NCT02909907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65653673|NCT02909907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65653674|NCT02909907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653675|NCT02909907|Cholinergic Agents|cholinergic agents|mesh-ancestor
65653676|NCT02909907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65653677|NCT02909907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653678|NCT00004898|Cyclophosphamide|cyclophosphamide|mesh-list
65653679|NCT00004898|Etoposide|etoposide|mesh-list
65653680|NCT00004898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65653681|NCT00004898|Immunologic Factors|immunologic factors|mesh-ancestor
65653682|NCT00004898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653683|NCT00004898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65653684|NCT00004898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65653685|NCT00004898|Alkylating Agents|alkylating agents|mesh-ancestor
65653686|NCT00004898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653687|NCT00004898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653688|NCT00004898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65653689|NCT00004898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65653690|NCT00004898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65653691|NCT00004898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65653692|NCT00004898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653693|NCT02106468|Prednisone|prednisone|mesh-list
65653694|NCT02106468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65653695|NCT02106468|Glucocorticoids|glucocorticoids|mesh-ancestor
65653696|NCT02106468|Hormones|hormones|mesh-ancestor
65653697|NCT02106468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65653698|NCT02106468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653699|NCT02106468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65653700|NCT02106468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653701|NCT03956446|Doxycycline|doxycycline|mesh-list
65653702|NCT03956446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65653703|NCT03956446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65653704|NCT03956446|Antimalarials|antimalarials|mesh-ancestor
65653705|NCT03956446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65653706|NCT03956446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65653707|NCT00325364|Insulin|insulin|mesh-list
65653708|NCT00325364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65653709|NCT00325364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65653710|NCT00325364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653711|NCT02104674|Montelukast|montelukast|mesh-list
65653712|NCT02104674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65653713|NCT02104674|Respiratory System Agents|respiratory system agents|mesh-ancestor
65653714|NCT02104674|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65653715|NCT02104674|Hormone Antagonists|hormone antagonists|mesh-ancestor
65653716|NCT02104674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65653717|NCT02104674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653718|NCT02104674|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65653719|NCT02104674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65653720|NCT02104674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653721|NCT01903330|Cyclophosphamide|cyclophosphamide|mesh-list
65653722|NCT01903330|Bevacizumab|bevacizumab|mesh-list
65653723|NCT01903330|Sargramostim|sargramostim|mesh-list
65653724|NCT01903330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65653725|NCT01903330|Immunologic Factors|immunologic factors|mesh-ancestor
65653726|NCT01903330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653727|NCT01903330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65653728|NCT01903330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65653729|NCT01903330|Alkylating Agents|alkylating agents|mesh-ancestor
65653730|NCT01903330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653731|NCT01903330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653732|NCT01903330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65653733|NCT01903330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65653734|NCT01903330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65653735|NCT01903330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65653736|NCT01903330|Growth Substances|growth substances|mesh-ancestor
65653737|NCT01903330|Growth Inhibitors|growth inhibitors|mesh-ancestor
65653738|NCT02907177|Ponesimod|ponesimod|mesh-list
65653739|NCT02907177|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65653740|NCT02907177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653741|NCT02907177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65653742|NCT02907177|Immunologic Factors|immunologic factors|mesh-ancestor
65653743|NCT02907177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451134|NCT01219036|Autonomic Agents|autonomic agents|mesh-ancestor
65653744|NCT00004172|Cyclophosphamide|cyclophosphamide|mesh-list
65653746|NCT00004172|Thiotepa|thiotepa|mesh-list
65653747|NCT00004172|Carboplatin|carboplatin|mesh-list
65653748|NCT00004172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65653749|NCT00004172|Immunologic Factors|immunologic factors|mesh-ancestor
65653750|NCT00004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653751|NCT00004172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65653752|NCT00004172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65653753|NCT00004172|Alkylating Agents|alkylating agents|mesh-ancestor
65653754|NCT00004172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653755|NCT00004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653756|NCT00004172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65653757|NCT04353310|Curcumin|curcumin|mesh-list
65653758|NCT04353310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65653759|NCT04353310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65653760|NCT04353310|Analgesics|analgesics|mesh-ancestor
65653761|NCT04353310|Sensory System Agents|sensory system agents|mesh-ancestor
65653762|NCT04353310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65653763|NCT04353310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653764|NCT04353310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65653765|NCT04353310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65653766|NCT04353310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653767|NCT04353310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653768|NCT04353310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653769|NCT00004166|Amifostine|amifostine|mesh-list
65653770|NCT00004166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65653771|NCT00004166|Protective Agents|protective agents|mesh-ancestor
65653772|NCT00004166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653773|NCT00004106|Temozolomide|temozolomide|mesh-list
65653774|NCT00004106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65653775|NCT00004106|Alkylating Agents|alkylating agents|mesh-ancestor
65653776|NCT00004106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653777|NCT00004106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653778|NCT00002246|Stavudine|stavudine|mesh-list
65653779|NCT00002246|Antimetabolites|antimetabolites|mesh-ancestor
65653780|NCT00002246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653781|NCT00002246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65653782|NCT00002246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65653783|NCT00002246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653784|NCT00002246|Antiviral Agents|antiviral agents|mesh-ancestor
65653785|NCT00002246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65653786|NCT00002246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65653787|NCT00002246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65653788|NCT00002240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65653789|NCT00002240|Nelfinavir|nelfinavir|mesh-list
65653790|NCT00002240|Didanosine|didanosine|mesh-list
65653791|NCT00002240|Stavudine|stavudine|mesh-list
65653792|NCT00002240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65653793|NCT00002240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65653794|NCT00002240|Protease Inhibitors|protease inhibitors|mesh-ancestor
65653795|NCT00002240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653796|NCT00002240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653797|NCT00002240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65653798|NCT00002240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65653799|NCT00002240|Antiviral Agents|antiviral agents|mesh-ancestor
65653800|NCT00002240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65653801|NCT00002240|Antimetabolites|antimetabolites|mesh-ancestor
65653802|NCT00002240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65653803|NCT00002240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65653804|NCT02250924|Caffeine|caffeine|mesh-list
65653805|NCT02250924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65653806|NCT02250924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653807|NCT02250924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65653808|NCT02250924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653809|NCT02250924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653810|NCT02250924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65653811|NCT02250924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65653812|NCT02250924|Purinergic Agents|purinergic agents|mesh-ancestor
65653813|NCT02250924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65653814|NCT03645148|Molgramostim|molgramostim|mesh-list
65653815|NCT03645148|Sargramostim|sargramostim|mesh-list
65653816|NCT03645148|Immunologic Factors|immunologic factors|mesh-ancestor
65653817|NCT03645148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653818|NCT03645148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653819|NCT04082728|Dipyrone|dipyrone|mesh-list
65653820|NCT04082728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65653821|NCT04082728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65653822|NCT04082728|Analgesics|analgesics|mesh-ancestor
65653823|NCT04082728|Sensory System Agents|sensory system agents|mesh-ancestor
65653824|NCT04082728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65653825|NCT04082728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653826|NCT04082728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65653827|NCT04082728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65653828|NCT04082728|Antipyretics|antipyretics|mesh-ancestor
65653829|NCT02906709|Insulin|insulin|mesh-list
65653830|NCT02906709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65653831|NCT02906709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653832|NCT00321308|Pemetrexed|pemetrexed|mesh-list
65653833|NCT00321308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653834|NCT00321308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653835|NCT00321308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653836|NCT00321308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65653837|NCT00321308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65653838|NCT02110134|Hydroquinone|hydroquinone|mesh-list
65653839|NCT02110134|Antioxidants|antioxidants|mesh-ancestor
65653840|NCT02110134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653841|NCT02110134|Protective Agents|protective agents|mesh-ancestor
65653842|NCT02110134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653843|NCT02110134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65653844|NCT00318656|Metformin|metformin|mesh-list
65653845|NCT00318656|Glimepiride|glimepiride|mesh-list
65653846|NCT00318656|Rosiglitazone|rosiglitazone|mesh-list
65653847|NCT00318656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65653848|NCT00318656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653849|NCT00318656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65653850|NCT00318656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65653851|NCT00318656|Immunologic Factors|immunologic factors|mesh-ancestor
65653852|NCT02110524|Paclitaxel|paclitaxel|mesh-list
65653853|NCT02110524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65653854|NCT02110524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653855|NCT02110524|Tubulin Modulators|tubulin modulators|mesh-ancestor
65653856|NCT02110524|Antimitotic Agents|antimitotic agents|mesh-ancestor
65653857|NCT02110524|Mitosis Modulators|mitosis modulators|mesh-ancestor
65653858|NCT02110524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653859|NCT00317486|Bosentan|bosentan|mesh-list
65653860|NCT00317486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65653861|NCT00317486|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65653862|NCT00317486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653863|NCT02107170|Remifentanil|remifentanil|mesh-list
65653864|NCT02107170|Propofol|propofol|mesh-list
65653865|NCT02107170|Sevoflurane|sevoflurane|mesh-list
65653866|NCT02107170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65653867|NCT02107170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65653868|NCT02107170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653869|NCT02107170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65653870|NCT02107170|Anesthetics, General|anesthetics, general|mesh-ancestor
65653871|NCT02107170|Anesthetics|anesthetics|mesh-ancestor
65653872|NCT02107170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65653873|NCT02107170|Narcotics|narcotics|mesh-ancestor
65653874|NCT02107170|Analgesics|analgesics|mesh-ancestor
65653875|NCT02107170|Sensory System Agents|sensory system agents|mesh-ancestor
65653876|NCT02107170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65653877|NCT02107170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65653878|NCT02107170|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65653879|NCT05725382|Remifentanil|remifentanil|mesh-list
65653880|NCT05725382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65653881|NCT05725382|Narcotics|narcotics|mesh-ancestor
65653882|NCT05725382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65653883|NCT05725382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653884|NCT05725382|Analgesics|analgesics|mesh-ancestor
65653885|NCT05725382|Sensory System Agents|sensory system agents|mesh-ancestor
65653886|NCT05725382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65653887|NCT00313196|Bosentan|bosentan|mesh-list
65653888|NCT00313196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65653889|NCT00313196|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65653890|NCT00313196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653891|NCT03656679|Iodine|iodine|mesh-list
65653892|NCT03656679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65653893|NCT03656679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65451281|NCT01217398|Bevacizumab|bevacizumab|mesh-list
65653894|NCT03656679|Trace Elements|trace elements|mesh-ancestor
65653895|NCT03656679|Micronutrients|micronutrients|mesh-ancestor
65653896|NCT03656679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653897|NCT03663166|Nivolumab|nivolumab|mesh-list
65653898|NCT03663166|Ipilimumab|ipilimumab|mesh-list
65653899|NCT03663166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65653900|NCT03663166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653901|NCT03663166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65653902|NCT03663166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653903|NCT03554304|Moxifloxacin|moxifloxacin|mesh-list
65653904|NCT03554304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65653905|NCT03554304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65653906|NCT03554304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65653907|NCT03554304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65653908|NCT03554304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65653909|NCT03554304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653910|NCT03554304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653911|NCT03554304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653912|NCT03554304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65653913|NCT03554304|Contraceptive Agents|contraceptive agents|mesh-ancestor
65653914|NCT03554304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65653915|NCT03554304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653916|NCT03554304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65653917|NCT03554304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65653918|NCT03554304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65653919|NCT02107716|Lidocaine|lidocaine|mesh-list
65653920|NCT02107716|Anesthetics, Local|anesthetics, local|mesh-ancestor
65653921|NCT02107716|Anesthetics|anesthetics|mesh-ancestor
65653922|NCT02107716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65653923|NCT02107716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653924|NCT02107716|Sensory System Agents|sensory system agents|mesh-ancestor
65653925|NCT02107716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65653926|NCT02107716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65653927|NCT02107716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65653928|NCT02107716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65653929|NCT02107716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65653930|NCT02107716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653931|NCT02110992|Docetaxel|docetaxel|mesh-list
65653932|NCT02110992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653933|NCT02110992|Tubulin Modulators|tubulin modulators|mesh-ancestor
65653934|NCT02110992|Antimitotic Agents|antimitotic agents|mesh-ancestor
65653935|NCT02110992|Mitosis Modulators|mitosis modulators|mesh-ancestor
65653936|NCT02110992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653937|NCT03306394|Trifluridine|trifluridine|mesh-list
65653938|NCT03306394|Antimetabolites|antimetabolites|mesh-ancestor
65653939|NCT03306394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653940|NCT03306394|Antiviral Agents|antiviral agents|mesh-ancestor
65653941|NCT03306394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65653942|NCT03532178|Rocuronium|rocuronium|mesh-list
65653943|NCT03532178|Succinylcholine|succinylcholine|mesh-list
65653944|NCT03532178|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65653945|NCT03532178|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65653946|NCT03532178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65653947|NCT03532178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65653948|NCT03532178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653949|NCT03532178|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
65653950|NCT00311090|Idraparinux|idraparinux|mesh-list
65653951|NCT00311090|Idrabiotaparinux|idrabiotaparinux|mesh-list
65653952|NCT00311090|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65653953|NCT00311090|Antithrombins|antithrombins|mesh-ancestor
65653954|NCT00311090|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65653955|NCT00311090|Protease Inhibitors|protease inhibitors|mesh-ancestor
65653956|NCT00311090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653957|NCT00311090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653958|NCT00311090|Anticoagulants|anticoagulants|mesh-ancestor
65653959|NCT02105610|Anesthetics|anesthetics|mesh-list
65653960|NCT02105610|Sevoflurane|sevoflurane|mesh-list
65653961|NCT02105610|Desflurane|desflurane|mesh-list
65653962|NCT02105610|Isoflurane|isoflurane|mesh-list
65653963|NCT02105610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
65653964|NCT02105610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65653965|NCT02105610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653966|NCT02105610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65653967|NCT02105610|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65653968|NCT02105610|Anesthetics, General|anesthetics, general|mesh-ancestor
65451365|NCT01215136|Paclitaxel|paclitaxel|mesh-list
65653969|NCT00301262|Sildenafil Citrate|sildenafil citrate|mesh-list
65653970|NCT00301262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653971|NCT00301262|Vasodilator Agents|vasodilator agents|mesh-ancestor
65653972|NCT00301262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65653973|NCT00301262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65653974|NCT00301262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65653975|NCT00301262|Urological Agents|urological agents|mesh-ancestor
65653976|NCT02254941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65653977|NCT02254941|Antibodies|antibodies|mesh-list
65653978|NCT02254941|Immunoglobulins|immunoglobulins|mesh-list
65653979|NCT02254941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65653980|NCT02254941|Immunologic Factors|immunologic factors|mesh-ancestor
65653981|NCT02254941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65653982|NCT02254941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653983|NCT03598270|Gemcitabine|gemcitabine|mesh-list
65653984|NCT03598270|Paclitaxel|paclitaxel|mesh-list
65653985|NCT03598270|Carboplatin|carboplatin|mesh-list
65653986|NCT03598270|Doxorubicin|doxorubicin|mesh-list
65653987|NCT03598270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65653988|NCT03598270|Atezolizumab|atezolizumab|mesh-list
65653989|NCT03598270|Niraparib|niraparib|mesh-list
65653990|NCT03598270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65653991|NCT03598270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65653992|NCT03598270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65653993|NCT03598270|Tubulin Modulators|tubulin modulators|mesh-ancestor
65653994|NCT03598270|Antimitotic Agents|antimitotic agents|mesh-ancestor
65653995|NCT03598270|Mitosis Modulators|mitosis modulators|mesh-ancestor
65653996|NCT03598270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65653997|NCT03598270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65653998|NCT03598270|Antimetabolites|antimetabolites|mesh-ancestor
65653999|NCT03598270|Antiviral Agents|antiviral agents|mesh-ancestor
65654000|NCT03598270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65654001|NCT03598270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654002|NCT03598270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65654003|NCT03598270|Immunologic Factors|immunologic factors|mesh-ancestor
65654004|NCT03598270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654005|NCT03598270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65654006|NCT03598270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65654007|NCT03598270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65654008|NCT03598270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65654009|NCT03077620|Suvorexant|suvorexant|mesh-list
65654010|NCT03077620|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65654011|NCT03077620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65654012|NCT03077620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65654013|NCT03077620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654014|NCT03077620|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65654015|NCT03077620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65654016|NCT03077620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654017|NCT03656445|Tranexamic Acid|tranexamic acid|mesh-list
65654018|NCT03656445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65654019|NCT03656445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65654020|NCT03656445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654021|NCT03656445|Hemostatics|hemostatics|mesh-ancestor
65654022|NCT03656445|Coagulants|coagulants|mesh-ancestor
65654023|NCT01903486|Prednisone|prednisone|mesh-list
65654024|NCT01903486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65654025|NCT01903486|Glucocorticoids|glucocorticoids|mesh-ancestor
65654026|NCT01903486|Hormones|hormones|mesh-ancestor
65654027|NCT01903486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65654028|NCT01903486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654029|NCT01903486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65654030|NCT01903486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654031|NCT03656289|Etonogestrel|etonogestrel|mesh-list
65654032|NCT03656289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65654033|NCT03656289|Contraceptive Agents|contraceptive agents|mesh-ancestor
65654034|NCT03656289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65654035|NCT03656289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654036|NCT03656289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65654037|NCT00599170|Rituximab|rituximab|mesh-list
65654038|NCT00599170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65654039|NCT00599170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654040|NCT00599170|Immunologic Factors|immunologic factors|mesh-ancestor
65654041|NCT00599170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654042|NCT00599170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65654043|NCT04256434|Nalbuphine|nalbuphine|mesh-list
65654044|NCT04256434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65654045|NCT04256434|Narcotics|narcotics|mesh-ancestor
65654046|NCT04256434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65654047|NCT04256434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654048|NCT04256434|Analgesics|analgesics|mesh-ancestor
65654049|NCT04256434|Sensory System Agents|sensory system agents|mesh-ancestor
65654050|NCT04256434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65654051|NCT03655665|Ofloxacin|ofloxacin|mesh-list
65654052|NCT03655665|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65654053|NCT03655665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65654054|NCT03655665|Renal Agents|renal agents|mesh-ancestor
65654055|NCT03655665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65654056|NCT03655665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65654057|NCT03655665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65654058|NCT03655665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654059|NCT03655665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654060|NCT03655665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654061|NCT03655665|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65654062|NCT03655665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65654063|NCT02588326|Mometasone Furoate|mometasone furoate|mesh-list
65654064|NCT02588326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65654065|NCT02588326|Dermatologic Agents|dermatologic agents|mesh-ancestor
65654066|NCT02588326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65654067|NCT02107950|Gemcitabine|gemcitabine|mesh-list
65654068|NCT02107950|Carboplatin|carboplatin|mesh-list
65654069|NCT02107950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654070|NCT02107950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65654071|NCT02107950|Antimetabolites|antimetabolites|mesh-ancestor
65654072|NCT02107950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654073|NCT02107950|Antiviral Agents|antiviral agents|mesh-ancestor
65654074|NCT02107950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65654075|NCT02107950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654076|NCT02107950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65654077|NCT02107950|Immunologic Factors|immunologic factors|mesh-ancestor
65654078|NCT02107950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654079|NCT02113800|Everolimus|everolimus|mesh-list
65654080|NCT02113800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654081|NCT02113800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65654082|NCT02113800|Immunologic Factors|immunologic factors|mesh-ancestor
65654083|NCT02113800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654084|NCT01066143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65654085|NCT01066143|Antidepressive Agents|antidepressive agents|mesh-ancestor
65654086|NCT01066143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65654087|NCT01066143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65654088|NCT01066143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65654089|NCT01066143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65654090|NCT01066143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654091|NCT02111928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65654092|NCT02111928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65654093|NCT02112006|Bupivacaine|bupivacaine|mesh-list
65654094|NCT02112006|Anesthetics, Local|anesthetics, local|mesh-ancestor
65654095|NCT02112006|Anesthetics|anesthetics|mesh-ancestor
65654096|NCT02112006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65654097|NCT02112006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654098|NCT02112006|Sensory System Agents|sensory system agents|mesh-ancestor
65654099|NCT02112006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65654100|NCT05128162|Psilocybin|psilocybin|mesh-list
65654101|NCT05128162|Hallucinogens|hallucinogens|mesh-ancestor
65654102|NCT05128162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654103|NCT05128162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65654104|NCT02251158|Ritonavir|ritonavir|mesh-list
65654105|NCT02251158|Tipranavir|tipranavir|mesh-list
65654106|NCT02251158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65654107|NCT02251158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65654108|NCT02251158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65654109|NCT02251158|Protease Inhibitors|protease inhibitors|mesh-ancestor
65654110|NCT02251158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654111|NCT02251158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654112|NCT02251158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65654113|NCT02251158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65654114|NCT02251158|Antiviral Agents|antiviral agents|mesh-ancestor
65654115|NCT02251158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65654116|NCT02251158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65654117|NCT02251158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65654118|NCT02652130|Remestemcel-l|remestemcel-l|mesh-list
65654119|NCT02652130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65654120|NCT02652130|Antiviral Agents|antiviral agents|mesh-ancestor
65654121|NCT02652130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65654122|NCT05404516|Cytarabine|cytarabine|mesh-list
65654123|NCT05404516|Sorafenib|sorafenib|mesh-list
65654124|NCT05404516|Idarubicin|idarubicin|mesh-list
65654125|NCT05404516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65654126|NCT05404516|Antimetabolites|antimetabolites|mesh-ancestor
65654127|NCT05404516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654128|NCT05404516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654129|NCT05404516|Antiviral Agents|antiviral agents|mesh-ancestor
65654130|NCT05404516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65654131|NCT05404516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65654132|NCT05404516|Immunologic Factors|immunologic factors|mesh-ancestor
65654133|NCT05404516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654134|NCT05404516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65654135|NCT05404516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654136|NCT05404516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65654137|NCT05404516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65654138|NCT05404516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65654139|NCT02114346|Atorvastatin|atorvastatin|mesh-list
65654140|NCT02114346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65654141|NCT02114346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65654142|NCT02114346|Antimetabolites|antimetabolites|mesh-ancestor
65654143|NCT02114346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654144|NCT02114346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65654145|NCT02114346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65654146|NCT02114346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654147|NCT02112162|Deoxyglucose|deoxyglucose|mesh-list
65654148|NCT02112162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65654149|NCT02112162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65654150|NCT02112162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654151|NCT02112162|Antimetabolites|antimetabolites|mesh-ancestor
65654152|NCT02112162|Antiviral Agents|antiviral agents|mesh-ancestor
65654153|NCT02112162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65654154|NCT02108808|Clopidogrel|clopidogrel|mesh-list
65654155|NCT02108808|Ticagrelor|ticagrelor|mesh-list
65654156|NCT02108808|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65654157|NCT02108808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65654158|NCT02108808|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65654159|NCT02108808|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65654160|NCT02108808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65654161|NCT02108808|Purinergic Agents|purinergic agents|mesh-ancestor
65654162|NCT02108808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65654163|NCT02108808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654164|NCT02108808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654165|NCT02108886|Montelukast|montelukast|mesh-list
65654166|NCT02108886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65654167|NCT02108886|Respiratory System Agents|respiratory system agents|mesh-ancestor
65654168|NCT02108886|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65654169|NCT02108886|Hormone Antagonists|hormone antagonists|mesh-ancestor
65654170|NCT02108886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65654171|NCT02108886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654172|NCT02108886|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65654173|NCT02108886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65654174|NCT02108886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654175|NCT02114502|Pyridoxine|pyridoxine|mesh-list
65654176|NCT02114502|Gemcitabine|gemcitabine|mesh-list
65654177|NCT02114502|Dexamethasone|dexamethasone|mesh-list
65654178|NCT02114502|Melphalan|melphalan|mesh-list
65654179|NCT02114502|Busulfan|busulfan|mesh-list
65654180|NCT02114502|Vorinostat|vorinostat|mesh-list
65654181|NCT02114502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65654182|NCT02114502|Antiemetics|antiemetics|mesh-ancestor
65654183|NCT02114502|Autonomic Agents|autonomic agents|mesh-ancestor
65654184|NCT02114502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65654185|NCT02114502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654186|NCT02114502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65654187|NCT02114502|Glucocorticoids|glucocorticoids|mesh-ancestor
65654188|NCT02114502|Hormones|hormones|mesh-ancestor
65654189|NCT02114502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65654190|NCT02114502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65654191|NCT02114502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654192|NCT02114502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65654193|NCT02114502|Antimetabolites|antimetabolites|mesh-ancestor
65654194|NCT02114502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451587|NCT01124032|Dopamine Agents|dopamine agents|mesh-ancestor
65654195|NCT02114502|Antiviral Agents|antiviral agents|mesh-ancestor
65654196|NCT02114502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65654197|NCT02114502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654198|NCT02114502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65654199|NCT02114502|Immunologic Factors|immunologic factors|mesh-ancestor
65654200|NCT02114502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65654201|NCT02114502|Alkylating Agents|alkylating agents|mesh-ancestor
65654202|NCT02114502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65654203|NCT02114502|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65654204|NCT02114502|Vitamin B Complex|vitamin b complex|mesh-ancestor
65654205|NCT02114502|Vitamins|vitamins|mesh-ancestor
65654206|NCT02114502|Micronutrients|micronutrients|mesh-ancestor
65654207|NCT03654027|Docetaxel|docetaxel|mesh-list
65654208|NCT03654027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654209|NCT03654027|Tubulin Modulators|tubulin modulators|mesh-ancestor
65654210|NCT03654027|Antimitotic Agents|antimitotic agents|mesh-ancestor
65654211|NCT03654027|Mitosis Modulators|mitosis modulators|mesh-ancestor
65654212|NCT03654027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654213|NCT02114658|Sorafenib|sorafenib|mesh-list
65654214|NCT02114658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654215|NCT02114658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65654216|NCT02114658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654217|NCT02114658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654218|NCT05126602|Vitamin D|vitamin d|mesh-list
65654219|NCT05126602|Ergocalciferols|ergocalciferols|mesh-list
65654220|NCT05126602|Cholecalciferol|cholecalciferol|mesh-list
65654221|NCT05126602|Vitamins|vitamins|mesh-list
65654222|NCT05126602|Micronutrients|micronutrients|mesh-ancestor
65654223|NCT05126602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654224|NCT05126602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65654225|NCT05126602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65654226|NCT02114736|Botulinum Toxins|botulinum toxins|mesh-list
65654227|NCT02114736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65654228|NCT02114736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65654229|NCT02114736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65654230|NCT02114736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654231|NCT02114736|Cholinergic Agents|cholinergic agents|mesh-ancestor
65654232|NCT02114736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65654233|NCT02114736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654234|NCT02114736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65654235|NCT02114736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65654236|NCT04600921|Ertugliflozin|ertugliflozin|mesh-list
65654237|NCT04600921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65654238|NCT04600921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654239|NCT04600921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65654240|NCT04600921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654241|NCT02112552|Paclitaxel|paclitaxel|mesh-list
65654242|NCT02112552|Carboplatin|carboplatin|mesh-list
65654243|NCT02112552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65654244|NCT02112552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654245|NCT02112552|Tubulin Modulators|tubulin modulators|mesh-ancestor
65654246|NCT02112552|Antimitotic Agents|antimitotic agents|mesh-ancestor
65654247|NCT02112552|Mitosis Modulators|mitosis modulators|mesh-ancestor
65654248|NCT02112552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654249|NCT02109354|Vaccines|vaccines|mesh-list
65654250|NCT02109354|Immunologic Factors|immunologic factors|mesh-ancestor
65654251|NCT02109354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654252|NCT03165136|Hydroxychloroquine|hydroxychloroquine|mesh-list
65654253|NCT03165136|Antimalarials|antimalarials|mesh-ancestor
65654254|NCT03165136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65654255|NCT03165136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65654256|NCT03165136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65654257|NCT03165136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654258|NCT03165136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654259|NCT03165136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65654260|NCT02109510|Lidocaine|lidocaine|mesh-list
65654261|NCT02109510|Dexmedetomidine|dexmedetomidine|mesh-list
65654262|NCT02109510|Ketamine|ketamine|mesh-list
65654263|NCT02109510|Anesthetics|anesthetics|mesh-list
65654264|NCT02109510|Propofol|propofol|mesh-list
65654265|NCT02109510|Sevoflurane|sevoflurane|mesh-list
65654266|NCT02109510|Rocuronium|rocuronium|mesh-list
65654267|NCT02109510|Anesthetics, Local|anesthetics, local|mesh-ancestor
65654268|NCT02109510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65654269|NCT02109510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654270|NCT02109510|Sensory System Agents|sensory system agents|mesh-ancestor
65451658|NCT01126216|Paclitaxel|paclitaxel|mesh-list
65654271|NCT02109510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65654272|NCT02109510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65654273|NCT02109510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65654274|NCT02109510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65654275|NCT02109510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65654276|NCT02109510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654277|NCT02109510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65654278|NCT02109510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65654279|NCT02109510|Anesthetics, General|anesthetics, general|mesh-ancestor
65654280|NCT02109510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65654282|NCT02109510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65654283|NCT02109510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65654284|NCT02109510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65654285|NCT02109510|Adrenergic Agents|adrenergic agents|mesh-ancestor
65654286|NCT02109510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65654287|NCT02109510|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65654288|NCT02109510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65654289|NCT02109510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65654290|NCT02109510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65654291|NCT02109510|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65654292|NCT02109510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65654293|NCT02109510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65654294|NCT02109510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65654295|NCT02109666|Abatacept|abatacept|mesh-list
65654296|NCT02109666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65654297|NCT02109666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654298|NCT02109666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654299|NCT02109666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65654300|NCT02109666|Immunologic Factors|immunologic factors|mesh-ancestor
65654301|NCT02109666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654302|NCT02109666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65654303|NCT02865928|Bupivacaine|bupivacaine|mesh-list
65654304|NCT02865928|Anesthetics, Local|anesthetics, local|mesh-ancestor
65654305|NCT02865928|Anesthetics|anesthetics|mesh-ancestor
65654306|NCT02865928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65654307|NCT02865928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654308|NCT02865928|Sensory System Agents|sensory system agents|mesh-ancestor
65654309|NCT02865928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65654310|NCT02109900|Progesterone|progesterone|mesh-list
65654311|NCT02109900|Progestins|progestins|mesh-ancestor
65654312|NCT02109900|Hormones|hormones|mesh-ancestor
65654313|NCT02109900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65654314|NCT02109900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654315|NCT02112630|Interferons|interferons|mesh-list
65654316|NCT02112630|Ribavirin|ribavirin|mesh-list
65654317|NCT02112630|Interferon-alpha|interferon-alpha|mesh-list
65654318|NCT02112630|Interferon alpha-2|interferon alpha-2|mesh-list
65654319|NCT02112630|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65654320|NCT02112630|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65654321|NCT02112630|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65654322|NCT02112630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654323|NCT02112630|Antiviral Agents|antiviral agents|mesh-ancestor
65654324|NCT02112630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65654325|NCT02112630|Antimetabolites|antimetabolites|mesh-ancestor
65654326|NCT02112630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654327|NCT02112630|Immunologic Factors|immunologic factors|mesh-ancestor
65654328|NCT02112630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654329|NCT04873375|Cemiplimab|cemiplimab|mesh-list
65654330|NCT04873375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65654331|NCT04873375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654332|NCT05125588|Meloxicam|meloxicam|mesh-list
65654333|NCT05125588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65654334|NCT05125588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65654335|NCT05125588|Analgesics|analgesics|mesh-ancestor
65654336|NCT05125588|Sensory System Agents|sensory system agents|mesh-ancestor
65654337|NCT05125588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65654338|NCT05125588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654339|NCT05125588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65654340|NCT05125588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65654341|NCT05125588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65654342|NCT05125588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65654343|NCT05125588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451740|NCT01581944|Goserelin|goserelin|mesh-list
65654344|NCT05125588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654345|NCT02115204|Cyclophosphamide|cyclophosphamide|mesh-list
65654347|NCT02115204|Fluorouracil|fluorouracil|mesh-list
65654348|NCT02115204|Methotrexate|methotrexate|mesh-list
65654349|NCT02115204|Epirubicin|epirubicin|mesh-list
65654350|NCT02115204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65654351|NCT02115204|Immunologic Factors|immunologic factors|mesh-ancestor
65654352|NCT02115204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654353|NCT02115204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65654354|NCT02115204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65654355|NCT02115204|Alkylating Agents|alkylating agents|mesh-ancestor
65654356|NCT02115204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654357|NCT02115204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654358|NCT02115204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65654359|NCT02115204|Tubulin Modulators|tubulin modulators|mesh-ancestor
65654360|NCT02115204|Antimitotic Agents|antimitotic agents|mesh-ancestor
65654361|NCT02115204|Mitosis Modulators|mitosis modulators|mesh-ancestor
65654362|NCT02115204|Antimetabolites|antimetabolites|mesh-ancestor
65654363|NCT02115204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65654364|NCT02115204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65654365|NCT02115204|Abortifacient Agents|abortifacient agents|mesh-ancestor
65654366|NCT02115204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65654367|NCT02115204|Dermatologic Agents|dermatologic agents|mesh-ancestor
65654368|NCT02115204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654369|NCT02115204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65654370|NCT02115204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65654371|NCT02115204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65654372|NCT02115204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65654373|NCT02115204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65654374|NCT02115360|Calcitonin|calcitonin|mesh-list
65654375|NCT02115360|Salmon calcitonin|salmon calcitonin|mesh-list
65654376|NCT02115360|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
65654377|NCT02115360|Fentanyl|fentanyl|mesh-list
65654378|NCT02115360|Katacalcin|katacalcin|mesh-list
65654379|NCT02115360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65654380|NCT02115360|Narcotics|narcotics|mesh-ancestor
65654381|NCT02115360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65654382|NCT02115360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654383|NCT02115360|Analgesics|analgesics|mesh-ancestor
65654384|NCT02115360|Sensory System Agents|sensory system agents|mesh-ancestor
65654385|NCT02115360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65654386|NCT02115360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65654387|NCT02115360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65654388|NCT02115360|Anesthetics, General|anesthetics, general|mesh-ancestor
65654389|NCT02115360|Anesthetics|anesthetics|mesh-ancestor
65654390|NCT02115360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65654391|NCT02115360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65654392|NCT02115360|Vasodilator Agents|vasodilator agents|mesh-ancestor
65654393|NCT02432404|NuvaRing|nuvaring|mesh-list
65654394|NCT02432404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65654395|NCT02432404|Contraceptive Agents|contraceptive agents|mesh-ancestor
65654396|NCT02432404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65654397|NCT02432404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654398|NCT02113176|Minocycline|minocycline|mesh-list
65654399|NCT02113176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65654400|NCT02113176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65654401|NCT02118870|Aspirin|aspirin|mesh-list
65654402|NCT02118870|Clopidogrel|clopidogrel|mesh-list
65654403|NCT02118870|Ticagrelor|ticagrelor|mesh-list
65654404|NCT02118870|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65654405|NCT02118870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65654406|NCT02118870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65654407|NCT02118870|Analgesics|analgesics|mesh-ancestor
65654408|NCT02118870|Sensory System Agents|sensory system agents|mesh-ancestor
65654409|NCT02118870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65654410|NCT02118870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654411|NCT02118870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65654412|NCT02118870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65654413|NCT02118870|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65654414|NCT02118870|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65654415|NCT02118870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654416|NCT02118870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65654417|NCT02118870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65654418|NCT02118870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654419|NCT02118870|Antipyretics|antipyretics|mesh-ancestor
65654420|NCT02118870|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65654421|NCT02118870|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65654422|NCT02118870|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65654423|NCT02118870|Purinergic Agents|purinergic agents|mesh-ancestor
65654424|NCT02118870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65654425|NCT02975349|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65654426|NCT02975349|Dermatologic Agents|dermatologic agents|mesh-ancestor
65654427|NCT02975349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65654428|NCT02975349|Immunologic Factors|immunologic factors|mesh-ancestor
65654429|NCT02975349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654430|NCT03552666|Vitamin D|vitamin d|mesh-list
65654431|NCT03552666|Cholecalciferol|cholecalciferol|mesh-list
65654432|NCT03552666|Vitamins|vitamins|mesh-ancestor
65654433|NCT03552666|Micronutrients|micronutrients|mesh-ancestor
65654434|NCT03552666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654435|NCT03552666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65654436|NCT03552666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65654437|NCT02115594|Fulvestrant|fulvestrant|mesh-list
65654438|NCT02115594|Entinostat|entinostat|mesh-list
65654439|NCT02115594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65654440|NCT02115594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654441|NCT02115594|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65654442|NCT02115594|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65654443|NCT02115594|Hormone Antagonists|hormone antagonists|mesh-ancestor
65654444|NCT02115594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65654445|NCT02115594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654446|NCT02115594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65654447|NCT02115594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654448|NCT02115594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654449|NCT05125042|Amiodarone|amiodarone|mesh-list
65654450|NCT05125042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65654451|NCT05125042|Vasodilator Agents|vasodilator agents|mesh-ancestor
65654452|NCT05125042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65654453|NCT05125042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65654454|NCT05125042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654455|NCT05125042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65654456|NCT05125042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65654457|NCT05125042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65654458|NCT05125042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654459|NCT05125042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65654460|NCT05125042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65654461|NCT05125042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65654462|NCT02113332|Liraglutide|liraglutide|mesh-list
65654463|NCT02113332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65654464|NCT02113332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654465|NCT02113332|Incretins|incretins|mesh-ancestor
65654466|NCT02113332|Hormones|hormones|mesh-ancestor
65654467|NCT02113332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65654468|NCT02119338|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65654469|NCT02119338|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65654470|NCT02119338|Dermatologic Agents|dermatologic agents|mesh-ancestor
65654471|NCT02918877|Propofol|propofol|mesh-list
65654472|NCT02918877|Sevoflurane|sevoflurane|mesh-list
65654473|NCT02918877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65654474|NCT02918877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65654475|NCT02918877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654476|NCT02918877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65654477|NCT02918877|Anesthetics, General|anesthetics, general|mesh-ancestor
65654478|NCT02918877|Anesthetics|anesthetics|mesh-ancestor
65654479|NCT02918877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65654480|NCT02918877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65654481|NCT03652857|Apatinib|apatinib|mesh-list
65654482|NCT03652857|Vinorelbine|vinorelbine|mesh-list
65654483|NCT03652857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654484|NCT03652857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65654485|NCT03652857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654486|NCT03652857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654487|NCT03652857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65654488|NCT03652857|Tubulin Modulators|tubulin modulators|mesh-ancestor
65654489|NCT03652857|Antimitotic Agents|antimitotic agents|mesh-ancestor
65654490|NCT03652857|Mitosis Modulators|mitosis modulators|mesh-ancestor
65654491|NCT05129410|Mycophenolic Acid|mycophenolic acid|mesh-list
65654492|NCT05129410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65654493|NCT05129410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654494|NCT05129410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65654495|NCT05129410|Antitubercular Agents|antitubercular agents|mesh-ancestor
65654496|NCT05129410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65654497|NCT05129410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65654498|NCT05129410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654499|NCT05129410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654500|NCT04221555|Docetaxel|docetaxel|mesh-list
65654501|NCT04221555|Oxaliplatin|oxaliplatin|mesh-list
65654502|NCT04221555|Durvalumab|durvalumab|mesh-list
65654503|NCT04221555|Tremelimumab|tremelimumab|mesh-list
65654504|NCT04221555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65654505|NCT04221555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654506|NCT04221555|Tubulin Modulators|tubulin modulators|mesh-ancestor
65654507|NCT04221555|Antimitotic Agents|antimitotic agents|mesh-ancestor
65654508|NCT04221555|Mitosis Modulators|mitosis modulators|mesh-ancestor
65654509|NCT04221555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654510|NCT04221555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65654511|NCT04221555|Immunologic Factors|immunologic factors|mesh-ancestor
65654512|NCT04221555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654513|NCT02113566|Acetaminophen|acetaminophen|mesh-list
65654514|NCT02113566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65654515|NCT02113566|Analgesics|analgesics|mesh-ancestor
65654516|NCT02113566|Sensory System Agents|sensory system agents|mesh-ancestor
65654517|NCT02113566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65654518|NCT02113566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654519|NCT02113566|Antipyretics|antipyretics|mesh-ancestor
65654520|NCT05124730|Metformin|metformin|mesh-list
65654521|NCT05124730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65654522|NCT05124730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654523|NCT02251626|Ubiquinone|ubiquinone|mesh-list
65654524|NCT02251626|Coenzyme Q10|coenzyme q10|mesh-list
65654525|NCT02251626|Micronutrients|micronutrients|mesh-ancestor
65654526|NCT02251626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654527|NCT02251626|Vitamins|vitamins|mesh-ancestor
65654528|NCT02123004|Clopidogrel|clopidogrel|mesh-list
65654529|NCT02123004|Ticagrelor|ticagrelor|mesh-list
65654530|NCT02123004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65654531|NCT02123004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65654532|NCT02123004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65654533|NCT02123004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65654534|NCT02123004|Purinergic Agents|purinergic agents|mesh-ancestor
65654535|NCT02123004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65654536|NCT02123004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654537|NCT02123004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654538|NCT01674712|Simvastatin|simvastatin|mesh-list
65654539|NCT01674712|Fenofibrate|fenofibrate|mesh-list
65654540|NCT01674712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65654541|NCT01674712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65654542|NCT01674712|Antimetabolites|antimetabolites|mesh-ancestor
65654543|NCT01674712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654544|NCT01674712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65654545|NCT01674712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65654546|NCT01674712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654547|NCT01368432|Citalopram|citalopram|mesh-list
65654548|NCT01368432|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65654549|NCT01368432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65654550|NCT01368432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65654551|NCT01368432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654552|NCT01368432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65654553|NCT01368432|Serotonin Agents|serotonin agents|mesh-ancestor
65654554|NCT01368432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654555|NCT01368432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65654556|NCT01368432|Antidepressive Agents|antidepressive agents|mesh-ancestor
65654557|NCT01368432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65654558|NCT05122780|Acetylcholine|acetylcholine|mesh-list
65654559|NCT05122780|Anticoagulants|anticoagulants|mesh-list
65654560|NCT05122780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65654561|NCT05122780|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65654562|NCT05122780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65654563|NCT05122780|Adrenergic Agents|adrenergic agents|mesh-ancestor
65654564|NCT05122780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65654565|NCT05122780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654566|NCT05122780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654567|NCT05122780|Vasodilator Agents|vasodilator agents|mesh-ancestor
65654568|NCT05122780|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65654569|NCT05122780|Cholinergic Agents|cholinergic agents|mesh-ancestor
65654570|NCT02119806|Fentanyl|fentanyl|mesh-list
65654571|NCT02119806|Midazolam|midazolam|mesh-list
65654572|NCT02119806|Propofol|propofol|mesh-list
65654573|NCT02119806|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65654574|NCT02119806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65654575|NCT02119806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654576|NCT02119806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65654577|NCT02119806|Anesthetics, General|anesthetics, general|mesh-ancestor
65654578|NCT02119806|Anesthetics|anesthetics|mesh-ancestor
65654579|NCT02119806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65654580|NCT02119806|Narcotics|narcotics|mesh-ancestor
65654581|NCT02119806|Analgesics|analgesics|mesh-ancestor
65654582|NCT02119806|Sensory System Agents|sensory system agents|mesh-ancestor
65654583|NCT02119806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65654584|NCT02119806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65654585|NCT02119806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65654586|NCT02119806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65654587|NCT02119806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65654588|NCT02119806|GABA Modulators|gaba modulators|mesh-ancestor
65654589|NCT02119806|GABA Agents|gaba agents|mesh-ancestor
65654590|NCT02119806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65654591|NCT02119806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654592|NCT02119884|Octreotide|octreotide|mesh-list
65654593|NCT02119884|Terlipressin|terlipressin|mesh-list
65654594|NCT02119884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65654595|NCT02119884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65654596|NCT02119884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654597|NCT02119884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65654598|NCT02119884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65654599|NCT05104918|Vortioxetine|vortioxetine|mesh-list
65654600|NCT05104918|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65654601|NCT05104918|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65654602|NCT05104918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65654603|NCT05104918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65654604|NCT05104918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654605|NCT05104918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65654606|NCT05104918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654607|NCT05104918|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65654608|NCT05104918|Antidepressive Agents|antidepressive agents|mesh-ancestor
65654609|NCT05104918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65654610|NCT05104918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65654611|NCT05104918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65654612|NCT05104918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65654613|NCT05104918|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65654614|NCT05104918|Serotonin Agents|serotonin agents|mesh-ancestor
65654615|NCT05104918|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65654616|NCT05104918|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65654617|NCT05104918|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65654618|NCT05104918|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65654619|NCT05089942|Insulin|insulin|mesh-list
65654620|NCT05089942|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65654621|NCT05089942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65654622|NCT05089942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654623|NCT04941508|Dexmedetomidine|dexmedetomidine|mesh-list
65654624|NCT04941508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65654625|NCT04941508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65654626|NCT04941508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654627|NCT04941508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65654628|NCT04941508|Analgesics|analgesics|mesh-ancestor
65654629|NCT04941508|Sensory System Agents|sensory system agents|mesh-ancestor
65654630|NCT04941508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65654631|NCT04941508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65654632|NCT04941508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65654633|NCT04941508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65654634|NCT04941508|Adrenergic Agents|adrenergic agents|mesh-ancestor
65654635|NCT04941508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65654636|NCT04941508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654637|NCT01062555|Cyclosporine|cyclosporine|mesh-list
65654638|NCT01062555|Sirolimus|sirolimus|mesh-list
65654639|NCT01062555|Mycophenolic Acid|mycophenolic acid|mesh-list
65654640|NCT01062555|Tacrolimus|tacrolimus|mesh-list
65654641|NCT01062555|Cyclosporins|cyclosporins|mesh-list
65654642|NCT01062555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65654643|NCT01062555|Immunologic Factors|immunologic factors|mesh-ancestor
65654644|NCT01062555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654645|NCT01062555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65654646|NCT01062555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654647|NCT01062555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654648|NCT01062555|Antifungal Agents|antifungal agents|mesh-ancestor
65654649|NCT01062555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65654650|NCT01062555|Dermatologic Agents|dermatologic agents|mesh-ancestor
65654651|NCT01062555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65654652|NCT01062555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65654653|NCT01062555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654654|NCT01062555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65654655|NCT01062555|Antitubercular Agents|antitubercular agents|mesh-ancestor
65654656|NCT01062555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65654658|NCT03622047|Dexmedetomidine|dexmedetomidine|mesh-list
65654659|NCT03622047|Ropivacaine|ropivacaine|mesh-list
65654660|NCT03622047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65654661|NCT03622047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65654662|NCT03622047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654663|NCT03622047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65654664|NCT03622047|Analgesics|analgesics|mesh-ancestor
65654665|NCT03622047|Sensory System Agents|sensory system agents|mesh-ancestor
65654666|NCT03622047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65654667|NCT03622047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65654668|NCT03622047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65654669|NCT03622047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65654670|NCT03622047|Adrenergic Agents|adrenergic agents|mesh-ancestor
65654671|NCT03622047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65654672|NCT03622047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654673|NCT03622047|Anesthetics, Local|anesthetics, local|mesh-ancestor
65654674|NCT03622047|Anesthetics|anesthetics|mesh-ancestor
65654675|NCT03622047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65654676|NCT03622047|Narcotics|narcotics|mesh-ancestor
65654677|NCT03622047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65654678|NCT03622047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65654679|NCT03622047|Anesthetics, General|anesthetics, general|mesh-ancestor
65654680|NCT05128630|Durvalumab|durvalumab|mesh-list
65654681|NCT05128630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65654682|NCT05128630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654683|NCT05073562|Folic Acid|folic acid|mesh-list
65654684|NCT05073562|Mebendazole|mebendazole|mesh-list
65654685|NCT05073562|Piperazine|piperazine|mesh-list
65654686|NCT05073562|Piperazine citrate|piperazine citrate|mesh-list
65654687|NCT05073562|DMP 777|dmp 777|mesh-list
65654688|NCT05073562|Hematinics|hematinics|mesh-ancestor
65654689|NCT05073562|Vitamin B Complex|vitamin b complex|mesh-ancestor
65654690|NCT05073562|Vitamins|vitamins|mesh-ancestor
65654691|NCT05073562|Micronutrients|micronutrients|mesh-ancestor
65654692|NCT05073562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654693|NCT05073562|Antinematodal Agents|antinematodal agents|mesh-ancestor
65654694|NCT05073562|Anthelmintics|anthelmintics|mesh-ancestor
65654695|NCT05073562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65654696|NCT05073562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65654697|NCT05073562|Tubulin Modulators|tubulin modulators|mesh-ancestor
65654698|NCT05073562|Antimitotic Agents|antimitotic agents|mesh-ancestor
65654699|NCT05073562|Mitosis Modulators|mitosis modulators|mesh-ancestor
65654700|NCT05073562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654701|NCT05073562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654702|NCT05073562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654703|NCT01368276|Molgramostim|molgramostim|mesh-list
65654704|NCT01368276|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
65654705|NCT01368276|Sargramostim|sargramostim|mesh-list
65654706|NCT01368276|Immunologic Factors|immunologic factors|mesh-ancestor
65654707|NCT01368276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654708|NCT01368276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654709|NCT01368276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65654710|NCT02116842|Fentanyl|fentanyl|mesh-list
65654711|NCT02116842|Bupivacaine|bupivacaine|mesh-list
65654712|NCT02116842|Anesthetics, Local|anesthetics, local|mesh-ancestor
65654713|NCT02116842|Anesthetics|anesthetics|mesh-ancestor
65654714|NCT02116842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65654715|NCT02116842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654716|NCT02116842|Sensory System Agents|sensory system agents|mesh-ancestor
65654717|NCT02116842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65654718|NCT02116842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65654719|NCT02116842|Narcotics|narcotics|mesh-ancestor
65654720|NCT02116842|Analgesics|analgesics|mesh-ancestor
65654721|NCT02116842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65654722|NCT02116842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65654723|NCT02116842|Anesthetics, General|anesthetics, general|mesh-ancestor
65654724|NCT02120118|Docetaxel|docetaxel|mesh-list
65654725|NCT02120118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654726|NCT02120118|Tubulin Modulators|tubulin modulators|mesh-ancestor
65654727|NCT02120118|Antimitotic Agents|antimitotic agents|mesh-ancestor
65654728|NCT02120118|Mitosis Modulators|mitosis modulators|mesh-ancestor
65654729|NCT02120118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654730|NCT04054089|Tenofovir|tenofovir|mesh-list
65654731|NCT04054089|Lamivudine|lamivudine|mesh-list
65654732|NCT04054089|Emtricitabine|emtricitabine|mesh-list
65654733|NCT04054089|Dolutegravir|dolutegravir|mesh-list
65654734|NCT04054089|Antiviral Agents|antiviral agents|mesh-ancestor
65654735|NCT04054089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65654736|NCT04054089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65654737|NCT04054089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65654738|NCT04054089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654739|NCT04054089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654740|NCT04054089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65654741|NCT04054089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65654742|NCT04054089|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65654743|NCT04054089|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65654744|NCT02120196|Rifaximin|rifaximin|mesh-list
65654745|NCT02120196|Norfloxacin|norfloxacin|mesh-list
65654746|NCT02120196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65654747|NCT02120196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65654748|NCT02120196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65654749|NCT02120196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65654750|NCT02120196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65654751|NCT02120196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654752|NCT02120196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654753|NCT02120196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654754|NCT02120196|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65654755|NCT02120196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65654756|NCT05001802|Ropivacaine|ropivacaine|mesh-list
65654757|NCT05001802|Anesthetics, Local|anesthetics, local|mesh-ancestor
65654758|NCT05001802|Anesthetics|anesthetics|mesh-ancestor
65654759|NCT05001802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65654760|NCT05001802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654761|NCT05001802|Sensory System Agents|sensory system agents|mesh-ancestor
65654762|NCT05001802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65654763|NCT02120274|Vitamin D|vitamin d|mesh-list
65654764|NCT02120274|Vitamins|vitamins|mesh-list
65654765|NCT02120274|Vitamin B 12|vitamin b 12|mesh-list
65654766|NCT02120274|Hydroxocobalamin|hydroxocobalamin|mesh-list
65654767|NCT02120274|Micronutrients|micronutrients|mesh-ancestor
65654768|NCT02120274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654769|NCT02120274|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65654770|NCT02120274|Vitamin B Complex|vitamin b complex|mesh-ancestor
65654771|NCT02120274|Hematinics|hematinics|mesh-ancestor
65654772|NCT02402842|Docetaxel|docetaxel|mesh-list
65654773|NCT02402842|Fluorouracil|fluorouracil|mesh-list
65654774|NCT02402842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654775|NCT02402842|Tubulin Modulators|tubulin modulators|mesh-ancestor
65654776|NCT02402842|Antimitotic Agents|antimitotic agents|mesh-ancestor
65654777|NCT02402842|Mitosis Modulators|mitosis modulators|mesh-ancestor
65654778|NCT02402842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654779|NCT02402842|Antimetabolites|antimetabolites|mesh-ancestor
65654780|NCT02402842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65654781|NCT02402842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65654782|NCT02402842|Immunologic Factors|immunologic factors|mesh-ancestor
65654783|NCT02402842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654784|NCT03652467|Chlorotrianisene|chlorotrianisene|mesh-list
65654785|NCT03652467|Deferoxamine|deferoxamine|mesh-list
65654786|NCT03652467|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65654787|NCT03652467|Estrogens|estrogens|mesh-ancestor
65654788|NCT03652467|Hormones|hormones|mesh-ancestor
65654789|NCT03652467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65654790|NCT03652467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654791|NCT03652467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65654792|NCT03652467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654793|NCT03652467|Siderophores|siderophores|mesh-ancestor
65654794|NCT03652467|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65654795|NCT03652467|Chelating Agents|chelating agents|mesh-ancestor
65654796|NCT03652467|Sequestering Agents|sequestering agents|mesh-ancestor
65654797|NCT03652467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654798|NCT02741570|Cisplatin|cisplatin|mesh-list
65654799|NCT02741570|Carboplatin|carboplatin|mesh-list
65654800|NCT02741570|Fluorouracil|fluorouracil|mesh-list
65654801|NCT02741570|Nivolumab|nivolumab|mesh-list
65654802|NCT02741570|Cetuximab|cetuximab|mesh-list
65654803|NCT02741570|Ipilimumab|ipilimumab|mesh-list
65654804|NCT02741570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654805|NCT02741570|Antimetabolites|antimetabolites|mesh-ancestor
65654806|NCT02741570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654807|NCT02741570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65654808|NCT02741570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65654809|NCT02741570|Immunologic Factors|immunologic factors|mesh-ancestor
65654810|NCT02741570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654811|NCT02741570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65654812|NCT02741570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65654813|NCT01061775|Exenatide|exenatide|mesh-list
65654814|NCT01061775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65654815|NCT01061775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654816|NCT01061775|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65654817|NCT01061775|Incretins|incretins|mesh-ancestor
65654818|NCT01061775|Hormones|hormones|mesh-ancestor
65654819|NCT01061775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65654820|NCT02123628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65654821|NCT02123628|Doxycycline|doxycycline|mesh-list
65654822|NCT02123628|Ciprofloxacin|ciprofloxacin|mesh-list
65654823|NCT02123628|Levofloxacin|levofloxacin|mesh-list
65654824|NCT02123628|Rifampin|rifampin|mesh-list
65654825|NCT02123628|Ceftriaxone|ceftriaxone|mesh-list
65654826|NCT02123628|Linezolid|linezolid|mesh-list
65654827|NCT02123628|Cefepime|cefepime|mesh-list
65654828|NCT02123628|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65654829|NCT02123628|Cefotaxime|cefotaxime|mesh-list
65654830|NCT02123628|Fusidic Acid|fusidic acid|mesh-list
65654831|NCT02123628|Trimethoprim|trimethoprim|mesh-list
65654832|NCT02123628|Sulfamethoxazole|sulfamethoxazole|mesh-list
65654833|NCT02123628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65654834|NCT02123628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65654835|NCT02123628|Antitubercular Agents|antitubercular agents|mesh-ancestor
65654836|NCT02123628|Antimalarials|antimalarials|mesh-ancestor
65654837|NCT02123628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65654838|NCT02123628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65654839|NCT02123628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65654840|NCT02123628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65654841|NCT02123628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654842|NCT02123628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654843|NCT02123628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654844|NCT02123628|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65654845|NCT02123628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65654846|NCT02123628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65654847|NCT02123628|Renal Agents|renal agents|mesh-ancestor
65654848|NCT02123628|Leprostatic Agents|leprostatic agents|mesh-ancestor
65654849|NCT02123628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65654850|NCT02123628|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65654851|NCT02123628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65654852|NCT02123628|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65654853|NCT02123628|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65654854|NCT02123628|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65654855|NCT02123628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65654856|NCT02123628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65654857|NCT02123628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65654858|NCT02123628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65654859|NCT02123628|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65654860|NCT02651116|Dextromethorphan|dextromethorphan|mesh-list
65654861|NCT02651116|Antitussive Agents|antitussive agents|mesh-ancestor
65654862|NCT02651116|Respiratory System Agents|respiratory system agents|mesh-ancestor
65654863|NCT02651116|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65654864|NCT02651116|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65654865|NCT02651116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65654866|NCT02651116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654867|NCT02651116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654868|NCT03528824|Diclofenac|diclofenac|mesh-list
65654869|NCT03528824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65654870|NCT03528824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65654871|NCT03528824|Analgesics|analgesics|mesh-ancestor
65654872|NCT03528824|Sensory System Agents|sensory system agents|mesh-ancestor
65654873|NCT03528824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65654874|NCT03528824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452257|NCT01228552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65654875|NCT03528824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65654876|NCT03528824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65654877|NCT03528824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65654878|NCT03528824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654879|NCT03528824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654880|NCT05045638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65654881|NCT05045638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65654882|NCT05045638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65654883|NCT05045638|Antimetabolites|antimetabolites|mesh-ancestor
65654884|NCT05045638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654885|NCT05045638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65654886|NCT05045638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65654887|NCT05045638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654888|NCT00289640|Ipilimumab|ipilimumab|mesh-list
65654889|NCT00289640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65654890|NCT00289640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654891|NCT00289640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65654892|NCT00289640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654893|NCT05039086|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
65654894|NCT05039086|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
65654895|NCT05039086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65654896|NCT05039086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654897|NCT05039086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654898|NCT03765632|Busulfan|busulfan|mesh-list
65654899|NCT03765632|Alkylating Agents|alkylating agents|mesh-ancestor
65654900|NCT03765632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654901|NCT03765632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65654902|NCT03765632|Immunologic Factors|immunologic factors|mesh-ancestor
65654903|NCT03765632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654904|NCT03765632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65654905|NCT03765632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654906|NCT03765632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65654907|NCT02973477|Dapagliflozin|dapagliflozin|mesh-list
65654908|NCT02973477|Glimepiride|glimepiride|mesh-list
65654909|NCT02973477|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65654910|NCT02973477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654911|NCT02973477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65654912|NCT02973477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654913|NCT02973477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65654914|NCT02973477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65654915|NCT02973477|Immunologic Factors|immunologic factors|mesh-ancestor
65654916|NCT03552354|Argatroban|argatroban|mesh-list
65654917|NCT03552354|Antithrombins|antithrombins|mesh-ancestor
65654918|NCT03552354|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65654919|NCT03552354|Protease Inhibitors|protease inhibitors|mesh-ancestor
65654920|NCT03552354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654921|NCT03552354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654922|NCT03552354|Anticoagulants|anticoagulants|mesh-ancestor
65654923|NCT03552354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65654924|NCT02288000|Memantine|memantine|mesh-list
65654925|NCT02288000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65654926|NCT02288000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65654927|NCT02288000|Dopamine Agents|dopamine agents|mesh-ancestor
65654928|NCT02288000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65654929|NCT02288000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654930|NCT02288000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654931|NCT02288000|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65654932|NCT02288000|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65654933|NCT02788656|Valsartan|valsartan|mesh-list
65654934|NCT02788656|Angiotensin II|angiotensin ii|mesh-list
65654935|NCT02788656|Giapreza|giapreza|mesh-list
65654936|NCT02788656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
65654937|NCT02788656|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65654938|NCT02788656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65654939|NCT02788656|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65654940|NCT02788656|Angiotensinogen|angiotensinogen|mesh-list
65654941|NCT02788656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65654942|NCT02788656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65654943|NCT02788656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654944|NCT02788656|Protease Inhibitors|protease inhibitors|mesh-ancestor
65654945|NCT02788656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65654946|NCT02788656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65654948|NCT05258110|BI 425809|bi 425809|mesh-list
65654949|NCT05258110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65654950|NCT05258110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65654951|NCT05258110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65654952|NCT05258110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654953|NCT05258110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65654954|NCT05258110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65654955|NCT05258110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65654956|NCT05258110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65654957|NCT05258110|Anesthetics, General|anesthetics, general|mesh-ancestor
65654958|NCT05258110|Anesthetics|anesthetics|mesh-ancestor
65654959|NCT05258110|GABA Modulators|gaba modulators|mesh-ancestor
65654960|NCT05258110|GABA Agents|gaba agents|mesh-ancestor
65654961|NCT05258110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65654962|NCT05258110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654963|NCT05258110|Nootropic Agents|nootropic agents|mesh-ancestor
65654964|NCT03652233|Nivolumab|nivolumab|mesh-list
65654965|NCT03652233|Afatinib|afatinib|mesh-list
65654966|NCT03652233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65654967|NCT03652233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654968|NCT03652233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65654969|NCT03652233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654970|NCT03652233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65654971|NCT03652233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654972|NCT02117466|Cetuximab|cetuximab|mesh-list
65654973|NCT02117466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65654974|NCT02117466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654975|NCT02117622|Insulin|insulin|mesh-list
65654976|NCT02117622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65654977|NCT02117622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654978|NCT04529902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
65654979|NCT04529902|Abatacept|abatacept|mesh-list
65654980|NCT04529902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65654981|NCT04529902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654982|NCT04529902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654983|NCT04529902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65654984|NCT04529902|Immunologic Factors|immunologic factors|mesh-ancestor
65654985|NCT04529902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65654986|NCT04529902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65654987|NCT04529902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65654988|NCT04693468|Palbociclib|palbociclib|mesh-list
65654989|NCT04693468|Axitinib|axitinib|mesh-list
65654990|NCT04693468|Crizotinib|crizotinib|mesh-list
65654991|NCT04693468|Talazoparib|talazoparib|mesh-list
65654992|NCT04693468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65654993|NCT04693468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65654994|NCT04693468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65654995|NCT04693468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65654996|NCT04693468|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65654997|NCT02288078|Dexamethasone|dexamethasone|mesh-list
65654998|NCT02288078|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65654999|NCT02288078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65655000|NCT02288078|Antiemetics|antiemetics|mesh-ancestor
65655001|NCT02288078|Autonomic Agents|autonomic agents|mesh-ancestor
65655002|NCT02288078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65655003|NCT02288078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655004|NCT02288078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65655005|NCT02288078|Glucocorticoids|glucocorticoids|mesh-ancestor
65655006|NCT02288078|Hormones|hormones|mesh-ancestor
65655007|NCT02288078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65655008|NCT02288078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65655009|NCT02288078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655010|NCT02288078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655011|NCT02288078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655012|NCT05220514|PK 11195|pk 11195|mesh-list
65655013|NCT05220514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655014|NCT02288234|Telavancin|telavancin|mesh-list
65655015|NCT02288234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65655016|NCT02288234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655017|NCT04654312|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65655018|NCT04654312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65655019|NCT04654312|Diuretics|diuretics|mesh-ancestor
65655020|NCT04654312|Natriuretic Agents|natriuretic agents|mesh-ancestor
65655021|NCT04654312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655022|NCT04654312|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65655023|NCT04654312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65655024|NCT04654312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655026|NCT02973087|Coagulants|coagulants|mesh-ancestor
65655027|NCT05284656|Folic Acid|folic acid|mesh-list
65655028|NCT05284656|Vitamin B Complex|vitamin b complex|mesh-list
65655029|NCT05284656|Pentoxifylline|pentoxifylline|mesh-list
65655030|NCT05284656|Hematinics|hematinics|mesh-ancestor
65655031|NCT05284656|Vitamins|vitamins|mesh-ancestor
65655032|NCT05284656|Micronutrients|micronutrients|mesh-ancestor
65655033|NCT05284656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655034|NCT05284656|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65655035|NCT05284656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655036|NCT05284656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655037|NCT05284656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65655038|NCT05284656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65655039|NCT05284656|Protective Agents|protective agents|mesh-ancestor
65655040|NCT05284656|Vasodilator Agents|vasodilator agents|mesh-ancestor
65655041|NCT05284656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65655042|NCT05284656|Antioxidants|antioxidants|mesh-ancestor
65655043|NCT02124174|Azacitidine|azacitidine|mesh-list
65655044|NCT02124174|Valproic Acid|valproic acid|mesh-list
65655045|NCT02124174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65655046|NCT02124174|Antimetabolites|antimetabolites|mesh-ancestor
65655047|NCT02124174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655048|NCT02124174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655049|NCT02124174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655050|NCT02124174|Anticonvulsants|anticonvulsants|mesh-ancestor
65655051|NCT02124174|GABA Agents|gaba agents|mesh-ancestor
65655052|NCT02124174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65655053|NCT02124174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655054|NCT02124174|Antimanic Agents|antimanic agents|mesh-ancestor
65655055|NCT02124174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65655056|NCT02124174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65655057|NCT02124174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65655058|NCT03956368|Atorvastatin|atorvastatin|mesh-list
65655059|NCT03956368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65655060|NCT03956368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65655061|NCT03956368|Antimetabolites|antimetabolites|mesh-ancestor
65655062|NCT03956368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655063|NCT03956368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65655064|NCT03956368|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65655065|NCT03956368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655066|NCT02124330|Bentonite|bentonite|mesh-list
65655067|NCT02124330|Antidotes|antidotes|mesh-ancestor
65655068|NCT02124330|Protective Agents|protective agents|mesh-ancestor
65655069|NCT02124330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655070|NCT02118090|Chloroquine|chloroquine|mesh-list
65655071|NCT02118090|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65655072|NCT02118090|Amebicides|amebicides|mesh-ancestor
65655073|NCT02118090|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65655074|NCT02118090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65655075|NCT02118090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655076|NCT02118090|Antimalarials|antimalarials|mesh-ancestor
65655077|NCT02118090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65655078|NCT02118090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65655079|NCT02118090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65655080|NCT02118090|Analgesics|analgesics|mesh-ancestor
65655081|NCT02118090|Sensory System Agents|sensory system agents|mesh-ancestor
65655082|NCT02118090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65655083|NCT02118090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655084|NCT02118090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65655085|NCT02118090|Filaricides|filaricides|mesh-ancestor
65655086|NCT02118090|Antinematodal Agents|antinematodal agents|mesh-ancestor
65655087|NCT02118090|Anthelmintics|anthelmintics|mesh-ancestor
65655088|NCT04235114|Nimotuzumab|nimotuzumab|mesh-list
65655089|NCT04235114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65655090|NCT04235114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655091|NCT03551808|Ketorolac|ketorolac|mesh-list
65655092|NCT03551808|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65655093|NCT03551808|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65655094|NCT03551808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65655095|NCT03551808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65655096|NCT03551808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65655097|NCT03551808|Analgesics|analgesics|mesh-ancestor
65655098|NCT03551808|Sensory System Agents|sensory system agents|mesh-ancestor
65655099|NCT03551808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65655100|NCT03551808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655101|NCT03551808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65655102|NCT03551808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65655103|NCT03551808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65655104|NCT03551808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655105|NCT03551808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655107|NCT04053543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65655108|NCT04202458|Tenecteplase|tenecteplase|mesh-list
65655109|NCT04202458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65655110|NCT04202458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65655111|NCT04202458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655112|NCT00273650|Vitamin B 12|vitamin b 12|mesh-list
65655113|NCT00273650|Vitamins|vitamins|mesh-ancestor
65655114|NCT00273650|Micronutrients|micronutrients|mesh-ancestor
65655115|NCT00273650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655116|NCT00273650|Vitamin B Complex|vitamin b complex|mesh-ancestor
65655117|NCT02121288|Clopidogrel|clopidogrel|mesh-list
65655118|NCT02121288|Ticagrelor|ticagrelor|mesh-list
65655119|NCT02121288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65655120|NCT02121288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65655121|NCT02121288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65655122|NCT02121288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65655123|NCT02121288|Purinergic Agents|purinergic agents|mesh-ancestor
65655124|NCT02121288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65655125|NCT02121288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655126|NCT02121288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655127|NCT01525329|Fluorouracil|fluorouracil|mesh-list
65655128|NCT01525329|Antimetabolites|antimetabolites|mesh-ancestor
65655129|NCT01525329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655130|NCT01525329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65655131|NCT01525329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655132|NCT01525329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65655133|NCT01525329|Immunologic Factors|immunologic factors|mesh-ancestor
65655134|NCT01525329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655135|NCT02121366|Ethanol|ethanol|mesh-list
65655136|NCT02121366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65655137|NCT02121366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655138|NCT02121366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65655139|NCT02121366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655140|NCT02121444|Interferons|interferons|mesh-list
65655141|NCT02121444|Interferon-beta|interferon-beta|mesh-list
65655142|NCT02121444|Interferon beta-1b|interferon beta-1b|mesh-list
65655143|NCT02121444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655144|NCT02121444|Antiviral Agents|antiviral agents|mesh-ancestor
65655145|NCT02121444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655146|NCT02121444|Immunologic Factors|immunologic factors|mesh-ancestor
65655147|NCT02121444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655148|NCT02121444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65655149|NCT04413526|Chlorotrianisene|chlorotrianisene|mesh-list
65655150|NCT04413526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65655151|NCT04413526|Estrogens|estrogens|mesh-ancestor
65655152|NCT04413526|Hormones|hormones|mesh-ancestor
65655153|NCT04413526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65655154|NCT04413526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655155|NCT04413526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65655156|NCT04413526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655157|NCT03665506|Trifluridine|trifluridine|mesh-list
65655158|NCT03665506|Antimetabolites|antimetabolites|mesh-ancestor
65655159|NCT03665506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655160|NCT03665506|Antiviral Agents|antiviral agents|mesh-ancestor
65655161|NCT03665506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655162|NCT03318874|Hyaluronic Acid|hyaluronic acid|mesh-list
65655163|NCT03318874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65655164|NCT03318874|Immunologic Factors|immunologic factors|mesh-ancestor
65655165|NCT03318874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655166|NCT03318874|Viscosupplements|viscosupplements|mesh-ancestor
65655167|NCT03318874|Protective Agents|protective agents|mesh-ancestor
65655168|NCT03551652|Rocuronium|rocuronium|mesh-list
65655169|NCT03551652|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65655170|NCT03551652|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65655171|NCT03551652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65655172|NCT03551652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65655173|NCT03551652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655174|NCT00263042|Rimonabant|rimonabant|mesh-list
65655175|NCT00263042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65655176|NCT00263042|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65655177|NCT00263042|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65655178|NCT00263042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65655179|NCT00263042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655181|NCT00263042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65655182|NCT00263042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655183|NCT05002192|Eucalyptol|eucalyptol|mesh-list
65655184|NCT05002192|Ambroxol|ambroxol|mesh-list
65655185|NCT05002192|Expectorants|expectorants|mesh-list
65655186|NCT05002192|Respiratory System Agents|respiratory system agents|mesh-ancestor
65655187|NCT05002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655188|NCT05002192|Antitussive Agents|antitussive agents|mesh-ancestor
65655189|NCT05002192|Insect Repellents|insect repellents|mesh-ancestor
65655190|NCT05002192|Protective Agents|protective agents|mesh-ancestor
65655191|NCT05002192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655192|NCT04973020|Efavirenz|efavirenz|mesh-list
65655193|NCT04973020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65655194|NCT04973020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65655195|NCT04973020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655196|NCT04973020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655197|NCT04973020|Antiviral Agents|antiviral agents|mesh-ancestor
65655198|NCT04973020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655199|NCT04973020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65655200|NCT04973020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65655201|NCT04973020|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65655202|NCT04973020|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65655203|NCT04973020|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65655204|NCT04973020|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65655205|NCT05724446|Prednisolone|prednisolone|mesh-list
65655206|NCT05724446|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65655207|NCT05724446|Methylprednisolone|methylprednisolone|mesh-list
65655208|NCT05724446|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65655209|NCT05724446|Prednisolone acetate|prednisolone acetate|mesh-list
65655210|NCT05724446|Clobetasol|clobetasol|mesh-list
65655211|NCT05724446|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65655212|NCT05724446|Prednisolone phosphate|prednisolone phosphate|mesh-list
65655213|NCT05724446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65655214|NCT05724446|Glucocorticoids|glucocorticoids|mesh-ancestor
65655215|NCT05724446|Hormones|hormones|mesh-ancestor
65655216|NCT05724446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65655217|NCT05724446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655218|NCT05724446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65655219|NCT05724446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655220|NCT05724446|Antiemetics|antiemetics|mesh-ancestor
65655221|NCT05724446|Autonomic Agents|autonomic agents|mesh-ancestor
65655222|NCT05724446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65655223|NCT05724446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65655224|NCT05724446|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65655225|NCT05724446|Protective Agents|protective agents|mesh-ancestor
65655226|NCT02124642|Folic Acid|folic acid|mesh-list
65655227|NCT02124642|Vitamin B Complex|vitamin b complex|mesh-list
65655228|NCT02124642|Hematinics|hematinics|mesh-ancestor
65655229|NCT02124642|Vitamins|vitamins|mesh-ancestor
65655230|NCT02124642|Micronutrients|micronutrients|mesh-ancestor
65655231|NCT02124642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655232|NCT03094234|Propranolol|propranolol|mesh-list
65655233|NCT03094234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65655234|NCT03094234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65655235|NCT03094234|Adrenergic Agents|adrenergic agents|mesh-ancestor
65655236|NCT03094234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65655237|NCT03094234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655238|NCT03094234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655239|NCT03094234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65655240|NCT03094234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65655241|NCT03094234|Vasodilator Agents|vasodilator agents|mesh-ancestor
65655242|NCT00260156|Vildagliptin|vildagliptin|mesh-list
65655243|NCT00260156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65655244|NCT00260156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655245|NCT00260156|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65655246|NCT00260156|Protease Inhibitors|protease inhibitors|mesh-ancestor
65655247|NCT00260156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655248|NCT00260156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655249|NCT04367103|Phenylephrine|phenylephrine|mesh-list
65655250|NCT04367103|Oxymetazoline|oxymetazoline|mesh-list
65655251|NCT04367103|Norepinephrine|norepinephrine|mesh-list
65655252|NCT04367103|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65655253|NCT04367103|Mydriatics|mydriatics|mesh-ancestor
65655254|NCT04367103|Autonomic Agents|autonomic agents|mesh-ancestor
65655255|NCT04367103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65655256|NCT04367103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655257|NCT04367103|Sympathomimetics|sympathomimetics|mesh-ancestor
65655258|NCT04367103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65655259|NCT04367103|Nasal Decongestants|nasal decongestants|mesh-ancestor
65655260|NCT04367103|Respiratory System Agents|respiratory system agents|mesh-ancestor
65655261|NCT04367103|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65655262|NCT04367103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65655263|NCT04367103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65655264|NCT04367103|Adrenergic Agents|adrenergic agents|mesh-ancestor
65655265|NCT04367103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65655266|NCT04367103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655267|NCT04367103|Protective Agents|protective agents|mesh-ancestor
65655268|NCT00260078|Ritonavir|ritonavir|mesh-list
65655269|NCT00260078|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65655270|NCT00260078|Darunavir|darunavir|mesh-list
65655271|NCT00260078|Tenofovir|tenofovir|mesh-list
65655272|NCT00260078|Nevirapine|nevirapine|mesh-list
65655273|NCT00260078|Efavirenz|efavirenz|mesh-list
65655274|NCT00260078|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65655275|NCT00260078|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65655276|NCT00260078|Protease Inhibitors|protease inhibitors|mesh-ancestor
65655277|NCT00260078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655278|NCT00260078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655279|NCT00260078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65655280|NCT00260078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65655281|NCT00260078|Antiviral Agents|antiviral agents|mesh-ancestor
65655282|NCT00260078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655283|NCT00260078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65655284|NCT00260078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65655285|NCT00260078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65655286|NCT00260078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65655287|NCT00260078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65655288|NCT00260078|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65655289|NCT00260078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65655290|NCT00260078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65655291|NCT00260078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65655292|NCT03034564|Droxidopa|droxidopa|mesh-list
65655293|NCT03034564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65655294|NCT03034564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65655295|NCT05342532|Amoxicillin|amoxicillin|mesh-list
65655296|NCT05342532|Clarithromycin|clarithromycin|mesh-list
65655297|NCT05342532|Omeprazole|omeprazole|mesh-list
65655298|NCT05342532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65655299|NCT05342532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655300|NCT05342532|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65655301|NCT05342532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65655302|NCT05342532|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65655303|NCT05342532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655304|NCT05342532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655305|NCT05342532|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65655306|NCT05342532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65655307|NCT05342532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65655308|NCT04469114|Tofacitinib|tofacitinib|mesh-list
65655309|NCT04469114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65655310|NCT04469114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655311|NCT04469114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655312|NCT02400567|Cyclophosphamide|cyclophosphamide|mesh-list
65655313|NCT02400567|Letrozole|letrozole|mesh-list
65655314|NCT02400567|Epirubicin|epirubicin|mesh-list
65655315|NCT02400567|Palbociclib|palbociclib|mesh-list
65655316|NCT02400567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65655317|NCT02400567|Immunologic Factors|immunologic factors|mesh-ancestor
65655318|NCT02400567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655319|NCT02400567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65655320|NCT02400567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65655321|NCT02400567|Alkylating Agents|alkylating agents|mesh-ancestor
65655322|NCT02400567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655323|NCT02400567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655324|NCT02400567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65655325|NCT02400567|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65655326|NCT02400567|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65655327|NCT02400567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655328|NCT02400567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65655329|NCT02400567|Hormone Antagonists|hormone antagonists|mesh-ancestor
65655330|NCT02400567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65655331|NCT02400567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65655332|NCT02400567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65655333|NCT02400567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65655334|NCT02400567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65655336|NCT02971683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65655337|NCT02971683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655338|NCT02971683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655339|NCT02971683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65655340|NCT02971683|Immunologic Factors|immunologic factors|mesh-ancestor
65655341|NCT02971683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655342|NCT02971683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65655343|NCT05501054|Nivolumab|nivolumab|mesh-list
65655344|NCT05501054|Ipilimumab|ipilimumab|mesh-list
65655345|NCT05501054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65655346|NCT05501054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655347|NCT05501054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65655348|NCT05501054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655349|NCT00228176|Rimonabant|rimonabant|mesh-list
65655350|NCT00228176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65655351|NCT00228176|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65655352|NCT00228176|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65655353|NCT00228176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65655354|NCT00228176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655355|NCT00228176|Hormones|hormones|mesh-ancestor
65655356|NCT00228176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65655357|NCT00228176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655358|NCT05131984|Ocrelizumab|ocrelizumab|mesh-list
65655359|NCT05131984|Immunologic Factors|immunologic factors|mesh-ancestor
65268045|NCT02698098|Narcotics|narcotics|mesh-ancestor
65655360|NCT05131984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655361|NCT01308190|Capecitabine|capecitabine|mesh-list
65655362|NCT01308190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65655363|NCT01308190|Antimetabolites|antimetabolites|mesh-ancestor
65655364|NCT01308190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655365|NCT01308190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655366|NCT01210768|Cyclophosphamide|cyclophosphamide|mesh-list
65655367|NCT01210768|Doxorubicin|doxorubicin|mesh-list
65655368|NCT01210768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65655369|NCT01210768|Epirubicin|epirubicin|mesh-list
65655370|NCT01210768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65655371|NCT01210768|Immunologic Factors|immunologic factors|mesh-ancestor
65655372|NCT01210768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655373|NCT01210768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65655374|NCT01210768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65655375|NCT01210768|Alkylating Agents|alkylating agents|mesh-ancestor
65655376|NCT01210768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655377|NCT01210768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655378|NCT01210768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65655379|NCT01210768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65655380|NCT01210768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65655381|NCT01210768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65655382|NCT01210768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655383|NCT02971605|Psilocybin|psilocybin|mesh-list
65655384|NCT02971605|Hallucinogens|hallucinogens|mesh-ancestor
65655385|NCT02971605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655386|NCT02971605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65655387|NCT04410874|Vaccines|vaccines|mesh-list
65655388|NCT04410874|Immunologic Factors|immunologic factors|mesh-ancestor
65655389|NCT04410874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655390|NCT02124954|Digoxin|digoxin|mesh-list
65655391|NCT02124954|Midazolam|midazolam|mesh-list
65655392|NCT02124954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65655393|NCT02124954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65655394|NCT02124954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65655395|NCT02124954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655396|NCT02124954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65655397|NCT02124954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65655398|NCT02124954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65655399|NCT02124954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65655400|NCT02124954|Anesthetics, General|anesthetics, general|mesh-ancestor
65655401|NCT02124954|Anesthetics|anesthetics|mesh-ancestor
65655402|NCT02124954|GABA Modulators|gaba modulators|mesh-ancestor
65655403|NCT02124954|GABA Agents|gaba agents|mesh-ancestor
65655404|NCT02124954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65655405|NCT02124954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655406|NCT02124954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65655407|NCT02124954|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65655408|NCT02124954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655409|NCT02124954|Protective Agents|protective agents|mesh-ancestor
65655410|NCT04441112|Triamcinolone|triamcinolone|mesh-list
65655411|NCT04441112|Ketorolac|ketorolac|mesh-list
65655412|NCT04441112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65655413|NCT04441112|Glucocorticoids|glucocorticoids|mesh-ancestor
65655414|NCT04441112|Hormones|hormones|mesh-ancestor
65655415|NCT04441112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65655416|NCT04441112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655417|NCT04441112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655418|NCT04441112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655419|NCT04441112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65655420|NCT04441112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65655421|NCT04441112|Analgesics|analgesics|mesh-ancestor
65655422|NCT04441112|Sensory System Agents|sensory system agents|mesh-ancestor
65655423|NCT04441112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65655424|NCT04441112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65655425|NCT04441112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65655426|NCT02121990|Paclitaxel|paclitaxel|mesh-list
65655427|NCT02121990|Bevacizumab|bevacizumab|mesh-list
65655428|NCT02121990|Olaparib|olaparib|mesh-list
65655429|NCT02121990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65655430|NCT02121990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655431|NCT02121990|Tubulin Modulators|tubulin modulators|mesh-ancestor
65655432|NCT02121990|Antimitotic Agents|antimitotic agents|mesh-ancestor
65655433|NCT02121990|Mitosis Modulators|mitosis modulators|mesh-ancestor
65268047|NCT02698098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655434|NCT02121990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655435|NCT02121990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65655436|NCT02121990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65655437|NCT02121990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65655438|NCT02121990|Growth Substances|growth substances|mesh-ancestor
65655439|NCT02121990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655440|NCT02121990|Growth Inhibitors|growth inhibitors|mesh-ancestor
65655441|NCT02121990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65655442|NCT02121990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655443|NCT05724056|Hyaluronic Acid|hyaluronic acid|mesh-list
65655444|NCT05724056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65655445|NCT05724056|Immunologic Factors|immunologic factors|mesh-ancestor
65655446|NCT05724056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655447|NCT05724056|Viscosupplements|viscosupplements|mesh-ancestor
65655448|NCT05724056|Protective Agents|protective agents|mesh-ancestor
65655449|NCT02609737|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
65655450|NCT02609737|Chelating Agents|chelating agents|mesh-ancestor
65655451|NCT02609737|Sequestering Agents|sequestering agents|mesh-ancestor
65655452|NCT02609737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655453|NCT01060059|Exenatide|exenatide|mesh-list
65655454|NCT01060059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65655455|NCT01060059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655456|NCT01060059|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65655457|NCT01060059|Incretins|incretins|mesh-ancestor
65655458|NCT01060059|Hormones|hormones|mesh-ancestor
65655459|NCT01060059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65655460|NCT04318015|Hydroxychloroquine|hydroxychloroquine|mesh-list
65655461|NCT04318015|Antimalarials|antimalarials|mesh-ancestor
65655462|NCT04318015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65655463|NCT04318015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65655464|NCT04318015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655465|NCT04318015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655466|NCT04318015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655467|NCT04318015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65655468|NCT04307797|Exenatide|exenatide|mesh-list
65655469|NCT04307797|Glucagon|glucagon|mesh-list
65655470|NCT04307797|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65655471|NCT04307797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65655472|NCT04307797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655473|NCT04307797|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65452865|NCT03414502|Antimetabolites|antimetabolites|mesh-ancestor
65655474|NCT04307797|Incretins|incretins|mesh-ancestor
65655475|NCT04307797|Hormones|hormones|mesh-ancestor
65655476|NCT04307797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65655477|NCT04307797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65655478|NCT02125188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65655479|NCT02125188|Hemostatics|hemostatics|mesh-ancestor
65655480|NCT02125188|Coagulants|coagulants|mesh-ancestor
65655481|NCT02125188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65655482|NCT02125188|Natriuretic Agents|natriuretic agents|mesh-ancestor
65655483|NCT02125188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655484|NCT02125344|Paclitaxel|paclitaxel|mesh-list
65655485|NCT02125344|Cyclophosphamide|cyclophosphamide|mesh-list
65655486|NCT02125344|Carboplatin|carboplatin|mesh-list
65655487|NCT02125344|Doxorubicin|doxorubicin|mesh-list
65655488|NCT02125344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65655489|NCT02125344|Trastuzumab|trastuzumab|mesh-list
65655490|NCT02125344|Epirubicin|epirubicin|mesh-list
65655491|NCT02125344|Pertuzumab|pertuzumab|mesh-list
65655492|NCT02125344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65655493|NCT02125344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655494|NCT02125344|Tubulin Modulators|tubulin modulators|mesh-ancestor
65655495|NCT02125344|Antimitotic Agents|antimitotic agents|mesh-ancestor
65655496|NCT02125344|Mitosis Modulators|mitosis modulators|mesh-ancestor
65655497|NCT02125344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655498|NCT02125344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65655499|NCT02125344|Immunologic Factors|immunologic factors|mesh-ancestor
65655500|NCT02125344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655501|NCT02125344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65655502|NCT02125344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65655503|NCT02125344|Alkylating Agents|alkylating agents|mesh-ancestor
65655504|NCT02125344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65655505|NCT02125344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65655506|NCT02125344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65655507|NCT02125344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65655508|NCT02125344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655509|NCT02125344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65655510|NCT05468840|Ketamine|ketamine|mesh-list
65655511|NCT05468840|Analgesics|analgesics|mesh-ancestor
65655512|NCT05468840|Sensory System Agents|sensory system agents|mesh-ancestor
65655513|NCT05468840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65655514|NCT05468840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655515|NCT05468840|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65655516|NCT05468840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65655517|NCT05468840|Anesthetics, General|anesthetics, general|mesh-ancestor
65655518|NCT05468840|Anesthetics|anesthetics|mesh-ancestor
65655519|NCT05468840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65655520|NCT05468840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65655521|NCT05468840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65655522|NCT05468840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65655523|NCT05468840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655524|NCT05723900|Castor Oil|castor oil|mesh-list
65655525|NCT05723900|Cathartics|cathartics|mesh-ancestor
65655526|NCT05723900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65655527|NCT02127138|Sirolimus|sirolimus|mesh-list
65655528|NCT02127138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65655529|NCT02127138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655530|NCT02127138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65655531|NCT02127138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655532|NCT02127138|Antifungal Agents|antifungal agents|mesh-ancestor
65655533|NCT02127138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65655534|NCT02127138|Immunologic Factors|immunologic factors|mesh-ancestor
65655535|NCT02127138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655536|NCT05726318|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65655537|NCT05726318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655538|NCT03651531|Metformin|metformin|mesh-list
65655539|NCT03651531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65655540|NCT03651531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655541|NCT02903511|Metformin|metformin|mesh-list
65655542|NCT02903511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65655543|NCT02903511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655544|NCT05325528|Oxaliplatin|oxaliplatin|mesh-list
65655545|NCT05325528|Tegafur|tegafur|mesh-list
65655546|NCT05325528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655547|NCT05325528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65655548|NCT05325528|Antimetabolites|antimetabolites|mesh-ancestor
65655549|NCT05325528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655550|NCT02125500|Sofosbuvir|sofosbuvir|mesh-list
65655551|NCT02125500|Ledipasvir|ledipasvir|mesh-list
65655553|NCT02125500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655554|NCT02125578|Interferons|interferons|mesh-list
65655555|NCT02125578|Interferon-beta|interferon-beta|mesh-list
65655556|NCT02125578|Interferon beta-1a|interferon beta-1a|mesh-list
65655557|NCT02125578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655558|NCT02125578|Antiviral Agents|antiviral agents|mesh-ancestor
65655559|NCT02125578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655560|NCT02125578|Immunologic Factors|immunologic factors|mesh-ancestor
65655561|NCT02125578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655562|NCT02125578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65655563|NCT02122536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65655564|NCT02122536|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65655565|NCT02122536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65655566|NCT02122536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65655567|NCT02122536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65655568|NCT02122536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655569|NCT02122536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65655570|NCT02122536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65655571|NCT02122536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655572|NCT02122536|Cholinergic Agents|cholinergic agents|mesh-ancestor
65655573|NCT02122536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65655574|NCT05606965|Vaccines|vaccines|mesh-list
65655575|NCT05606965|Immunologic Factors|immunologic factors|mesh-ancestor
65655576|NCT05606965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655577|NCT03830359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65655578|NCT03830359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65655579|NCT00141284|Lamivudine|lamivudine|mesh-list
65655580|NCT00141284|Zidovudine|zidovudine|mesh-list
65655581|NCT00141284|Nelfinavir|nelfinavir|mesh-list
65655582|NCT00141284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65655583|NCT00141284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65655584|NCT00141284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655585|NCT00141284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655586|NCT00141284|Antiviral Agents|antiviral agents|mesh-ancestor
65655587|NCT00141284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655588|NCT00141284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65655589|NCT00141284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65655590|NCT00141284|Antimetabolites|antimetabolites|mesh-ancestor
65655591|NCT00141284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65655592|NCT00141284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65655593|NCT00141284|Protease Inhibitors|protease inhibitors|mesh-ancestor
65655594|NCT04328506|Vorolanib|vorolanib|mesh-list
65655595|NCT04328506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65655596|NCT04328506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655597|NCT04328506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655598|NCT02125812|Moxifloxacin|moxifloxacin|mesh-list
65655599|NCT02125812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65655600|NCT02125812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655601|NCT02125812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65655602|NCT02125812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65655603|NCT02125812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655604|NCT02125812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655605|NCT02125812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655606|NCT02125890|Tranexamic Acid|tranexamic acid|mesh-list
65655607|NCT02125890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65655608|NCT02125890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65655609|NCT02125890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655610|NCT02125890|Hemostatics|hemostatics|mesh-ancestor
65655611|NCT02125890|Coagulants|coagulants|mesh-ancestor
65655612|NCT05433116|Pembrolizumab|pembrolizumab|mesh-list
65655613|NCT05433116|Lenvatinib|lenvatinib|mesh-list
65655614|NCT05433116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65655615|NCT05433116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655616|NCT05433116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65655617|NCT05433116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655618|NCT05433116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655619|NCT05287984|Cyclophosphamide|cyclophosphamide|mesh-list
65655620|NCT05287984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65655621|NCT05287984|Rituximab|rituximab|mesh-list
65655622|NCT05287984|Fludarabine|fludarabine|mesh-list
65655623|NCT05287984|Zanubrutinib|zanubrutinib|mesh-list
65655624|NCT05287984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65655625|NCT05287984|Immunologic Factors|immunologic factors|mesh-ancestor
65655626|NCT05287984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655627|NCT05287984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65655628|NCT05287984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65655629|NCT05287984|Alkylating Agents|alkylating agents|mesh-ancestor
65655630|NCT05287984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655631|NCT05287984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655632|NCT05287984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65655633|NCT05287984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65655634|NCT05287984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65655635|NCT05287984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655636|NCT02125968|Oxymetazoline|oxymetazoline|mesh-list
65655637|NCT02125968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65655638|NCT02125968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65655639|NCT02125968|Adrenergic Agents|adrenergic agents|mesh-ancestor
65655640|NCT02125968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65655641|NCT02125968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655642|NCT02125968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655643|NCT02125968|Sympathomimetics|sympathomimetics|mesh-ancestor
65655644|NCT02125968|Autonomic Agents|autonomic agents|mesh-ancestor
65655645|NCT02125968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65655646|NCT02125968|Nasal Decongestants|nasal decongestants|mesh-ancestor
65655647|NCT02125968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65655648|NCT02125968|Respiratory System Agents|respiratory system agents|mesh-ancestor
65655649|NCT00134264|Atorvastatin|atorvastatin|mesh-list
65655650|NCT00134264|Torcetrapib|torcetrapib|mesh-list
65655651|NCT00134264|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65655652|NCT00134264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65655653|NCT00134264|Antimetabolites|antimetabolites|mesh-ancestor
65655654|NCT00134264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655655|NCT00134264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65655656|NCT00134264|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65655657|NCT00134264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655658|NCT05285800|Bupivacaine|bupivacaine|mesh-list
65655659|NCT05285800|Anesthetics, Local|anesthetics, local|mesh-ancestor
65655660|NCT05285800|Anesthetics|anesthetics|mesh-ancestor
65655661|NCT05285800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65655662|NCT05285800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655663|NCT05285800|Sensory System Agents|sensory system agents|mesh-ancestor
65655664|NCT05285800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65655665|NCT02122692|Itraconazole|itraconazole|mesh-list
65655666|NCT02122692|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
65655667|NCT02122692|Antifungal Agents|antifungal agents|mesh-ancestor
65655668|NCT02122692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655669|NCT02122692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65655670|NCT02122692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65655671|NCT02122692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655672|NCT02122692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655673|NCT02122692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65655674|NCT02122692|Hormone Antagonists|hormone antagonists|mesh-ancestor
65655675|NCT02122692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65655676|NCT02122692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655677|NCT02122692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65655678|NCT00131924|Estrogens|estrogens|mesh-list
65655679|NCT00131924|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
65655680|NCT00131924|Hormones|hormones|mesh-ancestor
65655681|NCT00131924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65655682|NCT00131924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655683|NCT05284474|Mitogens|mitogens|mesh-list
65655684|NCT05284474|Mitosis Modulators|mitosis modulators|mesh-ancestor
65655685|NCT05284474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655686|NCT05609695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65655687|NCT05609695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655688|NCT05609695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655689|NCT04246060|Cysteamine|cysteamine|mesh-list
65655690|NCT04246060|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
65655691|NCT04246060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655692|NCT05129176|Metronidazole|metronidazole|mesh-list
65655693|NCT05129176|Levofloxacin|levofloxacin|mesh-list
65655694|NCT05129176|Ofloxacin|ofloxacin|mesh-list
65655695|NCT05129176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655696|NCT05129176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65655697|NCT05129176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65655698|NCT05129176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65655699|NCT05129176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65655700|NCT05129176|Renal Agents|renal agents|mesh-ancestor
65655701|NCT05129176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65655702|NCT05129176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65655703|NCT05129176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655704|NCT05129176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655705|NCT05129176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655706|NCT05129176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65655707|NCT05129176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65655708|NCT02127684|Ranibizumab|ranibizumab|mesh-list
65655709|NCT02127684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65655710|NCT02127684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65655711|NCT02127684|Growth Substances|growth substances|mesh-ancestor
65655712|NCT02127684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655713|NCT02127684|Growth Inhibitors|growth inhibitors|mesh-ancestor
65655714|NCT02127684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655715|NCT04712734|Iloperidone|iloperidone|mesh-list
65655716|NCT04712734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65655717|NCT04712734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65655718|NCT04712734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65655719|NCT04712734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655720|NCT04712734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65655721|NCT02126358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65655722|NCT02126358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65655723|NCT02126358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65655724|NCT02126358|Antimetabolites|antimetabolites|mesh-ancestor
65655725|NCT02126358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655726|NCT02126358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65655727|NCT02126358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65655728|NCT02126358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655729|NCT02127840|Epinephrine|epinephrine|mesh-list
65655730|NCT02127840|Racepinephrine|racepinephrine|mesh-list
65655731|NCT02127840|Epinephryl borate|epinephryl borate|mesh-list
65655732|NCT02127840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65655733|NCT02127840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65655734|NCT02127840|Adrenergic Agents|adrenergic agents|mesh-ancestor
65655735|NCT02127840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65655736|NCT02127840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655737|NCT02127840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655738|NCT02127840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65655739|NCT02127840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65655740|NCT02127840|Autonomic Agents|autonomic agents|mesh-ancestor
65655741|NCT02127840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65655742|NCT02127840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65655743|NCT02127840|Respiratory System Agents|respiratory system agents|mesh-ancestor
65655744|NCT02127840|Mydriatics|mydriatics|mesh-ancestor
65655745|NCT02127840|Sympathomimetics|sympathomimetics|mesh-ancestor
65655746|NCT02127840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65655748|NCT05031442|Dermatologic Agents|dermatologic agents|mesh-ancestor
65655749|NCT05031442|Sunscreening Agents|sunscreening agents|mesh-ancestor
65655750|NCT05031442|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65655751|NCT05031442|Protective Agents|protective agents|mesh-ancestor
65655752|NCT05031442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655753|NCT02127918|Clobazam|clobazam|mesh-list
65655754|NCT02127918|Anticonvulsants|anticonvulsants|mesh-ancestor
65655755|NCT02127918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65655756|NCT02127918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65655757|NCT02127918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65655758|NCT02127918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655759|NCT02127918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65655760|NCT02127918|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65655761|NCT02127918|GABA Agonists|gaba agonists|mesh-ancestor
65655762|NCT02127918|GABA Agents|gaba agents|mesh-ancestor
65655763|NCT02127918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65655764|NCT02127918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655765|NCT00127634|Insulin|insulin|mesh-list
65655766|NCT00127634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65655767|NCT00127634|Insulin Glargine|insulin glargine|mesh-list
65655768|NCT00127634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65655769|NCT00127634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655770|NCT02127996|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65655771|NCT02127996|Incretins|incretins|mesh-ancestor
65655772|NCT02127996|Hormones|hormones|mesh-ancestor
65655773|NCT02127996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65655774|NCT02127996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655775|NCT02131350|Ranibizumab|ranibizumab|mesh-list
65655776|NCT02131350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65655777|NCT02131350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65655778|NCT02131350|Growth Substances|growth substances|mesh-ancestor
65655779|NCT02131350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655780|NCT02131350|Growth Inhibitors|growth inhibitors|mesh-ancestor
65655781|NCT02131350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655782|NCT02128308|Moxifloxacin|moxifloxacin|mesh-list
65655783|NCT02128308|Levofloxacin|levofloxacin|mesh-list
65655785|NCT02128308|Cycloserine|cycloserine|mesh-list
65655786|NCT02128308|Pyrazinamide|pyrazinamide|mesh-list
65655787|NCT02128308|Aminosalicylic Acid|aminosalicylic acid|mesh-list
65655788|NCT02128308|Streptomycin|streptomycin|mesh-list
65655789|NCT02128308|Kanamycin|kanamycin|mesh-list
65655790|NCT02128308|Prothionamide|prothionamide|mesh-list
65655791|NCT02128308|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65655792|NCT02128308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65655793|NCT02128308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655794|NCT02128308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65655795|NCT02128308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65655796|NCT02128308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655797|NCT02128308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655798|NCT02128308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655799|NCT02128308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65655800|NCT02128308|Contraceptive Agents|contraceptive agents|mesh-ancestor
65655801|NCT02128308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65655802|NCT02128308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655803|NCT02128308|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65655804|NCT02128308|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65655805|NCT02128308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65655806|NCT02128308|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65655807|NCT02128308|Renal Agents|renal agents|mesh-ancestor
65655808|NCT02128308|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65655809|NCT02128308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65655810|NCT02128308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65655811|NCT02128308|Antitubercular Agents|antitubercular agents|mesh-ancestor
65655812|NCT02128308|Antimetabolites|antimetabolites|mesh-ancestor
65655813|NCT02128308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65655814|NCT02131506|Lapatinib|lapatinib|mesh-list
65655815|NCT02131506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65655816|NCT02131506|Doxorubicin|doxorubicin|mesh-list
65655817|NCT02131506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655818|NCT02131506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65655819|NCT02131506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655820|NCT02131506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655821|NCT02131506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65655822|NCT02131506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65655823|NCT02131506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65655824|NCT01674010|Inositol|inositol|mesh-list
65655825|NCT01674010|Lamotrigine|lamotrigine|mesh-list
65655826|NCT01674010|Valproic Acid|valproic acid|mesh-list
65655827|NCT01674010|Anticonvulsants|anticonvulsants|mesh-ancestor
65655828|NCT01674010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65655829|NCT01674010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65655830|NCT01674010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655831|NCT01674010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65655832|NCT01674010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655833|NCT01674010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65655834|NCT01674010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65655835|NCT01674010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65655836|NCT01674010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65655837|NCT01674010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65655838|NCT01674010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655839|NCT01674010|GABA Agents|gaba agents|mesh-ancestor
65655840|NCT01674010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65655841|NCT01674010|Antimanic Agents|antimanic agents|mesh-ancestor
65655842|NCT01674010|Vitamin B Complex|vitamin b complex|mesh-ancestor
65655843|NCT01674010|Vitamins|vitamins|mesh-ancestor
65655844|NCT01674010|Micronutrients|micronutrients|mesh-ancestor
65655845|NCT04617938|Analgesics, Opioid|analgesics, opioid|mesh-list
65655846|NCT04617938|Narcotics|narcotics|mesh-ancestor
65655847|NCT04617938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65655848|NCT04617938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453243|NCT00134901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65655849|NCT04617938|Analgesics|analgesics|mesh-ancestor
65655850|NCT04617938|Sensory System Agents|sensory system agents|mesh-ancestor
65655851|NCT04617938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65655853|NCT02252328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65655854|NCT02252328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65655855|NCT02252328|Antimetabolites|antimetabolites|mesh-ancestor
65655856|NCT02252328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655857|NCT02252328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65655858|NCT02252328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65655859|NCT02252328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655860|NCT05012254|Paclitaxel|paclitaxel|mesh-list
65655861|NCT05012254|Cisplatin|cisplatin|mesh-list
65655862|NCT05012254|Carboplatin|carboplatin|mesh-list
65655863|NCT05012254|Nivolumab|nivolumab|mesh-list
65655864|NCT05012254|Pemetrexed|pemetrexed|mesh-list
65655865|NCT05012254|Ipilimumab|ipilimumab|mesh-list
65655866|NCT05012254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65655867|NCT05012254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655868|NCT05012254|Tubulin Modulators|tubulin modulators|mesh-ancestor
65268065|NCT04220996|Serotonin Agents|serotonin agents|mesh-ancestor
65655869|NCT05012254|Antimitotic Agents|antimitotic agents|mesh-ancestor
65655870|NCT05012254|Mitosis Modulators|mitosis modulators|mesh-ancestor
65655871|NCT05012254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655872|NCT05012254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65655873|NCT05012254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65655874|NCT05012254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655875|NCT05012254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65655876|NCT05012254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65655877|NCT04656964|Midazolam|midazolam|mesh-list
65655878|NCT04656964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65655879|NCT04656964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65655880|NCT04656964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65655881|NCT04656964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655882|NCT04656964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65655883|NCT04656964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65655884|NCT04656964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65655885|NCT04656964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65655886|NCT04656964|Anesthetics, General|anesthetics, general|mesh-ancestor
65655887|NCT04656964|Anesthetics|anesthetics|mesh-ancestor
65655888|NCT04656964|GABA Modulators|gaba modulators|mesh-ancestor
65655889|NCT04656964|GABA Agents|gaba agents|mesh-ancestor
65655890|NCT04656964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65655891|NCT04656964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655892|NCT02136030|Amphotericin B|amphotericin b|mesh-list
65655893|NCT02136030|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65655894|NCT02136030|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
65655895|NCT02136030|Deoxycholic Acid|deoxycholic acid|mesh-list
65655896|NCT02136030|Amebicides|amebicides|mesh-ancestor
65655897|NCT02136030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65655898|NCT02136030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65655899|NCT02136030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655900|NCT02136030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65655901|NCT02136030|Antifungal Agents|antifungal agents|mesh-ancestor
65655902|NCT02136030|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65655903|NCT02136030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65655904|NCT02131818|Amoxicillin|amoxicillin|mesh-list
65655905|NCT02131818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65655906|NCT02131818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655907|NCT04605796|Bevacizumab|bevacizumab|mesh-list
65655908|NCT04605796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65655909|NCT04605796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655910|NCT04605796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65655911|NCT04605796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65655912|NCT04605796|Growth Substances|growth substances|mesh-ancestor
65655913|NCT04605796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655914|NCT04605796|Growth Inhibitors|growth inhibitors|mesh-ancestor
65655915|NCT01345669|Afatinib|afatinib|mesh-list
65655916|NCT01345669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655917|NCT01345669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65655918|NCT01345669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655919|NCT01345669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655920|NCT04313608|Gemcitabine|gemcitabine|mesh-list
65655921|NCT04313608|Oxaliplatin|oxaliplatin|mesh-list
65655922|NCT04313608|Obinutuzumab|obinutuzumab|mesh-list
65655923|NCT04313608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65655924|NCT04313608|Antimetabolites|antimetabolites|mesh-ancestor
65655925|NCT04313608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655926|NCT04313608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655927|NCT04313608|Antiviral Agents|antiviral agents|mesh-ancestor
65655928|NCT04313608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655929|NCT04313608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655930|NCT04313608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65655931|NCT04313608|Immunologic Factors|immunologic factors|mesh-ancestor
65655932|NCT04313608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655933|NCT04313608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65655934|NCT04502264|Botulinum Toxins|botulinum toxins|mesh-list
65655935|NCT04502264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65655936|NCT04502264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65655937|NCT04502264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65655938|NCT04502264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65655939|NCT04502264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655940|NCT04502264|Cholinergic Agents|cholinergic agents|mesh-ancestor
65655941|NCT04502264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65655942|NCT04502264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655943|NCT04502264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65655944|NCT04502264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65655945|NCT03202316|Atezolizumab|atezolizumab|mesh-list
65655946|NCT03202316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65655947|NCT03202316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655948|NCT03202316|Immunologic Factors|immunologic factors|mesh-ancestor
65655949|NCT03202316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655950|NCT03527732|Ivermectin|ivermectin|mesh-list
65655951|NCT03527732|Albendazole|albendazole|mesh-list
65655952|NCT03527732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65655953|NCT03527732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655954|NCT03527732|Anthelmintics|anthelmintics|mesh-ancestor
65655955|NCT03527732|Anticestodal Agents|anticestodal agents|mesh-ancestor
65655956|NCT03527732|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65655957|NCT03527732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65655958|NCT03527732|Tubulin Modulators|tubulin modulators|mesh-ancestor
65655959|NCT03527732|Antimitotic Agents|antimitotic agents|mesh-ancestor
65655960|NCT03527732|Mitosis Modulators|mitosis modulators|mesh-ancestor
65655961|NCT03527732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655962|NCT03527732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655963|NCT01673854|Ipilimumab|ipilimumab|mesh-list
65655964|NCT01673854|Vemurafenib|vemurafenib|mesh-list
65655965|NCT01673854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65655966|NCT01673854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655967|NCT01673854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65655968|NCT01673854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655969|NCT01673854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65655970|NCT01673854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65655971|NCT03549702|Povidone-Iodine|povidone-iodine|mesh-list
65655972|NCT03549702|Povidone|povidone|mesh-list
65655973|NCT03549702|Plasma Substitutes|plasma substitutes|mesh-ancestor
65655974|NCT03549702|Blood Substitutes|blood substitutes|mesh-ancestor
65655975|NCT03549702|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65655976|NCT03549702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655977|NCT02529904|Vaccines|vaccines|mesh-list
65655978|NCT02529904|Immunologic Factors|immunologic factors|mesh-ancestor
65655979|NCT02529904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655980|NCT03099356|Sirolimus|sirolimus|mesh-list
65655981|NCT03099356|Cyclophosphamide|cyclophosphamide|mesh-list
65655982|NCT03099356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65655983|NCT03099356|Immunologic Factors|immunologic factors|mesh-ancestor
65655984|NCT03099356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65655985|NCT03099356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65655986|NCT03099356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65655987|NCT03099356|Alkylating Agents|alkylating agents|mesh-ancestor
65655988|NCT03099356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65655989|NCT03099356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65655990|NCT03099356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65655991|NCT03099356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65655992|NCT03099356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65655993|NCT03099356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65655994|NCT03099356|Antifungal Agents|antifungal agents|mesh-ancestor
65655995|NCT01367886|Fesoterodine|fesoterodine|mesh-list
65655996|NCT01367886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65655997|NCT01367886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65655998|NCT01367886|Cholinergic Agents|cholinergic agents|mesh-ancestor
65655999|NCT01367886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65656000|NCT01367886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656001|NCT01367886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453401|NCT01141894|Dobutamine|dobutamine|mesh-list
65656002|NCT01367886|Urological Agents|urological agents|mesh-ancestor
65656003|NCT05222191|Chlorthalidone|chlorthalidone|mesh-list
65656004|NCT05222191|Spironolactone|spironolactone|mesh-list
65656005|NCT05222191|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65656006|NCT05222191|Hormone Antagonists|hormone antagonists|mesh-ancestor
65656007|NCT05222191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65656008|NCT05222191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656009|NCT05222191|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65656010|NCT05222191|Diuretics|diuretics|mesh-ancestor
65656011|NCT05222191|Natriuretic Agents|natriuretic agents|mesh-ancestor
65656012|NCT05222191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65656013|NCT05222191|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65656014|NCT05222191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65656015|NCT05222191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656016|NCT05706337|Propofol|propofol|mesh-list
65656017|NCT05706337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65656018|NCT05706337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65656019|NCT05706337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656020|NCT05706337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65656021|NCT05706337|Anesthetics, General|anesthetics, general|mesh-ancestor
65656022|NCT05706337|Anesthetics|anesthetics|mesh-ancestor
65656023|NCT05222113|Remdesivir|remdesivir|mesh-list
65656024|NCT05222113|Favipiravir|favipiravir|mesh-list
65656025|NCT05222113|Antimetabolites|antimetabolites|mesh-ancestor
65656026|NCT05222113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656027|NCT05222113|Antiviral Agents|antiviral agents|mesh-ancestor
65656028|NCT05222113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65656029|NCT03854578|Citalopram|citalopram|mesh-list
65656030|NCT03854578|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65656031|NCT03854578|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65656032|NCT03854578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65656033|NCT03854578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656034|NCT03854578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65656035|NCT03854578|Serotonin Agents|serotonin agents|mesh-ancestor
65656036|NCT03854578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656037|NCT03854578|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65656038|NCT03854578|Antidepressive Agents|antidepressive agents|mesh-ancestor
65656039|NCT03854578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65656040|NCT03038594|Hormones|hormones|mesh-list
65656041|NCT03038594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65656042|NCT03038594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656043|NCT02136888|Moxifloxacin|moxifloxacin|mesh-list
65656044|NCT02136888|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65656045|NCT02136888|Ponesimod|ponesimod|mesh-list
65656046|NCT02136888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65656047|NCT02136888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65656048|NCT02136888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65656049|NCT02136888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65656050|NCT02136888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656051|NCT02136888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656052|NCT02136888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656053|NCT02136888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65656054|NCT02136888|Contraceptive Agents|contraceptive agents|mesh-ancestor
65656055|NCT02136888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65656056|NCT02136888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656057|NCT02136888|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65656058|NCT02136888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65656059|NCT02136888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65656060|NCT02136888|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65656061|NCT02136888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65656062|NCT02136888|Immunologic Factors|immunologic factors|mesh-ancestor
65656063|NCT02132286|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65656064|NCT02132286|Antidepressive Agents|antidepressive agents|mesh-ancestor
65656065|NCT02132286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65656066|NCT02132286|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65656067|NCT02132286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65656068|NCT02132286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65656069|NCT02132286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656070|NCT05252754|Indomethacin|indomethacin|mesh-list
65656071|NCT05252754|Tacrolimus|tacrolimus|mesh-list
65656072|NCT05252754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65656073|NCT05252754|Immunologic Factors|immunologic factors|mesh-ancestor
65656074|NCT05252754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656075|NCT05252754|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65656076|NCT05252754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656077|NCT05252754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656078|NCT05252754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65656079|NCT05252754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65656080|NCT05252754|Analgesics|analgesics|mesh-ancestor
65656081|NCT05252754|Sensory System Agents|sensory system agents|mesh-ancestor
65656082|NCT05252754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65656083|NCT05252754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65656084|NCT05252754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65656085|NCT05252754|Gout Suppressants|gout suppressants|mesh-ancestor
65656086|NCT05252754|Tocolytic Agents|tocolytic agents|mesh-ancestor
65656087|NCT05252754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65656088|NCT05252754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65656089|NCT03548246|Hydrocortisone|hydrocortisone|mesh-list
65656090|NCT03548246|Fludrocortisone|fludrocortisone|mesh-list
65656091|NCT03548246|Abiraterone Acetate|abiraterone acetate|mesh-list
65656092|NCT03548246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65656093|NCT03548246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656094|NCT03548246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65656095|NCT03548246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656096|NCT03548246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656097|NCT03548246|Hormone Antagonists|hormone antagonists|mesh-ancestor
65656098|NCT03548246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65656099|NCT03548246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656100|NCT03548246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65656101|NCT02132442|Vitamin D|vitamin d|mesh-list
65656102|NCT02132442|Ergocalciferols|ergocalciferols|mesh-list
65656103|NCT02132442|Vitamins|vitamins|mesh-ancestor
65656104|NCT02132442|Micronutrients|micronutrients|mesh-ancestor
65656105|NCT02132442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656106|NCT02132442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65656107|NCT02132442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65656108|NCT05010148|Lidocaine|lidocaine|mesh-list
65656109|NCT05010148|Anesthetics, Local|anesthetics, local|mesh-ancestor
65656110|NCT05010148|Anesthetics|anesthetics|mesh-ancestor
65656111|NCT05010148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65656112|NCT05010148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656113|NCT05010148|Sensory System Agents|sensory system agents|mesh-ancestor
65656114|NCT05010148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65656115|NCT05010148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65656116|NCT05010148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65656117|NCT05010148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65656118|NCT05010148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65656119|NCT05010148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656120|NCT05138146|Doxorubicin|doxorubicin|mesh-list
65656121|NCT05138146|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65656122|NCT05138146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65656123|NCT05138146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656124|NCT05138146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65656125|NCT05138146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65656126|NCT05138146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656127|NCT05138146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656128|NCT05221879|Enoxaparin|enoxaparin|mesh-list
65656129|NCT05221879|Anticoagulants|anticoagulants|mesh-ancestor
65656130|NCT05221879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65656131|NCT05221879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65656132|NCT05221879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656133|NCT03450772|Pancrelipase|pancrelipase|mesh-list
65656134|NCT03450772|Pancreatin|pancreatin|mesh-list
65656135|NCT03450772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65656136|NCT02129088|Esketamine|esketamine|mesh-list
65656137|NCT02129088|Antidepressive Agents|antidepressive agents|mesh-ancestor
65656138|NCT02129088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65656139|NCT05137522|Methylprednisolone|methylprednisolone|mesh-list
65656140|NCT05137522|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65656141|NCT05137522|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65656142|NCT05137522|Prednisolone|prednisolone|mesh-list
65656143|NCT05137522|Prednisolone acetate|prednisolone acetate|mesh-list
65656144|NCT05137522|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65656145|NCT05137522|Prednisolone phosphate|prednisolone phosphate|mesh-list
65656146|NCT05137522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65453542|NCT00845026|Risperidone|risperidone|mesh-list
65656147|NCT05137522|Antiemetics|antiemetics|mesh-ancestor
65656148|NCT05137522|Autonomic Agents|autonomic agents|mesh-ancestor
65656149|NCT05137522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65656150|NCT05137522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656152|NCT05137522|Glucocorticoids|glucocorticoids|mesh-ancestor
65656153|NCT05137522|Hormones|hormones|mesh-ancestor
65656154|NCT05137522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65268075|NCT02702622|Vitamins|vitamins|mesh-ancestor
65656155|NCT05137522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65656156|NCT05137522|Protective Agents|protective agents|mesh-ancestor
65656157|NCT05137522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65656158|NCT05137522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656159|NCT02129166|Imatinib Mesylate|imatinib mesylate|mesh-list
65656160|NCT02129166|Dasatinib|dasatinib|mesh-list
65656161|NCT02129166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656162|NCT02129166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65656163|NCT02129166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656164|NCT02129166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656165|NCT02137278|Antihypertensive Agents|antihypertensive agents|mesh-list
65656166|NCT02137278|Levodopa|levodopa|mesh-list
65656167|NCT02137278|Antipsychotic Agents|antipsychotic agents|mesh-list
65656168|NCT02137278|Antidepressive Agents|antidepressive agents|mesh-list
65656169|NCT02137278|Diuretics|diuretics|mesh-list
65656170|NCT02137278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65656171|NCT02137278|Natriuretic Agents|natriuretic agents|mesh-ancestor
65656172|NCT02137278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656173|NCT02137278|Dopamine Agents|dopamine agents|mesh-ancestor
65656174|NCT02137278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65656175|NCT02137278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656176|NCT02137278|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65656177|NCT02137278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65656178|NCT02137278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65656179|NCT02137278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65656180|NCT05705635|Docetaxel|docetaxel|mesh-list
65656181|NCT05705635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656182|NCT05705635|Tubulin Modulators|tubulin modulators|mesh-ancestor
65656183|NCT05705635|Antimitotic Agents|antimitotic agents|mesh-ancestor
65656184|NCT05705635|Mitosis Modulators|mitosis modulators|mesh-ancestor
65656185|NCT05705635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656186|NCT05204550|Heparin|heparin|mesh-list
65656187|NCT05204550|Calcium heparin|calcium heparin|mesh-list
65656188|NCT05204550|Anticoagulants|anticoagulants|mesh-ancestor
65656189|NCT05204550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65656190|NCT05204550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65656191|NCT05204550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656192|NCT00085774|Albuterol|albuterol|mesh-list
65656193|NCT00085774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65656194|NCT00085774|Autonomic Agents|autonomic agents|mesh-ancestor
65656195|NCT00085774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65656196|NCT00085774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656197|NCT00085774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65656198|NCT00085774|Respiratory System Agents|respiratory system agents|mesh-ancestor
65656199|NCT00085774|Tocolytic Agents|tocolytic agents|mesh-ancestor
65656200|NCT00085774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65656201|NCT00085774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65656202|NCT00085774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65656203|NCT00085774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65656204|NCT00085774|Adrenergic Agents|adrenergic agents|mesh-ancestor
65656205|NCT00085774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65656206|NCT00085774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656207|NCT04491682|Megestrol|megestrol|mesh-list
65656208|NCT04491682|Megestrol Acetate|megestrol acetate|mesh-list
65656209|NCT04491682|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65656210|NCT04491682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65656211|NCT04491682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65656212|NCT04491682|Antimetabolites|antimetabolites|mesh-ancestor
65656213|NCT04491682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656214|NCT04491682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65656215|NCT04491682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65656216|NCT04491682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656217|NCT04491682|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65656218|NCT04491682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65656219|NCT04491682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65656220|NCT04491682|Contraceptive Agents|contraceptive agents|mesh-ancestor
65656221|NCT04491682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65453618|NCT01145950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65656222|NCT04491682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656223|NCT04491682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65656224|NCT04491682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65656225|NCT04491682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65656226|NCT04491682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656227|NCT04491682|Appetite Stimulants|appetite stimulants|mesh-ancestor
65656228|NCT04491682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65656229|NCT05193968|Nitroprusside|nitroprusside|mesh-list
65656230|NCT05193968|Norepinephrine|norepinephrine|mesh-list
65656231|NCT05193968|Acetylcholine|acetylcholine|mesh-list
65656232|NCT05193968|Terbutaline|terbutaline|mesh-list
65656233|NCT05193968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65656234|NCT05193968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65656235|NCT05193968|Adrenergic Agents|adrenergic agents|mesh-ancestor
65656236|NCT05193968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65656237|NCT05193968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656238|NCT05193968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656239|NCT05193968|Sympathomimetics|sympathomimetics|mesh-ancestor
65656240|NCT05193968|Autonomic Agents|autonomic agents|mesh-ancestor
65656241|NCT05193968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65656242|NCT05193968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65656243|NCT05193968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65656244|NCT05193968|Vasodilator Agents|vasodilator agents|mesh-ancestor
65656245|NCT05193968|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65656246|NCT05193968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65656247|NCT05193968|Cholinergic Agents|cholinergic agents|mesh-ancestor
65656248|NCT05193968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65656249|NCT05193968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65656250|NCT05193968|Respiratory System Agents|respiratory system agents|mesh-ancestor
65656251|NCT05193968|Tocolytic Agents|tocolytic agents|mesh-ancestor
65656252|NCT05193968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65656253|NCT05193968|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65656254|NCT05193968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65656255|NCT02137356|Capecitabine|capecitabine|mesh-list
65656256|NCT02137356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65656257|NCT02137356|Antimetabolites|antimetabolites|mesh-ancestor
65656258|NCT02137356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656259|NCT02137356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656260|NCT05137288|Atropine|atropine|mesh-list
65656261|NCT05137288|Ondansetron|ondansetron|mesh-list
65656262|NCT05137288|Bupivacaine|bupivacaine|mesh-list
65656263|NCT05137288|Anesthetics, Local|anesthetics, local|mesh-ancestor
65656264|NCT05137288|Anesthetics|anesthetics|mesh-ancestor
65656265|NCT05137288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65656266|NCT05137288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656267|NCT05137288|Sensory System Agents|sensory system agents|mesh-ancestor
65656268|NCT05137288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65656269|NCT05137288|Antiemetics|antiemetics|mesh-ancestor
65656270|NCT05137288|Autonomic Agents|autonomic agents|mesh-ancestor
65656271|NCT05137288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65656272|NCT05137288|Antipruritics|antipruritics|mesh-ancestor
65656273|NCT05137288|Dermatologic Agents|dermatologic agents|mesh-ancestor
65656274|NCT05137288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65656275|NCT05137288|Serotonin Agents|serotonin agents|mesh-ancestor
65656276|NCT05137288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65656277|NCT05137288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656278|NCT05137288|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65656279|NCT05137288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65656280|NCT05137288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65656281|NCT05137288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65656282|NCT05137288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65656283|NCT05137288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65656284|NCT05137288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65656285|NCT05137288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65268095|NCT02705508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65656286|NCT05137288|Respiratory System Agents|respiratory system agents|mesh-ancestor
65656287|NCT05137288|Mydriatics|mydriatics|mesh-ancestor
65656288|NCT05137288|Parasympatholytics|parasympatholytics|mesh-ancestor
65656289|NCT05137288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65656290|NCT05137288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65656291|NCT05137288|Cholinergic Agents|cholinergic agents|mesh-ancestor
65656292|NCT05135182|Metronidazole|metronidazole|mesh-list
65656293|NCT05135182|Furazolidone|furazolidone|mesh-list
65656294|NCT05135182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65656295|NCT05135182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65656296|NCT05135182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65656297|NCT05135182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65656298|NCT05135182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65656299|NCT05135182|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65656300|NCT05135182|Renal Agents|renal agents|mesh-ancestor
65656301|NCT05135182|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65656302|NCT05135182|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65656303|NCT05135182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656304|NCT05135182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656305|NCT02137434|Calcium, Dietary|calcium, dietary|mesh-list
65656306|NCT02137434|Calcium|calcium|mesh-list
65656307|NCT02137434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65656308|NCT02137434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656309|NCT02137434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65656310|NCT04965454|Choline|choline|mesh-list
65656311|NCT04965454|Lipotropic Agents|lipotropic agents|mesh-ancestor
65656312|NCT04965454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65656313|NCT04965454|Antimetabolites|antimetabolites|mesh-ancestor
65656314|NCT04965454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656315|NCT04965454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65656316|NCT04965454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65656317|NCT04965454|Nootropic Agents|nootropic agents|mesh-ancestor
65656318|NCT02137668|Vancomycin|vancomycin|mesh-list
65656319|NCT02137668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65656320|NCT02137668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65656321|NCT04216472|Paclitaxel|paclitaxel|mesh-list
65656322|NCT04216472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65656323|NCT04216472|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
65656324|NCT04216472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65656325|NCT04216472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656326|NCT04216472|Tubulin Modulators|tubulin modulators|mesh-ancestor
65656327|NCT04216472|Antimitotic Agents|antimitotic agents|mesh-ancestor
65656328|NCT04216472|Mitosis Modulators|mitosis modulators|mesh-ancestor
65656329|NCT04216472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656330|NCT04216472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656331|NCT03522428|Vitamin B 12|vitamin b 12|mesh-list
65656332|NCT03522428|Hydroxocobalamin|hydroxocobalamin|mesh-list
65656333|NCT03522428|Vitamins|vitamins|mesh-ancestor
65656334|NCT03522428|Micronutrients|micronutrients|mesh-ancestor
65656335|NCT03522428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656336|NCT03522428|Vitamin B Complex|vitamin b complex|mesh-ancestor
65656337|NCT03522428|Hematinics|hematinics|mesh-ancestor
65656338|NCT05575999|Ketorolac|ketorolac|mesh-list
65656339|NCT05575999|Ketamine|ketamine|mesh-list
65656340|NCT05575999|Bupivacaine|bupivacaine|mesh-list
65656341|NCT05575999|Anesthetics, Local|anesthetics, local|mesh-ancestor
65656342|NCT05575999|Anesthetics|anesthetics|mesh-ancestor
65656343|NCT05575999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65656344|NCT05575999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656345|NCT05575999|Sensory System Agents|sensory system agents|mesh-ancestor
65656346|NCT05575999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65656347|NCT05575999|Analgesics|analgesics|mesh-ancestor
65656348|NCT05575999|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65656349|NCT05575999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65656350|NCT05575999|Anesthetics, General|anesthetics, general|mesh-ancestor
65656351|NCT05575999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65656352|NCT05575999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65656353|NCT05575999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65656354|NCT05575999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656355|NCT05575999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65656356|NCT05575999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65656357|NCT05575999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65656358|NCT05575999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65656359|NCT05575999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65656360|NCT05575999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656361|NCT01062399|Everolimus|everolimus|mesh-list
65656362|NCT01062399|Temozolomide|temozolomide|mesh-list
65656363|NCT01062399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656364|NCT01062399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65656365|NCT01062399|Immunologic Factors|immunologic factors|mesh-ancestor
65656366|NCT01062399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656367|NCT01062399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65656368|NCT01062399|Alkylating Agents|alkylating agents|mesh-ancestor
65656369|NCT01062399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656370|NCT05136508|Propofol|propofol|mesh-list
65656371|NCT05136508|Sevoflurane|sevoflurane|mesh-list
65656372|NCT05136508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65656373|NCT05136508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65453780|NCT03530800|Dronabinol|dronabinol|mesh-list
65656374|NCT05136508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656375|NCT05136508|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65656376|NCT05136508|Anesthetics, General|anesthetics, general|mesh-ancestor
65656377|NCT05136508|Anesthetics|anesthetics|mesh-ancestor
65656378|NCT05136508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65656379|NCT05136508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65656380|NCT02129322|Oxaliplatin|oxaliplatin|mesh-list
65656382|NCT02129322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656383|NCT02129322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65656384|NCT02129322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656385|NCT02129322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656386|NCT05125978|Dipyrone|dipyrone|mesh-list
65656387|NCT05125978|Tramadol|tramadol|mesh-list
65656388|NCT05125978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65656389|NCT05125978|Narcotics|narcotics|mesh-ancestor
65656390|NCT05125978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65656391|NCT05125978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656392|NCT05125978|Analgesics|analgesics|mesh-ancestor
65656393|NCT05125978|Sensory System Agents|sensory system agents|mesh-ancestor
65656394|NCT05125978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65656395|NCT05125978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65656396|NCT05125978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65656397|NCT05125978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65656398|NCT05125978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65656399|NCT05125978|Antipyretics|antipyretics|mesh-ancestor
65656400|NCT03767712|Antibodies|antibodies|mesh-list
65656401|NCT03767712|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
65656402|NCT03767712|Immunologic Factors|immunologic factors|mesh-ancestor
65656403|NCT03767712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656404|NCT05221411|Mycophenolic Acid|mycophenolic acid|mesh-list
65656405|NCT05221411|Tacrolimus|tacrolimus|mesh-list
65656406|NCT05221411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65656407|NCT05221411|Immunologic Factors|immunologic factors|mesh-ancestor
65656408|NCT05221411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656409|NCT05221411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65656410|NCT05221411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656411|NCT05221411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656412|NCT05221411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65656413|NCT05221411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656414|NCT05221411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65656415|NCT05221411|Antitubercular Agents|antitubercular agents|mesh-ancestor
65656416|NCT05221411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65656417|NCT05221411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65656418|NCT05306002|Antioxidants|antioxidants|mesh-list
65656419|NCT05306002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656420|NCT05306002|Protective Agents|protective agents|mesh-ancestor
65656421|NCT05306002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656422|NCT04346914|Carboplatin|carboplatin|mesh-list
65656423|NCT04346914|Etoposide|etoposide|mesh-list
65656424|NCT04346914|Antibodies|antibodies|mesh-list
65656425|NCT04346914|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65656426|NCT04346914|Immunologic Factors|immunologic factors|mesh-ancestor
65656427|NCT04346914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656428|NCT04346914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656429|NCT04346914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65656430|NCT04346914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65656431|NCT04346914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65656432|NCT04346914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656433|NCT04346914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656434|NCT02129400|Anesthetics|anesthetics|mesh-list
65656435|NCT02129400|Xenon|xenon|mesh-list
65656436|NCT02129400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65656437|NCT02129400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656438|NCT02129400|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65656439|NCT02129400|Anesthetics, General|anesthetics, general|mesh-ancestor
65656440|NCT05305768|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65656441|NCT05305768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65656442|NCT05305768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65656443|NCT05305768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656444|NCT05305768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65656445|NCT05305768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65656446|NCT05305768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656447|NCT05305768|Cholinergic Agents|cholinergic agents|mesh-ancestor
65656448|NCT05305768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65656450|NCT02133378|Coagulants|coagulants|mesh-ancestor
65656451|NCT04171622|Pembrolizumab|pembrolizumab|mesh-list
65656452|NCT04171622|Lenvatinib|lenvatinib|mesh-list
65656453|NCT04171622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65656454|NCT04171622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656455|NCT04171622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65656456|NCT04171622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656457|NCT04171622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656458|NCT05234580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65656459|NCT02138058|Topiramate|topiramate|mesh-list
65656460|NCT02138058|Anticonvulsants|anticonvulsants|mesh-ancestor
65656461|NCT02138058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65656462|NCT02138058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656463|NCT02129634|Paclitaxel|paclitaxel|mesh-list
65656464|NCT02129634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65656465|NCT02129634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656466|NCT02129634|Tubulin Modulators|tubulin modulators|mesh-ancestor
65656467|NCT02129634|Antimitotic Agents|antimitotic agents|mesh-ancestor
65656468|NCT02129634|Mitosis Modulators|mitosis modulators|mesh-ancestor
65656469|NCT02129634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656470|NCT05174455|Niraparib|niraparib|mesh-list
65656471|NCT05174455|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65656472|NCT05174455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656473|NCT05174455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656474|NCT05174455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656475|NCT05162053|Clopidogrel|clopidogrel|mesh-list
65656476|NCT05162053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65656477|NCT05162053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65656478|NCT05162053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65656479|NCT05162053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65656480|NCT05162053|Purinergic Agents|purinergic agents|mesh-ancestor
65656481|NCT05162053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65656482|NCT05162053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656483|NCT05162053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656484|NCT02138292|Trametinib|trametinib|mesh-list
65656485|NCT02138292|Digoxin|digoxin|mesh-list
65656486|NCT02138292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656487|NCT02138292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65656488|NCT02138292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656489|NCT02138292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656490|NCT02138292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65656491|NCT02138292|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65656492|NCT02138292|Protective Agents|protective agents|mesh-ancestor
65656493|NCT02138292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656494|NCT02133612|Paclitaxel|paclitaxel|mesh-list
65656495|NCT02133612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65656496|NCT02133612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65656497|NCT02133612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656498|NCT02133612|Tubulin Modulators|tubulin modulators|mesh-ancestor
65656499|NCT02133612|Antimitotic Agents|antimitotic agents|mesh-ancestor
65656500|NCT02133612|Mitosis Modulators|mitosis modulators|mesh-ancestor
65656501|NCT02133612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656502|NCT03522194|Propofol|propofol|mesh-list
65656503|NCT03522194|Sevoflurane|sevoflurane|mesh-list
65656504|NCT03522194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65656505|NCT03522194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65656506|NCT03522194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656507|NCT03522194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65656508|NCT03522194|Anesthetics, General|anesthetics, general|mesh-ancestor
65656509|NCT03522194|Anesthetics|anesthetics|mesh-ancestor
65656510|NCT03522194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65656511|NCT03522194|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65656512|NCT02773238|Deoxyglucose|deoxyglucose|mesh-list
65656513|NCT02773238|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65656514|NCT02773238|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
65656515|NCT02773238|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
65656516|NCT02773238|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65656517|NCT02773238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656518|NCT02773238|Antimetabolites|antimetabolites|mesh-ancestor
65656519|NCT02773238|Antiviral Agents|antiviral agents|mesh-ancestor
65656520|NCT02773238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65656521|NCT04820686|Tenofovir|tenofovir|mesh-list
65656522|NCT04820686|Entecavir|entecavir|mesh-list
65656523|NCT04820686|Antiviral Agents|antiviral agents|mesh-ancestor
65656524|NCT04820686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65656525|NCT04820686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65656526|NCT04820686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65656527|NCT04820686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656528|NCT04820686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656529|NCT04820686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65656530|NCT04820686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65656531|NCT02260908|Enoxaparin|enoxaparin|mesh-list
65656532|NCT02260908|Anticoagulants|anticoagulants|mesh-ancestor
65656533|NCT02260908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65656534|NCT02260908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65656535|NCT02260908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656536|NCT02969655|Darbepoetin alfa|darbepoetin alfa|mesh-list
65656537|NCT02969655|Glycine|glycine|mesh-list
65656538|NCT02969655|Hematinics|hematinics|mesh-ancestor
65656539|NCT02969655|Glycine Agents|glycine agents|mesh-ancestor
65656540|NCT02969655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65656541|NCT02969655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656542|NCT02969655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656543|NCT04488874|Mannitol|mannitol|mesh-list
65656544|NCT04488874|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65656545|NCT04488874|Diuretics|diuretics|mesh-ancestor
65656546|NCT04488874|Natriuretic Agents|natriuretic agents|mesh-ancestor
65656547|NCT04488874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656548|NCT03651219|Irinotecan|irinotecan|mesh-list
65656549|NCT03651219|Apatinib|apatinib|mesh-list
65656550|NCT03651219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65656551|NCT03651219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65656552|NCT03651219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656553|NCT03651219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656554|NCT03651219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656555|NCT03651219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65268111|NCT02753738|Citalopram|citalopram|mesh-list
65656556|NCT02648698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65656557|NCT02648698|Levofloxacin|levofloxacin|mesh-list
65656558|NCT02648698|Tinidazole|tinidazole|mesh-list
65656559|NCT02648698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65656560|NCT02648698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65656561|NCT02648698|Renal Agents|renal agents|mesh-ancestor
65656562|NCT02648698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65656563|NCT02648698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65656564|NCT02648698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656565|NCT02648698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656566|NCT02648698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656567|NCT02648698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65656568|NCT02648698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65656569|NCT02648698|Alkylating Agents|alkylating agents|mesh-ancestor
65656570|NCT02648698|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65656571|NCT02648698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65656572|NCT02648698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65656573|NCT04059458|Calcium, Dietary|calcium, dietary|mesh-list
65656574|NCT04059458|Calcium|calcium|mesh-list
65656575|NCT04059458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65656576|NCT04059458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656577|NCT04059458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65656578|NCT05304598|Dexmedetomidine|dexmedetomidine|mesh-list
65656579|NCT05304598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65656580|NCT05304598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65656581|NCT05304598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656582|NCT05304598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65656583|NCT05304598|Analgesics|analgesics|mesh-ancestor
65656584|NCT05304598|Sensory System Agents|sensory system agents|mesh-ancestor
65656585|NCT05304598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65656586|NCT05304598|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65656587|NCT05304598|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65656588|NCT05304598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65656589|NCT05304598|Adrenergic Agents|adrenergic agents|mesh-ancestor
65656590|NCT05304598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65656591|NCT05304598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656592|NCT03524846|Vitamins|vitamins|mesh-list
65656593|NCT03524846|Ascorbic Acid|ascorbic acid|mesh-list
65656594|NCT03524846|Micronutrients|micronutrients|mesh-ancestor
65656595|NCT03524846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656596|NCT03524846|Antioxidants|antioxidants|mesh-ancestor
65656597|NCT03524846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656598|NCT03524846|Protective Agents|protective agents|mesh-ancestor
65656600|NCT05134558|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65656601|NCT05134558|Anesthetics, General|anesthetics, general|mesh-ancestor
65656602|NCT05134558|Anesthetics|anesthetics|mesh-ancestor
65656603|NCT05134558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65656604|NCT05134558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656605|NCT02970669|Valsartan|valsartan|mesh-list
65656606|NCT02970669|Enalapril|enalapril|mesh-list
65656607|NCT02970669|Enalaprilat|enalaprilat|mesh-list
65656608|NCT02970669|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65656609|NCT02970669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65656610|NCT02970669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65656611|NCT02970669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65656612|NCT02970669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656613|NCT02970669|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65656614|NCT02970669|Protease Inhibitors|protease inhibitors|mesh-ancestor
65656615|NCT02970669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656616|NCT02134002|Disulfiram|disulfiram|mesh-list
65656617|NCT02134002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65656618|NCT02134002|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65656619|NCT02134002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656620|NCT02134002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656621|NCT03650361|Adapalene|adapalene|mesh-list
65656622|NCT03650361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65656623|NCT03650361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65656624|NCT03650361|Analgesics|analgesics|mesh-ancestor
65656625|NCT03650361|Sensory System Agents|sensory system agents|mesh-ancestor
65268116|NCT02753738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65656626|NCT03650361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65656627|NCT03650361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656628|NCT03650361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65656629|NCT03650361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65656630|NCT03650361|Dermatologic Agents|dermatologic agents|mesh-ancestor
65656631|NCT02138994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65656632|NCT02138994|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
65656633|NCT02138994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65656634|NCT02138994|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65656635|NCT05303818|Rivaroxaban|rivaroxaban|mesh-list
65656636|NCT05303818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65656637|NCT05303818|Antithrombins|antithrombins|mesh-ancestor
65656638|NCT05303818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65656639|NCT05303818|Protease Inhibitors|protease inhibitors|mesh-ancestor
65656640|NCT05303818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656641|NCT05303818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656642|NCT05303818|Anticoagulants|anticoagulants|mesh-ancestor
65656643|NCT02902965|Dexamethasone|dexamethasone|mesh-list
65656644|NCT02902965|Bortezomib|bortezomib|mesh-list
65656645|NCT02902965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65656646|NCT02902965|Antiemetics|antiemetics|mesh-ancestor
65656647|NCT02902965|Autonomic Agents|autonomic agents|mesh-ancestor
65656648|NCT02902965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65656649|NCT02902965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656650|NCT02902965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65656651|NCT02902965|Glucocorticoids|glucocorticoids|mesh-ancestor
65656652|NCT02902965|Hormones|hormones|mesh-ancestor
65656653|NCT02902965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65656654|NCT02902965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65656655|NCT02902965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656656|NCT02130414|Cyclosporine|cyclosporine|mesh-list
65656657|NCT02130414|Cyclosporins|cyclosporins|mesh-list
65656658|NCT02130414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656659|NCT02130414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656660|NCT02130414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65656661|NCT02130414|Immunologic Factors|immunologic factors|mesh-ancestor
65656662|NCT02130414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656663|NCT02130414|Antifungal Agents|antifungal agents|mesh-ancestor
65656664|NCT02130414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65656665|NCT02130414|Dermatologic Agents|dermatologic agents|mesh-ancestor
65656666|NCT02130414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65656667|NCT02130414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65656668|NCT02642042|Docetaxel|docetaxel|mesh-list
65656669|NCT02642042|Trametinib|trametinib|mesh-list
65656670|NCT02642042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656671|NCT02642042|Tubulin Modulators|tubulin modulators|mesh-ancestor
65656672|NCT02642042|Antimitotic Agents|antimitotic agents|mesh-ancestor
65656673|NCT02642042|Mitosis Modulators|mitosis modulators|mesh-ancestor
65656674|NCT02642042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656675|NCT02642042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65656677|NCT02902809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65656678|NCT02902809|Immunologic Factors|immunologic factors|mesh-ancestor
65656679|NCT02902809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656680|NCT02134470|Testosterone|testosterone|mesh-list
65656681|NCT02134470|Androgens|androgens|mesh-ancestor
65656682|NCT02134470|Hormones|hormones|mesh-ancestor
65656683|NCT02134470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65656684|NCT02134470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656685|NCT02134626|Simvastatin|simvastatin|mesh-list
65656686|NCT02134626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65656687|NCT02134626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65656688|NCT02134626|Antimetabolites|antimetabolites|mesh-ancestor
65656689|NCT02134626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656690|NCT02134626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65656691|NCT02134626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65656692|NCT02134626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656693|NCT02969187|Bupivacaine|bupivacaine|mesh-list
65656694|NCT02969187|Anesthetics, Local|anesthetics, local|mesh-ancestor
65656695|NCT02969187|Anesthetics|anesthetics|mesh-ancestor
65268121|NCT02753738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65656696|NCT02969187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65656697|NCT02969187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656698|NCT02969187|Sensory System Agents|sensory system agents|mesh-ancestor
65656699|NCT02969187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65656700|NCT04893655|Dobutamine|dobutamine|mesh-list
65656701|NCT04893655|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65656702|NCT04893655|Sympathomimetics|sympathomimetics|mesh-ancestor
65656703|NCT04893655|Autonomic Agents|autonomic agents|mesh-ancestor
65656704|NCT04893655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65656705|NCT04893655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656706|NCT04893655|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65656707|NCT04893655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65656708|NCT04893655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65656709|NCT04893655|Adrenergic Agents|adrenergic agents|mesh-ancestor
65656710|NCT04893655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65656711|NCT04893655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656712|NCT04893655|Protective Agents|protective agents|mesh-ancestor
65656713|NCT02139618|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65656714|NCT02139618|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65656715|NCT02139618|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65656716|NCT02139618|Dermatologic Agents|dermatologic agents|mesh-ancestor
65656717|NCT05285085|Atorvastatin|atorvastatin|mesh-list
65656718|NCT05285085|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65656719|NCT05285085|Simvastatin|simvastatin|mesh-list
65656720|NCT05285085|Pravastatin|pravastatin|mesh-list
65656721|NCT05285085|Pitavastatin|pitavastatin|mesh-list
65656722|NCT05285085|Lovastatin|lovastatin|mesh-list
65656723|NCT05285085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65656724|NCT05285085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65656725|NCT05285085|Antimetabolites|antimetabolites|mesh-ancestor
65656726|NCT05285085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656727|NCT05285085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65656728|NCT05285085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65656729|NCT05285085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656730|NCT02139930|Nicotine|nicotine|mesh-list
65656731|NCT02139930|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65656732|NCT02139930|Autonomic Agents|autonomic agents|mesh-ancestor
65656733|NCT02139930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65656734|NCT02139930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656735|NCT02139930|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65656736|NCT02139930|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65656737|NCT02139930|Cholinergic Agents|cholinergic agents|mesh-ancestor
65656738|NCT02139930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65656739|NCT02139930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656740|NCT04843111|Vaccines|vaccines|mesh-list
65656741|NCT04843111|Immunologic Factors|immunologic factors|mesh-ancestor
65656742|NCT04843111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656743|NCT02130804|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
65656744|NCT02130804|Salicylates|salicylates|mesh-list
65656745|NCT02130804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65656746|NCT02130804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65656747|NCT02130804|Analgesics|analgesics|mesh-ancestor
65656748|NCT02130804|Sensory System Agents|sensory system agents|mesh-ancestor
65656749|NCT02130804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65656750|NCT02130804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656751|NCT02130804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65656752|NCT02130804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65656753|NCT02130804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65656754|NCT02130804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656755|NCT02130804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656756|NCT05303272|Mycophenolic Acid|mycophenolic acid|mesh-list
65656757|NCT05303272|Abatacept|abatacept|mesh-list
65656758|NCT05303272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65656759|NCT05303272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656760|NCT05303272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65656761|NCT05303272|Antitubercular Agents|antitubercular agents|mesh-ancestor
65656762|NCT05303272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65656763|NCT05303272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65656764|NCT05303272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656765|NCT05303272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656766|NCT05303272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65656767|NCT05303272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65656768|NCT05303272|Immunologic Factors|immunologic factors|mesh-ancestor
65656769|NCT05303272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656770|NCT05303272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65656771|NCT03549312|Tenofovir|tenofovir|mesh-list
65656772|NCT03549312|Emtricitabine|emtricitabine|mesh-list
65656773|NCT03549312|Sofosbuvir|sofosbuvir|mesh-list
65656774|NCT03549312|Cobicistat|cobicistat|mesh-list
65656775|NCT03549312|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65656776|NCT03549312|Velpatasvir|velpatasvir|mesh-list
65656777|NCT03549312|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65656778|NCT03549312|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65656779|NCT03549312|Elvitegravir|elvitegravir|mesh-list
65656780|NCT03549312|Antiviral Agents|antiviral agents|mesh-ancestor
65656781|NCT03549312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65656782|NCT03549312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65656783|NCT03549312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65656784|NCT03549312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656785|NCT03549312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656786|NCT03549312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65656787|NCT03549312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65656788|NCT03549312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65656789|NCT03549312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65656790|NCT03549312|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65656791|NCT03649269|Bezafibrate|bezafibrate|mesh-list
65656792|NCT03649269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65656793|NCT03649269|Antimetabolites|antimetabolites|mesh-ancestor
65656794|NCT03649269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656795|NCT03649269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65656796|NCT02134938|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
65656797|NCT02134938|Cathartics|cathartics|mesh-ancestor
65656798|NCT02134938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65656799|NCT05373446|Ritonavir|ritonavir|mesh-list
65656800|NCT05373446|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65656801|NCT05373446|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65656802|NCT05373446|Protease Inhibitors|protease inhibitors|mesh-ancestor
65656803|NCT05373446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656804|NCT05373446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656805|NCT05373446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65656806|NCT05373446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65656807|NCT05373446|Antiviral Agents|antiviral agents|mesh-ancestor
65656808|NCT05373446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65656809|NCT05373446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65656810|NCT05373446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65656811|NCT04734028|Clopidogrel|clopidogrel|mesh-list
65656812|NCT04734028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656813|NCT04734028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656814|NCT04734028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65656815|NCT04734028|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65656816|NCT04734028|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65656817|NCT04734028|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65656818|NCT04734028|Purinergic Agents|purinergic agents|mesh-ancestor
65656819|NCT04734028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65656820|NCT05285397|Liraglutide|liraglutide|mesh-list
65656821|NCT05285397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65656822|NCT05285397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656823|NCT05285397|Incretins|incretins|mesh-ancestor
65656824|NCT05285397|Hormones|hormones|mesh-ancestor
65656825|NCT05285397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65656826|NCT03050359|Lansoprazole|lansoprazole|mesh-list
65656827|NCT03050359|Dexlansoprazole|dexlansoprazole|mesh-list
65656828|NCT03050359|Bismuth|bismuth|mesh-list
65656829|NCT03050359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65656830|NCT03050359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65656831|NCT03050359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65656832|NCT03050359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656833|NCT03050359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656834|NCT03050359|Antacids|antacids|mesh-ancestor
65656835|NCT02140242|Daunorubicin|daunorubicin|mesh-list
65656836|NCT02140242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65656837|NCT02140242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656838|NCT02140242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65656839|NCT02140242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65656840|NCT02140242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656841|NCT02140242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656842|NCT05302726|Estrogens|estrogens|mesh-list
65656843|NCT05302726|Hormones|hormones|mesh-ancestor
65656844|NCT05302726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65656845|NCT05302726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656846|NCT02253264|Rituximab|rituximab|mesh-list
65656847|NCT02253264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65656848|NCT02253264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656849|NCT02253264|Immunologic Factors|immunologic factors|mesh-ancestor
65656850|NCT02253264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656851|NCT02253264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65656852|NCT03648333|Niacin|niacin|mesh-list
65656853|NCT03648333|Amlodipine|amlodipine|mesh-list
65656854|NCT03648333|Valsartan|valsartan|mesh-list
65656855|NCT03648333|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
65656856|NCT03648333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65656857|NCT03648333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65656858|NCT03648333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65656859|NCT03648333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656860|NCT03648333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65656861|NCT03648333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656862|NCT03648333|Vasodilator Agents|vasodilator agents|mesh-ancestor
65656863|NCT03648333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65656864|NCT03648333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65656865|NCT03648333|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65656866|NCT03648333|Antimetabolites|antimetabolites|mesh-ancestor
65656867|NCT03648333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65656868|NCT03648333|Vitamin B Complex|vitamin b complex|mesh-ancestor
65656869|NCT03648333|Vitamins|vitamins|mesh-ancestor
65656870|NCT03648333|Micronutrients|micronutrients|mesh-ancestor
65656871|NCT02252796|Paclitaxel|paclitaxel|mesh-list
65656872|NCT02252796|Carboplatin|carboplatin|mesh-list
65656873|NCT02252796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65656874|NCT02252796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656875|NCT02252796|Tubulin Modulators|tubulin modulators|mesh-ancestor
65656876|NCT02252796|Antimitotic Agents|antimitotic agents|mesh-ancestor
65656877|NCT02252796|Mitosis Modulators|mitosis modulators|mesh-ancestor
65656878|NCT02252796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656879|NCT02785770|Moxifloxacin|moxifloxacin|mesh-list
65656880|NCT02785770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65656881|NCT02785770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65656882|NCT02785770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65656883|NCT02785770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65656884|NCT02785770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656885|NCT02785770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656886|NCT02785770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656887|NCT04256707|Docetaxel|docetaxel|mesh-list
65656888|NCT04256707|Pembrolizumab|pembrolizumab|mesh-list
65656889|NCT04256707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65656890|NCT04256707|Tubulin Modulators|tubulin modulators|mesh-ancestor
65656891|NCT04256707|Antimitotic Agents|antimitotic agents|mesh-ancestor
65656892|NCT04256707|Mitosis Modulators|mitosis modulators|mesh-ancestor
65656893|NCT04256707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656894|NCT04256707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65656895|NCT04166474|Dolutegravir|dolutegravir|mesh-list
65656896|NCT04166474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65656897|NCT04166474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65656898|NCT04166474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65656899|NCT04166474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656900|NCT04166474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65656901|NCT04166474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65656902|NCT04166474|Antiviral Agents|antiviral agents|mesh-ancestor
65656903|NCT04166474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65656904|NCT04660123|Bismuth|bismuth|mesh-list
65656905|NCT04660123|Antacids|antacids|mesh-ancestor
65656906|NCT04660123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656907|NCT04660123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65656908|NCT04530136|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
65656909|NCT04530136|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65656910|NCT04530136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65656911|NCT04530136|Immunologic Factors|immunologic factors|mesh-ancestor
65656912|NCT04530136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656913|NCT02965833|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65656914|NCT02965833|Contact Lens Solutions|contact lens solutions|mesh-list
65656915|NCT02965833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65656916|NCT02965833|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65656917|NCT02965833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65656918|NCT02965833|Disinfectants|disinfectants|mesh-ancestor
65656919|NCT05579418|Evolocumab|evolocumab|mesh-list
65656920|NCT05579418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65656921|NCT05579418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65656922|NCT05579418|Antimetabolites|antimetabolites|mesh-ancestor
65656923|NCT05579418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656924|NCT05579418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65656925|NCT02968173|Palivizumab|palivizumab|mesh-list
65656926|NCT02968173|Antiviral Agents|antiviral agents|mesh-ancestor
65656927|NCT02968173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65656928|NCT04848584|Vaccines|vaccines|mesh-list
65656929|NCT04848584|Immunologic Factors|immunologic factors|mesh-ancestor
65656930|NCT04848584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656931|NCT02135640|Denosumab|denosumab|mesh-list
65656932|NCT02135640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65656933|NCT02135640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656934|NCT02784834|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65656935|NCT02784834|Dermatologic Agents|dermatologic agents|mesh-ancestor
65656936|NCT02784834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65656937|NCT02784834|Immunologic Factors|immunologic factors|mesh-ancestor
65656938|NCT02784834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656939|NCT04038099|Lidocaine|lidocaine|mesh-list
65656940|NCT04038099|Anesthetics, Local|anesthetics, local|mesh-ancestor
65656941|NCT04038099|Anesthetics|anesthetics|mesh-ancestor
65656942|NCT04038099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65656943|NCT04038099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656944|NCT04038099|Sensory System Agents|sensory system agents|mesh-ancestor
65656945|NCT04038099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65656946|NCT04038099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65656947|NCT04038099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65656948|NCT04038099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65656949|NCT04038099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65656950|NCT04038099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656951|NCT00495508|Lumefantrine|lumefantrine|mesh-list
65656952|NCT00495508|Artemether|artemether|mesh-list
65656953|NCT00495508|Quinine|quinine|mesh-list
65656954|NCT00495508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65656955|NCT00495508|Antimalarials|antimalarials|mesh-ancestor
65656956|NCT00495508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65656957|NCT00495508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65656958|NCT00495508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65656959|NCT00495508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65656960|NCT00495508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656961|NCT00495508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65656962|NCT00495508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65656963|NCT00495508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65656964|NCT00495508|Analgesics|analgesics|mesh-ancestor
65656965|NCT00495508|Sensory System Agents|sensory system agents|mesh-ancestor
65656966|NCT01554046|Methylphenidate|methylphenidate|mesh-list
65656967|NCT01554046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65656968|NCT01554046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656969|NCT01554046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65656970|NCT01554046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65656971|NCT01554046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65656972|NCT01554046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65656973|NCT01554046|Dopamine Agents|dopamine agents|mesh-ancestor
65656974|NCT01554046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65656976|NCT05284851|Immunologic Factors|immunologic factors|mesh-ancestor
65656977|NCT05284851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656978|NCT03049735|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65656979|NCT03049735|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65656980|NCT03049735|Norethindrone|norethindrone|mesh-list
65656981|NCT03049735|Norethindrone Acetate|norethindrone acetate|mesh-list
65656982|NCT03049735|Estradiol|estradiol|mesh-list
65656983|NCT03049735|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65656984|NCT03049735|Relugolix|relugolix|mesh-list
65656985|NCT03049735|Estrogens|estrogens|mesh-ancestor
65656986|NCT03049735|Hormones|hormones|mesh-ancestor
65656987|NCT03049735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65656988|NCT03049735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65656989|NCT03049735|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65656990|NCT03049735|Contraceptive Agents|contraceptive agents|mesh-ancestor
65656991|NCT03049735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65656992|NCT03049735|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65656993|NCT03049735|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65656994|NCT03049735|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65656995|NCT03049735|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65656996|NCT03049735|Androgen Antagonists|androgen antagonists|mesh-ancestor
65656997|NCT03049735|Hormone Antagonists|hormone antagonists|mesh-ancestor
65656998|NCT04785638|Bupivacaine|bupivacaine|mesh-list
65656999|NCT04785638|Anesthetics, Local|anesthetics, local|mesh-ancestor
65657000|NCT04785638|Anesthetics|anesthetics|mesh-ancestor
65657001|NCT04785638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65657002|NCT04785638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657003|NCT04785638|Sensory System Agents|sensory system agents|mesh-ancestor
65657004|NCT04785638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65657005|NCT04762472|Montelukast|montelukast|mesh-list
65657006|NCT04762472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65657007|NCT04762472|Respiratory System Agents|respiratory system agents|mesh-ancestor
65657008|NCT04762472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65657009|NCT04762472|Hormone Antagonists|hormone antagonists|mesh-ancestor
65657010|NCT04762472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65657011|NCT04762472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657012|NCT04762472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65657013|NCT04762472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65657014|NCT04762472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657015|NCT01295944|Bevacizumab|bevacizumab|mesh-list
65657016|NCT01295944|Carboplatin|carboplatin|mesh-list
65657017|NCT01295944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65657018|NCT01295944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657019|NCT01295944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65657020|NCT01295944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65657021|NCT01295944|Growth Substances|growth substances|mesh-ancestor
65657022|NCT01295944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657023|NCT01295944|Growth Inhibitors|growth inhibitors|mesh-ancestor
65657024|NCT04742348|Levodopa|levodopa|mesh-list
65657025|NCT04742348|Carbidopa|carbidopa|mesh-list
65657026|NCT04742348|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65657027|NCT04742348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65657028|NCT04742348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65657029|NCT04742348|Dopamine Agents|dopamine agents|mesh-ancestor
65657030|NCT04742348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65657031|NCT04742348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657032|NCT04742348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657033|NCT04742348|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65657034|NCT04742348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657035|NCT04742348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65657036|NCT04742348|Immunologic Factors|immunologic factors|mesh-ancestor
65657037|NCT04742348|Dopamine Agonists|dopamine agonists|mesh-ancestor
65657038|NCT03384784|Galantamine|galantamine|mesh-list
65657039|NCT03384784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65657040|NCT03384784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657041|NCT03384784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657042|NCT03384784|Cholinergic Agents|cholinergic agents|mesh-ancestor
65657043|NCT03384784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65657044|NCT03384784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657045|NCT03384784|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65454444|NCT03901690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657047|NCT03384784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65657048|NCT03384784|Nootropic Agents|nootropic agents|mesh-ancestor
65657049|NCT02140632|Methylprednisolone|methylprednisolone|mesh-list
65657050|NCT02140632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65657051|NCT02140632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65657052|NCT02140632|Prednisolone|prednisolone|mesh-list
65657053|NCT02140632|Prednisolone acetate|prednisolone acetate|mesh-list
65657054|NCT02140632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65657055|NCT02140632|Prednisolone phosphate|prednisolone phosphate|mesh-list
65657056|NCT02140632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65657057|NCT02140632|Antiemetics|antiemetics|mesh-ancestor
65657058|NCT02140632|Autonomic Agents|autonomic agents|mesh-ancestor
65657059|NCT02140632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65657060|NCT02140632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657061|NCT02140632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65657062|NCT02140632|Glucocorticoids|glucocorticoids|mesh-ancestor
65657063|NCT02140632|Hormones|hormones|mesh-ancestor
65657064|NCT02140632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65657065|NCT02140632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65657066|NCT02140632|Protective Agents|protective agents|mesh-ancestor
65657067|NCT02140632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65657068|NCT02140632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657069|NCT04712942|Azacitidine|azacitidine|mesh-list
65657070|NCT04712942|Pevonedistat|pevonedistat|mesh-list
65657071|NCT04712942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65657072|NCT04712942|Antimetabolites|antimetabolites|mesh-ancestor
65657073|NCT04712942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657074|NCT04712942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657075|NCT04712942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657076|NCT05578404|Cholecalciferol|cholecalciferol|mesh-list
65657077|NCT05578404|Vitamin D|vitamin d|mesh-list
65657078|NCT05578404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65657079|NCT05578404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657080|NCT05578404|Vitamins|vitamins|mesh-ancestor
65657081|NCT05578404|Micronutrients|micronutrients|mesh-ancestor
65657082|NCT05578404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65657083|NCT03521960|Buspirone|buspirone|mesh-list
65657084|NCT03521960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65657085|NCT03521960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65657086|NCT03521960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65657087|NCT03521960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657088|NCT03521960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65657089|NCT03521960|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65657090|NCT03521960|Serotonin Agents|serotonin agents|mesh-ancestor
65657091|NCT03521960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65657092|NCT03521960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657093|NCT05479578|Dexamethasone|dexamethasone|mesh-list
65657094|NCT05479578|Dexamethasone acetate|dexamethasone acetate|mesh-list
65657095|NCT05479578|Cyclophosphamide|cyclophosphamide|mesh-list
65657096|NCT05479578|Ichthammol|ichthammol|mesh-list
65657097|NCT05479578|BB 1101|bb 1101|mesh-list
65657098|NCT05479578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65657099|NCT05479578|Immunologic Factors|immunologic factors|mesh-ancestor
65657100|NCT05479578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657101|NCT05479578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65657102|NCT05479578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65657103|NCT05479578|Alkylating Agents|alkylating agents|mesh-ancestor
65657104|NCT05479578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657105|NCT05479578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657106|NCT05479578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65657107|NCT05479578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65657108|NCT05479578|Antiemetics|antiemetics|mesh-ancestor
65657109|NCT05479578|Autonomic Agents|autonomic agents|mesh-ancestor
65657110|NCT05479578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65657111|NCT05479578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65657112|NCT05479578|Glucocorticoids|glucocorticoids|mesh-ancestor
65657113|NCT05479578|Hormones|hormones|mesh-ancestor
65657114|NCT05479578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65657115|NCT05479578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65657116|NCT05479578|Protease Inhibitors|protease inhibitors|mesh-ancestor
65657117|NCT05479578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657118|NCT05479578|Dermatologic Agents|dermatologic agents|mesh-ancestor
65268141|NCT02705664|Amorolfine|amorolfine|mesh-list
65657119|NCT02899377|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
65454518|NCT03972462|Sirolimus|sirolimus|mesh-list
65657120|NCT02899377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657122|NCT02899377|Sequestering Agents|sequestering agents|mesh-ancestor
65657123|NCT05363462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65657124|NCT05363462|Vancomycin|vancomycin|mesh-list
65657125|NCT05363462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65657126|NCT04853628|Ethanol|ethanol|mesh-list
65657127|NCT04853628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65657128|NCT04853628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65657129|NCT04853628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65657130|NCT04853628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657131|NCT03521726|Amoxicillin|amoxicillin|mesh-list
65657132|NCT03521726|Rabeprazole|rabeprazole|mesh-list
65657133|NCT03521726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65657134|NCT03521726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65657135|NCT03521726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65657136|NCT03521726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65657137|NCT03521726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65657138|NCT03521726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657139|NCT03521726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657140|NCT03546426|Pembrolizumab|pembrolizumab|mesh-list
65657141|NCT03546426|Interleukin-2|interleukin-2|mesh-list
65657142|NCT03546426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65657143|NCT03546426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657144|NCT03546426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65657145|NCT03546426|Analgesics|analgesics|mesh-ancestor
65657146|NCT03546426|Sensory System Agents|sensory system agents|mesh-ancestor
65657147|NCT03546426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65657148|NCT03546426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657149|NCT02897349|Linagliptin|linagliptin|mesh-list
65657150|NCT02897349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65657151|NCT02897349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657152|NCT02897349|Incretins|incretins|mesh-ancestor
65657153|NCT02897349|Hormones|hormones|mesh-ancestor
65657154|NCT02897349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65657155|NCT02897349|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65657156|NCT02897349|Protease Inhibitors|protease inhibitors|mesh-ancestor
65657157|NCT02897349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657158|NCT02897349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657159|NCT04767984|Calcium, Dietary|calcium, dietary|mesh-list
65657160|NCT04767984|Atorvastatin|atorvastatin|mesh-list
65657161|NCT04767984|Calcium|calcium|mesh-list
65657162|NCT04767984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65657163|NCT04767984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657164|NCT04767984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65657165|NCT04767984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65657166|NCT04767984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65657167|NCT04767984|Antimetabolites|antimetabolites|mesh-ancestor
65657168|NCT04767984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657169|NCT04767984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65657170|NCT04767984|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65657171|NCT04767984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657172|NCT03134378|Amoxicillin|amoxicillin|mesh-list
65657173|NCT03134378|Clarithromycin|clarithromycin|mesh-list
65657174|NCT03134378|Rabeprazole|rabeprazole|mesh-list
65657175|NCT03134378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65657176|NCT03134378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65657177|NCT03134378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65657178|NCT03134378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657179|NCT03134378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657180|NCT03134378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65657181|NCT03134378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65657182|NCT03134378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65657183|NCT03134378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65657184|NCT03134378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65657185|NCT05434104|Metronidazole|metronidazole|mesh-list
65657186|NCT05434104|Fluconazole|fluconazole|mesh-list
65657187|NCT05434104|Lactoferrin|lactoferrin|mesh-list
65657188|NCT05434104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65657189|NCT05434104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65657190|NCT05434104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65657191|NCT05434104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65657192|NCT05434104|Antifungal Agents|antifungal agents|mesh-ancestor
65454651|NCT03894280|Xhance|xhance|mesh-list
65657193|NCT05434104|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65657194|NCT05434104|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65657195|NCT05434104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657196|NCT05434104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657197|NCT05434104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65657198|NCT05434104|Hormone Antagonists|hormone antagonists|mesh-ancestor
65657199|NCT05434104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65657200|NCT05434104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657201|NCT05434104|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65657202|NCT05434104|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65657203|NCT00488072|Mirtazapine|mirtazapine|mesh-list
65657204|NCT00488072|Antidepressive Agents|antidepressive agents|mesh-ancestor
65657205|NCT00488072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65657206|NCT00488072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65657207|NCT00488072|Histamine Antagonists|histamine antagonists|mesh-ancestor
65657208|NCT00488072|Histamine Agents|histamine agents|mesh-ancestor
65657209|NCT00488072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65657210|NCT00488072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657211|NCT00488072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657212|NCT00488072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65657213|NCT00488072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65657214|NCT00488072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65657215|NCT00488072|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65657216|NCT00488072|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65657217|NCT00488072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65657218|NCT00488072|Adrenergic Agents|adrenergic agents|mesh-ancestor
65657219|NCT00488072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65657220|NCT00488072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65657221|NCT00488072|Serotonin Agents|serotonin agents|mesh-ancestor
65657222|NCT00488072|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65657223|NCT03525704|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65657224|NCT03523832|Celecoxib|celecoxib|mesh-list
65657225|NCT03523832|Pregabalin|pregabalin|mesh-list
65657226|NCT03523832|Analgesics|analgesics|mesh-ancestor
65657227|NCT03523832|Sensory System Agents|sensory system agents|mesh-ancestor
65657228|NCT03523832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65657229|NCT03523832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657230|NCT03523832|Anticonvulsants|anticonvulsants|mesh-ancestor
65657231|NCT03523832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65657232|NCT03523832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65657233|NCT03523832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657234|NCT03523832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65657235|NCT03523832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65657236|NCT03523832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65657237|NCT03523832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65657238|NCT03523832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65657239|NCT03523832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65657240|NCT03523832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65657241|NCT03523832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65657242|NCT03523832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65657243|NCT03523832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65657244|NCT03523832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65657245|NCT03523832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657246|NCT05577624|Rifampin|rifampin|mesh-list
65657247|NCT05577624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65657248|NCT05577624|Antitubercular Agents|antitubercular agents|mesh-ancestor
65657249|NCT05577624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65657250|NCT05577624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65657251|NCT05577624|Leprostatic Agents|leprostatic agents|mesh-ancestor
65657252|NCT05577624|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65657253|NCT05577624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657254|NCT05577624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657255|NCT05577624|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65657256|NCT05577624|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65657257|NCT05577624|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65657258|NCT05577624|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65657259|NCT05577624|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65657260|NCT05577624|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65657261|NCT03294694|Fulvestrant|fulvestrant|mesh-list
65657262|NCT03294694|Spartalizumab|spartalizumab|mesh-list
65657263|NCT03294694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65657264|NCT03294694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657265|NCT03294694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65657266|NCT03294694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65657267|NCT03294694|Hormone Antagonists|hormone antagonists|mesh-ancestor
65657268|NCT03294694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65657269|NCT03294694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657270|NCT03294694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65657271|NCT03294694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657272|NCT03523754|Isosorbide|isosorbide|mesh-list
65657273|NCT03523754|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65657274|NCT03523754|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65657275|NCT03523754|Misoprostol|misoprostol|mesh-list
65657276|NCT03523754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65657277|NCT03523754|Abortifacient Agents|abortifacient agents|mesh-ancestor
65657278|NCT03523754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65657279|NCT03523754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657280|NCT03523754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65657281|NCT03523754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65657282|NCT03523754|Oxytocics|oxytocics|mesh-ancestor
65657283|NCT03523754|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65657284|NCT03523754|Diuretics|diuretics|mesh-ancestor
65657285|NCT03523754|Natriuretic Agents|natriuretic agents|mesh-ancestor
65657286|NCT03523754|Vasodilator Agents|vasodilator agents|mesh-ancestor
65657287|NCT03523754|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65657288|NCT03523754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657289|NCT04727034|Propofol|propofol|mesh-list
65657290|NCT04727034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65657291|NCT04727034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65657292|NCT04727034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657293|NCT04727034|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65657294|NCT04727034|Anesthetics, General|anesthetics, general|mesh-ancestor
65657295|NCT04727034|Anesthetics|anesthetics|mesh-ancestor
65657296|NCT03644511|Sorafenib|sorafenib|mesh-list
65657297|NCT03644511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657298|NCT03644511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65657299|NCT03644511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657300|NCT03644511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657301|NCT03290560|Kallikreins|kallikreins|mesh-list
65657302|NCT03290560|Coagulants|coagulants|mesh-ancestor
65657303|NCT03290560|Fertility Agents, Male|fertility agents, male|mesh-ancestor
65657304|NCT03290560|Fertility Agents|fertility agents|mesh-ancestor
65657305|NCT03290560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65657306|NCT03290560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657307|NCT04723134|Leucovorin|leucovorin|mesh-list
65657308|NCT04723134|Folic Acid|folic acid|mesh-list
65657309|NCT04723134|Calcium|calcium|mesh-list
65657310|NCT04723134|Levoleucovorin|levoleucovorin|mesh-list
65657311|NCT04723134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65657312|NCT04723134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657313|NCT04723134|Antidotes|antidotes|mesh-ancestor
65657314|NCT04723134|Protective Agents|protective agents|mesh-ancestor
65657315|NCT04723134|Vitamin B Complex|vitamin b complex|mesh-ancestor
65657316|NCT04723134|Vitamins|vitamins|mesh-ancestor
65657317|NCT04723134|Micronutrients|micronutrients|mesh-ancestor
65657318|NCT04723134|Hematinics|hematinics|mesh-ancestor
65657319|NCT01316419|Amlodipine|amlodipine|mesh-list
65657320|NCT01316419|Telmisartan|telmisartan|mesh-list
65657321|NCT01316419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65657322|NCT01316419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65657323|NCT01316419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65657324|NCT01316419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657325|NCT01316419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65657326|NCT01316419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657327|NCT01316419|Vasodilator Agents|vasodilator agents|mesh-ancestor
65657328|NCT01316419|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65657329|NCT01316419|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65657330|NCT03547362|Caseins|caseins|mesh-list
65657331|NCT03547362|Chelating Agents|chelating agents|mesh-ancestor
65657332|NCT03547362|Sequestering Agents|sequestering agents|mesh-ancestor
65657333|NCT03547362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657334|NCT04258150|Nivolumab|nivolumab|mesh-list
65657335|NCT04258150|Ipilimumab|ipilimumab|mesh-list
65657336|NCT04258150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65657337|NCT04258150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657338|NCT04258150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65657339|NCT04258150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657340|NCT02854696|Insulin|insulin|mesh-list
65657341|NCT02854696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65657342|NCT02854696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657343|NCT04664946|Neuroprotective Agents|neuroprotective agents|mesh-list
65657344|NCT04664946|Protective Agents|protective agents|mesh-ancestor
65657345|NCT04664946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657346|NCT02289248|Ketamine|ketamine|mesh-list
65657347|NCT02289248|Analgesics|analgesics|mesh-ancestor
65657348|NCT02289248|Sensory System Agents|sensory system agents|mesh-ancestor
65657349|NCT02289248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65657350|NCT02289248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657351|NCT02289248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65657352|NCT02289248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65657353|NCT02289248|Anesthetics, General|anesthetics, general|mesh-ancestor
65657354|NCT02289248|Anesthetics|anesthetics|mesh-ancestor
65657355|NCT02289248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65657356|NCT02289248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65657357|NCT02289248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65657358|NCT02289248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65657359|NCT02289248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657360|NCT02782468|Azacitidine|azacitidine|mesh-list
65657361|NCT02782468|Pevonedistat|pevonedistat|mesh-list
65657362|NCT02782468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65657363|NCT02782468|Antimetabolites|antimetabolites|mesh-ancestor
65657364|NCT02782468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657365|NCT02782468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657366|NCT02782468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657367|NCT02253420|Itraconazole|itraconazole|mesh-list
65657368|NCT02253420|Rifampin|rifampin|mesh-list
65657369|NCT02253420|Antifungal Agents|antifungal agents|mesh-ancestor
65657370|NCT02253420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65657371|NCT02253420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65657372|NCT02253420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65657373|NCT02253420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657374|NCT02253420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657375|NCT02253420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65657376|NCT02253420|Hormone Antagonists|hormone antagonists|mesh-ancestor
65657377|NCT02253420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65657378|NCT02253420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657379|NCT02253420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65657380|NCT02253420|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65657381|NCT02253420|Antitubercular Agents|antitubercular agents|mesh-ancestor
65657382|NCT02253420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65657383|NCT02253420|Leprostatic Agents|leprostatic agents|mesh-ancestor
65657384|NCT02253420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65657385|NCT02253420|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65657386|NCT02253420|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65657387|NCT02253420|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65657388|NCT02253420|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65657389|NCT02253420|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65657390|NCT02253420|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65657391|NCT02028364|Everolimus|everolimus|mesh-list
65657392|NCT02028364|Exemestane|exemestane|mesh-list
65657393|NCT02028364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657394|NCT02028364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65657395|NCT02028364|Immunologic Factors|immunologic factors|mesh-ancestor
65657396|NCT02028364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657397|NCT02028364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65657398|NCT02028364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65657399|NCT02028364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657400|NCT02028364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657401|NCT02028364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65657402|NCT02028364|Hormone Antagonists|hormone antagonists|mesh-ancestor
65657403|NCT02028364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65657404|NCT02897115|Adalimumab|adalimumab|mesh-list
65657405|NCT02897115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65657406|NCT02897115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65657407|NCT02897115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65657408|NCT02897115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65657409|NCT02897115|Analgesics|analgesics|mesh-ancestor
65657410|NCT02897115|Sensory System Agents|sensory system agents|mesh-ancestor
65657411|NCT02897115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65454816|NCT03894748|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65657412|NCT02897115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657414|NCT03806985|Hallucinogens|hallucinogens|mesh-ancestor
65657415|NCT03806985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657416|NCT03806985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65657417|NCT02289482|Ritonavir|ritonavir|mesh-list
65657418|NCT02289482|GSK-2838232|gsk-2838232|mesh-list
65657419|NCT02289482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65657420|NCT02289482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65657421|NCT02289482|Protease Inhibitors|protease inhibitors|mesh-ancestor
65657422|NCT02289482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657423|NCT02289482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657424|NCT02289482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65657425|NCT02289482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65657426|NCT02289482|Antiviral Agents|antiviral agents|mesh-ancestor
65657427|NCT02289482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65657428|NCT02289482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65657429|NCT02289482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65657430|NCT05277636|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65657431|NCT05277636|Hallucinogens|hallucinogens|mesh-ancestor
65657432|NCT05277636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657433|NCT05277636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65657434|NCT05277636|Serotonin Agents|serotonin agents|mesh-ancestor
65657435|NCT05277636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65657436|NCT05277636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657437|NCT05277636|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65657438|NCT05277636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65657439|NCT05277636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65657440|NCT05277636|Adrenergic Agents|adrenergic agents|mesh-ancestor
65657441|NCT04030195|Cyclophosphamide|cyclophosphamide|mesh-list
65657442|NCT04030195|Fludarabine|fludarabine|mesh-list
65657443|NCT04030195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65657444|NCT04030195|Immunologic Factors|immunologic factors|mesh-ancestor
65657445|NCT04030195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657446|NCT04030195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65657447|NCT04030195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65657448|NCT04030195|Alkylating Agents|alkylating agents|mesh-ancestor
65657449|NCT04030195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657450|NCT04030195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657451|NCT04030195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65657452|NCT02253966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65657453|NCT02253966|Methylprednisolone|methylprednisolone|mesh-list
65657454|NCT02253966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65657455|NCT02253966|Prednisolone|prednisolone|mesh-list
65657456|NCT02253966|Prednisolone acetate|prednisolone acetate|mesh-list
65657457|NCT02253966|Lidocaine|lidocaine|mesh-list
65657458|NCT02253966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65657459|NCT02253966|Prednisolone phosphate|prednisolone phosphate|mesh-list
65657460|NCT02253966|Anesthetics, Local|anesthetics, local|mesh-ancestor
65657461|NCT02253966|Anesthetics|anesthetics|mesh-ancestor
65657462|NCT02253966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65657463|NCT02253966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657464|NCT02253966|Sensory System Agents|sensory system agents|mesh-ancestor
65657465|NCT02253966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65657466|NCT02253966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65657467|NCT02253966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65657468|NCT02253966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65657469|NCT02253966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65657470|NCT02253966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657471|NCT02253966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65657472|NCT02253966|Antiemetics|antiemetics|mesh-ancestor
65657473|NCT02253966|Autonomic Agents|autonomic agents|mesh-ancestor
65657474|NCT02253966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65657475|NCT02253966|Glucocorticoids|glucocorticoids|mesh-ancestor
65657476|NCT02253966|Hormones|hormones|mesh-ancestor
65657477|NCT02253966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65657478|NCT02253966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65657479|NCT02253966|Protective Agents|protective agents|mesh-ancestor
65657480|NCT02253966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65657481|NCT02253966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657482|NCT01673620|Loratadine|loratadine|mesh-list
65657483|NCT01673620|Montelukast|montelukast|mesh-list
65657484|NCT01673620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65657485|NCT01673620|Respiratory System Agents|respiratory system agents|mesh-ancestor
65657486|NCT01673620|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65657487|NCT01673620|Hormone Antagonists|hormone antagonists|mesh-ancestor
65657488|NCT01673620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65657489|NCT01673620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657490|NCT01673620|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65657491|NCT01673620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65268185|NCT03288324|Tofacitinib|tofacitinib|mesh-list
65657492|NCT01673620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657493|NCT01673620|Antipruritics|antipruritics|mesh-ancestor
65657494|NCT01673620|Dermatologic Agents|dermatologic agents|mesh-ancestor
65657495|NCT01673620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65657496|NCT01673620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65657497|NCT01673620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65657498|NCT01673620|Histamine Antagonists|histamine antagonists|mesh-ancestor
65657499|NCT01673620|Histamine Agents|histamine agents|mesh-ancestor
65657500|NCT01673620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65657501|NCT04671355|Fluticasone|fluticasone|mesh-list
65657502|NCT04671355|Xhance|xhance|mesh-list
65657503|NCT04671355|Beclomethasone|beclomethasone|mesh-list
65657504|NCT04671355|Glycopyrrolate|glycopyrrolate|mesh-list
65657505|NCT04671355|Formoterol Fumarate|formoterol fumarate|mesh-list
65657506|NCT04671355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65657507|NCT04671355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65657508|NCT04671355|Autonomic Agents|autonomic agents|mesh-ancestor
65657509|NCT04671355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65657510|NCT04671355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657511|NCT04671355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65657512|NCT04671355|Respiratory System Agents|respiratory system agents|mesh-ancestor
65657513|NCT04671355|Dermatologic Agents|dermatologic agents|mesh-ancestor
65657514|NCT04671355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65657515|NCT04671355|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65657516|NCT04671355|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65657517|NCT04671355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65657518|NCT04671355|Adrenergic Agents|adrenergic agents|mesh-ancestor
65657519|NCT04671355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65657520|NCT04671355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657521|NCT04671355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65657522|NCT04671355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65657523|NCT04671355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65657524|NCT04671355|Cholinergic Agents|cholinergic agents|mesh-ancestor
65657525|NCT04671355|Glucocorticoids|glucocorticoids|mesh-ancestor
65657526|NCT04671355|Hormones|hormones|mesh-ancestor
65657527|NCT04671355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65657528|NCT03773107|Dexamethasone|dexamethasone|mesh-list
65657529|NCT03773107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65657530|NCT03773107|Antiemetics|antiemetics|mesh-ancestor
65657531|NCT03773107|Autonomic Agents|autonomic agents|mesh-ancestor
65657532|NCT03773107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65657533|NCT03773107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657534|NCT03773107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65657535|NCT03773107|Glucocorticoids|glucocorticoids|mesh-ancestor
65657536|NCT03773107|Hormones|hormones|mesh-ancestor
65657537|NCT03773107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65657538|NCT03773107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65657539|NCT03773107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657540|NCT03521492|Vitamin D|vitamin d|mesh-list
65657541|NCT03521492|Calcium|calcium|mesh-list
65657542|NCT03521492|Parathyroid Hormone|parathyroid hormone|mesh-list
65657543|NCT03521492|Hormones|hormones|mesh-list
65657544|NCT03521492|Vitamins|vitamins|mesh-ancestor
65657545|NCT03521492|Micronutrients|micronutrients|mesh-ancestor
65657546|NCT03521492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657547|NCT03521492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65657548|NCT03521492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65657549|NCT03521492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65657550|NCT03521414|Sevoflurane|sevoflurane|mesh-list
65657551|NCT03521414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65657552|NCT03521414|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65657553|NCT03521414|Anesthetics, General|anesthetics, general|mesh-ancestor
65657554|NCT03521414|Anesthetics|anesthetics|mesh-ancestor
65657555|NCT03521414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65657556|NCT03521414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657557|NCT00432094|Paclitaxel|paclitaxel|mesh-list
65657558|NCT00432094|Etoposide|etoposide|mesh-list
65657559|NCT00432094|Carboplatin|carboplatin|mesh-list
65657560|NCT00432094|Ifosfamide|ifosfamide|mesh-list
65657561|NCT00432094|Thiotepa|thiotepa|mesh-list
65657563|NCT00432094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65657564|NCT00432094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657565|NCT00432094|Tubulin Modulators|tubulin modulators|mesh-ancestor
65657566|NCT00432094|Antimitotic Agents|antimitotic agents|mesh-ancestor
65657567|NCT00432094|Mitosis Modulators|mitosis modulators|mesh-ancestor
65657568|NCT00432094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657569|NCT00432094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65657570|NCT00432094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65657571|NCT00432094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657572|NCT00432094|Immunologic Factors|immunologic factors|mesh-ancestor
65657573|NCT00432094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657574|NCT00432094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65657575|NCT00432094|Alkylating Agents|alkylating agents|mesh-ancestor
65657576|NCT00432094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65657577|NCT00432094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65657578|NCT00432094|Protective Agents|protective agents|mesh-ancestor
65657579|NCT05575518|Rifamycins|rifamycins|mesh-list
65657580|NCT05575518|Fluoroquinolones|fluoroquinolones|mesh-list
65657581|NCT05575518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65657582|NCT05575518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65657583|NCT05575518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65657584|NCT05575518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657585|NCT05575518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657586|NCT04562779|Naltrexone|naltrexone|mesh-list
65657587|NCT04562779|Ketamine|ketamine|mesh-list
65657588|NCT04562779|Analgesics|analgesics|mesh-ancestor
65657589|NCT04562779|Sensory System Agents|sensory system agents|mesh-ancestor
65657590|NCT04562779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65657591|NCT04562779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657592|NCT04562779|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65657593|NCT04562779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65657594|NCT04562779|Anesthetics, General|anesthetics, general|mesh-ancestor
65657595|NCT04562779|Anesthetics|anesthetics|mesh-ancestor
65657596|NCT04562779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65657597|NCT04562779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65657598|NCT04562779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65657599|NCT04562779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65657600|NCT04562779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657601|NCT04562779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65657602|NCT04562779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65657603|NCT03751761|Paclitaxel|paclitaxel|mesh-list
65657604|NCT03751761|Durvalumab|durvalumab|mesh-list
65657605|NCT03751761|Tremelimumab|tremelimumab|mesh-list
65657606|NCT03751761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65657607|NCT03751761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657608|NCT03751761|Tubulin Modulators|tubulin modulators|mesh-ancestor
65657609|NCT03751761|Antimitotic Agents|antimitotic agents|mesh-ancestor
65657610|NCT03751761|Mitosis Modulators|mitosis modulators|mesh-ancestor
65657611|NCT03751761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657612|NCT03751761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65657613|NCT03644823|Atezolizumab|atezolizumab|mesh-list
65657614|NCT03644823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657615|NCT00072358|Carbamide Peroxide|carbamide peroxide|mesh-list
65657616|NCT00072358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65657617|NCT00072358|Irinotecan|irinotecan|mesh-list
65657618|NCT00072358|Temozolomide|temozolomide|mesh-list
65657619|NCT00072358|Molgramostim|molgramostim|mesh-list
65657620|NCT00072358|Isotretinoin|isotretinoin|mesh-list
65657621|NCT00072358|Antibodies|antibodies|mesh-list
65657622|NCT00072358|Immunoglobulins|immunoglobulins|mesh-list
65657623|NCT00072358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65657624|NCT00072358|Sargramostim|sargramostim|mesh-list
65657625|NCT00072358|Immunoglobulin G|immunoglobulin g|mesh-list
65657626|NCT00072358|Immunologic Factors|immunologic factors|mesh-ancestor
65657627|NCT00072358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657628|NCT00072358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657629|NCT00072358|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65657630|NCT00072358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65657631|NCT00072358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657632|NCT00072358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657633|NCT00072358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65657634|NCT00072358|Alkylating Agents|alkylating agents|mesh-ancestor
65657635|NCT00072358|Dermatologic Agents|dermatologic agents|mesh-ancestor
65657636|NCT00072358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65657637|NCT00072358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65657638|NCT03104998|Ubiquinone|ubiquinone|mesh-list
65657639|NCT03104998|Coenzyme Q10|coenzyme q10|mesh-list
65657640|NCT03104998|Micronutrients|micronutrients|mesh-ancestor
65657641|NCT03104998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657642|NCT03104998|Vitamins|vitamins|mesh-ancestor
65657643|NCT03990766|Theophylline|theophylline|mesh-list
65657644|NCT03990766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65657645|NCT03990766|Autonomic Agents|autonomic agents|mesh-ancestor
65657646|NCT03990766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65657647|NCT03990766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657648|NCT03990766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65657649|NCT03990766|Respiratory System Agents|respiratory system agents|mesh-ancestor
65657650|NCT03990766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65657651|NCT03990766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657652|NCT03990766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657653|NCT03990766|Vasodilator Agents|vasodilator agents|mesh-ancestor
65657654|NCT03990766|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65657655|NCT03990766|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65657656|NCT03990766|Purinergic Agents|purinergic agents|mesh-ancestor
65657657|NCT03990766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65657658|NCT02294162|Ketamine|ketamine|mesh-list
65657659|NCT02294162|Analgesics|analgesics|mesh-ancestor
65657660|NCT02294162|Sensory System Agents|sensory system agents|mesh-ancestor
65657661|NCT02294162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65657662|NCT02294162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657663|NCT02294162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65657664|NCT02294162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65657665|NCT02294162|Anesthetics, General|anesthetics, general|mesh-ancestor
65657666|NCT02294162|Anesthetics|anesthetics|mesh-ancestor
65657667|NCT02294162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65657668|NCT02294162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65657669|NCT02294162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65657670|NCT02294162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65657671|NCT02294162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657672|NCT05176158|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65657673|NCT05176158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65657674|NCT05176158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65657675|NCT05176158|Analgesics|analgesics|mesh-ancestor
65657676|NCT05176158|Sensory System Agents|sensory system agents|mesh-ancestor
65657677|NCT05176158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65657678|NCT05176158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657679|NCT05176158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65657680|NCT05176158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65657681|NCT02294240|Folic Acid|folic acid|mesh-list
65657682|NCT02294240|Hematinics|hematinics|mesh-ancestor
65657683|NCT02294240|Vitamin B Complex|vitamin b complex|mesh-ancestor
65657684|NCT02294240|Vitamins|vitamins|mesh-ancestor
65657685|NCT02294240|Micronutrients|micronutrients|mesh-ancestor
65657686|NCT02294240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657687|NCT04305691|Ixazomib|ixazomib|mesh-list
65657688|NCT04305691|Glycine|glycine|mesh-list
65657689|NCT04305691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657690|NCT04305691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657691|NCT04305691|Protease Inhibitors|protease inhibitors|mesh-ancestor
65657692|NCT04305691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657693|NCT04305691|Glycine Agents|glycine agents|mesh-ancestor
65657694|NCT04305691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65657695|NCT04305691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657696|NCT04481724|Evening primrose oil|evening primrose oil|mesh-list
65657697|NCT04481724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65657698|NCT04481724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65657699|NCT04481724|Analgesics|analgesics|mesh-ancestor
65657700|NCT04481724|Sensory System Agents|sensory system agents|mesh-ancestor
65657701|NCT04481724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65657702|NCT04481724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657703|NCT04481724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65657704|NCT04481724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65657705|NCT04481724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65657706|NCT04481724|Antimetabolites|antimetabolites|mesh-ancestor
65657707|NCT04481724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657708|NCT04481724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65657709|NCT04481724|Dermatologic Agents|dermatologic agents|mesh-ancestor
65657710|NCT02298218|Meloxicam|meloxicam|mesh-list
65657711|NCT02298218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65657712|NCT02298218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65657713|NCT02298218|Analgesics|analgesics|mesh-ancestor
65657714|NCT02298218|Sensory System Agents|sensory system agents|mesh-ancestor
65657715|NCT02298218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65657716|NCT02298218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657717|NCT02298218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65657718|NCT02298218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65657719|NCT02298218|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65657720|NCT02298218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65657721|NCT02298218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657722|NCT02298218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657723|NCT03547830|Plerixafor|plerixafor|mesh-list
65657724|NCT03547830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65657725|NCT03547830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65657726|NCT03547830|Antiviral Agents|antiviral agents|mesh-ancestor
65657727|NCT03547830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65657728|NCT04390945|Capecitabine|capecitabine|mesh-list
65657729|NCT04390945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65657730|NCT04390945|Antimetabolites|antimetabolites|mesh-ancestor
65657731|NCT04390945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657732|NCT04390945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657733|NCT03734809|Pembrolizumab|pembrolizumab|mesh-list
65657734|NCT03734809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65657735|NCT03734809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657736|NCT02291666|Tolbutamide|tolbutamide|mesh-list
65657737|NCT02291666|Midazolam|midazolam|mesh-list
65657738|NCT02291666|Dextromethorphan|dextromethorphan|mesh-list
65657739|NCT02291666|Caffeine|caffeine|mesh-list
65657740|NCT02291666|Chlorzoxazone|chlorzoxazone|mesh-list
65657741|NCT02291666|Bupropion|bupropion|mesh-list
65657742|NCT02291666|Omeprazole|omeprazole|mesh-list
65657743|NCT02291666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65657744|NCT02291666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65657745|NCT02291666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65657746|NCT02291666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657747|NCT02291666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65657748|NCT02291666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65657749|NCT02291666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65657750|NCT02291666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65657751|NCT02291666|Anesthetics, General|anesthetics, general|mesh-ancestor
65657752|NCT02291666|Anesthetics|anesthetics|mesh-ancestor
65657753|NCT02291666|GABA Modulators|gaba modulators|mesh-ancestor
65657754|NCT02291666|GABA Agents|gaba agents|mesh-ancestor
65657755|NCT02291666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65657756|NCT02291666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657757|NCT02291666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65657758|NCT02291666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65657759|NCT02291666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657760|NCT02291666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65657761|NCT02291666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65657762|NCT02291666|Purinergic Agents|purinergic agents|mesh-ancestor
65657763|NCT02291666|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65657764|NCT02291666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65657765|NCT02291666|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65657766|NCT02291666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65657767|NCT02291666|Antidepressive Agents|antidepressive agents|mesh-ancestor
65657768|NCT02291666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65657769|NCT02291666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65657770|NCT02291666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65657771|NCT02291666|Dopamine Agents|dopamine agents|mesh-ancestor
65657772|NCT02291666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65657773|NCT02291666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65657774|NCT02291666|Antitussive Agents|antitussive agents|mesh-ancestor
65657775|NCT02291666|Respiratory System Agents|respiratory system agents|mesh-ancestor
65657776|NCT02291666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65657777|NCT02291666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65657778|NCT02291666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65657779|NCT02291666|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65657780|NCT02291666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65657781|NCT02291666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65657782|NCT03102658|Micafungin|micafungin|mesh-list
65657783|NCT03102658|Antifungal Agents|antifungal agents|mesh-ancestor
65657784|NCT03102658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65657785|NCT02646748|Pembrolizumab|pembrolizumab|mesh-list
65657786|NCT02646748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65657787|NCT02646748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657788|NCT03624985|Lidocaine|lidocaine|mesh-list
65657789|NCT03624985|Anesthetics, Local|anesthetics, local|mesh-ancestor
65657790|NCT03624985|Anesthetics|anesthetics|mesh-ancestor
65657791|NCT03624985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65657792|NCT03624985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657793|NCT03624985|Sensory System Agents|sensory system agents|mesh-ancestor
65657794|NCT03624985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65657795|NCT03624985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65657796|NCT03624985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65657797|NCT03624985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65657798|NCT03624985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65657799|NCT03624985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657800|NCT03521024|Lithium Carbonate|lithium carbonate|mesh-list
65657801|NCT03521024|Ether|ether|mesh-list
65657802|NCT03521024|Antidepressive Agents|antidepressive agents|mesh-ancestor
65657803|NCT03521024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65657804|NCT03521024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657805|NCT03521024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657806|NCT03521024|Antimanic Agents|antimanic agents|mesh-ancestor
65657807|NCT03521024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65657808|NCT03521024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65657809|NCT03521024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657810|NCT03521024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65657811|NCT03521024|Anesthetics, General|anesthetics, general|mesh-ancestor
65657812|NCT03521024|Anesthetics|anesthetics|mesh-ancestor
65657813|NCT02635672|Pembrolizumab|pembrolizumab|mesh-list
65657814|NCT02635672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65657815|NCT02635672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657816|NCT02294552|Mycophenolic Acid|mycophenolic acid|mesh-list
65657817|NCT02294552|Cyclophosphamide|cyclophosphamide|mesh-list
65657818|NCT02294552|Busulfan|busulfan|mesh-list
65657819|NCT02294552|Fludarabine|fludarabine|mesh-list
65657820|NCT02294552|Fludarabine phosphate|fludarabine phosphate|mesh-list
65657821|NCT02294552|Tacrolimus|tacrolimus|mesh-list
65657822|NCT02294552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65657823|NCT02294552|Immunologic Factors|immunologic factors|mesh-ancestor
65657824|NCT02294552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657825|NCT02294552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65657826|NCT02294552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65657827|NCT02294552|Alkylating Agents|alkylating agents|mesh-ancestor
65657828|NCT02294552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657829|NCT02294552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657830|NCT02294552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65657831|NCT02294552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65657832|NCT02294552|Antimetabolites|antimetabolites|mesh-ancestor
65657833|NCT02294552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65657834|NCT02294552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657835|NCT02294552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65657836|NCT02294552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65657837|NCT02294552|Antitubercular Agents|antitubercular agents|mesh-ancestor
65657838|NCT02294552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65657839|NCT02294552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65657840|NCT05574036|Vitamin E|vitamin e|mesh-list
65657841|NCT05574036|Febuxostat|febuxostat|mesh-list
65657842|NCT05574036|Vitamins|vitamins|mesh-ancestor
65657843|NCT05574036|Micronutrients|micronutrients|mesh-ancestor
65657844|NCT05574036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657845|NCT05574036|Antioxidants|antioxidants|mesh-ancestor
65657846|NCT05574036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657847|NCT05574036|Protective Agents|protective agents|mesh-ancestor
65657848|NCT05574036|Gout Suppressants|gout suppressants|mesh-ancestor
65657849|NCT05574036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65657850|NCT03517982|Mycophenolic Acid|mycophenolic acid|mesh-list
65657851|NCT03517982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65657852|NCT03517982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657853|NCT03517982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65657854|NCT03517982|Antitubercular Agents|antitubercular agents|mesh-ancestor
65657855|NCT03517982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65657856|NCT03517982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65657857|NCT03517982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657858|NCT03517982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657859|NCT03869944|Lamivudine|lamivudine|mesh-list
65657860|NCT03869944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65657861|NCT03869944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65657862|NCT03869944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657863|NCT03869944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657864|NCT03869944|Antiviral Agents|antiviral agents|mesh-ancestor
65657865|NCT03869944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65657867|NCT03869944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65657868|NCT03864094|Phenylephrine|phenylephrine|mesh-list
65657869|NCT03864094|Oxymetazoline|oxymetazoline|mesh-list
65657870|NCT03864094|Norepinephrine|norepinephrine|mesh-list
65657871|NCT03864094|Ephedrine|ephedrine|mesh-list
65657872|NCT03864094|Pseudoephedrine|pseudoephedrine|mesh-list
65657873|NCT03864094|Remifentanil|remifentanil|mesh-list
65657874|NCT03864094|Propofol|propofol|mesh-list
65657875|NCT03864094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65657876|NCT03864094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65657877|NCT03864094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657878|NCT03864094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65657879|NCT03864094|Anesthetics, General|anesthetics, general|mesh-ancestor
65657880|NCT03864094|Anesthetics|anesthetics|mesh-ancestor
65657881|NCT03864094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65657882|NCT03864094|Narcotics|narcotics|mesh-ancestor
65657883|NCT03864094|Analgesics|analgesics|mesh-ancestor
65657884|NCT03864094|Sensory System Agents|sensory system agents|mesh-ancestor
65657885|NCT03864094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65657886|NCT03864094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65657887|NCT03864094|Mydriatics|mydriatics|mesh-ancestor
65657888|NCT03864094|Autonomic Agents|autonomic agents|mesh-ancestor
65657889|NCT03864094|Sympathomimetics|sympathomimetics|mesh-ancestor
65657890|NCT03864094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65657891|NCT03864094|Nasal Decongestants|nasal decongestants|mesh-ancestor
65657892|NCT03864094|Respiratory System Agents|respiratory system agents|mesh-ancestor
65657893|NCT03864094|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65657894|NCT03864094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65657895|NCT03864094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65657896|NCT03864094|Adrenergic Agents|adrenergic agents|mesh-ancestor
65657897|NCT03864094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65657898|NCT03864094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657899|NCT03864094|Protective Agents|protective agents|mesh-ancestor
65657900|NCT03864094|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65657901|NCT03864094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65657902|NCT03864094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65657903|NCT05573802|Dexamethasone|dexamethasone|mesh-list
65657904|NCT05573802|Lenalidomide|lenalidomide|mesh-list
65657905|NCT05573802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65657906|NCT05573802|Antiemetics|antiemetics|mesh-ancestor
65657907|NCT05573802|Autonomic Agents|autonomic agents|mesh-ancestor
65657908|NCT05573802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65657909|NCT05573802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657910|NCT05573802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65657911|NCT05573802|Glucocorticoids|glucocorticoids|mesh-ancestor
65657912|NCT05573802|Hormones|hormones|mesh-ancestor
65657913|NCT05573802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65657914|NCT05573802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65657915|NCT05573802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657916|NCT05573802|Immunologic Factors|immunologic factors|mesh-ancestor
65657917|NCT05573802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65657918|NCT05573802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65657919|NCT05573802|Growth Substances|growth substances|mesh-ancestor
65657920|NCT05573802|Growth Inhibitors|growth inhibitors|mesh-ancestor
65657921|NCT04435522|Maraviroc|maraviroc|mesh-list
65657922|NCT04435522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65657923|NCT04435522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65657924|NCT04435522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657925|NCT04435522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65657926|NCT04435522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65657927|NCT04435522|Antiviral Agents|antiviral agents|mesh-ancestor
65657928|NCT04435522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65657929|NCT04435522|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65657930|NCT03575325|Cytarabine|cytarabine|mesh-list
65657931|NCT03575325|Daunorubicin|daunorubicin|mesh-list
65657932|NCT03575325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65657933|NCT03575325|Antimetabolites|antimetabolites|mesh-ancestor
65657934|NCT03575325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657935|NCT03575325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657936|NCT03575325|Antiviral Agents|antiviral agents|mesh-ancestor
65657937|NCT03575325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65657938|NCT03575325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65657939|NCT03575325|Immunologic Factors|immunologic factors|mesh-ancestor
65657940|NCT03575325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657941|NCT03575325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65657942|NCT03575325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65657943|NCT03575325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65657944|NCT03575325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657946|NCT03843970|Levobupivacaine|levobupivacaine|mesh-list
65657947|NCT03843970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65657948|NCT03843970|Anesthetics, Local|anesthetics, local|mesh-ancestor
65657949|NCT03843970|Anesthetics|anesthetics|mesh-ancestor
65657950|NCT03843970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65657951|NCT03843970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657952|NCT03843970|Sensory System Agents|sensory system agents|mesh-ancestor
65657953|NCT03843970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65657954|NCT03043651|Treprostinil|treprostinil|mesh-list
65657955|NCT03043651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65657956|NCT04353024|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
65657957|NCT04353024|Hallucinogens|hallucinogens|mesh-ancestor
65657958|NCT04353024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657959|NCT04353024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65657960|NCT04353024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65657961|NCT04353024|Serotonin Agents|serotonin agents|mesh-ancestor
65657962|NCT04353024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65657963|NCT04353024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657964|NCT04353024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65657965|NCT04465292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65657966|NCT04465292|Immunologic Factors|immunologic factors|mesh-ancestor
65657967|NCT04465292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657968|NCT02298530|Caffeine|caffeine|mesh-list
65657969|NCT02298530|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65657970|NCT02298530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657971|NCT02298530|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65657972|NCT02298530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657973|NCT02298530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657974|NCT02298530|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65657975|NCT02298530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65657976|NCT02298530|Purinergic Agents|purinergic agents|mesh-ancestor
65657977|NCT02298530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65657978|NCT05051436|Tadalafil|tadalafil|mesh-list
65657979|NCT05051436|Mirabegron|mirabegron|mesh-list
65657980|NCT05051436|Vasodilator Agents|vasodilator agents|mesh-ancestor
65657981|NCT05051436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65657982|NCT05051436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65657983|NCT05051436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65657984|NCT05051436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65657985|NCT05051436|Urological Agents|urological agents|mesh-ancestor
65657986|NCT05051436|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65657987|NCT05051436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65657988|NCT05051436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65657989|NCT05051436|Adrenergic Agents|adrenergic agents|mesh-ancestor
65657990|NCT05051436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65657991|NCT05051436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657992|NCT03644589|Pembrolizumab|pembrolizumab|mesh-list
65657993|NCT03644589|Immunoglobulins|immunoglobulins|mesh-list
65657994|NCT03644589|Immunoglobulin G|immunoglobulin g|mesh-list
65657995|NCT03644589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65657996|NCT03644589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65657997|NCT03644589|Immunologic Factors|immunologic factors|mesh-ancestor
65657998|NCT03644589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65657999|NCT03514550|Propofol|propofol|mesh-list
65658000|NCT03514550|Sevoflurane|sevoflurane|mesh-list
65658001|NCT03514550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65658002|NCT03514550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65658003|NCT03514550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658004|NCT03514550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65658005|NCT03514550|Anesthetics, General|anesthetics, general|mesh-ancestor
65658006|NCT03514550|Anesthetics|anesthetics|mesh-ancestor
65658007|NCT03514550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65658008|NCT03514550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65658009|NCT04173988|Cyclophosphamide|cyclophosphamide|mesh-list
65658010|NCT04173988|Fludarabine|fludarabine|mesh-list
65658011|NCT04173988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65658012|NCT04173988|Immunologic Factors|immunologic factors|mesh-ancestor
65658013|NCT04173988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658014|NCT04173988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65658015|NCT04173988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65658016|NCT04173988|Alkylating Agents|alkylating agents|mesh-ancestor
65658017|NCT04173988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658018|NCT04173988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658019|NCT04173988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65658020|NCT01344759|Dexmedetomidine|dexmedetomidine|mesh-list
65658022|NCT01344759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65658023|NCT01344759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65658024|NCT01344759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658025|NCT01344759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65658026|NCT01344759|Anesthetics, General|anesthetics, general|mesh-ancestor
65658027|NCT01344759|Anesthetics|anesthetics|mesh-ancestor
65658028|NCT01344759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65658029|NCT01344759|Analgesics|analgesics|mesh-ancestor
65658030|NCT01344759|Sensory System Agents|sensory system agents|mesh-ancestor
65658031|NCT01344759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65658032|NCT01344759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65658033|NCT01344759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65658034|NCT01344759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65658035|NCT01344759|Adrenergic Agents|adrenergic agents|mesh-ancestor
65658036|NCT01344759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65658037|NCT01344759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658038|NCT04299438|Propranolol|propranolol|mesh-list
65658039|NCT04299438|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65658040|NCT04299438|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65658041|NCT04299438|Adrenergic Agents|adrenergic agents|mesh-ancestor
65658042|NCT04299438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65658043|NCT04299438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658044|NCT04299438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658045|NCT04299438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65658046|NCT04299438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65658047|NCT04299438|Vasodilator Agents|vasodilator agents|mesh-ancestor
65658048|NCT02298764|Psychotropic Drugs|psychotropic drugs|mesh-list
65658049|NCT03517748|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65658050|NCT03517748|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65658051|NCT03517670|Milrinone|milrinone|mesh-list
65658052|NCT03517670|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65658053|NCT03517670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65658054|NCT03517670|Vasodilator Agents|vasodilator agents|mesh-ancestor
65658055|NCT03517670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65658056|NCT03517670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65658057|NCT03517670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658058|NCT03517670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658059|NCT03517670|Protective Agents|protective agents|mesh-ancestor
65658060|NCT03517670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658061|NCT03316573|Pembrolizumab|pembrolizumab|mesh-list
65658062|NCT03316573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65658063|NCT03316573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658064|NCT00109668|Beclomethasone|beclomethasone|mesh-list
65658065|NCT00109668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65658066|NCT00109668|Glucocorticoids|glucocorticoids|mesh-ancestor
65658067|NCT00109668|Hormones|hormones|mesh-ancestor
65658068|NCT00109668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65658069|NCT00109668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658070|NCT00109668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65658071|NCT00109668|Respiratory System Agents|respiratory system agents|mesh-ancestor
65658072|NCT03104140|Ketamine|ketamine|mesh-list
65658073|NCT03104140|Thiopental|thiopental|mesh-list
65658074|NCT03104140|Analgesics|analgesics|mesh-ancestor
65658075|NCT03104140|Sensory System Agents|sensory system agents|mesh-ancestor
65658076|NCT03104140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65658077|NCT03104140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658078|NCT03104140|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65658079|NCT03104140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65658080|NCT03104140|Anesthetics, General|anesthetics, general|mesh-ancestor
65658081|NCT03104140|Anesthetics|anesthetics|mesh-ancestor
65658082|NCT03104140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65658083|NCT03104140|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65658084|NCT03104140|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65658085|NCT03104140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65658086|NCT03104140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658087|NCT03104140|Anticonvulsants|anticonvulsants|mesh-ancestor
65658088|NCT03104140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65658089|NCT03104140|GABA Modulators|gaba modulators|mesh-ancestor
65658090|NCT03104140|GABA Agents|gaba agents|mesh-ancestor
65658091|NCT03520478|Bicalutamide|bicalutamide|mesh-list
65658092|NCT03520478|Androgen Antagonists|androgen antagonists|mesh-ancestor
65658093|NCT03520478|Hormone Antagonists|hormone antagonists|mesh-ancestor
65658094|NCT03520478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65658095|NCT03520478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658096|NCT03520478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658097|NCT00102648|Temozolomide|temozolomide|mesh-list
65658098|NCT00102648|Lonafarnib|lonafarnib|mesh-list
65658099|NCT00102648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65658100|NCT00102648|Alkylating Agents|alkylating agents|mesh-ancestor
65658101|NCT00102648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658102|NCT00102648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658103|NCT00102648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658104|NCT03290287|Bromides|bromides|mesh-list
65658105|NCT03290287|Anticonvulsants|anticonvulsants|mesh-ancestor
65658106|NCT02253888|Ritonavir|ritonavir|mesh-list
65658107|NCT02253888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65658108|NCT02253888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65658109|NCT02253888|Protease Inhibitors|protease inhibitors|mesh-ancestor
65658110|NCT02253888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658111|NCT02253888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658112|NCT02253888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65658113|NCT02253888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65658114|NCT02253888|Antiviral Agents|antiviral agents|mesh-ancestor
65658115|NCT02253888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65658116|NCT02253888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65658117|NCT02253888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65658118|NCT05430802|Pemetrexed|pemetrexed|mesh-list
65658119|NCT05430802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658120|NCT05430802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658121|NCT05430802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658122|NCT05430802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65658123|NCT05430802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65658124|NCT05524038|Dexamethasone|dexamethasone|mesh-list
65658125|NCT05524038|Dexamethasone acetate|dexamethasone acetate|mesh-list
65658126|NCT05524038|Bupivacaine|bupivacaine|mesh-list
65658127|NCT05524038|BB 1101|bb 1101|mesh-list
65658128|NCT05524038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65658129|NCT05524038|Antiemetics|antiemetics|mesh-ancestor
65658130|NCT05524038|Autonomic Agents|autonomic agents|mesh-ancestor
65658131|NCT05524038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65658132|NCT05524038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658133|NCT05524038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65658134|NCT05524038|Glucocorticoids|glucocorticoids|mesh-ancestor
65658135|NCT05524038|Hormones|hormones|mesh-ancestor
65658136|NCT05524038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65658137|NCT05524038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65658138|NCT05524038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658139|NCT05524038|Protease Inhibitors|protease inhibitors|mesh-ancestor
65658140|NCT05524038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658141|NCT05524038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658142|NCT05524038|Anesthetics, Local|anesthetics, local|mesh-ancestor
65658143|NCT05524038|Anesthetics|anesthetics|mesh-ancestor
65658144|NCT05524038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65658145|NCT05524038|Sensory System Agents|sensory system agents|mesh-ancestor
65658146|NCT03240835|Docetaxel|docetaxel|mesh-list
65658147|NCT03240835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658148|NCT03240835|Tubulin Modulators|tubulin modulators|mesh-ancestor
65658149|NCT03240835|Antimitotic Agents|antimitotic agents|mesh-ancestor
65658150|NCT03240835|Mitosis Modulators|mitosis modulators|mesh-ancestor
65658151|NCT03240835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658152|NCT04118868|Pembrolizumab|pembrolizumab|mesh-list
65658153|NCT04118868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65658154|NCT04118868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658155|NCT04900350|Azacitidine|azacitidine|mesh-list
65658156|NCT04900350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65658157|NCT04900350|Antimetabolites|antimetabolites|mesh-ancestor
65658158|NCT04900350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658159|NCT04900350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658160|NCT04900350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658161|NCT02292290|Pioglitazone|pioglitazone|mesh-list
65658162|NCT02292290|Liraglutide|liraglutide|mesh-list
65658163|NCT02292290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65658164|NCT02292290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658165|NCT02292290|Incretins|incretins|mesh-ancestor
65658166|NCT02292290|Hormones|hormones|mesh-ancestor
65658167|NCT02292290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65658168|NCT02299232|Dexmedetomidine|dexmedetomidine|mesh-list
65658169|NCT02299232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65658170|NCT02299232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65658171|NCT02299232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658172|NCT02299232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65658173|NCT02299232|Analgesics|analgesics|mesh-ancestor
65658174|NCT02299232|Sensory System Agents|sensory system agents|mesh-ancestor
65658175|NCT02299232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65658176|NCT02299232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65658177|NCT02299232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65658178|NCT02299232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65658179|NCT02299232|Adrenergic Agents|adrenergic agents|mesh-ancestor
65658180|NCT02299232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65658181|NCT02299232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658182|NCT02963493|Dexamethasone|dexamethasone|mesh-list
65658183|NCT02963493|Melphalan|melphalan|mesh-list
65658184|NCT02963493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65658185|NCT02963493|Antiemetics|antiemetics|mesh-ancestor
65658186|NCT02963493|Autonomic Agents|autonomic agents|mesh-ancestor
65658187|NCT02963493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65658188|NCT02963493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658189|NCT02963493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65658190|NCT02963493|Glucocorticoids|glucocorticoids|mesh-ancestor
65658191|NCT02963493|Hormones|hormones|mesh-ancestor
65658192|NCT02963493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65658193|NCT02963493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65658194|NCT02963493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658195|NCT02963493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65658196|NCT02963493|Alkylating Agents|alkylating agents|mesh-ancestor
65658197|NCT02963493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658198|NCT02963493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65658199|NCT02963493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65658200|NCT02963493|Immunologic Factors|immunologic factors|mesh-ancestor
65658201|NCT02299310|Valsartan|valsartan|mesh-list
65658202|NCT02299310|Perindopril|perindopril|mesh-list
65658203|NCT02299310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65658204|NCT02299310|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65658205|NCT02299310|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65658206|NCT02299310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658207|NCT02299310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65658208|NCT02299310|Protease Inhibitors|protease inhibitors|mesh-ancestor
65658209|NCT02299310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658210|NCT03519776|Progesterone|progesterone|mesh-list
65658211|NCT03519776|Progestins|progestins|mesh-ancestor
65658212|NCT03519776|Hormones|hormones|mesh-ancestor
65658213|NCT03519776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65658214|NCT03519776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658215|NCT03643497|Meropenem|meropenem|mesh-list
65658216|NCT03643497|Linezolid|linezolid|mesh-list
65658217|NCT03643497|Anti-Infective Agents|anti-infective agents|mesh-list
65658218|NCT03643497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65658219|NCT03643497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65658220|NCT03643497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658221|NCT03643497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658222|NCT02295566|Nitric Oxide|nitric oxide|mesh-list
65658223|NCT02295566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65658224|NCT02295566|Autonomic Agents|autonomic agents|mesh-ancestor
65658225|NCT02295566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65658226|NCT02295566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658227|NCT02295566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65658228|NCT02295566|Respiratory System Agents|respiratory system agents|mesh-ancestor
65658229|NCT02295566|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65658230|NCT02295566|Antioxidants|antioxidants|mesh-ancestor
65658231|NCT02295566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658232|NCT02295566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65658233|NCT02295566|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65658234|NCT02295566|Vasodilator Agents|vasodilator agents|mesh-ancestor
65658235|NCT02295566|Gasotransmitters|gasotransmitters|mesh-ancestor
65658236|NCT02295566|Protective Agents|protective agents|mesh-ancestor
65658237|NCT05283681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65658238|NCT05283681|Immunologic Factors|immunologic factors|mesh-ancestor
65658239|NCT05283681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658240|NCT03513458|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65658241|NCT03513458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65658243|NCT03516656|Calcium heparin|calcium heparin|mesh-list
65658244|NCT03516656|Anticoagulants|anticoagulants|mesh-ancestor
65658245|NCT03516656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65658246|NCT03516656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65658247|NCT03516656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658248|NCT03738397|Upadacitinib|upadacitinib|mesh-list
65658249|NCT03738397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65658250|NCT03738397|Immunologic Factors|immunologic factors|mesh-ancestor
65658251|NCT03738397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658252|NCT03738397|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65658253|NCT03738397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65658254|NCT03738397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658255|NCT03738397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658256|NCT03738397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65658257|NCT03519542|Sunitinib|sunitinib|mesh-list
65658258|NCT03519542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658259|NCT03519542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65658260|NCT03519542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65658261|NCT03519542|Growth Substances|growth substances|mesh-ancestor
65658262|NCT03519542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658263|NCT03519542|Growth Inhibitors|growth inhibitors|mesh-ancestor
65658264|NCT03519542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65658265|NCT03519542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658266|NCT03519542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658267|NCT03516500|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65658268|NCT03516500|Hematinics|hematinics|mesh-ancestor
65658269|NCT02293148|Moxifloxacin|moxifloxacin|mesh-list
65658270|NCT02293148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65658271|NCT02293148|Glycine|glycine|mesh-list
65658272|NCT02293148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65658273|NCT02293148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65658274|NCT02293148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65658275|NCT02293148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65658276|NCT02293148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658277|NCT02293148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268253|NCT05429684|Capecitabine|capecitabine|mesh-list
65658278|NCT02293148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658279|NCT02293148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65658280|NCT02293148|Contraceptive Agents|contraceptive agents|mesh-ancestor
65658281|NCT02293148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65658282|NCT02293148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658283|NCT02293148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65658284|NCT02293148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65658285|NCT02293148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65658286|NCT02293148|Glycine Agents|glycine agents|mesh-ancestor
65658287|NCT02293148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65658288|NCT03519386|Travoprost|travoprost|mesh-list
65658289|NCT03519386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65658290|NCT03519386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65658291|NCT03519386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65658292|NCT03519152|Diclofenac|diclofenac|mesh-list
65658293|NCT03519152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65658294|NCT03519152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65658295|NCT03519152|Analgesics|analgesics|mesh-ancestor
65658296|NCT03519152|Sensory System Agents|sensory system agents|mesh-ancestor
65658297|NCT03519152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65658298|NCT03519152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658299|NCT03519152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65658300|NCT03519152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65658301|NCT03519152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65658302|NCT03519152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658303|NCT03519152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658304|NCT02959983|Eluxadoline|eluxadoline|mesh-list
65658305|NCT02959983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65658306|NCT03516188|Antacids|antacids|mesh-list
65658307|NCT03516188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658308|NCT03516188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65658309|NCT03512990|Bupivacaine|bupivacaine|mesh-list
65658310|NCT03512990|Anesthetics, Local|anesthetics, local|mesh-ancestor
65658311|NCT03512990|Anesthetics|anesthetics|mesh-ancestor
65658312|NCT03512990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65658313|NCT03512990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658314|NCT03512990|Sensory System Agents|sensory system agents|mesh-ancestor
65658315|NCT03512990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65658316|NCT03512834|Paclitaxel|paclitaxel|mesh-list
65658317|NCT03512834|Avelumab|avelumab|mesh-list
65658318|NCT03512834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65658319|NCT03512834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658320|NCT03512834|Tubulin Modulators|tubulin modulators|mesh-ancestor
65658321|NCT03512834|Antimitotic Agents|antimitotic agents|mesh-ancestor
65658322|NCT03512834|Mitosis Modulators|mitosis modulators|mesh-ancestor
65658323|NCT03512834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658324|NCT03512834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65658325|NCT03640221|Ertugliflozin|ertugliflozin|mesh-list
65658326|NCT03640221|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65658327|NCT03640221|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65658328|NCT03640221|Antihypertensive Agents|antihypertensive agents|mesh-list
65658329|NCT03640221|Diuretics|diuretics|mesh-ancestor
65658330|NCT03640221|Natriuretic Agents|natriuretic agents|mesh-ancestor
65658331|NCT03640221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658332|NCT03640221|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65658333|NCT03640221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65658334|NCT03640221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658335|NCT03640221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65658336|NCT03518528|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65658337|NCT03518528|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65658338|NCT03518528|Estradiol|estradiol|mesh-list
65658339|NCT03518528|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65658340|NCT03518528|Estrogens|estrogens|mesh-ancestor
65658341|NCT03518528|Hormones|hormones|mesh-ancestor
65658342|NCT03518528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65658343|NCT03518528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658344|NCT03518528|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65658345|NCT03518528|Contraceptive Agents|contraceptive agents|mesh-ancestor
65658346|NCT03518528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65658347|NCT03518528|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65658348|NCT03515798|Paclitaxel|paclitaxel|mesh-list
65658349|NCT03515798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65658350|NCT03515798|Cyclophosphamide|cyclophosphamide|mesh-list
65658351|NCT03515798|Pembrolizumab|pembrolizumab|mesh-list
65658352|NCT03515798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65658353|NCT03515798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658354|NCT03515798|Tubulin Modulators|tubulin modulators|mesh-ancestor
65658355|NCT03515798|Antimitotic Agents|antimitotic agents|mesh-ancestor
65658356|NCT03515798|Mitosis Modulators|mitosis modulators|mesh-ancestor
65658357|NCT03515798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658358|NCT03515798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65658359|NCT03515798|Immunologic Factors|immunologic factors|mesh-ancestor
65658360|NCT03515798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658361|NCT03515798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65658362|NCT03515798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65658363|NCT03515798|Alkylating Agents|alkylating agents|mesh-ancestor
65658364|NCT03515798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65658365|NCT03515798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65658366|NCT03041701|Dasatinib|dasatinib|mesh-list
65658367|NCT03041701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658368|NCT03041701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658369|NCT03041701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65658370|NCT03041701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658371|NCT02293694|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65658372|NCT02293694|Medroxyprogesterone|medroxyprogesterone|mesh-list
65658373|NCT02293694|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65658374|NCT02293694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65658375|NCT02293694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65658376|NCT02293694|Contraceptive Agents|contraceptive agents|mesh-ancestor
65658377|NCT02293694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65658378|NCT02293694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658379|NCT02293694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65658380|NCT02293694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65658381|NCT02293694|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65658382|NCT02293694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65658383|NCT02293694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658384|NCT02956629|Ribavirin|ribavirin|mesh-list
65658385|NCT02956629|Uprifosbuvir|uprifosbuvir|mesh-list
65658386|NCT02956629|Ruzasvir|ruzasvir|mesh-list
65455828|NCT01166932|Oxacillin|oxacillin|mesh-list
65658387|NCT02956629|Antimetabolites|antimetabolites|mesh-ancestor
65658388|NCT02956629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658389|NCT02956629|Antiviral Agents|antiviral agents|mesh-ancestor
65658390|NCT02956629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65658391|NCT02297204|Aflibercept|aflibercept|mesh-list
65658392|NCT02297204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65658393|NCT02297204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65658394|NCT02297204|Growth Substances|growth substances|mesh-ancestor
65658395|NCT02297204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658396|NCT02297204|Growth Inhibitors|growth inhibitors|mesh-ancestor
65658397|NCT02297204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658398|NCT02294006|Metformin|metformin|mesh-list
65658399|NCT02294006|Everolimus|everolimus|mesh-list
65658400|NCT02294006|Octreotide|octreotide|mesh-list
65658401|NCT02294006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65658402|NCT02294006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658403|NCT02294006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658404|NCT02294006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65658405|NCT02294006|Immunologic Factors|immunologic factors|mesh-ancestor
65658406|NCT02294006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65658407|NCT02294006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65658408|NCT02294084|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65658409|NCT02294084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65658410|NCT02294084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658411|NCT02294084|Incretins|incretins|mesh-ancestor
65658412|NCT02294084|Hormones|hormones|mesh-ancestor
65658413|NCT02294084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65658414|NCT02294084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65658415|NCT02294084|Protease Inhibitors|protease inhibitors|mesh-ancestor
65658416|NCT02294084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658417|NCT02294084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658418|NCT01597258|Crizotinib|crizotinib|mesh-list
65658419|NCT01597258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658420|NCT01597258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65658421|NCT01597258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268256|NCT05429684|Letrozole|letrozole|mesh-list
65658422|NCT01597258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658423|NCT02958267|Hyaluronic Acid|hyaluronic acid|mesh-list
65658424|NCT02958267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65658425|NCT02958267|Immunologic Factors|immunologic factors|mesh-ancestor
65658426|NCT02958267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658427|NCT02958267|Viscosupplements|viscosupplements|mesh-ancestor
65658428|NCT02958267|Protective Agents|protective agents|mesh-ancestor
65658429|NCT02302430|Oxytocin|oxytocin|mesh-list
65658430|NCT02302430|Oxytocics|oxytocics|mesh-ancestor
65658431|NCT02302430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65658432|NCT02302430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658433|NCT02300948|Folic Acid|folic acid|mesh-list
65658434|NCT02300948|Vitamin B Complex|vitamin b complex|mesh-list
65658435|NCT02300948|Hematinics|hematinics|mesh-ancestor
65658436|NCT02300948|Vitamins|vitamins|mesh-ancestor
65658437|NCT02300948|Micronutrients|micronutrients|mesh-ancestor
65658438|NCT02300948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658439|NCT02302508|Clopidogrel|clopidogrel|mesh-list
65658440|NCT02302508|Ticagrelor|ticagrelor|mesh-list
65658441|NCT02302508|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65658442|NCT02302508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65658443|NCT02302508|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65658444|NCT02302508|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65658445|NCT02302508|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65658446|NCT02302508|Purinergic Agents|purinergic agents|mesh-ancestor
65658447|NCT02302508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65658448|NCT02302508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658449|NCT02302508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658450|NCT02297594|Ziresovir|ziresovir|mesh-list
65658451|NCT02297594|Antiviral Agents|antiviral agents|mesh-ancestor
65658452|NCT02297594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65658453|NCT02301026|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65658454|NCT02301026|Hematinics|hematinics|mesh-ancestor
65658455|NCT01952574|Erenumab|erenumab|mesh-list
65658456|NCT01952574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65658457|NCT01952574|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65658458|NCT01952574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658459|NCT01952574|Analgesics|analgesics|mesh-ancestor
65658460|NCT01952574|Sensory System Agents|sensory system agents|mesh-ancestor
65658461|NCT01952574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65658462|NCT01952574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658463|NCT01952574|Immunologic Factors|immunologic factors|mesh-ancestor
65658464|NCT02302586|Morphine|morphine|mesh-list
65658465|NCT02302586|Bupivacaine|bupivacaine|mesh-list
65658466|NCT02302586|Anesthetics, Local|anesthetics, local|mesh-ancestor
65658467|NCT02302586|Anesthetics|anesthetics|mesh-ancestor
65658468|NCT02302586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65658469|NCT02302586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658470|NCT02302586|Sensory System Agents|sensory system agents|mesh-ancestor
65658471|NCT02302586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65658472|NCT02302586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65658473|NCT02302586|Narcotics|narcotics|mesh-ancestor
65658474|NCT02302586|Analgesics|analgesics|mesh-ancestor
65658475|NCT04484272|Analgesics, Opioid|analgesics, opioid|mesh-list
65658476|NCT04484272|Narcotics|narcotics|mesh-ancestor
65658477|NCT04484272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65658478|NCT04484272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658479|NCT04484272|Analgesics|analgesics|mesh-ancestor
65658480|NCT04484272|Sensory System Agents|sensory system agents|mesh-ancestor
65658481|NCT04484272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65658482|NCT01551472|Vitamin E|vitamin e|mesh-list
65658483|NCT01551472|Vitamins|vitamins|mesh-ancestor
65658484|NCT01551472|Micronutrients|micronutrients|mesh-ancestor
65658485|NCT01551472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658486|NCT01551472|Antioxidants|antioxidants|mesh-ancestor
65658487|NCT01551472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658488|NCT01551472|Protective Agents|protective agents|mesh-ancestor
65658489|NCT02254044|Maytansine|maytansine|mesh-list
65658490|NCT02254044|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
65658491|NCT02254044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65658492|NCT02254044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658493|NCT02254044|Tubulin Modulators|tubulin modulators|mesh-ancestor
65658494|NCT02254044|Antimitotic Agents|antimitotic agents|mesh-ancestor
65658495|NCT02254044|Mitosis Modulators|mitosis modulators|mesh-ancestor
65658496|NCT02254044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268259|NCT05429684|Antibodies|antibodies|mesh-list
65658497|NCT02254044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65658498|NCT02959437|Pembrolizumab|pembrolizumab|mesh-list
65658499|NCT02959437|Azacitidine|azacitidine|mesh-list
65658500|NCT02959437|INCB057643|incb057643|mesh-list
65658501|NCT02959437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65658502|NCT02959437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658503|NCT02959437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65658504|NCT02959437|Antimetabolites|antimetabolites|mesh-ancestor
65658505|NCT02959437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658506|NCT02959437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658507|NCT02297906|Ketorolac|ketorolac|mesh-list
65658508|NCT02297906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65658509|NCT02297906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65658510|NCT02297906|Analgesics|analgesics|mesh-ancestor
65658511|NCT02297906|Sensory System Agents|sensory system agents|mesh-ancestor
65658512|NCT02297906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65658513|NCT02297906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658514|NCT02297906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65658515|NCT02297906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65658516|NCT02297906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65658517|NCT02297906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658518|NCT02297906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658519|NCT03511820|Amphotericin B|amphotericin b|mesh-list
65658520|NCT03511820|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65658521|NCT03511820|Amebicides|amebicides|mesh-ancestor
65658522|NCT03511820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65658523|NCT03511820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65658524|NCT03511820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65658525|NCT03511820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65658526|NCT03511820|Antifungal Agents|antifungal agents|mesh-ancestor
65658527|NCT02957331|Propranolol|propranolol|mesh-list
65658528|NCT02957331|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65658529|NCT02957331|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65658530|NCT02957331|Adrenergic Agents|adrenergic agents|mesh-ancestor
65658531|NCT02957331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65658532|NCT02957331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658533|NCT02957331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658534|NCT02957331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65658535|NCT02957331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65658536|NCT02957331|Vasodilator Agents|vasodilator agents|mesh-ancestor
65658537|NCT02298062|Infliximab|infliximab|mesh-list
65658538|NCT02298062|Dermatologic Agents|dermatologic agents|mesh-ancestor
65658539|NCT02298062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65658541|NCT03515018|Imatinib Mesylate|imatinib mesylate|mesh-list
65658542|NCT03515018|Hydroxyurea|hydroxyurea|mesh-list
65658543|NCT03515018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658544|NCT03515018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65658545|NCT03515018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658546|NCT03515018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658547|NCT03515018|Antisickling Agents|antisickling agents|mesh-ancestor
65658548|NCT03515018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65658549|NCT03748966|Calcitriol|calcitriol|mesh-list
65658550|NCT03748966|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
65658551|NCT03748966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65658552|NCT03748966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658553|NCT03748966|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65658554|NCT03748966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65658555|NCT03748966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658556|NCT03748966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65658557|NCT03748966|Vitamins|vitamins|mesh-ancestor
65658558|NCT03748966|Micronutrients|micronutrients|mesh-ancestor
65658559|NCT03748966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65658560|NCT05015608|Carboplatin|carboplatin|mesh-list
65658561|NCT05015608|Pemetrexed|pemetrexed|mesh-list
65658562|NCT05015608|Osimertinib|osimertinib|mesh-list
65658563|NCT05015608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658564|NCT05015608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658565|NCT05015608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658566|NCT05015608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65658567|NCT05015608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65658568|NCT05015608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65658569|NCT03510416|Apatinib|apatinib|mesh-list
65658570|NCT03510416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658571|NCT03510416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65658572|NCT03510416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658573|NCT03510416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658574|NCT03510962|Chlorhexidine|chlorhexidine|mesh-list
65658575|NCT03510962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65658576|NCT03510962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65658577|NCT03510962|Disinfectants|disinfectants|mesh-ancestor
65658578|NCT02646124|Naproxen|naproxen|mesh-list
65658579|NCT02646124|Diazepam|diazepam|mesh-list
65658580|NCT02646124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65658581|NCT02646124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65658582|NCT02646124|Analgesics|analgesics|mesh-ancestor
65658583|NCT02646124|Sensory System Agents|sensory system agents|mesh-ancestor
65658584|NCT02646124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65658585|NCT02646124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658586|NCT02646124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65658587|NCT02646124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65658588|NCT02646124|Gout Suppressants|gout suppressants|mesh-ancestor
65658589|NCT02646124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65658590|NCT02646124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658591|NCT02646124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658592|NCT02646124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65658593|NCT02646124|Anticonvulsants|anticonvulsants|mesh-ancestor
65658594|NCT02646124|Antiemetics|antiemetics|mesh-ancestor
65658595|NCT02646124|Autonomic Agents|autonomic agents|mesh-ancestor
65658596|NCT02646124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65658597|NCT02646124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65658598|NCT02646124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65658599|NCT02646124|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65658600|NCT02646124|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65658601|NCT02646124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65658602|NCT02646124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65658603|NCT02646124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65658604|NCT02646124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65658605|NCT02646124|Anesthetics, General|anesthetics, general|mesh-ancestor
65658606|NCT02646124|Anesthetics|anesthetics|mesh-ancestor
65658607|NCT02646124|GABA Modulators|gaba modulators|mesh-ancestor
65658608|NCT02646124|GABA Agents|gaba agents|mesh-ancestor
65658609|NCT02646124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65658610|NCT02306564|Cabergoline|cabergoline|mesh-list
65658611|NCT02306564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65658612|NCT02306564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65658613|NCT02306564|Dopamine Agonists|dopamine agonists|mesh-ancestor
65658614|NCT02306564|Dopamine Agents|dopamine agents|mesh-ancestor
65456019|NCT02531490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65658615|NCT02306564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65658616|NCT02306564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658617|NCT02306564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658618|NCT02301494|Fluocinonide|fluocinonide|mesh-list
65658619|NCT02301494|Imiquimod|imiquimod|mesh-list
65658620|NCT02301494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65658621|NCT02301494|Immunologic Factors|immunologic factors|mesh-ancestor
65658622|NCT02301494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658623|NCT02301494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658624|NCT02301494|Interferon Inducers|interferon inducers|mesh-ancestor
65658625|NCT02301494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65658626|NCT02301494|Glucocorticoids|glucocorticoids|mesh-ancestor
65658627|NCT02301494|Hormones|hormones|mesh-ancestor
65658628|NCT02301494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65658629|NCT02301494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65658630|NCT03101800|Azathioprine|azathioprine|mesh-list
65658631|NCT03101800|Allopurinol|allopurinol|mesh-list
65658632|NCT03101800|Antimetabolites|antimetabolites|mesh-ancestor
65658633|NCT03101800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658634|NCT03101800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658635|NCT03101800|Gout Suppressants|gout suppressants|mesh-ancestor
65658636|NCT03101800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65658637|NCT03101800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65658638|NCT03101800|Antioxidants|antioxidants|mesh-ancestor
65658639|NCT03101800|Protective Agents|protective agents|mesh-ancestor
65658640|NCT03101800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658641|NCT03101800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65658642|NCT03101800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658643|NCT03101800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65658644|NCT03101800|Immunologic Factors|immunologic factors|mesh-ancestor
65658645|NCT03507842|Cytarabine|cytarabine|mesh-list
65658646|NCT03507842|Daunorubicin|daunorubicin|mesh-list
65658647|NCT03507842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65658648|NCT03507842|Antimetabolites|antimetabolites|mesh-ancestor
65658649|NCT03507842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658650|NCT03507842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658651|NCT03507842|Antiviral Agents|antiviral agents|mesh-ancestor
65658652|NCT03507842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65658653|NCT03507842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65658654|NCT03507842|Immunologic Factors|immunologic factors|mesh-ancestor
65658655|NCT03507842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658656|NCT03507842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65658657|NCT03507842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65658658|NCT03507842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65658659|NCT03507842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658660|NCT03132584|Cyclophosphamide|cyclophosphamide|mesh-list
65658661|NCT03132584|Alemtuzumab|alemtuzumab|mesh-list
65658662|NCT03132584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65658663|NCT03132584|Immunologic Factors|immunologic factors|mesh-ancestor
65658664|NCT03132584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658665|NCT03132584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65658666|NCT03132584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65658667|NCT03132584|Alkylating Agents|alkylating agents|mesh-ancestor
65658668|NCT03132584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658669|NCT03132584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658670|NCT03132584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65658671|NCT03132584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65658672|NCT03656926|Cyclosporine|cyclosporine|mesh-list
65658673|NCT03656926|Cyclosporins|cyclosporins|mesh-list
65658674|NCT03656926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658675|NCT03656926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658676|NCT03656926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65658677|NCT03656926|Immunologic Factors|immunologic factors|mesh-ancestor
65658678|NCT03656926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658679|NCT03656926|Antifungal Agents|antifungal agents|mesh-ancestor
65658680|NCT03656926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65658681|NCT03656926|Dermatologic Agents|dermatologic agents|mesh-ancestor
65658682|NCT03656926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65658683|NCT03656926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65658684|NCT02301650|Tenofovir|tenofovir|mesh-list
65658685|NCT02301650|Lamivudine|lamivudine|mesh-list
65658686|NCT02301650|Telbivudine|telbivudine|mesh-list
65658687|NCT02301650|Antiviral Agents|antiviral agents|mesh-ancestor
65658688|NCT02301650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65658689|NCT02301650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65658690|NCT02301650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65658691|NCT02301650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658692|NCT02301650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658693|NCT02301650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65658694|NCT02301650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65658695|NCT03510338|Sildenafil Citrate|sildenafil citrate|mesh-list
65658696|NCT03510338|Vasodilator Agents|vasodilator agents|mesh-ancestor
65658697|NCT03510338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65658698|NCT03510338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65658699|NCT03510338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658700|NCT03510338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658701|NCT03510338|Urological Agents|urological agents|mesh-ancestor
65658702|NCT02303366|Pembrolizumab|pembrolizumab|mesh-list
65658703|NCT02303366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65658704|NCT02303366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658705|NCT02301806|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65658706|NCT02301806|Glimepiride|glimepiride|mesh-list
65658707|NCT02301806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65658708|NCT02301806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658709|NCT02301806|Incretins|incretins|mesh-ancestor
65658710|NCT02301806|Hormones|hormones|mesh-ancestor
65658711|NCT02301806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65658712|NCT02301806|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65658713|NCT02301806|Protease Inhibitors|protease inhibitors|mesh-ancestor
65658714|NCT02301806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658715|NCT02301806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658716|NCT02301806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65658717|NCT02301806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65658718|NCT02301806|Immunologic Factors|immunologic factors|mesh-ancestor
65658719|NCT03103204|Chlorhexidine|chlorhexidine|mesh-list
65268261|NCT05429684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658720|NCT03103204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65658721|NCT03103204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65658722|NCT03103204|Disinfectants|disinfectants|mesh-ancestor
65658723|NCT02301962|Panitumumab|panitumumab|mesh-list
65658724|NCT02301962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65658725|NCT02301962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658726|NCT02639650|Dactinomycin|dactinomycin|mesh-list
65658727|NCT02639650|Paclitaxel|paclitaxel|mesh-list
65658728|NCT02639650|Etoposide|etoposide|mesh-list
65658729|NCT02639650|Vincristine|vincristine|mesh-list
65658730|NCT02639650|Cyclophosphamide|cyclophosphamide|mesh-list
65658731|NCT02639650|Carboplatin|carboplatin|mesh-list
65658732|NCT02639650|Methotrexate|methotrexate|mesh-list
65658733|NCT02639650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65658734|NCT02639650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658735|NCT02639650|Tubulin Modulators|tubulin modulators|mesh-ancestor
65658736|NCT02639650|Antimitotic Agents|antimitotic agents|mesh-ancestor
65658737|NCT02639650|Mitosis Modulators|mitosis modulators|mesh-ancestor
65658738|NCT02639650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658739|NCT02639650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65658740|NCT02639650|Immunologic Factors|immunologic factors|mesh-ancestor
65658741|NCT02639650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658742|NCT02639650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65658743|NCT02639650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65658744|NCT02639650|Alkylating Agents|alkylating agents|mesh-ancestor
65658745|NCT02639650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65658746|NCT02639650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65658747|NCT02639650|Abortifacient Agents|abortifacient agents|mesh-ancestor
65658748|NCT02639650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65658749|NCT02639650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65658750|NCT02639650|Antimetabolites|antimetabolites|mesh-ancestor
65658751|NCT02639650|Dermatologic Agents|dermatologic agents|mesh-ancestor
65658752|NCT02639650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658753|NCT02639650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65658754|NCT02639650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65658755|NCT02639650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65658756|NCT02639650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65658757|NCT02639650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65658758|NCT02639650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65658759|NCT02639650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65658760|NCT02639650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65658761|NCT02303444|Sorafenib|sorafenib|mesh-list
65658762|NCT02303444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658763|NCT02303444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65658764|NCT02303444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658765|NCT02303444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658766|NCT03581734|Vaccines|vaccines|mesh-list
65658767|NCT03581734|Immunologic Factors|immunologic factors|mesh-ancestor
65658768|NCT03581734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658769|NCT02306798|Mesalamine|mesalamine|mesh-list
65658770|NCT02306798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65658771|NCT02306798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65658772|NCT02306798|Analgesics|analgesics|mesh-ancestor
65658773|NCT02306798|Sensory System Agents|sensory system agents|mesh-ancestor
65658774|NCT02306798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65658775|NCT02306798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658776|NCT02306798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65658777|NCT02306798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65658778|NCT02306954|Aldesleukin|aldesleukin|mesh-list
65658779|NCT02306954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658780|NCT02306954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65658781|NCT02306954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65658782|NCT02306954|Antiviral Agents|antiviral agents|mesh-ancestor
65658783|NCT02306954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65658784|NCT03509714|Ascorbic Acid|ascorbic acid|mesh-list
65658785|NCT03509714|Antioxidants|antioxidants|mesh-ancestor
65658786|NCT03509714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658787|NCT03509714|Protective Agents|protective agents|mesh-ancestor
65658788|NCT03509714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658789|NCT03509714|Vitamins|vitamins|mesh-ancestor
65658790|NCT03509714|Micronutrients|micronutrients|mesh-ancestor
65658791|NCT02302274|Flecainide|flecainide|mesh-list
65658792|NCT02302274|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65658793|NCT02302274|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65658794|NCT02302274|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65658795|NCT02302274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65658796|NCT02302274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658797|NCT02303600|Montelukast|montelukast|mesh-list
65658798|NCT02303600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65658799|NCT02303600|Respiratory System Agents|respiratory system agents|mesh-ancestor
65658800|NCT02303600|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65658801|NCT02303600|Hormone Antagonists|hormone antagonists|mesh-ancestor
65658802|NCT02303600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65658803|NCT02303600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658804|NCT02303600|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65658805|NCT02303600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65658806|NCT02303600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658807|NCT04463342|Methamphetamine|methamphetamine|mesh-list
65658808|NCT04463342|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65658809|NCT04463342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658810|NCT04463342|Sympathomimetics|sympathomimetics|mesh-ancestor
65658811|NCT04463342|Autonomic Agents|autonomic agents|mesh-ancestor
65658812|NCT04463342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65658813|NCT04463342|Dopamine Agents|dopamine agents|mesh-ancestor
65658814|NCT04463342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65658815|NCT04463342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658816|NCT04463342|Adrenergic Agents|adrenergic agents|mesh-ancestor
65658817|NCT04463342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65658818|NCT04463342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65658819|NCT04463342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65658820|NCT04463342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65658821|NCT02303912|Carboplatin|carboplatin|mesh-list
65658822|NCT02303912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658823|NCT01597492|Belimumab|belimumab|mesh-list
65658824|NCT01597492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65658825|NCT01597492|Immunologic Factors|immunologic factors|mesh-ancestor
65658826|NCT01597492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658827|NCT04569994|Insulin|insulin|mesh-list
65658828|NCT04569994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65658829|NCT04569994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658830|NCT00109590|Ritonavir|ritonavir|mesh-list
65658831|NCT00109590|Lopinavir|lopinavir|mesh-list
65658832|NCT00109590|Zidovudine|zidovudine|mesh-list
65658833|NCT00109590|Nevirapine|nevirapine|mesh-list
65658834|NCT00109590|Didanosine|didanosine|mesh-list
65658835|NCT00109590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65658836|NCT00109590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65658837|NCT00109590|Protease Inhibitors|protease inhibitors|mesh-ancestor
65658838|NCT00109590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658839|NCT00109590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456245|NCT03872596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65658840|NCT00109590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65658842|NCT00109590|Antiviral Agents|antiviral agents|mesh-ancestor
65658843|NCT00109590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65658844|NCT00109590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65658845|NCT00109590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65658846|NCT00109590|Antimetabolites|antimetabolites|mesh-ancestor
65658847|NCT00109590|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65658848|NCT00109590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65658849|NCT00109590|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65658850|NCT00109590|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65658851|NCT03507062|Plasma-lyte 148|plasma-lyte 148|mesh-list
65658852|NCT03507062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65658853|NCT03507062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65658854|NCT05243446|Losartan|losartan|mesh-list
65658855|NCT05243446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65658856|NCT05243446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65658857|NCT05243446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65658858|NCT05243446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65658859|NCT05243446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658860|NCT05213650|Methamphetamine|methamphetamine|mesh-list
65658861|NCT05213650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65658862|NCT05213650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658863|NCT05213650|Sympathomimetics|sympathomimetics|mesh-ancestor
65658864|NCT05213650|Autonomic Agents|autonomic agents|mesh-ancestor
65658865|NCT05213650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65658866|NCT05213650|Dopamine Agents|dopamine agents|mesh-ancestor
65658867|NCT05213650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65658868|NCT05213650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658869|NCT05213650|Adrenergic Agents|adrenergic agents|mesh-ancestor
65658870|NCT05213650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65658871|NCT05213650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65658872|NCT05213650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65658873|NCT05213650|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65658874|NCT02143362|Remifentanil|remifentanil|mesh-list
65658875|NCT02143362|Anesthetics|anesthetics|mesh-list
65658876|NCT02143362|Propofol|propofol|mesh-list
65658877|NCT02143362|Cisatracurium|cisatracurium|mesh-list
65658878|NCT02143362|Atracurium|atracurium|mesh-list
65658879|NCT02143362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65658880|NCT02143362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658881|NCT02143362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65658882|NCT02143362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65658883|NCT02143362|Anesthetics, General|anesthetics, general|mesh-ancestor
65658884|NCT02143362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65658885|NCT02143362|Narcotics|narcotics|mesh-ancestor
65658886|NCT02143362|Analgesics|analgesics|mesh-ancestor
65658887|NCT02143362|Sensory System Agents|sensory system agents|mesh-ancestor
65658888|NCT02143362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65658889|NCT02143362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65658890|NCT02143362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65658891|NCT02143362|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65658892|NCT02143362|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65658893|NCT02143362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65658894|NCT02143362|Cholinergic Agents|cholinergic agents|mesh-ancestor
65658895|NCT02143362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65658896|NCT02143362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658897|NCT03509324|Insulin Lispro|insulin lispro|mesh-list
65658898|NCT03509324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65658899|NCT03509324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658900|NCT02143440|Insulin|insulin|mesh-list
65658901|NCT02143440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65658902|NCT02143440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658903|NCT02143518|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65658904|NCT02143518|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
65658905|NCT02143518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65658906|NCT02143518|Immunologic Factors|immunologic factors|mesh-ancestor
65658907|NCT02143518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658908|NCT02143518|Antacids|antacids|mesh-ancestor
65658909|NCT02143518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658910|NCT02143518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65658911|NCT03682770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65658912|NCT03682770|Immunologic Factors|immunologic factors|mesh-ancestor
65658913|NCT03682770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658914|NCT03506828|Phenol|phenol|mesh-list
65658915|NCT03506828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65658916|NCT03506828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65658917|NCT03506828|Disinfectants|disinfectants|mesh-ancestor
65658918|NCT03506828|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65658919|NCT03506828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65658920|NCT00054964|Albuterol|albuterol|mesh-list
65658921|NCT00054964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65658922|NCT00054964|Autonomic Agents|autonomic agents|mesh-ancestor
65658923|NCT00054964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65658924|NCT00054964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658925|NCT00054964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65658926|NCT00054964|Respiratory System Agents|respiratory system agents|mesh-ancestor
65658927|NCT00054964|Tocolytic Agents|tocolytic agents|mesh-ancestor
65658928|NCT00054964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65658929|NCT00054964|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65658930|NCT00054964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65658931|NCT00054964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65658932|NCT00054964|Adrenergic Agents|adrenergic agents|mesh-ancestor
65658933|NCT00054964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65658934|NCT00054964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658935|NCT02781558|Sofosbuvir|sofosbuvir|mesh-list
65658936|NCT02781558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65658937|NCT02781558|Velpatasvir|velpatasvir|mesh-list
65658938|NCT02781558|Antiviral Agents|antiviral agents|mesh-ancestor
65658939|NCT02781558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65658940|NCT05073640|Pentoxifylline|pentoxifylline|mesh-list
65658941|NCT05073640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65658942|NCT05073640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658943|NCT05073640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658944|NCT05073640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65658945|NCT05073640|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65658946|NCT05073640|Protective Agents|protective agents|mesh-ancestor
65658947|NCT05073640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658948|NCT05073640|Vasodilator Agents|vasodilator agents|mesh-ancestor
65658949|NCT05073640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65658950|NCT05073640|Antioxidants|antioxidants|mesh-ancestor
65658951|NCT05073094|Esmolol|esmolol|mesh-list
65658952|NCT05073094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65658953|NCT05073094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65658954|NCT05073094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65658955|NCT05073094|Adrenergic Agents|adrenergic agents|mesh-ancestor
65658956|NCT05073094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65658957|NCT05073094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658958|NCT05073094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658959|NCT03509246|Doxorubicin|doxorubicin|mesh-list
65658960|NCT03509246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65658961|NCT03509246|Bortezomib|bortezomib|mesh-list
65658962|NCT03509246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65658963|NCT03509246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658964|NCT03509246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65658965|NCT03509246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65658966|NCT03509246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658967|NCT03509246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658968|NCT03509168|Misoprostol|misoprostol|mesh-list
65658969|NCT03509168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65658970|NCT03509168|Abortifacient Agents|abortifacient agents|mesh-ancestor
65658971|NCT03509168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65658972|NCT03509168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658973|NCT03509168|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65658974|NCT03509168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65658975|NCT03509168|Oxytocics|oxytocics|mesh-ancestor
65658976|NCT05072938|Nizatidine|nizatidine|mesh-list
65658977|NCT05072938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65658978|NCT05072938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65658979|NCT05072938|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65658980|NCT05072938|Histamine Antagonists|histamine antagonists|mesh-ancestor
65658981|NCT05072938|Histamine Agents|histamine agents|mesh-ancestor
65658982|NCT05072938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65658983|NCT05072938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658984|NCT05072938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65658985|NCT03041311|Carboplatin|carboplatin|mesh-list
65658986|NCT03041311|Etoposide|etoposide|mesh-list
65658987|NCT03041311|Atezolizumab|atezolizumab|mesh-list
65658988|NCT03041311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65658989|NCT03041311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65658990|NCT03041311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65658991|NCT03041311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65658992|NCT03041311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65658993|NCT03041311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658994|NCT05072860|Tranexamic Acid|tranexamic acid|mesh-list
65658995|NCT05072860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65658996|NCT05072860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65658997|NCT05072860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65658998|NCT05072860|Hemostatics|hemostatics|mesh-ancestor
65658999|NCT05072860|Coagulants|coagulants|mesh-ancestor
65659000|NCT02311946|Palbociclib|palbociclib|mesh-list
65659001|NCT02311946|Rabeprazole|rabeprazole|mesh-list
65659002|NCT02311946|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65659003|NCT02311946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65659004|NCT02311946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65659005|NCT02311946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659006|NCT02311946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659007|NCT02311946|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65659008|NCT02311946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65659009|NCT04302766|Remdesivir|remdesivir|mesh-list
65659010|NCT04302766|Antimetabolites|antimetabolites|mesh-ancestor
65659011|NCT04302766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659012|NCT04302766|Antiviral Agents|antiviral agents|mesh-ancestor
65659013|NCT04302766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65659014|NCT02312102|Lenalidomide|lenalidomide|mesh-list
65659015|NCT02312102|Bortezomib|bortezomib|mesh-list
65659016|NCT02312102|Immunologic Factors|immunologic factors|mesh-ancestor
65659017|NCT02312102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659018|NCT02312102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65659019|NCT02312102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65659020|NCT02312102|Growth Substances|growth substances|mesh-ancestor
65659021|NCT02312102|Growth Inhibitors|growth inhibitors|mesh-ancestor
65659022|NCT02312102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65659023|NCT05408221|Lenvatinib|lenvatinib|mesh-list
65659024|NCT05408221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65659025|NCT05408221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65659026|NCT05408221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659027|NCT05408221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659028|NCT02307968|Insulin|insulin|mesh-list
65659029|NCT02307968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65659030|NCT02307968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659031|NCT02312180|Plasminogen|plasminogen|mesh-list
65659032|NCT02312180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65659033|NCT02312180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65659034|NCT02312180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659035|NCT03504566|Empagliflozin|empagliflozin|mesh-list
65659036|NCT03504566|Linagliptin|linagliptin|mesh-list
65659037|NCT03504566|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
65659038|NCT03504566|Telmisartan|telmisartan|mesh-list
65659039|NCT03504566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65659040|NCT03504566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659041|NCT03504566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65659042|NCT03504566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659043|NCT03504566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65659044|NCT03504566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65659045|NCT03504566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65659046|NCT03504566|Incretins|incretins|mesh-ancestor
65659047|NCT03504566|Hormones|hormones|mesh-ancestor
65659048|NCT03504566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65659049|NCT03504566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65659050|NCT03504566|Protease Inhibitors|protease inhibitors|mesh-ancestor
65659051|NCT03504566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659052|NCT03504566|Anticoagulants|anticoagulants|mesh-ancestor
65659053|NCT03504566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65659054|NCT03504566|Antimetabolites|antimetabolites|mesh-ancestor
65659055|NCT03504566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65659056|NCT03504566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65659057|NCT03504566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65659058|NCT05070520|Lumefantrine|lumefantrine|mesh-list
65659059|NCT05070520|Artemether|artemether|mesh-list
65659060|NCT05070520|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65659061|NCT05070520|Antimalarials|antimalarials|mesh-ancestor
65659062|NCT05070520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65659063|NCT05070520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65659064|NCT05070520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65659065|NCT05070598|Paclitaxel|paclitaxel|mesh-list
65659067|NCT05070598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65659068|NCT05070598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65659069|NCT05070598|Tubulin Modulators|tubulin modulators|mesh-ancestor
65659070|NCT05070598|Antimitotic Agents|antimitotic agents|mesh-ancestor
65659071|NCT05070598|Mitosis Modulators|mitosis modulators|mesh-ancestor
65659072|NCT05070598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659073|NCT05070598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65659074|NCT05070598|Antimetabolites|antimetabolites|mesh-ancestor
65659075|NCT03884452|Atorvastatin|atorvastatin|mesh-list
65659076|NCT03884452|Simvastatin|simvastatin|mesh-list
65659077|NCT03884452|Ezetimibe|ezetimibe|mesh-list
65659078|NCT03884452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65659079|NCT03884452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65659080|NCT03884452|Antimetabolites|antimetabolites|mesh-ancestor
65659081|NCT03884452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659082|NCT03884452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65659083|NCT03884452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65659084|NCT03884452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659085|NCT03882892|Ezetimibe|ezetimibe|mesh-list
65659086|NCT03882892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65659087|NCT03882892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65659088|NCT03882892|Antimetabolites|antimetabolites|mesh-ancestor
65659089|NCT03882892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659090|NCT03882892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65659091|NCT02305160|Poractant alfa|poractant alfa|mesh-list
65659092|NCT02305160|Beractant|beractant|mesh-list
65659093|NCT02305160|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
65659094|NCT02305160|Respiratory System Agents|respiratory system agents|mesh-ancestor
65659095|NCT02305394|Ketamine|ketamine|mesh-list
65659096|NCT02305394|Propofol|propofol|mesh-list
65659097|NCT02305394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65659098|NCT02305394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65659099|NCT02305394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659100|NCT02305394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65659101|NCT02305394|Anesthetics, General|anesthetics, general|mesh-ancestor
65659102|NCT02305394|Anesthetics|anesthetics|mesh-ancestor
65659103|NCT02305394|Analgesics|analgesics|mesh-ancestor
65659104|NCT02305394|Sensory System Agents|sensory system agents|mesh-ancestor
65659105|NCT02305394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65659106|NCT02305394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65659107|NCT02305394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65659108|NCT02305394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65659109|NCT02305394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65659110|NCT02305394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659111|NCT05068960|Bupivacaine|bupivacaine|mesh-list
65659112|NCT05068960|Anesthetics, Local|anesthetics, local|mesh-ancestor
65659113|NCT05068960|Anesthetics|anesthetics|mesh-ancestor
65659114|NCT05068960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65659115|NCT05068960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659116|NCT05068960|Sensory System Agents|sensory system agents|mesh-ancestor
65659117|NCT05068960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65659118|NCT03569293|Upadacitinib|upadacitinib|mesh-list
65659119|NCT03569293|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65659120|NCT03569293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65659121|NCT03569293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659122|NCT03569293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659123|NCT03569293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65659124|NCT02305550|Nitric Oxide|nitric oxide|mesh-list
65659125|NCT02305550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65659126|NCT02305550|Autonomic Agents|autonomic agents|mesh-ancestor
65659127|NCT02305550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65659128|NCT02305550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659129|NCT02305550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65659130|NCT02305550|Respiratory System Agents|respiratory system agents|mesh-ancestor
65659131|NCT02305550|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65659132|NCT02305550|Antioxidants|antioxidants|mesh-ancestor
65659133|NCT02305550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659134|NCT02305550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65659135|NCT02305550|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65659136|NCT02305550|Vasodilator Agents|vasodilator agents|mesh-ancestor
65659137|NCT02305550|Gasotransmitters|gasotransmitters|mesh-ancestor
65659138|NCT02305550|Protective Agents|protective agents|mesh-ancestor
65659139|NCT03506516|Ethanol|ethanol|mesh-list
65659140|NCT03506516|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65659142|NCT03506516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65659143|NCT03506516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659144|NCT02312492|Palmitic Acid|palmitic acid|mesh-list
65659145|NCT02312492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659146|NCT02312492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659147|NCT02643394|Acetaminophen|acetaminophen|mesh-list
65659148|NCT02643394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65659149|NCT02643394|Analgesics|analgesics|mesh-ancestor
65659150|NCT02643394|Sensory System Agents|sensory system agents|mesh-ancestor
65659151|NCT02643394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65659152|NCT02643394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659153|NCT02643394|Antipyretics|antipyretics|mesh-ancestor
65659154|NCT03101644|Darunavir|darunavir|mesh-list
65659155|NCT03101644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65659156|NCT03101644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65659157|NCT03101644|Protease Inhibitors|protease inhibitors|mesh-ancestor
65659158|NCT03101644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659159|NCT03101644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659160|NCT03101644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65659161|NCT03101644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65659162|NCT03101644|Antiviral Agents|antiviral agents|mesh-ancestor
65659163|NCT03101644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65659164|NCT03132272|Autoantibodies|autoantibodies|mesh-list
65659165|NCT03132272|Immunologic Factors|immunologic factors|mesh-ancestor
65659166|NCT03132272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659167|NCT03503786|Paclitaxel|paclitaxel|mesh-list
65659168|NCT03503786|Carboplatin|carboplatin|mesh-list
65659169|NCT03503786|Avelumab|avelumab|mesh-list
65659170|NCT03503786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65659171|NCT03503786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65659172|NCT03503786|Tubulin Modulators|tubulin modulators|mesh-ancestor
65659173|NCT03503786|Antimitotic Agents|antimitotic agents|mesh-ancestor
65659174|NCT03503786|Mitosis Modulators|mitosis modulators|mesh-ancestor
65659175|NCT03503786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659176|NCT03503786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65659177|NCT02308982|Immunoglobulins|immunoglobulins|mesh-list
65659178|NCT02308982|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65659179|NCT02308982|Antibodies|antibodies|mesh-list
65659180|NCT02308982|gamma-Globulins|gamma-globulins|mesh-list
65659181|NCT02308982|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65659182|NCT02308982|Immunologic Factors|immunologic factors|mesh-ancestor
65659183|NCT02308982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659184|NCT05515627|Atezolizumab|atezolizumab|mesh-list
65659185|NCT05515627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65659186|NCT02178436|Gemcitabine|gemcitabine|mesh-list
65659187|NCT02178436|Paclitaxel|paclitaxel|mesh-list
65659188|NCT02178436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65659189|NCT02178436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65659190|NCT02178436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65659191|NCT02178436|Tubulin Modulators|tubulin modulators|mesh-ancestor
65659192|NCT02178436|Antimitotic Agents|antimitotic agents|mesh-ancestor
65659193|NCT02178436|Mitosis Modulators|mitosis modulators|mesh-ancestor
65659194|NCT02178436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659195|NCT02178436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65659196|NCT02178436|Antimetabolites|antimetabolites|mesh-ancestor
65659197|NCT02178436|Antiviral Agents|antiviral agents|mesh-ancestor
65659198|NCT02178436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65659199|NCT02178436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659200|NCT02178436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65659201|NCT02178436|Immunologic Factors|immunologic factors|mesh-ancestor
65659202|NCT02178436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659203|NCT02144064|Heparin|heparin|mesh-list
65659204|NCT02144064|Calcium heparin|calcium heparin|mesh-list
65659205|NCT02144064|Anticoagulants|anticoagulants|mesh-ancestor
65659206|NCT02144064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65659207|NCT02144064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65659208|NCT02144064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659209|NCT02144142|Anti-Infective Agents|anti-infective agents|mesh-list
65659210|NCT02144142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65659211|NCT02305862|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65659212|NCT02305862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65659213|NCT02305862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65659214|NCT02305862|Antimetabolites|antimetabolites|mesh-ancestor
65659215|NCT02305862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659216|NCT02305862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65659217|NCT02305862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65659218|NCT02305862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659219|NCT02305940|Doxycycline|doxycycline|mesh-list
65659220|NCT02305940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65659221|NCT02305940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65659222|NCT02305940|Antimalarials|antimalarials|mesh-ancestor
65659223|NCT02305940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65659224|NCT02305940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65659226|NCT02312804|Carboplatin|carboplatin|mesh-list
65659227|NCT02312804|Infigratinib|infigratinib|mesh-list
65659228|NCT02312804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65659229|NCT02312804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65659230|NCT02312804|Tubulin Modulators|tubulin modulators|mesh-ancestor
65659231|NCT02312804|Antimitotic Agents|antimitotic agents|mesh-ancestor
65659232|NCT02312804|Mitosis Modulators|mitosis modulators|mesh-ancestor
65659233|NCT02312804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659234|NCT03099616|Propofol|propofol|mesh-list
65659235|NCT03099616|Desflurane|desflurane|mesh-list
65659236|NCT03099616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65659237|NCT03099616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65659238|NCT03099616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659239|NCT03099616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65659240|NCT03099616|Anesthetics, General|anesthetics, general|mesh-ancestor
65659241|NCT03099616|Anesthetics|anesthetics|mesh-ancestor
65659242|NCT03099616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65659243|NCT04463966|Tranexamic Acid|tranexamic acid|mesh-list
65659244|NCT04463966|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65659245|NCT04463966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65659246|NCT04463966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659247|NCT04463966|Hemostatics|hemostatics|mesh-ancestor
65659248|NCT04463966|Coagulants|coagulants|mesh-ancestor
65659249|NCT00794248|Fexofenadine|fexofenadine|mesh-list
65659250|NCT00794248|Desloratadine|desloratadine|mesh-list
65659251|NCT00794248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65659252|NCT00794248|Cholinergic Agents|cholinergic agents|mesh-ancestor
65659253|NCT00794248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65659254|NCT00794248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659255|NCT00794248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659256|NCT00794248|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65659257|NCT00794248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65659258|NCT00794248|Histamine Antagonists|histamine antagonists|mesh-ancestor
65659259|NCT00794248|Histamine Agents|histamine agents|mesh-ancestor
65659260|NCT00794248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65659261|NCT02309450|Asunaprevir|asunaprevir|mesh-list
65659262|NCT02309450|Protease Inhibitors|protease inhibitors|mesh-ancestor
65659263|NCT02309450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659264|NCT02309450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659265|NCT04475224|Mitogens|mitogens|mesh-list
65659266|NCT04475224|Mitosis Modulators|mitosis modulators|mesh-ancestor
65659267|NCT04475224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659268|NCT05370235|Afamelanotide|afamelanotide|mesh-list
65659269|NCT05370235|Dermatologic Agents|dermatologic agents|mesh-ancestor
65659270|NCT00353496|Lanreotide|lanreotide|mesh-list
65659271|NCT00353496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65659272|NCT00389896|Oxymetazoline|oxymetazoline|mesh-list
65659273|NCT00389896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65659274|NCT00389896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65659275|NCT00389896|Adrenergic Agents|adrenergic agents|mesh-ancestor
65659276|NCT00389896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65659277|NCT00389896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659278|NCT00389896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659279|NCT00389896|Sympathomimetics|sympathomimetics|mesh-ancestor
65659280|NCT00389896|Autonomic Agents|autonomic agents|mesh-ancestor
65659281|NCT00389896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65659282|NCT00389896|Nasal Decongestants|nasal decongestants|mesh-ancestor
65659283|NCT00389896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65659284|NCT00389896|Respiratory System Agents|respiratory system agents|mesh-ancestor
65659285|NCT03388190|Leucovorin|leucovorin|mesh-list
65659286|NCT03388190|Fluorouracil|fluorouracil|mesh-list
65659287|NCT03388190|Oxaliplatin|oxaliplatin|mesh-list
65659288|NCT03388190|Nivolumab|nivolumab|mesh-list
65659289|NCT03388190|Levoleucovorin|levoleucovorin|mesh-list
65659290|NCT03388190|Antimetabolites|antimetabolites|mesh-ancestor
65456697|NCT01285414|Alkylating Agents|alkylating agents|mesh-ancestor
65659291|NCT03388190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659292|NCT03388190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65659293|NCT03388190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65659294|NCT03388190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65659295|NCT03388190|Immunologic Factors|immunologic factors|mesh-ancestor
65659296|NCT03388190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659297|NCT03388190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65268291|NCT02750696|Tramadol|tramadol|mesh-list
65659298|NCT03388190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65659299|NCT03388190|Antidotes|antidotes|mesh-ancestor
65659300|NCT03388190|Protective Agents|protective agents|mesh-ancestor
65659301|NCT03388190|Vitamin B Complex|vitamin b complex|mesh-ancestor
65659302|NCT03388190|Vitamins|vitamins|mesh-ancestor
65659303|NCT03388190|Micronutrients|micronutrients|mesh-ancestor
65659304|NCT02313272|Bevacizumab|bevacizumab|mesh-list
65659305|NCT02313272|Pembrolizumab|pembrolizumab|mesh-list
65659306|NCT02313272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65659307|NCT02313272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65659308|NCT02313272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65659309|NCT02313272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65659310|NCT02313272|Growth Substances|growth substances|mesh-ancestor
65659311|NCT02313272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659312|NCT02313272|Growth Inhibitors|growth inhibitors|mesh-ancestor
65659313|NCT03473977|Benralizumab|benralizumab|mesh-list
65659314|NCT03473977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65659315|NCT03473977|Respiratory System Agents|respiratory system agents|mesh-ancestor
65659316|NCT01361464|Tipifarnib|tipifarnib|mesh-list
65659317|NCT01361464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65659318|NCT04051255|Metronidazole|metronidazole|mesh-list
65659319|NCT04051255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65659320|NCT04051255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65659321|NCT04051255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65659322|NCT04051255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65659323|NCT03505736|Adenosine|adenosine|mesh-list
65659324|NCT03505736|Regadenoson|regadenoson|mesh-list
65659325|NCT03505736|Analgesics|analgesics|mesh-ancestor
65659326|NCT03505736|Sensory System Agents|sensory system agents|mesh-ancestor
65659327|NCT03505736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65659328|NCT03505736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659329|NCT03505736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65659330|NCT03505736|Vasodilator Agents|vasodilator agents|mesh-ancestor
65659331|NCT03505736|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65659332|NCT03505736|Purinergic Agonists|purinergic agonists|mesh-ancestor
65659333|NCT03505736|Purinergic Agents|purinergic agents|mesh-ancestor
65659334|NCT03505736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65659335|NCT03505736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659336|NCT03505736|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65659337|NCT02316626|Progesterone|progesterone|mesh-list
65659338|NCT02316626|Progestins|progestins|mesh-ancestor
65659339|NCT02316626|Hormones|hormones|mesh-ancestor
65659340|NCT02316626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65659341|NCT02316626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659342|NCT03505502|Tranexamic Acid|tranexamic acid|mesh-list
65659343|NCT03505502|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65659344|NCT03505502|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65659345|NCT03505502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659346|NCT03505502|Hemostatics|hemostatics|mesh-ancestor
65659347|NCT03505502|Coagulants|coagulants|mesh-ancestor
65659348|NCT03977896|Carbon-11 methionine|carbon-11 methionine|mesh-list
65659349|NCT03977896|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65659350|NCT03977896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659351|NCT04478266|Letrozole|letrozole|mesh-list
65659352|NCT04478266|Palbociclib|palbociclib|mesh-list
65659353|NCT04478266|Goserelin|goserelin|mesh-list
65659354|NCT04478266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65659355|NCT04478266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65659356|NCT04478266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65659357|NCT04478266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659358|NCT04478266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659359|NCT04478266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65659360|NCT04478266|Hormone Antagonists|hormone antagonists|mesh-ancestor
65659361|NCT04478266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65659362|NCT04478266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659363|NCT04478266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65659364|NCT04478266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65659365|NCT02316704|Tacrine|tacrine|mesh-list
65659366|NCT02316704|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65659367|NCT02316704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659368|NCT02316704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659369|NCT02316704|Cholinergic Agents|cholinergic agents|mesh-ancestor
65659370|NCT02316704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65659371|NCT02316704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659372|NCT02316704|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65659373|NCT02316704|Autonomic Agents|autonomic agents|mesh-ancestor
65659374|NCT02316704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65659375|NCT02316704|Nootropic Agents|nootropic agents|mesh-ancestor
65659376|NCT03501680|Insulin|insulin|mesh-list
65659377|NCT03501680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65659378|NCT03501680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659379|NCT02310074|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65659380|NCT02310074|Hormones|hormones|mesh-list
65659381|NCT02310074|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65659382|NCT02310074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65659383|NCT02310074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659384|NCT02310074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65659385|NCT02313584|Dabigatran|dabigatran|mesh-list
65659386|NCT02313584|Antithrombins|antithrombins|mesh-ancestor
65659387|NCT02313584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65659388|NCT02313584|Protease Inhibitors|protease inhibitors|mesh-ancestor
65659389|NCT02313584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659390|NCT02313584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659391|NCT02313584|Anticoagulants|anticoagulants|mesh-ancestor
65659392|NCT05063578|Lidocaine|lidocaine|mesh-list
65659393|NCT05063578|Anesthetics, Local|anesthetics, local|mesh-ancestor
65659394|NCT05063578|Anesthetics|anesthetics|mesh-ancestor
65659395|NCT05063578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65659396|NCT05063578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659397|NCT05063578|Sensory System Agents|sensory system agents|mesh-ancestor
65659398|NCT05063578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65659399|NCT05063578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65659400|NCT05063578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65659401|NCT05063578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65659402|NCT05063578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65659403|NCT05063578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659404|NCT05063422|Trimethoprim|trimethoprim|mesh-list
65659405|NCT05063422|Polymyxins|polymyxins|mesh-list
65659406|NCT05063422|Polymyxin B|polymyxin b|mesh-list
65659407|NCT05063422|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65659408|NCT05063422|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65659409|NCT05063422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65659410|NCT05063422|Renal Agents|renal agents|mesh-ancestor
65659411|NCT05063422|Antimalarials|antimalarials|mesh-ancestor
65659412|NCT05063422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65659413|NCT05063422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65659414|NCT05063422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65659415|NCT05063422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659416|NCT05063422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659417|NCT05063422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65659418|NCT05063422|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65659419|NCT05063422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65659420|NCT05063422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65659421|NCT05063422|Laxatives|laxatives|mesh-ancestor
65659422|NCT05063422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65659423|NCT03782350|Tranexamic Acid|tranexamic acid|mesh-list
65659424|NCT03782350|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65659425|NCT03782350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65659426|NCT03782350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659427|NCT03782350|Hemostatics|hemostatics|mesh-ancestor
65659428|NCT03782350|Coagulants|coagulants|mesh-ancestor
65659429|NCT03636256|Docetaxel|docetaxel|mesh-list
65659430|NCT03636256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65659431|NCT03636256|Tubulin Modulators|tubulin modulators|mesh-ancestor
65659432|NCT03636256|Antimitotic Agents|antimitotic agents|mesh-ancestor
65659433|NCT03636256|Mitosis Modulators|mitosis modulators|mesh-ancestor
65659434|NCT03636256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659435|NCT03098680|Verapamil|verapamil|mesh-list
65659436|NCT03098680|Nicardipine|nicardipine|mesh-list
65659437|NCT03098680|Phentolamine|phentolamine|mesh-list
65659438|NCT03098680|Phenylephrine|phenylephrine|mesh-list
65659439|NCT03098680|Dobutamine|dobutamine|mesh-list
65659440|NCT03098680|Oxymetazoline|oxymetazoline|mesh-list
65659441|NCT03098680|Albuterol|albuterol|mesh-list
65659442|NCT03098680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65659443|NCT03098680|Autonomic Agents|autonomic agents|mesh-ancestor
65456847|NCT01177852|Diphenhydramine|diphenhydramine|mesh-list
65659444|NCT03098680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65659445|NCT03098680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659446|NCT03098680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65659447|NCT03098680|Respiratory System Agents|respiratory system agents|mesh-ancestor
65659448|NCT03098680|Tocolytic Agents|tocolytic agents|mesh-ancestor
65659449|NCT03098680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65659450|NCT03098680|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65659451|NCT03098680|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65659452|NCT03098680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65659453|NCT03098680|Adrenergic Agents|adrenergic agents|mesh-ancestor
65659454|NCT03098680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65659455|NCT03098680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659456|NCT03098680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65659457|NCT03098680|Mydriatics|mydriatics|mesh-ancestor
65659458|NCT03098680|Sympathomimetics|sympathomimetics|mesh-ancestor
65659459|NCT03098680|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65659460|NCT03098680|Nasal Decongestants|nasal decongestants|mesh-ancestor
65659461|NCT03098680|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65659462|NCT03098680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65659463|NCT03098680|Protective Agents|protective agents|mesh-ancestor
65659464|NCT03098680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65659465|NCT03098680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65659466|NCT03098680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65659467|NCT03098680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65659468|NCT03098680|Vasodilator Agents|vasodilator agents|mesh-ancestor
65659469|NCT03098680|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65659470|NCT03098680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65659471|NCT03098680|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65659472|NCT03098680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65659473|NCT03098368|Rotigotine|rotigotine|mesh-list
65659474|NCT03098368|Dopamine Agonists|dopamine agonists|mesh-ancestor
65659475|NCT03098368|Dopamine Agents|dopamine agents|mesh-ancestor
65659476|NCT03098368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65659477|NCT03098368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659478|NCT03098368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659479|NCT05062486|Curcumin|curcumin|mesh-list
65659480|NCT05062486|Resveratrol|resveratrol|mesh-list
65659481|NCT05062486|Quercetin|quercetin|mesh-list
65659482|NCT05062486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65659483|NCT05062486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65659484|NCT05062486|Analgesics|analgesics|mesh-ancestor
65659485|NCT05062486|Sensory System Agents|sensory system agents|mesh-ancestor
65659486|NCT05062486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65659487|NCT05062486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659488|NCT05062486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65659489|NCT05062486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65659490|NCT05062486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65659491|NCT05062486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659492|NCT05062486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659493|NCT05062486|Antioxidants|antioxidants|mesh-ancestor
65659494|NCT05062486|Protective Agents|protective agents|mesh-ancestor
65659495|NCT05062486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65659496|NCT04474600|Propofol|propofol|mesh-list
65659497|NCT04474600|Desflurane|desflurane|mesh-list
65659498|NCT04474600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65659499|NCT04474600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65659500|NCT04474600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659501|NCT04474600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65659502|NCT04474600|Anesthetics, General|anesthetics, general|mesh-ancestor
65659503|NCT04474600|Anesthetics|anesthetics|mesh-ancestor
65659504|NCT04474600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65659505|NCT02314208|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
65659506|NCT02314208|Resveratrol|resveratrol|mesh-list
65659507|NCT02314208|Atorvastatin|atorvastatin|mesh-list
65659508|NCT02314208|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65659509|NCT02314208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65659510|NCT02314208|Antimetabolites|antimetabolites|mesh-ancestor
65659511|NCT02314208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659512|NCT02314208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65659513|NCT02314208|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65659514|NCT02314208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659515|NCT02314208|Antioxidants|antioxidants|mesh-ancestor
65659516|NCT02314208|Protective Agents|protective agents|mesh-ancestor
65268294|NCT02750696|Analgesics|analgesics|mesh-ancestor
65659517|NCT02314208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659518|NCT02314208|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65659519|NCT02314208|Cathartics|cathartics|mesh-ancestor
65659520|NCT02314208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65659521|NCT03100318|Dotinurad|dotinurad|mesh-list
65659522|NCT03100318|Benzbromarone|benzbromarone|mesh-list
65659523|NCT03100318|Uricosuric Agents|uricosuric agents|mesh-ancestor
65659524|NCT03100318|Gout Suppressants|gout suppressants|mesh-ancestor
65659525|NCT03100318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65659526|NCT03100318|Renal Agents|renal agents|mesh-ancestor
65659527|NCT02311010|Tacrolimus|tacrolimus|mesh-list
65659528|NCT02311010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65659529|NCT02311010|Immunologic Factors|immunologic factors|mesh-ancestor
65659530|NCT02311010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659531|NCT02311010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65659532|NCT02311010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659533|NCT02311010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659534|NCT05020600|Pregabalin|pregabalin|mesh-list
65659535|NCT05020600|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65659536|NCT05020600|Amitriptyline|amitriptyline|mesh-list
65659537|NCT05020600|Analgesics|analgesics|mesh-ancestor
65659538|NCT05020600|Sensory System Agents|sensory system agents|mesh-ancestor
65659539|NCT05020600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65659540|NCT05020600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659541|NCT05020600|Anticonvulsants|anticonvulsants|mesh-ancestor
65659542|NCT05020600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65659543|NCT05020600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65659544|NCT05020600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659545|NCT05020600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65659546|NCT05020600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65659547|NCT05020600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65659548|NCT05020600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65659549|NCT05020600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65659550|NCT05020600|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65659551|NCT05020600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65659552|NCT05020600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65659553|NCT05020600|Antidepressive Agents|antidepressive agents|mesh-ancestor
65659554|NCT05020600|Dopamine Agents|dopamine agents|mesh-ancestor
65659555|NCT05020600|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65659556|NCT05020600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65659557|NCT05020600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65659558|NCT05020600|Adrenergic Agents|adrenergic agents|mesh-ancestor
65659559|NCT02314286|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65659560|NCT02314286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65659561|NCT02314286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65659562|NCT02314286|Antimetabolites|antimetabolites|mesh-ancestor
65659563|NCT02314286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659564|NCT02314286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65659565|NCT02314286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65659566|NCT02314286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659567|NCT03132194|Dapsone|dapsone|mesh-list
65659568|NCT03132194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65659569|NCT03132194|Antimalarials|antimalarials|mesh-ancestor
65659570|NCT03132194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65659571|NCT03132194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65659572|NCT03132194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65659573|NCT03132194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659574|NCT03132194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659575|NCT03132194|Leprostatic Agents|leprostatic agents|mesh-ancestor
65659576|NCT03132194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65659577|NCT02311088|Caffeine|caffeine|mesh-list
65659578|NCT02311088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65659579|NCT02311088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659580|NCT02311088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65659581|NCT02311088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659582|NCT02311088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659583|NCT02311088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65659584|NCT02311088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65659585|NCT02311088|Purinergic Agents|purinergic agents|mesh-ancestor
65659586|NCT02311088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65659587|NCT03501212|Anesthetics|anesthetics|mesh-list
65659588|NCT03501212|Anesthetics, Local|anesthetics, local|mesh-list
65659589|NCT03501212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65659590|NCT03501212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659591|NCT03501212|Sensory System Agents|sensory system agents|mesh-ancestor
65659592|NCT03501212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65659593|NCT02317484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65659594|NCT02317484|Ipragliflozin|ipragliflozin|mesh-list
65659595|NCT02317484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659596|NCT02317484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65659597|NCT02317484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659598|NCT04435210|Hydralazine|hydralazine|mesh-list
65659599|NCT04435210|Nifedipine|nifedipine|mesh-list
65659600|NCT04435210|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65659601|NCT04435210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65659602|NCT04435210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659603|NCT04435210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65659604|NCT04435210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659605|NCT04435210|Vasodilator Agents|vasodilator agents|mesh-ancestor
65659606|NCT04435210|Tocolytic Agents|tocolytic agents|mesh-ancestor
65659607|NCT04435210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65659608|NCT04435210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65659609|NCT03501056|Antibodies|antibodies|mesh-list
65659610|NCT03501056|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65659611|NCT03501056|Immunologic Factors|immunologic factors|mesh-ancestor
65659612|NCT03501056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659613|NCT03292146|Denosumab|denosumab|mesh-list
65659614|NCT03292146|Alendronate|alendronate|mesh-list
65659615|NCT03292146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65659616|NCT03292146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659617|NCT02144376|Psyllium|psyllium|mesh-list
65659618|NCT02144376|Cathartics|cathartics|mesh-ancestor
65659619|NCT02144376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65659620|NCT02314754|Misoprostol|misoprostol|mesh-list
65659621|NCT02314754|Mifepristone|mifepristone|mesh-list
65659622|NCT02314754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65659623|NCT02314754|Abortifacient Agents|abortifacient agents|mesh-ancestor
65659624|NCT02314754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65659625|NCT02314754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659626|NCT02314754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65659627|NCT02314754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65659628|NCT02314754|Oxytocics|oxytocics|mesh-ancestor
65659629|NCT02314754|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65659630|NCT02314754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65659631|NCT02314754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65659632|NCT02314754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65659633|NCT02314754|Contraceptive Agents|contraceptive agents|mesh-ancestor
65659634|NCT02314754|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65659635|NCT02314754|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65659636|NCT02314754|Hormone Antagonists|hormone antagonists|mesh-ancestor
65659637|NCT02314754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65659638|NCT02314754|Luteolytic Agents|luteolytic agents|mesh-ancestor
65659639|NCT02314754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65659640|NCT02314754|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65659641|NCT02317640|Testosterone|testosterone|mesh-list
65659642|NCT02317640|Androgens|androgens|mesh-ancestor
65659643|NCT02317640|Hormones|hormones|mesh-ancestor
65659644|NCT02317640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65659645|NCT02317640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659646|NCT02716948|Nivolumab|nivolumab|mesh-list
65659647|NCT02716948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65659648|NCT02716948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65659649|NCT02716948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65659650|NCT02716948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659651|NCT03500900|Vildagliptin|vildagliptin|mesh-list
65659652|NCT03500900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65659653|NCT03500900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659654|NCT03500900|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65659655|NCT03500900|Protease Inhibitors|protease inhibitors|mesh-ancestor
65659656|NCT03500900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659657|NCT03500900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659658|NCT02144688|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65659659|NCT02144688|Antiviral Agents|antiviral agents|mesh-ancestor
65659660|NCT02144688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65659661|NCT02141100|Thioguanine|thioguanine|mesh-list
65659662|NCT02141100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65659663|NCT02141100|Antimetabolites|antimetabolites|mesh-ancestor
65659664|NCT02141100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659665|NCT02141100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65659666|NCT02141178|Bupivacaine|bupivacaine|mesh-list
65659667|NCT02141178|Anesthetics, Local|anesthetics, local|mesh-ancestor
65659668|NCT02141178|Anesthetics|anesthetics|mesh-ancestor
65659669|NCT02141178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65659670|NCT02141178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659671|NCT02141178|Sensory System Agents|sensory system agents|mesh-ancestor
65659672|NCT02141178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65659673|NCT02141412|Dexmedetomidine|dexmedetomidine|mesh-list
65659674|NCT02141412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65659675|NCT02141412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65659676|NCT02141412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659677|NCT02141412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65659678|NCT02141412|Analgesics|analgesics|mesh-ancestor
65659679|NCT02141412|Sensory System Agents|sensory system agents|mesh-ancestor
65659680|NCT02141412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65659681|NCT02141412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65659682|NCT02141412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65659683|NCT02141412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65659684|NCT02141412|Adrenergic Agents|adrenergic agents|mesh-ancestor
65659685|NCT02141412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65659686|NCT02141412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659687|NCT04463264|Nitazoxanide|nitazoxanide|mesh-list
65659688|NCT04463264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65659689|NCT04463264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65659690|NCT03210558|Testosterone|testosterone|mesh-list
65659691|NCT03210558|Androgens|androgens|mesh-ancestor
65659692|NCT03210558|Hormones|hormones|mesh-ancestor
65659693|NCT03210558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65659694|NCT03210558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659695|NCT05046262|Calcium|calcium|mesh-list
65659696|NCT05046262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65659697|NCT05046262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659698|NCT05036824|Tinzaparin|tinzaparin|mesh-list
65659699|NCT05036824|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65659700|NCT05036824|Dalteparin|dalteparin|mesh-list
65659701|NCT05036824|Anticoagulants|anticoagulants|mesh-ancestor
65659702|NCT05036824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65659703|NCT05036824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65659704|NCT05036824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659705|NCT03184194|Cyclophosphamide|cyclophosphamide|mesh-list
65659706|NCT03184194|Nivolumab|nivolumab|mesh-list
65659707|NCT03184194|Daratumumab|daratumumab|mesh-list
65659708|NCT03184194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65659709|NCT03184194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65659710|NCT03184194|Immunologic Factors|immunologic factors|mesh-ancestor
65659711|NCT03184194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659712|NCT03184194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65659713|NCT03184194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65659714|NCT03184194|Alkylating Agents|alkylating agents|mesh-ancestor
65659715|NCT03184194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659716|NCT03184194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65659717|NCT03184194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65659718|NCT03184194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65659719|NCT03184194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65659720|NCT04462250|Analgesics, Opioid|analgesics, opioid|mesh-list
65659721|NCT04462250|Narcotics|narcotics|mesh-ancestor
65659722|NCT04462250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65659723|NCT04462250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659724|NCT04462250|Analgesics|analgesics|mesh-ancestor
65659725|NCT04462250|Sensory System Agents|sensory system agents|mesh-ancestor
65659726|NCT04462250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65659727|NCT02144766|Ropivacaine|ropivacaine|mesh-list
65659728|NCT02144766|Anesthetics, Local|anesthetics, local|mesh-ancestor
65659729|NCT02144766|Anesthetics|anesthetics|mesh-ancestor
65659730|NCT02144766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65659731|NCT02144766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659732|NCT02144766|Sensory System Agents|sensory system agents|mesh-ancestor
65659733|NCT02144766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65659734|NCT05045248|Apraclonidine|apraclonidine|mesh-list
65659735|NCT05045248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65659736|NCT05045248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65659737|NCT05045248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65659738|NCT05045248|Adrenergic Agents|adrenergic agents|mesh-ancestor
65659739|NCT05045248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65659740|NCT05045248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659741|NCT05045248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659743|NCT02144922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65659744|NCT02144922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65659745|NCT02144922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65659746|NCT02144922|Antimetabolites|antimetabolites|mesh-ancestor
65659747|NCT02144922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659748|NCT02144922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659749|NCT02144922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65659750|NCT02261064|Amlodipine|amlodipine|mesh-list
65659751|NCT02261064|Telmisartan|telmisartan|mesh-list
65659752|NCT02261064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
65659753|NCT02261064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65659754|NCT02261064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65659755|NCT02261064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65659756|NCT02261064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659757|NCT02261064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65659758|NCT02261064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659759|NCT02261064|Vasodilator Agents|vasodilator agents|mesh-ancestor
65659760|NCT02261064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65659761|NCT02261064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65659762|NCT02955966|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65659763|NCT02955966|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65659764|NCT02955966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659765|NCT05035498|Phenylephrine|phenylephrine|mesh-list
65659766|NCT05035498|Oxymetazoline|oxymetazoline|mesh-list
65659767|NCT05035498|Norepinephrine|norepinephrine|mesh-list
65659768|NCT05035498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65659769|NCT05035498|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65659770|NCT05035498|Mydriatics|mydriatics|mesh-ancestor
65659771|NCT05035498|Autonomic Agents|autonomic agents|mesh-ancestor
65659772|NCT05035498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65659773|NCT05035498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659774|NCT05035498|Sympathomimetics|sympathomimetics|mesh-ancestor
65659775|NCT05035498|Nasal Decongestants|nasal decongestants|mesh-ancestor
65659776|NCT05035498|Respiratory System Agents|respiratory system agents|mesh-ancestor
65659777|NCT05035498|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65659778|NCT05035498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65659779|NCT05035498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65659780|NCT05035498|Adrenergic Agents|adrenergic agents|mesh-ancestor
65659781|NCT05035498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65659782|NCT05035498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659783|NCT05035498|Protective Agents|protective agents|mesh-ancestor
65659784|NCT03498326|Gemcitabine|gemcitabine|mesh-list
65659785|NCT03498326|Celecoxib|celecoxib|mesh-list
65659786|NCT03498326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65659787|NCT03498326|Antimetabolites|antimetabolites|mesh-ancestor
65659788|NCT03498326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659789|NCT03498326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65659790|NCT03498326|Antiviral Agents|antiviral agents|mesh-ancestor
65659791|NCT03498326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65659792|NCT03498326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659793|NCT03498326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65659794|NCT03498326|Immunologic Factors|immunologic factors|mesh-ancestor
65659795|NCT03498326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659796|NCT03498326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65659797|NCT03498326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65659798|NCT03498326|Analgesics|analgesics|mesh-ancestor
65659799|NCT03498326|Sensory System Agents|sensory system agents|mesh-ancestor
65659800|NCT03498326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65659801|NCT03498326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65659802|NCT03498326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65659803|NCT03498326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65659804|NCT03498326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65659805|NCT03498248|Lenograstim|lenograstim|mesh-list
65659806|NCT03498248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65659807|NCT03498248|Immunologic Factors|immunologic factors|mesh-ancestor
65659808|NCT03498248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659809|NCT01360996|Contraceptive Agents|contraceptive agents|mesh-list
65659810|NCT01360996|Contraceptives, Oral|contraceptives, oral|mesh-list
65659811|NCT01360996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65659812|NCT01360996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659813|NCT01360996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65659814|NCT03498170|Itraconazole|itraconazole|mesh-list
65659815|NCT03498170|Acumapimod|acumapimod|mesh-list
65659816|NCT03498170|Antifungal Agents|antifungal agents|mesh-ancestor
65659817|NCT03498170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65659818|NCT03498170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65659819|NCT03498170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65659820|NCT03498170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659821|NCT03498170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659822|NCT03498170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65659823|NCT03498170|Hormone Antagonists|hormone antagonists|mesh-ancestor
65659824|NCT03498170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65659825|NCT03498170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659826|NCT03498170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65659827|NCT03498170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65659829|NCT05055544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65659830|NCT05055544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65659831|NCT03498092|Dexmedetomidine|dexmedetomidine|mesh-list
65659832|NCT03498092|Bupivacaine|bupivacaine|mesh-list
65659833|NCT03498092|Anesthetics, Local|anesthetics, local|mesh-ancestor
65659834|NCT03498092|Anesthetics|anesthetics|mesh-ancestor
65659835|NCT03498092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65659836|NCT03498092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659837|NCT03498092|Sensory System Agents|sensory system agents|mesh-ancestor
65659838|NCT03498092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65659839|NCT03498092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65659840|NCT03498092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65659841|NCT03498092|Analgesics|analgesics|mesh-ancestor
65659842|NCT03498092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65659843|NCT03498092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65659844|NCT03498092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65659845|NCT03498092|Adrenergic Agents|adrenergic agents|mesh-ancestor
65659846|NCT03498092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65659847|NCT03498092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659848|NCT03500432|Lidocaine|lidocaine|mesh-list
65659849|NCT03500432|Anesthetics, Local|anesthetics, local|mesh-ancestor
65659850|NCT03500432|Anesthetics|anesthetics|mesh-ancestor
65659851|NCT03500432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65659852|NCT03500432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659853|NCT03500432|Sensory System Agents|sensory system agents|mesh-ancestor
65659854|NCT03500432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65659855|NCT03500432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65659856|NCT03500432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65659857|NCT03500432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65659858|NCT03500432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65659859|NCT03500432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659860|NCT01951885|Mycophenolic Acid|mycophenolic acid|mesh-list
65659861|NCT01951885|Methotrexate|methotrexate|mesh-list
65659862|NCT01951885|Tacrolimus|tacrolimus|mesh-list
65659863|NCT01951885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65659864|NCT01951885|Abortifacient Agents|abortifacient agents|mesh-ancestor
65659865|NCT01951885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65659866|NCT01951885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659867|NCT01951885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65659868|NCT01951885|Antimetabolites|antimetabolites|mesh-ancestor
65659869|NCT01951885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659870|NCT01951885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65659871|NCT01951885|Dermatologic Agents|dermatologic agents|mesh-ancestor
65659872|NCT01951885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659873|NCT01951885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65659874|NCT01951885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65659875|NCT01951885|Immunologic Factors|immunologic factors|mesh-ancestor
65659876|NCT01951885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65659877|NCT01951885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65659878|NCT01951885|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65659879|NCT01951885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65659880|NCT01951885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65659881|NCT01951885|Antitubercular Agents|antitubercular agents|mesh-ancestor
65659882|NCT01951885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65659883|NCT01951885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65659884|NCT02315690|Piperaquine|piperaquine|mesh-list
65659885|NCT02315690|Artenimol|artenimol|mesh-list
65659886|NCT02315690|Antimalarials|antimalarials|mesh-ancestor
65659887|NCT02315690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65659888|NCT02315690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65659889|NCT02315690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65659890|NCT02639338|Sofosbuvir|sofosbuvir|mesh-list
65659891|NCT02639338|Velpatasvir|velpatasvir|mesh-list
65659892|NCT02639338|Antiviral Agents|antiviral agents|mesh-ancestor
65659893|NCT02639338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65659894|NCT01754857|Rituximab|rituximab|mesh-list
65659895|NCT01754857|Lenalidomide|lenalidomide|mesh-list
65659896|NCT01754857|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65659897|NCT01754857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65659898|NCT01754857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65659899|NCT01754857|Immunologic Factors|immunologic factors|mesh-ancestor
65659900|NCT01754857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659901|NCT01754857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65659902|NCT01754857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65659903|NCT01754857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65659904|NCT01754857|Growth Substances|growth substances|mesh-ancestor
65659905|NCT01754857|Growth Inhibitors|growth inhibitors|mesh-ancestor
65659906|NCT01754857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65659907|NCT01754857|Alkylating Agents|alkylating agents|mesh-ancestor
65659908|NCT01754857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659909|NCT03497702|Cyclophosphamide|cyclophosphamide|mesh-list
65659910|NCT03497702|Docetaxel|docetaxel|mesh-list
65659911|NCT03497702|Doxorubicin|doxorubicin|mesh-list
65659912|NCT03497702|Letrozole|letrozole|mesh-list
65659913|NCT03497702|Leuprolide|leuprolide|mesh-list
65659914|NCT03497702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65659915|NCT03497702|Immunologic Factors|immunologic factors|mesh-ancestor
65659916|NCT03497702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659917|NCT03497702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65659918|NCT03497702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65659919|NCT03497702|Alkylating Agents|alkylating agents|mesh-ancestor
65659920|NCT03497702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659921|NCT03497702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65659922|NCT03497702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65659923|NCT03497702|Tubulin Modulators|tubulin modulators|mesh-ancestor
65659924|NCT03497702|Antimitotic Agents|antimitotic agents|mesh-ancestor
65659925|NCT03497702|Mitosis Modulators|mitosis modulators|mesh-ancestor
65659926|NCT03497702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65659927|NCT03497702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65659928|NCT03497702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65659929|NCT03497702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659930|NCT03497702|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65659931|NCT03497702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65659932|NCT03497702|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65659933|NCT03497702|Hormone Antagonists|hormone antagonists|mesh-ancestor
65659934|NCT03497702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65659935|NCT03497702|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65659936|NCT03497702|Fertility Agents|fertility agents|mesh-ancestor
65659937|NCT03497702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65659938|NCT03497702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65659939|NCT02900352|Zonisamide|zonisamide|mesh-list
65659940|NCT02900352|Anticonvulsants|anticonvulsants|mesh-ancestor
65659941|NCT02900352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65659942|NCT02900352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65659943|NCT02900352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659944|NCT02900352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65659945|NCT02900352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659946|NCT05034406|Lidocaine|lidocaine|mesh-list
65659947|NCT05034406|Levobupivacaine|levobupivacaine|mesh-list
65659948|NCT05034406|Anesthetics, Local|anesthetics, local|mesh-ancestor
65659949|NCT05034406|Anesthetics|anesthetics|mesh-ancestor
65659950|NCT05034406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65659951|NCT05034406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659952|NCT05034406|Sensory System Agents|sensory system agents|mesh-ancestor
65659953|NCT05034406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65659954|NCT05034406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65659955|NCT05034406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65659956|NCT05034406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65659957|NCT05034406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65659958|NCT05034406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659959|NCT02254668|Mycophenolic Acid|mycophenolic acid|mesh-list
65659960|NCT02254668|Everolimus|everolimus|mesh-list
65659961|NCT02254668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65659962|NCT02254668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65659963|NCT02254668|Immunologic Factors|immunologic factors|mesh-ancestor
65659964|NCT02254668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659965|NCT02254668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65659966|NCT02254668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65659967|NCT02254668|Antitubercular Agents|antitubercular agents|mesh-ancestor
65659968|NCT02254668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65659969|NCT02254668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65659970|NCT02254668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659971|NCT02254668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659972|NCT03095404|Lidocaine|lidocaine|mesh-list
65659973|NCT03095404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65659974|NCT03095404|Anesthetics, Local|anesthetics, local|mesh-ancestor
65659975|NCT03095404|Anesthetics|anesthetics|mesh-ancestor
65659976|NCT03095404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65659977|NCT03095404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65659978|NCT03095404|Sensory System Agents|sensory system agents|mesh-ancestor
65659979|NCT03095404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65659980|NCT03095404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65659981|NCT03095404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65659982|NCT03095404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65659983|NCT03095404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65659984|NCT03095404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659985|NCT02145546|Amiodarone|amiodarone|mesh-list
65659986|NCT02145546|Sotalol|sotalol|mesh-list
65659987|NCT02145546|Propafenone|propafenone|mesh-list
65659988|NCT02145546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65659989|NCT02145546|Vasodilator Agents|vasodilator agents|mesh-ancestor
65659990|NCT02145546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65659991|NCT02145546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65659992|NCT02145546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65659993|NCT02145546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65659994|NCT02145546|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65659995|NCT02145546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65659996|NCT02145546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65659997|NCT02145546|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65659998|NCT02145546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65659999|NCT02145546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65660000|NCT02145546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65660001|NCT02145546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65660002|NCT02145546|Adrenergic Agents|adrenergic agents|mesh-ancestor
65660003|NCT02145546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65660004|NCT02145546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660005|NCT02145546|Sympatholytics|sympatholytics|mesh-ancestor
65660006|NCT02145546|Autonomic Agents|autonomic agents|mesh-ancestor
65660007|NCT02145546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65660008|NCT02145546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65660009|NCT03039673|Interleukin-2|interleukin-2|mesh-list
65660010|NCT03039673|Riluzole|riluzole|mesh-list
65660011|NCT03039673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65660012|NCT03039673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65660013|NCT03039673|Analgesics|analgesics|mesh-ancestor
65660014|NCT03039673|Sensory System Agents|sensory system agents|mesh-ancestor
65660015|NCT03039673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65660016|NCT03039673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660017|NCT03039673|Anticonvulsants|anticonvulsants|mesh-ancestor
65660018|NCT03039673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65660019|NCT03039673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65660020|NCT03039673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65660021|NCT03039673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660022|NCT03039673|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65660023|NCT03039673|Protective Agents|protective agents|mesh-ancestor
65660024|NCT02145624|Vaccines|vaccines|mesh-list
65660025|NCT02145624|Immunologic Factors|immunologic factors|mesh-ancestor
65660026|NCT02145624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660027|NCT02321384|Ritonavir|ritonavir|mesh-list
65660028|NCT02321384|Midazolam|midazolam|mesh-list
65660029|NCT02321384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65660030|NCT02321384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65660031|NCT02321384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65660032|NCT02321384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660033|NCT02321384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65660034|NCT02321384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65660035|NCT02321384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65457450|NCT01289236|Sensory System Agents|sensory system agents|mesh-ancestor
65660036|NCT02321384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65660037|NCT02321384|Anesthetics, General|anesthetics, general|mesh-ancestor
65660038|NCT02321384|Anesthetics|anesthetics|mesh-ancestor
65660039|NCT02321384|GABA Modulators|gaba modulators|mesh-ancestor
65660040|NCT02321384|GABA Agents|gaba agents|mesh-ancestor
65660041|NCT02321384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65660042|NCT02321384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660043|NCT02321384|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65660044|NCT02321384|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65660045|NCT02321384|Protease Inhibitors|protease inhibitors|mesh-ancestor
65660046|NCT02321384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660047|NCT02321384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65660048|NCT02321384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65660049|NCT02321384|Antiviral Agents|antiviral agents|mesh-ancestor
65660050|NCT02321384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660051|NCT02321384|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65660052|NCT02321384|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65660053|NCT03095326|Zinc|zinc|mesh-list
65660054|NCT03095326|Zinc Sulfate|zinc sulfate|mesh-list
65660055|NCT03095326|Vaccines|vaccines|mesh-list
65660056|NCT03095326|Immunologic Factors|immunologic factors|mesh-ancestor
65660057|NCT03095326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660058|NCT03095326|Trace Elements|trace elements|mesh-ancestor
65660059|NCT03095326|Micronutrients|micronutrients|mesh-ancestor
65660060|NCT03095326|Astringents|astringents|mesh-ancestor
65660061|NCT03095326|Dermatologic Agents|dermatologic agents|mesh-ancestor
65660062|NCT02318810|Rocuronium|rocuronium|mesh-list
65660063|NCT02318810|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65660064|NCT02318810|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65660065|NCT02318810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65660066|NCT02318810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65660067|NCT02318810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660068|NCT03500120|Fludrocortisone|fludrocortisone|mesh-list
65660069|NCT03500120|Captopril|captopril|mesh-list
65660070|NCT03500120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65660071|NCT03500120|Protease Inhibitors|protease inhibitors|mesh-ancestor
65660072|NCT03500120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660073|NCT03500120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660074|NCT03500120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65660075|NCT03500120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65660076|NCT02141958|Fenretinide|fenretinide|mesh-list
65660077|NCT02141958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65660078|NCT02141958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65660079|NCT02141958|Protective Agents|protective agents|mesh-ancestor
65660080|NCT02141958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660081|NCT02142036|Trastuzumab|trastuzumab|mesh-list
65660082|NCT02142036|Cetuximab|cetuximab|mesh-list
65660083|NCT02142036|Panitumumab|panitumumab|mesh-list
65660084|NCT02142036|Everolimus|everolimus|mesh-list
65660085|NCT02142036|Sunitinib|sunitinib|mesh-list
65660086|NCT02142036|Dasatinib|dasatinib|mesh-list
65660087|NCT02142036|Lapatinib|lapatinib|mesh-list
65660088|NCT02142036|Gefitinib|gefitinib|mesh-list
65660089|NCT02142036|Afatinib|afatinib|mesh-list
65660090|NCT02142036|Vemurafenib|vemurafenib|mesh-list
65660091|NCT02142036|Dabrafenib|dabrafenib|mesh-list
65660092|NCT02142036|Crizotinib|crizotinib|mesh-list
65660093|NCT02142036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65660094|NCT02142036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65660095|NCT02142036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65660096|NCT02142036|Immunologic Factors|immunologic factors|mesh-ancestor
65660097|NCT02142036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660098|NCT02142036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65660099|NCT02142036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660100|NCT02142036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660101|NCT02142036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65660102|NCT02142036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65660103|NCT02142036|Growth Substances|growth substances|mesh-ancestor
65660104|NCT02142036|Growth Inhibitors|growth inhibitors|mesh-ancestor
65660105|NCT05053594|Neostigmine|neostigmine|mesh-list
65660106|NCT05053594|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65660107|NCT05053594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660108|NCT05053594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660109|NCT05053594|Cholinergic Agents|cholinergic agents|mesh-ancestor
65660110|NCT05053594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65660111|NCT05053594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660112|NCT05053594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65660113|NCT05053594|Autonomic Agents|autonomic agents|mesh-ancestor
65660114|NCT05053594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65660116|NCT02318888|Dialysis Solutions|dialysis solutions|mesh-ancestor
65660117|NCT02318888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65660118|NCT02142192|Natalizumab|natalizumab|mesh-list
65660119|NCT02142192|Immunologic Factors|immunologic factors|mesh-ancestor
65660120|NCT02142192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660121|NCT03097120|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65660122|NCT03097120|Medroxyprogesterone|medroxyprogesterone|mesh-list
65660123|NCT03097120|Estrogens|estrogens|mesh-list
65660124|NCT03097120|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65660125|NCT03097120|Hormones|hormones|mesh-ancestor
65660126|NCT03097120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65660127|NCT03097120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660128|NCT03097120|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65660129|NCT03097120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65660130|NCT03097120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65660131|NCT03097120|Contraceptive Agents|contraceptive agents|mesh-ancestor
65660132|NCT03097120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65660133|NCT03097120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65660134|NCT03097120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65660135|NCT03097120|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65660136|NCT03097120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65660137|NCT03097120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65660138|NCT02324582|Pembrolizumab|pembrolizumab|mesh-list
65660139|NCT02324582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65660140|NCT02324582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65660141|NCT01255891|Androgens|androgens|mesh-list
65660142|NCT01255891|Hormones|hormones|mesh-ancestor
65660143|NCT01255891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65660144|NCT01255891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660145|NCT02777190|Misoprostol|misoprostol|mesh-list
65660146|NCT02777190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65660147|NCT02777190|Abortifacient Agents|abortifacient agents|mesh-ancestor
65660148|NCT02777190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65660149|NCT02777190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660150|NCT02777190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65660151|NCT02777190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65660152|NCT02777190|Oxytocics|oxytocics|mesh-ancestor
65660153|NCT03494426|Pregabalin|pregabalin|mesh-list
65660154|NCT03494426|Tramadol|tramadol|mesh-list
65660155|NCT03494426|Antidepressive Agents|antidepressive agents|mesh-list
65660156|NCT03494426|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
65660157|NCT03494426|Analgesics|analgesics|mesh-ancestor
65660158|NCT03494426|Sensory System Agents|sensory system agents|mesh-ancestor
65660159|NCT03494426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65660160|NCT03494426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660161|NCT03494426|Anticonvulsants|anticonvulsants|mesh-ancestor
65660162|NCT03494426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65660163|NCT03494426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65660164|NCT03494426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660165|NCT03494426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65660166|NCT03494426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65660167|NCT03494426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65660168|NCT03494426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65660169|NCT03494426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65660170|NCT03494426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65660171|NCT03494426|Narcotics|narcotics|mesh-ancestor
65660172|NCT02432209|Orlistat|orlistat|mesh-list
65660173|NCT02432209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660174|NCT02432209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660175|NCT02432209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65660176|NCT02432209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65660177|NCT00108732|Metronidazole|metronidazole|mesh-list
65660178|NCT00108732|Goserelin|goserelin|mesh-list
65660179|NCT00108732|Bicalutamide|bicalutamide|mesh-list
65660180|NCT00108732|Vaccines|vaccines|mesh-list
65660181|NCT00108732|Sargramostim|sargramostim|mesh-list
65660182|NCT00108732|Immunologic Factors|immunologic factors|mesh-ancestor
65660183|NCT00108732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660184|NCT00108732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65660185|NCT00108732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65660186|NCT00108732|Androgen Antagonists|androgen antagonists|mesh-ancestor
65660187|NCT00108732|Hormone Antagonists|hormone antagonists|mesh-ancestor
65660188|NCT00108732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65660189|NCT00108732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660190|NCT00108732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65660191|NCT00108732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65660192|NCT00108732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65660193|NCT02319200|Metformin|metformin|mesh-list
65660194|NCT02319200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65660195|NCT02319200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660196|NCT02319278|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65660197|NCT02319278|Hematinics|hematinics|mesh-ancestor
65660198|NCT02319278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65660199|NCT02319278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65660200|NCT02324738|Piperaquine|piperaquine|mesh-list
65660201|NCT02324738|Artenimol|artenimol|mesh-list
65660202|NCT02324738|Mefloquine|mefloquine|mesh-list
65660203|NCT02324738|Antimalarials|antimalarials|mesh-ancestor
65660204|NCT02324738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65660205|NCT02324738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65660206|NCT02324738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660207|NCT02321852|Mannitol|mannitol|mesh-list
65660208|NCT02321852|Triflusal|triflusal|mesh-list
65660209|NCT02321852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65660210|NCT02321852|Diuretics|diuretics|mesh-ancestor
65660211|NCT02321852|Natriuretic Agents|natriuretic agents|mesh-ancestor
65660212|NCT02321852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660213|NCT02321852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65660214|NCT03499886|Ketamine|ketamine|mesh-list
65660215|NCT03499886|Analgesics|analgesics|mesh-ancestor
65660216|NCT03499886|Sensory System Agents|sensory system agents|mesh-ancestor
65660217|NCT03499886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65660218|NCT03499886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660219|NCT03499886|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65660220|NCT03499886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65660221|NCT03499886|Anesthetics, General|anesthetics, general|mesh-ancestor
65660222|NCT03499886|Anesthetics|anesthetics|mesh-ancestor
65660223|NCT03499886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65660224|NCT03499886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65660225|NCT03499886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65660226|NCT03499886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65660227|NCT03499886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660228|NCT05084430|Pembrolizumab|pembrolizumab|mesh-list
65660229|NCT05084430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65660230|NCT05084430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65660231|NCT02716038|Paclitaxel|paclitaxel|mesh-list
65660232|NCT02716038|Carboplatin|carboplatin|mesh-list
65660233|NCT02716038|Atezolizumab|atezolizumab|mesh-list
65660234|NCT02716038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65122990|NCT05096117|ASP8062|asp8062|mesh-list
65660235|NCT02716038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65660236|NCT02716038|Tubulin Modulators|tubulin modulators|mesh-ancestor
65660237|NCT02716038|Antimitotic Agents|antimitotic agents|mesh-ancestor
65660238|NCT02716038|Mitosis Modulators|mitosis modulators|mesh-ancestor
65660239|NCT02716038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660240|NCT03544710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
65660241|NCT03544710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660242|NCT02322008|Adalimumab|adalimumab|mesh-list
65660243|NCT02322008|Infliximab|infliximab|mesh-list
65660244|NCT02322008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65660245|NCT02322008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65660246|NCT02322008|Dermatologic Agents|dermatologic agents|mesh-ancestor
65660247|NCT02322008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65660248|NCT02647554|Urinastatin|urinastatin|mesh-list
65660249|NCT02647554|Trypsin Inhibitors|trypsin inhibitors|mesh-list
65660250|NCT02647554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65660251|NCT02647554|Protease Inhibitors|protease inhibitors|mesh-ancestor
65660252|NCT02647554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660253|NCT02647554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660254|NCT03499730|Midazolam|midazolam|mesh-list
65660255|NCT03499730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65660256|NCT03499730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65660257|NCT03499730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65660258|NCT03499730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660259|NCT03499730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65660260|NCT03499730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65660261|NCT03499730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65660262|NCT03499730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65660263|NCT03499730|Anesthetics, General|anesthetics, general|mesh-ancestor
65660264|NCT03499730|Anesthetics|anesthetics|mesh-ancestor
65660265|NCT03499730|GABA Modulators|gaba modulators|mesh-ancestor
65660266|NCT03499730|GABA Agents|gaba agents|mesh-ancestor
65457678|NCT00146640|Prednisone|prednisone|mesh-list
65660267|NCT03499730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65660268|NCT03499730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660269|NCT02143050|Metformin|metformin|mesh-list
65660270|NCT02143050|Trametinib|trametinib|mesh-list
65660271|NCT02143050|Dabrafenib|dabrafenib|mesh-list
65660272|NCT02143050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65660273|NCT02143050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660274|NCT02143050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65660275|NCT02143050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65660276|NCT02143050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660277|NCT02143050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660278|NCT02325206|Dapagliflozin|dapagliflozin|mesh-list
65660279|NCT02325206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65660280|NCT02325206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660281|NCT02325206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65660282|NCT02325206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660283|NCT02325362|Miglustat|miglustat|mesh-list
65660284|NCT02325362|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
65660285|NCT02325362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660286|NCT02325362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660287|NCT02325362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65660288|NCT02325362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65660289|NCT02325362|Antiviral Agents|antiviral agents|mesh-ancestor
65660290|NCT02325362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660291|NCT02325362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65660292|NCT02325362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65660293|NCT02325362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660294|NCT03003962|Gemcitabine|gemcitabine|mesh-list
65660295|NCT03003962|Paclitaxel|paclitaxel|mesh-list
65660296|NCT03003962|Cisplatin|cisplatin|mesh-list
65660297|NCT03003962|Carboplatin|carboplatin|mesh-list
65660298|NCT03003962|Pemetrexed|pemetrexed|mesh-list
65660299|NCT03003962|Durvalumab|durvalumab|mesh-list
65660300|NCT03003962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65660301|NCT03003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65660302|NCT03003962|Tubulin Modulators|tubulin modulators|mesh-ancestor
65660303|NCT03003962|Antimitotic Agents|antimitotic agents|mesh-ancestor
65660304|NCT03003962|Mitosis Modulators|mitosis modulators|mesh-ancestor
65660305|NCT03003962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660306|NCT03003962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65660307|NCT03003962|Antimetabolites|antimetabolites|mesh-ancestor
65660308|NCT03003962|Antiviral Agents|antiviral agents|mesh-ancestor
65660309|NCT03003962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660310|NCT03003962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660311|NCT03003962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65660312|NCT03003962|Immunologic Factors|immunologic factors|mesh-ancestor
65660313|NCT03003962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660314|NCT03003962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65660315|NCT03003962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65660316|NCT03003962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65660317|NCT04462094|Ketamine|ketamine|mesh-list
65660318|NCT04462094|Anesthetics|anesthetics|mesh-ancestor
65660319|NCT04462094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65660320|NCT04462094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660321|NCT04462094|Analgesics|analgesics|mesh-ancestor
65660322|NCT04462094|Sensory System Agents|sensory system agents|mesh-ancestor
65660323|NCT04462094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65660324|NCT04462094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65660325|NCT04462094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65660326|NCT04462094|Anesthetics, General|anesthetics, general|mesh-ancestor
65660327|NCT04462094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65660328|NCT04462094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65660329|NCT04462094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65660330|NCT04462094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660331|NCT02325440|Natalizumab|natalizumab|mesh-list
65660332|NCT02325440|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65660333|NCT02325440|Immunologic Factors|immunologic factors|mesh-ancestor
65660334|NCT02325440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660335|NCT02325440|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65660336|NCT02325440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660337|NCT02325440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65660338|NCT03499184|Metronidazole|metronidazole|mesh-list
65660339|NCT03499184|Amoxicillin|amoxicillin|mesh-list
65660340|NCT03499184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660341|NCT03499184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65660342|NCT03499184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65660343|NCT03499184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65660344|NCT00107952|Vancomycin|vancomycin|mesh-list
65660345|NCT00107952|Telavancin|telavancin|mesh-list
65660346|NCT00107952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65660347|NCT00107952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660348|NCT03499106|Itraconazole|itraconazole|mesh-list
65660349|NCT03499106|Praliciguat|praliciguat|mesh-list
65660350|NCT03499106|Antifungal Agents|antifungal agents|mesh-ancestor
65660351|NCT03499106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660352|NCT03499106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65660353|NCT03499106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65660354|NCT03499106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660355|NCT03499106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660356|NCT03499106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65660357|NCT03499106|Hormone Antagonists|hormone antagonists|mesh-ancestor
65660358|NCT03499106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65660359|NCT03499106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660360|NCT03499106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65660361|NCT03499106|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65660362|NCT03499106|Enzyme Activators|enzyme activators|mesh-ancestor
65660363|NCT03499106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65660364|NCT02146638|Fentanyl|fentanyl|mesh-list
65660365|NCT02146638|Morphine|morphine|mesh-list
65660366|NCT02146638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65660367|NCT02146638|Narcotics|narcotics|mesh-ancestor
65660368|NCT02146638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65660369|NCT02146638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660370|NCT02146638|Analgesics|analgesics|mesh-ancestor
65660371|NCT02146638|Sensory System Agents|sensory system agents|mesh-ancestor
65660372|NCT02146638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65660373|NCT02146638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65660374|NCT02146638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65660375|NCT02146638|Anesthetics, General|anesthetics, general|mesh-ancestor
65660376|NCT02146638|Anesthetics|anesthetics|mesh-ancestor
65660377|NCT02320448|Cisplatin|cisplatin|mesh-list
65660378|NCT02320448|Doxorubicin|doxorubicin|mesh-list
65660379|NCT02320448|Oxaliplatin|oxaliplatin|mesh-list
65660380|NCT02320448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65660381|NCT02320448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65268329|NCT04432610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65660382|NCT02320448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65660383|NCT02320448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65660384|NCT02320448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660385|NCT02320448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660386|NCT02320604|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65660387|NCT02320604|Antifungal Agents|antifungal agents|mesh-ancestor
65660388|NCT02320604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660389|NCT02320604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65660390|NCT02320604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65660391|NCT03493568|Dolutegravir|dolutegravir|mesh-list
65660392|NCT03493568|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65660393|NCT03493568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65660394|NCT03493568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65660395|NCT03493568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660396|NCT03493568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660397|NCT03493568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65660398|NCT03493568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65660399|NCT03493568|Antiviral Agents|antiviral agents|mesh-ancestor
65660400|NCT03493568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660401|NCT01366638|Ribavirin|ribavirin|mesh-list
65660402|NCT01366638|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65660403|NCT01366638|Simeprevir|simeprevir|mesh-list
65660404|NCT01366638|Antimetabolites|antimetabolites|mesh-ancestor
65660405|NCT01366638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660406|NCT01366638|Antiviral Agents|antiviral agents|mesh-ancestor
65660407|NCT01366638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660408|NCT01366638|Protease Inhibitors|protease inhibitors|mesh-ancestor
65660409|NCT01366638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660410|NCT02147808|Midazolam|midazolam|mesh-list
65660411|NCT02147808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65660412|NCT02147808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65660413|NCT02147808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65660414|NCT02147808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660415|NCT02147808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65660416|NCT02147808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65660417|NCT02147808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65660418|NCT02147808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65660419|NCT02147808|Anesthetics, General|anesthetics, general|mesh-ancestor
65660420|NCT02147808|Anesthetics|anesthetics|mesh-ancestor
65660421|NCT02147808|GABA Modulators|gaba modulators|mesh-ancestor
65660422|NCT02147808|GABA Agents|gaba agents|mesh-ancestor
65660423|NCT02147808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65660424|NCT02147808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660425|NCT03543072|Diphosphonates|diphosphonates|mesh-list
65660426|NCT03543072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65660427|NCT03543072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660429|NCT03493412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65660430|NCT03493412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65660431|NCT03493412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65660432|NCT03493412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660433|NCT03493412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65660434|NCT03493412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660435|NCT03493412|Vasodilator Agents|vasodilator agents|mesh-ancestor
65660436|NCT02147964|Ketoconazole|ketoconazole|mesh-list
65660437|NCT02147964|Methyltestosterone|methyltestosterone|mesh-list
65660438|NCT02147964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65660439|NCT02147964|Testosterone|testosterone|mesh-list
65660440|NCT02147964|Testosterone undecanoate|testosterone undecanoate|mesh-list
65660441|NCT02147964|Testosterone enanthate|testosterone enanthate|mesh-list
65660442|NCT02147964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65660443|NCT02147964|Dutasteride|dutasteride|mesh-list
65660444|NCT02147964|Acyline|acyline|mesh-list
65660445|NCT02147964|Androgens|androgens|mesh-ancestor
65660446|NCT02147964|Hormones|hormones|mesh-ancestor
65660447|NCT02147964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65660448|NCT02147964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660449|NCT02147964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65660450|NCT02147964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65660451|NCT02147964|Anabolic Agents|anabolic agents|mesh-ancestor
65660452|NCT02147964|Antifungal Agents|antifungal agents|mesh-ancestor
65660453|NCT02147964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660454|NCT02147964|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65660455|NCT02147964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65660456|NCT02147964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660457|NCT02147964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660458|NCT02147964|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65660459|NCT02147964|Hormone Antagonists|hormone antagonists|mesh-ancestor
65660460|NCT02147964|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65660461|NCT02147964|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65660462|NCT02147964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65660463|NCT02780700|Capecitabine|capecitabine|mesh-list
65660464|NCT02780700|Nintedanib|nintedanib|mesh-list
65660465|NCT02780700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65660466|NCT02780700|Antimetabolites|antimetabolites|mesh-ancestor
65660467|NCT02780700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660468|NCT02780700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65660469|NCT02780700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65660470|NCT02780700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660471|NCT02147262|Doxycycline|doxycycline|mesh-list
65660472|NCT02147262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65660473|NCT02147262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660474|NCT02147262|Antimalarials|antimalarials|mesh-ancestor
65660475|NCT02147262|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65660476|NCT02147262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65660477|NCT02447276|Fasinumab|fasinumab|mesh-list
65660478|NCT02447276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65660479|NCT02447276|Analgesics|analgesics|mesh-ancestor
65660480|NCT02447276|Sensory System Agents|sensory system agents|mesh-ancestor
65660481|NCT02447276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65660482|NCT02447276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660483|NCT05100134|Ceritinib|ceritinib|mesh-list
65660484|NCT05100134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65660485|NCT05100134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65660486|NCT05100134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660487|NCT05100134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660488|NCT05079620|Amoxicillin|amoxicillin|mesh-list
65660489|NCT05079620|Vancomycin|vancomycin|mesh-list
65660490|NCT05079620|Levofloxacin|levofloxacin|mesh-list
65660491|NCT05079620|Ofloxacin|ofloxacin|mesh-list
65660492|NCT05079620|Ceftriaxone|ceftriaxone|mesh-list
65660493|NCT05079620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65660494|NCT05079620|Clavulanic Acids|clavulanic acids|mesh-list
65660495|NCT05079620|Clavulanic Acid|clavulanic acid|mesh-list
65660496|NCT05079620|Cefepime|cefepime|mesh-list
65660497|NCT05079620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65660498|NCT05079620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660499|NCT05079620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65660500|NCT05079620|Renal Agents|renal agents|mesh-ancestor
65660501|NCT05079620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65660502|NCT05079620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65660503|NCT05079620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660504|NCT05079620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660505|NCT05079620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65660506|NCT05079620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65660507|NCT05079620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65660508|NCT05079620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65660509|NCT02323412|Amoxicillin|amoxicillin|mesh-list
65660510|NCT02323412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65660511|NCT02323412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660512|NCT04537910|Bamlanivimab|bamlanivimab|mesh-list
65660513|NCT04537910|Antiviral Agents|antiviral agents|mesh-ancestor
65660514|NCT04537910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660515|NCT03109730|Tenofovir|tenofovir|mesh-list
65660516|NCT03109730|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65660517|NCT03109730|Entecavir|entecavir|mesh-list
65660518|NCT03109730|Antiviral Agents|antiviral agents|mesh-ancestor
65660519|NCT03109730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660520|NCT03109730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65660521|NCT03109730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65660522|NCT03109730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660523|NCT03109730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660524|NCT03109730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65660525|NCT03109730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65660526|NCT03495206|Edaravone|edaravone|mesh-list
65660527|NCT03495206|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65660528|NCT03495206|Antioxidants|antioxidants|mesh-ancestor
65660529|NCT03495206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660530|NCT03495206|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65660531|NCT03495206|Protective Agents|protective agents|mesh-ancestor
65268333|NCT04643093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65660532|NCT03495206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660533|NCT04223024|Nimotuzumab|nimotuzumab|mesh-list
65660534|NCT04223024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65660535|NCT04223024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65660536|NCT03491696|Metyrapone|metyrapone|mesh-list
65660537|NCT03491696|Antimetabolites|antimetabolites|mesh-ancestor
65660538|NCT03491696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660539|NCT03491696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660540|NCT03492866|Gentamicins|gentamicins|mesh-list
65660541|NCT03492866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65660542|NCT03492866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660543|NCT03492866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65660544|NCT03492866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660545|NCT03492866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660546|NCT03492710|Immunoglobulins|immunoglobulins|mesh-list
65660547|NCT03492710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65660548|NCT03492710|Antibodies|antibodies|mesh-list
65660549|NCT03492710|Immunologic Factors|immunologic factors|mesh-ancestor
65660550|NCT03492710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660551|NCT03954938|Cocaine|cocaine|mesh-list
65660552|NCT03954938|Anesthetics, Local|anesthetics, local|mesh-ancestor
65660553|NCT03954938|Anesthetics|anesthetics|mesh-ancestor
65660554|NCT03954938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65660555|NCT03954938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660556|NCT03954938|Sensory System Agents|sensory system agents|mesh-ancestor
65660557|NCT03954938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65660558|NCT03954938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65660559|NCT03954938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65660560|NCT03954938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65660561|NCT03954938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65660562|NCT03954938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660563|NCT03954938|Dopamine Agents|dopamine agents|mesh-ancestor
65660564|NCT03954938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65660565|NCT02148120|Beclomethasone|beclomethasone|mesh-list
65660566|NCT02148120|Formoterol Fumarate|formoterol fumarate|mesh-list
65660567|NCT02148120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65660568|NCT02148120|Autonomic Agents|autonomic agents|mesh-ancestor
65660569|NCT02148120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457982|NCT02296918|Rituximab|rituximab|mesh-list
65660570|NCT02148120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660571|NCT02148120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65660572|NCT02148120|Respiratory System Agents|respiratory system agents|mesh-ancestor
65660573|NCT02148120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65660574|NCT02148120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65660575|NCT02148120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65660576|NCT02148120|Adrenergic Agents|adrenergic agents|mesh-ancestor
65660577|NCT02148120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65660578|NCT02148120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660579|NCT02148120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65660580|NCT02148120|Glucocorticoids|glucocorticoids|mesh-ancestor
65660581|NCT02148120|Hormones|hormones|mesh-ancestor
65660582|NCT02148120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65660583|NCT03492632|Hormones|hormones|mesh-list
65660584|NCT03492632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65660585|NCT03492632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660586|NCT02147574|Antidiarrheals|antidiarrheals|mesh-list
65660587|NCT02147574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65660588|NCT02147730|Anesthetics|anesthetics|mesh-list
65660589|NCT02147730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65660590|NCT02147730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660591|NCT02151630|Salicylic Acid|salicylic acid|mesh-list
65660592|NCT02151630|Salicylates|salicylates|mesh-list
65660593|NCT02151630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660594|NCT02151630|Antifungal Agents|antifungal agents|mesh-ancestor
65660595|NCT02151630|Keratolytic Agents|keratolytic agents|mesh-ancestor
65660596|NCT02151630|Dermatologic Agents|dermatologic agents|mesh-ancestor
65660597|NCT02151630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65660598|NCT02151630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65660599|NCT02151630|Analgesics|analgesics|mesh-ancestor
65660600|NCT02151630|Sensory System Agents|sensory system agents|mesh-ancestor
65660601|NCT02151630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65660602|NCT02151630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660603|NCT02151630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65660604|NCT02151630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65660605|NCT02151630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65660606|NCT02151630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660607|NCT02151630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660608|NCT03494972|Tetracycline|tetracycline|mesh-list
65660609|NCT03494972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65660610|NCT03494972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660611|NCT03494972|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65660612|NCT03494972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660613|NCT03494972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660614|NCT02224573|Cannabidiol|cannabidiol|mesh-list
65660615|NCT02224573|Anticonvulsants|anticonvulsants|mesh-ancestor
65660616|NCT03490058|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65660617|NCT03490058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65660618|NCT03490058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65660619|NCT03490058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660620|NCT03490058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660621|NCT03490058|Antiviral Agents|antiviral agents|mesh-ancestor
65660622|NCT03490058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660623|NCT03490058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65660624|NCT03490058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65660625|NCT02148432|Dexmedetomidine|dexmedetomidine|mesh-list
65660626|NCT02148432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65660627|NCT02148432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65660628|NCT02148432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660629|NCT02148432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65660630|NCT02148432|Analgesics|analgesics|mesh-ancestor
65660631|NCT02148432|Sensory System Agents|sensory system agents|mesh-ancestor
65660632|NCT02148432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65660633|NCT02148432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65660634|NCT02148432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65660635|NCT02148432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65660636|NCT02148432|Adrenergic Agents|adrenergic agents|mesh-ancestor
65660637|NCT02148432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65660638|NCT02148432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660639|NCT03756961|Lidocaine|lidocaine|mesh-list
65660640|NCT03756961|Dexmedetomidine|dexmedetomidine|mesh-list
65660641|NCT03756961|Remifentanil|remifentanil|mesh-list
65660642|NCT03756961|Oxycodone|oxycodone|mesh-list
65660643|NCT03756961|Propofol|propofol|mesh-list
65660644|NCT03756961|Desflurane|desflurane|mesh-list
65660645|NCT03756961|Esketamine|esketamine|mesh-list
65660646|NCT03756961|Anesthetics, Local|anesthetics, local|mesh-ancestor
65660647|NCT03756961|Anesthetics|anesthetics|mesh-ancestor
65660648|NCT03756961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65660649|NCT03756961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660650|NCT03756961|Sensory System Agents|sensory system agents|mesh-ancestor
65660651|NCT03756961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65660652|NCT03756961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65660653|NCT03756961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65660654|NCT03756961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65660655|NCT03756961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65660656|NCT03756961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660657|NCT03756961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65660658|NCT03756961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65660659|NCT03756961|Anesthetics, General|anesthetics, general|mesh-ancestor
65660660|NCT03756961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65660661|NCT03756961|Analgesics|analgesics|mesh-ancestor
65660662|NCT03756961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65660663|NCT03756961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65660664|NCT03756961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65660665|NCT03756961|Adrenergic Agents|adrenergic agents|mesh-ancestor
65660666|NCT03756961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65660667|NCT03756961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65660668|NCT03756961|Narcotics|narcotics|mesh-ancestor
65660669|NCT03756961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65660670|NCT03756961|Antidepressive Agents|antidepressive agents|mesh-ancestor
65660671|NCT03756961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65660672|NCT03350984|Insulin|insulin|mesh-list
65660673|NCT03350984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65660674|NCT03350984|Insulin Glargine|insulin glargine|mesh-list
65660675|NCT03350984|Insulin Lispro|insulin lispro|mesh-list
65660676|NCT03350984|Insulin, Isophane|insulin, isophane|mesh-list
65660677|NCT03350984|Isophane Insulin, Human|isophane insulin, human|mesh-list
65660678|NCT03350984|Isophane insulin, beef|isophane insulin, beef|mesh-list
65660679|NCT03350984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65660680|NCT03350984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660681|NCT05033314|Rivaroxaban|rivaroxaban|mesh-list
65660682|NCT05033314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65660683|NCT05033314|Antithrombins|antithrombins|mesh-ancestor
65660684|NCT05033314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65660685|NCT05033314|Protease Inhibitors|protease inhibitors|mesh-ancestor
65660686|NCT05033314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660687|NCT05033314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660688|NCT05033314|Anticoagulants|anticoagulants|mesh-ancestor
65660689|NCT03504423|Leucovorin|leucovorin|mesh-list
65660690|NCT03504423|Folic Acid|folic acid|mesh-list
65660691|NCT03504423|Oxaliplatin|oxaliplatin|mesh-list
65660692|NCT03504423|Irinotecan|irinotecan|mesh-list
65660693|NCT03504423|Folfirinox|folfirinox|mesh-list
65660694|NCT03504423|Levoleucovorin|levoleucovorin|mesh-list
65660695|NCT03504423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65660696|NCT03504423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65660697|NCT03504423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65660698|NCT03504423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660699|NCT03504423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660700|NCT03504423|Antidotes|antidotes|mesh-ancestor
65660701|NCT03504423|Protective Agents|protective agents|mesh-ancestor
65660702|NCT03504423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660703|NCT03504423|Vitamin B Complex|vitamin b complex|mesh-ancestor
65660704|NCT03504423|Vitamins|vitamins|mesh-ancestor
65660705|NCT03504423|Micronutrients|micronutrients|mesh-ancestor
65660706|NCT03504423|Hematinics|hematinics|mesh-ancestor
65660707|NCT03097198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65660708|NCT03097198|Tropicamide|tropicamide|mesh-list
65660709|NCT03097198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65660710|NCT03097198|Mydriatics|mydriatics|mesh-ancestor
65660711|NCT03097198|Autonomic Agents|autonomic agents|mesh-ancestor
65660712|NCT03097198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65660713|NCT03097198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660714|NCT03097198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65660715|NCT03097198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65660716|NCT03097198|Cholinergic Agents|cholinergic agents|mesh-ancestor
65660717|NCT03097198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65660718|NCT03097198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660719|NCT02770248|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65660720|NCT02770248|Brinzolamide|brinzolamide|mesh-list
65660721|NCT02770248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65660722|NCT02770248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65660723|NCT02770248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65660724|NCT02770248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65660725|NCT02770248|Adrenergic Agents|adrenergic agents|mesh-ancestor
65660726|NCT02770248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65660727|NCT02770248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660728|NCT02770248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660729|NCT02770248|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65660730|NCT02770248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660731|NCT03619005|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65660732|NCT03619005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65660733|NCT03619005|Immunologic Factors|immunologic factors|mesh-ancestor
65660734|NCT03619005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660735|NCT02686346|Etoposide|etoposide|mesh-list
65660736|NCT02686346|Ifosfamide|ifosfamide|mesh-list
65660737|NCT02686346|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65660738|NCT02686346|Carboplatin|carboplatin|mesh-list
65660739|NCT02686346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65660740|NCT02686346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65660741|NCT02686346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65660742|NCT02686346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65660743|NCT02686346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660744|NCT02686346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660745|NCT02686346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65660746|NCT02686346|Alkylating Agents|alkylating agents|mesh-ancestor
65660747|NCT02686346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65660748|NCT03489044|Levetiracetam|levetiracetam|mesh-list
65660749|NCT03489044|Anticonvulsants|anticonvulsants|mesh-ancestor
65660750|NCT03489044|Nootropic Agents|nootropic agents|mesh-ancestor
65123507|NCT02046395|Amlodipine|amlodipine|mesh-list
65660751|NCT01344369|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65660752|NCT01344369|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65660753|NCT01344369|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65660754|NCT01344369|Norethindrone|norethindrone|mesh-list
65660755|NCT01344369|Norethindrone Acetate|norethindrone acetate|mesh-list
65660756|NCT01344369|Estradiol|estradiol|mesh-list
65660757|NCT01344369|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65660758|NCT01344369|Estrogens|estrogens|mesh-ancestor
65660759|NCT01344369|Hormones|hormones|mesh-ancestor
65660760|NCT01344369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65660761|NCT01344369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660762|NCT01344369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65660763|NCT01344369|Contraceptive Agents|contraceptive agents|mesh-ancestor
65660764|NCT01344369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65660765|NCT01344369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65660766|NCT01344369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65660767|NCT01344369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65660768|NCT01344369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65660769|NCT03491072|Fentanyl|fentanyl|mesh-list
65660770|NCT03491072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65660771|NCT03491072|Narcotics|narcotics|mesh-ancestor
65660772|NCT03491072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65660773|NCT03491072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660774|NCT03491072|Analgesics|analgesics|mesh-ancestor
65660775|NCT03491072|Sensory System Agents|sensory system agents|mesh-ancestor
65660776|NCT03491072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65660777|NCT03491072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65660778|NCT03491072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65660779|NCT03491072|Anesthetics, General|anesthetics, general|mesh-ancestor
65660780|NCT03491072|Anesthetics|anesthetics|mesh-ancestor
65660781|NCT03503409|Ivosidenib|ivosidenib|mesh-list
65660782|NCT03503409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65660783|NCT03503409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660784|NCT03503409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660785|NCT03490994|Warfarin|warfarin|mesh-list
65660786|NCT03490994|Rivaroxaban|rivaroxaban|mesh-list
65660787|NCT03490994|Anticoagulants|anticoagulants|mesh-ancestor
65660788|NCT03490994|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65660789|NCT03490994|Antithrombins|antithrombins|mesh-ancestor
65660790|NCT03490994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65660791|NCT03490994|Protease Inhibitors|protease inhibitors|mesh-ancestor
65660792|NCT03490994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660793|NCT03490994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660794|NCT01360762|Pentamidine|pentamidine|mesh-list
65660795|NCT01360762|Antifungal Agents|antifungal agents|mesh-ancestor
65660796|NCT01360762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660797|NCT01360762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65660798|NCT01360762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65660799|NCT01360762|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65660800|NCT04382924|Ifenprodil|ifenprodil|mesh-list
65660801|NCT04382924|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65660802|NCT04382924|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65660803|NCT04382924|Adrenergic Agents|adrenergic agents|mesh-ancestor
65660804|NCT04382924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65660805|NCT04382924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660806|NCT04382924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660807|NCT04382924|Vasodilator Agents|vasodilator agents|mesh-ancestor
65660808|NCT04382924|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65660809|NCT04382924|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65660810|NCT00002601|Doxorubicin|doxorubicin|mesh-list
65660811|NCT00002601|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65660812|NCT00002601|Melphalan|melphalan|mesh-list
65660813|NCT00002601|Ifosfamide|ifosfamide|mesh-list
65660814|NCT00002601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65660815|NCT00002601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65660816|NCT00002601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65660817|NCT00002601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65660818|NCT00002601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660819|NCT00002601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660820|NCT00002601|Immunologic Factors|immunologic factors|mesh-ancestor
65660821|NCT00002601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660822|NCT00002601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65660823|NCT00002601|Alkylating Agents|alkylating agents|mesh-ancestor
65660824|NCT00002601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65660825|NCT00002601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65268338|NCT04643093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660826|NCT05033704|Plasma protein fraction|plasma protein fraction|mesh-list
65660827|NCT05033704|Plasma Substitutes|plasma substitutes|mesh-ancestor
65660828|NCT05033704|Blood Substitutes|blood substitutes|mesh-ancestor
65660829|NCT05693077|Vancomycin|vancomycin|mesh-list
65660830|NCT05693077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65660831|NCT05693077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660832|NCT02031861|Nifedipine|nifedipine|mesh-list
65660833|NCT02031861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65660834|NCT02031861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65660835|NCT02031861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660836|NCT02031861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65660837|NCT02031861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660838|NCT02031861|Vasodilator Agents|vasodilator agents|mesh-ancestor
65660839|NCT02031861|Tocolytic Agents|tocolytic agents|mesh-ancestor
65660840|NCT02031861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65660841|NCT03455439|Rivaroxaban|rivaroxaban|mesh-list
65660842|NCT03455439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65660843|NCT03455439|Antithrombins|antithrombins|mesh-ancestor
65660844|NCT03455439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65660845|NCT03455439|Protease Inhibitors|protease inhibitors|mesh-ancestor
65660846|NCT03455439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660847|NCT03455439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660848|NCT03455439|Anticoagulants|anticoagulants|mesh-ancestor
65660849|NCT02645474|Ropivacaine|ropivacaine|mesh-list
65660850|NCT02645474|Anesthetics, Local|anesthetics, local|mesh-ancestor
65660851|NCT02645474|Anesthetics|anesthetics|mesh-ancestor
65660852|NCT02645474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65660853|NCT02645474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660854|NCT02645474|Sensory System Agents|sensory system agents|mesh-ancestor
65660855|NCT02645474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65660856|NCT05052814|Chlorhexidine|chlorhexidine|mesh-list
65660857|NCT05052814|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65660858|NCT05052814|Root Canal Irrigants|root canal irrigants|mesh-list
65660859|NCT05052814|Calcium|calcium|mesh-list
65660860|NCT05052814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65660861|NCT05052814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660862|NCT05052814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65660863|NCT05052814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660864|NCT05052814|Disinfectants|disinfectants|mesh-ancestor
65660865|NCT05052814|Dermatologic Agents|dermatologic agents|mesh-ancestor
65660866|NCT05052814|Dental Disinfectants|dental disinfectants|mesh-ancestor
65660867|NCT03615417|Anesthetics|anesthetics|mesh-list
65660868|NCT03615417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65660869|NCT03615417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660870|NCT02155530|Atorvastatin|atorvastatin|mesh-list
65660871|NCT02155530|Pravastatin|pravastatin|mesh-list
65458285|NCT01189864|Antiemetics|antiemetics|mesh-ancestor
65660872|NCT02155530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65660873|NCT02155530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65660874|NCT02155530|Antimetabolites|antimetabolites|mesh-ancestor
65660875|NCT02155530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660876|NCT02155530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65660877|NCT02155530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65660878|NCT02155530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660879|NCT03516279|Pembrolizumab|pembrolizumab|mesh-list
65660880|NCT03516279|Imatinib Mesylate|imatinib mesylate|mesh-list
65660881|NCT03516279|Dasatinib|dasatinib|mesh-list
65660882|NCT03516279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65660883|NCT03516279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65660884|NCT03516279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65660885|NCT03516279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660886|NCT03516279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660887|NCT05051956|Palbociclib|palbociclib|mesh-list
65660888|NCT05051956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65660889|NCT05051956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65660890|NCT05051956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660891|NCT05051956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660892|NCT02769624|Treprostinil|treprostinil|mesh-list
65660893|NCT02769624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65660894|NCT03543774|Simvastatin|simvastatin|mesh-list
65660895|NCT03543774|Ezetimibe|ezetimibe|mesh-list
65660896|NCT03543774|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
65660897|NCT03543774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65660898|NCT03543774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65660899|NCT03543774|Antimetabolites|antimetabolites|mesh-ancestor
65660900|NCT03543774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660901|NCT03543774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65660902|NCT03543774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65660903|NCT03543774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660904|NCT03261830|Clindamycin|clindamycin|mesh-list
65660905|NCT03261830|Clindamycin palmitate|clindamycin palmitate|mesh-list
65660906|NCT03261830|Clindamycin phosphate|clindamycin phosphate|mesh-list
65660907|NCT03261830|Cefazolin|cefazolin|mesh-list
65660908|NCT03261830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65660909|NCT03261830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660910|NCT03261830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65660911|NCT03261830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660912|NCT03261830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660913|NCT02152176|Morphine|morphine|mesh-list
65660914|NCT02152176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65660915|NCT02152176|Narcotics|narcotics|mesh-ancestor
65660916|NCT02152176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65660917|NCT02152176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660918|NCT02152176|Analgesics|analgesics|mesh-ancestor
65660919|NCT02152176|Sensory System Agents|sensory system agents|mesh-ancestor
65660920|NCT02152176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65660921|NCT03617055|Cystatins|cystatins|mesh-list
65660922|NCT03617055|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65660923|NCT03617055|Protease Inhibitors|protease inhibitors|mesh-ancestor
65660924|NCT03617055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660925|NCT03617055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660926|NCT03488888|Bupivacaine|bupivacaine|mesh-list
65660927|NCT03488888|Anesthetics, Local|anesthetics, local|mesh-ancestor
65660928|NCT03488888|Anesthetics|anesthetics|mesh-ancestor
65660929|NCT03488888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65660930|NCT03488888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660931|NCT03488888|Sensory System Agents|sensory system agents|mesh-ancestor
65660932|NCT03488888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65660933|NCT05031676|Analgesics, Opioid|analgesics, opioid|mesh-list
65660934|NCT05031676|Anesthetics|anesthetics|mesh-list
65660935|NCT05031676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65660936|NCT05031676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660937|NCT05031676|Narcotics|narcotics|mesh-ancestor
65660938|NCT05031676|Analgesics|analgesics|mesh-ancestor
65660939|NCT05031676|Sensory System Agents|sensory system agents|mesh-ancestor
65660940|NCT05031676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65660941|NCT03488810|Hormones|hormones|mesh-list
65660942|NCT03488810|Androgens|androgens|mesh-list
65660943|NCT03488810|Androgen Antagonists|androgen antagonists|mesh-list
65660944|NCT03488810|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
65660945|NCT03488810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65660946|NCT03488810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660947|NCT03488810|Hormone Antagonists|hormone antagonists|mesh-ancestor
65660948|NCT03492242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65660949|NCT03492242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660950|NCT03492242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65660951|NCT03572283|Bethanechol|bethanechol|mesh-list
65660952|NCT03572283|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65660953|NCT03572283|Autonomic Agents|autonomic agents|mesh-ancestor
65660954|NCT03572283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65660955|NCT03572283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660956|NCT03572283|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65660957|NCT03572283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65660958|NCT03572283|Cholinergic Agents|cholinergic agents|mesh-ancestor
65660959|NCT03572283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65660960|NCT03572283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660961|NCT02254824|Atorvastatin|atorvastatin|mesh-list
65660962|NCT02254824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65660963|NCT02254824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65660964|NCT02254824|Antimetabolites|antimetabolites|mesh-ancestor
65660965|NCT02254824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660966|NCT02254824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65660967|NCT02254824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65660968|NCT02254824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660969|NCT01525316|Lactoferrin|lactoferrin|mesh-list
65660970|NCT01525316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65660972|NCT01673386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65660973|NCT01673386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65660974|NCT01673386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65660975|NCT01673386|Growth Substances|growth substances|mesh-ancestor
65660976|NCT01673386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660977|NCT01673386|Growth Inhibitors|growth inhibitors|mesh-ancestor
65660978|NCT01673386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65660979|NCT01673386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65660980|NCT01673386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660981|NCT00103740|Vitamin D|vitamin d|mesh-list
65660982|NCT00103740|Zoledronic Acid|zoledronic acid|mesh-list
65660983|NCT00103740|Risedronic Acid|risedronic acid|mesh-list
65660984|NCT00103740|Etidronic Acid|etidronic acid|mesh-list
65660985|NCT00103740|Calcium|calcium|mesh-list
65660986|NCT00103740|Vitamins|vitamins|mesh-ancestor
65660987|NCT00103740|Micronutrients|micronutrients|mesh-ancestor
65660988|NCT00103740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660989|NCT00103740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65660990|NCT00103740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65660991|NCT00103740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65660992|NCT00103740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65660993|NCT00103740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65660994|NCT03616509|Hormones|hormones|mesh-list
65660995|NCT03616509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65660996|NCT03616509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65660997|NCT02031939|Capecitabine|capecitabine|mesh-list
65660998|NCT02031939|Oxaliplatin|oxaliplatin|mesh-list
65660999|NCT02031939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65661000|NCT02031939|Antimetabolites|antimetabolites|mesh-ancestor
65661001|NCT02031939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661002|NCT02031939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661003|NCT02869893|Secretin|secretin|mesh-list
65661004|NCT02869893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65661005|NCT02869893|Hormones|hormones|mesh-ancestor
65661006|NCT02869893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65661007|NCT02869893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661008|NCT04907214|Empagliflozin|empagliflozin|mesh-list
65661009|NCT04907214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65661010|NCT04907214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661011|NCT04907214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65661012|NCT04907214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661013|NCT02152332|Moxifloxacin|moxifloxacin|mesh-list
65661014|NCT02152332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65661015|NCT02152332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65661016|NCT02152332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65661017|NCT02152332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65661018|NCT02152332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65661019|NCT02152332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458440|NCT00146328|Tipranavir|tipranavir|mesh-list
65661020|NCT02152332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661021|NCT02152332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661022|NCT02152332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65661023|NCT02152332|Contraceptive Agents|contraceptive agents|mesh-ancestor
65661024|NCT02152332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65661025|NCT02152332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661026|NCT02152332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65661027|NCT02152332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65661028|NCT02152332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65661029|NCT05118308|Liver Extracts|liver extracts|mesh-list
65661030|NCT05118308|Hematinics|hematinics|mesh-ancestor
65661031|NCT03617289|Magnesium Sulfate|magnesium sulfate|mesh-list
65661032|NCT03617289|Analgesics|analgesics|mesh-ancestor
65661033|NCT03617289|Sensory System Agents|sensory system agents|mesh-ancestor
65661034|NCT03617289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65661035|NCT03617289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661036|NCT03617289|Anesthetics|anesthetics|mesh-ancestor
65661037|NCT03617289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65661038|NCT03617289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65661039|NCT03617289|Anticonvulsants|anticonvulsants|mesh-ancestor
65661040|NCT03617289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65661041|NCT03617289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65661042|NCT03617289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661043|NCT03617289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65661044|NCT03617289|Tocolytic Agents|tocolytic agents|mesh-ancestor
65661045|NCT03617289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65661046|NCT02152410|Morphine|morphine|mesh-list
65661047|NCT02152410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65661048|NCT02152410|Narcotics|narcotics|mesh-ancestor
65661049|NCT02152410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65661050|NCT02152410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661051|NCT02152410|Analgesics|analgesics|mesh-ancestor
65661052|NCT02152410|Sensory System Agents|sensory system agents|mesh-ancestor
65661053|NCT02152410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65661054|NCT05043688|Paclitaxel|paclitaxel|mesh-list
65661055|NCT05043688|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65661056|NCT05043688|Carboplatin|carboplatin|mesh-list
65661057|NCT05043688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65661058|NCT05043688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661059|NCT05043688|Tubulin Modulators|tubulin modulators|mesh-ancestor
65661060|NCT05043688|Antimitotic Agents|antimitotic agents|mesh-ancestor
65661061|NCT05043688|Mitosis Modulators|mitosis modulators|mesh-ancestor
65661062|NCT05043688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661063|NCT03614715|Interferons|interferons|mesh-list
65661064|NCT03614715|Interferon-beta|interferon-beta|mesh-list
65661065|NCT03614715|Interferon beta-1a|interferon beta-1a|mesh-list
65661066|NCT03614715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661067|NCT03614715|Antiviral Agents|antiviral agents|mesh-ancestor
65661068|NCT03614715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65661069|NCT03614715|Immunologic Factors|immunologic factors|mesh-ancestor
65661070|NCT03614715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661071|NCT03614715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65661072|NCT02872935|Glycopyrrolate|glycopyrrolate|mesh-list
65661073|NCT02872935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65661074|NCT02872935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65661075|NCT02872935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65661076|NCT02872935|Cholinergic Agents|cholinergic agents|mesh-ancestor
65661077|NCT02872935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65661078|NCT02872935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661079|NCT02872935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661080|NCT00363038|Vitamins|vitamins|mesh-list
65661081|NCT00363038|Vitamin K|vitamin k|mesh-list
65661082|NCT00363038|Vitamin A|vitamin a|mesh-list
65661083|NCT00363038|Petrolatum|petrolatum|mesh-list
65661084|NCT00363038|Micronutrients|micronutrients|mesh-ancestor
65661085|NCT00363038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661086|NCT00363038|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65661087|NCT00363038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65661088|NCT00363038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661089|NCT00363038|Hemostatics|hemostatics|mesh-ancestor
65661090|NCT00363038|Coagulants|coagulants|mesh-ancestor
65661091|NCT00363038|Emollients|emollients|mesh-ancestor
65661092|NCT00363038|Dermatologic Agents|dermatologic agents|mesh-ancestor
65661093|NCT03489668|Metformin|metformin|mesh-list
65661094|NCT03489668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65458514|NCT01588522|Vitamins|vitamins|mesh-ancestor
65661095|NCT03489668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661097|NCT02872311|Immunologic Factors|immunologic factors|mesh-ancestor
65661098|NCT02872311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661099|NCT03614403|Vitamin D|vitamin d|mesh-list
65661100|NCT03614403|Cholecalciferol|cholecalciferol|mesh-list
65661101|NCT03614403|Vitamins|vitamins|mesh-ancestor
65661102|NCT03614403|Micronutrients|micronutrients|mesh-ancestor
65661103|NCT03614403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661104|NCT03614403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65661105|NCT03614403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65661106|NCT03488186|Lansoprazole|lansoprazole|mesh-list
65661107|NCT03488186|Dexlansoprazole|dexlansoprazole|mesh-list
65661108|NCT03488186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65661109|NCT03488186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65661110|NCT03488186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65661111|NCT03488186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661112|NCT03488186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661113|NCT05103644|Atorvastatin|atorvastatin|mesh-list
65661114|NCT05103644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65661115|NCT05103644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65661116|NCT05103644|Antimetabolites|antimetabolites|mesh-ancestor
65661117|NCT05103644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661118|NCT05103644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65661119|NCT05103644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65661120|NCT05103644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661121|NCT03887624|Ethosuximide|ethosuximide|mesh-list
65661122|NCT03887624|Citalopram|citalopram|mesh-list
65661123|NCT03887624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65661124|NCT03887624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65661125|NCT03887624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65661126|NCT03887624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661127|NCT03887624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65661128|NCT03887624|Serotonin Agents|serotonin agents|mesh-ancestor
65661129|NCT03887624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661130|NCT03887624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65661131|NCT03887624|Antidepressive Agents|antidepressive agents|mesh-ancestor
65661132|NCT03887624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65661133|NCT03887624|Anticonvulsants|anticonvulsants|mesh-ancestor
65661134|NCT02446028|Insulin Lispro|insulin lispro|mesh-list
65661135|NCT02446028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65661136|NCT02446028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661137|NCT03485846|Ritonavir|ritonavir|mesh-list
65661138|NCT03485846|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65661139|NCT03485846|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65661140|NCT03485846|Protease Inhibitors|protease inhibitors|mesh-ancestor
65661141|NCT03485846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661142|NCT03485846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661143|NCT03485846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65661144|NCT03485846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65661145|NCT03485846|Antiviral Agents|antiviral agents|mesh-ancestor
65661146|NCT03485846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65661147|NCT03485846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65661148|NCT03485846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65661149|NCT02032095|Immunoglobulins|immunoglobulins|mesh-list
65661150|NCT02032095|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65661151|NCT02032095|gamma-Globulins|gamma-globulins|mesh-list
65661152|NCT02032095|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65661153|NCT02032095|Immunologic Factors|immunologic factors|mesh-ancestor
65661154|NCT02032095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661155|NCT03613857|Clopidogrel|clopidogrel|mesh-list
65661156|NCT03613857|Ticagrelor|ticagrelor|mesh-list
65661157|NCT03613857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65661158|NCT03613857|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65661159|NCT03613857|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65661160|NCT03613857|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65661161|NCT03613857|Purinergic Agents|purinergic agents|mesh-ancestor
65661162|NCT03613857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65661163|NCT03613857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661164|NCT03613857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661165|NCT03613389|Vitamin E|vitamin e|mesh-list
65661166|NCT03613389|Vitamins|vitamins|mesh-ancestor
65661167|NCT03613389|Micronutrients|micronutrients|mesh-ancestor
65661168|NCT03613389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458583|NCT03844984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65661169|NCT03613389|Antioxidants|antioxidants|mesh-ancestor
65661170|NCT03613389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661171|NCT03613389|Protective Agents|protective agents|mesh-ancestor
65661172|NCT02259777|Amlodipine|amlodipine|mesh-list
65661173|NCT02259777|Telmisartan|telmisartan|mesh-list
65661174|NCT02259777|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
65661175|NCT02259777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65661176|NCT02259777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65661177|NCT02259777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65661178|NCT02259777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661179|NCT02259777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65661180|NCT02259777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661181|NCT02259777|Vasodilator Agents|vasodilator agents|mesh-ancestor
65661182|NCT02259777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65661183|NCT02259777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65661184|NCT03261375|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65661185|NCT03261375|Antihypertensive Agents|antihypertensive agents|mesh-list
65661186|NCT03261375|Nifedipine|nifedipine|mesh-list
65661187|NCT03261375|Diuretics|diuretics|mesh-ancestor
65661188|NCT03261375|Natriuretic Agents|natriuretic agents|mesh-ancestor
65661189|NCT03261375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661190|NCT03261375|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65661191|NCT03261375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65661192|NCT03261375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661193|NCT03261375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65661194|NCT03261375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65661195|NCT03261375|Vasodilator Agents|vasodilator agents|mesh-ancestor
65661196|NCT03261375|Tocolytic Agents|tocolytic agents|mesh-ancestor
65661197|NCT03261375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65661198|NCT03613545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65661199|NCT03613545|Rifaximin|rifaximin|mesh-list
65661200|NCT03613545|Antidepressive Agents|antidepressive agents|mesh-list
65661201|NCT03613545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65661202|NCT03613545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65661203|NCT03613545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65661204|NCT01361308|Paroxetine|paroxetine|mesh-list
65661205|NCT01361308|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65661206|NCT01361308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65661207|NCT01361308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65661208|NCT01361308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661209|NCT01361308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65661210|NCT01361308|Serotonin Agents|serotonin agents|mesh-ancestor
65661211|NCT01361308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661212|NCT01361308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65661213|NCT01361308|Antidepressive Agents|antidepressive agents|mesh-ancestor
65661214|NCT01361308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65661215|NCT01361308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65661216|NCT01361308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65661217|NCT01361308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661218|NCT05043142|Antibodies|antibodies|mesh-list
65661219|NCT05043142|Immunologic Factors|immunologic factors|mesh-ancestor
65661220|NCT05043142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661221|NCT03612297|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65661222|NCT03612297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65661223|NCT00103662|Plerixafor|plerixafor|mesh-list
65661224|NCT00103662|Lenograstim|lenograstim|mesh-list
65661225|NCT00103662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65661226|NCT00103662|Immunologic Factors|immunologic factors|mesh-ancestor
65661227|NCT00103662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661228|NCT00103662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65661229|NCT00103662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65661230|NCT00103662|Antiviral Agents|antiviral agents|mesh-ancestor
65661231|NCT00103662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65661232|NCT03612219|Apatinib|apatinib|mesh-list
65661233|NCT03612219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661234|NCT03612219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65661235|NCT03612219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661236|NCT03612219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661237|NCT05030116|Domperidone|domperidone|mesh-list
65661238|NCT05030116|Antiemetics|antiemetics|mesh-ancestor
65661239|NCT05030116|Autonomic Agents|autonomic agents|mesh-ancestor
65661240|NCT05030116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65661241|NCT05030116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661242|NCT05030116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65661243|NCT05030116|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65661244|NCT05030116|Dopamine Agents|dopamine agents|mesh-ancestor
65661245|NCT05030116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65661246|NCT05030116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661247|NCT03015129|Durvalumab|durvalumab|mesh-list
65661248|NCT03015129|Tremelimumab|tremelimumab|mesh-list
65661249|NCT03015129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65661250|NCT03015129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661251|NCT02148978|Saxagliptin|saxagliptin|mesh-list
65661252|NCT02148978|Incretins|incretins|mesh-ancestor
65661253|NCT02148978|Hormones|hormones|mesh-ancestor
65661254|NCT02148978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65661255|NCT02148978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661256|NCT02148978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65661257|NCT02148978|Protease Inhibitors|protease inhibitors|mesh-ancestor
65661258|NCT02148978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268350|NCT02701608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65661259|NCT02148978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661260|NCT02148978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65661261|NCT05048914|Acetaminophen|acetaminophen|mesh-list
65661262|NCT05048914|Dipyrone|dipyrone|mesh-list
65661263|NCT05048914|Ibuprofen|ibuprofen|mesh-list
65661264|NCT05048914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65661265|NCT05048914|Analgesics|analgesics|mesh-ancestor
65661266|NCT05048914|Sensory System Agents|sensory system agents|mesh-ancestor
65661267|NCT05048914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65661268|NCT05048914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661269|NCT05048914|Antipyretics|antipyretics|mesh-ancestor
65661270|NCT05048914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65661271|NCT05048914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65661272|NCT05048914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65661273|NCT05048914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65661274|NCT05048914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661275|NCT05048914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661276|NCT03046017|Lidocaine|lidocaine|mesh-list
65661277|NCT03046017|Anesthetics, Local|anesthetics, local|mesh-ancestor
65661278|NCT03046017|Anesthetics|anesthetics|mesh-ancestor
65661279|NCT03046017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65661280|NCT03046017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661281|NCT03046017|Sensory System Agents|sensory system agents|mesh-ancestor
65661282|NCT03046017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65661283|NCT03046017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65661284|NCT03046017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65661285|NCT03046017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65661286|NCT03046017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65661287|NCT03046017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661288|NCT04469686|Hydrocortisone|hydrocortisone|mesh-list
65661289|NCT04469686|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65661290|NCT04469686|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65661291|NCT04469686|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65661292|NCT04469686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65661293|NCT02149212|Aminaftone|aminaftone|mesh-list
65661294|NCT02149212|Hemostatics|hemostatics|mesh-ancestor
65661295|NCT02149212|Coagulants|coagulants|mesh-ancestor
65661296|NCT04667013|Tetramethylpyrazine|tetramethylpyrazine|mesh-list
65661297|NCT04667013|Vasodilator Agents|vasodilator agents|mesh-ancestor
65661299|NCT03611985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661300|NCT03097900|Caffeine|caffeine|mesh-list
65661301|NCT03097900|Caffeine citrate|caffeine citrate|mesh-list
65661302|NCT03097900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661303|NCT03097900|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65661304|NCT03097900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661305|NCT03097900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65661306|NCT03097900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661307|NCT03097900|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65661308|NCT03097900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65661309|NCT03097900|Purinergic Agents|purinergic agents|mesh-ancestor
65661310|NCT03097900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65661311|NCT00104676|Paclitaxel|paclitaxel|mesh-list
65661312|NCT00104676|Etoposide|etoposide|mesh-list
65661313|NCT00104676|Oxaliplatin|oxaliplatin|mesh-list
65661314|NCT00104676|Ifosfamide|ifosfamide|mesh-list
65661315|NCT00104676|Bleomycin|bleomycin|mesh-list
65661316|NCT00104676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65661317|NCT00104676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661318|NCT00104676|Tubulin Modulators|tubulin modulators|mesh-ancestor
65661319|NCT00104676|Antimitotic Agents|antimitotic agents|mesh-ancestor
65661320|NCT00104676|Mitosis Modulators|mitosis modulators|mesh-ancestor
65661321|NCT00104676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661322|NCT00104676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65661323|NCT00104676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65661324|NCT00104676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661325|NCT00104676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65661326|NCT00104676|Alkylating Agents|alkylating agents|mesh-ancestor
65661327|NCT00104676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65661329|NCT00354835|Cactinomycin|cactinomycin|mesh-list
65661330|NCT00354835|Cyclophosphamide|cyclophosphamide|mesh-list
65661331|NCT00354835|Irinotecan|irinotecan|mesh-list
65661332|NCT00354835|Vincristine|vincristine|mesh-list
65661333|NCT00354835|Camptothecin|camptothecin|mesh-list
65124083|NCT01780844|Prednisone|prednisone|mesh-list
65661334|NCT00354835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65661335|NCT00354835|Immunologic Factors|immunologic factors|mesh-ancestor
65661336|NCT00354835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661337|NCT00354835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65661338|NCT00354835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65661339|NCT00354835|Alkylating Agents|alkylating agents|mesh-ancestor
65661340|NCT00354835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661341|NCT00354835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661342|NCT00354835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65661343|NCT00354835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65661344|NCT00354835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65661345|NCT00354835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661346|NCT00354835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65661347|NCT00354835|Tubulin Modulators|tubulin modulators|mesh-ancestor
65661348|NCT00354835|Antimitotic Agents|antimitotic agents|mesh-ancestor
65661349|NCT00354835|Mitosis Modulators|mitosis modulators|mesh-ancestor
65661350|NCT00354835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65661351|NCT00354835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65661352|NCT00354835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65661353|NCT00354835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65661354|NCT00354835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65661355|NCT02768298|Enalapril|enalapril|mesh-list
65661356|NCT02768298|Enalaprilat|enalaprilat|mesh-list
65661357|NCT02768298|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65661358|NCT02768298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65661359|NCT02768298|Protease Inhibitors|protease inhibitors|mesh-ancestor
65661360|NCT02768298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661361|NCT02768298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661362|NCT02768298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65661363|NCT02768298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65661364|NCT05028322|Imiquimod|imiquimod|mesh-list
65661365|NCT05028322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65661366|NCT05028322|Immunologic Factors|immunologic factors|mesh-ancestor
65661367|NCT05028322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661368|NCT05028322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661369|NCT05028322|Interferon Inducers|interferon inducers|mesh-ancestor
65661370|NCT03096340|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
65661371|NCT03096340|Irinotecan|irinotecan|mesh-list
65661372|NCT03096340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65661373|NCT03096340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661374|NCT03096340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65661375|NCT03096340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65661376|NCT03096340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661377|NCT03096340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661378|NCT02152800|Valacyclovir|valacyclovir|mesh-list
65661379|NCT02152800|Antiviral Agents|antiviral agents|mesh-ancestor
65661380|NCT02152800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65661381|NCT02149758|Etoricoxib|etoricoxib|mesh-list
65661382|NCT02149758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65661383|NCT02149758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65661384|NCT02149758|Analgesics|analgesics|mesh-ancestor
65661385|NCT02149758|Sensory System Agents|sensory system agents|mesh-ancestor
65661386|NCT02149758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65661387|NCT02149758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661388|NCT02149758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65661389|NCT02149758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65661390|NCT02149758|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65661391|NCT02149758|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65661392|NCT02149758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458807|NCT01202422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65661393|NCT02149758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661395|NCT03542214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65661396|NCT03542214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661397|NCT03094468|Terbinafine|terbinafine|mesh-list
65661398|NCT03094468|Antifungal Agents|antifungal agents|mesh-ancestor
65661399|NCT03094468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65661400|NCT03094468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661401|NCT03094468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661402|NCT03744546|Tilavonemab|tilavonemab|mesh-list
65661403|NCT03744546|Nootropic Agents|nootropic agents|mesh-ancestor
65661404|NCT02775864|Antipsychotic Agents|antipsychotic agents|mesh-list
65661405|NCT02775864|Antidepressive Agents|antidepressive agents|mesh-list
65661406|NCT02775864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65661407|NCT02775864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65661408|NCT02775864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65661409|NCT02775864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661410|NCT03095872|Petrolatum|petrolatum|mesh-list
65661411|NCT03095872|Emollients|emollients|mesh-ancestor
65661412|NCT03095872|Dermatologic Agents|dermatologic agents|mesh-ancestor
65661413|NCT03096184|Apatinib|apatinib|mesh-list
65661414|NCT03096184|Tegafur|tegafur|mesh-list
65661415|NCT03096184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661416|NCT03096184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65661417|NCT03096184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661418|NCT03096184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661419|NCT03096184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65661420|NCT03096184|Antimetabolites|antimetabolites|mesh-ancestor
65661421|NCT02157012|Tofacitinib|tofacitinib|mesh-list
65661422|NCT02157012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65661423|NCT02157012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661424|NCT02157012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661425|NCT03096028|Vitamin B 12|vitamin b 12|mesh-list
65661426|NCT03096028|Hydroxocobalamin|hydroxocobalamin|mesh-list
65661427|NCT03096028|Vitamins|vitamins|mesh-ancestor
65661428|NCT03096028|Micronutrients|micronutrients|mesh-ancestor
65661429|NCT03096028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661430|NCT03096028|Vitamin B Complex|vitamin b complex|mesh-ancestor
65661431|NCT03096028|Hematinics|hematinics|mesh-ancestor
65661432|NCT02149914|Rabeprazole|rabeprazole|mesh-list
65661433|NCT02149914|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65661434|NCT02149914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65661435|NCT02149914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65661436|NCT02149914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661437|NCT02149914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661438|NCT02149992|Inositol|inositol|mesh-list
65661439|NCT02149992|Vitamin B Complex|vitamin b complex|mesh-ancestor
65661440|NCT02149992|Vitamins|vitamins|mesh-ancestor
65661441|NCT02149992|Micronutrients|micronutrients|mesh-ancestor
65661442|NCT02149992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661443|NCT04833582|Gemcitabine|gemcitabine|mesh-list
65661444|NCT04833582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65661445|NCT04833582|Antimetabolites|antimetabolites|mesh-ancestor
65661446|NCT04833582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661447|NCT04833582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661448|NCT04833582|Antiviral Agents|antiviral agents|mesh-ancestor
65661449|NCT04833582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65661450|NCT04833582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661451|NCT04833582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65661452|NCT04833582|Immunologic Factors|immunologic factors|mesh-ancestor
65661453|NCT04833582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661454|NCT05041582|Citalopram|citalopram|mesh-list
65661455|NCT05041582|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65661456|NCT05041582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65661457|NCT05041582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65661458|NCT05041582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661459|NCT05041582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65661460|NCT05041582|Serotonin Agents|serotonin agents|mesh-ancestor
65661461|NCT05041582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661462|NCT05041582|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65661463|NCT05041582|Antidepressive Agents|antidepressive agents|mesh-ancestor
65661464|NCT05041582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65661465|NCT05041270|Dexmedetomidine|dexmedetomidine|mesh-list
65458884|NCT03173092|Glucocorticoids|glucocorticoids|mesh-ancestor
65661466|NCT05041270|Nalbuphine|nalbuphine|mesh-list
65661467|NCT05041270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65661468|NCT05041270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65661469|NCT05041270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661470|NCT05041270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65661471|NCT05041270|Analgesics|analgesics|mesh-ancestor
65661472|NCT05041270|Sensory System Agents|sensory system agents|mesh-ancestor
65661473|NCT05041270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65661474|NCT05041270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65661475|NCT05041270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65661476|NCT05041270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65661477|NCT05041270|Adrenergic Agents|adrenergic agents|mesh-ancestor
65661478|NCT05041270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65661479|NCT05041270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661480|NCT05041270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65661481|NCT05041270|Narcotics|narcotics|mesh-ancestor
65661482|NCT02153424|Apixaban|apixaban|mesh-list
65661483|NCT02153424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65661484|NCT02153424|Antithrombins|antithrombins|mesh-ancestor
65661485|NCT02153424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65661486|NCT02153424|Protease Inhibitors|protease inhibitors|mesh-ancestor
65661487|NCT02153424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661488|NCT02153424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661489|NCT02153424|Anticoagulants|anticoagulants|mesh-ancestor
65661490|NCT05027386|Irinotecan|irinotecan|mesh-list
65661491|NCT05027386|Temozolomide|temozolomide|mesh-list
65661492|NCT05027386|Apatinib|apatinib|mesh-list
65661493|NCT05027386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65661494|NCT05027386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65661495|NCT05027386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661496|NCT05027386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661497|NCT05027386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661498|NCT05027386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65661499|NCT05027386|Alkylating Agents|alkylating agents|mesh-ancestor
65661500|NCT05027386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65661501|NCT04434430|Gabapentin|gabapentin|mesh-list
65661502|NCT04434430|Analgesics|analgesics|mesh-ancestor
65661503|NCT04434430|Sensory System Agents|sensory system agents|mesh-ancestor
65661504|NCT04434430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65661505|NCT04434430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661506|NCT04434430|Anticonvulsants|anticonvulsants|mesh-ancestor
65661507|NCT04434430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65661508|NCT04434430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65661509|NCT04434430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65661510|NCT04434430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65661511|NCT04434430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65661512|NCT04434430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65661513|NCT04434430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65661514|NCT04434430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661515|NCT04434430|Antimanic Agents|antimanic agents|mesh-ancestor
65661516|NCT03094156|Resveratrol|resveratrol|mesh-list
65661517|NCT03094156|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
65661518|NCT03094156|Antioxidants|antioxidants|mesh-ancestor
65661519|NCT03094156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661520|NCT03094156|Protective Agents|protective agents|mesh-ancestor
65661521|NCT03094156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661522|NCT03094156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661523|NCT03094156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65661524|NCT03094156|Dopamine Agents|dopamine agents|mesh-ancestor
65661525|NCT03094156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65661526|NCT02964273|Tolvaptan|tolvaptan|mesh-list
65661527|NCT02964273|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65661528|NCT02964273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661529|NCT02964273|Natriuretic Agents|natriuretic agents|mesh-ancestor
65661530|NCT02964273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661531|NCT05040724|Ivermectin|ivermectin|mesh-list
65661532|NCT05040724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65661533|NCT05040724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65661534|NCT03542058|Carvedilol|carvedilol|mesh-list
65661535|NCT03542058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65661536|NCT03542058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65661537|NCT03542058|Adrenergic Agents|adrenergic agents|mesh-ancestor
65661538|NCT03542058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65661539|NCT03542058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661540|NCT03542058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661541|NCT03542058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65661542|NCT03542058|Antioxidants|antioxidants|mesh-ancestor
65661543|NCT03542058|Protective Agents|protective agents|mesh-ancestor
65661544|NCT03542058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65661545|NCT03542058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65661546|NCT03542058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65661547|NCT03542058|Vasodilator Agents|vasodilator agents|mesh-ancestor
65661548|NCT03542058|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65661549|NCT03542058|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65661550|NCT03321513|Bevacizumab|bevacizumab|mesh-list
65661551|NCT03321513|Aflibercept|aflibercept|mesh-list
65661552|NCT03321513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65661553|NCT03321513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661554|NCT03321513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65661555|NCT03321513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65661556|NCT03321513|Growth Substances|growth substances|mesh-ancestor
65661557|NCT03321513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661558|NCT03321513|Growth Inhibitors|growth inhibitors|mesh-ancestor
65661559|NCT02032797|Progesterone|progesterone|mesh-list
65661560|NCT02032797|Progestins|progestins|mesh-ancestor
65661561|NCT02032797|Hormones|hormones|mesh-ancestor
65661562|NCT02032797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65661563|NCT02032797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661564|NCT05024266|Paclitaxel|paclitaxel|mesh-list
65661565|NCT05024266|Carboplatin|carboplatin|mesh-list
65661566|NCT05024266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65661567|NCT05024266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661568|NCT05024266|Tubulin Modulators|tubulin modulators|mesh-ancestor
65661569|NCT05024266|Antimitotic Agents|antimitotic agents|mesh-ancestor
65661570|NCT05024266|Mitosis Modulators|mitosis modulators|mesh-ancestor
65661571|NCT05024266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661572|NCT05383521|Tinidazole|tinidazole|mesh-list
65661573|NCT05383521|Alkylating Agents|alkylating agents|mesh-ancestor
65661574|NCT05383521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661575|NCT05383521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65661576|NCT05383521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65661577|NCT05383521|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65661578|NCT05383521|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65661579|NCT05383521|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65661580|NCT02773368|Insulin|insulin|mesh-list
65661581|NCT02773368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65661582|NCT02773368|Insulin Glargine|insulin glargine|mesh-list
65661583|NCT02773368|Liraglutide|liraglutide|mesh-list
65661584|NCT02773368|Xultophy|xultophy|mesh-list
65661585|NCT02773368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65661586|NCT02773368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661587|NCT02773368|Incretins|incretins|mesh-ancestor
65661588|NCT02773368|Hormones|hormones|mesh-ancestor
65661589|NCT02773368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65661590|NCT02893917|Olaparib|olaparib|mesh-list
65661591|NCT02893917|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65661592|NCT02893917|Cediranib|cediranib|mesh-list
65661593|NCT02893917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661594|NCT02893917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661595|NCT02893917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661596|NCT02893917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65661597|NCT02153658|Chlorhexidine|chlorhexidine|mesh-list
65661598|NCT02153658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65661599|NCT02153658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65661600|NCT02153658|Disinfectants|disinfectants|mesh-ancestor
65661601|NCT02157558|Fexofenadine|fexofenadine|mesh-list
65661602|NCT02157558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65661603|NCT02157558|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65661604|NCT02157558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65661605|NCT02157558|Histamine Antagonists|histamine antagonists|mesh-ancestor
65661606|NCT02157558|Histamine Agents|histamine agents|mesh-ancestor
65661607|NCT02157558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65661608|NCT02157558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661609|NCT02157558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661610|NCT05018182|Leucovorin|leucovorin|mesh-list
65661611|NCT05018182|Folic Acid|folic acid|mesh-list
65661612|NCT05018182|Fluorouracil|fluorouracil|mesh-list
65661613|NCT05018182|Capecitabine|capecitabine|mesh-list
65661614|NCT05018182|Oxaliplatin|oxaliplatin|mesh-list
65661615|NCT05018182|Irinotecan|irinotecan|mesh-list
65661616|NCT05018182|Levoleucovorin|levoleucovorin|mesh-list
65661617|NCT05018182|Antimetabolites|antimetabolites|mesh-ancestor
65661618|NCT05018182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661619|NCT05018182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65661620|NCT05018182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661621|NCT05018182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65661622|NCT05018182|Immunologic Factors|immunologic factors|mesh-ancestor
65661623|NCT05018182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661624|NCT05018182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65661625|NCT05018182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65661626|NCT05018182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661627|NCT05018182|Antidotes|antidotes|mesh-ancestor
65661628|NCT05018182|Protective Agents|protective agents|mesh-ancestor
65661629|NCT05018182|Vitamin B Complex|vitamin b complex|mesh-ancestor
65661630|NCT05018182|Vitamins|vitamins|mesh-ancestor
65661631|NCT05018182|Micronutrients|micronutrients|mesh-ancestor
65661632|NCT05018182|Hematinics|hematinics|mesh-ancestor
65661633|NCT04717765|Vitamin E|vitamin e|mesh-list
65661634|NCT04717765|alpha-Tocopherol|alpha-tocopherol|mesh-list
65661635|NCT04717765|Tocopherols|tocopherols|mesh-list
65661636|NCT04717765|Antioxidants|antioxidants|mesh-ancestor
65661637|NCT04717765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661638|NCT04717765|Protective Agents|protective agents|mesh-ancestor
65661639|NCT04717765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661640|NCT04717765|Vitamins|vitamins|mesh-ancestor
65661641|NCT04717765|Micronutrients|micronutrients|mesh-ancestor
65661642|NCT01336569|Timolol|timolol|mesh-list
65661643|NCT01336569|Travoprost|travoprost|mesh-list
65661644|NCT01336569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661645|NCT01336569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65661646|NCT01336569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65661647|NCT01336569|Adrenergic Agents|adrenergic agents|mesh-ancestor
65661648|NCT01336569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65661649|NCT01336569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661650|NCT01336569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65661651|NCT01336569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65661652|NCT03092986|Paclitaxel|paclitaxel|mesh-list
65661653|NCT03092986|Vinblastine|vinblastine|mesh-list
65661654|NCT03092986|Carboplatin|carboplatin|mesh-list
65661655|NCT03092986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65661656|NCT03092986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661657|NCT03092986|Tubulin Modulators|tubulin modulators|mesh-ancestor
65661658|NCT03092986|Antimitotic Agents|antimitotic agents|mesh-ancestor
65661659|NCT03092986|Mitosis Modulators|mitosis modulators|mesh-ancestor
65661660|NCT03092986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661661|NCT03092908|Acetic Acid|acetic acid|mesh-list
65661662|NCT03092908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65661663|NCT03092908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65661664|NCT03543306|Trametinib|trametinib|mesh-list
65661665|NCT03543306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661666|NCT03543306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65661667|NCT03543306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661668|NCT03543306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661669|NCT02157792|Gemcitabine|gemcitabine|mesh-list
65661670|NCT02157792|Carboplatin|carboplatin|mesh-list
65661671|NCT02157792|Irinotecan|irinotecan|mesh-list
65661672|NCT02157792|Etoposide|etoposide|mesh-list
65661673|NCT02157792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661674|NCT02157792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65661675|NCT02157792|Antimetabolites|antimetabolites|mesh-ancestor
65661676|NCT02157792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661677|NCT02157792|Antiviral Agents|antiviral agents|mesh-ancestor
65661678|NCT02157792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65661679|NCT02157792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661680|NCT02157792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65661681|NCT02157792|Immunologic Factors|immunologic factors|mesh-ancestor
65661682|NCT02157792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661683|NCT02157792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65661684|NCT02157792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65661685|NCT02157792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65661686|NCT02157792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65661687|NCT04829383|Bevacizumab|bevacizumab|mesh-list
65661688|NCT04829383|Atezolizumab|atezolizumab|mesh-list
65661689|NCT04829383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65661690|NCT04829383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661691|NCT04829383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65661692|NCT04829383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65661693|NCT04829383|Growth Substances|growth substances|mesh-ancestor
65661694|NCT04829383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661695|NCT04829383|Growth Inhibitors|growth inhibitors|mesh-ancestor
65661696|NCT05023408|Bleomycin|bleomycin|mesh-list
65661697|NCT05023408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65661698|NCT05023408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661699|NCT02772978|Tolcapone|tolcapone|mesh-list
65661700|NCT02772978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65661701|NCT02772978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65124446|NCT00555347|Modafinil|modafinil|mesh-list
65661702|NCT02772978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65661703|NCT02772978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661704|NCT02772978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661705|NCT03090490|Antipsychotic Agents|antipsychotic agents|mesh-list
65661706|NCT03090490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65661707|NCT03090490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65661708|NCT03090490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661709|NCT03090490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65661710|NCT02150616|Sevoflurane|sevoflurane|mesh-list
65661711|NCT02150616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65661712|NCT02150616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65661713|NCT02150616|Anesthetics, General|anesthetics, general|mesh-ancestor
65661714|NCT02150616|Anesthetics|anesthetics|mesh-ancestor
65661715|NCT02150616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65661716|NCT02150616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661717|NCT05164549|Buprenorphine|buprenorphine|mesh-list
65661718|NCT05164549|Methadone|methadone|mesh-list
65661719|NCT05164549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65661720|NCT05164549|Narcotics|narcotics|mesh-ancestor
65661721|NCT05164549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65661722|NCT05164549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661723|NCT05164549|Analgesics|analgesics|mesh-ancestor
65661724|NCT05164549|Sensory System Agents|sensory system agents|mesh-ancestor
65661725|NCT05164549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65661726|NCT05164549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65661727|NCT05164549|Antitussive Agents|antitussive agents|mesh-ancestor
65661728|NCT05164549|Respiratory System Agents|respiratory system agents|mesh-ancestor
65661729|NCT00104052|Ribavirin|ribavirin|mesh-list
65661730|NCT00104052|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65661731|NCT00104052|Interferon-alpha|interferon-alpha|mesh-list
65661732|NCT00104052|Antimetabolites|antimetabolites|mesh-ancestor
65661733|NCT00104052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661734|NCT00104052|Antiviral Agents|antiviral agents|mesh-ancestor
65661735|NCT00104052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65661736|NCT00104052|Immunologic Factors|immunologic factors|mesh-ancestor
65661737|NCT00104052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661738|NCT05038072|Triamcinolone|triamcinolone|mesh-list
65661739|NCT05038072|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65661740|NCT05038072|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65661741|NCT05038072|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65661742|NCT05038072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65661743|NCT05038072|Glucocorticoids|glucocorticoids|mesh-ancestor
65661744|NCT05038072|Hormones|hormones|mesh-ancestor
65661745|NCT05038072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65661746|NCT05038072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661747|NCT05038072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65661748|NCT05038072|Immunologic Factors|immunologic factors|mesh-ancestor
65661749|NCT05038072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661750|NCT05038072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661751|NCT02777970|Acetaminophen|acetaminophen|mesh-list
65661752|NCT02777970|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65661753|NCT02777970|Tramadol|tramadol|mesh-list
65661754|NCT02777970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65661755|NCT02777970|Analgesics|analgesics|mesh-ancestor
65661756|NCT02777970|Sensory System Agents|sensory system agents|mesh-ancestor
65661757|NCT02777970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65661758|NCT02777970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661759|NCT02777970|Antipyretics|antipyretics|mesh-ancestor
65661760|NCT02777970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65661761|NCT02777970|Narcotics|narcotics|mesh-ancestor
65661762|NCT02777970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65661763|NCT02777970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65661764|NCT02777970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65661765|NCT02777970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65661766|NCT01336023|Insulin|insulin|mesh-list
65661767|NCT01336023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65661768|NCT01336023|Liraglutide|liraglutide|mesh-list
65661769|NCT01336023|Insulin, Long-Acting|insulin, long-acting|mesh-list
65661770|NCT01336023|Xultophy|xultophy|mesh-list
65661771|NCT01336023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65661772|NCT01336023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661773|NCT01336023|Incretins|incretins|mesh-ancestor
65661774|NCT01336023|Hormones|hormones|mesh-ancestor
65661775|NCT01336023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65661776|NCT02255292|Cannabidiol|cannabidiol|mesh-list
65661777|NCT02255292|Anticonvulsants|anticonvulsants|mesh-ancestor
65661778|NCT03092206|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65661779|NCT03092206|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65661780|NCT03092206|Antiviral Agents|antiviral agents|mesh-ancestor
65661781|NCT03092206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65661782|NCT03092206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65661783|NCT03092206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65661784|NCT03092206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661785|NCT03092206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661786|NCT03092206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65661787|NCT03092206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65661788|NCT02254980|Vitamin E|vitamin e|mesh-list
65661789|NCT02254980|Vitamins|vitamins|mesh-ancestor
65661790|NCT02254980|Micronutrients|micronutrients|mesh-ancestor
65661791|NCT02254980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661792|NCT02254980|Antioxidants|antioxidants|mesh-ancestor
65661793|NCT02254980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661794|NCT02254980|Protective Agents|protective agents|mesh-ancestor
65661795|NCT05281003|Paclitaxel|paclitaxel|mesh-list
65661796|NCT05281003|Pembrolizumab|pembrolizumab|mesh-list
65661797|NCT05281003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65661798|NCT05281003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661799|NCT05281003|Tubulin Modulators|tubulin modulators|mesh-ancestor
65661800|NCT05281003|Antimitotic Agents|antimitotic agents|mesh-ancestor
65661801|NCT05281003|Mitosis Modulators|mitosis modulators|mesh-ancestor
65661802|NCT05281003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661803|NCT05281003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65661804|NCT02158182|Rifaximin|rifaximin|mesh-list
65661805|NCT02158182|Lactulose|lactulose|mesh-list
65661806|NCT02158182|N-Methylaspartate|n-methylaspartate|mesh-list
65661807|NCT02158182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65661808|NCT02158182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65661809|NCT02158182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65661810|NCT02158182|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
65661811|NCT02158182|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65661812|NCT02158182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65661813|NCT02158182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661814|NCT02158182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661815|NCT04786873|Clonidine|clonidine|mesh-list
65661816|NCT04786873|Analgesics|analgesics|mesh-ancestor
65661817|NCT04786873|Sensory System Agents|sensory system agents|mesh-ancestor
65661818|NCT04786873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65661819|NCT04786873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661820|NCT04786873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65661821|NCT04786873|Sympatholytics|sympatholytics|mesh-ancestor
65661822|NCT04786873|Autonomic Agents|autonomic agents|mesh-ancestor
65661823|NCT04786873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65661824|NCT04786873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65661825|NCT04786873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65661826|NCT04786873|Adrenergic Agents|adrenergic agents|mesh-ancestor
65661827|NCT04786873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65661828|NCT04786873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661829|NCT02033187|Chlorhexidine|chlorhexidine|mesh-list
65661830|NCT02033187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65661831|NCT02033187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65661832|NCT02033187|Disinfectants|disinfectants|mesh-ancestor
65661833|NCT02154360|Aprepitant|aprepitant|mesh-list
65661834|NCT02154360|Antiemetics|antiemetics|mesh-ancestor
65661835|NCT02154360|Autonomic Agents|autonomic agents|mesh-ancestor
65661836|NCT02154360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65661837|NCT02154360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661838|NCT02154360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65661839|NCT02154360|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65661840|NCT02154360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65661841|NCT02154360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661842|NCT02033031|Bevacizumab|bevacizumab|mesh-list
65661843|NCT02033031|Ranibizumab|ranibizumab|mesh-list
65661844|NCT02033031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65661845|NCT02033031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661846|NCT02033031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65661847|NCT02033031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65661848|NCT02033031|Growth Substances|growth substances|mesh-ancestor
65661849|NCT02033031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661850|NCT02033031|Growth Inhibitors|growth inhibitors|mesh-ancestor
65661851|NCT05034367|Mannitol|mannitol|mesh-list
65661852|NCT05034367|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65661853|NCT05034367|Diuretics|diuretics|mesh-ancestor
65661854|NCT05034367|Natriuretic Agents|natriuretic agents|mesh-ancestor
65661855|NCT05034367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661856|NCT02150928|Asparaginase|asparaginase|mesh-list
65661857|NCT02150928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661858|NCT03611049|Vitamin D|vitamin d|mesh-list
65661859|NCT03611049|Ergocalciferols|ergocalciferols|mesh-list
65661860|NCT03611049|Cholecalciferol|cholecalciferol|mesh-list
65661861|NCT03611049|Vitamins|vitamins|mesh-list
65661862|NCT03611049|Micronutrients|micronutrients|mesh-ancestor
65661863|NCT03611049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661864|NCT03611049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65661865|NCT03611049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65661866|NCT04822350|Avelumab|avelumab|mesh-list
65661867|NCT04822350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65661868|NCT04822350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661869|NCT03610893|Dexamethasone|dexamethasone|mesh-list
65661870|NCT03610893|Dexmedetomidine|dexmedetomidine|mesh-list
65661871|NCT03610893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65661872|NCT03610893|Antiemetics|antiemetics|mesh-ancestor
65661873|NCT03610893|Autonomic Agents|autonomic agents|mesh-ancestor
65661874|NCT03610893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65661875|NCT03610893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661876|NCT03610893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65661877|NCT03610893|Glucocorticoids|glucocorticoids|mesh-ancestor
65661878|NCT03610893|Hormones|hormones|mesh-ancestor
65661879|NCT03610893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65661880|NCT03610893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65661881|NCT03610893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661882|NCT03610893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65661883|NCT03610893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65661884|NCT03610893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65661885|NCT03610893|Analgesics|analgesics|mesh-ancestor
65661886|NCT03610893|Sensory System Agents|sensory system agents|mesh-ancestor
65661887|NCT03610893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65661888|NCT03610893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65661889|NCT03610893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65661890|NCT03610893|Adrenergic Agents|adrenergic agents|mesh-ancestor
65661891|NCT03610893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65661892|NCT03610893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661893|NCT04737109|Androgens|androgens|mesh-list
65661894|NCT04737109|Hormones|hormones|mesh-ancestor
65661895|NCT04737109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65661896|NCT04737109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661897|NCT02154438|Ketamine|ketamine|mesh-list
65661898|NCT02154438|Analgesics|analgesics|mesh-ancestor
65661899|NCT02154438|Sensory System Agents|sensory system agents|mesh-ancestor
65661900|NCT02154438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65661901|NCT02154438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661902|NCT02154438|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65661903|NCT02154438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65661904|NCT02154438|Anesthetics, General|anesthetics, general|mesh-ancestor
65661905|NCT02154438|Anesthetics|anesthetics|mesh-ancestor
65661906|NCT02154438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65661907|NCT02154438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65661908|NCT02154438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65661909|NCT02154438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65661910|NCT02154438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661911|NCT02520921|Aspirin|aspirin|mesh-list
65661912|NCT02520921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65661913|NCT02520921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65661914|NCT02520921|Analgesics|analgesics|mesh-ancestor
65661915|NCT02520921|Sensory System Agents|sensory system agents|mesh-ancestor
65661916|NCT02520921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65661917|NCT02520921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661918|NCT02520921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65661919|NCT02520921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65661920|NCT02520921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65661921|NCT02520921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65661922|NCT02520921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661923|NCT02520921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65661924|NCT02520921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65661925|NCT02520921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661926|NCT02520921|Antipyretics|antipyretics|mesh-ancestor
65661927|NCT05655013|Zoledronic Acid|zoledronic acid|mesh-list
65661928|NCT05655013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65661929|NCT05655013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661930|NCT02154594|Chlorhexidine|chlorhexidine|mesh-list
65661931|NCT02154594|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65661932|NCT02154594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65661933|NCT02154594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65661934|NCT02154594|Disinfectants|disinfectants|mesh-ancestor
65661935|NCT02154594|Dermatologic Agents|dermatologic agents|mesh-ancestor
65661936|NCT03610347|Paclitaxel|paclitaxel|mesh-list
65661937|NCT03610347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65661938|NCT03610347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661939|NCT03610347|Tubulin Modulators|tubulin modulators|mesh-ancestor
65661940|NCT03610347|Antimitotic Agents|antimitotic agents|mesh-ancestor
65661941|NCT03610347|Mitosis Modulators|mitosis modulators|mesh-ancestor
65661942|NCT03610347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661943|NCT01518517|Asparaginase|asparaginase|mesh-list
65661944|NCT01518517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661945|NCT02863575|Ibuprofen|ibuprofen|mesh-list
65661946|NCT02863575|Caffeine|caffeine|mesh-list
65661947|NCT02863575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65661948|NCT02863575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65661949|NCT02863575|Analgesics|analgesics|mesh-ancestor
65661950|NCT02863575|Sensory System Agents|sensory system agents|mesh-ancestor
65661951|NCT02863575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65661952|NCT02863575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661953|NCT02863575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65661954|NCT02863575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65661955|NCT02863575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65661956|NCT02863575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661957|NCT02863575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661958|NCT02863575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65661959|NCT02863575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65661960|NCT02863575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65661961|NCT02863575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65661962|NCT02863575|Purinergic Agents|purinergic agents|mesh-ancestor
65661963|NCT02863575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65661964|NCT05021770|Thiotepa|thiotepa|mesh-list
65661965|NCT05021770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65661966|NCT05021770|Alkylating Agents|alkylating agents|mesh-ancestor
65661967|NCT05021770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661968|NCT05021770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661969|NCT05021770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65661970|NCT05021770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65661971|NCT05021770|Immunologic Factors|immunologic factors|mesh-ancestor
65661972|NCT05021770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661973|NCT04722523|Carboplatin|carboplatin|mesh-list
65661974|NCT04722523|Docetaxel|docetaxel|mesh-list
65661975|NCT04722523|Cetuximab|cetuximab|mesh-list
65661976|NCT04722523|Cemiplimab|cemiplimab|mesh-list
65661977|NCT04722523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65661978|NCT04722523|Tubulin Modulators|tubulin modulators|mesh-ancestor
65661979|NCT04722523|Antimitotic Agents|antimitotic agents|mesh-ancestor
65661980|NCT04722523|Mitosis Modulators|mitosis modulators|mesh-ancestor
65661981|NCT04722523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661982|NCT04722523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65661983|NCT05230303|Caffeine|caffeine|mesh-list
65661984|NCT05230303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65661985|NCT05230303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661986|NCT05230303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65661987|NCT05230303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65661988|NCT05230303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65661989|NCT05230303|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65661990|NCT05230303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65661991|NCT05230303|Purinergic Agents|purinergic agents|mesh-ancestor
65661992|NCT05230303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65661993|NCT04287790|Naltrexone|naltrexone|mesh-list
65661994|NCT04287790|Disulfiram|disulfiram|mesh-list
65661995|NCT04287790|Acamprosate|acamprosate|mesh-list
65661996|NCT04287790|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65459404|NCT01299220|Dermatologic Agents|dermatologic agents|mesh-ancestor
65661997|NCT04287790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65661998|NCT04287790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65661999|NCT04287790|Sensory System Agents|sensory system agents|mesh-ancestor
65662000|NCT04287790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65662001|NCT04287790|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65662002|NCT04287790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662003|NCT04287790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662005|NCT03723967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65662006|NCT03723967|Carboplatin|carboplatin|mesh-list
65662007|NCT03723967|Durvalumab|durvalumab|mesh-list
65662008|NCT03723967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65662009|NCT03723967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65662010|NCT03723967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662011|NCT03723967|Tubulin Modulators|tubulin modulators|mesh-ancestor
65662012|NCT03723967|Antimitotic Agents|antimitotic agents|mesh-ancestor
65662013|NCT03723967|Mitosis Modulators|mitosis modulators|mesh-ancestor
65662014|NCT03723967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662015|NCT03723967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65662016|NCT03723967|Immunologic Factors|immunologic factors|mesh-ancestor
65662017|NCT03723967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662018|NCT05008666|Azacitidine|azacitidine|mesh-list
65662019|NCT05008666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65662020|NCT05008666|Antimetabolites|antimetabolites|mesh-ancestor
65662021|NCT05008666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662022|NCT05008666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662023|NCT05008666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662024|NCT05025787|Celecoxib|celecoxib|mesh-list
65662025|NCT05025787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65662026|NCT05025787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65662027|NCT05025787|Analgesics|analgesics|mesh-ancestor
65662028|NCT05025787|Sensory System Agents|sensory system agents|mesh-ancestor
65662029|NCT05025787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65662030|NCT05025787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662031|NCT05025787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65662032|NCT05025787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65662033|NCT05025787|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65662034|NCT05025787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65662035|NCT05025787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662036|NCT05025787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662037|NCT03659461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65662038|NCT03659461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65662039|NCT03659461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662040|NCT03659461|Incretins|incretins|mesh-ancestor
65662041|NCT03659461|Hormones|hormones|mesh-ancestor
65662042|NCT03659461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65662043|NCT03659461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65662044|NCT03659461|Protease Inhibitors|protease inhibitors|mesh-ancestor
65662045|NCT03659461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662046|NCT03659461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662047|NCT01227187|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
65662048|NCT01227187|Protein C|protein c|mesh-list
65662049|NCT01227187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65662050|NCT01227187|Anticoagulants|anticoagulants|mesh-ancestor
65662051|NCT01227187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65662052|NCT01227187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65662053|NCT01227187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662054|NCT03088072|Aspirin|aspirin|mesh-list
65662055|NCT03088072|Warfarin|warfarin|mesh-list
65662056|NCT03088072|Edoxaban|edoxaban|mesh-list
65662057|NCT03088072|Clopidogrel|clopidogrel|mesh-list
65662058|NCT03088072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65662059|NCT03088072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65662060|NCT03088072|Analgesics|analgesics|mesh-ancestor
65662061|NCT03088072|Sensory System Agents|sensory system agents|mesh-ancestor
65662062|NCT03088072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65662063|NCT03088072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662064|NCT03088072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65662065|NCT03088072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65662066|NCT03088072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65662067|NCT03088072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65662068|NCT03088072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662069|NCT03088072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65662070|NCT03088072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65662071|NCT03088072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662072|NCT03088072|Antipyretics|antipyretics|mesh-ancestor
65662073|NCT03088072|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65662074|NCT03088072|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65662075|NCT03088072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65662076|NCT03088072|Purinergic Agents|purinergic agents|mesh-ancestor
65662077|NCT03088072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65662078|NCT03088072|Anticoagulants|anticoagulants|mesh-ancestor
65662079|NCT03088072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65662080|NCT03088072|Antithrombins|antithrombins|mesh-ancestor
65662081|NCT03088072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65662082|NCT03088072|Protease Inhibitors|protease inhibitors|mesh-ancestor
65662083|NCT01077817|Alendronate|alendronate|mesh-list
65662084|NCT01077817|Risedronic Acid|risedronic acid|mesh-list
65662085|NCT01077817|Ibandronic Acid|ibandronic acid|mesh-list
65662086|NCT01077817|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65662087|NCT01077817|Etidronic Acid|etidronic acid|mesh-list
65662088|NCT01077817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65662089|NCT01077817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662090|NCT01077817|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65662091|NCT01077817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65662092|NCT01077817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662093|NCT01077817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65662094|NCT01077817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65662095|NCT01077817|Hormone Antagonists|hormone antagonists|mesh-ancestor
65662096|NCT01077817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65662097|NCT01077817|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65662098|NCT01077817|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65662099|NCT02638012|Hemostatics|hemostatics|mesh-list
65662100|NCT02638012|Coagulants|coagulants|mesh-ancestor
65662101|NCT05014906|Minocycline|minocycline|mesh-list
65662102|NCT05014906|Azelaic acid|azelaic acid|mesh-list
65662103|NCT05014906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65662104|NCT05014906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65662105|NCT05014906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662106|NCT05014906|Dermatologic Agents|dermatologic agents|mesh-ancestor
65662107|NCT00103506|Doxorubicin|doxorubicin|mesh-list
65662108|NCT00103506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65662109|NCT00103506|Bortezomib|bortezomib|mesh-list
65662110|NCT00103506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65662111|NCT00103506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662112|NCT00103506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65662113|NCT00103506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65662114|NCT00103506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662115|NCT00103506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662116|NCT02151240|Acyclovir|acyclovir|mesh-list
65662117|NCT02151240|Foscarnet|foscarnet|mesh-list
65662118|NCT02151240|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
65662119|NCT02151240|Antiviral Agents|antiviral agents|mesh-ancestor
65662120|NCT02151240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65662121|NCT02151240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65662122|NCT02151240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65662123|NCT02151240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662124|NCT02151240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662125|NCT02159196|Acetylcysteine|acetylcysteine|mesh-list
65662126|NCT02159196|Albuterol|albuterol|mesh-list
65662127|NCT02159196|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65662128|NCT02159196|Antiviral Agents|antiviral agents|mesh-ancestor
65662129|NCT02159196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65662130|NCT02159196|Expectorants|expectorants|mesh-ancestor
65662131|NCT02159196|Respiratory System Agents|respiratory system agents|mesh-ancestor
65662132|NCT02159196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65662133|NCT02159196|Antioxidants|antioxidants|mesh-ancestor
65662134|NCT02159196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662135|NCT02159196|Protective Agents|protective agents|mesh-ancestor
65662136|NCT02159196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662137|NCT02159196|Antidotes|antidotes|mesh-ancestor
65662138|NCT02159196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65662139|NCT02159196|Autonomic Agents|autonomic agents|mesh-ancestor
65662140|NCT02159196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65662141|NCT02159196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65662142|NCT02159196|Tocolytic Agents|tocolytic agents|mesh-ancestor
65662143|NCT02159196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65662144|NCT02159196|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65662145|NCT02159196|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65662146|NCT02159196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65662147|NCT02159196|Adrenergic Agents|adrenergic agents|mesh-ancestor
65662148|NCT02159196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65662150|NCT02765490|Odalasvir|odalasvir|mesh-list
65662151|NCT02765490|Antiviral Agents|antiviral agents|mesh-ancestor
65662152|NCT02765490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65662153|NCT02765490|Protease Inhibitors|protease inhibitors|mesh-ancestor
65662154|NCT02765490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662155|NCT02765490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662156|NCT02762370|Triamcinolone|triamcinolone|mesh-list
65662157|NCT02762370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65662158|NCT02762370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65662159|NCT02762370|FX006|fx006|mesh-list
65662160|NCT02762370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65662161|NCT02762370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65662162|NCT02762370|Glucocorticoids|glucocorticoids|mesh-ancestor
65662163|NCT02762370|Hormones|hormones|mesh-ancestor
65662164|NCT02762370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65662165|NCT02762370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662166|NCT02762370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65662167|NCT02762370|Immunologic Factors|immunologic factors|mesh-ancestor
65662168|NCT02762370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662169|NCT02762370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662170|NCT02639182|Axitinib|axitinib|mesh-list
65662171|NCT02639182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662172|NCT02639182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65662173|NCT02639182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662174|NCT02639182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662175|NCT02863419|Liraglutide|liraglutide|mesh-list
65662176|NCT02863419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65662177|NCT02863419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662178|NCT02863419|Incretins|incretins|mesh-ancestor
65662179|NCT02863419|Hormones|hormones|mesh-ancestor
65662180|NCT02863419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65662181|NCT03541668|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65662182|NCT03541668|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65662183|NCT03541668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65662184|NCT03541668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662185|NCT04961632|Tamoxifen|tamoxifen|mesh-list
65662186|NCT04961632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65662187|NCT04961632|Hormone Antagonists|hormone antagonists|mesh-ancestor
65662188|NCT04961632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65662189|NCT04961632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662190|NCT04961632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65662191|NCT04961632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662192|NCT04961632|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65662193|NCT04961632|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65662194|NCT04961632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65662195|NCT02155374|Insulin|insulin|mesh-list
65662196|NCT02155374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65662197|NCT02155374|Insulin, Short-Acting|insulin, short-acting|mesh-list
65662198|NCT02155374|Antineoplastic Agents|antineoplastic agents|mesh-list
65662199|NCT02155374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65662200|NCT02155374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662201|NCT04434118|Antirheumatic Agents|antirheumatic agents|mesh-list
65662202|NCT02765100|Minocycline|minocycline|mesh-list
65662203|NCT02765100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65662204|NCT02765100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65662205|NCT03091894|Dexmedetomidine|dexmedetomidine|mesh-list
65662206|NCT03091894|Propofol|propofol|mesh-list
65662207|NCT03091894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65662208|NCT03091894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65662209|NCT03091894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662210|NCT03091894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65662211|NCT03091894|Anesthetics, General|anesthetics, general|mesh-ancestor
65662212|NCT03091894|Anesthetics|anesthetics|mesh-ancestor
65662213|NCT03091894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65662214|NCT03091894|Analgesics|analgesics|mesh-ancestor
65662215|NCT03091894|Sensory System Agents|sensory system agents|mesh-ancestor
65662216|NCT03091894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65662217|NCT03091894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65662218|NCT03091894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65662219|NCT03091894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65459537|NCT05623852|Fucoidan|fucoidan|mesh-list
65662220|NCT03091894|Adrenergic Agents|adrenergic agents|mesh-ancestor
65662221|NCT03091894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65662222|NCT03091894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662223|NCT05014594|Dapagliflozin|dapagliflozin|mesh-list
65662224|NCT05014594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65662225|NCT05014594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662226|NCT05014594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65662227|NCT05014594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662228|NCT02761980|Acetaminophen|acetaminophen|mesh-list
65662229|NCT02761980|Ibuprofen|ibuprofen|mesh-list
65662230|NCT02761980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65662231|NCT02761980|Analgesics|analgesics|mesh-ancestor
65662232|NCT02761980|Sensory System Agents|sensory system agents|mesh-ancestor
65662233|NCT02761980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65662234|NCT02761980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662235|NCT02761980|Antipyretics|antipyretics|mesh-ancestor
65662236|NCT02761980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65662237|NCT02761980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65662238|NCT02761980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65662239|NCT02761980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65662240|NCT02761980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662241|NCT02761980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662242|NCT05007340|Dimercaprol|dimercaprol|mesh-list
65662243|NCT05007340|Chelating Agents|chelating agents|mesh-ancestor
65662244|NCT05007340|Sequestering Agents|sequestering agents|mesh-ancestor
65662245|NCT05007340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662246|NCT05014048|Vitamin D|vitamin d|mesh-list
65662247|NCT05014048|Cholecalciferol|cholecalciferol|mesh-list
65662248|NCT05014048|Vitamins|vitamins|mesh-ancestor
65662249|NCT05014048|Micronutrients|micronutrients|mesh-ancestor
65662250|NCT05014048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662251|NCT05014048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65662252|NCT05014048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65662253|NCT02163174|Pentoxifylline|pentoxifylline|mesh-list
65662254|NCT02163174|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65662255|NCT02163174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662256|NCT02163174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662257|NCT02163174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65662258|NCT02163174|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65662259|NCT02163174|Protective Agents|protective agents|mesh-ancestor
65662260|NCT02163174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662261|NCT02163174|Vasodilator Agents|vasodilator agents|mesh-ancestor
65662262|NCT02163174|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65662263|NCT02163174|Antioxidants|antioxidants|mesh-ancestor
65662264|NCT01744912|Lenalidomide|lenalidomide|mesh-list
65662265|NCT01744912|Immunologic Factors|immunologic factors|mesh-ancestor
65662266|NCT01744912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662267|NCT01744912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65662268|NCT01744912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65662269|NCT01744912|Growth Substances|growth substances|mesh-ancestor
65662270|NCT01744912|Growth Inhibitors|growth inhibitors|mesh-ancestor
65662271|NCT01744912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662272|NCT03540810|Hydroxychloroquine|hydroxychloroquine|mesh-list
65662273|NCT03540810|Antimalarials|antimalarials|mesh-ancestor
65662274|NCT03540810|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65662275|NCT03540810|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65662276|NCT03540810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65662277|NCT03540810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662278|NCT03540810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662279|NCT03540810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65662280|NCT02159820|Paclitaxel|paclitaxel|mesh-list
65662281|NCT02159820|Carboplatin|carboplatin|mesh-list
65662282|NCT02159820|Decitabine|decitabine|mesh-list
65662283|NCT02159820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65662284|NCT02159820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662285|NCT02159820|Tubulin Modulators|tubulin modulators|mesh-ancestor
65662286|NCT02159820|Antimitotic Agents|antimitotic agents|mesh-ancestor
65662287|NCT02159820|Mitosis Modulators|mitosis modulators|mesh-ancestor
65662288|NCT02159820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662289|NCT02159820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65662290|NCT02159820|Antimetabolites|antimetabolites|mesh-ancestor
65662291|NCT02159820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662292|NCT02862171|Dapivirine|dapivirine|mesh-list
65662293|NCT02862171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65662294|NCT02862171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65662295|NCT02862171|Antiviral Agents|antiviral agents|mesh-ancestor
65662296|NCT02862171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65662297|NCT05013112|Metformin|metformin|mesh-list
65662298|NCT05013112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65662299|NCT05013112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65662300|NCT05013112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662301|NCT05013112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662302|NCT05013034|Basiliximab|basiliximab|mesh-list
65662303|NCT05013034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65662304|NCT05013034|Immunologic Factors|immunologic factors|mesh-ancestor
65662305|NCT05013034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662306|NCT02638948|Methotrexate|methotrexate|mesh-list
65662307|NCT02638948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65662308|NCT02638948|Abortifacient Agents|abortifacient agents|mesh-ancestor
65662309|NCT02638948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65662310|NCT02638948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662311|NCT02638948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65662312|NCT02638948|Antimetabolites|antimetabolites|mesh-ancestor
65662313|NCT02638948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662314|NCT02638948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662315|NCT02638948|Dermatologic Agents|dermatologic agents|mesh-ancestor
65662316|NCT02638948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662317|NCT02638948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65662318|NCT02638948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65662319|NCT02638948|Immunologic Factors|immunologic factors|mesh-ancestor
65662320|NCT02638948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65662321|NCT02638948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65662322|NCT03091426|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
65662323|NCT03091426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65662324|NCT04465864|Dexamethasone|dexamethasone|mesh-list
65662325|NCT04465864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65662326|NCT04465864|Antiemetics|antiemetics|mesh-ancestor
65662327|NCT04465864|Autonomic Agents|autonomic agents|mesh-ancestor
65662328|NCT04465864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65662329|NCT04465864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662330|NCT04465864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65662331|NCT04465864|Glucocorticoids|glucocorticoids|mesh-ancestor
65662332|NCT04465864|Hormones|hormones|mesh-ancestor
65662333|NCT04465864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65662334|NCT04465864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65662335|NCT04465864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662336|NCT03091504|Albuterol|albuterol|mesh-list
65662337|NCT03091504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65662338|NCT03091504|Autonomic Agents|autonomic agents|mesh-ancestor
65662339|NCT03091504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65662340|NCT03091504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662341|NCT03091504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65662342|NCT03091504|Respiratory System Agents|respiratory system agents|mesh-ancestor
65662343|NCT03091504|Tocolytic Agents|tocolytic agents|mesh-ancestor
65662344|NCT03091504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65662345|NCT03091504|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65662346|NCT03091504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65662347|NCT03091504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65662348|NCT03091504|Adrenergic Agents|adrenergic agents|mesh-ancestor
65662349|NCT03091504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65662350|NCT03091504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662351|NCT05019586|Amoxicillin|amoxicillin|mesh-list
65662352|NCT05019586|Clarithromycin|clarithromycin|mesh-list
65662353|NCT05019586|Levofloxacin|levofloxacin|mesh-list
65662354|NCT05019586|Ofloxacin|ofloxacin|mesh-list
65662355|NCT05019586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65662356|NCT05019586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65662357|NCT05019586|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65662358|NCT05019586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662359|NCT05019586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662360|NCT05019586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65662361|NCT05019586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65662362|NCT05019586|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65662363|NCT05019586|Renal Agents|renal agents|mesh-ancestor
65662364|NCT05019586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65662365|NCT05019586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65662366|NCT05019586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662367|NCT05019586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65662368|NCT03081676|Glimepiride|glimepiride|mesh-list
65662369|NCT03081676|Glucagon|glucagon|mesh-list
65662370|NCT03081676|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
65662371|NCT03081676|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65662372|NCT03081676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65662373|NCT03081676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65662374|NCT03081676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662375|NCT03081676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65662376|NCT03081676|Immunologic Factors|immunologic factors|mesh-ancestor
65662377|NCT03081676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65662378|NCT03081676|Hormones|hormones|mesh-ancestor
65662379|NCT03081676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65662380|NCT03081676|Incretins|incretins|mesh-ancestor
65662381|NCT05013268|Paclitaxel|paclitaxel|mesh-list
65662382|NCT05013268|Docetaxel|docetaxel|mesh-list
65662383|NCT05013268|Carboplatin|carboplatin|mesh-list
65662384|NCT05013268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65662385|NCT05013268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662386|NCT05013268|Tubulin Modulators|tubulin modulators|mesh-ancestor
65662387|NCT05013268|Antimitotic Agents|antimitotic agents|mesh-ancestor
65662388|NCT05013268|Mitosis Modulators|mitosis modulators|mesh-ancestor
65662389|NCT05013268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662390|NCT00102960|Ritonavir|ritonavir|mesh-list
65662391|NCT00102960|Lopinavir|lopinavir|mesh-list
65662392|NCT00102960|Lamivudine|lamivudine|mesh-list
65662393|NCT00102960|Zidovudine|zidovudine|mesh-list
65662394|NCT00102960|Nevirapine|nevirapine|mesh-list
65662395|NCT00102960|Abacavir|abacavir|mesh-list
65662396|NCT00102960|Didanosine|didanosine|mesh-list
65662397|NCT00102960|Efavirenz|efavirenz|mesh-list
65662398|NCT00102960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65662399|NCT00102960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65662400|NCT00102960|Protease Inhibitors|protease inhibitors|mesh-ancestor
65662401|NCT00102960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662402|NCT00102960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662403|NCT00102960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65662404|NCT00102960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65662405|NCT00102960|Antiviral Agents|antiviral agents|mesh-ancestor
65662406|NCT00102960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65662407|NCT00102960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65662408|NCT00102960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65662409|NCT00102960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65662410|NCT00102960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65662411|NCT00102960|Antimetabolites|antimetabolites|mesh-ancestor
65662412|NCT00102960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65662413|NCT00102960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65662414|NCT00102960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65662415|NCT00102960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65662416|NCT00102960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65662417|NCT02858895|Interleukin-4|interleukin-4|mesh-list
65662418|NCT02858895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65662419|NCT02858895|Immunologic Factors|immunologic factors|mesh-ancestor
65268390|NCT02873598|Gemcitabine|gemcitabine|mesh-list
65662420|NCT02858895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662421|NCT02858895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662422|NCT02858895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65662423|NCT05018962|Paclitaxel|paclitaxel|mesh-list
65662424|NCT05018962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65662425|NCT05018962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662426|NCT05018962|Tubulin Modulators|tubulin modulators|mesh-ancestor
65662427|NCT05018962|Antimitotic Agents|antimitotic agents|mesh-ancestor
65662428|NCT05018962|Mitosis Modulators|mitosis modulators|mesh-ancestor
65662429|NCT05018962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662430|NCT02160054|Tacrolimus|tacrolimus|mesh-list
65662431|NCT02160054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65662432|NCT02160054|Immunologic Factors|immunologic factors|mesh-ancestor
65662433|NCT02160054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662434|NCT02160054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65662435|NCT02160054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662436|NCT02160054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662437|NCT03609489|Capecitabine|capecitabine|mesh-list
65662438|NCT03609489|Apatinib|apatinib|mesh-list
65662439|NCT03609489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65662440|NCT03609489|Antimetabolites|antimetabolites|mesh-ancestor
65662441|NCT03609489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662442|NCT03609489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662443|NCT03609489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65662444|NCT03609489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662445|NCT02033967|Milrinone|milrinone|mesh-list
65662446|NCT02033967|Vasodilator Agents|vasodilator agents|mesh-list
65662447|NCT02033967|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65662448|NCT02033967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65662449|NCT02033967|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65662450|NCT02033967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65662451|NCT02033967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662452|NCT02033967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662453|NCT02033967|Protective Agents|protective agents|mesh-ancestor
65662454|NCT02033967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662455|NCT02163330|Acetazolamide|acetazolamide|mesh-list
65662456|NCT02163330|Anticonvulsants|anticonvulsants|mesh-ancestor
65662457|NCT02163330|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65662458|NCT02163330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662459|NCT02163330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662460|NCT02163330|Diuretics|diuretics|mesh-ancestor
65662461|NCT02163330|Natriuretic Agents|natriuretic agents|mesh-ancestor
65662462|NCT02163330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662463|NCT03610035|Immunoglobulins|immunoglobulins|mesh-list
65662464|NCT03610035|Immunoglobulin G|immunoglobulin g|mesh-list
65662465|NCT03610035|Immunologic Factors|immunologic factors|mesh-ancestor
65662466|NCT03610035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662467|NCT02160132|Methylprednisolone|methylprednisolone|mesh-list
65662468|NCT02160132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65662469|NCT02160132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65662470|NCT02160132|Prednisolone|prednisolone|mesh-list
65662471|NCT02160132|Prednisolone acetate|prednisolone acetate|mesh-list
65662472|NCT02160132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65662473|NCT02160132|Prednisolone phosphate|prednisolone phosphate|mesh-list
65662474|NCT02160132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65662475|NCT02160132|Antiemetics|antiemetics|mesh-ancestor
65662476|NCT02160132|Autonomic Agents|autonomic agents|mesh-ancestor
65662477|NCT02160132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65662478|NCT02160132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662479|NCT02160132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65662480|NCT02160132|Glucocorticoids|glucocorticoids|mesh-ancestor
65662481|NCT02160132|Hormones|hormones|mesh-ancestor
65662482|NCT02160132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65662483|NCT02160132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65662484|NCT02160132|Protective Agents|protective agents|mesh-ancestor
65662485|NCT02160132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65662486|NCT02160132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662487|NCT02034201|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65662488|NCT02034201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65662489|NCT02034201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662490|NCT02034201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65662491|NCT02034201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65268391|NCT02873598|Paclitaxel|paclitaxel|mesh-list
65662492|NCT02034201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65662493|NCT02034201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662494|NCT02034201|Dopamine Agents|dopamine agents|mesh-ancestor
65662495|NCT02034201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65662496|NCT02637856|Ocrelizumab|ocrelizumab|mesh-list
65662497|NCT02637856|Immunologic Factors|immunologic factors|mesh-ancestor
65662498|NCT02637856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662499|NCT02858037|Dapivirine|dapivirine|mesh-list
65662500|NCT02858037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65662501|NCT02858037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65662502|NCT02858037|Antiviral Agents|antiviral agents|mesh-ancestor
65662503|NCT02858037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65662504|NCT01755975|Lenalidomide|lenalidomide|mesh-list
65662505|NCT01755975|Romidepsin|romidepsin|mesh-list
65662506|NCT01755975|Immunologic Factors|immunologic factors|mesh-ancestor
65662507|NCT01755975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662508|NCT01755975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65662509|NCT01755975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65662510|NCT01755975|Growth Substances|growth substances|mesh-ancestor
65662511|NCT01755975|Growth Inhibitors|growth inhibitors|mesh-ancestor
65662512|NCT01755975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662513|NCT01755975|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65662514|NCT01541709|Imatinib Mesylate|imatinib mesylate|mesh-list
65662515|NCT01541709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662516|NCT01541709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65662517|NCT01541709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662518|NCT01541709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662519|NCT04266340|Midazolam|midazolam|mesh-list
65662520|NCT04266340|Dexmedetomidine|dexmedetomidine|mesh-list
65662521|NCT04266340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65662522|NCT04266340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65662523|NCT04266340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662524|NCT04266340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65662525|NCT04266340|Analgesics|analgesics|mesh-ancestor
65662526|NCT04266340|Sensory System Agents|sensory system agents|mesh-ancestor
65662527|NCT04266340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65662528|NCT04266340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65662529|NCT04266340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65662530|NCT04266340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65662531|NCT04266340|Adrenergic Agents|adrenergic agents|mesh-ancestor
65662532|NCT04266340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65662533|NCT04266340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662534|NCT04266340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65662535|NCT04266340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65662536|NCT04266340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65662537|NCT04266340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65662538|NCT04266340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65662539|NCT04266340|Anesthetics, General|anesthetics, general|mesh-ancestor
65662540|NCT04266340|Anesthetics|anesthetics|mesh-ancestor
65662541|NCT04266340|GABA Modulators|gaba modulators|mesh-ancestor
65662542|NCT04266340|GABA Agents|gaba agents|mesh-ancestor
65662543|NCT02856555|Firsocostat|firsocostat|mesh-list
65662544|NCT02856555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662545|NCT02856555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662546|NCT02237079|Bazedoxifene|bazedoxifene|mesh-list
65662547|NCT02237079|Estrogens|estrogens|mesh-list
65662548|NCT02237079|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65662549|NCT02237079|Hormones|hormones|mesh-ancestor
65662550|NCT02237079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65662551|NCT02237079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662552|NCT02237079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65662553|NCT02237079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65662554|NCT02237079|Hormone Antagonists|hormone antagonists|mesh-ancestor
65662555|NCT02237079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65662556|NCT04463680|Rifampin|rifampin|mesh-list
65662557|NCT04463680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65662558|NCT04463680|Antitubercular Agents|antitubercular agents|mesh-ancestor
65662559|NCT04463680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65662560|NCT04463680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65662561|NCT04463680|Leprostatic Agents|leprostatic agents|mesh-ancestor
65662562|NCT04463680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65662563|NCT04463680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662564|NCT04463680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662565|NCT04463680|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65662566|NCT04463680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65662567|NCT04463680|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65662568|NCT04463680|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65662569|NCT04463680|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65662570|NCT04463680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65662571|NCT03609099|Moxifloxacin|moxifloxacin|mesh-list
65662572|NCT03609099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65662573|NCT03609099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65662574|NCT03609099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65662575|NCT03609099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65662576|NCT03609099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662577|NCT03609099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662578|NCT03609099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662579|NCT05000086|Diphosphonates|diphosphonates|mesh-list
65662580|NCT05000086|Methylene diphosphonate|methylene diphosphonate|mesh-list
65662581|NCT05000086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65662582|NCT05000086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662583|NCT05010538|Sarecycline|sarecycline|mesh-list
65662584|NCT05010538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65662585|NCT05010538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65662586|NCT05010538|Dermatologic Agents|dermatologic agents|mesh-ancestor
65662587|NCT01242267|Thalidomide|thalidomide|mesh-list
65662588|NCT01242267|Bortezomib|bortezomib|mesh-list
65662589|NCT01242267|Melphalan|melphalan|mesh-list
65662590|NCT01242267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662591|NCT01242267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65662592|NCT01242267|Alkylating Agents|alkylating agents|mesh-ancestor
65662593|NCT01242267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662594|NCT01242267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65662595|NCT01242267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65662596|NCT01242267|Immunologic Factors|immunologic factors|mesh-ancestor
65662597|NCT01242267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662598|NCT01242267|Leprostatic Agents|leprostatic agents|mesh-ancestor
65662599|NCT01242267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65662600|NCT01242267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65662601|NCT01242267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65662602|NCT01242267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65662603|NCT01242267|Growth Substances|growth substances|mesh-ancestor
65662604|NCT01242267|Growth Inhibitors|growth inhibitors|mesh-ancestor
65662605|NCT02637232|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65662606|NCT02637232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65662607|NCT02637232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65662608|NCT02637232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65662609|NCT02637232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65662610|NCT02637232|Adrenergic Agents|adrenergic agents|mesh-ancestor
65662611|NCT02637232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65662612|NCT02637232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662613|NCT02637232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662614|NCT02635984|Olanzapine|olanzapine|mesh-list
65662615|NCT02635984|Antiemetics|antiemetics|mesh-ancestor
65662616|NCT02635984|Autonomic Agents|autonomic agents|mesh-ancestor
65662617|NCT02635984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65662618|NCT02635984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662619|NCT02635984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65662620|NCT02635984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65662621|NCT02635984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65662622|NCT02635984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65662623|NCT02635984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65662624|NCT02635984|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65662625|NCT02635984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65662626|NCT02635984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65662627|NCT02635984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662628|NCT02635984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65662629|NCT02635984|Serotonin Agents|serotonin agents|mesh-ancestor
65662630|NCT03073408|Propofol|propofol|mesh-list
65662631|NCT03073408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65662632|NCT03073408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65662633|NCT03073408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662634|NCT03073408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65662635|NCT03073408|Anesthetics, General|anesthetics, general|mesh-ancestor
65662636|NCT03073408|Anesthetics|anesthetics|mesh-ancestor
65662637|NCT04993222|Amphotericin B|amphotericin b|mesh-list
65662638|NCT04993222|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65662639|NCT04993222|Amebicides|amebicides|mesh-ancestor
65662640|NCT04993222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65662641|NCT04993222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65662642|NCT04993222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65662643|NCT04993222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65662644|NCT04993222|Antifungal Agents|antifungal agents|mesh-ancestor
65662645|NCT03076762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65662646|NCT03076762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65662647|NCT03076762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65662648|NCT03076762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65662649|NCT03076762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662650|NCT03076762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65662651|NCT03076762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65662652|NCT03076762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662653|NCT03076762|Cholinergic Agents|cholinergic agents|mesh-ancestor
65662654|NCT03076762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65662655|NCT02747043|Rituximab|rituximab|mesh-list
65662656|NCT02747043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65662657|NCT02747043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662658|NCT02747043|Immunologic Factors|immunologic factors|mesh-ancestor
65662659|NCT02747043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662660|NCT02747043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65662661|NCT05004142|Letrozole|letrozole|mesh-list
65662662|NCT05004142|Fulvestrant|fulvestrant|mesh-list
65662663|NCT05004142|Goserelin|goserelin|mesh-list
65662664|NCT05004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662665|NCT05004142|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65662666|NCT05004142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65662667|NCT05004142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662668|NCT05004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662669|NCT05004142|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65662670|NCT05004142|Hormone Antagonists|hormone antagonists|mesh-ancestor
65662671|NCT05004142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65662672|NCT05004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662673|NCT05004142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65662674|NCT05004142|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65662675|NCT03076684|Allopurinol|allopurinol|mesh-list
65662676|NCT03076684|Antimetabolites|antimetabolites|mesh-ancestor
65662677|NCT03076684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662678|NCT03076684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662679|NCT03076684|Gout Suppressants|gout suppressants|mesh-ancestor
65662680|NCT03076684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65662681|NCT03076684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65662682|NCT03076684|Antioxidants|antioxidants|mesh-ancestor
65662683|NCT03076684|Protective Agents|protective agents|mesh-ancestor
65662684|NCT03076684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662685|NCT04999930|Tiotropium Bromide|tiotropium bromide|mesh-list
65662686|NCT04999930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65662687|NCT04999930|Autonomic Agents|autonomic agents|mesh-ancestor
65662688|NCT04999930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65662689|NCT04999930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662690|NCT04999930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65662691|NCT04999930|Respiratory System Agents|respiratory system agents|mesh-ancestor
65662692|NCT04999930|Parasympatholytics|parasympatholytics|mesh-ancestor
65662693|NCT04999930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65662694|NCT04999930|Cholinergic Agents|cholinergic agents|mesh-ancestor
65662695|NCT04999930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65662696|NCT04999930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662697|NCT03607851|Lacosamide|lacosamide|mesh-list
65662698|NCT03607851|Anticonvulsants|anticonvulsants|mesh-ancestor
65662699|NCT03607851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65662700|NCT03607851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65662701|NCT03607851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65662702|NCT03607851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662703|NCT04999540|Fulvestrant|fulvestrant|mesh-list
65662704|NCT04999540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65662705|NCT04999540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662706|NCT04999540|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65662707|NCT04999540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65662708|NCT04999540|Hormone Antagonists|hormone antagonists|mesh-ancestor
65662709|NCT04999540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65662710|NCT04999540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662711|NCT03608007|Ensartinib|ensartinib|mesh-list
65662712|NCT03608007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662713|NCT03608007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65662714|NCT03608007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662715|NCT03608007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662716|NCT02637076|Sodium Oxybate|sodium oxybate|mesh-list
65662717|NCT02637076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65662718|NCT02637076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65662719|NCT02637076|Anesthetics, General|anesthetics, general|mesh-ancestor
65662720|NCT02637076|Anesthetics|anesthetics|mesh-ancestor
65662721|NCT02637076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65662722|NCT02637076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662723|NCT03075358|Lidocaine|lidocaine|mesh-list
65662724|NCT03075358|Anesthetics, Local|anesthetics, local|mesh-ancestor
65662725|NCT03075358|Anesthetics|anesthetics|mesh-ancestor
65662726|NCT03075358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65662727|NCT03075358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662728|NCT03075358|Sensory System Agents|sensory system agents|mesh-ancestor
65662729|NCT03075358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65662730|NCT03075358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65662731|NCT03075358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65662732|NCT03075358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65662733|NCT03075358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65662734|NCT03075358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662735|NCT05003596|Methylprednisolone|methylprednisolone|mesh-list
65662736|NCT05003596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65662737|NCT05003596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65662738|NCT05003596|Prednisolone|prednisolone|mesh-list
65662739|NCT05003596|Prednisolone acetate|prednisolone acetate|mesh-list
65662740|NCT05003596|Narcotics|narcotics|mesh-list
65662741|NCT05003596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65662742|NCT05003596|Prednisolone phosphate|prednisolone phosphate|mesh-list
65662743|NCT05003596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65662744|NCT05003596|Antiemetics|antiemetics|mesh-ancestor
65662745|NCT05003596|Autonomic Agents|autonomic agents|mesh-ancestor
65662746|NCT05003596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65662747|NCT05003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662748|NCT05003596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65662749|NCT05003596|Glucocorticoids|glucocorticoids|mesh-ancestor
65662750|NCT05003596|Hormones|hormones|mesh-ancestor
65662751|NCT05003596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65662752|NCT05003596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65662753|NCT05003596|Protective Agents|protective agents|mesh-ancestor
65662754|NCT05003596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65662755|NCT05003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662756|NCT05003596|Analgesics|analgesics|mesh-ancestor
65662757|NCT05003596|Sensory System Agents|sensory system agents|mesh-ancestor
65662758|NCT05003596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65662759|NCT02854527|Metformin|metformin|mesh-list
65662760|NCT02854527|Digoxin|digoxin|mesh-list
65662761|NCT02854527|Furosemide|furosemide|mesh-list
65662762|NCT02854527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65662763|NCT02854527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65662764|NCT02854527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662765|NCT02854527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65662766|NCT02854527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65662767|NCT02854527|Antimetabolites|antimetabolites|mesh-ancestor
65662768|NCT02854527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662769|NCT02854527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65662770|NCT02854527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65662771|NCT02854527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662772|NCT02854527|Diuretics|diuretics|mesh-ancestor
65662773|NCT02854527|Natriuretic Agents|natriuretic agents|mesh-ancestor
65662774|NCT02854527|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65662775|NCT02854527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65662776|NCT02854527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65662777|NCT02854527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65662778|NCT02854527|Protective Agents|protective agents|mesh-ancestor
65662779|NCT04433572|Sirolimus|sirolimus|mesh-list
65662780|NCT04433572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65662781|NCT04433572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65662782|NCT04433572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65662783|NCT04433572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662784|NCT04433572|Antifungal Agents|antifungal agents|mesh-ancestor
65662785|NCT04433572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65662786|NCT04433572|Immunologic Factors|immunologic factors|mesh-ancestor
65662787|NCT04433572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662788|NCT03073018|Fosinopril|fosinopril|mesh-list
65662789|NCT03073018|Pravastatin|pravastatin|mesh-list
65662790|NCT03073018|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65662791|NCT03073018|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65662792|NCT03073018|Antimetabolites|antimetabolites|mesh-ancestor
65662793|NCT03073018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662794|NCT03073018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65662795|NCT03073018|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65662796|NCT03073018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662797|NCT03073018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65662798|NCT03073018|Protease Inhibitors|protease inhibitors|mesh-ancestor
65662799|NCT03073018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65662800|NCT03608241|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65662801|NCT03608241|Contraceptive Agents|contraceptive agents|mesh-list
65662802|NCT03608241|Contraceptives, Oral|contraceptives, oral|mesh-list
65662803|NCT03608241|Estradiol|estradiol|mesh-list
65662804|NCT03608241|Estrogens|estrogens|mesh-ancestor
65662805|NCT03608241|Hormones|hormones|mesh-ancestor
65662806|NCT03608241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65662807|NCT03608241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662808|NCT03608241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65662809|NCT03608241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65662810|NCT03608241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65662811|NCT03608241|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65662812|NCT03606057|Moxifloxacin|moxifloxacin|mesh-list
65662813|NCT03606057|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65662814|NCT03606057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65662815|NCT03606057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65662816|NCT03606057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65662817|NCT03606057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65662818|NCT03606057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662819|NCT03606057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662820|NCT03606057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662821|NCT03606057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65662822|NCT03606057|Contraceptive Agents|contraceptive agents|mesh-ancestor
65662823|NCT03606057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65662824|NCT03606057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662825|NCT03606057|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65662826|NCT03606057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65662827|NCT03606057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65662828|NCT03607383|Red yeast rice|red yeast rice|mesh-list
65662829|NCT03607383|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65662830|NCT03607383|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65662831|NCT03607383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65662832|NCT03607383|Antimetabolites|antimetabolites|mesh-ancestor
65662833|NCT03607383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662834|NCT03607383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662835|NCT03607383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65662836|NCT03607227|Levobupivacaine|levobupivacaine|mesh-list
65662837|NCT03607227|Anesthetics, Local|anesthetics, local|mesh-ancestor
65662838|NCT03607227|Anesthetics|anesthetics|mesh-ancestor
65662839|NCT03607227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65662840|NCT03607227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662841|NCT03607227|Sensory System Agents|sensory system agents|mesh-ancestor
65662842|NCT03607227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65662843|NCT03607149|Pemetrexed|pemetrexed|mesh-list
65662844|NCT03607149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662845|NCT03607149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662846|NCT03607149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662847|NCT03607149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65662848|NCT03607149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65662849|NCT04998838|Tenofovir|tenofovir|mesh-list
65662850|NCT04998838|Immunoglobulins|immunoglobulins|mesh-list
65662851|NCT04998838|Antibodies|antibodies|mesh-list
65662852|NCT04998838|gamma-Globulins|gamma-globulins|mesh-list
65662853|NCT04998838|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65662854|NCT04998838|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65662855|NCT04998838|Antiviral Agents|antiviral agents|mesh-ancestor
65662856|NCT04998838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65662857|NCT04998838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65662858|NCT04998838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65662859|NCT04998838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662860|NCT04998838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662861|NCT04998838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65662862|NCT04998838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65662863|NCT04998838|Immunologic Factors|immunologic factors|mesh-ancestor
65662864|NCT04998838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662865|NCT03607071|Prednisolone|prednisolone|mesh-list
65662866|NCT03607071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65662867|NCT03607071|Glucocorticoids|glucocorticoids|mesh-ancestor
65662868|NCT03607071|Hormones|hormones|mesh-ancestor
65662869|NCT03607071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65662870|NCT03607071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662871|NCT03607071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65662872|NCT03607071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662873|NCT02035215|Atorvastatin|atorvastatin|mesh-list
65662874|NCT02035215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65662875|NCT02035215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65662876|NCT02035215|Antimetabolites|antimetabolites|mesh-ancestor
65662877|NCT02035215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662878|NCT02035215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65662879|NCT02035215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65662880|NCT02035215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662881|NCT03605589|Pembrolizumab|pembrolizumab|mesh-list
65662882|NCT03605589|Blinatumomab|blinatumomab|mesh-list
65662883|NCT03605589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65662884|NCT03605589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662885|NCT05002270|Cetuximab|cetuximab|mesh-list
65662886|NCT05002270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65662887|NCT05002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662888|NCT05002036|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65662889|NCT05002036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65662890|NCT03074968|Benzydamine|benzydamine|mesh-list
65662891|NCT03074968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65662892|NCT04991584|Amoxicillin|amoxicillin|mesh-list
65662893|NCT04991584|Levofloxacin|levofloxacin|mesh-list
65662894|NCT04991584|Ofloxacin|ofloxacin|mesh-list
65662895|NCT04991584|Tetracycline|tetracycline|mesh-list
65662896|NCT04991584|Furazolidone|furazolidone|mesh-list
65662897|NCT04991584|Esomeprazole|esomeprazole|mesh-list
65662898|NCT04991584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65662899|NCT04991584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65662900|NCT04991584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65662901|NCT04991584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65662902|NCT04991584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65662903|NCT04991584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662904|NCT04991584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662905|NCT04991584|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65662906|NCT04991584|Renal Agents|renal agents|mesh-ancestor
65662907|NCT04991584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65662908|NCT04991584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65662909|NCT04991584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662910|NCT04991584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65662911|NCT04991584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65662912|NCT04991584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65662913|NCT04991584|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65662914|NCT04991584|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65662915|NCT04991584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65662916|NCT04991584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65662917|NCT04991584|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65662918|NCT05001412|Carboplatin|carboplatin|mesh-list
65662919|NCT05001412|Etoposide|etoposide|mesh-list
65662920|NCT05001412|Apatinib|apatinib|mesh-list
65662921|NCT05001412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65662922|NCT05001412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65662923|NCT05001412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65662924|NCT05001412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65662925|NCT05001412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662926|NCT05001412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662927|NCT05001412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65662928|NCT04991896|Metoprolol|metoprolol|mesh-list
65662929|NCT04991896|Sotalol|sotalol|mesh-list
65662930|NCT04991896|Flecainide|flecainide|mesh-list
65662931|NCT04991896|Bisoprolol|bisoprolol|mesh-list
65662932|NCT04991896|Betaxolol|betaxolol|mesh-list
65662933|NCT04991896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65662934|NCT04991896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65662935|NCT04991896|Sympatholytics|sympatholytics|mesh-ancestor
65662936|NCT04991896|Autonomic Agents|autonomic agents|mesh-ancestor
65662937|NCT04991896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65662938|NCT04991896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662939|NCT04991896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65662940|NCT04991896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65662941|NCT04991896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65662942|NCT04991896|Adrenergic Agents|adrenergic agents|mesh-ancestor
65662943|NCT04991896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65662944|NCT04991896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662945|NCT04991896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65662946|NCT04991896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65662947|NCT04991896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65662948|NCT03072394|Lidocaine|lidocaine|mesh-list
65662949|NCT03072394|Anesthetics, Local|anesthetics, local|mesh-list
65662950|NCT03072394|Anesthetics|anesthetics|mesh-list
65662951|NCT03072394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65662952|NCT03072394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662953|NCT03072394|Sensory System Agents|sensory system agents|mesh-ancestor
65662954|NCT03072394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65662955|NCT03072394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65662956|NCT03072394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65662957|NCT03072394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65662958|NCT03072394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65662959|NCT03072394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662960|NCT03072082|Aspirin|aspirin|mesh-list
65662961|NCT03072082|Metoprolol|metoprolol|mesh-list
65662962|NCT03072082|Isosorbide|isosorbide|mesh-list
65662963|NCT03072082|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65662964|NCT03072082|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65662965|NCT03072082|Trimetazidine|trimetazidine|mesh-list
65662966|NCT03072082|Clopidogrel|clopidogrel|mesh-list
65662967|NCT03072082|Atorvastatin|atorvastatin|mesh-list
65662968|NCT03072082|Calcium|calcium|mesh-list
65662969|NCT03072082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65662970|NCT03072082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65662971|NCT03072082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65662972|NCT03072082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65662974|NCT03072082|Sensory System Agents|sensory system agents|mesh-ancestor
65662975|NCT03072082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65662976|NCT03072082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65662977|NCT03072082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65662978|NCT03072082|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65662979|NCT03072082|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65662980|NCT03072082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65662981|NCT03072082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65662982|NCT03072082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65662983|NCT03072082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65662984|NCT03072082|Antipyretics|antipyretics|mesh-ancestor
65662985|NCT03072082|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65662986|NCT03072082|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65662987|NCT03072082|Antimetabolites|antimetabolites|mesh-ancestor
65662988|NCT03072082|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65662989|NCT03072082|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65662990|NCT03072082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65662991|NCT03072082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65662992|NCT03072082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65662993|NCT03072082|Purinergic Agents|purinergic agents|mesh-ancestor
65662994|NCT03072082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65662995|NCT03072082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65662996|NCT03072082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65662997|NCT03072082|Sympatholytics|sympatholytics|mesh-ancestor
65662998|NCT03072082|Autonomic Agents|autonomic agents|mesh-ancestor
65662999|NCT03072082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65663000|NCT03072082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65663001|NCT03072082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65663002|NCT03072082|Adrenergic Agents|adrenergic agents|mesh-ancestor
65663003|NCT03072082|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65663004|NCT03072082|Diuretics|diuretics|mesh-ancestor
65663005|NCT03072082|Natriuretic Agents|natriuretic agents|mesh-ancestor
65663006|NCT03072082|Vasodilator Agents|vasodilator agents|mesh-ancestor
65663007|NCT03072082|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65663008|NCT04934020|Metronidazole|metronidazole|mesh-list
65663009|NCT04934020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65663010|NCT04934020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65663011|NCT04934020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65663012|NCT04934020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65663013|NCT04904614|Letermovir|letermovir|mesh-list
65663014|NCT04904614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65663015|NCT04904614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663016|NCT04904614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663017|NCT04904614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663018|NCT04904614|Antiviral Agents|antiviral agents|mesh-ancestor
65663019|NCT04904614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65663020|NCT04987450|Prednisone|prednisone|mesh-list
65663021|NCT04987450|Methylprednisolone|methylprednisolone|mesh-list
65663022|NCT04987450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65663023|NCT04987450|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65663024|NCT04987450|Prednisolone|prednisolone|mesh-list
65663025|NCT04987450|Prednisolone acetate|prednisolone acetate|mesh-list
65663026|NCT04987450|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65663027|NCT04987450|Prednisolone phosphate|prednisolone phosphate|mesh-list
65663028|NCT04987450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65663029|NCT04987450|Glucocorticoids|glucocorticoids|mesh-ancestor
65663030|NCT04987450|Hormones|hormones|mesh-ancestor
65663031|NCT04987450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65663032|NCT04987450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663033|NCT04987450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65663034|NCT04987450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663035|NCT04987450|Antiemetics|antiemetics|mesh-ancestor
65663036|NCT04987450|Autonomic Agents|autonomic agents|mesh-ancestor
65663037|NCT04987450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65663038|NCT04987450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65663039|NCT04987450|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65663040|NCT04987450|Protective Agents|protective agents|mesh-ancestor
65663041|NCT03074578|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65663042|NCT03074578|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
65663043|NCT03074578|beta-Endorphin|beta-endorphin|mesh-list
65663044|NCT03074578|Hormones|hormones|mesh-ancestor
65663045|NCT03074578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65663046|NCT03074578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663047|NCT03074578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65663048|NCT03074578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663050|NCT04991194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663051|NCT04991194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663052|NCT03071770|Ivosidenib|ivosidenib|mesh-list
65663053|NCT03071770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663054|NCT03071770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663055|NCT03071770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663056|NCT04986982|Opicapone|opicapone|mesh-list
65663057|NCT04986982|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65663058|NCT04986982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663059|NCT04986982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663060|NCT04986982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65663061|NCT04986982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65663062|NCT03070054|Epinephrine|epinephrine|mesh-list
65663063|NCT03070054|Bupivacaine|bupivacaine|mesh-list
65663064|NCT03070054|Anesthetics, Local|anesthetics, local|mesh-ancestor
65663065|NCT03070054|Anesthetics|anesthetics|mesh-ancestor
65663066|NCT03070054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65663067|NCT03070054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663068|NCT03070054|Sensory System Agents|sensory system agents|mesh-ancestor
65663069|NCT03070054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65663070|NCT03070054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65663071|NCT03070054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65663072|NCT03070054|Adrenergic Agents|adrenergic agents|mesh-ancestor
65663073|NCT03070054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65663074|NCT03070054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663075|NCT03070054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65663076|NCT03070054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65663077|NCT03070054|Autonomic Agents|autonomic agents|mesh-ancestor
65663078|NCT03070054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65663079|NCT03070054|Respiratory System Agents|respiratory system agents|mesh-ancestor
65663080|NCT03070054|Mydriatics|mydriatics|mesh-ancestor
65663081|NCT03070054|Sympathomimetics|sympathomimetics|mesh-ancestor
65663082|NCT03070054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65663083|NCT04996498|Oxytocin|oxytocin|mesh-list
65663084|NCT04996498|Oxytocics|oxytocics|mesh-ancestor
65663085|NCT04996498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65663086|NCT04996498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663087|NCT03074344|Hyaluronic Acid|hyaluronic acid|mesh-list
65663088|NCT03074344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65663089|NCT03074344|Immunologic Factors|immunologic factors|mesh-ancestor
65663090|NCT03074344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663091|NCT03074344|Viscosupplements|viscosupplements|mesh-ancestor
65663092|NCT03074344|Protective Agents|protective agents|mesh-ancestor
65663093|NCT03605511|Complement System Proteins|complement system proteins|mesh-list
65663094|NCT03605511|Immunologic Factors|immunologic factors|mesh-ancestor
65663095|NCT03605511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663096|NCT02035371|Insulin|insulin|mesh-list
65663097|NCT02035371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65663098|NCT02035371|Insulin Aspart|insulin aspart|mesh-list
65663099|NCT02035371|Insulin, Long-Acting|insulin, long-acting|mesh-list
65663100|NCT02035371|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65663101|NCT02035371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65663102|NCT02035371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663103|NCT03069820|Docetaxel|docetaxel|mesh-list
65663104|NCT03069820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663105|NCT03069820|Tubulin Modulators|tubulin modulators|mesh-ancestor
65663106|NCT03069820|Antimitotic Agents|antimitotic agents|mesh-ancestor
65663107|NCT03069820|Mitosis Modulators|mitosis modulators|mesh-ancestor
65663108|NCT03069820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663109|NCT03605433|Rivaroxaban|rivaroxaban|mesh-list
65663110|NCT03605433|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65663111|NCT03605433|Antithrombins|antithrombins|mesh-ancestor
65663112|NCT03605433|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65663113|NCT03605433|Protease Inhibitors|protease inhibitors|mesh-ancestor
65663114|NCT03605433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663115|NCT03605433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663116|NCT03605433|Anticoagulants|anticoagulants|mesh-ancestor
65663117|NCT03071302|Tissue Inhibitor of Metalloproteinase-3|tissue inhibitor of metalloproteinase-3|mesh-list
65663118|NCT03071302|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
65663119|NCT03071302|Protease Inhibitors|protease inhibitors|mesh-ancestor
65663120|NCT03071302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663121|NCT03071302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663122|NCT03270501|Golimumab|golimumab|mesh-list
65663123|NCT03270501|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65663124|NCT03270501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65663125|NCT03270501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65663126|NCT03270501|Immunologic Factors|immunologic factors|mesh-ancestor
65663127|NCT03270501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663128|NCT03606681|Calcium, Dietary|calcium, dietary|mesh-list
65663129|NCT03606681|Calcium|calcium|mesh-list
65663130|NCT03606681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65663131|NCT03606681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663132|NCT03606681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65663133|NCT03071380|Rivaroxaban|rivaroxaban|mesh-list
65663134|NCT03071380|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65663135|NCT03071380|Antithrombins|antithrombins|mesh-ancestor
65663136|NCT03071380|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65663137|NCT03071380|Protease Inhibitors|protease inhibitors|mesh-ancestor
65663138|NCT03071380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663139|NCT03071380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663140|NCT03071380|Anticoagulants|anticoagulants|mesh-ancestor
65663141|NCT03605199|Denosumab|denosumab|mesh-list
65663142|NCT03605199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65663143|NCT03605199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663144|NCT03606369|Ondansetron|ondansetron|mesh-list
65663145|NCT03606369|Palonosetron|palonosetron|mesh-list
65663146|NCT03606369|Antiemetics|antiemetics|mesh-ancestor
65663147|NCT03606369|Autonomic Agents|autonomic agents|mesh-ancestor
65663148|NCT03606369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65663149|NCT03606369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663150|NCT03606369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65663151|NCT03606369|Antipruritics|antipruritics|mesh-ancestor
65663152|NCT03606369|Dermatologic Agents|dermatologic agents|mesh-ancestor
65663153|NCT03606369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65663154|NCT03606369|Serotonin Agents|serotonin agents|mesh-ancestor
65663155|NCT03606369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65663156|NCT03606369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663157|NCT03606369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65663158|NCT03606369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65663159|NCT03606369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65663160|NCT03606369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65663161|NCT03606369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65663162|NCT03606369|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65663163|NCT02635204|Clobetasol|clobetasol|mesh-list
65663164|NCT02635204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65663165|NCT02635204|Glucocorticoids|glucocorticoids|mesh-ancestor
65663166|NCT02635204|Hormones|hormones|mesh-ancestor
65663167|NCT02635204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65663168|NCT02635204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663169|NCT00102804|Pemetrexed|pemetrexed|mesh-list
65663170|NCT00102804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663171|NCT00102804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663172|NCT00102804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663173|NCT00102804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65663174|NCT00102804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65663175|NCT02163720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65663176|NCT02163720|Doxorubicin|doxorubicin|mesh-list
65663177|NCT02163720|Trabectedin|trabectedin|mesh-list
65663178|NCT02163720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65663179|NCT02163720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663180|NCT02163720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65663181|NCT02163720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65663182|NCT02163720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663183|NCT02163720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663184|NCT02163720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65663185|NCT02163720|Alkylating Agents|alkylating agents|mesh-ancestor
65663186|NCT03487874|Ropivacaine|ropivacaine|mesh-list
65663187|NCT03487874|Anesthetics, Local|anesthetics, local|mesh-ancestor
65663188|NCT03487874|Anesthetics|anesthetics|mesh-ancestor
65663189|NCT03487874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65663190|NCT03487874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663191|NCT03487874|Sensory System Agents|sensory system agents|mesh-ancestor
65460495|NCT01306318|Diclofenac|diclofenac|mesh-list
65663192|NCT03487874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65663193|NCT01494662|Capecitabine|capecitabine|mesh-list
65663194|NCT01494662|Trastuzumab|trastuzumab|mesh-list
65663195|NCT01494662|Maytansine|maytansine|mesh-list
65663196|NCT01494662|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65663197|NCT01494662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65663198|NCT01494662|Antimetabolites|antimetabolites|mesh-ancestor
65663199|NCT01494662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663200|NCT01494662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663201|NCT01494662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65663202|NCT01494662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65663203|NCT01494662|Tubulin Modulators|tubulin modulators|mesh-ancestor
65663204|NCT01494662|Antimitotic Agents|antimitotic agents|mesh-ancestor
65663205|NCT01494662|Mitosis Modulators|mitosis modulators|mesh-ancestor
65663206|NCT04989400|Misoprostol|misoprostol|mesh-list
65663207|NCT04989400|Ulipristal acetate|ulipristal acetate|mesh-list
65663208|NCT04989400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65663209|NCT04989400|Abortifacient Agents|abortifacient agents|mesh-ancestor
65663210|NCT04989400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65663211|NCT04989400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663212|NCT04989400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65663213|NCT04989400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65663214|NCT04989400|Oxytocics|oxytocics|mesh-ancestor
65663215|NCT04989400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65663216|NCT04989400|Contraceptive Agents|contraceptive agents|mesh-ancestor
65663217|NCT04989400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65663218|NCT02163954|Clopidogrel|clopidogrel|mesh-list
65663219|NCT02163954|Ticagrelor|ticagrelor|mesh-list
65663220|NCT02163954|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65663221|NCT02163954|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65663222|NCT02163954|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65663223|NCT02163954|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65663224|NCT02163954|Purinergic Agents|purinergic agents|mesh-ancestor
65663225|NCT02163954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65663226|NCT02163954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663227|NCT02163954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663228|NCT04985656|Decitabine|decitabine|mesh-list
65663229|NCT04985656|Pevonedistat|pevonedistat|mesh-list
65663230|NCT04985656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65663231|NCT04985656|Antimetabolites|antimetabolites|mesh-ancestor
65663232|NCT04985656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663233|NCT04985656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663234|NCT04985656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663235|NCT02164032|Insulin|insulin|mesh-list
65663236|NCT02164032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65663237|NCT02164032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65663238|NCT02164032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663239|NCT04682288|Levofloxacin|levofloxacin|mesh-list
65663240|NCT04682288|Ofloxacin|ofloxacin|mesh-list
65663241|NCT04682288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65663242|NCT04682288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65663243|NCT04682288|Renal Agents|renal agents|mesh-ancestor
65663244|NCT04682288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65663245|NCT04682288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65663246|NCT04682288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65663247|NCT04682288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663248|NCT04682288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663249|NCT04682288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663250|NCT04682288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65663251|NCT04682288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65663252|NCT00968149|Montelukast|montelukast|mesh-list
65663253|NCT00968149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65663254|NCT00968149|Respiratory System Agents|respiratory system agents|mesh-ancestor
65663255|NCT00968149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65663256|NCT00968149|Hormone Antagonists|hormone antagonists|mesh-ancestor
65663257|NCT00968149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65663258|NCT00968149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663259|NCT00968149|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65663260|NCT00968149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65663261|NCT00968149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663262|NCT04985344|Propranolol|propranolol|mesh-list
65663263|NCT04985344|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65663264|NCT04985344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65663265|NCT04985344|Adrenergic Agents|adrenergic agents|mesh-ancestor
65460561|NCT01306708|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65663266|NCT04985344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65663267|NCT04985344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663268|NCT04985344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663269|NCT04985344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65663270|NCT04985344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65663271|NCT04985344|Vasodilator Agents|vasodilator agents|mesh-ancestor
65663272|NCT02164110|Vaccines|vaccines|mesh-list
65663273|NCT02164110|Immunologic Factors|immunologic factors|mesh-ancestor
65663274|NCT02164110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663275|NCT02167464|Coal Tar|coal tar|mesh-list
65663276|NCT02167464|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
65663277|NCT02167464|Keratolytic Agents|keratolytic agents|mesh-ancestor
65663278|NCT02167464|Dermatologic Agents|dermatologic agents|mesh-ancestor
65663279|NCT02167464|Hormone Antagonists|hormone antagonists|mesh-ancestor
65663280|NCT02167464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65663281|NCT02167464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663282|NCT02167464|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65663283|NCT02167464|Diuretics|diuretics|mesh-ancestor
65663284|NCT02167464|Natriuretic Agents|natriuretic agents|mesh-ancestor
65663285|NCT03485456|Tobramycin|tobramycin|mesh-list
65663286|NCT03485456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65663287|NCT03485456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65663288|NCT03487562|Amoxicillin|amoxicillin|mesh-list
65663289|NCT03487562|Clarithromycin|clarithromycin|mesh-list
65663290|NCT03487562|Lansoprazole|lansoprazole|mesh-list
65663291|NCT03487562|Dexlansoprazole|dexlansoprazole|mesh-list
65663292|NCT03487562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65663293|NCT03487562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65663294|NCT03487562|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65663295|NCT03487562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663296|NCT03487562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663297|NCT03487562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65663298|NCT03487562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65663299|NCT03487562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65663300|NCT03487562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65663301|NCT03487562|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65663302|NCT03719924|Paclitaxel|paclitaxel|mesh-list
65663303|NCT03719924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65663304|NCT03719924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663305|NCT03719924|Tubulin Modulators|tubulin modulators|mesh-ancestor
65663306|NCT03719924|Antimitotic Agents|antimitotic agents|mesh-ancestor
65663307|NCT03719924|Mitosis Modulators|mitosis modulators|mesh-ancestor
65663308|NCT03719924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663309|NCT02167620|Metformin|metformin|mesh-list
65663310|NCT02167620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65663311|NCT02167620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663312|NCT03485300|Warfarin|warfarin|mesh-list
65663313|NCT03485300|Anticoagulants|anticoagulants|mesh-ancestor
65663314|NCT00963469|Loratadine|loratadine|mesh-list
65663315|NCT00963469|Montelukast|montelukast|mesh-list
65663316|NCT00963469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65663317|NCT00963469|Respiratory System Agents|respiratory system agents|mesh-ancestor
65663318|NCT00963469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65663319|NCT00963469|Hormone Antagonists|hormone antagonists|mesh-ancestor
65663320|NCT00963469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65663321|NCT00963469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663322|NCT00963469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65663323|NCT00963469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65663324|NCT00963469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663325|NCT00963469|Antipruritics|antipruritics|mesh-ancestor
65663326|NCT00963469|Dermatologic Agents|dermatologic agents|mesh-ancestor
65663327|NCT00963469|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65663328|NCT00963469|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65663329|NCT00963469|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65663330|NCT00963469|Histamine Antagonists|histamine antagonists|mesh-ancestor
65663331|NCT00963469|Histamine Agents|histamine agents|mesh-ancestor
65663332|NCT00963469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65663333|NCT00897949|Rizatriptan|rizatriptan|mesh-list
65663334|NCT00897949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65663335|NCT00897949|Serotonin Agents|serotonin agents|mesh-ancestor
65663336|NCT00897949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65663337|NCT00897949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663338|NCT00897949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663339|NCT05119855|Vaccines|vaccines|mesh-list
65460643|NCT03790228|Carboplatin|carboplatin|mesh-list
65663340|NCT05119855|Immunologic Factors|immunologic factors|mesh-ancestor
65663341|NCT05119855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663342|NCT04741945|Metformin|metformin|mesh-list
65663343|NCT04741945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65663344|NCT04741945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663345|NCT03487406|Aspirin|aspirin|mesh-list
65663346|NCT03487406|Ticagrelor|ticagrelor|mesh-list
65663347|NCT03487406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65663348|NCT03487406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65663349|NCT03487406|Analgesics|analgesics|mesh-ancestor
65663350|NCT03487406|Sensory System Agents|sensory system agents|mesh-ancestor
65663351|NCT03487406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65663352|NCT03487406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663353|NCT03487406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65663354|NCT03487406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65663355|NCT03487406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65268416|NCT02749994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663356|NCT03487406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65663357|NCT03487406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663358|NCT03487406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65663359|NCT03487406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65663360|NCT03487406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663361|NCT03487406|Antipyretics|antipyretics|mesh-ancestor
65663362|NCT03487406|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65663363|NCT03487406|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65663364|NCT03487406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65663365|NCT03487406|Purinergic Agents|purinergic agents|mesh-ancestor
65663366|NCT03487406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65663367|NCT00725491|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65663368|NCT00725491|Ganirelix|ganirelix|mesh-list
65663369|NCT00725491|Luteolytic Agents|luteolytic agents|mesh-ancestor
65663370|NCT00725491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65663371|NCT00725491|Contraceptive Agents|contraceptive agents|mesh-ancestor
65663372|NCT00725491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65663373|NCT00725491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663374|NCT00725491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65663375|NCT00725491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65663376|NCT00725491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663377|NCT00725491|Hormone Antagonists|hormone antagonists|mesh-ancestor
65663378|NCT00725491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65663379|NCT00724789|Ganirelix|ganirelix|mesh-list
65663380|NCT00724789|Hormone Antagonists|hormone antagonists|mesh-ancestor
65663381|NCT00724789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65663382|NCT00724789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663383|NCT00711607|Estradiol|estradiol|mesh-list
65663384|NCT00711607|Estrogens|estrogens|mesh-ancestor
65663385|NCT00711607|Hormones|hormones|mesh-ancestor
65663386|NCT00711607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65663387|NCT00711607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663388|NCT02164578|Aspirin|aspirin|mesh-list
65663389|NCT02164578|Rivaroxaban|rivaroxaban|mesh-list
65663390|NCT02164578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65663391|NCT02164578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65663392|NCT02164578|Analgesics|analgesics|mesh-ancestor
65663393|NCT02164578|Sensory System Agents|sensory system agents|mesh-ancestor
65663394|NCT02164578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65663395|NCT02164578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663396|NCT02164578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65663397|NCT02164578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65663398|NCT02164578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65663399|NCT02164578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65663400|NCT02164578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663401|NCT02164578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65663402|NCT02164578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65663403|NCT02164578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663404|NCT02164578|Antipyretics|antipyretics|mesh-ancestor
65663405|NCT02164578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65663406|NCT02164578|Antithrombins|antithrombins|mesh-ancestor
65663407|NCT02164578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65663408|NCT02164578|Protease Inhibitors|protease inhibitors|mesh-ancestor
65663409|NCT02164578|Anticoagulants|anticoagulants|mesh-ancestor
65663410|NCT03893318|Lidocaine|lidocaine|mesh-list
65663411|NCT03893318|Anesthetics, Local|anesthetics, local|mesh-ancestor
65663412|NCT03893318|Anesthetics|anesthetics|mesh-ancestor
65663413|NCT03893318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65663414|NCT03893318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663415|NCT03893318|Sensory System Agents|sensory system agents|mesh-ancestor
65663416|NCT03893318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65663417|NCT03893318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65663418|NCT03893318|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65663419|NCT03893318|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65663420|NCT03893318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65663421|NCT03893318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663423|NCT03625531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663424|NCT03625531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65663425|NCT03625531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65663426|NCT03625531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663427|NCT03625531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663428|NCT03625531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65663429|NCT03625531|Hormone Antagonists|hormone antagonists|mesh-ancestor
65663430|NCT03625531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65663431|NCT03625531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663432|NCT02167698|Methylprednisolone|methylprednisolone|mesh-list
65663433|NCT02167698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65663434|NCT02167698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65663435|NCT02167698|Prednisolone|prednisolone|mesh-list
65663436|NCT02167698|Prednisolone acetate|prednisolone acetate|mesh-list
65663437|NCT02167698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65663438|NCT02167698|Prednisolone phosphate|prednisolone phosphate|mesh-list
65663439|NCT02167698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65663440|NCT02167698|Antiemetics|antiemetics|mesh-ancestor
65663441|NCT02167698|Autonomic Agents|autonomic agents|mesh-ancestor
65663442|NCT02167698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65663443|NCT02167698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663444|NCT02167698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65663445|NCT02167698|Glucocorticoids|glucocorticoids|mesh-ancestor
65663446|NCT02167698|Hormones|hormones|mesh-ancestor
65663447|NCT02167698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65663448|NCT02167698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65663449|NCT02167698|Protective Agents|protective agents|mesh-ancestor
65663450|NCT02167698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65663451|NCT02167698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663452|NCT02634580|Ezetimibe|ezetimibe|mesh-list
65663453|NCT02634580|Evolocumab|evolocumab|mesh-list
65663454|NCT02634580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65663455|NCT02634580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65663456|NCT02634580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65663457|NCT02634580|Antimetabolites|antimetabolites|mesh-ancestor
65663458|NCT02634580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663459|NCT02634580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65663460|NCT02634580|Immunologic Factors|immunologic factors|mesh-ancestor
65663461|NCT02634580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663462|NCT00697255|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65663463|NCT00697255|Hormones|hormones|mesh-list
65663464|NCT00697255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65663465|NCT00697255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65663466|NCT00697255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663467|NCT00697255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65663468|NCT02164734|Remifentanil|remifentanil|mesh-list
65663469|NCT02164734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65663470|NCT02164734|Narcotics|narcotics|mesh-ancestor
65663471|NCT02164734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65663472|NCT02164734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663473|NCT02164734|Analgesics|analgesics|mesh-ancestor
65663474|NCT02164734|Sensory System Agents|sensory system agents|mesh-ancestor
65663475|NCT02164734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65663476|NCT00548912|Spironolactone|spironolactone|mesh-list
65663477|NCT00548912|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65663478|NCT00548912|Hormone Antagonists|hormone antagonists|mesh-ancestor
65663479|NCT00548912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65663480|NCT00548912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663481|NCT00548912|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65663482|NCT00548912|Diuretics|diuretics|mesh-ancestor
65663483|NCT00548912|Natriuretic Agents|natriuretic agents|mesh-ancestor
65663484|NCT05002933|Insulin Glargine|insulin glargine|mesh-list
65663485|NCT05002933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65663486|NCT05002933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460787|NCT05495464|Rituximab|rituximab|mesh-list
65663487|NCT03071068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65663488|NCT03071068|Antibodies|antibodies|mesh-list
65663489|NCT03071068|Immunoglobulins|immunoglobulins|mesh-list
65663490|NCT03071068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65663491|NCT03071068|Immunologic Factors|immunologic factors|mesh-ancestor
65663492|NCT03071068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663493|NCT03071068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663494|NCT03487172|Mannitol|mannitol|mesh-list
65663495|NCT03487172|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65663496|NCT03487172|Diuretics|diuretics|mesh-ancestor
65663497|NCT03487172|Natriuretic Agents|natriuretic agents|mesh-ancestor
65663498|NCT03487172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663499|NCT04995016|Pembrolizumab|pembrolizumab|mesh-list
65663500|NCT04995016|Axitinib|axitinib|mesh-list
65663501|NCT04995016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65663502|NCT04995016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663503|NCT04995016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65663504|NCT04995016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663505|NCT04995016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663506|NCT04994860|Sildenafil Citrate|sildenafil citrate|mesh-list
65663507|NCT04994860|Zamicastat|zamicastat|mesh-list
65663508|NCT04994860|Vasodilator Agents|vasodilator agents|mesh-ancestor
65663509|NCT04994860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65663510|NCT04994860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65663511|NCT04994860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663512|NCT04994860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663513|NCT04994860|Urological Agents|urological agents|mesh-ancestor
65663514|NCT03481400|Calcitonin|calcitonin|mesh-list
65663515|NCT03481400|Salmon calcitonin|salmon calcitonin|mesh-list
65663516|NCT03481400|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
65663517|NCT03481400|Katacalcin|katacalcin|mesh-list
65663518|NCT03481400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65663519|NCT03481400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663520|NCT03481400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65663521|NCT03481400|Vasodilator Agents|vasodilator agents|mesh-ancestor
65663522|NCT02851407|Defibrotide|defibrotide|mesh-list
65663523|NCT02851407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65663524|NCT02851407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65663525|NCT02851407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663526|NCT02851407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65663527|NCT02167854|Trastuzumab|trastuzumab|mesh-list
65663528|NCT02167854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65663529|NCT02167854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663530|NCT02161614|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65663531|NCT02161614|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65663532|NCT02161614|Estradiol|estradiol|mesh-list
65663533|NCT02161614|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65663534|NCT02161614|Estrogens|estrogens|mesh-ancestor
65663535|NCT02161614|Hormones|hormones|mesh-ancestor
65663536|NCT02161614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65663537|NCT02161614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663538|NCT02161614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65663539|NCT02161614|Contraceptive Agents|contraceptive agents|mesh-ancestor
65663540|NCT02161614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65663541|NCT02161614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65663542|NCT04994626|Rituximab|rituximab|mesh-list
65663543|NCT04994626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65663544|NCT04994626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663545|NCT04994626|Immunologic Factors|immunologic factors|mesh-ancestor
65663546|NCT04994626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663547|NCT04994626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65663548|NCT02168010|Neurotropin|neurotropin|mesh-list
65663549|NCT02168010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65663550|NCT02168010|Immunologic Factors|immunologic factors|mesh-ancestor
65663551|NCT02168010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663552|NCT02168010|Analgesics|analgesics|mesh-ancestor
65663553|NCT02168010|Sensory System Agents|sensory system agents|mesh-ancestor
65663554|NCT02168010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65663555|NCT02168010|Anticonvulsants|anticonvulsants|mesh-ancestor
65663556|NCT04994314|Fluorides|fluorides|mesh-list
65663557|NCT04994314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663558|NCT04994314|Cariostatic Agents|cariostatic agents|mesh-ancestor
65663559|NCT04994314|Protective Agents|protective agents|mesh-ancestor
65663560|NCT02161692|Cyclophosphamide|cyclophosphamide|mesh-list
65663561|NCT02161692|Carboplatin|carboplatin|mesh-list
65663562|NCT02161692|Etoposide|etoposide|mesh-list
65663563|NCT02161692|Bleomycin|bleomycin|mesh-list
65663564|NCT02161692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65663565|NCT02161692|Immunologic Factors|immunologic factors|mesh-ancestor
65663566|NCT02161692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663567|NCT02161692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65663568|NCT02161692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65663569|NCT02161692|Alkylating Agents|alkylating agents|mesh-ancestor
65663570|NCT02161692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663571|NCT02161692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663572|NCT02161692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65663573|NCT02161692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65663574|NCT02161692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65663575|NCT02161692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65663576|NCT02161692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663577|NCT02161692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65663578|NCT02746575|Metoprolol|metoprolol|mesh-list
65663579|NCT02746575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65663580|NCT02746575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65663581|NCT02746575|Sympatholytics|sympatholytics|mesh-ancestor
65663582|NCT02746575|Autonomic Agents|autonomic agents|mesh-ancestor
65663583|NCT02746575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65663584|NCT02746575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663585|NCT02746575|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65663586|NCT02746575|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65663587|NCT02746575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65663588|NCT02746575|Adrenergic Agents|adrenergic agents|mesh-ancestor
65663589|NCT02746575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65663590|NCT02746575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663591|NCT02161770|Osimertinib|osimertinib|mesh-list
65663592|NCT02161770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663593|NCT02161770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65663594|NCT02161770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663595|NCT02161770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663596|NCT03604575|Insulin|insulin|mesh-list
65663597|NCT03604575|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65663598|NCT03604575|Insulin Lispro|insulin lispro|mesh-list
65663599|NCT03604575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65663600|NCT03604575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663601|NCT04988932|Nitric Oxide|nitric oxide|mesh-list
65663602|NCT04988932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65663603|NCT04988932|Autonomic Agents|autonomic agents|mesh-ancestor
65663604|NCT04988932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65663605|NCT04988932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663606|NCT04988932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65663607|NCT04988932|Respiratory System Agents|respiratory system agents|mesh-ancestor
65663608|NCT04988932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65663609|NCT04988932|Antioxidants|antioxidants|mesh-ancestor
65663610|NCT04988932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663611|NCT04988932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65663612|NCT04988932|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65663613|NCT04988932|Vasodilator Agents|vasodilator agents|mesh-ancestor
65663614|NCT04988932|Gasotransmitters|gasotransmitters|mesh-ancestor
65663615|NCT04988932|Protective Agents|protective agents|mesh-ancestor
65663616|NCT03625466|Ivacaftor|ivacaftor|mesh-list
65663617|NCT03625466|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65663618|NCT03625466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65663619|NCT03625466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663620|NCT03604419|Metformin|metformin|mesh-list
65663621|NCT03604419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65663622|NCT03604419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663623|NCT03484832|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65663624|NCT03484832|Ethyl Chloride|ethyl chloride|mesh-list
65663625|NCT03484832|Anesthetics, Local|anesthetics, local|mesh-ancestor
65663626|NCT03484832|Anesthetics|anesthetics|mesh-ancestor
65663627|NCT03484832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65663628|NCT03484832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663629|NCT03484832|Sensory System Agents|sensory system agents|mesh-ancestor
65663630|NCT03484832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65663631|NCT03484832|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65663632|NCT04985110|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65663633|NCT04985110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65663634|NCT04985110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65663635|NCT04985110|Renal Agents|renal agents|mesh-ancestor
65663636|NCT04985110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65663637|NCT04985110|Antimalarials|antimalarials|mesh-ancestor
65663638|NCT04985110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65663639|NCT04985110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65663640|NCT02164812|Moxifloxacin|moxifloxacin|mesh-list
65663641|NCT02164812|Efavirenz|efavirenz|mesh-list
65663642|NCT02164812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65663643|NCT02164812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65663644|NCT02164812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65663645|NCT02164812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65663646|NCT02164812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663647|NCT02164812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663648|NCT02164812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663649|NCT02164812|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65663650|NCT02164812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65663651|NCT02164812|Antiviral Agents|antiviral agents|mesh-ancestor
65663652|NCT02164812|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65663653|NCT02164812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65663654|NCT02164812|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65663655|NCT02164812|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65663656|NCT02164812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65663657|NCT02164812|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65663658|NCT04988776|Bupivacaine|bupivacaine|mesh-list
65663659|NCT04988776|Anesthetics, Local|anesthetics, local|mesh-ancestor
65663660|NCT04988776|Anesthetics|anesthetics|mesh-ancestor
65663661|NCT04988776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65663662|NCT04988776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663663|NCT04988776|Sensory System Agents|sensory system agents|mesh-ancestor
65663664|NCT04988776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65663665|NCT02853123|Tiotropium Bromide|tiotropium bromide|mesh-list
65663666|NCT02853123|Olodaterol|olodaterol|mesh-list
65663667|NCT02853123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65663668|NCT02853123|Autonomic Agents|autonomic agents|mesh-ancestor
65663669|NCT02853123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65663670|NCT02853123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663671|NCT02853123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65663672|NCT02853123|Respiratory System Agents|respiratory system agents|mesh-ancestor
65663673|NCT02853123|Parasympatholytics|parasympatholytics|mesh-ancestor
65663674|NCT02853123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65663675|NCT02853123|Cholinergic Agents|cholinergic agents|mesh-ancestor
65663676|NCT02853123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65663677|NCT02853123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663678|NCT02255370|Curcumin|curcumin|mesh-list
65663679|NCT02255370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65663680|NCT02255370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65663681|NCT02255370|Analgesics|analgesics|mesh-ancestor
65663682|NCT02255370|Sensory System Agents|sensory system agents|mesh-ancestor
65663683|NCT02255370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65663684|NCT02255370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663685|NCT02255370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65663686|NCT02255370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65663687|NCT02255370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663688|NCT02255370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663689|NCT02255370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663690|NCT04984408|Vaccines|vaccines|mesh-list
65663691|NCT04984408|Immunologic Factors|immunologic factors|mesh-ancestor
65663692|NCT04984408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663693|NCT03484754|Botulinum Toxins|botulinum toxins|mesh-list
65663694|NCT03484754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65663695|NCT03484754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65663696|NCT03484754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663697|NCT03484754|Cholinergic Agents|cholinergic agents|mesh-ancestor
65663698|NCT03484754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65663699|NCT03484754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663700|NCT04459676|Mitogens|mitogens|mesh-list
65663701|NCT04459676|Mitosis Modulators|mitosis modulators|mesh-ancestor
65663702|NCT04459676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663703|NCT05376111|Azacitidine|azacitidine|mesh-list
65663704|NCT05376111|Venetoclax|venetoclax|mesh-list
65663705|NCT05376111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65663706|NCT05376111|Antimetabolites|antimetabolites|mesh-ancestor
65663707|NCT05376111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663708|NCT05376111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663709|NCT05376111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663710|NCT02164890|Micafungin|micafungin|mesh-list
65663711|NCT02164890|Antifungal Agents|antifungal agents|mesh-ancestor
65663712|NCT02164890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65663713|NCT02634346|Olanzapine|olanzapine|mesh-list
65663714|NCT02634346|Antiemetics|antiemetics|mesh-ancestor
65663715|NCT02634346|Autonomic Agents|autonomic agents|mesh-ancestor
65663716|NCT02634346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65663717|NCT02634346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663718|NCT02634346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65663719|NCT02634346|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65663720|NCT02634346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65663721|NCT02634346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65663722|NCT02634346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65663723|NCT02634346|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65663724|NCT02634346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65663725|NCT02634346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65663726|NCT02634346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663727|NCT02634346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65663728|NCT02634346|Serotonin Agents|serotonin agents|mesh-ancestor
65663729|NCT02168634|Botulinum Toxins|botulinum toxins|mesh-list
65663730|NCT02168634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65663731|NCT02168634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65663732|NCT02168634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663733|NCT02168634|Cholinergic Agents|cholinergic agents|mesh-ancestor
65663734|NCT02168634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65663735|NCT02168634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663736|NCT00812240|Imatinib Mesylate|imatinib mesylate|mesh-list
65663737|NCT00812240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663738|NCT00812240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65663739|NCT00812240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663740|NCT00812240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663741|NCT02165046|Budesonide|budesonide|mesh-list
65663742|NCT02165046|Procaterol|procaterol|mesh-list
65663743|NCT02165046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65663744|NCT02165046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65663745|NCT02165046|Autonomic Agents|autonomic agents|mesh-ancestor
65663746|NCT02165046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65663747|NCT02165046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663748|NCT02165046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65663749|NCT02165046|Respiratory System Agents|respiratory system agents|mesh-ancestor
65663750|NCT02165046|Glucocorticoids|glucocorticoids|mesh-ancestor
65663751|NCT02165046|Hormones|hormones|mesh-ancestor
65663752|NCT02165046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65663753|NCT02165046|Sympathomimetics|sympathomimetics|mesh-ancestor
65663754|NCT02165046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65663755|NCT02165046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65663756|NCT02165046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65663757|NCT02165046|Adrenergic Agents|adrenergic agents|mesh-ancestor
65663758|NCT02165046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65663759|NCT02165046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663760|NCT03070678|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65663761|NCT03070678|Mefenamic Acid|mefenamic acid|mesh-list
65663762|NCT03070678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65663763|NCT03070678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663764|NCT03070678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65663765|NCT03070678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663766|NCT03070678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65663767|NCT03070678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65663768|NCT03070678|Analgesics|analgesics|mesh-ancestor
65663769|NCT03070678|Sensory System Agents|sensory system agents|mesh-ancestor
65663770|NCT03070678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65663771|NCT03070678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65663772|NCT03070678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65663773|NCT03070678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65663774|NCT03070678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663775|NCT00101166|Vaccines|vaccines|mesh-list
65663776|NCT00101166|Immunologic Factors|immunologic factors|mesh-ancestor
65663777|NCT00101166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663778|NCT04994236|Leucovorin|leucovorin|mesh-list
65663779|NCT04994236|Fluorouracil|fluorouracil|mesh-list
65663780|NCT04994236|Oxaliplatin|oxaliplatin|mesh-list
65663781|NCT04994236|Antimetabolites|antimetabolites|mesh-ancestor
65461093|NCT03777280|Cobalt|cobalt|mesh-list
65663782|NCT04994236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663783|NCT04994236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65663784|NCT04994236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663785|NCT04994236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65663786|NCT04994236|Immunologic Factors|immunologic factors|mesh-ancestor
65663787|NCT04994236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663789|NCT04994236|Protective Agents|protective agents|mesh-ancestor
65663790|NCT04994236|Vitamin B Complex|vitamin b complex|mesh-ancestor
65663791|NCT04994236|Vitamins|vitamins|mesh-ancestor
65663792|NCT04994236|Micronutrients|micronutrients|mesh-ancestor
65663793|NCT03601611|Prednisolone|prednisolone|mesh-list
65663794|NCT03601611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65663795|NCT03601611|Glucocorticoids|glucocorticoids|mesh-ancestor
65663796|NCT03601611|Hormones|hormones|mesh-ancestor
65663797|NCT03601611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65663798|NCT03601611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663799|NCT03601611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65663800|NCT03601611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663801|NCT03597945|Lidocaine|lidocaine|mesh-list
65663802|NCT03597945|Magnesium Sulfate|magnesium sulfate|mesh-list
65663803|NCT03597945|Epinephrine|epinephrine|mesh-list
65663804|NCT03597945|Anesthetics, Local|anesthetics, local|mesh-ancestor
65663805|NCT03597945|Anesthetics|anesthetics|mesh-ancestor
65663806|NCT03597945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65663807|NCT03597945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663808|NCT03597945|Sensory System Agents|sensory system agents|mesh-ancestor
65663809|NCT03597945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65663810|NCT03597945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65663811|NCT03597945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65663812|NCT03597945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65663813|NCT03597945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65663814|NCT03597945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663815|NCT03597945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65663816|NCT03597945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65663817|NCT03597945|Adrenergic Agents|adrenergic agents|mesh-ancestor
65663818|NCT03597945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65663819|NCT03597945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65663820|NCT03597945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65663821|NCT03597945|Autonomic Agents|autonomic agents|mesh-ancestor
65663822|NCT03597945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65663823|NCT03597945|Respiratory System Agents|respiratory system agents|mesh-ancestor
65663824|NCT03597945|Mydriatics|mydriatics|mesh-ancestor
65663825|NCT03597945|Sympathomimetics|sympathomimetics|mesh-ancestor
65663826|NCT03597945|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65663827|NCT03597945|Analgesics|analgesics|mesh-ancestor
65663828|NCT03597945|Anticonvulsants|anticonvulsants|mesh-ancestor
65663829|NCT03597945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65663830|NCT03597945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65663831|NCT03597945|Tocolytic Agents|tocolytic agents|mesh-ancestor
65663832|NCT03597945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65663833|NCT03601533|Phenol|phenol|mesh-list
65663834|NCT03601533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65663835|NCT03601533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65663836|NCT03601533|Disinfectants|disinfectants|mesh-ancestor
65663837|NCT03601533|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65663838|NCT03601533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65663839|NCT03486626|Metformin|metformin|mesh-list
65663840|NCT03486626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65663841|NCT03486626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663842|NCT04983550|Doxorubicin|doxorubicin|mesh-list
65663843|NCT04983550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65663844|NCT04983550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65663845|NCT04983550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663846|NCT04983550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65663847|NCT04983550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65663848|NCT04983550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663849|NCT04983550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663850|NCT02255682|Simvastatin|simvastatin|mesh-list
65663851|NCT02255682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65663852|NCT02255682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65663853|NCT02255682|Antimetabolites|antimetabolites|mesh-ancestor
65663854|NCT02255682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663855|NCT02255682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65663856|NCT02255682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65663857|NCT02255682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663858|NCT05153486|Ethanol|ethanol|mesh-list
65663859|NCT05153486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65663860|NCT05153486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65663861|NCT05153486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65663862|NCT05153486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663863|NCT03136263|Oxytocin|oxytocin|mesh-list
65663864|NCT03136263|Oxytocics|oxytocics|mesh-ancestor
65663865|NCT03136263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65663866|NCT03136263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663867|NCT03095781|Pembrolizumab|pembrolizumab|mesh-list
65663868|NCT03095781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65663869|NCT03095781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663870|NCT03486548|Dexamethasone|dexamethasone|mesh-list
65663871|NCT03486548|Lidocaine|lidocaine|mesh-list
65663872|NCT03486548|Bupivacaine|bupivacaine|mesh-list
65663873|NCT03486548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65663874|NCT03486548|Antiemetics|antiemetics|mesh-ancestor
65663875|NCT03486548|Autonomic Agents|autonomic agents|mesh-ancestor
65663876|NCT03486548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65663877|NCT03486548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663878|NCT03486548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65663879|NCT03486548|Glucocorticoids|glucocorticoids|mesh-ancestor
65663880|NCT03486548|Hormones|hormones|mesh-ancestor
65663881|NCT03486548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65663882|NCT03486548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65663883|NCT03486548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663884|NCT03486548|Anesthetics, Local|anesthetics, local|mesh-ancestor
65663885|NCT03486548|Anesthetics|anesthetics|mesh-ancestor
65663886|NCT03486548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65663887|NCT03486548|Sensory System Agents|sensory system agents|mesh-ancestor
65663888|NCT03486548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65663889|NCT03486548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65663890|NCT03486548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65663891|NCT03486548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65663892|NCT03486548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663893|NCT04983160|Allopurinol|allopurinol|mesh-list
65663894|NCT04983160|Antimetabolites|antimetabolites|mesh-ancestor
65663895|NCT04983160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663896|NCT04983160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663897|NCT04983160|Gout Suppressants|gout suppressants|mesh-ancestor
65663898|NCT04983160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65663899|NCT04983160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65663900|NCT04983160|Antioxidants|antioxidants|mesh-ancestor
65663901|NCT04983160|Protective Agents|protective agents|mesh-ancestor
65663902|NCT04983160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663903|NCT05431270|Antibodies|antibodies|mesh-list
65663904|NCT05431270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65663905|NCT05431270|Immunologic Factors|immunologic factors|mesh-ancestor
65663906|NCT05431270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663907|NCT02759016|BI 836826|bi 836826|mesh-list
65663908|NCT02759016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65663909|NCT02759016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663910|NCT05379166|Azacitidine|azacitidine|mesh-list
65663911|NCT05379166|Venetoclax|venetoclax|mesh-list
65663912|NCT05379166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65663913|NCT05379166|Antimetabolites|antimetabolites|mesh-ancestor
65663914|NCT05379166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663915|NCT05379166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663916|NCT05379166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663917|NCT02852967|Belumosudil|belumosudil|mesh-list
65663918|NCT02852967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65663919|NCT02852967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663920|NCT02852967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663921|NCT03593044|Atropine|atropine|mesh-list
65663922|NCT03593044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65663923|NCT03593044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65663924|NCT03593044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65663925|NCT03593044|Autonomic Agents|autonomic agents|mesh-ancestor
65663926|NCT03593044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65663927|NCT03593044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663928|NCT03593044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65663929|NCT03593044|Respiratory System Agents|respiratory system agents|mesh-ancestor
65663930|NCT03593044|Mydriatics|mydriatics|mesh-ancestor
65663931|NCT03593044|Parasympatholytics|parasympatholytics|mesh-ancestor
65663932|NCT03593044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65663933|NCT03593044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65663934|NCT03593044|Cholinergic Agents|cholinergic agents|mesh-ancestor
65663935|NCT03593044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65268428|NCT04911062|Epinephrine|epinephrine|mesh-list
65663936|NCT03593044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663937|NCT03597087|Anesthetics|anesthetics|mesh-list
65663938|NCT03597087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65663939|NCT03597087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663940|NCT03603327|Antiviral Agents|antiviral agents|mesh-list
65663941|NCT03603327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65663942|NCT03596775|Dexmedetomidine|dexmedetomidine|mesh-list
65663943|NCT03596775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65663944|NCT03596775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65663945|NCT03596775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663946|NCT03596775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65663947|NCT03596775|Analgesics|analgesics|mesh-ancestor
65663948|NCT03596775|Sensory System Agents|sensory system agents|mesh-ancestor
65663949|NCT03596775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65663950|NCT03596775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65663951|NCT03596775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65663952|NCT03596775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65663953|NCT03596775|Adrenergic Agents|adrenergic agents|mesh-ancestor
65663954|NCT03596775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65663955|NCT03596775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663956|NCT03066466|Methotrexate|methotrexate|mesh-list
65663957|NCT03066466|Atorvastatin|atorvastatin|mesh-list
65663958|NCT03066466|Tacrolimus|tacrolimus|mesh-list
65663959|NCT03066466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65663960|NCT03066466|Abortifacient Agents|abortifacient agents|mesh-ancestor
65663961|NCT03066466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65663962|NCT03066466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663963|NCT03066466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65663964|NCT03066466|Antimetabolites|antimetabolites|mesh-ancestor
65663965|NCT03066466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65663966|NCT03066466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65663967|NCT03066466|Dermatologic Agents|dermatologic agents|mesh-ancestor
65663968|NCT03066466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65663969|NCT03066466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65663970|NCT03066466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65663971|NCT03066466|Immunologic Factors|immunologic factors|mesh-ancestor
65663972|NCT03066466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65663973|NCT03066466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65663974|NCT03066466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65663975|NCT03066466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65663976|NCT03066466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65663977|NCT03066466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65663978|NCT03066466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65663979|NCT03603249|Trimetazidine|trimetazidine|mesh-list
65663980|NCT03603249|Vasodilator Agents|vasodilator agents|mesh-ancestor
65663981|NCT03068260|Acetaminophen|acetaminophen|mesh-list
65663982|NCT03068260|Ibuprofen|ibuprofen|mesh-list
65663983|NCT03068260|Morphine|morphine|mesh-list
65663984|NCT03068260|Ropivacaine|ropivacaine|mesh-list
65663985|NCT03068260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65663986|NCT03068260|Narcotics|narcotics|mesh-ancestor
65663987|NCT03068260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65663988|NCT03068260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65663989|NCT03068260|Analgesics|analgesics|mesh-ancestor
65663990|NCT03068260|Sensory System Agents|sensory system agents|mesh-ancestor
65663991|NCT03068260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65663992|NCT03068260|Anesthetics, Local|anesthetics, local|mesh-ancestor
65663993|NCT03068260|Anesthetics|anesthetics|mesh-ancestor
65663994|NCT03068260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65663995|NCT03068260|Antipyretics|antipyretics|mesh-ancestor
65663996|NCT03068260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65663997|NCT03068260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65663998|NCT03068260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65663999|NCT03068260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65664000|NCT03068260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664001|NCT03068260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664002|NCT02237859|Vancomycin|vancomycin|mesh-list
65664003|NCT02237859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65664004|NCT02237859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65664005|NCT03594825|Valsartan|valsartan|mesh-list
65664006|NCT03594825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65664007|NCT03594825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65664008|NCT03594825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65664009|NCT03594825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664010|NCT02162550|Exenatide|exenatide|mesh-list
65664011|NCT02162550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65664012|NCT02162550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664013|NCT02162550|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65664014|NCT02162550|Incretins|incretins|mesh-ancestor
65664015|NCT02162550|Hormones|hormones|mesh-ancestor
65664016|NCT02162550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65664017|NCT03600831|Docetaxel|docetaxel|mesh-list
65664018|NCT03600831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664019|NCT03600831|Tubulin Modulators|tubulin modulators|mesh-ancestor
65664020|NCT03600831|Antimitotic Agents|antimitotic agents|mesh-ancestor
65664021|NCT03600831|Mitosis Modulators|mitosis modulators|mesh-ancestor
65664022|NCT03600831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664023|NCT02852265|Contraceptive Agents|contraceptive agents|mesh-list
65664024|NCT02852265|Etonogestrel|etonogestrel|mesh-list
65664025|NCT02852265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65664026|NCT02852265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664027|NCT02852265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65664028|NCT02852265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65664029|NCT02162784|Budesonide|budesonide|mesh-list
65664030|NCT02162784|Albuterol|albuterol|mesh-list
65664031|NCT02162784|Procaterol|procaterol|mesh-list
65664032|NCT02162784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65664033|NCT02162784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65664034|NCT02162784|Autonomic Agents|autonomic agents|mesh-ancestor
65664035|NCT02162784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65664036|NCT02162784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664037|NCT02162784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65664038|NCT02162784|Respiratory System Agents|respiratory system agents|mesh-ancestor
65664039|NCT02162784|Glucocorticoids|glucocorticoids|mesh-ancestor
65664040|NCT02162784|Hormones|hormones|mesh-ancestor
65664041|NCT02162784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65664042|NCT02162784|Tocolytic Agents|tocolytic agents|mesh-ancestor
65664043|NCT02162784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65664044|NCT02162784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65664045|NCT02162784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65664046|NCT02162784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65664047|NCT02162784|Adrenergic Agents|adrenergic agents|mesh-ancestor
65664048|NCT02162784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65664049|NCT02162784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664050|NCT02162784|Sympathomimetics|sympathomimetics|mesh-ancestor
65664051|NCT03539718|Taurolidine|taurolidine|mesh-list
65664052|NCT03539718|Heparin|heparin|mesh-list
65664053|NCT03539718|Calcium heparin|calcium heparin|mesh-list
65664054|NCT03539718|Anticoagulants|anticoagulants|mesh-ancestor
65664055|NCT03539718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65664056|NCT03539718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65664057|NCT03539718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664058|NCT03539718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65664059|NCT03539718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65664060|NCT03539718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664061|NCT02166450|Nystatin|nystatin|mesh-list
65664062|NCT02166450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65664063|NCT02166450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65664064|NCT02166450|Antifungal Agents|antifungal agents|mesh-ancestor
65664065|NCT02166450|Ionophores|ionophores|mesh-ancestor
65664066|NCT02166450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65664067|NCT02166450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664068|NCT03600363|Metformin|metformin|mesh-list
65664069|NCT03600363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65664070|NCT03600363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664071|NCT03600129|Ropivacaine|ropivacaine|mesh-list
65664072|NCT03600129|Anesthetics, Local|anesthetics, local|mesh-ancestor
65664073|NCT03600129|Anesthetics|anesthetics|mesh-ancestor
65664074|NCT03600129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65664075|NCT03600129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664076|NCT03600129|Sensory System Agents|sensory system agents|mesh-ancestor
65664077|NCT03600129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65664078|NCT02169570|Calcium, Dietary|calcium, dietary|mesh-list
65664079|NCT02169570|Vitamin D|vitamin d|mesh-list
65664080|NCT02169570|Ergocalciferols|ergocalciferols|mesh-list
65664081|NCT02169570|Cholecalciferol|cholecalciferol|mesh-list
65664082|NCT02169570|Vitamins|vitamins|mesh-list
65664083|NCT02169570|Calcium|calcium|mesh-list
65664084|NCT02169570|Micronutrients|micronutrients|mesh-ancestor
65664085|NCT02169570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664086|NCT02169570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65664087|NCT02169570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65664088|NCT02169648|Ranibizumab|ranibizumab|mesh-list
65664089|NCT02169648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65664090|NCT02169648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65664091|NCT02169648|Growth Substances|growth substances|mesh-ancestor
65664092|NCT02169648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664093|NCT02169648|Growth Inhibitors|growth inhibitors|mesh-ancestor
65664094|NCT02169648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664095|NCT03594591|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65664096|NCT03594591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664097|NCT02170896|Pantoprazole|pantoprazole|mesh-list
65664098|NCT02170896|Dabigatran|dabigatran|mesh-list
65664099|NCT02170896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65664100|NCT02170896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65664101|NCT02170896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65664102|NCT02170896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664103|NCT02170896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664104|NCT02170896|Antithrombins|antithrombins|mesh-ancestor
65664105|NCT02170896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65664106|NCT02170896|Protease Inhibitors|protease inhibitors|mesh-ancestor
65664107|NCT02170896|Anticoagulants|anticoagulants|mesh-ancestor
65664108|NCT03594513|Dipyrone|dipyrone|mesh-list
65664109|NCT03594513|Chlorhexidine|chlorhexidine|mesh-list
65664110|NCT03594513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65664111|NCT03594513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65664112|NCT03594513|Disinfectants|disinfectants|mesh-ancestor
65664113|NCT03594513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65664114|NCT03594513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65664115|NCT03594513|Analgesics|analgesics|mesh-ancestor
65664116|NCT03594513|Sensory System Agents|sensory system agents|mesh-ancestor
65664117|NCT03594513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65664118|NCT03594513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664119|NCT03594513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65664120|NCT03594513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65664121|NCT03594513|Antipyretics|antipyretics|mesh-ancestor
65664122|NCT02633800|Carboplatin|carboplatin|mesh-list
65664123|NCT02633800|Cetuximab|cetuximab|mesh-list
65664124|NCT02633800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664125|NCT02633800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65664126|NCT02169804|Enclomiphene|enclomiphene|mesh-list
65664127|NCT02169804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65664128|NCT02169804|Hormone Antagonists|hormone antagonists|mesh-ancestor
65664129|NCT02169804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65664130|NCT02169804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664131|NCT02169804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65664132|NCT02169804|Fertility Agents|fertility agents|mesh-ancestor
65664133|NCT02169804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65664134|NCT02169804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65664135|NCT02169804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65664136|NCT02170974|Dabigatran|dabigatran|mesh-list
65664137|NCT02170974|Antithrombins|antithrombins|mesh-ancestor
65664138|NCT02170974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65664139|NCT02170974|Protease Inhibitors|protease inhibitors|mesh-ancestor
65664140|NCT02170974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664141|NCT02170974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664142|NCT02170974|Anticoagulants|anticoagulants|mesh-ancestor
65664143|NCT02174718|Vitamin D|vitamin d|mesh-list
65664144|NCT02174718|Cholecalciferol|cholecalciferol|mesh-list
65664145|NCT02174718|Vitamins|vitamins|mesh-ancestor
65664146|NCT02174718|Micronutrients|micronutrients|mesh-ancestor
65664147|NCT02174718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664148|NCT02174718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65664149|NCT02174718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65664150|NCT05635162|Rituximab|rituximab|mesh-list
65664151|NCT05635162|Zanubrutinib|zanubrutinib|mesh-list
65664152|NCT05635162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65664153|NCT05635162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664154|NCT05635162|Immunologic Factors|immunologic factors|mesh-ancestor
65664155|NCT05635162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664156|NCT05635162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65664157|NCT05635162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65664158|NCT05635162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664159|NCT05635162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461465|NCT03772054|Anesthetics|anesthetics|mesh-ancestor
65664160|NCT02238171|Ipratropium|ipratropium|mesh-list
65664161|NCT02238171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65664162|NCT02238171|Autonomic Agents|autonomic agents|mesh-ancestor
65664163|NCT02238171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65664164|NCT02238171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664165|NCT02238171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65664166|NCT02238171|Respiratory System Agents|respiratory system agents|mesh-ancestor
65664167|NCT02238171|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65664168|NCT02238171|Cholinergic Agents|cholinergic agents|mesh-ancestor
65664169|NCT02238171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65664170|NCT02238171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664171|NCT02169882|Rifampin|rifampin|mesh-list
65664172|NCT02169882|Dexamethasone|dexamethasone|mesh-list
65664173|NCT02169882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65664174|NCT02169882|Antiemetics|antiemetics|mesh-ancestor
65664175|NCT02169882|Autonomic Agents|autonomic agents|mesh-ancestor
65664176|NCT02169882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65664177|NCT02169882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664178|NCT02169882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65664179|NCT02169882|Glucocorticoids|glucocorticoids|mesh-ancestor
65664180|NCT02169882|Hormones|hormones|mesh-ancestor
65664181|NCT02169882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65664182|NCT02169882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65664183|NCT02169882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664184|NCT02169882|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65664185|NCT02169882|Antitubercular Agents|antitubercular agents|mesh-ancestor
65664186|NCT02169882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65664187|NCT02169882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65664188|NCT02169882|Leprostatic Agents|leprostatic agents|mesh-ancestor
65664189|NCT02169882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65664190|NCT02169882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664191|NCT02169882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664192|NCT02169882|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65664193|NCT02169882|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65664194|NCT02169882|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65664195|NCT02169882|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65664196|NCT02169882|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65664197|NCT02169882|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65664198|NCT03602547|Vorolanib|vorolanib|mesh-list
65664199|NCT03602547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65664200|NCT03602547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664201|NCT03602547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664202|NCT03602469|Bupivacaine|bupivacaine|mesh-list
65664203|NCT03602469|Propofol|propofol|mesh-list
65664204|NCT03602469|Sevoflurane|sevoflurane|mesh-list
65664205|NCT03602469|Rocuronium|rocuronium|mesh-list
65664206|NCT03602469|Anesthetics, Local|anesthetics, local|mesh-ancestor
65664207|NCT03602469|Anesthetics|anesthetics|mesh-ancestor
65664208|NCT03602469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65664209|NCT03602469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664210|NCT03602469|Sensory System Agents|sensory system agents|mesh-ancestor
65664211|NCT03602469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65664212|NCT03602469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65664213|NCT03602469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65664214|NCT03602469|Anesthetics, General|anesthetics, general|mesh-ancestor
65664215|NCT03602469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65664216|NCT03602469|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65664217|NCT03602469|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65664218|NCT03602469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65664219|NCT03602469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65664220|NCT02170038|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65664221|NCT02170038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
65664222|NCT02170038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65664223|NCT02170038|Contraceptive Agents|contraceptive agents|mesh-ancestor
65664224|NCT02170038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65664225|NCT02170038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664226|NCT02170038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65664227|NCT02170038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65664228|NCT02170038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65664229|NCT02170038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65664230|NCT02170038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65461539|NCT03967496|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65664231|NCT02170038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
65664232|NCT02170038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65664233|NCT02170038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65664234|NCT05001373|Vaccines|vaccines|mesh-list
65664235|NCT05001373|Immunologic Factors|immunologic factors|mesh-ancestor
65664236|NCT05001373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664237|NCT02171052|Digoxin|digoxin|mesh-list
65664238|NCT02171052|Dabigatran|dabigatran|mesh-list
65664239|NCT02171052|Antithrombins|antithrombins|mesh-ancestor
65664240|NCT02171052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65664241|NCT02171052|Protease Inhibitors|protease inhibitors|mesh-ancestor
65664242|NCT02171052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664243|NCT02171052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664244|NCT02171052|Anticoagulants|anticoagulants|mesh-ancestor
65664245|NCT02171052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65664246|NCT02171052|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65664247|NCT02171052|Protective Agents|protective agents|mesh-ancestor
65664248|NCT02171052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664249|NCT03591549|Fulvestrant|fulvestrant|mesh-list
65664250|NCT03591549|Goserelin|goserelin|mesh-list
65664251|NCT03591549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65664252|NCT03591549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664253|NCT03591549|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65664254|NCT03591549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65664255|NCT03591549|Hormone Antagonists|hormone antagonists|mesh-ancestor
65664256|NCT03591549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65664257|NCT03591549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664258|NCT02261220|Durvalumab|durvalumab|mesh-list
65664259|NCT02261220|Tremelimumab|tremelimumab|mesh-list
65664260|NCT02261220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65664261|NCT02261220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664262|NCT02237937|Amitriptyline|amitriptyline|mesh-list
65664263|NCT02237937|Citalopram|citalopram|mesh-list
65664264|NCT02237937|Paroxetine|paroxetine|mesh-list
65664265|NCT02237937|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65664266|NCT02237937|Sertraline|sertraline|mesh-list
65664267|NCT02237937|Nortriptyline|nortriptyline|mesh-list
65664268|NCT02237937|Trimipramine|trimipramine|mesh-list
65664269|NCT02237937|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65664270|NCT02237937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65664271|NCT02237937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65664272|NCT02237937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664273|NCT02237937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65664274|NCT02237937|Serotonin Agents|serotonin agents|mesh-ancestor
65664275|NCT02237937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664276|NCT02237937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65664277|NCT02237937|Antidepressive Agents|antidepressive agents|mesh-ancestor
65664278|NCT02237937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65664279|NCT02237937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65664280|NCT02237937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65664281|NCT02237937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65664282|NCT02237937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664283|NCT02237937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65664284|NCT02237937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65664285|NCT02237937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65664286|NCT02237937|Analgesics|analgesics|mesh-ancestor
65664287|NCT02237937|Sensory System Agents|sensory system agents|mesh-ancestor
65664288|NCT02237937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65664289|NCT02237937|Adrenergic Agents|adrenergic agents|mesh-ancestor
65664290|NCT03659539|Propofol|propofol|mesh-list
65664291|NCT03659539|Desflurane|desflurane|mesh-list
65664292|NCT03659539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65664293|NCT03659539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65664294|NCT03659539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664295|NCT03659539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65664296|NCT03659539|Anesthetics, General|anesthetics, general|mesh-ancestor
65664297|NCT03659539|Anesthetics|anesthetics|mesh-ancestor
65664298|NCT03659539|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65664299|NCT02170116|Dabigatran|dabigatran|mesh-list
65664300|NCT02170116|Antithrombins|antithrombins|mesh-ancestor
65664301|NCT02170116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65664302|NCT02170116|Protease Inhibitors|protease inhibitors|mesh-ancestor
65664303|NCT02170116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664304|NCT02170116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461618|NCT03770806|Antipyretics|antipyretics|mesh-ancestor
65664305|NCT02170116|Anticoagulants|anticoagulants|mesh-ancestor
65664306|NCT03035227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
65664307|NCT03539562|Promethazine|promethazine|mesh-list
65664308|NCT03539562|Diphenhydramine|diphenhydramine|mesh-list
65664309|NCT03539562|Morphine|morphine|mesh-list
65664310|NCT03539562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65664311|NCT03539562|Narcotics|narcotics|mesh-ancestor
65664312|NCT03539562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65664313|NCT03539562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664314|NCT03539562|Analgesics|analgesics|mesh-ancestor
65664315|NCT03539562|Sensory System Agents|sensory system agents|mesh-ancestor
65664316|NCT03539562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65664317|NCT03539562|Antipruritics|antipruritics|mesh-ancestor
65664318|NCT03539562|Dermatologic Agents|dermatologic agents|mesh-ancestor
65664319|NCT03539562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65664320|NCT03539562|Histamine Antagonists|histamine antagonists|mesh-ancestor
65664321|NCT03539562|Histamine Agents|histamine agents|mesh-ancestor
65664322|NCT03539562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65664323|NCT03539562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664324|NCT03539562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65664325|NCT03539562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65664326|NCT03539562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65664327|NCT03539562|Anesthetics, Local|anesthetics, local|mesh-ancestor
65664328|NCT03539562|Anesthetics|anesthetics|mesh-ancestor
65664329|NCT03539562|Antiemetics|antiemetics|mesh-ancestor
65664330|NCT03539562|Autonomic Agents|autonomic agents|mesh-ancestor
65664331|NCT03539562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65664332|NCT03604315|Deoxyglucose|deoxyglucose|mesh-list
65664333|NCT03604315|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65664334|NCT03604315|Fluorides|fluorides|mesh-list
65664335|NCT03604315|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65664336|NCT03604315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664337|NCT03604315|Cariostatic Agents|cariostatic agents|mesh-ancestor
65664338|NCT03604315|Protective Agents|protective agents|mesh-ancestor
65664339|NCT03604315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664340|NCT03604315|Antimetabolites|antimetabolites|mesh-ancestor
65664341|NCT03604315|Antiviral Agents|antiviral agents|mesh-ancestor
65664342|NCT03604315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65664343|NCT03590769|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65664344|NCT03590769|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65664345|NCT03590769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664346|NCT00394069|Montelukast|montelukast|mesh-list
65664347|NCT00394069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65664348|NCT00394069|Respiratory System Agents|respiratory system agents|mesh-ancestor
65664349|NCT00394069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65664350|NCT00394069|Hormone Antagonists|hormone antagonists|mesh-ancestor
65664351|NCT00394069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65664352|NCT00394069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664353|NCT00394069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65664354|NCT00394069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65664355|NCT00394069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664356|NCT03598959|Tofacitinib|tofacitinib|mesh-list
65664357|NCT03598959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65664358|NCT03598959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664359|NCT03598959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664360|NCT03649633|Vitamins|vitamins|mesh-list
65664361|NCT03649633|Hydrocortisone|hydrocortisone|mesh-list
65664362|NCT03649633|Micronutrients|micronutrients|mesh-ancestor
65664363|NCT03649633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664364|NCT03649633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65664365|NCT02238717|Pregabalin|pregabalin|mesh-list
65664366|NCT02238717|PF-06372865|pf-06372865|mesh-list
65664367|NCT02238717|Analgesics|analgesics|mesh-ancestor
65664368|NCT02238717|Sensory System Agents|sensory system agents|mesh-ancestor
65664369|NCT02238717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65664370|NCT02238717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664371|NCT02238717|Anticonvulsants|anticonvulsants|mesh-ancestor
65664372|NCT02238717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65664373|NCT02238717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65664374|NCT02238717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664375|NCT02238717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65664376|NCT02238717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65664377|NCT02238717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65664378|NCT02238717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65664379|NCT02238717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65664380|NCT02238717|GABA Modulators|gaba modulators|mesh-ancestor
65664381|NCT02238717|GABA Agents|gaba agents|mesh-ancestor
65664382|NCT02238717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65664383|NCT05266066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65664384|NCT05266066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65664385|NCT05266066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65664386|NCT05266066|Antitubercular Agents|antitubercular agents|mesh-ancestor
65664387|NCT03470311|Benralizumab|benralizumab|mesh-list
65664388|NCT03470311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65664389|NCT03470311|Respiratory System Agents|respiratory system agents|mesh-ancestor
65664390|NCT03580005|Methylphenidate|methylphenidate|mesh-list
65664391|NCT03580005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65664392|NCT03580005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664393|NCT03580005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65664394|NCT03580005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65664395|NCT03580005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65664396|NCT03580005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664397|NCT03580005|Dopamine Agents|dopamine agents|mesh-ancestor
65664398|NCT03580005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65664399|NCT03579927|Cytarabine|cytarabine|mesh-list
65664400|NCT03579927|Rituximab|rituximab|mesh-list
65664401|NCT03579927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65664402|NCT03579927|Etoposide|etoposide|mesh-list
65664403|NCT03579927|Etoposide phosphate|etoposide phosphate|mesh-list
65664404|NCT03579927|Melphalan|melphalan|mesh-list
65664405|NCT03579927|Mechlorethamine|mechlorethamine|mesh-list
65664406|NCT03579927|Carmustine|carmustine|mesh-list
65664407|NCT03579927|Podophyllotoxin|podophyllotoxin|mesh-list
65664408|NCT03579927|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65664409|NCT03579927|Antibodies|antibodies|mesh-list
65664410|NCT03579927|Immunoglobulins|immunoglobulins|mesh-list
65664411|NCT03579927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65664412|NCT03579927|Lenograstim|lenograstim|mesh-list
65664413|NCT03579927|Immunologic Factors|immunologic factors|mesh-ancestor
65664414|NCT03579927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664415|NCT03579927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664416|NCT03579927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65664417|NCT03579927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65664418|NCT03579927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65664419|NCT03579927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65664420|NCT03579927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664421|NCT03579927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664422|NCT03579927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65664423|NCT03579927|Antimetabolites|antimetabolites|mesh-ancestor
65664424|NCT03579927|Antiviral Agents|antiviral agents|mesh-ancestor
65664425|NCT03579927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65664426|NCT03579927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65664427|NCT03579927|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65664428|NCT03579927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65664429|NCT03579927|Alkylating Agents|alkylating agents|mesh-ancestor
65664430|NCT03579927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65664431|NCT03579927|Keratolytic Agents|keratolytic agents|mesh-ancestor
65664432|NCT03579927|Dermatologic Agents|dermatologic agents|mesh-ancestor
65664433|NCT03579927|Tubulin Modulators|tubulin modulators|mesh-ancestor
65664434|NCT03579927|Antimitotic Agents|antimitotic agents|mesh-ancestor
65664435|NCT03579927|Mitosis Modulators|mitosis modulators|mesh-ancestor
65664436|NCT03587025|Amitriptyline|amitriptyline|mesh-list
65664437|NCT03587025|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65664438|NCT03587025|Antidepressive Agents|antidepressive agents|mesh-ancestor
65664439|NCT03587025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65664440|NCT03587025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65664441|NCT03587025|Analgesics|analgesics|mesh-ancestor
65664442|NCT03587025|Sensory System Agents|sensory system agents|mesh-ancestor
65664443|NCT03587025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65664444|NCT03587025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664445|NCT03587025|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65664446|NCT03587025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65664447|NCT03587025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65664448|NCT03587025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664449|NCT03587025|Adrenergic Agents|adrenergic agents|mesh-ancestor
65664450|NCT03587025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65664451|NCT02171208|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65664452|NCT02171208|Dermatologic Agents|dermatologic agents|mesh-ancestor
65664453|NCT02171208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65664454|NCT02171208|Immunologic Factors|immunologic factors|mesh-ancestor
65664455|NCT02171208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664456|NCT00140881|Montelukast|montelukast|mesh-list
65664457|NCT00140881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65664458|NCT00140881|Respiratory System Agents|respiratory system agents|mesh-ancestor
65664459|NCT00140881|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65664460|NCT00140881|Hormone Antagonists|hormone antagonists|mesh-ancestor
65664461|NCT00140881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65664462|NCT00140881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664463|NCT00140881|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65664464|NCT00140881|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65664465|NCT00140881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664466|NCT02848833|Empagliflozin|empagliflozin|mesh-list
65664467|NCT02848833|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65664468|NCT02848833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664469|NCT02848833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65664470|NCT02848833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664471|NCT03539328|Gemcitabine|gemcitabine|mesh-list
65664472|NCT03539328|Paclitaxel|paclitaxel|mesh-list
65664473|NCT03539328|Doxorubicin|doxorubicin|mesh-list
65664474|NCT03539328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65664475|NCT03539328|Pembrolizumab|pembrolizumab|mesh-list
65664476|NCT03539328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65664477|NCT03539328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664478|NCT03539328|Tubulin Modulators|tubulin modulators|mesh-ancestor
65664479|NCT03539328|Antimitotic Agents|antimitotic agents|mesh-ancestor
65664480|NCT03539328|Mitosis Modulators|mitosis modulators|mesh-ancestor
65664481|NCT03539328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664482|NCT03539328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65664483|NCT03539328|Antimetabolites|antimetabolites|mesh-ancestor
65664484|NCT03539328|Antiviral Agents|antiviral agents|mesh-ancestor
65664485|NCT03539328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65664486|NCT03539328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664487|NCT03539328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65664488|NCT03539328|Immunologic Factors|immunologic factors|mesh-ancestor
65664489|NCT03539328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664490|NCT03539328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65664491|NCT03539328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65664492|NCT03539328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65664493|NCT03539328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65664494|NCT00111709|Rizatriptan|rizatriptan|mesh-list
65664495|NCT00111709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65664496|NCT00111709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664497|NCT00111709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664498|NCT00111709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65664499|NCT00111709|Serotonin Agents|serotonin agents|mesh-ancestor
65664500|NCT02171442|Dabigatran|dabigatran|mesh-list
65664501|NCT02171442|Antithrombins|antithrombins|mesh-ancestor
65664502|NCT02171442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65664503|NCT02171442|Protease Inhibitors|protease inhibitors|mesh-ancestor
65664504|NCT02171442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664505|NCT02171442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664506|NCT02171442|Anticoagulants|anticoagulants|mesh-ancestor
65664507|NCT02035527|Docetaxel|docetaxel|mesh-list
65664508|NCT02035527|Sorafenib|sorafenib|mesh-list
65664509|NCT02035527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664510|NCT02035527|Tubulin Modulators|tubulin modulators|mesh-ancestor
65664511|NCT02035527|Antimitotic Agents|antimitotic agents|mesh-ancestor
65664512|NCT02035527|Mitosis Modulators|mitosis modulators|mesh-ancestor
65664513|NCT02035527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664514|NCT02035527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65664515|NCT02035527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664516|NCT00092131|Montelukast|montelukast|mesh-list
65664517|NCT00092131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65664518|NCT00092131|Respiratory System Agents|respiratory system agents|mesh-ancestor
65664519|NCT00092131|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65664520|NCT00092131|Hormone Antagonists|hormone antagonists|mesh-ancestor
65664521|NCT00092131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65664522|NCT00092131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664523|NCT00092131|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65664524|NCT00092131|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65664525|NCT00092131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664526|NCT02170584|Dabigatran|dabigatran|mesh-list
65664527|NCT02170584|Antithrombins|antithrombins|mesh-ancestor
65664528|NCT02170584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65664529|NCT02170584|Protease Inhibitors|protease inhibitors|mesh-ancestor
65664530|NCT02170584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664531|NCT02170584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664532|NCT02170584|Anticoagulants|anticoagulants|mesh-ancestor
65664533|NCT03577977|Interferons|interferons|mesh-list
65664534|NCT03577977|Interferon-beta|interferon-beta|mesh-list
65664535|NCT03577977|Interferon beta-1b|interferon beta-1b|mesh-list
65664536|NCT03577977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664537|NCT03577977|Antiviral Agents|antiviral agents|mesh-ancestor
65664538|NCT03577977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65664539|NCT03577977|Immunologic Factors|immunologic factors|mesh-ancestor
65664540|NCT03577977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664541|NCT03577977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65664542|NCT02668783|Ibuprofen|ibuprofen|mesh-list
65664543|NCT02668783|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65664544|NCT02668783|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65664545|NCT02668783|Etonogestrel|etonogestrel|mesh-list
65664546|NCT02668783|Estradiol|estradiol|mesh-list
65664547|NCT02668783|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65664548|NCT02668783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65664549|NCT02668783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65664550|NCT02668783|Analgesics|analgesics|mesh-ancestor
65664551|NCT02668783|Sensory System Agents|sensory system agents|mesh-ancestor
65664552|NCT02668783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65664553|NCT02668783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664554|NCT02668783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65664555|NCT02668783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65664556|NCT02668783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65664557|NCT02668783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664558|NCT02668783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664559|NCT02668783|Estrogens|estrogens|mesh-ancestor
65664560|NCT02668783|Hormones|hormones|mesh-ancestor
65664561|NCT02668783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65664562|NCT02668783|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65664563|NCT02668783|Contraceptive Agents|contraceptive agents|mesh-ancestor
65664564|NCT02668783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65664565|NCT02668783|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65664566|NCT05010304|Amoxicillin|amoxicillin|mesh-list
65664567|NCT05010304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65664568|NCT05010304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65664569|NCT03577899|Aflibercept|aflibercept|mesh-list
65664570|NCT03577899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65664571|NCT03577899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65664572|NCT03577899|Growth Substances|growth substances|mesh-ancestor
65664573|NCT03577899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664574|NCT03577899|Growth Inhibitors|growth inhibitors|mesh-ancestor
65664575|NCT03577899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664576|NCT02175342|Tiotropium Bromide|tiotropium bromide|mesh-list
65664577|NCT02175342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65664578|NCT02175342|Autonomic Agents|autonomic agents|mesh-ancestor
65664579|NCT02175342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65664580|NCT02175342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664581|NCT02175342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65664582|NCT02175342|Respiratory System Agents|respiratory system agents|mesh-ancestor
65664583|NCT02175342|Parasympatholytics|parasympatholytics|mesh-ancestor
65664584|NCT02175342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65664585|NCT02175342|Cholinergic Agents|cholinergic agents|mesh-ancestor
65664586|NCT02175342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65664587|NCT02175342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664588|NCT02171520|Dabigatran|dabigatran|mesh-list
65664589|NCT02171520|Antithrombins|antithrombins|mesh-ancestor
65664590|NCT02171520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65664591|NCT02171520|Protease Inhibitors|protease inhibitors|mesh-ancestor
65664592|NCT02171520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664593|NCT02171520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664594|NCT02171520|Anticoagulants|anticoagulants|mesh-ancestor
65664595|NCT00092053|Ibandronic Acid|ibandronic acid|mesh-list
65664596|NCT00092053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65664597|NCT00092053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664598|NCT00101010|Prednisone|prednisone|mesh-list
65664599|NCT00101010|Cyclophosphamide|cyclophosphamide|mesh-list
65664600|NCT00101010|Rituximab|rituximab|mesh-list
65664601|NCT00101010|Doxorubicin|doxorubicin|mesh-list
65664602|NCT00101010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65664603|NCT00101010|Vincristine|vincristine|mesh-list
65664604|NCT00101010|Lenograstim|lenograstim|mesh-list
65664605|NCT00101010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65664606|NCT00101010|Immunologic Factors|immunologic factors|mesh-ancestor
65664607|NCT00101010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664608|NCT00101010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65664609|NCT00101010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65664610|NCT00101010|Alkylating Agents|alkylating agents|mesh-ancestor
65664611|NCT00101010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664612|NCT00101010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664613|NCT00101010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65664614|NCT00101010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65664615|NCT00101010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65664616|NCT00101010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65664617|NCT00101010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65664618|NCT00101010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664619|NCT00101010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65664620|NCT00101010|Glucocorticoids|glucocorticoids|mesh-ancestor
65664621|NCT00101010|Hormones|hormones|mesh-ancestor
65664622|NCT00101010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65664623|NCT00101010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65664624|NCT00101010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65664625|NCT00101010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65664626|NCT00101010|Tubulin Modulators|tubulin modulators|mesh-ancestor
65664627|NCT00101010|Antimitotic Agents|antimitotic agents|mesh-ancestor
65664628|NCT00101010|Mitosis Modulators|mitosis modulators|mesh-ancestor
65664629|NCT03539172|Apatinib|apatinib|mesh-list
65664630|NCT03539172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664631|NCT03539172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65664632|NCT03539172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664633|NCT03539172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664634|NCT03209401|Carboplatin|carboplatin|mesh-list
65664635|NCT03209401|Niraparib|niraparib|mesh-list
65664636|NCT03209401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664637|NCT03209401|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65664638|NCT03209401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664639|NCT03209401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664640|NCT02175420|BCG Vaccine|bcg vaccine|mesh-list
65664641|NCT02175420|Immunologic Factors|immunologic factors|mesh-ancestor
65664642|NCT02175420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664643|NCT02175420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65664644|NCT04576104|Metformin|metformin|mesh-list
65664645|NCT04576104|Megestrol|megestrol|mesh-list
65664646|NCT04576104|Megestrol Acetate|megestrol acetate|mesh-list
65664647|NCT04576104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65664648|NCT04576104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664649|NCT04576104|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65664650|NCT04576104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65664651|NCT04576104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65664652|NCT04576104|Contraceptive Agents|contraceptive agents|mesh-ancestor
65664653|NCT04576104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65664654|NCT04576104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65664655|NCT04576104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65664656|NCT04576104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65664657|NCT04576104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664658|NCT04576104|Appetite Stimulants|appetite stimulants|mesh-ancestor
65664659|NCT04576104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65664660|NCT04859764|Betamethasone|betamethasone|mesh-list
65664661|NCT04859764|Bupivacaine|bupivacaine|mesh-list
65664662|NCT04859764|Anesthetics, Local|anesthetics, local|mesh-ancestor
65664663|NCT04859764|Anesthetics|anesthetics|mesh-ancestor
65664664|NCT04859764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65664665|NCT04859764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664666|NCT04859764|Sensory System Agents|sensory system agents|mesh-ancestor
65664667|NCT04859764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65664668|NCT04859764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65664669|NCT04859764|Glucocorticoids|glucocorticoids|mesh-ancestor
65664670|NCT04859764|Hormones|hormones|mesh-ancestor
65664671|NCT04859764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65664672|NCT04859764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65664673|NCT04859764|Respiratory System Agents|respiratory system agents|mesh-ancestor
65664674|NCT02170740|Pantoprazole|pantoprazole|mesh-list
65664675|NCT02170740|Dabigatran|dabigatran|mesh-list
65664676|NCT02170740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65664677|NCT02170740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65664678|NCT02170740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65664679|NCT02170740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664680|NCT02170740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664681|NCT02170740|Antithrombins|antithrombins|mesh-ancestor
65664682|NCT02170740|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65664683|NCT02170740|Protease Inhibitors|protease inhibitors|mesh-ancestor
65664684|NCT02170740|Anticoagulants|anticoagulants|mesh-ancestor
65664685|NCT02848599|Morphine|morphine|mesh-list
65664686|NCT02848599|Levobupivacaine|levobupivacaine|mesh-list
65664687|NCT02848599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65664688|NCT02848599|Narcotics|narcotics|mesh-ancestor
65664689|NCT02848599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65664690|NCT02848599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664691|NCT02848599|Analgesics|analgesics|mesh-ancestor
65664692|NCT02848599|Sensory System Agents|sensory system agents|mesh-ancestor
65664693|NCT02848599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65664694|NCT02848599|Anesthetics, Local|anesthetics, local|mesh-ancestor
65664695|NCT02848599|Anesthetics|anesthetics|mesh-ancestor
65664696|NCT02171598|Dabigatran|dabigatran|mesh-list
65664697|NCT02171598|Clopidogrel|clopidogrel|mesh-list
65664698|NCT02171598|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65664699|NCT02171598|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65664700|NCT02171598|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65664701|NCT02171598|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65664702|NCT02171598|Purinergic Agents|purinergic agents|mesh-ancestor
65664703|NCT02171598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65664704|NCT02171598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664705|NCT02171598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664706|NCT02171598|Antithrombins|antithrombins|mesh-ancestor
65664707|NCT02171598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65664708|NCT02171598|Protease Inhibitors|protease inhibitors|mesh-ancestor
65664709|NCT02171598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664710|NCT02171598|Anticoagulants|anticoagulants|mesh-ancestor
65664711|NCT02131597|Guadecitabine|guadecitabine|mesh-list
65664712|NCT02131597|Azacitidine|azacitidine|mesh-list
65664713|NCT02131597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664714|NCT02131597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65664715|NCT02131597|Antimetabolites|antimetabolites|mesh-ancestor
65664716|NCT02131597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664717|NCT02131597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664718|NCT03068962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
65664719|NCT03068962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65664720|NCT02171676|Docetaxel|docetaxel|mesh-list
65664721|NCT02171676|Afatinib|afatinib|mesh-list
65664722|NCT02171676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664723|NCT02171676|Tubulin Modulators|tubulin modulators|mesh-ancestor
65664724|NCT02171676|Antimitotic Agents|antimitotic agents|mesh-ancestor
65664725|NCT02171676|Mitosis Modulators|mitosis modulators|mesh-ancestor
65664726|NCT02171676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664727|NCT02171676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65664728|NCT02171676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664729|NCT02027935|Aldesleukin|aldesleukin|mesh-list
65664730|NCT02027935|Cyclophosphamide|cyclophosphamide|mesh-list
65664731|NCT02027935|Ipilimumab|ipilimumab|mesh-list
65664732|NCT02027935|Interleukin-2|interleukin-2|mesh-list
65664733|NCT02027935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65664734|NCT02027935|Immunologic Factors|immunologic factors|mesh-ancestor
65664735|NCT02027935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664736|NCT02027935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65664737|NCT02027935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65664738|NCT02027935|Alkylating Agents|alkylating agents|mesh-ancestor
65664739|NCT02027935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664740|NCT02027935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664741|NCT02027935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65664742|NCT02027935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65664743|NCT02027935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65664744|NCT02027935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65664745|NCT02027935|Analgesics|analgesics|mesh-ancestor
65664746|NCT02027935|Sensory System Agents|sensory system agents|mesh-ancestor
65664747|NCT02027935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65664748|NCT02027935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65664749|NCT02027935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65664750|NCT02027935|Antiviral Agents|antiviral agents|mesh-ancestor
65664751|NCT02027935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65664752|NCT03577743|Bevacizumab|bevacizumab|mesh-list
65664753|NCT03577743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65664754|NCT03577743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664755|NCT03577743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65664756|NCT03577743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65462078|NCT03760354|Hormones|hormones|mesh-ancestor
65664757|NCT03577743|Growth Substances|growth substances|mesh-ancestor
65664758|NCT03577743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664759|NCT03577743|Growth Inhibitors|growth inhibitors|mesh-ancestor
65664761|NCT04794790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65664762|NCT04794790|Naloxone|naloxone|mesh-list
65664763|NCT04794790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65664764|NCT04794790|Narcotics|narcotics|mesh-ancestor
65664765|NCT04794790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65664766|NCT04794790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664767|NCT04794790|Analgesics|analgesics|mesh-ancestor
65664768|NCT04794790|Sensory System Agents|sensory system agents|mesh-ancestor
65664769|NCT04794790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65664770|NCT04794790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65664771|NCT02171754|Ritonavir|ritonavir|mesh-list
65664772|NCT02171754|Afatinib|afatinib|mesh-list
65664773|NCT02171754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65664774|NCT02171754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65664775|NCT02171754|Protease Inhibitors|protease inhibitors|mesh-ancestor
65664776|NCT02171754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664777|NCT02171754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664778|NCT02171754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65664779|NCT02171754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65664780|NCT02171754|Antiviral Agents|antiviral agents|mesh-ancestor
65664781|NCT02171754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65664782|NCT02171754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65664783|NCT02171754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65664784|NCT02171754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664785|NCT02171754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65664786|NCT02171832|Olodaterol|olodaterol|mesh-list
65664787|NCT02171832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65664788|NCT02171832|Autonomic Agents|autonomic agents|mesh-ancestor
65664789|NCT02171832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65664790|NCT02171832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664791|NCT02171832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65664792|NCT02171832|Respiratory System Agents|respiratory system agents|mesh-ancestor
65664793|NCT02171910|Doxapram|doxapram|mesh-list
65664794|NCT02171910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65664795|NCT02171910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664796|NCT02171910|Respiratory System Agents|respiratory system agents|mesh-ancestor
65664797|NCT02178306|Telmisartan|telmisartan|mesh-list
65664798|NCT02178306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65664799|NCT02178306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65664800|NCT02178306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65664801|NCT02178306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664802|NCT05729386|Metformin|metformin|mesh-list
65664803|NCT05729386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65664804|NCT05729386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664805|NCT05729308|Anesthetics|anesthetics|mesh-list
65664806|NCT05729308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65664807|NCT05729308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664808|NCT00778999|Desogestrel|desogestrel|mesh-list
65664809|NCT00778999|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65664810|NCT00778999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65664811|NCT00778999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65664812|NCT00778999|Contraceptive Agents|contraceptive agents|mesh-ancestor
65664813|NCT00778999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65664814|NCT00778999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664815|NCT00778999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65664816|NCT00778999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65664817|NCT00778999|Progestins|progestins|mesh-ancestor
65664818|NCT00778999|Hormones|hormones|mesh-ancestor
65664819|NCT00778999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65664820|NCT02171988|Propranolol|propranolol|mesh-list
65664821|NCT02171988|Bisoprolol|bisoprolol|mesh-list
65664822|NCT02171988|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
65664823|NCT02171988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65664824|NCT02171988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65664825|NCT02171988|Adrenergic Agents|adrenergic agents|mesh-ancestor
65664826|NCT02171988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65664827|NCT02171988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664828|NCT02171988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664829|NCT02171988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65664830|NCT02171988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65664831|NCT02171988|Vasodilator Agents|vasodilator agents|mesh-ancestor
65664833|NCT02171988|Autonomic Agents|autonomic agents|mesh-ancestor
65664834|NCT02171988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65664835|NCT02171988|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65664836|NCT02171988|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65664837|NCT02171988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664838|NCT02171988|Cholinergic Agents|cholinergic agents|mesh-ancestor
65664839|NCT00725413|Etonogestrel|etonogestrel|mesh-list
65664840|NCT00725413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65664841|NCT00725413|Contraceptive Agents|contraceptive agents|mesh-ancestor
65664842|NCT00725413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65664843|NCT00725413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664844|NCT00725413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65664845|NCT00103038|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65664846|NCT00103038|Hematinics|hematinics|mesh-ancestor
65664847|NCT00103038|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65664848|NCT00103038|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65664849|NCT00620035|Etonogestrel|etonogestrel|mesh-list
65664850|NCT00620035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65664851|NCT00620035|Contraceptive Agents|contraceptive agents|mesh-ancestor
65664852|NCT00620035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65664853|NCT00620035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664854|NCT00620035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65664855|NCT00431431|Tibolone|tibolone|mesh-list
65664856|NCT00431431|Androgen Antagonists|androgen antagonists|mesh-ancestor
65664857|NCT00431431|Hormone Antagonists|hormone antagonists|mesh-ancestor
65664858|NCT00431431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65664859|NCT00431431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664860|NCT00431431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65664861|NCT00431431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65664862|NCT00431431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664863|NCT00431431|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65664864|NCT00431431|Anabolic Agents|anabolic agents|mesh-ancestor
65664865|NCT00431431|Hormones|hormones|mesh-ancestor
65664866|NCT04555044|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65664867|NCT04555044|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65664868|NCT04555044|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65664869|NCT04555044|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65664870|NCT02175888|Iron|iron|mesh-list
65664871|NCT02175888|Trace Elements|trace elements|mesh-ancestor
65664872|NCT02175888|Micronutrients|micronutrients|mesh-ancestor
65664873|NCT02175888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664874|NCT05577637|Tacrolimus|tacrolimus|mesh-list
65664875|NCT05577637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65664876|NCT05577637|Immunologic Factors|immunologic factors|mesh-ancestor
65664877|NCT05577637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664878|NCT05577637|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65664879|NCT05577637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664880|NCT05577637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664881|NCT02763579|Carboplatin|carboplatin|mesh-list
65664882|NCT02763579|Etoposide|etoposide|mesh-list
65664883|NCT02763579|Atezolizumab|atezolizumab|mesh-list
65664884|NCT02763579|Antibodies|antibodies|mesh-list
65664885|NCT02763579|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65664886|NCT02763579|Immunologic Factors|immunologic factors|mesh-ancestor
65664887|NCT02763579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664888|NCT02763579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664889|NCT02763579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65664890|NCT02763579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65664891|NCT02763579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65664892|NCT02763579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664893|NCT02763579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664894|NCT02176044|Nitroprusside|nitroprusside|mesh-list
65664895|NCT02176044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65664896|NCT02176044|Vasodilator Agents|vasodilator agents|mesh-ancestor
65664897|NCT02176044|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65664898|NCT02176044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664899|NCT02176122|Meropenem|meropenem|mesh-list
65664900|NCT02176122|Tazobactam|tazobactam|mesh-list
65664901|NCT02176122|Piperacillin|piperacillin|mesh-list
65664902|NCT02176122|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65664903|NCT02176122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65664904|NCT02176122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65664905|NCT02176122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65664906|NCT02176122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664907|NCT02176122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664908|NCT02967757|Liraglutide|liraglutide|mesh-list
65664909|NCT02967757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65664910|NCT02967757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664911|NCT02967757|Incretins|incretins|mesh-ancestor
65664912|NCT02967757|Hormones|hormones|mesh-ancestor
65664913|NCT02967757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65664914|NCT02261298|Nivolumab|nivolumab|mesh-list
65664915|NCT02261298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65664916|NCT02261298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664917|NCT02261298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65664918|NCT02261298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664919|NCT04680052|Rituximab|rituximab|mesh-list
65664920|NCT04680052|Lenalidomide|lenalidomide|mesh-list
65664921|NCT04680052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65664922|NCT04680052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664923|NCT04680052|Immunologic Factors|immunologic factors|mesh-ancestor
65664924|NCT04680052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664925|NCT04680052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65664926|NCT04680052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65664927|NCT04680052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65664928|NCT04680052|Growth Substances|growth substances|mesh-ancestor
65664929|NCT04680052|Growth Inhibitors|growth inhibitors|mesh-ancestor
65664930|NCT02176200|Fenoterol|fenoterol|mesh-list
65664931|NCT02176200|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
65664932|NCT02176200|Ipratropium|ipratropium|mesh-list
65664933|NCT02176200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65664934|NCT02176200|Autonomic Agents|autonomic agents|mesh-ancestor
65664935|NCT02176200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65664936|NCT02176200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664937|NCT02176200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65664938|NCT02176200|Respiratory System Agents|respiratory system agents|mesh-ancestor
65664939|NCT02176200|Sympathomimetics|sympathomimetics|mesh-ancestor
65664940|NCT02176200|Tocolytic Agents|tocolytic agents|mesh-ancestor
65664941|NCT02176200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65664942|NCT02176200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65664943|NCT02176200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65664944|NCT02176200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65664945|NCT02176200|Adrenergic Agents|adrenergic agents|mesh-ancestor
65664946|NCT02176200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65664947|NCT02176200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664948|NCT02176200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65664949|NCT02176200|Cholinergic Agents|cholinergic agents|mesh-ancestor
65664950|NCT03537612|Clonidine|clonidine|mesh-list
65664951|NCT03537612|Morphine|morphine|mesh-list
65664952|NCT03537612|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65664953|NCT03537612|Narcotics|narcotics|mesh-ancestor
65664954|NCT03537612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65664955|NCT03537612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664956|NCT03537612|Analgesics|analgesics|mesh-ancestor
65664957|NCT03537612|Sensory System Agents|sensory system agents|mesh-ancestor
65664958|NCT03537612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65664959|NCT03537612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65664960|NCT03537612|Sympatholytics|sympatholytics|mesh-ancestor
65664961|NCT03537612|Autonomic Agents|autonomic agents|mesh-ancestor
65664962|NCT03537612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65664963|NCT03537612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64770104|NCT04298567|Aspirin|aspirin|mesh-list
65664964|NCT03537612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65664965|NCT03537612|Adrenergic Agents|adrenergic agents|mesh-ancestor
65664966|NCT03537612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65664967|NCT03537612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664968|NCT00336063|Azacitidine|azacitidine|mesh-list
65664969|NCT00336063|Vorinostat|vorinostat|mesh-list
65664970|NCT00336063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65664971|NCT00336063|Antimetabolites|antimetabolites|mesh-ancestor
65664972|NCT00336063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664973|NCT00336063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664974|NCT00336063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664975|NCT00336063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65664976|NCT02172144|Moxifloxacin|moxifloxacin|mesh-list
65664977|NCT02172144|Olodaterol|olodaterol|mesh-list
65664978|NCT02172144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65664979|NCT02172144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65664980|NCT02172144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65664981|NCT02172144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65664982|NCT02172144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65664983|NCT02172144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65664984|NCT02172144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65664985|NCT02172144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664986|NCT02172144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65664988|NCT02172144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65664989|NCT02172144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65664990|NCT02172144|Respiratory System Agents|respiratory system agents|mesh-ancestor
65664991|NCT05729074|Pimecrolimus|pimecrolimus|mesh-list
65664992|NCT05729074|Varespladib methyl|varespladib methyl|mesh-list
65664993|NCT05729074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65664994|NCT05729074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65664995|NCT05729074|Analgesics|analgesics|mesh-ancestor
65664996|NCT05729074|Sensory System Agents|sensory system agents|mesh-ancestor
65664997|NCT05729074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65664998|NCT05729074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65664999|NCT05729074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65665000|NCT05729074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65665001|NCT05729074|Dermatologic Agents|dermatologic agents|mesh-ancestor
65665002|NCT05729074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65665003|NCT05729074|Immunologic Factors|immunologic factors|mesh-ancestor
65665004|NCT05729074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65665005|NCT05729074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665006|NCT05729074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665007|NCT05729074|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
65665008|NCT02176512|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65665009|NCT02176512|Telmisartan|telmisartan|mesh-list
65665010|NCT02176512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65665011|NCT02176512|Diuretics|diuretics|mesh-ancestor
65665012|NCT02176512|Natriuretic Agents|natriuretic agents|mesh-ancestor
65665013|NCT02176512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665014|NCT02176512|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65665015|NCT02176512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65665016|NCT02176512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665017|NCT02176512|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65665018|NCT02176512|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65665019|NCT03537534|Lidocaine|lidocaine|mesh-list
65665020|NCT03537534|Anesthetics, Local|anesthetics, local|mesh-ancestor
65665021|NCT03537534|Anesthetics|anesthetics|mesh-ancestor
65665022|NCT03537534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65665023|NCT03537534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665024|NCT03537534|Sensory System Agents|sensory system agents|mesh-ancestor
65665025|NCT03537534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665026|NCT03537534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65665027|NCT03537534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65665028|NCT03537534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65665029|NCT03537534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65665030|NCT03537534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665031|NCT03068650|Rindopepimut|rindopepimut|mesh-list
65665032|NCT03068650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65665033|NCT03068650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665034|NCT04646005|Cemiplimab|cemiplimab|mesh-list
65665035|NCT04646005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65665036|NCT04646005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665037|NCT02757768|Tamsulosin|tamsulosin|mesh-list
65665038|NCT02757768|Mirabegron|mirabegron|mesh-list
65665039|NCT02757768|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65665040|NCT02757768|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65665041|NCT02757768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65665042|NCT02757768|Adrenergic Agents|adrenergic agents|mesh-ancestor
65665043|NCT02757768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65665044|NCT02757768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665045|NCT02757768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665046|NCT02757768|Urological Agents|urological agents|mesh-ancestor
65665047|NCT02757768|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65665048|NCT02757768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65665049|NCT02757768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65665050|NCT03066076|Propylthiouracil|propylthiouracil|mesh-list
65665051|NCT03066076|Antithyroid Agents|antithyroid agents|mesh-list
65665052|NCT03066076|Antimetabolites|antimetabolites|mesh-ancestor
65665053|NCT03066076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665054|NCT03066076|Hormone Antagonists|hormone antagonists|mesh-ancestor
65665055|NCT03066076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65665056|NCT03066076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665057|NCT05225077|Dapagliflozin|dapagliflozin|mesh-list
65665058|NCT05225077|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65665059|NCT05225077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665060|NCT05225077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65665061|NCT05225077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665062|NCT03067792|Leucovorin|leucovorin|mesh-list
65665063|NCT03067792|Docetaxel|docetaxel|mesh-list
65665064|NCT03067792|Fluorouracil|fluorouracil|mesh-list
65665065|NCT03067792|Irinotecan|irinotecan|mesh-list
65665066|NCT03067792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665067|NCT03067792|Tubulin Modulators|tubulin modulators|mesh-ancestor
65665068|NCT03067792|Antimitotic Agents|antimitotic agents|mesh-ancestor
65665069|NCT03067792|Mitosis Modulators|mitosis modulators|mesh-ancestor
65665070|NCT03067792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665071|NCT03067792|Antimetabolites|antimetabolites|mesh-ancestor
65665072|NCT03067792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65665073|NCT03067792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65665074|NCT03067792|Immunologic Factors|immunologic factors|mesh-ancestor
65665075|NCT03067792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665076|NCT03067792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65665077|NCT03067792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65665078|NCT03067792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665079|NCT03067792|Antidotes|antidotes|mesh-ancestor
65665080|NCT03067792|Protective Agents|protective agents|mesh-ancestor
65665081|NCT03067792|Vitamin B Complex|vitamin b complex|mesh-ancestor
65665082|NCT03067792|Vitamins|vitamins|mesh-ancestor
65665083|NCT03067792|Micronutrients|micronutrients|mesh-ancestor
65665084|NCT05224999|Nivolumab|nivolumab|mesh-list
65665085|NCT05224999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65665086|NCT05224999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665087|NCT05224999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65665088|NCT05224999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665089|NCT03066154|Ritonavir|ritonavir|mesh-list
65665090|NCT03066154|Docetaxel|docetaxel|mesh-list
65665091|NCT03066154|Androgens|androgens|mesh-list
65665092|NCT03066154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665093|NCT03066154|Tubulin Modulators|tubulin modulators|mesh-ancestor
65665094|NCT03066154|Antimitotic Agents|antimitotic agents|mesh-ancestor
65665095|NCT03066154|Mitosis Modulators|mitosis modulators|mesh-ancestor
65665096|NCT03066154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665097|NCT03066154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65665098|NCT03066154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65665099|NCT03066154|Protease Inhibitors|protease inhibitors|mesh-ancestor
65665100|NCT03066154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665101|NCT03066154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65665102|NCT03066154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65665103|NCT03066154|Antiviral Agents|antiviral agents|mesh-ancestor
65665104|NCT03066154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65665105|NCT03066154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65665106|NCT03066154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65665107|NCT03066154|Hormones|hormones|mesh-ancestor
65665108|NCT03066154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65665109|NCT03066154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665110|NCT05224687|Daptomycin|daptomycin|mesh-list
65665111|NCT05224687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65665112|NCT05224687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65665113|NCT02753946|Tazobactam|tazobactam|mesh-list
65665114|NCT02753946|Piperacillin|piperacillin|mesh-list
65665115|NCT02753946|Fosfomycin|fosfomycin|mesh-list
65665116|NCT02753946|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65665117|NCT02753946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65665118|NCT02753946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65665119|NCT02753946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65665120|NCT02753946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665121|NCT02753946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665122|NCT02172222|Linagliptin|linagliptin|mesh-list
65665123|NCT02172222|Empagliflozin|empagliflozin|mesh-list
65665124|NCT02172222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65665125|NCT02172222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665126|NCT02172222|Incretins|incretins|mesh-ancestor
65665127|NCT02172222|Hormones|hormones|mesh-ancestor
65665128|NCT02172222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65665129|NCT02172222|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65665130|NCT02172222|Protease Inhibitors|protease inhibitors|mesh-ancestor
65665131|NCT02172222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665132|NCT02172222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665133|NCT02172222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65665134|NCT03625219|Prednisone|prednisone|mesh-list
65665135|NCT03625219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65665136|NCT03625219|Glucocorticoids|glucocorticoids|mesh-ancestor
65665137|NCT03625219|Hormones|hormones|mesh-ancestor
65665138|NCT03625219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65665139|NCT03625219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665140|NCT03625219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65665141|NCT03625219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665142|NCT03065842|Contraceptive Agents|contraceptive agents|mesh-list
65665143|NCT03065842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65665144|NCT03065842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665145|NCT02179008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65665146|NCT02179008|Latanoprost|latanoprost|mesh-list
65665147|NCT02179008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65665148|NCT02172300|Tiotropium Bromide|tiotropium bromide|mesh-list
65665149|NCT02172300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65665150|NCT02172300|Autonomic Agents|autonomic agents|mesh-ancestor
65665151|NCT02172300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665152|NCT02172300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665153|NCT02172300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65665154|NCT02172300|Respiratory System Agents|respiratory system agents|mesh-ancestor
65665155|NCT02172300|Parasympatholytics|parasympatholytics|mesh-ancestor
65665156|NCT02172300|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65665157|NCT02172300|Cholinergic Agents|cholinergic agents|mesh-ancestor
65665158|NCT02172300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65665159|NCT02172300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665160|NCT05223907|Propofol|propofol|mesh-list
65665161|NCT05223907|Etomidate|etomidate|mesh-list
65665162|NCT05223907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65665163|NCT05223907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65665164|NCT05223907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665165|NCT05223907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65665166|NCT05223907|Anesthetics, General|anesthetics, general|mesh-ancestor
65665167|NCT05223907|Anesthetics|anesthetics|mesh-ancestor
65665168|NCT03065998|Baclofen|baclofen|mesh-list
65665169|NCT03065998|Opipramol|opipramol|mesh-list
65665170|NCT03065998|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65665171|NCT03065998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665172|NCT03065998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65665173|NCT03065998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665174|NCT03065998|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65665175|NCT03065998|GABA Agonists|gaba agonists|mesh-ancestor
65665176|NCT03065998|GABA Agents|gaba agents|mesh-ancestor
65665177|NCT03065998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65665178|NCT03065998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665179|NCT03065998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65665180|NCT03065998|Antidepressive Agents|antidepressive agents|mesh-ancestor
65665181|NCT03065998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65665182|NCT03065998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65665183|NCT03065998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65665184|NCT03065998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65665185|NCT03065998|Adrenergic Agents|adrenergic agents|mesh-ancestor
65665186|NCT02172378|Tiotropium Bromide|tiotropium bromide|mesh-list
65665187|NCT02172378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65665188|NCT02172378|Autonomic Agents|autonomic agents|mesh-ancestor
65665189|NCT02172378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665190|NCT02172378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665191|NCT02172378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65665192|NCT02172378|Respiratory System Agents|respiratory system agents|mesh-ancestor
65665193|NCT02172378|Parasympatholytics|parasympatholytics|mesh-ancestor
65665194|NCT02172378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65665195|NCT02172378|Cholinergic Agents|cholinergic agents|mesh-ancestor
65665196|NCT02172378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65665197|NCT02172378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665198|NCT05728528|Factor VIII|factor viii|mesh-list
65665199|NCT05728528|Coagulants|coagulants|mesh-ancestor
65665200|NCT02256228|Ropivacaine|ropivacaine|mesh-list
65665201|NCT02256228|Anesthetics, Local|anesthetics, local|mesh-ancestor
65665202|NCT02256228|Anesthetics|anesthetics|mesh-ancestor
65665203|NCT02256228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65665204|NCT02256228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665205|NCT02256228|Sensory System Agents|sensory system agents|mesh-ancestor
65665206|NCT02256228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665207|NCT03067168|Bupivacaine|bupivacaine|mesh-list
65665208|NCT03067168|Anesthetics, Local|anesthetics, local|mesh-ancestor
65665209|NCT03067168|Anesthetics|anesthetics|mesh-ancestor
65665210|NCT03067168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65665211|NCT03067168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665212|NCT03067168|Sensory System Agents|sensory system agents|mesh-ancestor
65665213|NCT03067168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665214|NCT04774237|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65665215|NCT04774237|Carbachol|carbachol|mesh-list
65665216|NCT04774237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65665217|NCT04774237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65665218|NCT04774237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65665219|NCT04774237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65665220|NCT04774237|Adrenergic Agents|adrenergic agents|mesh-ancestor
65665221|NCT04774237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65665222|NCT04774237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665223|NCT04774237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665224|NCT04774237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65665225|NCT04774237|Miotics|miotics|mesh-ancestor
65665226|NCT04774237|Autonomic Agents|autonomic agents|mesh-ancestor
65665227|NCT04774237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665228|NCT04774237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65665229|NCT04774237|Cholinergic Agents|cholinergic agents|mesh-ancestor
65665230|NCT04774237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65665231|NCT04774237|Analgesics|analgesics|mesh-ancestor
65665232|NCT04774237|Sensory System Agents|sensory system agents|mesh-ancestor
65665233|NCT04774237|Protective Agents|protective agents|mesh-ancestor
65665234|NCT02172456|Tiotropium Bromide|tiotropium bromide|mesh-list
65665235|NCT02172456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65665236|NCT02172456|Autonomic Agents|autonomic agents|mesh-ancestor
65665237|NCT02172456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665238|NCT02172456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665239|NCT02172456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65665240|NCT02172456|Respiratory System Agents|respiratory system agents|mesh-ancestor
65665241|NCT02172456|Parasympatholytics|parasympatholytics|mesh-ancestor
65665242|NCT02172456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65665243|NCT02172456|Cholinergic Agents|cholinergic agents|mesh-ancestor
65665244|NCT02172456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65665245|NCT02172456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665246|NCT02172534|Bromides|bromides|mesh-list
65665247|NCT02172534|Tiotropium Bromide|tiotropium bromide|mesh-list
65665248|NCT02172534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65665249|NCT02172534|Autonomic Agents|autonomic agents|mesh-ancestor
65665250|NCT02172534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665251|NCT02172534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665252|NCT02172534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65127918|NCT04576143|Paclitaxel|paclitaxel|mesh-list
65665253|NCT02172534|Respiratory System Agents|respiratory system agents|mesh-ancestor
65665254|NCT02172534|Parasympatholytics|parasympatholytics|mesh-ancestor
65665255|NCT02172534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65665256|NCT02172534|Cholinergic Agents|cholinergic agents|mesh-ancestor
65665257|NCT02172534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65665258|NCT02172534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665259|NCT02172534|Anticonvulsants|anticonvulsants|mesh-ancestor
65665260|NCT04713631|Artesunate|artesunate|mesh-list
65665261|NCT04713631|Curcumin|curcumin|mesh-list
65665262|NCT04713631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65665263|NCT04713631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65665264|NCT04713631|Analgesics|analgesics|mesh-ancestor
65665265|NCT04713631|Sensory System Agents|sensory system agents|mesh-ancestor
65665266|NCT04713631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665267|NCT04713631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665268|NCT04713631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65665269|NCT04713631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65665270|NCT04713631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665271|NCT04713631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665272|NCT04713631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665273|NCT04713631|Antimalarials|antimalarials|mesh-ancestor
65665274|NCT04713631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65665275|NCT04713631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65665276|NCT04713631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65665277|NCT04713631|Antiviral Agents|antiviral agents|mesh-ancestor
65665278|NCT04713631|Schistosomicides|schistosomicides|mesh-ancestor
65665279|NCT04713631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65665280|NCT04713631|Anthelmintics|anthelmintics|mesh-ancestor
65665281|NCT04459078|Apatinib|apatinib|mesh-list
65665282|NCT04459078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65665283|NCT04459078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665284|NCT04459078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65665285|NCT04459078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665286|NCT04459078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665287|NCT05728372|Copper|copper|mesh-list
65665288|NCT05728372|Pembrolizumab|pembrolizumab|mesh-list
65665289|NCT05728372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65665290|NCT05728372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665291|NCT05728372|Trace Elements|trace elements|mesh-ancestor
65665292|NCT05728372|Micronutrients|micronutrients|mesh-ancestor
65665293|NCT05728372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665294|NCT02756832|Alogliptin|alogliptin|mesh-list
65665295|NCT02756832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65665296|NCT02756832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665297|NCT02756832|Incretins|incretins|mesh-ancestor
65665298|NCT02756832|Hormones|hormones|mesh-ancestor
65665299|NCT02756832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65665300|NCT02756832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65665301|NCT02756832|Protease Inhibitors|protease inhibitors|mesh-ancestor
65665302|NCT02756832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665303|NCT02756832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665304|NCT00108810|Ketoprofen|ketoprofen|mesh-list
65665305|NCT00108810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65665306|NCT00108810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65665307|NCT00108810|Analgesics|analgesics|mesh-ancestor
65665308|NCT00108810|Sensory System Agents|sensory system agents|mesh-ancestor
65665309|NCT00108810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665310|NCT00108810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665311|NCT00108810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65665312|NCT00108810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65665313|NCT00108810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65665314|NCT00108810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665315|NCT00108810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665316|NCT04448392|Valacyclovir|valacyclovir|mesh-list
65665317|NCT04448392|Antiviral Agents|antiviral agents|mesh-ancestor
65665318|NCT04448392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65665319|NCT05588284|Rivaroxaban|rivaroxaban|mesh-list
65665320|NCT05588284|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65665321|NCT05588284|Antithrombins|antithrombins|mesh-ancestor
65665322|NCT05588284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65665323|NCT05588284|Protease Inhibitors|protease inhibitors|mesh-ancestor
65665324|NCT05588284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665325|NCT05588284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665326|NCT05588284|Anticoagulants|anticoagulants|mesh-ancestor
65665327|NCT02256150|Mizoribine|mizoribine|mesh-list
65665328|NCT02256150|Cyclophosphamide|cyclophosphamide|mesh-list
65665329|NCT02256150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65665330|NCT02256150|Immunologic Factors|immunologic factors|mesh-ancestor
65665331|NCT02256150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665332|NCT02256150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65665333|NCT02256150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65665334|NCT02256150|Alkylating Agents|alkylating agents|mesh-ancestor
65665335|NCT02256150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665336|NCT02256150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665337|NCT02256150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65665338|NCT02256150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65665339|NCT02256150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65665340|NCT02256150|Analgesics|analgesics|mesh-ancestor
65665341|NCT02256150|Sensory System Agents|sensory system agents|mesh-ancestor
65665342|NCT02256150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665343|NCT02256150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65665344|NCT02256150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65665345|NCT02256150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65665346|NCT02256150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65665347|NCT02256150|Antimalarials|antimalarials|mesh-ancestor
65665348|NCT02256150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65665349|NCT02256150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65665350|NCT02256150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665351|NCT02177370|Fenoterol|fenoterol|mesh-list
65665352|NCT02177370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65665353|NCT02177370|Autonomic Agents|autonomic agents|mesh-ancestor
65665354|NCT02177370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665355|NCT02177370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462669|NCT05050318|Vaccines|vaccines|mesh-list
65665356|NCT02177370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65665357|NCT02177370|Respiratory System Agents|respiratory system agents|mesh-ancestor
65665358|NCT02177370|Sympathomimetics|sympathomimetics|mesh-ancestor
65665359|NCT02177370|Tocolytic Agents|tocolytic agents|mesh-ancestor
65665360|NCT02177370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65665361|NCT02177370|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65665362|NCT02177370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65665363|NCT02177370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65665364|NCT02177370|Adrenergic Agents|adrenergic agents|mesh-ancestor
65665365|NCT02177370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65665366|NCT02177370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665367|NCT03538704|Metformin|metformin|mesh-list
65665368|NCT03538704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65665369|NCT03538704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665370|NCT02172768|Micafungin|micafungin|mesh-list
65665371|NCT02172768|Antifungal Agents|antifungal agents|mesh-ancestor
65665372|NCT02172768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65665373|NCT02172846|Paclitaxel|paclitaxel|mesh-list
65665374|NCT02172846|Carboplatin|carboplatin|mesh-list
65665375|NCT02172846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65665376|NCT02172846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665377|NCT02172846|Tubulin Modulators|tubulin modulators|mesh-ancestor
65665378|NCT02172846|Antimitotic Agents|antimitotic agents|mesh-ancestor
65665379|NCT02172846|Mitosis Modulators|mitosis modulators|mesh-ancestor
65665380|NCT02172846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665381|NCT05727904|Pembrolizumab|pembrolizumab|mesh-list
65665382|NCT05727904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65665383|NCT05727904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665384|NCT00106626|Pemetrexed|pemetrexed|mesh-list
65665385|NCT00106626|Vorinostat|vorinostat|mesh-list
65665386|NCT00106626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665387|NCT00106626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665388|NCT00106626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665389|NCT00106626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65665390|NCT00106626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65665391|NCT00106626|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65665392|NCT02177448|Enalapril|enalapril|mesh-list
65665393|NCT02177448|Enalaprilat|enalaprilat|mesh-list
65665394|NCT02177448|Telmisartan|telmisartan|mesh-list
65665395|NCT02177448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65665396|NCT02177448|Protease Inhibitors|protease inhibitors|mesh-ancestor
65665397|NCT02177448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665398|NCT02177448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665399|NCT02177448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65665400|NCT02177448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65665401|NCT02177448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65665402|NCT03537144|Acetaminophen|acetaminophen|mesh-list
65665403|NCT03537144|Indomethacin|indomethacin|mesh-list
65665404|NCT03537144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65665405|NCT03537144|Analgesics|analgesics|mesh-ancestor
65665406|NCT03537144|Sensory System Agents|sensory system agents|mesh-ancestor
65665407|NCT03537144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665408|NCT03537144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665409|NCT03537144|Antipyretics|antipyretics|mesh-ancestor
65665410|NCT03537144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65665411|NCT03537144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65665412|NCT03537144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65665413|NCT03537144|Gout Suppressants|gout suppressants|mesh-ancestor
65665414|NCT03537144|Tocolytic Agents|tocolytic agents|mesh-ancestor
65665415|NCT03537144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65665416|NCT03537144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65665417|NCT03537144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665418|NCT03537144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665419|NCT03065764|Pembrolizumab|pembrolizumab|mesh-list
65665420|NCT03065764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65665421|NCT03065764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665422|NCT02755818|Heparin|heparin|mesh-list
65665423|NCT02755818|Calcium heparin|calcium heparin|mesh-list
65665424|NCT02755818|Anticoagulants|anticoagulants|mesh-ancestor
65665425|NCT02755818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65665426|NCT02755818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65665427|NCT02755818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665428|NCT02177760|Sirolimus|sirolimus|mesh-list
65462743|NCT03756220|Vitamin B Complex|vitamin b complex|mesh-ancestor
65665429|NCT02177760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65665430|NCT02177760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65665431|NCT02177760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65665432|NCT02177760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665433|NCT02177760|Antifungal Agents|antifungal agents|mesh-ancestor
65665434|NCT02177760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65665435|NCT02177760|Immunologic Factors|immunologic factors|mesh-ancestor
65665436|NCT02177760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665437|NCT02173782|Fenoterol|fenoterol|mesh-list
65665438|NCT02173782|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
65665439|NCT02173782|Ipratropium|ipratropium|mesh-list
65665440|NCT02173782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65665441|NCT02173782|Autonomic Agents|autonomic agents|mesh-ancestor
65665442|NCT02173782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665443|NCT02173782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665444|NCT02173782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65665445|NCT02173782|Respiratory System Agents|respiratory system agents|mesh-ancestor
65665446|NCT02173782|Sympathomimetics|sympathomimetics|mesh-ancestor
65665447|NCT02173782|Tocolytic Agents|tocolytic agents|mesh-ancestor
65665448|NCT02173782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65665449|NCT02173782|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65665450|NCT02173782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65665451|NCT02173782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65665452|NCT02173782|Adrenergic Agents|adrenergic agents|mesh-ancestor
65665453|NCT02173782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65665454|NCT02173782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665455|NCT02173782|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65665456|NCT02173782|Cholinergic Agents|cholinergic agents|mesh-ancestor
65665457|NCT05571592|Cannabidiol|cannabidiol|mesh-list
65665458|NCT05571592|Anticonvulsants|anticonvulsants|mesh-ancestor
65665459|NCT05717374|Dexamethasone|dexamethasone|mesh-list
65665460|NCT05717374|Dexamethasone acetate|dexamethasone acetate|mesh-list
65665461|NCT05717374|Methylprednisolone|methylprednisolone|mesh-list
65665462|NCT05717374|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65665463|NCT05717374|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65665464|NCT05717374|Prednisolone|prednisolone|mesh-list
65665465|NCT05717374|Prednisolone acetate|prednisolone acetate|mesh-list
65665466|NCT05717374|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65665467|NCT05717374|Prednisolone phosphate|prednisolone phosphate|mesh-list
65665468|NCT05717374|BB 1101|bb 1101|mesh-list
65665469|NCT05717374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65665470|NCT05717374|Antiemetics|antiemetics|mesh-ancestor
65665471|NCT05717374|Autonomic Agents|autonomic agents|mesh-ancestor
65665472|NCT05717374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665473|NCT05717374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665474|NCT05717374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65665475|NCT05717374|Glucocorticoids|glucocorticoids|mesh-ancestor
65665476|NCT05717374|Hormones|hormones|mesh-ancestor
65665477|NCT05717374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65665478|NCT05717374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65665479|NCT05717374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665480|NCT05717374|Protease Inhibitors|protease inhibitors|mesh-ancestor
65665481|NCT05717374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665482|NCT05717374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665483|NCT05717374|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65665484|NCT05717374|Protective Agents|protective agents|mesh-ancestor
65665485|NCT03537768|Levonorgestrel|levonorgestrel|mesh-list
65665486|NCT03537768|Ulipristal acetate|ulipristal acetate|mesh-list
65665487|NCT03537768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65665488|NCT03537768|Contraceptive Agents|contraceptive agents|mesh-ancestor
65665489|NCT03537768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65665490|NCT03537768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665491|NCT03537768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65665492|NCT03537768|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65665493|NCT03537768|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65665494|NCT02174094|Clobazam|clobazam|mesh-list
65665495|NCT02174094|Anticonvulsants|anticonvulsants|mesh-ancestor
65665496|NCT02174094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65665497|NCT02174094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65665498|NCT02174094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65665499|NCT02174094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665500|NCT02174094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65665501|NCT02174094|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65665502|NCT02174094|GABA Agonists|gaba agonists|mesh-ancestor
65665503|NCT02174094|GABA Agents|gaba agents|mesh-ancestor
65665504|NCT02174094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65665505|NCT02174094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665506|NCT02174172|Interferons|interferons|mesh-list
65665507|NCT02174172|Interferon-alpha|interferon-alpha|mesh-list
65665508|NCT02174172|Interferon alpha-2|interferon alpha-2|mesh-list
65665509|NCT02174172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65665510|NCT02174172|Bevacizumab|bevacizumab|mesh-list
65665511|NCT02174172|Ipilimumab|ipilimumab|mesh-list
65665512|NCT02174172|Obinutuzumab|obinutuzumab|mesh-list
65665513|NCT02174172|Atezolizumab|atezolizumab|mesh-list
65665514|NCT02174172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65665515|NCT02174172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665516|NCT02174172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65665517|NCT02174172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65665518|NCT02174172|Growth Substances|growth substances|mesh-ancestor
65665519|NCT02174172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665520|NCT02174172|Growth Inhibitors|growth inhibitors|mesh-ancestor
65665521|NCT02174172|Antiviral Agents|antiviral agents|mesh-ancestor
65665522|NCT02174172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65665523|NCT02174172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65665524|NCT02174172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665525|NCT02174172|Immunologic Factors|immunologic factors|mesh-ancestor
65665526|NCT02180334|Acetaminophen|acetaminophen|mesh-list
65665527|NCT02180334|Linagliptin|linagliptin|mesh-list
65665528|NCT02180334|Mosapride|mosapride|mesh-list
65665529|NCT02180334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65665530|NCT02180334|Analgesics|analgesics|mesh-ancestor
65665531|NCT02180334|Sensory System Agents|sensory system agents|mesh-ancestor
65665532|NCT02180334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665533|NCT02180334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665534|NCT02180334|Antipyretics|antipyretics|mesh-ancestor
65665535|NCT02180334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665536|NCT02180334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65665537|NCT02180334|Incretins|incretins|mesh-ancestor
65665538|NCT02180334|Hormones|hormones|mesh-ancestor
65665539|NCT02180334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65665540|NCT02180334|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65665541|NCT02180334|Protease Inhibitors|protease inhibitors|mesh-ancestor
65665542|NCT02180334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665543|NCT02180334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65665544|NCT02180334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65665545|NCT02180334|Serotonin Agents|serotonin agents|mesh-ancestor
65665546|NCT02180334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65665547|NCT02174250|Rifampin|rifampin|mesh-list
65665548|NCT02174250|Istradefylline|istradefylline|mesh-list
65665549|NCT02174250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65665550|NCT02174250|Antitubercular Agents|antitubercular agents|mesh-ancestor
65665551|NCT02174250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65665552|NCT02174250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65665553|NCT02174250|Leprostatic Agents|leprostatic agents|mesh-ancestor
65665554|NCT02174250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65665555|NCT02174250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665556|NCT02174250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665557|NCT02174250|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65665558|NCT02174250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65665559|NCT02174250|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65665560|NCT02174250|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65665561|NCT02174250|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65665562|NCT02174250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65665563|NCT02174250|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
65665564|NCT02174250|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65665565|NCT02174250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65665566|NCT02174250|Purinergic Agents|purinergic agents|mesh-ancestor
65665567|NCT02174250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65665568|NCT02174250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665569|NCT02174328|Aspirin|aspirin|mesh-list
65665570|NCT02174328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65665571|NCT02174328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65665572|NCT02174328|Analgesics|analgesics|mesh-ancestor
65665573|NCT02174328|Sensory System Agents|sensory system agents|mesh-ancestor
65665574|NCT02174328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665575|NCT02174328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665576|NCT02174328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65665577|NCT02174328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65665578|NCT02174328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65665579|NCT02174328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65665580|NCT02174328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462906|NCT04907032|Mirabegron|mirabegron|mesh-list
65665581|NCT02174328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65665582|NCT02174328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65665583|NCT02174328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665584|NCT02174328|Antipyretics|antipyretics|mesh-ancestor
65665585|NCT02177994|Ceftriaxone|ceftriaxone|mesh-list
65665586|NCT02177994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65665587|NCT02177994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65665588|NCT02755116|Olanzapine|olanzapine|mesh-list
65665589|NCT02755116|Antiemetics|antiemetics|mesh-ancestor
65665590|NCT02755116|Autonomic Agents|autonomic agents|mesh-ancestor
65665591|NCT02755116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665592|NCT02755116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665593|NCT02755116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65665594|NCT02755116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65665595|NCT02755116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65665596|NCT02755116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65665597|NCT02755116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65665598|NCT02755116|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65665599|NCT02755116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65665600|NCT02755116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65665601|NCT02755116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665602|NCT02755116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65665603|NCT02755116|Serotonin Agents|serotonin agents|mesh-ancestor
65665604|NCT02178150|Magnesium Oxide|magnesium oxide|mesh-list
65665605|NCT02178150|Antacids|antacids|mesh-ancestor
65665606|NCT02178150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665607|NCT02178150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65665608|NCT04411030|Itraconazole|itraconazole|mesh-list
65665609|NCT04411030|Midazolam|midazolam|mesh-list
65665610|NCT04411030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65665611|NCT04411030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65665612|NCT04411030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65665613|NCT04411030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665614|NCT04411030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65665615|NCT04411030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65665616|NCT04411030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65665617|NCT04411030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65665618|NCT04411030|Anesthetics, General|anesthetics, general|mesh-ancestor
65665619|NCT04411030|Anesthetics|anesthetics|mesh-ancestor
65665620|NCT04411030|GABA Modulators|gaba modulators|mesh-ancestor
65665621|NCT04411030|GABA Agents|gaba agents|mesh-ancestor
65665622|NCT04411030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65665623|NCT04411030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665624|NCT04411030|Antifungal Agents|antifungal agents|mesh-ancestor
65665625|NCT04411030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65665626|NCT04411030|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65665627|NCT04411030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65665628|NCT04411030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665629|NCT04411030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65665630|NCT04411030|Hormone Antagonists|hormone antagonists|mesh-ancestor
65665631|NCT04411030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65665632|NCT04411030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65665633|NCT04437654|Apixaban|apixaban|mesh-list
65665634|NCT04437654|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65665635|NCT04437654|Antithrombins|antithrombins|mesh-ancestor
65665636|NCT04437654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65665637|NCT04437654|Protease Inhibitors|protease inhibitors|mesh-ancestor
65665638|NCT04437654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665639|NCT04437654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665640|NCT04437654|Anticoagulants|anticoagulants|mesh-ancestor
65665641|NCT02185638|Appetite Depressants|appetite depressants|mesh-list
65665642|NCT02185638|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65665643|NCT02185716|Levobupivacaine|levobupivacaine|mesh-list
65665644|NCT02185716|Anesthetics, Local|anesthetics, local|mesh-ancestor
65665645|NCT02185716|Anesthetics|anesthetics|mesh-ancestor
65665646|NCT02185716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65665647|NCT02185716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665648|NCT02185716|Sensory System Agents|sensory system agents|mesh-ancestor
65665649|NCT02185716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665650|NCT02182050|Nintedanib|nintedanib|mesh-list
65665651|NCT02182050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665652|NCT02182050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65665653|NCT02182050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665654|NCT02182050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665655|NCT02182128|Nintedanib|nintedanib|mesh-list
65665656|NCT02182128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665657|NCT02182128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65665658|NCT02182128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665659|NCT02182128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665660|NCT02182206|Nintedanib|nintedanib|mesh-list
65665661|NCT02182206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665662|NCT02182206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65665663|NCT02182206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665664|NCT02182206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665665|NCT02180568|Ethiodized Oil|ethiodized oil|mesh-list
65665666|NCT02180568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665667|NCT02657889|Pembrolizumab|pembrolizumab|mesh-list
65665668|NCT02657889|Niraparib|niraparib|mesh-list
65665669|NCT02657889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65665670|NCT02657889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665671|NCT02657889|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65665672|NCT02657889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665673|NCT02657889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665674|NCT03536208|Warfarin|warfarin|mesh-list
65665675|NCT03536208|Anticoagulants|anticoagulants|mesh-ancestor
65665676|NCT03034915|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65665677|NCT03034915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65665678|NCT03034915|Autonomic Agents|autonomic agents|mesh-ancestor
65665679|NCT03034915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665680|NCT03034915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665681|NCT03034915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65665682|NCT03034915|Respiratory System Agents|respiratory system agents|mesh-ancestor
65665683|NCT03034915|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65665684|NCT03034915|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65665685|NCT03034915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65665686|NCT03034915|Adrenergic Agents|adrenergic agents|mesh-ancestor
65665687|NCT03034915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65665688|NCT03034915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665689|NCT02631538|Rituximab|rituximab|mesh-list
65665690|NCT02631538|Belimumab|belimumab|mesh-list
65665691|NCT02631538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65665692|NCT02631538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665693|NCT02631538|Immunologic Factors|immunologic factors|mesh-ancestor
65665694|NCT02631538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665695|NCT02631538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65665696|NCT02631538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65665697|NCT03578679|Ivermectin|ivermectin|mesh-list
65665698|NCT03578679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65665699|NCT03578679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65665700|NCT04930783|Nivolumab|nivolumab|mesh-list
65665701|NCT04930783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65665702|NCT04930783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665703|NCT04930783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65665704|NCT04930783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665705|NCT05666206|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65665706|NCT05666206|Hemostatics|hemostatics|mesh-ancestor
65665707|NCT05666206|Coagulants|coagulants|mesh-ancestor
65665708|NCT05459701|Dapagliflozin|dapagliflozin|mesh-list
65665709|NCT05459701|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65665710|NCT05459701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665711|NCT05459701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65665712|NCT05459701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665713|NCT05459389|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65665714|NCT05459389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65665715|NCT05458375|Estradiol|estradiol|mesh-list
65665716|NCT05458375|Estrogens|estrogens|mesh-ancestor
65665717|NCT05458375|Hormones|hormones|mesh-ancestor
65665718|NCT05458375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65665719|NCT05458375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665720|NCT02256462|Adalimumab|adalimumab|mesh-list
65665721|NCT02256462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65665722|NCT02256462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65665723|NCT02631148|Melatonin|melatonin|mesh-list
65665724|NCT02631148|Antioxidants|antioxidants|mesh-ancestor
65665725|NCT02631148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665726|NCT02631148|Protective Agents|protective agents|mesh-ancestor
65665727|NCT02631148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665728|NCT02631148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65665729|NCT02239107|Acetylcysteine|acetylcysteine|mesh-list
65463041|NCT01082250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65665730|NCT02239107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65665731|NCT02239107|Antiviral Agents|antiviral agents|mesh-ancestor
65665732|NCT02239107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65665734|NCT02239107|Respiratory System Agents|respiratory system agents|mesh-ancestor
65665735|NCT02239107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65665736|NCT02239107|Antioxidants|antioxidants|mesh-ancestor
65665737|NCT02239107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665738|NCT02239107|Protective Agents|protective agents|mesh-ancestor
65665739|NCT02239107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665740|NCT02239107|Antidotes|antidotes|mesh-ancestor
65665741|NCT02182518|Pseudoephedrine|pseudoephedrine|mesh-list
65665742|NCT02182518|Ephedrine|ephedrine|mesh-list
65665743|NCT02182518|Epinastine|epinastine|mesh-list
65665744|NCT02182518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65665745|NCT02182518|Autonomic Agents|autonomic agents|mesh-ancestor
65665746|NCT02182518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665747|NCT02182518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665748|NCT02182518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65665749|NCT02182518|Respiratory System Agents|respiratory system agents|mesh-ancestor
65665750|NCT02182518|Nasal Decongestants|nasal decongestants|mesh-ancestor
65665751|NCT02182518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65665752|NCT02182518|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65665753|NCT02182518|Sympathomimetics|sympathomimetics|mesh-ancestor
65665754|NCT02182518|Adrenergic Agents|adrenergic agents|mesh-ancestor
65665755|NCT02182518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65665756|NCT02182518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665757|NCT02182518|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65665758|NCT02182518|Histamine Antagonists|histamine antagonists|mesh-ancestor
65665759|NCT02182518|Histamine Agents|histamine agents|mesh-ancestor
65665760|NCT03881488|Pembrolizumab|pembrolizumab|mesh-list
65665761|NCT03881488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65665762|NCT03881488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665763|NCT05486182|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
65665764|NCT05486182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665765|NCT03810742|Irinotecan|irinotecan|mesh-list
65665766|NCT03810742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65665767|NCT03810742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65665768|NCT03810742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665769|NCT03810742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665770|NCT03810742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665771|NCT03574857|Metolazone|metolazone|mesh-list
65665772|NCT03574857|Chlorothiazide|chlorothiazide|mesh-list
65665773|NCT03574857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65665774|NCT03574857|Diuretics|diuretics|mesh-ancestor
65665775|NCT03574857|Natriuretic Agents|natriuretic agents|mesh-ancestor
65665776|NCT03574857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665777|NCT03574857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65665778|NCT03574857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65665779|NCT03574857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665780|NCT04200313|Pancrelipase|pancrelipase|mesh-list
65665781|NCT04200313|Pancreatin|pancreatin|mesh-list
65665782|NCT04200313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65665783|NCT02238639|Fibrin fragment D|fibrin fragment d|mesh-list
65665784|NCT02238639|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65665785|NCT02238639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65665786|NCT02238639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665787|NCT02238639|Hemostatics|hemostatics|mesh-ancestor
65665788|NCT02238639|Coagulants|coagulants|mesh-ancestor
65665789|NCT02186028|Vitamin D|vitamin d|mesh-list
65665790|NCT02186028|Vitamins|vitamins|mesh-ancestor
65665791|NCT02186028|Micronutrients|micronutrients|mesh-ancestor
65665792|NCT02186028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665793|NCT02186028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65665794|NCT02182596|Gemtuzumab|gemtuzumab|mesh-list
65665795|NCT02182596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65665796|NCT02182596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665797|NCT03574701|Vitamin A|vitamin a|mesh-list
65665798|NCT03574701|Vitamins|vitamins|mesh-ancestor
65665799|NCT03574701|Micronutrients|micronutrients|mesh-ancestor
65665800|NCT03574701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665801|NCT02180880|Pregabalin|pregabalin|mesh-list
65665802|NCT02180880|Oxcarbazepine|oxcarbazepine|mesh-list
65665803|NCT02180880|Analgesics|analgesics|mesh-ancestor
65665804|NCT02180880|Sensory System Agents|sensory system agents|mesh-ancestor
65665805|NCT02180880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665806|NCT02180880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665807|NCT02180880|Anticonvulsants|anticonvulsants|mesh-ancestor
65665808|NCT02180880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65665809|NCT02180880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65665810|NCT02180880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665811|NCT02180880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65665812|NCT02180880|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65665813|NCT02180880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65665814|NCT02180880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65665815|NCT02180880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65665816|NCT02180880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65665817|NCT02180880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65665818|NCT02180880|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65665819|NCT02180880|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65665820|NCT02186106|Cholecalciferol|cholecalciferol|mesh-list
65665821|NCT02186106|Vitamin D|vitamin d|mesh-list
65665822|NCT02186106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65665823|NCT02186106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665824|NCT02186106|Vitamins|vitamins|mesh-ancestor
65665825|NCT02186106|Micronutrients|micronutrients|mesh-ancestor
65665826|NCT02186106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65665827|NCT03943147|Mycophenolic Acid|mycophenolic acid|mesh-list
65665828|NCT03943147|BMS-986165|bms-986165|mesh-list
65665829|NCT03943147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65665830|NCT03943147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665831|NCT03943147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65665832|NCT03943147|Antitubercular Agents|antitubercular agents|mesh-ancestor
65665833|NCT03943147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65665834|NCT03943147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65665835|NCT03943147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665836|NCT03943147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665837|NCT03943147|Dermatologic Agents|dermatologic agents|mesh-ancestor
65665838|NCT03943147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65665839|NCT02182752|Tramadol|tramadol|mesh-list
65665840|NCT02182752|Ropivacaine|ropivacaine|mesh-list
65128469|NCT00571727|Mecasermin|mecasermin|mesh-list
65665841|NCT02182752|Anesthetics, Local|anesthetics, local|mesh-ancestor
65665842|NCT02182752|Anesthetics|anesthetics|mesh-ancestor
65665843|NCT02182752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65665844|NCT02182752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665845|NCT02182752|Sensory System Agents|sensory system agents|mesh-ancestor
65665846|NCT02182752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665847|NCT02182752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65665848|NCT02182752|Narcotics|narcotics|mesh-ancestor
65665849|NCT02182752|Analgesics|analgesics|mesh-ancestor
65665850|NCT03536598|Amlodipine|amlodipine|mesh-list
65665851|NCT03536598|Valsartan|valsartan|mesh-list
65665852|NCT03536598|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65665853|NCT03536598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65665854|NCT03536598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65665855|NCT03536598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65665856|NCT03536598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665857|NCT03536598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65665858|NCT03536598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665859|NCT03536598|Vasodilator Agents|vasodilator agents|mesh-ancestor
65665860|NCT03536598|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65665861|NCT03536598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65665862|NCT03536598|Antimetabolites|antimetabolites|mesh-ancestor
65665863|NCT03536598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65665864|NCT03536598|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65665865|NCT03536598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665866|NCT03536598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65665867|NCT03536598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65665868|NCT03576963|Nivolumab|nivolumab|mesh-list
65665869|NCT03576963|Guadecitabine|guadecitabine|mesh-list
65665870|NCT03576963|Azacitidine|azacitidine|mesh-list
65665871|NCT03576963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65665872|NCT03576963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665873|NCT03576963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65665874|NCT03576963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665875|NCT03576963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65665876|NCT03576963|Antimetabolites|antimetabolites|mesh-ancestor
65665877|NCT03576963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665878|NCT02186496|Amlodipine|amlodipine|mesh-list
65665879|NCT02186496|Candesartan|candesartan|mesh-list
65665880|NCT02186496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65665881|NCT02186496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65665882|NCT02186496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65665883|NCT02186496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665884|NCT02186496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65665885|NCT02186496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665886|NCT02186496|Vasodilator Agents|vasodilator agents|mesh-ancestor
65665887|NCT02186496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65665888|NCT02186496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65665889|NCT05615194|Dexmedetomidine|dexmedetomidine|mesh-list
65665890|NCT05615194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65665891|NCT05615194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65665892|NCT05615194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665893|NCT05615194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65665894|NCT05615194|Analgesics|analgesics|mesh-ancestor
65665895|NCT05615194|Sensory System Agents|sensory system agents|mesh-ancestor
65665896|NCT05615194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665897|NCT05615194|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65665898|NCT05615194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65665899|NCT05615194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65665900|NCT05615194|Adrenergic Agents|adrenergic agents|mesh-ancestor
65665901|NCT05615194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65665902|NCT05615194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665903|NCT02186574|Tenofovir|tenofovir|mesh-list
65665904|NCT02186574|Antiviral Agents|antiviral agents|mesh-ancestor
65665905|NCT02186574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65665906|NCT02186574|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65665907|NCT02186574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65665908|NCT02186574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665909|NCT02186574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665910|NCT02186574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65665911|NCT02186574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65665912|NCT03066700|Hemostatics|hemostatics|mesh-list
65665913|NCT03066700|Coagulants|coagulants|mesh-ancestor
65665914|NCT03066544|Dexamethasone|dexamethasone|mesh-list
65665915|NCT03066544|Ketorolac|ketorolac|mesh-list
65665916|NCT03066544|Naratriptan|naratriptan|mesh-list
65665917|NCT03066544|Bupivacaine|bupivacaine|mesh-list
65665918|NCT03066544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65665919|NCT03066544|Antiemetics|antiemetics|mesh-ancestor
65665920|NCT03066544|Autonomic Agents|autonomic agents|mesh-ancestor
65665921|NCT03066544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665922|NCT03066544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665923|NCT03066544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65665924|NCT03066544|Glucocorticoids|glucocorticoids|mesh-ancestor
65665925|NCT03066544|Hormones|hormones|mesh-ancestor
65665926|NCT03066544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65665927|NCT03066544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65665928|NCT03066544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665929|NCT03066544|Anesthetics, Local|anesthetics, local|mesh-ancestor
65665930|NCT03066544|Anesthetics|anesthetics|mesh-ancestor
65665931|NCT03066544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65665932|NCT03066544|Sensory System Agents|sensory system agents|mesh-ancestor
65665933|NCT03066544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65665934|NCT03066544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65665935|NCT03066544|Analgesics|analgesics|mesh-ancestor
65665936|NCT03066544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65665937|NCT03066544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65665938|NCT03066544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65665939|NCT03066544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665940|NCT03066544|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65665941|NCT03066544|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65665942|NCT03066544|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65665943|NCT03066544|Serotonin Agents|serotonin agents|mesh-ancestor
65665944|NCT03066544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65665945|NCT05425420|Methadone|methadone|mesh-list
65665946|NCT05425420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65665947|NCT05425420|Narcotics|narcotics|mesh-ancestor
65665948|NCT05425420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65665949|NCT05425420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665950|NCT05425420|Analgesics|analgesics|mesh-ancestor
65665951|NCT05425420|Sensory System Agents|sensory system agents|mesh-ancestor
65665952|NCT05425420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665953|NCT05425420|Antitussive Agents|antitussive agents|mesh-ancestor
65665954|NCT05425420|Respiratory System Agents|respiratory system agents|mesh-ancestor
65665955|NCT03182179|Ondansetron|ondansetron|mesh-list
65665957|NCT03182179|Autonomic Agents|autonomic agents|mesh-ancestor
65665958|NCT03182179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665959|NCT03182179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665960|NCT03182179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65665961|NCT03182179|Antipruritics|antipruritics|mesh-ancestor
65665962|NCT03182179|Dermatologic Agents|dermatologic agents|mesh-ancestor
65665963|NCT03182179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65665964|NCT03182179|Serotonin Agents|serotonin agents|mesh-ancestor
65665965|NCT03182179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65665966|NCT03182179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665967|NCT03182179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65665968|NCT03182179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65665969|NCT03182179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65665970|NCT03182179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65665971|NCT03182179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65665972|NCT03576651|Bevacizumab|bevacizumab|mesh-list
65665973|NCT03576651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65665974|NCT03576651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65665975|NCT03576651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65665976|NCT03576651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65665977|NCT03576651|Growth Substances|growth substances|mesh-ancestor
65665978|NCT03576651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665979|NCT03576651|Growth Inhibitors|growth inhibitors|mesh-ancestor
65665980|NCT04116112|Hydralazine|hydralazine|mesh-list
65665981|NCT04116112|Labetalol|labetalol|mesh-list
65665982|NCT04116112|Nicardipine|nicardipine|mesh-list
65665983|NCT04116112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65665984|NCT04116112|Vasodilator Agents|vasodilator agents|mesh-ancestor
65665985|NCT04116112|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65665986|NCT04116112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65665987|NCT04116112|Adrenergic Agents|adrenergic agents|mesh-ancestor
65665988|NCT04116112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65665989|NCT04116112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65665990|NCT04116112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65665991|NCT04116112|Sympathomimetics|sympathomimetics|mesh-ancestor
65665992|NCT04116112|Autonomic Agents|autonomic agents|mesh-ancestor
65665993|NCT04116112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65665994|NCT04116112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65665995|NCT04116112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65665996|NCT04116112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65665997|NCT04116112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65665998|NCT04116112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65665999|NCT03064906|Pancrelipase|pancrelipase|mesh-list
65666000|NCT03064906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65666001|NCT03034135|Copper|copper|mesh-list
65666002|NCT03034135|Temozolomide|temozolomide|mesh-list
65666003|NCT03034135|Disulfiram|disulfiram|mesh-list
65666004|NCT03034135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65666005|NCT03034135|Alkylating Agents|alkylating agents|mesh-ancestor
65666006|NCT03034135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666007|NCT03034135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666008|NCT03034135|Trace Elements|trace elements|mesh-ancestor
65666009|NCT03034135|Micronutrients|micronutrients|mesh-ancestor
65666010|NCT03034135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666011|NCT03034135|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65666012|NCT03034135|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65666013|NCT03034135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666014|NCT02239731|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65666015|NCT02239731|Doxycycline|doxycycline|mesh-list
65666016|NCT02239731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65666017|NCT02239731|Antimalarials|antimalarials|mesh-ancestor
65666018|NCT02239731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65666019|NCT02239731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65666020|NCT03571815|Listerine|listerine|mesh-list
65666021|NCT03571815|Fluorides|fluorides|mesh-list
65666022|NCT03571815|Sodium Fluoride|sodium fluoride|mesh-list
65666023|NCT03571815|Fluorides, Topical|fluorides, topical|mesh-list
65666024|NCT03571815|Cariostatic Agents|cariostatic agents|mesh-ancestor
65666025|NCT03571815|Protective Agents|protective agents|mesh-ancestor
65666026|NCT03571815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666027|NCT03571815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65666028|NCT03571815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65666029|NCT03571737|Ibuprofen|ibuprofen|mesh-list
65666030|NCT03571737|Lidocaine|lidocaine|mesh-list
65666031|NCT03571737|Anesthetics, Local|anesthetics, local|mesh-ancestor
65666032|NCT03571737|Anesthetics|anesthetics|mesh-ancestor
65666033|NCT03571737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65666034|NCT03571737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666035|NCT03571737|Sensory System Agents|sensory system agents|mesh-ancestor
65666036|NCT03571737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666037|NCT03571737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65666038|NCT03571737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65666039|NCT03571737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65666040|NCT03571737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65666041|NCT03571737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666042|NCT03571737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65666043|NCT03571737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65666045|NCT03571737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65666046|NCT03571737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65666047|NCT03571737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65666048|NCT03571737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666049|NCT03573999|Mannitol|mannitol|mesh-list
65666050|NCT03573999|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65666051|NCT03573999|Diuretics|diuretics|mesh-ancestor
65666052|NCT03573999|Natriuretic Agents|natriuretic agents|mesh-ancestor
65666053|NCT03573999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666054|NCT04606069|Regadenoson|regadenoson|mesh-list
65666055|NCT04606069|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65666056|NCT04606069|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65666057|NCT04606069|Purinergic Agonists|purinergic agonists|mesh-ancestor
65666058|NCT04606069|Purinergic Agents|purinergic agents|mesh-ancestor
65666059|NCT04606069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65666060|NCT04606069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666061|NCT04606069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666062|NCT03063190|Vitamin D|vitamin d|mesh-list
65666063|NCT03063190|Vitamins|vitamins|mesh-ancestor
65666064|NCT03063190|Micronutrients|micronutrients|mesh-ancestor
65666065|NCT03063190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666066|NCT03063190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65666067|NCT03576105|Photosensitizing Agents|photosensitizing agents|mesh-list
65666068|NCT03576105|Methylene Blue|methylene blue|mesh-list
65666069|NCT03576105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666070|NCT03576105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666071|NCT03576105|Dermatologic Agents|dermatologic agents|mesh-ancestor
65666072|NCT03573687|Caseins|caseins|mesh-list
65666073|NCT03573687|Chelating Agents|chelating agents|mesh-ancestor
65666074|NCT03573687|Sequestering Agents|sequestering agents|mesh-ancestor
65666075|NCT03573687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666076|NCT01671280|Azithromycin|azithromycin|mesh-list
65666077|NCT01671280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65666078|NCT01671280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65666079|NCT04904302|Nivolumab|nivolumab|mesh-list
65666080|NCT04904302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65666081|NCT04904302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666082|NCT04904302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65666083|NCT04904302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666084|NCT04862260|Atorvastatin|atorvastatin|mesh-list
65666085|NCT04862260|Ezetimibe|ezetimibe|mesh-list
65666086|NCT04862260|Evolocumab|evolocumab|mesh-list
65666087|NCT04862260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65666088|NCT04862260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65666089|NCT04862260|Antimetabolites|antimetabolites|mesh-ancestor
65666090|NCT04862260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666091|NCT04862260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65666092|NCT04862260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65666093|NCT04862260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666094|NCT03575637|Olanzapine|olanzapine|mesh-list
65666095|NCT03575637|Antiemetics|antiemetics|mesh-ancestor
65666096|NCT03575637|Autonomic Agents|autonomic agents|mesh-ancestor
65666097|NCT03575637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666098|NCT03575637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666099|NCT03575637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65666100|NCT03575637|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65666101|NCT03575637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65666102|NCT03575637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65666103|NCT03575637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65666104|NCT03575637|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65666105|NCT03575637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65463416|NCT03822884|Epoetin Alfa|epoetin alfa|mesh-list
65666106|NCT03575637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65666107|NCT03575637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666108|NCT03575637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65666109|NCT03575637|Serotonin Agents|serotonin agents|mesh-ancestor
65666110|NCT04851613|Fulvestrant|fulvestrant|mesh-list
65666111|NCT04851613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65666112|NCT04851613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666113|NCT04851613|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65666114|NCT04851613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65666115|NCT04851613|Hormone Antagonists|hormone antagonists|mesh-ancestor
65666116|NCT04851613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65666117|NCT04851613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666118|NCT03062800|Thalidomide|thalidomide|mesh-list
65666119|NCT03062800|Carboplatin|carboplatin|mesh-list
65666120|NCT03062800|Pemetrexed|pemetrexed|mesh-list
65666121|NCT03062800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666122|NCT03062800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666123|NCT03062800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666124|NCT03062800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65666125|NCT03062800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65666126|NCT03062800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65666127|NCT03062800|Immunologic Factors|immunologic factors|mesh-ancestor
65666128|NCT03062800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666129|NCT03062800|Leprostatic Agents|leprostatic agents|mesh-ancestor
65666130|NCT03062800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65666131|NCT03062800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65666132|NCT03062800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65666133|NCT03062800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65666134|NCT03062800|Growth Substances|growth substances|mesh-ancestor
65666135|NCT03062800|Growth Inhibitors|growth inhibitors|mesh-ancestor
65666136|NCT05709015|Chlorhexidine|chlorhexidine|mesh-list
65666137|NCT05709015|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65666138|NCT05709015|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65666139|NCT05709015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65666140|NCT05709015|Disinfectants|disinfectants|mesh-ancestor
65666141|NCT05709015|Dermatologic Agents|dermatologic agents|mesh-ancestor
65666142|NCT03418779|Prednisolone|prednisolone|mesh-list
65666143|NCT03418779|Cyclophosphamide|cyclophosphamide|mesh-list
65666144|NCT03418779|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65666145|NCT03418779|Immunologic Factors|immunologic factors|mesh-ancestor
65666146|NCT03418779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666147|NCT03418779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65666148|NCT03418779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65666149|NCT03418779|Alkylating Agents|alkylating agents|mesh-ancestor
65666150|NCT03418779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666151|NCT03418779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666152|NCT03418779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65666153|NCT03418779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65666154|NCT03418779|Glucocorticoids|glucocorticoids|mesh-ancestor
65666155|NCT03418779|Hormones|hormones|mesh-ancestor
65666156|NCT03418779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65666157|NCT03418779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65666158|NCT03573063|Androgens|androgens|mesh-list
65666159|NCT03573063|Hormones|hormones|mesh-ancestor
65666160|NCT03573063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65666161|NCT03573063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666162|NCT03572829|Dexamethasone|dexamethasone|mesh-list
65666163|NCT03572829|Ondansetron|ondansetron|mesh-list
65666164|NCT03572829|Aprepitant|aprepitant|mesh-list
65666165|NCT03572829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65666166|NCT03572829|Antiemetics|antiemetics|mesh-ancestor
65666167|NCT03572829|Autonomic Agents|autonomic agents|mesh-ancestor
65666168|NCT03572829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666169|NCT03572829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666170|NCT03572829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65666171|NCT03572829|Glucocorticoids|glucocorticoids|mesh-ancestor
65666172|NCT03572829|Hormones|hormones|mesh-ancestor
65666173|NCT03572829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65666174|NCT03572829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65666175|NCT03572829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666176|NCT03572829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666177|NCT03572829|Antipruritics|antipruritics|mesh-ancestor
65666178|NCT03572829|Dermatologic Agents|dermatologic agents|mesh-ancestor
65666179|NCT03572829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65666180|NCT03572829|Serotonin Agents|serotonin agents|mesh-ancestor
65666181|NCT03572829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65666182|NCT03572829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65666183|NCT03572829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65666184|NCT03572829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65666185|NCT03572829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65666186|NCT03572829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65666187|NCT03572829|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65666188|NCT03575247|Glucocorticoids|glucocorticoids|mesh-list
65666189|NCT03575247|Hormones|hormones|mesh-ancestor
65666190|NCT03575247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65666191|NCT03575247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666192|NCT03704623|Acetaminophen|acetaminophen|mesh-list
65666193|NCT03704623|Parecoxib|parecoxib|mesh-list
65666194|NCT03704623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65666195|NCT03704623|Analgesics|analgesics|mesh-ancestor
65666196|NCT03704623|Sensory System Agents|sensory system agents|mesh-ancestor
65666197|NCT03704623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666198|NCT03704623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666199|NCT03704623|Antipyretics|antipyretics|mesh-ancestor
65666200|NCT03704623|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65666201|NCT03704623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65666202|NCT03704623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666203|NCT03704623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666204|NCT03704623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65666205|NCT03704623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65666206|NCT03704623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65666207|NCT03572595|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65666208|NCT03572595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65666209|NCT03572595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666210|NCT03572517|Morphine|morphine|mesh-list
65666211|NCT03572517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65666212|NCT03572517|Narcotics|narcotics|mesh-ancestor
65666213|NCT03572517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65666214|NCT03572517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666215|NCT03572517|Analgesics|analgesics|mesh-ancestor
65666216|NCT03572517|Sensory System Agents|sensory system agents|mesh-ancestor
65666217|NCT03572517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666218|NCT04774393|Decitabine|decitabine|mesh-list
65666219|NCT04774393|Venetoclax|venetoclax|mesh-list
65666220|NCT04774393|Ivosidenib|ivosidenib|mesh-list
65666221|NCT04774393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65666222|NCT04774393|Antimetabolites|antimetabolites|mesh-ancestor
65666223|NCT04774393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666224|NCT04774393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666225|NCT04774393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666226|NCT03570645|Dexamethasone|dexamethasone|mesh-list
65666227|NCT03570645|Dexmedetomidine|dexmedetomidine|mesh-list
65666228|NCT03570645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65666229|NCT03570645|Antiemetics|antiemetics|mesh-ancestor
65666230|NCT03570645|Autonomic Agents|autonomic agents|mesh-ancestor
65666231|NCT03570645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666232|NCT03570645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666233|NCT03570645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65666234|NCT03570645|Glucocorticoids|glucocorticoids|mesh-ancestor
65666235|NCT03570645|Hormones|hormones|mesh-ancestor
65666236|NCT03570645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65666237|NCT03570645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65666238|NCT03570645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666239|NCT03570645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65666240|NCT03570645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65666241|NCT03570645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65666242|NCT03570645|Analgesics|analgesics|mesh-ancestor
65666243|NCT03570645|Sensory System Agents|sensory system agents|mesh-ancestor
65666244|NCT03570645|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65666245|NCT03570645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65666246|NCT03570645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65666247|NCT03570645|Adrenergic Agents|adrenergic agents|mesh-ancestor
65666248|NCT03570645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65666249|NCT03570645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666250|NCT03940690|Bevacizumab|bevacizumab|mesh-list
65666251|NCT03940690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65666252|NCT03940690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666253|NCT03940690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65666254|NCT03940690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65666256|NCT03940690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666257|NCT03940690|Growth Inhibitors|growth inhibitors|mesh-ancestor
65666258|NCT03567135|Temozolomide|temozolomide|mesh-list
65666259|NCT03567135|Apatinib|apatinib|mesh-list
65666260|NCT03567135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65666261|NCT03567135|Alkylating Agents|alkylating agents|mesh-ancestor
65666262|NCT03567135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666263|NCT03567135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666264|NCT03567135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65666265|NCT03567135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666266|NCT03701581|4-Aminopyridine|4-aminopyridine|mesh-list
65666267|NCT03701581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65666268|NCT03701581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65666269|NCT03701581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666270|NCT03698383|Trastuzumab|trastuzumab|mesh-list
65666271|NCT03698383|Gedatolisib|gedatolisib|mesh-list
65666272|NCT03698383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65666273|NCT03698383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666274|NCT03698383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65666275|NCT03698383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666276|NCT03698383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666277|NCT04760782|Abaloparatide|abaloparatide|mesh-list
65666278|NCT04760782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65666279|NCT04760782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666280|NCT05708859|Tirzepatide|tirzepatide|mesh-list
65666281|NCT05708859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65666282|NCT05708859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666283|NCT05708859|Incretins|incretins|mesh-ancestor
65666284|NCT05708859|Hormones|hormones|mesh-ancestor
65128908|NCT00575354|Anesthetics|anesthetics|mesh-ancestor
65666285|NCT05708859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65666286|NCT04740580|Acetylcysteine|acetylcysteine|mesh-list
65666287|NCT04740580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65666288|NCT04740580|Glycine|glycine|mesh-list
65666289|NCT04740580|Antiviral Agents|antiviral agents|mesh-ancestor
65666290|NCT04740580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65666291|NCT04740580|Expectorants|expectorants|mesh-ancestor
65666292|NCT04740580|Respiratory System Agents|respiratory system agents|mesh-ancestor
65666293|NCT04740580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65666294|NCT04740580|Antioxidants|antioxidants|mesh-ancestor
65666295|NCT04740580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666296|NCT04740580|Protective Agents|protective agents|mesh-ancestor
65666297|NCT04740580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666298|NCT04740580|Antidotes|antidotes|mesh-ancestor
65666299|NCT04740580|Glycine Agents|glycine agents|mesh-ancestor
65666300|NCT04740580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65666301|NCT03064282|Papaverine|papaverine|mesh-list
65666302|NCT03064282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65666303|NCT03064282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666304|NCT03064282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666305|NCT03064282|Vasodilator Agents|vasodilator agents|mesh-ancestor
65666306|NCT03064282|Urological Agents|urological agents|mesh-ancestor
65666307|NCT04679818|Fentanyl|fentanyl|mesh-list
65666308|NCT04679818|Analgesics, Opioid|analgesics, opioid|mesh-list
65666309|NCT04679818|Narcotics|narcotics|mesh-ancestor
65666310|NCT04679818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65666311|NCT04679818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666312|NCT04679818|Analgesics|analgesics|mesh-ancestor
65666313|NCT04679818|Sensory System Agents|sensory system agents|mesh-ancestor
65666314|NCT04679818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666315|NCT04679818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65666316|NCT04679818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65666317|NCT04679818|Anesthetics, General|anesthetics, general|mesh-ancestor
65666318|NCT04679818|Anesthetics|anesthetics|mesh-ancestor
65666319|NCT03027609|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65666320|NCT03027609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65666321|NCT03063112|Ethanol|ethanol|mesh-list
65666322|NCT03063112|Lidocaine|lidocaine|mesh-list
65666323|NCT03063112|Anesthetics, Local|anesthetics, local|mesh-ancestor
65666324|NCT03063112|Anesthetics|anesthetics|mesh-ancestor
65666325|NCT03063112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65666326|NCT03063112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666327|NCT03063112|Sensory System Agents|sensory system agents|mesh-ancestor
65463643|NCT04332874|Pembrolizumab|pembrolizumab|mesh-list
65666328|NCT03063112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666329|NCT03063112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65666330|NCT03063112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65666331|NCT03063112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65666332|NCT03063112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65666333|NCT03063112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666334|NCT03063112|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65666335|NCT03063112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65666336|NCT04767217|Lumefantrine|lumefantrine|mesh-list
65666338|NCT04767217|Piperaquine|piperaquine|mesh-list
65666339|NCT04767217|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65666340|NCT04767217|Artenimol|artenimol|mesh-list
65666341|NCT04767217|Antimalarials|antimalarials|mesh-ancestor
65666342|NCT04767217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65666343|NCT04767217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65666344|NCT04767217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65666345|NCT03701503|Hormones|hormones|mesh-list
65666346|NCT03701503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65666347|NCT03701503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666348|NCT03704155|Botulinum Toxins|botulinum toxins|mesh-list
65666349|NCT03704155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65666350|NCT03704155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65666351|NCT03704155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65666352|NCT03704155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65666353|NCT03704155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666354|NCT03704155|Cholinergic Agents|cholinergic agents|mesh-ancestor
65666355|NCT03704155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65666356|NCT03704155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666357|NCT03704155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65666358|NCT03704155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666359|NCT03698227|Doxorubicin|doxorubicin|mesh-list
65666360|NCT03698227|Dexrazoxane|dexrazoxane|mesh-list
65666361|NCT03698227|Razoxane|razoxane|mesh-list
65666362|NCT03698227|Olaratumab|olaratumab|mesh-list
65666363|NCT03698227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65666364|NCT03698227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666365|NCT03698227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65666366|NCT03698227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65666367|NCT03698227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666368|NCT03698227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666369|NCT03698227|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65666370|NCT03698227|Protective Agents|protective agents|mesh-ancestor
65666371|NCT03698227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666372|NCT03698227|Antimitotic Agents|antimitotic agents|mesh-ancestor
65666373|NCT03698227|Mitosis Modulators|mitosis modulators|mesh-ancestor
65666374|NCT01342965|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65666375|NCT01342965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666376|NCT01342965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65666377|NCT01342965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666378|NCT01342965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666379|NCT04434664|Metoprolol|metoprolol|mesh-list
65666380|NCT04434664|Amlodipine|amlodipine|mesh-list
65666381|NCT04434664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65666382|NCT04434664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65666383|NCT04434664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65666384|NCT04434664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666385|NCT04434664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65666386|NCT04434664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666387|NCT04434664|Vasodilator Agents|vasodilator agents|mesh-ancestor
65666388|NCT04434664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65666389|NCT04434664|Sympatholytics|sympatholytics|mesh-ancestor
65666390|NCT04434664|Autonomic Agents|autonomic agents|mesh-ancestor
65666391|NCT04434664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666392|NCT04434664|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65666393|NCT04434664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65666394|NCT04434664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65666395|NCT04434664|Adrenergic Agents|adrenergic agents|mesh-ancestor
65666396|NCT04434664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65666397|NCT02181348|Vitamin E|vitamin e|mesh-list
65666398|NCT02181348|Vitamins|vitamins|mesh-ancestor
65666399|NCT02181348|Micronutrients|micronutrients|mesh-ancestor
65666400|NCT02181348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666401|NCT02181348|Antioxidants|antioxidants|mesh-ancestor
65666402|NCT02181348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463718|NCT03251326|Vasodilator Agents|vasodilator agents|mesh-ancestor
65666403|NCT02181348|Protective Agents|protective agents|mesh-ancestor
65666404|NCT02186886|Golimumab|golimumab|mesh-list
65666405|NCT02186886|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65666406|NCT02186886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65666407|NCT02186886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65666408|NCT02186886|Immunologic Factors|immunologic factors|mesh-ancestor
65666409|NCT02186886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666410|NCT03722680|Riluzole|riluzole|mesh-list
65666411|NCT03722680|Anticonvulsants|anticonvulsants|mesh-ancestor
65666412|NCT03722680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65666413|NCT03722680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65666414|NCT03722680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65666415|NCT03722680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666416|NCT03722680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666417|NCT03722680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65666418|NCT03722680|Protective Agents|protective agents|mesh-ancestor
65666419|NCT02182986|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65666420|NCT02182986|Immunologic Factors|immunologic factors|mesh-ancestor
65666421|NCT02182986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666422|NCT03536910|Arginine Vasopressin|arginine vasopressin|mesh-list
65666423|NCT03536910|Hemostatics|hemostatics|mesh-ancestor
65666424|NCT03536910|Coagulants|coagulants|mesh-ancestor
65666425|NCT03536910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65666426|NCT03536910|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65666427|NCT03536910|Natriuretic Agents|natriuretic agents|mesh-ancestor
65666428|NCT03536910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666429|NCT04308174|Durvalumab|durvalumab|mesh-list
65666430|NCT04308174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65666431|NCT04308174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666432|NCT03697681|Tranexamic Acid|tranexamic acid|mesh-list
65666433|NCT03697681|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65666434|NCT03697681|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65666435|NCT03697681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666436|NCT03697681|Hemostatics|hemostatics|mesh-ancestor
65666437|NCT03697681|Coagulants|coagulants|mesh-ancestor
65666438|NCT02187276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
65666439|NCT02187276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666440|NCT02187276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666441|NCT02187276|Cholinergic Agents|cholinergic agents|mesh-ancestor
65666442|NCT02187276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65666443|NCT02187276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666444|NCT02683239|Fasinumab|fasinumab|mesh-list
65666445|NCT02683239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65666446|NCT02683239|Analgesics|analgesics|mesh-ancestor
65666447|NCT02683239|Sensory System Agents|sensory system agents|mesh-ancestor
65666448|NCT02683239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666449|NCT02683239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666450|NCT02183064|Meloxicam|meloxicam|mesh-list
65666451|NCT02183064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65666452|NCT02183064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65666453|NCT02183064|Analgesics|analgesics|mesh-ancestor
65666454|NCT02183064|Sensory System Agents|sensory system agents|mesh-ancestor
65666455|NCT02183064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666456|NCT02183064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666457|NCT02183064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65666458|NCT02183064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65666459|NCT02183064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65666460|NCT02183064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65666461|NCT02183064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666462|NCT02183064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666463|NCT03704077|Paclitaxel|paclitaxel|mesh-list
65666464|NCT03704077|Nivolumab|nivolumab|mesh-list
65666465|NCT03704077|Ramucirumab|ramucirumab|mesh-list
65666466|NCT03704077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65666467|NCT03704077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666468|NCT03704077|Tubulin Modulators|tubulin modulators|mesh-ancestor
65666469|NCT03704077|Antimitotic Agents|antimitotic agents|mesh-ancestor
65666470|NCT03704077|Mitosis Modulators|mitosis modulators|mesh-ancestor
65666471|NCT03704077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666472|NCT03704077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65666473|NCT03704077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65666474|NCT03618550|Gemcitabine|gemcitabine|mesh-list
65666475|NCT03618550|Doxorubicin|doxorubicin|mesh-list
65666476|NCT03618550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65463793|NCT03691948|Analgesics|analgesics|mesh-ancestor
65666477|NCT03618550|Pembrolizumab|pembrolizumab|mesh-list
65666478|NCT03618550|Vinorelbine|vinorelbine|mesh-list
65666479|NCT03618550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65666480|NCT03618550|Antimetabolites|antimetabolites|mesh-ancestor
65666481|NCT03618550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666482|NCT03618550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666483|NCT03618550|Antiviral Agents|antiviral agents|mesh-ancestor
65666484|NCT03618550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65666485|NCT03618550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666486|NCT03618550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65666487|NCT03618550|Immunologic Factors|immunologic factors|mesh-ancestor
65666488|NCT03618550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666489|NCT03618550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65666490|NCT03618550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65666491|NCT03618550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65666492|NCT03618550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65666493|NCT03618550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65666494|NCT03618550|Tubulin Modulators|tubulin modulators|mesh-ancestor
65666495|NCT03618550|Antimitotic Agents|antimitotic agents|mesh-ancestor
65666496|NCT03618550|Mitosis Modulators|mitosis modulators|mesh-ancestor
65666497|NCT02183142|Meloxicam|meloxicam|mesh-list
65666498|NCT02183142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65666499|NCT02183142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65666500|NCT02183142|Analgesics|analgesics|mesh-ancestor
65666501|NCT02183142|Sensory System Agents|sensory system agents|mesh-ancestor
65666502|NCT02183142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666503|NCT02183142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129130|NCT00637390|Alemtuzumab|alemtuzumab|mesh-list
65666504|NCT02183142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65666505|NCT02183142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65666506|NCT02183142|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65666507|NCT02183142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65666508|NCT02183142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666509|NCT02183142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666510|NCT02183220|Aspirin|aspirin|mesh-list
65666511|NCT02183220|Dipyrone|dipyrone|mesh-list
65666512|NCT02183220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65666513|NCT02183220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65666514|NCT02183220|Analgesics|analgesics|mesh-ancestor
65666515|NCT02183220|Sensory System Agents|sensory system agents|mesh-ancestor
65666516|NCT02183220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666517|NCT02183220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666518|NCT02183220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65666519|NCT02183220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65666520|NCT02183220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65666521|NCT02183220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65666522|NCT02183220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666523|NCT02183220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65666524|NCT02183220|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65666525|NCT02183220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666526|NCT02183220|Antipyretics|antipyretics|mesh-ancestor
65666527|NCT02187588|Ibuprofen|ibuprofen|mesh-list
65666528|NCT02187588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65666529|NCT02187588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65666530|NCT02187588|Analgesics|analgesics|mesh-ancestor
65666531|NCT02187588|Sensory System Agents|sensory system agents|mesh-ancestor
65666532|NCT02187588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666533|NCT02187588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666534|NCT02187588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65666535|NCT02187588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65666536|NCT02187588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65666537|NCT02187588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666538|NCT02187588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666539|NCT03528694|Durvalumab|durvalumab|mesh-list
65666540|NCT03528694|BCG Vaccine|bcg vaccine|mesh-list
65666541|NCT03528694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65666542|NCT03528694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666543|NCT03528694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65666544|NCT03528694|Immunologic Factors|immunologic factors|mesh-ancestor
65666545|NCT03528694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666546|NCT05364489|Bevacizumab|bevacizumab|mesh-list
65666547|NCT05364489|Oxaliplatin|oxaliplatin|mesh-list
65666548|NCT05364489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65666549|NCT05364489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666550|NCT05364489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65666551|NCT05364489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65666552|NCT05364489|Growth Substances|growth substances|mesh-ancestor
65666553|NCT05364489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666554|NCT05364489|Growth Inhibitors|growth inhibitors|mesh-ancestor
65666555|NCT02183298|Linagliptin|linagliptin|mesh-list
65666556|NCT02183298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65666557|NCT02183298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666558|NCT02183298|Incretins|incretins|mesh-ancestor
65666559|NCT02183298|Hormones|hormones|mesh-ancestor
65666560|NCT02183298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65666561|NCT02183298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65666562|NCT02183298|Protease Inhibitors|protease inhibitors|mesh-ancestor
65666563|NCT02183298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666564|NCT02183298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666565|NCT03697057|Anesthetics|anesthetics|mesh-list
65666566|NCT03697057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65666567|NCT03697057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666568|NCT02183376|Linagliptin|linagliptin|mesh-list
65666569|NCT02183376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65666570|NCT02183376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666571|NCT02183376|Incretins|incretins|mesh-ancestor
65666572|NCT02183376|Hormones|hormones|mesh-ancestor
65666573|NCT02183376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65666574|NCT02183376|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65666575|NCT02183376|Protease Inhibitors|protease inhibitors|mesh-ancestor
65666576|NCT02183376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666577|NCT02183376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666578|NCT02187822|Taxane|taxane|mesh-list
65666579|NCT02187822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666580|NCT03696901|Dalbavancin|dalbavancin|mesh-list
65666581|NCT03696901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65666582|NCT03696901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65666583|NCT02187900|Mycophenolic Acid|mycophenolic acid|mesh-list
65666584|NCT02187900|Cardiac Glycosides|cardiac glycosides|mesh-list
65666585|NCT02187900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65666586|NCT02187900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666587|NCT02187900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65666588|NCT02187900|Antitubercular Agents|antitubercular agents|mesh-ancestor
65666589|NCT02187900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65666590|NCT02187900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65666591|NCT02187900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666592|NCT02187900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666593|NCT02187900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65666594|NCT02187900|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65666595|NCT02187900|Protective Agents|protective agents|mesh-ancestor
65666596|NCT02187900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666597|NCT03062644|Celecoxib|celecoxib|mesh-list
65666598|NCT03062644|Tramadol|tramadol|mesh-list
65666599|NCT03062644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65666600|NCT03062644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65666601|NCT03062644|Analgesics|analgesics|mesh-ancestor
65666602|NCT03062644|Sensory System Agents|sensory system agents|mesh-ancestor
65666603|NCT03062644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666604|NCT03062644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666605|NCT03062644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65666606|NCT03062644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65666607|NCT03062644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65666608|NCT03062644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65666609|NCT03062644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666610|NCT03062644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666611|NCT03062644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65666612|NCT03062644|Narcotics|narcotics|mesh-ancestor
65666613|NCT03062644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65666614|NCT02190318|Losartan|losartan|mesh-list
65666615|NCT02190318|Spironolactone|spironolactone|mesh-list
65666616|NCT02190318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65666617|NCT02190318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65666618|NCT02190318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65666619|NCT02190318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65666620|NCT02190318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666621|NCT02190318|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65666622|NCT02190318|Hormone Antagonists|hormone antagonists|mesh-ancestor
65666623|NCT02190318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65666624|NCT02190318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666625|NCT02190318|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65666626|NCT02190318|Diuretics|diuretics|mesh-ancestor
65666627|NCT02190318|Natriuretic Agents|natriuretic agents|mesh-ancestor
65666628|NCT04743661|Antipyretics|antipyretics|mesh-list
65666629|NCT04743661|Dexamethasone|dexamethasone|mesh-list
65666630|NCT04743661|Bevacizumab|bevacizumab|mesh-list
65666631|NCT04743661|Irinotecan|irinotecan|mesh-list
65666632|NCT04743661|Temozolomide|temozolomide|mesh-list
65666633|NCT04743661|Antiemetics|antiemetics|mesh-list
65666634|NCT04743661|Emetics|emetics|mesh-list
65666635|NCT04743661|Histamine Antagonists|histamine antagonists|mesh-list
65666636|NCT04743661|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
65666637|NCT04743661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65666638|NCT04743661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666639|NCT04743661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65666640|NCT04743661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65666641|NCT04743661|Growth Substances|growth substances|mesh-ancestor
65666642|NCT04743661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666643|NCT04743661|Growth Inhibitors|growth inhibitors|mesh-ancestor
65666644|NCT04743661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65666645|NCT04743661|Autonomic Agents|autonomic agents|mesh-ancestor
65666646|NCT04743661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666647|NCT04743661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65666648|NCT04743661|Glucocorticoids|glucocorticoids|mesh-ancestor
65666649|NCT04743661|Hormones|hormones|mesh-ancestor
65666650|NCT04743661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65666651|NCT04743661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65666652|NCT04743661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65666653|NCT04743661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65666654|NCT04743661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666655|NCT04743661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666656|NCT04743661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65666657|NCT04743661|Alkylating Agents|alkylating agents|mesh-ancestor
65666658|NCT04743661|Histamine Agents|histamine agents|mesh-ancestor
65666659|NCT04743661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65666660|NCT02183532|Linagliptin|linagliptin|mesh-list
65666661|NCT02183532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65666662|NCT02183532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666663|NCT02183532|Incretins|incretins|mesh-ancestor
65666664|NCT02183532|Hormones|hormones|mesh-ancestor
65666665|NCT02183532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65666666|NCT02183532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65666667|NCT02183532|Protease Inhibitors|protease inhibitors|mesh-ancestor
65666668|NCT02183532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666669|NCT02183532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666670|NCT02629822|Tenofovir|tenofovir|mesh-list
65666671|NCT02629822|Lamivudine|lamivudine|mesh-list
65666672|NCT02629822|Antiviral Agents|antiviral agents|mesh-ancestor
65666673|NCT02629822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65666674|NCT02629822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65666675|NCT02629822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65666676|NCT02629822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666677|NCT02629822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666678|NCT02629822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65666679|NCT02629822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65666680|NCT03700801|Insulin|insulin|mesh-list
65666681|NCT03700801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65666682|NCT03700801|Metformin|metformin|mesh-list
65666683|NCT03700801|Insulin Aspart|insulin aspart|mesh-list
65666684|NCT03700801|Dapagliflozin|dapagliflozin|mesh-list
65666685|NCT03700801|Saxagliptin|saxagliptin|mesh-list
65666686|NCT03700801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65666687|NCT03700801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666688|NCT03700801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65666689|NCT03700801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666690|NCT03700801|Incretins|incretins|mesh-ancestor
65666691|NCT03700801|Hormones|hormones|mesh-ancestor
65666692|NCT03700801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65666693|NCT03700801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65666694|NCT03700801|Protease Inhibitors|protease inhibitors|mesh-ancestor
65666695|NCT03700801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666696|NCT03700645|Allopurinol|allopurinol|mesh-list
65666697|NCT03700645|Antimetabolites|antimetabolites|mesh-ancestor
65666698|NCT03700645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666699|NCT03700645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666700|NCT03700645|Gout Suppressants|gout suppressants|mesh-ancestor
65666701|NCT03700645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65666702|NCT03700645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65666703|NCT03700645|Antioxidants|antioxidants|mesh-ancestor
65666704|NCT03700645|Protective Agents|protective agents|mesh-ancestor
65666705|NCT03700645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666706|NCT03493048|Leucovorin|leucovorin|mesh-list
65666707|NCT03493048|Fluorouracil|fluorouracil|mesh-list
65666708|NCT03493048|Oxaliplatin|oxaliplatin|mesh-list
65666709|NCT03493048|Irinotecan|irinotecan|mesh-list
65666710|NCT03493048|Cetuximab|cetuximab|mesh-list
65666711|NCT03493048|Antimetabolites|antimetabolites|mesh-ancestor
65666712|NCT03493048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666713|NCT03493048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65666714|NCT03493048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666715|NCT03493048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65666716|NCT03493048|Immunologic Factors|immunologic factors|mesh-ancestor
65666717|NCT03493048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666718|NCT03493048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65666719|NCT03493048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65666720|NCT03493048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666721|NCT03493048|Antidotes|antidotes|mesh-ancestor
65666722|NCT03493048|Protective Agents|protective agents|mesh-ancestor
65666723|NCT03493048|Vitamin B Complex|vitamin b complex|mesh-ancestor
65666724|NCT03493048|Vitamins|vitamins|mesh-ancestor
65666725|NCT03493048|Micronutrients|micronutrients|mesh-ancestor
65666726|NCT03493048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65666727|NCT04499053|Durvalumab|durvalumab|mesh-list
65666728|NCT04499053|Tremelimumab|tremelimumab|mesh-list
65666729|NCT04499053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65666730|NCT04499053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666731|NCT03567681|Oxcarbazepine|oxcarbazepine|mesh-list
65666732|NCT03567681|Anticonvulsants|anticonvulsants|mesh-ancestor
65666733|NCT03567681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65666734|NCT03567681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65666735|NCT03567681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65666736|NCT03567681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666737|NCT03567681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65666738|NCT03567681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65666739|NCT03567447|Droxidopa|droxidopa|mesh-list
65666740|NCT03567447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65666741|NCT03567447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65666742|NCT03567369|Dexamethasone|dexamethasone|mesh-list
65666743|NCT03567369|Dexamethasone acetate|dexamethasone acetate|mesh-list
65666744|NCT03567369|BB 1101|bb 1101|mesh-list
65666745|NCT03567369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65666746|NCT03567369|Antiemetics|antiemetics|mesh-ancestor
65666747|NCT03567369|Autonomic Agents|autonomic agents|mesh-ancestor
65666748|NCT03567369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666749|NCT03567369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666750|NCT03567369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65666751|NCT03567369|Glucocorticoids|glucocorticoids|mesh-ancestor
65666752|NCT03567369|Hormones|hormones|mesh-ancestor
65666753|NCT03567369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65666754|NCT03567369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65666755|NCT03567369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666756|NCT03567369|Protease Inhibitors|protease inhibitors|mesh-ancestor
65666757|NCT03567369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666758|NCT03567369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666759|NCT03397654|Pembrolizumab|pembrolizumab|mesh-list
65666760|NCT03397654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65666761|NCT03397654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666762|NCT03266146|Methylprednisolone|methylprednisolone|mesh-list
65666763|NCT03266146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65666764|NCT03266146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65666765|NCT03266146|Prednisolone|prednisolone|mesh-list
65666766|NCT03266146|Prednisolone acetate|prednisolone acetate|mesh-list
65666767|NCT03266146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65666768|NCT03266146|Prednisolone phosphate|prednisolone phosphate|mesh-list
65666769|NCT03266146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65666770|NCT03266146|Antiemetics|antiemetics|mesh-ancestor
65666771|NCT03266146|Autonomic Agents|autonomic agents|mesh-ancestor
65666772|NCT03266146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666773|NCT03266146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666774|NCT03266146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65666775|NCT03266146|Glucocorticoids|glucocorticoids|mesh-ancestor
65666776|NCT03266146|Hormones|hormones|mesh-ancestor
65666777|NCT03266146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65666778|NCT03266146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65666779|NCT03266146|Protective Agents|protective agents|mesh-ancestor
65666780|NCT03266146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65666781|NCT03266146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666782|NCT03700489|Titanium dioxide|titanium dioxide|mesh-list
65666783|NCT03700489|Sunscreening Agents|sunscreening agents|mesh-ancestor
65666784|NCT03700489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65666785|NCT03700489|Protective Agents|protective agents|mesh-ancestor
65666786|NCT03700489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666787|NCT03700489|Dermatologic Agents|dermatologic agents|mesh-ancestor
65666788|NCT03700489|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65666789|NCT02800941|Warfarin|warfarin|mesh-list
65666790|NCT02800941|Anticoagulants|anticoagulants|mesh-list
65666791|NCT02800941|Acenocoumarol|acenocoumarol|mesh-list
65666792|NCT02800941|Fluindione|fluindione|mesh-list
65666793|NCT03695887|Nitrous Oxide|nitrous oxide|mesh-list
65666794|NCT03695887|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65666795|NCT03695887|Anesthetics, General|anesthetics, general|mesh-ancestor
65666796|NCT03695887|Anesthetics|anesthetics|mesh-ancestor
65666797|NCT03695887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65666798|NCT03695887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666799|NCT03695887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65666800|NCT03695887|Analgesics|analgesics|mesh-ancestor
65666801|NCT03695887|Sensory System Agents|sensory system agents|mesh-ancestor
65666802|NCT03695887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666803|NCT04432714|Prednisone|prednisone|mesh-list
65666804|NCT04432714|Cyclophosphamide|cyclophosphamide|mesh-list
65666805|NCT04432714|Rituximab|rituximab|mesh-list
65666806|NCT04432714|Doxorubicin|doxorubicin|mesh-list
65666807|NCT04432714|Etoposide|etoposide|mesh-list
65666808|NCT04432714|Vincristine|vincristine|mesh-list
65666809|NCT04432714|Lenalidomide|lenalidomide|mesh-list
65666810|NCT04432714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65666811|NCT04432714|Immunologic Factors|immunologic factors|mesh-ancestor
65666812|NCT04432714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666813|NCT04432714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65666814|NCT04432714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65666815|NCT04432714|Alkylating Agents|alkylating agents|mesh-ancestor
65666816|NCT04432714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666817|NCT04432714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666818|NCT04432714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65666819|NCT04432714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65666820|NCT04432714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65666821|NCT04432714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65666822|NCT04432714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65666823|NCT04432714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666824|NCT04432714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65666825|NCT04432714|Glucocorticoids|glucocorticoids|mesh-ancestor
65666826|NCT04432714|Hormones|hormones|mesh-ancestor
65666827|NCT04432714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65666828|NCT04432714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65666829|NCT04432714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65666830|NCT04432714|Tubulin Modulators|tubulin modulators|mesh-ancestor
65666831|NCT04432714|Antimitotic Agents|antimitotic agents|mesh-ancestor
65666832|NCT04432714|Mitosis Modulators|mitosis modulators|mesh-ancestor
65666833|NCT04432714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65666834|NCT04432714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65666835|NCT04432714|Growth Substances|growth substances|mesh-ancestor
65666836|NCT04432714|Growth Inhibitors|growth inhibitors|mesh-ancestor
65666837|NCT02752074|Pembrolizumab|pembrolizumab|mesh-list
65666838|NCT02752074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65666839|NCT02752074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666840|NCT03564795|Sulfadiazine|sulfadiazine|mesh-list
65666841|NCT03564795|Silver Sulfadiazine|silver sulfadiazine|mesh-list
65666842|NCT03564795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65666843|NCT03564795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65666844|NCT03564795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65666845|NCT03564795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65666846|NCT03564795|Coccidiostats|coccidiostats|mesh-ancestor
65666847|NCT03564795|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65666848|NCT03624595|Dexmedetomidine|dexmedetomidine|mesh-list
65666849|NCT03624595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65666850|NCT03624595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65464169|NCT03996694|Oxycodone|oxycodone|mesh-list
65666851|NCT03624595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666852|NCT03624595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65666853|NCT03624595|Analgesics|analgesics|mesh-ancestor
65666854|NCT03624595|Sensory System Agents|sensory system agents|mesh-ancestor
65666855|NCT03624595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666856|NCT03624595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65666857|NCT03624595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65666858|NCT03624595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65666859|NCT03624595|Adrenergic Agents|adrenergic agents|mesh-ancestor
65666860|NCT03624595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65666861|NCT03624595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666862|NCT03063892|Tranexamic Acid|tranexamic acid|mesh-list
65666863|NCT03063892|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65666864|NCT03063892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65666865|NCT03063892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666866|NCT03063892|Hemostatics|hemostatics|mesh-ancestor
65666867|NCT03063892|Coagulants|coagulants|mesh-ancestor
65666869|NCT03700333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666870|NCT03700333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666871|NCT03700333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666872|NCT03700333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65666873|NCT03700333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65666874|NCT03063580|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65666875|NCT03063580|Rifampin|rifampin|mesh-list
65666876|NCT03063580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65666877|NCT03063580|Antitubercular Agents|antitubercular agents|mesh-ancestor
65666878|NCT03063580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65666879|NCT03063580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65666880|NCT03063580|Leprostatic Agents|leprostatic agents|mesh-ancestor
65666881|NCT03063580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65666882|NCT03063580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666883|NCT03063580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666884|NCT03063580|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65666885|NCT03063580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65666886|NCT03063580|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65666887|NCT03063580|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65666888|NCT03063580|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65666889|NCT03063580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65666890|NCT03063580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65666891|NCT03063580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65666892|NCT03063580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666893|NCT05353101|Loteprednol Etabonate|loteprednol etabonate|mesh-list
65666894|NCT05353101|Cyclosporine|cyclosporine|mesh-list
65666895|NCT05353101|Tobramycin|tobramycin|mesh-list
65666896|NCT05353101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65666897|NCT05353101|Cyclosporins|cyclosporins|mesh-list
65666898|NCT05353101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666899|NCT05353101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666900|NCT05353101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65666901|NCT05353101|Immunologic Factors|immunologic factors|mesh-ancestor
65666902|NCT05353101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666903|NCT05353101|Antifungal Agents|antifungal agents|mesh-ancestor
65666904|NCT05353101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65666905|NCT05353101|Dermatologic Agents|dermatologic agents|mesh-ancestor
65666906|NCT05353101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65666907|NCT05353101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65666908|NCT05353101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65666909|NCT05353101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65666910|NCT05353101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65666911|NCT05139316|Prednisolone|prednisolone|mesh-list
65666912|NCT05139316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65666913|NCT05139316|Glucocorticoids|glucocorticoids|mesh-ancestor
65666914|NCT05139316|Hormones|hormones|mesh-ancestor
65666915|NCT05139316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65666916|NCT05139316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666917|NCT05139316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65666918|NCT05139316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666919|NCT03700177|Dexamethasone|dexamethasone|mesh-list
65666920|NCT03700177|Ropivacaine|ropivacaine|mesh-list
65666921|NCT03700177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65666922|NCT03700177|Antiemetics|antiemetics|mesh-ancestor
65666923|NCT03700177|Autonomic Agents|autonomic agents|mesh-ancestor
65666924|NCT03700177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666925|NCT03700177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666926|NCT03700177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65666928|NCT03700177|Hormones|hormones|mesh-ancestor
65666929|NCT03700177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65666930|NCT03700177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65666931|NCT03700177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65666932|NCT03700177|Anesthetics, Local|anesthetics, local|mesh-ancestor
65666933|NCT03700177|Anesthetics|anesthetics|mesh-ancestor
65666934|NCT03700177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65666935|NCT03700177|Sensory System Agents|sensory system agents|mesh-ancestor
65666936|NCT02183610|Linagliptin|linagliptin|mesh-list
65666937|NCT02183610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65666938|NCT02183610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65666939|NCT02183610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666940|NCT02183610|Incretins|incretins|mesh-ancestor
65666941|NCT02183610|Hormones|hormones|mesh-ancestor
65666942|NCT02183610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65666943|NCT02183610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65666944|NCT02183610|Protease Inhibitors|protease inhibitors|mesh-ancestor
65666945|NCT02183610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666946|NCT02183610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666947|NCT02183688|Acetaminophen|acetaminophen|mesh-list
65666948|NCT02183688|Caffeine|caffeine|mesh-list
65666949|NCT02183688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65666950|NCT02183688|Analgesics|analgesics|mesh-ancestor
65274193|NCT02688738|Antimalarials|antimalarials|mesh-ancestor
65666951|NCT02183688|Sensory System Agents|sensory system agents|mesh-ancestor
65666952|NCT02183688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666953|NCT02183688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666954|NCT02183688|Antipyretics|antipyretics|mesh-ancestor
65666955|NCT02183688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65666956|NCT02183688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65666957|NCT02183688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666958|NCT02183688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666959|NCT02183688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65666960|NCT02183688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65666961|NCT02183688|Purinergic Agents|purinergic agents|mesh-ancestor
65666962|NCT02183688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65666963|NCT02190708|Midazolam|midazolam|mesh-list
65666964|NCT02190708|Omeprazole|omeprazole|mesh-list
65666965|NCT02190708|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65666966|NCT02190708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65666967|NCT02190708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65666968|NCT02190708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65666969|NCT02190708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666970|NCT02190708|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65666971|NCT02190708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65666972|NCT02190708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65666973|NCT02190708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65666974|NCT02190708|Anesthetics, General|anesthetics, general|mesh-ancestor
65666975|NCT02190708|Anesthetics|anesthetics|mesh-ancestor
65666976|NCT02190708|GABA Modulators|gaba modulators|mesh-ancestor
65666977|NCT02190708|GABA Agents|gaba agents|mesh-ancestor
65666978|NCT02190708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65666979|NCT02190708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65666980|NCT02190708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65666981|NCT02190708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65666982|NCT02190708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65666983|NCT05338983|Anesthetics|anesthetics|mesh-list
65666984|NCT05338983|Mepivacaine|mepivacaine|mesh-list
65666985|NCT05338983|Anesthetics, Local|anesthetics, local|mesh-list
65666986|NCT05338983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65666987|NCT05338983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666988|NCT05338983|Sensory System Agents|sensory system agents|mesh-ancestor
65666989|NCT05338983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666990|NCT03063658|Acetaminophen|acetaminophen|mesh-list
65666991|NCT03063658|Ibuprofen|ibuprofen|mesh-list
65666992|NCT03063658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65666993|NCT03063658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65666994|NCT03063658|Analgesics|analgesics|mesh-ancestor
65666995|NCT03063658|Sensory System Agents|sensory system agents|mesh-ancestor
65666996|NCT03063658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65666997|NCT03063658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65666998|NCT03063658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65666999|NCT03063658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65667000|NCT03063658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65667001|NCT03063658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667002|NCT03063658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667003|NCT03063658|Antipyretics|antipyretics|mesh-ancestor
65667004|NCT03695107|Nifedipine|nifedipine|mesh-list
65667005|NCT03695107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65667006|NCT03695107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65667007|NCT03695107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667008|NCT03695107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65667009|NCT03695107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667010|NCT03695107|Vasodilator Agents|vasodilator agents|mesh-ancestor
65667011|NCT03695107|Tocolytic Agents|tocolytic agents|mesh-ancestor
65667012|NCT03695107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65667013|NCT02835339|Magnesium Sulfate|magnesium sulfate|mesh-list
65667014|NCT02835339|Analgesics|analgesics|mesh-ancestor
65667015|NCT02835339|Sensory System Agents|sensory system agents|mesh-ancestor
65667016|NCT02835339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65667017|NCT02835339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667018|NCT02835339|Anesthetics|anesthetics|mesh-ancestor
65667019|NCT02835339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65667020|NCT02835339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65667021|NCT02835339|Anticonvulsants|anticonvulsants|mesh-ancestor
65667022|NCT02835339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65667023|NCT02835339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65129656|NCT04574778|Antipyretics|antipyretics|mesh-ancestor
65667024|NCT02835339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667025|NCT02835339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65667026|NCT02835339|Tocolytic Agents|tocolytic agents|mesh-ancestor
65667027|NCT02835339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65667028|NCT03695029|Tenofovir|tenofovir|mesh-list
65667029|NCT03695029|Antiviral Agents|antiviral agents|mesh-ancestor
65667030|NCT03695029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65667031|NCT03695029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65667032|NCT03695029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65667033|NCT03695029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667034|NCT03695029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667035|NCT03695029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65667036|NCT03695029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65667037|NCT02259855|Interferons|interferons|mesh-list
65667038|NCT02259855|Ritonavir|ritonavir|mesh-list
65667039|NCT02259855|Ribavirin|ribavirin|mesh-list
65667040|NCT02259855|Tipranavir|tipranavir|mesh-list
65667041|NCT02259855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667042|NCT02259855|Antiviral Agents|antiviral agents|mesh-ancestor
65667043|NCT02259855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65667044|NCT02259855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65667045|NCT02259855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65667046|NCT02259855|Protease Inhibitors|protease inhibitors|mesh-ancestor
65667047|NCT02259855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667048|NCT02259855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667049|NCT02259855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65667050|NCT02259855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65667051|NCT02259855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65667052|NCT02259855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65667053|NCT02259855|Antimetabolites|antimetabolites|mesh-ancestor
65667054|NCT03703063|Leucovorin|leucovorin|mesh-list
65667055|NCT03703063|Gemcitabine|gemcitabine|mesh-list
65667056|NCT03703063|Paclitaxel|paclitaxel|mesh-list
65667057|NCT03703063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65667058|NCT03703063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667059|NCT03703063|Tubulin Modulators|tubulin modulators|mesh-ancestor
65667060|NCT03703063|Antimitotic Agents|antimitotic agents|mesh-ancestor
65667061|NCT03703063|Mitosis Modulators|mitosis modulators|mesh-ancestor
65667062|NCT03703063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667063|NCT03703063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65667064|NCT03703063|Antimetabolites|antimetabolites|mesh-ancestor
65667065|NCT03703063|Antiviral Agents|antiviral agents|mesh-ancestor
65667066|NCT03703063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65667067|NCT03703063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667068|NCT03703063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65667069|NCT03703063|Immunologic Factors|immunologic factors|mesh-ancestor
65667070|NCT03703063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667071|NCT03703063|Antidotes|antidotes|mesh-ancestor
65667072|NCT03703063|Protective Agents|protective agents|mesh-ancestor
65667073|NCT03703063|Vitamin B Complex|vitamin b complex|mesh-ancestor
65667074|NCT03703063|Vitamins|vitamins|mesh-ancestor
65667075|NCT03703063|Micronutrients|micronutrients|mesh-ancestor
65667076|NCT03702985|Capecitabine|capecitabine|mesh-list
65667077|NCT03702985|Irinotecan|irinotecan|mesh-list
65667078|NCT03702985|Amifostine|amifostine|mesh-list
65667079|NCT03702985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65667080|NCT03702985|Antimetabolites|antimetabolites|mesh-ancestor
65667081|NCT03702985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667082|NCT03702985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667083|NCT03702985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65667084|NCT03702985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65667085|NCT03702985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667086|NCT03702985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65667087|NCT03702985|Protective Agents|protective agents|mesh-ancestor
65667088|NCT03702985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667089|NCT05072314|Lidocaine|lidocaine|mesh-list
65667090|NCT05072314|Anesthetics, Local|anesthetics, local|mesh-ancestor
65667091|NCT05072314|Anesthetics|anesthetics|mesh-ancestor
65667092|NCT05072314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65667093|NCT05072314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667094|NCT05072314|Sensory System Agents|sensory system agents|mesh-ancestor
65667095|NCT05072314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65667096|NCT05072314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65667097|NCT05072314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65667098|NCT05072314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65274194|NCT02688738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65667099|NCT05072314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65667100|NCT05072314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667101|NCT04443088|Pembrolizumab|pembrolizumab|mesh-list
65667102|NCT04443088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65667103|NCT04443088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667104|NCT03064984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65667105|NCT03064984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65667106|NCT02184078|Nevirapine|nevirapine|mesh-list
65667107|NCT02184078|Rifabutin|rifabutin|mesh-list
65667108|NCT02184078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65667109|NCT02184078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65667110|NCT02184078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667111|NCT02184078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667112|NCT02184078|Antiviral Agents|antiviral agents|mesh-ancestor
65667113|NCT02184078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65667114|NCT02184078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65667115|NCT02184078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65667116|NCT02184078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65667117|NCT02184078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65667118|NCT02184078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65667119|NCT02184078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65667120|NCT02184078|Antitubercular Agents|antitubercular agents|mesh-ancestor
65667121|NCT02188368|Clarithromycin|clarithromycin|mesh-list
65667122|NCT02188368|Dexamethasone|dexamethasone|mesh-list
65667123|NCT02188368|Prednisone|prednisone|mesh-list
65667124|NCT02188368|Cyclophosphamide|cyclophosphamide|mesh-list
65667125|NCT02188368|Bortezomib|bortezomib|mesh-list
65667126|NCT02188368|Pomalidomide|pomalidomide|mesh-list
65667127|NCT02188368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65667128|NCT02188368|Immunologic Factors|immunologic factors|mesh-ancestor
65667129|NCT02188368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667130|NCT02188368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65667131|NCT02188368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65667132|NCT02188368|Alkylating Agents|alkylating agents|mesh-ancestor
65667133|NCT02188368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667134|NCT02188368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667135|NCT02188368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65667136|NCT02188368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65667137|NCT02188368|Antiemetics|antiemetics|mesh-ancestor
65667138|NCT02188368|Autonomic Agents|autonomic agents|mesh-ancestor
65667139|NCT02188368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65667140|NCT02188368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65667141|NCT02188368|Glucocorticoids|glucocorticoids|mesh-ancestor
65667142|NCT02188368|Hormones|hormones|mesh-ancestor
65667143|NCT02188368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65667144|NCT02188368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65667145|NCT02188368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667146|NCT02188368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65667147|NCT02188368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65667148|NCT02188368|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65667149|NCT02188368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65667150|NCT02188368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65667151|NCT02188368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65667152|NCT02188368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65667153|NCT02188368|Growth Substances|growth substances|mesh-ancestor
65667154|NCT02188368|Growth Inhibitors|growth inhibitors|mesh-ancestor
65667155|NCT04323436|Spartalizumab|spartalizumab|mesh-list
65667156|NCT04323436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65667157|NCT04323436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667158|NCT04323436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667159|NCT03694873|Celecoxib|celecoxib|mesh-list
65667160|NCT03694873|Tramadol|tramadol|mesh-list
65667161|NCT03694873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65667162|NCT03694873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65667163|NCT03694873|Analgesics|analgesics|mesh-ancestor
65667164|NCT03694873|Sensory System Agents|sensory system agents|mesh-ancestor
65667165|NCT03694873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65667166|NCT03694873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667167|NCT03694873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65667168|NCT03694873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65667169|NCT03694873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65667170|NCT03694873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65268472|NCT02700906|Lidocaine|lidocaine|mesh-list
65667171|NCT03694873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667172|NCT03694873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667173|NCT03694873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65667174|NCT03694873|Narcotics|narcotics|mesh-ancestor
65667175|NCT03694873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65667176|NCT04306315|Brodalumab|brodalumab|mesh-list
65667177|NCT04306315|Dermatologic Agents|dermatologic agents|mesh-ancestor
65667178|NCT02191020|Acitretin|acitretin|mesh-list
65667179|NCT02191020|Keratolytic Agents|keratolytic agents|mesh-ancestor
65667180|NCT02191020|Dermatologic Agents|dermatologic agents|mesh-ancestor
65667181|NCT04476199|Decitabine|decitabine|mesh-list
65667182|NCT04476199|Venetoclax|venetoclax|mesh-list
65667183|NCT04476199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65667184|NCT04476199|Antimetabolites|antimetabolites|mesh-ancestor
65667185|NCT04476199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667186|NCT04476199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667187|NCT04476199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667188|NCT02191176|Dextromethorphan|dextromethorphan|mesh-list
65667189|NCT02191176|Antitussive Agents|antitussive agents|mesh-ancestor
65667190|NCT02191176|Respiratory System Agents|respiratory system agents|mesh-ancestor
65667191|NCT02191176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65667192|NCT02191176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65667193|NCT02191176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65667194|NCT02191176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667195|NCT02191176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667196|NCT02184312|Nevirapine|nevirapine|mesh-list
65667197|NCT02184312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65667198|NCT02184312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65667199|NCT02184312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667200|NCT02184312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667201|NCT02184312|Antiviral Agents|antiviral agents|mesh-ancestor
65667202|NCT02184312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65667203|NCT02184312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65667204|NCT02184312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65667205|NCT02184312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65667206|NCT02184312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65667207|NCT04301011|Pembrolizumab|pembrolizumab|mesh-list
65667208|NCT04301011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65667209|NCT04301011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667210|NCT02191332|Nevirapine|nevirapine|mesh-list
65667211|NCT02191332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65667212|NCT02191332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65667213|NCT02191332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667214|NCT02191332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667215|NCT02191332|Antiviral Agents|antiviral agents|mesh-ancestor
65667216|NCT02191332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65667217|NCT02191332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65667218|NCT02191332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65667219|NCT02191332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65667220|NCT02191332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65667221|NCT02256774|Ritonavir|ritonavir|mesh-list
65667222|NCT02256774|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
65667223|NCT02256774|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65667224|NCT02256774|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65667225|NCT02256774|Protease Inhibitors|protease inhibitors|mesh-ancestor
65667226|NCT02256774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667227|NCT02256774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667228|NCT02256774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65667229|NCT02256774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65667230|NCT02256774|Antiviral Agents|antiviral agents|mesh-ancestor
65667231|NCT02256774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65667232|NCT02256774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65667233|NCT02256774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65667234|NCT02256774|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65667235|NCT02256774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65667236|NCT04285567|Cyclophosphamide|cyclophosphamide|mesh-list
65667237|NCT04285567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65667238|NCT04285567|Rituximab|rituximab|mesh-list
65667239|NCT04285567|Fludarabine|fludarabine|mesh-list
65667240|NCT04285567|Venetoclax|venetoclax|mesh-list
65667241|NCT04285567|Obinutuzumab|obinutuzumab|mesh-list
65667242|NCT04285567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65667243|NCT04285567|Immunologic Factors|immunologic factors|mesh-ancestor
65268473|NCT02700906|Anesthetics, Local|anesthetics, local|mesh-ancestor
65667244|NCT04285567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667245|NCT04285567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65667246|NCT04285567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65667247|NCT04285567|Alkylating Agents|alkylating agents|mesh-ancestor
65667248|NCT04285567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667249|NCT04285567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667250|NCT04285567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65667251|NCT04285567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65667252|NCT02189304|Budesonide|budesonide|mesh-list
65667253|NCT02189304|Glycopyrrolate|glycopyrrolate|mesh-list
65667254|NCT02189304|Formoterol Fumarate|formoterol fumarate|mesh-list
65667255|NCT02189304|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65667256|NCT02189304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65667257|NCT02189304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65667258|NCT02189304|Autonomic Agents|autonomic agents|mesh-ancestor
65667259|NCT02189304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65667260|NCT02189304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667261|NCT02189304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65667262|NCT02189304|Respiratory System Agents|respiratory system agents|mesh-ancestor
65667263|NCT02189304|Glucocorticoids|glucocorticoids|mesh-ancestor
65667264|NCT02189304|Hormones|hormones|mesh-ancestor
65667265|NCT02189304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65667266|NCT02189304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65667267|NCT02189304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65667268|NCT02189304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65667269|NCT02189304|Adrenergic Agents|adrenergic agents|mesh-ancestor
65667270|NCT02189304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65667271|NCT02189304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667272|NCT02189304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65667273|NCT02189304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65667274|NCT02189304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65667275|NCT02189304|Cholinergic Agents|cholinergic agents|mesh-ancestor
65667276|NCT02184858|Lisinopril|lisinopril|mesh-list
65667277|NCT02184858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65667278|NCT02184858|Protease Inhibitors|protease inhibitors|mesh-ancestor
65667279|NCT02184858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667280|NCT02184858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667281|NCT02184858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65667282|NCT02184858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65667283|NCT02184858|Protective Agents|protective agents|mesh-ancestor
65667284|NCT02184858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667285|NCT03535662|Itraconazole|itraconazole|mesh-list
65667286|NCT03535662|Antifungal Agents|antifungal agents|mesh-ancestor
65667287|NCT03535662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65667288|NCT03535662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65667289|NCT03535662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65667290|NCT03535662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667291|NCT03535662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667292|NCT03535662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65667293|NCT03535662|Hormone Antagonists|hormone antagonists|mesh-ancestor
65667294|NCT03535662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65667295|NCT03535662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667296|NCT03535662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65667297|NCT03702205|Betaine|betaine|mesh-list
65464622|NCT00094458|Infliximab|infliximab|mesh-list
65667298|NCT03702205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65667299|NCT03702205|Lipotropic Agents|lipotropic agents|mesh-ancestor
65667300|NCT03702205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65667301|NCT03702205|Antimetabolites|antimetabolites|mesh-ancestor
65667302|NCT03702205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667303|NCT03702205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65667304|NCT03698851|Methamphetamine|methamphetamine|mesh-list
65667305|NCT03698851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65667306|NCT03698851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667307|NCT03698851|Sympathomimetics|sympathomimetics|mesh-ancestor
65667308|NCT03698851|Autonomic Agents|autonomic agents|mesh-ancestor
65667309|NCT03698851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65667310|NCT03698851|Dopamine Agents|dopamine agents|mesh-ancestor
65667311|NCT03698851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65667312|NCT03698851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667313|NCT03698851|Adrenergic Agents|adrenergic agents|mesh-ancestor
65667314|NCT03698851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65667315|NCT03698851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65667316|NCT03698851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65667317|NCT03698851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65667318|NCT03125902|Paclitaxel|paclitaxel|mesh-list
65667319|NCT03125902|Atezolizumab|atezolizumab|mesh-list
65667320|NCT03125902|Antibodies|antibodies|mesh-list
65667321|NCT03125902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65667322|NCT03125902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65667323|NCT03125902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667324|NCT03125902|Tubulin Modulators|tubulin modulators|mesh-ancestor
65667325|NCT03125902|Antimitotic Agents|antimitotic agents|mesh-ancestor
65667326|NCT03125902|Mitosis Modulators|mitosis modulators|mesh-ancestor
65667327|NCT03125902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667328|NCT03125902|Immunologic Factors|immunologic factors|mesh-ancestor
65667329|NCT03125902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667330|NCT02189694|Hormones|hormones|mesh-list
65667331|NCT02189694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667332|NCT02189694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65667333|NCT02189772|Metadoxine|metadoxine|mesh-list
65667334|NCT02189772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65667335|NCT05057806|Empagliflozin|empagliflozin|mesh-list
65667336|NCT05057806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65667337|NCT05057806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667338|NCT05057806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65667339|NCT05057806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667340|NCT02192424|Insulin|insulin|mesh-list
65667341|NCT02192424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65667342|NCT02192424|Metformin|metformin|mesh-list
65667343|NCT02192424|Insulin Glargine|insulin glargine|mesh-list
65667344|NCT02192424|Insulin Lispro|insulin lispro|mesh-list
65667345|NCT02192424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65667346|NCT02192424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667347|NCT04276597|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
65667348|NCT04276597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65667349|NCT04276597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667350|NCT02257008|Ritonavir|ritonavir|mesh-list
65667351|NCT02257008|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65667352|NCT02257008|Nelfinavir|nelfinavir|mesh-list
65667353|NCT02257008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65667354|NCT02257008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65667355|NCT02257008|Protease Inhibitors|protease inhibitors|mesh-ancestor
65667356|NCT02257008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667357|NCT02257008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667358|NCT02257008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65667359|NCT02257008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65667360|NCT02257008|Antiviral Agents|antiviral agents|mesh-ancestor
65667361|NCT02257008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65667362|NCT02257008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65667363|NCT02257008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65667364|NCT03693391|Fluorides|fluorides|mesh-list
65667365|NCT03693391|Cariostatic Agents|cariostatic agents|mesh-ancestor
65667366|NCT03693391|Protective Agents|protective agents|mesh-ancestor
65667367|NCT03693391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667368|NCT02193594|Oxaliplatin|oxaliplatin|mesh-list
65667369|NCT02193594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667370|NCT02185326|Hormones|hormones|mesh-list
65667371|NCT02185326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65667372|NCT02185326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667373|NCT04412707|Dexamethasone|dexamethasone|mesh-list
65667374|NCT04412707|Melphalan|melphalan|mesh-list
65667375|NCT04412707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65667376|NCT04412707|Antiemetics|antiemetics|mesh-ancestor
65667377|NCT04412707|Autonomic Agents|autonomic agents|mesh-ancestor
65667378|NCT04412707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65667379|NCT04412707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667380|NCT04412707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65667381|NCT04412707|Glucocorticoids|glucocorticoids|mesh-ancestor
65667382|NCT04412707|Hormones|hormones|mesh-ancestor
65667383|NCT04412707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65667384|NCT04412707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65667385|NCT04412707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667386|NCT04412707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65667387|NCT04412707|Alkylating Agents|alkylating agents|mesh-ancestor
65667388|NCT04412707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667389|NCT04412707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65667390|NCT04412707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65667391|NCT04412707|Immunologic Factors|immunologic factors|mesh-ancestor
65667392|NCT03698695|Mefloquine|mefloquine|mesh-list
65667393|NCT03698695|Donepezil|donepezil|mesh-list
65667394|NCT03698695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65667395|NCT03698695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667396|NCT03698695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667397|NCT03698695|Cholinergic Agents|cholinergic agents|mesh-ancestor
65667398|NCT03698695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65667399|NCT03698695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667400|NCT03698695|Nootropic Agents|nootropic agents|mesh-ancestor
65667401|NCT03698695|Antimalarials|antimalarials|mesh-ancestor
65667402|NCT03698695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65667403|NCT03698695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65667404|NCT03698695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65667405|NCT04729296|Golimumab|golimumab|mesh-list
65667406|NCT04729296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65667407|NCT04729296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65667408|NCT04729296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65667409|NCT04729296|Immunologic Factors|immunologic factors|mesh-ancestor
65667410|NCT04729296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667411|NCT03698617|Propofol|propofol|mesh-list
65667412|NCT03698617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65667413|NCT03698617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65667414|NCT03698617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667415|NCT03698617|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65667416|NCT03698617|Anesthetics, General|anesthetics, general|mesh-ancestor
65667417|NCT03698617|Anesthetics|anesthetics|mesh-ancestor
65667418|NCT02194374|Cyclophosphamide|cyclophosphamide|mesh-list
65667419|NCT02194374|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65667420|NCT02194374|Rituximab|rituximab|mesh-list
65667421|NCT02194374|Fludarabine|fludarabine|mesh-list
65667422|NCT02194374|Fludarabine phosphate|fludarabine phosphate|mesh-list
65667423|NCT02194374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65667424|NCT02194374|Immunologic Factors|immunologic factors|mesh-ancestor
65667425|NCT02194374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667426|NCT02194374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65667427|NCT02194374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65667428|NCT02194374|Alkylating Agents|alkylating agents|mesh-ancestor
65667429|NCT02194374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667430|NCT02194374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667431|NCT02194374|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65667432|NCT02194374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65667433|NCT02194374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65667434|NCT02194374|Antimetabolites|antimetabolites|mesh-ancestor
65667435|NCT02194452|Octreotide|octreotide|mesh-list
65667436|NCT02194452|Edotreotide|edotreotide|mesh-list
65667437|NCT02194452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65667438|NCT02194452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65667439|NCT02194452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667440|NCT02194452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65667441|NCT02194452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667442|NCT01358721|Nivolumab|nivolumab|mesh-list
65667443|NCT01358721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65667444|NCT01358721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667445|NCT01358721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65667446|NCT01358721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667447|NCT02194686|Cilostazol|cilostazol|mesh-list
65667448|NCT02194686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65667449|NCT02194686|Autonomic Agents|autonomic agents|mesh-ancestor
65667450|NCT02194686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65667451|NCT02194686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667452|NCT02194686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65667453|NCT02194686|Respiratory System Agents|respiratory system agents|mesh-ancestor
65667454|NCT02194686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65667455|NCT02194686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65667456|NCT02194686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667457|NCT02194686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65667458|NCT02194686|Vasodilator Agents|vasodilator agents|mesh-ancestor
65667459|NCT02194686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65667460|NCT02194686|Protective Agents|protective agents|mesh-ancestor
65667461|NCT02194686|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65667462|NCT02194686|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65667463|NCT02194686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667464|NCT04622995|Diazepam|diazepam|mesh-list
65667465|NCT04622995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65667466|NCT04622995|Anticonvulsants|anticonvulsants|mesh-ancestor
65667467|NCT04622995|Antiemetics|antiemetics|mesh-ancestor
65667468|NCT04622995|Autonomic Agents|autonomic agents|mesh-ancestor
65667469|NCT04622995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65667470|NCT04622995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667471|NCT04622995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65667472|NCT04622995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65667473|NCT04622995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65667474|NCT04622995|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65667475|NCT04622995|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65667476|NCT04622995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65667477|NCT04622995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65667478|NCT04622995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65667479|NCT04622995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65667480|NCT04622995|Anesthetics, General|anesthetics, general|mesh-ancestor
65667481|NCT04622995|Anesthetics|anesthetics|mesh-ancestor
65667482|NCT04622995|GABA Modulators|gaba modulators|mesh-ancestor
65667483|NCT04622995|GABA Agents|gaba agents|mesh-ancestor
65667484|NCT04622995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65667485|NCT04622995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667486|NCT01341639|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65667487|NCT01341639|Immunologic Factors|immunologic factors|mesh-ancestor
65667488|NCT01341639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667489|NCT02194764|Naltrexone|naltrexone|mesh-list
65667490|NCT02194764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65667491|NCT02194764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65667492|NCT02194764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667493|NCT02194764|Sensory System Agents|sensory system agents|mesh-ancestor
65667494|NCT02194764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65667495|NCT02967640|Ketamine|ketamine|mesh-list
65667496|NCT02967640|Analgesics|analgesics|mesh-ancestor
65667497|NCT02967640|Sensory System Agents|sensory system agents|mesh-ancestor
65667498|NCT02967640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65667499|NCT02967640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667500|NCT02967640|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65667501|NCT02967640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65667502|NCT02967640|Anesthetics, General|anesthetics, general|mesh-ancestor
65667503|NCT02967640|Anesthetics|anesthetics|mesh-ancestor
65667504|NCT02967640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65667505|NCT02967640|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65667506|NCT02967640|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65667507|NCT02967640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65667508|NCT02967640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667509|NCT02194920|Parathyroid Hormone|parathyroid hormone|mesh-list
65667510|NCT02194920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65667511|NCT02194920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667512|NCT04233112|Melatonin|melatonin|mesh-list
65667513|NCT04233112|Antioxidants|antioxidants|mesh-ancestor
65667514|NCT04233112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667515|NCT04233112|Protective Agents|protective agents|mesh-ancestor
65667516|NCT04233112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667517|NCT04233112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65667518|NCT00005584|Prednisone|prednisone|mesh-list
65667519|NCT00005584|Epirubicin|epirubicin|mesh-list
65667520|NCT00005584|Bleomycin|bleomycin|mesh-list
65667521|NCT00005584|Vinblastine|vinblastine|mesh-list
65667522|NCT00005584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65667523|NCT00005584|Glucocorticoids|glucocorticoids|mesh-ancestor
65667524|NCT00005584|Hormones|hormones|mesh-ancestor
65667525|NCT00005584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65667526|NCT00005584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667527|NCT00005584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65667528|NCT00005584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667529|NCT00005584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65667530|NCT00005584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65667531|NCT00005584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65667532|NCT00005584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667533|NCT00005584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667534|NCT00005584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65667535|NCT00005584|Tubulin Modulators|tubulin modulators|mesh-ancestor
65667536|NCT00005584|Antimitotic Agents|antimitotic agents|mesh-ancestor
65667537|NCT00005584|Mitosis Modulators|mitosis modulators|mesh-ancestor
65667538|NCT02194218|Nevirapine|nevirapine|mesh-list
65667539|NCT02194218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65667540|NCT02194218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65667541|NCT02194218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667542|NCT02194218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667543|NCT02194218|Antiviral Agents|antiviral agents|mesh-ancestor
65667544|NCT02194218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65667545|NCT02194218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65667546|NCT02194218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65667547|NCT02194218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65667548|NCT02194218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65667549|NCT02194296|Ambroxol|ambroxol|mesh-list
65667550|NCT02194296|Expectorants|expectorants|mesh-ancestor
65667551|NCT02194296|Respiratory System Agents|respiratory system agents|mesh-ancestor
65667552|NCT04230148|Triclabendazole|triclabendazole|mesh-list
65667553|NCT04230148|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65667554|NCT04230148|Anthelmintics|anthelmintics|mesh-ancestor
65667555|NCT04230148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65667556|NCT04230148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65667557|NCT02197026|Hylan|hylan|mesh-list
65667558|NCT02197026|Viscosupplements|viscosupplements|mesh-ancestor
65667559|NCT02197026|Protective Agents|protective agents|mesh-ancestor
65667560|NCT02197026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667561|NCT02197104|Choline|choline|mesh-list
65667562|NCT02197104|Lipotropic Agents|lipotropic agents|mesh-ancestor
65667563|NCT02197104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65667564|NCT02197104|Antimetabolites|antimetabolites|mesh-ancestor
65667565|NCT02197104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667566|NCT02197104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65667567|NCT02197104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65667568|NCT02197104|Nootropic Agents|nootropic agents|mesh-ancestor
65667569|NCT02197182|Copper|copper|mesh-list
65667570|NCT02197182|Metronidazole|metronidazole|mesh-list
65667571|NCT02197182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65667572|NCT02197182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65667573|NCT02197182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65667574|NCT02197182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65667575|NCT02197182|Trace Elements|trace elements|mesh-ancestor
65667576|NCT02197182|Micronutrients|micronutrients|mesh-ancestor
65667577|NCT02197182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667578|NCT02197260|Amoxicillin|amoxicillin|mesh-list
65667579|NCT02197260|Metronidazole|metronidazole|mesh-list
65667580|NCT02197260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65667581|NCT02197260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65667582|NCT02197260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65667583|NCT02197260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65667584|NCT03687931|Dexamethasone|dexamethasone|mesh-list
65667585|NCT03687931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65667586|NCT03687931|Antiemetics|antiemetics|mesh-ancestor
65667587|NCT03687931|Autonomic Agents|autonomic agents|mesh-ancestor
65667588|NCT03687931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65667589|NCT03687931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667590|NCT03687931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65667591|NCT03687931|Glucocorticoids|glucocorticoids|mesh-ancestor
65667592|NCT03687931|Hormones|hormones|mesh-ancestor
65667593|NCT03687931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65667594|NCT03687931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65667595|NCT03687931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667596|NCT04224493|Rituximab|rituximab|mesh-list
65667597|NCT04224493|Lenalidomide|lenalidomide|mesh-list
65667598|NCT04224493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65667599|NCT04224493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667600|NCT04224493|Immunologic Factors|immunologic factors|mesh-ancestor
65667601|NCT04224493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667602|NCT04224493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65667603|NCT04224493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65667604|NCT04224493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65667605|NCT04224493|Growth Substances|growth substances|mesh-ancestor
65667606|NCT04224493|Growth Inhibitors|growth inhibitors|mesh-ancestor
65667607|NCT03534024|Curcumin|curcumin|mesh-list
65667608|NCT03534024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65667609|NCT03534024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65667610|NCT03534024|Analgesics|analgesics|mesh-ancestor
65667611|NCT03534024|Sensory System Agents|sensory system agents|mesh-ancestor
65667612|NCT03534024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65667613|NCT03534024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667614|NCT03534024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65667615|NCT03534024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65667616|NCT03534024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667617|NCT03534024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667618|NCT03534024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667619|NCT02753686|Tamoxifen|tamoxifen|mesh-list
65667620|NCT02753686|Everolimus|everolimus|mesh-list
65667621|NCT02753686|Letrozole|letrozole|mesh-list
65667622|NCT02753686|Fulvestrant|fulvestrant|mesh-list
65667623|NCT02753686|Anastrozole|anastrozole|mesh-list
65667624|NCT02753686|Exemestane|exemestane|mesh-list
65667625|NCT02753686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667626|NCT02753686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65667627|NCT02753686|Immunologic Factors|immunologic factors|mesh-ancestor
65667628|NCT02753686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667629|NCT02753686|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65667630|NCT02753686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65667631|NCT02753686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667632|NCT02753686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667633|NCT02753686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65667634|NCT02753686|Hormone Antagonists|hormone antagonists|mesh-ancestor
65667635|NCT02753686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65667636|NCT02753686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65667637|NCT02753686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65667638|NCT02753686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65667639|NCT02753686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65667640|NCT02753686|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65667641|NCT04216927|Nitric Oxide|nitric oxide|mesh-list
65667642|NCT04216927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65667643|NCT04216927|Autonomic Agents|autonomic agents|mesh-ancestor
65667644|NCT04216927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65667645|NCT04216927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667646|NCT04216927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65667647|NCT04216927|Respiratory System Agents|respiratory system agents|mesh-ancestor
65667648|NCT04216927|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65667649|NCT04216927|Antioxidants|antioxidants|mesh-ancestor
65667650|NCT04216927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667651|NCT04216927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65667652|NCT04216927|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65667653|NCT04216927|Vasodilator Agents|vasodilator agents|mesh-ancestor
65667654|NCT04216927|Gasotransmitters|gasotransmitters|mesh-ancestor
65667655|NCT04216927|Protective Agents|protective agents|mesh-ancestor
65667656|NCT02329834|Furosemide|furosemide|mesh-list
65667657|NCT02329834|Diuretics|diuretics|mesh-ancestor
65667658|NCT02329834|Natriuretic Agents|natriuretic agents|mesh-ancestor
65667659|NCT02329834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667660|NCT02329834|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65667661|NCT02329834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65667662|NCT02329834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667663|NCT02195466|Ritonavir|ritonavir|mesh-list
65667664|NCT02195466|Tipranavir|tipranavir|mesh-list
65667665|NCT02195466|Fluconazole|fluconazole|mesh-list
65667666|NCT02195466|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65667667|NCT02195466|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65667668|NCT02195466|Protease Inhibitors|protease inhibitors|mesh-ancestor
65667669|NCT02195466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667670|NCT02195466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667671|NCT02195466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65667672|NCT02195466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65667673|NCT02195466|Antiviral Agents|antiviral agents|mesh-ancestor
65464999|NCT00119678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667674|NCT02195466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65667675|NCT02195466|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65667676|NCT02195466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65667677|NCT02195466|Antifungal Agents|antifungal agents|mesh-ancestor
65667678|NCT02195466|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65667679|NCT02195466|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65667680|NCT02195466|Hormone Antagonists|hormone antagonists|mesh-ancestor
65667681|NCT02195466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65667682|NCT02195466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667683|NCT02195466|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65667684|NCT02195466|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65667685|NCT02195544|Hylan|hylan|mesh-list
65667686|NCT02195544|Viscosupplements|viscosupplements|mesh-ancestor
65667687|NCT02195544|Protective Agents|protective agents|mesh-ancestor
65667688|NCT02195544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667689|NCT02197494|Valsartan|valsartan|mesh-list
65667690|NCT02197494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65667691|NCT02197494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65667692|NCT02197494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65667693|NCT02197494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667694|NCT02650648|Cyclophosphamide|cyclophosphamide|mesh-list
65667695|NCT02650648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65667696|NCT02650648|Immunologic Factors|immunologic factors|mesh-ancestor
65667697|NCT02650648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667698|NCT02650648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65667699|NCT02650648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65667700|NCT02650648|Alkylating Agents|alkylating agents|mesh-ancestor
65667701|NCT02650648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667702|NCT02650648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667703|NCT02650648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65667704|NCT01340937|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65667705|NCT01340937|Immunologic Factors|immunologic factors|mesh-ancestor
65667706|NCT01340937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667707|NCT03692299|Metronidazole|metronidazole|mesh-list
65667708|NCT03692299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65667709|NCT03692299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65667710|NCT03692299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65667711|NCT03692299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65667712|NCT02197650|Asparaginase|asparaginase|mesh-list
65667713|NCT02197650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667714|NCT03682939|Vaccines|vaccines|mesh-list
65667715|NCT03682939|Immunologic Factors|immunologic factors|mesh-ancestor
65667716|NCT03682939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667717|NCT02201992|Crizotinib|crizotinib|mesh-list
65667718|NCT02201992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667719|NCT02201992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65667720|NCT02201992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667721|NCT02201992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667722|NCT03534492|Durvalumab|durvalumab|mesh-list
65667723|NCT03534492|Olaparib|olaparib|mesh-list
65667724|NCT03534492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65667725|NCT03534492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667726|NCT03534492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65667727|NCT03534492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667728|NCT03534492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667729|NCT03624283|Betahistine|betahistine|mesh-list
65667730|NCT03624283|Vasodilator Agents|vasodilator agents|mesh-ancestor
65667731|NCT03624283|Histamine Agonists|histamine agonists|mesh-ancestor
65667732|NCT03624283|Histamine Agents|histamine agents|mesh-ancestor
65667733|NCT03624283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65667734|NCT03624283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667735|NCT03624283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667736|NCT03687463|Decitabine|decitabine|mesh-list
65667737|NCT03687463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65667738|NCT03687463|Antimetabolites|antimetabolites|mesh-ancestor
65667739|NCT03687463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667740|NCT03687463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667741|NCT03687463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667742|NCT03692143|Alendronate|alendronate|mesh-list
65667743|NCT03692143|Teriparatide|teriparatide|mesh-list
65667744|NCT03692143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65667745|NCT03692143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667746|NCT03692143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65465089|NCT01079624|Glucagon|glucagon|mesh-list
65667747|NCT02201004|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
65667748|NCT02201004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65667749|NCT02201004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667750|NCT02201004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65667751|NCT02201004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667752|NCT02197884|Clarithromycin|clarithromycin|mesh-list
65667753|NCT02197884|Itraconazole|itraconazole|mesh-list
65130401|NCT04575194|Liraglutide|liraglutide|mesh-list
65667754|NCT02197884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65667755|NCT02197884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65667756|NCT02197884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65667757|NCT02197884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667758|NCT02197884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667759|NCT02197884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65667760|NCT02197884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65667761|NCT02197884|Antifungal Agents|antifungal agents|mesh-ancestor
65667762|NCT02197884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65667763|NCT02197884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65667764|NCT02197884|Hormone Antagonists|hormone antagonists|mesh-ancestor
65667765|NCT02197884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65667766|NCT02197884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667767|NCT04196491|Cyclophosphamide|cyclophosphamide|mesh-list
65667768|NCT04196491|Fludarabine|fludarabine|mesh-list
65667769|NCT04196491|Lenalidomide|lenalidomide|mesh-list
65667770|NCT04196491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65667771|NCT04196491|Immunologic Factors|immunologic factors|mesh-ancestor
65667772|NCT04196491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667773|NCT04196491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65667774|NCT04196491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65667775|NCT04196491|Alkylating Agents|alkylating agents|mesh-ancestor
65667776|NCT04196491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667777|NCT04196491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667778|NCT04196491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65667779|NCT04196491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65667780|NCT04196491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65667781|NCT04196491|Growth Substances|growth substances|mesh-ancestor
65667782|NCT04196491|Growth Inhibitors|growth inhibitors|mesh-ancestor
65667784|NCT02201082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65667785|NCT02201082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65667786|NCT03687229|Insulin|insulin|mesh-list
65667787|NCT03687229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65667788|NCT03687229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667789|NCT05085054|Osimertinib|osimertinib|mesh-list
65667790|NCT05085054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667791|NCT05085054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65667792|NCT05085054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667793|NCT05085054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667794|NCT03969121|Palbociclib|palbociclib|mesh-list
65667795|NCT03969121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667796|NCT03969121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65667797|NCT03969121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667798|NCT03969121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667799|NCT02201238|Diclofenac|diclofenac|mesh-list
65667800|NCT02201238|Menthol|menthol|mesh-list
65667801|NCT02201238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65667802|NCT02201238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65667803|NCT02201238|Analgesics|analgesics|mesh-ancestor
65667804|NCT02201238|Sensory System Agents|sensory system agents|mesh-ancestor
65667805|NCT02201238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65667806|NCT02201238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667807|NCT02201238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65667808|NCT02201238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65667809|NCT02201238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65667810|NCT02201238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667811|NCT02201238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667812|NCT02201238|Antipruritics|antipruritics|mesh-ancestor
65667813|NCT02201238|Dermatologic Agents|dermatologic agents|mesh-ancestor
65667814|NCT02257398|Moxifloxacin|moxifloxacin|mesh-list
65667815|NCT02257398|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65667816|NCT02257398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65667817|NCT02257398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65667818|NCT02257398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65667819|NCT02257398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65667820|NCT02257398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667821|NCT02257398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667822|NCT02257398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667823|NCT02257398|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65667824|NCT02257398|Contraceptive Agents|contraceptive agents|mesh-ancestor
65667825|NCT02257398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65667826|NCT02257398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667827|NCT02257398|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65667828|NCT02257398|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65667829|NCT02257398|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65667830|NCT02201316|Mosapride|mosapride|mesh-list
65667831|NCT02201316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667832|NCT02201316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65667833|NCT02201316|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65667834|NCT02201316|Serotonin Agents|serotonin agents|mesh-ancestor
65667835|NCT02201316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65667836|NCT02201316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667837|NCT02198820|Anesthetics|anesthetics|mesh-list
65667838|NCT02198820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65667839|NCT02198820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667840|NCT02257476|Dexamethasone|dexamethasone|mesh-list
65667841|NCT02257476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65667842|NCT02257476|Antiemetics|antiemetics|mesh-ancestor
65667843|NCT02257476|Autonomic Agents|autonomic agents|mesh-ancestor
65667844|NCT02257476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65667845|NCT02257476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667846|NCT02257476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65667847|NCT02257476|Glucocorticoids|glucocorticoids|mesh-ancestor
65667848|NCT02257476|Hormones|hormones|mesh-ancestor
65667849|NCT02257476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65667850|NCT02257476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65667851|NCT02257476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667852|NCT03946111|Naltrexone|naltrexone|mesh-list
65667853|NCT03946111|Bupropion|bupropion|mesh-list
65667854|NCT03946111|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65667855|NCT03946111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65667856|NCT03946111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667857|NCT03946111|Sensory System Agents|sensory system agents|mesh-ancestor
65667858|NCT03946111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65667859|NCT03946111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65667860|NCT03946111|Antidepressive Agents|antidepressive agents|mesh-ancestor
65667861|NCT03946111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65667862|NCT03946111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65667863|NCT03946111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65667864|NCT03946111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65667865|NCT03946111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667866|NCT03946111|Dopamine Agents|dopamine agents|mesh-ancestor
65667867|NCT03946111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65667868|NCT03946111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65667869|NCT03946111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65667870|NCT03946111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667871|NCT03943927|Metoprolol|metoprolol|mesh-list
65667872|NCT03943927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65667873|NCT03943927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65667874|NCT03943927|Sympatholytics|sympatholytics|mesh-ancestor
65667875|NCT03943927|Autonomic Agents|autonomic agents|mesh-ancestor
65667876|NCT03943927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65667877|NCT03943927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667878|NCT03943927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65667879|NCT03943927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65667880|NCT03943927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65667881|NCT03943927|Adrenergic Agents|adrenergic agents|mesh-ancestor
65667882|NCT03943927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65667883|NCT03943927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667884|NCT03533166|Chlorhexidine|chlorhexidine|mesh-list
65667885|NCT03533166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65667886|NCT03533166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65667887|NCT03533166|Disinfectants|disinfectants|mesh-ancestor
65667888|NCT03687073|Silybin|silybin|mesh-list
65667889|NCT03687073|Indole-3-carbinol|indole-3-carbinol|mesh-list
65667890|NCT03687073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65667891|NCT03687073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667892|NCT03687073|Protective Agents|protective agents|mesh-ancestor
65667893|NCT03687073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667894|NCT03687073|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65667895|NCT03682471|Deoxycholic Acid|deoxycholic acid|mesh-list
65667896|NCT03682471|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65667897|NCT03682471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65667898|NCT02202564|Ganciclovir|ganciclovir|mesh-list
65667899|NCT02202564|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65667900|NCT02202564|Antiviral Agents|antiviral agents|mesh-ancestor
65667901|NCT02202564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65667902|NCT02202564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65667903|NCT02202564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667904|NCT02202564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667905|NCT03029143|Vedolizumab|vedolizumab|mesh-list
65667906|NCT03029143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65667907|NCT02198508|Deferasirox|deferasirox|mesh-list
65667908|NCT02198508|Deferiprone|deferiprone|mesh-list
65667909|NCT02198508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65667910|NCT02198508|Chelating Agents|chelating agents|mesh-ancestor
65667911|NCT02198508|Sequestering Agents|sequestering agents|mesh-ancestor
65667912|NCT02198508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667913|NCT02202720|Sevoflurane|sevoflurane|mesh-list
65667914|NCT02202720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65667915|NCT02202720|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65667916|NCT02202720|Anesthetics, General|anesthetics, general|mesh-ancestor
65667917|NCT02202720|Anesthetics|anesthetics|mesh-ancestor
65667918|NCT02202720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65667919|NCT02202720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667920|NCT02206308|Antibodies|antibodies|mesh-list
65667921|NCT02206308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65667922|NCT02206308|Immunologic Factors|immunologic factors|mesh-ancestor
65667923|NCT02206308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667924|NCT03028129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65667925|NCT03028129|Isoniazid|isoniazid|mesh-list
65667926|NCT03028129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65667927|NCT03028129|Antitubercular Agents|antitubercular agents|mesh-ancestor
65667928|NCT03028129|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65667929|NCT03028129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65667930|NCT03028129|Antimetabolites|antimetabolites|mesh-ancestor
65667931|NCT03028129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667932|NCT03028129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65667933|NCT04059679|Aspirin|aspirin|mesh-list
65667934|NCT04059679|Rivaroxaban|rivaroxaban|mesh-list
65667935|NCT04059679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65667936|NCT04059679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65667937|NCT04059679|Analgesics|analgesics|mesh-ancestor
65667938|NCT04059679|Sensory System Agents|sensory system agents|mesh-ancestor
65667939|NCT04059679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65667940|NCT04059679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667941|NCT04059679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65667942|NCT04059679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65667943|NCT04059679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65667944|NCT04059679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65667945|NCT04059679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667946|NCT04059679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65667947|NCT04059679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65667948|NCT04059679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667949|NCT04059679|Antipyretics|antipyretics|mesh-ancestor
65667950|NCT04059679|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65667951|NCT04059679|Antithrombins|antithrombins|mesh-ancestor
65667952|NCT04059679|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65667953|NCT04059679|Protease Inhibitors|protease inhibitors|mesh-ancestor
65667954|NCT04059679|Anticoagulants|anticoagulants|mesh-ancestor
65667955|NCT03533556|Caffeine|caffeine|mesh-list
65667956|NCT03533556|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65667957|NCT03533556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667958|NCT03533556|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65667959|NCT03533556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667960|NCT03533556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667961|NCT03533556|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65667962|NCT03533556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65667963|NCT03533556|Purinergic Agents|purinergic agents|mesh-ancestor
65465297|NCT00388037|Sunitinib|sunitinib|mesh-list
65667964|NCT03533556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65667965|NCT02206854|Flurbiprofen|flurbiprofen|mesh-list
65667966|NCT02206854|Analgesics|analgesics|mesh-ancestor
65667967|NCT02206854|Sensory System Agents|sensory system agents|mesh-ancestor
65667968|NCT02206854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65667969|NCT02206854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65667970|NCT02206854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65667971|NCT02206854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65667972|NCT02206854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65667973|NCT02206854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65667974|NCT02206854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65667975|NCT02206854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667976|NCT02206854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667977|NCT03624205|Paclitaxel|paclitaxel|mesh-list
65667978|NCT03624205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65667979|NCT03624205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65667980|NCT03624205|Tubulin Modulators|tubulin modulators|mesh-ancestor
65667981|NCT03624205|Antimitotic Agents|antimitotic agents|mesh-ancestor
65667982|NCT03624205|Mitosis Modulators|mitosis modulators|mesh-ancestor
65667983|NCT03624205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667984|NCT02206932|Sofosbuvir|sofosbuvir|mesh-list
65667985|NCT02206932|Simeprevir|simeprevir|mesh-list
65667986|NCT02206932|Antiviral Agents|antiviral agents|mesh-ancestor
65667987|NCT02206932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65667988|NCT02206932|Protease Inhibitors|protease inhibitors|mesh-ancestor
65667989|NCT02206932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667990|NCT02206932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667991|NCT02207010|Adavosertib|adavosertib|mesh-list
65667992|NCT02207010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667993|NCT02207010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667994|NCT02203422|Cyclosporine|cyclosporine|mesh-list
65667995|NCT02203422|Cyclosporins|cyclosporins|mesh-list
65667996|NCT02203422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65667997|NCT02203422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65667998|NCT02203422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65667999|NCT02203422|Immunologic Factors|immunologic factors|mesh-ancestor
65668000|NCT02203422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668001|NCT02203422|Antifungal Agents|antifungal agents|mesh-ancestor
65668002|NCT02203422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65668003|NCT02203422|Dermatologic Agents|dermatologic agents|mesh-ancestor
65668004|NCT02203422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65668005|NCT02203422|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65668006|NCT03532854|Valsartan|valsartan|mesh-list
65668007|NCT03532854|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65668008|NCT03532854|Ezetimibe|ezetimibe|mesh-list
65668009|NCT03532854|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65668010|NCT03532854|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65668011|NCT03532854|Antimetabolites|antimetabolites|mesh-ancestor
65668012|NCT03532854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668013|NCT03532854|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65668014|NCT03532854|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65668015|NCT03532854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668016|NCT03532854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65668017|NCT03532854|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65668018|NCT03532854|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65668019|NCT02203500|Telmisartan|telmisartan|mesh-list
65668020|NCT02203500|Lacidipine|lacidipine|mesh-list
65668021|NCT02203500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65668022|NCT02203500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65668023|NCT02203500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65668024|NCT02203500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668025|NCT02203500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65668026|NCT02203500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65668027|NCT02203500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65668028|NCT02203500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668029|NCT02112526|Acalabrutinib|acalabrutinib|mesh-list
65668030|NCT02112526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668031|NCT02203656|Methyltestosterone|methyltestosterone|mesh-list
65668032|NCT02203656|Testosterone|testosterone|mesh-list
65668033|NCT02203656|Testosterone undecanoate|testosterone undecanoate|mesh-list
65668034|NCT02203656|Testosterone enanthate|testosterone enanthate|mesh-list
65668035|NCT02203656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65668036|NCT02203656|Androgens|androgens|mesh-ancestor
65668037|NCT02203656|Hormones|hormones|mesh-ancestor
65668038|NCT02203656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65668039|NCT02203656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668040|NCT02203656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65668041|NCT02203656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668042|NCT02203656|Anabolic Agents|anabolic agents|mesh-ancestor
65668043|NCT04431388|Levobupivacaine|levobupivacaine|mesh-list
65668044|NCT04431388|Anesthetics, Local|anesthetics, local|mesh-ancestor
65668045|NCT04431388|Anesthetics|anesthetics|mesh-ancestor
65668046|NCT04431388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65668047|NCT04431388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668048|NCT04431388|Sensory System Agents|sensory system agents|mesh-ancestor
65668049|NCT04431388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65668050|NCT02199444|Sevelamer|sevelamer|mesh-list
65668051|NCT02199444|Chelating Agents|chelating agents|mesh-ancestor
65668052|NCT02199444|Sequestering Agents|sequestering agents|mesh-ancestor
65668053|NCT02199444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668054|NCT02199522|Propofol|propofol|mesh-list
65668055|NCT02199522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65668056|NCT02199522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65668057|NCT02199522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668058|NCT02199522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65668059|NCT02199522|Anesthetics, General|anesthetics, general|mesh-ancestor
65668060|NCT02199522|Anesthetics|anesthetics|mesh-ancestor
65668061|NCT03532698|Aspirin|aspirin|mesh-list
65668062|NCT03532698|Osimertinib|osimertinib|mesh-list
65668063|NCT03532698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65668064|NCT03532698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65668065|NCT03532698|Analgesics|analgesics|mesh-ancestor
65668066|NCT03532698|Sensory System Agents|sensory system agents|mesh-ancestor
65668067|NCT03532698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65668068|NCT03532698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668069|NCT03532698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65668070|NCT03532698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65668071|NCT03532698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65668072|NCT03532698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65668073|NCT03532698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668074|NCT03532698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65668075|NCT03532698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65668076|NCT03532698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668077|NCT03532698|Antipyretics|antipyretics|mesh-ancestor
65668078|NCT03532698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668079|NCT03532698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65668080|NCT04169737|Venetoclax|venetoclax|mesh-list
65668081|NCT04169737|Obinutuzumab|obinutuzumab|mesh-list
65668082|NCT04169737|Acalabrutinib|acalabrutinib|mesh-list
65668083|NCT04169737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668084|NCT04169737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65668085|NCT03690739|Gemcitabine|gemcitabine|mesh-list
65668086|NCT03690739|Paclitaxel|paclitaxel|mesh-list
65668087|NCT03690739|Bevacizumab|bevacizumab|mesh-list
65668088|NCT03690739|Carboplatin|carboplatin|mesh-list
65668089|NCT03690739|Trabectedin|trabectedin|mesh-list
65668090|NCT03690739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65668091|NCT03690739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668092|NCT03690739|Tubulin Modulators|tubulin modulators|mesh-ancestor
65668093|NCT03690739|Antimitotic Agents|antimitotic agents|mesh-ancestor
65668094|NCT03690739|Mitosis Modulators|mitosis modulators|mesh-ancestor
65668095|NCT03690739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668096|NCT03690739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65668097|NCT03690739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65668098|NCT03690739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65668099|NCT03690739|Growth Substances|growth substances|mesh-ancestor
65668100|NCT03690739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668101|NCT03690739|Growth Inhibitors|growth inhibitors|mesh-ancestor
65668102|NCT03690739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65668103|NCT03690739|Antimetabolites|antimetabolites|mesh-ancestor
65668104|NCT03690739|Antiviral Agents|antiviral agents|mesh-ancestor
65668105|NCT03690739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65668106|NCT03690739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668107|NCT03690739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65668108|NCT03690739|Immunologic Factors|immunologic factors|mesh-ancestor
65668109|NCT03690739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65668110|NCT03690739|Alkylating Agents|alkylating agents|mesh-ancestor
65668111|NCT02199678|Ketamine|ketamine|mesh-list
65668112|NCT02199678|Analgesics|analgesics|mesh-ancestor
65668113|NCT02199678|Sensory System Agents|sensory system agents|mesh-ancestor
65668114|NCT02199678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65668115|NCT02199678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465457|NCT00384293|Niacin|niacin|mesh-list
65668116|NCT02199678|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65668118|NCT02199678|Anesthetics, General|anesthetics, general|mesh-ancestor
65668119|NCT02199678|Anesthetics|anesthetics|mesh-ancestor
65668120|NCT02199678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65668121|NCT02199678|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65668122|NCT02199678|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65668123|NCT02199678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65668124|NCT02199678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668125|NCT03681613|Pyrantel|pyrantel|mesh-list
65668126|NCT03681613|Pyrantel Pamoate|pyrantel pamoate|mesh-list
65668127|NCT03681613|Antinematodal Agents|antinematodal agents|mesh-ancestor
65668128|NCT03681613|Anthelmintics|anthelmintics|mesh-ancestor
65668129|NCT03681613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65668130|NCT03681613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65668131|NCT03681613|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
65668132|NCT03681613|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65668133|NCT03681613|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65668134|NCT03681613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65668135|NCT03681613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668136|NCT03690583|Zinc|zinc|mesh-list
65668137|NCT03690583|Zinc Sulfate|zinc sulfate|mesh-list
65668138|NCT03690583|Trace Elements|trace elements|mesh-ancestor
65668139|NCT03690583|Micronutrients|micronutrients|mesh-ancestor
65668140|NCT03690583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668141|NCT03690583|Astringents|astringents|mesh-ancestor
65668142|NCT03690583|Dermatologic Agents|dermatologic agents|mesh-ancestor
65668143|NCT02920008|Guadecitabine|guadecitabine|mesh-list
65668144|NCT02920008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668145|NCT01309672|Prednisone|prednisone|mesh-list
65668146|NCT01309672|Abiraterone Acetate|abiraterone acetate|mesh-list
65668147|NCT01309672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65668148|NCT01309672|Glucocorticoids|glucocorticoids|mesh-ancestor
65668149|NCT01309672|Hormones|hormones|mesh-ancestor
65668150|NCT01309672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65668151|NCT01309672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668152|NCT01309672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65668153|NCT01309672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668154|NCT01309672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65668155|NCT01309672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668156|NCT01309672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668157|NCT01309672|Hormone Antagonists|hormone antagonists|mesh-ancestor
65668158|NCT01309672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65668159|NCT03026257|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65668160|NCT03026257|Contact Lens Solutions|contact lens solutions|mesh-list
65668161|NCT03026257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65668162|NCT03026257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65668163|NCT03026257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65668164|NCT03026257|Disinfectants|disinfectants|mesh-ancestor
65668165|NCT02200146|Hydroxychloroquine|hydroxychloroquine|mesh-list
65668166|NCT02200146|Prednisone|prednisone|mesh-list
65668167|NCT02200146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65668168|NCT02200146|Glucocorticoids|glucocorticoids|mesh-ancestor
65668169|NCT02200146|Hormones|hormones|mesh-ancestor
65668170|NCT02200146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65668171|NCT02200146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668172|NCT02200146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65668173|NCT02200146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668174|NCT02200146|Antimalarials|antimalarials|mesh-ancestor
65668175|NCT02200146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65668176|NCT02200146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65668177|NCT02200146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65668178|NCT02200146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668179|NCT02200146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668180|NCT02200146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65668181|NCT02208492|Levetiracetam|levetiracetam|mesh-list
65668182|NCT02208492|Anticonvulsants|anticonvulsants|mesh-ancestor
65668183|NCT02208492|Nootropic Agents|nootropic agents|mesh-ancestor
65668184|NCT01933048|Vaccines|vaccines|mesh-list
65668185|NCT01933048|Immunologic Factors|immunologic factors|mesh-ancestor
65668186|NCT01933048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668187|NCT02208882|Midazolam|midazolam|mesh-list
65668188|NCT02208882|BMS-986120|bms-986120|mesh-list
65668189|NCT02208882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65668190|NCT02208882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65668191|NCT02208882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65668192|NCT02208882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668193|NCT02208882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65668194|NCT02208882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65668195|NCT02208882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65668196|NCT02208882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65668197|NCT02208882|Anesthetics, General|anesthetics, general|mesh-ancestor
65668198|NCT02208882|Anesthetics|anesthetics|mesh-ancestor
65668199|NCT02208882|GABA Modulators|gaba modulators|mesh-ancestor
65668200|NCT02208882|GABA Agents|gaba agents|mesh-ancestor
65668201|NCT02208882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65668202|NCT02208882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668203|NCT02208882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65668204|NCT03690115|Ponatinib|ponatinib|mesh-list
65668205|NCT03690115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668206|NCT03690115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65668207|NCT03690115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668208|NCT03690115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668209|NCT02204202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65668210|NCT02204202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65668211|NCT02204202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668212|NCT03703297|Durvalumab|durvalumab|mesh-list
65668213|NCT03703297|Tremelimumab|tremelimumab|mesh-list
65668214|NCT03703297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65668215|NCT03703297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668216|NCT01886794|Estrogens|estrogens|mesh-list
65668217|NCT01886794|Hormones|hormones|mesh-ancestor
65668218|NCT01886794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65668219|NCT01886794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668220|NCT02209350|Aspirin|aspirin|mesh-list
65668221|NCT02209350|Clopidogrel|clopidogrel|mesh-list
65668222|NCT02209350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65668223|NCT02209350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65668224|NCT02209350|Analgesics|analgesics|mesh-ancestor
65668225|NCT02209350|Sensory System Agents|sensory system agents|mesh-ancestor
65668226|NCT02209350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65668227|NCT02209350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668228|NCT02209350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65668229|NCT02209350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65668230|NCT02209350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65668231|NCT02209350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65668232|NCT02209350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668233|NCT02209350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65668234|NCT02209350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65668235|NCT02209350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668236|NCT02209350|Antipyretics|antipyretics|mesh-ancestor
65668237|NCT02209350|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65668238|NCT02209350|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65668239|NCT02209350|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65668240|NCT02209350|Purinergic Agents|purinergic agents|mesh-ancestor
65668241|NCT02209350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65668242|NCT02209428|Temozolomide|temozolomide|mesh-list
65668243|NCT02209428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65668244|NCT02209428|Alkylating Agents|alkylating agents|mesh-ancestor
65668245|NCT02209428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668246|NCT02209428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668247|NCT02200848|Rituximab|rituximab|mesh-list
65668248|NCT02200848|Lenalidomide|lenalidomide|mesh-list
65668249|NCT02200848|Glutarimide|glutarimide|mesh-list
65668250|NCT02200848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65668251|NCT02200848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668252|NCT02200848|Immunologic Factors|immunologic factors|mesh-ancestor
65668253|NCT02200848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668254|NCT02200848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65668255|NCT02200848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65668256|NCT02200848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65668257|NCT02200848|Growth Substances|growth substances|mesh-ancestor
65668258|NCT02200848|Growth Inhibitors|growth inhibitors|mesh-ancestor
65668259|NCT02200848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65668260|NCT02200848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668261|NCT02200848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668262|NCT03895567|Ceftriaxone|ceftriaxone|mesh-list
65668263|NCT03895567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65668264|NCT03895567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65668265|NCT02751450|Fluorides|fluorides|mesh-list
65668266|NCT02751450|Tin Fluorides|tin fluorides|mesh-list
65668267|NCT02751450|Fluorophosphate|fluorophosphate|mesh-list
65668268|NCT02751450|Cariostatic Agents|cariostatic agents|mesh-ancestor
65668269|NCT02751450|Protective Agents|protective agents|mesh-ancestor
65668270|NCT02751450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668271|NCT02209740|Tenofovir|tenofovir|mesh-list
65668272|NCT02209740|Antiviral Agents|antiviral agents|mesh-ancestor
65668273|NCT02209740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65668274|NCT02209740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65668275|NCT02209740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65668276|NCT02209740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668277|NCT02209740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668278|NCT02209740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65668279|NCT02209740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65668280|NCT02257788|Leronlimab|leronlimab|mesh-list
65668281|NCT02257788|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65668282|NCT02257788|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65668283|NCT02257788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668284|NCT02257788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65668285|NCT02257788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65668286|NCT02257788|Antiviral Agents|antiviral agents|mesh-ancestor
65668287|NCT02257788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65668288|NCT02220660|Olodaterol|olodaterol|mesh-list
65668289|NCT02220660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65668290|NCT02220660|Autonomic Agents|autonomic agents|mesh-ancestor
65668291|NCT02220660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65668292|NCT02220660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668293|NCT02220660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65668294|NCT02220660|Respiratory System Agents|respiratory system agents|mesh-ancestor
65668295|NCT01515748|Docetaxel|docetaxel|mesh-list
65668296|NCT01515748|Fluorouracil|fluorouracil|mesh-list
65668297|NCT01515748|Oxaliplatin|oxaliplatin|mesh-list
65668298|NCT01515748|Tegafur|tegafur|mesh-list
65668299|NCT01515748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668300|NCT01515748|Tubulin Modulators|tubulin modulators|mesh-ancestor
65668301|NCT01515748|Antimitotic Agents|antimitotic agents|mesh-ancestor
65668302|NCT01515748|Mitosis Modulators|mitosis modulators|mesh-ancestor
65668303|NCT01515748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668304|NCT01515748|Antimetabolites|antimetabolites|mesh-ancestor
65668305|NCT01515748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65668306|NCT01515748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65668307|NCT01515748|Immunologic Factors|immunologic factors|mesh-ancestor
65668308|NCT01515748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668309|NCT04973722|Denosumab|denosumab|mesh-list
65668310|NCT04973722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65668311|NCT04973722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668312|NCT03284034|Deoxycholic Acid|deoxycholic acid|mesh-list
65668313|NCT03284034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65668314|NCT03284034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65668315|NCT01358175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65668316|NCT01358175|Immunologic Factors|immunologic factors|mesh-ancestor
65668317|NCT01358175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668318|NCT02209974|Fluticasone|fluticasone|mesh-list
65668319|NCT02209974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65668320|NCT02209974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65668321|NCT02209974|Autonomic Agents|autonomic agents|mesh-ancestor
65668322|NCT02209974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65668323|NCT02209974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668324|NCT02209974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65668325|NCT02209974|Respiratory System Agents|respiratory system agents|mesh-ancestor
65668326|NCT02209974|Dermatologic Agents|dermatologic agents|mesh-ancestor
65668327|NCT02209974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65668328|NCT02212392|Meropenem|meropenem|mesh-list
65668329|NCT02212392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65668330|NCT02212392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65668331|NCT03679897|Ropivacaine|ropivacaine|mesh-list
65668332|NCT03679897|Levobupivacaine|levobupivacaine|mesh-list
65668333|NCT03679897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65668334|NCT03679897|Anesthetics, Local|anesthetics, local|mesh-ancestor
65668335|NCT03679897|Anesthetics|anesthetics|mesh-ancestor
65668336|NCT03679897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65668337|NCT03679897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668338|NCT03679897|Sensory System Agents|sensory system agents|mesh-ancestor
65668339|NCT03679897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65668340|NCT03060070|Dexmedetomidine|dexmedetomidine|mesh-list
65668341|NCT03060070|Ketamine|ketamine|mesh-list
65668342|NCT03060070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65668343|NCT03060070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65668344|NCT03060070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668345|NCT03060070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65668347|NCT03060070|Sensory System Agents|sensory system agents|mesh-ancestor
65668348|NCT03060070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65668349|NCT03060070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65668350|NCT03060070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65668351|NCT03060070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65668352|NCT03060070|Adrenergic Agents|adrenergic agents|mesh-ancestor
65668353|NCT03060070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65668354|NCT03060070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668355|NCT03060070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65668356|NCT03060070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65668357|NCT03060070|Anesthetics, General|anesthetics, general|mesh-ancestor
65668358|NCT03060070|Anesthetics|anesthetics|mesh-ancestor
65668359|NCT03060070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65668360|NCT03060070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65668361|NCT03683563|Citric Acid|citric acid|mesh-list
65668362|NCT03683563|Sodium Citrate|sodium citrate|mesh-list
65668363|NCT03683563|Anticoagulants|anticoagulants|mesh-ancestor
65668364|NCT03683563|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65668365|NCT03683563|Chelating Agents|chelating agents|mesh-ancestor
65668366|NCT03683563|Sequestering Agents|sequestering agents|mesh-ancestor
65668367|NCT03683563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668368|NCT03563625|Bupivacaine|bupivacaine|mesh-list
65668369|NCT03563625|Anesthetics, Local|anesthetics, local|mesh-ancestor
65668370|NCT03563625|Anesthetics|anesthetics|mesh-ancestor
65668371|NCT03563625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65668372|NCT03563625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668373|NCT03563625|Sensory System Agents|sensory system agents|mesh-ancestor
65668374|NCT03563625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65668375|NCT02832375|Fluorides|fluorides|mesh-list
65668376|NCT02832375|Tin Fluorides|tin fluorides|mesh-list
65668377|NCT02832375|Fluorophosphate|fluorophosphate|mesh-list
65668378|NCT02832375|Cariostatic Agents|cariostatic agents|mesh-ancestor
65668379|NCT02832375|Protective Agents|protective agents|mesh-ancestor
65668380|NCT02832375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668381|NCT04834024|Antibodies|antibodies|mesh-list
65668382|NCT04834024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65668383|NCT04834024|Immunologic Factors|immunologic factors|mesh-ancestor
65668384|NCT04834024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668385|NCT03683329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65668386|NCT03683329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65668387|NCT02218476|Coenzyme Q10|coenzyme q10|mesh-list
65668388|NCT02218476|Vitamins|vitamins|mesh-ancestor
65668389|NCT02218476|Micronutrients|micronutrients|mesh-ancestor
65668390|NCT02218476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668391|NCT02205996|Insulin|insulin|mesh-list
65668392|NCT02205996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65668393|NCT02205996|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65668394|NCT02205996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668395|NCT02220036|Magnesium Oxide|magnesium oxide|mesh-list
65668396|NCT02220036|Antacids|antacids|mesh-ancestor
65668397|NCT02220036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668398|NCT02220036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65668399|NCT02220114|Vigabatrin|vigabatrin|mesh-list
65668400|NCT02220114|Anticonvulsants|anticonvulsants|mesh-ancestor
65668401|NCT02220114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668402|NCT02220114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668403|NCT02220114|GABA Agents|gaba agents|mesh-ancestor
65668404|NCT02220114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65668405|NCT02220114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668406|NCT02221596|Vitamin D|vitamin d|mesh-list
65668407|NCT02221596|Vitamins|vitamins|mesh-ancestor
65668408|NCT02221596|Micronutrients|micronutrients|mesh-ancestor
65668409|NCT02221596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668410|NCT02221596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65668411|NCT02221752|Folic Acid|folic acid|mesh-list
65668412|NCT02221752|Vitamin B Complex|vitamin b complex|mesh-list
65668413|NCT02221752|Hematinics|hematinics|mesh-ancestor
65668414|NCT02221752|Vitamins|vitamins|mesh-ancestor
65668415|NCT02221752|Micronutrients|micronutrients|mesh-ancestor
65668416|NCT02221752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668417|NCT04971382|Curcumin|curcumin|mesh-list
65668418|NCT04971382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65668419|NCT04971382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65668420|NCT04971382|Analgesics|analgesics|mesh-ancestor
65668421|NCT04971382|Sensory System Agents|sensory system agents|mesh-ancestor
65668422|NCT04971382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65668423|NCT04971382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668424|NCT04971382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65668425|NCT04971382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65668426|NCT04971382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668427|NCT04971382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668428|NCT04971382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668429|NCT04971304|Lenograstim|lenograstim|mesh-list
65668430|NCT04971304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65668431|NCT04971304|Immunologic Factors|immunologic factors|mesh-ancestor
65668432|NCT04971304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668433|NCT02220348|Linaclotide|linaclotide|mesh-list
65668434|NCT02220348|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65668435|NCT02220348|Enzyme Activators|enzyme activators|mesh-ancestor
65668436|NCT02220348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668437|NCT02220348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65668438|NCT04151680|Rivaroxaban|rivaroxaban|mesh-list
65668439|NCT04151680|Apixaban|apixaban|mesh-list
65668440|NCT04151680|Edoxaban|edoxaban|mesh-list
65668441|NCT04151680|Dabigatran|dabigatran|mesh-list
65668442|NCT04151680|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65668443|NCT04151680|Antithrombins|antithrombins|mesh-ancestor
65668444|NCT04151680|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65668445|NCT04151680|Protease Inhibitors|protease inhibitors|mesh-ancestor
65668446|NCT04151680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668447|NCT04151680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668448|NCT04151680|Anticoagulants|anticoagulants|mesh-ancestor
65668449|NCT02221830|Oxytocin|oxytocin|mesh-list
65668450|NCT02221830|Oxytocics|oxytocics|mesh-ancestor
65668451|NCT02221830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65668452|NCT02221830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668453|NCT02224950|Emollients|emollients|mesh-list
65668454|NCT02224950|Chitosan|chitosan|mesh-list
65668455|NCT02224950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65668456|NCT02224950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65668457|NCT02224950|Antimetabolites|antimetabolites|mesh-ancestor
65668458|NCT02224950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668459|NCT02224950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65668460|NCT02224950|Chelating Agents|chelating agents|mesh-ancestor
65668461|NCT02224950|Sequestering Agents|sequestering agents|mesh-ancestor
65668462|NCT02224950|Hemostatics|hemostatics|mesh-ancestor
65668463|NCT02224950|Coagulants|coagulants|mesh-ancestor
65668464|NCT02224950|Dermatologic Agents|dermatologic agents|mesh-ancestor
65668465|NCT03039114|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65668466|NCT03039114|Obinutuzumab|obinutuzumab|mesh-list
65668467|NCT03039114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65668468|NCT03039114|Alkylating Agents|alkylating agents|mesh-ancestor
65668469|NCT03039114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668470|NCT03039114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668471|NCT03039114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65668472|NCT04970602|Methylene Blue|methylene blue|mesh-list
65668473|NCT04970602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668474|NCT04970602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668475|NCT04970446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65668476|NCT04970446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65668477|NCT02831673|Tenofovir|tenofovir|mesh-list
65668478|NCT02831673|Lamivudine|lamivudine|mesh-list
65668479|NCT02831673|Emtricitabine|emtricitabine|mesh-list
65668480|NCT02831673|Dolutegravir|dolutegravir|mesh-list
65668481|NCT02831673|Antiviral Agents|antiviral agents|mesh-ancestor
65668482|NCT02831673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65668483|NCT02831673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65668484|NCT02831673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65668485|NCT02831673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668486|NCT02831673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668487|NCT02831673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65668488|NCT02831673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65668489|NCT02831673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65668490|NCT02831673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65668491|NCT02220504|Antipsychotic Agents|antipsychotic agents|mesh-list
65668492|NCT02220504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65668493|NCT02220504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65668494|NCT02220504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668495|NCT02220504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65668496|NCT04962958|Leucovorin|leucovorin|mesh-list
65668497|NCT04962958|Fluorouracil|fluorouracil|mesh-list
65668498|NCT04962958|Oxaliplatin|oxaliplatin|mesh-list
65668499|NCT04962958|Antimetabolites|antimetabolites|mesh-ancestor
65668500|NCT04962958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668501|NCT04962958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65668502|NCT04962958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668503|NCT04962958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65668504|NCT04962958|Immunologic Factors|immunologic factors|mesh-ancestor
65668505|NCT04962958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668506|NCT04962958|Antidotes|antidotes|mesh-ancestor
65668507|NCT04962958|Protective Agents|protective agents|mesh-ancestor
65668508|NCT04962958|Vitamin B Complex|vitamin b complex|mesh-ancestor
65668509|NCT04962958|Vitamins|vitamins|mesh-ancestor
65668510|NCT04962958|Micronutrients|micronutrients|mesh-ancestor
65668511|NCT02031510|Dexmedetomidine|dexmedetomidine|mesh-list
65668512|NCT02031510|Bupivacaine|bupivacaine|mesh-list
65668513|NCT02031510|Anesthetics, Local|anesthetics, local|mesh-ancestor
65668514|NCT02031510|Anesthetics|anesthetics|mesh-ancestor
65668515|NCT02031510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65668516|NCT02031510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668517|NCT02031510|Sensory System Agents|sensory system agents|mesh-ancestor
65668518|NCT02031510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65668519|NCT02031510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65668520|NCT02031510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65668521|NCT02031510|Analgesics|analgesics|mesh-ancestor
65668522|NCT02031510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65668523|NCT02031510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65668524|NCT02031510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65668525|NCT02031510|Adrenergic Agents|adrenergic agents|mesh-ancestor
65668526|NCT02031510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65668527|NCT02031510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668528|NCT04961788|Antibodies|antibodies|mesh-list
65668529|NCT04961788|Immunologic Factors|immunologic factors|mesh-ancestor
65668530|NCT04961788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668531|NCT02222142|Anesthetics|anesthetics|mesh-list
65668532|NCT02222142|Isoflurane|isoflurane|mesh-list
65668533|NCT02222142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65668534|NCT02222142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668535|NCT02222142|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65668536|NCT02222142|Anesthetics, General|anesthetics, general|mesh-ancestor
65668537|NCT04426084|Antihypertensive Agents|antihypertensive agents|mesh-list
65668538|NCT04425382|Ritonavir|ritonavir|mesh-list
65668539|NCT04425382|Lopinavir|lopinavir|mesh-list
65668540|NCT04425382|Darunavir|darunavir|mesh-list
65668541|NCT04425382|Cobicistat|cobicistat|mesh-list
65668542|NCT04425382|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
65668543|NCT04425382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65668544|NCT04425382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65668545|NCT04425382|Protease Inhibitors|protease inhibitors|mesh-ancestor
65668546|NCT04425382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668547|NCT04425382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668548|NCT04425382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65668549|NCT04425382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65668550|NCT04425382|Antiviral Agents|antiviral agents|mesh-ancestor
65668551|NCT04425382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65668552|NCT04425382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65668553|NCT04425382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65668554|NCT03563937|Rivaroxaban|rivaroxaban|mesh-list
65668555|NCT03563937|Apixaban|apixaban|mesh-list
65668556|NCT03563937|Edoxaban|edoxaban|mesh-list
65668557|NCT03563937|Phenprocoumon|phenprocoumon|mesh-list
65668558|NCT03563937|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65668559|NCT03563937|Antithrombins|antithrombins|mesh-ancestor
65668560|NCT03563937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65668561|NCT03563937|Protease Inhibitors|protease inhibitors|mesh-ancestor
65668562|NCT03563937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668563|NCT03563937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668564|NCT03563937|Anticoagulants|anticoagulants|mesh-ancestor
65668565|NCT02231346|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
65668566|NCT02231346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65668567|NCT02231346|Autonomic Agents|autonomic agents|mesh-ancestor
65668568|NCT02231346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65668569|NCT02231346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668570|NCT02231346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65668571|NCT02231346|Respiratory System Agents|respiratory system agents|mesh-ancestor
65668572|NCT02225418|Ropivacaine|ropivacaine|mesh-list
65668573|NCT02225418|Anesthetics, Local|anesthetics, local|mesh-ancestor
65668574|NCT02225418|Anesthetics|anesthetics|mesh-ancestor
65668575|NCT02225418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65668576|NCT02225418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668577|NCT02225418|Sensory System Agents|sensory system agents|mesh-ancestor
65668578|NCT02225418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65668579|NCT02231424|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
65668580|NCT02231424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65668581|NCT02231424|Autonomic Agents|autonomic agents|mesh-ancestor
65668582|NCT02231424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65668583|NCT02231424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668584|NCT02231424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65668585|NCT02231424|Respiratory System Agents|respiratory system agents|mesh-ancestor
65668586|NCT05057130|Cisplatin|cisplatin|mesh-list
65668587|NCT05057130|Doxorubicin|doxorubicin|mesh-list
65668588|NCT05057130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65668589|NCT05057130|Methotrexate|methotrexate|mesh-list
65668590|NCT05057130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668591|NCT05057130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65668592|NCT05057130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65668593|NCT05057130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65668594|NCT05057130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668595|NCT05057130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668596|NCT05057130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65668597|NCT05057130|Abortifacient Agents|abortifacient agents|mesh-ancestor
65668598|NCT05057130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65668599|NCT05057130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668600|NCT05057130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65668601|NCT05057130|Antimetabolites|antimetabolites|mesh-ancestor
65668602|NCT05057130|Dermatologic Agents|dermatologic agents|mesh-ancestor
65668603|NCT05057130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65668604|NCT05057130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65668605|NCT05057130|Immunologic Factors|immunologic factors|mesh-ancestor
65668606|NCT05057130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65668607|NCT05057130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65668608|NCT02222220|Metoclopramide|metoclopramide|mesh-list
65668609|NCT02222220|Antiemetics|antiemetics|mesh-ancestor
65668610|NCT02222220|Autonomic Agents|autonomic agents|mesh-ancestor
65668611|NCT02222220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65668612|NCT02222220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668613|NCT02222220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65668614|NCT02222220|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65668615|NCT02222220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65668616|NCT02222220|Dopamine Agents|dopamine agents|mesh-ancestor
65668617|NCT02222220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65668618|NCT02222220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668619|NCT03677323|Sufentanil|sufentanil|mesh-list
65668620|NCT03677323|Droperidol|droperidol|mesh-list
65668621|NCT03677323|Propofol|propofol|mesh-list
65668622|NCT03677323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65668623|NCT03677323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65668624|NCT03677323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668625|NCT03677323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65668626|NCT03677323|Anesthetics, General|anesthetics, general|mesh-ancestor
65668627|NCT03677323|Anesthetics|anesthetics|mesh-ancestor
65668628|NCT03677323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65668629|NCT03677323|Narcotics|narcotics|mesh-ancestor
65668630|NCT03677323|Analgesics|analgesics|mesh-ancestor
65668631|NCT03677323|Sensory System Agents|sensory system agents|mesh-ancestor
65668632|NCT03677323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65668633|NCT03677323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65668634|NCT03677323|Antiemetics|antiemetics|mesh-ancestor
65668635|NCT03677323|Autonomic Agents|autonomic agents|mesh-ancestor
65668636|NCT03677323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65668637|NCT03677323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65668638|NCT03677323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65668639|NCT03677323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65668640|NCT03677323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65668641|NCT03677323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65668642|NCT03677323|Dopamine Agents|dopamine agents|mesh-ancestor
65668643|NCT03677323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65668644|NCT03677323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668645|NCT02225652|Paclitaxel|paclitaxel|mesh-list
65668646|NCT02225652|Cyclophosphamide|cyclophosphamide|mesh-list
65668647|NCT02225652|Fluorouracil|fluorouracil|mesh-list
65668648|NCT02225652|Epirubicin|epirubicin|mesh-list
65668649|NCT02225652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65668650|NCT02225652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668651|NCT02225652|Tubulin Modulators|tubulin modulators|mesh-ancestor
65668652|NCT02225652|Antimitotic Agents|antimitotic agents|mesh-ancestor
65668653|NCT02225652|Mitosis Modulators|mitosis modulators|mesh-ancestor
65668654|NCT02225652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668655|NCT02225652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65668656|NCT02225652|Immunologic Factors|immunologic factors|mesh-ancestor
65668657|NCT02225652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668658|NCT02225652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65668659|NCT02225652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65668660|NCT02225652|Alkylating Agents|alkylating agents|mesh-ancestor
65668661|NCT02225652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65668662|NCT02225652|Antimetabolites|antimetabolites|mesh-ancestor
65668663|NCT02225652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65668664|NCT02225652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65668665|NCT02225652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65668666|NCT02225652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65668667|NCT02225652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668668|NCT02222376|Pirfenidone|pirfenidone|mesh-list
65668669|NCT02222376|Analgesics|analgesics|mesh-ancestor
65668670|NCT02222376|Sensory System Agents|sensory system agents|mesh-ancestor
65668671|NCT02222376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65668672|NCT02222376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668673|NCT02222376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65668674|NCT02222376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65668675|NCT02222376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65668676|NCT02222376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65668677|NCT02222376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668678|NCT02231658|Liraglutide|liraglutide|mesh-list
65668679|NCT02231658|Lixisenatide|lixisenatide|mesh-list
65668680|NCT02231658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65668681|NCT02231658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668682|NCT02231658|Incretins|incretins|mesh-ancestor
65668683|NCT02231658|Hormones|hormones|mesh-ancestor
65668684|NCT02231658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65668685|NCT04542408|Heparin|heparin|mesh-list
65668686|NCT04542408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65668687|NCT04542408|Tinzaparin|tinzaparin|mesh-list
65668688|NCT04542408|Dalteparin|dalteparin|mesh-list
65668689|NCT04542408|Edoxaban|edoxaban|mesh-list
65668690|NCT04542408|Anticoagulants|anticoagulants|mesh-list
65668691|NCT04542408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65668692|NCT04542408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65668693|NCT04542408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668694|NCT04542408|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65668695|NCT04542408|Antithrombins|antithrombins|mesh-ancestor
65668696|NCT04542408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65668697|NCT04542408|Protease Inhibitors|protease inhibitors|mesh-ancestor
65668698|NCT04542408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668699|NCT03059134|Mirabegron|mirabegron|mesh-list
65668700|NCT03059134|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65668701|NCT03059134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65668702|NCT03059134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65668703|NCT03059134|Adrenergic Agents|adrenergic agents|mesh-ancestor
65668704|NCT03059134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65668705|NCT03059134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668706|NCT03059134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668707|NCT03059134|Urological Agents|urological agents|mesh-ancestor
65668708|NCT02225886|Ascorbic Acid|ascorbic acid|mesh-list
65668709|NCT02225886|Antioxidants|antioxidants|mesh-ancestor
65668710|NCT02225886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668711|NCT02225886|Protective Agents|protective agents|mesh-ancestor
65668712|NCT02225886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668713|NCT02225886|Vitamins|vitamins|mesh-ancestor
65668714|NCT02225886|Micronutrients|micronutrients|mesh-ancestor
65668715|NCT02928991|Vidarabine|vidarabine|mesh-list
65668716|NCT02928991|Fludarabine|fludarabine|mesh-list
65668717|NCT02928991|Fludarabine phosphate|fludarabine phosphate|mesh-list
65668718|NCT02928991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668719|NCT02928991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65668720|NCT02928991|Antimetabolites|antimetabolites|mesh-ancestor
65668721|NCT02928991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668722|NCT02928991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65668723|NCT02928991|Immunologic Factors|immunologic factors|mesh-ancestor
65668724|NCT02928991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668725|NCT02928991|Antiviral Agents|antiviral agents|mesh-ancestor
65668726|NCT02928991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65668727|NCT03554317|Nivolumab|nivolumab|mesh-list
65668728|NCT03554317|Methyltestosterone|methyltestosterone|mesh-list
65668729|NCT03554317|Testosterone|testosterone|mesh-list
65668730|NCT03554317|Testosterone undecanoate|testosterone undecanoate|mesh-list
65668731|NCT03554317|Testosterone enanthate|testosterone enanthate|mesh-list
65668732|NCT03554317|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65668733|NCT03554317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65668734|NCT03554317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668735|NCT03554317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65668736|NCT03554317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668737|NCT03554317|Androgens|androgens|mesh-ancestor
65668738|NCT03554317|Hormones|hormones|mesh-ancestor
65668739|NCT03554317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65668740|NCT03554317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668741|NCT03554317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65668742|NCT03554317|Anabolic Agents|anabolic agents|mesh-ancestor
65668743|NCT03623425|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65668744|NCT03623425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65668745|NCT03623425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668746|NCT04957420|Rotigotine|rotigotine|mesh-list
65668747|NCT04957420|Dopamine Agonists|dopamine agonists|mesh-ancestor
65668748|NCT04957420|Dopamine Agents|dopamine agents|mesh-ancestor
65668749|NCT04957420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65668750|NCT04957420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668751|NCT04957420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668752|NCT03350035|Ganaxolone|ganaxolone|mesh-list
65668753|NCT03350035|Neurosteroids|neurosteroids|mesh-ancestor
65668754|NCT03350035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65668755|NCT03350035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668756|NCT03350035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668757|NCT03350035|GABA Modulators|gaba modulators|mesh-ancestor
65668758|NCT03350035|GABA Agents|gaba agents|mesh-ancestor
65668759|NCT02905188|Cyclophosphamide|cyclophosphamide|mesh-list
65668760|NCT02905188|Fludarabine|fludarabine|mesh-list
65668761|NCT02905188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65668762|NCT02905188|Immunologic Factors|immunologic factors|mesh-ancestor
65668763|NCT02905188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668764|NCT02905188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65668765|NCT02905188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65668766|NCT02905188|Alkylating Agents|alkylating agents|mesh-ancestor
65668767|NCT02905188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668768|NCT02905188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668769|NCT02905188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65668770|NCT03676933|Hydrocortisone|hydrocortisone|mesh-list
65668771|NCT03676933|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
65668772|NCT03676933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65668773|NCT03676933|Dermatologic Agents|dermatologic agents|mesh-ancestor
65668774|NCT03671941|Ticagrelor|ticagrelor|mesh-list
65668775|NCT03671941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65668776|NCT03671941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65668777|NCT03671941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65668778|NCT03671941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65668779|NCT03671941|Purinergic Agents|purinergic agents|mesh-ancestor
65668780|NCT03671941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65668781|NCT03671941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668782|NCT03671941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668783|NCT03058900|Methotrexate|methotrexate|mesh-list
65668784|NCT03058900|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65668785|NCT03058900|Abortifacient Agents|abortifacient agents|mesh-ancestor
65668786|NCT03058900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65668787|NCT03058900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668788|NCT03058900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65668789|NCT03058900|Antimetabolites|antimetabolites|mesh-ancestor
65668790|NCT03058900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668791|NCT03058900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668792|NCT03058900|Dermatologic Agents|dermatologic agents|mesh-ancestor
65668793|NCT03058900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668794|NCT03058900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65668795|NCT03058900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65668796|NCT03058900|Immunologic Factors|immunologic factors|mesh-ancestor
65668797|NCT03058900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65668798|NCT03058900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65668799|NCT02226510|Metformin|metformin|mesh-list
65668800|NCT02226510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65668801|NCT02226510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131426|NCT04560465|Hemostatics|hemostatics|mesh-ancestor
65668802|NCT04445688|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65668803|NCT04445688|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65668804|NCT04445688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65668805|NCT04445688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65668806|NCT04445688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668808|NCT04445688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65668809|NCT04445688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668810|NCT04956094|Uric Acid|uric acid|mesh-list
65668811|NCT04956094|Antioxidants|antioxidants|mesh-ancestor
65668812|NCT04956094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668813|NCT04956094|Protective Agents|protective agents|mesh-ancestor
65668814|NCT04956094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668815|NCT03671707|Nicotine|nicotine|mesh-list
65668816|NCT03671707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65668817|NCT03671707|Autonomic Agents|autonomic agents|mesh-ancestor
65668818|NCT03671707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65668819|NCT03671707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668820|NCT03671707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65668821|NCT03671707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65668822|NCT03671707|Cholinergic Agents|cholinergic agents|mesh-ancestor
65668823|NCT03671707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65668824|NCT03671707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668825|NCT02226588|Misoprostol|misoprostol|mesh-list
65668826|NCT02226588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65668827|NCT02226588|Abortifacient Agents|abortifacient agents|mesh-ancestor
65668828|NCT02226588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65668829|NCT02226588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668830|NCT02226588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65668831|NCT02226588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65668832|NCT02226588|Oxytocics|oxytocics|mesh-ancestor
65668833|NCT03676621|Misoprostol|misoprostol|mesh-list
65668834|NCT03676621|Oxytocin|oxytocin|mesh-list
65668835|NCT03676621|Oxytocics|oxytocics|mesh-ancestor
65668836|NCT03676621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65668837|NCT03676621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668838|NCT03676621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65668839|NCT03676621|Abortifacient Agents|abortifacient agents|mesh-ancestor
65668840|NCT03676621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65668841|NCT03676621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65668842|NCT03678649|Capecitabine|capecitabine|mesh-list
65668843|NCT03678649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65668844|NCT03678649|Antimetabolites|antimetabolites|mesh-ancestor
65668845|NCT03678649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668846|NCT03678649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668847|NCT02845297|Pembrolizumab|pembrolizumab|mesh-list
65668848|NCT02845297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65668849|NCT02845297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668850|NCT02232360|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65668851|NCT02232360|Fenofibrate|fenofibrate|mesh-list
65668852|NCT02232360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65668853|NCT02232360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65668854|NCT02232360|Antimetabolites|antimetabolites|mesh-ancestor
65668855|NCT02232360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668856|NCT02232360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65668857|NCT02232360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65668858|NCT02232360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668859|NCT02226978|Ritonavir|ritonavir|mesh-list
65668860|NCT02226978|Tipranavir|tipranavir|mesh-list
65668861|NCT02226978|Valacyclovir|valacyclovir|mesh-list
65668862|NCT02226978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65668863|NCT02226978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65668864|NCT02226978|Protease Inhibitors|protease inhibitors|mesh-ancestor
65668865|NCT02226978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668866|NCT02226978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668867|NCT02226978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65668868|NCT02226978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65668869|NCT02226978|Antiviral Agents|antiviral agents|mesh-ancestor
65668870|NCT02226978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65668871|NCT02226978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65668872|NCT02226978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65668873|NCT02227056|Methylphenidate|methylphenidate|mesh-list
65668874|NCT02227056|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65668875|NCT02227056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668876|NCT02227056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65466202|NCT03732040|Fluorides|fluorides|mesh-list
65668877|NCT02227056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65668878|NCT02227056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65668879|NCT02227056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668880|NCT02227056|Dopamine Agents|dopamine agents|mesh-ancestor
65668881|NCT02227056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65668882|NCT05708157|Histamine Antagonists|histamine antagonists|mesh-list
65668883|NCT05708157|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
65668884|NCT05708157|Histamine Agents|histamine agents|mesh-ancestor
65668885|NCT05708157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65668886|NCT05708157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668887|NCT05708157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668888|NCT03058744|Clobetasol|clobetasol|mesh-list
65668889|NCT03058744|Halobetasol|halobetasol|mesh-list
65668890|NCT03058744|Tazarotene|tazarotene|mesh-list
65668891|NCT03058744|Dermatologic Agents|dermatologic agents|mesh-ancestor
65668892|NCT03058744|Keratolytic Agents|keratolytic agents|mesh-ancestor
65668893|NCT03058744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65668894|NCT03058744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65668895|NCT03058744|Glucocorticoids|glucocorticoids|mesh-ancestor
65668896|NCT03058744|Hormones|hormones|mesh-ancestor
65668897|NCT03058744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65668898|NCT03058744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668899|NCT02734537|Cisplatin|cisplatin|mesh-list
65668900|NCT02734537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668901|NCT03059056|Empagliflozin|empagliflozin|mesh-list
65668902|NCT03059056|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65668903|NCT03059056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668904|NCT03059056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65668905|NCT03059056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668906|NCT03058666|Calfactant|calfactant|mesh-list
65668907|NCT03058666|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
65668908|NCT03058666|Respiratory System Agents|respiratory system agents|mesh-ancestor
65668909|NCT02227212|Insulin|insulin|mesh-list
65668910|NCT02227212|Insulin Glargine|insulin glargine|mesh-list
65668911|NCT02227212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65668912|NCT02227212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668913|NCT00303849|Sodium thiosulfate|sodium thiosulfate|mesh-list
65668914|NCT00303849|Carboplatin|carboplatin|mesh-list
65668915|NCT00303849|Etoposide|etoposide|mesh-list
65668916|NCT00303849|Etoposide phosphate|etoposide phosphate|mesh-list
65668917|NCT00303849|Melphalan|melphalan|mesh-list
65668918|NCT00303849|Mechlorethamine|mechlorethamine|mesh-list
65668919|NCT00303849|Podophyllotoxin|podophyllotoxin|mesh-list
65668920|NCT00303849|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65668921|NCT00303849|Mannitol|mannitol|mesh-list
65668922|NCT00303849|Antidotes|antidotes|mesh-list
65668923|NCT00303849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668924|NCT00303849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65668925|NCT00303849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65668926|NCT00303849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65668927|NCT00303849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668928|NCT00303849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668929|NCT00303849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65668930|NCT00303849|Alkylating Agents|alkylating agents|mesh-ancestor
65668931|NCT00303849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65668932|NCT00303849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65668933|NCT00303849|Immunologic Factors|immunologic factors|mesh-ancestor
65668934|NCT00303849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668935|NCT00303849|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65668936|NCT00303849|Diuretics|diuretics|mesh-ancestor
65668937|NCT00303849|Natriuretic Agents|natriuretic agents|mesh-ancestor
65668938|NCT00303849|Keratolytic Agents|keratolytic agents|mesh-ancestor
65668939|NCT00303849|Dermatologic Agents|dermatologic agents|mesh-ancestor
65668940|NCT00303849|Tubulin Modulators|tubulin modulators|mesh-ancestor
65668941|NCT00303849|Antimitotic Agents|antimitotic agents|mesh-ancestor
65668942|NCT00303849|Mitosis Modulators|mitosis modulators|mesh-ancestor
65668943|NCT00303849|Protective Agents|protective agents|mesh-ancestor
65668944|NCT00303849|Antioxidants|antioxidants|mesh-ancestor
65668945|NCT00303849|Antitubercular Agents|antitubercular agents|mesh-ancestor
65668946|NCT00303849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65668947|NCT00303849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65668948|NCT00303849|Chelating Agents|chelating agents|mesh-ancestor
65668949|NCT00303849|Sequestering Agents|sequestering agents|mesh-ancestor
65668950|NCT04952272|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
65668951|NCT04952272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65668952|NCT04952272|Immunologic Factors|immunologic factors|mesh-ancestor
65668953|NCT04952272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668954|NCT01355523|Melatonin|melatonin|mesh-list
65668955|NCT01355523|Antioxidants|antioxidants|mesh-ancestor
65668956|NCT01355523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668957|NCT01355523|Protective Agents|protective agents|mesh-ancestor
65668958|NCT01355523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668959|NCT01355523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65668960|NCT02227914|Sorafenib|sorafenib|mesh-list
65668961|NCT02227914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668962|NCT02227914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65668963|NCT02227914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668964|NCT02227914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668965|NCT04161456|Apremilast|apremilast|mesh-list
65668966|NCT04161456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65668967|NCT04161456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65668968|NCT04161456|Analgesics|analgesics|mesh-ancestor
65668969|NCT04161456|Sensory System Agents|sensory system agents|mesh-ancestor
65668970|NCT04161456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65668971|NCT04161456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668972|NCT04161456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65668973|NCT04161456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65668974|NCT04161456|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65668975|NCT04161456|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65668976|NCT04161456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668977|NCT04161456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668978|NCT02224014|Brotizolam|brotizolam|mesh-list
65668979|NCT02224014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65668980|NCT02224014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65668981|NCT02224014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668982|NCT03671161|Insulin|insulin|mesh-list
65668983|NCT03671161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65668984|NCT03671161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668985|NCT04950400|Apatinib|apatinib|mesh-list
65668986|NCT04950400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65668987|NCT04950400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65668988|NCT04950400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65668989|NCT04950400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668990|NCT04949932|Turmeric extract|turmeric extract|mesh-list
65668991|NCT04949932|Antioxidants|antioxidants|mesh-ancestor
65668992|NCT04949932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65668993|NCT04949932|Protective Agents|protective agents|mesh-ancestor
65668994|NCT04949932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65668995|NCT02826603|Ustekinumab|ustekinumab|mesh-list
65668996|NCT02826603|Dermatologic Agents|dermatologic agents|mesh-ancestor
65668997|NCT02224170|Dexamethasone|dexamethasone|mesh-list
65668998|NCT02224170|Lidocaine|lidocaine|mesh-list
65668999|NCT02224170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65669000|NCT02224170|Antiemetics|antiemetics|mesh-ancestor
65669001|NCT02224170|Autonomic Agents|autonomic agents|mesh-ancestor
65669002|NCT02224170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65669003|NCT02224170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669004|NCT02224170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65669005|NCT02224170|Glucocorticoids|glucocorticoids|mesh-ancestor
65669006|NCT02224170|Hormones|hormones|mesh-ancestor
65669007|NCT02224170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65669008|NCT02224170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65669009|NCT02224170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669010|NCT02224170|Anesthetics, Local|anesthetics, local|mesh-ancestor
65669011|NCT02224170|Anesthetics|anesthetics|mesh-ancestor
65669012|NCT02224170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65669013|NCT02224170|Sensory System Agents|sensory system agents|mesh-ancestor
65669014|NCT02224170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65669015|NCT02224170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65669016|NCT02224170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65669017|NCT02224170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65669018|NCT02224170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669019|NCT03563235|Calcitriol|calcitriol|mesh-list
65669020|NCT03563235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65669021|NCT03563235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669022|NCT03563235|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65669023|NCT03563235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65669024|NCT03563235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669025|NCT03563235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65669026|NCT03563235|Vitamins|vitamins|mesh-ancestor
65466351|NCT01326585|BB 1101|bb 1101|mesh-list
65669027|NCT03563235|Micronutrients|micronutrients|mesh-ancestor
65669028|NCT03563235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65669030|NCT01329900|Ifosfamide|ifosfamide|mesh-list
65669031|NCT01329900|Ofatumumab|ofatumumab|mesh-list
65669032|NCT01329900|Lenograstim|lenograstim|mesh-list
65669033|NCT01329900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65669034|NCT01329900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669035|NCT01329900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65669036|NCT01329900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65669037|NCT01329900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65669038|NCT01329900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669039|NCT01329900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65669040|NCT01329900|Alkylating Agents|alkylating agents|mesh-ancestor
65669041|NCT01329900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65669042|NCT01329900|Immunologic Factors|immunologic factors|mesh-ancestor
65669043|NCT01329900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669044|NCT04948294|Pyrithione zinc|pyrithione zinc|mesh-list
65669045|NCT04948294|Keratolytic Agents|keratolytic agents|mesh-ancestor
65669046|NCT04948294|Dermatologic Agents|dermatologic agents|mesh-ancestor
65669047|NCT04948372|Terlipressin|terlipressin|mesh-list
65669048|NCT04948372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65669049|NCT04948372|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65669050|NCT04947748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65669051|NCT04947748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65669052|NCT04947826|Antibodies|antibodies|mesh-list
65669053|NCT04947826|Immunoglobulins|immunoglobulins|mesh-list
65669054|NCT04947826|Immunologic Factors|immunologic factors|mesh-ancestor
65669055|NCT04947826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669056|NCT05059977|Immunoglobulins|immunoglobulins|mesh-list
65669057|NCT05059977|gamma-Globulins|gamma-globulins|mesh-list
65669058|NCT05059977|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65669059|NCT05059977|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65669060|NCT05059977|Immunologic Factors|immunologic factors|mesh-ancestor
65669061|NCT05059977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669062|NCT02228616|Lactulose|lactulose|mesh-list
65669063|NCT02228616|Prucalopride|prucalopride|mesh-list
65669064|NCT02228616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65669065|NCT02228616|Laxatives|laxatives|mesh-ancestor
65669066|NCT02228616|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65669067|NCT02228616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65669068|NCT02228616|Serotonin Agents|serotonin agents|mesh-ancestor
65669069|NCT02228616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65669070|NCT02228616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669071|NCT02228616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669072|NCT03936894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65669073|NCT03936894|Immunologic Factors|immunologic factors|mesh-ancestor
65669074|NCT03936894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669075|NCT02744391|Levodopa|levodopa|mesh-list
65669076|NCT02744391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65669077|NCT02744391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65669078|NCT02744391|Dopamine Agents|dopamine agents|mesh-ancestor
65669079|NCT02744391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65669080|NCT02744391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669081|NCT02744391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669082|NCT02228772|Cytarabine|cytarabine|mesh-list
65669083|NCT02228772|Cyclophosphamide|cyclophosphamide|mesh-list
65669084|NCT02228772|Doxorubicin|doxorubicin|mesh-list
65669085|NCT02228772|Methotrexate|methotrexate|mesh-list
65669086|NCT02228772|Vincristine|vincristine|mesh-list
65669087|NCT02228772|Mercaptopurine|mercaptopurine|mesh-list
65669088|NCT02228772|Ixazomib|ixazomib|mesh-list
65669089|NCT02228772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65669090|NCT02228772|Immunologic Factors|immunologic factors|mesh-ancestor
65669091|NCT02228772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669092|NCT02228772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65669093|NCT02228772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65669094|NCT02228772|Alkylating Agents|alkylating agents|mesh-ancestor
65669095|NCT02228772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669096|NCT02228772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268486|NCT00636038|Antioxidants|antioxidants|mesh-ancestor
65669097|NCT02228772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65466429|NCT00096135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65669098|NCT02228772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65669099|NCT02228772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65669100|NCT02228772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65669101|NCT02228772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65669102|NCT02228772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65669103|NCT02228772|Abortifacient Agents|abortifacient agents|mesh-ancestor
65669104|NCT02228772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65669105|NCT02228772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65669106|NCT02228772|Antimetabolites|antimetabolites|mesh-ancestor
65669107|NCT02228772|Dermatologic Agents|dermatologic agents|mesh-ancestor
65669108|NCT02228772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65669109|NCT02228772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65669110|NCT02228772|Antiviral Agents|antiviral agents|mesh-ancestor
65669111|NCT02228772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65669112|NCT02228772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65669113|NCT02228772|Tubulin Modulators|tubulin modulators|mesh-ancestor
65669114|NCT02228772|Antimitotic Agents|antimitotic agents|mesh-ancestor
65669115|NCT02228772|Mitosis Modulators|mitosis modulators|mesh-ancestor
65669116|NCT02228772|Protease Inhibitors|protease inhibitors|mesh-ancestor
65669117|NCT03646968|Docetaxel|docetaxel|mesh-list
65669118|NCT03646968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669119|NCT03646968|Tubulin Modulators|tubulin modulators|mesh-ancestor
65669120|NCT03646968|Antimitotic Agents|antimitotic agents|mesh-ancestor
65669121|NCT03646968|Mitosis Modulators|mitosis modulators|mesh-ancestor
65669122|NCT03646968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669123|NCT02228850|Alprostadil|alprostadil|mesh-list
65669124|NCT02228850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65669125|NCT02228850|Vasodilator Agents|vasodilator agents|mesh-ancestor
65669126|NCT02228850|Urological Agents|urological agents|mesh-ancestor
65669127|NCT02822508|Laxatives|laxatives|mesh-list
65669128|NCT02822508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65669129|NCT03563001|Budesonide|budesonide|mesh-list
65669130|NCT03563001|Formoterol Fumarate|formoterol fumarate|mesh-list
65669131|NCT03563001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65669132|NCT03563001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65669133|NCT03563001|Autonomic Agents|autonomic agents|mesh-ancestor
65669134|NCT03563001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65669135|NCT03563001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669136|NCT03563001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65669137|NCT03563001|Respiratory System Agents|respiratory system agents|mesh-ancestor
65669138|NCT03563001|Glucocorticoids|glucocorticoids|mesh-ancestor
65669139|NCT03563001|Hormones|hormones|mesh-ancestor
65669140|NCT03563001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65669141|NCT03563001|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65669142|NCT03563001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65669143|NCT03563001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65669144|NCT03563001|Adrenergic Agents|adrenergic agents|mesh-ancestor
65669145|NCT03563001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65669146|NCT03563001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669147|NCT04768101|Corticosterone|corticosterone|mesh-list
65669148|NCT04768101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65669149|NCT02228928|Capsaicin|capsaicin|mesh-list
65669150|NCT02228928|Antipruritics|antipruritics|mesh-ancestor
65669151|NCT02228928|Dermatologic Agents|dermatologic agents|mesh-ancestor
65669152|NCT02228928|Sensory System Agents|sensory system agents|mesh-ancestor
65669153|NCT02228928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65669154|NCT02228928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669155|NCT03888378|Minocycline|minocycline|mesh-list
65669156|NCT03888378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65669157|NCT03888378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65669158|NCT03603288|Idebenone|idebenone|mesh-list
65669159|NCT03603288|Antioxidants|antioxidants|mesh-ancestor
65669160|NCT03603288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669161|NCT03603288|Protective Agents|protective agents|mesh-ancestor
65669162|NCT03603288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669163|NCT03857646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65669164|NCT03857646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65669165|NCT03857646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65669166|NCT03857646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65669167|NCT03844074|Bevacizumab|bevacizumab|mesh-list
65669168|NCT03844074|Ranibizumab|ranibizumab|mesh-list
65669169|NCT03844074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65669170|NCT03844074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669171|NCT03844074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65669172|NCT03844074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65669173|NCT03844074|Growth Substances|growth substances|mesh-ancestor
65669174|NCT03844074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669175|NCT03844074|Growth Inhibitors|growth inhibitors|mesh-ancestor
65669176|NCT02624986|Rituximab|rituximab|mesh-list
65669177|NCT02624986|Obinutuzumab|obinutuzumab|mesh-list
65669178|NCT02624986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65669179|NCT02624986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669180|NCT02624986|Immunologic Factors|immunologic factors|mesh-ancestor
65669181|NCT02624986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669182|NCT02624986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65669183|NCT04946734|Aspirin|aspirin|mesh-list
65669184|NCT04946734|Clopidogrel|clopidogrel|mesh-list
65669185|NCT04946734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65669186|NCT04946734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65669187|NCT04946734|Analgesics|analgesics|mesh-ancestor
65669188|NCT04946734|Sensory System Agents|sensory system agents|mesh-ancestor
65669189|NCT04946734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65669190|NCT04946734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669191|NCT04946734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65669192|NCT04946734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65669193|NCT04946734|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65669194|NCT04946734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65669195|NCT04946734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669196|NCT04946734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65669197|NCT04946734|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65669198|NCT04946734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65669199|NCT04946734|Antipyretics|antipyretics|mesh-ancestor
65669200|NCT04946734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65669201|NCT04946734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65669202|NCT04946734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65669203|NCT04946734|Purinergic Agents|purinergic agents|mesh-ancestor
65669204|NCT04946734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65669205|NCT04945954|Cyclophosphamide|cyclophosphamide|mesh-list
65669206|NCT04945954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65669207|NCT04945954|Immunologic Factors|immunologic factors|mesh-ancestor
65669208|NCT04945954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669209|NCT04945954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65669210|NCT04945954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65669211|NCT04945954|Alkylating Agents|alkylating agents|mesh-ancestor
65669212|NCT04945954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669213|NCT04945954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669214|NCT04945954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65669215|NCT04945096|Cytarabine|cytarabine|mesh-list
65669216|NCT04945096|Acetylcysteine|acetylcysteine|mesh-list
65669217|NCT04945096|Cyclosporine|cyclosporine|mesh-list
65669218|NCT04945096|Cyclophosphamide|cyclophosphamide|mesh-list
65669219|NCT04945096|Busulfan|busulfan|mesh-list
65669220|NCT04945096|Semustine|semustine|mesh-list
65669221|NCT04945096|Decitabine|decitabine|mesh-list
65669222|NCT04945096|Cyclosporins|cyclosporins|mesh-list
65669223|NCT04945096|Thymoglobulin|thymoglobulin|mesh-list
65669224|NCT04945096|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65669225|NCT04945096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65669226|NCT04945096|Immunologic Factors|immunologic factors|mesh-ancestor
65669227|NCT04945096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669228|NCT04945096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65669229|NCT04945096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65669230|NCT04945096|Alkylating Agents|alkylating agents|mesh-ancestor
65669231|NCT04945096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669232|NCT04945096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669233|NCT04945096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65669234|NCT04945096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65669235|NCT04945096|Antimetabolites|antimetabolites|mesh-ancestor
65669236|NCT04945096|Antiviral Agents|antiviral agents|mesh-ancestor
65669237|NCT04945096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65669238|NCT04945096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65669239|NCT04945096|Antifungal Agents|antifungal agents|mesh-ancestor
65669240|NCT04945096|Dermatologic Agents|dermatologic agents|mesh-ancestor
65669241|NCT04945096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65669242|NCT04945096|Expectorants|expectorants|mesh-ancestor
65669243|NCT04945096|Respiratory System Agents|respiratory system agents|mesh-ancestor
65669244|NCT04945096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65669245|NCT04945096|Antioxidants|antioxidants|mesh-ancestor
65669246|NCT04945096|Protective Agents|protective agents|mesh-ancestor
65669247|NCT04430452|Durvalumab|durvalumab|mesh-list
65669248|NCT04430452|Ipilimumab|ipilimumab|mesh-list
65669249|NCT04430452|Tremelimumab|tremelimumab|mesh-list
65669250|NCT04430452|Immunoglobulins|immunoglobulins|mesh-list
65669251|NCT04430452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65669252|NCT04430452|Immunoglobulin G|immunoglobulin g|mesh-list
65466575|NCT01080963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65669253|NCT04430452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65669254|NCT04430452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669255|NCT04430452|Immunologic Factors|immunologic factors|mesh-ancestor
65669256|NCT04430452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669257|NCT04430452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65669258|NCT04430452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669259|NCT04944082|Ivermectin|ivermectin|mesh-list
65669260|NCT04944082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65669261|NCT04944082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65669262|NCT04943692|Metformin|metformin|mesh-list
65669263|NCT04943692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65669264|NCT04943692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669265|NCT02587598|Cytarabine|cytarabine|mesh-list
65669266|NCT02587598|Azacitidine|azacitidine|mesh-list
65669267|NCT02587598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65669268|NCT02587598|Antimetabolites|antimetabolites|mesh-ancestor
65669269|NCT02587598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669270|NCT02587598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669271|NCT02587598|Antiviral Agents|antiviral agents|mesh-ancestor
65669272|NCT02587598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65669273|NCT02587598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65669274|NCT02587598|Immunologic Factors|immunologic factors|mesh-ancestor
65669275|NCT02587598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669276|NCT02587598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65669277|NCT04943536|Bicalutamide|bicalutamide|mesh-list
65669278|NCT04943536|Androgen Antagonists|androgen antagonists|mesh-ancestor
65669279|NCT04943536|Hormone Antagonists|hormone antagonists|mesh-ancestor
65669280|NCT04943536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65669281|NCT04943536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669282|NCT04943536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669283|NCT04943146|Aspirin|aspirin|mesh-list
65669284|NCT04943146|Prednisone|prednisone|mesh-list
65669285|NCT04943146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65669286|NCT04943146|Glucocorticoids|glucocorticoids|mesh-ancestor
65669287|NCT04943146|Hormones|hormones|mesh-ancestor
65669288|NCT04943146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65669289|NCT04943146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669290|NCT04943146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65669291|NCT04943146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669292|NCT04943146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65669293|NCT04943146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65669294|NCT04943146|Analgesics|analgesics|mesh-ancestor
65669295|NCT04943146|Sensory System Agents|sensory system agents|mesh-ancestor
65669296|NCT04943146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65669297|NCT04943146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65669298|NCT04943146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65669299|NCT04943146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65669300|NCT04943146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669301|NCT04943146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65669302|NCT04943146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65669303|NCT04943146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65669304|NCT04943146|Antipyretics|antipyretics|mesh-ancestor
65669305|NCT02485574|Calcium|calcium|mesh-list
65669306|NCT02485574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65669307|NCT02485574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669308|NCT04942834|Amiodarone|amiodarone|mesh-list
65669309|NCT04942834|Sotalol|sotalol|mesh-list
65669310|NCT04942834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
65669311|NCT04942834|Dronedarone|dronedarone|mesh-list
65669312|NCT04942834|Propafenone|propafenone|mesh-list
65669313|NCT04942834|Vasodilator Agents|vasodilator agents|mesh-ancestor
65669314|NCT04942834|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65669315|NCT04942834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65669316|NCT04942834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669317|NCT04942834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65669318|NCT04942834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65669319|NCT04942834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65669320|NCT04942834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65669321|NCT04942834|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65669322|NCT04942834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65669323|NCT04942834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65669324|NCT04942834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65669325|NCT04942834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65669326|NCT04942834|Adrenergic Agents|adrenergic agents|mesh-ancestor
65669327|NCT04942834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65669328|NCT04942834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466661|NCT03727048|Ketorolac|ketorolac|mesh-list
65669330|NCT04942834|Autonomic Agents|autonomic agents|mesh-ancestor
65669331|NCT04942834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65669332|NCT04942834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65669333|NCT04941976|Benzydamine|benzydamine|mesh-list
65669334|NCT04941976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65669335|NCT01291004|Drospirenone|drospirenone|mesh-list
65669336|NCT01291004|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65669337|NCT01291004|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65669338|NCT01291004|Levonorgestrel|levonorgestrel|mesh-list
65669339|NCT01291004|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65669340|NCT01291004|Desogestrel|desogestrel|mesh-list
65669341|NCT01291004|Contraceptive Agents|contraceptive agents|mesh-list
65669342|NCT01291004|Contraceptives, Oral|contraceptives, oral|mesh-list
65669343|NCT01291004|Estradiol|estradiol|mesh-list
65669344|NCT01291004|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65669345|NCT01291004|Estrogens|estrogens|mesh-ancestor
65669346|NCT01291004|Hormones|hormones|mesh-ancestor
65669347|NCT01291004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65669348|NCT01291004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669349|NCT01291004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65669350|NCT01291004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65669351|NCT01291004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65669352|NCT01291004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65669353|NCT01291004|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65669354|NCT01291004|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65669355|NCT01291004|Hormone Antagonists|hormone antagonists|mesh-ancestor
65669356|NCT01291004|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65669357|NCT01291004|Diuretics|diuretics|mesh-ancestor
65669358|NCT01291004|Natriuretic Agents|natriuretic agents|mesh-ancestor
65669359|NCT01291004|Progestins|progestins|mesh-ancestor
65669360|NCT04941118|Anesthetics|anesthetics|mesh-list
65669361|NCT04941118|Anesthetics, Local|anesthetics, local|mesh-list
65669362|NCT04941118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65669363|NCT04941118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669364|NCT04941118|Sensory System Agents|sensory system agents|mesh-ancestor
65669365|NCT04941118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65669366|NCT03483818|Antiviral Agents|antiviral agents|mesh-list
65669367|NCT03483818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65669368|NCT00374660|Oxaliplatin|oxaliplatin|mesh-list
65669369|NCT00374660|Irofulven|irofulven|mesh-list
65669370|NCT00374660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669371|NCT00374660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65669372|NCT00374660|Alkylating Agents|alkylating agents|mesh-ancestor
65669373|NCT00374660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669374|NCT02624050|Propofol|propofol|mesh-list
65669375|NCT02624050|Methohexital|methohexital|mesh-list
65669376|NCT02624050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65669377|NCT02624050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65669378|NCT02624050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669379|NCT02624050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65669380|NCT02624050|Anesthetics, General|anesthetics, general|mesh-ancestor
65669381|NCT02624050|Anesthetics|anesthetics|mesh-ancestor
65669382|NCT03131882|Triamcinolone|triamcinolone|mesh-list
65669383|NCT03131882|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65669384|NCT03131882|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65669385|NCT03131882|Hyaluronic Acid|hyaluronic acid|mesh-list
65669386|NCT03131882|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65669387|NCT03131882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65669388|NCT03131882|Glucocorticoids|glucocorticoids|mesh-ancestor
65669389|NCT03131882|Hormones|hormones|mesh-ancestor
65669390|NCT03131882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65669391|NCT03131882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669392|NCT03131882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65669393|NCT03131882|Immunologic Factors|immunologic factors|mesh-ancestor
65669394|NCT03131882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65669395|NCT03131882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669396|NCT03131882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65669397|NCT03131882|Viscosupplements|viscosupplements|mesh-ancestor
65669398|NCT03131882|Protective Agents|protective agents|mesh-ancestor
65669399|NCT03483350|Midazolam|midazolam|mesh-list
65669400|NCT03483350|Granisetron|granisetron|mesh-list
65669401|NCT03483350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65669402|NCT03483350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65669403|NCT03483350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65669404|NCT03483350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669405|NCT03483350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65669406|NCT03483350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65669407|NCT03483350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65669408|NCT03483350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65669409|NCT03483350|Anesthetics, General|anesthetics, general|mesh-ancestor
65669410|NCT03483350|Anesthetics|anesthetics|mesh-ancestor
65669411|NCT03483350|GABA Modulators|gaba modulators|mesh-ancestor
65669412|NCT03483350|GABA Agents|gaba agents|mesh-ancestor
65669413|NCT03483350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65669414|NCT03483350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669415|NCT03483350|Antiemetics|antiemetics|mesh-ancestor
65669416|NCT03483350|Autonomic Agents|autonomic agents|mesh-ancestor
65669417|NCT03483350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65669418|NCT03483350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65669419|NCT03483350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65669420|NCT03483350|Serotonin Agents|serotonin agents|mesh-ancestor
65669421|NCT03480308|Dexamethasone|dexamethasone|mesh-list
65669422|NCT03480308|Fentanyl|fentanyl|mesh-list
65669423|NCT03480308|Bupivacaine|bupivacaine|mesh-list
65669424|NCT03480308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65669425|NCT03480308|Antiemetics|antiemetics|mesh-ancestor
65669426|NCT03480308|Autonomic Agents|autonomic agents|mesh-ancestor
65669427|NCT03480308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65669428|NCT03480308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669429|NCT03480308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65669430|NCT03480308|Glucocorticoids|glucocorticoids|mesh-ancestor
65669431|NCT03480308|Hormones|hormones|mesh-ancestor
65669432|NCT03480308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65669433|NCT03480308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65669434|NCT03480308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669435|NCT03480308|Anesthetics, Local|anesthetics, local|mesh-ancestor
65669436|NCT03480308|Anesthetics|anesthetics|mesh-ancestor
65669437|NCT03480308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65669438|NCT03480308|Sensory System Agents|sensory system agents|mesh-ancestor
65669439|NCT03480308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65669440|NCT03480308|Narcotics|narcotics|mesh-ancestor
65669441|NCT03480308|Analgesics|analgesics|mesh-ancestor
65669442|NCT03480308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65669443|NCT03480308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65669444|NCT03480308|Anesthetics, General|anesthetics, general|mesh-ancestor
65669445|NCT05151614|Colchicine|colchicine|mesh-list
65669446|NCT05151614|Gout Suppressants|gout suppressants|mesh-ancestor
65669447|NCT05151614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65669448|NCT05151614|Tubulin Modulators|tubulin modulators|mesh-ancestor
65669449|NCT05151614|Antimitotic Agents|antimitotic agents|mesh-ancestor
65669450|NCT05151614|Mitosis Modulators|mitosis modulators|mesh-ancestor
65669451|NCT05151614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669452|NCT05151614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669453|NCT04937140|Antibodies|antibodies|mesh-list
65669454|NCT04937140|Immunologic Factors|immunologic factors|mesh-ancestor
65669455|NCT04937140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669456|NCT04409314|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
65669457|NCT04409314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65669458|NCT04409314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669459|NCT03482960|Xenon|xenon|mesh-list
65669460|NCT03482960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65669461|NCT03482960|Anesthetics, General|anesthetics, general|mesh-ancestor
65669462|NCT03482960|Anesthetics|anesthetics|mesh-ancestor
65669463|NCT03482960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65669464|NCT03482960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669465|NCT04409002|Niraparib|niraparib|mesh-list
65669466|NCT04409002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65669467|NCT04409002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65669468|NCT04409002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669469|NCT04409002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669470|NCT00099086|Docetaxel|docetaxel|mesh-list
65669471|NCT00099086|Leuprolide|leuprolide|mesh-list
65669472|NCT00099086|Goserelin|goserelin|mesh-list
65669473|NCT00099086|Bicalutamide|bicalutamide|mesh-list
65669474|NCT00099086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669475|NCT00099086|Tubulin Modulators|tubulin modulators|mesh-ancestor
65669476|NCT00099086|Antimitotic Agents|antimitotic agents|mesh-ancestor
65669477|NCT00099086|Mitosis Modulators|mitosis modulators|mesh-ancestor
65669478|NCT00099086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669479|NCT00099086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65669480|NCT00099086|Fertility Agents|fertility agents|mesh-ancestor
65669481|NCT00099086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65669482|NCT00099086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669483|NCT00099086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65669484|NCT00099086|Androgen Antagonists|androgen antagonists|mesh-ancestor
65669485|NCT00099086|Hormone Antagonists|hormone antagonists|mesh-ancestor
65669486|NCT00099086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65669488|NCT03479996|Anesthetics, Local|anesthetics, local|mesh-ancestor
65669489|NCT03479996|Anesthetics|anesthetics|mesh-ancestor
65669490|NCT03479996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65669491|NCT03479996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669492|NCT03479996|Sensory System Agents|sensory system agents|mesh-ancestor
65669493|NCT03479996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65669494|NCT04936282|Tacrolimus|tacrolimus|mesh-list
65669495|NCT04936282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65669496|NCT04936282|Immunologic Factors|immunologic factors|mesh-ancestor
65669497|NCT04936282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669498|NCT04936282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65669499|NCT04936282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65669500|NCT04936282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669501|NCT02524184|Sildenafil Citrate|sildenafil citrate|mesh-list
65669502|NCT02524184|Vasodilator Agents|vasodilator agents|mesh-ancestor
65669503|NCT02524184|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65669504|NCT02524184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65669505|NCT02524184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65669506|NCT02524184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669507|NCT02524184|Urological Agents|urological agents|mesh-ancestor
65669508|NCT04936204|Hyaluronic Acid|hyaluronic acid|mesh-list
65669509|NCT04936204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65669510|NCT04936204|Immunologic Factors|immunologic factors|mesh-ancestor
65669511|NCT04936204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669512|NCT04936204|Viscosupplements|viscosupplements|mesh-ancestor
65669513|NCT04936204|Protective Agents|protective agents|mesh-ancestor
65669514|NCT03486236|Ivacaftor|ivacaftor|mesh-list
65669515|NCT03486236|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65669516|NCT03486236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65669517|NCT03486236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669518|NCT04936126|Amantadine|amantadine|mesh-list
65669519|NCT04936126|Pramipexole|pramipexole|mesh-list
65669520|NCT04936126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65669521|NCT04936126|Antidepressive Agents|antidepressive agents|mesh-ancestor
65669522|NCT04936126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65669523|NCT04936126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65669524|NCT04936126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65669525|NCT04936126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65669526|NCT04936126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669527|NCT04936126|Antioxidants|antioxidants|mesh-ancestor
65669528|NCT04936126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669529|NCT04936126|Protective Agents|protective agents|mesh-ancestor
65669530|NCT04936126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65669531|NCT04936126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65669532|NCT04936126|Dopamine Agonists|dopamine agonists|mesh-ancestor
65669533|NCT04936126|Dopamine Agents|dopamine agents|mesh-ancestor
65669534|NCT04936126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65669535|NCT04936126|Antiviral Agents|antiviral agents|mesh-ancestor
65669536|NCT04936126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65669537|NCT04936126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65669538|NCT04936126|Analgesics|analgesics|mesh-ancestor
65669539|NCT04936126|Sensory System Agents|sensory system agents|mesh-ancestor
65669540|NCT04936126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65669541|NCT03479918|Prednisone|prednisone|mesh-list
65669542|NCT03479918|Cyclophosphamide|cyclophosphamide|mesh-list
65669543|NCT03479918|Doxorubicin|doxorubicin|mesh-list
65669544|NCT03479918|Etoposide|etoposide|mesh-list
65669545|NCT03479918|Vincristine|vincristine|mesh-list
65669546|NCT03479918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65669547|NCT03479918|Immunologic Factors|immunologic factors|mesh-ancestor
65669548|NCT03479918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669549|NCT03479918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65669550|NCT03479918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65669551|NCT03479918|Alkylating Agents|alkylating agents|mesh-ancestor
65669552|NCT03479918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669553|NCT03479918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669554|NCT03479918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65669555|NCT03479918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65669556|NCT03479918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65669557|NCT03479918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65669558|NCT03479918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65669559|NCT03479918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65669560|NCT03479918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65669561|NCT03479918|Glucocorticoids|glucocorticoids|mesh-ancestor
65669562|NCT03479918|Hormones|hormones|mesh-ancestor
65669563|NCT03479918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65669564|NCT03479918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65669565|NCT03479918|Tubulin Modulators|tubulin modulators|mesh-ancestor
65669566|NCT03479918|Antimitotic Agents|antimitotic agents|mesh-ancestor
65669567|NCT03479918|Mitosis Modulators|mitosis modulators|mesh-ancestor
65669568|NCT04935658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65669569|NCT04935658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65669570|NCT04935658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669571|NCT03486080|Lenograstim|lenograstim|mesh-list
65669572|NCT03486080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65669573|NCT03486080|Immunologic Factors|immunologic factors|mesh-ancestor
65669574|NCT03486080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669575|NCT03479450|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65669576|NCT03479450|Respiratory System Agents|respiratory system agents|mesh-ancestor
65669577|NCT03477344|Dexmedetomidine|dexmedetomidine|mesh-list
65669578|NCT03477344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65669579|NCT03477344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65669580|NCT03477344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669581|NCT03477344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65669582|NCT03477344|Analgesics|analgesics|mesh-ancestor
65669583|NCT03477344|Sensory System Agents|sensory system agents|mesh-ancestor
65669584|NCT03477344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65669585|NCT03477344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65669586|NCT03477344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65669587|NCT03477344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65669588|NCT03477344|Adrenergic Agents|adrenergic agents|mesh-ancestor
65669589|NCT03477344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65669590|NCT03477344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669591|NCT04933864|Methylene Blue|methylene blue|mesh-list
65669592|NCT04933864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65669593|NCT04933864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669594|NCT03477266|Mosapride|mosapride|mesh-list
65669595|NCT03477266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65669596|NCT03477266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65669597|NCT03477266|Serotonin Agents|serotonin agents|mesh-ancestor
65669598|NCT03477266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65669599|NCT03477266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669600|NCT03477266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669601|NCT03479372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65669602|NCT03479372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65669603|NCT03131336|Fibrin Foam|fibrin foam|mesh-list
65669604|NCT03131336|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
65669605|NCT03131336|Hemostatics|hemostatics|mesh-ancestor
65669606|NCT03131336|Coagulants|coagulants|mesh-ancestor
65669607|NCT03482492|Acetaminophen|acetaminophen|mesh-list
65669608|NCT03482492|Tramadol|tramadol|mesh-list
65669609|NCT03482492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65669610|NCT03482492|Analgesics|analgesics|mesh-ancestor
65669611|NCT03482492|Sensory System Agents|sensory system agents|mesh-ancestor
65669612|NCT03482492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65669613|NCT03482492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669614|NCT03482492|Antipyretics|antipyretics|mesh-ancestor
65669615|NCT03482492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65669616|NCT03482492|Narcotics|narcotics|mesh-ancestor
65669617|NCT03482492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65669618|NCT03477110|Temozolomide|temozolomide|mesh-list
65669619|NCT03477110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65669620|NCT03477110|Alkylating Agents|alkylating agents|mesh-ancestor
65669621|NCT03477110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669622|NCT03477110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669623|NCT03874286|Liver Extracts|liver extracts|mesh-list
65669624|NCT03874286|Hematinics|hematinics|mesh-ancestor
65669625|NCT04217954|Bevacizumab|bevacizumab|mesh-list
65669626|NCT04217954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65669627|NCT04217954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669628|NCT04217954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65669629|NCT04217954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65669630|NCT04217954|Growth Substances|growth substances|mesh-ancestor
65669631|NCT04217954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669632|NCT04217954|Growth Inhibitors|growth inhibitors|mesh-ancestor
65669633|NCT05259098|Sufentanil|sufentanil|mesh-list
65669634|NCT05259098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65669635|NCT05259098|Narcotics|narcotics|mesh-ancestor
65669636|NCT05259098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65669637|NCT05259098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669638|NCT05259098|Analgesics|analgesics|mesh-ancestor
65669639|NCT05259098|Sensory System Agents|sensory system agents|mesh-ancestor
65669640|NCT05259098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65669641|NCT05259098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65669642|NCT05259098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65669643|NCT05259098|Anesthetics, General|anesthetics, general|mesh-ancestor
65669644|NCT05259098|Anesthetics|anesthetics|mesh-ancestor
65669645|NCT03482180|Atorvastatin|atorvastatin|mesh-list
65669646|NCT03482180|Calcium|calcium|mesh-list
65669647|NCT03482180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65669648|NCT03482180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669649|NCT03482180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65669650|NCT03482180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65669651|NCT03482180|Antimetabolites|antimetabolites|mesh-ancestor
65669652|NCT03482180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669653|NCT03482180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65669654|NCT03482180|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65669655|NCT03482180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65669656|NCT04390646|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65669657|NCT04390646|Hormones|hormones|mesh-ancestor
65669658|NCT04390646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65669659|NCT04390646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669660|NCT03961568|Cenobamate|cenobamate|mesh-list
65669661|NCT03961568|Anticonvulsants|anticonvulsants|mesh-ancestor
65669662|NCT04294550|Naloxegol|naloxegol|mesh-list
65669663|NCT04294550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65669664|NCT04294550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669665|NCT04294550|Sensory System Agents|sensory system agents|mesh-ancestor
65669666|NCT04294550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65669667|NCT03476564|Pentoxifylline|pentoxifylline|mesh-list
65669668|NCT03476564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65669669|NCT03476564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65669670|NCT03476564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669671|NCT03476564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65669672|NCT03476564|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65669673|NCT03476564|Protective Agents|protective agents|mesh-ancestor
65669674|NCT03476564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669675|NCT03476564|Vasodilator Agents|vasodilator agents|mesh-ancestor
65669676|NCT03476564|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65669677|NCT03476564|Antioxidants|antioxidants|mesh-ancestor
65669678|NCT05258474|Niacinamide|niacinamide|mesh-list
65669679|NCT05258474|Niacin|niacin|mesh-list
65669680|NCT05258474|Nicotinic Acids|nicotinic acids|mesh-list
65669681|NCT05258474|Vitamin B Complex|vitamin b complex|mesh-ancestor
65669682|NCT05258474|Vitamins|vitamins|mesh-ancestor
65669683|NCT05258474|Micronutrients|micronutrients|mesh-ancestor
65669684|NCT05258474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669685|NCT05258474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65669686|NCT05258474|Antimetabolites|antimetabolites|mesh-ancestor
65669687|NCT05258474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669688|NCT05258474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65669689|NCT05258474|Vasodilator Agents|vasodilator agents|mesh-ancestor
65669690|NCT03478436|Doxycycline|doxycycline|mesh-list
65669691|NCT03478436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65669692|NCT03478436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65669693|NCT03478436|Antimalarials|antimalarials|mesh-ancestor
65669694|NCT03478436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65669695|NCT03478436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65669696|NCT01338987|Alovudine|alovudine|mesh-list
65669697|NCT01338987|Cyclophosphamide|cyclophosphamide|mesh-list
65669698|NCT01338987|Busulfan|busulfan|mesh-list
65669699|NCT01338987|Methotrexate|methotrexate|mesh-list
65669700|NCT01338987|Fludarabine|fludarabine|mesh-list
65669701|NCT01338987|Leuprolide|leuprolide|mesh-list
65669702|NCT01338987|Tacrolimus|tacrolimus|mesh-list
65669703|NCT01338987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65669704|NCT01338987|Immunologic Factors|immunologic factors|mesh-ancestor
65669705|NCT01338987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669706|NCT01338987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65669707|NCT01338987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65669708|NCT01338987|Alkylating Agents|alkylating agents|mesh-ancestor
65669709|NCT01338987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669710|NCT01338987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669712|NCT01338987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65669713|NCT01338987|Abortifacient Agents|abortifacient agents|mesh-ancestor
65669714|NCT01338987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65669715|NCT01338987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65669716|NCT01338987|Antimetabolites|antimetabolites|mesh-ancestor
65669717|NCT01338987|Dermatologic Agents|dermatologic agents|mesh-ancestor
65669718|NCT01338987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65669719|NCT01338987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65669720|NCT01338987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65669721|NCT01338987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65669722|NCT01338987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65669723|NCT01338987|Fertility Agents|fertility agents|mesh-ancestor
65669724|NCT01338987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65669725|NCT01338987|Antiviral Agents|antiviral agents|mesh-ancestor
65669726|NCT01338987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65669727|NCT03717896|Thiamine|thiamine|mesh-list
65669728|NCT03717896|Vitamins|vitamins|mesh-ancestor
65669729|NCT03717896|Micronutrients|micronutrients|mesh-ancestor
65669730|NCT03717896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669731|NCT03717896|Vitamin B Complex|vitamin b complex|mesh-ancestor
65669732|NCT03478280|Brodalumab|brodalumab|mesh-list
65669733|NCT03478280|Dermatologic Agents|dermatologic agents|mesh-ancestor
65669734|NCT04856007|Metformin|metformin|mesh-list
65669735|NCT04856007|Dapagliflozin|dapagliflozin|mesh-list
65669736|NCT04856007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65669737|NCT04856007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669738|NCT04856007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65669739|NCT04856007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669740|NCT04736979|Amoxicillin|amoxicillin|mesh-list
65669741|NCT04736979|Clavulanic Acid|clavulanic acid|mesh-list
65669742|NCT04736979|Clavulanic Acids|clavulanic acids|mesh-list
65669743|NCT04736979|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65669744|NCT04736979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65669745|NCT04736979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65669746|NCT04736979|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65669747|NCT04736979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65669748|NCT04736979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669749|NCT03562923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65669750|NCT03562923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65669751|NCT03562923|Autonomic Agents|autonomic agents|mesh-ancestor
65669752|NCT03562923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65669753|NCT03562923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669754|NCT03562923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65669755|NCT03562923|Respiratory System Agents|respiratory system agents|mesh-ancestor
65669756|NCT03562923|Glucocorticoids|glucocorticoids|mesh-ancestor
65669757|NCT03562923|Hormones|hormones|mesh-ancestor
65669758|NCT03562923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65669759|NCT03562923|Sympathomimetics|sympathomimetics|mesh-ancestor
65669760|NCT03593252|Metronidazole|metronidazole|mesh-list
65669761|NCT03593252|Cefazolin|cefazolin|mesh-list
65669762|NCT03593252|Neomycin|neomycin|mesh-list
65669763|NCT03593252|Picosulfate sodium|picosulfate sodium|mesh-list
65669764|NCT03593252|Magnesium Oxide|magnesium oxide|mesh-list
65669765|NCT03593252|Citric Acid|citric acid|mesh-list
65669766|NCT03593252|Sodium Citrate|sodium citrate|mesh-list
65669767|NCT03593252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65669768|NCT03593252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65669769|NCT03593252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65669770|NCT03593252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65669771|NCT03593252|Cathartics|cathartics|mesh-ancestor
65669772|NCT03593252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65669773|NCT03593252|Anticoagulants|anticoagulants|mesh-ancestor
65669774|NCT03593252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65669775|NCT03593252|Chelating Agents|chelating agents|mesh-ancestor
65669776|NCT03593252|Sequestering Agents|sequestering agents|mesh-ancestor
65669777|NCT03593252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669778|NCT03593252|Antacids|antacids|mesh-ancestor
65669779|NCT03593252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65669780|NCT03593252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65669781|NCT03476174|Pembrolizumab|pembrolizumab|mesh-list
65669782|NCT03476174|Interleukin-2|interleukin-2|mesh-list
65669783|NCT03476174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65669784|NCT03476174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669785|NCT03476174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65669786|NCT03476174|Analgesics|analgesics|mesh-ancestor
65669787|NCT03476174|Sensory System Agents|sensory system agents|mesh-ancestor
65669788|NCT03476174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65669789|NCT03476174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669790|NCT02523638|Interferons|interferons|mesh-list
65669791|NCT02523638|Interferon-alpha|interferon-alpha|mesh-list
65669792|NCT02523638|Interferon alpha-2|interferon alpha-2|mesh-list
65669793|NCT02523638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669794|NCT02523638|Antiviral Agents|antiviral agents|mesh-ancestor
65669795|NCT02523638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65669796|NCT02523638|Immunologic Factors|immunologic factors|mesh-ancestor
65669797|NCT02523638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669798|NCT05257148|Nebivolol|nebivolol|mesh-list
65669799|NCT05257148|Zofenopril|zofenopril|mesh-list
65669800|NCT05257148|Captopril|captopril|mesh-list
65669801|NCT05257148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65669802|NCT05257148|Vasodilator Agents|vasodilator agents|mesh-ancestor
65669803|NCT05257148|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65669804|NCT05257148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65669805|NCT05257148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65669806|NCT05257148|Adrenergic Agents|adrenergic agents|mesh-ancestor
65669807|NCT05257148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65669808|NCT05257148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669809|NCT05257148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669810|NCT05257148|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65669811|NCT05257148|Protease Inhibitors|protease inhibitors|mesh-ancestor
65669812|NCT05257148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65669813|NCT03481790|Folic Acid|folic acid|mesh-list
65669814|NCT03481790|Lactoferrin|lactoferrin|mesh-list
65669815|NCT03481790|Vitamins|vitamins|mesh-ancestor
65669816|NCT03481790|Micronutrients|micronutrients|mesh-ancestor
65669817|NCT03481790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669818|NCT03481790|Hematinics|hematinics|mesh-ancestor
65669819|NCT03481790|Vitamin B Complex|vitamin b complex|mesh-ancestor
65669820|NCT03481790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65669821|NCT03475862|Oxycodone|oxycodone|mesh-list
65669822|NCT03475862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65669823|NCT03475862|Narcotics|narcotics|mesh-ancestor
65669824|NCT03475862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65669825|NCT03475862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669826|NCT03475862|Analgesics|analgesics|mesh-ancestor
65669827|NCT03475862|Sensory System Agents|sensory system agents|mesh-ancestor
65669828|NCT03475862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65669829|NCT03368066|Cosyntropin|cosyntropin|mesh-list
65669830|NCT03368066|Hormones|hormones|mesh-ancestor
65669831|NCT03368066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65669832|NCT03368066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669833|NCT03475628|Daratumumab|daratumumab|mesh-list
65669834|NCT03475628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669835|NCT05195450|Tenofovir|tenofovir|mesh-list
65669836|NCT05195450|Antiviral Agents|antiviral agents|mesh-ancestor
65669837|NCT05195450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65669838|NCT05195450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65669839|NCT05195450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65669840|NCT05195450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65669841|NCT05195450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669842|NCT05195450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65132455|NCT01084655|Prednisone|prednisone|mesh-list
65669843|NCT05195450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65669844|NCT03477422|Meropenem|meropenem|mesh-list
65669845|NCT03477422|Ceftriaxone|ceftriaxone|mesh-list
65669846|NCT03477422|Sulbactam|sulbactam|mesh-list
65669847|NCT03477422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65669848|NCT03477422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65669849|NCT03477422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65669850|NCT03477422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65669851|NCT03477422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669852|NCT01355289|Interferons|interferons|mesh-list
65669853|NCT01355289|Ribavirin|ribavirin|mesh-list
65669854|NCT01355289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669855|NCT01355289|Antiviral Agents|antiviral agents|mesh-ancestor
65669856|NCT01355289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65669857|NCT01355289|Antimetabolites|antimetabolites|mesh-ancestor
65669858|NCT01355289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669859|NCT03473210|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65669860|NCT03473210|Erythromycin|erythromycin|mesh-list
65669861|NCT03473210|Ampicillin|ampicillin|mesh-list
65669862|NCT03473210|Dexamethasone|dexamethasone|mesh-list
65669863|NCT03473210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65467180|NCT01089140|Hemostatics|hemostatics|mesh-ancestor
65669864|NCT03473210|Antiemetics|antiemetics|mesh-ancestor
65669865|NCT03473210|Autonomic Agents|autonomic agents|mesh-ancestor
65669866|NCT03473210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65669867|NCT03473210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669868|NCT03473210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65669869|NCT03473210|Glucocorticoids|glucocorticoids|mesh-ancestor
65669871|NCT03473210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65669872|NCT03473210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65669873|NCT03473210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669874|NCT03473210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65669875|NCT03473210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669876|NCT03473210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65669877|NCT03473210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65669878|NCT03473132|Thrombin|thrombin|mesh-list
65669879|NCT03473132|Hemostatics|hemostatics|mesh-ancestor
65669880|NCT03473132|Coagulants|coagulants|mesh-ancestor
65669881|NCT03475160|Sildenafil Citrate|sildenafil citrate|mesh-list
65669882|NCT03475160|Citric Acid|citric acid|mesh-list
65669883|NCT03475160|Sodium Citrate|sodium citrate|mesh-list
65669884|NCT03475160|Anticoagulants|anticoagulants|mesh-ancestor
65669885|NCT03475160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65669886|NCT03475160|Chelating Agents|chelating agents|mesh-ancestor
65669887|NCT03475160|Sequestering Agents|sequestering agents|mesh-ancestor
65669888|NCT03475160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669889|NCT03475160|Vasodilator Agents|vasodilator agents|mesh-ancestor
65669890|NCT03475160|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65669891|NCT03475160|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65669892|NCT03475160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65669893|NCT03475160|Urological Agents|urological agents|mesh-ancestor
65669894|NCT00308516|Leucovorin|leucovorin|mesh-list
65669895|NCT00308516|Bevacizumab|bevacizumab|mesh-list
65669896|NCT00308516|Fluorouracil|fluorouracil|mesh-list
65669897|NCT00308516|Oxaliplatin|oxaliplatin|mesh-list
65669898|NCT00308516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65669899|NCT00308516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669900|NCT00308516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65669901|NCT00308516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65669902|NCT00308516|Growth Substances|growth substances|mesh-ancestor
65669903|NCT00308516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669904|NCT00308516|Growth Inhibitors|growth inhibitors|mesh-ancestor
65669905|NCT00308516|Antimetabolites|antimetabolites|mesh-ancestor
65669906|NCT00308516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669907|NCT00308516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65669908|NCT00308516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65669909|NCT00308516|Immunologic Factors|immunologic factors|mesh-ancestor
65669910|NCT00308516|Antidotes|antidotes|mesh-ancestor
65669911|NCT00308516|Protective Agents|protective agents|mesh-ancestor
65669912|NCT00308516|Vitamin B Complex|vitamin b complex|mesh-ancestor
65669913|NCT00308516|Vitamins|vitamins|mesh-ancestor
65669914|NCT00308516|Micronutrients|micronutrients|mesh-ancestor
65669915|NCT05155592|Adalimumab|adalimumab|mesh-list
65669916|NCT05155592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65669917|NCT05155592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65669918|NCT03474614|Propranolol|propranolol|mesh-list
65669919|NCT03474614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65669920|NCT03474614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65669921|NCT03474614|Adrenergic Agents|adrenergic agents|mesh-ancestor
65669922|NCT03474614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65669923|NCT03474614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669924|NCT03474614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669925|NCT03474614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65669926|NCT03474614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65669927|NCT03474614|Vasodilator Agents|vasodilator agents|mesh-ancestor
65669928|NCT05155202|Antihypertensive Agents|antihypertensive agents|mesh-list
65669929|NCT02737358|Acetylcysteine|acetylcysteine|mesh-list
65669930|NCT02737358|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65669931|NCT02737358|Antiviral Agents|antiviral agents|mesh-ancestor
65669932|NCT02737358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65669933|NCT02737358|Expectorants|expectorants|mesh-ancestor
65669934|NCT02737358|Respiratory System Agents|respiratory system agents|mesh-ancestor
65669935|NCT02737358|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65669936|NCT02737358|Antioxidants|antioxidants|mesh-ancestor
65669937|NCT02737358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669938|NCT02737358|Protective Agents|protective agents|mesh-ancestor
65669939|NCT02737358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669940|NCT02737358|Antidotes|antidotes|mesh-ancestor
65669941|NCT05052710|Midazolam|midazolam|mesh-list
65669942|NCT05052710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65669943|NCT05052710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65669944|NCT05052710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65669945|NCT05052710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669946|NCT05052710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65669947|NCT05052710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65669948|NCT05052710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65669949|NCT05052710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65669950|NCT05052710|Anesthetics, General|anesthetics, general|mesh-ancestor
65669951|NCT05052710|Anesthetics|anesthetics|mesh-ancestor
65669952|NCT05052710|GABA Modulators|gaba modulators|mesh-ancestor
65669953|NCT05052710|GABA Agents|gaba agents|mesh-ancestor
65669954|NCT05052710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65669955|NCT05052710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669956|NCT02866838|Tranexamic Acid|tranexamic acid|mesh-list
65669957|NCT02866838|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65669958|NCT02866838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65669959|NCT02866838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669960|NCT02866838|Hemostatics|hemostatics|mesh-ancestor
65669961|NCT02866838|Coagulants|coagulants|mesh-ancestor
65669962|NCT03474146|Chlorhexidine|chlorhexidine|mesh-list
65669963|NCT03474146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65669964|NCT03474146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65669965|NCT03474146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65669966|NCT03474146|Disinfectants|disinfectants|mesh-ancestor
65669967|NCT03474146|Dermatologic Agents|dermatologic agents|mesh-ancestor
65669968|NCT01090154|Certolizumab Pegol|certolizumab pegol|mesh-list
65669969|NCT01090154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65669970|NCT01090154|Immunologic Factors|immunologic factors|mesh-ancestor
65669971|NCT01090154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669972|NCT01090154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65669973|NCT02523092|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65669974|NCT02523092|Hormones|hormones|mesh-ancestor
65669975|NCT02523092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65669976|NCT02523092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669977|NCT01354431|Nivolumab|nivolumab|mesh-list
65669978|NCT01354431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65669979|NCT01354431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669980|NCT01354431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65669981|NCT01354431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669982|NCT02736578|Cetuximab|cetuximab|mesh-list
65669983|NCT02736578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65669984|NCT02736578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65669985|NCT02478788|Amphetamine|amphetamine|mesh-list
65669986|NCT02478788|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65669987|NCT02478788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65669988|NCT02478788|Sympathomimetics|sympathomimetics|mesh-ancestor
65669989|NCT02478788|Autonomic Agents|autonomic agents|mesh-ancestor
65669990|NCT02478788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65669991|NCT02478788|Dopamine Agents|dopamine agents|mesh-ancestor
65669992|NCT02478788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65669993|NCT02478788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65669994|NCT02478788|Adrenergic Agents|adrenergic agents|mesh-ancestor
65669995|NCT02478788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65669996|NCT02478788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65669997|NCT02478788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65669998|NCT02478788|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65669999|NCT05157542|Paclitaxel|paclitaxel|mesh-list
65670000|NCT05157542|Durvalumab|durvalumab|mesh-list
65670001|NCT05157542|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65670002|NCT05157542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65670003|NCT05157542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670004|NCT05157542|Tubulin Modulators|tubulin modulators|mesh-ancestor
65670005|NCT05157542|Antimitotic Agents|antimitotic agents|mesh-ancestor
65670006|NCT05157542|Mitosis Modulators|mitosis modulators|mesh-ancestor
65670007|NCT05157542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670008|NCT05157542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65670009|NCT03472976|Imiquimod|imiquimod|mesh-list
65670010|NCT03472976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65670011|NCT03472976|Immunologic Factors|immunologic factors|mesh-ancestor
65670012|NCT03472976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670013|NCT03472976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670014|NCT03472976|Interferon Inducers|interferon inducers|mesh-ancestor
65670015|NCT03473600|Triamcinolone|triamcinolone|mesh-list
65670016|NCT03473600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65670017|NCT03473600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65670018|NCT03473600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65670019|NCT03473600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65670020|NCT03473600|Glucocorticoids|glucocorticoids|mesh-ancestor
65670022|NCT03473600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65670023|NCT03473600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670024|NCT03473600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65670025|NCT03473600|Immunologic Factors|immunologic factors|mesh-ancestor
65670026|NCT03473600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670027|NCT03473600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670028|NCT04457648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65670029|NCT04457648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65670030|NCT02622724|Interferons|interferons|mesh-list
65670031|NCT02622724|Interferon-beta|interferon-beta|mesh-list
65670032|NCT02622724|Interferon beta-1a|interferon beta-1a|mesh-list
65670033|NCT02622724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670034|NCT02622724|Antiviral Agents|antiviral agents|mesh-ancestor
65670035|NCT02622724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65670036|NCT02622724|Immunologic Factors|immunologic factors|mesh-ancestor
65670037|NCT02622724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670038|NCT02622724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65670039|NCT01354353|Aripiprazole|aripiprazole|mesh-list
65670040|NCT01354353|Antidepressive Agents|antidepressive agents|mesh-ancestor
65670041|NCT01354353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65670042|NCT01354353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65670043|NCT01354353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65670044|NCT01354353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65670045|NCT01354353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670046|NCT01354353|Dopamine Agonists|dopamine agonists|mesh-ancestor
65670047|NCT01354353|Dopamine Agents|dopamine agents|mesh-ancestor
65670048|NCT01354353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65670049|NCT01354353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670050|NCT01354353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65670051|NCT01354353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65670052|NCT01354353|Serotonin Agents|serotonin agents|mesh-ancestor
65670053|NCT01354353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65670054|NCT01354353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65670055|NCT01354353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65670056|NCT01354353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65670057|NCT03070899|OBE2109|obe2109|mesh-list
65670058|NCT03070899|Hormone Antagonists|hormone antagonists|mesh-ancestor
65670059|NCT03070899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65670060|NCT03070899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670061|NCT04931524|Mitogens|mitogens|mesh-list
65670062|NCT04931524|Mitosis Modulators|mitosis modulators|mesh-ancestor
65670063|NCT04931524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670064|NCT03562611|Flurbiprofen|flurbiprofen|mesh-list
65670065|NCT03562611|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
65670066|NCT03562611|Nalbuphine|nalbuphine|mesh-list
65670067|NCT03562611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65670068|NCT03562611|Narcotics|narcotics|mesh-ancestor
65670069|NCT03562611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65670070|NCT03562611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670071|NCT03562611|Analgesics|analgesics|mesh-ancestor
65670072|NCT03562611|Sensory System Agents|sensory system agents|mesh-ancestor
65670073|NCT03562611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65670074|NCT03562611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65670075|NCT03562611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65670076|NCT03562611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65670077|NCT03562611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65670078|NCT03562611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65670079|NCT03562611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670080|NCT03562611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670081|NCT03057574|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65670082|NCT03057574|Hormones|hormones|mesh-ancestor
65670083|NCT03057574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65670084|NCT03057574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670085|NCT03057028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65670086|NCT03057028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65670087|NCT04929652|Irinotecan|irinotecan|mesh-list
65670088|NCT04929652|Molgramostim|molgramostim|mesh-list
65670089|NCT04929652|Sargramostim|sargramostim|mesh-list
65670090|NCT04929652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65467404|NCT05782192|Alogliptin|alogliptin|mesh-list
65670092|NCT04929652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670093|NCT04929652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670094|NCT04929652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670095|NCT04929652|Immunologic Factors|immunologic factors|mesh-ancestor
65670096|NCT04929652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670097|NCT01353963|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65670098|NCT01353963|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65670099|NCT01353963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65670100|NCT01353963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65670101|NCT01353963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670102|NCT01353963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65670103|NCT01353963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670104|NCT01353963|Antidepressive Agents|antidepressive agents|mesh-ancestor
65670105|NCT01353963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65670106|NCT04927936|Vaccines|vaccines|mesh-list
65670107|NCT04927936|Immunologic Factors|immunologic factors|mesh-ancestor
65670108|NCT04927936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670109|NCT04167813|Ondansetron|ondansetron|mesh-list
65670110|NCT04167813|Antiemetics|antiemetics|mesh-ancestor
65670111|NCT04167813|Autonomic Agents|autonomic agents|mesh-ancestor
65670112|NCT04167813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65670113|NCT04167813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670114|NCT04167813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65670115|NCT04167813|Antipruritics|antipruritics|mesh-ancestor
65670116|NCT04167813|Dermatologic Agents|dermatologic agents|mesh-ancestor
65670117|NCT04167813|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65670118|NCT04167813|Serotonin Agents|serotonin agents|mesh-ancestor
65670119|NCT04167813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65670120|NCT04167813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670121|NCT04167813|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65670122|NCT04167813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65670123|NCT04167813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65670124|NCT04167813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65670125|NCT04167813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65670126|NCT03562533|Paclitaxel|paclitaxel|mesh-list
65670127|NCT03562533|Carboplatin|carboplatin|mesh-list
65670128|NCT03562533|Doxorubicin|doxorubicin|mesh-list
65670129|NCT03562533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65670130|NCT03562533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65670131|NCT03562533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670132|NCT03562533|Tubulin Modulators|tubulin modulators|mesh-ancestor
65670133|NCT03562533|Antimitotic Agents|antimitotic agents|mesh-ancestor
65670134|NCT03562533|Mitosis Modulators|mitosis modulators|mesh-ancestor
65670135|NCT03562533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670136|NCT03562533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65670137|NCT03562533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65670138|NCT03562533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65670139|NCT03562533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670140|NCT04927858|Empagliflozin|empagliflozin|mesh-list
65670141|NCT04927858|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65670142|NCT04927858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670143|NCT04927858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65670144|NCT04927858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670145|NCT04014387|Zolpidem|zolpidem|mesh-list
65670146|NCT04014387|Suvorexant|suvorexant|mesh-list
65670147|NCT04014387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65670148|NCT04014387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65670149|NCT04014387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65670150|NCT04014387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670151|NCT04014387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65670152|NCT04014387|GABA Agonists|gaba agonists|mesh-ancestor
65670153|NCT04014387|GABA Agents|gaba agents|mesh-ancestor
65670154|NCT04014387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65670155|NCT04014387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670156|NCT04014387|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65670157|NCT05707455|Chrysarobin|chrysarobin|mesh-list
65670158|NCT05707455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65670159|NCT05707455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65670160|NCT05707455|Analgesics|analgesics|mesh-ancestor
65670161|NCT05707455|Sensory System Agents|sensory system agents|mesh-ancestor
65670162|NCT05707455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467475|NCT05781308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65670163|NCT05707455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670164|NCT05707455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65670165|NCT05707455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65670166|NCT04927000|Tofacitinib|tofacitinib|mesh-list
65670167|NCT04927000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65670168|NCT04927000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670169|NCT04927000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670170|NCT04926532|Sorafenib|sorafenib|mesh-list
65670171|NCT04926532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670172|NCT04926532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65670173|NCT04926532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670174|NCT04926532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670175|NCT03842709|Pramipexole|pramipexole|mesh-list
65670176|NCT03842709|Antioxidants|antioxidants|mesh-ancestor
65670177|NCT03842709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670178|NCT03842709|Protective Agents|protective agents|mesh-ancestor
65670179|NCT03842709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670180|NCT03842709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65670181|NCT03842709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65670182|NCT03842709|Dopamine Agonists|dopamine agonists|mesh-ancestor
65670183|NCT03842709|Dopamine Agents|dopamine agents|mesh-ancestor
65670184|NCT03842709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65670185|NCT05707533|Cefoxitin|cefoxitin|mesh-list
65670186|NCT05707533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65670187|NCT05707533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65670188|NCT03056482|Haloperidol|haloperidol|mesh-list
65670189|NCT03056482|Ondansetron|ondansetron|mesh-list
65670190|NCT03056482|Haloperidol decanoate|haloperidol decanoate|mesh-list
65670191|NCT03056482|Antiemetics|antiemetics|mesh-ancestor
65670192|NCT03056482|Autonomic Agents|autonomic agents|mesh-ancestor
65670193|NCT03056482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65670194|NCT03056482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670195|NCT03056482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65670196|NCT03056482|Antipruritics|antipruritics|mesh-ancestor
65670197|NCT03056482|Dermatologic Agents|dermatologic agents|mesh-ancestor
65670198|NCT03056482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65670199|NCT03056482|Serotonin Agents|serotonin agents|mesh-ancestor
65670200|NCT03056482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65670201|NCT03056482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670202|NCT03056482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65670203|NCT03056482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65670204|NCT03056482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65670205|NCT03056482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65670206|NCT03056482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65670207|NCT03056482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65670208|NCT03056482|Dopamine Agents|dopamine agents|mesh-ancestor
65670209|NCT03056482|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65670210|NCT02817555|Epoetin Alfa|epoetin alfa|mesh-list
65670211|NCT02817555|Darbepoetin alfa|darbepoetin alfa|mesh-list
65670212|NCT02817555|Hematinics|hematinics|mesh-ancestor
65670213|NCT04924192|Irinotecan|irinotecan|mesh-list
65670214|NCT04924192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65670215|NCT04924192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65670216|NCT04924192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670217|NCT04924192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670218|NCT04924192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670219|NCT02036073|Epoetin Alfa|epoetin alfa|mesh-list
65670220|NCT02036073|Hematinics|hematinics|mesh-ancestor
65670221|NCT02036229|Ivermectin|ivermectin|mesh-list
65670222|NCT02036229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65670223|NCT02036229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65670224|NCT04404088|Rituximab|rituximab|mesh-list
65670225|NCT04404088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65670226|NCT04404088|Lenalidomide|lenalidomide|mesh-list
65670227|NCT04404088|Acalabrutinib|acalabrutinib|mesh-list
65670228|NCT04404088|Antibodies|antibodies|mesh-list
65670229|NCT04404088|Immunoglobulins|immunoglobulins|mesh-list
65670230|NCT04404088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65670231|NCT04404088|Immunologic Factors|immunologic factors|mesh-ancestor
65670232|NCT04404088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670233|NCT04404088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670234|NCT04404088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65670235|NCT04404088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65670236|NCT04404088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65670237|NCT04404088|Growth Substances|growth substances|mesh-ancestor
65670238|NCT04404088|Growth Inhibitors|growth inhibitors|mesh-ancestor
65670239|NCT04922008|Capecitabine|capecitabine|mesh-list
65670240|NCT04922008|Trastuzumab|trastuzumab|mesh-list
65670241|NCT04922008|Vinorelbine|vinorelbine|mesh-list
65670242|NCT04922008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65670243|NCT04922008|Antimetabolites|antimetabolites|mesh-ancestor
65670244|NCT04922008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670245|NCT04922008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670246|NCT04922008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65670247|NCT04922008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65670248|NCT04922008|Tubulin Modulators|tubulin modulators|mesh-ancestor
65670249|NCT04922008|Antimitotic Agents|antimitotic agents|mesh-ancestor
65670250|NCT04922008|Mitosis Modulators|mitosis modulators|mesh-ancestor
65670251|NCT04921930|Artesunate|artesunate|mesh-list
65670252|NCT04921930|Antimalarials|antimalarials|mesh-ancestor
65670253|NCT04921930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65670254|NCT04921930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65670255|NCT04921930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65268544|NCT05428670|Growth Inhibitors|growth inhibitors|mesh-ancestor
65670256|NCT04921930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670257|NCT04921930|Antiviral Agents|antiviral agents|mesh-ancestor
65670258|NCT04921930|Schistosomicides|schistosomicides|mesh-ancestor
65670259|NCT04921930|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65670260|NCT04921930|Anthelmintics|anthelmintics|mesh-ancestor
65670261|NCT03056092|Ranibizumab|ranibizumab|mesh-list
65670262|NCT03056092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65670263|NCT03056092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65670264|NCT03056092|Growth Substances|growth substances|mesh-ancestor
65670265|NCT03056092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670266|NCT03056092|Growth Inhibitors|growth inhibitors|mesh-ancestor
65670267|NCT03056092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670268|NCT04921306|Clenbuterol|clenbuterol|mesh-list
65670269|NCT04921306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65670270|NCT04921306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65670271|NCT04921306|Adrenergic Agents|adrenergic agents|mesh-ancestor
65670272|NCT04921306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65670273|NCT04921306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670274|NCT04921306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670275|NCT04921306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65670276|NCT04921306|Autonomic Agents|autonomic agents|mesh-ancestor
65670277|NCT04921306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65670278|NCT04921306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65670279|NCT04921306|Respiratory System Agents|respiratory system agents|mesh-ancestor
65670280|NCT04921306|Sympathomimetics|sympathomimetics|mesh-ancestor
65670281|NCT04920760|Vitamin A|vitamin a|mesh-list
65670282|NCT04920760|Vitamins|vitamins|mesh-ancestor
65670283|NCT04920760|Micronutrients|micronutrients|mesh-ancestor
65670284|NCT04920760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670285|NCT03056248|Lithium Carbonate|lithium carbonate|mesh-list
65670286|NCT03056248|Antidepressive Agents|antidepressive agents|mesh-ancestor
65670287|NCT03056248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65670288|NCT03056248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670289|NCT03056248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670290|NCT03056248|Antimanic Agents|antimanic agents|mesh-ancestor
65670291|NCT03056248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65670292|NCT03056248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65670293|NCT03056248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670294|NCT04920604|Anesthetics|anesthetics|mesh-list
65670295|NCT04920604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65670296|NCT04920604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670297|NCT04920448|Acetylcysteine|acetylcysteine|mesh-list
65670298|NCT04920448|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65670299|NCT04920448|Antiviral Agents|antiviral agents|mesh-ancestor
65670300|NCT04920448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65670301|NCT04920448|Expectorants|expectorants|mesh-ancestor
65670302|NCT04920448|Respiratory System Agents|respiratory system agents|mesh-ancestor
65670303|NCT04920448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65670304|NCT04920448|Antioxidants|antioxidants|mesh-ancestor
65670305|NCT04920448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670306|NCT04920448|Protective Agents|protective agents|mesh-ancestor
65670307|NCT04920448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670308|NCT04920448|Antidotes|antidotes|mesh-ancestor
65670309|NCT03061006|Warfarin|warfarin|mesh-list
65670310|NCT03061006|Dabigatran|dabigatran|mesh-list
65670311|NCT03061006|Anticoagulants|anticoagulants|mesh-ancestor
65670312|NCT03061006|Antithrombins|antithrombins|mesh-ancestor
65670313|NCT03061006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65670314|NCT03061006|Protease Inhibitors|protease inhibitors|mesh-ancestor
65670315|NCT03061006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670316|NCT03061006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670317|NCT03060850|Abivertinib|abivertinib|mesh-list
65670318|NCT03060850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65670319|NCT03060850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670320|NCT03060850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670322|NCT04432558|Diclofenac|diclofenac|mesh-list
65670323|NCT04432558|Tramadol|tramadol|mesh-list
65670324|NCT04432558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65670325|NCT04432558|Analgesics|analgesics|mesh-ancestor
65670326|NCT04432558|Sensory System Agents|sensory system agents|mesh-ancestor
65670327|NCT04432558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65670328|NCT04432558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670329|NCT04432558|Antipyretics|antipyretics|mesh-ancestor
65670330|NCT04432558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65670331|NCT04432558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65670332|NCT04432558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65670333|NCT04432558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65670334|NCT04432558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670335|NCT04432558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670336|NCT04432558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65670337|NCT04432558|Narcotics|narcotics|mesh-ancestor
65670338|NCT04432558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65670339|NCT04761614|Calcium, Dietary|calcium, dietary|mesh-list
65670340|NCT04761614|Leucovorin|leucovorin|mesh-list
65670341|NCT04761614|Folic Acid|folic acid|mesh-list
65670342|NCT04761614|Bevacizumab|bevacizumab|mesh-list
65670343|NCT04761614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65670344|NCT04761614|Fluorouracil|fluorouracil|mesh-list
65670345|NCT04761614|Oxaliplatin|oxaliplatin|mesh-list
65670346|NCT04761614|Riluzole|riluzole|mesh-list
65670347|NCT04761614|Endothelial Growth Factors|endothelial growth factors|mesh-list
65670348|NCT04761614|Antibodies|antibodies|mesh-list
65670349|NCT04761614|Immunoglobulins|immunoglobulins|mesh-list
65670350|NCT04761614|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65670351|NCT04761614|Immunoglobulin G|immunoglobulin g|mesh-list
65670352|NCT04761614|Calcium|calcium|mesh-list
65670353|NCT04761614|Levoleucovorin|levoleucovorin|mesh-list
65670354|NCT04761614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670355|NCT04761614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65670356|NCT04761614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65670357|NCT04761614|Growth Substances|growth substances|mesh-ancestor
65670358|NCT04761614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670359|NCT04761614|Growth Inhibitors|growth inhibitors|mesh-ancestor
65670360|NCT04761614|Immunologic Factors|immunologic factors|mesh-ancestor
65670361|NCT04761614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65670362|NCT04761614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65670363|NCT04761614|Antimetabolites|antimetabolites|mesh-ancestor
65670364|NCT04761614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670365|NCT04761614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65670366|NCT04761614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65670367|NCT04761614|Antidotes|antidotes|mesh-ancestor
65670368|NCT04761614|Protective Agents|protective agents|mesh-ancestor
65670369|NCT04761614|Vitamin B Complex|vitamin b complex|mesh-ancestor
65670370|NCT04761614|Vitamins|vitamins|mesh-ancestor
65670371|NCT04761614|Micronutrients|micronutrients|mesh-ancestor
65670372|NCT04761614|Hematinics|hematinics|mesh-ancestor
65670373|NCT04761614|Anticonvulsants|anticonvulsants|mesh-ancestor
65670374|NCT04761614|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65670375|NCT04761614|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65670376|NCT04761614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65670377|NCT04761614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65670378|NCT04979650|Methylprednisolone|methylprednisolone|mesh-list
65670379|NCT04979650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65670380|NCT04979650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65670381|NCT04979650|Prednisolone|prednisolone|mesh-list
65670382|NCT04979650|Prednisolone acetate|prednisolone acetate|mesh-list
65670383|NCT04979650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65670384|NCT04979650|Prednisolone phosphate|prednisolone phosphate|mesh-list
65670385|NCT04979650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65670386|NCT04979650|Antiemetics|antiemetics|mesh-ancestor
65670387|NCT04979650|Autonomic Agents|autonomic agents|mesh-ancestor
65670388|NCT04979650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65670389|NCT04979650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670390|NCT04979650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65670391|NCT04979650|Glucocorticoids|glucocorticoids|mesh-ancestor
65670392|NCT04979650|Hormones|hormones|mesh-ancestor
65670393|NCT04979650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65670394|NCT04979650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65467735|NCT05432518|Everolimus|everolimus|mesh-list
65670395|NCT04979650|Protective Agents|protective agents|mesh-ancestor
65670396|NCT04979650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65670397|NCT04979650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670398|NCT04979884|Cyclosporine|cyclosporine|mesh-list
65670399|NCT04979884|Interleukin-2|interleukin-2|mesh-list
65670400|NCT04979884|Cyclosporins|cyclosporins|mesh-list
65670401|NCT04979884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670402|NCT04979884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670403|NCT04979884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65670404|NCT04979884|Immunologic Factors|immunologic factors|mesh-ancestor
65670405|NCT04979884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670406|NCT04979884|Antifungal Agents|antifungal agents|mesh-ancestor
65670407|NCT04979884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65670408|NCT04979884|Dermatologic Agents|dermatologic agents|mesh-ancestor
65670409|NCT04979884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65670410|NCT04979884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65670411|NCT04979884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670412|NCT04979884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65670413|NCT04979884|Analgesics|analgesics|mesh-ancestor
65670414|NCT04979884|Sensory System Agents|sensory system agents|mesh-ancestor
65670415|NCT04979884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65670416|NCT04650152|Fenofibrate|fenofibrate|mesh-list
65670417|NCT04650152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65670418|NCT04650152|Antimetabolites|antimetabolites|mesh-ancestor
65670419|NCT04650152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670420|NCT04650152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65670421|NCT04967950|Methotrexate|methotrexate|mesh-list
65670422|NCT04967950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65670423|NCT04967950|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65670424|NCT04967950|Abortifacient Agents|abortifacient agents|mesh-ancestor
65670425|NCT04967950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65670426|NCT04967950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670427|NCT04967950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65670428|NCT04967950|Antimetabolites|antimetabolites|mesh-ancestor
65670429|NCT04967950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670430|NCT04967950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670431|NCT04967950|Dermatologic Agents|dermatologic agents|mesh-ancestor
65670432|NCT04967950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670433|NCT04967950|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65670434|NCT04967950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65670435|NCT04967950|Immunologic Factors|immunologic factors|mesh-ancestor
65670436|NCT04967950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65670437|NCT04967950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65670438|NCT04967326|Carbamazepine|carbamazepine|mesh-list
65670439|NCT04967326|Phenytoin|phenytoin|mesh-list
65670440|NCT04967326|Valproic Acid|valproic acid|mesh-list
65670441|NCT04967326|Anticonvulsants|anticonvulsants|mesh-list
65670442|NCT04967326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670443|NCT04967326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670444|NCT04967326|GABA Agents|gaba agents|mesh-ancestor
65670445|NCT04967326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65670446|NCT04967326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670447|NCT04967326|Antimanic Agents|antimanic agents|mesh-ancestor
65670448|NCT04967326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65670449|NCT04967326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65670450|NCT04967326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65670451|NCT04967326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65670452|NCT04967326|Analgesics|analgesics|mesh-ancestor
65670453|NCT04967326|Sensory System Agents|sensory system agents|mesh-ancestor
65670454|NCT04967326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65670455|NCT04967326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65670456|NCT04967326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65670457|NCT04967326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65670458|NCT04967326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65670459|NCT04967326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65670460|NCT04967326|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65670461|NCT03062176|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65670462|NCT03062176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65670463|NCT02620384|Metolazone|metolazone|mesh-list
65670464|NCT02620384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65670465|NCT02620384|Diuretics|diuretics|mesh-ancestor
65670466|NCT02620384|Natriuretic Agents|natriuretic agents|mesh-ancestor
65670467|NCT02620384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670468|NCT02620384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65670469|NCT02620384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65670470|NCT02620384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670471|NCT02088632|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65670472|NCT02088632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65670473|NCT02088632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65670474|NCT02088632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670475|NCT02088632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65670476|NCT02088632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65670477|NCT02088632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670478|NCT02088632|Cholinergic Agents|cholinergic agents|mesh-ancestor
65670479|NCT02088632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65670480|NCT04918576|Tranexamic Acid|tranexamic acid|mesh-list
65670481|NCT04918576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65670482|NCT04918576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65670483|NCT04918576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670484|NCT04918576|Hemostatics|hemostatics|mesh-ancestor
65670485|NCT04918576|Coagulants|coagulants|mesh-ancestor
65670486|NCT03472508|Folic Acid|folic acid|mesh-list
65670487|NCT03472508|Vitamin B Complex|vitamin b complex|mesh-list
65670488|NCT03472508|Enalapril|enalapril|mesh-list
65670489|NCT03472508|Enalaprilat|enalaprilat|mesh-list
65670490|NCT03472508|Hematinics|hematinics|mesh-ancestor
65670491|NCT03472508|Vitamins|vitamins|mesh-ancestor
65670492|NCT03472508|Micronutrients|micronutrients|mesh-ancestor
65670493|NCT03472508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670494|NCT03472508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670495|NCT03472508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670496|NCT03472508|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65670497|NCT03472508|Protease Inhibitors|protease inhibitors|mesh-ancestor
65670498|NCT03472508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65670499|NCT04966234|Posaconazole|posaconazole|mesh-list
65670500|NCT04966234|Antifungal Agents|antifungal agents|mesh-ancestor
65670501|NCT04966234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65670502|NCT04966234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65670503|NCT04966234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65670504|NCT04966234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65670505|NCT04966234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65670506|NCT04966234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65670507|NCT04966234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670508|NCT04966234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670509|NCT04966234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65670510|NCT04966234|Hormone Antagonists|hormone antagonists|mesh-ancestor
65670511|NCT04966234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65670512|NCT04966234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670513|NCT03915860|Trifarotene|trifarotene|mesh-list
65670514|NCT03915860|Dermatologic Agents|dermatologic agents|mesh-ancestor
65670515|NCT04170998|Metformin|metformin|mesh-list
65670516|NCT04170998|Dapagliflozin|dapagliflozin|mesh-list
65670517|NCT04170998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65670518|NCT04170998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670519|NCT04170998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65670520|NCT04170998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670521|NCT04965532|Anesthetics|anesthetics|mesh-list
65670522|NCT04965532|Propofol|propofol|mesh-list
65670523|NCT04965532|Sevoflurane|sevoflurane|mesh-list
65670524|NCT04965532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65670525|NCT04965532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670526|NCT04965532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65670527|NCT04965532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65670528|NCT04965532|Anesthetics, General|anesthetics, general|mesh-ancestor
65670529|NCT04965532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65670530|NCT04965532|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65670531|NCT04965766|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
65670532|NCT04965766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65670533|NCT04965766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670534|NCT03055546|Oxytocin|oxytocin|mesh-list
65670535|NCT03055546|Oxytocics|oxytocics|mesh-ancestor
65670536|NCT03055546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65670537|NCT03055546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670538|NCT04918264|Capecitabine|capecitabine|mesh-list
65670539|NCT04918264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65670540|NCT04918264|Antimetabolites|antimetabolites|mesh-ancestor
65670541|NCT04918264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670542|NCT04918264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670543|NCT04917718|Tacrolimus|tacrolimus|mesh-list
65670544|NCT04917718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65670545|NCT04917718|Immunologic Factors|immunologic factors|mesh-ancestor
65670546|NCT04917718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670547|NCT04917718|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65670548|NCT04917718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670549|NCT04917718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670550|NCT04977778|Fluorides|fluorides|mesh-list
65670551|NCT04977778|Tin Fluorides|tin fluorides|mesh-list
65670552|NCT04977778|Cariostatic Agents|cariostatic agents|mesh-ancestor
65670553|NCT04977778|Protective Agents|protective agents|mesh-ancestor
65670554|NCT04977778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670555|NCT03055234|Treprostinil|treprostinil|mesh-list
65670556|NCT03055234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65670557|NCT03055312|Bicalutamide|bicalutamide|mesh-list
65670558|NCT03055312|Androgen Antagonists|androgen antagonists|mesh-ancestor
65670559|NCT03055312|Hormone Antagonists|hormone antagonists|mesh-ancestor
65670560|NCT03055312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65670561|NCT03055312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670562|NCT03055312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670563|NCT04977544|Sertraline|sertraline|mesh-list
65670564|NCT04977544|Antidepressive Agents|antidepressive agents|mesh-ancestor
65670565|NCT04977544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65670566|NCT04977544|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65670567|NCT04977544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65670568|NCT04977544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65670569|NCT04977544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670570|NCT04977544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65670571|NCT04977544|Serotonin Agents|serotonin agents|mesh-ancestor
65670572|NCT04977544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670573|NCT02626000|Pembrolizumab|pembrolizumab|mesh-list
65670574|NCT02626000|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
65670575|NCT02626000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65670576|NCT02626000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670577|NCT03769376|Salvin|salvin|mesh-list
65670578|NCT03769376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65670579|NCT03769376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65670580|NCT03769376|Antioxidants|antioxidants|mesh-ancestor
65670581|NCT03769376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670582|NCT03769376|Protective Agents|protective agents|mesh-ancestor
65670583|NCT03769376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670584|NCT05156450|Prednisone|prednisone|mesh-list
65670585|NCT05156450|Abiraterone Acetate|abiraterone acetate|mesh-list
65670586|NCT05156450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65670587|NCT05156450|Glucocorticoids|glucocorticoids|mesh-ancestor
65670588|NCT05156450|Hormones|hormones|mesh-ancestor
65670589|NCT05156450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65670590|NCT05156450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670591|NCT05156450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65670592|NCT05156450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670593|NCT05156450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65670594|NCT05156450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670595|NCT05156450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670596|NCT05156450|Hormone Antagonists|hormone antagonists|mesh-ancestor
65670597|NCT05156450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65670598|NCT03060304|Tamoxifen|tamoxifen|mesh-list
65670599|NCT03060304|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65670600|NCT03060304|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65670601|NCT03060304|Estradiol|estradiol|mesh-list
65670602|NCT03060304|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65670603|NCT03060304|Estrogens|estrogens|mesh-ancestor
65670604|NCT03060304|Hormones|hormones|mesh-ancestor
65670605|NCT03060304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65670606|NCT03060304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670607|NCT03060304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65670608|NCT03060304|Contraceptive Agents|contraceptive agents|mesh-ancestor
65670609|NCT03060304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65670610|NCT03060304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65670611|NCT03060304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65670612|NCT03060304|Hormone Antagonists|hormone antagonists|mesh-ancestor
65670613|NCT03060304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65670614|NCT03060304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670615|NCT03060304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65670616|NCT03060304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65670617|NCT03060304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65670619|NCT04432402|Oxaliplatin|oxaliplatin|mesh-list
65670620|NCT04432402|Lenalidomide|lenalidomide|mesh-list
65670621|NCT04432402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670622|NCT04432402|Immunologic Factors|immunologic factors|mesh-ancestor
65670623|NCT04432402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670624|NCT04432402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65670625|NCT04432402|Antimetabolites|antimetabolites|mesh-ancestor
65670626|NCT04432402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670627|NCT04432402|Antiviral Agents|antiviral agents|mesh-ancestor
65670628|NCT04432402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65670629|NCT04432402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670630|NCT04432402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65670631|NCT04432402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65670632|NCT04432402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65670633|NCT04432402|Growth Substances|growth substances|mesh-ancestor
65670634|NCT04432402|Growth Inhibitors|growth inhibitors|mesh-ancestor
65670635|NCT04432324|Immunoglobulins|immunoglobulins|mesh-list
65670636|NCT04432324|Antibodies|antibodies|mesh-list
65670637|NCT04432324|gamma-Globulins|gamma-globulins|mesh-list
65670638|NCT04432324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65670639|NCT04432324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65670640|NCT04432324|Immunologic Factors|immunologic factors|mesh-ancestor
65670641|NCT04432324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670642|NCT02736890|Botulinum Toxins|botulinum toxins|mesh-list
65670643|NCT02736890|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65670644|NCT02736890|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65670645|NCT02736890|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65670646|NCT02736890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65670647|NCT02736890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670648|NCT02736890|Cholinergic Agents|cholinergic agents|mesh-ancestor
65670649|NCT02736890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65670650|NCT02736890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670651|NCT02736890|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65670652|NCT02736890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65670653|NCT04977388|Droxidopa|droxidopa|mesh-list
65670654|NCT04977388|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65670655|NCT04977388|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65670656|NCT04917484|Octreotide|octreotide|mesh-list
65670657|NCT04917484|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65670658|NCT04917484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65670659|NCT04917484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65670660|NCT04917484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670661|NCT04917484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65670662|NCT04917484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670663|NCT03470480|Methamphetamine|methamphetamine|mesh-list
65670664|NCT03470480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65670665|NCT03470480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670666|NCT03470480|Sympathomimetics|sympathomimetics|mesh-ancestor
65670667|NCT03470480|Autonomic Agents|autonomic agents|mesh-ancestor
65670668|NCT03470480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65670669|NCT03470480|Dopamine Agents|dopamine agents|mesh-ancestor
65670670|NCT03470480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65670671|NCT03470480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670672|NCT03470480|Adrenergic Agents|adrenergic agents|mesh-ancestor
65670673|NCT03470480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65670674|NCT03470480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65670675|NCT03470480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65670676|NCT03470480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65670677|NCT03469856|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65670678|NCT03469856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65670679|NCT04917250|Gemcitabine|gemcitabine|mesh-list
65670680|NCT04917250|Dexamethasone|dexamethasone|mesh-list
65670681|NCT04917250|Etoposide|etoposide|mesh-list
65670682|NCT04917250|Pegaspargase|pegaspargase|mesh-list
65670683|NCT04917250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65670684|NCT04917250|Antiemetics|antiemetics|mesh-ancestor
65670685|NCT04917250|Autonomic Agents|autonomic agents|mesh-ancestor
65670686|NCT04917250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65670687|NCT04917250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670688|NCT04917250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65670689|NCT04917250|Glucocorticoids|glucocorticoids|mesh-ancestor
65670690|NCT04917250|Hormones|hormones|mesh-ancestor
65670691|NCT04917250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65670692|NCT04917250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65670693|NCT04917250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670694|NCT04917250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65670696|NCT04917250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670697|NCT04917250|Antiviral Agents|antiviral agents|mesh-ancestor
65670698|NCT04917250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65670699|NCT04917250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670700|NCT04917250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65670701|NCT04917250|Immunologic Factors|immunologic factors|mesh-ancestor
65670702|NCT04917250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65670703|NCT04917250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65670704|NCT04917250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65670705|NCT04859582|Pembrolizumab|pembrolizumab|mesh-list
65670706|NCT04859582|Fluorouracil|fluorouracil|mesh-list
65670707|NCT04859582|Capecitabine|capecitabine|mesh-list
65670708|NCT04859582|Oxaliplatin|oxaliplatin|mesh-list
65670709|NCT04859582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670710|NCT04859582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65670711|NCT04859582|Antimetabolites|antimetabolites|mesh-ancestor
65670712|NCT04859582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670713|NCT04859582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65670714|NCT04859582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65670715|NCT04859582|Immunologic Factors|immunologic factors|mesh-ancestor
65670716|NCT04859582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670717|NCT03469700|Anesthetics|anesthetics|mesh-list
65670718|NCT03469700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65670719|NCT03469700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670720|NCT04912726|Sildenafil Citrate|sildenafil citrate|mesh-list
65670721|NCT04912726|Vasodilator Agents|vasodilator agents|mesh-ancestor
65670722|NCT04912726|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65670723|NCT04912726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65670724|NCT04912726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670725|NCT04912726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670726|NCT04912726|Urological Agents|urological agents|mesh-ancestor
65670727|NCT02603900|Bupivacaine|bupivacaine|mesh-list
65670728|NCT02603900|Ropivacaine|ropivacaine|mesh-list
65670729|NCT02603900|Anesthetics, Local|anesthetics, local|mesh-ancestor
65670730|NCT02603900|Anesthetics|anesthetics|mesh-ancestor
65670731|NCT02603900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65670732|NCT02603900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670733|NCT02603900|Sensory System Agents|sensory system agents|mesh-ancestor
65670734|NCT02603900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65670735|NCT01669798|Nintedanib|nintedanib|mesh-list
65670736|NCT01669798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670737|NCT01669798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65670738|NCT01669798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133379|NCT01129882|Serotonin Agents|serotonin agents|mesh-ancestor
65670739|NCT01669798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670740|NCT02334722|Levetiracetam|levetiracetam|mesh-list
65670741|NCT02334722|Anticonvulsants|anticonvulsants|mesh-ancestor
65670742|NCT02334722|Nootropic Agents|nootropic agents|mesh-ancestor
65670743|NCT04458116|Curcumin|curcumin|mesh-list
65670744|NCT04458116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65670745|NCT04458116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65670746|NCT04458116|Analgesics|analgesics|mesh-ancestor
65670747|NCT04458116|Sensory System Agents|sensory system agents|mesh-ancestor
65670748|NCT04458116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65670749|NCT04458116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670750|NCT04458116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65670751|NCT04458116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65670752|NCT04458116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670753|NCT04458116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670754|NCT04458116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670755|NCT03469544|Hormones|hormones|mesh-list
65670756|NCT03469544|Antibodies|antibodies|mesh-list
65670757|NCT03469544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65670758|NCT03469544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670759|NCT03469544|Immunologic Factors|immunologic factors|mesh-ancestor
65670760|NCT03062254|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65670761|NCT03062254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670762|NCT04912258|Irinotecan|irinotecan|mesh-list
65670763|NCT04912258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65670764|NCT04912258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65670765|NCT04912258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670766|NCT04912258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670767|NCT04912258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670768|NCT01952288|Simvastatin|simvastatin|mesh-list
65670769|NCT01952288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65670770|NCT01952288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65670771|NCT01952288|Antimetabolites|antimetabolites|mesh-ancestor
65670772|NCT01952288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670773|NCT01952288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65670774|NCT01952288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65670775|NCT01952288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670776|NCT03054532|Durvalumab|durvalumab|mesh-list
65670777|NCT03054532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65670778|NCT03054532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670779|NCT04975360|Caffeine|caffeine|mesh-list
65670780|NCT04975360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65670781|NCT04975360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670782|NCT04975360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65670783|NCT04975360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670784|NCT04975360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670785|NCT04975360|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65670786|NCT04975360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65670787|NCT04975360|Purinergic Agents|purinergic agents|mesh-ancestor
65670788|NCT04975360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65670789|NCT00563576|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65670790|NCT00563576|Medroxyprogesterone|medroxyprogesterone|mesh-list
65670791|NCT00563576|Estradiol|estradiol|mesh-list
65670792|NCT00563576|Estrogens|estrogens|mesh-ancestor
65670793|NCT00563576|Hormones|hormones|mesh-ancestor
65670794|NCT00563576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65670795|NCT00563576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670796|NCT00563576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65670797|NCT00563576|Contraceptive Agents|contraceptive agents|mesh-ancestor
65670798|NCT00563576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65670799|NCT00563576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65670800|NCT00563576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65670801|NCT00563576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65670802|NCT00563576|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65670803|NCT00563576|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65670804|NCT00563576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65670805|NCT00563576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670806|NCT04915846|Tamoxifen|tamoxifen|mesh-list
65670807|NCT04915846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65670808|NCT04915846|Hormone Antagonists|hormone antagonists|mesh-ancestor
65670809|NCT04915846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65670810|NCT04915846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670811|NCT04915846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65670812|NCT04915846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670813|NCT04915846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65670814|NCT04915846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65670815|NCT04915846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65670816|NCT04774250|Zonisamide|zonisamide|mesh-list
65670817|NCT04774250|Anticonvulsants|anticonvulsants|mesh-ancestor
65670818|NCT04774250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65670819|NCT04774250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65670820|NCT04774250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670821|NCT04774250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65670822|NCT04774250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670823|NCT04031846|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65670824|NCT04031846|Immunologic Factors|immunologic factors|mesh-ancestor
65670825|NCT04031846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670826|NCT03782636|Aldesleukin|aldesleukin|mesh-list
65670827|NCT03782636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670828|NCT03782636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65670829|NCT03782636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65670830|NCT03782636|Antiviral Agents|antiviral agents|mesh-ancestor
65670831|NCT03782636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65670832|NCT04911244|Dimercaprol|dimercaprol|mesh-list
65670833|NCT04911244|Chelating Agents|chelating agents|mesh-ancestor
65670834|NCT04911244|Sequestering Agents|sequestering agents|mesh-ancestor
65670835|NCT04911244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670836|NCT03761810|Tretinoin|tretinoin|mesh-list
65670837|NCT03761810|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65670838|NCT03761810|Dermatologic Agents|dermatologic agents|mesh-ancestor
65468191|NCT04677049|Niacin|niacin|mesh-list
65670839|NCT03761810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670840|NCT03761810|Keratolytic Agents|keratolytic agents|mesh-ancestor
65670841|NCT04915456|Prednisolone|prednisolone|mesh-list
65670842|NCT04915456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65670843|NCT04915456|Glucocorticoids|glucocorticoids|mesh-ancestor
65670844|NCT04915456|Hormones|hormones|mesh-ancestor
65670845|NCT04915456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65670846|NCT04915456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670847|NCT04915456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65670848|NCT04915456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670849|NCT04841668|Metformin|metformin|mesh-list
65670850|NCT04841668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65670851|NCT04841668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670852|NCT04914910|Insulin|insulin|mesh-list
65670853|NCT04914910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65670854|NCT04914910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670855|NCT03469310|Acetaminophen|acetaminophen|mesh-list
65670856|NCT03469310|Tramadol|tramadol|mesh-list
65670857|NCT03469310|Codeine|codeine|mesh-list
65670858|NCT03469310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65670859|NCT03469310|Analgesics|analgesics|mesh-ancestor
65670860|NCT03469310|Sensory System Agents|sensory system agents|mesh-ancestor
65670861|NCT03469310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65670862|NCT03469310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670863|NCT03469310|Antipyretics|antipyretics|mesh-ancestor
65670864|NCT03469310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65670865|NCT03469310|Narcotics|narcotics|mesh-ancestor
65670866|NCT03469310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65670867|NCT03469310|Antitussive Agents|antitussive agents|mesh-ancestor
65670868|NCT03469310|Respiratory System Agents|respiratory system agents|mesh-ancestor
65670869|NCT03527186|Risperidone|risperidone|mesh-list
65670870|NCT03527186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65670871|NCT03527186|Serotonin Agents|serotonin agents|mesh-ancestor
65670872|NCT03527186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65670873|NCT03527186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670874|NCT03527186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670875|NCT03527186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65670876|NCT03527186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65670877|NCT03527186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65670878|NCT03527186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65670879|NCT03527186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65670880|NCT03527186|Dopamine Agents|dopamine agents|mesh-ancestor
65670881|NCT05159882|Dapagliflozin|dapagliflozin|mesh-list
65670882|NCT05159882|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65670883|NCT05159882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670884|NCT05159882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65670885|NCT05159882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670886|NCT04910698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65670887|NCT04910698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65670888|NCT04455464|Midodrine|midodrine|mesh-list
65670889|NCT04455464|Sympathomimetics|sympathomimetics|mesh-ancestor
65670890|NCT04455464|Autonomic Agents|autonomic agents|mesh-ancestor
65670891|NCT04455464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65670892|NCT04455464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670893|NCT04455464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65670894|NCT04455464|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65670895|NCT04455464|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65670896|NCT04455464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65670897|NCT04455464|Adrenergic Agents|adrenergic agents|mesh-ancestor
65670898|NCT04455464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65670899|NCT04455464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670900|NCT04914598|Cisplatin|cisplatin|mesh-list
65670901|NCT04914598|Endostar protein|endostar protein|mesh-list
65670902|NCT04914598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670903|NCT04914598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65670904|NCT04914598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65670905|NCT04914598|Growth Substances|growth substances|mesh-ancestor
65670906|NCT04914598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670907|NCT04914598|Growth Inhibitors|growth inhibitors|mesh-ancestor
65670908|NCT03054220|Tramadol|tramadol|mesh-list
65670909|NCT03054220|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65670910|NCT03054220|Dextromethorphan|dextromethorphan|mesh-list
65670911|NCT03054220|Paroxetine|paroxetine|mesh-list
65670912|NCT03054220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65670913|NCT03054220|Narcotics|narcotics|mesh-ancestor
65670914|NCT03054220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65468230|NCT04642287|Immunologic Factors|immunologic factors|mesh-ancestor
65670915|NCT03054220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670916|NCT03054220|Analgesics|analgesics|mesh-ancestor
65670917|NCT03054220|Sensory System Agents|sensory system agents|mesh-ancestor
65670918|NCT03054220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65670919|NCT03054220|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65670920|NCT03054220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65670921|NCT03054220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65670922|NCT03054220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670923|NCT03054220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65670924|NCT03054220|Antidepressive Agents|antidepressive agents|mesh-ancestor
65670925|NCT03054220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65670926|NCT03054220|Dopamine Agents|dopamine agents|mesh-ancestor
65670927|NCT03054220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65670928|NCT03054220|Serotonin Agents|serotonin agents|mesh-ancestor
65670929|NCT03054220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65670930|NCT03054220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65670931|NCT03054220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65670932|NCT03054220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65670933|NCT03054220|Antitussive Agents|antitussive agents|mesh-ancestor
65670934|NCT03054220|Respiratory System Agents|respiratory system agents|mesh-ancestor
65670935|NCT03054220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65670936|NCT03054220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65670937|NCT05388188|Sufentanil|sufentanil|mesh-list
65670938|NCT05388188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65670939|NCT05388188|Narcotics|narcotics|mesh-ancestor
65670940|NCT05388188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65670941|NCT05388188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670942|NCT05388188|Analgesics|analgesics|mesh-ancestor
65670943|NCT05388188|Sensory System Agents|sensory system agents|mesh-ancestor
65670944|NCT05388188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65670945|NCT05388188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65670946|NCT05388188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65670947|NCT05388188|Anesthetics, General|anesthetics, general|mesh-ancestor
65670948|NCT05388188|Anesthetics|anesthetics|mesh-ancestor
65670949|NCT04118036|Pembrolizumab|pembrolizumab|mesh-list
65670950|NCT04118036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65670951|NCT04118036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670952|NCT04909918|Dexamethasone|dexamethasone|mesh-list
65670953|NCT04909918|Methylprednisolone|methylprednisolone|mesh-list
65670954|NCT04909918|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65670955|NCT04909918|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65670956|NCT04909918|Prednisolone|prednisolone|mesh-list
65133610|NCT02882581|Metformin|metformin|mesh-list
65670957|NCT04909918|Prednisolone acetate|prednisolone acetate|mesh-list
65670958|NCT04909918|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65670959|NCT04909918|Prednisolone phosphate|prednisolone phosphate|mesh-list
65670960|NCT04909918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65670961|NCT04909918|Antiemetics|antiemetics|mesh-ancestor
65670962|NCT04909918|Autonomic Agents|autonomic agents|mesh-ancestor
65670963|NCT04909918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65670964|NCT04909918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670965|NCT04909918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65670966|NCT04909918|Glucocorticoids|glucocorticoids|mesh-ancestor
65670967|NCT04909918|Hormones|hormones|mesh-ancestor
65670968|NCT04909918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65670969|NCT04909918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65670970|NCT04909918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670971|NCT04909918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65670972|NCT04909918|Protective Agents|protective agents|mesh-ancestor
65670973|NCT04903678|Melphalan|melphalan|mesh-list
65670974|NCT04903678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65670975|NCT04903678|Alkylating Agents|alkylating agents|mesh-ancestor
65670976|NCT04903678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670977|NCT04903678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65670978|NCT04903678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65670979|NCT04903678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65670980|NCT04903678|Immunologic Factors|immunologic factors|mesh-ancestor
65670981|NCT04903678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670982|NCT04903366|Timolol|timolol|mesh-list
65670983|NCT04903366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65670984|NCT04903366|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65670985|NCT04903366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65670986|NCT04903366|Adrenergic Agents|adrenergic agents|mesh-ancestor
65670987|NCT04903366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65670988|NCT04903366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65670989|NCT04903366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65670990|NCT04903366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65670991|NCT03054610|Betamethasone|betamethasone|mesh-list
65670992|NCT03054610|Betamethasone Valerate|betamethasone valerate|mesh-list
65670993|NCT03054610|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65670994|NCT03054610|Betamethasone benzoate|betamethasone benzoate|mesh-list
65670995|NCT03054610|Ropivacaine|ropivacaine|mesh-list
65670996|NCT03054610|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
65670997|NCT03054610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65670998|NCT03054610|Botulinum Toxins|botulinum toxins|mesh-list
65670999|NCT03054610|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65671000|NCT03054610|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65671001|NCT03054610|Anesthetics, Local|anesthetics, local|mesh-ancestor
65671002|NCT03054610|Anesthetics|anesthetics|mesh-ancestor
65671003|NCT03054610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65671004|NCT03054610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671005|NCT03054610|Sensory System Agents|sensory system agents|mesh-ancestor
65671006|NCT03054610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671007|NCT03054610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65671008|NCT03054610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65671009|NCT03054610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671010|NCT03054610|Cholinergic Agents|cholinergic agents|mesh-ancestor
65671011|NCT03054610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65671012|NCT03054610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65671013|NCT03054610|Glucocorticoids|glucocorticoids|mesh-ancestor
65671015|NCT03054610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65671016|NCT03054610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65671017|NCT03054610|Respiratory System Agents|respiratory system agents|mesh-ancestor
65671018|NCT03054610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65671019|NCT03054610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65671020|NCT03054610|Autonomic Agents|autonomic agents|mesh-ancestor
65671021|NCT04909684|Pembrolizumab|pembrolizumab|mesh-list
65671022|NCT04909684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65671023|NCT04909684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671024|NCT03053830|Ketamine|ketamine|mesh-list
65671025|NCT03053830|Analgesics|analgesics|mesh-ancestor
65671026|NCT03053830|Sensory System Agents|sensory system agents|mesh-ancestor
65671027|NCT03053830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671028|NCT03053830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671029|NCT03053830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65671030|NCT03053830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65671031|NCT03053830|Anesthetics, General|anesthetics, general|mesh-ancestor
65671032|NCT03053830|Anesthetics|anesthetics|mesh-ancestor
65671033|NCT03053830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65671034|NCT03053830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65671035|NCT03053830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65671036|NCT03053830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65671037|NCT03053830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671038|NCT04913896|Oxaliplatin|oxaliplatin|mesh-list
65671039|NCT04913896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65671040|NCT04913896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671041|NCT04913896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671042|NCT03053284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65671043|NCT03053284|Pasireotide|pasireotide|mesh-list
65671044|NCT03053284|Hormones|hormones|mesh-ancestor
65671045|NCT03053284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65671046|NCT03053284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671047|NCT04901884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65671048|NCT04901884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65671049|NCT04901884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671050|NCT02811861|Pembrolizumab|pembrolizumab|mesh-list
65671051|NCT02811861|Everolimus|everolimus|mesh-list
65671052|NCT02811861|Sunitinib|sunitinib|mesh-list
65671053|NCT02811861|Lenvatinib|lenvatinib|mesh-list
65671054|NCT02811861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65671055|NCT02811861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671056|NCT02811861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65671057|NCT02811861|Immunologic Factors|immunologic factors|mesh-ancestor
65671058|NCT02811861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671059|NCT02811861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65671060|NCT02811861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65671061|NCT02811861|Growth Substances|growth substances|mesh-ancestor
65671062|NCT02811861|Growth Inhibitors|growth inhibitors|mesh-ancestor
65671063|NCT02811861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65671064|NCT02811861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65671065|NCT02811861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671067|NCT04908982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65671068|NCT04908982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65671069|NCT04908982|Analgesics|analgesics|mesh-ancestor
65671070|NCT04908982|Sensory System Agents|sensory system agents|mesh-ancestor
65671071|NCT04908982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671072|NCT04908982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671073|NCT04908982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65671074|NCT04908982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65671075|NCT04908982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65671076|NCT04908982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65671077|NCT04908982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671078|NCT04908982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65671079|NCT04908982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65671080|NCT04908982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65671081|NCT04908982|Antipyretics|antipyretics|mesh-ancestor
65671082|NCT04430998|Chlorhexidine|chlorhexidine|mesh-list
65671083|NCT04430998|Polaprezinc|polaprezinc|mesh-list
65671084|NCT04430998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65671085|NCT04430998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65671086|NCT04430998|Disinfectants|disinfectants|mesh-ancestor
65671087|NCT04430998|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65671088|NCT04430998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65671089|NCT04892758|Mometasone Furoate|mometasone furoate|mesh-list
65671090|NCT04892758|Formoterol Fumarate|formoterol fumarate|mesh-list
65671091|NCT04892758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65671092|NCT04892758|Autonomic Agents|autonomic agents|mesh-ancestor
65671093|NCT04892758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671094|NCT04892758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671095|NCT04892758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65671096|NCT04892758|Respiratory System Agents|respiratory system agents|mesh-ancestor
65671097|NCT04892758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65671098|NCT04892758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65671099|NCT04892758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65671100|NCT04892758|Adrenergic Agents|adrenergic agents|mesh-ancestor
65671101|NCT04892758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65671102|NCT04892758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671103|NCT04892758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65671104|NCT04892758|Dermatologic Agents|dermatologic agents|mesh-ancestor
65671105|NCT04892758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65671106|NCT04900948|Methylprednisolone|methylprednisolone|mesh-list
65671107|NCT04900948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65671108|NCT04900948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65671109|NCT04900948|Prednisolone|prednisolone|mesh-list
65671110|NCT04900948|Prednisolone acetate|prednisolone acetate|mesh-list
65671111|NCT04900948|Pimecrolimus|pimecrolimus|mesh-list
65671112|NCT04900948|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
65671113|NCT04900948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65671114|NCT04900948|Prednisolone phosphate|prednisolone phosphate|mesh-list
65671115|NCT04900948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65671116|NCT04900948|Antiemetics|antiemetics|mesh-ancestor
65671117|NCT04900948|Autonomic Agents|autonomic agents|mesh-ancestor
65671118|NCT04900948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671119|NCT04900948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671120|NCT04900948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65671121|NCT04900948|Glucocorticoids|glucocorticoids|mesh-ancestor
65671122|NCT04900948|Hormones|hormones|mesh-ancestor
65671123|NCT04900948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65671124|NCT04900948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65671125|NCT04900948|Protective Agents|protective agents|mesh-ancestor
65671126|NCT04900948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65671127|NCT04900948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671128|NCT04900948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65671129|NCT04900948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65671130|NCT04900948|Analgesics|analgesics|mesh-ancestor
65671131|NCT04900948|Sensory System Agents|sensory system agents|mesh-ancestor
65671132|NCT04900948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65671133|NCT04900948|Dermatologic Agents|dermatologic agents|mesh-ancestor
65671134|NCT04900948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65671135|NCT04900948|Immunologic Factors|immunologic factors|mesh-ancestor
65671136|NCT04900948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65671137|NCT04900948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65671138|NCT04900948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671139|NCT04901104|Thymalfasin|thymalfasin|mesh-list
65671140|NCT04901104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65671141|NCT04901104|Immunologic Factors|immunologic factors|mesh-ancestor
65671142|NCT04901104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671143|NCT04907812|Tranexamic Acid|tranexamic acid|mesh-list
65671144|NCT04907812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65671145|NCT04907812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65671146|NCT04907812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671147|NCT04907812|Hemostatics|hemostatics|mesh-ancestor
65671148|NCT04907812|Coagulants|coagulants|mesh-ancestor
65671149|NCT01889186|Venetoclax|venetoclax|mesh-list
65671150|NCT01889186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671151|NCT04892212|Sirolimus|sirolimus|mesh-list
65671152|NCT04892212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65671153|NCT04892212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65671154|NCT04892212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65671155|NCT04892212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671156|NCT04892212|Antifungal Agents|antifungal agents|mesh-ancestor
65671157|NCT04892212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65671158|NCT04892212|Immunologic Factors|immunologic factors|mesh-ancestor
65671159|NCT04892212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671160|NCT01510184|Rituximab|rituximab|mesh-list
65671161|NCT01510184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65671162|NCT01510184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65671163|NCT01510184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671164|NCT01510184|Immunologic Factors|immunologic factors|mesh-ancestor
65671165|NCT01510184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671166|NCT01510184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65671167|NCT04907344|Paclitaxel|paclitaxel|mesh-list
65671168|NCT04907344|Carboplatin|carboplatin|mesh-list
65671169|NCT04907344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65671170|NCT04907344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671171|NCT04907344|Tubulin Modulators|tubulin modulators|mesh-ancestor
65671172|NCT04907344|Antimitotic Agents|antimitotic agents|mesh-ancestor
65671173|NCT04907344|Mitosis Modulators|mitosis modulators|mesh-ancestor
65671174|NCT04907344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671175|NCT04906876|Gemcitabine|gemcitabine|mesh-list
65671176|NCT04906876|Docetaxel|docetaxel|mesh-list
65671177|NCT04906876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65671178|NCT04906876|Antimetabolites|antimetabolites|mesh-ancestor
65671179|NCT04906876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671180|NCT04906876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671181|NCT04906876|Antiviral Agents|antiviral agents|mesh-ancestor
65671182|NCT04906876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65671183|NCT04906876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65671184|NCT04906876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65671185|NCT04906876|Immunologic Factors|immunologic factors|mesh-ancestor
65671186|NCT04906876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671187|NCT04906876|Tubulin Modulators|tubulin modulators|mesh-ancestor
65671188|NCT04906876|Antimitotic Agents|antimitotic agents|mesh-ancestor
65671189|NCT04906876|Mitosis Modulators|mitosis modulators|mesh-ancestor
65671190|NCT04891744|Thalidomide|thalidomide|mesh-list
65671191|NCT04891744|Dexamethasone|dexamethasone|mesh-list
65671192|NCT04891744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65671193|NCT04891744|Antiemetics|antiemetics|mesh-ancestor
65671194|NCT04891744|Autonomic Agents|autonomic agents|mesh-ancestor
65671195|NCT04891744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671196|NCT04891744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671197|NCT04891744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65671198|NCT04891744|Glucocorticoids|glucocorticoids|mesh-ancestor
65671199|NCT04891744|Hormones|hormones|mesh-ancestor
65671200|NCT04891744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65671201|NCT04891744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65671202|NCT04891744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671203|NCT04891744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65671204|NCT04891744|Immunologic Factors|immunologic factors|mesh-ancestor
65671205|NCT04891744|Leprostatic Agents|leprostatic agents|mesh-ancestor
65671206|NCT04891744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65671207|NCT04891744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65671208|NCT04891744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65671209|NCT04891744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65671210|NCT04891744|Growth Substances|growth substances|mesh-ancestor
65671211|NCT04891744|Growth Inhibitors|growth inhibitors|mesh-ancestor
65671212|NCT04891900|Capecitabine|capecitabine|mesh-list
65671213|NCT04891900|Oxaliplatin|oxaliplatin|mesh-list
65671214|NCT04891900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65671215|NCT04891900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65671216|NCT04891900|Antimetabolites|antimetabolites|mesh-ancestor
65671217|NCT04891900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671218|NCT04891900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671219|NCT04891588|Timolol|timolol|mesh-list
65671220|NCT04891588|Latanoprost|latanoprost|mesh-list
65671221|NCT04891588|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65671222|NCT04891588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65671223|NCT04891588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671224|NCT04891588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65671225|NCT04891588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65671226|NCT04891588|Adrenergic Agents|adrenergic agents|mesh-ancestor
65671227|NCT04891588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65671228|NCT04891588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671229|NCT04891588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65671230|NCT04891588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65671231|NCT03050866|Antiemetics|antiemetics|mesh-list
65671232|NCT03050866|Histamine|histamine|mesh-list
65671233|NCT03050866|Histamine Antagonists|histamine antagonists|mesh-list
65671234|NCT03050866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
65671235|NCT03050866|Histamine Agonists|histamine agonists|mesh-ancestor
65671236|NCT03050866|Histamine Agents|histamine agents|mesh-ancestor
65671237|NCT03050866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65671238|NCT03050866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671239|NCT03050866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671240|NCT03050866|Autonomic Agents|autonomic agents|mesh-ancestor
65671241|NCT03050866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671242|NCT03050866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65671243|NCT03052660|Midazolam|midazolam|mesh-list
65671244|NCT03052660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65671245|NCT03052660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65671246|NCT03052660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65671247|NCT03052660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671248|NCT03052660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65671249|NCT03052660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65671250|NCT03052660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65671251|NCT03052660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65671252|NCT03052660|Anesthetics, General|anesthetics, general|mesh-ancestor
65671253|NCT03052660|Anesthetics|anesthetics|mesh-ancestor
65671254|NCT03052660|GABA Modulators|gaba modulators|mesh-ancestor
65671255|NCT03052660|GABA Agents|gaba agents|mesh-ancestor
65671256|NCT03052660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65671257|NCT03052660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671258|NCT05162456|Antibodies|antibodies|mesh-list
65671259|NCT05162456|Immunoglobulins|immunoglobulins|mesh-list
65671260|NCT05162456|Immunoglobulin G|immunoglobulin g|mesh-list
65671261|NCT05162456|Immunologic Factors|immunologic factors|mesh-ancestor
65671262|NCT05162456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671263|NCT05085782|Propranolol|propranolol|mesh-list
65671264|NCT05085782|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65671265|NCT05085782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65671266|NCT05085782|Adrenergic Agents|adrenergic agents|mesh-ancestor
65671267|NCT05085782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65671268|NCT05085782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671269|NCT05085782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671270|NCT05085782|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65671271|NCT05085782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65671272|NCT05085782|Vasodilator Agents|vasodilator agents|mesh-ancestor
65671273|NCT05137886|Decitabine|decitabine|mesh-list
65671274|NCT05137886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65671275|NCT05137886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65671276|NCT05137886|Antimetabolites|antimetabolites|mesh-ancestor
65671277|NCT05137886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671278|NCT05137886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671279|NCT05137886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65671280|NCT04976192|Omalizumab|omalizumab|mesh-list
65671281|NCT04976192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65671282|NCT04976192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65671283|NCT04976192|Respiratory System Agents|respiratory system agents|mesh-ancestor
65671284|NCT04890418|Ketamine|ketamine|mesh-list
65671285|NCT04890418|Analgesics|analgesics|mesh-ancestor
65671286|NCT04890418|Sensory System Agents|sensory system agents|mesh-ancestor
65671287|NCT04890418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671288|NCT04890418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671289|NCT04890418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65671290|NCT04890418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65671291|NCT04890418|Anesthetics, General|anesthetics, general|mesh-ancestor
65671293|NCT04890418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65671294|NCT04890418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65671295|NCT04890418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65671296|NCT04890418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65671297|NCT04890418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671298|NCT04455932|Liver Extracts|liver extracts|mesh-list
65671299|NCT04455932|Hematinics|hematinics|mesh-ancestor
65671300|NCT03051022|Dexamethasone|dexamethasone|mesh-list
65671301|NCT03051022|Morphine|morphine|mesh-list
65671302|NCT03051022|Bupivacaine|bupivacaine|mesh-list
65671303|NCT03051022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65671304|NCT03051022|Antiemetics|antiemetics|mesh-ancestor
65671305|NCT03051022|Autonomic Agents|autonomic agents|mesh-ancestor
65671306|NCT03051022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671307|NCT03051022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671308|NCT03051022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65671309|NCT03051022|Glucocorticoids|glucocorticoids|mesh-ancestor
65671310|NCT03051022|Hormones|hormones|mesh-ancestor
65671311|NCT03051022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65671312|NCT03051022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65671313|NCT03051022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671314|NCT03051022|Anesthetics, Local|anesthetics, local|mesh-ancestor
65671315|NCT03051022|Anesthetics|anesthetics|mesh-ancestor
65671316|NCT03051022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65671317|NCT03051022|Sensory System Agents|sensory system agents|mesh-ancestor
65671318|NCT03051022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65671319|NCT03051022|Narcotics|narcotics|mesh-ancestor
65671320|NCT03051022|Analgesics|analgesics|mesh-ancestor
65671321|NCT04648826|Azacitidine|azacitidine|mesh-list
65671322|NCT04648826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65671323|NCT04648826|Antimetabolites|antimetabolites|mesh-ancestor
65671324|NCT04648826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671325|NCT04648826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671326|NCT04648826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65671327|NCT03052348|Fusidic Acid|fusidic acid|mesh-list
65671328|NCT03052348|Betamethasone|betamethasone|mesh-list
65671329|NCT03052348|Betamethasone Valerate|betamethasone valerate|mesh-list
65671330|NCT03052348|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65671331|NCT03052348|Betamethasone benzoate|betamethasone benzoate|mesh-list
65671332|NCT03052348|Ether|ether|mesh-list
65671333|NCT03052348|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65671334|NCT03052348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65671335|NCT03052348|Glucocorticoids|glucocorticoids|mesh-ancestor
65671336|NCT03052348|Hormones|hormones|mesh-ancestor
65671337|NCT03052348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65671338|NCT03052348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671339|NCT03052348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65671340|NCT03052348|Respiratory System Agents|respiratory system agents|mesh-ancestor
65671341|NCT03052348|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65671342|NCT03052348|Anesthetics, General|anesthetics, general|mesh-ancestor
65671343|NCT03052348|Anesthetics|anesthetics|mesh-ancestor
65671344|NCT03052348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65671345|NCT03052348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65671346|NCT03052348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65671347|NCT03052348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65671348|NCT03052348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65671349|NCT03052348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671350|NCT03963518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65671351|NCT03963518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671352|NCT03963518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671353|NCT04606394|Albuterol|albuterol|mesh-list
65671354|NCT04606394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65671355|NCT04606394|Autonomic Agents|autonomic agents|mesh-ancestor
65671356|NCT04606394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671357|NCT04606394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671358|NCT04606394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65671359|NCT04606394|Respiratory System Agents|respiratory system agents|mesh-ancestor
65671360|NCT04606394|Tocolytic Agents|tocolytic agents|mesh-ancestor
65671361|NCT04606394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65468678|NCT03012529|Leprostatic Agents|leprostatic agents|mesh-ancestor
65671362|NCT04606394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65671363|NCT04606394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65671364|NCT04606394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65671365|NCT04606394|Adrenergic Agents|adrenergic agents|mesh-ancestor
65671366|NCT04606394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65671367|NCT04606394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671369|NCT04101890|Dermatologic Agents|dermatologic agents|mesh-ancestor
65671370|NCT04101890|Sunscreening Agents|sunscreening agents|mesh-ancestor
65671371|NCT04101890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65671372|NCT04101890|Protective Agents|protective agents|mesh-ancestor
65671373|NCT04101890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671374|NCT04456712|Ciprofloxacin|ciprofloxacin|mesh-list
65671375|NCT04456712|Levofloxacin|levofloxacin|mesh-list
65671376|NCT04456712|Ofloxacin|ofloxacin|mesh-list
65671377|NCT04456712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65671378|NCT04456712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65671379|NCT04456712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65671380|NCT04456712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65671381|NCT04456712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65671382|NCT04456712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671383|NCT04456712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671384|NCT04456712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65671385|NCT04456712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65671386|NCT04456712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65671387|NCT04456712|Renal Agents|renal agents|mesh-ancestor
65671388|NCT04884490|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65671389|NCT04884490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65671390|NCT04884490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65671391|NCT04884490|Renal Agents|renal agents|mesh-ancestor
65671392|NCT04884490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65671393|NCT04884490|Antimalarials|antimalarials|mesh-ancestor
65671394|NCT04884490|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65671395|NCT04884490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65671396|NCT04854434|Trifluridine|trifluridine|mesh-list
65671397|NCT04854434|Pembrolizumab|pembrolizumab|mesh-list
65671398|NCT04854434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65671399|NCT04854434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671400|NCT04854434|Antimetabolites|antimetabolites|mesh-ancestor
65671401|NCT04854434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671402|NCT04854434|Antiviral Agents|antiviral agents|mesh-ancestor
65671403|NCT04854434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65671404|NCT04897984|Anti-Infective Agents|anti-infective agents|mesh-list
65671405|NCT04897984|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65671406|NCT04456088|Nitric Oxide|nitric oxide|mesh-list
65671407|NCT04456088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65671408|NCT04456088|Autonomic Agents|autonomic agents|mesh-ancestor
65671409|NCT04456088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671410|NCT04456088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671411|NCT04456088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65671412|NCT04456088|Respiratory System Agents|respiratory system agents|mesh-ancestor
65671413|NCT04456088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65671414|NCT04456088|Antioxidants|antioxidants|mesh-ancestor
65671415|NCT04456088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671416|NCT04456088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65671417|NCT04456088|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65671418|NCT04456088|Vasodilator Agents|vasodilator agents|mesh-ancestor
65671419|NCT04456088|Gasotransmitters|gasotransmitters|mesh-ancestor
65671420|NCT04456088|Protective Agents|protective agents|mesh-ancestor
65671421|NCT04454840|Riluzole|riluzole|mesh-list
65671422|NCT04454840|Anticonvulsants|anticonvulsants|mesh-ancestor
65671423|NCT04454840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65671424|NCT04454840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65671425|NCT04454840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65671426|NCT04454840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671427|NCT04454840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671428|NCT04454840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65671429|NCT04454840|Protective Agents|protective agents|mesh-ancestor
65671430|NCT03050710|Lidocaine|lidocaine|mesh-list
65671431|NCT03050710|Anesthetics, Local|anesthetics, local|mesh-ancestor
65671432|NCT03050710|Anesthetics|anesthetics|mesh-ancestor
65671433|NCT03050710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65671434|NCT03050710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671435|NCT03050710|Sensory System Agents|sensory system agents|mesh-ancestor
65671436|NCT03050710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671437|NCT03050710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65671438|NCT03050710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65671439|NCT03050710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65671440|NCT03050710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65671441|NCT03050710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671442|NCT03051568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65671443|NCT03051568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65671444|NCT03051568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671445|NCT04897516|Benzonidazole|benzonidazole|mesh-list
65671446|NCT04897516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65671447|NCT04897516|Immunologic Factors|immunologic factors|mesh-ancestor
65671448|NCT04897516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671449|NCT04897516|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65671450|NCT04897516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65671451|NCT04897516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65671452|NCT04897516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65671453|NCT03993314|Bupivacaine|bupivacaine|mesh-list
65671454|NCT03993314|Chloroprocaine|chloroprocaine|mesh-list
65671455|NCT03993314|Anesthetics, Local|anesthetics, local|mesh-ancestor
65671456|NCT03993314|Anesthetics|anesthetics|mesh-ancestor
65671457|NCT03993314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65671458|NCT03993314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671459|NCT03993314|Sensory System Agents|sensory system agents|mesh-ancestor
65671460|NCT03993314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671461|NCT04883164|Antibodies|antibodies|mesh-list
65671462|NCT04883164|Immunologic Factors|immunologic factors|mesh-ancestor
65671463|NCT04883164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671464|NCT03161054|Prednisone|prednisone|mesh-list
65671465|NCT03161054|Cyclophosphamide|cyclophosphamide|mesh-list
65671466|NCT03161054|Rituximab|rituximab|mesh-list
65671467|NCT03161054|Etoposide|etoposide|mesh-list
65671468|NCT03161054|Vinorelbine|vinorelbine|mesh-list
65671469|NCT03161054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65671470|NCT03161054|Immunologic Factors|immunologic factors|mesh-ancestor
65671471|NCT03161054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671472|NCT03161054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65671473|NCT03161054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65671474|NCT03161054|Alkylating Agents|alkylating agents|mesh-ancestor
65671475|NCT03161054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671476|NCT03161054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671477|NCT03161054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65671478|NCT03161054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65671479|NCT03161054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65671480|NCT03161054|Glucocorticoids|glucocorticoids|mesh-ancestor
65671481|NCT03161054|Hormones|hormones|mesh-ancestor
65671482|NCT03161054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65671483|NCT03161054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65671484|NCT03161054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65671485|NCT03161054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65671486|NCT03161054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65671487|NCT03161054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65671488|NCT03161054|Tubulin Modulators|tubulin modulators|mesh-ancestor
65671489|NCT03161054|Antimitotic Agents|antimitotic agents|mesh-ancestor
65671490|NCT03161054|Mitosis Modulators|mitosis modulators|mesh-ancestor
65671491|NCT03050554|Avelumab|avelumab|mesh-list
65671492|NCT03050554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65671493|NCT03050554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671494|NCT03050164|Gefitinib|gefitinib|mesh-list
65671495|NCT03050164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671496|NCT03050164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65671497|NCT03050164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65671498|NCT03050164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671499|NCT03049930|Ketamine|ketamine|mesh-list
65671500|NCT03049930|Analgesics|analgesics|mesh-ancestor
65671501|NCT03049930|Sensory System Agents|sensory system agents|mesh-ancestor
65671502|NCT03049930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671503|NCT03049930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671504|NCT03049930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65671505|NCT03049930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65671506|NCT03049930|Anesthetics, General|anesthetics, general|mesh-ancestor
65671507|NCT03049930|Anesthetics|anesthetics|mesh-ancestor
65671508|NCT03049930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65671509|NCT03049930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65671510|NCT03049930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65671511|NCT03049930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65671512|NCT03049930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468843|NCT02205762|Analgesics|analgesics|mesh-ancestor
65671513|NCT02036463|Prednisone|prednisone|mesh-list
65671514|NCT02036463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65671515|NCT02036463|Glucocorticoids|glucocorticoids|mesh-ancestor
65671516|NCT02036463|Hormones|hormones|mesh-ancestor
65671517|NCT02036463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65671518|NCT02036463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671519|NCT02036463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65671520|NCT02036463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671521|NCT04887844|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
65671522|NCT04887844|Lidocaine|lidocaine|mesh-list
65671523|NCT04887844|Anesthetics, Local|anesthetics, local|mesh-ancestor
65671524|NCT04887844|Anesthetics|anesthetics|mesh-ancestor
65671525|NCT04887844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65671526|NCT04887844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671527|NCT04887844|Sensory System Agents|sensory system agents|mesh-ancestor
65671528|NCT04887844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671529|NCT04887844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65671530|NCT04887844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65671531|NCT04887844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65671532|NCT04887844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65671533|NCT04887844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671534|NCT04887844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65671535|NCT04887844|Glucocorticoids|glucocorticoids|mesh-ancestor
65671536|NCT04887844|Hormones|hormones|mesh-ancestor
65671537|NCT04887844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65671538|NCT02595320|Capecitabine|capecitabine|mesh-list
65671539|NCT02595320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65671540|NCT02595320|Antimetabolites|antimetabolites|mesh-ancestor
65671541|NCT02595320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671542|NCT02595320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671543|NCT02809053|Rituximab|rituximab|mesh-list
65671544|NCT02809053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65671545|NCT02809053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671546|NCT02809053|Immunologic Factors|immunologic factors|mesh-ancestor
65671547|NCT02809053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671548|NCT02809053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65671549|NCT04666688|Gemcitabine|gemcitabine|mesh-list
65671550|NCT04666688|Paclitaxel|paclitaxel|mesh-list
65671551|NCT04666688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65671552|NCT04666688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671553|NCT04666688|Tubulin Modulators|tubulin modulators|mesh-ancestor
65671554|NCT04666688|Antimitotic Agents|antimitotic agents|mesh-ancestor
65671555|NCT04666688|Mitosis Modulators|mitosis modulators|mesh-ancestor
65671556|NCT04666688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671557|NCT04666688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65671558|NCT04666688|Antimetabolites|antimetabolites|mesh-ancestor
65671559|NCT04666688|Antiviral Agents|antiviral agents|mesh-ancestor
65671560|NCT04666688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65671561|NCT04666688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65671562|NCT04666688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65671563|NCT04666688|Immunologic Factors|immunologic factors|mesh-ancestor
65671564|NCT04666688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671565|NCT03462290|Botulinum Toxins|botulinum toxins|mesh-list
65671566|NCT03462290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65671567|NCT03462290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65671568|NCT03462290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65671569|NCT03462290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65671570|NCT03462290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671571|NCT03462290|Cholinergic Agents|cholinergic agents|mesh-ancestor
65671572|NCT03462290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65671573|NCT03462290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671574|NCT03462290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65671575|NCT03462290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671576|NCT02047539|Aspirin|aspirin|mesh-list
65671577|NCT02047539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65671578|NCT02047539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65671579|NCT02047539|Analgesics|analgesics|mesh-ancestor
65671580|NCT02047539|Sensory System Agents|sensory system agents|mesh-ancestor
65671581|NCT02047539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671582|NCT02047539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671583|NCT02047539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65671584|NCT02047539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65671585|NCT02047539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65671586|NCT02047539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65671587|NCT02047539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671588|NCT02047539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65671589|NCT02047539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65671590|NCT02047539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65671591|NCT02047539|Antipyretics|antipyretics|mesh-ancestor
65671593|NCT02522858|Ephedrine|ephedrine|mesh-list
65671594|NCT02522858|Dexmedetomidine|dexmedetomidine|mesh-list
65671595|NCT02522858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65671596|NCT02522858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65671597|NCT02522858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671598|NCT02522858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65671599|NCT02522858|Analgesics|analgesics|mesh-ancestor
65671600|NCT02522858|Sensory System Agents|sensory system agents|mesh-ancestor
65671601|NCT02522858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671602|NCT02522858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65671603|NCT02522858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65671604|NCT02522858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65671605|NCT02522858|Adrenergic Agents|adrenergic agents|mesh-ancestor
65671606|NCT02522858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65671607|NCT02522858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671608|NCT02522858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65671609|NCT02522858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65671610|NCT02522858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65671611|NCT02522858|Autonomic Agents|autonomic agents|mesh-ancestor
65671612|NCT02522858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65671613|NCT02522858|Respiratory System Agents|respiratory system agents|mesh-ancestor
65671614|NCT02522858|Mydriatics|mydriatics|mesh-ancestor
65671615|NCT02522858|Parasympatholytics|parasympatholytics|mesh-ancestor
65671616|NCT02522858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65671617|NCT02522858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65671618|NCT02522858|Cholinergic Agents|cholinergic agents|mesh-ancestor
65671619|NCT02522858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65671620|NCT02522858|Sympathomimetics|sympathomimetics|mesh-ancestor
65671621|NCT02522858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65671622|NCT02036697|Fentanyl|fentanyl|mesh-list
65671623|NCT02036697|Morphine|morphine|mesh-list
65671624|NCT02036697|Bupivacaine|bupivacaine|mesh-list
65671625|NCT02036697|Anesthetics, Local|anesthetics, local|mesh-ancestor
65671626|NCT02036697|Anesthetics|anesthetics|mesh-ancestor
65134279|NCT04555694|Glucocorticoids|glucocorticoids|mesh-ancestor
65671627|NCT02036697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65671628|NCT02036697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671629|NCT02036697|Sensory System Agents|sensory system agents|mesh-ancestor
65671630|NCT02036697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671631|NCT02036697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65671632|NCT02036697|Narcotics|narcotics|mesh-ancestor
65671633|NCT02036697|Analgesics|analgesics|mesh-ancestor
65671634|NCT02036697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65671635|NCT02036697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65671636|NCT02036697|Anesthetics, General|anesthetics, general|mesh-ancestor
65671637|NCT04882462|Nimotuzumab|nimotuzumab|mesh-list
65671638|NCT04882462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65671639|NCT04882462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671640|NCT03106688|Carfentanil|carfentanil|mesh-list
65671641|NCT03106688|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65671642|NCT03106688|Narcotics|narcotics|mesh-ancestor
65671643|NCT03106688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65671644|NCT03106688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671645|NCT03106688|Analgesics|analgesics|mesh-ancestor
65671646|NCT03106688|Sensory System Agents|sensory system agents|mesh-ancestor
65671647|NCT03106688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671648|NCT02037009|Anesthetics|anesthetics|mesh-list
65671649|NCT02037009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65671650|NCT02037009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671651|NCT02260011|Bromides|bromides|mesh-list
65671652|NCT02260011|Norflurane|norflurane|mesh-list
65671653|NCT02260011|Ipratropium|ipratropium|mesh-list
65671654|NCT02260011|Anticonvulsants|anticonvulsants|mesh-ancestor
65671655|NCT02260011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65671656|NCT02260011|Autonomic Agents|autonomic agents|mesh-ancestor
65671657|NCT02260011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671658|NCT02260011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671659|NCT02260011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65468977|NCT01589354|Ropivacaine|ropivacaine|mesh-list
65671660|NCT02260011|Respiratory System Agents|respiratory system agents|mesh-ancestor
65671661|NCT02260011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65671662|NCT02260011|Cholinergic Agents|cholinergic agents|mesh-ancestor
65671663|NCT02260011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65671664|NCT02260011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671665|NCT02260011|Anesthetics|anesthetics|mesh-ancestor
65671666|NCT02260011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65671667|NCT04886752|Vitamins|vitamins|mesh-list
65671668|NCT04886752|Ascorbic Acid|ascorbic acid|mesh-list
65671669|NCT04886752|Vitamin B Complex|vitamin b complex|mesh-list
65671670|NCT04886752|Micronutrients|micronutrients|mesh-ancestor
65671671|NCT04886752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671672|NCT04886752|Antioxidants|antioxidants|mesh-ancestor
65671673|NCT04886752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671674|NCT04886752|Protective Agents|protective agents|mesh-ancestor
65671675|NCT02047773|Meropenem|meropenem|mesh-list
65671676|NCT02047773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65671677|NCT02047773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65671678|NCT04895800|Caffeine|caffeine|mesh-list
65671679|NCT04895800|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65671680|NCT04895800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671681|NCT04895800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65671682|NCT04895800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65671683|NCT04895800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671684|NCT04895800|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65671685|NCT04895800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65671686|NCT04895800|Purinergic Agents|purinergic agents|mesh-ancestor
65671687|NCT04895800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65671688|NCT04886362|Ivermectin|ivermectin|mesh-list
65671689|NCT04886362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65671690|NCT04886362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65671691|NCT02048007|Azithromycin|azithromycin|mesh-list
65671692|NCT02048007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65671693|NCT02048007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65671694|NCT02048085|Clopidogrel|clopidogrel|mesh-list
65671695|NCT02048085|Ticagrelor|ticagrelor|mesh-list
65671696|NCT02048085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65671697|NCT02048085|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65671698|NCT02048085|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65671699|NCT02048085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65671700|NCT02048085|Purinergic Agents|purinergic agents|mesh-ancestor
65671701|NCT02048085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65671702|NCT02048085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671703|NCT02048085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671704|NCT02808975|Adalimumab|adalimumab|mesh-list
65671705|NCT02808975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65671706|NCT02808975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65671707|NCT04885660|Lisinopril|lisinopril|mesh-list
65671708|NCT04885660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65671709|NCT04885660|Protease Inhibitors|protease inhibitors|mesh-ancestor
65671710|NCT04885660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65671711|NCT04885660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671712|NCT04885660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65671713|NCT04885660|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65671714|NCT04885660|Protective Agents|protective agents|mesh-ancestor
65671715|NCT04885660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671716|NCT02037633|Fentanyl|fentanyl|mesh-list
65671717|NCT02037633|Ropivacaine|ropivacaine|mesh-list
65671718|NCT02037633|Anesthetics, Local|anesthetics, local|mesh-ancestor
65671719|NCT02037633|Anesthetics|anesthetics|mesh-ancestor
65671720|NCT02037633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65671721|NCT02037633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671722|NCT02037633|Sensory System Agents|sensory system agents|mesh-ancestor
65671723|NCT02037633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671724|NCT02037633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65671725|NCT02037633|Narcotics|narcotics|mesh-ancestor
65671726|NCT02037633|Analgesics|analgesics|mesh-ancestor
65671727|NCT02037633|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65671728|NCT02037633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65671729|NCT02037633|Anesthetics, General|anesthetics, general|mesh-ancestor
65671730|NCT05684211|Cetuximab|cetuximab|mesh-list
65671731|NCT05684211|Antibodies|antibodies|mesh-list
65671732|NCT05684211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65671733|NCT05684211|Immunologic Factors|immunologic factors|mesh-ancestor
65671734|NCT05684211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671735|NCT05684211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65671736|NCT05684211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671737|NCT03130634|Silymarin|silymarin|mesh-list
65671738|NCT03130634|Antioxidants|antioxidants|mesh-ancestor
65671739|NCT03130634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671740|NCT03130634|Protective Agents|protective agents|mesh-ancestor
65671741|NCT03130634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671742|NCT02124824|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
65671743|NCT02124824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65671744|NCT02124824|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65671745|NCT02124824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671746|NCT04880746|Cladribine|cladribine|mesh-list
65671747|NCT04880746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671748|NCT04880746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65671749|NCT04880746|Immunologic Factors|immunologic factors|mesh-ancestor
65671750|NCT04880746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671751|NCT03050086|Minocycline|minocycline|mesh-list
65671752|NCT03050086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65671753|NCT03050086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65671754|NCT03050242|Glycopyrrolate|glycopyrrolate|mesh-list
65671755|NCT03050242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65671756|NCT03050242|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65671757|NCT03050242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65671758|NCT03050242|Cholinergic Agents|cholinergic agents|mesh-ancestor
65671759|NCT03050242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65671760|NCT03050242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671761|NCT03050242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671762|NCT04894630|Anti-Infective Agents|anti-infective agents|mesh-list
65671763|NCT04894630|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65671764|NCT04885270|Cisplatin|cisplatin|mesh-list
65671765|NCT04885270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671766|NCT04885426|Metformin|metformin|mesh-list
65671767|NCT04885426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65671768|NCT04885426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671769|NCT04879420|Teriparatide|teriparatide|mesh-list
65671770|NCT04879420|Risedronic Acid|risedronic acid|mesh-list
65671771|NCT04879420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65671772|NCT04879420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268598|NCT04219982|Mydriatics|mydriatics|mesh-ancestor
65671773|NCT04879420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65671774|NCT04879420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65671775|NCT04879420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65671776|NCT04879420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671777|NCT02808819|Benralizumab|benralizumab|mesh-list
65671778|NCT02808819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65671779|NCT02808819|Respiratory System Agents|respiratory system agents|mesh-ancestor
65671780|NCT04872244|Levonorgestrel|levonorgestrel|mesh-list
65671781|NCT04872244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65671782|NCT04872244|Contraceptive Agents|contraceptive agents|mesh-ancestor
65671783|NCT04872244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65671784|NCT04872244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671785|NCT04872244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65671786|NCT04872244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65671787|NCT04872244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65671788|NCT04872322|Ropivacaine|ropivacaine|mesh-list
65671789|NCT04872322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65671790|NCT04872322|Anesthetics, Local|anesthetics, local|mesh-ancestor
65671791|NCT04872322|Anesthetics|anesthetics|mesh-ancestor
65671792|NCT04872322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65671793|NCT04872322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671794|NCT04872322|Sensory System Agents|sensory system agents|mesh-ancestor
65671795|NCT04872322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671796|NCT04879030|Moxifloxacin|moxifloxacin|mesh-list
65671797|NCT04879030|Ciprofloxacin|ciprofloxacin|mesh-list
65671798|NCT04879030|Levofloxacin|levofloxacin|mesh-list
65671799|NCT04879030|Meropenem|meropenem|mesh-list
65671800|NCT04879030|Ceftriaxone|ceftriaxone|mesh-list
65671801|NCT04879030|Tazobactam|tazobactam|mesh-list
65671802|NCT04879030|Piperacillin|piperacillin|mesh-list
65671803|NCT04879030|Clavulanic Acid|clavulanic acid|mesh-list
65671804|NCT04879030|Imipenem|imipenem|mesh-list
65671805|NCT04879030|Ceftazidime|ceftazidime|mesh-list
65671806|NCT04879030|Ertapenem|ertapenem|mesh-list
65671807|NCT04879030|Lactams|lactams|mesh-list
65671808|NCT04879030|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65671809|NCT04879030|Cefotaxime|cefotaxime|mesh-list
65671810|NCT04879030|Cefixime|cefixime|mesh-list
65671811|NCT04879030|beta-Lactams|beta-lactams|mesh-list
65469125|NCT03478696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65671812|NCT04879030|Fluoroquinolones|fluoroquinolones|mesh-list
65671813|NCT04879030|Ticarcillin|ticarcillin|mesh-list
65671814|NCT04879030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65671815|NCT04879030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65671816|NCT04879030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65671817|NCT04879030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65671818|NCT04879030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65671819|NCT04879030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671820|NCT04879030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671821|NCT04879030|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65671822|NCT04879030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65671823|NCT04879030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65671824|NCT04879030|Renal Agents|renal agents|mesh-ancestor
65671825|NCT04879030|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65671826|NCT04879030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65671827|NCT04878718|Vancomycin|vancomycin|mesh-list
65671828|NCT04878718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65671829|NCT04878718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65671830|NCT04878016|Carboplatin|carboplatin|mesh-list
65671831|NCT04878016|Etoposide|etoposide|mesh-list
65671832|NCT04878016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671833|NCT04878016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65671834|NCT04878016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65671835|NCT04878016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65671836|NCT04878016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65671837|NCT04878016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671838|NCT04871152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65671839|NCT04871152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65671840|NCT04871152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65671841|NCT04871152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671842|NCT04871152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671843|NCT04871152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65671844|NCT04871152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65671845|NCT04871152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671846|NCT04871152|Cholinergic Agents|cholinergic agents|mesh-ancestor
65671847|NCT04871152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65671848|NCT04870372|Selegiline|selegiline|mesh-list
65671849|NCT04870372|Antidepressive Agents|antidepressive agents|mesh-ancestor
65671850|NCT04870372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65671851|NCT04870372|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65671852|NCT04870372|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65671853|NCT04870372|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65671854|NCT04870372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65671855|NCT04870372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671856|NCT04870372|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65671857|NCT04870372|Protective Agents|protective agents|mesh-ancestor
65671858|NCT04870372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671859|NCT02048319|Ethanol|ethanol|mesh-list
65671860|NCT02048319|Pasireotide|pasireotide|mesh-list
65671861|NCT02048319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65671862|NCT02048319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65671863|NCT02048319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65671864|NCT02048319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671865|NCT02048319|Hormones|hormones|mesh-ancestor
65671866|NCT02048319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65671867|NCT01594762|Pexiganan|pexiganan|mesh-list
65671868|NCT01594762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65671869|NCT01594762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65671870|NCT02048475|Desflurane|desflurane|mesh-list
65671871|NCT02048475|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65671872|NCT02048475|Anesthetics, General|anesthetics, general|mesh-ancestor
65671873|NCT02048475|Anesthetics|anesthetics|mesh-ancestor
65671874|NCT02048475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65671875|NCT02048475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671876|NCT03562143|Iron|iron|mesh-list
65671877|NCT03562143|Trace Elements|trace elements|mesh-ancestor
65671878|NCT03562143|Micronutrients|micronutrients|mesh-ancestor
65671879|NCT03562143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671880|NCT02048865|Apixaban|apixaban|mesh-list
65671881|NCT02048865|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65671882|NCT02048865|Antithrombins|antithrombins|mesh-ancestor
65671883|NCT02048865|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65671884|NCT02048865|Protease Inhibitors|protease inhibitors|mesh-ancestor
65671885|NCT02048865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65671886|NCT02048865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671887|NCT02048865|Anticoagulants|anticoagulants|mesh-ancestor
65671888|NCT02048943|Gemcitabine|gemcitabine|mesh-list
65671889|NCT02048943|Paclitaxel|paclitaxel|mesh-list
65671890|NCT02048943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65671891|NCT02048943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65671892|NCT02048943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671893|NCT02048943|Tubulin Modulators|tubulin modulators|mesh-ancestor
65671894|NCT02048943|Antimitotic Agents|antimitotic agents|mesh-ancestor
65671895|NCT02048943|Mitosis Modulators|mitosis modulators|mesh-ancestor
65671896|NCT02048943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671897|NCT02048943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65671898|NCT02048943|Antimetabolites|antimetabolites|mesh-ancestor
65671899|NCT02048943|Antiviral Agents|antiviral agents|mesh-ancestor
65671900|NCT02048943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65671901|NCT02048943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65671902|NCT02048943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65671903|NCT02048943|Immunologic Factors|immunologic factors|mesh-ancestor
65671904|NCT02048943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671905|NCT02050893|Midazolam|midazolam|mesh-list
65671906|NCT02050893|Propofol|propofol|mesh-list
65671907|NCT02050893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65671908|NCT02050893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65671909|NCT02050893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671910|NCT02050893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65671911|NCT02050893|Anesthetics, General|anesthetics, general|mesh-ancestor
65671912|NCT02050893|Anesthetics|anesthetics|mesh-ancestor
65671913|NCT02050893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65671914|NCT02050893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65671915|NCT02050893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65671916|NCT02050893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65671917|NCT02050893|GABA Modulators|gaba modulators|mesh-ancestor
65671918|NCT02050893|GABA Agents|gaba agents|mesh-ancestor
65671919|NCT02050893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65671920|NCT02050893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671921|NCT02806947|Sirolimus|sirolimus|mesh-list
65671922|NCT02806947|Prednisone|prednisone|mesh-list
65671923|NCT02806947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65671924|NCT02806947|Glucocorticoids|glucocorticoids|mesh-ancestor
65671925|NCT02806947|Hormones|hormones|mesh-ancestor
65671926|NCT02806947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65671927|NCT02806947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671928|NCT02806947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65671929|NCT02806947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671930|NCT02806947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65671931|NCT02806947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65671932|NCT02806947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65671933|NCT02806947|Antifungal Agents|antifungal agents|mesh-ancestor
65671934|NCT02806947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65671935|NCT02806947|Immunologic Factors|immunologic factors|mesh-ancestor
65671936|NCT03442114|Hydroxyurea|hydroxyurea|mesh-list
65671937|NCT03442114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671938|NCT03442114|Antisickling Agents|antisickling agents|mesh-ancestor
65671939|NCT03442114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65671940|NCT03442114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671941|NCT03442114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65671942|NCT02037399|Dexamethasone|dexamethasone|mesh-list
65671943|NCT02037399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65671944|NCT02037399|Antiemetics|antiemetics|mesh-ancestor
65671945|NCT02037399|Autonomic Agents|autonomic agents|mesh-ancestor
65671946|NCT02037399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671947|NCT02037399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671948|NCT02037399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65671949|NCT02037399|Glucocorticoids|glucocorticoids|mesh-ancestor
65671950|NCT02037399|Hormones|hormones|mesh-ancestor
65671951|NCT02037399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65671952|NCT02037399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65671953|NCT02037399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65671954|NCT02260089|Telmisartan|telmisartan|mesh-list
65671955|NCT02260089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65671956|NCT02260089|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65671957|NCT02260089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65671958|NCT02260089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671959|NCT02049255|Bupivacaine|bupivacaine|mesh-list
65671960|NCT02049255|Chloroprocaine|chloroprocaine|mesh-list
65671961|NCT02049255|Anesthetics, Local|anesthetics, local|mesh-ancestor
65671962|NCT02049255|Anesthetics|anesthetics|mesh-ancestor
65671963|NCT02049255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65671964|NCT02049255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671965|NCT02049255|Sensory System Agents|sensory system agents|mesh-ancestor
65671966|NCT02049255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671967|NCT02037711|Levobupivacaine|levobupivacaine|mesh-list
65671968|NCT02037711|Anesthetics, Local|anesthetics, local|mesh-ancestor
65671969|NCT02037711|Anesthetics|anesthetics|mesh-ancestor
65671970|NCT02037711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65671971|NCT02037711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671972|NCT02037711|Sensory System Agents|sensory system agents|mesh-ancestor
65671973|NCT02037711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671974|NCT03561675|Acetazolamide|acetazolamide|mesh-list
65671975|NCT03561675|Anticonvulsants|anticonvulsants|mesh-ancestor
65671976|NCT03561675|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65671977|NCT03561675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65671978|NCT03561675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671979|NCT03561675|Diuretics|diuretics|mesh-ancestor
65671980|NCT03561675|Natriuretic Agents|natriuretic agents|mesh-ancestor
65671981|NCT03561675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671982|NCT02049411|Ketamine|ketamine|mesh-list
65671983|NCT02049411|Analgesics|analgesics|mesh-ancestor
65671984|NCT02049411|Sensory System Agents|sensory system agents|mesh-ancestor
65671985|NCT02049411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65671986|NCT02049411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65671987|NCT02049411|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65671988|NCT02049411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65671989|NCT02049411|Anesthetics, General|anesthetics, general|mesh-ancestor
65671990|NCT02049411|Anesthetics|anesthetics|mesh-ancestor
65671991|NCT02049411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65671992|NCT02049411|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65671993|NCT02049411|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65671994|NCT02049411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65671995|NCT02049411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65671996|NCT02807493|Salicylic Acid|salicylic acid|mesh-list
65671997|NCT02807493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65671998|NCT02807493|Antifungal Agents|antifungal agents|mesh-ancestor
65671999|NCT02807493|Keratolytic Agents|keratolytic agents|mesh-ancestor
65672000|NCT02807493|Dermatologic Agents|dermatologic agents|mesh-ancestor
65672001|NCT02051751|Paclitaxel|paclitaxel|mesh-list
65672002|NCT02051751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65672003|NCT02051751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672004|NCT02051751|Tubulin Modulators|tubulin modulators|mesh-ancestor
65672005|NCT02051751|Antimitotic Agents|antimitotic agents|mesh-ancestor
65672006|NCT02051751|Mitosis Modulators|mitosis modulators|mesh-ancestor
65672007|NCT02051751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672008|NCT02049801|Cytarabine|cytarabine|mesh-list
65672009|NCT02049801|Idarubicin|idarubicin|mesh-list
65672010|NCT02049801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65672011|NCT02049801|Antimetabolites|antimetabolites|mesh-ancestor
65672012|NCT02049801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672013|NCT02049801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672014|NCT02049801|Antiviral Agents|antiviral agents|mesh-ancestor
65672015|NCT02049801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65672016|NCT02049801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65672017|NCT02049801|Immunologic Factors|immunologic factors|mesh-ancestor
65672018|NCT02049801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672019|NCT02049801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65672020|NCT02049801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65672021|NCT02049801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65672022|NCT02049801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672023|NCT02802345|Nintedanib|nintedanib|mesh-list
65672024|NCT02802345|Sildenafil Citrate|sildenafil citrate|mesh-list
65672025|NCT02802345|Vasodilator Agents|vasodilator agents|mesh-ancestor
65672026|NCT02802345|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65672027|NCT02802345|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65672028|NCT02802345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672029|NCT02802345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672030|NCT02802345|Urological Agents|urological agents|mesh-ancestor
65672031|NCT02802345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672032|NCT02802345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65672033|NCT02053779|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65672034|NCT02053779|Luteolytic Agents|luteolytic agents|mesh-ancestor
65672035|NCT02053779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65672036|NCT02053779|Contraceptive Agents|contraceptive agents|mesh-ancestor
65672037|NCT02053779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65672038|NCT02053779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672039|NCT02053779|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65672041|NCT02053779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672042|NCT02056041|Liver Extracts|liver extracts|mesh-list
65672043|NCT02056041|Hematinics|hematinics|mesh-ancestor
65672044|NCT02053857|Amoxicillin|amoxicillin|mesh-list
65672045|NCT02053857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65672046|NCT02053857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65672047|NCT02053935|Dopamine|dopamine|mesh-list
65672048|NCT02053935|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65672049|NCT02053935|Sympathomimetics|sympathomimetics|mesh-ancestor
65672050|NCT02053935|Autonomic Agents|autonomic agents|mesh-ancestor
65672051|NCT02053935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672052|NCT02053935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672053|NCT02053935|Dopamine Agents|dopamine agents|mesh-ancestor
65672054|NCT02053935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65672055|NCT02053935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672056|NCT02053935|Protective Agents|protective agents|mesh-ancestor
65672057|NCT02056353|Insulin|insulin|mesh-list
65672058|NCT02056353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65672059|NCT02056353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672060|NCT02056587|Everolimus|everolimus|mesh-list
65672061|NCT02056587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672062|NCT02056587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65672063|NCT02056587|Immunologic Factors|immunologic factors|mesh-ancestor
65672064|NCT02056587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672065|NCT02038335|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65672066|NCT02038335|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65672067|NCT02038335|Levonorgestrel|levonorgestrel|mesh-list
65672068|NCT02038335|Medroxyprogesterone|medroxyprogesterone|mesh-list
65672069|NCT02038335|Etonogestrel|etonogestrel|mesh-list
65672070|NCT02038335|Norethindrone|norethindrone|mesh-list
65672071|NCT02038335|Estradiol|estradiol|mesh-list
65672072|NCT02038335|Estrogens|estrogens|mesh-ancestor
65672073|NCT02038335|Hormones|hormones|mesh-ancestor
65672074|NCT02038335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65672075|NCT02038335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672076|NCT02038335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65672077|NCT02038335|Contraceptive Agents|contraceptive agents|mesh-ancestor
65672078|NCT02038335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65672079|NCT02038335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65672080|NCT02038335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65672081|NCT02038335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65672082|NCT02038335|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65672083|NCT02038335|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65672084|NCT02038335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65672085|NCT02038335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672086|NCT02056665|Minocycline|minocycline|mesh-list
65672087|NCT02056665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65672088|NCT02056665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65672089|NCT02056743|Fexofenadine|fexofenadine|mesh-list
65672090|NCT02056743|Losartan|losartan|mesh-list
65672091|NCT02056743|Midazolam|midazolam|mesh-list
65672092|NCT02056743|Dextromethorphan|dextromethorphan|mesh-list
65672093|NCT02056743|Caffeine|caffeine|mesh-list
65672094|NCT02056743|Omeprazole|omeprazole|mesh-list
65672095|NCT02056743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65672096|NCT02056743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65672097|NCT02056743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65672098|NCT02056743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672099|NCT02056743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65672100|NCT02056743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65672101|NCT02056743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65672102|NCT02056743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65672103|NCT02056743|Anesthetics, General|anesthetics, general|mesh-ancestor
65672104|NCT02056743|Anesthetics|anesthetics|mesh-ancestor
65672105|NCT02056743|GABA Modulators|gaba modulators|mesh-ancestor
65672106|NCT02056743|GABA Agents|gaba agents|mesh-ancestor
65672107|NCT02056743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65672108|NCT02056743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672109|NCT02056743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65672110|NCT02056743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65672111|NCT02056743|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65672112|NCT02056743|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65672113|NCT02056743|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65469429|NCT01088763|Antiemetics|antiemetics|mesh-ancestor
65672114|NCT02056743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65672115|NCT02056743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672116|NCT02056743|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65672117|NCT02056743|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65672118|NCT02056743|Purinergic Agents|purinergic agents|mesh-ancestor
65672119|NCT02056743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65672120|NCT02056743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65672121|NCT02056743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65672122|NCT02056743|Antitussive Agents|antitussive agents|mesh-ancestor
65672123|NCT02056743|Respiratory System Agents|respiratory system agents|mesh-ancestor
65672124|NCT02056743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65672125|NCT02056743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65672126|NCT02056743|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65672127|NCT02056743|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65672128|NCT02056743|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65672129|NCT02056743|Histamine Antagonists|histamine antagonists|mesh-ancestor
65672130|NCT02056743|Histamine Agents|histamine agents|mesh-ancestor
65672131|NCT02054637|Lanreotide|lanreotide|mesh-list
65672132|NCT02054637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672133|NCT02052609|Brodalumab|brodalumab|mesh-list
65672134|NCT02052609|Dermatologic Agents|dermatologic agents|mesh-ancestor
65672135|NCT02054793|Itraconazole|itraconazole|mesh-list
65672136|NCT02054793|Antifungal Agents|antifungal agents|mesh-ancestor
65672137|NCT02054793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65672138|NCT02054793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65672139|NCT02054793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65672140|NCT02054793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672141|NCT02054793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672142|NCT02054793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65672143|NCT02054793|Hormone Antagonists|hormone antagonists|mesh-ancestor
65672144|NCT02054793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65672145|NCT02054793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672146|NCT02054793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65672147|NCT02052687|Imiquimod|imiquimod|mesh-list
65672148|NCT02052687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65672149|NCT02052687|Immunologic Factors|immunologic factors|mesh-ancestor
65672150|NCT02052687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672151|NCT02052687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672152|NCT02052687|Interferon Inducers|interferon inducers|mesh-ancestor
65672153|NCT02057289|Micafungin|micafungin|mesh-list
65672154|NCT02057289|Antifungal Agents|antifungal agents|mesh-ancestor
65672155|NCT02057289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65672156|NCT02057367|Bupivacaine|bupivacaine|mesh-list
65672157|NCT02057367|Anesthetics, Local|anesthetics, local|mesh-ancestor
65672158|NCT02057367|Anesthetics|anesthetics|mesh-ancestor
65672159|NCT02057367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65672160|NCT02057367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672161|NCT02057367|Sensory System Agents|sensory system agents|mesh-ancestor
65672162|NCT02057367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672163|NCT02054949|Acetylcysteine|acetylcysteine|mesh-list
65672164|NCT02054949|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65672165|NCT02054949|Antiviral Agents|antiviral agents|mesh-ancestor
65672166|NCT02054949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65672167|NCT02054949|Expectorants|expectorants|mesh-ancestor
65672168|NCT02054949|Respiratory System Agents|respiratory system agents|mesh-ancestor
65672169|NCT02054949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65672170|NCT02054949|Antioxidants|antioxidants|mesh-ancestor
65672171|NCT02054949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672172|NCT02054949|Protective Agents|protective agents|mesh-ancestor
65672173|NCT02054949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672174|NCT02054949|Antidotes|antidotes|mesh-ancestor
65672175|NCT02748057|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65672176|NCT02748057|Ezetimibe|ezetimibe|mesh-list
65672177|NCT02748057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65672178|NCT02748057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65672179|NCT02748057|Antimetabolites|antimetabolites|mesh-ancestor
65672180|NCT02748057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672181|NCT02748057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65672182|NCT02748057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65672183|NCT02748057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672184|NCT02057601|Levobupivacaine|levobupivacaine|mesh-list
65672185|NCT02057601|Anesthetics, Local|anesthetics, local|mesh-ancestor
65672186|NCT02057601|Anesthetics|anesthetics|mesh-ancestor
65672187|NCT02057601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65672188|NCT02057601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672189|NCT02057601|Sensory System Agents|sensory system agents|mesh-ancestor
65672190|NCT02057601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672191|NCT02057679|Amoxicillin|amoxicillin|mesh-list
65672192|NCT02057679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65672193|NCT02057679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65672194|NCT02038491|Anesthetics|anesthetics|mesh-list
65672195|NCT02038491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65672196|NCT02038491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672197|NCT02055183|Antitoxins|antitoxins|mesh-list
65672198|NCT02055183|Botulinum Antitoxin|botulinum antitoxin|mesh-list
65672199|NCT02055183|Immunologic Factors|immunologic factors|mesh-ancestor
65672200|NCT02055183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672201|NCT02748213|Docetaxel|docetaxel|mesh-list
65672202|NCT02748213|Capecitabine|capecitabine|mesh-list
65672203|NCT02748213|Trastuzumab|trastuzumab|mesh-list
65672204|NCT02748213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672205|NCT02748213|Tubulin Modulators|tubulin modulators|mesh-ancestor
65672206|NCT02748213|Antimitotic Agents|antimitotic agents|mesh-ancestor
65672207|NCT02748213|Mitosis Modulators|mitosis modulators|mesh-ancestor
65672208|NCT02748213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672209|NCT02748213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65672210|NCT02748213|Antimetabolites|antimetabolites|mesh-ancestor
65672211|NCT02748213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65672212|NCT03804099|Aflibercept|aflibercept|mesh-list
65672213|NCT03804099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65672214|NCT03804099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65672215|NCT03804099|Growth Substances|growth substances|mesh-ancestor
65672216|NCT03804099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672217|NCT03804099|Growth Inhibitors|growth inhibitors|mesh-ancestor
65672218|NCT03804099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672219|NCT02058303|Bupivacaine|bupivacaine|mesh-list
65672220|NCT02058303|Anesthetics, Local|anesthetics, local|mesh-ancestor
65672221|NCT02058303|Anesthetics|anesthetics|mesh-ancestor
65672222|NCT02058303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65672223|NCT02058303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672224|NCT02058303|Sensory System Agents|sensory system agents|mesh-ancestor
65672225|NCT02058303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672226|NCT02058693|Amphetamine|amphetamine|mesh-list
65672227|NCT02058693|Adderall|adderall|mesh-list
65672228|NCT02058693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65672229|NCT02058693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672230|NCT02058693|Sympathomimetics|sympathomimetics|mesh-ancestor
65672231|NCT02058693|Autonomic Agents|autonomic agents|mesh-ancestor
65672232|NCT02058693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672233|NCT02058693|Dopamine Agents|dopamine agents|mesh-ancestor
65672234|NCT02058693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65672235|NCT02058693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672236|NCT02058693|Adrenergic Agents|adrenergic agents|mesh-ancestor
65672237|NCT02058693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65672238|NCT02058693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65672239|NCT02058693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65672240|NCT02058693|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65672241|NCT05256472|Axitinib|axitinib|mesh-list
65672242|NCT05256472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672243|NCT05256472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65672244|NCT05256472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672245|NCT05256472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672246|NCT04870060|Curcumin|curcumin|mesh-list
65672247|NCT04870060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65672248|NCT04870060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65672249|NCT04870060|Analgesics|analgesics|mesh-ancestor
65672250|NCT04870060|Sensory System Agents|sensory system agents|mesh-ancestor
65672251|NCT04870060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672252|NCT04870060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672253|NCT04870060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65672254|NCT04870060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65672255|NCT04870060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672256|NCT04870060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672257|NCT04870060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672258|NCT02613910|Acetaminophen|acetaminophen|mesh-list
65672259|NCT02613910|Cetirizine|cetirizine|mesh-list
65672260|NCT02613910|Prednisone|prednisone|mesh-list
65672261|NCT02613910|Prednisolone|prednisolone|mesh-list
65672262|NCT02613910|Ofatumumab|ofatumumab|mesh-list
65672263|NCT02613910|Histamine Antagonists|histamine antagonists|mesh-list
65672264|NCT02613910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
65672265|NCT02613910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65672266|NCT02613910|Glucocorticoids|glucocorticoids|mesh-ancestor
65672267|NCT02613910|Hormones|hormones|mesh-ancestor
65672268|NCT02613910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65672269|NCT02613910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672270|NCT02613910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65672271|NCT02613910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672272|NCT02613910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65672274|NCT02613910|Sensory System Agents|sensory system agents|mesh-ancestor
65672275|NCT02613910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672276|NCT02613910|Antipyretics|antipyretics|mesh-ancestor
65672277|NCT02613910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65672278|NCT02613910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65672279|NCT02613910|Histamine Agents|histamine agents|mesh-ancestor
65672280|NCT02613910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65672281|NCT02613910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672282|NCT02802735|Apremilast|apremilast|mesh-list
65672283|NCT02802735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65672284|NCT02802735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65672285|NCT02802735|Analgesics|analgesics|mesh-ancestor
65672286|NCT02802735|Sensory System Agents|sensory system agents|mesh-ancestor
65672287|NCT02802735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672288|NCT02802735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672289|NCT02802735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65672290|NCT02802735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65672291|NCT02802735|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65672292|NCT02802735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65672293|NCT02802735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672294|NCT02802735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672295|NCT03048214|Anesthetics|anesthetics|mesh-list
65672296|NCT03048214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65672297|NCT03048214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672298|NCT02060955|Bevacizumab|bevacizumab|mesh-list
65672299|NCT02060955|Irinotecan|irinotecan|mesh-list
65672300|NCT02060955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65672301|NCT02060955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672302|NCT02060955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65672303|NCT02060955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65672304|NCT02060955|Growth Substances|growth substances|mesh-ancestor
65672305|NCT02060955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672306|NCT02060955|Growth Inhibitors|growth inhibitors|mesh-ancestor
65672307|NCT02060955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65672308|NCT02060955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65672309|NCT02060955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672310|NCT02060955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672311|NCT02273362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65672312|NCT02273362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672313|NCT02273362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65672314|NCT02273362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672315|NCT02273362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672316|NCT05654649|Dexamethasone|dexamethasone|mesh-list
65672317|NCT05654649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65672318|NCT05654649|Antiemetics|antiemetics|mesh-ancestor
65672319|NCT05654649|Autonomic Agents|autonomic agents|mesh-ancestor
65672320|NCT05654649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672321|NCT05654649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672322|NCT05654649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65672323|NCT05654649|Glucocorticoids|glucocorticoids|mesh-ancestor
65672324|NCT05654649|Hormones|hormones|mesh-ancestor
65672325|NCT05654649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65672326|NCT05654649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65672327|NCT05654649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672328|NCT04877626|Artesunate|artesunate|mesh-list
65672329|NCT04877626|Antimalarials|antimalarials|mesh-ancestor
65672330|NCT04877626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65672331|NCT04877626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65672332|NCT04877626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65672333|NCT04877626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672334|NCT04877626|Antiviral Agents|antiviral agents|mesh-ancestor
65672335|NCT04877626|Schistosomicides|schistosomicides|mesh-ancestor
65672336|NCT04877626|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65672337|NCT04877626|Anthelmintics|anthelmintics|mesh-ancestor
65672338|NCT05255848|Heparin|heparin|mesh-list
65672339|NCT05255848|Calcium heparin|calcium heparin|mesh-list
65672340|NCT05255848|Anticoagulants|anticoagulants|mesh-ancestor
65469672|NCT03489304|Zaleplon|zaleplon|mesh-list
65672342|NCT05255848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65672343|NCT05255848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672344|NCT04430062|Anesthetics|anesthetics|mesh-list
65672345|NCT04430062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65672346|NCT04430062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672347|NCT02799381|Levodopa|levodopa|mesh-list
65672348|NCT02799381|Carbidopa|carbidopa|mesh-list
65672349|NCT02799381|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65672350|NCT02799381|Antiparkinson Agents|antiparkinson agents|mesh-list
65672351|NCT02799381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65672352|NCT02799381|Dopamine Agents|dopamine agents|mesh-ancestor
65672353|NCT02799381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65672354|NCT02799381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672355|NCT02799381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672356|NCT02799381|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65672357|NCT02799381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672358|NCT02799381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65672359|NCT02799381|Immunologic Factors|immunologic factors|mesh-ancestor
65672360|NCT02799381|Dopamine Agonists|dopamine agonists|mesh-ancestor
65672361|NCT04387942|Aldesleukin|aldesleukin|mesh-list
65672362|NCT04387942|Interleukin-2|interleukin-2|mesh-list
65672363|NCT04387942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672364|NCT04387942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65672365|NCT04387942|Analgesics|analgesics|mesh-ancestor
65672366|NCT04387942|Sensory System Agents|sensory system agents|mesh-ancestor
65672367|NCT04387942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672368|NCT04387942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672369|NCT04387942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65672370|NCT04387942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65672371|NCT04387942|Antiviral Agents|antiviral agents|mesh-ancestor
65672372|NCT04387942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65672373|NCT01333059|Fentanyl|fentanyl|mesh-list
65672374|NCT01333059|Midazolam|midazolam|mesh-list
65672375|NCT01333059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65672376|NCT01333059|Narcotics|narcotics|mesh-ancestor
65672377|NCT01333059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65672378|NCT01333059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672379|NCT01333059|Analgesics|analgesics|mesh-ancestor
65672380|NCT01333059|Sensory System Agents|sensory system agents|mesh-ancestor
65672381|NCT01333059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672382|NCT01333059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65672383|NCT01333059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65672384|NCT01333059|Anesthetics, General|anesthetics, general|mesh-ancestor
65672385|NCT01333059|Anesthetics|anesthetics|mesh-ancestor
65672386|NCT01333059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65672387|NCT01333059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65672388|NCT01333059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65672389|NCT01333059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65672390|NCT01333059|GABA Modulators|gaba modulators|mesh-ancestor
65672391|NCT01333059|GABA Agents|gaba agents|mesh-ancestor
65672392|NCT01333059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65672393|NCT01333059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672394|NCT04865848|Anesthetics|anesthetics|mesh-list
65672395|NCT04865848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65672396|NCT04865848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672397|NCT02060253|Paclitaxel|paclitaxel|mesh-list
65672398|NCT02060253|Trastuzumab|trastuzumab|mesh-list
65672399|NCT02060253|Pertuzumab|pertuzumab|mesh-list
65672400|NCT02060253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65672401|NCT02060253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672402|NCT02060253|Tubulin Modulators|tubulin modulators|mesh-ancestor
65672403|NCT02060253|Antimitotic Agents|antimitotic agents|mesh-ancestor
65672404|NCT02060253|Mitosis Modulators|mitosis modulators|mesh-ancestor
65672405|NCT02060253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672406|NCT02060253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65672407|NCT04364620|Docetaxel|docetaxel|mesh-list
65672408|NCT04364620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672409|NCT04364620|Tubulin Modulators|tubulin modulators|mesh-ancestor
65672410|NCT04364620|Antimitotic Agents|antimitotic agents|mesh-ancestor
65672411|NCT04364620|Mitosis Modulators|mitosis modulators|mesh-ancestor
65672412|NCT04364620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672413|NCT03560973|Gemcitabine|gemcitabine|mesh-list
65672414|NCT03560973|Ramucirumab|ramucirumab|mesh-list
65672415|NCT03560973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65672416|NCT03560973|Antimetabolites|antimetabolites|mesh-ancestor
65672417|NCT03560973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672418|NCT03560973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672419|NCT03560973|Antiviral Agents|antiviral agents|mesh-ancestor
65672420|NCT03560973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65672421|NCT03560973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672422|NCT03560973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65672423|NCT03560973|Immunologic Factors|immunologic factors|mesh-ancestor
65672424|NCT03560973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672425|NCT04383574|Vaccines|vaccines|mesh-list
65672426|NCT04383574|Immunologic Factors|immunologic factors|mesh-ancestor
65672427|NCT04383574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672428|NCT03046108|Triamcinolone|triamcinolone|mesh-list
65672429|NCT03046108|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65672430|NCT03046108|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65672431|NCT03046108|Mepivacaine|mepivacaine|mesh-list
65672432|NCT03046108|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65672433|NCT03046108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65672434|NCT03046108|Glucocorticoids|glucocorticoids|mesh-ancestor
65672435|NCT03046108|Hormones|hormones|mesh-ancestor
65672436|NCT03046108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65672437|NCT03046108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672438|NCT03046108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65672439|NCT03046108|Immunologic Factors|immunologic factors|mesh-ancestor
65672440|NCT03046108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672441|NCT03046108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672442|NCT03046108|Anesthetics, Local|anesthetics, local|mesh-ancestor
65672443|NCT03046108|Anesthetics|anesthetics|mesh-ancestor
65672444|NCT03046108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65672445|NCT03046108|Sensory System Agents|sensory system agents|mesh-ancestor
65672446|NCT03046108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672447|NCT02061267|Niacin|niacin|mesh-list
65672448|NCT02061267|Nicotinic Acids|nicotinic acids|mesh-list
65672449|NCT02061267|Vitamins|vitamins|mesh-ancestor
65672450|NCT02061267|Micronutrients|micronutrients|mesh-ancestor
65672451|NCT02061267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672452|NCT02061267|Vitamin B Complex|vitamin b complex|mesh-ancestor
65672453|NCT02061267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65672454|NCT02061267|Antimetabolites|antimetabolites|mesh-ancestor
65672455|NCT02061267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672456|NCT02061267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65672457|NCT02061267|Vasodilator Agents|vasodilator agents|mesh-ancestor
65672458|NCT01370655|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65672459|NCT01370655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65672460|NCT01370655|Diuretics|diuretics|mesh-ancestor
65672461|NCT01370655|Natriuretic Agents|natriuretic agents|mesh-ancestor
65672462|NCT01370655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672463|NCT01370655|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65672464|NCT01370655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65672465|NCT01370655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672466|NCT02612194|Crizotinib|crizotinib|mesh-list
65672467|NCT02612194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672468|NCT02612194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65672469|NCT02612194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672470|NCT02612194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672471|NCT03044626|Nivolumab|nivolumab|mesh-list
65672472|NCT03044626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65672473|NCT03044626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672474|NCT03044626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65672475|NCT03044626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672476|NCT04865224|Chrysarobin|chrysarobin|mesh-list
65672477|NCT04865224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65672478|NCT04865224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65672479|NCT04865224|Analgesics|analgesics|mesh-ancestor
65672480|NCT04865224|Sensory System Agents|sensory system agents|mesh-ancestor
65672481|NCT04865224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672482|NCT04865224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672483|NCT04865224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65672484|NCT04865224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65672485|NCT04865380|Tranexamic Acid|tranexamic acid|mesh-list
65672486|NCT04865380|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65672487|NCT04865380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65672488|NCT04865380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672489|NCT04865380|Hemostatics|hemostatics|mesh-ancestor
65672490|NCT04865380|Coagulants|coagulants|mesh-ancestor
65469806|NCT01099592|Citalopram|citalopram|mesh-list
65672491|NCT04869046|Acetaminophen|acetaminophen|mesh-list
65672492|NCT04869046|Ibuprofen|ibuprofen|mesh-list
65672493|NCT04869046|Analgesics|analgesics|mesh-list
65672494|NCT04869046|Levobupivacaine|levobupivacaine|mesh-list
65672495|NCT04869046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65672496|NCT04869046|Sensory System Agents|sensory system agents|mesh-ancestor
65672497|NCT04869046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672498|NCT04869046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672499|NCT04869046|Antipyretics|antipyretics|mesh-ancestor
65672500|NCT04869046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65672501|NCT04869046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65672502|NCT04869046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65672503|NCT04869046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65672504|NCT04869046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672505|NCT04869046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672506|NCT04869046|Anesthetics, Local|anesthetics, local|mesh-ancestor
65672507|NCT04869046|Anesthetics|anesthetics|mesh-ancestor
65672508|NCT04869046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65672509|NCT04385680|Chlorhexidine|chlorhexidine|mesh-list
65268615|NCT00913835|Doxorubicin|doxorubicin|mesh-list
65672510|NCT04385680|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65672511|NCT04385680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65672512|NCT04385680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65672513|NCT04385680|Disinfectants|disinfectants|mesh-ancestor
65672514|NCT04385680|Dermatologic Agents|dermatologic agents|mesh-ancestor
65672515|NCT02798211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65672516|NCT02798211|Immunologic Factors|immunologic factors|mesh-ancestor
65672517|NCT02798211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672518|NCT02060019|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
65672519|NCT02060019|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65672520|NCT02060019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65672521|NCT02060019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65672522|NCT02060019|Antimetabolites|antimetabolites|mesh-ancestor
65672523|NCT02060019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672524|NCT02060019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65672525|NCT02060019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65672526|NCT02060019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672527|NCT02060019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65672528|NCT05654415|Melatonin|melatonin|mesh-list
65672529|NCT05654415|Antioxidants|antioxidants|mesh-ancestor
65672530|NCT05654415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672531|NCT05654415|Protective Agents|protective agents|mesh-ancestor
65672532|NCT05654415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672533|NCT05654415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65672534|NCT03044938|Albuterol|albuterol|mesh-list
65672535|NCT03044938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65672536|NCT03044938|Autonomic Agents|autonomic agents|mesh-ancestor
65672537|NCT03044938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672538|NCT03044938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672539|NCT03044938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65672540|NCT03044938|Respiratory System Agents|respiratory system agents|mesh-ancestor
65672541|NCT03044938|Tocolytic Agents|tocolytic agents|mesh-ancestor
65672542|NCT03044938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65672543|NCT03044938|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65672544|NCT03044938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65672545|NCT03044938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65672546|NCT03044938|Adrenergic Agents|adrenergic agents|mesh-ancestor
65672547|NCT03044938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65672548|NCT03044938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672549|NCT03045484|Oxycodone|oxycodone|mesh-list
65672550|NCT03045484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65672551|NCT03045484|Narcotics|narcotics|mesh-ancestor
65672552|NCT03045484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65672553|NCT03045484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672554|NCT03045484|Analgesics|analgesics|mesh-ancestor
65672555|NCT03045484|Sensory System Agents|sensory system agents|mesh-ancestor
65672556|NCT03045484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672557|NCT04874506|TEMPO|tempo|mesh-list
65672558|NCT04874506|TEMPOL-H|tempol-h|mesh-list
65672559|NCT04874506|Antioxidants|antioxidants|mesh-ancestor
65672560|NCT04874506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672561|NCT04874506|Protective Agents|protective agents|mesh-ancestor
65672562|NCT04874506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672563|NCT04874506|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65672564|NCT04874428|Rivaroxaban|rivaroxaban|mesh-list
65672565|NCT04874428|Apixaban|apixaban|mesh-list
65672566|NCT04874428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65672567|NCT04874428|Antithrombins|antithrombins|mesh-ancestor
65672568|NCT04874428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65672569|NCT04874428|Protease Inhibitors|protease inhibitors|mesh-ancestor
65672570|NCT04874428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672571|NCT04874428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672572|NCT04874428|Anticoagulants|anticoagulants|mesh-ancestor
65672573|NCT04867720|Everolimus|everolimus|mesh-list
65672574|NCT04867720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672575|NCT04867720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65672576|NCT04867720|Immunologic Factors|immunologic factors|mesh-ancestor
65672577|NCT04867720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672578|NCT02799069|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65672579|NCT02799069|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65672580|NCT02799069|Dermatologic Agents|dermatologic agents|mesh-ancestor
65672581|NCT03497169|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65672582|NCT03497169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65268617|NCT00913835|Olaratumab|olaratumab|mesh-list
65672583|NCT03497169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672584|NCT03497169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65672585|NCT03497169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65672586|NCT03497169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65672587|NCT03497169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672588|NCT03497169|Dopamine Agents|dopamine agents|mesh-ancestor
65672589|NCT03497169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65672590|NCT02062047|Chlorhexidine|chlorhexidine|mesh-list
65672591|NCT02062047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65672592|NCT02062047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65672593|NCT02062047|Disinfectants|disinfectants|mesh-ancestor
65672594|NCT03045406|Dalteparin|dalteparin|mesh-list
65672595|NCT03045406|Tinzaparin|tinzaparin|mesh-list
65672596|NCT03045406|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65672597|NCT03045406|Apixaban|apixaban|mesh-list
65672598|NCT03045406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65672599|NCT03045406|Antithrombins|antithrombins|mesh-ancestor
65672600|NCT03045406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65672601|NCT03045406|Protease Inhibitors|protease inhibitors|mesh-ancestor
65672602|NCT03045406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672603|NCT03045406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672604|NCT03045406|Anticoagulants|anticoagulants|mesh-ancestor
65672605|NCT03045406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65672606|NCT03045406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65672607|NCT02798835|Dexamethasone|dexamethasone|mesh-list
65672608|NCT02798835|Dexamethasone acetate|dexamethasone acetate|mesh-list
65672609|NCT02798835|Fentanyl|fentanyl|mesh-list
65672610|NCT02798835|Bupivacaine|bupivacaine|mesh-list
65672611|NCT02798835|Ropivacaine|ropivacaine|mesh-list
65672612|NCT02798835|BB 1101|bb 1101|mesh-list
65672613|NCT02798835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65672614|NCT02798835|Antiemetics|antiemetics|mesh-ancestor
65672615|NCT02798835|Autonomic Agents|autonomic agents|mesh-ancestor
65672616|NCT02798835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672617|NCT02798835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672618|NCT02798835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65672619|NCT02798835|Glucocorticoids|glucocorticoids|mesh-ancestor
65672620|NCT02798835|Hormones|hormones|mesh-ancestor
65672621|NCT02798835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65672622|NCT02798835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65672623|NCT02798835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672624|NCT02798835|Protease Inhibitors|protease inhibitors|mesh-ancestor
65672625|NCT02798835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672626|NCT02798835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672627|NCT02798835|Anesthetics, Local|anesthetics, local|mesh-ancestor
65672628|NCT02798835|Anesthetics|anesthetics|mesh-ancestor
65672629|NCT02798835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65672630|NCT02798835|Sensory System Agents|sensory system agents|mesh-ancestor
65672631|NCT02798835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65672632|NCT02798835|Narcotics|narcotics|mesh-ancestor
65672633|NCT02798835|Analgesics|analgesics|mesh-ancestor
65672634|NCT02798835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65672635|NCT02798835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65672636|NCT02798835|Anesthetics, General|anesthetics, general|mesh-ancestor
65672637|NCT02061657|Misoprostol|misoprostol|mesh-list
65672638|NCT02061657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65672639|NCT02061657|Abortifacient Agents|abortifacient agents|mesh-ancestor
65672640|NCT02061657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65672641|NCT02061657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672642|NCT02061657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65672643|NCT02061657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65672644|NCT02061657|Oxytocics|oxytocics|mesh-ancestor
65672645|NCT03048136|Nivolumab|nivolumab|mesh-list
65672646|NCT03048136|Ipilimumab|ipilimumab|mesh-list
65672647|NCT03048136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65672648|NCT03048136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672649|NCT03048136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65672650|NCT03048136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672651|NCT02062203|Moxifloxacin|moxifloxacin|mesh-list
65672652|NCT02062203|Glycine|glycine|mesh-list
65672653|NCT02062203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65672654|NCT02062203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65672655|NCT02062203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65672656|NCT02062203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65672657|NCT02062203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672658|NCT02062203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672659|NCT02062203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672660|NCT02062203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672661|NCT02062203|Glycine Agents|glycine agents|mesh-ancestor
65672662|NCT02062203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65672663|NCT04863742|Prednisolone|prednisolone|mesh-list
65672664|NCT04863742|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65672665|NCT04863742|Methylprednisolone|methylprednisolone|mesh-list
65672666|NCT04863742|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65672667|NCT04863742|Prednisolone acetate|prednisolone acetate|mesh-list
65672668|NCT04863742|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65672669|NCT04863742|Prednisolone phosphate|prednisolone phosphate|mesh-list
65672670|NCT04863742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65672671|NCT04863742|Glucocorticoids|glucocorticoids|mesh-ancestor
65672672|NCT04863742|Hormones|hormones|mesh-ancestor
65672673|NCT04863742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65672674|NCT04863742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672675|NCT04863742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65672676|NCT04863742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672677|NCT04863742|Antiemetics|antiemetics|mesh-ancestor
65672678|NCT04863742|Autonomic Agents|autonomic agents|mesh-ancestor
65672679|NCT04863742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672680|NCT04863742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65672681|NCT04863742|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65672682|NCT04863742|Protective Agents|protective agents|mesh-ancestor
65672683|NCT02611882|Edetic Acid|edetic acid|mesh-list
65672684|NCT02611882|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
65672685|NCT02611882|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65672686|NCT02611882|Chelating Agents|chelating agents|mesh-ancestor
65672687|NCT02611882|Sequestering Agents|sequestering agents|mesh-ancestor
65672688|NCT02611882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672689|NCT02611882|Anticoagulants|anticoagulants|mesh-ancestor
65672690|NCT02611882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65672691|NCT02611882|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65672692|NCT02062281|Vaccines|vaccines|mesh-list
65672693|NCT02062281|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65672694|NCT02062281|Immunologic Factors|immunologic factors|mesh-ancestor
65672695|NCT02062281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672696|NCT05590455|Adalimumab|adalimumab|mesh-list
65672697|NCT05590455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65672698|NCT05590455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65672699|NCT03560583|Metoclopramide|metoclopramide|mesh-list
65672700|NCT03560583|Antiemetics|antiemetics|mesh-ancestor
65672701|NCT03560583|Autonomic Agents|autonomic agents|mesh-ancestor
65672702|NCT03560583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672703|NCT03560583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672704|NCT03560583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65672705|NCT03560583|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65672706|NCT03560583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65672707|NCT03560583|Dopamine Agents|dopamine agents|mesh-ancestor
65672708|NCT03560583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65672709|NCT03560583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672710|NCT03560427|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65672711|NCT03560427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65672712|NCT03560427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65672713|NCT03560427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65672714|NCT03560427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672715|NCT03560427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65672716|NCT03560427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470035|NCT03449758|Amebicides|amebicides|mesh-ancestor
65672717|NCT03560427|Analgesics|analgesics|mesh-ancestor
65672718|NCT03560427|Sensory System Agents|sensory system agents|mesh-ancestor
65672719|NCT03560427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672720|NCT03560427|Antidepressive Agents|antidepressive agents|mesh-ancestor
65672721|NCT03560427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65672722|NCT03560427|Dopamine Agents|dopamine agents|mesh-ancestor
65672723|NCT03797547|Aflibercept|aflibercept|mesh-list
65672724|NCT03797547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65672725|NCT03797547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65672726|NCT03797547|Growth Substances|growth substances|mesh-ancestor
65672727|NCT03797547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672728|NCT03797547|Growth Inhibitors|growth inhibitors|mesh-ancestor
65672729|NCT03797547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672730|NCT04867252|Inositol|inositol|mesh-list
65672731|NCT04867252|Metformin|metformin|mesh-list
65672732|NCT04867252|Pioglitazone|pioglitazone|mesh-list
65672733|NCT04867252|Resveratrol|resveratrol|mesh-list
65672734|NCT04867252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65672735|NCT04867252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672736|NCT04867252|Antioxidants|antioxidants|mesh-ancestor
65672737|NCT04867252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672738|NCT04867252|Protective Agents|protective agents|mesh-ancestor
65672739|NCT04867252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672740|NCT04867252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65672741|NCT04867252|Vitamin B Complex|vitamin b complex|mesh-ancestor
65672742|NCT04867252|Vitamins|vitamins|mesh-ancestor
65672743|NCT04867252|Micronutrients|micronutrients|mesh-ancestor
65672744|NCT04863274|Atorvastatin|atorvastatin|mesh-list
65672745|NCT04863274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65672746|NCT04863274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65672747|NCT04863274|Antimetabolites|antimetabolites|mesh-ancestor
65672748|NCT04863274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672749|NCT04863274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65672750|NCT04863274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65672751|NCT04863274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672752|NCT02063373|Hyaluronic Acid|hyaluronic acid|mesh-list
65672753|NCT02063373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65672754|NCT02063373|Immunologic Factors|immunologic factors|mesh-ancestor
65672755|NCT02063373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672756|NCT02063373|Viscosupplements|viscosupplements|mesh-ancestor
65672757|NCT02063373|Protective Agents|protective agents|mesh-ancestor
65672758|NCT02062749|Oxaliplatin|oxaliplatin|mesh-list
65672759|NCT02062749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672760|NCT02796651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65672761|NCT02796651|Formoterol Fumarate|formoterol fumarate|mesh-list
65672762|NCT02796651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65672763|NCT02796651|Autonomic Agents|autonomic agents|mesh-ancestor
65672764|NCT02796651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672765|NCT02796651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672766|NCT02796651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65672767|NCT02796651|Respiratory System Agents|respiratory system agents|mesh-ancestor
65672768|NCT02796651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65672769|NCT02796651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65672770|NCT02796651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65672771|NCT02796651|Adrenergic Agents|adrenergic agents|mesh-ancestor
65672772|NCT02796651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65672773|NCT02796651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672774|NCT03044080|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65672775|NCT03044080|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65672776|NCT03044080|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65672777|NCT03044080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65672778|NCT03044080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672779|NCT03044080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672780|NCT03044080|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65672781|NCT03044080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65672782|NCT03044080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672783|NCT03044080|Cholinergic Agents|cholinergic agents|mesh-ancestor
65672784|NCT03044080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65672785|NCT04429282|Ibuprofen|ibuprofen|mesh-list
65672786|NCT04429282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65672787|NCT04429282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65672788|NCT04429282|Analgesics|analgesics|mesh-ancestor
65672789|NCT04429282|Sensory System Agents|sensory system agents|mesh-ancestor
65672790|NCT04429282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672791|NCT04429282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672792|NCT04429282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65672793|NCT04429282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65672794|NCT04429282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65672795|NCT04429282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672796|NCT04429282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672797|NCT02063529|Leucovorin|leucovorin|mesh-list
65672798|NCT02063529|Fluorouracil|fluorouracil|mesh-list
65672799|NCT02063529|Oxaliplatin|oxaliplatin|mesh-list
65672800|NCT02063529|Irinotecan|irinotecan|mesh-list
65672801|NCT02063529|Cetuximab|cetuximab|mesh-list
65672802|NCT02063529|Levoleucovorin|levoleucovorin|mesh-list
65672803|NCT02063529|Antimetabolites|antimetabolites|mesh-ancestor
65672804|NCT02063529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672805|NCT02063529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65672806|NCT02063529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672807|NCT02063529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65672808|NCT02063529|Immunologic Factors|immunologic factors|mesh-ancestor
65672809|NCT02063529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672810|NCT02063529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65672811|NCT02063529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65672812|NCT02063529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672813|NCT02063529|Antidotes|antidotes|mesh-ancestor
65672814|NCT02063529|Protective Agents|protective agents|mesh-ancestor
65672815|NCT02063529|Vitamin B Complex|vitamin b complex|mesh-ancestor
65672816|NCT02063529|Vitamins|vitamins|mesh-ancestor
65672817|NCT02063529|Micronutrients|micronutrients|mesh-ancestor
65672818|NCT02063529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65672819|NCT02062983|Trastuzumab|trastuzumab|mesh-list
65672820|NCT02062983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65672821|NCT02062983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672822|NCT02613208|Paclitaxel|paclitaxel|mesh-list
65672823|NCT02613208|Bevacizumab|bevacizumab|mesh-list
65672824|NCT02613208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65672825|NCT02613208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672826|NCT02613208|Tubulin Modulators|tubulin modulators|mesh-ancestor
65672827|NCT02613208|Antimitotic Agents|antimitotic agents|mesh-ancestor
65672828|NCT02613208|Mitosis Modulators|mitosis modulators|mesh-ancestor
65672829|NCT02613208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672830|NCT02613208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65672831|NCT02613208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65672832|NCT02613208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65672833|NCT02613208|Growth Substances|growth substances|mesh-ancestor
65672834|NCT02613208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672835|NCT02613208|Growth Inhibitors|growth inhibitors|mesh-ancestor
65672836|NCT02063841|Bismuth|bismuth|mesh-list
65672837|NCT02063841|Antacids|antacids|mesh-ancestor
65672838|NCT02063841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672839|NCT02063841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65672840|NCT02064153|Dialysis Solutions|dialysis solutions|mesh-list
65672841|NCT02064153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65672842|NCT04872634|Cetuximab|cetuximab|mesh-list
65672843|NCT04872634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65672844|NCT04872634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672845|NCT01668784|Nivolumab|nivolumab|mesh-list
65672846|NCT01668784|Everolimus|everolimus|mesh-list
65672847|NCT01668784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65672848|NCT01668784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672849|NCT01668784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65672850|NCT01668784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672851|NCT01668784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65672852|NCT01668784|Immunologic Factors|immunologic factors|mesh-ancestor
65672853|NCT01668784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672854|NCT02750514|Nivolumab|nivolumab|mesh-list
65672855|NCT02750514|Ipilimumab|ipilimumab|mesh-list
65672856|NCT02750514|Dasatinib|dasatinib|mesh-list
65672857|NCT02750514|Linrodostat|linrodostat|mesh-list
65672858|NCT02750514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65672859|NCT02750514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672860|NCT02750514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65672861|NCT02750514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672862|NCT02750514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65672863|NCT02750514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672864|NCT02229240|rGLP-1 protein|rglp-1 protein|mesh-list
65672865|NCT02229240|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65470181|NCT01089309|Spironolactone|spironolactone|mesh-list
65672866|NCT02229240|Incretins|incretins|mesh-ancestor
65672867|NCT02229240|Hormones|hormones|mesh-ancestor
65672868|NCT02229240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65672869|NCT02229240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672870|NCT02820714|Laxatives|laxatives|mesh-list
65672871|NCT02820714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65672872|NCT02259426|Piperaquine|piperaquine|mesh-list
65672873|NCT02259426|Primaquine|primaquine|mesh-list
65672874|NCT02259426|Artenimol|artenimol|mesh-list
65672875|NCT02259426|Antimalarials|antimalarials|mesh-ancestor
65672876|NCT02259426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65672877|NCT02259426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65672878|NCT02259426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65672879|NCT03742518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65672880|NCT03738618|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65672881|NCT03738618|Hormones|hormones|mesh-ancestor
65672882|NCT03738618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65672883|NCT03738618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672884|NCT03412890|Norethindrone|norethindrone|mesh-list
65672885|NCT03412890|Norethindrone Acetate|norethindrone acetate|mesh-list
65672886|NCT03412890|Estradiol|estradiol|mesh-list
65672887|NCT03412890|Relugolix|relugolix|mesh-list
65672888|NCT03412890|Estrogens|estrogens|mesh-ancestor
65672889|NCT03412890|Hormones|hormones|mesh-ancestor
65672890|NCT03412890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65672891|NCT03412890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672892|NCT03412890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65672893|NCT03412890|Contraceptive Agents|contraceptive agents|mesh-ancestor
65672894|NCT03412890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65672895|NCT03412890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65672896|NCT03412890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65672897|NCT03412890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65672898|NCT03412890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65672899|NCT03412890|Androgen Antagonists|androgen antagonists|mesh-ancestor
65672900|NCT03412890|Hormone Antagonists|hormone antagonists|mesh-ancestor
65672901|NCT03371082|Insulin Glargine|insulin glargine|mesh-list
65672902|NCT03371082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65672903|NCT03371082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672904|NCT03340974|Avasopasem manganese|avasopasem manganese|mesh-list
65672905|NCT03340974|Antioxidants|antioxidants|mesh-ancestor
65672906|NCT03340974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672907|NCT03340974|Protective Agents|protective agents|mesh-ancestor
65672908|NCT03340974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672909|NCT02229786|Acetaminophen|acetaminophen|mesh-list
65672910|NCT02229786|Scopolamine|scopolamine|mesh-list
65672911|NCT02229786|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65672912|NCT02229786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65672913|NCT02229786|Analgesics|analgesics|mesh-ancestor
65672914|NCT02229786|Sensory System Agents|sensory system agents|mesh-ancestor
65672915|NCT02229786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672916|NCT02229786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672917|NCT02229786|Antipyretics|antipyretics|mesh-ancestor
65672918|NCT02229786|Parasympatholytics|parasympatholytics|mesh-ancestor
65672919|NCT02229786|Autonomic Agents|autonomic agents|mesh-ancestor
65672920|NCT02229786|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65672921|NCT02229786|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65672922|NCT02229786|Cholinergic Agents|cholinergic agents|mesh-ancestor
65672923|NCT02229786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65672924|NCT02229786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672925|NCT02229786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65672926|NCT02229786|Antiemetics|antiemetics|mesh-ancestor
65672927|NCT02229786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65672928|NCT02229786|Mydriatics|mydriatics|mesh-ancestor
65672929|NCT03287232|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65672930|NCT03287232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65672931|NCT03287232|Immunologic Factors|immunologic factors|mesh-ancestor
65672932|NCT03287232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672933|NCT02229942|Rituximab|rituximab|mesh-list
65672934|NCT02229942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65672935|NCT02229942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672936|NCT02229942|Immunologic Factors|immunologic factors|mesh-ancestor
65672937|NCT02229942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672938|NCT02229942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65672939|NCT03047278|Cetirizine|cetirizine|mesh-list
65672940|NCT03047278|Gabapentin|gabapentin|mesh-list
65672941|NCT03047278|Analgesics|analgesics|mesh-ancestor
65672942|NCT03047278|Sensory System Agents|sensory system agents|mesh-ancestor
65672943|NCT03047278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672944|NCT03047278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672945|NCT03047278|Anticonvulsants|anticonvulsants|mesh-ancestor
65672946|NCT03047278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65672947|NCT03047278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65672948|NCT03047278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65672949|NCT03047278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65672950|NCT03047278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65672951|NCT03047278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65672952|NCT03047278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65672953|NCT03047278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672954|NCT03047278|Antimanic Agents|antimanic agents|mesh-ancestor
65672955|NCT03047278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65672956|NCT03047278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65672957|NCT03047278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65672958|NCT03047278|Histamine Antagonists|histamine antagonists|mesh-ancestor
65672959|NCT03047278|Histamine Agents|histamine agents|mesh-ancestor
65672960|NCT03045016|Prazosin|prazosin|mesh-list
65672961|NCT03045016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65672962|NCT03045016|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65672963|NCT03045016|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65672964|NCT03045016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65672965|NCT03045016|Adrenergic Agents|adrenergic agents|mesh-ancestor
65672966|NCT03045016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65672967|NCT03045016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672968|NCT03045016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672969|NCT04849858|Bupivacaine|bupivacaine|mesh-list
65672970|NCT04849858|Anesthetics, Local|anesthetics, local|mesh-ancestor
65672971|NCT04849858|Anesthetics|anesthetics|mesh-ancestor
65672972|NCT04849858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65672973|NCT04849858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672974|NCT04849858|Sensory System Agents|sensory system agents|mesh-ancestor
65672975|NCT04849858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65672976|NCT03043612|Doxazosin|doxazosin|mesh-list
65672977|NCT03043612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65672978|NCT03043612|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65672979|NCT03043612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65672980|NCT03043612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65672981|NCT03043612|Adrenergic Agents|adrenergic agents|mesh-ancestor
65672982|NCT03043612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65672983|NCT03043612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672984|NCT03043612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672985|NCT02230176|Sunitinib|sunitinib|mesh-list
65672986|NCT02230176|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65672987|NCT02230176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65672988|NCT02230176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65672989|NCT02230176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65672990|NCT02230176|Growth Substances|growth substances|mesh-ancestor
65672991|NCT02230176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65672992|NCT02230176|Growth Inhibitors|growth inhibitors|mesh-ancestor
65672993|NCT02230176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65672994|NCT02230176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65672995|NCT02230176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65672996|NCT02230176|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65672997|NCT02232516|Lenalidomide|lenalidomide|mesh-list
65672998|NCT02232516|Romidepsin|romidepsin|mesh-list
65672999|NCT02232516|Immunologic Factors|immunologic factors|mesh-ancestor
65673000|NCT02232516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673001|NCT02232516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65673002|NCT02232516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65673003|NCT02232516|Growth Substances|growth substances|mesh-ancestor
65673004|NCT02232516|Growth Inhibitors|growth inhibitors|mesh-ancestor
65673005|NCT02232516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673006|NCT02232516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65673007|NCT04849390|Mometasone Furoate|mometasone furoate|mesh-list
65673008|NCT04849390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65673009|NCT04849390|Dermatologic Agents|dermatologic agents|mesh-ancestor
65673010|NCT04849390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65673011|NCT03647592|Bevacizumab|bevacizumab|mesh-list
65673012|NCT03647592|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65673013|NCT03647592|Gefitinib|gefitinib|mesh-list
65673014|NCT03647592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65673015|NCT03647592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673016|NCT03647592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65673017|NCT03647592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65673018|NCT03647592|Growth Substances|growth substances|mesh-ancestor
65673019|NCT03647592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470344|NCT03715582|Trimetazidine|trimetazidine|mesh-list
65673020|NCT03647592|Growth Inhibitors|growth inhibitors|mesh-ancestor
65673021|NCT03647592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65673022|NCT03647592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673023|NCT03647592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673024|NCT02232594|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
65673025|NCT02232594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65673026|NCT02232594|Autonomic Agents|autonomic agents|mesh-ancestor
65673027|NCT02232594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65673028|NCT02232594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673029|NCT02232594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65673030|NCT02232594|Respiratory System Agents|respiratory system agents|mesh-ancestor
65673032|NCT03180684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65673033|NCT03180684|Immunologic Factors|immunologic factors|mesh-ancestor
65673034|NCT03180684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673035|NCT03180684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673036|NCT03180684|Interferon Inducers|interferon inducers|mesh-ancestor
65673037|NCT04858516|Trastuzumab|trastuzumab|mesh-list
65673038|NCT04858516|Palbociclib|palbociclib|mesh-list
65673039|NCT04858516|Exemestane|exemestane|mesh-list
65673040|NCT04858516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65673041|NCT04858516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673042|NCT04858516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65673043|NCT04858516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673044|NCT04858516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673045|NCT04858516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65673046|NCT04858516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65673047|NCT04858516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65673048|NCT04858516|Hormone Antagonists|hormone antagonists|mesh-ancestor
65673049|NCT04858516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65673050|NCT04858516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673051|NCT03148860|Methotrexate|methotrexate|mesh-list
65673052|NCT03148860|Ustekinumab|ustekinumab|mesh-list
65673053|NCT03148860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65673054|NCT03148860|Abortifacient Agents|abortifacient agents|mesh-ancestor
65673055|NCT03148860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65673056|NCT03148860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673057|NCT03148860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65673058|NCT03148860|Antimetabolites|antimetabolites|mesh-ancestor
65673059|NCT03148860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673060|NCT03148860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673061|NCT03148860|Dermatologic Agents|dermatologic agents|mesh-ancestor
65673062|NCT03148860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673063|NCT03148860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65673064|NCT03148860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65673065|NCT03148860|Immunologic Factors|immunologic factors|mesh-ancestor
65673066|NCT03148860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65673067|NCT03148860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65673068|NCT03131154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65673069|NCT03131154|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65673070|NCT02232672|Choline|choline|mesh-list
65673071|NCT02232672|Lipotropic Agents|lipotropic agents|mesh-ancestor
65673072|NCT02232672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65673073|NCT02232672|Antimetabolites|antimetabolites|mesh-ancestor
65673074|NCT02232672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673075|NCT02232672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65673076|NCT02232672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65673077|NCT02232672|Nootropic Agents|nootropic agents|mesh-ancestor
65673078|NCT05072262|Dexamethasone|dexamethasone|mesh-list
65673079|NCT05072262|Nepafenac|nepafenac|mesh-list
65673080|NCT05072262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65673081|NCT05072262|Antiemetics|antiemetics|mesh-ancestor
65673082|NCT05072262|Autonomic Agents|autonomic agents|mesh-ancestor
65673083|NCT05072262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65673084|NCT05072262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673085|NCT05072262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65673086|NCT05072262|Glucocorticoids|glucocorticoids|mesh-ancestor
65673087|NCT05072262|Hormones|hormones|mesh-ancestor
65673088|NCT05072262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65673089|NCT05072262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65673090|NCT05072262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673091|NCT05072262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65673092|NCT05072262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65470410|NCT01049633|Valganciclovir|valganciclovir|mesh-list
65673094|NCT05072262|Sensory System Agents|sensory system agents|mesh-ancestor
65673095|NCT05072262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65673096|NCT04858048|Anesthetics|anesthetics|mesh-list
65673097|NCT04858048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65673098|NCT04858048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673099|NCT02234466|Dexamethasone|dexamethasone|mesh-list
65673100|NCT02234466|Ondansetron|ondansetron|mesh-list
65673101|NCT02234466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65673102|NCT02234466|Antiemetics|antiemetics|mesh-ancestor
65673103|NCT02234466|Autonomic Agents|autonomic agents|mesh-ancestor
65673104|NCT02234466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65673105|NCT02234466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673106|NCT02234466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65673107|NCT02234466|Glucocorticoids|glucocorticoids|mesh-ancestor
65673108|NCT02234466|Hormones|hormones|mesh-ancestor
65673109|NCT02234466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65673110|NCT02234466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65673111|NCT02234466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673112|NCT02234466|Antipruritics|antipruritics|mesh-ancestor
65673113|NCT02234466|Dermatologic Agents|dermatologic agents|mesh-ancestor
65673114|NCT02234466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65673115|NCT02234466|Serotonin Agents|serotonin agents|mesh-ancestor
65673116|NCT02234466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65673117|NCT02234466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673118|NCT02234466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65673119|NCT02234466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65673120|NCT02234466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65673121|NCT02234466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65673122|NCT02234466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65673123|NCT02230800|Tocovid|tocovid|mesh-list
65673124|NCT02230800|Pentoxifylline|pentoxifylline|mesh-list
65673125|NCT02230800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65673126|NCT02230800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673127|NCT02230800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673128|NCT02230800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65673129|NCT02230800|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65673130|NCT02230800|Protective Agents|protective agents|mesh-ancestor
65673131|NCT02230800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673132|NCT02230800|Vasodilator Agents|vasodilator agents|mesh-ancestor
65673133|NCT02230800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65673134|NCT02230800|Antioxidants|antioxidants|mesh-ancestor
65673135|NCT02230800|Vitamins|vitamins|mesh-ancestor
65673136|NCT02230800|Micronutrients|micronutrients|mesh-ancestor
65673137|NCT02234544|Vitamin D|vitamin d|mesh-list
65673138|NCT02234544|Cholecalciferol|cholecalciferol|mesh-list
65673139|NCT02234544|Ezetimibe|ezetimibe|mesh-list
65673140|NCT02234544|Vitamins|vitamins|mesh-ancestor
65673141|NCT02234544|Micronutrients|micronutrients|mesh-ancestor
65673142|NCT02234544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673143|NCT02234544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65673144|NCT02234544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65673145|NCT02234544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65673146|NCT02234544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65673147|NCT02234544|Antimetabolites|antimetabolites|mesh-ancestor
65673148|NCT02234544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673149|NCT02234544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65673150|NCT03043066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65673151|NCT03043066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65673152|NCT03043066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65673153|NCT03043066|Antitubercular Agents|antitubercular agents|mesh-ancestor
65673154|NCT04860076|Pembrolizumab|pembrolizumab|mesh-list
65673155|NCT04860076|Nivolumab|nivolumab|mesh-list
65673156|NCT04860076|Ipilimumab|ipilimumab|mesh-list
65673157|NCT04860076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65673158|NCT04860076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673159|NCT04860076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65673160|NCT04860076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673161|NCT04856878|Vancomycin|vancomycin|mesh-list
65673162|NCT04856878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65673163|NCT04856878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65673164|NCT04856644|Moxifloxacin|moxifloxacin|mesh-list
65673165|NCT04856644|Rifapentine|rifapentine|mesh-list
65673166|NCT04856644|Rifampin|rifampin|mesh-list
65673167|NCT04856644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65673168|NCT04856644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65673169|NCT04856644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65673170|NCT04856644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65673171|NCT04856644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673172|NCT04856644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673173|NCT04856644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673174|NCT04856644|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65673175|NCT04856644|Antitubercular Agents|antitubercular agents|mesh-ancestor
65673176|NCT04856644|Leprostatic Agents|leprostatic agents|mesh-ancestor
65673177|NCT04856644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65673178|NCT04856644|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65673179|NCT04856644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65673180|NCT04856644|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65673181|NCT04856644|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65673182|NCT04856644|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65673183|NCT04856644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65673184|NCT01329978|Sofosbuvir|sofosbuvir|mesh-list
65673185|NCT01329978|Antiviral Agents|antiviral agents|mesh-ancestor
65673186|NCT01329978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65673187|NCT04984278|Nabiximols|nabiximols|mesh-list
65673188|NCT04984278|Analgesics|analgesics|mesh-ancestor
65673189|NCT04984278|Sensory System Agents|sensory system agents|mesh-ancestor
65673190|NCT04984278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65673191|NCT04984278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673192|NCT02233218|Amlodipine|amlodipine|mesh-list
65673193|NCT02233218|Telmisartan|telmisartan|mesh-list
65673194|NCT02233218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65673195|NCT02233218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65673196|NCT02233218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65673197|NCT02233218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65673198|NCT02233218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673199|NCT02233218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65673200|NCT02233218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673201|NCT02233218|Vasodilator Agents|vasodilator agents|mesh-ancestor
65673202|NCT02233218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65673203|NCT02233218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65673204|NCT02233218|Antimetabolites|antimetabolites|mesh-ancestor
65673205|NCT02233218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65673206|NCT02233218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65673207|NCT02233218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673208|NCT02233218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65673209|NCT02233218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65673210|NCT02262546|Moxifloxacin|moxifloxacin|mesh-list
65673211|NCT02262546|Pramipexole|pramipexole|mesh-list
65673212|NCT02262546|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65673213|NCT02262546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65673214|NCT02262546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65673215|NCT02262546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65673216|NCT02262546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65673217|NCT02262546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673218|NCT02262546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673219|NCT02262546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673220|NCT02262546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65673221|NCT02262546|Contraceptive Agents|contraceptive agents|mesh-ancestor
65673222|NCT02262546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65673223|NCT02262546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673224|NCT02262546|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65673225|NCT02262546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65673226|NCT02262546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65673227|NCT02262546|Antioxidants|antioxidants|mesh-ancestor
65673228|NCT02262546|Protective Agents|protective agents|mesh-ancestor
65673229|NCT02262546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65673230|NCT02262546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65673231|NCT02262546|Dopamine Agonists|dopamine agonists|mesh-ancestor
65673232|NCT02262546|Dopamine Agents|dopamine agents|mesh-ancestor
65673233|NCT02262546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65673234|NCT04859530|Lugol's solution|lugol's solution|mesh-list
65673235|NCT04859530|Hemostatics|hemostatics|mesh-ancestor
65673236|NCT04859530|Coagulants|coagulants|mesh-ancestor
65673237|NCT03042052|Botulinum Toxins|botulinum toxins|mesh-list
65673238|NCT03042052|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65673239|NCT03042052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65673240|NCT03042052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673241|NCT03042052|Cholinergic Agents|cholinergic agents|mesh-ancestor
65673242|NCT03042052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65673243|NCT03042052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673244|NCT04856098|Glycopyrrolate|glycopyrrolate|mesh-list
65673245|NCT04856098|Bromides|bromides|mesh-list
65673246|NCT04856098|Maleic acid|maleic acid|mesh-list
65673247|NCT04856098|Charcoal|charcoal|mesh-list
65673248|NCT04856098|Anticonvulsants|anticonvulsants|mesh-ancestor
65673249|NCT04856098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673250|NCT04856098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673251|NCT04856098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65673252|NCT04856098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65673253|NCT04856098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65673254|NCT04856098|Cholinergic Agents|cholinergic agents|mesh-ancestor
65673255|NCT04856098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65673256|NCT04856098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673257|NCT04856098|Antidotes|antidotes|mesh-ancestor
65673258|NCT04856098|Protective Agents|protective agents|mesh-ancestor
65673259|NCT04859452|Metformin|metformin|mesh-list
65673260|NCT04859452|Glyburide|glyburide|mesh-list
65673261|NCT04859452|Valsartan|valsartan|mesh-list
65673262|NCT04859452|Simvastatin|simvastatin|mesh-list
65673263|NCT04859452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65673264|NCT04859452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673265|NCT04859452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65673266|NCT04859452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65673267|NCT04859452|Antimetabolites|antimetabolites|mesh-ancestor
65673268|NCT04859452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673269|NCT04859452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65673270|NCT04859452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65673271|NCT04859452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673272|NCT04859452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65673273|NCT04859452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65673274|NCT04859452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65673275|NCT02262624|Telmisartan|telmisartan|mesh-list
65673276|NCT02262624|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65673277|NCT02262624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65673278|NCT02262624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65673279|NCT02262624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65673280|NCT02262624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673281|NCT02262624|Diuretics|diuretics|mesh-ancestor
65673282|NCT02262624|Natriuretic Agents|natriuretic agents|mesh-ancestor
65673283|NCT02262624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673284|NCT02262624|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65673285|NCT02262624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65673286|NCT02233452|Ketamine|ketamine|mesh-list
65673287|NCT02233452|Methadone|methadone|mesh-list
65673288|NCT02233452|Analgesics|analgesics|mesh-ancestor
65673289|NCT02233452|Sensory System Agents|sensory system agents|mesh-ancestor
65673290|NCT02233452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65673291|NCT02233452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673292|NCT02233452|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65673293|NCT02233452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65673294|NCT02233452|Anesthetics, General|anesthetics, general|mesh-ancestor
65673295|NCT02233452|Anesthetics|anesthetics|mesh-ancestor
65673296|NCT02233452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65673297|NCT02233452|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65673298|NCT02233452|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65673299|NCT02233452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65673300|NCT02233452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673301|NCT02233452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65673302|NCT02233452|Narcotics|narcotics|mesh-ancestor
65673303|NCT02233452|Antitussive Agents|antitussive agents|mesh-ancestor
65673304|NCT02233452|Respiratory System Agents|respiratory system agents|mesh-ancestor
65673305|NCT02262702|Acetaminophen|acetaminophen|mesh-list
65673306|NCT02262702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65673307|NCT02262702|Analgesics|analgesics|mesh-ancestor
65673308|NCT02262702|Sensory System Agents|sensory system agents|mesh-ancestor
65673309|NCT02262702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65673310|NCT02262702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673311|NCT02262702|Antipyretics|antipyretics|mesh-ancestor
65673312|NCT04846894|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65673313|NCT04846894|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65673314|NCT04846894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673315|NCT03038776|Hemagglutinins|hemagglutinins|mesh-list
65673316|NCT03038776|Agglutinins|agglutinins|mesh-ancestor
65673317|NCT03038776|Immunologic Factors|immunologic factors|mesh-ancestor
65673318|NCT03038776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673320|NCT04648020|Analgesics|analgesics|mesh-ancestor
65673321|NCT04648020|Sensory System Agents|sensory system agents|mesh-ancestor
65673322|NCT04648020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65673323|NCT04648020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673324|NCT04648020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65673325|NCT04648020|Sympatholytics|sympatholytics|mesh-ancestor
65673326|NCT04648020|Autonomic Agents|autonomic agents|mesh-ancestor
65673327|NCT04648020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65673328|NCT04648020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65673329|NCT04648020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65673330|NCT04648020|Adrenergic Agents|adrenergic agents|mesh-ancestor
65673331|NCT04648020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65673332|NCT04648020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673333|NCT04845880|Myeloma Proteins|myeloma proteins|mesh-list
65673334|NCT04845880|Paraproteins|paraproteins|mesh-list
65673335|NCT04845880|Immunologic Factors|immunologic factors|mesh-ancestor
65673336|NCT04845880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673337|NCT04600752|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65673338|NCT04600752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65673339|NCT04600752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65673340|NCT04600752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65673341|NCT04600752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673342|NCT04600752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673343|NCT03041506|Lidocaine|lidocaine|mesh-list
65673344|NCT03041506|Midazolam|midazolam|mesh-list
65673345|NCT03041506|Ketamine|ketamine|mesh-list
65673346|NCT03041506|Anesthetics, Local|anesthetics, local|mesh-ancestor
65673347|NCT03041506|Anesthetics|anesthetics|mesh-ancestor
65673348|NCT03041506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65673349|NCT03041506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673350|NCT03041506|Sensory System Agents|sensory system agents|mesh-ancestor
65673351|NCT03041506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65673352|NCT03041506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65673353|NCT03041506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65673354|NCT03041506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65673355|NCT03041506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65673356|NCT03041506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673357|NCT03041506|Analgesics|analgesics|mesh-ancestor
65673358|NCT03041506|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65673359|NCT03041506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65673360|NCT03041506|Anesthetics, General|anesthetics, general|mesh-ancestor
65673361|NCT03041506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65673362|NCT03041506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65673363|NCT03041506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65673364|NCT03041506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65673365|NCT03041506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65673366|NCT03041506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65673367|NCT03041506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65673368|NCT03041506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65673369|NCT03041506|GABA Modulators|gaba modulators|mesh-ancestor
65673370|NCT03041506|GABA Agents|gaba agents|mesh-ancestor
65673371|NCT02580708|Trametinib|trametinib|mesh-list
65673372|NCT02580708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673373|NCT02580708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65673374|NCT02580708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673375|NCT02580708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673376|NCT02262780|Telmisartan|telmisartan|mesh-list
65673377|NCT02262780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65673378|NCT02262780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65673379|NCT02262780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65673380|NCT02262780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673381|NCT04845646|Itraconazole|itraconazole|mesh-list
65673382|NCT04845646|Phenytoin|phenytoin|mesh-list
65673383|NCT04845646|Antifungal Agents|antifungal agents|mesh-ancestor
65673384|NCT04845646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65673385|NCT04845646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65673386|NCT04845646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65673387|NCT04845646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673388|NCT04845646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673389|NCT04845646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65673390|NCT04845646|Hormone Antagonists|hormone antagonists|mesh-ancestor
65673391|NCT04845646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65673392|NCT04845646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673393|NCT04845646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65673394|NCT04845646|Anticonvulsants|anticonvulsants|mesh-ancestor
65673395|NCT04845646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65673396|NCT04845646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65673397|NCT04845646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65673398|NCT04845646|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65673399|NCT04845646|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65673400|NCT02570490|Linezolid|linezolid|mesh-list
65673401|NCT02570490|Fusidic Acid|fusidic acid|mesh-list
65673402|NCT02570490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65673403|NCT02570490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65673404|NCT02570490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65673405|NCT02570490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673406|NCT02570490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673407|NCT02565732|Botulinum Toxins|botulinum toxins|mesh-list
65673408|NCT02565732|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65673409|NCT02565732|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65673410|NCT02565732|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65673411|NCT02565732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65673412|NCT02565732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673413|NCT02565732|Cholinergic Agents|cholinergic agents|mesh-ancestor
65673414|NCT02565732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65673415|NCT02565732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673416|NCT02565732|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65673417|NCT02565732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65673418|NCT02561442|Ceftriaxone|ceftriaxone|mesh-list
65673419|NCT02561442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65673420|NCT02561442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65673421|NCT02262858|Telmisartan|telmisartan|mesh-list
65673422|NCT02262858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65673423|NCT02262858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65673424|NCT02262858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65673425|NCT02262858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65673426|NCT02262858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673427|NCT02262858|Diuretics|diuretics|mesh-ancestor
65673428|NCT02262858|Natriuretic Agents|natriuretic agents|mesh-ancestor
65673429|NCT02262858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673430|NCT02262858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65673431|NCT02262858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65673432|NCT02235012|Ketamine|ketamine|mesh-list
65673433|NCT02235012|Analgesics|analgesics|mesh-ancestor
65673434|NCT02235012|Sensory System Agents|sensory system agents|mesh-ancestor
65673435|NCT02235012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65673436|NCT02235012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673437|NCT02235012|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65673438|NCT02235012|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65673439|NCT02235012|Anesthetics, General|anesthetics, general|mesh-ancestor
65673440|NCT02235012|Anesthetics|anesthetics|mesh-ancestor
65673441|NCT02235012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65673442|NCT02235012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65673443|NCT02235012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65673444|NCT02235012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65673445|NCT02235012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673446|NCT02262936|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65673447|NCT02262936|Fesoterodine|fesoterodine|mesh-list
65673448|NCT02262936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65673449|NCT02262936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65673450|NCT02262936|Cholinergic Agents|cholinergic agents|mesh-ancestor
65673451|NCT02262936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65673452|NCT02262936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673453|NCT02262936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673454|NCT02262936|Urological Agents|urological agents|mesh-ancestor
65673455|NCT02262936|Hemostatics|hemostatics|mesh-ancestor
65673456|NCT02262936|Coagulants|coagulants|mesh-ancestor
65673457|NCT02262936|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65673458|NCT02262936|Natriuretic Agents|natriuretic agents|mesh-ancestor
65673459|NCT04838704|Mycophenolic Acid|mycophenolic acid|mesh-list
65673460|NCT04838704|Methotrexate|methotrexate|mesh-list
65673461|NCT04838704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65673462|NCT04838704|Abortifacient Agents|abortifacient agents|mesh-ancestor
65673463|NCT04838704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65673464|NCT04838704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673465|NCT04838704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65673466|NCT04838704|Antimetabolites|antimetabolites|mesh-ancestor
65673467|NCT04838704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673468|NCT04838704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673469|NCT04838704|Dermatologic Agents|dermatologic agents|mesh-ancestor
65673470|NCT04838704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673471|NCT04838704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65673472|NCT04838704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65673473|NCT04838704|Immunologic Factors|immunologic factors|mesh-ancestor
65673474|NCT04838704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65673475|NCT04838704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65673476|NCT04838704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65673477|NCT04838704|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65673478|NCT04838704|Antitubercular Agents|antitubercular agents|mesh-ancestor
65673479|NCT04838704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65673480|NCT04838704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65673481|NCT02259738|Kallikreins|kallikreins|mesh-list
65673482|NCT02259738|Coagulants|coagulants|mesh-ancestor
65673483|NCT02259738|Fertility Agents, Male|fertility agents, male|mesh-ancestor
65673484|NCT02259738|Fertility Agents|fertility agents|mesh-ancestor
65673485|NCT02259738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65673486|NCT02259738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673487|NCT04854460|Ivermectin|ivermectin|mesh-list
65673488|NCT04854460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65673489|NCT04854460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65673490|NCT04854538|Budesonide|budesonide|mesh-list
65673491|NCT04854538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65673492|NCT04854538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65673493|NCT04854538|Autonomic Agents|autonomic agents|mesh-ancestor
65673494|NCT04854538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65673495|NCT04854538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673496|NCT04854538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65673497|NCT04854538|Respiratory System Agents|respiratory system agents|mesh-ancestor
65673498|NCT04854538|Glucocorticoids|glucocorticoids|mesh-ancestor
65673499|NCT04854538|Hormones|hormones|mesh-ancestor
65673500|NCT04854538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65673501|NCT05331690|Dexamethasone|dexamethasone|mesh-list
65673502|NCT05331690|Nepafenac|nepafenac|mesh-list
65673503|NCT05331690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65673504|NCT05331690|Antiemetics|antiemetics|mesh-ancestor
65673505|NCT05331690|Autonomic Agents|autonomic agents|mesh-ancestor
65673506|NCT05331690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65673507|NCT05331690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673508|NCT05331690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65673509|NCT05331690|Glucocorticoids|glucocorticoids|mesh-ancestor
65673510|NCT05331690|Hormones|hormones|mesh-ancestor
65673511|NCT05331690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65673512|NCT05331690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65673513|NCT05331690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673514|NCT05331690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65673515|NCT05331690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65673516|NCT05331690|Analgesics|analgesics|mesh-ancestor
65673517|NCT05331690|Sensory System Agents|sensory system agents|mesh-ancestor
65673518|NCT05331690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65673519|NCT04373668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65673520|NCT04373668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65673521|NCT04373668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673522|NCT02263170|Phenobarbital|phenobarbital|mesh-list
65673523|NCT02263170|Anticonvulsants|anticonvulsants|mesh-ancestor
65673524|NCT02263170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65673525|NCT02263170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65673526|NCT02263170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673527|NCT02263170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65673528|NCT02263170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65673529|NCT02263170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65673530|NCT02263170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673531|NCT02263170|GABA Modulators|gaba modulators|mesh-ancestor
65673532|NCT02263170|GABA Agents|gaba agents|mesh-ancestor
65673533|NCT02263170|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65673534|NCT02263170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65673535|NCT02263170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65673536|NCT05252988|Loperamide|loperamide|mesh-list
65673537|NCT05252988|Antidiarrheals|antidiarrheals|mesh-list
65673538|NCT05252988|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65673539|NCT05252988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65673540|NCT05252988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65673541|NCT05252988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65673542|NCT05252988|Antimetabolites|antimetabolites|mesh-ancestor
65673543|NCT05252988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673544|NCT05252988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65673545|NCT03038230|Antibodies|antibodies|mesh-list
65673546|NCT03038230|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65673547|NCT03038230|Immunologic Factors|immunologic factors|mesh-ancestor
65673548|NCT03038230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673549|NCT04853758|Valsartan|valsartan|mesh-list
65673550|NCT04853758|Enalapril|enalapril|mesh-list
65673551|NCT04853758|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65673552|NCT04853758|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65673553|NCT04853758|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65673554|NCT04853758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65673555|NCT04853758|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65673556|NCT04853758|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65673557|NCT04853758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673558|NCT04853758|Protease Inhibitors|protease inhibitors|mesh-ancestor
65673559|NCT02784288|Paclitaxel|paclitaxel|mesh-list
65673560|NCT02784288|Carboplatin|carboplatin|mesh-list
65673561|NCT02784288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65673562|NCT02784288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673563|NCT02784288|Tubulin Modulators|tubulin modulators|mesh-ancestor
65673564|NCT02784288|Antimitotic Agents|antimitotic agents|mesh-ancestor
65673565|NCT02784288|Mitosis Modulators|mitosis modulators|mesh-ancestor
65673566|NCT02784288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673567|NCT03040180|Bleomycin|bleomycin|mesh-list
65673568|NCT03040180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65673569|NCT03040180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673570|NCT02235246|Magnesium Sulfate|magnesium sulfate|mesh-list
65673571|NCT02235246|Analgesics|analgesics|mesh-ancestor
65673572|NCT02235246|Sensory System Agents|sensory system agents|mesh-ancestor
65673573|NCT02235246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65673574|NCT02235246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673575|NCT02235246|Anesthetics|anesthetics|mesh-ancestor
65673576|NCT02235246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65673577|NCT02235246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65673578|NCT02235246|Anticonvulsants|anticonvulsants|mesh-ancestor
65673579|NCT02235246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65673580|NCT02235246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65673581|NCT02235246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673582|NCT02235246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65673583|NCT02235246|Tocolytic Agents|tocolytic agents|mesh-ancestor
65673584|NCT02235246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65673585|NCT02235324|Leucovorin|leucovorin|mesh-list
65673586|NCT02235324|Fluorouracil|fluorouracil|mesh-list
65673587|NCT02235324|Aflibercept|aflibercept|mesh-list
65673588|NCT02235324|Calcium|calcium|mesh-list
65673589|NCT02235324|Levoleucovorin|levoleucovorin|mesh-list
65673590|NCT02235324|Endothelial Growth Factors|endothelial growth factors|mesh-list
65673591|NCT02235324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65673592|NCT02235324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673593|NCT02235324|Antimetabolites|antimetabolites|mesh-ancestor
65673594|NCT02235324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673595|NCT02235324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65673596|NCT02235324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673597|NCT02235324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65673598|NCT02235324|Immunologic Factors|immunologic factors|mesh-ancestor
65673599|NCT02235324|Antidotes|antidotes|mesh-ancestor
65673600|NCT02235324|Protective Agents|protective agents|mesh-ancestor
65673601|NCT02235324|Vitamin B Complex|vitamin b complex|mesh-ancestor
65673602|NCT02235324|Vitamins|vitamins|mesh-ancestor
65673603|NCT02235324|Micronutrients|micronutrients|mesh-ancestor
65673604|NCT02235324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65673605|NCT02235324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65673606|NCT02235324|Growth Substances|growth substances|mesh-ancestor
65673607|NCT02235324|Growth Inhibitors|growth inhibitors|mesh-ancestor
65673608|NCT01230242|Levonorgestrel|levonorgestrel|mesh-list
65673609|NCT01230242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65673610|NCT01230242|Contraceptive Agents|contraceptive agents|mesh-ancestor
65673611|NCT01230242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65673612|NCT01230242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673613|NCT01230242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65673614|NCT01230242|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65673615|NCT01230242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65673617|NCT02263248|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65673618|NCT02263248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65673619|NCT02263248|Narcotics|narcotics|mesh-ancestor
65673620|NCT02263248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65673621|NCT02263248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673622|NCT02263248|Analgesics|analgesics|mesh-ancestor
65673623|NCT02263248|Sensory System Agents|sensory system agents|mesh-ancestor
65673624|NCT02263248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65673625|NCT02263248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65673626|NCT02263248|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65673627|NCT02263248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65673628|NCT02263248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65673629|NCT02263248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673630|NCT02263248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65673631|NCT02263248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65673632|NCT02263248|Antidepressive Agents|antidepressive agents|mesh-ancestor
65673633|NCT02263248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65673634|NCT04838860|Siltuximab|siltuximab|mesh-list
65673635|NCT04838860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673636|NCT05389514|Gemcitabine|gemcitabine|mesh-list
65673637|NCT05389514|Cyclophosphamide|cyclophosphamide|mesh-list
65673638|NCT05389514|Pembrolizumab|pembrolizumab|mesh-list
65673639|NCT05389514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65673640|NCT05389514|Immunologic Factors|immunologic factors|mesh-ancestor
65673641|NCT05389514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673642|NCT05389514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65673643|NCT05389514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65673644|NCT05389514|Alkylating Agents|alkylating agents|mesh-ancestor
65673645|NCT05389514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673646|NCT05389514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673647|NCT05389514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65673648|NCT05389514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65673649|NCT05389514|Antimetabolites|antimetabolites|mesh-ancestor
65673650|NCT05389514|Antiviral Agents|antiviral agents|mesh-ancestor
65673651|NCT05389514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65673652|NCT05389514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673653|NCT05389514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65673654|NCT04853524|Tenofovir|tenofovir|mesh-list
65673655|NCT04853524|Emtricitabine|emtricitabine|mesh-list
65673656|NCT04853524|JNJ-56136379|jnj-56136379|mesh-list
65673657|NCT04853524|Antiviral Agents|antiviral agents|mesh-ancestor
65673658|NCT04853524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65673659|NCT04853524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65673660|NCT04853524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65673661|NCT04853524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673662|NCT04853524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673663|NCT04853524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65673664|NCT04853524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65673665|NCT04852510|Metformin|metformin|mesh-list
65673666|NCT04852510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65673667|NCT04852510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673668|NCT05163704|Dexmedetomidine|dexmedetomidine|mesh-list
65673669|NCT05163704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65673670|NCT05163704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65673671|NCT05163704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673672|NCT05163704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65673673|NCT05163704|Analgesics|analgesics|mesh-ancestor
65673674|NCT05163704|Sensory System Agents|sensory system agents|mesh-ancestor
65673675|NCT05163704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65673676|NCT05163704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65673677|NCT05163704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65673678|NCT05163704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65673679|NCT05163704|Adrenergic Agents|adrenergic agents|mesh-ancestor
65673680|NCT05163704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65673681|NCT05163704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673682|NCT03130556|Rabeprazole|rabeprazole|mesh-list
65673683|NCT03130556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65673684|NCT03130556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65673685|NCT03130556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65673686|NCT03130556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673687|NCT03130556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673688|NCT04838080|Vaccines|vaccines|mesh-list
65673689|NCT04838080|Immunologic Factors|immunologic factors|mesh-ancestor
65673690|NCT04838080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673691|NCT04842838|Paclitaxel|paclitaxel|mesh-list
65673692|NCT04842838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65673693|NCT04842838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673694|NCT04842838|Tubulin Modulators|tubulin modulators|mesh-ancestor
65673695|NCT04842838|Antimitotic Agents|antimitotic agents|mesh-ancestor
65673696|NCT04842838|Mitosis Modulators|mitosis modulators|mesh-ancestor
65673697|NCT04842838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673698|NCT03037606|Rabeprazole|rabeprazole|mesh-list
65673699|NCT03037606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65673700|NCT03037606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65673701|NCT03037606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65673702|NCT03037606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673703|NCT03037606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673704|NCT03037372|Atorvastatin|atorvastatin|mesh-list
65673705|NCT03037372|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65673706|NCT03037372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65673707|NCT03037372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65673708|NCT03037372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65673709|NCT03037372|Antimetabolites|antimetabolites|mesh-ancestor
65673710|NCT03037372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673711|NCT03037372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65673712|NCT03037372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673713|NCT04842526|Irinotecan|irinotecan|mesh-list
65673714|NCT04842526|Temozolomide|temozolomide|mesh-list
65673715|NCT04842526|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65673716|NCT04842526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65673717|NCT04842526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673718|NCT04842526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673719|NCT04842526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673720|NCT04842526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65673721|NCT04842526|Alkylating Agents|alkylating agents|mesh-ancestor
65673722|NCT04850950|Tenofovir|tenofovir|mesh-list
65673723|NCT04850950|Antiviral Agents|antiviral agents|mesh-ancestor
65673724|NCT04850950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65673725|NCT04850950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65673726|NCT04850950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65673727|NCT04850950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673728|NCT04850950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673729|NCT04850950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65673730|NCT04850950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65673731|NCT04841980|Rifaximin|rifaximin|mesh-list
65673732|NCT04841980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65673733|NCT04841980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65673734|NCT04841980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65673735|NCT05307770|Melatonin|melatonin|mesh-list
65673736|NCT05307770|Antioxidants|antioxidants|mesh-ancestor
65673737|NCT05307770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673738|NCT05307770|Protective Agents|protective agents|mesh-ancestor
65673739|NCT05307770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673740|NCT05307770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65673741|NCT05164952|Zoledronic Acid|zoledronic acid|mesh-list
65673742|NCT05164952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65673743|NCT05164952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673744|NCT04850560|Decitabine|decitabine|mesh-list
65673745|NCT04850560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65673746|NCT04850560|Antimetabolites|antimetabolites|mesh-ancestor
65673747|NCT04850560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673748|NCT04850560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673749|NCT04850560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673750|NCT04850404|Ropivacaine|ropivacaine|mesh-list
65673751|NCT04850404|Rocuronium|rocuronium|mesh-list
65673752|NCT04850404|Anesthetics, Local|anesthetics, local|mesh-ancestor
65673753|NCT04850404|Anesthetics|anesthetics|mesh-ancestor
65673754|NCT04850404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65673755|NCT04850404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673756|NCT04850404|Sensory System Agents|sensory system agents|mesh-ancestor
65673757|NCT04850404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65673758|NCT04850404|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65673759|NCT04850404|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65673760|NCT04850404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65673761|NCT04428814|Ustekinumab|ustekinumab|mesh-list
65471081|NCT03957174|Rivastigmine|rivastigmine|mesh-list
65673762|NCT04428814|Dermatologic Agents|dermatologic agents|mesh-ancestor
65673763|NCT03036514|Sufentanil|sufentanil|mesh-list
65673764|NCT03036514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65673765|NCT03036514|Narcotics|narcotics|mesh-ancestor
65673766|NCT03036514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65673767|NCT03036514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673768|NCT03036514|Analgesics|analgesics|mesh-ancestor
65673769|NCT03036514|Sensory System Agents|sensory system agents|mesh-ancestor
65673770|NCT03036514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65673771|NCT03036514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65673772|NCT03036514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65673773|NCT03036514|Anesthetics, General|anesthetics, general|mesh-ancestor
65673774|NCT03036514|Anesthetics|anesthetics|mesh-ancestor
65673775|NCT04835896|Paclitaxel|paclitaxel|mesh-list
65673776|NCT04835896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65673777|NCT04835896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673778|NCT04835896|Tubulin Modulators|tubulin modulators|mesh-ancestor
65673779|NCT04835896|Antimitotic Agents|antimitotic agents|mesh-ancestor
65673780|NCT04835896|Mitosis Modulators|mitosis modulators|mesh-ancestor
65673781|NCT04835896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673782|NCT01668004|Golimumab|golimumab|mesh-list
65673783|NCT01668004|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65673784|NCT01668004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65673785|NCT01668004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65673786|NCT01668004|Immunologic Factors|immunologic factors|mesh-ancestor
65673787|NCT01668004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673788|NCT04835350|Pancrelipase|pancrelipase|mesh-list
65673789|NCT04835350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65673790|NCT01667926|Ketamine|ketamine|mesh-list
65673791|NCT01667926|Analgesics|analgesics|mesh-ancestor
65673792|NCT01667926|Sensory System Agents|sensory system agents|mesh-ancestor
65673793|NCT01667926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65673794|NCT01667926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673795|NCT01667926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65673796|NCT01667926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65673797|NCT01667926|Anesthetics, General|anesthetics, general|mesh-ancestor
65673798|NCT01667926|Anesthetics|anesthetics|mesh-ancestor
65673799|NCT01667926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65673800|NCT01667926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65673801|NCT01667926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65673802|NCT01667926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65673803|NCT01667926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673804|NCT03039478|Erythritol|erythritol|mesh-list
65673805|NCT03039478|Vasodilator Agents|vasodilator agents|mesh-ancestor
65673806|NCT04832776|Bevacizumab|bevacizumab|mesh-list
65673807|NCT04832776|Cetuximab|cetuximab|mesh-list
65673808|NCT04832776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65673809|NCT04832776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673810|NCT04832776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65673811|NCT04832776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65673812|NCT04832776|Growth Substances|growth substances|mesh-ancestor
65673813|NCT04832776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673814|NCT04832776|Growth Inhibitors|growth inhibitors|mesh-ancestor
65673815|NCT04835116|Acetaminophen|acetaminophen|mesh-list
65673816|NCT04835116|Tramadol|tramadol|mesh-list
65673817|NCT04835116|Analgesics|analgesics|mesh-list
65673818|NCT04835116|Orphenadrine|orphenadrine|mesh-list
65673819|NCT04835116|Dimenhydrinate|dimenhydrinate|mesh-list
65673820|NCT04835116|Bupivacaine|bupivacaine|mesh-list
65673821|NCT04835116|Anesthetics, Local|anesthetics, local|mesh-ancestor
65673822|NCT04835116|Anesthetics|anesthetics|mesh-ancestor
65673823|NCT04835116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65673824|NCT04835116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673825|NCT04835116|Sensory System Agents|sensory system agents|mesh-ancestor
65673826|NCT04835116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65673827|NCT04835116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65673828|NCT04835116|Antipyretics|antipyretics|mesh-ancestor
65673829|NCT04835116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65673830|NCT04835116|Narcotics|narcotics|mesh-ancestor
65673831|NCT04835116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65673832|NCT04835116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65673833|NCT04835116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65673834|NCT04835116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65673835|NCT04835116|Parasympatholytics|parasympatholytics|mesh-ancestor
65673836|NCT04835116|Autonomic Agents|autonomic agents|mesh-ancestor
65673837|NCT04835116|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65673838|NCT04835116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65673839|NCT04835116|Cholinergic Agents|cholinergic agents|mesh-ancestor
65673840|NCT04835116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65673841|NCT04835116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673842|NCT04835116|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
65673843|NCT04835116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65673844|NCT04835116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673846|NCT04835116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65673847|NCT04835116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65673848|NCT04835116|Histamine Antagonists|histamine antagonists|mesh-ancestor
65673849|NCT04835116|Histamine Agents|histamine agents|mesh-ancestor
65673850|NCT03036826|Meropenem|meropenem|mesh-list
65673851|NCT03036826|Tazobactam|tazobactam|mesh-list
65673852|NCT03036826|Piperacillin|piperacillin|mesh-list
65673853|NCT03036826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65673854|NCT03036826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65673855|NCT03036826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65673856|NCT03036826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65673857|NCT03036826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673858|NCT03036826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673859|NCT03036046|Fluconazole|fluconazole|mesh-list
65673860|NCT03036046|Posaconazole|posaconazole|mesh-list
65673861|NCT03036046|Olorofim|olorofim|mesh-list
65673862|NCT03036046|Antifungal Agents|antifungal agents|mesh-ancestor
65673863|NCT03036046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65673864|NCT03036046|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65673865|NCT03036046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65673866|NCT03036046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673867|NCT03036046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673868|NCT03036046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65673869|NCT03036046|Hormone Antagonists|hormone antagonists|mesh-ancestor
65673870|NCT03036046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65673871|NCT03036046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673872|NCT03036046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65673873|NCT03036046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65673874|NCT03036046|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65673875|NCT03036046|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65673876|NCT03036046|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65673877|NCT04831528|Bevacizumab|bevacizumab|mesh-list
65673878|NCT04831528|Trastuzumab|trastuzumab|mesh-list
65673879|NCT04831528|Cetuximab|cetuximab|mesh-list
65673880|NCT04831528|Pertuzumab|pertuzumab|mesh-list
65673881|NCT04831528|Lapatinib|lapatinib|mesh-list
65673882|NCT04831528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65673883|NCT04831528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673884|NCT04831528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65673885|NCT04831528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65673886|NCT04831528|Growth Substances|growth substances|mesh-ancestor
65673887|NCT04831528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673888|NCT04831528|Growth Inhibitors|growth inhibitors|mesh-ancestor
65673889|NCT04831528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65673890|NCT04831528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673891|NCT04831528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673892|NCT04824586|Insulin|insulin|mesh-list
65673893|NCT04824586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65673894|NCT04824586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65673895|NCT04824586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673896|NCT04824898|Simvastatin|simvastatin|mesh-list
65673897|NCT04824898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65673898|NCT04824898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65673899|NCT04824898|Antimetabolites|antimetabolites|mesh-ancestor
65673900|NCT04824898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673901|NCT04824898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65673902|NCT04824898|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65673903|NCT04824898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673904|NCT04824352|Apatinib|apatinib|mesh-list
65673905|NCT04824352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673906|NCT04824352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65673907|NCT04824352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673908|NCT04824352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673909|NCT04319614|Tranexamic Acid|tranexamic acid|mesh-list
65673910|NCT04319614|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65673911|NCT04319614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65673912|NCT04319614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673913|NCT04319614|Hemostatics|hemostatics|mesh-ancestor
65673914|NCT04319614|Coagulants|coagulants|mesh-ancestor
65673915|NCT01359904|Dialysis Solutions|dialysis solutions|mesh-list
65673916|NCT01359904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65673917|NCT04823260|Niacinamide|niacinamide|mesh-list
65673918|NCT04823260|Niacin|niacin|mesh-list
65673919|NCT04823260|Nicotinic Acids|nicotinic acids|mesh-list
65673920|NCT04823260|Vitamin B Complex|vitamin b complex|mesh-ancestor
65673921|NCT04823260|Vitamins|vitamins|mesh-ancestor
65673922|NCT04823260|Micronutrients|micronutrients|mesh-ancestor
65673923|NCT04823260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673924|NCT04823260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65673925|NCT04823260|Antimetabolites|antimetabolites|mesh-ancestor
65673926|NCT04823260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673927|NCT04823260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65673928|NCT04823260|Vasodilator Agents|vasodilator agents|mesh-ancestor
65673929|NCT04816240|Midodrine|midodrine|mesh-list
65673930|NCT04816240|Sympathomimetics|sympathomimetics|mesh-ancestor
65673931|NCT04816240|Autonomic Agents|autonomic agents|mesh-ancestor
65673932|NCT04816240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65673933|NCT04816240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673934|NCT04816240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65673935|NCT04816240|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65673936|NCT04816240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65673937|NCT04816240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65673938|NCT04816240|Adrenergic Agents|adrenergic agents|mesh-ancestor
65673939|NCT04816240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65673940|NCT04816240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673941|NCT04303780|Docetaxel|docetaxel|mesh-list
65673942|NCT04303780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673943|NCT04303780|Tubulin Modulators|tubulin modulators|mesh-ancestor
65673944|NCT04303780|Antimitotic Agents|antimitotic agents|mesh-ancestor
65673945|NCT04303780|Mitosis Modulators|mitosis modulators|mesh-ancestor
65673946|NCT04303780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673947|NCT04822012|Antibodies|antibodies|mesh-list
65673948|NCT04822012|Immunoglobulin G|immunoglobulin g|mesh-list
65673949|NCT04822012|Progesterone|progesterone|mesh-list
65673950|NCT04822012|Estrogens|estrogens|mesh-list
65673951|NCT04822012|Immunologic Factors|immunologic factors|mesh-ancestor
65673952|NCT04822012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673953|NCT04822012|Progestins|progestins|mesh-ancestor
65673954|NCT04822012|Hormones|hormones|mesh-ancestor
65673955|NCT04822012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65673956|NCT02328014|Acalabrutinib|acalabrutinib|mesh-list
65673957|NCT02328014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65673958|NCT05399732|Cyclosporine|cyclosporine|mesh-list
65673959|NCT05399732|Luspatercept|luspatercept|mesh-list
65673960|NCT05399732|Cyclosporins|cyclosporins|mesh-list
65673961|NCT05399732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673962|NCT05399732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673963|NCT05399732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65673964|NCT05399732|Immunologic Factors|immunologic factors|mesh-ancestor
65673965|NCT05399732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673966|NCT05399732|Antifungal Agents|antifungal agents|mesh-ancestor
65673967|NCT05399732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65673968|NCT05399732|Dermatologic Agents|dermatologic agents|mesh-ancestor
65673969|NCT05399732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65673970|NCT05399732|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65673971|NCT05399732|Hematinics|hematinics|mesh-ancestor
65673972|NCT05399576|Nicorandil|nicorandil|mesh-list
65673973|NCT05399576|Verapamil|verapamil|mesh-list
65673974|NCT05399576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65673975|NCT05399576|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65673976|NCT05399576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65673977|NCT05399576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673978|NCT05399576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65673979|NCT05399576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673980|NCT05399576|Vasodilator Agents|vasodilator agents|mesh-ancestor
65673981|NCT05399576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65673982|NCT05399576|Vitamin B Complex|vitamin b complex|mesh-ancestor
65673983|NCT05399576|Vitamins|vitamins|mesh-ancestor
65673984|NCT05399576|Micronutrients|micronutrients|mesh-ancestor
65673985|NCT05255900|Metyrapone|metyrapone|mesh-list
65673986|NCT05255900|Antimetabolites|antimetabolites|mesh-ancestor
65673987|NCT05255900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65673988|NCT05255900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65673989|NCT04615286|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65673990|NCT04615286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65471307|NCT00076752|Diphenhydramine|diphenhydramine|mesh-list
65673991|NCT04615286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65673992|NCT04615286|Antitubercular Agents|antitubercular agents|mesh-ancestor
65673993|NCT05397938|Alendronate|alendronate|mesh-list
65673994|NCT05397938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65673995|NCT05397938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65673996|NCT05133674|Tamoxifen|tamoxifen|mesh-list
65673997|NCT05133674|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65673998|NCT05133674|Hormone Antagonists|hormone antagonists|mesh-ancestor
65673999|NCT05133674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65674000|NCT05133674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674001|NCT05133674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65674002|NCT05133674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674003|NCT05133674|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65674004|NCT05133674|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65674005|NCT05133674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65674006|NCT02522936|Muramidase|muramidase|mesh-list
65674007|NCT02522936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674008|NCT04525898|Methadone|methadone|mesh-list
65674009|NCT04525898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65674010|NCT04525898|Narcotics|narcotics|mesh-ancestor
65674011|NCT04525898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65674012|NCT04525898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674013|NCT04525898|Analgesics|analgesics|mesh-ancestor
65674014|NCT04525898|Sensory System Agents|sensory system agents|mesh-ancestor
65674015|NCT04525898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65674016|NCT04525898|Antitussive Agents|antitussive agents|mesh-ancestor
65674017|NCT04525898|Respiratory System Agents|respiratory system agents|mesh-ancestor
65674018|NCT04282070|Gemcitabine|gemcitabine|mesh-list
65674019|NCT04282070|Paclitaxel|paclitaxel|mesh-list
65674020|NCT04282070|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65674021|NCT04282070|Cisplatin|cisplatin|mesh-list
65674022|NCT04282070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65674023|NCT04282070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674024|NCT04282070|Tubulin Modulators|tubulin modulators|mesh-ancestor
65674025|NCT04282070|Antimitotic Agents|antimitotic agents|mesh-ancestor
65674026|NCT04282070|Mitosis Modulators|mitosis modulators|mesh-ancestor
65674027|NCT04282070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674028|NCT04282070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65674029|NCT04282070|Antimetabolites|antimetabolites|mesh-ancestor
65674030|NCT04282070|Antiviral Agents|antiviral agents|mesh-ancestor
65674031|NCT04282070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674032|NCT04282070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674033|NCT04282070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65674034|NCT04282070|Immunologic Factors|immunologic factors|mesh-ancestor
65674035|NCT04282070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674036|NCT04347122|Tranexamic Acid|tranexamic acid|mesh-list
65674037|NCT04347122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65674038|NCT04347122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65674039|NCT04347122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674040|NCT04347122|Hemostatics|hemostatics|mesh-ancestor
65674041|NCT04347122|Coagulants|coagulants|mesh-ancestor
65674042|NCT04341116|Plonmarlimab|plonmarlimab|mesh-list
65674043|NCT04341116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65674044|NCT04341116|Antiviral Agents|antiviral agents|mesh-ancestor
65674045|NCT04341116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674046|NCT03467438|Polaprezinc|polaprezinc|mesh-list
65674047|NCT03467438|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65674048|NCT03467438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65674049|NCT05397236|Dexamethasone|dexamethasone|mesh-list
65674050|NCT05397236|Bupivacaine|bupivacaine|mesh-list
65674051|NCT05397236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65674052|NCT05397236|Antiemetics|antiemetics|mesh-ancestor
65674053|NCT05397236|Autonomic Agents|autonomic agents|mesh-ancestor
65674054|NCT05397236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65674055|NCT05397236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674056|NCT05397236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65674057|NCT05397236|Glucocorticoids|glucocorticoids|mesh-ancestor
65674058|NCT05397236|Hormones|hormones|mesh-ancestor
65674059|NCT05397236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65674060|NCT05397236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65674061|NCT05397236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674062|NCT05397236|Anesthetics, Local|anesthetics, local|mesh-ancestor
65674063|NCT05397236|Anesthetics|anesthetics|mesh-ancestor
65674064|NCT05397236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65674065|NCT05397236|Sensory System Agents|sensory system agents|mesh-ancestor
65674066|NCT05439278|Temozolomide|temozolomide|mesh-list
65674067|NCT05439278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65471387|NCT00088530|Prednisone|prednisone|mesh-list
65674068|NCT05439278|Alkylating Agents|alkylating agents|mesh-ancestor
65674069|NCT05439278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674070|NCT05439278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674071|NCT03130010|Nefopam|nefopam|mesh-list
65674072|NCT03130010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65674073|NCT03130010|Analgesics|analgesics|mesh-ancestor
65674074|NCT03130010|Sensory System Agents|sensory system agents|mesh-ancestor
65674075|NCT03130010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65674076|NCT03130010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674077|NCT05396144|Nitrous Oxide|nitrous oxide|mesh-list
65674078|NCT05396144|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65674079|NCT05396144|Anesthetics, General|anesthetics, general|mesh-ancestor
65674080|NCT05396144|Anesthetics|anesthetics|mesh-ancestor
65674081|NCT05396144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65674082|NCT05396144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674083|NCT05396144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65674084|NCT05396144|Analgesics|analgesics|mesh-ancestor
65674085|NCT05396144|Sensory System Agents|sensory system agents|mesh-ancestor
65674086|NCT05396144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65674087|NCT04201964|Tenecteplase|tenecteplase|mesh-list
65674088|NCT04201964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65674089|NCT04201964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65674090|NCT04201964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674091|NCT00157248|Dabigatran|dabigatran|mesh-list
65674092|NCT00157248|Antithrombins|antithrombins|mesh-ancestor
65674093|NCT00157248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65674094|NCT00157248|Protease Inhibitors|protease inhibitors|mesh-ancestor
65674095|NCT00157248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674096|NCT00157248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674097|NCT00157248|Anticoagulants|anticoagulants|mesh-ancestor
65674098|NCT02504580|Bupivacaine|bupivacaine|mesh-list
65674099|NCT02504580|Anesthetics, Local|anesthetics, local|mesh-ancestor
65674100|NCT02504580|Anesthetics|anesthetics|mesh-ancestor
65674101|NCT02504580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65674102|NCT02504580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674103|NCT02504580|Sensory System Agents|sensory system agents|mesh-ancestor
65674104|NCT02504580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65674105|NCT02235402|Lacidipine|lacidipine|mesh-list
65674106|NCT02235402|Bendroflumethiazide|bendroflumethiazide|mesh-list
65674107|NCT02235402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65674108|NCT02235402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65674109|NCT02235402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65674110|NCT02235402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674111|NCT02235402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65674112|NCT02235402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674113|NCT02235402|Diuretics|diuretics|mesh-ancestor
65674114|NCT02235402|Natriuretic Agents|natriuretic agents|mesh-ancestor
65674115|NCT02235402|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65674116|NCT02235480|Tazarotene|tazarotene|mesh-list
65674117|NCT02235480|Dermatologic Agents|dermatologic agents|mesh-ancestor
65674118|NCT02235480|Keratolytic Agents|keratolytic agents|mesh-ancestor
65674119|NCT02235558|Verapamil|verapamil|mesh-list
65674120|NCT02235558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65674121|NCT02235558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65674122|NCT02235558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65674123|NCT02235558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674124|NCT02235558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65674125|NCT02235558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674126|NCT02235558|Vasodilator Agents|vasodilator agents|mesh-ancestor
65674127|NCT04214418|Hydroxychloroquine|hydroxychloroquine|mesh-list
65674128|NCT04214418|Atezolizumab|atezolizumab|mesh-list
65674129|NCT04214418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674130|NCT04214418|Antimalarials|antimalarials|mesh-ancestor
65674131|NCT04214418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65674132|NCT04214418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65674133|NCT04214418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674134|NCT04214418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674135|NCT04214418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674136|NCT04214418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65674137|NCT02233920|Oxitropium|oxitropium|mesh-list
65674138|NCT02233920|Parasympatholytics|parasympatholytics|mesh-ancestor
65674139|NCT02233920|Autonomic Agents|autonomic agents|mesh-ancestor
65674140|NCT02233920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65674141|NCT02233920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674142|NCT02235948|Folic Acid|folic acid|mesh-list
65674143|NCT02235948|Hematinics|hematinics|mesh-ancestor
65674144|NCT02235948|Vitamin B Complex|vitamin b complex|mesh-ancestor
65674145|NCT02235948|Vitamins|vitamins|mesh-ancestor
65674146|NCT02235948|Micronutrients|micronutrients|mesh-ancestor
65674147|NCT02235948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674148|NCT02236026|Moxifloxacin|moxifloxacin|mesh-list
65674149|NCT02236026|ST 1435|st 1435|mesh-list
65674150|NCT02236026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65674151|NCT02236026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674152|NCT02236026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65674153|NCT02236026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65674154|NCT02236026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674155|NCT02236026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674156|NCT02236026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674157|NCT02236026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65674158|NCT02236026|Contraceptive Agents|contraceptive agents|mesh-ancestor
65674159|NCT02236026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65674160|NCT02236026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674161|NCT02236026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65674162|NCT02236182|Bromides|bromides|mesh-list
65674163|NCT02236182|Ipratropium|ipratropium|mesh-list
65674164|NCT02236182|Anticonvulsants|anticonvulsants|mesh-ancestor
65674165|NCT02236182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65674166|NCT02236182|Autonomic Agents|autonomic agents|mesh-ancestor
65674167|NCT02236182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65674168|NCT02236182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674169|NCT02236182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65674170|NCT02236182|Respiratory System Agents|respiratory system agents|mesh-ancestor
65674171|NCT02236182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65674172|NCT02236182|Cholinergic Agents|cholinergic agents|mesh-ancestor
65674173|NCT02236182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65674174|NCT02236182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674175|NCT04453280|Antibodies|antibodies|mesh-list
65674176|NCT04453280|Immunologic Factors|immunologic factors|mesh-ancestor
65674177|NCT04453280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674178|NCT01328756|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65674179|NCT01328756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65674180|NCT01328756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674181|NCT01328756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65674182|NCT01328756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65674183|NCT01328756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65674184|NCT01328756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674185|NCT01328756|Dopamine Agents|dopamine agents|mesh-ancestor
65674186|NCT01328756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65674187|NCT03466502|Vancomycin|vancomycin|mesh-list
65674188|NCT03466502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65674189|NCT03466502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674190|NCT05392634|Amoxicillin|amoxicillin|mesh-list
65674191|NCT05392634|Meropenem|meropenem|mesh-list
65674192|NCT05392634|Clavulanic Acids|clavulanic acids|mesh-list
65674193|NCT05392634|Clavulanic Acid|clavulanic acid|mesh-list
65674194|NCT05392634|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65674195|NCT05392634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65674196|NCT05392634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674197|NCT05392634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674198|NCT05392634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674199|NCT05392634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65674200|NCT01593228|Gemcitabine|gemcitabine|mesh-list
65674201|NCT01593228|Paclitaxel|paclitaxel|mesh-list
65674202|NCT01593228|Carboplatin|carboplatin|mesh-list
65674203|NCT01593228|Doxorubicin|doxorubicin|mesh-list
65674204|NCT01593228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65674205|NCT01593228|Irinotecan|irinotecan|mesh-list
65674206|NCT01593228|Topotecan|topotecan|mesh-list
65674207|NCT01593228|Iniparib|iniparib|mesh-list
65674208|NCT01593228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65674209|NCT01593228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674210|NCT01593228|Tubulin Modulators|tubulin modulators|mesh-ancestor
65674211|NCT01593228|Antimitotic Agents|antimitotic agents|mesh-ancestor
65674212|NCT01593228|Mitosis Modulators|mitosis modulators|mesh-ancestor
65674213|NCT01593228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674214|NCT01593228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65674215|NCT01593228|Antimetabolites|antimetabolites|mesh-ancestor
65674216|NCT01593228|Antiviral Agents|antiviral agents|mesh-ancestor
65674217|NCT01593228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674218|NCT01593228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674219|NCT01593228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65471530|NCT00356759|Warfarin|warfarin|mesh-list
65674220|NCT01593228|Immunologic Factors|immunologic factors|mesh-ancestor
65674221|NCT01593228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674222|NCT01593228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65674223|NCT01593228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65674224|NCT01593228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65674225|NCT01593228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65674226|NCT01593228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65674227|NCT02263638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65674228|NCT02263638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65674229|NCT03844620|Trifluridine|trifluridine|mesh-list
65674230|NCT03844620|Antimetabolites|antimetabolites|mesh-ancestor
65674231|NCT03844620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674232|NCT03844620|Antiviral Agents|antiviral agents|mesh-ancestor
65674233|NCT03844620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674234|NCT02236260|Lidocaine|lidocaine|mesh-list
65674235|NCT02236260|Anesthetics, Local|anesthetics, local|mesh-ancestor
65674236|NCT02236260|Anesthetics|anesthetics|mesh-ancestor
65674237|NCT02236260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65674238|NCT02236260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674239|NCT02236260|Sensory System Agents|sensory system agents|mesh-ancestor
65674240|NCT02236260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65674241|NCT02236260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65674242|NCT02236260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65674243|NCT02236260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65674244|NCT02236260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65674245|NCT02236260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674246|NCT04502706|Rituximab|rituximab|mesh-list
65674247|NCT04502706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65674248|NCT04502706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674249|NCT04502706|Immunologic Factors|immunologic factors|mesh-ancestor
65674250|NCT04502706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674251|NCT04502706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65674252|NCT01555554|Propranolol|propranolol|mesh-list
65674253|NCT01555554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65674254|NCT01555554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65674255|NCT01555554|Adrenergic Agents|adrenergic agents|mesh-ancestor
65674256|NCT01555554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65674257|NCT01555554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674258|NCT01555554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674259|NCT01555554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65674260|NCT01555554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65674261|NCT01555554|Vasodilator Agents|vasodilator agents|mesh-ancestor
65674262|NCT01435044|Sofosbuvir|sofosbuvir|mesh-list
65674263|NCT01435044|Ribavirin|ribavirin|mesh-list
65674264|NCT01435044|Antiviral Agents|antiviral agents|mesh-ancestor
65674265|NCT01435044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674266|NCT01435044|Antimetabolites|antimetabolites|mesh-ancestor
65674267|NCT01435044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674268|NCT01434498|Ribavirin|ribavirin|mesh-list
65674269|NCT01434498|Ledipasvir|ledipasvir|mesh-list
65674270|NCT01434498|Antimetabolites|antimetabolites|mesh-ancestor
65674271|NCT01434498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674272|NCT01434498|Antiviral Agents|antiviral agents|mesh-ancestor
65674273|NCT01434498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674274|NCT03735966|Carboplatin|carboplatin|mesh-list
65674275|NCT03735966|Docetaxel|docetaxel|mesh-list
65674276|NCT03735966|Trastuzumab|trastuzumab|mesh-list
65674277|NCT03735966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674278|NCT03735966|Tubulin Modulators|tubulin modulators|mesh-ancestor
65674279|NCT03735966|Antimitotic Agents|antimitotic agents|mesh-ancestor
65674280|NCT03735966|Mitosis Modulators|mitosis modulators|mesh-ancestor
65674281|NCT03735966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674282|NCT03735966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65674283|NCT03679650|Decitabine|decitabine|mesh-list
65674284|NCT03679650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65674285|NCT03679650|Antimetabolites|antimetabolites|mesh-ancestor
65674286|NCT03679650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674287|NCT03679650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674288|NCT03679650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674289|NCT01554696|Methotrexate|methotrexate|mesh-list
65674290|NCT01554696|Peficitinib|peficitinib|mesh-list
65674291|NCT01554696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65674292|NCT01554696|Abortifacient Agents|abortifacient agents|mesh-ancestor
65674293|NCT01554696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65471606|NCT03947528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65674294|NCT01554696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674295|NCT01554696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65674296|NCT01554696|Antimetabolites|antimetabolites|mesh-ancestor
65674297|NCT01554696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674298|NCT01554696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674299|NCT01554696|Dermatologic Agents|dermatologic agents|mesh-ancestor
65674300|NCT01554696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674301|NCT01554696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65674302|NCT01554696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65674303|NCT01554696|Immunologic Factors|immunologic factors|mesh-ancestor
65674304|NCT01554696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65674305|NCT01554696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65674306|NCT02265276|Pioglitazone|pioglitazone|mesh-list
65674307|NCT02265276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65674308|NCT02265276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674309|NCT02263872|Minocycline|minocycline|mesh-list
65674310|NCT02263872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65674311|NCT02263872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674312|NCT02261376|DS-1971a|ds-1971a|mesh-list
65674313|NCT02261376|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65674314|NCT02261376|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65674315|NCT02261376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65674316|NCT02261376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674317|NCT01535508|Vitamin D|vitamin d|mesh-list
65674318|NCT01535508|Vitamins|vitamins|mesh-ancestor
65674319|NCT01535508|Micronutrients|micronutrients|mesh-ancestor
65674320|NCT01535508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674321|NCT01535508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65674322|NCT02626338|Cytarabine|cytarabine|mesh-list
65674323|NCT02626338|Fludarabine|fludarabine|mesh-list
65674324|NCT02626338|Fludarabine phosphate|fludarabine phosphate|mesh-list
65674325|NCT02626338|Etoposide|etoposide|mesh-list
65674326|NCT02626338|Etoposide phosphate|etoposide phosphate|mesh-list
65674327|NCT02626338|Mitoxantrone|mitoxantrone|mesh-list
65674328|NCT02626338|Idarubicin|idarubicin|mesh-list
65674329|NCT02626338|Crenolanib|crenolanib|mesh-list
65674330|NCT02626338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674331|NCT02626338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65674332|NCT02626338|Antimetabolites|antimetabolites|mesh-ancestor
65674333|NCT02626338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674334|NCT02626338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65674335|NCT02626338|Immunologic Factors|immunologic factors|mesh-ancestor
65674336|NCT02626338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674337|NCT02626338|Antiviral Agents|antiviral agents|mesh-ancestor
65674338|NCT02626338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674339|NCT02626338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65674340|NCT02626338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65674341|NCT02626338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65674342|NCT02626338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674343|NCT02626338|Analgesics|analgesics|mesh-ancestor
65674344|NCT02626338|Sensory System Agents|sensory system agents|mesh-ancestor
65674345|NCT02626338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65674346|NCT02626338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65674347|NCT01416402|Colchicine|colchicine|mesh-list
65674348|NCT01416402|Febuxostat|febuxostat|mesh-list
65674349|NCT01416402|Gout Suppressants|gout suppressants|mesh-ancestor
65674350|NCT01416402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65674351|NCT01416402|Tubulin Modulators|tubulin modulators|mesh-ancestor
65674352|NCT01416402|Antimitotic Agents|antimitotic agents|mesh-ancestor
65674353|NCT01416402|Mitosis Modulators|mitosis modulators|mesh-ancestor
65674354|NCT01416402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674355|NCT01416402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674356|NCT01414920|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65674357|NCT01414920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65674358|NCT01414920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674359|NCT01414920|Incretins|incretins|mesh-ancestor
65674360|NCT01414920|Hormones|hormones|mesh-ancestor
65674361|NCT01414920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65674362|NCT01414920|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65674363|NCT01414920|Protease Inhibitors|protease inhibitors|mesh-ancestor
65674364|NCT01414920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674365|NCT01414920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674366|NCT02263950|Artemether|artemether|mesh-list
65674367|NCT02263950|Antimalarials|antimalarials|mesh-ancestor
65674368|NCT02263950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65674369|NCT02263950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65674370|NCT02263950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674371|NCT02261844|Resveratrol|resveratrol|mesh-list
65674372|NCT02261844|Antioxidants|antioxidants|mesh-ancestor
65674373|NCT02261844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674374|NCT02261844|Protective Agents|protective agents|mesh-ancestor
65674375|NCT02261844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674376|NCT02261844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674377|NCT02261844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65674378|NCT02261922|Ticagrelor|ticagrelor|mesh-list
65674379|NCT02261922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65674380|NCT02261922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65674381|NCT02261922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65674382|NCT02261922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65674383|NCT02261922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65674384|NCT02261922|Purinergic Agents|purinergic agents|mesh-ancestor
65674385|NCT02261922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65674386|NCT02261922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674387|NCT02261922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674388|NCT02264028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65674389|NCT02264106|Pantoprazole|pantoprazole|mesh-list
65674390|NCT02264106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65674391|NCT02264106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65674392|NCT02264106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65674393|NCT02264106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674394|NCT02264106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674395|NCT02262156|Antidepressive Agents|antidepressive agents|mesh-list
65674396|NCT02262156|Serotonin|serotonin|mesh-list
65674397|NCT02262156|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65674398|NCT02262156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65674399|NCT02262156|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65674400|NCT02262156|Serotonin Agents|serotonin agents|mesh-ancestor
65674401|NCT02262156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65674402|NCT02262156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674403|NCT02262156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674404|NCT02262156|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65674405|NCT02262156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65674406|NCT02612922|Nitazoxanide|nitazoxanide|mesh-list
65674407|NCT02612922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65674408|NCT02612922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674409|NCT02056782|Heparin|heparin|mesh-list
65674410|NCT02056782|Anticoagulants|anticoagulants|mesh-ancestor
65674411|NCT02056782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65674412|NCT02056782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65674413|NCT02056782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674414|NCT01516476|Liraglutide|liraglutide|mesh-list
65674415|NCT01516476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65674416|NCT01516476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674417|NCT01516476|Incretins|incretins|mesh-ancestor
65674418|NCT01516476|Hormones|hormones|mesh-ancestor
65674419|NCT01516476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65674420|NCT01516086|Fluticasone|fluticasone|mesh-list
65674421|NCT01516086|Xhance|xhance|mesh-list
65674422|NCT01516086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65674423|NCT01516086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65674424|NCT01516086|Autonomic Agents|autonomic agents|mesh-ancestor
65674425|NCT01516086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65674426|NCT01516086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674427|NCT01516086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65674428|NCT01516086|Respiratory System Agents|respiratory system agents|mesh-ancestor
65674429|NCT01516086|Dermatologic Agents|dermatologic agents|mesh-ancestor
65674430|NCT01516086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65674431|NCT01497834|Asunaprevir|asunaprevir|mesh-list
65674432|NCT01497834|Protease Inhibitors|protease inhibitors|mesh-ancestor
65674433|NCT01497834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674434|NCT01497834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674435|NCT02265822|Midazolam|midazolam|mesh-list
65674436|NCT02265822|Melatonin|melatonin|mesh-list
65674437|NCT02265822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65674438|NCT02265822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65674439|NCT02265822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65674440|NCT02265822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674441|NCT02265822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65674442|NCT02265822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65471756|NCT01096706|Antipyretics|antipyretics|mesh-ancestor
65674443|NCT02265822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65674444|NCT02265822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65674445|NCT02265822|Anesthetics, General|anesthetics, general|mesh-ancestor
65674446|NCT02265822|Anesthetics|anesthetics|mesh-ancestor
65674447|NCT02265822|GABA Modulators|gaba modulators|mesh-ancestor
65674448|NCT02265822|GABA Agents|gaba agents|mesh-ancestor
65674449|NCT02265822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65674450|NCT02265822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674451|NCT02265822|Antioxidants|antioxidants|mesh-ancestor
65674452|NCT02265822|Protective Agents|protective agents|mesh-ancestor
65674453|NCT02607930|Lamivudine|lamivudine|mesh-list
65674454|NCT02607930|Triumeq|triumeq|mesh-list
65674455|NCT02607930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65674456|NCT02607930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65674457|NCT02607930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674458|NCT02607930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674459|NCT02607930|Antiviral Agents|antiviral agents|mesh-ancestor
65674460|NCT02607930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674461|NCT02607930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65674462|NCT02607930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65674463|NCT02264184|Paroxetine|paroxetine|mesh-list
65674464|NCT02264184|Tamsulosin|tamsulosin|mesh-list
65674465|NCT02264184|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65674466|NCT02264184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65674467|NCT02264184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65674468|NCT02264184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674469|NCT02264184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65674470|NCT02264184|Serotonin Agents|serotonin agents|mesh-ancestor
65674471|NCT02264184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674472|NCT02264184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65674473|NCT02264184|Antidepressive Agents|antidepressive agents|mesh-ancestor
65674474|NCT02264184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65674475|NCT02264184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65674476|NCT02264184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65674477|NCT02264184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674478|NCT02264184|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65674479|NCT02264184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65674480|NCT02264184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65674481|NCT02264184|Adrenergic Agents|adrenergic agents|mesh-ancestor
65674482|NCT02264184|Urological Agents|urological agents|mesh-ancestor
65674483|NCT01260870|Paclitaxel|paclitaxel|mesh-list
65674484|NCT01260870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65674485|NCT01260870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674486|NCT01260870|Tubulin Modulators|tubulin modulators|mesh-ancestor
65674487|NCT01260870|Antimitotic Agents|antimitotic agents|mesh-ancestor
65674488|NCT01260870|Mitosis Modulators|mitosis modulators|mesh-ancestor
65674489|NCT01260870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674490|NCT02266056|Rocuronium|rocuronium|mesh-list
65674491|NCT02266056|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65674492|NCT02266056|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65674493|NCT02266056|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65674494|NCT02266056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65674495|NCT02266056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674496|NCT01482390|Ribavirin|ribavirin|mesh-list
65674497|NCT01482390|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65674498|NCT01482390|Antimetabolites|antimetabolites|mesh-ancestor
65674499|NCT01482390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674500|NCT01482390|Antiviral Agents|antiviral agents|mesh-ancestor
65674501|NCT01482390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674502|NCT01478178|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
65674503|NCT01478178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65674504|NCT01478178|Alkylating Agents|alkylating agents|mesh-ancestor
65674505|NCT01478178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674506|NCT01478178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674507|NCT01366014|Oxycodone|oxycodone|mesh-list
65674508|NCT01366014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65674509|NCT01366014|Narcotics|narcotics|mesh-ancestor
65674510|NCT01366014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65674511|NCT01366014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674512|NCT01366014|Analgesics|analgesics|mesh-ancestor
65674513|NCT01366014|Sensory System Agents|sensory system agents|mesh-ancestor
65674514|NCT01366014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65674515|NCT01361802|Ambroxol|ambroxol|mesh-list
65674516|NCT01361802|Expectorants|expectorants|mesh-ancestor
65674517|NCT01361802|Respiratory System Agents|respiratory system agents|mesh-ancestor
65674518|NCT01235754|Methyltestosterone|methyltestosterone|mesh-list
65471830|NCT00356525|Antimetabolites|antimetabolites|mesh-ancestor
65674519|NCT01235754|Testosterone|testosterone|mesh-list
65674520|NCT01235754|Testosterone undecanoate|testosterone undecanoate|mesh-list
65674521|NCT01235754|Testosterone enanthate|testosterone enanthate|mesh-list
65674522|NCT01235754|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65674523|NCT01235754|Androgens|androgens|mesh-ancestor
65674524|NCT01235754|Hormones|hormones|mesh-ancestor
65674525|NCT01235754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65674526|NCT01235754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674527|NCT01235754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65674528|NCT01235754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674529|NCT01235754|Anabolic Agents|anabolic agents|mesh-ancestor
65674530|NCT01234038|Paclitaxel|paclitaxel|mesh-list
65674531|NCT01234038|Carboplatin|carboplatin|mesh-list
65674532|NCT01234038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65674533|NCT01234038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674534|NCT01234038|Tubulin Modulators|tubulin modulators|mesh-ancestor
65674535|NCT01234038|Antimitotic Agents|antimitotic agents|mesh-ancestor
65674536|NCT01234038|Mitosis Modulators|mitosis modulators|mesh-ancestor
65674537|NCT01234038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674538|NCT01233960|Remestemcel-l|remestemcel-l|mesh-list
65674539|NCT01233960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65674540|NCT01233960|Antiviral Agents|antiviral agents|mesh-ancestor
65674541|NCT01233960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674542|NCT01229982|Latanoprost|latanoprost|mesh-list
65674543|NCT01229982|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65674544|NCT01229982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65674545|NCT01225380|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65674546|NCT01225380|Interferon-alpha|interferon-alpha|mesh-list
65674547|NCT01225380|Ribavirin|ribavirin|mesh-list
65674548|NCT01225380|Antiviral Agents|antiviral agents|mesh-ancestor
65674549|NCT01225380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674550|NCT01225380|Immunologic Factors|immunologic factors|mesh-ancestor
65674551|NCT01225380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674552|NCT01225380|Antimetabolites|antimetabolites|mesh-ancestor
65674553|NCT01225380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674554|NCT01349868|Formoterol Fumarate|formoterol fumarate|mesh-list
65674555|NCT01349868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65674556|NCT01349868|Autonomic Agents|autonomic agents|mesh-ancestor
65674557|NCT01349868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65674558|NCT01349868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674559|NCT01349868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65674560|NCT01349868|Respiratory System Agents|respiratory system agents|mesh-ancestor
65674561|NCT01349868|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65674562|NCT01349868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65674563|NCT01349868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65674564|NCT01349868|Adrenergic Agents|adrenergic agents|mesh-ancestor
65674565|NCT01349868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65674566|NCT01349868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674567|NCT02266524|Tamsulosin|tamsulosin|mesh-list
65674568|NCT02266524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65674569|NCT02266524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65674570|NCT02266524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65674571|NCT02266524|Adrenergic Agents|adrenergic agents|mesh-ancestor
65674572|NCT02266524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65674573|NCT02266524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674574|NCT02266524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674575|NCT02266524|Urological Agents|urological agents|mesh-ancestor
65674576|NCT01336686|Colchicine|colchicine|mesh-list
65674577|NCT01336686|Gout Suppressants|gout suppressants|mesh-ancestor
65674578|NCT01336686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65674579|NCT01336686|Tubulin Modulators|tubulin modulators|mesh-ancestor
65674580|NCT01336686|Antimitotic Agents|antimitotic agents|mesh-ancestor
65674581|NCT01336686|Mitosis Modulators|mitosis modulators|mesh-ancestor
65674582|NCT01336686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674583|NCT01336686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674584|NCT01455090|Ribavirin|ribavirin|mesh-list
65674585|NCT01455090|Asunaprevir|asunaprevir|mesh-list
65674586|NCT01455090|Antimetabolites|antimetabolites|mesh-ancestor
65674587|NCT01455090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674588|NCT01455090|Antiviral Agents|antiviral agents|mesh-ancestor
65674589|NCT01455090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674590|NCT01455090|Protease Inhibitors|protease inhibitors|mesh-ancestor
65674591|NCT01455090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674592|NCT01198626|Moxifloxacin|moxifloxacin|mesh-list
65674593|NCT01198626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65674594|NCT01198626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674595|NCT01198626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65674596|NCT01198626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65674597|NCT01198626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674598|NCT01198626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674599|NCT01198626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674600|NCT01194960|Docetaxel|docetaxel|mesh-list
65674601|NCT01194960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674602|NCT01194960|Tubulin Modulators|tubulin modulators|mesh-ancestor
65674603|NCT01194960|Antimitotic Agents|antimitotic agents|mesh-ancestor
65674604|NCT01194960|Mitosis Modulators|mitosis modulators|mesh-ancestor
65674605|NCT01194960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674606|NCT01331850|Ritonavir|ritonavir|mesh-list
65674607|NCT01331850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65674608|NCT01331850|Interferon-alpha|interferon-alpha|mesh-list
65674609|NCT01331850|Ribavirin|ribavirin|mesh-list
65674610|NCT01331850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65674611|NCT01331850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65674612|NCT01331850|Protease Inhibitors|protease inhibitors|mesh-ancestor
65674613|NCT01331850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674614|NCT01331850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674615|NCT01331850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65674616|NCT01331850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65674617|NCT01331850|Antiviral Agents|antiviral agents|mesh-ancestor
65674618|NCT01331850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674619|NCT01331850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65674620|NCT01331850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65674621|NCT01331850|Immunologic Factors|immunologic factors|mesh-ancestor
65674622|NCT01331850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674623|NCT01331850|Antimetabolites|antimetabolites|mesh-ancestor
65674624|NCT02101034|Cetuximab|cetuximab|mesh-list
65674625|NCT02101034|Palbociclib|palbociclib|mesh-list
65674626|NCT02101034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65674627|NCT02101034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674628|NCT02101034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65674629|NCT02101034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674630|NCT02101034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674631|NCT01328808|Acetaminophen|acetaminophen|mesh-list
65674632|NCT01328808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65674633|NCT01328808|Analgesics|analgesics|mesh-ancestor
65674634|NCT01328808|Sensory System Agents|sensory system agents|mesh-ancestor
65674635|NCT01328808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65674636|NCT01328808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674637|NCT01328808|Antipyretics|antipyretics|mesh-ancestor
65674638|NCT01968590|Vitamin D|vitamin d|mesh-list
65674639|NCT01968590|Cholecalciferol|cholecalciferol|mesh-list
65674640|NCT01968590|Vitamins|vitamins|mesh-ancestor
65674641|NCT01968590|Micronutrients|micronutrients|mesh-ancestor
65674642|NCT01968590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674643|NCT01968590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65674644|NCT01968590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65674645|NCT05626998|Dexmedetomidine|dexmedetomidine|mesh-list
65674646|NCT05626998|Gabapentin|gabapentin|mesh-list
65674647|NCT05626998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65674648|NCT05626998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65674649|NCT05626998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674650|NCT05626998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65674651|NCT05626998|Analgesics|analgesics|mesh-ancestor
65674652|NCT05626998|Sensory System Agents|sensory system agents|mesh-ancestor
65674653|NCT05626998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65674654|NCT05626998|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65674655|NCT05626998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65674656|NCT05626998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65674657|NCT05626998|Adrenergic Agents|adrenergic agents|mesh-ancestor
65674658|NCT05626998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65674659|NCT05626998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674660|NCT05626998|Anticonvulsants|anticonvulsants|mesh-ancestor
65674661|NCT05626998|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65674662|NCT05626998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65674663|NCT05626998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65674664|NCT05626998|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65674665|NCT05626998|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65674666|NCT05626998|Antimanic Agents|antimanic agents|mesh-ancestor
65674667|NCT01314222|Pregabalin|pregabalin|mesh-list
65674668|NCT01314222|Analgesics|analgesics|mesh-ancestor
65674669|NCT01314222|Sensory System Agents|sensory system agents|mesh-ancestor
65674670|NCT01314222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65674671|NCT01314222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674672|NCT01314222|Anticonvulsants|anticonvulsants|mesh-ancestor
65674673|NCT01314222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65674674|NCT01314222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65674675|NCT01314222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674676|NCT01314222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65674677|NCT01314222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65674678|NCT01314222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65674679|NCT01314222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65674680|NCT01314222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65674681|NCT05222828|Mepivacaine|mepivacaine|mesh-list
65674682|NCT05222828|Anesthetics, Local|anesthetics, local|mesh-ancestor
65674683|NCT05222828|Anesthetics|anesthetics|mesh-ancestor
65674684|NCT05222828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65674685|NCT05222828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674686|NCT05222828|Sensory System Agents|sensory system agents|mesh-ancestor
65674687|NCT05222828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65674688|NCT01309932|Interferons|interferons|mesh-list
65674689|NCT01309932|Ribavirin|ribavirin|mesh-list
65674690|NCT01309932|Interferon-alpha|interferon-alpha|mesh-list
65674691|NCT01309932|Interferon alpha-2|interferon alpha-2|mesh-list
65674692|NCT01309932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65674693|NCT01309932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
65674694|NCT01309932|Protease Inhibitors|protease inhibitors|mesh-list
65674695|NCT01309932|Asunaprevir|asunaprevir|mesh-list
65674696|NCT01309932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674697|NCT01309932|Antiviral Agents|antiviral agents|mesh-ancestor
65674698|NCT01309932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674699|NCT01309932|Antimetabolites|antimetabolites|mesh-ancestor
65674700|NCT01309932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674701|NCT01309932|Immunologic Factors|immunologic factors|mesh-ancestor
65674702|NCT01309932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674703|NCT01309932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674704|NCT01309932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65674705|NCT01309932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65674706|NCT01309932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65674707|NCT01733888|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65674708|NCT01733888|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65674709|NCT01733888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674710|NCT01181622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65674711|NCT01101594|Doxorubicin|doxorubicin|mesh-list
65674712|NCT01101594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65674713|NCT01101594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137356|NCT04533321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674714|NCT01101594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65674715|NCT01101594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65674716|NCT01101594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674717|NCT01101594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674718|NCT02269176|Losartan|losartan|mesh-list
65674719|NCT02269176|Telmisartan|telmisartan|mesh-list
65674720|NCT02269176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65674721|NCT02269176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65674722|NCT02269176|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65674723|NCT02269176|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65674724|NCT02269176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674725|NCT01094262|Oxycodone|oxycodone|mesh-list
65674726|NCT01094262|Analgesics|analgesics|mesh-list
65674727|NCT01094262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65674728|NCT01094262|Narcotics|narcotics|mesh-ancestor
65674729|NCT01094262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65674730|NCT01094262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674731|NCT01094262|Sensory System Agents|sensory system agents|mesh-ancestor
65674732|NCT01094262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65674733|NCT05626920|Disulfiram|disulfiram|mesh-list
65674734|NCT05626920|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65674735|NCT05626920|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65674736|NCT05626920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674737|NCT05626920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674738|NCT04476186|Acyclovir|acyclovir|mesh-list
65674739|NCT04476186|Antiviral Agents|antiviral agents|mesh-ancestor
65674740|NCT04476186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674741|NCT03440216|Meropenem|meropenem|mesh-list
65674742|NCT03440216|Ceftriaxone|ceftriaxone|mesh-list
65674743|NCT03440216|Temocillin|temocillin|mesh-list
65674744|NCT03440216|Penicillins|penicillins|mesh-list
65674745|NCT03440216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65674746|NCT03440216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674747|NCT01166412|Levonorgestrel|levonorgestrel|mesh-list
65674748|NCT01166412|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65674749|NCT01166412|Contraceptive Agents|contraceptive agents|mesh-ancestor
65674750|NCT01166412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65674751|NCT01166412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674752|NCT01166412|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65674753|NCT01166412|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65674754|NCT01166412|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65674755|NCT03428126|Durvalumab|durvalumab|mesh-list
65674756|NCT03428126|Trametinib|trametinib|mesh-list
65674757|NCT03428126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65674758|NCT03428126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674759|NCT03428126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65674760|NCT03428126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674761|NCT03428126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674762|NCT05370716|Pregabalin|pregabalin|mesh-list
65674763|NCT05370716|Analgesics|analgesics|mesh-ancestor
65674764|NCT05370716|Sensory System Agents|sensory system agents|mesh-ancestor
65674765|NCT05370716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65674766|NCT05370716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674767|NCT05370716|Anticonvulsants|anticonvulsants|mesh-ancestor
65674768|NCT05370716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65674769|NCT05370716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65674770|NCT05370716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674771|NCT05370716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65674772|NCT05370716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65674773|NCT05370716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65674774|NCT05370716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65674775|NCT05370716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65674776|NCT01038804|Docetaxel|docetaxel|mesh-list
65674777|NCT01038804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674778|NCT01038804|Tubulin Modulators|tubulin modulators|mesh-ancestor
65674779|NCT01038804|Antimitotic Agents|antimitotic agents|mesh-ancestor
65674780|NCT01038804|Mitosis Modulators|mitosis modulators|mesh-ancestor
65674781|NCT01038804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674782|NCT05118776|Bevacizumab|bevacizumab|mesh-list
65674783|NCT05118776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65674784|NCT05118776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674785|NCT05118776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65674786|NCT05118776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65674787|NCT05118776|Growth Substances|growth substances|mesh-ancestor
65674788|NCT05118776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674789|NCT05118776|Growth Inhibitors|growth inhibitors|mesh-ancestor
65674790|NCT05101070|Pembrolizumab|pembrolizumab|mesh-list
65674791|NCT05101070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65674792|NCT05101070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674793|NCT02269644|Azithromycin|azithromycin|mesh-list
65674794|NCT02269644|Linezolid|linezolid|mesh-list
65674795|NCT02269644|Dalbavancin|dalbavancin|mesh-list
65674796|NCT02269644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65674797|NCT02269644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674798|NCT02269644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65674799|NCT02269644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674800|NCT02269644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674801|NCT03367988|Analgesics, Opioid|analgesics, opioid|mesh-list
65674802|NCT03367988|Anesthetics|anesthetics|mesh-list
65674803|NCT03367988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65674804|NCT03367988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674805|NCT03367988|Narcotics|narcotics|mesh-ancestor
65674806|NCT03367988|Analgesics|analgesics|mesh-ancestor
65674807|NCT03367988|Sensory System Agents|sensory system agents|mesh-ancestor
65674808|NCT03367988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65674809|NCT03465488|Albendazole|albendazole|mesh-list
65674810|NCT03465488|Anthelmintics|anthelmintics|mesh-ancestor
65674811|NCT03465488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65674812|NCT03465488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674813|NCT03465488|Anticestodal Agents|anticestodal agents|mesh-ancestor
65674814|NCT03465488|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65674815|NCT03465488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65674816|NCT03465488|Tubulin Modulators|tubulin modulators|mesh-ancestor
65674817|NCT03465488|Antimitotic Agents|antimitotic agents|mesh-ancestor
65674818|NCT03465488|Mitosis Modulators|mitosis modulators|mesh-ancestor
65674819|NCT03465488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674820|NCT03465488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674821|NCT02267304|Morphine|morphine|mesh-list
65674822|NCT02267304|Naloxone|naloxone|mesh-list
65674823|NCT02267304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65674824|NCT02267304|Narcotics|narcotics|mesh-ancestor
65674825|NCT02267304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65674826|NCT02267304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674827|NCT02267304|Analgesics|analgesics|mesh-ancestor
65674828|NCT02267304|Sensory System Agents|sensory system agents|mesh-ancestor
65674829|NCT02267304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65674830|NCT02267304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65674831|NCT03465410|Tacrolimus|tacrolimus|mesh-list
65674832|NCT03465410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65674833|NCT03465410|Immunologic Factors|immunologic factors|mesh-ancestor
65674834|NCT03465410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674835|NCT03465410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65674836|NCT03465410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674837|NCT03465410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674838|NCT02522234|Lenograstim|lenograstim|mesh-list
65674839|NCT02522234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65674840|NCT02522234|Immunologic Factors|immunologic factors|mesh-ancestor
65674841|NCT02522234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674842|NCT00154284|Cyclosporine|cyclosporine|mesh-list
65674843|NCT00154284|Prednisone|prednisone|mesh-list
65674844|NCT00154284|Everolimus|everolimus|mesh-list
65674845|NCT00154284|Cyclosporins|cyclosporins|mesh-list
65674846|NCT00154284|Basiliximab|basiliximab|mesh-list
65674847|NCT00154284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65674848|NCT00154284|Glucocorticoids|glucocorticoids|mesh-ancestor
65674849|NCT00154284|Hormones|hormones|mesh-ancestor
65674850|NCT00154284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65674851|NCT00154284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674852|NCT00154284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65674853|NCT00154284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674854|NCT00154284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674855|NCT00154284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674856|NCT00154284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65674857|NCT00154284|Immunologic Factors|immunologic factors|mesh-ancestor
65674858|NCT00154284|Antifungal Agents|antifungal agents|mesh-ancestor
65674859|NCT00154284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674860|NCT00154284|Dermatologic Agents|dermatologic agents|mesh-ancestor
65674861|NCT00154284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65674862|NCT00154284|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65674863|NCT01037166|Entecavir|entecavir|mesh-list
65674864|NCT01037166|Antiviral Agents|antiviral agents|mesh-ancestor
65674865|NCT01037166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674866|NCT03247712|Nivolumab|nivolumab|mesh-list
65674867|NCT03247712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65674868|NCT03247712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674869|NCT03247712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65674870|NCT03247712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674871|NCT04497584|Prednisone|prednisone|mesh-list
65674872|NCT04497584|Afatinib|afatinib|mesh-list
65674873|NCT04497584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65674874|NCT04497584|Glucocorticoids|glucocorticoids|mesh-ancestor
65674875|NCT04497584|Hormones|hormones|mesh-ancestor
65674876|NCT04497584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65674877|NCT04497584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674878|NCT04497584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65674879|NCT04497584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674880|NCT04497584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65674881|NCT04497584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674882|NCT04497584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674883|NCT04491032|Anesthetics|anesthetics|mesh-list
65674884|NCT04491032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65674885|NCT04491032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674886|NCT02269800|Benzalkonium Compounds|benzalkonium compounds|mesh-list
65674887|NCT02269800|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65674888|NCT02269800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674889|NCT04487756|Carboplatin|carboplatin|mesh-list
65674890|NCT04487756|Atezolizumab|atezolizumab|mesh-list
65674891|NCT04487756|Vaccines|vaccines|mesh-list
65674892|NCT04487756|Immunologic Factors|immunologic factors|mesh-ancestor
65674893|NCT04487756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674894|NCT04487756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674895|NCT01281462|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
65674896|NCT01281462|Cephalosporins|cephalosporins|mesh-list
65674897|NCT01281462|Avibactam|avibactam|mesh-list
65674898|NCT01281462|Doripenem|doripenem|mesh-list
65674899|NCT01281462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65674900|NCT01281462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674901|NCT01281462|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65674903|NCT01281462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674904|NCT04453124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
65674905|NCT04453124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674906|NCT01024062|Paclitaxel|paclitaxel|mesh-list
65674907|NCT01024062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65674908|NCT01024062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674909|NCT01024062|Tubulin Modulators|tubulin modulators|mesh-ancestor
65674910|NCT01024062|Antimitotic Agents|antimitotic agents|mesh-ancestor
65674911|NCT01024062|Mitosis Modulators|mitosis modulators|mesh-ancestor
65674912|NCT01024062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674913|NCT04453436|Tenofovir|tenofovir|mesh-list
65674914|NCT04453436|Lamivudine|lamivudine|mesh-list
65674915|NCT04453436|Dolutegravir|dolutegravir|mesh-list
65674916|NCT04453436|Antiviral Agents|antiviral agents|mesh-ancestor
65674917|NCT04453436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674918|NCT04453436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65674919|NCT04453436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65674920|NCT04453436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674921|NCT04453436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674922|NCT04453436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65674923|NCT04453436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65674924|NCT04453436|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65674925|NCT04453436|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65674926|NCT02267616|Etonogestrel|etonogestrel|mesh-list
65674927|NCT02267616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65674928|NCT02267616|Contraceptive Agents|contraceptive agents|mesh-ancestor
65674929|NCT02267616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65674930|NCT02267616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674931|NCT02267616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65674932|NCT05232734|Caffeine|caffeine|mesh-list
65674933|NCT05232734|Caffeine citrate|caffeine citrate|mesh-list
65674934|NCT05232734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674935|NCT05232734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65674936|NCT05232734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674937|NCT05232734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65674938|NCT05232734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674939|NCT05232734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65674940|NCT05232734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65674941|NCT05232734|Purinergic Agents|purinergic agents|mesh-ancestor
65674942|NCT05232734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65674943|NCT03465098|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65674944|NCT03465098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65674945|NCT03465098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674946|NCT01023204|Paclitaxel|paclitaxel|mesh-list
65674947|NCT01023204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65674948|NCT01023204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674949|NCT01023204|Tubulin Modulators|tubulin modulators|mesh-ancestor
65674950|NCT01023204|Antimitotic Agents|antimitotic agents|mesh-ancestor
65674951|NCT01023204|Mitosis Modulators|mitosis modulators|mesh-ancestor
65674952|NCT01023204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674953|NCT04460456|Pembrolizumab|pembrolizumab|mesh-list
65674954|NCT04460456|Cemiplimab|cemiplimab|mesh-list
65674955|NCT04460456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65674956|NCT04460456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674957|NCT02268006|Capecitabine|capecitabine|mesh-list
65674958|NCT02268006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65674959|NCT02268006|Antimetabolites|antimetabolites|mesh-ancestor
65674960|NCT02268006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674961|NCT02268006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674962|NCT03462212|Paclitaxel|paclitaxel|mesh-list
65674963|NCT03462212|Bevacizumab|bevacizumab|mesh-list
65674964|NCT03462212|Carboplatin|carboplatin|mesh-list
65674965|NCT03462212|Rucaparib|rucaparib|mesh-list
65674966|NCT03462212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65674967|NCT03462212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65674968|NCT03462212|Tubulin Modulators|tubulin modulators|mesh-ancestor
65674969|NCT03462212|Antimitotic Agents|antimitotic agents|mesh-ancestor
65674970|NCT03462212|Mitosis Modulators|mitosis modulators|mesh-ancestor
65674971|NCT03462212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65674972|NCT03462212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65674973|NCT03462212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65472287|NCT01209650|Afatinib|afatinib|mesh-list
65674974|NCT03462212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65674975|NCT03462212|Growth Substances|growth substances|mesh-ancestor
65674976|NCT03462212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674977|NCT03462212|Growth Inhibitors|growth inhibitors|mesh-ancestor
65674978|NCT03462212|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65674979|NCT03462212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65674981|NCT01016808|Oxycodone|oxycodone|mesh-list
65674982|NCT01016808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65674983|NCT01016808|Narcotics|narcotics|mesh-ancestor
65674984|NCT01016808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65674985|NCT01016808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674986|NCT01016808|Analgesics|analgesics|mesh-ancestor
65674987|NCT01016808|Sensory System Agents|sensory system agents|mesh-ancestor
65674988|NCT01016808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65674989|NCT01014078|Azithromycin|azithromycin|mesh-list
65674990|NCT01014078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65674991|NCT01014078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65674992|NCT01014078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65674993|NCT01014078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65674994|NCT02522078|Misoprostol|misoprostol|mesh-list
65674995|NCT02522078|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65674996|NCT02522078|Abortifacient Agents|abortifacient agents|mesh-ancestor
65674997|NCT02522078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65674998|NCT02522078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65674999|NCT02522078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65675000|NCT02522078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65675001|NCT02522078|Oxytocics|oxytocics|mesh-ancestor
65675002|NCT00911274|Mycophenolic Acid|mycophenolic acid|mesh-list
65675003|NCT00911274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65675004|NCT00911274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675005|NCT00911274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65675006|NCT00911274|Antitubercular Agents|antitubercular agents|mesh-ancestor
65675007|NCT00911274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65675008|NCT00911274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65675009|NCT00911274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675010|NCT00911274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675011|NCT03468296|Aflibercept|aflibercept|mesh-list
65675012|NCT03468296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65675013|NCT03468296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65675014|NCT03468296|Growth Substances|growth substances|mesh-ancestor
65675015|NCT03468296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675016|NCT03468296|Growth Inhibitors|growth inhibitors|mesh-ancestor
65675017|NCT03468296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675018|NCT01130142|Gemcitabine|gemcitabine|mesh-list
65675019|NCT01130142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65675020|NCT01130142|Antimetabolites|antimetabolites|mesh-ancestor
65675021|NCT01130142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675022|NCT01130142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675023|NCT01130142|Antiviral Agents|antiviral agents|mesh-ancestor
65675024|NCT01130142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65675025|NCT01130142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675026|NCT01130142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65675027|NCT01130142|Immunologic Factors|immunologic factors|mesh-ancestor
65675028|NCT01130142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675029|NCT03464864|Treprostinil|treprostinil|mesh-list
65675030|NCT03464864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65675031|NCT03468140|Eculizumab|eculizumab|mesh-list
65675032|NCT03468140|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65675033|NCT03468140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65675034|NCT03468140|Immunologic Factors|immunologic factors|mesh-ancestor
65675035|NCT03468140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675036|NCT01009242|Methotrexate|methotrexate|mesh-list
65675037|NCT01009242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65675038|NCT01009242|Abortifacient Agents|abortifacient agents|mesh-ancestor
65675039|NCT01009242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65675040|NCT01009242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675041|NCT01009242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65675042|NCT01009242|Antimetabolites|antimetabolites|mesh-ancestor
65675043|NCT01009242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675044|NCT01009242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675045|NCT01009242|Dermatologic Agents|dermatologic agents|mesh-ancestor
65675046|NCT01009242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675047|NCT01009242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65675048|NCT01009242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65675049|NCT01009242|Immunologic Factors|immunologic factors|mesh-ancestor
65675050|NCT01009242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65675051|NCT01009242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65675052|NCT03468062|Dexmedetomidine|dexmedetomidine|mesh-list
65675053|NCT03468062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65675054|NCT03468062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65675055|NCT03468062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675056|NCT03468062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65675057|NCT03468062|Analgesics|analgesics|mesh-ancestor
65675058|NCT03468062|Sensory System Agents|sensory system agents|mesh-ancestor
65675059|NCT03468062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65675060|NCT03468062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65675061|NCT03468062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65675062|NCT03468062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65675063|NCT03468062|Adrenergic Agents|adrenergic agents|mesh-ancestor
65675064|NCT03468062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65675065|NCT03468062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675066|NCT03464552|Celecoxib|celecoxib|mesh-list
65675067|NCT03464552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65675068|NCT03464552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65675069|NCT03464552|Analgesics|analgesics|mesh-ancestor
65675070|NCT03464552|Sensory System Agents|sensory system agents|mesh-ancestor
65675071|NCT03464552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65675072|NCT03464552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675073|NCT03464552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65675074|NCT03464552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65675075|NCT03464552|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65675076|NCT03464552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65675077|NCT03464552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675078|NCT03464552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675079|NCT05628558|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65675080|NCT05628558|Hemostatics|hemostatics|mesh-ancestor
65675081|NCT05628558|Coagulants|coagulants|mesh-ancestor
65675082|NCT05628558|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65675083|NCT05628558|Natriuretic Agents|natriuretic agents|mesh-ancestor
65675084|NCT05628558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675085|NCT01007292|Rituximab|rituximab|mesh-list
65675086|NCT01007292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65675087|NCT01007292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675088|NCT01007292|Immunologic Factors|immunologic factors|mesh-ancestor
65675089|NCT01007292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675090|NCT01007292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65675091|NCT03467984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65675092|NCT03467984|Immunologic Factors|immunologic factors|mesh-ancestor
65675093|NCT03467984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675094|NCT01005108|Gabapentin|gabapentin|mesh-list
65675095|NCT01005108|Analgesics|analgesics|mesh-ancestor
65675096|NCT01005108|Sensory System Agents|sensory system agents|mesh-ancestor
65675097|NCT01005108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65675098|NCT01005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675099|NCT01005108|Anticonvulsants|anticonvulsants|mesh-ancestor
65675100|NCT01005108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65675101|NCT01005108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65675102|NCT01005108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65675103|NCT01005108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65675104|NCT01005108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65675105|NCT01005108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65675106|NCT01005108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65675107|NCT01005108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675108|NCT01005108|Antimanic Agents|antimanic agents|mesh-ancestor
65675109|NCT00905346|Topiramate|topiramate|mesh-list
65675110|NCT00905346|Anticonvulsants|anticonvulsants|mesh-ancestor
65675111|NCT00905346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65675112|NCT00905346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675113|NCT00902928|Enoxaparin|enoxaparin|mesh-list
65675114|NCT00902928|Anticoagulants|anticoagulants|mesh-ancestor
65675115|NCT00902928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65675116|NCT00902928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65675117|NCT00902928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675118|NCT04777994|Mitogens|mitogens|mesh-list
65675119|NCT04777994|Endothelial Growth Factors|endothelial growth factors|mesh-list
65675120|NCT04777994|Mitosis Modulators|mitosis modulators|mesh-ancestor
65675121|NCT04777994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675122|NCT04777994|Growth Substances|growth substances|mesh-ancestor
65675123|NCT04777994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675124|NCT04316702|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65675125|NCT04316702|Analgesics|analgesics|mesh-ancestor
65675126|NCT04316702|Sensory System Agents|sensory system agents|mesh-ancestor
65675127|NCT04316702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65675128|NCT04316702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675129|NCT04316702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65675130|NCT04316702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675131|NCT04316702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65675132|NCT04316702|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65675133|NCT04316702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65675134|NCT04316702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65675135|NCT04316702|Antidepressive Agents|antidepressive agents|mesh-ancestor
65675136|NCT04316702|Dopamine Agents|dopamine agents|mesh-ancestor
65675137|NCT01129674|Olanzapine|olanzapine|mesh-list
65675138|NCT01129674|Risperidone|risperidone|mesh-list
65675139|NCT01129674|Aripiprazole|aripiprazole|mesh-list
65675140|NCT01129674|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65675141|NCT01129674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65675142|NCT01129674|Serotonin Agents|serotonin agents|mesh-ancestor
65675143|NCT01129674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65675144|NCT01129674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675145|NCT01129674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675146|NCT01129674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65675147|NCT01129674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65675148|NCT01129674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65675149|NCT01129674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65675150|NCT01129674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65675151|NCT01129674|Dopamine Agents|dopamine agents|mesh-ancestor
65675152|NCT01129674|Antiemetics|antiemetics|mesh-ancestor
65675153|NCT01129674|Autonomic Agents|autonomic agents|mesh-ancestor
65675154|NCT01129674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65675155|NCT01129674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65675156|NCT01129674|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65675157|NCT01129674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65675158|NCT01129674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65268660|NCT00631631|Mifamurtide|mifamurtide|mesh-list
65675159|NCT01129674|Antidepressive Agents|antidepressive agents|mesh-ancestor
65675160|NCT01129674|Dopamine Agonists|dopamine agonists|mesh-ancestor
65675161|NCT01129674|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65675162|NCT01129674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65675163|NCT01129674|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65675164|NCT01129674|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65675165|NCT04750616|Niacinamide|niacinamide|mesh-list
65675166|NCT04750616|Niacin|niacin|mesh-list
65675167|NCT04750616|Nicotinic Acids|nicotinic acids|mesh-list
65675168|NCT04750616|Vitamin B Complex|vitamin b complex|mesh-ancestor
65675169|NCT04750616|Vitamins|vitamins|mesh-ancestor
65675170|NCT04750616|Micronutrients|micronutrients|mesh-ancestor
65675171|NCT04750616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675172|NCT04750616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65675173|NCT04750616|Antimetabolites|antimetabolites|mesh-ancestor
65675174|NCT04750616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675175|NCT04750616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65675176|NCT04750616|Vasodilator Agents|vasodilator agents|mesh-ancestor
65675177|NCT05045378|Midazolam|midazolam|mesh-list
65675178|NCT05045378|Ketamine|ketamine|mesh-list
65675179|NCT05045378|Analgesics|analgesics|mesh-ancestor
65675180|NCT05045378|Sensory System Agents|sensory system agents|mesh-ancestor
65675181|NCT05045378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65675182|NCT05045378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675183|NCT05045378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65675184|NCT05045378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65675185|NCT05045378|Anesthetics, General|anesthetics, general|mesh-ancestor
65675186|NCT05045378|Anesthetics|anesthetics|mesh-ancestor
65675187|NCT05045378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65675188|NCT05045378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65675189|NCT05045378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65675190|NCT05045378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65675191|NCT05045378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675192|NCT05045378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65675193|NCT05045378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65675194|NCT05045378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65675195|NCT05045378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65675196|NCT05045378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65675197|NCT05045378|GABA Modulators|gaba modulators|mesh-ancestor
65675198|NCT05045378|GABA Agents|gaba agents|mesh-ancestor
65675199|NCT05209152|Azacitidine|azacitidine|mesh-list
65675200|NCT05209152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65675201|NCT05209152|Antimetabolites|antimetabolites|mesh-ancestor
65675202|NCT05209152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675203|NCT05209152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675204|NCT05209152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675205|NCT03460964|Pilocarpine|pilocarpine|mesh-list
65675206|NCT03460964|Miotics|miotics|mesh-ancestor
65675207|NCT03460964|Autonomic Agents|autonomic agents|mesh-ancestor
65675208|NCT03460964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65675209|NCT03460964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675210|NCT03460964|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65675211|NCT03460964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65675212|NCT03460964|Cholinergic Agents|cholinergic agents|mesh-ancestor
65675213|NCT03460964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65675214|NCT03460964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675215|NCT03460808|Acetylcysteine|acetylcysteine|mesh-list
65675216|NCT03460808|Atorvastatin|atorvastatin|mesh-list
65675217|NCT03460808|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65675218|NCT03460808|Danazol|danazol|mesh-list
65675219|NCT03460808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65675220|NCT03460808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65675221|NCT03460808|Antimetabolites|antimetabolites|mesh-ancestor
65675222|NCT03460808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675223|NCT03460808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65675224|NCT03460808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65675225|NCT03460808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675226|NCT03460808|Antiviral Agents|antiviral agents|mesh-ancestor
65675227|NCT03460808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65675228|NCT03460808|Expectorants|expectorants|mesh-ancestor
65675229|NCT03460808|Respiratory System Agents|respiratory system agents|mesh-ancestor
65675230|NCT03460808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65675231|NCT03460808|Antioxidants|antioxidants|mesh-ancestor
65675232|NCT03460808|Protective Agents|protective agents|mesh-ancestor
65675233|NCT03460808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675234|NCT03460808|Antidotes|antidotes|mesh-ancestor
65675235|NCT03460808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65675236|NCT03460808|Hormone Antagonists|hormone antagonists|mesh-ancestor
65675237|NCT03460808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65675238|NCT04946630|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65675239|NCT04946630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65675240|NCT04946630|Autonomic Agents|autonomic agents|mesh-ancestor
65675241|NCT04946630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65675242|NCT04946630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675243|NCT04946630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65675244|NCT04946630|Respiratory System Agents|respiratory system agents|mesh-ancestor
65675245|NCT04946630|Glucocorticoids|glucocorticoids|mesh-ancestor
65675246|NCT04946630|Hormones|hormones|mesh-ancestor
65675247|NCT04946630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65675248|NCT04946630|Sympathomimetics|sympathomimetics|mesh-ancestor
65675249|NCT00900900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65675250|NCT00900900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65675251|NCT00900900|Immunologic Factors|immunologic factors|mesh-ancestor
65675252|NCT00900900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675253|NCT03460730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65675254|NCT03460730|Immunologic Factors|immunologic factors|mesh-ancestor
65675255|NCT03460730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675256|NCT04328844|Pemetrexed|pemetrexed|mesh-list
65675257|NCT04328844|Avelumab|avelumab|mesh-list
65675258|NCT04328844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675259|NCT04328844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675260|NCT04328844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675261|NCT04328844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65675262|NCT04328844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65675263|NCT04328844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65675264|NCT05627778|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65675265|NCT05627778|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65675266|NCT05627778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675267|NCT01120470|Prednisone|prednisone|mesh-list
65675268|NCT01120470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65675269|NCT01120470|Glucocorticoids|glucocorticoids|mesh-ancestor
65675270|NCT01120470|Hormones|hormones|mesh-ancestor
65472580|NCT03942068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675271|NCT01120470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65675272|NCT01120470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675273|NCT01120470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65675274|NCT01120470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675275|NCT01117584|Metformin|metformin|mesh-list
65675276|NCT01117584|Ipragliflozin|ipragliflozin|mesh-list
65675277|NCT01117584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65675278|NCT01117584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675279|NCT01117584|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65675280|NCT01117584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675281|NCT03135054|Homoharringtonine|homoharringtonine|mesh-list
65675282|NCT03135054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65675283|NCT03135054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675284|NCT03135054|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65675285|NCT03135054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675286|NCT03135054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675287|NCT00991068|Lidocaine|lidocaine|mesh-list
65675288|NCT00991068|Tetracaine|tetracaine|mesh-list
65675289|NCT00991068|Anesthetics, Local|anesthetics, local|mesh-ancestor
65675290|NCT00991068|Anesthetics|anesthetics|mesh-ancestor
65675291|NCT00991068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65675292|NCT00991068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675293|NCT00991068|Sensory System Agents|sensory system agents|mesh-ancestor
65675294|NCT00991068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65675295|NCT00991068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65675296|NCT00991068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65675297|NCT00991068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65675298|NCT00991068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65675299|NCT00991068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675300|NCT01114698|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65268663|NCT00631631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675301|NCT01114698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65675302|NCT01114698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65675303|NCT01114698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65675304|NCT01114698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675305|NCT01114698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65675306|NCT01114698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675307|NCT01114698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65675308|NCT01114698|Antidepressive Agents|antidepressive agents|mesh-ancestor
65675309|NCT01114698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65675310|NCT01114308|Buprenorphine|buprenorphine|mesh-list
65675311|NCT01114308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65675312|NCT01114308|Narcotics|narcotics|mesh-ancestor
65675313|NCT01114308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65675314|NCT01114308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675315|NCT01114308|Analgesics|analgesics|mesh-ancestor
65675316|NCT01114308|Sensory System Agents|sensory system agents|mesh-ancestor
65675317|NCT01114308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65675318|NCT01114308|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65675319|NCT05469126|Clarithromycin|clarithromycin|mesh-list
65675320|NCT05469126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65675321|NCT05469126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65675322|NCT05469126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65675323|NCT05469126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675324|NCT05469126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675325|NCT05469126|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65675326|NCT05469126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65675327|NCT00887250|Losartan|losartan|mesh-list
65675328|NCT00887250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65675329|NCT00887250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65675330|NCT00887250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65675331|NCT00887250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65675332|NCT00887250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675333|NCT00990912|Carboplatin|carboplatin|mesh-list
65675334|NCT00990912|Irinotecan|irinotecan|mesh-list
65675335|NCT00990912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675336|NCT00990912|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65675337|NCT00990912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65675338|NCT00990912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675339|NCT00990912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675340|NCT00973284|Mannitol|mannitol|mesh-list
65675341|NCT00973284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65675342|NCT00973284|Diuretics|diuretics|mesh-ancestor
65675343|NCT00973284|Natriuretic Agents|natriuretic agents|mesh-ancestor
65675344|NCT00973284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675345|NCT02599402|Nivolumab|nivolumab|mesh-list
65675346|NCT02599402|Ipilimumab|ipilimumab|mesh-list
65675347|NCT02599402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65675348|NCT02599402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675349|NCT02599402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65675350|NCT02599402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675351|NCT04768166|Miglustat|miglustat|mesh-list
65675352|NCT04768166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675353|NCT04768166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675354|NCT04768166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65675355|NCT04768166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65675356|NCT04768166|Antiviral Agents|antiviral agents|mesh-ancestor
65675357|NCT04768166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65675358|NCT04768166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65675359|NCT04768166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65675360|NCT04768166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675361|NCT04822090|Immunoglobulins|immunoglobulins|mesh-list
65675362|NCT04822090|Antibodies|antibodies|mesh-list
65675363|NCT04822090|gamma-Globulins|gamma-globulins|mesh-list
65675364|NCT04822090|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65675365|NCT04822090|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65675366|NCT04822090|Immunologic Factors|immunologic factors|mesh-ancestor
65675367|NCT04822090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675368|NCT03463382|Bupivacaine|bupivacaine|mesh-list
65675369|NCT03463382|Anesthetics, Local|anesthetics, local|mesh-ancestor
65675370|NCT03463382|Anesthetics|anesthetics|mesh-ancestor
65675371|NCT03463382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65675372|NCT03463382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675373|NCT03463382|Sensory System Agents|sensory system agents|mesh-ancestor
65675374|NCT03463382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65675375|NCT05618236|Atropine|atropine|mesh-list
65675376|NCT05618236|Neostigmine|neostigmine|mesh-list
65675377|NCT05618236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65675378|NCT05618236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65675379|NCT05618236|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65675380|NCT05618236|Autonomic Agents|autonomic agents|mesh-ancestor
65675381|NCT05618236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65675382|NCT05618236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675383|NCT05618236|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65675384|NCT05618236|Respiratory System Agents|respiratory system agents|mesh-ancestor
65675385|NCT05618236|Mydriatics|mydriatics|mesh-ancestor
65675386|NCT05618236|Parasympatholytics|parasympatholytics|mesh-ancestor
65675387|NCT05618236|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65675388|NCT05618236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65675389|NCT05618236|Cholinergic Agents|cholinergic agents|mesh-ancestor
65675390|NCT05618236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65675391|NCT05618236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675392|NCT05618236|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65675393|NCT05618236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675394|NCT05618236|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65675395|NCT00872430|Laxatives|laxatives|mesh-list
65675396|NCT00872430|Cathartics|cathartics|mesh-list
65675397|NCT00872430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65675398|NCT00871182|Tiotropium Bromide|tiotropium bromide|mesh-list
65675399|NCT00871182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65675400|NCT00871182|Autonomic Agents|autonomic agents|mesh-ancestor
65675401|NCT00871182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65675402|NCT00871182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675403|NCT00871182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65675404|NCT00871182|Respiratory System Agents|respiratory system agents|mesh-ancestor
65675405|NCT00871182|Parasympatholytics|parasympatholytics|mesh-ancestor
65675406|NCT00871182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65675407|NCT00871182|Cholinergic Agents|cholinergic agents|mesh-ancestor
65675408|NCT00871182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65675409|NCT00871182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675410|NCT04814056|Afatinib|afatinib|mesh-list
65675411|NCT04814056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675412|NCT04814056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65675413|NCT04814056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675414|NCT04814056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675415|NCT05627154|Citalopram|citalopram|mesh-list
65675416|NCT05627154|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65472732|NCT00354107|Dermatologic Agents|dermatologic agents|mesh-ancestor
65675417|NCT05627154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65675418|NCT05627154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65675419|NCT05627154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675420|NCT05627154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65675421|NCT05627154|Serotonin Agents|serotonin agents|mesh-ancestor
65675422|NCT05627154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675423|NCT05627154|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65675424|NCT05627154|Antidepressive Agents|antidepressive agents|mesh-ancestor
65675425|NCT05627154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65675426|NCT03974854|Gemcitabine|gemcitabine|mesh-list
65675427|NCT03974854|Capecitabine|capecitabine|mesh-list
65675428|NCT03974854|Irinotecan|irinotecan|mesh-list
65675429|NCT03974854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65675430|NCT03974854|Antimetabolites|antimetabolites|mesh-ancestor
65675431|NCT03974854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675432|NCT03974854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675433|NCT03974854|Antiviral Agents|antiviral agents|mesh-ancestor
65675434|NCT03974854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65675435|NCT03974854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675436|NCT03974854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65675437|NCT03974854|Immunologic Factors|immunologic factors|mesh-ancestor
65675438|NCT03974854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675439|NCT03974854|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65675440|NCT03974854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65675441|NCT00957918|Nicotine|nicotine|mesh-list
65675442|NCT00957918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65675443|NCT00957918|Autonomic Agents|autonomic agents|mesh-ancestor
65675444|NCT00957918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65675445|NCT00957918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675446|NCT00957918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65675447|NCT00957918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65675448|NCT00957918|Cholinergic Agents|cholinergic agents|mesh-ancestor
65675449|NCT00957918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65675450|NCT00957918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675451|NCT02734862|Fluconazole|fluconazole|mesh-list
65675452|NCT02734862|Caspofungin|caspofungin|mesh-list
65675453|NCT02734862|Rezafungin|rezafungin|mesh-list
65675454|NCT02734862|Antifungal Agents|antifungal agents|mesh-ancestor
65675455|NCT02734862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65675456|NCT02734862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65675457|NCT02734862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65675458|NCT02734862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675459|NCT02734862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675460|NCT02734862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65675461|NCT02734862|Hormone Antagonists|hormone antagonists|mesh-ancestor
65675462|NCT02734862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65675463|NCT02734862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675464|NCT02734862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65675465|NCT02734862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65675466|NCT00818844|Nepafenac|nepafenac|mesh-list
65675467|NCT00818844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65675468|NCT00818844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65675469|NCT00818844|Analgesics|analgesics|mesh-ancestor
65675470|NCT00818844|Sensory System Agents|sensory system agents|mesh-ancestor
65675471|NCT00818844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65675472|NCT00818844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675473|NCT00818844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65675474|NCT00818844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65675475|NCT00862524|Gemcitabine|gemcitabine|mesh-list
65675476|NCT00862524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65675477|NCT00862524|Antimetabolites|antimetabolites|mesh-ancestor
65675478|NCT00862524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675479|NCT00862524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675480|NCT00862524|Antiviral Agents|antiviral agents|mesh-ancestor
65675481|NCT00862524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65675482|NCT00862524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675483|NCT00862524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65675484|NCT00862524|Immunologic Factors|immunologic factors|mesh-ancestor
65675485|NCT00862524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675486|NCT00858702|Olmesartan|olmesartan|mesh-list
65675487|NCT00858702|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65675488|NCT00858702|Diuretics|diuretics|mesh-list
65675489|NCT00858702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65675490|NCT00858702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65675491|NCT00858702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65675492|NCT00858702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675493|NCT00858702|Natriuretic Agents|natriuretic agents|mesh-ancestor
65675494|NCT00858702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675495|NCT00817986|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
65675496|NCT00817986|Baclofen|baclofen|mesh-list
65675497|NCT00817986|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65675498|NCT00817986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675499|NCT00817986|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65675500|NCT00817986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65675501|NCT00817986|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65675502|NCT00817986|GABA Agonists|gaba agonists|mesh-ancestor
65675503|NCT00817986|GABA Agents|gaba agents|mesh-ancestor
65675504|NCT00817986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65675505|NCT00817986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675506|NCT02598934|Ibandronic Acid|ibandronic acid|mesh-list
65675507|NCT02598934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65675508|NCT02598934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675509|NCT00817362|Trastuzumab|trastuzumab|mesh-list
65675510|NCT00817362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65675511|NCT00817362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675512|NCT04176848|Durvalumab|durvalumab|mesh-list
65675513|NCT04176848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65675514|NCT04176848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675515|NCT04163978|Budesonide|budesonide|mesh-list
65675516|NCT04163978|Nitric Oxide|nitric oxide|mesh-list
65675517|NCT04163978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65675518|NCT04163978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65675519|NCT04163978|Autonomic Agents|autonomic agents|mesh-ancestor
65675520|NCT04163978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65675521|NCT04163978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675522|NCT04163978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65675523|NCT04163978|Respiratory System Agents|respiratory system agents|mesh-ancestor
65675524|NCT04163978|Glucocorticoids|glucocorticoids|mesh-ancestor
65675525|NCT04163978|Hormones|hormones|mesh-ancestor
65675526|NCT04163978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65675527|NCT04163978|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65675528|NCT04163978|Antioxidants|antioxidants|mesh-ancestor
65675529|NCT04163978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675530|NCT04163978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65675531|NCT04163978|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65675532|NCT04163978|Vasodilator Agents|vasodilator agents|mesh-ancestor
65675533|NCT04163978|Gasotransmitters|gasotransmitters|mesh-ancestor
65675534|NCT04163978|Protective Agents|protective agents|mesh-ancestor
65675535|NCT02598622|Acetylcarnitine|acetylcarnitine|mesh-list
65675536|NCT02598622|Vitamin B Complex|vitamin b complex|mesh-ancestor
65675537|NCT02598622|Vitamins|vitamins|mesh-ancestor
65675538|NCT02598622|Micronutrients|micronutrients|mesh-ancestor
65675539|NCT02598622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675540|NCT02598622|Nootropic Agents|nootropic agents|mesh-ancestor
65675541|NCT00810732|Nifedipine|nifedipine|mesh-list
65675542|NCT00810732|Sitaxsentan|sitaxsentan|mesh-list
65675543|NCT00810732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65675544|NCT00810732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65675545|NCT00810732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675546|NCT00810732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65675547|NCT00810732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675548|NCT00810732|Vasodilator Agents|vasodilator agents|mesh-ancestor
65675549|NCT00810732|Tocolytic Agents|tocolytic agents|mesh-ancestor
65675550|NCT00810732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65675551|NCT00810732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65675552|NCT03463070|Misoprostol|misoprostol|mesh-list
65675553|NCT03463070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65675554|NCT03463070|Abortifacient Agents|abortifacient agents|mesh-ancestor
65675555|NCT03463070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65675556|NCT03463070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675557|NCT03463070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65675558|NCT03463070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65675559|NCT03463070|Oxytocics|oxytocics|mesh-ancestor
65675560|NCT00807612|Paclitaxel|paclitaxel|mesh-list
65675561|NCT00807612|Carboplatin|carboplatin|mesh-list
65675562|NCT00807612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65675563|NCT00807612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65675564|NCT00807612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472878|NCT01210742|Hylan|hylan|mesh-list
65675565|NCT00807612|Tubulin Modulators|tubulin modulators|mesh-ancestor
65675566|NCT00807612|Antimitotic Agents|antimitotic agents|mesh-ancestor
65675567|NCT00807612|Mitosis Modulators|mitosis modulators|mesh-ancestor
65675568|NCT00807612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675569|NCT00807612|Immunologic Factors|immunologic factors|mesh-ancestor
65675570|NCT00807612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675571|NCT00805350|SR 46349B|sr 46349b|mesh-list
65675572|NCT00805350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65675573|NCT00805350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65675574|NCT00805350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675575|NCT00805350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65675576|NCT00805350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65675577|NCT00805350|Serotonin Agents|serotonin agents|mesh-ancestor
65675578|NCT00805350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65675579|NCT00805350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675580|NCT04546178|Antipsychotic Agents|antipsychotic agents|mesh-list
65675581|NCT04546178|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65675582|NCT04546178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65675583|NCT04546178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675584|NCT04546178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65675585|NCT03462836|Lidocaine|lidocaine|mesh-list
65675586|NCT03462836|Ketamine|ketamine|mesh-list
65675587|NCT03462836|Anesthetics, Local|anesthetics, local|mesh-ancestor
65675588|NCT03462836|Anesthetics|anesthetics|mesh-ancestor
65675589|NCT03462836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65675590|NCT03462836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675591|NCT03462836|Sensory System Agents|sensory system agents|mesh-ancestor
65675592|NCT03462836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65675593|NCT03462836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65268669|NCT02999022|Antimanic Agents|antimanic agents|mesh-ancestor
65675594|NCT03462836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65675595|NCT03462836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65675596|NCT03462836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65675597|NCT03462836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675598|NCT03462836|Analgesics|analgesics|mesh-ancestor
65675599|NCT03462836|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65675600|NCT03462836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65675601|NCT03462836|Anesthetics, General|anesthetics, general|mesh-ancestor
65675602|NCT03462836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65675603|NCT03462836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65675604|NCT03462836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65675605|NCT00849576|Insulin|insulin|mesh-list
65675606|NCT00849576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65675607|NCT00849576|Insulin Lispro|insulin lispro|mesh-list
65675608|NCT00849576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65675609|NCT00849576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675610|NCT00841698|Paroxetine|paroxetine|mesh-list
65675611|NCT00841698|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65675612|NCT00841698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65675613|NCT00841698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65675614|NCT00841698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675615|NCT00841698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65675616|NCT00841698|Serotonin Agents|serotonin agents|mesh-ancestor
65675617|NCT00841698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675618|NCT00841698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65675619|NCT00841698|Antidepressive Agents|antidepressive agents|mesh-ancestor
65675620|NCT00841698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65675621|NCT00841698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65675622|NCT00841698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65675623|NCT00841698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675624|NCT04383002|Nitric Oxide|nitric oxide|mesh-list
65675625|NCT04383002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65675626|NCT04383002|Autonomic Agents|autonomic agents|mesh-ancestor
65675627|NCT04383002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65675628|NCT04383002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675629|NCT04383002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65675630|NCT04383002|Respiratory System Agents|respiratory system agents|mesh-ancestor
65675631|NCT04383002|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65675632|NCT04383002|Antioxidants|antioxidants|mesh-ancestor
65675633|NCT04383002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675634|NCT04383002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65675635|NCT04383002|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65675636|NCT04383002|Vasodilator Agents|vasodilator agents|mesh-ancestor
65675637|NCT04383002|Gasotransmitters|gasotransmitters|mesh-ancestor
65675638|NCT04383002|Protective Agents|protective agents|mesh-ancestor
65472954|NCT01325051|Raltegravir Potassium|raltegravir potassium|mesh-list
65675639|NCT00841542|Amlodipine|amlodipine|mesh-list
65675640|NCT00841542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65675641|NCT00841542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65675642|NCT00841542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65675643|NCT00841542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675644|NCT00841542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65675645|NCT00841542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675646|NCT00841542|Vasodilator Agents|vasodilator agents|mesh-ancestor
65675647|NCT03623750|Cyclophosphamide|cyclophosphamide|mesh-list
65675648|NCT03623750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65675649|NCT03623750|Immunologic Factors|immunologic factors|mesh-ancestor
65675650|NCT03623750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675651|NCT03623750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65675652|NCT03623750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65675653|NCT03623750|Alkylating Agents|alkylating agents|mesh-ancestor
65675654|NCT03623750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675655|NCT03623750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675656|NCT03623750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65675657|NCT00840840|Amoxicillin|amoxicillin|mesh-list
65675658|NCT00840840|Clavulanic Acid|clavulanic acid|mesh-list
65675659|NCT00840840|Clavulanic Acids|clavulanic acids|mesh-list
65675660|NCT00840840|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65675661|NCT00840840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65675662|NCT00840840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65675663|NCT00840840|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65675664|NCT00840840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675665|NCT00840840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675666|NCT03595982|Nifedipine|nifedipine|mesh-list
65675667|NCT03595982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65675668|NCT03595982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65675669|NCT03595982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675670|NCT03595982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65675671|NCT03595982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675672|NCT03595982|Vasodilator Agents|vasodilator agents|mesh-ancestor
65675673|NCT03595982|Tocolytic Agents|tocolytic agents|mesh-ancestor
65675674|NCT03595982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65675675|NCT00944970|Adenosine|adenosine|mesh-list
65675676|NCT00944970|Binodenoson|binodenoson|mesh-list
65675677|NCT00944970|Analgesics|analgesics|mesh-ancestor
65675678|NCT00944970|Sensory System Agents|sensory system agents|mesh-ancestor
65675679|NCT00944970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65675680|NCT00944970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675681|NCT00944970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65675682|NCT00944970|Vasodilator Agents|vasodilator agents|mesh-ancestor
65675683|NCT00944970|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65675684|NCT00944970|Purinergic Agonists|purinergic agonists|mesh-ancestor
65675685|NCT00944970|Purinergic Agents|purinergic agents|mesh-ancestor
65675686|NCT00944970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65675687|NCT00944970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675688|NCT00840216|Clarithromycin|clarithromycin|mesh-list
65675689|NCT00840216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65675690|NCT00840216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65675691|NCT00840216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65675692|NCT00840216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675693|NCT00840216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675694|NCT00840216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65675695|NCT00840216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65675696|NCT03462446|Vitamin K|vitamin k|mesh-list
65675697|NCT03462446|Rivaroxaban|rivaroxaban|mesh-list
65675698|NCT03462446|Vitamins|vitamins|mesh-ancestor
65675699|NCT03462446|Micronutrients|micronutrients|mesh-ancestor
65675700|NCT03462446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675701|NCT03462446|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65675702|NCT03462446|Antithrombins|antithrombins|mesh-ancestor
65675703|NCT03462446|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65675704|NCT03462446|Protease Inhibitors|protease inhibitors|mesh-ancestor
65675705|NCT03462446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675706|NCT03462446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675707|NCT03462446|Anticoagulants|anticoagulants|mesh-ancestor
65675708|NCT03462446|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65675709|NCT03462446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65675710|NCT03462446|Hemostatics|hemostatics|mesh-ancestor
65675711|NCT03462446|Coagulants|coagulants|mesh-ancestor
65675712|NCT00944892|Fasinumab|fasinumab|mesh-list
65675713|NCT00944892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65675714|NCT00944892|Analgesics|analgesics|mesh-ancestor
65675715|NCT00944892|Sensory System Agents|sensory system agents|mesh-ancestor
65675716|NCT00944892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65675717|NCT00944892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675718|NCT00939276|Nepafenac|nepafenac|mesh-list
65675719|NCT00939276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65675720|NCT00939276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65675721|NCT00939276|Analgesics|analgesics|mesh-ancestor
65675722|NCT00939276|Sensory System Agents|sensory system agents|mesh-ancestor
65675723|NCT00939276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65675724|NCT00939276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675725|NCT00939276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65675726|NCT00939276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65675727|NCT03455426|Letrozole|letrozole|mesh-list
65675728|NCT03455426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675729|NCT03455426|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65675730|NCT03455426|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65675731|NCT03455426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675732|NCT03455426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675733|NCT03455426|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65675734|NCT03455426|Hormone Antagonists|hormone antagonists|mesh-ancestor
65675735|NCT03455426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65675736|NCT03455426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675737|NCT03453632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65675738|NCT03453632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65675739|NCT03453632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65675740|NCT03453632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675741|NCT03453632|Cholinergic Agents|cholinergic agents|mesh-ancestor
65675742|NCT03453632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65675743|NCT03453632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675744|NCT00791154|Carboplatin|carboplatin|mesh-list
65675745|NCT00791154|Etoposide|etoposide|mesh-list
65675746|NCT00791154|Rilotumumab|rilotumumab|mesh-list
65675747|NCT00791154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675748|NCT00791154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65675749|NCT00791154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65675750|NCT00791154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65675751|NCT00791154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675752|NCT00791154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675753|NCT00791154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65675754|NCT00938652|Gemcitabine|gemcitabine|mesh-list
65675755|NCT00938652|Carboplatin|carboplatin|mesh-list
65675756|NCT00938652|Iniparib|iniparib|mesh-list
65675757|NCT00938652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675758|NCT00938652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65675759|NCT00938652|Antimetabolites|antimetabolites|mesh-ancestor
65675760|NCT00938652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675761|NCT00938652|Antiviral Agents|antiviral agents|mesh-ancestor
65675762|NCT00938652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65675763|NCT00938652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675764|NCT00938652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65675765|NCT00938652|Immunologic Factors|immunologic factors|mesh-ancestor
65675766|NCT00938652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675767|NCT00938652|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65675768|NCT00928590|Timolol|timolol|mesh-list
65675769|NCT00928590|Travoprost|travoprost|mesh-list
65675770|NCT00928590|Cloprostenol|cloprostenol|mesh-list
65675771|NCT00928590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675772|NCT00928590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65675773|NCT00928590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65675774|NCT00928590|Adrenergic Agents|adrenergic agents|mesh-ancestor
65675775|NCT00928590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65675776|NCT00928590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675777|NCT00928590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65675778|NCT00928590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65675779|NCT00928590|Luteolytic Agents|luteolytic agents|mesh-ancestor
65675780|NCT00928590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65675781|NCT00928590|Contraceptive Agents|contraceptive agents|mesh-ancestor
65675782|NCT00928590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65675783|NCT00928590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65675784|NCT03512756|Gemcitabine|gemcitabine|mesh-list
65675785|NCT03512756|Sirolimus|sirolimus|mesh-list
65675786|NCT03512756|Capecitabine|capecitabine|mesh-list
65675787|NCT03512756|Phenytoin|phenytoin|mesh-list
65675788|NCT03512756|Methoxsalen|methoxsalen|mesh-list
65675789|NCT03512756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65675790|NCT03512756|Antimetabolites|antimetabolites|mesh-ancestor
65675791|NCT03512756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675792|NCT03512756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675793|NCT03512756|Antiviral Agents|antiviral agents|mesh-ancestor
65675794|NCT03512756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65675795|NCT03512756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675796|NCT03512756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65675797|NCT03512756|Immunologic Factors|immunologic factors|mesh-ancestor
65675798|NCT03512756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675799|NCT03512756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65675800|NCT03512756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65675801|NCT03512756|Antifungal Agents|antifungal agents|mesh-ancestor
65675802|NCT03512756|Anticonvulsants|anticonvulsants|mesh-ancestor
65675803|NCT03512756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65675804|NCT03512756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65675805|NCT03512756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65675806|NCT03512756|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65675807|NCT03512756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65675808|NCT03512756|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65675809|NCT03512756|Dermatologic Agents|dermatologic agents|mesh-ancestor
65675810|NCT04697940|Cyclophosphamide|cyclophosphamide|mesh-list
65675811|NCT04697940|Fludarabine|fludarabine|mesh-list
65675812|NCT04697940|Fludarabine phosphate|fludarabine phosphate|mesh-list
65675813|NCT04697940|Decitabine|decitabine|mesh-list
65675814|NCT04697940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65675815|NCT04697940|Immunologic Factors|immunologic factors|mesh-ancestor
65675816|NCT04697940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675817|NCT04697940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65675818|NCT04697940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65675819|NCT04697940|Alkylating Agents|alkylating agents|mesh-ancestor
65675820|NCT04697940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675821|NCT04697940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675822|NCT04697940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65675823|NCT04697940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65675824|NCT04697940|Antimetabolites|antimetabolites|mesh-ancestor
65675825|NCT04697940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675826|NCT00836706|Clarithromycin|clarithromycin|mesh-list
65675827|NCT00836706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65675828|NCT00836706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65675829|NCT00836706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65675830|NCT00836706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675831|NCT00836706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675832|NCT00836706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65675833|NCT00836706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65675834|NCT00836472|Metformin|metformin|mesh-list
65675835|NCT00836472|Glyburide|glyburide|mesh-list
65675836|NCT00836472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65675837|NCT00836472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675838|NCT04473846|Anesthetics|anesthetics|mesh-list
65675839|NCT04473846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65675840|NCT04473846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675841|NCT04179032|Belimumab|belimumab|mesh-list
65675842|NCT04179032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65675843|NCT04179032|Immunologic Factors|immunologic factors|mesh-ancestor
65675844|NCT04179032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675845|NCT03129698|Apatinib|apatinib|mesh-list
65675846|NCT03129698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675847|NCT03129698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65675848|NCT03129698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675849|NCT03129698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675850|NCT03355118|Anesthetics|anesthetics|mesh-list
65675851|NCT03355118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65675852|NCT03355118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675853|NCT03263078|Propofol|propofol|mesh-list
65675854|NCT03263078|Sevoflurane|sevoflurane|mesh-list
65675855|NCT03263078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65675856|NCT03263078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65675857|NCT03263078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675858|NCT03263078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65675859|NCT03263078|Anesthetics, General|anesthetics, general|mesh-ancestor
65675860|NCT03263078|Anesthetics|anesthetics|mesh-ancestor
65675861|NCT03263078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65675862|NCT03263078|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65675863|NCT05349006|Azathioprine|azathioprine|mesh-list
65675864|NCT05349006|Antimetabolites|antimetabolites|mesh-ancestor
65675865|NCT05349006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675866|NCT05349006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65675867|NCT05349006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675868|NCT05349006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65675869|NCT05349006|Immunologic Factors|immunologic factors|mesh-ancestor
65675870|NCT05349006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675871|NCT05349006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65675872|NCT00785226|Sorafenib|sorafenib|mesh-list
65675873|NCT00785226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675874|NCT00785226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65675875|NCT00785226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675876|NCT00785226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675877|NCT03448640|Tropicamide|tropicamide|mesh-list
65675878|NCT03448640|Mydriatics|mydriatics|mesh-ancestor
65675879|NCT03448640|Autonomic Agents|autonomic agents|mesh-ancestor
65675880|NCT03448640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65675881|NCT03448640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675882|NCT03448640|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65675883|NCT03448640|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65675884|NCT03448640|Cholinergic Agents|cholinergic agents|mesh-ancestor
65675885|NCT03448640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65675886|NCT03448640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675887|NCT00836004|Clindamycin|clindamycin|mesh-list
65675888|NCT00836004|Clindamycin palmitate|clindamycin palmitate|mesh-list
65675889|NCT00836004|Clindamycin phosphate|clindamycin phosphate|mesh-list
65675890|NCT00836004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65675891|NCT00836004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65675892|NCT00836004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65675893|NCT00836004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675894|NCT00836004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675895|NCT00917826|Valganciclovir|valganciclovir|mesh-list
65675896|NCT00917826|Ganciclovir|ganciclovir|mesh-list
65675897|NCT00917826|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65675898|NCT00917826|Arginine butyrate|arginine butyrate|mesh-list
65675899|NCT00917826|Antiviral Agents|antiviral agents|mesh-ancestor
65675900|NCT00917826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65675901|NCT00917826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65675902|NCT00917826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675903|NCT00917826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675904|NCT00917826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675905|NCT04819906|Moxifloxacin|moxifloxacin|mesh-list
65675906|NCT04819906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65675907|NCT04819906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65675908|NCT04819906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65675909|NCT04819906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65675910|NCT04819906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675911|NCT04819906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675912|NCT04819906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675913|NCT03102320|Gemcitabine|gemcitabine|mesh-list
65675914|NCT03102320|Maytansine|maytansine|mesh-list
65675915|NCT03102320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675916|NCT03102320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65675917|NCT03102320|Antimetabolites|antimetabolites|mesh-ancestor
65675918|NCT03102320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675919|NCT03102320|Antiviral Agents|antiviral agents|mesh-ancestor
65675920|NCT03102320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65675921|NCT03102320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675922|NCT03102320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65675923|NCT03102320|Immunologic Factors|immunologic factors|mesh-ancestor
65675924|NCT03102320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675925|NCT03102320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65675926|NCT03102320|Tubulin Modulators|tubulin modulators|mesh-ancestor
65675927|NCT03102320|Antimitotic Agents|antimitotic agents|mesh-ancestor
65675928|NCT03102320|Mitosis Modulators|mitosis modulators|mesh-ancestor
65675929|NCT00835692|Clarithromycin|clarithromycin|mesh-list
65675930|NCT00835692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65675931|NCT00835692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65675932|NCT00835692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65675933|NCT00835692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675934|NCT00835692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675935|NCT00835692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65473249|NCT01213550|Chlorhexidine|chlorhexidine|mesh-list
65675936|NCT00835692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65675938|NCT00835614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65675939|NCT00835614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65675940|NCT00835536|Ribavirin|ribavirin|mesh-list
65675941|NCT00835536|Antimetabolites|antimetabolites|mesh-ancestor
65675942|NCT00835536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675943|NCT00835536|Antiviral Agents|antiviral agents|mesh-ancestor
65675944|NCT00835536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65675945|NCT01744652|Dasatinib|dasatinib|mesh-list
65675946|NCT01744652|Crizotinib|crizotinib|mesh-list
65675947|NCT01744652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675948|NCT01744652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65675949|NCT01744652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675950|NCT01744652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675951|NCT04561362|Pembrolizumab|pembrolizumab|mesh-list
65675952|NCT04561362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65675953|NCT04561362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675954|NCT04060628|Docetaxel|docetaxel|mesh-list
65675955|NCT04060628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675956|NCT04060628|Tubulin Modulators|tubulin modulators|mesh-ancestor
65675957|NCT04060628|Antimitotic Agents|antimitotic agents|mesh-ancestor
65675958|NCT04060628|Mitosis Modulators|mitosis modulators|mesh-ancestor
65675959|NCT04060628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675960|NCT04356664|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65675961|NCT04356664|Luteolytic Agents|luteolytic agents|mesh-ancestor
65675962|NCT04356664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65675963|NCT04356664|Contraceptive Agents|contraceptive agents|mesh-ancestor
65675964|NCT04356664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65675965|NCT04356664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675966|NCT04356664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65675967|NCT04356664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65675968|NCT04356664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675969|NCT04037072|Mitomycins|mitomycins|mesh-list
65675970|NCT04037072|Mitomycin|mitomycin|mesh-list
65675971|NCT04037072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65675972|NCT04037072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65675973|NCT04037072|Alkylating Agents|alkylating agents|mesh-ancestor
65675974|NCT04037072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675975|NCT04037072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65675976|NCT04037072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65675977|NCT04819438|Riluzole|riluzole|mesh-list
65675978|NCT04819438|Anticonvulsants|anticonvulsants|mesh-ancestor
65675979|NCT04819438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65675980|NCT04819438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65675981|NCT04819438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65675982|NCT04819438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675983|NCT04819438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675984|NCT04819438|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65675985|NCT04819438|Protective Agents|protective agents|mesh-ancestor
65675986|NCT05616910|Nitric Oxide|nitric oxide|mesh-list
65675987|NCT05616910|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65675988|NCT05616910|Autonomic Agents|autonomic agents|mesh-ancestor
65675989|NCT05616910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65675990|NCT05616910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65675991|NCT05616910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65675992|NCT05616910|Respiratory System Agents|respiratory system agents|mesh-ancestor
65675993|NCT05616910|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65675994|NCT05616910|Antioxidants|antioxidants|mesh-ancestor
65675995|NCT05616910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65675996|NCT05616910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65675997|NCT05616910|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65675998|NCT05616910|Vasodilator Agents|vasodilator agents|mesh-ancestor
65675999|NCT05616910|Gasotransmitters|gasotransmitters|mesh-ancestor
65676000|NCT05616910|Protective Agents|protective agents|mesh-ancestor
65676001|NCT04537026|Dexamethasone|dexamethasone|mesh-list
65676002|NCT04537026|Dexamethasone acetate|dexamethasone acetate|mesh-list
65676003|NCT04537026|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65676004|NCT04537026|BB 1101|bb 1101|mesh-list
65676005|NCT04537026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65676006|NCT04537026|Antiemetics|antiemetics|mesh-ancestor
65676007|NCT04537026|Autonomic Agents|autonomic agents|mesh-ancestor
65676008|NCT04537026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676009|NCT04537026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676010|NCT04537026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65676011|NCT04537026|Glucocorticoids|glucocorticoids|mesh-ancestor
65676012|NCT04537026|Hormones|hormones|mesh-ancestor
65676013|NCT04537026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65676014|NCT04537026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65676015|NCT04537026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676016|NCT04537026|Protease Inhibitors|protease inhibitors|mesh-ancestor
65676017|NCT04537026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676018|NCT04537026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676019|NCT04819828|Diclofenac|diclofenac|mesh-list
65676020|NCT04819828|Tamsulosin|tamsulosin|mesh-list
65676021|NCT04819828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65676022|NCT04819828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65676023|NCT04819828|Analgesics|analgesics|mesh-ancestor
65676024|NCT04819828|Sensory System Agents|sensory system agents|mesh-ancestor
65676025|NCT04819828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676026|NCT04819828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676027|NCT04819828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65676028|NCT04819828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65676029|NCT04819828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65676030|NCT04819828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676031|NCT04819828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676032|NCT04819828|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65676033|NCT04819828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65676034|NCT04819828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65676035|NCT04819828|Adrenergic Agents|adrenergic agents|mesh-ancestor
65676036|NCT04819828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65676037|NCT04819828|Urological Agents|urological agents|mesh-ancestor
65676038|NCT02602288|Nicotine|nicotine|mesh-list
65676039|NCT02602288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65676040|NCT02602288|Autonomic Agents|autonomic agents|mesh-ancestor
65676041|NCT02602288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676042|NCT02602288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676043|NCT02602288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65676044|NCT02602288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65676045|NCT02602288|Cholinergic Agents|cholinergic agents|mesh-ancestor
65676046|NCT02602288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65676047|NCT02602288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676048|NCT03745352|Azacitidine|azacitidine|mesh-list
65676049|NCT03745352|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65676050|NCT03745352|Pevonedistat|pevonedistat|mesh-list
65676051|NCT03745352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65676052|NCT03745352|Antimetabolites|antimetabolites|mesh-ancestor
65676053|NCT03745352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676054|NCT03745352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676055|NCT03740126|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65676056|NCT03740126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65676057|NCT03740126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676058|NCT05617690|Propofol|propofol|mesh-list
65676059|NCT05617690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65676060|NCT05617690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65676061|NCT05617690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676062|NCT05617690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65676063|NCT05617690|Anesthetics, General|anesthetics, general|mesh-ancestor
65676064|NCT05617690|Anesthetics|anesthetics|mesh-ancestor
65676065|NCT03448094|Resveratrol|resveratrol|mesh-list
65676066|NCT03448094|Antioxidants|antioxidants|mesh-ancestor
65676067|NCT03448094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676068|NCT03448094|Protective Agents|protective agents|mesh-ancestor
65676069|NCT03448094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676070|NCT03448094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676071|NCT03448094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65676072|NCT04819204|Cetrorelix|cetrorelix|mesh-list
65676073|NCT04819204|Testosterone|testosterone|mesh-list
65676074|NCT04819204|Androgens|androgens|mesh-ancestor
65676075|NCT04819204|Hormones|hormones|mesh-ancestor
65676076|NCT04819204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65676077|NCT04819204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676078|NCT04819204|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65676079|NCT04819204|Fertility Agents|fertility agents|mesh-ancestor
65676080|NCT04819204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65676081|NCT04819204|Hormone Antagonists|hormone antagonists|mesh-ancestor
65676082|NCT02807454|Dexamethasone|dexamethasone|mesh-list
65676083|NCT02807454|Durvalumab|durvalumab|mesh-list
65676084|NCT02807454|Daratumumab|daratumumab|mesh-list
65676085|NCT02807454|Pomalidomide|pomalidomide|mesh-list
65473399|NCT01219400|Vildagliptin|vildagliptin|mesh-list
65676086|NCT02807454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65676087|NCT02807454|Antiemetics|antiemetics|mesh-ancestor
65676088|NCT02807454|Autonomic Agents|autonomic agents|mesh-ancestor
65676089|NCT02807454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676090|NCT02807454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676091|NCT02807454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65676092|NCT02807454|Glucocorticoids|glucocorticoids|mesh-ancestor
65676093|NCT02807454|Hormones|hormones|mesh-ancestor
65676094|NCT02807454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65676095|NCT02807454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65676096|NCT02807454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676097|NCT02807454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65676098|NCT02807454|Immunologic Factors|immunologic factors|mesh-ancestor
65676099|NCT02807454|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65676100|NCT02807454|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65676101|NCT02807454|Growth Substances|growth substances|mesh-ancestor
65676102|NCT02807454|Growth Inhibitors|growth inhibitors|mesh-ancestor
65676103|NCT05320874|Antibodies|antibodies|mesh-list
65676104|NCT05320874|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65676105|NCT05320874|Immunologic Factors|immunologic factors|mesh-ancestor
65676106|NCT05320874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676107|NCT03728556|Antibodies|antibodies|mesh-list
65676108|NCT03728556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65676109|NCT03728556|Immunologic Factors|immunologic factors|mesh-ancestor
65676110|NCT03728556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676111|NCT04501614|Ponatinib|ponatinib|mesh-list
65676112|NCT04501614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676113|NCT04501614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65676114|NCT04501614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676115|NCT04501614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676116|NCT05320640|Decitabine|decitabine|mesh-list
65676117|NCT05320640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65676118|NCT05320640|Antibodies|antibodies|mesh-list
65676119|NCT05320640|Immunologic Factors|immunologic factors|mesh-ancestor
65676120|NCT05320640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676121|NCT05320640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65676122|NCT05320640|Antimetabolites|antimetabolites|mesh-ancestor
65676123|NCT05320640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676124|NCT05320640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676125|NCT05320640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676126|NCT00835146|Ribavirin|ribavirin|mesh-list
65676127|NCT00835146|Antimetabolites|antimetabolites|mesh-ancestor
65676128|NCT00835146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676129|NCT00835146|Antiviral Agents|antiviral agents|mesh-ancestor
65676130|NCT00835146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65676131|NCT04472910|Folfirinox|folfirinox|mesh-list
65676132|NCT04472910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676133|NCT01479842|Rituximab|rituximab|mesh-list
65676134|NCT01479842|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65676135|NCT01479842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65676136|NCT01479842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676137|NCT01479842|Immunologic Factors|immunologic factors|mesh-ancestor
65676138|NCT01479842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676139|NCT01479842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65676140|NCT01479842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65676141|NCT01479842|Alkylating Agents|alkylating agents|mesh-ancestor
65676142|NCT01479842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676143|NCT04818736|Vaccines|vaccines|mesh-list
65676144|NCT04818736|Immunologic Factors|immunologic factors|mesh-ancestor
65676145|NCT04818736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676146|NCT03719430|Doxorubicin|doxorubicin|mesh-list
65676147|NCT03719430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65676148|NCT03719430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676149|NCT03719430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65676150|NCT03719430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65676151|NCT03719430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676152|NCT03719430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676153|NCT04811326|Latanoprost|latanoprost|mesh-list
65676154|NCT04811326|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65676155|NCT04811326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65676156|NCT00834990|Valproic Acid|valproic acid|mesh-list
65676157|NCT00834990|Anticonvulsants|anticonvulsants|mesh-ancestor
65676158|NCT00834990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676159|NCT00834990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676160|NCT00834990|GABA Agents|gaba agents|mesh-ancestor
65676161|NCT00834990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65676162|NCT00834990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676163|NCT00834990|Antimanic Agents|antimanic agents|mesh-ancestor
65676164|NCT00834990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65676165|NCT00834990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65676166|NCT00834990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65676167|NCT04479072|Aspirin|aspirin|mesh-list
65676168|NCT04479072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65676169|NCT04479072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65676170|NCT04479072|Analgesics|analgesics|mesh-ancestor
65676171|NCT04479072|Sensory System Agents|sensory system agents|mesh-ancestor
65676172|NCT04479072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676173|NCT04479072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676174|NCT04479072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65676175|NCT04479072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65676176|NCT04479072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65676177|NCT04479072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65676178|NCT04479072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676179|NCT04479072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65676180|NCT04479072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65676181|NCT04479072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676182|NCT04479072|Antipyretics|antipyretics|mesh-ancestor
65676183|NCT04425018|Paclitaxel|paclitaxel|mesh-list
65676184|NCT04425018|Trastuzumab|trastuzumab|mesh-list
65676185|NCT04425018|Pertuzumab|pertuzumab|mesh-list
65676186|NCT04425018|Margetuximab|margetuximab|mesh-list
65676187|NCT04425018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65676188|NCT04425018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676189|NCT04425018|Tubulin Modulators|tubulin modulators|mesh-ancestor
65676190|NCT04425018|Antimitotic Agents|antimitotic agents|mesh-ancestor
65676191|NCT04425018|Mitosis Modulators|mitosis modulators|mesh-ancestor
65676192|NCT04425018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676193|NCT04425018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65676194|NCT03036202|Epinephrine|epinephrine|mesh-list
65676195|NCT03036202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65676196|NCT03036202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65676197|NCT03036202|Adrenergic Agents|adrenergic agents|mesh-ancestor
65676198|NCT03036202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65676199|NCT03036202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676200|NCT03036202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676201|NCT03036202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65676202|NCT03036202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65676203|NCT03036202|Autonomic Agents|autonomic agents|mesh-ancestor
65676204|NCT03036202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676205|NCT03036202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65676206|NCT03036202|Respiratory System Agents|respiratory system agents|mesh-ancestor
65676207|NCT03036202|Mydriatics|mydriatics|mesh-ancestor
65676208|NCT03036202|Sympathomimetics|sympathomimetics|mesh-ancestor
65676209|NCT03036202|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65676210|NCT03245918|Aprepitant|aprepitant|mesh-list
65676211|NCT03245918|Fosaprepitant|fosaprepitant|mesh-list
65676212|NCT03245918|Antiemetics|antiemetics|mesh-ancestor
65676213|NCT03245918|Autonomic Agents|autonomic agents|mesh-ancestor
65676214|NCT03245918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676215|NCT03245918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676216|NCT03245918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65676217|NCT03245918|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65676218|NCT03245918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65676219|NCT03245918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676220|NCT02597062|Dexamethasone|dexamethasone|mesh-list
65676221|NCT02597062|Cyclophosphamide|cyclophosphamide|mesh-list
65676222|NCT02597062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65676223|NCT02597062|Immunologic Factors|immunologic factors|mesh-ancestor
65676224|NCT02597062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676225|NCT02597062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65676226|NCT02597062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65676227|NCT02597062|Alkylating Agents|alkylating agents|mesh-ancestor
65676228|NCT02597062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676229|NCT02597062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676230|NCT02597062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65676231|NCT02597062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65676232|NCT02597062|Antiemetics|antiemetics|mesh-ancestor
65676233|NCT02597062|Autonomic Agents|autonomic agents|mesh-ancestor
65676234|NCT02597062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676235|NCT02597062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65676236|NCT02597062|Glucocorticoids|glucocorticoids|mesh-ancestor
65676237|NCT02597062|Hormones|hormones|mesh-ancestor
65676238|NCT02597062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65676239|NCT02597062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65676240|NCT00834756|Azithromycin|azithromycin|mesh-list
65676241|NCT00834756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65676242|NCT00834756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65676243|NCT00828854|Entinostat|entinostat|mesh-list
65676244|NCT00828854|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65676245|NCT00828854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65676246|NCT00828854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676247|NCT00828854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676248|NCT00828854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65676249|NCT00828854|Hormone Antagonists|hormone antagonists|mesh-ancestor
65676250|NCT00828854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65676251|NCT00828854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676252|NCT00828854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676253|NCT00828854|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65676254|NCT00834522|Granisetron|granisetron|mesh-list
65676255|NCT00834522|Antiemetics|antiemetics|mesh-ancestor
65676256|NCT00834522|Autonomic Agents|autonomic agents|mesh-ancestor
65676257|NCT00834522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676258|NCT00834522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676259|NCT00834522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65676260|NCT00834522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65676261|NCT00834522|Serotonin Agents|serotonin agents|mesh-ancestor
65676262|NCT00834522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65676263|NCT00834522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676264|NCT00834444|Famciclovir|famciclovir|mesh-list
65676265|NCT00834444|Antiviral Agents|antiviral agents|mesh-ancestor
65676266|NCT00834444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65676267|NCT00834444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65676268|NCT00834444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676269|NCT00834444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676270|NCT05174858|Hemostatics|hemostatics|mesh-list
65676271|NCT05174858|Coagulants|coagulants|mesh-ancestor
65676272|NCT04831294|Cannabidiol|cannabidiol|mesh-list
65676273|NCT04831294|Anticonvulsants|anticonvulsants|mesh-ancestor
65676274|NCT00834132|Azithromycin|azithromycin|mesh-list
65676275|NCT00834132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65676276|NCT00834132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65676277|NCT00833664|Terbinafine|terbinafine|mesh-list
65676278|NCT00833664|Antifungal Agents|antifungal agents|mesh-ancestor
65676279|NCT00833664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65676280|NCT00833664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676281|NCT00833664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676282|NCT00833586|Terbinafine|terbinafine|mesh-list
65676283|NCT00833586|Antifungal Agents|antifungal agents|mesh-ancestor
65676284|NCT00833586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65676285|NCT00833586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676286|NCT00833586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676287|NCT02605954|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65676288|NCT02605954|Antiviral Agents|antiviral agents|mesh-ancestor
65676289|NCT02605954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65676290|NCT03447470|Nivolumab|nivolumab|mesh-list
65676291|NCT03447470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65676292|NCT03447470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676293|NCT03447470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65676294|NCT03447470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676295|NCT04817800|Azelastine|azelastine|mesh-list
65676296|NCT04817800|Beclomethasone|beclomethasone|mesh-list
65676297|NCT04817800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65676298|NCT04817800|Glucocorticoids|glucocorticoids|mesh-ancestor
65676299|NCT04817800|Hormones|hormones|mesh-ancestor
65676300|NCT04817800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65676301|NCT04817800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676302|NCT04817800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65676303|NCT04817800|Respiratory System Agents|respiratory system agents|mesh-ancestor
65676304|NCT04817800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65676305|NCT04817800|Autonomic Agents|autonomic agents|mesh-ancestor
65676306|NCT04817800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676307|NCT04817800|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65676308|NCT04817800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676309|NCT04817800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676310|NCT04817800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65676311|NCT04817800|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65676312|NCT04817800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65676313|NCT04817800|Histamine Antagonists|histamine antagonists|mesh-ancestor
65676314|NCT04817800|Histamine Agents|histamine agents|mesh-ancestor
65676315|NCT04817800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65676316|NCT00765804|Dexamethasone|dexamethasone|mesh-list
65676317|NCT00765804|Citric Acid|citric acid|mesh-list
65676318|NCT00765804|Sodium Citrate|sodium citrate|mesh-list
65676319|NCT00765804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65676320|NCT00765804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65676321|NCT00765804|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65676322|NCT00765804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65676323|NCT00765804|Antiemetics|antiemetics|mesh-ancestor
65676324|NCT00765804|Autonomic Agents|autonomic agents|mesh-ancestor
65676325|NCT00765804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676326|NCT00765804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676327|NCT00765804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65676328|NCT00765804|Glucocorticoids|glucocorticoids|mesh-ancestor
65676330|NCT00765804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65676331|NCT00765804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65676332|NCT00765804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676333|NCT00765804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676334|NCT00765804|Anticoagulants|anticoagulants|mesh-ancestor
65676335|NCT00765804|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65676336|NCT00765804|Chelating Agents|chelating agents|mesh-ancestor
65676337|NCT00765804|Sequestering Agents|sequestering agents|mesh-ancestor
65676338|NCT00764634|Vaccines|vaccines|mesh-list
65676339|NCT00764634|Immunologic Factors|immunologic factors|mesh-ancestor
65676340|NCT00764634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676341|NCT04345146|Bevacizumab|bevacizumab|mesh-list
65676342|NCT04345146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65676343|NCT04345146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676344|NCT04345146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65676345|NCT04345146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65676346|NCT04345146|Growth Substances|growth substances|mesh-ancestor
65676347|NCT04345146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676348|NCT04345146|Growth Inhibitors|growth inhibitors|mesh-ancestor
65676349|NCT03443726|Epinephrine|epinephrine|mesh-list
65676350|NCT03443726|Carticaine|carticaine|mesh-list
65676351|NCT03443726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65676352|NCT03443726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65676353|NCT03443726|Adrenergic Agents|adrenergic agents|mesh-ancestor
65676354|NCT03443726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65676355|NCT03443726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676356|NCT03443726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676357|NCT03443726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65676358|NCT03443726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65676359|NCT03443726|Autonomic Agents|autonomic agents|mesh-ancestor
65676360|NCT03443726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676361|NCT03443726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65676362|NCT03443726|Respiratory System Agents|respiratory system agents|mesh-ancestor
65676363|NCT03443726|Mydriatics|mydriatics|mesh-ancestor
65676364|NCT03443726|Sympathomimetics|sympathomimetics|mesh-ancestor
65676365|NCT03443726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65676366|NCT03443726|Anesthetics, Local|anesthetics, local|mesh-ancestor
65676367|NCT03443726|Anesthetics|anesthetics|mesh-ancestor
65676368|NCT03443726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65676369|NCT03443726|Sensory System Agents|sensory system agents|mesh-ancestor
65676370|NCT00760344|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65676371|NCT00760344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65676372|NCT00760344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676373|NCT00760344|Incretins|incretins|mesh-ancestor
65676374|NCT00760344|Hormones|hormones|mesh-ancestor
65676375|NCT00760344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65676376|NCT00760344|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65676377|NCT00760344|Protease Inhibitors|protease inhibitors|mesh-ancestor
65676378|NCT00760344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676379|NCT00760344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676380|NCT03443570|Rituximab|rituximab|mesh-list
65676381|NCT03443570|Bortezomib|bortezomib|mesh-list
65676382|NCT03443570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65676383|NCT03443570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676384|NCT03443570|Immunologic Factors|immunologic factors|mesh-ancestor
65676385|NCT03443570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676386|NCT03443570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65676387|NCT02718404|Analgesics|analgesics|mesh-list
65676388|NCT02718404|Sensory System Agents|sensory system agents|mesh-ancestor
65676389|NCT02718404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676390|NCT02718404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676391|NCT03443492|Leucovorin|leucovorin|mesh-list
65676392|NCT03443492|Gemcitabine|gemcitabine|mesh-list
65676393|NCT03443492|Oxaliplatin|oxaliplatin|mesh-list
65676394|NCT03443492|Irinotecan|irinotecan|mesh-list
65676395|NCT03443492|Levoleucovorin|levoleucovorin|mesh-list
65676396|NCT03443492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65676397|NCT03443492|Antimetabolites|antimetabolites|mesh-ancestor
65676398|NCT03443492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676399|NCT03443492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676400|NCT03443492|Antiviral Agents|antiviral agents|mesh-ancestor
65676401|NCT03443492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65676402|NCT03443492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676403|NCT03443492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65676404|NCT03443492|Immunologic Factors|immunologic factors|mesh-ancestor
65676405|NCT03443492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676406|NCT03443492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65676407|NCT03443492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65676408|NCT03443492|Antidotes|antidotes|mesh-ancestor
65676409|NCT03443492|Protective Agents|protective agents|mesh-ancestor
65676410|NCT03443492|Vitamin B Complex|vitamin b complex|mesh-ancestor
65676411|NCT03443492|Vitamins|vitamins|mesh-ancestor
65676412|NCT03443492|Micronutrients|micronutrients|mesh-ancestor
65676413|NCT01333046|Azacitidine|azacitidine|mesh-list
65676414|NCT01333046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65676415|NCT01333046|Antimetabolites|antimetabolites|mesh-ancestor
65676416|NCT01333046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676417|NCT01333046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676418|NCT01333046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676419|NCT00724698|Desloratadine|desloratadine|mesh-list
65676420|NCT00724698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65676421|NCT00724698|Cholinergic Agents|cholinergic agents|mesh-ancestor
65676422|NCT00724698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65676423|NCT00724698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676424|NCT00724698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676425|NCT00724698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65676426|NCT00724698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65676427|NCT00724698|Histamine Antagonists|histamine antagonists|mesh-ancestor
65676428|NCT00724698|Histamine Agents|histamine agents|mesh-ancestor
65676429|NCT00722592|Doxorubicin|doxorubicin|mesh-list
65676430|NCT00722592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65676431|NCT00722592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65676432|NCT00722592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676433|NCT00722592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65676434|NCT00722592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65676435|NCT00722592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676436|NCT00722592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676437|NCT00829998|Zaleplon|zaleplon|mesh-list
65676438|NCT00829998|Anticonvulsants|anticonvulsants|mesh-ancestor
65676439|NCT00829998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65676440|NCT00829998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65676441|NCT00829998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676442|NCT00829998|GABA Modulators|gaba modulators|mesh-ancestor
65676443|NCT00829998|GABA Agents|gaba agents|mesh-ancestor
65676444|NCT00829998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65676445|NCT00829998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676446|NCT00722358|Asunaprevir|asunaprevir|mesh-list
65676447|NCT00722358|Protease Inhibitors|protease inhibitors|mesh-ancestor
65676448|NCT00722358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676449|NCT00722358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676450|NCT00719550|Capecitabine|capecitabine|mesh-list
65676451|NCT00719550|Epirubicin|epirubicin|mesh-list
65676452|NCT00719550|Rilotumumab|rilotumumab|mesh-list
65676453|NCT00719550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676454|NCT00719550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65676455|NCT00719550|Antimetabolites|antimetabolites|mesh-ancestor
65676456|NCT00719550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676457|NCT00719550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65676458|NCT00719550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65676459|NCT00719550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65676460|NCT00719550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676461|NCT00719550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65676462|NCT03443180|Trypsin Inhibitors|trypsin inhibitors|mesh-list
65473788|NCT03706300|Ephedrine|ephedrine|mesh-list
65676463|NCT03443180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65676464|NCT03443180|Protease Inhibitors|protease inhibitors|mesh-ancestor
65676465|NCT03443180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676466|NCT03443180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676467|NCT05016518|Propofol|propofol|mesh-list
65676468|NCT05016518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65676469|NCT05016518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65676470|NCT05016518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676471|NCT05016518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65676472|NCT05016518|Anesthetics, General|anesthetics, general|mesh-ancestor
65676473|NCT05016518|Anesthetics|anesthetics|mesh-ancestor
65676474|NCT04249362|Durvalumab|durvalumab|mesh-list
65676475|NCT04249362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65676476|NCT04249362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676477|NCT03446534|Amoxicillin|amoxicillin|mesh-list
65676478|NCT03446534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65676479|NCT03446534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65676480|NCT00829764|Doxycycline|doxycycline|mesh-list
65676481|NCT00829764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65676482|NCT00829764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65676483|NCT00829764|Antimalarials|antimalarials|mesh-ancestor
65676484|NCT00829764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65676485|NCT00829764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65676486|NCT00718224|Enoxaparin|enoxaparin|mesh-list
65676487|NCT00718224|Semuloparin|semuloparin|mesh-list
65676488|NCT00718224|Anticoagulants|anticoagulants|mesh-ancestor
65676489|NCT00718224|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65676490|NCT00718224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65676491|NCT00718224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676492|NCT03129542|Midodrine|midodrine|mesh-list
65676493|NCT03129542|Sympathomimetics|sympathomimetics|mesh-ancestor
65676494|NCT03129542|Autonomic Agents|autonomic agents|mesh-ancestor
65676495|NCT03129542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676496|NCT03129542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676497|NCT03129542|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65676498|NCT03129542|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65676499|NCT03129542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65676500|NCT03129542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65676501|NCT03129542|Adrenergic Agents|adrenergic agents|mesh-ancestor
65676502|NCT03129542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65676503|NCT03129542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676504|NCT03129074|Capecitabine|capecitabine|mesh-list
65676505|NCT03129074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65676506|NCT03129074|Antimetabolites|antimetabolites|mesh-ancestor
65676507|NCT03129074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676508|NCT03129074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676509|NCT03449654|Liraglutide|liraglutide|mesh-list
65676510|NCT03449654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65676511|NCT03449654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676512|NCT03449654|Incretins|incretins|mesh-ancestor
65676513|NCT03449654|Hormones|hormones|mesh-ancestor
65676514|NCT03449654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65676515|NCT03388008|Mycophenolic Acid|mycophenolic acid|mesh-list
65676516|NCT03388008|Prednisone|prednisone|mesh-list
65676517|NCT03388008|Methylprednisolone|methylprednisolone|mesh-list
65676518|NCT03388008|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65676519|NCT03388008|Abatacept|abatacept|mesh-list
65676520|NCT03388008|Tacrolimus|tacrolimus|mesh-list
65676521|NCT03388008|Thymoglobulin|thymoglobulin|mesh-list
65676522|NCT03388008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65676523|NCT03388008|Glucocorticoids|glucocorticoids|mesh-ancestor
65676524|NCT03388008|Hormones|hormones|mesh-ancestor
65676525|NCT03388008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65676526|NCT03388008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676527|NCT03388008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65676528|NCT03388008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676529|NCT03388008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65676530|NCT03388008|Immunologic Factors|immunologic factors|mesh-ancestor
65676531|NCT03388008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65676532|NCT03388008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676533|NCT03388008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676534|NCT03388008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65676535|NCT03388008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65676536|NCT03388008|Antitubercular Agents|antitubercular agents|mesh-ancestor
65676537|NCT03388008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65676538|NCT03388008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65676539|NCT03388008|Antiemetics|antiemetics|mesh-ancestor
65676540|NCT03388008|Autonomic Agents|autonomic agents|mesh-ancestor
65676541|NCT03388008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676542|NCT03388008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65676543|NCT03388008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65676544|NCT03388008|Protective Agents|protective agents|mesh-ancestor
65676545|NCT03388008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65676546|NCT03388008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65676547|NCT00710580|Etanercept|etanercept|mesh-list
65676548|NCT00710580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65676549|NCT00710580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65676550|NCT00710580|Analgesics|analgesics|mesh-ancestor
65676551|NCT00710580|Sensory System Agents|sensory system agents|mesh-ancestor
65676552|NCT00710580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676553|NCT00710580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676554|NCT00710580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65676555|NCT00710580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65676556|NCT00710580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65676557|NCT00710580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65676558|NCT00710580|Immunologic Factors|immunologic factors|mesh-ancestor
65676559|NCT00829686|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65676560|NCT00829686|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65676561|NCT00829686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65676562|NCT00829686|Renal Agents|renal agents|mesh-ancestor
65676563|NCT00829686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65676564|NCT00829686|Antimalarials|antimalarials|mesh-ancestor
65676565|NCT00829686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65676566|NCT00829686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65676567|NCT00829530|Ramipril|ramipril|mesh-list
65676568|NCT00829530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65676569|NCT00829530|Protease Inhibitors|protease inhibitors|mesh-ancestor
65676570|NCT00829530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676571|NCT00829530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676572|NCT00829530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65676573|NCT01377194|Milnacipran|milnacipran|mesh-list
65676574|NCT01377194|Levomilnacipran|levomilnacipran|mesh-list
65676575|NCT01377194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65676576|NCT01377194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65676577|NCT01377194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65676578|NCT01377194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676579|NCT01377194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65676580|NCT01377194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676581|NCT01377194|Antidepressive Agents|antidepressive agents|mesh-ancestor
65676582|NCT01377194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65676583|NCT01377194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65676584|NCT01377194|Analgesics|analgesics|mesh-ancestor
65676585|NCT01377194|Sensory System Agents|sensory system agents|mesh-ancestor
65676586|NCT01377194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676587|NCT00829452|Ramipril|ramipril|mesh-list
65676588|NCT00829452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65676589|NCT00829452|Protease Inhibitors|protease inhibitors|mesh-ancestor
65676590|NCT00829452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676591|NCT00829452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676592|NCT00829452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65676593|NCT00747318|Fluticasone|fluticasone|mesh-list
65676595|NCT00747318|Formoterol Fumarate|formoterol fumarate|mesh-list
65676596|NCT00747318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65676597|NCT00747318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65676598|NCT00747318|Autonomic Agents|autonomic agents|mesh-ancestor
65676599|NCT00747318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676600|NCT00747318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676601|NCT00747318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65676602|NCT00747318|Respiratory System Agents|respiratory system agents|mesh-ancestor
65676603|NCT00747318|Dermatologic Agents|dermatologic agents|mesh-ancestor
65676604|NCT00747318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65676605|NCT00747318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65676606|NCT00747318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65676607|NCT00747318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65676608|NCT00747318|Adrenergic Agents|adrenergic agents|mesh-ancestor
65676609|NCT00747318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65676610|NCT00747318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676611|NCT00744276|Danazol|danazol|mesh-list
65473920|NCT01220102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676612|NCT00744276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65676613|NCT00744276|Hormone Antagonists|hormone antagonists|mesh-ancestor
65676614|NCT00744276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65676615|NCT00744276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676616|NCT03438344|Vaccines|vaccines|mesh-list
65676617|NCT03438344|Immunologic Factors|immunologic factors|mesh-ancestor
65676618|NCT03438344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676619|NCT04640402|Vaccines|vaccines|mesh-list
65676620|NCT04640402|Immunologic Factors|immunologic factors|mesh-ancestor
65676621|NCT04640402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676622|NCT03445910|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65676623|NCT03445910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65676624|NCT03445910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676625|NCT00692484|Chlorhexidine|chlorhexidine|mesh-list
65676626|NCT00692484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65676627|NCT00692484|Povidone-Iodine|povidone-iodine|mesh-list
65676628|NCT00692484|Povidone|povidone|mesh-list
65676629|NCT00692484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65676630|NCT00692484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65676631|NCT00692484|Disinfectants|disinfectants|mesh-ancestor
65676632|NCT00692484|Dermatologic Agents|dermatologic agents|mesh-ancestor
65676633|NCT00692484|Plasma Substitutes|plasma substitutes|mesh-ancestor
65676634|NCT00692484|Blood Substitutes|blood substitutes|mesh-ancestor
65676635|NCT00646542|Vildagliptin|vildagliptin|mesh-list
65676636|NCT00646542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65676637|NCT00646542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676638|NCT00646542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65676639|NCT00646542|Protease Inhibitors|protease inhibitors|mesh-ancestor
65676640|NCT00646542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676641|NCT00646542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676642|NCT05089370|Nivolumab|nivolumab|mesh-list
65676643|NCT05089370|Decitabine|decitabine|mesh-list
65676644|NCT05089370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65676645|NCT05089370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676646|NCT05089370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65676647|NCT05089370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676648|NCT05089370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65676649|NCT05089370|Antimetabolites|antimetabolites|mesh-ancestor
65676650|NCT05089370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676651|NCT03256344|Atezolizumab|atezolizumab|mesh-list
65676652|NCT03256344|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
65676653|NCT03256344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676654|NCT03256344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65676655|NCT02063139|Fluticasone|fluticasone|mesh-list
65676656|NCT02063139|Beclomethasone|beclomethasone|mesh-list
65676657|NCT02063139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65676658|NCT02063139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65676659|NCT02063139|Autonomic Agents|autonomic agents|mesh-ancestor
65676660|NCT02063139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676661|NCT02063139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676662|NCT02063139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65676663|NCT02063139|Respiratory System Agents|respiratory system agents|mesh-ancestor
65676664|NCT02063139|Dermatologic Agents|dermatologic agents|mesh-ancestor
65676665|NCT02063139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65676666|NCT02063139|Glucocorticoids|glucocorticoids|mesh-ancestor
65676667|NCT02063139|Hormones|hormones|mesh-ancestor
65676668|NCT02063139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65676669|NCT00690456|Metformin|metformin|mesh-list
65676670|NCT00690456|Rimonabant|rimonabant|mesh-list
65676671|NCT00690456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65676672|NCT00690456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676673|NCT00690456|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65676674|NCT00690456|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65676675|NCT00690456|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65676676|NCT00690456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65676677|NCT00690456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676678|NCT00690456|Hormones|hormones|mesh-ancestor
65676679|NCT00690456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65676680|NCT01370499|Serotonin|serotonin|mesh-list
65676681|NCT01370499|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65676682|NCT01370499|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65676683|NCT01370499|Serotonin Agents|serotonin agents|mesh-ancestor
65676684|NCT01370499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65676685|NCT01370499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676686|NCT01370499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676687|NCT01370499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65676688|NCT01370499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65676689|NCT03445286|Fluorides|fluorides|mesh-list
65676690|NCT03445286|Cariostatic Agents|cariostatic agents|mesh-ancestor
65676691|NCT03445286|Protective Agents|protective agents|mesh-ancestor
65676692|NCT03445286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676693|NCT00626106|Fulvestrant|fulvestrant|mesh-list
65676694|NCT00626106|Exemestane|exemestane|mesh-list
65676695|NCT00626106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65676696|NCT00626106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65676697|NCT00626106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676698|NCT00626106|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65676699|NCT00626106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65676700|NCT00626106|Hormone Antagonists|hormone antagonists|mesh-ancestor
65676701|NCT00626106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65676702|NCT00626106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676703|NCT00626106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65676704|NCT00626106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65676705|NCT00626106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676706|NCT00626106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676707|NCT00626106|Immunologic Factors|immunologic factors|mesh-ancestor
65676708|NCT02064465|Lamotrigine|lamotrigine|mesh-list
65676709|NCT02064465|Anticonvulsants|anticonvulsants|mesh-list
65676710|NCT02064465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65676711|NCT02064465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65676712|NCT02064465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676713|NCT02064465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65676714|NCT02064465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676715|NCT02064465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65676716|NCT02064465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65676717|NCT02064465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65676718|NCT02064465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65676719|NCT02064465|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65676720|NCT04530656|Vaccines|vaccines|mesh-list
65676721|NCT04530656|Immunologic Factors|immunologic factors|mesh-ancestor
65676722|NCT04530656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676723|NCT00690066|Remestemcel-l|remestemcel-l|mesh-list
65676724|NCT00690066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65676725|NCT00690066|Antiviral Agents|antiviral agents|mesh-ancestor
65676726|NCT00690066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65676727|NCT04509596|Capecitabine|capecitabine|mesh-list
65676728|NCT04509596|Trastuzumab|trastuzumab|mesh-list
65676729|NCT04509596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65676730|NCT04509596|Antimetabolites|antimetabolites|mesh-ancestor
65676731|NCT04509596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676732|NCT04509596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676733|NCT04509596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65676734|NCT01370265|Adenosine|adenosine|mesh-list
65676735|NCT01370265|Regadenoson|regadenoson|mesh-list
65676736|NCT01370265|Analgesics|analgesics|mesh-ancestor
65676737|NCT01370265|Sensory System Agents|sensory system agents|mesh-ancestor
65676738|NCT01370265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676739|NCT01370265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676740|NCT01370265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65676741|NCT01370265|Vasodilator Agents|vasodilator agents|mesh-ancestor
65676742|NCT01370265|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65676743|NCT01370265|Purinergic Agonists|purinergic agonists|mesh-ancestor
65676744|NCT01370265|Purinergic Agents|purinergic agents|mesh-ancestor
65676745|NCT01370265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65676746|NCT01370265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676747|NCT01370265|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65676748|NCT00734292|Fluticasone|fluticasone|mesh-list
65676749|NCT00734292|Xhance|xhance|mesh-list
65676750|NCT00734292|Formoterol Fumarate|formoterol fumarate|mesh-list
65676751|NCT00734292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65676752|NCT00734292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65676753|NCT00734292|Autonomic Agents|autonomic agents|mesh-ancestor
65676754|NCT00734292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676755|NCT00734292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676756|NCT00734292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65676757|NCT00734292|Respiratory System Agents|respiratory system agents|mesh-ancestor
65676758|NCT00734292|Dermatologic Agents|dermatologic agents|mesh-ancestor
65676759|NCT00734292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65676760|NCT00734292|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65474071|NCT05024032|Hormones|hormones|mesh-ancestor
65676762|NCT00734292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65676763|NCT00734292|Adrenergic Agents|adrenergic agents|mesh-ancestor
65676764|NCT00734292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65676765|NCT00734292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676766|NCT00687882|Anticoagulants|anticoagulants|mesh-list
65676767|NCT02064621|Amlodipine|amlodipine|mesh-list
65676768|NCT02064621|Candesartan|candesartan|mesh-list
65676769|NCT02064621|Candesartan cilexetil|candesartan cilexetil|mesh-list
65676770|NCT02064621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65676771|NCT02064621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65676772|NCT02064621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65676773|NCT02064621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676774|NCT02064621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65676775|NCT02064621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676776|NCT02064621|Vasodilator Agents|vasodilator agents|mesh-ancestor
65676777|NCT02064621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65676778|NCT02064621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65676779|NCT00684918|Obatoclax|obatoclax|mesh-list
65676780|NCT00684918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676781|NCT00684918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676782|NCT00726336|Tenofovir|tenofovir|mesh-list
65676783|NCT00726336|Dolutegravir|dolutegravir|mesh-list
65676784|NCT00726336|Antiviral Agents|antiviral agents|mesh-ancestor
65676785|NCT00726336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65676786|NCT00726336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65676787|NCT00726336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65676788|NCT00726336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676789|NCT00726336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676790|NCT00726336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65676791|NCT00726336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65676792|NCT00726336|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65676793|NCT00726336|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65676794|NCT02280720|Tryptophan|tryptophan|mesh-list
65676795|NCT02280720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65676796|NCT02280720|Antidepressive Agents|antidepressive agents|mesh-ancestor
65676797|NCT02280720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65676798|NCT02068131|Capecitabine|capecitabine|mesh-list
65676799|NCT02068131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65676800|NCT02068131|Antimetabolites|antimetabolites|mesh-ancestor
65676801|NCT02068131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676802|NCT02068131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676803|NCT02989584|Gemcitabine|gemcitabine|mesh-list
65676804|NCT02989584|Atezolizumab|atezolizumab|mesh-list
65676805|NCT02989584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676806|NCT02989584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65676807|NCT02989584|Antimetabolites|antimetabolites|mesh-ancestor
65676808|NCT02989584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676809|NCT02989584|Antiviral Agents|antiviral agents|mesh-ancestor
65676810|NCT02989584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65676811|NCT02989584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676812|NCT02989584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65676813|NCT02989584|Immunologic Factors|immunologic factors|mesh-ancestor
65676814|NCT02989584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676815|NCT02068209|Tramadol|tramadol|mesh-list
65676816|NCT02068209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65676817|NCT02068209|Narcotics|narcotics|mesh-ancestor
65676818|NCT02068209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65676819|NCT02068209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676820|NCT02068209|Analgesics|analgesics|mesh-ancestor
65676821|NCT02068209|Sensory System Agents|sensory system agents|mesh-ancestor
65676822|NCT02068209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676823|NCT00680784|Ketoprofen|ketoprofen|mesh-list
65676824|NCT00680784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65676825|NCT00680784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65676826|NCT00680784|Analgesics|analgesics|mesh-ancestor
65676827|NCT00680784|Sensory System Agents|sensory system agents|mesh-ancestor
65676828|NCT00680784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676829|NCT00680784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676830|NCT00680784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65676831|NCT00680784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65676832|NCT00680784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65676833|NCT00680784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474145|NCT01220648|Immunologic Factors|immunologic factors|mesh-ancestor
65676834|NCT00680784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676835|NCT02068287|Esmolol|esmolol|mesh-list
65676836|NCT02068287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65676837|NCT02068287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65676838|NCT02068287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65676839|NCT02068287|Adrenergic Agents|adrenergic agents|mesh-ancestor
65676840|NCT02068287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65676841|NCT02068287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676842|NCT02068287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676843|NCT02280876|Andrographolide|andrographolide|mesh-list
65676844|NCT02280876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65676845|NCT02280876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65676846|NCT02280876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65676847|NCT02280876|Analgesics|analgesics|mesh-ancestor
65676848|NCT02280876|Sensory System Agents|sensory system agents|mesh-ancestor
65676849|NCT02280876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676850|NCT02280876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676851|NCT02280876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65676852|NCT02280876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65676853|NCT02280876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65676854|NCT02280876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65676855|NCT02280876|Antiviral Agents|antiviral agents|mesh-ancestor
65676856|NCT02280876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65676857|NCT00680472|Ketoprofen|ketoprofen|mesh-list
65676858|NCT00680472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65676859|NCT00680472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65676860|NCT00680472|Analgesics|analgesics|mesh-ancestor
65676861|NCT00680472|Sensory System Agents|sensory system agents|mesh-ancestor
65676862|NCT00680472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676863|NCT00680472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676864|NCT00680472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65676865|NCT00680472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65676866|NCT00680472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65676867|NCT00680472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676868|NCT00680472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676869|NCT03444662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
65676870|NCT03444662|Nootropic Agents|nootropic agents|mesh-ancestor
65676871|NCT03444506|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
65676872|NCT03444506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65676873|NCT03444506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65676874|NCT03444506|Analgesics|analgesics|mesh-ancestor
65676875|NCT03444506|Sensory System Agents|sensory system agents|mesh-ancestor
65676876|NCT03444506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676877|NCT03444506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676878|NCT03444506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65676879|NCT03444506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65676880|NCT03444506|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65676881|NCT03444506|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65676882|NCT03444506|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65676883|NCT03444506|Histamine Antagonists|histamine antagonists|mesh-ancestor
65676884|NCT03444506|Histamine Agents|histamine agents|mesh-ancestor
65676885|NCT03444506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65676886|NCT03444506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676887|NCT02065947|Lidocaine|lidocaine|mesh-list
65676888|NCT02065947|Epinephrine|epinephrine|mesh-list
65676889|NCT02065947|Racepinephrine|racepinephrine|mesh-list
65676890|NCT02065947|Fentanyl|fentanyl|mesh-list
65676891|NCT02065947|Midazolam|midazolam|mesh-list
65676892|NCT02065947|Ketamine|ketamine|mesh-list
65676893|NCT02065947|Bupivacaine|bupivacaine|mesh-list
65676894|NCT02065947|Propofol|propofol|mesh-list
65676895|NCT02065947|Sevoflurane|sevoflurane|mesh-list
65676896|NCT02065947|Epinephryl borate|epinephryl borate|mesh-list
65676897|NCT02065947|Atracurium|atracurium|mesh-list
65676898|NCT02065947|Anesthetics, Local|anesthetics, local|mesh-ancestor
65676899|NCT02065947|Anesthetics|anesthetics|mesh-ancestor
65676900|NCT02065947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65676901|NCT02065947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676902|NCT02065947|Sensory System Agents|sensory system agents|mesh-ancestor
65676903|NCT02065947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676904|NCT02065947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65676905|NCT02065947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65676906|NCT02065947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65676907|NCT02065947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65676908|NCT02065947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676909|NCT02065947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65676910|NCT02065947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65676911|NCT02065947|Anesthetics, General|anesthetics, general|mesh-ancestor
65676912|NCT02065947|Analgesics|analgesics|mesh-ancestor
65676913|NCT02065947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65676914|NCT02065947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65676915|NCT02065947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65676916|NCT02065947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65676917|NCT02065947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65676918|NCT02065947|Narcotics|narcotics|mesh-ancestor
65676919|NCT02065947|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65676920|NCT02065947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65676921|NCT02065947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65676922|NCT02065947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65676923|NCT02065947|GABA Modulators|gaba modulators|mesh-ancestor
65676924|NCT02065947|GABA Agents|gaba agents|mesh-ancestor
65676925|NCT02065947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65676926|NCT02065947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65676927|NCT02065947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65676928|NCT02065947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65676929|NCT02065947|Adrenergic Agents|adrenergic agents|mesh-ancestor
65676930|NCT02065947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65676931|NCT02065947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65676932|NCT02065947|Autonomic Agents|autonomic agents|mesh-ancestor
65676933|NCT02065947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65676934|NCT02065947|Respiratory System Agents|respiratory system agents|mesh-ancestor
65676935|NCT02065947|Mydriatics|mydriatics|mesh-ancestor
65676936|NCT02065947|Sympathomimetics|sympathomimetics|mesh-ancestor
65676937|NCT02065947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65676938|NCT02065947|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65676939|NCT02065947|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65676940|NCT02065947|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65676941|NCT02065947|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65676942|NCT02065947|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65676943|NCT02065947|Cholinergic Agents|cholinergic agents|mesh-ancestor
65676944|NCT01359592|Prednisone|prednisone|mesh-list
65676945|NCT01359592|Cyclophosphamide|cyclophosphamide|mesh-list
65676946|NCT01359592|Rituximab|rituximab|mesh-list
65676947|NCT01359592|Doxorubicin|doxorubicin|mesh-list
65676948|NCT01359592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65676949|NCT01359592|Vincristine|vincristine|mesh-list
65676950|NCT01359592|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65676951|NCT01359592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65676952|NCT01359592|Immunologic Factors|immunologic factors|mesh-ancestor
65676953|NCT01359592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676954|NCT01359592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65676955|NCT01359592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65676956|NCT01359592|Alkylating Agents|alkylating agents|mesh-ancestor
65676957|NCT01359592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676958|NCT01359592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676959|NCT01359592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65676960|NCT01359592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65676961|NCT01359592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65676962|NCT01359592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65676963|NCT01359592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65676964|NCT01359592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65676965|NCT01359592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65676966|NCT01359592|Glucocorticoids|glucocorticoids|mesh-ancestor
65676967|NCT01359592|Hormones|hormones|mesh-ancestor
65676968|NCT01359592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65676969|NCT01359592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65676970|NCT01359592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65676971|NCT01359592|Tubulin Modulators|tubulin modulators|mesh-ancestor
65676972|NCT01359592|Antimitotic Agents|antimitotic agents|mesh-ancestor
65676973|NCT01359592|Mitosis Modulators|mitosis modulators|mesh-ancestor
65676974|NCT01359592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65676975|NCT03436472|Dexmedetomidine|dexmedetomidine|mesh-list
65676976|NCT03436472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65676977|NCT03436472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65676978|NCT03436472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65676979|NCT03436472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65676980|NCT03436472|Analgesics|analgesics|mesh-ancestor
65676981|NCT03436472|Sensory System Agents|sensory system agents|mesh-ancestor
65676982|NCT03436472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65676983|NCT03436472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65474291|NCT00323063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65676984|NCT03436472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65676985|NCT03436472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65676986|NCT03436472|Adrenergic Agents|adrenergic agents|mesh-ancestor
65676987|NCT03436472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65676988|NCT03436472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676989|NCT02066103|Paclitaxel|paclitaxel|mesh-list
65676990|NCT02066103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65676991|NCT02066103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65676992|NCT02066103|Tubulin Modulators|tubulin modulators|mesh-ancestor
65676993|NCT02066103|Antimitotic Agents|antimitotic agents|mesh-ancestor
65676994|NCT02066103|Mitosis Modulators|mitosis modulators|mesh-ancestor
65676995|NCT02066103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65676996|NCT04809532|Tramadol|tramadol|mesh-list
65676997|NCT04809532|Bupivacaine|bupivacaine|mesh-list
65676998|NCT04809532|Anesthetics, Local|anesthetics, local|mesh-ancestor
65676999|NCT04809532|Anesthetics|anesthetics|mesh-ancestor
65677000|NCT04809532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677001|NCT04809532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677002|NCT04809532|Sensory System Agents|sensory system agents|mesh-ancestor
65677003|NCT04809532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677004|NCT04809532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65677005|NCT04809532|Narcotics|narcotics|mesh-ancestor
65677006|NCT04809532|Analgesics|analgesics|mesh-ancestor
65677007|NCT04809142|Gemcitabine|gemcitabine|mesh-list
65677008|NCT04809142|Capecitabine|capecitabine|mesh-list
65677009|NCT04809142|Oxaliplatin|oxaliplatin|mesh-list
65677010|NCT04809142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65677011|NCT04809142|Antimetabolites|antimetabolites|mesh-ancestor
65677012|NCT04809142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677013|NCT04809142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677014|NCT04809142|Antiviral Agents|antiviral agents|mesh-ancestor
65677015|NCT04809142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65677016|NCT04809142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677017|NCT04809142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65677018|NCT04809142|Immunologic Factors|immunologic factors|mesh-ancestor
65677019|NCT04809142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677020|NCT02064777|Tacrolimus|tacrolimus|mesh-list
65677021|NCT02064777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65677022|NCT02064777|Immunologic Factors|immunologic factors|mesh-ancestor
65677023|NCT02064777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677024|NCT02064777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65677025|NCT02064777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677026|NCT02064777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677027|NCT02069145|Sorafenib|sorafenib|mesh-list
65677028|NCT02069145|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
65677029|NCT02069145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677030|NCT02069145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65677031|NCT02069145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677032|NCT02069145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677033|NCT02069145|Immunologic Factors|immunologic factors|mesh-ancestor
65677034|NCT02069145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677035|NCT04830358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65677036|NCT04830358|Immunologic Factors|immunologic factors|mesh-ancestor
65677037|NCT04830358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677038|NCT03444272|Sofosbuvir|sofosbuvir|mesh-list
65677039|NCT03444272|Antiviral Agents|antiviral agents|mesh-ancestor
65677040|NCT03444272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65677041|NCT03347331|Befiradol|befiradol|mesh-list
65677042|NCT03347331|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65677043|NCT03347331|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65677044|NCT03347331|Serotonin Agents|serotonin agents|mesh-ancestor
65677045|NCT03347331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677046|NCT03347331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677047|NCT03347331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677048|NCT05573373|Antineoplastic Agents|antineoplastic agents|mesh-list
65677049|NCT05573373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65677050|NCT05573373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677051|NCT05573373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677052|NCT03109652|Tranexamic Acid|tranexamic acid|mesh-list
65677053|NCT03109652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65677054|NCT03109652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65677055|NCT03109652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677056|NCT03109652|Hemostatics|hemostatics|mesh-ancestor
65677057|NCT03109652|Coagulants|coagulants|mesh-ancestor
65677058|NCT02069301|Fluoxetine|fluoxetine|mesh-list
65677059|NCT02069301|Antidepressive Agents|antidepressive agents|mesh-list
65677060|NCT02069301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65677061|NCT02069301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65677062|NCT02069301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65677063|NCT02069301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677064|NCT02069301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677065|NCT02069301|Serotonin Agents|serotonin agents|mesh-ancestor
65677066|NCT02069301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677067|NCT02069301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65677068|NCT02069301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65677069|NCT02069301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65677070|NCT02069301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65677071|NCT02069301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677072|NCT03035656|Ropivacaine|ropivacaine|mesh-list
65677073|NCT03035656|Anesthetics, Local|anesthetics, local|mesh-ancestor
65677074|NCT03035656|Anesthetics|anesthetics|mesh-ancestor
65677075|NCT03035656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677076|NCT03035656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677077|NCT03035656|Sensory System Agents|sensory system agents|mesh-ancestor
65677078|NCT03035656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677079|NCT03443960|Amitriptyline|amitriptyline|mesh-list
65677080|NCT03443960|Cyclobenzaprine|cyclobenzaprine|mesh-list
65677081|NCT03443960|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65677082|NCT03443960|Antidepressive Agents|antidepressive agents|mesh-ancestor
65677083|NCT03443960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65677084|NCT03443960|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65677085|NCT03443960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677086|NCT03443960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65677087|NCT03443960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677088|NCT03443960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65677089|NCT03443960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677090|NCT03443960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65677091|NCT03443960|Analgesics|analgesics|mesh-ancestor
65677092|NCT03443960|Sensory System Agents|sensory system agents|mesh-ancestor
65677093|NCT03443960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65677094|NCT03443960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65677095|NCT03443960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65677096|NCT03443960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677097|NCT03443960|Adrenergic Agents|adrenergic agents|mesh-ancestor
65677098|NCT03443960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677100|NCT05616754|Immunologic Factors|immunologic factors|mesh-ancestor
65677101|NCT05616754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677102|NCT03440996|Listerine|listerine|mesh-list
65677103|NCT03440996|Sodium Fluoride|sodium fluoride|mesh-list
65677104|NCT03440996|Cariostatic Agents|cariostatic agents|mesh-ancestor
65677105|NCT03440996|Protective Agents|protective agents|mesh-ancestor
65677106|NCT03440996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677107|NCT03440996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65677108|NCT03440996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65677109|NCT04451174|Prednisone|prednisone|mesh-list
65677110|NCT04451174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65677111|NCT04451174|Glucocorticoids|glucocorticoids|mesh-ancestor
65677112|NCT04451174|Hormones|hormones|mesh-ancestor
65677113|NCT04451174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65677114|NCT04451174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677115|NCT04451174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65677116|NCT04451174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677117|NCT04828642|Vitamins|vitamins|mesh-list
65677118|NCT04828642|Ascorbic Acid|ascorbic acid|mesh-list
65677119|NCT04828642|Vitamin E|vitamin e|mesh-list
65677120|NCT04828642|Tocopherols|tocopherols|mesh-list
65677121|NCT04828642|Micronutrients|micronutrients|mesh-ancestor
65677122|NCT04828642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677123|NCT04828642|Antioxidants|antioxidants|mesh-ancestor
65677124|NCT04828642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677125|NCT04828642|Protective Agents|protective agents|mesh-ancestor
65677126|NCT03433352|Methimazole|methimazole|mesh-list
65677127|NCT03433352|Propylthiouracil|propylthiouracil|mesh-list
65677128|NCT03433352|Antithyroid Agents|antithyroid agents|mesh-ancestor
65677129|NCT03433352|Hormone Antagonists|hormone antagonists|mesh-ancestor
65677130|NCT03433352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65677131|NCT03433352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677132|NCT03433352|Antimetabolites|antimetabolites|mesh-ancestor
65677133|NCT03433352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677134|NCT04828564|Ribavirin|ribavirin|mesh-list
65677135|NCT04828564|Favipiravir|favipiravir|mesh-list
65677136|NCT04828564|Antimetabolites|antimetabolites|mesh-ancestor
65677137|NCT04828564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677138|NCT04828564|Antiviral Agents|antiviral agents|mesh-ancestor
65677139|NCT04828564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65677140|NCT03435302|Temozolomide|temozolomide|mesh-list
65677141|NCT03435302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677142|NCT03435302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65677143|NCT03435302|Alkylating Agents|alkylating agents|mesh-ancestor
65677144|NCT03435302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677145|NCT04973150|Anesthetics|anesthetics|mesh-list
65677146|NCT04973150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677147|NCT04973150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677148|NCT04950608|Psilocybin|psilocybin|mesh-list
65677149|NCT04950608|Hallucinogens|hallucinogens|mesh-ancestor
65677150|NCT04950608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677151|NCT04950608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65677152|NCT03433196|Atorvastatin|atorvastatin|mesh-list
65677153|NCT03433196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65677154|NCT03433196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65677155|NCT03433196|Antimetabolites|antimetabolites|mesh-ancestor
65677156|NCT03433196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677157|NCT03433196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65677158|NCT03433196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65677159|NCT03433196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677160|NCT02792829|Lenvatinib|lenvatinib|mesh-list
65677161|NCT02792829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677162|NCT02792829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65677163|NCT02792829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677164|NCT02792829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677165|NCT02066571|Droxidopa|droxidopa|mesh-list
65677166|NCT02066571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65677167|NCT02066571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65677168|NCT02066649|Carvedilol|carvedilol|mesh-list
65677169|NCT02066649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65677170|NCT02066649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65677171|NCT02066649|Adrenergic Agents|adrenergic agents|mesh-ancestor
65677172|NCT02066649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677173|NCT02066649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677174|NCT02066649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677175|NCT02066649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65677176|NCT02066649|Antioxidants|antioxidants|mesh-ancestor
65677177|NCT02066649|Protective Agents|protective agents|mesh-ancestor
65677178|NCT02066649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65677179|NCT02066649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65677180|NCT02066649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65677181|NCT02066649|Vasodilator Agents|vasodilator agents|mesh-ancestor
65677182|NCT02066649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65677183|NCT02066649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65677184|NCT02070003|Analgesics, Opioid|analgesics, opioid|mesh-list
65677185|NCT02070003|Narcotics|narcotics|mesh-ancestor
65677186|NCT02070003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677187|NCT02070003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677188|NCT02070003|Analgesics|analgesics|mesh-ancestor
65677189|NCT02070003|Sensory System Agents|sensory system agents|mesh-ancestor
65677190|NCT02070003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677191|NCT02070159|Clopidogrel|clopidogrel|mesh-list
65677192|NCT02070159|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65677193|NCT02070159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65677194|NCT02070159|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65677195|NCT02070159|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65677196|NCT02070159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65677197|NCT02070159|Purinergic Agents|purinergic agents|mesh-ancestor
65677198|NCT02070159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677199|NCT02070159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677200|NCT02070159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677201|NCT05619328|Vitamins|vitamins|mesh-list
65677202|NCT05619328|Vitamin B Complex|vitamin b complex|mesh-list
65677203|NCT05619328|Micronutrients|micronutrients|mesh-ancestor
65677204|NCT05619328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677205|NCT03432884|Moxifloxacin|moxifloxacin|mesh-list
65677206|NCT03432884|Zanubrutinib|zanubrutinib|mesh-list
65677207|NCT03432884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65677208|NCT03432884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65677209|NCT03432884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65677210|NCT03432884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65677211|NCT03432884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677212|NCT03432884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677213|NCT03432884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677214|NCT03432884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65677215|NCT04827784|Anesthetics|anesthetics|mesh-list
65677216|NCT04827784|Anesthetics, Local|anesthetics, local|mesh-list
65677217|NCT04827784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677218|NCT04827784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677219|NCT04827784|Sensory System Agents|sensory system agents|mesh-ancestor
65677220|NCT04827784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677221|NCT03986996|Amoxicillin|amoxicillin|mesh-list
65677222|NCT03986996|Metronidazole|metronidazole|mesh-list
65677223|NCT03986996|Doxycycline|doxycycline|mesh-list
65677224|NCT03986996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65677225|NCT03986996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65677226|NCT03986996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65677227|NCT03986996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65677228|NCT03986996|Antimalarials|antimalarials|mesh-ancestor
65677229|NCT04796428|Dapagliflozin|dapagliflozin|mesh-list
65677230|NCT04796428|Empagliflozin|empagliflozin|mesh-list
65677231|NCT04796428|Canagliflozin|canagliflozin|mesh-list
65677232|NCT04796428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65677233|NCT04796428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677234|NCT04796428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65677235|NCT04796428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677236|NCT03432728|Anesthetics|anesthetics|mesh-list
65677237|NCT03432728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677238|NCT03432728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677239|NCT04450160|Temozolomide|temozolomide|mesh-list
65677240|NCT04450160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65677241|NCT04450160|Alkylating Agents|alkylating agents|mesh-ancestor
65677242|NCT04450160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677243|NCT04450160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677244|NCT03432572|Riboflavin|riboflavin|mesh-list
65677245|NCT03432572|Thiamine|thiamine|mesh-list
65677246|NCT03432572|Vitamin B Complex|vitamin b complex|mesh-ancestor
65677247|NCT03432572|Vitamins|vitamins|mesh-ancestor
65677248|NCT03432572|Micronutrients|micronutrients|mesh-ancestor
65677249|NCT03432572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677250|NCT03432572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65677251|NCT03432572|Dermatologic Agents|dermatologic agents|mesh-ancestor
65677252|NCT03854370|Chlorhexidine|chlorhexidine|mesh-list
65677253|NCT03854370|Povidone-Iodine|povidone-iodine|mesh-list
65677254|NCT03854370|Povidone|povidone|mesh-list
65677255|NCT03854370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65677256|NCT03854370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65677257|NCT03854370|Disinfectants|disinfectants|mesh-ancestor
65677258|NCT03854370|Plasma Substitutes|plasma substitutes|mesh-ancestor
65677259|NCT03854370|Blood Substitutes|blood substitutes|mesh-ancestor
65677260|NCT02260323|Antirheumatic Agents|antirheumatic agents|mesh-list
65677261|NCT02805504|Bupivacaine|bupivacaine|mesh-list
65677262|NCT02805504|Anesthetics, Local|anesthetics, local|mesh-ancestor
65677263|NCT02805504|Anesthetics|anesthetics|mesh-ancestor
65677264|NCT02805504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677265|NCT02805504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677266|NCT02805504|Sensory System Agents|sensory system agents|mesh-ancestor
65677267|NCT02805504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677268|NCT02783508|Meperidine|meperidine|mesh-list
65677269|NCT02783508|Nitrous Oxide|nitrous oxide|mesh-list
65677270|NCT02783508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65677271|NCT02783508|Anesthetics, General|anesthetics, general|mesh-ancestor
65677272|NCT02783508|Anesthetics|anesthetics|mesh-ancestor
65677273|NCT02783508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677274|NCT02783508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677275|NCT02783508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65677276|NCT02783508|Analgesics|analgesics|mesh-ancestor
65677277|NCT02783508|Sensory System Agents|sensory system agents|mesh-ancestor
65677278|NCT02783508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677279|NCT02783508|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65677280|NCT02783508|Narcotics|narcotics|mesh-ancestor
65677281|NCT02783508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65677282|NCT02071407|Midazolam|midazolam|mesh-list
65677283|NCT02071407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65677284|NCT02071407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65677285|NCT02071407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677286|NCT02071407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677287|NCT02071407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65677288|NCT02071407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65677289|NCT02071407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65677290|NCT02071407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65677291|NCT02071407|Anesthetics, General|anesthetics, general|mesh-ancestor
65677292|NCT02071407|Anesthetics|anesthetics|mesh-ancestor
65677293|NCT02071407|GABA Modulators|gaba modulators|mesh-ancestor
65677294|NCT02071407|GABA Agents|gaba agents|mesh-ancestor
65677295|NCT02071407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677296|NCT02071407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677297|NCT02281266|Entecavir|entecavir|mesh-list
65677298|NCT02281266|Thymalfasin|thymalfasin|mesh-list
65677299|NCT02281266|Antiviral Agents|antiviral agents|mesh-ancestor
65677300|NCT02281266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65677301|NCT02281266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65677302|NCT02281266|Immunologic Factors|immunologic factors|mesh-ancestor
65677303|NCT02281266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677304|NCT00625326|Calcipotriene|calcipotriene|mesh-list
65677305|NCT00625326|Dermatologic Agents|dermatologic agents|mesh-ancestor
65677306|NCT03434054|Losartan|losartan|mesh-list
65677307|NCT03434054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65677308|NCT03434054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65677309|NCT03434054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65677310|NCT03434054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65677311|NCT03434054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677312|NCT03433976|Anesthetics|anesthetics|mesh-list
65677313|NCT03433976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677314|NCT03433976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677315|NCT04473144|Urinastatin|urinastatin|mesh-list
65677316|NCT04473144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65677317|NCT04473144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65677318|NCT04473144|Protease Inhibitors|protease inhibitors|mesh-ancestor
65677319|NCT04473144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677320|NCT04473144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677321|NCT02605642|Infliximab|infliximab|mesh-list
65677322|NCT02605642|Dermatologic Agents|dermatologic agents|mesh-ancestor
65677323|NCT02605642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65677324|NCT02605642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65677325|NCT00624858|Naltrexone|naltrexone|mesh-list
65677326|NCT00624858|Bupropion|bupropion|mesh-list
65677327|NCT00624858|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65677328|NCT00624858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65677329|NCT00624858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677330|NCT00624858|Sensory System Agents|sensory system agents|mesh-ancestor
65677331|NCT00624858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677332|NCT00624858|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65677333|NCT00624858|Antidepressive Agents|antidepressive agents|mesh-ancestor
65677334|NCT00624858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65677335|NCT00624858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65677336|NCT00624858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65677337|NCT00624858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65677338|NCT00624858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677339|NCT00624858|Dopamine Agents|dopamine agents|mesh-ancestor
65677340|NCT00624858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677341|NCT00624858|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65677342|NCT00624858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65677343|NCT00624858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677344|NCT03128528|Empagliflozin|empagliflozin|mesh-list
65677345|NCT03128528|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65677346|NCT03128528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677347|NCT03128528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65677348|NCT03128528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677349|NCT02071641|Sunitinib|sunitinib|mesh-list
65677350|NCT02071641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677351|NCT02071641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65677352|NCT02071641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65677353|NCT02071641|Growth Substances|growth substances|mesh-ancestor
65677354|NCT02071641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677355|NCT02071641|Growth Inhibitors|growth inhibitors|mesh-ancestor
65677356|NCT02071641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65677357|NCT02071641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677358|NCT02071641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677360|NCT02253810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65677361|NCT02253810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65677362|NCT02253810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677363|NCT02253810|Hemostatics|hemostatics|mesh-ancestor
65677364|NCT02253810|Coagulants|coagulants|mesh-ancestor
65677365|NCT04679402|Carbon Monoxide|carbon monoxide|mesh-list
65677366|NCT04679402|Antimetabolites|antimetabolites|mesh-ancestor
65677367|NCT04679402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677368|NCT04679402|Gasotransmitters|gasotransmitters|mesh-ancestor
65677369|NCT04679402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677370|NCT04679402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677371|NCT03298893|Nivolumab|nivolumab|mesh-list
65677372|NCT03298893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677373|NCT03298893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65677374|NCT03298893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65677375|NCT03298893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677376|NCT04673786|Ustekinumab|ustekinumab|mesh-list
65677377|NCT04673786|Dermatologic Agents|dermatologic agents|mesh-ancestor
65677378|NCT00673062|Pseudoephedrine|pseudoephedrine|mesh-list
65677379|NCT00673062|Ephedrine|ephedrine|mesh-list
65677380|NCT00673062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65677381|NCT00673062|Autonomic Agents|autonomic agents|mesh-ancestor
65677382|NCT00673062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677383|NCT00673062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677384|NCT00673062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65677385|NCT00673062|Respiratory System Agents|respiratory system agents|mesh-ancestor
65677386|NCT00673062|Nasal Decongestants|nasal decongestants|mesh-ancestor
65677387|NCT00673062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65677388|NCT00673062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65677389|NCT00673062|Sympathomimetics|sympathomimetics|mesh-ancestor
65677390|NCT00673062|Adrenergic Agents|adrenergic agents|mesh-ancestor
65677391|NCT00673062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677392|NCT00673062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677393|NCT03559803|Cisplatin|cisplatin|mesh-list
65677394|NCT03559803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677395|NCT03439358|Magnesium Sulfate|magnesium sulfate|mesh-list
65677396|NCT03439358|Analgesics|analgesics|mesh-ancestor
65677397|NCT03439358|Sensory System Agents|sensory system agents|mesh-ancestor
65677398|NCT03439358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677399|NCT03439358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677400|NCT03439358|Anesthetics|anesthetics|mesh-ancestor
65677401|NCT03439358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677402|NCT03439358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65677403|NCT03439358|Anticonvulsants|anticonvulsants|mesh-ancestor
65677404|NCT03439358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65677405|NCT03439358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65677406|NCT03439358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677407|NCT03439358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65677408|NCT03439358|Tocolytic Agents|tocolytic agents|mesh-ancestor
65677409|NCT03439358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65677410|NCT02072031|Sunitinib|sunitinib|mesh-list
65677411|NCT02072031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677412|NCT02072031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65677413|NCT02072031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65677414|NCT02072031|Growth Substances|growth substances|mesh-ancestor
65677415|NCT02072031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677416|NCT02072031|Growth Inhibitors|growth inhibitors|mesh-ancestor
65677417|NCT02072031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65677418|NCT02072031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677419|NCT02072031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677420|NCT05616442|Vitamin E|vitamin e|mesh-list
65677421|NCT05616442|Ketotifen|ketotifen|mesh-list
65677422|NCT05616442|Vitamins|vitamins|mesh-ancestor
65677423|NCT05616442|Micronutrients|micronutrients|mesh-ancestor
65677424|NCT05616442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677425|NCT05616442|Antioxidants|antioxidants|mesh-ancestor
65677426|NCT05616442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677427|NCT05616442|Protective Agents|protective agents|mesh-ancestor
65677428|NCT05616442|Antipruritics|antipruritics|mesh-ancestor
65677429|NCT05616442|Dermatologic Agents|dermatologic agents|mesh-ancestor
65677430|NCT05616442|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65677431|NCT05616442|Histamine Antagonists|histamine antagonists|mesh-ancestor
65677432|NCT05616442|Histamine Agents|histamine agents|mesh-ancestor
65677433|NCT05616442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677434|NCT05616442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65677435|NCT02065401|Magnesium Hydroxide|magnesium hydroxide|mesh-list
65677437|NCT02065401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677438|NCT02065401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65677439|NCT00620256|Timolol|timolol|mesh-list
65677440|NCT00620256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65677441|NCT00620256|Latanoprost|latanoprost|mesh-list
65677442|NCT00620256|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65677443|NCT00620256|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65677444|NCT00620256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65677445|NCT00620256|Adrenergic Agents|adrenergic agents|mesh-ancestor
65677446|NCT00620256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677447|NCT00620256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677448|NCT00620256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677449|NCT00620256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65677450|NCT00620256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65677451|NCT04805710|Rivaroxaban|rivaroxaban|mesh-list
65677452|NCT04805710|Clopidogrel|clopidogrel|mesh-list
65677453|NCT04805710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65677454|NCT04805710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65677455|NCT04805710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65677456|NCT04805710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65677457|NCT04805710|Purinergic Agents|purinergic agents|mesh-ancestor
65677458|NCT04805710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677459|NCT04805710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677460|NCT04805710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677461|NCT04805710|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65677462|NCT04805710|Antithrombins|antithrombins|mesh-ancestor
65677463|NCT04805710|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65677464|NCT04805710|Protease Inhibitors|protease inhibitors|mesh-ancestor
65677465|NCT04805710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677466|NCT04805710|Anticoagulants|anticoagulants|mesh-ancestor
65677467|NCT02076477|Docetaxel|docetaxel|mesh-list
65677468|NCT02076477|Pemetrexed|pemetrexed|mesh-list
65677469|NCT02076477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677470|NCT02076477|Tubulin Modulators|tubulin modulators|mesh-ancestor
65677471|NCT02076477|Antimitotic Agents|antimitotic agents|mesh-ancestor
65677472|NCT02076477|Mitosis Modulators|mitosis modulators|mesh-ancestor
65677473|NCT02076477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677474|NCT02076477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677475|NCT02076477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65677476|NCT02076477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65677477|NCT04879550|Antithrombins|antithrombins|mesh-list
65677478|NCT04879550|Antithrombin III|antithrombin iii|mesh-list
65677479|NCT04879550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65677480|NCT04879550|Protease Inhibitors|protease inhibitors|mesh-ancestor
65677481|NCT04879550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677482|NCT04879550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677483|NCT04879550|Anticoagulants|anticoagulants|mesh-ancestor
65677484|NCT00613002|Testosterone|testosterone|mesh-list
65677485|NCT00613002|Androgens|androgens|mesh-ancestor
65677486|NCT00613002|Hormones|hormones|mesh-ancestor
65677487|NCT00613002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65677488|NCT00613002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677489|NCT02076945|Lidocaine|lidocaine|mesh-list
65677490|NCT02076945|Bupivacaine|bupivacaine|mesh-list
65677491|NCT02076945|Anesthetics, Local|anesthetics, local|mesh-ancestor
65677492|NCT02076945|Anesthetics|anesthetics|mesh-ancestor
65677493|NCT02076945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677494|NCT02076945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677495|NCT02076945|Sensory System Agents|sensory system agents|mesh-ancestor
65677496|NCT02076945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677497|NCT02076945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65677498|NCT02076945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65677499|NCT02076945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65677500|NCT02076945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65677501|NCT02076945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677502|NCT03438890|Chlorhexidine|chlorhexidine|mesh-list
65677503|NCT03438890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65677504|NCT03438890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65677505|NCT03438890|Disinfectants|disinfectants|mesh-ancestor
65677506|NCT00668772|Tiotropium Bromide|tiotropium bromide|mesh-list
65677507|NCT00668772|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65677508|NCT00668772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65677510|NCT00668772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677511|NCT00668772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677512|NCT00668772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65677513|NCT00668772|Respiratory System Agents|respiratory system agents|mesh-ancestor
65677514|NCT00668772|Parasympatholytics|parasympatholytics|mesh-ancestor
65677515|NCT00668772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65677516|NCT00668772|Cholinergic Agents|cholinergic agents|mesh-ancestor
65677517|NCT00668772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677518|NCT00668772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677519|NCT00668772|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65677520|NCT00668772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65677521|NCT00668772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65677522|NCT00668772|Adrenergic Agents|adrenergic agents|mesh-ancestor
65677523|NCT03438812|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65677524|NCT03438812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65677525|NCT03438812|Immunologic Factors|immunologic factors|mesh-ancestor
65677526|NCT03438812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677527|NCT02077257|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65677528|NCT02077257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65677529|NCT02077257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65677530|NCT02077257|Antimetabolites|antimetabolites|mesh-ancestor
65677531|NCT02077257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677532|NCT02077257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65677533|NCT02077257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65677534|NCT02077257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677535|NCT02732912|Zopiclone|zopiclone|mesh-list
65677536|NCT02732912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65677537|NCT02732912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677538|NCT02732912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677539|NCT02792517|Erenumab|erenumab|mesh-list
65677540|NCT02792517|Norgestimate|norgestimate|mesh-list
65677541|NCT02792517|Contraceptive Agents|contraceptive agents|mesh-list
65677542|NCT02792517|Contraceptives, Oral|contraceptives, oral|mesh-list
65677543|NCT02792517|Estradiol|estradiol|mesh-list
65677544|NCT02792517|Estrogens|estrogens|mesh-ancestor
65677545|NCT02792517|Hormones|hormones|mesh-ancestor
65677546|NCT02792517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65677547|NCT02792517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677548|NCT02792517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65677549|NCT02792517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65677550|NCT02792517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65677551|NCT02792517|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65677552|NCT02792517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677553|NCT02792517|Analgesics|analgesics|mesh-ancestor
65677554|NCT02792517|Sensory System Agents|sensory system agents|mesh-ancestor
65677555|NCT02792517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677556|NCT02792517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65677557|NCT03431714|Artesunate|artesunate|mesh-list
65677558|NCT03431714|Piperaquine|piperaquine|mesh-list
65677559|NCT03431714|Amodiaquine|amodiaquine|mesh-list
65677560|NCT03431714|Artenimol|artenimol|mesh-list
65677561|NCT03431714|Antimalarials|antimalarials|mesh-ancestor
65677562|NCT03431714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65677563|NCT03431714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65677564|NCT03431714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65677565|NCT03431714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677566|NCT03431714|Antiviral Agents|antiviral agents|mesh-ancestor
65677567|NCT03431714|Schistosomicides|schistosomicides|mesh-ancestor
65677568|NCT03431714|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65677569|NCT03431714|Anthelmintics|anthelmintics|mesh-ancestor
65677570|NCT03433586|Aspirin|aspirin|mesh-list
65677571|NCT03433586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65677572|NCT03433586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65677573|NCT03433586|Analgesics|analgesics|mesh-ancestor
65677574|NCT03433586|Sensory System Agents|sensory system agents|mesh-ancestor
65677575|NCT03433586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677576|NCT03433586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677577|NCT03433586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65677578|NCT03433586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65677579|NCT03433586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65677580|NCT03433586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65677581|NCT03433586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677582|NCT03433586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65677583|NCT03433586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65677584|NCT03433586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677585|NCT03433586|Antipyretics|antipyretics|mesh-ancestor
65677586|NCT03431558|Lactoferrin|lactoferrin|mesh-list
65677587|NCT03431558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65677588|NCT02273622|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
65677589|NCT02273622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65677590|NCT02273622|Antioxidants|antioxidants|mesh-ancestor
65677591|NCT02273622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677592|NCT02273622|Protective Agents|protective agents|mesh-ancestor
65677593|NCT02273622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677594|NCT02273622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65677595|NCT02077803|Metformin|metformin|mesh-list
65677596|NCT02077803|Canagliflozin|canagliflozin|mesh-list
65677597|NCT02077803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65677598|NCT02077803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677599|NCT02077803|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65677600|NCT02077803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677601|NCT03897998|Naloxone|naloxone|mesh-list
65677602|NCT03897998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65677603|NCT03897998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677604|NCT03897998|Sensory System Agents|sensory system agents|mesh-ancestor
65677605|NCT03897998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677606|NCT03126435|Gemcitabine|gemcitabine|mesh-list
65677607|NCT03126435|Paclitaxel|paclitaxel|mesh-list
65677608|NCT03126435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65677609|NCT03126435|Antimetabolites|antimetabolites|mesh-ancestor
65677610|NCT03126435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677611|NCT03126435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677612|NCT03126435|Antiviral Agents|antiviral agents|mesh-ancestor
65677613|NCT03126435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65677614|NCT03126435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677615|NCT03126435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65677616|NCT03126435|Immunologic Factors|immunologic factors|mesh-ancestor
65677617|NCT03126435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677618|NCT03126435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65677619|NCT03126435|Tubulin Modulators|tubulin modulators|mesh-ancestor
65677620|NCT03126435|Antimitotic Agents|antimitotic agents|mesh-ancestor
65677621|NCT03126435|Mitosis Modulators|mitosis modulators|mesh-ancestor
65677622|NCT03336398|Ketamine|ketamine|mesh-list
65677623|NCT03336398|Analgesics|analgesics|mesh-ancestor
65677624|NCT03336398|Sensory System Agents|sensory system agents|mesh-ancestor
65677625|NCT03336398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677626|NCT03336398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677627|NCT03336398|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65677628|NCT03336398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65677629|NCT03336398|Anesthetics, General|anesthetics, general|mesh-ancestor
65677630|NCT03336398|Anesthetics|anesthetics|mesh-ancestor
65677631|NCT03336398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677632|NCT03336398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65677633|NCT03336398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65677634|NCT03336398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677635|NCT03336398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677636|NCT02072811|Cytarabine|cytarabine|mesh-list
65677637|NCT02072811|Daunorubicin|daunorubicin|mesh-list
65677638|NCT02072811|Mitoxantrone|mitoxantrone|mesh-list
65677639|NCT02072811|Cladribine|cladribine|mesh-list
65677640|NCT02072811|Lenograstim|lenograstim|mesh-list
65677641|NCT02072811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65677642|NCT02072811|Antimetabolites|antimetabolites|mesh-ancestor
65677643|NCT02072811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677644|NCT02072811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677645|NCT02072811|Antiviral Agents|antiviral agents|mesh-ancestor
65677646|NCT02072811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65677647|NCT02072811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65677648|NCT02072811|Immunologic Factors|immunologic factors|mesh-ancestor
65677649|NCT02072811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677650|NCT02072811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65677651|NCT02072811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65677652|NCT02072811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65677653|NCT02072811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677654|NCT02072811|Analgesics|analgesics|mesh-ancestor
65677655|NCT02072811|Sensory System Agents|sensory system agents|mesh-ancestor
65677656|NCT02072811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677657|NCT02072811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65677658|NCT02080377|Glyburide|glyburide|mesh-list
65677659|NCT02080377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65677660|NCT02080377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677661|NCT02072967|Rituximab|rituximab|mesh-list
65677662|NCT02072967|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65677663|NCT02072967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65677664|NCT02072967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677665|NCT02072967|Immunologic Factors|immunologic factors|mesh-ancestor
65677666|NCT02072967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677667|NCT02072967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65677668|NCT02072967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65677669|NCT02072967|Alkylating Agents|alkylating agents|mesh-ancestor
65677670|NCT02072967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677671|NCT02073357|Anesthetics|anesthetics|mesh-list
65677672|NCT02073357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677673|NCT02073357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677674|NCT02073669|Interferons|interferons|mesh-list
65677675|NCT02073669|Interferon-gamma|interferon-gamma|mesh-list
65677676|NCT02073669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677677|NCT02073669|Antiviral Agents|antiviral agents|mesh-ancestor
65677678|NCT02073669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65677679|NCT03428282|Anesthetics|anesthetics|mesh-list
65677680|NCT03428282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677681|NCT03428282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677682|NCT00463242|S 20098|s 20098|mesh-list
65677683|NCT00463242|Paroxetine|paroxetine|mesh-list
65677684|NCT00463242|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65677685|NCT00463242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65677686|NCT00463242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65677687|NCT00463242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677688|NCT00463242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677689|NCT00463242|Serotonin Agents|serotonin agents|mesh-ancestor
65677690|NCT00463242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677691|NCT00463242|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65677692|NCT00463242|Antidepressive Agents|antidepressive agents|mesh-ancestor
65677693|NCT00463242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65677694|NCT00463242|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65677695|NCT00463242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65677696|NCT00463242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677697|NCT00463242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65677698|NCT00463242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677699|NCT02074137|Prednisone|prednisone|mesh-list
65677700|NCT02074137|Prednisolone|prednisolone|mesh-list
65677701|NCT02074137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65677702|NCT02074137|Glucocorticoids|glucocorticoids|mesh-ancestor
65677703|NCT02074137|Hormones|hormones|mesh-ancestor
65677704|NCT02074137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65677705|NCT02074137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677706|NCT02074137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65677707|NCT02074137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677708|NCT00600288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65677709|NCT00600288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65677710|NCT00594984|Irinotecan|irinotecan|mesh-list
65677711|NCT00594984|Cetuximab|cetuximab|mesh-list
65677712|NCT00594984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65677713|NCT00594984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65677714|NCT00594984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677715|NCT00594984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677716|NCT00594984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677717|NCT00594984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65677718|NCT01369485|Caffeine|caffeine|mesh-list
65677719|NCT01369485|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65677720|NCT01369485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677721|NCT01369485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65677722|NCT01369485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677723|NCT01369485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677724|NCT01369485|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65677725|NCT01369485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65677726|NCT01369485|Purinergic Agents|purinergic agents|mesh-ancestor
65677727|NCT01369485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677728|NCT03422978|Dexmedetomidine|dexmedetomidine|mesh-list
65677729|NCT03422978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65677730|NCT03422978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677731|NCT03422978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677732|NCT03422978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65677733|NCT03422978|Analgesics|analgesics|mesh-ancestor
65677734|NCT03422978|Sensory System Agents|sensory system agents|mesh-ancestor
65677735|NCT03422978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677736|NCT03422978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65677737|NCT03422978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65677738|NCT03422978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65677739|NCT03422978|Adrenergic Agents|adrenergic agents|mesh-ancestor
65677740|NCT03422978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677741|NCT03422978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677742|NCT02278692|Vitamin K|vitamin k|mesh-list
65677743|NCT02278692|Vitamins|vitamins|mesh-ancestor
65677744|NCT02278692|Micronutrients|micronutrients|mesh-ancestor
65677745|NCT02278692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677746|NCT02278692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65677747|NCT02278692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65677748|NCT02278692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677749|NCT02278692|Hemostatics|hemostatics|mesh-ancestor
65677750|NCT02278692|Coagulants|coagulants|mesh-ancestor
65677751|NCT02281968|Naproxen|naproxen|mesh-list
65677752|NCT02281968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65677753|NCT02281968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65677754|NCT02281968|Analgesics|analgesics|mesh-ancestor
65677755|NCT02281968|Sensory System Agents|sensory system agents|mesh-ancestor
65677756|NCT02281968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677757|NCT02281968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677758|NCT02281968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65677759|NCT02281968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65677760|NCT02281968|Gout Suppressants|gout suppressants|mesh-ancestor
65677761|NCT02281968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65677762|NCT02281968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677763|NCT02281968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677764|NCT02080845|Theobromine|theobromine|mesh-list
65677765|NCT02080845|Caffeine|caffeine|mesh-list
65677766|NCT02080845|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65677767|NCT02080845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677768|NCT02080845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65677769|NCT02080845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677770|NCT02080845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677771|NCT02080845|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65677772|NCT02080845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65677773|NCT02080845|Purinergic Agents|purinergic agents|mesh-ancestor
65677774|NCT02080845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677775|NCT02080845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65677776|NCT02080845|Autonomic Agents|autonomic agents|mesh-ancestor
65677777|NCT02080845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677778|NCT02080845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65677779|NCT02080845|Respiratory System Agents|respiratory system agents|mesh-ancestor
65677780|NCT02080845|Vasodilator Agents|vasodilator agents|mesh-ancestor
65677781|NCT02284230|Liraglutide|liraglutide|mesh-list
65677782|NCT02284230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65677783|NCT02284230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677784|NCT02284230|Incretins|incretins|mesh-ancestor
65677785|NCT02284230|Hormones|hormones|mesh-ancestor
65677786|NCT02284230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65677787|NCT02792088|Tenofovir|tenofovir|mesh-list
65677788|NCT02792088|Antiviral Agents|antiviral agents|mesh-ancestor
65677789|NCT02792088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65677790|NCT02792088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65677791|NCT02792088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65677792|NCT02792088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677793|NCT02792088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677794|NCT02792088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65677795|NCT02792088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65677796|NCT02074293|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65677797|NCT02074293|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65677798|NCT02074293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65677799|NCT02074293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677800|NCT02074293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268700|NCT04453046|Pembrolizumab|pembrolizumab|mesh-list
65677801|NCT02074293|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65677802|NCT02074293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65677803|NCT02074293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677804|NCT02074293|Cholinergic Agents|cholinergic agents|mesh-ancestor
65677805|NCT02074293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677806|NCT00451152|Hydrocortisone|hydrocortisone|mesh-list
65677808|NCT00451152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65677809|NCT00451152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65677810|NCT00451152|Growth Substances|growth substances|mesh-ancestor
65677811|NCT00451152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677812|NCT00451152|Growth Inhibitors|growth inhibitors|mesh-ancestor
65677813|NCT00451152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677814|NCT00451152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65677815|NCT02078583|Fentanyl|fentanyl|mesh-list
65677816|NCT02078583|Remifentanil|remifentanil|mesh-list
65677817|NCT02078583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65677818|NCT02078583|Narcotics|narcotics|mesh-ancestor
65677819|NCT02078583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677820|NCT02078583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677821|NCT02078583|Analgesics|analgesics|mesh-ancestor
65677822|NCT02078583|Sensory System Agents|sensory system agents|mesh-ancestor
65677823|NCT02078583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677824|NCT02078583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65677825|NCT02078583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65677826|NCT02078583|Anesthetics, General|anesthetics, general|mesh-ancestor
65677827|NCT02078583|Anesthetics|anesthetics|mesh-ancestor
65677828|NCT03069638|Dexmedetomidine|dexmedetomidine|mesh-list
65677829|NCT03069638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65677830|NCT03069638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677831|NCT03069638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677832|NCT03069638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65677833|NCT03069638|Analgesics|analgesics|mesh-ancestor
65677834|NCT03069638|Sensory System Agents|sensory system agents|mesh-ancestor
65677835|NCT03069638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677836|NCT03069638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65677837|NCT03069638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65677838|NCT03069638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65677839|NCT03069638|Adrenergic Agents|adrenergic agents|mesh-ancestor
65677840|NCT03069638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677841|NCT03069638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677842|NCT02948660|Zolpidem|zolpidem|mesh-list
65677843|NCT02948660|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65677844|NCT02948660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65677845|NCT02948660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677846|NCT02948660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677847|NCT02948660|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65677848|NCT02948660|GABA Agonists|gaba agonists|mesh-ancestor
65677849|NCT02948660|GABA Agents|gaba agents|mesh-ancestor
65677850|NCT02948660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677851|NCT02948660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677852|NCT02074605|Interferons|interferons|mesh-list
65677853|NCT02074605|Interferon-alpha|interferon-alpha|mesh-list
65677854|NCT02074605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677855|NCT02074605|Antiviral Agents|antiviral agents|mesh-ancestor
65677856|NCT02074605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65677857|NCT02074605|Immunologic Factors|immunologic factors|mesh-ancestor
65677858|NCT02074605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677859|NCT00448422|Prulifloxacin|prulifloxacin|mesh-list
65677860|NCT00448422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65677861|NCT00448422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65677862|NCT00448422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65677863|NCT00448422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65677864|NCT00448422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677865|NCT00448422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677866|NCT00448422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677867|NCT00583830|Paclitaxel|paclitaxel|mesh-list
65677868|NCT00583830|Carboplatin|carboplatin|mesh-list
65677869|NCT00583830|Mapatumumab|mapatumumab|mesh-list
65677870|NCT00583830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65677871|NCT00583830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65677872|NCT00583830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677873|NCT00583830|Tubulin Modulators|tubulin modulators|mesh-ancestor
65677874|NCT00583830|Antimitotic Agents|antimitotic agents|mesh-ancestor
65677875|NCT00583830|Mitosis Modulators|mitosis modulators|mesh-ancestor
65677876|NCT00583830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677877|NCT00583830|Immunologic Factors|immunologic factors|mesh-ancestor
65677878|NCT00583830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677879|NCT03430544|Cariprazine|cariprazine|mesh-list
65677880|NCT03430544|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65677881|NCT03430544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65677882|NCT03430544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677883|NCT03430544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677884|NCT03430544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65677886|NCT00583674|Capecitabine|capecitabine|mesh-list
65677887|NCT00583674|Trebananib|trebananib|mesh-list
65677888|NCT00583674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677889|NCT00583674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65677890|NCT00583674|Antimetabolites|antimetabolites|mesh-ancestor
65677891|NCT00583674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677892|NCT00583674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65677893|NCT00583674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65677894|NCT00583674|Growth Substances|growth substances|mesh-ancestor
65677895|NCT00583674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677896|NCT00583674|Growth Inhibitors|growth inhibitors|mesh-ancestor
65677897|NCT03422510|CXA-10|cxa-10|mesh-list
65677898|NCT03422510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65677899|NCT03430466|Fulvestrant|fulvestrant|mesh-list
65677900|NCT03430466|Tremelimumab|tremelimumab|mesh-list
65677901|NCT03430466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65677902|NCT03430466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65677903|NCT03430466|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65677904|NCT03430466|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65677905|NCT03430466|Hormone Antagonists|hormone antagonists|mesh-ancestor
65677906|NCT03430466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65677907|NCT03430466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677908|NCT02280174|Linagliptin|linagliptin|mesh-list
65677909|NCT02280174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65677910|NCT02280174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677911|NCT02280174|Incretins|incretins|mesh-ancestor
65677912|NCT02280174|Hormones|hormones|mesh-ancestor
65677913|NCT02280174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65677914|NCT02280174|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65677915|NCT02280174|Protease Inhibitors|protease inhibitors|mesh-ancestor
65677916|NCT02280174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677917|NCT02280174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677918|NCT00447564|Buprenorphine|buprenorphine|mesh-list
65677919|NCT00447564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65677920|NCT00447564|Narcotics|narcotics|mesh-ancestor
65677921|NCT00447564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677922|NCT00447564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677923|NCT00447564|Analgesics|analgesics|mesh-ancestor
65677924|NCT00447564|Sensory System Agents|sensory system agents|mesh-ancestor
65677925|NCT00447564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677926|NCT00447564|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65677927|NCT00576810|Picosulfate sodium|picosulfate sodium|mesh-list
65677928|NCT00576810|Cathartics|cathartics|mesh-ancestor
65677929|NCT00576810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65677930|NCT00576342|Timolol|timolol|mesh-list
65677931|NCT00576342|Dorzolamide|dorzolamide|mesh-list
65677932|NCT00576342|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65677933|NCT00576342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65677934|NCT00576342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65677935|NCT00576342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65677936|NCT00576342|Adrenergic Agents|adrenergic agents|mesh-ancestor
65677937|NCT00576342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677938|NCT00576342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677939|NCT00576342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677940|NCT00576342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65677941|NCT00576342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65677942|NCT00576342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65677943|NCT00576342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677944|NCT02282280|Prilocaine|prilocaine|mesh-list
65677945|NCT02282280|Anesthetics, Local|anesthetics, local|mesh-ancestor
65677946|NCT02282280|Anesthetics|anesthetics|mesh-ancestor
65677947|NCT02282280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677948|NCT02282280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677949|NCT02282280|Sensory System Agents|sensory system agents|mesh-ancestor
65677950|NCT02282280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677951|NCT00442104|Ganaxolone|ganaxolone|mesh-list
65677952|NCT00442104|Neurosteroids|neurosteroids|mesh-ancestor
65677953|NCT00442104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677954|NCT00442104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677955|NCT00442104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677956|NCT00442104|GABA Modulators|gaba modulators|mesh-ancestor
65677957|NCT00442104|GABA Agents|gaba agents|mesh-ancestor
65677958|NCT03429998|Evolocumab|evolocumab|mesh-list
65677959|NCT03429998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65677960|NCT03429998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65677961|NCT03429998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65677962|NCT03429998|Antimetabolites|antimetabolites|mesh-ancestor
65677963|NCT03429998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677964|NCT03429998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65677965|NCT03429998|Immunologic Factors|immunologic factors|mesh-ancestor
65677966|NCT03429998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677967|NCT00658008|Paroxetine|paroxetine|mesh-list
65677968|NCT00658008|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65677969|NCT00658008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65677970|NCT00658008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65677971|NCT00658008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677972|NCT00658008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677973|NCT00658008|Serotonin Agents|serotonin agents|mesh-ancestor
65677974|NCT00658008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677975|NCT00658008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65677976|NCT00658008|Antidepressive Agents|antidepressive agents|mesh-ancestor
65677977|NCT00658008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65677978|NCT00658008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65677979|NCT00658008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65677980|NCT00658008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65677981|NCT03427502|Epinephrine|epinephrine|mesh-list
65677982|NCT03427502|Bupivacaine|bupivacaine|mesh-list
65677983|NCT03427502|Anesthetics, Local|anesthetics, local|mesh-ancestor
65677984|NCT03427502|Anesthetics|anesthetics|mesh-ancestor
65677985|NCT03427502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65677986|NCT03427502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65677987|NCT03427502|Sensory System Agents|sensory system agents|mesh-ancestor
65677988|NCT03427502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65677989|NCT03427502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65677990|NCT03427502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65677991|NCT03427502|Adrenergic Agents|adrenergic agents|mesh-ancestor
65677992|NCT03427502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65677993|NCT03427502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65677994|NCT03427502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65677995|NCT03427502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65677996|NCT03427502|Autonomic Agents|autonomic agents|mesh-ancestor
65677997|NCT03427502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65677998|NCT03427502|Respiratory System Agents|respiratory system agents|mesh-ancestor
65677999|NCT03427502|Mydriatics|mydriatics|mesh-ancestor
65678000|NCT03427502|Sympathomimetics|sympathomimetics|mesh-ancestor
65678001|NCT03427502|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65678002|NCT00440388|Rituximab|rituximab|mesh-list
65678003|NCT00440388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65678004|NCT00440388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678005|NCT00440388|Immunologic Factors|immunologic factors|mesh-ancestor
65678006|NCT00440388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678007|NCT00440388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65678008|NCT03422042|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65678009|NCT03422042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65678010|NCT03422042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65678011|NCT03422042|Antitubercular Agents|antitubercular agents|mesh-ancestor
65678012|NCT04449224|Etanercept|etanercept|mesh-list
65678013|NCT04449224|Abatacept|abatacept|mesh-list
65678014|NCT04449224|Tofacitinib|tofacitinib|mesh-list
65678015|NCT04449224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65678016|NCT04449224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65678017|NCT04449224|Analgesics|analgesics|mesh-ancestor
65678018|NCT04449224|Sensory System Agents|sensory system agents|mesh-ancestor
65678019|NCT04449224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65678020|NCT04449224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678021|NCT04449224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65678022|NCT04449224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65678023|NCT04449224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65268703|NCT04216628|Oxytocin|oxytocin|mesh-list
65678024|NCT04449224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65678025|NCT04449224|Immunologic Factors|immunologic factors|mesh-ancestor
65678026|NCT04449224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65678027|NCT04449224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678028|NCT04449224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678029|NCT04449224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65678030|NCT04449224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678031|NCT00437112|Insulin|insulin|mesh-list
65678032|NCT00437112|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65678033|NCT00437112|Insulin Glargine|insulin glargine|mesh-list
65678034|NCT00437112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65678035|NCT00437112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678036|NCT00434850|Gusperimus|gusperimus|mesh-list
65678037|NCT00434850|Sirolimus|sirolimus|mesh-list
65678038|NCT00434850|Etanercept|etanercept|mesh-list
65678039|NCT00434850|Tacrolimus|tacrolimus|mesh-list
65678040|NCT00434850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65678041|NCT00434850|Basiliximab|basiliximab|mesh-list
65678042|NCT00434850|Daclizumab|daclizumab|mesh-list
65678043|NCT00434850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65678044|NCT00434850|Immunologic Factors|immunologic factors|mesh-ancestor
65678045|NCT00434850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678046|NCT00434850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65678047|NCT00434850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678048|NCT00434850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678049|NCT00434850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65678050|NCT00434850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65678051|NCT00434850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65678052|NCT00434850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678053|NCT00434850|Antifungal Agents|antifungal agents|mesh-ancestor
65678054|NCT00434850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65678055|NCT00434850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65678056|NCT00434850|Analgesics|analgesics|mesh-ancestor
65678057|NCT00434850|Sensory System Agents|sensory system agents|mesh-ancestor
65678058|NCT00434850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65678059|NCT00434850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65678060|NCT00434850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65678061|NCT00434850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65678062|NCT00434850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65678063|NCT00434850|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65678064|NCT00434850|Protective Agents|protective agents|mesh-ancestor
65678065|NCT04449380|Interferons|interferons|mesh-list
65678066|NCT04449380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678067|NCT04449380|Antiviral Agents|antiviral agents|mesh-ancestor
65678068|NCT04449380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65678069|NCT03128216|Bupivacaine|bupivacaine|mesh-list
65678070|NCT03128216|Ropivacaine|ropivacaine|mesh-list
65678071|NCT03128216|Anesthetics, Local|anesthetics, local|mesh-list
65678072|NCT03128216|Anesthetics|anesthetics|mesh-list
65678073|NCT03128216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65678074|NCT03128216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678075|NCT03128216|Sensory System Agents|sensory system agents|mesh-ancestor
65678076|NCT03128216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65678077|NCT00566202|Citalopram|citalopram|mesh-list
65678078|NCT00566202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65678079|NCT00566202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65678080|NCT00566202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65678081|NCT00566202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678082|NCT00566202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65678083|NCT00566202|Serotonin Agents|serotonin agents|mesh-ancestor
65678084|NCT00566202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678085|NCT00566202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65678086|NCT00566202|Antidepressive Agents|antidepressive agents|mesh-ancestor
65678087|NCT00566202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65678088|NCT02280486|Glimepiride|glimepiride|mesh-list
65678089|NCT02280486|Saxagliptin|saxagliptin|mesh-list
65678090|NCT02280486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65678091|NCT02280486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65678092|NCT02280486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678093|NCT02280486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65678094|NCT02280486|Immunologic Factors|immunologic factors|mesh-ancestor
65678095|NCT02280486|Incretins|incretins|mesh-ancestor
65678096|NCT02280486|Hormones|hormones|mesh-ancestor
65678097|NCT02280486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65678098|NCT02280486|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65678099|NCT02280486|Protease Inhibitors|protease inhibitors|mesh-ancestor
65678100|NCT02280486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678101|NCT02280486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678102|NCT00434226|Paclitaxel|paclitaxel|mesh-list
65678103|NCT00434226|Bevacizumab|bevacizumab|mesh-list
65678104|NCT00434226|Carboplatin|carboplatin|mesh-list
65678105|NCT00434226|Sunitinib|sunitinib|mesh-list
65678106|NCT00434226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65678107|NCT00434226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678108|NCT00434226|Tubulin Modulators|tubulin modulators|mesh-ancestor
65678109|NCT00434226|Antimitotic Agents|antimitotic agents|mesh-ancestor
65678110|NCT00434226|Mitosis Modulators|mitosis modulators|mesh-ancestor
65678111|NCT00434226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678112|NCT00434226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65678113|NCT00434226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65678114|NCT00434226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65678115|NCT00434226|Growth Substances|growth substances|mesh-ancestor
65678116|NCT00434226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678117|NCT00434226|Growth Inhibitors|growth inhibitors|mesh-ancestor
65678118|NCT00434226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65678119|NCT00434226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678120|NCT00430950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65678121|NCT00430950|Olmesartan|olmesartan|mesh-list
65678122|NCT00430950|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65678123|NCT00430950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65678124|NCT00430950|Diuretics|diuretics|mesh-ancestor
65678125|NCT00430950|Natriuretic Agents|natriuretic agents|mesh-ancestor
65678126|NCT00430950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678127|NCT00430950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65678128|NCT00430950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65678129|NCT00430950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678130|NCT00430950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65678131|NCT00430950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65678132|NCT00549744|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
65678133|NCT00549744|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65678134|NCT00549744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65678135|NCT00549744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678136|NCT00549744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678137|NCT02081391|Tapentadol|tapentadol|mesh-list
65678138|NCT02081391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65678139|NCT02081391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65678140|NCT02081391|Narcotics|narcotics|mesh-ancestor
65678141|NCT02081391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65678142|NCT02081391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678143|NCT02081391|Analgesics|analgesics|mesh-ancestor
65678144|NCT02081391|Sensory System Agents|sensory system agents|mesh-ancestor
65678145|NCT02081391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65678146|NCT02081391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65678147|NCT02081391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65678148|NCT02081391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65678149|NCT02081391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678150|NCT02081391|Adrenergic Agents|adrenergic agents|mesh-ancestor
65678151|NCT02081391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65678152|NCT00549510|Lisinopril|lisinopril|mesh-list
65678153|NCT00549510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65678154|NCT00549510|Protease Inhibitors|protease inhibitors|mesh-ancestor
65678155|NCT00549510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678156|NCT00549510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678157|NCT00549510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65678158|NCT00549510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65678159|NCT00549510|Protective Agents|protective agents|mesh-ancestor
65678160|NCT00549510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678161|NCT00430092|Fluprednisolone|fluprednisolone|mesh-list
65678162|NCT00430092|Difluprednate|difluprednate|mesh-list
65678163|NCT00430092|Glucocorticoids|glucocorticoids|mesh-ancestor
65678164|NCT00430092|Hormones|hormones|mesh-ancestor
65678165|NCT00430092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65678166|NCT00430092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678167|NCT00430092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65678168|NCT00427440|Rilotumumab|rilotumumab|mesh-list
65678169|NCT00427440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65678170|NCT00427440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65678171|NCT00427440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678172|NCT00427440|Immunologic Factors|immunologic factors|mesh-ancestor
65678173|NCT00427440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678174|NCT00650832|Darunavir|darunavir|mesh-list
65678175|NCT00650832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65678176|NCT00650832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65678177|NCT00650832|Protease Inhibitors|protease inhibitors|mesh-ancestor
65678178|NCT00650832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678179|NCT00650832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678180|NCT00650832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65678181|NCT00650832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65678182|NCT00650832|Antiviral Agents|antiviral agents|mesh-ancestor
65678183|NCT00650832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65678184|NCT00425100|Fesoterodine|fesoterodine|mesh-list
65678185|NCT00425100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65678186|NCT00425100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65678187|NCT00425100|Cholinergic Agents|cholinergic agents|mesh-ancestor
65678188|NCT00425100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65678189|NCT00425100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678190|NCT00425100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678191|NCT00425100|Urological Agents|urological agents|mesh-ancestor
65678192|NCT00546780|Bortezomib|bortezomib|mesh-list
65678193|NCT00546780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678194|NCT00420888|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65678195|NCT00420888|Immunoconjugates|immunoconjugates|mesh-list
65678196|NCT00420888|Immunologic Factors|immunologic factors|mesh-ancestor
65678197|NCT00420888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678198|NCT00543582|Azacitidine|azacitidine|mesh-list
65678199|NCT00543582|Mocetinostat|mocetinostat|mesh-list
65678200|NCT00543582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65678201|NCT00543582|Antimetabolites|antimetabolites|mesh-ancestor
65678202|NCT00543582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678203|NCT00543582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678204|NCT00543582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678205|NCT00543582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65678206|NCT00542724|Insulin|insulin|mesh-list
65678207|NCT00542724|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65678208|NCT00542724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65678209|NCT00542724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678210|NCT00412932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65678211|NCT00412932|Olmesartan|olmesartan|mesh-list
65678212|NCT00412932|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65678213|NCT00412932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65678214|NCT00412932|Diuretics|diuretics|mesh-ancestor
65678215|NCT00412932|Natriuretic Agents|natriuretic agents|mesh-ancestor
65678216|NCT00412932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678217|NCT00412932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65678218|NCT00412932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65678219|NCT00412932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678220|NCT00412932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65678221|NCT00412932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65678222|NCT00411528|Prednisone|prednisone|mesh-list
65678223|NCT00411528|Docetaxel|docetaxel|mesh-list
65678224|NCT00411528|Epothilone B|epothilone b|mesh-list
65678225|NCT00411528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678226|NCT00411528|Tubulin Modulators|tubulin modulators|mesh-ancestor
65678227|NCT00411528|Antimitotic Agents|antimitotic agents|mesh-ancestor
65678228|NCT00411528|Mitosis Modulators|mitosis modulators|mesh-ancestor
65678229|NCT00411528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678230|NCT00411528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65678231|NCT00411528|Glucocorticoids|glucocorticoids|mesh-ancestor
65678232|NCT00411528|Hormones|hormones|mesh-ancestor
65268705|NCT04216628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65678233|NCT00411528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65678234|NCT00411528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678235|NCT00411528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65678236|NCT00384150|Galiximab|galiximab|mesh-list
65678237|NCT00384150|Rituximab|rituximab|mesh-list
65678238|NCT00384150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65678239|NCT00384150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678240|NCT00384150|Immunologic Factors|immunologic factors|mesh-ancestor
65678241|NCT00384150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678242|NCT00384150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65678243|NCT00384150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65678244|NCT00532038|Ketoprofen|ketoprofen|mesh-list
65678245|NCT00532038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65678246|NCT00532038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65678247|NCT00532038|Analgesics|analgesics|mesh-ancestor
65678248|NCT00532038|Sensory System Agents|sensory system agents|mesh-ancestor
65678249|NCT00532038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65678250|NCT00532038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678251|NCT00532038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65678252|NCT00532038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65678253|NCT00532038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65678254|NCT00532038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678255|NCT00532038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678256|NCT00403416|Mycophenolic Acid|mycophenolic acid|mesh-list
65678257|NCT00403416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65678258|NCT00403416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678259|NCT00403416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65678260|NCT00403416|Antitubercular Agents|antitubercular agents|mesh-ancestor
65678261|NCT00403416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65678262|NCT00403416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65678263|NCT00403416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678264|NCT00403416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678265|NCT00401388|Allopurinol|allopurinol|mesh-list
65678266|NCT00401388|Antiemetics|antiemetics|mesh-list
65678267|NCT00401388|Loperamide|loperamide|mesh-list
65678268|NCT00401388|Antidiarrheals|antidiarrheals|mesh-list
65678269|NCT00401388|Antimetabolites|antimetabolites|mesh-ancestor
65678270|NCT00401388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678271|NCT00401388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678272|NCT00401388|Gout Suppressants|gout suppressants|mesh-ancestor
65678273|NCT00401388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65678274|NCT00401388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65678275|NCT00401388|Antioxidants|antioxidants|mesh-ancestor
65678276|NCT00401388|Protective Agents|protective agents|mesh-ancestor
65678277|NCT00401388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678278|NCT00401388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65678279|NCT00401388|Autonomic Agents|autonomic agents|mesh-ancestor
65678280|NCT00401388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65678281|NCT02282826|Acyclovir|acyclovir|mesh-list
65678282|NCT02282826|Antiviral Agents|antiviral agents|mesh-ancestor
65678283|NCT02282826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65678284|NCT00374166|Paroxetine|paroxetine|mesh-list
65678285|NCT00374166|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65678286|NCT00374166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65678287|NCT00374166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65678288|NCT00374166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678289|NCT00374166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65678290|NCT00374166|Serotonin Agents|serotonin agents|mesh-ancestor
65678291|NCT00374166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678292|NCT00374166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65678293|NCT00374166|Antidepressive Agents|antidepressive agents|mesh-ancestor
65678294|NCT00374166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65678295|NCT00374166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65678296|NCT00374166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65678297|NCT00374166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678298|NCT03559413|Imiquimod|imiquimod|mesh-list
65678299|NCT03559413|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65678300|NCT03559413|Immunologic Factors|immunologic factors|mesh-ancestor
65678301|NCT03559413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678302|NCT03559413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678303|NCT03559413|Interferon Inducers|interferon inducers|mesh-ancestor
65678304|NCT02078895|Botulinum Toxins|botulinum toxins|mesh-list
65678305|NCT02078895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65678306|NCT02078895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65678307|NCT02078895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65678308|NCT02078895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65678309|NCT02078895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678310|NCT02078895|Cholinergic Agents|cholinergic agents|mesh-ancestor
65678311|NCT02078895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65678312|NCT02078895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678313|NCT02078895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65678314|NCT02078895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65678315|NCT02078973|Tolvaptan|tolvaptan|mesh-list
65678316|NCT02078973|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65678317|NCT02078973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678318|NCT02078973|Natriuretic Agents|natriuretic agents|mesh-ancestor
65678319|NCT02078973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678320|NCT00397254|Rizatriptan|rizatriptan|mesh-list
65678321|NCT00397254|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65678322|NCT00397254|Serotonin Agents|serotonin agents|mesh-ancestor
65678323|NCT00397254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65678324|NCT00397254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678325|NCT00397254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678326|NCT01369641|Sodium thiosulfate|sodium thiosulfate|mesh-list
65678327|NCT01369641|Cisplatin|cisplatin|mesh-list
65475652|NCT01139840|Vitamin D|vitamin d|mesh-list
65678328|NCT01369641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678329|NCT01369641|Antidotes|antidotes|mesh-ancestor
65678330|NCT01369641|Protective Agents|protective agents|mesh-ancestor
65678331|NCT01369641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678332|NCT01369641|Antioxidants|antioxidants|mesh-ancestor
65678333|NCT01369641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678334|NCT01369641|Antitubercular Agents|antitubercular agents|mesh-ancestor
65678335|NCT01369641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65678336|NCT01369641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65678337|NCT01369641|Chelating Agents|chelating agents|mesh-ancestor
65678338|NCT01369641|Sequestering Agents|sequestering agents|mesh-ancestor
65678339|NCT02283060|Tenofovir|tenofovir|mesh-list
65678340|NCT02283060|Emtricitabine|emtricitabine|mesh-list
65678341|NCT02283060|Efavirenz|efavirenz|mesh-list
65678342|NCT02283060|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65678343|NCT02283060|Cobicistat|cobicistat|mesh-list
65678344|NCT02283060|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65678345|NCT02283060|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65678346|NCT02283060|Elvitegravir|elvitegravir|mesh-list
65678347|NCT02283060|Antiviral Agents|antiviral agents|mesh-ancestor
65678348|NCT02283060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65678349|NCT02283060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65678350|NCT02283060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65678351|NCT02283060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678352|NCT02283060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678353|NCT02283060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65678354|NCT02283060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65678355|NCT02283060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65678356|NCT02283060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65678357|NCT02283060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65678358|NCT02283060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65678359|NCT02283060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65678360|NCT02283060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65678361|NCT02283060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65678362|NCT02283060|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65678363|NCT03559725|Menthol|menthol|mesh-list
65678364|NCT03559725|Nicotine|nicotine|mesh-list
65678365|NCT03559725|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65678366|NCT03559725|Autonomic Agents|autonomic agents|mesh-ancestor
65678367|NCT03559725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65678368|NCT03559725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678369|NCT03559725|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65678370|NCT03559725|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65678371|NCT03559725|Cholinergic Agents|cholinergic agents|mesh-ancestor
65678372|NCT03559725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65678373|NCT03559725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678374|NCT03559725|Antipruritics|antipruritics|mesh-ancestor
65678375|NCT03559725|Dermatologic Agents|dermatologic agents|mesh-ancestor
65678376|NCT00529152|Deferiprone|deferiprone|mesh-list
65678377|NCT00529152|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65678378|NCT00529152|Chelating Agents|chelating agents|mesh-ancestor
65678379|NCT00529152|Sequestering Agents|sequestering agents|mesh-ancestor
65678380|NCT00529152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678381|NCT00525330|Metformin|metformin|mesh-list
65678382|NCT00525330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65678383|NCT00525330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678384|NCT02287272|Cimetidine|cimetidine|mesh-list
65678385|NCT02287272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65678386|NCT02287272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65678387|NCT02287272|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65678388|NCT02287272|Histamine Antagonists|histamine antagonists|mesh-ancestor
65678389|NCT02287272|Histamine Agents|histamine agents|mesh-ancestor
65678390|NCT02287272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65678391|NCT02287272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678392|NCT02287272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678393|NCT02287272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65678394|NCT02287272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65678395|NCT02287272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678396|NCT00392574|Prulifloxacin|prulifloxacin|mesh-list
65678397|NCT00392574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65678398|NCT00392574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65678399|NCT00392574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65678400|NCT00392574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65678401|NCT00392574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678402|NCT00392574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678403|NCT00392574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678404|NCT04470414|Antibodies|antibodies|mesh-list
65678405|NCT04470414|Immunoglobulin G|immunoglobulin g|mesh-list
65678406|NCT04470414|Immunologic Factors|immunologic factors|mesh-ancestor
65678407|NCT04470414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678408|NCT00363636|Galiximab|galiximab|mesh-list
65678409|NCT00363636|Rituximab|rituximab|mesh-list
65678410|NCT00363636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65678411|NCT00363636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678412|NCT00363636|Immunologic Factors|immunologic factors|mesh-ancestor
65678413|NCT00363636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678414|NCT00363636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65678415|NCT00363636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65678416|NCT02605174|Lasmiditan|lasmiditan|mesh-list
65678417|NCT02605174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65678418|NCT02605174|Serotonin Agents|serotonin agents|mesh-ancestor
65678419|NCT02605174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65678420|NCT02605174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678421|NCT02605174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678422|NCT00522834|Paclitaxel|paclitaxel|mesh-list
65678423|NCT00522834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65678424|NCT00522834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678425|NCT00522834|Tubulin Modulators|tubulin modulators|mesh-ancestor
65678426|NCT00522834|Antimitotic Agents|antimitotic agents|mesh-ancestor
65678427|NCT00522834|Mitosis Modulators|mitosis modulators|mesh-ancestor
65678428|NCT00522834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678429|NCT02075619|Amlodipine|amlodipine|mesh-list
65678430|NCT02075619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65678431|NCT02075619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65678432|NCT02075619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65678433|NCT02075619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65678434|NCT02075619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678435|NCT02075619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65678436|NCT02075619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678437|NCT02075619|Vasodilator Agents|vasodilator agents|mesh-ancestor
65678438|NCT02075619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65678439|NCT02075619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65678440|NCT02075619|Antimetabolites|antimetabolites|mesh-ancestor
65678441|NCT02075619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65678442|NCT02075619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65678443|NCT02075619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678444|NCT00358878|Satavaptan|satavaptan|mesh-list
65678445|NCT00358878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65678446|NCT00358878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678447|NCT00358878|Natriuretic Agents|natriuretic agents|mesh-ancestor
65678448|NCT00358878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678449|NCT02283372|Gemcitabine|gemcitabine|mesh-list
65678450|NCT02283372|Paclitaxel|paclitaxel|mesh-list
65678451|NCT02283372|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65678452|NCT02283372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65678453|NCT02283372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678454|NCT02283372|Tubulin Modulators|tubulin modulators|mesh-ancestor
65678455|NCT02283372|Antimitotic Agents|antimitotic agents|mesh-ancestor
65678456|NCT02283372|Mitosis Modulators|mitosis modulators|mesh-ancestor
65678457|NCT02283372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678458|NCT02283372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65678459|NCT02283372|Antimetabolites|antimetabolites|mesh-ancestor
65678460|NCT02283372|Antiviral Agents|antiviral agents|mesh-ancestor
65678461|NCT02283372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65678462|NCT02283372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678463|NCT02283372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65678464|NCT02283372|Immunologic Factors|immunologic factors|mesh-ancestor
65678465|NCT02283372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678466|NCT00507936|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65678467|NCT00507936|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65678468|NCT00507936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65678469|NCT00507936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65678470|NCT00507936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678471|NCT00507936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65678472|NCT00507936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475808|NCT04700176|Immunologic Factors|immunologic factors|mesh-ancestor
65678473|NCT00507936|Analgesics|analgesics|mesh-ancestor
65678474|NCT00507936|Sensory System Agents|sensory system agents|mesh-ancestor
65678475|NCT00507936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65678476|NCT00507936|Antidepressive Agents|antidepressive agents|mesh-ancestor
65678477|NCT00507936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65678478|NCT00507936|Dopamine Agents|dopamine agents|mesh-ancestor
65678479|NCT04427020|Caseins|caseins|mesh-list
65678480|NCT04427020|Chelating Agents|chelating agents|mesh-ancestor
65678481|NCT04427020|Sequestering Agents|sequestering agents|mesh-ancestor
65678482|NCT04427020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678483|NCT02083575|Vitamins|vitamins|mesh-list
65678484|NCT02083575|Ascorbic Acid|ascorbic acid|mesh-list
65678485|NCT02083575|Deferiprone|deferiprone|mesh-list
65678486|NCT02083575|Micronutrients|micronutrients|mesh-ancestor
65678487|NCT02083575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678488|NCT02083575|Antioxidants|antioxidants|mesh-ancestor
65678489|NCT02083575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678490|NCT02083575|Protective Agents|protective agents|mesh-ancestor
65678491|NCT02083575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65678492|NCT02083575|Chelating Agents|chelating agents|mesh-ancestor
65678493|NCT02083575|Sequestering Agents|sequestering agents|mesh-ancestor
65678494|NCT02286258|Calcium, Dietary|calcium, dietary|mesh-list
65678495|NCT02286258|Edetic Acid|edetic acid|mesh-list
65678496|NCT02286258|Calcium|calcium|mesh-list
65678497|NCT02286258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65678498|NCT02286258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678499|NCT02286258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65678500|NCT02286258|Chelating Agents|chelating agents|mesh-ancestor
65678501|NCT02286258|Sequestering Agents|sequestering agents|mesh-ancestor
65678502|NCT02286258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678503|NCT02286258|Anticoagulants|anticoagulants|mesh-ancestor
65678504|NCT02286258|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65678505|NCT02088411|Diclofenac|diclofenac|mesh-list
65678506|NCT02088411|Wobenzym|wobenzym|mesh-list
65678507|NCT02088411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65678508|NCT02088411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65678509|NCT02088411|Analgesics|analgesics|mesh-ancestor
65678510|NCT02088411|Sensory System Agents|sensory system agents|mesh-ancestor
65678511|NCT02088411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65678512|NCT02088411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678513|NCT02088411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65678514|NCT02088411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65678515|NCT02088411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65678516|NCT02088411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678517|NCT02088411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678518|NCT02088411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65678519|NCT02088411|Immunologic Factors|immunologic factors|mesh-ancestor
65678520|NCT02082327|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
65678521|NCT02082327|Antiviral Agents|antiviral agents|mesh-ancestor
65678522|NCT02082327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65678523|NCT02082327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678524|NCT02082327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678525|NCT02604550|Naproxen|naproxen|mesh-list
65678526|NCT02604550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65678527|NCT02604550|Ropivacaine|ropivacaine|mesh-list
65678528|NCT02604550|Anesthetics, Local|anesthetics, local|mesh-ancestor
65678529|NCT02604550|Anesthetics|anesthetics|mesh-ancestor
65678530|NCT02604550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65678531|NCT02604550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678532|NCT02604550|Sensory System Agents|sensory system agents|mesh-ancestor
65678533|NCT02604550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65678534|NCT02604550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65678535|NCT02604550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65678536|NCT02604550|Analgesics|analgesics|mesh-ancestor
65678537|NCT02604550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65678538|NCT02604550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65678539|NCT02604550|Gout Suppressants|gout suppressants|mesh-ancestor
65678540|NCT02604550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65678541|NCT02604550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678542|NCT02604550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678543|NCT02604550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65678544|NCT02604550|Narcotics|narcotics|mesh-ancestor
65678545|NCT02084043|Amikacin|amikacin|mesh-list
65678546|NCT02084043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65475878|NCT00566488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678547|NCT02084043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65678548|NCT03530670|Midazolam|midazolam|mesh-list
65678549|NCT03530670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65678550|NCT03530670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65678551|NCT03530670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65678552|NCT03530670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678553|NCT03530670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65678554|NCT03530670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65678555|NCT03530670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65678556|NCT03530670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65678557|NCT03530670|Anesthetics, General|anesthetics, general|mesh-ancestor
65678558|NCT03530670|Anesthetics|anesthetics|mesh-ancestor
65678559|NCT03530670|GABA Modulators|gaba modulators|mesh-ancestor
65678560|NCT03530670|GABA Agents|gaba agents|mesh-ancestor
65678561|NCT03530670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65678562|NCT03530670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678563|NCT00120042|Misoprostol|misoprostol|mesh-list
65678564|NCT00120042|Oxytocin|oxytocin|mesh-list
65678565|NCT00120042|Oxytocics|oxytocics|mesh-ancestor
65678566|NCT00120042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65678567|NCT00120042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678568|NCT00120042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65678569|NCT00120042|Abortifacient Agents|abortifacient agents|mesh-ancestor
65678570|NCT00120042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65678571|NCT00120042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65678572|NCT02084355|Fentanyl|fentanyl|mesh-list
65678573|NCT02084355|Oxycodone|oxycodone|mesh-list
65678574|NCT02084355|Hydromorphone|hydromorphone|mesh-list
65678575|NCT02084355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65678576|NCT02084355|Narcotics|narcotics|mesh-ancestor
65678577|NCT02084355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65678578|NCT02084355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678579|NCT02084355|Analgesics|analgesics|mesh-ancestor
65678580|NCT02084355|Sensory System Agents|sensory system agents|mesh-ancestor
65678581|NCT02084355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65678582|NCT02084355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65678583|NCT02084355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65678584|NCT02084355|Anesthetics, General|anesthetics, general|mesh-ancestor
65678585|NCT02084355|Anesthetics|anesthetics|mesh-ancestor
65678586|NCT00353574|Darusentan|darusentan|mesh-list
65678587|NCT00353574|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65678588|NCT00353574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678589|NCT02082405|Dexamethasone|dexamethasone|mesh-list
65678590|NCT02082405|Cyclophosphamide|cyclophosphamide|mesh-list
65678591|NCT02082405|Bortezomib|bortezomib|mesh-list
65678592|NCT02082405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65678593|NCT02082405|Immunologic Factors|immunologic factors|mesh-ancestor
65678594|NCT02082405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678595|NCT02082405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65678596|NCT02082405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65678597|NCT02082405|Alkylating Agents|alkylating agents|mesh-ancestor
65678598|NCT02082405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678599|NCT02082405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678600|NCT02082405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65678601|NCT02082405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65678602|NCT02082405|Antiemetics|antiemetics|mesh-ancestor
65678603|NCT02082405|Autonomic Agents|autonomic agents|mesh-ancestor
65678604|NCT02082405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65678605|NCT02082405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65678606|NCT02082405|Glucocorticoids|glucocorticoids|mesh-ancestor
65678607|NCT02082405|Hormones|hormones|mesh-ancestor
65678608|NCT02082405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65678609|NCT02082405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65678610|NCT04428268|Chloroquine|chloroquine|mesh-list
65678611|NCT04428268|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65678612|NCT04428268|Losartan|losartan|mesh-list
65678613|NCT04428268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65678614|NCT04428268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65678615|NCT04428268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65678616|NCT04428268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65678617|NCT04428268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678618|NCT04428268|Amebicides|amebicides|mesh-ancestor
65678619|NCT04428268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65678620|NCT04428268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65678621|NCT04428268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65678622|NCT04428268|Antimalarials|antimalarials|mesh-ancestor
65678623|NCT04428268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65678624|NCT04428268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65678625|NCT04428268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65678626|NCT04428268|Analgesics|analgesics|mesh-ancestor
65678627|NCT04428268|Sensory System Agents|sensory system agents|mesh-ancestor
65678628|NCT04428268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65678629|NCT04428268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678630|NCT04428268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65678631|NCT04428268|Filaricides|filaricides|mesh-ancestor
65678632|NCT04428268|Antinematodal Agents|antinematodal agents|mesh-ancestor
65678633|NCT04428268|Anthelmintics|anthelmintics|mesh-ancestor
65678634|NCT02084433|Anesthetics|anesthetics|mesh-list
65678635|NCT02084433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65678636|NCT02084433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678637|NCT00116298|Lamivudine|lamivudine|mesh-list
65678638|NCT00116298|Efavirenz|efavirenz|mesh-list
65678639|NCT00116298|Stavudine|stavudine|mesh-list
65678640|NCT00116298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65678641|NCT00116298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65678642|NCT00116298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678643|NCT00116298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678644|NCT00116298|Antiviral Agents|antiviral agents|mesh-ancestor
65678645|NCT00116298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65678646|NCT00116298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65678647|NCT00116298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65678648|NCT00116298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65678649|NCT00116298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65678650|NCT00116298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65678651|NCT00116298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65678652|NCT00116298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65678653|NCT00116298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65678654|NCT00116298|Antimetabolites|antimetabolites|mesh-ancestor
65678655|NCT04427098|Enoxaparin|enoxaparin|mesh-list
65678656|NCT04427098|Enoxaparin sodium|enoxaparin sodium|mesh-list
65678657|NCT04427098|Anticoagulants|anticoagulants|mesh-ancestor
65678658|NCT04427098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65678659|NCT04427098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65678660|NCT04427098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678661|NCT00352560|Irbesartan|irbesartan|mesh-list
65678662|NCT00352560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65678663|NCT00352560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65678664|NCT00352560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65678665|NCT00352560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678666|NCT00115050|Darunavir|darunavir|mesh-list
65678667|NCT00115050|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65678668|NCT00115050|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65678669|NCT00115050|Protease Inhibitors|protease inhibitors|mesh-ancestor
65678670|NCT00115050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678671|NCT00115050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678672|NCT00115050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65678673|NCT00115050|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65678674|NCT00115050|Antiviral Agents|antiviral agents|mesh-ancestor
65678675|NCT00115050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65678676|NCT05616364|Dexmedetomidine|dexmedetomidine|mesh-list
65678677|NCT05616364|Tramadol|tramadol|mesh-list
65678678|NCT05616364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65678679|NCT05616364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65678680|NCT05616364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678681|NCT05616364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65678682|NCT05616364|Analgesics|analgesics|mesh-ancestor
65678683|NCT05616364|Sensory System Agents|sensory system agents|mesh-ancestor
65678684|NCT05616364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65678685|NCT05616364|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65678686|NCT05616364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65678687|NCT05616364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65678688|NCT05616364|Adrenergic Agents|adrenergic agents|mesh-ancestor
65678689|NCT05616364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65678690|NCT05616364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678691|NCT05616364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65678692|NCT05616364|Narcotics|narcotics|mesh-ancestor
65678693|NCT00345618|Biotin|biotin|mesh-list
65678694|NCT00345618|Enoxaparin|enoxaparin|mesh-list
65678695|NCT00345618|Warfarin|warfarin|mesh-list
65678696|NCT00345618|Idraparinux|idraparinux|mesh-list
65678697|NCT00345618|Idrabiotaparinux|idrabiotaparinux|mesh-list
65678698|NCT00345618|Anticoagulants|anticoagulants|mesh-ancestor
65678699|NCT00345618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65678700|NCT00345618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65678701|NCT00345618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678702|NCT00345618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65678703|NCT00345618|Antithrombins|antithrombins|mesh-ancestor
65678704|NCT00345618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65678705|NCT00345618|Protease Inhibitors|protease inhibitors|mesh-ancestor
65678706|NCT00345618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678707|NCT00345618|Vitamin B Complex|vitamin b complex|mesh-ancestor
65678708|NCT00345618|Vitamins|vitamins|mesh-ancestor
65678709|NCT00345618|Micronutrients|micronutrients|mesh-ancestor
65678710|NCT00345618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678711|NCT03611868|Pembrolizumab|pembrolizumab|mesh-list
65678712|NCT03611868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65678713|NCT03611868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678714|NCT01866111|Cenobamate|cenobamate|mesh-list
65678715|NCT01866111|Anticonvulsants|anticonvulsants|mesh-ancestor
65678716|NCT02084589|Fentanyl|fentanyl|mesh-list
65678717|NCT02084589|Ropivacaine|ropivacaine|mesh-list
65678718|NCT02084589|Anesthetics, Local|anesthetics, local|mesh-ancestor
65678719|NCT02084589|Anesthetics|anesthetics|mesh-ancestor
65678720|NCT02084589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65678721|NCT02084589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678722|NCT02084589|Sensory System Agents|sensory system agents|mesh-ancestor
65678723|NCT02084589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65678724|NCT02084589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65678725|NCT02084589|Narcotics|narcotics|mesh-ancestor
65678726|NCT02084589|Analgesics|analgesics|mesh-ancestor
65678727|NCT02084589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65678728|NCT02084589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65678729|NCT02084589|Anesthetics, General|anesthetics, general|mesh-ancestor
65678730|NCT03557853|Golimumab|golimumab|mesh-list
65678731|NCT03557853|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65678732|NCT03557853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65678733|NCT03557853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65678734|NCT03557853|Immunologic Factors|immunologic factors|mesh-ancestor
65678735|NCT03557853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678736|NCT04346290|Dexmedetomidine|dexmedetomidine|mesh-list
65678737|NCT04346290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65678738|NCT04346290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65678739|NCT04346290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678740|NCT04346290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65678741|NCT04346290|Analgesics|analgesics|mesh-ancestor
65678742|NCT04346290|Sensory System Agents|sensory system agents|mesh-ancestor
65678743|NCT04346290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65678744|NCT04346290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65678745|NCT04346290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65678746|NCT04346290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65678747|NCT04346290|Adrenergic Agents|adrenergic agents|mesh-ancestor
65678748|NCT04346290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65678749|NCT04346290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678750|NCT04426552|Dexmedetomidine|dexmedetomidine|mesh-list
65678751|NCT04426552|Sevoflurane|sevoflurane|mesh-list
65678752|NCT04426552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65678753|NCT04426552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65678754|NCT04426552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678755|NCT04426552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65678756|NCT04426552|Analgesics|analgesics|mesh-ancestor
65678757|NCT04426552|Sensory System Agents|sensory system agents|mesh-ancestor
65678758|NCT04426552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65678759|NCT04426552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65678760|NCT04426552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65678761|NCT04426552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65678762|NCT04426552|Adrenergic Agents|adrenergic agents|mesh-ancestor
65678763|NCT04426552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65678764|NCT04426552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678765|NCT04426552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65678766|NCT04426552|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65678767|NCT04426552|Anesthetics, General|anesthetics, general|mesh-ancestor
65678768|NCT04426552|Anesthetics|anesthetics|mesh-ancestor
65678769|NCT04803370|Antibodies|antibodies|mesh-list
65678770|NCT04803370|Immunologic Factors|immunologic factors|mesh-ancestor
65678771|NCT04803370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678772|NCT01369329|Ustekinumab|ustekinumab|mesh-list
65678773|NCT01369329|Dermatologic Agents|dermatologic agents|mesh-ancestor
65678774|NCT04802980|Gemcitabine|gemcitabine|mesh-list
65678775|NCT04802980|Paclitaxel|paclitaxel|mesh-list
65678776|NCT04802980|Carboplatin|carboplatin|mesh-list
65678777|NCT04802980|Capecitabine|capecitabine|mesh-list
65678778|NCT04802980|Oxaliplatin|oxaliplatin|mesh-list
65678779|NCT04802980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65678780|NCT04802980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678781|NCT04802980|Tubulin Modulators|tubulin modulators|mesh-ancestor
65678782|NCT04802980|Antimitotic Agents|antimitotic agents|mesh-ancestor
65678783|NCT04802980|Mitosis Modulators|mitosis modulators|mesh-ancestor
65678784|NCT04802980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678785|NCT04802980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65678786|NCT04802980|Antimetabolites|antimetabolites|mesh-ancestor
65678787|NCT04802980|Antiviral Agents|antiviral agents|mesh-ancestor
65678788|NCT04802980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65678789|NCT04802980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678790|NCT04802980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65678791|NCT04802980|Immunologic Factors|immunologic factors|mesh-ancestor
65678792|NCT04802980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678793|NCT02088645|Cholecystokinin|cholecystokinin|mesh-list
65678794|NCT02088645|Gastrins|gastrins|mesh-list
65678795|NCT02088645|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65678796|NCT02088645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65678797|NCT02088645|Hormones|hormones|mesh-ancestor
65678798|NCT02088645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65678799|NCT02088645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678800|NCT03558477|Esomeprazole|esomeprazole|mesh-list
65678801|NCT03558477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65678802|NCT03558477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65678803|NCT03558477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65678804|NCT03558477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678805|NCT03558477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678806|NCT04792840|Letrozole|letrozole|mesh-list
65678807|NCT04792840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678808|NCT04792840|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65678809|NCT04792840|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65678810|NCT04792840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678811|NCT04792840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678812|NCT04792840|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65678813|NCT04792840|Hormone Antagonists|hormone antagonists|mesh-ancestor
65678814|NCT04792840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65678815|NCT04792840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678816|NCT02085213|Nitroglycerin|nitroglycerin|mesh-list
65678817|NCT02085213|Vasodilator Agents|vasodilator agents|mesh-ancestor
65678818|NCT02088801|Pyrithione zinc|pyrithione zinc|mesh-list
65678819|NCT02088801|Keratolytic Agents|keratolytic agents|mesh-ancestor
65678820|NCT02088801|Dermatologic Agents|dermatologic agents|mesh-ancestor
65678821|NCT02085291|Norepinephrine|norepinephrine|mesh-list
65678822|NCT02085291|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65678823|NCT02085291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65678824|NCT02085291|Adrenergic Agents|adrenergic agents|mesh-ancestor
65678825|NCT02085291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65678826|NCT02085291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678827|NCT02085291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678828|NCT02085291|Sympathomimetics|sympathomimetics|mesh-ancestor
65678829|NCT02085291|Autonomic Agents|autonomic agents|mesh-ancestor
65678830|NCT02085291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65678831|NCT02085291|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65678832|NCT04792138|Phenobarbital|phenobarbital|mesh-list
65678833|NCT04792138|Anticonvulsants|anticonvulsants|mesh-ancestor
65678834|NCT04792138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65678835|NCT04792138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65678836|NCT04792138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678837|NCT04792138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65678838|NCT04792138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65678839|NCT04792138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65678840|NCT04792138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678841|NCT04792138|GABA Modulators|gaba modulators|mesh-ancestor
65678842|NCT04792138|GABA Agents|gaba agents|mesh-ancestor
65678843|NCT04792138|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65678844|NCT04792138|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65678845|NCT04792138|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65678846|NCT04802122|Propofol|propofol|mesh-list
65678847|NCT04802122|Sevoflurane|sevoflurane|mesh-list
65678848|NCT04802122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65678849|NCT04802122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65678850|NCT04802122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678851|NCT04802122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65678852|NCT04802122|Anesthetics, General|anesthetics, general|mesh-ancestor
65678853|NCT04802122|Anesthetics|anesthetics|mesh-ancestor
65678854|NCT04802122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65678855|NCT04802122|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65678856|NCT04784728|Lidocaine|lidocaine|mesh-list
65678857|NCT04784728|Anesthetics, Local|anesthetics, local|mesh-ancestor
65678858|NCT04784728|Anesthetics|anesthetics|mesh-ancestor
65678859|NCT04784728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65678860|NCT04784728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678861|NCT04784728|Sensory System Agents|sensory system agents|mesh-ancestor
65678862|NCT04784728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65678863|NCT04784728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65678864|NCT04784728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65678865|NCT04784728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65678866|NCT04784728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65678867|NCT04784728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678868|NCT02085603|Saracatinib|saracatinib|mesh-list
65678869|NCT02085603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678870|NCT02085603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678871|NCT02085603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678872|NCT02090829|Oxytocin|oxytocin|mesh-list
65678873|NCT02090829|Oxytocics|oxytocics|mesh-ancestor
65678874|NCT02090829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65678875|NCT02090829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678876|NCT04801888|Vaccines|vaccines|mesh-list
65678877|NCT04801888|Immunologic Factors|immunologic factors|mesh-ancestor
65678878|NCT04801888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678879|NCT02089503|Ranibizumab|ranibizumab|mesh-list
65678880|NCT02089503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65678881|NCT02089503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65678882|NCT02089503|Growth Substances|growth substances|mesh-ancestor
65678883|NCT02089503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678884|NCT02089503|Growth Inhibitors|growth inhibitors|mesh-ancestor
65678885|NCT02089503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678886|NCT02091063|Ricolinostat|ricolinostat|mesh-list
65678887|NCT02091063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678888|NCT02091063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65678889|NCT02091063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678890|NCT02091063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678891|NCT02091219|Vitamin D|vitamin d|mesh-list
65678892|NCT02091219|Cholecalciferol|cholecalciferol|mesh-list
65678893|NCT02091219|Calcifediol|calcifediol|mesh-list
65678894|NCT02091219|Vitamins|vitamins|mesh-ancestor
65678895|NCT02091219|Micronutrients|micronutrients|mesh-ancestor
65678896|NCT02091219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678897|NCT02091219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65678898|NCT02091219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65678899|NCT02091297|Acetaminophen|acetaminophen|mesh-list
65678900|NCT02091297|Morphine|morphine|mesh-list
65678901|NCT02091297|Ropivacaine|ropivacaine|mesh-list
65678902|NCT02091297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65678903|NCT02091297|Narcotics|narcotics|mesh-ancestor
65678904|NCT02091297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65678905|NCT02091297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678906|NCT02091297|Analgesics|analgesics|mesh-ancestor
65678907|NCT02091297|Sensory System Agents|sensory system agents|mesh-ancestor
65678908|NCT02091297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65678909|NCT02091297|Anesthetics, Local|anesthetics, local|mesh-ancestor
65678910|NCT02091297|Anesthetics|anesthetics|mesh-ancestor
65678911|NCT02091297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65678912|NCT02091297|Antipyretics|antipyretics|mesh-ancestor
65678913|NCT04791202|Methylprednisolone|methylprednisolone|mesh-list
65678914|NCT04791202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65678915|NCT04791202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65678916|NCT04791202|Prednisolone|prednisolone|mesh-list
65678917|NCT04791202|Prednisolone acetate|prednisolone acetate|mesh-list
65678918|NCT04791202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65678919|NCT04791202|Prednisolone phosphate|prednisolone phosphate|mesh-list
65678920|NCT04791202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65678921|NCT04791202|Antiemetics|antiemetics|mesh-ancestor
65678922|NCT04791202|Autonomic Agents|autonomic agents|mesh-ancestor
65678923|NCT04791202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65678924|NCT04791202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678925|NCT04791202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65678926|NCT04791202|Glucocorticoids|glucocorticoids|mesh-ancestor
65678927|NCT04791202|Hormones|hormones|mesh-ancestor
65678928|NCT04791202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65678929|NCT04791202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65678930|NCT04791202|Protective Agents|protective agents|mesh-ancestor
65678931|NCT04791202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65678932|NCT04791202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678933|NCT04801342|Memantine|memantine|mesh-list
65678934|NCT04801342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65678935|NCT04801342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65678936|NCT04801342|Dopamine Agents|dopamine agents|mesh-ancestor
65678937|NCT04801342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65678938|NCT04801342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678939|NCT04801342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678940|NCT04801342|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65678941|NCT04801342|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65678942|NCT04801264|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65678943|NCT04801264|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
65678944|NCT04801264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65678945|NCT04801264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678946|NCT02590588|Idelalisib|idelalisib|mesh-list
65678947|NCT02590588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678948|NCT02590588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678949|NCT02590588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678950|NCT02086227|Glucagon|glucagon|mesh-list
65678951|NCT02086227|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65678952|NCT02086227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65678953|NCT02086227|Hormones|hormones|mesh-ancestor
65678954|NCT02086227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65678955|NCT02086227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678956|NCT02086227|Incretins|incretins|mesh-ancestor
65678957|NCT02086929|Trazodone|trazodone|mesh-list
65678958|NCT02086929|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65678959|NCT02086929|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65678960|NCT02086929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65678961|NCT02086929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65678962|NCT02086929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678963|NCT02086929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65678964|NCT02086929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678965|NCT02086929|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65678966|NCT02086929|Antidepressive Agents|antidepressive agents|mesh-ancestor
65678967|NCT02086929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65678968|NCT02086929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65678969|NCT02086929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65678970|NCT02086929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65678971|NCT02086929|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65678972|NCT02086929|Serotonin Agents|serotonin agents|mesh-ancestor
65678973|NCT02249013|Paclitaxel|paclitaxel|mesh-list
65678974|NCT02249013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65678975|NCT02249013|Carboplatin|carboplatin|mesh-list
65678976|NCT02249013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65678977|NCT02249013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65678978|NCT02249013|Tubulin Modulators|tubulin modulators|mesh-ancestor
65678979|NCT02249013|Antimitotic Agents|antimitotic agents|mesh-ancestor
65678980|NCT02249013|Mitosis Modulators|mitosis modulators|mesh-ancestor
65678981|NCT02249013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678982|NCT02249871|Omeprazole|omeprazole|mesh-list
65678983|NCT02249871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65678984|NCT02249871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65678985|NCT02249871|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65678986|NCT02249871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65678987|NCT02249871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678988|NCT02087007|Cilostazol|cilostazol|mesh-list
65678989|NCT02087007|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65678990|NCT02087007|Autonomic Agents|autonomic agents|mesh-ancestor
65678991|NCT02087007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65678992|NCT02087007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65678993|NCT02087007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65678994|NCT02087007|Respiratory System Agents|respiratory system agents|mesh-ancestor
65678995|NCT02087007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65678996|NCT02087007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65678997|NCT02087007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65678998|NCT02087007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65678999|NCT02087007|Vasodilator Agents|vasodilator agents|mesh-ancestor
65679000|NCT02087007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65679001|NCT02087007|Protective Agents|protective agents|mesh-ancestor
65679002|NCT02087007|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65679003|NCT02087007|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65679004|NCT02087007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679005|NCT01434602|Everolimus|everolimus|mesh-list
65679006|NCT01434602|Sorafenib|sorafenib|mesh-list
65679007|NCT01434602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679008|NCT01434602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65679009|NCT01434602|Immunologic Factors|immunologic factors|mesh-ancestor
65679010|NCT01434602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679011|NCT01434602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65679012|NCT01434602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679013|NCT01434602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679014|NCT02087475|Fluorouracil|fluorouracil|mesh-list
65679015|NCT02087475|Irinotecan|irinotecan|mesh-list
65679016|NCT02087475|Antimetabolites|antimetabolites|mesh-ancestor
65679017|NCT02087475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679018|NCT02087475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65679019|NCT02087475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679020|NCT02087475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65679021|NCT02087475|Immunologic Factors|immunologic factors|mesh-ancestor
65679022|NCT02087475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679023|NCT02087475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65679024|NCT02087475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65679025|NCT02087475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679026|NCT03421496|Cannabidiol|cannabidiol|mesh-list
65679027|NCT03421496|Vigabatrin|vigabatrin|mesh-list
65679028|NCT03421496|Anticonvulsants|anticonvulsants|mesh-ancestor
65679029|NCT03421496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679030|NCT03421496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679031|NCT03421496|GABA Agents|gaba agents|mesh-ancestor
65679032|NCT03421496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65679033|NCT03421496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679034|NCT05486949|Itraconazole|itraconazole|mesh-list
65679035|NCT05486949|Carbamazepine|carbamazepine|mesh-list
65679036|NCT05486949|Antifungal Agents|antifungal agents|mesh-ancestor
65679037|NCT05486949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65679038|NCT05486949|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65679039|NCT05486949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65679040|NCT05486949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679041|NCT05486949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679042|NCT05486949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65679043|NCT05486949|Hormone Antagonists|hormone antagonists|mesh-ancestor
65679044|NCT05486949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65679045|NCT05486949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679046|NCT05486949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65679047|NCT05486949|Anticonvulsants|anticonvulsants|mesh-ancestor
65679048|NCT05486949|Antimanic Agents|antimanic agents|mesh-ancestor
65679049|NCT05486949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65679050|NCT05486949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65679051|NCT05486949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65679052|NCT05486949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65679053|NCT05486949|Analgesics|analgesics|mesh-ancestor
65679054|NCT05486949|Sensory System Agents|sensory system agents|mesh-ancestor
65679055|NCT05486949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65679056|NCT05486949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65679057|NCT05486949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65679058|NCT05486949|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65679059|NCT05486949|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65679060|NCT03558243|Hemostatics|hemostatics|mesh-list
65679061|NCT03558243|Coagulants|coagulants|mesh-ancestor
65679062|NCT03426956|Canagliflozin|canagliflozin|mesh-list
65679063|NCT03426956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65679064|NCT03426956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679065|NCT03426956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65679066|NCT03426956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679067|NCT03557229|Vitamins|vitamins|mesh-list
65679068|NCT03557229|Vitamin E|vitamin e|mesh-list
65679069|NCT03557229|Acetylcysteine|acetylcysteine|mesh-list
65679070|NCT03557229|Melatonin|melatonin|mesh-list
65679071|NCT03557229|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65679072|NCT03557229|Micronutrients|micronutrients|mesh-ancestor
65679073|NCT03557229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679074|NCT03557229|Antioxidants|antioxidants|mesh-ancestor
65679075|NCT03557229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679076|NCT03557229|Protective Agents|protective agents|mesh-ancestor
65679077|NCT03557229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65679078|NCT03557229|Antiviral Agents|antiviral agents|mesh-ancestor
65679079|NCT03557229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65679080|NCT03557229|Expectorants|expectorants|mesh-ancestor
65679081|NCT03557229|Respiratory System Agents|respiratory system agents|mesh-ancestor
65679082|NCT03557229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65679083|NCT03557229|Antidotes|antidotes|mesh-ancestor
65679084|NCT02087631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65679085|NCT02087631|Antidepressive Agents|antidepressive agents|mesh-ancestor
65679086|NCT02087631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65679087|NCT02087631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65679088|NCT02087631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65679089|NCT02087631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65679090|NCT02087631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679091|NCT00940940|Vaccines|vaccines|mesh-list
65679092|NCT00940940|Immunologic Factors|immunologic factors|mesh-ancestor
65679093|NCT00940940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679094|NCT03557840|Temocillin|temocillin|mesh-list
65679095|NCT03557840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65679096|NCT03557840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65679097|NCT02092701|Cholecalciferol|cholecalciferol|mesh-list
65679098|NCT02092701|Vitamin D|vitamin d|mesh-list
65679099|NCT02092701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65679100|NCT02092701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679101|NCT02092701|Vitamins|vitamins|mesh-ancestor
65679102|NCT02092701|Micronutrients|micronutrients|mesh-ancestor
65679103|NCT02092701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65679104|NCT01767129|Quinidine|quinidine|mesh-list
65679105|NCT01767129|Dextromethorphan|dextromethorphan|mesh-list
65679106|NCT01767129|Antitussive Agents|antitussive agents|mesh-ancestor
65679107|NCT01767129|Respiratory System Agents|respiratory system agents|mesh-ancestor
65679108|NCT01767129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65679109|NCT01767129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65679110|NCT01767129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65679111|NCT01767129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679112|NCT01767129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679113|NCT01767129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65679114|NCT01767129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65679115|NCT01767129|Adrenergic Agents|adrenergic agents|mesh-ancestor
65679116|NCT01767129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65679117|NCT01767129|Antimalarials|antimalarials|mesh-ancestor
65679118|NCT01767129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65679119|NCT01767129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65679120|NCT01767129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65679121|NCT01767129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679122|NCT01767129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65679123|NCT01767129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65679124|NCT01767129|Cholinergic Agents|cholinergic agents|mesh-ancestor
65679125|NCT01767129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65679126|NCT01767129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65679127|NCT01767129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65679128|NCT01767129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65679129|NCT01767129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65679130|NCT01309191|Minoxidil|minoxidil|mesh-list
65679131|NCT01309191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65679132|NCT01309191|Vasodilator Agents|vasodilator agents|mesh-ancestor
65679133|NCT03420638|Epinephrine|epinephrine|mesh-list
65679134|NCT03420638|Bupivacaine|bupivacaine|mesh-list
65679135|NCT03420638|Anesthetics, Local|anesthetics, local|mesh-ancestor
65679136|NCT03420638|Anesthetics|anesthetics|mesh-ancestor
65679137|NCT03420638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65679138|NCT03420638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679139|NCT03420638|Sensory System Agents|sensory system agents|mesh-ancestor
65679140|NCT03420638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65679141|NCT03420638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65679142|NCT03420638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65679143|NCT03420638|Adrenergic Agents|adrenergic agents|mesh-ancestor
65679144|NCT03420638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65679145|NCT03420638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679146|NCT03420638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65679147|NCT03420638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65679148|NCT03420638|Autonomic Agents|autonomic agents|mesh-ancestor
65679149|NCT03420638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65679150|NCT03420638|Respiratory System Agents|respiratory system agents|mesh-ancestor
65679151|NCT03420638|Mydriatics|mydriatics|mesh-ancestor
65679152|NCT03420638|Sympathomimetics|sympathomimetics|mesh-ancestor
65679153|NCT03420638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65679154|NCT00715988|Methadone|methadone|mesh-list
65679155|NCT00715988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65679156|NCT00715988|Narcotics|narcotics|mesh-ancestor
65679157|NCT00715988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65679158|NCT00715988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679159|NCT00715988|Analgesics|analgesics|mesh-ancestor
65679160|NCT00715988|Sensory System Agents|sensory system agents|mesh-ancestor
65679161|NCT00715988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65679162|NCT00715988|Antitussive Agents|antitussive agents|mesh-ancestor
65679163|NCT00715988|Respiratory System Agents|respiratory system agents|mesh-ancestor
65679164|NCT02093091|Vitremer|vitremer|mesh-list
65679165|NCT02093091|Cariostatic Agents|cariostatic agents|mesh-ancestor
65679166|NCT02093091|Protective Agents|protective agents|mesh-ancestor
65679167|NCT02093091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679168|NCT02791269|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65679169|NCT02791269|Antiviral Agents|antiviral agents|mesh-ancestor
65679170|NCT02791269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65679171|NCT03556917|Caffeine|caffeine|mesh-list
65679172|NCT03556917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65679173|NCT03556917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679174|NCT03556917|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65679175|NCT03556917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679176|NCT03556917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679177|NCT03556917|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65679178|NCT03556917|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65679179|NCT03556917|Purinergic Agents|purinergic agents|mesh-ancestor
65679180|NCT03556917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65679181|NCT02090439|Silodosin|silodosin|mesh-list
65679182|NCT02090439|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65679183|NCT02090439|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65679184|NCT02090439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65679185|NCT02090439|Adrenergic Agents|adrenergic agents|mesh-ancestor
65679186|NCT02090439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65679187|NCT02090439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679188|NCT02090439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679189|NCT02090439|Urological Agents|urological agents|mesh-ancestor
65679190|NCT02696564|Losartan|losartan|mesh-list
65679191|NCT02696564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65679192|NCT02696564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65679193|NCT02696564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65679194|NCT02696564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65679195|NCT02696564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679196|NCT02093403|Decitabine|decitabine|mesh-list
65679197|NCT02093403|Azacitidine|azacitidine|mesh-list
65679198|NCT02093403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65679199|NCT02093403|Antimetabolites|antimetabolites|mesh-ancestor
65679200|NCT02093403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679201|NCT02093403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679202|NCT02093403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679203|NCT03426176|Oxytocin|oxytocin|mesh-list
65679204|NCT03426176|Oxytocics|oxytocics|mesh-ancestor
65679205|NCT03426176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65679206|NCT03426176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679207|NCT02095899|Rufinamide|rufinamide|mesh-list
65679208|NCT02095899|Anticonvulsants|anticonvulsants|mesh-ancestor
65679209|NCT02095899|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65679210|NCT02095899|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65679211|NCT02095899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65679212|NCT02095899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679213|NCT03525002|Bromocriptine|bromocriptine|mesh-list
65679214|NCT03525002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65679215|NCT03525002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65679216|NCT03525002|Hormone Antagonists|hormone antagonists|mesh-ancestor
65679217|NCT03525002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65679218|NCT03525002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679219|NCT03525002|Dopamine Agonists|dopamine agonists|mesh-ancestor
65679220|NCT03525002|Dopamine Agents|dopamine agents|mesh-ancestor
65679221|NCT03525002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65679222|NCT03525002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679223|NCT03426020|Midazolam|midazolam|mesh-list
65679224|NCT03426020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65679225|NCT03426020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65679226|NCT03426020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65679227|NCT03426020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679228|NCT03426020|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65679229|NCT03426020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65679230|NCT03426020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65679231|NCT03426020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65679232|NCT03426020|Anesthetics, General|anesthetics, general|mesh-ancestor
65679233|NCT03426020|Anesthetics|anesthetics|mesh-ancestor
65679234|NCT03426020|GABA Modulators|gaba modulators|mesh-ancestor
65679235|NCT03426020|GABA Agents|gaba agents|mesh-ancestor
65679236|NCT03426020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65679237|NCT03426020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679238|NCT03428906|Oxytocin|oxytocin|mesh-list
65679239|NCT03428906|Oxytocics|oxytocics|mesh-ancestor
65679240|NCT03428906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65679241|NCT03428906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679242|NCT02521298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65679243|NCT02521298|Methylprednisolone|methylprednisolone|mesh-list
65679244|NCT02521298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65679245|NCT02521298|Prednisolone|prednisolone|mesh-list
65679246|NCT02521298|Prednisolone acetate|prednisolone acetate|mesh-list
65679247|NCT02521298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65679248|NCT02521298|Prednisolone phosphate|prednisolone phosphate|mesh-list
65679249|NCT02521298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65679250|NCT02521298|Antiemetics|antiemetics|mesh-ancestor
65679251|NCT02521298|Autonomic Agents|autonomic agents|mesh-ancestor
65679252|NCT02521298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65679253|NCT02521298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679254|NCT02521298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65679255|NCT02521298|Glucocorticoids|glucocorticoids|mesh-ancestor
65679256|NCT02521298|Hormones|hormones|mesh-ancestor
65679257|NCT02521298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65679258|NCT02521298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65679259|NCT02521298|Protective Agents|protective agents|mesh-ancestor
65679260|NCT02521298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65679261|NCT02521298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679262|NCT00389870|Cyclosporine|cyclosporine|mesh-list
65679263|NCT00389870|Irinotecan|irinotecan|mesh-list
65679264|NCT00389870|Panitumumab|panitumumab|mesh-list
65679265|NCT00389870|Cyclosporins|cyclosporins|mesh-list
65679266|NCT00389870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65679267|NCT00389870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65679268|NCT00389870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679269|NCT00389870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679270|NCT00389870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679271|NCT00389870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65679272|NCT00389870|Immunologic Factors|immunologic factors|mesh-ancestor
65679273|NCT00389870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679274|NCT00389870|Antifungal Agents|antifungal agents|mesh-ancestor
65679275|NCT00389870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65679276|NCT00389870|Dermatologic Agents|dermatologic agents|mesh-ancestor
65679277|NCT00389870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65679278|NCT00389870|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65679279|NCT00389870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65679280|NCT00295646|Tamoxifen|tamoxifen|mesh-list
65679281|NCT00295646|Zoledronic Acid|zoledronic acid|mesh-list
65679282|NCT00295646|Anastrozole|anastrozole|mesh-list
65679283|NCT00295646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65679284|NCT00295646|Hormone Antagonists|hormone antagonists|mesh-ancestor
65679285|NCT00295646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65679286|NCT00295646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679287|NCT00295646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65679288|NCT00295646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679289|NCT00295646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65679290|NCT00295646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65679291|NCT00295646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65679292|NCT00295646|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65679293|NCT00295646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65679294|NCT00295646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679295|NCT00295646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679296|NCT03419858|Naloxone|naloxone|mesh-list
65679297|NCT03419858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65679298|NCT03419858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679299|NCT03419858|Sensory System Agents|sensory system agents|mesh-ancestor
65679300|NCT03419858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65679301|NCT03417206|Remifentanil|remifentanil|mesh-list
65679302|NCT03417206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65679303|NCT03417206|Narcotics|narcotics|mesh-ancestor
65679304|NCT03417206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65679305|NCT03417206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679306|NCT03417206|Analgesics|analgesics|mesh-ancestor
65679307|NCT03417206|Sensory System Agents|sensory system agents|mesh-ancestor
65679308|NCT03417206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65679309|NCT00003716|Rituximab|rituximab|mesh-list
65679310|NCT00003716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65679311|NCT00003716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679312|NCT00003716|Immunologic Factors|immunologic factors|mesh-ancestor
65679313|NCT00003716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679314|NCT00003716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65679315|NCT02593786|Nivolumab|nivolumab|mesh-list
65679316|NCT02593786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65679317|NCT02593786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679318|NCT02593786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65679319|NCT02593786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679320|NCT03425708|Febuxostat|febuxostat|mesh-list
65679321|NCT03425708|Gout Suppressants|gout suppressants|mesh-ancestor
65679322|NCT03425708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65679323|NCT03425552|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65679324|NCT03425552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65679325|NCT03425552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65679326|NCT03425552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65679327|NCT03425552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679328|NCT03425552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65679329|NCT03425552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65679330|NCT03425552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65679331|NCT03425552|Serotonin Agents|serotonin agents|mesh-ancestor
65679332|NCT03425552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65679333|NCT03425552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679334|NCT03425552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65679335|NCT03425552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65679336|NCT03425552|Dopamine Agents|dopamine agents|mesh-ancestor
65679337|NCT04791046|Antihypertensive Agents|antihypertensive agents|mesh-list
65679338|NCT03425474|Propofol|propofol|mesh-list
65679339|NCT03425474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65679340|NCT03425474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65679341|NCT03425474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679342|NCT03425474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65679343|NCT03425474|Anesthetics, General|anesthetics, general|mesh-ancestor
65679344|NCT03425474|Anesthetics|anesthetics|mesh-ancestor
65679345|NCT03419624|Metformin|metformin|mesh-list
65679346|NCT03419624|Dapagliflozin|dapagliflozin|mesh-list
65679347|NCT03419624|Exenatide|exenatide|mesh-list
65679348|NCT03419624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65679349|NCT03419624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679350|NCT03419624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65679351|NCT03419624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679352|NCT03419624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65679353|NCT03419624|Incretins|incretins|mesh-ancestor
65679354|NCT03419624|Hormones|hormones|mesh-ancestor
65679355|NCT03419624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65679356|NCT02096055|Idarubicin|idarubicin|mesh-list
65679357|NCT02096055|Cladribine|cladribine|mesh-list
65679358|NCT02096055|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
65679359|NCT02096055|Guadecitabine|guadecitabine|mesh-list
65679360|NCT02096055|Azacitidine|azacitidine|mesh-list
65679361|NCT02096055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65679362|NCT02096055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679363|NCT02096055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65679364|NCT02096055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65679365|NCT02096055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679366|NCT02096055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679367|NCT02096055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65679368|NCT02096055|Immunologic Factors|immunologic factors|mesh-ancestor
65679369|NCT02096055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679370|NCT02096055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65679371|NCT02096055|Antimetabolites|antimetabolites|mesh-ancestor
65679372|NCT03425162|Morphine|morphine|mesh-list
65679373|NCT03425162|Bupivacaine|bupivacaine|mesh-list
65679374|NCT03425162|Anesthetics, Local|anesthetics, local|mesh-ancestor
65679375|NCT03425162|Anesthetics|anesthetics|mesh-ancestor
65679376|NCT03425162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65679377|NCT03425162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679378|NCT03425162|Sensory System Agents|sensory system agents|mesh-ancestor
65679379|NCT03425162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65679380|NCT03425162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65679381|NCT03425162|Narcotics|narcotics|mesh-ancestor
65679382|NCT03425162|Analgesics|analgesics|mesh-ancestor
65679383|NCT02096133|Cholecalciferol|cholecalciferol|mesh-list
65679384|NCT02096133|Vitamin D|vitamin d|mesh-list
65679385|NCT02096133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65679386|NCT02096133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679387|NCT02096133|Vitamins|vitamins|mesh-ancestor
65679388|NCT02096133|Micronutrients|micronutrients|mesh-ancestor
65679389|NCT02096133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65679390|NCT02096289|Thioridazine|thioridazine|mesh-list
65679391|NCT02096289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65679392|NCT02096289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65679393|NCT02096289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65679394|NCT02096289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679395|NCT02096289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65679396|NCT02096289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65679397|NCT02096289|Dopamine Agents|dopamine agents|mesh-ancestor
65679398|NCT02096289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65679399|NCT02096289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679400|NCT02090673|Exenatide|exenatide|mesh-list
65679401|NCT02090673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65679402|NCT02090673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679403|NCT02090673|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65679404|NCT02090673|Incretins|incretins|mesh-ancestor
65679405|NCT02090673|Hormones|hormones|mesh-ancestor
65679406|NCT02090673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65679407|NCT03556371|Acetylcysteine|acetylcysteine|mesh-list
65679408|NCT03556371|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65679409|NCT03556371|Antiviral Agents|antiviral agents|mesh-ancestor
65679410|NCT03556371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65679411|NCT03556371|Expectorants|expectorants|mesh-ancestor
65679412|NCT03556371|Respiratory System Agents|respiratory system agents|mesh-ancestor
65679413|NCT03556371|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65679414|NCT03556371|Antioxidants|antioxidants|mesh-ancestor
65679415|NCT03556371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679416|NCT03556371|Protective Agents|protective agents|mesh-ancestor
65679417|NCT03556371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679418|NCT03556371|Antidotes|antidotes|mesh-ancestor
65679419|NCT03416270|Ertugliflozin|ertugliflozin|mesh-list
65679420|NCT03416270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65679421|NCT03416270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679422|NCT03416270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65679423|NCT03416270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679424|NCT02827526|Ketamine|ketamine|mesh-list
65679425|NCT02827526|Analgesics|analgesics|mesh-ancestor
65679426|NCT02827526|Sensory System Agents|sensory system agents|mesh-ancestor
65679427|NCT02827526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65679428|NCT02827526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679429|NCT02827526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65679430|NCT02827526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65679431|NCT02827526|Anesthetics, General|anesthetics, general|mesh-ancestor
65679432|NCT02827526|Anesthetics|anesthetics|mesh-ancestor
65679433|NCT02827526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65679434|NCT02827526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65679435|NCT02827526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65679436|NCT02827526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65679437|NCT02827526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679438|NCT04799314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65679439|NCT04799314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679440|NCT04799314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679441|NCT03425084|Morphine|morphine|mesh-list
65679442|NCT03425084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65679443|NCT03425084|Narcotics|narcotics|mesh-ancestor
65679444|NCT03425084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65679445|NCT03425084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679446|NCT03425084|Analgesics|analgesics|mesh-ancestor
65679447|NCT03425084|Sensory System Agents|sensory system agents|mesh-ancestor
65679448|NCT03425084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65679449|NCT03424928|Thalidomide|thalidomide|mesh-list
65679450|NCT03424928|Pomalidomide|pomalidomide|mesh-list
65679451|NCT03424928|Immunologic Factors|immunologic factors|mesh-ancestor
65679452|NCT03424928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679453|NCT03424928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65476784|NCT03323164|Timolol|timolol|mesh-list
65679454|NCT03424928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65679455|NCT03424928|Growth Substances|growth substances|mesh-ancestor
65679456|NCT03424928|Growth Inhibitors|growth inhibitors|mesh-ancestor
65679457|NCT03424928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679458|NCT03424928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65679459|NCT03424928|Leprostatic Agents|leprostatic agents|mesh-ancestor
65679460|NCT03424928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65679461|NCT03424928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65679462|NCT05435235|Dapagliflozin|dapagliflozin|mesh-list
65679463|NCT05435235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65679464|NCT05435235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679465|NCT05435235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65679466|NCT05435235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679467|NCT04799002|Melphalan|melphalan|mesh-list
65679468|NCT04799002|Topotecan|topotecan|mesh-list
65679469|NCT04799002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65679470|NCT04799002|Alkylating Agents|alkylating agents|mesh-ancestor
65679471|NCT04799002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679472|NCT04799002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679473|NCT04799002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65679474|NCT04799002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65679475|NCT04799002|Immunologic Factors|immunologic factors|mesh-ancestor
65679476|NCT04799002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679477|NCT04799002|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65679478|NCT04799002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65679479|NCT04799002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679480|NCT02096601|Levodopa|levodopa|mesh-list
65679481|NCT02096601|Carbidopa|carbidopa|mesh-list
65679482|NCT02096601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65679483|NCT02096601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65679484|NCT02096601|Dopamine Agents|dopamine agents|mesh-ancestor
65679485|NCT02096601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65679486|NCT02096601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679487|NCT02096601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679488|NCT02096601|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65679489|NCT02096601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679490|NCT02098785|Caffeine|caffeine|mesh-list
65679491|NCT02098785|Caffeine citrate|caffeine citrate|mesh-list
65679492|NCT02098785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679493|NCT02098785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65679494|NCT02098785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679495|NCT02098785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65679496|NCT02098785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679497|NCT02098785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65679498|NCT02098785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65679499|NCT02098785|Purinergic Agents|purinergic agents|mesh-ancestor
65679500|NCT02098785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65679501|NCT04798612|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65679502|NCT04798612|Antiviral Agents|antiviral agents|mesh-ancestor
65679503|NCT04798612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65679504|NCT02521064|Prednisone|prednisone|mesh-list
65679505|NCT02521064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65679506|NCT02521064|Glucocorticoids|glucocorticoids|mesh-ancestor
65679507|NCT02521064|Hormones|hormones|mesh-ancestor
65679508|NCT02521064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65679509|NCT02521064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679510|NCT02521064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65679511|NCT02521064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679512|NCT02096913|Ibuprofen|ibuprofen|mesh-list
65679513|NCT02096913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65679514|NCT02096913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65679515|NCT02096913|Analgesics|analgesics|mesh-ancestor
65679516|NCT02096913|Sensory System Agents|sensory system agents|mesh-ancestor
65679517|NCT02096913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65679518|NCT02096913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679519|NCT02096913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65679520|NCT02096913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65679521|NCT02096913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65679522|NCT02096913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679523|NCT02096913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679524|NCT03418610|Azelaic acid|azelaic acid|mesh-list
65679525|NCT03418610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679526|NCT03418610|Dermatologic Agents|dermatologic agents|mesh-ancestor
65679527|NCT04604366|Alprostadil|alprostadil|mesh-list
65679528|NCT04604366|Misoprostol|misoprostol|mesh-list
65679529|NCT04604366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65679530|NCT04604366|Abortifacient Agents|abortifacient agents|mesh-ancestor
65679531|NCT04604366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65679532|NCT04604366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679533|NCT04604366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65679534|NCT04604366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65679535|NCT04604366|Oxytocics|oxytocics|mesh-ancestor
65679536|NCT04604366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65679537|NCT04604366|Vasodilator Agents|vasodilator agents|mesh-ancestor
65679538|NCT04604366|Urological Agents|urological agents|mesh-ancestor
65679539|NCT02099253|Dexmedetomidine|dexmedetomidine|mesh-list
65679540|NCT02099253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65679541|NCT02099253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65679542|NCT02099253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679543|NCT02099253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65679544|NCT02099253|Analgesics|analgesics|mesh-ancestor
65679545|NCT02099253|Sensory System Agents|sensory system agents|mesh-ancestor
65679546|NCT02099253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65679547|NCT02099253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65679548|NCT02099253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65679549|NCT02099253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65679550|NCT02099253|Adrenergic Agents|adrenergic agents|mesh-ancestor
65679551|NCT02099253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65679552|NCT02099253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679553|NCT05818124|Oseltamivir|oseltamivir|mesh-list
65679554|NCT05818124|Antiviral Agents|antiviral agents|mesh-ancestor
65679555|NCT05818124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65679556|NCT05818124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679557|NCT05818124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679558|NCT05818111|Lidocaine|lidocaine|mesh-list
65679559|NCT05818111|Anesthetics, Local|anesthetics, local|mesh-ancestor
65679560|NCT05818111|Anesthetics|anesthetics|mesh-ancestor
65679561|NCT05818111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65679562|NCT05818111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679563|NCT05818111|Sensory System Agents|sensory system agents|mesh-ancestor
65679564|NCT05818111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65679565|NCT05818111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65679566|NCT05818111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65679567|NCT05818111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65679568|NCT05818111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65679569|NCT05818111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679570|NCT05818085|Allopurinol|allopurinol|mesh-list
65679571|NCT05818085|Antimetabolites|antimetabolites|mesh-ancestor
65679572|NCT05818085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679573|NCT05818085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679574|NCT05818085|Gout Suppressants|gout suppressants|mesh-ancestor
65679575|NCT05818085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65679576|NCT05818085|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65679577|NCT05818085|Antioxidants|antioxidants|mesh-ancestor
65679578|NCT05818085|Protective Agents|protective agents|mesh-ancestor
65679579|NCT05818085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679580|NCT05818007|Hyaluronic Acid|hyaluronic acid|mesh-list
65679581|NCT05818007|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65679582|NCT05818007|Immunologic Factors|immunologic factors|mesh-ancestor
65679583|NCT05818007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679584|NCT05818007|Viscosupplements|viscosupplements|mesh-ancestor
65679585|NCT05818007|Protective Agents|protective agents|mesh-ancestor
65679586|NCT05817955|Azacitidine|azacitidine|mesh-list
65679587|NCT05817955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65679588|NCT05817955|Antimetabolites|antimetabolites|mesh-ancestor
65679589|NCT05817955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679590|NCT05817955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679591|NCT05817955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679592|NCT05817851|Vitamins|vitamins|mesh-list
65679593|NCT05817851|Thiamine|thiamine|mesh-list
65679594|NCT05817851|Micronutrients|micronutrients|mesh-ancestor
65679595|NCT05817851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679596|NCT05817851|Vitamin B Complex|vitamin b complex|mesh-ancestor
65679597|NCT05817721|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65679598|NCT05817721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679599|NCT05817721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679600|NCT05817656|Sucralfate|sucralfate|mesh-list
65679601|NCT05817656|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65679602|NCT05817656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65679603|NCT05817461|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65679604|NCT05817409|Baclofen|baclofen|mesh-list
65679605|NCT05817409|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65679606|NCT05817409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679607|NCT05817409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65679608|NCT05817409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65679609|NCT05817409|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65679610|NCT05817409|GABA Agonists|gaba agonists|mesh-ancestor
65679611|NCT05817409|GABA Agents|gaba agents|mesh-ancestor
65679612|NCT05817409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65679613|NCT05817409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679614|NCT05817253|Coal Tar|coal tar|mesh-list
65679615|NCT05817253|Keratolytic Agents|keratolytic agents|mesh-ancestor
65679616|NCT05817253|Dermatologic Agents|dermatologic agents|mesh-ancestor
65679617|NCT05817240|Nintedanib|nintedanib|mesh-list
65679618|NCT05817240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679619|NCT05817240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65679620|NCT05817240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679621|NCT05817240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679622|NCT05817201|Tegafur|tegafur|mesh-list
65679623|NCT05817201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65679624|NCT05817201|Antimetabolites|antimetabolites|mesh-ancestor
65679625|NCT05817201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679626|NCT05817201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679627|NCT05817097|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65679628|NCT05817097|Protease Inhibitors|protease inhibitors|mesh-ancestor
65679629|NCT05817097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679630|NCT05817097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679631|NCT05817097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65679632|NCT05817097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679633|NCT05817019|Neostigmine|neostigmine|mesh-list
65679634|NCT05817019|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65679635|NCT05817019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679636|NCT05817019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679637|NCT05817019|Cholinergic Agents|cholinergic agents|mesh-ancestor
65679638|NCT05817019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65679639|NCT05817019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679640|NCT05817019|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65679641|NCT05817019|Autonomic Agents|autonomic agents|mesh-ancestor
65679642|NCT05817019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65679643|NCT05816772|Calcium|calcium|mesh-list
65679644|NCT05816772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65679645|NCT05816772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679646|NCT05816733|Dapagliflozin|dapagliflozin|mesh-list
65679647|NCT05816733|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65679648|NCT05816733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679649|NCT05816733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65679650|NCT05816733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679651|NCT05816720|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65679652|NCT05816720|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65679653|NCT05816720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679654|NCT05816707|Turmeric extract|turmeric extract|mesh-list
65679655|NCT05816707|Antioxidants|antioxidants|mesh-ancestor
65679656|NCT05816707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679657|NCT05816707|Protective Agents|protective agents|mesh-ancestor
65679658|NCT05816707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679659|NCT05816694|Paclitaxel|paclitaxel|mesh-list
65679660|NCT05816694|Cyclophosphamide|cyclophosphamide|mesh-list
65679661|NCT05816694|Cisplatin|cisplatin|mesh-list
65679662|NCT05816694|Epirubicin|epirubicin|mesh-list
65679663|NCT05816694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65679664|NCT05816694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679665|NCT05816694|Tubulin Modulators|tubulin modulators|mesh-ancestor
65679666|NCT05816694|Antimitotic Agents|antimitotic agents|mesh-ancestor
65679667|NCT05816694|Mitosis Modulators|mitosis modulators|mesh-ancestor
65679668|NCT05816694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679669|NCT05816694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65679670|NCT05816694|Immunologic Factors|immunologic factors|mesh-ancestor
65679671|NCT05816694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679672|NCT05816694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65679673|NCT05816694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65679674|NCT05816694|Alkylating Agents|alkylating agents|mesh-ancestor
65679675|NCT05816694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65477004|NCT00086190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679676|NCT05816694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65679677|NCT05816694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65679678|NCT05816694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65679679|NCT05816694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679680|NCT05816668|Tranexamic Acid|tranexamic acid|mesh-list
65679681|NCT05816668|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65679682|NCT05816668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65679683|NCT05816668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679685|NCT05816668|Coagulants|coagulants|mesh-ancestor
65679686|NCT05816655|Fulvestrant|fulvestrant|mesh-list
65679687|NCT05816655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65679688|NCT05816655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679689|NCT05816655|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65679690|NCT05816655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65679691|NCT05816655|Hormone Antagonists|hormone antagonists|mesh-ancestor
65679692|NCT05816655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65679693|NCT05816655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679694|NCT05816642|Sunitinib|sunitinib|mesh-list
65679695|NCT05816642|Axitinib|axitinib|mesh-list
65679696|NCT05816642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65679697|NCT05816642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679698|NCT05816642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65679699|NCT05816642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65679700|NCT05816642|Growth Substances|growth substances|mesh-ancestor
65679701|NCT05816642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679702|NCT05816642|Growth Inhibitors|growth inhibitors|mesh-ancestor
65679703|NCT05816642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65679704|NCT05816642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679705|NCT05816642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679706|NCT05816616|Xenon|xenon|mesh-list
65679707|NCT05816616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65679708|NCT05816616|Anesthetics, General|anesthetics, general|mesh-ancestor
65679709|NCT05816616|Anesthetics|anesthetics|mesh-ancestor
65679710|NCT05816616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65679711|NCT05816616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679712|NCT05816538|Anesthetics|anesthetics|mesh-list
65679713|NCT05816538|Levobupivacaine|levobupivacaine|mesh-list
65679714|NCT05816538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65679715|NCT05816538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679716|NCT05816538|Anesthetics, Local|anesthetics, local|mesh-ancestor
65679717|NCT05816538|Sensory System Agents|sensory system agents|mesh-ancestor
65679718|NCT05816538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65679719|NCT05813847|Anesthetics|anesthetics|mesh-list
65679720|NCT05813847|Anesthetics, Local|anesthetics, local|mesh-list
65679721|NCT05813847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65679722|NCT05813847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679723|NCT05813847|Sensory System Agents|sensory system agents|mesh-ancestor
65679724|NCT05813847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65679725|NCT05809583|Ozanimod|ozanimod|mesh-list
65679726|NCT05809583|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65679727|NCT05809583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679728|NCT05809583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65679729|NCT05809583|Immunologic Factors|immunologic factors|mesh-ancestor
65679730|NCT05809583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679731|NCT05809453|Lidocaine|lidocaine|mesh-list
65679732|NCT05809453|Cocaine|cocaine|mesh-list
65679733|NCT05809453|Anesthetics, Local|anesthetics, local|mesh-ancestor
65679734|NCT05809453|Anesthetics|anesthetics|mesh-ancestor
65679735|NCT05809453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65679736|NCT05809453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679737|NCT05809453|Sensory System Agents|sensory system agents|mesh-ancestor
65679738|NCT05809453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65679739|NCT05809453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65679740|NCT05809453|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65679741|NCT05809453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65679742|NCT05809453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65679743|NCT05809453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679744|NCT05809453|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65679745|NCT05809453|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65679746|NCT05809453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65679747|NCT05809453|Dopamine Agents|dopamine agents|mesh-ancestor
65679748|NCT05809453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65679749|NCT05803629|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65679750|NCT05803629|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65679751|NCT05803629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679752|NCT05803434|Cannabidiol|cannabidiol|mesh-list
65679753|NCT05803434|Anticonvulsants|anticonvulsants|mesh-ancestor
65679754|NCT05803421|Insulin Glargine|insulin glargine|mesh-list
65679755|NCT05803421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65679756|NCT05803421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679757|NCT05788081|Rituximab|rituximab|mesh-list
65679758|NCT05788081|Nivolumab|nivolumab|mesh-list
65679759|NCT05788081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65679760|NCT05788081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679761|NCT05788081|Immunologic Factors|immunologic factors|mesh-ancestor
65679762|NCT05788081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679763|NCT05788081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65679764|NCT05788081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65679765|NCT05788081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679766|NCT05784246|Mirikizumab|mirikizumab|mesh-list
65679767|NCT05784246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65679768|NCT05784246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65679769|NCT05784246|Analgesics|analgesics|mesh-ancestor
65679770|NCT05784246|Sensory System Agents|sensory system agents|mesh-ancestor
65679771|NCT05784246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65679772|NCT05784246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679773|NCT05784246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65679774|NCT05784246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65679775|NCT05784246|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65679776|NCT05784246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65679777|NCT05781542|MEDI9197|medi9197|mesh-list
65679778|NCT05781542|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65679779|NCT05781542|Immunologic Factors|immunologic factors|mesh-ancestor
65679780|NCT05781542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679781|NCT05777226|Epalrestat|epalrestat|mesh-list
65679782|NCT05777226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679783|NCT05777226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679784|NCT05769920|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65679785|NCT05769920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65679786|NCT05769010|Bevacizumab|bevacizumab|mesh-list
65679787|NCT05769010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65679788|NCT05769010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679789|NCT05769010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65679790|NCT05769010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65679791|NCT05769010|Growth Substances|growth substances|mesh-ancestor
65679792|NCT05769010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679793|NCT05769010|Growth Inhibitors|growth inhibitors|mesh-ancestor
65679794|NCT05767021|Mirikizumab|mirikizumab|mesh-list
65679795|NCT05767021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65679796|NCT05767021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65679797|NCT05767021|Analgesics|analgesics|mesh-ancestor
65679798|NCT05767021|Sensory System Agents|sensory system agents|mesh-ancestor
65679799|NCT05767021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65679800|NCT05767021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679801|NCT05767021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65679802|NCT05767021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65679803|NCT05767021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65679804|NCT05767021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65679805|NCT05766501|Islatravir|islatravir|mesh-list
65679806|NCT05766501|Antiviral Agents|antiviral agents|mesh-ancestor
65679807|NCT05766501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65679808|NCT05766501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679809|NCT05766501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679810|NCT05766501|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65679811|NCT05766501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65679812|NCT05766501|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65679813|NCT05763823|Letermovir|letermovir|mesh-list
65679814|NCT05763823|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65679815|NCT05763823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679816|NCT05763823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679817|NCT05763823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679818|NCT05763823|Antiviral Agents|antiviral agents|mesh-ancestor
65679819|NCT05763823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65679820|NCT05756777|Ivosidenib|ivosidenib|mesh-list
65679821|NCT05756777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679822|NCT05756777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65679823|NCT05756777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679824|NCT05748171|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65679825|NCT05748171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65679826|NCT05748171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679827|NCT05748171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65679828|NCT05730218|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65679829|NCT05730218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65679830|NCT05719883|Sirolimus|sirolimus|mesh-list
65679831|NCT05719883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65679832|NCT05719883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65679833|NCT05719883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65679834|NCT05719883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679835|NCT05719883|Antifungal Agents|antifungal agents|mesh-ancestor
65679836|NCT05719883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65679837|NCT05719883|Immunologic Factors|immunologic factors|mesh-ancestor
65679838|NCT05719883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679839|NCT05716607|Hydrocortisone|hydrocortisone|mesh-list
65679840|NCT05716607|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65679841|NCT05716607|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65679842|NCT05716607|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65679843|NCT05716607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65679844|NCT05715411|Methamphetamine|methamphetamine|mesh-list
65679845|NCT05715411|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65679846|NCT05715411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679847|NCT05715411|Sympathomimetics|sympathomimetics|mesh-ancestor
65679848|NCT05715411|Autonomic Agents|autonomic agents|mesh-ancestor
65679849|NCT05715411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65679850|NCT05715411|Dopamine Agents|dopamine agents|mesh-ancestor
65679851|NCT05715411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65679852|NCT05715411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679853|NCT05715411|Adrenergic Agents|adrenergic agents|mesh-ancestor
65679854|NCT05715411|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65679855|NCT05715411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65679856|NCT05715411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65679857|NCT05715411|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65679858|NCT05691712|Tirzepatide|tirzepatide|mesh-list
65679859|NCT05691712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65679860|NCT05691712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679861|NCT05691712|Incretins|incretins|mesh-ancestor
65679862|NCT05691712|Hormones|hormones|mesh-ancestor
65679863|NCT05691712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65679864|NCT05688579|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
65679865|NCT05688579|Mineralocorticoids|mineralocorticoids|mesh-list
65679866|NCT05688579|Hormone Antagonists|hormone antagonists|mesh-ancestor
65679867|NCT05688579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65679868|NCT05688579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679869|NCT05688579|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65679870|NCT05688579|Diuretics|diuretics|mesh-ancestor
65679871|NCT05688579|Natriuretic Agents|natriuretic agents|mesh-ancestor
65679872|NCT05688579|Hormones|hormones|mesh-ancestor
65679873|NCT05675501|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65679874|NCT05675501|Dermatologic Agents|dermatologic agents|mesh-ancestor
65679875|NCT05662111|Etidronic Acid|etidronic acid|mesh-list
65679876|NCT05662111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65679877|NCT05662111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679878|NCT05660850|Mannitol|mannitol|mesh-list
65679879|NCT05660850|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65679880|NCT05660850|Diuretics|diuretics|mesh-ancestor
65679881|NCT05660850|Natriuretic Agents|natriuretic agents|mesh-ancestor
65679882|NCT05660850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679883|NCT05659927|Antibodies|antibodies|mesh-list
65679884|NCT05659927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65679885|NCT05659927|Immunologic Factors|immunologic factors|mesh-ancestor
65679886|NCT05659927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679887|NCT05659823|Fentanyl|fentanyl|mesh-list
65679888|NCT05659823|Morphine|morphine|mesh-list
65679889|NCT05659823|Bupivacaine|bupivacaine|mesh-list
65679890|NCT05659823|Anesthetics, Local|anesthetics, local|mesh-ancestor
65679891|NCT05659823|Anesthetics|anesthetics|mesh-ancestor
65679892|NCT05659823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65679893|NCT05659823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679894|NCT05659823|Sensory System Agents|sensory system agents|mesh-ancestor
65679895|NCT05659823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65679896|NCT05659823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65679897|NCT05659823|Narcotics|narcotics|mesh-ancestor
65477244|NCT03905486|Pregabalin|pregabalin|mesh-list
65679898|NCT05659823|Analgesics|analgesics|mesh-ancestor
65679899|NCT05659823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65679900|NCT05659823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65679901|NCT05659823|Anesthetics, General|anesthetics, general|mesh-ancestor
65679902|NCT05646862|Fulvestrant|fulvestrant|mesh-list
65679903|NCT05646862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65679904|NCT05646862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679905|NCT05646862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65679906|NCT05646862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65679907|NCT05646862|Hormone Antagonists|hormone antagonists|mesh-ancestor
65679908|NCT05646862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65679909|NCT05646862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679910|NCT05645432|Pregnanolone|pregnanolone|mesh-list
65679911|NCT05645432|Brexanolone|brexanolone|mesh-list
65679912|NCT05645432|Anesthetics|anesthetics|mesh-ancestor
65679913|NCT05645432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65679914|NCT05645432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679915|NCT05645432|Neurosteroids|neurosteroids|mesh-ancestor
65679916|NCT05645432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65679917|NCT05645432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679918|NCT05645432|GABA Modulators|gaba modulators|mesh-ancestor
65679919|NCT05645432|GABA Agents|gaba agents|mesh-ancestor
65679920|NCT05640453|Pregabalin|pregabalin|mesh-list
65679921|NCT05640453|Dexmedetomidine|dexmedetomidine|mesh-list
65679922|NCT05640453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65679923|NCT05640453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65679924|NCT05640453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679925|NCT05640453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65679926|NCT05640453|Analgesics|analgesics|mesh-ancestor
65679927|NCT05640453|Sensory System Agents|sensory system agents|mesh-ancestor
65679928|NCT05640453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65679929|NCT05640453|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65679930|NCT05640453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65679931|NCT05640453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65679932|NCT05640453|Adrenergic Agents|adrenergic agents|mesh-ancestor
65679933|NCT05640453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65679934|NCT05640453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679935|NCT05640453|Anticonvulsants|anticonvulsants|mesh-ancestor
65679936|NCT05640453|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65679937|NCT05640453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65679938|NCT05640453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65679939|NCT05640453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65679940|NCT05640453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65679941|NCT05640453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65679942|NCT05635851|Nitroglycerin|nitroglycerin|mesh-list
65679943|NCT05635851|Vasodilator Agents|vasodilator agents|mesh-ancestor
65679944|NCT05627557|Acetaminophen|acetaminophen|mesh-list
65679945|NCT05627557|Diphenhydramine|diphenhydramine|mesh-list
65679946|NCT05627557|Promethazine|promethazine|mesh-list
65679947|NCT05627557|Prednisone|prednisone|mesh-list
65679948|NCT05627557|Methylprednisolone|methylprednisolone|mesh-list
65679949|NCT05627557|Obinutuzumab|obinutuzumab|mesh-list
65679950|NCT05627557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65679951|NCT05627557|Glucocorticoids|glucocorticoids|mesh-ancestor
65679952|NCT05627557|Hormones|hormones|mesh-ancestor
65679953|NCT05627557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65679954|NCT05627557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679955|NCT05627557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65679956|NCT05627557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679957|NCT05627557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65679958|NCT05627557|Analgesics|analgesics|mesh-ancestor
65679959|NCT05627557|Sensory System Agents|sensory system agents|mesh-ancestor
65679960|NCT05627557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65679961|NCT05627557|Antipyretics|antipyretics|mesh-ancestor
65679962|NCT05627557|Antiemetics|antiemetics|mesh-ancestor
65679963|NCT05627557|Autonomic Agents|autonomic agents|mesh-ancestor
65679964|NCT05627557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65679965|NCT05627557|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65679966|NCT05627557|Protective Agents|protective agents|mesh-ancestor
65679967|NCT05627557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65679968|NCT05627557|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65679969|NCT05627557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65679970|NCT05627557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65679971|NCT05627557|Anesthetics, Local|anesthetics, local|mesh-ancestor
65679972|NCT05627557|Anesthetics|anesthetics|mesh-ancestor
65679973|NCT05627557|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65679974|NCT05627557|Histamine Antagonists|histamine antagonists|mesh-ancestor
65679975|NCT05627557|Histamine Agents|histamine agents|mesh-ancestor
65679976|NCT05627557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65679977|NCT05627557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65679978|NCT05627557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65679979|NCT05627557|Antipruritics|antipruritics|mesh-ancestor
65679980|NCT05627557|Dermatologic Agents|dermatologic agents|mesh-ancestor
65679981|NCT05623020|Dexamethasone|dexamethasone|mesh-list
65679982|NCT05623020|Lenalidomide|lenalidomide|mesh-list
65679983|NCT05623020|Daratumumab|daratumumab|mesh-list
65679984|NCT05623020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65679985|NCT05623020|Antiemetics|antiemetics|mesh-ancestor
65679986|NCT05623020|Autonomic Agents|autonomic agents|mesh-ancestor
65679987|NCT05623020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65679988|NCT05623020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65679989|NCT05623020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65679990|NCT05623020|Glucocorticoids|glucocorticoids|mesh-ancestor
65679991|NCT05623020|Hormones|hormones|mesh-ancestor
65679992|NCT05623020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65679993|NCT05623020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65679994|NCT05623020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65679995|NCT05623020|Immunologic Factors|immunologic factors|mesh-ancestor
65679996|NCT05623020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65679997|NCT05623020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65679998|NCT05623020|Growth Substances|growth substances|mesh-ancestor
65679999|NCT05623020|Growth Inhibitors|growth inhibitors|mesh-ancestor
65680000|NCT05603832|Acetaminophen|acetaminophen|mesh-list
65680001|NCT05603832|Bupivacaine|bupivacaine|mesh-list
65680002|NCT05603832|Methocarbamol|methocarbamol|mesh-list
65680003|NCT05603832|Anesthetics, Local|anesthetics, local|mesh-ancestor
65680004|NCT05603832|Anesthetics|anesthetics|mesh-ancestor
65680005|NCT05603832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65680006|NCT05603832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680007|NCT05603832|Sensory System Agents|sensory system agents|mesh-ancestor
65680008|NCT05603832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65680009|NCT05603832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65680010|NCT05603832|Analgesics|analgesics|mesh-ancestor
65680011|NCT05603832|Antipyretics|antipyretics|mesh-ancestor
65680012|NCT05603832|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65680013|NCT05603832|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65680014|NCT05600426|Cyclosporine|cyclosporine|mesh-list
65680015|NCT05600426|Cyclophosphamide|cyclophosphamide|mesh-list
65680016|NCT05600426|Methotrexate|methotrexate|mesh-list
65680017|NCT05600426|Fludarabine|fludarabine|mesh-list
65680018|NCT05600426|Cyclosporins|cyclosporins|mesh-list
65680019|NCT05600426|Thymoglobulin|thymoglobulin|mesh-list
65680020|NCT05600426|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65680021|NCT05600426|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65680022|NCT05600426|Immunologic Factors|immunologic factors|mesh-ancestor
65680023|NCT05600426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680024|NCT05600426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65680025|NCT05600426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65680026|NCT05600426|Alkylating Agents|alkylating agents|mesh-ancestor
65680027|NCT05600426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680028|NCT05600426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680029|NCT05600426|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65680030|NCT05600426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65680031|NCT05600426|Abortifacient Agents|abortifacient agents|mesh-ancestor
65680032|NCT05600426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65680033|NCT05600426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65680034|NCT05600426|Antimetabolites|antimetabolites|mesh-ancestor
65680035|NCT05600426|Dermatologic Agents|dermatologic agents|mesh-ancestor
65680036|NCT05600426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680037|NCT05600426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65680038|NCT05600426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65680039|NCT05600426|Antifungal Agents|antifungal agents|mesh-ancestor
65680040|NCT05600426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65680041|NCT05600426|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65680042|NCT05599789|Docetaxel|docetaxel|mesh-list
65680043|NCT05599789|Pembrolizumab|pembrolizumab|mesh-list
65680044|NCT05599789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680045|NCT05599789|Tubulin Modulators|tubulin modulators|mesh-ancestor
65680046|NCT05599789|Antimitotic Agents|antimitotic agents|mesh-ancestor
65680047|NCT05599789|Mitosis Modulators|mitosis modulators|mesh-ancestor
65680048|NCT05599789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680049|NCT05599789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680050|NCT05596747|Insulin Glargine|insulin glargine|mesh-list
65680051|NCT05596747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65680052|NCT05596747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680053|NCT05583617|Lenalidomide|lenalidomide|mesh-list
65680054|NCT05583617|Immunologic Factors|immunologic factors|mesh-ancestor
65680055|NCT05583617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680056|NCT05583617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65680057|NCT05583617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65680058|NCT05583617|Growth Substances|growth substances|mesh-ancestor
65680059|NCT05583617|Growth Inhibitors|growth inhibitors|mesh-ancestor
65680060|NCT05583617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680061|NCT05581901|Methadone|methadone|mesh-list
65680062|NCT05581901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65680063|NCT05581901|Narcotics|narcotics|mesh-ancestor
65680064|NCT05581901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65680065|NCT05581901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680066|NCT05581901|Analgesics|analgesics|mesh-ancestor
65680067|NCT05581901|Sensory System Agents|sensory system agents|mesh-ancestor
65680068|NCT05581901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65680069|NCT05581901|Antitussive Agents|antitussive agents|mesh-ancestor
65680070|NCT05581901|Respiratory System Agents|respiratory system agents|mesh-ancestor
65680071|NCT05564637|Treprostinil|treprostinil|mesh-list
65680072|NCT05564637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65680073|NCT05562947|Ranibizumab|ranibizumab|mesh-list
65680074|NCT05562947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65680075|NCT05562947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65680076|NCT05562947|Growth Substances|growth substances|mesh-ancestor
65680077|NCT05562947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680078|NCT05562947|Growth Inhibitors|growth inhibitors|mesh-ancestor
65680079|NCT05562947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680080|NCT05562466|Budesonide|budesonide|mesh-list
65680081|NCT05562466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65680082|NCT05562466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65680083|NCT05562466|Autonomic Agents|autonomic agents|mesh-ancestor
65680084|NCT05562466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65680085|NCT05562466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680086|NCT05562466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65680087|NCT05562466|Respiratory System Agents|respiratory system agents|mesh-ancestor
65680088|NCT05562466|Glucocorticoids|glucocorticoids|mesh-ancestor
65680089|NCT05562466|Hormones|hormones|mesh-ancestor
65680090|NCT05562466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65680091|NCT05555706|Paclitaxel|paclitaxel|mesh-list
65680092|NCT05555706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65680093|NCT05555706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680094|NCT05555706|Tubulin Modulators|tubulin modulators|mesh-ancestor
65680095|NCT05555706|Antimitotic Agents|antimitotic agents|mesh-ancestor
65680096|NCT05555706|Mitosis Modulators|mitosis modulators|mesh-ancestor
65680097|NCT05555706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680098|NCT05536804|Tirzepatide|tirzepatide|mesh-list
65680099|NCT05536804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65680100|NCT05536804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680101|NCT05536804|Incretins|incretins|mesh-ancestor
65680102|NCT05536804|Hormones|hormones|mesh-ancestor
65680103|NCT05536804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65680104|NCT05525858|Bevacizumab|bevacizumab|mesh-list
65680105|NCT05525858|Trastuzumab|trastuzumab|mesh-list
65680106|NCT05525858|Pertuzumab|pertuzumab|mesh-list
65680107|NCT05525858|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65680108|NCT05525858|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65680109|NCT05525858|Atezolizumab|atezolizumab|mesh-list
65680110|NCT05525858|Vemurafenib|vemurafenib|mesh-list
65680111|NCT05525858|Maytansine|maytansine|mesh-list
65680112|NCT05525858|Pralsetinib|pralsetinib|mesh-list
65680113|NCT05525858|Entrectinib|entrectinib|mesh-list
65680114|NCT05525858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680115|NCT05525858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680116|NCT05525858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65680117|NCT05525858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65680118|NCT05525858|Growth Substances|growth substances|mesh-ancestor
65680119|NCT05525858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680120|NCT05525858|Growth Inhibitors|growth inhibitors|mesh-ancestor
65680121|NCT05525858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65680122|NCT05525858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680123|NCT05525858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680124|NCT05525858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65680125|NCT05525858|Tubulin Modulators|tubulin modulators|mesh-ancestor
65680126|NCT05525858|Antimitotic Agents|antimitotic agents|mesh-ancestor
65680127|NCT05525858|Mitosis Modulators|mitosis modulators|mesh-ancestor
65680128|NCT05520814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65680129|NCT05520814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680130|NCT05520814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680131|NCT05519085|Dexamethasone|dexamethasone|mesh-list
65680132|NCT05519085|Bortezomib|bortezomib|mesh-list
65680133|NCT05519085|Pomalidomide|pomalidomide|mesh-list
65680134|NCT05519085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65680135|NCT05519085|Antiemetics|antiemetics|mesh-ancestor
65680136|NCT05519085|Autonomic Agents|autonomic agents|mesh-ancestor
65680137|NCT05519085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65680138|NCT05519085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680139|NCT05519085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65680140|NCT05519085|Glucocorticoids|glucocorticoids|mesh-ancestor
65680141|NCT05519085|Hormones|hormones|mesh-ancestor
65680142|NCT05519085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65680143|NCT05519085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65680144|NCT05519085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680145|NCT05519085|Immunologic Factors|immunologic factors|mesh-ancestor
65680146|NCT05519085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65680147|NCT05519085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65680148|NCT05519085|Growth Substances|growth substances|mesh-ancestor
65680149|NCT05519085|Growth Inhibitors|growth inhibitors|mesh-ancestor
65680150|NCT05508061|Insulin|insulin|mesh-list
65680151|NCT05508061|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65680152|NCT05508061|Insulin Lispro|insulin lispro|mesh-list
65680153|NCT05508061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65680154|NCT05508061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680155|NCT05504642|Nivolumab|nivolumab|mesh-list
65680156|NCT05504642|Ipilimumab|ipilimumab|mesh-list
65680157|NCT05504642|Immunologic Factors|immunologic factors|mesh-list
65680158|NCT05504642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680159|NCT05504642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680160|NCT05504642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65680161|NCT05504642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680162|NCT05504642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680163|NCT05490953|Pentoxifylline|pentoxifylline|mesh-list
65680164|NCT05490953|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65680165|NCT05490953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680166|NCT05490953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680167|NCT05490953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65680168|NCT05490953|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65680169|NCT05490953|Protective Agents|protective agents|mesh-ancestor
65680170|NCT05490953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680171|NCT05490953|Vasodilator Agents|vasodilator agents|mesh-ancestor
65680172|NCT05490953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65680173|NCT05490953|Antioxidants|antioxidants|mesh-ancestor
65680174|NCT05487235|Atezolizumab|atezolizumab|mesh-list
65680175|NCT05487235|Omeprazole|omeprazole|mesh-list
65680176|NCT05487235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680177|NCT05487235|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65680178|NCT05487235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65680179|NCT05487235|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65680180|NCT05487235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680181|NCT05487235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680182|NCT05475483|Bevantolol|bevantolol|mesh-list
65680183|NCT05475483|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65680184|NCT05475483|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65680185|NCT05475483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65680186|NCT05475483|Adrenergic Agents|adrenergic agents|mesh-ancestor
65680187|NCT05475483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65680188|NCT05475483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680189|NCT05475483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680190|NCT05474729|Minocycline|minocycline|mesh-list
65680191|NCT05474729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65680192|NCT05474729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65680193|NCT05474001|Fentanyl|fentanyl|mesh-list
65680194|NCT05474001|Bupivacaine|bupivacaine|mesh-list
65680195|NCT05474001|Anesthetics, Local|anesthetics, local|mesh-ancestor
65680196|NCT05474001|Anesthetics|anesthetics|mesh-ancestor
65680197|NCT05474001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65680198|NCT05474001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680199|NCT05474001|Sensory System Agents|sensory system agents|mesh-ancestor
65680200|NCT05474001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65680201|NCT05474001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65680202|NCT05474001|Narcotics|narcotics|mesh-ancestor
65680203|NCT05474001|Analgesics|analgesics|mesh-ancestor
65680204|NCT05474001|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65680205|NCT05474001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65680206|NCT05474001|Anesthetics, General|anesthetics, general|mesh-ancestor
65680207|NCT05465954|Pembrolizumab|pembrolizumab|mesh-list
65680208|NCT05465954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680209|NCT05465954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680210|NCT05462756|Insulin|insulin|mesh-list
65680211|NCT05462756|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65680212|NCT05462756|Insulin Glargine|insulin glargine|mesh-list
65680213|NCT05462756|Insulin Lispro|insulin lispro|mesh-list
65680214|NCT05462756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65680215|NCT05462756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680216|NCT05445232|Midazolam|midazolam|mesh-list
65680217|NCT05445232|Caffeine|caffeine|mesh-list
65680218|NCT05445232|Warfarin|warfarin|mesh-list
65680219|NCT05445232|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65680220|NCT05445232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65680221|NCT05445232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65680222|NCT05445232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680223|NCT05445232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65680224|NCT05445232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65680225|NCT05445232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65680226|NCT05445232|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65680227|NCT05445232|Anesthetics, General|anesthetics, general|mesh-ancestor
65680228|NCT05445232|Anesthetics|anesthetics|mesh-ancestor
65680229|NCT05445232|GABA Modulators|gaba modulators|mesh-ancestor
65680230|NCT05445232|GABA Agents|gaba agents|mesh-ancestor
65680231|NCT05445232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65680232|NCT05445232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680233|NCT05445232|Anticoagulants|anticoagulants|mesh-ancestor
65680234|NCT05445232|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65680235|NCT05445232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65680236|NCT05445232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680237|NCT05445232|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65680238|NCT05445232|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65680239|NCT05445232|Purinergic Agents|purinergic agents|mesh-ancestor
65680240|NCT05433584|Tirzepatide|tirzepatide|mesh-list
65680241|NCT05433584|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65680242|NCT05433584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680243|NCT05433584|Incretins|incretins|mesh-ancestor
65680244|NCT05433584|Hormones|hormones|mesh-ancestor
65680245|NCT05433584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65680246|NCT05420805|Zinc Oxide|zinc oxide|mesh-list
65680247|NCT05420805|Butyric Acid|butyric acid|mesh-list
65680248|NCT05420805|Dermatologic Agents|dermatologic agents|mesh-ancestor
65680249|NCT05420805|Sunscreening Agents|sunscreening agents|mesh-ancestor
65680250|NCT05420805|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65680251|NCT05420805|Protective Agents|protective agents|mesh-ancestor
65680252|NCT05420805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680253|NCT05420805|Histamine Antagonists|histamine antagonists|mesh-ancestor
65680254|NCT05420805|Histamine Agents|histamine agents|mesh-ancestor
65680255|NCT05420805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65680256|NCT05420805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680257|NCT05419830|Antihypertensive Agents|antihypertensive agents|mesh-list
65680258|NCT05412004|Tirzepatide|tirzepatide|mesh-list
65680259|NCT05412004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65680260|NCT05412004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680261|NCT05412004|Incretins|incretins|mesh-ancestor
65680262|NCT05412004|Hormones|hormones|mesh-ancestor
65680263|NCT05412004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65680264|NCT05406583|Dolutegravir|dolutegravir|mesh-list
65680265|NCT05406583|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65680266|NCT05406583|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65680267|NCT05406583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680268|NCT05406583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680269|NCT05406583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65680270|NCT05406583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65680271|NCT05406583|Antiviral Agents|antiviral agents|mesh-ancestor
65680272|NCT05406583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65680273|NCT05405166|Dexamethasone|dexamethasone|mesh-list
65680274|NCT05405166|Pomalidomide|pomalidomide|mesh-list
65680275|NCT05405166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65477614|NCT01152476|Remifentanil|remifentanil|mesh-list
65680276|NCT05405166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65680277|NCT05405166|Antiemetics|antiemetics|mesh-ancestor
65680278|NCT05405166|Autonomic Agents|autonomic agents|mesh-ancestor
65680279|NCT05405166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65680280|NCT05405166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680281|NCT05405166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65680282|NCT05405166|Glucocorticoids|glucocorticoids|mesh-ancestor
65680283|NCT05405166|Hormones|hormones|mesh-ancestor
65680284|NCT05405166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65680285|NCT05405166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65680286|NCT05405166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680287|NCT05405166|Immunologic Factors|immunologic factors|mesh-ancestor
65680288|NCT05405166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65680289|NCT05405166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65680290|NCT05405166|Growth Substances|growth substances|mesh-ancestor
65680291|NCT05405166|Growth Inhibitors|growth inhibitors|mesh-ancestor
65680292|NCT05395533|Antibodies|antibodies|mesh-list
65680293|NCT05395533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65680294|NCT05395533|Immunologic Factors|immunologic factors|mesh-ancestor
65680295|NCT05395533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680296|NCT05389527|Pembrolizumab|pembrolizumab|mesh-list
65680297|NCT05389527|Lenvatinib|lenvatinib|mesh-list
65680298|NCT05389527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680299|NCT05389527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680300|NCT05389527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65680301|NCT05389527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680302|NCT05389527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680303|NCT05358522|Analgesics, Opioid|analgesics, opioid|mesh-list
65680304|NCT05358522|Narcotics|narcotics|mesh-ancestor
65680305|NCT05358522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65680306|NCT05358522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680307|NCT05358522|Analgesics|analgesics|mesh-ancestor
65680308|NCT05358522|Sensory System Agents|sensory system agents|mesh-ancestor
65680309|NCT05358522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65680310|NCT05355974|Norepinephrine|norepinephrine|mesh-list
65680311|NCT05355974|Plasma-lyte 148|plasma-lyte 148|mesh-list
65680312|NCT05355974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65680313|NCT05355974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65680314|NCT05355974|Adrenergic Agents|adrenergic agents|mesh-ancestor
65680315|NCT05355974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65680316|NCT05355974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680317|NCT05355974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680318|NCT05355974|Sympathomimetics|sympathomimetics|mesh-ancestor
65680319|NCT05355974|Autonomic Agents|autonomic agents|mesh-ancestor
65680320|NCT05355974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65680321|NCT05355974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65680322|NCT05355974|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65680323|NCT05355974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65680324|NCT05345171|Prednisolone|prednisolone|mesh-list
65680325|NCT05345171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65680326|NCT05345171|Glucocorticoids|glucocorticoids|mesh-ancestor
65680327|NCT05345171|Hormones|hormones|mesh-ancestor
65680328|NCT05345171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65680329|NCT05345171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680330|NCT05345171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65680331|NCT05345171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680332|NCT05340413|Olaparib|olaparib|mesh-list
65680333|NCT05340413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65680334|NCT05340413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680335|NCT05340413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680336|NCT05340413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680337|NCT05338970|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
65680338|NCT05338970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680339|NCT05338970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680340|NCT05337137|Bevacizumab|bevacizumab|mesh-list
65680341|NCT05337137|Nivolumab|nivolumab|mesh-list
65680342|NCT05337137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680343|NCT05337137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680344|NCT05337137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65680345|NCT05337137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65680346|NCT05337137|Growth Substances|growth substances|mesh-ancestor
65680347|NCT05337137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680348|NCT05337137|Growth Inhibitors|growth inhibitors|mesh-ancestor
65680349|NCT05337137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65680350|NCT05337137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680351|NCT05331183|Ivacaftor|ivacaftor|mesh-list
65680352|NCT05331183|Elexacaftor|elexacaftor|mesh-list
65680353|NCT05331183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65680354|NCT05331183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65477681|NCT04462276|Atezolizumab|atezolizumab|mesh-list
65680355|NCT05331183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680356|NCT05323955|Trastuzumab|trastuzumab|mesh-list
65680357|NCT05323955|Pertuzumab|pertuzumab|mesh-list
65680358|NCT05323955|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65680359|NCT05323955|Maytansine|maytansine|mesh-list
65680360|NCT05323955|Tucatinib|tucatinib|mesh-list
65680361|NCT05323955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680362|NCT05323955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680363|NCT05323955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65680364|NCT05323955|Tubulin Modulators|tubulin modulators|mesh-ancestor
65680365|NCT05323955|Antimitotic Agents|antimitotic agents|mesh-ancestor
65680366|NCT05323955|Mitosis Modulators|mitosis modulators|mesh-ancestor
65680367|NCT05323955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680368|NCT05323955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65680369|NCT05323955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680370|NCT05312970|Polidocanol|polidocanol|mesh-list
65680371|NCT05312970|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65680372|NCT05312970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65680373|NCT05312385|Propofol|propofol|mesh-list
65680374|NCT05312385|Isoflurane|isoflurane|mesh-list
65680375|NCT05312385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65680376|NCT05312385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65680377|NCT05312385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680378|NCT05312385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65680379|NCT05312385|Anesthetics, General|anesthetics, general|mesh-ancestor
65680380|NCT05312385|Anesthetics|anesthetics|mesh-ancestor
65680381|NCT05312385|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65680382|NCT05291338|Doxorubicin|doxorubicin|mesh-list
65680383|NCT05291338|Ethiodized Oil|ethiodized oil|mesh-list
65680384|NCT05291338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65680385|NCT05291338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680386|NCT05291338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65680387|NCT05291338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65680388|NCT05291338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680389|NCT05291338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680390|NCT05291039|Adalimumab|adalimumab|mesh-list
65680391|NCT05291039|Infliximab|infliximab|mesh-list
65680392|NCT05291039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65680393|NCT05291039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65680394|NCT05291039|Dermatologic Agents|dermatologic agents|mesh-ancestor
65680395|NCT05291039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65680396|NCT05289193|Nivolumab|nivolumab|mesh-list
65680397|NCT05289193|Ipilimumab|ipilimumab|mesh-list
65680398|NCT05289193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680399|NCT05289193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680400|NCT05289193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65680401|NCT05289193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680402|NCT05288166|Prednisone|prednisone|mesh-list
65680403|NCT05288166|Prednisolone|prednisolone|mesh-list
65680404|NCT05288166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65680405|NCT05288166|Glucocorticoids|glucocorticoids|mesh-ancestor
65680406|NCT05288166|Hormones|hormones|mesh-ancestor
65680407|NCT05288166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65680408|NCT05288166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680409|NCT05288166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65680410|NCT05288166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680411|NCT05285982|Nintedanib|nintedanib|mesh-list
65680412|NCT05285982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680413|NCT05285982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65680414|NCT05285982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680415|NCT05285982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680416|NCT05285917|Hydroxyurea|hydroxyurea|mesh-list
65680417|NCT05285917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680418|NCT05285917|Antisickling Agents|antisickling agents|mesh-ancestor
65680419|NCT05285917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680420|NCT05285917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680421|NCT05285917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65680422|NCT05282121|Empagliflozin|empagliflozin|mesh-list
65680423|NCT05282121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65680424|NCT05282121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680425|NCT05282121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65680426|NCT05282121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680427|NCT05269004|Ocrelizumab|ocrelizumab|mesh-list
65680428|NCT05269004|Immunologic Factors|immunologic factors|mesh-ancestor
65680429|NCT05269004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680430|NCT05260021|Tirzepatide|tirzepatide|mesh-list
65680431|NCT05260021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65680432|NCT05260021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680433|NCT05260021|Incretins|incretins|mesh-ancestor
65680434|NCT05260021|Hormones|hormones|mesh-ancestor
65680435|NCT05260021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65680436|NCT05259137|Enalaprilat|enalaprilat|mesh-list
65680437|NCT05259137|Enalapril|enalapril|mesh-list
65680438|NCT05259137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65680439|NCT05259137|Protease Inhibitors|protease inhibitors|mesh-ancestor
65680440|NCT05259137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680441|NCT05259137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680442|NCT05259137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65680443|NCT05249426|Cetuximab|cetuximab|mesh-list
65680444|NCT05249426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680445|NCT05249426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680446|NCT05232825|Diphenhydramine|diphenhydramine|mesh-list
65680447|NCT05232825|Promethazine|promethazine|mesh-list
65680448|NCT05232825|Dexamethasone|dexamethasone|mesh-list
65680449|NCT05232825|Methylprednisolone|methylprednisolone|mesh-list
65680450|NCT05232825|Desloratadine|desloratadine|mesh-list
65680451|NCT05232825|Ocrelizumab|ocrelizumab|mesh-list
65274200|NCT02686710|Sevoflurane|sevoflurane|mesh-list
65680452|NCT05232825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65680453|NCT05232825|Antiemetics|antiemetics|mesh-ancestor
65680454|NCT05232825|Autonomic Agents|autonomic agents|mesh-ancestor
65680455|NCT05232825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65680456|NCT05232825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680457|NCT05232825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65680458|NCT05232825|Glucocorticoids|glucocorticoids|mesh-ancestor
65680459|NCT05232825|Hormones|hormones|mesh-ancestor
65680460|NCT05232825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65680461|NCT05232825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65680462|NCT05232825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680463|NCT05232825|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65680464|NCT05232825|Protective Agents|protective agents|mesh-ancestor
65680465|NCT05232825|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65680466|NCT05232825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65680467|NCT05232825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65680468|NCT05232825|Anesthetics, Local|anesthetics, local|mesh-ancestor
65680469|NCT05232825|Anesthetics|anesthetics|mesh-ancestor
65680470|NCT05232825|Sensory System Agents|sensory system agents|mesh-ancestor
65680471|NCT05232825|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65680472|NCT05232825|Histamine Antagonists|histamine antagonists|mesh-ancestor
65680473|NCT05232825|Histamine Agents|histamine agents|mesh-ancestor
65680474|NCT05232825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65680475|NCT05232825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680476|NCT05232825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65680477|NCT05232825|Antipruritics|antipruritics|mesh-ancestor
65680478|NCT05232825|Dermatologic Agents|dermatologic agents|mesh-ancestor
65680479|NCT05232825|Immunologic Factors|immunologic factors|mesh-ancestor
65680480|NCT05232825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65680481|NCT05232825|Cholinergic Agents|cholinergic agents|mesh-ancestor
65680482|NCT05232825|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65680483|NCT05225558|Vancomycin|vancomycin|mesh-list
65680484|NCT05225558|Delpazolid|delpazolid|mesh-list
65680485|NCT05225558|Oxazolidinones|oxazolidinones|mesh-list
65680486|NCT05225558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65680487|NCT05225558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65680488|NCT05225558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65680489|NCT05225558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680490|NCT05225558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680491|NCT05215340|Pembrolizumab|pembrolizumab|mesh-list
65680492|NCT05215340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680493|NCT05215340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680494|NCT05211947|BI 425809|bi 425809|mesh-list
65680495|NCT05211947|Nootropic Agents|nootropic agents|mesh-ancestor
65680496|NCT05200988|Nivolumab|nivolumab|mesh-list
65680497|NCT05200988|Ipilimumab|ipilimumab|mesh-list
65680498|NCT05200988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680499|NCT05200988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680500|NCT05200988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65680501|NCT05200988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680502|NCT05159830|Cannabidiol|cannabidiol|mesh-list
65680503|NCT05159830|Anticonvulsants|anticonvulsants|mesh-ancestor
65680504|NCT05148715|Tacrolimus|tacrolimus|mesh-list
65680505|NCT05148715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65680506|NCT05148715|Immunologic Factors|immunologic factors|mesh-ancestor
65680507|NCT05148715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680508|NCT05148715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65680509|NCT05148715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680510|NCT05148715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680511|NCT05142189|Docetaxel|docetaxel|mesh-list
65680512|NCT05142189|Cemiplimab|cemiplimab|mesh-list
65680513|NCT05142189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680514|NCT05142189|Tubulin Modulators|tubulin modulators|mesh-ancestor
65680515|NCT05142189|Antimitotic Agents|antimitotic agents|mesh-ancestor
65680516|NCT05142189|Mitosis Modulators|mitosis modulators|mesh-ancestor
65680517|NCT05142189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680518|NCT05142189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680519|NCT05123703|Ocrelizumab|ocrelizumab|mesh-list
65680520|NCT05123703|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65680521|NCT05123703|Immunologic Factors|immunologic factors|mesh-ancestor
65680522|NCT05123703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680523|NCT05123703|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65680524|NCT05123703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680525|NCT05123703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65680526|NCT05121883|Edaravone|edaravone|mesh-list
65680527|NCT05121883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65680528|NCT05121883|Antioxidants|antioxidants|mesh-ancestor
65680529|NCT05121883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680530|NCT05121883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65680531|NCT05121883|Protective Agents|protective agents|mesh-ancestor
65680532|NCT05121883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680533|NCT05114746|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65680534|NCT05114746|177Lu-PSMA-617|177lu-psma-617|mesh-list
65680535|NCT05114746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65680536|NCT05114746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680537|NCT05112211|Doxycycline|doxycycline|mesh-list
65680538|NCT05112211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65680539|NCT05112211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65680540|NCT05112211|Antimalarials|antimalarials|mesh-ancestor
65680541|NCT05112211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65680542|NCT05112211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65680543|NCT05110040|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65680544|NCT05110040|Immunologic Factors|immunologic factors|mesh-ancestor
65680545|NCT05110040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680546|NCT05110001|Chlorhexidine|chlorhexidine|mesh-list
65680547|NCT05110001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65680548|NCT05110001|Natamycin|natamycin|mesh-list
65680549|NCT05110001|Moxifloxacin|moxifloxacin|mesh-list
65680550|NCT05110001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65680551|NCT05110001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65680552|NCT05110001|Disinfectants|disinfectants|mesh-ancestor
65680553|NCT05110001|Dermatologic Agents|dermatologic agents|mesh-ancestor
65680554|NCT05110001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65680555|NCT05110001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65680556|NCT05110001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65680557|NCT05110001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680558|NCT05110001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680559|NCT05110001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680560|NCT05110001|Antifungal Agents|antifungal agents|mesh-ancestor
65680561|NCT05107427|Avelumab|avelumab|mesh-list
65680562|NCT05107427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680563|NCT05107427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680564|NCT05104567|Pembrolizumab|pembrolizumab|mesh-list
65680565|NCT05104567|Cetuximab|cetuximab|mesh-list
65680566|NCT05104567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680567|NCT05104567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680568|NCT05090566|Dexamethasone|dexamethasone|mesh-list
65680569|NCT05090566|Lenalidomide|lenalidomide|mesh-list
65680570|NCT05090566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65680571|NCT05090566|Antiemetics|antiemetics|mesh-ancestor
65680572|NCT05090566|Autonomic Agents|autonomic agents|mesh-ancestor
65680573|NCT05090566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65680574|NCT05090566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680575|NCT05090566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65680576|NCT05090566|Glucocorticoids|glucocorticoids|mesh-ancestor
65680577|NCT05090566|Hormones|hormones|mesh-ancestor
65680578|NCT05090566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65680579|NCT05090566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65680580|NCT05090566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680581|NCT05090566|Immunologic Factors|immunologic factors|mesh-ancestor
65680582|NCT05090566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65680583|NCT05090566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65680584|NCT05090566|Growth Substances|growth substances|mesh-ancestor
65680585|NCT05090566|Growth Inhibitors|growth inhibitors|mesh-ancestor
65680587|NCT05071183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680588|NCT05071183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65680589|NCT05071183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680590|NCT05071183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680591|NCT05064280|Pembrolizumab|pembrolizumab|mesh-list
65680592|NCT05064280|Lenvatinib|lenvatinib|mesh-list
65680593|NCT05064280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680594|NCT05064280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680595|NCT05064280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65680596|NCT05064280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680597|NCT05064280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680598|NCT05042609|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65680599|NCT05042609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65680600|NCT05036226|Metformin|metformin|mesh-list
65680601|NCT05036226|Sirolimus|sirolimus|mesh-list
65680602|NCT05036226|Hydroxychloroquine|hydroxychloroquine|mesh-list
65680603|NCT05036226|Nelfinavir|nelfinavir|mesh-list
65680604|NCT05036226|Dasatinib|dasatinib|mesh-list
65680605|NCT05036226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65680606|NCT05036226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680607|NCT05036226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65680608|NCT05036226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65680609|NCT05036226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65680610|NCT05036226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680611|NCT05036226|Antifungal Agents|antifungal agents|mesh-ancestor
65680612|NCT05036226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65680613|NCT05036226|Immunologic Factors|immunologic factors|mesh-ancestor
65680614|NCT05036226|Antimalarials|antimalarials|mesh-ancestor
65680615|NCT05036226|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65680616|NCT05036226|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65680617|NCT05036226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680618|NCT05036226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680619|NCT05036226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65680620|NCT05036226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65680621|NCT05036226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65680622|NCT05036226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65680623|NCT05036226|Protease Inhibitors|protease inhibitors|mesh-ancestor
65680624|NCT05036226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65680625|NCT05036226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65680626|NCT05036226|Antiviral Agents|antiviral agents|mesh-ancestor
65680627|NCT05035745|Talazoparib|talazoparib|mesh-list
65680628|NCT05035745|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65680629|NCT05035745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680630|NCT05035745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680631|NCT05035745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680632|NCT05033080|Ivacaftor|ivacaftor|mesh-list
65680633|NCT05033080|Elexacaftor|elexacaftor|mesh-list
65680634|NCT05033080|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65680635|NCT05033080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65680636|NCT05033080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680637|NCT05020236|Dexamethasone|dexamethasone|mesh-list
65680638|NCT05020236|Daratumumab|daratumumab|mesh-list
65680639|NCT05020236|Pomalidomide|pomalidomide|mesh-list
65680640|NCT05020236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65680641|NCT05020236|Antiemetics|antiemetics|mesh-ancestor
65680642|NCT05020236|Autonomic Agents|autonomic agents|mesh-ancestor
65680643|NCT05020236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65680644|NCT05020236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680645|NCT05020236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65680646|NCT05020236|Glucocorticoids|glucocorticoids|mesh-ancestor
65680647|NCT05020236|Hormones|hormones|mesh-ancestor
65680648|NCT05020236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65680649|NCT05020236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65680650|NCT05020236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680651|NCT05020236|Immunologic Factors|immunologic factors|mesh-ancestor
65680652|NCT05020236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65680653|NCT05020236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65680654|NCT05020236|Growth Substances|growth substances|mesh-ancestor
65680655|NCT05020236|Growth Inhibitors|growth inhibitors|mesh-ancestor
65680656|NCT05005897|Vitamin B 12|vitamin b 12|mesh-list
65680657|NCT05005897|Hydroxocobalamin|hydroxocobalamin|mesh-list
65680658|NCT05005897|Vitamins|vitamins|mesh-ancestor
65680659|NCT05005897|Micronutrients|micronutrients|mesh-ancestor
65680660|NCT05005897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680661|NCT05005897|Vitamin B Complex|vitamin b complex|mesh-ancestor
65680662|NCT05005897|Hematinics|hematinics|mesh-ancestor
65680663|NCT04998851|Ocrelizumab|ocrelizumab|mesh-list
65680664|NCT04998851|Immunologic Factors|immunologic factors|mesh-ancestor
65680665|NCT04998851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680666|NCT04994977|Carboplatin|carboplatin|mesh-list
65680668|NCT04994977|Topotecan|topotecan|mesh-list
65680669|NCT04994977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680670|NCT04994977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65680671|NCT04994977|Alkylating Agents|alkylating agents|mesh-ancestor
65680672|NCT04994977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680673|NCT04994977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65680674|NCT04994977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65680675|NCT04994977|Immunologic Factors|immunologic factors|mesh-ancestor
65680676|NCT04994977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680677|NCT04994977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65680678|NCT04994977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65680679|NCT04994977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680680|NCT04987203|Nivolumab|nivolumab|mesh-list
65680681|NCT04987203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680682|NCT04987203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680683|NCT04987203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65680684|NCT04987203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680685|NCT04975308|Fulvestrant|fulvestrant|mesh-list
65680686|NCT04975308|Exemestane|exemestane|mesh-list
65680687|NCT04975308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65680688|NCT04975308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680689|NCT04975308|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65680690|NCT04975308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65680691|NCT04975308|Hormone Antagonists|hormone antagonists|mesh-ancestor
65680692|NCT04975308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65680693|NCT04975308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680694|NCT04975308|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65680695|NCT04975308|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65680696|NCT04975308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680697|NCT04975308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680698|NCT04943900|Nivolumab|nivolumab|mesh-list
65680699|NCT04943900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680700|NCT04943900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680701|NCT04943900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65680702|NCT04943900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680703|NCT04931615|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65680704|NCT04931615|Thrombin|thrombin|mesh-list
65680705|NCT04931615|Hemostatics|hemostatics|mesh-ancestor
65680706|NCT04931615|Coagulants|coagulants|mesh-ancestor
65680707|NCT04929223|Bevacizumab|bevacizumab|mesh-list
65680708|NCT04929223|Cetuximab|cetuximab|mesh-list
65680709|NCT04929223|Atezolizumab|atezolizumab|mesh-list
65680710|NCT04929223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680711|NCT04929223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680712|NCT04929223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65680713|NCT04929223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65680714|NCT04929223|Growth Substances|growth substances|mesh-ancestor
65680715|NCT04929223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680716|NCT04929223|Growth Inhibitors|growth inhibitors|mesh-ancestor
65680717|NCT04925375|Abatacept|abatacept|mesh-list
65680718|NCT04925375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65680719|NCT04925375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680720|NCT04925375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680721|NCT04925375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65680722|NCT04925375|Immunologic Factors|immunologic factors|mesh-ancestor
65680723|NCT04925375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680724|NCT04925375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65680725|NCT04879329|Pembrolizumab|pembrolizumab|mesh-list
65680726|NCT04879329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680727|NCT04879329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680728|NCT04878211|Interferons|interferons|mesh-list
65680729|NCT04878211|Ofatumumab|ofatumumab|mesh-list
65680730|NCT04878211|Glatiramer Acetate|glatiramer acetate|mesh-list
65680731|NCT04878211|(T,G)-A-L|(t,g)-a-l|mesh-list
65680732|NCT04878211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680733|NCT04878211|Antiviral Agents|antiviral agents|mesh-ancestor
65680734|NCT04878211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65680735|NCT04878211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65680736|NCT04878211|Immunologic Factors|immunologic factors|mesh-ancestor
65680737|NCT04878211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680738|NCT04878211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65680739|NCT04878211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65680740|NCT04869943|Exemestane|exemestane|mesh-list
65680741|NCT04869943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680742|NCT04869943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65680743|NCT04869943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65680744|NCT04869943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680745|NCT04869943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680746|NCT04869943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65680747|NCT04869943|Hormone Antagonists|hormone antagonists|mesh-ancestor
65680748|NCT04869943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65680749|NCT04869943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680750|NCT04866706|Hyaluronic Acid|hyaluronic acid|mesh-list
65680751|NCT04866706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65680752|NCT04866706|Immunologic Factors|immunologic factors|mesh-ancestor
65680753|NCT04866706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680754|NCT04866706|Viscosupplements|viscosupplements|mesh-ancestor
65680755|NCT04866706|Protective Agents|protective agents|mesh-ancestor
65680756|NCT04853251|Ranibizumab|ranibizumab|mesh-list
65680757|NCT04853251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65680758|NCT04853251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65680759|NCT04853251|Growth Substances|growth substances|mesh-ancestor
65680760|NCT04853251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680761|NCT04853251|Growth Inhibitors|growth inhibitors|mesh-ancestor
65680762|NCT04853251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680763|NCT04846478|Talazoparib|talazoparib|mesh-list
65680764|NCT04846478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65680765|NCT04846478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680766|NCT04846478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680767|NCT04846478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680768|NCT04844606|Mirikizumab|mirikizumab|mesh-list
65680769|NCT04844606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65680770|NCT04844606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65680771|NCT04844606|Analgesics|analgesics|mesh-ancestor
65680772|NCT04844606|Sensory System Agents|sensory system agents|mesh-ancestor
65680773|NCT04844606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65680774|NCT04844606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680775|NCT04844606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65680776|NCT04844606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65680777|NCT04844606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65680778|NCT04844606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65680779|NCT04834973|Pembrolizumab|pembrolizumab|mesh-list
65680780|NCT04834973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680781|NCT04834973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680782|NCT04826003|Obinutuzumab|obinutuzumab|mesh-list
65680783|NCT04826003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680784|NCT04826003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680785|NCT04809220|Dulaglutide|dulaglutide|mesh-list
65680786|NCT04809220|Biguanides|biguanides|mesh-list
65680787|NCT04809220|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
65680788|NCT04809220|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
65680789|NCT04809220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65680790|NCT04809220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680791|NCT04809220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680792|NCT04809220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680793|NCT04798781|Pembrolizumab|pembrolizumab|mesh-list
65680794|NCT04798781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680795|NCT04798781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680796|NCT04790903|Prednisone|prednisone|mesh-list
65680797|NCT04790903|Cyclophosphamide|cyclophosphamide|mesh-list
65680798|NCT04790903|Rituximab|rituximab|mesh-list
65680799|NCT04790903|Doxorubicin|doxorubicin|mesh-list
65680800|NCT04790903|Venetoclax|venetoclax|mesh-list
65680801|NCT04790903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65680802|NCT04790903|Immunologic Factors|immunologic factors|mesh-ancestor
65680803|NCT04790903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680804|NCT04790903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65680805|NCT04790903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65680806|NCT04790903|Alkylating Agents|alkylating agents|mesh-ancestor
65680807|NCT04790903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680808|NCT04790903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680809|NCT04790903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65680810|NCT04790903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65478130|NCT01265108|Hematinics|hematinics|mesh-ancestor
65680811|NCT04790903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65680812|NCT04790903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65680813|NCT04790903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65680814|NCT04790903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680815|NCT04790903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65680816|NCT04790903|Glucocorticoids|glucocorticoids|mesh-ancestor
65680817|NCT04790903|Hormones|hormones|mesh-ancestor
65680818|NCT04790903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65680819|NCT04790903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65680820|NCT04790370|Heparin|heparin|mesh-list
65680821|NCT04790370|Calcium heparin|calcium heparin|mesh-list
65680822|NCT04790370|Anticoagulants|anticoagulants|mesh-ancestor
65680823|NCT04790370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65680824|NCT04790370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65680825|NCT04790370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680826|NCT04774094|Ceftazidime|ceftazidime|mesh-list
65680827|NCT04774094|Avibactam|avibactam|mesh-list
65680828|NCT04774094|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
65680829|NCT04774094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65680830|NCT04774094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65680831|NCT04774094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65680832|NCT04774094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680833|NCT04774094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680834|NCT04764825|Morphine|morphine|mesh-list
65680835|NCT04764825|Methadone|methadone|mesh-list
65680836|NCT04764825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65680837|NCT04764825|Narcotics|narcotics|mesh-ancestor
65680838|NCT04764825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65680839|NCT04764825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680840|NCT04764825|Analgesics|analgesics|mesh-ancestor
65680841|NCT04764825|Sensory System Agents|sensory system agents|mesh-ancestor
65680842|NCT04764825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65680843|NCT04764825|Antitussive Agents|antitussive agents|mesh-ancestor
65680844|NCT04764825|Respiratory System Agents|respiratory system agents|mesh-ancestor
65680845|NCT04760743|Aluminum sulfate|aluminum sulfate|mesh-list
65680846|NCT04760743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65680847|NCT04760743|Immunologic Factors|immunologic factors|mesh-ancestor
65680848|NCT04760743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680849|NCT04760288|Pralsetinib|pralsetinib|mesh-list
65680850|NCT04760288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680851|NCT04756687|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65680852|NCT04756687|Dermatologic Agents|dermatologic agents|mesh-ancestor
65680853|NCT04756687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65680854|NCT04756687|Immunologic Factors|immunologic factors|mesh-ancestor
65680855|NCT04756687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680856|NCT04742738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65680857|NCT04742738|Aluminum sulfate|aluminum sulfate|mesh-list
65680858|NCT04742738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65680859|NCT04742738|Immunologic Factors|immunologic factors|mesh-ancestor
65680860|NCT04742738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680861|NCT04740671|Ranibizumab|ranibizumab|mesh-list
65680862|NCT04740671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65680863|NCT04740671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65680864|NCT04740671|Growth Substances|growth substances|mesh-ancestor
65680865|NCT04740671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680866|NCT04740671|Growth Inhibitors|growth inhibitors|mesh-ancestor
65680867|NCT04740671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680868|NCT04736199|Androgens|androgens|mesh-list
65680869|NCT04736199|Hormones|hormones|mesh-ancestor
65680870|NCT04736199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65680871|NCT04736199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680872|NCT04720157|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65680873|NCT04720157|177Lu-PSMA-617|177lu-psma-617|mesh-list
65680874|NCT04720157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65680875|NCT04720157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680876|NCT04706910|Furosemide|furosemide|mesh-list
65680877|NCT04706910|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
65680878|NCT04706910|Diuretics|diuretics|mesh-ancestor
65680879|NCT04706910|Natriuretic Agents|natriuretic agents|mesh-ancestor
65680880|NCT04706910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680881|NCT04706910|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65680882|NCT04706910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65680883|NCT04706910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680884|NCT04706910|Dopamine Agents|dopamine agents|mesh-ancestor
65680885|NCT04706910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65680886|NCT04704271|Dronabinol|dronabinol|mesh-list
65680887|NCT04704271|Hallucinogens|hallucinogens|mesh-ancestor
65680888|NCT04704271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680889|NCT04704271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65680890|NCT04704271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65680891|NCT04704271|Analgesics|analgesics|mesh-ancestor
65680892|NCT04704271|Sensory System Agents|sensory system agents|mesh-ancestor
65680893|NCT04704271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65680894|NCT04704271|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65680895|NCT04704271|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65680896|NCT04704271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65680897|NCT04704271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680898|NCT04704271|Hormones|hormones|mesh-ancestor
65680899|NCT04704271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65680900|NCT04680286|Methadone|methadone|mesh-list
65680901|NCT04680286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65680902|NCT04680286|Narcotics|narcotics|mesh-ancestor
65680903|NCT04680286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65680904|NCT04680286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680905|NCT04680286|Analgesics|analgesics|mesh-ancestor
65680906|NCT04680286|Sensory System Agents|sensory system agents|mesh-ancestor
65680907|NCT04680286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65680908|NCT04680286|Antitussive Agents|antitussive agents|mesh-ancestor
65680909|NCT04680286|Respiratory System Agents|respiratory system agents|mesh-ancestor
65680910|NCT04675762|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65680911|NCT04675762|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65680912|NCT04675762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680913|NCT04675762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65680914|NCT04675762|Immunologic Factors|immunologic factors|mesh-ancestor
65680915|NCT04675762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680916|NCT04672018|Omeprazole|omeprazole|mesh-list
65680917|NCT04672018|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65680918|NCT04672018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65680919|NCT04672018|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65680920|NCT04672018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680921|NCT04672018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680922|NCT04665570|Metformin|metformin|mesh-list
65680923|NCT04665570|Acarbose|acarbose|mesh-list
65680924|NCT04665570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65680925|NCT04665570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680926|NCT04665570|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65680927|NCT04665570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680928|NCT04665570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680929|NCT04657289|Ranibizumab|ranibizumab|mesh-list
65680930|NCT04657289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65680931|NCT04657289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65680932|NCT04657289|Growth Substances|growth substances|mesh-ancestor
65680933|NCT04657289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680934|NCT04657289|Growth Inhibitors|growth inhibitors|mesh-ancestor
65680935|NCT04657289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680936|NCT04656184|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65680937|NCT04656184|Immunoglobulins|immunoglobulins|mesh-list
65680938|NCT04656184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65680939|NCT04656184|Antibodies|antibodies|mesh-list
65680940|NCT04656184|gamma-Globulins|gamma-globulins|mesh-list
65680941|NCT04656184|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65680942|NCT04656184|Immunologic Factors|immunologic factors|mesh-ancestor
65680943|NCT04656184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680944|NCT04656184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65680945|NCT04644068|Paclitaxel|paclitaxel|mesh-list
65680946|NCT04644068|Carboplatin|carboplatin|mesh-list
65680947|NCT04644068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65680948|NCT04644068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680949|NCT04644068|Tubulin Modulators|tubulin modulators|mesh-ancestor
65680950|NCT04644068|Antimitotic Agents|antimitotic agents|mesh-ancestor
65680951|NCT04644068|Mitosis Modulators|mitosis modulators|mesh-ancestor
65680952|NCT04644068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680953|NCT04638881|Magnesium Sulfate|magnesium sulfate|mesh-list
65680954|NCT04638881|Analgesics|analgesics|mesh-ancestor
65680955|NCT04638881|Sensory System Agents|sensory system agents|mesh-ancestor
65680956|NCT04638881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65680957|NCT04638881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680958|NCT04638881|Anesthetics|anesthetics|mesh-ancestor
65478278|NCT01261832|Cilostazol|cilostazol|mesh-list
65680959|NCT04638881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65680960|NCT04638881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65680961|NCT04638881|Anticonvulsants|anticonvulsants|mesh-ancestor
65680962|NCT04638881|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65680963|NCT04638881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65680964|NCT04638881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680965|NCT04638881|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65680966|NCT04638881|Tocolytic Agents|tocolytic agents|mesh-ancestor
65680967|NCT04638881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65680968|NCT04627753|Rituximab|rituximab|mesh-list
65680969|NCT04627753|Lenalidomide|lenalidomide|mesh-list
65680970|NCT04627753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680971|NCT04627753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680972|NCT04627753|Immunologic Factors|immunologic factors|mesh-ancestor
65680973|NCT04627753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65680974|NCT04627753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65680975|NCT04627753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65680976|NCT04627753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65680977|NCT04627753|Growth Substances|growth substances|mesh-ancestor
65680978|NCT04627753|Growth Inhibitors|growth inhibitors|mesh-ancestor
65680979|NCT04624230|Tofacitinib|tofacitinib|mesh-list
65680980|NCT04624230|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65680981|NCT04624230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680982|NCT04624230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680983|NCT04603807|Crizotinib|crizotinib|mesh-list
65680984|NCT04603807|Entrectinib|entrectinib|mesh-list
65680985|NCT04603807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65680986|NCT04603807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65680987|NCT04603807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65680988|NCT04603807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65680989|NCT04603651|Bamlanivimab|bamlanivimab|mesh-list
65680990|NCT04603651|Antiviral Agents|antiviral agents|mesh-ancestor
65680991|NCT04603651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65680992|NCT04589845|Trastuzumab|trastuzumab|mesh-list
65680993|NCT04589845|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65680994|NCT04589845|Atezolizumab|atezolizumab|mesh-list
65680995|NCT04589845|Maytansine|maytansine|mesh-list
65680996|NCT04589845|Pralsetinib|pralsetinib|mesh-list
65680997|NCT04589845|Entrectinib|entrectinib|mesh-list
65680998|NCT04589845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65680999|NCT04589845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681000|NCT04589845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65681001|NCT04589845|Tubulin Modulators|tubulin modulators|mesh-ancestor
65681002|NCT04589845|Antimitotic Agents|antimitotic agents|mesh-ancestor
65681003|NCT04589845|Mitosis Modulators|mitosis modulators|mesh-ancestor
65681004|NCT04589845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681005|NCT04589845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65681006|NCT04589845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681007|NCT04586010|Teriflunomide|teriflunomide|mesh-list
65681008|NCT04586010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65681009|NCT04586010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65681010|NCT04586010|Analgesics|analgesics|mesh-ancestor
65681011|NCT04586010|Sensory System Agents|sensory system agents|mesh-ancestor
65681012|NCT04586010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65681013|NCT04586010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681014|NCT04586010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65681015|NCT04586010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65681016|NCT04586010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65681017|NCT04586010|Immunologic Factors|immunologic factors|mesh-ancestor
65681018|NCT04569032|Prednisone|prednisone|mesh-list
65681019|NCT04569032|Cyclophosphamide|cyclophosphamide|mesh-list
65681020|NCT04569032|Doxorubicin|doxorubicin|mesh-list
65681021|NCT04569032|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65681022|NCT04569032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65681023|NCT04569032|Immunologic Factors|immunologic factors|mesh-ancestor
65681024|NCT04569032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681025|NCT04569032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65681026|NCT04569032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65681027|NCT04569032|Alkylating Agents|alkylating agents|mesh-ancestor
65681028|NCT04569032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681029|NCT04569032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681030|NCT04569032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65681031|NCT04569032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65681032|NCT04569032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65681033|NCT04569032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65681034|NCT04569032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681035|NCT04569032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65681036|NCT04569032|Glucocorticoids|glucocorticoids|mesh-ancestor
65681038|NCT04569032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65681039|NCT04569032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65681040|NCT04569032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65681041|NCT04564612|Itraconazole|itraconazole|mesh-list
65681042|NCT04564612|Rabeprazole|rabeprazole|mesh-list
65681043|NCT04564612|Antifungal Agents|antifungal agents|mesh-ancestor
65681044|NCT04564612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65681045|NCT04564612|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65681046|NCT04564612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65681047|NCT04564612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681048|NCT04564612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681049|NCT04564612|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65681050|NCT04564612|Hormone Antagonists|hormone antagonists|mesh-ancestor
65681051|NCT04564612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65681052|NCT04564612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681053|NCT04564612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65681054|NCT04564612|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65681055|NCT04564612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65681056|NCT04564612|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65681057|NCT04557449|Letrozole|letrozole|mesh-list
65681058|NCT04557449|Fulvestrant|fulvestrant|mesh-list
65681059|NCT04557449|Midazolam|midazolam|mesh-list
65681060|NCT04557449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65681061|NCT04557449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65681062|NCT04557449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65681063|NCT04557449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681064|NCT04557449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65681065|NCT04557449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65681066|NCT04557449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65681067|NCT04557449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65681068|NCT04557449|Anesthetics, General|anesthetics, general|mesh-ancestor
65681069|NCT04557449|Anesthetics|anesthetics|mesh-ancestor
65681070|NCT04557449|GABA Modulators|gaba modulators|mesh-ancestor
65681071|NCT04557449|GABA Agents|gaba agents|mesh-ancestor
65681072|NCT04557449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65681073|NCT04557449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681074|NCT04557449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681075|NCT04557449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65681076|NCT04557449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65681077|NCT04557449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681078|NCT04557449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65681079|NCT04557449|Hormone Antagonists|hormone antagonists|mesh-ancestor
65681080|NCT04557449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65681081|NCT04557449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65681082|NCT04557449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65681083|NCT04549311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65681084|NCT04549311|Amoxicillin|amoxicillin|mesh-list
65681085|NCT04549311|Metronidazole|metronidazole|mesh-list
65681086|NCT04549311|Ciprofloxacin|ciprofloxacin|mesh-list
65681087|NCT04549311|Clavulanic Acids|clavulanic acids|mesh-list
65681088|NCT04549311|Clavulanic Acid|clavulanic acid|mesh-list
65681089|NCT04549311|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65681090|NCT04549311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65681091|NCT04549311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65681092|NCT04549311|Antitubercular Agents|antitubercular agents|mesh-ancestor
65681093|NCT04549311|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65681094|NCT04549311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65681095|NCT04549311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65681096|NCT04549311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65681097|NCT04549311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681098|NCT04549311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681099|NCT04549311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681100|NCT04549311|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65681101|NCT04549311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65681102|NCT04549311|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65681103|NCT04548999|Methylprednisolone|methylprednisolone|mesh-list
65681104|NCT04548999|Ocrelizumab|ocrelizumab|mesh-list
65681105|NCT04548999|Histamine Antagonists|histamine antagonists|mesh-list
65681106|NCT04548999|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
65681107|NCT04548999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65681108|NCT04548999|Antiemetics|antiemetics|mesh-ancestor
65478439|NCT01160432|Methadone|methadone|mesh-list
65681109|NCT04548999|Autonomic Agents|autonomic agents|mesh-ancestor
65681110|NCT04548999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65681111|NCT04548999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681112|NCT04548999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65681113|NCT04548999|Glucocorticoids|glucocorticoids|mesh-ancestor
65681114|NCT04548999|Hormones|hormones|mesh-ancestor
65681115|NCT04548999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65681116|NCT04548999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65681117|NCT04548999|Protective Agents|protective agents|mesh-ancestor
65681118|NCT04548999|Immunologic Factors|immunologic factors|mesh-ancestor
65681119|NCT04548999|Histamine Agents|histamine agents|mesh-ancestor
65681120|NCT04548999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65681121|NCT04548999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681122|NCT04545736|Metformin|metformin|mesh-list
65681123|NCT04545736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65681124|NCT04545736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681125|NCT04533451|Carboplatin|carboplatin|mesh-list
65681126|NCT04533451|Pembrolizumab|pembrolizumab|mesh-list
65681127|NCT04533451|Pemetrexed|pemetrexed|mesh-list
65681128|NCT04533451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681129|NCT04533451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65681130|NCT04533451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681131|NCT04533451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681132|NCT04533451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65681133|NCT04533451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65681134|NCT04520451|Glucocorticoids|glucocorticoids|mesh-list
65681135|NCT04520451|Hormones|hormones|mesh-ancestor
65681136|NCT04520451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65681137|NCT04520451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681138|NCT04518319|Olanzapine|olanzapine|mesh-list
65681139|NCT04518319|Antiemetics|antiemetics|mesh-ancestor
65681140|NCT04518319|Autonomic Agents|autonomic agents|mesh-ancestor
65681141|NCT04518319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65681142|NCT04518319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681143|NCT04518319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65681144|NCT04518319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65681145|NCT04518319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65681146|NCT04518319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65681147|NCT04518319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65681148|NCT04518319|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65681149|NCT04518319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65681150|NCT04518319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65681151|NCT04518319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681152|NCT04518319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65681153|NCT04518319|Serotonin Agents|serotonin agents|mesh-ancestor
65681154|NCT04516226|Chlorhexidine|chlorhexidine|mesh-list
65681155|NCT04516226|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65681156|NCT04516226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65681157|NCT04516226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65681158|NCT04516226|Disinfectants|disinfectants|mesh-ancestor
65681159|NCT04516226|Dermatologic Agents|dermatologic agents|mesh-ancestor
65681160|NCT04509674|Empagliflozin|empagliflozin|mesh-list
65681161|NCT04509674|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65681162|NCT04509674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681163|NCT04509674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65681164|NCT04509674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681165|NCT04496960|Tofacitinib|tofacitinib|mesh-list
65681166|NCT04496960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65681167|NCT04496960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681168|NCT04496960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681169|NCT04495868|Lidocaine|lidocaine|mesh-list
65681170|NCT04495868|Anesthetics, Local|anesthetics, local|mesh-ancestor
65681171|NCT04495868|Anesthetics|anesthetics|mesh-ancestor
65681172|NCT04495868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65681173|NCT04495868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681174|NCT04495868|Sensory System Agents|sensory system agents|mesh-ancestor
65681175|NCT04495868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65681176|NCT04495868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65681177|NCT04495868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65681178|NCT04495868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65681179|NCT04495868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65681180|NCT04495868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478507|NCT03876938|Serotonin Agents|serotonin agents|mesh-ancestor
65681181|NCT04483544|Pembrolizumab|pembrolizumab|mesh-list
65681182|NCT04483544|Olaparib|olaparib|mesh-list
65681183|NCT04483544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65681184|NCT04483544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681185|NCT04483544|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65681186|NCT04483544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681187|NCT04483544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681188|NCT04475029|Morphine|morphine|mesh-list
65681189|NCT04475029|Methadone|methadone|mesh-list
65681190|NCT04475029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65681191|NCT04475029|Narcotics|narcotics|mesh-ancestor
65681192|NCT04475029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65681193|NCT04475029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681194|NCT04475029|Analgesics|analgesics|mesh-ancestor
65681195|NCT04475029|Sensory System Agents|sensory system agents|mesh-ancestor
65681196|NCT04475029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65681197|NCT04475029|Antitussive Agents|antitussive agents|mesh-ancestor
65681198|NCT04475029|Respiratory System Agents|respiratory system agents|mesh-ancestor
65681199|NCT04457089|Simvastatin|simvastatin|mesh-list
65681200|NCT04457089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65681201|NCT04457089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65681202|NCT04457089|Antimetabolites|antimetabolites|mesh-ancestor
65681203|NCT04457089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681204|NCT04457089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65681205|NCT04457089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65681206|NCT04457089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681207|NCT04455750|Leuprolide|leuprolide|mesh-list
65681208|NCT04455750|Goserelin|goserelin|mesh-list
65681209|NCT04455750|Rucaparib|rucaparib|mesh-list
65681210|NCT04455750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65681211|NCT04455750|Fertility Agents|fertility agents|mesh-ancestor
65681212|NCT04455750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65681213|NCT04455750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681214|NCT04455750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65681215|NCT04455750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681216|NCT04455750|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65681217|NCT04455750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681218|NCT04455750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681219|NCT04449874|Bevacizumab|bevacizumab|mesh-list
65681220|NCT04449874|Cetuximab|cetuximab|mesh-list
65681221|NCT04449874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65681222|NCT04449874|Atezolizumab|atezolizumab|mesh-list
65681223|NCT04449874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65681224|NCT04449874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681225|NCT04449874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65681226|NCT04449874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65681227|NCT04449874|Growth Substances|growth substances|mesh-ancestor
65681228|NCT04449874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681229|NCT04449874|Growth Inhibitors|growth inhibitors|mesh-ancestor
65681230|NCT04449874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65681231|NCT04449874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681232|NCT04449874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681233|NCT04443062|177Lu-PSMA-617|177lu-psma-617|mesh-list
65681234|NCT04443062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65681235|NCT04443062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681236|NCT04404283|Rituximab|rituximab|mesh-list
65681237|NCT04404283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65681238|NCT04404283|Lenalidomide|lenalidomide|mesh-list
65681239|NCT04404283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65681240|NCT04404283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681241|NCT04404283|Immunologic Factors|immunologic factors|mesh-ancestor
65681242|NCT04404283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681243|NCT04404283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65681244|NCT04404283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65681245|NCT04404283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65681246|NCT04404283|Growth Substances|growth substances|mesh-ancestor
65681247|NCT04404283|Growth Inhibitors|growth inhibitors|mesh-ancestor
65681248|NCT04402385|Aspirin|aspirin|mesh-list
65681249|NCT04402385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65681250|NCT04402385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65681251|NCT04402385|Analgesics|analgesics|mesh-ancestor
65681252|NCT04402385|Sensory System Agents|sensory system agents|mesh-ancestor
65681253|NCT04402385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65681254|NCT04402385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681255|NCT04402385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65681256|NCT04402385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65681257|NCT04402385|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65681258|NCT04402385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65681259|NCT04402385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681260|NCT04402385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65681261|NCT04402385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65681262|NCT04402385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681263|NCT04402385|Antipyretics|antipyretics|mesh-ancestor
65681264|NCT04401761|Aspirin|aspirin|mesh-list
65681265|NCT04401761|Rivaroxaban|rivaroxaban|mesh-list
65681266|NCT04401761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65681267|NCT04401761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65681268|NCT04401761|Analgesics|analgesics|mesh-ancestor
65681269|NCT04401761|Sensory System Agents|sensory system agents|mesh-ancestor
65681270|NCT04401761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65681271|NCT04401761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681272|NCT04401761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65681273|NCT04401761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65681274|NCT04401761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65681275|NCT04401761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65681276|NCT04401761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681277|NCT04401761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65681278|NCT04401761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65681279|NCT04401761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681280|NCT04401761|Antipyretics|antipyretics|mesh-ancestor
65681281|NCT04401761|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65681282|NCT04401761|Antithrombins|antithrombins|mesh-ancestor
65681283|NCT04401761|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65681284|NCT04401761|Protease Inhibitors|protease inhibitors|mesh-ancestor
65681285|NCT04401761|Anticoagulants|anticoagulants|mesh-ancestor
65681286|NCT04396574|Lasmiditan|lasmiditan|mesh-list
65681287|NCT04396574|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65681288|NCT04396574|Serotonin Agents|serotonin agents|mesh-ancestor
65681289|NCT04396574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65681290|NCT04396574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681291|NCT04396574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681292|NCT04396236|Lasmiditan|lasmiditan|mesh-list
65681293|NCT04396236|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65681294|NCT04396236|Serotonin Agents|serotonin agents|mesh-ancestor
65681295|NCT04396236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65681296|NCT04396236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681297|NCT04396236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681298|NCT04389632|Pembrolizumab|pembrolizumab|mesh-list
65681299|NCT04389632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65681300|NCT04389632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681301|NCT04353661|Azithromycin|azithromycin|mesh-list
65681302|NCT04353661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65681303|NCT04353661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65681304|NCT04311502|Pyridoxine|pyridoxine|mesh-list
65681305|NCT04311502|Pyridoxal|pyridoxal|mesh-list
65681306|NCT04311502|Vitamin B 6|vitamin b 6|mesh-list
65681307|NCT04311502|Rifampin|rifampin|mesh-list
65681308|NCT04311502|Rifapentine|rifapentine|mesh-list
65681309|NCT04311502|Clofazimine|clofazimine|mesh-list
65681310|NCT04311502|Isoniazid|isoniazid|mesh-list
65681311|NCT04311502|Pyrazinamide|pyrazinamide|mesh-list
65681312|NCT04311502|Ethambutol|ethambutol|mesh-list
65681313|NCT04311502|Vitamins|vitamins|mesh-ancestor
65681314|NCT04311502|Micronutrients|micronutrients|mesh-ancestor
65681315|NCT04311502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681316|NCT04311502|Vitamin B Complex|vitamin b complex|mesh-ancestor
65681317|NCT04311502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65681318|NCT04311502|Antitubercular Agents|antitubercular agents|mesh-ancestor
65681319|NCT04311502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65681320|NCT04311502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65681321|NCT04311502|Leprostatic Agents|leprostatic agents|mesh-ancestor
65681322|NCT04311502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65681323|NCT04311502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681324|NCT04311502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681325|NCT04311502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65681326|NCT04311502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65681327|NCT04311502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65681328|NCT04311502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65681329|NCT04311502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65681330|NCT04311502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65681331|NCT04311502|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65681332|NCT04311502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65681333|NCT04311502|Antimetabolites|antimetabolites|mesh-ancestor
65681334|NCT04311502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65681335|NCT04311502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65681336|NCT04307485|Ticagrelor|ticagrelor|mesh-list
65681337|NCT04307485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65681338|NCT04307485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65681339|NCT04307485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65681340|NCT04307485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65681341|NCT04307485|Purinergic Agents|purinergic agents|mesh-ancestor
65681342|NCT04307485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65681343|NCT04307485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681344|NCT04307485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681345|NCT04302025|Atezolizumab|atezolizumab|mesh-list
65681346|NCT04302025|Vemurafenib|vemurafenib|mesh-list
65681347|NCT04302025|Pralsetinib|pralsetinib|mesh-list
65681348|NCT04302025|Entrectinib|entrectinib|mesh-list
65681349|NCT04302025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681350|NCT04302025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65681351|NCT04302025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681352|NCT04302025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681353|NCT04289467|Fenfluramine|fenfluramine|mesh-list
65681354|NCT04289467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65681355|NCT04289467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65681356|NCT04289467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65681357|NCT04289467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681358|NCT04289467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65681359|NCT04289467|Serotonin Agents|serotonin agents|mesh-ancestor
65681360|NCT04289467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681361|NCT04279574|Lithium Carbonate|lithium carbonate|mesh-list
65681362|NCT04279574|Antidepressive Agents|antidepressive agents|mesh-ancestor
65681363|NCT04279574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65681364|NCT04279574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681365|NCT04279574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681366|NCT04279574|Antimanic Agents|antimanic agents|mesh-ancestor
65681367|NCT04279574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65681368|NCT04279574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65681369|NCT04279574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681370|NCT04255433|Dulaglutide|dulaglutide|mesh-list
65681371|NCT04255433|Tirzepatide|tirzepatide|mesh-list
65681372|NCT04255433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65681373|NCT04255433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681374|NCT04255433|Incretins|incretins|mesh-ancestor
65681375|NCT04255433|Hormones|hormones|mesh-ancestor
65681376|NCT04255433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65681377|NCT04253561|Trastuzumab|trastuzumab|mesh-list
65681378|NCT04253561|Pertuzumab|pertuzumab|mesh-list
65681379|NCT04253561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65681380|NCT04253561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681381|NCT04248569|Nivolumab|nivolumab|mesh-list
65681382|NCT04248569|Ipilimumab|ipilimumab|mesh-list
65681383|NCT04248569|Poly ICLC|poly iclc|mesh-list
65681384|NCT04248569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65681385|NCT04248569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681386|NCT04248569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65681387|NCT04248569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681388|NCT04248569|Interferon Inducers|interferon inducers|mesh-ancestor
65681389|NCT04248569|Immunologic Factors|immunologic factors|mesh-ancestor
65681390|NCT04248569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681391|NCT04240171|Dapagliflozin|dapagliflozin|mesh-list
65681392|NCT04240171|Glimepiride|glimepiride|mesh-list
65681393|NCT04240171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65681394|NCT04240171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681395|NCT04240171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65681396|NCT04240171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681397|NCT04240171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65681398|NCT04240171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65681399|NCT04240171|Immunologic Factors|immunologic factors|mesh-ancestor
65681400|NCT04232553|Mirikizumab|mirikizumab|mesh-list
65681401|NCT04232553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65681402|NCT04232553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65681403|NCT04232553|Analgesics|analgesics|mesh-ancestor
65681404|NCT04232553|Sensory System Agents|sensory system agents|mesh-ancestor
65681405|NCT04232553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65681406|NCT04232553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681407|NCT04232553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65681408|NCT04232553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65681409|NCT04232553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65681410|NCT04232553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65681411|NCT04225598|Buprenorphine|buprenorphine|mesh-list
65681412|NCT04225598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65681413|NCT04225598|Narcotics|narcotics|mesh-ancestor
65681414|NCT04225598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65681415|NCT04225598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681416|NCT04225598|Analgesics|analgesics|mesh-ancestor
65681417|NCT04225598|Sensory System Agents|sensory system agents|mesh-ancestor
65681418|NCT04225598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65681419|NCT04225598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65681420|NCT04222972|Gemcitabine|gemcitabine|mesh-list
65681421|NCT04222972|Paclitaxel|paclitaxel|mesh-list
65681422|NCT04222972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65681423|NCT04222972|Carboplatin|carboplatin|mesh-list
65681424|NCT04222972|Pembrolizumab|pembrolizumab|mesh-list
65681425|NCT04222972|Pemetrexed|pemetrexed|mesh-list
65681426|NCT04222972|Pralsetinib|pralsetinib|mesh-list
65681427|NCT04222972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65681428|NCT04222972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681429|NCT04222972|Tubulin Modulators|tubulin modulators|mesh-ancestor
65681430|NCT04222972|Antimitotic Agents|antimitotic agents|mesh-ancestor
65681431|NCT04222972|Mitosis Modulators|mitosis modulators|mesh-ancestor
65681432|NCT04222972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681433|NCT04222972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65681434|NCT04222972|Antimetabolites|antimetabolites|mesh-ancestor
65681435|NCT04222972|Antiviral Agents|antiviral agents|mesh-ancestor
65681436|NCT04222972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65681437|NCT04222972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681438|NCT04222972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65681439|NCT04222972|Immunologic Factors|immunologic factors|mesh-ancestor
65681440|NCT04222972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681441|NCT04222972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65681442|NCT04222972|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65681443|NCT04222972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65681444|NCT04194944|Carboplatin|carboplatin|mesh-list
65681445|NCT04194944|Pembrolizumab|pembrolizumab|mesh-list
65681446|NCT04194944|Pemetrexed|pemetrexed|mesh-list
65681447|NCT04194944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681448|NCT04194944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65681449|NCT04194944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681450|NCT04194944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681451|NCT04194944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65681452|NCT04194944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65681453|NCT04191616|Dexamethasone|dexamethasone|mesh-list
65681454|NCT04191616|Pomalidomide|pomalidomide|mesh-list
65681455|NCT04191616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65681456|NCT04191616|Antiemetics|antiemetics|mesh-ancestor
65681457|NCT04191616|Autonomic Agents|autonomic agents|mesh-ancestor
65681458|NCT04191616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65681459|NCT04191616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681460|NCT04191616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65681461|NCT04191616|Glucocorticoids|glucocorticoids|mesh-ancestor
65681462|NCT04191616|Hormones|hormones|mesh-ancestor
65681463|NCT04191616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65681464|NCT04191616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65681465|NCT04191616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681466|NCT04191616|Immunologic Factors|immunologic factors|mesh-ancestor
65681467|NCT04191616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65681468|NCT04191616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65681469|NCT04191616|Growth Substances|growth substances|mesh-ancestor
65681470|NCT04191616|Growth Inhibitors|growth inhibitors|mesh-ancestor
65681471|NCT04180488|Histamine Antagonists|histamine antagonists|mesh-list
65681472|NCT04180488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
65681473|NCT04180488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
65681474|NCT04180488|Histamine Agents|histamine agents|mesh-ancestor
65681475|NCT04180488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65681476|NCT04180488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681477|NCT04180488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681478|NCT04170738|Amphetamine|amphetamine|mesh-list
65681479|NCT04170738|Adderall|adderall|mesh-list
65478803|NCT03871322|Vitamin D|vitamin d|mesh-list
65681480|NCT04170738|Dextroamphetamine|dextroamphetamine|mesh-list
65681481|NCT04170738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65681482|NCT04170738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681483|NCT04170738|Sympathomimetics|sympathomimetics|mesh-ancestor
65681484|NCT04170738|Autonomic Agents|autonomic agents|mesh-ancestor
65681485|NCT04170738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65681486|NCT04170738|Dopamine Agents|dopamine agents|mesh-ancestor
65681487|NCT04170738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65681488|NCT04170738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681489|NCT04170738|Adrenergic Agents|adrenergic agents|mesh-ancestor
65681490|NCT04170738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65681491|NCT04170738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65681492|NCT04170738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65681493|NCT04170738|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65681494|NCT04157335|Benralizumab|benralizumab|mesh-list
65681495|NCT04157335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65681496|NCT04157335|Respiratory System Agents|respiratory system agents|mesh-ancestor
65681497|NCT04094142|Lenalidomide|lenalidomide|mesh-list
65681498|NCT04094142|Acalabrutinib|acalabrutinib|mesh-list
65681499|NCT04094142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681500|NCT04094142|Immunologic Factors|immunologic factors|mesh-ancestor
65681501|NCT04094142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681502|NCT04094142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65681503|NCT04094142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65681504|NCT04094142|Growth Substances|growth substances|mesh-ancestor
65681505|NCT04094142|Growth Inhibitors|growth inhibitors|mesh-ancestor
65681506|NCT04089514|Adalimumab|adalimumab|mesh-list
65681507|NCT04089514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65681508|NCT04089514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65681509|NCT04088409|Adalimumab|adalimumab|mesh-list
65681510|NCT04088409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65681511|NCT04088409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65681512|NCT04086745|Adalimumab|adalimumab|mesh-list
65681513|NCT04086745|Etanercept|etanercept|mesh-list
65681514|NCT04086745|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
65681515|NCT04086745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65681516|NCT04086745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65681517|NCT04086745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65681518|NCT04086745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65681519|NCT04086745|Analgesics|analgesics|mesh-ancestor
65681520|NCT04086745|Sensory System Agents|sensory system agents|mesh-ancestor
65681521|NCT04086745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65681522|NCT04086745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681523|NCT04086745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65681524|NCT04086745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65681525|NCT04086745|Immunologic Factors|immunologic factors|mesh-ancestor
65681526|NCT04084314|Erenumab|erenumab|mesh-list
65681527|NCT04084314|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65681528|NCT04084314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681529|NCT04084314|Analgesics|analgesics|mesh-ancestor
65681530|NCT04084314|Sensory System Agents|sensory system agents|mesh-ancestor
65681531|NCT04084314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65681532|NCT04084314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681533|NCT04075266|Ocrelizumab|ocrelizumab|mesh-list
65681534|NCT04075266|Immunologic Factors|immunologic factors|mesh-ancestor
65681535|NCT04075266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681536|NCT04074746|Vidarabine|vidarabine|mesh-list
65681537|NCT04074746|Cyclophosphamide|cyclophosphamide|mesh-list
65681538|NCT04074746|Fludarabine|fludarabine|mesh-list
65681539|NCT04074746|Fludarabine phosphate|fludarabine phosphate|mesh-list
65681540|NCT04074746|Antibodies|antibodies|mesh-list
65681541|NCT04074746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65681542|NCT04074746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65681543|NCT04074746|Immunologic Factors|immunologic factors|mesh-ancestor
65681544|NCT04074746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681545|NCT04074746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65681546|NCT04074746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65681547|NCT04074746|Alkylating Agents|alkylating agents|mesh-ancestor
65681548|NCT04074746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681549|NCT04074746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681550|NCT04074746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65681551|NCT04074746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65681552|NCT04074746|Antimetabolites|antimetabolites|mesh-ancestor
65681553|NCT04074746|Antiviral Agents|antiviral agents|mesh-ancestor
65681554|NCT04074746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65681555|NCT04068207|Minocycline|minocycline|mesh-list
65681556|NCT04068207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65681557|NCT04068207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65681558|NCT04035005|Ocrelizumab|ocrelizumab|mesh-list
65681559|NCT04035005|Immunologic Factors|immunologic factors|mesh-ancestor
65681560|NCT04035005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681561|NCT04024761|Cyclophosphamide|cyclophosphamide|mesh-list
65681562|NCT04024761|Fludarabine|fludarabine|mesh-list
65681563|NCT04024761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65681564|NCT04024761|Immunologic Factors|immunologic factors|mesh-ancestor
65681565|NCT04024761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681566|NCT04024761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65681567|NCT04024761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65681568|NCT04024761|Alkylating Agents|alkylating agents|mesh-ancestor
65681569|NCT04024761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681570|NCT04024761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681571|NCT04024761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65681572|NCT04015180|Aflibercept|aflibercept|mesh-list
65681573|NCT04015180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65681574|NCT04015180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65681575|NCT04015180|Growth Substances|growth substances|mesh-ancestor
65681576|NCT04015180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681577|NCT04015180|Growth Inhibitors|growth inhibitors|mesh-ancestor
65681578|NCT04015180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681579|NCT04013854|Nivolumab|nivolumab|mesh-list
65681580|NCT04013854|Ipilimumab|ipilimumab|mesh-list
65681581|NCT04013854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65681582|NCT04013854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681583|NCT04013854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65681584|NCT04013854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681585|NCT04004988|Tirzepatide|tirzepatide|mesh-list
65681586|NCT04004988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65681587|NCT04004988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681588|NCT04004988|Incretins|incretins|mesh-ancestor
65681589|NCT04004988|Hormones|hormones|mesh-ancestor
65681590|NCT04004988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65681591|NCT03994627|Olaratumab|olaratumab|mesh-list
65681592|NCT03994627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681593|NCT03950817|Ketamine|ketamine|mesh-list
65681594|NCT03950817|Analgesics|analgesics|mesh-ancestor
65681595|NCT03950817|Sensory System Agents|sensory system agents|mesh-ancestor
65681596|NCT03950817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65681597|NCT03950817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681598|NCT03950817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65681599|NCT03950817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65681600|NCT03950817|Anesthetics, General|anesthetics, general|mesh-ancestor
65681601|NCT03950817|Anesthetics|anesthetics|mesh-ancestor
65681602|NCT03950817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65681603|NCT03950817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65681604|NCT03950817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65681605|NCT03950817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65681606|NCT03950817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681607|NCT03944772|Carboplatin|carboplatin|mesh-list
65681608|NCT03944772|Etoposide|etoposide|mesh-list
65681609|NCT03944772|Pemetrexed|pemetrexed|mesh-list
65681610|NCT03944772|Durvalumab|durvalumab|mesh-list
65681611|NCT03944772|Gefitinib|gefitinib|mesh-list
65681612|NCT03944772|Osimertinib|osimertinib|mesh-list
65681613|NCT03944772|Necitumumab|necitumumab|mesh-list
65681614|NCT03944772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681615|NCT03944772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65681616|NCT03944772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65681617|NCT03944772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65681618|NCT03944772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681619|NCT03944772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681620|NCT03944772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65681621|NCT03944772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65681622|NCT03944772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65681623|NCT03944772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65681624|NCT03934840|Prednisone|prednisone|mesh-list
65681625|NCT03934840|Carboplatin|carboplatin|mesh-list
65681626|NCT03934840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681627|NCT03934840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65681628|NCT03934840|Glucocorticoids|glucocorticoids|mesh-ancestor
65681629|NCT03934840|Hormones|hormones|mesh-ancestor
65681630|NCT03934840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65681631|NCT03934840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681632|NCT03934840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65681633|NCT03909165|Atropine|atropine|mesh-list
65681635|NCT03909165|Neostigmine|neostigmine|mesh-list
65681636|NCT03909165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65681637|NCT03909165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65681638|NCT03909165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65681639|NCT03909165|Autonomic Agents|autonomic agents|mesh-ancestor
65681640|NCT03909165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65681641|NCT03909165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681642|NCT03909165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65681643|NCT03909165|Respiratory System Agents|respiratory system agents|mesh-ancestor
65681644|NCT03909165|Mydriatics|mydriatics|mesh-ancestor
65681645|NCT03909165|Parasympatholytics|parasympatholytics|mesh-ancestor
65144300|NCT00598403|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
65681646|NCT03909165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65681647|NCT03909165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65681648|NCT03909165|Cholinergic Agents|cholinergic agents|mesh-ancestor
65681649|NCT03909165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65681650|NCT03909165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681651|NCT03909165|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65681652|NCT03909165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681653|NCT03909165|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65681654|NCT03879538|Nitrous Oxide|nitrous oxide|mesh-list
65681655|NCT03879538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65681656|NCT03879538|Anesthetics, General|anesthetics, general|mesh-ancestor
65681657|NCT03879538|Anesthetics|anesthetics|mesh-ancestor
65681658|NCT03879538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65681659|NCT03879538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681660|NCT03879538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65681661|NCT03879538|Analgesics|analgesics|mesh-ancestor
65681662|NCT03879538|Sensory System Agents|sensory system agents|mesh-ancestor
65681663|NCT03879538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65681664|NCT03850782|Bimatoprost|bimatoprost|mesh-list
65681665|NCT03850782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65681666|NCT03800134|Gemcitabine|gemcitabine|mesh-list
65681667|NCT03800134|Paclitaxel|paclitaxel|mesh-list
65681668|NCT03800134|Cisplatin|cisplatin|mesh-list
65681669|NCT03800134|Carboplatin|carboplatin|mesh-list
65681670|NCT03800134|Pemetrexed|pemetrexed|mesh-list
65681671|NCT03800134|Durvalumab|durvalumab|mesh-list
65681672|NCT03800134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65681673|NCT03800134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681674|NCT03800134|Tubulin Modulators|tubulin modulators|mesh-ancestor
65681675|NCT03800134|Antimitotic Agents|antimitotic agents|mesh-ancestor
65681676|NCT03800134|Mitosis Modulators|mitosis modulators|mesh-ancestor
65681677|NCT03800134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681678|NCT03800134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65681679|NCT03800134|Antimetabolites|antimetabolites|mesh-ancestor
65681680|NCT03800134|Antiviral Agents|antiviral agents|mesh-ancestor
65681681|NCT03800134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65681682|NCT03800134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681683|NCT03800134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65681684|NCT03800134|Immunologic Factors|immunologic factors|mesh-ancestor
65681685|NCT03800134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681686|NCT03800134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65681687|NCT03800134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65681688|NCT03800134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65681689|NCT03783442|Paclitaxel|paclitaxel|mesh-list
65681690|NCT03783442|Fluorouracil|fluorouracil|mesh-list
65681691|NCT03783442|Capecitabine|capecitabine|mesh-list
65681692|NCT03783442|Oxaliplatin|oxaliplatin|mesh-list
65681693|NCT03783442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65681694|NCT03783442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681695|NCT03783442|Tubulin Modulators|tubulin modulators|mesh-ancestor
65681696|NCT03783442|Antimitotic Agents|antimitotic agents|mesh-ancestor
65681697|NCT03783442|Mitosis Modulators|mitosis modulators|mesh-ancestor
65681698|NCT03783442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681699|NCT03783442|Antimetabolites|antimetabolites|mesh-ancestor
65681700|NCT03783442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65681701|NCT03783442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65681702|NCT03783442|Immunologic Factors|immunologic factors|mesh-ancestor
65681703|NCT03783442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681704|NCT03781765|Methylphenidate|methylphenidate|mesh-list
65681705|NCT03781765|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65681706|NCT03781765|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65681707|NCT03781765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681708|NCT03781765|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65681709|NCT03781765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65681710|NCT03781765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65681711|NCT03781765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681712|NCT03781765|Dopamine Agents|dopamine agents|mesh-ancestor
65681713|NCT03781765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65681714|NCT03781765|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65681715|NCT03781765|Adrenergic Agents|adrenergic agents|mesh-ancestor
65681716|NCT03781752|Methylphenidate|methylphenidate|mesh-list
65681717|NCT03781752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65681718|NCT03781752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681719|NCT03781752|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65681720|NCT03781752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65681721|NCT03781752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65681722|NCT03781752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681723|NCT03781752|Dopamine Agents|dopamine agents|mesh-ancestor
65681724|NCT03781752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65681725|NCT03772457|Rivaroxaban|rivaroxaban|mesh-list
65681726|NCT03772457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65681727|NCT03772457|Antithrombins|antithrombins|mesh-ancestor
65681728|NCT03772457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65681729|NCT03772457|Protease Inhibitors|protease inhibitors|mesh-ancestor
65681730|NCT03772457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681731|NCT03772457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681732|NCT03772457|Anticoagulants|anticoagulants|mesh-ancestor
65681733|NCT03761173|Anticoagulants|anticoagulants|mesh-list
65681734|NCT03718065|Lofexidine|lofexidine|mesh-list
65681735|NCT03718065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65681736|NCT03718065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65681737|NCT03718065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681738|NCT03718065|Sensory System Agents|sensory system agents|mesh-ancestor
65681739|NCT03718065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65681740|NCT03718065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65681741|NCT03718065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65681742|NCT03718065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65681743|NCT03718065|Adrenergic Agents|adrenergic agents|mesh-ancestor
65681744|NCT03718065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65681745|NCT03718065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681746|NCT03714958|Trametinib|trametinib|mesh-list
65681747|NCT03714958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681748|NCT03714958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65681749|NCT03714958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681750|NCT03714958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681751|NCT03708315|Dexmedetomidine|dexmedetomidine|mesh-list
65681752|NCT03708315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65681753|NCT03708315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65681754|NCT03708315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681755|NCT03708315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65681756|NCT03708315|Analgesics|analgesics|mesh-ancestor
65681757|NCT03708315|Sensory System Agents|sensory system agents|mesh-ancestor
65681758|NCT03708315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65681759|NCT03708315|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65681760|NCT03708315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65681761|NCT03708315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65681762|NCT03708315|Adrenergic Agents|adrenergic agents|mesh-ancestor
65681763|NCT03708315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65681764|NCT03708315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681765|NCT03693300|Durvalumab|durvalumab|mesh-list
65681766|NCT03693300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65681767|NCT03693300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681768|NCT03682536|Epoetin Alfa|epoetin alfa|mesh-list
65681769|NCT03682536|Luspatercept|luspatercept|mesh-list
65681770|NCT03682536|Hematinics|hematinics|mesh-ancestor
65681771|NCT03602586|Pembrolizumab|pembrolizumab|mesh-list
65681772|NCT03602586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65681773|NCT03602586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681774|NCT03599245|Ocrelizumab|ocrelizumab|mesh-list
65681775|NCT03599245|Immunologic Factors|immunologic factors|mesh-ancestor
65681776|NCT03599245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681777|NCT03593590|Ocrelizumab|ocrelizumab|mesh-list
65681778|NCT03593590|Immunologic Factors|immunologic factors|mesh-ancestor
65681779|NCT03593590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681780|NCT03582033|Dexamethasone|dexamethasone|mesh-list
65681781|NCT03582033|Pomalidomide|pomalidomide|mesh-list
65681782|NCT03582033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65681783|NCT03582033|Antiemetics|antiemetics|mesh-ancestor
65479100|NCT01169870|Paclitaxel|paclitaxel|mesh-list
65681784|NCT03582033|Autonomic Agents|autonomic agents|mesh-ancestor
65681785|NCT03582033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65681786|NCT03582033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681787|NCT03582033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65681788|NCT03582033|Glucocorticoids|glucocorticoids|mesh-ancestor
65681789|NCT03582033|Hormones|hormones|mesh-ancestor
65681790|NCT03582033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65681791|NCT03582033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65681792|NCT03582033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268747|NCT04218734|Metformin|metformin|mesh-list
65681793|NCT03582033|Immunologic Factors|immunologic factors|mesh-ancestor
65681794|NCT03582033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65681795|NCT03582033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65681796|NCT03582033|Growth Substances|growth substances|mesh-ancestor
65681797|NCT03582033|Growth Inhibitors|growth inhibitors|mesh-ancestor
65681798|NCT03579966|Amifampridine|amifampridine|mesh-list
65681799|NCT03579966|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65681800|NCT03579966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65681801|NCT03579966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681802|NCT03579966|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65681803|NCT03579966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65681804|NCT03579966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681805|NCT03551691|Omeprazole|omeprazole|mesh-list
65681806|NCT03551691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65681807|NCT03551691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65681808|NCT03551691|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65681809|NCT03551691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681810|NCT03551691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681811|NCT03543189|Nivolumab|nivolumab|mesh-list
65681812|NCT03543189|Androgens|androgens|mesh-list
65681813|NCT03543189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65681814|NCT03543189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681815|NCT03543189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65681816|NCT03543189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681817|NCT03543189|Hormones|hormones|mesh-ancestor
65681818|NCT03543189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65681819|NCT03543189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681820|NCT03519945|Mirikizumab|mirikizumab|mesh-list
65681821|NCT03519945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65681822|NCT03519945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65681823|NCT03519945|Analgesics|analgesics|mesh-ancestor
65681824|NCT03519945|Sensory System Agents|sensory system agents|mesh-ancestor
65681825|NCT03519945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65681826|NCT03519945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681827|NCT03519945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65681828|NCT03519945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65681829|NCT03519945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65681830|NCT03519945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65681831|NCT03510208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65681832|NCT03510208|Panitumumab|panitumumab|mesh-list
65681833|NCT03510208|Antibodies|antibodies|mesh-list
65681834|NCT03510208|Immunoglobulins|immunoglobulins|mesh-list
65681835|NCT03510208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65681836|NCT03510208|Immunologic Factors|immunologic factors|mesh-ancestor
65681837|NCT03510208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681838|NCT03510208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681839|NCT03508869|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65681840|NCT03508869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65681841|NCT03508869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65681842|NCT03508869|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65681843|NCT03508869|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65681844|NCT03508869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65681845|NCT03508869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65681846|NCT03508869|Adrenergic Agents|adrenergic agents|mesh-ancestor
65681847|NCT03508869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65681848|NCT03508869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681849|NCT03508869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681850|NCT03508869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65681851|NCT03508869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65681852|NCT03508869|Cholinergic Agents|cholinergic agents|mesh-ancestor
65681853|NCT03508869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65681854|NCT03508869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65681855|NCT03507699|Nivolumab|nivolumab|mesh-list
65681856|NCT03507699|Ipilimumab|ipilimumab|mesh-list
65681857|NCT03507699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65681858|NCT03507699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681859|NCT03507699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65681860|NCT03507699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681861|NCT03498716|Paclitaxel|paclitaxel|mesh-list
65681862|NCT03498716|Cyclophosphamide|cyclophosphamide|mesh-list
65681863|NCT03498716|Doxorubicin|doxorubicin|mesh-list
65681864|NCT03498716|Atezolizumab|atezolizumab|mesh-list
65681865|NCT03498716|Epirubicin|epirubicin|mesh-list
65681866|NCT03498716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65681867|NCT03498716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681868|NCT03498716|Tubulin Modulators|tubulin modulators|mesh-ancestor
65681869|NCT03498716|Antimitotic Agents|antimitotic agents|mesh-ancestor
65681870|NCT03498716|Mitosis Modulators|mitosis modulators|mesh-ancestor
65681871|NCT03498716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681872|NCT03498716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65681873|NCT03498716|Immunologic Factors|immunologic factors|mesh-ancestor
65681874|NCT03498716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681875|NCT03498716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65681876|NCT03498716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65681877|NCT03498716|Alkylating Agents|alkylating agents|mesh-ancestor
65681878|NCT03498716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65681879|NCT03498716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65681880|NCT03498716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65681881|NCT03498716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65681882|NCT03498716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681883|NCT03497923|Magnesium Sulfate|magnesium sulfate|mesh-list
65681884|NCT03497923|Analgesics|analgesics|mesh-ancestor
65681885|NCT03497923|Sensory System Agents|sensory system agents|mesh-ancestor
65681886|NCT03497923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65681887|NCT03497923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681888|NCT03497923|Anesthetics|anesthetics|mesh-ancestor
65681889|NCT03497923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65681890|NCT03497923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65681891|NCT03497923|Anticonvulsants|anticonvulsants|mesh-ancestor
65681892|NCT03497923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65681893|NCT03497923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65681894|NCT03497923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681895|NCT03497923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65681896|NCT03497923|Tocolytic Agents|tocolytic agents|mesh-ancestor
65681897|NCT03497923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65681898|NCT03493685|Irbesartan|irbesartan|mesh-list
65681899|NCT03493685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65681900|NCT03493685|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65681901|NCT03493685|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65681902|NCT03493685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681903|NCT03387423|Tofacitinib|tofacitinib|mesh-list
65681904|NCT03387423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65681905|NCT03387423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681906|NCT03387423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681907|NCT03383692|Ritonavir|ritonavir|mesh-list
65681908|NCT03383692|Itraconazole|itraconazole|mesh-list
65681909|NCT03383692|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65681910|NCT03383692|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65681911|NCT03383692|Protease Inhibitors|protease inhibitors|mesh-ancestor
65681912|NCT03383692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681913|NCT03383692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681914|NCT03383692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65681915|NCT03383692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65681916|NCT03383692|Antiviral Agents|antiviral agents|mesh-ancestor
65681917|NCT03383692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65681918|NCT03383692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65681919|NCT03383692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65681920|NCT03383692|Antifungal Agents|antifungal agents|mesh-ancestor
65681921|NCT03383692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65681922|NCT03383692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65681923|NCT03383692|Hormone Antagonists|hormone antagonists|mesh-ancestor
65681924|NCT03383692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65681925|NCT03383692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681926|NCT03377387|Capecitabine|capecitabine|mesh-list
65681927|NCT03377387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65681928|NCT03377387|Antimetabolites|antimetabolites|mesh-ancestor
65681929|NCT03377387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479312|NCT03349268|Xenon|xenon|mesh-list
65681930|NCT03377387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681931|NCT03372837|Rituximab|rituximab|mesh-list
65681932|NCT03372837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65681933|NCT03372837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681934|NCT03372837|Immunologic Factors|immunologic factors|mesh-ancestor
65681935|NCT03372837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681936|NCT03372837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65681937|NCT03312699|Vaccines|vaccines|mesh-list
65681938|NCT03312699|Immunologic Factors|immunologic factors|mesh-ancestor
65681939|NCT03312699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681940|NCT03300557|Exemestane|exemestane|mesh-list
65681941|NCT03300557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681942|NCT03300557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65681943|NCT03300557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65681944|NCT03300557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681945|NCT03300557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681946|NCT03300557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65681947|NCT03300557|Hormone Antagonists|hormone antagonists|mesh-ancestor
65681948|NCT03300557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65681949|NCT03300557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681950|NCT03290079|Pembrolizumab|pembrolizumab|mesh-list
65681951|NCT03290079|Lenvatinib|lenvatinib|mesh-list
65681952|NCT03290079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65681953|NCT03290079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681954|NCT03290079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65681955|NCT03290079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681956|NCT03290079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681957|NCT03269136|Thalidomide|thalidomide|mesh-list
65681958|NCT03269136|Dexamethasone|dexamethasone|mesh-list
65681959|NCT03269136|Dexamethasone acetate|dexamethasone acetate|mesh-list
65681960|NCT03269136|Lenalidomide|lenalidomide|mesh-list
65681961|NCT03269136|Pomalidomide|pomalidomide|mesh-list
65681962|NCT03269136|Antibodies|antibodies|mesh-list
65681963|NCT03269136|Immunoglobulins|immunoglobulins|mesh-list
65681964|NCT03269136|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65681965|NCT03269136|BB 1101|bb 1101|mesh-list
65681966|NCT03269136|Immunologic Factors|immunologic factors|mesh-ancestor
65681967|NCT03269136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65681968|NCT03269136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65681969|NCT03269136|Antiemetics|antiemetics|mesh-ancestor
65681970|NCT03269136|Autonomic Agents|autonomic agents|mesh-ancestor
65681971|NCT03269136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65681972|NCT03269136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65681973|NCT03269136|Glucocorticoids|glucocorticoids|mesh-ancestor
65681974|NCT03269136|Hormones|hormones|mesh-ancestor
65681975|NCT03269136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65681976|NCT03269136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65681977|NCT03269136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65681978|NCT03269136|Protease Inhibitors|protease inhibitors|mesh-ancestor
65681979|NCT03269136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65681980|NCT03269136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681981|NCT03269136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65681982|NCT03269136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65681983|NCT03269136|Growth Substances|growth substances|mesh-ancestor
65681984|NCT03269136|Growth Inhibitors|growth inhibitors|mesh-ancestor
65681985|NCT03269136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65681986|NCT03269136|Leprostatic Agents|leprostatic agents|mesh-ancestor
65681987|NCT03269136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65681988|NCT03269136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65681989|NCT03261284|Heparin|heparin|mesh-list
65681990|NCT03261284|Calcium heparin|calcium heparin|mesh-list
65681991|NCT03261284|Anticoagulants|anticoagulants|mesh-ancestor
65681992|NCT03261284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65681993|NCT03261284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65681994|NCT03261284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681995|NCT03238326|Brexpiprazole|brexpiprazole|mesh-list
65681996|NCT03238326|Serotonin Agents|serotonin agents|mesh-ancestor
65681997|NCT03238326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65681998|NCT03238326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65681999|NCT03238326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682000|NCT03238326|Dopamine Agonists|dopamine agonists|mesh-ancestor
65682001|NCT03238326|Dopamine Agents|dopamine agents|mesh-ancestor
65682002|NCT03219450|Cyclophosphamide|cyclophosphamide|mesh-list
65682003|NCT03219450|Pembrolizumab|pembrolizumab|mesh-list
65682004|NCT03219450|Immunologic Factors|immunologic factors|mesh-ancestor
65682005|NCT03219450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682006|NCT03219450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65682007|NCT03219450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65682008|NCT03219450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65682009|NCT03219450|Alkylating Agents|alkylating agents|mesh-ancestor
65268751|NCT04066478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65682010|NCT03219450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682011|NCT03219450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682012|NCT03219450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65682013|NCT03219450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65682014|NCT03198078|Aripiprazole|aripiprazole|mesh-list
65682015|NCT03198078|Brexpiprazole|brexpiprazole|mesh-list
65682016|NCT03198078|Antidepressive Agents|antidepressive agents|mesh-ancestor
65682017|NCT03198078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65682018|NCT03198078|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65682019|NCT03198078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65682020|NCT03198078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65682021|NCT03198078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682022|NCT03198078|Dopamine Agonists|dopamine agonists|mesh-ancestor
65682023|NCT03198078|Dopamine Agents|dopamine agents|mesh-ancestor
65682024|NCT03198078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65682025|NCT03198078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682026|NCT03198078|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65682027|NCT03198078|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65682028|NCT03198078|Serotonin Agents|serotonin agents|mesh-ancestor
65682029|NCT03198078|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65682030|NCT03198078|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65682031|NCT03198078|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65682032|NCT03198078|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65682033|NCT03198026|Obinutuzumab|obinutuzumab|mesh-list
65682034|NCT03198026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65682035|NCT03198026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682036|NCT03177291|Pirfenidone|pirfenidone|mesh-list
65682037|NCT03177291|Paclitaxel|paclitaxel|mesh-list
65682038|NCT03177291|Carboplatin|carboplatin|mesh-list
65682039|NCT03177291|Pemetrexed|pemetrexed|mesh-list
65682040|NCT03177291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65682041|NCT03177291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682042|NCT03177291|Tubulin Modulators|tubulin modulators|mesh-ancestor
65682043|NCT03177291|Antimitotic Agents|antimitotic agents|mesh-ancestor
65682044|NCT03177291|Mitosis Modulators|mitosis modulators|mesh-ancestor
65682045|NCT03177291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682046|NCT03177291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682047|NCT03177291|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65682048|NCT03177291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65682049|NCT03177291|Analgesics|analgesics|mesh-ancestor
65682050|NCT03177291|Sensory System Agents|sensory system agents|mesh-ancestor
65682051|NCT03177291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65682052|NCT03177291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682053|NCT03177291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65682054|NCT03177291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65682055|NCT03177291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65682056|NCT03177291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65682057|NCT03127267|Riluzole|riluzole|mesh-list
65682058|NCT03127267|Anticonvulsants|anticonvulsants|mesh-ancestor
65682059|NCT03127267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65682060|NCT03127267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65682061|NCT03127267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65682062|NCT03127267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682063|NCT03127267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682064|NCT03127267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65682065|NCT03127267|Protective Agents|protective agents|mesh-ancestor
65682066|NCT03099174|Letrozole|letrozole|mesh-list
65682067|NCT03099174|Fulvestrant|fulvestrant|mesh-list
65682068|NCT03099174|Anastrozole|anastrozole|mesh-list
65682069|NCT03099174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682070|NCT03099174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65682071|NCT03099174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65682072|NCT03099174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682073|NCT03099174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682074|NCT03099174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65682075|NCT03099174|Hormone Antagonists|hormone antagonists|mesh-ancestor
65682076|NCT03099174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65479397|NCT02965690|Cimetidine|cimetidine|mesh-list
65682077|NCT03099174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682078|NCT03099174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65682079|NCT03099174|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65682080|NCT03092466|Ropivacaine|ropivacaine|mesh-list
65682081|NCT03092466|Anesthetics, Local|anesthetics, local|mesh-ancestor
65682082|NCT03092466|Anesthetics|anesthetics|mesh-ancestor
65682083|NCT03092466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65682084|NCT03092466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682085|NCT03092466|Sensory System Agents|sensory system agents|mesh-ancestor
65682086|NCT03092466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65682087|NCT03085810|Ocrelizumab|ocrelizumab|mesh-list
65682088|NCT03085810|Immunologic Factors|immunologic factors|mesh-ancestor
65682089|NCT03085810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682090|NCT03043313|Trastuzumab|trastuzumab|mesh-list
65682091|NCT03043313|Tucatinib|tucatinib|mesh-list
65682092|NCT03043313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65682093|NCT03043313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682094|NCT03043313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65682095|NCT03043313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682096|NCT03043313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682097|NCT03017872|Ritonavir|ritonavir|mesh-list
65682098|NCT03017872|Darunavir|darunavir|mesh-list
65682099|NCT03017872|Dolutegravir|dolutegravir|mesh-list
65682100|NCT03017872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65682101|NCT03017872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65682102|NCT03017872|Protease Inhibitors|protease inhibitors|mesh-ancestor
65682103|NCT03017872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682104|NCT03017872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682105|NCT03017872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65682106|NCT03017872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65682107|NCT03017872|Antiviral Agents|antiviral agents|mesh-ancestor
65682108|NCT03017872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65682109|NCT03017872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65682110|NCT03017872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65682111|NCT03017872|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65682112|NCT03017872|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65682113|NCT03006172|Metformin|metformin|mesh-list
65682114|NCT03006172|Trastuzumab|trastuzumab|mesh-list
65682115|NCT03006172|Pertuzumab|pertuzumab|mesh-list
65682116|NCT03006172|Letrozole|letrozole|mesh-list
65682117|NCT03006172|Fulvestrant|fulvestrant|mesh-list
65682118|NCT03006172|Palbociclib|palbociclib|mesh-list
65682119|NCT03006172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65682120|NCT03006172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682121|NCT03006172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65682122|NCT03006172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682123|NCT03006172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65682124|NCT03006172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65682125|NCT03006172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682126|NCT03006172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682127|NCT03006172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65682128|NCT03006172|Hormone Antagonists|hormone antagonists|mesh-ancestor
65682129|NCT03006172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65682130|NCT03006172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65682131|NCT03006172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65682132|NCT03006172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65682133|NCT03000439|Tofacitinib|tofacitinib|mesh-list
65682134|NCT03000439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65682135|NCT03000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682136|NCT03000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682137|NCT03000205|Lidocaine|lidocaine|mesh-list
65682138|NCT03000205|Anesthetics, Local|anesthetics, local|mesh-ancestor
65682139|NCT03000205|Anesthetics|anesthetics|mesh-ancestor
65682140|NCT03000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65682141|NCT03000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682142|NCT03000205|Sensory System Agents|sensory system agents|mesh-ancestor
65682143|NCT03000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65682144|NCT03000205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65682145|NCT03000205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65682146|NCT03000205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65682147|NCT03000205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65682148|NCT03000205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682149|NCT02942095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65682150|NCT02942095|Ixazomib|ixazomib|mesh-list
65682151|NCT02942095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682152|NCT02942095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65682153|NCT02942095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682154|NCT02942095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682155|NCT02942095|Protease Inhibitors|protease inhibitors|mesh-ancestor
65682156|NCT02882282|Pembrolizumab|pembrolizumab|mesh-list
65682157|NCT02882282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65682158|NCT02882282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682159|NCT02872467|Oxytocin|oxytocin|mesh-list
65682160|NCT02872467|Oxytocics|oxytocics|mesh-ancestor
65682161|NCT02872467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65682162|NCT02872467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682163|NCT02872116|Leucovorin|leucovorin|mesh-list
65682164|NCT02872116|Fluorouracil|fluorouracil|mesh-list
65682165|NCT02872116|Capecitabine|capecitabine|mesh-list
65682166|NCT02872116|Oxaliplatin|oxaliplatin|mesh-list
65682167|NCT02872116|Nivolumab|nivolumab|mesh-list
65682168|NCT02872116|Ipilimumab|ipilimumab|mesh-list
65682169|NCT02872116|Antimetabolites|antimetabolites|mesh-ancestor
65682170|NCT02872116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682171|NCT02872116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65682172|NCT02872116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682173|NCT02872116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65682174|NCT02872116|Immunologic Factors|immunologic factors|mesh-ancestor
65682175|NCT02872116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682176|NCT02872116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65682177|NCT02872116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65682178|NCT02872116|Antidotes|antidotes|mesh-ancestor
65682179|NCT02872116|Protective Agents|protective agents|mesh-ancestor
65682180|NCT02872116|Vitamin B Complex|vitamin b complex|mesh-ancestor
65682181|NCT02872116|Vitamins|vitamins|mesh-ancestor
65682182|NCT02872116|Micronutrients|micronutrients|mesh-ancestor
65682183|NCT02800785|Moxifloxacin|moxifloxacin|mesh-list
65682184|NCT02800785|Metronidazole|metronidazole|mesh-list
65682185|NCT02800785|Ciprofloxacin|ciprofloxacin|mesh-list
65682186|NCT02800785|Levofloxacin|levofloxacin|mesh-list
65682187|NCT02800785|Ceftriaxone|ceftriaxone|mesh-list
65682188|NCT02800785|Cefazolin|cefazolin|mesh-list
65682189|NCT02800785|Clavulanic Acids|clavulanic acids|mesh-list
65682190|NCT02800785|Clavulanic Acid|clavulanic acid|mesh-list
65682191|NCT02800785|Cefuroxime|cefuroxime|mesh-list
65682192|NCT02800785|Ertapenem|ertapenem|mesh-list
65682193|NCT02800785|Tigecycline|tigecycline|mesh-list
65682194|NCT02800785|Cefotaxime|cefotaxime|mesh-list
65682195|NCT02800785|Cefoxitin|cefoxitin|mesh-list
65682196|NCT02800785|Ticarcillin|ticarcillin|mesh-list
65682197|NCT02800785|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
65682198|NCT02800785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65682199|NCT02800785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65682200|NCT02800785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65682201|NCT02800785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65682202|NCT02800785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682203|NCT02800785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682204|NCT02800785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682205|NCT02800785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65682206|NCT02800785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65682207|NCT02800785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65682208|NCT02800785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65682209|NCT02800785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65682210|NCT02800785|Renal Agents|renal agents|mesh-ancestor
65682211|NCT02800785|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65682212|NCT02800785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65682213|NCT02781519|Dronabinol|dronabinol|mesh-list
65682214|NCT02781519|Hallucinogens|hallucinogens|mesh-ancestor
65682215|NCT02781519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682216|NCT02781519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65682217|NCT02781519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65682218|NCT02781519|Analgesics|analgesics|mesh-ancestor
65682219|NCT02781519|Sensory System Agents|sensory system agents|mesh-ancestor
65682220|NCT02781519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65682221|NCT02781519|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65682222|NCT02781519|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65682223|NCT02781519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65682224|NCT02781519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682225|NCT02781519|Hormones|hormones|mesh-ancestor
65682226|NCT02781519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65682227|NCT02780583|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65682228|NCT02780583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65682229|NCT02706353|Pembrolizumab|pembrolizumab|mesh-list
65682230|NCT02706353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65682231|NCT02706353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682232|NCT02667587|Nivolumab|nivolumab|mesh-list
65682233|NCT02667587|Temozolomide|temozolomide|mesh-list
65682234|NCT02667587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65682235|NCT02667587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682236|NCT02667587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65682237|NCT02667587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682238|NCT02667587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65682239|NCT02667587|Alkylating Agents|alkylating agents|mesh-ancestor
65682240|NCT02650401|Entrectinib|entrectinib|mesh-list
65682241|NCT02650401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65682242|NCT02650401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682243|NCT02650401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682244|NCT02638090|Pembrolizumab|pembrolizumab|mesh-list
65682245|NCT02638090|Vorinostat|vorinostat|mesh-list
65682246|NCT02638090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65682247|NCT02638090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682248|NCT02638090|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65682249|NCT02638090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682250|NCT02638090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682251|NCT02617277|Durvalumab|durvalumab|mesh-list
65682252|NCT02617277|Adavosertib|adavosertib|mesh-list
65682253|NCT02617277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65682254|NCT02617277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682255|NCT02617277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682256|NCT02617277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682257|NCT02584465|Tamoxifen|tamoxifen|mesh-list
65682258|NCT02584465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65682259|NCT02584465|Hormone Antagonists|hormone antagonists|mesh-ancestor
65682260|NCT02584465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65682261|NCT02584465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682262|NCT02584465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65682263|NCT02584465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682264|NCT02584465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65682265|NCT02584465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65682266|NCT02584465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65682267|NCT02536664|Rituximab|rituximab|mesh-list
65682268|NCT02536664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65682269|NCT02536664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682270|NCT02536664|Immunologic Factors|immunologic factors|mesh-ancestor
65682271|NCT02536664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682272|NCT02536664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65682273|NCT02520154|Paclitaxel|paclitaxel|mesh-list
65682274|NCT02520154|Carboplatin|carboplatin|mesh-list
65682275|NCT02520154|Pembrolizumab|pembrolizumab|mesh-list
65682276|NCT02520154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65682277|NCT02520154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65682278|NCT02520154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682279|NCT02520154|Tubulin Modulators|tubulin modulators|mesh-ancestor
65682280|NCT02520154|Antimitotic Agents|antimitotic agents|mesh-ancestor
65682281|NCT02520154|Mitosis Modulators|mitosis modulators|mesh-ancestor
65682282|NCT02520154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682283|NCT02520154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65682284|NCT02426892|Nivolumab|nivolumab|mesh-list
65682285|NCT02426892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65682286|NCT02426892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682287|NCT02426892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65682288|NCT02426892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682289|NCT02375555|Dexamethasone|dexamethasone|mesh-list
65682290|NCT02375555|Lenalidomide|lenalidomide|mesh-list
65682291|NCT02375555|Bortezomib|bortezomib|mesh-list
65682292|NCT02375555|Elotuzumab|elotuzumab|mesh-list
65682293|NCT02375555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65682294|NCT02375555|Antiemetics|antiemetics|mesh-ancestor
65682295|NCT02375555|Autonomic Agents|autonomic agents|mesh-ancestor
65682296|NCT02375555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65682297|NCT02375555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682298|NCT02375555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65682299|NCT02375555|Glucocorticoids|glucocorticoids|mesh-ancestor
65682300|NCT02375555|Hormones|hormones|mesh-ancestor
65682301|NCT02375555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65682302|NCT02375555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65682303|NCT02375555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682304|NCT02375555|Immunologic Factors|immunologic factors|mesh-ancestor
65682305|NCT02375555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65682306|NCT02375555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65682307|NCT02375555|Growth Substances|growth substances|mesh-ancestor
65682308|NCT02375555|Growth Inhibitors|growth inhibitors|mesh-ancestor
65682310|NCT02364713|Paclitaxel|paclitaxel|mesh-list
65682311|NCT02364713|Bevacizumab|bevacizumab|mesh-list
65682312|NCT02364713|Doxorubicin|doxorubicin|mesh-list
65682313|NCT02364713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65682314|NCT02364713|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65682315|NCT02364713|Topotecan|topotecan|mesh-list
65682316|NCT02364713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65682317|NCT02364713|Endothelial Growth Factors|endothelial growth factors|mesh-list
65682318|NCT02364713|Antibodies|antibodies|mesh-list
65682319|NCT02364713|Immunoglobulins|immunoglobulins|mesh-list
65682320|NCT02364713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65682321|NCT02364713|Immunoglobulin G|immunoglobulin g|mesh-list
65682322|NCT02364713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65682323|NCT02364713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682324|NCT02364713|Tubulin Modulators|tubulin modulators|mesh-ancestor
65682325|NCT02364713|Antimitotic Agents|antimitotic agents|mesh-ancestor
65682326|NCT02364713|Mitosis Modulators|mitosis modulators|mesh-ancestor
65682327|NCT02364713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682328|NCT02364713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65682329|NCT02364713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65682330|NCT02364713|Growth Substances|growth substances|mesh-ancestor
65682331|NCT02364713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682332|NCT02364713|Growth Inhibitors|growth inhibitors|mesh-ancestor
65682333|NCT02364713|Immunologic Factors|immunologic factors|mesh-ancestor
65682334|NCT02364713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65682335|NCT02364713|Antimetabolites|antimetabolites|mesh-ancestor
65682336|NCT02364713|Antiviral Agents|antiviral agents|mesh-ancestor
65682337|NCT02364713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65682338|NCT02364713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682339|NCT02364713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65682340|NCT02364713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65682341|NCT02364713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65682342|NCT02364713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65682343|NCT02364713|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65682344|NCT02333370|Tamoxifen|tamoxifen|mesh-list
65682345|NCT02333370|Letrozole|letrozole|mesh-list
65682346|NCT02333370|Fulvestrant|fulvestrant|mesh-list
65682347|NCT02333370|Goserelin|goserelin|mesh-list
65682348|NCT02333370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682349|NCT02333370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65682350|NCT02333370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65682351|NCT02333370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682352|NCT02333370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682353|NCT02333370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65682354|NCT02333370|Hormone Antagonists|hormone antagonists|mesh-ancestor
65682355|NCT02333370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65682356|NCT02333370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682357|NCT02333370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65682358|NCT02333370|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65682359|NCT02333370|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65682360|NCT02333370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65682361|NCT02333370|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65682362|NCT02307812|Paclitaxel|paclitaxel|mesh-list
65682363|NCT02307812|Ramucirumab|ramucirumab|mesh-list
65682364|NCT02307812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65682365|NCT02307812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682366|NCT02307812|Tubulin Modulators|tubulin modulators|mesh-ancestor
65682367|NCT02307812|Antimitotic Agents|antimitotic agents|mesh-ancestor
65682368|NCT02307812|Mitosis Modulators|mitosis modulators|mesh-ancestor
65682369|NCT02307812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682370|NCT02246621|Letrozole|letrozole|mesh-list
65682371|NCT02246621|Anastrozole|anastrozole|mesh-list
65682372|NCT02246621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682373|NCT02246621|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65682374|NCT02246621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65682375|NCT02246621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682376|NCT02246621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682377|NCT02246621|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65682378|NCT02246621|Hormone Antagonists|hormone antagonists|mesh-ancestor
65682379|NCT02246621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65682380|NCT02246621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682381|NCT02246621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65682383|NCT02231775|Dabrafenib|dabrafenib|mesh-list
65682384|NCT02231775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682385|NCT02231775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65682386|NCT02231775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682387|NCT02231775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682388|NCT02107703|Fulvestrant|fulvestrant|mesh-list
65682389|NCT02107703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65682390|NCT02107703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682391|NCT02107703|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65682392|NCT02107703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65682393|NCT02107703|Hormone Antagonists|hormone antagonists|mesh-ancestor
65682394|NCT02107703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65682395|NCT02107703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682396|NCT02094625|Acetylcysteine|acetylcysteine|mesh-list
65682397|NCT02094625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65682398|NCT02094625|Antiviral Agents|antiviral agents|mesh-ancestor
65682399|NCT02094625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65682400|NCT02094625|Expectorants|expectorants|mesh-ancestor
65682401|NCT02094625|Respiratory System Agents|respiratory system agents|mesh-ancestor
65682402|NCT02094625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65682403|NCT02094625|Antioxidants|antioxidants|mesh-ancestor
65682404|NCT02094625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682405|NCT02094625|Protective Agents|protective agents|mesh-ancestor
65682406|NCT02094625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682407|NCT02094625|Antidotes|antidotes|mesh-ancestor
65682408|NCT02091141|Trastuzumab|trastuzumab|mesh-list
65682409|NCT02091141|Pertuzumab|pertuzumab|mesh-list
65682410|NCT02091141|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65682411|NCT02091141|Atezolizumab|atezolizumab|mesh-list
65682412|NCT02091141|Vemurafenib|vemurafenib|mesh-list
65682413|NCT02091141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65682414|NCT02091141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682415|NCT02091141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65682416|NCT02091141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682417|NCT02091141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682418|NCT02065765|Ramucirumab|ramucirumab|mesh-list
65682419|NCT02065765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682420|NCT02054520|Pembrolizumab|pembrolizumab|mesh-list
65682421|NCT02054520|Nivolumab|nivolumab|mesh-list
65682422|NCT02054520|Ipilimumab|ipilimumab|mesh-list
65682423|NCT02054520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65682424|NCT02054520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682425|NCT02054520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65682426|NCT02054520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682427|NCT01922921|polysaccharide-K|polysaccharide-k|mesh-list
65682428|NCT01922921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65682429|NCT01922921|Trastuzumab|trastuzumab|mesh-list
65682430|NCT01922921|Pertuzumab|pertuzumab|mesh-list
65682431|NCT01922921|Antibodies|antibodies|mesh-list
65682432|NCT01922921|Immunoglobulins|immunoglobulins|mesh-list
65682433|NCT01922921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65682434|NCT01922921|Immunologic Factors|immunologic factors|mesh-ancestor
65682435|NCT01922921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682436|NCT01922921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682437|NCT01922921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65682438|NCT01922921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65682439|NCT01922921|Antiviral Agents|antiviral agents|mesh-ancestor
65682440|NCT01922921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65682441|NCT01922921|Interferon Inducers|interferon inducers|mesh-ancestor
65682442|NCT01922921|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65682443|NCT01922921|Protective Agents|protective agents|mesh-ancestor
65682444|NCT01697566|Metformin|metformin|mesh-list
65682445|NCT01697566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65682446|NCT01697566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682447|NCT01546987|Leuprolide|leuprolide|mesh-list
65682448|NCT01546987|Goserelin|goserelin|mesh-list
65682449|NCT01546987|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65682450|NCT01546987|Flutamide|flutamide|mesh-list
65682451|NCT01546987|Bicalutamide|bicalutamide|mesh-list
65682452|NCT01546987|Buserelin|buserelin|mesh-list
65682453|NCT01546987|Androgens|androgens|mesh-list
65682454|NCT01546987|Androgen Antagonists|androgen antagonists|mesh-list
65682455|NCT01546987|Hormones|hormones|mesh-ancestor
65145123|NCT05644301|Celecoxib|celecoxib|mesh-list
65682456|NCT01546987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65682457|NCT01546987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682458|NCT01546987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65682459|NCT01546987|Fertility Agents|fertility agents|mesh-ancestor
65682460|NCT01546987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65682461|NCT01546987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65682462|NCT01546987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682463|NCT01546987|Hormone Antagonists|hormone antagonists|mesh-ancestor
65682464|NCT01546987|Luteolytic Agents|luteolytic agents|mesh-ancestor
65682465|NCT01546987|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65682466|NCT01546987|Contraceptive Agents|contraceptive agents|mesh-ancestor
65682467|NCT01546987|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65682468|NCT01367002|Paclitaxel|paclitaxel|mesh-list
65682469|NCT01367002|Carboplatin|carboplatin|mesh-list
65682470|NCT01367002|Trastuzumab|trastuzumab|mesh-list
65682471|NCT01367002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65682472|NCT01367002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682473|NCT01367002|Tubulin Modulators|tubulin modulators|mesh-ancestor
65682474|NCT01367002|Antimitotic Agents|antimitotic agents|mesh-ancestor
65682475|NCT01367002|Mitosis Modulators|mitosis modulators|mesh-ancestor
65682476|NCT01367002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682477|NCT01367002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65682478|NCT01012817|Topotecan|topotecan|mesh-list
65682479|NCT01012817|Veliparib|veliparib|mesh-list
65682480|NCT01012817|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65682481|NCT01012817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65682482|NCT01012817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682483|NCT01012817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682484|NCT01012817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682485|NCT01012817|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65682486|NCT00977691|Sirolimus|sirolimus|mesh-list
65682487|NCT00977691|Cyclophosphamide|cyclophosphamide|mesh-list
65682488|NCT00977691|Alemtuzumab|alemtuzumab|mesh-list
65682489|NCT00977691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65682490|NCT00977691|Immunologic Factors|immunologic factors|mesh-ancestor
65682491|NCT00977691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682492|NCT00977691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65682493|NCT00977691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65682494|NCT00977691|Alkylating Agents|alkylating agents|mesh-ancestor
65682495|NCT00977691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682496|NCT00977691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682497|NCT00977691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65682498|NCT00977691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65682499|NCT00977691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65682500|NCT00977691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65682501|NCT00977691|Antifungal Agents|antifungal agents|mesh-ancestor
65682502|NCT00977691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65682503|NCT00781612|Paclitaxel|paclitaxel|mesh-list
65682504|NCT00781612|Maytansine|maytansine|mesh-list
65682505|NCT00781612|Docetaxel|docetaxel|mesh-list
65682506|NCT00781612|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65682507|NCT00781612|Trastuzumab|trastuzumab|mesh-list
65682508|NCT00781612|Atezolizumab|atezolizumab|mesh-list
65682509|NCT00781612|Pertuzumab|pertuzumab|mesh-list
65682510|NCT00781612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65682511|NCT00781612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682512|NCT00781612|Tubulin Modulators|tubulin modulators|mesh-ancestor
65682513|NCT00781612|Antimitotic Agents|antimitotic agents|mesh-ancestor
65682514|NCT00781612|Mitosis Modulators|mitosis modulators|mesh-ancestor
65682515|NCT00781612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682516|NCT00781612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65682517|NCT00676715|Interferons|interferons|mesh-list
65682518|NCT00676715|Interferon-beta|interferon-beta|mesh-list
65682519|NCT00676715|Ocrelizumab|ocrelizumab|mesh-list
65682520|NCT00676715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682521|NCT00676715|Antiviral Agents|antiviral agents|mesh-ancestor
65682522|NCT00676715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65682523|NCT00676715|Immunologic Factors|immunologic factors|mesh-ancestor
65682524|NCT00676715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682525|NCT00588185|Deoxyglucose|deoxyglucose|mesh-list
65682526|NCT00588185|Testosterone|testosterone|mesh-list
65682527|NCT00588185|Dihydrotestosterone|dihydrotestosterone|mesh-list
65682528|NCT00588185|Androgens|androgens|mesh-ancestor
65682529|NCT00588185|Hormones|hormones|mesh-ancestor
65682530|NCT00588185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65682531|NCT00588185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682532|NCT00588185|Antimetabolites|antimetabolites|mesh-ancestor
65682533|NCT00588185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682534|NCT00588185|Antiviral Agents|antiviral agents|mesh-ancestor
65479844|NCT01288742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65682535|NCT00588185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65682536|NCT00304070|Cisplatin|cisplatin|mesh-list
65682537|NCT00304070|Doxorubicin|doxorubicin|mesh-list
65682538|NCT00304070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65682539|NCT00304070|Etoposide|etoposide|mesh-list
65682540|NCT00304070|Etoposide phosphate|etoposide phosphate|mesh-list
65682541|NCT00304070|Podophyllotoxin|podophyllotoxin|mesh-list
65682542|NCT00304070|Mitotane|mitotane|mesh-list
65682543|NCT00304070|Lenograstim|lenograstim|mesh-list
65682544|NCT00304070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682545|NCT00304070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65682546|NCT00304070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65682547|NCT00304070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65682548|NCT00304070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682549|NCT00304070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682550|NCT00304070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65682551|NCT00304070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65682552|NCT00304070|Immunologic Factors|immunologic factors|mesh-ancestor
65682553|NCT00304070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682554|NCT00304070|Keratolytic Agents|keratolytic agents|mesh-ancestor
65682555|NCT00304070|Dermatologic Agents|dermatologic agents|mesh-ancestor
65682556|NCT00304070|Tubulin Modulators|tubulin modulators|mesh-ancestor
65682557|NCT00304070|Antimitotic Agents|antimitotic agents|mesh-ancestor
65682558|NCT00304070|Mitosis Modulators|mitosis modulators|mesh-ancestor
65682559|NCT00304070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65682560|NCT00268476|Zoledronic Acid|zoledronic acid|mesh-list
65682561|NCT00268476|Metformin|metformin|mesh-list
65682562|NCT00268476|Prednisone|prednisone|mesh-list
65682563|NCT00268476|Prednisolone|prednisolone|mesh-list
65682564|NCT00268476|Celecoxib|celecoxib|mesh-list
65682565|NCT00268476|Docetaxel|docetaxel|mesh-list
65682566|NCT00268476|Estradiol|estradiol|mesh-list
65682567|NCT00268476|Androgens|androgens|mesh-list
65682568|NCT00268476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65682569|NCT00268476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682570|NCT00268476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682571|NCT00268476|Tubulin Modulators|tubulin modulators|mesh-ancestor
65682572|NCT00268476|Antimitotic Agents|antimitotic agents|mesh-ancestor
65682573|NCT00268476|Mitosis Modulators|mitosis modulators|mesh-ancestor
65682574|NCT00268476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682575|NCT00268476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65682576|NCT00268476|Glucocorticoids|glucocorticoids|mesh-ancestor
65682577|NCT00268476|Hormones|hormones|mesh-ancestor
65682578|NCT00268476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65682579|NCT00268476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65682580|NCT00268476|Estrogens|estrogens|mesh-ancestor
65682581|NCT00268476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65682582|NCT00268476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65682583|NCT00268476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65682584|NCT00268476|Analgesics|analgesics|mesh-ancestor
65682585|NCT00268476|Sensory System Agents|sensory system agents|mesh-ancestor
65682586|NCT00268476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65682587|NCT00268476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65682588|NCT00268476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65682589|NCT00268476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682590|NCT00268476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65682591|NCT00261443|Valproic Acid|valproic acid|mesh-list
65682592|NCT00261443|Aripiprazole|aripiprazole|mesh-list
65682593|NCT00261443|Lithium Carbonate|lithium carbonate|mesh-list
65682594|NCT00261443|Antidepressive Agents|antidepressive agents|mesh-ancestor
65682595|NCT00261443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65682596|NCT00261443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65682597|NCT00261443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65682598|NCT00261443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65682599|NCT00261443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682600|NCT00261443|Dopamine Agonists|dopamine agonists|mesh-ancestor
65682601|NCT00261443|Dopamine Agents|dopamine agents|mesh-ancestor
65682602|NCT00261443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65682603|NCT00261443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682604|NCT00261443|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65682605|NCT00261443|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65682606|NCT00261443|Serotonin Agents|serotonin agents|mesh-ancestor
65682607|NCT00261443|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65682608|NCT00261443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65682609|NCT00261443|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65682610|NCT00261443|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65682611|NCT00261443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682612|NCT00261443|Antimanic Agents|antimanic agents|mesh-ancestor
65682613|NCT00261443|Anticonvulsants|anticonvulsants|mesh-ancestor
65682614|NCT00261443|GABA Agents|gaba agents|mesh-ancestor
65682615|NCT00093379|Capecitabine|capecitabine|mesh-list
65682616|NCT00093379|Oxaliplatin|oxaliplatin|mesh-list
65682617|NCT00093379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65682618|NCT00093379|Antimetabolites|antimetabolites|mesh-ancestor
65682619|NCT00093379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682620|NCT00093379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682621|NCT00071708|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65682622|NCT00071708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65682623|NCT00071708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65682624|NCT00071708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65682625|NCT00071708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682626|NCT00071708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65682627|NCT00071708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682628|NCT00071708|Analgesics|analgesics|mesh-ancestor
65682629|NCT00071708|Sensory System Agents|sensory system agents|mesh-ancestor
65682630|NCT00071708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65682631|NCT00071708|Antidepressive Agents|antidepressive agents|mesh-ancestor
65682632|NCT00071708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65682633|NCT00071708|Dopamine Agents|dopamine agents|mesh-ancestor
65682634|NCT00000524|Cyclosporine|cyclosporine|mesh-list
65682635|NCT00000524|Prednisone|prednisone|mesh-list
65682636|NCT00000524|Cyclosporins|cyclosporins|mesh-list
65682637|NCT00000524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65682638|NCT00000524|Glucocorticoids|glucocorticoids|mesh-ancestor
65682639|NCT00000524|Hormones|hormones|mesh-ancestor
65682640|NCT00000524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65682641|NCT00000524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682642|NCT00000524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65682643|NCT00000524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682644|NCT00000524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682645|NCT00000524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682646|NCT00000524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65682647|NCT00000524|Immunologic Factors|immunologic factors|mesh-ancestor
65682648|NCT00000524|Antifungal Agents|antifungal agents|mesh-ancestor
65682649|NCT00000524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65682650|NCT00000524|Dermatologic Agents|dermatologic agents|mesh-ancestor
65682651|NCT00000524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65682652|NCT00000524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65682653|NCT02099331|Melatonin|melatonin|mesh-list
65682654|NCT02099331|Antioxidants|antioxidants|mesh-ancestor
65682655|NCT02099331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682656|NCT02099331|Protective Agents|protective agents|mesh-ancestor
65682657|NCT02099331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682658|NCT02099331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65682659|NCT05328388|Lycopene|lycopene|mesh-list
65682660|NCT05328388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65682661|NCT05328388|Antioxidants|antioxidants|mesh-ancestor
65682662|NCT05328388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682663|NCT05328388|Protective Agents|protective agents|mesh-ancestor
65682664|NCT05328388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682665|NCT05328388|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65682666|NCT05328388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65682667|NCT05328388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682668|NCT02097069|Folic Acid|folic acid|mesh-list
65682669|NCT02097069|Inositol|inositol|mesh-list
65682670|NCT02097069|Hematinics|hematinics|mesh-ancestor
65682671|NCT02097069|Vitamin B Complex|vitamin b complex|mesh-ancestor
65682672|NCT02097069|Vitamins|vitamins|mesh-ancestor
65682673|NCT02097069|Micronutrients|micronutrients|mesh-ancestor
65682674|NCT02097069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682675|NCT03424226|Acetazolamide|acetazolamide|mesh-list
65682676|NCT03424226|Anticonvulsants|anticonvulsants|mesh-ancestor
65682677|NCT03424226|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65682678|NCT03424226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682679|NCT03424226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682680|NCT03424226|Diuretics|diuretics|mesh-ancestor
65682681|NCT03424226|Natriuretic Agents|natriuretic agents|mesh-ancestor
65682682|NCT03424226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682683|NCT02250729|Pholcodine|pholcodine|mesh-list
65682684|NCT02250729|Analgesics|analgesics|mesh-ancestor
65682685|NCT02250729|Sensory System Agents|sensory system agents|mesh-ancestor
65682686|NCT02250729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65682687|NCT02250729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682688|NCT02250729|Antitussive Agents|antitussive agents|mesh-ancestor
65682689|NCT02250729|Respiratory System Agents|respiratory system agents|mesh-ancestor
65682691|NCT02097147|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
65682692|NCT02097147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65682693|NCT02097147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65682694|NCT02097147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65682695|NCT02097147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682696|NCT02097147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65682697|NCT02097147|Serotonin Agents|serotonin agents|mesh-ancestor
65682698|NCT02097147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682699|NCT02097147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65682700|NCT02097147|Antidepressive Agents|antidepressive agents|mesh-ancestor
65682701|NCT02097147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65682702|NCT02097147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65682703|NCT02097147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65682704|NCT02097147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682705|NCT02097147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65682706|NCT02097147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65682707|NCT03556839|Paclitaxel|paclitaxel|mesh-list
65682708|NCT03556839|Bevacizumab|bevacizumab|mesh-list
65682709|NCT03556839|Carboplatin|carboplatin|mesh-list
65682710|NCT03556839|Atezolizumab|atezolizumab|mesh-list
65682711|NCT03556839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65682712|NCT03556839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682713|NCT03556839|Tubulin Modulators|tubulin modulators|mesh-ancestor
65682714|NCT03556839|Antimitotic Agents|antimitotic agents|mesh-ancestor
65682715|NCT03556839|Mitosis Modulators|mitosis modulators|mesh-ancestor
65682716|NCT03556839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682717|NCT03556839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65682718|NCT03556839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65682719|NCT03556839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65682720|NCT03556839|Growth Substances|growth substances|mesh-ancestor
65682721|NCT03556839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682722|NCT03556839|Growth Inhibitors|growth inhibitors|mesh-ancestor
65682723|NCT03415802|Paclitaxel|paclitaxel|mesh-list
65682724|NCT03415802|Tegafur|tegafur|mesh-list
65682725|NCT03415802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65682726|NCT03415802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682727|NCT03415802|Tubulin Modulators|tubulin modulators|mesh-ancestor
65682728|NCT03415802|Antimitotic Agents|antimitotic agents|mesh-ancestor
65682729|NCT03415802|Mitosis Modulators|mitosis modulators|mesh-ancestor
65682730|NCT03415802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682731|NCT03415802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65682732|NCT03415802|Antimetabolites|antimetabolites|mesh-ancestor
65682733|NCT02099877|Fentanyl|fentanyl|mesh-list
65682734|NCT02099877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65682735|NCT02099877|Narcotics|narcotics|mesh-ancestor
65682736|NCT02099877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65682737|NCT02099877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682738|NCT02099877|Analgesics|analgesics|mesh-ancestor
65682739|NCT02099877|Sensory System Agents|sensory system agents|mesh-ancestor
65682740|NCT02099877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65682741|NCT02099877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65682742|NCT02099877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65682743|NCT02099877|Anesthetics, General|anesthetics, general|mesh-ancestor
65682744|NCT02099877|Anesthetics|anesthetics|mesh-ancestor
65682745|NCT02097381|Ritonavir|ritonavir|mesh-list
65682746|NCT02097381|Lopinavir|lopinavir|mesh-list
65682747|NCT02097381|Darunavir|darunavir|mesh-list
65682748|NCT02097381|Tenofovir|tenofovir|mesh-list
65682749|NCT02097381|Emtricitabine|emtricitabine|mesh-list
65682750|NCT02097381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65682751|NCT02097381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65682752|NCT02097381|Protease Inhibitors|protease inhibitors|mesh-ancestor
65682753|NCT02097381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682754|NCT02097381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682755|NCT02097381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65682756|NCT02097381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65682757|NCT02097381|Antiviral Agents|antiviral agents|mesh-ancestor
65682758|NCT02097381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65682759|NCT02097381|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65682760|NCT02097381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65682761|NCT02097381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65682762|NCT02097381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65682763|NCT02099955|Vitamin D|vitamin d|mesh-list
65682764|NCT02099955|Cholecalciferol|cholecalciferol|mesh-list
65682765|NCT02099955|Vitamins|vitamins|mesh-ancestor
65682766|NCT02099955|Micronutrients|micronutrients|mesh-ancestor
65682767|NCT02099955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682768|NCT02099955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65682769|NCT02099955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65682770|NCT02097459|Tamoxifen|tamoxifen|mesh-list
65682771|NCT02097459|Toremifene|toremifene|mesh-list
65682772|NCT02097459|Anastrozole|anastrozole|mesh-list
65682773|NCT02097459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65682774|NCT02097459|Hormone Antagonists|hormone antagonists|mesh-ancestor
65682775|NCT02097459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65682776|NCT02097459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682777|NCT02097459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65682778|NCT02097459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682779|NCT02097459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65682780|NCT02097459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65682781|NCT02097459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65682782|NCT02097459|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65682783|NCT02097459|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65682784|NCT02097459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682785|NCT02097459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682786|NCT02097615|Chlorhexidine|chlorhexidine|mesh-list
65682787|NCT02097615|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65682788|NCT02097615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65682789|NCT02097615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65682790|NCT02097615|Disinfectants|disinfectants|mesh-ancestor
65682791|NCT02097615|Dermatologic Agents|dermatologic agents|mesh-ancestor
65682792|NCT02590432|Linaclotide|linaclotide|mesh-list
65682793|NCT02590432|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65682794|NCT02590432|Enzyme Activators|enzyme activators|mesh-ancestor
65682795|NCT02590432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682796|NCT02590432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65682797|NCT02094339|Analgesics|analgesics|mesh-list
65682798|NCT02094339|Ropivacaine|ropivacaine|mesh-list
65682799|NCT02094339|Anesthetics, Local|anesthetics, local|mesh-ancestor
65682800|NCT02094339|Anesthetics|anesthetics|mesh-ancestor
65682801|NCT02094339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65682802|NCT02094339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682803|NCT02094339|Sensory System Agents|sensory system agents|mesh-ancestor
65682804|NCT02094339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65682805|NCT03415646|Morphine|morphine|mesh-list
65682806|NCT03415646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65682807|NCT03415646|Narcotics|narcotics|mesh-ancestor
65682808|NCT03415646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65682809|NCT03415646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682810|NCT03415646|Analgesics|analgesics|mesh-ancestor
65682811|NCT03415646|Sensory System Agents|sensory system agents|mesh-ancestor
65682812|NCT03415646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65682813|NCT03417518|Propofol|propofol|mesh-list
65682814|NCT03417518|Desflurane|desflurane|mesh-list
65682815|NCT03417518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65682816|NCT03417518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65682817|NCT03417518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682818|NCT03417518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65682819|NCT03417518|Anesthetics, General|anesthetics, general|mesh-ancestor
65682820|NCT03417518|Anesthetics|anesthetics|mesh-ancestor
65682821|NCT03417518|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65682822|NCT05169554|Amoxicillin|amoxicillin|mesh-list
65682823|NCT05169554|Clarithromycin|clarithromycin|mesh-list
65682824|NCT05169554|Rifampin|rifampin|mesh-list
65682825|NCT05169554|Clavulanic Acid|clavulanic acid|mesh-list
65682826|NCT05169554|Clavulanic Acids|clavulanic acids|mesh-list
65682827|NCT05169554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65682828|NCT05169554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65682829|NCT05169554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65682830|NCT05169554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65682831|NCT05169554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268762|NCT04032626|Growth Inhibitors|growth inhibitors|mesh-ancestor
65682832|NCT05169554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682833|NCT05169554|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65682834|NCT05169554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65682835|NCT05169554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65682836|NCT05169554|Antitubercular Agents|antitubercular agents|mesh-ancestor
65682837|NCT05169554|Leprostatic Agents|leprostatic agents|mesh-ancestor
65682838|NCT05169554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65682839|NCT05169554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65682840|NCT05169554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65682841|NCT05169554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65682842|NCT05169554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65682843|NCT05169554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65682844|NCT05169554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65682845|NCT05169554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65682846|NCT04085458|Factor VIII|factor viii|mesh-list
65682847|NCT04085458|Coagulants|coagulants|mesh-ancestor
65682848|NCT02094651|Valproic Acid|valproic acid|mesh-list
65682849|NCT02094651|Anticonvulsants|anticonvulsants|mesh-ancestor
65682850|NCT02094651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682851|NCT02094651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682852|NCT02094651|GABA Agents|gaba agents|mesh-ancestor
65682853|NCT02094651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65682854|NCT02094651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682855|NCT02094651|Antimanic Agents|antimanic agents|mesh-ancestor
65682856|NCT02094651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65682857|NCT02094651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65682858|NCT02094651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65682859|NCT02094807|Acetaminophen|acetaminophen|mesh-list
65682860|NCT02094807|Diclofenac|diclofenac|mesh-list
65682861|NCT02094807|Oxycodone|oxycodone|mesh-list
65682862|NCT02094807|Tramadol|tramadol|mesh-list
65682863|NCT02094807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65682864|NCT02094807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682865|NCT02094807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65682866|NCT02094807|Analgesics|analgesics|mesh-ancestor
65682867|NCT02094807|Sensory System Agents|sensory system agents|mesh-ancestor
65682868|NCT02094807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65682869|NCT02094807|Antipyretics|antipyretics|mesh-ancestor
65682870|NCT02094807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65682871|NCT02094807|Narcotics|narcotics|mesh-ancestor
65682872|NCT02094807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65682873|NCT02094807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65682874|NCT02094807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65682875|NCT02094807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65682876|NCT02094807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682877|NCT02094807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682878|NCT05139472|Empagliflozin|empagliflozin|mesh-list
65682879|NCT05139472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65682880|NCT05139472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682881|NCT05139472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65682882|NCT05139472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682883|NCT04757090|Trastuzumab|trastuzumab|mesh-list
65682884|NCT04757090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65682885|NCT04757090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682886|NCT03397862|Donepezil|donepezil|mesh-list
65682887|NCT03397862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65682888|NCT03397862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682889|NCT03397862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682890|NCT03397862|Cholinergic Agents|cholinergic agents|mesh-ancestor
65682891|NCT03397862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65682892|NCT03397862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682893|NCT03397862|Nootropic Agents|nootropic agents|mesh-ancestor
65682894|NCT02100267|Methacholine Chloride|methacholine chloride|mesh-list
65682895|NCT02100267|Miotics|miotics|mesh-ancestor
65682896|NCT02100267|Autonomic Agents|autonomic agents|mesh-ancestor
65682897|NCT02100267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65682898|NCT02100267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682899|NCT02100267|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65682900|NCT02100267|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
65682901|NCT02100267|Respiratory System Agents|respiratory system agents|mesh-ancestor
65682902|NCT02100267|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65682903|NCT02100267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65682904|NCT02100267|Cholinergic Agents|cholinergic agents|mesh-ancestor
65682905|NCT02100267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65682906|NCT02100267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682907|NCT02094963|Clopidogrel|clopidogrel|mesh-list
65682908|NCT02094963|Ticagrelor|ticagrelor|mesh-list
65682909|NCT02094963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65682910|NCT02094963|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65682911|NCT02094963|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65682912|NCT02094963|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65682913|NCT02094963|Purinergic Agents|purinergic agents|mesh-ancestor
65682914|NCT02094963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65682915|NCT02094963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682916|NCT02094963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682917|NCT03982810|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65682918|NCT03982810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65682919|NCT03982810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65682920|NCT03982810|Antitubercular Agents|antitubercular agents|mesh-ancestor
65682921|NCT03397706|Valganciclovir|valganciclovir|mesh-list
65682922|NCT03397706|Antiviral Agents|antiviral agents|mesh-ancestor
65682923|NCT03397706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65682924|NCT02098317|Vitamin D|vitamin d|mesh-list
65682925|NCT02098317|Vitamins|vitamins|mesh-ancestor
65682926|NCT02098317|Micronutrients|micronutrients|mesh-ancestor
65682927|NCT02098317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682928|NCT02098317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65682929|NCT02100423|Vitamin D|vitamin d|mesh-list
65682930|NCT02100423|Cholecalciferol|cholecalciferol|mesh-list
65682931|NCT02100423|Curcumin|curcumin|mesh-list
65682932|NCT02100423|Vitamins|vitamins|mesh-ancestor
65682933|NCT02100423|Micronutrients|micronutrients|mesh-ancestor
65682934|NCT02100423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682935|NCT02100423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65682936|NCT02100423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65682937|NCT02100423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65682938|NCT02100423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65682939|NCT02100423|Analgesics|analgesics|mesh-ancestor
65682940|NCT02100423|Sensory System Agents|sensory system agents|mesh-ancestor
65682941|NCT02100423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65682942|NCT02100423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65682943|NCT02100423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65682944|NCT02100423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682945|NCT02100423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682946|NCT02100423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682947|NCT05614648|Clonidine|clonidine|mesh-list
65682948|NCT05614648|Analgesics|analgesics|mesh-ancestor
65682949|NCT05614648|Sensory System Agents|sensory system agents|mesh-ancestor
65682950|NCT05614648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65682951|NCT05614648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682952|NCT05614648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65682953|NCT05614648|Sympatholytics|sympatholytics|mesh-ancestor
65682954|NCT05614648|Autonomic Agents|autonomic agents|mesh-ancestor
65682955|NCT05614648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65682956|NCT05614648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65682957|NCT05614648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65682958|NCT05614648|Adrenergic Agents|adrenergic agents|mesh-ancestor
65682959|NCT05614648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65682960|NCT05614648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682961|NCT02520752|Midazolam|midazolam|mesh-list
65682962|NCT02520752|Caffeine|caffeine|mesh-list
65682963|NCT02520752|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65682964|NCT02520752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65682965|NCT02520752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65682966|NCT02520752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682967|NCT02520752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65682968|NCT02520752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65682969|NCT02520752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65682970|NCT02520752|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65682971|NCT02520752|Anesthetics, General|anesthetics, general|mesh-ancestor
65682972|NCT02520752|Anesthetics|anesthetics|mesh-ancestor
65682973|NCT02520752|GABA Modulators|gaba modulators|mesh-ancestor
65682974|NCT02520752|GABA Agents|gaba agents|mesh-ancestor
65682975|NCT02520752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65682976|NCT02520752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65682977|NCT02520752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65682978|NCT02520752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65682979|NCT02520752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682980|NCT02520752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65682981|NCT02520752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65682982|NCT02520752|Purinergic Agents|purinergic agents|mesh-ancestor
65682983|NCT02095119|Gemcitabine|gemcitabine|mesh-list
65682984|NCT02095119|Nimotuzumab|nimotuzumab|mesh-list
65682985|NCT02095119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65682986|NCT02095119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65682987|NCT02095119|Antimetabolites|antimetabolites|mesh-ancestor
65682988|NCT02095119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480304|NCT01181882|Aspirin|aspirin|mesh-list
65682990|NCT02095119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65682991|NCT02095119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65682992|NCT02095119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65682993|NCT02095119|Immunologic Factors|immunologic factors|mesh-ancestor
65682994|NCT02095119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65682995|NCT02095119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65682996|NCT02098629|Milrinone|milrinone|mesh-list
65682997|NCT02098629|Esmolol|esmolol|mesh-list
65682998|NCT02098629|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65682999|NCT02098629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65683000|NCT02098629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65683001|NCT02098629|Adrenergic Agents|adrenergic agents|mesh-ancestor
65683002|NCT02098629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65683003|NCT02098629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683004|NCT02098629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683005|NCT02098629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65683006|NCT02098629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65683007|NCT02098629|Vasodilator Agents|vasodilator agents|mesh-ancestor
65683008|NCT02098629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65683009|NCT02098629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65683010|NCT02098629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683011|NCT02098629|Protective Agents|protective agents|mesh-ancestor
65683012|NCT02095509|Enoxaparin|enoxaparin|mesh-list
65683013|NCT02095509|Anticoagulants|anticoagulants|mesh-ancestor
65683014|NCT02095509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65683015|NCT02095509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65683016|NCT02095509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683017|NCT03397082|Lidocaine|lidocaine|mesh-list
65683018|NCT03397082|Anesthetics, Local|anesthetics, local|mesh-ancestor
65683019|NCT03397082|Anesthetics|anesthetics|mesh-ancestor
65683020|NCT03397082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65683021|NCT03397082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683022|NCT03397082|Sensory System Agents|sensory system agents|mesh-ancestor
65683023|NCT03397082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65683024|NCT03397082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65683025|NCT03397082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65683026|NCT03397082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65683027|NCT03397082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65683028|NCT03397082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683029|NCT02101047|Phenylephrine|phenylephrine|mesh-list
65683030|NCT02101047|Oxymetazoline|oxymetazoline|mesh-list
65683031|NCT02101047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65683032|NCT02101047|Mydriatics|mydriatics|mesh-ancestor
65683033|NCT02101047|Autonomic Agents|autonomic agents|mesh-ancestor
65683034|NCT02101047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65683035|NCT02101047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683036|NCT02101047|Sympathomimetics|sympathomimetics|mesh-ancestor
65683037|NCT02101047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65683038|NCT02101047|Nasal Decongestants|nasal decongestants|mesh-ancestor
65683039|NCT02101047|Respiratory System Agents|respiratory system agents|mesh-ancestor
65683040|NCT02101047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65683041|NCT02101047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65683042|NCT02101047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65683043|NCT02101047|Adrenergic Agents|adrenergic agents|mesh-ancestor
65683044|NCT02101047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65683045|NCT02101047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683046|NCT02101047|Protective Agents|protective agents|mesh-ancestor
65683047|NCT02095665|Acetaminophen|acetaminophen|mesh-list
65683048|NCT02095665|Tamsulosin|tamsulosin|mesh-list
65683049|NCT02095665|Mirabegron|mirabegron|mesh-list
65683050|NCT02095665|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65683051|NCT02095665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65683052|NCT02095665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65683053|NCT02095665|Adrenergic Agents|adrenergic agents|mesh-ancestor
65683054|NCT02095665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65683055|NCT02095665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683056|NCT02095665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683057|NCT02095665|Urological Agents|urological agents|mesh-ancestor
65683058|NCT02095665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65683059|NCT02095665|Analgesics|analgesics|mesh-ancestor
65683060|NCT02095665|Sensory System Agents|sensory system agents|mesh-ancestor
65683061|NCT02095665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65683062|NCT02095665|Antipyretics|antipyretics|mesh-ancestor
65683063|NCT02095665|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65683064|NCT02095665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65683065|NCT02095665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65683066|NCT03548428|Atezolizumab|atezolizumab|mesh-list
65683067|NCT03548428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683068|NCT02101125|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65683069|NCT02101125|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65683070|NCT02101125|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65683071|NCT02101125|Antimetabolites|antimetabolites|mesh-ancestor
65683072|NCT02101125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683073|NCT02101125|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65683074|NCT02101125|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65683075|NCT02101125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683076|NCT02101203|Buspirone|buspirone|mesh-list
65683077|NCT02101203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65683078|NCT02101203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65683079|NCT02101203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65683080|NCT02101203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683081|NCT02101203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65683082|NCT02101203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65683083|NCT02101203|Serotonin Agents|serotonin agents|mesh-ancestor
65683084|NCT02101203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65683085|NCT02101203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683086|NCT04523246|Vaccines|vaccines|mesh-list
65683087|NCT04523246|Immunologic Factors|immunologic factors|mesh-ancestor
65683088|NCT04523246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683089|NCT03396380|Calcium, Dietary|calcium, dietary|mesh-list
65683090|NCT03396380|Vitamin D|vitamin d|mesh-list
65683091|NCT03396380|Citric Acid|citric acid|mesh-list
65683092|NCT03396380|Sodium Citrate|sodium citrate|mesh-list
65683093|NCT03396380|Clomiphene|clomiphene|mesh-list
65683094|NCT03396380|Enclomiphene|enclomiphene|mesh-list
65683095|NCT03396380|Zuclomiphene|zuclomiphene|mesh-list
65683096|NCT03396380|Calcium|calcium|mesh-list
65683097|NCT03396380|Vitamins|vitamins|mesh-ancestor
65683098|NCT03396380|Micronutrients|micronutrients|mesh-ancestor
65683099|NCT03396380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683100|NCT03396380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65683101|NCT03396380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65683102|NCT03396380|Anticoagulants|anticoagulants|mesh-ancestor
65683103|NCT03396380|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65683104|NCT03396380|Chelating Agents|chelating agents|mesh-ancestor
65683105|NCT03396380|Sequestering Agents|sequestering agents|mesh-ancestor
65683106|NCT03396380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683107|NCT03396380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65683108|NCT03396380|Hormone Antagonists|hormone antagonists|mesh-ancestor
65683109|NCT03396380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65683110|NCT03396380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65683111|NCT03396380|Fertility Agents|fertility agents|mesh-ancestor
65683112|NCT03396380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65683113|NCT03396380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65683114|NCT03396380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65683115|NCT05040568|Cyclophosphamide|cyclophosphamide|mesh-list
65683116|NCT05040568|Fludarabine|fludarabine|mesh-list
65683117|NCT05040568|Fludarabine phosphate|fludarabine phosphate|mesh-list
65683118|NCT05040568|Cetuximab|cetuximab|mesh-list
65683119|NCT05040568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65683120|NCT05040568|Immunologic Factors|immunologic factors|mesh-ancestor
65683121|NCT05040568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683122|NCT05040568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65683123|NCT05040568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65683124|NCT05040568|Alkylating Agents|alkylating agents|mesh-ancestor
65683125|NCT05040568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683126|NCT05040568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683127|NCT05040568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65683128|NCT05040568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65683129|NCT05040568|Antimetabolites|antimetabolites|mesh-ancestor
65683130|NCT05040568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65683131|NCT04889716|Obinutuzumab|obinutuzumab|mesh-list
65683132|NCT04889716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65683133|NCT04889716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683134|NCT03414164|Procyanidin|procyanidin|mesh-list
65683135|NCT03414164|Antioxidants|antioxidants|mesh-ancestor
65683136|NCT03414164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683137|NCT03414164|Protective Agents|protective agents|mesh-ancestor
65480453|NCT01185470|Morphine|morphine|mesh-list
65683138|NCT03414164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683140|NCT05613478|Chlorotrianisene|chlorotrianisene|mesh-list
65683141|NCT05613478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683142|NCT05613478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65683143|NCT05613478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683144|NCT05613478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683145|NCT05613478|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65683146|NCT05613478|Estrogens|estrogens|mesh-ancestor
65683147|NCT05613478|Hormones|hormones|mesh-ancestor
65683148|NCT05613478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65683149|NCT05613478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683150|NCT05613478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65683151|NCT04412018|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
65683152|NCT04412018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65683153|NCT04412018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65683154|NCT03406988|Nifedipine|nifedipine|mesh-list
65683155|NCT03406988|Iloprost|iloprost|mesh-list
65683156|NCT03406988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65683157|NCT03406988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65683158|NCT03406988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683159|NCT03406988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65683160|NCT03406988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683161|NCT03406988|Vasodilator Agents|vasodilator agents|mesh-ancestor
65683162|NCT03406988|Tocolytic Agents|tocolytic agents|mesh-ancestor
65683163|NCT03406988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65683164|NCT03406988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65683165|NCT03406832|Nitroprusside|nitroprusside|mesh-list
65683166|NCT03406832|Tirofiban|tirofiban|mesh-list
65683167|NCT03406832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65683168|NCT03406832|Vasodilator Agents|vasodilator agents|mesh-ancestor
65683169|NCT03406832|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65683170|NCT03406832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683171|NCT03406832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65683172|NCT03406832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65683173|NCT03406832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65683174|NCT03405974|Aspirin|aspirin|mesh-list
65683175|NCT03405974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65683176|NCT03405974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65683177|NCT03405974|Analgesics|analgesics|mesh-ancestor
65683178|NCT03405974|Sensory System Agents|sensory system agents|mesh-ancestor
65683179|NCT03405974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65683180|NCT03405974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683181|NCT03405974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65683182|NCT03405974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65683183|NCT03405974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65683184|NCT03405974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65683185|NCT03405974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683186|NCT03405974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65683187|NCT03405974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65683188|NCT03405974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683189|NCT03405974|Antipyretics|antipyretics|mesh-ancestor
65683190|NCT04337060|Lidocaine|lidocaine|mesh-list
65683191|NCT04337060|Morphine|morphine|mesh-list
65683192|NCT04337060|Bupivacaine|bupivacaine|mesh-list
65683193|NCT04337060|Anesthetics, Local|anesthetics, local|mesh-ancestor
65683194|NCT04337060|Anesthetics|anesthetics|mesh-ancestor
65683195|NCT04337060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65683196|NCT04337060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683197|NCT04337060|Sensory System Agents|sensory system agents|mesh-ancestor
65683198|NCT04337060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65683199|NCT04337060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65683200|NCT04337060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65683201|NCT04337060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65683202|NCT04337060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65683203|NCT04337060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683204|NCT04337060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65683205|NCT04337060|Narcotics|narcotics|mesh-ancestor
65683206|NCT04337060|Analgesics|analgesics|mesh-ancestor
65683207|NCT04339036|Capecitabine|capecitabine|mesh-list
65683208|NCT04339036|Temozolomide|temozolomide|mesh-list
65683209|NCT04339036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65683210|NCT04339036|Antimetabolites|antimetabolites|mesh-ancestor
65480526|NCT01291316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65683211|NCT04339036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683212|NCT04339036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683213|NCT04339036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65683215|NCT04447274|Apatinib|apatinib|mesh-list
65683216|NCT04447274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683217|NCT04447274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65683218|NCT04447274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683219|NCT04447274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683220|NCT02977156|Ipilimumab|ipilimumab|mesh-list
65683221|NCT02977156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65683222|NCT02977156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683223|NCT02977156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65683224|NCT02977156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683225|NCT04790032|Cangrelor|cangrelor|mesh-list
65683226|NCT04790032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65683227|NCT04790032|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65683228|NCT04790032|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65683229|NCT04790032|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65683230|NCT04790032|Purinergic Agents|purinergic agents|mesh-ancestor
65683231|NCT04790032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65683232|NCT04790032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683233|NCT04790032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683234|NCT02413138|Hormones|hormones|mesh-list
65683235|NCT02413138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65683236|NCT02413138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683237|NCT01014598|Cisplatin|cisplatin|mesh-list
65683238|NCT01014598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683239|NCT03404804|Amoxicillin|amoxicillin|mesh-list
65683240|NCT03404804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65683241|NCT03404804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65683242|NCT03403946|Pyrithione zinc|pyrithione zinc|mesh-list
65683243|NCT03403946|Keratolytic Agents|keratolytic agents|mesh-ancestor
65683244|NCT03403946|Dermatologic Agents|dermatologic agents|mesh-ancestor
65683245|NCT05611372|Rasagiline|rasagiline|mesh-list
65683246|NCT05611372|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65683247|NCT05611372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683248|NCT05611372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683249|NCT05611372|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65683250|NCT05611372|Protective Agents|protective agents|mesh-ancestor
65683251|NCT05611372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683252|NCT04776148|Trifluridine|trifluridine|mesh-list
65683253|NCT04776148|Pembrolizumab|pembrolizumab|mesh-list
65683254|NCT04776148|Lenvatinib|lenvatinib|mesh-list
65683255|NCT04776148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65683256|NCT04776148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683257|NCT04776148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65683258|NCT04776148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683259|NCT04776148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683260|NCT04776148|Antimetabolites|antimetabolites|mesh-ancestor
65683261|NCT04776148|Antiviral Agents|antiviral agents|mesh-ancestor
65683262|NCT04776148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65683263|NCT03395756|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65683264|NCT03395756|Medroxyprogesterone|medroxyprogesterone|mesh-list
65683265|NCT03395756|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65683266|NCT03395756|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65683267|NCT03395756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65683268|NCT03395756|Contraceptive Agents|contraceptive agents|mesh-ancestor
65683269|NCT03395756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65683270|NCT03395756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683271|NCT03395756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65145933|NCT00623376|Hormones|hormones|mesh-ancestor
65683272|NCT03395756|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65683273|NCT03395756|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65683274|NCT03395756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65683275|NCT03395756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683276|NCT05613166|Everolimus|everolimus|mesh-list
65683277|NCT05613166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683278|NCT05613166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65683279|NCT05613166|Immunologic Factors|immunologic factors|mesh-ancestor
65683280|NCT05613166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683281|NCT05166668|Letrozole|letrozole|mesh-list
65683282|NCT05166668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683283|NCT05166668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65683284|NCT05166668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65683285|NCT05166668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683286|NCT05166668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683287|NCT05166668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65683288|NCT05166668|Hormone Antagonists|hormone antagonists|mesh-ancestor
65683289|NCT05166668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65683290|NCT05166668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683291|NCT05558176|Sildenafil Citrate|sildenafil citrate|mesh-list
65683292|NCT05558176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683293|NCT05558176|Vasodilator Agents|vasodilator agents|mesh-ancestor
65683294|NCT05558176|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65683295|NCT05558176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65683296|NCT05558176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683297|NCT05558176|Urological Agents|urological agents|mesh-ancestor
65683298|NCT04748224|Dexmedetomidine|dexmedetomidine|mesh-list
65683300|NCT04748224|Anesthetics, Local|anesthetics, local|mesh-ancestor
65683301|NCT04748224|Anesthetics|anesthetics|mesh-ancestor
65683302|NCT04748224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65683303|NCT04748224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683304|NCT04748224|Sensory System Agents|sensory system agents|mesh-ancestor
65683305|NCT04748224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65683306|NCT04748224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65683307|NCT04748224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65683308|NCT04748224|Analgesics|analgesics|mesh-ancestor
65683309|NCT04748224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65683310|NCT04748224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65683311|NCT04748224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65683312|NCT04748224|Adrenergic Agents|adrenergic agents|mesh-ancestor
65683313|NCT04748224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65683314|NCT04748224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683315|NCT03413150|Amiodarone|amiodarone|mesh-list
65683316|NCT03413150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65683317|NCT03413150|Vasodilator Agents|vasodilator agents|mesh-ancestor
65683318|NCT03413150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65683319|NCT03413150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65683320|NCT03413150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683321|NCT03413150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65683322|NCT03413150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65683323|NCT03413150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65683324|NCT03413150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683325|NCT03413150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65683326|NCT03413150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65683327|NCT03413150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65683328|NCT05474716|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65683329|NCT05474716|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65683330|NCT05474716|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65683331|NCT05474716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65683332|NCT05474716|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65683333|NCT05474716|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65683334|NCT05474716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65683335|NCT05474716|Adrenergic Agents|adrenergic agents|mesh-ancestor
65683336|NCT05474716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65683337|NCT05474716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683338|NCT05474716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683339|NCT03126578|Midazolam|midazolam|mesh-list
65683340|NCT03126578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65683341|NCT03126578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65683342|NCT03126578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65683343|NCT03126578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683344|NCT03126578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65683345|NCT03126578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65683346|NCT03126578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65683347|NCT03126578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65683348|NCT03126578|Anesthetics, General|anesthetics, general|mesh-ancestor
65683349|NCT03126578|Anesthetics|anesthetics|mesh-ancestor
65683350|NCT03126578|GABA Modulators|gaba modulators|mesh-ancestor
65683351|NCT03126578|GABA Agents|gaba agents|mesh-ancestor
65683352|NCT03126578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65683353|NCT03126578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683354|NCT03412994|Apatinib|apatinib|mesh-list
65683355|NCT03412994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683356|NCT03412994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65683357|NCT03412994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683358|NCT03412994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683360|NCT02588248|Menthol|menthol|mesh-list
65683361|NCT02588248|Antipruritics|antipruritics|mesh-ancestor
65683362|NCT02588248|Dermatologic Agents|dermatologic agents|mesh-ancestor
65683363|NCT02588248|Antiemetics|antiemetics|mesh-ancestor
65683364|NCT02588248|Autonomic Agents|autonomic agents|mesh-ancestor
65683365|NCT02588248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65683366|NCT02588248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683367|NCT02588248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65683368|NCT02588248|Parasympatholytics|parasympatholytics|mesh-ancestor
65683369|NCT03412682|Budesonide|budesonide|mesh-list
65683370|NCT03412682|Mesalamine|mesalamine|mesh-list
65683371|NCT03412682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65683372|NCT03412682|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65683373|NCT03412682|Autonomic Agents|autonomic agents|mesh-ancestor
65683374|NCT03412682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65683375|NCT03412682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683376|NCT03412682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65683377|NCT03412682|Respiratory System Agents|respiratory system agents|mesh-ancestor
65683378|NCT03412682|Glucocorticoids|glucocorticoids|mesh-ancestor
65683379|NCT03412682|Hormones|hormones|mesh-ancestor
65683380|NCT03412682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65683381|NCT03412682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65683382|NCT03412682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65683383|NCT03412682|Analgesics|analgesics|mesh-ancestor
65683384|NCT03412682|Sensory System Agents|sensory system agents|mesh-ancestor
65683385|NCT03412682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65683386|NCT03412526|Fludarabine|fludarabine|mesh-list
65683387|NCT03412526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683388|NCT03126422|Dexmedetomidine|dexmedetomidine|mesh-list
65683389|NCT03126422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65683390|NCT03126422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65683391|NCT03126422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683392|NCT03126422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65683393|NCT03126422|Analgesics|analgesics|mesh-ancestor
65683394|NCT03126422|Sensory System Agents|sensory system agents|mesh-ancestor
65683395|NCT03126422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65683396|NCT03126422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65683397|NCT03126422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65683398|NCT03126422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65683399|NCT03126422|Adrenergic Agents|adrenergic agents|mesh-ancestor
65683400|NCT03126422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65683401|NCT03126422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683402|NCT03395132|Fusidic Acid|fusidic acid|mesh-list
65683403|NCT03395132|Betamethasone|betamethasone|mesh-list
65683404|NCT03395132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65683405|NCT03395132|Glucocorticoids|glucocorticoids|mesh-ancestor
65683406|NCT03395132|Hormones|hormones|mesh-ancestor
65683407|NCT03395132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65683408|NCT03395132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683409|NCT03395132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65683410|NCT03395132|Respiratory System Agents|respiratory system agents|mesh-ancestor
65683411|NCT03395132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65683412|NCT03395132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65683413|NCT03395132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65683414|NCT03395132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683415|NCT03395132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683416|NCT03127124|Leucovorin|leucovorin|mesh-list
65683417|NCT03127124|Fluorouracil|fluorouracil|mesh-list
65683418|NCT03127124|Bevacizumab|bevacizumab|mesh-list
65683419|NCT03127124|Oxaliplatin|oxaliplatin|mesh-list
65683420|NCT03127124|Calcium|calcium|mesh-list
65683421|NCT03127124|Levoleucovorin|levoleucovorin|mesh-list
65683422|NCT03127124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65683423|NCT03127124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683424|NCT03127124|Antimetabolites|antimetabolites|mesh-ancestor
65683425|NCT03127124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683426|NCT03127124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65683427|NCT03127124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683428|NCT03127124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65683429|NCT03127124|Immunologic Factors|immunologic factors|mesh-ancestor
65683430|NCT03127124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65683431|NCT03127124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65683432|NCT03127124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65683433|NCT03127124|Growth Substances|growth substances|mesh-ancestor
65683434|NCT03127124|Growth Inhibitors|growth inhibitors|mesh-ancestor
65683435|NCT03127124|Antidotes|antidotes|mesh-ancestor
65683436|NCT03127124|Protective Agents|protective agents|mesh-ancestor
65683437|NCT03127124|Vitamin B Complex|vitamin b complex|mesh-ancestor
65683438|NCT03127124|Vitamins|vitamins|mesh-ancestor
65683439|NCT03127124|Micronutrients|micronutrients|mesh-ancestor
65683440|NCT03399110|Capecitabine|capecitabine|mesh-list
65683441|NCT03399110|Oxaliplatin|oxaliplatin|mesh-list
65683442|NCT03399110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65683443|NCT03399110|Antimetabolites|antimetabolites|mesh-ancestor
65683444|NCT03399110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683445|NCT03399110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683446|NCT05111912|Liraglutide|liraglutide|mesh-list
65683447|NCT05111912|Glucagon|glucagon|mesh-list
65683448|NCT05111912|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65683449|NCT05111912|Incretins|incretins|mesh-ancestor
65683450|NCT05111912|Hormones|hormones|mesh-ancestor
65683451|NCT05111912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65683452|NCT05111912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683453|NCT05111912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65683454|NCT05111912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65683455|NCT03127046|Aceclofenac|aceclofenac|mesh-list
65683456|NCT03127046|Diclofenac|diclofenac|mesh-list
65683457|NCT03127046|Esomeprazole|esomeprazole|mesh-list
65683458|NCT03127046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65683459|NCT03127046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65683460|NCT03127046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65683461|NCT03127046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683462|NCT03127046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683463|NCT03127046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65683464|NCT03127046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65683465|NCT03127046|Analgesics|analgesics|mesh-ancestor
65683466|NCT03127046|Sensory System Agents|sensory system agents|mesh-ancestor
65683467|NCT03127046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65683468|NCT03127046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683469|NCT03127046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65683470|NCT03127046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65683471|NCT03127046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65683472|NCT05105672|Cisplatin|cisplatin|mesh-list
65683473|NCT05105672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683474|NCT03399032|Caspofungin|caspofungin|mesh-list
65683475|NCT03399032|Antifungal Agents|antifungal agents|mesh-ancestor
65683476|NCT03399032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65683477|NCT03399032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683478|NCT03399032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683479|NCT03394820|Dexamethasone|dexamethasone|mesh-list
65683480|NCT03394820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65683481|NCT03394820|Antiemetics|antiemetics|mesh-ancestor
65683482|NCT03394820|Autonomic Agents|autonomic agents|mesh-ancestor
65683483|NCT03394820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65683484|NCT03394820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683485|NCT03394820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65683486|NCT03394820|Glucocorticoids|glucocorticoids|mesh-ancestor
65683487|NCT03394820|Hormones|hormones|mesh-ancestor
65683488|NCT03394820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65683489|NCT03394820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65683490|NCT03394820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683491|NCT01328054|Lapatinib|lapatinib|mesh-list
65683492|NCT01328054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683493|NCT01328054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65683494|NCT01328054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683495|NCT01328054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683496|NCT05067920|Antibodies|antibodies|mesh-list
65683497|NCT05067920|Immunologic Factors|immunologic factors|mesh-ancestor
65683498|NCT05067920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683499|NCT05002244|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65683500|NCT05002244|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65683501|NCT05002244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65683502|NCT05002244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65683503|NCT05002244|Antimetabolites|antimetabolites|mesh-ancestor
65683504|NCT05002244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683505|NCT05002244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65683506|NCT05002244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65683507|NCT05002244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683508|NCT05002244|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65683509|NCT05002244|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65683510|NCT03398876|Nicotine|nicotine|mesh-list
65683511|NCT03398876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65683512|NCT03398876|Autonomic Agents|autonomic agents|mesh-ancestor
65683513|NCT03398876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65683514|NCT03398876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683515|NCT03398876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65683516|NCT03398876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65683517|NCT03398876|Cholinergic Agents|cholinergic agents|mesh-ancestor
65683518|NCT03398876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65683519|NCT03398876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683520|NCT03394586|Golimumab|golimumab|mesh-list
65683521|NCT03394586|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65683522|NCT03394586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65683523|NCT03394586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65683524|NCT03394586|Immunologic Factors|immunologic factors|mesh-ancestor
65683525|NCT03394586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683526|NCT03394430|Midazolam|midazolam|mesh-list
65683527|NCT03394430|Dexmedetomidine|dexmedetomidine|mesh-list
65683528|NCT03394430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65683529|NCT03394430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65683530|NCT03394430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683531|NCT03394430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65683532|NCT03394430|Analgesics|analgesics|mesh-ancestor
65683533|NCT03394430|Sensory System Agents|sensory system agents|mesh-ancestor
65683534|NCT03394430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65683535|NCT03394430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65683536|NCT03394430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65683537|NCT03394430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65683538|NCT03394430|Adrenergic Agents|adrenergic agents|mesh-ancestor
65683539|NCT03394430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65683540|NCT03394430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683541|NCT03394430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65683542|NCT03394430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65683543|NCT03394430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65683544|NCT03394430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65683545|NCT03394430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65683546|NCT03394430|Anesthetics, General|anesthetics, general|mesh-ancestor
65683547|NCT03394430|Anesthetics|anesthetics|mesh-ancestor
65683548|NCT03394430|GABA Modulators|gaba modulators|mesh-ancestor
65683549|NCT03394430|GABA Agents|gaba agents|mesh-ancestor
65683550|NCT03394196|Ritonavir|ritonavir|mesh-list
65683551|NCT03394196|Lopinavir|lopinavir|mesh-list
65683552|NCT03394196|Darunavir|darunavir|mesh-list
65683553|NCT03394196|Tenofovir|tenofovir|mesh-list
65683554|NCT03394196|Lamivudine|lamivudine|mesh-list
65683555|NCT03394196|Zidovudine|zidovudine|mesh-list
65683556|NCT03394196|Emtricitabine|emtricitabine|mesh-list
65683557|NCT03394196|Raltegravir Potassium|raltegravir potassium|mesh-list
65683558|NCT03394196|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65683559|NCT03394196|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65683560|NCT03394196|Protease Inhibitors|protease inhibitors|mesh-ancestor
65683561|NCT03394196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683562|NCT03394196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683563|NCT03394196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65683564|NCT03394196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65683565|NCT03394196|Antiviral Agents|antiviral agents|mesh-ancestor
65683566|NCT03394196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65683567|NCT03394196|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65683568|NCT03394196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65683569|NCT03394196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65683570|NCT03394196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65683571|NCT03394196|Antimetabolites|antimetabolites|mesh-ancestor
65683572|NCT03394196|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65683573|NCT03394196|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65683574|NCT03398018|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65683575|NCT03398018|Hormones|hormones|mesh-ancestor
65683576|NCT03398018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65683577|NCT03398018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683578|NCT03411434|Methylphenidate|methylphenidate|mesh-list
65683579|NCT03411434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65683580|NCT03411434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683581|NCT03411434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65683582|NCT03411434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65683583|NCT03411434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65683584|NCT03411434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683585|NCT03411434|Dopamine Agents|dopamine agents|mesh-ancestor
65683586|NCT03411434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65683587|NCT03126656|Methyltestosterone|methyltestosterone|mesh-list
65683588|NCT03126656|Testosterone|testosterone|mesh-list
65683589|NCT03126656|Testosterone undecanoate|testosterone undecanoate|mesh-list
65683590|NCT03126656|Testosterone enanthate|testosterone enanthate|mesh-list
65683591|NCT03126656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65683592|NCT03126656|Androgens|androgens|mesh-ancestor
65683593|NCT03126656|Hormones|hormones|mesh-ancestor
65683594|NCT03126656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65683595|NCT03126656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683596|NCT03126656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65683597|NCT03126656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683598|NCT03126656|Anabolic Agents|anabolic agents|mesh-ancestor
65683599|NCT03385382|Dexamethasone|dexamethasone|mesh-list
65683600|NCT03385382|Ranibizumab|ranibizumab|mesh-list
65683601|NCT03385382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65683602|NCT03385382|Antiemetics|antiemetics|mesh-ancestor
65683603|NCT03385382|Autonomic Agents|autonomic agents|mesh-ancestor
65683604|NCT03385382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65683605|NCT03385382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683606|NCT03385382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65683607|NCT03385382|Glucocorticoids|glucocorticoids|mesh-ancestor
65683608|NCT03385382|Hormones|hormones|mesh-ancestor
65683609|NCT03385382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65683610|NCT03385382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65683611|NCT03385382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683612|NCT03385382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65683613|NCT03385382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65683614|NCT03385382|Growth Substances|growth substances|mesh-ancestor
65683615|NCT03385382|Growth Inhibitors|growth inhibitors|mesh-ancestor
65683616|NCT03394118|Osimertinib|osimertinib|mesh-list
65683617|NCT03394118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683618|NCT03394118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65683619|NCT03394118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683620|NCT03394118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683621|NCT03389672|Anesthetics|anesthetics|mesh-list
65683622|NCT03389672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65683623|NCT03389672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683624|NCT01941446|Moxifloxacin|moxifloxacin|mesh-list
65683625|NCT01941446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65683626|NCT01941446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65683627|NCT01941446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65683628|NCT01941446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65683629|NCT01941446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683630|NCT01941446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683631|NCT01941446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683632|NCT01907360|Methylphenidate|methylphenidate|mesh-list
65268772|NCT02747732|Alkylating Agents|alkylating agents|mesh-ancestor
65683633|NCT01907360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65683634|NCT01907360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683635|NCT01907360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65683636|NCT01907360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65683637|NCT01907360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65683638|NCT01907360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683639|NCT01907360|Dopamine Agents|dopamine agents|mesh-ancestor
65683640|NCT01907360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65683641|NCT03126188|Sertraline|sertraline|mesh-list
65683642|NCT03126188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65683643|NCT03126188|Antidepressive Agents|antidepressive agents|mesh-ancestor
65683644|NCT03126188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65683645|NCT03126188|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65683646|NCT03126188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65683647|NCT03126188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65683648|NCT03126188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683649|NCT03126188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65683650|NCT03126188|Serotonin Agents|serotonin agents|mesh-ancestor
65683651|NCT03126188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683652|NCT03126188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65683653|NCT03126188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65683654|NCT04446338|Antibodies|antibodies|mesh-list
65683655|NCT04446338|Immunologic Factors|immunologic factors|mesh-ancestor
65683656|NCT04446338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683658|NCT03393728|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65683659|NCT03393728|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65683660|NCT03393728|Adrenergic Agents|adrenergic agents|mesh-ancestor
65683661|NCT03393728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65683662|NCT03393728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683663|NCT03393728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683664|NCT03393728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65683665|NCT03393728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65683666|NCT03393728|Vasodilator Agents|vasodilator agents|mesh-ancestor
65683667|NCT03393572|Magnesium Sulfate|magnesium sulfate|mesh-list
65683668|NCT03393572|Nalbuphine|nalbuphine|mesh-list
65683669|NCT03393572|Bupivacaine|bupivacaine|mesh-list
65683670|NCT03393572|Anesthetics, Local|anesthetics, local|mesh-ancestor
65683671|NCT03393572|Anesthetics|anesthetics|mesh-ancestor
65683672|NCT03393572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65683673|NCT03393572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683674|NCT03393572|Sensory System Agents|sensory system agents|mesh-ancestor
65683675|NCT03393572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65683676|NCT03393572|Analgesics|analgesics|mesh-ancestor
65683677|NCT03393572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65683678|NCT03393572|Anticonvulsants|anticonvulsants|mesh-ancestor
65683679|NCT03393572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65683680|NCT03393572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65683681|NCT03393572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683682|NCT03393572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65683683|NCT03393572|Tocolytic Agents|tocolytic agents|mesh-ancestor
65683684|NCT03393572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65683685|NCT03393572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65683686|NCT03393572|Narcotics|narcotics|mesh-ancestor
65683687|NCT03393416|Antibodies|antibodies|mesh-list
65683688|NCT03393416|Immunologic Factors|immunologic factors|mesh-ancestor
65683689|NCT03393416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683690|NCT04445948|Amoxicillin|amoxicillin|mesh-list
65683691|NCT04445948|Metronidazole|metronidazole|mesh-list
65683692|NCT04445948|Clarithromycin|clarithromycin|mesh-list
65683693|NCT04445948|Lactoferrin|lactoferrin|mesh-list
65683694|NCT04445948|Esomeprazole|esomeprazole|mesh-list
65683695|NCT04445948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65683696|NCT04445948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65683697|NCT04445948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65683698|NCT04445948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65683699|NCT04445948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65683700|NCT04445948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65683701|NCT04445948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65683702|NCT04445948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683703|NCT04445948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683704|NCT04445948|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65683705|NCT04445948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65683706|NCT04445948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65683707|NCT02479646|Lenograstim|lenograstim|mesh-list
65683708|NCT02479646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65683709|NCT02479646|Immunologic Factors|immunologic factors|mesh-ancestor
65683710|NCT02479646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683711|NCT02467868|Lenograstim|lenograstim|mesh-list
65683712|NCT02467868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65683713|NCT02467868|Immunologic Factors|immunologic factors|mesh-ancestor
65683714|NCT02467868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683715|NCT02106507|Everolimus|everolimus|mesh-list
65683716|NCT02106507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683717|NCT02106507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65683718|NCT02106507|Immunologic Factors|immunologic factors|mesh-ancestor
65683719|NCT02106507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683720|NCT02103465|Rotigotine|rotigotine|mesh-list
65683721|NCT02103465|Dopamine Agonists|dopamine agonists|mesh-ancestor
65683722|NCT02103465|Dopamine Agents|dopamine agents|mesh-ancestor
65683723|NCT02103465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65683724|NCT02103465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683725|NCT02103465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683726|NCT02102139|Propofol|propofol|mesh-list
65683727|NCT02102139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65683728|NCT02102139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65683729|NCT02102139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481056|NCT01291628|Copper|copper|mesh-list
65683730|NCT02102139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65683732|NCT02102139|Anesthetics|anesthetics|mesh-ancestor
65683733|NCT02102295|Ascorbic Acid|ascorbic acid|mesh-list
65683734|NCT02102295|Ascorbate-2-phosphate|ascorbate-2-phosphate|mesh-list
65683735|NCT02102295|Fluorides|fluorides|mesh-list
65683736|NCT02102295|Cariostatic Agents|cariostatic agents|mesh-ancestor
65683737|NCT02102295|Protective Agents|protective agents|mesh-ancestor
65683738|NCT02102295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683739|NCT02102295|Antioxidants|antioxidants|mesh-ancestor
65683740|NCT02102295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683741|NCT02102295|Vitamins|vitamins|mesh-ancestor
65683742|NCT02102295|Micronutrients|micronutrients|mesh-ancestor
65683743|NCT02102295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683744|NCT02102373|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65683745|NCT02102373|Laxatives|laxatives|mesh-ancestor
65683746|NCT02102373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65683747|NCT02103777|Caffeine|caffeine|mesh-list
65683748|NCT02103777|Caffeine citrate|caffeine citrate|mesh-list
65683749|NCT02103777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683750|NCT02103777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65683751|NCT02103777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683752|NCT02103777|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65683753|NCT02103777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683754|NCT02103777|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65683755|NCT02103777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65683756|NCT02103777|Purinergic Agents|purinergic agents|mesh-ancestor
65683757|NCT02103777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65683758|NCT02104011|Propranolol|propranolol|mesh-list
65683759|NCT02104011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65683760|NCT02104011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65683761|NCT02104011|Adrenergic Agents|adrenergic agents|mesh-ancestor
65683762|NCT02104011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65683763|NCT02104011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683764|NCT02104011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683765|NCT02104011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65683766|NCT02104011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65683767|NCT02104011|Vasodilator Agents|vasodilator agents|mesh-ancestor
65683768|NCT03554889|Nimotuzumab|nimotuzumab|mesh-list
65683769|NCT03554889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65683770|NCT03554889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683771|NCT02251041|Tocopherols|tocopherols|mesh-list
65683772|NCT02251041|Vitamin E|vitamin e|mesh-list
65683773|NCT02251041|alpha-Tocopherol|alpha-tocopherol|mesh-list
65683774|NCT02251041|Infliximab|infliximab|mesh-list
65683775|NCT02251041|Epoprostenol|epoprostenol|mesh-list
65683776|NCT02251041|Tezosentan|tezosentan|mesh-list
65683777|NCT02251041|Melatonin|melatonin|mesh-list
65683778|NCT02251041|Antithrombins|antithrombins|mesh-list
65683779|NCT02251041|Antithrombin III|antithrombin iii|mesh-list
65683780|NCT02251041|Epoetin Alfa|epoetin alfa|mesh-list
65683781|NCT02251041|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
65683782|NCT02251041|Antioxidants|antioxidants|mesh-ancestor
65683783|NCT02251041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683784|NCT02251041|Protective Agents|protective agents|mesh-ancestor
65683785|NCT02251041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683786|NCT02251041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65683787|NCT02251041|Dermatologic Agents|dermatologic agents|mesh-ancestor
65683788|NCT02251041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65683789|NCT02251041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65683790|NCT02251041|Hematinics|hematinics|mesh-ancestor
65683791|NCT02251041|Vitamins|vitamins|mesh-ancestor
65683792|NCT02251041|Micronutrients|micronutrients|mesh-ancestor
65683793|NCT02251041|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65683794|NCT02251041|Protease Inhibitors|protease inhibitors|mesh-ancestor
65683795|NCT02251041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683796|NCT02251041|Anticoagulants|anticoagulants|mesh-ancestor
65683797|NCT02251041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65683798|NCT02251041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65683799|NCT02251041|Vasodilator Agents|vasodilator agents|mesh-ancestor
65683800|NCT02251041|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65683801|NCT02251041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65683802|NCT02251041|Immunologic Factors|immunologic factors|mesh-ancestor
65683803|NCT02104323|Endostatins|endostatins|mesh-list
65481131|NCT02459392|Glucocorticoids|glucocorticoids|mesh-ancestor
65683804|NCT02104323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683805|NCT02104323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65683806|NCT02104323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65683807|NCT02104323|Growth Substances|growth substances|mesh-ancestor
65683808|NCT02104323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683809|NCT02104323|Growth Inhibitors|growth inhibitors|mesh-ancestor
65683810|NCT02107365|Interferons|interferons|mesh-list
65683811|NCT02107365|Ribavirin|ribavirin|mesh-list
65683812|NCT02107365|Interferon-alpha|interferon-alpha|mesh-list
65683813|NCT02107365|Interferon alpha-2|interferon alpha-2|mesh-list
65683814|NCT02107365|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65683815|NCT02107365|Asunaprevir|asunaprevir|mesh-list
65683816|NCT02107365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683817|NCT02107365|Antiviral Agents|antiviral agents|mesh-ancestor
65683818|NCT02107365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65683819|NCT02107365|Antimetabolites|antimetabolites|mesh-ancestor
65683820|NCT02107365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683821|NCT02107365|Immunologic Factors|immunologic factors|mesh-ancestor
65683822|NCT02107365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683823|NCT02107365|Protease Inhibitors|protease inhibitors|mesh-ancestor
65683824|NCT02107365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683825|NCT02110719|Acetaminophen|acetaminophen|mesh-list
65683826|NCT02110719|Dexamethasone|dexamethasone|mesh-list
65683827|NCT02110719|Ibuprofen|ibuprofen|mesh-list
65683828|NCT02110719|Celecoxib|celecoxib|mesh-list
65683829|NCT02110719|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65683830|NCT02110719|Oxycodone|oxycodone|mesh-list
65683831|NCT02110719|Gabapentin|gabapentin|mesh-list
65683832|NCT02110719|Hydromorphone|hydromorphone|mesh-list
65683833|NCT02110719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65683834|NCT02110719|Antiemetics|antiemetics|mesh-ancestor
65683835|NCT02110719|Autonomic Agents|autonomic agents|mesh-ancestor
65683836|NCT02110719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65683837|NCT02110719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683838|NCT02110719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65683839|NCT02110719|Glucocorticoids|glucocorticoids|mesh-ancestor
65683840|NCT02110719|Hormones|hormones|mesh-ancestor
65683841|NCT02110719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65683842|NCT02110719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65683843|NCT02110719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683844|NCT02110719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65683845|NCT02110719|Analgesics|analgesics|mesh-ancestor
65683846|NCT02110719|Sensory System Agents|sensory system agents|mesh-ancestor
65683847|NCT02110719|Antipyretics|antipyretics|mesh-ancestor
65683848|NCT02110719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65683849|NCT02110719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65683850|NCT02110719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65683851|NCT02110719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683852|NCT02110719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683853|NCT02110719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65683854|NCT02110719|Narcotics|narcotics|mesh-ancestor
65683855|NCT02110719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65683856|NCT02110719|Anticonvulsants|anticonvulsants|mesh-ancestor
65683857|NCT02110719|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65683858|NCT02110719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65683859|NCT02110719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65683860|NCT02110719|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65146530|NCT00624039|Miotics|miotics|mesh-ancestor
65683861|NCT02110719|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65683862|NCT02110719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65683863|NCT02110719|Antimanic Agents|antimanic agents|mesh-ancestor
65683864|NCT02110719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65683865|NCT02105103|Insulin|insulin|mesh-list
65683866|NCT02105103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65683867|NCT02105103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683868|NCT03012165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65683869|NCT03012165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65683870|NCT02107755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65683871|NCT02107755|Ipilimumab|ipilimumab|mesh-list
65683872|NCT02107755|Antibodies|antibodies|mesh-list
65683873|NCT02107755|Immunoglobulins|immunoglobulins|mesh-list
65683874|NCT02107755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65683875|NCT02107755|Immunologic Factors|immunologic factors|mesh-ancestor
65683876|NCT02107755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683877|NCT02107755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683878|NCT02107755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65683879|NCT02107755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683880|NCT02110953|Irinotecan|irinotecan|mesh-list
65683881|NCT02110953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65683882|NCT02110953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65683883|NCT02110953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683884|NCT02110953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683885|NCT02110953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683886|NCT03554109|Leucovorin|leucovorin|mesh-list
65683887|NCT03554109|Paclitaxel|paclitaxel|mesh-list
65683888|NCT03554109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65683889|NCT03554109|Cyclophosphamide|cyclophosphamide|mesh-list
65683890|NCT03554109|Doxorubicin|doxorubicin|mesh-list
65683891|NCT03554109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65683892|NCT03554109|Fluorouracil|fluorouracil|mesh-list
65683893|NCT03554109|Avelumab|avelumab|mesh-list
65683894|NCT03554109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65683895|NCT03554109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65683896|NCT03554109|Tubulin Modulators|tubulin modulators|mesh-ancestor
65683897|NCT03554109|Antimitotic Agents|antimitotic agents|mesh-ancestor
65683898|NCT03554109|Mitosis Modulators|mitosis modulators|mesh-ancestor
65683899|NCT03554109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683900|NCT03554109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65683901|NCT03554109|Immunologic Factors|immunologic factors|mesh-ancestor
65683902|NCT03554109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683903|NCT03554109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65683904|NCT03554109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65683905|NCT03554109|Alkylating Agents|alkylating agents|mesh-ancestor
65683906|NCT03554109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65683907|NCT03554109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65683908|NCT03554109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65683909|NCT03554109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65683910|NCT03554109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683911|NCT03554109|Antimetabolites|antimetabolites|mesh-ancestor
65683912|NCT03554109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65683913|NCT03554109|Antidotes|antidotes|mesh-ancestor
65683914|NCT03554109|Protective Agents|protective agents|mesh-ancestor
65683915|NCT03554109|Vitamin B Complex|vitamin b complex|mesh-ancestor
65683916|NCT03554109|Vitamins|vitamins|mesh-ancestor
65683917|NCT03554109|Micronutrients|micronutrients|mesh-ancestor
65683918|NCT03554109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65683919|NCT03554031|Hormones|hormones|mesh-list
65683920|NCT03554031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65683921|NCT03554031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683922|NCT02111265|Sufentanil|sufentanil|mesh-list
65683923|NCT02111265|Remifentanil|remifentanil|mesh-list
65683924|NCT02111265|Cisatracurium|cisatracurium|mesh-list
65683925|NCT02111265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65683926|NCT02111265|Narcotics|narcotics|mesh-ancestor
65683927|NCT02111265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65683928|NCT02111265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683929|NCT02111265|Analgesics|analgesics|mesh-ancestor
65683930|NCT02111265|Sensory System Agents|sensory system agents|mesh-ancestor
65683931|NCT02111265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65683932|NCT02111265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65683933|NCT02111265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65683934|NCT02111265|Anesthetics, General|anesthetics, general|mesh-ancestor
65683935|NCT02111265|Anesthetics|anesthetics|mesh-ancestor
65683936|NCT02111265|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65683937|NCT02111265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65683938|NCT02251119|Ritonavir|ritonavir|mesh-list
65683939|NCT02251119|Tipranavir|tipranavir|mesh-list
65683940|NCT02251119|Loperamide|loperamide|mesh-list
65683941|NCT02251119|Antidiarrheals|antidiarrheals|mesh-list
65683942|NCT02251119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65683943|NCT02251119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65683944|NCT02251119|Protease Inhibitors|protease inhibitors|mesh-ancestor
65683945|NCT02251119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683946|NCT02251119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683947|NCT02251119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65683948|NCT02251119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65683949|NCT02251119|Antiviral Agents|antiviral agents|mesh-ancestor
65683950|NCT02251119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65683951|NCT02251119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65683952|NCT02251119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65683953|NCT02251119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65683954|NCT02105493|Nitroglycerin|nitroglycerin|mesh-list
65683955|NCT02105493|Vasodilator Agents|vasodilator agents|mesh-ancestor
65683956|NCT02111421|Dexmedetomidine|dexmedetomidine|mesh-list
65683957|NCT02111421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65683958|NCT02111421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65683959|NCT02111421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683960|NCT02111421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65683961|NCT02111421|Analgesics|analgesics|mesh-ancestor
65683962|NCT02111421|Sensory System Agents|sensory system agents|mesh-ancestor
65683963|NCT02111421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65683964|NCT02111421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65683965|NCT02111421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65683966|NCT02111421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65683967|NCT02111421|Adrenergic Agents|adrenergic agents|mesh-ancestor
65683968|NCT02111421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65683969|NCT02111421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683970|NCT02108301|Cyclosporine|cyclosporine|mesh-list
65683971|NCT02108301|Tacrolimus|tacrolimus|mesh-list
65683972|NCT02108301|Cyclosporins|cyclosporins|mesh-list
65683973|NCT02108301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65683974|NCT02108301|Immunologic Factors|immunologic factors|mesh-ancestor
65683975|NCT02108301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683976|NCT02108301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65683977|NCT02108301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683978|NCT02108301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683979|NCT02108301|Antifungal Agents|antifungal agents|mesh-ancestor
65683980|NCT02108301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65683981|NCT02108301|Dermatologic Agents|dermatologic agents|mesh-ancestor
65683982|NCT02108301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65683983|NCT02108535|Sulfadiazine|sulfadiazine|mesh-list
65683984|NCT02108535|Silver Sulfadiazine|silver sulfadiazine|mesh-list
65683985|NCT02108535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65683986|NCT02108535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65683987|NCT02108535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65683988|NCT02108535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65683989|NCT02108535|Coccidiostats|coccidiostats|mesh-ancestor
65683990|NCT02108535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65683991|NCT02114073|Cyclosporine|cyclosporine|mesh-list
65683992|NCT02114073|Betamethasone|betamethasone|mesh-list
65683993|NCT02114073|Cyclosporins|cyclosporins|mesh-list
65683994|NCT02114073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65683995|NCT02114073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65683996|NCT02114073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65683997|NCT02114073|Immunologic Factors|immunologic factors|mesh-ancestor
65683998|NCT02114073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65683999|NCT02114073|Antifungal Agents|antifungal agents|mesh-ancestor
65684000|NCT02114073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65684001|NCT02114073|Dermatologic Agents|dermatologic agents|mesh-ancestor
65684002|NCT02114073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65684003|NCT02114073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65684004|NCT02114073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65684005|NCT02114073|Glucocorticoids|glucocorticoids|mesh-ancestor
65684006|NCT02114073|Hormones|hormones|mesh-ancestor
65684007|NCT02114073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65684008|NCT02114073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65684009|NCT02114073|Respiratory System Agents|respiratory system agents|mesh-ancestor
65684010|NCT02114463|Flurbiprofen|flurbiprofen|mesh-list
65684011|NCT02114463|Analgesics|analgesics|mesh-list
65684012|NCT02114463|Ropivacaine|ropivacaine|mesh-list
65684013|NCT02114463|Anesthetics, Local|anesthetics, local|mesh-ancestor
65684014|NCT02114463|Anesthetics|anesthetics|mesh-ancestor
65684015|NCT02114463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65684016|NCT02114463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684017|NCT02114463|Sensory System Agents|sensory system agents|mesh-ancestor
65684018|NCT02114463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65684019|NCT02114463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65684020|NCT02114463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65684021|NCT02114463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65684022|NCT02114463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65684023|NCT02114463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65684024|NCT02114463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684025|NCT02114463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684026|NCT02114697|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65684027|NCT02114697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65684028|NCT02114697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65684029|NCT02114697|Antimetabolites|antimetabolites|mesh-ancestor
65684030|NCT02114697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684031|NCT02114697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65684032|NCT02114697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65684033|NCT02114697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684034|NCT02114775|Sildenafil Citrate|sildenafil citrate|mesh-list
65684035|NCT02114775|Hormones|hormones|mesh-list
65684036|NCT02114775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65684037|NCT02114775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481361|NCT04728646|Dexamethasone|dexamethasone|mesh-list
65684038|NCT02114775|Vasodilator Agents|vasodilator agents|mesh-ancestor
65684039|NCT02114775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65684040|NCT02114775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65684041|NCT02114775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684042|NCT02114775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684043|NCT02114775|Urological Agents|urological agents|mesh-ancestor
65684044|NCT02108847|Ropivacaine|ropivacaine|mesh-list
65684045|NCT02108847|Anesthetics, Local|anesthetics, local|mesh-ancestor
65684046|NCT02108847|Anesthetics|anesthetics|mesh-ancestor
65684047|NCT02108847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65684048|NCT02108847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684049|NCT02108847|Sensory System Agents|sensory system agents|mesh-ancestor
65684050|NCT02108847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65684051|NCT02251431|Exenatide|exenatide|mesh-list
65684052|NCT02251431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65684053|NCT02251431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684054|NCT02251431|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65684055|NCT02251431|Incretins|incretins|mesh-ancestor
65684056|NCT02251431|Hormones|hormones|mesh-ancestor
65684057|NCT02251431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65684058|NCT03553329|Trametinib|trametinib|mesh-list
65684059|NCT03553329|Dabrafenib|dabrafenib|mesh-list
65684060|NCT03553329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684061|NCT03553329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65684062|NCT03553329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684063|NCT03553329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684064|NCT02115087|Morphine|morphine|mesh-list
65684065|NCT02115087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65684066|NCT02115087|Narcotics|narcotics|mesh-ancestor
65684067|NCT02115087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65684068|NCT02115087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684069|NCT02115087|Analgesics|analgesics|mesh-ancestor
65684070|NCT02115087|Sensory System Agents|sensory system agents|mesh-ancestor
65684071|NCT02115087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65684072|NCT02115243|Ipilimumab|ipilimumab|mesh-list
65684073|NCT02115243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65684074|NCT02115243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684075|NCT02115243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65684076|NCT02115243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684077|NCT02109315|Liraglutide|liraglutide|mesh-list
65684078|NCT02109315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684079|NCT02109315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65684080|NCT02109315|Incretins|incretins|mesh-ancestor
65684081|NCT02109315|Hormones|hormones|mesh-ancestor
65684082|NCT02109315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65684083|NCT02112903|Vortioxetine|vortioxetine|mesh-list
65684084|NCT02112903|Antidepressive Agents|antidepressive agents|mesh-ancestor
65684085|NCT02112903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65684086|NCT02112903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65684087|NCT02112903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65684088|NCT02112903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65684089|NCT02112903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684090|NCT02112903|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65684091|NCT02112903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65684092|NCT02112903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65684093|NCT02112903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684094|NCT02112903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65684095|NCT02112903|Serotonin Agents|serotonin agents|mesh-ancestor
65684096|NCT02112903|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65684097|NCT02112903|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65684098|NCT02112903|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65684099|NCT02112903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65684100|NCT02112981|Sirolimus|sirolimus|mesh-list
65684101|NCT02112981|Everolimus|everolimus|mesh-list
65684102|NCT02112981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684103|NCT02112981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65684104|NCT02112981|Immunologic Factors|immunologic factors|mesh-ancestor
65684105|NCT02112981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684106|NCT02112981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65684107|NCT02112981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65684108|NCT02112981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65684109|NCT02112981|Antifungal Agents|antifungal agents|mesh-ancestor
65684110|NCT02113137|Chlorine dioxide|chlorine dioxide|mesh-list
65684111|NCT02113137|Dental Disinfectants|dental disinfectants|mesh-ancestor
65684112|NCT02113137|Disinfectants|disinfectants|mesh-ancestor
65684114|NCT02116257|Propacetamol|propacetamol|mesh-list
65684115|NCT02116257|Analgesics|analgesics|mesh-ancestor
65684116|NCT02116257|Sensory System Agents|sensory system agents|mesh-ancestor
65684117|NCT02116257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65684118|NCT02116257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684119|NCT02116257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65684120|NCT02116257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65684121|NCT02116257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65684122|NCT02116257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65684123|NCT02109627|Cytarabine|cytarabine|mesh-list
65684124|NCT02109627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65684125|NCT02109627|Antimetabolites|antimetabolites|mesh-ancestor
65684126|NCT02109627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684127|NCT02109627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684128|NCT02109627|Antiviral Agents|antiviral agents|mesh-ancestor
65684129|NCT02109627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65684130|NCT02109627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65684131|NCT02109627|Immunologic Factors|immunologic factors|mesh-ancestor
65684132|NCT02109627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684133|NCT02116569|Daratumumab|daratumumab|mesh-list
65684134|NCT02116569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684135|NCT02109783|Caffeine|caffeine|mesh-list
65684136|NCT02109783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65684137|NCT02109783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684138|NCT02109783|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65684139|NCT02109783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684140|NCT02109783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684141|NCT02109783|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65684142|NCT02109783|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65684143|NCT02109783|Purinergic Agents|purinergic agents|mesh-ancestor
65684144|NCT02109783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65684145|NCT02109861|Dexamethasone|dexamethasone|mesh-list
65684146|NCT02109861|Bortezomib|bortezomib|mesh-list
65684147|NCT02109861|Melphalan|melphalan|mesh-list
65684148|NCT02109861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65684149|NCT02109861|Antiemetics|antiemetics|mesh-ancestor
65684150|NCT02109861|Autonomic Agents|autonomic agents|mesh-ancestor
65684151|NCT02109861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65684152|NCT02109861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684153|NCT02109861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65684154|NCT02109861|Glucocorticoids|glucocorticoids|mesh-ancestor
65684155|NCT02109861|Hormones|hormones|mesh-ancestor
65684156|NCT02109861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65684157|NCT02109861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65684158|NCT02109861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684159|NCT02109861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65684160|NCT02109861|Alkylating Agents|alkylating agents|mesh-ancestor
65684161|NCT02109861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684162|NCT02109861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65684163|NCT02109861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65684164|NCT02109861|Immunologic Factors|immunologic factors|mesh-ancestor
65684165|NCT02118753|Eplerenone|eplerenone|mesh-list
65684166|NCT02118753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65684167|NCT02118753|Hormone Antagonists|hormone antagonists|mesh-ancestor
65684168|NCT02118753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65684169|NCT02118753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684170|NCT02118753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65684171|NCT02118753|Diuretics|diuretics|mesh-ancestor
65684172|NCT02118753|Natriuretic Agents|natriuretic agents|mesh-ancestor
65684173|NCT02118753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65684174|NCT02118909|Itraconazole|itraconazole|mesh-list
65684175|NCT02118909|Ciprofloxacin|ciprofloxacin|mesh-list
65684176|NCT02118909|Antifungal Agents|antifungal agents|mesh-ancestor
65684177|NCT02118909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65684178|NCT02118909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65684179|NCT02118909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65684180|NCT02118909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684181|NCT02118909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684182|NCT02118909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65684183|NCT02118909|Hormone Antagonists|hormone antagonists|mesh-ancestor
65684184|NCT02118909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65481509|NCT03851432|Metformin|metformin|mesh-list
65684185|NCT02118909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684186|NCT02118909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65684187|NCT02118909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65684188|NCT02118909|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65684189|NCT02118909|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65684190|NCT02118909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684191|NCT02118909|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65684193|NCT02118987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65684194|NCT02118987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65684195|NCT02118987|Respiratory System Agents|respiratory system agents|mesh-ancestor
65684196|NCT02119143|Vitamins|vitamins|mesh-list
65684197|NCT02119143|Micronutrients|micronutrients|mesh-ancestor
65684198|NCT02119143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684199|NCT02116959|Carboplatin|carboplatin|mesh-list
65684200|NCT02116959|Etoposide|etoposide|mesh-list
65684201|NCT02116959|Vincristine|vincristine|mesh-list
65684202|NCT02116959|Melphalan|melphalan|mesh-list
65684203|NCT02116959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684204|NCT02116959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65684205|NCT02116959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65684206|NCT02116959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65684207|NCT02116959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684208|NCT02116959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684209|NCT02116959|Tubulin Modulators|tubulin modulators|mesh-ancestor
65684210|NCT02116959|Antimitotic Agents|antimitotic agents|mesh-ancestor
65684211|NCT02116959|Mitosis Modulators|mitosis modulators|mesh-ancestor
65684212|NCT02116959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65684213|NCT02116959|Alkylating Agents|alkylating agents|mesh-ancestor
65684214|NCT02116959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65684215|NCT02116959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65684216|NCT02116959|Immunologic Factors|immunologic factors|mesh-ancestor
65684217|NCT02116959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684218|NCT03553173|Bupropion|bupropion|mesh-list
65684219|NCT03553173|Varenicline|varenicline|mesh-list
65684220|NCT03553173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65684221|NCT03553173|Antidepressive Agents|antidepressive agents|mesh-ancestor
65684222|NCT03553173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65684223|NCT03553173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65684224|NCT03553173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65684225|NCT03553173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65684226|NCT03553173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684227|NCT03553173|Dopamine Agents|dopamine agents|mesh-ancestor
65684228|NCT03553173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65684229|NCT03553173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684230|NCT03553173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65684231|NCT03553173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65684232|NCT03553173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684233|NCT03553173|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65684234|NCT03553173|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65684235|NCT03553173|Cholinergic Agents|cholinergic agents|mesh-ancestor
65684236|NCT01330017|Loratadine|loratadine|mesh-list
65684237|NCT01330017|Phenylephrine|phenylephrine|mesh-list
65684238|NCT01330017|Oxymetazoline|oxymetazoline|mesh-list
65684239|NCT01330017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65684240|NCT01330017|Mydriatics|mydriatics|mesh-ancestor
65684241|NCT01330017|Autonomic Agents|autonomic agents|mesh-ancestor
65684242|NCT01330017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65684243|NCT01330017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684244|NCT01330017|Sympathomimetics|sympathomimetics|mesh-ancestor
65684245|NCT01330017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65684246|NCT01330017|Nasal Decongestants|nasal decongestants|mesh-ancestor
65684247|NCT01330017|Respiratory System Agents|respiratory system agents|mesh-ancestor
65684248|NCT01330017|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65684249|NCT01330017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65684250|NCT01330017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65684251|NCT01330017|Adrenergic Agents|adrenergic agents|mesh-ancestor
65684252|NCT01330017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65684253|NCT01330017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684254|NCT01330017|Protective Agents|protective agents|mesh-ancestor
65684255|NCT01330017|Antipruritics|antipruritics|mesh-ancestor
65684256|NCT01330017|Dermatologic Agents|dermatologic agents|mesh-ancestor
65684257|NCT01330017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65684258|NCT01330017|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65684259|NCT01330017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65684260|NCT01330017|Histamine Antagonists|histamine antagonists|mesh-ancestor
65684261|NCT01330017|Histamine Agents|histamine agents|mesh-ancestor
65684262|NCT02123121|Resveratrol|resveratrol|mesh-list
65684263|NCT02123121|Antioxidants|antioxidants|mesh-ancestor
65684264|NCT02123121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684265|NCT02123121|Protective Agents|protective agents|mesh-ancestor
65684266|NCT02123121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684267|NCT02123121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684268|NCT02123121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65684269|NCT02117583|Oxycodone|oxycodone|mesh-list
65684270|NCT02117583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65684271|NCT02117583|Narcotics|narcotics|mesh-ancestor
65684272|NCT02117583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65684273|NCT02117583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684274|NCT02117583|Analgesics|analgesics|mesh-ancestor
65684275|NCT02117583|Sensory System Agents|sensory system agents|mesh-ancestor
65684276|NCT02117583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65684277|NCT02117739|Dapsone|dapsone|mesh-list
65684278|NCT02117739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65684279|NCT02117739|Antimalarials|antimalarials|mesh-ancestor
65684280|NCT02117739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65684281|NCT02117739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65684282|NCT02117739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65684283|NCT02117739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684284|NCT02117739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684285|NCT02117739|Leprostatic Agents|leprostatic agents|mesh-ancestor
65684286|NCT02117739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65684287|NCT02251509|Metoprolol|metoprolol|mesh-list
65684288|NCT02251509|Carvedilol|carvedilol|mesh-list
65684289|NCT02251509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65684290|NCT02251509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65684291|NCT02251509|Sympatholytics|sympatholytics|mesh-ancestor
65684292|NCT02251509|Autonomic Agents|autonomic agents|mesh-ancestor
65684293|NCT02251509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65684294|NCT02251509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684295|NCT02251509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65684296|NCT02251509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65684297|NCT02251509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65684298|NCT02251509|Adrenergic Agents|adrenergic agents|mesh-ancestor
65684299|NCT02251509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65684300|NCT02251509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684301|NCT02251509|Antioxidants|antioxidants|mesh-ancestor
65684302|NCT02251509|Protective Agents|protective agents|mesh-ancestor
65684303|NCT02251509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65684304|NCT02251509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65684305|NCT02251509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65684306|NCT02251509|Vasodilator Agents|vasodilator agents|mesh-ancestor
65684307|NCT02251509|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65684308|NCT02251509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65684309|NCT02986659|Metformin|metformin|mesh-list
65684310|NCT02986659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65684311|NCT02986659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684312|NCT02118051|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65684313|NCT02118051|Progesterone|progesterone|mesh-list
65684314|NCT02118051|Ganirelix|ganirelix|mesh-list
65684315|NCT02118051|Progestins|progestins|mesh-ancestor
65684316|NCT02118051|Hormones|hormones|mesh-ancestor
65684317|NCT02118051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65684318|NCT02118051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684319|NCT02118051|Hormone Antagonists|hormone antagonists|mesh-ancestor
65684320|NCT02118051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65684321|NCT02123355|Dexmedetomidine|dexmedetomidine|mesh-list
65684322|NCT02123355|Remifentanil|remifentanil|mesh-list
65684323|NCT02123355|Sevoflurane|sevoflurane|mesh-list
65684324|NCT02123355|Vecuronium Bromide|vecuronium bromide|mesh-list
65684325|NCT02123355|Anesthetics|anesthetics|mesh-ancestor
65684326|NCT02123355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65684327|NCT02123355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684328|NCT02123355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65684329|NCT02123355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65684330|NCT02123355|Analgesics|analgesics|mesh-ancestor
65684331|NCT02123355|Sensory System Agents|sensory system agents|mesh-ancestor
65684332|NCT02123355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65684333|NCT02123355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65684334|NCT02123355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65684335|NCT02123355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65684336|NCT02123355|Adrenergic Agents|adrenergic agents|mesh-ancestor
65684337|NCT02123355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65684338|NCT02123355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684339|NCT02123355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65684340|NCT02123355|Narcotics|narcotics|mesh-ancestor
65684341|NCT02123355|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65684342|NCT02123355|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65684343|NCT02123355|Anesthetics, General|anesthetics, general|mesh-ancestor
65684344|NCT02123355|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65684345|NCT02123355|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65684346|NCT02123355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65684347|NCT02123355|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65684348|NCT02123355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65684349|NCT02123355|Cholinergic Agents|cholinergic agents|mesh-ancestor
65684350|NCT02123433|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65684351|NCT02123433|Immunologic Factors|immunologic factors|mesh-ancestor
65684352|NCT02123433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684353|NCT02123589|Fentanyl|fentanyl|mesh-list
65684354|NCT02123589|Midazolam|midazolam|mesh-list
65684355|NCT02123589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65684356|NCT02123589|Narcotics|narcotics|mesh-ancestor
65684357|NCT02123589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65684358|NCT02123589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684359|NCT02123589|Analgesics|analgesics|mesh-ancestor
65684360|NCT02123589|Sensory System Agents|sensory system agents|mesh-ancestor
65684361|NCT02123589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65684362|NCT02123589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65684363|NCT02123589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65684364|NCT02123589|Anesthetics, General|anesthetics, general|mesh-ancestor
65684365|NCT02123589|Anesthetics|anesthetics|mesh-ancestor
65684366|NCT02123589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65684367|NCT02123589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65684368|NCT02123589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65684369|NCT02123589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65684370|NCT02123589|GABA Modulators|gaba modulators|mesh-ancestor
65684371|NCT02123589|GABA Agents|gaba agents|mesh-ancestor
65684372|NCT02123589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65684373|NCT02123589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684374|NCT02120547|Cenicriviroc|cenicriviroc|mesh-list
65684375|NCT02120547|Liver Extracts|liver extracts|mesh-list
65684376|NCT02120547|Hematinics|hematinics|mesh-ancestor
65684377|NCT02120547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65684378|NCT02120547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684379|NCT02120547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65684380|NCT02120547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65684381|NCT02120547|Antiviral Agents|antiviral agents|mesh-ancestor
65684382|NCT02120547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65684383|NCT02120703|Pregabalin|pregabalin|mesh-list
65684384|NCT02120703|Gabapentin|gabapentin|mesh-list
65684385|NCT02120703|Analgesics|analgesics|mesh-ancestor
65684386|NCT02120703|Sensory System Agents|sensory system agents|mesh-ancestor
65684387|NCT02120703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65684388|NCT02120703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684389|NCT02120703|Anticonvulsants|anticonvulsants|mesh-ancestor
65684390|NCT02120703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65684391|NCT02120703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65684392|NCT02120703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684393|NCT02120703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65684394|NCT02120703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65684395|NCT02120703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65684396|NCT02120703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65684397|NCT02120703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65684398|NCT02120703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65684399|NCT02120703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65684400|NCT02120703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65684401|NCT02120703|Antimanic Agents|antimanic agents|mesh-ancestor
65684402|NCT02118285|Cyclophosphamide|cyclophosphamide|mesh-list
65684403|NCT02118285|Fludarabine|fludarabine|mesh-list
65684404|NCT02118285|Interleukin-2|interleukin-2|mesh-list
65684405|NCT02118285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65684406|NCT02118285|Immunologic Factors|immunologic factors|mesh-ancestor
65684407|NCT02118285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684408|NCT02118285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65684409|NCT02118285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65684410|NCT02118285|Alkylating Agents|alkylating agents|mesh-ancestor
65481736|NCT01197170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65684411|NCT02118285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684412|NCT02118285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684413|NCT02118285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65684414|NCT02118285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65684416|NCT02118285|Sensory System Agents|sensory system agents|mesh-ancestor
65684417|NCT02118285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65684418|NCT03552705|Tranexamic Acid|tranexamic acid|mesh-list
65684419|NCT03552705|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65684420|NCT03552705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65684421|NCT03552705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684422|NCT03552705|Hemostatics|hemostatics|mesh-ancestor
65684423|NCT03552705|Coagulants|coagulants|mesh-ancestor
65684424|NCT02118675|Deuterium Oxide|deuterium oxide|mesh-list
65684425|NCT02118675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684426|NCT02118675|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65684427|NCT02118675|Protective Agents|protective agents|mesh-ancestor
65684428|NCT02118675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684429|NCT02123979|Rotigotine|rotigotine|mesh-list
65684430|NCT02123979|Dopamine Agonists|dopamine agonists|mesh-ancestor
65684431|NCT02123979|Dopamine Agents|dopamine agents|mesh-ancestor
65684432|NCT02123979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65684433|NCT02123979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684434|NCT02123979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684435|NCT03552315|Chromium|chromium|mesh-list
65684436|NCT03552315|Trace Elements|trace elements|mesh-ancestor
65684437|NCT03552315|Micronutrients|micronutrients|mesh-ancestor
65684438|NCT03552315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684439|NCT02120859|Paclitaxel|paclitaxel|mesh-list
65684440|NCT02120859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65684441|NCT02120859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684442|NCT02120859|Tubulin Modulators|tubulin modulators|mesh-ancestor
65684443|NCT02120859|Antimitotic Agents|antimitotic agents|mesh-ancestor
65684444|NCT02120859|Mitosis Modulators|mitosis modulators|mesh-ancestor
65684445|NCT02120859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684446|NCT02126943|Macitentan|macitentan|mesh-list
65684447|NCT02126943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65684448|NCT02126943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65684449|NCT02126943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684450|NCT02126943|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65684451|NCT03551847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65684452|NCT03551847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65684453|NCT03551847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65684454|NCT03551847|Antitubercular Agents|antitubercular agents|mesh-ancestor
65684455|NCT00150462|Dexamethasone|dexamethasone|mesh-list
65684456|NCT00150462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65684457|NCT00150462|Antiemetics|antiemetics|mesh-ancestor
65684458|NCT00150462|Autonomic Agents|autonomic agents|mesh-ancestor
65684459|NCT00150462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65684460|NCT00150462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684461|NCT00150462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65684462|NCT00150462|Glucocorticoids|glucocorticoids|mesh-ancestor
65684463|NCT00150462|Hormones|hormones|mesh-ancestor
65684464|NCT00150462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65684465|NCT00150462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65684466|NCT00150462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684467|NCT00095550|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65684468|NCT00095550|Irbesartan|irbesartan|mesh-list
65684469|NCT00095550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65684470|NCT00095550|Diuretics|diuretics|mesh-ancestor
65684471|NCT00095550|Natriuretic Agents|natriuretic agents|mesh-ancestor
65684472|NCT00095550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684473|NCT00095550|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65684474|NCT00095550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65684475|NCT00095550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684476|NCT00095550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65684477|NCT00095550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65684478|NCT00095394|Irbesartan|irbesartan|mesh-list
65684479|NCT00095394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65684480|NCT00095394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65147170|NCT01074268|Insulin|insulin|mesh-list
65684481|NCT00095394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65684482|NCT00095394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684483|NCT00093132|Satraplatin|satraplatin|mesh-list
65684484|NCT00093132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684486|NCT05717400|Sofosbuvir|sofosbuvir|mesh-list
65684487|NCT05717400|Velpatasvir|velpatasvir|mesh-list
65684488|NCT05717400|Bevacizumab|bevacizumab|mesh-list
65684489|NCT05717400|Atezolizumab|atezolizumab|mesh-list
65684490|NCT05717400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65684491|NCT05717400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684492|NCT05717400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65684493|NCT05717400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65684494|NCT05717400|Growth Substances|growth substances|mesh-ancestor
65684495|NCT05717400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684496|NCT05717400|Growth Inhibitors|growth inhibitors|mesh-ancestor
65684497|NCT05717400|Antimetabolites|antimetabolites|mesh-ancestor
65684498|NCT05717400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684499|NCT05717400|Antiviral Agents|antiviral agents|mesh-ancestor
65684500|NCT05717400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65684501|NCT00080106|Vaccines|vaccines|mesh-list
65684502|NCT00080106|Immunologic Factors|immunologic factors|mesh-ancestor
65684503|NCT00080106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684504|NCT00333216|Hydrocortisone|hydrocortisone|mesh-list
65684505|NCT00333216|Anecortave|anecortave|mesh-list
65684506|NCT00333216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65684507|NCT00333216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65684508|NCT00333216|Growth Substances|growth substances|mesh-ancestor
65684509|NCT00333216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684510|NCT00333216|Growth Inhibitors|growth inhibitors|mesh-ancestor
65684511|NCT00333216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684512|NCT00333216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65684513|NCT00332748|Taxane|taxane|mesh-list
65684514|NCT00332748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684515|NCT03530436|Curcumin|curcumin|mesh-list
65684516|NCT03530436|Turmeric extract|turmeric extract|mesh-list
65684517|NCT03530436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65684518|NCT03530436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65684519|NCT03530436|Analgesics|analgesics|mesh-ancestor
65684520|NCT03530436|Sensory System Agents|sensory system agents|mesh-ancestor
65684521|NCT03530436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65684522|NCT03530436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684523|NCT03530436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65684524|NCT03530436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65684525|NCT03530436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684526|NCT03530436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684527|NCT03530436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684528|NCT03530436|Antioxidants|antioxidants|mesh-ancestor
65684529|NCT03530436|Protective Agents|protective agents|mesh-ancestor
65684530|NCT03530280|Pregabalin|pregabalin|mesh-list
65684531|NCT03530280|Bupivacaine|bupivacaine|mesh-list
65684532|NCT03530280|Anesthetics, Local|anesthetics, local|mesh-ancestor
65684533|NCT03530280|Anesthetics|anesthetics|mesh-ancestor
65684534|NCT03530280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65684535|NCT03530280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684536|NCT03530280|Sensory System Agents|sensory system agents|mesh-ancestor
65684537|NCT03530280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65684538|NCT03530280|Analgesics|analgesics|mesh-ancestor
65684539|NCT03530280|Anticonvulsants|anticonvulsants|mesh-ancestor
65684540|NCT03530280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65684541|NCT03530280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65684542|NCT03530280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684543|NCT03530280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65684544|NCT03530280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65684545|NCT03530280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65684546|NCT03530280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65684547|NCT00079482|Cytarabine|cytarabine|mesh-list
65684548|NCT00079482|Etoposide|etoposide|mesh-list
65684549|NCT00079482|Mitoxantrone|mitoxantrone|mesh-list
65684550|NCT00079482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65684551|NCT00079482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684552|NCT00079482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65684553|NCT00079482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65684554|NCT00079482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684555|NCT00079482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684556|NCT00079482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65684557|NCT00079482|Antimetabolites|antimetabolites|mesh-ancestor
65684558|NCT00079482|Antiviral Agents|antiviral agents|mesh-ancestor
65684559|NCT00079482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65684560|NCT00079482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65684561|NCT00079482|Immunologic Factors|immunologic factors|mesh-ancestor
65684562|NCT00079482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684563|NCT00079482|Analgesics|analgesics|mesh-ancestor
65684564|NCT00079482|Sensory System Agents|sensory system agents|mesh-ancestor
65684565|NCT00079482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65684566|NCT00073866|Celecoxib|celecoxib|mesh-list
65684567|NCT00073866|Docetaxel|docetaxel|mesh-list
65684568|NCT00073866|Irinotecan|irinotecan|mesh-list
65684569|NCT00073866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684570|NCT00073866|Tubulin Modulators|tubulin modulators|mesh-ancestor
65684571|NCT00073866|Antimitotic Agents|antimitotic agents|mesh-ancestor
65684572|NCT00073866|Mitosis Modulators|mitosis modulators|mesh-ancestor
65684573|NCT00073866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684574|NCT00073866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65684575|NCT00073866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65684576|NCT00073866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684577|NCT00073866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65684578|NCT00073866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65684579|NCT00073866|Analgesics|analgesics|mesh-ancestor
65684580|NCT00073866|Sensory System Agents|sensory system agents|mesh-ancestor
65684581|NCT00073866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65684582|NCT00073866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684583|NCT00073866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65684584|NCT00073866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65684585|NCT00073866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65684586|NCT00073866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65684587|NCT00325650|Rimonabant|rimonabant|mesh-list
65684588|NCT00325650|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65684589|NCT00325650|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65684590|NCT00325650|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65684591|NCT00325650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65684592|NCT00325650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684593|NCT00325650|Hormones|hormones|mesh-ancestor
65684594|NCT00325650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65684595|NCT00325650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684596|NCT00070590|Bosentan|bosentan|mesh-list
65684597|NCT00070590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65268839|NCT04215432|Propolis|propolis|mesh-list
65684598|NCT00070590|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65684599|NCT00070590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684600|NCT00067782|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65684601|NCT00067782|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65684602|NCT00067782|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65684603|NCT00067782|Protease Inhibitors|protease inhibitors|mesh-ancestor
65684604|NCT00067782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684605|NCT00067782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684606|NCT00067782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65684607|NCT00067782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65684608|NCT00067782|Antiviral Agents|antiviral agents|mesh-ancestor
65684609|NCT00067782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65684610|NCT00058266|Genistein|genistein|mesh-list
65684611|NCT00058266|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65684612|NCT00058266|Protective Agents|protective agents|mesh-ancestor
65684613|NCT00058266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684614|NCT00058266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684615|NCT00058266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65684616|NCT00058266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684617|NCT00058266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684618|NCT00058266|Phytoestrogens|phytoestrogens|mesh-ancestor
65684619|NCT00058266|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65684620|NCT00058266|Estrogens|estrogens|mesh-ancestor
65684621|NCT00058266|Hormones|hormones|mesh-ancestor
65684622|NCT00058266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65684623|NCT00313794|Tremelimumab|tremelimumab|mesh-list
65684624|NCT00313794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684625|NCT00313248|Sagopilone|sagopilone|mesh-list
65684626|NCT00313248|Epothilones|epothilones|mesh-list
65684627|NCT00313248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684628|NCT00313248|Tubulin Modulators|tubulin modulators|mesh-ancestor
65684629|NCT00313248|Antimitotic Agents|antimitotic agents|mesh-ancestor
65684630|NCT00313248|Mitosis Modulators|mitosis modulators|mesh-ancestor
65684631|NCT00313248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684632|NCT00310830|Bosentan|bosentan|mesh-list
65684633|NCT00310830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65684634|NCT00310830|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65684635|NCT00310830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684636|NCT00035568|Metformin|metformin|mesh-list
65684637|NCT00035568|Glyburide|glyburide|mesh-list
65684638|NCT00035568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65684639|NCT00035568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684640|NCT00031512|Pleconaril|pleconaril|mesh-list
65684641|NCT00031512|Antiviral Agents|antiviral agents|mesh-ancestor
65684642|NCT00031512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65684643|NCT00307398|Hydrocortisone|hydrocortisone|mesh-list
65684644|NCT00307398|Anecortave|anecortave|mesh-list
65684645|NCT00307398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65684646|NCT00307398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65684647|NCT00307398|Growth Substances|growth substances|mesh-ancestor
65684648|NCT00307398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684649|NCT00307398|Growth Inhibitors|growth inhibitors|mesh-ancestor
65684650|NCT00307398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684651|NCT00307398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65684652|NCT01368081|Metformin|metformin|mesh-list
65684653|NCT01368081|Empagliflozin|empagliflozin|mesh-list
65684654|NCT01368081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65684655|NCT01368081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684656|NCT01368081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65684657|NCT01368081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684658|NCT02127489|Bupivacaine|bupivacaine|mesh-list
65684659|NCT02127489|Anesthetics, Local|anesthetics, local|mesh-ancestor
65684660|NCT02127489|Anesthetics|anesthetics|mesh-ancestor
65684661|NCT02127489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65684662|NCT02127489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684663|NCT02127489|Sensory System Agents|sensory system agents|mesh-ancestor
65684664|NCT02127489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65684665|NCT02124369|Gemcitabine|gemcitabine|mesh-list
65684666|NCT02124369|Paclitaxel|paclitaxel|mesh-list
65684667|NCT02124369|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65684668|NCT02124369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65684669|NCT02124369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684670|NCT02124369|Tubulin Modulators|tubulin modulators|mesh-ancestor
65684671|NCT02124369|Antimitotic Agents|antimitotic agents|mesh-ancestor
65684672|NCT02124369|Mitosis Modulators|mitosis modulators|mesh-ancestor
65684673|NCT02124369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684674|NCT02124369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65684675|NCT02124369|Antimetabolites|antimetabolites|mesh-ancestor
65684676|NCT02124369|Antiviral Agents|antiviral agents|mesh-ancestor
65684677|NCT02124369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65684678|NCT02124369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684679|NCT02124369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65684680|NCT02124369|Immunologic Factors|immunologic factors|mesh-ancestor
65684681|NCT02124369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684682|NCT00004914|Epoetin Alfa|epoetin alfa|mesh-list
65684683|NCT00004914|Hematinics|hematinics|mesh-ancestor
65684684|NCT00286806|Gossypol acetic acid|gossypol acetic acid|mesh-list
65684685|NCT00286806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65684686|NCT00286806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684687|NCT00286806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65684688|NCT00286806|Contraceptive Agents|contraceptive agents|mesh-ancestor
65684689|NCT00286806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65684690|NCT00286806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684691|NCT00286806|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
65684692|NCT00286806|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
65684693|NCT00286806|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65684694|NCT00004908|Cyclophosphamide|cyclophosphamide|mesh-list
65684695|NCT00004908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65684696|NCT00004908|Immunologic Factors|immunologic factors|mesh-ancestor
65684697|NCT00004908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684698|NCT00004908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65684699|NCT00004908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65684700|NCT00004908|Alkylating Agents|alkylating agents|mesh-ancestor
65684701|NCT00004908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684702|NCT00004908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684703|NCT00004908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65684704|NCT00004902|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
65684705|NCT00004902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684706|NCT00004902|Immunologic Factors|immunologic factors|mesh-ancestor
65684707|NCT00004902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684708|NCT04441398|Nitazoxanide|nitazoxanide|mesh-list
65684709|NCT04441398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65482043|NCT01066169|Lactitol|lactitol|mesh-list
65684710|NCT04441398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65684711|NCT03551067|Midazolam|midazolam|mesh-list
65684712|NCT03551067|Dexmedetomidine|dexmedetomidine|mesh-list
65684713|NCT03551067|Ketamine|ketamine|mesh-list
65684714|NCT03551067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65684715|NCT03551067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65684716|NCT03551067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684717|NCT03551067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65684718|NCT03551067|Analgesics|analgesics|mesh-ancestor
65684719|NCT03551067|Sensory System Agents|sensory system agents|mesh-ancestor
65684720|NCT03551067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65684721|NCT03551067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65684722|NCT03551067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65684723|NCT03551067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65684724|NCT03551067|Adrenergic Agents|adrenergic agents|mesh-ancestor
65684725|NCT03551067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65684726|NCT03551067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684727|NCT03551067|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65684728|NCT03551067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65684729|NCT03551067|Anesthetics, General|anesthetics, general|mesh-ancestor
65684730|NCT03551067|Anesthetics|anesthetics|mesh-ancestor
65684731|NCT03551067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65684732|NCT03551067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65684733|NCT03551067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65684734|NCT03551067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65684735|NCT03551067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65684736|NCT03551067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65684737|NCT03551067|GABA Modulators|gaba modulators|mesh-ancestor
65684738|NCT03551067|GABA Agents|gaba agents|mesh-ancestor
65684739|NCT03529266|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65684740|NCT03529266|Hemostatics|hemostatics|mesh-ancestor
65684741|NCT03529266|Coagulants|coagulants|mesh-ancestor
65684742|NCT02128191|Ibuprofen|ibuprofen|mesh-list
65684743|NCT02128191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65684744|NCT02128191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65684745|NCT02128191|Analgesics|analgesics|mesh-ancestor
65684746|NCT02128191|Sensory System Agents|sensory system agents|mesh-ancestor
65684747|NCT02128191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65684748|NCT02128191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684749|NCT02128191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65684750|NCT02128191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65684751|NCT02128191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65684752|NCT02128191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684753|NCT02128191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684754|NCT00004896|Cyclophosphamide|cyclophosphamide|mesh-list
65684755|NCT00004896|Busulfan|busulfan|mesh-list
65684756|NCT00004896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65684757|NCT00004896|Immunologic Factors|immunologic factors|mesh-ancestor
65684758|NCT00004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684759|NCT00004896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65684760|NCT00004896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65684761|NCT00004896|Alkylating Agents|alkylating agents|mesh-ancestor
65684762|NCT00004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684763|NCT00004896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684764|NCT00004896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65684765|NCT02121951|Lidocaine|lidocaine|mesh-list
65684766|NCT02121951|Fentanyl|fentanyl|mesh-list
65684767|NCT02121951|Midazolam|midazolam|mesh-list
65684768|NCT02121951|Anesthetics|anesthetics|mesh-list
65684769|NCT02121951|Levobupivacaine|levobupivacaine|mesh-list
65684770|NCT02121951|Anesthetics, Local|anesthetics, local|mesh-list
65684771|NCT02121951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65684772|NCT02121951|Narcotics|narcotics|mesh-ancestor
65684773|NCT02121951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65684774|NCT02121951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684775|NCT02121951|Analgesics|analgesics|mesh-ancestor
65684776|NCT02121951|Sensory System Agents|sensory system agents|mesh-ancestor
65684777|NCT02121951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65684778|NCT02121951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65684779|NCT02121951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65684780|NCT02121951|Anesthetics, General|anesthetics, general|mesh-ancestor
65684781|NCT02121951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65684782|NCT02121951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65684783|NCT02121951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65684784|NCT02121951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65684785|NCT02121951|GABA Modulators|gaba modulators|mesh-ancestor
65684786|NCT02121951|GABA Agents|gaba agents|mesh-ancestor
65684787|NCT02121951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65684788|NCT02121951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684789|NCT02121951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65684790|NCT02121951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65684791|NCT02121951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65684792|NCT02121951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65684793|NCT05473858|Phentolamine|phentolamine|mesh-list
65684794|NCT05473858|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65268893|NCT04677504|Growth Inhibitors|growth inhibitors|mesh-ancestor
65684795|NCT05473858|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65684796|NCT05473858|Adrenergic Agents|adrenergic agents|mesh-ancestor
65684797|NCT05473858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65684798|NCT05473858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684799|NCT05473858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684800|NCT05473858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65684801|NCT00004584|Ritonavir|ritonavir|mesh-list
65684802|NCT00004584|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65684803|NCT00004584|Saquinavir|saquinavir|mesh-list
65684804|NCT00004584|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65684805|NCT00004584|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65684806|NCT00004584|Protease Inhibitors|protease inhibitors|mesh-ancestor
65684807|NCT00004584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684808|NCT00004584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684809|NCT00004584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65684810|NCT00004584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65684811|NCT00004584|Antiviral Agents|antiviral agents|mesh-ancestor
65684812|NCT00004584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65684813|NCT00004584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65684814|NCT00004584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65684815|NCT00004230|Cyclophosphamide|cyclophosphamide|mesh-list
65684816|NCT00004230|Captopril|captopril|mesh-list
65684817|NCT00004230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65684818|NCT00004230|Immunologic Factors|immunologic factors|mesh-ancestor
65684819|NCT00004230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684820|NCT00004230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65684821|NCT00004230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65684822|NCT00004230|Alkylating Agents|alkylating agents|mesh-ancestor
65684823|NCT00004230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684824|NCT00004230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684825|NCT00004230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65684826|NCT00004230|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65684827|NCT00004230|Protease Inhibitors|protease inhibitors|mesh-ancestor
65684828|NCT00004230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684829|NCT00004230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65684830|NCT02252367|Tadalafil|tadalafil|mesh-list
65684831|NCT02252367|Vasodilator Agents|vasodilator agents|mesh-ancestor
65684832|NCT02252367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65684833|NCT02252367|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65684834|NCT02252367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684835|NCT02252367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684836|NCT02252367|Urological Agents|urological agents|mesh-ancestor
65684837|NCT00004182|Irinotecan|irinotecan|mesh-list
65684838|NCT00004182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65684839|NCT00004182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65684840|NCT00004182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684841|NCT00004182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684842|NCT00004182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684843|NCT02124525|Acetylcysteine|acetylcysteine|mesh-list
65684844|NCT02124525|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65684845|NCT02124525|Antiviral Agents|antiviral agents|mesh-ancestor
65684846|NCT02124525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65684847|NCT02124525|Expectorants|expectorants|mesh-ancestor
65684848|NCT02124525|Respiratory System Agents|respiratory system agents|mesh-ancestor
65684849|NCT02124525|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65684850|NCT02124525|Antioxidants|antioxidants|mesh-ancestor
65684851|NCT02124525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684852|NCT02124525|Protective Agents|protective agents|mesh-ancestor
65684853|NCT02124525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684854|NCT02124525|Antidotes|antidotes|mesh-ancestor
65684855|NCT04331002|Triamcinolone|triamcinolone|mesh-list
65684856|NCT04331002|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65684857|NCT04331002|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65684858|NCT04331002|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65482189|NCT01202084|Respiratory System Agents|respiratory system agents|mesh-ancestor
65684859|NCT04331002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65684860|NCT04331002|Glucocorticoids|glucocorticoids|mesh-ancestor
65684861|NCT04331002|Hormones|hormones|mesh-ancestor
65684862|NCT04331002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65684863|NCT04331002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684864|NCT04331002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65684865|NCT04331002|Immunologic Factors|immunologic factors|mesh-ancestor
65684866|NCT04331002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684867|NCT04331002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684868|NCT05725512|Prednisolone|prednisolone|mesh-list
65684869|NCT05725512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65684870|NCT05725512|Glucocorticoids|glucocorticoids|mesh-ancestor
65684871|NCT05725512|Hormones|hormones|mesh-ancestor
65684872|NCT05725512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65684873|NCT05725512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684874|NCT05725512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65684875|NCT05725512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684876|NCT02124681|Hydroxychloroquine|hydroxychloroquine|mesh-list
65684877|NCT02124681|Antimalarials|antimalarials|mesh-ancestor
65684878|NCT02124681|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65684879|NCT02124681|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65684880|NCT02124681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65684881|NCT02124681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684882|NCT02124681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684883|NCT02124681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65684884|NCT02128425|Leucovorin|leucovorin|mesh-list
65684885|NCT02128425|Fluorouracil|fluorouracil|mesh-list
65684886|NCT02128425|Oxaliplatin|oxaliplatin|mesh-list
65684887|NCT02128425|Irinotecan|irinotecan|mesh-list
65684888|NCT02128425|Levoleucovorin|levoleucovorin|mesh-list
65684889|NCT02128425|Antimetabolites|antimetabolites|mesh-ancestor
65684890|NCT02128425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684891|NCT02128425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65684892|NCT02128425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684893|NCT02128425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65684894|NCT02128425|Immunologic Factors|immunologic factors|mesh-ancestor
65684895|NCT02128425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684896|NCT02128425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65684897|NCT02128425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65684898|NCT02128425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684899|NCT02128425|Antidotes|antidotes|mesh-ancestor
65684900|NCT02128425|Protective Agents|protective agents|mesh-ancestor
65684901|NCT02128425|Vitamin B Complex|vitamin b complex|mesh-ancestor
65684902|NCT02128425|Vitamins|vitamins|mesh-ancestor
65684903|NCT02128425|Micronutrients|micronutrients|mesh-ancestor
65684904|NCT05641194|Caffeine|caffeine|mesh-list
65684905|NCT05641194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65684906|NCT05641194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684907|NCT05641194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65268932|NCT03851627|Hormones|hormones|mesh-ancestor
65684908|NCT05641194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684909|NCT05641194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684910|NCT05641194|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65684911|NCT05641194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65684912|NCT05641194|Purinergic Agents|purinergic agents|mesh-ancestor
65684913|NCT05641194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65684914|NCT03532620|Calcium, Dietary|calcium, dietary|mesh-list
65684915|NCT03532620|Atorvastatin|atorvastatin|mesh-list
65684916|NCT03532620|Pitavastatin|pitavastatin|mesh-list
65684917|NCT03532620|Calcium|calcium|mesh-list
65684918|NCT03532620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65684919|NCT03532620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684920|NCT03532620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65684921|NCT03532620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65684922|NCT03532620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65684923|NCT03532620|Antimetabolites|antimetabolites|mesh-ancestor
65684924|NCT03532620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684925|NCT03532620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65684926|NCT03532620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65684927|NCT03532620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684928|NCT02288130|Ulipristal acetate|ulipristal acetate|mesh-list
65684929|NCT02288130|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65684930|NCT02288130|Contraceptive Agents|contraceptive agents|mesh-ancestor
65684931|NCT02288130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65684932|NCT02288130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684933|NCT02288130|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65684934|NCT03529032|Methadone|methadone|mesh-list
65684935|NCT03529032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65482264|NCT01204346|Psychotropic Drugs|psychotropic drugs|mesh-list
65684936|NCT03529032|Narcotics|narcotics|mesh-ancestor
65684937|NCT03529032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65684938|NCT03529032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684939|NCT03529032|Analgesics|analgesics|mesh-ancestor
65684940|NCT03529032|Sensory System Agents|sensory system agents|mesh-ancestor
65684941|NCT03529032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65684942|NCT03529032|Antitussive Agents|antitussive agents|mesh-ancestor
65684943|NCT03529032|Respiratory System Agents|respiratory system agents|mesh-ancestor
65684944|NCT02122731|Amiloride|amiloride|mesh-list
65684945|NCT02122731|Diuretics|diuretics|mesh-ancestor
65684946|NCT02122731|Natriuretic Agents|natriuretic agents|mesh-ancestor
65684947|NCT02122731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684948|NCT02122731|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65684949|NCT02122731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65684950|NCT02122731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65684951|NCT02122731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684952|NCT02122731|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65684953|NCT02122731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65684954|NCT05458726|Paclitaxel|paclitaxel|mesh-list
65684955|NCT05458726|Carboplatin|carboplatin|mesh-list
65684956|NCT05458726|Pemetrexed|pemetrexed|mesh-list
65684957|NCT05458726|Osimertinib|osimertinib|mesh-list
65684958|NCT05458726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65684959|NCT05458726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684960|NCT05458726|Tubulin Modulators|tubulin modulators|mesh-ancestor
65684961|NCT05458726|Antimitotic Agents|antimitotic agents|mesh-ancestor
65684962|NCT05458726|Mitosis Modulators|mitosis modulators|mesh-ancestor
65684963|NCT05458726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684964|NCT05458726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684965|NCT05458726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65684966|NCT05458726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65684967|NCT05458726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65684968|NCT02122809|Chiauranib|chiauranib|mesh-list
65684969|NCT02122809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684970|NCT02122809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65684971|NCT02122809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684972|NCT02122809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684973|NCT00150618|Guanfacine|guanfacine|mesh-list
65684974|NCT00150618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65684975|NCT00150618|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65684976|NCT00150618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65684977|NCT00150618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65684978|NCT00150618|Adrenergic Agents|adrenergic agents|mesh-ancestor
65684979|NCT00150618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65684980|NCT00150618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684981|NCT00150618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65684982|NCT05455294|Decitabine|decitabine|mesh-list
65684983|NCT05455294|Venetoclax|venetoclax|mesh-list
65684984|NCT05455294|Navitoclax|navitoclax|mesh-list
65684985|NCT05455294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65684986|NCT05455294|Antimetabolites|antimetabolites|mesh-ancestor
65684987|NCT05455294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65684988|NCT05455294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65684989|NCT05455294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65684990|NCT03532464|Azithromycin|azithromycin|mesh-list
65684991|NCT03532464|Doxycycline|doxycycline|mesh-list
65684992|NCT03532464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65684993|NCT03532464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65684994|NCT03532464|Antimalarials|antimalarials|mesh-ancestor
65684995|NCT03532464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65684996|NCT03532464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65684997|NCT02128893|Isavuconazole|isavuconazole|mesh-list
65684998|NCT02128893|Esomeprazole|esomeprazole|mesh-list
65684999|NCT02128893|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65685000|NCT02128893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65685001|NCT02128893|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65685002|NCT02128893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685003|NCT02128893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685004|NCT02128893|Antifungal Agents|antifungal agents|mesh-ancestor
65685005|NCT02128893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65685006|NCT02128971|Ferrous fumarate|ferrous fumarate|mesh-list
65685007|NCT02128971|Trace Elements|trace elements|mesh-ancestor
65685008|NCT02128971|Micronutrients|micronutrients|mesh-ancestor
65685009|NCT02128971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685010|NCT02288208|Tenofovir|tenofovir|mesh-list
65685011|NCT02288208|Entecavir|entecavir|mesh-list
65685012|NCT02288208|Antiviral Agents|antiviral agents|mesh-list
65685013|NCT02288208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65685014|NCT02288208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65685015|NCT02288208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65685016|NCT02288208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685017|NCT02288208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685018|NCT02288208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65685019|NCT02288208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65685020|NCT05610826|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65685021|NCT05610826|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65685022|NCT05610826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685023|NCT02288286|Vaccines|vaccines|mesh-list
65685024|NCT02288286|Immunologic Factors|immunologic factors|mesh-ancestor
65685025|NCT02288286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685026|NCT02251977|Leucovorin|leucovorin|mesh-list
65685027|NCT02251977|Fluorouracil|fluorouracil|mesh-list
65685028|NCT02251977|Capecitabine|capecitabine|mesh-list
65685029|NCT02251977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685030|NCT02251977|Antimetabolites|antimetabolites|mesh-ancestor
65685031|NCT02251977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685032|NCT02251977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65685033|NCT02251977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685034|NCT02251977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65685035|NCT02251977|Immunologic Factors|immunologic factors|mesh-ancestor
65685036|NCT02251977|Antidotes|antidotes|mesh-ancestor
65685037|NCT02251977|Protective Agents|protective agents|mesh-ancestor
65685038|NCT02251977|Vitamin B Complex|vitamin b complex|mesh-ancestor
65685039|NCT02251977|Vitamins|vitamins|mesh-ancestor
65685040|NCT02251977|Micronutrients|micronutrients|mesh-ancestor
65685041|NCT03528954|Propofol|propofol|mesh-list
65685042|NCT03528954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65685043|NCT03528954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65685044|NCT03528954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685045|NCT03528954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65685046|NCT03528954|Anesthetics, General|anesthetics, general|mesh-ancestor
65685047|NCT03528954|Anesthetics|anesthetics|mesh-ancestor
65685048|NCT02125227|Metformin|metformin|mesh-list
65685049|NCT02125227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65685050|NCT02125227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65685051|NCT02125227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685052|NCT02125227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65685053|NCT02125227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65685054|NCT02125227|Antimetabolites|antimetabolites|mesh-ancestor
65685055|NCT02125227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685056|NCT02125227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65685057|NCT02125227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65685058|NCT02125227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685059|NCT02129127|Paclitaxel|paclitaxel|mesh-list
65685060|NCT02129127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65685061|NCT02129127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685062|NCT02129127|Tubulin Modulators|tubulin modulators|mesh-ancestor
65685063|NCT02129127|Antimitotic Agents|antimitotic agents|mesh-ancestor
65685064|NCT02129127|Mitosis Modulators|mitosis modulators|mesh-ancestor
65685065|NCT02129127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685066|NCT05554822|Aspirin|aspirin|mesh-list
65685067|NCT05554822|Clopidogrel|clopidogrel|mesh-list
65685068|NCT05554822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65685069|NCT05554822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65685070|NCT05554822|Analgesics|analgesics|mesh-ancestor
65685071|NCT05554822|Sensory System Agents|sensory system agents|mesh-ancestor
65685072|NCT05554822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65685073|NCT05554822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685074|NCT05554822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65685075|NCT05554822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65685076|NCT05554822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65685077|NCT05554822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65685078|NCT05554822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685079|NCT05554822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65685080|NCT05554822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65685081|NCT05554822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685082|NCT05554822|Antipyretics|antipyretics|mesh-ancestor
65685083|NCT05554822|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65685084|NCT05554822|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65685085|NCT05554822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65685086|NCT05554822|Purinergic Agents|purinergic agents|mesh-ancestor
65482434|NCT05153668|Everolimus|everolimus|mesh-list
65685087|NCT05554822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65685089|NCT02125305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65685090|NCT02125305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685091|NCT00254904|Gemcitabine|gemcitabine|mesh-list
65685092|NCT00254904|Cisplatin|cisplatin|mesh-list
65685093|NCT00254904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685094|NCT00254904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65685095|NCT00254904|Antimetabolites|antimetabolites|mesh-ancestor
65685096|NCT00254904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685097|NCT00254904|Antiviral Agents|antiviral agents|mesh-ancestor
65685098|NCT00254904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65685099|NCT00254904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685100|NCT00254904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65685101|NCT00254904|Immunologic Factors|immunologic factors|mesh-ancestor
65685102|NCT00254904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685103|NCT05725122|Tamsulosin|tamsulosin|mesh-list
65685104|NCT05725122|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65685105|NCT05725122|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65685106|NCT05725122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65685107|NCT05725122|Adrenergic Agents|adrenergic agents|mesh-ancestor
65685108|NCT05725122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65685109|NCT05725122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685110|NCT05725122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685111|NCT05725122|Urological Agents|urological agents|mesh-ancestor
65685112|NCT03880396|Cisplatin|cisplatin|mesh-list
65685113|NCT03880396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685114|NCT05554276|Antibodies|antibodies|mesh-list
65685115|NCT05554276|Immunologic Factors|immunologic factors|mesh-ancestor
65685116|NCT05554276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685117|NCT00253968|SR 46349B|sr 46349b|mesh-list
65685118|NCT00253968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65685119|NCT00253968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65685120|NCT00253968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685121|NCT00253968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65685122|NCT00253968|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65685123|NCT00253968|Serotonin Agents|serotonin agents|mesh-ancestor
65685124|NCT00253968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65685125|NCT00253968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685126|NCT03544606|Pyridoxine|pyridoxine|mesh-list
65685127|NCT03544606|Isosorbide|isosorbide|mesh-list
65685128|NCT03544606|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65685129|NCT03544606|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65685130|NCT03544606|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65685131|NCT03544606|Diuretics|diuretics|mesh-ancestor
65685132|NCT03544606|Natriuretic Agents|natriuretic agents|mesh-ancestor
65685133|NCT03544606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685134|NCT03544606|Vasodilator Agents|vasodilator agents|mesh-ancestor
65685135|NCT03544606|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65685136|NCT03544606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685137|NCT03544606|Vitamin B Complex|vitamin b complex|mesh-ancestor
65685138|NCT03544606|Vitamins|vitamins|mesh-ancestor
65685139|NCT03544606|Micronutrients|micronutrients|mesh-ancestor
65685140|NCT02741310|Sumatriptan|sumatriptan|mesh-list
65685141|NCT02741310|Erenumab|erenumab|mesh-list
65685142|NCT02741310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65685143|NCT02741310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65685144|NCT02741310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65685145|NCT02741310|Serotonin Agents|serotonin agents|mesh-ancestor
65685146|NCT02741310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65685147|NCT02741310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685148|NCT02741310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685149|NCT02741310|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65685150|NCT02741310|Analgesics|analgesics|mesh-ancestor
65685151|NCT02741310|Sensory System Agents|sensory system agents|mesh-ancestor
65685152|NCT02741310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65685153|NCT05700448|Gemcitabine|gemcitabine|mesh-list
65685154|NCT05700448|Oxaliplatin|oxaliplatin|mesh-list
65685155|NCT05700448|Pegaspargase|pegaspargase|mesh-list
65685156|NCT05700448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65685157|NCT05700448|Antimetabolites|antimetabolites|mesh-ancestor
65685158|NCT05700448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685159|NCT05700448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685160|NCT05700448|Antiviral Agents|antiviral agents|mesh-ancestor
65685161|NCT05700448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65685162|NCT05700448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685163|NCT05700448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65685164|NCT05700448|Immunologic Factors|immunologic factors|mesh-ancestor
65685165|NCT05700448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685166|NCT00243906|Plasminogen|plasminogen|mesh-list
65685167|NCT00243906|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65685168|NCT00243906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65685169|NCT00243906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65685170|NCT00243906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685171|NCT05537220|Acetylcysteine|acetylcysteine|mesh-list
65685172|NCT05537220|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65685173|NCT05537220|Antiviral Agents|antiviral agents|mesh-ancestor
65685174|NCT05537220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65685175|NCT05537220|Expectorants|expectorants|mesh-ancestor
65685176|NCT05537220|Respiratory System Agents|respiratory system agents|mesh-ancestor
65685177|NCT05537220|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65685178|NCT05537220|Antioxidants|antioxidants|mesh-ancestor
65685179|NCT05537220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685180|NCT05537220|Protective Agents|protective agents|mesh-ancestor
65685181|NCT05537220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685182|NCT05537220|Antidotes|antidotes|mesh-ancestor
65685183|NCT01367457|Sirolimus|sirolimus|mesh-list
65685184|NCT01367457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65685185|NCT01367457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65685186|NCT01367457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65685187|NCT01367457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685188|NCT01367457|Antifungal Agents|antifungal agents|mesh-ancestor
65685189|NCT01367457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65685190|NCT01367457|Immunologic Factors|immunologic factors|mesh-ancestor
65685191|NCT01367457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685192|NCT05553496|Cyclosporine|cyclosporine|mesh-list
65685193|NCT05553496|Dexamethasone|dexamethasone|mesh-list
65685194|NCT05553496|Dexamethasone acetate|dexamethasone acetate|mesh-list
65685195|NCT05553496|Cyclophosphamide|cyclophosphamide|mesh-list
65685196|NCT05553496|Rituximab|rituximab|mesh-list
65685197|NCT05553496|Tacrolimus|tacrolimus|mesh-list
65685198|NCT05553496|Cyclosporins|cyclosporins|mesh-list
65685199|NCT05553496|BB 1101|bb 1101|mesh-list
65685200|NCT05553496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65685201|NCT05553496|Immunologic Factors|immunologic factors|mesh-ancestor
65685202|NCT05553496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685203|NCT05553496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65685204|NCT05553496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65685205|NCT05553496|Alkylating Agents|alkylating agents|mesh-ancestor
65685206|NCT05553496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685207|NCT05553496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685208|NCT05553496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65685209|NCT05553496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65685210|NCT05553496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65685211|NCT05553496|Antiemetics|antiemetics|mesh-ancestor
65685212|NCT05553496|Autonomic Agents|autonomic agents|mesh-ancestor
65685213|NCT05553496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65685214|NCT05553496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65685215|NCT05553496|Glucocorticoids|glucocorticoids|mesh-ancestor
65685216|NCT05553496|Hormones|hormones|mesh-ancestor
65685217|NCT05553496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65685218|NCT05553496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65685219|NCT05553496|Protease Inhibitors|protease inhibitors|mesh-ancestor
65685220|NCT05553496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685221|NCT05553496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65685222|NCT05553496|Antifungal Agents|antifungal agents|mesh-ancestor
65685223|NCT05553496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65685224|NCT05553496|Dermatologic Agents|dermatologic agents|mesh-ancestor
65685225|NCT00239694|Vaccines|vaccines|mesh-list
65685226|NCT00239694|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65685227|NCT00239694|Immunologic Factors|immunologic factors|mesh-ancestor
65685228|NCT00239694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685229|NCT05700214|Lidocaine|lidocaine|mesh-list
65685230|NCT05700214|Ropivacaine|ropivacaine|mesh-list
65685231|NCT05700214|Anesthetics, Local|anesthetics, local|mesh-ancestor
65685232|NCT05700214|Anesthetics|anesthetics|mesh-ancestor
65685233|NCT05700214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65685234|NCT05700214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685235|NCT05700214|Sensory System Agents|sensory system agents|mesh-ancestor
65685236|NCT05700214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65685237|NCT05700214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65685238|NCT05700214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65685239|NCT05700214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65685240|NCT05700214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65685241|NCT05700214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685243|NCT05549284|Methotrexate|methotrexate|mesh-list
65685244|NCT05549284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65685245|NCT05549284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685246|NCT05549284|Immunologic Factors|immunologic factors|mesh-ancestor
65685247|NCT05549284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685248|NCT05549284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65685249|NCT05549284|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65685250|NCT05549284|Abortifacient Agents|abortifacient agents|mesh-ancestor
65685251|NCT05549284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65685252|NCT05549284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65685253|NCT05549284|Antimetabolites|antimetabolites|mesh-ancestor
65685254|NCT05549284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685255|NCT05549284|Dermatologic Agents|dermatologic agents|mesh-ancestor
65685256|NCT05549284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685257|NCT05549284|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65685258|NCT05549284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65685259|NCT05549284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65685260|NCT03065218|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
65685261|NCT03065218|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65685262|NCT03065218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685263|NCT00232752|Sirolimus|sirolimus|mesh-list
65685264|NCT00232752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65685265|NCT00232752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65685266|NCT00232752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65685267|NCT00232752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685268|NCT00232752|Antifungal Agents|antifungal agents|mesh-ancestor
65685269|NCT00232752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65685270|NCT00232752|Immunologic Factors|immunologic factors|mesh-ancestor
65685271|NCT00232752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685272|NCT02125617|Prednisolone|prednisolone|mesh-list
65685273|NCT02125617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65685274|NCT02125617|Glucocorticoids|glucocorticoids|mesh-ancestor
65685275|NCT02125617|Hormones|hormones|mesh-ancestor
65685276|NCT02125617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65685277|NCT02125617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685278|NCT02125617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65685279|NCT02125617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685280|NCT02131545|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65685281|NCT02131545|Antidepressive Agents|antidepressive agents|mesh-ancestor
65685282|NCT02131545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65685283|NCT02131545|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65685284|NCT02131545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65685285|NCT02131545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65685286|NCT02131545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685287|NCT00229008|Linezolid|linezolid|mesh-list
65685288|NCT00229008|Ceftazidime|ceftazidime|mesh-list
65685289|NCT00229008|Ceftobiprole|ceftobiprole|mesh-list
65685290|NCT00229008|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
65685291|NCT00229008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65685292|NCT00229008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65685293|NCT00229008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65685294|NCT00229008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685295|NCT00229008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685296|NCT05553184|Niacin|niacin|mesh-list
65685297|NCT05553184|Nicotinic Acids|nicotinic acids|mesh-list
65685298|NCT05553184|Niacinamide|niacinamide|mesh-list
65685299|NCT05553184|Formoterol Fumarate|formoterol fumarate|mesh-list
65685300|NCT05553184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65685301|NCT05553184|Autonomic Agents|autonomic agents|mesh-ancestor
65685302|NCT05553184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65685303|NCT05553184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685304|NCT05553184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65685305|NCT05553184|Respiratory System Agents|respiratory system agents|mesh-ancestor
65685306|NCT05553184|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65685307|NCT05553184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65685308|NCT05553184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65685309|NCT05553184|Adrenergic Agents|adrenergic agents|mesh-ancestor
65685310|NCT05553184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65685311|NCT05553184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685312|NCT05553184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65482655|NCT03902912|Hormones|hormones|mesh-ancestor
65685313|NCT05553184|Antimetabolites|antimetabolites|mesh-ancestor
65685314|NCT05553184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65685315|NCT05553184|Vasodilator Agents|vasodilator agents|mesh-ancestor
65685316|NCT05553184|Vitamin B Complex|vitamin b complex|mesh-ancestor
65685317|NCT05553184|Vitamins|vitamins|mesh-ancestor
65685318|NCT05553184|Micronutrients|micronutrients|mesh-ancestor
65685319|NCT03059992|Ibrexafungerp|ibrexafungerp|mesh-list
65685320|NCT03059992|Antifungal Agents|antifungal agents|mesh-ancestor
65685321|NCT03059992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65685322|NCT05242029|Psilocybin|psilocybin|mesh-list
65685323|NCT05242029|Hallucinogens|hallucinogens|mesh-ancestor
65685324|NCT05242029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685325|NCT05242029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65685326|NCT03528564|Epoetin Alfa|epoetin alfa|mesh-list
65685327|NCT03528564|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65685328|NCT03528564|Hematinics|hematinics|mesh-ancestor
65685329|NCT03531372|Antacids|antacids|mesh-list
65685330|NCT03531372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685331|NCT03531372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65685332|NCT02129595|Resveratrol|resveratrol|mesh-list
65685333|NCT02129595|Antioxidants|antioxidants|mesh-ancestor
65685334|NCT02129595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685335|NCT02129595|Protective Agents|protective agents|mesh-ancestor
65685336|NCT02129595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685337|NCT02129595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685338|NCT02129595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65685339|NCT02129673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65685340|NCT02129673|Latanoprost|latanoprost|mesh-list
65685341|NCT02129673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65685342|NCT02260557|Selexipag|selexipag|mesh-list
65685343|NCT02260557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65685344|NCT02129829|Tenofovir|tenofovir|mesh-list
65685345|NCT02129829|Antiviral Agents|antiviral agents|mesh-ancestor
65685346|NCT02129829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65685347|NCT02129829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65685348|NCT02129829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65685349|NCT02129829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685350|NCT02129829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685351|NCT02129829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65685352|NCT02129829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65685353|NCT02494882|Dexamethasone|dexamethasone|mesh-list
65685354|NCT02494882|Dasatinib|dasatinib|mesh-list
65685355|NCT02494882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65685356|NCT02494882|Antiemetics|antiemetics|mesh-ancestor
65685357|NCT02494882|Autonomic Agents|autonomic agents|mesh-ancestor
65685358|NCT02494882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65685359|NCT02494882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685360|NCT02494882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65685361|NCT02494882|Glucocorticoids|glucocorticoids|mesh-ancestor
65685362|NCT02494882|Hormones|hormones|mesh-ancestor
65685363|NCT02494882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65685364|NCT02494882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65685365|NCT02494882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685366|NCT02494882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65685367|NCT02494882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685368|NCT02494882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685369|NCT02129985|Metformin|metformin|mesh-list
65685370|NCT02129985|Exenatide|exenatide|mesh-list
65685371|NCT02129985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65685372|NCT02129985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685373|NCT02129985|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65685374|NCT02129985|Incretins|incretins|mesh-ancestor
65685375|NCT02129985|Hormones|hormones|mesh-ancestor
65685376|NCT02129985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65685377|NCT01730638|Histamine|histamine|mesh-list
65685378|NCT01730638|Glycine|glycine|mesh-list
65685379|NCT01730638|Histamine Agonists|histamine agonists|mesh-ancestor
65685380|NCT01730638|Histamine Agents|histamine agents|mesh-ancestor
65685381|NCT01730638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65685382|NCT01730638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685383|NCT01730638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685384|NCT01730638|Glycine Agents|glycine agents|mesh-ancestor
65685385|NCT02252523|Dexmedetomidine|dexmedetomidine|mesh-list
65685386|NCT02252523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65685387|NCT02252523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65685388|NCT02252523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685389|NCT02252523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65685390|NCT02252523|Analgesics|analgesics|mesh-ancestor
65685391|NCT02252523|Sensory System Agents|sensory system agents|mesh-ancestor
65685392|NCT02252523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65685393|NCT02252523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65685394|NCT02252523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65685395|NCT02252523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65685396|NCT02252523|Adrenergic Agents|adrenergic agents|mesh-ancestor
65685397|NCT02252523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65685398|NCT02252523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685400|NCT02132091|Vitamin E|vitamin e|mesh-list
65685401|NCT02132091|Micronutrients|micronutrients|mesh-ancestor
65685402|NCT02132091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685403|NCT02132091|Antioxidants|antioxidants|mesh-ancestor
65685404|NCT02132091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685405|NCT02132091|Protective Agents|protective agents|mesh-ancestor
65685406|NCT05548348|Aflutinib|aflutinib|mesh-list
65685407|NCT05548348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65685408|NCT05548348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685409|NCT05548348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685410|NCT05726370|Carboplatin|carboplatin|mesh-list
65685411|NCT05726370|Docetaxel|docetaxel|mesh-list
65685412|NCT05726370|Pembrolizumab|pembrolizumab|mesh-list
65685413|NCT05726370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685414|NCT05726370|Tubulin Modulators|tubulin modulators|mesh-ancestor
65685415|NCT05726370|Antimitotic Agents|antimitotic agents|mesh-ancestor
65685416|NCT05726370|Mitosis Modulators|mitosis modulators|mesh-ancestor
65685417|NCT05726370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685418|NCT05726370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65685419|NCT04469010|Iron|iron|mesh-list
65685420|NCT04469010|Chelating Agents|chelating agents|mesh-list
65685421|NCT04469010|Micronutrients|micronutrients|mesh-ancestor
65685422|NCT04469010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685423|NCT04469010|Trace Elements|trace elements|mesh-ancestor
65685424|NCT04469010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685425|NCT04469010|Sequestering Agents|sequestering agents|mesh-ancestor
65685426|NCT01121224|Clopidogrel|clopidogrel|mesh-list
65685427|NCT01121224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65685428|NCT01121224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65685429|NCT01121224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65685430|NCT01121224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65685431|NCT01121224|Purinergic Agents|purinergic agents|mesh-ancestor
65685432|NCT01121224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65685433|NCT01121224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685434|NCT01121224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685435|NCT00138762|Atorvastatin|atorvastatin|mesh-list
65685436|NCT00138762|Torcetrapib|torcetrapib|mesh-list
65685437|NCT00138762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65685438|NCT00138762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65685439|NCT00138762|Antimetabolites|antimetabolites|mesh-ancestor
65685440|NCT00138762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685441|NCT00138762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65685442|NCT00138762|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65685443|NCT00138762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685444|NCT03531294|Aflibercept|aflibercept|mesh-list
65685445|NCT03531294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65685446|NCT03531294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65685447|NCT03531294|Growth Substances|growth substances|mesh-ancestor
65685448|NCT03531294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685449|NCT03531294|Growth Inhibitors|growth inhibitors|mesh-ancestor
65685450|NCT03531294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685451|NCT03549975|Botulinum Toxins|botulinum toxins|mesh-list
65685452|NCT03549975|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65685453|NCT03549975|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65685454|NCT03549975|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65685455|NCT03549975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65685456|NCT03549975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685457|NCT03549975|Cholinergic Agents|cholinergic agents|mesh-ancestor
65685458|NCT03549975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65685459|NCT03549975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685460|NCT03549975|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65685461|NCT03549975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65685462|NCT05551624|Acetylcysteine|acetylcysteine|mesh-list
65685463|NCT05551624|Atorvastatin|atorvastatin|mesh-list
65685464|NCT05551624|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65685465|NCT05551624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65685466|NCT05551624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65685467|NCT05551624|Antimetabolites|antimetabolites|mesh-ancestor
65685468|NCT05551624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685469|NCT05551624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65685470|NCT05551624|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65685471|NCT05551624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685472|NCT05551624|Antiviral Agents|antiviral agents|mesh-ancestor
65685473|NCT05551624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65685474|NCT05551624|Expectorants|expectorants|mesh-ancestor
65685475|NCT05551624|Respiratory System Agents|respiratory system agents|mesh-ancestor
65685476|NCT05551624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65685477|NCT05551624|Antioxidants|antioxidants|mesh-ancestor
65685478|NCT05551624|Protective Agents|protective agents|mesh-ancestor
65685479|NCT05551624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685480|NCT05551624|Antidotes|antidotes|mesh-ancestor
65685481|NCT00134238|Atorvastatin|atorvastatin|mesh-list
65685482|NCT00134238|Torcetrapib|torcetrapib|mesh-list
65685483|NCT00134238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65685484|NCT00134238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65685485|NCT00134238|Antimetabolites|antimetabolites|mesh-ancestor
65685486|NCT00134238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685487|NCT00134238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65685488|NCT00134238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65685489|NCT00134238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685490|NCT02786901|Loteprednol Etabonate|loteprednol etabonate|mesh-list
65685491|NCT02786901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65685492|NCT03550677|Anesthetics|anesthetics|mesh-list
65685493|NCT03550677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65685494|NCT03550677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685495|NCT03634488|Hydroxyurea|hydroxyurea|mesh-list
65685496|NCT03634488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685497|NCT03634488|Antisickling Agents|antisickling agents|mesh-ancestor
65685498|NCT03634488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685499|NCT03634488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268937|NCT03851627|Anabolic Agents|anabolic agents|mesh-ancestor
65685500|NCT03634488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65685501|NCT02132403|Gemcitabine|gemcitabine|mesh-list
65685502|NCT02132403|Milk fat globule|milk fat globule|mesh-list
65685503|NCT02132403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65685504|NCT02132403|Antimetabolites|antimetabolites|mesh-ancestor
65685505|NCT02132403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685506|NCT02132403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685507|NCT02132403|Antiviral Agents|antiviral agents|mesh-ancestor
65685508|NCT02132403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65685509|NCT02132403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685510|NCT02132403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65685511|NCT02132403|Immunologic Factors|immunologic factors|mesh-ancestor
65685512|NCT02132403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685513|NCT04264806|Azacitidine|azacitidine|mesh-list
65685514|NCT04264806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65685515|NCT04264806|Antimetabolites|antimetabolites|mesh-ancestor
65685516|NCT04264806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685517|NCT04264806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685518|NCT04264806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685519|NCT05699824|Carvedilol|carvedilol|mesh-list
65685520|NCT05699824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65685521|NCT05699824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65685522|NCT05699824|Adrenergic Agents|adrenergic agents|mesh-ancestor
65685523|NCT05699824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65685524|NCT05699824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685525|NCT05699824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685526|NCT05699824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65685527|NCT05699824|Antioxidants|antioxidants|mesh-ancestor
65685528|NCT05699824|Protective Agents|protective agents|mesh-ancestor
65685529|NCT05699824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65685530|NCT05699824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65685531|NCT05699824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65685532|NCT05699824|Vasodilator Agents|vasodilator agents|mesh-ancestor
65685533|NCT05699824|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65685534|NCT05699824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65685535|NCT02132559|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65685536|NCT02132559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65685537|NCT02132559|Immunologic Factors|immunologic factors|mesh-ancestor
65685538|NCT02132559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685539|NCT00126984|Vaccines|vaccines|mesh-list
65685540|NCT00126984|Immunologic Factors|immunologic factors|mesh-ancestor
65685541|NCT00126984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685542|NCT02136147|Guanfacine|guanfacine|mesh-list
65685543|NCT02136147|Methylphenidate|methylphenidate|mesh-list
65685544|NCT02136147|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65685545|NCT02136147|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65685546|NCT02136147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65685547|NCT02136147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685548|NCT02136147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65685549|NCT02136147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65685550|NCT02136147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65685551|NCT02136147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685552|NCT02136147|Dopamine Agents|dopamine agents|mesh-ancestor
65685553|NCT02136147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65685554|NCT02136147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65685555|NCT02136147|Adrenergic Agents|adrenergic agents|mesh-ancestor
65685556|NCT02136147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65685557|NCT02136147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65685558|NCT02136147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65685559|NCT02136147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65685560|NCT05699746|Capecitabine|capecitabine|mesh-list
65685561|NCT05699746|Oxaliplatin|oxaliplatin|mesh-list
65685562|NCT05699746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65685563|NCT05699746|Antimetabolites|antimetabolites|mesh-ancestor
65685564|NCT05699746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685565|NCT05699746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685566|NCT03549897|Albuterol|albuterol|mesh-list
65685567|NCT03549897|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65685568|NCT03549897|Autonomic Agents|autonomic agents|mesh-ancestor
65685569|NCT03549897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65685570|NCT03549897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685571|NCT03549897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65268939|NCT03116126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65685572|NCT03549897|Respiratory System Agents|respiratory system agents|mesh-ancestor
65685573|NCT03549897|Tocolytic Agents|tocolytic agents|mesh-ancestor
65685574|NCT03549897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65685575|NCT03549897|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65685576|NCT03549897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65685577|NCT03549897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65685578|NCT03549897|Adrenergic Agents|adrenergic agents|mesh-ancestor
65685579|NCT03549897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65685580|NCT03549897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685581|NCT02133105|Simendan|simendan|mesh-list
65685582|NCT02133105|Dobutamine|dobutamine|mesh-list
65685583|NCT02133105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65685584|NCT02133105|Vasodilator Agents|vasodilator agents|mesh-ancestor
65685585|NCT02133105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65685586|NCT02133105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65685587|NCT02133105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685588|NCT02133105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685589|NCT02133105|Protective Agents|protective agents|mesh-ancestor
65685590|NCT02133105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685591|NCT02133105|Sympathomimetics|sympathomimetics|mesh-ancestor
65685592|NCT02133105|Autonomic Agents|autonomic agents|mesh-ancestor
65685593|NCT02133105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65685594|NCT02133105|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65685595|NCT02133105|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65685596|NCT02133105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65685597|NCT02133105|Adrenergic Agents|adrenergic agents|mesh-ancestor
65685598|NCT02133105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65685599|NCT04468464|Salicylic Acid|salicylic acid|mesh-list
65685600|NCT04468464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65685601|NCT04468464|Antifungal Agents|antifungal agents|mesh-ancestor
65685602|NCT04468464|Keratolytic Agents|keratolytic agents|mesh-ancestor
65685603|NCT04468464|Dermatologic Agents|dermatologic agents|mesh-ancestor
65685604|NCT02136693|Psyllium|psyllium|mesh-list
65685605|NCT02136693|Cathartics|cathartics|mesh-ancestor
65685606|NCT02136693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65685607|NCT02136771|Vitamin D|vitamin d|mesh-list
65685608|NCT02136771|Cholecalciferol|cholecalciferol|mesh-list
65685609|NCT02136771|Vitamins|vitamins|mesh-ancestor
65685610|NCT02136771|Micronutrients|micronutrients|mesh-ancestor
65685611|NCT02136771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685612|NCT02136771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65685613|NCT02136771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65685614|NCT00125970|Vaccines|vaccines|mesh-list
65685615|NCT00125970|Immunologic Factors|immunologic factors|mesh-ancestor
65685616|NCT00125970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685618|NCT03549663|Glucocorticoids|glucocorticoids|mesh-list
65685619|NCT03549663|Tacrolimus|tacrolimus|mesh-list
65685620|NCT03549663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65685621|NCT03549663|Hormones|hormones|mesh-ancestor
65685622|NCT03549663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65685623|NCT03549663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685624|NCT03549663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65685625|NCT03549663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685626|NCT03549663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65685627|NCT03549663|Immunologic Factors|immunologic factors|mesh-ancestor
65685628|NCT03549663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65685629|NCT03549663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685630|NCT03549663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685631|NCT02137083|Docetaxel|docetaxel|mesh-list
65685632|NCT02137083|Fulvestrant|fulvestrant|mesh-list
65685633|NCT02137083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685634|NCT02137083|Tubulin Modulators|tubulin modulators|mesh-ancestor
65685635|NCT02137083|Antimitotic Agents|antimitotic agents|mesh-ancestor
65685636|NCT02137083|Mitosis Modulators|mitosis modulators|mesh-ancestor
65685637|NCT02137083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685638|NCT02137083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65685639|NCT02137083|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65685640|NCT02137083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65685641|NCT02137083|Hormone Antagonists|hormone antagonists|mesh-ancestor
65685642|NCT02137083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65685643|NCT02137083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685644|NCT02137161|Tobramycin|tobramycin|mesh-list
65685645|NCT02137161|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
65685646|NCT02137161|Dexamethasone|dexamethasone|mesh-list
65685647|NCT02137161|Bromfenac|bromfenac|mesh-list
65685648|NCT02137161|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65685649|NCT02137161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65685650|NCT02137161|Antiemetics|antiemetics|mesh-ancestor
65685651|NCT02137161|Autonomic Agents|autonomic agents|mesh-ancestor
65685652|NCT02137161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65685653|NCT02137161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685654|NCT02137161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65685655|NCT02137161|Glucocorticoids|glucocorticoids|mesh-ancestor
65685656|NCT02137161|Hormones|hormones|mesh-ancestor
65685657|NCT02137161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65685658|NCT02137161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65685659|NCT02137161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685660|NCT02137161|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65685661|NCT02137161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65685662|NCT02137161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65685663|NCT02137161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65685664|NCT02137161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65685665|NCT02137161|Analgesics|analgesics|mesh-ancestor
65685666|NCT02137161|Sensory System Agents|sensory system agents|mesh-ancestor
65685667|NCT02137161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65685668|NCT02253069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
65685669|NCT02253069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65685670|NCT03527628|Cyclophosphamide|cyclophosphamide|mesh-list
65685671|NCT03527628|Dacarbazine|dacarbazine|mesh-list
65685672|NCT03527628|Doxorubicin|doxorubicin|mesh-list
65685673|NCT03527628|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65685674|NCT03527628|Bleomycin|bleomycin|mesh-list
65685675|NCT03527628|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65685676|NCT03527628|Vinblastine|vinblastine|mesh-list
65685677|NCT03527628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65685678|NCT03527628|Immunologic Factors|immunologic factors|mesh-ancestor
65685679|NCT03527628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685680|NCT03527628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65685681|NCT03527628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65685682|NCT03527628|Alkylating Agents|alkylating agents|mesh-ancestor
65685683|NCT03527628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685684|NCT03527628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685685|NCT03527628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65685686|NCT03527628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65685687|NCT03527628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65685688|NCT03527628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65685689|NCT03527628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685690|NCT03527628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65685691|NCT03527628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65685692|NCT03527628|Tubulin Modulators|tubulin modulators|mesh-ancestor
65685693|NCT03527628|Antimitotic Agents|antimitotic agents|mesh-ancestor
65685694|NCT03527628|Mitosis Modulators|mitosis modulators|mesh-ancestor
65685695|NCT04466670|Aspirin|aspirin|mesh-list
65685696|NCT04466670|Heparin|heparin|mesh-list
65685697|NCT04466670|Calcium heparin|calcium heparin|mesh-list
65685698|NCT04466670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65685699|NCT04466670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65685700|NCT04466670|Analgesics|analgesics|mesh-ancestor
65685701|NCT04466670|Sensory System Agents|sensory system agents|mesh-ancestor
65685702|NCT04466670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65685703|NCT04466670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685704|NCT04466670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65685705|NCT04466670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65685706|NCT04466670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65685707|NCT04466670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65685708|NCT04466670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685709|NCT04466670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65685710|NCT04466670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65685711|NCT04466670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685712|NCT04466670|Antipyretics|antipyretics|mesh-ancestor
65685713|NCT04466670|Anticoagulants|anticoagulants|mesh-ancestor
65685714|NCT04468542|Triamcinolone|triamcinolone|mesh-list
65685715|NCT04468542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65685716|NCT04468542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65685717|NCT04468542|Bupivacaine|bupivacaine|mesh-list
65685718|NCT04468542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65685719|NCT04468542|Anesthetics, Local|anesthetics, local|mesh-ancestor
65685720|NCT04468542|Anesthetics|anesthetics|mesh-ancestor
65685721|NCT04468542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65685722|NCT04468542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685723|NCT04468542|Sensory System Agents|sensory system agents|mesh-ancestor
65685724|NCT04468542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65685725|NCT04468542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65685726|NCT04468542|Glucocorticoids|glucocorticoids|mesh-ancestor
65685727|NCT04468542|Hormones|hormones|mesh-ancestor
65685728|NCT04468542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65685729|NCT04468542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65685730|NCT04468542|Immunologic Factors|immunologic factors|mesh-ancestor
65685731|NCT04468542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685732|NCT04468542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685733|NCT04550442|Azacitidine|azacitidine|mesh-list
65685734|NCT04550442|Venetoclax|venetoclax|mesh-list
65685735|NCT04550442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65685736|NCT04550442|Antimetabolites|antimetabolites|mesh-ancestor
65685737|NCT04550442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685738|NCT04550442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685739|NCT04550442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685740|NCT03525522|Betamethasone|betamethasone|mesh-list
65685741|NCT03525522|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65685742|NCT03525522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65685743|NCT03525522|Glucocorticoids|glucocorticoids|mesh-ancestor
65685744|NCT03525522|Hormones|hormones|mesh-ancestor
65685745|NCT03525522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65685746|NCT03525522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685747|NCT03525522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65685748|NCT03525522|Respiratory System Agents|respiratory system agents|mesh-ancestor
65685749|NCT03228732|Fluoxetine|fluoxetine|mesh-list
65685750|NCT03228732|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65685751|NCT03228732|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65685752|NCT03228732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65685753|NCT03228732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65685754|NCT03228732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685755|NCT03228732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65685756|NCT03228732|Serotonin Agents|serotonin agents|mesh-ancestor
65685757|NCT03228732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685758|NCT03228732|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65685759|NCT03228732|Antidepressive Agents|antidepressive agents|mesh-ancestor
65685760|NCT03228732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65685761|NCT03228732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65685762|NCT03228732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65685763|NCT03228732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685764|NCT03228732|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65685766|NCT03222492|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65685767|NCT03222492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65685768|NCT03222492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65685769|NCT03222492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685770|NCT03222492|Immunologic Factors|immunologic factors|mesh-ancestor
65685771|NCT03222492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685772|NCT04466436|Tryptophan|tryptophan|mesh-list
65685773|NCT04466436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65685774|NCT04466436|Antidepressive Agents|antidepressive agents|mesh-ancestor
65685775|NCT04466436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65685776|NCT04467450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65685777|NCT04467450|Botulinum Toxins|botulinum toxins|mesh-list
65685778|NCT04467450|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65685779|NCT04467450|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65685780|NCT04467450|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65685781|NCT04467450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65685782|NCT04467450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685783|NCT04467450|Cholinergic Agents|cholinergic agents|mesh-ancestor
65685784|NCT04467450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65685785|NCT04467450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685786|NCT04467450|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65685787|NCT04467450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65685788|NCT04467450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65685789|NCT03576612|Valacyclovir|valacyclovir|mesh-list
65685790|NCT03576612|Acyclovir|acyclovir|mesh-list
65685791|NCT03576612|Nivolumab|nivolumab|mesh-list
65685792|NCT03576612|Temozolomide|temozolomide|mesh-list
65685793|NCT03576612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65685794|NCT03576612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685795|NCT03576612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65274206|NCT02686710|Anesthetics|anesthetics|mesh-ancestor
65685796|NCT03576612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685797|NCT03576612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65685798|NCT03576612|Alkylating Agents|alkylating agents|mesh-ancestor
65685799|NCT03576612|Antiviral Agents|antiviral agents|mesh-ancestor
65685800|NCT03576612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65685801|NCT05230758|Metformin|metformin|mesh-list
65685802|NCT05230758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65685803|NCT05230758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685804|NCT03008382|Metoprolol|metoprolol|mesh-list
65685805|NCT03008382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65685806|NCT03008382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65685807|NCT03008382|Sympatholytics|sympatholytics|mesh-ancestor
65685808|NCT03008382|Autonomic Agents|autonomic agents|mesh-ancestor
65685809|NCT03008382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65685810|NCT03008382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685811|NCT03008382|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65685812|NCT03008382|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65685813|NCT03008382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65685814|NCT03008382|Adrenergic Agents|adrenergic agents|mesh-ancestor
65685815|NCT03008382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65685816|NCT03008382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685817|NCT02137239|Mycophenolic Acid|mycophenolic acid|mesh-list
65685818|NCT02137239|Prednisone|prednisone|mesh-list
65685819|NCT02137239|Methylprednisolone|methylprednisolone|mesh-list
65685820|NCT02137239|Everolimus|everolimus|mesh-list
65685821|NCT02137239|Abatacept|abatacept|mesh-list
65685822|NCT02137239|Tacrolimus|tacrolimus|mesh-list
65685823|NCT02137239|Thymoglobulin|thymoglobulin|mesh-list
65685824|NCT02137239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65685825|NCT02137239|Glucocorticoids|glucocorticoids|mesh-ancestor
65685826|NCT02137239|Hormones|hormones|mesh-ancestor
65685827|NCT02137239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65685828|NCT02137239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685829|NCT02137239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65685830|NCT02137239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685831|NCT02137239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65685832|NCT02137239|Immunologic Factors|immunologic factors|mesh-ancestor
65685833|NCT02137239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65685834|NCT02137239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685835|NCT02137239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685836|NCT02137239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65685837|NCT02137239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65685838|NCT02137239|Antitubercular Agents|antitubercular agents|mesh-ancestor
65685839|NCT02137239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65685840|NCT02137239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65685841|NCT02137239|Antiemetics|antiemetics|mesh-ancestor
65685842|NCT02137239|Autonomic Agents|autonomic agents|mesh-ancestor
65685843|NCT02137239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65685844|NCT02137239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65685845|NCT02137239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65685846|NCT02137239|Protective Agents|protective agents|mesh-ancestor
65685847|NCT02137239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65685848|NCT02137239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65685849|NCT02137395|Dexamethasone|dexamethasone|mesh-list
65685850|NCT02137395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65685851|NCT02137395|Antiemetics|antiemetics|mesh-ancestor
65685852|NCT02137395|Autonomic Agents|autonomic agents|mesh-ancestor
65685853|NCT02137395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65685854|NCT02137395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685855|NCT02137395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65685856|NCT02137395|Glucocorticoids|glucocorticoids|mesh-ancestor
65685857|NCT02137395|Hormones|hormones|mesh-ancestor
65685858|NCT02137395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65685859|NCT02137395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65685860|NCT02137395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685861|NCT02137629|Azacitidine|azacitidine|mesh-list
65685862|NCT02137629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65685863|NCT02137629|Antimetabolites|antimetabolites|mesh-ancestor
65685864|NCT02137629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685865|NCT02137629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685866|NCT02137629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685867|NCT02137707|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65685868|NCT02137707|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65685869|NCT02137707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685870|NCT02137707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65685871|NCT02137707|Immunologic Factors|immunologic factors|mesh-ancestor
65685872|NCT02137707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685873|NCT04301934|Estradiol|estradiol|mesh-list
65685874|NCT04301934|Estrogens|estrogens|mesh-list
65685875|NCT04301934|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65685876|NCT04301934|Hormones|hormones|mesh-ancestor
65685877|NCT04301934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65685878|NCT04301934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685879|NCT02261025|Aspirin|aspirin|mesh-list
65685880|NCT02261025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65685881|NCT02261025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65685882|NCT02261025|Analgesics|analgesics|mesh-ancestor
65685883|NCT02261025|Sensory System Agents|sensory system agents|mesh-ancestor
65685884|NCT02261025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65685885|NCT02261025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685886|NCT02261025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65685887|NCT02261025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65685888|NCT02261025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65685889|NCT02261025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65685890|NCT02261025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685891|NCT02261025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65685892|NCT02261025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65685893|NCT02261025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685894|NCT02261025|Antipyretics|antipyretics|mesh-ancestor
65685895|NCT02925234|Bevacizumab|bevacizumab|mesh-list
65685896|NCT02925234|Pembrolizumab|pembrolizumab|mesh-list
65685897|NCT02925234|Nivolumab|nivolumab|mesh-list
65685898|NCT02925234|Trastuzumab|trastuzumab|mesh-list
65685899|NCT02925234|Ipilimumab|ipilimumab|mesh-list
65685900|NCT02925234|Durvalumab|durvalumab|mesh-list
65685901|NCT02925234|Pertuzumab|pertuzumab|mesh-list
65685902|NCT02925234|Panitumumab|panitumumab|mesh-list
65685903|NCT02925234|Sunitinib|sunitinib|mesh-list
65685904|NCT02925234|Atezolizumab|atezolizumab|mesh-list
65685905|NCT02925234|Lenvatinib|lenvatinib|mesh-list
65685906|NCT02925234|Olaparib|olaparib|mesh-list
65685907|NCT02925234|Palbociclib|palbociclib|mesh-list
65685908|NCT02925234|Trametinib|trametinib|mesh-list
65685909|NCT02925234|Axitinib|axitinib|mesh-list
65685910|NCT02925234|Afatinib|afatinib|mesh-list
65685911|NCT02925234|Vemurafenib|vemurafenib|mesh-list
65685912|NCT02925234|Dabrafenib|dabrafenib|mesh-list
65685913|NCT02925234|Crizotinib|crizotinib|mesh-list
65685914|NCT02925234|Talazoparib|talazoparib|mesh-list
65685915|NCT02925234|Rucaparib|rucaparib|mesh-list
65685916|NCT02925234|Entrectinib|entrectinib|mesh-list
65685917|NCT02925234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65685918|NCT02925234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685919|NCT02925234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65685920|NCT02925234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65685921|NCT02925234|Growth Substances|growth substances|mesh-ancestor
65685922|NCT02925234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685923|NCT02925234|Growth Inhibitors|growth inhibitors|mesh-ancestor
65685924|NCT02925234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65685925|NCT02925234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685926|NCT02925234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65685927|NCT02925234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685928|NCT02925234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65685929|NCT02137863|Dexmedetomidine|dexmedetomidine|mesh-list
65685930|NCT02137863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65685931|NCT02137863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65685932|NCT02137863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685933|NCT02137863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65685934|NCT02137863|Analgesics|analgesics|mesh-ancestor
65685935|NCT02137863|Sensory System Agents|sensory system agents|mesh-ancestor
65685936|NCT02137863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65685937|NCT02137863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65685938|NCT02137863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65685939|NCT02137863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65685940|NCT02137863|Adrenergic Agents|adrenergic agents|mesh-ancestor
65685941|NCT02137863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65685942|NCT02137863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685944|NCT05177796|Cyclophosphamide|cyclophosphamide|mesh-list
65685945|NCT05177796|Carboplatin|carboplatin|mesh-list
65685946|NCT05177796|Doxorubicin|doxorubicin|mesh-list
65685947|NCT05177796|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65685948|NCT05177796|Pembrolizumab|pembrolizumab|mesh-list
65685949|NCT05177796|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65685950|NCT05177796|Daunorubicin|daunorubicin|mesh-list
65685951|NCT05177796|Panitumumab|panitumumab|mesh-list
65685952|NCT05177796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65685953|NCT05177796|Antibodies|antibodies|mesh-list
65685954|NCT05177796|Immunoglobulins|immunoglobulins|mesh-list
65685955|NCT05177796|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65685956|NCT05177796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65685957|NCT05177796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65685958|NCT05177796|Tubulin Modulators|tubulin modulators|mesh-ancestor
65685959|NCT05177796|Antimitotic Agents|antimitotic agents|mesh-ancestor
65685960|NCT05177796|Mitosis Modulators|mitosis modulators|mesh-ancestor
65685961|NCT05177796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65685962|NCT05177796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65685963|NCT05177796|Immunologic Factors|immunologic factors|mesh-ancestor
65685964|NCT05177796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685965|NCT05177796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65685966|NCT05177796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65685967|NCT05177796|Alkylating Agents|alkylating agents|mesh-ancestor
65685968|NCT05177796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65685969|NCT05177796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65685970|NCT05177796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65685971|NCT05177796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65685972|NCT05177796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685973|NCT02138019|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65685974|NCT02138019|Hemostatics|hemostatics|mesh-ancestor
65685975|NCT02138019|Coagulants|coagulants|mesh-ancestor
65685976|NCT02133885|Minocycline|minocycline|mesh-list
65685977|NCT02133885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65685978|NCT02133885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65685979|NCT02138409|Fentanyl|fentanyl|mesh-list
65685980|NCT02138409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65685981|NCT02138409|Narcotics|narcotics|mesh-ancestor
65685982|NCT02138409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65685983|NCT02138409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65685984|NCT02138409|Analgesics|analgesics|mesh-ancestor
65685985|NCT02138409|Sensory System Agents|sensory system agents|mesh-ancestor
65685986|NCT02138409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65685987|NCT02138409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65685988|NCT02138409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65685989|NCT02138409|Anesthetics, General|anesthetics, general|mesh-ancestor
65685990|NCT02138409|Anesthetics|anesthetics|mesh-ancestor
65685991|NCT02138799|Rifampin|rifampin|mesh-list
65685992|NCT02138799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65685993|NCT02138799|Antitubercular Agents|antitubercular agents|mesh-ancestor
65685994|NCT02138799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65685995|NCT02138799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65685996|NCT02138799|Leprostatic Agents|leprostatic agents|mesh-ancestor
65685997|NCT02138799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65685998|NCT02138799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65685999|NCT02138799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686000|NCT02138799|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65686001|NCT02138799|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65686002|NCT02138799|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65686003|NCT02138799|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65686004|NCT02138799|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65686005|NCT02138799|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65686006|NCT05578287|Celecoxib|celecoxib|mesh-list
65686007|NCT05578287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65686008|NCT05578287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65686009|NCT05578287|Analgesics|analgesics|mesh-ancestor
65686010|NCT05578287|Sensory System Agents|sensory system agents|mesh-ancestor
65686011|NCT05578287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65686012|NCT05578287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686013|NCT05578287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65686014|NCT05578287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65686015|NCT05578287|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65686016|NCT05578287|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65686017|NCT05578287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686018|NCT05578287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686019|NCT02975271|Serlopitant|serlopitant|mesh-list
65686020|NCT02975271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65686021|NCT02975271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65686022|NCT02975271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686023|NCT02975271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686024|NCT02741076|Oxymorphone|oxymorphone|mesh-list
65686025|NCT02741076|Morphine|morphine|mesh-list
65686026|NCT02741076|Oxycodone|oxycodone|mesh-list
65686027|NCT02741076|Analgesics, Opioid|analgesics, opioid|mesh-list
65686028|NCT02741076|Narcotics|narcotics|mesh-ancestor
65686029|NCT02741076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65686030|NCT02741076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686031|NCT02741076|Analgesics|analgesics|mesh-ancestor
65686032|NCT02741076|Sensory System Agents|sensory system agents|mesh-ancestor
65686033|NCT02741076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65686034|NCT02741076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65686035|NCT02973633|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
65686036|NCT02973633|Chelating Agents|chelating agents|mesh-ancestor
65686037|NCT02973633|Sequestering Agents|sequestering agents|mesh-ancestor
65686038|NCT02973633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686039|NCT01666444|Doxorubicin|doxorubicin|mesh-list
65686040|NCT01666444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65686041|NCT01666444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65686042|NCT01666444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686043|NCT01666444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65686044|NCT01666444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65686045|NCT01666444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686046|NCT01666444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686047|NCT05543122|Fluconazole|fluconazole|mesh-list
65686048|NCT05543122|Methotrexate|methotrexate|mesh-list
65686049|NCT05543122|Atenolol|atenolol|mesh-list
65686050|NCT05543122|Lamotrigine|lamotrigine|mesh-list
65686051|NCT05543122|Lacosamide|lacosamide|mesh-list
65686052|NCT05543122|Levetiracetam|levetiracetam|mesh-list
65686053|NCT05543122|Brivaracetam|brivaracetam|mesh-list
65686054|NCT05543122|Citalopram|citalopram|mesh-list
65686055|NCT05543122|Bupropion|bupropion|mesh-list
65686056|NCT05543122|Ezetimibe|ezetimibe|mesh-list
65686057|NCT05543122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65686058|NCT05543122|Abortifacient Agents|abortifacient agents|mesh-ancestor
65686059|NCT05543122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65686060|NCT05543122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686061|NCT05543122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65686062|NCT05543122|Antimetabolites|antimetabolites|mesh-ancestor
65686063|NCT05543122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686064|NCT05543122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686065|NCT05543122|Dermatologic Agents|dermatologic agents|mesh-ancestor
65686066|NCT05543122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686067|NCT05543122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65686068|NCT05543122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65686069|NCT05543122|Immunologic Factors|immunologic factors|mesh-ancestor
65686070|NCT05543122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65686071|NCT05543122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65686072|NCT05543122|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65686073|NCT05543122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65686074|NCT05543122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65686075|NCT05543122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65686076|NCT05543122|Serotonin Agents|serotonin agents|mesh-ancestor
65686077|NCT05543122|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65686078|NCT05543122|Antidepressive Agents|antidepressive agents|mesh-ancestor
65686079|NCT05543122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65686080|NCT05543122|Autonomic Agents|autonomic agents|mesh-ancestor
65686081|NCT05543122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65686082|NCT05543122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65686083|NCT05543122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65686084|NCT05543122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65686085|NCT05543122|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65686086|NCT05543122|Dopamine Agents|dopamine agents|mesh-ancestor
65686087|NCT05543122|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65686088|NCT05543122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65686089|NCT05543122|Anticonvulsants|anticonvulsants|mesh-ancestor
65686090|NCT05543122|Nootropic Agents|nootropic agents|mesh-ancestor
65686091|NCT05543122|Antifungal Agents|antifungal agents|mesh-ancestor
65686092|NCT05543122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65686093|NCT05543122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65686094|NCT05543122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65686095|NCT05543122|Hormone Antagonists|hormone antagonists|mesh-ancestor
65686096|NCT05543122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65686097|NCT05543122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65686098|NCT05543122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65686099|NCT05543122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65686100|NCT05543122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65686101|NCT05543122|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65686102|NCT05543122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65686103|NCT05543122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65686104|NCT05543122|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65686105|NCT05543122|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65686106|NCT05543122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65686107|NCT05543122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65686108|NCT05543122|Sympatholytics|sympatholytics|mesh-ancestor
65686109|NCT05543122|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65686110|NCT05543122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65686111|NCT05543122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65686112|NCT05543122|Adrenergic Agents|adrenergic agents|mesh-ancestor
65686113|NCT05120934|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65686114|NCT05120934|Amitriptyline|amitriptyline|mesh-list
65686115|NCT05120934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65686116|NCT05120934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65686117|NCT05120934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65686118|NCT05120934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686119|NCT05120934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65686120|NCT05120934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686121|NCT05120934|Analgesics|analgesics|mesh-ancestor
65686122|NCT05120934|Sensory System Agents|sensory system agents|mesh-ancestor
65686123|NCT05120934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65686124|NCT05120934|Antidepressive Agents|antidepressive agents|mesh-ancestor
65686125|NCT05120934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65686126|NCT05120934|Dopamine Agents|dopamine agents|mesh-ancestor
65686127|NCT05120934|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65686128|NCT05120934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65686129|NCT05120934|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65686130|NCT05120934|Adrenergic Agents|adrenergic agents|mesh-ancestor
65686131|NCT03548493|Magnesium Sulfate|magnesium sulfate|mesh-list
65686132|NCT03548493|Fentanyl|fentanyl|mesh-list
65686133|NCT03548493|Propofol|propofol|mesh-list
65686134|NCT03548493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65686135|NCT03548493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65686136|NCT03548493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686137|NCT03548493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65686138|NCT03548493|Anesthetics, General|anesthetics, general|mesh-ancestor
65686139|NCT03548493|Anesthetics|anesthetics|mesh-ancestor
65686140|NCT03548493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65686141|NCT03548493|Narcotics|narcotics|mesh-ancestor
65686142|NCT03548493|Analgesics|analgesics|mesh-ancestor
65686143|NCT03548493|Sensory System Agents|sensory system agents|mesh-ancestor
65686144|NCT03548493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65686145|NCT03548493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65686146|NCT03548493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65686147|NCT03548493|Anticonvulsants|anticonvulsants|mesh-ancestor
65686148|NCT03548493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65686149|NCT03548493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65686150|NCT03548493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686151|NCT03548493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65686152|NCT03548493|Tocolytic Agents|tocolytic agents|mesh-ancestor
65686153|NCT03548493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65686154|NCT02139267|Vaccines|vaccines|mesh-list
65686155|NCT02139267|Immunologic Factors|immunologic factors|mesh-ancestor
65686156|NCT02139267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686157|NCT02139345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65686158|NCT03549819|Cannabidiol|cannabidiol|mesh-list
65686159|NCT03549819|Anticonvulsants|anticonvulsants|mesh-ancestor
65686160|NCT03549741|Cabergoline|cabergoline|mesh-list
65686161|NCT03549741|Clomiphene|clomiphene|mesh-list
65686162|NCT03549741|Enclomiphene|enclomiphene|mesh-list
65686163|NCT03549741|Zuclomiphene|zuclomiphene|mesh-list
65686164|NCT03549741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686165|NCT03549741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65686166|NCT03549741|Hormone Antagonists|hormone antagonists|mesh-ancestor
65686167|NCT03549741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65686168|NCT03549741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686169|NCT03549741|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65686170|NCT03549741|Fertility Agents|fertility agents|mesh-ancestor
65148833|NCT01224639|Vaccines|vaccines|mesh-list
65686171|NCT03549741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65686172|NCT03549741|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65686173|NCT03549741|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65686174|NCT03549741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65686175|NCT03549741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65686176|NCT03549741|Dopamine Agonists|dopamine agonists|mesh-ancestor
65686177|NCT03549741|Dopamine Agents|dopamine agents|mesh-ancestor
65686178|NCT03549741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65686179|NCT03522402|Sevoflurane|sevoflurane|mesh-list
65686180|NCT03522402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65686181|NCT03522402|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65686182|NCT03522402|Anesthetics, General|anesthetics, general|mesh-ancestor
65686183|NCT03522402|Anesthetics|anesthetics|mesh-ancestor
65686184|NCT03522402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65686185|NCT03522402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686186|NCT02134899|Everolimus|everolimus|mesh-list
65686187|NCT02134899|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
65686188|NCT02134899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686189|NCT02134899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65686190|NCT02134899|Immunologic Factors|immunologic factors|mesh-ancestor
65686191|NCT02134899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686192|NCT02134899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686193|NCT02134899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686194|NCT05577819|Technetium Tc 99m Pyrophosphate|technetium tc 99m pyrophosphate|mesh-list
65686195|NCT05577819|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65686196|NCT05577819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686197|NCT04102098|Bevacizumab|bevacizumab|mesh-list
65686198|NCT04102098|Atezolizumab|atezolizumab|mesh-list
65686199|NCT04102098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65686200|NCT04102098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686201|NCT04102098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65686202|NCT04102098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65686203|NCT04102098|Growth Substances|growth substances|mesh-ancestor
65686204|NCT04102098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686205|NCT04102098|Growth Inhibitors|growth inhibitors|mesh-ancestor
65686206|NCT02135055|Midazolam|midazolam|mesh-list
65686207|NCT02135055|Morphine|morphine|mesh-list
65686208|NCT02135055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65686209|NCT02135055|Narcotics|narcotics|mesh-ancestor
65686210|NCT02135055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65686211|NCT02135055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686212|NCT02135055|Analgesics|analgesics|mesh-ancestor
65686213|NCT02135055|Sensory System Agents|sensory system agents|mesh-ancestor
65686214|NCT02135055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65686215|NCT02135055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65686216|NCT02135055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65686217|NCT02135055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65686218|NCT02135055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65686219|NCT02135055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65686220|NCT02135055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65686221|NCT02135055|Anesthetics, General|anesthetics, general|mesh-ancestor
65686222|NCT02135055|Anesthetics|anesthetics|mesh-ancestor
65686223|NCT02135055|GABA Modulators|gaba modulators|mesh-ancestor
65686224|NCT02135055|GABA Agents|gaba agents|mesh-ancestor
65686225|NCT02135055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65686226|NCT02135055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686227|NCT05546710|Anesthetics|anesthetics|mesh-list
65686228|NCT05546710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65686229|NCT05546710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686230|NCT02139579|Bevacizumab|bevacizumab|mesh-list
65686231|NCT02139579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65686232|NCT02139579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686233|NCT02139579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65686234|NCT02139579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65686235|NCT02139579|Growth Substances|growth substances|mesh-ancestor
65686236|NCT02139579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686237|NCT02139579|Growth Inhibitors|growth inhibitors|mesh-ancestor
65686238|NCT02139657|Immunoglobulins|immunoglobulins|mesh-list
65686239|NCT02139657|Immunologic Factors|immunologic factors|mesh-ancestor
65686240|NCT02139657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686241|NCT05550064|Contraceptive Agents|contraceptive agents|mesh-list
65686242|NCT05550064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65686243|NCT05550064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686244|NCT04076826|Midazolam|midazolam|mesh-list
65686245|NCT04076826|Dexmedetomidine|dexmedetomidine|mesh-list
65686246|NCT04076826|Propofol|propofol|mesh-list
65686247|NCT04076826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65686248|NCT04076826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65686249|NCT04076826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686250|NCT04076826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65686251|NCT04076826|Anesthetics, General|anesthetics, general|mesh-ancestor
65686252|NCT04076826|Anesthetics|anesthetics|mesh-ancestor
65686253|NCT04076826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65686254|NCT04076826|Analgesics|analgesics|mesh-ancestor
65686255|NCT04076826|Sensory System Agents|sensory system agents|mesh-ancestor
65686256|NCT04076826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65686257|NCT04076826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65686258|NCT04076826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65686259|NCT04076826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65686260|NCT04076826|Adrenergic Agents|adrenergic agents|mesh-ancestor
65686261|NCT04076826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65686262|NCT04076826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686263|NCT04076826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65686264|NCT04076826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65686265|NCT04076826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65686266|NCT04076826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65686267|NCT04076826|GABA Modulators|gaba modulators|mesh-ancestor
65686268|NCT04076826|GABA Agents|gaba agents|mesh-ancestor
65686269|NCT05577585|Midazolam|midazolam|mesh-list
65686270|NCT05577585|Ketamine|ketamine|mesh-list
65686271|NCT05577585|Analgesics|analgesics|mesh-ancestor
65686272|NCT05577585|Sensory System Agents|sensory system agents|mesh-ancestor
65686273|NCT05577585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65686274|NCT05577585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686275|NCT05577585|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65686276|NCT05577585|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65686277|NCT05577585|Anesthetics, General|anesthetics, general|mesh-ancestor
65686278|NCT05577585|Anesthetics|anesthetics|mesh-ancestor
65686279|NCT05577585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65686280|NCT05577585|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65686281|NCT05577585|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65686282|NCT05577585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65686283|NCT05577585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686284|NCT05577585|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65686285|NCT05577585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65686286|NCT05577585|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65686287|NCT05577585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65686288|NCT05577585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65686289|NCT05577585|GABA Modulators|gaba modulators|mesh-ancestor
65686290|NCT05577585|GABA Agents|gaba agents|mesh-ancestor
65686291|NCT04465968|Durvalumab|durvalumab|mesh-list
65686292|NCT04465968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65686293|NCT04465968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686294|NCT04465968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65686295|NCT04465968|Immunologic Factors|immunologic factors|mesh-ancestor
65686296|NCT04465968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686297|NCT03526770|Chlorhexidine|chlorhexidine|mesh-list
65686298|NCT03526770|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65686299|NCT03526770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65686300|NCT03526770|Disinfectants|disinfectants|mesh-ancestor
65686301|NCT02689440|Venetoclax|venetoclax|mesh-list
65686302|NCT02689440|Dasatinib|dasatinib|mesh-list
65686303|NCT02689440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686304|NCT02689440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65686305|NCT02689440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686306|NCT02689440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686307|NCT05577507|Calcium Carbonate|calcium carbonate|mesh-list
65686308|NCT05577507|Cholestyramine Resin|cholestyramine resin|mesh-list
65686309|NCT05577507|Calcium|calcium|mesh-list
65686310|NCT05577507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65686311|NCT05577507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686312|NCT05577507|Antacids|antacids|mesh-ancestor
65686313|NCT05577507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686314|NCT05577507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65686315|NCT05577507|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65686316|NCT05577507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65686317|NCT05577507|Antimetabolites|antimetabolites|mesh-ancestor
65686318|NCT05577507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65686319|NCT01565655|Peficitinib|peficitinib|mesh-list
65686320|NCT01565655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686321|NCT01565655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686322|NCT01565655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65686323|NCT01565655|Immunologic Factors|immunologic factors|mesh-ancestor
65686324|NCT01565655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686325|NCT05535322|Insulin|insulin|mesh-list
65686326|NCT05535322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65686327|NCT05535322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686328|NCT05577273|Trimethoprim|trimethoprim|mesh-list
65686329|NCT05577273|Sulfamethoxazole|sulfamethoxazole|mesh-list
65686330|NCT05577273|Penicillins|penicillins|mesh-list
65686331|NCT05577273|Cefuroxime|cefuroxime|mesh-list
65686332|NCT05577273|Cefuroxime axetil|cefuroxime axetil|mesh-list
65686333|NCT05577273|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65686334|NCT05577273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65686335|NCT05577273|Renal Agents|renal agents|mesh-ancestor
65686336|NCT05577273|Antimalarials|antimalarials|mesh-ancestor
65686337|NCT05577273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65686338|NCT05577273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65686339|NCT05577273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65686340|NCT05577273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686341|NCT05577273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686342|NCT05577273|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65686343|NCT05577273|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65686344|NCT05577273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65686345|NCT05577273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65686346|NCT02252913|Docetaxel|docetaxel|mesh-list
65686347|NCT02252913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686348|NCT02252913|Tubulin Modulators|tubulin modulators|mesh-ancestor
65686349|NCT02252913|Antimitotic Agents|antimitotic agents|mesh-ancestor
65686350|NCT02252913|Mitosis Modulators|mitosis modulators|mesh-ancestor
65686351|NCT02252913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686352|NCT02253459|Capecitabine|capecitabine|mesh-list
65686353|NCT02253459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65686354|NCT02253459|Antimetabolites|antimetabolites|mesh-ancestor
65686355|NCT02253459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686356|NCT02253459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686357|NCT02140047|Vaccines|vaccines|mesh-list
65686358|NCT02140047|Immunologic Factors|immunologic factors|mesh-ancestor
65686359|NCT02140047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686360|NCT02135913|Vitamin D|vitamin d|mesh-list
65686361|NCT02135913|Vitamins|vitamins|mesh-ancestor
65686362|NCT02135913|Micronutrients|micronutrients|mesh-ancestor
65686363|NCT02135913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686364|NCT02135913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65686365|NCT05505279|Nicotine|nicotine|mesh-list
65686366|NCT05505279|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65483690|NCT03216226|Hormones|hormones|mesh-ancestor
65686367|NCT05505279|Autonomic Agents|autonomic agents|mesh-ancestor
65686368|NCT05505279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65686369|NCT05505279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686370|NCT05505279|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65686371|NCT05505279|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65686372|NCT05505279|Cholinergic Agents|cholinergic agents|mesh-ancestor
65686373|NCT05505279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65686374|NCT05505279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686375|NCT05541640|Lidocaine|lidocaine|mesh-list
65686376|NCT05541640|Anesthetics, Local|anesthetics, local|mesh-ancestor
65686377|NCT05541640|Anesthetics|anesthetics|mesh-ancestor
65686378|NCT05541640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65686379|NCT05541640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686380|NCT05541640|Sensory System Agents|sensory system agents|mesh-ancestor
65686381|NCT05541640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65686382|NCT05541640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65686383|NCT05541640|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65686384|NCT05541640|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65686385|NCT05541640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65686386|NCT05541640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686387|NCT02739594|Ibandronic Acid|ibandronic acid|mesh-list
65686388|NCT02739594|Zoledronic Acid|zoledronic acid|mesh-list
65686389|NCT02739594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65686390|NCT02739594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686391|NCT05545618|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65686392|NCT05545618|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65149079|NCT04291729|Interferons|interferons|mesh-list
65686393|NCT05545618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686394|NCT02140281|Cefadroxil|cefadroxil|mesh-list
65686395|NCT02140281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65686396|NCT02140281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65686397|NCT05545462|Doxycycline|doxycycline|mesh-list
65686398|NCT05545462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65686399|NCT05545462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65686400|NCT05545462|Antimalarials|antimalarials|mesh-ancestor
65686401|NCT05545462|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65686402|NCT05545462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65686403|NCT05541172|Methyltestosterone|methyltestosterone|mesh-list
65686404|NCT05541172|Testosterone|testosterone|mesh-list
65686405|NCT05541172|Testosterone undecanoate|testosterone undecanoate|mesh-list
65686406|NCT05541172|Testosterone enanthate|testosterone enanthate|mesh-list
65686407|NCT05541172|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65686408|NCT05541172|Androgens|androgens|mesh-ancestor
65686409|NCT05541172|Hormones|hormones|mesh-ancestor
65686410|NCT05541172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65686411|NCT05541172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686412|NCT05541172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65686413|NCT05541172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686414|NCT05541172|Anabolic Agents|anabolic agents|mesh-ancestor
65686415|NCT05545384|Rituximab|rituximab|mesh-list
65686416|NCT05545384|Azathioprine|azathioprine|mesh-list
65686417|NCT05545384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65686418|NCT05545384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686419|NCT05545384|Immunologic Factors|immunologic factors|mesh-ancestor
65686420|NCT05545384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686421|NCT05545384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65686422|NCT05545384|Antimetabolites|antimetabolites|mesh-ancestor
65686423|NCT05545384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686424|NCT05545384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65686425|NCT05545384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65686426|NCT05478993|Dexamethasone|dexamethasone|mesh-list
65686427|NCT05478993|Pomalidomide|pomalidomide|mesh-list
65686428|NCT05478993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65686429|NCT05478993|Antiemetics|antiemetics|mesh-ancestor
65686430|NCT05478993|Autonomic Agents|autonomic agents|mesh-ancestor
65686431|NCT05478993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65686432|NCT05478993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686433|NCT05478993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65686434|NCT05478993|Glucocorticoids|glucocorticoids|mesh-ancestor
65686435|NCT05478993|Hormones|hormones|mesh-ancestor
65686436|NCT05478993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65686437|NCT05478993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65686438|NCT05478993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686439|NCT05478993|Immunologic Factors|immunologic factors|mesh-ancestor
65686440|NCT05478993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65686441|NCT05478993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65686442|NCT05478993|Growth Substances|growth substances|mesh-ancestor
65686443|NCT05478993|Growth Inhibitors|growth inhibitors|mesh-ancestor
65483766|NCT04504942|Leronlimab|leronlimab|mesh-list
65686444|NCT05699356|Estrogens|estrogens|mesh-list
65686445|NCT05699356|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65686446|NCT05699356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686447|NCT05699356|Hormones|hormones|mesh-ancestor
65686448|NCT05699356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65686449|NCT05699356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65686450|NCT05699356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686451|NCT05699356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686452|NCT05699356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65686453|NCT05699356|Hormone Antagonists|hormone antagonists|mesh-ancestor
65686454|NCT02140437|Fulvestrant|fulvestrant|mesh-list
65686455|NCT02140437|Anastrozole|anastrozole|mesh-list
65686456|NCT02140437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65686457|NCT02140437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686458|NCT02140437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65686459|NCT02140437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65686460|NCT02140437|Hormone Antagonists|hormone antagonists|mesh-ancestor
65686461|NCT02140437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65686462|NCT02140437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686463|NCT02140437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65686464|NCT02140437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65686465|NCT02140437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686466|NCT02140437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686467|NCT05591560|Itraconazole|itraconazole|mesh-list
65686468|NCT05591560|Antifungal Agents|antifungal agents|mesh-ancestor
65686469|NCT05591560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65686470|NCT05591560|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65686471|NCT05591560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65686472|NCT05591560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686473|NCT05591560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686474|NCT05591560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65686475|NCT05591560|Hormone Antagonists|hormone antagonists|mesh-ancestor
65686476|NCT05591560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65686477|NCT05591560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686478|NCT05591560|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65686479|NCT05540470|Chloroquine|chloroquine|mesh-list
65686480|NCT05540470|Primaquine|primaquine|mesh-list
65686481|NCT05540470|Tafenoquine|tafenoquine|mesh-list
65686482|NCT05540470|Amebicides|amebicides|mesh-ancestor
65686483|NCT05540470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65686484|NCT05540470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65686485|NCT05540470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65686486|NCT05540470|Antimalarials|antimalarials|mesh-ancestor
65686487|NCT05540470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65686488|NCT05009082|Paclitaxel|paclitaxel|mesh-list
65686489|NCT05009082|Bevacizumab|bevacizumab|mesh-list
65686490|NCT05009082|Carboplatin|carboplatin|mesh-list
65686491|NCT05009082|Niraparib|niraparib|mesh-list
65686492|NCT05009082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65686493|NCT05009082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686494|NCT05009082|Tubulin Modulators|tubulin modulators|mesh-ancestor
65686495|NCT05009082|Antimitotic Agents|antimitotic agents|mesh-ancestor
65686496|NCT05009082|Mitosis Modulators|mitosis modulators|mesh-ancestor
65686497|NCT05009082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686498|NCT05009082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65686499|NCT05009082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65686500|NCT05009082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65686501|NCT05009082|Growth Substances|growth substances|mesh-ancestor
65686502|NCT05009082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686503|NCT05009082|Growth Inhibitors|growth inhibitors|mesh-ancestor
65686504|NCT05009082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65686505|NCT05009082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686506|NCT05575167|Vitamin D|vitamin d|mesh-list
65686507|NCT05575167|Alendronate|alendronate|mesh-list
65686508|NCT05575167|Zoledronic Acid|zoledronic acid|mesh-list
65686509|NCT05575167|Vitamins|vitamins|mesh-ancestor
65686510|NCT05575167|Micronutrients|micronutrients|mesh-ancestor
65686511|NCT05575167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686512|NCT05575167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65686513|NCT02140515|Hormones|hormones|mesh-list
65686514|NCT02140515|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65686515|NCT02140515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65686516|NCT02140515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686517|NCT02260947|Ibuprofen|ibuprofen|mesh-list
65686518|NCT02260947|Pregabalin|pregabalin|mesh-list
65686519|NCT02260947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65686520|NCT02260947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65686521|NCT02260947|Analgesics|analgesics|mesh-ancestor
65686522|NCT02260947|Sensory System Agents|sensory system agents|mesh-ancestor
65686523|NCT02260947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65686524|NCT02260947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686525|NCT02260947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65686526|NCT02260947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65686527|NCT02260947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65686528|NCT02260947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686529|NCT02260947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686530|NCT02260947|Anticonvulsants|anticonvulsants|mesh-ancestor
65686531|NCT02260947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65686532|NCT02260947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65686533|NCT02260947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65686534|NCT02260947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65686535|NCT02260947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65686536|NCT02260947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65686537|NCT02260947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65686538|NCT02193282|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65686539|NCT02193282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686540|NCT02193282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65686541|NCT02193282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686542|NCT02193282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686543|NCT03547791|Betamethasone|betamethasone|mesh-list
65686544|NCT03547791|Betamethasone Valerate|betamethasone valerate|mesh-list
65686545|NCT03547791|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65686546|NCT03547791|Betamethasone benzoate|betamethasone benzoate|mesh-list
65686547|NCT03547791|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65686548|NCT03547791|Glucocorticoids|glucocorticoids|mesh-ancestor
65686549|NCT03547791|Hormones|hormones|mesh-ancestor
65686550|NCT03547791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65686551|NCT03547791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686552|NCT03547791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65686553|NCT03547791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65686554|NCT03547791|Respiratory System Agents|respiratory system agents|mesh-ancestor
65686555|NCT04818177|Immunoglobulins|immunoglobulins|mesh-list
65686556|NCT04818177|Antibodies|antibodies|mesh-list
65686557|NCT04818177|gamma-Globulins|gamma-globulins|mesh-list
65686558|NCT04818177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65686559|NCT04818177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65686560|NCT04818177|Immunologic Factors|immunologic factors|mesh-ancestor
65686561|NCT04818177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686562|NCT05544292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65686563|NCT04425460|Favipiravir|favipiravir|mesh-list
65686564|NCT04425460|Antiviral Agents|antiviral agents|mesh-ancestor
65686565|NCT04425460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65686566|NCT05576272|Gemcitabine|gemcitabine|mesh-list
65686567|NCT05576272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686568|NCT05576272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65686569|NCT05576272|Antimetabolites|antimetabolites|mesh-ancestor
65686570|NCT05576272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686571|NCT05576272|Antiviral Agents|antiviral agents|mesh-ancestor
65686572|NCT05576272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65686573|NCT05576272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686574|NCT05576272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65686575|NCT05576272|Immunologic Factors|immunologic factors|mesh-ancestor
65686576|NCT05576272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686577|NCT05179005|Imidacloprid|imidacloprid|mesh-list
65686578|NCT05179005|Cholinergic Agents|cholinergic agents|mesh-ancestor
65686579|NCT05179005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65686580|NCT05179005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686581|NCT05179005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686582|NCT05576116|Pancrelipase|pancrelipase|mesh-list
65686583|NCT05576116|Pancreatin|pancreatin|mesh-list
65686584|NCT05576116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65686585|NCT04765137|Atorvastatin|atorvastatin|mesh-list
65686586|NCT04765137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65686587|NCT04765137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65686588|NCT04765137|Antimetabolites|antimetabolites|mesh-ancestor
65686589|NCT04765137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686590|NCT04765137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65686591|NCT04765137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65686592|NCT04765137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686593|NCT05543824|Levobupivacaine|levobupivacaine|mesh-list
65686594|NCT05543824|Anesthetics, Local|anesthetics, local|mesh-ancestor
65686595|NCT05543824|Anesthetics|anesthetics|mesh-ancestor
65686596|NCT05543824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65686597|NCT05543824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686598|NCT05543824|Sensory System Agents|sensory system agents|mesh-ancestor
65686599|NCT05543824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65686600|NCT04703673|Nasal Decongestants|nasal decongestants|mesh-list
65686601|NCT04703673|Pseudoephedrine|pseudoephedrine|mesh-list
65686602|NCT04703673|Ephedrine|ephedrine|mesh-list
65686603|NCT04703673|Sympathomimetics|sympathomimetics|mesh-list
65686604|NCT04703673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65686605|NCT04703673|Respiratory System Agents|respiratory system agents|mesh-ancestor
65686606|NCT04703673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65686607|NCT04703673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686608|NCT04703673|Autonomic Agents|autonomic agents|mesh-ancestor
65686609|NCT04703673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65686610|NCT04703673|Adrenergic Agents|adrenergic agents|mesh-ancestor
65686611|NCT04703673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65686612|NCT04703673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686613|NCT04703673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65686614|NCT04703673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65686615|NCT05543746|Brexanolone|brexanolone|mesh-list
65686616|NCT05543746|Neurosteroids|neurosteroids|mesh-ancestor
65686617|NCT05543746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65686618|NCT05543746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686619|NCT05543746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686620|NCT05543746|GABA Modulators|gaba modulators|mesh-ancestor
65686621|NCT05543746|GABA Agents|gaba agents|mesh-ancestor
65686622|NCT03526536|Insulin|insulin|mesh-list
65686623|NCT03526536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65686624|NCT03526536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65686625|NCT03526536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686626|NCT05306301|Ponatinib|ponatinib|mesh-list
65686627|NCT05306301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686628|NCT05306301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65686629|NCT05306301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686630|NCT05306301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686631|NCT05543434|Hyaluronic Acid|hyaluronic acid|mesh-list
65686632|NCT05543434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65686633|NCT05543434|Immunologic Factors|immunologic factors|mesh-ancestor
65686634|NCT05543434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686635|NCT05543434|Viscosupplements|viscosupplements|mesh-ancestor
65686636|NCT05543434|Protective Agents|protective agents|mesh-ancestor
65686637|NCT01858896|Glucagon|glucagon|mesh-list
65686638|NCT01858896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65686639|NCT01858896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65686640|NCT01858896|Hormones|hormones|mesh-ancestor
65686641|NCT01858896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65686642|NCT01858896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686643|NCT01858896|Incretins|incretins|mesh-ancestor
65686644|NCT04940286|Gemcitabine|gemcitabine|mesh-list
65686645|NCT04940286|Paclitaxel|paclitaxel|mesh-list
65686646|NCT04940286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65686647|NCT04940286|Durvalumab|durvalumab|mesh-list
65686648|NCT04940286|Immunoglobulins|immunoglobulins|mesh-list
65686649|NCT04940286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65686650|NCT04940286|Immunoglobulin G|immunoglobulin g|mesh-list
65686651|NCT04940286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65686652|NCT04940286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686653|NCT04940286|Tubulin Modulators|tubulin modulators|mesh-ancestor
65686654|NCT04940286|Antimitotic Agents|antimitotic agents|mesh-ancestor
65686655|NCT04940286|Mitosis Modulators|mitosis modulators|mesh-ancestor
65686656|NCT04940286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686657|NCT04940286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65686658|NCT04940286|Antimetabolites|antimetabolites|mesh-ancestor
65686659|NCT04940286|Antiviral Agents|antiviral agents|mesh-ancestor
65686660|NCT04940286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65686661|NCT04940286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686662|NCT04940286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65686663|NCT04940286|Immunologic Factors|immunologic factors|mesh-ancestor
65686664|NCT04940286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686665|NCT04940286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65686666|NCT05538988|Cemiplimab|cemiplimab|mesh-list
65686667|NCT05538988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65686668|NCT05538988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686669|NCT04667637|Edaravone|edaravone|mesh-list
65686670|NCT04667637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65686671|NCT04667637|Antioxidants|antioxidants|mesh-ancestor
65686672|NCT04667637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686673|NCT04667637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65686674|NCT04667637|Protective Agents|protective agents|mesh-ancestor
65686675|NCT04667637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686676|NCT02253927|Ritonavir|ritonavir|mesh-list
65686677|NCT02253927|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65686678|NCT02253927|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65686679|NCT02253927|Protease Inhibitors|protease inhibitors|mesh-ancestor
65686680|NCT02253927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686681|NCT02253927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686682|NCT02253927|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65686683|NCT02253927|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65686684|NCT02253927|Antiviral Agents|antiviral agents|mesh-ancestor
65686685|NCT02253927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65686686|NCT02253927|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65686687|NCT02253927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65686688|NCT05572749|Metformin|metformin|mesh-list
65686689|NCT05572749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65149355|NCT02872090|Respiratory System Agents|respiratory system agents|mesh-ancestor
65686690|NCT05572749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686691|NCT03745144|Cladribine|cladribine|mesh-list
65686692|NCT03745144|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65686693|NCT03745144|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
65686694|NCT03745144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686695|NCT03745144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65686696|NCT03745144|Immunologic Factors|immunologic factors|mesh-ancestor
65686697|NCT03745144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686698|NCT03745144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65686699|NCT03745144|Contraceptive Agents|contraceptive agents|mesh-ancestor
65686700|NCT03745144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65686701|NCT03745144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65686702|NCT03745144|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65686703|NCT03745144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65686704|NCT03745144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65686705|NCT03745144|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65686706|NCT03745144|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
65686707|NCT03745144|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65686708|NCT03745144|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65686709|NCT05697016|Sivelestat|sivelestat|mesh-list
65686710|NCT05697016|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65686711|NCT05697016|Protease Inhibitors|protease inhibitors|mesh-ancestor
65686712|NCT05697016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686713|NCT05697016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686714|NCT04644237|Trastuzumab|trastuzumab|mesh-list
65686715|NCT04644237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65686716|NCT04644237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686717|NCT04634877|Paclitaxel|paclitaxel|mesh-list
65686718|NCT04634877|Docetaxel|docetaxel|mesh-list
65686719|NCT04634877|Cisplatin|cisplatin|mesh-list
65686720|NCT04634877|Carboplatin|carboplatin|mesh-list
65686721|NCT04634877|Pembrolizumab|pembrolizumab|mesh-list
65686722|NCT04634877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65686723|NCT04634877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686724|NCT04634877|Tubulin Modulators|tubulin modulators|mesh-ancestor
65686725|NCT04634877|Antimitotic Agents|antimitotic agents|mesh-ancestor
65686726|NCT04634877|Mitosis Modulators|mitosis modulators|mesh-ancestor
65686727|NCT04634877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686728|NCT04634877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65686729|NCT04629495|Sirolimus|sirolimus|mesh-list
65686730|NCT04629495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65686731|NCT04629495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65686732|NCT04629495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65686733|NCT04629495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686734|NCT04629495|Antifungal Agents|antifungal agents|mesh-ancestor
65686735|NCT04629495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65686736|NCT04629495|Immunologic Factors|immunologic factors|mesh-ancestor
65686737|NCT04629495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686738|NCT05538208|Mycophenolic Acid|mycophenolic acid|mesh-list
65686739|NCT05538208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65686740|NCT05538208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686741|NCT05538208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65686742|NCT05538208|Antitubercular Agents|antitubercular agents|mesh-ancestor
65686743|NCT05538208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65686744|NCT05538208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65686745|NCT05538208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686746|NCT05538208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686747|NCT01567995|Clobetasone butyrate|clobetasone butyrate|mesh-list
65686748|NCT01567995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65686749|NCT01567995|Glucocorticoids|glucocorticoids|mesh-ancestor
65686750|NCT01567995|Hormones|hormones|mesh-ancestor
65686751|NCT01567995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65686752|NCT01567995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686753|NCT05567523|Midazolam|midazolam|mesh-list
65686754|NCT05567523|Dexmedetomidine|dexmedetomidine|mesh-list
65686755|NCT05567523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65268947|NCT02983682|Lidocaine|lidocaine|mesh-list
65686756|NCT05567523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65686757|NCT05567523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686758|NCT05567523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65686759|NCT05567523|Analgesics|analgesics|mesh-ancestor
65686760|NCT05567523|Sensory System Agents|sensory system agents|mesh-ancestor
65686761|NCT05567523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65686762|NCT05567523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65686763|NCT05567523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65686764|NCT05567523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65686765|NCT05567523|Adrenergic Agents|adrenergic agents|mesh-ancestor
65686766|NCT05567523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65686767|NCT05567523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686768|NCT05567523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65686769|NCT05567523|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65686770|NCT05567523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65686771|NCT05567523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65686772|NCT05567523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65686773|NCT05567523|Anesthetics, General|anesthetics, general|mesh-ancestor
65686774|NCT05567523|Anesthetics|anesthetics|mesh-ancestor
65686775|NCT05567523|GABA Modulators|gaba modulators|mesh-ancestor
65686776|NCT05567523|GABA Agents|gaba agents|mesh-ancestor
65686777|NCT02584504|Atorvastatin|atorvastatin|mesh-list
65686778|NCT02584504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65686779|NCT02584504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65686780|NCT02584504|Antimetabolites|antimetabolites|mesh-ancestor
65686781|NCT02584504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686782|NCT02584504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65686783|NCT02584504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65686784|NCT02584504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686785|NCT04599777|Sorafenib|sorafenib|mesh-list
65686786|NCT04599777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686787|NCT04599777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65686788|NCT04599777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686789|NCT04599777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686790|NCT05180799|Nivolumab|nivolumab|mesh-list
65686791|NCT05180799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65686792|NCT05180799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686793|NCT05180799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65686794|NCT05180799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686795|NCT05044468|Lidocaine|lidocaine|mesh-list
65686796|NCT05044468|Bupivacaine|bupivacaine|mesh-list
65686797|NCT05044468|Anesthetics, Local|anesthetics, local|mesh-ancestor
65686798|NCT05044468|Anesthetics|anesthetics|mesh-ancestor
65686799|NCT05044468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65686800|NCT05044468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686801|NCT05044468|Sensory System Agents|sensory system agents|mesh-ancestor
65686802|NCT05044468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65686803|NCT05044468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65686804|NCT05044468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65686805|NCT05044468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65686806|NCT05044468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65686807|NCT05044468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686808|NCT05176509|Pembrolizumab|pembrolizumab|mesh-list
65686809|NCT05176509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65686810|NCT05176509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686811|NCT05007262|Calcium Dobesilate|calcium dobesilate|mesh-list
65686812|NCT05007262|Calcium|calcium|mesh-list
65686813|NCT05007262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65686814|NCT05007262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686815|NCT05007262|Hemostatics|hemostatics|mesh-ancestor
65686816|NCT05007262|Coagulants|coagulants|mesh-ancestor
65686817|NCT03546075|Resveratrol|resveratrol|mesh-list
65686818|NCT03546075|Antioxidants|antioxidants|mesh-ancestor
65686819|NCT03546075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686820|NCT03546075|Protective Agents|protective agents|mesh-ancestor
65686821|NCT03546075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686822|NCT03546075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686823|NCT03546075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65686824|NCT05537584|Bupropion|bupropion|mesh-list
65686825|NCT05537584|Sertraline|sertraline|mesh-list
65686826|NCT05537584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65686827|NCT05537584|Antidepressive Agents|antidepressive agents|mesh-ancestor
65686828|NCT05537584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65686829|NCT05537584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65686830|NCT05537584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65686831|NCT05537584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65686832|NCT05537584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686833|NCT05537584|Dopamine Agents|dopamine agents|mesh-ancestor
65686834|NCT05537584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65686835|NCT05537584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686836|NCT05537584|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65686837|NCT05537584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65686838|NCT05537584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686839|NCT05537584|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65686840|NCT05537584|Serotonin Agents|serotonin agents|mesh-ancestor
65686841|NCT01801072|Levetiracetam|levetiracetam|mesh-list
65686842|NCT01801072|Anticonvulsants|anticonvulsants|mesh-ancestor
65686843|NCT01801072|Nootropic Agents|nootropic agents|mesh-ancestor
65686844|NCT04459377|Ketamine|ketamine|mesh-list
65686845|NCT04459377|Esketamine|esketamine|mesh-list
65686846|NCT04459377|Analgesics|analgesics|mesh-ancestor
65686847|NCT04459377|Sensory System Agents|sensory system agents|mesh-ancestor
65686848|NCT04459377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65686849|NCT04459377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686850|NCT04459377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65686851|NCT04459377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65686852|NCT04459377|Anesthetics, General|anesthetics, general|mesh-ancestor
65686853|NCT04459377|Anesthetics|anesthetics|mesh-ancestor
65686854|NCT04459377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65686855|NCT04459377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65686856|NCT04459377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65686857|NCT04459377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65686858|NCT04459377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686859|NCT04459377|Antidepressive Agents|antidepressive agents|mesh-ancestor
65686860|NCT04459377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65686861|NCT00748618|Vitamin D|vitamin d|mesh-list
65686862|NCT00748618|Ergocalciferols|ergocalciferols|mesh-list
65686863|NCT00748618|Cholecalciferol|cholecalciferol|mesh-list
65686864|NCT00748618|Vitamins|vitamins|mesh-list
65686865|NCT00748618|Micronutrients|micronutrients|mesh-ancestor
65686866|NCT00748618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686867|NCT00748618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65686868|NCT00748618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65686869|NCT04447755|Lenvatinib|lenvatinib|mesh-list
65686870|NCT04447755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686871|NCT04447755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65686872|NCT04447755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686873|NCT04447755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686874|NCT02254005|Maytansine|maytansine|mesh-list
65686875|NCT02254005|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
65686876|NCT02254005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65686877|NCT02254005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686878|NCT02254005|Tubulin Modulators|tubulin modulators|mesh-ancestor
65686879|NCT02254005|Antimitotic Agents|antimitotic agents|mesh-ancestor
65686880|NCT02254005|Mitosis Modulators|mitosis modulators|mesh-ancestor
65686881|NCT02254005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686882|NCT02254005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65686883|NCT04404387|Ascorbic Acid|ascorbic acid|mesh-list
65686884|NCT04404387|Vitamins|vitamins|mesh-ancestor
65686885|NCT04404387|Micronutrients|micronutrients|mesh-ancestor
65686886|NCT04404387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686887|NCT04404387|Antioxidants|antioxidants|mesh-ancestor
65686888|NCT04404387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686889|NCT04404387|Protective Agents|protective agents|mesh-ancestor
65686890|NCT03546855|Apatinib|apatinib|mesh-list
65686891|NCT03546855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686892|NCT03546855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65686893|NCT03546855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686894|NCT03546855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686895|NCT05679310|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
65686896|NCT05679310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65686897|NCT05679310|Antioxidants|antioxidants|mesh-ancestor
65686898|NCT05679310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686899|NCT05679310|Protective Agents|protective agents|mesh-ancestor
65686900|NCT05679310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686901|NCT05679310|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65686902|NCT05537272|Ascorbic Acid|ascorbic acid|mesh-list
65686903|NCT05537272|Tadalafil|tadalafil|mesh-list
65686904|NCT05537272|Tamsulosin|tamsulosin|mesh-list
65686905|NCT05537272|Vitamins|vitamins|mesh-ancestor
65686906|NCT05537272|Micronutrients|micronutrients|mesh-ancestor
65686907|NCT05537272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686908|NCT05537272|Antioxidants|antioxidants|mesh-ancestor
65686909|NCT05537272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686910|NCT05537272|Protective Agents|protective agents|mesh-ancestor
65686911|NCT05537272|Vasodilator Agents|vasodilator agents|mesh-ancestor
65686912|NCT05537272|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65686913|NCT05537272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65686914|NCT05537272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686915|NCT05537272|Urological Agents|urological agents|mesh-ancestor
65686916|NCT05537272|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65686917|NCT05537272|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65686918|NCT05537272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65686919|NCT05537272|Adrenergic Agents|adrenergic agents|mesh-ancestor
65686920|NCT05537272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65686921|NCT05537194|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
65686922|NCT05537194|Calcium|calcium|mesh-list
65686923|NCT05537194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65686924|NCT05537194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686925|NCT05537194|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65686926|NCT05537194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65686927|NCT05537194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686928|NCT05536882|Adapalene|adapalene|mesh-list
65686929|NCT05536882|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65686930|NCT05536882|Dermatologic Agents|dermatologic agents|mesh-ancestor
65686931|NCT05536882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65686932|NCT05536882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65686933|NCT05536882|Analgesics|analgesics|mesh-ancestor
65686934|NCT05536882|Sensory System Agents|sensory system agents|mesh-ancestor
65686935|NCT05536882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65686936|NCT05536882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686937|NCT05536882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65686938|NCT05536882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65686939|NCT04605094|Benralizumab|benralizumab|mesh-list
65686940|NCT04605094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65686941|NCT04605094|Respiratory System Agents|respiratory system agents|mesh-ancestor
65686942|NCT03931161|Evolocumab|evolocumab|mesh-list
65686943|NCT03931161|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65686944|NCT03931161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65686945|NCT03931161|Antimetabolites|antimetabolites|mesh-ancestor
65686946|NCT03931161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686947|NCT03931161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65686948|NCT05037123|Ketamine|ketamine|mesh-list
65686949|NCT05037123|Analgesics|analgesics|mesh-ancestor
65686950|NCT05037123|Sensory System Agents|sensory system agents|mesh-ancestor
65686951|NCT05037123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65686952|NCT05037123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686953|NCT05037123|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65686954|NCT05037123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65686955|NCT05037123|Anesthetics, General|anesthetics, general|mesh-ancestor
65686956|NCT05037123|Anesthetics|anesthetics|mesh-ancestor
65686957|NCT05037123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65686958|NCT05037123|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65686959|NCT05037123|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65686960|NCT05037123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65686961|NCT05037123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686962|NCT04354155|Enoxaparin|enoxaparin|mesh-list
65686963|NCT04354155|Anticoagulants|anticoagulants|mesh-ancestor
65686964|NCT04354155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65484288|NCT01331590|Dexamethasone|dexamethasone|mesh-list
65686965|NCT04354155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65686966|NCT04354155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686967|NCT04450654|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65686968|NCT04450654|Immunologic Factors|immunologic factors|mesh-ancestor
65686969|NCT04450654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686971|NCT04350021|Capecitabine|capecitabine|mesh-list
65686972|NCT04350021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65686973|NCT04350021|Immunologic Factors|immunologic factors|mesh-ancestor
65686974|NCT04350021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686975|NCT04350021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65149647|NCT04288999|Capecitabine|capecitabine|mesh-list
65686976|NCT04350021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65686977|NCT04350021|Alkylating Agents|alkylating agents|mesh-ancestor
65686978|NCT04350021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686979|NCT04350021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65686980|NCT04350021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65686981|NCT04350021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65686982|NCT04350021|Antimetabolites|antimetabolites|mesh-ancestor
65686983|NCT05536570|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65686984|NCT05536570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65686985|NCT05536570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65686986|NCT05536570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686987|NCT05536570|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65686988|NCT05536570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65686989|NCT05536570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686990|NCT05536570|Cholinergic Agents|cholinergic agents|mesh-ancestor
65686991|NCT05536570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65686992|NCT03877965|Digoxin|digoxin|mesh-list
65686993|NCT03877965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65686994|NCT03877965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65686995|NCT03877965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65686996|NCT03877965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65686997|NCT03877965|Protective Agents|protective agents|mesh-ancestor
65686998|NCT03877965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65686999|NCT03871491|Azithromycin|azithromycin|mesh-list
65687000|NCT03871491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65687001|NCT03871491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65687002|NCT02253849|Ritonavir|ritonavir|mesh-list
65687003|NCT02253849|Tipranavir|tipranavir|mesh-list
65687004|NCT02253849|Carbamazepine|carbamazepine|mesh-list
65687005|NCT02253849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65687006|NCT02253849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65687007|NCT02253849|Protease Inhibitors|protease inhibitors|mesh-ancestor
65687008|NCT02253849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687009|NCT02253849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687010|NCT02253849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65687011|NCT02253849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65687012|NCT02253849|Antiviral Agents|antiviral agents|mesh-ancestor
65687013|NCT02253849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65687014|NCT02253849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65687015|NCT02253849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65687016|NCT02253849|Anticonvulsants|anticonvulsants|mesh-ancestor
65687017|NCT02253849|Antimanic Agents|antimanic agents|mesh-ancestor
65687018|NCT02253849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65687019|NCT02253849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65687020|NCT02253849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687021|NCT02253849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65687022|NCT02253849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65687023|NCT02253849|Analgesics|analgesics|mesh-ancestor
65687024|NCT02253849|Sensory System Agents|sensory system agents|mesh-ancestor
65687025|NCT02253849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687026|NCT02253849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65687027|NCT02253849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65687028|NCT02253849|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65687029|NCT02253849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65687030|NCT03545997|Montelukast|montelukast|mesh-list
65687031|NCT03545997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65687032|NCT03545997|Respiratory System Agents|respiratory system agents|mesh-ancestor
65687033|NCT03545997|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65687034|NCT03545997|Hormone Antagonists|hormone antagonists|mesh-ancestor
65687035|NCT03545997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65687036|NCT03545997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687037|NCT03545997|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65687038|NCT03545997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65484362|NCT04245436|Analgesics|analgesics|mesh-ancestor
65687039|NCT03545997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687041|NCT05696548|Lenvatinib|lenvatinib|mesh-list
65687042|NCT05696548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65687043|NCT05696548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687044|NCT05696548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65687045|NCT05696548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687046|NCT05696548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65687047|NCT05696548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687048|NCT03810495|Naltrexone|naltrexone|mesh-list
65687049|NCT03810495|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65687050|NCT03810495|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65687051|NCT03810495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687052|NCT03810495|Sensory System Agents|sensory system agents|mesh-ancestor
65687053|NCT03810495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687054|NCT04980885|Azacitidine|azacitidine|mesh-list
65687055|NCT04980885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65687056|NCT04980885|Antimetabolites|antimetabolites|mesh-ancestor
65687057|NCT04980885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687058|NCT04980885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687059|NCT04980885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687060|NCT04184505|Azacitidine|azacitidine|mesh-list
65687061|NCT04184505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65687062|NCT04184505|Antimetabolites|antimetabolites|mesh-ancestor
65687063|NCT04184505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687064|NCT04184505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687065|NCT04184505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687066|NCT03691935|Ropivacaine|ropivacaine|mesh-list
65687067|NCT03691935|Anesthetics|anesthetics|mesh-list
65687068|NCT03691935|Anesthetics, Local|anesthetics, local|mesh-ancestor
65687069|NCT03691935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65687070|NCT03691935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687071|NCT03691935|Sensory System Agents|sensory system agents|mesh-ancestor
65687072|NCT03691935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687073|NCT03760458|Lamivudine|lamivudine|mesh-list
65687074|NCT03760458|Abacavir|abacavir|mesh-list
65687075|NCT03760458|Dideoxynucleosides|dideoxynucleosides|mesh-list
65687076|NCT03760458|Dolutegravir|dolutegravir|mesh-list
65687077|NCT03760458|Triumeq|triumeq|mesh-list
65687078|NCT03760458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65687079|NCT03760458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65687080|NCT03760458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687081|NCT03760458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687082|NCT03760458|Antiviral Agents|antiviral agents|mesh-ancestor
65687083|NCT03760458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65687084|NCT03760458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65687085|NCT03760458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65687086|NCT03760458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65687087|NCT03760458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65687088|NCT03760458|Antimetabolites|antimetabolites|mesh-ancestor
65687089|NCT02066415|Erenumab|erenumab|mesh-list
65687090|NCT02066415|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65687091|NCT02066415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687092|NCT02066415|Analgesics|analgesics|mesh-ancestor
65687093|NCT02066415|Sensory System Agents|sensory system agents|mesh-ancestor
65687094|NCT02066415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687095|NCT02066415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687096|NCT04467918|Cannabidiol|cannabidiol|mesh-list
65687097|NCT04467918|Anticonvulsants|anticonvulsants|mesh-ancestor
65687098|NCT02582866|Lacosamide|lacosamide|mesh-list
65687099|NCT02582866|Anticonvulsants|anticonvulsants|mesh-ancestor
65687100|NCT02582866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65687101|NCT02582866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65687102|NCT02582866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65687103|NCT02582866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687104|NCT04720612|Omalizumab|omalizumab|mesh-list
65687105|NCT04720612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65687106|NCT04720612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65687107|NCT04720612|Respiratory System Agents|respiratory system agents|mesh-ancestor
65687108|NCT02584660|Rivaroxaban|rivaroxaban|mesh-list
65687109|NCT02584660|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65687110|NCT02584660|Antithrombins|antithrombins|mesh-ancestor
65687111|NCT02584660|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65687112|NCT02584660|Protease Inhibitors|protease inhibitors|mesh-ancestor
65484436|NCT02818582|Antimetabolites|antimetabolites|mesh-ancestor
65687113|NCT02584660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687114|NCT02584660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687115|NCT02584660|Anticoagulants|anticoagulants|mesh-ancestor
65687116|NCT04862286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65687117|NCT04862286|Immunologic Factors|immunologic factors|mesh-ancestor
65687118|NCT04862286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687119|NCT02143323|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65687120|NCT02143323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65687121|NCT02143323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65687122|NCT02143323|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65687123|NCT02143323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687124|NCT02143323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687125|NCT04315558|Bromides|bromides|mesh-list
65687126|NCT04315558|Ipratropium|ipratropium|mesh-list
65687127|NCT04315558|Anticonvulsants|anticonvulsants|mesh-ancestor
65687128|NCT04315558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65687129|NCT04315558|Autonomic Agents|autonomic agents|mesh-ancestor
65687130|NCT04315558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687131|NCT04315558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687132|NCT04315558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65687133|NCT04315558|Respiratory System Agents|respiratory system agents|mesh-ancestor
65687134|NCT04315558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65687135|NCT04315558|Cholinergic Agents|cholinergic agents|mesh-ancestor
65687136|NCT04315558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65687137|NCT04315558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687138|NCT04466904|Dulaglutide|dulaglutide|mesh-list
65687139|NCT04466904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65687140|NCT04466904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687141|NCT03524274|Antibodies|antibodies|mesh-list
65687142|NCT03524274|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65687143|NCT03524274|Immunologic Factors|immunologic factors|mesh-ancestor
65687144|NCT03524274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687145|NCT02143479|Tacrolimus|tacrolimus|mesh-list
65687146|NCT02143479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65687147|NCT02143479|Immunologic Factors|immunologic factors|mesh-ancestor
65687148|NCT02143479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687149|NCT02143479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65687150|NCT02143479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687151|NCT02143479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687152|NCT02254239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65687153|NCT02254239|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65687154|NCT02254239|Everolimus|everolimus|mesh-list
65687155|NCT02254239|Antibodies|antibodies|mesh-list
65687156|NCT02254239|Immunoglobulins|immunoglobulins|mesh-list
65687157|NCT02254239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65687158|NCT02254239|Immunoconjugates|immunoconjugates|mesh-list
65687159|NCT02254239|Immunologic Factors|immunologic factors|mesh-ancestor
65687160|NCT02254239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687161|NCT02254239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687162|NCT02254239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65687163|NCT05088369|Adrenomedullin|adrenomedullin|mesh-list
65687164|NCT05088369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65687165|NCT05088369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65687166|NCT05088369|Autonomic Agents|autonomic agents|mesh-ancestor
65687167|NCT05088369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687168|NCT05088369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687169|NCT05088369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65687170|NCT05088369|Respiratory System Agents|respiratory system agents|mesh-ancestor
65687171|NCT05088369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65687172|NCT05088369|Vasodilator Agents|vasodilator agents|mesh-ancestor
65687173|NCT05088369|Protective Agents|protective agents|mesh-ancestor
65687174|NCT05681182|Amiodarone|amiodarone|mesh-list
65687175|NCT05681182|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65687176|NCT05681182|Vasodilator Agents|vasodilator agents|mesh-ancestor
65687177|NCT05681182|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65687178|NCT05681182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65687179|NCT05681182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687180|NCT05681182|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65687181|NCT05681182|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65687182|NCT05681182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65687183|NCT05681182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687184|NCT05681182|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65687185|NCT05681182|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65687186|NCT05681182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65687187|NCT03521700|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65687188|NCT03521700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65687189|NCT03521700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65687190|NCT03521700|Antimetabolites|antimetabolites|mesh-ancestor
65687191|NCT03521700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687192|NCT03521700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65687193|NCT03521700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65687194|NCT03521700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687195|NCT02144025|Cyclosporine|cyclosporine|mesh-list
65687196|NCT02144025|Cyclosporins|cyclosporins|mesh-list
65687197|NCT02144025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687198|NCT02144025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687199|NCT02144025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65687200|NCT02144025|Immunologic Factors|immunologic factors|mesh-ancestor
65687201|NCT02144025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687202|NCT02144025|Antifungal Agents|antifungal agents|mesh-ancestor
65687203|NCT02144025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65687204|NCT02144025|Dermatologic Agents|dermatologic agents|mesh-ancestor
65687205|NCT02144025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65687206|NCT02144025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65687207|NCT03523650|Propranolol|propranolol|mesh-list
65687208|NCT03523650|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65687209|NCT03523650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65687210|NCT03523650|Adrenergic Agents|adrenergic agents|mesh-ancestor
65687211|NCT03523650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65687212|NCT03523650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687213|NCT03523650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687214|NCT03523650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65687215|NCT03523650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65687216|NCT03523650|Vasodilator Agents|vasodilator agents|mesh-ancestor
65687217|NCT01025505|Imatinib Mesylate|imatinib mesylate|mesh-list
65687218|NCT01025505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687219|NCT01025505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65687220|NCT01025505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687221|NCT01025505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687222|NCT02582632|Ritonavir|ritonavir|mesh-list
65687223|NCT02582632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65687224|NCT02582632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65687225|NCT02582632|Protease Inhibitors|protease inhibitors|mesh-ancestor
65687226|NCT02582632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687227|NCT02582632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687228|NCT02582632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65687229|NCT02582632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65687230|NCT02582632|Antiviral Agents|antiviral agents|mesh-ancestor
65687231|NCT02582632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65687232|NCT02582632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65687233|NCT02582632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65687234|NCT05414032|Cetuximab|cetuximab|mesh-list
65687235|NCT05414032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65687236|NCT05414032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687237|NCT03656562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65687238|NCT03656562|Immunologic Factors|immunologic factors|mesh-ancestor
65687239|NCT03656562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687240|NCT05381974|Psilocybin|psilocybin|mesh-list
65687241|NCT05381974|Hallucinogens|hallucinogens|mesh-ancestor
65687242|NCT05381974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687243|NCT05381974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65687244|NCT02178722|Pembrolizumab|pembrolizumab|mesh-list
65687245|NCT02178722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65687246|NCT02178722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687247|NCT05362318|Nicotine|nicotine|mesh-list
65687248|NCT05362318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65687249|NCT05362318|Autonomic Agents|autonomic agents|mesh-ancestor
65687250|NCT05362318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687251|NCT05362318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687252|NCT05362318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65687253|NCT05362318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65687254|NCT05362318|Cholinergic Agents|cholinergic agents|mesh-ancestor
65687255|NCT05362318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65687256|NCT05362318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687257|NCT03523572|Nivolumab|nivolumab|mesh-list
65687258|NCT03523572|Trastuzumab|trastuzumab|mesh-list
65687259|NCT03523572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65687260|NCT03523572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687261|NCT03523572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65687262|NCT03523572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687263|NCT00972309|Vaccines|vaccines|mesh-list
65687264|NCT00972309|Immunologic Factors|immunologic factors|mesh-ancestor
65687265|NCT00972309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687266|NCT03526224|Teriflunomide|teriflunomide|mesh-list
65687267|NCT03526224|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65687268|NCT03526224|Dermatologic Agents|dermatologic agents|mesh-ancestor
65687269|NCT03526224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65687270|NCT03526224|Immunologic Factors|immunologic factors|mesh-ancestor
65687271|NCT03526224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687272|NCT03526224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65687273|NCT03526224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65687274|NCT03526224|Analgesics|analgesics|mesh-ancestor
65687275|NCT03526224|Sensory System Agents|sensory system agents|mesh-ancestor
65687276|NCT03526224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687277|NCT03526224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65687278|NCT03526224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65687279|NCT03639246|Paclitaxel|paclitaxel|mesh-list
65687280|NCT03639246|Doxorubicin|doxorubicin|mesh-list
65687281|NCT03639246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65687282|NCT03639246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65687283|NCT03639246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687284|NCT03639246|Tubulin Modulators|tubulin modulators|mesh-ancestor
65687285|NCT03639246|Antimitotic Agents|antimitotic agents|mesh-ancestor
65687286|NCT03639246|Mitosis Modulators|mitosis modulators|mesh-ancestor
65687287|NCT03639246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687288|NCT03639246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65687289|NCT03639246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65687290|NCT03639246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65687291|NCT03639246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687292|NCT00545324|Fluticasone|fluticasone|mesh-list
65687293|NCT00545324|Montelukast|montelukast|mesh-list
65687294|NCT00545324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65687295|NCT00545324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65687296|NCT00545324|Autonomic Agents|autonomic agents|mesh-ancestor
65687297|NCT00545324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687298|NCT00545324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687299|NCT00545324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65687300|NCT00545324|Respiratory System Agents|respiratory system agents|mesh-ancestor
65687301|NCT00545324|Dermatologic Agents|dermatologic agents|mesh-ancestor
65687302|NCT00545324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65687303|NCT00545324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687304|NCT00545324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65687305|NCT00545324|Hormone Antagonists|hormone antagonists|mesh-ancestor
65687306|NCT00545324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65687307|NCT00545324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65687308|NCT00545324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65687309|NCT02582242|Insulin Aspart|insulin aspart|mesh-list
65687310|NCT02582242|Biphasic Insulins|biphasic insulins|mesh-list
65687311|NCT02582242|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65687312|NCT02582242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65687313|NCT02582242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687314|NCT05093582|Cromakalim|cromakalim|mesh-list
65687315|NCT05093582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65687316|NCT05093582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65687317|NCT05093582|Autonomic Agents|autonomic agents|mesh-ancestor
65687318|NCT05093582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687319|NCT05093582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687320|NCT05093582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65687321|NCT05093582|Respiratory System Agents|respiratory system agents|mesh-ancestor
65687322|NCT05093582|Parasympatholytics|parasympatholytics|mesh-ancestor
65687323|NCT05093582|Vasodilator Agents|vasodilator agents|mesh-ancestor
65687324|NCT05004038|BCG Vaccine|bcg vaccine|mesh-list
65687325|NCT05004038|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65687326|NCT05004038|Immunologic Factors|immunologic factors|mesh-ancestor
65687327|NCT05004038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687328|NCT04217356|Hydroxyurea|hydroxyurea|mesh-list
65687329|NCT04217356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687330|NCT04217356|Antisickling Agents|antisickling agents|mesh-ancestor
65687331|NCT04217356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687332|NCT04217356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687333|NCT04217356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65687334|NCT03609840|Thiotepa|thiotepa|mesh-list
65687335|NCT03609840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-list
65687336|NCT03609840|Antineoplastic Agents|antineoplastic agents|mesh-list
65687337|NCT03609840|Alkylating Agents|alkylating agents|mesh-ancestor
65687338|NCT03609840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687339|NCT03609840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65687340|NCT03609840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65687341|NCT03609840|Immunologic Factors|immunologic factors|mesh-ancestor
65687342|NCT03609840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687344|NCT03389126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65687345|NCT03389126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687346|NCT04212364|Naloxone|naloxone|mesh-list
65687347|NCT04212364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65687348|NCT04212364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687349|NCT04212364|Sensory System Agents|sensory system agents|mesh-ancestor
65687350|NCT04212364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687351|NCT04446104|Hydroxychloroquine|hydroxychloroquine|mesh-list
65687352|NCT04446104|Ivermectin|ivermectin|mesh-list
65687353|NCT04446104|Povidone-Iodine|povidone-iodine|mesh-list
65687354|NCT04446104|Povidone|povidone|mesh-list
65687355|NCT04446104|Antimalarials|antimalarials|mesh-ancestor
65687356|NCT04446104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65687357|NCT04446104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65687358|NCT04446104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65687359|NCT04446104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687360|NCT04446104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687361|NCT04446104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65687362|NCT04446104|Plasma Substitutes|plasma substitutes|mesh-ancestor
65687363|NCT04446104|Blood Substitutes|blood substitutes|mesh-ancestor
65687364|NCT04446104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65687365|NCT03388970|Vitamin K|vitamin k|mesh-list
65687366|NCT03388970|Vitamin K 1|vitamin k 1|mesh-list
65687367|NCT03388970|Vitamins|vitamins|mesh-ancestor
65687368|NCT03388970|Micronutrients|micronutrients|mesh-ancestor
65687369|NCT03388970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687370|NCT03388970|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65687371|NCT03388970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65687372|NCT03388970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687373|NCT03388970|Hemostatics|hemostatics|mesh-ancestor
65687374|NCT03388970|Coagulants|coagulants|mesh-ancestor
65687375|NCT00616941|Poly ICLC|poly iclc|mesh-list
65687376|NCT00616941|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65687377|NCT00616941|Interferon Inducers|interferon inducers|mesh-ancestor
65687378|NCT00616941|Immunologic Factors|immunologic factors|mesh-ancestor
65687379|NCT00616941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687380|NCT00616941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65687381|NCT04702022|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65687382|NCT04702022|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65687383|NCT04702022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687384|NCT05677282|Azithromycin|azithromycin|mesh-list
65687385|NCT05677282|Rifaximin|rifaximin|mesh-list
65687386|NCT05677282|Loperamide|loperamide|mesh-list
65687387|NCT05677282|Antidiarrheals|antidiarrheals|mesh-list
65687388|NCT05677282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65687389|NCT05677282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65687390|NCT05677282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65687391|NCT03388892|Paclitaxel|paclitaxel|mesh-list
65687392|NCT03388892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65687393|NCT03388892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687394|NCT03388892|Tubulin Modulators|tubulin modulators|mesh-ancestor
65687395|NCT03388892|Antimitotic Agents|antimitotic agents|mesh-ancestor
65687396|NCT03388892|Mitosis Modulators|mitosis modulators|mesh-ancestor
65687397|NCT03388892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687398|NCT02577718|Ethanol|ethanol|mesh-list
65687399|NCT02577718|Nitroglycerin|nitroglycerin|mesh-list
65687400|NCT02577718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65687401|NCT02577718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65687402|NCT02577718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65687403|NCT02577718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687404|NCT02577718|Vasodilator Agents|vasodilator agents|mesh-ancestor
65687405|NCT00520533|Sunitinib|sunitinib|mesh-list
65687406|NCT00520533|Antibodies|antibodies|mesh-list
65687407|NCT00520533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65687408|NCT00520533|Immunologic Factors|immunologic factors|mesh-ancestor
65687409|NCT00520533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687410|NCT00520533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687411|NCT00520533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65687412|NCT00520533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65687413|NCT00520533|Growth Substances|growth substances|mesh-ancestor
65687414|NCT00520533|Growth Inhibitors|growth inhibitors|mesh-ancestor
65687415|NCT00520533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65687416|NCT00520533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687417|NCT00520533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687418|NCT03388814|Bupivacaine|bupivacaine|mesh-list
65687419|NCT03388814|Anesthetics, Local|anesthetics, local|mesh-ancestor
65687420|NCT03388814|Anesthetics|anesthetics|mesh-ancestor
65687421|NCT03388814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65687422|NCT03388814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687423|NCT03388814|Sensory System Agents|sensory system agents|mesh-ancestor
65687424|NCT03388814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687425|NCT04680988|Gemcitabine|gemcitabine|mesh-list
65687426|NCT04680988|Paclitaxel|paclitaxel|mesh-list
65687427|NCT04680988|Pemetrexed|pemetrexed|mesh-list
65687428|NCT04680988|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65687429|NCT04680988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65687430|NCT04680988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687431|NCT04680988|Tubulin Modulators|tubulin modulators|mesh-ancestor
65687432|NCT04680988|Antimitotic Agents|antimitotic agents|mesh-ancestor
65687433|NCT04680988|Mitosis Modulators|mitosis modulators|mesh-ancestor
65687434|NCT04680988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687435|NCT04680988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65687436|NCT04680988|Antimetabolites|antimetabolites|mesh-ancestor
65687437|NCT04680988|Antiviral Agents|antiviral agents|mesh-ancestor
65687438|NCT04680988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65687439|NCT04680988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687440|NCT04680988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65687441|NCT04680988|Immunologic Factors|immunologic factors|mesh-ancestor
65687442|NCT04680988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687443|NCT04680988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65687444|NCT04680988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65687445|NCT02289144|Ceritinib|ceritinib|mesh-list
65687446|NCT02289144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687447|NCT02289144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65687448|NCT02289144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687449|NCT02289144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687450|NCT03393026|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65687451|NCT03393026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65687452|NCT03393026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65687453|NCT03393026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65687454|NCT03393026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687455|NCT03393026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65687456|NCT03393026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65687457|NCT03393026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65687458|NCT03393026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65687459|NCT03393026|Adrenergic Agents|adrenergic agents|mesh-ancestor
65687460|NCT03393026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65687461|NCT03393026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687462|NCT03393026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65687463|NCT03393026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65687464|NCT03393026|Serotonin Agents|serotonin agents|mesh-ancestor
65687465|NCT03393026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65687466|NCT03393026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65687467|NCT03393026|Dopamine Agents|dopamine agents|mesh-ancestor
65687468|NCT02144415|Amphetamine|amphetamine|mesh-list
65687469|NCT02144415|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65687470|NCT02144415|Dextroamphetamine|dextroamphetamine|mesh-list
65687471|NCT02144415|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65687472|NCT02144415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687473|NCT02144415|Sympathomimetics|sympathomimetics|mesh-ancestor
65687474|NCT02144415|Autonomic Agents|autonomic agents|mesh-ancestor
65687475|NCT02144415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687476|NCT02144415|Dopamine Agents|dopamine agents|mesh-ancestor
65687477|NCT02144415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65687478|NCT02144415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687479|NCT02144415|Adrenergic Agents|adrenergic agents|mesh-ancestor
65687480|NCT02144415|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65687481|NCT02144415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65687482|NCT02144415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65687483|NCT02144415|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65687484|NCT02739984|Evolocumab|evolocumab|mesh-list
65687485|NCT02739984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65687486|NCT02739984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65484812|NCT03635398|GABA Agents|gaba agents|mesh-ancestor
65687487|NCT02739984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65687488|NCT02739984|Antimetabolites|antimetabolites|mesh-ancestor
65687489|NCT02739984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687490|NCT02739984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65687491|NCT02739984|Immunologic Factors|immunologic factors|mesh-ancestor
65687492|NCT02739984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687493|NCT00496730|Atorvastatin|atorvastatin|mesh-list
65687494|NCT00496730|Simvastatin|simvastatin|mesh-list
65687495|NCT00496730|Ezetimibe|ezetimibe|mesh-list
65687496|NCT00496730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65687497|NCT00496730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65687498|NCT00496730|Antimetabolites|antimetabolites|mesh-ancestor
65687499|NCT00496730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687500|NCT00496730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65687501|NCT00496730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65687502|NCT00496730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687503|NCT00446186|Montelukast|montelukast|mesh-list
65687504|NCT00446186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687505|NCT00446186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687506|NCT00446186|Respiratory System Agents|respiratory system agents|mesh-ancestor
65687507|NCT00446186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65687508|NCT00446186|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65687509|NCT00446186|Hormone Antagonists|hormone antagonists|mesh-ancestor
65687510|NCT00446186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65687511|NCT00446186|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65687512|NCT00446186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65687513|NCT02140983|Liraglutide|liraglutide|mesh-list
65687514|NCT02140983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65687515|NCT02140983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687516|NCT02140983|Incretins|incretins|mesh-ancestor
65687517|NCT02140983|Hormones|hormones|mesh-ancestor
65687518|NCT02140983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65687519|NCT00394160|Montelukast|montelukast|mesh-list
65687520|NCT00394160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65687521|NCT00394160|Respiratory System Agents|respiratory system agents|mesh-ancestor
65687522|NCT00394160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65687523|NCT00394160|Hormone Antagonists|hormone antagonists|mesh-ancestor
65687524|NCT00394160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65687525|NCT00394160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687526|NCT00394160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65687527|NCT00394160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65687528|NCT00394160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687529|NCT03392792|Plasminogen|plasminogen|mesh-list
65687530|NCT03392792|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65687531|NCT03392792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65687532|NCT03392792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65687533|NCT03392792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687534|NCT02739828|Adalimumab|adalimumab|mesh-list
65687535|NCT02739828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65687536|NCT02739828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65687537|NCT02141139|Ibuprofen|ibuprofen|mesh-list
65687538|NCT02141139|Ketorolac|ketorolac|mesh-list
65687539|NCT02141139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65687540|NCT02141139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65687541|NCT02141139|Analgesics|analgesics|mesh-ancestor
65687542|NCT02141139|Sensory System Agents|sensory system agents|mesh-ancestor
65687543|NCT02141139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687544|NCT02141139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687545|NCT02141139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65687546|NCT02141139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65687547|NCT02141139|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65687548|NCT02141139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687549|NCT02141139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687550|NCT03108495|Pembrolizumab|pembrolizumab|mesh-list
65687551|NCT03108495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65687552|NCT03108495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687553|NCT05297032|Quercetin|quercetin|mesh-list
65687554|NCT05297032|Antioxidants|antioxidants|mesh-ancestor
65687555|NCT05297032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687556|NCT05297032|Protective Agents|protective agents|mesh-ancestor
65687557|NCT05297032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687558|NCT03388580|Dimercaprol|dimercaprol|mesh-list
65687559|NCT03388580|Chelating Agents|chelating agents|mesh-ancestor
65687560|NCT03388580|Sequestering Agents|sequestering agents|mesh-ancestor
65687561|NCT03388580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687562|NCT03525912|Ketamine|ketamine|mesh-list
65687563|NCT03525912|Analgesics|analgesics|mesh-list
65687564|NCT03525912|Sensory System Agents|sensory system agents|mesh-ancestor
65687565|NCT03525912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687566|NCT03525912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687567|NCT03525912|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65687568|NCT03525912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65687569|NCT03525912|Anesthetics, General|anesthetics, general|mesh-ancestor
65687570|NCT03525912|Anesthetics|anesthetics|mesh-ancestor
65687571|NCT03525912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65687572|NCT03525912|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65687573|NCT03525912|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65687574|NCT03525912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65687575|NCT03525912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687576|NCT02289378|Docetaxel|docetaxel|mesh-list
65687577|NCT02289378|Oxaliplatin|oxaliplatin|mesh-list
65687578|NCT02289378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687579|NCT02289378|Tubulin Modulators|tubulin modulators|mesh-ancestor
65687580|NCT02289378|Antimitotic Agents|antimitotic agents|mesh-ancestor
65687581|NCT02289378|Mitosis Modulators|mitosis modulators|mesh-ancestor
65687582|NCT02289378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687583|NCT03851614|Durvalumab|durvalumab|mesh-list
65687584|NCT03851614|Olaparib|olaparib|mesh-list
65687585|NCT03851614|Cediranib|cediranib|mesh-list
65687586|NCT03851614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65687587|NCT03851614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687588|NCT03851614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65687589|NCT03851614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687590|NCT03851614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687591|NCT03851614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65687592|NCT04565600|Etoricoxib|etoricoxib|mesh-list
65687593|NCT04565600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65687594|NCT04565600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65687595|NCT04565600|Analgesics|analgesics|mesh-ancestor
65687596|NCT04565600|Sensory System Agents|sensory system agents|mesh-ancestor
65687597|NCT04565600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687598|NCT04565600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687599|NCT04565600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65687600|NCT04565600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65687601|NCT04565600|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65687602|NCT04565600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65687603|NCT04565600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687604|NCT04565600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687605|NCT04435808|Hydroxychloroquine|hydroxychloroquine|mesh-list
65687606|NCT04435808|Antimalarials|antimalarials|mesh-ancestor
65687607|NCT04435808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65687608|NCT04435808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65687609|NCT04435808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65687610|NCT04435808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687611|NCT04435808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687612|NCT04435808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65687613|NCT03388346|Edetic Acid|edetic acid|mesh-list
65687614|NCT03388346|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65687615|NCT03388346|Chelating Agents|chelating agents|mesh-ancestor
65687616|NCT03388346|Sequestering Agents|sequestering agents|mesh-ancestor
65687617|NCT03388346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687618|NCT03388346|Anticoagulants|anticoagulants|mesh-ancestor
65687619|NCT03388346|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65687620|NCT03388346|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65687621|NCT05631730|Metoprolol|metoprolol|mesh-list
65687622|NCT05631730|Flecainide|flecainide|mesh-list
65687623|NCT05631730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65687624|NCT05631730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65687625|NCT05631730|Sympatholytics|sympatholytics|mesh-ancestor
65687626|NCT05631730|Autonomic Agents|autonomic agents|mesh-ancestor
65687627|NCT05631730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687628|NCT05631730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687629|NCT05631730|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65687630|NCT05631730|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65687631|NCT05631730|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65687632|NCT05631730|Adrenergic Agents|adrenergic agents|mesh-ancestor
65687633|NCT05631730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65687634|NCT05631730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687635|NCT05631730|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65687636|NCT05631730|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65687637|NCT05631730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65687638|NCT00092144|Montelukast|montelukast|mesh-list
65687639|NCT00092144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687640|NCT00092144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687641|NCT00092144|Respiratory System Agents|respiratory system agents|mesh-ancestor
65687642|NCT00092144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65687643|NCT00092144|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65687644|NCT00092144|Hormone Antagonists|hormone antagonists|mesh-ancestor
65687645|NCT00092144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65687646|NCT00092144|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65687647|NCT00092144|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65687648|NCT02289768|Salicylic Acid|salicylic acid|mesh-list
65687649|NCT02289768|Salicylates|salicylates|mesh-list
65687650|NCT02289768|Fluorouracil|fluorouracil|mesh-list
65687651|NCT02289768|Antimetabolites|antimetabolites|mesh-ancestor
65687652|NCT02289768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687653|NCT02289768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65687654|NCT02289768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687655|NCT02289768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65687656|NCT02289768|Immunologic Factors|immunologic factors|mesh-ancestor
65687657|NCT02289768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687658|NCT02289768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65687659|NCT02289768|Antifungal Agents|antifungal agents|mesh-ancestor
65687660|NCT02289768|Keratolytic Agents|keratolytic agents|mesh-ancestor
65687661|NCT02289768|Dermatologic Agents|dermatologic agents|mesh-ancestor
65687662|NCT02289768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65687663|NCT02289768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65687664|NCT02289768|Analgesics|analgesics|mesh-ancestor
65687665|NCT02289768|Sensory System Agents|sensory system agents|mesh-ancestor
65687666|NCT02289768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687667|NCT02289768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65687668|NCT02289768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65687669|NCT02289768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65687670|NCT02289768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687671|NCT05526586|Ethanol|ethanol|mesh-list
65687672|NCT05526586|Listerine|listerine|mesh-list
65687673|NCT05526586|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
65687674|NCT05526586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65687675|NCT05526586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65687676|NCT05526586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687677|NCT04330430|Nivolumab|nivolumab|mesh-list
65687678|NCT04330430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65687679|NCT04330430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687680|NCT04330430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65687681|NCT04330430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687682|NCT03387956|Dexamethasone|dexamethasone|mesh-list
65687683|NCT03387956|Atropine|atropine|mesh-list
65687684|NCT03387956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65687685|NCT03387956|Antiemetics|antiemetics|mesh-ancestor
65687686|NCT03387956|Autonomic Agents|autonomic agents|mesh-ancestor
65687687|NCT03387956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687688|NCT03387956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687689|NCT03387956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65687690|NCT03387956|Glucocorticoids|glucocorticoids|mesh-ancestor
65687691|NCT03387956|Hormones|hormones|mesh-ancestor
65687692|NCT03387956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65687693|NCT03387956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65687694|NCT03387956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687695|NCT03387956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65687696|NCT03387956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65687697|NCT03387956|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65687698|NCT03387956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65687699|NCT03387956|Respiratory System Agents|respiratory system agents|mesh-ancestor
65687700|NCT03387956|Mydriatics|mydriatics|mesh-ancestor
65687701|NCT03387956|Parasympatholytics|parasympatholytics|mesh-ancestor
65687702|NCT03387956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65687703|NCT03387956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65687704|NCT03387956|Cholinergic Agents|cholinergic agents|mesh-ancestor
65687705|NCT03387956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65687706|NCT03387956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687707|NCT03384524|Metoprolol|metoprolol|mesh-list
65687708|NCT03384524|Bromocriptine|bromocriptine|mesh-list
65687709|NCT03384524|Tamsulosin|tamsulosin|mesh-list
65687710|NCT03384524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65687711|NCT03384524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65687712|NCT03384524|Sympatholytics|sympatholytics|mesh-ancestor
65687713|NCT03384524|Autonomic Agents|autonomic agents|mesh-ancestor
65687714|NCT03384524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687715|NCT03384524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687716|NCT03384524|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65687717|NCT03384524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65687718|NCT03384524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65687719|NCT03384524|Adrenergic Agents|adrenergic agents|mesh-ancestor
65687720|NCT03384524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65687721|NCT03384524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687722|NCT03384524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65687723|NCT03384524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65687724|NCT03384524|Urological Agents|urological agents|mesh-ancestor
65687725|NCT03384524|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65687726|NCT03384524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65687727|NCT03384524|Hormone Antagonists|hormone antagonists|mesh-ancestor
65687728|NCT03384524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65687729|NCT03384524|Dopamine Agonists|dopamine agonists|mesh-ancestor
65687730|NCT03384524|Dopamine Agents|dopamine agents|mesh-ancestor
65687731|NCT02289924|Aflibercept|aflibercept|mesh-list
65687732|NCT02289924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65687733|NCT02289924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65687734|NCT02289924|Growth Substances|growth substances|mesh-ancestor
65687735|NCT02289924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687736|NCT02289924|Growth Inhibitors|growth inhibitors|mesh-ancestor
65687737|NCT02289924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687738|NCT03387644|Pregabalin|pregabalin|mesh-list
65687739|NCT03387644|Analgesics|analgesics|mesh-ancestor
65687740|NCT03387644|Sensory System Agents|sensory system agents|mesh-ancestor
65687741|NCT03387644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687742|NCT03387644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687743|NCT03387644|Anticonvulsants|anticonvulsants|mesh-ancestor
65687744|NCT03387644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65687745|NCT03387644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65687746|NCT03387644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687747|NCT03387644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65687748|NCT03387644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65687749|NCT03387644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65687750|NCT03387644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65687751|NCT03387644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65687752|NCT02290002|Calcium Dobesilate|calcium dobesilate|mesh-list
65687753|NCT02290002|Calcium|calcium|mesh-list
65687754|NCT02290002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65687755|NCT02290002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687756|NCT02290002|Hemostatics|hemostatics|mesh-ancestor
65687757|NCT02290002|Coagulants|coagulants|mesh-ancestor
65687758|NCT05671900|Gemcitabine|gemcitabine|mesh-list
65687759|NCT05671900|Docetaxel|docetaxel|mesh-list
65687760|NCT05671900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65687761|NCT05671900|Antimetabolites|antimetabolites|mesh-ancestor
65687762|NCT05671900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687763|NCT05671900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687764|NCT05671900|Antiviral Agents|antiviral agents|mesh-ancestor
65687765|NCT05671900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65687766|NCT05671900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687767|NCT05671900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65687768|NCT05671900|Immunologic Factors|immunologic factors|mesh-ancestor
65687769|NCT05671900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687770|NCT05671900|Tubulin Modulators|tubulin modulators|mesh-ancestor
65687771|NCT05671900|Antimitotic Agents|antimitotic agents|mesh-ancestor
65687772|NCT05671900|Mitosis Modulators|mitosis modulators|mesh-ancestor
65687773|NCT02294292|Carvedilol|carvedilol|mesh-list
65687774|NCT02294292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65687775|NCT02294292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65687776|NCT02294292|Adrenergic Agents|adrenergic agents|mesh-ancestor
65687777|NCT02294292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65687778|NCT02294292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687779|NCT02294292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687780|NCT02294292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65687781|NCT02294292|Antioxidants|antioxidants|mesh-ancestor
65687782|NCT02294292|Protective Agents|protective agents|mesh-ancestor
65687783|NCT02294292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65687784|NCT02294292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65687785|NCT02294292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65687786|NCT02294292|Vasodilator Agents|vasodilator agents|mesh-ancestor
65687787|NCT02294292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65687788|NCT02294292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65687789|NCT03387566|Immunoglobulins|immunoglobulins|mesh-list
65687790|NCT03387566|Endothelial Growth Factors|endothelial growth factors|mesh-list
65687791|NCT03387566|Immunologic Factors|immunologic factors|mesh-ancestor
65687792|NCT03387566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687793|NCT03387566|Growth Substances|growth substances|mesh-ancestor
65687795|NCT03391856|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65687796|NCT03391856|Antiviral Agents|antiviral agents|mesh-ancestor
65687797|NCT03391856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65687798|NCT03391856|Expectorants|expectorants|mesh-ancestor
65687799|NCT03391856|Respiratory System Agents|respiratory system agents|mesh-ancestor
65687800|NCT03391856|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65687801|NCT03391856|Antioxidants|antioxidants|mesh-ancestor
65687802|NCT03391856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687803|NCT03391856|Protective Agents|protective agents|mesh-ancestor
65687804|NCT03391856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687805|NCT03391856|Antidotes|antidotes|mesh-ancestor
65687806|NCT01664494|Capecitabine|capecitabine|mesh-list
65687807|NCT01664494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65687808|NCT01664494|Antimetabolites|antimetabolites|mesh-ancestor
65687809|NCT01664494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687810|NCT01664494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687811|NCT02290470|Dexamethasone|dexamethasone|mesh-list
65687812|NCT02290470|Dexamethasone acetate|dexamethasone acetate|mesh-list
65687813|NCT02290470|Paclitaxel|paclitaxel|mesh-list
65687814|NCT02290470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65687815|NCT02290470|Carboplatin|carboplatin|mesh-list
65687816|NCT02290470|Olanzapine|olanzapine|mesh-list
65687817|NCT02290470|Palonosetron|palonosetron|mesh-list
65687818|NCT02290470|BB 1101|bb 1101|mesh-list
65687819|NCT02290470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65687820|NCT02290470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687821|NCT02290470|Tubulin Modulators|tubulin modulators|mesh-ancestor
65687822|NCT02290470|Antimitotic Agents|antimitotic agents|mesh-ancestor
65687823|NCT02290470|Mitosis Modulators|mitosis modulators|mesh-ancestor
65687824|NCT02290470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687825|NCT02290470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65687826|NCT02290470|Antiemetics|antiemetics|mesh-ancestor
65687827|NCT02290470|Autonomic Agents|autonomic agents|mesh-ancestor
65687828|NCT02290470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687829|NCT02290470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687830|NCT02290470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65687831|NCT02290470|Glucocorticoids|glucocorticoids|mesh-ancestor
65687832|NCT02290470|Hormones|hormones|mesh-ancestor
65687833|NCT02290470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65687834|NCT02290470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65687835|NCT02290470|Protease Inhibitors|protease inhibitors|mesh-ancestor
65687836|NCT02290470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687837|NCT02290470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65687838|NCT02290470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65687839|NCT02290470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65687840|NCT02290470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65687841|NCT02290470|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65687842|NCT02290470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65687843|NCT02290470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65687844|NCT02290470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65687845|NCT02290470|Serotonin Agents|serotonin agents|mesh-ancestor
65687846|NCT02290470|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65687847|NCT02290470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65687848|NCT05172518|Capecitabine|capecitabine|mesh-list
65687849|NCT05172518|Taxane|taxane|mesh-list
65687850|NCT05172518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65687851|NCT05172518|Antimetabolites|antimetabolites|mesh-ancestor
65687852|NCT05172518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687853|NCT05172518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687854|NCT03724084|Cytarabine|cytarabine|mesh-list
65687855|NCT03724084|Daunorubicin|daunorubicin|mesh-list
65485189|NCT03974867|Hormones|hormones|mesh-ancestor
65687856|NCT03724084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65687857|NCT03724084|Antimetabolites|antimetabolites|mesh-ancestor
65687858|NCT03724084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687859|NCT03724084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687860|NCT03724084|Antiviral Agents|antiviral agents|mesh-ancestor
65687861|NCT03724084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65687862|NCT03724084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65687863|NCT03724084|Immunologic Factors|immunologic factors|mesh-ancestor
65687864|NCT03724084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687865|NCT03724084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65687866|NCT03724084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65687867|NCT03724084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65687868|NCT03724084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687869|NCT05172440|Axitinib|axitinib|mesh-list
65687870|NCT05172440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687871|NCT05172440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65687872|NCT05172440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687873|NCT05172440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687874|NCT02298582|Fentanyl|fentanyl|mesh-list
65687875|NCT02298582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65687876|NCT02298582|Narcotics|narcotics|mesh-ancestor
65687877|NCT02298582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65687878|NCT02298582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687879|NCT02298582|Analgesics|analgesics|mesh-ancestor
65687880|NCT02298582|Sensory System Agents|sensory system agents|mesh-ancestor
65687881|NCT02298582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687882|NCT02298582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65687883|NCT02298582|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65687884|NCT02298582|Anesthetics, General|anesthetics, general|mesh-ancestor
65687885|NCT02298582|Anesthetics|anesthetics|mesh-ancestor
65687886|NCT04446416|Bevacizumab|bevacizumab|mesh-list
65687887|NCT04446416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65687888|NCT04446416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687889|NCT04446416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65687890|NCT04446416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65687891|NCT04446416|Growth Substances|growth substances|mesh-ancestor
65687892|NCT04446416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687893|NCT04446416|Growth Inhibitors|growth inhibitors|mesh-ancestor
65687894|NCT02298660|Botulinum Toxins|botulinum toxins|mesh-list
65687895|NCT02298660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65687896|NCT02298660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65687897|NCT02298660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65687898|NCT02298660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65687899|NCT02298660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687900|NCT02298660|Cholinergic Agents|cholinergic agents|mesh-ancestor
65687901|NCT02298660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65687902|NCT02298660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687903|NCT02298660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65687904|NCT02298660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687905|NCT01396408|Sirolimus|sirolimus|mesh-list
65687906|NCT01396408|Sunitinib|sunitinib|mesh-list
65687907|NCT01396408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687908|NCT01396408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65687909|NCT01396408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65687910|NCT01396408|Growth Substances|growth substances|mesh-ancestor
65687911|NCT01396408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687912|NCT01396408|Growth Inhibitors|growth inhibitors|mesh-ancestor
65687913|NCT01396408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65687914|NCT01396408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687915|NCT01396408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687916|NCT01396408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65687917|NCT01396408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65687918|NCT01396408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65687919|NCT01396408|Antifungal Agents|antifungal agents|mesh-ancestor
65687920|NCT01396408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65687921|NCT01396408|Immunologic Factors|immunologic factors|mesh-ancestor
65687922|NCT03571334|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65687923|NCT03571334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65687924|NCT03571334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687925|NCT03571334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687926|NCT03571334|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65687927|NCT03571334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65687928|NCT03571334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687929|NCT03571334|Cholinergic Agents|cholinergic agents|mesh-ancestor
65687930|NCT03571334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65687931|NCT05440942|Trametinib|trametinib|mesh-list
65687932|NCT05440942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687933|NCT05440942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65687934|NCT05440942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687935|NCT05440942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687936|NCT02291094|Lidocaine|lidocaine|mesh-list
65687937|NCT02291094|Remifentanil|remifentanil|mesh-list
65687938|NCT02291094|Anesthetics, Local|anesthetics, local|mesh-ancestor
65687939|NCT02291094|Anesthetics|anesthetics|mesh-ancestor
65687940|NCT02291094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65687941|NCT02291094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687942|NCT02291094|Sensory System Agents|sensory system agents|mesh-ancestor
65687943|NCT02291094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65687944|NCT02291094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65687945|NCT02291094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65687946|NCT02291094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65687947|NCT02291094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65687948|NCT02291094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687949|NCT02291094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65687950|NCT02291094|Narcotics|narcotics|mesh-ancestor
65687951|NCT02291094|Analgesics|analgesics|mesh-ancestor
65687952|NCT03387098|Leucovorin|leucovorin|mesh-list
65687953|NCT03387098|Paclitaxel|paclitaxel|mesh-list
65687954|NCT03387098|Cyclophosphamide|cyclophosphamide|mesh-list
65687955|NCT03387098|Bevacizumab|bevacizumab|mesh-list
65687956|NCT03387098|Fluorouracil|fluorouracil|mesh-list
65687957|NCT03387098|Capecitabine|capecitabine|mesh-list
65687958|NCT03387098|Oxaliplatin|oxaliplatin|mesh-list
65687959|NCT03387098|Avelumab|avelumab|mesh-list
65687960|NCT03387098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65687961|NCT03387098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65687962|NCT03387098|Tubulin Modulators|tubulin modulators|mesh-ancestor
65687963|NCT03387098|Antimitotic Agents|antimitotic agents|mesh-ancestor
65687964|NCT03387098|Mitosis Modulators|mitosis modulators|mesh-ancestor
65687965|NCT03387098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687966|NCT03387098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65687967|NCT03387098|Immunologic Factors|immunologic factors|mesh-ancestor
65687968|NCT03387098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687969|NCT03387098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65687970|NCT03387098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65687971|NCT03387098|Alkylating Agents|alkylating agents|mesh-ancestor
65687972|NCT03387098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65687973|NCT03387098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65687974|NCT03387098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65687975|NCT03387098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65687976|NCT03387098|Growth Substances|growth substances|mesh-ancestor
65687977|NCT03387098|Growth Inhibitors|growth inhibitors|mesh-ancestor
65687978|NCT03387098|Antimetabolites|antimetabolites|mesh-ancestor
65687979|NCT03387098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65687980|NCT03387098|Antidotes|antidotes|mesh-ancestor
65687981|NCT03387098|Protective Agents|protective agents|mesh-ancestor
65687982|NCT03387098|Vitamin B Complex|vitamin b complex|mesh-ancestor
65687983|NCT03387098|Vitamins|vitamins|mesh-ancestor
65687984|NCT03387098|Micronutrients|micronutrients|mesh-ancestor
65687985|NCT02577016|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65687986|NCT02577016|Ipragliflozin|ipragliflozin|mesh-list
65687987|NCT02577016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65687988|NCT02577016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65687989|NCT02577016|Incretins|incretins|mesh-ancestor
65687990|NCT02577016|Hormones|hormones|mesh-ancestor
65687991|NCT02577016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65687992|NCT02577016|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65687993|NCT02577016|Protease Inhibitors|protease inhibitors|mesh-ancestor
65687994|NCT02577016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65687995|NCT02577016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65687996|NCT02577016|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65687997|NCT04465110|Grape Seed Extract|grape seed extract|mesh-list
65687998|NCT04465110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65687999|NCT04465110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688000|NCT04465110|Antioxidants|antioxidants|mesh-ancestor
65688001|NCT04465110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688002|NCT04465110|Protective Agents|protective agents|mesh-ancestor
65688003|NCT04465110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688004|NCT03391700|Rocuronium|rocuronium|mesh-list
65688005|NCT03391700|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65688006|NCT03391700|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65688007|NCT03391700|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65688008|NCT03391700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65688009|NCT03391700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688010|NCT02294838|Citric Acid|citric acid|mesh-list
65688011|NCT02294838|Sodium Citrate|sodium citrate|mesh-list
65688012|NCT02294838|Anticoagulants|anticoagulants|mesh-ancestor
65688013|NCT02294838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65688014|NCT02294838|Chelating Agents|chelating agents|mesh-ancestor
65688015|NCT02294838|Sequestering Agents|sequestering agents|mesh-ancestor
65688016|NCT02294838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688017|NCT03383822|Insulin|insulin|mesh-list
65688018|NCT03383822|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65688019|NCT03383822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65688020|NCT03383822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688021|NCT03514446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65688022|NCT03514446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65688023|NCT03383744|Vitamin A|vitamin a|mesh-list
65688024|NCT03383744|Vitamins|vitamins|mesh-ancestor
65688025|NCT03383744|Micronutrients|micronutrients|mesh-ancestor
65688026|NCT03383744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688027|NCT05662358|Denosumab|denosumab|mesh-list
65688028|NCT05662358|Alendronate|alendronate|mesh-list
65688029|NCT05662358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65688030|NCT05662358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688031|NCT02294994|Tirofiban|tirofiban|mesh-list
65688032|NCT02294994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65688033|NCT02294994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65688034|NCT02294994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688035|NCT02294994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65688036|NCT03386630|Sufentanil|sufentanil|mesh-list
65688037|NCT03386630|Morphine|morphine|mesh-list
65688038|NCT03386630|Dsuvia|dsuvia|mesh-list
65688039|NCT03386630|Bupivacaine|bupivacaine|mesh-list
65688040|NCT03386630|Anesthetics, Local|anesthetics, local|mesh-ancestor
65688041|NCT03386630|Anesthetics|anesthetics|mesh-ancestor
65688042|NCT03386630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65688043|NCT03386630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688044|NCT03386630|Sensory System Agents|sensory system agents|mesh-ancestor
65688045|NCT03386630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65688046|NCT03386630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65688047|NCT03386630|Narcotics|narcotics|mesh-ancestor
65688048|NCT03386630|Analgesics|analgesics|mesh-ancestor
65688049|NCT03386630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65688050|NCT03386630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65688051|NCT03386630|Anesthetics, General|anesthetics, general|mesh-ancestor
65688052|NCT03132714|Amoxicillin|amoxicillin|mesh-list
65688053|NCT03132714|Metronidazole|metronidazole|mesh-list
65688054|NCT03132714|Clarithromycin|clarithromycin|mesh-list
65688055|NCT03132714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65688056|NCT03132714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65688057|NCT03132714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65688058|NCT03132714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65688059|NCT03132714|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65688060|NCT03132714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688061|NCT03132714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688062|NCT03132714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65688063|NCT03132714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65688064|NCT03386318|Oxycodone|oxycodone|mesh-list
65688065|NCT03386318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65688066|NCT03386318|Narcotics|narcotics|mesh-ancestor
65688067|NCT03386318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65688068|NCT03386318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688069|NCT03386318|Analgesics|analgesics|mesh-ancestor
65688070|NCT03386318|Sensory System Agents|sensory system agents|mesh-ancestor
65688071|NCT03386318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65688072|NCT03339284|Dexamethasone|dexamethasone|mesh-list
65688073|NCT03339284|Dexamethasone acetate|dexamethasone acetate|mesh-list
65688074|NCT03339284|Ropivacaine|ropivacaine|mesh-list
65688075|NCT03339284|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65688076|NCT03339284|BB 1101|bb 1101|mesh-list
65688077|NCT03339284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65688078|NCT03339284|Antiemetics|antiemetics|mesh-ancestor
65688079|NCT03339284|Autonomic Agents|autonomic agents|mesh-ancestor
65688080|NCT03339284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65688081|NCT03339284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688082|NCT03339284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65688083|NCT03339284|Glucocorticoids|glucocorticoids|mesh-ancestor
65688084|NCT03339284|Hormones|hormones|mesh-ancestor
65688085|NCT03339284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65688086|NCT03339284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65688087|NCT03339284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688088|NCT03339284|Anesthetics, Local|anesthetics, local|mesh-ancestor
65688089|NCT03339284|Anesthetics|anesthetics|mesh-ancestor
65688090|NCT03339284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65688091|NCT03339284|Sensory System Agents|sensory system agents|mesh-ancestor
65688092|NCT03339284|Protease Inhibitors|protease inhibitors|mesh-ancestor
65688093|NCT03339284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688094|NCT03339284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688095|NCT02291562|Dronabinol|dronabinol|mesh-list
65688096|NCT02291562|Cannabidiol|cannabidiol|mesh-list
65688097|NCT02291562|Anticonvulsants|anticonvulsants|mesh-ancestor
65688098|NCT02291562|Hallucinogens|hallucinogens|mesh-ancestor
65688099|NCT02291562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688100|NCT02291562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65688101|NCT02291562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65688102|NCT02291562|Analgesics|analgesics|mesh-ancestor
65688103|NCT02291562|Sensory System Agents|sensory system agents|mesh-ancestor
65688104|NCT02291562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65688105|NCT02291562|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65688106|NCT02291562|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65688107|NCT02291562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65688108|NCT02291562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688109|NCT02291562|Hormones|hormones|mesh-ancestor
65688110|NCT02291562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65688111|NCT03316586|Nivolumab|nivolumab|mesh-list
65688112|NCT03316586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65688113|NCT03316586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688114|NCT03316586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65688115|NCT03316586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688116|NCT02994927|Prednisone|prednisone|mesh-list
65688117|NCT02994927|Cyclophosphamide|cyclophosphamide|mesh-list
65688118|NCT02994927|Rituximab|rituximab|mesh-list
65688119|NCT02994927|Azathioprine|azathioprine|mesh-list
65688120|NCT02994927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65688121|NCT02994927|Immunologic Factors|immunologic factors|mesh-ancestor
65688122|NCT02994927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688123|NCT02994927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65688124|NCT02994927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65688125|NCT02994927|Alkylating Agents|alkylating agents|mesh-ancestor
65688126|NCT02994927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688127|NCT02994927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688128|NCT02994927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65688129|NCT02994927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65688130|NCT02994927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65688131|NCT02994927|Glucocorticoids|glucocorticoids|mesh-ancestor
65688132|NCT02994927|Hormones|hormones|mesh-ancestor
65688133|NCT02994927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65688134|NCT02994927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65688135|NCT02994927|Antimetabolites|antimetabolites|mesh-ancestor
65688136|NCT02994927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65688137|NCT03383276|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65688138|NCT03383276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65688139|NCT02295150|Nadroparin|nadroparin|mesh-list
65688140|NCT02295150|Anticoagulants|anticoagulants|mesh-ancestor
65688141|NCT02295150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65688142|NCT02295150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65688143|NCT02295150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688144|NCT03390608|Trastuzumab|trastuzumab|mesh-list
65688145|NCT03390608|Estrogens|estrogens|mesh-list
65688146|NCT03390608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65688147|NCT03390608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688148|NCT03390608|Hormones|hormones|mesh-ancestor
65688149|NCT03390608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65688150|NCT03390608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688151|NCT03513822|Midazolam|midazolam|mesh-list
65688152|NCT03513822|Ketamine|ketamine|mesh-list
65688153|NCT03513822|Analgesics|analgesics|mesh-ancestor
65688154|NCT03513822|Sensory System Agents|sensory system agents|mesh-ancestor
65688155|NCT03513822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65688156|NCT03513822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688157|NCT03513822|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65688158|NCT03513822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65688159|NCT03513822|Anesthetics, General|anesthetics, general|mesh-ancestor
65688160|NCT03513822|Anesthetics|anesthetics|mesh-ancestor
65688161|NCT03513822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65688162|NCT03513822|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65688163|NCT03513822|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65688164|NCT03513822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65688165|NCT03513822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688166|NCT03513822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65688167|NCT03513822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65688168|NCT03513822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65688169|NCT03513822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65688170|NCT03513822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65688171|NCT03513822|GABA Modulators|gaba modulators|mesh-ancestor
65688172|NCT03513822|GABA Agents|gaba agents|mesh-ancestor
65688173|NCT03383120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65688174|NCT03383120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65688175|NCT03513432|Ethanol|ethanol|mesh-list
65688176|NCT03513432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65688177|NCT03513432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65688178|NCT03513432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65688179|NCT03513432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688180|NCT02299440|Ketamine|ketamine|mesh-list
65688181|NCT02299440|Analgesics|analgesics|mesh-ancestor
65688182|NCT02299440|Sensory System Agents|sensory system agents|mesh-ancestor
65688183|NCT02299440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65688184|NCT02299440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688185|NCT02299440|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65688186|NCT02299440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65688187|NCT02299440|Anesthetics, General|anesthetics, general|mesh-ancestor
65688188|NCT02299440|Anesthetics|anesthetics|mesh-ancestor
65688189|NCT02299440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65688190|NCT02299440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65688191|NCT02299440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65688192|NCT02299440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65688193|NCT02299440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688194|NCT02299518|Cytarabine|cytarabine|mesh-list
65688195|NCT02299518|Etoposide|etoposide|mesh-list
65688196|NCT02299518|Mitoxantrone|mitoxantrone|mesh-list
65688197|NCT02299518|Etoposide phosphate|etoposide phosphate|mesh-list
65688198|NCT02299518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65688199|NCT02299518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688200|NCT02299518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65688201|NCT02299518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65688202|NCT02299518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688203|NCT02299518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688204|NCT02299518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65688205|NCT02299518|Antimetabolites|antimetabolites|mesh-ancestor
65688206|NCT02299518|Antiviral Agents|antiviral agents|mesh-ancestor
65688207|NCT02299518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65688208|NCT02299518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65688209|NCT02299518|Immunologic Factors|immunologic factors|mesh-ancestor
65688210|NCT02299518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688211|NCT02299518|Analgesics|analgesics|mesh-ancestor
65688212|NCT02299518|Sensory System Agents|sensory system agents|mesh-ancestor
65688213|NCT02299518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65688214|NCT02145195|Vitamin D|vitamin d|mesh-list
65688215|NCT02145195|Cholecalciferol|cholecalciferol|mesh-list
65688216|NCT02145195|Vitamins|vitamins|mesh-ancestor
65688217|NCT02145195|Micronutrients|micronutrients|mesh-ancestor
65688218|NCT02145195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688219|NCT02145195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65688220|NCT02145195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65688221|NCT03517020|Nebivolol|nebivolol|mesh-list
65688222|NCT03517020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65688223|NCT03517020|Vasodilator Agents|vasodilator agents|mesh-ancestor
65688224|NCT03517020|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65688225|NCT03517020|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65688226|NCT03517020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65688227|NCT03517020|Adrenergic Agents|adrenergic agents|mesh-ancestor
65688228|NCT03517020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65688229|NCT03517020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688230|NCT03517020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688231|NCT02254629|Laxatives|laxatives|mesh-list
65688232|NCT02254629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65688233|NCT02145585|Anesthetics|anesthetics|mesh-list
65688234|NCT02145585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65688235|NCT02145585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688236|NCT02291796|Bezafibrate|bezafibrate|mesh-list
65688237|NCT02291796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65688238|NCT02291796|Antimetabolites|antimetabolites|mesh-ancestor
65688239|NCT02291796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688240|NCT02291796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65688241|NCT03544827|Atropine|atropine|mesh-list
65688242|NCT03544827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65688243|NCT03544827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65688244|NCT03544827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65688245|NCT03544827|Autonomic Agents|autonomic agents|mesh-ancestor
65688246|NCT03544827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65688247|NCT03544827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688248|NCT03544827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65688249|NCT03544827|Respiratory System Agents|respiratory system agents|mesh-ancestor
65688250|NCT03544827|Mydriatics|mydriatics|mesh-ancestor
65688251|NCT03544827|Parasympatholytics|parasympatholytics|mesh-ancestor
65688252|NCT03544827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65688253|NCT03544827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65688254|NCT03544827|Cholinergic Agents|cholinergic agents|mesh-ancestor
65688255|NCT03544827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65688256|NCT03544827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688257|NCT00107991|Etanercept|etanercept|mesh-list
65688258|NCT00107991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65688259|NCT00107991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65688260|NCT00107991|Analgesics|analgesics|mesh-ancestor
65688261|NCT00107991|Sensory System Agents|sensory system agents|mesh-ancestor
65688262|NCT00107991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65688263|NCT00107991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688264|NCT00107991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65688265|NCT00107991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65688266|NCT00107991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65688267|NCT00107991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65688268|NCT00107991|Immunologic Factors|immunologic factors|mesh-ancestor
65688269|NCT03513276|Epinephrine|epinephrine|mesh-list
65688270|NCT03513276|Racepinephrine|racepinephrine|mesh-list
65688271|NCT03513276|Ropivacaine|ropivacaine|mesh-list
65688272|NCT03513276|Epinephryl borate|epinephryl borate|mesh-list
65688273|NCT03513276|Anesthetics, Local|anesthetics, local|mesh-ancestor
65688274|NCT03513276|Anesthetics|anesthetics|mesh-ancestor
65688275|NCT03513276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65688276|NCT03513276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688277|NCT03513276|Sensory System Agents|sensory system agents|mesh-ancestor
65688278|NCT03513276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65688279|NCT03513276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65688280|NCT03513276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65688281|NCT03513276|Adrenergic Agents|adrenergic agents|mesh-ancestor
65688282|NCT03513276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65688283|NCT03513276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688284|NCT03513276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65688285|NCT03513276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65688286|NCT03513276|Autonomic Agents|autonomic agents|mesh-ancestor
65688287|NCT03513276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65688288|NCT03513276|Respiratory System Agents|respiratory system agents|mesh-ancestor
65688289|NCT03513276|Mydriatics|mydriatics|mesh-ancestor
65688290|NCT03513276|Sympathomimetics|sympathomimetics|mesh-ancestor
65688291|NCT03513276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65688292|NCT02291874|Ipragliflozin|ipragliflozin|mesh-list
65688293|NCT02291874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65688294|NCT02291874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688295|NCT02291874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65688296|NCT02291874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688297|NCT03516630|Moxifloxacin|moxifloxacin|mesh-list
65688298|NCT03516630|Trazodone|trazodone|mesh-list
65688299|NCT03516630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65688300|NCT03516630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65688301|NCT03516630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65688302|NCT03516630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65688303|NCT03516630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688304|NCT03516630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688305|NCT03516630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688306|NCT03516630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688307|NCT03516630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65688308|NCT03516630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65688309|NCT03516630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65688310|NCT03516630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65688311|NCT03516630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65688312|NCT03516630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65688313|NCT03516630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65688314|NCT03516630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65688315|NCT03516630|Serotonin Agents|serotonin agents|mesh-ancestor
65688316|NCT03516630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65688317|NCT03516630|Antidepressive Agents|antidepressive agents|mesh-ancestor
65688319|NCT02142075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65688320|NCT02142075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65688321|NCT02145975|Fentanyl|fentanyl|mesh-list
65688322|NCT02145975|Morphine|morphine|mesh-list
65688323|NCT02145975|Analgesics, Opioid|analgesics, opioid|mesh-list
65688324|NCT02145975|Narcotics|narcotics|mesh-ancestor
65688325|NCT02145975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65688326|NCT02145975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688327|NCT02145975|Analgesics|analgesics|mesh-ancestor
65688328|NCT02145975|Sensory System Agents|sensory system agents|mesh-ancestor
65688329|NCT02145975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65688330|NCT02145975|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65688331|NCT02145975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65688332|NCT02145975|Anesthetics, General|anesthetics, general|mesh-ancestor
65688333|NCT02145975|Anesthetics|anesthetics|mesh-ancestor
65688334|NCT02295852|Calcium|calcium|mesh-list
65688335|NCT02295852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65688336|NCT02295852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688337|NCT03142334|Pembrolizumab|pembrolizumab|mesh-list
65688338|NCT03142334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65688339|NCT03142334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688340|NCT02295930|Bevacizumab|bevacizumab|mesh-list
65688341|NCT02295930|Cetuximab|cetuximab|mesh-list
65688342|NCT02295930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65688343|NCT02295930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688344|NCT02295930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65688345|NCT02295930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65688346|NCT02295930|Growth Substances|growth substances|mesh-ancestor
65688347|NCT02295930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688348|NCT02295930|Growth Inhibitors|growth inhibitors|mesh-ancestor
65688349|NCT02142309|Pioglitazone|pioglitazone|mesh-list
65688350|NCT02142309|Glimepiride|glimepiride|mesh-list
65688351|NCT02142309|Vildagliptin|vildagliptin|mesh-list
65688352|NCT02142309|Canagliflozin|canagliflozin|mesh-list
65688353|NCT02142309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65688354|NCT02142309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688355|NCT02142309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65688356|NCT02142309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65688357|NCT02142309|Immunologic Factors|immunologic factors|mesh-ancestor
65688358|NCT02142309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65688359|NCT02142309|Protease Inhibitors|protease inhibitors|mesh-ancestor
65688360|NCT02142309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688361|NCT02142309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688362|NCT02142309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65688363|NCT02146209|Metronidazole|metronidazole|mesh-list
65688364|NCT02146209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65688365|NCT02146209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65688366|NCT02146209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65688367|NCT02146209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65688368|NCT02299908|Bupivacaine|bupivacaine|mesh-list
65688369|NCT02299908|Anesthetics, Local|anesthetics, local|mesh-list
65688370|NCT02299908|Anesthetics|anesthetics|mesh-list
65688371|NCT02299908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65688372|NCT02299908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65688373|NCT02299908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688374|NCT02299908|Sensory System Agents|sensory system agents|mesh-ancestor
65688375|NCT02299908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65688376|NCT02142543|Zinc Oxide|zinc oxide|mesh-list
65688377|NCT02142543|Dermatologic Agents|dermatologic agents|mesh-ancestor
65688378|NCT02142543|Sunscreening Agents|sunscreening agents|mesh-ancestor
65688379|NCT02142543|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65688380|NCT02142543|Protective Agents|protective agents|mesh-ancestor
65688381|NCT02142543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688382|NCT03390374|Nystatin|nystatin|mesh-list
65688383|NCT03390374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65688384|NCT03390374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65688385|NCT03390374|Antifungal Agents|antifungal agents|mesh-ancestor
65688386|NCT03390374|Ionophores|ionophores|mesh-ancestor
65688387|NCT03390374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65688388|NCT03390374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688389|NCT03545373|Amoxicillin|amoxicillin|mesh-list
65688390|NCT03545373|Azithromycin|azithromycin|mesh-list
65688391|NCT03545373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65688392|NCT03545373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65688393|NCT00492856|Methotrexate|methotrexate|mesh-list
65688394|NCT00492856|Mercaptopurine|mercaptopurine|mesh-list
65688395|NCT00492856|Tretinoin|tretinoin|mesh-list
65688396|NCT00492856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65688397|NCT00492856|Abortifacient Agents|abortifacient agents|mesh-ancestor
65688398|NCT00492856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65688399|NCT00492856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688400|NCT00492856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65688401|NCT00492856|Antimetabolites|antimetabolites|mesh-ancestor
65688402|NCT00492856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688403|NCT00492856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688404|NCT00492856|Dermatologic Agents|dermatologic agents|mesh-ancestor
65688405|NCT00492856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688406|NCT00492856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65688407|NCT00492856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65688408|NCT00492856|Immunologic Factors|immunologic factors|mesh-ancestor
65688409|NCT00492856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65688410|NCT00492856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65688411|NCT00492856|Keratolytic Agents|keratolytic agents|mesh-ancestor
65688412|NCT02142777|Equol|equol|mesh-list
65688413|NCT02142777|Phytoestrogens|phytoestrogens|mesh-ancestor
65688414|NCT02142777|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65688415|NCT02142777|Estrogens|estrogens|mesh-ancestor
65688416|NCT02142777|Hormones|hormones|mesh-ancestor
65688417|NCT02142777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65688418|NCT02142777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688419|NCT02955758|Pembrolizumab|pembrolizumab|mesh-list
65688420|NCT02955758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65688421|NCT02955758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688422|NCT02143167|4-Aminopyridine|4-aminopyridine|mesh-list
65688423|NCT02143167|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65688424|NCT02143167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65688425|NCT02143167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688426|NCT03544671|Vitamin D|vitamin d|mesh-list
65688427|NCT03544671|Vitamins|vitamins|mesh-ancestor
65688428|NCT03544671|Micronutrients|micronutrients|mesh-ancestor
65688429|NCT03544671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688430|NCT03544671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65688431|NCT03390062|Apatinib|apatinib|mesh-list
65688432|NCT03390062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688433|NCT03390062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65688434|NCT03390062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688435|NCT03390062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688436|NCT03382886|Bevacizumab|bevacizumab|mesh-list
65688437|NCT03382886|Nivolumab|nivolumab|mesh-list
65688438|NCT03382886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65688439|NCT03382886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688440|NCT03382886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65688441|NCT03382886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65688442|NCT03382886|Growth Substances|growth substances|mesh-ancestor
65688443|NCT03382886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688444|NCT03382886|Growth Inhibitors|growth inhibitors|mesh-ancestor
65688445|NCT03382886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65688446|NCT03382886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688447|NCT03125486|Belimumab|belimumab|mesh-list
65688448|NCT03125486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65688449|NCT03125486|Immunologic Factors|immunologic factors|mesh-ancestor
65688450|NCT03125486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688451|NCT02147925|Metformin|metformin|mesh-list
65688452|NCT02147925|Insulin Glargine|insulin glargine|mesh-list
65688453|NCT02147925|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65688454|NCT02147925|Liraglutide|liraglutide|mesh-list
65688455|NCT02147925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65688456|NCT02147925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688457|NCT02147925|Incretins|incretins|mesh-ancestor
65688458|NCT02147925|Hormones|hormones|mesh-ancestor
65688459|NCT02147925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65688460|NCT02147925|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65688461|NCT02147925|Protease Inhibitors|protease inhibitors|mesh-ancestor
65688462|NCT02147925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688463|NCT02147925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688464|NCT03544047|Paclitaxel|paclitaxel|mesh-list
65688465|NCT03544047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65688466|NCT03544047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688467|NCT03544047|Tubulin Modulators|tubulin modulators|mesh-ancestor
65688468|NCT03544047|Antimitotic Agents|antimitotic agents|mesh-ancestor
65688469|NCT03544047|Mitosis Modulators|mitosis modulators|mesh-ancestor
65688470|NCT03544047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688471|NCT03544125|Durvalumab|durvalumab|mesh-list
65688472|NCT03544125|Olaparib|olaparib|mesh-list
65688473|NCT03544125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65688474|NCT03544125|Immunoglobulins|immunoglobulins|mesh-list
65688475|NCT03544125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65688476|NCT03544125|Immunoglobulin G|immunoglobulin g|mesh-list
65688477|NCT03544125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65688478|NCT03544125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688479|NCT03544125|Immunologic Factors|immunologic factors|mesh-ancestor
65688480|NCT03544125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688481|NCT03544125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688482|NCT03544125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688483|NCT02146911|Bupropion|bupropion|mesh-list
65688484|NCT02146911|Varenicline|varenicline|mesh-list
65688485|NCT02146911|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65688486|NCT02146911|Antidepressive Agents|antidepressive agents|mesh-ancestor
65688487|NCT02146911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65688488|NCT02146911|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65688489|NCT02146911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65688490|NCT02146911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65688491|NCT02146911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688492|NCT02146911|Dopamine Agents|dopamine agents|mesh-ancestor
65688493|NCT02146911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65688494|NCT02146911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688495|NCT02146911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65688496|NCT02146911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65688497|NCT02146911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688498|NCT02146911|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65688499|NCT02146911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65688500|NCT02146911|Cholinergic Agents|cholinergic agents|mesh-ancestor
65688501|NCT02776683|Bevacizumab|bevacizumab|mesh-list
65688502|NCT02776683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65688503|NCT02776683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688504|NCT02776683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65688505|NCT02776683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65688506|NCT02776683|Growth Substances|growth substances|mesh-ancestor
65688507|NCT02776683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688508|NCT02776683|Growth Inhibitors|growth inhibitors|mesh-ancestor
65688509|NCT02963714|Vaccines|vaccines|mesh-list
65688510|NCT02963714|Immunologic Factors|immunologic factors|mesh-ancestor
65688511|NCT02963714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688512|NCT02148393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65688513|NCT02148393|Estradiol|estradiol|mesh-list
65688514|NCT02148393|Progesterone|progesterone|mesh-list
65688515|NCT02148393|Estrogens|estrogens|mesh-ancestor
65688516|NCT02148393|Hormones|hormones|mesh-ancestor
65688517|NCT02148393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65688518|NCT02148393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688519|NCT02148393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65688520|NCT02148393|Progestins|progestins|mesh-ancestor
65688521|NCT00104871|Bortezomib|bortezomib|mesh-list
65688522|NCT00104871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688523|NCT03385538|Clopidogrel|clopidogrel|mesh-list
65688524|NCT03385538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65688525|NCT03385538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65688526|NCT03385538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65688527|NCT03385538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65688528|NCT03385538|Purinergic Agents|purinergic agents|mesh-ancestor
65688529|NCT03385538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65688530|NCT03385538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688531|NCT03385538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688532|NCT03380468|Pemetrexed|pemetrexed|mesh-list
65688533|NCT03380468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688534|NCT03380468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688535|NCT03380468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688536|NCT03380468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65688537|NCT03380468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65688538|NCT02147379|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65688539|NCT02147379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65688540|NCT02147379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65688541|NCT02147379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65688542|NCT02147379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688543|NCT02147379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65688544|NCT02147379|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65688545|NCT02147379|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65688546|NCT02147379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65688547|NCT02147379|Adrenergic Agents|adrenergic agents|mesh-ancestor
65688548|NCT02147379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65688549|NCT02147379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688550|NCT02147379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65688551|NCT02147379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65688552|NCT02147379|Serotonin Agents|serotonin agents|mesh-ancestor
65688553|NCT02147379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65688554|NCT02147379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65688555|NCT02147379|Dopamine Agents|dopamine agents|mesh-ancestor
65688556|NCT02148549|Oxaliplatin|oxaliplatin|mesh-list
65688557|NCT02148549|Irinotecan|irinotecan|mesh-list
65688558|NCT02148549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688559|NCT02148549|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65688560|NCT02148549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65688561|NCT02148549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688562|NCT02148549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688563|NCT03375398|PAZ320|paz320|mesh-list
65688564|NCT03375398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65688565|NCT03375398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688566|NCT02147535|Methylphenidate|methylphenidate|mesh-list
65688567|NCT02147535|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65688568|NCT02147535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688569|NCT02147535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65688570|NCT02147535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65688571|NCT02147535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65688572|NCT02147535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688573|NCT02147535|Dopamine Agents|dopamine agents|mesh-ancestor
65688574|NCT02147535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65688575|NCT03446612|Nitroprusside|nitroprusside|mesh-list
65688576|NCT03446612|Acetylcholine|acetylcholine|mesh-list
65688577|NCT03446612|Darbepoetin alfa|darbepoetin alfa|mesh-list
65688578|NCT03446612|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
65688579|NCT03446612|Hematinics|hematinics|mesh-ancestor
65688580|NCT03446612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65688581|NCT03446612|Vasodilator Agents|vasodilator agents|mesh-ancestor
65688582|NCT03446612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65688583|NCT03446612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688584|NCT03446612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65688585|NCT03446612|Cholinergic Agents|cholinergic agents|mesh-ancestor
65688586|NCT03446612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65688587|NCT03446612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688588|NCT03446612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688589|NCT02148783|Methylphenidate|methylphenidate|mesh-list
65688590|NCT02148783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65688591|NCT02148783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688592|NCT02148783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65688593|NCT02148783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65688594|NCT02148783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65688595|NCT02148783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688596|NCT02148783|Dopamine Agents|dopamine agents|mesh-ancestor
65688597|NCT02148783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65688598|NCT02155803|Hormones|hormones|mesh-list
65688599|NCT02155803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65688600|NCT02155803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
65688601|NCT02155803|beta-Endorphin|beta-endorphin|mesh-list
65688602|NCT02155803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65688603|NCT02155803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688604|NCT02155803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65688605|NCT02155803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688606|NCT02148861|Insulin|insulin|mesh-list
65688607|NCT02148861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65688608|NCT02148861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65485947|NCT01308086|Leucovorin|leucovorin|mesh-list
65688609|NCT02148861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688610|NCT02152059|Nintedanib|nintedanib|mesh-list
65688611|NCT02152059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688612|NCT02152059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65688613|NCT02152059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688614|NCT02152059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688615|NCT02149095|Treprostinil|treprostinil|mesh-list
65688616|NCT02149095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65688617|NCT02149329|Meropenem|meropenem|mesh-list
65688618|NCT02149329|Imipenem|imipenem|mesh-list
65688619|NCT02149329|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
65688620|NCT02149329|Cilastatin|cilastatin|mesh-list
65688621|NCT02149329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65688622|NCT02149329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65688623|NCT02149329|Protease Inhibitors|protease inhibitors|mesh-ancestor
65688624|NCT02149329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688625|NCT02149329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688626|NCT03255512|Isosorbide|isosorbide|mesh-list
65688627|NCT03255512|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65688628|NCT03255512|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65688629|NCT03255512|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65688630|NCT03255512|Diuretics|diuretics|mesh-ancestor
65688631|NCT03255512|Natriuretic Agents|natriuretic agents|mesh-ancestor
65688632|NCT03255512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688633|NCT03255512|Vasodilator Agents|vasodilator agents|mesh-ancestor
65688634|NCT03255512|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65688635|NCT03255512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688636|NCT02149407|Glycerol|glycerol|mesh-list
65688637|NCT02149407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65688638|NCT02149407|Protective Agents|protective agents|mesh-ancestor
65688639|NCT02149407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688640|NCT03543657|Darbepoetin alfa|darbepoetin alfa|mesh-list
65688641|NCT03543657|Hematinics|hematinics|mesh-ancestor
65688642|NCT04925193|Dexamethasone|dexamethasone|mesh-list
65688643|NCT04925193|Daratumumab|daratumumab|mesh-list
65688644|NCT04925193|Pomalidomide|pomalidomide|mesh-list
65688645|NCT04925193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65688646|NCT04925193|Antiemetics|antiemetics|mesh-ancestor
65688647|NCT04925193|Autonomic Agents|autonomic agents|mesh-ancestor
65688648|NCT04925193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65688649|NCT04925193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688650|NCT04925193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65688651|NCT04925193|Glucocorticoids|glucocorticoids|mesh-ancestor
65688652|NCT04925193|Hormones|hormones|mesh-ancestor
65688653|NCT04925193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65688654|NCT04925193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65688655|NCT04925193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688656|NCT04925193|Immunologic Factors|immunologic factors|mesh-ancestor
65688657|NCT04925193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65688658|NCT04925193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65688659|NCT04925193|Growth Substances|growth substances|mesh-ancestor
65688660|NCT04925193|Growth Inhibitors|growth inhibitors|mesh-ancestor
65688661|NCT02580058|Doxorubicin|doxorubicin|mesh-list
65688662|NCT02580058|Avelumab|avelumab|mesh-list
65688663|NCT02580058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65688664|NCT02580058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688665|NCT02580058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65688666|NCT02580058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65688667|NCT02580058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688668|NCT02580058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688669|NCT02580058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65688670|NCT03542955|Etoricoxib|etoricoxib|mesh-list
65688671|NCT03542955|Analgesics|analgesics|mesh-list
65688672|NCT03542955|Sensory System Agents|sensory system agents|mesh-ancestor
65688673|NCT03542955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65688674|NCT03542955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688675|NCT03542955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65688676|NCT03542955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65688677|NCT03542955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65688678|NCT03542955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65688679|NCT03542955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65688680|NCT03542955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65688681|NCT03542955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688682|NCT03542955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688683|NCT03542331|Ethiodized Oil|ethiodized oil|mesh-list
65688684|NCT03542331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688685|NCT03554044|Tamoxifen|tamoxifen|mesh-list
65688686|NCT03554044|Gemcitabine|gemcitabine|mesh-list
65688688|NCT03554044|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65688689|NCT03554044|Carboplatin|carboplatin|mesh-list
65688690|NCT03554044|Letrozole|letrozole|mesh-list
65688691|NCT03554044|Fulvestrant|fulvestrant|mesh-list
65688692|NCT03554044|Anastrozole|anastrozole|mesh-list
65688693|NCT03554044|Exemestane|exemestane|mesh-list
65688694|NCT03554044|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
65688695|NCT03554044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65688696|NCT03554044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688697|NCT03554044|Tubulin Modulators|tubulin modulators|mesh-ancestor
65688698|NCT03554044|Antimitotic Agents|antimitotic agents|mesh-ancestor
65688699|NCT03554044|Mitosis Modulators|mitosis modulators|mesh-ancestor
65688700|NCT03554044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688701|NCT03554044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65688702|NCT03554044|Antimetabolites|antimetabolites|mesh-ancestor
65688703|NCT03554044|Antiviral Agents|antiviral agents|mesh-ancestor
65688704|NCT03554044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65688705|NCT03554044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688706|NCT03554044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65688707|NCT03554044|Immunologic Factors|immunologic factors|mesh-ancestor
65688708|NCT03554044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688709|NCT03554044|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65688710|NCT03554044|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65688711|NCT03554044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65688712|NCT03554044|Hormone Antagonists|hormone antagonists|mesh-ancestor
65688713|NCT03554044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65688714|NCT03554044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65688715|NCT03554044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65688716|NCT03554044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65688717|NCT03554044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65688718|NCT03554044|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65688719|NCT03554044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65688720|NCT05653882|Pembrolizumab|pembrolizumab|mesh-list
65688721|NCT05653882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65688722|NCT05653882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688723|NCT03458260|Rituximab|rituximab|mesh-list
65688724|NCT03458260|Etoposide|etoposide|mesh-list
65688725|NCT03458260|Ifosfamide|ifosfamide|mesh-list
65688726|NCT03458260|Pixantrone|pixantrone|mesh-list
65688727|NCT03458260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65688728|NCT03458260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688729|NCT03458260|Immunologic Factors|immunologic factors|mesh-ancestor
65688730|NCT03458260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688731|NCT03458260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65688732|NCT03458260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65688733|NCT03458260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65688734|NCT03458260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65688735|NCT03458260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688736|NCT03458260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688737|NCT03458260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65688738|NCT03458260|Alkylating Agents|alkylating agents|mesh-ancestor
65688739|NCT04988074|Cemiplimab|cemiplimab|mesh-list
65688740|NCT04988074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65688741|NCT04988074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688742|NCT00104637|Sildenafil Citrate|sildenafil citrate|mesh-list
65688743|NCT00104637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688744|NCT00104637|Vasodilator Agents|vasodilator agents|mesh-ancestor
65688745|NCT00104637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65688746|NCT00104637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65688747|NCT00104637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688748|NCT00104637|Urological Agents|urological agents|mesh-ancestor
65688749|NCT04810208|Docetaxel|docetaxel|mesh-list
65688750|NCT04810208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688751|NCT04810208|Tubulin Modulators|tubulin modulators|mesh-ancestor
65688752|NCT04810208|Antimitotic Agents|antimitotic agents|mesh-ancestor
65688753|NCT04810208|Mitosis Modulators|mitosis modulators|mesh-ancestor
65688754|NCT04810208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688755|NCT04445636|Dexmedetomidine|dexmedetomidine|mesh-list
65688756|NCT04445636|Morphine|morphine|mesh-list
65688757|NCT04445636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65688758|NCT04445636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65688759|NCT04445636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688760|NCT04445636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65688761|NCT04445636|Analgesics|analgesics|mesh-ancestor
65688762|NCT04445636|Sensory System Agents|sensory system agents|mesh-ancestor
65688763|NCT04445636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65688764|NCT04445636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65688765|NCT04445636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65688766|NCT04445636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65688767|NCT04445636|Adrenergic Agents|adrenergic agents|mesh-ancestor
65688768|NCT04445636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65688769|NCT04445636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688770|NCT04445636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65688771|NCT04445636|Narcotics|narcotics|mesh-ancestor
65688772|NCT02152917|Tranexamic Acid|tranexamic acid|mesh-list
65688773|NCT02152917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65688774|NCT02152917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65688775|NCT02152917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688776|NCT02152917|Hemostatics|hemostatics|mesh-ancestor
65688777|NCT02152917|Coagulants|coagulants|mesh-ancestor
65688779|NCT03111212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65688780|NCT03111212|Vasodilator Agents|vasodilator agents|mesh-ancestor
65688781|NCT03170206|Palbociclib|palbociclib|mesh-list
65688782|NCT03170206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688783|NCT03170206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65688784|NCT03170206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688785|NCT03170206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688786|NCT05424016|Propranolol|propranolol|mesh-list
65688787|NCT05424016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65688788|NCT05424016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65688789|NCT05424016|Adrenergic Agents|adrenergic agents|mesh-ancestor
65688790|NCT05424016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65688791|NCT05424016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688792|NCT05424016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688793|NCT05424016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65688794|NCT05424016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65688795|NCT05424016|Vasodilator Agents|vasodilator agents|mesh-ancestor
65688796|NCT02149953|Glycine|glycine|mesh-list
65688797|NCT02149953|Glycine Agents|glycine agents|mesh-ancestor
65688798|NCT02149953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65688799|NCT02149953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688800|NCT02149953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688801|NCT03380936|Tacrolimus|tacrolimus|mesh-list
65688802|NCT03380936|Immunoglobulins|immunoglobulins|mesh-list
65688803|NCT03380936|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65688804|NCT03380936|Antibodies|antibodies|mesh-list
65688805|NCT03380936|gamma-Globulins|gamma-globulins|mesh-list
65688806|NCT03380936|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65688807|NCT03380936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65688808|NCT03380936|Immunologic Factors|immunologic factors|mesh-ancestor
65688809|NCT03380936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688810|NCT03380936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65688811|NCT03380936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688812|NCT03380936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688813|NCT02150031|Chlorhexidine|chlorhexidine|mesh-list
65688814|NCT02150031|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65688815|NCT02150031|Lidocaine|lidocaine|mesh-list
65688816|NCT02150031|Epinephrine|epinephrine|mesh-list
65688817|NCT02150031|Racepinephrine|racepinephrine|mesh-list
65688818|NCT02150031|Epinephryl borate|epinephryl borate|mesh-list
65688819|NCT02150031|Anesthetics, Local|anesthetics, local|mesh-ancestor
65688820|NCT02150031|Anesthetics|anesthetics|mesh-ancestor
65688821|NCT02150031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65688822|NCT02150031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688823|NCT02150031|Sensory System Agents|sensory system agents|mesh-ancestor
65688824|NCT02150031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65688825|NCT02150031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65688826|NCT02150031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65688827|NCT02150031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65688828|NCT02150031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65688829|NCT02150031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688830|NCT02150031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65688831|NCT02150031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65688832|NCT02150031|Disinfectants|disinfectants|mesh-ancestor
65688833|NCT02150031|Dermatologic Agents|dermatologic agents|mesh-ancestor
65688834|NCT02150031|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65486175|NCT03780686|Dopamine Agents|dopamine agents|mesh-ancestor
65688835|NCT02150031|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65688836|NCT02150031|Adrenergic Agents|adrenergic agents|mesh-ancestor
65688837|NCT02150031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65688838|NCT02150031|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65688839|NCT02150031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65688840|NCT02150031|Autonomic Agents|autonomic agents|mesh-ancestor
65688841|NCT02150031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65688842|NCT02150031|Respiratory System Agents|respiratory system agents|mesh-ancestor
65688843|NCT02150031|Mydriatics|mydriatics|mesh-ancestor
65688844|NCT02150031|Sympathomimetics|sympathomimetics|mesh-ancestor
65688845|NCT02150031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65688846|NCT04655170|Albuterol|albuterol|mesh-list
65688847|NCT04655170|Formoterol Fumarate|formoterol fumarate|mesh-list
65688848|NCT04655170|Ipratropium|ipratropium|mesh-list
65688849|NCT04655170|Cholinergic Antagonists|cholinergic antagonists|mesh-list
65688850|NCT04655170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65688851|NCT04655170|Autonomic Agents|autonomic agents|mesh-ancestor
65688852|NCT04655170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65688853|NCT04655170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688854|NCT04655170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65688855|NCT04655170|Respiratory System Agents|respiratory system agents|mesh-ancestor
65688856|NCT04655170|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65688857|NCT04655170|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65688858|NCT04655170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65688859|NCT04655170|Adrenergic Agents|adrenergic agents|mesh-ancestor
65688860|NCT04655170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65688861|NCT04655170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688862|NCT04655170|Tocolytic Agents|tocolytic agents|mesh-ancestor
65688863|NCT04655170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65688864|NCT04655170|Cholinergic Agents|cholinergic agents|mesh-ancestor
65688865|NCT04651348|Antibodies|antibodies|mesh-list
65688866|NCT04651348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65688867|NCT04651348|Immunologic Factors|immunologic factors|mesh-ancestor
65688868|NCT04651348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688869|NCT02156661|Oxytocin|oxytocin|mesh-list
65688870|NCT02156661|Oxytocics|oxytocics|mesh-ancestor
65688871|NCT02156661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65688872|NCT02156661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688873|NCT03065062|Palbociclib|palbociclib|mesh-list
65688874|NCT03065062|Gedatolisib|gedatolisib|mesh-list
65688875|NCT03065062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688876|NCT03065062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65688877|NCT03065062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688878|NCT03065062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688879|NCT03374774|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65688880|NCT03374774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65688881|NCT03374774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688882|NCT04827862|Pembrolizumab|pembrolizumab|mesh-list
65688883|NCT04827862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65688884|NCT04827862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688885|NCT03374540|Vitamin K|vitamin k|mesh-list
65688886|NCT03374540|Rivaroxaban|rivaroxaban|mesh-list
65688887|NCT03374540|Vitamins|vitamins|mesh-ancestor
65688888|NCT03374540|Micronutrients|micronutrients|mesh-ancestor
65688889|NCT03374540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688890|NCT03374540|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65688891|NCT03374540|Antithrombins|antithrombins|mesh-ancestor
65688892|NCT03374540|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65688893|NCT03374540|Protease Inhibitors|protease inhibitors|mesh-ancestor
65688894|NCT03374540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688895|NCT03374540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688896|NCT03374540|Anticoagulants|anticoagulants|mesh-ancestor
65688897|NCT03374540|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65688898|NCT03374540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65688899|NCT03374540|Hemostatics|hemostatics|mesh-ancestor
65688900|NCT03374540|Coagulants|coagulants|mesh-ancestor
65688901|NCT02780115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65688902|NCT02780115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65688903|NCT03378674|Remifentanil|remifentanil|mesh-list
65688904|NCT03378674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65688905|NCT03378674|Narcotics|narcotics|mesh-ancestor
65688906|NCT03378674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65688907|NCT03378674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688908|NCT03378674|Analgesics|analgesics|mesh-ancestor
65688909|NCT03378674|Sensory System Agents|sensory system agents|mesh-ancestor
65688910|NCT03378674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65486258|NCT00092638|Ezetimibe|ezetimibe|mesh-list
65688911|NCT02157207|Vitamins|vitamins|mesh-list
65688912|NCT02157207|Vitamin E|vitamin e|mesh-list
65688913|NCT02157207|Antioxidants|antioxidants|mesh-list
65688914|NCT02157207|Micronutrients|micronutrients|mesh-ancestor
65688915|NCT02157207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688916|NCT02157207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688917|NCT02157207|Protective Agents|protective agents|mesh-ancestor
65688918|NCT02261103|Pramipexole|pramipexole|mesh-list
65688919|NCT02261103|Antioxidants|antioxidants|mesh-ancestor
65688920|NCT02261103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688921|NCT02261103|Protective Agents|protective agents|mesh-ancestor
65688922|NCT02261103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688923|NCT02261103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65688924|NCT02261103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65688925|NCT02261103|Dopamine Agonists|dopamine agonists|mesh-ancestor
65688926|NCT02261103|Dopamine Agents|dopamine agents|mesh-ancestor
65688927|NCT02261103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65688928|NCT04703686|Obinutuzumab|obinutuzumab|mesh-list
65688929|NCT04703686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65688930|NCT04703686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688931|NCT02766777|Lubiprostone|lubiprostone|mesh-list
65688932|NCT02766777|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65688933|NCT02766777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65688934|NCT02766777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688935|NCT03374306|Atropine|atropine|mesh-list
65688936|NCT03374306|Lubricant Eye Drops|lubricant eye drops|mesh-list
65688937|NCT03374306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65688938|NCT03374306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65688939|NCT03374306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65688940|NCT03374306|Autonomic Agents|autonomic agents|mesh-ancestor
65688941|NCT03374306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65688942|NCT03374306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688943|NCT03374306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65688944|NCT03374306|Respiratory System Agents|respiratory system agents|mesh-ancestor
65688945|NCT03374306|Mydriatics|mydriatics|mesh-ancestor
65688946|NCT03374306|Parasympatholytics|parasympatholytics|mesh-ancestor
65688947|NCT03374306|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65688948|NCT03374306|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65688949|NCT03374306|Cholinergic Agents|cholinergic agents|mesh-ancestor
65688950|NCT03374306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65688951|NCT03374306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688952|NCT03374306|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65688953|NCT03374306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65688954|NCT05534230|Dexmedetomidine|dexmedetomidine|mesh-list
65688955|NCT05534230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65688956|NCT05534230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65688957|NCT05534230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65688958|NCT05534230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688959|NCT05534230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65688960|NCT05534230|Analgesics|analgesics|mesh-ancestor
65688961|NCT05534230|Sensory System Agents|sensory system agents|mesh-ancestor
65688962|NCT05534230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65688963|NCT05534230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65688964|NCT05534230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65688965|NCT05534230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65688966|NCT05534230|Adrenergic Agents|adrenergic agents|mesh-ancestor
65688967|NCT05534230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65688968|NCT05534230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688969|NCT03369782|Rocuronium|rocuronium|mesh-list
65688970|NCT03369782|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65688971|NCT03369782|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65688972|NCT03369782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65688973|NCT03369782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65688974|NCT03369782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65688975|NCT00157014|Cyclosporine|cyclosporine|mesh-list
65688976|NCT00157014|Mycophenolic Acid|mycophenolic acid|mesh-list
65688977|NCT00157014|Prednisone|prednisone|mesh-list
65688978|NCT00157014|Methylprednisolone|methylprednisolone|mesh-list
65688979|NCT00157014|Tacrolimus|tacrolimus|mesh-list
65688980|NCT00157014|Cyclosporins|cyclosporins|mesh-list
65688981|NCT00157014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65688982|NCT00157014|Glucocorticoids|glucocorticoids|mesh-ancestor
65688983|NCT00157014|Hormones|hormones|mesh-ancestor
65688984|NCT00157014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65688985|NCT00157014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486324|NCT03783494|Propofol|propofol|mesh-list
65688986|NCT00157014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65688987|NCT00157014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65688988|NCT00157014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65688989|NCT00157014|Immunologic Factors|immunologic factors|mesh-ancestor
65688990|NCT00157014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65688991|NCT00157014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65688992|NCT00157014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65688993|NCT00157014|Antifungal Agents|antifungal agents|mesh-ancestor
65688994|NCT00157014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65688995|NCT00157014|Dermatologic Agents|dermatologic agents|mesh-ancestor
65688996|NCT00157014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65688997|NCT00157014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65688998|NCT00157014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65688999|NCT00157014|Antitubercular Agents|antitubercular agents|mesh-ancestor
65689000|NCT00157014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65689001|NCT00157014|Antiemetics|antiemetics|mesh-ancestor
65689002|NCT00157014|Autonomic Agents|autonomic agents|mesh-ancestor
65689003|NCT00157014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65689004|NCT00157014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65689005|NCT00157014|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65689006|NCT00157014|Protective Agents|protective agents|mesh-ancestor
65689007|NCT03374228|Linrodostat|linrodostat|mesh-list
65689008|NCT03374228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689009|NCT03374228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689010|NCT02778867|Fluticasone|fluticasone|mesh-list
65689012|NCT02778867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65689013|NCT02778867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65689014|NCT02778867|Autonomic Agents|autonomic agents|mesh-ancestor
65689015|NCT02778867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65689016|NCT02778867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689017|NCT02778867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65689018|NCT02778867|Respiratory System Agents|respiratory system agents|mesh-ancestor
65689019|NCT02778867|Dermatologic Agents|dermatologic agents|mesh-ancestor
65689020|NCT02778867|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65689021|NCT04232072|Ibuprofen|ibuprofen|mesh-list
65689022|NCT04232072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65689023|NCT04232072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65689024|NCT04232072|Analgesics|analgesics|mesh-ancestor
65689025|NCT04232072|Sensory System Agents|sensory system agents|mesh-ancestor
65689026|NCT04232072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65689027|NCT04232072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689028|NCT04232072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65689029|NCT04232072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65689030|NCT04232072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65689031|NCT04232072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689032|NCT04232072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689033|NCT02300064|Antioxidants|antioxidants|mesh-list
65689034|NCT02300064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689035|NCT02300064|Protective Agents|protective agents|mesh-ancestor
65689036|NCT02300064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689037|NCT02688712|Fluorouracil|fluorouracil|mesh-list
65689038|NCT02688712|Capecitabine|capecitabine|mesh-list
65689039|NCT02688712|Antimetabolites|antimetabolites|mesh-ancestor
65689040|NCT02688712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689041|NCT02688712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65689042|NCT02688712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689043|NCT02688712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65689044|NCT02688712|Immunologic Factors|immunologic factors|mesh-ancestor
65689045|NCT02688712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689046|NCT03373994|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65689047|NCT03373994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65689048|NCT03373994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689049|NCT02617550|Nitroglycerin|nitroglycerin|mesh-list
65689050|NCT02617550|Vasodilator Agents|vasodilator agents|mesh-ancestor
65689051|NCT03512808|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65689052|NCT03512808|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65689053|NCT03512808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65689054|NCT02519582|Niclosamide|niclosamide|mesh-list
65689055|NCT02519582|Anticestodal Agents|anticestodal agents|mesh-ancestor
65689056|NCT02519582|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65689057|NCT02519582|Anthelmintics|anthelmintics|mesh-ancestor
65689058|NCT02519582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65689059|NCT02519582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65689060|NCT02519582|Antinematodal Agents|antinematodal agents|mesh-ancestor
65689061|NCT02467582|Aspirin|aspirin|mesh-list
65689062|NCT02467582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65689063|NCT02467582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65689064|NCT02467582|Analgesics|analgesics|mesh-ancestor
65689065|NCT02467582|Sensory System Agents|sensory system agents|mesh-ancestor
65689066|NCT02467582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65689067|NCT02467582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689068|NCT02467582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65689069|NCT02467582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65689070|NCT02467582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65689071|NCT02467582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65689072|NCT02467582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689073|NCT02467582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65689074|NCT02467582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65689075|NCT02467582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689076|NCT02467582|Antipyretics|antipyretics|mesh-ancestor
65689077|NCT05467462|Tranexamic Acid|tranexamic acid|mesh-list
65689078|NCT05467462|Oxytocin|oxytocin|mesh-list
65689079|NCT05467462|Carbetocin|carbetocin|mesh-list
65689080|NCT05467462|Oxytocics|oxytocics|mesh-ancestor
65689081|NCT05467462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65689082|NCT05467462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689083|NCT05467462|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65689084|NCT05467462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65689085|NCT05467462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689086|NCT05467462|Hemostatics|hemostatics|mesh-ancestor
65689087|NCT05467462|Coagulants|coagulants|mesh-ancestor
65689088|NCT03369002|Seladelpar|seladelpar|mesh-list
65689089|NCT03369002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65689090|NCT03369002|Antimetabolites|antimetabolites|mesh-ancestor
65689091|NCT03369002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689092|NCT03369002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65689093|NCT02778399|OBE2109|obe2109|mesh-list
65689094|NCT02778399|Hormone Antagonists|hormone antagonists|mesh-ancestor
65689095|NCT02778399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65689096|NCT02778399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689097|NCT05533606|Lactams|lactams|mesh-list
65689098|NCT05533606|beta-Lactams|beta-lactams|mesh-list
65689099|NCT05533606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65689100|NCT05533606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65689101|NCT02300376|Edetic Acid|edetic acid|mesh-list
65689102|NCT02300376|Calcium|calcium|mesh-list
65689103|NCT02300376|Pentetic Acid|pentetic acid|mesh-list
65689104|NCT02300376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65689105|NCT02300376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689106|NCT02300376|Anticoagulants|anticoagulants|mesh-ancestor
65689107|NCT02300376|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65689108|NCT02300376|Chelating Agents|chelating agents|mesh-ancestor
65689109|NCT02300376|Sequestering Agents|sequestering agents|mesh-ancestor
65689110|NCT02300376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689111|NCT02300376|Antidotes|antidotes|mesh-ancestor
65689112|NCT02300376|Protective Agents|protective agents|mesh-ancestor
65689113|NCT02300376|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65689114|NCT02296398|Romidepsin|romidepsin|mesh-list
65689115|NCT02296398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65689116|NCT02296398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689117|NCT03520062|Liraglutide|liraglutide|mesh-list
65689118|NCT03520062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65689119|NCT03520062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689120|NCT03520062|Incretins|incretins|mesh-ancestor
65689121|NCT03520062|Hormones|hormones|mesh-ancestor
65689122|NCT03520062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65689123|NCT02206984|Tamoxifen|tamoxifen|mesh-list
65689124|NCT02206984|Fulvestrant|fulvestrant|mesh-list
65689125|NCT02206984|Anastrozole|anastrozole|mesh-list
65689126|NCT02206984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65689127|NCT02206984|Hormone Antagonists|hormone antagonists|mesh-ancestor
65689128|NCT02206984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65689129|NCT02206984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689130|NCT02206984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65689131|NCT02206984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689132|NCT02206984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65689133|NCT02206984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65689134|NCT02206984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65486471|NCT01321034|Micronutrients|micronutrients|mesh-ancestor
65689135|NCT02206984|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65689136|NCT02206984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65689137|NCT02206984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65689138|NCT02206984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689139|NCT02206984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689140|NCT03512574|Pregabalin|pregabalin|mesh-list
65689141|NCT03512574|Dexmedetomidine|dexmedetomidine|mesh-list
65689142|NCT03512574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65689143|NCT03512574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65689144|NCT03512574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689145|NCT03512574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65689146|NCT03512574|Analgesics|analgesics|mesh-ancestor
65689147|NCT03512574|Sensory System Agents|sensory system agents|mesh-ancestor
65689148|NCT03512574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65689149|NCT03512574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65689150|NCT03512574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65689151|NCT03512574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65689152|NCT03512574|Adrenergic Agents|adrenergic agents|mesh-ancestor
65689153|NCT03512574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65689154|NCT03512574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689155|NCT03512574|Anticonvulsants|anticonvulsants|mesh-ancestor
65689156|NCT03512574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65689157|NCT03512574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65689158|NCT03512574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65689159|NCT03512574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65689160|NCT03512574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65689161|NCT03512574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65689162|NCT01994980|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65689163|NCT01994980|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65689164|NCT01994980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65689165|NCT01994980|Antitubercular Agents|antitubercular agents|mesh-ancestor
65689166|NCT03377348|Triamcinolone|triamcinolone|mesh-list
65689167|NCT03377348|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65689168|NCT03377348|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65689169|NCT03377348|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65689170|NCT03377348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65689171|NCT03377348|Glucocorticoids|glucocorticoids|mesh-ancestor
65689172|NCT03377348|Hormones|hormones|mesh-ancestor
65689173|NCT03377348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65689174|NCT03377348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689175|NCT03377348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65689176|NCT03377348|Immunologic Factors|immunologic factors|mesh-ancestor
65689177|NCT03377348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689178|NCT03377348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689179|NCT02255253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65689180|NCT02255253|Telmisartan|telmisartan|mesh-list
65689181|NCT02255253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65689182|NCT02255253|Diuretics|diuretics|mesh-ancestor
65689183|NCT02255253|Natriuretic Agents|natriuretic agents|mesh-ancestor
65689184|NCT02255253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689185|NCT02255253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65689186|NCT02255253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65689187|NCT02255253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689188|NCT02255253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65689189|NCT02255253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65689190|NCT02300688|Maleic acid|maleic acid|mesh-list
65689191|NCT02300688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689192|NCT02300688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689193|NCT03896984|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65689194|NCT03896984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689195|NCT02151279|Chitosan|chitosan|mesh-list
65689196|NCT02151279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65689197|NCT02151279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65689198|NCT02151279|Antimetabolites|antimetabolites|mesh-ancestor
65274212|NCT01773083|Calcium heparin|calcium heparin|mesh-list
65689199|NCT02151279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689200|NCT02151279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65689201|NCT02151279|Chelating Agents|chelating agents|mesh-ancestor
65689202|NCT02151279|Sequestering Agents|sequestering agents|mesh-ancestor
65689203|NCT02151279|Hemostatics|hemostatics|mesh-ancestor
65689204|NCT02151279|Coagulants|coagulants|mesh-ancestor
65689205|NCT02159313|Riociguat|riociguat|mesh-list
65689206|NCT02159313|Enzyme Activators|enzyme activators|mesh-ancestor
65689207|NCT02159313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689208|NCT03515772|Darunavir|darunavir|mesh-list
65689209|NCT03515772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65689210|NCT03515772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65689211|NCT03515772|Protease Inhibitors|protease inhibitors|mesh-ancestor
65689212|NCT03515772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689213|NCT03515772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689214|NCT03515772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65689215|NCT03515772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65689216|NCT03515772|Antiviral Agents|antiviral agents|mesh-ancestor
65689217|NCT03515772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65689218|NCT03519750|Melatonin|melatonin|mesh-list
65689219|NCT03519750|Antioxidants|antioxidants|mesh-ancestor
65689220|NCT03519750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689221|NCT03519750|Protective Agents|protective agents|mesh-ancestor
65689222|NCT03519750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689223|NCT03519750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65689224|NCT02158143|Vitamin D|vitamin d|mesh-list
65689225|NCT02158143|Cholecalciferol|cholecalciferol|mesh-list
65689226|NCT02158143|Vitamins|vitamins|mesh-ancestor
65689227|NCT02158143|Micronutrients|micronutrients|mesh-ancestor
65689228|NCT02158143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689229|NCT02158143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65689230|NCT02158143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65689231|NCT02158221|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
65689232|NCT02158221|Growth Substances|growth substances|mesh-ancestor
65689233|NCT02158221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689234|NCT02158221|Vasodilator Agents|vasodilator agents|mesh-ancestor
65689235|NCT02158221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65689236|NCT02158221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689237|NCT02519816|Plasma-lyte 148|plasma-lyte 148|mesh-list
65689238|NCT02519816|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65689239|NCT02519816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65689240|NCT02301000|Metronidazole|metronidazole|mesh-list
65689241|NCT02301000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65689242|NCT02301000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65689243|NCT02301000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65689244|NCT02301000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65689245|NCT02292732|Trametinib|trametinib|mesh-list
65689246|NCT02292732|Norinyl|norinyl|mesh-list
65689247|NCT02292732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689248|NCT02292732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65689249|NCT02292732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689250|NCT02292732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689251|NCT02292732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65689252|NCT02292732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65689253|NCT02292732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65689254|NCT02292732|Contraceptive Agents|contraceptive agents|mesh-ancestor
65689255|NCT02292732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65689256|NCT02292732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689257|NCT02292732|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65689258|NCT02292732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65689259|NCT03376958|Apatinib|apatinib|mesh-list
65689260|NCT03376958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689261|NCT03376958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65689262|NCT03376958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689263|NCT03376958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689264|NCT03367676|Docetaxel|docetaxel|mesh-list
65689265|NCT03367676|Trastuzumab|trastuzumab|mesh-list
65689266|NCT03367676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689267|NCT03367676|Tubulin Modulators|tubulin modulators|mesh-ancestor
65689268|NCT03367676|Antimitotic Agents|antimitotic agents|mesh-ancestor
65689269|NCT03367676|Mitosis Modulators|mitosis modulators|mesh-ancestor
65689270|NCT03367676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689271|NCT03367676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65689272|NCT03515538|Cisplatin|cisplatin|mesh-list
65689273|NCT03515538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689274|NCT02158689|Letrozole|letrozole|mesh-list
65689275|NCT02158689|Menotropins|menotropins|mesh-list
65689276|NCT02158689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689277|NCT02158689|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65689278|NCT02158689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65689279|NCT02158689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689280|NCT02158689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689281|NCT02158689|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65689282|NCT02158689|Hormone Antagonists|hormone antagonists|mesh-ancestor
65486623|NCT03768908|Anthelmintics|anthelmintics|mesh-ancestor
65689283|NCT02158689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65689284|NCT02158689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689285|NCT02158689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65689286|NCT02158689|Fertility Agents|fertility agents|mesh-ancestor
65689287|NCT02158689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65689288|NCT03372200|Febuxostat|febuxostat|mesh-list
65689289|NCT03372200|Dotinurad|dotinurad|mesh-list
65689290|NCT03372200|Gout Suppressants|gout suppressants|mesh-ancestor
65689291|NCT03372200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65689292|NCT03372200|Uricosuric Agents|uricosuric agents|mesh-ancestor
65689293|NCT03372200|Renal Agents|renal agents|mesh-ancestor
65689294|NCT03372122|Chlorhexidine|chlorhexidine|mesh-list
65689295|NCT03372122|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65689296|NCT03372122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65689297|NCT03372122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65689298|NCT03372122|Disinfectants|disinfectants|mesh-ancestor
65689299|NCT03372122|Dermatologic Agents|dermatologic agents|mesh-ancestor
65689300|NCT02158845|Leuprolide|leuprolide|mesh-list
65689301|NCT02158845|Levonorgestrel|levonorgestrel|mesh-list
65689302|NCT02158845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65689303|NCT02158845|Fertility Agents|fertility agents|mesh-ancestor
65689304|NCT02158845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65689305|NCT02158845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689306|NCT02158845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65689307|NCT02158845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689308|NCT02158845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65689309|NCT02158845|Contraceptive Agents|contraceptive agents|mesh-ancestor
65689310|NCT02158845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65689311|NCT02158845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65689312|NCT02158845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65689313|NCT02292966|Asunaprevir|asunaprevir|mesh-list
65689314|NCT02292966|Protease Inhibitors|protease inhibitors|mesh-ancestor
65689315|NCT02292966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689316|NCT02292966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689317|NCT02519660|Lidocaine|lidocaine|mesh-list
65689318|NCT02519660|Tetracaine|tetracaine|mesh-list
65689319|NCT02519660|Prilocaine|prilocaine|mesh-list
65689320|NCT02519660|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65689321|NCT02519660|Anesthetics, Local|anesthetics, local|mesh-ancestor
65689322|NCT02519660|Anesthetics|anesthetics|mesh-ancestor
65689323|NCT02519660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65689324|NCT02519660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689325|NCT02519660|Sensory System Agents|sensory system agents|mesh-ancestor
65689326|NCT02519660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65689327|NCT02519660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65689328|NCT02519660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65689329|NCT02519660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65689330|NCT02519660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65689331|NCT02519660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689332|NCT02519660|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65689333|NCT02297568|Vitamin D|vitamin d|mesh-list
65689334|NCT02297568|Ergocalciferols|ergocalciferols|mesh-list
65689335|NCT02297568|Vitamins|vitamins|mesh-ancestor
65689336|NCT02297568|Micronutrients|micronutrients|mesh-ancestor
65689337|NCT02297568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689338|NCT02297568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65689339|NCT02297568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65689340|NCT03515382|Itraconazole|itraconazole|mesh-list
65689341|NCT03515382|Voriconazole|voriconazole|mesh-list
65689342|NCT03515382|Antifungal Agents|antifungal agents|mesh-ancestor
65689343|NCT03515382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65689344|NCT03515382|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65689345|NCT03515382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65689346|NCT03515382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689347|NCT03515382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689348|NCT03515382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65689349|NCT03515382|Hormone Antagonists|hormone antagonists|mesh-ancestor
65689350|NCT03515382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65689351|NCT03515382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689352|NCT03515382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65689353|NCT03511560|Tacrolimus|tacrolimus|mesh-list
65689354|NCT03511560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65689355|NCT03511560|Immunologic Factors|immunologic factors|mesh-ancestor
65689356|NCT03511560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689357|NCT03511560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65689358|NCT03511560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689359|NCT03511560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689360|NCT03688802|Varenicline|varenicline|mesh-list
65689361|NCT03688802|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65689362|NCT03688802|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65689363|NCT03688802|Cholinergic Agents|cholinergic agents|mesh-ancestor
65689364|NCT03688802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65689365|NCT03688802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689366|NCT03688802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689367|NCT02293356|Nimotuzumab|nimotuzumab|mesh-list
65689368|NCT02293356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65689369|NCT02293356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689370|NCT03616418|Antihypertensive Agents|antihypertensive agents|mesh-list
65689371|NCT03616418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65689372|NCT03371498|Methylprednisolone|methylprednisolone|mesh-list
65689373|NCT03371498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65689374|NCT03371498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65689375|NCT03371498|Prednisolone|prednisolone|mesh-list
65689376|NCT03371498|Prednisolone acetate|prednisolone acetate|mesh-list
65689377|NCT03371498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65689378|NCT03371498|Prednisolone phosphate|prednisolone phosphate|mesh-list
65689379|NCT03371498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65689380|NCT03371498|Antiemetics|antiemetics|mesh-ancestor
65689381|NCT03371498|Autonomic Agents|autonomic agents|mesh-ancestor
65689382|NCT03371498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65689383|NCT03371498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689384|NCT03371498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65689385|NCT03371498|Glucocorticoids|glucocorticoids|mesh-ancestor
65689386|NCT03371498|Hormones|hormones|mesh-ancestor
65689387|NCT03371498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65689388|NCT03371498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65689389|NCT03371498|Protective Agents|protective agents|mesh-ancestor
65689390|NCT03371498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65689391|NCT03371498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689392|NCT03376178|Lidocaine|lidocaine|mesh-list
65689393|NCT03376178|Ropivacaine|ropivacaine|mesh-list
65689394|NCT03376178|Anesthetics, Local|anesthetics, local|mesh-ancestor
65689395|NCT03376178|Anesthetics|anesthetics|mesh-ancestor
65689396|NCT03376178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65689397|NCT03376178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689398|NCT03376178|Sensory System Agents|sensory system agents|mesh-ancestor
65689399|NCT03376178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65689400|NCT03376178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65689401|NCT03376178|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65689402|NCT03376178|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65689403|NCT03376178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65689404|NCT03376178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689405|NCT03514836|Cyclophosphamide|cyclophosphamide|mesh-list
65689406|NCT03514836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65689407|NCT03514836|Immunologic Factors|immunologic factors|mesh-ancestor
65689408|NCT03514836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689409|NCT03514836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65689410|NCT03514836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65689411|NCT03514836|Alkylating Agents|alkylating agents|mesh-ancestor
65689412|NCT03514836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689413|NCT03514836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689414|NCT03514836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65689415|NCT03371342|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65689416|NCT03371342|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65689417|NCT03371342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65689418|NCT03371342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689419|NCT03371342|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65689420|NCT03371342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65689421|NCT03371342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689422|NCT03371342|Cholinergic Agents|cholinergic agents|mesh-ancestor
65689423|NCT03371342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65689424|NCT02302326|Folic Acid|folic acid|mesh-list
65689425|NCT02302326|Inositol|inositol|mesh-list
65689426|NCT02302326|Metformin|metformin|mesh-list
65689427|NCT02302326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65689428|NCT02302326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689429|NCT02302326|Hematinics|hematinics|mesh-ancestor
65689430|NCT02302326|Vitamin B Complex|vitamin b complex|mesh-ancestor
65689431|NCT02302326|Vitamins|vitamins|mesh-ancestor
65689433|NCT02293590|Sulfasalazine|sulfasalazine|mesh-list
65689434|NCT02293590|Certolizumab Pegol|certolizumab pegol|mesh-list
65689435|NCT02293590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65689436|NCT02293590|Immunologic Factors|immunologic factors|mesh-ancestor
65689437|NCT02293590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689438|NCT02293590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65689439|NCT02293590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65689440|NCT02293590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65689441|NCT02293590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65689442|NCT02293590|Analgesics|analgesics|mesh-ancestor
65689443|NCT02293590|Sensory System Agents|sensory system agents|mesh-ancestor
65689444|NCT02293590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65689445|NCT02293590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65689446|NCT02293590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65689447|NCT02302404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65689448|NCT03124082|Lidocaine|lidocaine|mesh-list
65689449|NCT03124082|Clonidine|clonidine|mesh-list
65689450|NCT03124082|Ketamine|ketamine|mesh-list
65689451|NCT03124082|Remifentanil|remifentanil|mesh-list
65689452|NCT03124082|Anesthetics, Local|anesthetics, local|mesh-ancestor
65689453|NCT03124082|Anesthetics|anesthetics|mesh-ancestor
65689454|NCT03124082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65689455|NCT03124082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689456|NCT03124082|Sensory System Agents|sensory system agents|mesh-ancestor
65689457|NCT03124082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65689458|NCT03124082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65689459|NCT03124082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65689460|NCT03124082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65689461|NCT03124082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65689462|NCT03124082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689463|NCT03124082|Analgesics|analgesics|mesh-ancestor
65689464|NCT03124082|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65689465|NCT03124082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65689466|NCT03124082|Anesthetics, General|anesthetics, general|mesh-ancestor
65689467|NCT03124082|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65689468|NCT03124082|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65689469|NCT03124082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65689470|NCT03124082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65689471|NCT03124082|Narcotics|narcotics|mesh-ancestor
65689472|NCT03124082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65689473|NCT03124082|Sympatholytics|sympatholytics|mesh-ancestor
65689474|NCT03124082|Autonomic Agents|autonomic agents|mesh-ancestor
65689475|NCT03124082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65689476|NCT03124082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65689477|NCT03124082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65689478|NCT03124082|Adrenergic Agents|adrenergic agents|mesh-ancestor
65689479|NCT03518502|Sorafenib|sorafenib|mesh-list
65689480|NCT03518502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689481|NCT03518502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65689482|NCT03518502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689483|NCT03518502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689484|NCT02301780|Aspirin|aspirin|mesh-list
65689485|NCT02301780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65689486|NCT02301780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65689487|NCT02301780|Analgesics|analgesics|mesh-ancestor
65689488|NCT02301780|Sensory System Agents|sensory system agents|mesh-ancestor
65689489|NCT02301780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65689490|NCT02301780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689491|NCT02301780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65689492|NCT02301780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65689493|NCT02301780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65689494|NCT02301780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65689495|NCT02301780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689496|NCT02301780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65689497|NCT02301780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65689498|NCT02301780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689499|NCT02301780|Antipyretics|antipyretics|mesh-ancestor
65689500|NCT04527068|Bevacizumab|bevacizumab|mesh-list
65689501|NCT04527068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65689502|NCT04527068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689503|NCT04527068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65689504|NCT04527068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65689505|NCT04527068|Growth Substances|growth substances|mesh-ancestor
65486849|NCT04592536|GABA Modulators|gaba modulators|mesh-ancestor
65689506|NCT04527068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689507|NCT04527068|Growth Inhibitors|growth inhibitors|mesh-ancestor
65689508|NCT02739360|Idelalisib|idelalisib|mesh-list
65689509|NCT02739360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689510|NCT02739360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689511|NCT02739360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689512|NCT03123770|Cyclophosphamide|cyclophosphamide|mesh-list
65689513|NCT03123770|Docetaxel|docetaxel|mesh-list
65689514|NCT03123770|Doxorubicin|doxorubicin|mesh-list
65689515|NCT03123770|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65689516|NCT03123770|Epirubicin|epirubicin|mesh-list
65689517|NCT03123770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65689518|NCT03123770|Immunologic Factors|immunologic factors|mesh-ancestor
65689519|NCT03123770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689520|NCT03123770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65689521|NCT03123770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65689522|NCT03123770|Alkylating Agents|alkylating agents|mesh-ancestor
65689523|NCT03123770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689524|NCT03123770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689525|NCT03123770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65689526|NCT03123770|Tubulin Modulators|tubulin modulators|mesh-ancestor
65689527|NCT03123770|Antimitotic Agents|antimitotic agents|mesh-ancestor
65689528|NCT03123770|Mitosis Modulators|mitosis modulators|mesh-ancestor
65689529|NCT03123770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65689530|NCT03123770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65689531|NCT03123770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65689532|NCT03123770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689533|NCT04464642|Methotrexate|methotrexate|mesh-list
65689534|NCT04464642|Tofacitinib|tofacitinib|mesh-list
65689535|NCT04464642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65689536|NCT04464642|Abortifacient Agents|abortifacient agents|mesh-ancestor
65689537|NCT04464642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65689538|NCT04464642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689539|NCT04464642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65689540|NCT04464642|Antimetabolites|antimetabolites|mesh-ancestor
65689541|NCT04464642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689542|NCT04464642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689543|NCT04464642|Dermatologic Agents|dermatologic agents|mesh-ancestor
65689544|NCT04464642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689545|NCT04464642|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65689546|NCT04464642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65689547|NCT04464642|Immunologic Factors|immunologic factors|mesh-ancestor
65689548|NCT04464642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65689549|NCT04464642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65689550|NCT04464642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65689551|NCT02293668|Letrozole|letrozole|mesh-list
65689552|NCT02293668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689553|NCT02293668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65689554|NCT02293668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65689555|NCT02293668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689556|NCT02293668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689557|NCT02293668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65689558|NCT02293668|Hormone Antagonists|hormone antagonists|mesh-ancestor
65689559|NCT02293668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65689560|NCT02293668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689561|NCT03123692|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
65689562|NCT03123692|Chelating Agents|chelating agents|mesh-ancestor
65689563|NCT03123692|Sequestering Agents|sequestering agents|mesh-ancestor
65689564|NCT03123692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689565|NCT04526210|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
65689566|NCT04526210|Choline|choline|mesh-list
65689567|NCT04526210|Bupropion|bupropion|mesh-list
65689568|NCT04526210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65689569|NCT04526210|Antidepressive Agents|antidepressive agents|mesh-ancestor
65689570|NCT04526210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65689571|NCT04526210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65689572|NCT04526210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65689573|NCT04526210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65689574|NCT04526210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689575|NCT04526210|Dopamine Agents|dopamine agents|mesh-ancestor
65486935|NCT03158272|Nivolumab|nivolumab|mesh-list
65689576|NCT04526210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65689577|NCT04526210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689578|NCT04526210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65689579|NCT04526210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65689580|NCT04526210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689581|NCT04526210|Lipotropic Agents|lipotropic agents|mesh-ancestor
65689582|NCT04526210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65689583|NCT04526210|Antimetabolites|antimetabolites|mesh-ancestor
65689584|NCT04526210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65689585|NCT04526210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65689586|NCT04526210|Nootropic Agents|nootropic agents|mesh-ancestor
65689587|NCT04526210|Chelating Agents|chelating agents|mesh-ancestor
65689588|NCT04526210|Sequestering Agents|sequestering agents|mesh-ancestor
65689589|NCT04526210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65689590|NCT04526210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65689591|NCT04526210|Growth Substances|growth substances|mesh-ancestor
65689592|NCT04526210|Growth Inhibitors|growth inhibitors|mesh-ancestor
65689593|NCT04526210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689594|NCT03375632|Dotinurad|dotinurad|mesh-list
65689595|NCT03375632|Uricosuric Agents|uricosuric agents|mesh-ancestor
65689596|NCT03375632|Gout Suppressants|gout suppressants|mesh-ancestor
65689597|NCT03375632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65689598|NCT03375632|Renal Agents|renal agents|mesh-ancestor
65689599|NCT02302170|Vaccines|vaccines|mesh-list
65689600|NCT02302170|Immunologic Factors|immunologic factors|mesh-ancestor
65689601|NCT02302170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689602|NCT03371186|Contraceptive Agents|contraceptive agents|mesh-list
65689603|NCT03371186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65689604|NCT03371186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689605|NCT02302950|Raltegravir Potassium|raltegravir potassium|mesh-list
65689606|NCT02302950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65689607|NCT02302950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65689608|NCT02302950|Antiviral Agents|antiviral agents|mesh-ancestor
65689609|NCT02302950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65689610|NCT02302950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65689611|NCT02302950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65689612|NCT02302950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689613|NCT02302950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689614|NCT02293824|Caffeine|caffeine|mesh-list
65689615|NCT02293824|Caffeine citrate|caffeine citrate|mesh-list
65689616|NCT02293824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689617|NCT02293824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65689618|NCT02293824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689619|NCT02293824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65689620|NCT02293824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689621|NCT02293824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65689622|NCT02293824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65689623|NCT02293824|Purinergic Agents|purinergic agents|mesh-ancestor
65689624|NCT02293824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65689625|NCT03366584|Vitamin D|vitamin d|mesh-list
65689626|NCT03366584|Cholecalciferol|cholecalciferol|mesh-list
65689627|NCT03366584|Beta Carotene|beta carotene|mesh-list
65689628|NCT03366584|Zinc|zinc|mesh-list
65689629|NCT03366584|Dexamethasone|dexamethasone|mesh-list
65689630|NCT03366584|Carotenoids|carotenoids|mesh-list
65689631|NCT03366584|Picolinic acid|picolinic acid|mesh-list
65689632|NCT03366584|Vitamins|vitamins|mesh-ancestor
65689633|NCT03366584|Micronutrients|micronutrients|mesh-ancestor
65689634|NCT03366584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689635|NCT03366584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65689636|NCT03366584|Antiemetics|antiemetics|mesh-ancestor
65689637|NCT03366584|Autonomic Agents|autonomic agents|mesh-ancestor
65689638|NCT03366584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65689639|NCT03366584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65689640|NCT03366584|Glucocorticoids|glucocorticoids|mesh-ancestor
65689641|NCT03366584|Hormones|hormones|mesh-ancestor
65689642|NCT03366584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65152313|NCT01235442|Etanercept|etanercept|mesh-list
65689643|NCT03366584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65689644|NCT03366584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689645|NCT03366584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65689646|NCT03366584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65689647|NCT03366584|Trace Elements|trace elements|mesh-ancestor
65689648|NCT03366584|Antioxidants|antioxidants|mesh-ancestor
65689649|NCT03366584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689650|NCT03366584|Protective Agents|protective agents|mesh-ancestor
65689651|NCT03366584|Provitamins|provitamins|mesh-ancestor
65689652|NCT03366584|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65689653|NCT03366584|Chelating Agents|chelating agents|mesh-ancestor
65689654|NCT03366584|Sequestering Agents|sequestering agents|mesh-ancestor
65689655|NCT03370562|Dexmedetomidine|dexmedetomidine|mesh-list
65689656|NCT03370562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65689657|NCT03370562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65689658|NCT03370562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689659|NCT03370562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65689660|NCT03370562|Analgesics|analgesics|mesh-ancestor
65689661|NCT03370562|Sensory System Agents|sensory system agents|mesh-ancestor
65689662|NCT03370562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65689663|NCT03370562|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65689664|NCT03370562|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65689665|NCT03370562|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65689666|NCT03370562|Adrenergic Agents|adrenergic agents|mesh-ancestor
65689667|NCT03370562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65689668|NCT03370562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689669|NCT03370328|Peppermint oil|peppermint oil|mesh-list
65689670|NCT03370328|Antiemetics|antiemetics|mesh-ancestor
65689671|NCT03370328|Autonomic Agents|autonomic agents|mesh-ancestor
65689672|NCT03370328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65689673|NCT03370328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689674|NCT03370328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65689675|NCT03370328|Parasympatholytics|parasympatholytics|mesh-ancestor
65689676|NCT02303106|Lamotrigine|lamotrigine|mesh-list
65689677|NCT02303106|Anticonvulsants|anticonvulsants|mesh-ancestor
65689678|NCT02303106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65689679|NCT02303106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65689680|NCT02303106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689681|NCT02303106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65689682|NCT02303106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689683|NCT02303106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65689684|NCT02303106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65689685|NCT02303106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65689686|NCT02303106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65689687|NCT02303106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65689688|NCT04525664|Amoxicillin|amoxicillin|mesh-list
65689689|NCT04525664|Clarithromycin|clarithromycin|mesh-list
65689690|NCT04525664|Omeprazole|omeprazole|mesh-list
65689691|NCT04525664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65689692|NCT04525664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65689693|NCT04525664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65689694|NCT04525664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65689695|NCT04525664|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65689696|NCT04525664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689697|NCT04525664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689698|NCT04525664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65689699|NCT04525664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65689700|NCT04525664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65689701|NCT03510546|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
65689702|NCT03510546|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65689703|NCT03510546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689704|NCT03510546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689705|NCT03510546|Cholinergic Agents|cholinergic agents|mesh-ancestor
65689706|NCT03510546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65689707|NCT03510546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689708|NCT03505008|Adalimumab|adalimumab|mesh-list
65689709|NCT03505008|Methotrexate|methotrexate|mesh-list
65689710|NCT03505008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65689711|NCT03505008|Abortifacient Agents|abortifacient agents|mesh-ancestor
65689712|NCT03505008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65689713|NCT03505008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689714|NCT03505008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65689715|NCT03505008|Antimetabolites|antimetabolites|mesh-ancestor
65689716|NCT03505008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689717|NCT03505008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689718|NCT03505008|Dermatologic Agents|dermatologic agents|mesh-ancestor
65689719|NCT03505008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689720|NCT03505008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65689721|NCT03505008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65689722|NCT03505008|Immunologic Factors|immunologic factors|mesh-ancestor
65689723|NCT03505008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65689724|NCT03505008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65689725|NCT03505008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65689726|NCT03507426|Ketamine|ketamine|mesh-list
65689727|NCT03507426|Analgesics|analgesics|mesh-ancestor
65689728|NCT03507426|Sensory System Agents|sensory system agents|mesh-ancestor
65689729|NCT03507426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65689730|NCT03507426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689731|NCT03507426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65689732|NCT03507426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65689733|NCT03507426|Anesthetics, General|anesthetics, general|mesh-ancestor
65689734|NCT03507426|Anesthetics|anesthetics|mesh-ancestor
65689735|NCT03507426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65689736|NCT03507426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65689737|NCT03507426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65689738|NCT03507426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65689739|NCT03507426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689740|NCT02311530|Felodipine|felodipine|mesh-list
65689741|NCT02311530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65689742|NCT02311530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65689743|NCT02311530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65689744|NCT02311530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65689745|NCT02311530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689746|NCT02311530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65689747|NCT02311530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689748|NCT02311530|Vasodilator Agents|vasodilator agents|mesh-ancestor
65689749|NCT04522466|Hydroxychloroquine|hydroxychloroquine|mesh-list
65689750|NCT04522466|Antimalarials|antimalarials|mesh-ancestor
65689751|NCT04522466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65689752|NCT04522466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65689753|NCT04522466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65689754|NCT04522466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689755|NCT04522466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689756|NCT04522466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65689757|NCT02306772|Mesalamine|mesalamine|mesh-list
65689758|NCT02306772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65689759|NCT02306772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65689760|NCT02306772|Analgesics|analgesics|mesh-ancestor
65689761|NCT02306772|Sensory System Agents|sensory system agents|mesh-ancestor
65689762|NCT02306772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65689763|NCT02306772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689764|NCT02306772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65689765|NCT02306772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65689766|NCT03507348|Rituximab|rituximab|mesh-list
65689767|NCT03507348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65689768|NCT03507348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689769|NCT03507348|Immunologic Factors|immunologic factors|mesh-ancestor
65689770|NCT03507348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689771|NCT03507348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65689772|NCT02518802|Pemetrexed|pemetrexed|mesh-list
65689773|NCT02518802|Gefitinib|gefitinib|mesh-list
65689774|NCT02518802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689775|NCT02518802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689776|NCT02518802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689777|NCT02518802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65689778|NCT02518802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65689779|NCT02518802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65689780|NCT04524026|Letrozole|letrozole|mesh-list
65689781|NCT04524026|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65689782|NCT04524026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689783|NCT04524026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65689784|NCT04524026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689785|NCT04524026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689786|NCT04524026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65689787|NCT04524026|Hormone Antagonists|hormone antagonists|mesh-ancestor
65689788|NCT04524026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65689789|NCT04524026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689790|NCT02311608|Octreotide|octreotide|mesh-list
65689791|NCT02311608|Terlipressin|terlipressin|mesh-list
65689792|NCT02311608|Somatostatin|somatostatin|mesh-list
65689793|NCT02311608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65689794|NCT02311608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65689795|NCT02311608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689796|NCT02311608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65689797|NCT02311608|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65689798|NCT02311608|Hormones|hormones|mesh-ancestor
65689799|NCT02311608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65689800|NCT02311608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689801|NCT02307006|Vancomycin|vancomycin|mesh-list
65689802|NCT02307006|Cefazolin|cefazolin|mesh-list
65689803|NCT02307006|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
65689804|NCT02307006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65689805|NCT02307006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65689807|NCT03362684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65689808|NCT03362684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689809|NCT02311686|Ethanol|ethanol|mesh-list
65689810|NCT02311686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65689811|NCT02311686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65689812|NCT02311686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65689813|NCT02311686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689814|NCT02311764|Carboplatin|carboplatin|mesh-list
65689815|NCT02311764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689816|NCT03365726|Dobutamine|dobutamine|mesh-list
65689817|NCT03365726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65689818|NCT03365726|Sympathomimetics|sympathomimetics|mesh-ancestor
65689819|NCT03365726|Autonomic Agents|autonomic agents|mesh-ancestor
65689820|NCT03365726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65689821|NCT03365726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689822|NCT03365726|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65689823|NCT03365726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65689824|NCT03365726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65689825|NCT03365726|Adrenergic Agents|adrenergic agents|mesh-ancestor
65689826|NCT03365726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65689827|NCT03365726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689828|NCT03365726|Protective Agents|protective agents|mesh-ancestor
65689829|NCT02303418|Oxytocin|oxytocin|mesh-list
65689830|NCT02303418|Carbetocin|carbetocin|mesh-list
65689831|NCT02303418|Oxytocics|oxytocics|mesh-ancestor
65689832|NCT02303418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65689833|NCT02303418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689834|NCT03510000|Empagliflozin|empagliflozin|mesh-list
65689835|NCT03510000|Pancrelipase|pancrelipase|mesh-list
65689836|NCT03510000|Hormones|hormones|mesh-list
65689837|NCT03510000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65689838|NCT03510000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689839|NCT03510000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65689840|NCT03510000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689841|NCT03510000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65689842|NCT03510000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65689843|NCT03358082|Hydrocortisone|hydrocortisone|mesh-list
65689844|NCT03358082|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65689845|NCT03358082|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65689846|NCT03358082|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65689847|NCT03358082|Tacrolimus|tacrolimus|mesh-list
65689848|NCT03358082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65689849|NCT03358082|Immunologic Factors|immunologic factors|mesh-ancestor
65689850|NCT03358082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689851|NCT03358082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65689852|NCT03358082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689853|NCT03358082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689854|NCT03358082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65689855|NCT03358004|Capecitabine|capecitabine|mesh-list
65689856|NCT03358004|Vinorelbine|vinorelbine|mesh-list
65689857|NCT03358004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65689858|NCT03358004|Antimetabolites|antimetabolites|mesh-ancestor
65689859|NCT03358004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689860|NCT03358004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689861|NCT03358004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65689862|NCT03358004|Tubulin Modulators|tubulin modulators|mesh-ancestor
65689863|NCT03358004|Antimitotic Agents|antimitotic agents|mesh-ancestor
65689864|NCT03358004|Mitosis Modulators|mitosis modulators|mesh-ancestor
65689865|NCT03509922|Sarpogrelate|sarpogrelate|mesh-list
65689866|NCT03509922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65689867|NCT03509922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65689868|NCT03509922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689869|NCT03509922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65689870|NCT03509922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65689871|NCT03509922|Serotonin Agents|serotonin agents|mesh-ancestor
65689872|NCT03509922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65689873|NCT03509922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689874|NCT03365336|Oseltamivir|oseltamivir|mesh-list
65689875|NCT03365336|Antiviral Agents|antiviral agents|mesh-ancestor
65689876|NCT03365336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65689877|NCT03365336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487226|NCT05096312|Zinc|zinc|mesh-list
65689878|NCT03365336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689879|NCT03362216|Diclofenac|diclofenac|mesh-list
65689880|NCT03362216|Salicylates|salicylates|mesh-list
65689881|NCT03362216|Methyl salicylate|methyl salicylate|mesh-list
65689882|NCT03362216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65689883|NCT03362216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65689884|NCT03362216|Analgesics|analgesics|mesh-ancestor
65689885|NCT03362216|Sensory System Agents|sensory system agents|mesh-ancestor
65689886|NCT03362216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65689887|NCT03362216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689888|NCT03362216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65689889|NCT03362216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65689890|NCT03362216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65689891|NCT03362216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689892|NCT03362216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689893|NCT02312076|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65689894|NCT02312076|Luteolytic Agents|luteolytic agents|mesh-ancestor
65689895|NCT02312076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65689896|NCT02312076|Contraceptive Agents|contraceptive agents|mesh-ancestor
65689897|NCT02312076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65689898|NCT02312076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689899|NCT02312076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65689900|NCT02312076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65689901|NCT02312076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689902|NCT02307396|Haloperidol|haloperidol|mesh-list
65689903|NCT02307396|Pimozide|pimozide|mesh-list
65689904|NCT02307396|Olanzapine|olanzapine|mesh-list
65689905|NCT02307396|Risperidone|risperidone|mesh-list
65689906|NCT02307396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65689907|NCT02307396|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65689908|NCT02307396|Ziprasidone|ziprasidone|mesh-list
65689909|NCT02307396|Amisulpride|amisulpride|mesh-list
65689910|NCT02307396|Perphenazine|perphenazine|mesh-list
65689911|NCT02307396|Sertindole|sertindole|mesh-list
65689912|NCT02307396|Fluphenazine|fluphenazine|mesh-list
65689913|NCT02307396|Fluphenazine depot|fluphenazine depot|mesh-list
65689914|NCT02307396|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
65689915|NCT02307396|Sulpiride|sulpiride|mesh-list
65689916|NCT02307396|Thioridazine|thioridazine|mesh-list
65689917|NCT02307396|Clopenthixol|clopenthixol|mesh-list
65689918|NCT02307396|Fluspirilene|fluspirilene|mesh-list
65689919|NCT02307396|Benperidol|benperidol|mesh-list
65689920|NCT02307396|Bromperidol|bromperidol|mesh-list
65689921|NCT02307396|Perazine|perazine|mesh-list
65689922|NCT02307396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65689923|NCT02307396|Serotonin Agents|serotonin agents|mesh-ancestor
65689924|NCT02307396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65689925|NCT02307396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689926|NCT02307396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689927|NCT02307396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65689928|NCT02307396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65689929|NCT02307396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65689930|NCT02307396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65689931|NCT02307396|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65689932|NCT02307396|Dopamine Agents|dopamine agents|mesh-ancestor
65689933|NCT02307396|Antiemetics|antiemetics|mesh-ancestor
65689934|NCT02307396|Autonomic Agents|autonomic agents|mesh-ancestor
65689935|NCT02307396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65689936|NCT02307396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65689937|NCT02307396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65689938|NCT02307396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65689939|NCT02307396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65689940|NCT02307396|Antidepressive Agents|antidepressive agents|mesh-ancestor
65689941|NCT02307396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65689942|NCT02307396|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65689943|NCT02307396|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65689944|NCT02307396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65689945|NCT03509688|Entecavir|entecavir|mesh-list
65689946|NCT03509688|Resveratrol|resveratrol|mesh-list
65689947|NCT03509688|Antiviral Agents|antiviral agents|mesh-ancestor
65689948|NCT03509688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65689949|NCT03509688|Antioxidants|antioxidants|mesh-ancestor
65689950|NCT03509688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689951|NCT03509688|Protective Agents|protective agents|mesh-ancestor
65689952|NCT03509688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689953|NCT03509688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689954|NCT03509688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65689955|NCT02303730|Insulin Glargine|insulin glargine|mesh-list
65689956|NCT02303730|Exenatide|exenatide|mesh-list
65689957|NCT02303730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65689958|NCT02303730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689959|NCT02303730|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65689960|NCT02303730|Incretins|incretins|mesh-ancestor
65689961|NCT02303730|Hormones|hormones|mesh-ancestor
65689962|NCT02303730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65689963|NCT04524728|Letrozole|letrozole|mesh-list
65689964|NCT04524728|Fulvestrant|fulvestrant|mesh-list
65689965|NCT04524728|Palbociclib|palbociclib|mesh-list
65689966|NCT04524728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65689967|NCT04524728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65689968|NCT04524728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65689969|NCT04524728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689970|NCT04524728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689971|NCT04524728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65689972|NCT04524728|Hormone Antagonists|hormone antagonists|mesh-ancestor
65689973|NCT04524728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65689974|NCT04524728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689975|NCT04524728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65689976|NCT04524728|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65689977|NCT04524728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65689978|NCT04523792|Buprenorphine|buprenorphine|mesh-list
65689979|NCT04523792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65689980|NCT04523792|Narcotics|narcotics|mesh-ancestor
65689981|NCT04523792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65689982|NCT04523792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689983|NCT04523792|Analgesics|analgesics|mesh-ancestor
65689984|NCT04523792|Sensory System Agents|sensory system agents|mesh-ancestor
65689985|NCT04523792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65689986|NCT04523792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65689987|NCT02312232|Levodopa|levodopa|mesh-list
65689988|NCT02312232|Carbidopa|carbidopa|mesh-list
65689989|NCT02312232|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65689990|NCT02312232|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65689991|NCT02312232|Dopamine Agents|dopamine agents|mesh-ancestor
65689992|NCT02312232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65689993|NCT02312232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65689994|NCT02312232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65689995|NCT02312232|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65689996|NCT02312232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689997|NCT02303886|Methylene Blue|methylene blue|mesh-list
65689998|NCT02303886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65689999|NCT02303886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690000|NCT02518958|Nivolumab|nivolumab|mesh-list
65690001|NCT02518958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65690002|NCT02518958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690003|NCT02518958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65690004|NCT02518958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690005|NCT03506802|Aldesleukin|aldesleukin|mesh-list
65690006|NCT03506802|Plerixafor|plerixafor|mesh-list
65690007|NCT03506802|Lenalidomide|lenalidomide|mesh-list
65690008|NCT03506802|Melphalan|melphalan|mesh-list
65690009|NCT03506802|Interleukin-2|interleukin-2|mesh-list
65690010|NCT03506802|Mechlorethamine|mechlorethamine|mesh-list
65690011|NCT03506802|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65690012|NCT03506802|Lenograstim|lenograstim|mesh-list
65690013|NCT03506802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65690014|NCT03506802|Immunologic Factors|immunologic factors|mesh-ancestor
65690015|NCT03506802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690016|NCT03506802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65690017|NCT03506802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65690018|NCT03506802|Growth Substances|growth substances|mesh-ancestor
65690019|NCT03506802|Growth Inhibitors|growth inhibitors|mesh-ancestor
65690020|NCT03506802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690021|NCT03506802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65690022|NCT03506802|Alkylating Agents|alkylating agents|mesh-ancestor
65690023|NCT03506802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690024|NCT03506802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65690025|NCT03506802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65690026|NCT03506802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65690027|NCT03506802|Analgesics|analgesics|mesh-ancestor
65690028|NCT03506802|Sensory System Agents|sensory system agents|mesh-ancestor
65690029|NCT03506802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65690030|NCT03506802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65487380|NCT04737278|Niacin|niacin|mesh-list
65690031|NCT03506802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65690032|NCT03506802|Antiviral Agents|antiviral agents|mesh-ancestor
65690033|NCT03506802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65690034|NCT02307864|Moxifloxacin|moxifloxacin|mesh-list
65690035|NCT02307864|Tramadol|tramadol|mesh-list
65690036|NCT02307864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65690037|NCT02307864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65690038|NCT02307864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65690039|NCT02307864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65690040|NCT02307864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65690041|NCT02307864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690042|NCT02307864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690043|NCT02307864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690044|NCT02307864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65690045|NCT02307864|Contraceptive Agents|contraceptive agents|mesh-ancestor
65690046|NCT02307864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65690047|NCT02307864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690048|NCT02307864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65690049|NCT02307864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65690050|NCT02307864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65690051|NCT02307864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65690052|NCT02307864|Narcotics|narcotics|mesh-ancestor
65690053|NCT02307864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65690054|NCT02307864|Analgesics|analgesics|mesh-ancestor
65690055|NCT02307864|Sensory System Agents|sensory system agents|mesh-ancestor
65690056|NCT02307864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65690057|NCT02304042|Oxytocin|oxytocin|mesh-list
65690058|NCT02304042|Carbetocin|carbetocin|mesh-list
65690059|NCT02304042|Oxytocics|oxytocics|mesh-ancestor
65690060|NCT02304042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65690061|NCT02304042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690062|NCT02308098|Budesonide|budesonide|mesh-list
65690063|NCT02308098|Formoterol Fumarate|formoterol fumarate|mesh-list
65690064|NCT02308098|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65690065|NCT02308098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65690066|NCT02308098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65690067|NCT02308098|Autonomic Agents|autonomic agents|mesh-ancestor
65690068|NCT02308098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65690069|NCT02308098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690070|NCT02308098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65690071|NCT02308098|Respiratory System Agents|respiratory system agents|mesh-ancestor
65690072|NCT02308098|Glucocorticoids|glucocorticoids|mesh-ancestor
65690073|NCT02308098|Hormones|hormones|mesh-ancestor
65690074|NCT02308098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65690075|NCT02308098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65690076|NCT02308098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65690077|NCT02308098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65690078|NCT02308098|Adrenergic Agents|adrenergic agents|mesh-ancestor
65690079|NCT02308098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65690080|NCT02308098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690081|NCT03504072|Etanercept|etanercept|mesh-list
65690082|NCT03504072|Tofacitinib|tofacitinib|mesh-list
65690083|NCT03504072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65690084|NCT03504072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65690085|NCT03504072|Analgesics|analgesics|mesh-ancestor
65690086|NCT03504072|Sensory System Agents|sensory system agents|mesh-ancestor
65690087|NCT03504072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65690088|NCT03504072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690089|NCT03504072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65690090|NCT03504072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65690091|NCT03504072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65690092|NCT03504072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65690093|NCT03504072|Immunologic Factors|immunologic factors|mesh-ancestor
65690094|NCT03504072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65690095|NCT03504072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690096|NCT03504072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690097|NCT03361280|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65690098|NCT03361280|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65690099|NCT03361280|Adrenergic Agents|adrenergic agents|mesh-ancestor
65690100|NCT03361280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65690101|NCT03361280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690102|NCT03361280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690103|NCT02308254|Lixisenatide|lixisenatide|mesh-list
65690104|NCT02308254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65690105|NCT02308254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690106|NCT03361124|Oxytocin|oxytocin|mesh-list
65690107|NCT03361124|Oxytocics|oxytocics|mesh-ancestor
65690108|NCT03361124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65690109|NCT03361124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690110|NCT03364088|Oxycodone|oxycodone|mesh-list
65690111|NCT03364088|Anesthetics|anesthetics|mesh-list
65690112|NCT03364088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65690113|NCT03364088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690114|NCT03364088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65690115|NCT03364088|Narcotics|narcotics|mesh-ancestor
65690116|NCT03364088|Analgesics|analgesics|mesh-ancestor
65690117|NCT03364088|Sensory System Agents|sensory system agents|mesh-ancestor
65690118|NCT03364088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65690119|NCT02304198|Udenafil|udenafil|mesh-list
65690120|NCT02304198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65690121|NCT02304198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65690122|NCT02304198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690123|NCT02304198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690124|NCT02304276|Calcium|calcium|mesh-list
65690125|NCT02304276|Fluorides|fluorides|mesh-list
65690126|NCT02304276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65690127|NCT02304276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690128|NCT02304276|Cariostatic Agents|cariostatic agents|mesh-ancestor
65690129|NCT02304276|Protective Agents|protective agents|mesh-ancestor
65690130|NCT04524260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65690131|NCT02308332|Tenofovir|tenofovir|mesh-list
65690132|NCT02308332|Emtricitabine|emtricitabine|mesh-list
65690133|NCT02308332|Rilpivirine|rilpivirine|mesh-list
65690134|NCT02308332|Antiviral Agents|antiviral agents|mesh-ancestor
65690135|NCT02308332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65690136|NCT02308332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65690137|NCT02308332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65690138|NCT02308332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690139|NCT02308332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690140|NCT02308332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65690141|NCT02308332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65690142|NCT03509298|Antibodies|antibodies|mesh-list
65690143|NCT03509298|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65690144|NCT03509298|Immunologic Factors|immunologic factors|mesh-ancestor
65690145|NCT03509298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690146|NCT03503994|Beclomethasone|beclomethasone|mesh-list
65690147|NCT03503994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65690148|NCT03503994|Glucocorticoids|glucocorticoids|mesh-ancestor
65690149|NCT03503994|Hormones|hormones|mesh-ancestor
65690150|NCT03503994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65690151|NCT03503994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690152|NCT03503994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65690153|NCT03503994|Respiratory System Agents|respiratory system agents|mesh-ancestor
65690154|NCT01796002|Romidepsin|romidepsin|mesh-list
65690155|NCT01796002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65690156|NCT01796002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690157|NCT03509142|Sirolimus|sirolimus|mesh-list
65690158|NCT03509142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65690159|NCT03509142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65690160|NCT03509142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65690161|NCT03509142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690162|NCT03509142|Antifungal Agents|antifungal agents|mesh-ancestor
65690163|NCT03509142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65690164|NCT03509142|Immunologic Factors|immunologic factors|mesh-ancestor
65690165|NCT03509142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690166|NCT03356912|Prednisone|prednisone|mesh-list
65690167|NCT03356912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65690168|NCT03356912|Glucocorticoids|glucocorticoids|mesh-ancestor
65690169|NCT03356912|Hormones|hormones|mesh-ancestor
65690170|NCT03356912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65690171|NCT03356912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690172|NCT03356912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65690173|NCT03356912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690174|NCT00102687|Azacitidine|azacitidine|mesh-list
65690175|NCT00102687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65690176|NCT00102687|Antimetabolites|antimetabolites|mesh-ancestor
65690177|NCT00102687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690178|NCT00102687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690179|NCT00102687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690180|NCT04509440|Triamcinolone|triamcinolone|mesh-list
65690181|NCT04509440|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65690182|NCT04509440|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65690183|NCT04509440|Anesthetics|anesthetics|mesh-list
65690184|NCT04509440|Mepivacaine|mepivacaine|mesh-list
65690185|NCT04509440|Anesthetics, Local|anesthetics, local|mesh-list
65690186|NCT04509440|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65690187|NCT04509440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65690188|NCT04509440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690189|NCT04509440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65690190|NCT04509440|Glucocorticoids|glucocorticoids|mesh-ancestor
65690191|NCT04509440|Hormones|hormones|mesh-ancestor
65690192|NCT04509440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65690193|NCT04509440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65690194|NCT04509440|Immunologic Factors|immunologic factors|mesh-ancestor
65690195|NCT04509440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690196|NCT04509440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690197|NCT04509440|Sensory System Agents|sensory system agents|mesh-ancestor
65690198|NCT04509440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65690199|NCT02312544|Timolol|timolol|mesh-list
65690200|NCT02312544|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65690201|NCT02312544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65690202|NCT02312544|Adrenergic Agents|adrenergic agents|mesh-ancestor
65690203|NCT02312544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65690204|NCT02312544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690205|NCT02312544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690206|NCT02312544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65690207|NCT02312544|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65690208|NCT03360734|Cetuximab|cetuximab|mesh-list
65690209|NCT03360734|Panitumumab|panitumumab|mesh-list
65690210|NCT03360734|Necitumumab|necitumumab|mesh-list
65690211|NCT03360734|Antibodies|antibodies|mesh-list
65690212|NCT03360734|Immunologic Factors|immunologic factors|mesh-ancestor
65690213|NCT03360734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690214|NCT03360734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65690215|NCT03360734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690216|NCT02308644|Bevacizumab|bevacizumab|mesh-list
65690217|NCT02308644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65690218|NCT02308644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690219|NCT02308644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65690220|NCT02308644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65690221|NCT02308644|Growth Substances|growth substances|mesh-ancestor
65690222|NCT02308644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690223|NCT02308644|Growth Inhibitors|growth inhibitors|mesh-ancestor
65690224|NCT04510636|Pembrolizumab|pembrolizumab|mesh-list
65690225|NCT04510636|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65690226|NCT04510636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65690227|NCT04510636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690228|NCT04510636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65690229|NCT04510636|Alkylating Agents|alkylating agents|mesh-ancestor
65690230|NCT04510636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690231|NCT03540849|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65690232|NCT03540849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65690233|NCT03540849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690234|NCT04520126|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
65690235|NCT04520126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65690236|NCT04520126|Antioxidants|antioxidants|mesh-ancestor
65690237|NCT04520126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690238|NCT04520126|Protective Agents|protective agents|mesh-ancestor
65690239|NCT04520126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690240|NCT04520126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65690241|NCT02304354|Rituximab|rituximab|mesh-list
65690242|NCT02304354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65690243|NCT02304354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690244|NCT02304354|Immunologic Factors|immunologic factors|mesh-ancestor
65690245|NCT02304354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690246|NCT02304354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65690247|NCT03356600|Apatinib|apatinib|mesh-list
65690248|NCT03356600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690249|NCT03356600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65690250|NCT03356600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690251|NCT03356600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690252|NCT04454476|Trametinib|trametinib|mesh-list
65690253|NCT04454476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690254|NCT04454476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65690255|NCT04454476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690256|NCT04454476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690257|NCT00102531|Cisplatin|cisplatin|mesh-list
65690258|NCT00102531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690259|NCT05347654|Sulfadiazine|sulfadiazine|mesh-list
65690260|NCT05347654|Silver Sulfadiazine|silver sulfadiazine|mesh-list
65690261|NCT05347654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65690262|NCT05347654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65690263|NCT05347654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65690264|NCT05347654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65690265|NCT05347654|Coccidiostats|coccidiostats|mesh-ancestor
65690266|NCT05347654|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65690267|NCT03360266|Listerine|listerine|mesh-list
65690268|NCT03360266|Fluorides|fluorides|mesh-list
65690269|NCT03360266|Sodium Fluoride|sodium fluoride|mesh-list
65690270|NCT03360266|Fluorides, Topical|fluorides, topical|mesh-list
65690271|NCT03360266|Cariostatic Agents|cariostatic agents|mesh-ancestor
65690272|NCT03360266|Protective Agents|protective agents|mesh-ancestor
65690273|NCT03360266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690274|NCT03360266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65690275|NCT03360266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65690276|NCT02154789|Polidocanol|polidocanol|mesh-list
65690277|NCT02154789|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65690278|NCT02154789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65690279|NCT02771145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65690280|NCT03506256|Norfloxacin|norfloxacin|mesh-list
65690281|NCT03506256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65690282|NCT03506256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65690283|NCT03506256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65690284|NCT03506256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65690285|NCT03506256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690286|NCT03506256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690287|NCT03506256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690288|NCT03506256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65690289|NCT03506256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65690290|NCT03356444|Docetaxel|docetaxel|mesh-list
65690291|NCT03356444|Abiraterone Acetate|abiraterone acetate|mesh-list
65690292|NCT03356444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690293|NCT03356444|Tubulin Modulators|tubulin modulators|mesh-ancestor
65690294|NCT03356444|Antimitotic Agents|antimitotic agents|mesh-ancestor
65690295|NCT03356444|Mitosis Modulators|mitosis modulators|mesh-ancestor
65690296|NCT03356444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690297|NCT03356444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65690298|NCT03356444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690299|NCT03356444|Hormone Antagonists|hormone antagonists|mesh-ancestor
65690300|NCT03356444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65690301|NCT03356444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690302|NCT03356444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65690303|NCT03503604|Leucovorin|leucovorin|mesh-list
65690304|NCT03503604|Gemcitabine|gemcitabine|mesh-list
65690305|NCT03503604|Paclitaxel|paclitaxel|mesh-list
65690306|NCT03503604|Carboplatin|carboplatin|mesh-list
65690307|NCT03503604|Fluorouracil|fluorouracil|mesh-list
65690308|NCT03503604|Oxaliplatin|oxaliplatin|mesh-list
65690309|NCT03503604|Irinotecan|irinotecan|mesh-list
65690310|NCT03503604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65690311|NCT03503604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690312|NCT03503604|Tubulin Modulators|tubulin modulators|mesh-ancestor
65690313|NCT03503604|Antimitotic Agents|antimitotic agents|mesh-ancestor
65690314|NCT03503604|Mitosis Modulators|mitosis modulators|mesh-ancestor
65690315|NCT03503604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690316|NCT03503604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65690317|NCT03503604|Antimetabolites|antimetabolites|mesh-ancestor
65690318|NCT03503604|Antiviral Agents|antiviral agents|mesh-ancestor
65690319|NCT03503604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65690320|NCT03503604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690321|NCT03503604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65690322|NCT03503604|Immunologic Factors|immunologic factors|mesh-ancestor
65690323|NCT03503604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690324|NCT03503604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65690325|NCT03503604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65690326|NCT03503604|Antidotes|antidotes|mesh-ancestor
65690327|NCT03503604|Protective Agents|protective agents|mesh-ancestor
65690328|NCT03503604|Vitamin B Complex|vitamin b complex|mesh-ancestor
65690329|NCT03503604|Vitamins|vitamins|mesh-ancestor
65690330|NCT03503604|Micronutrients|micronutrients|mesh-ancestor
65690331|NCT04508816|Cetuximab|cetuximab|mesh-list
65690332|NCT04508816|Nimotuzumab|nimotuzumab|mesh-list
65690333|NCT04508816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65690335|NCT03359876|Warfarin|warfarin|mesh-list
65690336|NCT03359876|Rivaroxaban|rivaroxaban|mesh-list
65690337|NCT03359876|Anticoagulants|anticoagulants|mesh-ancestor
65690338|NCT03359876|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65690339|NCT03359876|Antithrombins|antithrombins|mesh-ancestor
65690340|NCT03359876|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65690341|NCT03359876|Protease Inhibitors|protease inhibitors|mesh-ancestor
65690342|NCT03359876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690343|NCT03359876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690344|NCT04508894|Dexmedetomidine|dexmedetomidine|mesh-list
65690345|NCT04508894|Ketamine|ketamine|mesh-list
65690346|NCT04508894|Bupivacaine|bupivacaine|mesh-list
65690347|NCT04508894|Anesthetics, Local|anesthetics, local|mesh-ancestor
65690348|NCT04508894|Anesthetics|anesthetics|mesh-ancestor
65690349|NCT04508894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65690350|NCT04508894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690351|NCT04508894|Sensory System Agents|sensory system agents|mesh-ancestor
65690352|NCT04508894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65690353|NCT04508894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65690354|NCT04508894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65690355|NCT04508894|Analgesics|analgesics|mesh-ancestor
65690356|NCT04508894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65690357|NCT04508894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65690358|NCT04508894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65690359|NCT04508894|Adrenergic Agents|adrenergic agents|mesh-ancestor
65690360|NCT04508894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65690361|NCT04508894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690362|NCT04508894|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65690363|NCT04508894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65690364|NCT04508894|Anesthetics, General|anesthetics, general|mesh-ancestor
65690365|NCT04508894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65690366|NCT04508894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65690367|NCT05226832|Triamcinolone|triamcinolone|mesh-list
65690368|NCT05226832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65690369|NCT05226832|Glucocorticoids|glucocorticoids|mesh-ancestor
65690370|NCT05226832|Hormones|hormones|mesh-ancestor
65690371|NCT05226832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65690372|NCT05226832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690373|NCT03354572|Acetylcysteine|acetylcysteine|mesh-list
65690374|NCT03354572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65690375|NCT03354572|Antiviral Agents|antiviral agents|mesh-ancestor
65690376|NCT03354572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65690377|NCT03354572|Expectorants|expectorants|mesh-ancestor
65690378|NCT03354572|Respiratory System Agents|respiratory system agents|mesh-ancestor
65690379|NCT03354572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65690380|NCT03354572|Antioxidants|antioxidants|mesh-ancestor
65690381|NCT03354572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690382|NCT03354572|Protective Agents|protective agents|mesh-ancestor
65690383|NCT03354572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690384|NCT03354572|Antidotes|antidotes|mesh-ancestor
65690385|NCT03359798|Narcotics|narcotics|mesh-list
65690386|NCT03359798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65690387|NCT03359798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690388|NCT03359798|Analgesics|analgesics|mesh-ancestor
65690389|NCT03359798|Sensory System Agents|sensory system agents|mesh-ancestor
65690390|NCT03359798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65690391|NCT02309346|Clindamycin|clindamycin|mesh-list
65690392|NCT02309346|Clindamycin palmitate|clindamycin palmitate|mesh-list
65690393|NCT02309346|Clindamycin phosphate|clindamycin phosphate|mesh-list
65690394|NCT02309346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65690395|NCT02309346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65690396|NCT02309346|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65690397|NCT02309346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690398|NCT02309346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690399|NCT03356054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65690400|NCT03356054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65690401|NCT03356054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690402|NCT03354494|Desogestrel|desogestrel|mesh-list
65690403|NCT03354494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65690404|NCT03354494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65690405|NCT03354494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65690406|NCT03354494|Contraceptive Agents|contraceptive agents|mesh-ancestor
65690407|NCT03354494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65690408|NCT03354494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690409|NCT03354494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65690410|NCT03354494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65690411|NCT03354494|Progestins|progestins|mesh-ancestor
65690412|NCT03354494|Hormones|hormones|mesh-ancestor
65690413|NCT03354494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65690414|NCT05530954|Calcium|calcium|mesh-list
65690415|NCT05530954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65690416|NCT05530954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690417|NCT03354338|Amoxicillin|amoxicillin|mesh-list
65690418|NCT03354338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65690419|NCT03354338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65690420|NCT02304822|Ciprofloxacin|ciprofloxacin|mesh-list
65690421|NCT02304822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65690422|NCT02304822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65690423|NCT02304822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65690424|NCT02304822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65690425|NCT02304822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690426|NCT02304822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690427|NCT02304822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690428|NCT02304822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65690429|NCT02304822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65690430|NCT02309424|Acetic Acid|acetic acid|mesh-list
65690431|NCT02309424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65690432|NCT02309424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65690433|NCT03506178|Phenylephrine|phenylephrine|mesh-list
65690434|NCT03506178|Oxymetazoline|oxymetazoline|mesh-list
65690435|NCT03506178|Menthol|menthol|mesh-list
65690436|NCT03506178|Antipruritics|antipruritics|mesh-ancestor
65690437|NCT03506178|Dermatologic Agents|dermatologic agents|mesh-ancestor
65690438|NCT03506178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65690439|NCT03506178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65690440|NCT03506178|Adrenergic Agents|adrenergic agents|mesh-ancestor
65690441|NCT03506178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65690442|NCT03506178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690443|NCT03506178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690444|NCT03506178|Sympathomimetics|sympathomimetics|mesh-ancestor
65690445|NCT03506178|Autonomic Agents|autonomic agents|mesh-ancestor
65690446|NCT03506178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65690447|NCT03506178|Nasal Decongestants|nasal decongestants|mesh-ancestor
65690448|NCT03506178|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65690449|NCT03506178|Respiratory System Agents|respiratory system agents|mesh-ancestor
65690450|NCT03506178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65690451|NCT03506178|Mydriatics|mydriatics|mesh-ancestor
65690452|NCT03506178|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65690453|NCT03506178|Protective Agents|protective agents|mesh-ancestor
65690455|NCT05210374|Doxorubicin|doxorubicin|mesh-list
65690456|NCT05210374|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65690457|NCT05210374|Disulfiram|disulfiram|mesh-list
65690458|NCT05210374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65690459|NCT05210374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690460|NCT05210374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65690461|NCT05210374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65690462|NCT05210374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690463|NCT05210374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690464|NCT05210374|Trace Elements|trace elements|mesh-ancestor
65690465|NCT05210374|Micronutrients|micronutrients|mesh-ancestor
65690466|NCT05210374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690467|NCT05210374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65690468|NCT05210374|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65690469|NCT02578186|Diphenhydramine|diphenhydramine|mesh-list
65690470|NCT02578186|Promethazine|promethazine|mesh-list
65690471|NCT02578186|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65690472|NCT02578186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65690473|NCT02578186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65690474|NCT02578186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690475|NCT02578186|Anesthetics, Local|anesthetics, local|mesh-ancestor
65690476|NCT02578186|Anesthetics|anesthetics|mesh-ancestor
65690477|NCT02578186|Sensory System Agents|sensory system agents|mesh-ancestor
65690478|NCT02578186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65690479|NCT02578186|Antiemetics|antiemetics|mesh-ancestor
65487819|NCT03952260|Anesthetics|anesthetics|mesh-list
65690480|NCT02578186|Autonomic Agents|autonomic agents|mesh-ancestor
65690481|NCT02578186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65690482|NCT02578186|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65690483|NCT02578186|Histamine Antagonists|histamine antagonists|mesh-ancestor
65690484|NCT02578186|Histamine Agents|histamine agents|mesh-ancestor
65690485|NCT02578186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65690486|NCT02578186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690487|NCT02578186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65690488|NCT02578186|Antipruritics|antipruritics|mesh-ancestor
65690489|NCT02578186|Dermatologic Agents|dermatologic agents|mesh-ancestor
65690490|NCT04128436|Progesterone|progesterone|mesh-list
65690491|NCT04128436|Progestins|progestins|mesh-ancestor
65690492|NCT04128436|Hormones|hormones|mesh-ancestor
65690493|NCT04128436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65690494|NCT04128436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690495|NCT02309658|Gemcitabine|gemcitabine|mesh-list
65690496|NCT02309658|Cisplatin|cisplatin|mesh-list
65690497|NCT02309658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690498|NCT02309658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65690499|NCT02309658|Antimetabolites|antimetabolites|mesh-ancestor
65690500|NCT02309658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690501|NCT02309658|Antiviral Agents|antiviral agents|mesh-ancestor
65690502|NCT02309658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65690503|NCT02309658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690504|NCT02309658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65690505|NCT02309658|Immunologic Factors|immunologic factors|mesh-ancestor
65690506|NCT02309658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690507|NCT05532280|Etoricoxib|etoricoxib|mesh-list
65690508|NCT05532280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65690509|NCT05532280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65690510|NCT05532280|Analgesics|analgesics|mesh-ancestor
65690511|NCT05532280|Sensory System Agents|sensory system agents|mesh-ancestor
65690512|NCT05532280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65690513|NCT05532280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690514|NCT05532280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65690515|NCT05532280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65690516|NCT05532280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65690517|NCT05532280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65690518|NCT05532280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690519|NCT05532280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690520|NCT04517162|Povidone|povidone|mesh-list
65690521|NCT04517162|Plasma Substitutes|plasma substitutes|mesh-ancestor
65690522|NCT04517162|Blood Substitutes|blood substitutes|mesh-ancestor
65690523|NCT02155023|Insulin|insulin|mesh-list
65690524|NCT02155023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65690525|NCT02155023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65690526|NCT02155023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690527|NCT02163213|Immunoglobulins|immunoglobulins|mesh-list
65690528|NCT02163213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65690529|NCT02163213|Antibodies|antibodies|mesh-list
65690530|NCT02163213|Immunologic Factors|immunologic factors|mesh-ancestor
65690531|NCT02163213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690532|NCT04443920|Tranexamic Acid|tranexamic acid|mesh-list
65690533|NCT04443920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65690534|NCT04443920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65690535|NCT04443920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690536|NCT04443920|Hemostatics|hemostatics|mesh-ancestor
65690537|NCT04443920|Coagulants|coagulants|mesh-ancestor
65690538|NCT03359018|Apatinib|apatinib|mesh-list
65690539|NCT03359018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690540|NCT03359018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65690541|NCT03359018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690542|NCT03359018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690543|NCT05530252|Minocycline|minocycline|mesh-list
65690544|NCT05530252|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65690545|NCT05530252|Anti-Infective Agents|anti-infective agents|mesh-list
65690546|NCT02163291|Paclitaxel|paclitaxel|mesh-list
65690547|NCT02163291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65690548|NCT02163291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690549|NCT02163291|Tubulin Modulators|tubulin modulators|mesh-ancestor
65690550|NCT02163291|Antimitotic Agents|antimitotic agents|mesh-ancestor
65690551|NCT02163291|Mitosis Modulators|mitosis modulators|mesh-ancestor
65690552|NCT02163291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690553|NCT04704921|Ranibizumab|ranibizumab|mesh-list
65690554|NCT04704921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65690555|NCT04704921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65690556|NCT04704921|Growth Substances|growth substances|mesh-ancestor
65690557|NCT04704921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690558|NCT04704921|Growth Inhibitors|growth inhibitors|mesh-ancestor
65690559|NCT04704921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690560|NCT03508440|Prednisone|prednisone|mesh-list
65690561|NCT03508440|Prednisolone|prednisolone|mesh-list
65690562|NCT03508440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65690563|NCT03508440|Glucocorticoids|glucocorticoids|mesh-ancestor
65690564|NCT03508440|Hormones|hormones|mesh-ancestor
65690565|NCT03508440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65690566|NCT03508440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690567|NCT03508440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65690568|NCT03508440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690569|NCT03505788|Acetazolamide|acetazolamide|mesh-list
65690570|NCT03505788|Anticonvulsants|anticonvulsants|mesh-ancestor
65690571|NCT03505788|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65690572|NCT03505788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690573|NCT03505788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690574|NCT03505788|Diuretics|diuretics|mesh-ancestor
65690575|NCT03505788|Natriuretic Agents|natriuretic agents|mesh-ancestor
65690576|NCT03505788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690577|NCT02309970|Aspirin|aspirin|mesh-list
65690578|NCT02309970|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65690579|NCT02309970|Warfarin|warfarin|mesh-list
65690580|NCT02309970|Rivaroxaban|rivaroxaban|mesh-list
65690581|NCT02309970|Dabigatran|dabigatran|mesh-list
65690582|NCT02309970|Apixaban|apixaban|mesh-list
65690583|NCT02309970|Clopidogrel|clopidogrel|mesh-list
65690584|NCT02309970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65690585|NCT02309970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65690586|NCT02309970|Analgesics|analgesics|mesh-ancestor
65690587|NCT02309970|Sensory System Agents|sensory system agents|mesh-ancestor
65690588|NCT02309970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65690589|NCT02309970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690590|NCT02309970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65690591|NCT02309970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65690592|NCT02309970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65690593|NCT02309970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65690594|NCT02309970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690595|NCT02309970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65690596|NCT02309970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65690597|NCT02309970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690598|NCT02309970|Antipyretics|antipyretics|mesh-ancestor
65690599|NCT02309970|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65690600|NCT02309970|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65690601|NCT02309970|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65690602|NCT02309970|Purinergic Agents|purinergic agents|mesh-ancestor
65690603|NCT02309970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65690604|NCT02309970|Anticoagulants|anticoagulants|mesh-ancestor
65690605|NCT02309970|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65690606|NCT02309970|Antithrombins|antithrombins|mesh-ancestor
65690607|NCT02309970|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65690608|NCT02309970|Protease Inhibitors|protease inhibitors|mesh-ancestor
65690609|NCT03353948|Metformin|metformin|mesh-list
65690610|NCT03353948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65690611|NCT03353948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690612|NCT02161653|Pyridoxine|pyridoxine|mesh-list
65690613|NCT02161653|Prednisone|prednisone|mesh-list
65690614|NCT02161653|Pentoxifylline|pentoxifylline|mesh-list
65690615|NCT02161653|Metadoxine|metadoxine|mesh-list
65690616|NCT02161653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65690617|NCT02161653|Glucocorticoids|glucocorticoids|mesh-ancestor
65690618|NCT02161653|Hormones|hormones|mesh-ancestor
65690619|NCT02161653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65690620|NCT02161653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690621|NCT02161653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65690622|NCT02161653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690623|NCT02161653|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65690624|NCT02161653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690625|NCT02161653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690626|NCT02161653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65690627|NCT02161653|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65690628|NCT02161653|Protective Agents|protective agents|mesh-ancestor
65690629|NCT02161653|Vasodilator Agents|vasodilator agents|mesh-ancestor
65690630|NCT02161653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65690631|NCT02161653|Antioxidants|antioxidants|mesh-ancestor
65690632|NCT02161653|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65690633|NCT02161653|Vitamin B Complex|vitamin b complex|mesh-ancestor
65690634|NCT02161653|Vitamins|vitamins|mesh-ancestor
65690635|NCT02161653|Micronutrients|micronutrients|mesh-ancestor
65690636|NCT02576938|Triamcinolone|triamcinolone|mesh-list
65690637|NCT02576938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65690638|NCT02576938|Glucocorticoids|glucocorticoids|mesh-ancestor
65690639|NCT02576938|Hormones|hormones|mesh-ancestor
65690640|NCT02576938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65690641|NCT02576938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690642|NCT02305836|Donepezil|donepezil|mesh-list
65690643|NCT02305836|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65690644|NCT02305836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690645|NCT02305836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690646|NCT02305836|Cholinergic Agents|cholinergic agents|mesh-ancestor
65690647|NCT02305836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65690648|NCT02305836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690649|NCT02305836|Nootropic Agents|nootropic agents|mesh-ancestor
65690650|NCT03503136|Cisplatin|cisplatin|mesh-list
65690651|NCT03503136|Docetaxel|docetaxel|mesh-list
65690652|NCT03503136|Fluorouracil|fluorouracil|mesh-list
65690653|NCT03503136|Capecitabine|capecitabine|mesh-list
65690654|NCT03503136|Nedaplatin|nedaplatin|mesh-list
65690655|NCT03503136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690656|NCT03503136|Tubulin Modulators|tubulin modulators|mesh-ancestor
65690657|NCT03503136|Antimitotic Agents|antimitotic agents|mesh-ancestor
65690658|NCT03503136|Mitosis Modulators|mitosis modulators|mesh-ancestor
65690659|NCT03503136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690660|NCT03503136|Antimetabolites|antimetabolites|mesh-ancestor
65690661|NCT03503136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65690662|NCT03503136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65690663|NCT03503136|Immunologic Factors|immunologic factors|mesh-ancestor
65690664|NCT03503136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690665|NCT02305992|Bupivacaine|bupivacaine|mesh-list
65690666|NCT02305992|Anesthetics, Local|anesthetics, local|mesh-list
65690667|NCT02305992|Anesthetics|anesthetics|mesh-list
65690668|NCT02305992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65690669|NCT02305992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690670|NCT02305992|Sensory System Agents|sensory system agents|mesh-ancestor
65690671|NCT02305992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65690672|NCT03355352|Sufentanil|sufentanil|mesh-list
65690673|NCT03355352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65690674|NCT03355352|Narcotics|narcotics|mesh-ancestor
65690675|NCT03355352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65690676|NCT03355352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690677|NCT03355352|Analgesics|analgesics|mesh-ancestor
65690678|NCT03355352|Sensory System Agents|sensory system agents|mesh-ancestor
65690679|NCT03355352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65690680|NCT03355352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65690681|NCT03355352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65690682|NCT03355352|Anesthetics, General|anesthetics, general|mesh-ancestor
65690683|NCT03355352|Anesthetics|anesthetics|mesh-ancestor
65690684|NCT05529940|Folfirinox|folfirinox|mesh-list
65690685|NCT05529940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690686|NCT04463784|Efavirenz|efavirenz|mesh-list
65690687|NCT04463784|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65690688|NCT04463784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65690689|NCT04463784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690690|NCT04463784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690691|NCT04463784|Antiviral Agents|antiviral agents|mesh-ancestor
65690692|NCT04463784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65690693|NCT04463784|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65690694|NCT04463784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65690695|NCT04463784|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65690696|NCT04463784|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65690697|NCT04463784|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65690698|NCT04463784|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65690699|NCT02310360|Fallypride|fallypride|mesh-list
65690700|NCT02310360|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65690701|NCT02310360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65690702|NCT02310360|Dopamine Agents|dopamine agents|mesh-ancestor
65690703|NCT02310360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65690704|NCT02310360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690705|NCT02310360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690706|NCT03353480|Azithromycin|azithromycin|mesh-list
65690707|NCT03353480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65690708|NCT03353480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65690709|NCT02306070|Metformin|metformin|mesh-list
65690710|NCT02306070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65690711|NCT02306070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690712|NCT03502824|Anti-Infective Agents|anti-infective agents|mesh-list
65690713|NCT03502824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65690714|NCT03353324|Bevacizumab|bevacizumab|mesh-list
65690715|NCT03353324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65690716|NCT03353324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690717|NCT03353324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65690718|NCT03353324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65690719|NCT03353324|Growth Substances|growth substances|mesh-ancestor
65690720|NCT03353324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690721|NCT03353324|Growth Inhibitors|growth inhibitors|mesh-ancestor
65690722|NCT03354962|Nivolumab|nivolumab|mesh-list
65690723|NCT03354962|Ipilimumab|ipilimumab|mesh-list
65690724|NCT03354962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65690725|NCT03354962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690726|NCT03354962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65690727|NCT03354962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690728|NCT04511468|Copper|copper|mesh-list
65690729|NCT04511468|Chromium|chromium|mesh-list
65690730|NCT04511468|Micronutrients|micronutrients|mesh-ancestor
65690731|NCT04511468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690732|NCT04511468|Trace Elements|trace elements|mesh-ancestor
65690733|NCT05531422|Fentanyl|fentanyl|mesh-list
65690734|NCT05531422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65690735|NCT05531422|Narcotics|narcotics|mesh-ancestor
65690736|NCT05531422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65690737|NCT05531422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690738|NCT05531422|Analgesics|analgesics|mesh-ancestor
65690739|NCT05531422|Sensory System Agents|sensory system agents|mesh-ancestor
65690740|NCT05531422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65690741|NCT05531422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65690742|NCT05531422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65690743|NCT05531422|Anesthetics, General|anesthetics, general|mesh-ancestor
65690744|NCT05531422|Anesthetics|anesthetics|mesh-ancestor
65690745|NCT04646356|Tacrolimus|tacrolimus|mesh-list
65690746|NCT04646356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65690747|NCT04646356|Immunologic Factors|immunologic factors|mesh-ancestor
65690748|NCT04646356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690749|NCT04646356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65690750|NCT04646356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690751|NCT04646356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690752|NCT03354806|Analgesics|analgesics|mesh-list
65690753|NCT03354806|Sensory System Agents|sensory system agents|mesh-ancestor
65690754|NCT03354806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65690755|NCT03354806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690756|NCT05523934|Capsaicin|capsaicin|mesh-list
65690757|NCT05523934|Antipruritics|antipruritics|mesh-ancestor
65690758|NCT05523934|Dermatologic Agents|dermatologic agents|mesh-ancestor
65690759|NCT05523934|Sensory System Agents|sensory system agents|mesh-ancestor
65690760|NCT05523934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65690761|NCT05523934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690762|NCT05529082|Analgesics, Opioid|analgesics, opioid|mesh-list
65690763|NCT05529082|Narcotics|narcotics|mesh-ancestor
65690764|NCT05529082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65690765|NCT05529082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690766|NCT05529082|Analgesics|analgesics|mesh-ancestor
65690767|NCT05529082|Sensory System Agents|sensory system agents|mesh-ancestor
65690768|NCT05529082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65690769|NCT03350126|Nivolumab|nivolumab|mesh-list
65690770|NCT03350126|Ipilimumab|ipilimumab|mesh-list
65690771|NCT03350126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65690772|NCT03350126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690773|NCT03350126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65690774|NCT03350126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690775|NCT05285878|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65690776|NCT05285878|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65690777|NCT05285878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690778|NCT05285878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65690779|NCT05285878|Immunologic Factors|immunologic factors|mesh-ancestor
65690780|NCT05285878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690781|NCT02314182|Bevacizumab|bevacizumab|mesh-list
65690782|NCT02314182|Capecitabine|capecitabine|mesh-list
65690783|NCT02314182|Oxaliplatin|oxaliplatin|mesh-list
65690784|NCT02314182|Irinotecan|irinotecan|mesh-list
65690785|NCT02314182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65690786|NCT02314182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690787|NCT02314182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65690788|NCT02314182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65690789|NCT02314182|Growth Substances|growth substances|mesh-ancestor
65690790|NCT02314182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690791|NCT02314182|Growth Inhibitors|growth inhibitors|mesh-ancestor
65690792|NCT02314182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65690793|NCT02314182|Antimetabolites|antimetabolites|mesh-ancestor
65690794|NCT02314182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690795|NCT02314182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65690796|NCT02314182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65690797|NCT02314182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690798|NCT05531344|Tamsulosin|tamsulosin|mesh-list
65690799|NCT05531344|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65690800|NCT05531344|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65690801|NCT05531344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65690802|NCT05531344|Adrenergic Agents|adrenergic agents|mesh-ancestor
65690803|NCT05531344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65690804|NCT05531344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690805|NCT05531344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690806|NCT05531344|Urological Agents|urological agents|mesh-ancestor
65690807|NCT05531266|Glucocorticoids|glucocorticoids|mesh-list
65690808|NCT05531266|Hormones|hormones|mesh-ancestor
65690809|NCT05531266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65690810|NCT05531266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690811|NCT03349658|Anesthetics|anesthetics|mesh-list
65690812|NCT03349658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65690813|NCT03349658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690814|NCT03353012|Levonorgestrel|levonorgestrel|mesh-list
65690815|NCT03353012|Etonogestrel|etonogestrel|mesh-list
65690816|NCT03353012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65690817|NCT03353012|Contraceptive Agents|contraceptive agents|mesh-ancestor
65690818|NCT03353012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65690819|NCT03353012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690820|NCT03353012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65690821|NCT03353012|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65690822|NCT03353012|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65690823|NCT05528458|Osimertinib|osimertinib|mesh-list
65690824|NCT05528458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690825|NCT05528458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65690826|NCT05528458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690827|NCT05528458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690828|NCT04462614|Heparin|heparin|mesh-list
65690829|NCT04462614|Anticoagulants|anticoagulants|mesh-ancestor
65690830|NCT04462614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65690831|NCT04462614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65690832|NCT04462614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690833|NCT03349424|Somatostatin|somatostatin|mesh-list
65690834|NCT03349424|Hormones|hormones|mesh-ancestor
65690835|NCT03349424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65690836|NCT03349424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690837|NCT03349346|Rituximab|rituximab|mesh-list
65690838|NCT03349346|Carboplatin|carboplatin|mesh-list
65690839|NCT03349346|Etoposide|etoposide|mesh-list
65690840|NCT03349346|Ifosfamide|ifosfamide|mesh-list
65690841|NCT03349346|Idelalisib|idelalisib|mesh-list
65690842|NCT03349346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65690843|NCT03349346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690844|NCT03349346|Immunologic Factors|immunologic factors|mesh-ancestor
65690845|NCT03349346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690846|NCT03349346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65690847|NCT03349346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65690848|NCT03349346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65690849|NCT03349346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65690850|NCT03349346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690851|NCT03349346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690852|NCT03349346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65690853|NCT03349346|Alkylating Agents|alkylating agents|mesh-ancestor
65690854|NCT03502434|Petrolatum|petrolatum|mesh-list
65690855|NCT03502434|Emollients|emollients|mesh-ancestor
65690856|NCT03502434|Dermatologic Agents|dermatologic agents|mesh-ancestor
65690857|NCT03352700|Dyclonine|dyclonine|mesh-list
65690858|NCT03352700|Anesthetics, Local|anesthetics, local|mesh-ancestor
65690859|NCT03352700|Anesthetics|anesthetics|mesh-ancestor
65690860|NCT03352700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65690861|NCT03352700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690862|NCT03352700|Sensory System Agents|sensory system agents|mesh-ancestor
65488195|NCT03950544|Tigecycline|tigecycline|mesh-list
65690863|NCT03352700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65690864|NCT05522998|Propofol|propofol|mesh-list
65690865|NCT05522998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65690866|NCT05522998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65690867|NCT05522998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690868|NCT05522998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65690869|NCT05522998|Anesthetics, General|anesthetics, general|mesh-ancestor
65690870|NCT05522998|Anesthetics|anesthetics|mesh-ancestor
65690871|NCT03349190|Ulipristal acetate|ulipristal acetate|mesh-list
65690872|NCT03349190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65690873|NCT03349190|Contraceptive Agents|contraceptive agents|mesh-ancestor
65690874|NCT03349190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65690875|NCT03349190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690876|NCT03349190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65690877|NCT03498534|Isoniazid|isoniazid|mesh-list
65690878|NCT03498534|Antitubercular Agents|antitubercular agents|mesh-ancestor
65690879|NCT03498534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65690880|NCT03498534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65690881|NCT03498534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65690882|NCT03498534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65690883|NCT03498534|Antimetabolites|antimetabolites|mesh-ancestor
65690884|NCT03498534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690885|NCT03498534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65690886|NCT03502356|Azithromycin|azithromycin|mesh-list
65690887|NCT03502356|Cefazolin|cefazolin|mesh-list
65690888|NCT03502356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65690889|NCT03502356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65690890|NCT03498456|Amoxicillin|amoxicillin|mesh-list
65690891|NCT03498456|Clarithromycin|clarithromycin|mesh-list
65690892|NCT03498456|Lansoprazole|lansoprazole|mesh-list
65690893|NCT03498456|Dexlansoprazole|dexlansoprazole|mesh-list
65690894|NCT03498456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65690895|NCT03498456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65690896|NCT03498456|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65690897|NCT03498456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690898|NCT03498456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690899|NCT03498456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65690900|NCT03498456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65690901|NCT03498456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65690902|NCT03498456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65690903|NCT03498456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65690904|NCT02317146|Magnesium Sulfate|magnesium sulfate|mesh-list
65690905|NCT02317146|Analgesics|analgesics|mesh-ancestor
65690906|NCT02317146|Sensory System Agents|sensory system agents|mesh-ancestor
65690907|NCT02317146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65690908|NCT02317146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690909|NCT02317146|Anesthetics|anesthetics|mesh-ancestor
65690910|NCT02317146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65690911|NCT02317146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65690912|NCT02317146|Anticonvulsants|anticonvulsants|mesh-ancestor
65690913|NCT02317146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65690914|NCT02317146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65690915|NCT02317146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690916|NCT02317146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65690917|NCT02317146|Tocolytic Agents|tocolytic agents|mesh-ancestor
65690918|NCT02317146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65690919|NCT05528146|Psyllium|psyllium|mesh-list
65690920|NCT05528146|Cathartics|cathartics|mesh-ancestor
65690921|NCT05528146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65690922|NCT05553704|Metformin|metformin|mesh-list
65690923|NCT05553704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65690924|NCT05553704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690925|NCT03349112|Lidocaine|lidocaine|mesh-list
65690926|NCT03349112|Anesthetics, Local|anesthetics, local|mesh-ancestor
65690927|NCT03349112|Anesthetics|anesthetics|mesh-ancestor
65690928|NCT03349112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65690929|NCT03349112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690930|NCT03349112|Sensory System Agents|sensory system agents|mesh-ancestor
65690931|NCT03349112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65690932|NCT03349112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65690933|NCT03349112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65690934|NCT03349112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65690935|NCT03349112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65690936|NCT03349112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690937|NCT03498222|Carboplatin|carboplatin|mesh-list
65690938|NCT03498222|Pemetrexed|pemetrexed|mesh-list
65690939|NCT03498222|Atezolizumab|atezolizumab|mesh-list
65690940|NCT03498222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690942|NCT03498222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690943|NCT03498222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65690944|NCT03498222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65690945|NCT02518022|Insulin|insulin|mesh-list
65690946|NCT02518022|Insulin Lispro|insulin lispro|mesh-list
65690947|NCT02518022|Insulin Aspart|insulin aspart|mesh-list
65690948|NCT02518022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65690949|NCT02518022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690950|NCT05504252|Fluorouracil|fluorouracil|mesh-list
65690951|NCT05504252|Oxaliplatin|oxaliplatin|mesh-list
65690952|NCT05504252|Nivolumab|nivolumab|mesh-list
65690953|NCT05504252|Antimetabolites|antimetabolites|mesh-ancestor
65690954|NCT05504252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690955|NCT05504252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65690956|NCT05504252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690957|NCT05504252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65690958|NCT05504252|Immunologic Factors|immunologic factors|mesh-ancestor
65690959|NCT05504252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690960|NCT05504252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65690961|NCT05504252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65690962|NCT03497988|Oxytocin|oxytocin|mesh-list
65690963|NCT03497988|Oxytocics|oxytocics|mesh-ancestor
65690964|NCT03497988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65690965|NCT03497988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690966|NCT04610476|Sulfasalazine|sulfasalazine|mesh-list
65690967|NCT04610476|Prednisolone|prednisolone|mesh-list
65690968|NCT04610476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65690969|NCT04610476|Methylprednisolone|methylprednisolone|mesh-list
65690970|NCT04610476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65690971|NCT04610476|Prednisolone acetate|prednisolone acetate|mesh-list
65690972|NCT04610476|Adalimumab|adalimumab|mesh-list
65690973|NCT04610476|Etanercept|etanercept|mesh-list
65690974|NCT04610476|Apremilast|apremilast|mesh-list
65690975|NCT04610476|Golimumab|golimumab|mesh-list
65690976|NCT04610476|Methotrexate|methotrexate|mesh-list
65690977|NCT04610476|Abatacept|abatacept|mesh-list
65690978|NCT04610476|Infliximab|infliximab|mesh-list
65690979|NCT04610476|Certolizumab Pegol|certolizumab pegol|mesh-list
65690980|NCT04610476|Ustekinumab|ustekinumab|mesh-list
65690981|NCT04610476|Ixekizumab|ixekizumab|mesh-list
65690982|NCT04610476|Tofacitinib|tofacitinib|mesh-list
65690983|NCT04610476|Leflunomide|leflunomide|mesh-list
65690984|NCT04610476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65690985|NCT04610476|Prednisolone phosphate|prednisolone phosphate|mesh-list
65690986|NCT04610476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65690987|NCT04610476|Abortifacient Agents|abortifacient agents|mesh-ancestor
65690988|NCT04610476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65690989|NCT04610476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65690990|NCT04610476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65690991|NCT04610476|Antimetabolites|antimetabolites|mesh-ancestor
65690992|NCT04610476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65690993|NCT04610476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65690994|NCT04610476|Dermatologic Agents|dermatologic agents|mesh-ancestor
65690995|NCT04610476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65690996|NCT04610476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65690997|NCT04610476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65690998|NCT04610476|Immunologic Factors|immunologic factors|mesh-ancestor
65690999|NCT04610476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65691000|NCT04610476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65691001|NCT04610476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65691002|NCT04610476|Glucocorticoids|glucocorticoids|mesh-ancestor
65691003|NCT04610476|Hormones|hormones|mesh-ancestor
65691004|NCT04610476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65691005|NCT04610476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65691006|NCT04610476|Antiemetics|antiemetics|mesh-ancestor
65691007|NCT04610476|Autonomic Agents|autonomic agents|mesh-ancestor
65691008|NCT04610476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691009|NCT04610476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65691010|NCT04610476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65691011|NCT04610476|Protective Agents|protective agents|mesh-ancestor
65691012|NCT04610476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65691013|NCT04610476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65691014|NCT04610476|Analgesics|analgesics|mesh-ancestor
65691015|NCT04610476|Sensory System Agents|sensory system agents|mesh-ancestor
65488346|NCT00025662|Immunotoxins|immunotoxins|mesh-list
65691016|NCT04610476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65691017|NCT04610476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65691018|NCT04610476|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65691019|NCT04610476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65691020|NCT04610476|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65691021|NCT04610476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691022|NCT03348800|Anesthetics|anesthetics|mesh-list
65691023|NCT03348800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65691024|NCT03348800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691025|NCT02314806|Clindamycin|clindamycin|mesh-list
65691026|NCT02314806|Clindamycin palmitate|clindamycin palmitate|mesh-list
65691027|NCT02314806|Clindamycin phosphate|clindamycin phosphate|mesh-list
65691028|NCT02314806|Gentamicins|gentamicins|mesh-list
65691029|NCT02314806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65691030|NCT02314806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65691031|NCT02314806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691032|NCT02314806|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65691033|NCT02314806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691034|NCT02314806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691035|NCT00709202|Betahistine|betahistine|mesh-list
65691036|NCT00709202|Vasodilator Agents|vasodilator agents|mesh-ancestor
65691037|NCT00709202|Histamine Agonists|histamine agonists|mesh-ancestor
65691038|NCT00709202|Histamine Agents|histamine agents|mesh-ancestor
65691039|NCT00709202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65691040|NCT00709202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691041|NCT00709202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691042|NCT05517538|Botulinum Toxins|botulinum toxins|mesh-list
65691043|NCT05517538|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65691044|NCT05517538|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65691045|NCT05517538|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65691046|NCT05517538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65691047|NCT05517538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691048|NCT05517538|Cholinergic Agents|cholinergic agents|mesh-ancestor
65691049|NCT05517538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65691050|NCT05517538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691051|NCT05517538|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65691052|NCT05517538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691053|NCT02321280|Denosumab|denosumab|mesh-list
65691054|NCT02321280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65691055|NCT02321280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691056|NCT05016310|Vitamin D|vitamin d|mesh-list
65691057|NCT05016310|Ergocalciferols|ergocalciferols|mesh-list
65691058|NCT05016310|Cholecalciferol|cholecalciferol|mesh-list
65691059|NCT05016310|Vitamins|vitamins|mesh-list
65691060|NCT05016310|Micronutrients|micronutrients|mesh-ancestor
65691061|NCT05016310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691062|NCT05016310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65691063|NCT05016310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65691064|NCT05527444|Thalidomide|thalidomide|mesh-list
65691065|NCT05527444|Adalimumab|adalimumab|mesh-list
65691066|NCT05527444|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65691067|NCT05527444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65691068|NCT05527444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65691069|NCT05527444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65691070|NCT05527444|Immunologic Factors|immunologic factors|mesh-ancestor
65691071|NCT05527444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691072|NCT05527444|Leprostatic Agents|leprostatic agents|mesh-ancestor
65691073|NCT05527444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65691074|NCT05527444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691075|NCT05527444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65691076|NCT05527444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65691077|NCT05527444|Growth Substances|growth substances|mesh-ancestor
65691078|NCT05527444|Growth Inhibitors|growth inhibitors|mesh-ancestor
65691079|NCT05527444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691080|NCT05439902|Tamsulosin|tamsulosin|mesh-list
65691081|NCT05439902|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65691082|NCT05439902|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65691083|NCT05439902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65691084|NCT05439902|Adrenergic Agents|adrenergic agents|mesh-ancestor
65691085|NCT05439902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65691086|NCT05439902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691087|NCT05439902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691088|NCT05439902|Urological Agents|urological agents|mesh-ancestor
65691089|NCT02315118|Rituximab|rituximab|mesh-list
65691090|NCT02315118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65691091|NCT02315118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691092|NCT02315118|Immunologic Factors|immunologic factors|mesh-ancestor
65691093|NCT02315118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691094|NCT02315118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65691095|NCT03122756|Dexamethasone|dexamethasone|mesh-list
65691096|NCT03122756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65691097|NCT03122756|Antiemetics|antiemetics|mesh-ancestor
65691098|NCT03122756|Autonomic Agents|autonomic agents|mesh-ancestor
65691099|NCT03122756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691100|NCT03122756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691101|NCT03122756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65691102|NCT03122756|Glucocorticoids|glucocorticoids|mesh-ancestor
65691104|NCT03122756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65691105|NCT03122756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65691106|NCT03122756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691107|NCT03122678|Thiamine|thiamine|mesh-list
65691108|NCT03122678|Vitamins|vitamins|mesh-ancestor
65691109|NCT03122678|Micronutrients|micronutrients|mesh-ancestor
65691110|NCT03122678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691111|NCT03122678|Vitamin B Complex|vitamin b complex|mesh-ancestor
65691112|NCT02317770|Lidocaine|lidocaine|mesh-list
65691113|NCT02317770|Anesthetics, Local|anesthetics, local|mesh-ancestor
65691114|NCT02317770|Anesthetics|anesthetics|mesh-ancestor
65691115|NCT02317770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65691116|NCT02317770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691117|NCT02317770|Sensory System Agents|sensory system agents|mesh-ancestor
65691118|NCT02317770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691119|NCT02317770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65691120|NCT02317770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65691121|NCT02317770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65691122|NCT02317770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65691123|NCT02317770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691124|NCT05527054|Diuretics|diuretics|mesh-list
65691125|NCT05527054|Natriuretic Agents|natriuretic agents|mesh-ancestor
65691126|NCT05527054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691127|NCT04506242|Apatinib|apatinib|mesh-list
65691128|NCT04506242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691129|NCT04506242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65691130|NCT04506242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691131|NCT04506242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691132|NCT05526898|Triamcinolone|triamcinolone|mesh-list
65691133|NCT05526898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65691134|NCT05526898|Glucocorticoids|glucocorticoids|mesh-ancestor
65691135|NCT05526898|Hormones|hormones|mesh-ancestor
65691136|NCT05526898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65691137|NCT05526898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691138|NCT05526820|Vaccines|vaccines|mesh-list
65691139|NCT05526820|Immunologic Factors|immunologic factors|mesh-ancestor
65691140|NCT05526820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691141|NCT03352076|Danazol|danazol|mesh-list
65691142|NCT03352076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65691143|NCT03352076|Hormone Antagonists|hormone antagonists|mesh-ancestor
65691144|NCT03352076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65691145|NCT03352076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691146|NCT03497442|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65691147|NCT03497442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65691148|NCT03497442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65691149|NCT03497442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65691150|NCT03497442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65691151|NCT03497442|Adrenergic Agents|adrenergic agents|mesh-ancestor
65691152|NCT03497442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65691153|NCT03497442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691154|NCT03497442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691155|NCT02738580|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65691156|NCT02738580|Hormones|hormones|mesh-ancestor
65691157|NCT02738580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65691158|NCT02738580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691159|NCT03497364|Bupivacaine|bupivacaine|mesh-list
65691160|NCT03497364|Ropivacaine|ropivacaine|mesh-list
65691161|NCT03497364|Anesthetics, Local|anesthetics, local|mesh-ancestor
65691162|NCT03497364|Anesthetics|anesthetics|mesh-ancestor
65691163|NCT03497364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65691164|NCT03497364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488510|NCT03949842|Xhance|xhance|mesh-list
65691165|NCT03497364|Sensory System Agents|sensory system agents|mesh-ancestor
65691166|NCT03497364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691167|NCT03348254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65691168|NCT03348254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65691169|NCT03348254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691170|NCT03348254|Antitubercular Agents|antitubercular agents|mesh-ancestor
65691171|NCT05521048|Doxycycline|doxycycline|mesh-list
65691172|NCT05521048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65691173|NCT05521048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691174|NCT05521048|Antimalarials|antimalarials|mesh-ancestor
65691175|NCT05521048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65691176|NCT05521048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65691177|NCT05516446|Chromium|chromium|mesh-list
65691178|NCT05516446|Paclitaxel|paclitaxel|mesh-list
65691179|NCT05516446|Everolimus|everolimus|mesh-list
65691180|NCT05516446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65691181|NCT05516446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691182|NCT05516446|Tubulin Modulators|tubulin modulators|mesh-ancestor
65691183|NCT05516446|Antimitotic Agents|antimitotic agents|mesh-ancestor
65691184|NCT05516446|Mitosis Modulators|mitosis modulators|mesh-ancestor
65691185|NCT05516446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691186|NCT05516446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65691187|NCT05516446|Immunologic Factors|immunologic factors|mesh-ancestor
65691188|NCT05516446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691189|NCT05516446|Trace Elements|trace elements|mesh-ancestor
65691190|NCT05516446|Micronutrients|micronutrients|mesh-ancestor
65691191|NCT05232344|Estradiol|estradiol|mesh-list
65691192|NCT05232344|Progesterone|progesterone|mesh-list
65691193|NCT05232344|Estrogens|estrogens|mesh-ancestor
65691194|NCT05232344|Hormones|hormones|mesh-ancestor
65691195|NCT05232344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65691196|NCT05232344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691197|NCT05232344|Progestins|progestins|mesh-ancestor
65691198|NCT02318082|Aldesleukin|aldesleukin|mesh-list
65691199|NCT02318082|Interleukin-2|interleukin-2|mesh-list
65691200|NCT02318082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691201|NCT02318082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65691202|NCT02318082|Analgesics|analgesics|mesh-ancestor
65691203|NCT02318082|Sensory System Agents|sensory system agents|mesh-ancestor
65691204|NCT02318082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691205|NCT02318082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691206|NCT02318082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65691207|NCT02318082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65691208|NCT02318082|Antiviral Agents|antiviral agents|mesh-ancestor
65691209|NCT02318082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691210|NCT03348098|Paclitaxel|paclitaxel|mesh-list
65691211|NCT03348098|Apatinib|apatinib|mesh-list
65691212|NCT03348098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65691213|NCT03348098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691214|NCT03348098|Tubulin Modulators|tubulin modulators|mesh-ancestor
65691215|NCT03348098|Antimitotic Agents|antimitotic agents|mesh-ancestor
65691216|NCT03348098|Mitosis Modulators|mitosis modulators|mesh-ancestor
65691217|NCT03348098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691218|NCT03348098|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65691219|NCT03348098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691220|NCT03351842|Cisplatin|cisplatin|mesh-list
65691221|NCT03351842|Carboplatin|carboplatin|mesh-list
65691222|NCT03351842|Pemetrexed|pemetrexed|mesh-list
65691223|NCT03351842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691224|NCT03351842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691225|NCT03351842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691226|NCT03351842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65691227|NCT03351842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65691228|NCT02447406|Docetaxel|docetaxel|mesh-list
65691229|NCT02447406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691230|NCT02447406|Tubulin Modulators|tubulin modulators|mesh-ancestor
65691231|NCT02447406|Antimitotic Agents|antimitotic agents|mesh-ancestor
65691232|NCT02447406|Mitosis Modulators|mitosis modulators|mesh-ancestor
65691233|NCT02447406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691234|NCT04505228|Atropine|atropine|mesh-list
65691235|NCT04505228|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65691236|NCT04505228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65691237|NCT04505228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65691238|NCT04505228|Autonomic Agents|autonomic agents|mesh-ancestor
65691239|NCT04505228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691240|NCT04505228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691241|NCT04505228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65691242|NCT04505228|Respiratory System Agents|respiratory system agents|mesh-ancestor
65691244|NCT04505228|Parasympatholytics|parasympatholytics|mesh-ancestor
65691245|NCT04505228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65691246|NCT04505228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65691247|NCT04505228|Cholinergic Agents|cholinergic agents|mesh-ancestor
65691248|NCT04505228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65691249|NCT04505228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691250|NCT05584826|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65691251|NCT05584826|Hallucinogens|hallucinogens|mesh-ancestor
65691252|NCT05584826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691253|NCT05584826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65691254|NCT05584826|Serotonin Agents|serotonin agents|mesh-ancestor
65691255|NCT05584826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65691256|NCT05584826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691257|NCT05584826|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65691258|NCT05584826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65691259|NCT05584826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65691260|NCT05584826|Adrenergic Agents|adrenergic agents|mesh-ancestor
65691261|NCT03161028|Thioctic Acid|thioctic acid|mesh-list
65691262|NCT03161028|Antioxidants|antioxidants|mesh-ancestor
65691263|NCT03161028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691264|NCT03161028|Protective Agents|protective agents|mesh-ancestor
65691265|NCT03161028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691266|NCT03161028|Vitamin B Complex|vitamin b complex|mesh-ancestor
65691267|NCT03161028|Vitamins|vitamins|mesh-ancestor
65691268|NCT03161028|Micronutrients|micronutrients|mesh-ancestor
65691269|NCT02322372|Bupivacaine|bupivacaine|mesh-list
65691270|NCT02322372|Anesthetics|anesthetics|mesh-ancestor
65691271|NCT02322372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65691272|NCT02322372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691273|NCT02322372|Anesthetics, Local|anesthetics, local|mesh-ancestor
65691274|NCT02322372|Sensory System Agents|sensory system agents|mesh-ancestor
65691275|NCT02322372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691276|NCT01376804|Valganciclovir|valganciclovir|mesh-list
65691277|NCT01376804|Antiviral Agents|antiviral agents|mesh-ancestor
65691278|NCT01376804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691279|NCT05526118|Tenofovir|tenofovir|mesh-list
65691280|NCT05526118|Emtricitabine|emtricitabine|mesh-list
65691281|NCT05526118|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65691282|NCT05526118|Antiviral Agents|antiviral agents|mesh-ancestor
65691283|NCT05526118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691284|NCT05526118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65691285|NCT05526118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65691286|NCT05526118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268979|NCT02022098|Cisplatin|cisplatin|mesh-list
65691287|NCT05526118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691288|NCT05526118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65691289|NCT05526118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65691290|NCT03122132|Ritonavir|ritonavir|mesh-list
65691291|NCT03122132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65691292|NCT03122132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65691293|NCT03122132|Protease Inhibitors|protease inhibitors|mesh-ancestor
65691294|NCT03122132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691295|NCT03122132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691296|NCT03122132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65691297|NCT03122132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65691298|NCT03122132|Antiviral Agents|antiviral agents|mesh-ancestor
65691299|NCT03122132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691300|NCT03122132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65691301|NCT03122132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65691302|NCT03351686|Tranexamic Acid|tranexamic acid|mesh-list
65691303|NCT03351686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65691304|NCT03351686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65691305|NCT03351686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691306|NCT03351686|Hemostatics|hemostatics|mesh-ancestor
65691307|NCT03351686|Coagulants|coagulants|mesh-ancestor
65691308|NCT03347864|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
65691309|NCT03347864|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65691310|NCT03347864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691311|NCT02319018|Calcium, Dietary|calcium, dietary|mesh-list
65691312|NCT02319018|Leucovorin|leucovorin|mesh-list
65691313|NCT02319018|Folic Acid|folic acid|mesh-list
65691314|NCT02319018|Fluorouracil|fluorouracil|mesh-list
65691315|NCT02319018|Oxaliplatin|oxaliplatin|mesh-list
65691316|NCT02319018|Calcium|calcium|mesh-list
65488649|NCT00233987|Alkylating Agents|alkylating agents|mesh-ancestor
65691317|NCT02319018|Levoleucovorin|levoleucovorin|mesh-list
65691318|NCT02319018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65691319|NCT02319018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691320|NCT02319018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65691322|NCT02319018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691323|NCT02319018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65691324|NCT02319018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691325|NCT02319018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65691326|NCT02319018|Immunologic Factors|immunologic factors|mesh-ancestor
65691327|NCT02319018|Antidotes|antidotes|mesh-ancestor
65691328|NCT02319018|Protective Agents|protective agents|mesh-ancestor
65691329|NCT02319018|Vitamin B Complex|vitamin b complex|mesh-ancestor
65691330|NCT02319018|Vitamins|vitamins|mesh-ancestor
65691331|NCT02319018|Micronutrients|micronutrients|mesh-ancestor
65691332|NCT02319018|Hematinics|hematinics|mesh-ancestor
65691333|NCT02574520|Bupivacaine|bupivacaine|mesh-list
65691334|NCT02574520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65691335|NCT02574520|Anesthetics, Local|anesthetics, local|mesh-ancestor
65691336|NCT02574520|Anesthetics|anesthetics|mesh-ancestor
65691337|NCT02574520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65691338|NCT02574520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691339|NCT02574520|Sensory System Agents|sensory system agents|mesh-ancestor
65691340|NCT02574520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691341|NCT05043506|Palbociclib|palbociclib|mesh-list
65691342|NCT05043506|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65691343|NCT05043506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691344|NCT05043506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65691345|NCT05043506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691346|NCT05043506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691347|NCT05043506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65691348|NCT05043506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65691349|NCT05043506|Hormone Antagonists|hormone antagonists|mesh-ancestor
65691350|NCT05043506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65691351|NCT05043506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691352|NCT04425226|Pembrolizumab|pembrolizumab|mesh-list
65691353|NCT04425226|Lenvatinib|lenvatinib|mesh-list
65691354|NCT04425226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65691355|NCT04425226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691356|NCT04425226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65691357|NCT04425226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691358|NCT04425226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691359|NCT05520658|Fluorouracil|fluorouracil|mesh-list
65691360|NCT05520658|Digoxin|digoxin|mesh-list
65691361|NCT05520658|Furosemide|furosemide|mesh-list
65691362|NCT05520658|Antimetabolites|antimetabolites|mesh-ancestor
65691363|NCT05520658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691364|NCT05520658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65691365|NCT05520658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691366|NCT05520658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65691367|NCT05520658|Immunologic Factors|immunologic factors|mesh-ancestor
65691368|NCT05520658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691369|NCT05520658|Diuretics|diuretics|mesh-ancestor
65691370|NCT05520658|Natriuretic Agents|natriuretic agents|mesh-ancestor
65691371|NCT05520658|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65691372|NCT05520658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65691373|NCT05520658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65691374|NCT05520658|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65691375|NCT05520658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691376|NCT05520658|Protective Agents|protective agents|mesh-ancestor
65691377|NCT03351296|Bevacizumab|bevacizumab|mesh-list
65691378|NCT03351296|Capecitabine|capecitabine|mesh-list
65691379|NCT03351296|Temozolomide|temozolomide|mesh-list
65691380|NCT03351296|Streptozocin|streptozocin|mesh-list
65691381|NCT03351296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65691382|NCT03351296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691383|NCT03351296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65691384|NCT03351296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65691385|NCT03351296|Growth Substances|growth substances|mesh-ancestor
65691386|NCT03351296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691387|NCT03351296|Growth Inhibitors|growth inhibitors|mesh-ancestor
65691388|NCT03351296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65691389|NCT03351296|Antimetabolites|antimetabolites|mesh-ancestor
65691390|NCT03351296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488724|NCT00256295|Antiviral Agents|antiviral agents|mesh-ancestor
65691391|NCT03351296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65691392|NCT03351296|Alkylating Agents|alkylating agents|mesh-ancestor
65691393|NCT03351296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65691394|NCT04462926|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65691395|NCT04462926|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65691396|NCT04462926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691397|NCT05140954|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65691398|NCT05140954|Antiviral Agents|antiviral agents|mesh-ancestor
65691399|NCT05140954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691400|NCT05140954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65691401|NCT05140954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65691402|NCT05140954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691403|NCT05140954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691404|NCT05140954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65691405|NCT05140954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65691406|NCT05135650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65691407|NCT05135650|Antibodies|antibodies|mesh-list
65691408|NCT05135650|Immunoglobulins|immunoglobulins|mesh-list
65691409|NCT05135650|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65691410|NCT05135650|Immunologic Factors|immunologic factors|mesh-ancestor
65691411|NCT05135650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691412|NCT05135650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691413|NCT03351062|Tamoxifen|tamoxifen|mesh-list
65691414|NCT03351062|Toremifene|toremifene|mesh-list
65691415|NCT03351062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65691416|NCT03351062|Hormone Antagonists|hormone antagonists|mesh-ancestor
65691417|NCT03351062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65691418|NCT03351062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691419|NCT03351062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65691420|NCT03351062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691421|NCT03351062|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65691422|NCT03351062|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65691423|NCT03351062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65691424|NCT03496740|Bupivacaine|bupivacaine|mesh-list
65691425|NCT03496740|Anesthetics, Local|anesthetics, local|mesh-ancestor
65691426|NCT03496740|Anesthetics|anesthetics|mesh-ancestor
65691427|NCT03496740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65691428|NCT03496740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691429|NCT03496740|Sensory System Agents|sensory system agents|mesh-ancestor
65691430|NCT03496740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691431|NCT05515822|Oxycodone|oxycodone|mesh-list
65691432|NCT05515822|Dezocine|dezocine|mesh-list
65691433|NCT05515822|Esketamine|esketamine|mesh-list
65691434|NCT05515822|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65691435|NCT05515822|Narcotics|narcotics|mesh-ancestor
65691436|NCT05515822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65691437|NCT05515822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691438|NCT05515822|Analgesics|analgesics|mesh-ancestor
65691439|NCT05515822|Sensory System Agents|sensory system agents|mesh-ancestor
65691440|NCT05515822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691441|NCT05515822|Antidepressive Agents|antidepressive agents|mesh-ancestor
65691442|NCT05515822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65691443|NCT02325024|Nabiximols|nabiximols|mesh-list
65691444|NCT02325024|Analgesics|analgesics|mesh-ancestor
65691445|NCT02325024|Sensory System Agents|sensory system agents|mesh-ancestor
65691446|NCT02325024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691447|NCT02325024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691448|NCT04294654|Vortioxetine|vortioxetine|mesh-list
65691449|NCT04294654|Antidepressive Agents|antidepressive agents|mesh-ancestor
65691450|NCT04294654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65691451|NCT04294654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65691452|NCT04294654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65691453|NCT04294654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65691454|NCT04294654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691455|NCT04294654|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65691456|NCT04294654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65691457|NCT04294654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65691458|NCT04294654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691459|NCT04294654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65691460|NCT04294654|Serotonin Agents|serotonin agents|mesh-ancestor
65691461|NCT04294654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65691462|NCT04294654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65691463|NCT04294654|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65691464|NCT04294654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65691466|NCT03496506|Clopidogrel|clopidogrel|mesh-list
65691467|NCT03496506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65691468|NCT03496506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65691469|NCT03496506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65691470|NCT03496506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65691471|NCT03496506|Purinergic Agents|purinergic agents|mesh-ancestor
65691472|NCT03496506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65691473|NCT03496506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691474|NCT03496506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691475|NCT03496506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65691476|NCT04766684|Lidocaine|lidocaine|mesh-list
65691477|NCT04766684|Anesthetics, Local|anesthetics, local|mesh-ancestor
65691478|NCT04766684|Anesthetics|anesthetics|mesh-ancestor
65691479|NCT04766684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65691480|NCT04766684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691481|NCT04766684|Sensory System Agents|sensory system agents|mesh-ancestor
65691482|NCT04766684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691483|NCT04766684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65691484|NCT04766684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65691485|NCT04766684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65691486|NCT04766684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65691487|NCT04766684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691488|NCT02319564|Beclomethasone|beclomethasone|mesh-list
65691489|NCT02319564|Albuterol|albuterol|mesh-list
65691490|NCT02319564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65691491|NCT02319564|Autonomic Agents|autonomic agents|mesh-ancestor
65691492|NCT02319564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691493|NCT02319564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691494|NCT02319564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65691495|NCT02319564|Respiratory System Agents|respiratory system agents|mesh-ancestor
65691496|NCT02319564|Tocolytic Agents|tocolytic agents|mesh-ancestor
65691497|NCT02319564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65691498|NCT02319564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65691499|NCT02319564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65691500|NCT02319564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65691501|NCT02319564|Adrenergic Agents|adrenergic agents|mesh-ancestor
65691502|NCT02319564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65691503|NCT02319564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691504|NCT02319564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65691505|NCT02319564|Glucocorticoids|glucocorticoids|mesh-ancestor
65691506|NCT02319564|Hormones|hormones|mesh-ancestor
65268982|NCT02746250|Antidepressive Agents|antidepressive agents|mesh-list
65691507|NCT02319564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65691508|NCT05056402|Vaccines|vaccines|mesh-list
65691509|NCT05056402|Immunologic Factors|immunologic factors|mesh-ancestor
65691510|NCT05056402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691511|NCT02325180|Lumefantrine|lumefantrine|mesh-list
65691512|NCT02325180|Artemether|artemether|mesh-list
65691513|NCT02325180|Piperaquine|piperaquine|mesh-list
65691514|NCT02325180|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65691515|NCT02325180|Artenimol|artenimol|mesh-list
65691516|NCT02325180|Antimalarials|antimalarials|mesh-ancestor
65691517|NCT02325180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65691518|NCT02325180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65691519|NCT02325180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691520|NCT00709592|Mycophenolic Acid|mycophenolic acid|mesh-list
65691521|NCT00709592|Tacrolimus|tacrolimus|mesh-list
65691522|NCT00709592|Thymoglobulin|thymoglobulin|mesh-list
65691523|NCT00709592|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65691524|NCT00709592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65691525|NCT00709592|Immunologic Factors|immunologic factors|mesh-ancestor
65691526|NCT00709592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691527|NCT00709592|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65691528|NCT00709592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691529|NCT00709592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691530|NCT00709592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65691531|NCT00709592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691532|NCT00709592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65691533|NCT00709592|Antitubercular Agents|antitubercular agents|mesh-ancestor
65691534|NCT00709592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65691535|NCT00709592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691536|NCT05515354|Nicotine|nicotine|mesh-list
65691537|NCT05515354|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65691538|NCT05515354|Autonomic Agents|autonomic agents|mesh-ancestor
65488872|NCT03066622|Olanzapine|olanzapine|mesh-list
65691539|NCT05515354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691540|NCT05515354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691542|NCT05515354|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65691543|NCT05515354|Cholinergic Agents|cholinergic agents|mesh-ancestor
65691544|NCT05515354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65691545|NCT05515354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691546|NCT02437370|Gemcitabine|gemcitabine|mesh-list
65691547|NCT02437370|Docetaxel|docetaxel|mesh-list
65691548|NCT02437370|Pembrolizumab|pembrolizumab|mesh-list
65691549|NCT02437370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65691550|NCT02437370|Antimetabolites|antimetabolites|mesh-ancestor
65691551|NCT02437370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691552|NCT02437370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691553|NCT02437370|Antiviral Agents|antiviral agents|mesh-ancestor
65691554|NCT02437370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691555|NCT02437370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691556|NCT02437370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65691557|NCT02437370|Immunologic Factors|immunologic factors|mesh-ancestor
65691558|NCT02437370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691559|NCT02437370|Tubulin Modulators|tubulin modulators|mesh-ancestor
65691560|NCT02437370|Antimitotic Agents|antimitotic agents|mesh-ancestor
65691561|NCT02437370|Mitosis Modulators|mitosis modulators|mesh-ancestor
65691562|NCT02437370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65691563|NCT05515120|Aspirin|aspirin|mesh-list
65691564|NCT05515120|Vitamin K|vitamin k|mesh-list
65691565|NCT05515120|Rivaroxaban|rivaroxaban|mesh-list
65691566|NCT05515120|Acenocoumarol|acenocoumarol|mesh-list
65691567|NCT05515120|Vitamins|vitamins|mesh-ancestor
65691568|NCT05515120|Micronutrients|micronutrients|mesh-ancestor
65691569|NCT05515120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691570|NCT05515120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65691571|NCT05515120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65691572|NCT05515120|Analgesics|analgesics|mesh-ancestor
65691573|NCT05515120|Sensory System Agents|sensory system agents|mesh-ancestor
65691574|NCT05515120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691575|NCT05515120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65691576|NCT05515120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65691577|NCT05515120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65691578|NCT05515120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65691579|NCT05515120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691580|NCT05515120|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65691581|NCT05515120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65691582|NCT05515120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691583|NCT05515120|Antipyretics|antipyretics|mesh-ancestor
65691584|NCT05515120|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65691585|NCT05515120|Antithrombins|antithrombins|mesh-ancestor
65691586|NCT05515120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65691587|NCT05515120|Protease Inhibitors|protease inhibitors|mesh-ancestor
65691588|NCT05515120|Anticoagulants|anticoagulants|mesh-ancestor
65691589|NCT05515120|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65691590|NCT05515120|Hemostatics|hemostatics|mesh-ancestor
65691591|NCT05515120|Coagulants|coagulants|mesh-ancestor
65691592|NCT02323230|Cyclophosphamide|cyclophosphamide|mesh-list
65691593|NCT02323230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65691594|NCT02323230|Immunologic Factors|immunologic factors|mesh-ancestor
65691595|NCT02323230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691596|NCT02323230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65691597|NCT02323230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65691598|NCT02323230|Alkylating Agents|alkylating agents|mesh-ancestor
65691599|NCT02323230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691600|NCT02323230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691601|NCT02323230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65691602|NCT04657640|Iron|iron|mesh-list
65691603|NCT04657640|Trace Elements|trace elements|mesh-list
65691604|NCT04657640|Folic Acid|folic acid|mesh-list
65691605|NCT04657640|Micronutrients|micronutrients|mesh-list
65691606|NCT04657640|Vitamin B Complex|vitamin b complex|mesh-list
65691607|NCT04657640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691608|NCT04657640|Hematinics|hematinics|mesh-ancestor
65691609|NCT04657640|Vitamins|vitamins|mesh-ancestor
65691610|NCT05042128|Gemcitabine|gemcitabine|mesh-list
65691611|NCT05042128|Paclitaxel|paclitaxel|mesh-list
65691612|NCT05042128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65691613|NCT05042128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691614|NCT05042128|Tubulin Modulators|tubulin modulators|mesh-ancestor
65691615|NCT05042128|Antimitotic Agents|antimitotic agents|mesh-ancestor
65691616|NCT05042128|Mitosis Modulators|mitosis modulators|mesh-ancestor
65691617|NCT05042128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691618|NCT05042128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65691620|NCT05042128|Antiviral Agents|antiviral agents|mesh-ancestor
65691621|NCT05042128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691622|NCT05042128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691623|NCT05042128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65691624|NCT05042128|Immunologic Factors|immunologic factors|mesh-ancestor
65691625|NCT05042128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691626|NCT03495804|Mannitol|mannitol|mesh-list
65691627|NCT03495804|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65691628|NCT03495804|Diuretics|diuretics|mesh-ancestor
65691629|NCT03495804|Natriuretic Agents|natriuretic agents|mesh-ancestor
65691630|NCT03495804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691631|NCT05519410|Lenvatinib|lenvatinib|mesh-list
65691632|NCT05519410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691633|NCT05519410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65691634|NCT05519410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691635|NCT05519410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691636|NCT05578586|Meropenem|meropenem|mesh-list
65691637|NCT05578586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65691638|NCT05578586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691639|NCT02570074|Fosfomycin|fosfomycin|mesh-list
65691640|NCT02570074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65691641|NCT02570074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691642|NCT02569996|Rituximab|rituximab|mesh-list
65691643|NCT02569996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65691644|NCT02569996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691645|NCT02569996|Immunologic Factors|immunologic factors|mesh-ancestor
65691646|NCT02569996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691647|NCT02569996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65691648|NCT02325882|Fentanyl|fentanyl|mesh-list
65691649|NCT02325882|Dexmedetomidine|dexmedetomidine|mesh-list
65691650|NCT02325882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65691651|NCT02325882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65691652|NCT02325882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691653|NCT02325882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65691654|NCT02325882|Analgesics|analgesics|mesh-ancestor
65691655|NCT02325882|Sensory System Agents|sensory system agents|mesh-ancestor
65691656|NCT02325882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691657|NCT02325882|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65691658|NCT02325882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65691659|NCT02325882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65691660|NCT02325882|Adrenergic Agents|adrenergic agents|mesh-ancestor
65691661|NCT02325882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65691662|NCT02325882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691663|NCT02325882|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65691664|NCT02325882|Narcotics|narcotics|mesh-ancestor
65691665|NCT02325882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65691666|NCT02325882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65691667|NCT02325882|Anesthetics, General|anesthetics, general|mesh-ancestor
65691668|NCT02325882|Anesthetics|anesthetics|mesh-ancestor
65691669|NCT00708500|Interferons|interferons|mesh-list
65691670|NCT00708500|Ribavirin|ribavirin|mesh-list
65691671|NCT00708500|Interferon-alpha|interferon-alpha|mesh-list
65691672|NCT00708500|Interferon alpha-2|interferon alpha-2|mesh-list
65691673|NCT00708500|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65691674|NCT00708500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691675|NCT00708500|Antiviral Agents|antiviral agents|mesh-ancestor
65691676|NCT00708500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691677|NCT00708500|Antimetabolites|antimetabolites|mesh-ancestor
65691678|NCT00708500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691679|NCT00708500|Immunologic Factors|immunologic factors|mesh-ancestor
65691680|NCT00708500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691681|NCT05144100|Cisplatin|cisplatin|mesh-list
65691682|NCT05144100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691683|NCT02320032|Aripiprazole|aripiprazole|mesh-list
65691684|NCT02320032|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
65691685|NCT02320032|Antidepressive Agents|antidepressive agents|mesh-ancestor
65691686|NCT02320032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65691687|NCT02320032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65691688|NCT02320032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65691689|NCT02320032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65691690|NCT02320032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691691|NCT02320032|Dopamine Agonists|dopamine agonists|mesh-ancestor
65691692|NCT02320032|Dopamine Agents|dopamine agents|mesh-ancestor
65691693|NCT02320032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65691694|NCT02320032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691695|NCT02320032|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65691696|NCT02320032|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65691697|NCT02320032|Serotonin Agents|serotonin agents|mesh-ancestor
65691698|NCT02320032|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65691699|NCT02320032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65691700|NCT02320032|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65691701|NCT02320032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65691702|NCT05514652|Analgesics, Opioid|analgesics, opioid|mesh-list
65691703|NCT05514652|Anesthetics|anesthetics|mesh-list
65691704|NCT05514652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65691705|NCT05514652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691706|NCT05514652|Narcotics|narcotics|mesh-ancestor
65691707|NCT05514652|Analgesics|analgesics|mesh-ancestor
65691708|NCT05514652|Sensory System Agents|sensory system agents|mesh-ancestor
65691709|NCT05514652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691710|NCT00673244|Furosemide|furosemide|mesh-list
65691711|NCT00673244|Diuretics|diuretics|mesh-ancestor
65691712|NCT00673244|Natriuretic Agents|natriuretic agents|mesh-ancestor
65691713|NCT00673244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691714|NCT00673244|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65691715|NCT00673244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65691716|NCT00673244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691717|NCT02517788|Interferons|interferons|mesh-list
65691718|NCT02517788|Interferon-beta|interferon-beta|mesh-list
65691719|NCT02517788|Interferon beta-1a|interferon beta-1a|mesh-list
65691720|NCT02517788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691721|NCT02517788|Antiviral Agents|antiviral agents|mesh-ancestor
65691722|NCT02517788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691723|NCT02517788|Immunologic Factors|immunologic factors|mesh-ancestor
65691724|NCT02517788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691725|NCT02517788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65691726|NCT04599790|Lenvatinib|lenvatinib|mesh-list
65691727|NCT04599790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691728|NCT04599790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65691729|NCT04599790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691730|NCT04599790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691731|NCT03132168|Anesthetics|anesthetics|mesh-list
65691732|NCT03132168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65691733|NCT03132168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691734|NCT04937062|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
65691735|NCT04937062|Glycerol|glycerol|mesh-list
65691736|NCT04937062|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65691737|NCT04937062|Protective Agents|protective agents|mesh-ancestor
65691738|NCT04937062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691739|NCT04937062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691740|NCT02324010|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65691741|NCT02324010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65691742|NCT02324010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691743|NCT02324010|Incretins|incretins|mesh-ancestor
65691744|NCT02324010|Hormones|hormones|mesh-ancestor
65691745|NCT02324010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65691746|NCT02324010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65691747|NCT02324010|Protease Inhibitors|protease inhibitors|mesh-ancestor
65691748|NCT02324010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691749|NCT02324010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691750|NCT02320734|Rocuronium|rocuronium|mesh-list
65691751|NCT02320734|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65691752|NCT02320734|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65691753|NCT02320734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65691754|NCT02320734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691755|NCT02320734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691756|NCT03346226|Dexmedetomidine|dexmedetomidine|mesh-list
65691757|NCT03346226|Propofol|propofol|mesh-list
65691758|NCT03346226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65691759|NCT03346226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65691760|NCT03346226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691761|NCT03346226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65691762|NCT03346226|Anesthetics, General|anesthetics, general|mesh-ancestor
65691763|NCT03346226|Anesthetics|anesthetics|mesh-ancestor
65691764|NCT03346226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65691765|NCT03346226|Analgesics|analgesics|mesh-ancestor
65691766|NCT03346226|Sensory System Agents|sensory system agents|mesh-ancestor
65691767|NCT03346226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691768|NCT03346226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65691769|NCT03346226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65691770|NCT03346226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65691771|NCT03346226|Adrenergic Agents|adrenergic agents|mesh-ancestor
65691772|NCT03346226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65691773|NCT03346226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691774|NCT03347240|Baclofen|baclofen|mesh-list
65691775|NCT03347240|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65691776|NCT03347240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691777|NCT03347240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65691778|NCT03347240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691779|NCT03347240|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65691780|NCT03347240|GABA Agonists|gaba agonists|mesh-ancestor
65691781|NCT03347240|GABA Agents|gaba agents|mesh-ancestor
65691782|NCT03347240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65691783|NCT03347240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691784|NCT02324088|Cyclophosphamide|cyclophosphamide|mesh-list
65691785|NCT02324088|Docetaxel|docetaxel|mesh-list
65691786|NCT02324088|Epirubicin|epirubicin|mesh-list
65691787|NCT02324088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65691788|NCT02324088|Immunologic Factors|immunologic factors|mesh-ancestor
65691789|NCT02324088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691790|NCT02324088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65691791|NCT02324088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65691792|NCT02324088|Alkylating Agents|alkylating agents|mesh-ancestor
65691793|NCT02324088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691794|NCT02324088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691795|NCT02324088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65691796|NCT02324088|Tubulin Modulators|tubulin modulators|mesh-ancestor
65691797|NCT02324088|Antimitotic Agents|antimitotic agents|mesh-ancestor
65691798|NCT02324088|Mitosis Modulators|mitosis modulators|mesh-ancestor
65691799|NCT02324088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65691800|NCT02324088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65691801|NCT02324088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65691802|NCT02324088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691803|NCT02324166|Cefazolin|cefazolin|mesh-list
65691804|NCT02324166|Lidocaine|lidocaine|mesh-list
65691805|NCT02324166|Anesthetics, Local|anesthetics, local|mesh-ancestor
65691806|NCT02324166|Anesthetics|anesthetics|mesh-ancestor
65691807|NCT02324166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65154459|NCT04258423|Everolimus|everolimus|mesh-list
65691808|NCT02324166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691809|NCT02324166|Sensory System Agents|sensory system agents|mesh-ancestor
65691810|NCT02324166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691811|NCT02324166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65691812|NCT02324166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65691813|NCT02324166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65691814|NCT02324166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65691815|NCT02324166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691816|NCT02324166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65691817|NCT02324166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691818|NCT03346538|Edaravone|edaravone|mesh-list
65691819|NCT03346538|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65691820|NCT03346538|Antioxidants|antioxidants|mesh-ancestor
65691821|NCT03346538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691822|NCT03346538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65691823|NCT03346538|Protective Agents|protective agents|mesh-ancestor
65691824|NCT03346538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691825|NCT02513342|Docetaxel|docetaxel|mesh-list
65691826|NCT02513342|Endostar protein|endostar protein|mesh-list
65691827|NCT02513342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691828|NCT02513342|Tubulin Modulators|tubulin modulators|mesh-ancestor
65691829|NCT02513342|Antimitotic Agents|antimitotic agents|mesh-ancestor
65691830|NCT02513342|Mitosis Modulators|mitosis modulators|mesh-ancestor
65691831|NCT02513342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691832|NCT02513342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65691833|NCT02513342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65691834|NCT02513342|Growth Substances|growth substances|mesh-ancestor
65691835|NCT02513342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691836|NCT02513342|Growth Inhibitors|growth inhibitors|mesh-ancestor
65691837|NCT03495024|Varenicline|varenicline|mesh-list
65691838|NCT03495024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65691839|NCT03495024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65691840|NCT03495024|Cholinergic Agents|cholinergic agents|mesh-ancestor
65691841|NCT03495024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65489172|NCT03972683|Phenylephrine|phenylephrine|mesh-list
65691842|NCT03495024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691843|NCT03495024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691845|NCT04188314|Isoflurane|isoflurane|mesh-list
65691846|NCT04188314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65691847|NCT04188314|Anesthetics, General|anesthetics, general|mesh-ancestor
65691848|NCT04188314|Anesthetics|anesthetics|mesh-ancestor
65691849|NCT04188314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65691850|NCT04188314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691851|NCT05512780|Letrozole|letrozole|mesh-list
65691852|NCT05512780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691853|NCT05512780|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65691854|NCT05512780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65691855|NCT05512780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691856|NCT05512780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691857|NCT05512780|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65691858|NCT05512780|Hormone Antagonists|hormone antagonists|mesh-ancestor
65691859|NCT05512780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65691860|NCT05512780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691861|NCT02517164|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65691862|NCT02517164|Calcifediol|calcifediol|mesh-list
65691863|NCT02517164|Vitamins|vitamins|mesh-ancestor
65691864|NCT02517164|Micronutrients|micronutrients|mesh-ancestor
65691865|NCT02517164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691866|NCT02517164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65691867|NCT04834362|Insulin|insulin|mesh-list
65691868|NCT04834362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65691869|NCT04834362|Insulin Glargine|insulin glargine|mesh-list
65691870|NCT04834362|Insulin Aspart|insulin aspart|mesh-list
65691871|NCT04834362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65691872|NCT04834362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691873|NCT05512702|Heparin|heparin|mesh-list
65691874|NCT05512702|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65691875|NCT05512702|Plasminogen|plasminogen|mesh-list
65691876|NCT05512702|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65691877|NCT05512702|Tinzaparin|tinzaparin|mesh-list
65691878|NCT05512702|Dalteparin|dalteparin|mesh-list
65691879|NCT05512702|Anticoagulants|anticoagulants|mesh-ancestor
65691880|NCT05512702|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65691881|NCT05512702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65268989|NCT02746250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691882|NCT05512702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691883|NCT05512546|Aspirin|aspirin|mesh-list
65691884|NCT05512546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65691885|NCT05512546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65691886|NCT05512546|Analgesics|analgesics|mesh-ancestor
65691887|NCT05512546|Sensory System Agents|sensory system agents|mesh-ancestor
65691888|NCT05512546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691889|NCT05512546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691890|NCT05512546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65691891|NCT05512546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65691892|NCT05512546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65691893|NCT05512546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65691894|NCT05512546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691895|NCT05512546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65691896|NCT05512546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65691897|NCT05512546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691898|NCT05512546|Antipyretics|antipyretics|mesh-ancestor
65691899|NCT04681482|Apixaban|apixaban|mesh-list
65691900|NCT04681482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65691901|NCT04681482|Antithrombins|antithrombins|mesh-ancestor
65691902|NCT04681482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65691903|NCT04681482|Protease Inhibitors|protease inhibitors|mesh-ancestor
65691904|NCT04681482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691905|NCT04681482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691906|NCT04681482|Anticoagulants|anticoagulants|mesh-ancestor
65691907|NCT03345134|Pembrolizumab|pembrolizumab|mesh-list
65691908|NCT03345134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65691909|NCT03345134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691910|NCT04770532|Insulin|insulin|mesh-list
65691911|NCT04770532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65691912|NCT04770532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65691913|NCT04770532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691914|NCT02512562|Simeprevir|simeprevir|mesh-list
65691915|NCT02512562|Odalasvir|odalasvir|mesh-list
65691916|NCT02512562|Antiviral Agents|antiviral agents|mesh-ancestor
65691917|NCT02512562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691918|NCT02512562|Protease Inhibitors|protease inhibitors|mesh-ancestor
65691919|NCT02512562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691920|NCT02512562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691922|NCT02516774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65691923|NCT02516774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65691924|NCT05510986|Fentanyl|fentanyl|mesh-list
65691925|NCT05510986|Oxycodone|oxycodone|mesh-list
65691926|NCT05510986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65691927|NCT05510986|Narcotics|narcotics|mesh-ancestor
65691928|NCT05510986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65691929|NCT05510986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691930|NCT05510986|Analgesics|analgesics|mesh-ancestor
65691931|NCT05510986|Sensory System Agents|sensory system agents|mesh-ancestor
65691932|NCT05510986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691933|NCT05510986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65691934|NCT05510986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65691935|NCT05510986|Anesthetics, General|anesthetics, general|mesh-ancestor
65691936|NCT05510986|Anesthetics|anesthetics|mesh-ancestor
65691937|NCT04872400|Vancomycin|vancomycin|mesh-list
65691938|NCT04872400|Tobramycin|tobramycin|mesh-list
65691939|NCT04872400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65691940|NCT04872400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691941|NCT02151084|Gemcitabine|gemcitabine|mesh-list
65691942|NCT02151084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691943|NCT02151084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65691944|NCT02151084|Antimetabolites|antimetabolites|mesh-ancestor
65691945|NCT02151084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691946|NCT02151084|Antiviral Agents|antiviral agents|mesh-ancestor
65691947|NCT02151084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691948|NCT02151084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691949|NCT02151084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65691950|NCT02151084|Immunologic Factors|immunologic factors|mesh-ancestor
65691951|NCT02151084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691952|NCT00101907|Gemcitabine|gemcitabine|mesh-list
65691953|NCT00101907|Panitumumab|panitumumab|mesh-list
65691954|NCT00101907|Motesanib diphosphate|motesanib diphosphate|mesh-list
65691955|NCT00101907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691956|NCT00101907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65691957|NCT00101907|Antimetabolites|antimetabolites|mesh-ancestor
65268990|NCT02746250|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65691958|NCT00101907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691959|NCT00101907|Antiviral Agents|antiviral agents|mesh-ancestor
65691960|NCT00101907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691961|NCT00101907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691962|NCT00101907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65691963|NCT00101907|Immunologic Factors|immunologic factors|mesh-ancestor
65691964|NCT00101907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691965|NCT00101907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65691966|NCT00101907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65691967|NCT03491748|Cefpodoxime|cefpodoxime|mesh-list
65691968|NCT03491748|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
65691969|NCT03491748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65691970|NCT03491748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691971|NCT04769206|Galantamine|galantamine|mesh-list
65691972|NCT04769206|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65691973|NCT04769206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691974|NCT04769206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691975|NCT04769206|Cholinergic Agents|cholinergic agents|mesh-ancestor
65691976|NCT04769206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65691977|NCT04769206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65691978|NCT04769206|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65691979|NCT04769206|Autonomic Agents|autonomic agents|mesh-ancestor
65691980|NCT04769206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65691981|NCT04769206|Nootropic Agents|nootropic agents|mesh-ancestor
65691982|NCT03492996|Delpazolid|delpazolid|mesh-list
65691983|NCT03492996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65691984|NCT03492996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65691985|NCT03492996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65691986|NCT03492996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65691987|NCT03492996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65691988|NCT03772028|Cisplatin|cisplatin|mesh-list
65691989|NCT03772028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65691990|NCT02161965|Warfarin|warfarin|mesh-list
65691991|NCT02161965|Rivaroxaban|rivaroxaban|mesh-list
65691992|NCT02161965|Fluindione|fluindione|mesh-list
65691993|NCT02161965|Phenindione|phenindione|mesh-list
65691994|NCT02161965|Anticoagulants|anticoagulants|mesh-ancestor
65691995|NCT02161965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65691996|NCT02161965|Antithrombins|antithrombins|mesh-ancestor
65691997|NCT02161965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65691998|NCT02161965|Protease Inhibitors|protease inhibitors|mesh-ancestor
65691999|NCT02161965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692000|NCT02161965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692002|NCT02050308|Varenicline|varenicline|mesh-list
65692003|NCT02050308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65692004|NCT02050308|Autonomic Agents|autonomic agents|mesh-ancestor
65692005|NCT02050308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692006|NCT02050308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692007|NCT02050308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65692008|NCT02050308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65692009|NCT02050308|Cholinergic Agents|cholinergic agents|mesh-ancestor
65692010|NCT02050308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65692011|NCT02050308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692012|NCT02516618|Fasinumab|fasinumab|mesh-list
65692013|NCT02516618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65692014|NCT02516618|Analgesics|analgesics|mesh-ancestor
65692015|NCT02516618|Sensory System Agents|sensory system agents|mesh-ancestor
65692016|NCT02516618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692017|NCT02516618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692018|NCT05507554|Analgesics|analgesics|mesh-list
65692019|NCT05507554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
65692020|NCT05507554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692021|NCT05507554|Sensory System Agents|sensory system agents|mesh-ancestor
65692022|NCT05507554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692023|NCT02516462|Hormones|hormones|mesh-list
65692024|NCT02516462|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65692025|NCT02516462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65692026|NCT02516462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692027|NCT04650204|Anticonvulsants|anticonvulsants|mesh-list
65692028|NCT04501250|Insulin|insulin|mesh-list
65692029|NCT04501250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65692030|NCT04501250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65692031|NCT04501250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692032|NCT02761629|Interferons|interferons|mesh-list
65692033|NCT02761629|Ribavirin|ribavirin|mesh-list
65692034|NCT02761629|Interferon-alpha|interferon-alpha|mesh-list
65692035|NCT02761629|Interferon alpha-2|interferon alpha-2|mesh-list
65692036|NCT02761629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65692037|NCT02761629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692038|NCT02761629|Antiviral Agents|antiviral agents|mesh-ancestor
65692039|NCT02761629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65692040|NCT02761629|Antimetabolites|antimetabolites|mesh-ancestor
65692041|NCT02761629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692042|NCT02761629|Immunologic Factors|immunologic factors|mesh-ancestor
65692043|NCT02761629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692044|NCT03345992|Clarithromycin|clarithromycin|mesh-list
65692045|NCT03345992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65692046|NCT03345992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65692047|NCT03345992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65692048|NCT03345992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692049|NCT03345992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692050|NCT03345992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65692051|NCT03345992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65692052|NCT02162121|Ketorolac|ketorolac|mesh-list
65692053|NCT02162121|Buprenorphine|buprenorphine|mesh-list
65692054|NCT02162121|Anesthetics|anesthetics|mesh-list
65692055|NCT02162121|Ropivacaine|ropivacaine|mesh-list
65692056|NCT02162121|Levobupivacaine|levobupivacaine|mesh-list
65692057|NCT02162121|Mepivacaine|mepivacaine|mesh-list
65692058|NCT02162121|Anesthetics, Local|anesthetics, local|mesh-list
65692059|NCT02162121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65692060|NCT02162121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692061|NCT02162121|Sensory System Agents|sensory system agents|mesh-ancestor
65692062|NCT02162121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692063|NCT02162121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65692064|NCT02162121|Narcotics|narcotics|mesh-ancestor
65692065|NCT02162121|Analgesics|analgesics|mesh-ancestor
65692066|NCT02162121|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65692067|NCT02162121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65692068|NCT02162121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65692069|NCT02162121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65692070|NCT02162121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65692071|NCT02162121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65692072|NCT02162121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692073|NCT02162121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692074|NCT02511704|Nicotine|nicotine|mesh-list
65692075|NCT02511704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65692076|NCT02511704|Autonomic Agents|autonomic agents|mesh-ancestor
65692077|NCT02511704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692078|NCT02511704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692079|NCT02511704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65692080|NCT02511704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65692081|NCT02511704|Cholinergic Agents|cholinergic agents|mesh-ancestor
65692082|NCT02511704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65692083|NCT02511704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692084|NCT04500704|Carboplatin|carboplatin|mesh-list
65692085|NCT04500704|Pemetrexed|pemetrexed|mesh-list
65692086|NCT04500704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692087|NCT04500704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692088|NCT04500704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692089|NCT04500704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65692090|NCT04500704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65692091|NCT02164773|Magnesium Sulfate|magnesium sulfate|mesh-list
65692092|NCT02164773|Analgesics|analgesics|mesh-ancestor
65692093|NCT02164773|Sensory System Agents|sensory system agents|mesh-ancestor
65692094|NCT02164773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692095|NCT02164773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692096|NCT02164773|Anesthetics|anesthetics|mesh-ancestor
65692097|NCT02164773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65692098|NCT02164773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65692099|NCT02164773|Anticonvulsants|anticonvulsants|mesh-ancestor
65692100|NCT02164773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65692101|NCT02164773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65692102|NCT02164773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692103|NCT02164773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65692104|NCT02164773|Tocolytic Agents|tocolytic agents|mesh-ancestor
65692105|NCT02164773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65692106|NCT00101439|Ezetimibe|ezetimibe|mesh-list
65692107|NCT00101439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65692108|NCT00101439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65692109|NCT00101439|Antimetabolites|antimetabolites|mesh-ancestor
65692110|NCT00101439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692111|NCT00101439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65692112|NCT03344822|Choline|choline|mesh-list
65692113|NCT03344822|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65692114|NCT03344822|Lipotropic Agents|lipotropic agents|mesh-ancestor
65692115|NCT03344822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65692116|NCT03344822|Antimetabolites|antimetabolites|mesh-ancestor
65692117|NCT03344822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692118|NCT03344822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65692119|NCT03344822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65692120|NCT03344822|Nootropic Agents|nootropic agents|mesh-ancestor
65692121|NCT03344822|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65692122|NCT02162745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65692123|NCT02506790|Toremifene|toremifene|mesh-list
65692124|NCT02506790|Metformin|metformin|mesh-list
65692125|NCT02506790|Melatonin|melatonin|mesh-list
65692126|NCT02506790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65692127|NCT02506790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692128|NCT02506790|Antioxidants|antioxidants|mesh-ancestor
65692129|NCT02506790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692130|NCT02506790|Protective Agents|protective agents|mesh-ancestor
65692131|NCT02506790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65692132|NCT02506790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65692133|NCT02506790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692134|NCT02506790|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65692135|NCT02506790|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65692136|NCT02506790|Hormone Antagonists|hormone antagonists|mesh-ancestor
65692137|NCT02506790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65692138|NCT02506790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65692139|NCT04500002|Isoniazid|isoniazid|mesh-list
65692140|NCT04500002|Misoprostol|misoprostol|mesh-list
65692141|NCT04500002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65692142|NCT04500002|Abortifacient Agents|abortifacient agents|mesh-ancestor
65692143|NCT04500002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65692144|NCT04500002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692145|NCT04500002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65692146|NCT04500002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65692148|NCT04500002|Antitubercular Agents|antitubercular agents|mesh-ancestor
65692149|NCT04500002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65692150|NCT04500002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65692151|NCT04500002|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65692152|NCT04500002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65692153|NCT04500002|Antimetabolites|antimetabolites|mesh-ancestor
65692154|NCT04500002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692155|NCT04500002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65692156|NCT02515682|Equol|equol|mesh-list
65692157|NCT02515682|Phytoestrogens|phytoestrogens|mesh-ancestor
65692158|NCT02515682|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65692159|NCT02515682|Estrogens|estrogens|mesh-ancestor
65692160|NCT02515682|Hormones|hormones|mesh-ancestor
65692161|NCT02515682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65692162|NCT02515682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692163|NCT02515604|Misoprostol|misoprostol|mesh-list
65692164|NCT02515604|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65692165|NCT02515604|Abortifacient Agents|abortifacient agents|mesh-ancestor
65692166|NCT02515604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65692167|NCT02515604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692168|NCT02515604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65692169|NCT02515604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65692170|NCT02515604|Oxytocics|oxytocics|mesh-ancestor
65692171|NCT02510534|Menotropins|menotropins|mesh-list
65692172|NCT02510534|Progesterone|progesterone|mesh-list
65692173|NCT02510534|Progestins|progestins|mesh-ancestor
65692174|NCT02510534|Hormones|hormones|mesh-ancestor
65692175|NCT02510534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65692176|NCT02510534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692177|NCT02510534|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65692178|NCT02510534|Fertility Agents|fertility agents|mesh-ancestor
65692179|NCT02510534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65692180|NCT02510612|Dexmedetomidine|dexmedetomidine|mesh-list
65692181|NCT02510612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65692182|NCT02510612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65692183|NCT02510612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692184|NCT02510612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65692185|NCT02510612|Analgesics|analgesics|mesh-ancestor
65692186|NCT02510612|Sensory System Agents|sensory system agents|mesh-ancestor
65692187|NCT02510612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692188|NCT02510612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65692189|NCT02510612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65692190|NCT02510612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65692191|NCT02510612|Adrenergic Agents|adrenergic agents|mesh-ancestor
65692192|NCT02510612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65692193|NCT02510612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692194|NCT03749616|Acetaminophen|acetaminophen|mesh-list
65692195|NCT03749616|Ibuprofen|ibuprofen|mesh-list
65692196|NCT03749616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65692197|NCT03749616|Analgesics|analgesics|mesh-ancestor
65692198|NCT03749616|Sensory System Agents|sensory system agents|mesh-ancestor
65692199|NCT03749616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692200|NCT03749616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692201|NCT03749616|Antipyretics|antipyretics|mesh-ancestor
65692202|NCT03749616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65692203|NCT03749616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65692204|NCT03749616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65692205|NCT03749616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65692206|NCT03749616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692207|NCT03749616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692208|NCT00101283|Gemcitabine|gemcitabine|mesh-list
65692209|NCT00101283|Carboplatin|carboplatin|mesh-list
65692210|NCT00101283|Pemetrexed|pemetrexed|mesh-list
65692211|NCT00101283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692212|NCT00101283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65692213|NCT00101283|Antimetabolites|antimetabolites|mesh-ancestor
65692214|NCT00101283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692215|NCT00101283|Antiviral Agents|antiviral agents|mesh-ancestor
65692216|NCT00101283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65692217|NCT00101283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692218|NCT00101283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65692219|NCT00101283|Immunologic Factors|immunologic factors|mesh-ancestor
65692220|NCT00101283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692221|NCT00101283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65692222|NCT00101283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65692223|NCT04532502|Anesthetics|anesthetics|mesh-list
65692224|NCT04532502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
65692225|NCT04532502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65692226|NCT04532502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692227|NCT04532502|Anesthetics, General|anesthetics, general|mesh-ancestor
65692228|NCT02515526|Tolbutamide|tolbutamide|mesh-list
65692230|NCT02515526|Digoxin|digoxin|mesh-list
65692231|NCT02515526|Midazolam|midazolam|mesh-list
65692232|NCT02515526|Dextromethorphan|dextromethorphan|mesh-list
65692233|NCT02515526|Caffeine|caffeine|mesh-list
65692234|NCT02515526|Omeprazole|omeprazole|mesh-list
65692235|NCT02515526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65692236|NCT02515526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65692237|NCT02515526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65692238|NCT02515526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692239|NCT02515526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65692240|NCT02515526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65692241|NCT02515526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65692242|NCT02515526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65692243|NCT02515526|Anesthetics, General|anesthetics, general|mesh-ancestor
65692244|NCT02515526|Anesthetics|anesthetics|mesh-ancestor
65692245|NCT02515526|GABA Modulators|gaba modulators|mesh-ancestor
65692246|NCT02515526|GABA Agents|gaba agents|mesh-ancestor
65692247|NCT02515526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65692248|NCT02515526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692249|NCT02515526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65692250|NCT02515526|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65692251|NCT02515526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692252|NCT02515526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65692253|NCT02515526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65692254|NCT02515526|Purinergic Agents|purinergic agents|mesh-ancestor
65692255|NCT02515526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65692256|NCT02515526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65692257|NCT02515526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65692258|NCT02515526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65692259|NCT02515526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65154906|NCT00910039|Sunitinib|sunitinib|mesh-list
65692260|NCT02515526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65692261|NCT02515526|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65692262|NCT02515526|Protective Agents|protective agents|mesh-ancestor
65692263|NCT02515526|Antitussive Agents|antitussive agents|mesh-ancestor
65692264|NCT02515526|Respiratory System Agents|respiratory system agents|mesh-ancestor
65692265|NCT02515526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65692266|NCT02515526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65692267|NCT02515526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65692268|NCT02515448|Gentamicins|gentamicins|mesh-list
65692269|NCT02515448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65692270|NCT02515448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65692271|NCT02515448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65692272|NCT02515448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692273|NCT02515448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692274|NCT02170857|Hyaluronic Acid|hyaluronic acid|mesh-list
65692275|NCT02170857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65692276|NCT02170857|Immunologic Factors|immunologic factors|mesh-ancestor
65692277|NCT02170857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692278|NCT02170857|Viscosupplements|viscosupplements|mesh-ancestor
65692279|NCT02170857|Protective Agents|protective agents|mesh-ancestor
65692280|NCT04460820|Doxorubicin|doxorubicin|mesh-list
65692281|NCT04460820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65692282|NCT04460820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65692283|NCT04460820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692284|NCT04460820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65692285|NCT04460820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65692286|NCT04460820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692287|NCT04460820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692288|NCT02170935|Dabigatran|dabigatran|mesh-list
65692289|NCT02170935|Antithrombins|antithrombins|mesh-ancestor
65692290|NCT02170935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65692291|NCT02170935|Protease Inhibitors|protease inhibitors|mesh-ancestor
65692292|NCT02170935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692293|NCT02170935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692294|NCT02170935|Anticoagulants|anticoagulants|mesh-ancestor
65692295|NCT03488316|Calcium|calcium|mesh-list
65692296|NCT03488316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65692297|NCT03488316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692298|NCT02510222|Magnesium Sulfate|magnesium sulfate|mesh-list
65692299|NCT02510222|Analgesics|analgesics|mesh-ancestor
65692300|NCT02510222|Sensory System Agents|sensory system agents|mesh-ancestor
65692301|NCT02510222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692302|NCT02510222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692303|NCT02510222|Anesthetics|anesthetics|mesh-ancestor
65692304|NCT02510222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65692305|NCT02510222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65692306|NCT02510222|Anticonvulsants|anticonvulsants|mesh-ancestor
65692307|NCT02510222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65692308|NCT02510222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65692309|NCT02510222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692310|NCT02510222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65692311|NCT02510222|Tocolytic Agents|tocolytic agents|mesh-ancestor
65692312|NCT02510222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65692313|NCT05100264|Acetic Acid|acetic acid|mesh-list
65692314|NCT05100264|Retinol acetate|retinol acetate|mesh-list
65692315|NCT05100264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65692316|NCT05100264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65692317|NCT05100264|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65692318|NCT05100264|Immunologic Factors|immunologic factors|mesh-ancestor
65692319|NCT05100264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692320|NCT05100264|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65692321|NCT05100264|Protective Agents|protective agents|mesh-ancestor
65692322|NCT05100264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692323|NCT02505776|Bimatoprost|bimatoprost|mesh-list
65692324|NCT02505776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65692325|NCT02171013|Dabigatran|dabigatran|mesh-list
65692326|NCT02171013|Antithrombins|antithrombins|mesh-ancestor
65692327|NCT02171013|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65692328|NCT02171013|Protease Inhibitors|protease inhibitors|mesh-ancestor
65692329|NCT02171013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692330|NCT02171013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692331|NCT02171013|Anticoagulants|anticoagulants|mesh-ancestor
65692332|NCT02167425|Methadone|methadone|mesh-list
65692333|NCT02167425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65692334|NCT02167425|Narcotics|narcotics|mesh-ancestor
65692335|NCT02167425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65692336|NCT02167425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692337|NCT02167425|Analgesics|analgesics|mesh-ancestor
65692338|NCT02167425|Sensory System Agents|sensory system agents|mesh-ancestor
65692339|NCT02167425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692340|NCT02167425|Antitussive Agents|antitussive agents|mesh-ancestor
65692341|NCT02167425|Respiratory System Agents|respiratory system agents|mesh-ancestor
65692342|NCT03111732|Pembrolizumab|pembrolizumab|mesh-list
65692343|NCT03111732|Capecitabine|capecitabine|mesh-list
65692344|NCT03111732|Oxaliplatin|oxaliplatin|mesh-list
65692345|NCT03111732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65692346|NCT03111732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692347|NCT03111732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65692348|NCT03111732|Antimetabolites|antimetabolites|mesh-ancestor
65692349|NCT03111732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692350|NCT01663714|Tositumomab I-131|tositumomab i-131|mesh-list
65692351|NCT01663714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692352|NCT02505386|Ertapenem|ertapenem|mesh-list
65692353|NCT02505386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65692354|NCT02505386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65692355|NCT05507086|Anti-Infective Agents|anti-infective agents|mesh-list
65692356|NCT05507086|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65692357|NCT02514980|Ketamine|ketamine|mesh-list
65692358|NCT02514980|Bupivacaine|bupivacaine|mesh-list
65692359|NCT02514980|Anesthetics, Local|anesthetics, local|mesh-ancestor
65692360|NCT02514980|Anesthetics|anesthetics|mesh-ancestor
65692361|NCT02514980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65692362|NCT02514980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692363|NCT02514980|Sensory System Agents|sensory system agents|mesh-ancestor
65692364|NCT02514980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692365|NCT02514980|Analgesics|analgesics|mesh-ancestor
65692366|NCT02514980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65692367|NCT02514980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65692368|NCT02514980|Anesthetics, General|anesthetics, general|mesh-ancestor
65692369|NCT02514980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65692370|NCT02514980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65692371|NCT02514980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65692372|NCT02514980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692373|NCT04920942|Ivermectin|ivermectin|mesh-list
65489700|NCT05167084|Hydrocortisone|hydrocortisone|mesh-list
65692374|NCT04920942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65692375|NCT04920942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65692376|NCT02165475|Loperamide|loperamide|mesh-list
65692377|NCT02165475|Antidiarrheals|antidiarrheals|mesh-list
65692378|NCT02165475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65692379|NCT04862338|Niacinamide|niacinamide|mesh-list
65692380|NCT04862338|Niacin|niacin|mesh-list
65692381|NCT04862338|Nicotinic Acids|nicotinic acids|mesh-list
65692382|NCT04862338|Vitamin B Complex|vitamin b complex|mesh-ancestor
65692383|NCT04862338|Vitamins|vitamins|mesh-ancestor
65692384|NCT04862338|Micronutrients|micronutrients|mesh-ancestor
65692385|NCT04862338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692386|NCT04862338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65692387|NCT04862338|Antimetabolites|antimetabolites|mesh-ancestor
65692388|NCT04862338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692389|NCT04862338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65692390|NCT04862338|Vasodilator Agents|vasodilator agents|mesh-ancestor
65692391|NCT02171325|Irinotecan|irinotecan|mesh-list
65692392|NCT02171325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65692393|NCT02171325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65692394|NCT02171325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692395|NCT02171325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692396|NCT02171325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692397|NCT02509286|Leucovorin|leucovorin|mesh-list
65692398|NCT02509286|Paclitaxel|paclitaxel|mesh-list
65692399|NCT02509286|Docetaxel|docetaxel|mesh-list
65692400|NCT02509286|Carboplatin|carboplatin|mesh-list
65692401|NCT02509286|Fluorouracil|fluorouracil|mesh-list
65692402|NCT02509286|Oxaliplatin|oxaliplatin|mesh-list
65692403|NCT02509286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65692404|NCT02509286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692405|NCT02509286|Tubulin Modulators|tubulin modulators|mesh-ancestor
65692406|NCT02509286|Antimitotic Agents|antimitotic agents|mesh-ancestor
65692407|NCT02509286|Mitosis Modulators|mitosis modulators|mesh-ancestor
65692408|NCT02509286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692409|NCT02509286|Antimetabolites|antimetabolites|mesh-ancestor
65692410|NCT02509286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65692411|NCT02509286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65692412|NCT02509286|Immunologic Factors|immunologic factors|mesh-ancestor
65692413|NCT02509286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692414|NCT02509286|Antidotes|antidotes|mesh-ancestor
65692415|NCT02509286|Protective Agents|protective agents|mesh-ancestor
65692416|NCT02509286|Vitamin B Complex|vitamin b complex|mesh-ancestor
65692417|NCT02509286|Vitamins|vitamins|mesh-ancestor
65692418|NCT02509286|Micronutrients|micronutrients|mesh-ancestor
65692419|NCT03065244|Infliximab|infliximab|mesh-list
65692420|NCT03065244|Immunoglobulins|immunoglobulins|mesh-list
65692421|NCT03065244|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65692422|NCT03065244|gamma-Globulins|gamma-globulins|mesh-list
65692423|NCT03065244|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65692424|NCT03065244|Immunologic Factors|immunologic factors|mesh-ancestor
65692425|NCT03065244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692426|NCT03065244|Dermatologic Agents|dermatologic agents|mesh-ancestor
65692427|NCT03065244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65692428|NCT03065244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65692429|NCT02171481|Dabigatran|dabigatran|mesh-list
65692430|NCT02171481|Antithrombins|antithrombins|mesh-ancestor
65692431|NCT02171481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65692432|NCT02171481|Protease Inhibitors|protease inhibitors|mesh-ancestor
65692433|NCT02171481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692434|NCT02171481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692435|NCT02171481|Anticoagulants|anticoagulants|mesh-ancestor
65692436|NCT02171559|Enoxaparin|enoxaparin|mesh-list
65692437|NCT02171559|Dabigatran|dabigatran|mesh-list
65692438|NCT02171559|Anticoagulants|anticoagulants|mesh-ancestor
65692439|NCT02171559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65692440|NCT02171559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65692441|NCT02171559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692442|NCT02171559|Antithrombins|antithrombins|mesh-ancestor
65692443|NCT02171559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65692444|NCT02171559|Protease Inhibitors|protease inhibitors|mesh-ancestor
65692445|NCT02171559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692446|NCT04901754|Apatinib|apatinib|mesh-list
65692447|NCT04901754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692448|NCT04901754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65692449|NCT04901754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692450|NCT04901754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692451|NCT02509208|Hemostatics|hemostatics|mesh-list
65692452|NCT02509208|Coagulants|coagulants|mesh-ancestor
65692453|NCT02504996|Acetaminophen|acetaminophen|mesh-list
65692454|NCT02504996|Morphine|morphine|mesh-list
65692455|NCT02504996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65692456|NCT02504996|Narcotics|narcotics|mesh-ancestor
65692457|NCT02504996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65692458|NCT02504996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692459|NCT02504996|Analgesics|analgesics|mesh-ancestor
65692460|NCT02504996|Sensory System Agents|sensory system agents|mesh-ancestor
65692461|NCT02504996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692462|NCT02504996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65692463|NCT02504996|Antipyretics|antipyretics|mesh-ancestor
65692464|NCT02509052|Leflunomide|leflunomide|mesh-list
65692465|NCT02509052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692466|NCT02509052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692467|NCT02509052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65692468|NCT02509052|Immunologic Factors|immunologic factors|mesh-ancestor
65692469|NCT02509052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692470|NCT00100815|Gemcitabine|gemcitabine|mesh-list
65692471|NCT00100815|Bevacizumab|bevacizumab|mesh-list
65692472|NCT00100815|Capecitabine|capecitabine|mesh-list
65692473|NCT00100815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65692474|NCT00100815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692475|NCT00100815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65692476|NCT00100815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65692477|NCT00100815|Growth Substances|growth substances|mesh-ancestor
65692478|NCT00100815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692479|NCT00100815|Growth Inhibitors|growth inhibitors|mesh-ancestor
65692480|NCT00100815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65692481|NCT00100815|Antimetabolites|antimetabolites|mesh-ancestor
65692482|NCT00100815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692483|NCT00100815|Antiviral Agents|antiviral agents|mesh-ancestor
65692484|NCT00100815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65692485|NCT00100815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692486|NCT00100815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65692487|NCT00100815|Immunologic Factors|immunologic factors|mesh-ancestor
65692488|NCT00708422|Travoprost|travoprost|mesh-list
65692489|NCT00708422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65692490|NCT00708422|Latanoprost|latanoprost|mesh-list
65692491|NCT00708422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65692492|NCT00708422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65692493|NCT02514200|Riboflavin|riboflavin|mesh-list
65692494|NCT02514200|Vitamin B Complex|vitamin b complex|mesh-ancestor
65692495|NCT02514200|Vitamins|vitamins|mesh-ancestor
65692496|NCT02514200|Micronutrients|micronutrients|mesh-ancestor
65692497|NCT02514200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692498|NCT02514200|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65692499|NCT02514200|Dermatologic Agents|dermatologic agents|mesh-ancestor
65692500|NCT02504450|Haloperidol|haloperidol|mesh-list
65692501|NCT02504450|Ziprasidone|ziprasidone|mesh-list
65692502|NCT02504450|Loxapine|loxapine|mesh-list
65692503|NCT02504450|Antiemetics|antiemetics|mesh-ancestor
65692504|NCT02504450|Autonomic Agents|autonomic agents|mesh-ancestor
65692505|NCT02504450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692506|NCT02504450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692507|NCT02504450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65692508|NCT02504450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65692509|NCT02504450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65692510|NCT02504450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65692511|NCT02504450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65692512|NCT02504450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65692513|NCT02504450|Dopamine Agents|dopamine agents|mesh-ancestor
65692514|NCT02504450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65692515|NCT02504450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692516|NCT02504450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65692517|NCT02504450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65692518|NCT02504450|Serotonin Agents|serotonin agents|mesh-ancestor
65692519|NCT02171637|Afatinib|afatinib|mesh-list
65692520|NCT02171637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692521|NCT02171637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65692522|NCT02171637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692523|NCT02171637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692524|NCT02171715|Afatinib|afatinib|mesh-list
65692525|NCT02171715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692526|NCT02171715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65692527|NCT02171715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692528|NCT02171715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692529|NCT02504372|Pembrolizumab|pembrolizumab|mesh-list
65692530|NCT02504372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65692531|NCT02504372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692532|NCT02760069|Ondansetron|ondansetron|mesh-list
65692533|NCT02760069|Antiemetics|antiemetics|mesh-ancestor
65692534|NCT02760069|Autonomic Agents|autonomic agents|mesh-ancestor
65692535|NCT02760069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692536|NCT02760069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692537|NCT02760069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65692538|NCT02760069|Antipruritics|antipruritics|mesh-ancestor
65692539|NCT02760069|Dermatologic Agents|dermatologic agents|mesh-ancestor
65692540|NCT02760069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65692541|NCT02760069|Serotonin Agents|serotonin agents|mesh-ancestor
65692542|NCT02760069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65692543|NCT02760069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692544|NCT02760069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65692545|NCT02760069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65692546|NCT02760069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65692547|NCT02760069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65692548|NCT02760069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65692549|NCT02504138|Anesthetics|anesthetics|mesh-list
65692551|NCT02504138|Desflurane|desflurane|mesh-list
65692552|NCT02504138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65692553|NCT02504138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692554|NCT02504138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65692555|NCT02504138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65692556|NCT02504138|Anesthetics, General|anesthetics, general|mesh-ancestor
65692557|NCT02504138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65692558|NCT02508584|Antibodies|antibodies|mesh-list
65692559|NCT02508584|Immunologic Factors|immunologic factors|mesh-ancestor
65692560|NCT02508584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692561|NCT02171793|Olodaterol|olodaterol|mesh-list
65692562|NCT02171793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65692563|NCT02171793|Autonomic Agents|autonomic agents|mesh-ancestor
65692564|NCT02171793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692565|NCT02171793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692566|NCT02171793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65692567|NCT02171793|Respiratory System Agents|respiratory system agents|mesh-ancestor
65692568|NCT02171871|Respiratory System Agents|respiratory system agents|mesh-list
65692569|NCT02508350|Daptomycin|daptomycin|mesh-list
65692570|NCT02508350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65692571|NCT02508350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65692572|NCT02503826|Midazolam|midazolam|mesh-list
65692573|NCT02503826|Sufentanil|sufentanil|mesh-list
65692574|NCT02503826|Dsuvia|dsuvia|mesh-list
65692575|NCT02503826|Propofol|propofol|mesh-list
65692576|NCT02503826|Cisatracurium|cisatracurium|mesh-list
65692577|NCT02503826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65692578|NCT02503826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65692579|NCT02503826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692580|NCT02503826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65692581|NCT02503826|Anesthetics, General|anesthetics, general|mesh-ancestor
65692582|NCT02503826|Anesthetics|anesthetics|mesh-ancestor
65692583|NCT02503826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65692584|NCT02503826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65692585|NCT02503826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65692586|NCT02503826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65692587|NCT02503826|GABA Modulators|gaba modulators|mesh-ancestor
65692588|NCT02503826|GABA Agents|gaba agents|mesh-ancestor
65692589|NCT02503826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65692590|NCT02503826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692591|NCT02503826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65692592|NCT02503826|Narcotics|narcotics|mesh-ancestor
65692593|NCT02503826|Analgesics|analgesics|mesh-ancestor
65692594|NCT02503826|Sensory System Agents|sensory system agents|mesh-ancestor
65692595|NCT02503826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692596|NCT02503826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65692597|NCT02503826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65692598|NCT03121664|Itraconazole|itraconazole|mesh-list
65692599|NCT03121664|Antifungal Agents|antifungal agents|mesh-ancestor
65692600|NCT03121664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65692601|NCT03121664|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65692602|NCT03121664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65692603|NCT03121664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692604|NCT03121664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692605|NCT03121664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65692606|NCT03121664|Hormone Antagonists|hormone antagonists|mesh-ancestor
65692607|NCT03121664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65692608|NCT03121664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692609|NCT03121664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65692610|NCT02503904|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65692611|NCT02503904|Metronidazole|metronidazole|mesh-list
65692612|NCT02503904|Lidocaine|lidocaine|mesh-list
65692613|NCT02503904|Epinephrine|epinephrine|mesh-list
65692614|NCT02503904|Anesthetics, Local|anesthetics, local|mesh-ancestor
65692615|NCT02503904|Anesthetics|anesthetics|mesh-ancestor
65692616|NCT02503904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65692617|NCT02503904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692618|NCT02503904|Sensory System Agents|sensory system agents|mesh-ancestor
65692619|NCT02503904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692620|NCT02503904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65692621|NCT02503904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65692622|NCT02503904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65692623|NCT02503904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65692624|NCT02503904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692625|NCT02503904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65692626|NCT02503904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65692627|NCT02503904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65692628|NCT02503904|Adrenergic Agents|adrenergic agents|mesh-ancestor
65692629|NCT02503904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65692630|NCT02503904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65692631|NCT02503904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65692632|NCT02503904|Autonomic Agents|autonomic agents|mesh-ancestor
65692633|NCT02503904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65692634|NCT02503904|Respiratory System Agents|respiratory system agents|mesh-ancestor
65692635|NCT02503904|Mydriatics|mydriatics|mesh-ancestor
65692636|NCT02503904|Sympathomimetics|sympathomimetics|mesh-ancestor
65692637|NCT02503904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65692638|NCT02503904|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65692639|NCT02503904|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65692640|NCT02172105|Olodaterol|olodaterol|mesh-list
65692641|NCT02172105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65692642|NCT02172105|Autonomic Agents|autonomic agents|mesh-ancestor
65692643|NCT02172105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692644|NCT02172105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692645|NCT02172105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65692646|NCT02172105|Respiratory System Agents|respiratory system agents|mesh-ancestor
65692647|NCT03121352|Paclitaxel|paclitaxel|mesh-list
65692648|NCT03121352|Carboplatin|carboplatin|mesh-list
65692649|NCT03121352|Pembrolizumab|pembrolizumab|mesh-list
65692650|NCT03121352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65692651|NCT03121352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692652|NCT03121352|Tubulin Modulators|tubulin modulators|mesh-ancestor
65692653|NCT03121352|Antimitotic Agents|antimitotic agents|mesh-ancestor
65692654|NCT03121352|Mitosis Modulators|mitosis modulators|mesh-ancestor
65692655|NCT03121352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692656|NCT03121352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65692657|NCT02513654|Lamotrigine|lamotrigine|mesh-list
65692658|NCT02513654|Anticonvulsants|anticonvulsants|mesh-ancestor
65692659|NCT02513654|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65692660|NCT02513654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65692661|NCT02513654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692662|NCT02513654|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65692663|NCT02513654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692664|NCT02513654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65692665|NCT02513654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65692666|NCT02513654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65692667|NCT02513654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65692668|NCT02513654|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65692669|NCT02513888|Vitamin D|vitamin d|mesh-list
65692670|NCT02513888|Vitamins|vitamins|mesh-ancestor
65692671|NCT02513888|Micronutrients|micronutrients|mesh-ancestor
65692672|NCT02513888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692673|NCT02513888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65692674|NCT00101595|Dasatinib|dasatinib|mesh-list
65692675|NCT00101595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692676|NCT00101595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65692677|NCT00101595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692678|NCT00101595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692679|NCT02174757|Doxycycline|doxycycline|mesh-list
65692680|NCT02174757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65692681|NCT02174757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65692682|NCT02174757|Antimalarials|antimalarials|mesh-ancestor
65692683|NCT02174757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65692684|NCT02174757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65692685|NCT02168127|Methylphenidate|methylphenidate|mesh-list
65692686|NCT02168127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65692687|NCT02168127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692688|NCT02168127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65692689|NCT02168127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65692690|NCT02168127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65692691|NCT02168127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692692|NCT02168127|Dopamine Agents|dopamine agents|mesh-ancestor
65692693|NCT02168127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65692694|NCT05233202|Simendan|simendan|mesh-list
65692695|NCT05233202|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65692696|NCT05233202|Vasodilator Agents|vasodilator agents|mesh-ancestor
65692697|NCT05233202|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65692698|NCT05233202|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65692699|NCT05233202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692700|NCT05233202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692701|NCT05233202|Protective Agents|protective agents|mesh-ancestor
65692702|NCT05233202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692703|NCT02255955|Acetaminophen|acetaminophen|mesh-list
65692704|NCT02255955|Naproxen|naproxen|mesh-list
65692705|NCT02255955|Codeine|codeine|mesh-list
65692706|NCT02255955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65692707|NCT02255955|Analgesics|analgesics|mesh-ancestor
65692708|NCT02255955|Sensory System Agents|sensory system agents|mesh-ancestor
65692709|NCT02255955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692710|NCT02255955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692711|NCT02255955|Antipyretics|antipyretics|mesh-ancestor
65692712|NCT02255955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65692713|NCT02255955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65692714|NCT02255955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65692715|NCT02255955|Gout Suppressants|gout suppressants|mesh-ancestor
65692716|NCT02255955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65692717|NCT02255955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692718|NCT02255955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692719|NCT02255955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65692720|NCT02255955|Narcotics|narcotics|mesh-ancestor
65692721|NCT02255955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65692722|NCT02255955|Antitussive Agents|antitussive agents|mesh-ancestor
65692723|NCT02255955|Respiratory System Agents|respiratory system agents|mesh-ancestor
65692724|NCT02172261|Glimepiride|glimepiride|mesh-list
65692725|NCT02172261|Empagliflozin|empagliflozin|mesh-list
65692726|NCT02172261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65692727|NCT02172261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65692728|NCT02172261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692729|NCT02172261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65692730|NCT02172261|Immunologic Factors|immunologic factors|mesh-ancestor
65692731|NCT02172261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65692732|NCT02172261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692733|NCT02501564|Naproxen|naproxen|mesh-list
65692734|NCT02501564|Codeine|codeine|mesh-list
65692735|NCT02501564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65692736|NCT02501564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65692737|NCT02501564|Analgesics|analgesics|mesh-ancestor
65692738|NCT02501564|Sensory System Agents|sensory system agents|mesh-ancestor
65692739|NCT02501564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692740|NCT02501564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692741|NCT02501564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65692742|NCT02501564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65692743|NCT02501564|Gout Suppressants|gout suppressants|mesh-ancestor
65692744|NCT02501564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65692745|NCT02501564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692746|NCT02501564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692747|NCT02501564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65692748|NCT02501564|Narcotics|narcotics|mesh-ancestor
65692749|NCT02501564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65692750|NCT02501564|Antitussive Agents|antitussive agents|mesh-ancestor
65692751|NCT02501564|Respiratory System Agents|respiratory system agents|mesh-ancestor
65692752|NCT02172339|Tiotropium Bromide|tiotropium bromide|mesh-list
65692753|NCT02172339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65692754|NCT02172339|Autonomic Agents|autonomic agents|mesh-ancestor
65692755|NCT02172339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692756|NCT02172339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692757|NCT02172339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65692758|NCT02172339|Respiratory System Agents|respiratory system agents|mesh-ancestor
65692759|NCT02172339|Parasympatholytics|parasympatholytics|mesh-ancestor
65692760|NCT02172339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65692761|NCT02172339|Cholinergic Agents|cholinergic agents|mesh-ancestor
65692762|NCT02172339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65692763|NCT02172339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692765|NCT02172417|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65692766|NCT02172417|Cimetidine|cimetidine|mesh-list
65692767|NCT02172417|Tiotropium Bromide|tiotropium bromide|mesh-list
65692768|NCT02172417|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65692769|NCT02172417|Autonomic Agents|autonomic agents|mesh-ancestor
65692770|NCT02172417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692771|NCT02172417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692772|NCT02172417|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65692773|NCT02172417|Respiratory System Agents|respiratory system agents|mesh-ancestor
65692774|NCT02172417|Parasympatholytics|parasympatholytics|mesh-ancestor
65692775|NCT02172417|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65692776|NCT02172417|Cholinergic Agents|cholinergic agents|mesh-ancestor
65692777|NCT02172417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65692778|NCT02172417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692779|NCT02172417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65692780|NCT02172417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65692781|NCT02172417|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65692782|NCT02172417|Histamine Antagonists|histamine antagonists|mesh-ancestor
65692783|NCT02172417|Histamine Agents|histamine agents|mesh-ancestor
65692784|NCT02172417|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65692785|NCT02172417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65692786|NCT02172417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692787|NCT02168205|Pomalidomide|pomalidomide|mesh-list
65692788|NCT02168205|Caffeine|caffeine|mesh-list
65155441|NCT01258595|Vaccines|vaccines|mesh-list
65692789|NCT02168205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65692790|NCT02168205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692791|NCT02168205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65692792|NCT02168205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692793|NCT02168205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692794|NCT02168205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65692795|NCT02168205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65692796|NCT02168205|Purinergic Agents|purinergic agents|mesh-ancestor
65692797|NCT02168205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65692798|NCT02168205|Immunologic Factors|immunologic factors|mesh-ancestor
65692799|NCT02168205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65692800|NCT02168205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65692801|NCT02168205|Growth Substances|growth substances|mesh-ancestor
65692802|NCT02168205|Growth Inhibitors|growth inhibitors|mesh-ancestor
65692803|NCT02168205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692804|NCT03343652|Nivolumab|nivolumab|mesh-list
65692805|NCT03343652|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65692806|NCT03343652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65692807|NCT03343652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692808|NCT03343652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65692809|NCT03343652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692810|NCT03343652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65692811|NCT03343652|Alkylating Agents|alkylating agents|mesh-ancestor
65692812|NCT02175069|Ropivacaine|ropivacaine|mesh-list
65692813|NCT02175069|Anesthetics, Local|anesthetics, local|mesh-ancestor
65692814|NCT02175069|Anesthetics|anesthetics|mesh-ancestor
65692815|NCT02175069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65692816|NCT02175069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692817|NCT02175069|Sensory System Agents|sensory system agents|mesh-ancestor
65692818|NCT02175069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692819|NCT04498520|Fulvestrant|fulvestrant|mesh-list
65692820|NCT04498520|Palbociclib|palbociclib|mesh-list
65692821|NCT04498520|Abexinostat|abexinostat|mesh-list
65692822|NCT04498520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65692823|NCT04498520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692824|NCT04498520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65692825|NCT04498520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65692826|NCT04498520|Hormone Antagonists|hormone antagonists|mesh-ancestor
65692827|NCT04498520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65692828|NCT04498520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692829|NCT04498520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65692830|NCT04498520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692831|NCT04498520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692832|NCT04498520|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65692833|NCT02172495|Bromides|bromides|mesh-list
65692834|NCT02172495|Tiotropium Bromide|tiotropium bromide|mesh-list
65692835|NCT02172495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65692836|NCT02172495|Autonomic Agents|autonomic agents|mesh-ancestor
65692837|NCT02172495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692838|NCT02172495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692839|NCT02172495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65692840|NCT02172495|Respiratory System Agents|respiratory system agents|mesh-ancestor
65692841|NCT02172495|Parasympatholytics|parasympatholytics|mesh-ancestor
65692842|NCT02172495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65692843|NCT02172495|Cholinergic Agents|cholinergic agents|mesh-ancestor
65692844|NCT02172495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65692845|NCT02172495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692846|NCT02172495|Anticonvulsants|anticonvulsants|mesh-ancestor
65692847|NCT02172573|Pramipexole|pramipexole|mesh-list
65692848|NCT02172573|Bromocriptine|bromocriptine|mesh-list
65692849|NCT02172573|Antioxidants|antioxidants|mesh-ancestor
65692850|NCT02172573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692851|NCT02172573|Protective Agents|protective agents|mesh-ancestor
65692852|NCT02172573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692853|NCT02172573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65692854|NCT02172573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65692855|NCT02172573|Dopamine Agonists|dopamine agonists|mesh-ancestor
65692856|NCT02172573|Dopamine Agents|dopamine agents|mesh-ancestor
65692857|NCT02172573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65692858|NCT02172573|Hormone Antagonists|hormone antagonists|mesh-ancestor
65692859|NCT02172573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65692860|NCT02175381|Gemcitabine|gemcitabine|mesh-list
65692861|NCT02175381|Carboplatin|carboplatin|mesh-list
65692862|NCT02175381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692863|NCT02175381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65692864|NCT02175381|Antimetabolites|antimetabolites|mesh-ancestor
65692865|NCT02175381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692866|NCT02175381|Antiviral Agents|antiviral agents|mesh-ancestor
65692867|NCT02175381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65692868|NCT02175381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692869|NCT02175381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65692870|NCT02175381|Immunologic Factors|immunologic factors|mesh-ancestor
65692871|NCT02175381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692872|NCT03540225|Progesterone|progesterone|mesh-list
65692873|NCT03540225|Progestins|progestins|mesh-ancestor
65692874|NCT03540225|Hormones|hormones|mesh-ancestor
65692875|NCT03540225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65692876|NCT03540225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692877|NCT02507648|Oseltamivir|oseltamivir|mesh-list
65692878|NCT02507648|Antiviral Agents|antiviral agents|mesh-ancestor
65692879|NCT02507648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65692880|NCT02507648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692881|NCT02507648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692882|NCT02172729|Lidocaine|lidocaine|mesh-list
65692883|NCT02172729|Anesthetics, Local|anesthetics, local|mesh-ancestor
65692884|NCT02172729|Anesthetics|anesthetics|mesh-ancestor
65692885|NCT02172729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65692886|NCT02172729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692887|NCT02172729|Sensory System Agents|sensory system agents|mesh-ancestor
65692888|NCT02172729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692889|NCT02172729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65692890|NCT02172729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65692891|NCT02172729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65692892|NCT02172729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65692893|NCT02172729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692894|NCT02172807|Tiotropium Bromide|tiotropium bromide|mesh-list
65692895|NCT02172807|Oxitropium|oxitropium|mesh-list
65692896|NCT02172807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65692897|NCT02172807|Autonomic Agents|autonomic agents|mesh-ancestor
65692898|NCT02172807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692899|NCT02172807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692900|NCT02172807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65692901|NCT02172807|Respiratory System Agents|respiratory system agents|mesh-ancestor
65692902|NCT02172807|Parasympatholytics|parasympatholytics|mesh-ancestor
65692903|NCT02172807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65692904|NCT02172807|Cholinergic Agents|cholinergic agents|mesh-ancestor
65692905|NCT02172807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65490219|NCT01372540|Mitosis Modulators|mitosis modulators|mesh-ancestor
65692906|NCT02172807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692907|NCT04568421|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65692908|NCT04568421|Immunologic Factors|immunologic factors|mesh-ancestor
65692909|NCT04568421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692910|NCT02502968|Cytarabine|cytarabine|mesh-list
65692911|NCT02502968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65692912|NCT02502968|Antimetabolites|antimetabolites|mesh-ancestor
65692913|NCT02502968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692914|NCT02502968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692915|NCT02502968|Antiviral Agents|antiviral agents|mesh-ancestor
65692916|NCT02502968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65692917|NCT02502968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65692918|NCT02502968|Immunologic Factors|immunologic factors|mesh-ancestor
65692919|NCT02502968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692920|NCT04557735|Ravulizumab|ravulizumab|mesh-list
65692921|NCT04557735|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65692922|NCT04557735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65692923|NCT04557735|Immunologic Factors|immunologic factors|mesh-ancestor
65692924|NCT04557735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692925|NCT02168751|Propofol|propofol|mesh-list
65692926|NCT02168751|Sevoflurane|sevoflurane|mesh-list
65692927|NCT02168751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65692928|NCT02168751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65692929|NCT02168751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692930|NCT02168751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65692931|NCT02168751|Anesthetics, General|anesthetics, general|mesh-ancestor
65692932|NCT02168751|Anesthetics|anesthetics|mesh-ancestor
65692933|NCT02168751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65692934|NCT02168751|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65692935|NCT02507570|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65692936|NCT02507570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692937|NCT03344042|Fentanyl|fentanyl|mesh-list
65692938|NCT03344042|Sufentanil|sufentanil|mesh-list
65692939|NCT03344042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65692940|NCT03344042|Narcotics|narcotics|mesh-ancestor
65692941|NCT03344042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65692942|NCT03344042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692943|NCT03344042|Analgesics|analgesics|mesh-ancestor
65692944|NCT03344042|Sensory System Agents|sensory system agents|mesh-ancestor
65692945|NCT03344042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692946|NCT03344042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65692947|NCT03344042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65692948|NCT03344042|Anesthetics, General|anesthetics, general|mesh-ancestor
65692949|NCT03344042|Anesthetics|anesthetics|mesh-ancestor
65692950|NCT02175927|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65692951|NCT02175927|Amoxicillin|amoxicillin|mesh-list
65692952|NCT02175927|Metronidazole|metronidazole|mesh-list
65692953|NCT02175927|Tetracycline|tetracycline|mesh-list
65692954|NCT02175927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65692955|NCT02175927|Potassium Citrate|potassium citrate|mesh-list
65692956|NCT02175927|Lansoprazole|lansoprazole|mesh-list
65692957|NCT02175927|Bismuth|bismuth|mesh-list
65692958|NCT02175927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65692959|NCT02175927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692960|NCT02175927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65692961|NCT02175927|Antitubercular Agents|antitubercular agents|mesh-ancestor
65692962|NCT02175927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65692963|NCT02175927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65692964|NCT02175927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65692965|NCT02175927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65692966|NCT02175927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65692967|NCT02175927|Antacids|antacids|mesh-ancestor
65692968|NCT02175927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65692969|NCT02175927|Diuretics|diuretics|mesh-ancestor
65692970|NCT02175927|Natriuretic Agents|natriuretic agents|mesh-ancestor
65692971|NCT02175927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692972|NCT02175927|Expectorants|expectorants|mesh-ancestor
65692973|NCT02175927|Respiratory System Agents|respiratory system agents|mesh-ancestor
65692974|NCT00707486|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
65692975|NCT00707486|Hemostatics|hemostatics|mesh-ancestor
65692976|NCT00707486|Coagulants|coagulants|mesh-ancestor
65692977|NCT02496182|Pirfenidone|pirfenidone|mesh-list
65692978|NCT02496182|Analgesics|analgesics|mesh-ancestor
65692979|NCT02496182|Sensory System Agents|sensory system agents|mesh-ancestor
65692980|NCT02496182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65692981|NCT02496182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692982|NCT02496182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65692983|NCT02496182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65692984|NCT02496182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65692985|NCT02496182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65692986|NCT02496182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692987|NCT02168907|Thioctic Acid|thioctic acid|mesh-list
65692988|NCT02168907|Rituximab|rituximab|mesh-list
65692989|NCT02168907|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65692990|NCT02168907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65692991|NCT02168907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65692992|NCT02168907|Immunologic Factors|immunologic factors|mesh-ancestor
65692993|NCT02168907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65692994|NCT02168907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65692995|NCT02168907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65692996|NCT02168907|Alkylating Agents|alkylating agents|mesh-ancestor
65692997|NCT02168907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65692998|NCT02168907|Antioxidants|antioxidants|mesh-ancestor
65692999|NCT02168907|Protective Agents|protective agents|mesh-ancestor
65693000|NCT02168907|Vitamin B Complex|vitamin b complex|mesh-ancestor
65693001|NCT02168907|Vitamins|vitamins|mesh-ancestor
65693002|NCT02168907|Micronutrients|micronutrients|mesh-ancestor
65693003|NCT02500784|Formoterol Fumarate|formoterol fumarate|mesh-list
65693004|NCT02500784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65693005|NCT02500784|Autonomic Agents|autonomic agents|mesh-ancestor
65693006|NCT02500784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693007|NCT02500784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693008|NCT02500784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65693009|NCT02500784|Respiratory System Agents|respiratory system agents|mesh-ancestor
65693010|NCT02500784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65693011|NCT02500784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65693012|NCT02500784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65693013|NCT02500784|Adrenergic Agents|adrenergic agents|mesh-ancestor
65693014|NCT02500784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65693015|NCT02500784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693016|NCT02500940|Leucovorin|leucovorin|mesh-list
65693017|NCT02500940|Fluorouracil|fluorouracil|mesh-list
65693018|NCT02500940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693019|NCT02500940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693020|NCT02500940|Antimetabolites|antimetabolites|mesh-ancestor
65693021|NCT02500940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693022|NCT02500940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65693023|NCT02500940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65693024|NCT02500940|Immunologic Factors|immunologic factors|mesh-ancestor
65693025|NCT02500940|Antidotes|antidotes|mesh-ancestor
65693026|NCT02500940|Protective Agents|protective agents|mesh-ancestor
65693027|NCT02500940|Vitamin B Complex|vitamin b complex|mesh-ancestor
65693028|NCT02500940|Vitamins|vitamins|mesh-ancestor
65693029|NCT02500940|Micronutrients|micronutrients|mesh-ancestor
65693030|NCT02495636|Atezolizumab|atezolizumab|mesh-list
65693031|NCT02495636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693032|NCT02169063|Listerine|listerine|mesh-list
65693033|NCT02169063|Fluorides|fluorides|mesh-list
65693034|NCT02169063|Sodium Fluoride|sodium fluoride|mesh-list
65693035|NCT02169063|Cariostatic Agents|cariostatic agents|mesh-ancestor
65693036|NCT02169063|Protective Agents|protective agents|mesh-ancestor
65693037|NCT02169063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693038|NCT02169063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65693039|NCT02169063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65693040|NCT04496882|Tenofovir|tenofovir|mesh-list
65693041|NCT04496882|Antiviral Agents|antiviral agents|mesh-ancestor
65693042|NCT04496882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65693043|NCT04496882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65693044|NCT04496882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65693045|NCT04496882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693046|NCT04496882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693047|NCT04496882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65693048|NCT04496882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65693049|NCT02502500|Celecoxib|celecoxib|mesh-list
65693050|NCT02502500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65693051|NCT02502500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65693052|NCT02502500|Analgesics|analgesics|mesh-ancestor
65693053|NCT02502500|Sensory System Agents|sensory system agents|mesh-ancestor
65693054|NCT02502500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693055|NCT02502500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490370|NCT01328652|Dexlansoprazole|dexlansoprazole|mesh-list
65693056|NCT02502500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65693057|NCT02502500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65693058|NCT02502500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65693059|NCT02502500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65693060|NCT02502500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693061|NCT02502500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693063|NCT02173665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65693064|NCT02173665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693065|NCT02173665|Incretins|incretins|mesh-ancestor
65693066|NCT02173665|Hormones|hormones|mesh-ancestor
65693067|NCT02173665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65693068|NCT02173665|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65693069|NCT02173665|Protease Inhibitors|protease inhibitors|mesh-ancestor
65693070|NCT02173665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693071|NCT02173665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693072|NCT02495324|Valsartan|valsartan|mesh-list
65693073|NCT02495324|Olmesartan|olmesartan|mesh-list
65693074|NCT02495324|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65693075|NCT02495324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65693076|NCT02495324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65693077|NCT02495324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65693078|NCT02495324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693079|NCT02500238|Carbon Monoxide|carbon monoxide|mesh-list
65693080|NCT02500238|Antimetabolites|antimetabolites|mesh-ancestor
65693081|NCT02500238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693082|NCT02500238|Gasotransmitters|gasotransmitters|mesh-ancestor
65693083|NCT02500238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65693084|NCT02500238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693085|NCT04625283|Ketamine|ketamine|mesh-list
65693086|NCT04625283|Analgesics|analgesics|mesh-ancestor
65693087|NCT04625283|Sensory System Agents|sensory system agents|mesh-ancestor
65693088|NCT04625283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693089|NCT04625283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693090|NCT04625283|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65693091|NCT04625283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65693092|NCT04625283|Anesthetics, General|anesthetics, general|mesh-ancestor
65693093|NCT04625283|Anesthetics|anesthetics|mesh-ancestor
65693094|NCT04625283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65693095|NCT04625283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65693096|NCT04625283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65693097|NCT04625283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65693098|NCT04625283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693099|NCT02256033|Istradefylline|istradefylline|mesh-list
65693100|NCT02256033|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
65693101|NCT02256033|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65693102|NCT02256033|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65693103|NCT02256033|Purinergic Agents|purinergic agents|mesh-ancestor
65693104|NCT02256033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65693105|NCT02256033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693106|NCT02256033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693107|NCT02502110|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65693108|NCT02502110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65693109|NCT02502110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65693110|NCT02502110|Antimetabolites|antimetabolites|mesh-ancestor
65693111|NCT02502110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693112|NCT02502110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65693113|NCT02502110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65693114|NCT02502110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693115|NCT02502344|Metformin|metformin|mesh-list
65693116|NCT02502344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65693117|NCT02502344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693118|NCT02174211|Ranibizumab|ranibizumab|mesh-list
65693119|NCT02174211|Aflibercept|aflibercept|mesh-list
65693120|NCT02174211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65693121|NCT02174211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65693122|NCT02174211|Growth Substances|growth substances|mesh-ancestor
65693123|NCT02174211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693124|NCT02174211|Growth Inhibitors|growth inhibitors|mesh-ancestor
65693125|NCT02174211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693126|NCT04496492|Tocotrienols|tocotrienols|mesh-list
65693127|NCT04496492|Vitamin E|vitamin e|mesh-list
65693128|NCT04496492|Tocopherols|tocopherols|mesh-list
65693129|NCT04496492|Antioxidants|antioxidants|mesh-ancestor
65693130|NCT04496492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693131|NCT04496492|Protective Agents|protective agents|mesh-ancestor
65490444|NCT01213680|Ferric Compounds|ferric compounds|mesh-list
65693132|NCT04496492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693133|NCT04496492|Vitamins|vitamins|mesh-ancestor
65693134|NCT04496492|Micronutrients|micronutrients|mesh-ancestor
65693135|NCT02500004|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65693136|NCT02500004|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65693137|NCT02500004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693138|NCT02502032|Cisatracurium|cisatracurium|mesh-list
65693139|NCT02502032|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65693140|NCT02502032|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65693141|NCT02502032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693142|NCT02502032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693143|NCT02494856|Naproxen|naproxen|mesh-list
65693144|NCT02494856|Esomeprazole|esomeprazole|mesh-list
65693145|NCT02494856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65693146|NCT02494856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65693147|NCT02494856|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65693148|NCT02494856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693149|NCT02494856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693150|NCT02494856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65693151|NCT02494856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65693152|NCT02494856|Analgesics|analgesics|mesh-ancestor
65693153|NCT02494856|Sensory System Agents|sensory system agents|mesh-ancestor
65693154|NCT02494856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693155|NCT02494856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693156|NCT02494856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65693157|NCT02494856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65693158|NCT02494856|Gout Suppressants|gout suppressants|mesh-ancestor
65693159|NCT02494856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65693160|NCT04495010|Nivolumab|nivolumab|mesh-list
65693161|NCT04495010|Ipilimumab|ipilimumab|mesh-list
65693162|NCT04495010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65693163|NCT04495010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693164|NCT04495010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65693165|NCT04495010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693166|NCT03343418|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65693167|NCT03343418|Hemostatics|hemostatics|mesh-ancestor
65693168|NCT03343418|Coagulants|coagulants|mesh-ancestor
65693169|NCT03343418|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65693170|NCT03343418|Natriuretic Agents|natriuretic agents|mesh-ancestor
65693171|NCT03343418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693172|NCT02501798|Methylphenidate|methylphenidate|mesh-list
65693173|NCT02501798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65693174|NCT02501798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693175|NCT02501798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65693176|NCT02501798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65693177|NCT02501798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65693178|NCT02501798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693179|NCT02501798|Dopamine Agents|dopamine agents|mesh-ancestor
65693180|NCT02501798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65693181|NCT02169609|Interleukin-2|interleukin-2|mesh-list
65693182|NCT02169609|Dinutuximab|dinutuximab|mesh-list
65693183|NCT02169609|Isotretinoin|isotretinoin|mesh-list
65693184|NCT02169609|Sargramostim|sargramostim|mesh-list
65693185|NCT02169609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693186|NCT02169609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65693187|NCT02169609|Analgesics|analgesics|mesh-ancestor
65693188|NCT02169609|Sensory System Agents|sensory system agents|mesh-ancestor
65693189|NCT02169609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693190|NCT02169609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693191|NCT02169609|Immunologic Factors|immunologic factors|mesh-ancestor
65693192|NCT02169609|Dermatologic Agents|dermatologic agents|mesh-ancestor
65693193|NCT02499614|Crizotinib|crizotinib|mesh-list
65693194|NCT02499614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693195|NCT02499614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65693196|NCT02499614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693197|NCT02499614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693198|NCT02169843|Dexmedetomidine|dexmedetomidine|mesh-list
65693199|NCT02169843|Sevoflurane|sevoflurane|mesh-list
65693200|NCT02169843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65693201|NCT02169843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65693202|NCT02169843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693203|NCT02169843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65693204|NCT02169843|Analgesics|analgesics|mesh-ancestor
65693205|NCT02169843|Sensory System Agents|sensory system agents|mesh-ancestor
65693206|NCT02169843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693207|NCT02169843|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65693208|NCT02169843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65693209|NCT02169843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65693210|NCT02169843|Adrenergic Agents|adrenergic agents|mesh-ancestor
65693211|NCT02169843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65693212|NCT02169843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693213|NCT02169843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65693214|NCT02169843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65693215|NCT02169843|Anesthetics, General|anesthetics, general|mesh-ancestor
65693216|NCT02169843|Anesthetics|anesthetics|mesh-ancestor
65693217|NCT03341390|Aspirin|aspirin|mesh-list
65693218|NCT03341390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65693219|NCT03341390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65693220|NCT03341390|Analgesics|analgesics|mesh-ancestor
65693221|NCT03341390|Sensory System Agents|sensory system agents|mesh-ancestor
65693222|NCT03341390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693223|NCT03341390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693224|NCT03341390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65693225|NCT03341390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65693226|NCT03341390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65693227|NCT03341390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65693228|NCT03341390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693229|NCT03341390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65693230|NCT03341390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65693231|NCT03341390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693232|NCT03341390|Antipyretics|antipyretics|mesh-ancestor
65693233|NCT02174445|Imatinib Mesylate|imatinib mesylate|mesh-list
65693234|NCT02174445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693235|NCT02174445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65693236|NCT02174445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693237|NCT02174445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693238|NCT00707174|Imiquimod|imiquimod|mesh-list
65693239|NCT00707174|Tazarotene|tazarotene|mesh-list
65693240|NCT00707174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65693241|NCT00707174|Immunologic Factors|immunologic factors|mesh-ancestor
65693242|NCT00707174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693243|NCT00707174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693244|NCT00707174|Interferon Inducers|interferon inducers|mesh-ancestor
65693245|NCT00707174|Dermatologic Agents|dermatologic agents|mesh-ancestor
65693246|NCT00707174|Keratolytic Agents|keratolytic agents|mesh-ancestor
65693247|NCT03341234|Bupivacaine|bupivacaine|mesh-list
65693248|NCT03341234|Anesthetics, Local|anesthetics, local|mesh-ancestor
65693249|NCT03341234|Anesthetics|anesthetics|mesh-ancestor
65693250|NCT03341234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65693251|NCT03341234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693252|NCT03341234|Sensory System Agents|sensory system agents|mesh-ancestor
65693253|NCT03341234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693254|NCT02499224|Monoclonal antibody YYB-101|monoclonal antibody yyb-101|mesh-list
65693255|NCT02499224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693256|NCT03120494|Tenofovir|tenofovir|mesh-list
65693257|NCT03120494|Emtricitabine|emtricitabine|mesh-list
65693258|NCT03120494|Antiviral Agents|antiviral agents|mesh-ancestor
65693259|NCT03120494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65693260|NCT03120494|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65693261|NCT03120494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65693262|NCT03120494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693263|NCT03120494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693264|NCT03120494|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65693265|NCT03120494|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65693266|NCT03537573|Analgesics, Opioid|analgesics, opioid|mesh-list
65693267|NCT03537573|Narcotics|narcotics|mesh-ancestor
65693268|NCT03537573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65693269|NCT03537573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693270|NCT03537573|Analgesics|analgesics|mesh-ancestor
65693271|NCT03537573|Sensory System Agents|sensory system agents|mesh-ancestor
65693272|NCT03537573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693273|NCT03120962|Famciclovir|famciclovir|mesh-list
65693274|NCT03120962|Oxycodone|oxycodone|mesh-list
65693275|NCT03120962|Gabapentin|gabapentin|mesh-list
65693276|NCT03120962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65693277|NCT03120962|Narcotics|narcotics|mesh-ancestor
65693278|NCT03120962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65693279|NCT03120962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693280|NCT03120962|Analgesics|analgesics|mesh-ancestor
65693281|NCT03120962|Sensory System Agents|sensory system agents|mesh-ancestor
65693282|NCT03120962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693283|NCT03120962|Anticonvulsants|anticonvulsants|mesh-ancestor
65693284|NCT03120962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65693285|NCT03120962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65693286|NCT03120962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65693287|NCT03120962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65693288|NCT03120962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65693289|NCT03120962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65693290|NCT03120962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693291|NCT03120962|Antimanic Agents|antimanic agents|mesh-ancestor
65693292|NCT03120962|Antiviral Agents|antiviral agents|mesh-ancestor
65693293|NCT03120962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65693294|NCT03120962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65693295|NCT03120962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693297|NCT02178813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65693298|NCT02178813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65693299|NCT03340922|Long-Acting Thyroid Stimulator|long-acting thyroid stimulator|mesh-list
65693300|NCT03340922|Immunologic Factors|immunologic factors|mesh-ancestor
65693301|NCT03340922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693302|NCT02177253|Bromides|bromides|mesh-list
65693303|NCT02177253|Albuterol|albuterol|mesh-list
65693304|NCT02177253|Ipratropium|ipratropium|mesh-list
65693305|NCT02177253|Anticonvulsants|anticonvulsants|mesh-ancestor
65693306|NCT02177253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65693307|NCT02177253|Autonomic Agents|autonomic agents|mesh-ancestor
65693308|NCT02177253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693309|NCT02177253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693310|NCT02177253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65693311|NCT02177253|Respiratory System Agents|respiratory system agents|mesh-ancestor
65693312|NCT02177253|Tocolytic Agents|tocolytic agents|mesh-ancestor
65693313|NCT02177253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65693314|NCT02177253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65693315|NCT02177253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65693316|NCT02177253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65693317|NCT02177253|Adrenergic Agents|adrenergic agents|mesh-ancestor
65693318|NCT02177253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65693319|NCT02177253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693320|NCT02177253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65693321|NCT02177253|Cholinergic Agents|cholinergic agents|mesh-ancestor
65693322|NCT02177331|Lacidipine|lacidipine|mesh-list
65693323|NCT02177331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65693324|NCT02177331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65693325|NCT02177331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65693326|NCT02177331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693327|NCT02177331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65693328|NCT02177331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693329|NCT02177409|Amlodipine|amlodipine|mesh-list
65693330|NCT02177409|Telmisartan|telmisartan|mesh-list
65693331|NCT02177409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65693332|NCT02177409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65693333|NCT02177409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65693334|NCT02177409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693335|NCT02177409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65693336|NCT02177409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693337|NCT02177409|Vasodilator Agents|vasodilator agents|mesh-ancestor
65693338|NCT02177409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65693339|NCT02177409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65693340|NCT02170623|Pantoprazole|pantoprazole|mesh-list
65693341|NCT02170623|Dabigatran|dabigatran|mesh-list
65693342|NCT02170623|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65693343|NCT02170623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65693344|NCT02170623|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65693345|NCT02170623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693346|NCT02170623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693347|NCT02170623|Antithrombins|antithrombins|mesh-ancestor
65693348|NCT02170623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65693349|NCT02170623|Protease Inhibitors|protease inhibitors|mesh-ancestor
65693350|NCT02170623|Anticoagulants|anticoagulants|mesh-ancestor
65693351|NCT02170701|Dabigatran|dabigatran|mesh-list
65693352|NCT02170701|Antithrombins|antithrombins|mesh-ancestor
65693353|NCT02170701|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65693354|NCT02170701|Protease Inhibitors|protease inhibitors|mesh-ancestor
65693355|NCT02170701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693356|NCT02170701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693358|NCT02498756|Ipilimumab|ipilimumab|mesh-list
65693359|NCT02498756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65693360|NCT02498756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693361|NCT02498756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65693362|NCT02498756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693363|NCT03336632|Cyclosporine|cyclosporine|mesh-list
65693364|NCT03336632|Cyclophosphamide|cyclophosphamide|mesh-list
65693365|NCT03336632|Cyclosporins|cyclosporins|mesh-list
65693366|NCT03336632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65693367|NCT03336632|Immunologic Factors|immunologic factors|mesh-ancestor
65693368|NCT03336632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693369|NCT03336632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65693370|NCT03336632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65693371|NCT03336632|Alkylating Agents|alkylating agents|mesh-ancestor
65693372|NCT03336632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693373|NCT03336632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693374|NCT03336632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65693375|NCT03336632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693376|NCT03336632|Antifungal Agents|antifungal agents|mesh-ancestor
65693377|NCT03336632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65693378|NCT03336632|Dermatologic Agents|dermatologic agents|mesh-ancestor
65156012|NCT00990652|Bortezomib|bortezomib|mesh-list
65693379|NCT03336632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65693380|NCT02498288|Isotretinoin|isotretinoin|mesh-list
65693381|NCT02498288|Dermatologic Agents|dermatologic agents|mesh-ancestor
65693382|NCT02756403|Azithromycin|azithromycin|mesh-list
65693383|NCT02756403|Metronidazole|metronidazole|mesh-list
65693384|NCT02756403|Doxycycline|doxycycline|mesh-list
65693385|NCT02756403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65693386|NCT02756403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65693387|NCT02756403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65693388|NCT02756403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65693389|NCT02756403|Antimalarials|antimalarials|mesh-ancestor
65693390|NCT02494466|Montelukast|montelukast|mesh-list
65693391|NCT02494466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65693392|NCT02494466|Respiratory System Agents|respiratory system agents|mesh-ancestor
65693393|NCT02494466|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65693394|NCT02494466|Hormone Antagonists|hormone antagonists|mesh-ancestor
65693395|NCT02494466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65693396|NCT02494466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693397|NCT02494466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65693398|NCT02494466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65693399|NCT02494466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693400|NCT02177487|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65693401|NCT02177487|Telmisartan|telmisartan|mesh-list
65693402|NCT02177487|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
65693403|NCT02177487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65693404|NCT02177487|Diuretics|diuretics|mesh-ancestor
65693405|NCT02177487|Natriuretic Agents|natriuretic agents|mesh-ancestor
65693406|NCT02177487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693407|NCT02177487|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65693408|NCT02177487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65693409|NCT02177487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693410|NCT02177487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65693411|NCT02177487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65693412|NCT02177643|Diacetylrhein|diacetylrhein|mesh-list
65693413|NCT02177643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65693414|NCT03340376|Doxorubicin|doxorubicin|mesh-list
65693415|NCT03340376|Atezolizumab|atezolizumab|mesh-list
65693416|NCT03340376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65693417|NCT03340376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693418|NCT03340376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65693419|NCT03340376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65693420|NCT03340376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693421|NCT03340376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693422|NCT02182167|Acetylcysteine|acetylcysteine|mesh-list
65693423|NCT02182167|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65693424|NCT02182167|Antiviral Agents|antiviral agents|mesh-ancestor
65693425|NCT02182167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65693426|NCT02182167|Expectorants|expectorants|mesh-ancestor
65693427|NCT02182167|Respiratory System Agents|respiratory system agents|mesh-ancestor
65693428|NCT02182167|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65693429|NCT02182167|Antioxidants|antioxidants|mesh-ancestor
65490748|NCT01120314|Anticoagulants|anticoagulants|mesh-ancestor
65693430|NCT02182167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693431|NCT02182167|Protective Agents|protective agents|mesh-ancestor
65693432|NCT02182167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693433|NCT02182167|Antidotes|antidotes|mesh-ancestor
65693434|NCT03336242|Cannabidiol|cannabidiol|mesh-list
65693435|NCT03336242|Anticonvulsants|anticonvulsants|mesh-ancestor
65693436|NCT02182245|Paclitaxel|paclitaxel|mesh-list
65693437|NCT02182245|Carboplatin|carboplatin|mesh-list
65693438|NCT02182245|Nintedanib|nintedanib|mesh-list
65693439|NCT02182245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65693440|NCT02182245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693441|NCT02182245|Tubulin Modulators|tubulin modulators|mesh-ancestor
65693442|NCT02182245|Antimitotic Agents|antimitotic agents|mesh-ancestor
65693443|NCT02182245|Mitosis Modulators|mitosis modulators|mesh-ancestor
65693444|NCT02182245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693445|NCT02182245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65693446|NCT02182245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693447|NCT05233124|Aspirin|aspirin|mesh-list
65693448|NCT05233124|Rivaroxaban|rivaroxaban|mesh-list
65693449|NCT05233124|Clopidogrel|clopidogrel|mesh-list
65693450|NCT05233124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65693451|NCT05233124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65693452|NCT05233124|Analgesics|analgesics|mesh-ancestor
65693453|NCT05233124|Sensory System Agents|sensory system agents|mesh-ancestor
65693454|NCT05233124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693455|NCT05233124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693456|NCT05233124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65693457|NCT05233124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65693458|NCT05233124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65693459|NCT05233124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65693460|NCT05233124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693461|NCT05233124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65693462|NCT05233124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65693463|NCT05233124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693464|NCT05233124|Antipyretics|antipyretics|mesh-ancestor
65693465|NCT05233124|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65693466|NCT05233124|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65693467|NCT05233124|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65693468|NCT05233124|Purinergic Agents|purinergic agents|mesh-ancestor
65693469|NCT05233124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65693470|NCT05233124|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65693471|NCT05233124|Antithrombins|antithrombins|mesh-ancestor
65693472|NCT05233124|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65693473|NCT05233124|Protease Inhibitors|protease inhibitors|mesh-ancestor
65693474|NCT05233124|Anticoagulants|anticoagulants|mesh-ancestor
65693475|NCT03339752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65693476|NCT03339752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65693477|NCT03339752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65693478|NCT03339752|Antimetabolites|antimetabolites|mesh-ancestor
65693479|NCT03339752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693480|NCT03339752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65693481|NCT03339752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65693482|NCT03339752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693483|NCT03339362|Methylprednisolone|methylprednisolone|mesh-list
65693484|NCT03339362|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65693485|NCT03339362|Bupivacaine|bupivacaine|mesh-list
65693486|NCT03339362|Anesthetics, Local|anesthetics, local|mesh-ancestor
65693487|NCT03339362|Anesthetics|anesthetics|mesh-ancestor
65693488|NCT03339362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65693489|NCT03339362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693490|NCT03339362|Sensory System Agents|sensory system agents|mesh-ancestor
65693491|NCT03339362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693492|NCT03339362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65693493|NCT03339362|Antiemetics|antiemetics|mesh-ancestor
65693494|NCT03339362|Autonomic Agents|autonomic agents|mesh-ancestor
65693495|NCT03339362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65693496|NCT03339362|Glucocorticoids|glucocorticoids|mesh-ancestor
65693497|NCT03339362|Hormones|hormones|mesh-ancestor
65693498|NCT03339362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65693499|NCT03339362|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65693500|NCT03339362|Protective Agents|protective agents|mesh-ancestor
65693501|NCT02497820|Aspirin|aspirin|mesh-list
65693502|NCT02497820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65693503|NCT02497820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65490835|NCT01319344|Eplerenone|eplerenone|mesh-list
65693504|NCT02497820|Analgesics|analgesics|mesh-ancestor
65693505|NCT02497820|Sensory System Agents|sensory system agents|mesh-ancestor
65693506|NCT02497820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693507|NCT02497820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693508|NCT02497820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65693509|NCT02497820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65693510|NCT02497820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65693511|NCT02497820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65693512|NCT02497820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693513|NCT02497820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65693514|NCT02497820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65693515|NCT02497820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693516|NCT02497820|Antipyretics|antipyretics|mesh-ancestor
65693517|NCT02497508|Nivolumab|nivolumab|mesh-list
65693518|NCT02497508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65693519|NCT02497508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693520|NCT02497508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65693521|NCT02497508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693522|NCT03338426|Atorvastatin|atorvastatin|mesh-list
65693523|NCT03338426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65693524|NCT03338426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65693525|NCT03338426|Antimetabolites|antimetabolites|mesh-ancestor
65156159|NCT02867176|Antimanic Agents|antimanic agents|mesh-ancestor
65693526|NCT03338426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693527|NCT03338426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65693528|NCT03338426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65693529|NCT03338426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693530|NCT03338348|Azacitidine|azacitidine|mesh-list
65693531|NCT03338348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65693532|NCT03338348|Antimetabolites|antimetabolites|mesh-ancestor
65693533|NCT03338348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693534|NCT03338348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693535|NCT03338348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693536|NCT03334838|Nifurtimox|nifurtimox|mesh-list
65693537|NCT03334838|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65693538|NCT03334838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65693539|NCT03334838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65693540|NCT03334838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65693541|NCT02497118|Vinorelbine|vinorelbine|mesh-list
65693542|NCT02497118|Endostatins|endostatins|mesh-list
65693543|NCT02497118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693544|NCT02497118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65693545|NCT02497118|Tubulin Modulators|tubulin modulators|mesh-ancestor
65693546|NCT02497118|Antimitotic Agents|antimitotic agents|mesh-ancestor
65693547|NCT02497118|Mitosis Modulators|mitosis modulators|mesh-ancestor
65693548|NCT02497118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693549|NCT02497118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65693550|NCT02497118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65693551|NCT02497118|Growth Substances|growth substances|mesh-ancestor
65693552|NCT02497118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693553|NCT02497118|Growth Inhibitors|growth inhibitors|mesh-ancestor
65693554|NCT02496962|Atorvastatin|atorvastatin|mesh-list
65693555|NCT02496962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65693556|NCT02496962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65693557|NCT02496962|Antimetabolites|antimetabolites|mesh-ancestor
65693558|NCT02496962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693559|NCT02496962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65693560|NCT02496962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65693561|NCT02496962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693562|NCT03334136|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65693563|NCT03334136|Calcifediol|calcifediol|mesh-list
65693564|NCT03334136|Vitamins|vitamins|mesh-ancestor
65693565|NCT03334136|Micronutrients|micronutrients|mesh-ancestor
65693566|NCT03334136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693567|NCT03334136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65693568|NCT03120728|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65693569|NCT03120728|Etonogestrel|etonogestrel|mesh-list
65693570|NCT03120728|NuvaRing|nuvaring|mesh-list
65693571|NCT03120728|Contraceptive Agents|contraceptive agents|mesh-list
65693572|NCT03120728|Estradiol|estradiol|mesh-list
65693573|NCT03120728|Estrogens|estrogens|mesh-ancestor
65693574|NCT03120728|Hormones|hormones|mesh-ancestor
65693575|NCT03120728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65693576|NCT03120728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693577|NCT03120728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65693578|NCT03120728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65693579|NCT03120728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65693580|NCT03120728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65693581|NCT03120728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65693582|NCT02496650|Dexmedetomidine|dexmedetomidine|mesh-list
65693583|NCT02496650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65693584|NCT02496650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65693585|NCT02496650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693586|NCT02496650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65693587|NCT02496650|Analgesics|analgesics|mesh-ancestor
65693588|NCT02496650|Sensory System Agents|sensory system agents|mesh-ancestor
65693589|NCT02496650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693590|NCT02496650|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65693591|NCT02496650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65693592|NCT02496650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65693593|NCT02496650|Adrenergic Agents|adrenergic agents|mesh-ancestor
65693594|NCT02496650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65693595|NCT02496650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693596|NCT02492438|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65693597|NCT02492438|Immunologic Factors|immunologic factors|mesh-ancestor
65693598|NCT02492438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693599|NCT03342170|Thrombin|thrombin|mesh-list
65693600|NCT03342170|Hemostatics|hemostatics|mesh-ancestor
65693601|NCT03342170|Coagulants|coagulants|mesh-ancestor
65693602|NCT03333824|Midazolam|midazolam|mesh-list
65693603|NCT03333824|Granisetron|granisetron|mesh-list
65693604|NCT03333824|Caffeine|caffeine|mesh-list
65693605|NCT03333824|Omeprazole|omeprazole|mesh-list
65693606|NCT03333824|Adavosertib|adavosertib|mesh-list
65693607|NCT03333824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65693608|NCT03333824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65693609|NCT03333824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65693610|NCT03333824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693611|NCT03333824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65693612|NCT03333824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65693613|NCT03333824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65693614|NCT03333824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65693615|NCT03333824|Anesthetics, General|anesthetics, general|mesh-ancestor
65693616|NCT03333824|Anesthetics|anesthetics|mesh-ancestor
65693617|NCT03333824|GABA Modulators|gaba modulators|mesh-ancestor
65693618|NCT03333824|GABA Agents|gaba agents|mesh-ancestor
65693619|NCT03333824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65693620|NCT03333824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693621|NCT03333824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65693622|NCT03333824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65693623|NCT03333824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693624|NCT03333824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65693625|NCT03333824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65693626|NCT03333824|Purinergic Agents|purinergic agents|mesh-ancestor
65693627|NCT03333824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65693628|NCT03333824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65693629|NCT03333824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65693630|NCT03333824|Antiemetics|antiemetics|mesh-ancestor
65693631|NCT03333824|Autonomic Agents|autonomic agents|mesh-ancestor
65693632|NCT03333824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693633|NCT03333824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65693634|NCT03333824|Serotonin Agents|serotonin agents|mesh-ancestor
65693635|NCT02496494|Tacrolimus|tacrolimus|mesh-list
65693636|NCT02496494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65693637|NCT02496494|Immunologic Factors|immunologic factors|mesh-ancestor
65693638|NCT02496494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693639|NCT02496494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65693640|NCT02496494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693641|NCT02496494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693642|NCT03333278|Vitamins|vitamins|mesh-list
65693643|NCT03333278|Ascorbic Acid|ascorbic acid|mesh-list
65693644|NCT03333278|Thiamine|thiamine|mesh-list
65693645|NCT03333278|Hydrocortisone|hydrocortisone|mesh-list
65693646|NCT03333278|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65693647|NCT03333278|Micronutrients|micronutrients|mesh-ancestor
65693648|NCT03333278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693649|NCT03333278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65693650|NCT03333278|Antioxidants|antioxidants|mesh-ancestor
65693651|NCT03333278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693652|NCT03333278|Protective Agents|protective agents|mesh-ancestor
65693653|NCT03333278|Vitamin B Complex|vitamin b complex|mesh-ancestor
65693654|NCT04847596|Ofatumumab|ofatumumab|mesh-list
65693655|NCT04847596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693656|NCT00706628|Nintedanib|nintedanib|mesh-list
65693657|NCT00706628|Afatinib|afatinib|mesh-list
65693658|NCT00706628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693659|NCT00706628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65693661|NCT00706628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693662|NCT05465330|Propofol|propofol|mesh-list
65693663|NCT05465330|Desflurane|desflurane|mesh-list
65693664|NCT05465330|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65693665|NCT05465330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65693666|NCT05465330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693667|NCT05465330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65693668|NCT05465330|Anesthetics, General|anesthetics, general|mesh-ancestor
65693669|NCT05465330|Anesthetics|anesthetics|mesh-ancestor
65693670|NCT05465330|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65693671|NCT05463614|Propranolol|propranolol|mesh-list
65693672|NCT05463614|Propafenone|propafenone|mesh-list
65693673|NCT05463614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65693674|NCT05463614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65693675|NCT05463614|Adrenergic Agents|adrenergic agents|mesh-ancestor
65693676|NCT05463614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65693677|NCT05463614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693678|NCT05463614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693679|NCT05463614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65693680|NCT05463614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65693681|NCT05463614|Vasodilator Agents|vasodilator agents|mesh-ancestor
65693682|NCT05463614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65693683|NCT05463614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65693684|NCT05463614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65693685|NCT03332888|Rituximab|rituximab|mesh-list
65693686|NCT03332888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65693687|NCT03332888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693688|NCT03332888|Immunologic Factors|immunologic factors|mesh-ancestor
65693689|NCT03332888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693690|NCT03332888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65693691|NCT03332732|Metronidazole|metronidazole|mesh-list
65693692|NCT03332732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65693693|NCT03332732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65693694|NCT03332732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65693695|NCT03332732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65693696|NCT02492360|Cisplatin|cisplatin|mesh-list
65693697|NCT02492360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693698|NCT02492282|Remifentanil|remifentanil|mesh-list
65693699|NCT02492282|Propofol|propofol|mesh-list
65693700|NCT02492282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65693701|NCT02492282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65693702|NCT02492282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693703|NCT02492282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65693704|NCT02492282|Anesthetics, General|anesthetics, general|mesh-ancestor
65693705|NCT02492282|Anesthetics|anesthetics|mesh-ancestor
65693706|NCT02492282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65693707|NCT02492282|Narcotics|narcotics|mesh-ancestor
65693708|NCT02492282|Analgesics|analgesics|mesh-ancestor
65693709|NCT02492282|Sensory System Agents|sensory system agents|mesh-ancestor
65693710|NCT02492282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693711|NCT02492126|Citric Acid|citric acid|mesh-list
65693712|NCT02492126|Sodium Citrate|sodium citrate|mesh-list
65693713|NCT02492126|Anticoagulants|anticoagulants|mesh-ancestor
65693714|NCT02492126|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65693715|NCT02492126|Chelating Agents|chelating agents|mesh-ancestor
65693716|NCT02492126|Sequestering Agents|sequestering agents|mesh-ancestor
65693717|NCT02492126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693718|NCT05464862|Lidocaine|lidocaine|mesh-list
65693719|NCT05464862|Anesthetics, Local|anesthetics, local|mesh-ancestor
65693720|NCT05464862|Anesthetics|anesthetics|mesh-ancestor
65693721|NCT05464862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65693722|NCT05464862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693723|NCT05464862|Sensory System Agents|sensory system agents|mesh-ancestor
65693724|NCT05464862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693725|NCT05464862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65693726|NCT05464862|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65693727|NCT05464862|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65693728|NCT05464862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65693729|NCT05464862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693730|NCT03324776|Insulin|insulin|mesh-list
65693731|NCT03324776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65693732|NCT03324776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65491048|NCT01123278|Testosterone|testosterone|mesh-list
65693733|NCT03324776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693734|NCT02561806|Ustekinumab|ustekinumab|mesh-list
65693735|NCT02561806|Ixekizumab|ixekizumab|mesh-list
65693736|NCT02561806|Dermatologic Agents|dermatologic agents|mesh-ancestor
65693737|NCT03332576|Cyclophosphamide|cyclophosphamide|mesh-list
65693738|NCT03332576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65693739|NCT03332576|Immunologic Factors|immunologic factors|mesh-ancestor
65693740|NCT03332576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693741|NCT03332576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65693742|NCT03332576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65693743|NCT03332576|Alkylating Agents|alkylating agents|mesh-ancestor
65693744|NCT03332576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693745|NCT03332576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693746|NCT03332576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65693747|NCT03330860|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65693748|NCT03330860|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
65693749|NCT03330860|beta-Endorphin|beta-endorphin|mesh-list
65693750|NCT03330860|Hormones|hormones|mesh-ancestor
65693751|NCT03330860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65693752|NCT03330860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693753|NCT03330860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65693754|NCT03330860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693755|NCT03324542|Ranibizumab|ranibizumab|mesh-list
65693756|NCT03324542|Aflibercept|aflibercept|mesh-list
65693757|NCT03324542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693758|NCT03324542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65693759|NCT03324542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65693760|NCT03324542|Growth Substances|growth substances|mesh-ancestor
65693761|NCT03324542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693762|NCT03324542|Growth Inhibitors|growth inhibitors|mesh-ancestor
65693763|NCT03330782|Remifentanil|remifentanil|mesh-list
65693764|NCT03330782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65693765|NCT03330782|Narcotics|narcotics|mesh-ancestor
65693766|NCT03330782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65693767|NCT03330782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693768|NCT03330782|Analgesics|analgesics|mesh-ancestor
65693769|NCT03330782|Sensory System Agents|sensory system agents|mesh-ancestor
65693770|NCT03330782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693771|NCT05506462|Ketamine|ketamine|mesh-list
65693772|NCT05506462|Analgesics|analgesics|mesh-ancestor
65693773|NCT05506462|Sensory System Agents|sensory system agents|mesh-ancestor
65693774|NCT05506462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693775|NCT05506462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693776|NCT05506462|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65693777|NCT05506462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65693778|NCT05506462|Anesthetics, General|anesthetics, general|mesh-ancestor
65693779|NCT05506462|Anesthetics|anesthetics|mesh-ancestor
65693780|NCT05506462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65693781|NCT05506462|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65693782|NCT05506462|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65693783|NCT05506462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65693784|NCT05506462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693785|NCT05501704|Tamoxifen|tamoxifen|mesh-list
65693786|NCT05501704|Anastrozole|anastrozole|mesh-list
65693787|NCT05501704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65693788|NCT05501704|Hormone Antagonists|hormone antagonists|mesh-ancestor
65693789|NCT05501704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65693790|NCT05501704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693791|NCT05501704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65693792|NCT05501704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693793|NCT05501704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65693794|NCT05501704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65693795|NCT05501704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65693796|NCT05501704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65693797|NCT05501704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65693798|NCT05501704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693799|NCT05501704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693800|NCT05505994|Dapagliflozin|dapagliflozin|mesh-list
65693801|NCT05505994|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65693802|NCT05505994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693803|NCT05505994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65491122|NCT03934710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693804|NCT05505994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693805|NCT02491268|Cilostazol|cilostazol|mesh-list
65693806|NCT02491268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65693807|NCT02491268|Autonomic Agents|autonomic agents|mesh-ancestor
65693808|NCT02491268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693809|NCT02491268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693810|NCT02491268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65693811|NCT02491268|Respiratory System Agents|respiratory system agents|mesh-ancestor
65693812|NCT02491268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65693813|NCT02491268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65693814|NCT02491268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693815|NCT02491268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65693816|NCT02491268|Vasodilator Agents|vasodilator agents|mesh-ancestor
65693817|NCT02491268|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65693818|NCT02491268|Protective Agents|protective agents|mesh-ancestor
65693819|NCT02491268|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65693820|NCT02491268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65693821|NCT02491268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693822|NCT03323684|Acetaminophen|acetaminophen|mesh-list
65693823|NCT03323684|Ketorolac|ketorolac|mesh-list
65693824|NCT03323684|Fentanyl|fentanyl|mesh-list
65693825|NCT03323684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65693826|NCT03323684|Narcotics|narcotics|mesh-ancestor
65693827|NCT03323684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65693828|NCT03323684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693829|NCT03323684|Analgesics|analgesics|mesh-ancestor
65693830|NCT03323684|Sensory System Agents|sensory system agents|mesh-ancestor
65693831|NCT03323684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693832|NCT03323684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65693833|NCT03323684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65693834|NCT03323684|Anesthetics, General|anesthetics, general|mesh-ancestor
65693835|NCT03323684|Anesthetics|anesthetics|mesh-ancestor
65693836|NCT03323684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65693837|NCT03323684|Antipyretics|antipyretics|mesh-ancestor
65693838|NCT03323684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65693839|NCT03323684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65693840|NCT03323684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65693841|NCT03323684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65693842|NCT03323684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693843|NCT03323684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693844|NCT02182401|Tolbutamide|tolbutamide|mesh-list
65693845|NCT02182401|Midazolam|midazolam|mesh-list
65693846|NCT02182401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65693847|NCT02182401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65693848|NCT02182401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65693849|NCT02182401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693850|NCT02182401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65693851|NCT02182401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65693852|NCT02182401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65693853|NCT02182401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65693854|NCT02182401|Anesthetics, General|anesthetics, general|mesh-ancestor
65693855|NCT02182401|Anesthetics|anesthetics|mesh-ancestor
65693856|NCT02182401|GABA Modulators|gaba modulators|mesh-ancestor
65693857|NCT02182401|GABA Agents|gaba agents|mesh-ancestor
65693858|NCT02182401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65693859|NCT02182401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693860|NCT02182401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65693861|NCT04292080|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65693862|NCT04292080|Dermatologic Agents|dermatologic agents|mesh-ancestor
65693863|NCT04292080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65693864|NCT04292080|Immunologic Factors|immunologic factors|mesh-ancestor
65693865|NCT04292080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693866|NCT02177955|Midazolam|midazolam|mesh-list
65693867|NCT02177955|Diazepam|diazepam|mesh-list
65693868|NCT02177955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65693869|NCT02177955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65693870|NCT02177955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65693871|NCT02177955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693872|NCT02177955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65693873|NCT02177955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65693874|NCT02177955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65693875|NCT02177955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65693876|NCT02177955|Anesthetics, General|anesthetics, general|mesh-ancestor
65693877|NCT02177955|Anesthetics|anesthetics|mesh-ancestor
65693878|NCT02177955|GABA Modulators|gaba modulators|mesh-ancestor
65693879|NCT02177955|GABA Agents|gaba agents|mesh-ancestor
65693880|NCT02177955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65693881|NCT02177955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693882|NCT02177955|Anticonvulsants|anticonvulsants|mesh-ancestor
65693883|NCT02177955|Antiemetics|antiemetics|mesh-ancestor
65693884|NCT02177955|Autonomic Agents|autonomic agents|mesh-ancestor
65693885|NCT02177955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693886|NCT02177955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65693887|NCT02177955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65693888|NCT02177955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65693889|NCT03323528|Benzalkonium Compounds|benzalkonium compounds|mesh-list
65693890|NCT03323528|Benzocaine|benzocaine|mesh-list
65693891|NCT03323528|Anesthetics, Local|anesthetics, local|mesh-ancestor
65693892|NCT03323528|Anesthetics|anesthetics|mesh-ancestor
65693893|NCT03323528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65693894|NCT03323528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693895|NCT03323528|Sensory System Agents|sensory system agents|mesh-ancestor
65693896|NCT03323528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693897|NCT03323528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65693898|NCT03323528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65693899|NCT05501158|Tamoxifen|tamoxifen|mesh-list
65693900|NCT05501158|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65693901|NCT05501158|Hormone Antagonists|hormone antagonists|mesh-ancestor
65693902|NCT05501158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65693903|NCT05501158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693904|NCT05501158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65693905|NCT05501158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693906|NCT05501158|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65693907|NCT05501158|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65693908|NCT05501158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65693909|NCT03537807|Riluzole|riluzole|mesh-list
65693910|NCT03537807|Anticonvulsants|anticonvulsants|mesh-ancestor
65693911|NCT03537807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65693912|NCT03537807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65693913|NCT03537807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65693914|NCT03537807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693915|NCT03537807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693916|NCT03537807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65693917|NCT03537807|Protective Agents|protective agents|mesh-ancestor
65693918|NCT02182479|Fenoterol|fenoterol|mesh-list
65693919|NCT02182479|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
65693920|NCT02182479|Ipratropium|ipratropium|mesh-list
65693921|NCT02182479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65693922|NCT02182479|Autonomic Agents|autonomic agents|mesh-ancestor
65693923|NCT02182479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693924|NCT02182479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693925|NCT02182479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65693926|NCT02182479|Respiratory System Agents|respiratory system agents|mesh-ancestor
65693927|NCT02182479|Sympathomimetics|sympathomimetics|mesh-ancestor
65693928|NCT02182479|Tocolytic Agents|tocolytic agents|mesh-ancestor
65693929|NCT02182479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65693930|NCT02182479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65693931|NCT02182479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65693932|NCT02182479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65693933|NCT02182479|Adrenergic Agents|adrenergic agents|mesh-ancestor
65693934|NCT02182479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65693935|NCT02182479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693936|NCT02182479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65693937|NCT02182479|Cholinergic Agents|cholinergic agents|mesh-ancestor
65693938|NCT02560558|Abatacept|abatacept|mesh-list
65693939|NCT02560558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65693940|NCT02560558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693941|NCT02560558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65693942|NCT02560558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65693943|NCT02560558|Immunologic Factors|immunologic factors|mesh-ancestor
65693944|NCT02560558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693945|NCT02560558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65693946|NCT03329456|Ropivacaine|ropivacaine|mesh-list
65693947|NCT03329456|Anesthetics, Local|anesthetics, local|mesh-ancestor
65693948|NCT03329456|Anesthetics|anesthetics|mesh-ancestor
65693949|NCT03329456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65693950|NCT03329456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693951|NCT03329456|Sensory System Agents|sensory system agents|mesh-ancestor
65693952|NCT03329456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693953|NCT02178033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65693954|NCT02491736|Ketoprofen|ketoprofen|mesh-list
65693955|NCT02491736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65693956|NCT02491736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65693957|NCT02491736|Analgesics|analgesics|mesh-ancestor
65693958|NCT02491736|Sensory System Agents|sensory system agents|mesh-ancestor
65693959|NCT02491736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693960|NCT02491736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693961|NCT02491736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65693962|NCT02491736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65693963|NCT02491736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65693964|NCT02491736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65693965|NCT02491736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693966|NCT05501080|Spironolactone|spironolactone|mesh-list
65693967|NCT05501080|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65693968|NCT05501080|Hormone Antagonists|hormone antagonists|mesh-ancestor
65693969|NCT05501080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65693970|NCT05501080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693971|NCT05501080|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65693972|NCT05501080|Diuretics|diuretics|mesh-ancestor
65693973|NCT05501080|Natriuretic Agents|natriuretic agents|mesh-ancestor
65693974|NCT02491970|Fluticasone|fluticasone|mesh-list
65693976|NCT02491970|Formoterol Fumarate|formoterol fumarate|mesh-list
65693977|NCT02491970|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65693978|NCT02491970|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65693979|NCT02491970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65693980|NCT02491970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65693981|NCT02491970|Autonomic Agents|autonomic agents|mesh-ancestor
65693982|NCT02491970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65693983|NCT02491970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65693984|NCT02491970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65693985|NCT02491970|Respiratory System Agents|respiratory system agents|mesh-ancestor
65693986|NCT02491970|Dermatologic Agents|dermatologic agents|mesh-ancestor
65693987|NCT02491970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65693988|NCT02491970|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65693989|NCT02491970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65693990|NCT02491970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65693991|NCT02491970|Adrenergic Agents|adrenergic agents|mesh-ancestor
65693992|NCT02491970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65693993|NCT02491970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65693994|NCT02491970|Glucocorticoids|glucocorticoids|mesh-ancestor
65693995|NCT02491970|Hormones|hormones|mesh-ancestor
65693996|NCT02491970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65693997|NCT02491970|Sympathomimetics|sympathomimetics|mesh-ancestor
65693998|NCT02182557|Ketotifen|ketotifen|mesh-list
65693999|NCT02182557|Epinastine|epinastine|mesh-list
65694000|NCT02182557|Antipruritics|antipruritics|mesh-ancestor
65694001|NCT02182557|Dermatologic Agents|dermatologic agents|mesh-ancestor
65694002|NCT02182557|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65694003|NCT02182557|Histamine Antagonists|histamine antagonists|mesh-ancestor
65694004|NCT02182557|Histamine Agents|histamine agents|mesh-ancestor
65694005|NCT02182557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65694006|NCT02182557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694007|NCT02182557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694008|NCT02182557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65694009|NCT02182635|Oxitropium|oxitropium|mesh-list
65694010|NCT02182635|Parasympatholytics|parasympatholytics|mesh-ancestor
65694011|NCT02182635|Autonomic Agents|autonomic agents|mesh-ancestor
65694012|NCT02182635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694013|NCT02182635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694014|NCT02182713|Bromides|bromides|mesh-list
65694015|NCT02182713|Albuterol|albuterol|mesh-list
65694016|NCT02182713|Ipratropium|ipratropium|mesh-list
65694017|NCT02182713|Anticonvulsants|anticonvulsants|mesh-ancestor
65694018|NCT02182713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65694019|NCT02182713|Autonomic Agents|autonomic agents|mesh-ancestor
65694020|NCT02182713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694021|NCT02182713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694022|NCT02182713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65694023|NCT02182713|Respiratory System Agents|respiratory system agents|mesh-ancestor
65694024|NCT02182713|Tocolytic Agents|tocolytic agents|mesh-ancestor
65694025|NCT02182713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65694026|NCT02182713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65694027|NCT02182713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65694028|NCT02182713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65694029|NCT02182713|Adrenergic Agents|adrenergic agents|mesh-ancestor
65694030|NCT02182713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65694031|NCT02182713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694032|NCT02182713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65694033|NCT02182713|Cholinergic Agents|cholinergic agents|mesh-ancestor
65694034|NCT03323372|Listerine|listerine|mesh-list
65694035|NCT03323372|Fluorides|fluorides|mesh-list
65694036|NCT03323372|Sodium Fluoride|sodium fluoride|mesh-list
65694037|NCT03323372|Cariostatic Agents|cariostatic agents|mesh-ancestor
65694038|NCT03323372|Protective Agents|protective agents|mesh-ancestor
65694039|NCT03323372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694040|NCT03323372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65694041|NCT03323372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65694042|NCT02180529|Methylphenidate|methylphenidate|mesh-list
65694043|NCT02180529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65694044|NCT02180529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694045|NCT02180529|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65694046|NCT02180529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65694047|NCT02180529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65694048|NCT02180529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694049|NCT02180529|Dopamine Agents|dopamine agents|mesh-ancestor
65694050|NCT02180529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65694051|NCT02182791|Nevirapine|nevirapine|mesh-list
65694052|NCT02182791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65694053|NCT02182791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65694054|NCT02182791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694055|NCT02182791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694056|NCT02182791|Antiviral Agents|antiviral agents|mesh-ancestor
65694057|NCT02182791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65694058|NCT02182791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65694059|NCT02182791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65694060|NCT02182791|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65694061|NCT02182791|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65694062|NCT03536325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65694063|NCT03536325|Immunologic Factors|immunologic factors|mesh-ancestor
65694064|NCT03536325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694065|NCT03536637|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65694066|NCT03536637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65694067|NCT03536637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65694068|NCT02488538|Fluoxetine|fluoxetine|mesh-list
65694069|NCT02488538|Contraceptive Agents|contraceptive agents|mesh-list
65694070|NCT02488538|Contraceptives, Oral|contraceptives, oral|mesh-list
65694071|NCT02488538|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65694072|NCT02488538|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65694073|NCT02488538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65694074|NCT02488538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65694075|NCT02488538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694076|NCT02488538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65694077|NCT02488538|Serotonin Agents|serotonin agents|mesh-ancestor
65694078|NCT02488538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694079|NCT02488538|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65694080|NCT02488538|Antidepressive Agents|antidepressive agents|mesh-ancestor
65694081|NCT02488538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65694082|NCT02488538|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65694083|NCT02488538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65694084|NCT02488538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694085|NCT02488538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65694086|NCT02488538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65694087|NCT02568046|Leucovorin|leucovorin|mesh-list
65694088|NCT02568046|Fluorouracil|fluorouracil|mesh-list
65694089|NCT02568046|Irinotecan|irinotecan|mesh-list
65694090|NCT02568046|Antimetabolites|antimetabolites|mesh-ancestor
65694091|NCT02568046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694092|NCT02568046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65694093|NCT02568046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65694094|NCT02568046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65694095|NCT02568046|Immunologic Factors|immunologic factors|mesh-ancestor
65694096|NCT02568046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694097|NCT02568046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65694098|NCT02568046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65694099|NCT02568046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694100|NCT02568046|Antidotes|antidotes|mesh-ancestor
65694101|NCT02568046|Protective Agents|protective agents|mesh-ancestor
65491419|NCT05760430|Bevacizumab|bevacizumab|mesh-list
65694102|NCT02568046|Vitamin B Complex|vitamin b complex|mesh-ancestor
65694103|NCT02568046|Vitamins|vitamins|mesh-ancestor
65694104|NCT02568046|Micronutrients|micronutrients|mesh-ancestor
65694105|NCT03536481|Ensartinib|ensartinib|mesh-list
65694106|NCT03536481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65694107|NCT03536481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65694108|NCT03536481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694109|NCT03536481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694110|NCT02488616|Insulin|insulin|mesh-list
65694111|NCT02488616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65694112|NCT02488616|Hormones|hormones|mesh-list
65694113|NCT02488616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65694114|NCT02488616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694115|NCT02488616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65694116|NCT02256423|Ibuprofen|ibuprofen|mesh-list
65694117|NCT02256423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65694118|NCT02256423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65694119|NCT02256423|Analgesics|analgesics|mesh-ancestor
65694120|NCT02256423|Sensory System Agents|sensory system agents|mesh-ancestor
65694121|NCT02256423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694122|NCT02256423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694123|NCT02256423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65694124|NCT02256423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65694125|NCT02256423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65694126|NCT02256423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694127|NCT02256423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694128|NCT03320486|Ketoconazole|ketoconazole|mesh-list
65694129|NCT03320486|Antifungal Agents|antifungal agents|mesh-ancestor
65694130|NCT03320486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65694131|NCT03320486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65694132|NCT03320486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65694133|NCT03320486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694134|NCT03320486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694135|NCT03320486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65694136|NCT03320486|Hormone Antagonists|hormone antagonists|mesh-ancestor
65694137|NCT03320486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65694138|NCT03320486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694139|NCT03320486|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65694140|NCT02567656|Tenalisib|tenalisib|mesh-list
65694141|NCT02567656|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
65694142|NCT02567656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694143|NCT02567656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694144|NCT02185833|Dirithromycin|dirithromycin|mesh-list
65694145|NCT02185833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65694146|NCT02185833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65694147|NCT02180997|Tamsulosin|tamsulosin|mesh-list
65694148|NCT02180997|Solifenacin Succinate|solifenacin succinate|mesh-list
65694149|NCT02180997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65694150|NCT02180997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65694151|NCT02180997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65694152|NCT02180997|Adrenergic Agents|adrenergic agents|mesh-ancestor
65694153|NCT02180997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65694154|NCT02180997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694155|NCT02180997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694156|NCT02180997|Urological Agents|urological agents|mesh-ancestor
65694157|NCT02180997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65694158|NCT02180997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65694159|NCT02180997|Cholinergic Agents|cholinergic agents|mesh-ancestor
65694160|NCT02560012|Sirolimus|sirolimus|mesh-list
65694161|NCT02560012|Everolimus|everolimus|mesh-list
65694162|NCT02560012|Sorafenib|sorafenib|mesh-list
65694163|NCT02560012|Sunitinib|sunitinib|mesh-list
65694164|NCT02560012|Axitinib|axitinib|mesh-list
65694165|NCT02560012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65694166|NCT02560012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65694167|NCT02560012|Immunologic Factors|immunologic factors|mesh-ancestor
65694168|NCT02560012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694169|NCT02560012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65694170|NCT02560012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694171|NCT02560012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694172|NCT02560012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65694173|NCT02560012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65694174|NCT02560012|Growth Substances|growth substances|mesh-ancestor
65694175|NCT02560012|Growth Inhibitors|growth inhibitors|mesh-ancestor
65694176|NCT02560012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65694177|NCT02560012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65694178|NCT02560012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65694179|NCT02560012|Antifungal Agents|antifungal agents|mesh-ancestor
65694180|NCT03320174|Tafenoquine|tafenoquine|mesh-list
65694181|NCT03320174|Antimalarials|antimalarials|mesh-ancestor
65694182|NCT03320174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65694183|NCT03320174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65694184|NCT03320174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65694185|NCT03328364|Docetaxel|docetaxel|mesh-list
65694186|NCT03328364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65694187|NCT03328364|Tubulin Modulators|tubulin modulators|mesh-ancestor
65694188|NCT03328364|Antimitotic Agents|antimitotic agents|mesh-ancestor
65694189|NCT03328364|Mitosis Modulators|mitosis modulators|mesh-ancestor
65694190|NCT03328364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694191|NCT04515472|Hormones|hormones|mesh-list
65694192|NCT04515472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694193|NCT04515472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65694194|NCT03328052|Antidepressive Agents|antidepressive agents|mesh-list
65694195|NCT03328052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65694196|NCT04514302|Immunoglobulins|immunoglobulins|mesh-list
65694197|NCT04514302|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65694198|NCT04514302|Antibodies|antibodies|mesh-list
65694199|NCT04514302|Immunologic Factors|immunologic factors|mesh-ancestor
65694200|NCT04514302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694201|NCT03319784|Triamcinolone|triamcinolone|mesh-list
65694202|NCT03319784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65694203|NCT03319784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65694204|NCT03319784|Ketorolac|ketorolac|mesh-list
65694205|NCT03319784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65694206|NCT03319784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65694207|NCT03319784|Glucocorticoids|glucocorticoids|mesh-ancestor
65694208|NCT03319784|Hormones|hormones|mesh-ancestor
65694209|NCT03319784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65694210|NCT03319784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694211|NCT03319784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65694212|NCT03319784|Immunologic Factors|immunologic factors|mesh-ancestor
65694213|NCT03319784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694214|NCT03319784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694215|NCT03319784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65694216|NCT03319784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65694217|NCT03319784|Analgesics|analgesics|mesh-ancestor
65694218|NCT03319784|Sensory System Agents|sensory system agents|mesh-ancestor
65694219|NCT03319784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694220|NCT03319784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65694221|NCT03319784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65694222|NCT03319706|Olmesartan|olmesartan|mesh-list
65694223|NCT03319706|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65694224|NCT03319706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65694225|NCT03319706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65694226|NCT03319706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65694227|NCT03319706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694228|NCT03322358|Diphenhydramine|diphenhydramine|mesh-list
65694229|NCT03322358|Promethazine|promethazine|mesh-list
65694230|NCT03322358|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65694231|NCT03322358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65694232|NCT03322358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65694233|NCT03322358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694234|NCT03322358|Anesthetics, Local|anesthetics, local|mesh-ancestor
65694235|NCT03322358|Anesthetics|anesthetics|mesh-ancestor
65694236|NCT03322358|Sensory System Agents|sensory system agents|mesh-ancestor
65694237|NCT03322358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694238|NCT03322358|Antiemetics|antiemetics|mesh-ancestor
65694239|NCT03322358|Autonomic Agents|autonomic agents|mesh-ancestor
65694240|NCT03322358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65694241|NCT03322358|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65694242|NCT03322358|Histamine Antagonists|histamine antagonists|mesh-ancestor
65694243|NCT03322358|Histamine Agents|histamine agents|mesh-ancestor
65694244|NCT03322358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65694245|NCT03322358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694246|NCT03322358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65694247|NCT03322358|Antipruritics|antipruritics|mesh-ancestor
65694248|NCT03322358|Dermatologic Agents|dermatologic agents|mesh-ancestor
65694249|NCT05045170|Dexmedetomidine|dexmedetomidine|mesh-list
65694250|NCT05045170|Propofol|propofol|mesh-list
65694251|NCT05045170|Anesthetics|anesthetics|mesh-ancestor
65694252|NCT05045170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65694253|NCT05045170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694254|NCT05045170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65694255|NCT05045170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65694256|NCT05045170|Anesthetics, General|anesthetics, general|mesh-ancestor
65694257|NCT05045170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65694258|NCT05045170|Analgesics|analgesics|mesh-ancestor
65694259|NCT05045170|Sensory System Agents|sensory system agents|mesh-ancestor
65694260|NCT05045170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694261|NCT05045170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65694262|NCT05045170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65694263|NCT05045170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65694264|NCT05045170|Adrenergic Agents|adrenergic agents|mesh-ancestor
65694265|NCT05045170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65694266|NCT05045170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694268|NCT05500690|Hematinics|hematinics|mesh-ancestor
65694269|NCT05500690|Vitamin B Complex|vitamin b complex|mesh-ancestor
65694270|NCT05500690|Vitamins|vitamins|mesh-ancestor
65694271|NCT05500690|Micronutrients|micronutrients|mesh-ancestor
65694272|NCT05500690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694273|NCT03322124|Octenidine|octenidine|mesh-list
65694274|NCT03322124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65694275|NCT03322124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65694276|NCT04442984|Leucovorin|leucovorin|mesh-list
65694277|NCT04442984|Oxaliplatin|oxaliplatin|mesh-list
65694278|NCT04442984|Irinotecan|irinotecan|mesh-list
65694279|NCT04442984|Fluorouracil|fluorouracil|mesh-list
65694280|NCT04442984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65694281|NCT04442984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65694282|NCT04442984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65694283|NCT04442984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694284|NCT04442984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694285|NCT04442984|Antidotes|antidotes|mesh-ancestor
65694286|NCT04442984|Protective Agents|protective agents|mesh-ancestor
65694287|NCT04442984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694288|NCT04442984|Vitamin B Complex|vitamin b complex|mesh-ancestor
65694289|NCT04442984|Vitamins|vitamins|mesh-ancestor
65694290|NCT04442984|Micronutrients|micronutrients|mesh-ancestor
65694291|NCT04442984|Antimetabolites|antimetabolites|mesh-ancestor
65694292|NCT04442984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65694293|NCT04442984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65694294|NCT04442984|Immunologic Factors|immunologic factors|mesh-ancestor
65694295|NCT03327506|Alprazolam|alprazolam|mesh-list
65694296|NCT03327506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65694297|NCT03327506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65694298|NCT03327506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694299|NCT03327506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65694300|NCT03327506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65694301|NCT03327506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65694302|NCT03327506|GABA Modulators|gaba modulators|mesh-ancestor
65694303|NCT03327506|GABA Agents|gaba agents|mesh-ancestor
65694304|NCT03327506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65694305|NCT03327506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694306|NCT02487914|Lidocaine|lidocaine|mesh-list
65694307|NCT02487914|Anesthetics, Local|anesthetics, local|mesh-ancestor
65694308|NCT02487914|Anesthetics|anesthetics|mesh-ancestor
65694309|NCT02487914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65694310|NCT02487914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694311|NCT02487914|Sensory System Agents|sensory system agents|mesh-ancestor
65694312|NCT02487914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694313|NCT02487914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65694314|NCT02487914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65694315|NCT02487914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65694316|NCT02487914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65694317|NCT02487914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694318|NCT02487680|Chromium|chromium|mesh-list
65694319|NCT02487680|Picolinic acid|picolinic acid|mesh-list
65694320|NCT02487680|Trace Elements|trace elements|mesh-ancestor
65694321|NCT02487680|Micronutrients|micronutrients|mesh-ancestor
65694322|NCT02487680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694323|NCT02487680|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65694324|NCT02487680|Chelating Agents|chelating agents|mesh-ancestor
65694325|NCT02487680|Sequestering Agents|sequestering agents|mesh-ancestor
65694326|NCT02487680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694327|NCT03319550|Caseins|caseins|mesh-list
65694328|NCT03319550|Chelating Agents|chelating agents|mesh-ancestor
65694329|NCT03319550|Sequestering Agents|sequestering agents|mesh-ancestor
65694330|NCT03319550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694331|NCT04442906|Fentanyl|fentanyl|mesh-list
65694332|NCT04442906|Dexmedetomidine|dexmedetomidine|mesh-list
65694333|NCT04442906|Bupivacaine|bupivacaine|mesh-list
65694334|NCT04442906|Anesthetics, Local|anesthetics, local|mesh-ancestor
65694335|NCT04442906|Anesthetics|anesthetics|mesh-ancestor
65694336|NCT04442906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65694337|NCT04442906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694338|NCT04442906|Sensory System Agents|sensory system agents|mesh-ancestor
65694339|NCT04442906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694340|NCT04442906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65694341|NCT04442906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65694342|NCT04442906|Analgesics|analgesics|mesh-ancestor
65694343|NCT04442906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65694344|NCT04442906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65694345|NCT04442906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65694346|NCT04442906|Adrenergic Agents|adrenergic agents|mesh-ancestor
65694347|NCT04442906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65694348|NCT04442906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694349|NCT04442906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65694350|NCT04442906|Narcotics|narcotics|mesh-ancestor
65694351|NCT04442906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65694352|NCT04442906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65694353|NCT04442906|Anesthetics, General|anesthetics, general|mesh-ancestor
65694354|NCT04510012|Complement System Proteins|complement system proteins|mesh-list
65694355|NCT04510012|Immunologic Factors|immunologic factors|mesh-ancestor
65694356|NCT04510012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694357|NCT03327350|Anticoagulants|anticoagulants|mesh-list
65694358|NCT04695340|Psyllium|psyllium|mesh-list
65694359|NCT04695340|Cathartics|cathartics|mesh-ancestor
65694360|NCT04695340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65694361|NCT03327272|Methylprednisolone|methylprednisolone|mesh-list
65694362|NCT03327272|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65694363|NCT03327272|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65694364|NCT03327272|Prednisolone|prednisolone|mesh-list
65694365|NCT03327272|Prednisolone acetate|prednisolone acetate|mesh-list
65694366|NCT03327272|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65694367|NCT03327272|Prednisolone phosphate|prednisolone phosphate|mesh-list
65694368|NCT03327272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65694369|NCT03327272|Antiemetics|antiemetics|mesh-ancestor
65694370|NCT03327272|Autonomic Agents|autonomic agents|mesh-ancestor
65694371|NCT03327272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694372|NCT03327272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694373|NCT03327272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65694374|NCT03327272|Glucocorticoids|glucocorticoids|mesh-ancestor
65694375|NCT03327272|Hormones|hormones|mesh-ancestor
65694376|NCT03327272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65694377|NCT03327272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65694378|NCT03327272|Protective Agents|protective agents|mesh-ancestor
65694379|NCT03327272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65694380|NCT03327272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65694381|NCT05508178|Vaccines|vaccines|mesh-list
65694382|NCT05508178|Immunologic Factors|immunologic factors|mesh-ancestor
65694383|NCT05508178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694384|NCT03327116|Methotrexate|methotrexate|mesh-list
65694385|NCT03327116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65694386|NCT03327116|Abortifacient Agents|abortifacient agents|mesh-ancestor
65694387|NCT03327116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65694388|NCT03327116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694389|NCT03327116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65694390|NCT03327116|Antimetabolites|antimetabolites|mesh-ancestor
65694391|NCT03327116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694392|NCT03327116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65694393|NCT03327116|Dermatologic Agents|dermatologic agents|mesh-ancestor
65694394|NCT03327116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694395|NCT03327116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65694396|NCT03327116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65694397|NCT03327116|Immunologic Factors|immunologic factors|mesh-ancestor
65694398|NCT03327116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65694399|NCT03327116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65694400|NCT03326960|Propofol|propofol|mesh-list
65694401|NCT03326960|Sevoflurane|sevoflurane|mesh-list
65694402|NCT03326960|Desflurane|desflurane|mesh-list
65694403|NCT03326960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65694404|NCT03326960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65694405|NCT03326960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694406|NCT03326960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65694407|NCT03326960|Anesthetics, General|anesthetics, general|mesh-ancestor
65694408|NCT03326960|Anesthetics|anesthetics|mesh-ancestor
65694409|NCT03326960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65694410|NCT03326960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65694411|NCT03319238|Ketamine|ketamine|mesh-list
65694412|NCT03319238|Analgesics|analgesics|mesh-ancestor
65694413|NCT03319238|Sensory System Agents|sensory system agents|mesh-ancestor
65694414|NCT03319238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694415|NCT03319238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694416|NCT03319238|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65694417|NCT03319238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65694418|NCT03319238|Anesthetics, General|anesthetics, general|mesh-ancestor
65694419|NCT03319238|Anesthetics|anesthetics|mesh-ancestor
65694420|NCT03319238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65694421|NCT03319238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65694422|NCT03319238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65694423|NCT03319238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65694424|NCT03319238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694425|NCT03321890|Prednisone|prednisone|mesh-list
65694426|NCT03321890|Cyclophosphamide|cyclophosphamide|mesh-list
65694427|NCT03321890|Methotrexate|methotrexate|mesh-list
65694428|NCT03321890|Etoposide|etoposide|mesh-list
65694429|NCT03321890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65694430|NCT03321890|Immunologic Factors|immunologic factors|mesh-ancestor
65694431|NCT03321890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694432|NCT03321890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65694433|NCT03321890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65694434|NCT03321890|Alkylating Agents|alkylating agents|mesh-ancestor
65694435|NCT03321890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694436|NCT03321890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65694437|NCT03321890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65694438|NCT03321890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65694439|NCT03321890|Glucocorticoids|glucocorticoids|mesh-ancestor
65694440|NCT03321890|Hormones|hormones|mesh-ancestor
65694441|NCT03321890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65694442|NCT03321890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65694443|NCT03321890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65694444|NCT03321890|Abortifacient Agents|abortifacient agents|mesh-ancestor
65694445|NCT03321890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65694446|NCT03321890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65694447|NCT03321890|Antimetabolites|antimetabolites|mesh-ancestor
65694448|NCT03321890|Dermatologic Agents|dermatologic agents|mesh-ancestor
65694449|NCT03321890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694450|NCT03321890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65694451|NCT03321890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65694452|NCT03321890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65694453|NCT03321890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65694454|NCT03321890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65694455|NCT05464394|Tranexamic Acid|tranexamic acid|mesh-list
65694456|NCT05464394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65694457|NCT05464394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65694458|NCT05464394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694459|NCT05464394|Hemostatics|hemostatics|mesh-ancestor
65694460|NCT05464394|Coagulants|coagulants|mesh-ancestor
65694461|NCT05499598|Vitamin A|vitamin a|mesh-list
65694462|NCT05499598|Vitamins|vitamins|mesh-ancestor
65694463|NCT05499598|Micronutrients|micronutrients|mesh-ancestor
65694464|NCT05499598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694465|NCT03321734|Caffeine|caffeine|mesh-list
65694466|NCT03321734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65694467|NCT03321734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694468|NCT03321734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65694469|NCT03321734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694470|NCT03321734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694471|NCT03321734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65694472|NCT03321734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65694473|NCT03321734|Purinergic Agents|purinergic agents|mesh-ancestor
65694474|NCT03321734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65694475|NCT05504278|Carboplatin|carboplatin|mesh-list
65694476|NCT05504278|Pemetrexed|pemetrexed|mesh-list
65694477|NCT05504278|Cetuximab|cetuximab|mesh-list
65694478|NCT05504278|Cisplatin|cisplatin|mesh-list
65694479|NCT05504278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491795|NCT03773796|Nabilone|nabilone|mesh-list
65694480|NCT05504278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694481|NCT05504278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694482|NCT05504278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65694483|NCT05504278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65694484|NCT05504278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65694485|NCT04442750|Bupivacaine|bupivacaine|mesh-list
65694486|NCT04442750|Anesthetics, Local|anesthetics, local|mesh-ancestor
65694487|NCT04442750|Anesthetics|anesthetics|mesh-ancestor
65694488|NCT04442750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65694489|NCT04442750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694490|NCT04442750|Sensory System Agents|sensory system agents|mesh-ancestor
65694491|NCT04442750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694492|NCT02753127|Leucovorin|leucovorin|mesh-list
65694493|NCT02753127|Bevacizumab|bevacizumab|mesh-list
65694494|NCT02753127|Fluorouracil|fluorouracil|mesh-list
65694495|NCT02753127|Irinotecan|irinotecan|mesh-list
65694496|NCT02753127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65694497|NCT02753127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65694498|NCT02753127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65694499|NCT02753127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65694500|NCT02753127|Growth Substances|growth substances|mesh-ancestor
65694501|NCT02753127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694502|NCT02753127|Growth Inhibitors|growth inhibitors|mesh-ancestor
65694503|NCT02753127|Antimetabolites|antimetabolites|mesh-ancestor
65694504|NCT02753127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694505|NCT02753127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65694506|NCT02753127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65694507|NCT02753127|Immunologic Factors|immunologic factors|mesh-ancestor
65694508|NCT02753127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65694509|NCT02753127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65694510|NCT02753127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694511|NCT02753127|Antidotes|antidotes|mesh-ancestor
65694512|NCT02753127|Protective Agents|protective agents|mesh-ancestor
65694513|NCT02753127|Vitamin B Complex|vitamin b complex|mesh-ancestor
65694514|NCT02753127|Vitamins|vitamins|mesh-ancestor
65694515|NCT02753127|Micronutrients|micronutrients|mesh-ancestor
65694516|NCT03326258|Nivolumab|nivolumab|mesh-list
65694517|NCT03326258|Ipilimumab|ipilimumab|mesh-list
65694518|NCT03326258|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
65694519|NCT03326258|Antibodies|antibodies|mesh-list
65694520|NCT03326258|Immunoglobulins|immunoglobulins|mesh-list
65694521|NCT03326258|Immunoconjugates|immunoconjugates|mesh-list
65694522|NCT03326258|Immunotoxins|immunotoxins|mesh-list
65694523|NCT03326258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65694524|NCT03326258|Immunologic Factors|immunologic factors|mesh-ancestor
65694525|NCT03326258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694526|NCT03326258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65694527|NCT03326258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65694528|NCT03326258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65694529|NCT03326258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694530|NCT03326102|Paclitaxel|paclitaxel|mesh-list
65694531|NCT03326102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65694532|NCT03326102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65694533|NCT03326102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65694534|NCT03326102|Tubulin Modulators|tubulin modulators|mesh-ancestor
65694535|NCT03326102|Antimitotic Agents|antimitotic agents|mesh-ancestor
65694536|NCT03326102|Mitosis Modulators|mitosis modulators|mesh-ancestor
65694537|NCT03326102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694538|NCT02487212|Clobetasol|clobetasol|mesh-list
65694539|NCT02487212|Petrolatum|petrolatum|mesh-list
65694540|NCT02487212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65694541|NCT02487212|Glucocorticoids|glucocorticoids|mesh-ancestor
65694542|NCT02487212|Hormones|hormones|mesh-ancestor
65694543|NCT02487212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65694544|NCT02487212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694545|NCT02487212|Emollients|emollients|mesh-ancestor
65694546|NCT02487212|Dermatologic Agents|dermatologic agents|mesh-ancestor
65694547|NCT04583488|Docetaxel|docetaxel|mesh-list
65694548|NCT04583488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65694549|NCT04583488|Tubulin Modulators|tubulin modulators|mesh-ancestor
65694550|NCT04583488|Antimitotic Agents|antimitotic agents|mesh-ancestor
65694551|NCT04583488|Mitosis Modulators|mitosis modulators|mesh-ancestor
65694552|NCT04583488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694553|NCT03318536|Granisetron|granisetron|mesh-list
65694554|NCT03318536|Serotonin|serotonin|mesh-list
65491872|NCT03923010|Itraconazole|itraconazole|mesh-list
65694555|NCT03318536|Antiemetics|antiemetics|mesh-ancestor
65694556|NCT03318536|Autonomic Agents|autonomic agents|mesh-ancestor
65694557|NCT03318536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694558|NCT03318536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694559|NCT03318536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65694560|NCT03318536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65694561|NCT03318536|Serotonin Agents|serotonin agents|mesh-ancestor
65694562|NCT03318536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65694563|NCT03318536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694564|NCT03318536|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65694565|NCT03537027|Vitamin D|vitamin d|mesh-list
65694566|NCT03537027|Cholecalciferol|cholecalciferol|mesh-list
65694567|NCT03537027|Vitamins|vitamins|mesh-ancestor
65694568|NCT03537027|Micronutrients|micronutrients|mesh-ancestor
65694569|NCT03537027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694570|NCT03537027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65694571|NCT03537027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65694572|NCT02183025|Meloxicam|meloxicam|mesh-list
65694573|NCT02183025|Mefenamic Acid|mefenamic acid|mesh-list
65694574|NCT02183025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65694575|NCT02183025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65694576|NCT02183025|Analgesics|analgesics|mesh-ancestor
65694577|NCT02183025|Sensory System Agents|sensory system agents|mesh-ancestor
65694578|NCT02183025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694579|NCT02183025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694580|NCT02183025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65694581|NCT02183025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65694582|NCT02183025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65694583|NCT02183025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65694584|NCT02183025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694585|NCT02183025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694586|NCT04282174|Cyclophosphamide|cyclophosphamide|mesh-list
65694587|NCT04282174|Melphalan|melphalan|mesh-list
65694588|NCT04282174|Busulfan|busulfan|mesh-list
65694589|NCT04282174|Thiotepa|thiotepa|mesh-list
65694590|NCT04282174|Fludarabine|fludarabine|mesh-list
65694591|NCT04282174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65694592|NCT04282174|Immunologic Factors|immunologic factors|mesh-ancestor
65694593|NCT04282174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694594|NCT04282174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65694595|NCT04282174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65694596|NCT04282174|Alkylating Agents|alkylating agents|mesh-ancestor
65694597|NCT04282174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694598|NCT04282174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65694599|NCT04282174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65694600|NCT02181309|Meloxicam|meloxicam|mesh-list
65694601|NCT02181309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65694602|NCT02181309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65694603|NCT02181309|Analgesics|analgesics|mesh-ancestor
65694604|NCT02181309|Sensory System Agents|sensory system agents|mesh-ancestor
65694605|NCT02181309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694606|NCT02181309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694607|NCT02181309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65694608|NCT02181309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65694609|NCT02181309|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65694610|NCT02181309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65694611|NCT02181309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694612|NCT02181309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694613|NCT02186145|Metronidazole|metronidazole|mesh-list
65694614|NCT02186145|Nystatin|nystatin|mesh-list
65694615|NCT02186145|Dexamethasone|dexamethasone|mesh-list
65694616|NCT02186145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65694617|NCT02186145|Antiemetics|antiemetics|mesh-ancestor
65694618|NCT02186145|Autonomic Agents|autonomic agents|mesh-ancestor
65694619|NCT02186145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694620|NCT02186145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694621|NCT02186145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65694622|NCT02186145|Glucocorticoids|glucocorticoids|mesh-ancestor
65694623|NCT02186145|Hormones|hormones|mesh-ancestor
65694624|NCT02186145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65694625|NCT02186145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65694626|NCT02186145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65694627|NCT02186145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65694628|NCT02186145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65694629|NCT02186145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65694630|NCT02186145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65694631|NCT02186145|Antifungal Agents|antifungal agents|mesh-ancestor
65694632|NCT02186145|Ionophores|ionophores|mesh-ancestor
65491938|NCT01131546|Vasodilator Agents|vasodilator agents|mesh-ancestor
65694634|NCT02186145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694635|NCT03325868|Ulipristal acetate|ulipristal acetate|mesh-list
65694636|NCT03325868|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65694637|NCT03325868|Contraceptive Agents|contraceptive agents|mesh-ancestor
65694638|NCT03325868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65694639|NCT03325868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694640|NCT03325868|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65694641|NCT02183103|Meloxicam|meloxicam|mesh-list
65694642|NCT02183103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65694643|NCT02183103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65694644|NCT02183103|Analgesics|analgesics|mesh-ancestor
65694645|NCT02183103|Sensory System Agents|sensory system agents|mesh-ancestor
65694646|NCT02183103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694647|NCT02183103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694648|NCT02183103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65694649|NCT02183103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65694650|NCT02183103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65694651|NCT02183103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65694652|NCT02183103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694653|NCT02183103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694654|NCT03325790|Ebselen|ebselen|mesh-list
65694655|NCT03325790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65694656|NCT03325790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65694657|NCT03325790|Analgesics|analgesics|mesh-ancestor
65694658|NCT03325790|Sensory System Agents|sensory system agents|mesh-ancestor
65694659|NCT03325790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694660|NCT03325790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694661|NCT03325790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65694662|NCT03325790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65694663|NCT03325790|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65694664|NCT03325790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65694665|NCT03325790|Antioxidants|antioxidants|mesh-ancestor
65694666|NCT03325790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694667|NCT03325790|Protective Agents|protective agents|mesh-ancestor
65694668|NCT03325790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65694669|NCT03325790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694670|NCT03325790|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65694671|NCT02181543|Clonidine|clonidine|mesh-list
65694672|NCT02181543|Analgesics|analgesics|mesh-ancestor
65694673|NCT02181543|Sensory System Agents|sensory system agents|mesh-ancestor
65694674|NCT02181543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694675|NCT02181543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694676|NCT02181543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65694677|NCT02181543|Sympatholytics|sympatholytics|mesh-ancestor
65694678|NCT02181543|Autonomic Agents|autonomic agents|mesh-ancestor
65694679|NCT02181543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65694680|NCT02181543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65694681|NCT02181543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65694682|NCT02181543|Adrenergic Agents|adrenergic agents|mesh-ancestor
65694683|NCT02181543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65694684|NCT02181543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694685|NCT02181621|Cadexomer iodine|cadexomer iodine|mesh-list
65694686|NCT02181621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65694687|NCT02181621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65694688|NCT02490176|Liraglutide|liraglutide|mesh-list
65694689|NCT02490176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65694690|NCT02490176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694691|NCT02490176|Incretins|incretins|mesh-ancestor
65694692|NCT02490176|Hormones|hormones|mesh-ancestor
65694693|NCT02490176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65694694|NCT02183181|Meloxicam|meloxicam|mesh-list
65694695|NCT02183181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65269034|NCT00909857|Hormones|hormones|mesh-ancestor
65694696|NCT02183181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65694697|NCT02183181|Analgesics|analgesics|mesh-ancestor
65694698|NCT02183181|Sensory System Agents|sensory system agents|mesh-ancestor
65694699|NCT02183181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694700|NCT02183181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694701|NCT02183181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65694702|NCT02183181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65694703|NCT02183181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65694704|NCT02183181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65694705|NCT02183181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694706|NCT02183181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694707|NCT02490098|Insulin|insulin|mesh-list
65694708|NCT02490098|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65694709|NCT02490098|Glucagon|glucagon|mesh-list
65694710|NCT02490098|Hormones|hormones|mesh-list
65694711|NCT02490098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65694712|NCT02490098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694713|NCT02490098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65694714|NCT02490098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65694715|NCT02486822|Oxytocin|oxytocin|mesh-list
65694716|NCT02486822|Oxytocics|oxytocics|mesh-ancestor
65694717|NCT02486822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65694718|NCT02486822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694719|NCT02186457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65694720|NCT02186457|Polymyxins|polymyxins|mesh-list
65694721|NCT02186457|Polymyxin B|polymyxin b|mesh-list
65694722|NCT02186457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65694723|NCT02186535|Vitamin D|vitamin d|mesh-list
65694724|NCT02186535|Calcium|calcium|mesh-list
65694725|NCT02186535|Vitamins|vitamins|mesh-ancestor
65694726|NCT02186535|Micronutrients|micronutrients|mesh-ancestor
65694727|NCT02186535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694728|NCT02186535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65694729|NCT02186535|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65694730|NCT03325400|Fluorides|fluorides|mesh-list
65694731|NCT03325400|Cariostatic Agents|cariostatic agents|mesh-ancestor
65694732|NCT03325400|Protective Agents|protective agents|mesh-ancestor
65694733|NCT03325400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694734|NCT02181933|Lamivudine|lamivudine|mesh-list
65694735|NCT02181933|Zidovudine|zidovudine|mesh-list
65694736|NCT02181933|Nevirapine|nevirapine|mesh-list
65694737|NCT02181933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65694738|NCT02181933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65694739|NCT02181933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694740|NCT02181933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694741|NCT02181933|Antiviral Agents|antiviral agents|mesh-ancestor
65694742|NCT02181933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65694743|NCT02181933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65694744|NCT02181933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65694745|NCT02181933|Antimetabolites|antimetabolites|mesh-ancestor
65694746|NCT02181933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65694747|NCT02181933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65694748|NCT02183337|Pioglitazone|pioglitazone|mesh-list
65694749|NCT02183337|Linagliptin|linagliptin|mesh-list
65694750|NCT02183337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65694751|NCT02183337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694752|NCT02183337|Incretins|incretins|mesh-ancestor
65694753|NCT02183337|Hormones|hormones|mesh-ancestor
65694754|NCT02183337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65694755|NCT02183337|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65694756|NCT02183337|Protease Inhibitors|protease inhibitors|mesh-ancestor
65694757|NCT02183337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694758|NCT02183337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694759|NCT02489786|Digoxin|digoxin|mesh-list
65694760|NCT02489786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65694761|NCT02489786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65694762|NCT02489786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694763|NCT02489786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694764|NCT02489786|Protective Agents|protective agents|mesh-ancestor
65694765|NCT02489786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694766|NCT02489864|Terlipressin|terlipressin|mesh-list
65694767|NCT02489864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65694768|NCT02489864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65694769|NCT02182011|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65694770|NCT02182011|Tenecteplase|tenecteplase|mesh-list
65694771|NCT02182011|Streptokinase|streptokinase|mesh-list
65694772|NCT02182011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65694773|NCT02182011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65694774|NCT02182011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694775|NCT02486744|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65694776|NCT02486744|Hormones|hormones|mesh-ancestor
65694777|NCT02486744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65694778|NCT02486744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694779|NCT02186769|Risperidone|risperidone|mesh-list
65694780|NCT02186769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65694781|NCT02186769|Serotonin Agents|serotonin agents|mesh-ancestor
65694782|NCT02186769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65694783|NCT02186769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694784|NCT02186769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694785|NCT02186769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65694786|NCT02186769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65694787|NCT02186769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65694788|NCT02186769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65694789|NCT02186769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65694790|NCT02186769|Dopamine Agents|dopamine agents|mesh-ancestor
65694791|NCT02486432|Levodopa|levodopa|mesh-list
65694792|NCT02486432|Carbidopa|carbidopa|mesh-list
65694793|NCT02486432|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65694794|NCT02486432|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65694795|NCT02486432|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65694796|NCT02486432|Dopamine Agents|dopamine agents|mesh-ancestor
65694797|NCT02486432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65694798|NCT02486432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694799|NCT02486432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694800|NCT02486432|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65694801|NCT02486432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694802|NCT02486432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65694803|NCT02486432|Immunologic Factors|immunologic factors|mesh-ancestor
65694804|NCT02486432|Dopamine Agonists|dopamine agonists|mesh-ancestor
65694805|NCT02489240|Vitamin D|vitamin d|mesh-list
65694806|NCT02489240|Cholecalciferol|cholecalciferol|mesh-list
65694807|NCT02489240|Vitamins|vitamins|mesh-ancestor
65694808|NCT02489240|Micronutrients|micronutrients|mesh-ancestor
65694809|NCT02489240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694810|NCT02489240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65694811|NCT02489240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65694812|NCT02183415|Linagliptin|linagliptin|mesh-list
65694813|NCT02183415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65694814|NCT02183415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694815|NCT02183415|Incretins|incretins|mesh-ancestor
65694816|NCT02183415|Hormones|hormones|mesh-ancestor
65694817|NCT02183415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65694818|NCT02183415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65694819|NCT02183415|Protease Inhibitors|protease inhibitors|mesh-ancestor
65694820|NCT02183415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694821|NCT02183415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694822|NCT02486510|Maraviroc|maraviroc|mesh-list
65694823|NCT02486510|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65694824|NCT02486510|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65694825|NCT02486510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694826|NCT02486510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65694827|NCT02486510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65694828|NCT02486510|Antiviral Agents|antiviral agents|mesh-ancestor
65694829|NCT02486510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65694830|NCT02486510|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65694831|NCT04493528|Lidocaine|lidocaine|mesh-list
65694832|NCT04493528|Anesthetics, Local|anesthetics, local|mesh-ancestor
65694833|NCT04493528|Anesthetics|anesthetics|mesh-ancestor
65694834|NCT04493528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65694835|NCT04493528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694836|NCT04493528|Sensory System Agents|sensory system agents|mesh-ancestor
65694837|NCT04493528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694838|NCT04493528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65694839|NCT04493528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65694840|NCT04493528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65694841|NCT04493528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65694842|NCT04493528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694843|NCT02183493|Linagliptin|linagliptin|mesh-list
65694844|NCT02183493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65694845|NCT02183493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694846|NCT02183493|Incretins|incretins|mesh-ancestor
65694847|NCT02183493|Hormones|hormones|mesh-ancestor
65694848|NCT02183493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65694849|NCT02183493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65694850|NCT02183493|Protease Inhibitors|protease inhibitors|mesh-ancestor
65694851|NCT02183493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694852|NCT02183493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694853|NCT02187081|Sorafenib|sorafenib|mesh-list
65694854|NCT02187081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65694855|NCT02187081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65492162|NCT01131936|Amlodipine|amlodipine|mesh-list
65694856|NCT02187081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694857|NCT02187081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694858|NCT02485106|Rifaximin|rifaximin|mesh-list
65694859|NCT02485106|Pentoxifylline|pentoxifylline|mesh-list
65694860|NCT02485106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65694861|NCT02485106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65694862|NCT02485106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65694863|NCT02485106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65694864|NCT02485106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694865|NCT02485106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694866|NCT02485106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65694867|NCT02485106|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65694868|NCT02485106|Protective Agents|protective agents|mesh-ancestor
65694869|NCT02485106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694870|NCT02485106|Vasodilator Agents|vasodilator agents|mesh-ancestor
65694871|NCT02485106|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65694872|NCT02485106|Antioxidants|antioxidants|mesh-ancestor
65694873|NCT02485028|Mirodenafil|mirodenafil|mesh-list
65694874|NCT02485028|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65694875|NCT02485028|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65694876|NCT02485028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694877|NCT02485028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694878|NCT02183571|Metformin|metformin|mesh-list
65694879|NCT02183571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65694880|NCT02183571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694881|NCT03318146|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65694882|NCT03318146|Latanoprost|latanoprost|mesh-list
65694883|NCT03318146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65694884|NCT02183649|Carbetapentane|carbetapentane|mesh-list
65694885|NCT02183649|Antitussive Agents|antitussive agents|mesh-ancestor
65694886|NCT02183649|Respiratory System Agents|respiratory system agents|mesh-ancestor
65694887|NCT02187315|Cisplatin|cisplatin|mesh-list
65694888|NCT02187315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65694889|NCT02256735|Moxifloxacin|moxifloxacin|mesh-list
65694890|NCT02256735|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
65694891|NCT02256735|Ritobegron|ritobegron|mesh-list
65694892|NCT02256735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65694893|NCT02256735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65694894|NCT02256735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65694895|NCT02256735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65694896|NCT02256735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65694897|NCT02256735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694898|NCT02256735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65694899|NCT02256735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694900|NCT02256735|Mydriatics|mydriatics|mesh-ancestor
65694901|NCT02256735|Autonomic Agents|autonomic agents|mesh-ancestor
65694902|NCT02256735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694903|NCT02256735|Sympathomimetics|sympathomimetics|mesh-ancestor
65694904|NCT02256735|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65694905|NCT02256735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65694906|NCT02256735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65694907|NCT02256735|Adrenergic Agents|adrenergic agents|mesh-ancestor
65694908|NCT02256735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65694909|NCT02183805|Cyclophosphamide|cyclophosphamide|mesh-list
65694910|NCT02183805|Carboplatin|carboplatin|mesh-list
65694911|NCT02183805|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65694912|NCT02183805|Paclitaxel|paclitaxel|mesh-list
65694913|NCT02183805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65694914|NCT02183805|Immunologic Factors|immunologic factors|mesh-ancestor
65694915|NCT02183805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694916|NCT02183805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65694917|NCT02183805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65694918|NCT02183805|Alkylating Agents|alkylating agents|mesh-ancestor
65694919|NCT02183805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694920|NCT02183805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65694921|NCT02183805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65694922|NCT02183805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65694923|NCT02183805|Tubulin Modulators|tubulin modulators|mesh-ancestor
65694924|NCT02183805|Antimitotic Agents|antimitotic agents|mesh-ancestor
65694925|NCT02183805|Mitosis Modulators|mitosis modulators|mesh-ancestor
65694926|NCT03316352|Bupivacaine|bupivacaine|mesh-list
65694927|NCT03316352|Anesthetics|anesthetics|mesh-list
65694928|NCT03316352|Anesthetics, Local|anesthetics, local|mesh-ancestor
65694929|NCT03316352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65694930|NCT03316352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694931|NCT03316352|Sensory System Agents|sensory system agents|mesh-ancestor
65694932|NCT03316352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694933|NCT02187705|Telmisartan|telmisartan|mesh-list
65694934|NCT02187705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65694935|NCT02187705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65694936|NCT02187705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65694937|NCT02187705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694938|NCT03317912|Lidocaine|lidocaine|mesh-list
65694939|NCT03317912|Anesthetics, Local|anesthetics, local|mesh-ancestor
65694940|NCT03317912|Anesthetics|anesthetics|mesh-ancestor
65694941|NCT03317912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65694942|NCT03317912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694943|NCT03317912|Sensory System Agents|sensory system agents|mesh-ancestor
65694944|NCT03317912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694945|NCT03317912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65694946|NCT03317912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65694947|NCT03317912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65694948|NCT03317912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65694949|NCT03317912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694950|NCT03321110|Ubiquinone|ubiquinone|mesh-list
65694951|NCT03321110|Coenzyme Q10|coenzyme q10|mesh-list
65694952|NCT03321110|Micronutrients|micronutrients|mesh-ancestor
65694953|NCT03321110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694954|NCT03321110|Vitamins|vitamins|mesh-ancestor
65694955|NCT03317600|Lidocaine|lidocaine|mesh-list
65694956|NCT03317600|Anesthetics, Local|anesthetics, local|mesh-ancestor
65694957|NCT03317600|Anesthetics|anesthetics|mesh-ancestor
65694958|NCT03317600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65694959|NCT03317600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694960|NCT03317600|Sensory System Agents|sensory system agents|mesh-ancestor
65694961|NCT03317600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694962|NCT03317600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65694963|NCT03317600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65694964|NCT03317600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65694965|NCT03317600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65694966|NCT03317600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694967|NCT02184117|Adenosine|adenosine|mesh-list
65694968|NCT02184117|Analgesics|analgesics|mesh-ancestor
65694969|NCT02184117|Sensory System Agents|sensory system agents|mesh-ancestor
65694970|NCT02184117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694971|NCT02184117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694972|NCT02184117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65694973|NCT02184117|Vasodilator Agents|vasodilator agents|mesh-ancestor
65694974|NCT02184117|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65694975|NCT02184117|Purinergic Agonists|purinergic agonists|mesh-ancestor
65694976|NCT02184117|Purinergic Agents|purinergic agents|mesh-ancestor
65694977|NCT02184117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65694978|NCT02184117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65694979|NCT02184273|Dipyrone|dipyrone|mesh-list
65694980|NCT02184273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65694981|NCT02184273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65694982|NCT02184273|Analgesics|analgesics|mesh-ancestor
65694983|NCT02184273|Sensory System Agents|sensory system agents|mesh-ancestor
65694984|NCT02184273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694985|NCT02184273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694986|NCT02184273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65694987|NCT02184273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65694988|NCT02184273|Antipyretics|antipyretics|mesh-ancestor
65694989|NCT02486198|Oxaliplatin|oxaliplatin|mesh-list
65694990|NCT02486198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65694991|NCT02188173|Dexamethasone|dexamethasone|mesh-list
65694992|NCT02188173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65694993|NCT02188173|Antiemetics|antiemetics|mesh-ancestor
65694994|NCT02188173|Autonomic Agents|autonomic agents|mesh-ancestor
65694995|NCT02188173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65694996|NCT02188173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65694997|NCT02188173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65694998|NCT02188173|Glucocorticoids|glucocorticoids|mesh-ancestor
65694999|NCT02188173|Hormones|hormones|mesh-ancestor
65695000|NCT02188173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65695001|NCT02188173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65695002|NCT02188173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695003|NCT02184351|Clotrimazole|clotrimazole|mesh-list
65695004|NCT02184351|Miconazole|miconazole|mesh-list
65695005|NCT02184351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65492327|NCT01233570|Tacrolimus|tacrolimus|mesh-list
65695006|NCT02184351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65695007|NCT02184351|Antifungal Agents|antifungal agents|mesh-ancestor
65695008|NCT02184351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65695009|NCT02184351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65695010|NCT02184351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695011|NCT02184351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695012|NCT02184351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65695013|NCT02184351|Hormone Antagonists|hormone antagonists|mesh-ancestor
65695014|NCT02184351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65695015|NCT02184351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695016|NCT02184351|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65695017|NCT02184351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65695018|NCT02184429|PF-06669571|pf-06669571|mesh-list
65695019|NCT02184429|Dopamine Agonists|dopamine agonists|mesh-ancestor
65695020|NCT02184429|Dopamine Agents|dopamine agents|mesh-ancestor
65695021|NCT02184429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65695022|NCT02184429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695023|NCT02184429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695025|NCT02484170|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65695026|NCT02484170|Diuretics|diuretics|mesh-ancestor
65695027|NCT02484170|Natriuretic Agents|natriuretic agents|mesh-ancestor
65695028|NCT02484170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695029|NCT02188407|Propofol|propofol|mesh-list
65695030|NCT02188407|Sevoflurane|sevoflurane|mesh-list
65695031|NCT02188407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65695032|NCT02188407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65695033|NCT02188407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695034|NCT02188407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65695035|NCT02188407|Anesthetics, General|anesthetics, general|mesh-ancestor
65695036|NCT02188407|Anesthetics|anesthetics|mesh-ancestor
65695037|NCT02188407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65695038|NCT02188407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65695039|NCT03317210|Epoetin Alfa|epoetin alfa|mesh-list
65695040|NCT03317210|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65695041|NCT03317210|Hematinics|hematinics|mesh-ancestor
65695042|NCT02488694|Pemetrexed|pemetrexed|mesh-list
65695043|NCT02488694|Afatinib|afatinib|mesh-list
65695044|NCT02488694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695045|NCT02488694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695046|NCT02488694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695047|NCT02488694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65695048|NCT02488694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65695049|NCT02488694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65695050|NCT03316898|Memantine|memantine|mesh-list
65695051|NCT03316898|Donepezil|donepezil|mesh-list
65695052|NCT03316898|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65695053|NCT03316898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695054|NCT03316898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695055|NCT03316898|Cholinergic Agents|cholinergic agents|mesh-ancestor
65695056|NCT03316898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65695057|NCT03316898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695058|NCT03316898|Nootropic Agents|nootropic agents|mesh-ancestor
65695059|NCT03316898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65695060|NCT03316898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65695061|NCT03316898|Dopamine Agents|dopamine agents|mesh-ancestor
65695062|NCT03316898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65695063|NCT03316898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65695064|NCT02188953|Calcium, Dietary|calcium, dietary|mesh-list
65695065|NCT02188953|Calcium Carbonate|calcium carbonate|mesh-list
65695066|NCT02188953|Calcium|calcium|mesh-list
65695067|NCT02188953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65695068|NCT02188953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695069|NCT02188953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65695070|NCT02188953|Antacids|antacids|mesh-ancestor
65695071|NCT02188953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695072|NCT02188953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65695073|NCT02184819|Riboflavin|riboflavin|mesh-list
65695074|NCT02184819|Simendan|simendan|mesh-list
65695075|NCT02184819|Vitamin B Complex|vitamin b complex|mesh-ancestor
65695076|NCT02184819|Vitamins|vitamins|mesh-ancestor
65695077|NCT02184819|Micronutrients|micronutrients|mesh-ancestor
65695078|NCT02184819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492384|NCT05401032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65695079|NCT02184819|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65695080|NCT02184819|Dermatologic Agents|dermatologic agents|mesh-ancestor
65695081|NCT02184819|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65695082|NCT02184819|Vasodilator Agents|vasodilator agents|mesh-ancestor
65695083|NCT02184819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65695084|NCT02184819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65695085|NCT02184819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695086|NCT02184819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695087|NCT02184819|Protective Agents|protective agents|mesh-ancestor
65695088|NCT05714306|Cyclophosphamide|cyclophosphamide|mesh-list
65695089|NCT05714306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65695090|NCT05714306|Immunologic Factors|immunologic factors|mesh-ancestor
65695091|NCT05714306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695092|NCT05714306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65695093|NCT05714306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65695094|NCT05714306|Alkylating Agents|alkylating agents|mesh-ancestor
65695095|NCT05714306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695096|NCT05714306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695097|NCT05714306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65695098|NCT02256813|Vitamin K|vitamin k|mesh-list
65695099|NCT02256813|Vitamin K 1|vitamin k 1|mesh-list
65695100|NCT02256813|Midazolam|midazolam|mesh-list
65695101|NCT02256813|Dextromethorphan|dextromethorphan|mesh-list
65695102|NCT02256813|Caffeine|caffeine|mesh-list
65695103|NCT02256813|Omeprazole|omeprazole|mesh-list
65695104|NCT02256813|Warfarin|warfarin|mesh-list
65695105|NCT02256813|Vitamins|vitamins|mesh-ancestor
65695106|NCT02256813|Micronutrients|micronutrients|mesh-ancestor
65695107|NCT02256813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695108|NCT02256813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65695109|NCT02256813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65695110|NCT02256813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65695111|NCT02256813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65695112|NCT02256813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65695113|NCT02256813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65695114|NCT02256813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65695115|NCT02256813|Anesthetics, General|anesthetics, general|mesh-ancestor
65695116|NCT02256813|Anesthetics|anesthetics|mesh-ancestor
65695117|NCT02256813|GABA Modulators|gaba modulators|mesh-ancestor
65695118|NCT02256813|GABA Agents|gaba agents|mesh-ancestor
65695119|NCT02256813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65695120|NCT02256813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695121|NCT02256813|Anticoagulants|anticoagulants|mesh-ancestor
65695122|NCT02256813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65695123|NCT02256813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65695124|NCT02256813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695125|NCT02256813|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65695126|NCT02256813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65695127|NCT02256813|Purinergic Agents|purinergic agents|mesh-ancestor
65695128|NCT02256813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65695129|NCT02256813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65695130|NCT02256813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65695131|NCT02256813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65695132|NCT02256813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65695133|NCT02256813|Hemostatics|hemostatics|mesh-ancestor
65695134|NCT02256813|Coagulants|coagulants|mesh-ancestor
65695135|NCT02256813|Antitussive Agents|antitussive agents|mesh-ancestor
65695136|NCT02256813|Respiratory System Agents|respiratory system agents|mesh-ancestor
65695137|NCT02256813|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65695138|NCT02256813|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65695139|NCT02479958|Chlorhexidine|chlorhexidine|mesh-list
65695140|NCT02479958|Anti-Infective Agents|anti-infective agents|mesh-list
65695141|NCT02479958|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65695142|NCT02479958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65695143|NCT02479958|Disinfectants|disinfectants|mesh-ancestor
65695144|NCT02483624|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
65695145|NCT02483624|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65695146|NCT02483624|Protective Agents|protective agents|mesh-ancestor
65695147|NCT02483624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695148|NCT02483624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695149|NCT02184897|Lenograstim|lenograstim|mesh-list
65695150|NCT02184897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65695151|NCT02184897|Immunologic Factors|immunologic factors|mesh-ancestor
65695152|NCT02184897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695153|NCT02184975|Hemostatics|hemostatics|mesh-list
65695154|NCT02184975|Coagulants|coagulants|mesh-ancestor
65695155|NCT02189343|Thalidomide|thalidomide|mesh-list
65695156|NCT02189343|Dexamethasone|dexamethasone|mesh-list
65695157|NCT02189343|Dexamethasone acetate|dexamethasone acetate|mesh-list
65695158|NCT02189343|Pomalidomide|pomalidomide|mesh-list
65695160|NCT02189343|BB 1101|bb 1101|mesh-list
65695161|NCT02189343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65695162|NCT02189343|Antiemetics|antiemetics|mesh-ancestor
65695163|NCT02189343|Autonomic Agents|autonomic agents|mesh-ancestor
65695164|NCT02189343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65695165|NCT02189343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695166|NCT02189343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65695167|NCT02189343|Glucocorticoids|glucocorticoids|mesh-ancestor
65695168|NCT02189343|Hormones|hormones|mesh-ancestor
65695169|NCT02189343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65695170|NCT02189343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65695171|NCT02189343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695172|NCT02189343|Protease Inhibitors|protease inhibitors|mesh-ancestor
65695173|NCT02189343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695174|NCT02189343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695175|NCT02189343|Immunologic Factors|immunologic factors|mesh-ancestor
65695176|NCT02189343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65695177|NCT02189343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65695178|NCT02189343|Growth Substances|growth substances|mesh-ancestor
65695179|NCT02189343|Growth Inhibitors|growth inhibitors|mesh-ancestor
65695180|NCT02189343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65695181|NCT02189343|Leprostatic Agents|leprostatic agents|mesh-ancestor
65695182|NCT02189343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65695183|NCT02189343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65695184|NCT02189343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65695185|NCT03535701|Paclitaxel|paclitaxel|mesh-list
65695186|NCT03535701|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65695187|NCT03535701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65695188|NCT03535701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695189|NCT03535701|Tubulin Modulators|tubulin modulators|mesh-ancestor
65695190|NCT03535701|Antimitotic Agents|antimitotic agents|mesh-ancestor
65695191|NCT03535701|Mitosis Modulators|mitosis modulators|mesh-ancestor
65695192|NCT03535701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695193|NCT02486276|Cilostazol|cilostazol|mesh-list
65695194|NCT02486276|Sumatriptan|sumatriptan|mesh-list
65695195|NCT02486276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65695196|NCT02486276|Autonomic Agents|autonomic agents|mesh-ancestor
65695197|NCT02486276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65695198|NCT02486276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695199|NCT02486276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65695200|NCT02486276|Respiratory System Agents|respiratory system agents|mesh-ancestor
65695201|NCT02486276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65695202|NCT02486276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65695203|NCT02486276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695204|NCT02486276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65695205|NCT02486276|Vasodilator Agents|vasodilator agents|mesh-ancestor
65695206|NCT02486276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65695207|NCT02486276|Protective Agents|protective agents|mesh-ancestor
65695208|NCT02486276|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65695209|NCT02486276|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65695210|NCT02486276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695211|NCT02486276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65695212|NCT02486276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65695213|NCT02486276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65695214|NCT02486276|Serotonin Agents|serotonin agents|mesh-ancestor
65695215|NCT02486276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65695216|NCT02189577|Glycopyrrolate|glycopyrrolate|mesh-list
65695217|NCT02189577|Bromides|bromides|mesh-list
65695218|NCT02189577|Anticonvulsants|anticonvulsants|mesh-ancestor
65695219|NCT02189577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65695220|NCT02189577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65695221|NCT02189577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65695222|NCT02189577|Cholinergic Agents|cholinergic agents|mesh-ancestor
65695223|NCT02189577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65695224|NCT02189577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695225|NCT02189577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695226|NCT05713994|Bevacizumab|bevacizumab|mesh-list
65695227|NCT05713994|Sorafenib|sorafenib|mesh-list
65695228|NCT05713994|Atezolizumab|atezolizumab|mesh-list
65695229|NCT05713994|Apatinib|apatinib|mesh-list
65695230|NCT05713994|Lenvatinib|lenvatinib|mesh-list
65695231|NCT05713994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65695232|NCT05713994|Antibodies|antibodies|mesh-list
65695233|NCT05713994|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65492535|NCT03917004|Nitroglycerin|nitroglycerin|mesh-list
65695234|NCT05713994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65695235|NCT05713994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695236|NCT05713994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65695237|NCT05713994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65695238|NCT05713994|Growth Substances|growth substances|mesh-ancestor
65695239|NCT05713994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695240|NCT05713994|Growth Inhibitors|growth inhibitors|mesh-ancestor
65695241|NCT05713994|Immunologic Factors|immunologic factors|mesh-ancestor
65695242|NCT05713994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65695243|NCT05713994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695244|NCT05713994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695245|NCT02189655|Bupivacaine|bupivacaine|mesh-list
65695246|NCT02189655|Anesthetics, Local|anesthetics, local|mesh-ancestor
65695247|NCT02189655|Anesthetics|anesthetics|mesh-ancestor
65695248|NCT02189655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65695249|NCT02189655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695250|NCT02189655|Sensory System Agents|sensory system agents|mesh-ancestor
65695251|NCT02189655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65695252|NCT04633863|Lubricant Eye Drops|lubricant eye drops|mesh-list
65695253|NCT04633863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65695254|NCT04633863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65695255|NCT02193633|Paclitaxel|paclitaxel|mesh-list
65695256|NCT02193633|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65695257|NCT02193633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65695258|NCT02193633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695259|NCT02193633|Tubulin Modulators|tubulin modulators|mesh-ancestor
65695260|NCT02193633|Antimitotic Agents|antimitotic agents|mesh-ancestor
65695261|NCT02193633|Mitosis Modulators|mitosis modulators|mesh-ancestor
65695262|NCT02193633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695263|NCT03315338|Prednisone|prednisone|mesh-list
65695264|NCT03315338|Cortisone|cortisone|mesh-list
65695265|NCT03315338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65695266|NCT03315338|Glucocorticoids|glucocorticoids|mesh-ancestor
65695267|NCT03315338|Hormones|hormones|mesh-ancestor
65695268|NCT03315338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65695269|NCT03315338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695270|NCT03315338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65695271|NCT03315338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695272|NCT05713838|Durvalumab|durvalumab|mesh-list
65695273|NCT05713838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65695274|NCT05713838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695275|NCT02483156|Ribavirin|ribavirin|mesh-list
65695276|NCT02483156|Sofosbuvir|sofosbuvir|mesh-list
65695277|NCT02483156|Antimetabolites|antimetabolites|mesh-ancestor
65695278|NCT02483156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695279|NCT02483156|Antiviral Agents|antiviral agents|mesh-ancestor
65695280|NCT02483156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65695281|NCT00706004|Lubiprostone|lubiprostone|mesh-list
65695282|NCT00706004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65695283|NCT00706004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65695284|NCT00706004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695285|NCT02485340|Isosorbide|isosorbide|mesh-list
65695286|NCT02485340|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65695287|NCT02485340|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65695288|NCT02485340|Sumatriptan|sumatriptan|mesh-list
65695289|NCT02485340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65695290|NCT02485340|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65695291|NCT02485340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65695292|NCT02485340|Serotonin Agents|serotonin agents|mesh-ancestor
65695293|NCT02485340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65695294|NCT02485340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695295|NCT02485340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695296|NCT02485340|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65695297|NCT02485340|Diuretics|diuretics|mesh-ancestor
65695298|NCT02485340|Natriuretic Agents|natriuretic agents|mesh-ancestor
65695299|NCT02485340|Vasodilator Agents|vasodilator agents|mesh-ancestor
65695300|NCT02485340|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65695301|NCT04492514|Mavrilimumab|mavrilimumab|mesh-list
65695302|NCT04492514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65695303|NCT02485262|Sofosbuvir|sofosbuvir|mesh-list
65695304|NCT02485262|Simeprevir|simeprevir|mesh-list
65695305|NCT02485262|Antiviral Agents|antiviral agents|mesh-ancestor
65695306|NCT02485262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65695307|NCT02485262|Protease Inhibitors|protease inhibitors|mesh-ancestor
65695308|NCT02485262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695309|NCT02485262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695310|NCT02479490|Prednisone|prednisone|mesh-list
65695311|NCT02479490|Everolimus|everolimus|mesh-list
65695312|NCT02479490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65695313|NCT02479490|Glucocorticoids|glucocorticoids|mesh-ancestor
65695314|NCT02479490|Hormones|hormones|mesh-ancestor
65695315|NCT02479490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65695316|NCT02479490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695317|NCT02479490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65695318|NCT02479490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695319|NCT02479490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65695320|NCT02479490|Immunologic Factors|immunologic factors|mesh-ancestor
65695321|NCT02479256|Tamoxifen|tamoxifen|mesh-list
65695322|NCT02479256|Citric Acid|citric acid|mesh-list
65695323|NCT02479256|Sodium Citrate|sodium citrate|mesh-list
65695324|NCT02479256|Clomiphene|clomiphene|mesh-list
65695325|NCT02479256|Enclomiphene|enclomiphene|mesh-list
65695326|NCT02479256|Zuclomiphene|zuclomiphene|mesh-list
65695327|NCT02479256|Anticoagulants|anticoagulants|mesh-ancestor
65695328|NCT02479256|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65695329|NCT02479256|Chelating Agents|chelating agents|mesh-ancestor
65695330|NCT02479256|Sequestering Agents|sequestering agents|mesh-ancestor
65695331|NCT02479256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695332|NCT02479256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65695333|NCT02479256|Hormone Antagonists|hormone antagonists|mesh-ancestor
65695334|NCT02479256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65695335|NCT02479256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695336|NCT02479256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65695337|NCT02479256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695338|NCT02479256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65695339|NCT02479256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65695340|NCT02479256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65695341|NCT02479256|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65695342|NCT02479256|Fertility Agents|fertility agents|mesh-ancestor
65695343|NCT02479256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65695344|NCT02482766|Poractant alfa|poractant alfa|mesh-list
65695345|NCT02482766|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
65695346|NCT02482766|Respiratory System Agents|respiratory system agents|mesh-ancestor
65695347|NCT04492280|Hydrocortisone|hydrocortisone|mesh-list
65695348|NCT04492280|Fludrocortisone|fludrocortisone|mesh-list
65695349|NCT04492280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65695350|NCT02479178|Docetaxel|docetaxel|mesh-list
65695351|NCT02479178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695352|NCT02479178|Tubulin Modulators|tubulin modulators|mesh-ancestor
65695353|NCT02479178|Antimitotic Agents|antimitotic agents|mesh-ancestor
65695354|NCT02479178|Mitosis Modulators|mitosis modulators|mesh-ancestor
65695355|NCT02479178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695356|NCT03314792|Oxycodone|oxycodone|mesh-list
65695357|NCT03314792|Tapentadol|tapentadol|mesh-list
65695358|NCT03314792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65695359|NCT03314792|Narcotics|narcotics|mesh-ancestor
65695360|NCT03314792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65695361|NCT03314792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695362|NCT03314792|Analgesics|analgesics|mesh-ancestor
65695363|NCT03314792|Sensory System Agents|sensory system agents|mesh-ancestor
65695364|NCT03314792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65695365|NCT03314792|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65695366|NCT03314792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65695367|NCT03314792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65695368|NCT03314792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695369|NCT03314792|Adrenergic Agents|adrenergic agents|mesh-ancestor
65695370|NCT03314792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65695371|NCT02476526|Acetylcysteine|acetylcysteine|mesh-list
65695372|NCT02476526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65695373|NCT02476526|Antiviral Agents|antiviral agents|mesh-ancestor
65695374|NCT02476526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65695375|NCT02476526|Expectorants|expectorants|mesh-ancestor
65695376|NCT02476526|Respiratory System Agents|respiratory system agents|mesh-ancestor
65695377|NCT02476526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65695378|NCT02476526|Antioxidants|antioxidants|mesh-ancestor
65695379|NCT02476526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695380|NCT02476526|Protective Agents|protective agents|mesh-ancestor
65695381|NCT02476526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695382|NCT02476526|Antidotes|antidotes|mesh-ancestor
65695383|NCT02479022|Insulin|insulin|mesh-list
65695384|NCT02479022|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65695385|NCT02479022|Insulin Glargine|insulin glargine|mesh-list
65695386|NCT02479022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65695387|NCT02479022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695388|NCT03314636|Dexamethasone|dexamethasone|mesh-list
65695389|NCT03314636|Lenalidomide|lenalidomide|mesh-list
65695390|NCT03314636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65695391|NCT03314636|Antiemetics|antiemetics|mesh-ancestor
65695392|NCT03314636|Autonomic Agents|autonomic agents|mesh-ancestor
65695393|NCT03314636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65695394|NCT03314636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695395|NCT03314636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65695396|NCT03314636|Glucocorticoids|glucocorticoids|mesh-ancestor
65695397|NCT03314636|Hormones|hormones|mesh-ancestor
65695398|NCT03314636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65695399|NCT03314636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65695400|NCT03314636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695401|NCT03314636|Immunologic Factors|immunologic factors|mesh-ancestor
65695402|NCT03314636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65695403|NCT03314636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65695404|NCT03314636|Growth Substances|growth substances|mesh-ancestor
65695405|NCT03314636|Growth Inhibitors|growth inhibitors|mesh-ancestor
65695406|NCT02476760|Insulin|insulin|mesh-list
65695407|NCT02476760|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65695408|NCT02476760|Metformin|metformin|mesh-list
65695409|NCT02476760|Pioglitazone|pioglitazone|mesh-list
65695410|NCT02476760|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65695411|NCT02476760|Liraglutide|liraglutide|mesh-list
65695412|NCT02476760|Exenatide|exenatide|mesh-list
65695413|NCT02476760|Glimepiride|glimepiride|mesh-list
65695414|NCT02476760|Rosiglitazone|rosiglitazone|mesh-list
65695415|NCT02476760|Vildagliptin|vildagliptin|mesh-list
65695416|NCT02476760|Saxagliptin|saxagliptin|mesh-list
65695417|NCT02476760|Acarbose|acarbose|mesh-list
65695418|NCT02476760|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65695419|NCT02476760|Repaglinide|repaglinide|mesh-list
65695420|NCT02476760|Gliclazide|gliclazide|mesh-list
65695421|NCT02476760|Glipizide|glipizide|mesh-list
65695422|NCT02476760|Biguanides|biguanides|mesh-list
65695423|NCT02476760|Tolbutamide|tolbutamide|mesh-list
65695424|NCT02476760|Voglibose|voglibose|mesh-list
65695425|NCT02476760|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
65695426|NCT02476760|Nateglinide|nateglinide|mesh-list
65695427|NCT02476760|Miglitol|miglitol|mesh-list
65695428|NCT02476760|Troglitazone|troglitazone|mesh-list
65695429|NCT02476760|Meglitinide|meglitinide|mesh-list
65695430|NCT02476760|Acetohexamide|acetohexamide|mesh-list
65695431|NCT02476760|Chlorpropamide|chlorpropamide|mesh-list
65695432|NCT02476760|Phenformin|phenformin|mesh-list
65695433|NCT02476760|Buformin|buformin|mesh-list
65695434|NCT02476760|Glibornuride|glibornuride|mesh-list
65695435|NCT02476760|Tolazamide|tolazamide|mesh-list
65695436|NCT02476760|Carbutamide|carbutamide|mesh-list
65695437|NCT02476760|Gliquidone|gliquidone|mesh-list
65695438|NCT02476760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65695439|NCT02476760|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
65695440|NCT02476760|Incretins|incretins|mesh-list
65695441|NCT02476760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695442|NCT02476760|Hormones|hormones|mesh-ancestor
65695443|NCT02476760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65695444|NCT02476760|Protease Inhibitors|protease inhibitors|mesh-ancestor
65695445|NCT02476760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695446|NCT02476760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695447|NCT02476760|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65695448|NCT02476760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65695449|NCT02476760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65695450|NCT02476760|Immunologic Factors|immunologic factors|mesh-ancestor
65695451|NCT05460338|Cholecalciferol|cholecalciferol|mesh-list
65695452|NCT05460338|Vitamin D|vitamin d|mesh-list
65695453|NCT05460338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65695454|NCT05460338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695455|NCT05460338|Vitamins|vitamins|mesh-ancestor
65695456|NCT05460338|Micronutrients|micronutrients|mesh-ancestor
65695457|NCT05460338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65695458|NCT02476136|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65695459|NCT02476136|Fluoxetine|fluoxetine|mesh-list
65492763|NCT04722978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65695460|NCT02476136|Paroxetine|paroxetine|mesh-list
65695461|NCT02476136|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65695462|NCT02476136|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65695463|NCT02476136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65695464|NCT02476136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65695465|NCT02476136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695466|NCT02476136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65695467|NCT02476136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695468|NCT02476136|Analgesics|analgesics|mesh-ancestor
65695469|NCT02476136|Sensory System Agents|sensory system agents|mesh-ancestor
65695470|NCT02476136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65695471|NCT02476136|Antidepressive Agents|antidepressive agents|mesh-ancestor
65695472|NCT02476136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65695473|NCT02476136|Dopamine Agents|dopamine agents|mesh-ancestor
65695474|NCT02476136|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65695475|NCT02476136|Serotonin Agents|serotonin agents|mesh-ancestor
65695476|NCT02476136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65695477|NCT02476136|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65695478|NCT02476136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65695479|NCT02476136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695480|NCT05437094|Itraconazole|itraconazole|mesh-list
65695481|NCT05437094|Antifungal Agents|antifungal agents|mesh-ancestor
65695482|NCT05437094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65695483|NCT05437094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65695484|NCT05437094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65695485|NCT05437094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695486|NCT05437094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695487|NCT05437094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65695488|NCT05437094|Hormone Antagonists|hormone antagonists|mesh-ancestor
65695489|NCT05437094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65695490|NCT05437094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695491|NCT05437094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65695492|NCT05413772|Temocillin|temocillin|mesh-list
65695493|NCT05413772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65695494|NCT05413772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65695495|NCT05713292|Pirfenidone|pirfenidone|mesh-list
65695496|NCT05713292|Analgesics|analgesics|mesh-ancestor
65695497|NCT05713292|Sensory System Agents|sensory system agents|mesh-ancestor
65695498|NCT05713292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65695499|NCT05713292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695500|NCT05713292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65695501|NCT05713292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65695502|NCT05713292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65695503|NCT05713292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65695504|NCT05713292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695505|NCT02478710|Vancomycin|vancomycin|mesh-list
65695506|NCT02478710|Tobramycin|tobramycin|mesh-list
65695507|NCT02478710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65695508|NCT02478710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65695509|NCT02475824|Midazolam|midazolam|mesh-list
65695510|NCT02475824|Meperidine|meperidine|mesh-list
65695511|NCT02475824|Dexmedetomidine|dexmedetomidine|mesh-list
65695512|NCT02475824|Propofol|propofol|mesh-list
65695513|NCT02475824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65695514|NCT02475824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65695515|NCT02475824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695516|NCT02475824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65695517|NCT02475824|Anesthetics, General|anesthetics, general|mesh-ancestor
65695518|NCT02475824|Anesthetics|anesthetics|mesh-ancestor
65695519|NCT02475824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65695520|NCT02475824|Analgesics|analgesics|mesh-ancestor
65695521|NCT02475824|Sensory System Agents|sensory system agents|mesh-ancestor
65695522|NCT02475824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65695523|NCT02475824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65695524|NCT02475824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65695525|NCT02475824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65695526|NCT02475824|Adrenergic Agents|adrenergic agents|mesh-ancestor
65695527|NCT02475824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65695528|NCT02475824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695529|NCT02475824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65695530|NCT02475824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65695531|NCT02475824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65695532|NCT02475824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65695533|NCT02475824|GABA Modulators|gaba modulators|mesh-ancestor
65695534|NCT02475824|GABA Agents|gaba agents|mesh-ancestor
65695535|NCT02475824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65695536|NCT02475824|Narcotics|narcotics|mesh-ancestor
65695537|NCT02478242|Nafamostat|nafamostat|mesh-list
65695538|NCT02478242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65695539|NCT02478242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65695540|NCT02478242|Analgesics|analgesics|mesh-ancestor
65695541|NCT02478242|Sensory System Agents|sensory system agents|mesh-ancestor
65695542|NCT02478242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65695543|NCT02478242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695544|NCT02478242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65695545|NCT02478242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65695546|NCT02478242|Anticoagulants|anticoagulants|mesh-ancestor
65695547|NCT02478242|Protease Inhibitors|protease inhibitors|mesh-ancestor
65695548|NCT02478242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695549|NCT02478242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695550|NCT02478242|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65695551|NCT02478242|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65695552|NCT02478242|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65695553|NCT02478242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65695554|NCT02478242|Immunologic Factors|immunologic factors|mesh-ancestor
65695555|NCT02475746|Itraconazole|itraconazole|mesh-list
65695556|NCT02475746|PF-06372865|pf-06372865|mesh-list
65695557|NCT02475746|Antifungal Agents|antifungal agents|mesh-ancestor
65695558|NCT02475746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65695559|NCT02475746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65695560|NCT02475746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65695561|NCT02475746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695562|NCT02475746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695563|NCT02475746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65695564|NCT02475746|Hormone Antagonists|hormone antagonists|mesh-ancestor
65695565|NCT02475746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65695566|NCT02475746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695567|NCT02475746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65695568|NCT02475746|GABA Modulators|gaba modulators|mesh-ancestor
65695569|NCT02475746|GABA Agents|gaba agents|mesh-ancestor
65695570|NCT02475746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65695571|NCT05715164|Nicotine|nicotine|mesh-list
65695572|NCT05715164|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65695573|NCT05715164|Autonomic Agents|autonomic agents|mesh-ancestor
65695574|NCT05715164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65695575|NCT05715164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695576|NCT05715164|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65695577|NCT05715164|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65695578|NCT05715164|Cholinergic Agents|cholinergic agents|mesh-ancestor
65695579|NCT05715164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65695580|NCT05715164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695581|NCT02475356|Levonorgestrel|levonorgestrel|mesh-list
65695582|NCT02475356|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65695583|NCT02475356|Contraceptive Agents|contraceptive agents|mesh-ancestor
65695584|NCT02475356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65695585|NCT02475356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695586|NCT02475356|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65695587|NCT02475356|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65695588|NCT02475356|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65695589|NCT02480894|Maraviroc|maraviroc|mesh-list
65695590|NCT02480894|Fostemsavir|fostemsavir|mesh-list
65695591|NCT02480894|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65695592|NCT02480894|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65695593|NCT02480894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695594|NCT02480894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65695595|NCT02480894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65695596|NCT02480894|Antiviral Agents|antiviral agents|mesh-ancestor
65695597|NCT02480894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65695598|NCT02480894|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65695599|NCT02474654|Ketorolac|ketorolac|mesh-list
65695600|NCT02474654|Epinephrine|epinephrine|mesh-list
65695601|NCT02474654|Racepinephrine|racepinephrine|mesh-list
65695602|NCT02474654|Fentanyl|fentanyl|mesh-list
65695603|NCT02474654|Bupivacaine|bupivacaine|mesh-list
65695604|NCT02474654|Epinephryl borate|epinephryl borate|mesh-list
65695605|NCT02474654|Anesthetics, Local|anesthetics, local|mesh-ancestor
65695606|NCT02474654|Anesthetics|anesthetics|mesh-ancestor
65695607|NCT02474654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65695608|NCT02474654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695609|NCT02474654|Sensory System Agents|sensory system agents|mesh-ancestor
65695610|NCT02474654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65695611|NCT02474654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65695612|NCT02474654|Narcotics|narcotics|mesh-ancestor
65695613|NCT02474654|Analgesics|analgesics|mesh-ancestor
65695614|NCT02474654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65695615|NCT02474654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65695616|NCT02474654|Anesthetics, General|anesthetics, general|mesh-ancestor
65695617|NCT02474654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65695618|NCT02474654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65695619|NCT02474654|Adrenergic Agents|adrenergic agents|mesh-ancestor
65695620|NCT02474654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65695621|NCT02474654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695622|NCT02474654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65695623|NCT02474654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65695624|NCT02474654|Autonomic Agents|autonomic agents|mesh-ancestor
65695625|NCT02474654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65695626|NCT02474654|Respiratory System Agents|respiratory system agents|mesh-ancestor
65695628|NCT02474654|Sympathomimetics|sympathomimetics|mesh-ancestor
65695629|NCT02474654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65695630|NCT02474654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65695631|NCT02474654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65695632|NCT02474654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65695633|NCT02474654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65695634|NCT02474654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65695635|NCT02474654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695636|NCT02477852|Rifampin|rifampin|mesh-list
65695637|NCT02477852|Isoniazid|isoniazid|mesh-list
65695638|NCT02477852|Pyrazinamide|pyrazinamide|mesh-list
65695639|NCT02477852|Ethambutol|ethambutol|mesh-list
65695640|NCT02477852|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65695641|NCT02477852|Antitubercular Agents|antitubercular agents|mesh-ancestor
65695642|NCT02477852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65695643|NCT02477852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65695644|NCT02477852|Leprostatic Agents|leprostatic agents|mesh-ancestor
65695645|NCT02477852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65695646|NCT02477852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695647|NCT02477852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695648|NCT02477852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65695649|NCT02477852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65695650|NCT02477852|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65695651|NCT02477852|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65695652|NCT02477852|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65695653|NCT02477852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65695654|NCT02477852|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65695655|NCT02477852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65695656|NCT02477852|Antimetabolites|antimetabolites|mesh-ancestor
65695657|NCT02477852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65695658|NCT02474810|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65695659|NCT02474810|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65695660|NCT02474810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65695661|NCT02474810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695662|NCT02725268|Paclitaxel|paclitaxel|mesh-list
65695663|NCT02725268|Serabelisib|serabelisib|mesh-list
65695664|NCT02725268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65695665|NCT02725268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695666|NCT02725268|Tubulin Modulators|tubulin modulators|mesh-ancestor
65695667|NCT02725268|Antimitotic Agents|antimitotic agents|mesh-ancestor
65695668|NCT02725268|Mitosis Modulators|mitosis modulators|mesh-ancestor
65695669|NCT02725268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695670|NCT02725268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695671|NCT05038592|Decitabine|decitabine|mesh-list
65695672|NCT05038592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65695673|NCT05038592|Antimetabolites|antimetabolites|mesh-ancestor
65695674|NCT05038592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695675|NCT05038592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695676|NCT05038592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695677|NCT00705536|Insulin|insulin|mesh-list
65695678|NCT00705536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65695679|NCT00705536|Insulin Lispro|insulin lispro|mesh-list
65695680|NCT00705536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65695681|NCT00705536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695682|NCT02724878|Bevacizumab|bevacizumab|mesh-list
65695683|NCT02724878|Atezolizumab|atezolizumab|mesh-list
65695684|NCT02724878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65695685|NCT02724878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695686|NCT02724878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65695687|NCT02724878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65695688|NCT02724878|Growth Substances|growth substances|mesh-ancestor
65695689|NCT02724878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695690|NCT02724878|Growth Inhibitors|growth inhibitors|mesh-ancestor
65695691|NCT02474420|Amlodipine|amlodipine|mesh-list
65695692|NCT02474420|Deferasirox|deferasirox|mesh-list
65695693|NCT02474420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65695694|NCT02474420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65695695|NCT02474420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65695696|NCT02474420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695697|NCT02474420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65695698|NCT02474420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695699|NCT02474420|Vasodilator Agents|vasodilator agents|mesh-ancestor
65695700|NCT02474420|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65695701|NCT02474420|Chelating Agents|chelating agents|mesh-ancestor
65695702|NCT02474420|Sequestering Agents|sequestering agents|mesh-ancestor
65695703|NCT02474186|Paclitaxel|paclitaxel|mesh-list
65695704|NCT02474186|Docetaxel|docetaxel|mesh-list
65695705|NCT02474186|Capecitabine|capecitabine|mesh-list
65695706|NCT02474186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65695707|NCT02474186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695708|NCT02474186|Tubulin Modulators|tubulin modulators|mesh-ancestor
65695709|NCT02474186|Antimitotic Agents|antimitotic agents|mesh-ancestor
65695710|NCT02474186|Mitosis Modulators|mitosis modulators|mesh-ancestor
65695711|NCT02474186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695712|NCT02474186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65695713|NCT02474186|Antimetabolites|antimetabolites|mesh-ancestor
65695714|NCT02477306|Rabeprazole|rabeprazole|mesh-list
65695715|NCT02477306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65695716|NCT02477306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65695717|NCT02477306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65695718|NCT02477306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695719|NCT02477306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695720|NCT04868786|Mycophenolic Acid|mycophenolic acid|mesh-list
65695721|NCT04868786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65695722|NCT04868786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695723|NCT04868786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65695724|NCT04868786|Antitubercular Agents|antitubercular agents|mesh-ancestor
65695725|NCT04868786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65695726|NCT04868786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65695727|NCT04868786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695728|NCT04868786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695729|NCT04862468|Dexamethasone|dexamethasone|mesh-list
65695730|NCT04862468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65695731|NCT04862468|Antiemetics|antiemetics|mesh-ancestor
65695732|NCT04862468|Autonomic Agents|autonomic agents|mesh-ancestor
65695733|NCT04862468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65695734|NCT04862468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695735|NCT04862468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65695736|NCT04862468|Glucocorticoids|glucocorticoids|mesh-ancestor
65695737|NCT04862468|Hormones|hormones|mesh-ancestor
65695738|NCT04862468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65695739|NCT04862468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65695740|NCT04862468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695741|NCT02472626|Thioctic Acid|thioctic acid|mesh-list
65695742|NCT02472626|Cytarabine|cytarabine|mesh-list
65695743|NCT02472626|Daunorubicin|daunorubicin|mesh-list
65695744|NCT02472626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65695745|NCT02472626|Antimetabolites|antimetabolites|mesh-ancestor
65695746|NCT02472626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695747|NCT02472626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695748|NCT02472626|Antiviral Agents|antiviral agents|mesh-ancestor
65695749|NCT02472626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65695750|NCT02472626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65695751|NCT02472626|Immunologic Factors|immunologic factors|mesh-ancestor
65695752|NCT02472626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695753|NCT02472626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65695754|NCT02472626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65695755|NCT02472626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65695756|NCT02472626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695757|NCT02472626|Antioxidants|antioxidants|mesh-ancestor
65695758|NCT02472626|Protective Agents|protective agents|mesh-ancestor
65695759|NCT02472626|Vitamin B Complex|vitamin b complex|mesh-ancestor
65695760|NCT02472626|Vitamins|vitamins|mesh-ancestor
65695761|NCT02472626|Micronutrients|micronutrients|mesh-ancestor
65695762|NCT02472392|Cyclophosphamide|cyclophosphamide|mesh-list
65695763|NCT02472392|Melphalan|melphalan|mesh-list
65695764|NCT02472392|Busulfan|busulfan|mesh-list
65695765|NCT02472392|Fludarabine|fludarabine|mesh-list
65695766|NCT02472392|Thymoglobulin|thymoglobulin|mesh-list
65695767|NCT02472392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65695768|NCT02472392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65695769|NCT02472392|Immunologic Factors|immunologic factors|mesh-ancestor
65695770|NCT02472392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695771|NCT02472392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65695772|NCT02472392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65695773|NCT02472392|Alkylating Agents|alkylating agents|mesh-ancestor
65695774|NCT02472392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695775|NCT02472392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695776|NCT02472392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65695777|NCT02472158|Chlorhexidine|chlorhexidine|mesh-list
65695778|NCT02472158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65695779|NCT02472158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65695780|NCT02472158|Disinfectants|disinfectants|mesh-ancestor
65695781|NCT02472080|Gemcitabine|gemcitabine|mesh-list
65695782|NCT02472080|Oxaliplatin|oxaliplatin|mesh-list
65695783|NCT02472080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65695784|NCT02472080|Antimetabolites|antimetabolites|mesh-ancestor
65695785|NCT02472080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695786|NCT02472080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695787|NCT02472080|Antiviral Agents|antiviral agents|mesh-ancestor
65695788|NCT02472080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65695789|NCT02472080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695790|NCT02472080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65695791|NCT02472080|Immunologic Factors|immunologic factors|mesh-ancestor
65695792|NCT02472080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695793|NCT02473562|Varenicline|varenicline|mesh-list
65695794|NCT02473562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65695795|NCT02473562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65695796|NCT02473562|Cholinergic Agents|cholinergic agents|mesh-ancestor
65695797|NCT02473562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65695798|NCT02473562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695799|NCT02473562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695800|NCT02724020|Everolimus|everolimus|mesh-list
65695801|NCT02724020|Serabelisib|serabelisib|mesh-list
65695802|NCT02724020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695803|NCT02724020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65695804|NCT02724020|Immunologic Factors|immunologic factors|mesh-ancestor
65695805|NCT02724020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695806|NCT02724020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65269057|NCT00911807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65695807|NCT02724020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695808|NCT02816736|Valsartan|valsartan|mesh-list
65695809|NCT02816736|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65695810|NCT02816736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65695811|NCT02816736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65695812|NCT02816736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65695813|NCT02816736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695814|NCT02477072|Heparin|heparin|mesh-list
65695815|NCT02477072|Calcium heparin|calcium heparin|mesh-list
65695816|NCT02477072|Anticoagulants|anticoagulants|mesh-ancestor
65695817|NCT02477072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65695818|NCT02477072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65695819|NCT02477072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695820|NCT05103410|Aripiprazole|aripiprazole|mesh-list
65695821|NCT05103410|Antidepressive Agents|antidepressive agents|mesh-ancestor
65695822|NCT05103410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65695823|NCT05103410|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65695824|NCT05103410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65695825|NCT05103410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65695826|NCT05103410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695827|NCT05103410|Dopamine Agonists|dopamine agonists|mesh-ancestor
65695828|NCT05103410|Dopamine Agents|dopamine agents|mesh-ancestor
65695829|NCT05103410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65695830|NCT05103410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695831|NCT05103410|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65695832|NCT05103410|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65695833|NCT05103410|Serotonin Agents|serotonin agents|mesh-ancestor
65695834|NCT05103410|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65695835|NCT05103410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65695836|NCT05103410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65695837|NCT05103410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65695838|NCT02472236|Digoxin|digoxin|mesh-list
65695839|NCT02472236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65695840|NCT02472236|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65695841|NCT02472236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695842|NCT02472236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695843|NCT02472236|Protective Agents|protective agents|mesh-ancestor
65695844|NCT02472236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695845|NCT03108872|Anticoagulants|anticoagulants|mesh-list
65695846|NCT02194491|AS2471907|as2471907|mesh-list
65695847|NCT02194491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65695848|NCT02194491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695849|NCT03487770|Aripiprazole|aripiprazole|mesh-list
65695850|NCT03487770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65695851|NCT03487770|Antidepressive Agents|antidepressive agents|mesh-ancestor
65695852|NCT03487770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65695853|NCT03487770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65695854|NCT03487770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65695855|NCT03487770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65695856|NCT03487770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695857|NCT03487770|Dopamine Agonists|dopamine agonists|mesh-ancestor
65695858|NCT03487770|Dopamine Agents|dopamine agents|mesh-ancestor
65695859|NCT03487770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65695860|NCT03487770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695861|NCT03487770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65695862|NCT03487770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65695863|NCT03487770|Serotonin Agents|serotonin agents|mesh-ancestor
65695864|NCT03487770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65695865|NCT03487770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65695866|NCT03487770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65269067|NCT04117451|Propolis|propolis|mesh-list
65695867|NCT03487770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65695868|NCT02473328|Ritonavir|ritonavir|mesh-list
65695869|NCT02473328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65695870|NCT02473328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65695871|NCT02473328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65695872|NCT02473328|Protease Inhibitors|protease inhibitors|mesh-ancestor
65695873|NCT02473328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695874|NCT02473328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695875|NCT02473328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65695876|NCT02473328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65695877|NCT02473328|Antiviral Agents|antiviral agents|mesh-ancestor
65695878|NCT02473328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65695879|NCT02473328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65695880|NCT02473328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65695881|NCT02473406|Thymalfasin|thymalfasin|mesh-list
65695882|NCT02473406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65695883|NCT02473406|Immunologic Factors|immunologic factors|mesh-ancestor
65695884|NCT02473406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695885|NCT02473094|Metformin|metformin|mesh-list
65695886|NCT02473094|Capecitabine|capecitabine|mesh-list
65695887|NCT02473094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65695888|NCT02473094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695889|NCT02473094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65695890|NCT02473094|Antimetabolites|antimetabolites|mesh-ancestor
65695891|NCT02473094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695892|NCT02473094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695893|NCT03492138|Dexamethasone|dexamethasone|mesh-list
65695894|NCT03492138|Ixazomib|ixazomib|mesh-list
65695895|NCT03492138|TIC10 compound|tic10 compound|mesh-list
65695896|NCT03492138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65695897|NCT03492138|Antiemetics|antiemetics|mesh-ancestor
65695898|NCT03492138|Autonomic Agents|autonomic agents|mesh-ancestor
65695899|NCT03492138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65695900|NCT03492138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695901|NCT03492138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65695902|NCT03492138|Glucocorticoids|glucocorticoids|mesh-ancestor
65695903|NCT03492138|Hormones|hormones|mesh-ancestor
65695904|NCT03492138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65695905|NCT03492138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65695906|NCT03492138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695907|NCT03492138|Protease Inhibitors|protease inhibitors|mesh-ancestor
65695908|NCT03492138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695909|NCT03492138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695910|NCT02472938|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65695911|NCT02472938|Dermatologic Agents|dermatologic agents|mesh-ancestor
65695912|NCT02472938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65695913|NCT02472938|Immunologic Factors|immunologic factors|mesh-ancestor
65695914|NCT02472938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695915|NCT03131700|Bevacizumab|bevacizumab|mesh-list
65695916|NCT03131700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65695917|NCT03131700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695918|NCT03131700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65695919|NCT03131700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65695920|NCT03131700|Growth Substances|growth substances|mesh-ancestor
65695921|NCT03131700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695922|NCT03131700|Growth Inhibitors|growth inhibitors|mesh-ancestor
65695924|NCT04730258|Decitabine|decitabine|mesh-list
65695925|NCT04730258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65695926|NCT04730258|Antimetabolites|antimetabolites|mesh-ancestor
65695927|NCT04730258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695928|NCT04730258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695929|NCT04730258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695930|NCT04706936|Cyclophosphamide|cyclophosphamide|mesh-list
65695931|NCT04706936|Fludarabine|fludarabine|mesh-list
65695932|NCT04706936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65695933|NCT04706936|Immunologic Factors|immunologic factors|mesh-ancestor
65695934|NCT04706936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695935|NCT04706936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65695936|NCT04706936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65695937|NCT04706936|Alkylating Agents|alkylating agents|mesh-ancestor
65695938|NCT04706936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695939|NCT04706936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695940|NCT04706936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65695941|NCT02194881|Ivacaftor|ivacaftor|mesh-list
65695942|NCT02194881|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65695943|NCT02194881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65695944|NCT02194881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695945|NCT02194179|Nevirapine|nevirapine|mesh-list
65695946|NCT02194179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65695947|NCT02194179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65695948|NCT02194179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65695949|NCT02194179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695950|NCT02194179|Antiviral Agents|antiviral agents|mesh-ancestor
65695951|NCT02194179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65695952|NCT02194179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65695953|NCT02194179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65695954|NCT02194179|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65695955|NCT02194179|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65695956|NCT02194257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65695957|NCT02194257|Ambroxol|ambroxol|mesh-list
65695958|NCT02194257|Expectorants|expectorants|mesh-ancestor
65695959|NCT02194257|Respiratory System Agents|respiratory system agents|mesh-ancestor
65695960|NCT02195115|Amitriptyline|amitriptyline|mesh-list
65695961|NCT02195115|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65695962|NCT02195115|Antidepressive Agents|antidepressive agents|mesh-ancestor
65695963|NCT02195115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65695964|NCT02195115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65695965|NCT02195115|Analgesics|analgesics|mesh-ancestor
65695966|NCT02195115|Sensory System Agents|sensory system agents|mesh-ancestor
65695967|NCT02195115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65695968|NCT02195115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695969|NCT02195115|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65695970|NCT02195115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65695971|NCT02195115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65695972|NCT02195115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695973|NCT02195115|Adrenergic Agents|adrenergic agents|mesh-ancestor
65695974|NCT02195115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65695975|NCT05144529|Nivolumab|nivolumab|mesh-list
65695976|NCT05144529|Ipilimumab|ipilimumab|mesh-list
65695977|NCT05144529|Evolocumab|evolocumab|mesh-list
65695978|NCT05144529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65695979|NCT05144529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695980|NCT05144529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65695981|NCT05144529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695982|NCT05144529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65695983|NCT05144529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65695984|NCT05144529|Antimetabolites|antimetabolites|mesh-ancestor
65695985|NCT05144529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65695986|NCT02195973|Paclitaxel|paclitaxel|mesh-list
65695987|NCT02195973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65695988|NCT02195973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65695989|NCT02195973|Tubulin Modulators|tubulin modulators|mesh-ancestor
65695990|NCT02195973|Antimitotic Agents|antimitotic agents|mesh-ancestor
65695991|NCT02195973|Mitosis Modulators|mitosis modulators|mesh-ancestor
65695992|NCT02195973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695993|NCT02196207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65493304|NCT05426486|Docetaxel|docetaxel|mesh-list
65695994|NCT02196207|Immunologic Factors|immunologic factors|mesh-ancestor
65695995|NCT02196207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65695997|NCT02195271|Antioxidants|antioxidants|mesh-ancestor
65695998|NCT02195271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65695999|NCT02195271|Protective Agents|protective agents|mesh-ancestor
65696000|NCT02195271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696001|NCT02195271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65696002|NCT02196285|Vaccines|vaccines|mesh-list
65696003|NCT02196285|Immunologic Factors|immunologic factors|mesh-ancestor
65696004|NCT02196285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696005|NCT05096169|Citric Acid|citric acid|mesh-list
65696006|NCT05096169|Sodium Citrate|sodium citrate|mesh-list
65696007|NCT05096169|Clomiphene|clomiphene|mesh-list
65696008|NCT05096169|Enclomiphene|enclomiphene|mesh-list
65696009|NCT05096169|Zuclomiphene|zuclomiphene|mesh-list
65696010|NCT05096169|Anticoagulants|anticoagulants|mesh-ancestor
65696011|NCT05096169|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65696012|NCT05096169|Chelating Agents|chelating agents|mesh-ancestor
65696013|NCT05096169|Sequestering Agents|sequestering agents|mesh-ancestor
65696014|NCT05096169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696015|NCT05096169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65696016|NCT05096169|Hormone Antagonists|hormone antagonists|mesh-ancestor
65696017|NCT05096169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65696018|NCT05096169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696019|NCT05096169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65696020|NCT05096169|Fertility Agents|fertility agents|mesh-ancestor
65696021|NCT05096169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65696022|NCT05096169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65696023|NCT05096169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65696024|NCT04229979|Cytarabine|cytarabine|mesh-list
65696025|NCT04229979|Azacitidine|azacitidine|mesh-list
65696026|NCT04229979|Decitabine|decitabine|mesh-list
65696027|NCT04229979|Venetoclax|venetoclax|mesh-list
65696028|NCT04229979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65696029|NCT04229979|Antimetabolites|antimetabolites|mesh-ancestor
65696030|NCT04229979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696031|NCT04229979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696032|NCT04229979|Antiviral Agents|antiviral agents|mesh-ancestor
65696033|NCT04229979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65696034|NCT04229979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65696035|NCT04229979|Immunologic Factors|immunologic factors|mesh-ancestor
65696036|NCT04229979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696037|NCT04229979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696038|NCT02196441|Bupivacaine|bupivacaine|mesh-list
65696039|NCT02196441|Anesthetics, Local|anesthetics, local|mesh-list
65696040|NCT02196441|Tetracaine|tetracaine|mesh-list
65696041|NCT02196441|Anesthetics|anesthetics|mesh-list
65696042|NCT02196441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65696043|NCT02196441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696044|NCT02196441|Sensory System Agents|sensory system agents|mesh-ancestor
65696045|NCT02196441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696046|NCT02195661|Melatonin|melatonin|mesh-list
65696047|NCT02195661|Chloral Hydrate|chloral hydrate|mesh-list
65696048|NCT02195661|Antioxidants|antioxidants|mesh-ancestor
65696049|NCT02195661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696050|NCT02195661|Protective Agents|protective agents|mesh-ancestor
65696051|NCT02195661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696052|NCT02195661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65696053|NCT02195661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65696054|NCT03534297|Dapansutrile|dapansutrile|mesh-list
65696055|NCT03534297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65696056|NCT02195817|Nalmefene|nalmefene|mesh-list
65696057|NCT02195817|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65696058|NCT02195817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696059|NCT02195817|Sensory System Agents|sensory system agents|mesh-ancestor
65696060|NCT02195817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696061|NCT02197143|Esomeprazole|esomeprazole|mesh-list
65696062|NCT02197143|Ranitidine|ranitidine|mesh-list
65696063|NCT02197143|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65696064|NCT02197143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65696065|NCT02197143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65493377|NCT05318469|Ivermectin|ivermectin|mesh-list
65696066|NCT02197143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65696067|NCT02197143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696068|NCT02197143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696069|NCT02197143|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65696070|NCT02197143|Histamine Antagonists|histamine antagonists|mesh-ancestor
65696071|NCT02197143|Histamine Agents|histamine agents|mesh-ancestor
65696072|NCT02197143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65696073|NCT02197143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696074|NCT02096874|Bevacizumab|bevacizumab|mesh-list
65696075|NCT02096874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65696076|NCT02096874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696077|NCT02096874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65696078|NCT02096874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65696079|NCT02096874|Growth Substances|growth substances|mesh-ancestor
65696080|NCT02096874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696081|NCT02096874|Growth Inhibitors|growth inhibitors|mesh-ancestor
65696082|NCT02575794|Masoprocol|masoprocol|mesh-list
65696083|NCT02575794|Antioxidants|antioxidants|mesh-ancestor
65696084|NCT02575794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696085|NCT02575794|Protective Agents|protective agents|mesh-ancestor
65696086|NCT02575794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696087|NCT02575794|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65696088|NCT02575794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696089|NCT02575794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65696090|NCT02575794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65696091|NCT02575794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65696092|NCT02575794|Analgesics|analgesics|mesh-ancestor
65696093|NCT02575794|Sensory System Agents|sensory system agents|mesh-ancestor
65696094|NCT02575794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696095|NCT02575794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65696096|NCT02575794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65696097|NCT02198547|Magnesium Sulfate|magnesium sulfate|mesh-list
65696098|NCT02198547|Ropivacaine|ropivacaine|mesh-list
65696099|NCT02198547|Anesthetics, Local|anesthetics, local|mesh-ancestor
65696100|NCT02198547|Anesthetics|anesthetics|mesh-ancestor
65696101|NCT02198547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65696102|NCT02198547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696103|NCT02198547|Sensory System Agents|sensory system agents|mesh-ancestor
65696104|NCT02198547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696105|NCT02198547|Analgesics|analgesics|mesh-ancestor
65696106|NCT02198547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65696107|NCT02198547|Anticonvulsants|anticonvulsants|mesh-ancestor
65696108|NCT02198547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65696109|NCT02198547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65696110|NCT02198547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696111|NCT02198547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65696112|NCT02198547|Tocolytic Agents|tocolytic agents|mesh-ancestor
65696113|NCT02198547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65696114|NCT01024608|Beclomethasone|beclomethasone|mesh-list
65696115|NCT01024608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65696116|NCT01024608|Glucocorticoids|glucocorticoids|mesh-ancestor
65696117|NCT01024608|Hormones|hormones|mesh-ancestor
65696118|NCT01024608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65696119|NCT01024608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696120|NCT01024608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65696121|NCT01024608|Respiratory System Agents|respiratory system agents|mesh-ancestor
65696122|NCT03489798|Alprostadil|alprostadil|mesh-list
65696123|NCT03489798|Misoprostol|misoprostol|mesh-list
65696124|NCT03489798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65696125|NCT03489798|Abortifacient Agents|abortifacient agents|mesh-ancestor
65696126|NCT03489798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65696127|NCT03489798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696128|NCT03489798|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65696129|NCT03489798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65696130|NCT03489798|Oxytocics|oxytocics|mesh-ancestor
65696131|NCT03489798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65696132|NCT03489798|Vasodilator Agents|vasodilator agents|mesh-ancestor
65696133|NCT03489798|Urological Agents|urological agents|mesh-ancestor
65696134|NCT02031081|Prucalopride|prucalopride|mesh-list
65696135|NCT02031081|Laxatives|laxatives|mesh-ancestor
65696136|NCT02031081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65696137|NCT02031081|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65696138|NCT02031081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65696139|NCT02031081|Serotonin Agents|serotonin agents|mesh-ancestor
65696140|NCT02031081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65696141|NCT02031081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696142|NCT02031081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696143|NCT02198859|Lithium Carbonate|lithium carbonate|mesh-list
65696144|NCT02198859|Antidepressive Agents|antidepressive agents|mesh-ancestor
65696146|NCT02198859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696147|NCT02198859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696148|NCT02198859|Antimanic Agents|antimanic agents|mesh-ancestor
65696149|NCT02198859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65696150|NCT02198859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65696151|NCT02198859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696152|NCT02199171|Carboplatin|carboplatin|mesh-list
65696153|NCT02199171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696154|NCT00910650|Aldesleukin|aldesleukin|mesh-list
65696155|NCT00910650|Interleukin-2|interleukin-2|mesh-list
65696156|NCT00910650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696157|NCT00910650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65696158|NCT00910650|Analgesics|analgesics|mesh-ancestor
65696159|NCT00910650|Sensory System Agents|sensory system agents|mesh-ancestor
65696160|NCT00910650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696161|NCT00910650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696162|NCT00910650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65696163|NCT00910650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65696164|NCT00910650|Antiviral Agents|antiviral agents|mesh-ancestor
65696165|NCT00910650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65696166|NCT02199327|Interferons|interferons|mesh-list
65696167|NCT02199327|Interferon-alpha|interferon-alpha|mesh-list
65696168|NCT02199327|Interferon alpha-2|interferon alpha-2|mesh-list
65696169|NCT02199327|Mitomycins|mitomycins|mesh-list
65696170|NCT02199327|Mitomycin|mitomycin|mesh-list
65696171|NCT02199327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696172|NCT02199327|Antiviral Agents|antiviral agents|mesh-ancestor
65696173|NCT02199327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65696174|NCT02199327|Immunologic Factors|immunologic factors|mesh-ancestor
65696175|NCT02199327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696176|NCT02199327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65696177|NCT02199327|Alkylating Agents|alkylating agents|mesh-ancestor
65696178|NCT02199327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696179|NCT02199327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65696180|NCT02199327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696181|NCT00756288|Photosensitizing Agents|photosensitizing agents|mesh-list
65696182|NCT00756288|Dermatologic Agents|dermatologic agents|mesh-ancestor
65696183|NCT02198001|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65696184|NCT02198001|Amoxicillin|amoxicillin|mesh-list
65696185|NCT02198001|Clavulanic Acid|clavulanic acid|mesh-list
65696186|NCT02198001|Clavulanic Acids|clavulanic acids|mesh-list
65696187|NCT02198001|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65696188|NCT02198001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65696189|NCT02198001|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65696190|NCT02198001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696191|NCT02198001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696192|NCT05116800|Gemcitabine|gemcitabine|mesh-list
65696193|NCT05116800|Docetaxel|docetaxel|mesh-list
65696194|NCT05116800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65696195|NCT05116800|Antimetabolites|antimetabolites|mesh-ancestor
65696196|NCT05116800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696197|NCT05116800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696198|NCT05116800|Antiviral Agents|antiviral agents|mesh-ancestor
65696199|NCT05116800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65696200|NCT05116800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696201|NCT05116800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65696202|NCT05116800|Immunologic Factors|immunologic factors|mesh-ancestor
65696203|NCT05116800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696204|NCT05116800|Tubulin Modulators|tubulin modulators|mesh-ancestor
65696205|NCT05116800|Antimitotic Agents|antimitotic agents|mesh-ancestor
65696206|NCT05116800|Mitosis Modulators|mitosis modulators|mesh-ancestor
65696207|NCT04078737|Aspirin|aspirin|mesh-list
65696208|NCT04078737|Clopidogrel|clopidogrel|mesh-list
65696209|NCT04078737|Ticagrelor|ticagrelor|mesh-list
65696210|NCT04078737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65696211|NCT04078737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65696212|NCT04078737|Analgesics|analgesics|mesh-ancestor
65696213|NCT04078737|Sensory System Agents|sensory system agents|mesh-ancestor
65696214|NCT04078737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696215|NCT04078737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696216|NCT04078737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65696217|NCT04078737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65696218|NCT04078737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65696219|NCT04078737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65696220|NCT04078737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696221|NCT04078737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65696223|NCT04078737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696224|NCT04078737|Antipyretics|antipyretics|mesh-ancestor
65696225|NCT04078737|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65696226|NCT04078737|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65696227|NCT04078737|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65696228|NCT04078737|Purinergic Agents|purinergic agents|mesh-ancestor
65696229|NCT04078737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65696230|NCT03491904|Fasinumab|fasinumab|mesh-list
65696231|NCT03491904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65696232|NCT03491904|Analgesics|analgesics|mesh-ancestor
65696233|NCT03491904|Sensory System Agents|sensory system agents|mesh-ancestor
65696234|NCT03491904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696235|NCT03491904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696236|NCT02199951|Piperaquine|piperaquine|mesh-list
65696237|NCT02199951|Artenimol|artenimol|mesh-list
65696238|NCT02199951|Antimalarials|antimalarials|mesh-ancestor
65696239|NCT02199951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65696240|NCT02199951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65696241|NCT02199951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65696242|NCT03533361|Lenvatinib|lenvatinib|mesh-list
65696243|NCT03533361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696244|NCT03533361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65696245|NCT03533361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696246|NCT03533361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696247|NCT01433328|Lidocaine|lidocaine|mesh-list
65696248|NCT01433328|Anesthetics, Local|anesthetics, local|mesh-ancestor
65696249|NCT01433328|Anesthetics|anesthetics|mesh-ancestor
65696250|NCT01433328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65696251|NCT01433328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696252|NCT01433328|Sensory System Agents|sensory system agents|mesh-ancestor
65696253|NCT01433328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696254|NCT01433328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65696255|NCT01433328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65696256|NCT01433328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65696257|NCT01433328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65696258|NCT01433328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696259|NCT02198469|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65696260|NCT02198469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65696261|NCT02198469|Dermatologic Agents|dermatologic agents|mesh-ancestor
65696262|NCT02200185|Morphine|morphine|mesh-list
65696263|NCT02200185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65696264|NCT02200185|Narcotics|narcotics|mesh-ancestor
65696265|NCT02200185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65696266|NCT02200185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696267|NCT02200185|Analgesics|analgesics|mesh-ancestor
65696268|NCT02200185|Sensory System Agents|sensory system agents|mesh-ancestor
65696269|NCT02200185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696270|NCT02201043|Thalidomide|thalidomide|mesh-list
65696271|NCT02201043|Tolnaftate|tolnaftate|mesh-list
65696272|NCT02201043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65696273|NCT02201043|Immunologic Factors|immunologic factors|mesh-ancestor
65696274|NCT02201043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696275|NCT02201043|Leprostatic Agents|leprostatic agents|mesh-ancestor
65696276|NCT02201043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65696277|NCT02201043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65696278|NCT02201043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65696279|NCT02201043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65696280|NCT02201043|Growth Substances|growth substances|mesh-ancestor
65696281|NCT02201043|Growth Inhibitors|growth inhibitors|mesh-ancestor
65696282|NCT02201043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696283|NCT02201043|Antifungal Agents|antifungal agents|mesh-ancestor
65696284|NCT02201121|Phenylephrine|phenylephrine|mesh-list
65696285|NCT02201121|Dopamine|dopamine|mesh-list
65696286|NCT02201121|Oxymetazoline|oxymetazoline|mesh-list
65696287|NCT02201121|Ephedrine|ephedrine|mesh-list
65696288|NCT02201121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65696289|NCT02201121|Mydriatics|mydriatics|mesh-ancestor
65696290|NCT02201121|Autonomic Agents|autonomic agents|mesh-ancestor
65696291|NCT02201121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696292|NCT02201121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696293|NCT02201121|Sympathomimetics|sympathomimetics|mesh-ancestor
65696294|NCT02201121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65696295|NCT02201121|Nasal Decongestants|nasal decongestants|mesh-ancestor
65696296|NCT02201121|Respiratory System Agents|respiratory system agents|mesh-ancestor
65493600|NCT04887857|Cc-486|cc-486|mesh-list
65696297|NCT02201121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65696298|NCT02201121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65696299|NCT02201121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65696300|NCT02201121|Adrenergic Agents|adrenergic agents|mesh-ancestor
65696301|NCT02201121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65696302|NCT02201121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696303|NCT02201121|Protective Agents|protective agents|mesh-ancestor
65696304|NCT02201121|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65696305|NCT02201121|Dopamine Agents|dopamine agents|mesh-ancestor
65696306|NCT02200575|Telmisartan|telmisartan|mesh-list
65696307|NCT02200575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65696308|NCT02200575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65696309|NCT02200575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65696310|NCT02200575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696311|NCT02201199|Insulin|insulin|mesh-list
65696312|NCT02201199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65696313|NCT02201199|Insulin Glargine|insulin glargine|mesh-list
65696314|NCT02201199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65696315|NCT02201199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696316|NCT02200653|Losartan|losartan|mesh-list
65696317|NCT02200653|Telmisartan|telmisartan|mesh-list
65696318|NCT02200653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65696319|NCT02200653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65696320|NCT02200653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65696321|NCT02200653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65696322|NCT02200653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696323|NCT03999411|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65696324|NCT03999411|Nicotine|nicotine|mesh-list
65696325|NCT03999411|Antiviral Agents|antiviral agents|mesh-ancestor
65696326|NCT03999411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65696327|NCT03999411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65696328|NCT03999411|Autonomic Agents|autonomic agents|mesh-ancestor
65696329|NCT03999411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696330|NCT03999411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696331|NCT03999411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65696332|NCT03999411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65696333|NCT03999411|Cholinergic Agents|cholinergic agents|mesh-ancestor
65696334|NCT03999411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65696335|NCT03999411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696336|NCT05261997|Metformin|metformin|mesh-list
65696337|NCT05261997|Acarbose|acarbose|mesh-list
65696338|NCT05261997|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65696339|NCT05261997|Pancreatin|pancreatin|mesh-list
65696340|NCT05261997|Pancrelipase|pancrelipase|mesh-list
65696341|NCT05261997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696342|NCT05261997|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65696343|NCT05261997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696344|NCT05261997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696345|NCT05261997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65696346|NCT02206425|Ascorbic Acid|ascorbic acid|mesh-list
65696347|NCT02206425|Dexamethasone|dexamethasone|mesh-list
65696348|NCT02206425|Dexamethasone acetate|dexamethasone acetate|mesh-list
65696349|NCT02206425|Prednisone|prednisone|mesh-list
65696350|NCT02206425|Cyclophosphamide|cyclophosphamide|mesh-list
65696351|NCT02206425|Melphalan|melphalan|mesh-list
65696352|NCT02206425|Doxorubicin|doxorubicin|mesh-list
65696353|NCT02206425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65696354|NCT02206425|Lenalidomide|lenalidomide|mesh-list
65696355|NCT02206425|Pomalidomide|pomalidomide|mesh-list
65696356|NCT02206425|BB 1101|bb 1101|mesh-list
65696357|NCT02206425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65696358|NCT02206425|Immunologic Factors|immunologic factors|mesh-ancestor
65696359|NCT02206425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696360|NCT02206425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65696361|NCT02206425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65696362|NCT02206425|Alkylating Agents|alkylating agents|mesh-ancestor
65696363|NCT02206425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696364|NCT02206425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696365|NCT02206425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65696366|NCT02206425|Vitamins|vitamins|mesh-ancestor
65696367|NCT02206425|Micronutrients|micronutrients|mesh-ancestor
65696368|NCT02206425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65696369|NCT02206425|Antiemetics|antiemetics|mesh-ancestor
65696370|NCT02206425|Autonomic Agents|autonomic agents|mesh-ancestor
65696371|NCT02206425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696372|NCT02206425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65696373|NCT02206425|Glucocorticoids|glucocorticoids|mesh-ancestor
65696375|NCT02206425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65696376|NCT02206425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65696377|NCT02206425|Protease Inhibitors|protease inhibitors|mesh-ancestor
65696378|NCT02206425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696379|NCT02206425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65696380|NCT02206425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65696381|NCT02206425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65696382|NCT02206425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65696383|NCT02206425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65696384|NCT02206425|Growth Substances|growth substances|mesh-ancestor
65696385|NCT02206425|Growth Inhibitors|growth inhibitors|mesh-ancestor
65696386|NCT02206425|Antioxidants|antioxidants|mesh-ancestor
65696387|NCT02206425|Protective Agents|protective agents|mesh-ancestor
65696388|NCT02201667|Aspirin|aspirin|mesh-list
65696389|NCT02201667|Clopidogrel|clopidogrel|mesh-list
65696390|NCT02201667|Ticagrelor|ticagrelor|mesh-list
65696391|NCT02201667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65696392|NCT02201667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65696393|NCT02201667|Analgesics|analgesics|mesh-ancestor
65696394|NCT02201667|Sensory System Agents|sensory system agents|mesh-ancestor
65696395|NCT02201667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696396|NCT02201667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696397|NCT02201667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65696398|NCT02201667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65696399|NCT02201667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65696400|NCT02201667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65696401|NCT02201667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696402|NCT02201667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65696403|NCT02201667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65696404|NCT02201667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696405|NCT02201667|Antipyretics|antipyretics|mesh-ancestor
65696406|NCT02201667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65696407|NCT02201667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65696408|NCT02201667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65696409|NCT02201667|Purinergic Agents|purinergic agents|mesh-ancestor
65696410|NCT02201667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65696411|NCT02206503|Dexamethasone|dexamethasone|mesh-list
65696412|NCT02206503|Cyclophosphamide|cyclophosphamide|mesh-list
65696413|NCT02206503|Lenalidomide|lenalidomide|mesh-list
65696414|NCT02206503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65696415|NCT02206503|Immunologic Factors|immunologic factors|mesh-ancestor
65696416|NCT02206503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696417|NCT02206503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65696418|NCT02206503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65696419|NCT02206503|Alkylating Agents|alkylating agents|mesh-ancestor
65696420|NCT02206503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696421|NCT02206503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696422|NCT02206503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65696423|NCT02206503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65696424|NCT02206503|Antiemetics|antiemetics|mesh-ancestor
65696425|NCT02206503|Autonomic Agents|autonomic agents|mesh-ancestor
65696426|NCT02206503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696427|NCT02206503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65696428|NCT02206503|Glucocorticoids|glucocorticoids|mesh-ancestor
65696429|NCT02206503|Hormones|hormones|mesh-ancestor
65696430|NCT02206503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65696431|NCT02206503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65696432|NCT02206503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65696433|NCT02206503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65696434|NCT02206503|Growth Substances|growth substances|mesh-ancestor
65696435|NCT02206503|Growth Inhibitors|growth inhibitors|mesh-ancestor
65696436|NCT02206659|Telmisartan|telmisartan|mesh-list
65696437|NCT02206659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65696438|NCT02206659|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65696439|NCT02206659|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65696440|NCT02206659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696441|NCT02206737|Nicotine|nicotine|mesh-list
65696442|NCT02206737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65696443|NCT02206737|Autonomic Agents|autonomic agents|mesh-ancestor
65696444|NCT02206737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696445|NCT02206737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696446|NCT02206737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65696447|NCT02206737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65696448|NCT02206737|Cholinergic Agents|cholinergic agents|mesh-ancestor
65696449|NCT02206737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65696450|NCT02206737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696452|NCT03533127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65696453|NCT03533127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696454|NCT03533127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65696455|NCT03533127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65696456|NCT03533127|Growth Substances|growth substances|mesh-ancestor
65696457|NCT03533127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696458|NCT03533127|Growth Inhibitors|growth inhibitors|mesh-ancestor
65696459|NCT02207361|Paclitaxel|paclitaxel|mesh-list
65696460|NCT02207361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65696461|NCT02207361|Carboplatin|carboplatin|mesh-list
65696462|NCT02207361|Epirubicin|epirubicin|mesh-list
65696463|NCT02207361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65696464|NCT02207361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696465|NCT02207361|Tubulin Modulators|tubulin modulators|mesh-ancestor
65696466|NCT02207361|Antimitotic Agents|antimitotic agents|mesh-ancestor
65696467|NCT02207361|Mitosis Modulators|mitosis modulators|mesh-ancestor
65696468|NCT02207361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696469|NCT02207361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65696470|NCT02207361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65696471|NCT02207361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65696472|NCT02207361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696473|NCT02207439|Nelfinavir|nelfinavir|mesh-list
65696474|NCT02207439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65696475|NCT02207439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65696476|NCT02207439|Protease Inhibitors|protease inhibitors|mesh-ancestor
65696477|NCT02207439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696478|NCT02207439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696479|NCT02207439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65696480|NCT02207439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65696481|NCT02207439|Antiviral Agents|antiviral agents|mesh-ancestor
65696482|NCT02207439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65696483|NCT02202525|Telmisartan|telmisartan|mesh-list
65696484|NCT02202525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65696485|NCT02202525|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65696486|NCT02202525|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65696487|NCT02202525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696488|NCT02202603|Teriparatide|teriparatide|mesh-list
65696489|NCT02202603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65696490|NCT02202603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696491|NCT02202603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65696492|NCT02202993|Mibefradil|mibefradil|mesh-list
65696493|NCT02202993|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65696494|NCT02202993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65696495|NCT02202993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65696496|NCT02202993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696497|NCT02202993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65696498|NCT02202993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696499|NCT02202993|Vasodilator Agents|vasodilator agents|mesh-ancestor
65696500|NCT02202993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65696501|NCT02202993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65696502|NCT02202993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696503|NCT02190357|Rifaximin|rifaximin|mesh-list
65696504|NCT02190357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65696505|NCT02190357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65696506|NCT02190357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65696507|NCT02257671|Contraceptive Agents|contraceptive agents|mesh-list
65696508|NCT02257671|Levonorgestrel|levonorgestrel|mesh-list
65696509|NCT02257671|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65696510|NCT02257671|Contraceptives, Oral|contraceptives, oral|mesh-list
65696511|NCT02257671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65696512|NCT02257671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696513|NCT02257671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65696514|NCT02257671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65696515|NCT02257671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65696516|NCT02257671|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65696517|NCT02257671|Estrogens|estrogens|mesh-ancestor
65696518|NCT02257671|Hormones|hormones|mesh-ancestor
65696519|NCT02257671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65696520|NCT01460160|Dasatinib|dasatinib|mesh-list
65696521|NCT01460160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696522|NCT01460160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65696523|NCT01460160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696524|NCT01460160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696525|NCT02203227|Turmeric extract|turmeric extract|mesh-list
65696526|NCT02203227|Antioxidants|antioxidants|mesh-ancestor
65696527|NCT02203227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696528|NCT02203227|Protective Agents|protective agents|mesh-ancestor
65696529|NCT02203227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696530|NCT01170702|Ropivacaine|ropivacaine|mesh-list
65696531|NCT01170702|Anesthetics, Local|anesthetics, local|mesh-ancestor
65696532|NCT01170702|Anesthetics|anesthetics|mesh-ancestor
65696533|NCT01170702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65696534|NCT01170702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696535|NCT01170702|Sensory System Agents|sensory system agents|mesh-ancestor
65696536|NCT01170702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696537|NCT02203461|Ritonavir|ritonavir|mesh-list
65696538|NCT02203461|Lopinavir|lopinavir|mesh-list
65696539|NCT02203461|Darunavir|darunavir|mesh-list
65696540|NCT02203461|Tenofovir|tenofovir|mesh-list
65696541|NCT02203461|Emtricitabine|emtricitabine|mesh-list
65696542|NCT02203461|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65696543|NCT02203461|Cobicistat|cobicistat|mesh-list
65696544|NCT02203461|Elvitegravir|elvitegravir|mesh-list
65696545|NCT02203461|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65696546|NCT02203461|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65696547|NCT02203461|Protease Inhibitors|protease inhibitors|mesh-ancestor
65696548|NCT02203461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696549|NCT02203461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696550|NCT02203461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65696551|NCT02203461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65696552|NCT02203461|Antiviral Agents|antiviral agents|mesh-ancestor
65696553|NCT02203461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65696554|NCT02203461|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65696555|NCT02203461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65696556|NCT02203461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65696557|NCT02203461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65696558|NCT02203461|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65696559|NCT02191059|Docetaxel|docetaxel|mesh-list
65696560|NCT02191059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696561|NCT02191059|Tubulin Modulators|tubulin modulators|mesh-ancestor
65696562|NCT02191059|Antimitotic Agents|antimitotic agents|mesh-ancestor
65696563|NCT02191059|Mitosis Modulators|mitosis modulators|mesh-ancestor
65696564|NCT02191059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696565|NCT02191215|Nevirapine|nevirapine|mesh-list
65696566|NCT02191215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65696567|NCT02191215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65696568|NCT02191215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696569|NCT02191215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696570|NCT02191215|Antiviral Agents|antiviral agents|mesh-ancestor
65696571|NCT02191215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65696572|NCT02191215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65696573|NCT02191215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65696574|NCT02191215|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65696575|NCT02191215|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65696576|NCT02209155|Verapamil|verapamil|mesh-list
65696577|NCT02209155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65696578|NCT02209155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65696579|NCT02209155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65696580|NCT02209155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696581|NCT02209155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65696582|NCT02209155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696583|NCT02209155|Vasodilator Agents|vasodilator agents|mesh-ancestor
65696584|NCT03485118|Rituximab|rituximab|mesh-list
65696585|NCT03485118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65696586|NCT03485118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696587|NCT03485118|Immunologic Factors|immunologic factors|mesh-ancestor
65696588|NCT03485118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696589|NCT03485118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65696590|NCT02191293|Nevirapine|nevirapine|mesh-list
65696591|NCT02191293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65696592|NCT02191293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65696593|NCT02191293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696594|NCT02191293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696595|NCT02191293|Antiviral Agents|antiviral agents|mesh-ancestor
65696596|NCT02191293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65696597|NCT02191293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65696598|NCT02191293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65696599|NCT02191293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65696600|NCT02191293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65696601|NCT02880540|Fentanyl|fentanyl|mesh-list
65696602|NCT02880540|Dexmedetomidine|dexmedetomidine|mesh-list
65696603|NCT02880540|Morphine|morphine|mesh-list
65696604|NCT02880540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65696605|NCT02880540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65696606|NCT02880540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696607|NCT02880540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65696608|NCT02880540|Analgesics|analgesics|mesh-ancestor
65696609|NCT02880540|Sensory System Agents|sensory system agents|mesh-ancestor
65696610|NCT02880540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696611|NCT02880540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65696612|NCT02880540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65696613|NCT02880540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65696614|NCT02880540|Adrenergic Agents|adrenergic agents|mesh-ancestor
65696615|NCT02880540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65696616|NCT02880540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696617|NCT02880540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65696618|NCT02880540|Narcotics|narcotics|mesh-ancestor
65696619|NCT02880540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65696620|NCT02880540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65696621|NCT02880540|Anesthetics, General|anesthetics, general|mesh-ancestor
65696622|NCT02880540|Anesthetics|anesthetics|mesh-ancestor
65696623|NCT02191371|Propofol|propofol|mesh-list
65696624|NCT02191371|Desflurane|desflurane|mesh-list
65696625|NCT02191371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65696626|NCT02191371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65696627|NCT02191371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696628|NCT02191371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65696629|NCT02191371|Anesthetics, General|anesthetics, general|mesh-ancestor
65696630|NCT02191371|Anesthetics|anesthetics|mesh-ancestor
65696631|NCT02191371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65696632|NCT03532737|Pembrolizumab|pembrolizumab|mesh-list
65696633|NCT03532737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65696634|NCT03532737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696635|NCT02741388|Gemcitabine|gemcitabine|mesh-list
65696636|NCT02741388|Cytarabine|cytarabine|mesh-list
65696637|NCT02741388|Dexamethasone|dexamethasone|mesh-list
65696638|NCT02741388|Rituximab|rituximab|mesh-list
65696639|NCT02741388|Oxaliplatin|oxaliplatin|mesh-list
65696640|NCT02741388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65696641|NCT02741388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696642|NCT02741388|Immunologic Factors|immunologic factors|mesh-ancestor
65696643|NCT02741388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696644|NCT02741388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65696645|NCT02741388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65696646|NCT02741388|Antiemetics|antiemetics|mesh-ancestor
65696647|NCT02741388|Autonomic Agents|autonomic agents|mesh-ancestor
65696648|NCT02741388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696649|NCT02741388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65696650|NCT02741388|Glucocorticoids|glucocorticoids|mesh-ancestor
65696651|NCT02741388|Hormones|hormones|mesh-ancestor
65696652|NCT02741388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65696653|NCT02741388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65696654|NCT02741388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65696655|NCT02741388|Antimetabolites|antimetabolites|mesh-ancestor
65696656|NCT02741388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696657|NCT02741388|Antiviral Agents|antiviral agents|mesh-ancestor
65696658|NCT02741388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65696659|NCT02741388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696660|NCT02741388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65696661|NCT02191527|Chrysarobin|chrysarobin|mesh-list
65696662|NCT02191527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65696663|NCT02191527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65696664|NCT02191527|Analgesics|analgesics|mesh-ancestor
65696665|NCT02191527|Sensory System Agents|sensory system agents|mesh-ancestor
65696666|NCT02191527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696667|NCT02191527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696668|NCT02191527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65696669|NCT02191527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65696670|NCT03484962|Antibodies|antibodies|mesh-list
65696671|NCT03484962|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65696672|NCT03484962|Immunologic Factors|immunologic factors|mesh-ancestor
65696673|NCT03484962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696674|NCT01331616|Bevacizumab|bevacizumab|mesh-list
65696675|NCT01331616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65696676|NCT01331616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696677|NCT01331616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65696678|NCT01331616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65696679|NCT01331616|Growth Substances|growth substances|mesh-ancestor
65696680|NCT01331616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696681|NCT01331616|Growth Inhibitors|growth inhibitors|mesh-ancestor
65696682|NCT02209701|Porfiromycin|porfiromycin|mesh-list
65696683|NCT02209701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65696684|NCT02209701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696685|NCT02191839|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65696686|NCT02191839|Protein C Inhibitor|protein c inhibitor|mesh-list
65696687|NCT02191839|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65696688|NCT02191839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65696689|NCT02191839|Protease Inhibitors|protease inhibitors|mesh-ancestor
65696690|NCT02191839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696691|NCT02191839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696692|NCT02204397|Ustekinumab|ustekinumab|mesh-list
65696693|NCT02204397|Dermatologic Agents|dermatologic agents|mesh-ancestor
65696694|NCT02192229|Vitamin D|vitamin d|mesh-list
65696695|NCT02192229|Cholecalciferol|cholecalciferol|mesh-list
65696696|NCT02192229|Vitamins|vitamins|mesh-ancestor
65696697|NCT02192229|Micronutrients|micronutrients|mesh-ancestor
65696698|NCT02192229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696699|NCT02192229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65696700|NCT02192229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65696701|NCT02192463|Nevirapine|nevirapine|mesh-list
65696702|NCT02192463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65696703|NCT02192463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65696704|NCT02192463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696705|NCT02192463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696706|NCT02192463|Antiviral Agents|antiviral agents|mesh-ancestor
65696707|NCT02192463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65696708|NCT02192463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65696709|NCT02192463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65696710|NCT02192463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65696711|NCT02192463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65696712|NCT02204475|Interferons|interferons|mesh-list
65696713|NCT02204475|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65696714|NCT02204475|Grazoprevir|grazoprevir|mesh-list
65696715|NCT02204475|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65696716|NCT02204475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696717|NCT02204475|Antiviral Agents|antiviral agents|mesh-ancestor
65696718|NCT02204475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65696719|NCT02210169|Vancomycin|vancomycin|mesh-list
65696720|NCT02210169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65696721|NCT02210169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65696722|NCT02210949|Epoetin Alfa|epoetin alfa|mesh-list
65696723|NCT02210949|Hematinics|hematinics|mesh-ancestor
65696724|NCT02204553|Panobinostat|panobinostat|mesh-list
65696725|NCT02204553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696726|NCT02204553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65696727|NCT02204553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696728|NCT02204553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696729|NCT01109004|Dexamethasone|dexamethasone|mesh-list
65696730|NCT01109004|Lenalidomide|lenalidomide|mesh-list
65696731|NCT01109004|Bortezomib|bortezomib|mesh-list
65696732|NCT01109004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65696733|NCT01109004|Antiemetics|antiemetics|mesh-ancestor
65696734|NCT01109004|Autonomic Agents|autonomic agents|mesh-ancestor
65696735|NCT01109004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696736|NCT01109004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696737|NCT01109004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65696738|NCT01109004|Glucocorticoids|glucocorticoids|mesh-ancestor
65696739|NCT01109004|Hormones|hormones|mesh-ancestor
65696740|NCT01109004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65696741|NCT01109004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65696742|NCT01109004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696743|NCT01109004|Immunologic Factors|immunologic factors|mesh-ancestor
65696744|NCT01109004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65696745|NCT01109004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65696746|NCT01109004|Growth Substances|growth substances|mesh-ancestor
65696747|NCT01109004|Growth Inhibitors|growth inhibitors|mesh-ancestor
65696748|NCT02211729|Azithromycin|azithromycin|mesh-list
65696750|NCT02211729|Sulfadoxine|sulfadoxine|mesh-list
65696751|NCT02211729|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65696752|NCT02211729|Amodiaquine|amodiaquine|mesh-list
65696753|NCT02211729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65696754|NCT02211729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65696755|NCT02211729|Antimalarials|antimalarials|mesh-ancestor
65696756|NCT02211729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65696757|NCT02211729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65696758|NCT02211729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65696759|NCT02211729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696760|NCT02211729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696761|NCT02211729|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65696762|NCT02211729|Renal Agents|renal agents|mesh-ancestor
65696763|NCT05151510|Lidocaine|lidocaine|mesh-list
65696764|NCT05151510|Anesthetics, Local|anesthetics, local|mesh-ancestor
65696765|NCT05151510|Anesthetics|anesthetics|mesh-ancestor
65696766|NCT05151510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65696767|NCT05151510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696768|NCT05151510|Sensory System Agents|sensory system agents|mesh-ancestor
65696769|NCT05151510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696770|NCT05151510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65696771|NCT05151510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65696772|NCT05151510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65696773|NCT05151510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65696774|NCT05151510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696775|NCT02212119|Botulinum Toxins|botulinum toxins|mesh-list
65696776|NCT02212119|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65696777|NCT02212119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65696778|NCT02212119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696779|NCT02212119|Cholinergic Agents|cholinergic agents|mesh-ancestor
65696780|NCT02212119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65696781|NCT02212119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696782|NCT03484650|Lidocaine|lidocaine|mesh-list
65696783|NCT03484650|Anesthetics, Local|anesthetics, local|mesh-ancestor
65696784|NCT03484650|Anesthetics|anesthetics|mesh-ancestor
65696785|NCT03484650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65696786|NCT03484650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696787|NCT03484650|Sensory System Agents|sensory system agents|mesh-ancestor
65696788|NCT03484650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696789|NCT03484650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65696790|NCT03484650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65696791|NCT03484650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65696792|NCT03484650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65696793|NCT03484650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696794|NCT02192697|Naquotinib|naquotinib|mesh-list
65696795|NCT02192697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696796|NCT02192697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65696797|NCT02192697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696798|NCT02192697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696799|NCT05153928|Norethindrone|norethindrone|mesh-list
65696800|NCT05153928|Norethindrone Acetate|norethindrone acetate|mesh-list
65696801|NCT05153928|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65696802|NCT05153928|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65696803|NCT05153928|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65696804|NCT05153928|Contraceptive Agents|contraceptive agents|mesh-ancestor
65696805|NCT05153928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65696806|NCT05153928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696807|NCT05153928|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65696808|NCT05153928|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65696809|NCT02214771|Fidaxomicin|fidaxomicin|mesh-list
65696810|NCT02214771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65696811|NCT02214771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65696812|NCT02192853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65696813|NCT02192853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65696814|NCT02192853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696815|NCT02192853|Incretins|incretins|mesh-ancestor
65696816|NCT02192853|Hormones|hormones|mesh-ancestor
65696817|NCT02192853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65696818|NCT02192853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65696819|NCT02192853|Protease Inhibitors|protease inhibitors|mesh-ancestor
65696820|NCT02192853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696821|NCT02192853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696822|NCT05151042|Salicylic Acid|salicylic acid|mesh-list
65696823|NCT05151042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65696824|NCT05151042|Antifungal Agents|antifungal agents|mesh-ancestor
65696825|NCT05151042|Keratolytic Agents|keratolytic agents|mesh-ancestor
65696826|NCT05151042|Dermatologic Agents|dermatologic agents|mesh-ancestor
65696827|NCT04574154|Anesthetics|anesthetics|mesh-list
65696828|NCT04574154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65696829|NCT04574154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696830|NCT03484416|Vitamin D|vitamin d|mesh-list
65696831|NCT03484416|Calcium Carbonate|calcium carbonate|mesh-list
65696832|NCT03484416|Calcium|calcium|mesh-list
65696833|NCT03484416|Vitamins|vitamins|mesh-ancestor
65696834|NCT03484416|Micronutrients|micronutrients|mesh-ancestor
65696835|NCT03484416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696836|NCT03484416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65696837|NCT03484416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65696838|NCT03484416|Antacids|antacids|mesh-ancestor
65696839|NCT03484416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696840|NCT03484416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65696841|NCT02205255|Azithromycin|azithromycin|mesh-list
65696842|NCT02205255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65696843|NCT02205255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65696844|NCT02220153|Rozanolixizumab|rozanolixizumab|mesh-list
65696845|NCT02220153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65696846|NCT02220153|Immunologic Factors|immunologic factors|mesh-ancestor
65696847|NCT02220153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696848|NCT03476772|Nalbuphine|nalbuphine|mesh-list
65696849|NCT03476772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65696850|NCT03476772|Narcotics|narcotics|mesh-ancestor
65696851|NCT03476772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65696852|NCT03476772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696853|NCT03476772|Analgesics|analgesics|mesh-ancestor
65696854|NCT03476772|Sensory System Agents|sensory system agents|mesh-ancestor
65696855|NCT03476772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696856|NCT03535233|Triamcinolone|triamcinolone|mesh-list
65696857|NCT03535233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65696858|NCT03535233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65696859|NCT03535233|Clobetasol|clobetasol|mesh-list
65696860|NCT03535233|Minoxidil|minoxidil|mesh-list
65696861|NCT03535233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65696862|NCT03535233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65696863|NCT03535233|Glucocorticoids|glucocorticoids|mesh-ancestor
65696864|NCT03535233|Hormones|hormones|mesh-ancestor
65696865|NCT03535233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65696866|NCT03535233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696867|NCT03535233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65696868|NCT03535233|Immunologic Factors|immunologic factors|mesh-ancestor
65696869|NCT03535233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696870|NCT03535233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696871|NCT03535233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65696872|NCT03535233|Vasodilator Agents|vasodilator agents|mesh-ancestor
65696873|NCT02205489|Cetirizine|cetirizine|mesh-list
65696874|NCT02205489|Acyclovir|acyclovir|mesh-list
65696875|NCT02205489|Ibuprofen|ibuprofen|mesh-list
65696876|NCT02205489|Methylprednisolone|methylprednisolone|mesh-list
65696877|NCT02205489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65696878|NCT02205489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65696879|NCT02205489|Prednisolone|prednisolone|mesh-list
65696880|NCT02205489|Prednisolone acetate|prednisolone acetate|mesh-list
65696881|NCT02205489|Alemtuzumab|alemtuzumab|mesh-list
65696882|NCT02205489|Esomeprazole|esomeprazole|mesh-list
65696883|NCT02205489|Ranitidine|ranitidine|mesh-list
65696884|NCT02205489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65696885|NCT02205489|Prednisolone phosphate|prednisolone phosphate|mesh-list
65696886|NCT02205489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65696887|NCT02205489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65696888|NCT02205489|Analgesics|analgesics|mesh-ancestor
65696889|NCT02205489|Sensory System Agents|sensory system agents|mesh-ancestor
65696890|NCT02205489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696891|NCT02205489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696892|NCT02205489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65696893|NCT02205489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65696894|NCT02205489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65696895|NCT02205489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696896|NCT02205489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012943|NCT05147857|Misoprostol|misoprostol|mesh-list
65696897|NCT02205489|Antiemetics|antiemetics|mesh-ancestor
65696899|NCT02205489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65696900|NCT02205489|Glucocorticoids|glucocorticoids|mesh-ancestor
65696901|NCT02205489|Hormones|hormones|mesh-ancestor
65696902|NCT02205489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65696903|NCT02205489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65696904|NCT02205489|Protective Agents|protective agents|mesh-ancestor
65696905|NCT02205489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65696906|NCT02205489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696907|NCT02205489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65696908|NCT02205489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65696909|NCT02205489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65696910|NCT02205489|Antiviral Agents|antiviral agents|mesh-ancestor
65696911|NCT02205489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65696912|NCT02205489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65696913|NCT02205489|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65696914|NCT02205489|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65696915|NCT02205489|Histamine Antagonists|histamine antagonists|mesh-ancestor
65696916|NCT02205489|Histamine Agents|histamine agents|mesh-ancestor
65696917|NCT02205489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65696918|NCT02205489|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65696919|NCT02523846|Morphine|morphine|mesh-list
65696920|NCT02523846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65696921|NCT02523846|Narcotics|narcotics|mesh-ancestor
65696922|NCT02523846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65696923|NCT02523846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696924|NCT02523846|Analgesics|analgesics|mesh-ancestor
65696925|NCT02523846|Sensory System Agents|sensory system agents|mesh-ancestor
65696926|NCT02523846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696927|NCT03484260|Testosterone|testosterone|mesh-list
65696928|NCT03484260|Androgens|androgens|mesh-ancestor
65696929|NCT03484260|Hormones|hormones|mesh-ancestor
65696930|NCT03484260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65696931|NCT03484260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696932|NCT05195775|Tadalafil|tadalafil|mesh-list
65696933|NCT05195775|Vasodilator Agents|vasodilator agents|mesh-ancestor
65696934|NCT05195775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65696935|NCT05195775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65696936|NCT05195775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696937|NCT05195775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696938|NCT05195775|Urological Agents|urological agents|mesh-ancestor
65696939|NCT03480906|Latanoprost|latanoprost|mesh-list
65696940|NCT03480906|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65696941|NCT03480906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65696942|NCT05262465|Azacitidine|azacitidine|mesh-list
65696943|NCT05262465|Venetoclax|venetoclax|mesh-list
65696944|NCT05262465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65696945|NCT05262465|Antimetabolites|antimetabolites|mesh-ancestor
65696946|NCT05262465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696947|NCT05262465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696948|NCT05262465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696949|NCT02220621|Hyaluronic Acid|hyaluronic acid|mesh-list
65696950|NCT02220621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65696951|NCT02220621|Immunologic Factors|immunologic factors|mesh-ancestor
65696952|NCT02220621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696953|NCT02220621|Viscosupplements|viscosupplements|mesh-ancestor
65696954|NCT02220621|Protective Agents|protective agents|mesh-ancestor
65696955|NCT04370418|Fluorouracil|fluorouracil|mesh-list
65696956|NCT04370418|Antimetabolites|antimetabolites|mesh-ancestor
65696957|NCT04370418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696958|NCT04370418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65696959|NCT04370418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65696960|NCT04370418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65696961|NCT04370418|Immunologic Factors|immunologic factors|mesh-ancestor
65696962|NCT04370418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696963|NCT02220777|Omeprazole|omeprazole|mesh-list
65696964|NCT02220777|ASP8477|asp8477|mesh-list
65696965|NCT02220777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65696966|NCT02220777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65696967|NCT02220777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65696968|NCT02220777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65696969|NCT02220777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696970|NCT03476616|Valsartan|valsartan|mesh-list
65696971|NCT03476616|Eplerenone|eplerenone|mesh-list
65696972|NCT03476616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65013096|NCT05148910|Copper|copper|mesh-list
65696973|NCT03476616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65696974|NCT03476616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65696975|NCT03476616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696976|NCT03476616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65696978|NCT03476616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65696979|NCT03476616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696980|NCT03476616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65696981|NCT03476616|Diuretics|diuretics|mesh-ancestor
65696982|NCT03476616|Natriuretic Agents|natriuretic agents|mesh-ancestor
65696983|NCT02205879|Pregabalin|pregabalin|mesh-list
65696984|NCT02205879|Analgesics|analgesics|mesh-ancestor
65696985|NCT02205879|Sensory System Agents|sensory system agents|mesh-ancestor
65696986|NCT02205879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65696987|NCT02205879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65696988|NCT02205879|Anticonvulsants|anticonvulsants|mesh-ancestor
65696989|NCT02205879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65696990|NCT02205879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65696991|NCT02205879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65696992|NCT02205879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65696993|NCT02205879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65696994|NCT02205879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65696995|NCT02205879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65696996|NCT02205879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65696997|NCT03483948|Azacitidine|azacitidine|mesh-list
65696998|NCT03483948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65696999|NCT03483948|Antimetabolites|antimetabolites|mesh-ancestor
65697000|NCT03483948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697001|NCT03483948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697002|NCT03483948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697003|NCT03483870|Morphine|morphine|mesh-list
65697004|NCT03483870|Granisetron|granisetron|mesh-list
65697005|NCT03483870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65697006|NCT03483870|Narcotics|narcotics|mesh-ancestor
65697007|NCT03483870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65697008|NCT03483870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697009|NCT03483870|Analgesics|analgesics|mesh-ancestor
65697010|NCT03483870|Sensory System Agents|sensory system agents|mesh-ancestor
65697011|NCT03483870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65697012|NCT03483870|Antiemetics|antiemetics|mesh-ancestor
65697013|NCT03483870|Autonomic Agents|autonomic agents|mesh-ancestor
65697014|NCT03483870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65697015|NCT03483870|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65697016|NCT03483870|Serotonin Agents|serotonin agents|mesh-ancestor
65697017|NCT03483870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65697018|NCT03483870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697019|NCT02221323|Insulin Lispro|insulin lispro|mesh-list
65697020|NCT02221323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65697021|NCT02221323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697022|NCT03480516|Fluorides|fluorides|mesh-list
65697023|NCT03480516|Sodium Fluoride|sodium fluoride|mesh-list
65697024|NCT03480516|Fluorides, Topical|fluorides, topical|mesh-list
65697025|NCT03480516|Cariostatic Agents|cariostatic agents|mesh-ancestor
65697026|NCT03480516|Protective Agents|protective agents|mesh-ancestor
65697027|NCT03480516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697028|NCT02221401|Metformin|metformin|mesh-list
65697029|NCT02221401|Linagliptin|linagliptin|mesh-list
65697030|NCT02221401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65697031|NCT02221401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697032|NCT02221401|Incretins|incretins|mesh-ancestor
65697033|NCT02221401|Hormones|hormones|mesh-ancestor
65697034|NCT02221401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65697035|NCT02221401|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65697036|NCT02221401|Protease Inhibitors|protease inhibitors|mesh-ancestor
65697037|NCT02221401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697038|NCT02221401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697039|NCT03483636|Lemborexant|lemborexant|mesh-list
65697040|NCT03483636|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65697041|NCT03483636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65697042|NCT03483636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697043|NCT03483636|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65697044|NCT03483636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65697045|NCT03483636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65697046|NCT03483636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697047|NCT02221479|Plerixafor|plerixafor|mesh-list
65697048|NCT02221479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65697049|NCT02221479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65697050|NCT02221479|Antiviral Agents|antiviral agents|mesh-ancestor
65697051|NCT02221479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65697052|NCT02221635|Risperidone|risperidone|mesh-list
65697053|NCT02221635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65697054|NCT02221635|Serotonin Agents|serotonin agents|mesh-ancestor
65697055|NCT02221635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65697056|NCT02221635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697057|NCT02221635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697058|NCT02221635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65697059|NCT02221635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65697060|NCT02221635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65697061|NCT02221635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65697062|NCT02221635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65697063|NCT02221635|Dopamine Agents|dopamine agents|mesh-ancestor
65697064|NCT03480360|Mycophenolic Acid|mycophenolic acid|mesh-list
65697065|NCT03480360|Cyclophosphamide|cyclophosphamide|mesh-list
65697066|NCT03480360|Fludarabine|fludarabine|mesh-list
65697067|NCT03480360|Tacrolimus|tacrolimus|mesh-list
65697068|NCT03480360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65697069|NCT03480360|Immunologic Factors|immunologic factors|mesh-ancestor
65697070|NCT03480360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697071|NCT03480360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65697072|NCT03480360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65697073|NCT03480360|Alkylating Agents|alkylating agents|mesh-ancestor
65697074|NCT03480360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697075|NCT03480360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697076|NCT03480360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65697077|NCT03480360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65697078|NCT03480360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697079|NCT03480360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65697080|NCT03480360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65697081|NCT03480360|Antitubercular Agents|antitubercular agents|mesh-ancestor
65697082|NCT03480360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65697083|NCT03480360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65697084|NCT02723864|Veliparib|veliparib|mesh-list
65697085|NCT02723864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697086|NCT02723864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65697087|NCT02723864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697088|NCT02723864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697089|NCT02471690|Oritavancin|oritavancin|mesh-list
65697090|NCT02471690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65697091|NCT02471690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65697092|NCT02225067|Calcium|calcium|mesh-list
65697093|NCT02225067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65697094|NCT02225067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697095|NCT03475758|Goserelin|goserelin|mesh-list
65697096|NCT03475758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65697097|NCT03475758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697098|NCT02231385|Acetic Acid|acetic acid|mesh-list
65697099|NCT02231385|Retinol acetate|retinol acetate|mesh-list
65697100|NCT02231385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65697101|NCT02231385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65697102|NCT02231385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65697103|NCT02231385|Immunologic Factors|immunologic factors|mesh-ancestor
65697104|NCT02231385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697105|NCT02231385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65697106|NCT02231385|Protective Agents|protective agents|mesh-ancestor
65697107|NCT02231385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697108|NCT02523768|Basiliximab|basiliximab|mesh-list
65697109|NCT02523768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65697110|NCT02523768|Immunologic Factors|immunologic factors|mesh-ancestor
65697111|NCT02523768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697112|NCT03479736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65697113|NCT03479736|Fluoroquinolones|fluoroquinolones|mesh-list
65697114|NCT03479736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65697115|NCT03479736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65697116|NCT03479736|Antitubercular Agents|antitubercular agents|mesh-ancestor
65697117|NCT03479736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65697118|NCT03479736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697119|NCT03479736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697120|NCT03203642|XL647|xl647|mesh-list
65697121|NCT03203642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697122|NCT03203642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65697123|NCT03203642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697124|NCT03203642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697125|NCT03475680|Gentamicins|gentamicins|mesh-list
65697127|NCT03475680|Sennosides|sennosides|mesh-list
65697128|NCT03475680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65697129|NCT03475680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65697130|NCT03475680|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65697131|NCT03475680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697132|NCT03475680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697133|NCT03475680|Laxatives|laxatives|mesh-ancestor
65697134|NCT03475680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65697135|NCT03475680|Amebicides|amebicides|mesh-ancestor
65697136|NCT03475680|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65697137|NCT03475680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65697138|NCT03475680|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65697139|NCT04621136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65697140|NCT04621136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65697141|NCT03475524|Metformin|metformin|mesh-list
65697142|NCT03475524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65697143|NCT03475524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697144|NCT02259075|Botulinum Toxins|botulinum toxins|mesh-list
65697145|NCT02259075|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65697146|NCT02259075|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65697147|NCT02259075|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65697148|NCT02259075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65697149|NCT02259075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697150|NCT02259075|Cholinergic Agents|cholinergic agents|mesh-ancestor
65697151|NCT02259075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65697152|NCT02259075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697153|NCT02259075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65697154|NCT02259075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65697155|NCT02471846|Atezolizumab|atezolizumab|mesh-list
65697156|NCT02471846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697157|NCT02472782|Teriparatide|teriparatide|mesh-list
65697158|NCT02472782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65697159|NCT02472782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697160|NCT02472782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65697161|NCT02258607|Trametinib|trametinib|mesh-list
65697162|NCT02258607|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
65697163|NCT02258607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697164|NCT02258607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65697165|NCT02258607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697166|NCT02258607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697167|NCT03792750|Nivolumab|nivolumab|mesh-list
65697168|NCT03792750|Linrodostat|linrodostat|mesh-list
65697169|NCT03792750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65697170|NCT03792750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697171|NCT03792750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65697172|NCT03792750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697173|NCT03792750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697174|NCT02258763|Amoxicillin|amoxicillin|mesh-list
65697175|NCT02258763|Clavulanic Acid|clavulanic acid|mesh-list
65697176|NCT02258763|Clavulanic Acids|clavulanic acids|mesh-list
65697177|NCT02258763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65697178|NCT02258763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65697179|NCT02258763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65697180|NCT02258763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65697181|NCT02258763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697182|NCT02258763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697183|NCT02469974|Busulfan|busulfan|mesh-list
65697184|NCT02469974|Immunologic Factors|immunologic factors|mesh-ancestor
65697185|NCT02469974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697186|NCT02469974|Alkylating Agents|alkylating agents|mesh-ancestor
65697187|NCT02469974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697188|NCT02469974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65697189|NCT02469974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65697190|NCT02469974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697191|NCT02469974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65697192|NCT02231931|Metformin|metformin|mesh-list
65697193|NCT02231931|Digoxin|digoxin|mesh-list
65697194|NCT02231931|Furosemide|furosemide|mesh-list
65697195|NCT02231931|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65697197|NCT02231931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697198|NCT02231931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65697199|NCT02231931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65697200|NCT02231931|Antimetabolites|antimetabolites|mesh-ancestor
65697201|NCT02231931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697202|NCT02231931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65697203|NCT02231931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65697204|NCT02231931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697205|NCT02231931|Diuretics|diuretics|mesh-ancestor
65697206|NCT02231931|Natriuretic Agents|natriuretic agents|mesh-ancestor
65697207|NCT02231931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65697208|NCT02231931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65697209|NCT02231931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65697210|NCT02231931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65697211|NCT02231931|Protective Agents|protective agents|mesh-ancestor
65697212|NCT03131622|Coal Tar|coal tar|mesh-list
65697213|NCT03131622|Keratolytic Agents|keratolytic agents|mesh-ancestor
65697214|NCT03131622|Dermatologic Agents|dermatologic agents|mesh-ancestor
65697215|NCT03482544|Pregabalin|pregabalin|mesh-list
65697216|NCT03482544|Analgesics|analgesics|mesh-ancestor
65697217|NCT03482544|Sensory System Agents|sensory system agents|mesh-ancestor
65697218|NCT03482544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65697219|NCT03482544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697220|NCT03482544|Anticonvulsants|anticonvulsants|mesh-ancestor
65697221|NCT03482544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65697222|NCT03482544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65697223|NCT03482544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697224|NCT03482544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65697225|NCT03482544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65697226|NCT03482544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65697227|NCT03482544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65697228|NCT03482544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65697229|NCT02750709|Nitisinone|nitisinone|mesh-list
65697230|NCT02750709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697231|NCT02750709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697232|NCT02222649|Vitamin D|vitamin d|mesh-list
65697233|NCT02222649|Cholecalciferol|cholecalciferol|mesh-list
65697234|NCT02222649|Vitamins|vitamins|mesh-ancestor
65697235|NCT02222649|Micronutrients|micronutrients|mesh-ancestor
65697236|NCT02222649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697237|NCT02222649|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65697238|NCT02222649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65697239|NCT02222727|Donepezil|donepezil|mesh-list
65697240|NCT02222727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65697241|NCT02222727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697242|NCT02222727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697243|NCT02222727|Cholinergic Agents|cholinergic agents|mesh-ancestor
65697244|NCT02222727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65697245|NCT02222727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697246|NCT02222727|Nootropic Agents|nootropic agents|mesh-ancestor
65697247|NCT02723786|Mycophenolic Acid|mycophenolic acid|mesh-list
65697248|NCT02723786|Azathioprine|azathioprine|mesh-list
65697249|NCT02723786|Tacrolimus|tacrolimus|mesh-list
65697250|NCT02723786|Basiliximab|basiliximab|mesh-list
65697251|NCT02723786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65697252|NCT02723786|Immunologic Factors|immunologic factors|mesh-ancestor
65697253|NCT02723786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697254|NCT02723786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65697255|NCT02723786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697256|NCT02723786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697257|NCT02723786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65697258|NCT02723786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697259|NCT02723786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65697260|NCT02723786|Antitubercular Agents|antitubercular agents|mesh-ancestor
65697261|NCT02723786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65697262|NCT02723786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65697263|NCT02723786|Antimetabolites|antimetabolites|mesh-ancestor
65697264|NCT02723786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65697265|NCT02723786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65697266|NCT03310736|Hepcidins|hepcidins|mesh-list
65697267|NCT03310736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65697268|NCT02226783|Omeprazole|omeprazole|mesh-list
65697269|NCT02226783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65697270|NCT02226783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65697271|NCT02226783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65697272|NCT02226783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697273|NCT02226783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697274|NCT03482232|Acetaminophen|acetaminophen|mesh-list
65697275|NCT03482232|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65697276|NCT03482232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65697277|NCT03482232|Anti-Infective Agents|anti-infective agents|mesh-list
65697278|NCT03482232|Ibuprofen|ibuprofen|mesh-list
65697279|NCT03482232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65697280|NCT03482232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65697281|NCT03482232|Hypolipidemic Agents|hypolipidemic agents|mesh-list
65697282|NCT03482232|Expectorants|expectorants|mesh-list
65697283|NCT03482232|Antitubercular Agents|antitubercular agents|mesh-ancestor
65697284|NCT03482232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65697285|NCT03482232|Analgesics|analgesics|mesh-ancestor
65697286|NCT03482232|Sensory System Agents|sensory system agents|mesh-ancestor
65697287|NCT03482232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65697288|NCT03482232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697289|NCT03482232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65697290|NCT03482232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65697291|NCT03482232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159894|NCT04286152|Adrenergic Agents|adrenergic agents|mesh-ancestor
65697292|NCT03482232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697293|NCT03482232|Antipyretics|antipyretics|mesh-ancestor
65697294|NCT03482232|Antimetabolites|antimetabolites|mesh-ancestor
65697295|NCT03482232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65697296|NCT03482232|Respiratory System Agents|respiratory system agents|mesh-ancestor
65697297|NCT02227017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65697298|NCT04542200|Antibodies|antibodies|mesh-list
65697299|NCT04542200|Immunologic Factors|immunologic factors|mesh-ancestor
65697300|NCT04542200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697301|NCT02227173|Flurbiprofen|flurbiprofen|mesh-list
65697302|NCT02227173|Digoxin|digoxin|mesh-list
65697303|NCT02227173|Montelukast|montelukast|mesh-list
65697304|NCT02227173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65697305|NCT02227173|Respiratory System Agents|respiratory system agents|mesh-ancestor
65697306|NCT02227173|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65697307|NCT02227173|Hormone Antagonists|hormone antagonists|mesh-ancestor
65697308|NCT02227173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65697309|NCT02227173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697310|NCT02227173|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65697311|NCT02227173|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65697312|NCT02227173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697313|NCT02227173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65697314|NCT02227173|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65697315|NCT02227173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697316|NCT02227173|Protective Agents|protective agents|mesh-ancestor
65697317|NCT02227173|Analgesics|analgesics|mesh-ancestor
65697318|NCT02227173|Sensory System Agents|sensory system agents|mesh-ancestor
65697319|NCT02227173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65697320|NCT02227173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65697321|NCT02227173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65697322|NCT02227173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65697323|NCT02227173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65697324|NCT02227173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65697325|NCT04477850|Luspatercept|luspatercept|mesh-list
65697326|NCT04477850|Hematinics|hematinics|mesh-ancestor
65697327|NCT02469740|Clopidogrel|clopidogrel|mesh-list
65697328|NCT02469740|Ticagrelor|ticagrelor|mesh-list
65697329|NCT02469740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65697330|NCT02469740|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65697331|NCT02469740|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65697332|NCT02469740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65697333|NCT02469740|Purinergic Agents|purinergic agents|mesh-ancestor
65697334|NCT02469740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65697335|NCT02469740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697336|NCT02469740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697337|NCT04432220|Apixaban|apixaban|mesh-list
65697338|NCT04432220|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65697339|NCT04432220|Antithrombins|antithrombins|mesh-ancestor
65697340|NCT04432220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65697341|NCT04432220|Protease Inhibitors|protease inhibitors|mesh-ancestor
65697342|NCT04432220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697343|NCT04432220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697344|NCT04432220|Anticoagulants|anticoagulants|mesh-ancestor
65697345|NCT03520842|Methotrexate|methotrexate|mesh-list
65697346|NCT03520842|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65697347|NCT03520842|Abortifacient Agents|abortifacient agents|mesh-ancestor
65697348|NCT03520842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65697349|NCT03520842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697350|NCT03520842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65697351|NCT03520842|Antimetabolites|antimetabolites|mesh-ancestor
65697352|NCT03520842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697353|NCT03520842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697354|NCT03520842|Dermatologic Agents|dermatologic agents|mesh-ancestor
65697355|NCT03520842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697356|NCT03520842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65697357|NCT03520842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65697358|NCT03520842|Immunologic Factors|immunologic factors|mesh-ancestor
65697359|NCT03520842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65697360|NCT03520842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65697361|NCT04405622|Gemcitabine|gemcitabine|mesh-list
65697362|NCT04405622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65697363|NCT04405622|Antimetabolites|antimetabolites|mesh-ancestor
65697364|NCT04405622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697365|NCT04405622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697366|NCT04405622|Antiviral Agents|antiviral agents|mesh-ancestor
65697367|NCT04405622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65697368|NCT04405622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697369|NCT04405622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65697370|NCT04405622|Immunologic Factors|immunologic factors|mesh-ancestor
65697371|NCT04405622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697372|NCT03481998|Letrozole|letrozole|mesh-list
65697373|NCT03481998|Fulvestrant|fulvestrant|mesh-list
65697374|NCT03481998|Anastrozole|anastrozole|mesh-list
65697375|NCT03481998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697376|NCT03481998|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65697377|NCT03481998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65697378|NCT03481998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697379|NCT03481998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697380|NCT03481998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65697381|NCT03481998|Hormone Antagonists|hormone antagonists|mesh-ancestor
65697382|NCT03481998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65697383|NCT03481998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697384|NCT03481998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65697385|NCT03481998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65697386|NCT02723084|Ribavirin|ribavirin|mesh-list
65697387|NCT02723084|Sofosbuvir|sofosbuvir|mesh-list
65697388|NCT02723084|Antimetabolites|antimetabolites|mesh-ancestor
65697389|NCT02723084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697390|NCT02723084|Antiviral Agents|antiviral agents|mesh-ancestor
65697391|NCT02723084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65697392|NCT02750943|Fluorides|fluorides|mesh-list
65697393|NCT02750943|Tin Fluorides|tin fluorides|mesh-list
65697394|NCT02750943|Fluorophosphate|fluorophosphate|mesh-list
65697395|NCT02750943|Cariostatic Agents|cariostatic agents|mesh-ancestor
65697396|NCT02750943|Protective Agents|protective agents|mesh-ancestor
65697397|NCT02750943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697398|NCT03481920|Avelumab|avelumab|mesh-list
65697399|NCT03481920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65697400|NCT03481920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697401|NCT02227797|Voriconazole|voriconazole|mesh-list
65697402|NCT02227797|Antifungal Agents|antifungal agents|mesh-ancestor
65697403|NCT02227797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65697404|NCT02227797|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65697405|NCT02227797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65697406|NCT02227797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697407|NCT02227797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697408|NCT02227797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65697409|NCT02227797|Hormone Antagonists|hormone antagonists|mesh-ancestor
65697410|NCT02227797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65697411|NCT02227797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697412|NCT02227797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65697413|NCT05784311|Metronidazole|metronidazole|mesh-list
65697414|NCT05784311|Cefuroxime|cefuroxime|mesh-list
65697415|NCT05784311|Cefuroxime axetil|cefuroxime axetil|mesh-list
65697416|NCT05784311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65697417|NCT05784311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65697418|NCT05784311|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65697419|NCT05784311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65013538|NCT05591144|Hormones|hormones|mesh-ancestor
65697420|NCT05783921|Paclitaxel|paclitaxel|mesh-list
65697421|NCT05783921|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65697422|NCT05783921|Cisplatin|cisplatin|mesh-list
65697423|NCT05783921|Carboplatin|carboplatin|mesh-list
65697424|NCT05783921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65697425|NCT05783921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697426|NCT05783921|Tubulin Modulators|tubulin modulators|mesh-ancestor
65697427|NCT05783921|Antimitotic Agents|antimitotic agents|mesh-ancestor
65697428|NCT05783921|Mitosis Modulators|mitosis modulators|mesh-ancestor
65697429|NCT05783921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697430|NCT05783778|Testosterone|testosterone|mesh-list
65697431|NCT05783778|Androgens|androgens|mesh-ancestor
65697432|NCT05783778|Hormones|hormones|mesh-ancestor
65697433|NCT05783778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65697434|NCT05783778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697435|NCT05783661|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65697436|NCT05783661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65697437|NCT05783648|Tranexamic Acid|tranexamic acid|mesh-list
65697438|NCT05783648|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65697439|NCT05783648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65697440|NCT05783648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697441|NCT05783648|Hemostatics|hemostatics|mesh-ancestor
65697442|NCT05783648|Coagulants|coagulants|mesh-ancestor
65697443|NCT05783609|Rituximab|rituximab|mesh-list
65697444|NCT05783609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65697445|NCT05783609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697446|NCT05783609|Immunologic Factors|immunologic factors|mesh-ancestor
65697447|NCT05783609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697448|NCT05783609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65697449|NCT05783557|Clevidipine|clevidipine|mesh-list
65697450|NCT05783557|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65697451|NCT05783557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65697452|NCT05783557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697453|NCT05783557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65697454|NCT05783557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697455|NCT05783544|Interferons|interferons|mesh-list
65697456|NCT05783544|Interferon-gamma|interferon-gamma|mesh-list
65697457|NCT05783544|Interleukin-4|interleukin-4|mesh-list
65697458|NCT05783544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697459|NCT05783544|Antiviral Agents|antiviral agents|mesh-ancestor
65697460|NCT05783544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65697461|NCT05783544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65697462|NCT05783544|Immunologic Factors|immunologic factors|mesh-ancestor
65697463|NCT05783544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697464|NCT05783544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65697465|NCT05783518|Propofol|propofol|mesh-list
65697466|NCT05783518|Desflurane|desflurane|mesh-list
65697467|NCT05783518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65697468|NCT05783518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65697469|NCT05783518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697470|NCT05783518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65697471|NCT05783518|Anesthetics, General|anesthetics, general|mesh-ancestor
65697472|NCT05783518|Anesthetics|anesthetics|mesh-ancestor
65697473|NCT05783518|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65697474|NCT05783492|Ketamine|ketamine|mesh-list
65697475|NCT05783492|Analgesics|analgesics|mesh-ancestor
65697476|NCT05783492|Sensory System Agents|sensory system agents|mesh-ancestor
65697477|NCT05783492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65697478|NCT05783492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697479|NCT05783492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65697480|NCT05783492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65697481|NCT05783492|Anesthetics, General|anesthetics, general|mesh-ancestor
65697482|NCT05783492|Anesthetics|anesthetics|mesh-ancestor
65697483|NCT05783492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65697484|NCT05783492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65697485|NCT05783492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65697486|NCT05783492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65697487|NCT05783492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697488|NCT05783479|Estradiol|estradiol|mesh-list
65697489|NCT05783479|Hyaluronic Acid|hyaluronic acid|mesh-list
65697490|NCT05783479|Estrogens|estrogens|mesh-ancestor
65697491|NCT05783479|Hormones|hormones|mesh-ancestor
65697492|NCT05783479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65697493|NCT05783479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697494|NCT05783479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65697495|NCT05783479|Immunologic Factors|immunologic factors|mesh-ancestor
65697497|NCT05783479|Protective Agents|protective agents|mesh-ancestor
65697498|NCT05783453|Emollients|emollients|mesh-list
65697499|NCT05783453|Dermatologic Agents|dermatologic agents|mesh-ancestor
65697500|NCT05782972|Dapagliflozin|dapagliflozin|mesh-list
65697501|NCT05782972|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65697502|NCT05782972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697503|NCT05782972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65697504|NCT05782972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697505|NCT05782933|Rituximab|rituximab|mesh-list
65697506|NCT05782933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65697507|NCT05782933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697508|NCT05782933|Immunologic Factors|immunologic factors|mesh-ancestor
65697509|NCT05782933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697510|NCT05782933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65697511|NCT05782920|Hyaluronic Acid|hyaluronic acid|mesh-list
65697512|NCT05782920|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65697513|NCT05782920|Immunologic Factors|immunologic factors|mesh-ancestor
65697514|NCT05782920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697515|NCT05782920|Viscosupplements|viscosupplements|mesh-ancestor
65697516|NCT05782920|Protective Agents|protective agents|mesh-ancestor
65697517|NCT05782907|Upadacitinib|upadacitinib|mesh-list
65697518|NCT05782907|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65697519|NCT05782907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65697520|NCT05782907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697521|NCT05782907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697522|NCT05782907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65697523|NCT05782881|Glucagon|glucagon|mesh-list
65697524|NCT05782881|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65697525|NCT05782881|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65697526|NCT05782881|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65697527|NCT05782881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65697528|NCT05782881|Hormones|hormones|mesh-ancestor
65697529|NCT05782881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65697530|NCT05782881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697531|NCT05782881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697532|NCT05782881|Incretins|incretins|mesh-ancestor
65697533|NCT05782881|Protease Inhibitors|protease inhibitors|mesh-ancestor
65697534|NCT05782816|Oxytocin|oxytocin|mesh-list
65697535|NCT05782816|Oxytocics|oxytocics|mesh-ancestor
65697536|NCT05782816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65697537|NCT05782816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697538|NCT05782777|Ezetimibe|ezetimibe|mesh-list
65697539|NCT05782777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65697540|NCT05782777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65697541|NCT05782777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65697542|NCT05782777|Antimetabolites|antimetabolites|mesh-ancestor
65697543|NCT05782777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697544|NCT05782777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65697545|NCT05782777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697546|NCT05782764|Endostar protein|endostar protein|mesh-list
65697547|NCT05782764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65697548|NCT05782764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65697549|NCT05782764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65697550|NCT05782764|Growth Substances|growth substances|mesh-ancestor
65697551|NCT05782764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697552|NCT05782764|Growth Inhibitors|growth inhibitors|mesh-ancestor
65697553|NCT05782764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697554|NCT05782764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697555|NCT05782751|Mitogens|mitogens|mesh-list
65697556|NCT05782751|Mitosis Modulators|mitosis modulators|mesh-ancestor
65697557|NCT05782751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697558|NCT05781074|Lenvatinib|lenvatinib|mesh-list
65697559|NCT05781074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697560|NCT05781074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65697561|NCT05781074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697562|NCT05781074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697563|NCT05780541|Remdesivir|remdesivir|mesh-list
65697564|NCT05780541|Antimetabolites|antimetabolites|mesh-ancestor
65697565|NCT05780541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697566|NCT05780541|Antiviral Agents|antiviral agents|mesh-ancestor
65697567|NCT05780541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65697568|NCT05780463|Remdesivir|remdesivir|mesh-list
65697569|NCT05780463|Antimetabolites|antimetabolites|mesh-ancestor
65697570|NCT05780463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697571|NCT05780463|Antiviral Agents|antiviral agents|mesh-ancestor
65697572|NCT05780463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65697573|NCT05780281|Remdesivir|remdesivir|mesh-list
65697574|NCT05780281|Antimetabolites|antimetabolites|mesh-ancestor
65697575|NCT05780281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697576|NCT05780281|Antiviral Agents|antiviral agents|mesh-ancestor
65697577|NCT05780281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65697578|NCT05780268|Remdesivir|remdesivir|mesh-list
65697579|NCT05780268|Bamlanivimab|bamlanivimab|mesh-list
65697580|NCT05780268|Antimetabolites|antimetabolites|mesh-ancestor
65697581|NCT05780268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697582|NCT05780268|Antiviral Agents|antiviral agents|mesh-ancestor
65697583|NCT05780268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65697584|NCT05779657|Midazolam|midazolam|mesh-list
65697585|NCT05779657|Ketamine|ketamine|mesh-list
65697586|NCT05779657|Analgesics|analgesics|mesh-ancestor
65697587|NCT05779657|Sensory System Agents|sensory system agents|mesh-ancestor
65697588|NCT05779657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65697589|NCT05779657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697590|NCT05779657|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65697591|NCT05779657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65697592|NCT05779657|Anesthetics, General|anesthetics, general|mesh-ancestor
65697593|NCT05779657|Anesthetics|anesthetics|mesh-ancestor
65697594|NCT05779657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65697595|NCT05779657|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65697596|NCT05779657|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65697597|NCT05779657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65697598|NCT05779657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697599|NCT05779657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65697600|NCT05779657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65697601|NCT05779657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65697602|NCT05779657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65697603|NCT05779657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65697604|NCT05779657|GABA Modulators|gaba modulators|mesh-ancestor
65697605|NCT05779657|GABA Agents|gaba agents|mesh-ancestor
65697606|NCT05774054|Norepinephrine|norepinephrine|mesh-list
65697607|NCT05774054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65697608|NCT05774054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65697609|NCT05774054|Adrenergic Agents|adrenergic agents|mesh-ancestor
65697610|NCT05774054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65697611|NCT05774054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697612|NCT05774054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697613|NCT05774054|Sympathomimetics|sympathomimetics|mesh-ancestor
65697614|NCT05774054|Autonomic Agents|autonomic agents|mesh-ancestor
65697615|NCT05774054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65697616|NCT05774054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65697617|NCT05751148|Bupivacaine|bupivacaine|mesh-list
65697618|NCT05751148|Prilocaine|prilocaine|mesh-list
65697619|NCT05751148|Anesthetics, Local|anesthetics, local|mesh-ancestor
65697620|NCT05751148|Anesthetics|anesthetics|mesh-ancestor
65697621|NCT05751148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65697622|NCT05751148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697623|NCT05751148|Sensory System Agents|sensory system agents|mesh-ancestor
65697624|NCT05751148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65697625|NCT05727176|Futibatinib|futibatinib|mesh-list
65697626|NCT05727176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697627|NCT05711199|Nitroglycerin|nitroglycerin|mesh-list
65697628|NCT05711199|Vasodilator Agents|vasodilator agents|mesh-ancestor
65697629|NCT05704673|Morphine|morphine|mesh-list
65697630|NCT05704673|Nalbuphine|nalbuphine|mesh-list
65697631|NCT05704673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65697632|NCT05704673|Narcotics|narcotics|mesh-ancestor
65697633|NCT05704673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65697634|NCT05704673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697635|NCT05704673|Analgesics|analgesics|mesh-ancestor
65697636|NCT05704673|Sensory System Agents|sensory system agents|mesh-ancestor
65697637|NCT05704673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65697638|NCT05703971|Atezolizumab|atezolizumab|mesh-list
65697639|NCT05703971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697640|NCT05703074|Niacinamide|niacinamide|mesh-list
65697641|NCT05703074|Niacin|niacin|mesh-list
65697642|NCT05703074|Nicotinic Acids|nicotinic acids|mesh-list
65697643|NCT05703074|Vitamin B Complex|vitamin b complex|mesh-ancestor
65697644|NCT05703074|Vitamins|vitamins|mesh-ancestor
65697645|NCT05703074|Micronutrients|micronutrients|mesh-ancestor
65697646|NCT05703074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697647|NCT05703074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65697648|NCT05703074|Antimetabolites|antimetabolites|mesh-ancestor
65697649|NCT05703074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697650|NCT05703074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65697651|NCT05703074|Vasodilator Agents|vasodilator agents|mesh-ancestor
65697652|NCT05701865|Ethanol|ethanol|mesh-list
65697653|NCT05701865|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65697654|NCT05701865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65697655|NCT05701865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65697656|NCT05701865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697657|NCT05701345|Antidepressive Agents|antidepressive agents|mesh-list
65697658|NCT05701345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65697659|NCT05687032|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65697660|NCT05687032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65697661|NCT05687032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697662|NCT05687032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65697663|NCT05674721|Ibuprofen|ibuprofen|mesh-list
65697664|NCT05674721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65697665|NCT05674721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65697666|NCT05674721|Analgesics|analgesics|mesh-ancestor
65697667|NCT05674721|Sensory System Agents|sensory system agents|mesh-ancestor
65697668|NCT05674721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65697669|NCT05674721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697670|NCT05674721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65697671|NCT05674721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65697672|NCT05674721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65697673|NCT05674721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697674|NCT05674721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697675|NCT05664464|Sulfasalazine|sulfasalazine|mesh-list
65697676|NCT05664464|Temozolomide|temozolomide|mesh-list
65697677|NCT05664464|Gabapentin|gabapentin|mesh-list
65697678|NCT05664464|Memantine|memantine|mesh-list
65697679|NCT05664464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65697680|NCT05664464|Alkylating Agents|alkylating agents|mesh-ancestor
65697681|NCT05664464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697682|NCT05664464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697683|NCT05664464|Analgesics|analgesics|mesh-ancestor
65697684|NCT05664464|Sensory System Agents|sensory system agents|mesh-ancestor
65697685|NCT05664464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65697686|NCT05664464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697687|NCT05664464|Anticonvulsants|anticonvulsants|mesh-ancestor
65697688|NCT05664464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65697689|NCT05664464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65697690|NCT05664464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65697691|NCT05664464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65697692|NCT05664464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65697693|NCT05664464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65697694|NCT05664464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65697695|NCT05664464|Antimanic Agents|antimanic agents|mesh-ancestor
65697696|NCT05664464|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65697697|NCT05664464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65697698|NCT05664464|Dopamine Agents|dopamine agents|mesh-ancestor
65697699|NCT05664464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65697700|NCT05664464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65697701|NCT05664464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65697702|NCT05664464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65697703|NCT05664464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65697704|NCT05664464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65697705|NCT05657457|Tenecteplase|tenecteplase|mesh-list
65697706|NCT05657457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65697707|NCT05657457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65697708|NCT05657457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697709|NCT05646316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65697710|NCT05635344|Pembrolizumab|pembrolizumab|mesh-list
65697711|NCT05635344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65697712|NCT05635344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697713|NCT05630989|Hydroxychloroquine|hydroxychloroquine|mesh-list
65697714|NCT05630989|Mitogens|mitogens|mesh-list
65697715|NCT05630989|Antimalarials|antimalarials|mesh-ancestor
65697716|NCT05630989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65697717|NCT05630989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65697718|NCT05630989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65697719|NCT05630989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697720|NCT05630989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697721|NCT05630989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65697722|NCT05630989|Mitosis Modulators|mitosis modulators|mesh-ancestor
65697723|NCT05626530|Letermovir|letermovir|mesh-list
65697724|NCT05626530|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65697725|NCT05626530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697726|NCT05626530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697727|NCT05626530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697728|NCT05626530|Antiviral Agents|antiviral agents|mesh-ancestor
65697729|NCT05626530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65697730|NCT05610163|Leucovorin|leucovorin|mesh-list
65697731|NCT05610163|Fluorouracil|fluorouracil|mesh-list
65697732|NCT05610163|Capecitabine|capecitabine|mesh-list
65697733|NCT05610163|Oxaliplatin|oxaliplatin|mesh-list
65697734|NCT05610163|Irinotecan|irinotecan|mesh-list
65697735|NCT05610163|Calcium|calcium|mesh-list
65697736|NCT05610163|Levoleucovorin|levoleucovorin|mesh-list
65697737|NCT05610163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65697738|NCT05610163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697739|NCT05610163|Antimetabolites|antimetabolites|mesh-ancestor
65697740|NCT05610163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697741|NCT05610163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65697742|NCT05610163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697743|NCT05610163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65697744|NCT05610163|Immunologic Factors|immunologic factors|mesh-ancestor
65697745|NCT05610163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65697746|NCT05610163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65697747|NCT05610163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697748|NCT05610163|Antidotes|antidotes|mesh-ancestor
65697749|NCT05610163|Protective Agents|protective agents|mesh-ancestor
65697750|NCT05610163|Vitamin B Complex|vitamin b complex|mesh-ancestor
65697751|NCT05610163|Vitamins|vitamins|mesh-ancestor
65697752|NCT05610163|Micronutrients|micronutrients|mesh-ancestor
65697753|NCT05603104|Lamotrigine|lamotrigine|mesh-list
65697754|NCT05603104|Ketamine|ketamine|mesh-list
65697755|NCT05603104|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65697756|NCT05603104|Valproic Acid|valproic acid|mesh-list
65697757|NCT05603104|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65697758|NCT05603104|Clozapine|clozapine|mesh-list
65697759|NCT05603104|Antipsychotic Agents|antipsychotic agents|mesh-list
65697760|NCT05603104|Citalopram|citalopram|mesh-list
65697761|NCT05603104|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65697762|NCT05603104|Sertraline|sertraline|mesh-list
65697763|NCT05603104|Antidepressive Agents|antidepressive agents|mesh-list
65697764|NCT05603104|Esketamine|esketamine|mesh-list
65697765|NCT05603104|Analgesics|analgesics|mesh-ancestor
65697766|NCT05603104|Sensory System Agents|sensory system agents|mesh-ancestor
65697767|NCT05603104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65697768|NCT05603104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697769|NCT05603104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65697770|NCT05603104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65697771|NCT05603104|Anesthetics, General|anesthetics, general|mesh-ancestor
65697772|NCT05603104|Anesthetics|anesthetics|mesh-ancestor
65697773|NCT05603104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65697774|NCT05603104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65697775|NCT05603104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65697776|NCT05603104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65697777|NCT05603104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697778|NCT05603104|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65697779|NCT05603104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65697780|NCT05603104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65697781|NCT05603104|Serotonin Agents|serotonin agents|mesh-ancestor
65697782|NCT05603104|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65697783|NCT05603104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65697784|NCT05603104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65697785|NCT05603104|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65697786|NCT05603104|Dopamine Agents|dopamine agents|mesh-ancestor
65697787|NCT05603104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697788|NCT05603104|Antimanic Agents|antimanic agents|mesh-ancestor
65697789|NCT05603104|Anticonvulsants|anticonvulsants|mesh-ancestor
65697790|NCT05603104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65697791|NCT05603104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65697792|NCT05603104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65697793|NCT05603104|GABA Agents|gaba agents|mesh-ancestor
65697794|NCT05603104|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65697795|NCT05603104|GABA Antagonists|gaba antagonists|mesh-ancestor
65697796|NCT05601674|Anesthetics|anesthetics|mesh-list
65697797|NCT05601674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65697798|NCT05601674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697799|NCT05584657|Amoxicillin|amoxicillin|mesh-list
65697800|NCT05584657|Clavulanic Acid|clavulanic acid|mesh-list
65697801|NCT05584657|Clavulanic Acids|clavulanic acids|mesh-list
65697802|NCT05584657|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65697803|NCT05584657|Lactams|lactams|mesh-list
65697804|NCT05584657|Probenecid|probenecid|mesh-list
65697805|NCT05584657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65697806|NCT05584657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65697807|NCT05584657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65697808|NCT05584657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697809|NCT05584657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697810|NCT05584657|Uricosuric Agents|uricosuric agents|mesh-ancestor
65697811|NCT05584657|Gout Suppressants|gout suppressants|mesh-ancestor
65697812|NCT05584657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65697813|NCT05584657|Renal Agents|renal agents|mesh-ancestor
65697814|NCT05567835|Leucovorin|leucovorin|mesh-list
65697815|NCT05567835|Docetaxel|docetaxel|mesh-list
65697816|NCT05567835|Fluorouracil|fluorouracil|mesh-list
65697817|NCT05567835|Oxaliplatin|oxaliplatin|mesh-list
65697818|NCT05567835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697819|NCT05567835|Tubulin Modulators|tubulin modulators|mesh-ancestor
65697820|NCT05567835|Antimitotic Agents|antimitotic agents|mesh-ancestor
65697821|NCT05567835|Mitosis Modulators|mitosis modulators|mesh-ancestor
65697822|NCT05567835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697823|NCT05567835|Antimetabolites|antimetabolites|mesh-ancestor
65697824|NCT05567835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65697825|NCT05567835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65697826|NCT05567835|Immunologic Factors|immunologic factors|mesh-ancestor
65697827|NCT05567835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697828|NCT05567835|Antidotes|antidotes|mesh-ancestor
65697829|NCT05567835|Protective Agents|protective agents|mesh-ancestor
65697830|NCT05567835|Vitamin B Complex|vitamin b complex|mesh-ancestor
65697831|NCT05567835|Vitamins|vitamins|mesh-ancestor
65697832|NCT05567835|Micronutrients|micronutrients|mesh-ancestor
65697833|NCT05563961|Acetaminophen|acetaminophen|mesh-list
65697834|NCT05563961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65697835|NCT05563961|Analgesics|analgesics|mesh-ancestor
65697836|NCT05563961|Sensory System Agents|sensory system agents|mesh-ancestor
65697837|NCT05563961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65697838|NCT05563961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697839|NCT05563961|Antipyretics|antipyretics|mesh-ancestor
65697840|NCT05558956|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65697841|NCT05558956|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65697842|NCT05558956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697843|NCT05551104|Labetalol|labetalol|mesh-list
65697844|NCT05551104|Nifedipine|nifedipine|mesh-list
65697845|NCT05551104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65697846|NCT05551104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65697847|NCT05551104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697848|NCT05551104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65697849|NCT05551104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697850|NCT05551104|Vasodilator Agents|vasodilator agents|mesh-ancestor
65697851|NCT05551104|Tocolytic Agents|tocolytic agents|mesh-ancestor
65697852|NCT05551104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65697853|NCT05551104|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65697854|NCT05551104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65697855|NCT05551104|Adrenergic Agents|adrenergic agents|mesh-ancestor
65697856|NCT05551104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65697857|NCT05551104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65697858|NCT05551104|Sympathomimetics|sympathomimetics|mesh-ancestor
65697859|NCT05551104|Autonomic Agents|autonomic agents|mesh-ancestor
65697860|NCT05551104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65697861|NCT05551104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65697862|NCT05551104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65697863|NCT05527314|Fentanyl|fentanyl|mesh-list
65697864|NCT05527314|Remifentanil|remifentanil|mesh-list
65697865|NCT05527314|Sevoflurane|sevoflurane|mesh-list
65697866|NCT05527314|Cisatracurium|cisatracurium|mesh-list
65697867|NCT05527314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65697868|NCT05527314|Narcotics|narcotics|mesh-ancestor
65697869|NCT05527314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65697870|NCT05527314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697871|NCT05527314|Analgesics|analgesics|mesh-ancestor
65697872|NCT05527314|Sensory System Agents|sensory system agents|mesh-ancestor
65697873|NCT05527314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65697874|NCT05527314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65697875|NCT05527314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65697876|NCT05527314|Anesthetics, General|anesthetics, general|mesh-ancestor
65697877|NCT05527314|Anesthetics|anesthetics|mesh-ancestor
65697878|NCT05527314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65697879|NCT05527314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65697880|NCT05527314|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65697881|NCT05527314|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65697882|NCT05517122|Niacinamide|niacinamide|mesh-list
65697883|NCT05517122|Niacin|niacin|mesh-list
65697884|NCT05517122|Nicotinic Acids|nicotinic acids|mesh-list
65697885|NCT05517122|Vitamin B Complex|vitamin b complex|mesh-ancestor
65697886|NCT05517122|Vitamins|vitamins|mesh-ancestor
65697887|NCT05517122|Micronutrients|micronutrients|mesh-ancestor
65697888|NCT05517122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697889|NCT05517122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65697890|NCT05517122|Antimetabolites|antimetabolites|mesh-ancestor
65697891|NCT05517122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697892|NCT05517122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65697893|NCT05517122|Vasodilator Agents|vasodilator agents|mesh-ancestor
65697894|NCT05498155|Durvalumab|durvalumab|mesh-list
65697895|NCT05498155|Olaparib|olaparib|mesh-list
65697896|NCT05498155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65697897|NCT05498155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697898|NCT05498155|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65697899|NCT05498155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697900|NCT05498155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697901|NCT05484505|Nicotine|nicotine|mesh-list
65697902|NCT05484505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65697903|NCT05484505|Autonomic Agents|autonomic agents|mesh-ancestor
65697904|NCT05484505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65697905|NCT05484505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697906|NCT05484505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65697907|NCT05484505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65697908|NCT05484505|Cholinergic Agents|cholinergic agents|mesh-ancestor
65697909|NCT05484505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65697910|NCT05484505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697911|NCT05478161|Fexofenadine|fexofenadine|mesh-list
65697912|NCT05478161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65697913|NCT05478161|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65697914|NCT05478161|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65697915|NCT05478161|Histamine Antagonists|histamine antagonists|mesh-ancestor
65697916|NCT05478161|Histamine Agents|histamine agents|mesh-ancestor
65697917|NCT05478161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65697918|NCT05478161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697919|NCT05478161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697920|NCT05476822|Antibodies|antibodies|mesh-list
65697921|NCT05476822|Immunologic Factors|immunologic factors|mesh-ancestor
65697922|NCT05476822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697923|NCT05473364|Acetazolamide|acetazolamide|mesh-list
65697924|NCT05473364|Anticonvulsants|anticonvulsants|mesh-ancestor
65697925|NCT05473364|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65697926|NCT05473364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697927|NCT05473364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697928|NCT05473364|Diuretics|diuretics|mesh-ancestor
65697929|NCT05473364|Natriuretic Agents|natriuretic agents|mesh-ancestor
65697930|NCT05473364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697931|NCT05468489|Carboplatin|carboplatin|mesh-list
65697932|NCT05468489|Etoposide|etoposide|mesh-list
65697933|NCT05468489|Etoposide phosphate|etoposide phosphate|mesh-list
65697934|NCT05468489|Atezolizumab|atezolizumab|mesh-list
65697935|NCT05468489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697936|NCT05468489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65697937|NCT05468489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65697938|NCT05468489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65697939|NCT05468489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697940|NCT05468489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697941|NCT05457972|Estradiol|estradiol|mesh-list
65697942|NCT05457972|Estrogens|estrogens|mesh-ancestor
65697943|NCT05457972|Hormones|hormones|mesh-ancestor
65697944|NCT05457972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65697945|NCT05457972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697946|NCT05413811|Fluorouracil|fluorouracil|mesh-list
65697947|NCT05413811|Antimetabolites|antimetabolites|mesh-ancestor
65697948|NCT05413811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697949|NCT05413811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65697950|NCT05413811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697951|NCT05413811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65697952|NCT05413811|Immunologic Factors|immunologic factors|mesh-ancestor
65697953|NCT05413811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697954|NCT05412030|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65697955|NCT05412030|Immunologic Factors|immunologic factors|mesh-ancestor
65697956|NCT05412030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697957|NCT05392608|Fulvestrant|fulvestrant|mesh-list
65697958|NCT05392608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65697959|NCT05392608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697960|NCT05392608|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65697961|NCT05392608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65697962|NCT05392608|Hormone Antagonists|hormone antagonists|mesh-ancestor
65697963|NCT05392608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65697964|NCT05392608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697965|NCT05382494|Mometasone Furoate|mometasone furoate|mesh-list
65697966|NCT05382494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65697967|NCT05382494|Dermatologic Agents|dermatologic agents|mesh-ancestor
65697968|NCT05382494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65697970|NCT05351346|Cyclophosphamide|cyclophosphamide|mesh-list
65697971|NCT05351346|Rituximab|rituximab|mesh-list
65697972|NCT05351346|Doxorubicin|doxorubicin|mesh-list
65697973|NCT05351346|Vincristine|vincristine|mesh-list
65697974|NCT05351346|Lenalidomide|lenalidomide|mesh-list
65697975|NCT05351346|Decitabine|decitabine|mesh-list
65697976|NCT05351346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65697977|NCT05351346|Immunologic Factors|immunologic factors|mesh-ancestor
65697978|NCT05351346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65697979|NCT05351346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65697980|NCT05351346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65697981|NCT05351346|Alkylating Agents|alkylating agents|mesh-ancestor
65697982|NCT05351346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65697983|NCT05351346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65697984|NCT05351346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65697985|NCT05351346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65697986|NCT05351346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65697987|NCT05351346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65697988|NCT05351346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65697989|NCT05351346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65697990|NCT05351346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65697991|NCT05351346|Glucocorticoids|glucocorticoids|mesh-ancestor
65697992|NCT05351346|Hormones|hormones|mesh-ancestor
65697993|NCT05351346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65697994|NCT05351346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65697995|NCT05351346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65697996|NCT05351346|Tubulin Modulators|tubulin modulators|mesh-ancestor
65697997|NCT05351346|Antimitotic Agents|antimitotic agents|mesh-ancestor
65697998|NCT05351346|Mitosis Modulators|mitosis modulators|mesh-ancestor
65697999|NCT05351346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65698000|NCT05351346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65698001|NCT05351346|Growth Substances|growth substances|mesh-ancestor
65698002|NCT05351346|Growth Inhibitors|growth inhibitors|mesh-ancestor
65698003|NCT05351346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65698004|NCT05351346|Antimetabolites|antimetabolites|mesh-ancestor
65698005|NCT05327010|Talazoparib|talazoparib|mesh-list
65698006|NCT05327010|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65698007|NCT05327010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65698008|NCT05327010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698009|NCT05327010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698010|NCT05323019|Ketamine|ketamine|mesh-list
65698011|NCT05323019|Esketamine|esketamine|mesh-list
65698012|NCT05323019|Analgesics|analgesics|mesh-ancestor
65698013|NCT05323019|Sensory System Agents|sensory system agents|mesh-ancestor
65698014|NCT05323019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65698015|NCT05323019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698016|NCT05323019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65698017|NCT05323019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65698018|NCT05323019|Anesthetics, General|anesthetics, general|mesh-ancestor
65698019|NCT05323019|Anesthetics|anesthetics|mesh-ancestor
65698020|NCT05323019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65698021|NCT05323019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65698022|NCT05323019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65698023|NCT05323019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65698024|NCT05323019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698025|NCT05323019|Antidepressive Agents|antidepressive agents|mesh-ancestor
65698026|NCT05323019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65698027|NCT05280743|Oxycodone|oxycodone|mesh-list
65698028|NCT05280743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65698029|NCT05280743|Narcotics|narcotics|mesh-ancestor
65698030|NCT05280743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65698031|NCT05280743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698032|NCT05280743|Analgesics|analgesics|mesh-ancestor
65698033|NCT05280743|Sensory System Agents|sensory system agents|mesh-ancestor
65698034|NCT05280743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65698035|NCT05276258|Bupivacaine|bupivacaine|mesh-list
65698036|NCT05276258|Anesthetics, Local|anesthetics, local|mesh-ancestor
65698037|NCT05276258|Anesthetics|anesthetics|mesh-ancestor
65698038|NCT05276258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65698039|NCT05276258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698040|NCT05276258|Sensory System Agents|sensory system agents|mesh-ancestor
65698041|NCT05276258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65698042|NCT05261490|Doxorubicin|doxorubicin|mesh-list
65698043|NCT05261490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65698044|NCT05261490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65698045|NCT05261490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698046|NCT05261490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65698047|NCT05261490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65698048|NCT05261490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65698049|NCT05261490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698050|NCT05233982|Olaparib|olaparib|mesh-list
65698051|NCT05233982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65698052|NCT05233982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65698053|NCT05233982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698054|NCT05233982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698055|NCT05200845|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65698056|NCT05199493|Angiotensin II|angiotensin ii|mesh-list
65698057|NCT05199493|Giapreza|giapreza|mesh-list
65698058|NCT05199493|Angiotensinogen|angiotensinogen|mesh-list
65698059|NCT05199493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65698060|NCT05199493|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65698061|NCT05199493|Protease Inhibitors|protease inhibitors|mesh-ancestor
65698062|NCT05199493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65698063|NCT05199493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698064|NCT05179876|Selexipag|selexipag|mesh-list
65698065|NCT05179876|Tadalafil|tadalafil|mesh-list
65698066|NCT05179876|Macitentan|macitentan|mesh-list
65698067|NCT05179876|Vasodilator Agents|vasodilator agents|mesh-ancestor
65698068|NCT05179876|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65698069|NCT05179876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65698070|NCT05179876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65698071|NCT05179876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698072|NCT05179876|Urological Agents|urological agents|mesh-ancestor
65698073|NCT05179876|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65698074|NCT05179876|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65698075|NCT05179876|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65698076|NCT05179876|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65698077|NCT05169658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65698078|NCT05169658|Obinutuzumab|obinutuzumab|mesh-list
65698079|NCT05169658|Antibodies|antibodies|mesh-list
65698080|NCT05169658|Immunoglobulins|immunoglobulins|mesh-list
65698081|NCT05169658|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65698082|NCT05169658|Immunoconjugates|immunoconjugates|mesh-list
65698083|NCT05169658|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65698084|NCT05169658|Immunologic Factors|immunologic factors|mesh-ancestor
65698085|NCT05169658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698086|NCT05169658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698087|NCT05141305|Clopidogrel|clopidogrel|mesh-list
65698088|NCT05141305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698089|NCT05141305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698090|NCT05141305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65698091|NCT05141305|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65698092|NCT05141305|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65698093|NCT05141305|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65698094|NCT05141305|Purinergic Agents|purinergic agents|mesh-ancestor
65698095|NCT05141305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65698096|NCT05112536|Paclitaxel|paclitaxel|mesh-list
65698097|NCT05112536|Carboplatin|carboplatin|mesh-list
65698098|NCT05112536|Doxorubicin|doxorubicin|mesh-list
65698099|NCT05112536|Pembrolizumab|pembrolizumab|mesh-list
65698100|NCT05112536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65698101|NCT05112536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698102|NCT05112536|Tubulin Modulators|tubulin modulators|mesh-ancestor
65698103|NCT05112536|Antimitotic Agents|antimitotic agents|mesh-ancestor
65698104|NCT05112536|Mitosis Modulators|mitosis modulators|mesh-ancestor
65698105|NCT05112536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269085|NCT03812588|Citalopram|citalopram|mesh-list
65698106|NCT05112536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65698107|NCT05112536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65698108|NCT05112536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65698109|NCT05112536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65698110|NCT05112536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698111|NCT05109455|Proanthocyanidin|proanthocyanidin|mesh-list
65698112|NCT05109455|Procyanidin|procyanidin|mesh-list
65698113|NCT05109455|Antioxidants|antioxidants|mesh-ancestor
65698114|NCT05109455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698115|NCT05109455|Protective Agents|protective agents|mesh-ancestor
65698116|NCT05109455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698117|NCT05109455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65698118|NCT05109455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65698119|NCT05109455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65698120|NCT05098028|Rifaximin|rifaximin|mesh-list
65698121|NCT05098028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65698122|NCT05098028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65698123|NCT05098028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65698124|NCT05079360|Everolimus|everolimus|mesh-list
65698125|NCT05079360|Exemestane|exemestane|mesh-list
65698126|NCT05079360|Estrogens|estrogens|mesh-list
65698127|NCT05079360|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
65698128|NCT05079360|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-list
65698129|NCT05079360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698130|NCT05079360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65698131|NCT05079360|Immunologic Factors|immunologic factors|mesh-ancestor
65698132|NCT05079360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698133|NCT05079360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65698134|NCT05079360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65698135|NCT05079360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65698136|NCT05079360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698137|NCT05079360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65698138|NCT05079360|Hormone Antagonists|hormone antagonists|mesh-ancestor
65698139|NCT05079360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65698140|NCT05079360|Hormones|hormones|mesh-ancestor
65698141|NCT05078060|Vaccines|vaccines|mesh-list
65698142|NCT05078060|Immunologic Factors|immunologic factors|mesh-ancestor
65698143|NCT05078060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698144|NCT05075980|Cisplatin|cisplatin|mesh-list
65698145|NCT05075980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698146|NCT05071053|Ramucirumab|ramucirumab|mesh-list
65698147|NCT05071053|Maytansine|maytansine|mesh-list
65698148|NCT05071053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698149|NCT05071053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65698150|NCT05071053|Tubulin Modulators|tubulin modulators|mesh-ancestor
65698151|NCT05071053|Antimitotic Agents|antimitotic agents|mesh-ancestor
65698152|NCT05071053|Mitosis Modulators|mitosis modulators|mesh-ancestor
65698153|NCT05071053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698154|NCT05063786|Capecitabine|capecitabine|mesh-list
65698155|NCT05063786|Trastuzumab|trastuzumab|mesh-list
65698156|NCT05063786|Vinorelbine|vinorelbine|mesh-list
65698157|NCT05063786|Fulvestrant|fulvestrant|mesh-list
65698158|NCT05063786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65698159|NCT05063786|Antimetabolites|antimetabolites|mesh-ancestor
65698160|NCT05063786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698161|NCT05063786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698162|NCT05063786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698163|NCT05063786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65698164|NCT05063786|Tubulin Modulators|tubulin modulators|mesh-ancestor
65698165|NCT05063786|Antimitotic Agents|antimitotic agents|mesh-ancestor
65698166|NCT05063786|Mitosis Modulators|mitosis modulators|mesh-ancestor
65698167|NCT05063786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65698168|NCT05063786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65698169|NCT05063786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65698170|NCT05063786|Hormone Antagonists|hormone antagonists|mesh-ancestor
65698171|NCT05063786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65698172|NCT05063786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698173|NCT05035836|Tamoxifen|tamoxifen|mesh-list
65698174|NCT05035836|Letrozole|letrozole|mesh-list
65698175|NCT05035836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698176|NCT05035836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65698177|NCT05035836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65698178|NCT05035836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65698179|NCT05035836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698180|NCT05035836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65698181|NCT05035836|Hormone Antagonists|hormone antagonists|mesh-ancestor
65698182|NCT05035836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65698183|NCT05035836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698184|NCT05035836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65698185|NCT05035836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65698186|NCT05035836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65698187|NCT05035836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65698188|NCT05012787|Vaccines|vaccines|mesh-list
65698189|NCT05012787|1018 oligonucleotide|1018 oligonucleotide|mesh-list
65698190|NCT05012787|Immunologic Factors|immunologic factors|mesh-ancestor
65698191|NCT05012787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698192|NCT05012787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65698193|NCT05005260|Bupivacaine|bupivacaine|mesh-list
65698194|NCT05005260|Anesthetics, Local|anesthetics, local|mesh-ancestor
65698195|NCT05005260|Anesthetics|anesthetics|mesh-ancestor
65698196|NCT05005260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65698197|NCT05005260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698198|NCT05005260|Sensory System Agents|sensory system agents|mesh-ancestor
65698199|NCT05005260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65698200|NCT04990167|Bromides|bromides|mesh-list
65698201|NCT04990167|Tiotropium Bromide|tiotropium bromide|mesh-list
65698202|NCT04990167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65698203|NCT04990167|Autonomic Agents|autonomic agents|mesh-ancestor
65698204|NCT04990167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65698205|NCT04990167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698206|NCT04990167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65698207|NCT04990167|Respiratory System Agents|respiratory system agents|mesh-ancestor
65698208|NCT04990167|Parasympatholytics|parasympatholytics|mesh-ancestor
65698209|NCT04990167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65698210|NCT04990167|Cholinergic Agents|cholinergic agents|mesh-ancestor
65698211|NCT04990167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65698212|NCT04990167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698213|NCT04990167|Anticonvulsants|anticonvulsants|mesh-ancestor
65698214|NCT04939090|Megestrol|megestrol|mesh-list
65698215|NCT04939090|Megestrol Acetate|megestrol acetate|mesh-list
65698216|NCT04939090|Olanzapine|olanzapine|mesh-list
65698217|NCT04939090|Antiemetics|antiemetics|mesh-ancestor
65698218|NCT04939090|Autonomic Agents|autonomic agents|mesh-ancestor
65698219|NCT04939090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65698220|NCT04939090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698221|NCT04939090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65698222|NCT04939090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65698223|NCT04939090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65698224|NCT04939090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65698225|NCT04939090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65698226|NCT04939090|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65698227|NCT04939090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65698228|NCT04939090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65698229|NCT04939090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698230|NCT04939090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65698231|NCT04939090|Serotonin Agents|serotonin agents|mesh-ancestor
65698232|NCT04939090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65698233|NCT04939090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65698234|NCT04939090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65698235|NCT04939090|Contraceptive Agents|contraceptive agents|mesh-ancestor
65698236|NCT04939090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65698237|NCT04939090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65698238|NCT04939090|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65698239|NCT04939090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65698240|NCT04939090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698241|NCT04939090|Appetite Stimulants|appetite stimulants|mesh-ancestor
65698242|NCT04939090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65698243|NCT04926181|Androgens|androgens|mesh-list
65698244|NCT04926181|Hormones|hormones|mesh-ancestor
65698245|NCT04926181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65698246|NCT04926181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698247|NCT04918927|Nitazoxanide|nitazoxanide|mesh-list
65698248|NCT04918927|Favipiravir|favipiravir|mesh-list
65698249|NCT04918927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65698250|NCT04918927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65698251|NCT04918927|Antiviral Agents|antiviral agents|mesh-ancestor
65698252|NCT04907825|Warfarin|warfarin|mesh-list
65698253|NCT04907825|Anticoagulants|anticoagulants|mesh-list
65698254|NCT04907084|Fenofibrate|fenofibrate|mesh-list
65698255|NCT04907084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65698256|NCT04907084|Antimetabolites|antimetabolites|mesh-ancestor
65698257|NCT04907084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698258|NCT04907084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65698259|NCT04899349|Metformin|metformin|mesh-list
65698260|NCT04899349|Dapagliflozin|dapagliflozin|mesh-list
65698261|NCT04899349|Fulvestrant|fulvestrant|mesh-list
65698262|NCT04899349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65698263|NCT04899349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698264|NCT04899349|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65698265|NCT04899349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698266|NCT04899349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65698267|NCT04899349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698268|NCT04899349|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65698269|NCT04899349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65698270|NCT04899349|Hormone Antagonists|hormone antagonists|mesh-ancestor
65698271|NCT04899349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65698272|NCT04893356|Dacarbazine|dacarbazine|mesh-list
65698273|NCT04893356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65698274|NCT04893356|Alkylating Agents|alkylating agents|mesh-ancestor
65698275|NCT04893356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698276|NCT04893356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698277|NCT04857983|Memantine|memantine|mesh-list
65698278|NCT04857983|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65698279|NCT04857983|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65698280|NCT04857983|Dopamine Agents|dopamine agents|mesh-ancestor
65698281|NCT04857983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65698282|NCT04857983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698283|NCT04857983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698284|NCT04857983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65698285|NCT04857983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65698286|NCT04777708|Pembrolizumab|pembrolizumab|mesh-list
65698287|NCT04777708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698288|NCT04777708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698289|NCT04763512|Caseins|caseins|mesh-list
65698290|NCT04763512|Chelating Agents|chelating agents|mesh-ancestor
65698291|NCT04763512|Sequestering Agents|sequestering agents|mesh-ancestor
65698292|NCT04763512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698293|NCT04730349|Nivolumab|nivolumab|mesh-list
65698294|NCT04730349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698295|NCT04730349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698296|NCT04730349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65698297|NCT04730349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698298|NCT04602117|Paclitaxel|paclitaxel|mesh-list
65698299|NCT04602117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65698300|NCT04602117|Trastuzumab|trastuzumab|mesh-list
65698301|NCT04602117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65698302|NCT04602117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698303|NCT04602117|Tubulin Modulators|tubulin modulators|mesh-ancestor
65698304|NCT04602117|Antimitotic Agents|antimitotic agents|mesh-ancestor
65698305|NCT04602117|Mitosis Modulators|mitosis modulators|mesh-ancestor
65698306|NCT04602117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698307|NCT04602117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698308|NCT04601857|Pembrolizumab|pembrolizumab|mesh-list
65698309|NCT04601857|Futibatinib|futibatinib|mesh-list
65698310|NCT04601857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698311|NCT04601857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698312|NCT04590508|Xanthohumol|xanthohumol|mesh-list
65698313|NCT04590508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698314|NCT04590508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65698315|NCT04590508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65698316|NCT04590508|Growth Substances|growth substances|mesh-ancestor
65698317|NCT04590508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698318|NCT04590508|Growth Inhibitors|growth inhibitors|mesh-ancestor
65698319|NCT04564443|Calcium|calcium|mesh-list
65698320|NCT04564443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65698321|NCT04564443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698322|NCT04541355|Sodium thiosulfate|sodium thiosulfate|mesh-list
65698323|NCT04541355|Cisplatin|cisplatin|mesh-list
65698324|NCT04541355|Antidotes|antidotes|mesh-list
65698325|NCT04541355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698326|NCT04541355|Protective Agents|protective agents|mesh-ancestor
65698327|NCT04541355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698328|NCT04541355|Antioxidants|antioxidants|mesh-ancestor
65698329|NCT04541355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698331|NCT04541355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65698332|NCT04541355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65698333|NCT04541355|Chelating Agents|chelating agents|mesh-ancestor
65698334|NCT04541355|Sequestering Agents|sequestering agents|mesh-ancestor
65698335|NCT04517396|Fenofibrate|fenofibrate|mesh-list
65698336|NCT04517396|Fenofibric acid|fenofibric acid|mesh-list
65698337|NCT04517396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65698338|NCT04517396|Antimetabolites|antimetabolites|mesh-ancestor
65698339|NCT04517396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698340|NCT04517396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65698341|NCT04517396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65698342|NCT04501978|Remdesivir|remdesivir|mesh-list
65698343|NCT04501978|Bamlanivimab|bamlanivimab|mesh-list
65698344|NCT04501978|Antimetabolites|antimetabolites|mesh-ancestor
65698345|NCT04501978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698346|NCT04501978|Antiviral Agents|antiviral agents|mesh-ancestor
65698347|NCT04501978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65698348|NCT04382352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65698349|NCT04382352|Trastuzumab|trastuzumab|mesh-list
65698350|NCT04382352|Antibodies|antibodies|mesh-list
65698351|NCT04382352|Immunoglobulins|immunoglobulins|mesh-list
65698352|NCT04382352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65698353|NCT04382352|Immunologic Factors|immunologic factors|mesh-ancestor
65698354|NCT04382352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698355|NCT04382352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698356|NCT04354246|Pembrolizumab|pembrolizumab|mesh-list
65698357|NCT04354246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698358|NCT04354246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698359|NCT04353492|Ofatumumab|ofatumumab|mesh-list
65698360|NCT04353492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698361|NCT04311424|Tirzepatide|tirzepatide|mesh-list
65698362|NCT04311424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65698363|NCT04311424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698364|NCT04311424|Incretins|incretins|mesh-ancestor
65698365|NCT04311424|Hormones|hormones|mesh-ancestor
65698366|NCT04311424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65698367|NCT04301765|Testosterone|testosterone|mesh-list
65698368|NCT04301765|Androgens|androgens|mesh-ancestor
65698369|NCT04301765|Hormones|hormones|mesh-ancestor
65698370|NCT04301765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65698371|NCT04301765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698372|NCT04296396|Oxycodone|oxycodone|mesh-list
65698373|NCT04296396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65698374|NCT04296396|Narcotics|narcotics|mesh-ancestor
65698375|NCT04296396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65698376|NCT04296396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698377|NCT04296396|Analgesics|analgesics|mesh-ancestor
65698378|NCT04296396|Sensory System Agents|sensory system agents|mesh-ancestor
65698379|NCT04296396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65698380|NCT04291456|Minocycline|minocycline|mesh-list
65698381|NCT04291456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65698382|NCT04291456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65698383|NCT04266977|Dexamethasone|dexamethasone|mesh-list
65698384|NCT04266977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65698385|NCT04266977|Antiemetics|antiemetics|mesh-ancestor
65698386|NCT04266977|Autonomic Agents|autonomic agents|mesh-ancestor
65698387|NCT04266977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65698388|NCT04266977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698389|NCT04266977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65698390|NCT04266977|Glucocorticoids|glucocorticoids|mesh-ancestor
65698391|NCT04266977|Hormones|hormones|mesh-ancestor
65698392|NCT04266977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65698393|NCT04266977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65698394|NCT04266977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698395|NCT04261439|Spartalizumab|spartalizumab|mesh-list
65698396|NCT04261439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65698397|NCT04261439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698398|NCT04261439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698399|NCT04195945|Cytarabine|cytarabine|mesh-list
65698400|NCT04195945|Daunorubicin|daunorubicin|mesh-list
65698401|NCT04195945|Mitoxantrone|mitoxantrone|mesh-list
65698402|NCT04195945|Cladribine|cladribine|mesh-list
65698403|NCT04195945|Lenograstim|lenograstim|mesh-list
65698404|NCT04195945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65698405|NCT04195945|Antimetabolites|antimetabolites|mesh-ancestor
65161004|NCT01239992|Vitamins|vitamins|mesh-ancestor
65698406|NCT04195945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698407|NCT04195945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698408|NCT04195945|Antiviral Agents|antiviral agents|mesh-ancestor
65698409|NCT04195945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65698410|NCT04195945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65698411|NCT04195945|Immunologic Factors|immunologic factors|mesh-ancestor
65698412|NCT04195945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698413|NCT04195945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65698414|NCT04195945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65698415|NCT04195945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65698416|NCT04195945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65698417|NCT04195945|Analgesics|analgesics|mesh-ancestor
65698418|NCT04195945|Sensory System Agents|sensory system agents|mesh-ancestor
65698419|NCT04195945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65698420|NCT04195945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65698421|NCT04189445|Futibatinib|futibatinib|mesh-list
65698422|NCT04189445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698423|NCT04172922|Sirolimus|sirolimus|mesh-list
65698424|NCT04172922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65698425|NCT04172922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65698426|NCT04172922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65698427|NCT04172922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698428|NCT04172922|Antifungal Agents|antifungal agents|mesh-ancestor
65698429|NCT04172922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65698430|NCT04172922|Immunologic Factors|immunologic factors|mesh-ancestor
65698431|NCT04172922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698432|NCT04149899|Timolol|timolol|mesh-list
65698433|NCT04149899|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65698434|NCT04149899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65698435|NCT04149899|Adrenergic Agents|adrenergic agents|mesh-ancestor
65698436|NCT04149899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65698437|NCT04149899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698438|NCT04149899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698439|NCT04149899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65698440|NCT04149899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65698441|NCT04139772|Docetaxel|docetaxel|mesh-list
65698442|NCT04139772|Abiraterone Acetate|abiraterone acetate|mesh-list
65698443|NCT04139772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698444|NCT04139772|Tubulin Modulators|tubulin modulators|mesh-ancestor
65698445|NCT04139772|Antimitotic Agents|antimitotic agents|mesh-ancestor
65698446|NCT04139772|Mitosis Modulators|mitosis modulators|mesh-ancestor
65698447|NCT04139772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698448|NCT04139772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65698449|NCT04139772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65698450|NCT04139772|Hormone Antagonists|hormone antagonists|mesh-ancestor
65698451|NCT04139772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65698452|NCT04139772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698453|NCT04139772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65698454|NCT04136353|Hormones|hormones|mesh-list
65698455|NCT04136353|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65698456|NCT04136353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65698457|NCT04136353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698458|NCT04094688|Vitamin D|vitamin d|mesh-list
65698459|NCT04094688|Cholecalciferol|cholecalciferol|mesh-list
65698460|NCT04094688|Leucovorin|leucovorin|mesh-list
65698461|NCT04094688|Bevacizumab|bevacizumab|mesh-list
65698462|NCT04094688|Fluorouracil|fluorouracil|mesh-list
65698463|NCT04094688|Oxaliplatin|oxaliplatin|mesh-list
65698464|NCT04094688|Irinotecan|irinotecan|mesh-list
65698465|NCT04094688|Levoleucovorin|levoleucovorin|mesh-list
65698466|NCT04094688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698467|NCT04094688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698468|NCT04094688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65698469|NCT04094688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65698470|NCT04094688|Growth Substances|growth substances|mesh-ancestor
65698471|NCT04094688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698472|NCT04094688|Growth Inhibitors|growth inhibitors|mesh-ancestor
65698473|NCT04094688|Vitamins|vitamins|mesh-ancestor
65698474|NCT04094688|Micronutrients|micronutrients|mesh-ancestor
65698475|NCT04094688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65698476|NCT04094688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65698477|NCT04094688|Antimetabolites|antimetabolites|mesh-ancestor
65698478|NCT04094688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698479|NCT04094688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65698480|NCT04094688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65698481|NCT04094688|Immunologic Factors|immunologic factors|mesh-ancestor
65698482|NCT04094688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65698483|NCT04094688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65698484|NCT04094688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65698485|NCT04094688|Antidotes|antidotes|mesh-ancestor
65698486|NCT04094688|Protective Agents|protective agents|mesh-ancestor
65698487|NCT04094688|Vitamin B Complex|vitamin b complex|mesh-ancestor
65698488|NCT04091204|Olaparib|olaparib|mesh-list
65698489|NCT04091204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65698490|NCT04091204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65698491|NCT04091204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698492|NCT04091204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698493|NCT04050670|Tirzepatide|tirzepatide|mesh-list
65698494|NCT04050670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65698495|NCT04050670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698496|NCT04050670|Incretins|incretins|mesh-ancestor
65698497|NCT04050670|Hormones|hormones|mesh-ancestor
65698498|NCT04050670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65698499|NCT04041050|Celecoxib|celecoxib|mesh-list
65698500|NCT04041050|Navitoclax|navitoclax|mesh-list
65698501|NCT04041050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65698502|NCT04041050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65698503|NCT04041050|Analgesics|analgesics|mesh-ancestor
65698504|NCT04041050|Sensory System Agents|sensory system agents|mesh-ancestor
65698505|NCT04041050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65698506|NCT04041050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698507|NCT04041050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65698508|NCT04041050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65698509|NCT04041050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65698510|NCT04041050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65698511|NCT04041050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65698512|NCT04041050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698513|NCT04041050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698514|NCT04028245|Spartalizumab|spartalizumab|mesh-list
65698515|NCT04028245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65698516|NCT04028245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698517|NCT04028245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698518|NCT04017650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65698519|NCT04017650|Nivolumab|nivolumab|mesh-list
65698520|NCT04017650|Cetuximab|cetuximab|mesh-list
65698521|NCT04017650|Antibodies|antibodies|mesh-list
65698522|NCT04017650|Immunoglobulins|immunoglobulins|mesh-list
65698523|NCT04017650|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65698524|NCT04017650|Immunologic Factors|immunologic factors|mesh-ancestor
65698525|NCT04017650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698526|NCT04017650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698527|NCT04017650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65698528|NCT04017650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698529|NCT03988036|Pembrolizumab|pembrolizumab|mesh-list
65698530|NCT03988036|Trastuzumab|trastuzumab|mesh-list
65698531|NCT03988036|Pertuzumab|pertuzumab|mesh-list
65698532|NCT03988036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698533|NCT03988036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698534|NCT03975114|Durvalumab|durvalumab|mesh-list
65698535|NCT03975114|Tremelimumab|tremelimumab|mesh-list
65698536|NCT03975114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698537|NCT03975114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698538|NCT03955783|Venetoclax|venetoclax|mesh-list
65698539|NCT03955783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698540|NCT03942120|Ustekinumab|ustekinumab|mesh-list
65698541|NCT03942120|Dermatologic Agents|dermatologic agents|mesh-ancestor
65698542|NCT03940742|Tirzepatide|tirzepatide|mesh-list
65698543|NCT03940742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65698544|NCT03940742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698545|NCT03940742|Incretins|incretins|mesh-ancestor
65698546|NCT03940742|Hormones|hormones|mesh-ancestor
65698547|NCT03940742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65698548|NCT03893240|Antibodies|antibodies|mesh-list
65698549|NCT03893240|Antibodies, Blocking|antibodies, blocking|mesh-list
65698550|NCT03893240|Immunologic Factors|immunologic factors|mesh-ancestor
65698551|NCT03893240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698552|NCT03878199|Cytarabine|cytarabine|mesh-list
65698553|NCT03878199|Daunorubicin|daunorubicin|mesh-list
65698554|NCT03878199|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
65698555|NCT03878199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65698556|NCT03878199|Antimetabolites|antimetabolites|mesh-ancestor
65698557|NCT03878199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698558|NCT03878199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698559|NCT03878199|Antiviral Agents|antiviral agents|mesh-ancestor
65698560|NCT03878199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65698561|NCT03878199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65698562|NCT03878199|Immunologic Factors|immunologic factors|mesh-ancestor
65698563|NCT03878199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698564|NCT03878199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65698565|NCT03878199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65698566|NCT03878199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65698567|NCT03878199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65698568|NCT03878199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65698569|NCT03875378|Estrogens|estrogens|mesh-list
65698570|NCT03875378|Hormones|hormones|mesh-ancestor
65698571|NCT03875378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65698572|NCT03875378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698573|NCT03875274|Morphine|morphine|mesh-list
65698574|NCT03875274|Ropivacaine|ropivacaine|mesh-list
65698575|NCT03875274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65698576|NCT03875274|Narcotics|narcotics|mesh-ancestor
65698577|NCT03875274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65698578|NCT03875274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698579|NCT03875274|Analgesics|analgesics|mesh-ancestor
65698580|NCT03875274|Sensory System Agents|sensory system agents|mesh-ancestor
65698581|NCT03875274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65698582|NCT03875274|Anesthetics, Local|anesthetics, local|mesh-ancestor
65698583|NCT03875274|Anesthetics|anesthetics|mesh-ancestor
65698584|NCT03775850|Pembrolizumab|pembrolizumab|mesh-list
65698585|NCT03775850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698586|NCT03775850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698587|NCT03762109|Dantrolene|dantrolene|mesh-list
65698588|NCT03762109|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65698589|NCT03762109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698590|NCT03762109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65698591|NCT03762109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65698592|NCT03739996|Cabotegravir|cabotegravir|mesh-list
65698593|NCT03739996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
65698594|NCT03739996|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65698595|NCT03739996|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65698596|NCT03739996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65698597|NCT03739996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698598|NCT03739996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65698599|NCT03739996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65698600|NCT03739996|Antiviral Agents|antiviral agents|mesh-ancestor
65698601|NCT03739996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65698602|NCT03739996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65698603|NCT03732664|Pembrolizumab|pembrolizumab|mesh-list
65698604|NCT03732664|Nivolumab|nivolumab|mesh-list
65698605|NCT03732664|Durvalumab|durvalumab|mesh-list
65698606|NCT03732664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698607|NCT03732664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698608|NCT03732664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65698609|NCT03732664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698610|NCT03620032|Vinorelbine|vinorelbine|mesh-list
65698611|NCT03620032|Nimotuzumab|nimotuzumab|mesh-list
65698612|NCT03620032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65698613|NCT03620032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698614|NCT03620032|Tubulin Modulators|tubulin modulators|mesh-ancestor
65698615|NCT03620032|Antimitotic Agents|antimitotic agents|mesh-ancestor
65698616|NCT03620032|Mitosis Modulators|mitosis modulators|mesh-ancestor
65698617|NCT03620032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698618|NCT03620032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698619|NCT03504397|Leucovorin|leucovorin|mesh-list
65698620|NCT03504397|Folic Acid|folic acid|mesh-list
65698621|NCT03504397|Fluorouracil|fluorouracil|mesh-list
65698622|NCT03504397|Oxaliplatin|oxaliplatin|mesh-list
65698623|NCT03504397|Levoleucovorin|levoleucovorin|mesh-list
65698624|NCT03504397|Antimetabolites|antimetabolites|mesh-ancestor
65698625|NCT03504397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698626|NCT03504397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65698627|NCT03504397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698628|NCT03504397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65698629|NCT03504397|Immunologic Factors|immunologic factors|mesh-ancestor
65698630|NCT03504397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698631|NCT03504397|Antidotes|antidotes|mesh-ancestor
65698632|NCT03504397|Protective Agents|protective agents|mesh-ancestor
65698633|NCT03504397|Vitamin B Complex|vitamin b complex|mesh-ancestor
65698634|NCT03504397|Vitamins|vitamins|mesh-ancestor
65698635|NCT03504397|Micronutrients|micronutrients|mesh-ancestor
65698636|NCT03504397|Hematinics|hematinics|mesh-ancestor
65698637|NCT03480191|Daptomycin|daptomycin|mesh-list
65698638|NCT03480191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65698639|NCT03480191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65698640|NCT03472560|Avelumab|avelumab|mesh-list
65698641|NCT03472560|Axitinib|axitinib|mesh-list
65698642|NCT03472560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698643|NCT03472560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698644|NCT03472560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65698645|NCT03472560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65698646|NCT03472560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698647|NCT03410784|Paclitaxel|paclitaxel|mesh-list
65698648|NCT03410784|Carboplatin|carboplatin|mesh-list
65698649|NCT03410784|Pembrolizumab|pembrolizumab|mesh-list
65698650|NCT03410784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65698651|NCT03410784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698652|NCT03410784|Tubulin Modulators|tubulin modulators|mesh-ancestor
65698653|NCT03410784|Antimitotic Agents|antimitotic agents|mesh-ancestor
65698654|NCT03410784|Mitosis Modulators|mitosis modulators|mesh-ancestor
65698655|NCT03410784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698656|NCT03410784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698657|NCT03363841|Ibrexafungerp|ibrexafungerp|mesh-list
65698658|NCT03363841|Antifungal Agents|antifungal agents|mesh-ancestor
65698659|NCT03363841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65698660|NCT03355482|Methylprednisolone|methylprednisolone|mesh-list
65698661|NCT03355482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65698662|NCT03355482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65698663|NCT03355482|Prednisolone|prednisolone|mesh-list
65698664|NCT03355482|Prednisolone acetate|prednisolone acetate|mesh-list
65698665|NCT03355482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65698666|NCT03355482|Prednisolone phosphate|prednisolone phosphate|mesh-list
65698667|NCT03355482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65698668|NCT03355482|Antiemetics|antiemetics|mesh-ancestor
65698669|NCT03355482|Autonomic Agents|autonomic agents|mesh-ancestor
65698670|NCT03355482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65698671|NCT03355482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698672|NCT03355482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65698673|NCT03355482|Glucocorticoids|glucocorticoids|mesh-ancestor
65698674|NCT03355482|Hormones|hormones|mesh-ancestor
65698675|NCT03355482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65698676|NCT03355482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65698677|NCT03355482|Protective Agents|protective agents|mesh-ancestor
65698678|NCT03355482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65698679|NCT03355482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698680|NCT03340064|Levetiracetam|levetiracetam|mesh-list
65698681|NCT03340064|Anticonvulsants|anticonvulsants|mesh-ancestor
65698682|NCT03340064|Nootropic Agents|nootropic agents|mesh-ancestor
65698683|NCT03326921|Vidarabine|vidarabine|mesh-list
65698684|NCT03326921|Fludarabine|fludarabine|mesh-list
65698685|NCT03326921|Fludarabine phosphate|fludarabine phosphate|mesh-list
65698686|NCT03326921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698687|NCT03326921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65698688|NCT03326921|Antimetabolites|antimetabolites|mesh-ancestor
65698689|NCT03326921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698690|NCT03326921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65698691|NCT03326921|Immunologic Factors|immunologic factors|mesh-ancestor
65698692|NCT03326921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698693|NCT03326921|Antiviral Agents|antiviral agents|mesh-ancestor
65698694|NCT03326921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65698695|NCT03315260|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65698696|NCT03315260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698697|NCT03310619|Nivolumab|nivolumab|mesh-list
65698698|NCT03310619|Durvalumab|durvalumab|mesh-list
65698699|NCT03310619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698700|NCT03310619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698701|NCT03310619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65698702|NCT03310619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698703|NCT03263572|Cytarabine|cytarabine|mesh-list
65698704|NCT03263572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65698705|NCT03263572|Methotrexate|methotrexate|mesh-list
65698706|NCT03263572|Blinatumomab|blinatumomab|mesh-list
65698707|NCT03263572|Ponatinib|ponatinib|mesh-list
65698708|NCT03263572|Antibodies|antibodies|mesh-list
65698709|NCT03263572|Immunoglobulins|immunoglobulins|mesh-list
65698710|NCT03263572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65698711|NCT03263572|Muromonab-CD3|muromonab-cd3|mesh-list
65698712|NCT03263572|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65698713|NCT03263572|Immunologic Factors|immunologic factors|mesh-ancestor
65698714|NCT03263572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698715|NCT03263572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698716|NCT03263572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65698717|NCT03263572|Abortifacient Agents|abortifacient agents|mesh-ancestor
65698718|NCT03263572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65698719|NCT03263572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65698720|NCT03263572|Antimetabolites|antimetabolites|mesh-ancestor
65698721|NCT03263572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698722|NCT03263572|Dermatologic Agents|dermatologic agents|mesh-ancestor
65698723|NCT03263572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65698724|NCT03263572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65698725|NCT03263572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65698726|NCT03263572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65698727|NCT03263572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65698728|NCT03263572|Antiviral Agents|antiviral agents|mesh-ancestor
65698729|NCT03263572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65698730|NCT03263572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65698731|NCT03263117|Anesthetics|anesthetics|mesh-list
65698732|NCT03263117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65698733|NCT03263117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698734|NCT03190785|Benzoic Acid|benzoic acid|mesh-list
65698735|NCT03190785|Antifungal Agents|antifungal agents|mesh-ancestor
65698736|NCT03190785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65698737|NCT03093064|Natalizumab|natalizumab|mesh-list
65698738|NCT03093064|Immunologic Factors|immunologic factors|mesh-ancestor
65698739|NCT03093064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698740|NCT03060577|Evolocumab|evolocumab|mesh-list
65698741|NCT03060577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65698742|NCT03060577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65698743|NCT03060577|Antimetabolites|antimetabolites|mesh-ancestor
65698744|NCT03060577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698745|NCT03060577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65698746|NCT02797275|Albuterol|albuterol|mesh-list
65698747|NCT02797275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65698748|NCT02797275|Autonomic Agents|autonomic agents|mesh-ancestor
65698749|NCT02797275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65698750|NCT02797275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698751|NCT02797275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65698752|NCT02797275|Respiratory System Agents|respiratory system agents|mesh-ancestor
65698753|NCT02797275|Tocolytic Agents|tocolytic agents|mesh-ancestor
65698754|NCT02797275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65698755|NCT02797275|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65698756|NCT02797275|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65698757|NCT02797275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65698758|NCT02797275|Adrenergic Agents|adrenergic agents|mesh-ancestor
65698759|NCT02797275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65698760|NCT02797275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698761|NCT02792114|Cyclophosphamide|cyclophosphamide|mesh-list
65698762|NCT02792114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65698763|NCT02792114|Immunologic Factors|immunologic factors|mesh-ancestor
65698764|NCT02792114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698765|NCT02792114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65698766|NCT02792114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65698767|NCT02792114|Alkylating Agents|alkylating agents|mesh-ancestor
65698768|NCT02792114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698769|NCT02792114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698770|NCT02792114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65698771|NCT02787005|Pembrolizumab|pembrolizumab|mesh-list
65698772|NCT02787005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698773|NCT02787005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698774|NCT02750319|Acetylcysteine|acetylcysteine|mesh-list
65698775|NCT02750319|Amiodarone|amiodarone|mesh-list
65698776|NCT02750319|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65698777|NCT02750319|Antiviral Agents|antiviral agents|mesh-ancestor
65698778|NCT02750319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65698779|NCT02750319|Expectorants|expectorants|mesh-ancestor
65698780|NCT02750319|Respiratory System Agents|respiratory system agents|mesh-ancestor
65698781|NCT02750319|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65698782|NCT02750319|Antioxidants|antioxidants|mesh-ancestor
65698783|NCT02750319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698784|NCT02750319|Protective Agents|protective agents|mesh-ancestor
65698785|NCT02750319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698786|NCT02750319|Antidotes|antidotes|mesh-ancestor
65698787|NCT02750319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65698788|NCT02750319|Vasodilator Agents|vasodilator agents|mesh-ancestor
65698789|NCT02750319|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65698790|NCT02750319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65698791|NCT02750319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65698792|NCT02750319|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65698793|NCT02750319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65698794|NCT02750319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65698795|NCT02750319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65698796|NCT02750319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65698797|NCT02750319|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65698799|NCT02734290|Pembrolizumab|pembrolizumab|mesh-list
65698800|NCT02734290|Capecitabine|capecitabine|mesh-list
65698801|NCT02734290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65698802|NCT02734290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698803|NCT02734290|Tubulin Modulators|tubulin modulators|mesh-ancestor
65698804|NCT02734290|Antimitotic Agents|antimitotic agents|mesh-ancestor
65698805|NCT02734290|Mitosis Modulators|mitosis modulators|mesh-ancestor
65698806|NCT02734290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698807|NCT02734290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698808|NCT02734290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65698809|NCT02734290|Antimetabolites|antimetabolites|mesh-ancestor
65698810|NCT02673333|Pembrolizumab|pembrolizumab|mesh-list
65698811|NCT02673333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698812|NCT02673333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698813|NCT02633189|Bevacizumab|bevacizumab|mesh-list
65698814|NCT02633189|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65698815|NCT02633189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698816|NCT02633189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698817|NCT02633189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65698818|NCT02633189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65698819|NCT02633189|Growth Substances|growth substances|mesh-ancestor
65698820|NCT02633189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698821|NCT02633189|Growth Inhibitors|growth inhibitors|mesh-ancestor
65698822|NCT02633189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65698823|NCT02633189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65698824|NCT02633189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698825|NCT02621242|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65698826|NCT02621242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65698827|NCT02621242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65698828|NCT02621242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65698829|NCT02621242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698830|NCT02621242|Antiviral Agents|antiviral agents|mesh-ancestor
65698831|NCT02621242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65698832|NCT02621242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65698833|NCT02621242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65698834|NCT02601313|Cyclophosphamide|cyclophosphamide|mesh-list
65698835|NCT02601313|Fludarabine|fludarabine|mesh-list
65698836|NCT02601313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65698837|NCT02601313|Immunologic Factors|immunologic factors|mesh-ancestor
65698838|NCT02601313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698839|NCT02601313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65698840|NCT02601313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65698841|NCT02601313|Alkylating Agents|alkylating agents|mesh-ancestor
65698842|NCT02601313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698843|NCT02601313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698844|NCT02601313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65698845|NCT02526368|Carbamide Peroxide|carbamide peroxide|mesh-list
65698846|NCT02526368|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65698847|NCT02526368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65698848|NCT02514083|Fludarabine|fludarabine|mesh-list
65698849|NCT02514083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698850|NCT02500576|Aldesleukin|aldesleukin|mesh-list
65698851|NCT02500576|Cyclophosphamide|cyclophosphamide|mesh-list
65698852|NCT02500576|Pembrolizumab|pembrolizumab|mesh-list
65698853|NCT02500576|Fludarabine|fludarabine|mesh-list
65698854|NCT02500576|Fludarabine phosphate|fludarabine phosphate|mesh-list
65698855|NCT02500576|Interleukin-2|interleukin-2|mesh-list
65698856|NCT02500576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65698857|NCT02500576|Immunologic Factors|immunologic factors|mesh-ancestor
65698858|NCT02500576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698859|NCT02500576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65698860|NCT02500576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65698861|NCT02500576|Alkylating Agents|alkylating agents|mesh-ancestor
65698862|NCT02500576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698863|NCT02500576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698864|NCT02500576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65698865|NCT02500576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698866|NCT02500576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65698867|NCT02500576|Antimetabolites|antimetabolites|mesh-ancestor
65698868|NCT02500576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65698869|NCT02500576|Analgesics|analgesics|mesh-ancestor
65698870|NCT02500576|Sensory System Agents|sensory system agents|mesh-ancestor
65698871|NCT02500576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65698872|NCT02500576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65698873|NCT02500576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65698874|NCT02500576|Antiviral Agents|antiviral agents|mesh-ancestor
65698875|NCT02500576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65698876|NCT02453282|Gemcitabine|gemcitabine|mesh-list
65698877|NCT02453282|Paclitaxel|paclitaxel|mesh-list
65698878|NCT02453282|Cisplatin|cisplatin|mesh-list
65698879|NCT02453282|Carboplatin|carboplatin|mesh-list
65698880|NCT02453282|Pemetrexed|pemetrexed|mesh-list
65698881|NCT02453282|Durvalumab|durvalumab|mesh-list
65698882|NCT02453282|Tremelimumab|tremelimumab|mesh-list
65698883|NCT02453282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65698884|NCT02453282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65698885|NCT02453282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698886|NCT02453282|Tubulin Modulators|tubulin modulators|mesh-ancestor
65698887|NCT02453282|Antimitotic Agents|antimitotic agents|mesh-ancestor
65698888|NCT02453282|Mitosis Modulators|mitosis modulators|mesh-ancestor
65698889|NCT02453282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698890|NCT02453282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65698891|NCT02453282|Antimetabolites|antimetabolites|mesh-ancestor
65698892|NCT02453282|Antiviral Agents|antiviral agents|mesh-ancestor
65698893|NCT02453282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65698894|NCT02453282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65698895|NCT02453282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65698896|NCT02453282|Immunologic Factors|immunologic factors|mesh-ancestor
65698897|NCT02453282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698898|NCT02453282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65698899|NCT02453282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65698900|NCT02453282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698901|NCT02395848|Fidaxomicin|fidaxomicin|mesh-list
65698902|NCT02395848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65698903|NCT02395848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65698904|NCT02214381|Paclitaxel|paclitaxel|mesh-list
65698905|NCT02214381|Cyclophosphamide|cyclophosphamide|mesh-list
65698906|NCT02214381|Doxorubicin|doxorubicin|mesh-list
65698907|NCT02214381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65698908|NCT02214381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698909|NCT02214381|Tubulin Modulators|tubulin modulators|mesh-ancestor
65698910|NCT02214381|Antimitotic Agents|antimitotic agents|mesh-ancestor
65698911|NCT02214381|Mitosis Modulators|mitosis modulators|mesh-ancestor
65698912|NCT02214381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698913|NCT02214381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65698914|NCT02214381|Immunologic Factors|immunologic factors|mesh-ancestor
65698915|NCT02214381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698916|NCT02214381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65698917|NCT02214381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65698918|NCT02214381|Alkylating Agents|alkylating agents|mesh-ancestor
65698919|NCT02214381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65698920|NCT02214381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65698921|NCT02214381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65698922|NCT02214381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65698923|NCT02214381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65698924|NCT02081326|BCG Vaccine|bcg vaccine|mesh-list
65698925|NCT02081326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65698926|NCT02081326|Immunologic Factors|immunologic factors|mesh-ancestor
65698927|NCT02081326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698928|NCT02078427|BAX 855|bax 855|mesh-list
65698929|NCT02078427|Coagulants|coagulants|mesh-ancestor
65698930|NCT02061761|Nivolumab|nivolumab|mesh-list
65698931|NCT02061761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698932|NCT02061761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698933|NCT02061761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65269100|NCT02387099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698934|NCT02061761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698935|NCT01927068|Paclitaxel|paclitaxel|mesh-list
65698936|NCT01927068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65698937|NCT01927068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698938|NCT01927068|Tubulin Modulators|tubulin modulators|mesh-ancestor
65698939|NCT01927068|Antimitotic Agents|antimitotic agents|mesh-ancestor
65698940|NCT01927068|Mitosis Modulators|mitosis modulators|mesh-ancestor
65698941|NCT01927068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698942|NCT01898104|Capecitabine|capecitabine|mesh-list
65698943|NCT01898104|Valproic Acid|valproic acid|mesh-list
65698944|NCT01898104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65698945|NCT01898104|Antimetabolites|antimetabolites|mesh-ancestor
65698946|NCT01898104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698947|NCT01898104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698948|NCT01898104|Anticonvulsants|anticonvulsants|mesh-ancestor
65698949|NCT01898104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65698950|NCT01898104|GABA Agents|gaba agents|mesh-ancestor
65698951|NCT01898104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65698952|NCT01898104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698953|NCT01898104|Antimanic Agents|antimanic agents|mesh-ancestor
65698954|NCT01898104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65698955|NCT01898104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65698956|NCT01898104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65698957|NCT01817452|Paclitaxel|paclitaxel|mesh-list
65698958|NCT01817452|Trastuzumab|trastuzumab|mesh-list
65698959|NCT01817452|Pertuzumab|pertuzumab|mesh-list
65698960|NCT01817452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65698961|NCT01817452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698962|NCT01817452|Tubulin Modulators|tubulin modulators|mesh-ancestor
65698963|NCT01817452|Antimitotic Agents|antimitotic agents|mesh-ancestor
65698964|NCT01817452|Mitosis Modulators|mitosis modulators|mesh-ancestor
65698965|NCT01817452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698966|NCT01817452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698967|NCT01815242|Gemcitabine|gemcitabine|mesh-list
65698968|NCT01815242|Paclitaxel|paclitaxel|mesh-list
65698969|NCT01815242|Carboplatin|carboplatin|mesh-list
65698970|NCT01815242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65698971|NCT01815242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698972|NCT01815242|Tubulin Modulators|tubulin modulators|mesh-ancestor
65698973|NCT01815242|Antimitotic Agents|antimitotic agents|mesh-ancestor
65698974|NCT01815242|Mitosis Modulators|mitosis modulators|mesh-ancestor
65698975|NCT01815242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698976|NCT01815242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65698977|NCT01815242|Antimetabolites|antimetabolites|mesh-ancestor
65698978|NCT01815242|Antiviral Agents|antiviral agents|mesh-ancestor
65698979|NCT01815242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65698980|NCT01815242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65698981|NCT01815242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65698982|NCT01815242|Immunologic Factors|immunologic factors|mesh-ancestor
65698983|NCT01815242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65698984|NCT01802749|Gemcitabine|gemcitabine|mesh-list
65698985|NCT01802749|Paclitaxel|paclitaxel|mesh-list
65698986|NCT01802749|Bevacizumab|bevacizumab|mesh-list
65698987|NCT01802749|Carboplatin|carboplatin|mesh-list
65698988|NCT01802749|Doxorubicin|doxorubicin|mesh-list
65698989|NCT01802749|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65698990|NCT01802749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65698991|NCT01802749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65698992|NCT01802749|Tubulin Modulators|tubulin modulators|mesh-ancestor
65698993|NCT01802749|Antimitotic Agents|antimitotic agents|mesh-ancestor
65698994|NCT01802749|Mitosis Modulators|mitosis modulators|mesh-ancestor
65698995|NCT01802749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65698996|NCT01802749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65698997|NCT01802749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65698998|NCT01802749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65698999|NCT01802749|Growth Substances|growth substances|mesh-ancestor
65699000|NCT01802749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699001|NCT01802749|Growth Inhibitors|growth inhibitors|mesh-ancestor
65699002|NCT01802749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65699003|NCT01802749|Antimetabolites|antimetabolites|mesh-ancestor
65699004|NCT01802749|Antiviral Agents|antiviral agents|mesh-ancestor
65699005|NCT01802749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65699006|NCT01802749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699007|NCT01802749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65699008|NCT01802749|Immunologic Factors|immunologic factors|mesh-ancestor
65699009|NCT01802749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65699010|NCT01802749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65493829|NCT04233866|Levoleucovorin|levoleucovorin|mesh-list
65699011|NCT01802749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65699012|NCT01801904|Panitumumab|panitumumab|mesh-list
65699013|NCT01801904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65699014|NCT01801904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699015|NCT01779206|Paclitaxel|paclitaxel|mesh-list
65699016|NCT01779206|Docetaxel|docetaxel|mesh-list
65699017|NCT01779206|Cyclophosphamide|cyclophosphamide|mesh-list
65699018|NCT01779206|Epirubicin|epirubicin|mesh-list
65699019|NCT01779206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65699020|NCT01779206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699021|NCT01779206|Tubulin Modulators|tubulin modulators|mesh-ancestor
65699022|NCT01779206|Antimitotic Agents|antimitotic agents|mesh-ancestor
65699023|NCT01779206|Mitosis Modulators|mitosis modulators|mesh-ancestor
65699024|NCT01779206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699025|NCT01779206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65699026|NCT01779206|Immunologic Factors|immunologic factors|mesh-ancestor
65699027|NCT01779206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699028|NCT01779206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65699029|NCT01779206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65699030|NCT01779206|Alkylating Agents|alkylating agents|mesh-ancestor
65699031|NCT01779206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65699032|NCT01779206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65699033|NCT01779206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65699034|NCT01779206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65699035|NCT01779206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699036|NCT01745965|Trastuzumab|trastuzumab|mesh-list
65699037|NCT01745965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65699038|NCT01745965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699039|NCT01706120|Paclitaxel|paclitaxel|mesh-list
65699040|NCT01706120|Bevacizumab|bevacizumab|mesh-list
65699041|NCT01706120|Carboplatin|carboplatin|mesh-list
65699042|NCT01706120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65699043|NCT01706120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699044|NCT01706120|Tubulin Modulators|tubulin modulators|mesh-ancestor
65699045|NCT01706120|Antimitotic Agents|antimitotic agents|mesh-ancestor
65699046|NCT01706120|Mitosis Modulators|mitosis modulators|mesh-ancestor
65699047|NCT01706120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699048|NCT01706120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65699049|NCT01706120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65699050|NCT01706120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65699051|NCT01706120|Growth Substances|growth substances|mesh-ancestor
65699052|NCT01706120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699053|NCT01706120|Growth Inhibitors|growth inhibitors|mesh-ancestor
65699054|NCT01682941|Phytoestrogens|phytoestrogens|mesh-list
65699055|NCT01682941|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65699056|NCT01682941|Estrogens|estrogens|mesh-ancestor
65699057|NCT01682941|Hormones|hormones|mesh-ancestor
65699058|NCT01682941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65699059|NCT01682941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699060|NCT01656551|Gemcitabine|gemcitabine|mesh-list
65699061|NCT01656551|Pemetrexed|pemetrexed|mesh-list
65699062|NCT01656551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699063|NCT01656551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65699064|NCT01656551|Antimetabolites|antimetabolites|mesh-ancestor
65699065|NCT01656551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699066|NCT01656551|Antiviral Agents|antiviral agents|mesh-ancestor
65699067|NCT01656551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65699068|NCT01656551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699069|NCT01656551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65699070|NCT01656551|Immunologic Factors|immunologic factors|mesh-ancestor
65699071|NCT01656551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699072|NCT01656551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65699073|NCT01656551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65699074|NCT01649674|Picosulfate sodium|picosulfate sodium|mesh-list
65699075|NCT01649674|Magnesium citrate|magnesium citrate|mesh-list
65699076|NCT01649674|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65699077|NCT01649674|Cathartics|cathartics|mesh-ancestor
65699078|NCT01649674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65699079|NCT01628211|Leucovorin|leucovorin|mesh-list
65699080|NCT01628211|Folic Acid|folic acid|mesh-list
65699081|NCT01628211|Fluorouracil|fluorouracil|mesh-list
65699082|NCT01628211|Oxaliplatin|oxaliplatin|mesh-list
65699083|NCT01628211|Levoleucovorin|levoleucovorin|mesh-list
65699084|NCT01628211|Antimetabolites|antimetabolites|mesh-ancestor
65699085|NCT01628211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699086|NCT01628211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65699087|NCT01628211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699088|NCT01628211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65015159|NCT00165633|Vitamin K 2|vitamin k 2|mesh-list
65699089|NCT01628211|Immunologic Factors|immunologic factors|mesh-ancestor
65699090|NCT01628211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699091|NCT01628211|Antidotes|antidotes|mesh-ancestor
65699092|NCT01628211|Protective Agents|protective agents|mesh-ancestor
65699093|NCT01628211|Vitamin B Complex|vitamin b complex|mesh-ancestor
65699095|NCT01628211|Micronutrients|micronutrients|mesh-ancestor
65699096|NCT01628211|Hematinics|hematinics|mesh-ancestor
65699097|NCT01593488|Cytarabine|cytarabine|mesh-list
65699098|NCT01593488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65699099|NCT01593488|Antimetabolites|antimetabolites|mesh-ancestor
65699100|NCT01593488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699101|NCT01593488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699102|NCT01593488|Antiviral Agents|antiviral agents|mesh-ancestor
65699103|NCT01593488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65699104|NCT01593488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65699105|NCT01593488|Immunologic Factors|immunologic factors|mesh-ancestor
65699106|NCT01593488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699107|NCT01405586|Gemcitabine|gemcitabine|mesh-list
65699108|NCT01405586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699109|NCT01405586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65699110|NCT01405586|Antimetabolites|antimetabolites|mesh-ancestor
65699111|NCT01405586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699112|NCT01405586|Antiviral Agents|antiviral agents|mesh-ancestor
65699113|NCT01405586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65699114|NCT01405586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699115|NCT01405586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65699116|NCT01405586|Immunologic Factors|immunologic factors|mesh-ancestor
65699117|NCT01405586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699118|NCT01309230|Vaccines|vaccines|mesh-list
65699119|NCT01309230|Immunologic Factors|immunologic factors|mesh-ancestor
65699120|NCT01309230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699121|NCT01238692|Rituximab|rituximab|mesh-list
65699122|NCT01238692|Panobinostat|panobinostat|mesh-list
65699123|NCT01238692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65699124|NCT01238692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699125|NCT01238692|Immunologic Factors|immunologic factors|mesh-ancestor
65699126|NCT01238692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699127|NCT01238692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65699128|NCT01238692|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65699129|NCT01238692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699130|NCT01238692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699131|NCT01209871|Immunoglobulins|immunoglobulins|mesh-list
65699132|NCT01209871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65699133|NCT01209871|Antibodies|antibodies|mesh-list
65699134|NCT01209871|Immunologic Factors|immunologic factors|mesh-ancestor
65699135|NCT01209871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699136|NCT01042379|Metformin|metformin|mesh-list
65699137|NCT01042379|Paclitaxel|paclitaxel|mesh-list
65699138|NCT01042379|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65699139|NCT01042379|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65699140|NCT01042379|Carboplatin|carboplatin|mesh-list
65699141|NCT01042379|Doxorubicin|doxorubicin|mesh-list
65699142|NCT01042379|Pembrolizumab|pembrolizumab|mesh-list
65699143|NCT01042379|Trastuzumab|trastuzumab|mesh-list
65699144|NCT01042379|Irinotecan|irinotecan|mesh-list
65699145|NCT01042379|Durvalumab|durvalumab|mesh-list
65699146|NCT01042379|Letrozole|letrozole|mesh-list
65699147|NCT01042379|Olaparib|olaparib|mesh-list
65699148|NCT01042379|Pertuzumab|pertuzumab|mesh-list
65699149|NCT01042379|Veliparib|veliparib|mesh-list
65699150|NCT01042379|Cemiplimab|cemiplimab|mesh-list
65699151|NCT01042379|Talazoparib|talazoparib|mesh-list
65699152|NCT01042379|Trebananib|trebananib|mesh-list
65699153|NCT01042379|Tucatinib|tucatinib|mesh-list
65699154|NCT01042379|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65699155|NCT01042379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65699156|NCT01042379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699157|NCT01042379|Tubulin Modulators|tubulin modulators|mesh-ancestor
65699158|NCT01042379|Antimitotic Agents|antimitotic agents|mesh-ancestor
65699159|NCT01042379|Mitosis Modulators|mitosis modulators|mesh-ancestor
65699160|NCT01042379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699161|NCT01042379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65699162|NCT01042379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699163|NCT01042379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65699164|NCT01042379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65699165|NCT01042379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65015243|NCT00511576|Docetaxel|docetaxel|mesh-list
65699166|NCT01042379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699167|NCT01042379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65699168|NCT01042379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65699169|NCT01042379|Immunologic Factors|immunologic factors|mesh-ancestor
65699170|NCT01042379|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65699171|NCT01042379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65699172|NCT01042379|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65699173|NCT01042379|Hormone Antagonists|hormone antagonists|mesh-ancestor
65699174|NCT01042379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65699175|NCT01042379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65699176|NCT01042379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65699177|NCT01042379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65699178|NCT01042379|Growth Substances|growth substances|mesh-ancestor
65699179|NCT01042379|Growth Inhibitors|growth inhibitors|mesh-ancestor
65699180|NCT01042379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65699181|NCT00996983|Ziconotide|ziconotide|mesh-list
65699182|NCT00996983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65699183|NCT00996983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65699184|NCT00996983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699185|NCT00996983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65699186|NCT00996983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699187|NCT00996983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65699188|NCT00996983|Protective Agents|protective agents|mesh-ancestor
65699189|NCT00996983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65699190|NCT00996983|Analgesics|analgesics|mesh-ancestor
65699191|NCT00996983|Sensory System Agents|sensory system agents|mesh-ancestor
65699192|NCT00996983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65699193|NCT00660842|Paclitaxel|paclitaxel|mesh-list
65699194|NCT00660842|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65699195|NCT00660842|Carboplatin|carboplatin|mesh-list
65699196|NCT00660842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65699197|NCT00660842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699198|NCT00660842|Tubulin Modulators|tubulin modulators|mesh-ancestor
65699199|NCT00660842|Antimitotic Agents|antimitotic agents|mesh-ancestor
65699200|NCT00660842|Mitosis Modulators|mitosis modulators|mesh-ancestor
65699201|NCT00660842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699202|NCT00657878|Gemcitabine|gemcitabine|mesh-list
65699203|NCT00657878|Paclitaxel|paclitaxel|mesh-list
65699204|NCT00657878|Carboplatin|carboplatin|mesh-list
65699205|NCT00657878|Doxorubicin|doxorubicin|mesh-list
65699206|NCT00657878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65699207|NCT00657878|Topotecan|topotecan|mesh-list
65699208|NCT00657878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65699209|NCT00657878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699210|NCT00657878|Tubulin Modulators|tubulin modulators|mesh-ancestor
65699211|NCT00657878|Antimitotic Agents|antimitotic agents|mesh-ancestor
65699212|NCT00657878|Mitosis Modulators|mitosis modulators|mesh-ancestor
65699213|NCT00657878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699214|NCT00657878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65699215|NCT00657878|Antimetabolites|antimetabolites|mesh-ancestor
65699216|NCT00657878|Antiviral Agents|antiviral agents|mesh-ancestor
65699217|NCT00657878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65699218|NCT00657878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699219|NCT00657878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65699220|NCT00657878|Immunologic Factors|immunologic factors|mesh-ancestor
65699221|NCT00657878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699222|NCT00657878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65699223|NCT00657878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65699224|NCT00657878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65699225|NCT00657878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65699226|NCT00642057|Tetrabenazine|tetrabenazine|mesh-list
65699227|NCT00642057|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65699228|NCT00642057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65699229|NCT00642057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65699230|NCT00642057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699231|NCT00642057|Adrenergic Agents|adrenergic agents|mesh-ancestor
65699232|NCT00642057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65699233|NCT00642057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699234|NCT00526396|Cisplatin|cisplatin|mesh-list
65699235|NCT00526396|Etoposide|etoposide|mesh-list
65699236|NCT00526396|Etoposide phosphate|etoposide phosphate|mesh-list
65699237|NCT00526396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699238|NCT00526396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65699239|NCT00526396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65699240|NCT00526396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65699241|NCT00526396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699242|NCT00526396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015305|NCT00512980|Prednisone|prednisone|mesh-list
65699244|NCT00431704|Trastuzumab|trastuzumab|mesh-list
65699245|NCT00431704|Vinorelbine|vinorelbine|mesh-list
65699246|NCT00431704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699247|NCT00431704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65699248|NCT00431704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65699249|NCT00431704|Tubulin Modulators|tubulin modulators|mesh-ancestor
65699250|NCT00431704|Antimitotic Agents|antimitotic agents|mesh-ancestor
65699251|NCT00431704|Mitosis Modulators|mitosis modulators|mesh-ancestor
65699252|NCT00431704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699253|NCT00412022|Tamoxifen|tamoxifen|mesh-list
65699254|NCT00412022|Zoledronic Acid|zoledronic acid|mesh-list
65699255|NCT00412022|Letrozole|letrozole|mesh-list
65699256|NCT00412022|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65699257|NCT00412022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699258|NCT00412022|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65699259|NCT00412022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65699260|NCT00412022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699261|NCT00412022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699262|NCT00412022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65699263|NCT00412022|Hormone Antagonists|hormone antagonists|mesh-ancestor
65699264|NCT00412022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65699265|NCT00412022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699266|NCT00412022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65699267|NCT00412022|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65699268|NCT00412022|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65699269|NCT00412022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65699270|NCT00412022|Luteolytic Agents|luteolytic agents|mesh-ancestor
65699271|NCT00412022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65699272|NCT00412022|Contraceptive Agents|contraceptive agents|mesh-ancestor
65699273|NCT00412022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65699274|NCT00412022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65699275|NCT03474510|Bupivacaine|bupivacaine|mesh-list
65699276|NCT03474510|Ropivacaine|ropivacaine|mesh-list
65699277|NCT03474510|Anesthetics, Local|anesthetics, local|mesh-ancestor
65699278|NCT03474510|Anesthetics|anesthetics|mesh-ancestor
65699279|NCT03474510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65699280|NCT03474510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699281|NCT03474510|Sensory System Agents|sensory system agents|mesh-ancestor
65699282|NCT03474510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65699283|NCT02470832|Itraconazole|itraconazole|mesh-list
65699284|NCT02470832|Antifungal Agents|antifungal agents|mesh-ancestor
65699285|NCT02470832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65699286|NCT02470832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65699287|NCT02470832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65699288|NCT02470832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699289|NCT02470832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699290|NCT02470832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65699291|NCT02470832|Hormone Antagonists|hormone antagonists|mesh-ancestor
65699292|NCT02470832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65699293|NCT02470832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699294|NCT02470832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65699295|NCT05258682|Acetylcysteine|acetylcysteine|mesh-list
65699296|NCT05258682|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65699297|NCT05258682|Antiviral Agents|antiviral agents|mesh-ancestor
65699298|NCT05258682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65699299|NCT05258682|Expectorants|expectorants|mesh-ancestor
65699300|NCT05258682|Respiratory System Agents|respiratory system agents|mesh-ancestor
65699301|NCT05258682|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65699302|NCT05258682|Antioxidants|antioxidants|mesh-ancestor
65699303|NCT05258682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699304|NCT05258682|Protective Agents|protective agents|mesh-ancestor
65699305|NCT05258682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699306|NCT05258682|Antidotes|antidotes|mesh-ancestor
65699307|NCT02228031|Oxytocin|oxytocin|mesh-list
65699308|NCT02228031|Oxytocics|oxytocics|mesh-ancestor
65699309|NCT02228031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65699310|NCT02228031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699311|NCT04458948|Azithromycin|azithromycin|mesh-list
65699312|NCT04458948|Hydroxychloroquine|hydroxychloroquine|mesh-list
65699313|NCT04458948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65699314|NCT04458948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65699315|NCT04458948|Antimalarials|antimalarials|mesh-ancestor
65699316|NCT04458948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65699318|NCT04458948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699319|NCT04458948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699320|NCT04458948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65699321|NCT02232399|Simendan|simendan|mesh-list
65699322|NCT02232399|Milrinone|milrinone|mesh-list
65699323|NCT02232399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65699324|NCT02232399|Vasodilator Agents|vasodilator agents|mesh-ancestor
65699325|NCT02232399|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65699326|NCT02232399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65699327|NCT02232399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699328|NCT02232399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699329|NCT02232399|Protective Agents|protective agents|mesh-ancestor
65699330|NCT02232399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699331|NCT02232399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65699332|NCT00704522|Ribavirin|ribavirin|mesh-list
65699333|NCT00704522|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65699334|NCT00704522|Antimetabolites|antimetabolites|mesh-ancestor
65699335|NCT00704522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699336|NCT00704522|Antiviral Agents|antiviral agents|mesh-ancestor
65699337|NCT00704522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65699338|NCT04458558|Mifepristone|mifepristone|mesh-list
65699339|NCT04458558|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65699340|NCT04458558|Abortifacient Agents|abortifacient agents|mesh-ancestor
65699341|NCT04458558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65699342|NCT04458558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699343|NCT04458558|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65699344|NCT04458558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65699345|NCT04458558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65699346|NCT04458558|Contraceptive Agents|contraceptive agents|mesh-ancestor
65699347|NCT04458558|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65699348|NCT04458558|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65699349|NCT04458558|Hormone Antagonists|hormone antagonists|mesh-ancestor
65699350|NCT04458558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65699351|NCT04458558|Luteolytic Agents|luteolytic agents|mesh-ancestor
65699352|NCT04458558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65699353|NCT04458558|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65699354|NCT03478332|Nitroglycerin|nitroglycerin|mesh-list
65699355|NCT03478332|Vasodilator Agents|vasodilator agents|mesh-ancestor
65699356|NCT03930498|Antibodies|antibodies|mesh-list
65699357|NCT03930498|Antibodies, Blocking|antibodies, blocking|mesh-list
65699358|NCT03930498|Immunologic Factors|immunologic factors|mesh-ancestor
65699359|NCT03930498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699360|NCT03817554|Dopamine|dopamine|mesh-list
65699361|NCT03817554|Pramipexole|pramipexole|mesh-list
65699362|NCT03817554|Dopamine Agonists|dopamine agonists|mesh-list
65699363|NCT03817554|Antioxidants|antioxidants|mesh-ancestor
65699364|NCT03817554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699365|NCT03817554|Protective Agents|protective agents|mesh-ancestor
65699366|NCT03817554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699367|NCT03817554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65699368|NCT03817554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65699369|NCT03817554|Dopamine Agents|dopamine agents|mesh-ancestor
65699370|NCT03817554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65699371|NCT03817554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65699372|NCT03817554|Sympathomimetics|sympathomimetics|mesh-ancestor
65699373|NCT03817554|Autonomic Agents|autonomic agents|mesh-ancestor
65699374|NCT03817554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65699375|NCT02223819|Crizotinib|crizotinib|mesh-list
65699376|NCT02223819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699377|NCT02223819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65699378|NCT02223819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699379|NCT02223819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699380|NCT03474198|Levofloxacin|levofloxacin|mesh-list
65699381|NCT03474198|Rifampin|rifampin|mesh-list
65699382|NCT03474198|Isoniazid|isoniazid|mesh-list
65699383|NCT03474198|Linezolid|linezolid|mesh-list
65699384|NCT03474198|Pyrazinamide|pyrazinamide|mesh-list
65699385|NCT03474198|Ethambutol|ethambutol|mesh-list
65699386|NCT03474198|Rifapentine|rifapentine|mesh-list
65699387|NCT03474198|Bedaquiline|bedaquiline|mesh-list
65699388|NCT03474198|Clofazimine|clofazimine|mesh-list
65699389|NCT03474198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65015449|NCT00151047|Mitosis Modulators|mitosis modulators|mesh-ancestor
65699390|NCT03474198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65699391|NCT03474198|Renal Agents|renal agents|mesh-ancestor
65699392|NCT03474198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65699393|NCT03474198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65699394|NCT03474198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65699395|NCT03474198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699396|NCT03474198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699397|NCT03474198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699398|NCT03474198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65699399|NCT03474198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65699400|NCT03474198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65699401|NCT03474198|Antitubercular Agents|antitubercular agents|mesh-ancestor
65699402|NCT03474198|Leprostatic Agents|leprostatic agents|mesh-ancestor
65699403|NCT03474198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65699404|NCT03474198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65699405|NCT03474198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65699406|NCT03474198|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65699407|NCT03474198|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65699408|NCT03474198|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65699409|NCT03474198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65699410|NCT03474198|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65699411|NCT03474198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65699412|NCT03474198|Antimetabolites|antimetabolites|mesh-ancestor
65699413|NCT03474198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65699414|NCT03474198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65699415|NCT03474198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65699416|NCT02723630|Lenvatinib|lenvatinib|mesh-list
65699417|NCT02723630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699418|NCT02723630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65699419|NCT02723630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699420|NCT02723630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699421|NCT02866227|TOL-463|tol-463|mesh-list
65699422|NCT02866227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65699423|NCT05258136|Antibodies|antibodies|mesh-list
65699424|NCT05258136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65699425|NCT05258136|Immunologic Factors|immunologic factors|mesh-ancestor
65699426|NCT05258136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699427|NCT04356326|Aspirin|aspirin|mesh-list
65699428|NCT04356326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65699429|NCT04356326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65699430|NCT04356326|Analgesics|analgesics|mesh-ancestor
65699431|NCT04356326|Sensory System Agents|sensory system agents|mesh-ancestor
65699432|NCT04356326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65699433|NCT04356326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699434|NCT04356326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65699435|NCT04356326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65699436|NCT04356326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65699437|NCT04356326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65699438|NCT04356326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699439|NCT04356326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65699440|NCT04356326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65699441|NCT04356326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699442|NCT04356326|Antipyretics|antipyretics|mesh-ancestor
65699443|NCT02224131|Aspirin|aspirin|mesh-list
65699444|NCT02224131|Clopidogrel|clopidogrel|mesh-list
65699445|NCT02224131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65699446|NCT02224131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65699447|NCT02224131|Analgesics|analgesics|mesh-ancestor
65699448|NCT02224131|Sensory System Agents|sensory system agents|mesh-ancestor
65699449|NCT02224131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65699450|NCT02224131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699451|NCT02224131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65699452|NCT02224131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65699453|NCT02224131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65699454|NCT02224131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65699455|NCT02224131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699456|NCT02224131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65699457|NCT02224131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65699458|NCT02224131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699459|NCT02224131|Antipyretics|antipyretics|mesh-ancestor
65699460|NCT02224131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65699461|NCT02224131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65699462|NCT02224131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65699463|NCT02224131|Purinergic Agents|purinergic agents|mesh-ancestor
65699464|NCT02224131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65699465|NCT02068586|Sunitinib|sunitinib|mesh-list
65699466|NCT02068586|Valproic Acid|valproic acid|mesh-list
65699467|NCT02068586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699468|NCT02068586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65699469|NCT02068586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65699470|NCT02068586|Growth Substances|growth substances|mesh-ancestor
65699471|NCT02068586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699472|NCT02068586|Growth Inhibitors|growth inhibitors|mesh-ancestor
65699473|NCT02068586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65699474|NCT02068586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699475|NCT02068586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699476|NCT02068586|Anticonvulsants|anticonvulsants|mesh-ancestor
65699477|NCT02068586|GABA Agents|gaba agents|mesh-ancestor
65699478|NCT02068586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65699479|NCT02068586|Antimanic Agents|antimanic agents|mesh-ancestor
65699480|NCT02068586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65699481|NCT02068586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65699482|NCT02068586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65699483|NCT04634799|Plasminogen|plasminogen|mesh-list
65699484|NCT04634799|Plasminogen Inactivators|plasminogen inactivators|mesh-list
65699485|NCT04634799|Plasminogen Activator Inhibitor 1|plasminogen activator inhibitor 1|mesh-list
65699486|NCT04634799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65699487|NCT04634799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65699488|NCT04634799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699489|NCT04634799|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65699490|NCT04634799|Protease Inhibitors|protease inhibitors|mesh-ancestor
65699491|NCT04634799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699492|NCT03473964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65699493|NCT03473964|Hormones|hormones|mesh-ancestor
65699494|NCT03473964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65699495|NCT03473964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699496|NCT03309644|Iodine|iodine|mesh-list
65699497|NCT03309644|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65699498|NCT03309644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65699499|NCT03309644|Trace Elements|trace elements|mesh-ancestor
65699500|NCT03309644|Micronutrients|micronutrients|mesh-ancestor
65699501|NCT03309644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699502|NCT03478020|Contraceptive Agents|contraceptive agents|mesh-list
65699503|NCT03478020|Contraceptives, Oral|contraceptives, oral|mesh-list
65699504|NCT03478020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65699505|NCT03478020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65699506|NCT03478020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699507|NCT03478020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65699508|NCT02008292|Physostigmine|physostigmine|mesh-list
65699509|NCT02008292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65699510|NCT02008292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699511|NCT02008292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699512|NCT02008292|Cholinergic Agents|cholinergic agents|mesh-ancestor
65699513|NCT02008292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65699514|NCT02008292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699515|NCT02008292|Miotics|miotics|mesh-ancestor
65699516|NCT02008292|Autonomic Agents|autonomic agents|mesh-ancestor
65699517|NCT02008292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65699518|NCT03477864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65699519|NCT03477864|Ipilimumab|ipilimumab|mesh-list
65699520|NCT03477864|Cemiplimab|cemiplimab|mesh-list
65699521|NCT03477864|Antibodies|antibodies|mesh-list
65699522|NCT03477864|Immunoglobulins|immunoglobulins|mesh-list
65699523|NCT03477864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65699524|NCT03477864|Immunologic Factors|immunologic factors|mesh-ancestor
65699525|NCT03477864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699526|NCT03477864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699527|NCT03477864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65699528|NCT03477864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699529|NCT02229045|Paclitaxel|paclitaxel|mesh-list
65699530|NCT02229045|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65699531|NCT02229045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65699532|NCT02229045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699533|NCT02229045|Tubulin Modulators|tubulin modulators|mesh-ancestor
65699534|NCT02229045|Antimitotic Agents|antimitotic agents|mesh-ancestor
65699535|NCT02229045|Mitosis Modulators|mitosis modulators|mesh-ancestor
65699536|NCT02229045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699537|NCT02229123|Levetiracetam|levetiracetam|mesh-list
65699538|NCT02229123|Anticonvulsants|anticonvulsants|mesh-ancestor
65015596|NCT00151203|Glucocorticoids|glucocorticoids|mesh-ancestor
65699539|NCT02229123|Nootropic Agents|nootropic agents|mesh-ancestor
65699540|NCT02229201|Propofol|propofol|mesh-list
65699541|NCT02229201|Sevoflurane|sevoflurane|mesh-list
65699542|NCT02229201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65699543|NCT02229201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65699544|NCT02229201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699545|NCT02229201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65699546|NCT02229201|Anesthetics, General|anesthetics, general|mesh-ancestor
65699547|NCT02229201|Anesthetics|anesthetics|mesh-ancestor
65699548|NCT02229201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65699549|NCT02229201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65699550|NCT02224443|Fentanyl|fentanyl|mesh-list
65699551|NCT02224443|Midazolam|midazolam|mesh-list
65699552|NCT02224443|Dexmedetomidine|dexmedetomidine|mesh-list
65699553|NCT02224443|Remifentanil|remifentanil|mesh-list
65699554|NCT02224443|Propofol|propofol|mesh-list
65699555|NCT02224443|Etomidate|etomidate|mesh-list
65699556|NCT02224443|Sevoflurane|sevoflurane|mesh-list
65699557|NCT02224443|Atracurium|atracurium|mesh-list
65699558|NCT02224443|Cisatracurium|cisatracurium|mesh-list
65699559|NCT02224443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65699560|NCT02224443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65699561|NCT02224443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699562|NCT02224443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65699563|NCT02224443|Anesthetics, General|anesthetics, general|mesh-ancestor
65699564|NCT02224443|Anesthetics|anesthetics|mesh-ancestor
65699565|NCT02224443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65699566|NCT02224443|Analgesics|analgesics|mesh-ancestor
65699567|NCT02224443|Sensory System Agents|sensory system agents|mesh-ancestor
65699568|NCT02224443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65699569|NCT02224443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65699570|NCT02224443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65699571|NCT02224443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65699572|NCT02224443|Adrenergic Agents|adrenergic agents|mesh-ancestor
65699573|NCT02224443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65699574|NCT02224443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699575|NCT02224443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65699576|NCT02224443|Narcotics|narcotics|mesh-ancestor
65699577|NCT02224443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65699578|NCT02224443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65699579|NCT02224443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65699580|NCT02224443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65699581|NCT02224443|GABA Modulators|gaba modulators|mesh-ancestor
65699582|NCT02224443|GABA Agents|gaba agents|mesh-ancestor
65699583|NCT02224443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65699584|NCT02224443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65699585|NCT02224443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65699586|NCT02224443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65699587|NCT02224443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65699588|NCT02224443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65699589|NCT02224443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65699590|NCT02224443|Cholinergic Agents|cholinergic agents|mesh-ancestor
65699591|NCT05183126|Paclitaxel|paclitaxel|mesh-list
65699592|NCT05183126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65699593|NCT05183126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65699594|NCT05183126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699595|NCT05183126|Tubulin Modulators|tubulin modulators|mesh-ancestor
65699596|NCT05183126|Antimitotic Agents|antimitotic agents|mesh-ancestor
65699597|NCT05183126|Mitosis Modulators|mitosis modulators|mesh-ancestor
65699598|NCT05183126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699599|NCT01944800|Ticagrelor|ticagrelor|mesh-list
65699600|NCT01944800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65699601|NCT01944800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65699602|NCT01944800|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65699603|NCT01944800|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65699604|NCT01944800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65699605|NCT01944800|Purinergic Agents|purinergic agents|mesh-ancestor
65699606|NCT01944800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65699607|NCT01944800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699608|NCT01944800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699609|NCT03617367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65699610|NCT03617367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65699611|NCT03617367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65699612|NCT03617367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65699613|NCT03617367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699614|NCT03617367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65699615|NCT03617367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65699616|NCT03617367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699617|NCT03617367|Cholinergic Agents|cholinergic agents|mesh-ancestor
65699618|NCT03617367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65699619|NCT02470676|Progesterone|progesterone|mesh-list
65699620|NCT02470676|Progestins|progestins|mesh-ancestor
65699621|NCT02470676|Hormones|hormones|mesh-ancestor
65699622|NCT02470676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65699623|NCT02470676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699624|NCT01933724|Prednisone|prednisone|mesh-list
65699625|NCT01933724|Glucocorticoids|glucocorticoids|mesh-list
65699626|NCT01933724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65699627|NCT01933724|Hormones|hormones|mesh-ancestor
65699628|NCT01933724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65699629|NCT01933724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699630|NCT01933724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65699631|NCT01933724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699632|NCT02229747|Diclofenac|diclofenac|mesh-list
65699633|NCT02229747|Meloxicam|meloxicam|mesh-list
65699634|NCT02229747|Nimesulide|nimesulide|mesh-list
65699635|NCT02229747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65699636|NCT02229747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65699637|NCT02229747|Analgesics|analgesics|mesh-ancestor
65699638|NCT02229747|Sensory System Agents|sensory system agents|mesh-ancestor
65699639|NCT02229747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65699640|NCT02229747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699641|NCT02229747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65699642|NCT02229747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65699643|NCT02229747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65699644|NCT02229747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699645|NCT02229747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699646|NCT02229747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65699647|NCT02232789|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65699648|NCT02232789|Hallucinogens|hallucinogens|mesh-ancestor
65699649|NCT02232789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699650|NCT02232789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65699651|NCT02232789|Serotonin Agents|serotonin agents|mesh-ancestor
65699652|NCT02232789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65699653|NCT02232789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699654|NCT02232789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65699655|NCT02232789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65699656|NCT02232789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65699657|NCT02232789|Adrenergic Agents|adrenergic agents|mesh-ancestor
65699658|NCT03030222|Empagliflozin|empagliflozin|mesh-list
65699659|NCT03030222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65699660|NCT03030222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699661|NCT03030222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65699662|NCT03030222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699663|NCT02232945|Oseltamivir|oseltamivir|mesh-list
65699664|NCT02232945|Antiviral Agents|antiviral agents|mesh-ancestor
65699665|NCT02232945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65699666|NCT02232945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699667|NCT02232945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699668|NCT02546622|Factor VIII|factor viii|mesh-list
65699669|NCT02546622|Coagulants|coagulants|mesh-ancestor
65699670|NCT02229825|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65699671|NCT02229825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65699672|NCT02229825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65699673|NCT02229825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65699674|NCT02229825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699675|NCT02229825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65699676|NCT02229825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699677|NCT02229825|Analgesics|analgesics|mesh-ancestor
65699678|NCT02229825|Sensory System Agents|sensory system agents|mesh-ancestor
65699679|NCT02229825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65699680|NCT02229825|Antidepressive Agents|antidepressive agents|mesh-ancestor
65699681|NCT02229825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65699682|NCT02229825|Dopamine Agents|dopamine agents|mesh-ancestor
65699683|NCT03309566|Tenofovir|tenofovir|mesh-list
65699684|NCT03309566|Emtricitabine|emtricitabine|mesh-list
65699685|NCT03309566|Efavirenz|efavirenz|mesh-list
65699686|NCT03309566|Antiviral Agents|antiviral agents|mesh-ancestor
65699687|NCT03309566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65699688|NCT03309566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65699689|NCT03309566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65015728|NCT02950441|Niacin|niacin|mesh-list
65699690|NCT03309566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699691|NCT03309566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699692|NCT03309566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65699693|NCT03309566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65699694|NCT03309566|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65699695|NCT03309566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65699696|NCT03309566|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65699697|NCT03309566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65699698|NCT03309566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65699699|NCT03309566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65699700|NCT00735657|Iodine|iodine|mesh-list
65699701|NCT00735657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65699702|NCT00735657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65699703|NCT00735657|Trace Elements|trace elements|mesh-ancestor
65699704|NCT00735657|Micronutrients|micronutrients|mesh-ancestor
65699705|NCT00735657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699706|NCT04030143|Aripiprazole|aripiprazole|mesh-list
65699707|NCT04030143|Antidepressive Agents|antidepressive agents|mesh-ancestor
65699708|NCT04030143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65699709|NCT04030143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65699710|NCT04030143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65699711|NCT04030143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65699712|NCT04030143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699713|NCT04030143|Dopamine Agonists|dopamine agonists|mesh-ancestor
65699714|NCT04030143|Dopamine Agents|dopamine agents|mesh-ancestor
65699715|NCT04030143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65699716|NCT04030143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699717|NCT04030143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65699718|NCT04030143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65699719|NCT04030143|Serotonin Agents|serotonin agents|mesh-ancestor
65699720|NCT04030143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65699721|NCT04030143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65699722|NCT04030143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65699723|NCT04030143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65699724|NCT02470442|Sevoflurane|sevoflurane|mesh-list
65699725|NCT02470442|Desflurane|desflurane|mesh-list
65699726|NCT02470442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65699727|NCT02470442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65699728|NCT02470442|Anesthetics, General|anesthetics, general|mesh-ancestor
65699729|NCT02470442|Anesthetics|anesthetics|mesh-ancestor
65699730|NCT02470442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65699731|NCT02470442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699732|NCT01329939|Montelukast|montelukast|mesh-list
65699733|NCT01329939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65699734|NCT01329939|Respiratory System Agents|respiratory system agents|mesh-ancestor
65699735|NCT01329939|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65699736|NCT01329939|Hormone Antagonists|hormone antagonists|mesh-ancestor
65699737|NCT01329939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65699738|NCT01329939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699739|NCT01329939|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65699740|NCT01329939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65699741|NCT01329939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699742|NCT02499900|Glatiramer Acetate|glatiramer acetate|mesh-list
65699743|NCT02499900|(T,G)-A-L|(t,g)-a-l|mesh-list
65699744|NCT02499900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65699745|NCT02499900|Immunologic Factors|immunologic factors|mesh-ancestor
65699746|NCT02499900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699747|NCT02499900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65699748|NCT02499900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65699749|NCT04554693|Metronidazole|metronidazole|mesh-list
65699750|NCT04554693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65699751|NCT04554693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65699752|NCT04554693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65699753|NCT04554693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65699754|NCT02230371|Granisetron|granisetron|mesh-list
65699755|NCT02230371|Antiemetics|antiemetics|mesh-ancestor
65699756|NCT02230371|Autonomic Agents|autonomic agents|mesh-ancestor
65699757|NCT02230371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65699758|NCT02230371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699759|NCT02230371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65699760|NCT02230371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65699761|NCT02230371|Serotonin Agents|serotonin agents|mesh-ancestor
65699762|NCT02230371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65699763|NCT02230371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699764|NCT03313934|Hyaluronic Acid|hyaluronic acid|mesh-list
65699765|NCT03313934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65699766|NCT03313934|Immunologic Factors|immunologic factors|mesh-ancestor
65699767|NCT03313934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699768|NCT03313934|Viscosupplements|viscosupplements|mesh-ancestor
65699769|NCT03313934|Protective Agents|protective agents|mesh-ancestor
65699770|NCT03313856|Magnesium Oxide|magnesium oxide|mesh-list
65699771|NCT03313856|Antacids|antacids|mesh-ancestor
65699772|NCT03313856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699773|NCT03313856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65699774|NCT03798626|Leucovorin|leucovorin|mesh-list
65699775|NCT03798626|Paclitaxel|paclitaxel|mesh-list
65699776|NCT03798626|Bevacizumab|bevacizumab|mesh-list
65699777|NCT03798626|Fluorouracil|fluorouracil|mesh-list
65699778|NCT03798626|Oxaliplatin|oxaliplatin|mesh-list
65699779|NCT03798626|Irinotecan|irinotecan|mesh-list
65699780|NCT03798626|Ramucirumab|ramucirumab|mesh-list
65699781|NCT03798626|Levoleucovorin|levoleucovorin|mesh-list
65699782|NCT03798626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65699783|NCT03798626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699784|NCT03798626|Tubulin Modulators|tubulin modulators|mesh-ancestor
65699785|NCT03798626|Antimitotic Agents|antimitotic agents|mesh-ancestor
65699786|NCT03798626|Mitosis Modulators|mitosis modulators|mesh-ancestor
65699787|NCT03798626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699788|NCT03798626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65699789|NCT03798626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65699790|NCT03798626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65699791|NCT03798626|Growth Substances|growth substances|mesh-ancestor
65699792|NCT03798626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699793|NCT03798626|Growth Inhibitors|growth inhibitors|mesh-ancestor
65699794|NCT03798626|Antimetabolites|antimetabolites|mesh-ancestor
65699795|NCT03798626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65699796|NCT03798626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65699797|NCT03798626|Immunologic Factors|immunologic factors|mesh-ancestor
65699798|NCT03798626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65699799|NCT03798626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65699800|NCT03798626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699801|NCT03798626|Antidotes|antidotes|mesh-ancestor
65699802|NCT03798626|Protective Agents|protective agents|mesh-ancestor
65699803|NCT03798626|Vitamin B Complex|vitamin b complex|mesh-ancestor
65699804|NCT03798626|Vitamins|vitamins|mesh-ancestor
65699805|NCT03798626|Micronutrients|micronutrients|mesh-ancestor
65699806|NCT05137626|Digoxin|digoxin|mesh-list
65699807|NCT05137626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65699808|NCT05137626|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65699809|NCT05137626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699810|NCT05137626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699811|NCT05137626|Protective Agents|protective agents|mesh-ancestor
65699812|NCT05137626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699813|NCT03427125|Sevelamer|sevelamer|mesh-list
65699814|NCT03427125|Chelating Agents|chelating agents|mesh-ancestor
65699815|NCT03427125|Sequestering Agents|sequestering agents|mesh-ancestor
65699816|NCT03427125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699817|NCT02233023|Dopamine|dopamine|mesh-list
65699818|NCT02233023|Pramipexole|pramipexole|mesh-list
65699819|NCT02233023|Bromocriptine|bromocriptine|mesh-list
65699820|NCT02233023|Dopamine Agonists|dopamine agonists|mesh-list
65699821|NCT02233023|Antioxidants|antioxidants|mesh-ancestor
65699822|NCT02233023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699823|NCT02233023|Protective Agents|protective agents|mesh-ancestor
65699824|NCT02233023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699825|NCT02233023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65699826|NCT02233023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65699827|NCT02233023|Dopamine Agents|dopamine agents|mesh-ancestor
65699828|NCT02233023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65699829|NCT02233023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65699830|NCT02233023|Sympathomimetics|sympathomimetics|mesh-ancestor
65699831|NCT02233023|Autonomic Agents|autonomic agents|mesh-ancestor
65699832|NCT02233023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65699833|NCT02233023|Hormone Antagonists|hormone antagonists|mesh-ancestor
65699834|NCT02233023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65699835|NCT03710642|Prazosin|prazosin|mesh-list
65699836|NCT03710642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65699837|NCT03710642|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65699838|NCT03710642|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65699839|NCT03710642|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65699840|NCT03710642|Adrenergic Agents|adrenergic agents|mesh-ancestor
65699841|NCT03710642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65699842|NCT03710642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699843|NCT03710642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699844|NCT02259309|Misoprostol|misoprostol|mesh-list
65699845|NCT02259309|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65699846|NCT02259309|Abortifacient Agents|abortifacient agents|mesh-ancestor
65699847|NCT02259309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65699848|NCT02259309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699849|NCT02259309|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65699850|NCT02259309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65699851|NCT02259309|Oxytocics|oxytocics|mesh-ancestor
65699852|NCT04459026|Ropivacaine|ropivacaine|mesh-list
65699853|NCT04459026|Anesthetics, Local|anesthetics, local|mesh-ancestor
65699854|NCT04459026|Anesthetics|anesthetics|mesh-ancestor
65699855|NCT04459026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65699856|NCT04459026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699857|NCT04459026|Sensory System Agents|sensory system agents|mesh-ancestor
65699858|NCT04459026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65699859|NCT03473418|Ketoconazole|ketoconazole|mesh-list
65699860|NCT03473418|Terconazole|terconazole|mesh-list
65699861|NCT03473418|Antifungal Agents|antifungal agents|mesh-ancestor
65699862|NCT03473418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65699863|NCT03473418|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65699864|NCT03473418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65699865|NCT03473418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699866|NCT03473418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699867|NCT03473418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65699868|NCT03473418|Hormone Antagonists|hormone antagonists|mesh-ancestor
65699869|NCT03473418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65699870|NCT03473418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699871|NCT03473418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65699872|NCT04282278|Apatinib|apatinib|mesh-list
65699873|NCT04282278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699874|NCT04282278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65699875|NCT04282278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699876|NCT04282278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699877|NCT00705224|Interferons|interferons|mesh-list
65699878|NCT00705224|Ribavirin|ribavirin|mesh-list
65699879|NCT00705224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699880|NCT00705224|Antiviral Agents|antiviral agents|mesh-ancestor
65699881|NCT00705224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65699882|NCT00705224|Antimetabolites|antimetabolites|mesh-ancestor
65699883|NCT00705224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699884|NCT02457156|Octreotide|octreotide|mesh-list
65699885|NCT02457156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65699886|NCT02457156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65699887|NCT02457156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699888|NCT02523300|Methylprednisolone|methylprednisolone|mesh-list
65699889|NCT02523300|Glucocorticoids|glucocorticoids|mesh-list
65699890|NCT02523300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65699891|NCT02523300|Antiemetics|antiemetics|mesh-ancestor
65699892|NCT02523300|Autonomic Agents|autonomic agents|mesh-ancestor
65699893|NCT02523300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65699894|NCT02523300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699895|NCT02523300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65699896|NCT02523300|Hormones|hormones|mesh-ancestor
65699897|NCT02523300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65699898|NCT02523300|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65699899|NCT02523300|Protective Agents|protective agents|mesh-ancestor
65699900|NCT02325960|Insulin Glargine|insulin glargine|mesh-list
65699901|NCT02325960|Exenatide|exenatide|mesh-list
65699902|NCT02325960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65699903|NCT02325960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699904|NCT02325960|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65699905|NCT02325960|Incretins|incretins|mesh-ancestor
65699906|NCT02325960|Hormones|hormones|mesh-ancestor
65699907|NCT02325960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65699908|NCT05265650|Nivolumab|nivolumab|mesh-list
65699909|NCT05265650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65699910|NCT05265650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699911|NCT05265650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65699912|NCT05265650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699913|NCT02234349|Pancrelipase|pancrelipase|mesh-list
65699914|NCT02234349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65015955|NCT00518479|Diuretics|diuretics|mesh-ancestor
65699915|NCT04458636|Prednisolone|prednisolone|mesh-list
65699916|NCT04458636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65699917|NCT04458636|Glucocorticoids|glucocorticoids|mesh-ancestor
65699919|NCT04458636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65699920|NCT04458636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699921|NCT04458636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65699922|NCT04458636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699923|NCT03304652|Zaleplon|zaleplon|mesh-list
65699924|NCT03304652|Anticonvulsants|anticonvulsants|mesh-ancestor
65699925|NCT03304652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65699926|NCT03304652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65699927|NCT03304652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699928|NCT03304652|GABA Modulators|gaba modulators|mesh-ancestor
65699929|NCT03304652|GABA Agents|gaba agents|mesh-ancestor
65699930|NCT03304652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65699931|NCT03304652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699932|NCT03162783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65699933|NCT03162783|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65699934|NCT02523144|Dexmedetomidine|dexmedetomidine|mesh-list
65699935|NCT02523144|Chloral Hydrate|chloral hydrate|mesh-list
65699936|NCT02523144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65699937|NCT02523144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65699938|NCT02523144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699939|NCT02523144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65699940|NCT02523144|Analgesics|analgesics|mesh-ancestor
65699941|NCT02523144|Sensory System Agents|sensory system agents|mesh-ancestor
65699942|NCT02523144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65699943|NCT02523144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65699944|NCT02523144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65699945|NCT02523144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65699946|NCT02523144|Adrenergic Agents|adrenergic agents|mesh-ancestor
65699947|NCT02523144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65699948|NCT02523144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699949|NCT03856047|Liraglutide|liraglutide|mesh-list
65699950|NCT03856047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65699951|NCT03856047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699952|NCT03856047|Incretins|incretins|mesh-ancestor
65699953|NCT03856047|Hormones|hormones|mesh-ancestor
65699954|NCT03856047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65699955|NCT00704132|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65699956|NCT00704132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65699957|NCT00704132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699958|NCT00704132|Incretins|incretins|mesh-ancestor
65699959|NCT00704132|Hormones|hormones|mesh-ancestor
65699960|NCT00704132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65699961|NCT00704132|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65699962|NCT00704132|Protease Inhibitors|protease inhibitors|mesh-ancestor
65699963|NCT00704132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699964|NCT00704132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699965|NCT03304496|Nitroglycerin|nitroglycerin|mesh-list
65699966|NCT03304496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65699967|NCT03304496|Vasodilator Agents|vasodilator agents|mesh-ancestor
65699968|NCT03840837|Rivastigmine|rivastigmine|mesh-list
65699969|NCT03840837|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65699970|NCT03840837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699971|NCT03840837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699972|NCT03840837|Cholinergic Agents|cholinergic agents|mesh-ancestor
65699973|NCT03840837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65699974|NCT03840837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699975|NCT03840837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65699976|NCT03840837|Protective Agents|protective agents|mesh-ancestor
65699977|NCT03527238|Tacrolimus|tacrolimus|mesh-list
65699978|NCT03527238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65699979|NCT03527238|Immunologic Factors|immunologic factors|mesh-ancestor
65699980|NCT03527238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699981|NCT03527238|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65699982|NCT03527238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65699983|NCT03527238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65699984|NCT03832179|Dexamethasone|dexamethasone|mesh-list
65699985|NCT03832179|Bevacizumab|bevacizumab|mesh-list
65699986|NCT03832179|Ranibizumab|ranibizumab|mesh-list
65699987|NCT03832179|Aflibercept|aflibercept|mesh-list
65699988|NCT03832179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65699989|NCT03832179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65699991|NCT03832179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65699992|NCT03832179|Growth Substances|growth substances|mesh-ancestor
65699993|NCT03832179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65699994|NCT03832179|Growth Inhibitors|growth inhibitors|mesh-ancestor
65699995|NCT03832179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65699996|NCT03832179|Antiemetics|antiemetics|mesh-ancestor
65699997|NCT03832179|Autonomic Agents|autonomic agents|mesh-ancestor
65699998|NCT03832179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65699999|NCT03832179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65700000|NCT03832179|Glucocorticoids|glucocorticoids|mesh-ancestor
65700001|NCT03832179|Hormones|hormones|mesh-ancestor
65700002|NCT03832179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65700003|NCT03832179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65700004|NCT03123783|Nivolumab|nivolumab|mesh-list
65700005|NCT03123783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65700006|NCT03123783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700007|NCT03123783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65700008|NCT03123783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700009|NCT05154396|Loperamide|loperamide|mesh-list
65700010|NCT05154396|Antidiarrheals|antidiarrheals|mesh-ancestor
65700011|NCT05154396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65700012|NCT04740645|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65700013|NCT04740645|Hemostatics|hemostatics|mesh-ancestor
65700014|NCT04740645|Coagulants|coagulants|mesh-ancestor
65700015|NCT04740645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65700016|NCT04740645|Natriuretic Agents|natriuretic agents|mesh-ancestor
65700017|NCT04740645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700018|NCT04735185|Anesthetics|anesthetics|mesh-list
65700019|NCT04735185|Anesthetics, Local|anesthetics, local|mesh-list
65700020|NCT04735185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65700021|NCT04735185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700022|NCT04735185|Sensory System Agents|sensory system agents|mesh-ancestor
65700023|NCT04735185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700024|NCT02802813|Piperaquine|piperaquine|mesh-list
65700025|NCT02802813|Primaquine|primaquine|mesh-list
65700026|NCT02802813|Artenimol|artenimol|mesh-list
65700027|NCT02802813|Artemisinins|artemisinins|mesh-list
65700028|NCT02802813|Antimalarials|antimalarials|mesh-ancestor
65700029|NCT02802813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65700030|NCT02802813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65700031|NCT02802813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65700032|NCT05134584|Lactulose|lactulose|mesh-list
65700033|NCT05134584|Linaclotide|linaclotide|mesh-list
65700034|NCT05134584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65700035|NCT05134584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65700036|NCT05134584|Enzyme Activators|enzyme activators|mesh-ancestor
65700037|NCT05134584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700038|NCT05633277|Polidocanol|polidocanol|mesh-list
65700039|NCT05633277|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65700040|NCT05633277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65700041|NCT04692831|Pertuzumab|pertuzumab|mesh-list
65700042|NCT04692831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65700043|NCT04692831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700044|NCT03312140|Choline|choline|mesh-list
65700045|NCT03312140|Lipotropic Agents|lipotropic agents|mesh-ancestor
65700046|NCT03312140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65700047|NCT03312140|Antimetabolites|antimetabolites|mesh-ancestor
65700048|NCT03312140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700049|NCT03312140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65700050|NCT03312140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65700051|NCT03312140|Nootropic Agents|nootropic agents|mesh-ancestor
65700052|NCT02233179|Calpastatin|calpastatin|mesh-list
65700053|NCT02233179|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65700054|NCT02233179|Protease Inhibitors|protease inhibitors|mesh-ancestor
65700055|NCT02233179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700056|NCT02233179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700057|NCT04596657|Vitamin D|vitamin d|mesh-list
65700058|NCT04596657|Vitamins|vitamins|mesh-ancestor
65700059|NCT04596657|Micronutrients|micronutrients|mesh-ancestor
65700060|NCT04596657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700061|NCT04596657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65700062|NCT03311984|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65700063|NCT03311984|Dalteparin|dalteparin|mesh-list
65700064|NCT03311984|Anticoagulants|anticoagulants|mesh-ancestor
65700065|NCT03311984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65700066|NCT03311984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65700067|NCT03311984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700068|NCT03311906|Hyaluronic Acid|hyaluronic acid|mesh-list
65700069|NCT03311906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65700070|NCT03311906|Immunologic Factors|immunologic factors|mesh-ancestor
65700071|NCT03311906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700072|NCT03311906|Viscosupplements|viscosupplements|mesh-ancestor
65700073|NCT03311906|Protective Agents|protective agents|mesh-ancestor
65700074|NCT04554459|Ponatinib|ponatinib|mesh-list
65700075|NCT04554459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700076|NCT04554459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65700077|NCT04554459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700078|NCT04554459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700079|NCT03311750|Panitumumab|panitumumab|mesh-list
65700080|NCT03311750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65700081|NCT03311750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700082|NCT03311672|Pembrolizumab|pembrolizumab|mesh-list
65700083|NCT03311672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65700084|NCT03311672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700085|NCT03311516|Insulin|insulin|mesh-list
65700086|NCT03311516|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65700087|NCT03311516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65700088|NCT03311516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700089|NCT04528329|Dexamethasone|dexamethasone|mesh-list
65700090|NCT04528329|Dexamethasone acetate|dexamethasone acetate|mesh-list
65700091|NCT04528329|BB 1101|bb 1101|mesh-list
65700092|NCT04528329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65700093|NCT04528329|Antiemetics|antiemetics|mesh-ancestor
65700094|NCT04528329|Autonomic Agents|autonomic agents|mesh-ancestor
65700095|NCT04528329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700096|NCT04528329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700097|NCT04528329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65700098|NCT04528329|Glucocorticoids|glucocorticoids|mesh-ancestor
65700099|NCT04528329|Hormones|hormones|mesh-ancestor
65700100|NCT04528329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65700101|NCT04528329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65700102|NCT04528329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700103|NCT04528329|Protease Inhibitors|protease inhibitors|mesh-ancestor
65700104|NCT04528329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700105|NCT04528329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700106|NCT02811939|Dronabinol|dronabinol|mesh-list
65700107|NCT02811939|Hallucinogens|hallucinogens|mesh-ancestor
65700108|NCT02811939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700109|NCT02811939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65700110|NCT02811939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65700111|NCT02811939|Analgesics|analgesics|mesh-ancestor
65700112|NCT02811939|Sensory System Agents|sensory system agents|mesh-ancestor
65700113|NCT02811939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700114|NCT02811939|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65700115|NCT02811939|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65700116|NCT02811939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65700117|NCT02811939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700118|NCT02811939|Hormones|hormones|mesh-ancestor
65700119|NCT02811939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65700120|NCT01329549|Carboplatin|carboplatin|mesh-list
65700121|NCT01329549|Nintedanib|nintedanib|mesh-list
65700122|NCT01329549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700123|NCT01329549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65700124|NCT01329549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700125|NCT01329549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700126|NCT02234739|Voriconazole|voriconazole|mesh-list
65700127|NCT02234739|Antifungal Agents|antifungal agents|mesh-ancestor
65700128|NCT02234739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65700129|NCT02234739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65700130|NCT02234739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65700131|NCT02234739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700132|NCT02234739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700133|NCT02234739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65700134|NCT02234739|Hormone Antagonists|hormone antagonists|mesh-ancestor
65700135|NCT02234739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65700136|NCT02234739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700137|NCT02234739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65700138|NCT02736474|Naltrexone|naltrexone|mesh-list
65700139|NCT02736474|Bupropion|bupropion|mesh-list
65700140|NCT02736474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65700141|NCT02736474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65700142|NCT02736474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700143|NCT02736474|Sensory System Agents|sensory system agents|mesh-ancestor
65700144|NCT02736474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700145|NCT02736474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65700146|NCT02736474|Antidepressive Agents|antidepressive agents|mesh-ancestor
65700147|NCT02736474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65700148|NCT02736474|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65700149|NCT02736474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65700150|NCT02736474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65700151|NCT02736474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700152|NCT02736474|Dopamine Agents|dopamine agents|mesh-ancestor
65700153|NCT02736474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65700154|NCT02736474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65700155|NCT02736474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65700156|NCT02736474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700158|NCT03302390|Epinephrine|epinephrine|mesh-list
65700159|NCT03302390|Anesthetics, Local|anesthetics, local|mesh-ancestor
65700160|NCT03302390|Anesthetics|anesthetics|mesh-ancestor
65700161|NCT03302390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65700162|NCT03302390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700163|NCT03302390|Sensory System Agents|sensory system agents|mesh-ancestor
65700164|NCT03302390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700165|NCT03302390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65700166|NCT03302390|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65700167|NCT03302390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65700168|NCT03302390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65700169|NCT03302390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700170|NCT03302390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65700171|NCT03302390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65700172|NCT03302390|Adrenergic Agents|adrenergic agents|mesh-ancestor
65700173|NCT03302390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65700174|NCT03302390|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65700175|NCT03302390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65700176|NCT03302390|Autonomic Agents|autonomic agents|mesh-ancestor
65700177|NCT03302390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65700178|NCT03302390|Respiratory System Agents|respiratory system agents|mesh-ancestor
65700179|NCT03302390|Mydriatics|mydriatics|mesh-ancestor
65700180|NCT03302390|Sympathomimetics|sympathomimetics|mesh-ancestor
65700181|NCT03302390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65700182|NCT03712371|Chitosan|chitosan|mesh-list
65700183|NCT03712371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65700184|NCT03712371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65700185|NCT03712371|Antimetabolites|antimetabolites|mesh-ancestor
65700186|NCT03712371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700187|NCT03712371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65700188|NCT03712371|Chelating Agents|chelating agents|mesh-ancestor
65700189|NCT03712371|Sequestering Agents|sequestering agents|mesh-ancestor
65700190|NCT03712371|Hemostatics|hemostatics|mesh-ancestor
65700191|NCT03712371|Coagulants|coagulants|mesh-ancestor
65700192|NCT03472950|Ranolazine|ranolazine|mesh-list
65700193|NCT03472950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65700194|NCT03472950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65700195|NCT03472950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700196|NCT03301766|Lidocaine|lidocaine|mesh-list
65700197|NCT03301766|Anesthetics, Local|anesthetics, local|mesh-ancestor
65700198|NCT03301766|Anesthetics|anesthetics|mesh-ancestor
65700199|NCT03301766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65269110|NCT04788641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700200|NCT03301766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700201|NCT03301766|Sensory System Agents|sensory system agents|mesh-ancestor
65700202|NCT03301766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700203|NCT03301766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65700204|NCT03301766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65700205|NCT03301766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65700206|NCT03301766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65700207|NCT03301766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700208|NCT03706521|Lorecivivint|lorecivivint|mesh-list
65700209|NCT03706521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65700210|NCT02259543|Tetracycline|tetracycline|mesh-list
65700211|NCT02259543|Citric Acid|citric acid|mesh-list
65700212|NCT02259543|Sodium Citrate|sodium citrate|mesh-list
65700213|NCT02259543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65016215|NCT00520000|Paclitaxel|paclitaxel|mesh-list
65700214|NCT02259543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65700215|NCT02259543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65700217|NCT02259543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700218|NCT02259543|Anticoagulants|anticoagulants|mesh-ancestor
65700219|NCT02259543|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65700220|NCT02259543|Chelating Agents|chelating agents|mesh-ancestor
65700221|NCT02259543|Sequestering Agents|sequestering agents|mesh-ancestor
65700222|NCT03301454|Paclitaxel|paclitaxel|mesh-list
65700223|NCT03301454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65700224|NCT03301454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700225|NCT03301454|Tubulin Modulators|tubulin modulators|mesh-ancestor
65700226|NCT03301454|Antimitotic Agents|antimitotic agents|mesh-ancestor
65700227|NCT03301454|Mitosis Modulators|mitosis modulators|mesh-ancestor
65700228|NCT03301454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700229|NCT04343235|Labetalol|labetalol|mesh-list
65700230|NCT04343235|Furosemide|furosemide|mesh-list
65700231|NCT04343235|Diuretics|diuretics|mesh-ancestor
65700232|NCT04343235|Natriuretic Agents|natriuretic agents|mesh-ancestor
65700233|NCT04343235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700234|NCT04343235|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65700235|NCT04343235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65700236|NCT04343235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700237|NCT04343235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65700238|NCT04343235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65700239|NCT04343235|Adrenergic Agents|adrenergic agents|mesh-ancestor
65700240|NCT04343235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65700241|NCT04343235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65700242|NCT04343235|Sympathomimetics|sympathomimetics|mesh-ancestor
65700243|NCT04343235|Autonomic Agents|autonomic agents|mesh-ancestor
65700244|NCT04343235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700245|NCT04343235|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65700246|NCT04343235|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65700247|NCT05727410|Docetaxel|docetaxel|mesh-list
65700248|NCT05727410|Nivolumab|nivolumab|mesh-list
65700249|NCT05727410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700250|NCT05727410|Tubulin Modulators|tubulin modulators|mesh-ancestor
65700251|NCT05727410|Antimitotic Agents|antimitotic agents|mesh-ancestor
65700252|NCT05727410|Mitosis Modulators|mitosis modulators|mesh-ancestor
65700253|NCT05727410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700254|NCT05727410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65700255|NCT05727410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65700256|NCT02467010|Dexamethasone|dexamethasone|mesh-list
65700257|NCT02467010|Cyclophosphamide|cyclophosphamide|mesh-list
65700258|NCT02467010|Bortezomib|bortezomib|mesh-list
65700259|NCT02467010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65700260|NCT02467010|Immunologic Factors|immunologic factors|mesh-ancestor
65700261|NCT02467010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700262|NCT02467010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65700263|NCT02467010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65700264|NCT02467010|Alkylating Agents|alkylating agents|mesh-ancestor
65700265|NCT02467010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700266|NCT02467010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700267|NCT02467010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65700268|NCT02467010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65700269|NCT02467010|Antiemetics|antiemetics|mesh-ancestor
65700270|NCT02467010|Autonomic Agents|autonomic agents|mesh-ancestor
65700271|NCT02467010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700272|NCT02467010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65700273|NCT02467010|Glucocorticoids|glucocorticoids|mesh-ancestor
65700274|NCT02467010|Hormones|hormones|mesh-ancestor
65700275|NCT02467010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65700276|NCT02467010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65700277|NCT02232555|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65700278|NCT02232555|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65700279|NCT02232555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65700280|NCT02232555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65700281|NCT02232555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700282|NCT02232555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65700283|NCT02232555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700284|NCT02232555|Analgesics|analgesics|mesh-ancestor
65700285|NCT02232555|Sensory System Agents|sensory system agents|mesh-ancestor
65016258|NCT00520585|Atorvastatin|atorvastatin|mesh-list
65700286|NCT02232555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700287|NCT02232555|Antidepressive Agents|antidepressive agents|mesh-ancestor
65700288|NCT02232555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65700289|NCT02232555|Dopamine Agents|dopamine agents|mesh-ancestor
65700290|NCT02235519|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65700291|NCT02235519|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65700292|NCT02235519|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65700293|NCT02235519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700294|NCT00702650|Testosterone|testosterone|mesh-list
65700295|NCT00702650|Androgens|androgens|mesh-ancestor
65700297|NCT00702650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65700298|NCT00702650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700299|NCT03230916|Relebactam|relebactam|mesh-list
65700300|NCT03230916|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65700301|NCT03230916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700302|NCT03230916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700303|NCT03230916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65700304|NCT03230916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65700305|NCT04210713|Minocycline|minocycline|mesh-list
65700306|NCT04210713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65700307|NCT04210713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65700308|NCT01337115|Ropivacaine|ropivacaine|mesh-list
65700309|NCT01337115|Anesthetics, Local|anesthetics, local|mesh-list
65700310|NCT01337115|Anesthetics|anesthetics|mesh-list
65700311|NCT01337115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65700312|NCT01337115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700313|NCT01337115|Sensory System Agents|sensory system agents|mesh-ancestor
65700314|NCT01337115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700315|NCT03761784|Tretinoin|tretinoin|mesh-list
65700316|NCT03761784|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65700317|NCT03761784|Dermatologic Agents|dermatologic agents|mesh-ancestor
65700318|NCT03761784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700319|NCT03761784|Keratolytic Agents|keratolytic agents|mesh-ancestor
65700320|NCT05727098|Ketamine|ketamine|mesh-list
65700321|NCT05727098|Bupivacaine|bupivacaine|mesh-list
65700322|NCT05727098|Anesthetics, Local|anesthetics, local|mesh-list
65700323|NCT05727098|Anesthetics|anesthetics|mesh-list
65700324|NCT05727098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65700325|NCT05727098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700326|NCT05727098|Sensory System Agents|sensory system agents|mesh-ancestor
65700327|NCT05727098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700328|NCT05727098|Analgesics|analgesics|mesh-ancestor
65700329|NCT05727098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65700330|NCT05727098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65700331|NCT05727098|Anesthetics, General|anesthetics, general|mesh-ancestor
65700332|NCT05727098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65700333|NCT05727098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65700334|NCT05727098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65700335|NCT05727098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700336|NCT03300440|Vitamins|vitamins|mesh-list
65700337|NCT03300440|Biotin|biotin|mesh-list
65700338|NCT03300440|Vitamin B Complex|vitamin b complex|mesh-list
65700339|NCT03300440|Micronutrients|micronutrients|mesh-ancestor
65700340|NCT03300440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700341|NCT02236065|Lenograstim|lenograstim|mesh-list
65700342|NCT02236065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65700343|NCT02236065|Immunologic Factors|immunologic factors|mesh-ancestor
65700344|NCT02236065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700345|NCT02467556|Morphine|morphine|mesh-list
65700346|NCT02467556|Memantine|memantine|mesh-list
65700347|NCT02467556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65700348|NCT02467556|Narcotics|narcotics|mesh-ancestor
65700349|NCT02467556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65700350|NCT02467556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700351|NCT02467556|Analgesics|analgesics|mesh-ancestor
65700352|NCT02467556|Sensory System Agents|sensory system agents|mesh-ancestor
65700353|NCT02467556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700354|NCT02467556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65700355|NCT02467556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65700356|NCT02467556|Dopamine Agents|dopamine agents|mesh-ancestor
65700357|NCT02467556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65700358|NCT02467556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700359|NCT02467556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65700360|NCT02467556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65700361|NCT02262585|Telmisartan|telmisartan|mesh-list
65700362|NCT02262585|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65700363|NCT02262585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65700364|NCT02262585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65700365|NCT02262585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700366|NCT03309176|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65700367|NCT03309176|Medroxyprogesterone|medroxyprogesterone|mesh-list
65700368|NCT03309176|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65700369|NCT03309176|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65700370|NCT03309176|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65700371|NCT03309176|Contraceptive Agents|contraceptive agents|mesh-ancestor
65700372|NCT03309176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65700373|NCT03309176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700374|NCT03309176|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65700375|NCT03309176|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65700376|NCT03309176|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65700377|NCT03309176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65700378|NCT03309176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700379|NCT02602353|Loxoprofen|loxoprofen|mesh-list
65700380|NCT02602353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65700381|NCT02602353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65700382|NCT02602353|Analgesics|analgesics|mesh-ancestor
65700383|NCT02602353|Sensory System Agents|sensory system agents|mesh-ancestor
65700384|NCT02602353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700385|NCT02602353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700386|NCT02602353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65700387|NCT02602353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65700388|NCT04983498|Ondansetron|ondansetron|mesh-list
65700389|NCT04983498|Antiemetics|antiemetics|mesh-ancestor
65700390|NCT04983498|Autonomic Agents|autonomic agents|mesh-ancestor
65700391|NCT04983498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700392|NCT04983498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700393|NCT04983498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65700394|NCT04983498|Antipruritics|antipruritics|mesh-ancestor
65700395|NCT04983498|Dermatologic Agents|dermatologic agents|mesh-ancestor
65700396|NCT04983498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65700397|NCT04983498|Serotonin Agents|serotonin agents|mesh-ancestor
65700398|NCT04983498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65700399|NCT04983498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700400|NCT04983498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65700401|NCT04983498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65700402|NCT04983498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65700403|NCT04983498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65700404|NCT04983498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65700405|NCT03300362|Vaccines|vaccines|mesh-list
65700406|NCT03300362|Immunologic Factors|immunologic factors|mesh-ancestor
65700407|NCT03300362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700408|NCT02467400|Propranolol|propranolol|mesh-list
65700409|NCT02467400|Atenolol|atenolol|mesh-list
65700410|NCT02467400|Nebivolol|nebivolol|mesh-list
65700411|NCT02467400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65700412|NCT02467400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65700413|NCT02467400|Adrenergic Agents|adrenergic agents|mesh-ancestor
65700414|NCT02467400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65269116|NCT04331288|Ethanol|ethanol|mesh-list
65700415|NCT02467400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700416|NCT02467400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700417|NCT02467400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65700418|NCT02467400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65700419|NCT02467400|Vasodilator Agents|vasodilator agents|mesh-ancestor
65700420|NCT02467400|Sympatholytics|sympatholytics|mesh-ancestor
65700421|NCT02467400|Autonomic Agents|autonomic agents|mesh-ancestor
65700422|NCT02467400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700423|NCT02467400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65700424|NCT02467400|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65700425|NCT02467400|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65700426|NCT02467400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65700427|NCT04002141|Letrozole|letrozole|mesh-list
65700428|NCT04002141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700429|NCT04002141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65700430|NCT04002141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65700431|NCT04002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700432|NCT04002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700433|NCT04002141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65700434|NCT04002141|Hormone Antagonists|hormone antagonists|mesh-ancestor
65700435|NCT04002141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65700436|NCT04002141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700437|NCT03308708|Norepinephrine|norepinephrine|mesh-list
65700438|NCT03308708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65700439|NCT03308708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65700440|NCT03308708|Adrenergic Agents|adrenergic agents|mesh-ancestor
65700441|NCT03308708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65700442|NCT03308708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700443|NCT03308708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700444|NCT03308708|Sympathomimetics|sympathomimetics|mesh-ancestor
65700445|NCT03308708|Autonomic Agents|autonomic agents|mesh-ancestor
65700446|NCT03308708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700447|NCT03308708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65700448|NCT02262741|Durvalumab|durvalumab|mesh-list
65700449|NCT02262741|Tremelimumab|tremelimumab|mesh-list
65700450|NCT02262741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65700451|NCT02262741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700452|NCT00250341|Beclomethasone|beclomethasone|mesh-list
65700453|NCT00250341|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65700454|NCT00250341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65700455|NCT00250341|Glucocorticoids|glucocorticoids|mesh-ancestor
65700456|NCT00250341|Hormones|hormones|mesh-ancestor
65700457|NCT00250341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65700458|NCT00250341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700459|NCT00250341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65700460|NCT00250341|Respiratory System Agents|respiratory system agents|mesh-ancestor
65700461|NCT00250341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65700462|NCT00250341|Autonomic Agents|autonomic agents|mesh-ancestor
65700463|NCT00250341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700464|NCT00250341|Sympathomimetics|sympathomimetics|mesh-ancestor
65700465|NCT05156970|Carboplatin|carboplatin|mesh-list
65700466|NCT05156970|Docetaxel|docetaxel|mesh-list
65700467|NCT05156970|Apatinib|apatinib|mesh-list
65700468|NCT05156970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700469|NCT05156970|Tubulin Modulators|tubulin modulators|mesh-ancestor
65700470|NCT05156970|Antimitotic Agents|antimitotic agents|mesh-ancestor
65700471|NCT05156970|Mitosis Modulators|mitosis modulators|mesh-ancestor
65700472|NCT05156970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700473|NCT05156970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65700474|NCT05156970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700475|NCT02233881|Ipratropium|ipratropium|mesh-list
65700476|NCT02233881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65700477|NCT02233881|Autonomic Agents|autonomic agents|mesh-ancestor
65700478|NCT02233881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700479|NCT02233881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700480|NCT02233881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65700481|NCT02233881|Respiratory System Agents|respiratory system agents|mesh-ancestor
65700482|NCT02233881|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65700483|NCT02233881|Cholinergic Agents|cholinergic agents|mesh-ancestor
65700484|NCT02233881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65700485|NCT02233881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700486|NCT02234037|Decitabine|decitabine|mesh-list
65700487|NCT02234037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65700488|NCT02234037|Antimetabolites|antimetabolites|mesh-ancestor
65700489|NCT02234037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700490|NCT02234037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700491|NCT02234037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700492|NCT02234193|Lidocaine|lidocaine|mesh-list
65700493|NCT02234193|Epinephrine|epinephrine|mesh-list
65700494|NCT02234193|Anesthetics, Local|anesthetics, local|mesh-ancestor
65700495|NCT02234193|Anesthetics|anesthetics|mesh-ancestor
65700496|NCT02234193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65700497|NCT02234193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700498|NCT02234193|Sensory System Agents|sensory system agents|mesh-ancestor
65700499|NCT02234193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700500|NCT02234193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65700501|NCT02234193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65700502|NCT02234193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65700503|NCT02234193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65700504|NCT02234193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700505|NCT02234193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65700506|NCT02234193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65700507|NCT02234193|Adrenergic Agents|adrenergic agents|mesh-ancestor
65700508|NCT02234193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65700509|NCT02234193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65700510|NCT02234193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65700511|NCT02234193|Autonomic Agents|autonomic agents|mesh-ancestor
65700512|NCT02234193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65700513|NCT02234193|Respiratory System Agents|respiratory system agents|mesh-ancestor
65700514|NCT02234193|Mydriatics|mydriatics|mesh-ancestor
65700515|NCT02234193|Sympathomimetics|sympathomimetics|mesh-ancestor
65700516|NCT02234193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65700518|NCT04476459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700519|NCT04476459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65700520|NCT04476459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700521|NCT04476459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700522|NCT02262897|Paclitaxel|paclitaxel|mesh-list
65700523|NCT02262897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65700524|NCT02262897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65700525|NCT02262897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700526|NCT02262897|Tubulin Modulators|tubulin modulators|mesh-ancestor
65700527|NCT02262897|Antimitotic Agents|antimitotic agents|mesh-ancestor
65700528|NCT02262897|Mitosis Modulators|mitosis modulators|mesh-ancestor
65700529|NCT02262897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700530|NCT02723006|Nivolumab|nivolumab|mesh-list
65700531|NCT02723006|Ipilimumab|ipilimumab|mesh-list
65700532|NCT02723006|Vedolizumab|vedolizumab|mesh-list
65700533|NCT02723006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65700534|NCT02723006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700535|NCT02723006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65700536|NCT02723006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700537|NCT02723006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65700538|NCT03308552|Paclitaxel|paclitaxel|mesh-list
65700539|NCT03308552|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65700540|NCT03308552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65700541|NCT03308552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700542|NCT03308552|Tubulin Modulators|tubulin modulators|mesh-ancestor
65700543|NCT03308552|Antimitotic Agents|antimitotic agents|mesh-ancestor
65700544|NCT03308552|Mitosis Modulators|mitosis modulators|mesh-ancestor
65700545|NCT03308552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700546|NCT03308084|Dexamethasone|dexamethasone|mesh-list
65700547|NCT03308084|Methylprednisolone|methylprednisolone|mesh-list
65700548|NCT03308084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65700549|NCT03308084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65700550|NCT03308084|Prednisolone|prednisolone|mesh-list
65700551|NCT03308084|Prednisolone acetate|prednisolone acetate|mesh-list
65700552|NCT03308084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65700553|NCT03308084|Prednisolone phosphate|prednisolone phosphate|mesh-list
65700554|NCT03308084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65700555|NCT03308084|Antiemetics|antiemetics|mesh-ancestor
65700556|NCT03308084|Autonomic Agents|autonomic agents|mesh-ancestor
65700557|NCT03308084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700558|NCT03308084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700559|NCT03308084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65700560|NCT03308084|Glucocorticoids|glucocorticoids|mesh-ancestor
65700561|NCT03308084|Hormones|hormones|mesh-ancestor
65700562|NCT03308084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65700563|NCT03308084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65700564|NCT03308084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700565|NCT03308084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65700566|NCT03308084|Protective Agents|protective agents|mesh-ancestor
65700567|NCT00702962|Carboplatin|carboplatin|mesh-list
65700568|NCT00702962|Etoposide|etoposide|mesh-list
65700569|NCT00702962|Vorinostat|vorinostat|mesh-list
65700570|NCT00702962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700571|NCT00702962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65700572|NCT00702962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65700573|NCT00702962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65700574|NCT00702962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700575|NCT00702962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700576|NCT00702962|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65700577|NCT01379508|Tenofovir|tenofovir|mesh-list
65700578|NCT01379508|Telbivudine|telbivudine|mesh-list
65700579|NCT01379508|Antiviral Agents|antiviral agents|mesh-ancestor
65700580|NCT01379508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65700581|NCT01379508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65700582|NCT01379508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65016494|NCT00523159|Sargramostim|sargramostim|mesh-list
65700583|NCT01379508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700584|NCT01379508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700585|NCT01379508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65700586|NCT01379508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65700587|NCT05162430|Propofol|propofol|mesh-list
65700588|NCT05162430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65700589|NCT05162430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65700590|NCT05162430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700591|NCT05162430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65700592|NCT05162430|Anesthetics, General|anesthetics, general|mesh-ancestor
65700593|NCT05162430|Anesthetics|anesthetics|mesh-ancestor
65700594|NCT05031026|Dexmedetomidine|dexmedetomidine|mesh-list
65700595|NCT05031026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65700596|NCT05031026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65700597|NCT05031026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700598|NCT05031026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65700599|NCT05031026|Analgesics|analgesics|mesh-ancestor
65700600|NCT05031026|Sensory System Agents|sensory system agents|mesh-ancestor
65700601|NCT05031026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700602|NCT05031026|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65700603|NCT05031026|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65700604|NCT05031026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65700605|NCT05031026|Adrenergic Agents|adrenergic agents|mesh-ancestor
65700606|NCT05031026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65700607|NCT05031026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700608|NCT02264769|Carbetocin|carbetocin|mesh-list
65700609|NCT02264769|Oxytocics|oxytocics|mesh-ancestor
65700610|NCT02264769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65700611|NCT02264769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700612|NCT02264847|Clomiphene|clomiphene|mesh-list
65700613|NCT02264847|Enclomiphene|enclomiphene|mesh-list
65700614|NCT02264847|Zuclomiphene|zuclomiphene|mesh-list
65700615|NCT02264847|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65700616|NCT02264847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65700617|NCT02264847|Hormone Antagonists|hormone antagonists|mesh-ancestor
65700618|NCT02264847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65700619|NCT02264847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700620|NCT02264847|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65700621|NCT02264847|Fertility Agents|fertility agents|mesh-ancestor
65700622|NCT02264847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65700623|NCT02264847|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65700624|NCT02264847|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65700625|NCT04965506|Dulaglutide|dulaglutide|mesh-list
65700626|NCT04965506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65700627|NCT04965506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700628|NCT03469128|Sertraline|sertraline|mesh-list
65700629|NCT03469128|Antidepressive Agents|antidepressive agents|mesh-ancestor
65700630|NCT03469128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65700631|NCT03469128|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65700632|NCT03469128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65700633|NCT03469128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65269124|NCT02741414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65700634|NCT03469128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700635|NCT03469128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65700636|NCT03469128|Serotonin Agents|serotonin agents|mesh-ancestor
65700637|NCT03469128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700638|NCT05161572|Oxaliplatin|oxaliplatin|mesh-list
65700639|NCT05161572|Tegafur|tegafur|mesh-list
65700640|NCT05161572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700641|NCT05161572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65700642|NCT05161572|Antimetabolites|antimetabolites|mesh-ancestor
65700643|NCT05161572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700644|NCT03472170|Lactoferrin|lactoferrin|mesh-list
65700645|NCT03472170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65700646|NCT04156698|Docetaxel|docetaxel|mesh-list
65700647|NCT04156698|Capecitabine|capecitabine|mesh-list
65700648|NCT04156698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700649|NCT04156698|Tubulin Modulators|tubulin modulators|mesh-ancestor
65700650|NCT04156698|Antimitotic Agents|antimitotic agents|mesh-ancestor
65700651|NCT04156698|Mitosis Modulators|mitosis modulators|mesh-ancestor
65700652|NCT04156698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700653|NCT04156698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65700654|NCT04156698|Antimetabolites|antimetabolites|mesh-ancestor
65700655|NCT03108326|Infliximab|infliximab|mesh-list
65700656|NCT03108326|Ustekinumab|ustekinumab|mesh-list
65700657|NCT03108326|Vedolizumab|vedolizumab|mesh-list
65700658|NCT03108326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65700659|NCT03108326|Dermatologic Agents|dermatologic agents|mesh-ancestor
65700660|NCT03108326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65700661|NCT04964024|Antibodies|antibodies|mesh-list
65700662|NCT04964024|Immunologic Factors|immunologic factors|mesh-ancestor
65700663|NCT04964024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700664|NCT02519439|Ganaxolone|ganaxolone|mesh-list
65700665|NCT02519439|Neurosteroids|neurosteroids|mesh-ancestor
65700666|NCT02519439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65700667|NCT02519439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700668|NCT02519439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700669|NCT02519439|GABA Modulators|gaba modulators|mesh-ancestor
65700670|NCT02519439|GABA Agents|gaba agents|mesh-ancestor
65700671|NCT02466542|Esmolol|esmolol|mesh-list
65700672|NCT02466542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65700673|NCT02466542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65700674|NCT02466542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65700675|NCT02466542|Adrenergic Agents|adrenergic agents|mesh-ancestor
65700676|NCT02466542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65700677|NCT02466542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700678|NCT02466542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700679|NCT05067270|Insulin Lispro|insulin lispro|mesh-list
65700680|NCT05067270|Treprostinil|treprostinil|mesh-list
65700681|NCT05067270|Citric Acid|citric acid|mesh-list
65700682|NCT05067270|Sodium Citrate|sodium citrate|mesh-list
65700683|NCT05067270|Anticoagulants|anticoagulants|mesh-ancestor
65700684|NCT05067270|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65700685|NCT05067270|Chelating Agents|chelating agents|mesh-ancestor
65700686|NCT05067270|Sequestering Agents|sequestering agents|mesh-ancestor
65700687|NCT05067270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700688|NCT05067270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65700689|NCT05067270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700690|NCT05067270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65700691|NCT01437735|Montelukast|montelukast|mesh-list
65700692|NCT01437735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65700693|NCT01437735|Respiratory System Agents|respiratory system agents|mesh-ancestor
65700694|NCT01437735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65700695|NCT01437735|Hormone Antagonists|hormone antagonists|mesh-ancestor
65700696|NCT01437735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65700697|NCT01437735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700698|NCT01437735|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65700699|NCT01437735|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65700700|NCT01437735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700701|NCT02722304|Protease Inhibitors|protease inhibitors|mesh-list
65700702|NCT02722304|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65700703|NCT02722304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700704|NCT02722304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700705|NCT02722304|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65700706|NCT02722304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65700707|NCT03470610|Estradiol|estradiol|mesh-list
65700708|NCT03470610|Progesterone|progesterone|mesh-list
65700709|NCT03470610|Estrogens|estrogens|mesh-ancestor
65700710|NCT03470610|Hormones|hormones|mesh-ancestor
65700711|NCT03470610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65700712|NCT03470610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700713|NCT03470610|Progestins|progestins|mesh-ancestor
65700714|NCT02509845|Anti-Infective Agents|anti-infective agents|mesh-list
65700715|NCT02509845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65700716|NCT03307148|Gemcitabine|gemcitabine|mesh-list
65700717|NCT03307148|Paclitaxel|paclitaxel|mesh-list
65700718|NCT03307148|Tretinoin|tretinoin|mesh-list
65700719|NCT03307148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65700720|NCT03307148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700721|NCT03307148|Tubulin Modulators|tubulin modulators|mesh-ancestor
65700722|NCT03307148|Antimitotic Agents|antimitotic agents|mesh-ancestor
65700723|NCT03307148|Mitosis Modulators|mitosis modulators|mesh-ancestor
65700724|NCT03307148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700725|NCT03307148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65700726|NCT03307148|Antimetabolites|antimetabolites|mesh-ancestor
65700727|NCT03307148|Antiviral Agents|antiviral agents|mesh-ancestor
65700728|NCT03307148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65700729|NCT03307148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700730|NCT03307148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65700731|NCT03307148|Immunologic Factors|immunologic factors|mesh-ancestor
65700732|NCT03307148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700733|NCT03307148|Keratolytic Agents|keratolytic agents|mesh-ancestor
65700734|NCT03307148|Dermatologic Agents|dermatologic agents|mesh-ancestor
65700735|NCT03984591|Eplerenone|eplerenone|mesh-list
65700736|NCT03984591|Spironolactone|spironolactone|mesh-list
65700737|NCT03984591|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65700738|NCT03984591|Hormone Antagonists|hormone antagonists|mesh-ancestor
65700739|NCT03984591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65700740|NCT03984591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700741|NCT03984591|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65700742|NCT03984591|Diuretics|diuretics|mesh-ancestor
65700743|NCT03984591|Natriuretic Agents|natriuretic agents|mesh-ancestor
65700744|NCT03984591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65700745|NCT02503137|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65700746|NCT03470532|Epinephrine|epinephrine|mesh-list
65700747|NCT03470532|Racepinephrine|racepinephrine|mesh-list
65700748|NCT03470532|Mepivacaine|mepivacaine|mesh-list
65700749|NCT03470532|Carticaine|carticaine|mesh-list
65700750|NCT03470532|Epinephryl borate|epinephryl borate|mesh-list
65700751|NCT03470532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65700752|NCT03470532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65700753|NCT03470532|Adrenergic Agents|adrenergic agents|mesh-ancestor
65700754|NCT03470532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65700755|NCT03470532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700756|NCT03470532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700757|NCT03470532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65700758|NCT03470532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65700759|NCT03470532|Autonomic Agents|autonomic agents|mesh-ancestor
65700760|NCT03470532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700761|NCT03470532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65700762|NCT03470532|Respiratory System Agents|respiratory system agents|mesh-ancestor
65700763|NCT03470532|Mydriatics|mydriatics|mesh-ancestor
65700764|NCT03470532|Sympathomimetics|sympathomimetics|mesh-ancestor
65700765|NCT03470532|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65700766|NCT03470532|Anesthetics, Local|anesthetics, local|mesh-ancestor
65700767|NCT03470532|Anesthetics|anesthetics|mesh-ancestor
65700768|NCT03470532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65700769|NCT03470532|Sensory System Agents|sensory system agents|mesh-ancestor
65700770|NCT02502669|Finasteride|finasteride|mesh-list
65700771|NCT02502669|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65700772|NCT02502669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65700773|NCT02502669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700774|NCT02502669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700775|NCT02502669|Hormone Antagonists|hormone antagonists|mesh-ancestor
65700776|NCT02502669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65700777|NCT02502669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700778|NCT02502669|Urological Agents|urological agents|mesh-ancestor
65700779|NCT03306914|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65700780|NCT03306914|Plasma Substitutes|plasma substitutes|mesh-ancestor
65700781|NCT03306914|Blood Substitutes|blood substitutes|mesh-ancestor
65700782|NCT03306836|Heparin|heparin|mesh-list
65700783|NCT03306836|Calcium heparin|calcium heparin|mesh-list
65700784|NCT03306836|Anticoagulants|anticoagulants|mesh-ancestor
65700785|NCT03306836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65700786|NCT03306836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65700787|NCT03306836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700788|NCT04487145|Piperaquine|piperaquine|mesh-list
65700789|NCT04487145|Artenimol|artenimol|mesh-list
65700790|NCT04487145|Antimalarials|antimalarials|mesh-ancestor
65700791|NCT04487145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65700792|NCT04487145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65700793|NCT04487145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65700794|NCT04780568|Osimertinib|osimertinib|mesh-list
65700795|NCT04780568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700796|NCT04780568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65700797|NCT04780568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700798|NCT04780568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700799|NCT00709956|Iloprost|iloprost|mesh-list
65700800|NCT00709956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65700801|NCT00709956|Vasodilator Agents|vasodilator agents|mesh-ancestor
65700802|NCT02268201|Tacrolimus|tacrolimus|mesh-list
65700803|NCT02268201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65700804|NCT02268201|Immunologic Factors|immunologic factors|mesh-ancestor
65700805|NCT02268201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700806|NCT02268201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65700807|NCT02268201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700808|NCT02268201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700809|NCT03306602|Z 350|z 350|mesh-list
65700810|NCT03306602|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65700811|NCT03306602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65700812|NCT03306602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700813|NCT03306602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700814|NCT03306602|Hormone Antagonists|hormone antagonists|mesh-ancestor
65700815|NCT03306602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65700816|NCT03306602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700817|NCT02268279|Solithromycin|solithromycin|mesh-list
65700818|NCT02268279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65700819|NCT02268279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65700820|NCT02268357|Propranolol|propranolol|mesh-list
65700821|NCT02268357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65700822|NCT02268357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65700823|NCT02268357|Adrenergic Agents|adrenergic agents|mesh-ancestor
65700824|NCT02268357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65700825|NCT02268357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700826|NCT02268357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700827|NCT02268357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65700828|NCT02268357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65700829|NCT02268357|Vasodilator Agents|vasodilator agents|mesh-ancestor
65700830|NCT02268435|Imatinib Mesylate|imatinib mesylate|mesh-list
65700831|NCT02268435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700832|NCT02268435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65700833|NCT02268435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700834|NCT02268435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700835|NCT02466464|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
65700836|NCT02466464|Hemostatics|hemostatics|mesh-ancestor
65700837|NCT02466464|Coagulants|coagulants|mesh-ancestor
65700838|NCT01423149|Fosbretabulin|fosbretabulin|mesh-list
65700839|NCT01423149|Combretastatin|combretastatin|mesh-list
65700840|NCT01423149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65700841|NCT01423149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700842|NCT01423149|Tubulin Modulators|tubulin modulators|mesh-ancestor
65700843|NCT01423149|Antimitotic Agents|antimitotic agents|mesh-ancestor
65700844|NCT01423149|Mitosis Modulators|mitosis modulators|mesh-ancestor
65700845|NCT01423149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700846|NCT03470454|Linagliptin|linagliptin|mesh-list
65700847|NCT03470454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65700848|NCT03470454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700849|NCT03470454|Incretins|incretins|mesh-ancestor
65700850|NCT03470454|Hormones|hormones|mesh-ancestor
65700851|NCT03470454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65700852|NCT03470454|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65700853|NCT03470454|Protease Inhibitors|protease inhibitors|mesh-ancestor
65700854|NCT03470454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700855|NCT03470454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700856|NCT03130842|Midazolam|midazolam|mesh-list
65700857|NCT03130842|Alprazolam|alprazolam|mesh-list
65700858|NCT03130842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65700859|NCT03130842|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65700860|NCT03130842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65700861|NCT03130842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700862|NCT03130842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65700863|NCT03130842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65700864|NCT03130842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65700865|NCT03130842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65700866|NCT03130842|Anesthetics, General|anesthetics, general|mesh-ancestor
65700867|NCT03130842|Anesthetics|anesthetics|mesh-ancestor
65700868|NCT03130842|GABA Modulators|gaba modulators|mesh-ancestor
65700869|NCT03130842|GABA Agents|gaba agents|mesh-ancestor
65700870|NCT03130842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65700871|NCT03130842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700872|NCT03130764|Durvalumab|durvalumab|mesh-list
65700873|NCT03130764|Tremelimumab|tremelimumab|mesh-list
65700874|NCT03130764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65700875|NCT03130764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700876|NCT01234779|Olanzapine|olanzapine|mesh-list
65700877|NCT01234779|Antiemetics|antiemetics|mesh-ancestor
65700878|NCT01234779|Autonomic Agents|autonomic agents|mesh-ancestor
65700879|NCT01234779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700880|NCT01234779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700881|NCT01234779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65700882|NCT01234779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65700883|NCT01234779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65700884|NCT01234779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65700885|NCT01234779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65700886|NCT01234779|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65700887|NCT01234779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65700888|NCT01234779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65700889|NCT01234779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700890|NCT01234779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65700891|NCT01234779|Serotonin Agents|serotonin agents|mesh-ancestor
65700892|NCT03306446|Adalimumab|adalimumab|mesh-list
65700893|NCT03306446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65700894|NCT03306446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65700895|NCT03223350|Capsaicin|capsaicin|mesh-list
65700896|NCT03223350|Antipruritics|antipruritics|mesh-ancestor
65700897|NCT03223350|Dermatologic Agents|dermatologic agents|mesh-ancestor
65700898|NCT03223350|Sensory System Agents|sensory system agents|mesh-ancestor
65700899|NCT03223350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700900|NCT03223350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700901|NCT03306368|Analgesics, Opioid|analgesics, opioid|mesh-list
65700902|NCT03306368|Narcotics|narcotics|mesh-ancestor
65700903|NCT03306368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65700904|NCT03306368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700905|NCT03306368|Analgesics|analgesics|mesh-ancestor
65700906|NCT03306368|Sensory System Agents|sensory system agents|mesh-ancestor
65700907|NCT03306368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700908|NCT02840136|Meropenem|meropenem|mesh-list
65700909|NCT02840136|Tazobactam|tazobactam|mesh-list
65700910|NCT02840136|Piperacillin|piperacillin|mesh-list
65700911|NCT02840136|Ceftazidime|ceftazidime|mesh-list
65700912|NCT02840136|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65700913|NCT02840136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65700914|NCT02840136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65700915|NCT02840136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65700916|NCT02840136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700917|NCT02840136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700918|NCT03306290|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65700919|NCT03306290|Cefoxitin|cefoxitin|mesh-list
65700920|NCT03306290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65700921|NCT01616199|Vemurafenib|vemurafenib|mesh-list
65700922|NCT01616199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700923|NCT01616199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65700924|NCT01616199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700925|NCT01616199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700926|NCT03306212|Botulinum Toxins|botulinum toxins|mesh-list
65700927|NCT03306212|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65700928|NCT03306212|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65700929|NCT03306212|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65700930|NCT03306212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65700931|NCT03306212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700932|NCT03306212|Cholinergic Agents|cholinergic agents|mesh-ancestor
65700933|NCT03306212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65700934|NCT03306212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700935|NCT03306212|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65700936|NCT03306212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65700937|NCT04506138|Paclitaxel|paclitaxel|mesh-list
65700938|NCT04506138|Carboplatin|carboplatin|mesh-list
65700939|NCT04506138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65700940|NCT04506138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700941|NCT04506138|Tubulin Modulators|tubulin modulators|mesh-ancestor
65700942|NCT04506138|Antimitotic Agents|antimitotic agents|mesh-ancestor
65700943|NCT04506138|Mitosis Modulators|mitosis modulators|mesh-ancestor
65700944|NCT04506138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700945|NCT01407003|Licogliflozin|licogliflozin|mesh-list
65700946|NCT01407003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65700947|NCT01407003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700948|NCT01407003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65700949|NCT01407003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700950|NCT05346302|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65700951|NCT05346302|Immunologic Factors|immunologic factors|mesh-ancestor
65700952|NCT05346302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700953|NCT01232595|Vancomycin|vancomycin|mesh-list
65700954|NCT01232595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65700955|NCT01232595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65700956|NCT01231347|Gemcitabine|gemcitabine|mesh-list
65700957|NCT01231347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65016822|NCT00167817|Serotonin Agents|serotonin agents|mesh-ancestor
65700958|NCT01231347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65700959|NCT01231347|Antimetabolites|antimetabolites|mesh-ancestor
65700960|NCT01231347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700961|NCT01231347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65700962|NCT01231347|Antiviral Agents|antiviral agents|mesh-ancestor
65700963|NCT01231347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65700964|NCT01231347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700965|NCT01231347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65700966|NCT01231347|Immunologic Factors|immunologic factors|mesh-ancestor
65700967|NCT01231347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700968|NCT01230957|Vaccines|vaccines|mesh-list
65700969|NCT01230957|Immunologic Factors|immunologic factors|mesh-ancestor
65700970|NCT01230957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700971|NCT01228383|Vaccines|vaccines|mesh-list
65700972|NCT01228383|Antibodies|antibodies|mesh-list
65700973|NCT01228383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65700974|NCT01228383|Immunoglobulins|immunoglobulins|mesh-list
65700975|NCT01228383|gamma-Globulins|gamma-globulins|mesh-list
65700976|NCT01228383|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65700977|NCT01228383|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65700978|NCT01228383|Immunologic Factors|immunologic factors|mesh-ancestor
65700979|NCT01228383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700980|NCT03305978|Ivermectin|ivermectin|mesh-list
65700981|NCT03305978|Selamectin|selamectin|mesh-list
65700982|NCT03305978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65700983|NCT03305978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65700984|NCT01594983|Fenofibrate|fenofibrate|mesh-list
65700985|NCT01594983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65700986|NCT01594983|Antimetabolites|antimetabolites|mesh-ancestor
65700987|NCT01594983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700988|NCT01594983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65700989|NCT03305510|Vitamin D|vitamin d|mesh-list
65700990|NCT03305510|Vitamins|vitamins|mesh-ancestor
65700991|NCT03305510|Micronutrients|micronutrients|mesh-ancestor
65700992|NCT03305510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65700993|NCT03305510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65700994|NCT01224795|Peramivir|peramivir|mesh-list
65700995|NCT01224795|Antiviral Agents|antiviral agents|mesh-ancestor
65700996|NCT01224795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65700997|NCT01224795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65700998|NCT01224795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65700999|NCT01402401|Trastuzumab|trastuzumab|mesh-list
65701000|NCT01402401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65701001|NCT01402401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701002|NCT02720510|Dexamethasone|dexamethasone|mesh-list
65701003|NCT02720510|Lenalidomide|lenalidomide|mesh-list
65701004|NCT02720510|Bortezomib|bortezomib|mesh-list
65701005|NCT02720510|Panobinostat|panobinostat|mesh-list
65701006|NCT02720510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65701007|NCT02720510|Antiemetics|antiemetics|mesh-ancestor
65701008|NCT02720510|Autonomic Agents|autonomic agents|mesh-ancestor
65701009|NCT02720510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65701010|NCT02720510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701011|NCT02720510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65701012|NCT02720510|Glucocorticoids|glucocorticoids|mesh-ancestor
65701013|NCT02720510|Hormones|hormones|mesh-ancestor
65701014|NCT02720510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65701015|NCT02720510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65701016|NCT02720510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701017|NCT02720510|Immunologic Factors|immunologic factors|mesh-ancestor
65701018|NCT02720510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65701019|NCT02720510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65701020|NCT02720510|Growth Substances|growth substances|mesh-ancestor
65701021|NCT02720510|Growth Inhibitors|growth inhibitors|mesh-ancestor
65701022|NCT02720510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65701023|NCT02720510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701024|NCT02720510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701025|NCT01220271|Temozolomide|temozolomide|mesh-list
65701026|NCT01220271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65701027|NCT01220271|Alkylating Agents|alkylating agents|mesh-ancestor
65701028|NCT01220271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701029|NCT01220271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701030|NCT02468102|Rivaroxaban|rivaroxaban|mesh-list
65701031|NCT02468102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65701032|NCT02468102|Antithrombins|antithrombins|mesh-ancestor
65701033|NCT02468102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65701034|NCT02468102|Protease Inhibitors|protease inhibitors|mesh-ancestor
65701035|NCT02468102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701036|NCT02468102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701037|NCT02468102|Anticoagulants|anticoagulants|mesh-ancestor
65701038|NCT01205061|Lidocaine|lidocaine|mesh-list
65701039|NCT01205061|Anesthetics, Local|anesthetics, local|mesh-ancestor
65701040|NCT01205061|Anesthetics|anesthetics|mesh-ancestor
65701041|NCT01205061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65701042|NCT01205061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701043|NCT01205061|Sensory System Agents|sensory system agents|mesh-ancestor
65701044|NCT01205061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65701045|NCT01205061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65701046|NCT01205061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65701047|NCT01205061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65701048|NCT01205061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65701049|NCT01205061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701050|NCT01204749|Paclitaxel|paclitaxel|mesh-list
65701051|NCT01204749|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65701052|NCT01204749|Trebananib|trebananib|mesh-list
65701053|NCT01204749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
65701054|NCT01204749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65701055|NCT01204749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701056|NCT01204749|Tubulin Modulators|tubulin modulators|mesh-ancestor
65701057|NCT01204749|Antimitotic Agents|antimitotic agents|mesh-ancestor
65701058|NCT01204749|Mitosis Modulators|mitosis modulators|mesh-ancestor
65701059|NCT01204749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701060|NCT01204749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65701061|NCT01204749|Growth Substances|growth substances|mesh-ancestor
65701062|NCT01204749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701063|NCT01204749|Growth Inhibitors|growth inhibitors|mesh-ancestor
65701064|NCT02466698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65701065|NCT02466698|Metronidazole|metronidazole|mesh-list
65701066|NCT02466698|Vancomycin|vancomycin|mesh-list
65701067|NCT02466698|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65701068|NCT02466698|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65701069|NCT02466698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65701070|NCT02466698|Antitubercular Agents|antitubercular agents|mesh-ancestor
65701071|NCT02466698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65701072|NCT02466698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65701073|NCT02466698|Laxatives|laxatives|mesh-ancestor
65701074|NCT02466698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65701075|NCT02720198|Milnacipran|milnacipran|mesh-list
65701076|NCT02720198|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65701077|NCT02720198|Levomilnacipran|levomilnacipran|mesh-list
65701078|NCT02720198|Antidepressive Agents|antidepressive agents|mesh-ancestor
65701079|NCT02720198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65701080|NCT02720198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65701081|NCT02720198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65701082|NCT02720198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65701083|NCT02720198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701084|NCT02720198|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65701085|NCT02720198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65701086|NCT02720198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65701087|NCT02720198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701088|NCT02720198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65701089|NCT02720198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65701090|NCT02720198|Analgesics|analgesics|mesh-ancestor
65701091|NCT02720198|Sensory System Agents|sensory system agents|mesh-ancestor
65701092|NCT02720198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65701093|NCT01193361|Interferons|interferons|mesh-list
65701094|NCT01193361|Ribavirin|ribavirin|mesh-list
65701095|NCT01193361|Interferon-alpha|interferon-alpha|mesh-list
65701096|NCT01193361|Interferon alpha-2|interferon alpha-2|mesh-list
65701097|NCT01193361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65701098|NCT01193361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701099|NCT01193361|Antiviral Agents|antiviral agents|mesh-ancestor
65701100|NCT01193361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65701101|NCT01193361|Antimetabolites|antimetabolites|mesh-ancestor
65701102|NCT01193361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701103|NCT01193361|Immunologic Factors|immunologic factors|mesh-ancestor
65701104|NCT01193361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701105|NCT02263677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65701106|NCT02263677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65701107|NCT02263677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701108|NCT02263677|Incretins|incretins|mesh-ancestor
65701109|NCT02263677|Hormones|hormones|mesh-ancestor
65701110|NCT02263677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65701111|NCT02263677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65701112|NCT02263677|Protease Inhibitors|protease inhibitors|mesh-ancestor
65701113|NCT02263677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701114|NCT02263677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701116|NCT01390545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701117|NCT01591473|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
65701118|NCT01591473|Poly I-C|poly i-c|mesh-list
65701119|NCT01591473|Antiviral Agents|antiviral agents|mesh-ancestor
65701120|NCT01591473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65701121|NCT01591473|Interferon Inducers|interferon inducers|mesh-ancestor
65701122|NCT01591473|Immunologic Factors|immunologic factors|mesh-ancestor
65701123|NCT01591473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701124|NCT01192035|Ritonavir|ritonavir|mesh-list
65701125|NCT01192035|Lopinavir|lopinavir|mesh-list
65701126|NCT01192035|Nevirapine|nevirapine|mesh-list
65701127|NCT01192035|Efavirenz|efavirenz|mesh-list
65701128|NCT01192035|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65701129|NCT01192035|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65701130|NCT01192035|Protease Inhibitors|protease inhibitors|mesh-ancestor
65701131|NCT01192035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701132|NCT01192035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701133|NCT01192035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65701134|NCT01192035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65701135|NCT01192035|Antiviral Agents|antiviral agents|mesh-ancestor
65701136|NCT01192035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65701137|NCT01192035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65701138|NCT01192035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65701139|NCT01192035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65701140|NCT01192035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65701141|NCT01192035|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65701142|NCT01192035|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65701143|NCT01192035|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65701144|NCT01192035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65701145|NCT01192035|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65701146|NCT01384383|Ledipasvir|ledipasvir|mesh-list
65701147|NCT01384383|Antiviral Agents|antiviral agents|mesh-ancestor
65701148|NCT01384383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65701149|NCT01557777|Navitoclax|navitoclax|mesh-list
65701150|NCT01557777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701151|NCT02268825|Pembrolizumab|pembrolizumab|mesh-list
65701152|NCT02268825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65701153|NCT02268825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701154|NCT01381731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65701155|NCT01381731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65701156|NCT02268903|Furosemide|furosemide|mesh-list
65701157|NCT02268903|Diuretics|diuretics|mesh-list
65701158|NCT02268903|Natriuretic Agents|natriuretic agents|mesh-ancestor
65701159|NCT02268903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701160|NCT02268903|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65701161|NCT02268903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65701162|NCT02268903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701163|NCT01369095|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65701164|NCT01369095|Citalopram|citalopram|mesh-list
65701165|NCT01369095|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65701166|NCT01369095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65701167|NCT01369095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65701168|NCT01369095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701169|NCT01369095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65701170|NCT01369095|Serotonin Agents|serotonin agents|mesh-ancestor
65701171|NCT01369095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701172|NCT01369095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65701173|NCT01369095|Antidepressive Agents|antidepressive agents|mesh-ancestor
65701174|NCT01369095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65701175|NCT01369095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65701176|NCT01369095|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65701177|NCT01369095|Analgesics|analgesics|mesh-ancestor
65701178|NCT01369095|Sensory System Agents|sensory system agents|mesh-ancestor
65701179|NCT01369095|Dopamine Agents|dopamine agents|mesh-ancestor
65701180|NCT02266173|Pertuzumab|pertuzumab|mesh-list
65701181|NCT02266173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65701182|NCT02266173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701183|NCT01168713|Levofloxacin|levofloxacin|mesh-list
65701184|NCT01168713|Ofloxacin|ofloxacin|mesh-list
65701185|NCT01168713|Solithromycin|solithromycin|mesh-list
65017040|NCT00526513|Insulin glulisine|insulin glulisine|mesh-list
65701186|NCT01168713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65701187|NCT01168713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65701188|NCT01168713|Renal Agents|renal agents|mesh-ancestor
65701189|NCT01168713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65701190|NCT01168713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65701191|NCT01168713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65701192|NCT01168713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701193|NCT01168713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701194|NCT01168713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701195|NCT01168713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65701196|NCT01168713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65701197|NCT02269293|Paclitaxel|paclitaxel|mesh-list
65701198|NCT02269293|Carboplatin|carboplatin|mesh-list
65701199|NCT02269293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65701200|NCT02269293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701201|NCT02269293|Tubulin Modulators|tubulin modulators|mesh-ancestor
65701202|NCT02269293|Antimitotic Agents|antimitotic agents|mesh-ancestor
65701203|NCT02269293|Mitosis Modulators|mitosis modulators|mesh-ancestor
65701204|NCT02269293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701205|NCT01545453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65701206|NCT01545453|Immunologic Factors|immunologic factors|mesh-ancestor
65701207|NCT01545453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701208|NCT01366131|Paclitaxel|paclitaxel|mesh-list
65701209|NCT01366131|Bevacizumab|bevacizumab|mesh-list
65701210|NCT01366131|Carboplatin|carboplatin|mesh-list
65701211|NCT01366131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65701212|NCT01366131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701213|NCT01366131|Tubulin Modulators|tubulin modulators|mesh-ancestor
65701214|NCT01366131|Antimitotic Agents|antimitotic agents|mesh-ancestor
65701215|NCT01366131|Mitosis Modulators|mitosis modulators|mesh-ancestor
65701216|NCT01366131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701217|NCT01366131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65701218|NCT01366131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65701219|NCT01366131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65701220|NCT01366131|Growth Substances|growth substances|mesh-ancestor
65701221|NCT01366131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701222|NCT01366131|Growth Inhibitors|growth inhibitors|mesh-ancestor
65701223|NCT01365195|Ketamine|ketamine|mesh-list
65701224|NCT01365195|Analgesics|analgesics|mesh-ancestor
65701225|NCT01365195|Sensory System Agents|sensory system agents|mesh-ancestor
65701226|NCT01365195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65701227|NCT01365195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701228|NCT01365195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65701229|NCT01365195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65701230|NCT01365195|Anesthetics, General|anesthetics, general|mesh-ancestor
65701231|NCT01365195|Anesthetics|anesthetics|mesh-ancestor
65701232|NCT01365195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65701233|NCT01365195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65701234|NCT01365195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65701235|NCT01365195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65701236|NCT01365195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701237|NCT02269449|Hemostatics|hemostatics|mesh-list
65701238|NCT02269449|Coagulants|coagulants|mesh-ancestor
65701239|NCT01160601|Paclitaxel|paclitaxel|mesh-list
65701240|NCT01160601|Carboplatin|carboplatin|mesh-list
65701241|NCT01160601|Bavituximab|bavituximab|mesh-list
65701242|NCT01160601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65701243|NCT01160601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701244|NCT01160601|Tubulin Modulators|tubulin modulators|mesh-ancestor
65701245|NCT01160601|Antimitotic Agents|antimitotic agents|mesh-ancestor
65701246|NCT01160601|Mitosis Modulators|mitosis modulators|mesh-ancestor
65701247|NCT01160601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701248|NCT01160601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65701249|NCT02269605|Bryostatin 1|bryostatin 1|mesh-list
65701250|NCT02269605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65701251|NCT02269605|Immunologic Factors|immunologic factors|mesh-ancestor
65701252|NCT02269605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701253|NCT02269605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701254|NCT01356849|Atrasentan|atrasentan|mesh-list
65701255|NCT01356849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701256|NCT01356849|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65701257|NCT01356849|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65701258|NCT01356849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701259|NCT02266485|Pravastatin|pravastatin|mesh-list
65701260|NCT02266485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65701261|NCT02266485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65701262|NCT02266485|Antimetabolites|antimetabolites|mesh-ancestor
65701263|NCT02266485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701264|NCT02266485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65701265|NCT02266485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65701266|NCT02266485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701267|NCT02263989|Telmisartan|telmisartan|mesh-list
65701268|NCT02263989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65701269|NCT02263989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65701270|NCT02263989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65701271|NCT02263989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701272|NCT01516203|Rifampin|rifampin|mesh-list
65701273|NCT01516203|Isoniazid|isoniazid|mesh-list
65701274|NCT01516203|Pyrazinamide|pyrazinamide|mesh-list
65701275|NCT01516203|Ethambutol|ethambutol|mesh-list
65701276|NCT01516203|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65701277|NCT01516203|Antitubercular Agents|antitubercular agents|mesh-ancestor
65701278|NCT01516203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65701279|NCT01516203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65701280|NCT01516203|Leprostatic Agents|leprostatic agents|mesh-ancestor
65701281|NCT01516203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65701282|NCT01516203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701283|NCT01516203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701284|NCT01516203|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65701285|NCT01516203|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65701286|NCT01516203|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65701287|NCT01516203|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65701288|NCT01516203|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65701289|NCT01516203|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65701290|NCT01516203|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65701291|NCT01516203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65701292|NCT01516203|Antimetabolites|antimetabolites|mesh-ancestor
65701293|NCT01516203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65701294|NCT01321359|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
65701295|NCT01321359|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
65701296|NCT01321359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701297|NCT01321359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701298|NCT00703118|Ribavirin|ribavirin|mesh-list
65701299|NCT00703118|Interferon alpha-2|interferon alpha-2|mesh-list
65701300|NCT00703118|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65701301|NCT00703118|Antimetabolites|antimetabolites|mesh-ancestor
65701302|NCT00703118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701303|NCT00703118|Antiviral Agents|antiviral agents|mesh-ancestor
65701304|NCT00703118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65701305|NCT00703118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701306|NCT01510119|Hydroxychloroquine|hydroxychloroquine|mesh-list
65701307|NCT01510119|Everolimus|everolimus|mesh-list
65701308|NCT01510119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701309|NCT01510119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65701310|NCT01510119|Immunologic Factors|immunologic factors|mesh-ancestor
65701311|NCT01510119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701312|NCT01510119|Antimalarials|antimalarials|mesh-ancestor
65701313|NCT01510119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65701314|NCT01510119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65701315|NCT01510119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65701316|NCT01510119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701317|NCT01510119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701318|NCT01510119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65701319|NCT01150695|Vaccines|vaccines|mesh-list
65701320|NCT01150695|Immunologic Factors|immunologic factors|mesh-ancestor
65701321|NCT01150695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701322|NCT01302249|Timolol|timolol|mesh-list
65701323|NCT01302249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65701324|NCT01302249|Latanoprost|latanoprost|mesh-list
65701325|NCT01302249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65701326|NCT01302249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701327|NCT01302249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65701328|NCT01302249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65701329|NCT01302249|Adrenergic Agents|adrenergic agents|mesh-ancestor
65701330|NCT01302249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65701331|NCT01302249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701332|NCT01302249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65701333|NCT01302249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65701334|NCT02261636|Mesalamine|mesalamine|mesh-list
65701335|NCT02261636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65701336|NCT02261636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65701337|NCT02261636|Analgesics|analgesics|mesh-ancestor
65701338|NCT02261636|Sensory System Agents|sensory system agents|mesh-ancestor
65701339|NCT02261636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65701340|NCT02261636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701341|NCT02261636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65701342|NCT02261636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65701343|NCT05191706|Dexamethasone|dexamethasone|mesh-list
65701344|NCT05191706|Prednisolone|prednisolone|mesh-list
65701345|NCT05191706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65701346|NCT05191706|Methylprednisolone|methylprednisolone|mesh-list
65701347|NCT05191706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65701348|NCT05191706|Prednisolone acetate|prednisolone acetate|mesh-list
65701349|NCT05191706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65701350|NCT05191706|Prednisolone phosphate|prednisolone phosphate|mesh-list
65701351|NCT05191706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65701352|NCT05191706|Antiemetics|antiemetics|mesh-ancestor
65701353|NCT05191706|Autonomic Agents|autonomic agents|mesh-ancestor
65701354|NCT05191706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65701355|NCT05191706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701356|NCT05191706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65701357|NCT05191706|Glucocorticoids|glucocorticoids|mesh-ancestor
65701358|NCT05191706|Hormones|hormones|mesh-ancestor
65701359|NCT05191706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65701360|NCT05191706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65701361|NCT05191706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701362|NCT05191706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65701363|NCT05191706|Protective Agents|protective agents|mesh-ancestor
65701364|NCT01493505|Paclitaxel|paclitaxel|mesh-list
65701365|NCT01493505|Carboplatin|carboplatin|mesh-list
65701366|NCT01493505|Trebananib|trebananib|mesh-list
65701367|NCT01493505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65701368|NCT01493505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701369|NCT01493505|Tubulin Modulators|tubulin modulators|mesh-ancestor
65701370|NCT01493505|Antimitotic Agents|antimitotic agents|mesh-ancestor
65701371|NCT01493505|Mitosis Modulators|mitosis modulators|mesh-ancestor
65701372|NCT01493505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701373|NCT01493505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65701374|NCT01493505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65701375|NCT01493505|Growth Substances|growth substances|mesh-ancestor
65701376|NCT01493505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701377|NCT01493505|Growth Inhibitors|growth inhibitors|mesh-ancestor
65701378|NCT01301157|Calcipotriene|calcipotriene|mesh-list
65701379|NCT01301157|Dermatologic Agents|dermatologic agents|mesh-ancestor
65701380|NCT02264145|Norflurane|norflurane|mesh-list
65701381|NCT02264145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65701382|NCT02264145|Anesthetics|anesthetics|mesh-ancestor
65701383|NCT02264145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65701384|NCT02264145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701385|NCT05157464|Losartan|losartan|mesh-list
65701386|NCT05157464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65701387|NCT05157464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65701388|NCT05157464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65701389|NCT05157464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65701390|NCT05157464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701391|NCT02264301|Puerarin|puerarin|mesh-list
65701392|NCT02264301|Vasodilator Agents|vasodilator agents|mesh-ancestor
65701393|NCT04476069|Ibuprofen|ibuprofen|mesh-list
65701394|NCT04476069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65701395|NCT04476069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65701396|NCT04476069|Analgesics|analgesics|mesh-ancestor
65701397|NCT04476069|Sensory System Agents|sensory system agents|mesh-ancestor
65701398|NCT04476069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65701399|NCT04476069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701400|NCT04476069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65701401|NCT04476069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65701402|NCT04476069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65701403|NCT04476069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701404|NCT04476069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701405|NCT01480479|Temozolomide|temozolomide|mesh-list
65701406|NCT01480479|Molgramostim|molgramostim|mesh-list
65701407|NCT01480479|Rindopepimut|rindopepimut|mesh-list
65017255|NCT00173667|Nifedipine|nifedipine|mesh-list
65701408|NCT01480479|Sargramostim|sargramostim|mesh-list
65701409|NCT01480479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65701410|NCT01480479|Alkylating Agents|alkylating agents|mesh-ancestor
65701411|NCT01480479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701412|NCT01480479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701413|NCT01480479|Immunologic Factors|immunologic factors|mesh-ancestor
65701414|NCT01480479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701415|NCT01480479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65701417|NCT01116141|Methotrexate|methotrexate|mesh-list
65701418|NCT01116141|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65701419|NCT01116141|Abortifacient Agents|abortifacient agents|mesh-ancestor
65701420|NCT01116141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65701421|NCT01116141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701422|NCT01116141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65701423|NCT01116141|Antimetabolites|antimetabolites|mesh-ancestor
65701424|NCT01116141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701425|NCT01116141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701426|NCT01116141|Dermatologic Agents|dermatologic agents|mesh-ancestor
65701427|NCT01116141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701428|NCT01116141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65701429|NCT01116141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65701430|NCT01116141|Immunologic Factors|immunologic factors|mesh-ancestor
65701431|NCT01116141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65701432|NCT01116141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65701433|NCT01116141|Hematinics|hematinics|mesh-ancestor
65701434|NCT01116141|Vitamin B Complex|vitamin b complex|mesh-ancestor
65701435|NCT01116141|Vitamins|vitamins|mesh-ancestor
65701436|NCT01116141|Micronutrients|micronutrients|mesh-ancestor
65701437|NCT01280565|Dacarbazine|dacarbazine|mesh-list
65701438|NCT01280565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65701439|NCT01280565|Alkylating Agents|alkylating agents|mesh-ancestor
65701440|NCT01280565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701441|NCT01280565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701442|NCT05627739|Mycophenolic Acid|mycophenolic acid|mesh-list
65701443|NCT05627739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65701444|NCT05627739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701445|NCT05627739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65701446|NCT05627739|Antitubercular Agents|antitubercular agents|mesh-ancestor
65701447|NCT05627739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65701448|NCT05627739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65701449|NCT05627739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701450|NCT05627739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701451|NCT01113957|Doxorubicin|doxorubicin|mesh-list
65701452|NCT01113957|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65701453|NCT01113957|Temozolomide|temozolomide|mesh-list
65701454|NCT01113957|Veliparib|veliparib|mesh-list
65701455|NCT01113957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65701456|NCT01113957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701457|NCT01113957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65701458|NCT01113957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65701459|NCT01113957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701460|NCT01113957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701461|NCT01113957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65701462|NCT01113957|Alkylating Agents|alkylating agents|mesh-ancestor
65701463|NCT01113957|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65701464|NCT01111773|Lidocaine|lidocaine|mesh-list
65701465|NCT01111773|Tetracaine|tetracaine|mesh-list
65701466|NCT01111773|Anesthetics, Local|anesthetics, local|mesh-ancestor
65701467|NCT01111773|Anesthetics|anesthetics|mesh-ancestor
65701468|NCT01111773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65701469|NCT01111773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701470|NCT01111773|Sensory System Agents|sensory system agents|mesh-ancestor
65701471|NCT01111773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65701472|NCT01111773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65701473|NCT01111773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65701474|NCT01111773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65701475|NCT01111773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65701476|NCT01111773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701477|NCT01280331|Morphine|morphine|mesh-list
65701478|NCT01280331|Oxycodone|oxycodone|mesh-list
65701479|NCT01280331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65701480|NCT01280331|Narcotics|narcotics|mesh-ancestor
65701481|NCT01280331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65701482|NCT01280331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701483|NCT01280331|Analgesics|analgesics|mesh-ancestor
65701484|NCT01280331|Sensory System Agents|sensory system agents|mesh-ancestor
65701485|NCT01280331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65701486|NCT01266525|Donepezil|donepezil|mesh-list
65701487|NCT01266525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65701488|NCT01266525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701489|NCT01266525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701490|NCT01266525|Cholinergic Agents|cholinergic agents|mesh-ancestor
65701491|NCT01266525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65701492|NCT01266525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701493|NCT01266525|Nootropic Agents|nootropic agents|mesh-ancestor
65701494|NCT01265901|Cyclophosphamide|cyclophosphamide|mesh-list
65701495|NCT01265901|Sunitinib|sunitinib|mesh-list
65701496|NCT01265901|Molgramostim|molgramostim|mesh-list
65701497|NCT01265901|Sargramostim|sargramostim|mesh-list
65701498|NCT01265901|Immunologic Factors|immunologic factors|mesh-ancestor
65701499|NCT01265901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701500|NCT01265901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65701501|NCT01265901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65701502|NCT01265901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65701503|NCT01265901|Alkylating Agents|alkylating agents|mesh-ancestor
65701504|NCT01265901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701505|NCT01265901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701506|NCT01265901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65701507|NCT01265901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65701508|NCT01265901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65701509|NCT01265901|Growth Substances|growth substances|mesh-ancestor
65701510|NCT01265901|Growth Inhibitors|growth inhibitors|mesh-ancestor
65701511|NCT01265901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65701512|NCT01265901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701513|NCT05231382|Leucovorin|leucovorin|mesh-list
65701514|NCT05231382|Fluorouracil|fluorouracil|mesh-list
65701515|NCT05231382|Raltitrexed|raltitrexed|mesh-list
65701516|NCT05231382|Oxaliplatin|oxaliplatin|mesh-list
65701517|NCT05231382|Antimetabolites|antimetabolites|mesh-ancestor
65701518|NCT05231382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701519|NCT05231382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65701520|NCT05231382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701521|NCT05231382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65701522|NCT05231382|Immunologic Factors|immunologic factors|mesh-ancestor
65701523|NCT05231382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701524|NCT05231382|Antidotes|antidotes|mesh-ancestor
65701525|NCT05231382|Protective Agents|protective agents|mesh-ancestor
65701526|NCT05231382|Vitamin B Complex|vitamin b complex|mesh-ancestor
65701527|NCT05231382|Vitamins|vitamins|mesh-ancestor
65701528|NCT05231382|Micronutrients|micronutrients|mesh-ancestor
65701529|NCT05231382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65701530|NCT05231382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701531|NCT01262001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65701532|NCT01262001|Immunologic Factors|immunologic factors|mesh-ancestor
65701533|NCT01262001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701534|NCT01460511|Epinephrine|epinephrine|mesh-list
65701535|NCT01460511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65701536|NCT01460511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65701537|NCT01460511|Adrenergic Agents|adrenergic agents|mesh-ancestor
65701538|NCT01460511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65701539|NCT01460511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701540|NCT01460511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701541|NCT01460511|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65701542|NCT01460511|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65701543|NCT01460511|Autonomic Agents|autonomic agents|mesh-ancestor
65701544|NCT01460511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65701545|NCT01460511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65701546|NCT01460511|Respiratory System Agents|respiratory system agents|mesh-ancestor
65701547|NCT01460511|Mydriatics|mydriatics|mesh-ancestor
65701548|NCT01460511|Sympathomimetics|sympathomimetics|mesh-ancestor
65701549|NCT01460511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65701550|NCT03135171|Trastuzumab|trastuzumab|mesh-list
65701551|NCT03135171|Pertuzumab|pertuzumab|mesh-list
65701552|NCT03135171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65701553|NCT03135171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701554|NCT01449591|Metronidazole|metronidazole|mesh-list
65701555|NCT01449591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65701556|NCT01449591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65701557|NCT01449591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65017404|NCT00529750|Atenolol|atenolol|mesh-list
65701558|NCT01449591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65701559|NCT00909753|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65701560|NCT00909753|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65701561|NCT00909753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65701562|NCT01444365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65701563|NCT01444365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65701565|NCT01444365|Sensory System Agents|sensory system agents|mesh-ancestor
65701566|NCT01444365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65701567|NCT01444365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701568|NCT01444365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65701569|NCT01444365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65701570|NCT01098435|ALKS-33|alks-33|mesh-list
65701571|NCT01098435|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65701572|NCT01098435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701573|NCT01098435|Sensory System Agents|sensory system agents|mesh-ancestor
65701574|NCT01098435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65701575|NCT00909597|Pioglitazone|pioglitazone|mesh-list
65701576|NCT00909597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65701577|NCT00909597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65701578|NCT00909597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701579|NCT00909597|Incretins|incretins|mesh-ancestor
65701580|NCT00909597|Hormones|hormones|mesh-ancestor
65701581|NCT00909597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65701582|NCT01077297|Tezosentan|tezosentan|mesh-list
65701583|NCT01077297|Vasodilator Agents|vasodilator agents|mesh-ancestor
65701584|NCT05653245|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
65701585|NCT05653245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701586|NCT05379855|Atropine|atropine|mesh-list
65701587|NCT05379855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65701588|NCT05379855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65701589|NCT05379855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65701590|NCT05379855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65701591|NCT05379855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65701592|NCT05379855|Autonomic Agents|autonomic agents|mesh-ancestor
65701593|NCT05379855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65701594|NCT05379855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701595|NCT05379855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65701596|NCT05379855|Respiratory System Agents|respiratory system agents|mesh-ancestor
65701597|NCT05379855|Mydriatics|mydriatics|mesh-ancestor
65701598|NCT05379855|Parasympatholytics|parasympatholytics|mesh-ancestor
65701599|NCT05379855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65701600|NCT05379855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65701601|NCT05379855|Cholinergic Agents|cholinergic agents|mesh-ancestor
65701602|NCT05379855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65701603|NCT05379855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701604|NCT02718326|Aflibercept|aflibercept|mesh-list
65701605|NCT02718326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65701606|NCT02718326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65701607|NCT02718326|Growth Substances|growth substances|mesh-ancestor
65701608|NCT02718326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701609|NCT02718326|Growth Inhibitors|growth inhibitors|mesh-ancestor
65701610|NCT02718326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701611|NCT03691584|Dimercaprol|dimercaprol|mesh-list
65701612|NCT03691584|Chelating Agents|chelating agents|mesh-ancestor
65701613|NCT03691584|Sequestering Agents|sequestering agents|mesh-ancestor
65701614|NCT03691584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701615|NCT04655144|Dexamethasone|dexamethasone|mesh-list
65701616|NCT04655144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65701617|NCT04655144|Antiemetics|antiemetics|mesh-ancestor
65701618|NCT04655144|Autonomic Agents|autonomic agents|mesh-ancestor
65701619|NCT04655144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65701620|NCT04655144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701621|NCT04655144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65701622|NCT04655144|Glucocorticoids|glucocorticoids|mesh-ancestor
65701623|NCT04655144|Hormones|hormones|mesh-ancestor
65701624|NCT04655144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65701625|NCT04655144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65701626|NCT04655144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701627|NCT03468972|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65701628|NCT03468972|Immunologic Factors|immunologic factors|mesh-ancestor
65701629|NCT03468972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701630|NCT03600714|Interferons|interferons|mesh-list
65701631|NCT03600714|Ritonavir|ritonavir|mesh-list
65701632|NCT03600714|Lonafarnib|lonafarnib|mesh-list
65701633|NCT03600714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701634|NCT03600714|Antiviral Agents|antiviral agents|mesh-ancestor
65701635|NCT03600714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65701636|NCT03600714|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65701637|NCT03600714|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65701638|NCT03600714|Protease Inhibitors|protease inhibitors|mesh-ancestor
65701639|NCT03600714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701640|NCT03600714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701641|NCT03600714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65701642|NCT03600714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65701643|NCT03600714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65701644|NCT03600714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65701645|NCT04590326|Cemiplimab|cemiplimab|mesh-list
65701646|NCT04590326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65701647|NCT04590326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701648|NCT05163366|Ketamine|ketamine|mesh-list
65701649|NCT05163366|Morphine|morphine|mesh-list
65701650|NCT05163366|Analgesics|analgesics|mesh-ancestor
65701651|NCT05163366|Sensory System Agents|sensory system agents|mesh-ancestor
65701652|NCT05163366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65701653|NCT05163366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701654|NCT05163366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65701655|NCT05163366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65701656|NCT05163366|Anesthetics, General|anesthetics, general|mesh-ancestor
65701657|NCT05163366|Anesthetics|anesthetics|mesh-ancestor
65701658|NCT05163366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65701659|NCT05163366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65701660|NCT05163366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65701661|NCT05163366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65701662|NCT05163366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701663|NCT05163366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65701664|NCT05163366|Narcotics|narcotics|mesh-ancestor
65701665|NCT00900783|Valacyclovir|valacyclovir|mesh-list
65701666|NCT00900783|Antiviral Agents|antiviral agents|mesh-ancestor
65701667|NCT00900783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65701668|NCT01035879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65701669|NCT01035879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65701670|NCT01035879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701671|NCT01035879|Incretins|incretins|mesh-ancestor
65701672|NCT01035879|Hormones|hormones|mesh-ancestor
65164275|NCT04230031|Daratumumab|daratumumab|mesh-list
65701673|NCT01035879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65701674|NCT01035879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65701675|NCT01035879|Protease Inhibitors|protease inhibitors|mesh-ancestor
65701676|NCT01035879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701677|NCT01035879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701678|NCT04978298|Phenelzine|phenelzine|mesh-list
65701679|NCT04978298|Ozanimod|ozanimod|mesh-list
65701680|NCT04978298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65701681|NCT04978298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701682|NCT04978298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65701683|NCT04978298|Immunologic Factors|immunologic factors|mesh-ancestor
65701684|NCT04978298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701685|NCT04978298|Antidepressive Agents|antidepressive agents|mesh-ancestor
65701686|NCT04978298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65701687|NCT04978298|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65701688|NCT04978298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701689|NCT01029873|Cisplatin|cisplatin|mesh-list
65701690|NCT01029873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701691|NCT01024101|Paclitaxel|paclitaxel|mesh-list
65701692|NCT01024101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65701693|NCT01024101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701694|NCT01024101|Tubulin Modulators|tubulin modulators|mesh-ancestor
65701695|NCT01024101|Antimitotic Agents|antimitotic agents|mesh-ancestor
65701696|NCT01024101|Mitosis Modulators|mitosis modulators|mesh-ancestor
65701697|NCT01024101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701698|NCT04489706|Arsenic Trioxide|arsenic trioxide|mesh-list
65701699|NCT04489706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701700|NCT00818571|Vildagliptin|vildagliptin|mesh-list
65701701|NCT00818571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65701702|NCT00818571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701703|NCT00818571|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65701704|NCT00818571|Protease Inhibitors|protease inhibitors|mesh-ancestor
65701705|NCT00818571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701706|NCT00818571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701707|NCT00818493|Acetaminophen|acetaminophen|mesh-list
65701708|NCT00818493|Morphine|morphine|mesh-list
65017552|NCT00531076|Bevacizumab|bevacizumab|mesh-list
65701709|NCT00818493|Oxycodone|oxycodone|mesh-list
65701710|NCT00818493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65701711|NCT00818493|Narcotics|narcotics|mesh-ancestor
65701712|NCT00818493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65701713|NCT00818493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701714|NCT00818493|Analgesics|analgesics|mesh-ancestor
65701715|NCT00818493|Sensory System Agents|sensory system agents|mesh-ancestor
65701716|NCT00818493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65701717|NCT00818493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65701718|NCT00818493|Antipyretics|antipyretics|mesh-ancestor
65701719|NCT04455126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65701720|NCT04455126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65701721|NCT00893139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65701722|NCT00893139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65701723|NCT01378962|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65701724|NCT01378962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701725|NCT01378962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65701726|NCT01378962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701727|NCT01378962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701728|NCT00892203|Sumatriptan|sumatriptan|mesh-list
65701729|NCT00892203|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65701730|NCT00892203|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65701731|NCT00892203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65701732|NCT00892203|Serotonin Agents|serotonin agents|mesh-ancestor
65701733|NCT00892203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65701734|NCT00892203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701735|NCT00892203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701737|NCT05151471|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65701738|NCT05151471|Antioxidants|antioxidants|mesh-ancestor
65701739|NCT05151471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701740|NCT05151471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65701741|NCT05151471|Protective Agents|protective agents|mesh-ancestor
65701742|NCT05151471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701743|NCT04375956|Pembrolizumab|pembrolizumab|mesh-list
65701744|NCT04375956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65701745|NCT04375956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701746|NCT04495478|Ramucirumab|ramucirumab|mesh-list
65701747|NCT04495478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65701748|NCT04495478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701749|NCT04495478|Immunologic Factors|immunologic factors|mesh-ancestor
65701750|NCT04495478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701751|NCT04487444|Thymalfasin|thymalfasin|mesh-list
65701752|NCT04487444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65701753|NCT04487444|Immunologic Factors|immunologic factors|mesh-ancestor
65701754|NCT04487444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701755|NCT02717156|Pembrolizumab|pembrolizumab|mesh-list
65701756|NCT02717156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65701757|NCT02717156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701758|NCT00884715|Octreotide|octreotide|mesh-list
65701759|NCT00884715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65701760|NCT00884715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65701761|NCT00884715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701762|NCT03603080|Metformin|metformin|mesh-list
65701763|NCT03603080|Topiramate|topiramate|mesh-list
65701764|NCT03603080|Anti-Obesity Agents|anti-obesity agents|mesh-list
65701765|NCT03603080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65701766|NCT03603080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701767|NCT03603080|Anticonvulsants|anticonvulsants|mesh-ancestor
65701768|NCT01019187|Modafinil|modafinil|mesh-list
65701769|NCT01019187|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65701770|NCT01019187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701771|NCT01019187|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65701772|NCT01019187|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65701773|NCT01019187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65701774|NCT01019187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701775|NCT05088876|Acetaminophen|acetaminophen|mesh-list
65701776|NCT05088876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65701777|NCT05088876|Analgesics|analgesics|mesh-ancestor
65701778|NCT05088876|Sensory System Agents|sensory system agents|mesh-ancestor
65701779|NCT05088876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65701780|NCT05088876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701781|NCT05088876|Antipyretics|antipyretics|mesh-ancestor
65701782|NCT05084508|Vaccines|vaccines|mesh-list
65701783|NCT05084508|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65017626|NCT00144872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65701784|NCT05084508|Immunologic Factors|immunologic factors|mesh-ancestor
65701785|NCT05084508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701787|NCT01018875|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65701788|NCT01018875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701789|NCT01018875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701790|NCT01018875|Cholinergic Agents|cholinergic agents|mesh-ancestor
65701791|NCT01018875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65701792|NCT01018875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701793|NCT01018875|Nootropic Agents|nootropic agents|mesh-ancestor
65701794|NCT05390736|Vitamin D|vitamin d|mesh-list
65701795|NCT05390736|Vitamins|vitamins|mesh-ancestor
65701796|NCT05390736|Micronutrients|micronutrients|mesh-ancestor
65701797|NCT05390736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701798|NCT05390736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65701799|NCT00806403|Reteplase|reteplase|mesh-list
65701800|NCT00806403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65701801|NCT00806403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65701802|NCT00806403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701803|NCT01007721|Fluticasone|fluticasone|mesh-list
65701804|NCT01007721|Xhance|xhance|mesh-list
65701805|NCT01007721|Montelukast|montelukast|mesh-list
65701806|NCT01007721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65701807|NCT01007721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65701808|NCT01007721|Autonomic Agents|autonomic agents|mesh-ancestor
65701809|NCT01007721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65701810|NCT01007721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701811|NCT01007721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65701812|NCT01007721|Respiratory System Agents|respiratory system agents|mesh-ancestor
65701813|NCT01007721|Dermatologic Agents|dermatologic agents|mesh-ancestor
65701814|NCT01007721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65701815|NCT01007721|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65701816|NCT01007721|Hormone Antagonists|hormone antagonists|mesh-ancestor
65701817|NCT01007721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65701818|NCT01007721|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65701819|NCT01007721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65701820|NCT01007721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701821|NCT00701558|Gemcitabine|gemcitabine|mesh-list
65701822|NCT00701558|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65701823|NCT00701558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65701824|NCT00701558|Antimetabolites|antimetabolites|mesh-ancestor
65701825|NCT00701558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701826|NCT00701558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701827|NCT00701558|Antiviral Agents|antiviral agents|mesh-ancestor
65701828|NCT00701558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65701829|NCT00701558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701830|NCT00701558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65701831|NCT00701558|Immunologic Factors|immunologic factors|mesh-ancestor
65701832|NCT00701558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701833|NCT00701558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65701834|NCT03233828|Aldesleukin|aldesleukin|mesh-list
65701835|NCT03233828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701836|NCT03233828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65701837|NCT03233828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65701838|NCT03233828|Antiviral Agents|antiviral agents|mesh-ancestor
65701839|NCT03233828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65701840|NCT03882177|Vitamin B 6|vitamin b 6|mesh-list
65701841|NCT03882177|Pyridoxal|pyridoxal|mesh-list
65701842|NCT03882177|Pyridoxine|pyridoxine|mesh-list
65701843|NCT03882177|Pravastatin|pravastatin|mesh-list
65701844|NCT03882177|Vitamins|vitamins|mesh-ancestor
65701845|NCT03882177|Micronutrients|micronutrients|mesh-ancestor
65701846|NCT03882177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701847|NCT03882177|Vitamin B Complex|vitamin b complex|mesh-ancestor
65701848|NCT03882177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65701849|NCT03882177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65701850|NCT03882177|Antimetabolites|antimetabolites|mesh-ancestor
65701851|NCT03882177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701852|NCT03882177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65701853|NCT03882177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65701854|NCT03882177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701855|NCT01007097|Glimepiride|glimepiride|mesh-list
65701856|NCT01007097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65701857|NCT01007097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65701858|NCT01007097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701859|NCT01007097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65017708|NCT00168636|Vitamin A|vitamin a|mesh-list
65701860|NCT01007097|Immunologic Factors|immunologic factors|mesh-ancestor
65701862|NCT05115903|Etanercept|etanercept|mesh-list
65701863|NCT05115903|Golimumab|golimumab|mesh-list
65701864|NCT05115903|Infliximab|infliximab|mesh-list
65701865|NCT05115903|Certolizumab Pegol|certolizumab pegol|mesh-list
65701866|NCT05115903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65701867|NCT05115903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65701868|NCT05115903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65701869|NCT05115903|Dermatologic Agents|dermatologic agents|mesh-ancestor
65701870|NCT05115903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65701871|NCT05115903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65701872|NCT05115903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65701873|NCT05115903|Analgesics|analgesics|mesh-ancestor
65701874|NCT05115903|Sensory System Agents|sensory system agents|mesh-ancestor
65701875|NCT05115903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65701876|NCT05115903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701877|NCT05115903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65701878|NCT05115903|Immunologic Factors|immunologic factors|mesh-ancestor
65701879|NCT05115903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65701880|NCT03695250|Nivolumab|nivolumab|mesh-list
65701881|NCT03695250|Linrodostat|linrodostat|mesh-list
65701882|NCT03695250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65701883|NCT03695250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701884|NCT03695250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65269151|NCT02741414|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65701885|NCT03695250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701886|NCT03695250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701887|NCT03223298|Botulinum Toxins|botulinum toxins|mesh-list
65701888|NCT03223298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65701889|NCT03223298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65701890|NCT03223298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65701891|NCT03223298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65701892|NCT03223298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701893|NCT03223298|Cholinergic Agents|cholinergic agents|mesh-ancestor
65701894|NCT03223298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65701895|NCT03223298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701896|NCT03223298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65701897|NCT03223298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65701898|NCT04614636|Cyclophosphamide|cyclophosphamide|mesh-list
65701899|NCT04614636|Fludarabine|fludarabine|mesh-list
65701900|NCT04614636|Daratumumab|daratumumab|mesh-list
65701901|NCT04614636|Elotuzumab|elotuzumab|mesh-list
65701902|NCT04614636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65701903|NCT04614636|Immunologic Factors|immunologic factors|mesh-ancestor
65701904|NCT04614636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701905|NCT04614636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65701906|NCT04614636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65701907|NCT04614636|Alkylating Agents|alkylating agents|mesh-ancestor
65701908|NCT04614636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701909|NCT04614636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701910|NCT04614636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65701911|NCT00869661|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65701912|NCT00869661|Interferon-alpha|interferon-alpha|mesh-list
65701913|NCT00869661|Ribavirin|ribavirin|mesh-list
65701914|NCT00869661|Antiviral Agents|antiviral agents|mesh-ancestor
65701915|NCT00869661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65701916|NCT00869661|Immunologic Factors|immunologic factors|mesh-ancestor
65701917|NCT00869661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701918|NCT00869661|Antimetabolites|antimetabolites|mesh-ancestor
65701919|NCT00869661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701920|NCT03192566|Acetaminophen|acetaminophen|mesh-list
65701921|NCT03192566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65701922|NCT03192566|Analgesics|analgesics|mesh-ancestor
65701923|NCT03192566|Sensory System Agents|sensory system agents|mesh-ancestor
65701924|NCT03192566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65701925|NCT03192566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701926|NCT03192566|Antipyretics|antipyretics|mesh-ancestor
65701927|NCT03296930|Ritonavir|ritonavir|mesh-list
65701928|NCT03296930|Ribavirin|ribavirin|mesh-list
65701929|NCT03296930|Sofosbuvir|sofosbuvir|mesh-list
65701930|NCT03296930|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65701931|NCT03296930|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65701932|NCT03296930|Protease Inhibitors|protease inhibitors|mesh-ancestor
65701933|NCT03296930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701934|NCT03296930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701935|NCT03296930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65701936|NCT03296930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65701937|NCT03296930|Antiviral Agents|antiviral agents|mesh-ancestor
65701938|NCT03296930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65701939|NCT03296930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65701940|NCT03296930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65701941|NCT03296930|Antimetabolites|antimetabolites|mesh-ancestor
65701942|NCT04607772|Gemcitabine|gemcitabine|mesh-list
65701943|NCT04607772|Rituximab|rituximab|mesh-list
65701944|NCT04607772|Oxaliplatin|oxaliplatin|mesh-list
65701945|NCT04607772|Lenalidomide|lenalidomide|mesh-list
65701946|NCT04607772|Venetoclax|venetoclax|mesh-list
65701947|NCT04607772|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65701948|NCT04607772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65701949|NCT04607772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701950|NCT04607772|Immunologic Factors|immunologic factors|mesh-ancestor
65701951|NCT04607772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701952|NCT04607772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65701953|NCT04607772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65701954|NCT04607772|Antimetabolites|antimetabolites|mesh-ancestor
65701955|NCT04607772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701956|NCT04607772|Antiviral Agents|antiviral agents|mesh-ancestor
65701957|NCT04607772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65701958|NCT04607772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701959|NCT04607772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65701960|NCT04607772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65701961|NCT04607772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65701962|NCT04607772|Growth Substances|growth substances|mesh-ancestor
65701963|NCT04607772|Growth Inhibitors|growth inhibitors|mesh-ancestor
65701964|NCT04607772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65701965|NCT04607772|Alkylating Agents|alkylating agents|mesh-ancestor
65701966|NCT01001715|Fasinumab|fasinumab|mesh-list
65701967|NCT01001715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65701968|NCT01001715|Analgesics|analgesics|mesh-ancestor
65701969|NCT01001715|Sensory System Agents|sensory system agents|mesh-ancestor
65701970|NCT01001715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65701971|NCT01001715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701972|NCT02464124|Nitazoxanide|nitazoxanide|mesh-list
65701973|NCT02464124|Lactulose|lactulose|mesh-list
65701974|NCT02464124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65701975|NCT02464124|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65701976|NCT02464124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65701977|NCT00859521|Levetiracetam|levetiracetam|mesh-list
65701978|NCT00859521|Anticonvulsants|anticonvulsants|mesh-ancestor
65701979|NCT00859521|Nootropic Agents|nootropic agents|mesh-ancestor
65701980|NCT05398770|Vitamin D|vitamin d|mesh-list
65701981|NCT05398770|Vitamins|vitamins|mesh-ancestor
65701982|NCT05398770|Micronutrients|micronutrients|mesh-ancestor
65701983|NCT05398770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65701984|NCT05398770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65701985|NCT03033914|Doxorubicin|doxorubicin|mesh-list
65701986|NCT03033914|Bleomycin|bleomycin|mesh-list
65701987|NCT03033914|Nivolumab|nivolumab|mesh-list
65701988|NCT03033914|Dacarbazine|dacarbazine|mesh-list
65701989|NCT03033914|Vinblastine|vinblastine|mesh-list
65701990|NCT03033914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65701991|NCT03033914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65701992|NCT03033914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65701993|NCT03033914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65701994|NCT03033914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65701995|NCT03033914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65701996|NCT03033914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65701997|NCT03033914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65701998|NCT03033914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65701999|NCT03033914|Alkylating Agents|alkylating agents|mesh-ancestor
65702000|NCT03033914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65702001|NCT03033914|Tubulin Modulators|tubulin modulators|mesh-ancestor
65702002|NCT03033914|Antimitotic Agents|antimitotic agents|mesh-ancestor
65702003|NCT03033914|Mitosis Modulators|mitosis modulators|mesh-ancestor
65702004|NCT00843687|Risperidone|risperidone|mesh-list
65702005|NCT00843687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65702006|NCT00843687|Serotonin Agents|serotonin agents|mesh-ancestor
65702007|NCT00843687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65702008|NCT00843687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702009|NCT00843687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702010|NCT00843687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65702011|NCT00843687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65702012|NCT00843687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65702013|NCT00843687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65702014|NCT00843687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65702016|NCT04642131|Caffeine|caffeine|mesh-list
65702017|NCT04642131|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65702018|NCT04642131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702019|NCT04642131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65702020|NCT04642131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702021|NCT04642131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702022|NCT04642131|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65702023|NCT04642131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65702024|NCT04642131|Purinergic Agents|purinergic agents|mesh-ancestor
65702025|NCT04642131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65702026|NCT02463812|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65702027|NCT02463812|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65702028|NCT02463812|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65702029|NCT02463812|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65702030|NCT00789633|Gemcitabine|gemcitabine|mesh-list
65702031|NCT00789633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65702032|NCT00789633|Antimetabolites|antimetabolites|mesh-ancestor
65702033|NCT00789633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702034|NCT00789633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702035|NCT00789633|Antiviral Agents|antiviral agents|mesh-ancestor
65702036|NCT00789633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65702037|NCT00789633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702038|NCT00789633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65702039|NCT00789633|Immunologic Factors|immunologic factors|mesh-ancestor
65702040|NCT00789633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702041|NCT00788541|Hydrocortisone|hydrocortisone|mesh-list
65702042|NCT00788541|Anecortave|anecortave|mesh-list
65702043|NCT00788541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65702044|NCT00788541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65702045|NCT00788541|Growth Substances|growth substances|mesh-ancestor
65702046|NCT00788541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702047|NCT00788541|Growth Inhibitors|growth inhibitors|mesh-ancestor
65702048|NCT00788541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702049|NCT00788541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65702050|NCT03296540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65702051|NCT03296540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65702052|NCT04489160|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
65702053|NCT04489160|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65702054|NCT04489160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65702055|NCT04489160|Immunologic Factors|immunologic factors|mesh-ancestor
65702056|NCT04489160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702057|NCT00786201|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65702058|NCT00786201|Immunologic Factors|immunologic factors|mesh-ancestor
65702059|NCT00786201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702060|NCT02320292|Rituximab|rituximab|mesh-list
65702061|NCT02320292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65702062|NCT02320292|Antibodies|antibodies|mesh-list
65702063|NCT02320292|Immunoglobulins|immunoglobulins|mesh-list
65702064|NCT02320292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65702065|NCT02320292|Immunologic Factors|immunologic factors|mesh-ancestor
65702066|NCT02320292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702067|NCT02320292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702068|NCT02320292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65702069|NCT05514483|Ondansetron|ondansetron|mesh-list
65702070|NCT05514483|Antiemetics|antiemetics|mesh-ancestor
65702071|NCT05514483|Autonomic Agents|autonomic agents|mesh-ancestor
65702072|NCT05514483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65702073|NCT05514483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702074|NCT05514483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65702075|NCT05514483|Antipruritics|antipruritics|mesh-ancestor
65702076|NCT05514483|Dermatologic Agents|dermatologic agents|mesh-ancestor
65702077|NCT05514483|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65702078|NCT05514483|Serotonin Agents|serotonin agents|mesh-ancestor
65702079|NCT05514483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65702080|NCT05514483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702081|NCT05514483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65702082|NCT05514483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65702083|NCT05514483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65702084|NCT05514483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65702085|NCT05514483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65702086|NCT00841815|Amlodipine|amlodipine|mesh-list
65702087|NCT00841815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65017927|NCT00168909|Alfacalcidol|alfacalcidol|mesh-list
65702088|NCT00841815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65702089|NCT00841815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65702090|NCT00841815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702091|NCT00841815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65702092|NCT00841815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702093|NCT00841815|Vasodilator Agents|vasodilator agents|mesh-ancestor
65702094|NCT03296306|Cisplatin|cisplatin|mesh-list
65702095|NCT03296306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702096|NCT04440280|Acetylcysteine|acetylcysteine|mesh-list
65702097|NCT04440280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65702098|NCT04440280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65702099|NCT04440280|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65702100|NCT04440280|Antiviral Agents|antiviral agents|mesh-ancestor
65702101|NCT04440280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65702102|NCT04440280|Expectorants|expectorants|mesh-ancestor
65702103|NCT04440280|Respiratory System Agents|respiratory system agents|mesh-ancestor
65702104|NCT04440280|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65702105|NCT04440280|Antioxidants|antioxidants|mesh-ancestor
65702106|NCT04440280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702107|NCT04440280|Protective Agents|protective agents|mesh-ancestor
65702108|NCT04440280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702109|NCT04440280|Antidotes|antidotes|mesh-ancestor
65702110|NCT00841659|Paroxetine|paroxetine|mesh-list
65702111|NCT00841659|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65702112|NCT00841659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65702113|NCT00841659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65702114|NCT00841659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702115|NCT00841659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65702116|NCT00841659|Serotonin Agents|serotonin agents|mesh-ancestor
65702117|NCT00841659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702118|NCT00841659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65702119|NCT00841659|Antidepressive Agents|antidepressive agents|mesh-ancestor
65702120|NCT00841659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65702121|NCT00841659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65702122|NCT00841659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65702123|NCT00841659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702124|NCT04061252|Brodalumab|brodalumab|mesh-list
65702125|NCT04061252|Dermatologic Agents|dermatologic agents|mesh-ancestor
65702126|NCT05563558|Carboplatin|carboplatin|mesh-list
65702127|NCT05563558|Pembrolizumab|pembrolizumab|mesh-list
65702128|NCT05563558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702129|NCT05563558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65702130|NCT04473417|Dapagliflozin|dapagliflozin|mesh-list
65702131|NCT04473417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65702132|NCT04473417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702133|NCT04473417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65702134|NCT04473417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702135|NCT01001091|Dexamethasone|dexamethasone|mesh-list
65702136|NCT01001091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65702137|NCT01001091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65702138|NCT01001091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65702139|NCT01001091|Antiemetics|antiemetics|mesh-ancestor
65702140|NCT01001091|Autonomic Agents|autonomic agents|mesh-ancestor
65702141|NCT01001091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65702142|NCT01001091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702143|NCT01001091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65702144|NCT01001091|Glucocorticoids|glucocorticoids|mesh-ancestor
65702145|NCT01001091|Hormones|hormones|mesh-ancestor
65702146|NCT01001091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65702147|NCT01001091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65702148|NCT01001091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702149|NCT05076682|Efavirenz|efavirenz|mesh-list
65702150|NCT05076682|Cromolyn Sodium|cromolyn sodium|mesh-list
65702151|NCT05076682|Choline|choline|mesh-list
65702152|NCT05076682|Antibodies|antibodies|mesh-list
65702153|NCT05076682|Immunologic Factors|immunologic factors|mesh-ancestor
65702154|NCT05076682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702155|NCT05076682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65702156|NCT05076682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65702157|NCT05076682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702158|NCT05076682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702159|NCT05076682|Antiviral Agents|antiviral agents|mesh-ancestor
65702160|NCT05076682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65702161|NCT05076682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65702162|NCT05076682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65702163|NCT05076682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65702164|NCT05076682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65702165|NCT05076682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65702166|NCT05076682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65702167|NCT05076682|Lipotropic Agents|lipotropic agents|mesh-ancestor
65702168|NCT05076682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65702169|NCT05076682|Antimetabolites|antimetabolites|mesh-ancestor
65702170|NCT05076682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65702171|NCT05076682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65702172|NCT05076682|Nootropic Agents|nootropic agents|mesh-ancestor
65702173|NCT05076682|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
65702174|NCT05076682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65702175|NCT05076682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65702176|NCT05076682|Respiratory System Agents|respiratory system agents|mesh-ancestor
65269161|NCT02744690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702178|NCT00840879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65702179|NCT00840879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65702180|NCT00840879|Analgesics|analgesics|mesh-ancestor
65702181|NCT00840879|Sensory System Agents|sensory system agents|mesh-ancestor
65702182|NCT00840879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65702183|NCT00840879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702184|NCT00840879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65702185|NCT00840879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65702186|NCT00840879|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65702187|NCT00840879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65702188|NCT00840879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702189|NCT00840879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702190|NCT02163434|Gabapentin|gabapentin|mesh-list
65702191|NCT02163434|Metoclopramide|metoclopramide|mesh-list
65702192|NCT02163434|Analgesics|analgesics|mesh-ancestor
65702193|NCT02163434|Sensory System Agents|sensory system agents|mesh-ancestor
65702194|NCT02163434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65702195|NCT02163434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702196|NCT02163434|Anticonvulsants|anticonvulsants|mesh-ancestor
65702197|NCT02163434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65702198|NCT02163434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65702199|NCT02163434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65702200|NCT02163434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65702201|NCT02163434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65702202|NCT02163434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65702203|NCT02163434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65702204|NCT02163434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702205|NCT02163434|Antimanic Agents|antimanic agents|mesh-ancestor
65702206|NCT02163434|Antiemetics|antiemetics|mesh-ancestor
65702207|NCT02163434|Autonomic Agents|autonomic agents|mesh-ancestor
65702208|NCT02163434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65702209|NCT02163434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65702210|NCT02163434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65702211|NCT02163434|Dopamine Agents|dopamine agents|mesh-ancestor
65702212|NCT04015622|Docetaxel|docetaxel|mesh-list
65702213|NCT04015622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702214|NCT04015622|Tubulin Modulators|tubulin modulators|mesh-ancestor
65702215|NCT04015622|Antimitotic Agents|antimitotic agents|mesh-ancestor
65702216|NCT04015622|Mitosis Modulators|mitosis modulators|mesh-ancestor
65702217|NCT04015622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702218|NCT00840411|Clarithromycin|clarithromycin|mesh-list
65702219|NCT00840411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65702220|NCT00840411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65702221|NCT00840411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65702222|NCT00840411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702223|NCT00840411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702224|NCT00840411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65702225|NCT00840411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65702226|NCT00840099|Amoxicillin|amoxicillin|mesh-list
65702227|NCT00840099|Clavulanic Acid|clavulanic acid|mesh-list
65702228|NCT00840099|Clavulanic Acids|clavulanic acids|mesh-list
65702229|NCT00840099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65702230|NCT00840099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65702231|NCT00840099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65702232|NCT00840099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65702233|NCT00840099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702234|NCT00840099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702235|NCT03108248|Doxorubicin|doxorubicin|mesh-list
65702236|NCT03108248|Ethiodized Oil|ethiodized oil|mesh-list
65702237|NCT03108248|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
65702238|NCT03108248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65702239|NCT03108248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702240|NCT03108248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65702241|NCT03108248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65702242|NCT03108248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702243|NCT03108248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702244|NCT03108248|Hemostatics|hemostatics|mesh-ancestor
65702245|NCT03108248|Coagulants|coagulants|mesh-ancestor
65702246|NCT04934722|Pembrolizumab|pembrolizumab|mesh-list
65702247|NCT04934722|Androgens|androgens|mesh-list
65702248|NCT04934722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65702249|NCT04934722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702250|NCT04934722|Hormones|hormones|mesh-ancestor
65702251|NCT04934722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65702252|NCT04934722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702253|NCT00836901|Amoxicillin|amoxicillin|mesh-list
65702254|NCT00836901|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65702255|NCT00836901|Clavulanic Acids|clavulanic acids|mesh-list
65702256|NCT00836901|Clavulanic Acid|clavulanic acid|mesh-list
65702257|NCT00836901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65702258|NCT00836901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65702259|NCT00836901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65702260|NCT00836901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702261|NCT00836901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702262|NCT04460560|Terlipressin|terlipressin|mesh-list
65702263|NCT04460560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65702264|NCT04460560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65702265|NCT05468697|Palbociclib|palbociclib|mesh-list
65702266|NCT05468697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702267|NCT05468697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65702268|NCT05468697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702269|NCT05468697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702270|NCT04537689|Cyclosporine|cyclosporine|mesh-list
65702271|NCT04537689|Methotrexate|methotrexate|mesh-list
65702272|NCT04537689|Ixekizumab|ixekizumab|mesh-list
65702273|NCT04537689|Acitretin|acitretin|mesh-list
65702274|NCT04537689|Cyclosporins|cyclosporins|mesh-list
65702275|NCT04537689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65702276|NCT04537689|Abortifacient Agents|abortifacient agents|mesh-ancestor
65702277|NCT04537689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65702278|NCT04537689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702279|NCT04537689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65702280|NCT04537689|Antimetabolites|antimetabolites|mesh-ancestor
65702281|NCT04537689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702282|NCT04537689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702283|NCT04537689|Dermatologic Agents|dermatologic agents|mesh-ancestor
65702284|NCT04537689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702285|NCT04537689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65702286|NCT04537689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65702287|NCT04537689|Immunologic Factors|immunologic factors|mesh-ancestor
65702288|NCT04537689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65702289|NCT04537689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65702290|NCT04537689|Antifungal Agents|antifungal agents|mesh-ancestor
65702291|NCT04537689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65702292|NCT04537689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65702293|NCT04537689|Keratolytic Agents|keratolytic agents|mesh-ancestor
65702294|NCT03295760|Ubiquinone|ubiquinone|mesh-list
65702295|NCT03295760|Coenzyme Q10|coenzyme q10|mesh-list
65702296|NCT03295760|Micronutrients|micronutrients|mesh-ancestor
65702297|NCT03295760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702298|NCT03295760|Vitamins|vitamins|mesh-ancestor
65702299|NCT05563012|Capecitabine|capecitabine|mesh-list
65702300|NCT05563012|Oxaliplatin|oxaliplatin|mesh-list
65702301|NCT05563012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65702302|NCT05563012|Antimetabolites|antimetabolites|mesh-ancestor
65702303|NCT05563012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702304|NCT05563012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702305|NCT04501653|Methylphenidate|methylphenidate|mesh-list
65702306|NCT04501653|Psilocybin|psilocybin|mesh-list
65702307|NCT04501653|Psilocin|psilocin|mesh-list
65702308|NCT04501653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65702309|NCT04501653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702310|NCT04501653|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65702311|NCT04501653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65702312|NCT04501653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65702313|NCT04501653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702314|NCT04501653|Dopamine Agents|dopamine agents|mesh-ancestor
65702315|NCT04501653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65702316|NCT04501653|Hallucinogens|hallucinogens|mesh-ancestor
65702317|NCT04501653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65702318|NCT04730206|Camostat|camostat|mesh-list
65702319|NCT04730206|Protease Inhibitors|protease inhibitors|mesh-ancestor
65702320|NCT04730206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702321|NCT04730206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702322|NCT04730206|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65702323|NCT04730206|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65702324|NCT00990327|Adenosine|adenosine|mesh-list
65702325|NCT00990327|Analgesics|analgesics|mesh-ancestor
65702326|NCT00990327|Sensory System Agents|sensory system agents|mesh-ancestor
65702327|NCT00990327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65702328|NCT00990327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702329|NCT00990327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65702330|NCT00990327|Vasodilator Agents|vasodilator agents|mesh-ancestor
65702331|NCT00990327|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65702332|NCT00990327|Purinergic Agonists|purinergic agonists|mesh-ancestor
65702333|NCT00990327|Purinergic Agents|purinergic agents|mesh-ancestor
65702334|NCT00990327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65702335|NCT00990327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702336|NCT03050814|Leucovorin|leucovorin|mesh-list
65702337|NCT03050814|Bevacizumab|bevacizumab|mesh-list
65702338|NCT03050814|Avelumab|avelumab|mesh-list
65702339|NCT03050814|Fluorouracil|fluorouracil|mesh-list
65702340|NCT03050814|Capecitabine|capecitabine|mesh-list
65702341|NCT03050814|Oxaliplatin|oxaliplatin|mesh-list
65702342|NCT03050814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65702343|NCT03050814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702344|NCT03050814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65702345|NCT03050814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65702346|NCT03050814|Growth Substances|growth substances|mesh-ancestor
65702347|NCT03050814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702348|NCT03050814|Growth Inhibitors|growth inhibitors|mesh-ancestor
65702349|NCT03050814|Antimetabolites|antimetabolites|mesh-ancestor
65702350|NCT03050814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702351|NCT03050814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65702352|NCT03050814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65702353|NCT03050814|Immunologic Factors|immunologic factors|mesh-ancestor
65702354|NCT03050814|Antidotes|antidotes|mesh-ancestor
65702355|NCT03050814|Protective Agents|protective agents|mesh-ancestor
65702356|NCT03050814|Vitamin B Complex|vitamin b complex|mesh-ancestor
65702357|NCT03050814|Vitamins|vitamins|mesh-ancestor
65702358|NCT03050814|Micronutrients|micronutrients|mesh-ancestor
65702359|NCT02462174|Ketamine|ketamine|mesh-list
65702360|NCT02462174|Bupivacaine|bupivacaine|mesh-list
65702361|NCT02462174|Anesthetics, Local|anesthetics, local|mesh-ancestor
65702362|NCT02462174|Anesthetics|anesthetics|mesh-ancestor
65702363|NCT02462174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65702364|NCT02462174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702365|NCT02462174|Sensory System Agents|sensory system agents|mesh-ancestor
65702366|NCT02462174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65702367|NCT02462174|Analgesics|analgesics|mesh-ancestor
65702368|NCT02462174|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65702369|NCT02462174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65702370|NCT02462174|Anesthetics, General|anesthetics, general|mesh-ancestor
65702371|NCT02462174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65702372|NCT02462174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65702373|NCT02462174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65702374|NCT02462174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702375|NCT02564146|Gemcitabine|gemcitabine|mesh-list
65702376|NCT02564146|Paclitaxel|paclitaxel|mesh-list
65702377|NCT02564146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65702378|NCT02564146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65702379|NCT02564146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702380|NCT02564146|Tubulin Modulators|tubulin modulators|mesh-ancestor
65702381|NCT02564146|Antimitotic Agents|antimitotic agents|mesh-ancestor
65702382|NCT02564146|Mitosis Modulators|mitosis modulators|mesh-ancestor
65702383|NCT02564146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702384|NCT02564146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65702385|NCT02564146|Antimetabolites|antimetabolites|mesh-ancestor
65702386|NCT02564146|Antiviral Agents|antiviral agents|mesh-ancestor
65702387|NCT02564146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65702388|NCT02564146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702389|NCT02564146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65018304|NCT00146159|Mitoxantrone|mitoxantrone|mesh-list
65702390|NCT02564146|Immunologic Factors|immunologic factors|mesh-ancestor
65702391|NCT02564146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702392|NCT00981357|Naproxen|naproxen|mesh-list
65702393|NCT00981357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65702394|NCT00981357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65702395|NCT00981357|Analgesics|analgesics|mesh-ancestor
65702396|NCT00981357|Sensory System Agents|sensory system agents|mesh-ancestor
65702397|NCT00981357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65702398|NCT00981357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702399|NCT00981357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65702400|NCT00981357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65702401|NCT00981357|Gout Suppressants|gout suppressants|mesh-ancestor
65702402|NCT00981357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65702403|NCT00981357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702404|NCT00981357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702405|NCT02462252|Cyclosporine|cyclosporine|mesh-list
65702406|NCT02462252|Methylprednisolone|methylprednisolone|mesh-list
65702407|NCT02462252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65702408|NCT02462252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65702409|NCT02462252|Cyclosporins|cyclosporins|mesh-list
65702410|NCT02462252|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65702411|NCT02462252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702412|NCT02462252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702413|NCT02462252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65702414|NCT02462252|Immunologic Factors|immunologic factors|mesh-ancestor
65702415|NCT02462252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702416|NCT02462252|Antifungal Agents|antifungal agents|mesh-ancestor
65702417|NCT02462252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65702418|NCT02462252|Dermatologic Agents|dermatologic agents|mesh-ancestor
65702419|NCT02462252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65702420|NCT02462252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65702421|NCT02462252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65702422|NCT02462252|Antiemetics|antiemetics|mesh-ancestor
65702423|NCT02462252|Autonomic Agents|autonomic agents|mesh-ancestor
65702424|NCT02462252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65702425|NCT02462252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65702426|NCT02462252|Glucocorticoids|glucocorticoids|mesh-ancestor
65702427|NCT02462252|Hormones|hormones|mesh-ancestor
65702428|NCT02462252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65702429|NCT02462252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65702430|NCT02462252|Protective Agents|protective agents|mesh-ancestor
65702431|NCT02462252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65702432|NCT02462252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702433|NCT03130452|Amoxicillin|amoxicillin|mesh-list
65702434|NCT03130452|Metronidazole|metronidazole|mesh-list
65702435|NCT03130452|Clarithromycin|clarithromycin|mesh-list
65702436|NCT03130452|Lansoprazole|lansoprazole|mesh-list
65702437|NCT03130452|Dexlansoprazole|dexlansoprazole|mesh-list
65702438|NCT03130452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65702439|NCT03130452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65702440|NCT03130452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65702441|NCT03130452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65702442|NCT03130452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65702443|NCT03130452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702444|NCT03130452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702445|NCT03130452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65702446|NCT03130452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65702447|NCT03130452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65702448|NCT03130452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65702449|NCT03130452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65702450|NCT00979251|Oseltamivir|oseltamivir|mesh-list
65702451|NCT00979251|Amantadine|amantadine|mesh-list
65702452|NCT00979251|Antiviral Agents|antiviral agents|mesh-ancestor
65702453|NCT00979251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65702454|NCT00979251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702455|NCT00979251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702456|NCT00979251|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65702457|NCT00979251|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65702458|NCT00979251|Dopamine Agents|dopamine agents|mesh-ancestor
65702459|NCT00979251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65702460|NCT00979251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702461|NCT00979251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65702462|NCT00979251|Analgesics|analgesics|mesh-ancestor
65702463|NCT00979251|Sensory System Agents|sensory system agents|mesh-ancestor
65702464|NCT00979251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65702466|NCT04551352|Obinutuzumab|obinutuzumab|mesh-list
65702467|NCT04551352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65702468|NCT04551352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65702469|NCT04551352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65702470|NCT04551352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702471|NCT05398224|Rituximab|rituximab|mesh-list
65702472|NCT05398224|Methotrexate|methotrexate|mesh-list
65702473|NCT05398224|Zanubrutinib|zanubrutinib|mesh-list
65702474|NCT05398224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65702475|NCT05398224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702476|NCT05398224|Immunologic Factors|immunologic factors|mesh-ancestor
65702477|NCT05398224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702478|NCT05398224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65702479|NCT05398224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65702480|NCT05398224|Abortifacient Agents|abortifacient agents|mesh-ancestor
65702481|NCT05398224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65702482|NCT05398224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65702483|NCT05398224|Antimetabolites|antimetabolites|mesh-ancestor
65702484|NCT05398224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702485|NCT05398224|Dermatologic Agents|dermatologic agents|mesh-ancestor
65702486|NCT05398224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702487|NCT05398224|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65702488|NCT05398224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65702489|NCT05398224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65702490|NCT05398224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65702491|NCT04542304|Metolazone|metolazone|mesh-list
65702492|NCT04542304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65702493|NCT04542304|Diuretics|diuretics|mesh-ancestor
65702494|NCT04542304|Natriuretic Agents|natriuretic agents|mesh-ancestor
65702495|NCT04542304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702496|NCT04542304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65702497|NCT04542304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65702498|NCT04542304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702499|NCT02463110|Sertraline|sertraline|mesh-list
65702500|NCT02463110|Antidepressive Agents|antidepressive agents|mesh-ancestor
65702501|NCT02463110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65702502|NCT02463110|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65702503|NCT02463110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65702504|NCT02463110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65702505|NCT02463110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702506|NCT02463110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65702507|NCT02463110|Serotonin Agents|serotonin agents|mesh-ancestor
65702508|NCT02463110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702509|NCT04495257|Nivolumab|nivolumab|mesh-list
65702510|NCT04495257|Ipilimumab|ipilimumab|mesh-list
65702511|NCT04495257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65702512|NCT04495257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702513|NCT04495257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65702514|NCT04495257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702515|NCT05502952|Pentoxifylline|pentoxifylline|mesh-list
65702516|NCT05502952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65702517|NCT05502952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702518|NCT05502952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702519|NCT05502952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65702520|NCT05502952|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65702521|NCT05502952|Protective Agents|protective agents|mesh-ancestor
65702522|NCT05502952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702523|NCT05502952|Vasodilator Agents|vasodilator agents|mesh-ancestor
65702524|NCT05502952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65702525|NCT05502952|Antioxidants|antioxidants|mesh-ancestor
65702526|NCT05457855|Fluticasone|fluticasone|mesh-list
65702527|NCT05457855|Montelukast|montelukast|mesh-list
65702528|NCT05457855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65702529|NCT05457855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65702530|NCT05457855|Autonomic Agents|autonomic agents|mesh-ancestor
65702531|NCT05457855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65702532|NCT05457855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702533|NCT05457855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65702534|NCT05457855|Respiratory System Agents|respiratory system agents|mesh-ancestor
65702535|NCT05457855|Dermatologic Agents|dermatologic agents|mesh-ancestor
65702536|NCT05457855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65702537|NCT05457855|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65702538|NCT05457855|Hormone Antagonists|hormone antagonists|mesh-ancestor
65702539|NCT05457855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65702540|NCT05457855|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65702541|NCT05457855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65702542|NCT05457855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702543|NCT03910244|Pomalidomide|pomalidomide|mesh-list
65702544|NCT03910244|Immunologic Factors|immunologic factors|mesh-ancestor
65702545|NCT03910244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702546|NCT03910244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65269165|NCT02744690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702547|NCT03910244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65702548|NCT03910244|Growth Substances|growth substances|mesh-ancestor
65702549|NCT03910244|Growth Inhibitors|growth inhibitors|mesh-ancestor
65702550|NCT03910244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702551|NCT05497804|Dexamethasone|dexamethasone|mesh-list
65702552|NCT05497804|Dexamethasone acetate|dexamethasone acetate|mesh-list
65702553|NCT05497804|Lenalidomide|lenalidomide|mesh-list
65702554|NCT05497804|Daratumumab|daratumumab|mesh-list
65702555|NCT05497804|Ichthammol|ichthammol|mesh-list
65702556|NCT05497804|BB 1101|bb 1101|mesh-list
65702557|NCT05497804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65702558|NCT05497804|Antiemetics|antiemetics|mesh-ancestor
65702559|NCT05497804|Autonomic Agents|autonomic agents|mesh-ancestor
65702560|NCT05497804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65702561|NCT05497804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702562|NCT05497804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65702563|NCT05497804|Glucocorticoids|glucocorticoids|mesh-ancestor
65702564|NCT05497804|Hormones|hormones|mesh-ancestor
65702565|NCT05497804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65702566|NCT05497804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65702567|NCT05497804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702568|NCT05497804|Protease Inhibitors|protease inhibitors|mesh-ancestor
65702569|NCT05497804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702570|NCT05497804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702571|NCT05497804|Immunologic Factors|immunologic factors|mesh-ancestor
65702572|NCT05497804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65702573|NCT05497804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65702574|NCT05497804|Growth Substances|growth substances|mesh-ancestor
65702575|NCT05497804|Growth Inhibitors|growth inhibitors|mesh-ancestor
65702576|NCT05497804|Dermatologic Agents|dermatologic agents|mesh-ancestor
65702577|NCT00835575|Mirtazapine|mirtazapine|mesh-list
65702578|NCT00835575|Antidepressive Agents|antidepressive agents|mesh-ancestor
65702579|NCT00835575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65702580|NCT00835575|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65702581|NCT00835575|Histamine Antagonists|histamine antagonists|mesh-ancestor
65702582|NCT00835575|Histamine Agents|histamine agents|mesh-ancestor
65702583|NCT00835575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65702584|NCT00835575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702585|NCT00835575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702586|NCT00835575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65702587|NCT00835575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65702588|NCT00835575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65702589|NCT00835575|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65702590|NCT00835575|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65702591|NCT00835575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65702592|NCT00835575|Adrenergic Agents|adrenergic agents|mesh-ancestor
65702593|NCT00835575|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65702594|NCT00835575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65702595|NCT00835575|Serotonin Agents|serotonin agents|mesh-ancestor
65702596|NCT00835575|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65702597|NCT00777309|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65702598|NCT00777309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702599|NCT00777309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65702600|NCT00777309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702601|NCT00777309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702602|NCT03295214|Acetaminophen|acetaminophen|mesh-list
65702603|NCT03295214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65702604|NCT03295214|Analgesics|analgesics|mesh-ancestor
65702605|NCT03295214|Sensory System Agents|sensory system agents|mesh-ancestor
65702606|NCT03295214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65702607|NCT03295214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702608|NCT03295214|Antipyretics|antipyretics|mesh-ancestor
65702609|NCT04604704|Niacinamide|niacinamide|mesh-list
65702610|NCT04604704|Naltrexone|naltrexone|mesh-list
65702611|NCT04604704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65702612|NCT04604704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65702613|NCT04604704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702614|NCT04604704|Sensory System Agents|sensory system agents|mesh-ancestor
65702615|NCT04604704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65702616|NCT04604704|Vitamin B Complex|vitamin b complex|mesh-ancestor
65702617|NCT04604704|Vitamins|vitamins|mesh-ancestor
65702618|NCT04604704|Micronutrients|micronutrients|mesh-ancestor
65702619|NCT00776373|Cytarabine|cytarabine|mesh-list
65702620|NCT00776373|Sirolimus|sirolimus|mesh-list
65702621|NCT00776373|Etoposide|etoposide|mesh-list
65702622|NCT00776373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65702623|NCT00776373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702624|NCT00776373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65702625|NCT00776373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65702626|NCT00776373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702627|NCT00776373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702628|NCT00776373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65702629|NCT00776373|Antimetabolites|antimetabolites|mesh-ancestor
65702630|NCT00776373|Antiviral Agents|antiviral agents|mesh-ancestor
65702631|NCT00776373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65702632|NCT00776373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65702633|NCT00776373|Immunologic Factors|immunologic factors|mesh-ancestor
65702634|NCT00776373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702635|NCT00776373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65702636|NCT00776373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65702637|NCT00776373|Antifungal Agents|antifungal agents|mesh-ancestor
65702638|NCT00772785|Buprenorphine|buprenorphine|mesh-list
65702639|NCT00772785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65702640|NCT00772785|Narcotics|narcotics|mesh-ancestor
65702641|NCT00772785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65702642|NCT00772785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702643|NCT00772785|Analgesics|analgesics|mesh-ancestor
65702644|NCT00772785|Sensory System Agents|sensory system agents|mesh-ancestor
65702645|NCT00772785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65702646|NCT00772785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65702647|NCT02461706|Cannabidiol|cannabidiol|mesh-list
65702648|NCT02461706|Anticonvulsants|anticonvulsants|mesh-ancestor
65702649|NCT05497570|Tenoxicam|tenoxicam|mesh-list
65702650|NCT05497570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65702651|NCT05497570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65702652|NCT05497570|Analgesics|analgesics|mesh-ancestor
65702653|NCT05497570|Sensory System Agents|sensory system agents|mesh-ancestor
65702654|NCT05497570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65702655|NCT05497570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702656|NCT05497570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65702657|NCT05497570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65702658|NCT05497570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65702659|NCT05497570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702660|NCT05497570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702661|NCT00963885|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65702662|NCT00963885|Lactams|lactams|mesh-list
65702663|NCT00963885|Antiviral Agents|antiviral agents|mesh-ancestor
65702664|NCT00963885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65702665|NCT00963885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65702666|NCT05497492|Lidocaine|lidocaine|mesh-list
65702667|NCT05497492|Sufentanil|sufentanil|mesh-list
65702668|NCT05497492|Propofol|propofol|mesh-list
65702669|NCT05497492|Esketamine|esketamine|mesh-list
65702670|NCT05497492|Anesthetics, Local|anesthetics, local|mesh-ancestor
65702671|NCT05497492|Anesthetics|anesthetics|mesh-ancestor
65702672|NCT05497492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65702673|NCT05497492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702674|NCT05497492|Sensory System Agents|sensory system agents|mesh-ancestor
65702675|NCT05497492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65702676|NCT05497492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65702677|NCT05497492|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65702678|NCT05497492|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65702679|NCT05497492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65702680|NCT05497492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702681|NCT05497492|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65702682|NCT05497492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65702683|NCT05497492|Anesthetics, General|anesthetics, general|mesh-ancestor
65702684|NCT05497492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65702685|NCT05497492|Narcotics|narcotics|mesh-ancestor
65702686|NCT05497492|Analgesics|analgesics|mesh-ancestor
65702687|NCT05497492|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65702688|NCT05497492|Antidepressive Agents|antidepressive agents|mesh-ancestor
65702689|NCT05497492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65702690|NCT00835497|Metformin|metformin|mesh-list
65702691|NCT00835497|Glipizide|glipizide|mesh-list
65702692|NCT00835497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65702693|NCT00835497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702695|NCT04279054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65702696|NCT04279054|Narcotics|narcotics|mesh-ancestor
65702697|NCT04279054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65702698|NCT04279054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702699|NCT04279054|Analgesics|analgesics|mesh-ancestor
65702700|NCT04279054|Sensory System Agents|sensory system agents|mesh-ancestor
65702701|NCT04279054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65702702|NCT05005689|Fluorides|fluorides|mesh-list
65702703|NCT05005689|Sodium Fluoride|sodium fluoride|mesh-list
65702704|NCT05005689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702705|NCT05005689|Cariostatic Agents|cariostatic agents|mesh-ancestor
65702706|NCT05005689|Protective Agents|protective agents|mesh-ancestor
65702707|NCT00763503|Calcitriol|calcitriol|mesh-list
65702708|NCT00763503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65702709|NCT00763503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702710|NCT00763503|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65702711|NCT00763503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65702712|NCT00763503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702713|NCT00763503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65702714|NCT00763503|Vitamins|vitamins|mesh-ancestor
65702715|NCT00763503|Micronutrients|micronutrients|mesh-ancestor
65702716|NCT00763503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65702717|NCT00761709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65702718|NCT00761709|Latanoprost|latanoprost|mesh-list
65702719|NCT00761709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65702720|NCT00760539|Timolol|timolol|mesh-list
65702721|NCT00760539|Travoprost|travoprost|mesh-list
65702722|NCT00760539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65702723|NCT00760539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65702724|NCT00760539|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65702725|NCT00760539|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65702726|NCT00760539|Adrenergic Agents|adrenergic agents|mesh-ancestor
65702727|NCT00760539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65702728|NCT00760539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702729|NCT00760539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702730|NCT00760539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65702731|NCT00760539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65702732|NCT04976049|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65702733|NCT04976049|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65702734|NCT04976049|Dermatologic Agents|dermatologic agents|mesh-ancestor
65702735|NCT00759135|Finasteride|finasteride|mesh-list
65702736|NCT00759135|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65702737|NCT00759135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65702738|NCT00759135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702739|NCT00759135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702740|NCT00759135|Hormone Antagonists|hormone antagonists|mesh-ancestor
65702741|NCT00759135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65702742|NCT00759135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702743|NCT00759135|Urological Agents|urological agents|mesh-ancestor
65702744|NCT00835263|Lamotrigine|lamotrigine|mesh-list
65702745|NCT00835263|Anticonvulsants|anticonvulsants|mesh-ancestor
65702746|NCT00835263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65702747|NCT00835263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65702748|NCT00835263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702749|NCT00835263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65702750|NCT00835263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702751|NCT00835263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65702752|NCT00835263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65702753|NCT00835263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65702754|NCT00835263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65702755|NCT00835263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65702756|NCT02639910|Venetoclax|venetoclax|mesh-list
65702757|NCT02639910|Idelalisib|idelalisib|mesh-list
65702758|NCT02639910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702759|NCT02639910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702760|NCT02639910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702761|NCT04454580|Azacitidine|azacitidine|mesh-list
65702762|NCT04454580|Decitabine|decitabine|mesh-list
65702763|NCT04454580|Venetoclax|venetoclax|mesh-list
65018603|NCT00146783|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65702764|NCT04454580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65702765|NCT04454580|Antimetabolites|antimetabolites|mesh-ancestor
65702766|NCT04454580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702767|NCT04454580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702768|NCT04454580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702770|NCT00948909|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65702771|NCT00948909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65269169|NCT02736032|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65702772|NCT00948909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702773|NCT00948909|Cholinergic Agents|cholinergic agents|mesh-ancestor
65702774|NCT00948909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65702775|NCT00948909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702776|NCT00948909|Nootropic Agents|nootropic agents|mesh-ancestor
65702777|NCT02522910|Docetaxel|docetaxel|mesh-list
65702778|NCT02522910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702779|NCT02522910|Tubulin Modulators|tubulin modulators|mesh-ancestor
65702780|NCT02522910|Antimitotic Agents|antimitotic agents|mesh-ancestor
65702781|NCT02522910|Mitosis Modulators|mitosis modulators|mesh-ancestor
65702782|NCT02522910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702783|NCT00948753|Maraviroc|maraviroc|mesh-list
65702784|NCT00948753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65702785|NCT00948753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65702786|NCT00948753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702787|NCT00948753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65702788|NCT00948753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65702789|NCT00948753|Antiviral Agents|antiviral agents|mesh-ancestor
65702790|NCT00948753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65702791|NCT00948753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65702792|NCT05397834|Fluticasone|fluticasone|mesh-list
65702793|NCT05397834|Xhance|xhance|mesh-list
65702794|NCT05397834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65702795|NCT05397834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65702796|NCT05397834|Autonomic Agents|autonomic agents|mesh-ancestor
65702797|NCT05397834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65702798|NCT05397834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702799|NCT05397834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65702800|NCT05397834|Respiratory System Agents|respiratory system agents|mesh-ancestor
65702801|NCT05397834|Dermatologic Agents|dermatologic agents|mesh-ancestor
65702802|NCT05397834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65702803|NCT03134547|Sevoflurane|sevoflurane|mesh-list
65702804|NCT03134547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65702805|NCT03134547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65702806|NCT03134547|Anesthetics, General|anesthetics, general|mesh-ancestor
65702807|NCT03134547|Anesthetics|anesthetics|mesh-ancestor
65702808|NCT03134547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65702809|NCT03134547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702810|NCT01963208|Ganaxolone|ganaxolone|mesh-list
65702811|NCT01963208|Neurosteroids|neurosteroids|mesh-ancestor
65702812|NCT01963208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65702813|NCT01963208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702814|NCT01963208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702815|NCT01963208|GABA Modulators|gaba modulators|mesh-ancestor
65702816|NCT01963208|GABA Agents|gaba agents|mesh-ancestor
65702817|NCT00834873|Carvedilol|carvedilol|mesh-list
65702818|NCT00834873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65702819|NCT00834873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65702820|NCT00834873|Adrenergic Agents|adrenergic agents|mesh-ancestor
65702821|NCT00834873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65702822|NCT00834873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702823|NCT00834873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702824|NCT00834873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65702825|NCT00834873|Antioxidants|antioxidants|mesh-ancestor
65702826|NCT00834873|Protective Agents|protective agents|mesh-ancestor
65702827|NCT00834873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65702828|NCT00834873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65702829|NCT00834873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65702830|NCT00834873|Vasodilator Agents|vasodilator agents|mesh-ancestor
65702831|NCT00834873|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65702832|NCT00834873|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65702833|NCT01377480|Posaconazole|posaconazole|mesh-list
65702834|NCT01377480|Benzonidazole|benzonidazole|mesh-list
65702835|NCT01377480|Antifungal Agents|antifungal agents|mesh-ancestor
65702836|NCT01377480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65702837|NCT01377480|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65702838|NCT01377480|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65702839|NCT01377480|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65702840|NCT01377480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65702841|NCT01377480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65702842|NCT01377480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702843|NCT01377480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702844|NCT01377480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65702845|NCT01377480|Hormone Antagonists|hormone antagonists|mesh-ancestor
65702846|NCT01377480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65702847|NCT01377480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702848|NCT01377480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65702849|NCT01377480|Immunologic Factors|immunologic factors|mesh-ancestor
65702850|NCT04263909|Sufentanil|sufentanil|mesh-list
65702851|NCT04263909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65702852|NCT04263909|Narcotics|narcotics|mesh-ancestor
65702853|NCT04263909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65702854|NCT04263909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702855|NCT04263909|Analgesics|analgesics|mesh-ancestor
65702856|NCT04263909|Sensory System Agents|sensory system agents|mesh-ancestor
65702857|NCT04263909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65702858|NCT04263909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65702859|NCT04263909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65702860|NCT04263909|Anesthetics, General|anesthetics, general|mesh-ancestor
65702861|NCT04263909|Anesthetics|anesthetics|mesh-ancestor
65702862|NCT01421264|Gabapentin|gabapentin|mesh-list
65702863|NCT01421264|Analgesics|analgesics|mesh-ancestor
65702864|NCT01421264|Sensory System Agents|sensory system agents|mesh-ancestor
65702865|NCT01421264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65702866|NCT01421264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702867|NCT01421264|Anticonvulsants|anticonvulsants|mesh-ancestor
65702868|NCT01421264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65702869|NCT01421264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65702870|NCT01421264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65702871|NCT01421264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65702872|NCT01421264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65702873|NCT01421264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65702874|NCT01421264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65702875|NCT01421264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702876|NCT01421264|Antimanic Agents|antimanic agents|mesh-ancestor
65702877|NCT04415840|Acetic Acid|acetic acid|mesh-list
65702878|NCT04415840|Retinol acetate|retinol acetate|mesh-list
65702879|NCT04415840|Lugol's solution|lugol's solution|mesh-list
65702880|NCT04415840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65702881|NCT04415840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65702882|NCT04415840|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65702883|NCT04415840|Immunologic Factors|immunologic factors|mesh-ancestor
65702884|NCT04415840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702885|NCT04415840|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65702886|NCT04415840|Protective Agents|protective agents|mesh-ancestor
65702887|NCT04415840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65702888|NCT04415840|Hemostatics|hemostatics|mesh-ancestor
65702889|NCT04415840|Coagulants|coagulants|mesh-ancestor
65702890|NCT04488614|Zoledronic Acid|zoledronic acid|mesh-list
65702891|NCT04488614|Estrogens|estrogens|mesh-list
65702892|NCT04488614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65702893|NCT04488614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702894|NCT04488614|Hormones|hormones|mesh-ancestor
65702895|NCT04488614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65702896|NCT00834795|Carvedilol|carvedilol|mesh-list
65702897|NCT00834795|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65702898|NCT00834795|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65702899|NCT00834795|Adrenergic Agents|adrenergic agents|mesh-ancestor
65702900|NCT00834795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65702901|NCT00834795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702902|NCT00834795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702903|NCT00834795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65702904|NCT00834795|Antioxidants|antioxidants|mesh-ancestor
65702905|NCT00834795|Protective Agents|protective agents|mesh-ancestor
65702906|NCT00834795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65702907|NCT00834795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65702908|NCT00834795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65702909|NCT00834795|Vasodilator Agents|vasodilator agents|mesh-ancestor
65702910|NCT00834795|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65702911|NCT00834795|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65702912|NCT00834717|Granisetron|granisetron|mesh-list
65702913|NCT00834717|Antiemetics|antiemetics|mesh-ancestor
65702914|NCT00834717|Autonomic Agents|autonomic agents|mesh-ancestor
65702915|NCT00834717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65702916|NCT00834717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702917|NCT00834717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65702918|NCT00834717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65702919|NCT00834717|Serotonin Agents|serotonin agents|mesh-ancestor
65702920|NCT00834717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65702921|NCT00834717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702922|NCT00834639|Valproic Acid|valproic acid|mesh-list
65702923|NCT00834639|Anticonvulsants|anticonvulsants|mesh-ancestor
65702924|NCT00834639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702925|NCT00834639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702926|NCT00834639|GABA Agents|gaba agents|mesh-ancestor
65702927|NCT00834639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65702928|NCT00834639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702929|NCT00834639|Antimanic Agents|antimanic agents|mesh-ancestor
65702930|NCT00834639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65702931|NCT00834639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65702932|NCT00834639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65702933|NCT00834561|Lamotrigine|lamotrigine|mesh-list
65702934|NCT00834561|Anticonvulsants|anticonvulsants|mesh-ancestor
65702935|NCT00834561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65702936|NCT00834561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65702937|NCT00834561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702938|NCT00834561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65702939|NCT00834561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702940|NCT00834561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65702941|NCT00834561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65702942|NCT00834561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65702943|NCT00834561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65702944|NCT00834561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65702945|NCT00754221|Reboxetine|reboxetine|mesh-list
65702946|NCT00754221|Antidepressive Agents|antidepressive agents|mesh-ancestor
65702947|NCT00754221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65702948|NCT00754221|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65702949|NCT00754221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65702950|NCT00754221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65702951|NCT00754221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702952|NCT00754221|Adrenergic Agents|adrenergic agents|mesh-ancestor
65702953|NCT00754221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65702954|NCT00754221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702955|NCT00834405|Leflunomide|leflunomide|mesh-list
65702956|NCT00834405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65702957|NCT00834405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702958|NCT00834405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65702959|NCT00834405|Immunologic Factors|immunologic factors|mesh-ancestor
65702960|NCT00834405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702961|NCT00834249|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65702962|NCT00834249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65702963|NCT00834249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65702964|NCT00834249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65702965|NCT00834249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702966|NCT00834249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65702967|NCT00834249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702968|NCT00834249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65702969|NCT00834249|Antidepressive Agents|antidepressive agents|mesh-ancestor
65702970|NCT00834249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65702971|NCT00751803|Eletriptan|eletriptan|mesh-list
65702972|NCT00751803|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65702973|NCT00751803|Serotonin Agents|serotonin agents|mesh-ancestor
65702974|NCT00751803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65702975|NCT00751803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702976|NCT00751803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702977|NCT05420961|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65702978|NCT05420961|Immunologic Factors|immunologic factors|mesh-ancestor
65702979|NCT05420961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702980|NCT05402397|Losartan|losartan|mesh-list
65702981|NCT05402397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65702982|NCT05402397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65702983|NCT05402397|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65702984|NCT05402397|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65702985|NCT05402397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702986|NCT00833937|Zolpidem|zolpidem|mesh-list
65702987|NCT00833937|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65702988|NCT00833937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65702989|NCT00833937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65702990|NCT00833937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65702991|NCT00833937|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65702992|NCT00833937|GABA Agonists|gaba agonists|mesh-ancestor
65702993|NCT00833937|GABA Agents|gaba agents|mesh-ancestor
65702994|NCT00833937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65702995|NCT00833937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65702996|NCT00831051|Morphine|morphine|mesh-list
65702997|NCT00831051|Oxycodone|oxycodone|mesh-list
65702998|NCT00831051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65702999|NCT00831051|Narcotics|narcotics|mesh-ancestor
65703000|NCT00831051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65703001|NCT00831051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703002|NCT00831051|Analgesics|analgesics|mesh-ancestor
65703003|NCT00831051|Sensory System Agents|sensory system agents|mesh-ancestor
65703004|NCT00831051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65703005|NCT00750633|Moxifloxacin|moxifloxacin|mesh-list
65703006|NCT00750633|Dexamethasone|dexamethasone|mesh-list
65703007|NCT00750633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65703008|NCT00750633|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65703009|NCT00750633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65703010|NCT00750633|Antiemetics|antiemetics|mesh-ancestor
65703011|NCT00750633|Autonomic Agents|autonomic agents|mesh-ancestor
65703012|NCT00750633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65703013|NCT00750633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703014|NCT00750633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65703015|NCT00750633|Glucocorticoids|glucocorticoids|mesh-ancestor
65703016|NCT00750633|Hormones|hormones|mesh-ancestor
65703017|NCT00750633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65703018|NCT00750633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65703019|NCT00750633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703020|NCT00750633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65703021|NCT00750633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65703022|NCT00750633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65703023|NCT00750633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65703024|NCT00750633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65703025|NCT00750633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703026|NCT00750243|Naproxen|naproxen|mesh-list
65703027|NCT00750243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65703028|NCT00750243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65703029|NCT00750243|Analgesics|analgesics|mesh-ancestor
65703030|NCT00750243|Sensory System Agents|sensory system agents|mesh-ancestor
65703031|NCT00750243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65703032|NCT00750243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703033|NCT00750243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65703034|NCT00750243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65703035|NCT00750243|Gout Suppressants|gout suppressants|mesh-ancestor
65703036|NCT00750243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65703037|NCT00750243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65703038|NCT00750243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703039|NCT00924170|Cyclophosphamide|cyclophosphamide|mesh-list
65703040|NCT00924170|Fludarabine|fludarabine|mesh-list
65703041|NCT00924170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65703042|NCT00924170|Immunologic Factors|immunologic factors|mesh-ancestor
65703043|NCT00924170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703044|NCT00924170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65703045|NCT00924170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65703046|NCT00924170|Alkylating Agents|alkylating agents|mesh-ancestor
65703047|NCT00924170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703048|NCT00924170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703049|NCT00924170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65703050|NCT04809285|Insulin|insulin|mesh-list
65703051|NCT04809285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65703052|NCT04809285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703053|NCT00920985|Contraceptive Agents|contraceptive agents|mesh-list
65703054|NCT00920985|Gestodene|gestodene|mesh-list
65703055|NCT00920985|Contraceptives, Oral|contraceptives, oral|mesh-list
65703056|NCT00920985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65703057|NCT00920985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703058|NCT00920985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65703059|NCT00920985|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65703060|NCT00920985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65018897|NCT02941198|Copper|copper|mesh-list
65703061|NCT00920985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65703062|NCT00920985|Progestins|progestins|mesh-ancestor
65703063|NCT00920985|Hormones|hormones|mesh-ancestor
65269171|NCT02736032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65703064|NCT00920985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65703065|NCT05388747|Cefuroxime|cefuroxime|mesh-list
65703066|NCT05388747|Cefuroxime axetil|cefuroxime axetil|mesh-list
65703067|NCT05388747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65703068|NCT05388747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65703069|NCT00828321|Ramipril|ramipril|mesh-list
65703070|NCT00828321|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65703071|NCT00828321|Protease Inhibitors|protease inhibitors|mesh-ancestor
65703072|NCT00828321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65703073|NCT00828321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703074|NCT00828321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65703075|NCT01352715|Ritonavir|ritonavir|mesh-list
65703076|NCT01352715|Lopinavir|lopinavir|mesh-list
65703077|NCT01352715|Tenofovir|tenofovir|mesh-list
65703078|NCT01352715|Lamivudine|lamivudine|mesh-list
65703079|NCT01352715|Zidovudine|zidovudine|mesh-list
65703080|NCT01352715|Emtricitabine|emtricitabine|mesh-list
65703081|NCT01352715|Raltegravir Potassium|raltegravir potassium|mesh-list
65703082|NCT01352715|Abacavir|abacavir|mesh-list
65703083|NCT01352715|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
65703084|NCT01352715|Dideoxynucleosides|dideoxynucleosides|mesh-list
65703085|NCT01352715|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65703086|NCT01352715|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65703087|NCT01352715|Protease Inhibitors|protease inhibitors|mesh-ancestor
65703088|NCT01352715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65703089|NCT01352715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703090|NCT01352715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65703091|NCT01352715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65703092|NCT01352715|Antiviral Agents|antiviral agents|mesh-ancestor
65703093|NCT01352715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65703094|NCT01352715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65703095|NCT01352715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65703096|NCT01352715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65703097|NCT01352715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65703098|NCT01352715|Antimetabolites|antimetabolites|mesh-ancestor
65703099|NCT01352715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65703100|NCT01352715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65703101|NCT00743925|Atorvastatin|atorvastatin|mesh-list
65703102|NCT00743925|Varespladib methyl|varespladib methyl|mesh-list
65703103|NCT00743925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65703104|NCT00743925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65703105|NCT00743925|Antimetabolites|antimetabolites|mesh-ancestor
65703106|NCT00743925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703107|NCT00743925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65703108|NCT00743925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65703109|NCT00743925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65703110|NCT00743925|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
65703111|NCT04221945|Cisplatin|cisplatin|mesh-list
65703112|NCT04221945|Pembrolizumab|pembrolizumab|mesh-list
65703113|NCT04221945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703114|NCT04221945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65703115|NCT04218123|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65703116|NCT04218123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65703117|NCT04218123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65703118|NCT04218123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65703119|NCT04218123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703120|NCT04218123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65703121|NCT04218123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703122|NCT04218123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65703123|NCT04218123|Antidepressive Agents|antidepressive agents|mesh-ancestor
65703124|NCT04218123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65703125|NCT00738387|Docetaxel|docetaxel|mesh-list
65703126|NCT00738387|Vadimezan|vadimezan|mesh-list
65703127|NCT00738387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703128|NCT00738387|Tubulin Modulators|tubulin modulators|mesh-ancestor
65703129|NCT00738387|Antimitotic Agents|antimitotic agents|mesh-ancestor
65703130|NCT00738387|Mitosis Modulators|mitosis modulators|mesh-ancestor
65703131|NCT00738387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703132|NCT03710421|Cyclophosphamide|cyclophosphamide|mesh-list
65703133|NCT03710421|Fludarabine|fludarabine|mesh-list
65703134|NCT03710421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65018990|NCT00147875|Hormones|hormones|mesh-ancestor
65703135|NCT03710421|Immunologic Factors|immunologic factors|mesh-ancestor
65703136|NCT03710421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703137|NCT03710421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65703138|NCT03710421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65703139|NCT03710421|Alkylating Agents|alkylating agents|mesh-ancestor
65703140|NCT03710421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703141|NCT03710421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703142|NCT03710421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65703143|NCT00645177|Paclitaxel|paclitaxel|mesh-list
65703144|NCT00645177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65703145|NCT00645177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703146|NCT00645177|Tubulin Modulators|tubulin modulators|mesh-ancestor
65703147|NCT00645177|Antimitotic Agents|antimitotic agents|mesh-ancestor
65703148|NCT00645177|Mitosis Modulators|mitosis modulators|mesh-ancestor
65703149|NCT00645177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703150|NCT00643383|Acetaminophen|acetaminophen|mesh-list
65703151|NCT00643383|Tramadol|tramadol|mesh-list
65703152|NCT00643383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65703153|NCT00643383|Analgesics|analgesics|mesh-ancestor
65703154|NCT00643383|Sensory System Agents|sensory system agents|mesh-ancestor
65703155|NCT00643383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65703156|NCT00643383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703157|NCT00643383|Antipyretics|antipyretics|mesh-ancestor
65703158|NCT00643383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65703159|NCT00643383|Narcotics|narcotics|mesh-ancestor
65703160|NCT00643383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65703161|NCT02559622|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65703162|NCT02559622|Immunologic Factors|immunologic factors|mesh-ancestor
65703163|NCT02559622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703164|NCT04285450|Vitamin K|vitamin k|mesh-list
65703165|NCT04285450|Vitamins|vitamins|mesh-ancestor
65703166|NCT04285450|Micronutrients|micronutrients|mesh-ancestor
65703167|NCT04285450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703168|NCT04285450|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65703169|NCT04285450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65703170|NCT04285450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703171|NCT04285450|Hemostatics|hemostatics|mesh-ancestor
65703172|NCT04285450|Coagulants|coagulants|mesh-ancestor
65703173|NCT05497102|Lenalidomide|lenalidomide|mesh-list
65703174|NCT05497102|Immunologic Factors|immunologic factors|mesh-ancestor
65703175|NCT05497102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703176|NCT05497102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65703177|NCT05497102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65703178|NCT05497102|Growth Substances|growth substances|mesh-ancestor
65703179|NCT05497102|Growth Inhibitors|growth inhibitors|mesh-ancestor
65703180|NCT05497102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703181|NCT04017442|Morphine|morphine|mesh-list
65703182|NCT04017442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65703183|NCT04017442|Narcotics|narcotics|mesh-ancestor
65703184|NCT04017442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65703185|NCT04017442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703186|NCT04017442|Analgesics|analgesics|mesh-ancestor
65703187|NCT04017442|Sensory System Agents|sensory system agents|mesh-ancestor
65703188|NCT04017442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65703189|NCT04016818|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65703190|NCT04016818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65703191|NCT04016818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703192|NCT05490160|Tranexamic Acid|tranexamic acid|mesh-list
65703193|NCT05490160|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65703194|NCT05490160|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65703195|NCT05490160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703196|NCT05490160|Hemostatics|hemostatics|mesh-ancestor
65703197|NCT05490160|Coagulants|coagulants|mesh-ancestor
65703198|NCT05495620|Dexamethasone|dexamethasone|mesh-list
65703199|NCT05495620|Lenalidomide|lenalidomide|mesh-list
65703200|NCT05495620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65703201|NCT05495620|Antiemetics|antiemetics|mesh-ancestor
65703202|NCT05495620|Autonomic Agents|autonomic agents|mesh-ancestor
65703203|NCT05495620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65703204|NCT05495620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703205|NCT05495620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65703206|NCT05495620|Glucocorticoids|glucocorticoids|mesh-ancestor
65703207|NCT05495620|Hormones|hormones|mesh-ancestor
65703208|NCT05495620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65703209|NCT05495620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65703210|NCT05495620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703211|NCT05495620|Immunologic Factors|immunologic factors|mesh-ancestor
65019057|NCT00148031|Ribavirin|ribavirin|mesh-list
65703212|NCT05495620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65703213|NCT05495620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65703214|NCT05495620|Growth Substances|growth substances|mesh-ancestor
65703215|NCT05495620|Growth Inhibitors|growth inhibitors|mesh-ancestor
65703216|NCT05490082|Solifenacin Succinate|solifenacin succinate|mesh-list
65703217|NCT05490082|Mirabegron|mirabegron|mesh-list
65703218|NCT05490082|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65703219|NCT05490082|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65703220|NCT05490082|Cholinergic Agents|cholinergic agents|mesh-ancestor
65703221|NCT05490082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65703222|NCT05490082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703223|NCT05490082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703224|NCT05490082|Urological Agents|urological agents|mesh-ancestor
65703225|NCT05490082|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65703226|NCT05490082|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65703227|NCT05490082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65703228|NCT05490082|Adrenergic Agents|adrenergic agents|mesh-ancestor
65703229|NCT02559310|Moxifloxacin|moxifloxacin|mesh-list
65703230|NCT02559310|Linezolid|linezolid|mesh-list
65703231|NCT02559310|Lefamulin|lefamulin|mesh-list
65703232|NCT02559310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65703233|NCT02559310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65703234|NCT02559310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65703235|NCT02559310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65703236|NCT02559310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65703237|NCT02559310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703238|NCT02559310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703239|NCT02559310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65703240|NCT05489848|Paclitaxel|paclitaxel|mesh-list
65703241|NCT05489848|Carboplatin|carboplatin|mesh-list
65703242|NCT05489848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65703243|NCT05489848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703244|NCT05489848|Tubulin Modulators|tubulin modulators|mesh-ancestor
65703245|NCT05489848|Antimitotic Agents|antimitotic agents|mesh-ancestor
65703246|NCT05489848|Mitosis Modulators|mitosis modulators|mesh-ancestor
65703247|NCT05489848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703248|NCT03517449|Paclitaxel|paclitaxel|mesh-list
65703249|NCT03517449|Doxorubicin|doxorubicin|mesh-list
65703250|NCT03517449|Pembrolizumab|pembrolizumab|mesh-list
65703251|NCT03517449|Lenvatinib|lenvatinib|mesh-list
65703252|NCT03517449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65703253|NCT03517449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703254|NCT03517449|Tubulin Modulators|tubulin modulators|mesh-ancestor
65703255|NCT03517449|Antimitotic Agents|antimitotic agents|mesh-ancestor
65703256|NCT03517449|Mitosis Modulators|mitosis modulators|mesh-ancestor
65703257|NCT03517449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703258|NCT03517449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65703259|NCT03517449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65703260|NCT03517449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65703261|NCT03517449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65703262|NCT03517449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65703263|NCT03517449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65703264|NCT05489692|Leucovorin|leucovorin|mesh-list
65703265|NCT05489692|Fluorouracil|fluorouracil|mesh-list
65703266|NCT05489692|Oxaliplatin|oxaliplatin|mesh-list
65703267|NCT05489692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65703268|NCT05489692|Antimetabolites|antimetabolites|mesh-ancestor
65703269|NCT05489692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703270|NCT05489692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65703271|NCT05489692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703272|NCT05489692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65703273|NCT05489692|Immunologic Factors|immunologic factors|mesh-ancestor
65703274|NCT05489692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703275|NCT05489692|Antidotes|antidotes|mesh-ancestor
65703276|NCT05489692|Protective Agents|protective agents|mesh-ancestor
65703277|NCT05489692|Vitamin B Complex|vitamin b complex|mesh-ancestor
65703278|NCT05489692|Vitamins|vitamins|mesh-ancestor
65703279|NCT05489692|Micronutrients|micronutrients|mesh-ancestor
65703280|NCT00721695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65703281|NCT00721695|Mydriatics|mydriatics|mesh-list
65703282|NCT00721695|Autonomic Agents|autonomic agents|mesh-ancestor
65703283|NCT00721695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65703284|NCT00721695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703285|NCT00625833|Reboxetine|reboxetine|mesh-list
65703286|NCT00625833|Antidepressive Agents|antidepressive agents|mesh-ancestor
65703287|NCT00625833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65269174|NCT02736032|Progesterone|progesterone|mesh-list
65703288|NCT00625833|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65703289|NCT00625833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65703290|NCT00625833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65703291|NCT00625833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703292|NCT00625833|Adrenergic Agents|adrenergic agents|mesh-ancestor
65703293|NCT00625833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65703294|NCT00625833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703295|NCT00670358|Prednisone|prednisone|mesh-list
65703296|NCT00670358|Cyclophosphamide|cyclophosphamide|mesh-list
65703297|NCT00670358|Rituximab|rituximab|mesh-list
65703298|NCT00670358|Doxorubicin|doxorubicin|mesh-list
65703299|NCT00670358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65703300|NCT00670358|Vincristine|vincristine|mesh-list
65703301|NCT00670358|Lenalidomide|lenalidomide|mesh-list
65703302|NCT00670358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65703303|NCT00670358|Immunologic Factors|immunologic factors|mesh-ancestor
65703304|NCT00670358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703305|NCT00670358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65703306|NCT00670358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65703307|NCT00670358|Alkylating Agents|alkylating agents|mesh-ancestor
65703308|NCT00670358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703309|NCT00670358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703310|NCT00670358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65703311|NCT00670358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65703312|NCT00670358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65703313|NCT00670358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65703314|NCT00670358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65703315|NCT00670358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65703316|NCT00670358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65703317|NCT00670358|Glucocorticoids|glucocorticoids|mesh-ancestor
65703318|NCT00670358|Hormones|hormones|mesh-ancestor
65703319|NCT00670358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65703320|NCT00670358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65703321|NCT00670358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65703322|NCT00670358|Tubulin Modulators|tubulin modulators|mesh-ancestor
65703323|NCT00670358|Antimitotic Agents|antimitotic agents|mesh-ancestor
65703324|NCT00670358|Mitosis Modulators|mitosis modulators|mesh-ancestor
65703325|NCT00670358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65703326|NCT00670358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65703327|NCT00670358|Growth Substances|growth substances|mesh-ancestor
65703328|NCT00670358|Growth Inhibitors|growth inhibitors|mesh-ancestor
65703329|NCT03299036|Doxorubicin|doxorubicin|mesh-list
65703330|NCT03299036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65703331|NCT03299036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703332|NCT03299036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65703333|NCT03299036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65703334|NCT03299036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65703335|NCT03299036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703336|NCT03290846|Secretin|secretin|mesh-list
65703337|NCT03290846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65703338|NCT03290846|Hormones|hormones|mesh-ancestor
65703339|NCT03290846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65703340|NCT03290846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703341|NCT03298958|Sirolimus|sirolimus|mesh-list
65703342|NCT03298958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65703343|NCT03298958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65703344|NCT03298958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65703345|NCT03298958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703346|NCT03298958|Antifungal Agents|antifungal agents|mesh-ancestor
65703347|NCT03298958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65703348|NCT03298958|Immunologic Factors|immunologic factors|mesh-ancestor
65703349|NCT03298958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703350|NCT04488926|Palmidrol|palmidrol|mesh-list
65703351|NCT04488926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65703352|NCT04488926|Analgesics|analgesics|mesh-ancestor
65703353|NCT04488926|Sensory System Agents|sensory system agents|mesh-ancestor
65703354|NCT04488926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65703355|NCT04488926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703356|NCT04488926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65703357|NCT04488926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65703358|NCT04488926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65703359|NCT04488926|Antiviral Agents|antiviral agents|mesh-ancestor
65703360|NCT04488926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65165976|NCT02732197|GABA Agents|gaba agents|mesh-ancestor
65703361|NCT04488926|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65703362|NCT04488926|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65703363|NCT04488926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65703364|NCT04488926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703365|NCT04488926|Hormones|hormones|mesh-ancestor
65703366|NCT04488926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65703367|NCT04328714|Interferons|interferons|mesh-list
65703368|NCT04328714|Interferon-gamma|interferon-gamma|mesh-list
65703369|NCT04328714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703370|NCT04328714|Antiviral Agents|antiviral agents|mesh-ancestor
65703371|NCT04328714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65703372|NCT04310540|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65703373|NCT04310540|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65703374|NCT04310540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703375|NCT03290456|Prednisone|prednisone|mesh-list
65703376|NCT03290456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65703377|NCT03290456|Glucocorticoids|glucocorticoids|mesh-ancestor
65703378|NCT03290456|Hormones|hormones|mesh-ancestor
65703379|NCT03290456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65703380|NCT03290456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703381|NCT03290456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65703382|NCT03290456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703383|NCT02555878|Rivaroxaban|rivaroxaban|mesh-list
65703384|NCT02555878|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65703385|NCT02555878|Antithrombins|antithrombins|mesh-ancestor
65703386|NCT02555878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65703387|NCT02555878|Protease Inhibitors|protease inhibitors|mesh-ancestor
65703388|NCT02555878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65703389|NCT02555878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703390|NCT02555878|Anticoagulants|anticoagulants|mesh-ancestor
65703391|NCT03298646|Diclofenac|diclofenac|mesh-list
65703392|NCT03298646|Lidocaine|lidocaine|mesh-list
65703393|NCT03298646|Anesthetics, Local|anesthetics, local|mesh-ancestor
65703394|NCT03298646|Anesthetics|anesthetics|mesh-ancestor
65703395|NCT03298646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65703396|NCT03298646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703397|NCT03298646|Sensory System Agents|sensory system agents|mesh-ancestor
65703398|NCT03298646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65703399|NCT03298646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65703400|NCT03298646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65703401|NCT03298646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65703402|NCT03298646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65703403|NCT03298646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703404|NCT03298646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65703405|NCT03298646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65703406|NCT03298646|Analgesics|analgesics|mesh-ancestor
65703407|NCT03298646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65703408|NCT03298646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65703409|NCT03298646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65703410|NCT03298646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65703411|NCT02460692|Dronabinol|dronabinol|mesh-list
65703412|NCT02460692|Hallucinogens|hallucinogens|mesh-ancestor
65703413|NCT02460692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703414|NCT02460692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65703415|NCT02460692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65703416|NCT02460692|Analgesics|analgesics|mesh-ancestor
65703417|NCT02460692|Sensory System Agents|sensory system agents|mesh-ancestor
65703418|NCT02460692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65703419|NCT02460692|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65703420|NCT02460692|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65703421|NCT02460692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65703422|NCT02460692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703423|NCT02460692|Hormones|hormones|mesh-ancestor
65703424|NCT02460692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65703425|NCT05494060|Capecitabine|capecitabine|mesh-list
65703426|NCT05494060|Oxaliplatin|oxaliplatin|mesh-list
65703427|NCT05494060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65703428|NCT05494060|Antimetabolites|antimetabolites|mesh-ancestor
65703429|NCT05494060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703430|NCT05494060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703431|NCT05488990|Calcitriol|calcitriol|mesh-list
65703432|NCT05488990|Calcipotriene|calcipotriene|mesh-list
65703433|NCT05488990|Dermatologic Agents|dermatologic agents|mesh-ancestor
65703434|NCT05488990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65703435|NCT05488990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703436|NCT05488990|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65703437|NCT05488990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65703438|NCT05488990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703439|NCT05488990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65703440|NCT05488990|Vitamins|vitamins|mesh-ancestor
65703441|NCT05488990|Micronutrients|micronutrients|mesh-ancestor
65703442|NCT05488990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65703443|NCT03289520|Clopidogrel|clopidogrel|mesh-list
65703444|NCT03289520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65703445|NCT03289520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65703446|NCT03289520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65703447|NCT03289520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65703448|NCT03289520|Purinergic Agents|purinergic agents|mesh-ancestor
65703449|NCT03289520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65703450|NCT03289520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703451|NCT03289520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703452|NCT03293108|Vitamin D|vitamin d|mesh-list
65703453|NCT03293108|Denosumab|denosumab|mesh-list
65703454|NCT03293108|Calcium|calcium|mesh-list
65703455|NCT03293108|Vitamins|vitamins|mesh-ancestor
65703456|NCT03293108|Micronutrients|micronutrients|mesh-ancestor
65703457|NCT03293108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703458|NCT03293108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65703459|NCT03293108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65703460|NCT03292796|Bimatoprost|bimatoprost|mesh-list
65703461|NCT03292796|Latanoprost|latanoprost|mesh-list
65703462|NCT03292796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65703463|NCT03292796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65703464|NCT03292796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65703465|NCT03288896|Ethanol|ethanol|mesh-list
65703466|NCT03288896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65703467|NCT03288896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65703468|NCT03288896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65703469|NCT03288896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703470|NCT03288818|Mechlorethamine|mechlorethamine|mesh-list
65703471|NCT03288818|Alkylating Agents|alkylating agents|mesh-ancestor
65703472|NCT03288818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703473|NCT03288818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65703474|NCT03288818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703475|NCT03292172|Atezolizumab|atezolizumab|mesh-list
65703476|NCT03292172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703477|NCT02461004|Ezetimibe|ezetimibe|mesh-list
65703478|NCT02461004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65703479|NCT02461004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65703480|NCT02461004|Antimetabolites|antimetabolites|mesh-ancestor
65703481|NCT02461004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703482|NCT02461004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65703483|NCT03288428|Morphine|morphine|mesh-list
65703484|NCT03288428|Nalbuphine|nalbuphine|mesh-list
65703485|NCT03288428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65703486|NCT03288428|Narcotics|narcotics|mesh-ancestor
65703487|NCT03288428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65703488|NCT03288428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703489|NCT03288428|Analgesics|analgesics|mesh-ancestor
65703490|NCT03288428|Sensory System Agents|sensory system agents|mesh-ancestor
65703491|NCT03288428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65703492|NCT03288350|Avelumab|avelumab|mesh-list
65703493|NCT03288350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65703494|NCT03288350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703495|NCT00003224|Vaccines|vaccines|mesh-list
65703496|NCT00003224|Freund's Adjuvant|freund's adjuvant|mesh-list
65703497|NCT00003224|Immunologic Factors|immunologic factors|mesh-ancestor
65703498|NCT00003224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703499|NCT00003224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65703500|NCT03288038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65703501|NCT03288038|Ezetimibe|ezetimibe|mesh-list
65703502|NCT03288038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65703503|NCT03288038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65703504|NCT03288038|Antimetabolites|antimetabolites|mesh-ancestor
65703505|NCT03288038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703506|NCT03288038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65703507|NCT03288038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65703508|NCT03288038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65703509|NCT03287882|Micronutrients|micronutrients|mesh-list
65703510|NCT03287882|Trace Elements|trace elements|mesh-list
65703511|NCT03287882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019366|NCT02927353|Adalimumab|adalimumab|mesh-list
65703512|NCT03291314|Avelumab|avelumab|mesh-list
65703513|NCT03291314|Axitinib|axitinib|mesh-list
65703514|NCT03291314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65703515|NCT03291314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703516|NCT03291314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65703517|NCT03291314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65703518|NCT03291314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703519|NCT03291158|Minocycline|minocycline|mesh-list
65703520|NCT03291158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65703521|NCT03291158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65703522|NCT03283202|Prednisone|prednisone|mesh-list
65703523|NCT03283202|Prednisolone|prednisolone|mesh-list
65703524|NCT03283202|Cyclophosphamide|cyclophosphamide|mesh-list
65703525|NCT03283202|Rituximab|rituximab|mesh-list
65703526|NCT03283202|Vincristine|vincristine|mesh-list
65703527|NCT03283202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65703528|NCT03283202|Immunologic Factors|immunologic factors|mesh-ancestor
65703529|NCT03283202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703530|NCT03283202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65703531|NCT03283202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65703532|NCT03283202|Alkylating Agents|alkylating agents|mesh-ancestor
65703533|NCT03283202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703534|NCT03283202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703535|NCT03283202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65703536|NCT03283202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65703537|NCT03283202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65703538|NCT03283202|Glucocorticoids|glucocorticoids|mesh-ancestor
65703539|NCT03283202|Hormones|hormones|mesh-ancestor
65703540|NCT03283202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65703541|NCT03283202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65703542|NCT03283202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65703543|NCT03283202|Tubulin Modulators|tubulin modulators|mesh-ancestor
65703544|NCT03283202|Antimitotic Agents|antimitotic agents|mesh-ancestor
65703545|NCT03283202|Mitosis Modulators|mitosis modulators|mesh-ancestor
65703546|NCT03283046|Dexamethasone|dexamethasone|mesh-list
65703547|NCT03283046|Nivolumab|nivolumab|mesh-list
65703548|NCT03283046|Lenalidomide|lenalidomide|mesh-list
65703549|NCT03283046|Ipilimumab|ipilimumab|mesh-list
65703550|NCT03283046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65703551|NCT03283046|Antiemetics|antiemetics|mesh-ancestor
65703552|NCT03283046|Autonomic Agents|autonomic agents|mesh-ancestor
65703553|NCT03283046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65703554|NCT03283046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703555|NCT03283046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65703556|NCT03283046|Glucocorticoids|glucocorticoids|mesh-ancestor
65703557|NCT03283046|Hormones|hormones|mesh-ancestor
65703558|NCT03283046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65703559|NCT03283046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65703560|NCT03283046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703561|NCT03283046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65703562|NCT03283046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65703563|NCT03283046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703564|NCT03283046|Immunologic Factors|immunologic factors|mesh-ancestor
65703565|NCT03283046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65703566|NCT03283046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65703567|NCT03283046|Growth Substances|growth substances|mesh-ancestor
65703568|NCT03283046|Growth Inhibitors|growth inhibitors|mesh-ancestor
65703569|NCT03287180|Buprenorphine|buprenorphine|mesh-list
65703570|NCT03287180|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65703571|NCT03287180|Naloxone|naloxone|mesh-list
65703572|NCT03287180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65703573|NCT03287180|Narcotics|narcotics|mesh-ancestor
65703574|NCT03287180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65703575|NCT03287180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703576|NCT03287180|Analgesics|analgesics|mesh-ancestor
65703577|NCT03287180|Sensory System Agents|sensory system agents|mesh-ancestor
65703578|NCT03287180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65703579|NCT03287180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65703581|NCT02460146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65703582|NCT02460302|Progesterone|progesterone|mesh-list
65703583|NCT02460302|Progestins|progestins|mesh-ancestor
65703584|NCT02460302|Hormones|hormones|mesh-ancestor
65269176|NCT02736032|Hormones|hormones|mesh-ancestor
65703585|NCT02460302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65703586|NCT02460302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703587|NCT03282188|Sargramostim|sargramostim|mesh-list
65703588|NCT03282188|Immunologic Factors|immunologic factors|mesh-ancestor
65703589|NCT03282188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703590|NCT03384212|Cytarabine|cytarabine|mesh-list
65703591|NCT03384212|Fludarabine|fludarabine|mesh-list
65703592|NCT03384212|Busulfan|busulfan|mesh-list
65703593|NCT03384212|Cladribine|cladribine|mesh-list
65703594|NCT03384212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703595|NCT03384212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65703596|NCT03384212|Antimetabolites|antimetabolites|mesh-ancestor
65703597|NCT03384212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703598|NCT03384212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65703599|NCT03384212|Immunologic Factors|immunologic factors|mesh-ancestor
65703600|NCT03384212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703601|NCT03384212|Antiviral Agents|antiviral agents|mesh-ancestor
65703602|NCT03384212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65703603|NCT03384212|Alkylating Agents|alkylating agents|mesh-ancestor
65703604|NCT03384212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65703605|NCT03384212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65703606|NCT02460068|Nivolumab|nivolumab|mesh-list
65703607|NCT02460068|Ipilimumab|ipilimumab|mesh-list
65703608|NCT02460068|Fotemustine|fotemustine|mesh-list
65703609|NCT02460068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65703610|NCT02460068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703611|NCT02460068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65703612|NCT02460068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703613|NCT03286244|Paclitaxel|paclitaxel|mesh-list
65703614|NCT03286244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65703615|NCT03286244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703616|NCT03286244|Tubulin Modulators|tubulin modulators|mesh-ancestor
65703617|NCT03286244|Antimitotic Agents|antimitotic agents|mesh-ancestor
65703618|NCT03286244|Mitosis Modulators|mitosis modulators|mesh-ancestor
65703619|NCT03286244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703620|NCT03282110|Citalopram|citalopram|mesh-list
65703621|NCT03282110|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65703622|NCT03282110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65703623|NCT03282110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65703624|NCT03282110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703625|NCT03282110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65703626|NCT03282110|Serotonin Agents|serotonin agents|mesh-ancestor
65703627|NCT03282110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703628|NCT03282110|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65703629|NCT03282110|Antidepressive Agents|antidepressive agents|mesh-ancestor
65703630|NCT03282110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65703631|NCT03269786|Bilirubin|bilirubin|mesh-list
65703632|NCT03269786|Antioxidants|antioxidants|mesh-ancestor
65703633|NCT03269786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703634|NCT03269786|Protective Agents|protective agents|mesh-ancestor
65703635|NCT03269786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703636|NCT02459600|Cyclopentolate|cyclopentolate|mesh-list
65703637|NCT02459600|Mydriatics|mydriatics|mesh-ancestor
65703638|NCT02459600|Autonomic Agents|autonomic agents|mesh-ancestor
65703639|NCT02459600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65703640|NCT02459600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703641|NCT02459600|Parasympatholytics|parasympatholytics|mesh-ancestor
65703642|NCT02459600|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65703643|NCT02459600|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65703644|NCT02459600|Cholinergic Agents|cholinergic agents|mesh-ancestor
65703645|NCT02459600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65703646|NCT02459600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703647|NCT03269318|Theophylline|theophylline|mesh-list
65703648|NCT03269318|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65703649|NCT03269318|Montelukast|montelukast|mesh-list
65703650|NCT03269318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65703651|NCT03269318|Autonomic Agents|autonomic agents|mesh-ancestor
65703652|NCT03269318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65703653|NCT03269318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703654|NCT03269318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65703655|NCT03269318|Respiratory System Agents|respiratory system agents|mesh-ancestor
65703656|NCT03269318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65703657|NCT03269318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65703658|NCT03269318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65703659|NCT03269318|Adrenergic Agents|adrenergic agents|mesh-ancestor
65703660|NCT03269318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65703661|NCT03269318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703662|NCT03269318|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65703663|NCT03269318|Hormone Antagonists|hormone antagonists|mesh-ancestor
65703664|NCT03269318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65703665|NCT03269318|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65703666|NCT03269318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65703667|NCT03269318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65703668|NCT03269318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65703669|NCT03269318|Vasodilator Agents|vasodilator agents|mesh-ancestor
65703670|NCT03269318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65703671|NCT03269318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65703672|NCT03269318|Purinergic Agents|purinergic agents|mesh-ancestor
65703673|NCT03284762|Rivaroxaban|rivaroxaban|mesh-list
65703674|NCT03284762|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65703675|NCT03284762|Antithrombins|antithrombins|mesh-ancestor
65703676|NCT03284762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65703677|NCT03284762|Protease Inhibitors|protease inhibitors|mesh-ancestor
65703678|NCT03284762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65703679|NCT03284762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703680|NCT03284762|Anticoagulants|anticoagulants|mesh-ancestor
65703681|NCT04186598|Nifedipine|nifedipine|mesh-list
65703682|NCT04186598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65703683|NCT04186598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65703684|NCT04186598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703685|NCT04186598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65703686|NCT04186598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703687|NCT04186598|Vasodilator Agents|vasodilator agents|mesh-ancestor
65703688|NCT04186598|Tocolytic Agents|tocolytic agents|mesh-ancestor
65703689|NCT04186598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65703690|NCT04172558|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65703691|NCT04172558|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65703692|NCT04172558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65703693|NCT04172558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65703694|NCT04172558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703695|NCT04172558|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65703696|NCT04172558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65703697|NCT04172558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703698|NCT04172558|Cholinergic Agents|cholinergic agents|mesh-ancestor
65703699|NCT04172558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65703700|NCT03107858|Dopamine|dopamine|mesh-list
65703701|NCT03107858|Norepinephrine|norepinephrine|mesh-list
65703702|NCT03107858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65703703|NCT03107858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65703704|NCT03107858|Adrenergic Agents|adrenergic agents|mesh-ancestor
65703705|NCT03107858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65703706|NCT03107858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703707|NCT03107858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703708|NCT03107858|Sympathomimetics|sympathomimetics|mesh-ancestor
65703709|NCT03107858|Autonomic Agents|autonomic agents|mesh-ancestor
65703710|NCT03107858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65703711|NCT03107858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65703712|NCT03107858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65703713|NCT03107858|Dopamine Agents|dopamine agents|mesh-ancestor
65703714|NCT03107858|Protective Agents|protective agents|mesh-ancestor
65703715|NCT03269162|Docetaxel|docetaxel|mesh-list
65703716|NCT03269162|Pemetrexed|pemetrexed|mesh-list
65703717|NCT03269162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703718|NCT03269162|Tubulin Modulators|tubulin modulators|mesh-ancestor
65703719|NCT03269162|Antimitotic Agents|antimitotic agents|mesh-ancestor
65703720|NCT03269162|Mitosis Modulators|mitosis modulators|mesh-ancestor
65703721|NCT03269162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703722|NCT03269162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65703723|NCT03269162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65703724|NCT03269162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65703725|NCT03284294|Cholecalciferol|cholecalciferol|mesh-list
65703726|NCT03284294|Vitamin D|vitamin d|mesh-list
65703727|NCT03284294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65703728|NCT03284294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703729|NCT03284294|Vitamins|vitamins|mesh-ancestor
65703730|NCT03284294|Micronutrients|micronutrients|mesh-ancestor
65703731|NCT03284294|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65703732|NCT02558296|Bexagliflozin|bexagliflozin|mesh-list
65703733|NCT02558296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65703734|NCT02558296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019581|NCT00170898|Analgesics|analgesics|mesh-ancestor
65703735|NCT03268226|Beclomethasone|beclomethasone|mesh-list
65703736|NCT03268226|Glycopyrrolate|glycopyrrolate|mesh-list
65703737|NCT03268226|Formoterol Fumarate|formoterol fumarate|mesh-list
65703738|NCT03268226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65703739|NCT03268226|Autonomic Agents|autonomic agents|mesh-ancestor
65703740|NCT03268226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65703741|NCT03268226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703742|NCT03268226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65703743|NCT03268226|Respiratory System Agents|respiratory system agents|mesh-ancestor
65703744|NCT03268226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65703745|NCT03268226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65703746|NCT03268226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65703747|NCT03268226|Adrenergic Agents|adrenergic agents|mesh-ancestor
65703748|NCT03268226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65703749|NCT03268226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703750|NCT03268226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65703751|NCT03268226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65703752|NCT03268226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65703753|NCT03268226|Cholinergic Agents|cholinergic agents|mesh-ancestor
65703754|NCT03268226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65703755|NCT03268226|Glucocorticoids|glucocorticoids|mesh-ancestor
65703756|NCT03268226|Hormones|hormones|mesh-ancestor
65703757|NCT03268226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65703758|NCT04108858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65703759|NCT04108858|Trastuzumab|trastuzumab|mesh-list
65703760|NCT04108858|Pertuzumab|pertuzumab|mesh-list
65703761|NCT04108858|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
65703762|NCT04108858|Antibodies|antibodies|mesh-list
65703763|NCT04108858|Immunoglobulins|immunoglobulins|mesh-list
65703764|NCT04108858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65703765|NCT04108858|Immunologic Factors|immunologic factors|mesh-ancestor
65703766|NCT04108858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703767|NCT04108858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703768|NCT02737475|Cyclophosphamide|cyclophosphamide|mesh-list
65703769|NCT02737475|Nivolumab|nivolumab|mesh-list
65703770|NCT02737475|Ipilimumab|ipilimumab|mesh-list
65703771|NCT02737475|Vaccines|vaccines|mesh-list
65703772|NCT02737475|Immunologic Factors|immunologic factors|mesh-ancestor
65703773|NCT02737475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703774|NCT02737475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65703775|NCT02737475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65703776|NCT02737475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65703777|NCT02737475|Alkylating Agents|alkylating agents|mesh-ancestor
65703778|NCT02737475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703779|NCT02737475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703780|NCT02737475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65703781|NCT02737475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65703782|NCT02737475|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65703783|NCT02457806|Phenylephrine|phenylephrine|mesh-list
65703784|NCT02457806|Oxymetazoline|oxymetazoline|mesh-list
65703785|NCT02457806|Tetracaine|tetracaine|mesh-list
65703786|NCT02457806|Anesthetics, Local|anesthetics, local|mesh-ancestor
65703787|NCT02457806|Anesthetics|anesthetics|mesh-ancestor
65703788|NCT02457806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65703789|NCT02457806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703790|NCT02457806|Sensory System Agents|sensory system agents|mesh-ancestor
65703791|NCT02457806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65703792|NCT02457806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65703793|NCT02457806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65703794|NCT02457806|Adrenergic Agents|adrenergic agents|mesh-ancestor
65703795|NCT02457806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65703796|NCT02457806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703797|NCT02457806|Sympathomimetics|sympathomimetics|mesh-ancestor
65703798|NCT02457806|Autonomic Agents|autonomic agents|mesh-ancestor
65703799|NCT02457806|Nasal Decongestants|nasal decongestants|mesh-ancestor
65703800|NCT02457806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65703801|NCT02457806|Respiratory System Agents|respiratory system agents|mesh-ancestor
65703802|NCT02457806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65703803|NCT02457806|Mydriatics|mydriatics|mesh-ancestor
65703804|NCT02457806|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65703805|NCT02457806|Protective Agents|protective agents|mesh-ancestor
65703806|NCT02459756|Citric Acid|citric acid|mesh-list
65703807|NCT02459756|Sodium Citrate|sodium citrate|mesh-list
65703808|NCT02459756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703809|NCT02459756|Anticoagulants|anticoagulants|mesh-ancestor
65703810|NCT02459756|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65703811|NCT02459756|Chelating Agents|chelating agents|mesh-ancestor
65703812|NCT02459756|Sequestering Agents|sequestering agents|mesh-ancestor
65703813|NCT02557672|Thrombin|thrombin|mesh-list
65703814|NCT02557672|Hemostatics|hemostatics|mesh-ancestor
65703815|NCT02557672|Coagulants|coagulants|mesh-ancestor
65703816|NCT02458274|Dimercaprol|dimercaprol|mesh-list
65703817|NCT02458274|Chelating Agents|chelating agents|mesh-ancestor
65703818|NCT02458274|Sequestering Agents|sequestering agents|mesh-ancestor
65703819|NCT02458274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703820|NCT02632175|Adalimumab|adalimumab|mesh-list
65703821|NCT02632175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65703822|NCT02632175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65703823|NCT02458196|Mycophenolic Acid|mycophenolic acid|mesh-list
65703824|NCT02458196|Prednisone|prednisone|mesh-list
65703825|NCT02458196|Prednisolone|prednisolone|mesh-list
65703826|NCT02458196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65703827|NCT02458196|Glucocorticoids|glucocorticoids|mesh-ancestor
65703828|NCT02458196|Hormones|hormones|mesh-ancestor
65703829|NCT02458196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65703830|NCT02458196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703831|NCT02458196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65703832|NCT02458196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703833|NCT02458196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65703834|NCT02458196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65703835|NCT02458196|Antitubercular Agents|antitubercular agents|mesh-ancestor
65703836|NCT02458196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65703837|NCT02458196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65703838|NCT02458196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65703839|NCT02458196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703840|NCT05207735|Capecitabine|capecitabine|mesh-list
65703841|NCT05207735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65703842|NCT05207735|Antimetabolites|antimetabolites|mesh-ancestor
65703843|NCT05207735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703844|NCT05207735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703845|NCT03264638|Cyproterone Acetate|cyproterone acetate|mesh-list
65703846|NCT03264638|Cyproterone|cyproterone|mesh-list
65703847|NCT03264638|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
65703848|NCT03264638|Androgen Antagonists|androgen antagonists|mesh-ancestor
65703849|NCT03264638|Hormone Antagonists|hormone antagonists|mesh-ancestor
65703850|NCT03264638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65703851|NCT03264638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703852|NCT03264638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703853|NCT03264638|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65703854|NCT03264638|Contraceptive Agents|contraceptive agents|mesh-ancestor
65703855|NCT03264638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65703856|NCT04502381|Amphotericin B|amphotericin b|mesh-list
65703857|NCT04502381|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65703858|NCT04502381|Deoxycholic Acid|deoxycholic acid|mesh-list
65703859|NCT04502381|Amebicides|amebicides|mesh-ancestor
65703860|NCT04502381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65703861|NCT04502381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65703862|NCT04502381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65703863|NCT04502381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65703864|NCT04502381|Antifungal Agents|antifungal agents|mesh-ancestor
65703865|NCT04502381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65703866|NCT04502381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65703867|NCT03264794|Gefitinib|gefitinib|mesh-list
65703868|NCT03264794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703869|NCT03264794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65703870|NCT03264794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65703871|NCT03264794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703872|NCT02925923|Clopidogrel|clopidogrel|mesh-list
65703873|NCT02925923|Ticagrelor|ticagrelor|mesh-list
65703874|NCT02925923|Eptifibatide|eptifibatide|mesh-list
65703875|NCT02925923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65703876|NCT02925923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65703877|NCT02925923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65703878|NCT02925923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65703879|NCT02925923|Purinergic Agents|purinergic agents|mesh-ancestor
65703880|NCT02925923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65703881|NCT02925923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703882|NCT02925923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703883|NCT03280316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65703884|NCT03280316|Botulinum Toxins|botulinum toxins|mesh-list
65703885|NCT03280316|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65703886|NCT03280316|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65703887|NCT03280316|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65703888|NCT03280316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65019740|NCT05786430|Pemetrexed|pemetrexed|mesh-list
65703889|NCT03280316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703890|NCT03280316|Cholinergic Agents|cholinergic agents|mesh-ancestor
65703891|NCT03280316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65703892|NCT03280316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703893|NCT03280316|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65703894|NCT03280316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65703895|NCT03280316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65703896|NCT03280316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65703897|NCT03280316|Urological Agents|urological agents|mesh-ancestor
65703898|NCT02410343|Hormones|hormones|mesh-list
65703899|NCT02410343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65703900|NCT02410343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703901|NCT05234840|Triamcinolone|triamcinolone|mesh-list
65703902|NCT05234840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65703903|NCT05234840|Glucocorticoids|glucocorticoids|mesh-ancestor
65703904|NCT05234840|Hormones|hormones|mesh-ancestor
65703905|NCT05234840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65703906|NCT05234840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703907|NCT03280004|Moxifloxacin|moxifloxacin|mesh-list
65703908|NCT03280004|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65703909|NCT03280004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65703910|NCT03280004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65703911|NCT03280004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65703912|NCT03280004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65703913|NCT03280004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65703914|NCT03280004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703915|NCT03280004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703916|NCT03280004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65703917|NCT03280004|Contraceptive Agents|contraceptive agents|mesh-ancestor
65703918|NCT03280004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65703919|NCT03280004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703920|NCT03280004|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65703921|NCT03280004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65703922|NCT03280004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65703923|NCT03434379|Bevacizumab|bevacizumab|mesh-list
65703924|NCT03434379|Sorafenib|sorafenib|mesh-list
65703925|NCT03434379|Atezolizumab|atezolizumab|mesh-list
65703926|NCT03434379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65703927|NCT03434379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703928|NCT03434379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65703929|NCT03434379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65703930|NCT03434379|Growth Substances|growth substances|mesh-ancestor
65703931|NCT03434379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703932|NCT03434379|Growth Inhibitors|growth inhibitors|mesh-ancestor
65703933|NCT03434379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65703934|NCT03434379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65703935|NCT03434379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703936|NCT02459288|Clopidogrel|clopidogrel|mesh-list
65703937|NCT02459288|Ticagrelor|ticagrelor|mesh-list
65703938|NCT02459288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65703939|NCT02459288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65703940|NCT02459288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65703941|NCT02459288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65703942|NCT02459288|Purinergic Agents|purinergic agents|mesh-ancestor
65703943|NCT02459288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65703944|NCT02459288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703945|NCT02459288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703946|NCT00734253|Pyridoxamine|pyridoxamine|mesh-list
65703947|NCT00734253|Vitamin B Complex|vitamin b complex|mesh-ancestor
65703948|NCT00734253|Vitamins|vitamins|mesh-ancestor
65703949|NCT00734253|Micronutrients|micronutrients|mesh-ancestor
65703950|NCT00734253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703951|NCT05166239|Lenvatinib|lenvatinib|mesh-list
65703952|NCT05166239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703953|NCT05166239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65703954|NCT05166239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65703955|NCT05166239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703956|NCT00730665|Esomeprazole|esomeprazole|mesh-list
65703957|NCT00730665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65703958|NCT00730665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65703959|NCT00730665|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65703960|NCT00730665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65703961|NCT00730665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703962|NCT00714597|Enoxaparin|enoxaparin|mesh-list
65703963|NCT00714597|Semuloparin|semuloparin|mesh-list
65703964|NCT00714597|Enoxaparin sodium|enoxaparin sodium|mesh-list
65703965|NCT00714597|Anticoagulants|anticoagulants|mesh-ancestor
65703966|NCT00714597|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65703967|NCT00714597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65703968|NCT00714597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703969|NCT03919526|Cyclophosphamide|cyclophosphamide|mesh-list
65703970|NCT03919526|Fludarabine|fludarabine|mesh-list
65703971|NCT03919526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65703972|NCT03919526|Immunologic Factors|immunologic factors|mesh-ancestor
65703973|NCT03919526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703974|NCT03919526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65703975|NCT03919526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65703976|NCT03919526|Alkylating Agents|alkylating agents|mesh-ancestor
65703977|NCT03919526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703978|NCT03919526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65703979|NCT03919526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65703980|NCT03265886|Bupivacaine|bupivacaine|mesh-list
65703981|NCT03265886|Anesthetics, Local|anesthetics, local|mesh-ancestor
65703982|NCT03265886|Anesthetics|anesthetics|mesh-ancestor
65703983|NCT03265886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65703984|NCT03265886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703985|NCT03265886|Sensory System Agents|sensory system agents|mesh-ancestor
65703986|NCT03265886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65703987|NCT00728091|Satavaptan|satavaptan|mesh-list
65703988|NCT00728091|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65703989|NCT00728091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65703990|NCT00728091|Natriuretic Agents|natriuretic agents|mesh-ancestor
65703991|NCT00728091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65703992|NCT03275090|SMOFlipid|smoflipid|mesh-list
65703993|NCT03275090|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65703994|NCT03275090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65703995|NCT03275090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65703996|NCT03382821|Dexamethasone|dexamethasone|mesh-list
65703997|NCT03382821|Dexamethasone acetate|dexamethasone acetate|mesh-list
65703998|NCT03382821|Triamcinolone|triamcinolone|mesh-list
65703999|NCT03382821|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65704000|NCT03382821|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65704001|NCT03382821|Lidocaine|lidocaine|mesh-list
65704002|NCT03382821|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65704003|NCT03382821|BB 1101|bb 1101|mesh-list
65704004|NCT03382821|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65704005|NCT03382821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65704006|NCT03382821|Antiemetics|antiemetics|mesh-ancestor
65704007|NCT03382821|Autonomic Agents|autonomic agents|mesh-ancestor
65704008|NCT03382821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65704009|NCT03382821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704010|NCT03382821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65704011|NCT03382821|Glucocorticoids|glucocorticoids|mesh-ancestor
65704012|NCT03382821|Hormones|hormones|mesh-ancestor
65704013|NCT03382821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65704014|NCT03382821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65704015|NCT03382821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704016|NCT03382821|Protease Inhibitors|protease inhibitors|mesh-ancestor
65704017|NCT03382821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704018|NCT03382821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704019|NCT03382821|Anesthetics, Local|anesthetics, local|mesh-ancestor
65704020|NCT03382821|Anesthetics|anesthetics|mesh-ancestor
65704021|NCT03382821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65704022|NCT03382821|Sensory System Agents|sensory system agents|mesh-ancestor
65704023|NCT03382821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65704024|NCT03382821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65704025|NCT03382821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65704026|NCT03382821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65704027|NCT03382821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65704028|NCT03382821|Immunologic Factors|immunologic factors|mesh-ancestor
65704029|NCT03263624|Tazarotene|tazarotene|mesh-list
65704030|NCT03263624|Dermatologic Agents|dermatologic agents|mesh-ancestor
65704031|NCT03263624|Keratolytic Agents|keratolytic agents|mesh-ancestor
65704032|NCT00711555|Dexamethasone|dexamethasone|mesh-list
65704033|NCT00711555|Ondansetron|ondansetron|mesh-list
65704034|NCT00711555|Aprepitant|aprepitant|mesh-list
65704035|NCT00711555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65704036|NCT00711555|Antiemetics|antiemetics|mesh-ancestor
65704037|NCT00711555|Autonomic Agents|autonomic agents|mesh-ancestor
65704038|NCT00711555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65704039|NCT00711555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704040|NCT00711555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65704041|NCT00711555|Glucocorticoids|glucocorticoids|mesh-ancestor
65704042|NCT00711555|Hormones|hormones|mesh-ancestor
65704043|NCT00711555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65704044|NCT00711555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65704045|NCT00711555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704046|NCT00711555|Antipruritics|antipruritics|mesh-ancestor
65704047|NCT00711555|Dermatologic Agents|dermatologic agents|mesh-ancestor
65704048|NCT00711555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65704049|NCT00711555|Serotonin Agents|serotonin agents|mesh-ancestor
65704050|NCT00711555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65704051|NCT00711555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704052|NCT00711555|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65704053|NCT00711555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65704054|NCT00711555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65704055|NCT00711555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65704056|NCT00711555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65704057|NCT00711555|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65704058|NCT03263390|Anti-Obesity Agents|anti-obesity agents|mesh-list
65704059|NCT02280993|Dexamethasone|dexamethasone|mesh-list
65704060|NCT02280993|Cisplatin|cisplatin|mesh-list
65704061|NCT02280993|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65704062|NCT02280993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65704063|NCT02280993|Antiemetics|antiemetics|mesh-ancestor
65704064|NCT02280993|Autonomic Agents|autonomic agents|mesh-ancestor
65704065|NCT02280993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65704066|NCT02280993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704067|NCT02280993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65704068|NCT02280993|Glucocorticoids|glucocorticoids|mesh-ancestor
65704069|NCT02280993|Hormones|hormones|mesh-ancestor
65704070|NCT02280993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65704071|NCT02280993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65704072|NCT02280993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704073|NCT02280993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65704074|NCT05488522|Bevacizumab|bevacizumab|mesh-list
65704075|NCT05488522|Atezolizumab|atezolizumab|mesh-list
65704076|NCT05488522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65704077|NCT05488522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704078|NCT05488522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65704079|NCT05488522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65704080|NCT05488522|Growth Substances|growth substances|mesh-ancestor
65704081|NCT05488522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704082|NCT05488522|Growth Inhibitors|growth inhibitors|mesh-ancestor
65704083|NCT05492968|Phenylephrine|phenylephrine|mesh-list
65704084|NCT05492968|Epinephrine|epinephrine|mesh-list
65704085|NCT05492968|Oxymetazoline|oxymetazoline|mesh-list
65704086|NCT05492968|Norepinephrine|norepinephrine|mesh-list
65704087|NCT05492968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65704088|NCT05492968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65704089|NCT05492968|Adrenergic Agents|adrenergic agents|mesh-ancestor
65704090|NCT05492968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65704091|NCT05492968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704092|NCT05492968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704093|NCT05492968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65704094|NCT05492968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65704095|NCT05492968|Autonomic Agents|autonomic agents|mesh-ancestor
65704096|NCT05492968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65704097|NCT05492968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65704098|NCT05492968|Respiratory System Agents|respiratory system agents|mesh-ancestor
65704099|NCT05492968|Mydriatics|mydriatics|mesh-ancestor
65704100|NCT05492968|Sympathomimetics|sympathomimetics|mesh-ancestor
65704101|NCT05492968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65704102|NCT05492968|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65704103|NCT05492968|Nasal Decongestants|nasal decongestants|mesh-ancestor
65704104|NCT05492968|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65704105|NCT05492968|Protective Agents|protective agents|mesh-ancestor
65704106|NCT02457026|Triamcinolone|triamcinolone|mesh-list
65704107|NCT02457026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65704108|NCT02457026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65704109|NCT02457026|Aflibercept|aflibercept|mesh-list
65704110|NCT02457026|Verteporfin|verteporfin|mesh-list
65704111|NCT02457026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65704112|NCT02457026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65019953|NCT05781321|Temozolomide|temozolomide|mesh-list
65704113|NCT02457026|Glucocorticoids|glucocorticoids|mesh-ancestor
65704114|NCT02457026|Hormones|hormones|mesh-ancestor
65704115|NCT02457026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65704116|NCT02457026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704117|NCT02457026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65704118|NCT02457026|Immunologic Factors|immunologic factors|mesh-ancestor
65704119|NCT02457026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704120|NCT02457026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704121|NCT02457026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65704122|NCT02457026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65704123|NCT02457026|Growth Substances|growth substances|mesh-ancestor
65704124|NCT02457026|Growth Inhibitors|growth inhibitors|mesh-ancestor
65704125|NCT02457026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704126|NCT02457026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65704127|NCT02457026|Dermatologic Agents|dermatologic agents|mesh-ancestor
65704128|NCT05492812|Melatonin|melatonin|mesh-list
65704129|NCT05492812|Chloral Hydrate|chloral hydrate|mesh-list
65704130|NCT05492812|Hydroxyzine|hydroxyzine|mesh-list
65704131|NCT05492812|Antioxidants|antioxidants|mesh-ancestor
65704132|NCT05492812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704133|NCT05492812|Protective Agents|protective agents|mesh-ancestor
65704134|NCT05492812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704135|NCT05492812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65704136|NCT05492812|Antipruritics|antipruritics|mesh-ancestor
65704137|NCT05492812|Dermatologic Agents|dermatologic agents|mesh-ancestor
65704138|NCT05492812|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65704139|NCT05492812|Histamine Antagonists|histamine antagonists|mesh-ancestor
65704140|NCT05492812|Histamine Agents|histamine agents|mesh-ancestor
65704141|NCT05492812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65704142|NCT05492812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65704143|NCT02458118|Secretin|secretin|mesh-list
65704144|NCT02458118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65704145|NCT02458118|Hormones|hormones|mesh-ancestor
65704146|NCT02458118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65704147|NCT02458118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704148|NCT05487742|Dexmedetomidine|dexmedetomidine|mesh-list
65704149|NCT05487742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65704150|NCT05487742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65704151|NCT05487742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704152|NCT05487742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65704153|NCT05487742|Analgesics|analgesics|mesh-ancestor
65704154|NCT05487742|Sensory System Agents|sensory system agents|mesh-ancestor
65704155|NCT05487742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65704156|NCT05487742|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65704157|NCT05487742|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65704158|NCT05487742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65704159|NCT05487742|Adrenergic Agents|adrenergic agents|mesh-ancestor
65704160|NCT05487742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65704161|NCT05487742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704162|NCT02457650|Cyclophosphamide|cyclophosphamide|mesh-list
65704163|NCT02457650|Fludarabine|fludarabine|mesh-list
65704164|NCT02457650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65704165|NCT02457650|Immunologic Factors|immunologic factors|mesh-ancestor
65704166|NCT02457650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704167|NCT02457650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65704168|NCT02457650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65704169|NCT02457650|Alkylating Agents|alkylating agents|mesh-ancestor
65704170|NCT02457650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704171|NCT02457650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704172|NCT02457650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65704173|NCT02456948|Minocycline|minocycline|mesh-list
65704174|NCT02456948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65704175|NCT02456948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65704176|NCT05487508|Dexamethasone|dexamethasone|mesh-list
65704177|NCT05487508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65704178|NCT05487508|Antiemetics|antiemetics|mesh-ancestor
65704179|NCT05487508|Autonomic Agents|autonomic agents|mesh-ancestor
65704180|NCT05487508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65704181|NCT05487508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704182|NCT05487508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65704183|NCT05487508|Glucocorticoids|glucocorticoids|mesh-ancestor
65704184|NCT05487508|Hormones|hormones|mesh-ancestor
65704185|NCT05487508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65704186|NCT05487508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65704187|NCT05487508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704188|NCT02713490|Bupivacaine|bupivacaine|mesh-list
65704189|NCT02713490|Anesthetics, Local|anesthetics, local|mesh-ancestor
65704190|NCT02713490|Anesthetics|anesthetics|mesh-ancestor
65704191|NCT02713490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65704192|NCT02713490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704193|NCT02713490|Sensory System Agents|sensory system agents|mesh-ancestor
65704194|NCT02713490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65704195|NCT03787628|Cannabidiol|cannabidiol|mesh-list
65704196|NCT03787628|Anticonvulsants|anticonvulsants|mesh-ancestor
65704197|NCT04401904|Dapagliflozin|dapagliflozin|mesh-list
65704198|NCT04401904|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65704199|NCT04401904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704200|NCT04401904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65704201|NCT04401904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704202|NCT05491720|Risperidone|risperidone|mesh-list
65704203|NCT05491720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65704204|NCT05491720|Serotonin Agents|serotonin agents|mesh-ancestor
65704205|NCT05491720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65704206|NCT05491720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704207|NCT05491720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704208|NCT05491720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65704209|NCT05491720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65704210|NCT05491720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65704211|NCT05491720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65704212|NCT05491720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65704213|NCT05491720|Dopamine Agents|dopamine agents|mesh-ancestor
65704214|NCT05387954|Anticoagulants|anticoagulants|mesh-list
65704215|NCT05387954|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
65704216|NCT05387954|Antithrombins|antithrombins|mesh-ancestor
65704217|NCT05387954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65704218|NCT05387954|Protease Inhibitors|protease inhibitors|mesh-ancestor
65704219|NCT05387954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704220|NCT05387954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704221|NCT03262688|Bupivacaine|bupivacaine|mesh-list
65704222|NCT03262688|Anesthetics, Local|anesthetics, local|mesh-ancestor
65704223|NCT03262688|Anesthetics|anesthetics|mesh-ancestor
65704224|NCT03262688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65704225|NCT03262688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704226|NCT03262688|Sensory System Agents|sensory system agents|mesh-ancestor
65704227|NCT03262688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65704228|NCT05486884|Benzocaine|benzocaine|mesh-list
65704229|NCT05486884|Anesthetics, Local|anesthetics, local|mesh-ancestor
65704230|NCT05486884|Anesthetics|anesthetics|mesh-ancestor
65704231|NCT05486884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65704232|NCT05486884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704233|NCT05486884|Sensory System Agents|sensory system agents|mesh-ancestor
65704234|NCT05486884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65704235|NCT05485792|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65704236|NCT05485792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65704237|NCT05485792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704238|NCT03797924|Ropivacaine|ropivacaine|mesh-list
65704239|NCT03797924|Anesthetics, Local|anesthetics, local|mesh-ancestor
65704240|NCT03797924|Anesthetics|anesthetics|mesh-ancestor
65704241|NCT03797924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65704242|NCT03797924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704243|NCT03797924|Sensory System Agents|sensory system agents|mesh-ancestor
65704244|NCT03797924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65704245|NCT05486650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65704246|NCT05486650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704247|NCT05486650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704248|NCT05074628|Nitrofurantoin|nitrofurantoin|mesh-list
65704249|NCT05074628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65704250|NCT05074628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65704251|NCT05074628|Renal Agents|renal agents|mesh-ancestor
65704252|NCT05074628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65704253|NCT04273516|Rivaroxaban|rivaroxaban|mesh-list
65704254|NCT04273516|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65704255|NCT04273516|Antithrombins|antithrombins|mesh-ancestor
65704256|NCT04273516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65704257|NCT04273516|Protease Inhibitors|protease inhibitors|mesh-ancestor
65704258|NCT04273516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704259|NCT04273516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704260|NCT04273516|Anticoagulants|anticoagulants|mesh-ancestor
65704261|NCT02458742|Morphine|morphine|mesh-list
65704262|NCT02458742|Bupivacaine|bupivacaine|mesh-list
65704263|NCT02458742|Anesthetics, Local|anesthetics, local|mesh-ancestor
65704264|NCT02458742|Anesthetics|anesthetics|mesh-ancestor
65704265|NCT02458742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65704266|NCT02458742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704267|NCT02458742|Sensory System Agents|sensory system agents|mesh-ancestor
65704268|NCT02458742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65704269|NCT02458742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65704270|NCT02458742|Narcotics|narcotics|mesh-ancestor
65704271|NCT02458742|Analgesics|analgesics|mesh-ancestor
65704272|NCT02403310|Cytarabine|cytarabine|mesh-list
65704273|NCT02403310|Daunorubicin|daunorubicin|mesh-list
65704274|NCT02403310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65704275|NCT02403310|Antimetabolites|antimetabolites|mesh-ancestor
65704276|NCT02403310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704277|NCT02403310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704278|NCT02403310|Antiviral Agents|antiviral agents|mesh-ancestor
65704279|NCT02403310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65704280|NCT02403310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65704281|NCT02403310|Immunologic Factors|immunologic factors|mesh-ancestor
65704282|NCT02403310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704283|NCT02403310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65704284|NCT02403310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65704285|NCT02403310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65704286|NCT02403310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704287|NCT01665274|Capecitabine|capecitabine|mesh-list
65704288|NCT01665274|Oxaliplatin|oxaliplatin|mesh-list
65704289|NCT01665274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65704290|NCT01665274|Antimetabolites|antimetabolites|mesh-ancestor
65704291|NCT01665274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704292|NCT01665274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704293|NCT05387876|Vitamin D|vitamin d|mesh-list
65704294|NCT05387876|Vitamins|vitamins|mesh-ancestor
65704295|NCT05387876|Micronutrients|micronutrients|mesh-ancestor
65704296|NCT05387876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704297|NCT05387876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65704298|NCT04560166|Irinotecan|irinotecan|mesh-list
65704299|NCT04560166|Temozolomide|temozolomide|mesh-list
65704300|NCT04560166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65704301|NCT04560166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65704302|NCT04560166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704303|NCT04560166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704304|NCT04560166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704305|NCT04560166|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65704306|NCT04560166|Alkylating Agents|alkylating agents|mesh-ancestor
65704307|NCT03262376|Vitamins|vitamins|mesh-list
65704308|NCT03262376|Micronutrients|micronutrients|mesh-ancestor
65704309|NCT03262376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704310|NCT05480098|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65704311|NCT05480098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65704312|NCT05480098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65704313|NCT05480098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65704314|NCT05480098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65704315|NCT05480098|Adrenergic Agents|adrenergic agents|mesh-ancestor
65704316|NCT05480098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65704317|NCT05480098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704318|NCT05480098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704319|NCT05484466|Entecavir|entecavir|mesh-list
65704320|NCT05484466|Antiviral Agents|antiviral agents|mesh-ancestor
65704321|NCT05484466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65704322|NCT02456714|Folfirinox|folfirinox|mesh-list
65704323|NCT02456714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704324|NCT03258866|Rituximab|rituximab|mesh-list
65704325|NCT03258866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65704326|NCT03258866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704327|NCT03258866|Immunologic Factors|immunologic factors|mesh-ancestor
65704328|NCT03258866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704329|NCT03258866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65704330|NCT03258476|Guanfacine|guanfacine|mesh-list
65704331|NCT03258476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65704332|NCT03258476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65704333|NCT03258476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65704334|NCT03258476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65704335|NCT03258476|Adrenergic Agents|adrenergic agents|mesh-ancestor
65704336|NCT03258476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65704337|NCT03258476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704338|NCT03258476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704339|NCT05484154|Protein C|protein c|mesh-list
65704340|NCT05484154|Anticoagulants|anticoagulants|mesh-ancestor
65704341|NCT05484154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65704342|NCT05484154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65704343|NCT05484154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704344|NCT03258398|Avelumab|avelumab|mesh-list
65704345|NCT03258398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65704346|NCT03258398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704347|NCT03261596|Mebendazole|mebendazole|mesh-list
65704348|NCT03261596|Piperazine|piperazine|mesh-list
65704349|NCT03261596|Piperazine citrate|piperazine citrate|mesh-list
65704350|NCT03261596|DMP 777|dmp 777|mesh-list
65704351|NCT03261596|Antinematodal Agents|antinematodal agents|mesh-ancestor
65704352|NCT03261596|Anthelmintics|anthelmintics|mesh-ancestor
65704353|NCT03261596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65704354|NCT03261596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65704355|NCT03261596|Tubulin Modulators|tubulin modulators|mesh-ancestor
65704356|NCT03261596|Antimitotic Agents|antimitotic agents|mesh-ancestor
65704357|NCT03261596|Mitosis Modulators|mitosis modulators|mesh-ancestor
65704358|NCT03261596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704359|NCT03261596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704360|NCT03261596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704361|NCT03825874|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65704362|NCT03825874|Amikacin|amikacin|mesh-list
65704363|NCT03825874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65704364|NCT03786614|Antidepressive Agents|antidepressive agents|mesh-list
65704365|NCT03786614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65704366|NCT03772574|Nicotine|nicotine|mesh-list
65704367|NCT03772574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65704368|NCT03772574|Autonomic Agents|autonomic agents|mesh-ancestor
65704369|NCT03772574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65704370|NCT03772574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704371|NCT03772574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65704372|NCT03772574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65704373|NCT03772574|Cholinergic Agents|cholinergic agents|mesh-ancestor
65704374|NCT03772574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65704375|NCT03772574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704376|NCT03694808|Vaccines|vaccines|mesh-list
65704377|NCT03694808|Immunologic Factors|immunologic factors|mesh-ancestor
65704378|NCT03694808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704379|NCT02456558|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65704380|NCT02456558|Deferiprone|deferiprone|mesh-list
65704381|NCT02456558|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65704382|NCT02456558|Chelating Agents|chelating agents|mesh-ancestor
65704383|NCT02456558|Sequestering Agents|sequestering agents|mesh-ancestor
65704384|NCT02456558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704385|NCT05479240|Capecitabine|capecitabine|mesh-list
65704386|NCT05479240|Oxaliplatin|oxaliplatin|mesh-list
65704387|NCT05479240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65704388|NCT05479240|Antimetabolites|antimetabolites|mesh-ancestor
65704389|NCT05479240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704390|NCT05479240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704391|NCT03798080|Insulin|insulin|mesh-list
65704392|NCT03798080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65704393|NCT03798080|Metformin|metformin|mesh-list
65704394|NCT03798080|Insulin Glargine|insulin glargine|mesh-list
65704395|NCT03798080|Lixisenatide|lixisenatide|mesh-list
65704396|NCT03798080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65704397|NCT03798080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704398|NCT03257930|Ethanol|ethanol|mesh-list
65704399|NCT03257930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65704400|NCT03257930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65704401|NCT03257930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65704402|NCT03257930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704403|NCT03257852|Methotrexate|methotrexate|mesh-list
65704404|NCT03257852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65704405|NCT03257852|Abortifacient Agents|abortifacient agents|mesh-ancestor
65704406|NCT03257852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65704407|NCT03257852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704408|NCT03257852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65704409|NCT03257852|Antimetabolites|antimetabolites|mesh-ancestor
65704410|NCT03257852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704411|NCT03257852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020253|NCT05266469|Ofatumumab|ofatumumab|mesh-list
65020254|NCT05266469|Ocrelizumab|ocrelizumab|mesh-list
65020255|NCT05266469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020256|NCT05266469|Immunologic Factors|immunologic factors|mesh-ancestor
65704412|NCT03257852|Dermatologic Agents|dermatologic agents|mesh-ancestor
65704413|NCT03257852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704414|NCT03257852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65704415|NCT03257852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65704416|NCT03257852|Immunologic Factors|immunologic factors|mesh-ancestor
65704417|NCT03257852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65704418|NCT03257852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65704420|NCT05498896|Cyclophosphamide|cyclophosphamide|mesh-list
65704421|NCT05498896|Doxorubicin|doxorubicin|mesh-list
65704422|NCT05498896|Atezolizumab|atezolizumab|mesh-list
65704423|NCT05498896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65704424|NCT05498896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704425|NCT05498896|Tubulin Modulators|tubulin modulators|mesh-ancestor
65704426|NCT05498896|Antimitotic Agents|antimitotic agents|mesh-ancestor
65704427|NCT05498896|Mitosis Modulators|mitosis modulators|mesh-ancestor
65704428|NCT05498896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704429|NCT05498896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65704430|NCT05498896|Immunologic Factors|immunologic factors|mesh-ancestor
65704431|NCT05498896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704432|NCT05498896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65704433|NCT05498896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65704434|NCT05498896|Alkylating Agents|alkylating agents|mesh-ancestor
65704435|NCT05498896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65704436|NCT05498896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65704437|NCT05498896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65704438|NCT05498896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65704439|NCT05498896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704440|NCT02743221|Trifluridine|trifluridine|mesh-list
65704441|NCT02743221|Bevacizumab|bevacizumab|mesh-list
65704442|NCT02743221|Capecitabine|capecitabine|mesh-list
65704443|NCT02743221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65704444|NCT02743221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704445|NCT02743221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65704446|NCT02743221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65704447|NCT02743221|Growth Substances|growth substances|mesh-ancestor
65704448|NCT02743221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704449|NCT02743221|Growth Inhibitors|growth inhibitors|mesh-ancestor
65704450|NCT02743221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65704451|NCT02743221|Antimetabolites|antimetabolites|mesh-ancestor
65704452|NCT02743221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704453|NCT02743221|Antiviral Agents|antiviral agents|mesh-ancestor
65704454|NCT02743221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65704455|NCT03955887|Dimercaprol|dimercaprol|mesh-list
65704456|NCT03955887|Chelating Agents|chelating agents|mesh-ancestor
65704457|NCT03955887|Sequestering Agents|sequestering agents|mesh-ancestor
65704458|NCT03955887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704459|NCT03260972|Chloroprocaine|chloroprocaine|mesh-list
65704460|NCT03260972|Anesthetics, Local|anesthetics, local|mesh-ancestor
65704461|NCT03260972|Anesthetics|anesthetics|mesh-ancestor
65704462|NCT03260972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65704463|NCT03260972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704464|NCT03260972|Sensory System Agents|sensory system agents|mesh-ancestor
65704465|NCT03260972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65704466|NCT03370263|Belimumab|belimumab|mesh-list
65704467|NCT03370263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65704468|NCT03370263|Immunologic Factors|immunologic factors|mesh-ancestor
65704469|NCT03370263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704470|NCT00692445|Mecamylamine|mecamylamine|mesh-list
65704471|NCT00692445|Dexetimide|dexetimide|mesh-list
65704472|NCT00692445|Citalopram|citalopram|mesh-list
65704473|NCT00692445|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65704474|NCT00692445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65704475|NCT00692445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65704476|NCT00692445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704477|NCT00692445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65704478|NCT00692445|Serotonin Agents|serotonin agents|mesh-ancestor
65704479|NCT00692445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704480|NCT00692445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65704481|NCT00692445|Antidepressive Agents|antidepressive agents|mesh-ancestor
65704482|NCT00692445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65704483|NCT00692445|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65704484|NCT00692445|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65704485|NCT00692445|Parasympatholytics|parasympatholytics|mesh-ancestor
65704486|NCT00692445|Autonomic Agents|autonomic agents|mesh-ancestor
65704487|NCT00692445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65704488|NCT00692445|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65704489|NCT00692445|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65704490|NCT00692445|Cholinergic Agents|cholinergic agents|mesh-ancestor
65704491|NCT00692445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65704492|NCT00692445|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
65704493|NCT00692445|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65704495|NCT03256292|Androgens|androgens|mesh-ancestor
65704496|NCT03256292|Hormones|hormones|mesh-ancestor
65704497|NCT03256292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65704498|NCT03256292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704499|NCT04473261|Iodine|iodine|mesh-list
65704500|NCT04473261|Cadexomer iodine|cadexomer iodine|mesh-list
65704501|NCT04473261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65704502|NCT04473261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65704503|NCT04473261|Trace Elements|trace elements|mesh-ancestor
65704504|NCT04473261|Micronutrients|micronutrients|mesh-ancestor
65704505|NCT04473261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704506|NCT01358968|Gemcitabine|gemcitabine|mesh-list
65704507|NCT01358968|Pemetrexed|pemetrexed|mesh-list
65704508|NCT01358968|Desipramine|desipramine|mesh-list
65704509|NCT01358968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65704510|NCT01358968|Antimetabolites|antimetabolites|mesh-ancestor
65704511|NCT01358968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704512|NCT01358968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704513|NCT01358968|Antiviral Agents|antiviral agents|mesh-ancestor
65704514|NCT01358968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65704515|NCT01358968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704516|NCT01358968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65704517|NCT01358968|Immunologic Factors|immunologic factors|mesh-ancestor
65704518|NCT01358968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704519|NCT01358968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65704520|NCT01358968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65704521|NCT01358968|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65704522|NCT01358968|Antidepressive Agents|antidepressive agents|mesh-ancestor
65704523|NCT01358968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65704524|NCT01358968|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65704525|NCT01358968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65704526|NCT01358968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65704527|NCT01358968|Adrenergic Agents|adrenergic agents|mesh-ancestor
65704528|NCT01358968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65704529|NCT02281305|Colchicine|colchicine|mesh-list
65704530|NCT02281305|Gout Suppressants|gout suppressants|mesh-ancestor
65704531|NCT02281305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65704532|NCT02281305|Tubulin Modulators|tubulin modulators|mesh-ancestor
65704533|NCT02281305|Antimitotic Agents|antimitotic agents|mesh-ancestor
65704534|NCT02281305|Mitosis Modulators|mitosis modulators|mesh-ancestor
65704535|NCT02281305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704536|NCT02281305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704537|NCT00624351|Epratuzumab|epratuzumab|mesh-list
65704538|NCT00624351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65704539|NCT00624351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704540|NCT03964090|Cytarabine|cytarabine|mesh-list
65704541|NCT03964090|Isavuconazole|isavuconazole|mesh-list
65704542|NCT03964090|Methotrexate|methotrexate|mesh-list
65704543|NCT03964090|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65704544|NCT03964090|Abortifacient Agents|abortifacient agents|mesh-ancestor
65704545|NCT03964090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65704546|NCT03964090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704547|NCT03964090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65704548|NCT03964090|Antimetabolites|antimetabolites|mesh-ancestor
65704549|NCT03964090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704550|NCT03964090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704551|NCT03964090|Dermatologic Agents|dermatologic agents|mesh-ancestor
65704552|NCT03964090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704553|NCT03964090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65704554|NCT03964090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65704555|NCT03964090|Immunologic Factors|immunologic factors|mesh-ancestor
65704556|NCT03964090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65704557|NCT03964090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65704558|NCT03964090|Antiviral Agents|antiviral agents|mesh-ancestor
65704559|NCT03964090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65704560|NCT03964090|Antifungal Agents|antifungal agents|mesh-ancestor
65704561|NCT03251690|Tenofovir|tenofovir|mesh-list
65704562|NCT03251690|Emtricitabine|emtricitabine|mesh-list
65704563|NCT03251690|Efavirenz|efavirenz|mesh-list
65704564|NCT03251690|Rilpivirine|rilpivirine|mesh-list
65704565|NCT03251690|Antiviral Agents|antiviral agents|mesh-ancestor
65704566|NCT03251690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65704567|NCT03251690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65704568|NCT03251690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65704569|NCT03251690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704570|NCT03251690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704571|NCT03251690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65704572|NCT03251690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65704573|NCT03251690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65704574|NCT03251690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65704575|NCT03251690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65704576|NCT03251690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65704577|NCT03251690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65704578|NCT03251690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65704580|NCT03251768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65704581|NCT03251768|Immunologic Factors|immunologic factors|mesh-ancestor
65704582|NCT03251768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704583|NCT00687687|Paclitaxel|paclitaxel|mesh-list
65704584|NCT00687687|Carboplatin|carboplatin|mesh-list
65704585|NCT00687687|Iniparib|iniparib|mesh-list
65704586|NCT00687687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65704587|NCT00687687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704588|NCT00687687|Tubulin Modulators|tubulin modulators|mesh-ancestor
65704589|NCT00687687|Antimitotic Agents|antimitotic agents|mesh-ancestor
65704590|NCT00687687|Mitosis Modulators|mitosis modulators|mesh-ancestor
65704591|NCT00687687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704592|NCT00687687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65704593|NCT00687687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704594|NCT00701090|Metformin|metformin|mesh-list
65704595|NCT00701090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65704596|NCT00701090|Glimepiride|glimepiride|mesh-list
65704597|NCT00701090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65704598|NCT00701090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704599|NCT00701090|Incretins|incretins|mesh-ancestor
65704600|NCT00701090|Hormones|hormones|mesh-ancestor
65704601|NCT00701090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65704602|NCT00701090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65704603|NCT00701090|Protease Inhibitors|protease inhibitors|mesh-ancestor
65704604|NCT00701090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704605|NCT00701090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704606|NCT00701090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65704607|NCT00701090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65704608|NCT00701090|Immunologic Factors|immunologic factors|mesh-ancestor
65704609|NCT00614601|Vaccines|vaccines|mesh-list
65704610|NCT00614601|Immunologic Factors|immunologic factors|mesh-ancestor
65704611|NCT00614601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704612|NCT02283489|Paclitaxel|paclitaxel|mesh-list
65704613|NCT02283489|Endostatins|endostatins|mesh-list
65704614|NCT02283489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65704615|NCT02283489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704616|NCT02283489|Tubulin Modulators|tubulin modulators|mesh-ancestor
65704617|NCT02283489|Antimitotic Agents|antimitotic agents|mesh-ancestor
65704618|NCT02283489|Mitosis Modulators|mitosis modulators|mesh-ancestor
65704619|NCT02283489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704620|NCT02283489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65704621|NCT02283489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65704622|NCT02283489|Growth Substances|growth substances|mesh-ancestor
65704623|NCT02283489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704624|NCT02283489|Growth Inhibitors|growth inhibitors|mesh-ancestor
65704625|NCT02455232|Lidocaine|lidocaine|mesh-list
65704626|NCT02455232|Anesthetics, Local|anesthetics, local|mesh-ancestor
65704627|NCT02455232|Anesthetics|anesthetics|mesh-ancestor
65704628|NCT02455232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65704629|NCT02455232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704630|NCT02455232|Sensory System Agents|sensory system agents|mesh-ancestor
65704631|NCT02455232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65704632|NCT02455232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65704633|NCT02455232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65704634|NCT02455232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65704635|NCT02455232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65704636|NCT02455232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704637|NCT03259958|Donepezil|donepezil|mesh-list
65704638|NCT03259958|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65704639|NCT03259958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704640|NCT03259958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704641|NCT03259958|Cholinergic Agents|cholinergic agents|mesh-ancestor
65704642|NCT03259958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65704643|NCT03259958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704644|NCT03259958|Nootropic Agents|nootropic agents|mesh-ancestor
65704645|NCT02923947|Osimertinib|osimertinib|mesh-list
65704646|NCT02923947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704647|NCT02923947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65704648|NCT02923947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704649|NCT02923947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704650|NCT00679731|Methotrexate|methotrexate|mesh-list
65704651|NCT00679731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65704652|NCT00679731|Abortifacient Agents|abortifacient agents|mesh-ancestor
65704653|NCT00679731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65704654|NCT00679731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704655|NCT00679731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65704656|NCT00679731|Antimetabolites|antimetabolites|mesh-ancestor
65704657|NCT00679731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704658|NCT00679731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704659|NCT00679731|Dermatologic Agents|dermatologic agents|mesh-ancestor
65704660|NCT00679731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704661|NCT00679731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65704662|NCT00679731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65704663|NCT00679731|Immunologic Factors|immunologic factors|mesh-ancestor
65704664|NCT00679731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65704665|NCT00679731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65704666|NCT02455856|Itraconazole|itraconazole|mesh-list
65704667|NCT02455856|Antifungal Agents|antifungal agents|mesh-ancestor
65704668|NCT02455856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65704669|NCT02455856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65704670|NCT02455856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65704671|NCT02455856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704672|NCT02455856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704673|NCT02455856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65704674|NCT02455856|Hormone Antagonists|hormone antagonists|mesh-ancestor
65704675|NCT02455856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65704676|NCT02455856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704677|NCT02455856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65704678|NCT02283645|Minoxidil|minoxidil|mesh-list
65704679|NCT02283645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65704680|NCT02283645|Vasodilator Agents|vasodilator agents|mesh-ancestor
65704681|NCT00602745|Fluorouracil|fluorouracil|mesh-list
65704682|NCT00602745|Antimetabolites|antimetabolites|mesh-ancestor
65704683|NCT00602745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704684|NCT00602745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65704685|NCT00602745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704686|NCT00602745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65704687|NCT00602745|Immunologic Factors|immunologic factors|mesh-ancestor
65704688|NCT00602745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704689|NCT03251222|Dexmedetomidine|dexmedetomidine|mesh-list
65704690|NCT03251222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65704691|NCT03251222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65704692|NCT03251222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704693|NCT03251222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65704694|NCT03251222|Analgesics|analgesics|mesh-ancestor
65704695|NCT03251222|Sensory System Agents|sensory system agents|mesh-ancestor
65704696|NCT03251222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65704697|NCT03251222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65704698|NCT03251222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65704699|NCT03251222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65704700|NCT03251222|Adrenergic Agents|adrenergic agents|mesh-ancestor
65704701|NCT03251222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65704702|NCT03251222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704703|NCT04487834|Simethicone|simethicone|mesh-list
65704704|NCT04487834|Antifoaming Agents|antifoaming agents|mesh-ancestor
65704705|NCT04487834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704706|NCT04487834|Emollients|emollients|mesh-ancestor
65704707|NCT04487834|Dermatologic Agents|dermatologic agents|mesh-ancestor
65704708|NCT03250910|Ribavirin|ribavirin|mesh-list
65704709|NCT03250910|Sofosbuvir|sofosbuvir|mesh-list
65704710|NCT03250910|Velpatasvir|velpatasvir|mesh-list
65704711|NCT03250910|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65704712|NCT03250910|Antimetabolites|antimetabolites|mesh-ancestor
65704713|NCT03250910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704714|NCT03250910|Antiviral Agents|antiviral agents|mesh-ancestor
65704715|NCT03250910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65704716|NCT02283801|Lamotrigine|lamotrigine|mesh-list
65704717|NCT02283801|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
65704718|NCT02283801|Anticonvulsants|anticonvulsants|mesh-ancestor
65704719|NCT02283801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65704720|NCT02283801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65704721|NCT02283801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704722|NCT02283801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65704723|NCT02283801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704724|NCT02283801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65704725|NCT02283801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65704726|NCT02283801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65704727|NCT02283801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65704728|NCT02283801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65704729|NCT02283801|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65704730|NCT02455154|Letrozole|letrozole|mesh-list
65704731|NCT02455154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704732|NCT02455154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65704733|NCT02455154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65704734|NCT02455154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704735|NCT02455154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704736|NCT02455154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65704737|NCT02455154|Hormone Antagonists|hormone antagonists|mesh-ancestor
65704738|NCT02455154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65704739|NCT02455154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704740|NCT03254810|Adalimumab|adalimumab|mesh-list
65704741|NCT03254810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65704742|NCT03254810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65704743|NCT03255044|Atorvastatin|atorvastatin|mesh-list
65704744|NCT03255044|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65704745|NCT03255044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65704746|NCT03255044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65704747|NCT03255044|Antimetabolites|antimetabolites|mesh-ancestor
65704748|NCT03255044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704749|NCT03255044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65704750|NCT03255044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65704751|NCT03255044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704752|NCT00677079|Iniparib|iniparib|mesh-list
65704753|NCT00677079|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65704754|NCT00677079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704755|NCT00677079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704756|NCT00677079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704757|NCT03950674|Folic Acid|folic acid|mesh-list
65704758|NCT03950674|Vitamin B 12|vitamin b 12|mesh-list
65704759|NCT03950674|Dexamethasone|dexamethasone|mesh-list
65704760|NCT03950674|Carboplatin|carboplatin|mesh-list
65704761|NCT03950674|Pembrolizumab|pembrolizumab|mesh-list
65704762|NCT03950674|Pemetrexed|pemetrexed|mesh-list
65704763|NCT03950674|Vitamins|vitamins|mesh-ancestor
65704764|NCT03950674|Micronutrients|micronutrients|mesh-ancestor
65704765|NCT03950674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704766|NCT03950674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65704767|NCT03950674|Antiemetics|antiemetics|mesh-ancestor
65704768|NCT03950674|Autonomic Agents|autonomic agents|mesh-ancestor
65704769|NCT03950674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65704770|NCT03950674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65704771|NCT03950674|Glucocorticoids|glucocorticoids|mesh-ancestor
65704772|NCT03950674|Hormones|hormones|mesh-ancestor
65704773|NCT03950674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65704774|NCT03950674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65704775|NCT03950674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704776|NCT03950674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65704777|NCT03950674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704778|NCT03950674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704779|NCT03950674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65704780|NCT03950674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65704781|NCT03950674|Hematinics|hematinics|mesh-ancestor
65704782|NCT03950674|Vitamin B Complex|vitamin b complex|mesh-ancestor
65704783|NCT03245996|Atenolol|atenolol|mesh-list
65704784|NCT03245996|Nebivolol|nebivolol|mesh-list
65704785|NCT03245996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65704786|NCT03245996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65704787|NCT03245996|Sympatholytics|sympatholytics|mesh-ancestor
65704788|NCT03245996|Autonomic Agents|autonomic agents|mesh-ancestor
65704789|NCT03245996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65704790|NCT03245996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704791|NCT03245996|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65704792|NCT03245996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65704793|NCT03245996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65704794|NCT03245996|Adrenergic Agents|adrenergic agents|mesh-ancestor
65704795|NCT03245996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65704796|NCT03245996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704797|NCT03245996|Vasodilator Agents|vasodilator agents|mesh-ancestor
65704798|NCT03245996|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65704799|NCT03245996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65704800|NCT03245996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65704801|NCT02281929|Amoxicillin|amoxicillin|mesh-list
65704802|NCT02281929|Clavulanic Acids|clavulanic acids|mesh-list
65704803|NCT02281929|Clavulanic Acid|clavulanic acid|mesh-list
65704804|NCT02281929|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65704805|NCT02281929|Prednisolone|prednisolone|mesh-list
65704806|NCT02281929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65704807|NCT02281929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65704808|NCT02281929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65704809|NCT02281929|Glucocorticoids|glucocorticoids|mesh-ancestor
65704810|NCT02281929|Hormones|hormones|mesh-ancestor
65704811|NCT02281929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65704812|NCT02281929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704813|NCT02281929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65704814|NCT02281929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704815|NCT02281929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704816|NCT02281929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704817|NCT02281929|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65704818|NCT04424056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65704819|NCT04424056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65704820|NCT05478772|Fluconazole|fluconazole|mesh-list
65704821|NCT05478772|Antifungal Agents|antifungal agents|mesh-ancestor
65704822|NCT05478772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65704823|NCT05478772|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65704824|NCT05478772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65704825|NCT05478772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704826|NCT05478772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704827|NCT05478772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65704828|NCT05478772|Hormone Antagonists|hormone antagonists|mesh-ancestor
65704829|NCT05478772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65704830|NCT05478772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167480|NCT04297215|Anti-Infective Agents|anti-infective agents|mesh-list
65704831|NCT05478772|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65704832|NCT05478772|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65704833|NCT02945852|Apatinib|apatinib|mesh-list
65704834|NCT02945852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704835|NCT02945852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65704836|NCT02945852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704837|NCT02945852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704838|NCT03245528|Angiotensin II|angiotensin ii|mesh-list
65704839|NCT03245528|Giapreza|giapreza|mesh-list
65704840|NCT03245528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65704841|NCT00495885|Volinanserin|volinanserin|mesh-list
65704842|NCT00495885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65704843|NCT00495885|Serotonin Agents|serotonin agents|mesh-ancestor
65704844|NCT00495885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65704845|NCT00495885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704846|NCT00495885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704847|NCT03254186|Propranolol|propranolol|mesh-list
65704848|NCT03254186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65704849|NCT03254186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65704850|NCT03254186|Adrenergic Agents|adrenergic agents|mesh-ancestor
65704851|NCT03254186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65704852|NCT03254186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704853|NCT03254186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704854|NCT03254186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65704855|NCT03254186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65704856|NCT03254186|Vasodilator Agents|vasodilator agents|mesh-ancestor
65704857|NCT00589875|Valacyclovir|valacyclovir|mesh-list
65704858|NCT00589875|Antiviral Agents|antiviral agents|mesh-ancestor
65704859|NCT00589875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65704860|NCT05483062|Fluorides|fluorides|mesh-list
65704861|NCT05483062|Tin Fluorides|tin fluorides|mesh-list
65704862|NCT05483062|Cariostatic Agents|cariostatic agents|mesh-ancestor
65704863|NCT05483062|Protective Agents|protective agents|mesh-ancestor
65704864|NCT05483062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704865|NCT02282085|Olanzapine|olanzapine|mesh-list
65704866|NCT02282085|Risperidone|risperidone|mesh-list
65704867|NCT02282085|Aripiprazole|aripiprazole|mesh-list
65704868|NCT02282085|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65704869|NCT02282085|Ziprasidone|ziprasidone|mesh-list
65704870|NCT02282085|Antipsychotic Agents|antipsychotic agents|mesh-list
65704871|NCT02282085|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65704872|NCT02282085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65704873|NCT02282085|Serotonin Agents|serotonin agents|mesh-ancestor
65704874|NCT02282085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65704875|NCT02282085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704876|NCT02282085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704877|NCT02282085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65704878|NCT02282085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65704879|NCT02282085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65704880|NCT02282085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65704881|NCT02282085|Dopamine Agents|dopamine agents|mesh-ancestor
65704882|NCT02282085|Antiemetics|antiemetics|mesh-ancestor
65704883|NCT02282085|Autonomic Agents|autonomic agents|mesh-ancestor
65704884|NCT02282085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65704885|NCT02282085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65704886|NCT02282085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65704887|NCT02282085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65704888|NCT02282085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65704889|NCT02282085|Antidepressive Agents|antidepressive agents|mesh-ancestor
65704890|NCT02282085|Dopamine Agonists|dopamine agonists|mesh-ancestor
65704891|NCT02282085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65704892|NCT02282085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65704893|NCT02282085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65704894|NCT02282085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65704895|NCT02282085|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65704896|NCT02282085|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65704897|NCT02282085|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65704898|NCT02282085|Adrenergic Agents|adrenergic agents|mesh-ancestor
65704899|NCT03244592|Minocycline|minocycline|mesh-list
65704900|NCT03244592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65704901|NCT03244592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65704902|NCT03253328|Acetylcysteine|acetylcysteine|mesh-list
65704903|NCT03253328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65269187|NCT02744768|Dasatinib|dasatinib|mesh-list
65704904|NCT03253328|Antiviral Agents|antiviral agents|mesh-ancestor
65704905|NCT03253328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65704906|NCT03253328|Expectorants|expectorants|mesh-ancestor
65704907|NCT03253328|Respiratory System Agents|respiratory system agents|mesh-ancestor
65704908|NCT03253328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65704909|NCT03253328|Antioxidants|antioxidants|mesh-ancestor
65704910|NCT03253328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704911|NCT03253328|Protective Agents|protective agents|mesh-ancestor
65704912|NCT03253328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704913|NCT03253328|Antidotes|antidotes|mesh-ancestor
65704914|NCT03253250|Tenofovir|tenofovir|mesh-list
65704915|NCT03253250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65704916|NCT03253250|Entecavir|entecavir|mesh-list
65704917|NCT03253250|Adefovir|adefovir|mesh-list
65704918|NCT03253250|Antiviral Agents|antiviral agents|mesh-ancestor
65704919|NCT03253250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65704920|NCT03253250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65704921|NCT03253250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65704922|NCT03253250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704923|NCT03253250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704924|NCT03253250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65704925|NCT03253250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65704926|NCT03253562|Metformin|metformin|mesh-list
65704927|NCT03253562|Vildagliptin|vildagliptin|mesh-list
65704928|NCT03253562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65704929|NCT03253562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704930|NCT03253562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65704931|NCT03253562|Protease Inhibitors|protease inhibitors|mesh-ancestor
65704932|NCT03253562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704933|NCT03253562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704934|NCT03250052|Linagliptin|linagliptin|mesh-list
65704935|NCT03250052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65704936|NCT03250052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704937|NCT03250052|Incretins|incretins|mesh-ancestor
65704938|NCT03250052|Hormones|hormones|mesh-ancestor
65704939|NCT03250052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65704940|NCT03250052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65704941|NCT03250052|Protease Inhibitors|protease inhibitors|mesh-ancestor
65704942|NCT03250052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704943|NCT03250052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704944|NCT05478382|Pregabalin|pregabalin|mesh-list
65704945|NCT05478382|Analgesics|analgesics|mesh-ancestor
65704946|NCT05478382|Sensory System Agents|sensory system agents|mesh-ancestor
65704947|NCT05478382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65704948|NCT05478382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704949|NCT05478382|Anticonvulsants|anticonvulsants|mesh-ancestor
65704950|NCT05478382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65704951|NCT05478382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65704952|NCT05478382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704953|NCT05478382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65704954|NCT05478382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65704955|NCT05478382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65704956|NCT05478382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65704957|NCT05478382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65704958|NCT03244358|Epalrestat|epalrestat|mesh-list
65704959|NCT03244358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704960|NCT03244358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704961|NCT03249740|Sunitinib|sunitinib|mesh-list
65704962|NCT03249740|Aflibercept|aflibercept|mesh-list
65704963|NCT03249740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65704964|NCT03249740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65704965|NCT03249740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65704966|NCT03249740|Growth Substances|growth substances|mesh-ancestor
65704967|NCT03249740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704968|NCT03249740|Growth Inhibitors|growth inhibitors|mesh-ancestor
65704969|NCT03249740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65704970|NCT03249740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704971|NCT03249740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704972|NCT03057977|Empagliflozin|empagliflozin|mesh-list
65704973|NCT03057977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65704974|NCT03057977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704975|NCT03057977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65269188|NCT02744768|Blinatumomab|blinatumomab|mesh-list
65704976|NCT03057977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704977|NCT03249506|Dapagliflozin|dapagliflozin|mesh-list
65704978|NCT03249506|Empagliflozin|empagliflozin|mesh-list
65704979|NCT03249506|Canagliflozin|canagliflozin|mesh-list
65704980|NCT03249506|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
65704981|NCT03249506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65704982|NCT03249506|Glucagon|glucagon|mesh-list
65704983|NCT03249506|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65704984|NCT03249506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65704985|NCT03249506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704986|NCT03249506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65704987|NCT03249506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65704988|NCT03249506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65704989|NCT03249506|Hormones|hormones|mesh-ancestor
65704990|NCT03249506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65704991|NCT03249506|Incretins|incretins|mesh-ancestor
65704992|NCT03249506|Protease Inhibitors|protease inhibitors|mesh-ancestor
65704993|NCT03249506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65704994|NCT03249662|Bupivacaine|bupivacaine|mesh-list
65704995|NCT03249662|Anesthetics, Local|anesthetics, local|mesh-ancestor
65704996|NCT03249662|Anesthetics|anesthetics|mesh-ancestor
65704997|NCT03249662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65704998|NCT03249662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65704999|NCT03249662|Sensory System Agents|sensory system agents|mesh-ancestor
65705000|NCT03249662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65705001|NCT03249428|Nicotine|nicotine|mesh-list
65705002|NCT03249428|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65705003|NCT03249428|Autonomic Agents|autonomic agents|mesh-ancestor
65705004|NCT03249428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65705005|NCT03249428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705006|NCT03249428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65705007|NCT03249428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65705008|NCT03249428|Cholinergic Agents|cholinergic agents|mesh-ancestor
65705009|NCT03249428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65705010|NCT03249428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705011|NCT03243500|Lidocaine|lidocaine|mesh-list
65705012|NCT03243500|Bupivacaine|bupivacaine|mesh-list
65705013|NCT03243500|Atracurium|atracurium|mesh-list
65705014|NCT03243500|Anesthetics, Local|anesthetics, local|mesh-ancestor
65705015|NCT03243500|Anesthetics|anesthetics|mesh-ancestor
65705016|NCT03243500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65705017|NCT03243500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705018|NCT03243500|Sensory System Agents|sensory system agents|mesh-ancestor
65705019|NCT03243500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65705020|NCT03243500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65705021|NCT03243500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65705022|NCT03243500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65705023|NCT03243500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65705024|NCT03243500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705025|NCT03243500|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65705026|NCT03243500|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65705027|NCT03243500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65705028|NCT03243500|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65705029|NCT03243500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65705030|NCT03243500|Cholinergic Agents|cholinergic agents|mesh-ancestor
65705031|NCT03243500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65705032|NCT03238898|Botulinum Toxins|botulinum toxins|mesh-list
65705033|NCT03238898|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65705034|NCT03238898|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65705035|NCT03238898|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65705036|NCT03238898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65705037|NCT03238898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705038|NCT03238898|Cholinergic Agents|cholinergic agents|mesh-ancestor
65705039|NCT03238898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65705040|NCT03238898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705041|NCT03238898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65705042|NCT03238898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65705043|NCT03249194|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65705044|NCT03249194|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65705045|NCT03249194|Antiviral Agents|antiviral agents|mesh-list
65705046|NCT03249194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65705047|NCT04486508|Heparin|heparin|mesh-list
65705048|NCT04486508|Calcium heparin|calcium heparin|mesh-list
65705049|NCT04486508|Enoxaparin|enoxaparin|mesh-list
65705050|NCT04486508|Enoxaparin sodium|enoxaparin sodium|mesh-list
65705051|NCT04486508|Atorvastatin|atorvastatin|mesh-list
65705052|NCT04486508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65705053|NCT04486508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65705054|NCT04486508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65705055|NCT04486508|Antimetabolites|antimetabolites|mesh-ancestor
65705056|NCT04486508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705057|NCT04486508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65705058|NCT04486508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705059|NCT04486508|Anticoagulants|anticoagulants|mesh-ancestor
65705060|NCT04486508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65705061|NCT04486508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65705062|NCT02552212|Certolizumab Pegol|certolizumab pegol|mesh-list
65705063|NCT02552212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65705064|NCT02552212|Immunologic Factors|immunologic factors|mesh-ancestor
65705065|NCT02552212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705066|NCT02552212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65705067|NCT02454764|Interferons|interferons|mesh-list
65705068|NCT02454764|Tenofovir|tenofovir|mesh-list
65705069|NCT02454764|Interferon-alpha|interferon-alpha|mesh-list
65705070|NCT02454764|Interferon alpha-2|interferon alpha-2|mesh-list
65705071|NCT02454764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65705072|NCT02454764|Antiviral Agents|antiviral agents|mesh-ancestor
65705073|NCT02454764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65705074|NCT02454764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65705075|NCT02454764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65705076|NCT02454764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705077|NCT02454764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705078|NCT02454764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65705079|NCT02454764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65705080|NCT02454764|Immunologic Factors|immunologic factors|mesh-ancestor
65705081|NCT02454764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705082|NCT00685919|Carbidopa|carbidopa|mesh-list
65705083|NCT00685919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65705084|NCT00685919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65705085|NCT00685919|Dopamine Agents|dopamine agents|mesh-ancestor
65705086|NCT00685919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65705087|NCT00685919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705088|NCT00685919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705089|NCT00685919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65705090|NCT00685919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705091|NCT03243344|Surgiflo|surgiflo|mesh-list
65705092|NCT03243344|Hemostatics|hemostatics|mesh-ancestor
65705093|NCT03243344|Coagulants|coagulants|mesh-ancestor
65705094|NCT03243032|Ibuprofen|ibuprofen|mesh-list
65705095|NCT03243032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65705096|NCT03243032|Anesthetics|anesthetics|mesh-list
65705097|NCT03243032|Anesthetics, Local|anesthetics, local|mesh-list
65705098|NCT03243032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65705099|NCT03243032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705100|NCT03243032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65705101|NCT03243032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65705102|NCT03243032|Analgesics|analgesics|mesh-ancestor
65705103|NCT03243032|Sensory System Agents|sensory system agents|mesh-ancestor
65705104|NCT03243032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65705105|NCT03243032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65705106|NCT03243032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65705107|NCT03243032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705108|NCT03243032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705109|NCT03249038|Chrysarobin|chrysarobin|mesh-list
65705110|NCT03249038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65705111|NCT03249038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65705112|NCT03249038|Analgesics|analgesics|mesh-ancestor
65705113|NCT03249038|Sensory System Agents|sensory system agents|mesh-ancestor
65705114|NCT03249038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65705115|NCT03249038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705116|NCT03249038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65705117|NCT03249038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65705118|NCT03061331|Ivacaftor|ivacaftor|mesh-list
65705119|NCT03061331|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65705120|NCT03061331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65705121|NCT03061331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705122|NCT01568177|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
65705123|NCT01568177|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65705124|NCT01568177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705125|NCT00700778|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65705126|NCT00700778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65705127|NCT00700778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705128|NCT05213585|Ivermectin|ivermectin|mesh-list
65705129|NCT05213585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65705130|NCT05213585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65705131|NCT05482282|Vaccines|vaccines|mesh-list
65705132|NCT05482282|Immunologic Factors|immunologic factors|mesh-ancestor
65705133|NCT05482282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705134|NCT05209529|Durvalumab|durvalumab|mesh-list
65705135|NCT05209529|Olaparib|olaparib|mesh-list
65705136|NCT05209529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65705137|NCT05209529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65705138|NCT05209529|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65705139|NCT05209529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705140|NCT05209529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705141|NCT04424134|Spironolactone|spironolactone|mesh-list
65705142|NCT04424134|Bromhexine|bromhexine|mesh-list
65705143|NCT04424134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65705144|NCT04424134|Hormone Antagonists|hormone antagonists|mesh-ancestor
65705145|NCT04424134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65705146|NCT04424134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705147|NCT04424134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65705148|NCT04424134|Diuretics|diuretics|mesh-ancestor
65705149|NCT04424134|Natriuretic Agents|natriuretic agents|mesh-ancestor
65705150|NCT04424134|Expectorants|expectorants|mesh-ancestor
65705151|NCT04424134|Respiratory System Agents|respiratory system agents|mesh-ancestor
65705152|NCT04486430|Salicylates|salicylates|mesh-list
65705153|NCT04486430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65705154|NCT04486430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65705155|NCT04486430|Analgesics|analgesics|mesh-ancestor
65705156|NCT04486430|Sensory System Agents|sensory system agents|mesh-ancestor
65705157|NCT04486430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65705158|NCT04486430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705159|NCT04486430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65705160|NCT04486430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65705161|NCT04486430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65705162|NCT04486430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705163|NCT04486430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705164|NCT03248726|Bisacodyl|bisacodyl|mesh-list
65705165|NCT03248726|Cathartics|cathartics|mesh-ancestor
65705166|NCT03248726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65705167|NCT03248726|Laxatives|laxatives|mesh-ancestor
65705168|NCT03386500|Manganese|manganese|mesh-list
65705169|NCT03386500|Trace Elements|trace elements|mesh-ancestor
65705170|NCT03386500|Micronutrients|micronutrients|mesh-ancestor
65705171|NCT03386500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705172|NCT05208827|Vitamin D|vitamin d|mesh-list
65705173|NCT05208827|Ergocalciferols|ergocalciferols|mesh-list
65705174|NCT05208827|Cholecalciferol|cholecalciferol|mesh-list
65705175|NCT05208827|Vitamins|vitamins|mesh-list
65705176|NCT05208827|Micronutrients|micronutrients|mesh-ancestor
65705177|NCT05208827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705178|NCT05208827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65705179|NCT05208827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65705180|NCT04947059|Gemcitabine|gemcitabine|mesh-list
65705181|NCT04947059|Epirubicin|epirubicin|mesh-list
65705182|NCT04947059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65705183|NCT04947059|Antimetabolites|antimetabolites|mesh-ancestor
65705184|NCT04947059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705185|NCT04947059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65705186|NCT04947059|Antiviral Agents|antiviral agents|mesh-ancestor
65705187|NCT04947059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65705188|NCT04947059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705189|NCT04947059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65705190|NCT04947059|Immunologic Factors|immunologic factors|mesh-ancestor
65705191|NCT04947059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705192|NCT04947059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65705193|NCT04947059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65705194|NCT04947059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65705195|NCT05481970|Dexamethasone|dexamethasone|mesh-list
65705196|NCT05481970|Lidocaine|lidocaine|mesh-list
65705197|NCT05481970|Fentanyl|fentanyl|mesh-list
65705198|NCT05481970|Dexmedetomidine|dexmedetomidine|mesh-list
65705199|NCT05481970|Ketamine|ketamine|mesh-list
65705200|NCT05481970|Propofol|propofol|mesh-list
65705201|NCT05481970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65705202|NCT05481970|Antiemetics|antiemetics|mesh-ancestor
65705203|NCT05481970|Autonomic Agents|autonomic agents|mesh-ancestor
65705204|NCT05481970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65705205|NCT05481970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705206|NCT05481970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65705207|NCT05481970|Glucocorticoids|glucocorticoids|mesh-ancestor
65705208|NCT05481970|Hormones|hormones|mesh-ancestor
65705209|NCT05481970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65705210|NCT05481970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65705211|NCT05481970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65705212|NCT05481970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705213|NCT05481970|Anesthetics, Local|anesthetics, local|mesh-ancestor
65705214|NCT05481970|Anesthetics|anesthetics|mesh-ancestor
65705215|NCT05481970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65705216|NCT05481970|Sensory System Agents|sensory system agents|mesh-ancestor
65705217|NCT05481970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65705218|NCT05481970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65705219|NCT05481970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65705220|NCT05481970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65705221|NCT05481970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65705222|NCT05481970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65705223|NCT05481970|Anesthetics, General|anesthetics, general|mesh-ancestor
65705224|NCT05481970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65705225|NCT05481970|Analgesics|analgesics|mesh-ancestor
65705226|NCT05481970|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65705227|NCT05481970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65705228|NCT05481970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65705229|NCT05481970|Adrenergic Agents|adrenergic agents|mesh-ancestor
65705230|NCT05481970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65705231|NCT05481970|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65705232|NCT05481970|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65705233|NCT05481970|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65705234|NCT05481970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65705235|NCT05481970|Narcotics|narcotics|mesh-ancestor
65705236|NCT05481970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65705237|NCT03248648|Ketamine|ketamine|mesh-list
65705238|NCT03248648|Neostigmine|neostigmine|mesh-list
65705239|NCT03248648|Analgesics|analgesics|mesh-ancestor
65705240|NCT03248648|Sensory System Agents|sensory system agents|mesh-ancestor
65705241|NCT03248648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65705242|NCT03248648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705243|NCT03248648|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65705244|NCT03248648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65705245|NCT03248648|Anesthetics, General|anesthetics, general|mesh-ancestor
65705246|NCT03248648|Anesthetics|anesthetics|mesh-ancestor
65705247|NCT03248648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65705248|NCT03248648|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65705249|NCT03248648|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65705250|NCT03248648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65705251|NCT03248648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705252|NCT03248648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65705253|NCT03248648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705254|NCT03248648|Cholinergic Agents|cholinergic agents|mesh-ancestor
65705255|NCT03248648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65705256|NCT03248648|Autonomic Agents|autonomic agents|mesh-ancestor
65705257|NCT03241784|Interleukin-2|interleukin-2|mesh-list
65705258|NCT03241784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65705259|NCT03241784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65705260|NCT03241784|Analgesics|analgesics|mesh-ancestor
65705261|NCT03241784|Sensory System Agents|sensory system agents|mesh-ancestor
65705262|NCT03241784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65705263|NCT03241784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705264|NCT05212337|Denosumab|denosumab|mesh-list
65705265|NCT05212337|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65705266|NCT05212337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705267|NCT03242096|Sirolimus|sirolimus|mesh-list
65705268|NCT03242096|Paclitaxel|paclitaxel|mesh-list
65705269|NCT03242096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65705270|NCT03242096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65705271|NCT03242096|Tubulin Modulators|tubulin modulators|mesh-ancestor
65705272|NCT03242096|Antimitotic Agents|antimitotic agents|mesh-ancestor
65705273|NCT03242096|Mitosis Modulators|mitosis modulators|mesh-ancestor
65705274|NCT03242096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705275|NCT03242096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65705276|NCT03242096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65705277|NCT03242096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65705278|NCT03242096|Antifungal Agents|antifungal agents|mesh-ancestor
65705279|NCT03242096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65705280|NCT03242096|Immunologic Factors|immunologic factors|mesh-ancestor
65705281|NCT03242096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705282|NCT03241472|Letrozole|letrozole|mesh-list
65705283|NCT03241472|Clomiphene|clomiphene|mesh-list
65705284|NCT03241472|Enclomiphene|enclomiphene|mesh-list
65705285|NCT03241472|Zuclomiphene|zuclomiphene|mesh-list
65705286|NCT03241472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705287|NCT03241472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65705288|NCT03241472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65705289|NCT03241472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65705290|NCT03241472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705291|NCT03241472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65705292|NCT03241472|Hormone Antagonists|hormone antagonists|mesh-ancestor
65705293|NCT03241472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65705294|NCT03241472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705295|NCT03241472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65705296|NCT03241472|Fertility Agents|fertility agents|mesh-ancestor
65705297|NCT03241472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65705298|NCT03241472|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65705299|NCT03241472|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65705300|NCT04313075|Leronlimab|leronlimab|mesh-list
65705301|NCT04313075|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65705302|NCT04313075|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65705303|NCT04313075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705304|NCT04313075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65705305|NCT04313075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65705306|NCT04313075|Antiviral Agents|antiviral agents|mesh-ancestor
65705307|NCT04313075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65705308|NCT03241550|Isavuconazole|isavuconazole|mesh-list
65705309|NCT03241550|Antifungal Agents|antifungal agents|mesh-ancestor
65705310|NCT03241550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65705311|NCT03241706|Glucagon|glucagon|mesh-list
65705312|NCT03241706|Somatostatin|somatostatin|mesh-list
65705313|NCT03241706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705314|NCT03241706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65705315|NCT03241706|Hormones|hormones|mesh-ancestor
65705316|NCT03241706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65705317|NCT03237416|Midazolam|midazolam|mesh-list
65705318|NCT03237416|Dabigatran|dabigatran|mesh-list
65705319|NCT03237416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65705320|NCT03237416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65705321|NCT03237416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65705322|NCT03237416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705323|NCT03237416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65705324|NCT03237416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65705325|NCT03237416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65705326|NCT03237416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65705327|NCT03237416|Anesthetics, General|anesthetics, general|mesh-ancestor
65705328|NCT03237416|Anesthetics|anesthetics|mesh-ancestor
65705329|NCT03237416|GABA Modulators|gaba modulators|mesh-ancestor
65705330|NCT03237416|GABA Agents|gaba agents|mesh-ancestor
65705331|NCT03237416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65705332|NCT03237416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705333|NCT03237416|Antithrombins|antithrombins|mesh-ancestor
65705334|NCT03237416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65705335|NCT03237416|Protease Inhibitors|protease inhibitors|mesh-ancestor
65705336|NCT03237416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705337|NCT03237416|Anticoagulants|anticoagulants|mesh-ancestor
65705338|NCT05211011|Fosfomycin|fosfomycin|mesh-list
65705339|NCT05211011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65705340|NCT05211011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65705341|NCT03312400|Danazol|danazol|mesh-list
65705342|NCT03312400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65705343|NCT03312400|Hormone Antagonists|hormone antagonists|mesh-ancestor
65705344|NCT03312400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65705345|NCT03312400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705346|NCT03247868|Botulinum Toxins|botulinum toxins|mesh-list
65705347|NCT03247868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65705348|NCT03247868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65705349|NCT03247868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705350|NCT03247868|Cholinergic Agents|cholinergic agents|mesh-ancestor
65705351|NCT03247868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65705352|NCT03247868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705353|NCT04094519|Digoxin|digoxin|mesh-list
65705354|NCT04094519|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65705355|NCT04094519|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65705356|NCT04094519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65705357|NCT04094519|Antimetabolites|antimetabolites|mesh-ancestor
65705358|NCT04094519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705359|NCT04094519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65705360|NCT04094519|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65705361|NCT04094519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705362|NCT04094519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65705363|NCT04094519|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65705364|NCT04094519|Protective Agents|protective agents|mesh-ancestor
65705365|NCT04094519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705366|NCT02189798|Imidacloprid|imidacloprid|mesh-list
65705367|NCT02189798|Cholinergic Agents|cholinergic agents|mesh-ancestor
65705368|NCT02189798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65705369|NCT02189798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705370|NCT02189798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705371|NCT03107702|Melatonin|melatonin|mesh-list
65705372|NCT03107702|Antioxidants|antioxidants|mesh-ancestor
65705373|NCT03107702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705374|NCT03107702|Protective Agents|protective agents|mesh-ancestor
65705375|NCT03107702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705376|NCT03107702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65705377|NCT02554318|Rifampin|rifampin|mesh-list
65705378|NCT02554318|Isoniazid|isoniazid|mesh-list
65705379|NCT02554318|Pyrazinamide|pyrazinamide|mesh-list
65705380|NCT02554318|Ethambutol|ethambutol|mesh-list
65705381|NCT02554318|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65705382|NCT02554318|Antitubercular Agents|antitubercular agents|mesh-ancestor
65705383|NCT02554318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65705384|NCT02554318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65705385|NCT02554318|Leprostatic Agents|leprostatic agents|mesh-ancestor
65705386|NCT02554318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65705387|NCT02554318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705388|NCT02554318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705389|NCT02554318|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65705390|NCT02554318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65705391|NCT02554318|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65705392|NCT02554318|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65705393|NCT02554318|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65705394|NCT02554318|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65705395|NCT02554318|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65705396|NCT02554318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65705397|NCT02554318|Antimetabolites|antimetabolites|mesh-ancestor
65705398|NCT02554318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65705399|NCT03587662|Gemcitabine|gemcitabine|mesh-list
65705400|NCT03587662|Doxorubicin|doxorubicin|mesh-list
65705401|NCT03587662|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65705402|NCT03587662|Daunorubicin|daunorubicin|mesh-list
65705403|NCT03587662|Ixazomib|ixazomib|mesh-list
65705404|NCT03587662|Glycine|glycine|mesh-list
65705405|NCT03587662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65705406|NCT03587662|Antimetabolites|antimetabolites|mesh-ancestor
65705407|NCT03587662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705408|NCT03587662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65705409|NCT03587662|Antiviral Agents|antiviral agents|mesh-ancestor
65705410|NCT03587662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65705411|NCT03587662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705412|NCT03587662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65705413|NCT03587662|Immunologic Factors|immunologic factors|mesh-ancestor
65705414|NCT03587662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705415|NCT03587662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65705416|NCT03587662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65705417|NCT03587662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65705418|NCT03587662|Protease Inhibitors|protease inhibitors|mesh-ancestor
65705419|NCT03587662|Glycine Agents|glycine agents|mesh-ancestor
65705420|NCT03587662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65705421|NCT03976973|Acetylcysteine|acetylcysteine|mesh-list
65705422|NCT03976973|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65705423|NCT03976973|Antiviral Agents|antiviral agents|mesh-ancestor
65705424|NCT03976973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65705425|NCT03976973|Expectorants|expectorants|mesh-ancestor
65705426|NCT03976973|Respiratory System Agents|respiratory system agents|mesh-ancestor
65705427|NCT03976973|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65705428|NCT03976973|Antioxidants|antioxidants|mesh-ancestor
65705429|NCT03976973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705430|NCT03976973|Protective Agents|protective agents|mesh-ancestor
65705431|NCT03976973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705432|NCT03976973|Antidotes|antidotes|mesh-ancestor
65705433|NCT04066751|Ivacaftor|ivacaftor|mesh-list
65705434|NCT04066751|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65705435|NCT04066751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65705436|NCT04066751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705437|NCT02550106|Omalizumab|omalizumab|mesh-list
65705438|NCT02550106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65705439|NCT02550106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65705440|NCT02550106|Respiratory System Agents|respiratory system agents|mesh-ancestor
65705441|NCT03237260|Vedolizumab|vedolizumab|mesh-list
65705442|NCT03237260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65705443|NCT03247400|Atorvastatin|atorvastatin|mesh-list
65705444|NCT03247400|Simvastatin|simvastatin|mesh-list
65705445|NCT03247400|Calcium|calcium|mesh-list
65705446|NCT03247400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65705447|NCT03247400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705448|NCT03247400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65705449|NCT03247400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65705450|NCT03247400|Antimetabolites|antimetabolites|mesh-ancestor
65705451|NCT03247400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705452|NCT03247400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65705453|NCT03247400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65705454|NCT03247400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705455|NCT05480566|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
65705456|NCT05480566|Autonomic Agents|autonomic agents|mesh-ancestor
65705457|NCT05480566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65705458|NCT05480566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705459|NCT05480566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65705460|NCT05480566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65705461|NCT05480566|Respiratory System Agents|respiratory system agents|mesh-ancestor
65021328|NCT00582075|Temozolomide|temozolomide|mesh-list
65705462|NCT02453516|Epinephrine|epinephrine|mesh-list
65705463|NCT02453516|Ropivacaine|ropivacaine|mesh-list
65705464|NCT02453516|Anesthetics, Local|anesthetics, local|mesh-ancestor
65705465|NCT02453516|Anesthetics|anesthetics|mesh-ancestor
65705466|NCT02453516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65705467|NCT02453516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705468|NCT02453516|Sensory System Agents|sensory system agents|mesh-ancestor
65705469|NCT02453516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65705470|NCT02453516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65705471|NCT02453516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65705472|NCT02453516|Adrenergic Agents|adrenergic agents|mesh-ancestor
65705473|NCT02453516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65705474|NCT02453516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705475|NCT02453516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65705476|NCT02453516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65705477|NCT02453516|Autonomic Agents|autonomic agents|mesh-ancestor
65705478|NCT02453516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65705479|NCT02453516|Respiratory System Agents|respiratory system agents|mesh-ancestor
65705480|NCT02453516|Mydriatics|mydriatics|mesh-ancestor
65705481|NCT02453516|Sympathomimetics|sympathomimetics|mesh-ancestor
65705482|NCT02453516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65705483|NCT03716609|Magnesium citrate|magnesium citrate|mesh-list
65705484|NCT03716609|Citric Acid|citric acid|mesh-list
65705485|NCT03716609|Sodium Citrate|sodium citrate|mesh-list
65705486|NCT03716609|Anticoagulants|anticoagulants|mesh-ancestor
65705487|NCT03716609|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65705488|NCT03716609|Chelating Agents|chelating agents|mesh-ancestor
65705489|NCT03716609|Sequestering Agents|sequestering agents|mesh-ancestor
65705490|NCT03716609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705491|NCT03716609|Cathartics|cathartics|mesh-ancestor
65705492|NCT03716609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65705493|NCT03709355|Clarithromycin|clarithromycin|mesh-list
65705494|NCT03709355|Rifampin|rifampin|mesh-list
65705495|NCT03709355|Rifabutin|rifabutin|mesh-list
65705496|NCT03709355|Elsulfavirine|elsulfavirine|mesh-list
65705497|NCT03709355|Omeprazole|omeprazole|mesh-list
65705498|NCT03709355|Atorvastatin|atorvastatin|mesh-list
65705499|NCT03709355|Levonorgestrel|levonorgestrel|mesh-list
65705500|NCT03709355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65705501|NCT03709355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65705502|NCT03709355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65705503|NCT03709355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65705504|NCT03709355|Antimetabolites|antimetabolites|mesh-ancestor
65705505|NCT03709355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705506|NCT03709355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65705507|NCT03709355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65705508|NCT03709355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705509|NCT03709355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65705510|NCT03709355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65705511|NCT03709355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65705512|NCT03709355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65705513|NCT03709355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65705514|NCT03709355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65705515|NCT03709355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65705516|NCT03709355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65705517|NCT03709355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65705518|NCT03709355|Contraceptive Agents|contraceptive agents|mesh-ancestor
65705519|NCT03709355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65705520|NCT03709355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705521|NCT03709355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65705522|NCT03709355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65705523|NCT03709355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65705524|NCT03709355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65705525|NCT03709355|Antitubercular Agents|antitubercular agents|mesh-ancestor
65705526|NCT03709355|Leprostatic Agents|leprostatic agents|mesh-ancestor
65705527|NCT03709355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65705528|NCT03709355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65705529|NCT03709355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65705530|NCT03709355|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65705531|NCT03709355|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65705532|NCT03709355|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65705533|NCT03709355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65705534|NCT03709355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65705535|NCT03709355|Estrogens|estrogens|mesh-ancestor
65705536|NCT03709355|Hormones|hormones|mesh-ancestor
65021396|NCT02915731|Vitamin A|vitamin a|mesh-list
65705537|NCT03709355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65705538|NCT03709355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65705539|NCT03709355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65705540|NCT03709355|Antiviral Agents|antiviral agents|mesh-ancestor
65705541|NCT03709355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65705542|NCT05209217|Ketamine|ketamine|mesh-list
65705543|NCT05209217|Analgesics|analgesics|mesh-ancestor
65705544|NCT05209217|Sensory System Agents|sensory system agents|mesh-ancestor
65705545|NCT05209217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65705546|NCT05209217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705547|NCT05209217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65705548|NCT05209217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65705549|NCT05209217|Anesthetics, General|anesthetics, general|mesh-ancestor
65705550|NCT05209217|Anesthetics|anesthetics|mesh-ancestor
65705551|NCT05209217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65705552|NCT05209217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65705553|NCT05209217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65705554|NCT05209217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65705555|NCT05209217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705556|NCT01662310|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65705557|NCT01662310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65705558|NCT01662310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65705559|NCT01662310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65705560|NCT01662310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705561|NCT01662310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65705562|NCT01662310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65705563|NCT01662310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65705564|NCT01662310|Serotonin Agents|serotonin agents|mesh-ancestor
65705565|NCT01662310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65705566|NCT01662310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705567|NCT01662310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65705568|NCT01662310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65705569|NCT01662310|Dopamine Agents|dopamine agents|mesh-ancestor
65705570|NCT00700622|Insulin|insulin|mesh-list
65705571|NCT00700622|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65705572|NCT00700622|Insulin Glargine|insulin glargine|mesh-list
65705573|NCT00700622|Insulin Lispro|insulin lispro|mesh-list
65705574|NCT00700622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65705575|NCT00700622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705576|NCT03628625|Letrozole|letrozole|mesh-list
65705577|NCT03628625|Misoprostol|misoprostol|mesh-list
65705578|NCT03628625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65705579|NCT03628625|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65705580|NCT03628625|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65705581|NCT03628625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705582|NCT03628625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705583|NCT03628625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65705584|NCT03628625|Hormone Antagonists|hormone antagonists|mesh-ancestor
65705585|NCT03628625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65705586|NCT03628625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705587|NCT03628625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65705588|NCT03628625|Abortifacient Agents|abortifacient agents|mesh-ancestor
65705589|NCT03628625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65705590|NCT03628625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65705591|NCT03628625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65705592|NCT03628625|Oxytocics|oxytocics|mesh-ancestor
65705593|NCT04469764|Letrozole|letrozole|mesh-list
65705594|NCT04469764|Anastrozole|anastrozole|mesh-list
65705595|NCT04469764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65705596|NCT04469764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65705597|NCT04469764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65705598|NCT04469764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705599|NCT04469764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705600|NCT04469764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65705601|NCT04469764|Hormone Antagonists|hormone antagonists|mesh-ancestor
65705602|NCT04469764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65705603|NCT04469764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705604|NCT04469764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65705605|NCT02553928|Memantine|memantine|mesh-list
65705606|NCT02553928|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65705607|NCT02553928|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65705608|NCT02553928|Dopamine Agents|dopamine agents|mesh-ancestor
65705609|NCT02553928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65705610|NCT02553928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705611|NCT02553928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705612|NCT02553928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65705613|NCT02553928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65705614|NCT03908255|Vitamins|vitamins|mesh-list
65705615|NCT03908255|Micronutrients|micronutrients|mesh-ancestor
65705616|NCT03908255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705617|NCT03246776|Triclosan|triclosan|mesh-list
65705618|NCT03246776|Halometasone|halometasone|mesh-list
65705619|NCT03246776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65705620|NCT03246776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65705621|NCT03246776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65705622|NCT03246776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65705623|NCT03246776|Antimetabolites|antimetabolites|mesh-ancestor
65705624|NCT03246776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705625|NCT03246776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65705626|NCT03246776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65705627|NCT03246776|Dermatologic Agents|dermatologic agents|mesh-ancestor
65705628|NCT03246776|Glucocorticoids|glucocorticoids|mesh-ancestor
65705629|NCT03246776|Hormones|hormones|mesh-ancestor
65705630|NCT03246776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65705631|NCT03246776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705632|NCT03246386|Posaconazole|posaconazole|mesh-list
65705633|NCT03246386|Antifungal Agents|antifungal agents|mesh-ancestor
65705634|NCT03246386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65705635|NCT03246386|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65705636|NCT03246386|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65705637|NCT03246386|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65705638|NCT03246386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65705639|NCT03246386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65705640|NCT03246386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705641|NCT03246386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705642|NCT03246386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65705643|NCT03246386|Hormone Antagonists|hormone antagonists|mesh-ancestor
65168302|NCT04214821|Levofloxacin|levofloxacin|mesh-list
65705644|NCT03246386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65705645|NCT03246386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705646|NCT03851081|Vincristine|vincristine|mesh-list
65705647|NCT03851081|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65705648|NCT03851081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65705649|NCT03851081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65705650|NCT03851081|Tubulin Modulators|tubulin modulators|mesh-ancestor
65705651|NCT03851081|Antimitotic Agents|antimitotic agents|mesh-ancestor
65705652|NCT03851081|Mitosis Modulators|mitosis modulators|mesh-ancestor
65705653|NCT03851081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705654|NCT03851081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65705655|NCT03851081|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65705656|NCT03239600|Methotrexate|methotrexate|mesh-list
65705657|NCT03239600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65705658|NCT03239600|Abortifacient Agents|abortifacient agents|mesh-ancestor
65705659|NCT03239600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65705660|NCT03239600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705661|NCT03239600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65705662|NCT03239600|Antimetabolites|antimetabolites|mesh-ancestor
65705663|NCT03239600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705664|NCT03239600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65705665|NCT03239600|Dermatologic Agents|dermatologic agents|mesh-ancestor
65705666|NCT03239600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705667|NCT03239600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65705668|NCT03239600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65705669|NCT03239600|Immunologic Factors|immunologic factors|mesh-ancestor
65705670|NCT03239600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65705671|NCT03239600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65705672|NCT02966093|Lenvatinib|lenvatinib|mesh-list
65705673|NCT02966093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65705674|NCT02966093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65705675|NCT02966093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705676|NCT02966093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705677|NCT03229616|Cyclophosphamide|cyclophosphamide|mesh-list
65705678|NCT03229616|Busulfan|busulfan|mesh-list
65705679|NCT03229616|Etoposide|etoposide|mesh-list
65705680|NCT03229616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65705681|NCT03229616|Immunologic Factors|immunologic factors|mesh-ancestor
65705682|NCT03229616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705683|NCT03229616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65705684|NCT03229616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65705685|NCT03229616|Alkylating Agents|alkylating agents|mesh-ancestor
65705686|NCT03229616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705687|NCT03229616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65705688|NCT03229616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65705689|NCT03229616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65705690|NCT03229616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65705691|NCT03229616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65705692|NCT03229616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705693|NCT03234842|Paclitaxel|paclitaxel|mesh-list
65705694|NCT03234842|Carboplatin|carboplatin|mesh-list
65705695|NCT03234842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65705696|NCT03234842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65705697|NCT03234842|Tubulin Modulators|tubulin modulators|mesh-ancestor
65705698|NCT03234842|Antimitotic Agents|antimitotic agents|mesh-ancestor
65705699|NCT03234842|Mitosis Modulators|mitosis modulators|mesh-ancestor
65705700|NCT03234842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705701|NCT03229148|Anesthetics|anesthetics|mesh-list
65705702|NCT03229148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65705703|NCT03229148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705704|NCT03228992|Ibuprofen|ibuprofen|mesh-list
65705705|NCT03228992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65705706|NCT03228992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65705707|NCT03228992|Analgesics|analgesics|mesh-ancestor
65705708|NCT03228992|Sensory System Agents|sensory system agents|mesh-ancestor
65705709|NCT03228992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65705710|NCT03228992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705711|NCT03228992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65705712|NCT03228992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65705713|NCT03228992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65705714|NCT03228992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705715|NCT03228992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705716|NCT02627963|Sorafenib|sorafenib|mesh-list
65705717|NCT02627963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65705718|NCT02627963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65705719|NCT02627963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705720|NCT02627963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705721|NCT02452502|Atorvastatin|atorvastatin|mesh-list
65705722|NCT02452502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65705723|NCT02452502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65705724|NCT02452502|Antimetabolites|antimetabolites|mesh-ancestor
65705725|NCT02452502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705726|NCT02452502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65705727|NCT02452502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65705728|NCT02452502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705729|NCT03234296|Metronidazole|metronidazole|mesh-list
65705730|NCT03234296|Levofloxacin|levofloxacin|mesh-list
65705731|NCT03234296|Ertapenem|ertapenem|mesh-list
65705732|NCT03234296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65705733|NCT03234296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65705734|NCT03234296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65705735|NCT03234296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65705736|NCT03234296|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65705737|NCT03234296|Renal Agents|renal agents|mesh-ancestor
65705738|NCT03234296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65705739|NCT03234296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65705740|NCT03234296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705741|NCT03234296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705742|NCT03234296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65705743|NCT03234296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65705744|NCT03234296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65705745|NCT03228368|Atezolizumab|atezolizumab|mesh-list
65705746|NCT03228368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65705747|NCT03665129|Avdoralimab|avdoralimab|mesh-list
65705748|NCT03665129|Durvalumab|durvalumab|mesh-list
65705749|NCT03665129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65705750|NCT03665129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65705751|NCT03665129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65705752|NCT03665129|Antiviral Agents|antiviral agents|mesh-ancestor
65705753|NCT03665129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65705754|NCT03235700|Nicorandil|nicorandil|mesh-list
65705755|NCT03235700|Adenosine|adenosine|mesh-list
65705756|NCT03235700|Analgesics|analgesics|mesh-ancestor
65021617|NCT02913118|Azithromycin|azithromycin|mesh-list
65705758|NCT03235700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65705759|NCT03235700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705760|NCT03235700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65705761|NCT03235700|Vasodilator Agents|vasodilator agents|mesh-ancestor
65705762|NCT03235700|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65705763|NCT03235700|Purinergic Agonists|purinergic agonists|mesh-ancestor
65705764|NCT03235700|Purinergic Agents|purinergic agents|mesh-ancestor
65705765|NCT03235700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65705766|NCT03235700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705767|NCT03235700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65705768|NCT03235700|Vitamin B Complex|vitamin b complex|mesh-ancestor
65705769|NCT03235700|Vitamins|vitamins|mesh-ancestor
65705770|NCT03235700|Micronutrients|micronutrients|mesh-ancestor
65705771|NCT03234062|Choline|choline|mesh-list
65705772|NCT03234062|Lipotropic Agents|lipotropic agents|mesh-ancestor
65705773|NCT03234062|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65705774|NCT03234062|Antimetabolites|antimetabolites|mesh-ancestor
65705775|NCT03234062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705776|NCT03234062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65705777|NCT03234062|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65705778|NCT03234062|Nootropic Agents|nootropic agents|mesh-ancestor
65705779|NCT05702879|Prednisolone|prednisolone|mesh-list
65705780|NCT05702879|Adalimumab|adalimumab|mesh-list
65705781|NCT05702879|Etanercept|etanercept|mesh-list
65705782|NCT05702879|Golimumab|golimumab|mesh-list
65705783|NCT05702879|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
65705784|NCT05702879|Infliximab|infliximab|mesh-list
65705785|NCT05702879|Ustekinumab|ustekinumab|mesh-list
65705786|NCT05702879|Vedolizumab|vedolizumab|mesh-list
65705787|NCT05702879|Ozanimod|ozanimod|mesh-list
65705788|NCT05702879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65705789|NCT05702879|Glucocorticoids|glucocorticoids|mesh-ancestor
65705790|NCT05702879|Hormones|hormones|mesh-ancestor
65705791|NCT05702879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65705792|NCT05702879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168469|NCT02700763|Dabrafenib|dabrafenib|mesh-list
65705793|NCT05702879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65705794|NCT05702879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65705795|NCT05702879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65705796|NCT05702879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65705797|NCT05702879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65705798|NCT05702879|Dermatologic Agents|dermatologic agents|mesh-ancestor
65705799|NCT05702879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65705800|NCT05702879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65705801|NCT05702879|Analgesics|analgesics|mesh-ancestor
65705802|NCT05702879|Sensory System Agents|sensory system agents|mesh-ancestor
65705803|NCT05702879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65705804|NCT05702879|Immunologic Factors|immunologic factors|mesh-ancestor
65705805|NCT05702879|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65705806|NCT05702879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705807|NCT03235778|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
65705808|NCT03235778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65705809|NCT03235778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65705810|NCT03235778|Analgesics|analgesics|mesh-ancestor
65705811|NCT03235778|Sensory System Agents|sensory system agents|mesh-ancestor
65705812|NCT03235778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65705813|NCT03235778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705814|NCT03235778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65705815|NCT03235778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65705816|NCT04439513|Hemostatics|hemostatics|mesh-list
65705817|NCT04439513|Coagulants|coagulants|mesh-ancestor
65705818|NCT02452970|Gemcitabine|gemcitabine|mesh-list
65705819|NCT02452970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65705820|NCT02452970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65705821|NCT02452970|Antimetabolites|antimetabolites|mesh-ancestor
65705822|NCT02452970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705823|NCT02452970|Antiviral Agents|antiviral agents|mesh-ancestor
65705824|NCT02452970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65705825|NCT02452970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705826|NCT02452970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65705827|NCT02452970|Immunologic Factors|immunologic factors|mesh-ancestor
65705828|NCT02452970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705829|NCT03227900|Lidocaine|lidocaine|mesh-list
65705830|NCT03227900|Anesthetics, Local|anesthetics, local|mesh-ancestor
65705831|NCT03227900|Anesthetics|anesthetics|mesh-ancestor
65705832|NCT03227900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65705833|NCT03227900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705834|NCT03227900|Sensory System Agents|sensory system agents|mesh-ancestor
65705835|NCT03227900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65705836|NCT03227900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65705837|NCT03227900|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65705838|NCT03227900|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65705839|NCT03227900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65705840|NCT03227900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705841|NCT03120182|Aspirin|aspirin|mesh-list
65705842|NCT03120182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65705843|NCT03120182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65705844|NCT03120182|Analgesics|analgesics|mesh-ancestor
65705845|NCT03120182|Sensory System Agents|sensory system agents|mesh-ancestor
65705846|NCT03120182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65705847|NCT03120182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705848|NCT03120182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65705849|NCT03120182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65705850|NCT03120182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65705851|NCT03120182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65705852|NCT03120182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705853|NCT03120182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65705854|NCT03120182|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65705855|NCT03120182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705856|NCT03120182|Antipyretics|antipyretics|mesh-ancestor
65705857|NCT02074436|Aminocaproic Acid|aminocaproic acid|mesh-list
65705858|NCT02074436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65705859|NCT02074436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65705860|NCT02074436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705861|NCT02074436|Hemostatics|hemostatics|mesh-ancestor
65705862|NCT02074436|Coagulants|coagulants|mesh-ancestor
65705863|NCT03227432|Dexamethasone|dexamethasone|mesh-list
65705864|NCT03227432|Nivolumab|nivolumab|mesh-list
65705865|NCT03227432|Pomalidomide|pomalidomide|mesh-list
65705866|NCT03227432|Elotuzumab|elotuzumab|mesh-list
65705867|NCT03227432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65705868|NCT03227432|Antiemetics|antiemetics|mesh-ancestor
65705869|NCT03227432|Autonomic Agents|autonomic agents|mesh-ancestor
65705870|NCT03227432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65705871|NCT03227432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705872|NCT03227432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65705873|NCT03227432|Glucocorticoids|glucocorticoids|mesh-ancestor
65705874|NCT03227432|Hormones|hormones|mesh-ancestor
65705875|NCT03227432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65705876|NCT03227432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65705877|NCT03227432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65705878|NCT03227432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65705879|NCT03227432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65705880|NCT03227432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705881|NCT03227432|Immunologic Factors|immunologic factors|mesh-ancestor
65705882|NCT03227432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65705883|NCT03227432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65705884|NCT03227432|Growth Substances|growth substances|mesh-ancestor
65705885|NCT03227432|Growth Inhibitors|growth inhibitors|mesh-ancestor
65705886|NCT03222518|Acetaminophen|acetaminophen|mesh-list
65705887|NCT03222518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65705888|NCT03222518|Piroxicam|piroxicam|mesh-list
65705889|NCT03222518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65705890|NCT03222518|Analgesics|analgesics|mesh-ancestor
65705891|NCT03222518|Sensory System Agents|sensory system agents|mesh-ancestor
65705892|NCT03222518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65705893|NCT03222518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705894|NCT03222518|Antipyretics|antipyretics|mesh-ancestor
65705895|NCT03222518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65705896|NCT03222518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65705897|NCT03222518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65705898|NCT03222518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65705899|NCT03222518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705900|NCT01750281|Docetaxel|docetaxel|mesh-list
65705901|NCT01750281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65705902|NCT01750281|Tubulin Modulators|tubulin modulators|mesh-ancestor
65705903|NCT01750281|Antimitotic Agents|antimitotic agents|mesh-ancestor
65705904|NCT01750281|Mitosis Modulators|mitosis modulators|mesh-ancestor
65705905|NCT01750281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705906|NCT03222206|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
65705907|NCT03222206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65705908|NCT03222206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65705909|NCT03222206|Analgesics|analgesics|mesh-ancestor
65705910|NCT03222206|Sensory System Agents|sensory system agents|mesh-ancestor
65705911|NCT03222206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65705912|NCT03222206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705913|NCT03222206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65705914|NCT03222206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65705916|NCT03221816|Pyridoxine|pyridoxine|mesh-list
65705917|NCT03221816|Vitamin B 12|vitamin b 12|mesh-list
65705918|NCT03221816|Hematinics|hematinics|mesh-ancestor
65705919|NCT03221816|Vitamin B Complex|vitamin b complex|mesh-ancestor
65705920|NCT03221816|Vitamins|vitamins|mesh-ancestor
65705921|NCT03221816|Micronutrients|micronutrients|mesh-ancestor
65705922|NCT03221816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705923|NCT03119636|Levodopa|levodopa|mesh-list
65705924|NCT03119636|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65705925|NCT03119636|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65705926|NCT03119636|Dopamine Agents|dopamine agents|mesh-ancestor
65705927|NCT03119636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65705928|NCT03119636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705929|NCT03119636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705930|NCT03226340|Niacin|niacin|mesh-list
65705931|NCT03226340|Amlodipine|amlodipine|mesh-list
65705932|NCT03226340|Telmisartan|telmisartan|mesh-list
65705933|NCT03226340|Chlorthalidone|chlorthalidone|mesh-list
65705934|NCT03226340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65705935|NCT03226340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65705936|NCT03226340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65705937|NCT03226340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705938|NCT03226340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65705939|NCT03226340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705940|NCT03226340|Vasodilator Agents|vasodilator agents|mesh-ancestor
65705941|NCT03226340|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65705942|NCT03226340|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65705943|NCT03226340|Diuretics|diuretics|mesh-ancestor
65705944|NCT03226340|Natriuretic Agents|natriuretic agents|mesh-ancestor
65705945|NCT03226340|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65705946|NCT03226340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65705947|NCT03226340|Antimetabolites|antimetabolites|mesh-ancestor
65705948|NCT03226340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65705949|NCT03226340|Vitamin B Complex|vitamin b complex|mesh-ancestor
65705950|NCT03226340|Vitamins|vitamins|mesh-ancestor
65705951|NCT03226340|Micronutrients|micronutrients|mesh-ancestor
65705952|NCT03221504|Oxymetazoline|oxymetazoline|mesh-list
65705953|NCT03221504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65705954|NCT03221504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65705955|NCT03221504|Adrenergic Agents|adrenergic agents|mesh-ancestor
65705956|NCT03221504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65705957|NCT03221504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705958|NCT03221504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705959|NCT03221504|Sympathomimetics|sympathomimetics|mesh-ancestor
65705960|NCT03221504|Autonomic Agents|autonomic agents|mesh-ancestor
65705961|NCT03221504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65705962|NCT03221504|Nasal Decongestants|nasal decongestants|mesh-ancestor
65705963|NCT03221504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65705964|NCT03221504|Respiratory System Agents|respiratory system agents|mesh-ancestor
65705965|NCT03221582|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65705966|NCT03221582|Antiviral Agents|antiviral agents|mesh-ancestor
65705967|NCT03221582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65705968|NCT03232034|Calcium|calcium|mesh-list
65705969|NCT03232034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65705970|NCT03232034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705971|NCT03225950|Antibodies|antibodies|mesh-list
65705972|NCT03225950|Immunologic Factors|immunologic factors|mesh-ancestor
65705973|NCT03225950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705974|NCT03119948|Botulinum Toxins|botulinum toxins|mesh-list
65705975|NCT03119948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65705976|NCT03119948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65705977|NCT03119948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705978|NCT03119948|Cholinergic Agents|cholinergic agents|mesh-ancestor
65705979|NCT03119948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65705980|NCT03119948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705981|NCT03232112|Exenatide|exenatide|mesh-list
65705982|NCT03232112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65705983|NCT03232112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705984|NCT03232112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65705985|NCT03232112|Incretins|incretins|mesh-ancestor
65705986|NCT03232112|Hormones|hormones|mesh-ancestor
65705987|NCT03232112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65705988|NCT03000569|Levodopa|levodopa|mesh-list
65705989|NCT03000569|Antiparkinson Agents|antiparkinson agents|mesh-list
65705990|NCT03000569|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65705991|NCT03000569|Dopamine Agents|dopamine agents|mesh-ancestor
65705992|NCT03000569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65705993|NCT03000569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65705994|NCT03000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65705995|NCT02554786|Fluticasone|fluticasone|mesh-list
65705996|NCT02554786|Xhance|xhance|mesh-list
65705997|NCT02554786|Mometasone Furoate|mometasone furoate|mesh-list
65705998|NCT02554786|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65705999|NCT02554786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65706000|NCT02554786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65706001|NCT02554786|Autonomic Agents|autonomic agents|mesh-ancestor
65706002|NCT02554786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65706003|NCT02554786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706004|NCT02554786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65706005|NCT02554786|Respiratory System Agents|respiratory system agents|mesh-ancestor
65706006|NCT02554786|Dermatologic Agents|dermatologic agents|mesh-ancestor
65706007|NCT02554786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65706008|NCT02554786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65706009|NCT02554786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65706010|NCT02554786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65706011|NCT02554786|Adrenergic Agents|adrenergic agents|mesh-ancestor
65706012|NCT02554786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65706013|NCT02554786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706014|NCT03225326|Carticaine|carticaine|mesh-list
65706015|NCT03225326|Anesthetics, Local|anesthetics, local|mesh-ancestor
65706016|NCT03225326|Anesthetics|anesthetics|mesh-ancestor
65706017|NCT03225326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65706018|NCT03225326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706019|NCT03225326|Sensory System Agents|sensory system agents|mesh-ancestor
65706020|NCT03225326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65706021|NCT03220880|Dexmedetomidine|dexmedetomidine|mesh-list
65706022|NCT03220880|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65706023|NCT03220880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65706024|NCT03220880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706025|NCT03220880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65706026|NCT03220880|Analgesics|analgesics|mesh-ancestor
65706027|NCT03220880|Sensory System Agents|sensory system agents|mesh-ancestor
65706028|NCT03220880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65706029|NCT03220880|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65706030|NCT03220880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65706031|NCT03220880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65706032|NCT03220880|Adrenergic Agents|adrenergic agents|mesh-ancestor
65706033|NCT03220880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65706034|NCT03220880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706035|NCT02929589|Ibuprofen|ibuprofen|mesh-list
65706036|NCT02929589|Analgesics, Opioid|analgesics, opioid|mesh-list
65706037|NCT02929589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65706038|NCT02929589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65706039|NCT02929589|Analgesics|analgesics|mesh-ancestor
65706040|NCT02929589|Sensory System Agents|sensory system agents|mesh-ancestor
65706041|NCT02929589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65706042|NCT02929589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706043|NCT02929589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65706044|NCT02929589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65706045|NCT02929589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65706046|NCT02929589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706047|NCT02929589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706048|NCT02929589|Narcotics|narcotics|mesh-ancestor
65706049|NCT02929589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65706050|NCT02910635|Moxifloxacin|moxifloxacin|mesh-list
65706051|NCT02910635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65706052|NCT02910635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65706053|NCT02910635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65706054|NCT02910635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65706055|NCT02910635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706056|NCT02910635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706057|NCT02910635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706058|NCT02614547|Brexanolone|brexanolone|mesh-list
65706059|NCT02614547|Neurosteroids|neurosteroids|mesh-ancestor
65706060|NCT02614547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65706061|NCT02614547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706062|NCT02614547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706063|NCT02614547|GABA Modulators|gaba modulators|mesh-ancestor
65706064|NCT02614547|GABA Agents|gaba agents|mesh-ancestor
65706065|NCT04472481|Ergocalciferols|ergocalciferols|mesh-list
65706066|NCT04472481|Vitamin D|vitamin d|mesh-list
65706067|NCT04472481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65706068|NCT04472481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706069|NCT04472481|Vitamins|vitamins|mesh-ancestor
65706070|NCT04472481|Micronutrients|micronutrients|mesh-ancestor
65706071|NCT04472481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65706072|NCT01233297|Azithromycin|azithromycin|mesh-list
65706073|NCT01233297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65706074|NCT01233297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65706075|NCT04681079|Albuterol|albuterol|mesh-list
65706076|NCT04681079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65706077|NCT04681079|Autonomic Agents|autonomic agents|mesh-ancestor
65706078|NCT04681079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65706079|NCT04681079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706080|NCT04681079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65706081|NCT04681079|Respiratory System Agents|respiratory system agents|mesh-ancestor
65706082|NCT04681079|Tocolytic Agents|tocolytic agents|mesh-ancestor
65706083|NCT04681079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65706084|NCT04681079|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65706085|NCT04681079|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65706086|NCT04681079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65706087|NCT04681079|Adrenergic Agents|adrenergic agents|mesh-ancestor
65706088|NCT04681079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65706089|NCT04681079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706090|NCT00580125|Aripiprazole|aripiprazole|mesh-list
65706091|NCT00580125|Antidepressive Agents|antidepressive agents|mesh-ancestor
65706092|NCT00580125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65706093|NCT00580125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65706094|NCT00580125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65706095|NCT00580125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65706096|NCT00580125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706097|NCT00580125|Dopamine Agonists|dopamine agonists|mesh-ancestor
65706098|NCT00580125|Dopamine Agents|dopamine agents|mesh-ancestor
65706099|NCT00580125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65706100|NCT00580125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706101|NCT00580125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65706102|NCT00580125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65706103|NCT00580125|Serotonin Agents|serotonin agents|mesh-ancestor
65706104|NCT00580125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65706105|NCT00580125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65706106|NCT00580125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65706107|NCT00580125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65706108|NCT01179009|Clonidine|clonidine|mesh-list
65706109|NCT01179009|Scopolamine|scopolamine|mesh-list
65706110|NCT01179009|Ketamine|ketamine|mesh-list
65706111|NCT01179009|Lorazepam|lorazepam|mesh-list
65706112|NCT01179009|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65706113|NCT01179009|Analgesics|analgesics|mesh-ancestor
65706114|NCT01179009|Sensory System Agents|sensory system agents|mesh-ancestor
65706115|NCT01179009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65706116|NCT01179009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706117|NCT01179009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65706118|NCT01179009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65706119|NCT01179009|Anesthetics, General|anesthetics, general|mesh-ancestor
65706120|NCT01179009|Anesthetics|anesthetics|mesh-ancestor
65706121|NCT01179009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65706122|NCT01179009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65706123|NCT01179009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65706124|NCT01179009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65706125|NCT01179009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706126|NCT01179009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65706127|NCT01179009|Sympatholytics|sympatholytics|mesh-ancestor
65706128|NCT01179009|Autonomic Agents|autonomic agents|mesh-ancestor
65706129|NCT01179009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65706130|NCT01179009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65706131|NCT01179009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65706132|NCT01179009|Adrenergic Agents|adrenergic agents|mesh-ancestor
65706133|NCT01179009|Anticonvulsants|anticonvulsants|mesh-ancestor
65706134|NCT01179009|Antiemetics|antiemetics|mesh-ancestor
65706135|NCT01179009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65706136|NCT01179009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65706137|NCT01179009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65706138|NCT01179009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65706139|NCT01179009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65706140|NCT01179009|GABA Modulators|gaba modulators|mesh-ancestor
65706141|NCT01179009|GABA Agents|gaba agents|mesh-ancestor
65706142|NCT01179009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65706143|NCT01179009|Mydriatics|mydriatics|mesh-ancestor
65706144|NCT01179009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65706145|NCT01179009|Cholinergic Agents|cholinergic agents|mesh-ancestor
65706146|NCT01179009|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65706147|NCT01179009|Parasympatholytics|parasympatholytics|mesh-ancestor
65706148|NCT00579189|Moxifloxacin|moxifloxacin|mesh-list
65706149|NCT00579189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65706150|NCT00579189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65706151|NCT00579189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65706152|NCT00579189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65706153|NCT00579189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65706154|NCT00579189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706155|NCT00579189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706156|NCT00579189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706157|NCT00667953|Temozolomide|temozolomide|mesh-list
65706158|NCT00667953|Imatinib Mesylate|imatinib mesylate|mesh-list
65706159|NCT00667953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65706160|NCT00667953|Alkylating Agents|alkylating agents|mesh-ancestor
65706161|NCT00667953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706162|NCT00667953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706163|NCT00667953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65706164|NCT00667953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706165|NCT00578955|Azithromycin|azithromycin|mesh-list
65706166|NCT00578955|Dexamethasone|dexamethasone|mesh-list
65706167|NCT00578955|Dexamethasone acetate|dexamethasone acetate|mesh-list
65706168|NCT00578955|BB 1101|bb 1101|mesh-list
65706169|NCT00578955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65706170|NCT00578955|Antiemetics|antiemetics|mesh-ancestor
65706171|NCT00578955|Autonomic Agents|autonomic agents|mesh-ancestor
65706172|NCT00578955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65706173|NCT00578955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706174|NCT00578955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65706175|NCT00578955|Glucocorticoids|glucocorticoids|mesh-ancestor
65706176|NCT00578955|Hormones|hormones|mesh-ancestor
65706177|NCT00578955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65706178|NCT00578955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65706179|NCT00578955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706180|NCT00578955|Protease Inhibitors|protease inhibitors|mesh-ancestor
65706181|NCT00578955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706182|NCT00578955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706183|NCT00578955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65706184|NCT00578955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65706185|NCT00576537|Vaccines|vaccines|mesh-list
65706186|NCT00576537|Immunologic Factors|immunologic factors|mesh-ancestor
65706187|NCT00576537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706188|NCT02282241|Melatonin|melatonin|mesh-list
65706189|NCT02282241|Antioxidants|antioxidants|mesh-ancestor
65706190|NCT02282241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706191|NCT02282241|Protective Agents|protective agents|mesh-ancestor
65706192|NCT02282241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706193|NCT02282241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65706194|NCT02424851|Thalidomide|thalidomide|mesh-list
65706195|NCT02424851|Dexamethasone|dexamethasone|mesh-list
65706196|NCT02424851|Bortezomib|bortezomib|mesh-list
65706197|NCT02424851|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65706198|NCT02424851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65706199|NCT02424851|Antiemetics|antiemetics|mesh-ancestor
65706200|NCT02424851|Autonomic Agents|autonomic agents|mesh-ancestor
65706201|NCT02424851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65706202|NCT02424851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706203|NCT02424851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65706204|NCT02424851|Glucocorticoids|glucocorticoids|mesh-ancestor
65706205|NCT02424851|Hormones|hormones|mesh-ancestor
65706206|NCT02424851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65706207|NCT02424851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65706208|NCT02424851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706209|NCT02424851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65706210|NCT02424851|Alkylating Agents|alkylating agents|mesh-ancestor
65706211|NCT02424851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706212|NCT02424851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65706213|NCT02424851|Immunologic Factors|immunologic factors|mesh-ancestor
65706214|NCT02424851|Leprostatic Agents|leprostatic agents|mesh-ancestor
65706215|NCT02424851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65706216|NCT02424851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65706217|NCT02424851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65706218|NCT02424851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65706219|NCT02424851|Growth Substances|growth substances|mesh-ancestor
65706220|NCT02424851|Growth Inhibitors|growth inhibitors|mesh-ancestor
65706221|NCT02284035|Raltegravir Potassium|raltegravir potassium|mesh-list
65706222|NCT02284035|Lamivudine|lamivudine|mesh-list
65706223|NCT02284035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65706224|NCT02284035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65706225|NCT02284035|Antiviral Agents|antiviral agents|mesh-ancestor
65706226|NCT02284035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65706227|NCT02284035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65706228|NCT02284035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65706229|NCT02284035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706230|NCT02284035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706231|NCT02284035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65706232|NCT02284035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65706233|NCT00484419|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65706234|NCT00484419|Rosiglitazone|rosiglitazone|mesh-list
65706235|NCT00484419|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65706236|NCT00484419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65706237|NCT00484419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706238|NCT00484419|Incretins|incretins|mesh-ancestor
65706239|NCT00484419|Hormones|hormones|mesh-ancestor
64811493|NCT01447589|Nelfinavir|nelfinavir|mesh-list
65706240|NCT00484419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65706241|NCT00484419|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65706242|NCT00484419|Protease Inhibitors|protease inhibitors|mesh-ancestor
65706243|NCT00484419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706244|NCT00484419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706245|NCT00484419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65706246|NCT00484419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65706247|NCT00484419|Antimetabolites|antimetabolites|mesh-ancestor
65706248|NCT00484419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65706249|NCT02273895|Scopolamine|scopolamine|mesh-list
65706250|NCT02273895|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65706251|NCT02273895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65706252|NCT02273895|Antiemetics|antiemetics|mesh-ancestor
65706253|NCT02273895|Autonomic Agents|autonomic agents|mesh-ancestor
65706254|NCT02273895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65706255|NCT02273895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706256|NCT02273895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65706257|NCT02273895|Mydriatics|mydriatics|mesh-ancestor
65706258|NCT02273895|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65706259|NCT02273895|Cholinergic Agents|cholinergic agents|mesh-ancestor
65706260|NCT02273895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65706261|NCT02273895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706262|NCT02273895|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65706263|NCT02273895|Parasympatholytics|parasympatholytics|mesh-ancestor
65706264|NCT00480831|Paclitaxel|paclitaxel|mesh-list
65706265|NCT00480831|Bevacizumab|bevacizumab|mesh-list
65706266|NCT00480831|Carboplatin|carboplatin|mesh-list
65706267|NCT00480831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65706268|NCT00480831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706269|NCT00480831|Tubulin Modulators|tubulin modulators|mesh-ancestor
65706270|NCT00480831|Antimitotic Agents|antimitotic agents|mesh-ancestor
65706271|NCT00480831|Mitosis Modulators|mitosis modulators|mesh-ancestor
65706272|NCT00480831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706273|NCT00480831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65706274|NCT00480831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65706275|NCT00480831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65706276|NCT00480831|Growth Substances|growth substances|mesh-ancestor
65706277|NCT00480831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706278|NCT00480831|Growth Inhibitors|growth inhibitors|mesh-ancestor
65706279|NCT02549092|Levodopa|levodopa|mesh-list
65706280|NCT02549092|Carbidopa|carbidopa|mesh-list
65706281|NCT02549092|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65706282|NCT02549092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65706283|NCT02549092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65706284|NCT02549092|Dopamine Agents|dopamine agents|mesh-ancestor
65706285|NCT02549092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65706286|NCT02549092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706287|NCT02549092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706288|NCT02549092|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65706289|NCT02549092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706290|NCT02549092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65706291|NCT02549092|Immunologic Factors|immunologic factors|mesh-ancestor
65706292|NCT02549092|Dopamine Agonists|dopamine agonists|mesh-ancestor
65706293|NCT03220256|Lamotrigine|lamotrigine|mesh-list
65706294|NCT03220256|Anticonvulsants|anticonvulsants|mesh-ancestor
65706295|NCT03220256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65706296|NCT03220256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65706297|NCT03220256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706298|NCT03220256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65706299|NCT03220256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706300|NCT03220256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65706301|NCT03220256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65706302|NCT03220256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65706303|NCT03220256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65706304|NCT03220256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65706305|NCT03220490|Timolol|timolol|mesh-list
65706306|NCT03220490|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65706307|NCT03220490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65706308|NCT03220490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65706309|NCT03220490|Adrenergic Agents|adrenergic agents|mesh-ancestor
65706310|NCT03220490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65706311|NCT03220490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168965|NCT00618397|Anesthetics|anesthetics|mesh-ancestor
65706312|NCT03220490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706313|NCT03220490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65706314|NCT03220490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65706315|NCT03220490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65706316|NCT03220490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65706317|NCT03220490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65706318|NCT02553772|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65706319|NCT02553772|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65706320|NCT02553772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65706321|NCT02553772|Laxatives|laxatives|mesh-ancestor
65706322|NCT02553772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65706323|NCT03119714|Pemirolast|pemirolast|mesh-list
65706324|NCT03119714|Histamine Antagonists|histamine antagonists|mesh-ancestor
65706325|NCT03119714|Histamine Agents|histamine agents|mesh-ancestor
65706326|NCT03119714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65706327|NCT03119714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706328|NCT03119714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706329|NCT00562887|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65706330|NCT00562887|Immunologic Factors|immunologic factors|mesh-ancestor
65706331|NCT00562887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706332|NCT05468554|Metformin|metformin|mesh-list
65706333|NCT05468554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65706334|NCT05468554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706335|NCT04617821|Gemcitabine|gemcitabine|mesh-list
65706336|NCT04617821|Paclitaxel|paclitaxel|mesh-list
65706337|NCT04617821|Folfirinox|folfirinox|mesh-list
65706338|NCT04617821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65706339|NCT04617821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706340|NCT04617821|Tubulin Modulators|tubulin modulators|mesh-ancestor
65706341|NCT04617821|Antimitotic Agents|antimitotic agents|mesh-ancestor
65706342|NCT04617821|Mitosis Modulators|mitosis modulators|mesh-ancestor
65706343|NCT04617821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706344|NCT04617821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65706345|NCT04617821|Antimetabolites|antimetabolites|mesh-ancestor
65706346|NCT04617821|Antiviral Agents|antiviral agents|mesh-ancestor
65706347|NCT04617821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65706348|NCT04617821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706349|NCT04617821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65706350|NCT04617821|Immunologic Factors|immunologic factors|mesh-ancestor
65706351|NCT04617821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706352|NCT03219008|Lithium Carbonate|lithium carbonate|mesh-list
65706353|NCT03219008|Mirtazapine|mirtazapine|mesh-list
65706354|NCT03219008|Fluvoxamine|fluvoxamine|mesh-list
65706355|NCT03219008|Fluoxetine|fluoxetine|mesh-list
65706356|NCT03219008|Bupropion|bupropion|mesh-list
65022214|NCT00164463|Antimetabolites|antimetabolites|mesh-ancestor
65706357|NCT03219008|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
65706358|NCT03219008|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65706359|NCT03219008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65706360|NCT03219008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65706361|NCT03219008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706362|NCT03219008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65706363|NCT03219008|Serotonin Agents|serotonin agents|mesh-ancestor
65706364|NCT03219008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706365|NCT03219008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65706366|NCT03219008|Antidepressive Agents|antidepressive agents|mesh-ancestor
65706367|NCT03219008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65706368|NCT03219008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65706369|NCT03219008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65706370|NCT03219008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706371|NCT03219008|Antimanic Agents|antimanic agents|mesh-ancestor
65706372|NCT03219008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65706373|NCT03219008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65706374|NCT03219008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65706375|NCT03219008|Histamine Antagonists|histamine antagonists|mesh-ancestor
65706376|NCT03219008|Histamine Agents|histamine agents|mesh-ancestor
65706377|NCT03219008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65706378|NCT03219008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65706379|NCT03219008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65706380|NCT03219008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65706381|NCT03219008|Adrenergic Agents|adrenergic agents|mesh-ancestor
65706382|NCT03219008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65706383|NCT03219008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65706384|NCT03219008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65706385|NCT03219008|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65706386|NCT03219008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65706387|NCT03219008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65706388|NCT03219008|Dopamine Agents|dopamine agents|mesh-ancestor
65706389|NCT03218930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65706390|NCT03218930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65706391|NCT03218930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65706392|NCT03218930|Antitubercular Agents|antitubercular agents|mesh-ancestor
65706393|NCT00562497|Remestemcel-l|remestemcel-l|mesh-list
65706394|NCT00562497|Prednisone|prednisone|mesh-list
65706395|NCT00562497|Methylprednisolone|methylprednisolone|mesh-list
65706396|NCT00562497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65706397|NCT00562497|Glucocorticoids|glucocorticoids|mesh-ancestor
65706398|NCT00562497|Hormones|hormones|mesh-ancestor
65706399|NCT00562497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65706400|NCT00562497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706401|NCT00562497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65706402|NCT00562497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706403|NCT00562497|Antiemetics|antiemetics|mesh-ancestor
65706404|NCT00562497|Autonomic Agents|autonomic agents|mesh-ancestor
65706405|NCT00562497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65706406|NCT00562497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65706407|NCT00562497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65706408|NCT00562497|Protective Agents|protective agents|mesh-ancestor
65706409|NCT00562497|Antiviral Agents|antiviral agents|mesh-ancestor
65706410|NCT00562497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65706411|NCT00468975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65706412|NCT00468975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65706413|NCT00468975|Autonomic Agents|autonomic agents|mesh-ancestor
65706414|NCT00468975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65706415|NCT00468975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706416|NCT00468975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65706417|NCT00468975|Respiratory System Agents|respiratory system agents|mesh-ancestor
65706418|NCT00468975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65706419|NCT00468975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65706420|NCT00468975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65706421|NCT00468975|Adrenergic Agents|adrenergic agents|mesh-ancestor
65706422|NCT00468975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65706423|NCT00468975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706424|NCT01503515|Fluconazole|fluconazole|mesh-list
65706425|NCT01503515|Voriconazole|voriconazole|mesh-list
65706426|NCT01503515|Caspofungin|caspofungin|mesh-list
65706427|NCT01503515|Antifungal Agents|antifungal agents|mesh-ancestor
65706428|NCT01503515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65706429|NCT01503515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65706430|NCT01503515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65706431|NCT01503515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706432|NCT01503515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706433|NCT01503515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65706434|NCT01503515|Hormone Antagonists|hormone antagonists|mesh-ancestor
65706435|NCT01503515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65706436|NCT01503515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706437|NCT01503515|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65706438|NCT01503515|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65706439|NCT01503515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65706440|NCT00468273|Immunoglobulins|immunoglobulins|mesh-list
65706441|NCT00468273|Antibodies|antibodies|mesh-list
65706442|NCT00468273|gamma-Globulins|gamma-globulins|mesh-list
65706443|NCT00468273|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65706444|NCT00468273|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65706445|NCT00468273|Immunologic Factors|immunologic factors|mesh-ancestor
65706446|NCT00468273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706447|NCT03217916|polysaccharide-K|polysaccharide-k|mesh-list
65706448|NCT03217916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65706449|NCT03217916|Immunologic Factors|immunologic factors|mesh-ancestor
65706450|NCT03217916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706451|NCT03217916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65706452|NCT03217916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706453|NCT03217916|Antiviral Agents|antiviral agents|mesh-ancestor
65706454|NCT03217916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65706455|NCT03217916|Interferon Inducers|interferon inducers|mesh-ancestor
65706456|NCT03217916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65706457|NCT03217916|Protective Agents|protective agents|mesh-ancestor
65706458|NCT00468117|Etanercept|etanercept|mesh-list
65706459|NCT00468117|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65706460|NCT00468117|Basiliximab|basiliximab|mesh-list
65706461|NCT00468117|Daclizumab|daclizumab|mesh-list
65706462|NCT00468117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65706463|NCT00468117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65706464|NCT00468117|Analgesics|analgesics|mesh-ancestor
65706465|NCT00468117|Sensory System Agents|sensory system agents|mesh-ancestor
65706466|NCT00468117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65706467|NCT00468117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706468|NCT00468117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65706469|NCT00468117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65706470|NCT00468117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65706471|NCT00468117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65706472|NCT00468117|Immunologic Factors|immunologic factors|mesh-ancestor
65706473|NCT00468039|Metformin|metformin|mesh-list
65706474|NCT00468039|Vildagliptin|vildagliptin|mesh-list
65706475|NCT00468039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65706476|NCT00468039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706477|NCT00468039|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65706478|NCT00468039|Protease Inhibitors|protease inhibitors|mesh-ancestor
65706479|NCT00468039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706480|NCT00468039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706481|NCT02742519|Ivacaftor|ivacaftor|mesh-list
65706482|NCT02742519|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65706483|NCT02742519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65706484|NCT02742519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706485|NCT01375010|Vitamin D|vitamin d|mesh-list
65706486|NCT01375010|Cholecalciferol|cholecalciferol|mesh-list
65706487|NCT01375010|Vitamins|vitamins|mesh-list
65706488|NCT01375010|Micronutrients|micronutrients|mesh-ancestor
65706489|NCT01375010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706490|NCT01375010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65706491|NCT01375010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65706492|NCT03231176|Capecitabine|capecitabine|mesh-list
65706493|NCT03231176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65706494|NCT03231176|Antimetabolites|antimetabolites|mesh-ancestor
65706495|NCT03231176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706496|NCT03231176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706497|NCT00467025|Sorafenib|sorafenib|mesh-list
65706498|NCT00467025|Trebananib|trebananib|mesh-list
65706499|NCT00467025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706500|NCT00467025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65706501|NCT00467025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706502|NCT00467025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706503|NCT00467025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65022361|NCT05293600|Serotonin Agents|serotonin agents|mesh-ancestor
65706504|NCT00467025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65706505|NCT00467025|Growth Substances|growth substances|mesh-ancestor
65706506|NCT00467025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706507|NCT00467025|Growth Inhibitors|growth inhibitors|mesh-ancestor
65706508|NCT03230786|Metformin|metformin|mesh-list
65706509|NCT03230786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65706510|NCT03230786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706511|NCT02451098|Atorvastatin|atorvastatin|mesh-list
65706512|NCT02451098|Ezetimibe|ezetimibe|mesh-list
65706513|NCT02451098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65706514|NCT02451098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65706515|NCT02451098|Antimetabolites|antimetabolites|mesh-ancestor
65706516|NCT02451098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706517|NCT02451098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65706518|NCT02451098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65706519|NCT02451098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706520|NCT00546273|Vaccines|vaccines|mesh-list
65706521|NCT00546273|Immunologic Factors|immunologic factors|mesh-ancestor
65706522|NCT00546273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706523|NCT02452112|Lidocaine|lidocaine|mesh-list
65706524|NCT02452112|Anesthetics, Local|anesthetics, local|mesh-ancestor
65706525|NCT02452112|Anesthetics|anesthetics|mesh-ancestor
65706526|NCT02452112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65706527|NCT02452112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706528|NCT02452112|Sensory System Agents|sensory system agents|mesh-ancestor
65706529|NCT02452112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65706530|NCT02452112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65706531|NCT02452112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65706532|NCT02452112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65706533|NCT02452112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65706534|NCT02452112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706535|NCT00659061|Micronutrients|micronutrients|mesh-list
65706536|NCT00659061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706537|NCT02451956|Paclitaxel|paclitaxel|mesh-list
65706538|NCT02451956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65706539|NCT02451956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706540|NCT02451956|Tubulin Modulators|tubulin modulators|mesh-ancestor
65706541|NCT02451956|Antimitotic Agents|antimitotic agents|mesh-ancestor
65706542|NCT02451956|Mitosis Modulators|mitosis modulators|mesh-ancestor
65706543|NCT02451956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706544|NCT02725372|Nitric Oxide|nitric oxide|mesh-list
65706545|NCT02725372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65706546|NCT02725372|Autonomic Agents|autonomic agents|mesh-ancestor
65706547|NCT02725372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65706548|NCT02725372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706549|NCT02725372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65706550|NCT02725372|Respiratory System Agents|respiratory system agents|mesh-ancestor
65706551|NCT02725372|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65706552|NCT02725372|Antioxidants|antioxidants|mesh-ancestor
65706553|NCT02725372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706554|NCT02725372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65706555|NCT02725372|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65706556|NCT02725372|Vasodilator Agents|vasodilator agents|mesh-ancestor
65706557|NCT02725372|Gasotransmitters|gasotransmitters|mesh-ancestor
65706558|NCT02725372|Protective Agents|protective agents|mesh-ancestor
65706559|NCT02450786|Donepezil|donepezil|mesh-list
65706560|NCT02450786|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65706561|NCT02450786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706562|NCT02450786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706563|NCT02450786|Cholinergic Agents|cholinergic agents|mesh-ancestor
65706564|NCT02450786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65706565|NCT02450786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706566|NCT02450786|Nootropic Agents|nootropic agents|mesh-ancestor
65706567|NCT00539721|Ondansetron|ondansetron|mesh-list
65706568|NCT00539721|Rolapitant|rolapitant|mesh-list
65706569|NCT00539721|Antiemetics|antiemetics|mesh-ancestor
65706570|NCT00539721|Autonomic Agents|autonomic agents|mesh-ancestor
65706571|NCT00539721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65706572|NCT00539721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706573|NCT00539721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65706574|NCT00539721|Antipruritics|antipruritics|mesh-ancestor
65706575|NCT00539721|Dermatologic Agents|dermatologic agents|mesh-ancestor
65706576|NCT00539721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65706577|NCT00539721|Serotonin Agents|serotonin agents|mesh-ancestor
65706578|NCT00539721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65706579|NCT00539721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706580|NCT00539721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65706581|NCT00539721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65706582|NCT00539721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65706583|NCT00539721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65706584|NCT00539721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65706585|NCT00539721|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65706586|NCT00464061|Volinanserin|volinanserin|mesh-list
65706587|NCT00464061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65706588|NCT00464061|Serotonin Agents|serotonin agents|mesh-ancestor
65706589|NCT00464061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65706590|NCT00464061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706591|NCT00464061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706592|NCT03230630|Melatonin|melatonin|mesh-list
65706593|NCT03230630|Antioxidants|antioxidants|mesh-ancestor
65706594|NCT03230630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706595|NCT03230630|Protective Agents|protective agents|mesh-ancestor
65706596|NCT03230630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706597|NCT03230630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65706598|NCT00460941|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65706599|NCT00460941|Incretins|incretins|mesh-ancestor
65706600|NCT00460941|Hormones|hormones|mesh-ancestor
65706601|NCT00460941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65706602|NCT00460941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706603|NCT00460317|Paclitaxel|paclitaxel|mesh-list
65706604|NCT00460317|Carboplatin|carboplatin|mesh-list
65706605|NCT00460317|Motesanib diphosphate|motesanib diphosphate|mesh-list
65706606|NCT00460317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65706607|NCT00460317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706608|NCT00460317|Tubulin Modulators|tubulin modulators|mesh-ancestor
65706609|NCT00460317|Antimitotic Agents|antimitotic agents|mesh-ancestor
65706610|NCT00460317|Mitosis Modulators|mitosis modulators|mesh-ancestor
65706611|NCT00460317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706612|NCT00460317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65706613|NCT00460317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706614|NCT03213548|Daminozide|daminozide|mesh-list
65706615|NCT03213548|Plant Growth Regulators|plant growth regulators|mesh-ancestor
65706616|NCT03213548|Growth Substances|growth substances|mesh-ancestor
65706617|NCT03213548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706618|NCT00534027|Conatumumab|conatumumab|mesh-list
65706619|NCT00534027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65706620|NCT00534027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706621|NCT02279589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65706622|NCT02279589|Immunologic Factors|immunologic factors|mesh-ancestor
65706623|NCT02279589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706624|NCT02548078|Vaccines|vaccines|mesh-list
65706625|NCT02548078|Immunologic Factors|immunologic factors|mesh-ancestor
65706626|NCT02548078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706627|NCT00532311|Atorvastatin|atorvastatin|mesh-list
65706628|NCT00532311|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65706629|NCT00532311|Simvastatin|simvastatin|mesh-list
65706630|NCT00532311|Pravastatin|pravastatin|mesh-list
65706631|NCT00532311|Lovastatin|lovastatin|mesh-list
65706632|NCT00532311|L 647318|l 647318|mesh-list
65706633|NCT00532311|Dihydromevinolin|dihydromevinolin|mesh-list
65706634|NCT00532311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65706635|NCT00532311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65706636|NCT00532311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65706637|NCT00532311|Antimetabolites|antimetabolites|mesh-ancestor
65706638|NCT00532311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706639|NCT00532311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65706640|NCT00532311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706641|NCT03230474|Morphine|morphine|mesh-list
65706642|NCT03230474|Naloxone|naloxone|mesh-list
65706643|NCT03230474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65706644|NCT03230474|Narcotics|narcotics|mesh-ancestor
65706645|NCT03230474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65706646|NCT03230474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706647|NCT03230474|Analgesics|analgesics|mesh-ancestor
65706648|NCT03230474|Sensory System Agents|sensory system agents|mesh-ancestor
65706649|NCT03230474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65706650|NCT03230474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65706651|NCT02671435|Bevacizumab|bevacizumab|mesh-list
65706652|NCT02671435|Cetuximab|cetuximab|mesh-list
65022502|NCT05060068|Ketamine|ketamine|mesh-list
65706653|NCT02671435|Durvalumab|durvalumab|mesh-list
65706654|NCT02671435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65706655|NCT02671435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706656|NCT02671435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65706657|NCT02671435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65706658|NCT02671435|Growth Substances|growth substances|mesh-ancestor
65706659|NCT02671435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706660|NCT02671435|Growth Inhibitors|growth inhibitors|mesh-ancestor
65706661|NCT05476354|Amlodipine|amlodipine|mesh-list
65706662|NCT05476354|Irbesartan|irbesartan|mesh-list
65706663|NCT05476354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65706664|NCT05476354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65706665|NCT05476354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65706666|NCT05476354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706667|NCT05476354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65706668|NCT05476354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706669|NCT05476354|Vasodilator Agents|vasodilator agents|mesh-ancestor
65706670|NCT05476354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65706671|NCT05476354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65706672|NCT00529503|Rituximab|rituximab|mesh-list
65706673|NCT00529503|Dacetuzumab|dacetuzumab|mesh-list
65706674|NCT00529503|Carboplatin|carboplatin|mesh-list
65706675|NCT00529503|Etoposide|etoposide|mesh-list
65706676|NCT00529503|Ifosfamide|ifosfamide|mesh-list
65706677|NCT00529503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65706678|NCT00529503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706679|NCT00529503|Immunologic Factors|immunologic factors|mesh-ancestor
65269194|NCT00909779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65706680|NCT00529503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706681|NCT00529503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65706682|NCT00529503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65706683|NCT00529503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65706684|NCT00529503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65706685|NCT00529503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706686|NCT00529503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706687|NCT00529503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65706688|NCT00529503|Alkylating Agents|alkylating agents|mesh-ancestor
65706689|NCT05459194|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65706690|NCT05459194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65706691|NCT05459194|Autonomic Agents|autonomic agents|mesh-ancestor
65706692|NCT05459194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65706693|NCT05459194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706694|NCT05459194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65706695|NCT05459194|Respiratory System Agents|respiratory system agents|mesh-ancestor
65706696|NCT05459194|Glucocorticoids|glucocorticoids|mesh-ancestor
65706697|NCT05459194|Hormones|hormones|mesh-ancestor
65706698|NCT05459194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65706699|NCT05459194|Sympathomimetics|sympathomimetics|mesh-ancestor
65706700|NCT05476198|Anesthetics|anesthetics|mesh-list
65706701|NCT05476198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65706702|NCT05476198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706703|NCT02280057|Metformin|metformin|mesh-list
65706704|NCT02280057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65706705|NCT02280057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706706|NCT02282709|Asunaprevir|asunaprevir|mesh-list
65706707|NCT02282709|Protease Inhibitors|protease inhibitors|mesh-ancestor
65706708|NCT02282709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706709|NCT02282709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706710|NCT02282787|Dexmedetomidine|dexmedetomidine|mesh-list
65706711|NCT02282787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65706712|NCT02282787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65706713|NCT02282787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706714|NCT02282787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65706715|NCT02282787|Analgesics|analgesics|mesh-ancestor
65706716|NCT02282787|Sensory System Agents|sensory system agents|mesh-ancestor
65706717|NCT02282787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65706718|NCT02282787|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65706719|NCT02282787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65706720|NCT02282787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65706721|NCT02282787|Adrenergic Agents|adrenergic agents|mesh-ancestor
65706722|NCT02282787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65706723|NCT02282787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706724|NCT03223844|Dextroamphetamine|dextroamphetamine|mesh-list
65706725|NCT03223844|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65706726|NCT03223844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706727|NCT03223844|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65706728|NCT03223844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65706729|NCT03223844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65706730|NCT03223844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706731|NCT03223844|Dopamine Agents|dopamine agents|mesh-ancestor
65706732|NCT03223844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65706733|NCT00458601|Temozolomide|temozolomide|mesh-list
65706734|NCT00458601|Molgramostim|molgramostim|mesh-list
65706735|NCT00458601|Rindopepimut|rindopepimut|mesh-list
65706736|NCT00458601|Sargramostim|sargramostim|mesh-list
65706737|NCT00458601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65706738|NCT00458601|Alkylating Agents|alkylating agents|mesh-ancestor
65706739|NCT00458601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706740|NCT00458601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706741|NCT00458601|Immunologic Factors|immunologic factors|mesh-ancestor
65706742|NCT00458601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706743|NCT00458601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65706744|NCT00658047|Methotrexate|methotrexate|mesh-list
65706745|NCT00658047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65706746|NCT00658047|Abortifacient Agents|abortifacient agents|mesh-ancestor
65706747|NCT00658047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65706748|NCT00658047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706749|NCT00658047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65706750|NCT00658047|Antimetabolites|antimetabolites|mesh-ancestor
65706751|NCT00658047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706752|NCT00658047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706753|NCT00658047|Dermatologic Agents|dermatologic agents|mesh-ancestor
65706754|NCT00658047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706755|NCT00658047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65706756|NCT00658047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65706757|NCT00658047|Immunologic Factors|immunologic factors|mesh-ancestor
65706758|NCT00658047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65706759|NCT00658047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65706760|NCT03230162|Heparin|heparin|mesh-list
65706761|NCT03230162|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65706762|NCT03230162|Tinzaparin|tinzaparin|mesh-list
65706763|NCT03230162|Dalteparin|dalteparin|mesh-list
65706764|NCT03230162|Sildenafil Citrate|sildenafil citrate|mesh-list
65706765|NCT03230162|Anticoagulants|anticoagulants|mesh-ancestor
65706766|NCT03230162|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65706767|NCT03230162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65706768|NCT03230162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706769|NCT03230162|Vasodilator Agents|vasodilator agents|mesh-ancestor
65706770|NCT03230162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65706771|NCT03230162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65706772|NCT03230162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706773|NCT03230162|Urological Agents|urological agents|mesh-ancestor
65706774|NCT00455559|Imatinib Mesylate|imatinib mesylate|mesh-list
65706775|NCT00455559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706776|NCT00455559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65706777|NCT00455559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706778|NCT00455559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706779|NCT02916433|Octreotide|octreotide|mesh-list
65706780|NCT02916433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65706781|NCT02916433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65706782|NCT02916433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706783|NCT02284269|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65706784|NCT02284269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706785|NCT02284269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65706786|NCT02284269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706787|NCT04059523|Tretinoin|tretinoin|mesh-list
65706788|NCT04059523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706789|NCT04059523|Keratolytic Agents|keratolytic agents|mesh-ancestor
65706790|NCT04059523|Dermatologic Agents|dermatologic agents|mesh-ancestor
65706791|NCT00657501|Testosterone|testosterone|mesh-list
65706792|NCT00657501|Androgens|androgens|mesh-ancestor
65706793|NCT00657501|Hormones|hormones|mesh-ancestor
65706794|NCT00657501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65706795|NCT00657501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706796|NCT03675841|Carbamide Peroxide|carbamide peroxide|mesh-list
65706797|NCT03675841|Pazufloxacin|pazufloxacin|mesh-list
65706798|NCT03675841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65706799|NCT03675841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65706800|NCT03675841|Antitubercular Agents|antitubercular agents|mesh-ancestor
65706801|NCT03675841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65706802|NCT03675841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65706803|NCT03675841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65706804|NCT03675841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706805|NCT03675841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706806|NCT03675841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706807|NCT03229694|Bosentan|bosentan|mesh-list
65706808|NCT03229694|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
65706809|NCT03229694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65706810|NCT03229694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706811|NCT03223064|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65706812|NCT03223064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65706813|NCT03223064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706814|NCT03209648|Itraconazole|itraconazole|mesh-list
65706815|NCT03209648|Antifungal Agents|antifungal agents|mesh-ancestor
65706816|NCT03209648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65706817|NCT03209648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65706818|NCT03209648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65706819|NCT03209648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706820|NCT03209648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706821|NCT03209648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65706822|NCT03209648|Hormone Antagonists|hormone antagonists|mesh-ancestor
65706823|NCT03209648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65706824|NCT03209648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706825|NCT03209648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65706826|NCT04058899|Dexmedetomidine|dexmedetomidine|mesh-list
65706827|NCT04058899|Nalbuphine|nalbuphine|mesh-list
65706828|NCT04058899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65706829|NCT04058899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65706830|NCT04058899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706831|NCT04058899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65706832|NCT04058899|Analgesics|analgesics|mesh-ancestor
65706833|NCT04058899|Sensory System Agents|sensory system agents|mesh-ancestor
65706834|NCT04058899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65706835|NCT04058899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65706836|NCT04058899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65706837|NCT04058899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65706838|NCT04058899|Adrenergic Agents|adrenergic agents|mesh-ancestor
65706839|NCT04058899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65706840|NCT04058899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706841|NCT04058899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65706842|NCT04058899|Narcotics|narcotics|mesh-ancestor
65706843|NCT00657189|Sifalimumab|sifalimumab|mesh-list
65706844|NCT00657189|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65706845|NCT00657189|Immunologic Factors|immunologic factors|mesh-ancestor
65706846|NCT00657189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706847|NCT03209180|Carvedilol|carvedilol|mesh-list
65706848|NCT03209180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65706849|NCT03209180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65706850|NCT03209180|Adrenergic Agents|adrenergic agents|mesh-ancestor
65706851|NCT03209180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65706852|NCT03209180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706853|NCT03209180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706854|NCT03209180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65706855|NCT03209180|Antioxidants|antioxidants|mesh-ancestor
65706856|NCT03209180|Protective Agents|protective agents|mesh-ancestor
65706857|NCT03209180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65706858|NCT03209180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65706859|NCT03209180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65706860|NCT03209180|Vasodilator Agents|vasodilator agents|mesh-ancestor
65706861|NCT03209180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65706862|NCT03209180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65706863|NCT03215017|Loperamide|loperamide|mesh-list
65706864|NCT03215017|Sorbitol|sorbitol|mesh-list
65706865|NCT03215017|Antidiarrheals|antidiarrheals|mesh-ancestor
65706866|NCT03215017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65706867|NCT03215017|Cathartics|cathartics|mesh-ancestor
65706868|NCT02500849|Busulfan|busulfan|mesh-list
65706869|NCT02500849|Alkylating Agents|alkylating agents|mesh-ancestor
65706870|NCT02500849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706871|NCT02500849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65706872|NCT02500849|Immunologic Factors|immunologic factors|mesh-ancestor
65706873|NCT02500849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706874|NCT02500849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65706875|NCT02500849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706876|NCT02500849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65706877|NCT03209102|Hydrocortisone|hydrocortisone|mesh-list
65706878|NCT03209102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65706879|NCT02280447|Vaccines|vaccines|mesh-list
65706880|NCT02280447|Immunologic Factors|immunologic factors|mesh-ancestor
65706881|NCT02280447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706882|NCT00528333|Cytarabine|cytarabine|mesh-list
65706883|NCT00528333|Lintuzumab|lintuzumab|mesh-list
65706884|NCT00528333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65706885|NCT00528333|Antimetabolites|antimetabolites|mesh-ancestor
65706886|NCT00528333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706887|NCT00528333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706888|NCT00528333|Antiviral Agents|antiviral agents|mesh-ancestor
65706889|NCT00528333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65706890|NCT00528333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65706891|NCT00528333|Immunologic Factors|immunologic factors|mesh-ancestor
65706892|NCT00528333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706893|NCT00528333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65706894|NCT00526227|Clotrimazole|clotrimazole|mesh-list
65706895|NCT00526227|Miconazole|miconazole|mesh-list
65706896|NCT00526227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65706897|NCT00526227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65706898|NCT00526227|Antifungal Agents|antifungal agents|mesh-ancestor
65706899|NCT00526227|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65706900|NCT00526227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65706901|NCT00526227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706902|NCT00526227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706903|NCT00526227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65706904|NCT00526227|Hormone Antagonists|hormone antagonists|mesh-ancestor
65706905|NCT00526227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65706906|NCT00526227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706907|NCT00526227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65706908|NCT00526227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65706909|NCT02280603|Minoxidil|minoxidil|mesh-list
65706910|NCT02280603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65706911|NCT02280603|Vasodilator Agents|vasodilator agents|mesh-ancestor
65706912|NCT00524277|Molgramostim|molgramostim|mesh-list
65706913|NCT00524277|Vaccines|vaccines|mesh-list
65706914|NCT00524277|Sargramostim|sargramostim|mesh-list
65706915|NCT00524277|Immunologic Factors|immunologic factors|mesh-ancestor
65706916|NCT00524277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706917|NCT00524277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706918|NCT02284503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65706919|NCT02284503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65706920|NCT02284503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65706921|NCT02284503|Antimetabolites|antimetabolites|mesh-ancestor
65706922|NCT02284503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706923|NCT02284503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65706924|NCT02284503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65706925|NCT02284503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706926|NCT00650949|Carboplatin|carboplatin|mesh-list
65706927|NCT00650949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706928|NCT00520923|Olanzapine|olanzapine|mesh-list
65706929|NCT00520923|Antiemetics|antiemetics|mesh-ancestor
65706930|NCT00520923|Autonomic Agents|autonomic agents|mesh-ancestor
65706931|NCT00520923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65706932|NCT00520923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706933|NCT00520923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65706934|NCT00520923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65706935|NCT00520923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65706936|NCT00520923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65706937|NCT00520923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65706938|NCT00520923|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65706939|NCT00520923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65706940|NCT00520923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65706941|NCT00520923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65706942|NCT00520923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65706943|NCT00520923|Serotonin Agents|serotonin agents|mesh-ancestor
65706944|NCT02283177|Cytarabine|cytarabine|mesh-list
65706945|NCT02283177|Daunorubicin|daunorubicin|mesh-list
65706946|NCT02283177|Idarubicin|idarubicin|mesh-list
65706947|NCT02283177|Crenolanib|crenolanib|mesh-list
65706948|NCT02283177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65706949|NCT02283177|Antimetabolites|antimetabolites|mesh-ancestor
65706950|NCT02283177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022815|NCT00165087|Razoxane|razoxane|mesh-list
65706951|NCT02283177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706952|NCT02283177|Antiviral Agents|antiviral agents|mesh-ancestor
65706953|NCT02283177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65706954|NCT02283177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65706955|NCT02283177|Immunologic Factors|immunologic factors|mesh-ancestor
65706956|NCT02283177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706957|NCT02283177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65706958|NCT02283177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65706959|NCT02283177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65706960|NCT02283177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706961|NCT00514371|Bortezomib|bortezomib|mesh-list
65706962|NCT00514371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65706963|NCT03214510|Fentanyl|fentanyl|mesh-list
65706964|NCT03214510|Hydromorphone|hydromorphone|mesh-list
65706965|NCT03214510|Bupivacaine|bupivacaine|mesh-list
65706966|NCT03214510|Anesthetics, Local|anesthetics, local|mesh-ancestor
65706967|NCT03214510|Anesthetics|anesthetics|mesh-ancestor
65706968|NCT03214510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65706969|NCT03214510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706970|NCT03214510|Sensory System Agents|sensory system agents|mesh-ancestor
65706971|NCT03214510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65706972|NCT03214510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65706973|NCT03214510|Narcotics|narcotics|mesh-ancestor
65706974|NCT03214510|Analgesics|analgesics|mesh-ancestor
65706975|NCT03214510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65706976|NCT03214510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65706977|NCT03214510|Anesthetics, General|anesthetics, general|mesh-ancestor
65706978|NCT02547766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65706979|NCT02547766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65706980|NCT04470531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65706981|NCT04470531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65706982|NCT04470531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65706983|NCT04470531|Renal Agents|renal agents|mesh-ancestor
65706984|NCT04470531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65706985|NCT04470531|Antimalarials|antimalarials|mesh-ancestor
65706986|NCT04470531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65706987|NCT04470531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65706988|NCT02286453|Diclofenac|diclofenac|mesh-list
65706989|NCT02286453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65706990|NCT02286453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65706991|NCT02286453|Analgesics|analgesics|mesh-ancestor
65706992|NCT02286453|Sensory System Agents|sensory system agents|mesh-ancestor
65706993|NCT02286453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65706994|NCT02286453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65706995|NCT02286453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65706996|NCT02286453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65706997|NCT02286453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65706998|NCT02286453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65706999|NCT02286453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707000|NCT02547454|Epoetin Alfa|epoetin alfa|mesh-list
65707001|NCT02547454|Hematinics|hematinics|mesh-ancestor
65707002|NCT00385515|Meclocycline|meclocycline|mesh-list
65707003|NCT00385515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65707004|NCT00385515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65707005|NCT02286609|Deflazacort|deflazacort|mesh-list
65707006|NCT02286609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65707007|NCT02286609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65707008|NCT02286609|Immunologic Factors|immunologic factors|mesh-ancestor
65707009|NCT02286609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707010|NCT00508989|Niacin|niacin|mesh-list
65707011|NCT00508989|Acetylcholine|acetylcholine|mesh-list
65707012|NCT00508989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65707013|NCT00508989|Antimetabolites|antimetabolites|mesh-ancestor
65707014|NCT00508989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707015|NCT00508989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65707016|NCT00508989|Vasodilator Agents|vasodilator agents|mesh-ancestor
65707017|NCT00508989|Vitamin B Complex|vitamin b complex|mesh-ancestor
65707018|NCT00508989|Vitamins|vitamins|mesh-ancestor
65707019|NCT00508989|Micronutrients|micronutrients|mesh-ancestor
65707020|NCT00508989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707021|NCT00508989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65707022|NCT00508989|Cholinergic Agents|cholinergic agents|mesh-ancestor
65707023|NCT00508989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65707024|NCT05457868|Albuterol|albuterol|mesh-list
65707025|NCT05457868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65707026|NCT05457868|Autonomic Agents|autonomic agents|mesh-ancestor
65707027|NCT05457868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022868|NCT02935933|Analgesics|analgesics|mesh-ancestor
65707028|NCT05457868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707029|NCT05457868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65707030|NCT05457868|Respiratory System Agents|respiratory system agents|mesh-ancestor
65707031|NCT05457868|Tocolytic Agents|tocolytic agents|mesh-ancestor
65707032|NCT05457868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65707033|NCT05457868|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65707034|NCT05457868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65707035|NCT05457868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65707036|NCT05457868|Adrenergic Agents|adrenergic agents|mesh-ancestor
65707037|NCT05457868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65707038|NCT05457868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707039|NCT02286687|Talazoparib|talazoparib|mesh-list
65707040|NCT02286687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65707041|NCT02286687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707042|NCT02286687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707043|NCT02286687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707044|NCT03104842|Dexamethasone|dexamethasone|mesh-list
65707045|NCT03104842|Lenalidomide|lenalidomide|mesh-list
65707046|NCT03104842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65707047|NCT03104842|Antiemetics|antiemetics|mesh-ancestor
65707048|NCT03104842|Autonomic Agents|autonomic agents|mesh-ancestor
65707049|NCT03104842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65707050|NCT03104842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707051|NCT03104842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65707052|NCT03104842|Glucocorticoids|glucocorticoids|mesh-ancestor
65707053|NCT03104842|Hormones|hormones|mesh-ancestor
65707054|NCT03104842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65707055|NCT03104842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65707056|NCT03104842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707057|NCT03104842|Immunologic Factors|immunologic factors|mesh-ancestor
65707058|NCT03104842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65707059|NCT03104842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65707060|NCT03104842|Growth Substances|growth substances|mesh-ancestor
65707061|NCT03104842|Growth Inhibitors|growth inhibitors|mesh-ancestor
65707062|NCT00436683|Sevelamer|sevelamer|mesh-list
65707063|NCT00436683|Chelating Agents|chelating agents|mesh-ancestor
65707064|NCT00436683|Sequestering Agents|sequestering agents|mesh-ancestor
65707065|NCT00436683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707066|NCT02498600|Nivolumab|nivolumab|mesh-list
65707067|NCT02498600|Ipilimumab|ipilimumab|mesh-list
65707068|NCT02498600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65707069|NCT02498600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707070|NCT02498600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65707071|NCT02498600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707072|NCT00434811|Sirolimus|sirolimus|mesh-list
65707073|NCT00434811|Etanercept|etanercept|mesh-list
65707074|NCT00434811|Tacrolimus|tacrolimus|mesh-list
65707075|NCT00434811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65707076|NCT00434811|Basiliximab|basiliximab|mesh-list
65707077|NCT00434811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65707078|NCT00434811|Immunologic Factors|immunologic factors|mesh-ancestor
65707079|NCT00434811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707080|NCT00434811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65707081|NCT00434811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707082|NCT00434811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707083|NCT00434811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65707084|NCT00434811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65707085|NCT00434811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65707086|NCT00434811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707087|NCT00434811|Antifungal Agents|antifungal agents|mesh-ancestor
65707088|NCT00434811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65707089|NCT00434811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65707090|NCT00434811|Analgesics|analgesics|mesh-ancestor
65707091|NCT00434811|Sensory System Agents|sensory system agents|mesh-ancestor
65707092|NCT00434811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65707093|NCT00434811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65707094|NCT00434811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65707095|NCT00434811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65707096|NCT03519256|Nivolumab|nivolumab|mesh-list
65707097|NCT03519256|Linrodostat|linrodostat|mesh-list
65707098|NCT03519256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65707099|NCT03519256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707100|NCT03519256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65707101|NCT03519256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707102|NCT03519256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022946|NCT00406172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707103|NCT03133845|Fentanyl|fentanyl|mesh-list
65707104|NCT03133845|Midazolam|midazolam|mesh-list
65707105|NCT03133845|Morphine|morphine|mesh-list
65707106|NCT03133845|Anesthetics|anesthetics|mesh-list
65707107|NCT03133845|Propofol|propofol|mesh-list
65707108|NCT03133845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65707109|NCT03133845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707110|NCT03133845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65707111|NCT03133845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65707112|NCT03133845|Anesthetics, General|anesthetics, general|mesh-ancestor
65707113|NCT03133845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65707114|NCT03133845|Narcotics|narcotics|mesh-ancestor
65707115|NCT03133845|Analgesics|analgesics|mesh-ancestor
65707116|NCT03133845|Sensory System Agents|sensory system agents|mesh-ancestor
65707117|NCT03133845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65707118|NCT03133845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65707119|NCT03133845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65707120|NCT03133845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65707121|NCT03133845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65707122|NCT03133845|GABA Modulators|gaba modulators|mesh-ancestor
65707123|NCT03133845|GABA Agents|gaba agents|mesh-ancestor
65707124|NCT03133845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65707125|NCT03133845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707126|NCT00120393|Ritonavir|ritonavir|mesh-list
65707127|NCT00120393|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65707128|NCT00120393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65707129|NCT00120393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65707130|NCT00120393|Protease Inhibitors|protease inhibitors|mesh-ancestor
65707131|NCT00120393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707132|NCT00120393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707133|NCT00120393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65707134|NCT00120393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65707135|NCT00120393|Antiviral Agents|antiviral agents|mesh-ancestor
65707136|NCT00120393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65707137|NCT00120393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65707138|NCT00120393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65707139|NCT05726019|Colchicine|colchicine|mesh-list
65707140|NCT05726019|Gout Suppressants|gout suppressants|mesh-ancestor
65707141|NCT05726019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65707142|NCT05726019|Tubulin Modulators|tubulin modulators|mesh-ancestor
65707143|NCT05726019|Antimitotic Agents|antimitotic agents|mesh-ancestor
65707144|NCT05726019|Mitosis Modulators|mitosis modulators|mesh-ancestor
65707145|NCT05726019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707146|NCT05726019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707147|NCT00116415|Lamivudine|lamivudine|mesh-list
65707148|NCT00116415|Efavirenz|efavirenz|mesh-list
65707149|NCT00116415|Didanosine|didanosine|mesh-list
65707150|NCT00116415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65707151|NCT00116415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65707152|NCT00116415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707153|NCT00116415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707154|NCT00116415|Antiviral Agents|antiviral agents|mesh-ancestor
65707155|NCT00116415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65707156|NCT00116415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65707157|NCT00116415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65707158|NCT00116415|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65707159|NCT00116415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65707160|NCT00116415|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65707161|NCT00116415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65707162|NCT00116415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65707163|NCT00116415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65707164|NCT00116415|Antimetabolites|antimetabolites|mesh-ancestor
65707165|NCT03207698|Metformin|metformin|mesh-list
65707166|NCT03207698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65707167|NCT03207698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707168|NCT03208712|Atezolizumab|atezolizumab|mesh-list
65707169|NCT03208712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707170|NCT03201380|Choline|choline|mesh-list
65707171|NCT03201380|Lipotropic Agents|lipotropic agents|mesh-ancestor
65707172|NCT03201380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65707173|NCT03201380|Antimetabolites|antimetabolites|mesh-ancestor
65707174|NCT03201380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707175|NCT03201380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65707176|NCT03201380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65707177|NCT03201380|Nootropic Agents|nootropic agents|mesh-ancestor
65707178|NCT03208556|Cyclophosphamide|cyclophosphamide|mesh-list
65707179|NCT03208556|Fludarabine|fludarabine|mesh-list
65707180|NCT03208556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65707181|NCT03208556|Immunologic Factors|immunologic factors|mesh-ancestor
65707182|NCT03208556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707183|NCT03208556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65707184|NCT03208556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65707185|NCT03208556|Alkylating Agents|alkylating agents|mesh-ancestor
65707186|NCT03208556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707187|NCT03208556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707188|NCT03208556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65707189|NCT03201146|Cisplatin|cisplatin|mesh-list
65707190|NCT03201146|Carboplatin|carboplatin|mesh-list
65707191|NCT03201146|Pemetrexed|pemetrexed|mesh-list
65707192|NCT03201146|Apatinib|apatinib|mesh-list
65707193|NCT03201146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707194|NCT03201146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707195|NCT03201146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707196|NCT03201146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65707197|NCT03201146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65707198|NCT03201146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65707199|NCT00370383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65707200|NCT00370383|Satraplatin|satraplatin|mesh-list
65707201|NCT00370383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707202|NCT00370383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65707203|NCT00370383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707204|NCT00370383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707205|NCT00367887|Ribavirin|ribavirin|mesh-list
65707206|NCT00367887|Interferon alpha-2|interferon alpha-2|mesh-list
65707207|NCT00367887|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65707208|NCT00367887|Interferon-alpha|interferon-alpha|mesh-list
65707209|NCT00367887|Antimetabolites|antimetabolites|mesh-ancestor
65707210|NCT00367887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707211|NCT00367887|Antiviral Agents|antiviral agents|mesh-ancestor
65707212|NCT00367887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65707213|NCT00367887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707214|NCT00367887|Immunologic Factors|immunologic factors|mesh-ancestor
65707215|NCT00367887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707216|NCT02547220|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
65707217|NCT02547220|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65707218|NCT02547220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65707219|NCT02547220|Immunologic Factors|immunologic factors|mesh-ancestor
65707220|NCT02547220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707221|NCT03207308|Vitamin A|vitamin a|mesh-list
65707222|NCT03207308|Vitamins|vitamins|mesh-ancestor
65707223|NCT03207308|Micronutrients|micronutrients|mesh-ancestor
65707224|NCT03207308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707225|NCT00366795|Satavaptan|satavaptan|mesh-list
65707226|NCT00366795|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65707227|NCT00366795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707228|NCT00366795|Natriuretic Agents|natriuretic agents|mesh-ancestor
65707229|NCT00366795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707230|NCT00422019|Rilotumumab|rilotumumab|mesh-list
65707231|NCT00422019|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65707232|NCT00422019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65707233|NCT00422019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707234|NCT00422019|Immunologic Factors|immunologic factors|mesh-ancestor
65707235|NCT00422019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707236|NCT03207542|Daratumumab|daratumumab|mesh-list
65707237|NCT03207542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707238|NCT00360867|Motesanib diphosphate|motesanib diphosphate|mesh-list
65707239|NCT00360867|Imetelstat|imetelstat|mesh-list
65707240|NCT00360867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65707241|NCT00360867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707242|NCT00360867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707243|NCT02287389|Mitomycins|mitomycins|mesh-list
65707244|NCT02287389|Mitomycin|mitomycin|mesh-list
65707245|NCT02287389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65707246|NCT02287389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707247|NCT02287389|Alkylating Agents|alkylating agents|mesh-ancestor
65707248|NCT02287389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707249|NCT02287389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65707250|NCT02287389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707251|NCT00057993|Trastuzumab|trastuzumab|mesh-list
65707252|NCT00057993|Exemestane|exemestane|mesh-list
65707253|NCT00057993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65707254|NCT00057993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023090|NCT02934022|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65707255|NCT00057993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65707256|NCT00057993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65707257|NCT00057993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707258|NCT00057993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707259|NCT00057993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65707260|NCT00057993|Hormone Antagonists|hormone antagonists|mesh-ancestor
65707261|NCT00057993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65707262|NCT00057993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707263|NCT02284737|Sildenafil Citrate|sildenafil citrate|mesh-list
65707264|NCT02284737|Vasodilator Agents|vasodilator agents|mesh-ancestor
65707265|NCT02284737|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65707266|NCT02284737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65707267|NCT02284737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707268|NCT02284737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707269|NCT02284737|Urological Agents|urological agents|mesh-ancestor
65707271|NCT02448290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707272|NCT02448290|Tubulin Modulators|tubulin modulators|mesh-ancestor
65707273|NCT02448290|Antimitotic Agents|antimitotic agents|mesh-ancestor
65707274|NCT02448290|Mitosis Modulators|mitosis modulators|mesh-ancestor
65707275|NCT02448290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707276|NCT00357279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65707277|NCT04484558|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65707278|NCT04484558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65707279|NCT04484558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65707280|NCT04484558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707281|NCT00055575|Scopolamine|scopolamine|mesh-list
65707282|NCT00055575|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65707283|NCT00055575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65707284|NCT00055575|Antiemetics|antiemetics|mesh-ancestor
65707285|NCT00055575|Autonomic Agents|autonomic agents|mesh-ancestor
65707286|NCT00055575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65707287|NCT00055575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707288|NCT00055575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65707289|NCT00055575|Mydriatics|mydriatics|mesh-ancestor
65707290|NCT00055575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65707291|NCT00055575|Cholinergic Agents|cholinergic agents|mesh-ancestor
65707292|NCT00055575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65707293|NCT00055575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707294|NCT00055575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65707295|NCT00055575|Parasympatholytics|parasympatholytics|mesh-ancestor
65707296|NCT00051129|Hydrocortisone|hydrocortisone|mesh-list
65707297|NCT00051129|Anecortave|anecortave|mesh-list
65707298|NCT00051129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65707299|NCT00051129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65707300|NCT00051129|Growth Substances|growth substances|mesh-ancestor
65707301|NCT00051129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707302|NCT00051129|Growth Inhibitors|growth inhibitors|mesh-ancestor
65707303|NCT00051129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707304|NCT00051129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65707305|NCT03200600|Dexamethasone|dexamethasone|mesh-list
65707306|NCT03200600|Dexamethasone acetate|dexamethasone acetate|mesh-list
65707307|NCT03200600|Flurbiprofen|flurbiprofen|mesh-list
65707308|NCT03200600|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
65707309|NCT03200600|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65707310|NCT03200600|BB 1101|bb 1101|mesh-list
65707311|NCT03200600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65707312|NCT03200600|Antiemetics|antiemetics|mesh-ancestor
65707313|NCT03200600|Autonomic Agents|autonomic agents|mesh-ancestor
65707314|NCT03200600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65707315|NCT03200600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707316|NCT03200600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65707317|NCT03200600|Glucocorticoids|glucocorticoids|mesh-ancestor
65707318|NCT03200600|Hormones|hormones|mesh-ancestor
65707319|NCT03200600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65707320|NCT03200600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65707321|NCT03200600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707322|NCT03200600|Protease Inhibitors|protease inhibitors|mesh-ancestor
65707323|NCT03200600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707324|NCT03200600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707325|NCT03200600|Analgesics|analgesics|mesh-ancestor
65707326|NCT03200600|Sensory System Agents|sensory system agents|mesh-ancestor
65707327|NCT03200600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65707328|NCT03200600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65707329|NCT03200600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65707330|NCT03200600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65707331|NCT01491893|Vaccines|vaccines|mesh-list
65707332|NCT01491893|Immunologic Factors|immunologic factors|mesh-ancestor
65707333|NCT01491893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707334|NCT00049959|Verteporfin|verteporfin|mesh-list
65707335|NCT00049959|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65707336|NCT00049959|Dermatologic Agents|dermatologic agents|mesh-ancestor
65707337|NCT03119324|Nimesulide|nimesulide|mesh-list
65707338|NCT03119324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65707339|NCT03119324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65707340|NCT03119324|Analgesics|analgesics|mesh-ancestor
65707341|NCT03119324|Sensory System Agents|sensory system agents|mesh-ancestor
65707342|NCT03119324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65707343|NCT03119324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707344|NCT03119324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65707345|NCT03119324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65707346|NCT03119324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65707347|NCT03119324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707348|NCT03119324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707349|NCT00415623|Amlodipine|amlodipine|mesh-list
65707350|NCT00415623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65707351|NCT00415623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65707352|NCT00415623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65707353|NCT00415623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707354|NCT00415623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65707355|NCT00415623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707356|NCT00415623|Vasodilator Agents|vasodilator agents|mesh-ancestor
65707357|NCT03133923|Vaccines|vaccines|mesh-list
65707358|NCT03133923|Immunologic Factors|immunologic factors|mesh-ancestor
65707359|NCT03133923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707360|NCT03134001|Analgesics|analgesics|mesh-list
65707361|NCT03134001|Sensory System Agents|sensory system agents|mesh-ancestor
65707362|NCT03134001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65707363|NCT03134001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707364|NCT01969409|Rituximab|rituximab|mesh-list
65707365|NCT01969409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65707366|NCT01969409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707367|NCT01969409|Immunologic Factors|immunologic factors|mesh-ancestor
65707368|NCT01969409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707369|NCT01969409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65707370|NCT05218577|Selenium|selenium|mesh-list
65707371|NCT05218577|Antioxidants|antioxidants|mesh-ancestor
65707372|NCT05218577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707373|NCT05218577|Protective Agents|protective agents|mesh-ancestor
65707374|NCT05218577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707375|NCT05218577|Trace Elements|trace elements|mesh-ancestor
65707376|NCT05218577|Micronutrients|micronutrients|mesh-ancestor
65707377|NCT00150813|Levetiracetam|levetiracetam|mesh-list
65707378|NCT00150813|Anticonvulsants|anticonvulsants|mesh-ancestor
65707379|NCT00150813|Nootropic Agents|nootropic agents|mesh-ancestor
65707380|NCT02712788|Milrinone|milrinone|mesh-list
65707381|NCT02712788|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65707382|NCT02712788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65707383|NCT02712788|Vasodilator Agents|vasodilator agents|mesh-ancestor
65707384|NCT02712788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65707385|NCT02712788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65707386|NCT02712788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707387|NCT02712788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707388|NCT02712788|Protective Agents|protective agents|mesh-ancestor
65707389|NCT02712788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707390|NCT00035529|Abatacept|abatacept|mesh-list
65707391|NCT00035529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65707392|NCT00035529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707393|NCT00035529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707394|NCT00035529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65707395|NCT00035529|Immunologic Factors|immunologic factors|mesh-ancestor
65707396|NCT00035529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707397|NCT00035529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65707398|NCT04470609|Vaccines|vaccines|mesh-list
65707399|NCT04470609|Immunologic Factors|immunologic factors|mesh-ancestor
65707400|NCT04470609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707401|NCT00356109|Insulin|insulin|mesh-list
65707402|NCT00356109|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65707403|NCT00356109|Insulin Glargine|insulin glargine|mesh-list
65707404|NCT00356109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65707405|NCT00356109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707406|NCT03206138|Imiquimod|imiquimod|mesh-list
65707407|NCT03206138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65707408|NCT03206138|Immunologic Factors|immunologic factors|mesh-ancestor
65707409|NCT03206138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707410|NCT03206138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707411|NCT03206138|Interferon Inducers|interferon inducers|mesh-ancestor
65707412|NCT04530305|Upadacitinib|upadacitinib|mesh-list
65707413|NCT04530305|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65707414|NCT04530305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65707415|NCT04530305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707416|NCT04530305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707417|NCT04530305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65707418|NCT00006225|Flt3 ligand protein|flt3 ligand protein|mesh-list
65707419|NCT00006225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65707420|NCT00006225|Immunologic Factors|immunologic factors|mesh-ancestor
65707421|NCT00006225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707422|NCT00006225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65707423|NCT00006225|Protective Agents|protective agents|mesh-ancestor
65707424|NCT00005595|Arsenic Trioxide|arsenic trioxide|mesh-list
65707425|NCT00005595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707426|NCT02447822|Thymoglobulin|thymoglobulin|mesh-list
65707427|NCT02447822|Immunologic Factors|immunologic factors|mesh-ancestor
65707428|NCT02447822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707429|NCT02447822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65707430|NCT04477265|Solifenacin Succinate|solifenacin succinate|mesh-list
65707431|NCT04477265|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65707432|NCT04477265|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65707433|NCT04477265|Cholinergic Agents|cholinergic agents|mesh-ancestor
65707434|NCT04477265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65707435|NCT04477265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707436|NCT04477265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707437|NCT04477265|Urological Agents|urological agents|mesh-ancestor
65707438|NCT00353457|Capecitabine|capecitabine|mesh-list
65707439|NCT00353457|Oxaliplatin|oxaliplatin|mesh-list
65707440|NCT00353457|Cetuximab|cetuximab|mesh-list
65707441|NCT00353457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65707442|NCT00353457|Antimetabolites|antimetabolites|mesh-ancestor
65707443|NCT00353457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707444|NCT00353457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707445|NCT00353457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65707446|NCT00411099|S 20098|s 20098|mesh-list
65707447|NCT00411099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65707448|NCT00411099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65707449|NCT00411099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707450|NCT03195530|Propofol|propofol|mesh-list
65707451|NCT03195530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65707452|NCT03195530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65707453|NCT03195530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707454|NCT03195530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65707455|NCT03195530|Anesthetics, General|anesthetics, general|mesh-ancestor
65707456|NCT03195530|Anesthetics|anesthetics|mesh-ancestor
65707457|NCT03195452|Raltegravir Potassium|raltegravir potassium|mesh-list
65707458|NCT03195452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
65707459|NCT03195452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65707460|NCT03195452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65707461|NCT03195452|Antiviral Agents|antiviral agents|mesh-ancestor
65707462|NCT03195452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65707463|NCT03195452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65707464|NCT03195452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65707465|NCT03195452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707466|NCT03195452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707467|NCT03195452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65707468|NCT00406809|Navitoclax|navitoclax|mesh-list
65707469|NCT00406809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707470|NCT03200210|Febuxostat|febuxostat|mesh-list
65707471|NCT03200210|Gout Suppressants|gout suppressants|mesh-ancestor
65707472|NCT03200210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65707473|NCT00004899|Etoposide|etoposide|mesh-list
65707474|NCT00004899|Busulfan|busulfan|mesh-list
65707475|NCT00004899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65707476|NCT00004899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707477|NCT00004899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65707478|NCT00004899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65707479|NCT00004899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707480|NCT00004899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707481|NCT00004899|Immunologic Factors|immunologic factors|mesh-ancestor
65707482|NCT00004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707483|NCT00004899|Alkylating Agents|alkylating agents|mesh-ancestor
65707484|NCT00004899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65707485|NCT00004899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65707486|NCT00004899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65707487|NCT03199976|Fluticasone|fluticasone|mesh-list
65707488|NCT03199976|Xhance|xhance|mesh-list
65707489|NCT03199976|Bromides|bromides|mesh-list
65707490|NCT03199976|Albuterol|albuterol|mesh-list
65707491|NCT03199976|Tiotropium Bromide|tiotropium bromide|mesh-list
65707492|NCT03199976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65707493|NCT03199976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65707494|NCT03199976|Autonomic Agents|autonomic agents|mesh-ancestor
65707495|NCT03199976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65707496|NCT03199976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707497|NCT03199976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65707498|NCT03199976|Respiratory System Agents|respiratory system agents|mesh-ancestor
65707499|NCT03199976|Dermatologic Agents|dermatologic agents|mesh-ancestor
65707500|NCT03199976|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65707501|NCT03199976|Parasympatholytics|parasympatholytics|mesh-ancestor
65707502|NCT03199976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65707503|NCT03199976|Cholinergic Agents|cholinergic agents|mesh-ancestor
65707504|NCT03199976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65707505|NCT03199976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707506|NCT03199976|Anticonvulsants|anticonvulsants|mesh-ancestor
65707507|NCT03199976|Tocolytic Agents|tocolytic agents|mesh-ancestor
65707508|NCT03199976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65707509|NCT03199976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65707510|NCT03199976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65707511|NCT03199976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65707512|NCT03199976|Adrenergic Agents|adrenergic agents|mesh-ancestor
65707513|NCT00369317|Cytarabine|cytarabine|mesh-list
65707514|NCT00369317|Etoposide|etoposide|mesh-list
65707515|NCT00369317|Daunorubicin|daunorubicin|mesh-list
65707516|NCT00369317|Etoposide phosphate|etoposide phosphate|mesh-list
65707517|NCT00369317|Asparaginase|asparaginase|mesh-list
65707518|NCT00369317|Thioguanine|thioguanine|mesh-list
65707519|NCT00369317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65707520|NCT00369317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707521|NCT00369317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65707522|NCT00369317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65707523|NCT00369317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707524|NCT00369317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707525|NCT00369317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65707526|NCT00369317|Antimetabolites|antimetabolites|mesh-ancestor
65707527|NCT00369317|Antiviral Agents|antiviral agents|mesh-ancestor
65707528|NCT00369317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65707529|NCT00369317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65707530|NCT00369317|Immunologic Factors|immunologic factors|mesh-ancestor
65707531|NCT00369317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707532|NCT00369317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65707533|NCT02447666|Azacitidine|azacitidine|mesh-list
65707534|NCT02447666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65707535|NCT02447666|Antimetabolites|antimetabolites|mesh-ancestor
65707536|NCT02447666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707537|NCT02447666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707538|NCT02447666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707539|NCT04469829|Methotrexate|methotrexate|mesh-list
65707540|NCT04469829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65707541|NCT04469829|Abortifacient Agents|abortifacient agents|mesh-ancestor
65707542|NCT04469829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65707543|NCT04469829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707544|NCT04469829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65707545|NCT04469829|Antimetabolites|antimetabolites|mesh-ancestor
65707546|NCT04469829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707547|NCT04469829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707548|NCT04469829|Dermatologic Agents|dermatologic agents|mesh-ancestor
65707549|NCT04469829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707550|NCT04469829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65707551|NCT04469829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65707552|NCT04469829|Immunologic Factors|immunologic factors|mesh-ancestor
65707553|NCT04469829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65023392|NCT02924974|Lidocaine|lidocaine|mesh-list
65707554|NCT04469829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65707555|NCT00405951|Docetaxel|docetaxel|mesh-list
65707556|NCT00405951|Obatoclax|obatoclax|mesh-list
65707557|NCT00405951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707558|NCT00405951|Tubulin Modulators|tubulin modulators|mesh-ancestor
65707559|NCT00405951|Antimitotic Agents|antimitotic agents|mesh-ancestor
65707560|NCT00405951|Mitosis Modulators|mitosis modulators|mesh-ancestor
65707561|NCT00405951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707562|NCT00405951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707563|NCT03194984|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65707564|NCT03194984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65707565|NCT03194984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65707566|NCT03669757|Betamethasone|betamethasone|mesh-list
65707567|NCT03669757|Betamethasone Valerate|betamethasone valerate|mesh-list
65707568|NCT03669757|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65707569|NCT03669757|Betamethasone benzoate|betamethasone benzoate|mesh-list
65707570|NCT03669757|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65707571|NCT03669757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65707572|NCT03669757|Glucocorticoids|glucocorticoids|mesh-ancestor
65707573|NCT03669757|Hormones|hormones|mesh-ancestor
65707574|NCT03669757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65170235|NCT02680951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65707575|NCT03669757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707576|NCT03669757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65707577|NCT03669757|Respiratory System Agents|respiratory system agents|mesh-ancestor
65707578|NCT02303821|Cytarabine|cytarabine|mesh-list
65707579|NCT02303821|Dexamethasone|dexamethasone|mesh-list
65707580|NCT02303821|Hydrocortisone|hydrocortisone|mesh-list
65707581|NCT02303821|Cyclophosphamide|cyclophosphamide|mesh-list
65707582|NCT02303821|Methotrexate|methotrexate|mesh-list
65707583|NCT02303821|Vincristine|vincristine|mesh-list
65707584|NCT02303821|Daunorubicin|daunorubicin|mesh-list
65707585|NCT02303821|Asparaginase|asparaginase|mesh-list
65707586|NCT02303821|Mitoxantrone|mitoxantrone|mesh-list
65707587|NCT02303821|Mercaptopurine|mercaptopurine|mesh-list
65707588|NCT02303821|Pegaspargase|pegaspargase|mesh-list
65707589|NCT02303821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65707590|NCT02303821|Immunologic Factors|immunologic factors|mesh-ancestor
65707591|NCT02303821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707592|NCT02303821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65707593|NCT02303821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65707594|NCT02303821|Alkylating Agents|alkylating agents|mesh-ancestor
65707595|NCT02303821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707596|NCT02303821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707597|NCT02303821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65707598|NCT02303821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65707599|NCT02303821|Antiemetics|antiemetics|mesh-ancestor
65707600|NCT02303821|Autonomic Agents|autonomic agents|mesh-ancestor
65707601|NCT02303821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65707602|NCT02303821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65707603|NCT02303821|Glucocorticoids|glucocorticoids|mesh-ancestor
65707604|NCT02303821|Hormones|hormones|mesh-ancestor
65707605|NCT02303821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65707606|NCT02303821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65707607|NCT02303821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65707608|NCT02303821|Abortifacient Agents|abortifacient agents|mesh-ancestor
65707609|NCT02303821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65707610|NCT02303821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65707611|NCT02303821|Antimetabolites|antimetabolites|mesh-ancestor
65707612|NCT02303821|Dermatologic Agents|dermatologic agents|mesh-ancestor
65707613|NCT02303821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707614|NCT02303821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65707615|NCT02303821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65707616|NCT02303821|Antiviral Agents|antiviral agents|mesh-ancestor
65707617|NCT02303821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65707618|NCT02303821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65707619|NCT02303821|Tubulin Modulators|tubulin modulators|mesh-ancestor
65707620|NCT02303821|Antimitotic Agents|antimitotic agents|mesh-ancestor
65707621|NCT02303821|Mitosis Modulators|mitosis modulators|mesh-ancestor
65707622|NCT02303821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65707623|NCT02303821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65707624|NCT02303821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65707625|NCT02303821|Analgesics|analgesics|mesh-ancestor
65707626|NCT02303821|Sensory System Agents|sensory system agents|mesh-ancestor
65707627|NCT03913091|Bupivacaine|bupivacaine|mesh-list
65707628|NCT03913091|Anesthetics, Local|anesthetics, local|mesh-ancestor
65707629|NCT03913091|Anesthetics|anesthetics|mesh-ancestor
65023467|NCT02923999|Antibodies|antibodies|mesh-list
65707630|NCT03913091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65707631|NCT03913091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707632|NCT03913091|Sensory System Agents|sensory system agents|mesh-ancestor
65707633|NCT03913091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65707634|NCT00330369|Darusentan|darusentan|mesh-list
65707635|NCT00330369|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65707636|NCT00330369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707637|NCT03199664|Tacrolimus|tacrolimus|mesh-list
65707638|NCT03199664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65707639|NCT03199664|Immunologic Factors|immunologic factors|mesh-ancestor
65707640|NCT03199664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707641|NCT03199664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65707642|NCT03199664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707643|NCT03199664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707644|NCT02447510|Mitogens|mitogens|mesh-list
65707645|NCT02447510|Mitosis Modulators|mitosis modulators|mesh-ancestor
65707646|NCT02447510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707647|NCT05674643|Acetaminophen|acetaminophen|mesh-list
65707648|NCT05674643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65707649|NCT05674643|Analgesics|analgesics|mesh-ancestor
65707650|NCT05674643|Sensory System Agents|sensory system agents|mesh-ancestor
65707651|NCT05674643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65707652|NCT05674643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707653|NCT05674643|Antipyretics|antipyretics|mesh-ancestor
65707654|NCT02149537|Hydroxyurea|hydroxyurea|mesh-list
65707655|NCT02149537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707656|NCT02149537|Antisickling Agents|antisickling agents|mesh-ancestor
65707657|NCT02149537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707658|NCT02149537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707659|NCT02149537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65707660|NCT03179917|Pembrolizumab|pembrolizumab|mesh-list
65707661|NCT03179917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65707662|NCT03179917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707663|NCT05216237|Oxaliplatin|oxaliplatin|mesh-list
65707664|NCT05216237|Apatinib|apatinib|mesh-list
65707665|NCT05216237|Tegafur|tegafur|mesh-list
65707666|NCT05216237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707667|NCT05216237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65707668|NCT05216237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707669|NCT05216237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707670|NCT05216237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65707671|NCT05216237|Antimetabolites|antimetabolites|mesh-ancestor
65707672|NCT00322257|Insulin|insulin|mesh-list
65707673|NCT00322257|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65707674|NCT00322257|Insulin Aspart|insulin aspart|mesh-list
65707675|NCT00322257|Insulin Detemir|insulin detemir|mesh-list
65707676|NCT00322257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65707677|NCT00322257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707678|NCT03674671|Ketamine|ketamine|mesh-list
65707679|NCT03674671|Analgesics|analgesics|mesh-ancestor
65707680|NCT03674671|Sensory System Agents|sensory system agents|mesh-ancestor
65707681|NCT03674671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65707682|NCT03674671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707683|NCT03674671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65707684|NCT03674671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65707685|NCT03674671|Anesthetics, General|anesthetics, general|mesh-ancestor
65707686|NCT03674671|Anesthetics|anesthetics|mesh-ancestor
65707687|NCT03674671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65707688|NCT03674671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65707689|NCT03674671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65707690|NCT03674671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65707691|NCT03674671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707692|NCT00312975|Tremelimumab|tremelimumab|mesh-list
65707693|NCT00312975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707694|NCT03199820|Dinoprostone|dinoprostone|mesh-list
65707695|NCT03199820|Oxytocics|oxytocics|mesh-ancestor
65707696|NCT03199820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65707697|NCT03199820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707698|NCT03199430|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65707699|NCT03199430|Antioxidants|antioxidants|mesh-ancestor
65707700|NCT03199430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707701|NCT03199430|Protective Agents|protective agents|mesh-ancestor
65707702|NCT03199430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707703|NCT03199430|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65707704|NCT03199430|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65707705|NCT03199430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707706|NCT03199430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65707707|NCT02287857|Tenofovir|tenofovir|mesh-list
65707708|NCT02287857|Antiviral Agents|antiviral agents|mesh-ancestor
65707709|NCT02287857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65707710|NCT02287857|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65707711|NCT02287857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65707713|NCT02287857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707714|NCT02287857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65707715|NCT02287857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65707716|NCT01318499|Nepafenac|nepafenac|mesh-list
65707717|NCT01318499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65707718|NCT01318499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65707719|NCT01318499|Analgesics|analgesics|mesh-ancestor
65707720|NCT01318499|Sensory System Agents|sensory system agents|mesh-ancestor
65707721|NCT01318499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65707722|NCT01318499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707723|NCT01318499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65707724|NCT01318499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65707725|NCT00397293|Topotecan|topotecan|mesh-list
65707726|NCT00397293|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65707727|NCT00397293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65707728|NCT00397293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707729|NCT00397293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707730|NCT00397293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707731|NCT03628079|Mebendazole|mebendazole|mesh-list
65707732|NCT03628079|Antinematodal Agents|antinematodal agents|mesh-ancestor
65707733|NCT03628079|Anthelmintics|anthelmintics|mesh-ancestor
65707734|NCT03628079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65707735|NCT03628079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65707736|NCT03628079|Tubulin Modulators|tubulin modulators|mesh-ancestor
65707737|NCT03628079|Antimitotic Agents|antimitotic agents|mesh-ancestor
65707738|NCT03628079|Mitosis Modulators|mitosis modulators|mesh-ancestor
65707739|NCT03628079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707740|NCT03628079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707741|NCT03204734|Capecitabine|capecitabine|mesh-list
65707742|NCT03204734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65707743|NCT03204734|Antimetabolites|antimetabolites|mesh-ancestor
65707744|NCT03204734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707745|NCT03204734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707746|NCT00396357|Metformin|metformin|mesh-list
65707747|NCT00396357|Vildagliptin|vildagliptin|mesh-list
65707748|NCT00396357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65707749|NCT00396357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707750|NCT00396357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65707751|NCT00396357|Protease Inhibitors|protease inhibitors|mesh-ancestor
65707752|NCT00396357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707753|NCT00396357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707754|NCT00394563|Tanezumab|tanezumab|mesh-list
65707755|NCT00394563|Analgesics|analgesics|mesh-ancestor
65707756|NCT00394563|Sensory System Agents|sensory system agents|mesh-ancestor
65707757|NCT00394563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65707758|NCT00394563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707759|NCT02446730|Clopidogrel|clopidogrel|mesh-list
65707760|NCT02446730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65707761|NCT02446730|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65707762|NCT02446730|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65707763|NCT02446730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65707764|NCT02446730|Purinergic Agents|purinergic agents|mesh-ancestor
65707765|NCT02446730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65707766|NCT02446730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707767|NCT02446730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707768|NCT02449538|Everolimus|everolimus|mesh-list
65707769|NCT02449538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707770|NCT02449538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65707771|NCT02449538|Immunologic Factors|immunologic factors|mesh-ancestor
65707772|NCT02449538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707773|NCT02446652|Paclitaxel|paclitaxel|mesh-list
65707774|NCT02446652|Carboplatin|carboplatin|mesh-list
65707775|NCT02446652|Hydralazine|hydralazine|mesh-list
65707776|NCT02446652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65707777|NCT02446652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707778|NCT02446652|Tubulin Modulators|tubulin modulators|mesh-ancestor
65707779|NCT02446652|Antimitotic Agents|antimitotic agents|mesh-ancestor
65707780|NCT02446652|Mitosis Modulators|mitosis modulators|mesh-ancestor
65023610|NCT04689100|Fluorouracil|fluorouracil|mesh-list
65707781|NCT02446652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707782|NCT02446652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65707783|NCT02446652|Vasodilator Agents|vasodilator agents|mesh-ancestor
65707784|NCT00299715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65707785|NCT00299715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65707786|NCT00299715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65707787|NCT00299715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65707788|NCT00299715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707789|NCT00299715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65707790|NCT00299715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65707791|NCT00299715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65707792|NCT00299715|Serotonin Agents|serotonin agents|mesh-ancestor
65707793|NCT00299715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65707794|NCT00299715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707795|NCT00299715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65707796|NCT00299715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65707797|NCT00299715|Dopamine Agents|dopamine agents|mesh-ancestor
65707798|NCT00299325|Rimonabant|rimonabant|mesh-list
65707799|NCT00299325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65707800|NCT00299325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65707801|NCT00299325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65707802|NCT00299325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65707803|NCT00299325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707804|NCT00299325|Hormones|hormones|mesh-ancestor
65707805|NCT00299325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65707806|NCT00299325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707807|NCT00391209|Insulin|insulin|mesh-list
65707808|NCT00391209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65707809|NCT00391209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65707810|NCT00391209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707811|NCT02446574|Paclitaxel|paclitaxel|mesh-list
65707812|NCT02446574|Cisplatin|cisplatin|mesh-list
65707813|NCT02446574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65707814|NCT02446574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707815|NCT02446574|Tubulin Modulators|tubulin modulators|mesh-ancestor
65707816|NCT02446574|Antimitotic Agents|antimitotic agents|mesh-ancestor
65707817|NCT02446574|Mitosis Modulators|mitosis modulators|mesh-ancestor
65707818|NCT02446574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707819|NCT01775813|Metformin|metformin|mesh-list
65707820|NCT01775813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65707821|NCT01775813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707822|NCT00287547|Abatacept|abatacept|mesh-list
65707823|NCT00287547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65707824|NCT00287547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707825|NCT00287547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707826|NCT00287547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65707827|NCT00287547|Immunologic Factors|immunologic factors|mesh-ancestor
65707828|NCT00287547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707829|NCT00287547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65707830|NCT03204578|Midazolam|midazolam|mesh-list
65707831|NCT03204578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65707832|NCT03204578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65707833|NCT03204578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65707834|NCT03204578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707835|NCT03204578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65707836|NCT03204578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65707837|NCT03204578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65707838|NCT03204578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65707839|NCT03204578|Anesthetics, General|anesthetics, general|mesh-ancestor
65707840|NCT03204578|Anesthetics|anesthetics|mesh-ancestor
65707841|NCT03204578|GABA Modulators|gaba modulators|mesh-ancestor
65707842|NCT03204578|GABA Agents|gaba agents|mesh-ancestor
65707843|NCT03204578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65707844|NCT03204578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707845|NCT01694069|Tazobactam|tazobactam|mesh-list
65707846|NCT01694069|Piperacillin|piperacillin|mesh-list
65707847|NCT01694069|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65707848|NCT01694069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65707849|NCT01694069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65707850|NCT01694069|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65707851|NCT01694069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707852|NCT01694069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707853|NCT03204032|Thalidomide|thalidomide|mesh-list
65707854|NCT03204032|Temozolomide|temozolomide|mesh-list
65707855|NCT03204032|Tegafur|tegafur|mesh-list
65707856|NCT03204032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65707857|NCT03204032|Alkylating Agents|alkylating agents|mesh-ancestor
65707858|NCT03204032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707859|NCT03204032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707860|NCT03204032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65707861|NCT03204032|Immunologic Factors|immunologic factors|mesh-ancestor
65707862|NCT03204032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707863|NCT03204032|Leprostatic Agents|leprostatic agents|mesh-ancestor
65707864|NCT03204032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65707865|NCT03204032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65707866|NCT03204032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65707867|NCT03204032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65707868|NCT03204032|Growth Substances|growth substances|mesh-ancestor
65707869|NCT03204032|Growth Inhibitors|growth inhibitors|mesh-ancestor
65707870|NCT03204032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65707871|NCT03204032|Antimetabolites|antimetabolites|mesh-ancestor
65707872|NCT02285751|Aspirin|aspirin|mesh-list
65707873|NCT02285751|Clopidogrel|clopidogrel|mesh-list
65707874|NCT02285751|Ticagrelor|ticagrelor|mesh-list
65707875|NCT02285751|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65707876|NCT02285751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65707877|NCT02285751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65707878|NCT02285751|Analgesics|analgesics|mesh-ancestor
65707879|NCT02285751|Sensory System Agents|sensory system agents|mesh-ancestor
65707880|NCT02285751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65707881|NCT02285751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707882|NCT02285751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65707883|NCT02285751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65707884|NCT02285751|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65707885|NCT02285751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65707886|NCT02285751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707887|NCT02285751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65707888|NCT02285751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65707889|NCT02285751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707890|NCT02285751|Antipyretics|antipyretics|mesh-ancestor
65707891|NCT02285751|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65707892|NCT02285751|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65707893|NCT02285751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65707894|NCT02285751|Purinergic Agents|purinergic agents|mesh-ancestor
65707895|NCT02285751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65707896|NCT05114915|Docetaxel|docetaxel|mesh-list
65707897|NCT05114915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707898|NCT05114915|Tubulin Modulators|tubulin modulators|mesh-ancestor
65707899|NCT05114915|Antimitotic Agents|antimitotic agents|mesh-ancestor
65707900|NCT05114915|Mitosis Modulators|mitosis modulators|mesh-ancestor
65707901|NCT05114915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707902|NCT03532035|Brincidofovir|brincidofovir|mesh-list
65707903|NCT03532035|Antiviral Agents|antiviral agents|mesh-ancestor
65707904|NCT03532035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65707905|NCT05724849|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65707906|NCT05724849|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65707907|NCT05724849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65707908|NCT05724849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65707909|NCT05724849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707910|NCT05724849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65707911|NCT05724849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707912|NCT05724849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65707913|NCT05724849|Antidepressive Agents|antidepressive agents|mesh-ancestor
65707914|NCT05724849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65707915|NCT00282867|Insulin|insulin|mesh-list
65707916|NCT00282867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65707917|NCT00282867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707918|NCT03198338|Bupivacaine|bupivacaine|mesh-list
65707919|NCT03198338|Anesthetics, Local|anesthetics, local|mesh-ancestor
65707920|NCT03198338|Anesthetics|anesthetics|mesh-ancestor
65707921|NCT03198338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65707922|NCT03198338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707923|NCT03198338|Sensory System Agents|sensory system agents|mesh-ancestor
65707924|NCT03198338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65707925|NCT05222633|Ranibizumab|ranibizumab|mesh-list
65707926|NCT05222633|Aflibercept|aflibercept|mesh-list
65707927|NCT05222633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65707928|NCT05222633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65707929|NCT05222633|Growth Substances|growth substances|mesh-ancestor
65707930|NCT05222633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707931|NCT05222633|Growth Inhibitors|growth inhibitors|mesh-ancestor
65707932|NCT05222633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707933|NCT05222243|Calcium|calcium|mesh-list
65707934|NCT05222243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65707935|NCT05222243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707936|NCT04469283|Caffeine|caffeine|mesh-list
65707937|NCT04469283|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65707938|NCT04469283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707939|NCT04469283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65707940|NCT04469283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707941|NCT04469283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707942|NCT04469283|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65707943|NCT04469283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65707944|NCT04469283|Purinergic Agents|purinergic agents|mesh-ancestor
65707945|NCT04469283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65707946|NCT02285829|Bromides|bromides|mesh-list
65707947|NCT02285829|Rocuronium|rocuronium|mesh-list
65707948|NCT02285829|Cisatracurium|cisatracurium|mesh-list
65707949|NCT02285829|Anticonvulsants|anticonvulsants|mesh-ancestor
65707950|NCT02285829|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65707951|NCT02285829|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65707952|NCT02285829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65707953|NCT02285829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65707954|NCT02285829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707955|NCT03203408|Hylan|hylan|mesh-list
65707956|NCT03203408|Viscosupplements|viscosupplements|mesh-ancestor
65707957|NCT03203408|Protective Agents|protective agents|mesh-ancestor
65707958|NCT03203408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707959|NCT02285985|Saxagliptin|saxagliptin|mesh-list
65707960|NCT02285985|Incretins|incretins|mesh-ancestor
65707961|NCT02285985|Hormones|hormones|mesh-ancestor
65707962|NCT02285985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65707963|NCT02285985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707964|NCT02285985|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65707965|NCT02285985|Protease Inhibitors|protease inhibitors|mesh-ancestor
65707966|NCT02285985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707967|NCT02285985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707968|NCT02285985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65707969|NCT02445872|Dexamethasone|dexamethasone|mesh-list
65707970|NCT02445872|Aprepitant|aprepitant|mesh-list
65707971|NCT02445872|Palonosetron|palonosetron|mesh-list
65707972|NCT02445872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65707973|NCT02445872|Antiemetics|antiemetics|mesh-ancestor
65707974|NCT02445872|Autonomic Agents|autonomic agents|mesh-ancestor
65707975|NCT02445872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65707976|NCT02445872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65707977|NCT02445872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65707978|NCT02445872|Glucocorticoids|glucocorticoids|mesh-ancestor
65707979|NCT02445872|Hormones|hormones|mesh-ancestor
65707980|NCT02445872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65707981|NCT02445872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65707982|NCT02445872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707983|NCT02445872|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65707984|NCT02445872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65707985|NCT02445872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707986|NCT02445872|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65707987|NCT02445872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65707988|NCT02445872|Serotonin Agents|serotonin agents|mesh-ancestor
65707989|NCT05221775|Lenvatinib|lenvatinib|mesh-list
65707990|NCT05221775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65707991|NCT05221775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65707992|NCT05221775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65707993|NCT05221775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65707994|NCT04700423|Ivermectin|ivermectin|mesh-list
65707995|NCT04700423|Albendazole|albendazole|mesh-list
65707996|NCT04700423|Moxidectin|moxidectin|mesh-list
65707997|NCT04700423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65707998|NCT04700423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65707999|NCT04700423|Anthelmintics|anthelmintics|mesh-ancestor
65708000|NCT04700423|Anticestodal Agents|anticestodal agents|mesh-ancestor
65708001|NCT04700423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65708002|NCT04700423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65708003|NCT04700423|Tubulin Modulators|tubulin modulators|mesh-ancestor
65708004|NCT04700423|Antimitotic Agents|antimitotic agents|mesh-ancestor
65708005|NCT04700423|Mitosis Modulators|mitosis modulators|mesh-ancestor
65708006|NCT04700423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708007|NCT04700423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708008|NCT04700423|Antinematodal Agents|antinematodal agents|mesh-ancestor
65708009|NCT02286219|Immunoglobulins|immunoglobulins|mesh-list
65708010|NCT02286219|Immunoglobulin G|immunoglobulin g|mesh-list
65708011|NCT02286219|Immunologic Factors|immunologic factors|mesh-ancestor
65708012|NCT02286219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708013|NCT02445716|Methyltestosterone|methyltestosterone|mesh-list
65708014|NCT02445716|Testosterone|testosterone|mesh-list
65708015|NCT02445716|Testosterone undecanoate|testosterone undecanoate|mesh-list
65708016|NCT02445716|Testosterone enanthate|testosterone enanthate|mesh-list
65708017|NCT02445716|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65708018|NCT02445716|Androgens|androgens|mesh-ancestor
65708019|NCT02445716|Hormones|hormones|mesh-ancestor
65708020|NCT02445716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65708021|NCT02445716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708022|NCT02445716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65708023|NCT02445716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708024|NCT02445716|Anabolic Agents|anabolic agents|mesh-ancestor
65708025|NCT03197636|Pembrolizumab|pembrolizumab|mesh-list
65708026|NCT03197636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65708027|NCT03197636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708028|NCT05724381|Phenol|phenol|mesh-list
65708029|NCT05724381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65708030|NCT05724381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65708031|NCT05724381|Disinfectants|disinfectants|mesh-ancestor
65708032|NCT05724381|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65708033|NCT05724381|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65708034|NCT03194594|Dexamethasone|dexamethasone|mesh-list
65708035|NCT03194594|Ketamine|ketamine|mesh-list
65708036|NCT03194594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65708037|NCT03194594|Antiemetics|antiemetics|mesh-ancestor
65708038|NCT03194594|Autonomic Agents|autonomic agents|mesh-ancestor
65708039|NCT03194594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65708040|NCT03194594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708041|NCT03194594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65708042|NCT03194594|Glucocorticoids|glucocorticoids|mesh-ancestor
65708043|NCT03194594|Hormones|hormones|mesh-ancestor
65708044|NCT03194594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65708045|NCT03194594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65708046|NCT03194594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708047|NCT03194594|Analgesics|analgesics|mesh-ancestor
65708048|NCT03194594|Sensory System Agents|sensory system agents|mesh-ancestor
65708049|NCT03194594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65708050|NCT03194594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65708051|NCT03194594|Anesthetics, General|anesthetics, general|mesh-ancestor
65708052|NCT03194594|Anesthetics|anesthetics|mesh-ancestor
65708053|NCT03194594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65708054|NCT03194594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65708055|NCT03194594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65708056|NCT03194594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65708057|NCT03194594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708058|NCT04407377|Cyclobenzaprine|cyclobenzaprine|mesh-list
65708059|NCT04407377|Tolperisone|tolperisone|mesh-list
65708060|NCT04407377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65708061|NCT04407377|Antidepressive Agents|antidepressive agents|mesh-ancestor
65708062|NCT04407377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65708063|NCT04407377|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65708064|NCT04407377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708065|NCT04407377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65708066|NCT04407377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65708067|NCT04407377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65708068|NCT04407377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65708069|NCT03203174|Botulinum Toxins|botulinum toxins|mesh-list
65708070|NCT03203174|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65708071|NCT03203174|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65708072|NCT03203174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65708073|NCT03203174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65708074|NCT03203174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708075|NCT03203174|Cholinergic Agents|cholinergic agents|mesh-ancestor
65708076|NCT03203174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65708077|NCT03203174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708078|NCT03203174|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65708079|NCT03203174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65708080|NCT00257205|Temozolomide|temozolomide|mesh-list
65708081|NCT00257205|Dacarbazine|dacarbazine|mesh-list
65708082|NCT00257205|Tremelimumab|tremelimumab|mesh-list
65708083|NCT00257205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65708084|NCT00257205|Alkylating Agents|alkylating agents|mesh-ancestor
65708085|NCT00257205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708086|NCT00257205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708087|NCT03194204|Doxycycline|doxycycline|mesh-list
65708088|NCT03194204|Uric Acid|uric acid|mesh-list
65708089|NCT03194204|Rheumatoid Factor|rheumatoid factor|mesh-list
65708090|NCT03194204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65708091|NCT03194204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65708092|NCT03194204|Antimalarials|antimalarials|mesh-ancestor
65708093|NCT03194204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65708094|NCT03194204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65708095|NCT03194204|Antioxidants|antioxidants|mesh-ancestor
65708096|NCT03194204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708097|NCT03194204|Protective Agents|protective agents|mesh-ancestor
65708098|NCT03194204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708099|NCT03194204|Immunologic Factors|immunologic factors|mesh-ancestor
65708100|NCT04045301|Omalizumab|omalizumab|mesh-list
65708101|NCT04045301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65708102|NCT04045301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65708103|NCT04045301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65708104|NCT04045301|Respiratory System Agents|respiratory system agents|mesh-ancestor
65708105|NCT04045301|Immunologic Factors|immunologic factors|mesh-ancestor
65708106|NCT04045301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708107|NCT03197480|Aflibercept|aflibercept|mesh-list
65708108|NCT03197480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65708109|NCT03197480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65708110|NCT03197480|Growth Substances|growth substances|mesh-ancestor
65708111|NCT03197480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708112|NCT03197480|Growth Inhibitors|growth inhibitors|mesh-ancestor
65708113|NCT03197480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708114|NCT00151281|Thalidomide|thalidomide|mesh-list
65708115|NCT00151281|Prednisone|prednisone|mesh-list
65708116|NCT00151281|Cyclophosphamide|cyclophosphamide|mesh-list
65708117|NCT00151281|Rituximab|rituximab|mesh-list
65708118|NCT00151281|Etoposide|etoposide|mesh-list
65708119|NCT00151281|Procarbazine|procarbazine|mesh-list
65708120|NCT00151281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65708121|NCT00151281|Immunologic Factors|immunologic factors|mesh-ancestor
65708122|NCT00151281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708123|NCT00151281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65708124|NCT00151281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65708125|NCT00151281|Alkylating Agents|alkylating agents|mesh-ancestor
65708126|NCT00151281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708127|NCT00151281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708128|NCT00151281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65708129|NCT00151281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65708130|NCT00151281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65708131|NCT00151281|Glucocorticoids|glucocorticoids|mesh-ancestor
65708132|NCT00151281|Hormones|hormones|mesh-ancestor
65708133|NCT00151281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65708134|NCT00151281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65708135|NCT00151281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65708136|NCT00151281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65708137|NCT00151281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65708138|NCT00151281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708139|NCT00151281|Leprostatic Agents|leprostatic agents|mesh-ancestor
65708140|NCT00151281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65708141|NCT00151281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65708142|NCT00151281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65708143|NCT00151281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65708144|NCT00151281|Growth Substances|growth substances|mesh-ancestor
65708145|NCT00151281|Growth Inhibitors|growth inhibitors|mesh-ancestor
65708146|NCT03202862|Fulvestrant|fulvestrant|mesh-list
65708147|NCT03202862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65708148|NCT03202862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708149|NCT03202862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65708150|NCT03202862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65708151|NCT03202862|Hormone Antagonists|hormone antagonists|mesh-ancestor
65708152|NCT03202862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65708153|NCT03202862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708154|NCT00255099|Etravirine|etravirine|mesh-list
65023992|NCT04788823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708155|NCT00255099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65708156|NCT00255099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65708157|NCT00255099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708158|NCT00255099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708159|NCT00255099|Antiviral Agents|antiviral agents|mesh-ancestor
65708160|NCT00255099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65708161|NCT00231153|Povidone-Iodine|povidone-iodine|mesh-list
65708162|NCT00231153|Povidone|povidone|mesh-list
65708163|NCT00231153|Plasma Substitutes|plasma substitutes|mesh-ancestor
65708164|NCT00231153|Blood Substitutes|blood substitutes|mesh-ancestor
65708165|NCT00231153|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65708166|NCT00231153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65708167|NCT03202784|Berotralstat|berotralstat|mesh-list
65708168|NCT03202784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708169|NCT03202784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708170|NCT05220527|Triamcinolone|triamcinolone|mesh-list
65708171|NCT05220527|Hyaluronic Acid|hyaluronic acid|mesh-list
65708172|NCT05220527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65708173|NCT05220527|Glucocorticoids|glucocorticoids|mesh-ancestor
65708174|NCT05220527|Hormones|hormones|mesh-ancestor
65708175|NCT05220527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65708176|NCT05220527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708177|NCT05220527|Immunologic Factors|immunologic factors|mesh-ancestor
65708178|NCT05220527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65708179|NCT05220527|Viscosupplements|viscosupplements|mesh-ancestor
65708180|NCT05220527|Protective Agents|protective agents|mesh-ancestor
65708181|NCT03197402|Caseins|caseins|mesh-list
65708182|NCT03197402|Chelating Agents|chelating agents|mesh-ancestor
65708183|NCT03197402|Sequestering Agents|sequestering agents|mesh-ancestor
65708184|NCT03197402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708185|NCT05723991|Gemcitabine|gemcitabine|mesh-list
65708186|NCT05723991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65708187|NCT05723991|Antimetabolites|antimetabolites|mesh-ancestor
65708188|NCT05723991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708189|NCT05723991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708190|NCT05723991|Antiviral Agents|antiviral agents|mesh-ancestor
65708191|NCT05723991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65708192|NCT05723991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708193|NCT05723991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65708194|NCT05723991|Immunologic Factors|immunologic factors|mesh-ancestor
65708195|NCT05723991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708196|NCT05681039|Carboplatin|carboplatin|mesh-list
65708197|NCT05681039|Atezolizumab|atezolizumab|mesh-list
65708198|NCT05681039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708199|NCT04263831|Aldesleukin|aldesleukin|mesh-list
65708200|NCT04263831|Interleukin-2|interleukin-2|mesh-list
65708201|NCT04263831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708202|NCT04263831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65708203|NCT04263831|Analgesics|analgesics|mesh-ancestor
65708204|NCT04263831|Sensory System Agents|sensory system agents|mesh-ancestor
65708205|NCT04263831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65708206|NCT04263831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708207|NCT04263831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65708208|NCT04263831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65708209|NCT04263831|Antiviral Agents|antiviral agents|mesh-ancestor
65708210|NCT04263831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65708211|NCT01318109|Metformin|metformin|mesh-list
65708212|NCT01318109|Alogliptin|alogliptin|mesh-list
65708213|NCT01318109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65708214|NCT01318109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708215|NCT01318109|Incretins|incretins|mesh-ancestor
65708216|NCT01318109|Hormones|hormones|mesh-ancestor
65708217|NCT01318109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65708218|NCT01318109|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65708219|NCT01318109|Protease Inhibitors|protease inhibitors|mesh-ancestor
65708220|NCT01318109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708221|NCT01318109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708222|NCT05721027|Dexamethasone|dexamethasone|mesh-list
65708223|NCT05721027|Ibuprofen|ibuprofen|mesh-list
65708224|NCT05721027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65708225|NCT05721027|Antiemetics|antiemetics|mesh-ancestor
65708226|NCT05721027|Autonomic Agents|autonomic agents|mesh-ancestor
65708227|NCT05721027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65708228|NCT05721027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708229|NCT05721027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65708230|NCT05721027|Glucocorticoids|glucocorticoids|mesh-ancestor
65708231|NCT05721027|Hormones|hormones|mesh-ancestor
65708232|NCT05721027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65708233|NCT05721027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65708234|NCT05721027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708235|NCT05721027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65708236|NCT05721027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65708237|NCT05721027|Analgesics|analgesics|mesh-ancestor
65708238|NCT05721027|Sensory System Agents|sensory system agents|mesh-ancestor
65708239|NCT05721027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65708240|NCT05721027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65708241|NCT05721027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708242|NCT05721027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708244|NCT05720871|Antipruritics|antipruritics|mesh-ancestor
65708245|NCT05720871|Dermatologic Agents|dermatologic agents|mesh-ancestor
65708246|NCT05720871|Sensory System Agents|sensory system agents|mesh-ancestor
65708247|NCT05720871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65708248|NCT05720871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708249|NCT05672927|Vaccines|vaccines|mesh-list
65708250|NCT05672927|Immunologic Factors|immunologic factors|mesh-ancestor
65708251|NCT05672927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708252|NCT05636267|Carboplatin|carboplatin|mesh-list
65708253|NCT05636267|Pemetrexed|pemetrexed|mesh-list
65708254|NCT05636267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708255|NCT05636267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708256|NCT05636267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708257|NCT05636267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65708258|NCT05636267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65708259|NCT03873311|Cytarabine|cytarabine|mesh-list
65708260|NCT03873311|Azacitidine|azacitidine|mesh-list
65708261|NCT03873311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65708262|NCT03873311|Antimetabolites|antimetabolites|mesh-ancestor
65708263|NCT03873311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708264|NCT03873311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708265|NCT03873311|Antiviral Agents|antiviral agents|mesh-ancestor
65708266|NCT03873311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65708267|NCT03873311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65708268|NCT03873311|Immunologic Factors|immunologic factors|mesh-ancestor
65708269|NCT03873311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708270|NCT03873311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708271|NCT04789499|Theophylline|theophylline|mesh-list
65708272|NCT04789499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65708273|NCT04789499|Autonomic Agents|autonomic agents|mesh-ancestor
65708274|NCT04789499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65708275|NCT04789499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708276|NCT04789499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65708277|NCT04789499|Respiratory System Agents|respiratory system agents|mesh-ancestor
65708278|NCT04789499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65708279|NCT04789499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708280|NCT04789499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708281|NCT04789499|Vasodilator Agents|vasodilator agents|mesh-ancestor
65708282|NCT04789499|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65708283|NCT04789499|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65708284|NCT04789499|Purinergic Agents|purinergic agents|mesh-ancestor
65708285|NCT04789499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65708286|NCT00162279|Abatacept|abatacept|mesh-list
65708287|NCT00162279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65708288|NCT00162279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708289|NCT00162279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708290|NCT00162279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65708291|NCT00162279|Immunologic Factors|immunologic factors|mesh-ancestor
65708292|NCT00162279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708293|NCT00162279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65708294|NCT00145431|Atorvastatin|atorvastatin|mesh-list
65708295|NCT00145431|Torcetrapib|torcetrapib|mesh-list
65708296|NCT00145431|Fenofibrate|fenofibrate|mesh-list
65708297|NCT00145431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65708298|NCT00145431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65708299|NCT00145431|Antimetabolites|antimetabolites|mesh-ancestor
65708300|NCT00145431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708301|NCT00145431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65708302|NCT00145431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65708303|NCT00145431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708304|NCT00135369|Lamivudine|lamivudine|mesh-list
65708305|NCT00135369|Efavirenz|efavirenz|mesh-list
65708306|NCT00135369|Stavudine|stavudine|mesh-list
65708307|NCT00135369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65708308|NCT00135369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65708309|NCT00135369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708310|NCT00135369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708312|NCT00135369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65708313|NCT00135369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65708314|NCT00135369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65708315|NCT00135369|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65708316|NCT00135369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65708317|NCT00135369|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65708318|NCT00135369|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65708319|NCT00135369|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65708320|NCT00135369|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65708321|NCT00135369|Antimetabolites|antimetabolites|mesh-ancestor
65708322|NCT03530319|Azithromycin|azithromycin|mesh-list
65708323|NCT03530319|Doxycycline|doxycycline|mesh-list
65708324|NCT03530319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65708325|NCT03530319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65708326|NCT03530319|Antimalarials|antimalarials|mesh-ancestor
65708327|NCT03530319|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65708328|NCT03530319|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65708329|NCT05726253|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65708330|NCT05726253|Amoxicillin|amoxicillin|mesh-list
65708331|NCT05726253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65708332|NCT02445404|Dexamethasone|dexamethasone|mesh-list
65708333|NCT02445404|Prednisone|prednisone|mesh-list
65708334|NCT02445404|Cyclophosphamide|cyclophosphamide|mesh-list
65708335|NCT02445404|Ifosfamide|ifosfamide|mesh-list
65708336|NCT02445404|Carboplatin|carboplatin|mesh-list
65708337|NCT02445404|Etoposide|etoposide|mesh-list
65708338|NCT02445404|Vincristine|vincristine|mesh-list
65708339|NCT02445404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65708340|NCT02445404|Immunologic Factors|immunologic factors|mesh-ancestor
65708341|NCT02445404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708342|NCT02445404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65708343|NCT02445404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65708344|NCT02445404|Alkylating Agents|alkylating agents|mesh-ancestor
65708345|NCT02445404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708346|NCT02445404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708347|NCT02445404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65708348|NCT02445404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65708349|NCT02445404|Antiemetics|antiemetics|mesh-ancestor
65708350|NCT02445404|Autonomic Agents|autonomic agents|mesh-ancestor
65708351|NCT02445404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65708352|NCT02445404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65708353|NCT02445404|Glucocorticoids|glucocorticoids|mesh-ancestor
65708354|NCT02445404|Hormones|hormones|mesh-ancestor
65708355|NCT02445404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65708356|NCT02445404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65708357|NCT02445404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708358|NCT02445404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65708359|NCT02445404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65708360|NCT02445404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65708361|NCT02445404|Tubulin Modulators|tubulin modulators|mesh-ancestor
65708362|NCT02445404|Antimitotic Agents|antimitotic agents|mesh-ancestor
65708363|NCT02445404|Mitosis Modulators|mitosis modulators|mesh-ancestor
65708364|NCT03530085|Fludarabine|fludarabine|mesh-list
65708365|NCT03530085|Busulfan|busulfan|mesh-list
65708366|NCT03530085|Decitabine|decitabine|mesh-list
65708367|NCT03530085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708368|NCT03530085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65708369|NCT03530085|Antimetabolites|antimetabolites|mesh-ancestor
65708370|NCT03530085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708371|NCT03530085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65708372|NCT03530085|Immunologic Factors|immunologic factors|mesh-ancestor
65708373|NCT03530085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708374|NCT03530085|Alkylating Agents|alkylating agents|mesh-ancestor
65708375|NCT03530085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65708376|NCT03530085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65708377|NCT03530085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708378|NCT03196934|Cannabidiol|cannabidiol|mesh-list
65708379|NCT03196934|Anticonvulsants|anticonvulsants|mesh-ancestor
65708380|NCT05304351|Vaccines|vaccines|mesh-list
65708381|NCT05304351|Immunologic Factors|immunologic factors|mesh-ancestor
65708382|NCT05304351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024215|NCT00181935|Olanzapine|olanzapine|mesh-list
65708383|NCT03197012|Octreotide|octreotide|mesh-list
65708384|NCT03197012|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
65708385|NCT03197012|Edotreotide|edotreotide|mesh-list
65708386|NCT03197012|Chelating Agents|chelating agents|mesh-ancestor
65708387|NCT03197012|Sequestering Agents|sequestering agents|mesh-ancestor
65708388|NCT03197012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708389|NCT03197012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65708390|NCT03197012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65708391|NCT03197012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65708392|NCT03197012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708393|NCT03530007|Ondansetron|ondansetron|mesh-list
65708394|NCT03530007|Antiemetics|antiemetics|mesh-ancestor
65708395|NCT03530007|Autonomic Agents|autonomic agents|mesh-ancestor
65708396|NCT03530007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65708397|NCT03530007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708398|NCT03530007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65708399|NCT03530007|Antipruritics|antipruritics|mesh-ancestor
65708400|NCT03530007|Dermatologic Agents|dermatologic agents|mesh-ancestor
65708401|NCT03530007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65708402|NCT03530007|Serotonin Agents|serotonin agents|mesh-ancestor
65708403|NCT03530007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65708404|NCT03530007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708405|NCT03530007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65708406|NCT03530007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65708407|NCT03530007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65708408|NCT03530007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65708409|NCT03530007|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65708410|NCT03529929|Methylprednisolone|methylprednisolone|mesh-list
65708411|NCT03529929|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65708412|NCT03529929|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65708413|NCT03529929|Prednisolone|prednisolone|mesh-list
65708414|NCT03529929|Prednisolone acetate|prednisolone acetate|mesh-list
65708415|NCT03529929|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65708416|NCT03529929|Prednisolone phosphate|prednisolone phosphate|mesh-list
65708417|NCT03529929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65708418|NCT03529929|Antiemetics|antiemetics|mesh-ancestor
65708419|NCT03529929|Autonomic Agents|autonomic agents|mesh-ancestor
65708420|NCT03529929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65708421|NCT03529929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708422|NCT03529929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65708423|NCT03529929|Glucocorticoids|glucocorticoids|mesh-ancestor
65708424|NCT03529929|Hormones|hormones|mesh-ancestor
65708425|NCT03529929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65708426|NCT03529929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65708427|NCT03529929|Protective Agents|protective agents|mesh-ancestor
65708428|NCT03529929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65708429|NCT03529929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708430|NCT03052751|Rozanolixizumab|rozanolixizumab|mesh-list
65708431|NCT03052751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65708432|NCT03052751|Immunologic Factors|immunologic factors|mesh-ancestor
65708433|NCT03052751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708434|NCT03525561|Acetazolamide|acetazolamide|mesh-list
65708435|NCT03525561|Anticonvulsants|anticonvulsants|mesh-ancestor
65708436|NCT03525561|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65708437|NCT03525561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708438|NCT03525561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708439|NCT03525561|Diuretics|diuretics|mesh-ancestor
65708440|NCT03525561|Natriuretic Agents|natriuretic agents|mesh-ancestor
65708441|NCT03525561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708442|NCT05696691|Ketamine|ketamine|mesh-list
65708443|NCT05696691|Analgesics|analgesics|mesh-ancestor
65708444|NCT05696691|Sensory System Agents|sensory system agents|mesh-ancestor
65708445|NCT05696691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65708446|NCT05696691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708447|NCT05696691|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65708448|NCT05696691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65708449|NCT05696691|Anesthetics, General|anesthetics, general|mesh-ancestor
65708450|NCT05696691|Anesthetics|anesthetics|mesh-ancestor
65708451|NCT05696691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65708452|NCT05696691|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65708453|NCT05696691|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65708454|NCT05696691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65708455|NCT05696691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708456|NCT03527355|Vaccines|vaccines|mesh-list
65708457|NCT03527355|Immunologic Factors|immunologic factors|mesh-ancestor
65708458|NCT03527355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708459|NCT04458909|Gemcitabine|gemcitabine|mesh-list
65708460|NCT04458909|Cisplatin|cisplatin|mesh-list
65708461|NCT04458909|Carboplatin|carboplatin|mesh-list
65708462|NCT04458909|Nivolumab|nivolumab|mesh-list
65708463|NCT04458909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708464|NCT04458909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65708465|NCT04458909|Antimetabolites|antimetabolites|mesh-ancestor
65708466|NCT04458909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708467|NCT04458909|Antiviral Agents|antiviral agents|mesh-ancestor
65708468|NCT04458909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65708469|NCT04458909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708470|NCT04458909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65708471|NCT04458909|Immunologic Factors|immunologic factors|mesh-ancestor
65708472|NCT04458909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708473|NCT04458909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65708474|NCT04458909|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65708475|NCT05707169|Lidocaine|lidocaine|mesh-list
65708476|NCT05707169|Epinephrine|epinephrine|mesh-list
65708477|NCT05707169|Racepinephrine|racepinephrine|mesh-list
65708478|NCT05707169|Levobupivacaine|levobupivacaine|mesh-list
65708479|NCT05707169|Epinephryl borate|epinephryl borate|mesh-list
65708480|NCT05707169|Anesthetics, Local|anesthetics, local|mesh-ancestor
65708481|NCT05707169|Anesthetics|anesthetics|mesh-ancestor
65708482|NCT05707169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65708483|NCT05707169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708484|NCT05707169|Sensory System Agents|sensory system agents|mesh-ancestor
65708485|NCT05707169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65708486|NCT05707169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65708487|NCT05707169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65708488|NCT05707169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65708489|NCT05707169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65708490|NCT05707169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708491|NCT05707169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65708492|NCT05707169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65708493|NCT05707169|Adrenergic Agents|adrenergic agents|mesh-ancestor
65708494|NCT05707169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65708495|NCT05707169|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65708496|NCT05707169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65708497|NCT05707169|Autonomic Agents|autonomic agents|mesh-ancestor
65708498|NCT05707169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65708499|NCT05707169|Respiratory System Agents|respiratory system agents|mesh-ancestor
65708500|NCT05707169|Mydriatics|mydriatics|mesh-ancestor
65708501|NCT05707169|Sympathomimetics|sympathomimetics|mesh-ancestor
65708502|NCT05707169|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65708503|NCT05052827|Caseins|caseins|mesh-list
65708504|NCT05052827|Chelating Agents|chelating agents|mesh-ancestor
65708505|NCT05052827|Sequestering Agents|sequestering agents|mesh-ancestor
65708506|NCT05052827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708507|NCT02712008|Aflibercept|aflibercept|mesh-list
65708508|NCT02712008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65708509|NCT02712008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65708510|NCT02712008|Growth Substances|growth substances|mesh-ancestor
65708511|NCT02712008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708512|NCT02712008|Growth Inhibitors|growth inhibitors|mesh-ancestor
65708513|NCT02712008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708514|NCT05130515|Niraparib|niraparib|mesh-list
65708515|NCT05130515|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65708516|NCT05130515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708517|NCT05130515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708518|NCT05130515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708519|NCT03193814|Apatinib|apatinib|mesh-list
65708520|NCT03193814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708521|NCT03193814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65708522|NCT03193814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708523|NCT03193814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708524|NCT05706779|Cetuximab|cetuximab|mesh-list
65708525|NCT05706779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65708526|NCT05706779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708527|NCT02450084|Fentanyl|fentanyl|mesh-list
65708528|NCT02450084|Ropivacaine|ropivacaine|mesh-list
65708529|NCT02450084|Anesthetics, Local|anesthetics, local|mesh-ancestor
65708530|NCT02450084|Anesthetics|anesthetics|mesh-ancestor
65708531|NCT02450084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65708532|NCT02450084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708533|NCT02450084|Sensory System Agents|sensory system agents|mesh-ancestor
65708534|NCT02450084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65708535|NCT02450084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65708536|NCT02450084|Narcotics|narcotics|mesh-ancestor
65708537|NCT02450084|Analgesics|analgesics|mesh-ancestor
65708538|NCT02450084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65708539|NCT02450084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65708540|NCT02450084|Anesthetics, General|anesthetics, general|mesh-ancestor
65708541|NCT03201770|Artesunate|artesunate|mesh-list
65708542|NCT03201770|Pyronaridine|pyronaridine|mesh-list
65708543|NCT03201770|Antimalarials|antimalarials|mesh-ancestor
65708544|NCT03201770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65708545|NCT03201770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65708546|NCT03201770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65708547|NCT03201770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708548|NCT03201770|Antiviral Agents|antiviral agents|mesh-ancestor
65708549|NCT03201770|Schistosomicides|schistosomicides|mesh-ancestor
65708550|NCT03201770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65708551|NCT03201770|Anthelmintics|anthelmintics|mesh-ancestor
65708552|NCT03626831|Evolocumab|evolocumab|mesh-list
65708553|NCT03626831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65708554|NCT03626831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65708555|NCT03626831|Antimetabolites|antimetabolites|mesh-ancestor
65708556|NCT03626831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708557|NCT03626831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65708558|NCT04213209|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65708559|NCT04213209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65708560|NCT04213209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708561|NCT03196466|Topiramate|topiramate|mesh-list
65708562|NCT03196466|Pregabalin|pregabalin|mesh-list
65708563|NCT03196466|Lamotrigine|lamotrigine|mesh-list
65708564|NCT03196466|Zonisamide|zonisamide|mesh-list
65708565|NCT03196466|Lacosamide|lacosamide|mesh-list
65708566|NCT03196466|Carbamazepine|carbamazepine|mesh-list
65708567|NCT03196466|Phenytoin|phenytoin|mesh-list
65708568|NCT03196466|Oxcarbazepine|oxcarbazepine|mesh-list
65708569|NCT03196466|Rufinamide|rufinamide|mesh-list
65708570|NCT03196466|Cannabidiol|cannabidiol|mesh-list
65708571|NCT03196466|Levetiracetam|levetiracetam|mesh-list
65708572|NCT03196466|Valproic Acid|valproic acid|mesh-list
65708573|NCT03196466|Brivaracetam|brivaracetam|mesh-list
65708574|NCT03196466|Phenobarbital|phenobarbital|mesh-list
65708575|NCT03196466|Clobazam|clobazam|mesh-list
65708576|NCT03196466|Ethosuximide|ethosuximide|mesh-list
65708577|NCT03196466|Stiripentol|stiripentol|mesh-list
65708578|NCT03196466|Tiagabine|tiagabine|mesh-list
65708579|NCT03196466|Primidone|primidone|mesh-list
65708580|NCT03196466|Felbamate|felbamate|mesh-list
65708581|NCT03196466|Analgesics|analgesics|mesh-ancestor
65708582|NCT03196466|Sensory System Agents|sensory system agents|mesh-ancestor
65708583|NCT03196466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65708584|NCT03196466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708585|NCT03196466|Anticonvulsants|anticonvulsants|mesh-ancestor
65708586|NCT03196466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65708587|NCT03196466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65708588|NCT03196466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708589|NCT03196466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65708590|NCT03196466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65708591|NCT03196466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65708592|NCT03196466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65708593|NCT03196466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65708594|NCT03196466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65708595|NCT03196466|Nootropic Agents|nootropic agents|mesh-ancestor
65708596|NCT03196466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65708597|NCT03196466|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65708598|NCT03196466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708599|NCT03196466|GABA Agents|gaba agents|mesh-ancestor
65708600|NCT03196466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65708601|NCT03196466|Antimanic Agents|antimanic agents|mesh-ancestor
65708602|NCT03196466|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65708603|NCT03196466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65708604|NCT03196466|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65708605|NCT03196466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65708606|NCT03196466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65708607|NCT03196466|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65708608|NCT03196466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65708609|NCT03196466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65708610|NCT03196466|GABA Modulators|gaba modulators|mesh-ancestor
65708611|NCT03196466|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65708612|NCT03196466|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65708613|NCT03196466|GABA Agonists|gaba agonists|mesh-ancestor
65708614|NCT03196466|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
65708615|NCT03196466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65708616|NCT04204941|Doxorubicin|doxorubicin|mesh-list
65708617|NCT04204941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65708618|NCT04204941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65708619|NCT04204941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708620|NCT04204941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65708621|NCT04204941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65708622|NCT04204941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708623|NCT04204941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708624|NCT04188405|Decitabine|decitabine|mesh-list
65708625|NCT04188405|Venetoclax|venetoclax|mesh-list
65708626|NCT04188405|Ponatinib|ponatinib|mesh-list
65708627|NCT04188405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65708628|NCT04188405|Antimetabolites|antimetabolites|mesh-ancestor
65708629|NCT04188405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708630|NCT04188405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708631|NCT04188405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708632|NCT04188405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65708633|NCT04176393|Ivosidenib|ivosidenib|mesh-list
65708634|NCT04176393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708635|NCT04176393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708636|NCT04176393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708637|NCT02449070|Nicorandil|nicorandil|mesh-list
65708638|NCT02449070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65708639|NCT02449070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65708640|NCT02449070|Vasodilator Agents|vasodilator agents|mesh-ancestor
65708641|NCT02449070|Vitamin B Complex|vitamin b complex|mesh-ancestor
65708642|NCT02449070|Vitamins|vitamins|mesh-ancestor
65708643|NCT02449070|Micronutrients|micronutrients|mesh-ancestor
65708644|NCT02449070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708645|NCT03529149|Diltiazem|diltiazem|mesh-list
65708646|NCT03529149|Urapidil|urapidil|mesh-list
65708647|NCT03529149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65708648|NCT03529149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65708649|NCT03529149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65708650|NCT03529149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708651|NCT03529149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65708652|NCT03529149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708653|NCT03529149|Vasodilator Agents|vasodilator agents|mesh-ancestor
65708654|NCT03529149|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65708655|NCT03529149|Serotonin Agents|serotonin agents|mesh-ancestor
65708656|NCT03529149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65708657|NCT03529149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65708658|NCT03529149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65708659|NCT03529149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65708660|NCT03529149|Adrenergic Agents|adrenergic agents|mesh-ancestor
65708661|NCT03524937|Melatonin|melatonin|mesh-list
65708662|NCT03524937|Antioxidants|antioxidants|mesh-ancestor
65708663|NCT03524937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708664|NCT03524937|Protective Agents|protective agents|mesh-ancestor
65708665|NCT03524937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708666|NCT03524937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65708667|NCT04073433|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65708668|NCT04073433|Hallucinogens|hallucinogens|mesh-ancestor
65708669|NCT04073433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708670|NCT04073433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65708671|NCT04073433|Serotonin Agents|serotonin agents|mesh-ancestor
65708672|NCT04073433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65708673|NCT04073433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708674|NCT04073433|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65708675|NCT04073433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65708676|NCT04073433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65708677|NCT04073433|Adrenergic Agents|adrenergic agents|mesh-ancestor
65708678|NCT03193502|Rivaroxaban|rivaroxaban|mesh-list
65708679|NCT03193502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65708680|NCT03193502|Antithrombins|antithrombins|mesh-ancestor
65708681|NCT03193502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65708682|NCT03193502|Protease Inhibitors|protease inhibitors|mesh-ancestor
65708683|NCT03193502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708684|NCT03193502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708685|NCT03193502|Anticoagulants|anticoagulants|mesh-ancestor
65708686|NCT02711306|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
65708687|NCT02711306|Cathartics|cathartics|mesh-ancestor
65708688|NCT02711306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65708689|NCT03193112|S 20098|s 20098|mesh-list
65708690|NCT03193112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65708691|NCT03193112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65708692|NCT03193112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708693|NCT03196154|Insulin|insulin|mesh-list
65708694|NCT03196154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65708695|NCT03196154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708696|NCT03193424|Docetaxel|docetaxel|mesh-list
65708697|NCT03193424|Apatinib|apatinib|mesh-list
65708698|NCT03193424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708699|NCT03193424|Tubulin Modulators|tubulin modulators|mesh-ancestor
65708700|NCT03193424|Antimitotic Agents|antimitotic agents|mesh-ancestor
65708701|NCT03193424|Mitosis Modulators|mitosis modulators|mesh-ancestor
65708702|NCT03193424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708703|NCT03193424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65708704|NCT03193424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708705|NCT03193346|Botulinum Toxins|botulinum toxins|mesh-list
65708706|NCT03193346|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65708707|NCT03193346|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65708708|NCT03193346|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65708709|NCT03193346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65708710|NCT03193346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708711|NCT03193346|Cholinergic Agents|cholinergic agents|mesh-ancestor
65708712|NCT03193346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65708713|NCT03193346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708714|NCT03193346|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65708715|NCT03193346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65708716|NCT03118076|Dexmedetomidine|dexmedetomidine|mesh-list
65708717|NCT03118076|Ropivacaine|ropivacaine|mesh-list
65708718|NCT03118076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65708719|NCT03118076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65708720|NCT03118076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708721|NCT03118076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65708722|NCT03118076|Analgesics|analgesics|mesh-ancestor
65708723|NCT03118076|Sensory System Agents|sensory system agents|mesh-ancestor
65708724|NCT03118076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65708725|NCT03118076|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65708726|NCT03118076|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65708727|NCT03118076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65708728|NCT03118076|Adrenergic Agents|adrenergic agents|mesh-ancestor
65708729|NCT03118076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65708730|NCT03118076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708731|NCT03118076|Anesthetics, Local|anesthetics, local|mesh-ancestor
65708732|NCT03118076|Anesthetics|anesthetics|mesh-ancestor
65708733|NCT03528915|Rifamycins|rifamycins|mesh-list
65708734|NCT03528915|Rifamycin SV|rifamycin sv|mesh-list
65708735|NCT03528915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65708736|NCT03528915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65708737|NCT03528915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65708738|NCT03192878|Infliximab|infliximab|mesh-list
65708739|NCT03192878|Dermatologic Agents|dermatologic agents|mesh-ancestor
65708740|NCT03192878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65708741|NCT03192878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65708742|NCT03241940|Cyclophosphamide|cyclophosphamide|mesh-list
65708743|NCT03241940|Fludarabine|fludarabine|mesh-list
65708744|NCT03241940|Fludarabine phosphate|fludarabine phosphate|mesh-list
65708745|NCT03241940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65708746|NCT03241940|Immunologic Factors|immunologic factors|mesh-ancestor
65708747|NCT03241940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708748|NCT03241940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65708749|NCT03241940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65708750|NCT03241940|Alkylating Agents|alkylating agents|mesh-ancestor
65708751|NCT03241940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708752|NCT03241940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708753|NCT03241940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65708754|NCT03241940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65708755|NCT03241940|Antimetabolites|antimetabolites|mesh-ancestor
65708756|NCT00294320|Imiquimod|imiquimod|mesh-list
65708757|NCT00294320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65708758|NCT00294320|Immunologic Factors|immunologic factors|mesh-ancestor
65708759|NCT00294320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708760|NCT00294320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708761|NCT00294320|Interferon Inducers|interferon inducers|mesh-ancestor
65708762|NCT03526575|Zaleplon|zaleplon|mesh-list
65708763|NCT03526575|Zolpidem|zolpidem|mesh-list
65708764|NCT03526575|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65708765|NCT03526575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65708766|NCT03526575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65708767|NCT03526575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708768|NCT03526575|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65708769|NCT03526575|GABA Agonists|gaba agonists|mesh-ancestor
65708770|NCT03526575|GABA Agents|gaba agents|mesh-ancestor
65708771|NCT03526575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65708772|NCT03526575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708773|NCT03526575|Anticonvulsants|anticonvulsants|mesh-ancestor
65708774|NCT03526575|GABA Modulators|gaba modulators|mesh-ancestor
65708775|NCT00189254|Imiquimod|imiquimod|mesh-list
65708776|NCT00189254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65708777|NCT00189254|Immunologic Factors|immunologic factors|mesh-ancestor
65708778|NCT00189254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708779|NCT00189254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708780|NCT00189254|Interferon Inducers|interferon inducers|mesh-ancestor
65708781|NCT03526419|Bupivacaine|bupivacaine|mesh-list
65708782|NCT03526419|Anesthetics, Local|anesthetics, local|mesh-ancestor
65708783|NCT03526419|Anesthetics|anesthetics|mesh-ancestor
65708784|NCT03526419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65708785|NCT03526419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708786|NCT03526419|Sensory System Agents|sensory system agents|mesh-ancestor
65708787|NCT03526419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65708788|NCT03192644|Leucovorin|leucovorin|mesh-list
65708789|NCT03192644|Oxaliplatin|oxaliplatin|mesh-list
65708790|NCT03192644|Ethiodized Oil|ethiodized oil|mesh-list
65708791|NCT03192644|Epirubicin|epirubicin|mesh-list
65708792|NCT03192644|Calcium|calcium|mesh-list
65708793|NCT03192644|Levoleucovorin|levoleucovorin|mesh-list
65708794|NCT03192644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708795|NCT03192644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65708796|NCT03192644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708797|NCT03192644|Antidotes|antidotes|mesh-ancestor
65708798|NCT03192644|Protective Agents|protective agents|mesh-ancestor
65708799|NCT03192644|Vitamin B Complex|vitamin b complex|mesh-ancestor
65708800|NCT03192644|Vitamins|vitamins|mesh-ancestor
65708801|NCT03192644|Micronutrients|micronutrients|mesh-ancestor
65708802|NCT03192644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65708803|NCT03192644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65708804|NCT03192644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65708805|NCT03192644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708806|NCT03192644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708807|NCT03110055|Grazoprevir|grazoprevir|mesh-list
65708808|NCT03110055|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65708809|NCT03110055|Antiviral Agents|antiviral agents|mesh-ancestor
65708810|NCT03110055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65708811|NCT04939623|Benzoic Acid|benzoic acid|mesh-list
65708812|NCT04939623|Probenecid|probenecid|mesh-list
65708813|NCT04939623|Uricosuric Agents|uricosuric agents|mesh-ancestor
65708814|NCT04939623|Gout Suppressants|gout suppressants|mesh-ancestor
65708815|NCT04939623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65708816|NCT04939623|Renal Agents|renal agents|mesh-ancestor
65708817|NCT04939623|Antifungal Agents|antifungal agents|mesh-ancestor
65708818|NCT04939623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65708819|NCT01190852|Fluticasone|fluticasone|mesh-list
65708820|NCT01190852|Azelastine|azelastine|mesh-list
65708821|NCT01190852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65708822|NCT01190852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65708823|NCT01190852|Autonomic Agents|autonomic agents|mesh-ancestor
65708824|NCT01190852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65708825|NCT01190852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708826|NCT01190852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65708827|NCT01190852|Respiratory System Agents|respiratory system agents|mesh-ancestor
65708828|NCT01190852|Dermatologic Agents|dermatologic agents|mesh-ancestor
65708829|NCT01190852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65708830|NCT01190852|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65708831|NCT01190852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708832|NCT01190852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708833|NCT01190852|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65708834|NCT01190852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65708835|NCT01190852|Histamine Antagonists|histamine antagonists|mesh-ancestor
65708836|NCT01190852|Histamine Agents|histamine agents|mesh-ancestor
65708837|NCT01190852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65708838|NCT02710214|Estrogens|estrogens|mesh-list
65708839|NCT02710214|Hormones|hormones|mesh-ancestor
65708840|NCT02710214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65708841|NCT02710214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708842|NCT03782415|Temozolomide|temozolomide|mesh-list
65708843|NCT03782415|Ibudilast|ibudilast|mesh-list
65708844|NCT03782415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65708845|NCT03782415|Alkylating Agents|alkylating agents|mesh-ancestor
65708846|NCT03782415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708847|NCT03782415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708848|NCT03782415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65708849|NCT03782415|Autonomic Agents|autonomic agents|mesh-ancestor
65708850|NCT03782415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65708851|NCT03782415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708852|NCT03782415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65708853|NCT03782415|Respiratory System Agents|respiratory system agents|mesh-ancestor
65708854|NCT03782415|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65708855|NCT03782415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708856|NCT03782415|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65708857|NCT03782415|Vasodilator Agents|vasodilator agents|mesh-ancestor
65708858|NCT05561205|Methylphenidate|methylphenidate|mesh-list
65708859|NCT05561205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65708860|NCT05561205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708861|NCT05561205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65708862|NCT05561205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65708863|NCT05561205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65708864|NCT05561205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708865|NCT05561205|Dopamine Agents|dopamine agents|mesh-ancestor
65708866|NCT05561205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65708867|NCT03052517|Indoleacetic Acids|indoleacetic acids|mesh-list
65708868|NCT03052517|Plant Growth Regulators|plant growth regulators|mesh-ancestor
65708869|NCT03052517|Growth Substances|growth substances|mesh-ancestor
65708870|NCT03052517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708871|NCT02443844|Tamsulosin|tamsulosin|mesh-list
65708872|NCT02443844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65708873|NCT02443844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65708874|NCT02443844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65708875|NCT02443844|Adrenergic Agents|adrenergic agents|mesh-ancestor
65708876|NCT02443844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65708877|NCT02443844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708878|NCT02443844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708879|NCT02443844|Urological Agents|urological agents|mesh-ancestor
65708880|NCT02440100|Midazolam|midazolam|mesh-list
65708881|NCT02440100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65708882|NCT02440100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65708883|NCT02440100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65708884|NCT02440100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708885|NCT02440100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65708886|NCT02440100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65708887|NCT02440100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65708888|NCT02440100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65708889|NCT02440100|Anesthetics, General|anesthetics, general|mesh-ancestor
65708890|NCT02440100|Anesthetics|anesthetics|mesh-ancestor
65708891|NCT02440100|GABA Modulators|gaba modulators|mesh-ancestor
65708892|NCT02440100|GABA Agents|gaba agents|mesh-ancestor
65708893|NCT02440100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65708894|NCT02440100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708895|NCT03524313|Carbon Monoxide|carbon monoxide|mesh-list
65708896|NCT03524313|Antimetabolites|antimetabolites|mesh-ancestor
65708897|NCT03524313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708898|NCT03524313|Gasotransmitters|gasotransmitters|mesh-ancestor
65708899|NCT03524313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65708900|NCT03524313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708901|NCT02439944|Nicotine|nicotine|mesh-list
65708902|NCT02439944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65708903|NCT02439944|Autonomic Agents|autonomic agents|mesh-ancestor
65708904|NCT02439944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65708905|NCT02439944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708906|NCT02439944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65708907|NCT02439944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65708908|NCT02439944|Cholinergic Agents|cholinergic agents|mesh-ancestor
65708909|NCT02439944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65708910|NCT02439944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708911|NCT03133065|Antiviral Agents|antiviral agents|mesh-list
65708912|NCT03133065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65708913|NCT03190616|Apatinib|apatinib|mesh-list
65708914|NCT03190616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708915|NCT03190616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65708916|NCT03190616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708917|NCT03190616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708918|NCT02443922|Metformin|metformin|mesh-list
65708919|NCT02443922|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65708920|NCT02443922|Glimepiride|glimepiride|mesh-list
65708921|NCT02443922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65708922|NCT02443922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708923|NCT02443922|Incretins|incretins|mesh-ancestor
65708924|NCT02443922|Hormones|hormones|mesh-ancestor
65708925|NCT02443922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65708926|NCT02443922|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65708927|NCT02443922|Protease Inhibitors|protease inhibitors|mesh-ancestor
65708928|NCT02443922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708929|NCT02443922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708930|NCT02443922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65708931|NCT02443922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65708932|NCT02443922|Immunologic Factors|immunologic factors|mesh-ancestor
65708933|NCT04799847|Catumaxomab|catumaxomab|mesh-list
65708934|NCT04799847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65708935|NCT02439866|Methylprednisolone|methylprednisolone|mesh-list
65708936|NCT02439866|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65708937|NCT02439866|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65708938|NCT02439866|Prednisolone|prednisolone|mesh-list
65708939|NCT02439866|Prednisolone acetate|prednisolone acetate|mesh-list
65708940|NCT02439866|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65708941|NCT02439866|Prednisolone phosphate|prednisolone phosphate|mesh-list
65708942|NCT02439866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65708943|NCT02439866|Antiemetics|antiemetics|mesh-ancestor
65708944|NCT02439866|Autonomic Agents|autonomic agents|mesh-ancestor
65708945|NCT02439866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65708946|NCT02439866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708947|NCT02439866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65708948|NCT02439866|Glucocorticoids|glucocorticoids|mesh-ancestor
65708949|NCT02439866|Hormones|hormones|mesh-ancestor
65708950|NCT02439866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65708951|NCT02439866|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65708952|NCT02439866|Protective Agents|protective agents|mesh-ancestor
65708953|NCT02439866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65708954|NCT02439866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708955|NCT02439788|Cyclophosphamide|cyclophosphamide|mesh-list
65708956|NCT02439788|Fludarabine|fludarabine|mesh-list
65708957|NCT02439788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65708958|NCT02439788|Immunologic Factors|immunologic factors|mesh-ancestor
65708959|NCT02439788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708960|NCT02439788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65708961|NCT02439788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65708962|NCT02439788|Alkylating Agents|alkylating agents|mesh-ancestor
65708963|NCT02439788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708964|NCT02439788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708965|NCT02439788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65708966|NCT03188510|Mirikizumab|mirikizumab|mesh-list
65708967|NCT03188510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65708968|NCT03188510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65708969|NCT03188510|Analgesics|analgesics|mesh-ancestor
65708970|NCT03188510|Sensory System Agents|sensory system agents|mesh-ancestor
65708971|NCT03188510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65708972|NCT03188510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708973|NCT03188510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65708974|NCT03188510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65708975|NCT03188510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65708976|NCT03188510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65708977|NCT03188198|Prednisone|prednisone|mesh-list
65708978|NCT03188198|Cyclophosphamide|cyclophosphamide|mesh-list
65708979|NCT03188198|Rituximab|rituximab|mesh-list
65708980|NCT03188198|Doxorubicin|doxorubicin|mesh-list
65708981|NCT03188198|Etoposide|etoposide|mesh-list
65708982|NCT03188198|Etoposide phosphate|etoposide phosphate|mesh-list
65708983|NCT03188198|Vincristine|vincristine|mesh-list
65708984|NCT03188198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65708985|NCT03188198|Immunologic Factors|immunologic factors|mesh-ancestor
65708986|NCT03188198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65708987|NCT03188198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65708988|NCT03188198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65708989|NCT03188198|Alkylating Agents|alkylating agents|mesh-ancestor
65708990|NCT03188198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65708991|NCT03188198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65708992|NCT03188198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65708993|NCT03188198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65708994|NCT03188198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65708995|NCT03188198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65708996|NCT03188198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65708997|NCT03188198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65708998|NCT03188198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65708999|NCT03188198|Glucocorticoids|glucocorticoids|mesh-ancestor
65709000|NCT03188198|Hormones|hormones|mesh-ancestor
65709001|NCT03188198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65709002|NCT03188198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65709003|NCT03188198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65709004|NCT03188198|Tubulin Modulators|tubulin modulators|mesh-ancestor
65709005|NCT03188198|Antimitotic Agents|antimitotic agents|mesh-ancestor
65709006|NCT03188198|Mitosis Modulators|mitosis modulators|mesh-ancestor
65709007|NCT03188276|Sofosbuvir|sofosbuvir|mesh-list
65709008|NCT03188276|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
65709009|NCT03188276|Ledipasvir|ledipasvir|mesh-list
65709010|NCT03188276|Antiviral Agents|antiviral agents|mesh-ancestor
65709011|NCT03188276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65709012|NCT03190304|Enalapril|enalapril|mesh-list
65709013|NCT03190304|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65709014|NCT03190304|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65709015|NCT03190304|Protease Inhibitors|protease inhibitors|mesh-ancestor
65709016|NCT03190304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709017|NCT03190304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65709018|NCT02439632|Levofloxacin|levofloxacin|mesh-list
65709019|NCT02439632|Ofloxacin|ofloxacin|mesh-list
65709020|NCT02439632|Prulifloxacin|prulifloxacin|mesh-list
65709021|NCT02439632|Fluoroquinolones|fluoroquinolones|mesh-list
65709022|NCT02439632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65709023|NCT02439632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65709024|NCT02439632|Renal Agents|renal agents|mesh-ancestor
65709025|NCT02439632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65709026|NCT02439632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65709027|NCT02439632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65709028|NCT02439632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65709029|NCT02439632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709030|NCT02439632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709031|NCT02439632|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65709032|NCT02439632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65709033|NCT02439632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65709034|NCT02443064|Vancomycin|vancomycin|mesh-list
65709035|NCT02443064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65709036|NCT02443064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65709037|NCT02741271|Mometasone Furoate|mometasone furoate|mesh-list
65709038|NCT02741271|Prednisone|prednisone|mesh-list
65709039|NCT02741271|Prednisolone|prednisolone|mesh-list
65709040|NCT02741271|Albuterol|albuterol|mesh-list
65709041|NCT02741271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65709042|NCT02741271|Glucocorticoids|glucocorticoids|mesh-ancestor
65709043|NCT02741271|Hormones|hormones|mesh-ancestor
65709044|NCT02741271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65709045|NCT02741271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709046|NCT02741271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65709047|NCT02741271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709048|NCT02741271|Autonomic Agents|autonomic agents|mesh-ancestor
65709049|NCT02741271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709050|NCT02741271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65709051|NCT02741271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65709052|NCT02741271|Respiratory System Agents|respiratory system agents|mesh-ancestor
65709053|NCT02741271|Tocolytic Agents|tocolytic agents|mesh-ancestor
65709054|NCT02741271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65709055|NCT02741271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65709056|NCT02741271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65709057|NCT02741271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65709058|NCT02741271|Adrenergic Agents|adrenergic agents|mesh-ancestor
65709059|NCT02741271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65709060|NCT02741271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709061|NCT02741271|Dermatologic Agents|dermatologic agents|mesh-ancestor
65709062|NCT02741271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65709063|NCT02443142|Acetaminophen|acetaminophen|mesh-list
65709064|NCT02443142|Ibuprofen|ibuprofen|mesh-list
65709065|NCT02443142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65709066|NCT02443142|Analgesics|analgesics|mesh-ancestor
65709067|NCT02443142|Sensory System Agents|sensory system agents|mesh-ancestor
65709068|NCT02443142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709069|NCT02443142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024917|NCT00534625|Zileuton|zileuton|mesh-list
65709070|NCT02443142|Antipyretics|antipyretics|mesh-ancestor
65709071|NCT02443142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65709072|NCT02443142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65709073|NCT02443142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65709074|NCT02443142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65709075|NCT02443142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65709076|NCT02443142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709077|NCT03524079|Ajmaline|ajmaline|mesh-list
65709078|NCT03524079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65709079|NCT03524079|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65709080|NCT03524079|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65709081|NCT03524079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65709082|NCT03524079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709083|NCT02438852|Ropivacaine|ropivacaine|mesh-list
65709084|NCT02438852|Anesthetics, Local|anesthetics, local|mesh-ancestor
65709085|NCT02438852|Anesthetics|anesthetics|mesh-ancestor
65709086|NCT02438852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65709087|NCT02438852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709088|NCT02438852|Sensory System Agents|sensory system agents|mesh-ancestor
65709089|NCT02438852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709090|NCT05522673|Rolipram|rolipram|mesh-list
65709091|NCT05522673|Antidepressive Agents|antidepressive agents|mesh-ancestor
65709092|NCT05522673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65709093|NCT05522673|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65709094|NCT05522673|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65709095|NCT05522673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65709096|NCT05522673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709097|NCT02442674|Tolvaptan|tolvaptan|mesh-list
65709098|NCT02442674|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65709099|NCT02442674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709100|NCT02442674|Natriuretic Agents|natriuretic agents|mesh-ancestor
65709101|NCT02442674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709102|NCT02442752|Dexlansoprazole|dexlansoprazole|mesh-list
65709103|NCT02442752|Lansoprazole|lansoprazole|mesh-list
65709104|NCT02442752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65709105|NCT02442752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65709106|NCT02442752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65709107|NCT02442752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65709108|NCT02442752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709109|NCT02442362|Paclitaxel|paclitaxel|mesh-list
65709110|NCT02442362|Fluorouracil|fluorouracil|mesh-list
65709111|NCT02442362|Oxaliplatin|oxaliplatin|mesh-list
65709112|NCT02442362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65709113|NCT02442362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709114|NCT02442362|Tubulin Modulators|tubulin modulators|mesh-ancestor
65709115|NCT02442362|Antimitotic Agents|antimitotic agents|mesh-ancestor
65709116|NCT02442362|Mitosis Modulators|mitosis modulators|mesh-ancestor
65709117|NCT02442362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709118|NCT02442362|Antimetabolites|antimetabolites|mesh-ancestor
65709119|NCT02442362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65709120|NCT02442362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65709121|NCT02442362|Immunologic Factors|immunologic factors|mesh-ancestor
65709122|NCT02442362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709123|NCT04440488|Protease Inhibitors|protease inhibitors|mesh-list
65709124|NCT04440488|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65709125|NCT04440488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65709126|NCT04440488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709127|NCT04440488|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65709128|NCT04440488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65709129|NCT02433860|Nicotine|nicotine|mesh-list
65709130|NCT02433860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65709131|NCT02433860|Autonomic Agents|autonomic agents|mesh-ancestor
65709132|NCT02433860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709133|NCT02433860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709134|NCT02433860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65709135|NCT02433860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65709136|NCT02433860|Cholinergic Agents|cholinergic agents|mesh-ancestor
65709137|NCT02433860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65709138|NCT02433860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709139|NCT03189914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65709140|NCT03189914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709141|NCT03523455|Iron protein succinylate|iron protein succinylate|mesh-list
65709142|NCT03523455|Hematinics|hematinics|mesh-ancestor
65709143|NCT03189836|Rituximab|rituximab|mesh-list
65709144|NCT03189836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65709145|NCT03189836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709146|NCT03189836|Immunologic Factors|immunologic factors|mesh-ancestor
65709147|NCT03189836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709148|NCT03189836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65709149|NCT04466943|Rocuronium|rocuronium|mesh-list
65709150|NCT04466943|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65709151|NCT04466943|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65709152|NCT04466943|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65709153|NCT04466943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709154|NCT04466943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709155|NCT03212469|Durvalumab|durvalumab|mesh-list
65709156|NCT03212469|Tremelimumab|tremelimumab|mesh-list
65709157|NCT03212469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65709158|NCT03212469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709159|NCT02442440|Anisodamine|anisodamine|mesh-list
65709160|NCT02442440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65709161|NCT02442440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65709162|NCT02442440|Adrenergic Agents|adrenergic agents|mesh-ancestor
65709163|NCT02442440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65709164|NCT02442440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709165|NCT02442440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709166|NCT02442440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65709167|NCT02442440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65709168|NCT02442440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65709169|NCT02442440|Analgesics|analgesics|mesh-ancestor
65709170|NCT02442440|Sensory System Agents|sensory system agents|mesh-ancestor
65709171|NCT02442440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709172|NCT02442440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65709173|NCT02442440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65709174|NCT02442440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65709175|NCT02442440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65709176|NCT02442440|Parasympatholytics|parasympatholytics|mesh-ancestor
65709177|NCT02442440|Autonomic Agents|autonomic agents|mesh-ancestor
65709178|NCT02442440|Vasodilator Agents|vasodilator agents|mesh-ancestor
65709179|NCT02442440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65709180|NCT02442440|Antioxidants|antioxidants|mesh-ancestor
65709181|NCT02442440|Protective Agents|protective agents|mesh-ancestor
65709182|NCT03187496|Midazolam|midazolam|mesh-list
65709183|NCT03187496|Caffeine|caffeine|mesh-list
65709184|NCT03187496|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65709185|NCT03187496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65709186|NCT03187496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65709187|NCT03187496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65709188|NCT03187496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709189|NCT03187496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65709190|NCT03187496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65709191|NCT03187496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65709192|NCT03187496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65709193|NCT03187496|Anesthetics, General|anesthetics, general|mesh-ancestor
65709194|NCT03187496|Anesthetics|anesthetics|mesh-ancestor
65709195|NCT03187496|GABA Modulators|gaba modulators|mesh-ancestor
65709196|NCT03187496|GABA Agents|gaba agents|mesh-ancestor
65709197|NCT03187496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65709198|NCT03187496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709199|NCT03187496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65709200|NCT03187496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65709201|NCT03187496|Antimetabolites|antimetabolites|mesh-ancestor
65709202|NCT03187496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65709203|NCT03187496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65709204|NCT03187496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65709205|NCT03187496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65709206|NCT03187496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65709207|NCT03187496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65709208|NCT03187496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65709209|NCT03187496|Purinergic Agents|purinergic agents|mesh-ancestor
65709210|NCT02438072|Fexofenadine|fexofenadine|mesh-list
65709211|NCT02438072|Flurbiprofen|flurbiprofen|mesh-list
65709212|NCT02438072|Midazolam|midazolam|mesh-list
65709213|NCT02438072|Dextromethorphan|dextromethorphan|mesh-list
65709214|NCT02438072|Caffeine|caffeine|mesh-list
65709215|NCT02438072|Bupropion|bupropion|mesh-list
65709216|NCT02438072|Omeprazole|omeprazole|mesh-list
65709217|NCT02438072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65709218|NCT02438072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65709219|NCT02438072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65709220|NCT02438072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709221|NCT02438072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65709222|NCT02438072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65709223|NCT02438072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65709224|NCT02438072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65709225|NCT02438072|Anesthetics, General|anesthetics, general|mesh-ancestor
65709226|NCT02438072|Anesthetics|anesthetics|mesh-ancestor
65709227|NCT02438072|GABA Modulators|gaba modulators|mesh-ancestor
65709228|NCT02438072|GABA Agents|gaba agents|mesh-ancestor
65709229|NCT02438072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65709230|NCT02438072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709231|NCT02438072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65709232|NCT02438072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65709233|NCT02438072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65709234|NCT02438072|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65709235|NCT02438072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65709236|NCT02438072|Purinergic Agents|purinergic agents|mesh-ancestor
65709237|NCT02438072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65709238|NCT02438072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65709239|NCT02438072|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65709240|NCT02438072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65709241|NCT02438072|Antidepressive Agents|antidepressive agents|mesh-ancestor
65709242|NCT02438072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65709243|NCT02438072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65709244|NCT02438072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65709245|NCT02438072|Dopamine Agents|dopamine agents|mesh-ancestor
65709246|NCT02438072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65709247|NCT02438072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65709248|NCT02438072|Antitussive Agents|antitussive agents|mesh-ancestor
65709249|NCT02438072|Respiratory System Agents|respiratory system agents|mesh-ancestor
65709250|NCT02438072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65709251|NCT02438072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65709252|NCT02438072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65709253|NCT02438072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65709254|NCT02438072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65709255|NCT02438072|Histamine Antagonists|histamine antagonists|mesh-ancestor
65709256|NCT02438072|Histamine Agents|histamine agents|mesh-ancestor
65709257|NCT02438072|Analgesics|analgesics|mesh-ancestor
65709258|NCT02438072|Sensory System Agents|sensory system agents|mesh-ancestor
65709259|NCT02438072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709260|NCT02438072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65709261|NCT02438072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65709262|NCT02438072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65709263|NCT02438072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65709264|NCT02438072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65709265|NCT03522987|Citalopram|citalopram|mesh-list
65709266|NCT03522987|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65709267|NCT03522987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65709268|NCT03522987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65709269|NCT03522987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709270|NCT03522987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65709271|NCT03522987|Serotonin Agents|serotonin agents|mesh-ancestor
65709272|NCT03522987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709273|NCT03522987|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65709274|NCT03522987|Antidepressive Agents|antidepressive agents|mesh-ancestor
65709275|NCT03522987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65709276|NCT02433626|Cisplatin|cisplatin|mesh-list
65709277|NCT02433626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709278|NCT02442128|Fentanyl|fentanyl|mesh-list
65709279|NCT02442128|Propofol|propofol|mesh-list
65709280|NCT02442128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65709281|NCT02442128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65709282|NCT02442128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709283|NCT02442128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65709284|NCT02442128|Anesthetics, General|anesthetics, general|mesh-ancestor
65709285|NCT02442128|Anesthetics|anesthetics|mesh-ancestor
65709286|NCT02442128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65709287|NCT02442128|Narcotics|narcotics|mesh-ancestor
65709288|NCT02442128|Analgesics|analgesics|mesh-ancestor
65709289|NCT02442128|Sensory System Agents|sensory system agents|mesh-ancestor
65709290|NCT02442128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709291|NCT02442128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65709292|NCT04465773|Remifentanil|remifentanil|mesh-list
65709293|NCT04465773|Propofol|propofol|mesh-list
65709294|NCT04465773|Anesthetics|anesthetics|mesh-ancestor
65709295|NCT04465773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65709296|NCT04465773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709297|NCT04465773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65709298|NCT04465773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65709299|NCT04465773|Anesthetics, General|anesthetics, general|mesh-ancestor
65709300|NCT04465773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65709301|NCT04465773|Narcotics|narcotics|mesh-ancestor
65709302|NCT04465773|Analgesics|analgesics|mesh-ancestor
65709303|NCT04465773|Sensory System Agents|sensory system agents|mesh-ancestor
65709304|NCT04465773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709305|NCT02709746|Vortioxetine|vortioxetine|mesh-list
65709306|NCT02709746|Fluoxetine|fluoxetine|mesh-list
65709307|NCT02709746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65709308|NCT02709746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65171977|NCT00927472|Malathion|malathion|mesh-list
65709309|NCT02709746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65709310|NCT02709746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709311|NCT02709746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65709312|NCT02709746|Serotonin Agents|serotonin agents|mesh-ancestor
65709313|NCT02709746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709314|NCT02709746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65709315|NCT02709746|Antidepressive Agents|antidepressive agents|mesh-ancestor
65709316|NCT02709746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65709317|NCT02709746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65709318|NCT02709746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65709319|NCT02709746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65709320|NCT02709746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65709321|NCT02709746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65709322|NCT02709746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65709323|NCT02709746|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65709324|NCT02709746|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65709325|NCT02709746|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65709326|NCT02709746|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65709327|NCT02441894|Diphenhydramine|diphenhydramine|mesh-list
65709328|NCT02441894|Promethazine|promethazine|mesh-list
65709329|NCT02441894|Dexamethasone|dexamethasone|mesh-list
65709330|NCT02441894|Prednisolone|prednisolone|mesh-list
65709331|NCT02441894|Ondansetron|ondansetron|mesh-list
65709332|NCT02441894|Metoclopramide|metoclopramide|mesh-list
65709333|NCT02441894|Granisetron|granisetron|mesh-list
65709334|NCT02441894|Ranitidine|ranitidine|mesh-list
65709335|NCT02441894|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
65709336|NCT02441894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65709337|NCT02441894|Antiemetics|antiemetics|mesh-ancestor
65709338|NCT02441894|Autonomic Agents|autonomic agents|mesh-ancestor
65709339|NCT02441894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709340|NCT02441894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709341|NCT02441894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65709342|NCT02441894|Glucocorticoids|glucocorticoids|mesh-ancestor
65709343|NCT02441894|Hormones|hormones|mesh-ancestor
65709344|NCT02441894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65709345|NCT02441894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65709346|NCT02441894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709347|NCT02441894|Antipruritics|antipruritics|mesh-ancestor
65709348|NCT02441894|Dermatologic Agents|dermatologic agents|mesh-ancestor
65709349|NCT02441894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65709350|NCT02441894|Serotonin Agents|serotonin agents|mesh-ancestor
65709351|NCT02441894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65709352|NCT02441894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709353|NCT02441894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65709354|NCT02441894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65709355|NCT02441894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65709356|NCT02441894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65709357|NCT02441894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65709358|NCT02441894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65709359|NCT02441894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65709360|NCT02441894|Anesthetics, Local|anesthetics, local|mesh-ancestor
65709361|NCT02441894|Anesthetics|anesthetics|mesh-ancestor
65709362|NCT02441894|Sensory System Agents|sensory system agents|mesh-ancestor
65709363|NCT02441894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65709364|NCT02441894|Histamine Antagonists|histamine antagonists|mesh-ancestor
65709365|NCT02441894|Histamine Agents|histamine agents|mesh-ancestor
65709366|NCT02441894|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65709367|NCT02441894|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65709368|NCT02441894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65709369|NCT02441894|Dopamine Agents|dopamine agents|mesh-ancestor
65709370|NCT02441894|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65709371|NCT02441894|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65709372|NCT02433704|Cefazolin|cefazolin|mesh-list
65709373|NCT02433704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65709374|NCT02433704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65709375|NCT05453825|Paclitaxel|paclitaxel|mesh-list
65709376|NCT05453825|Irinotecan|irinotecan|mesh-list
65709377|NCT05453825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65709378|NCT05453825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709379|NCT05453825|Tubulin Modulators|tubulin modulators|mesh-ancestor
65709380|NCT05453825|Antimitotic Agents|antimitotic agents|mesh-ancestor
65709381|NCT05453825|Mitosis Modulators|mitosis modulators|mesh-ancestor
65709382|NCT05453825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709383|NCT05453825|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65709384|NCT05453825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65709385|NCT05453825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65709386|NCT02441816|Aflibercept|aflibercept|mesh-list
65709387|NCT02441816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65709388|NCT02441816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65709389|NCT02441816|Growth Substances|growth substances|mesh-ancestor
65709390|NCT02441816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709391|NCT02441816|Growth Inhibitors|growth inhibitors|mesh-ancestor
65709392|NCT02441816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709393|NCT02433314|Brexanolone|brexanolone|mesh-list
65709394|NCT02433314|Neurosteroids|neurosteroids|mesh-ancestor
65709395|NCT02433314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65709396|NCT02433314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709397|NCT02433314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709398|NCT02433314|GABA Modulators|gaba modulators|mesh-ancestor
65709399|NCT02433314|GABA Agents|gaba agents|mesh-ancestor
65709400|NCT02290431|Dexamethasone|dexamethasone|mesh-list
65709401|NCT02290431|Bortezomib|bortezomib|mesh-list
65709402|NCT02290431|Panobinostat|panobinostat|mesh-list
65709403|NCT02290431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65709404|NCT02290431|Antiemetics|antiemetics|mesh-ancestor
65709405|NCT02290431|Autonomic Agents|autonomic agents|mesh-ancestor
65709406|NCT02290431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709407|NCT02290431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709408|NCT02290431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65709409|NCT02290431|Glucocorticoids|glucocorticoids|mesh-ancestor
65709410|NCT02290431|Hormones|hormones|mesh-ancestor
65709411|NCT02290431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65709412|NCT02290431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65709413|NCT02290431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709414|NCT02290431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65709415|NCT02290431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65709416|NCT02290431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709417|NCT02441270|Cyclophosphamide|cyclophosphamide|mesh-list
65709418|NCT02441270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65709419|NCT02441270|Immunologic Factors|immunologic factors|mesh-ancestor
65709420|NCT02441270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709421|NCT02441270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65709422|NCT02441270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65709423|NCT02441270|Alkylating Agents|alkylating agents|mesh-ancestor
65709424|NCT02441270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709425|NCT02441270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709426|NCT02441270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65709427|NCT02436980|Midazolam|midazolam|mesh-list
65709428|NCT02436980|Tramadol|tramadol|mesh-list
65709429|NCT02436980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65709430|NCT02436980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65709431|NCT02436980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65709432|NCT02436980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709433|NCT02436980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65709434|NCT02436980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65709435|NCT02436980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65709436|NCT02436980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65709437|NCT02436980|Anesthetics, General|anesthetics, general|mesh-ancestor
65709438|NCT02436980|Anesthetics|anesthetics|mesh-ancestor
65709439|NCT02436980|GABA Modulators|gaba modulators|mesh-ancestor
65709440|NCT02436980|GABA Agents|gaba agents|mesh-ancestor
65709441|NCT02436980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65709442|NCT02436980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709443|NCT02436980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65709444|NCT02436980|Narcotics|narcotics|mesh-ancestor
65025283|NCT05275738|Niacin|niacin|mesh-list
65709445|NCT02436980|Analgesics|analgesics|mesh-ancestor
65709446|NCT02436980|Sensory System Agents|sensory system agents|mesh-ancestor
65709447|NCT02436980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709448|NCT02436902|Sorafenib|sorafenib|mesh-list
65709449|NCT02436902|Chlorotrianisene|chlorotrianisene|mesh-list
65709450|NCT02436902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709451|NCT02436902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65709452|NCT02436902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65709453|NCT02436902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709454|NCT02436902|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65709455|NCT02436902|Estrogens|estrogens|mesh-ancestor
65709456|NCT02436902|Hormones|hormones|mesh-ancestor
65709457|NCT02436902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65709458|NCT02436902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709459|NCT02436902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65709460|NCT02436512|Nitric Oxide|nitric oxide|mesh-list
65709461|NCT02436512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65709462|NCT02436512|Autonomic Agents|autonomic agents|mesh-ancestor
65709463|NCT02436512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709464|NCT02436512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709465|NCT02436512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65709466|NCT02436512|Respiratory System Agents|respiratory system agents|mesh-ancestor
65709467|NCT02436512|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65709468|NCT02436512|Antioxidants|antioxidants|mesh-ancestor
65709469|NCT02436512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709470|NCT02436512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65709471|NCT02436512|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65709472|NCT02436512|Vasodilator Agents|vasodilator agents|mesh-ancestor
65709473|NCT02436512|Gasotransmitters|gasotransmitters|mesh-ancestor
65709474|NCT02436512|Protective Agents|protective agents|mesh-ancestor
65709475|NCT04466241|Ritonavir|ritonavir|mesh-list
65709476|NCT04466241|Lopinavir|lopinavir|mesh-list
65709477|NCT04466241|Telmisartan|telmisartan|mesh-list
65709478|NCT04466241|Atorvastatin|atorvastatin|mesh-list
65709479|NCT04466241|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65709480|NCT04466241|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65709481|NCT04466241|Antimetabolites|antimetabolites|mesh-ancestor
65709482|NCT04466241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709483|NCT04466241|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65709484|NCT04466241|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65709485|NCT04466241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65709486|NCT04466241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65709487|NCT04466241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65709488|NCT04466241|Protease Inhibitors|protease inhibitors|mesh-ancestor
65709489|NCT04466241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65709490|NCT04466241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65709491|NCT04466241|Antiviral Agents|antiviral agents|mesh-ancestor
65709492|NCT04466241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65709493|NCT04466241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65709494|NCT04466241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65709495|NCT04466241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65709496|NCT04466241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65709497|NCT04466241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65709498|NCT02440880|Dexamethasone|dexamethasone|mesh-list
65709499|NCT02440880|Dexamethasone acetate|dexamethasone acetate|mesh-list
65709500|NCT02440880|BB 1101|bb 1101|mesh-list
65709501|NCT02440880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65709502|NCT02440880|Antiemetics|antiemetics|mesh-ancestor
65709503|NCT02440880|Autonomic Agents|autonomic agents|mesh-ancestor
65709504|NCT02440880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709505|NCT02440880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709506|NCT02440880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65709507|NCT02440880|Glucocorticoids|glucocorticoids|mesh-ancestor
65709508|NCT02440880|Hormones|hormones|mesh-ancestor
65709509|NCT02440880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65709510|NCT02440880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65709511|NCT02440880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709512|NCT02440880|Protease Inhibitors|protease inhibitors|mesh-ancestor
65709513|NCT02440880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65709514|NCT02440880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709515|NCT03186482|Rifampin|rifampin|mesh-list
65709516|NCT03186482|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65709517|NCT03186482|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65709518|NCT03186482|Antitubercular Agents|antitubercular agents|mesh-ancestor
65709519|NCT03186482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65709520|NCT03186482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65709521|NCT03186482|Leprostatic Agents|leprostatic agents|mesh-ancestor
65709522|NCT03186482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65709523|NCT03186482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65709524|NCT03186482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709525|NCT03186482|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65709526|NCT03186482|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65709527|NCT03186482|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65709528|NCT03186482|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65709529|NCT03186482|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65709530|NCT03186482|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65709531|NCT03186482|Antiviral Agents|antiviral agents|mesh-ancestor
65709532|NCT03186482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65709533|NCT03186482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65709534|NCT03186482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65709536|NCT03522207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65709537|NCT03522207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65709538|NCT03522207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65709539|NCT03522207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709540|NCT03522207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65709541|NCT03522207|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65709542|NCT03522207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65709543|NCT03522207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65709544|NCT03522207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709545|NCT03522207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65709546|NCT03522207|Serotonin Agents|serotonin agents|mesh-ancestor
65709547|NCT03522207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65709548|NCT03522207|Antidepressive Agents|antidepressive agents|mesh-ancestor
65709549|NCT03051659|Pembrolizumab|pembrolizumab|mesh-list
65709550|NCT03051659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65709551|NCT03051659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709552|NCT03528057|Hemostatics|hemostatics|mesh-list
65709553|NCT03528057|Coagulants|coagulants|mesh-ancestor
65709554|NCT05706233|Analgesics|analgesics|mesh-list
65709555|NCT05706233|Sensory System Agents|sensory system agents|mesh-ancestor
65709556|NCT05706233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709557|NCT05706233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709558|NCT05018273|Atezolizumab|atezolizumab|mesh-list
65709559|NCT05018273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709560|NCT02707952|Ritonavir|ritonavir|mesh-list
65709561|NCT02707952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65709562|NCT02707952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65709563|NCT02707952|Protease Inhibitors|protease inhibitors|mesh-ancestor
65709564|NCT02707952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65709565|NCT02707952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709566|NCT02707952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65709567|NCT02707952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65709568|NCT02707952|Antiviral Agents|antiviral agents|mesh-ancestor
65709569|NCT02707952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65709570|NCT02707952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65709571|NCT02707952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65709572|NCT02720445|Nicotine|nicotine|mesh-list
65709573|NCT02720445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65709574|NCT02720445|Autonomic Agents|autonomic agents|mesh-ancestor
65709575|NCT02720445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709576|NCT02720445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709577|NCT02720445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65709578|NCT02720445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65709579|NCT02720445|Cholinergic Agents|cholinergic agents|mesh-ancestor
65709580|NCT02720445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65709581|NCT02720445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709582|NCT02291211|Cisplatin|cisplatin|mesh-list
65709583|NCT02291211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709584|NCT03117998|Volagidemab|volagidemab|mesh-list
65709585|NCT03117998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65709586|NCT03117998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709587|NCT05392101|Deferasirox|deferasirox|mesh-list
65709588|NCT05392101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65709589|NCT05392101|Chelating Agents|chelating agents|mesh-ancestor
65709590|NCT05392101|Sequestering Agents|sequestering agents|mesh-ancestor
65709591|NCT05392101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709592|NCT02291367|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65709593|NCT02291367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65025436|NCT00538720|Vitamin D|vitamin d|mesh-list
65709594|NCT02291367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65709595|NCT02291367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65709596|NCT02291367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709597|NCT02291367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65709598|NCT02291367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709600|NCT02291367|Sensory System Agents|sensory system agents|mesh-ancestor
65709601|NCT02291367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709602|NCT02291367|Antidepressive Agents|antidepressive agents|mesh-ancestor
65709603|NCT02291367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65709604|NCT02291367|Dopamine Agents|dopamine agents|mesh-ancestor
65709605|NCT02440958|Folfirinox|folfirinox|mesh-list
65172287|NCT04982614|Vaccines|vaccines|mesh-list
65709606|NCT02440958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709607|NCT02432534|Atorvastatin|atorvastatin|mesh-list
65709608|NCT02432534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65709609|NCT02432534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65709610|NCT02432534|Antimetabolites|antimetabolites|mesh-ancestor
65709611|NCT02432534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709612|NCT02432534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65709613|NCT02432534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65709614|NCT02432534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65709615|NCT02432612|Nabiximols|nabiximols|mesh-list
65709616|NCT02432612|Analgesics|analgesics|mesh-ancestor
65709617|NCT02432612|Sensory System Agents|sensory system agents|mesh-ancestor
65709618|NCT02432612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709619|NCT02432612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709620|NCT05705843|Vancomycin|vancomycin|mesh-list
65709621|NCT05705843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65709622|NCT05705843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65709623|NCT02436044|Leucovorin|leucovorin|mesh-list
65709624|NCT02436044|Fluorouracil|fluorouracil|mesh-list
65709625|NCT02436044|Oxaliplatin|oxaliplatin|mesh-list
65709626|NCT02436044|Levoleucovorin|levoleucovorin|mesh-list
65709627|NCT02436044|Antimetabolites|antimetabolites|mesh-ancestor
65709628|NCT02436044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709629|NCT02436044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65709630|NCT02436044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709631|NCT02436044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65709632|NCT02436044|Immunologic Factors|immunologic factors|mesh-ancestor
65709633|NCT02436044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709634|NCT02436044|Antidotes|antidotes|mesh-ancestor
65709635|NCT02436044|Protective Agents|protective agents|mesh-ancestor
65709636|NCT02436044|Vitamin B Complex|vitamin b complex|mesh-ancestor
65709637|NCT02436044|Vitamins|vitamins|mesh-ancestor
65709638|NCT02436044|Micronutrients|micronutrients|mesh-ancestor
65709639|NCT02435732|Heparin|heparin|mesh-list
65709640|NCT02435732|Anticoagulants|anticoagulants|mesh-ancestor
65709641|NCT02435732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65709642|NCT02435732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65709643|NCT02435732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709644|NCT02435654|Olanzapine|olanzapine|mesh-list
65709645|NCT02435654|Antiemetics|antiemetics|mesh-ancestor
65709646|NCT02435654|Autonomic Agents|autonomic agents|mesh-ancestor
65709647|NCT02435654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709648|NCT02435654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709649|NCT02435654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65709650|NCT02435654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65709651|NCT02435654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65709652|NCT02435654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65709653|NCT02435654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65709654|NCT02435654|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65709655|NCT02435654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65709656|NCT02435654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65709657|NCT02435654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709658|NCT02435654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65709659|NCT02435654|Serotonin Agents|serotonin agents|mesh-ancestor
65709660|NCT03191162|Benzonidazole|benzonidazole|mesh-list
65709661|NCT03191162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65709662|NCT03191162|Immunologic Factors|immunologic factors|mesh-ancestor
65709663|NCT03191162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709664|NCT03191162|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65709665|NCT03191162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65709666|NCT03191162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65709667|NCT03191162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65709668|NCT05620901|Prednisolone acetate|prednisolone acetate|mesh-list
65709669|NCT05620901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65709670|NCT05620901|Methylprednisolone|methylprednisolone|mesh-list
65709671|NCT05620901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65709672|NCT05620901|Prednisolone|prednisolone|mesh-list
65709673|NCT05620901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65709674|NCT05620901|Prednisolone phosphate|prednisolone phosphate|mesh-list
65709675|NCT05620901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65709676|NCT05620901|Antiemetics|antiemetics|mesh-ancestor
65709677|NCT05620901|Autonomic Agents|autonomic agents|mesh-ancestor
65709678|NCT05620901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709679|NCT05620901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709680|NCT05620901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65709681|NCT05620901|Glucocorticoids|glucocorticoids|mesh-ancestor
65709682|NCT05620901|Hormones|hormones|mesh-ancestor
65709683|NCT05620901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65709684|NCT05620901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65709685|NCT05620901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709686|NCT05620901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65709687|NCT05620901|Protective Agents|protective agents|mesh-ancestor
65709688|NCT05288153|Metformin|metformin|mesh-list
65709689|NCT05288153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65709690|NCT05288153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709691|NCT05571527|Hyaluronic Acid|hyaluronic acid|mesh-list
65709692|NCT05571527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65709693|NCT05571527|Immunologic Factors|immunologic factors|mesh-ancestor
65709694|NCT05571527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709695|NCT05571527|Viscosupplements|viscosupplements|mesh-ancestor
65709696|NCT05571527|Protective Agents|protective agents|mesh-ancestor
65709697|NCT02432066|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
65709698|NCT02432066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65709699|NCT02432066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65709700|NCT02432066|Cholinergic Agents|cholinergic agents|mesh-ancestor
65709701|NCT02432066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65709702|NCT02432066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709703|NCT02432066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709704|NCT04825223|Vaccines|vaccines|mesh-list
65709705|NCT04825223|Immunologic Factors|immunologic factors|mesh-ancestor
65709706|NCT04825223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709707|NCT04824599|Ropivacaine|ropivacaine|mesh-list
65709708|NCT04824599|Anesthetics, Local|anesthetics, local|mesh-list
65709709|NCT04824599|Anesthetics|anesthetics|mesh-list
65709710|NCT04824599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65709711|NCT04824599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709712|NCT04824599|Sensory System Agents|sensory system agents|mesh-ancestor
65709713|NCT04824599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709714|NCT05233514|Metformin|metformin|mesh-list
65709715|NCT05233514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65709716|NCT05233514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709717|NCT02431832|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65709718|NCT02431832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65709719|NCT02431832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65709720|NCT02431832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65709721|NCT02431832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65709722|NCT02431832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709723|NCT02435186|Paclitaxel|paclitaxel|mesh-list
65709724|NCT02435186|Cisplatin|cisplatin|mesh-list
65709725|NCT02435186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65709726|NCT02435186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709727|NCT02435186|Tubulin Modulators|tubulin modulators|mesh-ancestor
65709728|NCT02435186|Antimitotic Agents|antimitotic agents|mesh-ancestor
65709729|NCT02435186|Mitosis Modulators|mitosis modulators|mesh-ancestor
65709730|NCT02435186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709731|NCT02435108|Crizotinib|crizotinib|mesh-list
65709732|NCT02435108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709733|NCT02435108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65709734|NCT02435108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65709735|NCT02435108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709736|NCT05568407|Avelumab|avelumab|mesh-list
65709737|NCT05568407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65709738|NCT05568407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709739|NCT02434952|Piperaquine|piperaquine|mesh-list
65709740|NCT02434952|Primaquine|primaquine|mesh-list
65709741|NCT02434952|Artenimol|artenimol|mesh-list
65709742|NCT02434952|Antimalarials|antimalarials|mesh-ancestor
65709743|NCT02434952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65709744|NCT02434952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65709745|NCT02434952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65709746|NCT03117920|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
65709747|NCT03117920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65709748|NCT03117920|Alkylating Agents|alkylating agents|mesh-ancestor
65709749|NCT03117920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709750|NCT03117920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709751|NCT03626753|Acetaminophen|acetaminophen|mesh-list
65709752|NCT03626753|Piroxicam|piroxicam|mesh-list
65709753|NCT03626753|Nefopam|nefopam|mesh-list
65709754|NCT03626753|Proroxan|proroxan|mesh-list
65709755|NCT03626753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65709756|NCT03626753|Analgesics|analgesics|mesh-ancestor
65709757|NCT03626753|Sensory System Agents|sensory system agents|mesh-ancestor
65709758|NCT03626753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709759|NCT03626753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709760|NCT03626753|Antipyretics|antipyretics|mesh-ancestor
65709761|NCT03626753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65709762|NCT03626753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65709763|NCT03626753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65709764|NCT03626753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65709765|NCT03626753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65709766|NCT03626753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709767|NCT03626753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65709768|NCT03626753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65709769|NCT03626753|Adrenergic Agents|adrenergic agents|mesh-ancestor
65709770|NCT03626753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65709771|NCT03626753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65709772|NCT02440256|Analgesics, Opioid|analgesics, opioid|mesh-list
65709773|NCT02440256|Narcotics|narcotics|mesh-ancestor
65709774|NCT02440256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65709775|NCT02440256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709776|NCT02440256|Analgesics|analgesics|mesh-ancestor
65709777|NCT02440256|Sensory System Agents|sensory system agents|mesh-ancestor
65709778|NCT02440256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709779|NCT05157698|Naltrexone|naltrexone|mesh-list
65709780|NCT05157698|Bupropion|bupropion|mesh-list
65709781|NCT05157698|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65709782|NCT05157698|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65709783|NCT05157698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709784|NCT05157698|Sensory System Agents|sensory system agents|mesh-ancestor
65709785|NCT05157698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709786|NCT05157698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65709787|NCT05157698|Antidepressive Agents|antidepressive agents|mesh-ancestor
65709788|NCT05157698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65709789|NCT05157698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65709790|NCT05157698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65709791|NCT05157698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65709792|NCT05157698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709793|NCT05157698|Dopamine Agents|dopamine agents|mesh-ancestor
65709794|NCT05157698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65709795|NCT05157698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65709796|NCT05157698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65709797|NCT05157698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65709798|NCT03185624|Rifaximin|rifaximin|mesh-list
65709799|NCT03185624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65709800|NCT03185624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65709801|NCT03185624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65709802|NCT02707640|Acetylcysteine|acetylcysteine|mesh-list
65709803|NCT02707640|Pirfenidone|pirfenidone|mesh-list
65709804|NCT02707640|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65709805|NCT02707640|Antiviral Agents|antiviral agents|mesh-ancestor
65709806|NCT02707640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65709807|NCT02707640|Expectorants|expectorants|mesh-ancestor
65709808|NCT02707640|Respiratory System Agents|respiratory system agents|mesh-ancestor
65709809|NCT02707640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65709810|NCT02707640|Antioxidants|antioxidants|mesh-ancestor
65709811|NCT02707640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709812|NCT02707640|Protective Agents|protective agents|mesh-ancestor
65709813|NCT02707640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709814|NCT02707640|Antidotes|antidotes|mesh-ancestor
65709815|NCT02707640|Analgesics|analgesics|mesh-ancestor
65709816|NCT02707640|Sensory System Agents|sensory system agents|mesh-ancestor
65709817|NCT02707640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709818|NCT02707640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65709819|NCT02707640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65709820|NCT02707640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65709821|NCT02707640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65709822|NCT02707640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709823|NCT03190694|Dapagliflozin|dapagliflozin|mesh-list
65709824|NCT03190694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65709825|NCT03190694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709826|NCT03190694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65709827|NCT03190694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709828|NCT02430272|Glycopyrrolate|glycopyrrolate|mesh-list
65709829|NCT02430272|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65709830|NCT02430272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65709831|NCT02430272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65709832|NCT02430272|Cholinergic Agents|cholinergic agents|mesh-ancestor
65709833|NCT02430272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65709834|NCT02430272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709835|NCT02430272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709836|NCT03188978|Atorvastatin|atorvastatin|mesh-list
65709837|NCT03188978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65709838|NCT03188978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65709839|NCT03188978|Antimetabolites|antimetabolites|mesh-ancestor
65709840|NCT03188978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709841|NCT03188978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65709842|NCT03188978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65709843|NCT03188978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65709844|NCT02431286|Dexamethasone|dexamethasone|mesh-list
65709845|NCT02431286|Aprepitant|aprepitant|mesh-list
65709846|NCT02431286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65709847|NCT02431286|Antiemetics|antiemetics|mesh-ancestor
65709848|NCT02431286|Autonomic Agents|autonomic agents|mesh-ancestor
65709849|NCT02431286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709850|NCT02431286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709851|NCT02431286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65709852|NCT02431286|Glucocorticoids|glucocorticoids|mesh-ancestor
65709853|NCT02431286|Hormones|hormones|mesh-ancestor
65709854|NCT02431286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65709855|NCT02431286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65709856|NCT02431286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709857|NCT02431286|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65709858|NCT02431286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65709859|NCT02431286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709860|NCT04579367|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
65709861|NCT04579367|Ezetimibe|ezetimibe|mesh-list
65709862|NCT04579367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65709863|NCT04579367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65709864|NCT04579367|Antimetabolites|antimetabolites|mesh-ancestor
65709865|NCT04579367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709866|NCT04579367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65709867|NCT04579367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65709868|NCT04579367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65709869|NCT04579367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709870|NCT02431208|Dexamethasone|dexamethasone|mesh-list
65709871|NCT02431208|Lenalidomide|lenalidomide|mesh-list
65709872|NCT02431208|Atezolizumab|atezolizumab|mesh-list
65709873|NCT02431208|Daratumumab|daratumumab|mesh-list
65709874|NCT02431208|Pomalidomide|pomalidomide|mesh-list
65709875|NCT02431208|Antibodies|antibodies|mesh-list
65709876|NCT02431208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65709877|NCT02431208|Immunologic Factors|immunologic factors|mesh-ancestor
65709878|NCT02431208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709879|NCT02431208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65709880|NCT02431208|Antiemetics|antiemetics|mesh-ancestor
65709881|NCT02431208|Autonomic Agents|autonomic agents|mesh-ancestor
65709882|NCT02431208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709883|NCT02431208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65709884|NCT02431208|Glucocorticoids|glucocorticoids|mesh-ancestor
65709885|NCT02431208|Hormones|hormones|mesh-ancestor
65709886|NCT02431208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65709887|NCT02431208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65709888|NCT02431208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709889|NCT02431208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65709890|NCT02431208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65709891|NCT02431208|Growth Substances|growth substances|mesh-ancestor
65709892|NCT02431208|Growth Inhibitors|growth inhibitors|mesh-ancestor
65709893|NCT03107078|Methylprednisolone|methylprednisolone|mesh-list
65709894|NCT03107078|Glucocorticoids|glucocorticoids|mesh-list
65025746|NCT00183924|Docetaxel|docetaxel|mesh-list
65709895|NCT03107078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65709896|NCT03107078|Antiemetics|antiemetics|mesh-ancestor
65709897|NCT03107078|Autonomic Agents|autonomic agents|mesh-ancestor
65709898|NCT03107078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709899|NCT03107078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709900|NCT03107078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65709901|NCT03107078|Hormones|hormones|mesh-ancestor
65709902|NCT03107078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65709903|NCT03107078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65709904|NCT03107078|Protective Agents|protective agents|mesh-ancestor
65709905|NCT02430350|Edaravone|edaravone|mesh-list
65709906|NCT02430350|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65709907|NCT02430350|Antioxidants|antioxidants|mesh-ancestor
65709908|NCT02430350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709909|NCT02430350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65709910|NCT02430350|Protective Agents|protective agents|mesh-ancestor
65709911|NCT02430350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709912|NCT02429960|Remifentanil|remifentanil|mesh-list
65709913|NCT02429960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65709914|NCT02429960|Narcotics|narcotics|mesh-ancestor
65709915|NCT02429960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65709916|NCT02429960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709917|NCT02429960|Analgesics|analgesics|mesh-ancestor
65709918|NCT02429960|Sensory System Agents|sensory system agents|mesh-ancestor
65709919|NCT02429960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709920|NCT02429804|Listerine|listerine|mesh-list
65709921|NCT02429804|Deoxyglucose|deoxyglucose|mesh-list
65709922|NCT02429804|Fluorides|fluorides|mesh-list
65709923|NCT02429804|Sodium Fluoride|sodium fluoride|mesh-list
65709924|NCT02429804|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65709925|NCT02429804|Cariostatic Agents|cariostatic agents|mesh-ancestor
65709926|NCT02429804|Protective Agents|protective agents|mesh-ancestor
65709927|NCT02429804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709928|NCT02429804|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65709929|NCT02429804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709930|NCT02429804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65709931|NCT02429804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65709932|NCT02429804|Antimetabolites|antimetabolites|mesh-ancestor
65709933|NCT02429804|Antiviral Agents|antiviral agents|mesh-ancestor
65709934|NCT03185156|Propofol|propofol|mesh-list
65709935|NCT03185156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65709936|NCT03185156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65709937|NCT03185156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709938|NCT03185156|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65709939|NCT03185156|Anesthetics, General|anesthetics, general|mesh-ancestor
65709940|NCT03185156|Anesthetics|anesthetics|mesh-ancestor
65709941|NCT02429726|Cisplatin|cisplatin|mesh-list
65709942|NCT02429726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65709943|NCT02429882|Brodalumab|brodalumab|mesh-list
65709944|NCT02429882|Dermatologic Agents|dermatologic agents|mesh-ancestor
65709945|NCT02430896|Methylphenidate|methylphenidate|mesh-list
65709946|NCT02430896|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65709947|NCT02430896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65709948|NCT02430896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709949|NCT02430896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65709950|NCT02430896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65709951|NCT02430896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65709952|NCT02430896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709953|NCT02430896|Dopamine Agents|dopamine agents|mesh-ancestor
65709954|NCT02430896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65709955|NCT02430896|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65709956|NCT02430896|Adrenergic Agents|adrenergic agents|mesh-ancestor
65709957|NCT03184844|Thalidomide|thalidomide|mesh-list
65709958|NCT03184844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65709959|NCT03184844|Immunologic Factors|immunologic factors|mesh-ancestor
65709960|NCT03184844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709961|NCT03184844|Leprostatic Agents|leprostatic agents|mesh-ancestor
65709962|NCT03184844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65709963|NCT03184844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65709964|NCT03184844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65709965|NCT03184844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65709966|NCT03184844|Growth Substances|growth substances|mesh-ancestor
65709967|NCT03184844|Growth Inhibitors|growth inhibitors|mesh-ancestor
65709968|NCT03184844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025816|NCT00159380|Pimagedine|pimagedine|mesh-list
65709969|NCT02425202|Ketamine|ketamine|mesh-list
65709970|NCT02425202|Analgesics|analgesics|mesh-ancestor
65709971|NCT02425202|Sensory System Agents|sensory system agents|mesh-ancestor
65709972|NCT02425202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65709973|NCT02425202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709974|NCT02425202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65709975|NCT02425202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65709976|NCT02425202|Anesthetics, General|anesthetics, general|mesh-ancestor
65709977|NCT02425202|Anesthetics|anesthetics|mesh-ancestor
65709978|NCT02425202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65709979|NCT02425202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65709980|NCT02425202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65709981|NCT02425202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65709982|NCT02425202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709983|NCT03182504|Meropenem|meropenem|mesh-list
65709984|NCT03182504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65709985|NCT03182504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65709986|NCT02428946|Bromocriptine|bromocriptine|mesh-list
65709987|NCT02428946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65709988|NCT02428946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65709989|NCT02428946|Hormone Antagonists|hormone antagonists|mesh-ancestor
65709990|NCT02428946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65709991|NCT02428946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65709992|NCT02428946|Dopamine Agonists|dopamine agonists|mesh-ancestor
65709993|NCT02428946|Dopamine Agents|dopamine agents|mesh-ancestor
65709994|NCT02428946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65709995|NCT02428946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709996|NCT02424656|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65709997|NCT02424656|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65709998|NCT02424656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65709999|NCT02428868|Tranexamic Acid|tranexamic acid|mesh-list
65710000|NCT02428868|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65710001|NCT02428868|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65710002|NCT02428868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710003|NCT02428868|Hemostatics|hemostatics|mesh-ancestor
65710004|NCT02428868|Coagulants|coagulants|mesh-ancestor
65710005|NCT03181880|Bromides|bromides|mesh-list
65710006|NCT03181880|Formoterol Fumarate|formoterol fumarate|mesh-list
65710007|NCT03181880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65710008|NCT03181880|Autonomic Agents|autonomic agents|mesh-ancestor
65710009|NCT03181880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65710010|NCT03181880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710011|NCT03181880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65710012|NCT03181880|Respiratory System Agents|respiratory system agents|mesh-ancestor
65710013|NCT03181880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65710014|NCT03181880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65710015|NCT03181880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65710016|NCT03181880|Adrenergic Agents|adrenergic agents|mesh-ancestor
65710017|NCT03181880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65710018|NCT03181880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710019|NCT03181880|Anticonvulsants|anticonvulsants|mesh-ancestor
65710020|NCT03178994|Ketoconazole|ketoconazole|mesh-list
65710021|NCT03178994|Antifungal Agents|antifungal agents|mesh-ancestor
65710022|NCT03178994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65710023|NCT03178994|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65710024|NCT03178994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65710025|NCT03178994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710026|NCT03178994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710027|NCT03178994|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65710028|NCT03178994|Hormone Antagonists|hormone antagonists|mesh-ancestor
65710029|NCT03178994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65710030|NCT03178994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710031|NCT03178994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65710032|NCT03182114|Bupivacaine|bupivacaine|mesh-list
65710033|NCT03182114|Anesthetics, Local|anesthetics, local|mesh-ancestor
65710034|NCT03182114|Anesthetics|anesthetics|mesh-ancestor
65710035|NCT03182114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65710036|NCT03182114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710037|NCT03182114|Sensory System Agents|sensory system agents|mesh-ancestor
65710038|NCT03182114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65710039|NCT02428322|Vitamin D|vitamin d|mesh-list
65710040|NCT02428322|Cholecalciferol|cholecalciferol|mesh-list
65710041|NCT02428322|Vitamins|vitamins|mesh-ancestor
65710042|NCT02428322|Micronutrients|micronutrients|mesh-ancestor
65025886|NCT00541177|Mydriatics|mydriatics|mesh-ancestor
65710043|NCT02428322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710044|NCT02428322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65710045|NCT02428322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65710046|NCT03053063|Selonsertib|selonsertib|mesh-list
65710047|NCT03053063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65710048|NCT03053063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710049|NCT03053063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710050|NCT00702338|Hormones|hormones|mesh-list
65710051|NCT00702338|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65710052|NCT00702338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65710053|NCT00702338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710054|NCT05484557|Enoxaparin|enoxaparin|mesh-list
65710055|NCT05484557|Enoxaparin sodium|enoxaparin sodium|mesh-list
65710056|NCT05484557|Apixaban|apixaban|mesh-list
65710057|NCT05484557|Anticoagulants|anticoagulants|mesh-ancestor
65710058|NCT05484557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65710059|NCT05484557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65710060|NCT05484557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710061|NCT05484557|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65710062|NCT05484557|Antithrombins|antithrombins|mesh-ancestor
65710063|NCT05484557|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65710064|NCT05484557|Protease Inhibitors|protease inhibitors|mesh-ancestor
65710065|NCT05484557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710066|NCT02427932|Gentamicins|gentamicins|mesh-list
65710067|NCT02427932|Ampicillin|ampicillin|mesh-list
65710068|NCT02427932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65710069|NCT02427932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65710070|NCT02427932|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65710071|NCT02427932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710072|NCT02427932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710073|NCT03626519|Menthol|menthol|mesh-list
65710074|NCT03626519|Antipruritics|antipruritics|mesh-ancestor
65710075|NCT03626519|Dermatologic Agents|dermatologic agents|mesh-ancestor
65710076|NCT03184766|Ibuprofen|ibuprofen|mesh-list
65710077|NCT03184766|Pseudoephedrine|pseudoephedrine|mesh-list
65710078|NCT03184766|Ephedrine|ephedrine|mesh-list
65710079|NCT03184766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65710080|NCT03184766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65710081|NCT03184766|Analgesics|analgesics|mesh-ancestor
65710082|NCT03184766|Sensory System Agents|sensory system agents|mesh-ancestor
65710083|NCT03184766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65710084|NCT03184766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710085|NCT03184766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65710086|NCT03184766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65710087|NCT03184766|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65710088|NCT03184766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710089|NCT03184766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710090|NCT03184766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65710091|NCT03184766|Autonomic Agents|autonomic agents|mesh-ancestor
65710092|NCT03184766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65710093|NCT03184766|Respiratory System Agents|respiratory system agents|mesh-ancestor
65710094|NCT03184766|Nasal Decongestants|nasal decongestants|mesh-ancestor
65710095|NCT03184766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65710096|NCT03184766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65710097|NCT03184766|Sympathomimetics|sympathomimetics|mesh-ancestor
65710098|NCT03184766|Adrenergic Agents|adrenergic agents|mesh-ancestor
65710099|NCT03184766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65710100|NCT03181646|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
65710101|NCT03181646|Nootropic Agents|nootropic agents|mesh-ancestor
65710102|NCT02420834|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65710103|NCT02420834|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65710104|NCT02420834|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65710105|NCT02420834|Laxatives|laxatives|mesh-ancestor
65710106|NCT02420834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65710107|NCT02423954|Sirolimus|sirolimus|mesh-list
65710108|NCT02423954|Capecitabine|capecitabine|mesh-list
65710109|NCT02423954|Nivolumab|nivolumab|mesh-list
65710110|NCT02423954|Irinotecan|irinotecan|mesh-list
65710111|NCT02423954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65710112|NCT02423954|Antimetabolites|antimetabolites|mesh-ancestor
65710113|NCT02423954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710114|NCT02423954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710115|NCT02423954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65710116|NCT02423954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65710117|NCT02423954|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65710118|NCT02423954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65710119|NCT02423954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710120|NCT02423954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65710121|NCT02423954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65710122|NCT02423954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65710123|NCT02423954|Antifungal Agents|antifungal agents|mesh-ancestor
65710124|NCT02423954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65710125|NCT02423954|Immunologic Factors|immunologic factors|mesh-ancestor
65710126|NCT02423954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710127|NCT04221503|Niraparib|niraparib|mesh-list
65710128|NCT04221503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65710129|NCT04221503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710130|NCT04221503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710131|NCT04221503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710132|NCT02427308|Miltefosine|miltefosine|mesh-list
65710133|NCT02427308|Antifungal Agents|antifungal agents|mesh-ancestor
65710134|NCT02427308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65710135|NCT02427308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710136|NCT02427308|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65710137|NCT02427308|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65710138|NCT03178292|Levofloxacin|levofloxacin|mesh-list
65710139|NCT03178292|Ofloxacin|ofloxacin|mesh-list
65710140|NCT03178292|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65710141|NCT03178292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65710142|NCT03178292|Renal Agents|renal agents|mesh-ancestor
65710143|NCT03178292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65710144|NCT03178292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65710145|NCT03178292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65710146|NCT03178292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710147|NCT03178292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710148|NCT03178292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710149|NCT03178292|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65710150|NCT03178292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65710151|NCT02427386|Estradiol|estradiol|mesh-list
65710152|NCT02427386|Estrogens|estrogens|mesh-list
65710153|NCT02427386|Hormones|hormones|mesh-ancestor
65710154|NCT02427386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65710155|NCT02427386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710156|NCT03181178|Micronutrients|micronutrients|mesh-list
65710157|NCT03181178|Trace Elements|trace elements|mesh-list
65710158|NCT03181178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710159|NCT05478551|Botulinum Toxins|botulinum toxins|mesh-list
65710160|NCT05478551|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65710161|NCT05478551|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65710162|NCT05478551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65710163|NCT05478551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710164|NCT05478551|Cholinergic Agents|cholinergic agents|mesh-ancestor
65710165|NCT05478551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65710166|NCT05478551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710167|NCT04523363|Metformin|metformin|mesh-list
65710168|NCT04523363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65710169|NCT04523363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710170|NCT02420444|BCG Vaccine|bcg vaccine|mesh-list
65710171|NCT02420444|Immunologic Factors|immunologic factors|mesh-ancestor
65710172|NCT02420444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710173|NCT02420444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65710174|NCT03180944|Lugol's solution|lugol's solution|mesh-list
65710175|NCT03180944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65710176|NCT03180944|Hemostatics|hemostatics|mesh-ancestor
65710177|NCT03180944|Coagulants|coagulants|mesh-ancestor
65710178|NCT04025879|Paclitaxel|paclitaxel|mesh-list
65710179|NCT04025879|Docetaxel|docetaxel|mesh-list
65710180|NCT04025879|Carboplatin|carboplatin|mesh-list
65710181|NCT04025879|Nivolumab|nivolumab|mesh-list
65710182|NCT04025879|Pemetrexed|pemetrexed|mesh-list
65710183|NCT04025879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65710184|NCT04025879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710185|NCT04025879|Tubulin Modulators|tubulin modulators|mesh-ancestor
65710186|NCT04025879|Antimitotic Agents|antimitotic agents|mesh-ancestor
65710187|NCT04025879|Mitosis Modulators|mitosis modulators|mesh-ancestor
65710188|NCT04025879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710189|NCT04025879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65710190|NCT04025879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65710191|NCT04025879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710192|NCT04025879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65710193|NCT04025879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65026034|NCT00542074|Ethanol|ethanol|mesh-list
65710194|NCT03180710|Insulin Lispro|insulin lispro|mesh-list
65710195|NCT03180710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65710196|NCT03180710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710197|NCT04322669|Pidotimod|pidotimod|mesh-list
65710198|NCT04322669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65710199|NCT04322669|Immunologic Factors|immunologic factors|mesh-ancestor
65710200|NCT04322669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710201|NCT03180476|Apatinib|apatinib|mesh-list
65710202|NCT03180476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710203|NCT03180476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65710204|NCT03180476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172879|NCT04255498|Analgesics|analgesics|mesh-ancestor
65710205|NCT03180476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710206|NCT03180632|Lorazepam|lorazepam|mesh-list
65710207|NCT03180632|Anticonvulsants|anticonvulsants|mesh-ancestor
65710208|NCT03180632|Antiemetics|antiemetics|mesh-ancestor
65710209|NCT03180632|Autonomic Agents|autonomic agents|mesh-ancestor
65710210|NCT03180632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65710211|NCT03180632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710212|NCT03180632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65710213|NCT03180632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65710214|NCT03180632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65710215|NCT03180632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65710216|NCT03180632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65710217|NCT03180632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65710218|NCT03180632|GABA Modulators|gaba modulators|mesh-ancestor
65710219|NCT03180632|GABA Agents|gaba agents|mesh-ancestor
65710220|NCT03180632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65710221|NCT03180632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710222|NCT02420132|Ranibizumab|ranibizumab|mesh-list
65710223|NCT02420132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65710224|NCT02420132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65710225|NCT02420132|Growth Substances|growth substances|mesh-ancestor
65710226|NCT02420132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710227|NCT02420132|Growth Inhibitors|growth inhibitors|mesh-ancestor
65710228|NCT02420132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710229|NCT04414475|Dexamethasone|dexamethasone|mesh-list
65710230|NCT04414475|Bortezomib|bortezomib|mesh-list
65710231|NCT04414475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65710232|NCT04414475|Antiemetics|antiemetics|mesh-ancestor
65710233|NCT04414475|Autonomic Agents|autonomic agents|mesh-ancestor
65710234|NCT04414475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65710235|NCT04414475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710236|NCT04414475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65710237|NCT04414475|Glucocorticoids|glucocorticoids|mesh-ancestor
65710238|NCT04414475|Hormones|hormones|mesh-ancestor
65710239|NCT04414475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65710240|NCT04414475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65710241|NCT04414475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710242|NCT03183752|Metformin|metformin|mesh-list
65710243|NCT03183752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65710244|NCT03183752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710245|NCT03183674|Oxytocin|oxytocin|mesh-list
65710246|NCT03183674|Oxytocics|oxytocics|mesh-ancestor
65710247|NCT03183674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65710248|NCT03183674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710249|NCT03117530|Minocycline|minocycline|mesh-list
65710250|NCT03117530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65710251|NCT03117530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65710252|NCT03889925|Hyaluronic Acid|hyaluronic acid|mesh-list
65710253|NCT03889925|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65710254|NCT03889925|Immunologic Factors|immunologic factors|mesh-ancestor
65710255|NCT03889925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710256|NCT03889925|Viscosupplements|viscosupplements|mesh-ancestor
65710257|NCT03889925|Protective Agents|protective agents|mesh-ancestor
65710258|NCT05103254|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
65710259|NCT05103254|Ezetimibe|ezetimibe|mesh-list
65710260|NCT05103254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65710261|NCT05103254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65710262|NCT05103254|Antimetabolites|antimetabolites|mesh-ancestor
65710263|NCT05103254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710264|NCT05103254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65710265|NCT05103254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026127|NCT00542893|Oblimersen|oblimersen|mesh-list
65710266|NCT05103254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65710267|NCT05103254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710268|NCT02426840|Calcium, Dietary|calcium, dietary|mesh-list
65710269|NCT02426840|Vitamin D|vitamin d|mesh-list
65710270|NCT02426840|Ergocalciferols|ergocalciferols|mesh-list
65710271|NCT02426840|Cholecalciferol|cholecalciferol|mesh-list
65710272|NCT02426840|Vitamins|vitamins|mesh-list
65710273|NCT02426840|Calcium|calcium|mesh-list
65710274|NCT02426840|Micronutrients|micronutrients|mesh-ancestor
65710275|NCT02426840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710276|NCT02426840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65710277|NCT02426840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65710278|NCT03178526|Lovastatin|lovastatin|mesh-list
65710279|NCT03178526|L 647318|l 647318|mesh-list
65710280|NCT03178526|Dihydromevinolin|dihydromevinolin|mesh-list
65710281|NCT03178526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65710282|NCT03178526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65710283|NCT03178526|Antimetabolites|antimetabolites|mesh-ancestor
65710284|NCT03178526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710285|NCT03178526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65710286|NCT03178526|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65710287|NCT03178526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710288|NCT03857321|Insulin|insulin|mesh-list
65710289|NCT03857321|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65710290|NCT03857321|Insulin, Isophane|insulin, isophane|mesh-list
65710291|NCT03857321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65710292|NCT03857321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710293|NCT02423642|Heparin|heparin|mesh-list
65710294|NCT02423642|Anticoagulants|anticoagulants|mesh-ancestor
65710295|NCT02423642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710296|NCT02423642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65710297|NCT02423642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65710298|NCT03180242|Trastuzumab|trastuzumab|mesh-list
65710299|NCT03180242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65710300|NCT03180242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710301|NCT00709904|Semuloparin|semuloparin|mesh-list
65710302|NCT00709904|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65710303|NCT00709904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65710304|NCT00709904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65710305|NCT00709904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710306|NCT00709904|Anticoagulants|anticoagulants|mesh-ancestor
65710307|NCT04356989|Rivaroxaban|rivaroxaban|mesh-list
65710308|NCT04356989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65710309|NCT04356989|Antithrombins|antithrombins|mesh-ancestor
65710310|NCT04356989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65710311|NCT04356989|Protease Inhibitors|protease inhibitors|mesh-ancestor
65710312|NCT04356989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710313|NCT04356989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710314|NCT04356989|Anticoagulants|anticoagulants|mesh-ancestor
65710315|NCT03183596|Dexamethasone|dexamethasone|mesh-list
65710316|NCT03183596|Bupivacaine|bupivacaine|mesh-list
65710317|NCT03183596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65710318|NCT03183596|Antiemetics|antiemetics|mesh-ancestor
65710319|NCT03183596|Autonomic Agents|autonomic agents|mesh-ancestor
65710320|NCT03183596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65710321|NCT03183596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710322|NCT03183596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65710323|NCT03183596|Glucocorticoids|glucocorticoids|mesh-ancestor
65710324|NCT03183596|Hormones|hormones|mesh-ancestor
65710325|NCT03183596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65710326|NCT03183596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65710327|NCT03183596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710328|NCT03183596|Anesthetics, Local|anesthetics, local|mesh-ancestor
65710329|NCT03183596|Anesthetics|anesthetics|mesh-ancestor
65710330|NCT03183596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65710331|NCT03183596|Sensory System Agents|sensory system agents|mesh-ancestor
65710332|NCT03742505|Cholecalciferol|cholecalciferol|mesh-list
65710333|NCT03742505|Vitamin D|vitamin d|mesh-list
65710334|NCT03742505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65710335|NCT03742505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710336|NCT03742505|Vitamins|vitamins|mesh-ancestor
65710337|NCT03742505|Micronutrients|micronutrients|mesh-ancestor
65710338|NCT03742505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65710339|NCT03117062|Salicylic Acid|salicylic acid|mesh-list
65710340|NCT03117062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65710341|NCT03117062|Antifungal Agents|antifungal agents|mesh-ancestor
65710342|NCT03117062|Keratolytic Agents|keratolytic agents|mesh-ancestor
65710343|NCT03117062|Dermatologic Agents|dermatologic agents|mesh-ancestor
65710344|NCT03620669|Durvalumab|durvalumab|mesh-list
65710345|NCT03620669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65710346|NCT03620669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710347|NCT04325243|Sildenafil Citrate|sildenafil citrate|mesh-list
65710348|NCT04325243|Vasodilator Agents|vasodilator agents|mesh-ancestor
65710349|NCT04325243|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65710350|NCT04325243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65710351|NCT04325243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710352|NCT04325243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710353|NCT04325243|Urological Agents|urological agents|mesh-ancestor
65710354|NCT02419820|Aspirin|aspirin|mesh-list
65710355|NCT02419820|Clopidogrel|clopidogrel|mesh-list
65710356|NCT02419820|APD791|apd791|mesh-list
65710357|NCT02419820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65710358|NCT02419820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65710359|NCT02419820|Analgesics|analgesics|mesh-ancestor
65710360|NCT02419820|Sensory System Agents|sensory system agents|mesh-ancestor
65710361|NCT02419820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65710362|NCT02419820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710363|NCT02419820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65710364|NCT02419820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65710365|NCT02419820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65710366|NCT02419820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65710367|NCT02419820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710368|NCT02419820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65710369|NCT02419820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65710370|NCT02419820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710371|NCT02419820|Antipyretics|antipyretics|mesh-ancestor
65710372|NCT02419820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65710373|NCT02419820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65710374|NCT02419820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65710375|NCT02419820|Purinergic Agents|purinergic agents|mesh-ancestor
65710376|NCT02419820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65710377|NCT02419820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65710378|NCT02419820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65710379|NCT02419820|Serotonin Agents|serotonin agents|mesh-ancestor
65710380|NCT05692739|Cyclosporine|cyclosporine|mesh-list
65710381|NCT05692739|Lubricant Eye Drops|lubricant eye drops|mesh-list
65710382|NCT05692739|Cyclosporins|cyclosporins|mesh-list
65710383|NCT05692739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710384|NCT05692739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710385|NCT05692739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710386|NCT05692739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65710387|NCT05692739|Immunologic Factors|immunologic factors|mesh-ancestor
65710388|NCT05692739|Antifungal Agents|antifungal agents|mesh-ancestor
65710389|NCT05692739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65710390|NCT05692739|Dermatologic Agents|dermatologic agents|mesh-ancestor
65710391|NCT05692739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65710392|NCT05692739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65710393|NCT05692739|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65710394|NCT05692739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65710395|NCT02419352|Atropine|atropine|mesh-list
65710396|NCT02419352|Neostigmine|neostigmine|mesh-list
65710397|NCT02419352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65710398|NCT02419352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65710399|NCT02419352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65710400|NCT02419352|Autonomic Agents|autonomic agents|mesh-ancestor
65710401|NCT02419352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65710402|NCT02419352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710403|NCT02419352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65710404|NCT02419352|Respiratory System Agents|respiratory system agents|mesh-ancestor
65710405|NCT02419352|Mydriatics|mydriatics|mesh-ancestor
65710406|NCT02419352|Parasympatholytics|parasympatholytics|mesh-ancestor
65710407|NCT02419352|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65710408|NCT02419352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65710409|NCT02419352|Cholinergic Agents|cholinergic agents|mesh-ancestor
65710410|NCT02419352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65710411|NCT02419352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710412|NCT02419352|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65710413|NCT02419352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710414|NCT02419352|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65710415|NCT03365687|Vitamin D|vitamin d|mesh-list
65710416|NCT03365687|Cholecalciferol|cholecalciferol|mesh-list
65710417|NCT03365687|Vitamins|vitamins|mesh-ancestor
65710418|NCT03365687|Micronutrients|micronutrients|mesh-ancestor
65710419|NCT03365687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710420|NCT03365687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65710421|NCT03365687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65710422|NCT02419118|Dexamethasone|dexamethasone|mesh-list
65710423|NCT02419118|Lenalidomide|lenalidomide|mesh-list
65710424|NCT02419118|Daratumumab|daratumumab|mesh-list
65710425|NCT02419118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65710426|NCT02419118|Antiemetics|antiemetics|mesh-ancestor
65710427|NCT02419118|Autonomic Agents|autonomic agents|mesh-ancestor
65710428|NCT02419118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65710429|NCT02419118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710430|NCT02419118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65710431|NCT02419118|Glucocorticoids|glucocorticoids|mesh-ancestor
65710432|NCT02419118|Hormones|hormones|mesh-ancestor
65710433|NCT02419118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65710434|NCT02419118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65710435|NCT02419118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710436|NCT02419118|Immunologic Factors|immunologic factors|mesh-ancestor
65710437|NCT02419118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65710438|NCT02419118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65710439|NCT02419118|Growth Substances|growth substances|mesh-ancestor
65710440|NCT02419118|Growth Inhibitors|growth inhibitors|mesh-ancestor
65710441|NCT02426294|Pioglitazone|pioglitazone|mesh-list
65710442|NCT02426294|Glimepiride|glimepiride|mesh-list
65710443|NCT02426294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65710444|NCT02426294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710445|NCT02426294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65710446|NCT02426294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65710447|NCT02426294|Immunologic Factors|immunologic factors|mesh-ancestor
65710448|NCT02426450|Leucovorin|leucovorin|mesh-list
65710449|NCT02426450|Fluorouracil|fluorouracil|mesh-list
65710450|NCT02426450|Oxaliplatin|oxaliplatin|mesh-list
65710451|NCT02426450|Antimetabolites|antimetabolites|mesh-ancestor
65710452|NCT02426450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710453|NCT02426450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65710454|NCT02426450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710455|NCT02426450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65710456|NCT02426450|Immunologic Factors|immunologic factors|mesh-ancestor
65710457|NCT02426450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710458|NCT02426450|Antidotes|antidotes|mesh-ancestor
65710459|NCT02426450|Protective Agents|protective agents|mesh-ancestor
65710460|NCT02426450|Vitamin B Complex|vitamin b complex|mesh-ancestor
65710461|NCT02426450|Vitamins|vitamins|mesh-ancestor
65710462|NCT02426450|Micronutrients|micronutrients|mesh-ancestor
65710463|NCT03811847|Methylphenidate|methylphenidate|mesh-list
65710464|NCT03811847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65710465|NCT03811847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710466|NCT03811847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65710467|NCT03811847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65710468|NCT03811847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65710469|NCT03811847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710470|NCT03811847|Dopamine Agents|dopamine agents|mesh-ancestor
65710471|NCT03811847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65710472|NCT02426060|Warfarin|warfarin|mesh-list
65710473|NCT02426060|Anticoagulants|anticoagulants|mesh-ancestor
65710474|NCT02422784|Vitamin D|vitamin d|mesh-list
65710475|NCT02422784|Ergocalciferols|ergocalciferols|mesh-list
65710476|NCT02422784|Cholecalciferol|cholecalciferol|mesh-list
65710477|NCT02422784|Vitamins|vitamins|mesh-list
65710478|NCT02422784|Micronutrients|micronutrients|mesh-ancestor
65710479|NCT02422784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710480|NCT02422784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65710481|NCT02422784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65710482|NCT03740009|Bazedoxifene|bazedoxifene|mesh-list
65710483|NCT03740009|Estrogens|estrogens|mesh-list
65710484|NCT03740009|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65710485|NCT03740009|Hormones|hormones|mesh-ancestor
65710486|NCT03740009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65710487|NCT03740009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710488|NCT03740009|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65710489|NCT03740009|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65710490|NCT03740009|Hormone Antagonists|hormone antagonists|mesh-ancestor
65710491|NCT03740009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65710492|NCT02418572|Testosterone|testosterone|mesh-list
65710493|NCT02418572|Androgens|androgens|mesh-ancestor
65710494|NCT02418572|Hormones|hormones|mesh-ancestor
65710495|NCT02418572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65710496|NCT02418572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710497|NCT05514899|Dronabinol|dronabinol|mesh-list
65710498|NCT05514899|Cannabidiol|cannabidiol|mesh-list
65710499|NCT05514899|Anticonvulsants|anticonvulsants|mesh-ancestor
65710500|NCT05514899|Hallucinogens|hallucinogens|mesh-ancestor
65710501|NCT05514899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710502|NCT05514899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65710503|NCT05514899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65710504|NCT05514899|Analgesics|analgesics|mesh-ancestor
65710505|NCT05514899|Sensory System Agents|sensory system agents|mesh-ancestor
65710506|NCT05514899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65173176|NCT00629889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65710507|NCT05514899|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65710508|NCT05514899|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65710509|NCT05514899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65710510|NCT05514899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710511|NCT05514899|Hormones|hormones|mesh-ancestor
65710512|NCT05514899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65710513|NCT03179618|Vasodilator Agents|vasodilator agents|mesh-list
65710514|NCT03179618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65710515|NCT03179618|Lipid Regulating Agents|lipid regulating agents|mesh-list
65710516|NCT03182894|Pembrolizumab|pembrolizumab|mesh-list
65710517|NCT03182894|Azacitidine|azacitidine|mesh-list
65710518|NCT03182894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65710519|NCT03182894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710520|NCT03182894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65710521|NCT03182894|Antimetabolites|antimetabolites|mesh-ancestor
65710522|NCT03182894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710523|NCT03182894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710524|NCT02418884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65710525|NCT02418884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65710526|NCT02418884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65710527|NCT02418884|Antimetabolites|antimetabolites|mesh-ancestor
65710528|NCT02418884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710529|NCT02418884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65710530|NCT02418884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65710531|NCT02418884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710532|NCT02423096|Haloperidol|haloperidol|mesh-list
65710533|NCT02423096|Olanzapine|olanzapine|mesh-list
65710534|NCT02423096|Risperidone|risperidone|mesh-list
65710535|NCT02423096|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65710536|NCT02423096|Sulpiride|sulpiride|mesh-list
65710537|NCT02423096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65710538|NCT02423096|Serotonin Agents|serotonin agents|mesh-ancestor
65710539|NCT02423096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65710540|NCT02423096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710541|NCT02423096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710542|NCT02423096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65710543|NCT02423096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65710544|NCT02423096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65710545|NCT02423096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65710546|NCT02423096|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65710547|NCT02423096|Dopamine Agents|dopamine agents|mesh-ancestor
65710548|NCT02423096|Antiemetics|antiemetics|mesh-ancestor
65710549|NCT02423096|Autonomic Agents|autonomic agents|mesh-ancestor
65710550|NCT02423096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65710551|NCT02423096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65710552|NCT02423096|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65710553|NCT02423096|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65710554|NCT02423096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65710555|NCT02423096|Antidepressive Agents|antidepressive agents|mesh-ancestor
65710556|NCT02423096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65710557|NCT02423096|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65710558|NCT03629951|Antipsychotic Agents|antipsychotic agents|mesh-list
65710559|NCT03629951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65710560|NCT03629951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65710561|NCT03629951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710562|NCT03629951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65710563|NCT02423018|Pregabalin|pregabalin|mesh-list
65710564|NCT02423018|Analgesics|analgesics|mesh-ancestor
65710565|NCT02423018|Sensory System Agents|sensory system agents|mesh-ancestor
65710566|NCT02423018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65710567|NCT02423018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710568|NCT02423018|Anticonvulsants|anticonvulsants|mesh-ancestor
65710569|NCT02423018|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65710570|NCT02423018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65710571|NCT02423018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710572|NCT02423018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65710573|NCT02423018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65026396|NCT00544570|Carmustine|carmustine|mesh-list
65710574|NCT02423018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65710575|NCT02423018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65710576|NCT02423018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65710578|NCT03179384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65710579|NCT03179384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65710580|NCT05691959|Calcium|calcium|mesh-list
65710581|NCT05691959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65710582|NCT05691959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710583|NCT02422706|Metronidazole|metronidazole|mesh-list
65710584|NCT02422706|Clarithromycin|clarithromycin|mesh-list
65710585|NCT02422706|Levofloxacin|levofloxacin|mesh-list
65710586|NCT02422706|Ofloxacin|ofloxacin|mesh-list
65710587|NCT02422706|Nitazoxanide|nitazoxanide|mesh-list
65710588|NCT02422706|Doxycycline|doxycycline|mesh-list
65710589|NCT02422706|Omeprazole|omeprazole|mesh-list
65710590|NCT02422706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65710591|NCT02422706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65710592|NCT02422706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65710593|NCT02422706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65710594|NCT02422706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65710595|NCT02422706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65710596|NCT02422706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65710597|NCT02422706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710598|NCT02422706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710599|NCT02422706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65710600|NCT02422706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65710601|NCT02422706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65710602|NCT02422706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65710603|NCT02422706|Renal Agents|renal agents|mesh-ancestor
65710604|NCT02422706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65710605|NCT02422706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65710606|NCT02422706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710607|NCT02422706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65710608|NCT02422706|Antimalarials|antimalarials|mesh-ancestor
65710609|NCT03058757|Mitomycins|mitomycins|mesh-list
65710610|NCT03058757|Mitomycin|mitomycin|mesh-list
65710611|NCT03058757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65710612|NCT03058757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710613|NCT03058757|Alkylating Agents|alkylating agents|mesh-ancestor
65710614|NCT03058757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710615|NCT03058757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65710616|NCT03058757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710617|NCT03138889|Paclitaxel|paclitaxel|mesh-list
65710618|NCT03138889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65710619|NCT03138889|Carboplatin|carboplatin|mesh-list
65710620|NCT03138889|Pembrolizumab|pembrolizumab|mesh-list
65710621|NCT03138889|Pemetrexed|pemetrexed|mesh-list
65710622|NCT03138889|Atezolizumab|atezolizumab|mesh-list
65710623|NCT03138889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65710624|NCT03138889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710625|NCT03138889|Tubulin Modulators|tubulin modulators|mesh-ancestor
65710626|NCT03138889|Antimitotic Agents|antimitotic agents|mesh-ancestor
65710627|NCT03138889|Mitosis Modulators|mitosis modulators|mesh-ancestor
65710628|NCT03138889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710629|NCT03138889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65710630|NCT03138889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710631|NCT03138889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65710632|NCT03138889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65710633|NCT01881763|Ketamine|ketamine|mesh-list
65710634|NCT01881763|Methohexital|methohexital|mesh-list
65710635|NCT01881763|Analgesics|analgesics|mesh-ancestor
65710636|NCT01881763|Sensory System Agents|sensory system agents|mesh-ancestor
65710637|NCT01881763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65710638|NCT01881763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710639|NCT01881763|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65710640|NCT01881763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65710641|NCT01881763|Anesthetics, General|anesthetics, general|mesh-ancestor
65710642|NCT01881763|Anesthetics|anesthetics|mesh-ancestor
65710643|NCT01881763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65710644|NCT01881763|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65710645|NCT01881763|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65710646|NCT01881763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65710647|NCT01881763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710648|NCT03669601|Gemcitabine|gemcitabine|mesh-list
65710649|NCT03669601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65710650|NCT03669601|Antimetabolites|antimetabolites|mesh-ancestor
65710651|NCT03669601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710652|NCT03669601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710653|NCT03669601|Antiviral Agents|antiviral agents|mesh-ancestor
65710654|NCT03669601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65710655|NCT03669601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710656|NCT03669601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65710657|NCT03669601|Immunologic Factors|immunologic factors|mesh-ancestor
65710658|NCT03669601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710659|NCT02959463|Pembrolizumab|pembrolizumab|mesh-list
65710660|NCT02959463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65710661|NCT02959463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710662|NCT02416388|Cytarabine|cytarabine|mesh-list
65710663|NCT02416388|Cyclosporine|cyclosporine|mesh-list
65710664|NCT02416388|Mycophenolic Acid|mycophenolic acid|mesh-list
65710665|NCT02416388|Dexamethasone|dexamethasone|mesh-list
65710666|NCT02416388|Methotrexate|methotrexate|mesh-list
65710667|NCT02416388|Daunorubicin|daunorubicin|mesh-list
65710668|NCT02416388|Venetoclax|venetoclax|mesh-list
65710669|NCT02416388|Idarubicin|idarubicin|mesh-list
65710670|NCT02416388|Cyclosporins|cyclosporins|mesh-list
65710671|NCT02416388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65710672|NCT02416388|Antiemetics|antiemetics|mesh-ancestor
65710673|NCT02416388|Autonomic Agents|autonomic agents|mesh-ancestor
65710674|NCT02416388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65710675|NCT02416388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710676|NCT02416388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65710677|NCT02416388|Glucocorticoids|glucocorticoids|mesh-ancestor
65710678|NCT02416388|Hormones|hormones|mesh-ancestor
65710679|NCT02416388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65710680|NCT02416388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65710681|NCT02416388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710682|NCT02416388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65710683|NCT02416388|Abortifacient Agents|abortifacient agents|mesh-ancestor
65710684|NCT02416388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65710685|NCT02416388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65710686|NCT02416388|Antimetabolites|antimetabolites|mesh-ancestor
65710687|NCT02416388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710688|NCT02416388|Dermatologic Agents|dermatologic agents|mesh-ancestor
65710689|NCT02416388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710690|NCT02416388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65710691|NCT02416388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65710692|NCT02416388|Immunologic Factors|immunologic factors|mesh-ancestor
65710693|NCT02416388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65710694|NCT02416388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65710695|NCT02416388|Antiviral Agents|antiviral agents|mesh-ancestor
65710696|NCT02416388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65710697|NCT02416388|Antifungal Agents|antifungal agents|mesh-ancestor
65710698|NCT02416388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65710699|NCT02416388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65710700|NCT02416388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65710701|NCT02416388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65710702|NCT02416388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65710703|NCT02416388|Antitubercular Agents|antitubercular agents|mesh-ancestor
65710704|NCT02416388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65710705|NCT02886065|Lenalidomide|lenalidomide|mesh-list
65710706|NCT02886065|Poly ICLC|poly iclc|mesh-list
65710707|NCT02886065|Citarinostat|citarinostat|mesh-list
65710708|NCT02886065|Immunologic Factors|immunologic factors|mesh-ancestor
65710709|NCT02886065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710710|NCT02886065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65710711|NCT02886065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65710712|NCT02886065|Growth Substances|growth substances|mesh-ancestor
65710713|NCT02886065|Growth Inhibitors|growth inhibitors|mesh-ancestor
65710714|NCT02886065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710715|NCT02886065|Interferon Inducers|interferon inducers|mesh-ancestor
65710716|NCT02886065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65710717|NCT02886065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710718|NCT02886065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710719|NCT03392441|Insulin|insulin|mesh-list
65710720|NCT03392441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65710721|NCT03392441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710722|NCT03177824|Sildenafil Citrate|sildenafil citrate|mesh-list
65710723|NCT03177824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710724|NCT03177824|Vasodilator Agents|vasodilator agents|mesh-ancestor
65710725|NCT03177824|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65710726|NCT03177824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65710727|NCT03177824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710728|NCT03177824|Urological Agents|urological agents|mesh-ancestor
65710729|NCT02416232|Trametinib|trametinib|mesh-list
65710730|NCT02416232|Dabrafenib|dabrafenib|mesh-list
65710731|NCT02416232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710732|NCT02416232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65710733|NCT02416232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710734|NCT02416232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710735|NCT04482842|Warfarin|warfarin|mesh-list
65710736|NCT04482842|Anticoagulants|anticoagulants|mesh-ancestor
65710737|NCT02767661|Capecitabine|capecitabine|mesh-list
65710738|NCT02767661|Letrozole|letrozole|mesh-list
65710739|NCT02767661|Anastrozole|anastrozole|mesh-list
65710740|NCT02767661|Exemestane|exemestane|mesh-list
65710741|NCT02767661|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65710742|NCT02767661|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65710743|NCT02767661|Antimetabolites|antimetabolites|mesh-ancestor
65710744|NCT02767661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710745|NCT02767661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710746|NCT02767661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65710747|NCT02767661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710748|NCT02767661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65710749|NCT02767661|Hormone Antagonists|hormone antagonists|mesh-ancestor
65710750|NCT02767661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65710751|NCT02767661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710752|NCT02767661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65710753|NCT02415920|Oxytocin|oxytocin|mesh-list
65710754|NCT02415920|Oxytocics|oxytocics|mesh-ancestor
65710755|NCT02415920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65710756|NCT02415920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710757|NCT05691491|Temozolomide|temozolomide|mesh-list
65710758|NCT05691491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65710759|NCT05691491|Alkylating Agents|alkylating agents|mesh-ancestor
65710760|NCT05691491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710761|NCT05691491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710762|NCT03389243|Acetaminophen|acetaminophen|mesh-list
65710763|NCT03389243|Dipyrone|dipyrone|mesh-list
65710764|NCT03389243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65710765|NCT03389243|Analgesics|analgesics|mesh-ancestor
65710766|NCT03389243|Sensory System Agents|sensory system agents|mesh-ancestor
65710767|NCT03389243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65710768|NCT03389243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710769|NCT03389243|Antipyretics|antipyretics|mesh-ancestor
65710770|NCT03389243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65710771|NCT03389243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65710772|NCT03389243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65710773|NCT02421926|Imatinib Mesylate|imatinib mesylate|mesh-list
65710774|NCT02421926|Dasatinib|dasatinib|mesh-list
65710775|NCT02421926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710776|NCT02421926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65710777|NCT02421926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710778|NCT02421926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710779|NCT02410460|Lidocaine|lidocaine|mesh-list
65710780|NCT02410460|Clonidine|clonidine|mesh-list
65710781|NCT02410460|Midazolam|midazolam|mesh-list
65710782|NCT02410460|Glycopyrrolate|glycopyrrolate|mesh-list
65710783|NCT02410460|Scopolamine|scopolamine|mesh-list
65710784|NCT02410460|Ketamine|ketamine|mesh-list
65710785|NCT02410460|Ondansetron|ondansetron|mesh-list
65710786|NCT02410460|Metoclopramide|metoclopramide|mesh-list
65710787|NCT02410460|Bupivacaine|bupivacaine|mesh-list
65710788|NCT02410460|Propofol|propofol|mesh-list
65710789|NCT02410460|Sevoflurane|sevoflurane|mesh-list
65710790|NCT02410460|Desflurane|desflurane|mesh-list
65710791|NCT02410460|Famotidine|famotidine|mesh-list
65710792|NCT02410460|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65710793|NCT02410460|Anesthetics, Local|anesthetics, local|mesh-ancestor
65710794|NCT02410460|Anesthetics|anesthetics|mesh-ancestor
65710795|NCT02410460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65710796|NCT02410460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710797|NCT02410460|Sensory System Agents|sensory system agents|mesh-ancestor
65710798|NCT02410460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65710799|NCT02410460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65710800|NCT02410460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65710801|NCT02410460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65026618|NCT00160589|Histamine Agents|histamine agents|mesh-ancestor
65710802|NCT02410460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65710803|NCT02410460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710804|NCT02410460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65710805|NCT02410460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65710807|NCT02410460|Analgesics|analgesics|mesh-ancestor
65710808|NCT02410460|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65710809|NCT02410460|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65710810|NCT02410460|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65710811|NCT02410460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65710812|NCT02410460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65710813|NCT02410460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65710814|NCT02410460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65710815|NCT02410460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65710816|NCT02410460|GABA Modulators|gaba modulators|mesh-ancestor
65710817|NCT02410460|GABA Agents|gaba agents|mesh-ancestor
65710818|NCT02410460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65710819|NCT02410460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65710820|NCT02410460|Antiemetics|antiemetics|mesh-ancestor
65710821|NCT02410460|Autonomic Agents|autonomic agents|mesh-ancestor
65710822|NCT02410460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65710823|NCT02410460|Antipruritics|antipruritics|mesh-ancestor
65710824|NCT02410460|Dermatologic Agents|dermatologic agents|mesh-ancestor
65710825|NCT02410460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65710826|NCT02410460|Serotonin Agents|serotonin agents|mesh-ancestor
65710827|NCT02410460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65710828|NCT02410460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65710829|NCT02410460|Sympatholytics|sympatholytics|mesh-ancestor
65710830|NCT02410460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65710831|NCT02410460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65710832|NCT02410460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65710833|NCT02410460|Adrenergic Agents|adrenergic agents|mesh-ancestor
65710834|NCT02410460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65710835|NCT02410460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65710836|NCT02410460|Dopamine Agents|dopamine agents|mesh-ancestor
65710837|NCT02410460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65710838|NCT02410460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65710839|NCT02410460|Cholinergic Agents|cholinergic agents|mesh-ancestor
65710840|NCT02410460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65710841|NCT02410460|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65710842|NCT02410460|Histamine Antagonists|histamine antagonists|mesh-ancestor
65710843|NCT02410460|Histamine Agents|histamine agents|mesh-ancestor
65710844|NCT02410460|Mydriatics|mydriatics|mesh-ancestor
65710845|NCT02410460|Parasympatholytics|parasympatholytics|mesh-ancestor
65710846|NCT02410226|Anesthetics|anesthetics|mesh-list
65710847|NCT02410226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65710848|NCT02410226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710849|NCT03116672|Diclofenac|diclofenac|mesh-list
65710850|NCT03116672|Ketorolac|ketorolac|mesh-list
65710851|NCT03116672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65710852|NCT03116672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65710853|NCT03116672|Analgesics|analgesics|mesh-ancestor
65710854|NCT03116672|Sensory System Agents|sensory system agents|mesh-ancestor
65710855|NCT03116672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65710856|NCT03116672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710857|NCT03116672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65710858|NCT03116672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65710859|NCT03116672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65710860|NCT03116672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710861|NCT03116672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710862|NCT03174860|Diclofenac|diclofenac|mesh-list
65710863|NCT03174860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65710864|NCT03174860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65710865|NCT03174860|Analgesics|analgesics|mesh-ancestor
65710866|NCT03174860|Sensory System Agents|sensory system agents|mesh-ancestor
65710867|NCT03174860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65710868|NCT03174860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710869|NCT03174860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65710870|NCT03174860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65710871|NCT03174860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65710872|NCT03174860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710873|NCT03174860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710874|NCT03174548|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65710875|NCT03174548|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65710876|NCT03174548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710877|NCT03174548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65026706|NCT00546520|Hormones|hormones|mesh-ancestor
65710878|NCT03174548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710880|NCT02417090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65710881|NCT02417090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710882|NCT00703820|Cytarabine|cytarabine|mesh-list
65710883|NCT00703820|Etoposide|etoposide|mesh-list
65710884|NCT00703820|Daunorubicin|daunorubicin|mesh-list
65710885|NCT00703820|Clofarabine|clofarabine|mesh-list
65710886|NCT00703820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65710887|NCT00703820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710888|NCT00703820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65710889|NCT00703820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65710890|NCT00703820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710891|NCT00703820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710892|NCT00703820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65710893|NCT00703820|Antimetabolites|antimetabolites|mesh-ancestor
65710894|NCT00703820|Antiviral Agents|antiviral agents|mesh-ancestor
65710895|NCT00703820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65710896|NCT00703820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65710897|NCT00703820|Immunologic Factors|immunologic factors|mesh-ancestor
65710898|NCT00703820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710899|NCT00703820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65710900|NCT03177980|Clonidine|clonidine|mesh-list
65710901|NCT03177980|Fentanyl|fentanyl|mesh-list
65710902|NCT03177980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65710903|NCT03177980|Narcotics|narcotics|mesh-ancestor
65710904|NCT03177980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65710905|NCT03177980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710906|NCT03177980|Analgesics|analgesics|mesh-ancestor
65710907|NCT03177980|Sensory System Agents|sensory system agents|mesh-ancestor
65710908|NCT03177980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65710909|NCT03177980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65710910|NCT03177980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65710911|NCT03177980|Anesthetics, General|anesthetics, general|mesh-ancestor
65710912|NCT03177980|Anesthetics|anesthetics|mesh-ancestor
65710913|NCT03177980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65710914|NCT03177980|Sympatholytics|sympatholytics|mesh-ancestor
65710915|NCT03177980|Autonomic Agents|autonomic agents|mesh-ancestor
65710916|NCT03177980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65710917|NCT03177980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65710918|NCT03177980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65710919|NCT03177980|Adrenergic Agents|adrenergic agents|mesh-ancestor
65710920|NCT03177980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65710921|NCT03177980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710922|NCT03174782|Bupivacaine|bupivacaine|mesh-list
65710923|NCT03174782|Anesthetics, Local|anesthetics, local|mesh-ancestor
65710924|NCT03174782|Anesthetics|anesthetics|mesh-ancestor
65710925|NCT03174782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65710926|NCT03174782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710927|NCT03174782|Sensory System Agents|sensory system agents|mesh-ancestor
65710928|NCT03174782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65710929|NCT02443077|Cytarabine|cytarabine|mesh-list
65710930|NCT02443077|Cyclophosphamide|cyclophosphamide|mesh-list
65710931|NCT02443077|Melphalan|melphalan|mesh-list
65710932|NCT02443077|Mechlorethamine|mechlorethamine|mesh-list
65710933|NCT02443077|Carmustine|carmustine|mesh-list
65710934|NCT02443077|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65710935|NCT02443077|Etoposide|etoposide|mesh-list
65710936|NCT02443077|Etoposide phosphate|etoposide phosphate|mesh-list
65710937|NCT02443077|Podophyllotoxin|podophyllotoxin|mesh-list
65710938|NCT02443077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65710939|NCT02443077|Immunologic Factors|immunologic factors|mesh-ancestor
65710940|NCT02443077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710941|NCT02443077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65710942|NCT02443077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65710943|NCT02443077|Alkylating Agents|alkylating agents|mesh-ancestor
65710944|NCT02443077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710945|NCT02443077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710946|NCT02443077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65710947|NCT02443077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65710948|NCT02443077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65710949|NCT02443077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65710950|NCT02443077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710951|NCT02443077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65710952|NCT02443077|Antimetabolites|antimetabolites|mesh-ancestor
65710953|NCT02443077|Antiviral Agents|antiviral agents|mesh-ancestor
65710954|NCT02443077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65710955|NCT02443077|Keratolytic Agents|keratolytic agents|mesh-ancestor
65710956|NCT02443077|Dermatologic Agents|dermatologic agents|mesh-ancestor
65710957|NCT02443077|Tubulin Modulators|tubulin modulators|mesh-ancestor
65710958|NCT02443077|Antimitotic Agents|antimitotic agents|mesh-ancestor
65710959|NCT02443077|Mitosis Modulators|mitosis modulators|mesh-ancestor
65710960|NCT03177434|Lactulose|lactulose|mesh-list
65710961|NCT03177434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65710962|NCT02587325|Sirolimus|sirolimus|mesh-list
65710963|NCT02587325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65710964|NCT02587325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65710965|NCT02587325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65710966|NCT02587325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65710967|NCT02587325|Antifungal Agents|antifungal agents|mesh-ancestor
65710968|NCT02587325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65710969|NCT02587325|Immunologic Factors|immunologic factors|mesh-ancestor
65710970|NCT02587325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710971|NCT02414984|Golimumab|golimumab|mesh-list
65710972|NCT02414984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65710973|NCT02414984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65710974|NCT02414984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65710975|NCT02414984|Immunologic Factors|immunologic factors|mesh-ancestor
65710976|NCT02414984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710977|NCT02415062|Donepezil|donepezil|mesh-list
65710978|NCT02415062|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65710979|NCT02415062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710980|NCT02415062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710981|NCT02415062|Cholinergic Agents|cholinergic agents|mesh-ancestor
65710982|NCT02415062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65710983|NCT02415062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710984|NCT02415062|Nootropic Agents|nootropic agents|mesh-ancestor
65710985|NCT02408978|Naproxen|naproxen|mesh-list
65710986|NCT02408978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65710987|NCT02408978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65710988|NCT02408978|Analgesics|analgesics|mesh-ancestor
65710989|NCT02408978|Sensory System Agents|sensory system agents|mesh-ancestor
65710990|NCT02408978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65710991|NCT02408978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65710992|NCT02408978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65710993|NCT02408978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65710994|NCT02408978|Gout Suppressants|gout suppressants|mesh-ancestor
65710995|NCT02408978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65710996|NCT02408978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65710997|NCT02408978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65710998|NCT02408744|Pirfenidone|pirfenidone|mesh-list
65710999|NCT02408744|Analgesics|analgesics|mesh-ancestor
65711000|NCT02408744|Sensory System Agents|sensory system agents|mesh-ancestor
65711001|NCT02408744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65711002|NCT02408744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711003|NCT02408744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65711004|NCT02408744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65711005|NCT02408744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65711006|NCT02408744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65711007|NCT02408744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711008|NCT03174080|Fluorides|fluorides|mesh-list
65711009|NCT03174080|Cariostatic Agents|cariostatic agents|mesh-ancestor
65711010|NCT03174080|Protective Agents|protective agents|mesh-ancestor
65711011|NCT03174080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711012|NCT03116516|Amlodipine|amlodipine|mesh-list
65711013|NCT03116516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65711014|NCT03116516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65711015|NCT03116516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65711016|NCT03116516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65711017|NCT03116516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711018|NCT03116516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65711019|NCT03116516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711020|NCT03116516|Vasodilator Agents|vasodilator agents|mesh-ancestor
65711021|NCT03116516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65711022|NCT03116516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65711023|NCT03116516|Antimetabolites|antimetabolites|mesh-ancestor
65711024|NCT03116516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65711025|NCT03116516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65711026|NCT03116516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711027|NCT01564537|Dexamethasone|dexamethasone|mesh-list
65711028|NCT01564537|Lenalidomide|lenalidomide|mesh-list
65711029|NCT01564537|Ixazomib|ixazomib|mesh-list
65711030|NCT01564537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65711032|NCT01564537|Autonomic Agents|autonomic agents|mesh-ancestor
65711033|NCT01564537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65711034|NCT01564537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711035|NCT01564537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65711036|NCT01564537|Glucocorticoids|glucocorticoids|mesh-ancestor
65711037|NCT01564537|Hormones|hormones|mesh-ancestor
65711038|NCT01564537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65711039|NCT01564537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65711040|NCT01564537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711041|NCT01564537|Immunologic Factors|immunologic factors|mesh-ancestor
65711042|NCT01564537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65711043|NCT01564537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65711044|NCT01564537|Growth Substances|growth substances|mesh-ancestor
65711045|NCT01564537|Growth Inhibitors|growth inhibitors|mesh-ancestor
65711046|NCT01564537|Protease Inhibitors|protease inhibitors|mesh-ancestor
65711047|NCT01564537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711048|NCT01564537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711049|NCT02446457|Rituximab|rituximab|mesh-list
65711050|NCT02446457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65711051|NCT02446457|Pembrolizumab|pembrolizumab|mesh-list
65711052|NCT02446457|Lenalidomide|lenalidomide|mesh-list
65711053|NCT02446457|Antibodies|antibodies|mesh-list
65711054|NCT02446457|Immunoglobulins|immunoglobulins|mesh-list
65711055|NCT02446457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65711056|NCT02446457|Immunologic Factors|immunologic factors|mesh-ancestor
65711057|NCT02446457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711058|NCT02446457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711059|NCT02446457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65711060|NCT02446457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65711061|NCT02446457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65711062|NCT02446457|Growth Substances|growth substances|mesh-ancestor
65711063|NCT02446457|Growth Inhibitors|growth inhibitors|mesh-ancestor
65711064|NCT03174236|Metronidazole|metronidazole|mesh-list
65711065|NCT03174236|Gentamicins|gentamicins|mesh-list
65711066|NCT03174236|Ceftriaxone|ceftriaxone|mesh-list
65711067|NCT03174236|Penicillins|penicillins|mesh-list
65711068|NCT03174236|Penicillin G|penicillin g|mesh-list
65711069|NCT03174236|Penicillin G Benzathine|penicillin g benzathine|mesh-list
65711070|NCT03174236|Penicillin G Procaine|penicillin g procaine|mesh-list
65711071|NCT03174236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65711072|NCT03174236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65711073|NCT03174236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65711074|NCT03174236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65711075|NCT03174236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65711076|NCT03174236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711077|NCT03174236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711078|NCT03172052|Streptokinase|streptokinase|mesh-list
65711079|NCT03172052|Mesna|mesna|mesh-list
65711080|NCT03172052|Protective Agents|protective agents|mesh-ancestor
65711081|NCT03172052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711082|NCT03172052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65711083|NCT03172052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65711084|NCT03172052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711085|NCT03171818|Darbepoetin alfa|darbepoetin alfa|mesh-list
65711086|NCT03171818|Hematinics|hematinics|mesh-ancestor
65711087|NCT05672459|Cyclophosphamide|cyclophosphamide|mesh-list
65711088|NCT05672459|Fludarabine|fludarabine|mesh-list
65711089|NCT05672459|Fludarabine phosphate|fludarabine phosphate|mesh-list
65711090|NCT05672459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65711091|NCT05672459|Immunologic Factors|immunologic factors|mesh-ancestor
65711092|NCT05672459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711093|NCT05672459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65711094|NCT05672459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65711095|NCT05672459|Alkylating Agents|alkylating agents|mesh-ancestor
65711096|NCT05672459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711097|NCT05672459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711098|NCT05672459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65711099|NCT05672459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65711100|NCT05672459|Antimetabolites|antimetabolites|mesh-ancestor
65711101|NCT02408354|Glycerol|glycerol|mesh-list
65711102|NCT02408354|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65711103|NCT02408354|Protective Agents|protective agents|mesh-ancestor
65711104|NCT02408354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711105|NCT03176264|Bevacizumab|bevacizumab|mesh-list
65711106|NCT03176264|Spartalizumab|spartalizumab|mesh-list
65711107|NCT03176264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65711108|NCT03176264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711109|NCT03176264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65711110|NCT03176264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65711111|NCT03176264|Growth Substances|growth substances|mesh-ancestor
65711112|NCT03176264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711113|NCT03176264|Growth Inhibitors|growth inhibitors|mesh-ancestor
65711114|NCT03176264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65711115|NCT03176264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711116|NCT02406170|Paclitaxel|paclitaxel|mesh-list
65711117|NCT02406170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65711118|NCT02406170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711119|NCT02406170|Tubulin Modulators|tubulin modulators|mesh-ancestor
65711120|NCT02406170|Antimitotic Agents|antimitotic agents|mesh-ancestor
65711121|NCT02406170|Mitosis Modulators|mitosis modulators|mesh-ancestor
65711122|NCT02406170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711123|NCT02413658|Phenytoin|phenytoin|mesh-list
65711124|NCT02413658|Anticonvulsants|anticonvulsants|mesh-ancestor
65711125|NCT02413658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65711126|NCT02413658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65711127|NCT02413658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65711128|NCT02413658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711129|NCT02413658|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65711130|NCT02413658|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65711131|NCT02406014|Diclofenac|diclofenac|mesh-list
65711132|NCT02406014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65711133|NCT02406014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65711134|NCT02406014|Analgesics|analgesics|mesh-ancestor
65711135|NCT02406014|Sensory System Agents|sensory system agents|mesh-ancestor
65711136|NCT02406014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65711137|NCT02406014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711138|NCT02406014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65711139|NCT02406014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65711140|NCT02406014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65711141|NCT02406014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711142|NCT02406014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711143|NCT02406092|Prednisone|prednisone|mesh-list
65711144|NCT02406092|Cyclophosphamide|cyclophosphamide|mesh-list
65711145|NCT02406092|Rituximab|rituximab|mesh-list
65711146|NCT02406092|Doxorubicin|doxorubicin|mesh-list
65711147|NCT02406092|Fludarabine|fludarabine|mesh-list
65711148|NCT02406092|Vincristine|vincristine|mesh-list
65711149|NCT02406092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65711150|NCT02406092|Immunologic Factors|immunologic factors|mesh-ancestor
65711151|NCT02406092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711152|NCT02406092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65711153|NCT02406092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65711154|NCT02406092|Alkylating Agents|alkylating agents|mesh-ancestor
65711155|NCT02406092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711156|NCT02406092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711157|NCT02406092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65711158|NCT02406092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65711159|NCT02406092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65711160|NCT02406092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65711161|NCT02406092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65711162|NCT02406092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711163|NCT02406092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65711164|NCT02406092|Glucocorticoids|glucocorticoids|mesh-ancestor
65711165|NCT02406092|Hormones|hormones|mesh-ancestor
65711166|NCT02406092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65711167|NCT02406092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65711168|NCT02406092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65711169|NCT02406092|Tubulin Modulators|tubulin modulators|mesh-ancestor
65711170|NCT02406092|Antimitotic Agents|antimitotic agents|mesh-ancestor
65711171|NCT02406092|Mitosis Modulators|mitosis modulators|mesh-ancestor
65711172|NCT02413268|Nitroglycerin|nitroglycerin|mesh-list
65711173|NCT02413268|Vasodilator Agents|vasodilator agents|mesh-ancestor
65711174|NCT02405858|Prednisolone|prednisolone|mesh-list
65711175|NCT02405858|Abiraterone Acetate|abiraterone acetate|mesh-list
65711176|NCT02405858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65711177|NCT02405858|Glucocorticoids|glucocorticoids|mesh-ancestor
65711178|NCT02405858|Hormones|hormones|mesh-ancestor
65711179|NCT02405858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65711180|NCT02405858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711181|NCT02405858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65711182|NCT02405858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711183|NCT02405858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65711184|NCT02405858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711185|NCT02405858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711186|NCT02405858|Hormone Antagonists|hormone antagonists|mesh-ancestor
65711187|NCT02405858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65711188|NCT03171740|Midazolam|midazolam|mesh-list
65711189|NCT03171740|Dexmedetomidine|dexmedetomidine|mesh-list
65711190|NCT03171740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65711191|NCT03171740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65711192|NCT03171740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65711193|NCT03171740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711194|NCT03171740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65711195|NCT03171740|Analgesics|analgesics|mesh-ancestor
65711196|NCT03171740|Sensory System Agents|sensory system agents|mesh-ancestor
65711197|NCT03171740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65711198|NCT03171740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65711199|NCT03171740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65711200|NCT03171740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65711201|NCT03171740|Adrenergic Agents|adrenergic agents|mesh-ancestor
65711202|NCT03171740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65711203|NCT03171740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711204|NCT03171740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65711205|NCT03171740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65711206|NCT03171740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65711207|NCT03171740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65711208|NCT03171740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65711209|NCT03171740|Anesthetics, General|anesthetics, general|mesh-ancestor
65711210|NCT03171740|Anesthetics|anesthetics|mesh-ancestor
65711211|NCT03171740|GABA Modulators|gaba modulators|mesh-ancestor
65711212|NCT03171740|GABA Agents|gaba agents|mesh-ancestor
65711213|NCT03176186|Xenon|xenon|mesh-list
65711214|NCT03176186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65711215|NCT03176186|Anesthetics, General|anesthetics, general|mesh-ancestor
65711216|NCT03176186|Anesthetics|anesthetics|mesh-ancestor
65711217|NCT03176186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65711218|NCT03176186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711219|NCT04482764|Valproic Acid|valproic acid|mesh-list
65711220|NCT04482764|Anticonvulsants|anticonvulsants|mesh-ancestor
65711221|NCT04482764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711222|NCT04482764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711223|NCT04482764|GABA Agents|gaba agents|mesh-ancestor
65711224|NCT04482764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65711225|NCT04482764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711226|NCT04482764|Antimanic Agents|antimanic agents|mesh-ancestor
65711227|NCT04482764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65711228|NCT04482764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65711229|NCT04482764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65711230|NCT02408042|Rituximab|rituximab|mesh-list
65711231|NCT02408042|Pembrolizumab|pembrolizumab|mesh-list
65711232|NCT02408042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65711233|NCT02408042|Carboplatin|carboplatin|mesh-list
65711234|NCT02408042|Etoposide|etoposide|mesh-list
65711235|NCT02408042|Ifosfamide|ifosfamide|mesh-list
65711236|NCT02408042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65711237|NCT02408042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711238|NCT02408042|Immunologic Factors|immunologic factors|mesh-ancestor
65711239|NCT02408042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711240|NCT02408042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65711241|NCT02408042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65711242|NCT02408042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65711243|NCT02408042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65711244|NCT02408042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711245|NCT02408042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711246|NCT02408042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65711247|NCT02408042|Alkylating Agents|alkylating agents|mesh-ancestor
65711248|NCT03172988|Dexamethasone|dexamethasone|mesh-list
65711249|NCT03172988|Dexamethasone acetate|dexamethasone acetate|mesh-list
65711250|NCT03172988|Flurbiprofen|flurbiprofen|mesh-list
65711251|NCT03172988|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
65711252|NCT03172988|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65711253|NCT03172988|BB 1101|bb 1101|mesh-list
65711254|NCT03172988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65711255|NCT03172988|Antiemetics|antiemetics|mesh-ancestor
65711256|NCT03172988|Autonomic Agents|autonomic agents|mesh-ancestor
65711257|NCT03172988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65711258|NCT03172988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711259|NCT03172988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65711261|NCT03172988|Hormones|hormones|mesh-ancestor
65711262|NCT03172988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65711263|NCT03172988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65711264|NCT03172988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711265|NCT03172988|Protease Inhibitors|protease inhibitors|mesh-ancestor
65711266|NCT03172988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711267|NCT03172988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711268|NCT03172988|Analgesics|analgesics|mesh-ancestor
65711269|NCT03172988|Sensory System Agents|sensory system agents|mesh-ancestor
65711270|NCT03172988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65711271|NCT03172988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65711272|NCT03172988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65711273|NCT03172988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65711274|NCT03042611|Apatinib|apatinib|mesh-list
65711275|NCT03042611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711276|NCT03042611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65711277|NCT03042611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711278|NCT03042611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711279|NCT03171584|Itraconazole|itraconazole|mesh-list
65711280|NCT03171584|Fluconazole|fluconazole|mesh-list
65711281|NCT03171584|Terbinafine|terbinafine|mesh-list
65711282|NCT03171584|Antifungal Agents|antifungal agents|mesh-ancestor
65711283|NCT03171584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65711284|NCT03171584|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65711285|NCT03171584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65711286|NCT03171584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711287|NCT03171584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711288|NCT03171584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65711289|NCT03171584|Hormone Antagonists|hormone antagonists|mesh-ancestor
65711290|NCT03171584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65711291|NCT03171584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711292|NCT03171584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65711293|NCT03171584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65711294|NCT03171584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65711295|NCT02950259|Indomethacin|indomethacin|mesh-list
65711296|NCT02950259|Cyclophosphamide|cyclophosphamide|mesh-list
65711297|NCT02950259|Omeprazole|omeprazole|mesh-list
65711298|NCT02950259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65711299|NCT02950259|Immunologic Factors|immunologic factors|mesh-ancestor
65711300|NCT02950259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711301|NCT02950259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65711302|NCT02950259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65711303|NCT02950259|Alkylating Agents|alkylating agents|mesh-ancestor
65711304|NCT02950259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711305|NCT02950259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711306|NCT02950259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65711307|NCT02950259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65711308|NCT02950259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65711309|NCT02950259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65711310|NCT02950259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711311|NCT02950259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65711312|NCT02950259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65711313|NCT02950259|Analgesics|analgesics|mesh-ancestor
65711314|NCT02950259|Sensory System Agents|sensory system agents|mesh-ancestor
65711315|NCT02950259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65711316|NCT02950259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65711317|NCT02950259|Gout Suppressants|gout suppressants|mesh-ancestor
65711318|NCT02950259|Tocolytic Agents|tocolytic agents|mesh-ancestor
65711319|NCT02950259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65711320|NCT02950259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65711321|NCT02349815|Levonorgestrel|levonorgestrel|mesh-list
65711322|NCT02349815|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65711323|NCT02349815|Contraceptive Agents|contraceptive agents|mesh-ancestor
65711324|NCT02349815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65711325|NCT02349815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711326|NCT02349815|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65711327|NCT02349815|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65711328|NCT02349815|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65711329|NCT02818517|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65711330|NCT02818517|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65711331|NCT02818517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65711332|NCT02818517|Adrenergic Agents|adrenergic agents|mesh-ancestor
65711333|NCT02818517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65711334|NCT02818517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711335|NCT02818517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711336|NCT02818517|Protease Inhibitors|protease inhibitors|mesh-ancestor
65711337|NCT02818517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711338|NCT02412566|SMOFlipid|smoflipid|mesh-list
65711339|NCT02412566|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65711340|NCT02412566|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65711341|NCT02412566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65711342|NCT02407340|Benzalkonium Compounds|benzalkonium compounds|mesh-list
65711343|NCT02407340|Oxytocin|oxytocin|mesh-list
65711344|NCT02407340|Oxytocics|oxytocics|mesh-ancestor
65711345|NCT02407340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65711346|NCT02407340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711347|NCT02407340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65711348|NCT02407340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65711349|NCT02405156|Letrozole|letrozole|mesh-list
65711350|NCT02405156|Misoprostol|misoprostol|mesh-list
65711351|NCT02405156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711352|NCT02405156|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65711353|NCT02405156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65711354|NCT02405156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711355|NCT02405156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711356|NCT02405156|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65711357|NCT02405156|Hormone Antagonists|hormone antagonists|mesh-ancestor
65711358|NCT02405156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65711359|NCT02405156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711360|NCT02405156|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65711361|NCT02405156|Abortifacient Agents|abortifacient agents|mesh-ancestor
65711362|NCT02405156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65711363|NCT02405156|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65711364|NCT02405156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65711365|NCT02405156|Oxytocics|oxytocics|mesh-ancestor
65711366|NCT02411942|Adapalene|adapalene|mesh-list
65711367|NCT02411942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65711368|NCT02411942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65711369|NCT02411942|Analgesics|analgesics|mesh-ancestor
65711370|NCT02411942|Sensory System Agents|sensory system agents|mesh-ancestor
65711371|NCT02411942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65711372|NCT02411942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711373|NCT02411942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65711374|NCT02411942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65711375|NCT02411942|Dermatologic Agents|dermatologic agents|mesh-ancestor
65711376|NCT02406950|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65711377|NCT02406950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65711378|NCT02406950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711379|NCT02406950|Incretins|incretins|mesh-ancestor
65711380|NCT02406950|Hormones|hormones|mesh-ancestor
65711381|NCT02406950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65711382|NCT02406950|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65711383|NCT02406950|Protease Inhibitors|protease inhibitors|mesh-ancestor
65711384|NCT02406950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711385|NCT02406950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711386|NCT02406872|Propofol|propofol|mesh-list
65711387|NCT02406872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65711388|NCT02406872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65711389|NCT02406872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711390|NCT02406872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65711391|NCT02406872|Anesthetics, General|anesthetics, general|mesh-ancestor
65711392|NCT02406872|Anesthetics|anesthetics|mesh-ancestor
65711393|NCT03172676|Amoxicillin|amoxicillin|mesh-list
65711394|NCT03172676|Clarithromycin|clarithromycin|mesh-list
65711395|NCT03172676|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65711396|NCT03172676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65711397|NCT03172676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65711398|NCT03172676|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65711399|NCT03172676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711400|NCT03172676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711401|NCT03172676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65711402|NCT03172676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65711403|NCT02404844|Tamoxifen|tamoxifen|mesh-list
65711404|NCT02404844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65711405|NCT02404844|Hormone Antagonists|hormone antagonists|mesh-ancestor
65711406|NCT02404844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65711407|NCT02404844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711408|NCT02404844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65711409|NCT02404844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711410|NCT02404844|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65711411|NCT02404844|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65711412|NCT02404844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65711413|NCT04482296|Zinc Sulfate|zinc sulfate|mesh-list
65711414|NCT04482296|Astringents|astringents|mesh-ancestor
65711415|NCT04482296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711416|NCT04482296|Dermatologic Agents|dermatologic agents|mesh-ancestor
65711417|NCT03116282|Ethanol|ethanol|mesh-list
65711418|NCT03116282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65711419|NCT03116282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65711420|NCT03116282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65711421|NCT03116282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711422|NCT02404454|Hyaluronic Acid|hyaluronic acid|mesh-list
65711423|NCT02404454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65711424|NCT02404454|Immunologic Factors|immunologic factors|mesh-ancestor
65711425|NCT02404454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711426|NCT02404454|Viscosupplements|viscosupplements|mesh-ancestor
65711427|NCT02404454|Protective Agents|protective agents|mesh-ancestor
65711428|NCT03115892|Chlorhexidine|chlorhexidine|mesh-list
65711429|NCT03115892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65711430|NCT03115892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65711431|NCT03115892|Disinfectants|disinfectants|mesh-ancestor
65711432|NCT02411786|Molgramostim|molgramostim|mesh-list
65711433|NCT02411786|Sargramostim|sargramostim|mesh-list
65711434|NCT02411786|Immunologic Factors|immunologic factors|mesh-ancestor
65711435|NCT02411786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711436|NCT02411786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711437|NCT02404376|Exenatide|exenatide|mesh-list
65711438|NCT02404376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65711439|NCT02404376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711440|NCT02404376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65711441|NCT02404376|Incretins|incretins|mesh-ancestor
65711442|NCT02404376|Hormones|hormones|mesh-ancestor
65711443|NCT02404376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65711444|NCT04466085|Vaccines|vaccines|mesh-list
65711445|NCT04466085|Immunologic Factors|immunologic factors|mesh-ancestor
65711446|NCT04466085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711447|NCT03517995|Sulforaphane|sulforaphane|mesh-list
65711448|NCT03517995|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65711449|NCT03517995|Protective Agents|protective agents|mesh-ancestor
65711450|NCT03517995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711451|NCT03517995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711452|NCT02411630|Tenofovir|tenofovir|mesh-list
65711453|NCT02411630|Emtricitabine|emtricitabine|mesh-list
65711454|NCT02411630|Antiviral Agents|antiviral agents|mesh-ancestor
65711455|NCT02411630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65711456|NCT02411630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65711457|NCT02411630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65711458|NCT02411630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711459|NCT02411630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711460|NCT02411630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65711461|NCT02411630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65711462|NCT02411318|Ethanol|ethanol|mesh-list
65711463|NCT02411318|Caffeine|caffeine|mesh-list
65711464|NCT02411318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65711465|NCT02411318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711466|NCT02411318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65711467|NCT02411318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711468|NCT02411318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711469|NCT02411318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65711470|NCT02411318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65711471|NCT02411318|Purinergic Agents|purinergic agents|mesh-ancestor
65711472|NCT02411318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65711473|NCT02411318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65711474|NCT02411318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65711475|NCT02411318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65711476|NCT03133299|Vitamin D|vitamin d|mesh-list
65711477|NCT03133299|Glucocorticoids|glucocorticoids|mesh-list
65711478|NCT03133299|Vitamins|vitamins|mesh-ancestor
65711479|NCT03133299|Micronutrients|micronutrients|mesh-ancestor
65711480|NCT03133299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711481|NCT03133299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65711482|NCT03133299|Hormones|hormones|mesh-ancestor
65711483|NCT03133299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65711484|NCT04465695|Interferons|interferons|mesh-list
65711485|NCT04465695|Interferon-beta|interferon-beta|mesh-list
65711486|NCT04465695|Clofazimine|clofazimine|mesh-list
65711487|NCT04465695|Interferon beta-1b|interferon beta-1b|mesh-list
65711488|NCT04465695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711489|NCT04465695|Antiviral Agents|antiviral agents|mesh-ancestor
65711490|NCT04465695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65711491|NCT04465695|Immunologic Factors|immunologic factors|mesh-ancestor
65711492|NCT04465695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711493|NCT04465695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65711494|NCT04465695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65711495|NCT04465695|Leprostatic Agents|leprostatic agents|mesh-ancestor
65711496|NCT04465695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65711497|NCT03115736|Tenofovir|tenofovir|mesh-list
65711498|NCT03115736|Antiviral Agents|antiviral agents|mesh-ancestor
65711499|NCT03115736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65711500|NCT03115736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65711501|NCT03115736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65711502|NCT03115736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711503|NCT03115736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711504|NCT03115736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65711505|NCT03115736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65711506|NCT04465851|Curcumin|curcumin|mesh-list
65711507|NCT04465851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65711508|NCT04465851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65711509|NCT04465851|Analgesics|analgesics|mesh-ancestor
65711510|NCT04465851|Sensory System Agents|sensory system agents|mesh-ancestor
65711511|NCT04465851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65711512|NCT04465851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711513|NCT04465851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65711514|NCT04465851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65711515|NCT04465851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711516|NCT04465851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711517|NCT04465851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711518|NCT04465539|Hydrocortisone|hydrocortisone|mesh-list
65711519|NCT04465539|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65711520|NCT04465539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65711521|NCT04465539|Plasma Substitutes|plasma substitutes|mesh-ancestor
65711522|NCT04465539|Blood Substitutes|blood substitutes|mesh-ancestor
65711523|NCT02404142|Atracurium|atracurium|mesh-list
65711524|NCT02404142|Curare|curare|mesh-list
65711525|NCT02404142|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65711526|NCT02404142|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65711527|NCT02404142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65711528|NCT02404142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65711529|NCT02404142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711530|NCT02404142|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65711531|NCT02404142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65711532|NCT02404142|Cholinergic Agents|cholinergic agents|mesh-ancestor
65711533|NCT02404142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65711534|NCT02404142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711535|NCT03522051|Calcium|calcium|mesh-list
65711536|NCT03522051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65711537|NCT03522051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711538|NCT03171974|Dexamethasone|dexamethasone|mesh-list
65711539|NCT03171974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65711540|NCT03171974|Antiemetics|antiemetics|mesh-ancestor
65711541|NCT03171974|Autonomic Agents|autonomic agents|mesh-ancestor
65711542|NCT03171974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65711543|NCT03171974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711544|NCT03171974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65711545|NCT03171974|Glucocorticoids|glucocorticoids|mesh-ancestor
65711546|NCT03171974|Hormones|hormones|mesh-ancestor
65711547|NCT03171974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65711548|NCT03171974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65711549|NCT03171974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711550|NCT02292069|Amlodipine|amlodipine|mesh-list
65711551|NCT02292069|Atorvastatin|atorvastatin|mesh-list
65711552|NCT02292069|Calcium|calcium|mesh-list
65711553|NCT02292069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65711554|NCT02292069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711555|NCT02292069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65027375|NCT00551239|Rituximab|rituximab|mesh-list
65711556|NCT02292069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65711557|NCT02292069|Antimetabolites|antimetabolites|mesh-ancestor
65711558|NCT02292069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711559|NCT02292069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65711560|NCT02292069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65711561|NCT02292069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711562|NCT02292069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65711563|NCT02292069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65711564|NCT02292069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65711565|NCT02292069|Vasodilator Agents|vasodilator agents|mesh-ancestor
65711566|NCT02404064|Metronidazole|metronidazole|mesh-list
65711567|NCT02404064|Cefotaxime|cefotaxime|mesh-list
65711568|NCT02404064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65711569|NCT02404064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65711570|NCT02404064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65711571|NCT02404064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65711572|NCT02294643|Aspirin|aspirin|mesh-list
65711573|NCT02294643|Sarpogrelate|sarpogrelate|mesh-list
65711574|NCT02294643|Clopidogrel|clopidogrel|mesh-list
65711575|NCT02294643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65711576|NCT02294643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65711577|NCT02294643|Analgesics|analgesics|mesh-ancestor
65711578|NCT02294643|Sensory System Agents|sensory system agents|mesh-ancestor
65711579|NCT02294643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65711580|NCT02294643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711581|NCT02294643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65711582|NCT02294643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65711583|NCT02294643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65711584|NCT02294643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65711585|NCT02294643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711586|NCT02294643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65711587|NCT02294643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65711588|NCT02294643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711589|NCT02294643|Antipyretics|antipyretics|mesh-ancestor
65711590|NCT02294643|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65711591|NCT02294643|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65711592|NCT02294643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65711593|NCT02294643|Purinergic Agents|purinergic agents|mesh-ancestor
65711594|NCT02294643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65711595|NCT02294643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65711596|NCT02294643|Serotonin Agents|serotonin agents|mesh-ancestor
65711597|NCT02410694|Thalidomide|thalidomide|mesh-list
65711598|NCT02410694|Dexamethasone|dexamethasone|mesh-list
65711599|NCT02410694|Ixazomib|ixazomib|mesh-list
65711600|NCT02410694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65711601|NCT02410694|Antiemetics|antiemetics|mesh-ancestor
65711602|NCT02410694|Autonomic Agents|autonomic agents|mesh-ancestor
65711603|NCT02410694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65711604|NCT02410694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711605|NCT02410694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65711606|NCT02410694|Glucocorticoids|glucocorticoids|mesh-ancestor
65711607|NCT02410694|Hormones|hormones|mesh-ancestor
65711608|NCT02410694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65711609|NCT02410694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65711610|NCT02410694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711611|NCT02410694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65711612|NCT02410694|Immunologic Factors|immunologic factors|mesh-ancestor
65711613|NCT02410694|Leprostatic Agents|leprostatic agents|mesh-ancestor
65711614|NCT02410694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65711615|NCT02410694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65711616|NCT02410694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65711617|NCT02410694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65711618|NCT02410694|Growth Substances|growth substances|mesh-ancestor
65711619|NCT02410694|Growth Inhibitors|growth inhibitors|mesh-ancestor
65711620|NCT02410694|Protease Inhibitors|protease inhibitors|mesh-ancestor
65711621|NCT02410694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711622|NCT02410694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711623|NCT03521895|Aflibercept|aflibercept|mesh-list
65711624|NCT03521895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65711625|NCT03521895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65711626|NCT03521895|Growth Substances|growth substances|mesh-ancestor
65711627|NCT03521895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711628|NCT03521895|Growth Inhibitors|growth inhibitors|mesh-ancestor
65711629|NCT03521895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711630|NCT02401880|Empagliflozin|empagliflozin|mesh-list
65711631|NCT02401880|Linagliptin|linagliptin|mesh-list
65711632|NCT02401880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65711633|NCT02401880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711635|NCT02401880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711636|NCT02401880|Incretins|incretins|mesh-ancestor
65711637|NCT02401880|Hormones|hormones|mesh-ancestor
65711638|NCT02401880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65711639|NCT02401880|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65711640|NCT02401880|Protease Inhibitors|protease inhibitors|mesh-ancestor
65711641|NCT02401880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711642|NCT03170726|Ibuprofen|ibuprofen|mesh-list
65711643|NCT03170726|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65711644|NCT03170726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65711645|NCT03170726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65711646|NCT03170726|Analgesics|analgesics|mesh-ancestor
65711647|NCT03170726|Sensory System Agents|sensory system agents|mesh-ancestor
65711648|NCT03170726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65711649|NCT03170726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711650|NCT03170726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65711651|NCT03170726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65711652|NCT03170726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65711653|NCT03170726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711654|NCT03170726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711655|NCT02180867|Doxorubicin|doxorubicin|mesh-list
65711656|NCT02180867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65711657|NCT02180867|Daunorubicin|daunorubicin|mesh-list
65711658|NCT02180867|Ifosfamide|ifosfamide|mesh-list
65711659|NCT02180867|Isophosphamide mustard|isophosphamide mustard|mesh-list
65711660|NCT02180867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65711661|NCT02180867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711662|NCT02180867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65711663|NCT02180867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65711664|NCT02180867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711665|NCT02180867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711666|NCT02180867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65711667|NCT02180867|Alkylating Agents|alkylating agents|mesh-ancestor
65711668|NCT03175016|Irinotecan|irinotecan|mesh-list
65711669|NCT03175016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65711670|NCT03175016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65711671|NCT03175016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711672|NCT03175016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711673|NCT03175016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711674|NCT03174938|Flutemetamol|flutemetamol|mesh-list
65711675|NCT03174938|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65711676|NCT03174938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711677|NCT03520257|Apatinib|apatinib|mesh-list
65711678|NCT03520257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711679|NCT03520257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65711680|NCT03520257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711681|NCT03520257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711682|NCT02292303|Zinc|zinc|mesh-list
65711683|NCT02292303|Zinc Oxide|zinc oxide|mesh-list
65711684|NCT02292303|Trace Elements|trace elements|mesh-ancestor
65711685|NCT02292303|Micronutrients|micronutrients|mesh-ancestor
65711686|NCT02292303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711687|NCT02292303|Dermatologic Agents|dermatologic agents|mesh-ancestor
65711688|NCT02292303|Sunscreening Agents|sunscreening agents|mesh-ancestor
65711689|NCT02292303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65711690|NCT02292303|Protective Agents|protective agents|mesh-ancestor
65711691|NCT02294955|Amiodarone|amiodarone|mesh-list
65711692|NCT02294955|Sotalol|sotalol|mesh-list
65711693|NCT02294955|Flecainide|flecainide|mesh-list
65711694|NCT02294955|Dronedarone|dronedarone|mesh-list
65711695|NCT02294955|Propafenone|propafenone|mesh-list
65711696|NCT02294955|Disopyramide|disopyramide|mesh-list
65711697|NCT02294955|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65711698|NCT02294955|Vasodilator Agents|vasodilator agents|mesh-ancestor
65711699|NCT02294955|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65711700|NCT02294955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65711701|NCT02294955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711702|NCT02294955|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65027530|NCT00162188|Efavirenz|efavirenz|mesh-list
65269211|NCT02744378|Tacrolimus|tacrolimus|mesh-list
65711703|NCT02294955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65711704|NCT02294955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65711705|NCT02294955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711706|NCT02294955|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65711707|NCT02294955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65711708|NCT02294955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65711709|NCT02294955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65711710|NCT02294955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65711711|NCT02294955|Adrenergic Agents|adrenergic agents|mesh-ancestor
65711712|NCT02294955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65711713|NCT02294955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711714|NCT02294955|Sympatholytics|sympatholytics|mesh-ancestor
65711715|NCT02294955|Autonomic Agents|autonomic agents|mesh-ancestor
65711716|NCT02294955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65711717|NCT02294955|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65711718|NCT02396888|Insulin|insulin|mesh-list
65711719|NCT02396888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65711720|NCT02396888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711721|NCT03517683|Methamphetamine|methamphetamine|mesh-list
65711722|NCT03517683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65711723|NCT03517683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711724|NCT03517683|Sympathomimetics|sympathomimetics|mesh-ancestor
65711725|NCT03517683|Autonomic Agents|autonomic agents|mesh-ancestor
65711726|NCT03517683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65711727|NCT03517683|Dopamine Agents|dopamine agents|mesh-ancestor
65711728|NCT03517683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65711729|NCT03517683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711730|NCT03517683|Adrenergic Agents|adrenergic agents|mesh-ancestor
65711731|NCT03517683|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65711732|NCT03517683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65711733|NCT03517683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65711734|NCT03517683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65711735|NCT02401334|Anti-Infective Agents|anti-infective agents|mesh-list
65711736|NCT02401334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65711737|NCT05442515|Cyclophosphamide|cyclophosphamide|mesh-list
65711738|NCT05442515|Fludarabine|fludarabine|mesh-list
65711739|NCT05442515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65711740|NCT05442515|Immunologic Factors|immunologic factors|mesh-ancestor
65711741|NCT05442515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711742|NCT05442515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65711743|NCT05442515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65711744|NCT05442515|Alkylating Agents|alkylating agents|mesh-ancestor
65711745|NCT05442515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711746|NCT05442515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711747|NCT05442515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65711748|NCT00801489|Cytarabine|cytarabine|mesh-list
65711749|NCT00801489|Fludarabine|fludarabine|mesh-list
65711750|NCT00801489|Fludarabine phosphate|fludarabine phosphate|mesh-list
65711751|NCT00801489|Decitabine|decitabine|mesh-list
65711752|NCT00801489|Idarubicin|idarubicin|mesh-list
65711753|NCT00801489|Gemtuzumab|gemtuzumab|mesh-list
65711754|NCT00801489|Calicheamicins|calicheamicins|mesh-list
65711755|NCT00801489|Lenograstim|lenograstim|mesh-list
65711756|NCT00801489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711757|NCT00801489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65711758|NCT00801489|Antimetabolites|antimetabolites|mesh-ancestor
65711759|NCT00801489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711760|NCT00801489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65711761|NCT00801489|Immunologic Factors|immunologic factors|mesh-ancestor
65711762|NCT00801489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711763|NCT00801489|Antiviral Agents|antiviral agents|mesh-ancestor
65711764|NCT00801489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65711765|NCT00801489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65711766|NCT00801489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711767|NCT00801489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65711768|NCT00801489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65711769|NCT00801489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65711770|NCT00801489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65711771|NCT02164643|Flutemetamol|flutemetamol|mesh-list
65711772|NCT02164643|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65711773|NCT02164643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711774|NCT02292459|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65711775|NCT02292459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65711776|NCT02292459|Laxatives|laxatives|mesh-ancestor
65711777|NCT02292459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65711778|NCT04465071|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65711779|NCT04465071|Lubricant Eye Drops|lubricant eye drops|mesh-list
65711780|NCT04465071|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65711781|NCT03170336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65027592|NCT00409071|Sinomenine|sinomenine|mesh-list
65711782|NCT03170336|Amiloride|amiloride|mesh-list
65711783|NCT03170336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65711784|NCT03170336|Diuretics|diuretics|mesh-ancestor
65711785|NCT03170336|Natriuretic Agents|natriuretic agents|mesh-ancestor
65711786|NCT03170336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711787|NCT03170336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65711788|NCT03170336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65711789|NCT03170336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711790|NCT03170336|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65711791|NCT03170336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65711792|NCT03170336|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65711793|NCT03170336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65711794|NCT02699684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65711795|NCT02699684|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65711796|NCT02699684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65711797|NCT02699684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65711798|NCT02295189|Triamcinolone|triamcinolone|mesh-list
65711799|NCT02295189|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65711800|NCT02295189|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65711801|NCT02295189|Ketorolac|ketorolac|mesh-list
65711802|NCT02295189|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65711803|NCT02295189|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65711804|NCT02295189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65711805|NCT02295189|Glucocorticoids|glucocorticoids|mesh-ancestor
65711806|NCT02295189|Hormones|hormones|mesh-ancestor
65711807|NCT02295189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65711808|NCT02295189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711809|NCT02295189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65711810|NCT02295189|Immunologic Factors|immunologic factors|mesh-ancestor
65711811|NCT02295189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711812|NCT02295189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711813|NCT02295189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65711814|NCT02295189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65711815|NCT02295189|Analgesics|analgesics|mesh-ancestor
65711816|NCT02295189|Sensory System Agents|sensory system agents|mesh-ancestor
65711817|NCT02295189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65711818|NCT02295189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65711819|NCT02295189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65711820|NCT04055012|Metformin|metformin|mesh-list
65711821|NCT04055012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65711822|NCT04055012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711823|NCT03519633|Neostigmine|neostigmine|mesh-list
65711824|NCT03519633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65711825|NCT03519633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711826|NCT03519633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711827|NCT03519633|Cholinergic Agents|cholinergic agents|mesh-ancestor
65711828|NCT03519633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65711829|NCT03519633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711830|NCT03519633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65711831|NCT03519633|Autonomic Agents|autonomic agents|mesh-ancestor
65711832|NCT03519633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65711833|NCT02289027|Vaccines|vaccines|mesh-list
65711834|NCT02289027|Immunologic Factors|immunologic factors|mesh-ancestor
65711835|NCT02289027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711836|NCT02396030|Magnesium Sulfate|magnesium sulfate|mesh-list
65711837|NCT02396030|Analgesics|analgesics|mesh-ancestor
65711838|NCT02396030|Sensory System Agents|sensory system agents|mesh-ancestor
65711839|NCT02396030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65711840|NCT02396030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711841|NCT02396030|Anesthetics|anesthetics|mesh-ancestor
65711842|NCT02396030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65711843|NCT02396030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65711844|NCT02396030|Anticonvulsants|anticonvulsants|mesh-ancestor
65711845|NCT02396030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65711846|NCT02396030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65711847|NCT02396030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711848|NCT02396030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65711849|NCT02396030|Tocolytic Agents|tocolytic agents|mesh-ancestor
65711850|NCT02396030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65711851|NCT02289261|Dexmedetomidine|dexmedetomidine|mesh-list
65711852|NCT02289261|Morphine|morphine|mesh-list
65711853|NCT02289261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65711854|NCT02289261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65711855|NCT02289261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711856|NCT02289261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65711857|NCT02289261|Analgesics|analgesics|mesh-ancestor
65711858|NCT02289261|Sensory System Agents|sensory system agents|mesh-ancestor
65711859|NCT02289261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65711860|NCT02289261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65711861|NCT02289261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65711862|NCT02289261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65711863|NCT02289261|Adrenergic Agents|adrenergic agents|mesh-ancestor
65711864|NCT02289261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65711865|NCT02289261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711866|NCT02289261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65711867|NCT02289261|Narcotics|narcotics|mesh-ancestor
65711868|NCT03168074|Lenvatinib|lenvatinib|mesh-list
65711869|NCT03168074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711870|NCT03168074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65711871|NCT03168074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711872|NCT03168074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711873|NCT02396108|Paclitaxel|paclitaxel|mesh-list
65711874|NCT02396108|Carboplatin|carboplatin|mesh-list
65711875|NCT02396108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65711876|NCT02396108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711877|NCT02396108|Tubulin Modulators|tubulin modulators|mesh-ancestor
65711878|NCT02396108|Antimitotic Agents|antimitotic agents|mesh-ancestor
65711879|NCT02396108|Mitosis Modulators|mitosis modulators|mesh-ancestor
65711880|NCT02396108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711881|NCT02403596|Tranexamic Acid|tranexamic acid|mesh-list
65711882|NCT02403596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65711883|NCT02403596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65711884|NCT02403596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711885|NCT02403596|Hemostatics|hemostatics|mesh-ancestor
65711886|NCT02403596|Coagulants|coagulants|mesh-ancestor
65711887|NCT02289495|Ritonavir|ritonavir|mesh-list
65711888|NCT02289495|GSK-2838232|gsk-2838232|mesh-list
65711889|NCT02289495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65711890|NCT02289495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65711891|NCT02289495|Protease Inhibitors|protease inhibitors|mesh-ancestor
65711892|NCT02289495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711893|NCT02289495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711894|NCT02289495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65711895|NCT02289495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65711896|NCT02289495|Antiviral Agents|antiviral agents|mesh-ancestor
65711897|NCT02289495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65711898|NCT02289495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65711899|NCT02289495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65711900|NCT01774721|Gefitinib|gefitinib|mesh-list
65711901|NCT01774721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711902|NCT01774721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65711903|NCT01774721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711904|NCT01774721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711905|NCT02395952|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65711906|NCT02395952|Laxatives|laxatives|mesh-ancestor
65711907|NCT02395952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65711908|NCT03516903|Folic Acid|folic acid|mesh-list
65711909|NCT03516903|Methotrexate|methotrexate|mesh-list
65711910|NCT03516903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65711911|NCT03516903|Abortifacient Agents|abortifacient agents|mesh-ancestor
65711912|NCT03516903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65711913|NCT03516903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711914|NCT03516903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65711915|NCT03516903|Antimetabolites|antimetabolites|mesh-ancestor
65711916|NCT03516903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711917|NCT03516903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711918|NCT03516903|Dermatologic Agents|dermatologic agents|mesh-ancestor
65711919|NCT03516903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711920|NCT03516903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65711921|NCT03516903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65711922|NCT03516903|Immunologic Factors|immunologic factors|mesh-ancestor
65711923|NCT03516903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65711924|NCT03516903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65711925|NCT03516903|Hematinics|hematinics|mesh-ancestor
65711926|NCT03516903|Vitamin B Complex|vitamin b complex|mesh-ancestor
65711927|NCT03516903|Vitamins|vitamins|mesh-ancestor
65711928|NCT03516903|Micronutrients|micronutrients|mesh-ancestor
65711929|NCT03516747|Hormones|hormones|mesh-list
65711930|NCT03516747|Parathyroid Hormone|parathyroid hormone|mesh-list
65027739|NCT00162734|Interferons|interferons|mesh-list
65711931|NCT03516747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65711932|NCT03516747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711933|NCT03516747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65711934|NCT03516669|Amoxicillin|amoxicillin|mesh-list
65711935|NCT03516669|Clarithromycin|clarithromycin|mesh-list
65711936|NCT03516669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65711937|NCT03516669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65711938|NCT03516669|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65711939|NCT03516669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711940|NCT03516669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711941|NCT03516669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65711942|NCT03516669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65711943|NCT02289807|Cisplatin|cisplatin|mesh-list
65711944|NCT02289807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711945|NCT02298153|Atezolizumab|atezolizumab|mesh-list
65711946|NCT02298153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711947|NCT01275677|Paclitaxel|paclitaxel|mesh-list
65711948|NCT01275677|Docetaxel|docetaxel|mesh-list
65711949|NCT01275677|Cyclophosphamide|cyclophosphamide|mesh-list
65711950|NCT01275677|Doxorubicin|doxorubicin|mesh-list
65711951|NCT01275677|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65711952|NCT01275677|Trastuzumab|trastuzumab|mesh-list
65711953|NCT01275677|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65711954|NCT01275677|Daunorubicin|daunorubicin|mesh-list
65711955|NCT01275677|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
65711956|NCT01275677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65711957|NCT01275677|Antibodies|antibodies|mesh-list
65711958|NCT01275677|Immunoglobulins|immunoglobulins|mesh-list
65711959|NCT01275677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65711960|NCT01275677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65711961|NCT01275677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65711962|NCT01275677|Tubulin Modulators|tubulin modulators|mesh-ancestor
65711963|NCT01275677|Antimitotic Agents|antimitotic agents|mesh-ancestor
65711964|NCT01275677|Mitosis Modulators|mitosis modulators|mesh-ancestor
65711965|NCT01275677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65711966|NCT01275677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65711967|NCT01275677|Immunologic Factors|immunologic factors|mesh-ancestor
65711968|NCT01275677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711969|NCT01275677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65711970|NCT01275677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65711971|NCT01275677|Alkylating Agents|alkylating agents|mesh-ancestor
65711972|NCT01275677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65711973|NCT01275677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65711974|NCT01275677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65711975|NCT01275677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65711976|NCT01275677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65711977|NCT02298387|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65711978|NCT02298387|Immunologic Factors|immunologic factors|mesh-ancestor
65711979|NCT02298387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711980|NCT02293551|Insulin Lispro|insulin lispro|mesh-list
65711981|NCT02293551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65711982|NCT02293551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711983|NCT02296047|Bromides|bromides|mesh-list
65711984|NCT02296047|Albuterol|albuterol|mesh-list
65711985|NCT02296047|Ipratropium|ipratropium|mesh-list
65711986|NCT02296047|Anticonvulsants|anticonvulsants|mesh-ancestor
65711987|NCT02296047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65711988|NCT02296047|Autonomic Agents|autonomic agents|mesh-ancestor
65711989|NCT02296047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65711990|NCT02296047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65711991|NCT02296047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65711992|NCT02296047|Respiratory System Agents|respiratory system agents|mesh-ancestor
65711993|NCT02296047|Tocolytic Agents|tocolytic agents|mesh-ancestor
65711994|NCT02296047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65711995|NCT02296047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65711996|NCT02296047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65711997|NCT02296047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65711998|NCT02296047|Adrenergic Agents|adrenergic agents|mesh-ancestor
65174660|NCT00600067|Phentermine|phentermine|mesh-list
65711999|NCT02296047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65712000|NCT02296047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712001|NCT02296047|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65712002|NCT02296047|Cholinergic Agents|cholinergic agents|mesh-ancestor
65712003|NCT02293785|Oxycodone|oxycodone|mesh-list
65027811|NCT03757585|Antidotes|antidotes|mesh-ancestor
65712004|NCT02293785|Naloxone|naloxone|mesh-list
65712005|NCT02293785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65712006|NCT02293785|Narcotics|narcotics|mesh-ancestor
65712007|NCT02293785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65712008|NCT02293785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712009|NCT02293785|Analgesics|analgesics|mesh-ancestor
65712010|NCT02293785|Sensory System Agents|sensory system agents|mesh-ancestor
65712011|NCT02293785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65712012|NCT02293785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65712013|NCT01162109|Zinc Sulfate|zinc sulfate|mesh-list
65712014|NCT01162109|Astringents|astringents|mesh-ancestor
65712015|NCT01162109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712016|NCT01162109|Dermatologic Agents|dermatologic agents|mesh-ancestor
65712017|NCT02296203|Irinotecan|irinotecan|mesh-list
65712018|NCT02296203|Cetuximab|cetuximab|mesh-list
65712019|NCT02296203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65712020|NCT02296203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65712021|NCT02296203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65712022|NCT02296203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712023|NCT02296203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712024|NCT02296203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65712025|NCT03514251|Parathyroid Hormone|parathyroid hormone|mesh-list
65712026|NCT03514251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65712027|NCT03514251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712028|NCT02296281|Pirfenidone|pirfenidone|mesh-list
65712029|NCT02296281|Analgesics|analgesics|mesh-ancestor
65712030|NCT02296281|Sensory System Agents|sensory system agents|mesh-ancestor
65712031|NCT02296281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65712032|NCT02296281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712033|NCT02296281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65712034|NCT02296281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65712035|NCT02296281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65712036|NCT02296281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65712037|NCT02296281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712038|NCT02299245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65712039|NCT02299245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65712040|NCT02299245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65712041|NCT02299245|Antimetabolites|antimetabolites|mesh-ancestor
65712042|NCT02299245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712043|NCT02299245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65712044|NCT02299245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65712045|NCT02299245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65712046|NCT03513549|Loxapine|loxapine|mesh-list
65712047|NCT03513549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65712048|NCT03513549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65712049|NCT03513549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65712050|NCT03513549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712051|NCT03513549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65712052|NCT03513549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65712053|NCT03513549|Dopamine Agents|dopamine agents|mesh-ancestor
65712054|NCT03513549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65712055|NCT03513549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712056|NCT03513471|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65712057|NCT03513471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65712058|NCT03513393|Velpatasvir|velpatasvir|mesh-list
65712059|NCT03513393|Omeprazole|omeprazole|mesh-list
65712060|NCT03513393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65712061|NCT03513393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65712062|NCT03513393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65712063|NCT03513393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65712064|NCT03513393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712065|NCT03513393|Antiviral Agents|antiviral agents|mesh-ancestor
65712066|NCT03513393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65712067|NCT02299401|Misoprostol|misoprostol|mesh-list
65712068|NCT02299401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65712069|NCT02299401|Abortifacient Agents|abortifacient agents|mesh-ancestor
65712070|NCT02299401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65712071|NCT02299401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174795|NCT02652325|Iodine|iodine|mesh-list
65712072|NCT02299401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65712073|NCT02299401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65712074|NCT02299401|Oxytocics|oxytocics|mesh-ancestor
65712075|NCT02699450|Ranibizumab|ranibizumab|mesh-list
65712076|NCT02699450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65712077|NCT02699450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65712078|NCT02699450|Growth Substances|growth substances|mesh-ancestor
65712079|NCT02699450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712080|NCT02699450|Growth Inhibitors|growth inhibitors|mesh-ancestor
65712081|NCT02699450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712082|NCT02299557|Phenylephrine|phenylephrine|mesh-list
65712083|NCT02299557|Oxymetazoline|oxymetazoline|mesh-list
65712084|NCT02299557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65712085|NCT02299557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65712086|NCT02299557|Adrenergic Agents|adrenergic agents|mesh-ancestor
65712087|NCT02299557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65712088|NCT02299557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712089|NCT02299557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712090|NCT02299557|Sympathomimetics|sympathomimetics|mesh-ancestor
65712091|NCT02299557|Autonomic Agents|autonomic agents|mesh-ancestor
65712092|NCT02299557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65712093|NCT02299557|Nasal Decongestants|nasal decongestants|mesh-ancestor
65712094|NCT02299557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65712095|NCT02299557|Respiratory System Agents|respiratory system agents|mesh-ancestor
65712096|NCT02299557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65712097|NCT02299557|Mydriatics|mydriatics|mesh-ancestor
65712098|NCT02299557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65712099|NCT02299557|Protective Agents|protective agents|mesh-ancestor
65712100|NCT02302989|Ranibizumab|ranibizumab|mesh-list
65712101|NCT02302989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65712102|NCT02302989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65712103|NCT02302989|Growth Substances|growth substances|mesh-ancestor
65712104|NCT02302989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712105|NCT02302989|Growth Inhibitors|growth inhibitors|mesh-ancestor
65712106|NCT02302989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712107|NCT02296671|Leucovorin|leucovorin|mesh-list
65712108|NCT02296671|Fluorouracil|fluorouracil|mesh-list
65712109|NCT02296671|Oxaliplatin|oxaliplatin|mesh-list
65712110|NCT02296671|Pemetrexed|pemetrexed|mesh-list
65712111|NCT02296671|Antimetabolites|antimetabolites|mesh-ancestor
65712112|NCT02296671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712113|NCT02296671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65712114|NCT02296671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712115|NCT02296671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65712116|NCT02296671|Immunologic Factors|immunologic factors|mesh-ancestor
65712117|NCT02296671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712118|NCT02296671|Antidotes|antidotes|mesh-ancestor
65712119|NCT02296671|Protective Agents|protective agents|mesh-ancestor
65712120|NCT02296671|Vitamin B Complex|vitamin b complex|mesh-ancestor
65712121|NCT02296671|Vitamins|vitamins|mesh-ancestor
65712122|NCT02296671|Micronutrients|micronutrients|mesh-ancestor
65712123|NCT02296671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65712124|NCT02296671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65712125|NCT02296671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65712126|NCT02296749|Sirolimus|sirolimus|mesh-list
65712127|NCT02296749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65712128|NCT02296749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65712129|NCT02296749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65712130|NCT02296749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712131|NCT02296749|Antifungal Agents|antifungal agents|mesh-ancestor
65712132|NCT02296749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65712133|NCT02296749|Immunologic Factors|immunologic factors|mesh-ancestor
65712134|NCT02296749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712135|NCT04481750|Edaravone|edaravone|mesh-list
65712136|NCT04481750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65712137|NCT04481750|Antioxidants|antioxidants|mesh-ancestor
65712138|NCT04481750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712139|NCT04481750|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65712140|NCT04481750|Protective Agents|protective agents|mesh-ancestor
65712141|NCT04481750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712142|NCT02303223|Propofol|propofol|mesh-list
65712143|NCT02303223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65712144|NCT02303223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65712145|NCT02303223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712146|NCT02303223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65712147|NCT02303223|Anesthetics, General|anesthetics, general|mesh-ancestor
65712148|NCT02303223|Anesthetics|anesthetics|mesh-ancestor
65712149|NCT03168698|Oxytocin|oxytocin|mesh-list
65712150|NCT03168698|Carbetocin|carbetocin|mesh-list
65712151|NCT03168698|Oxytocics|oxytocics|mesh-ancestor
65712152|NCT03168698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65712153|NCT03168698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712154|NCT04464135|Acetic Acid|acetic acid|mesh-list
65712155|NCT04464135|Retinol acetate|retinol acetate|mesh-list
65712156|NCT04464135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65712157|NCT04464135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65712158|NCT04464135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65712159|NCT04464135|Immunologic Factors|immunologic factors|mesh-ancestor
65712160|NCT04464135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712161|NCT04464135|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65712162|NCT04464135|Protective Agents|protective agents|mesh-ancestor
65712163|NCT04464135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712164|NCT03510351|Tazobactam|tazobactam|mesh-list
65712165|NCT03510351|Ceftolozane|ceftolozane|mesh-list
65712166|NCT03510351|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
65712167|NCT03510351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65712168|NCT03510351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65712169|NCT03510351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65712170|NCT03510351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65712171|NCT03510351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712172|NCT03510351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65712173|NCT03510351|Renal Agents|renal agents|mesh-ancestor
65712174|NCT02403284|Liraglutide|liraglutide|mesh-list
65712175|NCT02403284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65712176|NCT02403284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712177|NCT02403284|Incretins|incretins|mesh-ancestor
65712178|NCT02403284|Hormones|hormones|mesh-ancestor
65712179|NCT02403284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65712180|NCT02400866|Olanzapine|olanzapine|mesh-list
65712181|NCT02400866|Antiemetics|antiemetics|mesh-ancestor
65712182|NCT02400866|Autonomic Agents|autonomic agents|mesh-ancestor
65712183|NCT02400866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65712184|NCT02400866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712185|NCT02400866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65712186|NCT02400866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65712187|NCT02400866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65712188|NCT02400866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65712189|NCT02400866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65712190|NCT02400866|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65712191|NCT02400866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65712192|NCT02400866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65712193|NCT02400866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712194|NCT02400866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65712195|NCT02400866|Serotonin Agents|serotonin agents|mesh-ancestor
65712196|NCT02400788|Sorafenib|sorafenib|mesh-list
65712197|NCT02400788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712198|NCT02400788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65712199|NCT02400788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65712200|NCT02400788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712201|NCT02403128|Aflibercept|aflibercept|mesh-list
65712202|NCT02403128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65712203|NCT02403128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65712204|NCT02403128|Growth Substances|growth substances|mesh-ancestor
65712205|NCT02403128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712206|NCT02403128|Growth Inhibitors|growth inhibitors|mesh-ancestor
65712207|NCT02403128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712208|NCT02297217|Paclitaxel|paclitaxel|mesh-list
65712209|NCT02297217|Carboplatin|carboplatin|mesh-list
65712210|NCT02297217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65712211|NCT02297217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712212|NCT02297217|Tubulin Modulators|tubulin modulators|mesh-ancestor
65712213|NCT02297217|Antimitotic Agents|antimitotic agents|mesh-ancestor
65712214|NCT02297217|Mitosis Modulators|mitosis modulators|mesh-ancestor
65712215|NCT02297217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712216|NCT03515577|Edetic Acid|edetic acid|mesh-list
65712217|NCT03515577|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65712218|NCT03515577|Chelating Agents|chelating agents|mesh-ancestor
65712219|NCT03515577|Sequestering Agents|sequestering agents|mesh-ancestor
65712220|NCT03515577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712221|NCT03515577|Anticoagulants|anticoagulants|mesh-ancestor
65712222|NCT03515577|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65712223|NCT03515577|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65712224|NCT02300649|Dexmedetomidine|dexmedetomidine|mesh-list
65712225|NCT02300649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65712226|NCT02300649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65712227|NCT02300649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712228|NCT02300649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65712229|NCT02300649|Analgesics|analgesics|mesh-ancestor
65712230|NCT02300649|Sensory System Agents|sensory system agents|mesh-ancestor
65712231|NCT02300649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65712232|NCT02300649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65712233|NCT02300649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65712234|NCT02300649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65712236|NCT02300649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65712237|NCT02300649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712238|NCT02449161|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65712239|NCT02449161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65712240|NCT02449161|Contraceptive Agents|contraceptive agents|mesh-ancestor
65712241|NCT02449161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65712242|NCT02449161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712243|NCT02449161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65712244|NCT02449161|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65712245|NCT02449161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65712246|NCT02449161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712247|NCT02297529|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
65712248|NCT02297529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65712249|NCT02297529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712250|NCT02303769|Tamsulosin|tamsulosin|mesh-list
65712251|NCT02303769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65712252|NCT02303769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65712253|NCT02303769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65712254|NCT02303769|Adrenergic Agents|adrenergic agents|mesh-ancestor
65712255|NCT02303769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65712256|NCT02303769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712257|NCT02303769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712258|NCT02303769|Urological Agents|urological agents|mesh-ancestor
65712259|NCT02303847|Ketamine|ketamine|mesh-list
65712260|NCT02303847|Analgesics|analgesics|mesh-ancestor
65712261|NCT02303847|Sensory System Agents|sensory system agents|mesh-ancestor
65712262|NCT02303847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65712263|NCT02303847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712264|NCT02303847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65712265|NCT02303847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65712266|NCT02303847|Anesthetics, General|anesthetics, general|mesh-ancestor
65712267|NCT02303847|Anesthetics|anesthetics|mesh-ancestor
65712268|NCT02303847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65712269|NCT02303847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65712270|NCT02303847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65712271|NCT02303847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65712272|NCT02303847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712273|NCT02297763|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65712274|NCT02297763|Antidepressive Agents|antidepressive agents|mesh-ancestor
65712275|NCT02297763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65712276|NCT02297763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65712277|NCT02297763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65712278|NCT02297763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65712279|NCT02297763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712280|NCT03511833|Ketamine|ketamine|mesh-list
65712281|NCT03511833|Morphine|morphine|mesh-list
65712282|NCT03511833|Analgesics|analgesics|mesh-ancestor
65712283|NCT03511833|Sensory System Agents|sensory system agents|mesh-ancestor
65712284|NCT03511833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65712285|NCT03511833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712286|NCT03511833|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65712287|NCT03511833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65712288|NCT03511833|Anesthetics, General|anesthetics, general|mesh-ancestor
65712289|NCT03511833|Anesthetics|anesthetics|mesh-ancestor
65712290|NCT03511833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65712291|NCT03511833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65712292|NCT03511833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65712293|NCT03511833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65712294|NCT03511833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712295|NCT03511833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65712296|NCT03511833|Narcotics|narcotics|mesh-ancestor
65712297|NCT03511755|Neurotransmitter Agents|neurotransmitter agents|mesh-list
65712298|NCT03511755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712299|NCT03511755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712300|NCT02696798|Ixekizumab|ixekizumab|mesh-list
65712301|NCT02696798|Dermatologic Agents|dermatologic agents|mesh-ancestor
65712302|NCT02304081|Saxagliptin|saxagliptin|mesh-list
65712303|NCT02304081|Incretins|incretins|mesh-ancestor
65712304|NCT02304081|Hormones|hormones|mesh-ancestor
65712305|NCT02304081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65712306|NCT02304081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712307|NCT02304081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65712308|NCT02304081|Protease Inhibitors|protease inhibitors|mesh-ancestor
65712309|NCT02304081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65712310|NCT02304081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712311|NCT02304081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65712312|NCT02304237|Progesterone|progesterone|mesh-list
65712313|NCT02304237|Progestins|progestins|mesh-ancestor
65712314|NCT02304237|Hormones|hormones|mesh-ancestor
65712315|NCT02304237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65712316|NCT02304237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712317|NCT03515187|Bromides|bromides|mesh-list
65712318|NCT03515187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65712319|NCT03515187|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65712320|NCT03515187|Hyaluronic Acid|hyaluronic acid|mesh-list
65712321|NCT03515187|Anticonvulsants|anticonvulsants|mesh-ancestor
65712322|NCT03515187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65712323|NCT03515187|Immunologic Factors|immunologic factors|mesh-ancestor
65712324|NCT03515187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712325|NCT03515187|Viscosupplements|viscosupplements|mesh-ancestor
65712326|NCT03515187|Protective Agents|protective agents|mesh-ancestor
65712327|NCT02297997|Cetylpyridinium|cetylpyridinium|mesh-list
65712328|NCT02297997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65712329|NCT02297997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65712330|NCT02395016|Gemcitabine|gemcitabine|mesh-list
65712331|NCT02395016|Nimotuzumab|nimotuzumab|mesh-list
65712332|NCT02395016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65712333|NCT02395016|Antimetabolites|antimetabolites|mesh-ancestor
65712334|NCT02395016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712335|NCT02395016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712336|NCT02395016|Antiviral Agents|antiviral agents|mesh-ancestor
65712337|NCT02395016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65712338|NCT02395016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65712339|NCT02395016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65712340|NCT02395016|Immunologic Factors|immunologic factors|mesh-ancestor
65712341|NCT02395016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712342|NCT02395016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65712343|NCT04480268|Gemcitabine|gemcitabine|mesh-list
65712344|NCT04480268|Paclitaxel|paclitaxel|mesh-list
65712345|NCT04480268|Capecitabine|capecitabine|mesh-list
65712346|NCT04480268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65712347|NCT04480268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712348|NCT04480268|Tubulin Modulators|tubulin modulators|mesh-ancestor
65712349|NCT04480268|Antimitotic Agents|antimitotic agents|mesh-ancestor
65712350|NCT04480268|Mitosis Modulators|mitosis modulators|mesh-ancestor
65712351|NCT04480268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712352|NCT04480268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65712353|NCT04480268|Antimetabolites|antimetabolites|mesh-ancestor
65712354|NCT04480268|Antiviral Agents|antiviral agents|mesh-ancestor
65712355|NCT04480268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65712356|NCT04480268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65712357|NCT04480268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65712358|NCT04480268|Immunologic Factors|immunologic factors|mesh-ancestor
65712359|NCT04480268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712360|NCT03510975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65712361|NCT03510975|Hemostatics|hemostatics|mesh-ancestor
65712362|NCT03510975|Coagulants|coagulants|mesh-ancestor
65712363|NCT03510975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65712364|NCT03510975|Natriuretic Agents|natriuretic agents|mesh-ancestor
65712365|NCT03510975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712366|NCT03169790|Leucovorin|leucovorin|mesh-list
65712367|NCT03169790|Paclitaxel|paclitaxel|mesh-list
65712368|NCT03169790|Cyclophosphamide|cyclophosphamide|mesh-list
65712369|NCT03169790|Bevacizumab|bevacizumab|mesh-list
65712370|NCT03169790|Rituximab|rituximab|mesh-list
65712371|NCT03169790|Fluorouracil|fluorouracil|mesh-list
65712372|NCT03169790|Capecitabine|capecitabine|mesh-list
65712373|NCT03169790|Oxaliplatin|oxaliplatin|mesh-list
65712374|NCT03169790|Avelumab|avelumab|mesh-list
65712375|NCT03169790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65712376|NCT03169790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712377|NCT03169790|Tubulin Modulators|tubulin modulators|mesh-ancestor
65712378|NCT03169790|Antimitotic Agents|antimitotic agents|mesh-ancestor
65712379|NCT03169790|Mitosis Modulators|mitosis modulators|mesh-ancestor
65712380|NCT03169790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712381|NCT03169790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65712382|NCT03169790|Immunologic Factors|immunologic factors|mesh-ancestor
65712383|NCT03169790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712384|NCT03169790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65712385|NCT03169790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65712386|NCT03169790|Alkylating Agents|alkylating agents|mesh-ancestor
65712387|NCT03169790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65712388|NCT03169790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65712389|NCT03169790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65712390|NCT03169790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65712391|NCT03169790|Growth Substances|growth substances|mesh-ancestor
65712392|NCT03169790|Growth Inhibitors|growth inhibitors|mesh-ancestor
65712393|NCT03169790|Antimetabolites|antimetabolites|mesh-ancestor
65712394|NCT03169790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65712395|NCT03169790|Antidotes|antidotes|mesh-ancestor
65712396|NCT03169790|Protective Agents|protective agents|mesh-ancestor
65712397|NCT03169790|Vitamin B Complex|vitamin b complex|mesh-ancestor
65712398|NCT03169790|Vitamins|vitamins|mesh-ancestor
65712399|NCT03169790|Micronutrients|micronutrients|mesh-ancestor
65712400|NCT02304393|Atezolizumab|atezolizumab|mesh-list
65712401|NCT02304393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712402|NCT02402972|Leucovorin|leucovorin|mesh-list
65712403|NCT02402972|Oxaliplatin|oxaliplatin|mesh-list
65712404|NCT02402972|Floxuridine|floxuridine|mesh-list
65712405|NCT02402972|Levoleucovorin|levoleucovorin|mesh-list
65712406|NCT02402972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712407|NCT02402972|Antidotes|antidotes|mesh-ancestor
65712408|NCT02402972|Protective Agents|protective agents|mesh-ancestor
65712409|NCT02402972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712410|NCT02402972|Vitamin B Complex|vitamin b complex|mesh-ancestor
65712411|NCT02402972|Vitamins|vitamins|mesh-ancestor
65712412|NCT02402972|Micronutrients|micronutrients|mesh-ancestor
65712413|NCT02402972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65712414|NCT02402972|Antimetabolites|antimetabolites|mesh-ancestor
65712415|NCT02402972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712416|NCT02394470|Deuterium Oxide|deuterium oxide|mesh-list
65712417|NCT02394470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712418|NCT02394470|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65712419|NCT02394470|Protective Agents|protective agents|mesh-ancestor
65712420|NCT02394470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712421|NCT02304627|Insulin|insulin|mesh-list
65712422|NCT02304627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65712423|NCT02304627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712424|NCT03508713|Antirheumatic Agents|antirheumatic agents|mesh-list
65712425|NCT02394158|Metformin|metformin|mesh-list
65712426|NCT02394158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65712427|NCT02394158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712428|NCT03508635|Prednisone|prednisone|mesh-list
65712429|NCT03508635|Cortisone|cortisone|mesh-list
65712430|NCT03508635|Mifepristone|mifepristone|mesh-list
65712431|NCT03508635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65712432|NCT03508635|Glucocorticoids|glucocorticoids|mesh-ancestor
65712433|NCT03508635|Hormones|hormones|mesh-ancestor
65712434|NCT03508635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65712435|NCT03508635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712436|NCT03508635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65712437|NCT03508635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712438|NCT03508635|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65712439|NCT03508635|Abortifacient Agents|abortifacient agents|mesh-ancestor
65712440|NCT03508635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65712441|NCT03508635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65712442|NCT03508635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65712443|NCT03508635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65712444|NCT03508635|Contraceptive Agents|contraceptive agents|mesh-ancestor
65712445|NCT03508635|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65712446|NCT03508635|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65712447|NCT03508635|Hormone Antagonists|hormone antagonists|mesh-ancestor
65712448|NCT03508635|Luteolytic Agents|luteolytic agents|mesh-ancestor
65712449|NCT03508635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65712450|NCT03508635|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65712451|NCT04481282|Terbutaline|terbutaline|mesh-list
65712452|NCT04481282|Danazol|danazol|mesh-list
65712453|NCT04481282|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65712454|NCT04481282|Autonomic Agents|autonomic agents|mesh-ancestor
65712455|NCT04481282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65712456|NCT04481282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712457|NCT04481282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65712458|NCT04481282|Respiratory System Agents|respiratory system agents|mesh-ancestor
65712459|NCT04481282|Sympathomimetics|sympathomimetics|mesh-ancestor
65712460|NCT04481282|Tocolytic Agents|tocolytic agents|mesh-ancestor
65712461|NCT04481282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65712462|NCT04481282|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65712463|NCT04481282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65712464|NCT04481282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65712465|NCT04481282|Adrenergic Agents|adrenergic agents|mesh-ancestor
65712466|NCT04481282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65712467|NCT04481282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712468|NCT04481282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65712469|NCT04481282|Hormone Antagonists|hormone antagonists|mesh-ancestor
65712470|NCT04481282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65712471|NCT02541604|Atezolizumab|atezolizumab|mesh-list
65712472|NCT02541604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712473|NCT02393846|Ketoprofen|ketoprofen|mesh-list
65712474|NCT02393846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65712475|NCT02393846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65712476|NCT02393846|Analgesics|analgesics|mesh-ancestor
65712477|NCT02393846|Sensory System Agents|sensory system agents|mesh-ancestor
65712478|NCT02393846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65712479|NCT02393846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712480|NCT02393846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65712481|NCT02393846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65712482|NCT02393846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65712483|NCT02393846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65712484|NCT02393846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712485|NCT02302209|Oxytocin|oxytocin|mesh-list
65712486|NCT02302209|Oxytocics|oxytocics|mesh-ancestor
65712487|NCT02302209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65712488|NCT02302209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712489|NCT02394002|Propofol|propofol|mesh-list
65712490|NCT02394002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65712491|NCT02394002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65712492|NCT02394002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712493|NCT02394002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65712494|NCT02394002|Anesthetics, General|anesthetics, general|mesh-ancestor
65712495|NCT02394002|Anesthetics|anesthetics|mesh-ancestor
65712496|NCT02306577|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65712497|NCT02306577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65712498|NCT02306577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65712499|NCT02306577|Antiviral Agents|antiviral agents|mesh-ancestor
65712500|NCT02306577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65712501|NCT02402348|Metformin|metformin|mesh-list
65712502|NCT02402348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65712503|NCT02402348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712504|NCT02399462|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65712505|NCT02399462|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
65712506|NCT02399462|beta-Endorphin|beta-endorphin|mesh-list
65712507|NCT02399462|Hormones|hormones|mesh-ancestor
65712508|NCT02399462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65712509|NCT02399462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712510|NCT02399462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65712511|NCT02399462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712512|NCT02305173|Dexamethasone|dexamethasone|mesh-list
65712513|NCT02305173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65712514|NCT02305173|Antiemetics|antiemetics|mesh-ancestor
65712515|NCT02305173|Autonomic Agents|autonomic agents|mesh-ancestor
65712516|NCT02305173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65712517|NCT02305173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712518|NCT02305173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65712519|NCT02305173|Glucocorticoids|glucocorticoids|mesh-ancestor
65712520|NCT02305173|Hormones|hormones|mesh-ancestor
65175186|NCT04669132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65712521|NCT02305173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65712522|NCT02305173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65712523|NCT02305173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712525|NCT03505047|Trace Elements|trace elements|mesh-ancestor
65712526|NCT03505047|Micronutrients|micronutrients|mesh-ancestor
65712527|NCT03505047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712528|NCT02402114|Hydrocortisone|hydrocortisone|mesh-list
65712529|NCT02402114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65712530|NCT02305485|Everolimus|everolimus|mesh-list
65712531|NCT02305485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712532|NCT02305485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65712533|NCT02305485|Immunologic Factors|immunologic factors|mesh-ancestor
65712534|NCT02305485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712535|NCT02311569|Mirabegron|mirabegron|mesh-list
65712536|NCT02311569|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65712537|NCT02311569|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65712538|NCT02311569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65712539|NCT02311569|Adrenergic Agents|adrenergic agents|mesh-ancestor
65712540|NCT02311569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65712541|NCT02311569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712542|NCT02311569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712543|NCT02311569|Urological Agents|urological agents|mesh-ancestor
65712544|NCT02393456|Oxytocin|oxytocin|mesh-list
65712545|NCT02393456|Oxytocics|oxytocics|mesh-ancestor
65712546|NCT02393456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65712547|NCT02393456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712548|NCT02393612|Sarpogrelate|sarpogrelate|mesh-list
65712549|NCT02393612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65712550|NCT02393612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65712551|NCT02393612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712552|NCT02393612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65712553|NCT02393612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65712554|NCT02393612|Serotonin Agents|serotonin agents|mesh-ancestor
65712555|NCT02393612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65712556|NCT02393612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712557|NCT02306733|Oxytocin|oxytocin|mesh-list
65712558|NCT02306733|Ergonovine|ergonovine|mesh-list
65712559|NCT02306733|Oxytocics|oxytocics|mesh-ancestor
65712560|NCT02306733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65712561|NCT02306733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712562|NCT02698436|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65712563|NCT02698436|Dermatologic Agents|dermatologic agents|mesh-ancestor
65712564|NCT03507465|Capecitabine|capecitabine|mesh-list
65712565|NCT03507465|Letrozole|letrozole|mesh-list
65712566|NCT03507465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65712567|NCT03507465|Antimetabolites|antimetabolites|mesh-ancestor
65712568|NCT03507465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712569|NCT03507465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712570|NCT03507465|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65712571|NCT03507465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65712572|NCT03507465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65712573|NCT03507465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65712574|NCT03507465|Hormone Antagonists|hormone antagonists|mesh-ancestor
65712575|NCT03507465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65712576|NCT03507465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712577|NCT05476042|Epoetin Alfa|epoetin alfa|mesh-list
65712578|NCT05476042|Hematinics|hematinics|mesh-ancestor
65712579|NCT03507387|Phenylephrine|phenylephrine|mesh-list
65712580|NCT03507387|Oxymetazoline|oxymetazoline|mesh-list
65712581|NCT03507387|Bupivacaine|bupivacaine|mesh-list
65712582|NCT03507387|Anesthetics, Local|anesthetics, local|mesh-ancestor
65712583|NCT03507387|Anesthetics|anesthetics|mesh-ancestor
65712584|NCT03507387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65712585|NCT03507387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712586|NCT03507387|Sensory System Agents|sensory system agents|mesh-ancestor
65712587|NCT03507387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65712588|NCT03507387|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65712589|NCT03507387|Mydriatics|mydriatics|mesh-ancestor
65712590|NCT03507387|Autonomic Agents|autonomic agents|mesh-ancestor
65712591|NCT03507387|Sympathomimetics|sympathomimetics|mesh-ancestor
65712592|NCT03507387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65712593|NCT03507387|Nasal Decongestants|nasal decongestants|mesh-ancestor
65712594|NCT03507387|Respiratory System Agents|respiratory system agents|mesh-ancestor
65712595|NCT03507387|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65712596|NCT03507387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65712597|NCT03507387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65712598|NCT03507387|Adrenergic Agents|adrenergic agents|mesh-ancestor
65712599|NCT03507387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65712600|NCT03507387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028406|NCT05674513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65028407|NCT05674513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028408|NCT05674513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65028409|NCT05669482|Gemcitabine|gemcitabine|mesh-list
65028410|NCT05669482|Paclitaxel|paclitaxel|mesh-list
65028411|NCT05669482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65028412|NCT05669482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028413|NCT05669482|Tubulin Modulators|tubulin modulators|mesh-ancestor
65028414|NCT05669482|Antimitotic Agents|antimitotic agents|mesh-ancestor
65028415|NCT05669482|Mitosis Modulators|mitosis modulators|mesh-ancestor
65028416|NCT05669482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028439|NCT05630872|Lamivudine|lamivudine|mesh-list
65712601|NCT03507387|Protective Agents|protective agents|mesh-ancestor
65712603|NCT05454358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712604|NCT05454358|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65712605|NCT05454358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65712606|NCT05454358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65712607|NCT05454358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712608|NCT05454358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65712609|NCT05454358|Hormone Antagonists|hormone antagonists|mesh-ancestor
65712610|NCT05454358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65712611|NCT05454358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712612|NCT02694536|Gemcitabine|gemcitabine|mesh-list
65712613|NCT02694536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65712614|NCT02694536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65712615|NCT02694536|Antimetabolites|antimetabolites|mesh-ancestor
65712616|NCT02694536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712617|NCT02694536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712618|NCT02694536|Antiviral Agents|antiviral agents|mesh-ancestor
65712619|NCT02694536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65712620|NCT02694536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65712621|NCT02694536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65712622|NCT02694536|Immunologic Factors|immunologic factors|mesh-ancestor
65712623|NCT02694536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712624|NCT02694536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65712625|NCT02312037|Gemtuzumab|gemtuzumab|mesh-list
65712626|NCT02312037|Antibodies|antibodies|mesh-list
65712627|NCT02312037|Immunoconjugates|immunoconjugates|mesh-list
65712628|NCT02312037|Immunologic Factors|immunologic factors|mesh-ancestor
65712629|NCT02312037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712630|NCT02312037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65712631|NCT02312037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712632|NCT03167918|Calcium, Dietary|calcium, dietary|mesh-list
65712633|NCT03167918|Metformin|metformin|mesh-list
65712634|NCT03167918|Calcium Dobesilate|calcium dobesilate|mesh-list
65712635|NCT03167918|Calcium|calcium|mesh-list
65712636|NCT03167918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65712637|NCT03167918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712638|NCT03167918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65712639|NCT03167918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65712640|NCT03167918|Hemostatics|hemostatics|mesh-ancestor
65712641|NCT03167918|Coagulants|coagulants|mesh-ancestor
65712642|NCT05745818|Colchicine|colchicine|mesh-list
65712643|NCT05745818|Gout Suppressants|gout suppressants|mesh-ancestor
65712644|NCT05745818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65712645|NCT05745818|Tubulin Modulators|tubulin modulators|mesh-ancestor
65712646|NCT05745818|Antimitotic Agents|antimitotic agents|mesh-ancestor
65712647|NCT05745818|Mitosis Modulators|mitosis modulators|mesh-ancestor
65712648|NCT05745818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712649|NCT05745818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712650|NCT02393300|Tranexamic Acid|tranexamic acid|mesh-list
65712651|NCT02393300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65712652|NCT02393300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65712653|NCT02393300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712654|NCT02393300|Hemostatics|hemostatics|mesh-ancestor
65712655|NCT02393300|Coagulants|coagulants|mesh-ancestor
65712656|NCT03106610|Nivolumab|nivolumab|mesh-list
65712657|NCT03106610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65712658|NCT03106610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712659|NCT03106610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65712660|NCT03106610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712661|NCT02678884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65712662|NCT02678884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65712663|NCT02678884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712664|NCT03504735|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
65712665|NCT03504735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65712666|NCT03504735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65712667|NCT03504735|Antimetabolites|antimetabolites|mesh-ancestor
65712668|NCT03504735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712669|NCT03504735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65712670|NCT03504735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65712671|NCT03504735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65712672|NCT03504735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65028483|NCT05617118|Baclofen|baclofen|mesh-list
65028484|NCT05617118|Botulinum Toxins|botulinum toxins|mesh-list
65028551|NCT05550662|Xenon|xenon|mesh-list
65712673|NCT03504735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65712674|NCT03504735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712675|NCT03504735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65712677|NCT05475886|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65712678|NCT05475886|Plasma Substitutes|plasma substitutes|mesh-ancestor
65712679|NCT05475886|Blood Substitutes|blood substitutes|mesh-ancestor
65712680|NCT02312115|Furosemide|furosemide|mesh-list
65712681|NCT02312115|Diuretics|diuretics|mesh-ancestor
65712682|NCT02312115|Natriuretic Agents|natriuretic agents|mesh-ancestor
65712683|NCT02312115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712684|NCT02312115|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65712685|NCT02312115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65712686|NCT02312115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712687|NCT03106532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65712688|NCT03106532|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65712689|NCT03026140|Celecoxib|celecoxib|mesh-list
65712690|NCT03026140|Nivolumab|nivolumab|mesh-list
65712691|NCT03026140|Ipilimumab|ipilimumab|mesh-list
65712692|NCT03026140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65712693|NCT03026140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712694|NCT03026140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65712695|NCT03026140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712696|NCT03026140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65712697|NCT03026140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65712698|NCT03026140|Analgesics|analgesics|mesh-ancestor
65712699|NCT03026140|Sensory System Agents|sensory system agents|mesh-ancestor
65712700|NCT03026140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65712701|NCT03026140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712702|NCT03026140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65712703|NCT03026140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65712704|NCT03026140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65712705|NCT03026140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65712706|NCT03026140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65712707|NCT02398994|Methylprednisolone|methylprednisolone|mesh-list
65712708|NCT02398994|Immunoglobulins|immunoglobulins|mesh-list
65712709|NCT02398994|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65712710|NCT02398994|gamma-Globulins|gamma-globulins|mesh-list
65712711|NCT02398994|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65712712|NCT02398994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65712713|NCT02398994|Antiemetics|antiemetics|mesh-ancestor
65712714|NCT02398994|Autonomic Agents|autonomic agents|mesh-ancestor
65712715|NCT02398994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65712716|NCT02398994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712717|NCT02398994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65712718|NCT02398994|Glucocorticoids|glucocorticoids|mesh-ancestor
65712719|NCT02398994|Hormones|hormones|mesh-ancestor
65712720|NCT02398994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65712721|NCT02398994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65712722|NCT02398994|Protective Agents|protective agents|mesh-ancestor
65712723|NCT02398994|Immunologic Factors|immunologic factors|mesh-ancestor
65712724|NCT02306889|Fenofibrate|fenofibrate|mesh-list
65712725|NCT02306889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65712726|NCT02306889|Antimetabolites|antimetabolites|mesh-ancestor
65712727|NCT02306889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712728|NCT02306889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65712729|NCT02393144|Meperidine|meperidine|mesh-list
65712730|NCT02393144|Analgesics, Opioid|analgesics, opioid|mesh-list
65712731|NCT02393144|Analgesics|analgesics|mesh-list
65712732|NCT02393144|Oxytocin|oxytocin|mesh-list
65712733|NCT02393144|Dinoprostone|dinoprostone|mesh-list
65712734|NCT02393144|Oxytocics|oxytocics|mesh-ancestor
65712735|NCT02393144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65712736|NCT02393144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712737|NCT02393144|Narcotics|narcotics|mesh-ancestor
65712738|NCT02393144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65712739|NCT02393144|Sensory System Agents|sensory system agents|mesh-ancestor
65712740|NCT02393144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65712741|NCT02393144|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65712742|NCT02306031|Diclofenac|diclofenac|mesh-list
65712743|NCT02306031|Lubricant Eye Drops|lubricant eye drops|mesh-list
65712744|NCT02306031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65712745|NCT02306031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65712746|NCT02306031|Analgesics|analgesics|mesh-ancestor
65712747|NCT02306031|Sensory System Agents|sensory system agents|mesh-ancestor
65712748|NCT02306031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65712749|NCT02306031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712750|NCT02306031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65712751|NCT02306031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65712752|NCT02306031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65712753|NCT02306031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65712754|NCT02306031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712755|NCT02306031|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65712756|NCT02306031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65712757|NCT02392910|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65712758|NCT02392910|Hematinics|hematinics|mesh-ancestor
65712759|NCT02307045|Nicotine|nicotine|mesh-list
65712760|NCT02307045|Varenicline|varenicline|mesh-list
65712761|NCT02307045|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65712762|NCT02307045|Autonomic Agents|autonomic agents|mesh-ancestor
65712763|NCT02307045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65712764|NCT02307045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712765|NCT02307045|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65712766|NCT02307045|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65712767|NCT02307045|Cholinergic Agents|cholinergic agents|mesh-ancestor
65712768|NCT02307045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65712769|NCT02307045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712770|NCT03167372|Imidacloprid|imidacloprid|mesh-list
65712771|NCT03167372|Cholinergic Agents|cholinergic agents|mesh-ancestor
65712772|NCT03167372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65712773|NCT03167372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712774|NCT03167372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712775|NCT03504345|Progesterone|progesterone|mesh-list
65712776|NCT03504345|Progestins|progestins|mesh-ancestor
65712777|NCT03504345|Hormones|hormones|mesh-ancestor
65712778|NCT03504345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65712779|NCT03504345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712780|NCT02307201|Magnesium Sulfate|magnesium sulfate|mesh-list
65712781|NCT02307201|Analgesics|analgesics|mesh-ancestor
65712782|NCT02307201|Sensory System Agents|sensory system agents|mesh-ancestor
65712783|NCT02307201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65712784|NCT02307201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712785|NCT02307201|Anesthetics|anesthetics|mesh-ancestor
65712786|NCT02307201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65712787|NCT02307201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65712788|NCT02307201|Anticonvulsants|anticonvulsants|mesh-ancestor
65712789|NCT02307201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65712790|NCT02307201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65712791|NCT02307201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712792|NCT02307201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65712793|NCT02307201|Tocolytic Agents|tocolytic agents|mesh-ancestor
65712794|NCT02307201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65712795|NCT02306187|Eldecalcitol|eldecalcitol|mesh-list
65712796|NCT02306187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65712797|NCT02306187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712798|NCT03167216|Cetirizine|cetirizine|mesh-list
65712799|NCT03167216|Cromolyn Sodium|cromolyn sodium|mesh-list
65712800|NCT03167216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65712801|NCT03167216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65712802|NCT03167216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65712803|NCT03167216|Histamine Antagonists|histamine antagonists|mesh-ancestor
65712804|NCT03167216|Histamine Agents|histamine agents|mesh-ancestor
65712805|NCT03167216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65712806|NCT03167216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712807|NCT03167216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712808|NCT03167216|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
65712809|NCT03167216|Immunologic Factors|immunologic factors|mesh-ancestor
65712810|NCT03167216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65712811|NCT03167216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65712812|NCT03167216|Respiratory System Agents|respiratory system agents|mesh-ancestor
65712813|NCT02393066|Dexmedetomidine|dexmedetomidine|mesh-list
65712814|NCT02393066|Propofol|propofol|mesh-list
65712815|NCT02393066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65712816|NCT02393066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65712817|NCT02393066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712818|NCT02393066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65712819|NCT02393066|Anesthetics, General|anesthetics, general|mesh-ancestor
65712820|NCT02393066|Anesthetics|anesthetics|mesh-ancestor
65712821|NCT02393066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65712823|NCT02393066|Sensory System Agents|sensory system agents|mesh-ancestor
65712824|NCT02393066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65712825|NCT02393066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65712826|NCT02393066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65712827|NCT02393066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65712828|NCT02393066|Adrenergic Agents|adrenergic agents|mesh-ancestor
65712829|NCT02393066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65712830|NCT02393066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712831|NCT02398838|Misoprostol|misoprostol|mesh-list
65712832|NCT02398838|Mifepristone|mifepristone|mesh-list
65712833|NCT02398838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65712834|NCT02398838|Abortifacient Agents|abortifacient agents|mesh-ancestor
65712835|NCT02398838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65712836|NCT02398838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712837|NCT02398838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65712838|NCT02398838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65712839|NCT02398838|Oxytocics|oxytocics|mesh-ancestor
65712840|NCT02398838|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65712841|NCT02398838|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65712842|NCT02398838|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65712843|NCT02398838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65712844|NCT02398838|Contraceptive Agents|contraceptive agents|mesh-ancestor
65712845|NCT02398838|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65712846|NCT02398838|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65712847|NCT02398838|Hormone Antagonists|hormone antagonists|mesh-ancestor
65712848|NCT02398838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65712849|NCT02398838|Luteolytic Agents|luteolytic agents|mesh-ancestor
65712850|NCT02398838|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65712851|NCT02398838|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65712852|NCT02398682|Tin Fluorides|tin fluorides|mesh-list
65712853|NCT02398682|Cariostatic Agents|cariostatic agents|mesh-ancestor
65712854|NCT02398682|Protective Agents|protective agents|mesh-ancestor
65712855|NCT02398682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712856|NCT02312427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65712857|NCT02312427|Protease Inhibitors|protease inhibitors|mesh-ancestor
65712858|NCT02312427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65712859|NCT02312427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712860|NCT02312427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65712861|NCT02312427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712862|NCT03504033|Desflurane|desflurane|mesh-list
65712863|NCT03504033|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65712864|NCT03504033|Anesthetics, General|anesthetics, general|mesh-ancestor
65712865|NCT03504033|Anesthetics|anesthetics|mesh-ancestor
65712866|NCT03504033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65712867|NCT03504033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712868|NCT03132519|Remifentanil|remifentanil|mesh-list
65712869|NCT03132519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65712870|NCT03132519|Narcotics|narcotics|mesh-ancestor
65712871|NCT03132519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65712872|NCT03132519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712873|NCT03132519|Analgesics|analgesics|mesh-ancestor
65712874|NCT03132519|Sensory System Agents|sensory system agents|mesh-ancestor
65712875|NCT03132519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65712876|NCT02398448|Allopurinol|allopurinol|mesh-list
65712877|NCT02398448|Antimetabolites|antimetabolites|mesh-ancestor
65712878|NCT02398448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712879|NCT02398448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65712880|NCT02398448|Gout Suppressants|gout suppressants|mesh-ancestor
65712881|NCT02398448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65712882|NCT02398448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65712883|NCT02398448|Antioxidants|antioxidants|mesh-ancestor
65712884|NCT02398448|Protective Agents|protective agents|mesh-ancestor
65712885|NCT02398448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712886|NCT02392520|Cetrorelix|cetrorelix|mesh-list
65712887|NCT02392520|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65712888|NCT02392520|Fertility Agents|fertility agents|mesh-ancestor
65712889|NCT02392520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65712890|NCT02392520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712891|NCT02392520|Hormone Antagonists|hormone antagonists|mesh-ancestor
65712892|NCT02392520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65712893|NCT02316249|Estradiol|estradiol|mesh-list
65028699|NCT05113901|Hormones|hormones|mesh-ancestor
65712894|NCT02316249|Hormones|hormones|mesh-ancestor
65712895|NCT02316249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65712896|NCT02316249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712897|NCT02316249|Estrogens|estrogens|mesh-ancestor
65712898|NCT02696096|Buprenorphine|buprenorphine|mesh-list
65712899|NCT02696096|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65712900|NCT02696096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65712901|NCT02696096|Narcotics|narcotics|mesh-ancestor
65712902|NCT02696096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65712903|NCT02696096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712904|NCT02696096|Analgesics|analgesics|mesh-ancestor
65712905|NCT02696096|Sensory System Agents|sensory system agents|mesh-ancestor
65712906|NCT02696096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65712907|NCT02696096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65712908|NCT02316327|Gemcitabine|gemcitabine|mesh-list
65712909|NCT02316327|Bevacizumab|bevacizumab|mesh-list
65712910|NCT02316327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65712911|NCT02316327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712912|NCT02316327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65712913|NCT02316327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65712914|NCT02316327|Growth Substances|growth substances|mesh-ancestor
65712915|NCT02316327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712916|NCT02316327|Growth Inhibitors|growth inhibitors|mesh-ancestor
65712917|NCT02316327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65712918|NCT02316327|Antimetabolites|antimetabolites|mesh-ancestor
65712919|NCT02316327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712920|NCT02316327|Antiviral Agents|antiviral agents|mesh-ancestor
65712921|NCT02316327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65712922|NCT02316327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65712923|NCT02316327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65712924|NCT02316327|Immunologic Factors|immunologic factors|mesh-ancestor
65712925|NCT02695628|Misonidazole|misonidazole|mesh-list
65712926|NCT02695628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712927|NCT02695628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65712928|NCT02695628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65712929|NCT02695628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65712930|NCT02392364|Aflibercept|aflibercept|mesh-list
65712931|NCT02392364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65712932|NCT02392364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65712933|NCT02392364|Growth Substances|growth substances|mesh-ancestor
65712934|NCT02392364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712935|NCT02392364|Growth Inhibitors|growth inhibitors|mesh-ancestor
65712936|NCT02392364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712937|NCT02392676|Olaparib|olaparib|mesh-list
65712938|NCT02392676|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65712939|NCT02392676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65712940|NCT02392676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712941|NCT02392676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712942|NCT03106298|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65712943|NCT03106298|Hematinics|hematinics|mesh-ancestor
65712944|NCT02307591|Amiodarone|amiodarone|mesh-list
65712945|NCT02307591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65712946|NCT02307591|Vasodilator Agents|vasodilator agents|mesh-ancestor
65712947|NCT02307591|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65712948|NCT02307591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65712949|NCT02307591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712950|NCT02307591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65712951|NCT02307591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65712952|NCT02307591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65712953|NCT02307591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65712954|NCT02307591|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65712955|NCT02307591|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65712956|NCT02307591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65712957|NCT03506997|Pembrolizumab|pembrolizumab|mesh-list
65712958|NCT03506997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65712959|NCT03506997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712960|NCT02398136|Midazolam|midazolam|mesh-list
65712961|NCT02398136|Ketamine|ketamine|mesh-list
65712962|NCT02398136|Analgesics|analgesics|mesh-ancestor
65712963|NCT02398136|Sensory System Agents|sensory system agents|mesh-ancestor
65712964|NCT02398136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65712965|NCT02398136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712966|NCT02398136|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65712967|NCT02398136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65028771|NCT04892446|Pomalidomide|pomalidomide|mesh-list
65712968|NCT02398136|Anesthetics, General|anesthetics, general|mesh-ancestor
65712969|NCT02398136|Anesthetics|anesthetics|mesh-ancestor
65712970|NCT02398136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65712971|NCT02398136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65712972|NCT02398136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65712973|NCT02398136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65712974|NCT02398136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712975|NCT02398136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65712976|NCT02398136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65712977|NCT02398136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65712978|NCT02398136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65712979|NCT02398136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65712980|NCT02398136|GABA Modulators|gaba modulators|mesh-ancestor
65712981|NCT02398136|GABA Agents|gaba agents|mesh-ancestor
65712982|NCT05745584|Mirabegron|mirabegron|mesh-list
65712983|NCT05745584|Cholinergic Antagonists|cholinergic antagonists|mesh-list
65712984|NCT05745584|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65712985|NCT05745584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65712986|NCT05745584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65712987|NCT05745584|Adrenergic Agents|adrenergic agents|mesh-ancestor
65712988|NCT05745584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65712989|NCT05745584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65712990|NCT05745584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65712991|NCT05745584|Urological Agents|urological agents|mesh-ancestor
65712992|NCT05745584|Cholinergic Agents|cholinergic agents|mesh-ancestor
65712993|NCT02312661|Metformin|metformin|mesh-list
65712994|NCT02312661|Paclitaxel|paclitaxel|mesh-list
65712995|NCT02312661|Carboplatin|carboplatin|mesh-list
65712996|NCT02312661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65712997|NCT02312661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65712998|NCT02312661|Tubulin Modulators|tubulin modulators|mesh-ancestor
65712999|NCT02312661|Antimitotic Agents|antimitotic agents|mesh-ancestor
65713000|NCT02312661|Mitosis Modulators|mitosis modulators|mesh-ancestor
65713001|NCT02312661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713002|NCT02312661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65713003|NCT02312661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713004|NCT02398058|Olaparib|olaparib|mesh-list
65713005|NCT02398058|Trabectedin|trabectedin|mesh-list
65713006|NCT02398058|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65713007|NCT02398058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713008|NCT02398058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713009|NCT02398058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713010|NCT02398058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65713011|NCT02398058|Alkylating Agents|alkylating agents|mesh-ancestor
65713012|NCT03501615|Immunotoxin HA22|immunotoxin ha22|mesh-list
65713013|NCT03501615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713014|NCT05745350|Pembrolizumab|pembrolizumab|mesh-list
65713015|NCT05745350|Etoposide|etoposide|mesh-list
65713016|NCT05745350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65713017|NCT05745350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713018|NCT05745350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65713019|NCT05745350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65713020|NCT05745350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65713021|NCT05745350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713022|NCT05745350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713023|NCT03506919|Allopurinol|allopurinol|mesh-list
65713024|NCT03506919|Antimetabolites|antimetabolites|mesh-ancestor
65713025|NCT03506919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713026|NCT03506919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713027|NCT03506919|Gout Suppressants|gout suppressants|mesh-ancestor
65713028|NCT03506919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65713029|NCT03506919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65713030|NCT03506919|Antioxidants|antioxidants|mesh-ancestor
65713031|NCT03506919|Protective Agents|protective agents|mesh-ancestor
65713032|NCT03506919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713033|NCT02545504|Leucovorin|leucovorin|mesh-list
65713034|NCT02545504|Fluorouracil|fluorouracil|mesh-list
65713035|NCT02545504|Oxaliplatin|oxaliplatin|mesh-list
65713036|NCT02545504|Antimetabolites|antimetabolites|mesh-ancestor
65713037|NCT02545504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713038|NCT02545504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65713039|NCT02545504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713040|NCT02545504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65713041|NCT02545504|Immunologic Factors|immunologic factors|mesh-ancestor
65713042|NCT02545504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713044|NCT02545504|Protective Agents|protective agents|mesh-ancestor
65713045|NCT02545504|Vitamin B Complex|vitamin b complex|mesh-ancestor
65713046|NCT02545504|Vitamins|vitamins|mesh-ancestor
65713047|NCT02545504|Micronutrients|micronutrients|mesh-ancestor
65713048|NCT03506841|Cerebrolysin|cerebrolysin|mesh-list
65713049|NCT03506841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65713050|NCT03506841|Protective Agents|protective agents|mesh-ancestor
65713051|NCT03506841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713052|NCT03506841|Nootropic Agents|nootropic agents|mesh-ancestor
65713053|NCT02397512|Lactulose|lactulose|mesh-list
65713054|NCT02397512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65713055|NCT02313051|Everolimus|everolimus|mesh-list
65713056|NCT02313051|Letrozole|letrozole|mesh-list
65713057|NCT02313051|Goserelin|goserelin|mesh-list
65713058|NCT02313051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713059|NCT02313051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65713060|NCT02313051|Immunologic Factors|immunologic factors|mesh-ancestor
65713061|NCT02313051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713062|NCT02313051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65713063|NCT02313051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65713064|NCT02313051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713065|NCT02313051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713066|NCT02313051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65713067|NCT02313051|Hormone Antagonists|hormone antagonists|mesh-ancestor
65713068|NCT02313051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65713069|NCT02313051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65713070|NCT02397590|Atorvastatin|atorvastatin|mesh-list
65713071|NCT02397590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65713072|NCT02397590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65713073|NCT02397590|Antimetabolites|antimetabolites|mesh-ancestor
65713074|NCT02397590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713075|NCT02397590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65713076|NCT02397590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65713077|NCT02397590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713078|NCT02397356|Ketamine|ketamine|mesh-list
65713079|NCT02397356|Analgesics|analgesics|mesh-ancestor
65713080|NCT02397356|Sensory System Agents|sensory system agents|mesh-ancestor
65713081|NCT02397356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65713082|NCT02397356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713083|NCT02397356|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65713084|NCT02397356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65713085|NCT02397356|Anesthetics, General|anesthetics, general|mesh-ancestor
65713086|NCT02397356|Anesthetics|anesthetics|mesh-ancestor
65713087|NCT02397356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65713088|NCT02397356|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65713089|NCT02397356|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65713090|NCT02397356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65713091|NCT02397356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713092|NCT02307825|Azithromycin|azithromycin|mesh-list
65713093|NCT02307825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65713094|NCT02307825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65713095|NCT02540668|Warfarin|warfarin|mesh-list
65713096|NCT02540668|Anticoagulants|anticoagulants|mesh-ancestor
65713097|NCT03506763|Diclofenac|diclofenac|mesh-list
65713098|NCT03506763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65713099|NCT03506763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65713100|NCT03506763|Analgesics|analgesics|mesh-ancestor
65713101|NCT03506763|Sensory System Agents|sensory system agents|mesh-ancestor
65713102|NCT03506763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65713103|NCT03506763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713104|NCT03506763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65713105|NCT03506763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65713106|NCT03506763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65713107|NCT03506763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713108|NCT03506763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713109|NCT02441439|Iron|iron|mesh-list
65713110|NCT02441439|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65713111|NCT02441439|Trace Elements|trace elements|mesh-ancestor
65713112|NCT02441439|Micronutrients|micronutrients|mesh-ancestor
65713113|NCT02441439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713114|NCT02441439|Hematinics|hematinics|mesh-ancestor
65713115|NCT02308137|Domperidone|domperidone|mesh-list
65713116|NCT02308137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713117|NCT02308137|Antiemetics|antiemetics|mesh-ancestor
65713118|NCT02308137|Autonomic Agents|autonomic agents|mesh-ancestor
65713119|NCT02308137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65713120|NCT02308137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713121|NCT02308137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65713122|NCT02308137|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65713123|NCT02308137|Dopamine Agents|dopamine agents|mesh-ancestor
65713124|NCT02308137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65713125|NCT03501459|Rituximab|rituximab|mesh-list
65713126|NCT03501459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65713127|NCT03501459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713128|NCT03501459|Immunologic Factors|immunologic factors|mesh-ancestor
65713129|NCT03501459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713130|NCT03501459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65713131|NCT02317263|Testosterone|testosterone|mesh-list
65713132|NCT02317263|Androgens|androgens|mesh-ancestor
65713133|NCT02317263|Hormones|hormones|mesh-ancestor
65713134|NCT02317263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65713135|NCT02317263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713136|NCT02317341|Midazolam|midazolam|mesh-list
65713137|NCT02317341|Ketamine|ketamine|mesh-list
65713138|NCT02317341|Analgesics|analgesics|mesh-ancestor
65713139|NCT02317341|Sensory System Agents|sensory system agents|mesh-ancestor
65713140|NCT02317341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65713141|NCT02317341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713142|NCT02317341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65713143|NCT02317341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65713144|NCT02317341|Anesthetics, General|anesthetics, general|mesh-ancestor
65713145|NCT02317341|Anesthetics|anesthetics|mesh-ancestor
65713146|NCT02317341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65713147|NCT02317341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65713148|NCT02317341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65713149|NCT02317341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65713150|NCT02317341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713151|NCT02317341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65713152|NCT02317341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65713153|NCT02317341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65713154|NCT02317341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65713155|NCT02317341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65713156|NCT02317341|GABA Modulators|gaba modulators|mesh-ancestor
65713157|NCT02317341|GABA Agents|gaba agents|mesh-ancestor
65713158|NCT02339740|Vitamins|vitamins|mesh-list
65713159|NCT02339740|Vitamin A|vitamin a|mesh-list
65713160|NCT02339740|Cytarabine|cytarabine|mesh-list
65713161|NCT02339740|Dexamethasone|dexamethasone|mesh-list
65713162|NCT02339740|Dexamethasone acetate|dexamethasone acetate|mesh-list
65713163|NCT02339740|Mitoxantrone|mitoxantrone|mesh-list
65713164|NCT02339740|Idarubicin|idarubicin|mesh-list
65713165|NCT02339740|Tretinoin|tretinoin|mesh-list
65713166|NCT02339740|Retinol palmitate|retinol palmitate|mesh-list
65713167|NCT02339740|Arsenic Trioxide|arsenic trioxide|mesh-list
65713168|NCT02339740|BB 1101|bb 1101|mesh-list
65713169|NCT02339740|Micronutrients|micronutrients|mesh-ancestor
65713170|NCT02339740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713171|NCT02339740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65713172|NCT02339740|Antiemetics|antiemetics|mesh-ancestor
65713173|NCT02339740|Autonomic Agents|autonomic agents|mesh-ancestor
65713174|NCT02339740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65713175|NCT02339740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65713176|NCT02339740|Glucocorticoids|glucocorticoids|mesh-ancestor
65713177|NCT02339740|Hormones|hormones|mesh-ancestor
65713178|NCT02339740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65713179|NCT02339740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65713180|NCT02339740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713181|NCT02339740|Protease Inhibitors|protease inhibitors|mesh-ancestor
65713182|NCT02339740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713183|NCT02339740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713184|NCT02339740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65713185|NCT02339740|Antimetabolites|antimetabolites|mesh-ancestor
65713186|NCT02339740|Antiviral Agents|antiviral agents|mesh-ancestor
65713187|NCT02339740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65713188|NCT02339740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65713189|NCT02339740|Immunologic Factors|immunologic factors|mesh-ancestor
65713190|NCT02339740|Analgesics|analgesics|mesh-ancestor
65713191|NCT02339740|Sensory System Agents|sensory system agents|mesh-ancestor
65713192|NCT02339740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65713193|NCT02339740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65713194|NCT02339740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65029015|NCT04472767|Nivolumab|nivolumab|mesh-list
65713195|NCT02339740|Keratolytic Agents|keratolytic agents|mesh-ancestor
65713196|NCT02339740|Dermatologic Agents|dermatologic agents|mesh-ancestor
65713197|NCT02339740|Antioxidants|antioxidants|mesh-ancestor
65713198|NCT02339740|Protective Agents|protective agents|mesh-ancestor
65713199|NCT02339740|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65713200|NCT02317419|Gemcitabine|gemcitabine|mesh-list
65713201|NCT02317419|Paclitaxel|paclitaxel|mesh-list
65713202|NCT02317419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65713203|NCT02317419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713204|NCT02317419|Tubulin Modulators|tubulin modulators|mesh-ancestor
65713205|NCT02317419|Antimitotic Agents|antimitotic agents|mesh-ancestor
65713206|NCT02317419|Mitosis Modulators|mitosis modulators|mesh-ancestor
65713207|NCT02317419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713208|NCT02317419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65713209|NCT02317419|Antimetabolites|antimetabolites|mesh-ancestor
65713210|NCT02317419|Antiviral Agents|antiviral agents|mesh-ancestor
65713211|NCT02317419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65713212|NCT02317419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713213|NCT02317419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65713214|NCT02317419|Immunologic Factors|immunologic factors|mesh-ancestor
65713215|NCT02317419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713216|NCT02317497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65713217|NCT02957968|Paclitaxel|paclitaxel|mesh-list
65713218|NCT02957968|Cyclophosphamide|cyclophosphamide|mesh-list
65713219|NCT02957968|Carboplatin|carboplatin|mesh-list
65713220|NCT02957968|Doxorubicin|doxorubicin|mesh-list
65713221|NCT02957968|Pembrolizumab|pembrolizumab|mesh-list
65713222|NCT02957968|Decitabine|decitabine|mesh-list
65713223|NCT02957968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65713224|NCT02957968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713225|NCT02957968|Tubulin Modulators|tubulin modulators|mesh-ancestor
65713226|NCT02957968|Antimitotic Agents|antimitotic agents|mesh-ancestor
65713227|NCT02957968|Mitosis Modulators|mitosis modulators|mesh-ancestor
65713228|NCT02957968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713229|NCT02957968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65713230|NCT02957968|Immunologic Factors|immunologic factors|mesh-ancestor
65713231|NCT02957968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713232|NCT02957968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65713233|NCT02957968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65713234|NCT02957968|Alkylating Agents|alkylating agents|mesh-ancestor
65713235|NCT02957968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65713236|NCT02957968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65713237|NCT02957968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65713238|NCT02957968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65713239|NCT02957968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713240|NCT02957968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65713241|NCT02957968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65713242|NCT02957968|Antimetabolites|antimetabolites|mesh-ancestor
65713243|NCT05452174|Mirtazapine|mirtazapine|mesh-list
65713244|NCT05452174|Antidepressive Agents|antidepressive agents|mesh-ancestor
65713245|NCT05452174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65713246|NCT05452174|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65713247|NCT05452174|Histamine Antagonists|histamine antagonists|mesh-ancestor
65713248|NCT05452174|Histamine Agents|histamine agents|mesh-ancestor
65713249|NCT05452174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65713250|NCT05452174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713251|NCT05452174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713252|NCT05452174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65713253|NCT05452174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65713254|NCT05452174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65713255|NCT05452174|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65713256|NCT05452174|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65175937|NCT00598975|Irinotecan|irinotecan|mesh-list
65713257|NCT05452174|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65713258|NCT05452174|Adrenergic Agents|adrenergic agents|mesh-ancestor
65713259|NCT05452174|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65713260|NCT05452174|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65713261|NCT05452174|Serotonin Agents|serotonin agents|mesh-ancestor
65713262|NCT05452174|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65713263|NCT03943888|Atropine|atropine|mesh-list
65713264|NCT03943888|Neostigmine|neostigmine|mesh-list
65713265|NCT03943888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65713266|NCT03943888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65713267|NCT03943888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65713268|NCT03943888|Autonomic Agents|autonomic agents|mesh-ancestor
65713269|NCT03943888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65713270|NCT03943888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713271|NCT03943888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65713272|NCT03943888|Respiratory System Agents|respiratory system agents|mesh-ancestor
65713273|NCT03943888|Mydriatics|mydriatics|mesh-ancestor
65713274|NCT03943888|Parasympatholytics|parasympatholytics|mesh-ancestor
65713275|NCT03943888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65713276|NCT03943888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65713277|NCT03943888|Cholinergic Agents|cholinergic agents|mesh-ancestor
65713278|NCT03943888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65713279|NCT03943888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713280|NCT03943888|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65713281|NCT03943888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713282|NCT03943888|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65713283|NCT00433511|Paclitaxel|paclitaxel|mesh-list
65713284|NCT00433511|Cyclophosphamide|cyclophosphamide|mesh-list
65713285|NCT00433511|Bevacizumab|bevacizumab|mesh-list
65713286|NCT00433511|Doxorubicin|doxorubicin|mesh-list
65713287|NCT00433511|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65713288|NCT00433511|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65713289|NCT00433511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65713290|NCT00433511|Antibodies|antibodies|mesh-list
65713291|NCT00433511|Immunoglobulins|immunoglobulins|mesh-list
65713292|NCT00433511|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65713293|NCT00433511|Immunoglobulin G|immunoglobulin g|mesh-list
65713294|NCT00433511|Endothelial Growth Factors|endothelial growth factors|mesh-list
65713295|NCT00433511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65713296|NCT00433511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713297|NCT00433511|Tubulin Modulators|tubulin modulators|mesh-ancestor
65713298|NCT00433511|Antimitotic Agents|antimitotic agents|mesh-ancestor
65713299|NCT00433511|Mitosis Modulators|mitosis modulators|mesh-ancestor
65713300|NCT00433511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713301|NCT00433511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65713302|NCT00433511|Immunologic Factors|immunologic factors|mesh-ancestor
65713303|NCT00433511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713304|NCT00433511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65713305|NCT00433511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65713306|NCT00433511|Alkylating Agents|alkylating agents|mesh-ancestor
65713307|NCT00433511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65713308|NCT00433511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65713309|NCT00433511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65713310|NCT00433511|Growth Substances|growth substances|mesh-ancestor
65713311|NCT00433511|Growth Inhibitors|growth inhibitors|mesh-ancestor
65713312|NCT00433511|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65713313|NCT00433511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65713314|NCT00433511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65713315|NCT00433511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713316|NCT03502551|Ketamine|ketamine|mesh-list
65713317|NCT03502551|Analgesics|analgesics|mesh-ancestor
65713318|NCT03502551|Sensory System Agents|sensory system agents|mesh-ancestor
65713319|NCT03502551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65713320|NCT03502551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713321|NCT03502551|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65713322|NCT03502551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65713323|NCT03502551|Anesthetics, General|anesthetics, general|mesh-ancestor
65713324|NCT03502551|Anesthetics|anesthetics|mesh-ancestor
65713325|NCT03502551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65269220|NCT02744378|Hormones|hormones|mesh-ancestor
65713326|NCT03502551|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65713327|NCT03502551|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65713328|NCT03502551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65713329|NCT03502551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713330|NCT02314377|Bevacizumab|bevacizumab|mesh-list
65713331|NCT02314377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65713332|NCT02314377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713333|NCT02314377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65713334|NCT02314377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65713335|NCT02314377|Growth Substances|growth substances|mesh-ancestor
65713336|NCT02314377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713337|NCT02314377|Growth Inhibitors|growth inhibitors|mesh-ancestor
65713338|NCT02942290|Azacitidine|azacitidine|mesh-list
65713339|NCT02942290|Venetoclax|venetoclax|mesh-list
65713340|NCT02942290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65713341|NCT02942290|Antimetabolites|antimetabolites|mesh-ancestor
65713342|NCT02942290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713343|NCT02942290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713344|NCT02942290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713345|NCT02540356|Antibodies|antibodies|mesh-list
65713346|NCT02540356|Immunoglobulins|immunoglobulins|mesh-list
65713347|NCT02540356|Immunologic Factors|immunologic factors|mesh-ancestor
65713348|NCT02540356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713349|NCT05463094|Metformin|metformin|mesh-list
65713350|NCT05463094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65713351|NCT05463094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713352|NCT05431348|Hydrocortisone|hydrocortisone|mesh-list
65713353|NCT05431348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65713354|NCT02392130|Clobetasol|clobetasol|mesh-list
65713355|NCT02392130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65713356|NCT02392130|Glucocorticoids|glucocorticoids|mesh-ancestor
65713357|NCT02392130|Hormones|hormones|mesh-ancestor
65713358|NCT02392130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65713359|NCT02392130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713360|NCT00070499|Imatinib Mesylate|imatinib mesylate|mesh-list
65713361|NCT00070499|Dasatinib|dasatinib|mesh-list
65713362|NCT00070499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713363|NCT00070499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65713364|NCT00070499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713365|NCT00070499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713366|NCT05356091|Sevoflurane|sevoflurane|mesh-list
65713367|NCT05356091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65713368|NCT05356091|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65713369|NCT05356091|Anesthetics, General|anesthetics, general|mesh-ancestor
65713370|NCT05356091|Anesthetics|anesthetics|mesh-ancestor
65713371|NCT05356091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65713372|NCT05356091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713373|NCT05351021|Metformin|metformin|mesh-list
65713374|NCT05351021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65713375|NCT05351021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713376|NCT02688764|Calcium|calcium|mesh-list
65713377|NCT02688764|Calcium acetate|calcium acetate|mesh-list
65713378|NCT02688764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65713379|NCT02688764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713380|NCT02688764|Chelating Agents|chelating agents|mesh-ancestor
65713381|NCT02688764|Sequestering Agents|sequestering agents|mesh-ancestor
65713382|NCT02688764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713383|NCT02688608|Pembrolizumab|pembrolizumab|mesh-list
65713384|NCT02688608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65713385|NCT02688608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713386|NCT04544111|Trametinib|trametinib|mesh-list
65713387|NCT04544111|Dabrafenib|dabrafenib|mesh-list
65713388|NCT04544111|Spartalizumab|spartalizumab|mesh-list
65713389|NCT04544111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713390|NCT04544111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65713391|NCT04544111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713392|NCT04544111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713393|NCT04544111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65713394|NCT02688530|Dexamethasone|dexamethasone|mesh-list
65713395|NCT02688530|Dexamethasone acetate|dexamethasone acetate|mesh-list
65713396|NCT02688530|BB 1101|bb 1101|mesh-list
65713397|NCT02688530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65713398|NCT02688530|Antiemetics|antiemetics|mesh-ancestor
65713399|NCT02688530|Autonomic Agents|autonomic agents|mesh-ancestor
65713400|NCT02688530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65713401|NCT02688530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713402|NCT02688530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65713403|NCT02688530|Glucocorticoids|glucocorticoids|mesh-ancestor
65713404|NCT02688530|Hormones|hormones|mesh-ancestor
65713405|NCT02688530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65713406|NCT02688530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65713407|NCT02688530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713408|NCT02688530|Protease Inhibitors|protease inhibitors|mesh-ancestor
65713409|NCT02688530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713410|NCT02688530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713411|NCT05744804|Aspirin|aspirin|mesh-list
65713412|NCT05744804|Rivaroxaban|rivaroxaban|mesh-list
65713413|NCT05744804|Clopidogrel|clopidogrel|mesh-list
65713414|NCT05744804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65713415|NCT05744804|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65713416|NCT05744804|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65713417|NCT05744804|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65713418|NCT05744804|Purinergic Agents|purinergic agents|mesh-ancestor
65713419|NCT05744804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65713420|NCT05744804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713421|NCT05744804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713422|NCT05744804|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65713423|NCT05744804|Antithrombins|antithrombins|mesh-ancestor
65713424|NCT05744804|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65713425|NCT05744804|Protease Inhibitors|protease inhibitors|mesh-ancestor
65713426|NCT05744804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713427|NCT05744804|Anticoagulants|anticoagulants|mesh-ancestor
65713428|NCT05744804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65713429|NCT05744804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65713430|NCT05744804|Analgesics|analgesics|mesh-ancestor
65713431|NCT05744804|Sensory System Agents|sensory system agents|mesh-ancestor
65713432|NCT05744804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65713433|NCT05744804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65713434|NCT05744804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65713435|NCT05744804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65713436|NCT05744804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65713437|NCT05744804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65713438|NCT05744804|Antipyretics|antipyretics|mesh-ancestor
65713439|NCT05746442|Nicotine|nicotine|mesh-list
65713440|NCT05746442|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65713441|NCT05746442|Autonomic Agents|autonomic agents|mesh-ancestor
65713442|NCT05746442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65713443|NCT05746442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713444|NCT05746442|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65713445|NCT05746442|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65713446|NCT05746442|Cholinergic Agents|cholinergic agents|mesh-ancestor
65713447|NCT05746442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65713448|NCT05746442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713449|NCT05744726|Bone wax|bone wax|mesh-list
65713450|NCT05744726|Hemostatics|hemostatics|mesh-ancestor
65713451|NCT05744726|Coagulants|coagulants|mesh-ancestor
65713452|NCT02467270|Ponatinib|ponatinib|mesh-list
65713453|NCT02467270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713454|NCT02467270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65713455|NCT02467270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713456|NCT02467270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713457|NCT05369819|Midazolam|midazolam|mesh-list
65713458|NCT05369819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65713459|NCT05369819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65713460|NCT05369819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65713461|NCT05369819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713462|NCT05369819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65713463|NCT05369819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65713464|NCT05369819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65713465|NCT05369819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65713466|NCT05369819|Anesthetics, General|anesthetics, general|mesh-ancestor
65713467|NCT05369819|Anesthetics|anesthetics|mesh-ancestor
65713468|NCT05369819|GABA Modulators|gaba modulators|mesh-ancestor
65713469|NCT05369819|GABA Agents|gaba agents|mesh-ancestor
65713470|NCT05369819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65713471|NCT05369819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713472|NCT05150795|Pregabalin|pregabalin|mesh-list
65713473|NCT05150795|Fentanyl|fentanyl|mesh-list
65713474|NCT05150795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65713475|NCT05150795|Narcotics|narcotics|mesh-ancestor
65176153|NCT00654667|Antioxidants|antioxidants|mesh-ancestor
65713476|NCT05150795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65713477|NCT05150795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713478|NCT05150795|Analgesics|analgesics|mesh-ancestor
65713479|NCT05150795|Sensory System Agents|sensory system agents|mesh-ancestor
65713480|NCT05150795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65713481|NCT05150795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65713482|NCT05150795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65713483|NCT05150795|Anesthetics, General|anesthetics, general|mesh-ancestor
65713484|NCT05150795|Anesthetics|anesthetics|mesh-ancestor
65713485|NCT05150795|Anticonvulsants|anticonvulsants|mesh-ancestor
65713486|NCT05150795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65713487|NCT05150795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65713488|NCT05150795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713489|NCT05150795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65713490|NCT05150795|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65713491|NCT05150795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65713492|NCT05150795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65713493|NCT05746208|Pembrolizumab|pembrolizumab|mesh-list
65713494|NCT05746208|Lenvatinib|lenvatinib|mesh-list
65713495|NCT05746208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65713496|NCT05746208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713497|NCT05746208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65713498|NCT05746208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713499|NCT05746208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713500|NCT03166280|Sofosbuvir|sofosbuvir|mesh-list
65713501|NCT03166280|Antiviral Agents|antiviral agents|mesh-ancestor
65713502|NCT03166280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65713503|NCT02533570|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65713504|NCT02533570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65713505|NCT02533570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65713506|NCT02533570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713507|NCT02533570|Immunologic Factors|immunologic factors|mesh-ancestor
65713508|NCT02533570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713509|NCT02268448|Clonidine|clonidine|mesh-list
65713510|NCT02268448|Naltrexone|naltrexone|mesh-list
65713511|NCT02268448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65713512|NCT02268448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65713513|NCT02268448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713514|NCT02268448|Sensory System Agents|sensory system agents|mesh-ancestor
65713515|NCT02268448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65713516|NCT02268448|Analgesics|analgesics|mesh-ancestor
65713517|NCT02268448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65713518|NCT02268448|Sympatholytics|sympatholytics|mesh-ancestor
65713519|NCT02268448|Autonomic Agents|autonomic agents|mesh-ancestor
65713520|NCT02268448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65713521|NCT02268448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65713522|NCT02268448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65713523|NCT02268448|Adrenergic Agents|adrenergic agents|mesh-ancestor
65713524|NCT02268448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65713525|NCT02268448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713526|NCT05744570|Anesthetics|anesthetics|mesh-list
65713527|NCT05744570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65713528|NCT05744570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713529|NCT05601440|Gemcitabine|gemcitabine|mesh-list
65713530|NCT05601440|Fulvestrant|fulvestrant|mesh-list
65713531|NCT05601440|Niraparib|niraparib|mesh-list
65713532|NCT05601440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65713533|NCT05601440|Antimetabolites|antimetabolites|mesh-ancestor
65713534|NCT05601440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713535|NCT05601440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713536|NCT05601440|Antiviral Agents|antiviral agents|mesh-ancestor
65713537|NCT05601440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65713538|NCT05601440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713539|NCT05601440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65713540|NCT05601440|Immunologic Factors|immunologic factors|mesh-ancestor
65713541|NCT05601440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713542|NCT05601440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65713543|NCT05601440|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65713544|NCT05601440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65713545|NCT05601440|Hormone Antagonists|hormone antagonists|mesh-ancestor
65713546|NCT05601440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65713547|NCT05601440|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65713548|NCT03036839|Sofosbuvir|sofosbuvir|mesh-list
65713549|NCT03036839|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
65713550|NCT03036839|Ledipasvir|ledipasvir|mesh-list
65713551|NCT03036839|Antiviral Agents|antiviral agents|mesh-ancestor
65713552|NCT03036839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65713553|NCT04977791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65713554|NCT04977791|Antibodies|antibodies|mesh-list
65713555|NCT04977791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65713556|NCT04977791|Immunologic Factors|immunologic factors|mesh-ancestor
65713557|NCT04977791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713558|NCT04977791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713559|NCT04977791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713560|NCT04152863|Pembrolizumab|pembrolizumab|mesh-list
65713561|NCT04152863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65713562|NCT04152863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713563|NCT03625739|Amoxicillin|amoxicillin|mesh-list
65713564|NCT03625739|Moxifloxacin|moxifloxacin|mesh-list
65713565|NCT03625739|Levofloxacin|levofloxacin|mesh-list
65713566|NCT03625739|Isoniazid|isoniazid|mesh-list
65713567|NCT03625739|Cycloserine|cycloserine|mesh-list
65713568|NCT03625739|Clavulanic Acid|clavulanic acid|mesh-list
65713569|NCT03625739|Imipenem|imipenem|mesh-list
65713570|NCT03625739|Amikacin|amikacin|mesh-list
65713571|NCT03625739|Pyrazinamide|pyrazinamide|mesh-list
65713572|NCT03625739|Ethambutol|ethambutol|mesh-list
65713573|NCT03625739|Bedaquiline|bedaquiline|mesh-list
65713574|NCT03625739|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65713575|NCT03625739|Clofazimine|clofazimine|mesh-list
65713576|NCT03625739|Gatifloxacin|gatifloxacin|mesh-list
65713577|NCT03625739|Aminosalicylic Acid|aminosalicylic acid|mesh-list
65713578|NCT03625739|Streptomycin|streptomycin|mesh-list
65713579|NCT03625739|Ethionamide|ethionamide|mesh-list
65713580|NCT03625739|Kanamycin|kanamycin|mesh-list
65713581|NCT03625739|Capreomycin|capreomycin|mesh-list
65713582|NCT03625739|Thioacetazone|thioacetazone|mesh-list
65713583|NCT03625739|Antitubercular Agents|antitubercular agents|mesh-list
65713584|NCT03625739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65713585|NCT03625739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65713586|NCT03625739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65713587|NCT03625739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65713588|NCT03625739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713589|NCT03625739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713590|NCT03625739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713591|NCT03625739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65713592|NCT03625739|Renal Agents|renal agents|mesh-ancestor
65713593|NCT03625739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65713594|NCT03625739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65713595|NCT03625739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65713596|NCT03625739|Leprostatic Agents|leprostatic agents|mesh-ancestor
65713597|NCT03625739|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65713598|NCT03625739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65713599|NCT03625739|Antimetabolites|antimetabolites|mesh-ancestor
65713600|NCT03625739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65713601|NCT03625739|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65713602|NCT03625739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65713603|NCT03625739|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65713604|NCT03625739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65713605|NCT03625739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65713606|NCT03904199|Insulin|insulin|mesh-list
65713607|NCT03904199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65713608|NCT03904199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65713609|NCT03904199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713610|NCT03902951|Leuprolide|leuprolide|mesh-list
65713611|NCT03902951|Abiraterone Acetate|abiraterone acetate|mesh-list
65713612|NCT03902951|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65713613|NCT03902951|Fertility Agents|fertility agents|mesh-ancestor
65713614|NCT03902951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65713615|NCT03902951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713616|NCT03902951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65713617|NCT03902951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713618|NCT03902951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65713619|NCT03902951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713620|NCT03902951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713621|NCT03902951|Hormone Antagonists|hormone antagonists|mesh-ancestor
65713622|NCT03902951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65713623|NCT03902951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65713624|NCT01286207|Rizatriptan|rizatriptan|mesh-list
65713625|NCT01286207|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65713626|NCT01286207|Serotonin Agents|serotonin agents|mesh-ancestor
65713627|NCT01286207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65713628|NCT01286207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713629|NCT01286207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713630|NCT05408026|Dexamethasone|dexamethasone|mesh-list
65713631|NCT05408026|Bortezomib|bortezomib|mesh-list
65713632|NCT05408026|Daratumumab|daratumumab|mesh-list
65713633|NCT05408026|Pomalidomide|pomalidomide|mesh-list
65713634|NCT05408026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65713635|NCT05408026|Antiemetics|antiemetics|mesh-ancestor
65713636|NCT05408026|Autonomic Agents|autonomic agents|mesh-ancestor
65713637|NCT05408026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65713638|NCT05408026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713639|NCT05408026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65713640|NCT05408026|Glucocorticoids|glucocorticoids|mesh-ancestor
65713641|NCT05408026|Hormones|hormones|mesh-ancestor
65713642|NCT05408026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65713643|NCT05408026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65713644|NCT05408026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713645|NCT05408026|Immunologic Factors|immunologic factors|mesh-ancestor
65713646|NCT05408026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65713647|NCT05408026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65713648|NCT05408026|Growth Substances|growth substances|mesh-ancestor
65713649|NCT05408026|Growth Inhibitors|growth inhibitors|mesh-ancestor
65713650|NCT02170090|Gemcitabine|gemcitabine|mesh-list
65713651|NCT02170090|Capecitabine|capecitabine|mesh-list
65713652|NCT02170090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713653|NCT02170090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65713654|NCT02170090|Antimetabolites|antimetabolites|mesh-ancestor
65713655|NCT02170090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713656|NCT02170090|Antiviral Agents|antiviral agents|mesh-ancestor
65713657|NCT02170090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65713658|NCT02170090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713659|NCT02170090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65713660|NCT02170090|Immunologic Factors|immunologic factors|mesh-ancestor
65713661|NCT02170090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713663|NCT04423510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65713664|NCT04423510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65713665|NCT04423510|Disinfectants|disinfectants|mesh-ancestor
65713666|NCT04423510|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65713667|NCT04423510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65713668|NCT00968201|Montelukast|montelukast|mesh-list
65713669|NCT00968201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65713670|NCT00968201|Respiratory System Agents|respiratory system agents|mesh-ancestor
65713671|NCT00968201|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65713672|NCT00968201|Hormone Antagonists|hormone antagonists|mesh-ancestor
65713673|NCT00968201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65713674|NCT00968201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713675|NCT00968201|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65713676|NCT00968201|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65713677|NCT00968201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713678|NCT00943397|Montelukast|montelukast|mesh-list
65713679|NCT00943397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65713680|NCT00943397|Respiratory System Agents|respiratory system agents|mesh-ancestor
65713681|NCT00943397|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65713682|NCT00943397|Hormone Antagonists|hormone antagonists|mesh-ancestor
65713683|NCT00943397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65713684|NCT00943397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713685|NCT00943397|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65713686|NCT00943397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65713687|NCT00943397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713688|NCT00817817|Mometasone Furoate|mometasone furoate|mesh-list
65713689|NCT00817817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65713690|NCT00817817|Dermatologic Agents|dermatologic agents|mesh-ancestor
65713691|NCT00817817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65713692|NCT00702845|Hormones|hormones|mesh-list
65713693|NCT00702845|Progesterone|progesterone|mesh-list
65713694|NCT00702845|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65713695|NCT00702845|Ganirelix|ganirelix|mesh-list
65713696|NCT00702845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65713697|NCT00702845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713698|NCT00702845|Progestins|progestins|mesh-ancestor
65713699|NCT00702845|Hormone Antagonists|hormone antagonists|mesh-ancestor
65713700|NCT00647933|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65713701|NCT00647933|Lynestrenol|lynestrenol|mesh-list
65713702|NCT00647933|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65713703|NCT00647933|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65713704|NCT00647933|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65713705|NCT00647933|Contraceptive Agents|contraceptive agents|mesh-ancestor
65713706|NCT00647933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65713707|NCT00647933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713708|NCT00647933|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65713709|NCT00647933|Estrogens|estrogens|mesh-ancestor
65713710|NCT00647933|Hormones|hormones|mesh-ancestor
65713711|NCT00647933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65713712|NCT00647933|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65713713|NCT00641771|Cholecalciferol|cholecalciferol|mesh-list
65713714|NCT00641771|Vitamin D|vitamin d|mesh-list
65713715|NCT00641771|Alendronate|alendronate|mesh-list
65713716|NCT00641771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65713717|NCT00641771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713718|NCT00641771|Vitamins|vitamins|mesh-ancestor
65713719|NCT00641771|Micronutrients|micronutrients|mesh-ancestor
65713720|NCT00641771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65713721|NCT00519857|Tibolone|tibolone|mesh-list
65713722|NCT00519857|Androgen Antagonists|androgen antagonists|mesh-ancestor
65713723|NCT00519857|Hormone Antagonists|hormone antagonists|mesh-ancestor
65713724|NCT00519857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65713725|NCT00519857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713726|NCT00519857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65713727|NCT00519857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65713728|NCT00519857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713729|NCT00519857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65713730|NCT00519857|Anabolic Agents|anabolic agents|mesh-ancestor
65713731|NCT00519857|Hormones|hormones|mesh-ancestor
65713732|NCT00431093|Tibolone|tibolone|mesh-list
65713733|NCT00431093|Estradiol|estradiol|mesh-list
65713734|NCT00431093|Estrogens|estrogens|mesh-ancestor
65713735|NCT00431093|Hormones|hormones|mesh-ancestor
65713736|NCT00431093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65713737|NCT00431093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713738|NCT00431093|Androgen Antagonists|androgen antagonists|mesh-ancestor
65713739|NCT00431093|Hormone Antagonists|hormone antagonists|mesh-ancestor
65713740|NCT00431093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65713741|NCT00431093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65713742|NCT00431093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713743|NCT00431093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65713744|NCT00431093|Anabolic Agents|anabolic agents|mesh-ancestor
65713745|NCT03665597|Pembrolizumab|pembrolizumab|mesh-list
65713746|NCT03665597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65713747|NCT03665597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713748|NCT00092963|Rizatriptan|rizatriptan|mesh-list
65713749|NCT00092963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65713750|NCT00092963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713751|NCT00092963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713752|NCT00092963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65713753|NCT00092963|Serotonin Agents|serotonin agents|mesh-ancestor
65713754|NCT00092885|Montelukast|montelukast|mesh-list
65713755|NCT00092885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65713756|NCT00092885|Respiratory System Agents|respiratory system agents|mesh-ancestor
65713757|NCT00092885|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65713758|NCT00092885|Hormone Antagonists|hormone antagonists|mesh-ancestor
65713759|NCT00092885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65713760|NCT00092885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713761|NCT00092885|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65713762|NCT00092885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65713763|NCT00092885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713764|NCT03673735|Durvalumab|durvalumab|mesh-list
65713765|NCT03673735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713766|NCT03673735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65713767|NCT01272037|Tamoxifen|tamoxifen|mesh-list
65713768|NCT01272037|Letrozole|letrozole|mesh-list
65713769|NCT01272037|Anastrozole|anastrozole|mesh-list
65713770|NCT01272037|Exemestane|exemestane|mesh-list
65713771|NCT01272037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713772|NCT01272037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713773|NCT01272037|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65713774|NCT01272037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65713775|NCT01272037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713776|NCT01272037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65713777|NCT01272037|Hormone Antagonists|hormone antagonists|mesh-ancestor
65713778|NCT01272037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65713779|NCT01272037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713780|NCT01272037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65713781|NCT01272037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65713782|NCT01272037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65713783|NCT01272037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65713784|NCT00092105|Montelukast|montelukast|mesh-list
65713785|NCT00092105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65713786|NCT00092105|Respiratory System Agents|respiratory system agents|mesh-ancestor
65713787|NCT00092105|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65713788|NCT00092105|Hormone Antagonists|hormone antagonists|mesh-ancestor
65713789|NCT00092105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65713790|NCT00092105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713791|NCT00092105|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65713792|NCT00092105|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65713793|NCT00092105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713794|NCT00092027|Alendronate|alendronate|mesh-list
65713795|NCT00092027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713796|NCT00092027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65713797|NCT00076973|Montelukast|montelukast|mesh-list
65713798|NCT00076973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65713799|NCT00076973|Respiratory System Agents|respiratory system agents|mesh-ancestor
65029593|NCT02427620|Antiemetics|antiemetics|mesh-ancestor
65713800|NCT00076973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65713801|NCT00076973|Hormone Antagonists|hormone antagonists|mesh-ancestor
65713802|NCT00076973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65713803|NCT00076973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713804|NCT00076973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65713805|NCT00076973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65713806|NCT00076973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713808|NCT03565991|Talazoparib|talazoparib|mesh-list
65713809|NCT03565991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65713810|NCT03565991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713811|NCT03565991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65713812|NCT03565991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713813|NCT03565991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713814|NCT02314533|Fenofibrate|fenofibrate|mesh-list
65713815|NCT02314533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65713816|NCT02314533|Antimetabolites|antimetabolites|mesh-ancestor
65713817|NCT02314533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713818|NCT02314533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65713819|NCT03502395|Lidocaine|lidocaine|mesh-list
65713820|NCT03502395|Anesthetics, Local|anesthetics, local|mesh-ancestor
65713821|NCT03502395|Anesthetics|anesthetics|mesh-ancestor
65713822|NCT03502395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65713823|NCT03502395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713824|NCT03502395|Sensory System Agents|sensory system agents|mesh-ancestor
65713825|NCT03502395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65713826|NCT03502395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65713827|NCT03502395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65713828|NCT03502395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65713829|NCT03502395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65713830|NCT03502395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713831|NCT02318043|Fluticasone|fluticasone|mesh-list
65713832|NCT02318043|Budesonide|budesonide|mesh-list
65713833|NCT02318043|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65713834|NCT02318043|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65713835|NCT02318043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65713836|NCT02318043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65713837|NCT02318043|Autonomic Agents|autonomic agents|mesh-ancestor
65713838|NCT02318043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65713839|NCT02318043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713840|NCT02318043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65713841|NCT02318043|Respiratory System Agents|respiratory system agents|mesh-ancestor
65713842|NCT02318043|Dermatologic Agents|dermatologic agents|mesh-ancestor
65713843|NCT02318043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65713844|NCT02318043|Glucocorticoids|glucocorticoids|mesh-ancestor
65713845|NCT02318043|Hormones|hormones|mesh-ancestor
65713846|NCT02318043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65713847|NCT02318043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65713848|NCT02318043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65713849|NCT02318043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65713850|NCT02318043|Adrenergic Agents|adrenergic agents|mesh-ancestor
65713851|NCT02318043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65713852|NCT02318043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713853|NCT02318043|Sympathomimetics|sympathomimetics|mesh-ancestor
65713854|NCT03433313|Trastuzumab|trastuzumab|mesh-list
65713855|NCT03433313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65713856|NCT03433313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713857|NCT02318121|Oxytocin|oxytocin|mesh-list
65713858|NCT02318121|Oxytocics|oxytocics|mesh-ancestor
65713859|NCT02318121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65713860|NCT02318121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713861|NCT02318199|Anesthetics|anesthetics|mesh-list
65713862|NCT02318199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65713863|NCT02318199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713864|NCT05225597|Carbachol|carbachol|mesh-list
65713865|NCT05225597|Epinephrine|epinephrine|mesh-list
65713866|NCT05225597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65713867|NCT05225597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65713868|NCT05225597|Adrenergic Agents|adrenergic agents|mesh-ancestor
65713869|NCT05225597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65713870|NCT05225597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713871|NCT05225597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713872|NCT05225597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65713873|NCT05225597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65713874|NCT05225597|Autonomic Agents|autonomic agents|mesh-ancestor
65713875|NCT05225597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65713876|NCT05225597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65713877|NCT05225597|Respiratory System Agents|respiratory system agents|mesh-ancestor
65713878|NCT05225597|Mydriatics|mydriatics|mesh-ancestor
65713879|NCT05225597|Sympathomimetics|sympathomimetics|mesh-ancestor
65713880|NCT05225597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65713881|NCT05225597|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65713882|NCT05225597|Miotics|miotics|mesh-ancestor
65713883|NCT05225597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65713884|NCT05225597|Cholinergic Agents|cholinergic agents|mesh-ancestor
65713885|NCT05225597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65713886|NCT05225597|Analgesics|analgesics|mesh-ancestor
65713887|NCT05225597|Sensory System Agents|sensory system agents|mesh-ancestor
65713888|NCT05225597|Protective Agents|protective agents|mesh-ancestor
65713889|NCT03393845|Pembrolizumab|pembrolizumab|mesh-list
65713890|NCT03393845|Fulvestrant|fulvestrant|mesh-list
65713891|NCT03393845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65713892|NCT03393845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713893|NCT03393845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65713894|NCT03393845|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65713895|NCT03393845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65713896|NCT03393845|Hormone Antagonists|hormone antagonists|mesh-ancestor
65713897|NCT03393845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65713898|NCT03393845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713899|NCT00958633|Citalopram|citalopram|mesh-list
65713900|NCT00958633|Bupropion|bupropion|mesh-list
65713901|NCT00958633|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65713902|NCT00958633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65713903|NCT00958633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65713904|NCT00958633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713905|NCT00958633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65713906|NCT00958633|Serotonin Agents|serotonin agents|mesh-ancestor
65713907|NCT00958633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713908|NCT00958633|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65713909|NCT00958633|Antidepressive Agents|antidepressive agents|mesh-ancestor
65713910|NCT00958633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65713911|NCT00958633|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65713912|NCT00958633|Dopamine Agents|dopamine agents|mesh-ancestor
65713913|NCT00958633|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65713914|NCT00958633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65713915|NCT00958633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713916|NCT03070327|Cyclophosphamide|cyclophosphamide|mesh-list
65713917|NCT03070327|Lenalidomide|lenalidomide|mesh-list
65713918|NCT03070327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65713919|NCT03070327|Immunologic Factors|immunologic factors|mesh-ancestor
65713920|NCT03070327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713921|NCT03070327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65713922|NCT03070327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65713923|NCT03070327|Alkylating Agents|alkylating agents|mesh-ancestor
65713924|NCT03070327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713925|NCT03070327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713926|NCT03070327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65713927|NCT03070327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65713928|NCT03070327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65713929|NCT03070327|Growth Substances|growth substances|mesh-ancestor
65713930|NCT03070327|Growth Inhibitors|growth inhibitors|mesh-ancestor
65713931|NCT00543127|Fulvestrant|fulvestrant|mesh-list
65713932|NCT00543127|Anastrozole|anastrozole|mesh-list
65713933|NCT00543127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65713934|NCT00543127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713935|NCT00543127|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65713936|NCT00543127|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65713937|NCT00543127|Hormone Antagonists|hormone antagonists|mesh-ancestor
65713938|NCT00543127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65713939|NCT00543127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713940|NCT00543127|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65713941|NCT00543127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65713942|NCT00543127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713943|NCT00543127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713944|NCT00409435|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
65713945|NCT00409435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65713946|NCT00409435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713947|NCT00409435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713948|NCT00409435|Cholinergic Agents|cholinergic agents|mesh-ancestor
65713949|NCT00409435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65713950|NCT00409435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713951|NCT03673501|Sunitinib|sunitinib|mesh-list
65713952|NCT03673501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713953|NCT03673501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65713954|NCT03673501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65713955|NCT03673501|Growth Substances|growth substances|mesh-ancestor
65713956|NCT03673501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713957|NCT03673501|Growth Inhibitors|growth inhibitors|mesh-ancestor
65713958|NCT03673501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65713959|NCT03673501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713960|NCT03673501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713961|NCT02309385|Dexamethasone|dexamethasone|mesh-list
65713962|NCT02309385|Dexamethasone acetate|dexamethasone acetate|mesh-list
65713963|NCT02309385|Prednisolone|prednisolone|mesh-list
65713964|NCT02309385|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65713965|NCT02309385|Methylprednisolone|methylprednisolone|mesh-list
65713966|NCT02309385|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65713967|NCT02309385|Prednisolone acetate|prednisolone acetate|mesh-list
65713968|NCT02309385|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65713969|NCT02309385|Prednisolone phosphate|prednisolone phosphate|mesh-list
65713970|NCT02309385|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65713971|NCT02309385|BB 1101|bb 1101|mesh-list
65713972|NCT02309385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65713973|NCT02309385|Antiemetics|antiemetics|mesh-ancestor
65713974|NCT02309385|Autonomic Agents|autonomic agents|mesh-ancestor
65713975|NCT02309385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65713976|NCT02309385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713977|NCT02309385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65713978|NCT02309385|Glucocorticoids|glucocorticoids|mesh-ancestor
65713979|NCT02309385|Hormones|hormones|mesh-ancestor
65713980|NCT02309385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65713981|NCT02309385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65713982|NCT02309385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713983|NCT02309385|Protease Inhibitors|protease inhibitors|mesh-ancestor
65713984|NCT02309385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65713985|NCT02309385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713986|NCT02309385|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65713987|NCT02309385|Protective Agents|protective agents|mesh-ancestor
65713988|NCT02315001|Liraglutide|liraglutide|mesh-list
65713989|NCT02315001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65713990|NCT02315001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65713991|NCT02315001|Incretins|incretins|mesh-ancestor
65713992|NCT02315001|Hormones|hormones|mesh-ancestor
65713993|NCT02315001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65713994|NCT02315157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65713995|NCT02315157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65713996|NCT02315157|Alkylating Agents|alkylating agents|mesh-ancestor
65713997|NCT02315157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65713998|NCT02315157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65713999|NCT02309463|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
65714000|NCT02309463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714001|NCT03500367|Sirolimus|sirolimus|mesh-list
65714002|NCT03500367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65714003|NCT03500367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65714004|NCT03500367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65714005|NCT03500367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714006|NCT03500367|Antifungal Agents|antifungal agents|mesh-ancestor
65714007|NCT03500367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65714008|NCT03500367|Immunologic Factors|immunologic factors|mesh-ancestor
65714009|NCT03500367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714010|NCT02318433|Dexamethasone|dexamethasone|mesh-list
65714011|NCT02318433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65714012|NCT02318433|Antiemetics|antiemetics|mesh-ancestor
65714013|NCT02318433|Autonomic Agents|autonomic agents|mesh-ancestor
65714014|NCT02318433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65714015|NCT02318433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714016|NCT02318433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65714017|NCT02318433|Glucocorticoids|glucocorticoids|mesh-ancestor
65714018|NCT02318433|Hormones|hormones|mesh-ancestor
65714019|NCT02318433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65714020|NCT02318433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65714021|NCT02318433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714022|NCT02318511|Hyaluronic Acid|hyaluronic acid|mesh-list
65714023|NCT02318511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65714024|NCT02318511|Immunologic Factors|immunologic factors|mesh-ancestor
65714025|NCT02318511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714026|NCT02318511|Viscosupplements|viscosupplements|mesh-ancestor
65714027|NCT02318511|Protective Agents|protective agents|mesh-ancestor
65714028|NCT02315391|Glycine|glycine|mesh-list
65714029|NCT02315391|Glycine Agents|glycine agents|mesh-ancestor
65714030|NCT02315391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65714031|NCT02315391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714032|NCT02315391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714033|NCT03022981|Sofosbuvir|sofosbuvir|mesh-list
65714034|NCT03022981|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65714035|NCT03022981|Velpatasvir|velpatasvir|mesh-list
65714036|NCT03022981|Antiviral Agents|antiviral agents|mesh-ancestor
65714037|NCT03022981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65714038|NCT03164967|Immunoglobulin G|immunoglobulin g|mesh-list
65714039|NCT03164967|Immunologic Factors|immunologic factors|mesh-ancestor
65714040|NCT03164967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714041|NCT03502005|Tenofovir|tenofovir|mesh-list
65714042|NCT03502005|Emtricitabine|emtricitabine|mesh-list
65714043|NCT03502005|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65714044|NCT03502005|Antiviral Agents|antiviral agents|mesh-ancestor
65714045|NCT03502005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65714046|NCT03502005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65714047|NCT03502005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65714048|NCT03502005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714049|NCT03502005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714050|NCT03502005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65714051|NCT03502005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65714052|NCT02315547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65714053|NCT02315547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65714054|NCT03669445|Dexamethasone|dexamethasone|mesh-list
65714055|NCT03669445|Lenalidomide|lenalidomide|mesh-list
65714056|NCT03669445|Daratumumab|daratumumab|mesh-list
65714057|NCT03669445|Ixazomib|ixazomib|mesh-list
65714058|NCT03669445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65714059|NCT03669445|Antiemetics|antiemetics|mesh-ancestor
65714060|NCT03669445|Autonomic Agents|autonomic agents|mesh-ancestor
65714061|NCT03669445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65714062|NCT03669445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714063|NCT03669445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65714064|NCT03669445|Glucocorticoids|glucocorticoids|mesh-ancestor
65714065|NCT03669445|Hormones|hormones|mesh-ancestor
65714066|NCT03669445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65714067|NCT03669445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65714068|NCT03669445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714069|NCT03669445|Immunologic Factors|immunologic factors|mesh-ancestor
65714070|NCT03669445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65714071|NCT03669445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65714072|NCT03669445|Growth Substances|growth substances|mesh-ancestor
65714073|NCT03669445|Growth Inhibitors|growth inhibitors|mesh-ancestor
65714074|NCT03669445|Protease Inhibitors|protease inhibitors|mesh-ancestor
65714075|NCT03669445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714076|NCT03669445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714077|NCT03500133|Cytarabine|cytarabine|mesh-list
65714078|NCT03500133|Methylprednisolone|methylprednisolone|mesh-list
65714079|NCT03500133|Cisplatin|cisplatin|mesh-list
65714080|NCT03500133|Etoposide|etoposide|mesh-list
65714081|NCT03500133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714082|NCT03500133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65714083|NCT03500133|Antimetabolites|antimetabolites|mesh-ancestor
65714084|NCT03500133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714085|NCT03500133|Antiviral Agents|antiviral agents|mesh-ancestor
65714086|NCT03500133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65714087|NCT03500133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65714088|NCT03500133|Immunologic Factors|immunologic factors|mesh-ancestor
65714089|NCT03500133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714090|NCT03500133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65714091|NCT03500133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65714092|NCT03500133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65714093|NCT03500133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714094|NCT03500133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65029924|NCT00775749|Nicotine|nicotine|mesh-list
65714095|NCT03500133|Antiemetics|antiemetics|mesh-ancestor
65714096|NCT03500133|Autonomic Agents|autonomic agents|mesh-ancestor
65714097|NCT03500133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65714098|NCT03500133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65714099|NCT03500133|Glucocorticoids|glucocorticoids|mesh-ancestor
65714100|NCT03500133|Hormones|hormones|mesh-ancestor
65714101|NCT03500133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65714102|NCT03500133|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65714103|NCT03500133|Protective Agents|protective agents|mesh-ancestor
65714104|NCT04462809|Talazoparib|talazoparib|mesh-list
65714105|NCT04462809|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65714106|NCT04462809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714107|NCT04462809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714108|NCT04462809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714109|NCT02320773|Mirabegron|mirabegron|mesh-list
65714110|NCT02320773|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65714111|NCT02320773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65714112|NCT02320773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65714113|NCT02320773|Adrenergic Agents|adrenergic agents|mesh-ancestor
65714114|NCT02320773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65714115|NCT02320773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714116|NCT02320773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714117|NCT02320773|Urological Agents|urological agents|mesh-ancestor
65714118|NCT03377699|Insulin|insulin|mesh-list
65714119|NCT03377699|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65714120|NCT03377699|Insulin Aspart|insulin aspart|mesh-list
65714121|NCT03377699|Insulin Detemir|insulin detemir|mesh-list
65714122|NCT03377699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65714123|NCT03377699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714124|NCT04463901|Mitomycins|mitomycins|mesh-list
65714125|NCT04463901|Mitomycin|mitomycin|mesh-list
65714126|NCT04463901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65714127|NCT04463901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714128|NCT04463901|Alkylating Agents|alkylating agents|mesh-ancestor
65714129|NCT04463901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714130|NCT04463901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65714131|NCT04463901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714132|NCT01314443|Vitamin E|vitamin e|mesh-list
65714133|NCT01314443|Tocopherols|tocopherols|mesh-list
65714134|NCT01314443|Tocotrienols|tocotrienols|mesh-list
65714135|NCT01314443|alpha-Tocopherol|alpha-tocopherol|mesh-list
65714136|NCT01314443|gamma-Tocopherol|gamma-tocopherol|mesh-list
65714137|NCT01314443|Nicotine|nicotine|mesh-list
65714138|NCT01314443|Vitamins|vitamins|mesh-ancestor
65714139|NCT01314443|Micronutrients|micronutrients|mesh-ancestor
65714140|NCT01314443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714141|NCT01314443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65714142|NCT01314443|Autonomic Agents|autonomic agents|mesh-ancestor
65714143|NCT01314443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65714144|NCT01314443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65714145|NCT01314443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65714146|NCT01314443|Cholinergic Agents|cholinergic agents|mesh-ancestor
65714147|NCT01314443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65714148|NCT01314443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714149|NCT01314443|Antioxidants|antioxidants|mesh-ancestor
65714150|NCT01314443|Protective Agents|protective agents|mesh-ancestor
65714151|NCT02310009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65714152|NCT02310009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65714153|NCT03498417|Antibodies|antibodies|mesh-list
65714154|NCT03498417|Immunologic Factors|immunologic factors|mesh-ancestor
65714155|NCT03498417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714156|NCT03212651|Pembrolizumab|pembrolizumab|mesh-list
65714157|NCT03212651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65714158|NCT03212651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714159|NCT02319135|Cytarabine|cytarabine|mesh-list
65714160|NCT02319135|Fludarabine|fludarabine|mesh-list
65714161|NCT02319135|Lenograstim|lenograstim|mesh-list
65714162|NCT02319135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714163|NCT02319135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65714164|NCT02319135|Antimetabolites|antimetabolites|mesh-ancestor
65714165|NCT02319135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714166|NCT02319135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65714167|NCT02319135|Immunologic Factors|immunologic factors|mesh-ancestor
65714168|NCT02319135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714169|NCT02319135|Antiviral Agents|antiviral agents|mesh-ancestor
65714170|NCT02319135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65030001|NCT00192855|Entacapone|entacapone|mesh-list
65714171|NCT02319135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65714172|NCT04738097|Clopidogrel|clopidogrel|mesh-list
65714173|NCT04738097|Ticagrelor|ticagrelor|mesh-list
65714174|NCT04738097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65714175|NCT04738097|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65714176|NCT04738097|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65714177|NCT04738097|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65714178|NCT04738097|Purinergic Agents|purinergic agents|mesh-ancestor
65714179|NCT04738097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65714180|NCT04738097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714181|NCT04738097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714182|NCT03499743|Celecoxib|celecoxib|mesh-list
65714183|NCT03499743|Scopolamine|scopolamine|mesh-list
65714184|NCT03499743|Bromides|bromides|mesh-list
65714185|NCT03499743|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65714186|NCT03499743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65714187|NCT03499743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65714188|NCT03499743|Analgesics|analgesics|mesh-ancestor
65714189|NCT03499743|Sensory System Agents|sensory system agents|mesh-ancestor
65714190|NCT03499743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65714191|NCT03499743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714192|NCT03499743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65714193|NCT03499743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65714194|NCT03499743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65714195|NCT03499743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65714196|NCT03499743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714197|NCT03499743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714198|NCT03499743|Anticonvulsants|anticonvulsants|mesh-ancestor
65714199|NCT03499743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65714200|NCT03499743|Antiemetics|antiemetics|mesh-ancestor
65714201|NCT03499743|Autonomic Agents|autonomic agents|mesh-ancestor
65714202|NCT03499743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65714203|NCT03499743|Mydriatics|mydriatics|mesh-ancestor
65714204|NCT03499743|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65714205|NCT03499743|Cholinergic Agents|cholinergic agents|mesh-ancestor
65714206|NCT03499743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65714207|NCT03499743|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65714208|NCT03499743|Parasympatholytics|parasympatholytics|mesh-ancestor
65714209|NCT02310087|Vitamin E|vitamin e|mesh-list
65714210|NCT02310087|Vitamins|vitamins|mesh-ancestor
65714211|NCT02310087|Micronutrients|micronutrients|mesh-ancestor
65714212|NCT02310087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714213|NCT02310087|Antioxidants|antioxidants|mesh-ancestor
65714214|NCT02310087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714215|NCT02310087|Protective Agents|protective agents|mesh-ancestor
65714216|NCT02923921|Leucovorin|leucovorin|mesh-list
65714217|NCT02923921|Oxaliplatin|oxaliplatin|mesh-list
65714218|NCT02923921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714219|NCT02923921|Antidotes|antidotes|mesh-ancestor
65714220|NCT02923921|Protective Agents|protective agents|mesh-ancestor
65714221|NCT02923921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714222|NCT02923921|Vitamin B Complex|vitamin b complex|mesh-ancestor
65714223|NCT02923921|Vitamins|vitamins|mesh-ancestor
65714224|NCT02923921|Micronutrients|micronutrients|mesh-ancestor
65714225|NCT02310243|Palbociclib|palbociclib|mesh-list
65714226|NCT02310243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714227|NCT02310243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65714228|NCT02310243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714229|NCT02310243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714230|NCT05062889|Leucovorin|leucovorin|mesh-list
65714231|NCT05062889|Trifluridine|trifluridine|mesh-list
65714232|NCT05062889|Fluorouracil|fluorouracil|mesh-list
65714233|NCT05062889|Capecitabine|capecitabine|mesh-list
65714234|NCT05062889|Oxaliplatin|oxaliplatin|mesh-list
65714235|NCT05062889|Irinotecan|irinotecan|mesh-list
65714236|NCT05062889|Levoleucovorin|levoleucovorin|mesh-list
65714237|NCT05062889|Antimetabolites|antimetabolites|mesh-ancestor
65714238|NCT05062889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714239|NCT05062889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65714240|NCT05062889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714241|NCT05062889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65714242|NCT05062889|Immunologic Factors|immunologic factors|mesh-ancestor
65714243|NCT05062889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714244|NCT05062889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65714245|NCT05062889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65714246|NCT05062889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714247|NCT05062889|Antidotes|antidotes|mesh-ancestor
65714248|NCT05062889|Protective Agents|protective agents|mesh-ancestor
65714249|NCT05062889|Vitamin B Complex|vitamin b complex|mesh-ancestor
65714250|NCT05062889|Vitamins|vitamins|mesh-ancestor
65714251|NCT05062889|Micronutrients|micronutrients|mesh-ancestor
65714252|NCT05062889|Antiviral Agents|antiviral agents|mesh-ancestor
65714253|NCT05062889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65714254|NCT03497715|Ibuprofen|ibuprofen|mesh-list
65714255|NCT03497715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65714256|NCT03497715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65714257|NCT03497715|Analgesics|analgesics|mesh-ancestor
65714258|NCT03497715|Sensory System Agents|sensory system agents|mesh-ancestor
65714259|NCT03497715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65714260|NCT03497715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714261|NCT03497715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65714262|NCT03497715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65714263|NCT03497715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65714264|NCT03497715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714265|NCT03497715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714266|NCT02321241|Aflibercept|aflibercept|mesh-list
65714267|NCT02321241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65714268|NCT02321241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65714269|NCT02321241|Growth Substances|growth substances|mesh-ancestor
65714270|NCT02321241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714271|NCT02321241|Growth Inhibitors|growth inhibitors|mesh-ancestor
65714272|NCT02321241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714273|NCT03583307|Sirolimus|sirolimus|mesh-list
65714274|NCT03583307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65714275|NCT03583307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65714276|NCT03583307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65714277|NCT03583307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714278|NCT03583307|Antifungal Agents|antifungal agents|mesh-ancestor
65714279|NCT03583307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65714280|NCT03583307|Immunologic Factors|immunologic factors|mesh-ancestor
65714281|NCT03583307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714282|NCT03039023|Choline|choline|mesh-list
65714283|NCT03039023|Lipotropic Agents|lipotropic agents|mesh-ancestor
65714284|NCT03039023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65714285|NCT03039023|Antimetabolites|antimetabolites|mesh-ancestor
65714286|NCT03039023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714287|NCT03039023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65714288|NCT03039023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65714289|NCT03039023|Nootropic Agents|nootropic agents|mesh-ancestor
65714290|NCT02321397|Oxycodone|oxycodone|mesh-list
65714291|NCT02321397|Naloxone|naloxone|mesh-list
65714292|NCT02321397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65714293|NCT02321397|Narcotics|narcotics|mesh-ancestor
65714294|NCT02321397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65714295|NCT02321397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714296|NCT02321397|Analgesics|analgesics|mesh-ancestor
65714297|NCT02321397|Sensory System Agents|sensory system agents|mesh-ancestor
65714298|NCT02321397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65714299|NCT02321397|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65714300|NCT02319915|Tranexamic Acid|tranexamic acid|mesh-list
65714301|NCT02319915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65714302|NCT02319915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65714303|NCT02319915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714304|NCT02319915|Hemostatics|hemostatics|mesh-ancestor
65714305|NCT02319915|Coagulants|coagulants|mesh-ancestor
65714306|NCT04898309|Complement C1s|complement c1s|mesh-list
65714307|NCT04898309|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
65714308|NCT04898309|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
65714309|NCT04898309|Immunologic Factors|immunologic factors|mesh-ancestor
65714310|NCT04898309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714311|NCT04898309|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65714312|NCT04898309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65714313|NCT03498963|Dimercaprol|dimercaprol|mesh-list
65714314|NCT03498963|Chelating Agents|chelating agents|mesh-ancestor
65714315|NCT03498963|Sequestering Agents|sequestering agents|mesh-ancestor
65714316|NCT03498963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714317|NCT02311101|Mitomycins|mitomycins|mesh-list
65714318|NCT02311101|Mitomycin|mitomycin|mesh-list
65714319|NCT02311101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65714320|NCT02311101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714321|NCT02311101|Alkylating Agents|alkylating agents|mesh-ancestor
65714322|NCT02311101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714323|NCT02311101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65714324|NCT02311101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714325|NCT04620187|Cisplatin|cisplatin|mesh-list
65714326|NCT04620187|Carboplatin|carboplatin|mesh-list
65714327|NCT04620187|Trastuzumab|trastuzumab|mesh-list
65714328|NCT04620187|Maytansine|maytansine|mesh-list
65714329|NCT04620187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714330|NCT04620187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65714331|NCT04620187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65714332|NCT04620187|Tubulin Modulators|tubulin modulators|mesh-ancestor
65714333|NCT04620187|Antimitotic Agents|antimitotic agents|mesh-ancestor
65714334|NCT04620187|Mitosis Modulators|mitosis modulators|mesh-ancestor
65714335|NCT04620187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714336|NCT04608487|Cyclophosphamide|cyclophosphamide|mesh-list
65714337|NCT04608487|Fludarabine|fludarabine|mesh-list
65714338|NCT04608487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65714339|NCT04608487|Immunologic Factors|immunologic factors|mesh-ancestor
65714340|NCT04608487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714341|NCT04608487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65714342|NCT04608487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65714343|NCT04608487|Alkylating Agents|alkylating agents|mesh-ancestor
65714344|NCT04608487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714345|NCT04608487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714346|NCT04608487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65714347|NCT03668665|Hyaluronic Acid|hyaluronic acid|mesh-list
65714348|NCT03668665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65714349|NCT03668665|Immunologic Factors|immunologic factors|mesh-ancestor
65714350|NCT03668665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714351|NCT03668665|Viscosupplements|viscosupplements|mesh-ancestor
65714352|NCT03668665|Protective Agents|protective agents|mesh-ancestor
65714353|NCT02320383|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65714354|NCT02320383|Obinutuzumab|obinutuzumab|mesh-list
65714355|NCT02320383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65714356|NCT02320383|Alkylating Agents|alkylating agents|mesh-ancestor
65714357|NCT02320383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714358|NCT02320383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714359|NCT02320383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65714360|NCT03704909|Epinephrine|epinephrine|mesh-list
65714361|NCT03704909|Racepinephrine|racepinephrine|mesh-list
65714362|NCT03704909|Ephedrine|ephedrine|mesh-list
65714363|NCT03704909|Epinephryl borate|epinephryl borate|mesh-list
65714364|NCT03704909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65714365|NCT03704909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65714366|NCT03704909|Adrenergic Agents|adrenergic agents|mesh-ancestor
65714367|NCT03704909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65714368|NCT03704909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714369|NCT03704909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714370|NCT03704909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65714371|NCT03704909|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65714372|NCT03704909|Autonomic Agents|autonomic agents|mesh-ancestor
65714373|NCT03704909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65714374|NCT03704909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65714375|NCT03704909|Respiratory System Agents|respiratory system agents|mesh-ancestor
65714376|NCT03704909|Mydriatics|mydriatics|mesh-ancestor
65714377|NCT03704909|Sympathomimetics|sympathomimetics|mesh-ancestor
65714378|NCT03704909|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65714379|NCT03704909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65714380|NCT03704831|Anesthetics|anesthetics|mesh-list
65714381|NCT03704831|Anesthetics, Local|anesthetics, local|mesh-list
65714382|NCT03704831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65714383|NCT03704831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714384|NCT03704831|Sensory System Agents|sensory system agents|mesh-ancestor
65714385|NCT03704831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65714386|NCT03494517|Magnesium Sulfate|magnesium sulfate|mesh-list
65714387|NCT03494517|Analgesics|analgesics|mesh-ancestor
65714388|NCT03494517|Sensory System Agents|sensory system agents|mesh-ancestor
65714389|NCT03494517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65714390|NCT03494517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714391|NCT03494517|Anesthetics|anesthetics|mesh-ancestor
65714392|NCT03494517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65714393|NCT03494517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65714394|NCT03494517|Anticonvulsants|anticonvulsants|mesh-ancestor
65714395|NCT03494517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65714396|NCT03494517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65714397|NCT03494517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714398|NCT03494517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65714399|NCT03494517|Tocolytic Agents|tocolytic agents|mesh-ancestor
65714400|NCT03494517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65714401|NCT04912505|Aspirin|aspirin|mesh-list
65714402|NCT04912505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65714403|NCT04912505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65714404|NCT04912505|Analgesics|analgesics|mesh-ancestor
65714405|NCT04912505|Sensory System Agents|sensory system agents|mesh-ancestor
65714406|NCT04912505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65714407|NCT04912505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714408|NCT04912505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65714409|NCT04912505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65714410|NCT04912505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65714411|NCT04912505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65714412|NCT04912505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714413|NCT04912505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65714414|NCT04912505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65714415|NCT04912505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714416|NCT04912505|Antipyretics|antipyretics|mesh-ancestor
65714417|NCT04912427|Dexamethasone|dexamethasone|mesh-list
65714418|NCT04912427|Bortezomib|bortezomib|mesh-list
65714419|NCT04912427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65714420|NCT04912427|Antiemetics|antiemetics|mesh-ancestor
65714421|NCT04912427|Autonomic Agents|autonomic agents|mesh-ancestor
65714422|NCT04912427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65714423|NCT04912427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714424|NCT04912427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65714425|NCT04912427|Glucocorticoids|glucocorticoids|mesh-ancestor
65714426|NCT04912427|Hormones|hormones|mesh-ancestor
65714427|NCT04912427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65714428|NCT04912427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65714429|NCT04912427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714430|NCT02322645|Eszopiclone|eszopiclone|mesh-list
65714431|NCT02322645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65714432|NCT02322645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65714433|NCT02322645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714434|NCT04050761|Nivolumab|nivolumab|mesh-list
65714435|NCT04050761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65714436|NCT04050761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714437|NCT04050761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65714438|NCT04050761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714439|NCT04785261|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65714440|NCT04785261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65714441|NCT03496389|Acetaminophen|acetaminophen|mesh-list
65714442|NCT03496389|Gabapentin|gabapentin|mesh-list
65714443|NCT03496389|Tramadol|tramadol|mesh-list
65714444|NCT03496389|Analgesics|analgesics|mesh-ancestor
65714445|NCT03496389|Sensory System Agents|sensory system agents|mesh-ancestor
65714446|NCT03496389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65714447|NCT03496389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714448|NCT03496389|Anticonvulsants|anticonvulsants|mesh-ancestor
65714449|NCT03496389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65714450|NCT03496389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65714451|NCT03496389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65714452|NCT03496389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65714453|NCT03496389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65714454|NCT03496389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65714455|NCT03496389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65714456|NCT03496389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714457|NCT03496389|Antimanic Agents|antimanic agents|mesh-ancestor
65714458|NCT03496389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65714459|NCT03496389|Narcotics|narcotics|mesh-ancestor
65714460|NCT03496389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65714461|NCT03496389|Antipyretics|antipyretics|mesh-ancestor
65714462|NCT03491709|Cetuximab|cetuximab|mesh-list
65714463|NCT03491709|Antibodies|antibodies|mesh-list
65714464|NCT03491709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65714465|NCT03491709|Immunologic Factors|immunologic factors|mesh-ancestor
65714466|NCT03491709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714467|NCT03491709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65714468|NCT03491709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714469|NCT02325063|Botulinum Toxins|botulinum toxins|mesh-list
65714470|NCT02325063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65714471|NCT02325063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65714472|NCT02325063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714473|NCT02325063|Cholinergic Agents|cholinergic agents|mesh-ancestor
65714474|NCT02325063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65714475|NCT02325063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714476|NCT02323191|Atezolizumab|atezolizumab|mesh-list
65714477|NCT02323191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714478|NCT02323269|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65714479|NCT02323269|Dermatologic Agents|dermatologic agents|mesh-ancestor
65714480|NCT02323269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65714481|NCT02323269|Immunologic Factors|immunologic factors|mesh-ancestor
65714482|NCT02323269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714483|NCT02323347|Progesterone|progesterone|mesh-list
65714484|NCT02323347|Progestins|progestins|mesh-ancestor
65714485|NCT02323347|Hormones|hormones|mesh-ancestor
65714486|NCT02323347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65714487|NCT02323347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714488|NCT03495765|Ranibizumab|ranibizumab|mesh-list
65714489|NCT03495765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65714490|NCT03495765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65714491|NCT03495765|Growth Substances|growth substances|mesh-ancestor
65714492|NCT03495765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714493|NCT03495765|Growth Inhibitors|growth inhibitors|mesh-ancestor
65714494|NCT03495765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714495|NCT03495609|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65714496|NCT03495609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65714497|NCT03495609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714498|NCT03491475|Ajmaline|ajmaline|mesh-list
65714499|NCT03491475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65714500|NCT03491475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65714501|NCT03491475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65714502|NCT03491475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65714503|NCT03491475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714504|NCT03499119|Erenumab|erenumab|mesh-list
65714505|NCT03499119|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65177188|NCT02844790|Insulin|insulin|mesh-list
65714506|NCT03499119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714507|NCT03499119|Analgesics|analgesics|mesh-ancestor
65714508|NCT03499119|Sensory System Agents|sensory system agents|mesh-ancestor
65714509|NCT03499119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65714510|NCT03499119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714511|NCT03328845|Insulin|insulin|mesh-list
65714512|NCT03328845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65714513|NCT03328845|Insulin Lispro|insulin lispro|mesh-list
65714514|NCT03328845|Insulin Aspart|insulin aspart|mesh-list
65714515|NCT03328845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65714516|NCT03328845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714517|NCT02323737|Cisplatin|cisplatin|mesh-list
65714518|NCT02323737|Irinotecan|irinotecan|mesh-list
65714519|NCT02323737|Etoposide|etoposide|mesh-list
65714520|NCT02323737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714521|NCT02323737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65714522|NCT02323737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65714523|NCT02323737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714524|NCT02323737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714525|NCT02323737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65714526|NCT02323737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65714527|NCT03037359|Immunoglobulin G|immunoglobulin g|mesh-list
65714528|NCT03037359|Immunologic Factors|immunologic factors|mesh-ancestor
65714529|NCT03037359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714530|NCT03491085|Amoxicillin|amoxicillin|mesh-list
65714531|NCT03491085|Clavulanic Acid|clavulanic acid|mesh-list
65714532|NCT03491085|Clavulanic Acids|clavulanic acids|mesh-list
65714533|NCT03491085|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65714534|NCT03491085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65714535|NCT03491085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65714536|NCT03491085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65714537|NCT03491085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714538|NCT03491085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714539|NCT02323971|Ticagrelor|ticagrelor|mesh-list
65714540|NCT02323971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65714541|NCT02323971|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65714542|NCT02323971|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65714543|NCT02323971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65714544|NCT02323971|Purinergic Agents|purinergic agents|mesh-ancestor
65714545|NCT02323971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65714546|NCT02323971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714547|NCT02323971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714548|NCT03148899|Oxytocin|oxytocin|mesh-list
65714549|NCT03148899|Oxytocics|oxytocics|mesh-ancestor
65714550|NCT03148899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65714551|NCT03148899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714552|NCT03495063|Caffeine|caffeine|mesh-list
65030458|NCT00194064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65714553|NCT03495063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65714554|NCT03495063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714555|NCT03495063|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65714556|NCT03495063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714557|NCT03495063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714558|NCT03495063|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65714559|NCT03495063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65714560|NCT03495063|Purinergic Agents|purinergic agents|mesh-ancestor
65714561|NCT03495063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65714562|NCT03490617|Misoprostol|misoprostol|mesh-list
65714563|NCT03490617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65714564|NCT03490617|Abortifacient Agents|abortifacient agents|mesh-ancestor
65714565|NCT03490617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65714566|NCT03490617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714567|NCT03490617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65714568|NCT03490617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65714569|NCT03490617|Oxytocics|oxytocics|mesh-ancestor
65714570|NCT03494907|Moxifloxacin|moxifloxacin|mesh-list
65714571|NCT03494907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65714572|NCT03494907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65714573|NCT03494907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65714574|NCT03494907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65714575|NCT03494907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65714576|NCT03494907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714577|NCT03494907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714578|NCT03494907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714579|NCT03494907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65714580|NCT03494907|Contraceptive Agents|contraceptive agents|mesh-ancestor
65714581|NCT03494907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65714582|NCT03494907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714583|NCT03494907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65714584|NCT03494907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65714585|NCT03494907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65714586|NCT03490539|Mycophenolic Acid|mycophenolic acid|mesh-list
65714587|NCT03490539|Azathioprine|azathioprine|mesh-list
65714588|NCT03490539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65714589|NCT03490539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714590|NCT03490539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65714591|NCT03490539|Antitubercular Agents|antitubercular agents|mesh-ancestor
65714592|NCT03490539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65714593|NCT03490539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65714594|NCT03490539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714595|NCT03490539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714596|NCT03490539|Antimetabolites|antimetabolites|mesh-ancestor
65714597|NCT03490539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65714598|NCT03490539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65714599|NCT03490539|Immunologic Factors|immunologic factors|mesh-ancestor
65714600|NCT03490539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714601|NCT03490539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65714602|NCT03493503|Albuterol|albuterol|mesh-list
65714603|NCT03493503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65714604|NCT03493503|Autonomic Agents|autonomic agents|mesh-ancestor
65714605|NCT03493503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65714606|NCT03493503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714607|NCT03493503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65714608|NCT03493503|Respiratory System Agents|respiratory system agents|mesh-ancestor
65714609|NCT03493503|Tocolytic Agents|tocolytic agents|mesh-ancestor
65714610|NCT03493503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65714611|NCT03493503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65714612|NCT03493503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65714613|NCT03493503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65714614|NCT03493503|Adrenergic Agents|adrenergic agents|mesh-ancestor
65714615|NCT03493503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65714616|NCT03493503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714617|NCT02143414|Prednisone|prednisone|mesh-list
65714618|NCT02143414|Cortisone|cortisone|mesh-list
65714619|NCT02143414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65714620|NCT02143414|Methotrexate|methotrexate|mesh-list
65714621|NCT02143414|Vincristine|vincristine|mesh-list
65714622|NCT02143414|Dasatinib|dasatinib|mesh-list
65714623|NCT02143414|Mercaptopurine|mercaptopurine|mesh-list
65714624|NCT02143414|Blinatumomab|blinatumomab|mesh-list
65714625|NCT02143414|Antibodies|antibodies|mesh-list
65714626|NCT02143414|Immunoglobulins|immunoglobulins|mesh-list
65714628|NCT02143414|Muromonab-CD3|muromonab-cd3|mesh-list
65714629|NCT02143414|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65714630|NCT02143414|Immunologic Factors|immunologic factors|mesh-ancestor
65714631|NCT02143414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714632|NCT02143414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714633|NCT02143414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65714634|NCT02143414|Glucocorticoids|glucocorticoids|mesh-ancestor
65714635|NCT02143414|Hormones|hormones|mesh-ancestor
65714636|NCT02143414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65714637|NCT02143414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65714638|NCT02143414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65714639|NCT02143414|Abortifacient Agents|abortifacient agents|mesh-ancestor
65714640|NCT02143414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65714641|NCT02143414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65714642|NCT02143414|Antimetabolites|antimetabolites|mesh-ancestor
65714643|NCT02143414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714644|NCT02143414|Dermatologic Agents|dermatologic agents|mesh-ancestor
65714645|NCT02143414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714646|NCT02143414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65714647|NCT02143414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65714648|NCT02143414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65714649|NCT02143414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65714650|NCT02143414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65714651|NCT02143414|Tubulin Modulators|tubulin modulators|mesh-ancestor
65714652|NCT02143414|Antimitotic Agents|antimitotic agents|mesh-ancestor
65714653|NCT02143414|Mitosis Modulators|mitosis modulators|mesh-ancestor
65714654|NCT02143414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65714655|NCT04791761|Acetaminophen|acetaminophen|mesh-list
65714656|NCT04791761|Ibuprofen|ibuprofen|mesh-list
65714657|NCT04791761|Oxycodone|oxycodone|mesh-list
65714658|NCT04791761|Analgesics, Opioid|analgesics, opioid|mesh-list
65714659|NCT04791761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65714660|NCT04791761|Analgesics|analgesics|mesh-ancestor
65714661|NCT04791761|Sensory System Agents|sensory system agents|mesh-ancestor
65714662|NCT04791761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65714663|NCT04791761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714664|NCT04791761|Antipyretics|antipyretics|mesh-ancestor
65714665|NCT04791761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65714666|NCT04791761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65714667|NCT04791761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65714668|NCT04791761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65714669|NCT04791761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714670|NCT04791761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714671|NCT04791761|Narcotics|narcotics|mesh-ancestor
65714672|NCT04791761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65714673|NCT03667963|Lactulose|lactulose|mesh-list
65714674|NCT03667963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65714675|NCT03489837|Dipropizine|dipropizine|mesh-list
65714676|NCT03489837|Antitussive Agents|antitussive agents|mesh-ancestor
65714677|NCT03489837|Respiratory System Agents|respiratory system agents|mesh-ancestor
65714678|NCT03014479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65714679|NCT03014479|Protease Inhibitors|protease inhibitors|mesh-ancestor
65714680|NCT03014479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714681|NCT03014479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714682|NCT03014479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65714683|NCT03014479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714684|NCT04902443|Nivolumab|nivolumab|mesh-list
65714685|NCT04902443|Pomalidomide|pomalidomide|mesh-list
65714686|NCT04902443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65714687|NCT04902443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714688|NCT04902443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65714689|NCT04902443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714690|NCT04902443|Immunologic Factors|immunologic factors|mesh-ancestor
65714691|NCT04902443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714692|NCT04902443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65714693|NCT04902443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65714694|NCT04902443|Growth Substances|growth substances|mesh-ancestor
65714695|NCT04902443|Growth Inhibitors|growth inhibitors|mesh-ancestor
65714696|NCT03625505|Venetoclax|venetoclax|mesh-list
65714697|NCT03625505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714698|NCT03493269|Midazolam|midazolam|mesh-list
65714699|NCT03493269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65030532|NCT00176475|Rituximab|rituximab|mesh-list
65714700|NCT03493269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65714702|NCT03493269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714703|NCT03493269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65714704|NCT03493269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65714705|NCT03493269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65714706|NCT03493269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65714707|NCT03493269|Anesthetics, General|anesthetics, general|mesh-ancestor
65714708|NCT03493269|Anesthetics|anesthetics|mesh-ancestor
65714709|NCT03493269|GABA Modulators|gaba modulators|mesh-ancestor
65714710|NCT03493269|GABA Agents|gaba agents|mesh-ancestor
65714711|NCT03493269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65714712|NCT03493269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714713|NCT04257682|Bupivacaine|bupivacaine|mesh-list
65714714|NCT04257682|Ropivacaine|ropivacaine|mesh-list
65714715|NCT04257682|Anesthetics, Local|anesthetics, local|mesh-list
65714716|NCT04257682|Mepivacaine|mepivacaine|mesh-list
65714717|NCT04257682|Anesthetics|anesthetics|mesh-list
65714718|NCT04257682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65714719|NCT04257682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714720|NCT04257682|Sensory System Agents|sensory system agents|mesh-ancestor
65714721|NCT04257682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65714722|NCT05426434|Pyrimethamine|pyrimethamine|mesh-list
65714723|NCT05426434|Piperaquine|piperaquine|mesh-list
65714724|NCT05426434|Sulfadoxine|sulfadoxine|mesh-list
65714725|NCT05426434|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65714726|NCT05426434|Artenimol|artenimol|mesh-list
65714727|NCT05426434|Antimalarials|antimalarials|mesh-ancestor
65714728|NCT05426434|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65714729|NCT05426434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65714730|NCT05426434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65714731|NCT05426434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65714732|NCT05426434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714733|NCT05426434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714734|NCT05426434|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65714735|NCT05426434|Renal Agents|renal agents|mesh-ancestor
65714736|NCT05404906|Azacitidine|azacitidine|mesh-list
65714737|NCT05404906|Venetoclax|venetoclax|mesh-list
65714738|NCT05404906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65714739|NCT05404906|Antimetabolites|antimetabolites|mesh-ancestor
65714740|NCT05404906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714741|NCT05404906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714742|NCT05404906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714743|NCT03020407|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65714744|NCT03020407|Dopamine|dopamine|mesh-list
65714745|NCT03020407|Epinephrine|epinephrine|mesh-list
65714746|NCT03020407|Norepinephrine|norepinephrine|mesh-list
65714747|NCT03020407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65714748|NCT03020407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65714749|NCT03020407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65714750|NCT03020407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65714751|NCT03020407|Adrenergic Agents|adrenergic agents|mesh-ancestor
65714752|NCT03020407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65714753|NCT03020407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714754|NCT03020407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714755|NCT03020407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65714756|NCT03020407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65714757|NCT03020407|Autonomic Agents|autonomic agents|mesh-ancestor
65714758|NCT03020407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65714759|NCT03020407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65714760|NCT03020407|Respiratory System Agents|respiratory system agents|mesh-ancestor
65714761|NCT03020407|Mydriatics|mydriatics|mesh-ancestor
65714762|NCT03020407|Sympathomimetics|sympathomimetics|mesh-ancestor
65714763|NCT03020407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65714764|NCT03020407|Dopamine Agents|dopamine agents|mesh-ancestor
65714765|NCT03020407|Protective Agents|protective agents|mesh-ancestor
65714766|NCT03624959|Itraconazole|itraconazole|mesh-list
65714767|NCT03624959|Rifampin|rifampin|mesh-list
65714768|NCT03624959|Gemfibrozil|gemfibrozil|mesh-list
65714769|NCT03624959|Ozanimod|ozanimod|mesh-list
65714770|NCT03624959|Antifungal Agents|antifungal agents|mesh-ancestor
65714771|NCT03624959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65714772|NCT03624959|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65714773|NCT03624959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65714774|NCT03624959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714775|NCT03624959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714776|NCT03624959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65714777|NCT03624959|Hormone Antagonists|hormone antagonists|mesh-ancestor
65714778|NCT03624959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65714779|NCT03624959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714780|NCT03624959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65714781|NCT03624959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65714782|NCT03624959|Antitubercular Agents|antitubercular agents|mesh-ancestor
65714783|NCT03624959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65714784|NCT03624959|Leprostatic Agents|leprostatic agents|mesh-ancestor
65714785|NCT03624959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65714786|NCT03624959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65714787|NCT03624959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65714788|NCT03624959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65714789|NCT03624959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65714790|NCT03624959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65714791|NCT03624959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65714792|NCT03624959|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65714793|NCT03624959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65714794|NCT03624959|Immunologic Factors|immunologic factors|mesh-ancestor
65714795|NCT03624959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65714796|NCT03624959|Antimetabolites|antimetabolites|mesh-ancestor
65714797|NCT03624959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65714798|NCT03624959|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65714799|NCT02536846|Olanzapine|olanzapine|mesh-list
65714800|NCT02536846|Antiemetics|antiemetics|mesh-ancestor
65714801|NCT02536846|Autonomic Agents|autonomic agents|mesh-ancestor
65714802|NCT02536846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65714803|NCT02536846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714804|NCT02536846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65714805|NCT02536846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65714806|NCT02536846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65714807|NCT02536846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65714808|NCT02536846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65714809|NCT02536846|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65714810|NCT02536846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65714811|NCT02536846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65714812|NCT02536846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714813|NCT02536846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65714814|NCT02536846|Serotonin Agents|serotonin agents|mesh-ancestor
65714815|NCT03014011|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65714816|NCT03014011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714817|NCT02293655|Methylphenidate|methylphenidate|mesh-list
65714818|NCT02293655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65714819|NCT02293655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714820|NCT02293655|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65714821|NCT02293655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65714822|NCT02293655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65714823|NCT02293655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714824|NCT02293655|Dopamine Agents|dopamine agents|mesh-ancestor
65714825|NCT02293655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65714826|NCT04452214|Carboplatin|carboplatin|mesh-list
65714827|NCT04452214|Pembrolizumab|pembrolizumab|mesh-list
65714828|NCT04452214|Pemetrexed|pemetrexed|mesh-list
65714829|NCT04452214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714830|NCT04452214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65714831|NCT04452214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714832|NCT04452214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714833|NCT04452214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65714834|NCT04452214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65714835|NCT01764191|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65714836|NCT01764191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65714837|NCT01764191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714838|NCT05439460|Phenylephrine|phenylephrine|mesh-list
65714839|NCT05439460|Vasopressins|vasopressins|mesh-list
65714840|NCT05439460|Arginine Vasopressin|arginine vasopressin|mesh-list
65714841|NCT05439460|Epinephrine|epinephrine|mesh-list
65714842|NCT05439460|Racepinephrine|racepinephrine|mesh-list
65714843|NCT05439460|Oxymetazoline|oxymetazoline|mesh-list
65714844|NCT05439460|Epinephryl borate|epinephryl borate|mesh-list
65714845|NCT05439460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65714846|NCT05439460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65714847|NCT05439460|Adrenergic Agents|adrenergic agents|mesh-ancestor
65714848|NCT05439460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65714849|NCT05439460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714850|NCT05439460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714851|NCT05439460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65714852|NCT05439460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65714853|NCT05439460|Autonomic Agents|autonomic agents|mesh-ancestor
65714854|NCT05439460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65714855|NCT05439460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65714856|NCT05439460|Respiratory System Agents|respiratory system agents|mesh-ancestor
65714857|NCT05439460|Mydriatics|mydriatics|mesh-ancestor
65714858|NCT05439460|Sympathomimetics|sympathomimetics|mesh-ancestor
65714859|NCT05439460|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65714860|NCT05439460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65714861|NCT05439460|Nasal Decongestants|nasal decongestants|mesh-ancestor
65714862|NCT05439460|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65714863|NCT05439460|Protective Agents|protective agents|mesh-ancestor
65714864|NCT05439460|Hemostatics|hemostatics|mesh-ancestor
65714865|NCT05439460|Coagulants|coagulants|mesh-ancestor
65714866|NCT05439460|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65714867|NCT05439460|Natriuretic Agents|natriuretic agents|mesh-ancestor
65714868|NCT01661140|Methotrexate|methotrexate|mesh-list
65714869|NCT01661140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65714870|NCT01661140|Abortifacient Agents|abortifacient agents|mesh-ancestor
65714871|NCT01661140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65714872|NCT01661140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714873|NCT01661140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65714874|NCT01661140|Antimetabolites|antimetabolites|mesh-ancestor
65714875|NCT01661140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714876|NCT01661140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714877|NCT01661140|Dermatologic Agents|dermatologic agents|mesh-ancestor
65714878|NCT01661140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714879|NCT01661140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65714880|NCT01661140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65714881|NCT01661140|Immunologic Factors|immunologic factors|mesh-ancestor
65714882|NCT01661140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65714883|NCT01661140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65714884|NCT03019549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65714885|NCT03019549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65714886|NCT03019549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65714887|NCT03019549|Antimetabolites|antimetabolites|mesh-ancestor
65714888|NCT03019549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714889|NCT03019549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65714890|NCT03019549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65714891|NCT03019549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714892|NCT05399602|Anesthetics|anesthetics|mesh-list
65714893|NCT05399602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65714894|NCT05399602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714895|NCT05397886|Propofol|propofol|mesh-list
65714896|NCT05397886|Flumazenil|flumazenil|mesh-list
65714897|NCT05397886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65714898|NCT05397886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65714899|NCT05397886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714900|NCT05397886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65714901|NCT05397886|Anesthetics, General|anesthetics, general|mesh-ancestor
65714902|NCT05397886|Anesthetics|anesthetics|mesh-ancestor
65714903|NCT05397886|Antidotes|antidotes|mesh-ancestor
65714904|NCT05397886|Protective Agents|protective agents|mesh-ancestor
65714905|NCT05397886|GABA Modulators|gaba modulators|mesh-ancestor
65714906|NCT05397886|GABA Agents|gaba agents|mesh-ancestor
65714907|NCT05397886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65714908|NCT05397886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714909|NCT05436886|Gabapentin|gabapentin|mesh-list
65714910|NCT05436886|Analgesics|analgesics|mesh-ancestor
65714911|NCT05436886|Sensory System Agents|sensory system agents|mesh-ancestor
65714912|NCT05436886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65714913|NCT05436886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714914|NCT05436886|Anticonvulsants|anticonvulsants|mesh-ancestor
65714915|NCT05436886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65714916|NCT05436886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65714917|NCT05436886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65714918|NCT05436886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65714919|NCT05436886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65714920|NCT05436886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65714921|NCT05436886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65714922|NCT05436886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714923|NCT05436886|Antimanic Agents|antimanic agents|mesh-ancestor
65714924|NCT01373151|Adalimumab|adalimumab|mesh-list
65714925|NCT01373151|Methotrexate|methotrexate|mesh-list
65714926|NCT01373151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65714928|NCT01373151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65714929|NCT01373151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714930|NCT01373151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65714931|NCT01373151|Antimetabolites|antimetabolites|mesh-ancestor
65714932|NCT01373151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714933|NCT01373151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714934|NCT01373151|Dermatologic Agents|dermatologic agents|mesh-ancestor
65714935|NCT01373151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714936|NCT01373151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65714937|NCT01373151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65714938|NCT01373151|Immunologic Factors|immunologic factors|mesh-ancestor
65714939|NCT01373151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65714940|NCT01373151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65714941|NCT01373151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65714942|NCT05436652|Prednisolone|prednisolone|mesh-list
65714943|NCT05436652|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65714944|NCT05436652|Methylprednisolone|methylprednisolone|mesh-list
65714945|NCT05436652|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65714946|NCT05436652|Prednisolone acetate|prednisolone acetate|mesh-list
65714947|NCT05436652|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65714948|NCT05436652|Prednisolone phosphate|prednisolone phosphate|mesh-list
65714949|NCT05436652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65714950|NCT05436652|Glucocorticoids|glucocorticoids|mesh-ancestor
65714951|NCT05436652|Hormones|hormones|mesh-ancestor
65714952|NCT05436652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65714953|NCT05436652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714954|NCT05436652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65714955|NCT05436652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714956|NCT05436652|Antiemetics|antiemetics|mesh-ancestor
65714957|NCT05436652|Autonomic Agents|autonomic agents|mesh-ancestor
65714958|NCT05436652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65714959|NCT05436652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65714960|NCT05436652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65714961|NCT05436652|Protective Agents|protective agents|mesh-ancestor
65714962|NCT01660906|Dasatinib|dasatinib|mesh-list
65714963|NCT01660906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714964|NCT01660906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65714965|NCT01660906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65714966|NCT01660906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714967|NCT05435014|Ethiodized Oil|ethiodized oil|mesh-list
65714968|NCT05435014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714969|NCT03666949|Anesthetics|anesthetics|mesh-list
65714970|NCT03666949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65714971|NCT03666949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714972|NCT00886691|Bevacizumab|bevacizumab|mesh-list
65714973|NCT00886691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65714974|NCT00886691|Everolimus|everolimus|mesh-list
65714975|NCT00886691|Endothelial Growth Factors|endothelial growth factors|mesh-list
65714976|NCT00886691|Antibodies|antibodies|mesh-list
65714977|NCT00886691|Immunoglobulins|immunoglobulins|mesh-list
65714978|NCT00886691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65714979|NCT00886691|Immunoglobulin G|immunoglobulin g|mesh-list
65714980|NCT00886691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714981|NCT00886691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65714982|NCT00886691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65714983|NCT00886691|Growth Substances|growth substances|mesh-ancestor
65714984|NCT00886691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65714985|NCT00886691|Growth Inhibitors|growth inhibitors|mesh-ancestor
65714986|NCT00886691|Immunologic Factors|immunologic factors|mesh-ancestor
65714987|NCT00886691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65714988|NCT00960297|Paclitaxel|paclitaxel|mesh-list
65714989|NCT00960297|Bevacizumab|bevacizumab|mesh-list
65714990|NCT00960297|Carboplatin|carboplatin|mesh-list
65714991|NCT00960297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65714992|NCT00960297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65714993|NCT00960297|Tubulin Modulators|tubulin modulators|mesh-ancestor
65714994|NCT00960297|Antimitotic Agents|antimitotic agents|mesh-ancestor
65714995|NCT00960297|Mitosis Modulators|mitosis modulators|mesh-ancestor
65714996|NCT00960297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65714997|NCT00960297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65714998|NCT00960297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65714999|NCT00960297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65715000|NCT00960297|Growth Substances|growth substances|mesh-ancestor
65715001|NCT00960297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715002|NCT00960297|Growth Inhibitors|growth inhibitors|mesh-ancestor
65715003|NCT05112861|Bevacizumab|bevacizumab|mesh-list
65715004|NCT05112861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65715005|NCT05112861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715006|NCT05112861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65715007|NCT05112861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65715008|NCT05112861|Growth Substances|growth substances|mesh-ancestor
65715009|NCT05112861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715010|NCT05112861|Growth Inhibitors|growth inhibitors|mesh-ancestor
65715011|NCT03012061|Fluticasone|fluticasone|mesh-list
65715012|NCT03012061|Xhance|xhance|mesh-list
65715013|NCT03012061|Albuterol|albuterol|mesh-list
65715014|NCT03012061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65715015|NCT03012061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65715016|NCT03012061|Autonomic Agents|autonomic agents|mesh-ancestor
65715017|NCT03012061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65715018|NCT03012061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715019|NCT03012061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65715020|NCT03012061|Respiratory System Agents|respiratory system agents|mesh-ancestor
65715021|NCT03012061|Dermatologic Agents|dermatologic agents|mesh-ancestor
65715022|NCT03012061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65715023|NCT03012061|Tocolytic Agents|tocolytic agents|mesh-ancestor
65715024|NCT03012061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65715025|NCT03012061|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65715026|NCT03012061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65715027|NCT03012061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65715028|NCT03012061|Adrenergic Agents|adrenergic agents|mesh-ancestor
65715029|NCT03012061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65715030|NCT03012061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715031|NCT00408863|Tibolone|tibolone|mesh-list
65715032|NCT00408863|Androgen Antagonists|androgen antagonists|mesh-ancestor
65715033|NCT00408863|Hormone Antagonists|hormone antagonists|mesh-ancestor
65715034|NCT00408863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65715035|NCT00408863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715036|NCT00408863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65715037|NCT00408863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65715038|NCT00408863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715039|NCT00408863|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65715040|NCT00408863|Anabolic Agents|anabolic agents|mesh-ancestor
65715041|NCT00408863|Hormones|hormones|mesh-ancestor
65715042|NCT05085327|Sunscreening Agents|sunscreening agents|mesh-list
65715043|NCT05085327|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65715044|NCT05085327|Protective Agents|protective agents|mesh-ancestor
65715045|NCT05085327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715046|NCT05085327|Dermatologic Agents|dermatologic agents|mesh-ancestor
65715047|NCT03666715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65715048|NCT03666715|Antipsychotic Agents|antipsychotic agents|mesh-list
65715049|NCT03666715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65715050|NCT03666715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65715051|NCT03666715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715052|NCT03666715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65715053|NCT03666715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65715054|NCT03666715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65715055|NCT03666715|Serotonin Agents|serotonin agents|mesh-ancestor
65715056|NCT03666715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65715057|NCT03666715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715058|NCT03666715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65715059|NCT03666715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65715060|NCT03666715|Dopamine Agents|dopamine agents|mesh-ancestor
65715061|NCT04949399|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65715062|NCT04949399|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65715063|NCT04949399|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65715064|NCT04949399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65715065|NCT04949399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715066|NCT04949399|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65715067|NCT04949399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65715068|NCT04949399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715069|NCT04949399|Cholinergic Agents|cholinergic agents|mesh-ancestor
65715070|NCT04949399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65715071|NCT03131973|Leucovorin|leucovorin|mesh-list
65715072|NCT03131973|Flurbiprofen|flurbiprofen|mesh-list
65715073|NCT03131973|Methotrexate|methotrexate|mesh-list
65030898|NCT05311774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65715074|NCT03131973|Digoxin|digoxin|mesh-list
65715075|NCT03131973|Midazolam|midazolam|mesh-list
65715076|NCT03131973|Caffeine|caffeine|mesh-list
65715077|NCT03131973|Omeprazole|omeprazole|mesh-list
65715078|NCT03131973|Pravastatin|pravastatin|mesh-list
65715079|NCT03131973|Montelukast|montelukast|mesh-list
65715080|NCT03131973|Branebrutinib|branebrutinib|mesh-list
65715081|NCT03131973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65715082|NCT03131973|Abortifacient Agents|abortifacient agents|mesh-ancestor
65715083|NCT03131973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65715084|NCT03131973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715085|NCT03131973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65715086|NCT03131973|Antimetabolites|antimetabolites|mesh-ancestor
65715087|NCT03131973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715088|NCT03131973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715089|NCT03131973|Dermatologic Agents|dermatologic agents|mesh-ancestor
65715090|NCT03131973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715091|NCT03131973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65715092|NCT03131973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65715093|NCT03131973|Immunologic Factors|immunologic factors|mesh-ancestor
65715094|NCT03131973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65715095|NCT03131973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65715096|NCT03131973|Antidotes|antidotes|mesh-ancestor
65715097|NCT03131973|Protective Agents|protective agents|mesh-ancestor
65715098|NCT03131973|Vitamin B Complex|vitamin b complex|mesh-ancestor
65715099|NCT03131973|Vitamins|vitamins|mesh-ancestor
65715100|NCT03131973|Micronutrients|micronutrients|mesh-ancestor
65715101|NCT03131973|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65715102|NCT03131973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65715103|NCT03131973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65715104|NCT03131973|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65715105|NCT03131973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65715106|NCT03131973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65715107|NCT03131973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65715108|NCT03131973|Anesthetics, General|anesthetics, general|mesh-ancestor
65715109|NCT03131973|Anesthetics|anesthetics|mesh-ancestor
65715110|NCT03131973|GABA Modulators|gaba modulators|mesh-ancestor
65715111|NCT03131973|GABA Agents|gaba agents|mesh-ancestor
65715112|NCT03131973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65715113|NCT03131973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65715114|NCT03131973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65715115|NCT03131973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65715116|NCT03131973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65715117|NCT03131973|Purinergic Agents|purinergic agents|mesh-ancestor
65715118|NCT03131973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65715119|NCT03131973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65715120|NCT03131973|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65715121|NCT03131973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65715122|NCT03131973|Respiratory System Agents|respiratory system agents|mesh-ancestor
65715123|NCT03131973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65715124|NCT03131973|Hormone Antagonists|hormone antagonists|mesh-ancestor
65715125|NCT03131973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65715126|NCT03131973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65715127|NCT03131973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65715128|NCT03131973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65715129|NCT03131973|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65715130|NCT03131973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65715131|NCT03131973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65715132|NCT03131973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65715133|NCT03131973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65715134|NCT03131973|Analgesics|analgesics|mesh-ancestor
65715135|NCT03131973|Sensory System Agents|sensory system agents|mesh-ancestor
65715136|NCT03131973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65715137|NCT03131973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65715138|NCT03131973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65715139|NCT03131973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65177852|NCT05334316|Hormones|hormones|mesh-ancestor
65715140|NCT03131973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65715141|NCT03131973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65715142|NCT05078931|Pembrolizumab|pembrolizumab|mesh-list
65715143|NCT05078931|Lenvatinib|lenvatinib|mesh-list
65715144|NCT05078931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65715145|NCT05078931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715146|NCT05078931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65715147|NCT05078931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715148|NCT05078931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030971|NCT05276206|Anesthetics|anesthetics|mesh-list
65715149|NCT04247165|Gemcitabine|gemcitabine|mesh-list
65715151|NCT04247165|Nivolumab|nivolumab|mesh-list
65715152|NCT04247165|Ipilimumab|ipilimumab|mesh-list
65715153|NCT04247165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65715154|NCT04247165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715155|NCT04247165|Tubulin Modulators|tubulin modulators|mesh-ancestor
65715156|NCT04247165|Antimitotic Agents|antimitotic agents|mesh-ancestor
65715157|NCT04247165|Mitosis Modulators|mitosis modulators|mesh-ancestor
65715158|NCT04247165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715159|NCT04247165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65715160|NCT04247165|Antimetabolites|antimetabolites|mesh-ancestor
65715161|NCT04247165|Antiviral Agents|antiviral agents|mesh-ancestor
65715162|NCT04247165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65715163|NCT04247165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715164|NCT04247165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65715165|NCT04247165|Immunologic Factors|immunologic factors|mesh-ancestor
65715166|NCT04247165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715167|NCT04247165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65715168|NCT04247165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65715169|NCT04825197|Poractant alfa|poractant alfa|mesh-list
65715170|NCT04825197|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
65715171|NCT04825197|Respiratory System Agents|respiratory system agents|mesh-ancestor
65715172|NCT04187105|Cyclophosphamide|cyclophosphamide|mesh-list
65715173|NCT04187105|Fludarabine|fludarabine|mesh-list
65715174|NCT04187105|Tacrolimus|tacrolimus|mesh-list
65715175|NCT04187105|Complement Factor H|complement factor h|mesh-list
65715176|NCT04187105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65715177|NCT04187105|Immunologic Factors|immunologic factors|mesh-ancestor
65715178|NCT04187105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715179|NCT04187105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65715180|NCT04187105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65715181|NCT04187105|Alkylating Agents|alkylating agents|mesh-ancestor
65715182|NCT04187105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715183|NCT04187105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715184|NCT04187105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65715185|NCT04187105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65715186|NCT04187105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715187|NCT04187105|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65715188|NCT04703361|Niacin|niacin|mesh-list
65715189|NCT04703361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65715190|NCT04703361|Antimetabolites|antimetabolites|mesh-ancestor
65715191|NCT04703361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715192|NCT04703361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65715193|NCT04703361|Vasodilator Agents|vasodilator agents|mesh-ancestor
65715194|NCT04703361|Vitamin B Complex|vitamin b complex|mesh-ancestor
65715195|NCT04703361|Vitamins|vitamins|mesh-ancestor
65715196|NCT04703361|Micronutrients|micronutrients|mesh-ancestor
65715197|NCT04703361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715198|NCT03010423|Nicorandil|nicorandil|mesh-list
65715199|NCT03010423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65715200|NCT03010423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65715201|NCT03010423|Vasodilator Agents|vasodilator agents|mesh-ancestor
65715202|NCT03010423|Vitamin B Complex|vitamin b complex|mesh-ancestor
65715203|NCT03010423|Vitamins|vitamins|mesh-ancestor
65715204|NCT03010423|Micronutrients|micronutrients|mesh-ancestor
65715205|NCT03010423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715206|NCT05576597|Butyric Acid|butyric acid|mesh-list
65715207|NCT05576597|Histamine Antagonists|histamine antagonists|mesh-ancestor
65715208|NCT05576597|Histamine Agents|histamine agents|mesh-ancestor
65715209|NCT05576597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65715210|NCT05576597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715211|NCT05576597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715212|NCT04724837|Dapagliflozin|dapagliflozin|mesh-list
65715213|NCT04724837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65715214|NCT04724837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715215|NCT04724837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65715216|NCT04724837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715217|NCT03665779|Pyridoxine|pyridoxine|mesh-list
65715218|NCT03665779|Isosorbide|isosorbide|mesh-list
65715219|NCT03665779|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65715220|NCT03665779|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65715221|NCT03665779|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65715222|NCT03665779|Diuretics|diuretics|mesh-ancestor
65715223|NCT03665779|Natriuretic Agents|natriuretic agents|mesh-ancestor
65715224|NCT03665779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715225|NCT03665779|Vasodilator Agents|vasodilator agents|mesh-ancestor
65715226|NCT03665779|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65715227|NCT03665779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715228|NCT03665779|Vitamin B Complex|vitamin b complex|mesh-ancestor
65715229|NCT03665779|Vitamins|vitamins|mesh-ancestor
65715230|NCT03665779|Micronutrients|micronutrients|mesh-ancestor
65715231|NCT04946435|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65715232|NCT04946435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65715233|NCT04944017|Ketamine|ketamine|mesh-list
65715234|NCT04944017|Analgesics|analgesics|mesh-ancestor
65715235|NCT04944017|Sensory System Agents|sensory system agents|mesh-ancestor
65715236|NCT04944017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65715237|NCT04944017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715238|NCT04944017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65715239|NCT04944017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65715240|NCT04944017|Anesthetics, General|anesthetics, general|mesh-ancestor
65715241|NCT04944017|Anesthetics|anesthetics|mesh-ancestor
65715242|NCT04944017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65715243|NCT04944017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65715244|NCT04944017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65715245|NCT04944017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65715246|NCT04944017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715247|NCT03703427|Capecitabine|capecitabine|mesh-list
65715248|NCT03703427|Vinorelbine|vinorelbine|mesh-list
65715249|NCT03703427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65715250|NCT03703427|Antimetabolites|antimetabolites|mesh-ancestor
65715251|NCT03703427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715252|NCT03703427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715253|NCT03703427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65715254|NCT03703427|Tubulin Modulators|tubulin modulators|mesh-ancestor
65715255|NCT03703427|Antimitotic Agents|antimitotic agents|mesh-ancestor
65715256|NCT03703427|Mitosis Modulators|mitosis modulators|mesh-ancestor
65715257|NCT03703349|Magnesium Sulfate|magnesium sulfate|mesh-list
65715258|NCT03703349|Analgesics|analgesics|mesh-ancestor
65715259|NCT03703349|Sensory System Agents|sensory system agents|mesh-ancestor
65715260|NCT03703349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65715261|NCT03703349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715262|NCT03703349|Anesthetics|anesthetics|mesh-ancestor
65715263|NCT03703349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65715264|NCT03703349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65715265|NCT03703349|Anticonvulsants|anticonvulsants|mesh-ancestor
65715266|NCT03703349|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65715267|NCT03703349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65715268|NCT03703349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715269|NCT03703349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65715270|NCT03703349|Tocolytic Agents|tocolytic agents|mesh-ancestor
65715271|NCT03703349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65715272|NCT03532139|Enoxaparin|enoxaparin|mesh-list
65715273|NCT03532139|Enoxaparin sodium|enoxaparin sodium|mesh-list
65715274|NCT03532139|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65715275|NCT03532139|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65715276|NCT03532139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65715277|NCT03532139|Antimetabolites|antimetabolites|mesh-ancestor
65715278|NCT03532139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715279|NCT03532139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65715280|NCT03532139|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65715281|NCT03532139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715282|NCT03532139|Anticoagulants|anticoagulants|mesh-ancestor
65715283|NCT03532139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65715284|NCT03532139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65715285|NCT03008005|Dronabinol|dronabinol|mesh-list
65715286|NCT03008005|Hallucinogens|hallucinogens|mesh-ancestor
65715287|NCT03008005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715288|NCT03008005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65715289|NCT03008005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65715290|NCT03008005|Analgesics|analgesics|mesh-ancestor
65715291|NCT03008005|Sensory System Agents|sensory system agents|mesh-ancestor
65715292|NCT03008005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65715293|NCT03008005|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65715294|NCT03008005|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65715295|NCT03008005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65715296|NCT03008005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715297|NCT03008005|Hormones|hormones|mesh-ancestor
65715298|NCT03008005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65031121|NCT00195000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715299|NCT03666325|Pembrolizumab|pembrolizumab|mesh-list
65715301|NCT03666325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65715302|NCT03666325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715303|NCT02440425|Paclitaxel|paclitaxel|mesh-list
65715304|NCT02440425|Pembrolizumab|pembrolizumab|mesh-list
65715305|NCT02440425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65715306|NCT02440425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715307|NCT02440425|Tubulin Modulators|tubulin modulators|mesh-ancestor
65715308|NCT02440425|Antimitotic Agents|antimitotic agents|mesh-ancestor
65715309|NCT02440425|Mitosis Modulators|mitosis modulators|mesh-ancestor
65715310|NCT02440425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715311|NCT02440425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65715312|NCT04931511|Betamethasone|betamethasone|mesh-list
65715313|NCT04931511|Betamethasone Valerate|betamethasone valerate|mesh-list
65715314|NCT04931511|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65715315|NCT04931511|Betamethasone benzoate|betamethasone benzoate|mesh-list
65715316|NCT04931511|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65715317|NCT04931511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65715318|NCT04931511|Glucocorticoids|glucocorticoids|mesh-ancestor
65715319|NCT04931511|Hormones|hormones|mesh-ancestor
65715320|NCT04931511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65715321|NCT04931511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269384|NCT05580029|Hormones|hormones|mesh-ancestor
65715322|NCT04931511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65715323|NCT04931511|Respiratory System Agents|respiratory system agents|mesh-ancestor
65715324|NCT04182321|Metformin|metformin|mesh-list
65715325|NCT04182321|Entecavir|entecavir|mesh-list
65715326|NCT04182321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65715327|NCT04182321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715328|NCT04182321|Antiviral Agents|antiviral agents|mesh-ancestor
65715329|NCT04182321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65715330|NCT03702959|Betamethasone|betamethasone|mesh-list
65715331|NCT03702959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65715332|NCT03702959|Glucocorticoids|glucocorticoids|mesh-ancestor
65715333|NCT03702959|Hormones|hormones|mesh-ancestor
65715334|NCT03702959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65715335|NCT03702959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715336|NCT03702959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65715337|NCT03702959|Respiratory System Agents|respiratory system agents|mesh-ancestor
65715338|NCT04879823|Acetaminophen|acetaminophen|mesh-list
65715339|NCT04879823|Dexamethasone|dexamethasone|mesh-list
65715340|NCT04879823|Ibuprofen|ibuprofen|mesh-list
65715341|NCT04879823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65715342|NCT04879823|Antiemetics|antiemetics|mesh-ancestor
65715343|NCT04879823|Autonomic Agents|autonomic agents|mesh-ancestor
65715344|NCT04879823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65715345|NCT04879823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715346|NCT04879823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65715347|NCT04879823|Glucocorticoids|glucocorticoids|mesh-ancestor
65715348|NCT04879823|Hormones|hormones|mesh-ancestor
65715349|NCT04879823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65715350|NCT04879823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65715351|NCT04879823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715352|NCT04879823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65715353|NCT04879823|Analgesics|analgesics|mesh-ancestor
65715354|NCT04879823|Sensory System Agents|sensory system agents|mesh-ancestor
65715355|NCT04879823|Antipyretics|antipyretics|mesh-ancestor
65715356|NCT04879823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65715357|NCT04879823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65715358|NCT04879823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65715359|NCT04879823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715360|NCT04879823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715361|NCT03001219|Methotrexate|methotrexate|mesh-list
65715362|NCT03001219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65715363|NCT03001219|Abortifacient Agents|abortifacient agents|mesh-ancestor
65715364|NCT03001219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65715365|NCT03001219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715366|NCT03001219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65715367|NCT03001219|Antimetabolites|antimetabolites|mesh-ancestor
65715368|NCT03001219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715369|NCT03001219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715370|NCT03001219|Dermatologic Agents|dermatologic agents|mesh-ancestor
65715371|NCT03001219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715372|NCT03001219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65715373|NCT03001219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65715374|NCT03001219|Immunologic Factors|immunologic factors|mesh-ancestor
65715375|NCT03001219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65715376|NCT03001219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65715377|NCT03702803|Alprazolam|alprazolam|mesh-list
65715378|NCT03702803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65715379|NCT03702803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65715380|NCT03702803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715381|NCT03702803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65715382|NCT03702803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65715383|NCT03702803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65715384|NCT03702803|GABA Modulators|gaba modulators|mesh-ancestor
65715385|NCT03702803|GABA Agents|gaba agents|mesh-ancestor
65715386|NCT03702803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65715387|NCT03702803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715388|NCT03487809|Budesonide|budesonide|mesh-list
65715389|NCT03487809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65715390|NCT03487809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65715391|NCT03487809|Autonomic Agents|autonomic agents|mesh-ancestor
65715392|NCT03487809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65715393|NCT03487809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715394|NCT03487809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65715395|NCT03487809|Respiratory System Agents|respiratory system agents|mesh-ancestor
65715396|NCT03487809|Glucocorticoids|glucocorticoids|mesh-ancestor
65715397|NCT03487809|Hormones|hormones|mesh-ancestor
65715398|NCT03487809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65715399|NCT03702647|Ropivacaine|ropivacaine|mesh-list
65715400|NCT03702647|Anesthetics, Local|anesthetics, local|mesh-ancestor
65715401|NCT03702647|Anesthetics|anesthetics|mesh-ancestor
65715402|NCT03702647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65715403|NCT03702647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715404|NCT03702647|Sensory System Agents|sensory system agents|mesh-ancestor
65715405|NCT03702647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65715406|NCT04583787|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
65715407|NCT04583787|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65715408|NCT04583787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715409|NCT03000673|Heparin|heparin|mesh-list
65715410|NCT03000673|Enoxaparin|enoxaparin|mesh-list
65715411|NCT03000673|Calcium heparin|calcium heparin|mesh-list
65715412|NCT03000673|Anticoagulants|anticoagulants|mesh-ancestor
65715413|NCT03000673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65715414|NCT03000673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65715415|NCT03000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715416|NCT05423249|Ascorbic Acid|ascorbic acid|mesh-list
65715417|NCT05423249|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
65715418|NCT05423249|Antioxidants|antioxidants|mesh-ancestor
65715419|NCT05423249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715420|NCT05423249|Protective Agents|protective agents|mesh-ancestor
65715421|NCT05423249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715422|NCT05423249|Vitamins|vitamins|mesh-ancestor
65715423|NCT05423249|Micronutrients|micronutrients|mesh-ancestor
65715424|NCT05423249|Antidiarrheals|antidiarrheals|mesh-ancestor
65715425|NCT05423249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65715426|NCT02912455|Canagliflozin|canagliflozin|mesh-list
65715427|NCT02912455|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65715428|NCT02912455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715429|NCT02912455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65715430|NCT02912455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715431|NCT03702491|Oxaliplatin|oxaliplatin|mesh-list
65715432|NCT03702491|Apatinib|apatinib|mesh-list
65715433|NCT03702491|Tegafur|tegafur|mesh-list
65715434|NCT03702491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715435|NCT03702491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65715436|NCT03702491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715437|NCT03702491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715438|NCT03702491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65715439|NCT03702491|Antimetabolites|antimetabolites|mesh-ancestor
65715440|NCT03663751|Decitabine|decitabine|mesh-list
65715441|NCT03663751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65715442|NCT03663751|Antimetabolites|antimetabolites|mesh-ancestor
65715443|NCT03663751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715444|NCT03663751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715445|NCT03663751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715446|NCT04054687|Tranexamic Acid|tranexamic acid|mesh-list
65715447|NCT04054687|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65715448|NCT04054687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65715449|NCT04054687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715450|NCT04054687|Hemostatics|hemostatics|mesh-ancestor
65715451|NCT04054687|Coagulants|coagulants|mesh-ancestor
65715452|NCT03492489|Cemiplimab|cemiplimab|mesh-list
65715453|NCT03492489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65715454|NCT03492489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715455|NCT02531698|Vaccines|vaccines|mesh-list
65715456|NCT02531698|Immunologic Factors|immunologic factors|mesh-ancestor
65715457|NCT02531698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715458|NCT04308837|Diphenhydramine|diphenhydramine|mesh-list
65715459|NCT04308837|Promethazine|promethazine|mesh-list
65715460|NCT04308837|Dexamethasone|dexamethasone|mesh-list
65715461|NCT04308837|Paclitaxel|paclitaxel|mesh-list
65715462|NCT04308837|Carboplatin|carboplatin|mesh-list
65715463|NCT04308837|Palonosetron|palonosetron|mesh-list
65715464|NCT04308837|Famotidine|famotidine|mesh-list
65715465|NCT04308837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65715466|NCT04308837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715467|NCT04308837|Tubulin Modulators|tubulin modulators|mesh-ancestor
65715468|NCT04308837|Antimitotic Agents|antimitotic agents|mesh-ancestor
65715469|NCT04308837|Mitosis Modulators|mitosis modulators|mesh-ancestor
65715470|NCT04308837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715471|NCT04308837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65715472|NCT04308837|Antiemetics|antiemetics|mesh-ancestor
65715473|NCT04308837|Autonomic Agents|autonomic agents|mesh-ancestor
65715474|NCT04308837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65715475|NCT04308837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715476|NCT04308837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65715477|NCT04308837|Glucocorticoids|glucocorticoids|mesh-ancestor
65715478|NCT04308837|Hormones|hormones|mesh-ancestor
65715479|NCT04308837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65715480|NCT04308837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65715481|NCT04308837|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65715482|NCT04308837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65715483|NCT04308837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65715484|NCT04308837|Anesthetics, Local|anesthetics, local|mesh-ancestor
65715485|NCT04308837|Anesthetics|anesthetics|mesh-ancestor
65715486|NCT04308837|Sensory System Agents|sensory system agents|mesh-ancestor
65715487|NCT04308837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65715488|NCT04308837|Histamine Antagonists|histamine antagonists|mesh-ancestor
65715489|NCT04308837|Histamine Agents|histamine agents|mesh-ancestor
65715490|NCT04308837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65715491|NCT04308837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65715492|NCT04308837|Antipruritics|antipruritics|mesh-ancestor
65715493|NCT04308837|Dermatologic Agents|dermatologic agents|mesh-ancestor
65715494|NCT04308837|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65715495|NCT04308837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65715496|NCT04308837|Serotonin Agents|serotonin agents|mesh-ancestor
65715497|NCT04308837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65715498|NCT04308837|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65715499|NCT04692467|Amlodipine|amlodipine|mesh-list
65715500|NCT04692467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65715501|NCT04692467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65715502|NCT04692467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65715503|NCT04692467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715504|NCT04692467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65715505|NCT04692467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715506|NCT04692467|Vasodilator Agents|vasodilator agents|mesh-ancestor
65715507|NCT03664375|Botulinum Toxins|botulinum toxins|mesh-list
65715508|NCT03664375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65715509|NCT03664375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65715510|NCT03664375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65715511|NCT03664375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65715512|NCT03664375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715513|NCT03664375|Cholinergic Agents|cholinergic agents|mesh-ancestor
65715514|NCT03664375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65715515|NCT03664375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715516|NCT03664375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65715517|NCT03664375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65715518|NCT00403793|Methyltestosterone|methyltestosterone|mesh-list
65715519|NCT00403793|Etonogestrel|etonogestrel|mesh-list
65715520|NCT00403793|Testosterone|testosterone|mesh-list
65715521|NCT00403793|Testosterone undecanoate|testosterone undecanoate|mesh-list
65715522|NCT00403793|Testosterone enanthate|testosterone enanthate|mesh-list
65715523|NCT00403793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65715524|NCT00403793|Androgens|androgens|mesh-ancestor
65715525|NCT00403793|Hormones|hormones|mesh-ancestor
65715526|NCT00403793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65715527|NCT00403793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715528|NCT00403793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65715529|NCT00403793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715530|NCT00403793|Anabolic Agents|anabolic agents|mesh-ancestor
65715531|NCT00403793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65715532|NCT00403793|Contraceptive Agents|contraceptive agents|mesh-ancestor
65715533|NCT00403793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65715534|NCT00403793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65715536|NCT05597098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715537|NCT05597098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715538|NCT03034577|Neostigmine|neostigmine|mesh-list
65715539|NCT03034577|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65715540|NCT03034577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715541|NCT03034577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715542|NCT03034577|Cholinergic Agents|cholinergic agents|mesh-ancestor
65715543|NCT03034577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65715544|NCT03034577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715545|NCT03034577|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65715546|NCT03034577|Autonomic Agents|autonomic agents|mesh-ancestor
65715547|NCT03034577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65715548|NCT04364997|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65715549|NCT04364997|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65715550|NCT04364997|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65715551|NCT04364997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65715552|NCT04364997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65715553|NCT04364997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715554|NCT04364997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65715555|NCT04364997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715556|NCT04364997|Analgesics|analgesics|mesh-ancestor
65715557|NCT04364997|Sensory System Agents|sensory system agents|mesh-ancestor
65715558|NCT04364997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65715559|NCT04364997|Antidepressive Agents|antidepressive agents|mesh-ancestor
65715560|NCT04364997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65715561|NCT04364997|Dopamine Agents|dopamine agents|mesh-ancestor
65715562|NCT05417386|Leucovorin|leucovorin|mesh-list
65715563|NCT05417386|Fluorouracil|fluorouracil|mesh-list
65715564|NCT05417386|Capecitabine|capecitabine|mesh-list
65715565|NCT05417386|Oxaliplatin|oxaliplatin|mesh-list
65715566|NCT05417386|Irinotecan|irinotecan|mesh-list
65715567|NCT05417386|Camptothecin|camptothecin|mesh-list
65715568|NCT05417386|Folfirinox|folfirinox|mesh-list
65715569|NCT05417386|Levoleucovorin|levoleucovorin|mesh-list
65715570|NCT05417386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715571|NCT05417386|Antimetabolites|antimetabolites|mesh-ancestor
65715572|NCT05417386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715573|NCT05417386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65715574|NCT05417386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715575|NCT05417386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65715576|NCT05417386|Immunologic Factors|immunologic factors|mesh-ancestor
65715577|NCT05417386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65715578|NCT05417386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65715579|NCT05417386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715580|NCT05417386|Antidotes|antidotes|mesh-ancestor
65715581|NCT05417386|Protective Agents|protective agents|mesh-ancestor
65715582|NCT05417386|Vitamin B Complex|vitamin b complex|mesh-ancestor
65715583|NCT05417386|Vitamins|vitamins|mesh-ancestor
65715584|NCT05417386|Micronutrients|micronutrients|mesh-ancestor
65715585|NCT05417386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65715586|NCT04005729|Cangrelor|cangrelor|mesh-list
65715587|NCT04005729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65715588|NCT04005729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65715589|NCT04005729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65715590|NCT04005729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65715591|NCT04005729|Purinergic Agents|purinergic agents|mesh-ancestor
65715592|NCT04005729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65715593|NCT04005729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715594|NCT04005729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715595|NCT03487107|Sofosbuvir|sofosbuvir|mesh-list
65715596|NCT03487107|Yimitasvir|yimitasvir|mesh-list
65715597|NCT03487107|Antiviral Agents|antiviral agents|mesh-ancestor
65715598|NCT03487107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65715599|NCT02997163|Talazoparib|talazoparib|mesh-list
65715600|NCT02997163|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65715601|NCT02997163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031498|NCT02904772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65715602|NCT02997163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715603|NCT02997163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715604|NCT03705065|Bupivacaine|bupivacaine|mesh-list
65715605|NCT03705065|Anesthetics, Local|anesthetics, local|mesh-ancestor
65715606|NCT03705065|Anesthetics|anesthetics|mesh-ancestor
65715607|NCT03705065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65715608|NCT03705065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715609|NCT03705065|Sensory System Agents|sensory system agents|mesh-ancestor
65715610|NCT03705065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65715611|NCT03702023|Acetaminophen|acetaminophen|mesh-list
65715612|NCT03702023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65715613|NCT03702023|Analgesics|analgesics|mesh-ancestor
65715614|NCT03702023|Sensory System Agents|sensory system agents|mesh-ancestor
65715615|NCT03702023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65715616|NCT03702023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715617|NCT03702023|Antipyretics|antipyretics|mesh-ancestor
65715618|NCT04259944|Capecitabine|capecitabine|mesh-list
65715619|NCT04259944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65715620|NCT04259944|Antimetabolites|antimetabolites|mesh-ancestor
65715621|NCT04259944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715622|NCT04259944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715623|NCT03698513|Aspirin|aspirin|mesh-list
65715624|NCT03698513|Clopidogrel|clopidogrel|mesh-list
65715625|NCT03698513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65715626|NCT03698513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65715627|NCT03698513|Analgesics|analgesics|mesh-ancestor
65715628|NCT03698513|Sensory System Agents|sensory system agents|mesh-ancestor
65715629|NCT03698513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65715630|NCT03698513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715631|NCT03698513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65715632|NCT03698513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65715633|NCT03698513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65715634|NCT03698513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65715635|NCT03698513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715636|NCT03698513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65715637|NCT03698513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65715638|NCT03698513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715639|NCT03698513|Antipyretics|antipyretics|mesh-ancestor
65715640|NCT03698513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65715641|NCT03698513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65715642|NCT03698513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65715643|NCT03698513|Purinergic Agents|purinergic agents|mesh-ancestor
65715644|NCT03698513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65715645|NCT03698435|Valganciclovir|valganciclovir|mesh-list
65715646|NCT03698435|Ganciclovir|ganciclovir|mesh-list
65715647|NCT03698435|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65715648|NCT03698435|Antiviral Agents|antiviral agents|mesh-ancestor
65715649|NCT03698435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65715650|NCT03698435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65715651|NCT03698435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715652|NCT03698435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715653|NCT01652092|Vidarabine|vidarabine|mesh-list
65715654|NCT01652092|Cyclophosphamide|cyclophosphamide|mesh-list
65715655|NCT01652092|Melphalan|melphalan|mesh-list
65715656|NCT01652092|Busulfan|busulfan|mesh-list
65715657|NCT01652092|Fludarabine|fludarabine|mesh-list
65715658|NCT01652092|Fludarabine phosphate|fludarabine phosphate|mesh-list
65715659|NCT01652092|Alemtuzumab|alemtuzumab|mesh-list
65715660|NCT01652092|Mesna|mesna|mesh-list
65715661|NCT01652092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65715662|NCT01652092|Immunologic Factors|immunologic factors|mesh-ancestor
65715663|NCT01652092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715664|NCT01652092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65715665|NCT01652092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65715666|NCT01652092|Alkylating Agents|alkylating agents|mesh-ancestor
65715667|NCT01652092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715668|NCT01652092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715669|NCT01652092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65715670|NCT01652092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65715671|NCT01652092|Antimetabolites|antimetabolites|mesh-ancestor
65715672|NCT01652092|Antiviral Agents|antiviral agents|mesh-ancestor
65715673|NCT01652092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65715674|NCT01652092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65715675|NCT01652092|Protective Agents|protective agents|mesh-ancestor
65715676|NCT04572815|Interleukin-12|interleukin-12|mesh-list
65715678|NCT04572815|Immunoglobulins|immunoglobulins|mesh-list
65715679|NCT04572815|Immunoglobulin G|immunoglobulin g|mesh-list
65715680|NCT04572815|Immunologic Factors|immunologic factors|mesh-ancestor
65715681|NCT04572815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715682|NCT04572815|Dermatologic Agents|dermatologic agents|mesh-ancestor
65715683|NCT04572815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65715684|NCT04572815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65715685|NCT04572815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65715686|NCT04572815|Growth Substances|growth substances|mesh-ancestor
65715687|NCT04572815|Growth Inhibitors|growth inhibitors|mesh-ancestor
65715688|NCT04572815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715689|NCT03698045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65715690|NCT03698045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65715691|NCT03697889|Naproxen|naproxen|mesh-list
65715692|NCT03697889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65715693|NCT03697889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65715694|NCT03697889|Analgesics|analgesics|mesh-ancestor
65715695|NCT03697889|Sensory System Agents|sensory system agents|mesh-ancestor
65715696|NCT03697889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65715697|NCT03697889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715698|NCT03697889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65715699|NCT03697889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65715700|NCT03697889|Gout Suppressants|gout suppressants|mesh-ancestor
65715701|NCT03697889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65715702|NCT03697889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715703|NCT03697889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715704|NCT03692819|Amoxicillin|amoxicillin|mesh-list
65715705|NCT03692819|Metronidazole|metronidazole|mesh-list
65715706|NCT03692819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65715707|NCT03692819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65715708|NCT03692819|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65715709|NCT03692819|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65715710|NCT00458536|Molgramostim|molgramostim|mesh-list
65715711|NCT00458536|Sargramostim|sargramostim|mesh-list
65715712|NCT00458536|Immunologic Factors|immunologic factors|mesh-ancestor
65715713|NCT00458536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715714|NCT00458536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715715|NCT03697811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65715716|NCT03697811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65715717|NCT05577364|Prednisone|prednisone|mesh-list
65715718|NCT05577364|Cyclophosphamide|cyclophosphamide|mesh-list
65715719|NCT05577364|Doxorubicin|doxorubicin|mesh-list
65715720|NCT05577364|Vincristine|vincristine|mesh-list
65715721|NCT05577364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65715722|NCT05577364|Immunologic Factors|immunologic factors|mesh-ancestor
65715723|NCT05577364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715724|NCT05577364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65715725|NCT05577364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65715726|NCT05577364|Alkylating Agents|alkylating agents|mesh-ancestor
65715727|NCT05577364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715728|NCT05577364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715729|NCT05577364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65715730|NCT05577364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65715731|NCT05577364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65715732|NCT05577364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65715733|NCT05577364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715734|NCT05577364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65715735|NCT05577364|Glucocorticoids|glucocorticoids|mesh-ancestor
65715736|NCT05577364|Hormones|hormones|mesh-ancestor
65715737|NCT05577364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65715738|NCT05577364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65715739|NCT05577364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65715740|NCT05577364|Tubulin Modulators|tubulin modulators|mesh-ancestor
65715741|NCT05577364|Antimitotic Agents|antimitotic agents|mesh-ancestor
65715742|NCT05577364|Mitosis Modulators|mitosis modulators|mesh-ancestor
65715743|NCT03697655|Daratumumab|daratumumab|mesh-list
65715744|NCT03697655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715745|NCT03701321|Dexamethasone|dexamethasone|mesh-list
65715746|NCT03701321|Dexamethasone acetate|dexamethasone acetate|mesh-list
65715747|NCT03701321|Bortezomib|bortezomib|mesh-list
65715748|NCT03701321|Venetoclax|venetoclax|mesh-list
65715749|NCT03701321|Daratumumab|daratumumab|mesh-list
65715750|NCT03701321|Ichthammol|ichthammol|mesh-list
65715751|NCT03701321|BB 1101|bb 1101|mesh-list
65715752|NCT03701321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65715753|NCT03701321|Antiemetics|antiemetics|mesh-ancestor
65715754|NCT03701321|Autonomic Agents|autonomic agents|mesh-ancestor
65715755|NCT03701321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65715756|NCT03701321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715757|NCT03701321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65715758|NCT03701321|Glucocorticoids|glucocorticoids|mesh-ancestor
65715759|NCT03701321|Hormones|hormones|mesh-ancestor
65715760|NCT03701321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65715761|NCT03701321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65715762|NCT03701321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715763|NCT03701321|Protease Inhibitors|protease inhibitors|mesh-ancestor
65715764|NCT03701321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715765|NCT03701321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715766|NCT03701321|Dermatologic Agents|dermatologic agents|mesh-ancestor
65715767|NCT02526550|Vaccines|vaccines|mesh-list
65715768|NCT02526550|Immunologic Factors|immunologic factors|mesh-ancestor
65715769|NCT02526550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715770|NCT05565352|Ketamine|ketamine|mesh-list
65715771|NCT05565352|Analgesics|analgesics|mesh-ancestor
65715772|NCT05565352|Sensory System Agents|sensory system agents|mesh-ancestor
65715773|NCT05565352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65715774|NCT05565352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715775|NCT05565352|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65715776|NCT05565352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65715777|NCT05565352|Anesthetics, General|anesthetics, general|mesh-ancestor
65715778|NCT05565352|Anesthetics|anesthetics|mesh-ancestor
65715779|NCT05565352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65715780|NCT05565352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65715781|NCT05565352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65715782|NCT05565352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65715783|NCT05565352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715784|NCT04423276|Donepezil|donepezil|mesh-list
65715785|NCT04423276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65715786|NCT04423276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715787|NCT04423276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715788|NCT04423276|Cholinergic Agents|cholinergic agents|mesh-ancestor
65715789|NCT04423276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65715790|NCT04423276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715791|NCT04423276|Nootropic Agents|nootropic agents|mesh-ancestor
65715792|NCT05564416|Atezolizumab|atezolizumab|mesh-list
65715793|NCT05564416|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65715794|NCT05564416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715795|NCT05564416|Immunologic Factors|immunologic factors|mesh-ancestor
65715796|NCT05564416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715797|NCT03701087|Vitamin D|vitamin d|mesh-list
65715798|NCT03701087|Vitamins|vitamins|mesh-ancestor
65715799|NCT03701087|Micronutrients|micronutrients|mesh-ancestor
65715800|NCT03701087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715801|NCT03701087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65715802|NCT03934372|Ponatinib|ponatinib|mesh-list
65715803|NCT03934372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715804|NCT03934372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65715805|NCT03934372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715806|NCT03934372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715807|NCT03697265|Pregnanolone|pregnanolone|mesh-list
65715808|NCT03697265|Anesthetics|anesthetics|mesh-ancestor
65715809|NCT03697265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65715810|NCT03697265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715811|NCT04523129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65715812|NCT04523129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65715813|NCT04513067|Pembrolizumab|pembrolizumab|mesh-list
65715814|NCT04513067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65715815|NCT04513067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715816|NCT04512911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
65715817|NCT04336943|Durvalumab|durvalumab|mesh-list
65715818|NCT04336943|Olaparib|olaparib|mesh-list
65715819|NCT04336943|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65715820|NCT04336943|Immunoglobulins|immunoglobulins|mesh-list
65715821|NCT04336943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65715822|NCT04336943|Immunoglobulin G|immunoglobulin g|mesh-list
65715823|NCT04336943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65715824|NCT04336943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715825|NCT04336943|Immunologic Factors|immunologic factors|mesh-ancestor
65715826|NCT04336943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715827|NCT04336943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715828|NCT04336943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031658|NCT02904031|Vitamins|vitamins|mesh-ancestor
65715829|NCT03030989|Chlorhexidine|chlorhexidine|mesh-list
65715830|NCT03030989|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65715831|NCT03030989|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65715832|NCT03030989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65715833|NCT03030989|Disinfectants|disinfectants|mesh-ancestor
65715834|NCT03030989|Dermatologic Agents|dermatologic agents|mesh-ancestor
65715835|NCT04511039|Trifluridine|trifluridine|mesh-list
65715836|NCT04511039|Talazoparib|talazoparib|mesh-list
65715837|NCT04511039|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65715838|NCT04511039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715839|NCT04511039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715840|NCT04511039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715841|NCT04511039|Antimetabolites|antimetabolites|mesh-ancestor
65715842|NCT04511039|Antiviral Agents|antiviral agents|mesh-ancestor
65715843|NCT04511039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65715844|NCT03696641|Lithium Carbonate|lithium carbonate|mesh-list
65715845|NCT03696641|Antidepressive Agents|antidepressive agents|mesh-ancestor
65715846|NCT03696641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65715847|NCT03696641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715848|NCT03696641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715849|NCT03696641|Antimanic Agents|antimanic agents|mesh-ancestor
65715850|NCT03696641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65715851|NCT03696641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65715852|NCT03696641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715853|NCT03696329|Tetrabenazine|tetrabenazine|mesh-list
65715854|NCT03696329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65715855|NCT03696329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65715856|NCT03696329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65715857|NCT03696329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715858|NCT03696329|Adrenergic Agents|adrenergic agents|mesh-ancestor
65715859|NCT03696329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65715860|NCT03696329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715861|NCT03696095|Ropivacaine|ropivacaine|mesh-list
65715862|NCT03696095|Anesthetics, Local|anesthetics, local|mesh-ancestor
65715863|NCT03696095|Anesthetics|anesthetics|mesh-ancestor
65715864|NCT03696095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65715865|NCT03696095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715866|NCT03696095|Sensory System Agents|sensory system agents|mesh-ancestor
65715867|NCT03696095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65715868|NCT03700229|Rituximab|rituximab|mesh-list
65715869|NCT03700229|Bortezomib|bortezomib|mesh-list
65715870|NCT03700229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65715871|NCT03700229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715872|NCT03700229|Immunologic Factors|immunologic factors|mesh-ancestor
65715873|NCT03700229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715874|NCT03700229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65715875|NCT03695861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65715876|NCT03695861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65715877|NCT03695861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715878|NCT03695705|Rifaximin|rifaximin|mesh-list
65715879|NCT03695705|Norfloxacin|norfloxacin|mesh-list
65715880|NCT03695705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65715881|NCT03695705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65715882|NCT03695705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65715883|NCT03695705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65715884|NCT03695705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65715885|NCT03695705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715886|NCT03695705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715887|NCT03695705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715888|NCT03695705|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65715889|NCT03695705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65715890|NCT03699839|Vaccines|vaccines|mesh-list
65715891|NCT03699839|Immunologic Factors|immunologic factors|mesh-ancestor
65715892|NCT03699839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715893|NCT04050215|Edetic Acid|edetic acid|mesh-list
65715894|NCT04050215|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65715895|NCT04050215|Chelating Agents|chelating agents|mesh-ancestor
65715896|NCT04050215|Sequestering Agents|sequestering agents|mesh-ancestor
65715897|NCT04050215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715898|NCT04050215|Anticoagulants|anticoagulants|mesh-ancestor
65715899|NCT04050215|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65715900|NCT04050215|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65031722|NCT02903251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715901|NCT03691649|Timolol|timolol|mesh-list
65715902|NCT03691649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65715903|NCT03691649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65715904|NCT03691649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715905|NCT03691649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65715906|NCT03691649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65715907|NCT03691649|Adrenergic Agents|adrenergic agents|mesh-ancestor
65715908|NCT03691649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65715909|NCT03691649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715910|NCT03691649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65715911|NCT03691649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65715912|NCT03699449|Paclitaxel|paclitaxel|mesh-list
65715913|NCT03699449|Durvalumab|durvalumab|mesh-list
65715914|NCT03699449|Olaparib|olaparib|mesh-list
65715915|NCT03699449|Tremelimumab|tremelimumab|mesh-list
65715916|NCT03699449|Cediranib|cediranib|mesh-list
65715917|NCT03699449|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65715918|NCT03699449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65715919|NCT03699449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715920|NCT03699449|Tubulin Modulators|tubulin modulators|mesh-ancestor
65715921|NCT03699449|Antimitotic Agents|antimitotic agents|mesh-ancestor
65715922|NCT03699449|Mitosis Modulators|mitosis modulators|mesh-ancestor
65715923|NCT03699449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715924|NCT03699449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65715925|NCT03699449|Immunologic Factors|immunologic factors|mesh-ancestor
65715926|NCT03699449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715927|NCT03699449|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65715928|NCT03699449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715929|NCT03699449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65715930|NCT04475939|Pembrolizumab|pembrolizumab|mesh-list
65715931|NCT04475939|Niraparib|niraparib|mesh-list
65715932|NCT04475939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65715933|NCT04475939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715934|NCT04475939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65715935|NCT04475939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715936|NCT04475939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715937|NCT03699293|Aspirin|aspirin|mesh-list
65715938|NCT03699293|Celecoxib|celecoxib|mesh-list
65715939|NCT03699293|Naproxen|naproxen|mesh-list
65715940|NCT03699293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65715941|NCT03699293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65715942|NCT03699293|Analgesics|analgesics|mesh-ancestor
65715943|NCT03699293|Sensory System Agents|sensory system agents|mesh-ancestor
65715944|NCT03699293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65715945|NCT03699293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715946|NCT03699293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65715947|NCT03699293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65715948|NCT03699293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65715949|NCT03699293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65715950|NCT03699293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715951|NCT03699293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65715952|NCT03699293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65715953|NCT03699293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715954|NCT03699293|Antipyretics|antipyretics|mesh-ancestor
65715955|NCT03699293|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65715956|NCT03699293|Gout Suppressants|gout suppressants|mesh-ancestor
65715957|NCT03029819|Nicotine|nicotine|mesh-list
65715958|NCT03029819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65715959|NCT03029819|Autonomic Agents|autonomic agents|mesh-ancestor
65715960|NCT03029819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65715961|NCT03029819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715962|NCT03029819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65715963|NCT03029819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65715964|NCT03029819|Cholinergic Agents|cholinergic agents|mesh-ancestor
65715965|NCT03029819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65715966|NCT03029819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715967|NCT03105830|Acetaminophen|acetaminophen|mesh-list
65715968|NCT03105830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65715969|NCT03105830|Analgesics|analgesics|mesh-ancestor
65715970|NCT03105830|Sensory System Agents|sensory system agents|mesh-ancestor
65715971|NCT03105830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65715972|NCT03105830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715973|NCT03105830|Antipyretics|antipyretics|mesh-ancestor
65715974|NCT03691415|Deoxycholic Acid|deoxycholic acid|mesh-list
65715975|NCT03691415|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65031797|NCT02902315|Micronutrients|micronutrients|mesh-ancestor
65715976|NCT03691415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65715977|NCT03699215|Simendan|simendan|mesh-list
65715978|NCT03699215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65715979|NCT03699215|Vasodilator Agents|vasodilator agents|mesh-ancestor
65715980|NCT03699215|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65715981|NCT03699215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65715982|NCT03699215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715983|NCT03699215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715984|NCT03699215|Protective Agents|protective agents|mesh-ancestor
65715985|NCT03699215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65715987|NCT03694535|Mitomycin|mitomycin|mesh-list
65715988|NCT03694535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65715989|NCT03694535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65715990|NCT03694535|Alkylating Agents|alkylating agents|mesh-ancestor
65715991|NCT03694535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65715992|NCT03694535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65715993|NCT03694535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65715994|NCT05358938|Pembrolizumab|pembrolizumab|mesh-list
65715995|NCT05358938|Ipilimumab|ipilimumab|mesh-list
65715996|NCT05358938|Avelumab|avelumab|mesh-list
65715997|NCT05358938|Cemiplimab|cemiplimab|mesh-list
65715998|NCT05358938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65715999|NCT05358938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65716000|NCT05358938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65716001|NCT05358938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716002|NCT03115034|Melatonin|melatonin|mesh-list
65716003|NCT03115034|Antioxidants|antioxidants|mesh-ancestor
65716004|NCT03115034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716005|NCT03115034|Protective Agents|protective agents|mesh-ancestor
65716006|NCT03115034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716007|NCT03115034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65716008|NCT05563220|Everolimus|everolimus|mesh-list
65716009|NCT05563220|Palbociclib|palbociclib|mesh-list
65716010|NCT05563220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65716011|NCT05563220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65716012|NCT05563220|Immunologic Factors|immunologic factors|mesh-ancestor
65716013|NCT05563220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716014|NCT05563220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65716015|NCT05563220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716016|NCT05563220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716017|NCT05525546|Vaccines|vaccines|mesh-list
65716018|NCT05525546|Immunologic Factors|immunologic factors|mesh-ancestor
65716019|NCT05525546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716020|NCT03027557|Denosumab|denosumab|mesh-list
65716021|NCT03027557|Cinacalcet|cinacalcet|mesh-list
65716022|NCT03027557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65716023|NCT03027557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716024|NCT03027557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65716025|NCT03027557|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65716026|NCT03027557|Hormone Antagonists|hormone antagonists|mesh-ancestor
65716027|NCT03027557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65716028|NCT04423211|Leuprolide|leuprolide|mesh-list
65716029|NCT04423211|Goserelin|goserelin|mesh-list
65716030|NCT04423211|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65716031|NCT04423211|Fertility Agents|fertility agents|mesh-ancestor
65716032|NCT04423211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65716033|NCT04423211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716034|NCT04423211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65716035|NCT04423211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65716036|NCT03688295|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65716037|NCT03688295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65716038|NCT03688295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65716039|NCT03688295|Antitubercular Agents|antitubercular agents|mesh-ancestor
65716040|NCT02691572|Acetaminophen|acetaminophen|mesh-list
65716041|NCT02691572|Ketorolac|ketorolac|mesh-list
65716042|NCT02691572|Fentanyl|fentanyl|mesh-list
65716043|NCT02691572|Bupivacaine|bupivacaine|mesh-list
65716044|NCT02691572|Anesthetics, Local|anesthetics, local|mesh-ancestor
65716045|NCT02691572|Anesthetics|anesthetics|mesh-ancestor
65716046|NCT02691572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65716047|NCT02691572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716048|NCT02691572|Sensory System Agents|sensory system agents|mesh-ancestor
65716049|NCT02691572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65716050|NCT02691572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65716051|NCT02691572|Narcotics|narcotics|mesh-ancestor
65716052|NCT02691572|Analgesics|analgesics|mesh-ancestor
65031872|NCT02901106|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65716054|NCT02691572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65716055|NCT02691572|Anesthetics, General|anesthetics, general|mesh-ancestor
65716056|NCT02691572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65716057|NCT02691572|Antipyretics|antipyretics|mesh-ancestor
65716058|NCT02691572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65716059|NCT02691572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65716060|NCT02691572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65716061|NCT02691572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65716062|NCT02691572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716063|NCT02691572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716064|NCT05320172|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65716065|NCT05320172|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65716066|NCT05300048|Paclitaxel|paclitaxel|mesh-list
65716067|NCT05300048|Serabelisib|serabelisib|mesh-list
65716068|NCT05300048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65716069|NCT05300048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65716070|NCT05300048|Tubulin Modulators|tubulin modulators|mesh-ancestor
65716071|NCT05300048|Antimitotic Agents|antimitotic agents|mesh-ancestor
65716072|NCT05300048|Mitosis Modulators|mitosis modulators|mesh-ancestor
65716073|NCT05300048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716074|NCT05300048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716075|NCT03693833|Cannabidiol|cannabidiol|mesh-list
65716076|NCT03693833|Anticonvulsants|anticonvulsants|mesh-ancestor
65716077|NCT03693599|Carbetocin|carbetocin|mesh-list
65716078|NCT03693599|Syntometrine|syntometrine|mesh-list
65716079|NCT03693599|Oxytocics|oxytocics|mesh-ancestor
65716080|NCT03693599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65716081|NCT03693599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716082|NCT04277663|Interferons|interferons|mesh-list
65716083|NCT04277663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65716084|NCT04277663|Antiviral Agents|antiviral agents|mesh-ancestor
65716085|NCT04277663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65716086|NCT04270643|Vitamin D|vitamin d|mesh-list
65716087|NCT04270643|Cholecalciferol|cholecalciferol|mesh-list
65716088|NCT04270643|Vitamins|vitamins|mesh-ancestor
65716089|NCT04270643|Micronutrients|micronutrients|mesh-ancestor
65716090|NCT04270643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716091|NCT04270643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65716092|NCT04270643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65716093|NCT03693131|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
65716094|NCT03693131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65716095|NCT03693131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65716096|NCT02677844|Loperamide|loperamide|mesh-list
65716097|NCT02677844|Antidiarrheals|antidiarrheals|mesh-list
65716098|NCT02677844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65716099|NCT03687905|Hydroxychloroquine|hydroxychloroquine|mesh-list
65716100|NCT03687905|Chloroquine|chloroquine|mesh-list
65716101|NCT03687905|Antimalarials|antimalarials|mesh-ancestor
65716102|NCT03687905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65716103|NCT03687905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65716104|NCT03687905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65716105|NCT03687905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716106|NCT03687905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716107|NCT03687905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65716108|NCT03687905|Amebicides|amebicides|mesh-ancestor
65716109|NCT03687515|Prednisone|prednisone|mesh-list
65716110|NCT03687515|Budesonide|budesonide|mesh-list
65716111|NCT03687515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65716112|NCT03687515|Glucocorticoids|glucocorticoids|mesh-ancestor
65716113|NCT03687515|Hormones|hormones|mesh-ancestor
65716114|NCT03687515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65716115|NCT03687515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716116|NCT03687515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65716117|NCT03687515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65716118|NCT03687515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65716119|NCT03687515|Autonomic Agents|autonomic agents|mesh-ancestor
65716120|NCT03687515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65716121|NCT03687515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65716122|NCT03687515|Respiratory System Agents|respiratory system agents|mesh-ancestor
65716123|NCT02691494|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65716124|NCT02691494|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65716125|NCT02691494|Norethindrone|norethindrone|mesh-list
65716126|NCT02691494|Norethindrone Acetate|norethindrone acetate|mesh-list
65716127|NCT02691494|Estradiol|estradiol|mesh-list
65716128|NCT02691494|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65716129|NCT02691494|Estrogens|estrogens|mesh-ancestor
65716130|NCT02691494|Hormones|hormones|mesh-ancestor
65716131|NCT02691494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65716132|NCT02691494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716133|NCT02691494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65716134|NCT02691494|Contraceptive Agents|contraceptive agents|mesh-ancestor
65716135|NCT02691494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65716136|NCT02691494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65716137|NCT02691494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65716138|NCT02691494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65716139|NCT02691494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65716140|NCT04145297|Hydroxychloroquine|hydroxychloroquine|mesh-list
65716141|NCT04145297|Antimalarials|antimalarials|mesh-ancestor
65716142|NCT04145297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65716143|NCT04145297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65716144|NCT04145297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65716145|NCT04145297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716146|NCT04145297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716147|NCT04145297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65716149|NCT04140305|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65716150|NCT04140305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716151|NCT04140305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65716152|NCT04140305|Immunologic Factors|immunologic factors|mesh-ancestor
65716153|NCT04140305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716154|NCT02682602|Tacrine|tacrine|mesh-list
65716155|NCT02682602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65716156|NCT02682602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716157|NCT02682602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716158|NCT02682602|Cholinergic Agents|cholinergic agents|mesh-ancestor
65716159|NCT02682602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65716160|NCT02682602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716161|NCT02682602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65716162|NCT02682602|Autonomic Agents|autonomic agents|mesh-ancestor
65716163|NCT02682602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65716164|NCT02682602|Nootropic Agents|nootropic agents|mesh-ancestor
65716165|NCT03691337|Bupivacaine|bupivacaine|mesh-list
65716166|NCT03691337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65716167|NCT03691337|Anesthetics, Local|anesthetics, local|mesh-ancestor
65716168|NCT03691337|Anesthetics|anesthetics|mesh-ancestor
65716169|NCT03691337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65716170|NCT03691337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716171|NCT03691337|Sensory System Agents|sensory system agents|mesh-ancestor
65716172|NCT03691337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65716173|NCT02681510|Nicotine|nicotine|mesh-list
65716174|NCT02681510|Varenicline|varenicline|mesh-list
65716175|NCT02681510|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65716176|NCT02681510|Autonomic Agents|autonomic agents|mesh-ancestor
65716177|NCT02681510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65716178|NCT02681510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716179|NCT02681510|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65716180|NCT02681510|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65269527|NCT00910715|Doxycycline|doxycycline|mesh-list
65716181|NCT02681510|Cholinergic Agents|cholinergic agents|mesh-ancestor
65716182|NCT02681510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65716183|NCT02681510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716184|NCT03690323|Gemcitabine|gemcitabine|mesh-list
65716185|NCT03690323|Paclitaxel|paclitaxel|mesh-list
65716186|NCT03690323|Folfirinox|folfirinox|mesh-list
65716187|NCT03690323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65716188|NCT03690323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65716189|NCT03690323|Tubulin Modulators|tubulin modulators|mesh-ancestor
65716190|NCT03690323|Antimitotic Agents|antimitotic agents|mesh-ancestor
65716191|NCT03690323|Mitosis Modulators|mitosis modulators|mesh-ancestor
65716192|NCT03690323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716193|NCT03690323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65716194|NCT03690323|Antimetabolites|antimetabolites|mesh-ancestor
65716195|NCT03690323|Antiviral Agents|antiviral agents|mesh-ancestor
65716196|NCT03690323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65716197|NCT03690323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716198|NCT03690323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65716199|NCT03690323|Immunologic Factors|immunologic factors|mesh-ancestor
65716200|NCT03690323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716201|NCT03682211|Fentanyl|fentanyl|mesh-list
65716202|NCT03682211|Morphine|morphine|mesh-list
65716203|NCT03682211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65716204|NCT03682211|Narcotics|narcotics|mesh-ancestor
65032021|NCT02898961|Gentamicins|gentamicins|mesh-list
65716205|NCT03682211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65716206|NCT03682211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716207|NCT03682211|Analgesics|analgesics|mesh-ancestor
65716208|NCT03682211|Sensory System Agents|sensory system agents|mesh-ancestor
65716209|NCT03682211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65716210|NCT03682211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65716211|NCT03682211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65716212|NCT03682211|Anesthetics, General|anesthetics, general|mesh-ancestor
65716213|NCT03682211|Anesthetics|anesthetics|mesh-ancestor
65716214|NCT04132505|Hydroxychloroquine|hydroxychloroquine|mesh-list
65716215|NCT04132505|Antimalarials|antimalarials|mesh-ancestor
65716216|NCT04132505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65716217|NCT04132505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65716218|NCT04132505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65716219|NCT04132505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716220|NCT04132505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716221|NCT04132505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65716222|NCT02690714|Plasminogen|plasminogen|mesh-list
65716223|NCT02690714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65716224|NCT02690714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65716225|NCT02690714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716226|NCT03690167|Mitogens|mitogens|mesh-list
65716227|NCT03690167|Mitosis Modulators|mitosis modulators|mesh-ancestor
65716228|NCT03690167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716229|NCT03165890|Acetazolamide|acetazolamide|mesh-list
65716230|NCT03165890|Anticonvulsants|anticonvulsants|mesh-ancestor
65716231|NCT03165890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65716232|NCT03165890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716233|NCT03165890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716234|NCT03165890|Diuretics|diuretics|mesh-ancestor
65716235|NCT03165890|Natriuretic Agents|natriuretic agents|mesh-ancestor
65716236|NCT03165890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716237|NCT03681509|Pramipexole|pramipexole|mesh-list
65716238|NCT03681509|Antioxidants|antioxidants|mesh-ancestor
65716239|NCT03681509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716240|NCT03681509|Protective Agents|protective agents|mesh-ancestor
65716241|NCT03681509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716242|NCT03681509|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65716243|NCT03681509|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65716244|NCT03681509|Dopamine Agonists|dopamine agonists|mesh-ancestor
65716245|NCT03681509|Dopamine Agents|dopamine agents|mesh-ancestor
65716246|NCT03681509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65716247|NCT03686267|Lithium Carbonate|lithium carbonate|mesh-list
65716248|NCT03686267|Antidepressive Agents|antidepressive agents|mesh-ancestor
65716249|NCT03686267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65716250|NCT03686267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716251|NCT03686267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716252|NCT03686267|Antimanic Agents|antimanic agents|mesh-ancestor
65716253|NCT03686267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65716254|NCT03686267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65716255|NCT03686267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716256|NCT03161210|Anesthetics|anesthetics|mesh-list
65716257|NCT03161210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65716258|NCT03161210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716259|NCT01898793|Aldesleukin|aldesleukin|mesh-list
65716260|NCT01898793|Cyclophosphamide|cyclophosphamide|mesh-list
65716261|NCT01898793|Fludarabine|fludarabine|mesh-list
65716262|NCT01898793|Fludarabine phosphate|fludarabine phosphate|mesh-list
65716263|NCT01898793|Interleukin-2|interleukin-2|mesh-list
65716264|NCT01898793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65716265|NCT01898793|Immunologic Factors|immunologic factors|mesh-ancestor
65716266|NCT01898793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716267|NCT01898793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65716268|NCT01898793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65716269|NCT01898793|Alkylating Agents|alkylating agents|mesh-ancestor
65716270|NCT01898793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716271|NCT01898793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65716272|NCT01898793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65716273|NCT01898793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65716274|NCT01898793|Antimetabolites|antimetabolites|mesh-ancestor
65716275|NCT01898793|Antiviral Agents|antiviral agents|mesh-ancestor
65716276|NCT01898793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65716277|NCT01898793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65716278|NCT01898793|Analgesics|analgesics|mesh-ancestor
65716279|NCT01898793|Sensory System Agents|sensory system agents|mesh-ancestor
64473392|NCT00133978|Selenium|selenium|mesh-list
65716280|NCT01898793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65716281|NCT01898793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65716282|NCT01898793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65716283|NCT03164096|Bupivacaine|bupivacaine|mesh-list
65716284|NCT03164096|Anesthetics, Local|anesthetics, local|mesh-ancestor
65716285|NCT03164096|Anesthetics|anesthetics|mesh-ancestor
65716286|NCT03164096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65716287|NCT03164096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716288|NCT03164096|Sensory System Agents|sensory system agents|mesh-ancestor
65716289|NCT03164096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65716290|NCT03164018|4-Aminopyridine|4-aminopyridine|mesh-list
65716291|NCT03164018|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65716292|NCT03164018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65716293|NCT03164018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716294|NCT03163784|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65716295|NCT03163784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65716296|NCT03163784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65716297|NCT03163784|Antitubercular Agents|antitubercular agents|mesh-ancestor
65716298|NCT03681431|Ceftriaxone|ceftriaxone|mesh-list
65716299|NCT03681431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65716300|NCT03681431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65716301|NCT03681197|Metformin|metformin|mesh-list
65716302|NCT03681197|Clomiphene|clomiphene|mesh-list
65716303|NCT03681197|Enclomiphene|enclomiphene|mesh-list
65716304|NCT03681197|Zuclomiphene|zuclomiphene|mesh-list
65716305|NCT03681197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65716306|NCT03681197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716307|NCT03681197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65716308|NCT03681197|Hormone Antagonists|hormone antagonists|mesh-ancestor
65716309|NCT03681197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65716310|NCT03681197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65716311|NCT03681197|Fertility Agents|fertility agents|mesh-ancestor
65716312|NCT03681197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65716313|NCT03681197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65716314|NCT03681197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65716315|NCT03485703|Azithromycin|azithromycin|mesh-list
65716316|NCT03485703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65716317|NCT03485703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65716318|NCT03165344|Prednisone|prednisone|mesh-list
65716319|NCT03165344|Triamcinolone|triamcinolone|mesh-list
65716320|NCT03165344|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65716321|NCT03165344|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65716322|NCT03165344|Hydrocortisone|hydrocortisone|mesh-list
65716323|NCT03165344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65716324|NCT03165344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65716325|NCT03165344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65716326|NCT03165344|Aluminum phosphate|aluminum phosphate|mesh-list
65716327|NCT03165344|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65716328|NCT03165344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65716329|NCT03165344|Glucocorticoids|glucocorticoids|mesh-ancestor
65716330|NCT03165344|Hormones|hormones|mesh-ancestor
65716331|NCT03165344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65716332|NCT03165344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716333|NCT03165344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65716334|NCT03165344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65716335|NCT03165344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65716336|NCT03165344|Immunologic Factors|immunologic factors|mesh-ancestor
65716337|NCT03165344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716338|NCT03165344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716339|NCT03165344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65716340|NCT03165344|Antacids|antacids|mesh-ancestor
65716341|NCT03165344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65716342|NCT03487029|Oxymetazoline|oxymetazoline|mesh-list
65716343|NCT03487029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65716344|NCT03487029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65716345|NCT03487029|Adrenergic Agents|adrenergic agents|mesh-ancestor
65716346|NCT03487029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65716347|NCT03487029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716348|NCT03487029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716349|NCT03487029|Sympathomimetics|sympathomimetics|mesh-ancestor
65716350|NCT03487029|Autonomic Agents|autonomic agents|mesh-ancestor
65716351|NCT03487029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65716352|NCT03487029|Nasal Decongestants|nasal decongestants|mesh-ancestor
65716353|NCT03487029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65716354|NCT03487029|Respiratory System Agents|respiratory system agents|mesh-ancestor
65716355|NCT03689465|Cyclosporine|cyclosporine|mesh-list
65716356|NCT03689465|Mycophenolic Acid|mycophenolic acid|mesh-list
65716358|NCT03689465|Cyclosporins|cyclosporins|mesh-list
65716359|NCT03689465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65716360|NCT03689465|Abortifacient Agents|abortifacient agents|mesh-ancestor
65716361|NCT03689465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65716362|NCT03689465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716363|NCT03689465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65716364|NCT03689465|Antimetabolites|antimetabolites|mesh-ancestor
65716365|NCT03689465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716366|NCT03689465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65716367|NCT03689465|Dermatologic Agents|dermatologic agents|mesh-ancestor
65716368|NCT03689465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716369|NCT03689465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65716370|NCT03689465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65716371|NCT03689465|Immunologic Factors|immunologic factors|mesh-ancestor
65716372|NCT03689465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65716373|NCT03689465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65716374|NCT03689465|Antifungal Agents|antifungal agents|mesh-ancestor
65716375|NCT03689465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65716376|NCT03689465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65716377|NCT03689465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65716378|NCT03689465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65716379|NCT03689465|Antitubercular Agents|antitubercular agents|mesh-ancestor
65716380|NCT03689465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65716381|NCT03485625|Acetaminophen|acetaminophen|mesh-list
65716382|NCT03485625|Ketorolac|ketorolac|mesh-list
65716383|NCT03485625|Lidocaine|lidocaine|mesh-list
65716384|NCT03485625|Anesthetics, Local|anesthetics, local|mesh-ancestor
65716385|NCT03485625|Anesthetics|anesthetics|mesh-ancestor
65716386|NCT03485625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65716387|NCT03485625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716388|NCT03485625|Sensory System Agents|sensory system agents|mesh-ancestor
65716389|NCT03485625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65716390|NCT03485625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65716391|NCT03485625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65716392|NCT03485625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65716393|NCT03485625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65716394|NCT03485625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716395|NCT03485625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65716396|NCT03485625|Analgesics|analgesics|mesh-ancestor
65716397|NCT03485625|Antipyretics|antipyretics|mesh-ancestor
65716398|NCT03485625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65716399|NCT03485625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65716400|NCT03485625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65716401|NCT03485625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65716402|NCT03485625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716403|NCT03680885|Lidocaine|lidocaine|mesh-list
65716404|NCT03680885|Anesthetics, Local|anesthetics, local|mesh-ancestor
65716405|NCT03680885|Anesthetics|anesthetics|mesh-ancestor
65716406|NCT03680885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65716407|NCT03680885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716408|NCT03680885|Sensory System Agents|sensory system agents|mesh-ancestor
65716409|NCT03680885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65716410|NCT03680885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65716411|NCT03680885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65716412|NCT03680885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65716413|NCT03680885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65716414|NCT03680885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716415|NCT03033069|Sertraline|sertraline|mesh-list
65716416|NCT03033069|Brexpiprazole|brexpiprazole|mesh-list
65716417|NCT03033069|Antidepressive Agents|antidepressive agents|mesh-ancestor
65716418|NCT03033069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65716419|NCT03033069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65716420|NCT03033069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65716421|NCT03033069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65716422|NCT03033069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716423|NCT03033069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65716424|NCT03033069|Serotonin Agents|serotonin agents|mesh-ancestor
65716425|NCT03033069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716426|NCT03033069|Dopamine Agonists|dopamine agonists|mesh-ancestor
65716427|NCT03033069|Dopamine Agents|dopamine agents|mesh-ancestor
65716428|NCT03685409|Metformin|metformin|mesh-list
65716429|NCT03685409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65716430|NCT03685409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716432|NCT03165500|Diazepam|diazepam|mesh-list
65716433|NCT03165500|Nitrous Oxide|nitrous oxide|mesh-list
65716434|NCT03165500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65716435|NCT03165500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65716436|NCT03165500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65716437|NCT03165500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716438|NCT03165500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65716439|NCT03165500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65716440|NCT03165500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65716441|NCT03165500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65716442|NCT03165500|Anesthetics, General|anesthetics, general|mesh-ancestor
65716443|NCT03165500|Anesthetics|anesthetics|mesh-ancestor
65716444|NCT03165500|GABA Modulators|gaba modulators|mesh-ancestor
65716445|NCT03165500|GABA Agents|gaba agents|mesh-ancestor
65716446|NCT03165500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65716447|NCT03165500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716448|NCT03165500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65716449|NCT03165500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65716450|NCT03165500|Analgesics|analgesics|mesh-ancestor
65716451|NCT03165500|Sensory System Agents|sensory system agents|mesh-ancestor
65716452|NCT03165500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65716453|NCT03165500|Anticonvulsants|anticonvulsants|mesh-ancestor
65716454|NCT03165500|Antiemetics|antiemetics|mesh-ancestor
65716455|NCT03165500|Autonomic Agents|autonomic agents|mesh-ancestor
65716456|NCT03165500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65716457|NCT03165500|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65716458|NCT03165500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65716459|NCT03163238|Dexmedetomidine|dexmedetomidine|mesh-list
65716460|NCT03163238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65716461|NCT03163238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65716462|NCT03163238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716463|NCT03163238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65716464|NCT03163238|Analgesics|analgesics|mesh-ancestor
65716465|NCT03163238|Sensory System Agents|sensory system agents|mesh-ancestor
65716466|NCT03163238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65716467|NCT03163238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65716468|NCT03163238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65716469|NCT03163238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65716470|NCT03163238|Adrenergic Agents|adrenergic agents|mesh-ancestor
65716471|NCT03163238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65716472|NCT03163238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716473|NCT05127044|Bilirubin|bilirubin|mesh-list
65716474|NCT05127044|Antioxidants|antioxidants|mesh-ancestor
65716475|NCT05127044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716476|NCT05127044|Protective Agents|protective agents|mesh-ancestor
65716477|NCT05127044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716478|NCT03486561|Ranolazine|ranolazine|mesh-list
65716479|NCT03486561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65716480|NCT03486561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65716481|NCT03486561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716482|NCT03680573|Allopurinol|allopurinol|mesh-list
65716483|NCT03680573|Nitroprusside|nitroprusside|mesh-list
65716484|NCT03680573|Nitroarginine|nitroarginine|mesh-list
65716485|NCT03680573|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
65716486|NCT03680573|Antimetabolites|antimetabolites|mesh-ancestor
65716487|NCT03680573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716488|NCT03680573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716489|NCT03680573|Gout Suppressants|gout suppressants|mesh-ancestor
65716490|NCT03680573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65716491|NCT03680573|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65716492|NCT03680573|Antioxidants|antioxidants|mesh-ancestor
65716493|NCT03680573|Protective Agents|protective agents|mesh-ancestor
65716494|NCT03680573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716495|NCT03680573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65716496|NCT03680573|Vasodilator Agents|vasodilator agents|mesh-ancestor
65716497|NCT03680573|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65716498|NCT03689075|Tacrolimus|tacrolimus|mesh-list
65716499|NCT03689075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65716500|NCT03689075|Immunologic Factors|immunologic factors|mesh-ancestor
65716501|NCT03689075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716502|NCT03689075|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65716503|NCT03689075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716504|NCT03689075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716505|NCT03680495|Methylprednisolone|methylprednisolone|mesh-list
65716506|NCT03680495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65716507|NCT03680495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65716509|NCT03680495|Prednisolone acetate|prednisolone acetate|mesh-list
65716510|NCT03680495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65716511|NCT03680495|Prednisolone phosphate|prednisolone phosphate|mesh-list
65716512|NCT03680495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65716513|NCT03680495|Antiemetics|antiemetics|mesh-ancestor
65716514|NCT03680495|Autonomic Agents|autonomic agents|mesh-ancestor
65716515|NCT03680495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65716516|NCT03680495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716517|NCT03680495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65716518|NCT03680495|Glucocorticoids|glucocorticoids|mesh-ancestor
65716519|NCT03680495|Hormones|hormones|mesh-ancestor
65716520|NCT03680495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65716521|NCT03680495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65716522|NCT03680495|Protective Agents|protective agents|mesh-ancestor
65716523|NCT03680495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65716524|NCT03680495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65716525|NCT03647969|Nivolumab|nivolumab|mesh-list
65716526|NCT03647969|Ipilimumab|ipilimumab|mesh-list
65716527|NCT03647969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65716528|NCT03647969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65716529|NCT03647969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65716530|NCT03647969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716531|NCT03492255|Mycophenolic Acid|mycophenolic acid|mesh-list
65716532|NCT03492255|Prednisone|prednisone|mesh-list
65716533|NCT03492255|Methylprednisolone|methylprednisolone|mesh-list
65716534|NCT03492255|Cyclophosphamide|cyclophosphamide|mesh-list
65716535|NCT03492255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65716536|NCT03492255|Immunologic Factors|immunologic factors|mesh-ancestor
65716537|NCT03492255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716538|NCT03492255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65716539|NCT03492255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65716540|NCT03492255|Alkylating Agents|alkylating agents|mesh-ancestor
65716541|NCT03492255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716542|NCT03492255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65716543|NCT03492255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65716544|NCT03492255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65716545|NCT03492255|Glucocorticoids|glucocorticoids|mesh-ancestor
65716546|NCT03492255|Hormones|hormones|mesh-ancestor
65716547|NCT03492255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65716548|NCT03492255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65716549|NCT03492255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65716550|NCT03492255|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65716551|NCT03492255|Antitubercular Agents|antitubercular agents|mesh-ancestor
65716552|NCT03492255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65716553|NCT03492255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65716554|NCT03492255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716555|NCT03492255|Antiemetics|antiemetics|mesh-ancestor
65716556|NCT03492255|Autonomic Agents|autonomic agents|mesh-ancestor
65716557|NCT03492255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65716558|NCT03492255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65716559|NCT03492255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65716560|NCT03492255|Protective Agents|protective agents|mesh-ancestor
65716561|NCT03684863|Capecitabine|capecitabine|mesh-list
65716562|NCT03684863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65716563|NCT03684863|Antimetabolites|antimetabolites|mesh-ancestor
65716564|NCT03684863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716565|NCT03684863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65716566|NCT03680339|Misoprostol|misoprostol|mesh-list
65716567|NCT03680339|Oxytocin|oxytocin|mesh-list
65716568|NCT03680339|Oxytocics|oxytocics|mesh-ancestor
65716569|NCT03680339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65716570|NCT03680339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716571|NCT03680339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65716572|NCT03680339|Abortifacient Agents|abortifacient agents|mesh-ancestor
65716573|NCT03680339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65716574|NCT03680339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65716575|NCT03680183|Entecavir|entecavir|mesh-list
65716576|NCT03680183|Antiviral Agents|antiviral agents|mesh-ancestor
65716577|NCT03680183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65716578|NCT02136069|Infliximab|infliximab|mesh-list
65716579|NCT02136069|Etrolizumab|etrolizumab|mesh-list
65716580|NCT02136069|Dermatologic Agents|dermatologic agents|mesh-ancestor
65716581|NCT02136069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65716583|NCT02136069|Immunologic Factors|immunologic factors|mesh-ancestor
65716584|NCT02136069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716585|NCT02917031|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65716586|NCT02917031|Saxagliptin|saxagliptin|mesh-list
65716587|NCT02917031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65716588|NCT02917031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716589|NCT02917031|Incretins|incretins|mesh-ancestor
65716590|NCT02917031|Hormones|hormones|mesh-ancestor
65716591|NCT02917031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65716592|NCT02917031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65716593|NCT02917031|Protease Inhibitors|protease inhibitors|mesh-ancestor
65716594|NCT02917031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716595|NCT02917031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032471|NCT05422885|Antioxidants|antioxidants|mesh-ancestor
65716596|NCT04460547|Interferons|interferons|mesh-list
65716597|NCT04460547|Interferon-beta|interferon-beta|mesh-list
65716598|NCT04460547|Interferon beta-1a|interferon beta-1a|mesh-list
65716599|NCT04460547|Hydroxychloroquine|hydroxychloroquine|mesh-list
65716600|NCT04460547|Ivermectin|ivermectin|mesh-list
65716601|NCT04460547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65716602|NCT04460547|Antiviral Agents|antiviral agents|mesh-ancestor
65716603|NCT04460547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65716604|NCT04460547|Antimalarials|antimalarials|mesh-ancestor
65716605|NCT04460547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65716606|NCT04460547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65716607|NCT04460547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716608|NCT04460547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716609|NCT04460547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65716610|NCT04460547|Immunologic Factors|immunologic factors|mesh-ancestor
65716611|NCT04460547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716612|NCT04460547|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65716613|NCT03132051|Triamcinolone|triamcinolone|mesh-list
65716614|NCT03132051|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65716615|NCT03132051|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65716616|NCT03132051|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65716617|NCT03132051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65716618|NCT03132051|Glucocorticoids|glucocorticoids|mesh-ancestor
65716619|NCT03132051|Hormones|hormones|mesh-ancestor
65716620|NCT03132051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65716621|NCT03132051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716622|NCT03132051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65716623|NCT03132051|Immunologic Factors|immunologic factors|mesh-ancestor
65716624|NCT03132051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179282|NCT02829424|Immunologic Factors|immunologic factors|mesh-ancestor
65716625|NCT03132051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716626|NCT03684707|Metformin|metformin|mesh-list
65716627|NCT03684707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65716628|NCT03684707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716629|NCT01018563|Farletuzumab|farletuzumab|mesh-list
65716630|NCT01018563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65716631|NCT02528188|Tanezumab|tanezumab|mesh-list
65716632|NCT02528188|Analgesics|analgesics|mesh-ancestor
65716633|NCT02528188|Sensory System Agents|sensory system agents|mesh-ancestor
65716634|NCT02528188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65716635|NCT02528188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716636|NCT03684395|Warfarin|warfarin|mesh-list
65716637|NCT03684395|Rivaroxaban|rivaroxaban|mesh-list
65716638|NCT03684395|Dabigatran|dabigatran|mesh-list
65716639|NCT03684395|Apixaban|apixaban|mesh-list
65716640|NCT03684395|Anticoagulants|anticoagulants|mesh-ancestor
65716641|NCT03684395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65716642|NCT03684395|Antithrombins|antithrombins|mesh-ancestor
65716643|NCT03684395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65716644|NCT03684395|Protease Inhibitors|protease inhibitors|mesh-ancestor
65716645|NCT03684395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716646|NCT03684395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716647|NCT04460001|Triamcinolone|triamcinolone|mesh-list
65716648|NCT04460001|Ranibizumab|ranibizumab|mesh-list
65716649|NCT04460001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65716650|NCT04460001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65716651|NCT04460001|Growth Substances|growth substances|mesh-ancestor
65716652|NCT04460001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716653|NCT04460001|Growth Inhibitors|growth inhibitors|mesh-ancestor
65716654|NCT04460001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65716655|NCT04460001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65716656|NCT04460001|Glucocorticoids|glucocorticoids|mesh-ancestor
65716657|NCT04460001|Hormones|hormones|mesh-ancestor
65716658|NCT04460001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65716659|NCT03484845|Ferrous fumarate|ferrous fumarate|mesh-list
65716660|NCT03484845|Lactoferrin|lactoferrin|mesh-list
65716661|NCT03484845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65716662|NCT03484845|Trace Elements|trace elements|mesh-ancestor
65716663|NCT03484845|Micronutrients|micronutrients|mesh-ancestor
65716664|NCT03484845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716665|NCT03679481|Tranexamic Acid|tranexamic acid|mesh-list
65716666|NCT03679481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65716667|NCT03679481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65716668|NCT03679481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716669|NCT03679481|Hemostatics|hemostatics|mesh-ancestor
65716670|NCT03679481|Coagulants|coagulants|mesh-ancestor
65716671|NCT04461249|Travoprost|travoprost|mesh-list
65716672|NCT04461249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65716673|NCT04461249|Latanoprost|latanoprost|mesh-list
65716674|NCT04461249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65032616|NCT02607748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716675|NCT04461249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65716676|NCT05151549|Carboplatin|carboplatin|mesh-list
65716677|NCT05151549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65716678|NCT05151393|Vitamin D|vitamin d|mesh-list
65716679|NCT05151393|Cholecalciferol|cholecalciferol|mesh-list
65716680|NCT05151393|Vitamins|vitamins|mesh-ancestor
65716681|NCT05151393|Micronutrients|micronutrients|mesh-ancestor
65716682|NCT05151393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716683|NCT05151393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65716684|NCT05151393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65716685|NCT03484611|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65716686|NCT03484611|Cetrorelix|cetrorelix|mesh-list
65716687|NCT03484611|Menotropins|menotropins|mesh-list
65716688|NCT03484611|Progesterone|progesterone|mesh-list
65716689|NCT03484611|Progestins|progestins|mesh-ancestor
65716690|NCT03484611|Hormones|hormones|mesh-ancestor
65716691|NCT03484611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65716692|NCT03484611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716693|NCT03484611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65716694|NCT03484611|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65716695|NCT03484611|Fertility Agents|fertility agents|mesh-ancestor
65716696|NCT03484611|Hormone Antagonists|hormone antagonists|mesh-ancestor
65716697|NCT03679325|Vitamin D|vitamin d|mesh-list
65716698|NCT03679325|Vitamins|vitamins|mesh-ancestor
65716699|NCT03679325|Micronutrients|micronutrients|mesh-ancestor
65716700|NCT03679325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716701|NCT03679325|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65716702|NCT03878927|Gemtuzumab|gemtuzumab|mesh-list
65716703|NCT03878927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65716704|NCT03878927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65716705|NCT03623789|Tranylcypromine|tranylcypromine|mesh-list
65716706|NCT03623789|Tranexamic Acid|tranexamic acid|mesh-list
65716707|NCT03623789|Hemostatics|hemostatics|mesh-list
65716708|NCT03623789|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65716709|NCT03623789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65716710|NCT03623789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716711|NCT03623789|Coagulants|coagulants|mesh-ancestor
65716712|NCT03623789|Antidepressive Agents|antidepressive agents|mesh-ancestor
65716713|NCT03623789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65716714|NCT03623789|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65716715|NCT03623789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716716|NCT03623789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65716717|NCT03623789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65716718|NCT03623789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65716719|NCT03623789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716720|NCT03873389|Ocrelizumab|ocrelizumab|mesh-list
65716721|NCT03873389|Immunologic Factors|immunologic factors|mesh-ancestor
65716722|NCT03873389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716723|NCT03623555|Hydrocortisone|hydrocortisone|mesh-list
65716724|NCT03623555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65716725|NCT03623711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65716726|NCT03623711|Citalopram|citalopram|mesh-list
65716727|NCT03623711|Bupropion|bupropion|mesh-list
65716728|NCT03623711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65716729|NCT03623711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65716730|NCT03623711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65716731|NCT03623711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716732|NCT03623711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65716733|NCT03623711|Serotonin Agents|serotonin agents|mesh-ancestor
65716734|NCT03623711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716735|NCT03623711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65716736|NCT03623711|Antidepressive Agents|antidepressive agents|mesh-ancestor
65716737|NCT03623711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65716738|NCT03623711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65716739|NCT03623711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65716740|NCT03623711|Dopamine Agents|dopamine agents|mesh-ancestor
65716741|NCT03623711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65716742|NCT03623711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65716743|NCT03623711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716744|NCT03623711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65716745|NCT03623711|Analgesics|analgesics|mesh-ancestor
65716746|NCT03623711|Sensory System Agents|sensory system agents|mesh-ancestor
65716747|NCT05368090|Epinephrine|epinephrine|mesh-list
65716748|NCT05368090|Racepinephrine|racepinephrine|mesh-list
65716749|NCT05368090|Epinephryl borate|epinephryl borate|mesh-list
65716750|NCT05368090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65716752|NCT05368090|Adrenergic Agents|adrenergic agents|mesh-ancestor
65716753|NCT05368090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65716754|NCT05368090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716755|NCT05368090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716756|NCT05368090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65716757|NCT05368090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65716758|NCT05368090|Autonomic Agents|autonomic agents|mesh-ancestor
65716759|NCT05368090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65716760|NCT05368090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65716761|NCT05368090|Respiratory System Agents|respiratory system agents|mesh-ancestor
65716762|NCT05368090|Mydriatics|mydriatics|mesh-ancestor
65716763|NCT05368090|Sympathomimetics|sympathomimetics|mesh-ancestor
65716764|NCT05368090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65716765|NCT05382442|Leucovorin|leucovorin|mesh-list
65716766|NCT05382442|Bevacizumab|bevacizumab|mesh-list
65716767|NCT05382442|Fluorouracil|fluorouracil|mesh-list
65716768|NCT05382442|Capecitabine|capecitabine|mesh-list
65716769|NCT05382442|Oxaliplatin|oxaliplatin|mesh-list
65716770|NCT05382442|Irinotecan|irinotecan|mesh-list
65716771|NCT05382442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65716772|NCT05382442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65716773|NCT05382442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65716774|NCT05382442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65716775|NCT05382442|Growth Substances|growth substances|mesh-ancestor
65716776|NCT05382442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716777|NCT05382442|Growth Inhibitors|growth inhibitors|mesh-ancestor
65716778|NCT05382442|Antimetabolites|antimetabolites|mesh-ancestor
65716779|NCT05382442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716780|NCT05382442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65716781|NCT05382442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65716782|NCT05382442|Immunologic Factors|immunologic factors|mesh-ancestor
65716783|NCT05382442|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65716784|NCT05382442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65716785|NCT05382442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716786|NCT05382442|Antidotes|antidotes|mesh-ancestor
65716787|NCT05382442|Protective Agents|protective agents|mesh-ancestor
65716788|NCT05382442|Vitamin B Complex|vitamin b complex|mesh-ancestor
65716789|NCT05382442|Vitamins|vitamins|mesh-ancestor
65716790|NCT05382442|Micronutrients|micronutrients|mesh-ancestor
65716791|NCT05362474|Montelukast|montelukast|mesh-list
65716792|NCT05362474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65716793|NCT05362474|Respiratory System Agents|respiratory system agents|mesh-ancestor
65716794|NCT05362474|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65716795|NCT05362474|Hormone Antagonists|hormone antagonists|mesh-ancestor
65716796|NCT05362474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65716797|NCT05362474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716798|NCT05362474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65716799|NCT05362474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65716800|NCT05362474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716801|NCT05607316|Metformin|metformin|mesh-list
65716802|NCT05607316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65716803|NCT05607316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716804|NCT05599516|Vaccines|vaccines|mesh-list
65716805|NCT05599516|Immunologic Factors|immunologic factors|mesh-ancestor
65716806|NCT05599516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716807|NCT05380024|Ensartinib|ensartinib|mesh-list
65716808|NCT05380024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65716809|NCT05380024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65716810|NCT05380024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716811|NCT05380024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716812|NCT04251910|Dexmedetomidine|dexmedetomidine|mesh-list
65716813|NCT04251910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65716814|NCT04251910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65716815|NCT04251910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716816|NCT04251910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65716817|NCT04251910|Analgesics|analgesics|mesh-ancestor
65716818|NCT04251910|Sensory System Agents|sensory system agents|mesh-ancestor
65716819|NCT04251910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65716820|NCT04251910|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65716821|NCT04251910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65032690|NCT02229877|Omeprazole|omeprazole|mesh-list
65716822|NCT04251910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65716823|NCT04251910|Adrenergic Agents|adrenergic agents|mesh-ancestor
65716824|NCT04251910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65716825|NCT04251910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716826|NCT05342194|Gemcitabine|gemcitabine|mesh-list
65716827|NCT05342194|Oxaliplatin|oxaliplatin|mesh-list
65716828|NCT05342194|Lenvatinib|lenvatinib|mesh-list
65716829|NCT05342194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65716830|NCT05342194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65716831|NCT05342194|Antimetabolites|antimetabolites|mesh-ancestor
65716832|NCT05342194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716833|NCT05342194|Antiviral Agents|antiviral agents|mesh-ancestor
65716834|NCT05342194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65716835|NCT05342194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716836|NCT05342194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65716837|NCT05342194|Immunologic Factors|immunologic factors|mesh-ancestor
65716838|NCT05342194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716839|NCT05342194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65716840|NCT04247074|Botulinum Toxins|botulinum toxins|mesh-list
65716841|NCT04247074|Neurotransmitter Agents|neurotransmitter agents|mesh-list
65716842|NCT04247074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65716843|NCT04247074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65716844|NCT04247074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716845|NCT04247074|Cholinergic Agents|cholinergic agents|mesh-ancestor
65716846|NCT04247074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716847|NCT05306548|Triamcinolone|triamcinolone|mesh-list
65716848|NCT05306548|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65716849|NCT05306548|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65716850|NCT05306548|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65716851|NCT05306548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65716852|NCT05306548|Glucocorticoids|glucocorticoids|mesh-ancestor
65716853|NCT05306548|Hormones|hormones|mesh-ancestor
65716854|NCT05306548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65716855|NCT05306548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716856|NCT05306548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65716857|NCT05306548|Immunologic Factors|immunologic factors|mesh-ancestor
65716858|NCT05306548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716859|NCT05306548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716860|NCT05306470|Lidocaine|lidocaine|mesh-list
65716861|NCT05306470|Ethyl Chloride|ethyl chloride|mesh-list
65716862|NCT05306470|Anesthetics, Local|anesthetics, local|mesh-ancestor
65716863|NCT05306470|Anesthetics|anesthetics|mesh-ancestor
65716864|NCT05306470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65716865|NCT05306470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716866|NCT05306470|Sensory System Agents|sensory system agents|mesh-ancestor
65716867|NCT05306470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65716868|NCT05306470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65716869|NCT05306470|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65716870|NCT05306470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65716871|NCT05306470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65716872|NCT05306470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716873|NCT05340010|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65716874|NCT05340010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65716875|NCT05340010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716876|NCT05507476|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65716877|NCT05507476|Epinephrine|epinephrine|mesh-list
65716878|NCT05507476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65716879|NCT05507476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65716880|NCT05507476|Adrenergic Agents|adrenergic agents|mesh-ancestor
65716881|NCT05507476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65716882|NCT05507476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716883|NCT05507476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716884|NCT05507476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65716885|NCT05507476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65716886|NCT05507476|Autonomic Agents|autonomic agents|mesh-ancestor
65716887|NCT05507476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65716888|NCT05507476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65716889|NCT05507476|Respiratory System Agents|respiratory system agents|mesh-ancestor
65716890|NCT05507476|Mydriatics|mydriatics|mesh-ancestor
65716891|NCT05507476|Sympathomimetics|sympathomimetics|mesh-ancestor
65716892|NCT05507476|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65716893|NCT05507476|Hemostatics|hemostatics|mesh-ancestor
65716894|NCT05507476|Coagulants|coagulants|mesh-ancestor
65716895|NCT05507476|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65716896|NCT05507476|Natriuretic Agents|natriuretic agents|mesh-ancestor
65716898|NCT05339386|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65716899|NCT05339386|Anesthetics, General|anesthetics, general|mesh-ancestor
65716900|NCT05339386|Anesthetics|anesthetics|mesh-ancestor
65716901|NCT05339386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65716902|NCT05339386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716903|NCT05339074|Ketamine|ketamine|mesh-list
65716904|NCT05339074|Analgesics|analgesics|mesh-ancestor
65716905|NCT05339074|Sensory System Agents|sensory system agents|mesh-ancestor
65716906|NCT05339074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65716907|NCT05339074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716908|NCT05339074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65716909|NCT05339074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65716910|NCT05339074|Anesthetics, General|anesthetics, general|mesh-ancestor
65716911|NCT05339074|Anesthetics|anesthetics|mesh-ancestor
65716912|NCT05339074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65716913|NCT05339074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65716914|NCT05339074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65716915|NCT05339074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65716916|NCT05339074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716917|NCT05560282|Fenfluramine|fenfluramine|mesh-list
65716918|NCT05560282|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65716919|NCT05560282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65716920|NCT05560282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65716921|NCT05560282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716922|NCT05560282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65716923|NCT05560282|Serotonin Agents|serotonin agents|mesh-ancestor
65716924|NCT05560282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716925|NCT03530267|Aflibercept|aflibercept|mesh-list
65716926|NCT03530267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65716927|NCT03530267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65716928|NCT03530267|Growth Substances|growth substances|mesh-ancestor
65716929|NCT03530267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716930|NCT03530267|Growth Inhibitors|growth inhibitors|mesh-ancestor
65716931|NCT03530267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65716932|NCT05338450|Clemastine|clemastine|mesh-list
65716933|NCT05338450|Antipruritics|antipruritics|mesh-ancestor
65716934|NCT05338450|Dermatologic Agents|dermatologic agents|mesh-ancestor
65716935|NCT05338450|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65716936|NCT05338450|Histamine Antagonists|histamine antagonists|mesh-ancestor
65716937|NCT05338450|Histamine Agents|histamine agents|mesh-ancestor
65716938|NCT05338450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65716939|NCT05338450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716940|NCT05338450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716941|NCT05338450|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65716942|NCT05351944|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65716943|NCT05351944|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65716944|NCT05351944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65716945|NCT05351944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65716946|NCT05351944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716947|NCT05351944|Adrenergic Agents|adrenergic agents|mesh-ancestor
65716948|NCT05351944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65716949|NCT05351944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716950|NCT03677297|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65716951|NCT03677297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65716952|NCT03677297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65716953|NCT03677297|Antimetabolites|antimetabolites|mesh-ancestor
65716954|NCT03677297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269564|NCT05501600|Lidocaine|lidocaine|mesh-list
65716955|NCT03677297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65716956|NCT03677297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65716957|NCT03677297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716958|NCT03676985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65716959|NCT03676985|Antibodies|antibodies|mesh-list
65716960|NCT03676985|Immunoglobulins|immunoglobulins|mesh-list
65716961|NCT03676985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65716962|NCT03676985|Immunologic Factors|immunologic factors|mesh-ancestor
65716963|NCT03676985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716964|NCT03676985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65716965|NCT05348824|Sodium Hypochlorite|sodium hypochlorite|mesh-list
65716966|NCT05348824|Eusol|eusol|mesh-list
65716967|NCT05348824|Disinfectants|disinfectants|mesh-ancestor
65716968|NCT05348824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65716969|NCT02988401|Insulin|insulin|mesh-list
65716970|NCT02988401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65716971|NCT02988401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716972|NCT02960555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65716973|NCT02960555|Immunologic Factors|immunologic factors|mesh-ancestor
65716974|NCT02960555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716975|NCT05266924|Hormones|hormones|mesh-list
65716976|NCT05266924|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65716977|NCT05266924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65716978|NCT05266924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716979|NCT05266456|Vaccines|vaccines|mesh-list
65716980|NCT05266456|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65716981|NCT05266456|Immunologic Factors|immunologic factors|mesh-ancestor
65716982|NCT05266456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716983|NCT05486416|Propofol|propofol|mesh-list
65716984|NCT05486416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65716985|NCT05486416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65716986|NCT05486416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65716987|NCT05486416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65716988|NCT05486416|Anesthetics, General|anesthetics, general|mesh-ancestor
65716989|NCT05486416|Anesthetics|anesthetics|mesh-ancestor
65716990|NCT02269917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
65716991|NCT02269917|Protease Inhibitors|protease inhibitors|mesh-list
65716992|NCT02269917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65716993|NCT02269917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65716994|NCT02269917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65716995|NCT02269917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65716996|NCT02269917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65716997|NCT02269917|Antiviral Agents|antiviral agents|mesh-ancestor
65716998|NCT02269917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65716999|NCT05294146|Clofazimine|clofazimine|mesh-list
65717000|NCT05294146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65717001|NCT05294146|Leprostatic Agents|leprostatic agents|mesh-ancestor
65717002|NCT05294146|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65717003|NCT05294146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65717004|NCT05293288|Anesthetics|anesthetics|mesh-list
65717005|NCT05293288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65717006|NCT05293288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717007|NCT03484221|Fluorouracil|fluorouracil|mesh-list
65717008|NCT03484221|Capecitabine|capecitabine|mesh-list
65717009|NCT03484221|Oxaliplatin|oxaliplatin|mesh-list
65717010|NCT03484221|Irinotecan|irinotecan|mesh-list
65717011|NCT03484221|Antimetabolites|antimetabolites|mesh-ancestor
65717012|NCT03484221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717013|NCT03484221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65717014|NCT03484221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717015|NCT03484221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65717016|NCT03484221|Immunologic Factors|immunologic factors|mesh-ancestor
65717017|NCT03484221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717018|NCT03484221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65717019|NCT03484221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65717020|NCT03484221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717021|NCT03857139|Nicotine|nicotine|mesh-list
65717022|NCT03857139|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65717023|NCT03857139|Autonomic Agents|autonomic agents|mesh-ancestor
65717024|NCT03857139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717025|NCT03857139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717026|NCT03857139|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65717027|NCT03857139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65717028|NCT03857139|Cholinergic Agents|cholinergic agents|mesh-ancestor
65717029|NCT03857139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65717030|NCT03857139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717031|NCT01658020|Moxifloxacin|moxifloxacin|mesh-list
65717032|NCT01658020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65717033|NCT01658020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65717034|NCT01658020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65717035|NCT01658020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65717036|NCT01658020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717037|NCT01658020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717038|NCT01658020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717039|NCT05255770|Benzocaine|benzocaine|mesh-list
65717040|NCT05255770|Anesthetics, Local|anesthetics, local|mesh-ancestor
65717041|NCT05255770|Anesthetics|anesthetics|mesh-ancestor
65717042|NCT05255770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65717043|NCT05255770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717044|NCT05255770|Sensory System Agents|sensory system agents|mesh-ancestor
65717045|NCT05255770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717046|NCT05322538|Vitamin D|vitamin d|mesh-list
64474226|NCT02104414|Autonomic Agents|autonomic agents|mesh-ancestor
65717047|NCT05322538|Ergocalciferols|ergocalciferols|mesh-list
65717048|NCT05322538|Cholecalciferol|cholecalciferol|mesh-list
65717049|NCT05322538|Vitamins|vitamins|mesh-list
65717050|NCT05322538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65717051|NCT05322538|Micronutrients|micronutrients|mesh-ancestor
65717052|NCT05322538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717053|NCT05322538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65717054|NCT05322538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65717055|NCT04965220|Trametinib|trametinib|mesh-list
65717056|NCT04965220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717057|NCT04965220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65717058|NCT04965220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717059|NCT04965220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717060|NCT05322070|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
65717061|NCT05322070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65717062|NCT05322070|Glucocorticoids|glucocorticoids|mesh-ancestor
65717063|NCT05322070|Hormones|hormones|mesh-ancestor
65717064|NCT05322070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65717065|NCT05322070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717066|NCT03131037|Valacyclovir|valacyclovir|mesh-list
65717067|NCT03131037|Antiviral Agents|antiviral agents|mesh-ancestor
65717068|NCT03131037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65717069|NCT03483753|Vasopressins|vasopressins|mesh-list
65717070|NCT03483753|Arginine Vasopressin|arginine vasopressin|mesh-list
65717071|NCT03483753|Norepinephrine|norepinephrine|mesh-list
65717072|NCT03483753|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65717073|NCT03483753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65717074|NCT03483753|Adrenergic Agents|adrenergic agents|mesh-ancestor
65717075|NCT03483753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65717076|NCT03483753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717077|NCT03483753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717078|NCT03483753|Sympathomimetics|sympathomimetics|mesh-ancestor
65717079|NCT03483753|Autonomic Agents|autonomic agents|mesh-ancestor
65717080|NCT03483753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717081|NCT03483753|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65717082|NCT03483753|Hemostatics|hemostatics|mesh-ancestor
65717083|NCT03483753|Coagulants|coagulants|mesh-ancestor
65717084|NCT03483753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65717085|NCT03483753|Natriuretic Agents|natriuretic agents|mesh-ancestor
65717086|NCT03389477|Cisplatin|cisplatin|mesh-list
65717087|NCT03389477|Cetuximab|cetuximab|mesh-list
65717088|NCT03389477|Palbociclib|palbociclib|mesh-list
65717089|NCT03389477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717090|NCT03389477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65717091|NCT03389477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65717092|NCT03389477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717093|NCT03389477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717094|NCT02680574|Darbepoetin alfa|darbepoetin alfa|mesh-list
65717095|NCT02680574|Hematinics|hematinics|mesh-ancestor
65717096|NCT03672149|Cefazolin|cefazolin|mesh-list
65717097|NCT03672149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65717098|NCT03672149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65717099|NCT03672071|Ephedrine|ephedrine|mesh-list
65717100|NCT03672071|Pseudoephedrine|pseudoephedrine|mesh-list
65717101|NCT03672071|Norepinephrine|norepinephrine|mesh-list
65717102|NCT03672071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65717103|NCT03672071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717104|NCT03672071|Sympathomimetics|sympathomimetics|mesh-ancestor
65717105|NCT03672071|Autonomic Agents|autonomic agents|mesh-ancestor
65717106|NCT03672071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717107|NCT03672071|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65717108|NCT03672071|Adrenergic Agents|adrenergic agents|mesh-ancestor
65717109|NCT03672071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65717110|NCT03672071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717111|NCT03672071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65717112|NCT03672071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65717113|NCT03672071|Respiratory System Agents|respiratory system agents|mesh-ancestor
65717114|NCT03672071|Nasal Decongestants|nasal decongestants|mesh-ancestor
65717115|NCT03672071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65717116|NCT03672071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65717117|NCT03480945|Nitroprusside|nitroprusside|mesh-list
65717118|NCT03480945|Serotonin|serotonin|mesh-list
65717119|NCT03480945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65717120|NCT03480945|Serotonin Agents|serotonin agents|mesh-ancestor
65717121|NCT03480945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65717122|NCT03480945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717123|NCT03480945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518188|NCT02357290|Acetylcysteine|acetylcysteine|mesh-list
65717124|NCT03480945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65717125|NCT03480945|Vasodilator Agents|vasodilator agents|mesh-ancestor
65717126|NCT03480945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65717128|NCT03483207|Warfarin|warfarin|mesh-list
65717129|NCT03483207|Anticoagulants|anticoagulants|mesh-ancestor
65717130|NCT03483207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65717131|NCT03483207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65717132|NCT03483207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717133|NCT05132985|Carboplatin|carboplatin|mesh-list
65717134|NCT05132985|Pemetrexed|pemetrexed|mesh-list
65717135|NCT05132985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717136|NCT05132985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717137|NCT05132985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717138|NCT05132985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65717139|NCT05132985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65717140|NCT05118399|Bupivacaine|bupivacaine|mesh-list
65717141|NCT05118399|Anesthetics, Local|anesthetics, local|mesh-ancestor
65717142|NCT05118399|Anesthetics|anesthetics|mesh-ancestor
65717143|NCT05118399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65717144|NCT05118399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717145|NCT05118399|Sensory System Agents|sensory system agents|mesh-ancestor
65717146|NCT05118399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717147|NCT03739593|Dexamethasone|dexamethasone|mesh-list
65717148|NCT03739593|Dexamethasone acetate|dexamethasone acetate|mesh-list
65717149|NCT03739593|BB 1101|bb 1101|mesh-list
65717150|NCT03739593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65717151|NCT03739593|Antiemetics|antiemetics|mesh-ancestor
65717152|NCT03739593|Autonomic Agents|autonomic agents|mesh-ancestor
65717153|NCT03739593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717154|NCT03739593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717155|NCT03739593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65717156|NCT03739593|Glucocorticoids|glucocorticoids|mesh-ancestor
65717157|NCT03739593|Hormones|hormones|mesh-ancestor
65717158|NCT03739593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65717159|NCT03739593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65717160|NCT03739593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717161|NCT03739593|Protease Inhibitors|protease inhibitors|mesh-ancestor
65717162|NCT03739593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717163|NCT03739593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717164|NCT05053334|Omalizumab|omalizumab|mesh-list
65717165|NCT05053334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65717166|NCT05053334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65717167|NCT05053334|Respiratory System Agents|respiratory system agents|mesh-ancestor
65717168|NCT03480867|Temozolomide|temozolomide|mesh-list
65717169|NCT03480867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65717170|NCT03480867|Alkylating Agents|alkylating agents|mesh-ancestor
65717171|NCT03480867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717172|NCT03480867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717173|NCT05254912|Sunscreening Agents|sunscreening agents|mesh-list
65717174|NCT05254912|Petrolatum|petrolatum|mesh-list
65717175|NCT05254912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65717176|NCT05254912|Protective Agents|protective agents|mesh-ancestor
65717177|NCT05254912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717178|NCT05254912|Dermatologic Agents|dermatologic agents|mesh-ancestor
65717179|NCT05254912|Emollients|emollients|mesh-ancestor
65717180|NCT03480789|Dexmedetomidine|dexmedetomidine|mesh-list
65717181|NCT03480789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65717182|NCT03480789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65717183|NCT03480789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717184|NCT03480789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65717185|NCT03480789|Analgesics|analgesics|mesh-ancestor
65717186|NCT03480789|Sensory System Agents|sensory system agents|mesh-ancestor
65717187|NCT03480789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717188|NCT03480789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65717189|NCT03480789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65717190|NCT03480789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65717191|NCT03480789|Adrenergic Agents|adrenergic agents|mesh-ancestor
65717192|NCT03480789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65717193|NCT03480789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717194|NCT05251636|Aflibercept|aflibercept|mesh-list
65717195|NCT05251636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65717196|NCT05251636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65717197|NCT05251636|Growth Substances|growth substances|mesh-ancestor
65717198|NCT05251636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717199|NCT05251636|Growth Inhibitors|growth inhibitors|mesh-ancestor
65717200|NCT05251636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717201|NCT03475407|Dexamethasone|dexamethasone|mesh-list
65717202|NCT03475407|Dexamethasone acetate|dexamethasone acetate|mesh-list
65717203|NCT03475407|BB 1101|bb 1101|mesh-list
65717204|NCT03475407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65717205|NCT03475407|Antiemetics|antiemetics|mesh-ancestor
65717206|NCT03475407|Autonomic Agents|autonomic agents|mesh-ancestor
65717207|NCT03475407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717208|NCT03475407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717209|NCT03475407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65717210|NCT03475407|Glucocorticoids|glucocorticoids|mesh-ancestor
65717211|NCT03475407|Hormones|hormones|mesh-ancestor
65717212|NCT03475407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65717213|NCT03475407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65717214|NCT03475407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717215|NCT03475407|Protease Inhibitors|protease inhibitors|mesh-ancestor
65717216|NCT03475407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717217|NCT03475407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717218|NCT03655197|Doxycycline|doxycycline|mesh-list
65717219|NCT03655197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65717220|NCT03655197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65717221|NCT03655197|Antimalarials|antimalarials|mesh-ancestor
65717222|NCT03655197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65717223|NCT03655197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65717224|NCT05317624|Methylprednisolone|methylprednisolone|mesh-list
65717225|NCT05317624|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65717226|NCT05317624|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65717227|NCT05317624|Prednisolone|prednisolone|mesh-list
65717228|NCT05317624|Prednisolone acetate|prednisolone acetate|mesh-list
65717229|NCT05317624|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65717230|NCT05317624|Prednisolone phosphate|prednisolone phosphate|mesh-list
65717231|NCT05317624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65717232|NCT05317624|Antiemetics|antiemetics|mesh-ancestor
65717233|NCT05317624|Autonomic Agents|autonomic agents|mesh-ancestor
65717234|NCT05317624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717235|NCT05317624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717236|NCT05317624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65717237|NCT05317624|Glucocorticoids|glucocorticoids|mesh-ancestor
65717238|NCT05317624|Hormones|hormones|mesh-ancestor
65717239|NCT05317624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65717240|NCT05317624|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65717241|NCT05317624|Protective Agents|protective agents|mesh-ancestor
65717242|NCT05317624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65717243|NCT05317624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717244|NCT03475017|Curcumin|curcumin|mesh-list
65717245|NCT03475017|Piperine|piperine|mesh-list
65717246|NCT03475017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65717247|NCT03475017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65717248|NCT03475017|Analgesics|analgesics|mesh-ancestor
65717249|NCT03475017|Sensory System Agents|sensory system agents|mesh-ancestor
65717250|NCT03475017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717251|NCT03475017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717252|NCT03475017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65717253|NCT03475017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65717254|NCT03475017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717255|NCT03475017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717256|NCT03475017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717257|NCT03475017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65717258|NCT03474939|Midazolam|midazolam|mesh-list
65717259|NCT03474939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65717260|NCT03474939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65717261|NCT03474939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65717262|NCT03474939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717263|NCT03474939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65717264|NCT03474939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65717265|NCT03474939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65717266|NCT03474939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65717267|NCT03474939|Anesthetics, General|anesthetics, general|mesh-ancestor
65717268|NCT03474939|Anesthetics|anesthetics|mesh-ancestor
65717269|NCT03474939|GABA Modulators|gaba modulators|mesh-ancestor
65717270|NCT03474939|GABA Agents|gaba agents|mesh-ancestor
65717271|NCT03474939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65033127|NCT00202293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65717272|NCT03474939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717273|NCT03131583|Colchicine|colchicine|mesh-list
65717275|NCT03131583|Gout Suppressants|gout suppressants|mesh-ancestor
65717276|NCT03131583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65717277|NCT03131583|Tubulin Modulators|tubulin modulators|mesh-ancestor
65717278|NCT03131583|Antimitotic Agents|antimitotic agents|mesh-ancestor
65717279|NCT03131583|Mitosis Modulators|mitosis modulators|mesh-ancestor
65717280|NCT03131583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717281|NCT03131583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717282|NCT04672928|Paclitaxel|paclitaxel|mesh-list
65717283|NCT04672928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65717284|NCT04672928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717285|NCT04672928|Tubulin Modulators|tubulin modulators|mesh-ancestor
65717286|NCT04672928|Antimitotic Agents|antimitotic agents|mesh-ancestor
65717287|NCT04672928|Mitosis Modulators|mitosis modulators|mesh-ancestor
65717288|NCT04672928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717289|NCT03480321|Cilostazol|cilostazol|mesh-list
65717290|NCT03480321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65717291|NCT03480321|Autonomic Agents|autonomic agents|mesh-ancestor
65717292|NCT03480321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717293|NCT03480321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717294|NCT03480321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65717295|NCT03480321|Respiratory System Agents|respiratory system agents|mesh-ancestor
65717296|NCT03480321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65717297|NCT03480321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65717298|NCT03480321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717299|NCT03480321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65717300|NCT03480321|Vasodilator Agents|vasodilator agents|mesh-ancestor
65717301|NCT03480321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65717302|NCT03480321|Protective Agents|protective agents|mesh-ancestor
65717303|NCT03480321|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65717304|NCT03480321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65717305|NCT03480321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717306|NCT04928950|Charcoal|charcoal|mesh-list
65717307|NCT04928950|Antidotes|antidotes|mesh-ancestor
65717308|NCT04928950|Protective Agents|protective agents|mesh-ancestor
65717309|NCT04928950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717310|NCT03482115|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
65717311|NCT03482115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717312|NCT02986269|Anesthetics|anesthetics|mesh-list
65717313|NCT02986269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65717314|NCT02986269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717315|NCT05313256|Lidocaine|lidocaine|mesh-list
65717316|NCT05313256|Epinephrine|epinephrine|mesh-list
65717317|NCT05313256|Racepinephrine|racepinephrine|mesh-list
65717318|NCT05313256|Epinephryl borate|epinephryl borate|mesh-list
65717319|NCT05313256|Anesthetics, Local|anesthetics, local|mesh-ancestor
65717320|NCT05313256|Anesthetics|anesthetics|mesh-ancestor
65717321|NCT05313256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65717322|NCT05313256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717323|NCT05313256|Sensory System Agents|sensory system agents|mesh-ancestor
65717324|NCT05313256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717325|NCT05313256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65717326|NCT05313256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65717327|NCT05313256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65717328|NCT05313256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65717329|NCT05313256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717330|NCT05313256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65717331|NCT05313256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65717332|NCT05313256|Adrenergic Agents|adrenergic agents|mesh-ancestor
65717333|NCT05313256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65717334|NCT05313256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65717335|NCT05313256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65717336|NCT05313256|Autonomic Agents|autonomic agents|mesh-ancestor
65717337|NCT05313256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65717338|NCT05313256|Respiratory System Agents|respiratory system agents|mesh-ancestor
65717339|NCT05313256|Mydriatics|mydriatics|mesh-ancestor
65717340|NCT05313256|Sympathomimetics|sympathomimetics|mesh-ancestor
65717341|NCT05313256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65717342|NCT03474237|Hormones|hormones|mesh-list
65717343|NCT03474237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65717344|NCT03474237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717345|NCT05276830|Dexmedetomidine|dexmedetomidine|mesh-list
65717346|NCT05276830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65717347|NCT05276830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65033275|NCT02907307|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65717348|NCT05276830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717349|NCT05276830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65717350|NCT05276830|Analgesics|analgesics|mesh-ancestor
65717351|NCT05276830|Sensory System Agents|sensory system agents|mesh-ancestor
65717352|NCT05276830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717353|NCT05276830|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65717354|NCT05276830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65717355|NCT05276830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65717356|NCT05276830|Adrenergic Agents|adrenergic agents|mesh-ancestor
65717357|NCT05276830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65717358|NCT05276830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717359|NCT03480165|Parecoxib|parecoxib|mesh-list
65717360|NCT03480165|Ropivacaine|ropivacaine|mesh-list
65717361|NCT03480165|Anesthetics, Local|anesthetics, local|mesh-ancestor
65717362|NCT03480165|Anesthetics|anesthetics|mesh-ancestor
65717363|NCT03480165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65717364|NCT03480165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717365|NCT03480165|Sensory System Agents|sensory system agents|mesh-ancestor
65717366|NCT03480165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717367|NCT03480165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65717368|NCT03480165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65717369|NCT03480165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717370|NCT03480165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717371|NCT03480165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65717372|NCT03480165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65717373|NCT03480165|Analgesics|analgesics|mesh-ancestor
65717374|NCT03480165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65717375|NCT03480165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65717376|NCT05311852|Palmidrol|palmidrol|mesh-list
65717377|NCT05311852|Antioxidants|antioxidants|mesh-list
65717378|NCT05311852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717379|NCT05311852|Protective Agents|protective agents|mesh-ancestor
65717380|NCT05311852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717381|NCT05311852|Analgesics|analgesics|mesh-ancestor
65717382|NCT05311852|Sensory System Agents|sensory system agents|mesh-ancestor
65717383|NCT05311852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717384|NCT05311852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65717385|NCT05311852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65717386|NCT05311852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65717387|NCT05311852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65717388|NCT05311852|Antiviral Agents|antiviral agents|mesh-ancestor
65717389|NCT05311852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65717390|NCT05311852|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65717391|NCT05311852|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65717392|NCT05311852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65717393|NCT05311852|Hormones|hormones|mesh-ancestor
65717394|NCT05311852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65717395|NCT03948867|Hydroxyurea|hydroxyurea|mesh-list
65717396|NCT03948867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717397|NCT03948867|Antisickling Agents|antisickling agents|mesh-ancestor
65717398|NCT03948867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717399|NCT03948867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717400|NCT03948867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65717401|NCT01373918|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65717402|NCT01373918|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65717403|NCT01373918|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65717404|NCT01373918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65717405|NCT03671915|Insulin|insulin|mesh-list
65717406|NCT03671915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65717407|NCT03671915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717408|NCT03302195|Heparin|heparin|mesh-list
65717409|NCT03302195|Anticoagulants|anticoagulants|mesh-ancestor
65717410|NCT03302195|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65717411|NCT03302195|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65717412|NCT03302195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717413|NCT02515773|Metformin|metformin|mesh-list
65717414|NCT02515773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65717415|NCT02515773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717416|NCT05275426|Gemcitabine|gemcitabine|mesh-list
65717417|NCT05275426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65717418|NCT05275426|Antimetabolites|antimetabolites|mesh-ancestor
65717419|NCT05275426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717421|NCT05275426|Antiviral Agents|antiviral agents|mesh-ancestor
65717422|NCT05275426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65717423|NCT05275426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717424|NCT05275426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65717425|NCT05275426|Immunologic Factors|immunologic factors|mesh-ancestor
65717426|NCT05275426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717427|NCT03114020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65717428|NCT03114020|Hyaluronic Acid|hyaluronic acid|mesh-list
65717429|NCT03114020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65717430|NCT03114020|Immunologic Factors|immunologic factors|mesh-ancestor
65717431|NCT03114020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717432|NCT03114020|Viscosupplements|viscosupplements|mesh-ancestor
65717433|NCT03114020|Protective Agents|protective agents|mesh-ancestor
65717434|NCT04460079|Lenograstim|lenograstim|mesh-list
65717435|NCT04460079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65717436|NCT04460079|Immunologic Factors|immunologic factors|mesh-ancestor
65717437|NCT04460079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717438|NCT03473691|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
65717439|NCT03473691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65717440|NCT03473691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717441|NCT03676361|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65717442|NCT03676361|Hemostatics|hemostatics|mesh-ancestor
65717443|NCT03676361|Coagulants|coagulants|mesh-ancestor
65717444|NCT03676361|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65717445|NCT03676361|Natriuretic Agents|natriuretic agents|mesh-ancestor
65717446|NCT03676361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717447|NCT05219110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65717448|NCT01712763|Goserelin|goserelin|mesh-list
65717449|NCT01712763|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65717450|NCT01712763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65717451|NCT01712763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717452|NCT01712763|Luteolytic Agents|luteolytic agents|mesh-ancestor
65717453|NCT01712763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65717454|NCT01712763|Contraceptive Agents|contraceptive agents|mesh-ancestor
65717455|NCT01712763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65717456|NCT01712763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717457|NCT01712763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65717458|NCT02827877|Copper|copper|mesh-list
65717459|NCT02827877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65717460|NCT02827877|Trastuzumab|trastuzumab|mesh-list
65717461|NCT02827877|Pertuzumab|pertuzumab|mesh-list
65717462|NCT02827877|Antibodies|antibodies|mesh-list
65717463|NCT02827877|Immunoglobulins|immunoglobulins|mesh-list
65717464|NCT02827877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65717465|NCT02827877|Immunologic Factors|immunologic factors|mesh-ancestor
65717466|NCT02827877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717467|NCT02827877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717468|NCT02827877|Trace Elements|trace elements|mesh-ancestor
65717469|NCT02827877|Micronutrients|micronutrients|mesh-ancestor
65717470|NCT05218486|Isotretinoin|isotretinoin|mesh-list
65717471|NCT05218486|Dermatologic Agents|dermatologic agents|mesh-ancestor
65717472|NCT05216770|Bupivacaine|bupivacaine|mesh-list
65717473|NCT05216770|Anesthetics, Local|anesthetics, local|mesh-ancestor
65717474|NCT05216770|Anesthetics|anesthetics|mesh-ancestor
65717475|NCT05216770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65717476|NCT05216770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717477|NCT05216770|Sensory System Agents|sensory system agents|mesh-ancestor
65717478|NCT05216770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717479|NCT05236036|Mycophenolic Acid|mycophenolic acid|mesh-list
65717480|NCT05236036|Temozolomide|temozolomide|mesh-list
65717481|NCT05236036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65717482|NCT05236036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717483|NCT05236036|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65717484|NCT05236036|Antitubercular Agents|antitubercular agents|mesh-ancestor
65717485|NCT05236036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65717486|NCT05236036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65717487|NCT05236036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717488|NCT05236036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717489|NCT05236036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65717490|NCT05236036|Alkylating Agents|alkylating agents|mesh-ancestor
65717491|NCT02781779|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65717492|NCT02781779|Laxatives|laxatives|mesh-ancestor
65717493|NCT02781779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65717494|NCT05270200|Azacitidine|azacitidine|mesh-list
65717495|NCT05270200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65717496|NCT05270200|Antimetabolites|antimetabolites|mesh-ancestor
65717497|NCT05270200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717498|NCT05270200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717499|NCT05270200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717501|NCT04953104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65717502|NCT04953104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717503|NCT04953104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65717504|NCT04953104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717505|NCT03671057|Midazolam|midazolam|mesh-list
65717506|NCT03671057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65717507|NCT03671057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65717508|NCT03671057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65717509|NCT03671057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717510|NCT03671057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65717511|NCT03671057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65717512|NCT03671057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65717513|NCT03671057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65717514|NCT03671057|Anesthetics, General|anesthetics, general|mesh-ancestor
65717515|NCT03671057|Anesthetics|anesthetics|mesh-ancestor
65717516|NCT03671057|GABA Modulators|gaba modulators|mesh-ancestor
65717517|NCT03671057|GABA Agents|gaba agents|mesh-ancestor
65717518|NCT03671057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65717519|NCT03671057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717520|NCT03670901|Rituximab|rituximab|mesh-list
65717521|NCT03670901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65717522|NCT03670901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717523|NCT03670901|Immunologic Factors|immunologic factors|mesh-ancestor
65717524|NCT03670901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717525|NCT03670901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65717526|NCT05166616|Osimertinib|osimertinib|mesh-list
65717527|NCT05166616|Triptolide|triptolide|mesh-list
65717528|NCT05166616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717529|NCT05166616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65717530|NCT05166616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717531|NCT05166616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717532|NCT05166616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65717533|NCT05166616|Alkylating Agents|alkylating agents|mesh-ancestor
65717534|NCT05166616|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
65717535|NCT05166616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717536|NCT05166616|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65717537|NCT05166616|Contraceptive Agents|contraceptive agents|mesh-ancestor
65717538|NCT05166616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65717539|NCT05166616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65717540|NCT05166616|Immunologic Factors|immunologic factors|mesh-ancestor
65717541|NCT05213728|Vaccines|vaccines|mesh-list
65717542|NCT05213728|Immunologic Factors|immunologic factors|mesh-ancestor
65717543|NCT05213728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717544|NCT05165836|Dexmedetomidine|dexmedetomidine|mesh-list
65717545|NCT05165836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65717546|NCT05165836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65717547|NCT05165836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717548|NCT05165836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65717549|NCT05165836|Analgesics|analgesics|mesh-ancestor
65717550|NCT05165836|Sensory System Agents|sensory system agents|mesh-ancestor
65717551|NCT05165836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717552|NCT05165836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65717553|NCT05165836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65717554|NCT05165836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65717555|NCT05165836|Adrenergic Agents|adrenergic agents|mesh-ancestor
65717556|NCT05165836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65717557|NCT05165836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717558|NCT05213104|Flecainide|flecainide|mesh-list
65717559|NCT05213104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65717560|NCT05213104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65717561|NCT05213104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65717562|NCT05213104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65717563|NCT05213104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717564|NCT04238416|Lactulose|lactulose|mesh-list
65717565|NCT04238416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65717566|NCT05162014|Empagliflozin|empagliflozin|mesh-list
65717567|NCT05162014|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65717568|NCT05162014|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65717569|NCT05162014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717570|NCT05162014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717571|NCT05226754|Diacetylrhein|diacetylrhein|mesh-list
65717572|NCT05226754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65717573|NCT01657162|Alendronate|alendronate|mesh-list
65717574|NCT01657162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65717575|NCT01657162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717576|NCT05159752|Afamelanotide|afamelanotide|mesh-list
65717577|NCT05159752|Dermatologic Agents|dermatologic agents|mesh-ancestor
65717578|NCT05209906|Fentanyl|fentanyl|mesh-list
65717579|NCT05209906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65717580|NCT05209906|Narcotics|narcotics|mesh-ancestor
65717581|NCT05209906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65717582|NCT05209906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717583|NCT05209906|Analgesics|analgesics|mesh-ancestor
65717584|NCT05209906|Sensory System Agents|sensory system agents|mesh-ancestor
65717585|NCT05209906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717586|NCT05209906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65717587|NCT05209906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65717588|NCT05209906|Anesthetics, General|anesthetics, general|mesh-ancestor
65717589|NCT05209906|Anesthetics|anesthetics|mesh-ancestor
65717590|NCT04422184|Potassium Citrate|potassium citrate|mesh-list
65717591|NCT04422184|Diuretics|diuretics|mesh-ancestor
65717592|NCT04422184|Natriuretic Agents|natriuretic agents|mesh-ancestor
65717593|NCT04422184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717594|NCT04422184|Expectorants|expectorants|mesh-ancestor
65717595|NCT04422184|Respiratory System Agents|respiratory system agents|mesh-ancestor
65717596|NCT05633810|Aspirin|aspirin|mesh-list
65717597|NCT05633810|Colchicine|colchicine|mesh-list
65717598|NCT05633810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65717599|NCT05633810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65717600|NCT05633810|Analgesics|analgesics|mesh-ancestor
65717601|NCT05633810|Sensory System Agents|sensory system agents|mesh-ancestor
65717602|NCT05633810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717603|NCT05633810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717604|NCT05633810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65717605|NCT05633810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65717606|NCT05633810|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65717607|NCT05633810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65717608|NCT05633810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717609|NCT05633810|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65717610|NCT05633810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65717611|NCT05633810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717612|NCT05633810|Antipyretics|antipyretics|mesh-ancestor
65717613|NCT05633810|Gout Suppressants|gout suppressants|mesh-ancestor
65717614|NCT05633810|Tubulin Modulators|tubulin modulators|mesh-ancestor
65717615|NCT05633810|Antimitotic Agents|antimitotic agents|mesh-ancestor
65717616|NCT05633810|Mitosis Modulators|mitosis modulators|mesh-ancestor
65717617|NCT05633810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717618|NCT05205382|Nicotine|nicotine|mesh-list
65717619|NCT05205382|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65717620|NCT05205382|Autonomic Agents|autonomic agents|mesh-ancestor
65717621|NCT05205382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717622|NCT05205382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717623|NCT05205382|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65717624|NCT05205382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65717625|NCT05205382|Cholinergic Agents|cholinergic agents|mesh-ancestor
65717626|NCT05205382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65717627|NCT05205382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717628|NCT05152576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65717629|NCT05152576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65717630|NCT05152576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65717631|NCT05152576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717632|NCT05152576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717633|NCT05152576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65717634|NCT05152576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65717635|NCT05152576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717636|NCT05152576|Cholinergic Agents|cholinergic agents|mesh-ancestor
65717637|NCT05152576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65717638|NCT05203822|Itraconazole|itraconazole|mesh-list
65717639|NCT05203822|Tepotinib|tepotinib|mesh-list
65717640|NCT05203822|Antifungal Agents|antifungal agents|mesh-ancestor
65717641|NCT05203822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65717642|NCT05203822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65717643|NCT05203822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65717644|NCT05203822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717645|NCT05203822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717646|NCT05203822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65717647|NCT05203822|Hormone Antagonists|hormone antagonists|mesh-ancestor
65717648|NCT05203822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65717649|NCT05203822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717650|NCT05203822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65717651|NCT05203822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717652|NCT01373294|Lenalidomide|lenalidomide|mesh-list
65717653|NCT01373294|BCG Vaccine|bcg vaccine|mesh-list
65717654|NCT01373294|Immunologic Factors|immunologic factors|mesh-ancestor
65717655|NCT01373294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717656|NCT01373294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65717657|NCT01373294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65717658|NCT01373294|Growth Substances|growth substances|mesh-ancestor
65717659|NCT01373294|Growth Inhibitors|growth inhibitors|mesh-ancestor
65717660|NCT01373294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717661|NCT01373294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65717662|NCT05220358|Fostemsavir|fostemsavir|mesh-list
65717663|NCT05220358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65717664|NCT05220358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65717665|NCT05220358|Antiviral Agents|antiviral agents|mesh-ancestor
65717666|NCT05220358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65717667|NCT05220358|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65717668|NCT05220358|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65717669|NCT05220358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717670|NCT04422028|Desogestrel|desogestrel|mesh-list
65717671|NCT04422028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65717672|NCT04422028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65717673|NCT04422028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65717674|NCT04422028|Contraceptive Agents|contraceptive agents|mesh-ancestor
65717675|NCT04422028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65717676|NCT04422028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717677|NCT04422028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65717678|NCT04422028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65717679|NCT04422028|Progestins|progestins|mesh-ancestor
65717680|NCT04422028|Hormones|hormones|mesh-ancestor
65717681|NCT04422028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65717682|NCT01656304|Bevacizumab|bevacizumab|mesh-list
65717683|NCT01656304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65717684|NCT01656304|Antibodies|antibodies|mesh-list
65717685|NCT01656304|Immunoglobulins|immunoglobulins|mesh-list
65717686|NCT01656304|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65717687|NCT01656304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717688|NCT01656304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65717689|NCT01656304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65717690|NCT01656304|Growth Substances|growth substances|mesh-ancestor
65717691|NCT01656304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717692|NCT01656304|Growth Inhibitors|growth inhibitors|mesh-ancestor
65717693|NCT01656304|Immunologic Factors|immunologic factors|mesh-ancestor
65717694|NCT05105542|Cholinergic Agents|cholinergic agents|mesh-list
65717695|NCT05105542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65717696|NCT05105542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717697|NCT05105542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717698|NCT04421872|Anesthetics|anesthetics|mesh-list
65717699|NCT04421872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65717700|NCT04421872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717701|NCT05098366|Furosemide|furosemide|mesh-list
65717702|NCT05098366|Diuretics|diuretics|mesh-ancestor
65717703|NCT05098366|Natriuretic Agents|natriuretic agents|mesh-ancestor
65717704|NCT05098366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717705|NCT05098366|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65717706|NCT05098366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65717707|NCT05098366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717708|NCT04227028|Bevacizumab|bevacizumab|mesh-list
65717709|NCT04227028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65717710|NCT04227028|Endothelial Growth Factors|endothelial growth factors|mesh-list
65717711|NCT04227028|Antibodies|antibodies|mesh-list
65717712|NCT04227028|Immunoglobulins|immunoglobulins|mesh-list
65717713|NCT04227028|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65717714|NCT04227028|Immunoglobulin G|immunoglobulin g|mesh-list
65717715|NCT04227028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717716|NCT04227028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65717717|NCT04227028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65717718|NCT04227028|Growth Substances|growth substances|mesh-ancestor
65717719|NCT04227028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717720|NCT04227028|Growth Inhibitors|growth inhibitors|mesh-ancestor
65717721|NCT04227028|Immunologic Factors|immunologic factors|mesh-ancestor
65717723|NCT03023423|Daratumumab|daratumumab|mesh-list
65717724|NCT03023423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717725|NCT03675191|Orlistat|orlistat|mesh-list
65717726|NCT03675191|Phentermine|phentermine|mesh-list
65717727|NCT03675191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717728|NCT03675191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717729|NCT03675191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65717730|NCT03675191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65717731|NCT03675191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65717732|NCT03675191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717733|NCT03675191|Appetite Depressants|appetite depressants|mesh-ancestor
65717734|NCT03675191|Sympathomimetics|sympathomimetics|mesh-ancestor
65717735|NCT03675191|Autonomic Agents|autonomic agents|mesh-ancestor
65717736|NCT03675191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717737|NCT03675191|Adrenergic Agents|adrenergic agents|mesh-ancestor
65717738|NCT03675191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65717739|NCT03198689|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65717740|NCT03198689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65717741|NCT03198689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717742|NCT02635061|Nivolumab|nivolumab|mesh-list
65717743|NCT02635061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65717744|NCT02635061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717745|NCT02635061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65717746|NCT02635061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717747|NCT05096728|Nifedipine|nifedipine|mesh-list
65717748|NCT05096728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65717749|NCT05096728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65717750|NCT05096728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717751|NCT05096728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65717752|NCT05096728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717753|NCT05096728|Vasodilator Agents|vasodilator agents|mesh-ancestor
65717754|NCT05096728|Tocolytic Agents|tocolytic agents|mesh-ancestor
65717755|NCT05096728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65717756|NCT03190265|Cyclophosphamide|cyclophosphamide|mesh-list
65717757|NCT03190265|Nivolumab|nivolumab|mesh-list
65717758|NCT03190265|Ipilimumab|ipilimumab|mesh-list
65717759|NCT03190265|Pancrelipase|pancrelipase|mesh-list
65717760|NCT03190265|Vaccines|vaccines|mesh-list
65717761|NCT03190265|Immunologic Factors|immunologic factors|mesh-ancestor
65717762|NCT03190265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717763|NCT03190265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65717764|NCT03190265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65717765|NCT03190265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65717766|NCT03190265|Alkylating Agents|alkylating agents|mesh-ancestor
65717767|NCT03190265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717768|NCT03190265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717769|NCT03190265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65717770|NCT03190265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65717771|NCT03190265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65717772|NCT03190265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65717773|NCT04421716|Ursolic acid|ursolic acid|mesh-list
65717774|NCT04421716|Curcumin|curcumin|mesh-list
65717775|NCT04421716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65717776|NCT04421716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65717777|NCT04421716|Analgesics|analgesics|mesh-ancestor
65717778|NCT04421716|Sensory System Agents|sensory system agents|mesh-ancestor
65717779|NCT04421716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717780|NCT04421716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717781|NCT04421716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65717782|NCT04421716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65717783|NCT04421716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717784|NCT04421716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717785|NCT04421716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717786|NCT04421716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65717787|NCT04421716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65717788|NCT04421716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65717789|NCT05184868|Insulin Aspart|insulin aspart|mesh-list
65717790|NCT05184868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65717791|NCT05184868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717792|NCT04226950|Interferons|interferons|mesh-list
65717793|NCT04226950|Interferon-alpha|interferon-alpha|mesh-list
65033655|NCT00410631|Cyclophosphamide|cyclophosphamide|mesh-list
65717794|NCT04226950|Interferon alpha-2|interferon alpha-2|mesh-list
65717795|NCT04226950|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65717796|NCT04226950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717797|NCT04226950|Antiviral Agents|antiviral agents|mesh-ancestor
65717798|NCT04226950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65717799|NCT04226950|Immunologic Factors|immunologic factors|mesh-ancestor
65717800|NCT04226950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717801|NCT05085574|Celecoxib|celecoxib|mesh-list
65717802|NCT05085574|Famotidine|famotidine|mesh-list
65717803|NCT05085574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65717804|NCT05085574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65717805|NCT05085574|Analgesics|analgesics|mesh-ancestor
65717806|NCT05085574|Sensory System Agents|sensory system agents|mesh-ancestor
65717807|NCT05085574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717808|NCT05085574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717809|NCT05085574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65717810|NCT05085574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65717811|NCT05085574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65717812|NCT05085574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65717813|NCT05085574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717814|NCT05085574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717815|NCT05085574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65717816|NCT05085574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65717817|NCT05085574|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65717818|NCT05085574|Histamine Antagonists|histamine antagonists|mesh-ancestor
65717819|NCT05085574|Histamine Agents|histamine agents|mesh-ancestor
65717820|NCT05085574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65717821|NCT05085496|Atezolizumab|atezolizumab|mesh-list
65717822|NCT05085496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65717823|NCT05085496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717824|NCT05085496|Immunologic Factors|immunologic factors|mesh-ancestor
65717825|NCT05085496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717826|NCT05085340|Pyrimethamine|pyrimethamine|mesh-list
65717827|NCT05085340|Sulfadoxine|sulfadoxine|mesh-list
65717828|NCT05085340|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65717829|NCT05085340|Antimalarials|antimalarials|mesh-ancestor
65717830|NCT05085340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65717831|NCT05085340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65717832|NCT05085340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65717833|NCT05085340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65717834|NCT05085340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717835|NCT05085340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717836|NCT05085340|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65717837|NCT05085340|Renal Agents|renal agents|mesh-ancestor
65717838|NCT02667236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65717839|NCT01126749|Gemcitabine|gemcitabine|mesh-list
65717840|NCT01126749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717841|NCT01126749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65717842|NCT01126749|Antimetabolites|antimetabolites|mesh-ancestor
65717843|NCT01126749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717844|NCT01126749|Antiviral Agents|antiviral agents|mesh-ancestor
65717845|NCT01126749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65717846|NCT01126749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717847|NCT01126749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65717848|NCT01126749|Immunologic Factors|immunologic factors|mesh-ancestor
65717849|NCT01126749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717850|NCT03674411|Mycophenolic Acid|mycophenolic acid|mesh-list
65717851|NCT03674411|Cyclophosphamide|cyclophosphamide|mesh-list
65717852|NCT03674411|Melphalan|melphalan|mesh-list
65717853|NCT03674411|Busulfan|busulfan|mesh-list
65717854|NCT03674411|Fludarabine|fludarabine|mesh-list
65717855|NCT03674411|Tacrolimus|tacrolimus|mesh-list
65717856|NCT03674411|Lenograstim|lenograstim|mesh-list
65717857|NCT03674411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65717858|NCT03674411|Immunologic Factors|immunologic factors|mesh-ancestor
65717859|NCT03674411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717860|NCT03674411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65717861|NCT03674411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65717862|NCT03674411|Alkylating Agents|alkylating agents|mesh-ancestor
65717863|NCT03674411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717864|NCT03674411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717865|NCT03674411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65717866|NCT03674411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65717867|NCT03674411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717868|NCT03674411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65033737|NCT00410748|Hydromorphone|hydromorphone|mesh-list
65717869|NCT03674411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65717870|NCT03674411|Antitubercular Agents|antitubercular agents|mesh-ancestor
65717871|NCT03674411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65717872|NCT03674411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65717873|NCT03674411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65717875|NCT03674333|Hematinics|hematinics|mesh-ancestor
65717876|NCT03674333|Vitamin B Complex|vitamin b complex|mesh-ancestor
65717877|NCT03674333|Vitamins|vitamins|mesh-ancestor
65717878|NCT03674333|Micronutrients|micronutrients|mesh-ancestor
65717879|NCT03674333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717880|NCT03674099|Methylprednisolone|methylprednisolone|mesh-list
65717881|NCT03674099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65717882|NCT03674099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65717883|NCT03674099|Prednisolone|prednisolone|mesh-list
65717884|NCT03674099|Prednisolone acetate|prednisolone acetate|mesh-list
65717885|NCT03674099|Imatinib Mesylate|imatinib mesylate|mesh-list
65717886|NCT03674099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65717887|NCT03674099|Prednisolone phosphate|prednisolone phosphate|mesh-list
65717888|NCT03674099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65717889|NCT03674099|Antiemetics|antiemetics|mesh-ancestor
65717890|NCT03674099|Autonomic Agents|autonomic agents|mesh-ancestor
65717891|NCT03674099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717892|NCT03674099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717893|NCT03674099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65717894|NCT03674099|Glucocorticoids|glucocorticoids|mesh-ancestor
65717895|NCT03674099|Hormones|hormones|mesh-ancestor
65717896|NCT03674099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65717897|NCT03674099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65717898|NCT03674099|Protective Agents|protective agents|mesh-ancestor
65717899|NCT03674099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65717900|NCT03674099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717901|NCT03674099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65717902|NCT03674099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717903|NCT03674099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717904|NCT05124340|Vaccines|vaccines|mesh-list
65717905|NCT05124340|Immunologic Factors|immunologic factors|mesh-ancestor
65717906|NCT05124340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717907|NCT05085028|Pembrolizumab|pembrolizumab|mesh-list
65717908|NCT05085028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65717909|NCT05085028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717910|NCT05084404|Guanabenz|guanabenz|mesh-list
65717911|NCT05084404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65717912|NCT05084404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65717913|NCT05084404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65717914|NCT05084404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65717915|NCT05084404|Adrenergic Agents|adrenergic agents|mesh-ancestor
65717916|NCT05084404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65717917|NCT05084404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717918|NCT05084404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717919|NCT03473613|Calcium, Dietary|calcium, dietary|mesh-list
65717920|NCT03473613|Cabergoline|cabergoline|mesh-list
65717921|NCT03473613|Calcium|calcium|mesh-list
65717922|NCT03473613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65717923|NCT03473613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717924|NCT03473613|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65717925|NCT03473613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65717926|NCT03473613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65717927|NCT03473613|Dopamine Agonists|dopamine agonists|mesh-ancestor
65717928|NCT03473613|Dopamine Agents|dopamine agents|mesh-ancestor
65717929|NCT03473613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65717930|NCT03473613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717931|NCT03670043|Metformin|metformin|mesh-list
65717932|NCT03670043|Psyllium|psyllium|mesh-list
65717933|NCT03670043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65717934|NCT03670043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717935|NCT03670043|Cathartics|cathartics|mesh-ancestor
65717936|NCT03670043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65717937|NCT01701986|Gemcitabine|gemcitabine|mesh-list
65717938|NCT01701986|Mycophenolic Acid|mycophenolic acid|mesh-list
65717939|NCT01701986|Rituximab|rituximab|mesh-list
65717940|NCT01701986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65717941|NCT01701986|Busulfan|busulfan|mesh-list
65717942|NCT01701986|Clofarabine|clofarabine|mesh-list
65717943|NCT01701986|Antibodies|antibodies|mesh-list
65717944|NCT01701986|Immunoglobulins|immunoglobulins|mesh-list
65717945|NCT01701986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65717946|NCT01701986|Tacrolimus|tacrolimus|mesh-list
65717947|NCT01701986|Thymoglobulin|thymoglobulin|mesh-list
65717948|NCT01701986|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65717949|NCT01701986|Immunologic Factors|immunologic factors|mesh-ancestor
65717950|NCT01701986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717951|NCT01701986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717952|NCT01701986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65717953|NCT01701986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65717954|NCT01701986|Antimetabolites|antimetabolites|mesh-ancestor
65717955|NCT01701986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717956|NCT01701986|Antiviral Agents|antiviral agents|mesh-ancestor
65717957|NCT01701986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65717958|NCT01701986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717959|NCT01701986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65717960|NCT01701986|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65717961|NCT01701986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65717962|NCT01701986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65717963|NCT01701986|Antitubercular Agents|antitubercular agents|mesh-ancestor
65717964|NCT01701986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65717965|NCT01701986|Alkylating Agents|alkylating agents|mesh-ancestor
65717966|NCT01701986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65717967|NCT01701986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65717968|NCT05561660|Aspirin|aspirin|mesh-list
65717969|NCT05561660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65717970|NCT05561660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65717971|NCT05561660|Analgesics|analgesics|mesh-ancestor
65717972|NCT05561660|Sensory System Agents|sensory system agents|mesh-ancestor
65717973|NCT05561660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717974|NCT05561660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717975|NCT05561660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65717976|NCT05561660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65717977|NCT05561660|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65717978|NCT05561660|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65717979|NCT05561660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717980|NCT05561660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65717981|NCT05561660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65717982|NCT05561660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717983|NCT05561660|Antipyretics|antipyretics|mesh-ancestor
65717984|NCT03042819|Doxorubicin|doxorubicin|mesh-list
65717985|NCT03042819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65717986|NCT03042819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65717987|NCT03042819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65717988|NCT03042819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65717989|NCT03042819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65717990|NCT03042819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65717991|NCT02832687|Acetaminophen|acetaminophen|mesh-list
65717992|NCT02832687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65717993|NCT02832687|Analgesics|analgesics|mesh-ancestor
65717994|NCT02832687|Sensory System Agents|sensory system agents|mesh-ancestor
65717995|NCT02832687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65717996|NCT02832687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65717997|NCT02832687|Antipyretics|antipyretics|mesh-ancestor
65717998|NCT04372017|Vitamin D|vitamin d|mesh-list
65717999|NCT04372017|Hydroxychloroquine|hydroxychloroquine|mesh-list
65718000|NCT04372017|Vitamins|vitamins|mesh-ancestor
65718001|NCT04372017|Micronutrients|micronutrients|mesh-ancestor
65718002|NCT04372017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718003|NCT04372017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65718004|NCT04372017|Antimalarials|antimalarials|mesh-ancestor
65718005|NCT04372017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65718006|NCT04372017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65718007|NCT04372017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65718008|NCT04372017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718009|NCT04372017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718010|NCT04372017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65718011|NCT05233358|Pembrolizumab|pembrolizumab|mesh-list
65718012|NCT05233358|Nivolumab|nivolumab|mesh-list
65718013|NCT05233358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65718014|NCT05233358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65718015|NCT05233358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718016|NCT05233358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718017|NCT02387918|Dexamethasone|dexamethasone|mesh-list
65718018|NCT02387918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65718019|NCT02387918|Antiemetics|antiemetics|mesh-ancestor
65718020|NCT02387918|Autonomic Agents|autonomic agents|mesh-ancestor
65718021|NCT02387918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718022|NCT02387918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718023|NCT02387918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65718024|NCT02387918|Glucocorticoids|glucocorticoids|mesh-ancestor
65718025|NCT02387918|Hormones|hormones|mesh-ancestor
65718026|NCT02387918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65718027|NCT02387918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65718028|NCT02387918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718029|NCT04312971|Norepinephrine|norepinephrine|mesh-list
65718030|NCT04312971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65718031|NCT04312971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65718032|NCT04312971|Adrenergic Agents|adrenergic agents|mesh-ancestor
65718033|NCT04312971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65718034|NCT04312971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718035|NCT04312971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718036|NCT04312971|Sympathomimetics|sympathomimetics|mesh-ancestor
65718037|NCT04312971|Autonomic Agents|autonomic agents|mesh-ancestor
65718038|NCT04312971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718039|NCT04312971|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65718040|NCT05231330|Fluorides|fluorides|mesh-list
65718041|NCT05231330|Cariostatic Agents|cariostatic agents|mesh-ancestor
65718042|NCT05231330|Protective Agents|protective agents|mesh-ancestor
65718043|NCT05231330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718044|NCT03179475|Oxycodone|oxycodone|mesh-list
65718045|NCT03179475|Naloxone|naloxone|mesh-list
65718046|NCT03179475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65718047|NCT03179475|Narcotics|narcotics|mesh-ancestor
65718048|NCT03179475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65718049|NCT03179475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718050|NCT03179475|Analgesics|analgesics|mesh-ancestor
65718051|NCT03179475|Sensory System Agents|sensory system agents|mesh-ancestor
65718052|NCT03179475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718053|NCT03179475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65718054|NCT03105986|Probenecid|probenecid|mesh-list
65718055|NCT03105986|Uricosuric Agents|uricosuric agents|mesh-ancestor
65718056|NCT03105986|Gout Suppressants|gout suppressants|mesh-ancestor
65718057|NCT03105986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65718058|NCT03105986|Renal Agents|renal agents|mesh-ancestor
65718059|NCT03132129|Manganese|manganese|mesh-list
65718060|NCT03132129|Calcium|calcium|mesh-list
65718061|NCT03132129|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65718062|NCT03132129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718063|NCT03132129|Trace Elements|trace elements|mesh-ancestor
65718064|NCT03132129|Micronutrients|micronutrients|mesh-ancestor
65718065|NCT02391662|Gemcitabine|gemcitabine|mesh-list
65718066|NCT02391662|Paclitaxel|paclitaxel|mesh-list
65718067|NCT02391662|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65718068|NCT02391662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65718069|NCT02391662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718070|NCT02391662|Tubulin Modulators|tubulin modulators|mesh-ancestor
65718071|NCT02391662|Antimitotic Agents|antimitotic agents|mesh-ancestor
65718072|NCT02391662|Mitosis Modulators|mitosis modulators|mesh-ancestor
65718073|NCT02391662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718074|NCT02391662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65718075|NCT02391662|Antimetabolites|antimetabolites|mesh-ancestor
65718076|NCT02391662|Antiviral Agents|antiviral agents|mesh-ancestor
65718077|NCT02391662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65718078|NCT02391662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718079|NCT02391662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65718080|NCT02391662|Immunologic Factors|immunologic factors|mesh-ancestor
65718081|NCT02391662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718082|NCT05076604|Cardioplegic Solutions|cardioplegic solutions|mesh-list
65718083|NCT05076604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65718084|NCT05258955|Chlorhexidine|chlorhexidine|mesh-list
65718085|NCT05258955|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65718086|NCT05258955|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65718087|NCT05258955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65718088|NCT05258955|Disinfectants|disinfectants|mesh-ancestor
65718089|NCT05258955|Dermatologic Agents|dermatologic agents|mesh-ancestor
65718090|NCT05173324|Vaccines|vaccines|mesh-list
65718091|NCT05173324|Immunologic Factors|immunologic factors|mesh-ancestor
65718092|NCT05173324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718093|NCT04029038|Cyclophosphamide|cyclophosphamide|mesh-list
65718094|NCT04029038|Fludarabine|fludarabine|mesh-list
65718095|NCT04029038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65718096|NCT04029038|Immunologic Factors|immunologic factors|mesh-ancestor
65718097|NCT04029038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718098|NCT04029038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65718099|NCT04029038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65718100|NCT04029038|Alkylating Agents|alkylating agents|mesh-ancestor
65718101|NCT04029038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718102|NCT04029038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718103|NCT04029038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65718104|NCT04223518|Immunoglobulins|immunoglobulins|mesh-list
65718105|NCT04223518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65718106|NCT04223518|Antibodies|antibodies|mesh-list
65718107|NCT04223518|Immunologic Factors|immunologic factors|mesh-ancestor
65718108|NCT04223518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718109|NCT02387450|Sildenafil Citrate|sildenafil citrate|mesh-list
65718110|NCT02387450|Vasodilator Agents|vasodilator agents|mesh-ancestor
65718111|NCT02387450|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65718112|NCT02387450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65718113|NCT02387450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718114|NCT02387450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718115|NCT02387450|Urological Agents|urological agents|mesh-ancestor
65718116|NCT02390882|Tamsulosin|tamsulosin|mesh-list
65718117|NCT02390882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65718118|NCT02390882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65718119|NCT02390882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65718120|NCT02390882|Adrenergic Agents|adrenergic agents|mesh-ancestor
65718121|NCT02390882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65718122|NCT02390882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718123|NCT02390882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718124|NCT02390882|Urological Agents|urological agents|mesh-ancestor
65718125|NCT05258799|Cytarabine|cytarabine|mesh-list
65718126|NCT05258799|Decitabine|decitabine|mesh-list
65718127|NCT05258799|Aclarubicin|aclarubicin|mesh-list
65718128|NCT05258799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65718129|NCT05258799|Antimetabolites|antimetabolites|mesh-ancestor
65718130|NCT05258799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718131|NCT05258799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718132|NCT05258799|Antiviral Agents|antiviral agents|mesh-ancestor
65718133|NCT05258799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65718134|NCT05258799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65718135|NCT05258799|Immunologic Factors|immunologic factors|mesh-ancestor
65718136|NCT05258799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718137|NCT05258799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718138|NCT05258799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65718139|NCT05258799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65718140|NCT05258799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65718141|NCT02387138|Oxaliplatin|oxaliplatin|mesh-list
65718142|NCT02387138|Irinotecan|irinotecan|mesh-list
65718143|NCT02387138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718144|NCT02387138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65718145|NCT02387138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65718146|NCT02387138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718147|NCT02387138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718148|NCT02387060|Fentanyl|fentanyl|mesh-list
65718149|NCT02387060|Bupivacaine|bupivacaine|mesh-list
65718150|NCT02387060|Anesthetics, Local|anesthetics, local|mesh-ancestor
65718151|NCT02387060|Anesthetics|anesthetics|mesh-ancestor
65718152|NCT02387060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65718153|NCT02387060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718154|NCT02387060|Sensory System Agents|sensory system agents|mesh-ancestor
65718155|NCT02387060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718156|NCT02387060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65718157|NCT02387060|Narcotics|narcotics|mesh-ancestor
65718158|NCT02387060|Analgesics|analgesics|mesh-ancestor
65718159|NCT02387060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65718160|NCT02387060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65718161|NCT02387060|Anesthetics, General|anesthetics, general|mesh-ancestor
65718162|NCT01365052|Naproxen|naproxen|mesh-list
65718163|NCT01365052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65718164|NCT01365052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65718165|NCT01365052|Analgesics|analgesics|mesh-ancestor
65718166|NCT01365052|Sensory System Agents|sensory system agents|mesh-ancestor
65718167|NCT01365052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718168|NCT01365052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718169|NCT01365052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65718170|NCT01365052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65718171|NCT01365052|Gout Suppressants|gout suppressants|mesh-ancestor
65718172|NCT01365052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65718173|NCT01365052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718174|NCT01365052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718175|NCT05155215|Cyclophosphamide|cyclophosphamide|mesh-list
65718176|NCT05155215|Fludarabine|fludarabine|mesh-list
65718177|NCT05155215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65718178|NCT05155215|Immunologic Factors|immunologic factors|mesh-ancestor
65718179|NCT05155215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718180|NCT05155215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65718181|NCT05155215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65718182|NCT05155215|Alkylating Agents|alkylating agents|mesh-ancestor
65718183|NCT05155215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718184|NCT05155215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718185|NCT05155215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65718186|NCT03471585|Dronabinol|dronabinol|mesh-list
65718187|NCT03471585|Hallucinogens|hallucinogens|mesh-ancestor
65718188|NCT03471585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718189|NCT03471585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65718190|NCT03471585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65718191|NCT03471585|Analgesics|analgesics|mesh-ancestor
65718192|NCT03471585|Sensory System Agents|sensory system agents|mesh-ancestor
65718193|NCT03471585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718194|NCT03471585|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65718195|NCT03471585|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65718196|NCT03471585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65718197|NCT03471585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718198|NCT03471585|Hormones|hormones|mesh-ancestor
65718199|NCT03471585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65718200|NCT05072782|Methotrexate|methotrexate|mesh-list
65718201|NCT05072782|Infliximab|infliximab|mesh-list
65718202|NCT05072782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65718203|NCT05072782|Abortifacient Agents|abortifacient agents|mesh-ancestor
65718204|NCT05072782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65718205|NCT05072782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718206|NCT05072782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65718207|NCT05072782|Antimetabolites|antimetabolites|mesh-ancestor
65718208|NCT05072782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718209|NCT05072782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718210|NCT05072782|Dermatologic Agents|dermatologic agents|mesh-ancestor
65718211|NCT05072782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718212|NCT05072782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65718213|NCT05072782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65718214|NCT05072782|Immunologic Factors|immunologic factors|mesh-ancestor
65718215|NCT05072782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65718216|NCT05072782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65718217|NCT05072782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65718218|NCT03379389|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65718219|NCT03379389|Methenamine hippurate|methenamine hippurate|mesh-list
65718220|NCT03379389|Methenamine mandelate|methenamine mandelate|mesh-list
65718221|NCT03379389|Methenamine|methenamine|mesh-list
65718222|NCT03379389|Acriflavine|acriflavine|mesh-list
65718223|NCT03379389|Methylene Blue|methylene blue|mesh-list
65718224|NCT03379389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65718225|NCT03379389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718226|NCT03379389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718227|NCT03379389|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65718228|NCT03379389|Renal Agents|renal agents|mesh-ancestor
65718229|NCT03379389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65718230|NCT05170438|Paclitaxel|paclitaxel|mesh-list
65718231|NCT05170438|Lenvatinib|lenvatinib|mesh-list
65718232|NCT05170438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65718233|NCT05170438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718234|NCT05170438|Tubulin Modulators|tubulin modulators|mesh-ancestor
65718235|NCT05170438|Antimitotic Agents|antimitotic agents|mesh-ancestor
65718236|NCT05170438|Mitosis Modulators|mitosis modulators|mesh-ancestor
65718237|NCT05170438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718238|NCT05170438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65718239|NCT05170438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718240|NCT05109520|Insulin Glargine|insulin glargine|mesh-list
65718241|NCT05109520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65718242|NCT05109520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718243|NCT03478605|Dexamethasone|dexamethasone|mesh-list
65718244|NCT03478605|Ondansetron|ondansetron|mesh-list
65718245|NCT03478605|Olanzapine|olanzapine|mesh-list
65718246|NCT03478605|Aprepitant|aprepitant|mesh-list
65718247|NCT03478605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65718248|NCT03478605|Antiemetics|antiemetics|mesh-ancestor
65718249|NCT03478605|Autonomic Agents|autonomic agents|mesh-ancestor
65718250|NCT03478605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718251|NCT03478605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034123|NCT00203814|Artesunate|artesunate|mesh-list
65718252|NCT03478605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65718253|NCT03478605|Glucocorticoids|glucocorticoids|mesh-ancestor
65718255|NCT03478605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65718256|NCT03478605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65718257|NCT03478605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718258|NCT03478605|Antipruritics|antipruritics|mesh-ancestor
65718259|NCT03478605|Dermatologic Agents|dermatologic agents|mesh-ancestor
65718260|NCT03478605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65718261|NCT03478605|Serotonin Agents|serotonin agents|mesh-ancestor
65718262|NCT03478605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65718263|NCT03478605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718264|NCT03478605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65718265|NCT03478605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65718266|NCT03478605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65718267|NCT03478605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65718268|NCT03478605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65718269|NCT03478605|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65718270|NCT03478605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65718271|NCT03478605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65718272|NCT03478605|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65718273|NCT05109364|Terazosin|terazosin|mesh-list
65718274|NCT05109364|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65718275|NCT05109364|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65718276|NCT05109364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65718277|NCT05109364|Adrenergic Agents|adrenergic agents|mesh-ancestor
65718278|NCT05109364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65718279|NCT05109364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718280|NCT05109364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718281|NCT05109364|Urological Agents|urological agents|mesh-ancestor
65718282|NCT05053750|Paclitaxel|paclitaxel|mesh-list
65718283|NCT05053750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65718284|NCT05053750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65718285|NCT05053750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718286|NCT05053750|Tubulin Modulators|tubulin modulators|mesh-ancestor
65718287|NCT05053750|Antimitotic Agents|antimitotic agents|mesh-ancestor
65718288|NCT05053750|Mitosis Modulators|mitosis modulators|mesh-ancestor
65718289|NCT05053750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718290|NCT04233892|Estrogens|estrogens|mesh-list
65718291|NCT04233892|Hormones|hormones|mesh-ancestor
65718292|NCT04233892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65718293|NCT04233892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718294|NCT02386358|Benzonidazole|benzonidazole|mesh-list
65718295|NCT02386358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65718296|NCT02386358|Immunologic Factors|immunologic factors|mesh-ancestor
65718297|NCT02386358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718298|NCT02386358|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65718299|NCT02386358|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65718300|NCT02386358|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65718301|NCT02386358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65718302|NCT03283371|Natalizumab|natalizumab|mesh-list
65718303|NCT03283371|Immunologic Factors|immunologic factors|mesh-ancestor
65718304|NCT03283371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718305|NCT05069350|Bupivacaine|bupivacaine|mesh-list
65718306|NCT05069350|Anesthetics, Local|anesthetics, local|mesh-ancestor
65718307|NCT05069350|Anesthetics|anesthetics|mesh-ancestor
65718308|NCT05069350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65718309|NCT05069350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718310|NCT05069350|Sensory System Agents|sensory system agents|mesh-ancestor
65718311|NCT05069350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718312|NCT04997902|Tipifarnib|tipifarnib|mesh-list
65718313|NCT04997902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718314|NCT03471351|Pembrolizumab|pembrolizumab|mesh-list
65718315|NCT03471351|Tenalisib|tenalisib|mesh-list
65718316|NCT03471351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65718317|NCT03471351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718318|NCT03471351|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
65718319|NCT03471351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718320|NCT03471351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718321|NCT02386592|Chlorhexidine|chlorhexidine|mesh-list
65718322|NCT02386592|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65718323|NCT02386592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65718324|NCT02386592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65034189|NCT00199017|Hormones|hormones|mesh-ancestor
65718325|NCT02386592|Disinfectants|disinfectants|mesh-ancestor
65718326|NCT02386592|Dermatologic Agents|dermatologic agents|mesh-ancestor
65718328|NCT02390258|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65718329|NCT02390258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65718330|NCT02390258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718331|NCT03891446|Bimatoprost|bimatoprost|mesh-list
65718332|NCT03891446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65718333|NCT03059511|Nalbuphine|nalbuphine|mesh-list
65718334|NCT03059511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65718335|NCT03059511|Narcotics|narcotics|mesh-ancestor
65718336|NCT03059511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65718337|NCT03059511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718338|NCT03059511|Analgesics|analgesics|mesh-ancestor
65718339|NCT03059511|Sensory System Agents|sensory system agents|mesh-ancestor
65718340|NCT03059511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718341|NCT04439786|Lidocaine|lidocaine|mesh-list
65718342|NCT04439786|Anesthetics, Local|anesthetics, local|mesh-ancestor
65718343|NCT04439786|Anesthetics|anesthetics|mesh-ancestor
65718344|NCT04439786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65718345|NCT04439786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718346|NCT04439786|Sensory System Agents|sensory system agents|mesh-ancestor
65718347|NCT04439786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718348|NCT04439786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65718349|NCT04439786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65718350|NCT04439786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65718351|NCT04439786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65718352|NCT04439786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718353|NCT03821792|Prednisone|prednisone|mesh-list
65718354|NCT03821792|Cortisone|cortisone|mesh-list
65718355|NCT03821792|Abiraterone Acetate|abiraterone acetate|mesh-list
65718356|NCT03821792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65718357|NCT03821792|Glucocorticoids|glucocorticoids|mesh-ancestor
65718358|NCT03821792|Hormones|hormones|mesh-ancestor
65718359|NCT03821792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65718360|NCT03821792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718361|NCT03821792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65718362|NCT03821792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718363|NCT03821792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65718364|NCT03821792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718365|NCT03821792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718366|NCT03821792|Hormone Antagonists|hormone antagonists|mesh-ancestor
65718367|NCT03821792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65718368|NCT02665286|Naproxen|naproxen|mesh-list
65718369|NCT02665286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65718370|NCT02665286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65718371|NCT02665286|Orphenadrine|orphenadrine|mesh-list
65718372|NCT02665286|Methocarbamol|methocarbamol|mesh-list
65718373|NCT02665286|Cholinergic Antagonists|cholinergic antagonists|mesh-list
65718374|NCT02665286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65718375|NCT02665286|Analgesics|analgesics|mesh-ancestor
65718376|NCT02665286|Sensory System Agents|sensory system agents|mesh-ancestor
65718377|NCT02665286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718378|NCT02665286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718379|NCT02665286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65718380|NCT02665286|Gout Suppressants|gout suppressants|mesh-ancestor
65718381|NCT02665286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65718382|NCT02665286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718383|NCT02665286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718384|NCT02665286|Cholinergic Agents|cholinergic agents|mesh-ancestor
65718385|NCT02665286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65718386|NCT02665286|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65718387|NCT02665286|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65718388|NCT02665286|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65718389|NCT02665286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65718390|NCT02665286|Parasympatholytics|parasympatholytics|mesh-ancestor
65718391|NCT02665286|Autonomic Agents|autonomic agents|mesh-ancestor
65718392|NCT02665286|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65718393|NCT02665286|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
65718394|NCT02665286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65718395|NCT02390102|Epoetin Alfa|epoetin alfa|mesh-list
65718396|NCT02390102|Hematinics|hematinics|mesh-ancestor
65718397|NCT02134925|Poly ICLC|poly iclc|mesh-list
65718398|NCT02134925|Interferon Inducers|interferon inducers|mesh-ancestor
65718399|NCT02134925|Immunologic Factors|immunologic factors|mesh-ancestor
65718400|NCT02134925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718401|NCT03663673|Decanoic acid|decanoic acid|mesh-list
65718402|NCT03663673|Antifungal Agents|antifungal agents|mesh-ancestor
65718403|NCT03663673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65718405|NCT04058743|Chromium|chromium|mesh-list
65718406|NCT04058743|Nickel|nickel|mesh-list
65718407|NCT04058743|Trace Elements|trace elements|mesh-ancestor
65718408|NCT04058743|Micronutrients|micronutrients|mesh-ancestor
65718409|NCT04058743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718410|NCT03664063|Azithromycin|azithromycin|mesh-list
65718411|NCT03664063|Ivermectin|ivermectin|mesh-list
65718412|NCT03664063|Albendazole|albendazole|mesh-list
65718413|NCT03664063|Diethylcarbamazine|diethylcarbamazine|mesh-list
65718414|NCT03664063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65718415|NCT03664063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65718416|NCT03664063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65718417|NCT03664063|Anthelmintics|anthelmintics|mesh-ancestor
65718418|NCT03664063|Anticestodal Agents|anticestodal agents|mesh-ancestor
65718419|NCT03664063|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65718420|NCT03664063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65718421|NCT03664063|Tubulin Modulators|tubulin modulators|mesh-ancestor
65718422|NCT03664063|Antimitotic Agents|antimitotic agents|mesh-ancestor
65718423|NCT03664063|Mitosis Modulators|mitosis modulators|mesh-ancestor
65718424|NCT03664063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718425|NCT03664063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718426|NCT03664063|Filaricides|filaricides|mesh-ancestor
65718427|NCT03664063|Antinematodal Agents|antinematodal agents|mesh-ancestor
65718428|NCT03664063|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65718429|NCT03664063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718430|NCT02911285|Acetylcysteine|acetylcysteine|mesh-list
65718431|NCT02911285|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65718432|NCT02911285|Antiviral Agents|antiviral agents|mesh-ancestor
65718433|NCT02911285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65718434|NCT02911285|Expectorants|expectorants|mesh-ancestor
65718435|NCT02911285|Respiratory System Agents|respiratory system agents|mesh-ancestor
65718436|NCT02911285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65718437|NCT02911285|Antioxidants|antioxidants|mesh-ancestor
65718438|NCT02911285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718439|NCT02911285|Protective Agents|protective agents|mesh-ancestor
65718440|NCT02911285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718441|NCT02911285|Antidotes|antidotes|mesh-ancestor
65718442|NCT01061515|Bevacizumab|bevacizumab|mesh-list
65718443|NCT01061515|Capecitabine|capecitabine|mesh-list
65718444|NCT01061515|Oxaliplatin|oxaliplatin|mesh-list
65718445|NCT01061515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65718446|NCT01061515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718447|NCT01061515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65718448|NCT01061515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65718449|NCT01061515|Growth Substances|growth substances|mesh-ancestor
65718450|NCT01061515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718451|NCT01061515|Growth Inhibitors|growth inhibitors|mesh-ancestor
65718452|NCT01061515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65718453|NCT01061515|Antimetabolites|antimetabolites|mesh-ancestor
65718454|NCT01061515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718455|NCT01069939|Esomeprazole|esomeprazole|mesh-list
65718456|NCT01069939|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65718457|NCT01069939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65718458|NCT01069939|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65718459|NCT01069939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718460|NCT01069939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718461|NCT01069705|Tobramycin|tobramycin|mesh-list
65718462|NCT01069705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65718463|NCT01069705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65718464|NCT01996865|Rituximab|rituximab|mesh-list
65718465|NCT01996865|Lenalidomide|lenalidomide|mesh-list
65718466|NCT01996865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65718467|NCT01996865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718468|NCT01996865|Immunologic Factors|immunologic factors|mesh-ancestor
65718469|NCT01996865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718470|NCT01996865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65718471|NCT01996865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65718472|NCT01996865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65718473|NCT01996865|Growth Substances|growth substances|mesh-ancestor
65718474|NCT01996865|Growth Inhibitors|growth inhibitors|mesh-ancestor
65718475|NCT01069627|Bevacizumab|bevacizumab|mesh-list
65718476|NCT01069627|Fotemustine|fotemustine|mesh-list
65034335|NCT01235923|Epoetin Alfa|epoetin alfa|mesh-list
65718477|NCT01069627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65718478|NCT01069627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718479|NCT01069627|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65718480|NCT01069627|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65718481|NCT01069627|Growth Substances|growth substances|mesh-ancestor
65718482|NCT01069627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718483|NCT01069627|Growth Inhibitors|growth inhibitors|mesh-ancestor
65718484|NCT04057261|Liraglutide|liraglutide|mesh-list
65718485|NCT04057261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65718486|NCT04057261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718487|NCT04057261|Incretins|incretins|mesh-ancestor
65718489|NCT04057261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65718490|NCT01947023|Lapatinib|lapatinib|mesh-list
65718491|NCT01947023|Dabrafenib|dabrafenib|mesh-list
65718492|NCT01947023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718493|NCT01947023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65718494|NCT01947023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718495|NCT01947023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718496|NCT01064245|Mannitol|mannitol|mesh-list
65718497|NCT01064245|Methacholine Chloride|methacholine chloride|mesh-list
65718498|NCT01064245|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65718499|NCT01064245|Diuretics|diuretics|mesh-ancestor
65718500|NCT01064245|Natriuretic Agents|natriuretic agents|mesh-ancestor
65718501|NCT01064245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718502|NCT01064245|Miotics|miotics|mesh-ancestor
65718503|NCT01064245|Autonomic Agents|autonomic agents|mesh-ancestor
65718504|NCT01064245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718505|NCT01064245|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65718506|NCT01064245|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
65718507|NCT01064245|Respiratory System Agents|respiratory system agents|mesh-ancestor
65718508|NCT01064245|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65718509|NCT01064245|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65718510|NCT01064245|Cholinergic Agents|cholinergic agents|mesh-ancestor
65718511|NCT01064245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65718512|NCT01064245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718513|NCT04056949|Paclitaxel|paclitaxel|mesh-list
65718514|NCT04056949|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65718515|NCT04056949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65718516|NCT04056949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718517|NCT04056949|Tubulin Modulators|tubulin modulators|mesh-ancestor
65718518|NCT04056949|Antimitotic Agents|antimitotic agents|mesh-ancestor
65718519|NCT04056949|Mitosis Modulators|mitosis modulators|mesh-ancestor
65718520|NCT04056949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718521|NCT03662425|Oxytocin|oxytocin|mesh-list
65718522|NCT03662425|Oxytocics|oxytocics|mesh-ancestor
65718523|NCT03662425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65718524|NCT03662425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718525|NCT03673163|Lidocaine|lidocaine|mesh-list
65718526|NCT03673163|Anesthetics, Local|anesthetics, local|mesh-ancestor
65718527|NCT03673163|Anesthetics|anesthetics|mesh-ancestor
65718528|NCT03673163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65718529|NCT03673163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718530|NCT03673163|Sensory System Agents|sensory system agents|mesh-ancestor
65718531|NCT03673163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718532|NCT03673163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65718533|NCT03673163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65718534|NCT03673163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65718535|NCT03673163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65718536|NCT03673163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718537|NCT03662269|Indomethacin|indomethacin|mesh-list
65718538|NCT03662269|Omeprazole|omeprazole|mesh-list
65718539|NCT03662269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65718540|NCT03662269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65718541|NCT03662269|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65718542|NCT03662269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718543|NCT03662269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718544|NCT03662269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65718545|NCT03662269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65718546|NCT03662269|Analgesics|analgesics|mesh-ancestor
65718547|NCT03662269|Sensory System Agents|sensory system agents|mesh-ancestor
65718548|NCT03662269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718549|NCT03662269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718550|NCT03662269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65718551|NCT03662269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65034411|NCT00373711|Trace Elements|trace elements|mesh-ancestor
65718552|NCT03662269|Gout Suppressants|gout suppressants|mesh-ancestor
65718553|NCT03662269|Tocolytic Agents|tocolytic agents|mesh-ancestor
65718554|NCT03662269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65718555|NCT03662269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65718556|NCT04056325|Ivermectin|ivermectin|mesh-list
65718557|NCT04056325|Moxidectin|moxidectin|mesh-list
65718558|NCT04056325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65718559|NCT04056325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65718560|NCT04056325|Anthelmintics|anthelmintics|mesh-ancestor
65718561|NCT04056325|Antinematodal Agents|antinematodal agents|mesh-ancestor
65718562|NCT03662971|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65718563|NCT03662971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65718564|NCT03662893|Muscarinic Antagonists|muscarinic antagonists|mesh-list
65718565|NCT03662893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65718566|NCT03662893|Cholinergic Agents|cholinergic agents|mesh-ancestor
65718567|NCT03662893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65718568|NCT03662893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718569|NCT03662893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718570|NCT01624805|Cyclosporine|cyclosporine|mesh-list
65718571|NCT01624805|Methylprednisolone|methylprednisolone|mesh-list
65718572|NCT01624805|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65718573|NCT01624805|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65718574|NCT01624805|Prednisolone|prednisolone|mesh-list
65718575|NCT01624805|Prednisolone acetate|prednisolone acetate|mesh-list
65718576|NCT01624805|Lenograstim|lenograstim|mesh-list
65718577|NCT01624805|Cyclosporins|cyclosporins|mesh-list
65718578|NCT01624805|Thymoglobulin|thymoglobulin|mesh-list
65718579|NCT01624805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65718580|NCT01624805|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65718581|NCT01624805|Prednisolone phosphate|prednisolone phosphate|mesh-list
65718582|NCT01624805|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65718583|NCT01624805|Immunologic Factors|immunologic factors|mesh-ancestor
65718584|NCT01624805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718585|NCT01624805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718586|NCT01624805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718587|NCT01624805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65718588|NCT01624805|Antifungal Agents|antifungal agents|mesh-ancestor
65718589|NCT01624805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65718590|NCT01624805|Dermatologic Agents|dermatologic agents|mesh-ancestor
65718591|NCT01624805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65718592|NCT01624805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65718593|NCT01624805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65718594|NCT01624805|Antiemetics|antiemetics|mesh-ancestor
65718595|NCT01624805|Autonomic Agents|autonomic agents|mesh-ancestor
65718596|NCT01624805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718597|NCT01624805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65718598|NCT01624805|Glucocorticoids|glucocorticoids|mesh-ancestor
65718599|NCT01624805|Hormones|hormones|mesh-ancestor
65718600|NCT01624805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65718601|NCT01624805|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65718602|NCT01624805|Protective Agents|protective agents|mesh-ancestor
65718603|NCT01624805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65718604|NCT01624805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718605|NCT01585025|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
65718606|NCT01585025|Cathartics|cathartics|mesh-ancestor
65718607|NCT01585025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65718608|NCT00328653|Cyclosporine|cyclosporine|mesh-list
65718609|NCT00328653|Cyclosporins|cyclosporins|mesh-list
65718610|NCT00328653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718611|NCT00328653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718612|NCT00328653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65718613|NCT00328653|Immunologic Factors|immunologic factors|mesh-ancestor
65718614|NCT00328653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718615|NCT00328653|Antifungal Agents|antifungal agents|mesh-ancestor
65718616|NCT00328653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65718617|NCT00328653|Dermatologic Agents|dermatologic agents|mesh-ancestor
65718618|NCT00328653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65718619|NCT00328653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65718620|NCT03662113|Domperidone|domperidone|mesh-list
65718621|NCT03662113|Simethicone|simethicone|mesh-list
65718622|NCT03662113|Antiemetics|antiemetics|mesh-ancestor
65718623|NCT03662113|Autonomic Agents|autonomic agents|mesh-ancestor
65718624|NCT03662113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718625|NCT03662113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718626|NCT03662113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65718627|NCT03662113|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65718628|NCT03662113|Dopamine Agents|dopamine agents|mesh-ancestor
65718629|NCT03662113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65718630|NCT03662113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718631|NCT03662113|Antifoaming Agents|antifoaming agents|mesh-ancestor
65718633|NCT03662113|Dermatologic Agents|dermatologic agents|mesh-ancestor
65718634|NCT03662035|Apatinib|apatinib|mesh-list
65718635|NCT03662035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718636|NCT03662035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65718637|NCT03662035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718638|NCT03662035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718639|NCT05798546|Cyclophosphamide|cyclophosphamide|mesh-list
65718640|NCT05798546|Fludarabine|fludarabine|mesh-list
65718641|NCT05798546|Interleukin-2|interleukin-2|mesh-list
65718642|NCT05798546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65718643|NCT05798546|Immunologic Factors|immunologic factors|mesh-ancestor
65718644|NCT05798546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718645|NCT05798546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65718646|NCT05798546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65718647|NCT05798546|Alkylating Agents|alkylating agents|mesh-ancestor
65718648|NCT05798546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718649|NCT05798546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718650|NCT05798546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65718651|NCT05798546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65718652|NCT05798546|Analgesics|analgesics|mesh-ancestor
65718653|NCT05798546|Sensory System Agents|sensory system agents|mesh-ancestor
65718654|NCT05798546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718655|NCT05798533|Cyclophosphamide|cyclophosphamide|mesh-list
65718656|NCT05798533|Fludarabine|fludarabine|mesh-list
65718657|NCT05798533|Interleukin-2|interleukin-2|mesh-list
65718658|NCT05798533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65718659|NCT05798533|Immunologic Factors|immunologic factors|mesh-ancestor
65718660|NCT05798533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718661|NCT05798533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65718662|NCT05798533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65718663|NCT05798533|Alkylating Agents|alkylating agents|mesh-ancestor
65718664|NCT05798533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718665|NCT05798533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718666|NCT05798533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65718667|NCT05798533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65718668|NCT05798533|Analgesics|analgesics|mesh-ancestor
65718669|NCT05798533|Sensory System Agents|sensory system agents|mesh-ancestor
65718670|NCT05798533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718671|NCT05798403|Solifenacin Succinate|solifenacin succinate|mesh-list
65718672|NCT05798403|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65718673|NCT05798403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65718674|NCT05798403|Cholinergic Agents|cholinergic agents|mesh-ancestor
65718675|NCT05798403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65718676|NCT05798403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718677|NCT05798403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718678|NCT05798403|Urological Agents|urological agents|mesh-ancestor
65718679|NCT05798195|Dexamethasone|dexamethasone|mesh-list
65718680|NCT05798195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65718681|NCT05798195|Antiemetics|antiemetics|mesh-ancestor
65718682|NCT05798195|Autonomic Agents|autonomic agents|mesh-ancestor
65718683|NCT05798195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718684|NCT05798195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718685|NCT05798195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65718686|NCT05798195|Glucocorticoids|glucocorticoids|mesh-ancestor
65718687|NCT05798195|Hormones|hormones|mesh-ancestor
65181330|NCT04237090|Antiemetics|antiemetics|mesh-ancestor
65718688|NCT05798195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65718689|NCT05798195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65718690|NCT05798195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718691|NCT05798156|Rituximab|rituximab|mesh-list
65718692|NCT05798156|Obinutuzumab|obinutuzumab|mesh-list
65718693|NCT05798156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65718694|NCT05798156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718695|NCT05798156|Immunologic Factors|immunologic factors|mesh-ancestor
65718696|NCT05798156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718697|NCT05798156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65718698|NCT05797948|Cyclophosphamide|cyclophosphamide|mesh-list
65718699|NCT05797948|Fludarabine|fludarabine|mesh-list
65718700|NCT05797948|Lenalidomide|lenalidomide|mesh-list
65718701|NCT05797948|Azacitidine|azacitidine|mesh-list
65718702|NCT05797948|Obinutuzumab|obinutuzumab|mesh-list
65718703|NCT05797948|Zanubrutinib|zanubrutinib|mesh-list
65718704|NCT05797948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65718705|NCT05797948|Immunologic Factors|immunologic factors|mesh-ancestor
65718706|NCT05797948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718707|NCT05797948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65718708|NCT05797948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65718709|NCT05797948|Alkylating Agents|alkylating agents|mesh-ancestor
65718710|NCT05797948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718711|NCT05797948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718712|NCT05797948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65718713|NCT05797948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65718714|NCT05797948|Antimetabolites|antimetabolites|mesh-ancestor
65718715|NCT05797948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65718716|NCT05797948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65718717|NCT05797948|Growth Substances|growth substances|mesh-ancestor
65718718|NCT05797948|Growth Inhibitors|growth inhibitors|mesh-ancestor
65718719|NCT05797948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718720|NCT05797948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65718721|NCT05797948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65718722|NCT05797870|Ethiodized Oil|ethiodized oil|mesh-list
65718723|NCT05797870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718724|NCT05797818|Chlorhexidine|chlorhexidine|mesh-list
65718725|NCT05797818|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65718726|NCT05797818|Methylene Blue|methylene blue|mesh-list
65718727|NCT05797818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65718728|NCT05797818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65718729|NCT05797818|Disinfectants|disinfectants|mesh-ancestor
65718730|NCT05797818|Dermatologic Agents|dermatologic agents|mesh-ancestor
65718731|NCT05797818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718732|NCT05797818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718733|NCT05797805|Pembrolizumab|pembrolizumab|mesh-list
65718734|NCT05797805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65718735|NCT05797805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718736|NCT05797792|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65718737|NCT05797792|Plasminogen|plasminogen|mesh-list
65718738|NCT05797792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65718739|NCT05797792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65718740|NCT05797792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718741|NCT05797753|Itraconazole|itraconazole|mesh-list
65718742|NCT05797753|Erythromycin|erythromycin|mesh-list
65718743|NCT05797753|Erythromycin Estolate|erythromycin estolate|mesh-list
65718744|NCT05797753|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65718745|NCT05797753|Erythromycin stearate|erythromycin stearate|mesh-list
65718746|NCT05797753|Antifungal Agents|antifungal agents|mesh-ancestor
65718747|NCT05797753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65718748|NCT05797753|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65718749|NCT05797753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65718750|NCT05797753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718751|NCT05797753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718752|NCT05797753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65718753|NCT05797753|Hormone Antagonists|hormone antagonists|mesh-ancestor
65718754|NCT05797753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65718755|NCT05797753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718756|NCT05797753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65718757|NCT05797753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65718758|NCT05797753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65718759|NCT05797753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65718760|NCT05797740|Cladribine|cladribine|mesh-list
65718761|NCT05797740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718762|NCT05797740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65718763|NCT05797740|Immunologic Factors|immunologic factors|mesh-ancestor
65718764|NCT05797740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718765|NCT05797714|Tenofovir|tenofovir|mesh-list
65718766|NCT05797714|Antiviral Agents|antiviral agents|mesh-ancestor
65718767|NCT05797714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65718768|NCT05797714|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65718769|NCT05797714|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65718770|NCT05797714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718771|NCT05797714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718772|NCT05797714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65718773|NCT05797714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65718774|NCT05797623|Cyclosporine|cyclosporine|mesh-list
65718775|NCT05797623|Cyclosporins|cyclosporins|mesh-list
65718776|NCT05797623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718777|NCT05797623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718778|NCT05797623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65718779|NCT05797623|Immunologic Factors|immunologic factors|mesh-ancestor
65718780|NCT05797623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718781|NCT05797623|Antifungal Agents|antifungal agents|mesh-ancestor
65718782|NCT05797623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65718783|NCT05797623|Dermatologic Agents|dermatologic agents|mesh-ancestor
65718784|NCT05797623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65718785|NCT05797623|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65718787|NCT05797584|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65718788|NCT05797584|Sympathomimetics|sympathomimetics|mesh-ancestor
65718789|NCT05797584|Autonomic Agents|autonomic agents|mesh-ancestor
65718790|NCT05797584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718791|NCT05797584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718792|NCT05797584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65718793|NCT05797584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65718794|NCT05797584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65718795|NCT05797584|Adrenergic Agents|adrenergic agents|mesh-ancestor
65718796|NCT05797584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65718797|NCT05797584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718798|NCT05797584|Protective Agents|protective agents|mesh-ancestor
65718799|NCT05797558|Eplerenone|eplerenone|mesh-list
65718800|NCT05797558|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
65718801|NCT05797558|Mineralocorticoids|mineralocorticoids|mesh-list
65718802|NCT05797558|Hormone Antagonists|hormone antagonists|mesh-ancestor
65718803|NCT05797558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65718804|NCT05797558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718805|NCT05797558|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65718806|NCT05797558|Diuretics|diuretics|mesh-ancestor
65718807|NCT05797558|Natriuretic Agents|natriuretic agents|mesh-ancestor
65718808|NCT05797558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65718809|NCT05797558|Hormones|hormones|mesh-ancestor
65718810|NCT05797493|Atezolizumab|atezolizumab|mesh-list
65718811|NCT05797493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718812|NCT05797467|Bevacizumab|bevacizumab|mesh-list
65718813|NCT05797467|Cetuximab|cetuximab|mesh-list
65718814|NCT05797467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65718815|NCT05797467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718816|NCT05797467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65718817|NCT05797467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65718818|NCT05797467|Growth Substances|growth substances|mesh-ancestor
65718819|NCT05797467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718820|NCT05797467|Growth Inhibitors|growth inhibitors|mesh-ancestor
65718821|NCT05797376|Rivaroxaban|rivaroxaban|mesh-list
65718822|NCT05797376|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65718823|NCT05797376|Antithrombins|antithrombins|mesh-ancestor
65718824|NCT05797376|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65718825|NCT05797376|Protease Inhibitors|protease inhibitors|mesh-ancestor
65718826|NCT05797376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718827|NCT05797376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718828|NCT05797376|Anticoagulants|anticoagulants|mesh-ancestor
65718829|NCT05797220|Diltiazem|diltiazem|mesh-list
65718830|NCT05797220|Botulinum Toxins|botulinum toxins|mesh-list
65718831|NCT05797220|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65718832|NCT05797220|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65718833|NCT05797220|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65718834|NCT05797220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65718835|NCT05797220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718836|NCT05797220|Cholinergic Agents|cholinergic agents|mesh-ancestor
65718837|NCT05797220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65718838|NCT05797220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718839|NCT05797220|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65718840|NCT05797220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718841|NCT05797220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65718842|NCT05797220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65718843|NCT05797220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65718844|NCT05797220|Vasodilator Agents|vasodilator agents|mesh-ancestor
65718845|NCT05797077|Capecitabine|capecitabine|mesh-list
65718846|NCT05797077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65718847|NCT05797077|Antimetabolites|antimetabolites|mesh-ancestor
65718848|NCT05797077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718849|NCT05797077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718850|NCT05797038|Tacrolimus|tacrolimus|mesh-list
65718851|NCT05797038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65718852|NCT05797038|Immunologic Factors|immunologic factors|mesh-ancestor
65718853|NCT05797038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718854|NCT05797038|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65718855|NCT05797038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718856|NCT05797038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718857|NCT05796973|Atorvastatin|atorvastatin|mesh-list
65718858|NCT05796973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65718859|NCT05796973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65718860|NCT05796973|Antimetabolites|antimetabolites|mesh-ancestor
65718861|NCT05796973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718862|NCT05796973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65718863|NCT05796973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65718864|NCT05796973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718865|NCT05796791|Ketamine|ketamine|mesh-list
65718866|NCT05796791|Analgesics|analgesics|mesh-ancestor
65718867|NCT05796791|Sensory System Agents|sensory system agents|mesh-ancestor
65718868|NCT05796791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718869|NCT05796791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718870|NCT05796791|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65718871|NCT05796791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65718872|NCT05796791|Anesthetics, General|anesthetics, general|mesh-ancestor
65718873|NCT05796791|Anesthetics|anesthetics|mesh-ancestor
65718874|NCT05796791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65718875|NCT05796791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65718876|NCT05796791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65718877|NCT05796791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65718878|NCT05796791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718879|NCT05795933|Vitamin D|vitamin d|mesh-list
65718880|NCT05795933|Cholecalciferol|cholecalciferol|mesh-list
65718881|NCT05795933|Vitamins|vitamins|mesh-ancestor
65718882|NCT05795933|Micronutrients|micronutrients|mesh-ancestor
65718883|NCT05795933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718884|NCT05795933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65718885|NCT05795933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65718886|NCT05794399|Warfarin|warfarin|mesh-list
65718887|NCT05794399|Rivaroxaban|rivaroxaban|mesh-list
65718888|NCT05794399|Anticoagulants|anticoagulants|mesh-ancestor
65718889|NCT05794399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65718890|NCT05794399|Antithrombins|antithrombins|mesh-ancestor
65718891|NCT05794399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65718892|NCT05794399|Protease Inhibitors|protease inhibitors|mesh-ancestor
65718893|NCT05794399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718894|NCT05794399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718895|NCT05792774|Bupivacaine|bupivacaine|mesh-list
65718896|NCT05792774|Anesthetics, Local|anesthetics, local|mesh-ancestor
65718897|NCT05792774|Anesthetics|anesthetics|mesh-ancestor
65718898|NCT05792774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65718899|NCT05792774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718900|NCT05792774|Sensory System Agents|sensory system agents|mesh-ancestor
65718901|NCT05792774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718902|NCT05782127|Venetoclax|venetoclax|mesh-list
65718903|NCT05782127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718904|NCT05776927|Fluticasone|fluticasone|mesh-list
65718905|NCT05776927|Xhance|xhance|mesh-list
65718906|NCT05776927|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65718907|NCT05776927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65718908|NCT05776927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65718909|NCT05776927|Autonomic Agents|autonomic agents|mesh-ancestor
65718910|NCT05776927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718911|NCT05776927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718912|NCT05776927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65718913|NCT05776927|Respiratory System Agents|respiratory system agents|mesh-ancestor
65718914|NCT05776927|Dermatologic Agents|dermatologic agents|mesh-ancestor
65718915|NCT05776927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65718916|NCT05776927|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65718917|NCT05776927|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65718918|NCT05776927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65718919|NCT05776927|Adrenergic Agents|adrenergic agents|mesh-ancestor
65718920|NCT05776927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65718921|NCT05776927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718922|NCT05775809|Serotonin|serotonin|mesh-list
65718923|NCT05775809|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65718924|NCT05775809|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65718925|NCT05775809|Serotonin Agents|serotonin agents|mesh-ancestor
65718926|NCT05775809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65718927|NCT05775809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718928|NCT05775809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718929|NCT05775809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65718930|NCT05775809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65718932|NCT05768139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65718933|NCT05768139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65718934|NCT05768139|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65718935|NCT05768139|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65718936|NCT05768139|Hormone Antagonists|hormone antagonists|mesh-ancestor
65718937|NCT05768139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65718938|NCT05768139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718939|NCT05763875|Ezetimibe|ezetimibe|mesh-list
65718940|NCT05763875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65718941|NCT05763875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65718942|NCT05763875|Antimetabolites|antimetabolites|mesh-ancestor
65718943|NCT05763875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718944|NCT05763875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65718945|NCT05741385|Metoprolol|metoprolol|mesh-list
65718946|NCT05741385|Midazolam|midazolam|mesh-list
65718947|NCT05741385|Caffeine|caffeine|mesh-list
65718948|NCT05741385|Omeprazole|omeprazole|mesh-list
65718949|NCT05741385|Warfarin|warfarin|mesh-list
65718950|NCT05741385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65718951|NCT05741385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65718952|NCT05741385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65718953|NCT05741385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718954|NCT05741385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65718955|NCT05741385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65718956|NCT05741385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65718957|NCT05741385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65718958|NCT05741385|Anesthetics, General|anesthetics, general|mesh-ancestor
65718959|NCT05741385|Anesthetics|anesthetics|mesh-ancestor
65718960|NCT05741385|GABA Modulators|gaba modulators|mesh-ancestor
65718961|NCT05741385|GABA Agents|gaba agents|mesh-ancestor
65718962|NCT05741385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65718963|NCT05741385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718964|NCT05741385|Anticoagulants|anticoagulants|mesh-ancestor
65718965|NCT05741385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65718966|NCT05741385|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65718967|NCT05741385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718968|NCT05741385|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65718969|NCT05741385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65718970|NCT05741385|Purinergic Agents|purinergic agents|mesh-ancestor
65718971|NCT05741385|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65718972|NCT05741385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65718973|NCT05741385|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65718974|NCT05741385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65718975|NCT05741385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65718976|NCT05741385|Sympatholytics|sympatholytics|mesh-ancestor
65718977|NCT05741385|Autonomic Agents|autonomic agents|mesh-ancestor
65718978|NCT05741385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65718979|NCT05741385|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65718980|NCT05741385|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65718981|NCT05741385|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65718982|NCT05741385|Adrenergic Agents|adrenergic agents|mesh-ancestor
65718983|NCT05741372|Metformin|metformin|mesh-list
65718984|NCT05741372|Digoxin|digoxin|mesh-list
65718985|NCT05741372|Furosemide|furosemide|mesh-list
65718986|NCT05741372|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65718987|NCT05741372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65718988|NCT05741372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65718989|NCT05741372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65718990|NCT05741372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65718991|NCT05741372|Antimetabolites|antimetabolites|mesh-ancestor
65718992|NCT05741372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65718993|NCT05741372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65718994|NCT05741372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65718995|NCT05741372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65718996|NCT05741372|Diuretics|diuretics|mesh-ancestor
65718997|NCT05741372|Natriuretic Agents|natriuretic agents|mesh-ancestor
65718998|NCT05741372|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65718999|NCT05741372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65719000|NCT05741372|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65719001|NCT05741372|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65719002|NCT05741372|Protective Agents|protective agents|mesh-ancestor
65719003|NCT05731895|BI 425809|bi 425809|mesh-list
65719004|NCT05731895|Nootropic Agents|nootropic agents|mesh-ancestor
65719005|NCT05726383|Viscum album peptide|viscum album peptide|mesh-list
65719006|NCT05726383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719007|NCT05726383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65719008|NCT05726383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65719009|NCT05726383|Antiviral Agents|antiviral agents|mesh-ancestor
65719010|NCT05726383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65719011|NCT05718843|BI 425809|bi 425809|mesh-list
65719012|NCT05718843|Nootropic Agents|nootropic agents|mesh-ancestor
65719013|NCT05703854|Cyclophosphamide|cyclophosphamide|mesh-list
65719014|NCT05703854|Fludarabine|fludarabine|mesh-list
65719015|NCT05703854|Fludarabine phosphate|fludarabine phosphate|mesh-list
65719016|NCT05703854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65719017|NCT05703854|Immunologic Factors|immunologic factors|mesh-ancestor
65719018|NCT05703854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719019|NCT05703854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65719020|NCT05703854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65719021|NCT05703854|Alkylating Agents|alkylating agents|mesh-ancestor
65719022|NCT05703854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719023|NCT05703854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719024|NCT05703854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65719025|NCT05703854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65719026|NCT05703854|Antimetabolites|antimetabolites|mesh-ancestor
65719027|NCT05692999|Pembrolizumab|pembrolizumab|mesh-list
65719028|NCT05692999|Pemetrexed|pemetrexed|mesh-list
65719029|NCT05692999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65719030|NCT05692999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719031|NCT05692999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719032|NCT05692999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719033|NCT05692999|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65719034|NCT05692999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65719035|NCT05665595|Pembrolizumab|pembrolizumab|mesh-list
65719036|NCT05665595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65719037|NCT05665595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719038|NCT05665140|Dexamethasone|dexamethasone|mesh-list
65719039|NCT05665140|Lenalidomide|lenalidomide|mesh-list
65719040|NCT05665140|Bortezomib|bortezomib|mesh-list
65719041|NCT05665140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65719042|NCT05665140|Antiemetics|antiemetics|mesh-ancestor
65719043|NCT05665140|Autonomic Agents|autonomic agents|mesh-ancestor
65719044|NCT05665140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65719045|NCT05665140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719046|NCT05665140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65719047|NCT05665140|Glucocorticoids|glucocorticoids|mesh-ancestor
65719048|NCT05665140|Hormones|hormones|mesh-ancestor
65719049|NCT05665140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65719050|NCT05665140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65719051|NCT05665140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719052|NCT05665140|Immunologic Factors|immunologic factors|mesh-ancestor
65719053|NCT05665140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65719054|NCT05665140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65719055|NCT05665140|Growth Substances|growth substances|mesh-ancestor
65719056|NCT05665140|Growth Inhibitors|growth inhibitors|mesh-ancestor
65719057|NCT05661591|Fluconazole|fluconazole|mesh-list
65719058|NCT05661591|Antifungal Agents|antifungal agents|mesh-ancestor
65719059|NCT05661591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65719060|NCT05661591|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65719061|NCT05661591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65719062|NCT05661591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719063|NCT05661591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719064|NCT05661591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65719065|NCT05661591|Hormone Antagonists|hormone antagonists|mesh-ancestor
65719066|NCT05661591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65719067|NCT05661591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719068|NCT05661591|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65719069|NCT05661591|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65719070|NCT05661201|Doxorubicin|doxorubicin|mesh-list
65719071|NCT05661201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65719072|NCT05661201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719073|NCT05661201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65719074|NCT05661201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65719075|NCT05661201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719076|NCT05661201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719077|NCT05653193|Interferons|interferons|mesh-list
65719078|NCT05653193|Interferon-gamma|interferon-gamma|mesh-list
65034937|NCT00176540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719079|NCT05653193|Clotrimazole|clotrimazole|mesh-list
65719080|NCT05653193|Miconazole|miconazole|mesh-list
65719081|NCT05653193|Antifungal Agents|antifungal agents|mesh-list
65719082|NCT05653193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719083|NCT05653193|Antiviral Agents|antiviral agents|mesh-ancestor
65719084|NCT05653193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65719085|NCT05653193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65719086|NCT05653193|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65719087|NCT05653193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65719088|NCT05653193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719089|NCT05653193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719090|NCT05653193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65719091|NCT05653193|Hormone Antagonists|hormone antagonists|mesh-ancestor
65719092|NCT05653193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65719093|NCT05653193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719094|NCT05653193|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65719095|NCT05653193|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65719096|NCT05639647|Aztreonam|aztreonam|mesh-list
65719097|NCT05639647|Avibactam|avibactam|mesh-list
65719098|NCT05639647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65719099|NCT05639647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65719100|NCT05639647|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65719101|NCT05639647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719102|NCT05639647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719103|NCT05634148|Dexmedetomidine|dexmedetomidine|mesh-list
65719104|NCT05634148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65719105|NCT05634148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65719106|NCT05634148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719107|NCT05634148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65719108|NCT05634148|Analgesics|analgesics|mesh-ancestor
65719109|NCT05634148|Sensory System Agents|sensory system agents|mesh-ancestor
65719110|NCT05634148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65719111|NCT05634148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65719112|NCT05634148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65719113|NCT05634148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65719114|NCT05634148|Adrenergic Agents|adrenergic agents|mesh-ancestor
65719115|NCT05634148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65719116|NCT05634148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719117|NCT05631899|Cyclophosphamide|cyclophosphamide|mesh-list
65719118|NCT05631899|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65719119|NCT05631899|Paclitaxel|paclitaxel|mesh-list
65719120|NCT05631899|Antibodies|antibodies|mesh-list
65719121|NCT05631899|Immunoglobulins|immunoglobulins|mesh-list
65719122|NCT05631899|Antibodies, Blocking|antibodies, blocking|mesh-list
65719123|NCT05631899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65719124|NCT05631899|Immunologic Factors|immunologic factors|mesh-ancestor
65719125|NCT05631899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719126|NCT05631899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65719127|NCT05631899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65719128|NCT05631899|Alkylating Agents|alkylating agents|mesh-ancestor
65719129|NCT05631899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719130|NCT05631899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719131|NCT05631899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65719132|NCT05631899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65719133|NCT05631899|Tubulin Modulators|tubulin modulators|mesh-ancestor
65719134|NCT05631899|Antimitotic Agents|antimitotic agents|mesh-ancestor
65719135|NCT05631899|Mitosis Modulators|mitosis modulators|mesh-ancestor
65719136|NCT05625412|Docetaxel|docetaxel|mesh-list
65719137|NCT05625412|Capecitabine|capecitabine|mesh-list
65719138|NCT05625412|Nivolumab|nivolumab|mesh-list
65719139|NCT05625412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719140|NCT05625412|Tubulin Modulators|tubulin modulators|mesh-ancestor
65719141|NCT05625412|Antimitotic Agents|antimitotic agents|mesh-ancestor
65719142|NCT05625412|Mitosis Modulators|mitosis modulators|mesh-ancestor
65719143|NCT05625412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719144|NCT05625412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65719145|NCT05625412|Antimetabolites|antimetabolites|mesh-ancestor
65719146|NCT05625412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65719147|NCT05625412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65719148|NCT05624281|Nintedanib|nintedanib|mesh-list
65719149|NCT05624281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719150|NCT05624281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65719151|NCT05624281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719152|NCT05624281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719153|NCT05622708|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65719154|NCT05622708|Immunologic Factors|immunologic factors|mesh-ancestor
65719155|NCT05622708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719156|NCT05622123|Exenatide|exenatide|mesh-list
65719157|NCT05622123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65719158|NCT05622123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719159|NCT05622123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65719160|NCT05622123|Incretins|incretins|mesh-ancestor
65719161|NCT05622123|Hormones|hormones|mesh-ancestor
65719162|NCT05622123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65719163|NCT05601492|Thalidomide|thalidomide|mesh-list
65719164|NCT05601492|Apremilast|apremilast|mesh-list
65719165|NCT05601492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65719166|NCT05601492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65719167|NCT05601492|Analgesics|analgesics|mesh-ancestor
65719168|NCT05601492|Sensory System Agents|sensory system agents|mesh-ancestor
65719169|NCT05601492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65719170|NCT05601492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719171|NCT05601492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65719172|NCT05601492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65719173|NCT05601492|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65719174|NCT05601492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65719175|NCT05601492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719176|NCT05601492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719177|NCT05601492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65719178|NCT05601492|Immunologic Factors|immunologic factors|mesh-ancestor
65719179|NCT05601492|Leprostatic Agents|leprostatic agents|mesh-ancestor
65719180|NCT05601492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65719181|NCT05601492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65719182|NCT05601492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65719183|NCT05601492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65719184|NCT05601492|Growth Substances|growth substances|mesh-ancestor
65719185|NCT05601492|Growth Inhibitors|growth inhibitors|mesh-ancestor
65719186|NCT05601492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719187|NCT05597878|Acetaminophen|acetaminophen|mesh-list
65719188|NCT05597878|Ketorolac|ketorolac|mesh-list
65719189|NCT05597878|Ketamine|ketamine|mesh-list
65719190|NCT05597878|Oxycodone|oxycodone|mesh-list
65719191|NCT05597878|Analgesics|analgesics|mesh-ancestor
65719192|NCT05597878|Sensory System Agents|sensory system agents|mesh-ancestor
65719193|NCT05597878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65719194|NCT05597878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719195|NCT05597878|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65719196|NCT05597878|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65719197|NCT05597878|Anesthetics, General|anesthetics, general|mesh-ancestor
65719198|NCT05597878|Anesthetics|anesthetics|mesh-ancestor
65719199|NCT05597878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65719200|NCT05597878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65719201|NCT05597878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65719202|NCT05597878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65719203|NCT05597878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719204|NCT05597878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65719205|NCT05597878|Antipyretics|antipyretics|mesh-ancestor
65719206|NCT05597878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65719207|NCT05597878|Narcotics|narcotics|mesh-ancestor
65181860|NCT02805556|Fostemsavir|fostemsavir|mesh-list
65719208|NCT05597878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65719209|NCT05597878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65719210|NCT05597878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65719211|NCT05597878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65719212|NCT05597878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719213|NCT05594082|Trastuzumab|trastuzumab|mesh-list
65719214|NCT05594082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65719215|NCT05594082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719216|NCT05585125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65719217|NCT05585125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65719218|NCT05585125|Adrenergic Agents|adrenergic agents|mesh-ancestor
65719219|NCT05585125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65719220|NCT05585125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719221|NCT05585125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719222|NCT05582434|Clindamycin|clindamycin|mesh-list
65719223|NCT05582434|Clindamycin palmitate|clindamycin palmitate|mesh-list
65719224|NCT05582434|Clindamycin phosphate|clindamycin phosphate|mesh-list
65719225|NCT05582434|Adapalene|adapalene|mesh-list
65719226|NCT05582434|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65719227|NCT05582434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65719228|NCT05582434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65035093|NCT00176774|Antidotes|antidotes|mesh-ancestor
65719230|NCT05582434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719231|NCT05582434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719232|NCT05582434|Dermatologic Agents|dermatologic agents|mesh-ancestor
65719233|NCT05582434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65719234|NCT05582434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65719235|NCT05582434|Analgesics|analgesics|mesh-ancestor
65719236|NCT05582434|Sensory System Agents|sensory system agents|mesh-ancestor
65719237|NCT05582434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65719238|NCT05582434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719239|NCT05582434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65719240|NCT05582434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65719241|NCT05566639|Vaccines|vaccines|mesh-list
65719242|NCT05566639|Immunologic Factors|immunologic factors|mesh-ancestor
65719243|NCT05566639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719244|NCT05542394|Curcumin|curcumin|mesh-list
65719245|NCT05542394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65719246|NCT05542394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65719247|NCT05542394|Analgesics|analgesics|mesh-ancestor
65719248|NCT05542394|Sensory System Agents|sensory system agents|mesh-ancestor
65719249|NCT05542394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65719250|NCT05542394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719251|NCT05542394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65719252|NCT05542394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65719253|NCT05542394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719254|NCT05542394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719255|NCT05542394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719256|NCT05525078|Nicotine|nicotine|mesh-list
65719257|NCT05525078|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65719258|NCT05525078|Autonomic Agents|autonomic agents|mesh-ancestor
65719259|NCT05525078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65719260|NCT05525078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719261|NCT05525078|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65719262|NCT05525078|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65719263|NCT05525078|Cholinergic Agents|cholinergic agents|mesh-ancestor
65719264|NCT05525078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65719265|NCT05525078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719266|NCT05522660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65719267|NCT05522660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719268|NCT05522660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719269|NCT05512039|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65719270|NCT05512039|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65719271|NCT05512039|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65719272|NCT05512039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65719273|NCT05512039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719274|NCT05512039|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65719275|NCT05512039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65719276|NCT05512039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719277|NCT05512039|Cholinergic Agents|cholinergic agents|mesh-ancestor
65719278|NCT05512039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65719279|NCT05508867|Gemcitabine|gemcitabine|mesh-list
65719280|NCT05508867|Pembrolizumab|pembrolizumab|mesh-list
65719281|NCT05508867|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65719282|NCT05508867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65719283|NCT05508867|Antimetabolites|antimetabolites|mesh-ancestor
65719284|NCT05508867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719285|NCT05508867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719286|NCT05508867|Antiviral Agents|antiviral agents|mesh-ancestor
65719287|NCT05508867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65719288|NCT05508867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719289|NCT05508867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65719290|NCT05508867|Immunologic Factors|immunologic factors|mesh-ancestor
65719291|NCT05508867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719292|NCT05508867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65719293|NCT05508867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65719294|NCT05508867|Alkylating Agents|alkylating agents|mesh-ancestor
65719295|NCT05506787|Esketamine|esketamine|mesh-list
65719296|NCT05506787|Antidepressive Agents|antidepressive agents|mesh-ancestor
65719297|NCT05506787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65719298|NCT05503511|Bumetanide|bumetanide|mesh-list
65719299|NCT05503511|Diuretics|diuretics|mesh-ancestor
65719300|NCT05503511|Natriuretic Agents|natriuretic agents|mesh-ancestor
65719301|NCT05503511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719302|NCT05503511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65719303|NCT05503511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65719304|NCT05503511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719306|NCT05503355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719307|NCT05453851|Pancrelipase|pancrelipase|mesh-list
65719308|NCT05453851|Pancreatin|pancreatin|mesh-list
65719309|NCT05453851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65719310|NCT05453500|Prednisone|prednisone|mesh-list
65719311|NCT05453500|Cortisone|cortisone|mesh-list
65719312|NCT05453500|Cyclophosphamide|cyclophosphamide|mesh-list
65719313|NCT05453500|Rituximab|rituximab|mesh-list
65719314|NCT05453500|Doxorubicin|doxorubicin|mesh-list
65719315|NCT05453500|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65719316|NCT05453500|Etoposide|etoposide|mesh-list
65719317|NCT05453500|Vincristine|vincristine|mesh-list
65719318|NCT05453500|Etoposide phosphate|etoposide phosphate|mesh-list
65719319|NCT05453500|Daunorubicin|daunorubicin|mesh-list
65719320|NCT05453500|Podophyllotoxin|podophyllotoxin|mesh-list
65719321|NCT05453500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65719322|NCT05453500|Antibodies|antibodies|mesh-list
65719323|NCT05453500|Immunoglobulins|immunoglobulins|mesh-list
65719324|NCT05453500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65719325|NCT05453500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65719326|NCT05453500|Immunologic Factors|immunologic factors|mesh-ancestor
65719327|NCT05453500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719328|NCT05453500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65719329|NCT05453500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65719330|NCT05453500|Alkylating Agents|alkylating agents|mesh-ancestor
65719331|NCT05453500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719332|NCT05453500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719333|NCT05453500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65719334|NCT05453500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65719335|NCT05453500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65719336|NCT05453500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65719337|NCT05453500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719338|NCT05453500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65719339|NCT05453500|Glucocorticoids|glucocorticoids|mesh-ancestor
65719340|NCT05453500|Hormones|hormones|mesh-ancestor
65719341|NCT05453500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65719342|NCT05453500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65719343|NCT05453500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65719344|NCT05453500|Tubulin Modulators|tubulin modulators|mesh-ancestor
65719345|NCT05453500|Antimitotic Agents|antimitotic agents|mesh-ancestor
65719346|NCT05453500|Mitosis Modulators|mitosis modulators|mesh-ancestor
65719347|NCT05453500|Keratolytic Agents|keratolytic agents|mesh-ancestor
65719348|NCT05453500|Dermatologic Agents|dermatologic agents|mesh-ancestor
65719349|NCT05446870|Paclitaxel|paclitaxel|mesh-list
65719350|NCT05446870|Docetaxel|docetaxel|mesh-list
65719351|NCT05446870|Bevacizumab|bevacizumab|mesh-list
65719352|NCT05446870|Carboplatin|carboplatin|mesh-list
65719353|NCT05446870|Pembrolizumab|pembrolizumab|mesh-list
65719354|NCT05446870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65719355|NCT05446870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719356|NCT05446870|Tubulin Modulators|tubulin modulators|mesh-ancestor
65719357|NCT05446870|Antimitotic Agents|antimitotic agents|mesh-ancestor
65719358|NCT05446870|Mitosis Modulators|mitosis modulators|mesh-ancestor
65719359|NCT05446870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719360|NCT05446870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65719361|NCT05446870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65719362|NCT05446870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65719363|NCT05446870|Growth Substances|growth substances|mesh-ancestor
65719364|NCT05446870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719365|NCT05446870|Growth Inhibitors|growth inhibitors|mesh-ancestor
65719366|NCT05445024|Sufentanil|sufentanil|mesh-list
65719367|NCT05445024|Nalbuphine|nalbuphine|mesh-list
65719368|NCT05445024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65719369|NCT05445024|Narcotics|narcotics|mesh-ancestor
65719370|NCT05445024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65719371|NCT05445024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719372|NCT05445024|Analgesics|analgesics|mesh-ancestor
65719373|NCT05445024|Sensory System Agents|sensory system agents|mesh-ancestor
65719374|NCT05445024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65719375|NCT05445024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65719376|NCT05445024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65719377|NCT05445024|Anesthetics, General|anesthetics, general|mesh-ancestor
65719378|NCT05445024|Anesthetics|anesthetics|mesh-ancestor
65719379|NCT05429814|Menthol|menthol|mesh-list
65719380|NCT05429814|Antipruritics|antipruritics|mesh-ancestor
65719381|NCT05429814|Dermatologic Agents|dermatologic agents|mesh-ancestor
65719382|NCT05420337|Morphine|morphine|mesh-list
65719383|NCT05420337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65719384|NCT05420337|Narcotics|narcotics|mesh-ancestor
65719385|NCT05420337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65719386|NCT05420337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719387|NCT05420337|Analgesics|analgesics|mesh-ancestor
65719388|NCT05420337|Sensory System Agents|sensory system agents|mesh-ancestor
65719389|NCT05420337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65719390|NCT05419050|Denosumab|denosumab|mesh-list
65719391|NCT05419050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65719392|NCT05419050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719393|NCT05416333|Azelaic acid|azelaic acid|mesh-list
65719394|NCT05416333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719395|NCT05416333|Dermatologic Agents|dermatologic agents|mesh-ancestor
65719396|NCT05416320|Calcipotriene|calcipotriene|mesh-list
65719397|NCT05416320|Dermatologic Agents|dermatologic agents|mesh-ancestor
65719398|NCT05409872|Vitamin D|vitamin d|mesh-list
65719399|NCT05409872|Vitamins|vitamins|mesh-list
65719400|NCT05409872|Inositol|inositol|mesh-list
65719401|NCT05409872|Vitamin B 6|vitamin b 6|mesh-list
65719402|NCT05409872|Pyridoxal|pyridoxal|mesh-list
65719403|NCT05409872|Pyridoxine|pyridoxine|mesh-list
65719404|NCT05409872|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65719405|NCT05409872|Micronutrients|micronutrients|mesh-ancestor
65719406|NCT05409872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719407|NCT05409872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65719408|NCT05409872|Vitamin B Complex|vitamin b complex|mesh-ancestor
65719409|NCT05409872|Antioxidants|antioxidants|mesh-ancestor
65719410|NCT05409872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719411|NCT05409872|Protective Agents|protective agents|mesh-ancestor
65719412|NCT05409872|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65719413|NCT05409872|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65719414|NCT05409872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719415|NCT05409872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65719416|NCT05390905|Tramadol|tramadol|mesh-list
65719417|NCT05390905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65719418|NCT05390905|Narcotics|narcotics|mesh-ancestor
65719419|NCT05390905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65719420|NCT05390905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719421|NCT05390905|Analgesics|analgesics|mesh-ancestor
65719422|NCT05390905|Sensory System Agents|sensory system agents|mesh-ancestor
65719423|NCT05390905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65719424|NCT05366621|Denosumab|denosumab|mesh-list
65719425|NCT05366621|Diphosphonates|diphosphonates|mesh-list
65719426|NCT05366621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719427|NCT05366621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65719428|NCT05359653|Clemastine|clemastine|mesh-list
65719429|NCT05359653|Antipruritics|antipruritics|mesh-ancestor
65719430|NCT05359653|Dermatologic Agents|dermatologic agents|mesh-ancestor
65719431|NCT05359653|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65719432|NCT05359653|Histamine Antagonists|histamine antagonists|mesh-ancestor
65719433|NCT05359653|Histamine Agents|histamine agents|mesh-ancestor
65719434|NCT05359653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65719435|NCT05359653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719436|NCT05359653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719437|NCT05359653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65269586|NCT02730572|Dopamine Agents|dopamine agents|mesh-ancestor
65719438|NCT05359146|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
65719439|NCT05359146|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65719440|NCT05359146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719441|NCT05339256|Buprenorphine|buprenorphine|mesh-list
65719442|NCT05339256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65719443|NCT05339256|Narcotics|narcotics|mesh-ancestor
65719444|NCT05339256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65719445|NCT05339256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719446|NCT05339256|Analgesics|analgesics|mesh-ancestor
65719447|NCT05339256|Sensory System Agents|sensory system agents|mesh-ancestor
65719448|NCT05339256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65719449|NCT05339256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65719450|NCT05335252|Dronabinol|dronabinol|mesh-list
65719451|NCT05335252|Hallucinogens|hallucinogens|mesh-ancestor
65719452|NCT05335252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719453|NCT05335252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65719454|NCT05335252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65719455|NCT05335252|Analgesics|analgesics|mesh-ancestor
65035316|NCT02236195|Mocetinostat|mocetinostat|mesh-list
65719456|NCT05335252|Sensory System Agents|sensory system agents|mesh-ancestor
65719457|NCT05335252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65719458|NCT05335252|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65719459|NCT05335252|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65719460|NCT05335252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65719461|NCT05335252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719462|NCT05335252|Hormones|hormones|mesh-ancestor
65719463|NCT05335252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65719464|NCT05325775|SR 142801|sr 142801|mesh-list
65719465|NCT05325775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65719466|NCT05325775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65719467|NCT05325775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65719468|NCT05325775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719469|NCT05325775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65719470|NCT05301842|Durvalumab|durvalumab|mesh-list
65719471|NCT05301842|Lenvatinib|lenvatinib|mesh-list
65719472|NCT05301842|Tremelimumab|tremelimumab|mesh-list
65719473|NCT05301842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65719474|NCT05301842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719475|NCT05301842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65719476|NCT05301842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719477|NCT05301842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719478|NCT05298592|Nivolumab|nivolumab|mesh-list
65719479|NCT05298592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65719480|NCT05298592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719481|NCT05298592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65719482|NCT05298592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719483|NCT05298423|Paclitaxel|paclitaxel|mesh-list
65719484|NCT05298423|Etoposide|etoposide|mesh-list
65719485|NCT05298423|Carboplatin|carboplatin|mesh-list
65719486|NCT05298423|Pembrolizumab|pembrolizumab|mesh-list
65719487|NCT05298423|Pemetrexed|pemetrexed|mesh-list
65719488|NCT05298423|Durvalumab|durvalumab|mesh-list
65719489|NCT05298423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65719490|NCT05298423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719491|NCT05298423|Tubulin Modulators|tubulin modulators|mesh-ancestor
65719492|NCT05298423|Antimitotic Agents|antimitotic agents|mesh-ancestor
65719493|NCT05298423|Mitosis Modulators|mitosis modulators|mesh-ancestor
65719494|NCT05298423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719495|NCT05298423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65719496|NCT05298423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65719497|NCT05298423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65719498|NCT05298423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719499|NCT05298423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65719500|NCT05298423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65719501|NCT05289908|Folic Acid|folic acid|mesh-list
65719502|NCT05289908|Vitamin B 12|vitamin b 12|mesh-list
65719503|NCT05289908|Dexamethasone|dexamethasone|mesh-list
65719504|NCT05289908|Pemetrexed|pemetrexed|mesh-list
65719505|NCT05289908|Vitamins|vitamins|mesh-ancestor
65719506|NCT05289908|Micronutrients|micronutrients|mesh-ancestor
65719507|NCT05289908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719508|NCT05289908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65719509|NCT05289908|Antiemetics|antiemetics|mesh-ancestor
65719510|NCT05289908|Autonomic Agents|autonomic agents|mesh-ancestor
65719511|NCT05289908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65719512|NCT05289908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65719513|NCT05289908|Glucocorticoids|glucocorticoids|mesh-ancestor
65719514|NCT05289908|Hormones|hormones|mesh-ancestor
65719515|NCT05289908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65719516|NCT05289908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65719517|NCT05289908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719518|NCT05289908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719519|NCT05289908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719520|NCT05289908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65719521|NCT05289908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65719522|NCT05289908|Hematinics|hematinics|mesh-ancestor
65719523|NCT05289908|Vitamin B Complex|vitamin b complex|mesh-ancestor
65719524|NCT05284084|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
65719525|NCT05284084|Histamine Antagonists|histamine antagonists|mesh-ancestor
65719526|NCT05284084|Histamine Agents|histamine agents|mesh-ancestor
65719527|NCT05284084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65719528|NCT05284084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719529|NCT05284084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719530|NCT05256745|Paclitaxel|paclitaxel|mesh-list
65719531|NCT05256745|Docetaxel|docetaxel|mesh-list
65719532|NCT05256745|Cyclophosphamide|cyclophosphamide|mesh-list
65719533|NCT05256745|Carboplatin|carboplatin|mesh-list
65719534|NCT05256745|Doxorubicin|doxorubicin|mesh-list
65719535|NCT05256745|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65719536|NCT05256745|Trastuzumab|trastuzumab|mesh-list
65719537|NCT05256745|Pertuzumab|pertuzumab|mesh-list
65719538|NCT05256745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65719539|NCT05256745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719540|NCT05256745|Tubulin Modulators|tubulin modulators|mesh-ancestor
65719541|NCT05256745|Antimitotic Agents|antimitotic agents|mesh-ancestor
65719542|NCT05256745|Mitosis Modulators|mitosis modulators|mesh-ancestor
65719543|NCT05256745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719544|NCT05256745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65719545|NCT05256745|Immunologic Factors|immunologic factors|mesh-ancestor
65719546|NCT05256745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719547|NCT05256745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65719548|NCT05256745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65719549|NCT05256745|Alkylating Agents|alkylating agents|mesh-ancestor
65719550|NCT05256745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65719551|NCT05256745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65719552|NCT05256745|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65719553|NCT05256745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65719554|NCT05256745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719555|NCT05256745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65719556|NCT05254171|Gemcitabine|gemcitabine|mesh-list
65719557|NCT05254171|Paclitaxel|paclitaxel|mesh-list
65719558|NCT05254171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65719559|NCT05254171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719560|NCT05254171|Tubulin Modulators|tubulin modulators|mesh-ancestor
65719561|NCT05254171|Antimitotic Agents|antimitotic agents|mesh-ancestor
65719562|NCT05254171|Mitosis Modulators|mitosis modulators|mesh-ancestor
65719563|NCT05254171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719564|NCT05254171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65719565|NCT05254171|Antimetabolites|antimetabolites|mesh-ancestor
65719566|NCT05254171|Antiviral Agents|antiviral agents|mesh-ancestor
65719567|NCT05254171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65719568|NCT05254171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719569|NCT05254171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65719570|NCT05254171|Immunologic Factors|immunologic factors|mesh-ancestor
65719571|NCT05254171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719572|NCT05247905|Capecitabine|capecitabine|mesh-list
65719573|NCT05247905|Temozolomide|temozolomide|mesh-list
65719574|NCT05247905|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65719575|NCT05247905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65719576|NCT05247905|Antimetabolites|antimetabolites|mesh-ancestor
65719577|NCT05247905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719578|NCT05247905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719579|NCT05247905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65719580|NCT05247905|Alkylating Agents|alkylating agents|mesh-ancestor
65719581|NCT05247905|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65719582|NCT05226598|Paclitaxel|paclitaxel|mesh-list
65719583|NCT05226598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65719584|NCT05226598|Carboplatin|carboplatin|mesh-list
65719585|NCT05226598|Pembrolizumab|pembrolizumab|mesh-list
65719586|NCT05226598|Pemetrexed|pemetrexed|mesh-list
65719587|NCT05226598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65719588|NCT05226598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719589|NCT05226598|Tubulin Modulators|tubulin modulators|mesh-ancestor
65719590|NCT05226598|Antimitotic Agents|antimitotic agents|mesh-ancestor
65719591|NCT05226598|Mitosis Modulators|mitosis modulators|mesh-ancestor
65719592|NCT05226598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719593|NCT05226598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65719594|NCT05226598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719595|NCT05226598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65719596|NCT05226598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65719597|NCT05226351|Dronabinol|dronabinol|mesh-list
65719598|NCT05226351|Hallucinogens|hallucinogens|mesh-ancestor
65719599|NCT05226351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719600|NCT05226351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65719601|NCT05226351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65719602|NCT05226351|Analgesics|analgesics|mesh-ancestor
65719603|NCT05226351|Sensory System Agents|sensory system agents|mesh-ancestor
65719604|NCT05226351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65719605|NCT05226351|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65719606|NCT05226351|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65719607|NCT05226351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65719608|NCT05226351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719610|NCT05226351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65719611|NCT05224141|Carboplatin|carboplatin|mesh-list
65719612|NCT05224141|Pembrolizumab|pembrolizumab|mesh-list
65719613|NCT05224141|Etoposide|etoposide|mesh-list
65719614|NCT05224141|Atezolizumab|atezolizumab|mesh-list
65719615|NCT05224141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719616|NCT05224141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65719617|NCT05224141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65719618|NCT05224141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65719619|NCT05224141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65719620|NCT05224141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719621|NCT05224141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719622|NCT05215548|Afatinib|afatinib|mesh-list
65719623|NCT05215548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719624|NCT05215548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65719625|NCT05215548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719626|NCT05215548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719627|NCT05209555|Pilocarpine|pilocarpine|mesh-list
65719628|NCT05209555|Miotics|miotics|mesh-ancestor
65719629|NCT05209555|Autonomic Agents|autonomic agents|mesh-ancestor
65719630|NCT05209555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65719631|NCT05209555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719632|NCT05209555|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65719633|NCT05209555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65719634|NCT05209555|Cholinergic Agents|cholinergic agents|mesh-ancestor
65719635|NCT05209555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65719636|NCT05209555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719637|NCT05202145|Cyclosporine|cyclosporine|mesh-list
65719638|NCT05202145|Tacrolimus|tacrolimus|mesh-list
65719639|NCT05202145|Cyclosporins|cyclosporins|mesh-list
65719640|NCT05202145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65719641|NCT05202145|Immunologic Factors|immunologic factors|mesh-ancestor
65719642|NCT05202145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719643|NCT05202145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65719644|NCT05202145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719645|NCT05202145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719646|NCT05202145|Antifungal Agents|antifungal agents|mesh-ancestor
65719647|NCT05202145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65719648|NCT05202145|Dermatologic Agents|dermatologic agents|mesh-ancestor
65719649|NCT05202145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65719650|NCT05187182|Leucovorin|leucovorin|mesh-list
65719651|NCT05187182|Pembrolizumab|pembrolizumab|mesh-list
65719652|NCT05187182|Nivolumab|nivolumab|mesh-list
65719653|NCT05187182|Trastuzumab|trastuzumab|mesh-list
65719654|NCT05187182|Oxaliplatin|oxaliplatin|mesh-list
65719655|NCT05187182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65719656|NCT05187182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719657|NCT05187182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65719658|NCT05187182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719659|NCT05187182|Antidotes|antidotes|mesh-ancestor
65719660|NCT05187182|Protective Agents|protective agents|mesh-ancestor
65719661|NCT05187182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719662|NCT05187182|Vitamin B Complex|vitamin b complex|mesh-ancestor
65719663|NCT05187182|Vitamins|vitamins|mesh-ancestor
65719664|NCT05187182|Micronutrients|micronutrients|mesh-ancestor
65719665|NCT05150938|Vitamin K|vitamin k|mesh-list
65719666|NCT05150938|Heparin|heparin|mesh-list
65719667|NCT05150938|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65719668|NCT05150938|Tinzaparin|tinzaparin|mesh-list
65719669|NCT05150938|Dalteparin|dalteparin|mesh-list
65719670|NCT05150938|Rivaroxaban|rivaroxaban|mesh-list
65719671|NCT05150938|Vitamins|vitamins|mesh-ancestor
65719672|NCT05150938|Micronutrients|micronutrients|mesh-ancestor
65719673|NCT05150938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719674|NCT05150938|Anticoagulants|anticoagulants|mesh-ancestor
65719675|NCT05150938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65719676|NCT05150938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65719677|NCT05150938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719678|NCT05150938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65719679|NCT05150938|Antithrombins|antithrombins|mesh-ancestor
65719680|NCT05150938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65719681|NCT05150938|Protease Inhibitors|protease inhibitors|mesh-ancestor
65719682|NCT05150938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719683|NCT05150938|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65719684|NCT05150938|Hemostatics|hemostatics|mesh-ancestor
65719685|NCT05150938|Coagulants|coagulants|mesh-ancestor
65719686|NCT05142904|Iodine|iodine|mesh-list
65719687|NCT05142904|Cadexomer iodine|cadexomer iodine|mesh-list
65719688|NCT05142904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65719689|NCT05142904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65719690|NCT05142904|Trace Elements|trace elements|mesh-ancestor
65719691|NCT05142904|Micronutrients|micronutrients|mesh-ancestor
65719692|NCT05142904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719693|NCT05122767|Dolutegravir|dolutegravir|mesh-list
65719694|NCT05122767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65719695|NCT05122767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65719696|NCT05122767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719697|NCT05122767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719698|NCT05122767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65719699|NCT05122767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65719700|NCT05122767|Antiviral Agents|antiviral agents|mesh-ancestor
65719701|NCT05122767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65719702|NCT05107856|Azacitidine|azacitidine|mesh-list
65719703|NCT05107856|Venetoclax|venetoclax|mesh-list
65719704|NCT05107856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65719705|NCT05107856|Antimetabolites|antimetabolites|mesh-ancestor
65719706|NCT05107856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719707|NCT05107856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719708|NCT05107856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719709|NCT05065190|Nintedanib|nintedanib|mesh-list
65719710|NCT05065190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719711|NCT05065190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65719712|NCT05065190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719713|NCT05065190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719714|NCT05060549|Cariprazine|cariprazine|mesh-list
65719715|NCT05060549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65719716|NCT05060549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65719717|NCT05060549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65719718|NCT05060549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719719|NCT05060549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65719720|NCT05042648|Buprenorphine|buprenorphine|mesh-list
65719721|NCT05042648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65719722|NCT05042648|Narcotics|narcotics|mesh-ancestor
65719723|NCT05042648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65719724|NCT05042648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719725|NCT05042648|Analgesics|analgesics|mesh-ancestor
65719726|NCT05042648|Sensory System Agents|sensory system agents|mesh-ancestor
65719727|NCT05042648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65719728|NCT05042648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65719729|NCT05036317|Empagliflozin|empagliflozin|mesh-list
65719730|NCT05036317|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65719731|NCT05036317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719732|NCT05036317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65719733|NCT05036317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719734|NCT05009979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65719735|NCT05009979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65719736|NCT05009979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719737|NCT05005442|Pembrolizumab|pembrolizumab|mesh-list
65719738|NCT05005442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65719739|NCT05005442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719740|NCT04990388|Acetaminophen|acetaminophen|mesh-list
65719741|NCT04990388|Antipyretics|antipyretics|mesh-list
65719742|NCT04990388|Cetirizine|cetirizine|mesh-list
65719743|NCT04990388|Ibuprofen|ibuprofen|mesh-list
65719744|NCT04990388|Famotidine|famotidine|mesh-list
65719745|NCT04990388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65719746|NCT04990388|Analgesics|analgesics|mesh-ancestor
65719747|NCT04990388|Sensory System Agents|sensory system agents|mesh-ancestor
65719748|NCT04990388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65719749|NCT04990388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719750|NCT04990388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65719751|NCT04990388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65719752|NCT04990388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65719753|NCT04990388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65719754|NCT04990388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719755|NCT04990388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719756|NCT04990388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65719757|NCT04990388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65719758|NCT04990388|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65719759|NCT04990388|Histamine Antagonists|histamine antagonists|mesh-ancestor
65719760|NCT04990388|Histamine Agents|histamine agents|mesh-ancestor
65719761|NCT04990388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65719762|NCT04990388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65719763|NCT04990388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65719764|NCT04990388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65719765|NCT04941716|Venetoclax|venetoclax|mesh-list
65719766|NCT04941716|Acalabrutinib|acalabrutinib|mesh-list
65719767|NCT04941716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719768|NCT04933617|Prednisone|prednisone|mesh-list
65719769|NCT04933617|Cyclophosphamide|cyclophosphamide|mesh-list
65719770|NCT04933617|Rituximab|rituximab|mesh-list
65719771|NCT04933617|Doxorubicin|doxorubicin|mesh-list
65719772|NCT04933617|Etoposide|etoposide|mesh-list
65719773|NCT04933617|Vincristine|vincristine|mesh-list
65719774|NCT04933617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65719775|NCT04933617|Immunologic Factors|immunologic factors|mesh-ancestor
65719776|NCT04933617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719777|NCT04933617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65719778|NCT04933617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65719779|NCT04933617|Alkylating Agents|alkylating agents|mesh-ancestor
65719780|NCT04933617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719781|NCT04933617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719782|NCT04933617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65719783|NCT04933617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65719784|NCT04933617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65719785|NCT04933617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65719786|NCT04933617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65719787|NCT04933617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719788|NCT04933617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65719789|NCT04933617|Glucocorticoids|glucocorticoids|mesh-ancestor
65719790|NCT04933617|Hormones|hormones|mesh-ancestor
65719791|NCT04933617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65719792|NCT04933617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65719793|NCT04933617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65719794|NCT04933617|Tubulin Modulators|tubulin modulators|mesh-ancestor
65719795|NCT04933617|Antimitotic Agents|antimitotic agents|mesh-ancestor
65719796|NCT04933617|Mitosis Modulators|mitosis modulators|mesh-ancestor
65719797|NCT04933539|Dexamethasone|dexamethasone|mesh-list
65719798|NCT04933539|Daratumumab|daratumumab|mesh-list
65719799|NCT04933539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65719800|NCT04933539|Antiemetics|antiemetics|mesh-ancestor
65719801|NCT04933539|Autonomic Agents|autonomic agents|mesh-ancestor
65719802|NCT04933539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65719803|NCT04933539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719804|NCT04933539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65719805|NCT04933539|Glucocorticoids|glucocorticoids|mesh-ancestor
65719806|NCT04933539|Hormones|hormones|mesh-ancestor
65719807|NCT04933539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65719808|NCT04933539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65719809|NCT04933539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719810|NCT04916002|Cemiplimab|cemiplimab|mesh-list
65719811|NCT04916002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65719812|NCT04916002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719813|NCT04899115|Vancomycin|vancomycin|mesh-list
65719814|NCT04899115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65719815|NCT04899115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65719816|NCT04896866|Anti-Infective Agents|anti-infective agents|mesh-list
65719817|NCT04896866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65719818|NCT04881240|Cyclophosphamide|cyclophosphamide|mesh-list
65719819|NCT04881240|Fludarabine|fludarabine|mesh-list
65719820|NCT04881240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65719821|NCT04881240|Immunologic Factors|immunologic factors|mesh-ancestor
65719822|NCT04881240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719823|NCT04881240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65719824|NCT04881240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65719825|NCT04881240|Alkylating Agents|alkylating agents|mesh-ancestor
65719826|NCT04881240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719827|NCT04881240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719828|NCT04881240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65719829|NCT04876248|Lenalidomide|lenalidomide|mesh-list
65719830|NCT04876248|Immunologic Factors|immunologic factors|mesh-ancestor
65719831|NCT04876248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719832|NCT04876248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65719833|NCT04876248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65719834|NCT04876248|Growth Substances|growth substances|mesh-ancestor
65719835|NCT04876248|Growth Inhibitors|growth inhibitors|mesh-ancestor
65719836|NCT04876248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719837|NCT04871269|Dronabinol|dronabinol|mesh-list
65719838|NCT04871269|Hallucinogens|hallucinogens|mesh-ancestor
65719839|NCT04871269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719840|NCT04871269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65719841|NCT04871269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65719842|NCT04871269|Analgesics|analgesics|mesh-ancestor
65719843|NCT04871269|Sensory System Agents|sensory system agents|mesh-ancestor
65719844|NCT04871269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65719845|NCT04871269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65719846|NCT04871269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65719847|NCT04871269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65719848|NCT04871269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719849|NCT04871269|Hormones|hormones|mesh-ancestor
65719850|NCT04871269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65719851|NCT04852887|Tamoxifen|tamoxifen|mesh-list
65719852|NCT04852887|Letrozole|letrozole|mesh-list
65719853|NCT04852887|Exemestane|exemestane|mesh-list
65719854|NCT04852887|Anastrozole|anastrozole|mesh-list
65719855|NCT04852887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719856|NCT04852887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65719857|NCT04852887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65719858|NCT04852887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719859|NCT04852887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719860|NCT04852887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65719861|NCT04852887|Hormone Antagonists|hormone antagonists|mesh-ancestor
65719862|NCT04852887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65719863|NCT04852887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719864|NCT04852887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65719865|NCT04852887|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65719866|NCT04852887|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65719867|NCT04852887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65719868|NCT04837131|Ixazomib|ixazomib|mesh-list
65719869|NCT04837131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719870|NCT04837131|Protease Inhibitors|protease inhibitors|mesh-ancestor
65719871|NCT04837131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719872|NCT04837131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719873|NCT04789096|Pembrolizumab|pembrolizumab|mesh-list
65719874|NCT04789096|Trastuzumab|trastuzumab|mesh-list
65719875|NCT04789096|Capecitabine|capecitabine|mesh-list
65719876|NCT04789096|Tucatinib|tucatinib|mesh-list
65719877|NCT04789096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65719878|NCT04789096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719879|NCT04789096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65719880|NCT04789096|Antimetabolites|antimetabolites|mesh-ancestor
65719881|NCT04789096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719882|NCT04789096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65719883|NCT04789096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719884|NCT04768010|Misoprostol|misoprostol|mesh-list
65719885|NCT04768010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65719886|NCT04768010|Abortifacient Agents|abortifacient agents|mesh-ancestor
65719887|NCT04768010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65719888|NCT04768010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719889|NCT04768010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65719890|NCT04768010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65719891|NCT04768010|Oxytocics|oxytocics|mesh-ancestor
65719892|NCT04764214|Osimertinib|osimertinib|mesh-list
65719893|NCT04764214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719894|NCT04764214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65719895|NCT04764214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719896|NCT04764214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719897|NCT04756063|Ascorbic Acid|ascorbic acid|mesh-list
65719898|NCT04756063|Vitamins|vitamins|mesh-ancestor
65719899|NCT04756063|Micronutrients|micronutrients|mesh-ancestor
65719900|NCT04756063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719901|NCT04756063|Antioxidants|antioxidants|mesh-ancestor
65719902|NCT04756063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719903|NCT04756063|Protective Agents|protective agents|mesh-ancestor
65719904|NCT04744116|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
65719905|NCT04744116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65719906|NCT04744116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719907|NCT04744116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719908|NCT04740931|Aflibercept|aflibercept|mesh-list
65719909|NCT04740931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65719910|NCT04740931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65719911|NCT04740931|Growth Substances|growth substances|mesh-ancestor
65719912|NCT04740931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719913|NCT04740931|Growth Inhibitors|growth inhibitors|mesh-ancestor
65719914|NCT04740931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719916|NCT04738487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65719917|NCT04738487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719918|NCT04710030|Valacyclovir|valacyclovir|mesh-list
65719919|NCT04710030|Antiviral Agents|antiviral agents|mesh-ancestor
65719920|NCT04710030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65719921|NCT04703075|Rifapentine|rifapentine|mesh-list
65719922|NCT04703075|Rifampin|rifampin|mesh-list
65719923|NCT04703075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65719924|NCT04703075|Antitubercular Agents|antitubercular agents|mesh-ancestor
65719925|NCT04703075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65719926|NCT04703075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65719927|NCT04703075|Leprostatic Agents|leprostatic agents|mesh-ancestor
65719928|NCT04703075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65719929|NCT04703075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719930|NCT04703075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719931|NCT04703075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65719932|NCT04703075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65719933|NCT04703075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65719934|NCT04703075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65719935|NCT04703075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65719936|NCT04703075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65719937|NCT04677972|Ebselen|ebselen|mesh-list
65719938|NCT04677972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65719939|NCT04677972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65719940|NCT04677972|Analgesics|analgesics|mesh-ancestor
65719941|NCT04677972|Sensory System Agents|sensory system agents|mesh-ancestor
65719942|NCT04677972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65719943|NCT04677972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719944|NCT04677972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65719945|NCT04677972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65719946|NCT04677972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65719947|NCT04677972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65719948|NCT04677972|Antioxidants|antioxidants|mesh-ancestor
65719949|NCT04677972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719950|NCT04677972|Protective Agents|protective agents|mesh-ancestor
65719951|NCT04677972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65719952|NCT04677972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719953|NCT04677972|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65719954|NCT04675710|Pembrolizumab|pembrolizumab|mesh-list
65719955|NCT04675710|Trametinib|trametinib|mesh-list
65719956|NCT04675710|Dabrafenib|dabrafenib|mesh-list
65719957|NCT04675710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65719958|NCT04675710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719959|NCT04675710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65719960|NCT04675710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719961|NCT04675710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719962|NCT04653818|Sofosbuvir|sofosbuvir|mesh-list
65719963|NCT04653818|Velpatasvir|velpatasvir|mesh-list
65719964|NCT04653818|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65719965|NCT04653818|Antiviral Agents|antiviral agents|mesh-ancestor
65719966|NCT04653818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65719967|NCT04609566|Pembrolizumab|pembrolizumab|mesh-list
65719968|NCT04609566|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65719969|NCT04609566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65719970|NCT04609566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719971|NCT04608955|Bedaquiline|bedaquiline|mesh-list
65719972|NCT04608955|Antitubercular Agents|antitubercular agents|mesh-ancestor
65719973|NCT04608955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65719974|NCT04608955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65719975|NCT04595370|Dapagliflozin|dapagliflozin|mesh-list
65719976|NCT04595370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65719977|NCT04595370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719978|NCT04595370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65719979|NCT04595370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719980|NCT04579848|Folic Acid|folic acid|mesh-list
65719981|NCT04579848|Methotrexate|methotrexate|mesh-list
65719982|NCT04579848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65719983|NCT04579848|Abortifacient Agents|abortifacient agents|mesh-ancestor
65719984|NCT04579848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65719985|NCT04579848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65719986|NCT04579848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65719987|NCT04579848|Antimetabolites|antimetabolites|mesh-ancestor
65719988|NCT04579848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65719989|NCT04579848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65719990|NCT04579848|Dermatologic Agents|dermatologic agents|mesh-ancestor
65719991|NCT04579848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65719992|NCT04579848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65719993|NCT04579848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65719994|NCT04579848|Immunologic Factors|immunologic factors|mesh-ancestor
65719995|NCT04579848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65719996|NCT04579848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65719997|NCT04579848|Hematinics|hematinics|mesh-ancestor
65719998|NCT04579848|Vitamin B Complex|vitamin b complex|mesh-ancestor
65719999|NCT04579848|Vitamins|vitamins|mesh-ancestor
65720000|NCT04579848|Micronutrients|micronutrients|mesh-ancestor
65720001|NCT04578652|Metformin|metformin|mesh-list
65720002|NCT04578652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65720003|NCT04578652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720004|NCT04570631|Dexamethasone|dexamethasone|mesh-list
65720005|NCT04570631|Bortezomib|bortezomib|mesh-list
65720006|NCT04570631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65720007|NCT04570631|Antiemetics|antiemetics|mesh-ancestor
65720008|NCT04570631|Autonomic Agents|autonomic agents|mesh-ancestor
65720009|NCT04570631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65720010|NCT04570631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720011|NCT04570631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65720012|NCT04570631|Glucocorticoids|glucocorticoids|mesh-ancestor
65720013|NCT04570631|Hormones|hormones|mesh-ancestor
65720014|NCT04570631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65720015|NCT04570631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65720016|NCT04570631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720017|NCT04564742|Dapagliflozin|dapagliflozin|mesh-list
65720018|NCT04564742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65720019|NCT04564742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720020|NCT04564742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65720021|NCT04564742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720022|NCT04559581|Nintedanib|nintedanib|mesh-list
65720023|NCT04559581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720024|NCT04559581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65720025|NCT04559581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720026|NCT04559581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720027|NCT04555837|Pembrolizumab|pembrolizumab|mesh-list
65720028|NCT04555837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65720029|NCT04555837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720030|NCT04550832|Moxifloxacin|moxifloxacin|mesh-list
65720031|NCT04550832|Bedaquiline|bedaquiline|mesh-list
65720032|NCT04550832|Delpazolid|delpazolid|mesh-list
65720033|NCT04550832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65720034|NCT04550832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65720035|NCT04550832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65720036|NCT04550832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65720037|NCT04550832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720038|NCT04550832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720039|NCT04550832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720040|NCT04550832|Antitubercular Agents|antitubercular agents|mesh-ancestor
65720041|NCT04550832|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65720042|NCT04477629|Mycophenolic Acid|mycophenolic acid|mesh-list
65720043|NCT04477629|Abatacept|abatacept|mesh-list
65720044|NCT04477629|Tacrolimus|tacrolimus|mesh-list
65720045|NCT04477629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65720046|NCT04477629|Immunologic Factors|immunologic factors|mesh-ancestor
65720047|NCT04477629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720048|NCT04477629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65720049|NCT04477629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720050|NCT04477629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720051|NCT04477629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65720052|NCT04477629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720053|NCT04477629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65720054|NCT04477629|Antitubercular Agents|antitubercular agents|mesh-ancestor
65720055|NCT04477629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65720056|NCT04477629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65720057|NCT04477629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65720058|NCT04477629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65720059|NCT04476277|Biotin|biotin|mesh-list
65720060|NCT04476277|Vitamin B Complex|vitamin b complex|mesh-ancestor
65720061|NCT04476277|Vitamins|vitamins|mesh-ancestor
65720062|NCT04476277|Micronutrients|micronutrients|mesh-ancestor
65720063|NCT04476277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720064|NCT04430738|Leucovorin|leucovorin|mesh-list
65720065|NCT04430738|Pembrolizumab|pembrolizumab|mesh-list
65720066|NCT04430738|Trastuzumab|trastuzumab|mesh-list
65720067|NCT04430738|Fluorouracil|fluorouracil|mesh-list
65720068|NCT04430738|Capecitabine|capecitabine|mesh-list
65720069|NCT04430738|Oxaliplatin|oxaliplatin|mesh-list
65720071|NCT04430738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65720072|NCT04430738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720073|NCT04430738|Antimetabolites|antimetabolites|mesh-ancestor
65720074|NCT04430738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720075|NCT04430738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65720076|NCT04430738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65720077|NCT04430738|Immunologic Factors|immunologic factors|mesh-ancestor
65720078|NCT04430738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720079|NCT04430738|Antidotes|antidotes|mesh-ancestor
65720080|NCT04430738|Protective Agents|protective agents|mesh-ancestor
65720081|NCT04430738|Vitamin B Complex|vitamin b complex|mesh-ancestor
65720082|NCT04430738|Vitamins|vitamins|mesh-ancestor
65720083|NCT04430738|Micronutrients|micronutrients|mesh-ancestor
65720084|NCT04430738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65720085|NCT04430738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720086|NCT04430517|Niacinamide|niacinamide|mesh-list
65720087|NCT04430517|Niacin|niacin|mesh-list
65720088|NCT04430517|Nicotinic Acids|nicotinic acids|mesh-list
65720089|NCT04430517|Vitamin B Complex|vitamin b complex|mesh-ancestor
65720090|NCT04430517|Vitamins|vitamins|mesh-ancestor
65720091|NCT04430517|Micronutrients|micronutrients|mesh-ancestor
65720092|NCT04430517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720093|NCT04430517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65720094|NCT04430517|Antimetabolites|antimetabolites|mesh-ancestor
65720095|NCT04430517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720096|NCT04430517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65720097|NCT04430517|Vasodilator Agents|vasodilator agents|mesh-ancestor
65720098|NCT04414943|Ketamine|ketamine|mesh-list
65720099|NCT04414943|Esketamine|esketamine|mesh-list
65720100|NCT04414943|Analgesics|analgesics|mesh-ancestor
65720101|NCT04414943|Sensory System Agents|sensory system agents|mesh-ancestor
65720102|NCT04414943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65720103|NCT04414943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720104|NCT04414943|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65720105|NCT04414943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65720106|NCT04414943|Anesthetics, General|anesthetics, general|mesh-ancestor
65720107|NCT04414943|Anesthetics|anesthetics|mesh-ancestor
65720108|NCT04414943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65720109|NCT04414943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65720110|NCT04414943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65720111|NCT04414943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65720112|NCT04414943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720113|NCT04414943|Antidepressive Agents|antidepressive agents|mesh-ancestor
65720114|NCT04414943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65720115|NCT04354025|Cytarabine|cytarabine|mesh-list
65720116|NCT04354025|Fludarabine|fludarabine|mesh-list
65720117|NCT04354025|Interleukin-2|interleukin-2|mesh-list
65720118|NCT04354025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720119|NCT04354025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65720120|NCT04354025|Antimetabolites|antimetabolites|mesh-ancestor
65720121|NCT04354025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720122|NCT04354025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65720123|NCT04354025|Immunologic Factors|immunologic factors|mesh-ancestor
65720124|NCT04354025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720125|NCT04354025|Antiviral Agents|antiviral agents|mesh-ancestor
65720126|NCT04354025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65720127|NCT04354025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65720128|NCT04354025|Analgesics|analgesics|mesh-ancestor
65720129|NCT04354025|Sensory System Agents|sensory system agents|mesh-ancestor
65720130|NCT04354025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65720131|NCT04347720|Acetaminophen|acetaminophen|mesh-list
65720132|NCT04347720|Ibuprofen|ibuprofen|mesh-list
65720133|NCT04347720|Indomethacin|indomethacin|mesh-list
65720134|NCT04347720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65720135|NCT04347720|Analgesics|analgesics|mesh-ancestor
65720136|NCT04347720|Sensory System Agents|sensory system agents|mesh-ancestor
65720137|NCT04347720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65720138|NCT04347720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720139|NCT04347720|Antipyretics|antipyretics|mesh-ancestor
65720140|NCT04347720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65720141|NCT04347720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65720142|NCT04347720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65035976|NCT00560443|Analgesics|analgesics|mesh-ancestor
65720143|NCT04347720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65720144|NCT04347720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720145|NCT04347720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720146|NCT04347720|Gout Suppressants|gout suppressants|mesh-ancestor
65720147|NCT04347720|Tocolytic Agents|tocolytic agents|mesh-ancestor
65720148|NCT04347720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65720149|NCT04325802|Naltrexone|naltrexone|mesh-list
65720150|NCT04325802|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65720151|NCT04325802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65720152|NCT04325802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720153|NCT04325802|Sensory System Agents|sensory system agents|mesh-ancestor
65720154|NCT04325802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65720155|NCT04325217|Nintedanib|nintedanib|mesh-list
65720156|NCT04325217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720157|NCT04325217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65720158|NCT04325217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720159|NCT04325217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720160|NCT04285346|Ganaxolone|ganaxolone|mesh-list
65720161|NCT04285346|Neurosteroids|neurosteroids|mesh-ancestor
65720162|NCT04285346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65720163|NCT04285346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720164|NCT04285346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720165|NCT04285346|GABA Modulators|gaba modulators|mesh-ancestor
65720166|NCT04285346|GABA Agents|gaba agents|mesh-ancestor
65720167|NCT04275999|Ivermectin|ivermectin|mesh-list
65720168|NCT04275999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65720169|NCT04275999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65720170|NCT04249401|Warfarin|warfarin|mesh-list
65720171|NCT04249401|Rivaroxaban|rivaroxaban|mesh-list
65720172|NCT04249401|Dabigatran|dabigatran|mesh-list
65720173|NCT04249401|Apixaban|apixaban|mesh-list
65720174|NCT04249401|Anticoagulants|anticoagulants|mesh-ancestor
65720175|NCT04249401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65720176|NCT04249401|Antithrombins|antithrombins|mesh-ancestor
65720177|NCT04249401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65720178|NCT04249401|Protease Inhibitors|protease inhibitors|mesh-ancestor
65720179|NCT04249401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720180|NCT04249401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720181|NCT04241562|Mitogens|mitogens|mesh-list
65720182|NCT04241562|Mitosis Modulators|mitosis modulators|mesh-ancestor
65720183|NCT04241562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720184|NCT04229004|Gemcitabine|gemcitabine|mesh-list
65720185|NCT04229004|Paclitaxel|paclitaxel|mesh-list
65720186|NCT04229004|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65720187|NCT04229004|Spartalizumab|spartalizumab|mesh-list
65720188|NCT04229004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65720189|NCT04229004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720190|NCT04229004|Tubulin Modulators|tubulin modulators|mesh-ancestor
65720191|NCT04229004|Antimitotic Agents|antimitotic agents|mesh-ancestor
65720192|NCT04229004|Mitosis Modulators|mitosis modulators|mesh-ancestor
65720193|NCT04229004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720194|NCT04229004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65720195|NCT04229004|Antimetabolites|antimetabolites|mesh-ancestor
65720196|NCT04229004|Antiviral Agents|antiviral agents|mesh-ancestor
65720197|NCT04229004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65720198|NCT04229004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720199|NCT04229004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65720200|NCT04229004|Immunologic Factors|immunologic factors|mesh-ancestor
65720201|NCT04229004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720202|NCT04229004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65720203|NCT04209192|Amikacin|amikacin|mesh-list
65720204|NCT04209192|Fosfomycin|fosfomycin|mesh-list
65720205|NCT04209192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65720206|NCT04209192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65720207|NCT04207931|Fluocinonide|fluocinonide|mesh-list
65720208|NCT04207931|Triamcinolone|triamcinolone|mesh-list
65720209|NCT04207931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65720210|NCT04207931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65720211|NCT04207931|Betamethasone|betamethasone|mesh-list
65720212|NCT04207931|Betamethasone Valerate|betamethasone valerate|mesh-list
65720213|NCT04207931|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65720214|NCT04207931|Betamethasone benzoate|betamethasone benzoate|mesh-list
65720215|NCT04207931|Clobetasol|clobetasol|mesh-list
65720216|NCT04207931|Minoxidil|minoxidil|mesh-list
65720217|NCT04207931|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65720218|NCT04207931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65720219|NCT04207931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65720220|NCT04207931|Glucocorticoids|glucocorticoids|mesh-ancestor
65720221|NCT04207931|Hormones|hormones|mesh-ancestor
65720222|NCT04207931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65720224|NCT04207931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65720225|NCT04207931|Immunologic Factors|immunologic factors|mesh-ancestor
65720226|NCT04207931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720227|NCT04207931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720228|NCT04207931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65720229|NCT04207931|Respiratory System Agents|respiratory system agents|mesh-ancestor
65720230|NCT04207931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65720231|NCT04207931|Vasodilator Agents|vasodilator agents|mesh-ancestor
65720232|NCT04207931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65720233|NCT04199468|Ketamine|ketamine|mesh-list
65720234|NCT04199468|Dronabinol|dronabinol|mesh-list
65720235|NCT04199468|Analgesics|analgesics|mesh-ancestor
65720236|NCT04199468|Sensory System Agents|sensory system agents|mesh-ancestor
65720237|NCT04199468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65720238|NCT04199468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720239|NCT04199468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65720240|NCT04199468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65720241|NCT04199468|Anesthetics, General|anesthetics, general|mesh-ancestor
65720242|NCT04199468|Anesthetics|anesthetics|mesh-ancestor
65720243|NCT04199468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65720244|NCT04199468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65720245|NCT04199468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65720246|NCT04199468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65720247|NCT04199468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720248|NCT04199468|Hallucinogens|hallucinogens|mesh-ancestor
65720249|NCT04199468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65720250|NCT04199468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65720251|NCT04199468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65720252|NCT04199468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65720253|NCT04199468|Hormones|hormones|mesh-ancestor
65720254|NCT04199468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65720255|NCT04178148|Amikacin|amikacin|mesh-list
65720256|NCT04178148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65720257|NCT04178148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65720258|NCT04127578|Sirolimus|sirolimus|mesh-list
65720259|NCT04127578|Methylprednisolone|methylprednisolone|mesh-list
65720260|NCT04127578|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65720261|NCT04127578|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65720262|NCT04127578|Prednisolone|prednisolone|mesh-list
65720263|NCT04127578|Prednisolone acetate|prednisolone acetate|mesh-list
65720264|NCT04127578|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65720265|NCT04127578|Prednisolone phosphate|prednisolone phosphate|mesh-list
65720266|NCT04127578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65720267|NCT04127578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65720268|NCT04127578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65720269|NCT04127578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720270|NCT04127578|Antifungal Agents|antifungal agents|mesh-ancestor
65720271|NCT04127578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65720272|NCT04127578|Immunologic Factors|immunologic factors|mesh-ancestor
65720273|NCT04127578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720274|NCT04127578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65720275|NCT04127578|Antiemetics|antiemetics|mesh-ancestor
65720276|NCT04127578|Autonomic Agents|autonomic agents|mesh-ancestor
65720277|NCT04127578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65720278|NCT04127578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65720279|NCT04127578|Glucocorticoids|glucocorticoids|mesh-ancestor
65720280|NCT04127578|Hormones|hormones|mesh-ancestor
65720281|NCT04127578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65720282|NCT04127578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65720283|NCT04127578|Protective Agents|protective agents|mesh-ancestor
65720284|NCT04127578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65720285|NCT04126681|Interferons|interferons|mesh-list
65720286|NCT04126681|Imatinib Mesylate|imatinib mesylate|mesh-list
65720287|NCT04126681|Dasatinib|dasatinib|mesh-list
65720288|NCT04126681|Hydroxyurea|hydroxyurea|mesh-list
65720289|NCT04126681|Homoharringtonine|homoharringtonine|mesh-list
65720290|NCT04126681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720291|NCT04126681|Antiviral Agents|antiviral agents|mesh-ancestor
65720292|NCT04126681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65720293|NCT04126681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65720294|NCT04126681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720295|NCT04126681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720296|NCT04126681|Antisickling Agents|antisickling agents|mesh-ancestor
65720297|NCT04126681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65720298|NCT04126681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65720299|NCT04126681|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65720301|NCT04118855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720302|NCT04118855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65720303|NCT04118855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720304|NCT04118855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720305|NCT04117087|Nivolumab|nivolumab|mesh-list
65720306|NCT04117087|Ipilimumab|ipilimumab|mesh-list
65720307|NCT04117087|Poly ICLC|poly iclc|mesh-list
65720308|NCT04117087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65720309|NCT04117087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720310|NCT04117087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65720311|NCT04117087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720312|NCT04117087|Interferon Inducers|interferon inducers|mesh-ancestor
65720313|NCT04117087|Immunologic Factors|immunologic factors|mesh-ancestor
65720314|NCT04117087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720315|NCT04084860|Ketamine|ketamine|mesh-list
65720316|NCT04084860|Analgesics|analgesics|mesh-ancestor
65720317|NCT04084860|Sensory System Agents|sensory system agents|mesh-ancestor
65720318|NCT04084860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65720319|NCT04084860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720320|NCT04084860|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65720321|NCT04084860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65720322|NCT04084860|Anesthetics, General|anesthetics, general|mesh-ancestor
65720323|NCT04084860|Anesthetics|anesthetics|mesh-ancestor
65720324|NCT04084860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65720325|NCT04084860|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65720326|NCT04084860|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65720327|NCT04084860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65720328|NCT04084860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720329|NCT04068103|Calcium, Dietary|calcium, dietary|mesh-list
65720330|NCT04068103|Leucovorin|leucovorin|mesh-list
65720331|NCT04068103|Folic Acid|folic acid|mesh-list
65720332|NCT04068103|Fluorouracil|fluorouracil|mesh-list
65720333|NCT04068103|Capecitabine|capecitabine|mesh-list
65720334|NCT04068103|Oxaliplatin|oxaliplatin|mesh-list
65720335|NCT04068103|Calcium|calcium|mesh-list
65720336|NCT04068103|Levoleucovorin|levoleucovorin|mesh-list
65720337|NCT04068103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65720338|NCT04068103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720339|NCT04068103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65720340|NCT04068103|Antimetabolites|antimetabolites|mesh-ancestor
65720341|NCT04068103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720342|NCT04068103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65720343|NCT04068103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720344|NCT04068103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65720345|NCT04068103|Immunologic Factors|immunologic factors|mesh-ancestor
65720346|NCT04068103|Antidotes|antidotes|mesh-ancestor
65720347|NCT04068103|Protective Agents|protective agents|mesh-ancestor
65720348|NCT04068103|Vitamin B Complex|vitamin b complex|mesh-ancestor
65720349|NCT04068103|Vitamins|vitamins|mesh-ancestor
65720350|NCT04068103|Micronutrients|micronutrients|mesh-ancestor
65720351|NCT04068103|Hematinics|hematinics|mesh-ancestor
65720352|NCT04029480|Metformin|metformin|mesh-list
65720353|NCT04029480|Ertugliflozin|ertugliflozin|mesh-list
65720354|NCT04029480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65720355|NCT04029480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720356|NCT04029480|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65720357|NCT04029480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720358|NCT04011150|Fentanyl|fentanyl|mesh-list
65720359|NCT04011150|Ropivacaine|ropivacaine|mesh-list
65720360|NCT04011150|Anesthetics, Local|anesthetics, local|mesh-list
65720361|NCT04011150|Anesthetics|anesthetics|mesh-list
65720362|NCT04011150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65720363|NCT04011150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720364|NCT04011150|Sensory System Agents|sensory system agents|mesh-ancestor
65720365|NCT04011150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65720366|NCT04011150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65720367|NCT04011150|Narcotics|narcotics|mesh-ancestor
65720368|NCT04011150|Analgesics|analgesics|mesh-ancestor
65720369|NCT04011150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65720370|NCT04011150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65720371|NCT04011150|Anesthetics, General|anesthetics, general|mesh-ancestor
65720372|NCT03994796|Entrectinib|entrectinib|mesh-list
65720373|NCT03994796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65720374|NCT03994796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720375|NCT03994796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720377|NCT03971253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720378|NCT03971253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720379|NCT03971253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65720380|NCT03971253|Immunologic Factors|immunologic factors|mesh-ancestor
65720381|NCT03971253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720382|NCT03954041|Glyburide|glyburide|mesh-list
65720383|NCT03954041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65720384|NCT03954041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720385|NCT03939897|Fulvestrant|fulvestrant|mesh-list
65720386|NCT03939897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65720387|NCT03939897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720388|NCT03939897|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65720389|NCT03939897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65720390|NCT03939897|Hormone Antagonists|hormone antagonists|mesh-ancestor
65720391|NCT03939897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65720392|NCT03939897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720393|NCT03927378|Ketamine|ketamine|mesh-list
65720394|NCT03927378|Esketamine|esketamine|mesh-list
65720395|NCT03927378|Analgesics|analgesics|mesh-ancestor
65720396|NCT03927378|Sensory System Agents|sensory system agents|mesh-ancestor
65720397|NCT03927378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65720398|NCT03927378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720399|NCT03927378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65720400|NCT03927378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65720401|NCT03927378|Anesthetics, General|anesthetics, general|mesh-ancestor
65720402|NCT03927378|Anesthetics|anesthetics|mesh-ancestor
65720403|NCT03927378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65720404|NCT03927378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65720405|NCT03927378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65720406|NCT03927378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65720407|NCT03927378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720408|NCT03927378|Antidepressive Agents|antidepressive agents|mesh-ancestor
65720409|NCT03927378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65720410|NCT03879798|Irinotecan|irinotecan|mesh-list
65720411|NCT03879798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65720412|NCT03879798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65720413|NCT03879798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720414|NCT03879798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720415|NCT03879798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720416|NCT03875391|Oxytocin|oxytocin|mesh-list
65720417|NCT03875391|Oxytocics|oxytocics|mesh-ancestor
65720418|NCT03875391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65720419|NCT03875391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720420|NCT03836066|Bevacizumab|bevacizumab|mesh-list
65720421|NCT03836066|Atezolizumab|atezolizumab|mesh-list
65720422|NCT03836066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65720423|NCT03836066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720424|NCT03836066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65183055|NCT00697567|Vaccines|vaccines|mesh-list
65720425|NCT03836066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65720426|NCT03836066|Growth Substances|growth substances|mesh-ancestor
65720427|NCT03836066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720428|NCT03836066|Growth Inhibitors|growth inhibitors|mesh-ancestor
65720429|NCT03778242|Tranexamic Acid|tranexamic acid|mesh-list
65720430|NCT03778242|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65720431|NCT03778242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65720432|NCT03778242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720433|NCT03778242|Hemostatics|hemostatics|mesh-ancestor
65720434|NCT03778242|Coagulants|coagulants|mesh-ancestor
65720435|NCT03772613|Heparin|heparin|mesh-list
65720436|NCT03772613|Calcium heparin|calcium heparin|mesh-list
65720437|NCT03772613|Anticoagulants|anticoagulants|mesh-ancestor
65720438|NCT03772613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65720439|NCT03772613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65720440|NCT03772613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720441|NCT03739814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65720442|NCT03739814|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65720443|NCT03739814|Blinatumomab|blinatumomab|mesh-list
65720444|NCT03739814|Antibodies|antibodies|mesh-list
65720445|NCT03739814|Immunoglobulins|immunoglobulins|mesh-list
65720446|NCT03739814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65720447|NCT03739814|Muromonab-CD3|muromonab-cd3|mesh-list
65720448|NCT03739814|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65720449|NCT03739814|Immunologic Factors|immunologic factors|mesh-ancestor
65720450|NCT03739814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720451|NCT03739814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720452|NCT03739814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65720453|NCT03739814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65720454|NCT03730194|Melatonin|melatonin|mesh-list
65720455|NCT03730194|Antioxidants|antioxidants|mesh-ancestor
65720456|NCT03730194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720457|NCT03730194|Protective Agents|protective agents|mesh-ancestor
65720458|NCT03730194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720459|NCT03730194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65720460|NCT03709680|Cyclophosphamide|cyclophosphamide|mesh-list
65720461|NCT03709680|Temozolomide|temozolomide|mesh-list
65720462|NCT03709680|Irinotecan|irinotecan|mesh-list
65720463|NCT03709680|Topotecan|topotecan|mesh-list
65720464|NCT03709680|Palbociclib|palbociclib|mesh-list
65720465|NCT03709680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65720466|NCT03709680|Immunologic Factors|immunologic factors|mesh-ancestor
65720467|NCT03709680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720468|NCT03709680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65720469|NCT03709680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65720470|NCT03709680|Alkylating Agents|alkylating agents|mesh-ancestor
65720471|NCT03709680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720472|NCT03709680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720473|NCT03709680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65720474|NCT03709680|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65720475|NCT03709680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65720476|NCT03709680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720477|NCT03709680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65720478|NCT03698461|Leucovorin|leucovorin|mesh-list
65720479|NCT03698461|Bevacizumab|bevacizumab|mesh-list
65720480|NCT03698461|Fluorouracil|fluorouracil|mesh-list
65720481|NCT03698461|Oxaliplatin|oxaliplatin|mesh-list
65720482|NCT03698461|Atezolizumab|atezolizumab|mesh-list
65720483|NCT03698461|Levoleucovorin|levoleucovorin|mesh-list
65720484|NCT03698461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65720485|NCT03698461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720486|NCT03698461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65720487|NCT03698461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65720488|NCT03698461|Growth Substances|growth substances|mesh-ancestor
65720489|NCT03698461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720490|NCT03698461|Growth Inhibitors|growth inhibitors|mesh-ancestor
65720491|NCT03698461|Antimetabolites|antimetabolites|mesh-ancestor
65720492|NCT03698461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720493|NCT03698461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65720494|NCT03698461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65720495|NCT03698461|Immunologic Factors|immunologic factors|mesh-ancestor
65720496|NCT03698461|Antidotes|antidotes|mesh-ancestor
65720497|NCT03698461|Protective Agents|protective agents|mesh-ancestor
65720498|NCT03698461|Vitamin B Complex|vitamin b complex|mesh-ancestor
65720499|NCT03698461|Vitamins|vitamins|mesh-ancestor
65720500|NCT03698461|Micronutrients|micronutrients|mesh-ancestor
65720501|NCT03623321|Pimavanserin|pimavanserin|mesh-list
65720502|NCT03623321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65720503|NCT03623321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65720504|NCT03623321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65720505|NCT03623321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65720506|NCT03623321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65720507|NCT03623321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720508|NCT03623321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65720509|NCT03623321|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65720510|NCT03623321|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65720511|NCT03623321|Serotonin Agents|serotonin agents|mesh-ancestor
65720512|NCT03623321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65720513|NCT03623321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720514|NCT03612960|Nicotine|nicotine|mesh-list
65720515|NCT03612960|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65720516|NCT03612960|Autonomic Agents|autonomic agents|mesh-ancestor
65720517|NCT03612960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65720518|NCT03612960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720519|NCT03612960|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65720520|NCT03612960|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65720521|NCT03612960|Cholinergic Agents|cholinergic agents|mesh-ancestor
65720522|NCT03612960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65720523|NCT03612960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720524|NCT03601923|Niraparib|niraparib|mesh-list
64477673|NCT01891669|PF-06263507|pf-06263507|mesh-list
65720525|NCT03601923|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65720526|NCT03601923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720527|NCT03601923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720528|NCT03601923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720530|NCT03594110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65720531|NCT03594110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720532|NCT03594110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65720533|NCT03594110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720534|NCT03590652|Dexamethasone|dexamethasone|mesh-list
65720535|NCT03590652|Daratumumab|daratumumab|mesh-list
65720536|NCT03590652|Pomalidomide|pomalidomide|mesh-list
65720537|NCT03590652|Ixazomib|ixazomib|mesh-list
65720538|NCT03590652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65720539|NCT03590652|Antiemetics|antiemetics|mesh-ancestor
65720540|NCT03590652|Autonomic Agents|autonomic agents|mesh-ancestor
65720541|NCT03590652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65720542|NCT03590652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720543|NCT03590652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65720544|NCT03590652|Glucocorticoids|glucocorticoids|mesh-ancestor
65720545|NCT03590652|Hormones|hormones|mesh-ancestor
65720546|NCT03590652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65720547|NCT03590652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65720548|NCT03590652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720549|NCT03590652|Immunologic Factors|immunologic factors|mesh-ancestor
65720550|NCT03590652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65720551|NCT03590652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65720552|NCT03590652|Growth Substances|growth substances|mesh-ancestor
65720553|NCT03590652|Growth Inhibitors|growth inhibitors|mesh-ancestor
65720554|NCT03590652|Protease Inhibitors|protease inhibitors|mesh-ancestor
65720555|NCT03590652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720556|NCT03590652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720557|NCT03535363|Osimertinib|osimertinib|mesh-list
65720558|NCT03535363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720559|NCT03535363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65720560|NCT03535363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720561|NCT03535363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720562|NCT03483038|Irinotecan|irinotecan|mesh-list
65720563|NCT03483038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65720564|NCT03483038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65720565|NCT03483038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720566|NCT03483038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720567|NCT03483038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720568|NCT03462459|Vancomycin|vancomycin|mesh-list
65720569|NCT03462459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65720570|NCT03462459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65720571|NCT03417284|Melphalan|melphalan|mesh-list
65720572|NCT03417284|Lenograstim|lenograstim|mesh-list
65720573|NCT03417284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65720574|NCT03417284|Immunologic Factors|immunologic factors|mesh-ancestor
65720575|NCT03417284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720576|NCT03417284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65720577|NCT03417284|Alkylating Agents|alkylating agents|mesh-ancestor
65720578|NCT03417284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720579|NCT03417284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720580|NCT03417284|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65720581|NCT03417284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65720582|NCT03384836|Pembrolizumab|pembrolizumab|mesh-list
65720583|NCT03384836|Propranolol|propranolol|mesh-list
65720584|NCT03384836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65720585|NCT03384836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720586|NCT03384836|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65720587|NCT03384836|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65720588|NCT03384836|Adrenergic Agents|adrenergic agents|mesh-ancestor
65720589|NCT03384836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65720590|NCT03384836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720591|NCT03384836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720592|NCT03384836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65720593|NCT03384836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65720594|NCT03384836|Vasodilator Agents|vasodilator agents|mesh-ancestor
65720595|NCT03377179|Hydroxychloroquine|hydroxychloroquine|mesh-list
65720596|NCT03377179|Antimalarials|antimalarials|mesh-ancestor
65720597|NCT03377179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65720598|NCT03377179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65720599|NCT03377179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65720600|NCT03377179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720601|NCT03377179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720602|NCT03377179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65720604|NCT03363464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65720605|NCT03363464|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65720606|NCT03363464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720607|NCT03363464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65720608|NCT03363464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720609|NCT03363464|Protease Inhibitors|protease inhibitors|mesh-ancestor
65720610|NCT03363464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720611|NCT03337698|Linagliptin|linagliptin|mesh-list
65720612|NCT03337698|Gemcitabine|gemcitabine|mesh-list
65720613|NCT03337698|Bevacizumab|bevacizumab|mesh-list
65720614|NCT03337698|Carboplatin|carboplatin|mesh-list
65720615|NCT03337698|Docetaxel|docetaxel|mesh-list
65720616|NCT03337698|Pemetrexed|pemetrexed|mesh-list
65720617|NCT03337698|Atezolizumab|atezolizumab|mesh-list
65720618|NCT03337698|Evolocumab|evolocumab|mesh-list
65720619|NCT03337698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65720620|NCT03337698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720621|NCT03337698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65720622|NCT03337698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65720623|NCT03337698|Growth Substances|growth substances|mesh-ancestor
65720624|NCT03337698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720625|NCT03337698|Growth Inhibitors|growth inhibitors|mesh-ancestor
65720626|NCT03337698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65720627|NCT03337698|Antimetabolites|antimetabolites|mesh-ancestor
65720628|NCT03337698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720629|NCT03337698|Antiviral Agents|antiviral agents|mesh-ancestor
65720630|NCT03337698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65720631|NCT03337698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720632|NCT03337698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65720633|NCT03337698|Immunologic Factors|immunologic factors|mesh-ancestor
65720634|NCT03337698|Tubulin Modulators|tubulin modulators|mesh-ancestor
65720635|NCT03337698|Antimitotic Agents|antimitotic agents|mesh-ancestor
65720636|NCT03337698|Mitosis Modulators|mitosis modulators|mesh-ancestor
65720637|NCT03337698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65720638|NCT03337698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65720639|NCT03337698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65720640|NCT03337698|Incretins|incretins|mesh-ancestor
65720641|NCT03337698|Hormones|hormones|mesh-ancestor
65720642|NCT03337698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65720643|NCT03337698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65720644|NCT03337698|Protease Inhibitors|protease inhibitors|mesh-ancestor
65720645|NCT03337698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65720646|NCT03337698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65720647|NCT03337698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65720648|NCT03332797|Palbociclib|palbociclib|mesh-list
65720649|NCT03332797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720650|NCT03332797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65720651|NCT03332797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720652|NCT03332797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720653|NCT03290937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65720654|NCT03290937|Cetuximab|cetuximab|mesh-list
65720655|NCT03290937|Irinotecan|irinotecan|mesh-list
65720656|NCT03290937|Camptothecin|camptothecin|mesh-list
65720657|NCT03290937|Antibodies|antibodies|mesh-list
65720658|NCT03290937|Immunoglobulins|immunoglobulins|mesh-list
65720659|NCT03290937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65720660|NCT03290937|Immunoglobulin G|immunoglobulin g|mesh-list
65720661|NCT03290937|Immunologic Factors|immunologic factors|mesh-ancestor
65720662|NCT03290937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720663|NCT03290937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720664|NCT03290937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65720665|NCT03290937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65720666|NCT03290937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720667|NCT03290937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720668|NCT03290937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65720669|NCT03278782|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65720670|NCT03278782|Pembrolizumab|pembrolizumab|mesh-list
65720671|NCT03278782|Romidepsin|romidepsin|mesh-list
65720672|NCT03278782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65720673|NCT03278782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720674|NCT03278782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65720675|NCT03278782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65720676|NCT03261102|Adalimumab|adalimumab|mesh-list
65720677|NCT03261102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65720678|NCT03261102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65720679|NCT03241732|Acetylcysteine|acetylcysteine|mesh-list
65720680|NCT03241732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65720681|NCT03241732|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65720682|NCT03241732|Antiviral Agents|antiviral agents|mesh-ancestor
65720683|NCT03241732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65720684|NCT03241732|Expectorants|expectorants|mesh-ancestor
65720685|NCT03241732|Respiratory System Agents|respiratory system agents|mesh-ancestor
65720686|NCT03241732|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65720687|NCT03241732|Antioxidants|antioxidants|mesh-ancestor
65720688|NCT03241732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720689|NCT03241732|Protective Agents|protective agents|mesh-ancestor
65720690|NCT03241732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720691|NCT03241732|Antidotes|antidotes|mesh-ancestor
65720692|NCT03224767|Vemurafenib|vemurafenib|mesh-list
65720693|NCT03224767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720694|NCT03224767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65720695|NCT03224767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720696|NCT03224767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720697|NCT03206047|Poly I-C|poly i-c|mesh-list
65720698|NCT03206047|Atezolizumab|atezolizumab|mesh-list
65720699|NCT03206047|Guadecitabine|guadecitabine|mesh-list
65720700|NCT03206047|Azacitidine|azacitidine|mesh-list
65720701|NCT03206047|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65720702|NCT03206047|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65720703|NCT03206047|Poly ICLC|poly iclc|mesh-list
65720704|NCT03206047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720705|NCT03206047|Immunologic Factors|immunologic factors|mesh-ancestor
65720706|NCT03206047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720707|NCT03206047|Interferon Inducers|interferon inducers|mesh-ancestor
65720708|NCT03206047|Laxatives|laxatives|mesh-ancestor
65720709|NCT03206047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65720710|NCT03206047|Antiviral Agents|antiviral agents|mesh-ancestor
65720711|NCT03206047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65720712|NCT03206047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65720713|NCT03206047|Antimetabolites|antimetabolites|mesh-ancestor
65720714|NCT03206047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720715|NCT03206047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720716|NCT03150693|Cytarabine|cytarabine|mesh-list
65720717|NCT03150693|Dexamethasone|dexamethasone|mesh-list
65720718|NCT03150693|Cyclophosphamide|cyclophosphamide|mesh-list
65720719|NCT03150693|Rituximab|rituximab|mesh-list
65720720|NCT03150693|Doxorubicin|doxorubicin|mesh-list
65720721|NCT03150693|Methotrexate|methotrexate|mesh-list
65720722|NCT03150693|Vincristine|vincristine|mesh-list
65720723|NCT03150693|Daunorubicin|daunorubicin|mesh-list
65720724|NCT03150693|Asparaginase|asparaginase|mesh-list
65720725|NCT03150693|Mercaptopurine|mercaptopurine|mesh-list
65720726|NCT03150693|Thioguanine|thioguanine|mesh-list
65720727|NCT03150693|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65720728|NCT03150693|Pegaspargase|pegaspargase|mesh-list
65720729|NCT03150693|Allopurinol|allopurinol|mesh-list
65720730|NCT03150693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65720731|NCT03150693|Immunologic Factors|immunologic factors|mesh-ancestor
65720732|NCT03150693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720733|NCT03150693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65720734|NCT03150693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65720735|NCT03150693|Alkylating Agents|alkylating agents|mesh-ancestor
65720736|NCT03150693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720737|NCT03150693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720738|NCT03150693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65720739|NCT03150693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65720740|NCT03150693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65720741|NCT03150693|Antiemetics|antiemetics|mesh-ancestor
65720742|NCT03150693|Autonomic Agents|autonomic agents|mesh-ancestor
65720743|NCT03150693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65720744|NCT03150693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65720745|NCT03150693|Glucocorticoids|glucocorticoids|mesh-ancestor
65720746|NCT03150693|Hormones|hormones|mesh-ancestor
65720747|NCT03150693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65720748|NCT03150693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65720749|NCT03150693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65036573|NCT00202020|Protective Agents|protective agents|mesh-ancestor
65720750|NCT03150693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65720751|NCT03150693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65720752|NCT03150693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720753|NCT03150693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65720754|NCT03150693|Abortifacient Agents|abortifacient agents|mesh-ancestor
65720755|NCT03150693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65720756|NCT03150693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65720757|NCT03150693|Antimetabolites|antimetabolites|mesh-ancestor
65720758|NCT03150693|Dermatologic Agents|dermatologic agents|mesh-ancestor
65720759|NCT03150693|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65720760|NCT03150693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65720761|NCT03150693|Antiviral Agents|antiviral agents|mesh-ancestor
65720762|NCT03150693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65720763|NCT03150693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65720764|NCT03150693|Tubulin Modulators|tubulin modulators|mesh-ancestor
65720765|NCT03150693|Antimitotic Agents|antimitotic agents|mesh-ancestor
65720766|NCT03150693|Mitosis Modulators|mitosis modulators|mesh-ancestor
65720767|NCT03150693|Gout Suppressants|gout suppressants|mesh-ancestor
65720768|NCT03150693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65720769|NCT03150693|Antioxidants|antioxidants|mesh-ancestor
65720770|NCT03150693|Protective Agents|protective agents|mesh-ancestor
65720771|NCT03056755|Letrozole|letrozole|mesh-list
65720772|NCT03056755|Fulvestrant|fulvestrant|mesh-list
65720773|NCT03056755|Leuprolide|leuprolide|mesh-list
65720774|NCT03056755|Goserelin|goserelin|mesh-list
65720775|NCT03056755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720776|NCT03056755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65720777|NCT03056755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65720778|NCT03056755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720779|NCT03056755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720780|NCT03056755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65720781|NCT03056755|Hormone Antagonists|hormone antagonists|mesh-ancestor
65720782|NCT03056755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65720783|NCT03056755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720784|NCT03056755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65720785|NCT03056755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65720786|NCT03056755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65720787|NCT03056755|Fertility Agents|fertility agents|mesh-ancestor
65720788|NCT03056755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65720789|NCT02968212|Clofazimine|clofazimine|mesh-list
65720790|NCT02968212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65720791|NCT02968212|Leprostatic Agents|leprostatic agents|mesh-ancestor
65720792|NCT02968212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65720793|NCT02968212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65720794|NCT02967692|Trametinib|trametinib|mesh-list
65720795|NCT02967692|Dabrafenib|dabrafenib|mesh-list
65720796|NCT02967692|Spartalizumab|spartalizumab|mesh-list
65720797|NCT02967692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720798|NCT02967692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65720799|NCT02967692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720800|NCT02967692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720801|NCT02967692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65720802|NCT02931253|Metformin|metformin|mesh-list
65720803|NCT02931253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65720804|NCT02931253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720805|NCT02848131|Dasatinib|dasatinib|mesh-list
65720806|NCT02848131|Quercetin|quercetin|mesh-list
65720807|NCT02848131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720808|NCT02848131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65720809|NCT02848131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720810|NCT02848131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720811|NCT02848131|Antioxidants|antioxidants|mesh-ancestor
65720812|NCT02848131|Protective Agents|protective agents|mesh-ancestor
65720813|NCT02848131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720814|NCT02846376|Nivolumab|nivolumab|mesh-list
65720815|NCT02846376|Ipilimumab|ipilimumab|mesh-list
65720816|NCT02846376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65720817|NCT02846376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720818|NCT02846376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65720819|NCT02846376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720820|NCT02803437|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65720821|NCT02803437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720822|NCT02626455|Prednisone|prednisone|mesh-list
65720823|NCT02626455|Cyclophosphamide|cyclophosphamide|mesh-list
65720824|NCT02626455|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65720825|NCT02626455|Rituximab|rituximab|mesh-list
65720826|NCT02626455|Doxorubicin|doxorubicin|mesh-list
65720827|NCT02626455|Vincristine|vincristine|mesh-list
65720828|NCT02626455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65720829|NCT02626455|Immunologic Factors|immunologic factors|mesh-ancestor
65720830|NCT02626455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720831|NCT02626455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65720832|NCT02626455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65720833|NCT02626455|Alkylating Agents|alkylating agents|mesh-ancestor
65720834|NCT02626455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720835|NCT02626455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720836|NCT02626455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65720837|NCT02626455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65720838|NCT02626455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65720839|NCT02626455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65720840|NCT02626455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65720841|NCT02626455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720842|NCT02626455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65720843|NCT02626455|Glucocorticoids|glucocorticoids|mesh-ancestor
65720844|NCT02626455|Hormones|hormones|mesh-ancestor
65720845|NCT02626455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65720846|NCT02626455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65720847|NCT02626455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65720848|NCT02626455|Tubulin Modulators|tubulin modulators|mesh-ancestor
65720849|NCT02626455|Antimitotic Agents|antimitotic agents|mesh-ancestor
65720850|NCT02626455|Mitosis Modulators|mitosis modulators|mesh-ancestor
65720851|NCT02598349|Capecitabine|capecitabine|mesh-list
65720852|NCT02598349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65720853|NCT02598349|Antimetabolites|antimetabolites|mesh-ancestor
65720854|NCT02598349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720855|NCT02598349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720856|NCT02590601|Bromocriptine|bromocriptine|mesh-list
65720857|NCT02590601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65720858|NCT02590601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65720859|NCT02590601|Hormone Antagonists|hormone antagonists|mesh-ancestor
65720860|NCT02590601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65720861|NCT02590601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720862|NCT02590601|Dopamine Agonists|dopamine agonists|mesh-ancestor
65720863|NCT02590601|Dopamine Agents|dopamine agents|mesh-ancestor
65720864|NCT02590601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65720865|NCT02590601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720866|NCT02577406|Cytarabine|cytarabine|mesh-list
65720867|NCT02577406|Azacitidine|azacitidine|mesh-list
65720868|NCT02577406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65720869|NCT02577406|Antimetabolites|antimetabolites|mesh-ancestor
65720870|NCT02577406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720871|NCT02577406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720872|NCT02577406|Antiviral Agents|antiviral agents|mesh-ancestor
65720873|NCT02577406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65720874|NCT02577406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65720875|NCT02577406|Immunologic Factors|immunologic factors|mesh-ancestor
65720876|NCT02577406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720877|NCT02577406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720878|NCT02567435|Sirolimus|sirolimus|mesh-list
65720879|NCT02567435|Dactinomycin|dactinomycin|mesh-list
65720880|NCT02567435|Cactinomycin|cactinomycin|mesh-list
65720881|NCT02567435|Cyclophosphamide|cyclophosphamide|mesh-list
65720882|NCT02567435|Irinotecan|irinotecan|mesh-list
65720883|NCT02567435|Vincristine|vincristine|mesh-list
65720884|NCT02567435|Vinorelbine|vinorelbine|mesh-list
65720885|NCT02567435|Camptothecin|camptothecin|mesh-list
65720886|NCT02567435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65720887|NCT02567435|Immunologic Factors|immunologic factors|mesh-ancestor
65720888|NCT02567435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720889|NCT02567435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65720890|NCT02567435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65720891|NCT02567435|Alkylating Agents|alkylating agents|mesh-ancestor
65720892|NCT02567435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720893|NCT02567435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720894|NCT02567435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65720895|NCT02567435|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65720896|NCT02567435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65720897|NCT02567435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720898|NCT02567435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65720899|NCT02567435|Tubulin Modulators|tubulin modulators|mesh-ancestor
65720900|NCT02567435|Antimitotic Agents|antimitotic agents|mesh-ancestor
65720901|NCT02567435|Mitosis Modulators|mitosis modulators|mesh-ancestor
65720902|NCT02567435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65720903|NCT02567435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65720904|NCT02567435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65720905|NCT02567435|Antifungal Agents|antifungal agents|mesh-ancestor
65720906|NCT02567435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65720907|NCT02567435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65720909|NCT02501096|Lenvatinib|lenvatinib|mesh-list
65720910|NCT02501096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65720911|NCT02501096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720912|NCT02501096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65720913|NCT02501096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720914|NCT02501096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720915|NCT02484443|Dinutuximab|dinutuximab|mesh-list
65720916|NCT02484443|Sargramostim|sargramostim|mesh-list
65720917|NCT02484443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65720918|NCT02484443|Immunologic Factors|immunologic factors|mesh-ancestor
65720919|NCT02484443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720920|NCT02484443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720921|NCT02451982|Cyclophosphamide|cyclophosphamide|mesh-list
65720922|NCT02451982|Nivolumab|nivolumab|mesh-list
65720923|NCT02451982|Immunologic Factors|immunologic factors|mesh-ancestor
65720924|NCT02451982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720925|NCT02451982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65720926|NCT02451982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65720927|NCT02451982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65720928|NCT02451982|Alkylating Agents|alkylating agents|mesh-ancestor
65720929|NCT02451982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720930|NCT02451982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720931|NCT02451982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65720932|NCT02451982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65720933|NCT02451982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65720934|NCT02306161|Cyclophosphamide|cyclophosphamide|mesh-list
65720935|NCT02306161|Ifosfamide|ifosfamide|mesh-list
65720936|NCT02306161|Isophosphamide mustard|isophosphamide mustard|mesh-list
65720937|NCT02306161|Doxorubicin|doxorubicin|mesh-list
65720938|NCT02306161|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65720939|NCT02306161|Etoposide|etoposide|mesh-list
65720940|NCT02306161|Etoposide phosphate|etoposide phosphate|mesh-list
65720941|NCT02306161|Vincristine|vincristine|mesh-list
65720942|NCT02306161|Daunorubicin|daunorubicin|mesh-list
65720943|NCT02306161|Podophyllotoxin|podophyllotoxin|mesh-list
65720944|NCT02306161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65720945|NCT02306161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65720946|NCT02306161|Immunologic Factors|immunologic factors|mesh-ancestor
65720947|NCT02306161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720948|NCT02306161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65720949|NCT02306161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65720950|NCT02306161|Alkylating Agents|alkylating agents|mesh-ancestor
65720951|NCT02306161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720952|NCT02306161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720953|NCT02306161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65720954|NCT02306161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65720955|NCT02306161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65720956|NCT02306161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65720957|NCT02306161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720958|NCT02306161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65720959|NCT02306161|Tubulin Modulators|tubulin modulators|mesh-ancestor
65720960|NCT02306161|Antimitotic Agents|antimitotic agents|mesh-ancestor
65720961|NCT02306161|Mitosis Modulators|mitosis modulators|mesh-ancestor
65720962|NCT02306161|Keratolytic Agents|keratolytic agents|mesh-ancestor
65720963|NCT02306161|Dermatologic Agents|dermatologic agents|mesh-ancestor
65720964|NCT02288247|Prednisolone|prednisolone|mesh-list
65720965|NCT02288247|Docetaxel|docetaxel|mesh-list
65720966|NCT02288247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720967|NCT02288247|Tubulin Modulators|tubulin modulators|mesh-ancestor
65720968|NCT02288247|Antimitotic Agents|antimitotic agents|mesh-ancestor
65720969|NCT02288247|Mitosis Modulators|mitosis modulators|mesh-ancestor
65720970|NCT02288247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720971|NCT02288247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65720972|NCT02288247|Glucocorticoids|glucocorticoids|mesh-ancestor
65720973|NCT02288247|Hormones|hormones|mesh-ancestor
65720974|NCT02288247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65720975|NCT02288247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720976|NCT02288247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65720977|NCT02254278|Cisplatin|cisplatin|mesh-list
65720978|NCT02254278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720979|NCT02253316|Dexamethasone|dexamethasone|mesh-list
65720980|NCT02253316|Dexamethasone acetate|dexamethasone acetate|mesh-list
65720981|NCT02253316|Lenalidomide|lenalidomide|mesh-list
65720982|NCT02253316|Ixazomib|ixazomib|mesh-list
65720983|NCT02253316|BB 1101|bb 1101|mesh-list
65720984|NCT02253316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65720985|NCT02253316|Antiemetics|antiemetics|mesh-ancestor
65720986|NCT02253316|Autonomic Agents|autonomic agents|mesh-ancestor
65720987|NCT02253316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65720988|NCT02253316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65720989|NCT02253316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65720990|NCT02253316|Glucocorticoids|glucocorticoids|mesh-ancestor
65720991|NCT02253316|Hormones|hormones|mesh-ancestor
65720992|NCT02253316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65720993|NCT02253316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65720994|NCT02253316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65720995|NCT02253316|Protease Inhibitors|protease inhibitors|mesh-ancestor
65720996|NCT02253316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65720997|NCT02253316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65720998|NCT02253316|Immunologic Factors|immunologic factors|mesh-ancestor
65720999|NCT02253316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65721000|NCT02253316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65721001|NCT02253316|Growth Substances|growth substances|mesh-ancestor
65721002|NCT02253316|Growth Inhibitors|growth inhibitors|mesh-ancestor
65721003|NCT02240498|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65721004|NCT02240498|Methylene Blue|methylene blue|mesh-list
65721005|NCT02240498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721006|NCT02240498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721007|NCT02240498|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65721008|NCT02240498|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65721009|NCT02240498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65721010|NCT02178098|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
65721011|NCT02178098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65721012|NCT02178098|Antimetabolites|antimetabolites|mesh-ancestor
65721013|NCT02178098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721014|NCT02178098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65721015|NCT02178098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721016|NCT02178098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65721017|NCT02178098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721018|NCT02176148|Fluocinonide|fluocinonide|mesh-list
65721019|NCT02176148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65721020|NCT02176148|Glucocorticoids|glucocorticoids|mesh-ancestor
65721021|NCT02176148|Hormones|hormones|mesh-ancestor
65721022|NCT02176148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65721023|NCT02176148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721024|NCT02176148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65721025|NCT02101853|Calcium, Dietary|calcium, dietary|mesh-list
65721026|NCT02101853|Leucovorin|leucovorin|mesh-list
65721027|NCT02101853|Folic Acid|folic acid|mesh-list
65721028|NCT02101853|Cytarabine|cytarabine|mesh-list
65721029|NCT02101853|Dexamethasone|dexamethasone|mesh-list
65721030|NCT02101853|Dexamethasone acetate|dexamethasone acetate|mesh-list
65721031|NCT02101853|Hydrocortisone|hydrocortisone|mesh-list
65721032|NCT02101853|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65721033|NCT02101853|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65721034|NCT02101853|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65721035|NCT02101853|Cyclophosphamide|cyclophosphamide|mesh-list
65721036|NCT02101853|Methotrexate|methotrexate|mesh-list
65721037|NCT02101853|Etoposide|etoposide|mesh-list
65721038|NCT02101853|Vincristine|vincristine|mesh-list
65721039|NCT02101853|Etoposide phosphate|etoposide phosphate|mesh-list
65721040|NCT02101853|Asparaginase|asparaginase|mesh-list
65721041|NCT02101853|Mitoxantrone|mitoxantrone|mesh-list
65721042|NCT02101853|Mercaptopurine|mercaptopurine|mesh-list
65721043|NCT02101853|Podophyllotoxin|podophyllotoxin|mesh-list
65721044|NCT02101853|Pegaspargase|pegaspargase|mesh-list
65721045|NCT02101853|Thioguanine|thioguanine|mesh-list
65721046|NCT02101853|Blinatumomab|blinatumomab|mesh-list
65721047|NCT02101853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65721048|NCT02101853|Muromonab-CD3|muromonab-cd3|mesh-list
65721049|NCT02101853|Antibodies|antibodies|mesh-list
65721050|NCT02101853|Immunoglobulins|immunoglobulins|mesh-list
65721051|NCT02101853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65721052|NCT02101853|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65721053|NCT02101853|BB 1101|bb 1101|mesh-list
65721054|NCT02101853|Calcium|calcium|mesh-list
65721055|NCT02101853|2-Aminopurine|2-aminopurine|mesh-list
65721056|NCT02101853|Levoleucovorin|levoleucovorin|mesh-list
65721057|NCT02101853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65721058|NCT02101853|Immunologic Factors|immunologic factors|mesh-ancestor
65721059|NCT02101853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721060|NCT02101853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65721061|NCT02101853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65721062|NCT02101853|Alkylating Agents|alkylating agents|mesh-ancestor
65721063|NCT02101853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721064|NCT02101853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721065|NCT02101853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65721066|NCT02101853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65721067|NCT02101853|Antiemetics|antiemetics|mesh-ancestor
65721068|NCT02101853|Autonomic Agents|autonomic agents|mesh-ancestor
65721069|NCT02101853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65721070|NCT02101853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65721071|NCT02101853|Glucocorticoids|glucocorticoids|mesh-ancestor
65721072|NCT02101853|Hormones|hormones|mesh-ancestor
65721073|NCT02101853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65721074|NCT02101853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65721075|NCT02101853|Protease Inhibitors|protease inhibitors|mesh-ancestor
65721076|NCT02101853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721077|NCT02101853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65721078|NCT02101853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65721079|NCT02101853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65721080|NCT02101853|Abortifacient Agents|abortifacient agents|mesh-ancestor
65721081|NCT02101853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65721082|NCT02101853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65721083|NCT02101853|Antimetabolites|antimetabolites|mesh-ancestor
65721084|NCT02101853|Dermatologic Agents|dermatologic agents|mesh-ancestor
65721085|NCT02101853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65721086|NCT02101853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65721087|NCT02101853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65721088|NCT02101853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65721089|NCT02101853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65721090|NCT02101853|Antiviral Agents|antiviral agents|mesh-ancestor
65721091|NCT02101853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65721092|NCT02101853|Antidotes|antidotes|mesh-ancestor
65721093|NCT02101853|Protective Agents|protective agents|mesh-ancestor
65721094|NCT02101853|Vitamin B Complex|vitamin b complex|mesh-ancestor
65721095|NCT02101853|Vitamins|vitamins|mesh-ancestor
65721096|NCT02101853|Micronutrients|micronutrients|mesh-ancestor
65721097|NCT02101853|Tubulin Modulators|tubulin modulators|mesh-ancestor
65721098|NCT02101853|Antimitotic Agents|antimitotic agents|mesh-ancestor
65721099|NCT02101853|Mitosis Modulators|mitosis modulators|mesh-ancestor
65721100|NCT02101853|Hematinics|hematinics|mesh-ancestor
65721101|NCT02101853|Analgesics|analgesics|mesh-ancestor
65721102|NCT02101853|Sensory System Agents|sensory system agents|mesh-ancestor
65721103|NCT02101853|Keratolytic Agents|keratolytic agents|mesh-ancestor
65721104|NCT01885689|Sirolimus|sirolimus|mesh-list
65721105|NCT01885689|Melphalan|melphalan|mesh-list
65721106|NCT01885689|Clofarabine|clofarabine|mesh-list
65721107|NCT01885689|Tacrolimus|tacrolimus|mesh-list
65721108|NCT01885689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65721109|NCT01885689|Immunologic Factors|immunologic factors|mesh-ancestor
65721110|NCT01885689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721111|NCT01885689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65721112|NCT01885689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721113|NCT01885689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721114|NCT01885689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65721115|NCT01885689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65721116|NCT01885689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65721117|NCT01885689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721118|NCT01885689|Antifungal Agents|antifungal agents|mesh-ancestor
65721119|NCT01885689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65721120|NCT01885689|Alkylating Agents|alkylating agents|mesh-ancestor
65721121|NCT01885689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65721122|NCT01885689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65721123|NCT01885689|Antimetabolites|antimetabolites|mesh-ancestor
65721124|NCT01799538|Albuterol|albuterol|mesh-list
65721125|NCT01799538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65721126|NCT01799538|Autonomic Agents|autonomic agents|mesh-ancestor
65721127|NCT01799538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65721128|NCT01799538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721129|NCT01799538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65721130|NCT01799538|Respiratory System Agents|respiratory system agents|mesh-ancestor
65721131|NCT01799538|Tocolytic Agents|tocolytic agents|mesh-ancestor
65721132|NCT01799538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65721133|NCT01799538|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65721134|NCT01799538|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65721135|NCT01799538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65721136|NCT01799538|Adrenergic Agents|adrenergic agents|mesh-ancestor
65721137|NCT01799538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65721138|NCT01799538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721139|NCT01798004|Cyclophosphamide|cyclophosphamide|mesh-list
65721140|NCT01798004|Melphalan|melphalan|mesh-list
65721141|NCT01798004|Busulfan|busulfan|mesh-list
65721142|NCT01798004|Mechlorethamine|mechlorethamine|mesh-list
65721143|NCT01798004|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65721144|NCT01798004|Cisplatin|cisplatin|mesh-list
65721145|NCT01798004|Doxorubicin|doxorubicin|mesh-list
65721146|NCT01798004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65721147|NCT01798004|Etoposide|etoposide|mesh-list
65721148|NCT01798004|Vincristine|vincristine|mesh-list
65721149|NCT01798004|Etoposide phosphate|etoposide phosphate|mesh-list
65721150|NCT01798004|Topotecan|topotecan|mesh-list
65721151|NCT01798004|Podophyllotoxin|podophyllotoxin|mesh-list
65721152|NCT01798004|Lenograstim|lenograstim|mesh-list
65721153|NCT01798004|Mesna|mesna|mesh-list
65721154|NCT01798004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65721155|NCT01798004|Immunologic Factors|immunologic factors|mesh-ancestor
65721156|NCT01798004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721157|NCT01798004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65721158|NCT01798004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65721159|NCT01798004|Alkylating Agents|alkylating agents|mesh-ancestor
65721160|NCT01798004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721161|NCT01798004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721162|NCT01798004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65721163|NCT01798004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65721164|NCT01798004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65721165|NCT01798004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65721166|NCT01798004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721167|NCT01798004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65721168|NCT01798004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65721169|NCT01798004|Tubulin Modulators|tubulin modulators|mesh-ancestor
65721170|NCT01798004|Antimitotic Agents|antimitotic agents|mesh-ancestor
65721171|NCT01798004|Mitosis Modulators|mitosis modulators|mesh-ancestor
65721172|NCT01798004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65721173|NCT01798004|Protective Agents|protective agents|mesh-ancestor
65721174|NCT01798004|Keratolytic Agents|keratolytic agents|mesh-ancestor
65721175|NCT01798004|Dermatologic Agents|dermatologic agents|mesh-ancestor
65721176|NCT01711541|Paclitaxel|paclitaxel|mesh-list
65721177|NCT01711541|Cisplatin|cisplatin|mesh-list
65721178|NCT01711541|Carboplatin|carboplatin|mesh-list
65721179|NCT01711541|Fluorouracil|fluorouracil|mesh-list
65721180|NCT01711541|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65721181|NCT01711541|Hydroxyurea|hydroxyurea|mesh-list
65721182|NCT01711541|Veliparib|veliparib|mesh-list
65721183|NCT01711541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65721184|NCT01711541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721185|NCT01711541|Tubulin Modulators|tubulin modulators|mesh-ancestor
65721186|NCT01711541|Antimitotic Agents|antimitotic agents|mesh-ancestor
65721187|NCT01711541|Mitosis Modulators|mitosis modulators|mesh-ancestor
65721188|NCT01711541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721189|NCT01711541|Antimetabolites|antimetabolites|mesh-ancestor
65269595|NCT02730026|Ketoprofen|ketoprofen|mesh-list
65721190|NCT01711541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65721191|NCT01711541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65721192|NCT01711541|Immunologic Factors|immunologic factors|mesh-ancestor
65721193|NCT01711541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721194|NCT01711541|Antisickling Agents|antisickling agents|mesh-ancestor
65721195|NCT01711541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721196|NCT01711541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65721197|NCT01711541|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65721198|NCT01693380|Vaccines|vaccines|mesh-list
65721199|NCT01693380|Immunologic Factors|immunologic factors|mesh-ancestor
65721200|NCT01693380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721201|NCT01542879|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65721202|NCT01542879|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65721203|NCT01542879|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65721204|NCT01542879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721205|NCT01542879|Hematinics|hematinics|mesh-ancestor
65721206|NCT01542879|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65721207|NCT01542879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65721208|NCT01492972|Leuprolide|leuprolide|mesh-list
65721209|NCT01492972|Goserelin|goserelin|mesh-list
65721210|NCT01492972|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65721211|NCT01492972|Buserelin|buserelin|mesh-list
65721212|NCT01492972|Androgens|androgens|mesh-list
65721213|NCT01492972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65721214|NCT01492972|Fertility Agents|fertility agents|mesh-ancestor
65721215|NCT01492972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65721216|NCT01492972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721217|NCT01492972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65721218|NCT01492972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721220|NCT01492972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65721221|NCT01492972|Luteolytic Agents|luteolytic agents|mesh-ancestor
65721222|NCT01492972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65721223|NCT01492972|Contraceptive Agents|contraceptive agents|mesh-ancestor
65721224|NCT01492972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65721225|NCT01445509|Bevacizumab|bevacizumab|mesh-list
65721226|NCT01445509|Dasatinib|dasatinib|mesh-list
65721227|NCT01445509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65721228|NCT01445509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721229|NCT01445509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65721230|NCT01445509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65721231|NCT01445509|Growth Substances|growth substances|mesh-ancestor
65721232|NCT01445509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721233|NCT01445509|Growth Inhibitors|growth inhibitors|mesh-ancestor
65721234|NCT01445509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65721235|NCT01445509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721236|NCT01445509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721237|NCT01419561|Zidovudine|zidovudine|mesh-list
65721238|NCT01419561|Rituximab|rituximab|mesh-list
65721239|NCT01419561|Doxorubicin|doxorubicin|mesh-list
65721240|NCT01419561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65721241|NCT01419561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65721242|NCT01419561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721243|NCT01419561|Immunologic Factors|immunologic factors|mesh-ancestor
65721244|NCT01419561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721245|NCT01419561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65721246|NCT01419561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65721247|NCT01419561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65721248|NCT01419561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65721249|NCT01419561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721250|NCT01419561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721251|NCT01419561|Antimetabolites|antimetabolites|mesh-ancestor
65721252|NCT01419561|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65721253|NCT01419561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65721254|NCT01419561|Antiviral Agents|antiviral agents|mesh-ancestor
65721255|NCT01419561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65721256|NCT01419561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65721257|NCT01419561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65721258|NCT01256398|Calcium, Dietary|calcium, dietary|mesh-list
65721259|NCT01256398|Leucovorin|leucovorin|mesh-list
65721260|NCT01256398|Folic Acid|folic acid|mesh-list
65721261|NCT01256398|Cytarabine|cytarabine|mesh-list
65721262|NCT01256398|Dexamethasone|dexamethasone|mesh-list
65721263|NCT01256398|Dexamethasone acetate|dexamethasone acetate|mesh-list
65721264|NCT01256398|Cyclophosphamide|cyclophosphamide|mesh-list
65721265|NCT01256398|Melphalan|melphalan|mesh-list
65721266|NCT01256398|Mechlorethamine|mechlorethamine|mesh-list
65721267|NCT01256398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65721268|NCT01256398|Methotrexate|methotrexate|mesh-list
65721269|NCT01256398|Fludarabine|fludarabine|mesh-list
65721270|NCT01256398|Fludarabine phosphate|fludarabine phosphate|mesh-list
65721271|NCT01256398|Etoposide|etoposide|mesh-list
65721272|NCT01256398|Vincristine|vincristine|mesh-list
65721273|NCT01256398|Daunorubicin|daunorubicin|mesh-list
65721274|NCT01256398|Dasatinib|dasatinib|mesh-list
65721275|NCT01256398|Mercaptopurine|mercaptopurine|mesh-list
65721276|NCT01256398|Alemtuzumab|alemtuzumab|mesh-list
65721277|NCT01256398|Etoposide phosphate|etoposide phosphate|mesh-list
65721278|NCT01256398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65721279|NCT01256398|Tacrolimus|tacrolimus|mesh-list
65721280|NCT01256398|Antibodies|antibodies|mesh-list
65721281|NCT01256398|Immunoglobulins|immunoglobulins|mesh-list
65721282|NCT01256398|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65721283|NCT01256398|Lenograstim|lenograstim|mesh-list
65721284|NCT01256398|BB 1101|bb 1101|mesh-list
65721285|NCT01256398|Calcium|calcium|mesh-list
65721286|NCT01256398|Levoleucovorin|levoleucovorin|mesh-list
65721287|NCT01256398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65721288|NCT01256398|Immunologic Factors|immunologic factors|mesh-ancestor
65721289|NCT01256398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721290|NCT01256398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65721291|NCT01256398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65721292|NCT01256398|Alkylating Agents|alkylating agents|mesh-ancestor
65721293|NCT01256398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721294|NCT01256398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721295|NCT01256398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65721296|NCT01256398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65721297|NCT01256398|Antiemetics|antiemetics|mesh-ancestor
65721298|NCT01256398|Autonomic Agents|autonomic agents|mesh-ancestor
65721299|NCT01256398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65721300|NCT01256398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65721301|NCT01256398|Glucocorticoids|glucocorticoids|mesh-ancestor
65721302|NCT01256398|Hormones|hormones|mesh-ancestor
65721303|NCT01256398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65721304|NCT01256398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65721305|NCT01256398|Protease Inhibitors|protease inhibitors|mesh-ancestor
65721306|NCT01256398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721307|NCT01256398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65721308|NCT01256398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65721309|NCT01256398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65721310|NCT01256398|Abortifacient Agents|abortifacient agents|mesh-ancestor
65721311|NCT01256398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65721312|NCT01256398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65721313|NCT01256398|Antimetabolites|antimetabolites|mesh-ancestor
65721314|NCT01256398|Dermatologic Agents|dermatologic agents|mesh-ancestor
65721315|NCT01256398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65721316|NCT01256398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65721317|NCT01256398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65721318|NCT01256398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65721319|NCT01256398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65721320|NCT01256398|Antiviral Agents|antiviral agents|mesh-ancestor
65721321|NCT01256398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65721322|NCT01256398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65721323|NCT01256398|Antidotes|antidotes|mesh-ancestor
65721324|NCT01256398|Protective Agents|protective agents|mesh-ancestor
65721325|NCT01256398|Vitamin B Complex|vitamin b complex|mesh-ancestor
65721326|NCT01256398|Vitamins|vitamins|mesh-ancestor
65721327|NCT01256398|Micronutrients|micronutrients|mesh-ancestor
65721328|NCT01256398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65721329|NCT01256398|Tubulin Modulators|tubulin modulators|mesh-ancestor
65721330|NCT01256398|Antimitotic Agents|antimitotic agents|mesh-ancestor
65721331|NCT01256398|Mitosis Modulators|mitosis modulators|mesh-ancestor
65721332|NCT01256398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65721333|NCT01256398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65721334|NCT01256398|Hematinics|hematinics|mesh-ancestor
65721335|NCT01196390|Paclitaxel|paclitaxel|mesh-list
65721336|NCT01196390|Carboplatin|carboplatin|mesh-list
65721337|NCT01196390|Trastuzumab|trastuzumab|mesh-list
65721338|NCT01196390|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65721339|NCT01196390|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
65721340|NCT01196390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65721341|NCT01196390|Antibodies|antibodies|mesh-list
65721342|NCT01196390|Immunoglobulins|immunoglobulins|mesh-list
65721343|NCT01196390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65721344|NCT01196390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65721345|NCT01196390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721346|NCT01196390|Tubulin Modulators|tubulin modulators|mesh-ancestor
65721347|NCT01196390|Antimitotic Agents|antimitotic agents|mesh-ancestor
65721348|NCT01196390|Mitosis Modulators|mitosis modulators|mesh-ancestor
65721349|NCT01196390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721350|NCT01196390|Immunologic Factors|immunologic factors|mesh-ancestor
65721351|NCT01196390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721352|NCT01175356|Vitamin A|vitamin a|mesh-list
65721353|NCT01175356|Cyclophosphamide|cyclophosphamide|mesh-list
65721354|NCT01175356|Melphalan|melphalan|mesh-list
65721355|NCT01175356|Busulfan|busulfan|mesh-list
65721356|NCT01175356|Mechlorethamine|mechlorethamine|mesh-list
65721357|NCT01175356|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65721358|NCT01175356|Cisplatin|cisplatin|mesh-list
65721359|NCT01175356|Doxorubicin|doxorubicin|mesh-list
65721360|NCT01175356|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65721361|NCT01175356|Etoposide|etoposide|mesh-list
65721362|NCT01175356|Vincristine|vincristine|mesh-list
65721363|NCT01175356|Topotecan|topotecan|mesh-list
65721364|NCT01175356|Tretinoin|tretinoin|mesh-list
65721365|NCT01175356|Etoposide phosphate|etoposide phosphate|mesh-list
65721366|NCT01175356|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65721367|NCT01175356|Isotretinoin|isotretinoin|mesh-list
65721368|NCT01175356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65721369|NCT01175356|Immunologic Factors|immunologic factors|mesh-ancestor
65721370|NCT01175356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721371|NCT01175356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65721372|NCT01175356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65721373|NCT01175356|Alkylating Agents|alkylating agents|mesh-ancestor
65721374|NCT01175356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721375|NCT01175356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721376|NCT01175356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65721377|NCT01175356|Vitamins|vitamins|mesh-ancestor
65721378|NCT01175356|Micronutrients|micronutrients|mesh-ancestor
65721379|NCT01175356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65721380|NCT01175356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65721381|NCT01175356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65721382|NCT01175356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721383|NCT01175356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65721384|NCT01175356|Tubulin Modulators|tubulin modulators|mesh-ancestor
65721385|NCT01175356|Antimitotic Agents|antimitotic agents|mesh-ancestor
65721386|NCT01175356|Mitosis Modulators|mitosis modulators|mesh-ancestor
65721387|NCT01175356|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65721388|NCT01175356|Keratolytic Agents|keratolytic agents|mesh-ancestor
65721389|NCT01175356|Dermatologic Agents|dermatologic agents|mesh-ancestor
65721390|NCT01175356|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65721391|NCT01167712|Paclitaxel|paclitaxel|mesh-list
65721392|NCT01167712|Bevacizumab|bevacizumab|mesh-list
65721393|NCT01167712|Carboplatin|carboplatin|mesh-list
65721394|NCT01167712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65721395|NCT01167712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65721396|NCT01167712|Endothelial Growth Factors|endothelial growth factors|mesh-list
65721397|NCT01167712|Antibodies|antibodies|mesh-list
65721398|NCT01167712|Immunoglobulins|immunoglobulins|mesh-list
65721399|NCT01167712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65721400|NCT01167712|Immunoglobulin G|immunoglobulin g|mesh-list
65721401|NCT01167712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65721402|NCT01167712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721403|NCT01167712|Tubulin Modulators|tubulin modulators|mesh-ancestor
65721404|NCT01167712|Antimitotic Agents|antimitotic agents|mesh-ancestor
65721405|NCT01167712|Mitosis Modulators|mitosis modulators|mesh-ancestor
65721406|NCT01167712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721407|NCT01167712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65721408|NCT01167712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65721409|NCT01167712|Growth Substances|growth substances|mesh-ancestor
65721410|NCT01167712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721411|NCT01167712|Growth Inhibitors|growth inhibitors|mesh-ancestor
65721412|NCT01167712|Immunologic Factors|immunologic factors|mesh-ancestor
65721413|NCT01081262|Paclitaxel|paclitaxel|mesh-list
65721414|NCT01081262|Bevacizumab|bevacizumab|mesh-list
65721415|NCT01081262|Carboplatin|carboplatin|mesh-list
65721416|NCT01081262|Capecitabine|capecitabine|mesh-list
65721417|NCT01081262|Oxaliplatin|oxaliplatin|mesh-list
65721418|NCT01081262|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65721419|NCT01081262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65721420|NCT01081262|Endothelial Growth Factors|endothelial growth factors|mesh-list
65721421|NCT01081262|Antibodies|antibodies|mesh-list
65721422|NCT01081262|Immunoglobulins|immunoglobulins|mesh-list
65721423|NCT01081262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65721424|NCT01081262|Immunoglobulin G|immunoglobulin g|mesh-list
65721425|NCT01081262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65721426|NCT01081262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721427|NCT01081262|Tubulin Modulators|tubulin modulators|mesh-ancestor
65721428|NCT01081262|Antimitotic Agents|antimitotic agents|mesh-ancestor
65721429|NCT01081262|Mitosis Modulators|mitosis modulators|mesh-ancestor
65721430|NCT01081262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721431|NCT01081262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65721432|NCT01081262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65721433|NCT01081262|Growth Substances|growth substances|mesh-ancestor
65721434|NCT01081262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721435|NCT01081262|Growth Inhibitors|growth inhibitors|mesh-ancestor
65721436|NCT01081262|Immunologic Factors|immunologic factors|mesh-ancestor
65721437|NCT01081262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65721438|NCT01081262|Antimetabolites|antimetabolites|mesh-ancestor
65721439|NCT01020383|Abciximab|abciximab|mesh-list
65721440|NCT01020383|Anticoagulants|anticoagulants|mesh-ancestor
65721441|NCT01020383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65721442|NCT00977574|Sirolimus|sirolimus|mesh-list
65721443|NCT00977574|Paclitaxel|paclitaxel|mesh-list
65721444|NCT00977574|Epothilones|epothilones|mesh-list
65721445|NCT00977574|Epothilone B|epothilone b|mesh-list
65721446|NCT00977574|Bevacizumab|bevacizumab|mesh-list
65721447|NCT00977574|Carboplatin|carboplatin|mesh-list
65721448|NCT00977574|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65721449|NCT00977574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65721450|NCT00977574|Endothelial Growth Factors|endothelial growth factors|mesh-list
65721451|NCT00977574|Antibodies|antibodies|mesh-list
65721453|NCT00977574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65721454|NCT00977574|Immunoglobulin G|immunoglobulin g|mesh-list
65721455|NCT00977574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65721456|NCT00977574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721457|NCT00977574|Tubulin Modulators|tubulin modulators|mesh-ancestor
65721458|NCT00977574|Antimitotic Agents|antimitotic agents|mesh-ancestor
65721459|NCT00977574|Mitosis Modulators|mitosis modulators|mesh-ancestor
65721460|NCT00977574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721461|NCT00977574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65721462|NCT00977574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65721463|NCT00977574|Growth Substances|growth substances|mesh-ancestor
65721464|NCT00977574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721465|NCT00977574|Growth Inhibitors|growth inhibitors|mesh-ancestor
65721466|NCT00977574|Immunologic Factors|immunologic factors|mesh-ancestor
65721467|NCT00977574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65721468|NCT00977574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65721469|NCT00977574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65721470|NCT00977574|Antifungal Agents|antifungal agents|mesh-ancestor
65721471|NCT00977574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65721472|NCT00889876|Metformin|metformin|mesh-list
65721473|NCT00889876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65721474|NCT00889876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721475|NCT00887146|Vincristine|vincristine|mesh-list
65721476|NCT00887146|Temozolomide|temozolomide|mesh-list
65721477|NCT00887146|Procarbazine|procarbazine|mesh-list
65721478|NCT00887146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65721479|NCT00887146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721480|NCT00887146|Tubulin Modulators|tubulin modulators|mesh-ancestor
65721481|NCT00887146|Antimitotic Agents|antimitotic agents|mesh-ancestor
65721482|NCT00887146|Mitosis Modulators|mitosis modulators|mesh-ancestor
65721483|NCT00887146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721484|NCT00887146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65721485|NCT00887146|Alkylating Agents|alkylating agents|mesh-ancestor
65721486|NCT00673010|Iodine|iodine|mesh-list
65721487|NCT00673010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65721488|NCT00673010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65721489|NCT00673010|Trace Elements|trace elements|mesh-ancestor
65721490|NCT00673010|Micronutrients|micronutrients|mesh-ancestor
65721491|NCT00673010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721492|NCT00587067|Floxuridine|floxuridine|mesh-list
65721493|NCT00587067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65721494|NCT00587067|Antimetabolites|antimetabolites|mesh-ancestor
65721495|NCT00587067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721496|NCT00587067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721497|NCT00577278|Sirolimus|sirolimus|mesh-list
65721498|NCT00577278|Rituximab|rituximab|mesh-list
65721499|NCT00577278|Fludarabine|fludarabine|mesh-list
65721500|NCT00577278|Fludarabine phosphate|fludarabine phosphate|mesh-list
65721501|NCT00577278|Melphalan|melphalan|mesh-list
65721502|NCT00577278|Tacrolimus|tacrolimus|mesh-list
65721503|NCT00577278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65721504|NCT00577278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65721505|NCT00577278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721506|NCT00577278|Immunologic Factors|immunologic factors|mesh-ancestor
65721507|NCT00577278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721508|NCT00577278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65721509|NCT00577278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65721510|NCT00577278|Antimetabolites|antimetabolites|mesh-ancestor
65721511|NCT00577278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721512|NCT00577278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65721513|NCT00577278|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65721514|NCT00577278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721515|NCT00577278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65721516|NCT00577278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65721517|NCT00577278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65721518|NCT00577278|Antifungal Agents|antifungal agents|mesh-ancestor
65721519|NCT00577278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65721520|NCT00577278|Alkylating Agents|alkylating agents|mesh-ancestor
65721521|NCT00577278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65721522|NCT00569127|Interferons|interferons|mesh-list
65721523|NCT00569127|Interferon-alpha|interferon-alpha|mesh-list
65721524|NCT00569127|Interferon alpha-2|interferon alpha-2|mesh-list
65721525|NCT00569127|Bevacizumab|bevacizumab|mesh-list
65037325|NCT00585091|Phenylephrine|phenylephrine|mesh-list
65721526|NCT00569127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65721527|NCT00569127|Octreotide|octreotide|mesh-list
65721528|NCT00569127|Endothelial Growth Factors|endothelial growth factors|mesh-list
65721529|NCT00569127|Antibodies|antibodies|mesh-list
65721530|NCT00569127|Immunoglobulins|immunoglobulins|mesh-list
65721531|NCT00569127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65721532|NCT00569127|Immunoglobulin G|immunoglobulin g|mesh-list
65721533|NCT00569127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721534|NCT00569127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65721535|NCT00569127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65721536|NCT00569127|Growth Substances|growth substances|mesh-ancestor
65721537|NCT00569127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721538|NCT00569127|Growth Inhibitors|growth inhibitors|mesh-ancestor
65721539|NCT00569127|Immunologic Factors|immunologic factors|mesh-ancestor
65721540|NCT00569127|Antiviral Agents|antiviral agents|mesh-ancestor
65721541|NCT00569127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65721542|NCT00569127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65721543|NCT00569127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65721544|NCT00453154|Cisplatin|cisplatin|mesh-list
65721545|NCT00453154|Carboplatin|carboplatin|mesh-list
65721546|NCT00453154|Etoposide|etoposide|mesh-list
65721547|NCT00453154|Etoposide phosphate|etoposide phosphate|mesh-list
65721548|NCT00453154|Sunitinib|sunitinib|mesh-list
65721549|NCT00453154|Podophyllotoxin|podophyllotoxin|mesh-list
65721550|NCT00453154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721551|NCT00453154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65721552|NCT00453154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65721553|NCT00453154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65721554|NCT00453154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721555|NCT00453154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721556|NCT00453154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65721557|NCT00453154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65721558|NCT00453154|Growth Substances|growth substances|mesh-ancestor
65721559|NCT00453154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721560|NCT00453154|Growth Inhibitors|growth inhibitors|mesh-ancestor
65721561|NCT00453154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65721562|NCT00453154|Keratolytic Agents|keratolytic agents|mesh-ancestor
65721563|NCT00453154|Dermatologic Agents|dermatologic agents|mesh-ancestor
65721564|NCT00453154|Tubulin Modulators|tubulin modulators|mesh-ancestor
65721565|NCT00453154|Antimitotic Agents|antimitotic agents|mesh-ancestor
65721566|NCT00453154|Mitosis Modulators|mitosis modulators|mesh-ancestor
65721567|NCT00408005|Calcium, Dietary|calcium, dietary|mesh-list
65721568|NCT00408005|Leucovorin|leucovorin|mesh-list
65721569|NCT00408005|Folic Acid|folic acid|mesh-list
65721570|NCT00408005|Cytarabine|cytarabine|mesh-list
65721571|NCT00408005|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
65721572|NCT00408005|Dexamethasone|dexamethasone|mesh-list
65721573|NCT00408005|Dexamethasone acetate|dexamethasone acetate|mesh-list
65721574|NCT00408005|Prednisone|prednisone|mesh-list
65721575|NCT00408005|Cortisone|cortisone|mesh-list
65721576|NCT00408005|Cyclophosphamide|cyclophosphamide|mesh-list
65721577|NCT00408005|Doxorubicin|doxorubicin|mesh-list
65721578|NCT00408005|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65721579|NCT00408005|Methotrexate|methotrexate|mesh-list
65721580|NCT00408005|Vincristine|vincristine|mesh-list
65721581|NCT00408005|Daunorubicin|daunorubicin|mesh-list
65721582|NCT00408005|Asparaginase|asparaginase|mesh-list
65721583|NCT00408005|Mercaptopurine|mercaptopurine|mesh-list
65721584|NCT00408005|Pegaspargase|pegaspargase|mesh-list
65721585|NCT00408005|Thioguanine|thioguanine|mesh-list
65721586|NCT00408005|BB 1101|bb 1101|mesh-list
65721587|NCT00408005|Calcium|calcium|mesh-list
65721588|NCT00408005|2-Aminopurine|2-aminopurine|mesh-list
65721589|NCT00408005|Levoleucovorin|levoleucovorin|mesh-list
65721590|NCT00408005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65721591|NCT00408005|Immunologic Factors|immunologic factors|mesh-ancestor
65721592|NCT00408005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721593|NCT00408005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65721594|NCT00408005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65721595|NCT00408005|Alkylating Agents|alkylating agents|mesh-ancestor
65721596|NCT00408005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721597|NCT00408005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721598|NCT00408005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65721599|NCT00408005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65721600|NCT00408005|Antiemetics|antiemetics|mesh-ancestor
65721601|NCT00408005|Autonomic Agents|autonomic agents|mesh-ancestor
65721602|NCT00408005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65721603|NCT00408005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65721604|NCT00408005|Glucocorticoids|glucocorticoids|mesh-ancestor
65721605|NCT00408005|Hormones|hormones|mesh-ancestor
65721606|NCT00408005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65721607|NCT00408005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65721608|NCT00408005|Protease Inhibitors|protease inhibitors|mesh-ancestor
65721609|NCT00408005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721610|NCT00408005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65721611|NCT00408005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65721612|NCT00408005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65721613|NCT00408005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65721614|NCT00408005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65721615|NCT00408005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65721616|NCT00408005|Abortifacient Agents|abortifacient agents|mesh-ancestor
65721617|NCT00408005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65721618|NCT00408005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65721619|NCT00408005|Antimetabolites|antimetabolites|mesh-ancestor
65721620|NCT00408005|Dermatologic Agents|dermatologic agents|mesh-ancestor
65721621|NCT00408005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65721622|NCT00408005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65721623|NCT00408005|Antiviral Agents|antiviral agents|mesh-ancestor
65721624|NCT00408005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65721625|NCT00408005|Antidotes|antidotes|mesh-ancestor
65721626|NCT00408005|Protective Agents|protective agents|mesh-ancestor
65721627|NCT00408005|Vitamin B Complex|vitamin b complex|mesh-ancestor
65721628|NCT00408005|Vitamins|vitamins|mesh-ancestor
65721629|NCT00408005|Micronutrients|micronutrients|mesh-ancestor
65721630|NCT00408005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65721631|NCT00408005|Tubulin Modulators|tubulin modulators|mesh-ancestor
65721632|NCT00408005|Antimitotic Agents|antimitotic agents|mesh-ancestor
65721633|NCT00408005|Mitosis Modulators|mitosis modulators|mesh-ancestor
65721634|NCT00408005|Hematinics|hematinics|mesh-ancestor
65721635|NCT00334815|Bevacizumab|bevacizumab|mesh-list
65721636|NCT00334815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65721637|NCT00334815|Cisplatin|cisplatin|mesh-list
65721638|NCT00334815|Docetaxel|docetaxel|mesh-list
65721639|NCT00334815|Etoposide|etoposide|mesh-list
65721640|NCT00334815|Etoposide phosphate|etoposide phosphate|mesh-list
65721641|NCT00334815|Podophyllotoxin|podophyllotoxin|mesh-list
65721642|NCT00334815|Endothelial Growth Factors|endothelial growth factors|mesh-list
65721643|NCT00334815|Antibodies|antibodies|mesh-list
65721644|NCT00334815|Immunoglobulins|immunoglobulins|mesh-list
65721645|NCT00334815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65721646|NCT00334815|Lenograstim|lenograstim|mesh-list
65721647|NCT00334815|Immunoglobulin G|immunoglobulin g|mesh-list
65721648|NCT00334815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721649|NCT00334815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65721650|NCT00334815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65721651|NCT00334815|Growth Substances|growth substances|mesh-ancestor
65721652|NCT00334815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721653|NCT00334815|Growth Inhibitors|growth inhibitors|mesh-ancestor
65721654|NCT00334815|Immunologic Factors|immunologic factors|mesh-ancestor
65721655|NCT00334815|Tubulin Modulators|tubulin modulators|mesh-ancestor
65721656|NCT00334815|Antimitotic Agents|antimitotic agents|mesh-ancestor
65721657|NCT00334815|Mitosis Modulators|mitosis modulators|mesh-ancestor
65721658|NCT00334815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721659|NCT00334815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65721660|NCT00334815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65721661|NCT00334815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65721662|NCT00334815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721663|NCT00334815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65721664|NCT00334815|Keratolytic Agents|keratolytic agents|mesh-ancestor
65721665|NCT00334815|Dermatologic Agents|dermatologic agents|mesh-ancestor
65721666|NCT00309257|Valsartan|valsartan|mesh-list
65721667|NCT00309257|Benazepril|benazepril|mesh-list
65721668|NCT00309257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65721669|NCT00309257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65721670|NCT00309257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65721671|NCT00309257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721672|NCT00309257|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65721673|NCT00309257|Protease Inhibitors|protease inhibitors|mesh-ancestor
65721674|NCT00309257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721675|NCT00258960|Cyclophosphamide|cyclophosphamide|mesh-list
65721676|NCT00258960|Doxorubicin|doxorubicin|mesh-list
65721677|NCT00258960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65721678|NCT00258960|Trastuzumab|trastuzumab|mesh-list
65721679|NCT00258960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65721680|NCT00258960|Immunologic Factors|immunologic factors|mesh-ancestor
65721681|NCT00258960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721682|NCT00258960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65721683|NCT00258960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65721684|NCT00258960|Alkylating Agents|alkylating agents|mesh-ancestor
65721685|NCT00258960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721686|NCT00258960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721687|NCT00258960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65721688|NCT00258960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65721689|NCT00258960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65721690|NCT00258960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65721691|NCT00258960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721692|NCT00258960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65721693|NCT00254423|Dasatinib|dasatinib|mesh-list
65721694|NCT00254423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721695|NCT00254423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65721696|NCT00254423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721697|NCT00254423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721698|NCT00121992|Cyclophosphamide|cyclophosphamide|mesh-list
65721699|NCT00121992|Docetaxel|docetaxel|mesh-list
65721700|NCT00121992|Doxorubicin|doxorubicin|mesh-list
65721701|NCT00121992|Fluorouracil|fluorouracil|mesh-list
65721702|NCT00121992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65721703|NCT00121992|Immunologic Factors|immunologic factors|mesh-ancestor
65721704|NCT00121992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721705|NCT00121992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65721706|NCT00121992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65721707|NCT00121992|Alkylating Agents|alkylating agents|mesh-ancestor
65721708|NCT00121992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721709|NCT00121992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721710|NCT00121992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65721711|NCT00121992|Tubulin Modulators|tubulin modulators|mesh-ancestor
65721712|NCT00121992|Antimitotic Agents|antimitotic agents|mesh-ancestor
65721713|NCT00121992|Mitosis Modulators|mitosis modulators|mesh-ancestor
65721714|NCT00121992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65721715|NCT00121992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65721716|NCT00121992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65721717|NCT00121992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721718|NCT00121992|Antimetabolites|antimetabolites|mesh-ancestor
65721719|NCT00121992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65721720|NCT00070564|Paclitaxel|paclitaxel|mesh-list
65721721|NCT00070564|Cyclophosphamide|cyclophosphamide|mesh-list
65721722|NCT00070564|Doxorubicin|doxorubicin|mesh-list
65721723|NCT00070564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65721724|NCT00070564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65721725|NCT00070564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721726|NCT00070564|Tubulin Modulators|tubulin modulators|mesh-ancestor
65721727|NCT00070564|Antimitotic Agents|antimitotic agents|mesh-ancestor
65721728|NCT00070564|Mitosis Modulators|mitosis modulators|mesh-ancestor
65721729|NCT00070564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721730|NCT00070564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65721731|NCT00070564|Immunologic Factors|immunologic factors|mesh-ancestor
65721732|NCT00070564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721733|NCT00070564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65721734|NCT00070564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65721735|NCT00070564|Alkylating Agents|alkylating agents|mesh-ancestor
65721736|NCT00070564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65721737|NCT00070564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65721738|NCT00070564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65721739|NCT00070564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65721740|NCT00070564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721741|NCT05158647|Magnesium Sulfate|magnesium sulfate|mesh-list
65721742|NCT05158647|Analgesics|analgesics|mesh-ancestor
65721743|NCT05158647|Sensory System Agents|sensory system agents|mesh-ancestor
65721744|NCT05158647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65721745|NCT05158647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721746|NCT05158647|Anesthetics|anesthetics|mesh-ancestor
65721747|NCT05158647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65721748|NCT05158647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65721749|NCT05158647|Anticonvulsants|anticonvulsants|mesh-ancestor
65721750|NCT05158647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65721751|NCT05158647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65721752|NCT05158647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721753|NCT05158647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65721754|NCT05158647|Tocolytic Agents|tocolytic agents|mesh-ancestor
65721755|NCT05158647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65721756|NCT03471117|Pioglitazone|pioglitazone|mesh-list
65721757|NCT03471117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65721758|NCT03471117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721759|NCT02738151|Insulin|insulin|mesh-list
65721760|NCT02738151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65721761|NCT02738151|Insulin Glargine|insulin glargine|mesh-list
65721762|NCT02738151|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65721763|NCT02738151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721764|NCT05212389|Contraceptive Agents|contraceptive agents|mesh-list
65721765|NCT05212389|Contraceptives, Oral|contraceptives, oral|mesh-list
65721766|NCT05212389|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65721767|NCT05212389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65721768|NCT05212389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721769|NCT05212389|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65721770|NCT03471039|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
65721771|NCT03471039|Growth Substances|growth substances|mesh-ancestor
65721772|NCT03471039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721773|NCT03471039|Vasodilator Agents|vasodilator agents|mesh-ancestor
65721774|NCT03471039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65721775|NCT03471039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721776|NCT03472677|Capsaicin|capsaicin|mesh-list
65721777|NCT03472677|Antipruritics|antipruritics|mesh-ancestor
65721778|NCT03472677|Dermatologic Agents|dermatologic agents|mesh-ancestor
65721779|NCT03472677|Sensory System Agents|sensory system agents|mesh-ancestor
65721780|NCT03472677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65721781|NCT03472677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721782|NCT02673567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65721783|NCT02673567|Antibodies|antibodies|mesh-list
65721784|NCT02673567|Immunoglobulins|immunoglobulins|mesh-list
65721785|NCT02673567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65721786|NCT02673567|Immunologic Factors|immunologic factors|mesh-ancestor
65721787|NCT02673567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721788|NCT02673567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721789|NCT00702195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65721790|NCT00702195|Hormones|hormones|mesh-ancestor
65721791|NCT00702195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65721792|NCT00702195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721793|NCT02993731|Gemcitabine|gemcitabine|mesh-list
65721794|NCT02993731|Paclitaxel|paclitaxel|mesh-list
65721795|NCT02993731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65721796|NCT02993731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721797|NCT02993731|Tubulin Modulators|tubulin modulators|mesh-ancestor
65721798|NCT02993731|Antimitotic Agents|antimitotic agents|mesh-ancestor
65721799|NCT02993731|Mitosis Modulators|mitosis modulators|mesh-ancestor
65721800|NCT02993731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721801|NCT02993731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65721802|NCT02993731|Antimetabolites|antimetabolites|mesh-ancestor
65721803|NCT02993731|Antiviral Agents|antiviral agents|mesh-ancestor
65721804|NCT02993731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65721805|NCT02993731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721806|NCT02993731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65721807|NCT02993731|Immunologic Factors|immunologic factors|mesh-ancestor
65721808|NCT02993731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721809|NCT02915159|Abatacept|abatacept|mesh-list
65721810|NCT02915159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65721811|NCT02915159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721812|NCT02915159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721813|NCT02915159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65721814|NCT02915159|Immunologic Factors|immunologic factors|mesh-ancestor
65721815|NCT02915159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721816|NCT02915159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65721817|NCT03669263|Fentanyl|fentanyl|mesh-list
65721818|NCT03669263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65721819|NCT03669263|Narcotics|narcotics|mesh-ancestor
65721820|NCT03669263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65721821|NCT03669263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721822|NCT03669263|Analgesics|analgesics|mesh-ancestor
65721823|NCT03669263|Sensory System Agents|sensory system agents|mesh-ancestor
65721824|NCT03669263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65721825|NCT03669263|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65721826|NCT03669263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65721827|NCT03669263|Anesthetics, General|anesthetics, general|mesh-ancestor
65721828|NCT03669263|Anesthetics|anesthetics|mesh-ancestor
65721829|NCT02669264|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
65721830|NCT02669264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65721831|NCT02669264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721832|NCT02521870|Pembrolizumab|pembrolizumab|mesh-list
65721833|NCT02521870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65721834|NCT02521870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721835|NCT02385656|Modafinil|modafinil|mesh-list
65721836|NCT02385656|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65721837|NCT02385656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721838|NCT02385656|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65721839|NCT02385656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65721840|NCT02385656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65721841|NCT02385656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721842|NCT02389868|Lovastatin|lovastatin|mesh-list
65721843|NCT02389868|L 647318|l 647318|mesh-list
65721844|NCT02389868|Dihydromevinolin|dihydromevinolin|mesh-list
65721845|NCT02389868|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65721846|NCT02389868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65721847|NCT02389868|Antimetabolites|antimetabolites|mesh-ancestor
65721848|NCT02389868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721849|NCT02389868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65721850|NCT02389868|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65721851|NCT02389868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721852|NCT03623087|Gemcitabine|gemcitabine|mesh-list
65721853|NCT03623087|Dexamethasone|dexamethasone|mesh-list
65721854|NCT03623087|Etoposide|etoposide|mesh-list
65721855|NCT03623087|Asparaginase|asparaginase|mesh-list
65721856|NCT03623087|Ifosfamide|ifosfamide|mesh-list
65721857|NCT03623087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65721858|NCT03623087|Antiemetics|antiemetics|mesh-ancestor
65721859|NCT03623087|Autonomic Agents|autonomic agents|mesh-ancestor
65721860|NCT03623087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65721861|NCT03623087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721862|NCT03623087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65721863|NCT03623087|Glucocorticoids|glucocorticoids|mesh-ancestor
65721864|NCT03623087|Hormones|hormones|mesh-ancestor
65721865|NCT03623087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65721866|NCT03623087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65721867|NCT03623087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721868|NCT03623087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65721869|NCT03623087|Antimetabolites|antimetabolites|mesh-ancestor
65721870|NCT03623087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721871|NCT03623087|Antiviral Agents|antiviral agents|mesh-ancestor
65721872|NCT03623087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65721873|NCT03623087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721874|NCT03623087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65721875|NCT03623087|Immunologic Factors|immunologic factors|mesh-ancestor
65721876|NCT03623087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65721877|NCT03623087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65721878|NCT03623087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65721879|NCT03623087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65721880|NCT03623087|Alkylating Agents|alkylating agents|mesh-ancestor
65721881|NCT05420636|Paclitaxel|paclitaxel|mesh-list
65721882|NCT05420636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65721883|NCT05420636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721884|NCT05420636|Tubulin Modulators|tubulin modulators|mesh-ancestor
65721885|NCT05420636|Antimitotic Agents|antimitotic agents|mesh-ancestor
65721886|NCT05420636|Mitosis Modulators|mitosis modulators|mesh-ancestor
65721887|NCT05420636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721888|NCT05066308|Cannabidiol|cannabidiol|mesh-list
65721889|NCT05066308|Anticonvulsants|anticonvulsants|mesh-ancestor
65721890|NCT03113396|Baclofen|baclofen|mesh-list
65721891|NCT03113396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65721892|NCT03113396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721893|NCT03113396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65721894|NCT03113396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65721895|NCT03113396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65721896|NCT03113396|GABA Agonists|gaba agonists|mesh-ancestor
65721897|NCT03113396|GABA Agents|gaba agents|mesh-ancestor
65721898|NCT03113396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65721899|NCT03113396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721900|NCT05065372|Metformin|metformin|mesh-list
65721901|NCT05065372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65721902|NCT05065372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721903|NCT03020615|Hydroxyurea|hydroxyurea|mesh-list
65721904|NCT03020615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721905|NCT03020615|Antisickling Agents|antisickling agents|mesh-ancestor
65721906|NCT03020615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721907|NCT03020615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721908|NCT03020615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65721909|NCT05063500|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
65721910|NCT05063500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65721912|NCT05063500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721913|NCT05063500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65721914|NCT03693170|Cetuximab|cetuximab|mesh-list
65721915|NCT03693170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65721916|NCT03693170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721917|NCT05062954|Proanthocyanidin|proanthocyanidin|mesh-list
65721918|NCT05062954|Procyanidin|procyanidin|mesh-list
65721919|NCT05062954|Antioxidants|antioxidants|mesh-ancestor
65721920|NCT05062954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721921|NCT05062954|Protective Agents|protective agents|mesh-ancestor
65721922|NCT05062954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721923|NCT05062954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65721924|NCT05062954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65721925|NCT05062954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65721926|NCT05048524|Leucovorin|leucovorin|mesh-list
65721927|NCT05048524|Gemcitabine|gemcitabine|mesh-list
65721928|NCT05048524|Oxaliplatin|oxaliplatin|mesh-list
65721929|NCT05048524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65721930|NCT05048524|Antimetabolites|antimetabolites|mesh-ancestor
65721931|NCT05048524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721932|NCT05048524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721933|NCT05048524|Antiviral Agents|antiviral agents|mesh-ancestor
65721934|NCT05048524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65721935|NCT05048524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721936|NCT05048524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65721937|NCT05048524|Immunologic Factors|immunologic factors|mesh-ancestor
65721938|NCT05048524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721939|NCT05048524|Antidotes|antidotes|mesh-ancestor
65721940|NCT05048524|Protective Agents|protective agents|mesh-ancestor
65721941|NCT05048524|Vitamin B Complex|vitamin b complex|mesh-ancestor
65721942|NCT05048524|Vitamins|vitamins|mesh-ancestor
65721943|NCT05048524|Micronutrients|micronutrients|mesh-ancestor
65721944|NCT02389400|Methotrexate|methotrexate|mesh-list
65721945|NCT02389400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65721946|NCT02389400|Abortifacient Agents|abortifacient agents|mesh-ancestor
65721947|NCT02389400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65721948|NCT02389400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721949|NCT02389400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65721950|NCT02389400|Antimetabolites|antimetabolites|mesh-ancestor
65721951|NCT02389400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721952|NCT02389400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721953|NCT02389400|Dermatologic Agents|dermatologic agents|mesh-ancestor
65721954|NCT02389400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721955|NCT02389400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65721956|NCT02389400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65721957|NCT02389400|Immunologic Factors|immunologic factors|mesh-ancestor
65721958|NCT02389400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65721959|NCT02389400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65721960|NCT03581240|Eflornithine|eflornithine|mesh-list
65721961|NCT03581240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65721962|NCT03581240|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65721963|NCT03581240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65721964|NCT03581240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65721965|NCT03581240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65721966|NCT03581240|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
65721967|NCT03581240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65721968|NCT03581240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721969|NCT02389322|BCG Vaccine|bcg vaccine|mesh-list
65721970|NCT02389322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65721971|NCT02389322|Immunologic Factors|immunologic factors|mesh-ancestor
65721972|NCT02389322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721973|NCT05059600|Pregnanolone|pregnanolone|mesh-list
65721974|NCT05059600|Brexanolone|brexanolone|mesh-list
65721975|NCT05059600|Anesthetics|anesthetics|mesh-ancestor
65721976|NCT05059600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65721977|NCT05059600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721978|NCT05059600|Neurosteroids|neurosteroids|mesh-ancestor
65721979|NCT05059600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65721980|NCT05059600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721981|NCT05059600|GABA Modulators|gaba modulators|mesh-ancestor
65721982|NCT05059600|GABA Agents|gaba agents|mesh-ancestor
65721983|NCT03669029|Golimumab|golimumab|mesh-list
65721984|NCT03669029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65721985|NCT03669029|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65721986|NCT03669029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65721987|NCT03669029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65721988|NCT03669029|Immunologic Factors|immunologic factors|mesh-ancestor
65721989|NCT03669029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65721990|NCT03668015|Sorbitol|sorbitol|mesh-list
65721991|NCT03668015|Cathartics|cathartics|mesh-ancestor
65721992|NCT03668015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65721993|NCT02385734|Mitogens|mitogens|mesh-list
65721994|NCT02385734|Mitosis Modulators|mitosis modulators|mesh-ancestor
65721995|NCT02385734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65721996|NCT02385500|Fesoterodine|fesoterodine|mesh-list
65721997|NCT02385500|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65721998|NCT02385500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65721999|NCT02385500|Cholinergic Agents|cholinergic agents|mesh-ancestor
65722000|NCT02385500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65722001|NCT02385500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722002|NCT02385500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722003|NCT02385500|Urological Agents|urological agents|mesh-ancestor
65722004|NCT05058976|Vitamin D|vitamin d|mesh-list
65722005|NCT05058976|Zoledronic Acid|zoledronic acid|mesh-list
65722006|NCT05058976|Calcium|calcium|mesh-list
65722007|NCT05058976|Vitamins|vitamins|mesh-ancestor
65722008|NCT05058976|Micronutrients|micronutrients|mesh-ancestor
65722009|NCT05058976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722010|NCT05058976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65722011|NCT05058976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65722012|NCT02385422|Propranolol|propranolol|mesh-list
65722013|NCT02385422|Carvedilol|carvedilol|mesh-list
65722014|NCT02385422|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65722015|NCT02385422|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65722016|NCT02385422|Adrenergic Agents|adrenergic agents|mesh-ancestor
65722017|NCT02385422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65722018|NCT02385422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722019|NCT02385422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722020|NCT02385422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65722021|NCT02385422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65722022|NCT02385422|Vasodilator Agents|vasodilator agents|mesh-ancestor
65722023|NCT02385422|Antioxidants|antioxidants|mesh-ancestor
65722024|NCT02385422|Protective Agents|protective agents|mesh-ancestor
65722025|NCT02385422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65722026|NCT02385422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65722027|NCT02385422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65722028|NCT02385422|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65722029|NCT02385422|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65722030|NCT02520388|Methylphenidate|methylphenidate|mesh-list
65722031|NCT02520388|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65722032|NCT02520388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722033|NCT02520388|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65722034|NCT02520388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65722035|NCT02520388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65722036|NCT02520388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722037|NCT02520388|Dopamine Agents|dopamine agents|mesh-ancestor
65722038|NCT02520388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65722039|NCT03579446|Oxymorphone|oxymorphone|mesh-list
65722040|NCT03579446|Morphine|morphine|mesh-list
65722041|NCT03579446|Oxycodone|oxycodone|mesh-list
65722042|NCT03579446|Hydromorphone|hydromorphone|mesh-list
65722043|NCT03579446|Hydrocodone|hydrocodone|mesh-list
65722044|NCT03579446|Levorphanol|levorphanol|mesh-list
65722045|NCT03579446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65722046|NCT03579446|Narcotics|narcotics|mesh-ancestor
65722047|NCT03579446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65722048|NCT03579446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722049|NCT03579446|Analgesics|analgesics|mesh-ancestor
65722050|NCT03579446|Sensory System Agents|sensory system agents|mesh-ancestor
65722051|NCT03579446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722052|NCT03579446|Antitussive Agents|antitussive agents|mesh-ancestor
65722053|NCT03579446|Respiratory System Agents|respiratory system agents|mesh-ancestor
65722054|NCT03579446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65722055|NCT03667937|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65722056|NCT03667937|Laxatives|laxatives|mesh-ancestor
65722057|NCT03667937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65722058|NCT05045794|Liver Extracts|liver extracts|mesh-list
65722059|NCT05045794|Hematinics|hematinics|mesh-ancestor
65722060|NCT02385266|Cycloserine|cycloserine|mesh-list
65722061|NCT02385266|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65722062|NCT02385266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65722063|NCT02385266|Renal Agents|renal agents|mesh-ancestor
65722064|NCT02385266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65722065|NCT02385266|Antitubercular Agents|antitubercular agents|mesh-ancestor
65722066|NCT02385266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65722067|NCT02385266|Antimetabolites|antimetabolites|mesh-ancestor
65722068|NCT02385266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722069|NCT03667235|Glutaral|glutaral|mesh-list
65722070|NCT03667235|Disinfectants|disinfectants|mesh-ancestor
65722071|NCT03667235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65722072|NCT02668640|Adalimumab|adalimumab|mesh-list
65722073|NCT02668640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65722074|NCT02668640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65722075|NCT05043766|Naltrexone|naltrexone|mesh-list
65722076|NCT05043766|Oxycodone|oxycodone|mesh-list
65722077|NCT05043766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65722078|NCT05043766|Narcotics|narcotics|mesh-ancestor
65722079|NCT05043766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65722080|NCT05043766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722081|NCT05043766|Analgesics|analgesics|mesh-ancestor
65722082|NCT05043766|Sensory System Agents|sensory system agents|mesh-ancestor
65722083|NCT05043766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722084|NCT05043766|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65722085|NCT05043766|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65722086|NCT03462368|Anti-Infective Agents|anti-infective agents|mesh-list
65722087|NCT03462368|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65722088|NCT02383238|Dapagliflozin|dapagliflozin|mesh-list
65722089|NCT02383238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65722090|NCT02383238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722091|NCT02383238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65722092|NCT02383238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722093|NCT03011333|Epinephrine|epinephrine|mesh-list
65722094|NCT03011333|Bupivacaine|bupivacaine|mesh-list
65722095|NCT03011333|Anesthetics, Local|anesthetics, local|mesh-ancestor
65722096|NCT03011333|Anesthetics|anesthetics|mesh-ancestor
65722097|NCT03011333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65722098|NCT03011333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722099|NCT03011333|Sensory System Agents|sensory system agents|mesh-ancestor
65722100|NCT03011333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722101|NCT03011333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65722102|NCT03011333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65722103|NCT03011333|Adrenergic Agents|adrenergic agents|mesh-ancestor
65722104|NCT03011333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65722105|NCT03011333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722106|NCT03011333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65722107|NCT03011333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65722108|NCT03011333|Autonomic Agents|autonomic agents|mesh-ancestor
65722109|NCT03011333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65722110|NCT03011333|Respiratory System Agents|respiratory system agents|mesh-ancestor
65722111|NCT03011333|Mydriatics|mydriatics|mesh-ancestor
65722112|NCT03011333|Sympathomimetics|sympathomimetics|mesh-ancestor
65722113|NCT03011333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65722114|NCT04570397|Ravulizumab|ravulizumab|mesh-list
65722115|NCT04570397|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65722116|NCT04570397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65722117|NCT04570397|Immunologic Factors|immunologic factors|mesh-ancestor
65722118|NCT04570397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722119|NCT02385188|Acetaminophen|acetaminophen|mesh-list
65722120|NCT02385188|Imiquimod|imiquimod|mesh-list
65722121|NCT02385188|Lidocaine|lidocaine|mesh-list
65722122|NCT02385188|Petrolatum|petrolatum|mesh-list
65722123|NCT02385188|Anesthetics, Local|anesthetics, local|mesh-ancestor
65722124|NCT02385188|Anesthetics|anesthetics|mesh-ancestor
65722125|NCT02385188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65722126|NCT02385188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722127|NCT02385188|Sensory System Agents|sensory system agents|mesh-ancestor
65722128|NCT02385188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722129|NCT02385188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65722130|NCT02385188|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65722131|NCT02385188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65722132|NCT02385188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65722133|NCT02385188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722134|NCT02385188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65722135|NCT02385188|Analgesics|analgesics|mesh-ancestor
65722136|NCT02385188|Antipyretics|antipyretics|mesh-ancestor
65722137|NCT02385188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65722138|NCT02385188|Immunologic Factors|immunologic factors|mesh-ancestor
65722139|NCT02385188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722140|NCT02385188|Interferon Inducers|interferon inducers|mesh-ancestor
65722141|NCT02385188|Emollients|emollients|mesh-ancestor
65722142|NCT02385188|Dermatologic Agents|dermatologic agents|mesh-ancestor
65722143|NCT02385032|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65722144|NCT02385032|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65722145|NCT02385032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65722146|NCT02384954|Rituximab|rituximab|mesh-list
65722147|NCT02384954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65722148|NCT02384954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722149|NCT02384954|Immunologic Factors|immunologic factors|mesh-ancestor
65722150|NCT02384954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722151|NCT02384954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65722152|NCT02384876|Ephedrine|ephedrine|mesh-list
65722153|NCT02384876|Pseudoephedrine|pseudoephedrine|mesh-list
65722154|NCT02384876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65722155|NCT02384876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65722156|NCT02384876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722157|NCT02384876|Sympathomimetics|sympathomimetics|mesh-ancestor
65722158|NCT02384876|Autonomic Agents|autonomic agents|mesh-ancestor
65722159|NCT02384876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722160|NCT02384876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65722161|NCT02384876|Adrenergic Agents|adrenergic agents|mesh-ancestor
65722162|NCT02384876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65722163|NCT02384876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722164|NCT02384876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65722165|NCT02384876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65722166|NCT02384876|Respiratory System Agents|respiratory system agents|mesh-ancestor
65722167|NCT02384876|Nasal Decongestants|nasal decongestants|mesh-ancestor
65722168|NCT03013985|Insulin Glargine|insulin glargine|mesh-list
65722169|NCT03013985|Insulin glulisine|insulin glulisine|mesh-list
65722170|NCT03013985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65722171|NCT03013985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722172|NCT02377388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65722173|NCT02377388|Saxagliptin|saxagliptin|mesh-list
65722174|NCT02377388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65722175|NCT02377388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722176|NCT02377388|Incretins|incretins|mesh-ancestor
65722177|NCT02377388|Hormones|hormones|mesh-ancestor
65722178|NCT02377388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65722179|NCT02377388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65722180|NCT02377388|Protease Inhibitors|protease inhibitors|mesh-ancestor
65722181|NCT02377388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722182|NCT02377388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722183|NCT02382380|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
65722184|NCT02382380|Chelating Agents|chelating agents|mesh-ancestor
65722185|NCT02382380|Sequestering Agents|sequestering agents|mesh-ancestor
65722186|NCT02382380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722187|NCT02382146|Dexamethasone|dexamethasone|mesh-list
65722188|NCT02382146|Dexamethasone acetate|dexamethasone acetate|mesh-list
65722189|NCT02382146|Ondansetron|ondansetron|mesh-list
65722190|NCT02382146|BB 1101|bb 1101|mesh-list
65722191|NCT02382146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65722192|NCT02382146|Antiemetics|antiemetics|mesh-ancestor
65722193|NCT02382146|Autonomic Agents|autonomic agents|mesh-ancestor
65722194|NCT02382146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722195|NCT02382146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722196|NCT02382146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65722197|NCT02382146|Glucocorticoids|glucocorticoids|mesh-ancestor
65722198|NCT02382146|Hormones|hormones|mesh-ancestor
65722199|NCT02382146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65722200|NCT02382146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65722201|NCT02382146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722202|NCT02382146|Protease Inhibitors|protease inhibitors|mesh-ancestor
65722203|NCT02382146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722204|NCT02382146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722205|NCT02382146|Antipruritics|antipruritics|mesh-ancestor
65722206|NCT02382146|Dermatologic Agents|dermatologic agents|mesh-ancestor
65722207|NCT02382146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65722208|NCT02382146|Serotonin Agents|serotonin agents|mesh-ancestor
65722209|NCT02382146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65722210|NCT02382146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65722211|NCT02382146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65722212|NCT02382146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65722213|NCT02382146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65722214|NCT02382146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64523253|NCT01682837|Citric Acid|citric acid|mesh-list
65722215|NCT02382068|Dexamethasone|dexamethasone|mesh-list
65722216|NCT02382068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65722217|NCT02382068|Antiemetics|antiemetics|mesh-ancestor
65722218|NCT02382068|Autonomic Agents|autonomic agents|mesh-ancestor
65722219|NCT02382068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722220|NCT02382068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722221|NCT02382068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65722222|NCT02382068|Glucocorticoids|glucocorticoids|mesh-ancestor
65722223|NCT02382068|Hormones|hormones|mesh-ancestor
65722224|NCT02382068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65722225|NCT02382068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65722226|NCT02382068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722227|NCT04731272|Dulaglutide|dulaglutide|mesh-list
65722228|NCT04731272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65722229|NCT04731272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722230|NCT02381600|Vitamin D|vitamin d|mesh-list
65722231|NCT02381600|Vitamins|vitamins|mesh-ancestor
65722232|NCT02381600|Micronutrients|micronutrients|mesh-ancestor
65722233|NCT02381600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722234|NCT02381600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65722235|NCT03113084|Heparin|heparin|mesh-list
65722236|NCT03113084|Calcium heparin|calcium heparin|mesh-list
65722237|NCT03113084|Anticoagulants|anticoagulants|mesh-ancestor
65722238|NCT03113084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65722239|NCT03113084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65722240|NCT03113084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722241|NCT02377076|Calcium, Dietary|calcium, dietary|mesh-list
65722242|NCT02377076|Calcium|calcium|mesh-list
65722243|NCT02377076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65722244|NCT02377076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722245|NCT02377076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65722246|NCT04439474|Vitamin D|vitamin d|mesh-list
65722247|NCT04439474|Cholecalciferol|cholecalciferol|mesh-list
65722248|NCT04439474|Vitamins|vitamins|mesh-ancestor
65722249|NCT04439474|Micronutrients|micronutrients|mesh-ancestor
65722250|NCT04439474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722251|NCT04439474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65722252|NCT04439474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65722253|NCT04990258|Infliximab|infliximab|mesh-list
65722254|NCT04990258|Dermatologic Agents|dermatologic agents|mesh-ancestor
65722255|NCT04990258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65722256|NCT04990258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65722257|NCT02662556|Sufentanil|sufentanil|mesh-list
65722258|NCT02662556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65722259|NCT02662556|Narcotics|narcotics|mesh-ancestor
65722260|NCT02662556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65722261|NCT02662556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722262|NCT02662556|Analgesics|analgesics|mesh-ancestor
65722263|NCT02662556|Sensory System Agents|sensory system agents|mesh-ancestor
65722264|NCT02662556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722265|NCT02662556|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65722266|NCT02662556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65722267|NCT02662556|Anesthetics, General|anesthetics, general|mesh-ancestor
65722268|NCT02662556|Anesthetics|anesthetics|mesh-ancestor
65722269|NCT04262336|Sodium thiosulfate|sodium thiosulfate|mesh-list
65722270|NCT04262336|Hyaluronic Acid|hyaluronic acid|mesh-list
65722271|NCT04262336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65722272|NCT04262336|Immunologic Factors|immunologic factors|mesh-ancestor
65722273|NCT04262336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722274|NCT04262336|Viscosupplements|viscosupplements|mesh-ancestor
65722275|NCT04262336|Protective Agents|protective agents|mesh-ancestor
65722276|NCT04262336|Antidotes|antidotes|mesh-ancestor
65722277|NCT04262336|Antioxidants|antioxidants|mesh-ancestor
65722278|NCT04262336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722279|NCT04262336|Antitubercular Agents|antitubercular agents|mesh-ancestor
65722280|NCT04262336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65722281|NCT04262336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65722282|NCT04262336|Chelating Agents|chelating agents|mesh-ancestor
65722283|NCT04262336|Sequestering Agents|sequestering agents|mesh-ancestor
65722284|NCT05054374|Fulvestrant|fulvestrant|mesh-list
65722285|NCT05054374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65722286|NCT05054374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722287|NCT05054374|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65722288|NCT05054374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65722289|NCT05054374|Hormone Antagonists|hormone antagonists|mesh-ancestor
65722290|NCT05054374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65722291|NCT05054374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722292|NCT02376452|Leucovorin|leucovorin|mesh-list
65722293|NCT02376452|Fluorouracil|fluorouracil|mesh-list
65722294|NCT02376452|Raltitrexed|raltitrexed|mesh-list
65722295|NCT02376452|Irinotecan|irinotecan|mesh-list
65722296|NCT02376452|Antimetabolites|antimetabolites|mesh-ancestor
65722297|NCT02376452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722298|NCT02376452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65722299|NCT02376452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722300|NCT02376452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65722301|NCT02376452|Immunologic Factors|immunologic factors|mesh-ancestor
65722302|NCT02376452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722303|NCT02376452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65722304|NCT02376452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65722305|NCT02376452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722306|NCT02376452|Antidotes|antidotes|mesh-ancestor
65722307|NCT02376452|Protective Agents|protective agents|mesh-ancestor
65722308|NCT02376452|Vitamin B Complex|vitamin b complex|mesh-ancestor
65722309|NCT02376452|Vitamins|vitamins|mesh-ancestor
65722310|NCT02376452|Micronutrients|micronutrients|mesh-ancestor
65722311|NCT02376452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65722312|NCT02516098|Scopolamine|scopolamine|mesh-list
65722313|NCT02516098|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65722314|NCT02516098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65722315|NCT02516098|Antiemetics|antiemetics|mesh-ancestor
65722316|NCT02516098|Autonomic Agents|autonomic agents|mesh-ancestor
65722317|NCT02516098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722318|NCT02516098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722319|NCT02516098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65722320|NCT02516098|Mydriatics|mydriatics|mesh-ancestor
65722321|NCT02516098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65722322|NCT02516098|Cholinergic Agents|cholinergic agents|mesh-ancestor
65722323|NCT02516098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65722324|NCT02516098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722325|NCT02516098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65722326|NCT02516098|Parasympatholytics|parasympatholytics|mesh-ancestor
65722327|NCT02372318|Nalmefene|nalmefene|mesh-list
65722328|NCT02372318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65722329|NCT02372318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722330|NCT02372318|Sensory System Agents|sensory system agents|mesh-ancestor
65722331|NCT02372318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722332|NCT03105674|Anesthetics|anesthetics|mesh-list
65722333|NCT03105674|Anesthetics, Local|anesthetics, local|mesh-list
65722334|NCT03105674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65722335|NCT03105674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722336|NCT03105674|Sensory System Agents|sensory system agents|mesh-ancestor
65722337|NCT03105674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722338|NCT02380898|Ketorolac|ketorolac|mesh-list
65722339|NCT02380898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65722340|NCT02380898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65722341|NCT02380898|Analgesics|analgesics|mesh-ancestor
65722342|NCT02380898|Sensory System Agents|sensory system agents|mesh-ancestor
65722343|NCT02380898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722344|NCT02380898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722345|NCT02380898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65722346|NCT02380898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65722347|NCT02380898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65722348|NCT02380898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722349|NCT02380898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722350|NCT04985890|UB-421|ub-421|mesh-list
65722351|NCT04985890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65722352|NCT04985890|Antiviral Agents|antiviral agents|mesh-ancestor
65722353|NCT04985890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65722354|NCT04098068|Pembrolizumab|pembrolizumab|mesh-list
65722355|NCT04098068|Antibodies|antibodies|mesh-list
65722356|NCT04098068|Immunologic Factors|immunologic factors|mesh-ancestor
65722357|NCT04098068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722358|NCT04098068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65722359|NCT04098068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722360|NCT02376296|Docetaxel|docetaxel|mesh-list
65722361|NCT02376296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722362|NCT02376296|Tubulin Modulators|tubulin modulators|mesh-ancestor
65722363|NCT02376296|Antimitotic Agents|antimitotic agents|mesh-ancestor
65722364|NCT02376296|Mitosis Modulators|mitosis modulators|mesh-ancestor
65722365|NCT02376296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722366|NCT01364428|Insulin|insulin|mesh-list
65722367|NCT01364428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65722368|NCT01364428|Insulin, Long-Acting|insulin, long-acting|mesh-list
65038142|NCT00183833|Capecitabine|capecitabine|mesh-list
65722369|NCT01364428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65722370|NCT01364428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722371|NCT02380586|Anesthetics|anesthetics|mesh-list
65722372|NCT02380586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65722373|NCT02380586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722374|NCT02375828|Glyburide|glyburide|mesh-list
65722375|NCT02375828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65722376|NCT02375828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722377|NCT02371226|Insulin|insulin|mesh-list
65722378|NCT02371226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65722379|NCT02371226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65722380|NCT02371226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722381|NCT02371304|Capecitabine|capecitabine|mesh-list
65722382|NCT02371304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65722383|NCT02371304|Antimetabolites|antimetabolites|mesh-ancestor
65722384|NCT02371304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722385|NCT02371304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722386|NCT02380352|Amoxicillin|amoxicillin|mesh-list
65722387|NCT02380352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65722388|NCT02380352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65722389|NCT02380118|Midazolam|midazolam|mesh-list
65722390|NCT02380118|Haloperidol|haloperidol|mesh-list
65722391|NCT02380118|Olanzapine|olanzapine|mesh-list
65722392|NCT02380118|Haloperidol decanoate|haloperidol decanoate|mesh-list
65722393|NCT02380118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65722394|NCT02380118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65722395|NCT02380118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65722396|NCT02380118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722397|NCT02380118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65722398|NCT02380118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65722399|NCT02380118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65722400|NCT02380118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65722401|NCT02380118|Anesthetics, General|anesthetics, general|mesh-ancestor
65722402|NCT02380118|Anesthetics|anesthetics|mesh-ancestor
65722403|NCT02380118|GABA Modulators|gaba modulators|mesh-ancestor
65722404|NCT02380118|GABA Agents|gaba agents|mesh-ancestor
65722405|NCT02380118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65722406|NCT02380118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722407|NCT02380118|Antiemetics|antiemetics|mesh-ancestor
65722408|NCT02380118|Autonomic Agents|autonomic agents|mesh-ancestor
65722409|NCT02380118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722410|NCT02380118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65722411|NCT02380118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65269600|NCT02730026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722412|NCT02380118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65722413|NCT02380118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65722414|NCT02380118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65722415|NCT02380118|Serotonin Agents|serotonin agents|mesh-ancestor
65722416|NCT02380118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65722417|NCT02380118|Dopamine Agents|dopamine agents|mesh-ancestor
65722418|NCT02380118|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65722419|NCT03113708|Heparin|heparin|mesh-list
65722420|NCT03113708|Calcium heparin|calcium heparin|mesh-list
65722421|NCT03113708|Anticoagulants|anticoagulants|mesh-ancestor
65722422|NCT03113708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65722423|NCT03113708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65722424|NCT03113708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722425|NCT02371148|Rituximab|rituximab|mesh-list
65722426|NCT02371148|Bortezomib|bortezomib|mesh-list
65722427|NCT02371148|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65722428|NCT02371148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65722429|NCT02371148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722430|NCT02371148|Immunologic Factors|immunologic factors|mesh-ancestor
65722431|NCT02371148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722432|NCT02371148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65722433|NCT02371148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65722434|NCT02371148|Alkylating Agents|alkylating agents|mesh-ancestor
65722435|NCT02371148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722436|NCT02370680|Aspirin|aspirin|mesh-list
65722437|NCT02370680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65722438|NCT02370680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65722439|NCT02370680|Analgesics|analgesics|mesh-ancestor
65722440|NCT02370680|Sensory System Agents|sensory system agents|mesh-ancestor
65722441|NCT02370680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722442|NCT02370680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038220|NCT00210366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722443|NCT02370680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65722444|NCT02370680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65722445|NCT02370680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65722446|NCT02370680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65722447|NCT02370680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722448|NCT02370680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65722449|NCT02370680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65722450|NCT02370680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722452|NCT02370758|Valganciclovir|valganciclovir|mesh-list
65722453|NCT02370758|Ganciclovir|ganciclovir|mesh-list
65722454|NCT02370758|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65722455|NCT02370758|Antiviral Agents|antiviral agents|mesh-ancestor
65722456|NCT02370758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65722457|NCT02370758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65722458|NCT02370758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722459|NCT02370758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722460|NCT02379650|Hydroxychloroquine|hydroxychloroquine|mesh-list
65722461|NCT02379650|Antimalarials|antimalarials|mesh-ancestor
65722462|NCT02379650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65722463|NCT02379650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65722464|NCT02379650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65722465|NCT02379650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722466|NCT02379650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722467|NCT02379650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65722468|NCT04661150|Capecitabine|capecitabine|mesh-list
65722469|NCT04661150|Oxaliplatin|oxaliplatin|mesh-list
65722470|NCT04661150|Trastuzumab|trastuzumab|mesh-list
65722471|NCT04661150|Atezolizumab|atezolizumab|mesh-list
65722472|NCT04661150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65722473|NCT04661150|Antimetabolites|antimetabolites|mesh-ancestor
65722474|NCT04661150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722475|NCT04661150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722476|NCT04661150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65722477|NCT04613492|Durvalumab|durvalumab|mesh-list
65722478|NCT04613492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65722479|NCT04613492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722480|NCT02379026|Vitamin D|vitamin d|mesh-list
65722481|NCT02379026|Cholecalciferol|cholecalciferol|mesh-list
65722482|NCT02379026|Vitamins|vitamins|mesh-ancestor
65722483|NCT02379026|Micronutrients|micronutrients|mesh-ancestor
65722484|NCT02379026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722485|NCT02379026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65722486|NCT02379026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65722487|NCT02991859|Fluticasone|fluticasone|mesh-list
65722488|NCT02991859|Xhance|xhance|mesh-list
65722489|NCT02991859|Budesonide|budesonide|mesh-list
65722490|NCT02991859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65722491|NCT02991859|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65722492|NCT02991859|Autonomic Agents|autonomic agents|mesh-ancestor
65722493|NCT02991859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722494|NCT02991859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722495|NCT02991859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65722496|NCT02991859|Respiratory System Agents|respiratory system agents|mesh-ancestor
65722497|NCT02991859|Dermatologic Agents|dermatologic agents|mesh-ancestor
65722498|NCT02991859|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65722499|NCT02991859|Glucocorticoids|glucocorticoids|mesh-ancestor
65722500|NCT02991859|Hormones|hormones|mesh-ancestor
65722501|NCT02991859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65722502|NCT02374736|Immunoglobulins|immunoglobulins|mesh-list
65722503|NCT02374736|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65722504|NCT02374736|Antibodies|antibodies|mesh-list
65722505|NCT02374736|Immunoglobulin G|immunoglobulin g|mesh-list
65722506|NCT02374736|Immunologic Factors|immunologic factors|mesh-ancestor
65722507|NCT02374736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722508|NCT02369978|Benzonidazole|benzonidazole|mesh-list
65722509|NCT02369978|Nifurtimox|nifurtimox|mesh-list
65722510|NCT02369978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65722511|NCT02369978|Immunologic Factors|immunologic factors|mesh-ancestor
65722512|NCT02369978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722513|NCT02369978|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65722514|NCT02369978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65722515|NCT02369978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65722516|NCT02369978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65722517|NCT03661489|Propofol|propofol|mesh-list
65722518|NCT03661489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65722519|NCT03661489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65722520|NCT03661489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722521|NCT03661489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65722522|NCT03661489|Anesthetics, General|anesthetics, general|mesh-ancestor
65722523|NCT03661489|Anesthetics|anesthetics|mesh-ancestor
65722524|NCT04056169|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65722525|NCT04056169|Ezetimibe|ezetimibe|mesh-list
65722526|NCT04056169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65722527|NCT04056169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65722528|NCT04056169|Antimetabolites|antimetabolites|mesh-ancestor
65722529|NCT04056169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722530|NCT04056169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65722531|NCT04056169|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65722532|NCT04056169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722533|NCT05030194|Nicotine|nicotine|mesh-list
65722534|NCT05030194|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65722535|NCT05030194|Autonomic Agents|autonomic agents|mesh-ancestor
65722536|NCT05030194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722537|NCT05030194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722538|NCT05030194|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65722539|NCT05030194|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65722540|NCT05030194|Cholinergic Agents|cholinergic agents|mesh-ancestor
65722541|NCT05030194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65722542|NCT05030194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722543|NCT02988115|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
65722544|NCT02988115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65722545|NCT02988115|Antimetabolites|antimetabolites|mesh-ancestor
65722546|NCT02988115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722547|NCT02988115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65722548|NCT02988115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722549|NCT02988115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65722550|NCT02988115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722551|NCT04209946|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65722552|NCT04209946|Respiratory System Agents|respiratory system agents|mesh-ancestor
65722553|NCT03008915|Aspirin|aspirin|mesh-list
65722554|NCT03008915|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65722555|NCT03008915|Protein C Inhibitor|protein c inhibitor|mesh-list
65722556|NCT03008915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65722557|NCT03008915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65722558|NCT03008915|Analgesics|analgesics|mesh-ancestor
65722559|NCT03008915|Sensory System Agents|sensory system agents|mesh-ancestor
65722560|NCT03008915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722561|NCT03008915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722562|NCT03008915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65722563|NCT03008915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65722564|NCT03008915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65722565|NCT03008915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65722566|NCT03008915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722567|NCT03008915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65722568|NCT03008915|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65722569|NCT03008915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722570|NCT03008915|Antipyretics|antipyretics|mesh-ancestor
65722571|NCT03008915|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65722572|NCT03008915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65722573|NCT03008915|Protease Inhibitors|protease inhibitors|mesh-ancestor
65722574|NCT03622489|Acetaminophen|acetaminophen|mesh-list
65722575|NCT03622489|Dipyrone|dipyrone|mesh-list
65722576|NCT03622489|Ibuprofen|ibuprofen|mesh-list
65722577|NCT03622489|Morphine|morphine|mesh-list
65722578|NCT03622489|Tramadol|tramadol|mesh-list
65722579|NCT03622489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65722580|NCT03622489|Narcotics|narcotics|mesh-ancestor
65722581|NCT03622489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65722582|NCT03622489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722583|NCT03622489|Analgesics|analgesics|mesh-ancestor
65722584|NCT03622489|Sensory System Agents|sensory system agents|mesh-ancestor
65722585|NCT03622489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722586|NCT03622489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65722587|NCT03622489|Antipyretics|antipyretics|mesh-ancestor
65722588|NCT03622489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65722589|NCT03622489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65722590|NCT03622489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65722591|NCT03622489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65722592|NCT03622489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722593|NCT03622489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722594|NCT03667001|Lidocaine|lidocaine|mesh-list
65722595|NCT03667001|Anesthetics, Local|anesthetics, local|mesh-ancestor
65722596|NCT03667001|Anesthetics|anesthetics|mesh-ancestor
65038364|NCT00217386|Etanercept|etanercept|mesh-list
65722597|NCT03667001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65722598|NCT03667001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722599|NCT03667001|Sensory System Agents|sensory system agents|mesh-ancestor
65722600|NCT03667001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722601|NCT03667001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65722602|NCT03667001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65722603|NCT03667001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65722604|NCT03667001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65722605|NCT03667001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722606|NCT03666299|Lidocaine|lidocaine|mesh-list
65722607|NCT03666299|Anesthetics, Local|anesthetics, local|mesh-ancestor
65722608|NCT03666299|Anesthetics|anesthetics|mesh-ancestor
65722609|NCT03666299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65722610|NCT03666299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722611|NCT03666299|Sensory System Agents|sensory system agents|mesh-ancestor
65722612|NCT03666299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722613|NCT03666299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65722614|NCT03666299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65722615|NCT03666299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65722616|NCT03666299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65722617|NCT03666299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722618|NCT03660397|Antihypertensive Agents|antihypertensive agents|mesh-list
65722619|NCT03591380|Belimumab|belimumab|mesh-list
65722620|NCT03591380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65722621|NCT03591380|Immunologic Factors|immunologic factors|mesh-ancestor
65722622|NCT03591380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722623|NCT04057469|Tulobuterol|tulobuterol|mesh-list
65722624|NCT04057469|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65722625|NCT04057469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65722626|NCT04057469|Adrenergic Agents|adrenergic agents|mesh-ancestor
65722627|NCT04057469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65722628|NCT04057469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722629|NCT04057469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722630|NCT04057469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65722631|NCT04057469|Autonomic Agents|autonomic agents|mesh-ancestor
65722632|NCT04057469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722633|NCT04057469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65722634|NCT04057469|Respiratory System Agents|respiratory system agents|mesh-ancestor
65722635|NCT03666221|Nimotuzumab|nimotuzumab|mesh-list
65722636|NCT03666221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65722637|NCT03666221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722638|NCT03658291|Levofloxacin|levofloxacin|mesh-list
65722639|NCT03658291|Ofloxacin|ofloxacin|mesh-list
65722640|NCT03658291|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65722641|NCT03658291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65722642|NCT03658291|Renal Agents|renal agents|mesh-ancestor
65722643|NCT03658291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65722644|NCT03658291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65722645|NCT03658291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65722646|NCT03658291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722647|NCT03658291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722648|NCT03658291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722649|NCT03658291|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65722650|NCT03658291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65722651|NCT03658213|Goserelin|goserelin|mesh-list
65722652|NCT03658213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65722653|NCT03658213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722654|NCT02515630|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
65722655|NCT02515630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65722656|NCT02515630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722657|NCT02515630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722658|NCT03006887|Pembrolizumab|pembrolizumab|mesh-list
65722659|NCT03006887|Lenvatinib|lenvatinib|mesh-list
65722660|NCT03006887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65722661|NCT03006887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722662|NCT03006887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65722663|NCT03006887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722664|NCT03006887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722665|NCT02377856|Interferons|interferons|mesh-list
65722666|NCT02377856|Ribavirin|ribavirin|mesh-list
65722667|NCT02377856|Interferon-alpha|interferon-alpha|mesh-list
65722668|NCT02377856|Interferon alpha-2|interferon alpha-2|mesh-list
65722669|NCT02377856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65722670|NCT02377856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722671|NCT02377856|Antiviral Agents|antiviral agents|mesh-ancestor
65722672|NCT02377856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65722673|NCT02377856|Antimetabolites|antimetabolites|mesh-ancestor
65722674|NCT02377856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722675|NCT02377856|Immunologic Factors|immunologic factors|mesh-ancestor
65722676|NCT02377856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722677|NCT02377778|Thiopental|thiopental|mesh-list
65722678|NCT02377778|Propofol|propofol|mesh-list
65722679|NCT02377778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65722680|NCT02377778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65722681|NCT02377778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722682|NCT02377778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65722683|NCT02377778|Anesthetics, General|anesthetics, general|mesh-ancestor
65722684|NCT02377778|Anesthetics|anesthetics|mesh-ancestor
65722685|NCT02377778|Anticonvulsants|anticonvulsants|mesh-ancestor
65722686|NCT02377778|GABA Modulators|gaba modulators|mesh-ancestor
65722687|NCT02377778|GABA Agents|gaba agents|mesh-ancestor
65722688|NCT02377778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65722689|NCT02377778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722690|NCT02514772|Rituximab|rituximab|mesh-list
65722691|NCT02514772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65722692|NCT02514772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722693|NCT02514772|Immunologic Factors|immunologic factors|mesh-ancestor
65722694|NCT02514772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722695|NCT02514772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65722696|NCT03658057|Rocuronium|rocuronium|mesh-list
65722697|NCT03658057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65722698|NCT03658057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65722699|NCT03658057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65722700|NCT03658057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722701|NCT03658057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722702|NCT03657979|Ropivacaine|ropivacaine|mesh-list
65722703|NCT03657979|Anesthetics, Local|anesthetics, local|mesh-ancestor
65722704|NCT03657979|Anesthetics|anesthetics|mesh-ancestor
65722705|NCT03657979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65722706|NCT03657979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722707|NCT03657979|Sensory System Agents|sensory system agents|mesh-ancestor
65722708|NCT03657979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722709|NCT03659851|Simendan|simendan|mesh-list
65722710|NCT03659851|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65722711|NCT03659851|Vasodilator Agents|vasodilator agents|mesh-ancestor
65722712|NCT03659851|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65722713|NCT03659851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65722714|NCT03659851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722715|NCT03659851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722716|NCT03659851|Protective Agents|protective agents|mesh-ancestor
65722717|NCT03659851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722718|NCT04551521|Trastuzumab|trastuzumab|mesh-list
65722719|NCT04551521|Pertuzumab|pertuzumab|mesh-list
65722720|NCT04551521|Atezolizumab|atezolizumab|mesh-list
65722721|NCT04551521|Vemurafenib|vemurafenib|mesh-list
65722722|NCT04551521|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65722723|NCT04551521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65722724|NCT04551521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722725|NCT04551521|Immunologic Factors|immunologic factors|mesh-ancestor
65722726|NCT04551521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722727|NCT04551521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65722728|NCT04551521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722729|NCT04551521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722730|NCT03659383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65722731|NCT03659383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722732|NCT02368730|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65722733|NCT02368730|Hemostatics|hemostatics|mesh-ancestor
65722734|NCT02368730|Coagulants|coagulants|mesh-ancestor
65722735|NCT02368730|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65722736|NCT02368730|Natriuretic Agents|natriuretic agents|mesh-ancestor
65722737|NCT02368730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722738|NCT03659305|Bevacizumab|bevacizumab|mesh-list
65722739|NCT03659305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65722740|NCT03659305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722741|NCT03659305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65722742|NCT03659305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65722743|NCT03659305|Growth Substances|growth substances|mesh-ancestor
65722744|NCT03659305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722745|NCT03659305|Growth Inhibitors|growth inhibitors|mesh-ancestor
65722747|NCT02788981|Mifepristone|mifepristone|mesh-list
65722748|NCT02788981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65722749|NCT02788981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722750|NCT02788981|Tubulin Modulators|tubulin modulators|mesh-ancestor
65722751|NCT02788981|Antimitotic Agents|antimitotic agents|mesh-ancestor
65722752|NCT02788981|Mitosis Modulators|mitosis modulators|mesh-ancestor
65722753|NCT02788981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722754|NCT02788981|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65722755|NCT02788981|Abortifacient Agents|abortifacient agents|mesh-ancestor
65722756|NCT02788981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65722757|NCT02788981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722758|NCT02788981|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65722759|NCT02788981|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65722760|NCT02788981|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65722761|NCT02788981|Contraceptive Agents|contraceptive agents|mesh-ancestor
65722762|NCT02788981|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65722763|NCT02788981|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65722764|NCT02788981|Hormone Antagonists|hormone antagonists|mesh-ancestor
65722765|NCT02788981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65722766|NCT02788981|Luteolytic Agents|luteolytic agents|mesh-ancestor
65722767|NCT02788981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65722768|NCT02788981|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65722769|NCT02368964|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65722770|NCT02368964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65722771|NCT02368964|Luteolytic Agents|luteolytic agents|mesh-ancestor
65722772|NCT02368964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65722773|NCT02368964|Contraceptive Agents|contraceptive agents|mesh-ancestor
65722774|NCT02368964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65722775|NCT02368964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722776|NCT02368964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65722777|NCT02368964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65722778|NCT02368964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722779|NCT02373722|Petrolatum|petrolatum|mesh-list
65722780|NCT02373722|Mineral Oil|mineral oil|mesh-list
65722781|NCT02373722|Emollients|emollients|mesh-ancestor
65722782|NCT02373722|Dermatologic Agents|dermatologic agents|mesh-ancestor
65722783|NCT03000179|Avelumab|avelumab|mesh-list
65722784|NCT03000179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65722785|NCT03000179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722786|NCT03658993|Rifaximin|rifaximin|mesh-list
65722787|NCT03658993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65722788|NCT03658993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65722789|NCT03658993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65722790|NCT02373410|Bupivacaine|bupivacaine|mesh-list
65722791|NCT02373410|Anesthetics, Local|anesthetics, local|mesh-ancestor
65722792|NCT02373410|Anesthetics|anesthetics|mesh-ancestor
65722793|NCT02373410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65722794|NCT02373410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722795|NCT02373410|Sensory System Agents|sensory system agents|mesh-ancestor
65722796|NCT02373410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722797|NCT02920177|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65722798|NCT02920177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65722799|NCT02920177|Glucocorticoids|glucocorticoids|mesh-ancestor
65722800|NCT02920177|Hormones|hormones|mesh-ancestor
65722801|NCT02920177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65722802|NCT02920177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722803|NCT02920177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65722804|NCT02920177|Immunologic Factors|immunologic factors|mesh-ancestor
65722805|NCT03006341|Telmisartan|telmisartan|mesh-list
65722806|NCT03006341|Warfarin|warfarin|mesh-list
65722807|NCT03006341|Dabigatran|dabigatran|mesh-list
65722808|NCT03006341|Anticoagulants|anticoagulants|mesh-ancestor
65722809|NCT03006341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65722810|NCT03006341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65722811|NCT03006341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65722812|NCT03006341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722813|NCT03006341|Antithrombins|antithrombins|mesh-ancestor
65722814|NCT03006341|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65722815|NCT03006341|Protease Inhibitors|protease inhibitors|mesh-ancestor
65722816|NCT03006341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722817|NCT05022784|Nintedanib|nintedanib|mesh-list
65722818|NCT05022784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038594|NCT00218049|Dopamine Agents|dopamine agents|mesh-ancestor
65722819|NCT05022784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65722820|NCT05022784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722821|NCT05022784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722822|NCT04413799|Lidocaine|lidocaine|mesh-list
65722823|NCT04413799|Ketamine|ketamine|mesh-list
65722824|NCT04413799|Anesthetics, Local|anesthetics, local|mesh-ancestor
65722825|NCT04413799|Anesthetics|anesthetics|mesh-ancestor
65722826|NCT04413799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65722827|NCT04413799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722828|NCT04413799|Sensory System Agents|sensory system agents|mesh-ancestor
65722829|NCT04413799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722830|NCT04413799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65722831|NCT04413799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65722832|NCT04413799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65722833|NCT04413799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65722834|NCT04413799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722835|NCT04413799|Analgesics|analgesics|mesh-ancestor
65722836|NCT04413799|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65722837|NCT04413799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65722838|NCT04413799|Anesthetics, General|anesthetics, general|mesh-ancestor
65722839|NCT04413799|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65722840|NCT04413799|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65722841|NCT04413799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65722842|NCT03665753|Ketorolac|ketorolac|mesh-list
65722843|NCT03665753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65722844|NCT03665753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65722845|NCT03665753|Analgesics|analgesics|mesh-ancestor
65722846|NCT03665753|Sensory System Agents|sensory system agents|mesh-ancestor
65722847|NCT03665753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722848|NCT03665753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722849|NCT03665753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65722850|NCT03665753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65722851|NCT03665753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65722852|NCT03665753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722853|NCT03665753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722854|NCT02368652|Amlodipine|amlodipine|mesh-list
65722855|NCT02368652|Candesartan|candesartan|mesh-list
65722856|NCT02368652|Candesartan cilexetil|candesartan cilexetil|mesh-list
65722857|NCT02368652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65722858|NCT02368652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65722859|NCT02368652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65722860|NCT02368652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722861|NCT02368652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65722862|NCT02368652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722863|NCT02368652|Vasodilator Agents|vasodilator agents|mesh-ancestor
65722864|NCT02368652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65722865|NCT02368652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65722866|NCT02512042|Brinzolamide|brinzolamide|mesh-list
65722867|NCT02512042|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65722868|NCT02512042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722869|NCT02512042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722870|NCT03665519|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65722871|NCT03665519|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65722872|NCT03665519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65722873|NCT03923270|Durvalumab|durvalumab|mesh-list
65722874|NCT03923270|Olaparib|olaparib|mesh-list
65722875|NCT03923270|Tremelimumab|tremelimumab|mesh-list
65722876|NCT03923270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65722877|NCT03923270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65722878|NCT03923270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722879|NCT03923270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65722880|NCT03923270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722881|NCT03923270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722882|NCT03923270|Immunologic Factors|immunologic factors|mesh-ancestor
65722883|NCT03923270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722884|NCT04386746|Gemcitabine|gemcitabine|mesh-list
65722885|NCT04386746|Docetaxel|docetaxel|mesh-list
65722886|NCT04386746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65722887|NCT04386746|Antimetabolites|antimetabolites|mesh-ancestor
65722888|NCT04386746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722889|NCT04386746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722890|NCT04386746|Antiviral Agents|antiviral agents|mesh-ancestor
65038669|NCT00409097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65722891|NCT04386746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65722892|NCT04386746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722893|NCT04386746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65722894|NCT04386746|Immunologic Factors|immunologic factors|mesh-ancestor
65722895|NCT04386746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722896|NCT04386746|Tubulin Modulators|tubulin modulators|mesh-ancestor
65722897|NCT04386746|Antimitotic Agents|antimitotic agents|mesh-ancestor
65722898|NCT04386746|Mitosis Modulators|mitosis modulators|mesh-ancestor
65722899|NCT01066897|Pramipexole|pramipexole|mesh-list
65722900|NCT01066897|Antioxidants|antioxidants|mesh-ancestor
65722901|NCT01066897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722902|NCT01066897|Protective Agents|protective agents|mesh-ancestor
65722903|NCT01066897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722904|NCT01066897|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65722905|NCT01066897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65722906|NCT01066897|Dopamine Agonists|dopamine agonists|mesh-ancestor
65722907|NCT01066897|Dopamine Agents|dopamine agents|mesh-ancestor
65722908|NCT01066897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65722909|NCT02373254|Acetaminophen|acetaminophen|mesh-list
65722910|NCT02373254|Ibuprofen|ibuprofen|mesh-list
65722911|NCT02373254|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65722912|NCT02373254|Hydrocodone|hydrocodone|mesh-list
65722913|NCT02373254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65722914|NCT02373254|Analgesics|analgesics|mesh-ancestor
65722915|NCT02373254|Sensory System Agents|sensory system agents|mesh-ancestor
65722916|NCT02373254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722917|NCT02373254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722918|NCT02373254|Antipyretics|antipyretics|mesh-ancestor
65722919|NCT02373254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65722920|NCT02373254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65722921|NCT02373254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65722922|NCT02373254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65722923|NCT02373254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65722924|NCT02373254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722925|NCT02373254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65722926|NCT02373254|Narcotics|narcotics|mesh-ancestor
65722927|NCT02373254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65722928|NCT02373254|Antitussive Agents|antitussive agents|mesh-ancestor
65722929|NCT02373254|Respiratory System Agents|respiratory system agents|mesh-ancestor
65722930|NCT03657355|Zolpidem|zolpidem|mesh-list
65722931|NCT03657355|Suvorexant|suvorexant|mesh-list
65722932|NCT03657355|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65722933|NCT03657355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65722934|NCT03657355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65722935|NCT03657355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722936|NCT03657355|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65722937|NCT03657355|GABA Agonists|gaba agonists|mesh-ancestor
65722938|NCT03657355|GABA Agents|gaba agents|mesh-ancestor
65722939|NCT03657355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65722940|NCT03657355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722941|NCT03657355|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65722942|NCT02985541|Levonorgestrel|levonorgestrel|mesh-list
65722943|NCT02985541|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65722944|NCT02985541|Contraceptive Agents|contraceptive agents|mesh-ancestor
65722945|NCT02985541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65722946|NCT02985541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722947|NCT02985541|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65722948|NCT02985541|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65722949|NCT02985541|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65722950|NCT02365532|Dofetilide|dofetilide|mesh-list
65722951|NCT02365532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65722952|NCT02365532|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65722953|NCT02365532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65722954|NCT02365532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722955|NCT03113162|Cytarabine|cytarabine|mesh-list
65722956|NCT03113162|Etoposide|etoposide|mesh-list
65722957|NCT03113162|Melphalan|melphalan|mesh-list
65722958|NCT03113162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65722959|NCT03113162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65722960|NCT03113162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65722961|NCT03113162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65722962|NCT03113162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038742|NCT00211302|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65722963|NCT03113162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722964|NCT03113162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65722965|NCT03113162|Antimetabolites|antimetabolites|mesh-ancestor
65722966|NCT03113162|Antiviral Agents|antiviral agents|mesh-ancestor
65722967|NCT03113162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65722968|NCT03113162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65722969|NCT03113162|Immunologic Factors|immunologic factors|mesh-ancestor
65722970|NCT03113162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722971|NCT03113162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65722972|NCT03113162|Alkylating Agents|alkylating agents|mesh-ancestor
65722973|NCT03113162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65722975|NCT02356705|Midazolam|midazolam|mesh-list
65722976|NCT02356705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65722977|NCT02356705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65722978|NCT02356705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65722979|NCT02356705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65722980|NCT02356705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65722981|NCT02356705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65722982|NCT02356705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65722983|NCT02356705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65722984|NCT02356705|Anesthetics, General|anesthetics, general|mesh-ancestor
65722985|NCT02356705|Anesthetics|anesthetics|mesh-ancestor
65722986|NCT02356705|GABA Modulators|gaba modulators|mesh-ancestor
65722987|NCT02356705|GABA Agents|gaba agents|mesh-ancestor
65722988|NCT02356705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65722989|NCT02356705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65722990|NCT02356705|Anesthetics, Local|anesthetics, local|mesh-ancestor
65722991|NCT02356705|Sensory System Agents|sensory system agents|mesh-ancestor
65722992|NCT02356705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65722993|NCT02356705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65722994|NCT02356705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65722995|NCT02356705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65722996|NCT02356705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65722997|NCT03541850|Ascorbic Acid|ascorbic acid|mesh-list
65722998|NCT03541850|Methyltestosterone|methyltestosterone|mesh-list
65722999|NCT03541850|Hormones|hormones|mesh-list
65723000|NCT03541850|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65723001|NCT03541850|Androgens|androgens|mesh-list
65723002|NCT03541850|Androgen Antagonists|androgen antagonists|mesh-list
65185590|NCT05383131|Analgesics|analgesics|mesh-ancestor
65723003|NCT03541850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65723004|NCT03541850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723005|NCT03541850|Antioxidants|antioxidants|mesh-ancestor
65723006|NCT03541850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723007|NCT03541850|Protective Agents|protective agents|mesh-ancestor
65723008|NCT03541850|Vitamins|vitamins|mesh-ancestor
65723009|NCT03541850|Micronutrients|micronutrients|mesh-ancestor
65723010|NCT03541850|Estrogens|estrogens|mesh-ancestor
65723011|NCT03541850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65723012|NCT03541850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723013|NCT03541850|Anabolic Agents|anabolic agents|mesh-ancestor
65723014|NCT03541850|Hormone Antagonists|hormone antagonists|mesh-ancestor
65723015|NCT02511184|Pembrolizumab|pembrolizumab|mesh-list
65723016|NCT02511184|Crizotinib|crizotinib|mesh-list
65723017|NCT02511184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65723018|NCT02511184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723019|NCT02511184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65723020|NCT02511184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723021|NCT02511184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723022|NCT02367560|Methylprednisolone|methylprednisolone|mesh-list
65723023|NCT02367560|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65723024|NCT02367560|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65723025|NCT02367560|Prednisolone|prednisolone|mesh-list
65723026|NCT02367560|Prednisolone acetate|prednisolone acetate|mesh-list
65723027|NCT02367560|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65723028|NCT02367560|Prednisolone phosphate|prednisolone phosphate|mesh-list
65723029|NCT02367560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65723030|NCT02367560|Antiemetics|antiemetics|mesh-ancestor
65723031|NCT02367560|Autonomic Agents|autonomic agents|mesh-ancestor
65723032|NCT02367560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723033|NCT02367560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723034|NCT02367560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65723035|NCT02367560|Glucocorticoids|glucocorticoids|mesh-ancestor
65723036|NCT02367560|Hormones|hormones|mesh-ancestor
65723037|NCT02367560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65723038|NCT02367560|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65723039|NCT02367560|Protective Agents|protective agents|mesh-ancestor
65723040|NCT02367560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65723041|NCT02367560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723042|NCT02372942|Progesterone|progesterone|mesh-list
65723043|NCT02372942|Progestins|progestins|mesh-ancestor
65723044|NCT02372942|Hormones|hormones|mesh-ancestor
65723045|NCT02372942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65723046|NCT02372942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723047|NCT02364986|Interferons|interferons|mesh-list
65723048|NCT02364986|Interferon-beta|interferon-beta|mesh-list
65723049|NCT02364986|Interferon beta-1a|interferon beta-1a|mesh-list
65723050|NCT02364986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723051|NCT02364986|Antiviral Agents|antiviral agents|mesh-ancestor
65723052|NCT02364986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65723053|NCT02364986|Immunologic Factors|immunologic factors|mesh-ancestor
65723054|NCT02364986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723055|NCT02364986|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65723056|NCT03506360|Dexamethasone|dexamethasone|mesh-list
65723057|NCT03506360|Dexamethasone acetate|dexamethasone acetate|mesh-list
65723058|NCT03506360|Pembrolizumab|pembrolizumab|mesh-list
65723059|NCT03506360|Ixazomib|ixazomib|mesh-list
65723060|NCT03506360|Ichthammol|ichthammol|mesh-list
65723061|NCT03506360|BB 1101|bb 1101|mesh-list
65723062|NCT03506360|Glycine|glycine|mesh-list
65723063|NCT03506360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65723064|NCT03506360|Antiemetics|antiemetics|mesh-ancestor
65723065|NCT03506360|Autonomic Agents|autonomic agents|mesh-ancestor
65723066|NCT03506360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723067|NCT03506360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723068|NCT03506360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65723069|NCT03506360|Glucocorticoids|glucocorticoids|mesh-ancestor
65723070|NCT03506360|Hormones|hormones|mesh-ancestor
65723071|NCT03506360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65723072|NCT03506360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65723073|NCT03506360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723074|NCT03506360|Protease Inhibitors|protease inhibitors|mesh-ancestor
65723075|NCT03506360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723076|NCT03506360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723077|NCT03506360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65723078|NCT03506360|Dermatologic Agents|dermatologic agents|mesh-ancestor
65723079|NCT03506360|Glycine Agents|glycine agents|mesh-ancestor
65723080|NCT03506360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65723081|NCT02372786|Lidocaine|lidocaine|mesh-list
65723082|NCT02372786|Tetracaine|tetracaine|mesh-list
65723083|NCT02372786|Prilocaine|prilocaine|mesh-list
65723084|NCT02372786|Anesthetics, Local|anesthetics, local|mesh-ancestor
65723085|NCT02372786|Anesthetics|anesthetics|mesh-ancestor
65723086|NCT02372786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65723087|NCT02372786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723088|NCT02372786|Sensory System Agents|sensory system agents|mesh-ancestor
65723089|NCT02372786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723090|NCT02372786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65723091|NCT02372786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65723092|NCT02372786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65723093|NCT02372786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65723094|NCT02372786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723095|NCT02367404|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65723096|NCT02367404|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65723097|NCT02367404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65723098|NCT02367404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65723099|NCT02367404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723100|NCT02367404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65723101|NCT02367404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723102|NCT02367404|Analgesics|analgesics|mesh-ancestor
65723103|NCT02367404|Sensory System Agents|sensory system agents|mesh-ancestor
65723104|NCT02367404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723105|NCT02367404|Antidepressive Agents|antidepressive agents|mesh-ancestor
65723106|NCT02367404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65723107|NCT02367404|Dopamine Agents|dopamine agents|mesh-ancestor
65723108|NCT03715946|Nivolumab|nivolumab|mesh-list
65723109|NCT03715946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65723110|NCT03715946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723111|NCT03715946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65038890|NCT00187070|Doxorubicin|doxorubicin|mesh-list
65723112|NCT03715946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723113|NCT02367248|Deferoxamine|deferoxamine|mesh-list
65723114|NCT02367248|Siderophores|siderophores|mesh-ancestor
65723115|NCT02367248|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65723116|NCT02367248|Chelating Agents|chelating agents|mesh-ancestor
65723117|NCT02367248|Sequestering Agents|sequestering agents|mesh-ancestor
65723118|NCT02367248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723119|NCT03656965|Acyclovir|acyclovir|mesh-list
65723120|NCT03656965|Antiviral Agents|antiviral agents|mesh-ancestor
65723121|NCT03656965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65723122|NCT02384239|Tamoxifen|tamoxifen|mesh-list
65723123|NCT02384239|Fulvestrant|fulvestrant|mesh-list
65723124|NCT02384239|Palbociclib|palbociclib|mesh-list
65723125|NCT02384239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65723126|NCT02384239|Hormone Antagonists|hormone antagonists|mesh-ancestor
65723127|NCT02384239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65723128|NCT02384239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723129|NCT02384239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65723130|NCT02384239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723131|NCT02384239|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65723132|NCT02384239|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65723133|NCT02384239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65723134|NCT02384239|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65723135|NCT02384239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65723136|NCT02384239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723137|NCT02384239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723138|NCT02364752|Diuretics|diuretics|mesh-list
65723139|NCT02364752|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
65723140|NCT02364752|Natriuretic Agents|natriuretic agents|mesh-ancestor
65723141|NCT02364752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723142|NCT02364752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65723143|NCT02364752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723144|NCT02372240|Dexamethasone|dexamethasone|mesh-list
65723145|NCT02372240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65723146|NCT02372240|Antiemetics|antiemetics|mesh-ancestor
65723147|NCT02372240|Autonomic Agents|autonomic agents|mesh-ancestor
65723148|NCT02372240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723149|NCT02372240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723150|NCT02372240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65723151|NCT02372240|Glucocorticoids|glucocorticoids|mesh-ancestor
65723152|NCT02372240|Hormones|hormones|mesh-ancestor
65723153|NCT02372240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65723154|NCT02372240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65723155|NCT02372240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723156|NCT02364206|Temozolomide|temozolomide|mesh-list
65723157|NCT02364206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65723158|NCT02364206|Alkylating Agents|alkylating agents|mesh-ancestor
65723159|NCT02364206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723160|NCT02364206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723161|NCT02366546|Cyclophosphamide|cyclophosphamide|mesh-list
65723162|NCT02366546|Fludarabine|fludarabine|mesh-list
65723163|NCT02366546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65723164|NCT02366546|Immunologic Factors|immunologic factors|mesh-ancestor
65723165|NCT02366546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723166|NCT02366546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65723167|NCT02366546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65723168|NCT02366546|Alkylating Agents|alkylating agents|mesh-ancestor
65723169|NCT02366546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723170|NCT02366546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723171|NCT02366546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65723172|NCT03029702|Metformin|metformin|mesh-list
65723173|NCT03029702|Glyburide|glyburide|mesh-list
65723174|NCT03029702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65723175|NCT03029702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723176|NCT02364362|Docetaxel|docetaxel|mesh-list
65723177|NCT02364362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723178|NCT02364362|Tubulin Modulators|tubulin modulators|mesh-ancestor
65723179|NCT02364362|Antimitotic Agents|antimitotic agents|mesh-ancestor
65723180|NCT02364362|Mitosis Modulators|mitosis modulators|mesh-ancestor
65723181|NCT02364362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723182|NCT04384484|Gemcitabine|gemcitabine|mesh-list
65723183|NCT04384484|Rituximab|rituximab|mesh-list
65723184|NCT04384484|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
65723185|NCT04384484|Oxaliplatin|oxaliplatin|mesh-list
65723186|NCT04384484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65723187|NCT04384484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723188|NCT04384484|Immunologic Factors|immunologic factors|mesh-ancestor
65723189|NCT04384484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723190|NCT04384484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65723191|NCT04384484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65723192|NCT04384484|Antimetabolites|antimetabolites|mesh-ancestor
65723193|NCT04384484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723194|NCT04384484|Antiviral Agents|antiviral agents|mesh-ancestor
65723195|NCT04384484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65723196|NCT04384484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723197|NCT04384484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65723198|NCT03004469|Finasteride|finasteride|mesh-list
65723199|NCT03004469|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65723200|NCT03004469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65723201|NCT03004469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723202|NCT03004469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723203|NCT03004469|Hormone Antagonists|hormone antagonists|mesh-ancestor
65723204|NCT03004469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65723205|NCT03004469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723206|NCT03004469|Urological Agents|urological agents|mesh-ancestor
65723207|NCT02358824|Amlodipine|amlodipine|mesh-list
65723208|NCT02358824|Telmisartan|telmisartan|mesh-list
65723209|NCT02358824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65723210|NCT02358824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65723211|NCT02358824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65723212|NCT02358824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723213|NCT02358824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65723214|NCT02358824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723215|NCT02358824|Vasodilator Agents|vasodilator agents|mesh-ancestor
65723216|NCT02358824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65723217|NCT02358824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65723218|NCT02359136|Epinephrine|epinephrine|mesh-list
65723219|NCT02359136|Analgesics|analgesics|mesh-list
65723220|NCT02359136|Anesthetics|anesthetics|mesh-list
65723221|NCT02359136|Ropivacaine|ropivacaine|mesh-list
65723222|NCT02359136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65185809|NCT04582942|Lactulose|lactulose|mesh-list
65723223|NCT02359136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723224|NCT02359136|Anesthetics, Local|anesthetics, local|mesh-ancestor
65723225|NCT02359136|Sensory System Agents|sensory system agents|mesh-ancestor
65723226|NCT02359136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723227|NCT02359136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65723228|NCT02359136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65723229|NCT02359136|Adrenergic Agents|adrenergic agents|mesh-ancestor
65723230|NCT02359136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65723231|NCT02359136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723232|NCT02359136|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65723233|NCT02359136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65723234|NCT02359136|Autonomic Agents|autonomic agents|mesh-ancestor
65723235|NCT02359136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65723236|NCT02359136|Respiratory System Agents|respiratory system agents|mesh-ancestor
65723237|NCT02359136|Mydriatics|mydriatics|mesh-ancestor
65723238|NCT02359136|Sympathomimetics|sympathomimetics|mesh-ancestor
65723239|NCT02359136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65723240|NCT02998151|Minocycline|minocycline|mesh-list
65723241|NCT02998151|Acamprosate|acamprosate|mesh-list
65723242|NCT02998151|Baclofen|baclofen|mesh-list
65723243|NCT02998151|Lovastatin|lovastatin|mesh-list
65723244|NCT02998151|L 647318|l 647318|mesh-list
65723245|NCT02998151|Dihydromevinolin|dihydromevinolin|mesh-list
65723246|NCT02998151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65723247|NCT02998151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65723248|NCT02998151|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65723249|NCT02998151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723250|NCT02998151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65723251|NCT02998151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723252|NCT02998151|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65723253|NCT02998151|GABA Agonists|gaba agonists|mesh-ancestor
65723254|NCT02998151|GABA Agents|gaba agents|mesh-ancestor
65723255|NCT02998151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65723256|NCT02998151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723257|NCT02998151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65723258|NCT02998151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65723259|NCT02998151|Antimetabolites|antimetabolites|mesh-ancestor
65723260|NCT02998151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65723261|NCT02998151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65723262|NCT02998151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723263|NCT02998151|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65723264|NCT01066819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65723266|NCT01066819|Antiviral Agents|antiviral agents|mesh-ancestor
65723267|NCT01066819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65723268|NCT04057937|Apremilast|apremilast|mesh-list
65723269|NCT04057937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65723270|NCT04057937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65723271|NCT04057937|Analgesics|analgesics|mesh-ancestor
65723272|NCT04057937|Sensory System Agents|sensory system agents|mesh-ancestor
65723273|NCT04057937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723274|NCT04057937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723275|NCT04057937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65723276|NCT04057937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65723277|NCT04057937|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65723278|NCT04057937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65723279|NCT04057937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723280|NCT04057937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723281|NCT01069523|Guanfacine|guanfacine|mesh-list
65723282|NCT01069523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65723283|NCT01069523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65723284|NCT01069523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65723285|NCT01069523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65723286|NCT01069523|Adrenergic Agents|adrenergic agents|mesh-ancestor
65723287|NCT01069523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65723288|NCT01069523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723289|NCT01069523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723290|NCT01069289|Budesonide|budesonide|mesh-list
65723291|NCT01069289|Formoterol Fumarate|formoterol fumarate|mesh-list
65723292|NCT01069289|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65723293|NCT01069289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65723294|NCT01069289|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65723295|NCT01069289|Autonomic Agents|autonomic agents|mesh-ancestor
65723296|NCT01069289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723297|NCT01069289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723298|NCT01069289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65723299|NCT01069289|Respiratory System Agents|respiratory system agents|mesh-ancestor
65723300|NCT01069289|Glucocorticoids|glucocorticoids|mesh-ancestor
65723301|NCT01069289|Hormones|hormones|mesh-ancestor
65723302|NCT01069289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65723303|NCT01069289|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65723304|NCT01069289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65723305|NCT01069289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65723306|NCT01069289|Adrenergic Agents|adrenergic agents|mesh-ancestor
65723307|NCT01069289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65723308|NCT01069289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723309|NCT03303989|Mycophenolic Acid|mycophenolic acid|mesh-list
65723310|NCT03303989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65723311|NCT03303989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723312|NCT03303989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65723313|NCT03303989|Antitubercular Agents|antitubercular agents|mesh-ancestor
65723314|NCT03303989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65723315|NCT03303989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65723316|NCT03303989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723317|NCT03303989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723318|NCT02510794|Ranibizumab|ranibizumab|mesh-list
65723319|NCT02510794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65723320|NCT02510794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65723321|NCT02510794|Growth Substances|growth substances|mesh-ancestor
65723322|NCT02510794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723323|NCT02510794|Growth Inhibitors|growth inhibitors|mesh-ancestor
65723324|NCT02510794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723325|NCT04056923|Methylene Blue|methylene blue|mesh-list
65723326|NCT04056923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723327|NCT04056923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723328|NCT03664115|Itraconazole|itraconazole|mesh-list
65723329|NCT03664115|Antifungal Agents|antifungal agents|mesh-ancestor
65723330|NCT03664115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65723331|NCT03664115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65723332|NCT03664115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65723333|NCT03664115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723334|NCT03664115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723335|NCT03664115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65723336|NCT03664115|Hormone Antagonists|hormone antagonists|mesh-ancestor
65723337|NCT03664115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65723338|NCT03664115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723339|NCT03664115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65723340|NCT03664037|Dexamethasone|dexamethasone|mesh-list
65723341|NCT03664037|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65723342|NCT03664037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65723343|NCT03664037|Antiemetics|antiemetics|mesh-ancestor
65723344|NCT03664037|Autonomic Agents|autonomic agents|mesh-ancestor
65723345|NCT03664037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723346|NCT03664037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723347|NCT03664037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65723348|NCT03664037|Glucocorticoids|glucocorticoids|mesh-ancestor
65723349|NCT03664037|Hormones|hormones|mesh-ancestor
65723350|NCT03664037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65723351|NCT03664037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65723352|NCT03664037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723353|NCT04056845|Acetaminophen|acetaminophen|mesh-list
65723354|NCT04056845|Diclofenac|diclofenac|mesh-list
65723355|NCT04056845|Analgesics|analgesics|mesh-list
65723356|NCT04056845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65723357|NCT04056845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65723358|NCT04056845|Sensory System Agents|sensory system agents|mesh-ancestor
65723359|NCT04056845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723360|NCT04056845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723361|NCT04056845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65723362|NCT04056845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65723363|NCT04056845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65723364|NCT04056845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723365|NCT04056845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723366|NCT04056845|Antipyretics|antipyretics|mesh-ancestor
65723367|NCT02510014|Buprenorphine|buprenorphine|mesh-list
65723368|NCT02510014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65723369|NCT02510014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65723370|NCT02510014|Narcotics|narcotics|mesh-ancestor
65723371|NCT02510014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65723372|NCT02510014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723373|NCT02510014|Analgesics|analgesics|mesh-ancestor
65723374|NCT02510014|Sensory System Agents|sensory system agents|mesh-ancestor
65723375|NCT02510014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723376|NCT02510014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65723377|NCT02509312|Ketorolac|ketorolac|mesh-list
65723378|NCT02509312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65723379|NCT02509312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65723380|NCT02509312|Analgesics|analgesics|mesh-ancestor
65723381|NCT02509312|Sensory System Agents|sensory system agents|mesh-ancestor
65723382|NCT02509312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723383|NCT02509312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723384|NCT02509312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65723385|NCT02509312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65723386|NCT02509312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65723387|NCT02509312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723388|NCT02509312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723389|NCT02362958|Capecitabine|capecitabine|mesh-list
65723390|NCT02362958|Vinorelbine|vinorelbine|mesh-list
65723391|NCT02362958|Lapatinib|lapatinib|mesh-list
65723392|NCT02362958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65723393|NCT02362958|Antimetabolites|antimetabolites|mesh-ancestor
65723394|NCT02362958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723395|NCT02362958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723396|NCT02362958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65723397|NCT02362958|Tubulin Modulators|tubulin modulators|mesh-ancestor
65723398|NCT02362958|Antimitotic Agents|antimitotic agents|mesh-ancestor
65723399|NCT02362958|Mitosis Modulators|mitosis modulators|mesh-ancestor
65723400|NCT02362958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65723401|NCT02362958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723402|NCT04973800|Simvastatin|simvastatin|mesh-list
65723403|NCT04973800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65723404|NCT04973800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65723405|NCT04973800|Antimetabolites|antimetabolites|mesh-ancestor
65723406|NCT04973800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723407|NCT04973800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65723408|NCT04973800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65723409|NCT04973800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039214|NCT00188864|Hormones|hormones|mesh-ancestor
65723410|NCT05020522|Phenobarbital|phenobarbital|mesh-list
65723411|NCT05020522|Anticonvulsants|anticonvulsants|mesh-ancestor
65723412|NCT05020522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65723413|NCT05020522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65723414|NCT05020522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723415|NCT05020522|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65723416|NCT05020522|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65723417|NCT05020522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65723418|NCT05020522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723419|NCT05020522|GABA Modulators|gaba modulators|mesh-ancestor
65723420|NCT05020522|GABA Agents|gaba agents|mesh-ancestor
65723421|NCT05020522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65723422|NCT05020522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65723423|NCT05020522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65723424|NCT02519842|Dexamethasone|dexamethasone|mesh-list
65723425|NCT02519842|Ondansetron|ondansetron|mesh-list
65723426|NCT02519842|Fosaprepitant|fosaprepitant|mesh-list
65723427|NCT02519842|Aprepitant|aprepitant|mesh-list
65723428|NCT02519842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
65723429|NCT02519842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65723430|NCT02519842|Antiemetics|antiemetics|mesh-ancestor
65723431|NCT02519842|Autonomic Agents|autonomic agents|mesh-ancestor
65723432|NCT02519842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723433|NCT02519842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723434|NCT02519842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65723435|NCT02519842|Glucocorticoids|glucocorticoids|mesh-ancestor
65723436|NCT02519842|Hormones|hormones|mesh-ancestor
65723437|NCT02519842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65723438|NCT02519842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65723439|NCT02519842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723440|NCT02519842|Antipruritics|antipruritics|mesh-ancestor
65723441|NCT02519842|Dermatologic Agents|dermatologic agents|mesh-ancestor
65723442|NCT02519842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65723443|NCT02519842|Serotonin Agents|serotonin agents|mesh-ancestor
65723444|NCT02519842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65723445|NCT02519842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723446|NCT02519842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65723447|NCT02519842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65723448|NCT02519842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65723449|NCT02519842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65723450|NCT02519842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65723451|NCT02519842|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65723452|NCT02509078|Cisatracurium|cisatracurium|mesh-list
65723453|NCT02509078|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65723454|NCT02509078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65723455|NCT02509078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723456|NCT02509078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723457|NCT02993783|Vedolizumab|vedolizumab|mesh-list
65723458|NCT02993783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65723459|NCT03661775|Magnesium Sulfate|magnesium sulfate|mesh-list
65723460|NCT03661775|Analgesics|analgesics|mesh-ancestor
65723461|NCT03661775|Sensory System Agents|sensory system agents|mesh-ancestor
65723462|NCT03661775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723463|NCT03661775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723464|NCT03661775|Anesthetics|anesthetics|mesh-ancestor
65723465|NCT03661775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65723466|NCT03661775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65723467|NCT03661775|Anticonvulsants|anticonvulsants|mesh-ancestor
65723468|NCT03661775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65723469|NCT03661775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65723470|NCT03661775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723471|NCT03661775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65723472|NCT03661775|Tocolytic Agents|tocolytic agents|mesh-ancestor
65723473|NCT03661775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65723474|NCT03660761|Apatinib|apatinib|mesh-list
65723475|NCT03660761|Temozolomide|temozolomide|mesh-list
65723476|NCT03660761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723477|NCT03660761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65723478|NCT03660761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723479|NCT03660761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723480|NCT03660761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65723481|NCT03660761|Alkylating Agents|alkylating agents|mesh-ancestor
65723482|NCT02993471|Vitamin K|vitamin k|mesh-list
65723483|NCT02993471|Midazolam|midazolam|mesh-list
65039275|NCT00189059|Adrenergic Agents|adrenergic agents|mesh-ancestor
65723484|NCT02993471|Dextromethorphan|dextromethorphan|mesh-list
65723485|NCT02993471|Caffeine|caffeine|mesh-list
65723486|NCT02993471|Ixekizumab|ixekizumab|mesh-list
65723487|NCT02993471|Omeprazole|omeprazole|mesh-list
65723488|NCT02993471|Warfarin|warfarin|mesh-list
65723489|NCT02993471|Vitamins|vitamins|mesh-ancestor
65723490|NCT02993471|Micronutrients|micronutrients|mesh-ancestor
65723491|NCT02993471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723492|NCT02993471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65723493|NCT02993471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65723494|NCT02993471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65723495|NCT02993471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65723496|NCT02993471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65723497|NCT02993471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65723498|NCT02993471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65723499|NCT02993471|Anesthetics, General|anesthetics, general|mesh-ancestor
65723500|NCT02993471|Anesthetics|anesthetics|mesh-ancestor
65723501|NCT02993471|GABA Modulators|gaba modulators|mesh-ancestor
65723502|NCT02993471|GABA Agents|gaba agents|mesh-ancestor
65723503|NCT02993471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65723504|NCT02993471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723505|NCT02993471|Anticoagulants|anticoagulants|mesh-ancestor
65723506|NCT02993471|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65723507|NCT02993471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65723508|NCT02993471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723509|NCT02993471|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65723510|NCT02993471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65723511|NCT02993471|Purinergic Agents|purinergic agents|mesh-ancestor
65723512|NCT02993471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65723513|NCT02993471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65723514|NCT02993471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65723515|NCT02993471|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65723516|NCT02993471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65723517|NCT02993471|Hemostatics|hemostatics|mesh-ancestor
65723518|NCT02993471|Coagulants|coagulants|mesh-ancestor
65723519|NCT02993471|Antitussive Agents|antitussive agents|mesh-ancestor
65723520|NCT02993471|Respiratory System Agents|respiratory system agents|mesh-ancestor
65723521|NCT02993471|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65723522|NCT02993471|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65723523|NCT02993471|Dermatologic Agents|dermatologic agents|mesh-ancestor
65723524|NCT01068743|Metformin|metformin|mesh-list
65723525|NCT01068743|Saxagliptin|saxagliptin|mesh-list
65723526|NCT01068743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65723527|NCT01068743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723528|NCT01068743|Incretins|incretins|mesh-ancestor
65723529|NCT01068743|Hormones|hormones|mesh-ancestor
65723530|NCT01068743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65723531|NCT01068743|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65723532|NCT01068743|Protease Inhibitors|protease inhibitors|mesh-ancestor
65723533|NCT01068743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723534|NCT01068743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723535|NCT03622541|Sorafenib|sorafenib|mesh-list
65723536|NCT03622541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723537|NCT03622541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65723538|NCT03622541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723539|NCT03622541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723540|NCT03658733|Amoxicillin|amoxicillin|mesh-list
65723541|NCT03658733|Tetracycline|tetracycline|mesh-list
65723542|NCT03658733|Furazolidone|furazolidone|mesh-list
65723543|NCT03658733|Esomeprazole|esomeprazole|mesh-list
65723544|NCT03658733|Rabeprazole|rabeprazole|mesh-list
65723545|NCT03658733|Bismuth|bismuth|mesh-list
65723546|NCT03658733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65723547|NCT03658733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65723548|NCT03658733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65723549|NCT03658733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65723550|NCT03658733|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65723551|NCT03658733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723552|NCT03658733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723553|NCT03658733|Antacids|antacids|mesh-ancestor
65723554|NCT03658733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65723555|NCT03658733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65723556|NCT03658733|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65723557|NCT03658733|Renal Agents|renal agents|mesh-ancestor
65723558|NCT03658733|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65723559|NCT03658733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65723560|NCT03658733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65723561|NCT03658733|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65723562|NCT04056143|Rivaroxaban|rivaroxaban|mesh-list
65723563|NCT04056143|Apixaban|apixaban|mesh-list
65723564|NCT04056143|Edoxaban|edoxaban|mesh-list
65723565|NCT04056143|Dabigatran|dabigatran|mesh-list
65723566|NCT04056143|Thromboplastin|thromboplastin|mesh-list
65723567|NCT04056143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65723568|NCT04056143|Antithrombins|antithrombins|mesh-ancestor
65723569|NCT04056143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65723570|NCT04056143|Protease Inhibitors|protease inhibitors|mesh-ancestor
65723571|NCT04056143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723572|NCT04056143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723573|NCT04056143|Anticoagulants|anticoagulants|mesh-ancestor
65723574|NCT04056143|Hemostatics|hemostatics|mesh-ancestor
65723575|NCT04056143|Coagulants|coagulants|mesh-ancestor
65723576|NCT03661463|Aspirin|aspirin|mesh-list
65723577|NCT03661463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65723578|NCT03661463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65723579|NCT03661463|Analgesics|analgesics|mesh-ancestor
65723580|NCT03661463|Sensory System Agents|sensory system agents|mesh-ancestor
65723581|NCT03661463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723582|NCT03661463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723583|NCT03661463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65723584|NCT03661463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65723585|NCT03661463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65723586|NCT03661463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65723587|NCT03661463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723588|NCT03661463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65723589|NCT03661463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65723590|NCT03661463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723591|NCT03661463|Antipyretics|antipyretics|mesh-ancestor
65723592|NCT03661385|Nitric Oxide|nitric oxide|mesh-list
65723593|NCT03661385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65723594|NCT03661385|Autonomic Agents|autonomic agents|mesh-ancestor
65723595|NCT03661385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723596|NCT03661385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723597|NCT03661385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65723598|NCT03661385|Respiratory System Agents|respiratory system agents|mesh-ancestor
65723599|NCT03661385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65723600|NCT03661385|Antioxidants|antioxidants|mesh-ancestor
65723601|NCT03661385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723602|NCT03661385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65723603|NCT03661385|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65723604|NCT03661385|Vasodilator Agents|vasodilator agents|mesh-ancestor
65723605|NCT03661385|Gasotransmitters|gasotransmitters|mesh-ancestor
65723606|NCT03661385|Protective Agents|protective agents|mesh-ancestor
65723607|NCT03658421|Dexmedetomidine|dexmedetomidine|mesh-list
65723608|NCT03658421|Morphine|morphine|mesh-list
65723609|NCT03658421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65723610|NCT03658421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65723611|NCT03658421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723612|NCT03658421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65723613|NCT03658421|Analgesics|analgesics|mesh-ancestor
65723614|NCT03658421|Sensory System Agents|sensory system agents|mesh-ancestor
65723615|NCT03658421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723616|NCT03658421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65723617|NCT03658421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65723618|NCT03658421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65723619|NCT03658421|Adrenergic Agents|adrenergic agents|mesh-ancestor
65723620|NCT03658421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65723621|NCT03658421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723622|NCT03658421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65723623|NCT03658421|Narcotics|narcotics|mesh-ancestor
65723624|NCT03660293|Captopril|captopril|mesh-list
65723625|NCT03660293|Atorvastatin|atorvastatin|mesh-list
65723626|NCT03660293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65723627|NCT03660293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65723628|NCT03660293|Antimetabolites|antimetabolites|mesh-ancestor
65723629|NCT03660293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723630|NCT03660293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65723631|NCT03660293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65723632|NCT03660293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723633|NCT03660293|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65723634|NCT03660293|Protease Inhibitors|protease inhibitors|mesh-ancestor
65723635|NCT03660293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65723636|NCT02986139|Etanercept|etanercept|mesh-list
65723637|NCT02986139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65723638|NCT02986139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65723639|NCT02986139|Analgesics|analgesics|mesh-ancestor
65723640|NCT02986139|Sensory System Agents|sensory system agents|mesh-ancestor
65723641|NCT02986139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723642|NCT02986139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723643|NCT02986139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65723644|NCT02986139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65723645|NCT02986139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65723646|NCT02986139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65723647|NCT02986139|Immunologic Factors|immunologic factors|mesh-ancestor
65723648|NCT02906917|Insulin|insulin|mesh-list
65723649|NCT02906917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65723650|NCT02906917|Insulin Glargine|insulin glargine|mesh-list
65723651|NCT02906917|Insulin Aspart|insulin aspart|mesh-list
65723652|NCT02906917|Insulin, Long-Acting|insulin, long-acting|mesh-list
65723653|NCT02906917|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65723654|NCT02906917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65723655|NCT02906917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723656|NCT01066585|Ivermectin|ivermectin|mesh-list
65723657|NCT01066585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65723658|NCT01066585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65723659|NCT03654703|Cyclophosphamide|cyclophosphamide|mesh-list
65723660|NCT03654703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65723661|NCT03654703|Immunologic Factors|immunologic factors|mesh-ancestor
65723662|NCT03654703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723663|NCT03654703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65723664|NCT03654703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65723665|NCT03654703|Alkylating Agents|alkylating agents|mesh-ancestor
65723666|NCT03654703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723667|NCT03654703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723668|NCT03654703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65723669|NCT02980783|Lidocaine|lidocaine|mesh-list
65723670|NCT02980783|Anesthetics, Local|anesthetics, local|mesh-ancestor
65723671|NCT02980783|Anesthetics|anesthetics|mesh-ancestor
65186259|NCT02753764|Hormones|hormones|mesh-ancestor
65723672|NCT02980783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65723673|NCT02980783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723674|NCT02980783|Sensory System Agents|sensory system agents|mesh-ancestor
65723675|NCT02980783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723676|NCT02980783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65723677|NCT02980783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65723678|NCT02980783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65723679|NCT02980783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65723680|NCT02980783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723681|NCT02989649|Metformin|metformin|mesh-list
65723682|NCT02989649|Pioglitazone|pioglitazone|mesh-list
65723683|NCT02989649|Alogliptin|alogliptin|mesh-list
65723684|NCT02989649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65723685|NCT02989649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723686|NCT02989649|Incretins|incretins|mesh-ancestor
65723687|NCT02989649|Hormones|hormones|mesh-ancestor
65723688|NCT02989649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65723689|NCT02989649|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65723690|NCT02989649|Protease Inhibitors|protease inhibitors|mesh-ancestor
65723691|NCT02989649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723692|NCT02989649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723693|NCT03659435|Rivastigmine|rivastigmine|mesh-list
65723694|NCT03659435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65723695|NCT03659435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723696|NCT03659435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723697|NCT03659435|Cholinergic Agents|cholinergic agents|mesh-ancestor
65723698|NCT03659435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65723699|NCT03659435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723700|NCT03659435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65723701|NCT03659435|Protective Agents|protective agents|mesh-ancestor
65723702|NCT01067339|Darapladib|darapladib|mesh-list
65723703|NCT01067339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
65723704|NCT01067339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723705|NCT01067339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723706|NCT04484675|Milrinone|milrinone|mesh-list
65723707|NCT04484675|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65723708|NCT04484675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65723709|NCT04484675|Vasodilator Agents|vasodilator agents|mesh-ancestor
65723710|NCT04484675|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65723711|NCT04484675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65723712|NCT04484675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723713|NCT04484675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723714|NCT04484675|Protective Agents|protective agents|mesh-ancestor
65723715|NCT04484675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723716|NCT03658109|Lidocaine|lidocaine|mesh-list
65723717|NCT03658109|Anesthetics, Local|anesthetics, local|mesh-ancestor
65723718|NCT03658109|Anesthetics|anesthetics|mesh-ancestor
65723719|NCT03658109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65723720|NCT03658109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723721|NCT03658109|Sensory System Agents|sensory system agents|mesh-ancestor
65723722|NCT03658109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723723|NCT03658109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65723724|NCT03658109|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65723725|NCT03658109|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65723726|NCT03658109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65723727|NCT03658109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723728|NCT03658031|Dapagliflozin|dapagliflozin|mesh-list
65723729|NCT03658031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65723730|NCT03658031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723731|NCT03658031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65723732|NCT03658031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723733|NCT03660917|Riluzole|riluzole|mesh-list
65723734|NCT03660917|Anticonvulsants|anticonvulsants|mesh-ancestor
65723735|NCT03660917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65723736|NCT03660917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65723737|NCT03660917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65723738|NCT03660917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723739|NCT03660917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723740|NCT03660917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65723741|NCT03660917|Protective Agents|protective agents|mesh-ancestor
65723742|NCT02977507|Sunscreening Agents|sunscreening agents|mesh-list
65723743|NCT02977507|Hydroquinone|hydroquinone|mesh-list
65723744|NCT02977507|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65723745|NCT02977507|Protective Agents|protective agents|mesh-ancestor
65723746|NCT02977507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723747|NCT02977507|Dermatologic Agents|dermatologic agents|mesh-ancestor
65723748|NCT02977507|Antioxidants|antioxidants|mesh-ancestor
65723749|NCT02977507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723750|NCT04471415|Atezolizumab|atezolizumab|mesh-list
65723751|NCT04471415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723752|NCT02976103|Analgesics|analgesics|mesh-list
65723753|NCT02976103|Sensory System Agents|sensory system agents|mesh-ancestor
65723754|NCT02976103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723755|NCT02976103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723756|NCT02897375|Carboplatin|carboplatin|mesh-list
65723757|NCT02897375|Palbociclib|palbociclib|mesh-list
65723758|NCT02897375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723759|NCT02897375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65723760|NCT02897375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723761|NCT02897375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723762|NCT05157243|Nitazoxanide|nitazoxanide|mesh-list
65723763|NCT05157243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65723764|NCT05157243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65723765|NCT03653845|Epinephrine|epinephrine|mesh-list
65723766|NCT03653845|Racepinephrine|racepinephrine|mesh-list
65723767|NCT03653845|Epinephryl borate|epinephryl borate|mesh-list
65723768|NCT03653845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65723769|NCT03653845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65723770|NCT03653845|Adrenergic Agents|adrenergic agents|mesh-ancestor
65723771|NCT03653845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65723772|NCT03653845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723773|NCT03653845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723774|NCT03653845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65723775|NCT03653845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65723776|NCT03653845|Autonomic Agents|autonomic agents|mesh-ancestor
65723777|NCT03653845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723778|NCT03653845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65723779|NCT03653845|Respiratory System Agents|respiratory system agents|mesh-ancestor
65723780|NCT03653845|Mydriatics|mydriatics|mesh-ancestor
65723781|NCT03653845|Sympathomimetics|sympathomimetics|mesh-ancestor
65723782|NCT03653845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65723783|NCT03470961|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65723784|NCT03470961|Immunologic Factors|immunologic factors|mesh-ancestor
65723785|NCT03470961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723786|NCT03470961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65723787|NCT01066039|Bisoprolol|bisoprolol|mesh-list
65723788|NCT01066039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65723789|NCT01066039|Sympatholytics|sympatholytics|mesh-ancestor
65723790|NCT01066039|Autonomic Agents|autonomic agents|mesh-ancestor
65723791|NCT01066039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723792|NCT01066039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723793|NCT01066039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65723794|NCT01066039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65723795|NCT01066039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65723796|NCT01066039|Adrenergic Agents|adrenergic agents|mesh-ancestor
65723797|NCT01066039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65723798|NCT01066039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723799|NCT04217967|Lenalidomide|lenalidomide|mesh-list
65723800|NCT04217967|Ixazomib|ixazomib|mesh-list
65723801|NCT04217967|Immunologic Factors|immunologic factors|mesh-ancestor
65723802|NCT04217967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723803|NCT04217967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65723804|NCT04217967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65723805|NCT04217967|Growth Substances|growth substances|mesh-ancestor
65723806|NCT04217967|Growth Inhibitors|growth inhibitors|mesh-ancestor
65723807|NCT04217967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723808|NCT04217967|Protease Inhibitors|protease inhibitors|mesh-ancestor
65723809|NCT04217967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723810|NCT04217967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723811|NCT02919761|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65723812|NCT02919761|Hormones|hormones|mesh-ancestor
65723813|NCT02919761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65723814|NCT02919761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723815|NCT02910167|Acetaminophen|acetaminophen|mesh-list
65723816|NCT02910167|Scopolamine|scopolamine|mesh-list
65723817|NCT02910167|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65723818|NCT02910167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65723819|NCT02910167|Analgesics|analgesics|mesh-ancestor
65723820|NCT02910167|Sensory System Agents|sensory system agents|mesh-ancestor
65723821|NCT02910167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723822|NCT02910167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723823|NCT02910167|Antipyretics|antipyretics|mesh-ancestor
65723824|NCT02910167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65723825|NCT02910167|Antiemetics|antiemetics|mesh-ancestor
65723826|NCT02910167|Autonomic Agents|autonomic agents|mesh-ancestor
65723827|NCT02910167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65723828|NCT02910167|Mydriatics|mydriatics|mesh-ancestor
65723829|NCT02910167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65723830|NCT02910167|Cholinergic Agents|cholinergic agents|mesh-ancestor
65723831|NCT02910167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65723832|NCT02910167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723833|NCT02910167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65723834|NCT02910167|Parasympatholytics|parasympatholytics|mesh-ancestor
65723835|NCT04458285|Valsartan|valsartan|mesh-list
65723836|NCT04458285|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65723837|NCT04458285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65723838|NCT04458285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65723839|NCT04458285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65723840|NCT04458285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723841|NCT05156541|Interferons|interferons|mesh-list
65723842|NCT05156541|Interferon-gamma|interferon-gamma|mesh-list
65723843|NCT05156541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723844|NCT05156541|Antiviral Agents|antiviral agents|mesh-ancestor
65723845|NCT05156541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65723846|NCT01067105|Ciclesonide|ciclesonide|mesh-list
65723847|NCT01067105|Glucocorticoids|glucocorticoids|mesh-ancestor
65723848|NCT01067105|Hormones|hormones|mesh-ancestor
65723849|NCT01067105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65723850|NCT01067105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723851|NCT01067105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65723852|NCT03470727|Dialysis Solutions|dialysis solutions|mesh-list
65723853|NCT03470727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65723854|NCT05156385|Antihypertensive Agents|antihypertensive agents|mesh-list
65723855|NCT03470649|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65039642|NCT00220506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65723856|NCT03470649|Hematinics|hematinics|mesh-ancestor
65723857|NCT02910011|Doxycycline|doxycycline|mesh-list
65723858|NCT02910011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65723859|NCT02910011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65723860|NCT02910011|Antimalarials|antimalarials|mesh-ancestor
65723861|NCT02910011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65723862|NCT02910011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65723863|NCT04456803|Sevelamer|sevelamer|mesh-list
65723864|NCT04456803|Chelating Agents|chelating agents|mesh-ancestor
65723865|NCT04456803|Sequestering Agents|sequestering agents|mesh-ancestor
65723866|NCT04456803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723867|NCT02908529|Oxybutynin|oxybutynin|mesh-list
65723868|NCT02908529|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65723869|NCT02908529|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65723870|NCT02908529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65723871|NCT02908529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65723872|NCT02908529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723873|NCT02908529|Adrenergic Agents|adrenergic agents|mesh-ancestor
65723874|NCT02908529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65723875|NCT02908529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723876|NCT02908529|Parasympatholytics|parasympatholytics|mesh-ancestor
65723877|NCT02908529|Autonomic Agents|autonomic agents|mesh-ancestor
65723878|NCT02908529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723879|NCT02908529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65723880|NCT02908529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65723881|NCT02908529|Cholinergic Agents|cholinergic agents|mesh-ancestor
65723882|NCT02908529|Urological Agents|urological agents|mesh-ancestor
65723883|NCT03469557|Capecitabine|capecitabine|mesh-list
65723884|NCT03469557|Oxaliplatin|oxaliplatin|mesh-list
65723885|NCT03469557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723886|NCT03469557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65723887|NCT03469557|Antimetabolites|antimetabolites|mesh-ancestor
65723888|NCT03469557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723889|NCT04768569|Zonisamide|zonisamide|mesh-list
65723890|NCT04768569|Anticonvulsants|anticonvulsants|mesh-ancestor
65723891|NCT04768569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65723892|NCT04768569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65723893|NCT04768569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723894|NCT04768569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65723895|NCT04768569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723896|NCT02643381|Ketamine|ketamine|mesh-list
65723897|NCT02643381|Etomidate|etomidate|mesh-list
65723898|NCT02643381|Analgesics|analgesics|mesh-ancestor
65723899|NCT02643381|Sensory System Agents|sensory system agents|mesh-ancestor
65723900|NCT02643381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723901|NCT02643381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723902|NCT02643381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65723903|NCT02643381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65723904|NCT02643381|Anesthetics, General|anesthetics, general|mesh-ancestor
65723905|NCT02643381|Anesthetics|anesthetics|mesh-ancestor
65723906|NCT02643381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65723907|NCT02643381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65723908|NCT02643381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65723909|NCT02643381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65723910|NCT02643381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723911|NCT02643381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65723912|NCT04328961|Ascorbic Acid|ascorbic acid|mesh-list
65723913|NCT04328961|Hydroxychloroquine|hydroxychloroquine|mesh-list
65723914|NCT04328961|Antimalarials|antimalarials|mesh-ancestor
65723915|NCT04328961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65723916|NCT04328961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65723917|NCT04328961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65723918|NCT04328961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65723919|NCT04328961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723920|NCT04328961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65723921|NCT04328961|Antioxidants|antioxidants|mesh-ancestor
65723922|NCT04328961|Protective Agents|protective agents|mesh-ancestor
65723923|NCT04328961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723924|NCT04328961|Vitamins|vitamins|mesh-ancestor
65723925|NCT04328961|Micronutrients|micronutrients|mesh-ancestor
65723926|NCT00455403|Chloroquine|chloroquine|mesh-list
65723927|NCT00455403|Amebicides|amebicides|mesh-ancestor
65723928|NCT00455403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65723929|NCT00455403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65723930|NCT00455403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65723931|NCT00455403|Antimalarials|antimalarials|mesh-ancestor
65723932|NCT00455403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65723933|NCT03470337|Wobenzym|wobenzym|mesh-list
65723934|NCT03470337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65723935|NCT03470337|Immunologic Factors|immunologic factors|mesh-ancestor
65723936|NCT03470337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723938|NCT03576261|Plasma Substitutes|plasma substitutes|mesh-ancestor
65723939|NCT03576261|Blood Substitutes|blood substitutes|mesh-ancestor
65723940|NCT03469323|Succinylcholine|succinylcholine|mesh-list
65723941|NCT03469323|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
65723942|NCT03469323|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65723943|NCT03469323|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65723944|NCT03469323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723945|NCT03469323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723946|NCT05160285|Nivolumab|nivolumab|mesh-list
65723947|NCT05160285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65723948|NCT05160285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723949|NCT05160285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65723950|NCT05160285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723951|NCT05160051|FAPI-46|fapi-46|mesh-list
65723952|NCT05160051|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65723953|NCT05160051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723954|NCT03471819|Serotonin|serotonin|mesh-list
65723955|NCT03471819|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65723956|NCT03471819|Serotonin Agents|serotonin agents|mesh-ancestor
65723957|NCT03471819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65723958|NCT03471819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723959|NCT03471819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723960|NCT03618693|Anesthetics|anesthetics|mesh-list
65723961|NCT03618693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65723962|NCT03618693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723963|NCT01064167|Tranexamic Acid|tranexamic acid|mesh-list
65723964|NCT01064167|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65723965|NCT01064167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65723966|NCT01064167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723967|NCT01064167|Hemostatics|hemostatics|mesh-ancestor
65723968|NCT01064167|Coagulants|coagulants|mesh-ancestor
65723969|NCT04205305|Labetalol|labetalol|mesh-list
65723970|NCT04205305|Nicardipine|nicardipine|mesh-list
65723971|NCT04205305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65723972|NCT04205305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65723973|NCT04205305|Adrenergic Agents|adrenergic agents|mesh-ancestor
65723974|NCT04205305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65723975|NCT04205305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65723976|NCT04205305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723977|NCT04205305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65723978|NCT04205305|Sympathomimetics|sympathomimetics|mesh-ancestor
65723979|NCT04205305|Autonomic Agents|autonomic agents|mesh-ancestor
65723980|NCT04205305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65723981|NCT04205305|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65723982|NCT04205305|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65723983|NCT04205305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65723984|NCT04205305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65723985|NCT04205305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65723986|NCT04205305|Vasodilator Agents|vasodilator agents|mesh-ancestor
65723987|NCT03470103|Aflibercept|aflibercept|mesh-list
65723988|NCT03470103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65723989|NCT03470103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65723990|NCT03470103|Growth Substances|growth substances|mesh-ancestor
65723991|NCT03470103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65723992|NCT03470103|Growth Inhibitors|growth inhibitors|mesh-ancestor
65723993|NCT03470103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65723994|NCT01064947|Retapamulin|retapamulin|mesh-list
65723995|NCT01064947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65723996|NCT01064947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65723997|NCT03469947|Tranexamic Acid|tranexamic acid|mesh-list
65723998|NCT03469947|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65723999|NCT03469947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65724000|NCT03469947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724001|NCT03469947|Hemostatics|hemostatics|mesh-ancestor
65724002|NCT03469947|Coagulants|coagulants|mesh-ancestor
65724003|NCT05157087|Omalizumab|omalizumab|mesh-list
65724004|NCT05157087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65724005|NCT05157087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65724006|NCT05157087|Respiratory System Agents|respiratory system agents|mesh-ancestor
65724007|NCT05163249|Osimertinib|osimertinib|mesh-list
65724008|NCT05163249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724009|NCT05163249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65724010|NCT05163249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039857|NCT00123227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724011|NCT05163249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724012|NCT04054063|Etomidate|etomidate|mesh-list
65724013|NCT04054063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65724014|NCT04054063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65724015|NCT04054063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724016|NCT04054063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65724017|NCT04054063|Anesthetics, General|anesthetics, general|mesh-ancestor
65724018|NCT04054063|Anesthetics|anesthetics|mesh-ancestor
65724019|NCT03652441|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65724020|NCT03652441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65724021|NCT03652441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724022|NCT05097651|Cannabidiol|cannabidiol|mesh-list
65724023|NCT05097651|Anticonvulsants|anticonvulsants|mesh-ancestor
65724024|NCT02918071|Benralizumab|benralizumab|mesh-list
65724025|NCT02918071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65724026|NCT02918071|Respiratory System Agents|respiratory system agents|mesh-ancestor
65724027|NCT05162625|Moxifloxacin|moxifloxacin|mesh-list
65724028|NCT05162625|Ciprofloxacin|ciprofloxacin|mesh-list
65724029|NCT05162625|Cefazolin|cefazolin|mesh-list
65724030|NCT05162625|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65724031|NCT05162625|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65724032|NCT05162625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65724033|NCT05162625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65724034|NCT05162625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65724035|NCT05162625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65724036|NCT05162625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724037|NCT05162625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724038|NCT05162625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724039|NCT05162625|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65724040|NCT05162625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65724041|NCT04698603|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
65724042|NCT04698603|Hallucinogens|hallucinogens|mesh-ancestor
65724043|NCT04698603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724044|NCT04698603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65724045|NCT04698603|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65724046|NCT04698603|Serotonin Agents|serotonin agents|mesh-ancestor
65724047|NCT04698603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65724048|NCT04698603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724049|NCT04698603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65724050|NCT02506816|Olaparib|olaparib|mesh-list
65724051|NCT02506816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65724052|NCT02506816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724053|NCT02506816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724054|NCT02506816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724055|NCT05009901|Thioctic Acid|thioctic acid|mesh-list
65724056|NCT05009901|Antioxidants|antioxidants|mesh-ancestor
65724057|NCT05009901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724058|NCT05009901|Protective Agents|protective agents|mesh-ancestor
65724059|NCT05009901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724060|NCT05009901|Vitamin B Complex|vitamin b complex|mesh-ancestor
65724061|NCT05009901|Vitamins|vitamins|mesh-ancestor
65724062|NCT05009901|Micronutrients|micronutrients|mesh-ancestor
65724063|NCT01063855|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
65724064|NCT01063855|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65724065|NCT01063855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724066|NCT01063855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724067|NCT05162001|Disulfiram|disulfiram|mesh-list
65724068|NCT05162001|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65724069|NCT05162001|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65724070|NCT05162001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724071|NCT05162001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724072|NCT03469167|Epinephrine|epinephrine|mesh-list
65724073|NCT03469167|CEGP-003|cegp-003|mesh-list
65724074|NCT03469167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65724075|NCT03469167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65724076|NCT03469167|Adrenergic Agents|adrenergic agents|mesh-ancestor
65724077|NCT03469167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65724078|NCT03469167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724079|NCT03469167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724080|NCT03469167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65724081|NCT03469167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65724082|NCT03469167|Autonomic Agents|autonomic agents|mesh-ancestor
65724083|NCT03469167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65724084|NCT03469167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65724085|NCT03469167|Respiratory System Agents|respiratory system agents|mesh-ancestor
65724086|NCT03469167|Mydriatics|mydriatics|mesh-ancestor
65724087|NCT03469167|Sympathomimetics|sympathomimetics|mesh-ancestor
65724088|NCT03469167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65724089|NCT03469167|Hemostatics|hemostatics|mesh-ancestor
65724090|NCT03469167|Coagulants|coagulants|mesh-ancestor
65724091|NCT01063153|Methylphenidate|methylphenidate|mesh-list
65724092|NCT01063153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65724093|NCT01063153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724094|NCT01063153|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65724095|NCT01063153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65724096|NCT01063153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65724097|NCT01063153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724098|NCT01063153|Dopamine Agents|dopamine agents|mesh-ancestor
65724099|NCT01063153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65724100|NCT05161221|Acetaminophen|acetaminophen|mesh-list
65724101|NCT05161221|Naproxen|naproxen|mesh-list
65724102|NCT05161221|Oxycodone|oxycodone|mesh-list
65724103|NCT05161221|Bupivacaine|bupivacaine|mesh-list
65724104|NCT05161221|Anesthetics, Local|anesthetics, local|mesh-ancestor
65724105|NCT05161221|Anesthetics|anesthetics|mesh-ancestor
65724106|NCT05161221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65724107|NCT05161221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724108|NCT05161221|Sensory System Agents|sensory system agents|mesh-ancestor
65724109|NCT05161221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65724110|NCT05161221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65724111|NCT05161221|Narcotics|narcotics|mesh-ancestor
65724112|NCT05161221|Analgesics|analgesics|mesh-ancestor
65724113|NCT05161221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65724114|NCT05161221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65724115|NCT05161221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65724116|NCT05161221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65724117|NCT05161221|Gout Suppressants|gout suppressants|mesh-ancestor
65724118|NCT05161221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65724119|NCT05161221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724120|NCT05161221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724121|NCT05161221|Antipyretics|antipyretics|mesh-ancestor
65724122|NCT02505334|Liraglutide|liraglutide|mesh-list
65724123|NCT02505334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65724124|NCT02505334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724125|NCT02505334|Incretins|incretins|mesh-ancestor
65724126|NCT02505334|Hormones|hormones|mesh-ancestor
65724127|NCT02505334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65724128|NCT03469089|Ketamine|ketamine|mesh-list
65724129|NCT03469089|Modafinil|modafinil|mesh-list
65724130|NCT03469089|Analgesics|analgesics|mesh-ancestor
65724131|NCT03469089|Sensory System Agents|sensory system agents|mesh-ancestor
65724132|NCT03469089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65724133|NCT03469089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724134|NCT03469089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65724135|NCT03469089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65724136|NCT03469089|Anesthetics, General|anesthetics, general|mesh-ancestor
65724137|NCT03469089|Anesthetics|anesthetics|mesh-ancestor
65724138|NCT03469089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65724139|NCT03469089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65724140|NCT03469089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65724141|NCT03469089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65724142|NCT03469089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724143|NCT03469089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65724144|NCT03469089|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65724145|NCT03469089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65724146|NCT03469089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65724147|NCT04969510|Pramoxine|pramoxine|mesh-list
65724148|NCT04969510|Anesthetics, Local|anesthetics, local|mesh-ancestor
65724149|NCT04969510|Anesthetics|anesthetics|mesh-ancestor
65724150|NCT04969510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65724151|NCT04969510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724152|NCT04969510|Sensory System Agents|sensory system agents|mesh-ancestor
65724153|NCT04969510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65724154|NCT02504320|Febuxostat|febuxostat|mesh-list
65724155|NCT02504320|Gout Suppressants|gout suppressants|mesh-ancestor
65724156|NCT02504320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65724157|NCT05014516|Xenon|xenon|mesh-list
65724158|NCT05014516|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65724159|NCT05014516|Anesthetics, General|anesthetics, general|mesh-ancestor
65724160|NCT05014516|Anesthetics|anesthetics|mesh-ancestor
65724161|NCT05014516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65724162|NCT05014516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724163|NCT01061671|Simvastatin|simvastatin|mesh-list
65724164|NCT01061671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65724165|NCT01061671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65724166|NCT01061671|Antimetabolites|antimetabolites|mesh-ancestor
65724167|NCT01061671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724168|NCT01061671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65724169|NCT01061671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65724170|NCT01061671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724171|NCT05013424|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65724172|NCT05013424|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65724173|NCT05013424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65724174|NCT05013424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65724175|NCT05013424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724176|NCT05013424|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65724177|NCT05013424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65724178|NCT05013424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724179|NCT05013424|Cholinergic Agents|cholinergic agents|mesh-ancestor
65724180|NCT05013424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65724181|NCT04969120|Metoclopramide|metoclopramide|mesh-list
65724182|NCT04969120|Antiemetics|antiemetics|mesh-ancestor
65724183|NCT04969120|Autonomic Agents|autonomic agents|mesh-ancestor
65724184|NCT04969120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65724185|NCT04969120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724186|NCT04969120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65724187|NCT04969120|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65724188|NCT04969120|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65724189|NCT04969120|Dopamine Agents|dopamine agents|mesh-ancestor
65724190|NCT04969120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65724191|NCT04969120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724192|NCT00709995|Sunitinib|sunitinib|mesh-list
65724193|NCT00709995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724194|NCT00709995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65724195|NCT00709995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65724196|NCT00709995|Growth Substances|growth substances|mesh-ancestor
65724197|NCT00709995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724198|NCT00709995|Growth Inhibitors|growth inhibitors|mesh-ancestor
65724199|NCT00709995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65724200|NCT00709995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724201|NCT00709995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724202|NCT02503540|Aflibercept|aflibercept|mesh-list
65724203|NCT02503540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65724204|NCT02503540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65724205|NCT02503540|Growth Substances|growth substances|mesh-ancestor
65724206|NCT02503540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724207|NCT02503540|Growth Inhibitors|growth inhibitors|mesh-ancestor
65724208|NCT02503540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724209|NCT04053985|Lenvatinib|lenvatinib|mesh-list
65724210|NCT04053985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724211|NCT04053985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65724212|NCT04053985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724213|NCT04053985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724214|NCT04455243|Acetylcysteine|acetylcysteine|mesh-list
65724215|NCT04455243|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65724216|NCT04455243|Antiviral Agents|antiviral agents|mesh-ancestor
65724217|NCT04455243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65724218|NCT04455243|Expectorants|expectorants|mesh-ancestor
65724219|NCT04455243|Respiratory System Agents|respiratory system agents|mesh-ancestor
65724220|NCT04455243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65724221|NCT04455243|Antioxidants|antioxidants|mesh-ancestor
65724222|NCT04455243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724223|NCT04455243|Protective Agents|protective agents|mesh-ancestor
65724224|NCT04455243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724225|NCT04455243|Antidotes|antidotes|mesh-ancestor
65724226|NCT04454775|Protein C|protein c|mesh-list
65724227|NCT04454775|Antithrombins|antithrombins|mesh-list
65724228|NCT04454775|Antithrombin III|antithrombin iii|mesh-list
65724229|NCT04454775|Protein S|protein s|mesh-list
65724230|NCT04454775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65724231|NCT04454775|Protease Inhibitors|protease inhibitors|mesh-ancestor
65724232|NCT04454775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724233|NCT04454775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724234|NCT04454775|Anticoagulants|anticoagulants|mesh-ancestor
65724235|NCT04454775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65724236|NCT04454775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65724237|NCT03651661|Insulin|insulin|mesh-list
65724238|NCT03651661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65724239|NCT03651661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65724240|NCT03651661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724241|NCT01060111|Topiramate|topiramate|mesh-list
65724242|NCT01060111|Propranolol|propranolol|mesh-list
65724243|NCT01060111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65724244|NCT01060111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65724245|NCT01060111|Adrenergic Agents|adrenergic agents|mesh-ancestor
65724246|NCT01060111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65724247|NCT01060111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724248|NCT01060111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724249|NCT01060111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65724250|NCT01060111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65724251|NCT01060111|Vasodilator Agents|vasodilator agents|mesh-ancestor
65724252|NCT01060111|Anticonvulsants|anticonvulsants|mesh-ancestor
65724253|NCT01060111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65724254|NCT02969863|Pancrelipase|pancrelipase|mesh-list
65724255|NCT02969863|Pancreatin|pancreatin|mesh-list
65724256|NCT02969863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65724257|NCT03651427|Estradiol|estradiol|mesh-list
65724258|NCT03651427|Estrogens|estrogens|mesh-ancestor
65724259|NCT03651427|Hormones|hormones|mesh-ancestor
65724260|NCT03651427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65724261|NCT03651427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724262|NCT05285293|Vitamin A|vitamin a|mesh-list
65724263|NCT05285293|Vitamins|vitamins|mesh-ancestor
65724264|NCT05285293|Micronutrients|micronutrients|mesh-ancestor
65724265|NCT05285293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724266|NCT03650257|Temozolomide|temozolomide|mesh-list
65724267|NCT03650257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65724268|NCT03650257|Alkylating Agents|alkylating agents|mesh-ancestor
65724269|NCT03650257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724270|NCT03650257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724271|NCT03649243|Propolis|propolis|mesh-list
65724272|NCT03649243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65724273|NCT03649165|Acetaminophen|acetaminophen|mesh-list
65724274|NCT03649165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65724275|NCT03649165|Analgesics|analgesics|mesh-ancestor
65724276|NCT03649165|Sensory System Agents|sensory system agents|mesh-ancestor
65724277|NCT03649165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65724278|NCT03649165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724279|NCT03649165|Antipyretics|antipyretics|mesh-ancestor
65724280|NCT03649009|Thiamine|thiamine|mesh-list
65724281|NCT03649009|Hydrocortisone|hydrocortisone|mesh-list
65724282|NCT03649009|Metoclopramide|metoclopramide|mesh-list
65724283|NCT03649009|Vitamins|vitamins|mesh-ancestor
65724284|NCT03649009|Micronutrients|micronutrients|mesh-ancestor
65724285|NCT03649009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724286|NCT03649009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65724287|NCT03649009|Vitamin B Complex|vitamin b complex|mesh-ancestor
65724288|NCT03649009|Antiemetics|antiemetics|mesh-ancestor
65724289|NCT03649009|Autonomic Agents|autonomic agents|mesh-ancestor
65724290|NCT03649009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65724291|NCT03649009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65724292|NCT03649009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65724293|NCT03649009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65724294|NCT03649009|Dopamine Agents|dopamine agents|mesh-ancestor
65724295|NCT03649009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65724296|NCT03649009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724297|NCT03650023|Chitosan|chitosan|mesh-list
65724298|NCT03650023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65724299|NCT03650023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65724300|NCT03650023|Antimetabolites|antimetabolites|mesh-ancestor
65724301|NCT03650023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724302|NCT03650023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65724303|NCT03650023|Chelating Agents|chelating agents|mesh-ancestor
65724304|NCT03650023|Sequestering Agents|sequestering agents|mesh-ancestor
65724305|NCT03650023|Hemostatics|hemostatics|mesh-ancestor
65724306|NCT03650023|Coagulants|coagulants|mesh-ancestor
65724307|NCT04054999|Hydroxocobalamin|hydroxocobalamin|mesh-list
65724308|NCT04054999|Vitamin B 12|vitamin b 12|mesh-list
65724309|NCT04054999|Methylene Blue|methylene blue|mesh-list
64525340|NCT03169764|Vitamins|vitamins|mesh-ancestor
65724310|NCT04054999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724311|NCT04054999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724312|NCT04054999|Hematinics|hematinics|mesh-ancestor
65724313|NCT04054999|Vitamin B Complex|vitamin b complex|mesh-ancestor
65040155|NCT00221637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65724314|NCT04054999|Vitamins|vitamins|mesh-ancestor
65724315|NCT04054999|Micronutrients|micronutrients|mesh-ancestor
65724316|NCT04054999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724317|NCT03649945|Docetaxel|docetaxel|mesh-list
65724318|NCT03649945|Endostar protein|endostar protein|mesh-list
65724319|NCT03649945|Nedaplatin|nedaplatin|mesh-list
65724320|NCT03649945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724321|NCT03649945|Tubulin Modulators|tubulin modulators|mesh-ancestor
65724322|NCT03649945|Antimitotic Agents|antimitotic agents|mesh-ancestor
65724323|NCT03649945|Mitosis Modulators|mitosis modulators|mesh-ancestor
65724324|NCT03649945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724325|NCT03649945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65724326|NCT03649945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65724327|NCT03649945|Growth Substances|growth substances|mesh-ancestor
65724328|NCT03649945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724329|NCT03649945|Growth Inhibitors|growth inhibitors|mesh-ancestor
65724330|NCT03650881|Adapalene|adapalene|mesh-list
65724331|NCT03650881|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65724332|NCT03650881|Dermatologic Agents|dermatologic agents|mesh-ancestor
65724333|NCT03650881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65724334|NCT03650881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65724335|NCT03650881|Analgesics|analgesics|mesh-ancestor
65724336|NCT03650881|Sensory System Agents|sensory system agents|mesh-ancestor
65724337|NCT03650881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65724338|NCT03650881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724339|NCT03650881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65724340|NCT03650881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65724341|NCT02904265|Acetazolamide|acetazolamide|mesh-list
65724342|NCT02904265|Diazepam|diazepam|mesh-list
65724343|NCT02904265|Anticonvulsants|anticonvulsants|mesh-ancestor
65724344|NCT02904265|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65724345|NCT02904265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724346|NCT02904265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724347|NCT02904265|Diuretics|diuretics|mesh-ancestor
65724348|NCT02904265|Natriuretic Agents|natriuretic agents|mesh-ancestor
65724349|NCT02904265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724350|NCT02904265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65724351|NCT02904265|Antiemetics|antiemetics|mesh-ancestor
65724352|NCT02904265|Autonomic Agents|autonomic agents|mesh-ancestor
65724353|NCT02904265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65724354|NCT02904265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65724355|NCT02904265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65724356|NCT02904265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65724357|NCT02904265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65724358|NCT02904265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65724359|NCT02904265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65724360|NCT02904265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65724361|NCT02904265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65724362|NCT02904265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65724363|NCT02904265|Anesthetics, General|anesthetics, general|mesh-ancestor
65724364|NCT02904265|Anesthetics|anesthetics|mesh-ancestor
65724365|NCT02904265|GABA Modulators|gaba modulators|mesh-ancestor
65724366|NCT02904265|GABA Agents|gaba agents|mesh-ancestor
65724367|NCT02904265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65724368|NCT03648229|Timolol|timolol|mesh-list
65724369|NCT03648229|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65724370|NCT03648229|Latanoprost|latanoprost|mesh-list
65724371|NCT03648229|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65724372|NCT03648229|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65724373|NCT03648229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65724374|NCT03648229|Adrenergic Agents|adrenergic agents|mesh-ancestor
65724375|NCT03648229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65724376|NCT03648229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724377|NCT03648229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724378|NCT03648229|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65724379|NCT03648229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65724380|NCT05285449|Cannabidiol|cannabidiol|mesh-list
65724381|NCT05285449|Anticonvulsants|anticonvulsants|mesh-ancestor
65724382|NCT03648697|Cyclophosphamide|cyclophosphamide|mesh-list
65724383|NCT03648697|Fludarabine|fludarabine|mesh-list
65724384|NCT03648697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65724385|NCT03648697|Immunologic Factors|immunologic factors|mesh-ancestor
65724386|NCT03648697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724387|NCT03648697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65724388|NCT03648697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65724389|NCT03648697|Alkylating Agents|alkylating agents|mesh-ancestor
65724390|NCT03648697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724391|NCT03648697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724392|NCT03648697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65724393|NCT04535037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65724394|NCT04535037|Immunologic Factors|immunologic factors|mesh-ancestor
65724395|NCT04535037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724396|NCT02967679|Biotin|biotin|mesh-list
65724397|NCT02967679|Vitamin B Complex|vitamin b complex|mesh-ancestor
65724398|NCT02967679|Vitamins|vitamins|mesh-ancestor
65724399|NCT02967679|Micronutrients|micronutrients|mesh-ancestor
65724400|NCT02967679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724401|NCT04447053|Belimumab|belimumab|mesh-list
65724402|NCT04447053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65724403|NCT04447053|Immunologic Factors|immunologic factors|mesh-ancestor
65724404|NCT04447053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724405|NCT04361799|Insulin|insulin|mesh-list
65724406|NCT04361799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65724407|NCT04361799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724408|NCT04450173|Venetoclax|venetoclax|mesh-list
65724409|NCT04450173|Obinutuzumab|obinutuzumab|mesh-list
65724410|NCT04450173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724411|NCT04450173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65724412|NCT05390073|Hormones|hormones|mesh-list
65724413|NCT05390073|Mitogens|mitogens|mesh-list
65724414|NCT05390073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724415|NCT05390073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65724416|NCT05390073|Mitosis Modulators|mitosis modulators|mesh-ancestor
65724417|NCT05390073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724418|NCT04328727|Cyclosporine|cyclosporine|mesh-list
65724419|NCT04328727|Cyclosporins|cyclosporins|mesh-list
65724420|NCT04328727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65724421|NCT04328727|Thymoglobulin|thymoglobulin|mesh-list
65724422|NCT04328727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724423|NCT04328727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724424|NCT04328727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65724425|NCT04328727|Immunologic Factors|immunologic factors|mesh-ancestor
65724426|NCT04328727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724427|NCT04328727|Antifungal Agents|antifungal agents|mesh-ancestor
65724428|NCT04328727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65724429|NCT04328727|Dermatologic Agents|dermatologic agents|mesh-ancestor
65724430|NCT04328727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65724431|NCT04328727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65724432|NCT03647839|Nivolumab|nivolumab|mesh-list
65724433|NCT03647839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65724434|NCT03647839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724435|NCT03647839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65724436|NCT03647839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724437|NCT04454619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65724438|NCT04454307|Tramadol|tramadol|mesh-list
65724439|NCT04454307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65724440|NCT04454307|Narcotics|narcotics|mesh-ancestor
65724441|NCT04454307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65724442|NCT04454307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724443|NCT04454307|Analgesics|analgesics|mesh-ancestor
65724444|NCT04454307|Sensory System Agents|sensory system agents|mesh-ancestor
65724445|NCT04454307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65724446|NCT05388123|Rituximab|rituximab|mesh-list
65724447|NCT05388123|Vemurafenib|vemurafenib|mesh-list
65724448|NCT05388123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65724449|NCT05388123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724450|NCT05388123|Immunologic Factors|immunologic factors|mesh-ancestor
65724451|NCT05388123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724452|NCT05388123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65724453|NCT05388123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65724454|NCT05388123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724455|NCT05388123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724456|NCT04455711|Lidocaine|lidocaine|mesh-list
65724457|NCT04455711|Remifentanil|remifentanil|mesh-list
65724458|NCT04455711|Anesthetics, Local|anesthetics, local|mesh-ancestor
65724459|NCT04455711|Anesthetics|anesthetics|mesh-ancestor
65724460|NCT04455711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65724461|NCT04455711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724462|NCT04455711|Sensory System Agents|sensory system agents|mesh-ancestor
65724463|NCT04455711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65724464|NCT04455711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65724465|NCT04455711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65724467|NCT04455711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65724468|NCT04455711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724469|NCT04455711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65724470|NCT04455711|Narcotics|narcotics|mesh-ancestor
65724471|NCT04455711|Analgesics|analgesics|mesh-ancestor
65724472|NCT03717987|Botulinum Toxins|botulinum toxins|mesh-list
65724473|NCT03717987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65724474|NCT03717987|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65724475|NCT03717987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65724476|NCT03717987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65724477|NCT03717987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724478|NCT03717987|Cholinergic Agents|cholinergic agents|mesh-ancestor
65724479|NCT03717987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65724480|NCT03717987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724481|NCT03717987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65724482|NCT03717987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65724483|NCT04062669|Vaccines|vaccines|mesh-list
65724484|NCT04062669|Immunologic Factors|immunologic factors|mesh-ancestor
65724485|NCT04062669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724486|NCT05387967|Valsartan|valsartan|mesh-list
65724487|NCT05387967|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65724488|NCT05387967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65724489|NCT05387967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65724490|NCT05387967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65724491|NCT05387967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724492|NCT03856359|Rifaximin|rifaximin|mesh-list
65724493|NCT03856359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65724494|NCT03856359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65724495|NCT03856359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65724496|NCT04052659|Azacitidine|azacitidine|mesh-list
65724497|NCT04052659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65724498|NCT04052659|Antimetabolites|antimetabolites|mesh-ancestor
65724499|NCT04052659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724500|NCT04052659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724501|NCT04052659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724502|NCT02964247|Liraglutide|liraglutide|mesh-list
65724503|NCT02964247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65724504|NCT02964247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724505|NCT02964247|Incretins|incretins|mesh-ancestor
65724506|NCT02964247|Hormones|hormones|mesh-ancestor
65724507|NCT02964247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65724508|NCT03654729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
65724509|NCT03654729|Edetic Acid|edetic acid|mesh-list
65724510|NCT03654729|Anticoagulants|anticoagulants|mesh-ancestor
65724511|NCT03654729|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65724512|NCT03654729|Chelating Agents|chelating agents|mesh-ancestor
65724513|NCT03654729|Sequestering Agents|sequestering agents|mesh-ancestor
65724514|NCT03654729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724515|NCT03654729|Vitamin B Complex|vitamin b complex|mesh-ancestor
65724516|NCT03654729|Vitamins|vitamins|mesh-ancestor
65724517|NCT03654729|Micronutrients|micronutrients|mesh-ancestor
65724518|NCT03654729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724519|NCT04052269|Sildenafil Citrate|sildenafil citrate|mesh-list
65724520|NCT04052269|Tadalafil|tadalafil|mesh-list
65724521|NCT04052269|Vasodilator Agents|vasodilator agents|mesh-ancestor
65724522|NCT04052269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65724523|NCT04052269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65724524|NCT04052269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724525|NCT04052269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724526|NCT04052269|Urological Agents|urological agents|mesh-ancestor
65724527|NCT01377987|Acetazolamide|acetazolamide|mesh-list
65724528|NCT01377987|Anticonvulsants|anticonvulsants|mesh-ancestor
65724529|NCT01377987|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65724530|NCT01377987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724531|NCT01377987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724532|NCT01377987|Diuretics|diuretics|mesh-ancestor
65724533|NCT01377987|Natriuretic Agents|natriuretic agents|mesh-ancestor
65724534|NCT01377987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724535|NCT03645187|Celecoxib|celecoxib|mesh-list
65724536|NCT03645187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65724537|NCT03645187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65724538|NCT03645187|Analgesics|analgesics|mesh-ancestor
65724539|NCT03645187|Sensory System Agents|sensory system agents|mesh-ancestor
65724540|NCT03645187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65724541|NCT03645187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724542|NCT03645187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65724543|NCT03645187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65724544|NCT03645187|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65724545|NCT03645187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65724546|NCT03645187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724547|NCT03645187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724548|NCT03645109|Vitamin D|vitamin d|mesh-list
65724549|NCT03645109|Cholecalciferol|cholecalciferol|mesh-list
65724550|NCT03645109|Vitamins|vitamins|mesh-ancestor
65724551|NCT03645109|Micronutrients|micronutrients|mesh-ancestor
65724552|NCT03645109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724553|NCT03645109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65724554|NCT03645109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65724555|NCT04455555|Rotigotine|rotigotine|mesh-list
65724556|NCT04455555|Dopamine Agonists|dopamine agonists|mesh-ancestor
65724557|NCT04455555|Dopamine Agents|dopamine agents|mesh-ancestor
65724558|NCT04455555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65724559|NCT04455555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724560|NCT04455555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724561|NCT02898259|Rituximab|rituximab|mesh-list
65724562|NCT02898259|Lenalidomide|lenalidomide|mesh-list
65724563|NCT02898259|Ixazomib|ixazomib|mesh-list
65724564|NCT02898259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65724565|NCT02898259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724566|NCT02898259|Immunologic Factors|immunologic factors|mesh-ancestor
65724567|NCT02898259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724568|NCT02898259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65724569|NCT02898259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65724570|NCT02898259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65724571|NCT02898259|Growth Substances|growth substances|mesh-ancestor
65724572|NCT02898259|Growth Inhibitors|growth inhibitors|mesh-ancestor
65724573|NCT02898259|Protease Inhibitors|protease inhibitors|mesh-ancestor
65724574|NCT02898259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724575|NCT02898259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724576|NCT03646357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65724577|NCT03646357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65724578|NCT03646357|Adrenergic Agents|adrenergic agents|mesh-ancestor
65724579|NCT03646357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65724580|NCT03646357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724581|NCT03646357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724582|NCT02963935|Liraglutide|liraglutide|mesh-list
65724583|NCT02963935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65724584|NCT02963935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724585|NCT02963935|Incretins|incretins|mesh-ancestor
65724586|NCT02963935|Hormones|hormones|mesh-ancestor
65724587|NCT02963935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65724588|NCT02899195|Durvalumab|durvalumab|mesh-list
65724589|NCT02899195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65724590|NCT02899195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724591|NCT03644641|Propofol|propofol|mesh-list
65724592|NCT03644641|Desflurane|desflurane|mesh-list
65724593|NCT03644641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65724594|NCT03644641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65724595|NCT03644641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724596|NCT03644641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65724597|NCT03644641|Anesthetics, General|anesthetics, general|mesh-ancestor
65724598|NCT03644641|Anesthetics|anesthetics|mesh-ancestor
65724599|NCT03644641|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65724600|NCT05283421|Estrogens|estrogens|mesh-list
65724601|NCT05283421|Hormones|hormones|mesh-ancestor
65724602|NCT05283421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65724603|NCT05283421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724604|NCT03630991|Calcium, Dietary|calcium, dietary|mesh-list
65724605|NCT03630991|Edetic Acid|edetic acid|mesh-list
65724606|NCT03630991|Calcium|calcium|mesh-list
65724607|NCT03630991|Pentetic Acid|pentetic acid|mesh-list
65724608|NCT03630991|Succimer|succimer|mesh-list
65724609|NCT03630991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724610|NCT03630991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65724611|NCT03630991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65724612|NCT03630991|Anticoagulants|anticoagulants|mesh-ancestor
65724613|NCT03630991|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65724614|NCT03630991|Chelating Agents|chelating agents|mesh-ancestor
65724615|NCT03630991|Sequestering Agents|sequestering agents|mesh-ancestor
65040456|NCT00124280|Everolimus|everolimus|mesh-list
65724616|NCT03630991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724617|NCT03630991|Antidotes|antidotes|mesh-ancestor
65724618|NCT03630991|Protective Agents|protective agents|mesh-ancestor
65724619|NCT03630991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65724620|NCT02963701|Ibuprofen|ibuprofen|mesh-list
65724621|NCT02963701|Pseudoephedrine|pseudoephedrine|mesh-list
65724622|NCT02963701|Ephedrine|ephedrine|mesh-list
65724623|NCT02963701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65724624|NCT02963701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65724625|NCT02963701|Analgesics|analgesics|mesh-ancestor
65724626|NCT02963701|Sensory System Agents|sensory system agents|mesh-ancestor
65724627|NCT02963701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65724628|NCT02963701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724629|NCT02963701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65724630|NCT02963701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65724631|NCT02963701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65724632|NCT02963701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724633|NCT02963701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724634|NCT02963701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65724635|NCT02963701|Autonomic Agents|autonomic agents|mesh-ancestor
65724636|NCT02963701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65724637|NCT02963701|Respiratory System Agents|respiratory system agents|mesh-ancestor
65724638|NCT02963701|Nasal Decongestants|nasal decongestants|mesh-ancestor
65724639|NCT02963701|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65724640|NCT02963701|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65724641|NCT02963701|Sympathomimetics|sympathomimetics|mesh-ancestor
65724642|NCT02963701|Adrenergic Agents|adrenergic agents|mesh-ancestor
65724643|NCT02963701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65724644|NCT02961751|Ciprofloxacin|ciprofloxacin|mesh-list
65724645|NCT02961751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65724646|NCT02961751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65724647|NCT02961751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65724648|NCT02961751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65724649|NCT02961751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724650|NCT02961751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724651|NCT02961751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724652|NCT02961751|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65724653|NCT02961751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65724654|NCT03643549|Temozolomide|temozolomide|mesh-list
65724655|NCT03643549|Bortezomib|bortezomib|mesh-list
65724656|NCT03643549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65724657|NCT03643549|Alkylating Agents|alkylating agents|mesh-ancestor
65724658|NCT03643549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724659|NCT03643549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724660|NCT02362035|Pembrolizumab|pembrolizumab|mesh-list
65724661|NCT02362035|Acalabrutinib|acalabrutinib|mesh-list
65724662|NCT02362035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65724663|NCT02362035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724664|NCT05262205|Anesthetics|anesthetics|mesh-list
65724665|NCT05262205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65724666|NCT05262205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724667|NCT03641053|Iodine|iodine|mesh-list
65724668|NCT03641053|Povidone-Iodine|povidone-iodine|mesh-list
65724669|NCT03641053|Povidone|povidone|mesh-list
65724670|NCT03641053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65724671|NCT03641053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65724672|NCT03641053|Trace Elements|trace elements|mesh-ancestor
65724673|NCT03641053|Micronutrients|micronutrients|mesh-ancestor
65724674|NCT03641053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724675|NCT03641053|Plasma Substitutes|plasma substitutes|mesh-ancestor
65724676|NCT03641053|Blood Substitutes|blood substitutes|mesh-ancestor
65724677|NCT04455477|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65724678|NCT04455477|Natriuretic Agents|natriuretic agents|mesh-ancestor
65724679|NCT04455477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724680|NCT05345691|Denosumab|denosumab|mesh-list
65724681|NCT05345691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65724682|NCT05345691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724683|NCT05165277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65724684|NCT03468777|Lansoprazole|lansoprazole|mesh-list
65724685|NCT03468777|Dexlansoprazole|dexlansoprazole|mesh-list
65724686|NCT03468777|Ranitidine|ranitidine|mesh-list
65724687|NCT03468777|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65724688|NCT03468777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65724689|NCT03468777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65724690|NCT03468777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65724691|NCT03468777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724692|NCT03468777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724693|NCT03468777|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65724694|NCT03468777|Histamine Antagonists|histamine antagonists|mesh-ancestor
65724695|NCT03468777|Histamine Agents|histamine agents|mesh-ancestor
65724696|NCT03468777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65724697|NCT03468777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724698|NCT03640377|Praziquantel|praziquantel|mesh-list
65724699|NCT03640377|Anthelmintics|anthelmintics|mesh-ancestor
65724700|NCT03640377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65724701|NCT03640377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65724702|NCT05323149|Tranexamic Acid|tranexamic acid|mesh-list
65724703|NCT05323149|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65724704|NCT05323149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65724705|NCT05323149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724706|NCT05323149|Hemostatics|hemostatics|mesh-ancestor
65724707|NCT05323149|Coagulants|coagulants|mesh-ancestor
65724708|NCT05303805|Sevoflurane|sevoflurane|mesh-list
65724709|NCT05303805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65724710|NCT05303805|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65724711|NCT05303805|Anesthetics, General|anesthetics, general|mesh-ancestor
65724712|NCT05303805|Anesthetics|anesthetics|mesh-ancestor
65724713|NCT05303805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65724714|NCT05303805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724715|NCT03642847|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65724716|NCT03642847|Immunologic Factors|immunologic factors|mesh-ancestor
65724717|NCT03642847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724718|NCT03621163|Lithium Carbonate|lithium carbonate|mesh-list
65724719|NCT03621163|Antidepressive Agents|antidepressive agents|mesh-ancestor
65724720|NCT03621163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65724721|NCT03621163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724722|NCT03621163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724723|NCT03621163|Antimanic Agents|antimanic agents|mesh-ancestor
65724724|NCT03621163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65724725|NCT03621163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65724726|NCT03621163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724727|NCT03632187|Abatacept|abatacept|mesh-list
65724728|NCT03632187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65724729|NCT03632187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724730|NCT03632187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724731|NCT03632187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65724732|NCT03632187|Immunologic Factors|immunologic factors|mesh-ancestor
65724733|NCT03632187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724734|NCT03632187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65724735|NCT05110209|Bevacizumab|bevacizumab|mesh-list
65724736|NCT05110209|Ranibizumab|ranibizumab|mesh-list
65724737|NCT05110209|Aflibercept|aflibercept|mesh-list
65724738|NCT05110209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65724739|NCT05110209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724740|NCT05110209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65724741|NCT05110209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65724742|NCT05110209|Growth Substances|growth substances|mesh-ancestor
65724743|NCT05110209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724744|NCT05110209|Growth Inhibitors|growth inhibitors|mesh-ancestor
65724745|NCT04454151|Azithromycin|azithromycin|mesh-list
65724746|NCT04454151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65724747|NCT04454151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65724748|NCT05272683|Itraconazole|itraconazole|mesh-list
65724749|NCT05272683|Antifungal Agents|antifungal agents|mesh-ancestor
65724750|NCT05272683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65724751|NCT05272683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65724752|NCT05272683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65724753|NCT05272683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724754|NCT05272683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724755|NCT05272683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65724756|NCT05272683|Hormone Antagonists|hormone antagonists|mesh-ancestor
65724757|NCT05272683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65724758|NCT05272683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724759|NCT05272683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65724760|NCT03934671|Antioxidants|antioxidants|mesh-list
65724761|NCT03934671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724762|NCT03934671|Protective Agents|protective agents|mesh-ancestor
65724763|NCT03934671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724764|NCT03130179|Nicotine|nicotine|mesh-list
65724765|NCT03130179|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65724766|NCT03130179|Autonomic Agents|autonomic agents|mesh-ancestor
65724767|NCT03130179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65724768|NCT03130179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724769|NCT03130179|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65724770|NCT03130179|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65724771|NCT03130179|Cholinergic Agents|cholinergic agents|mesh-ancestor
65724772|NCT03130179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65724773|NCT03130179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724774|NCT03466983|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65724775|NCT03466983|Hematinics|hematinics|mesh-ancestor
65724776|NCT05439213|Epinephrine|epinephrine|mesh-list
65724777|NCT05439213|Racepinephrine|racepinephrine|mesh-list
65724778|NCT05439213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65724779|NCT05439213|Epinephryl borate|epinephryl borate|mesh-list
65724780|NCT05439213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65724781|NCT05439213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65724782|NCT05439213|Adrenergic Agents|adrenergic agents|mesh-ancestor
65724783|NCT05439213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65724784|NCT05439213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724785|NCT05439213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724786|NCT05439213|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65724787|NCT05439213|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65724788|NCT05439213|Autonomic Agents|autonomic agents|mesh-ancestor
65724789|NCT05439213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65724790|NCT05439213|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65724791|NCT05439213|Respiratory System Agents|respiratory system agents|mesh-ancestor
65724792|NCT05439213|Mydriatics|mydriatics|mesh-ancestor
65724793|NCT05439213|Sympathomimetics|sympathomimetics|mesh-ancestor
65724794|NCT05439213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65724795|NCT05398653|Cyclosporine|cyclosporine|mesh-list
65724796|NCT05398653|Cyclosporins|cyclosporins|mesh-list
65724797|NCT05398653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724798|NCT05398653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724799|NCT05398653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65724800|NCT05398653|Immunologic Factors|immunologic factors|mesh-ancestor
65724801|NCT05398653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724802|NCT05398653|Antifungal Agents|antifungal agents|mesh-ancestor
65724803|NCT05398653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65724804|NCT05398653|Dermatologic Agents|dermatologic agents|mesh-ancestor
65724805|NCT05398653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65724806|NCT05398653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65724807|NCT03466749|Paclitaxel|paclitaxel|mesh-list
65724808|NCT03466749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65724809|NCT03466749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724810|NCT03466749|Tubulin Modulators|tubulin modulators|mesh-ancestor
65724811|NCT03466749|Antimitotic Agents|antimitotic agents|mesh-ancestor
65724812|NCT03466749|Mitosis Modulators|mitosis modulators|mesh-ancestor
65724813|NCT03466749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724814|NCT03466437|Methamphetamine|methamphetamine|mesh-list
65724815|NCT03466437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65724816|NCT03466437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724817|NCT03466437|Sympathomimetics|sympathomimetics|mesh-ancestor
65724818|NCT03466437|Autonomic Agents|autonomic agents|mesh-ancestor
65724819|NCT03466437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65724820|NCT03466437|Dopamine Agents|dopamine agents|mesh-ancestor
65724821|NCT03466437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65724822|NCT03466437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724823|NCT03466437|Adrenergic Agents|adrenergic agents|mesh-ancestor
65724824|NCT03466437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65724825|NCT03466437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65724826|NCT03466437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65724827|NCT03466437|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65724828|NCT03466359|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
65724829|NCT03466359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724830|NCT03466359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724831|NCT01909245|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65724832|NCT01909245|Gastrins|gastrins|mesh-list
65724833|NCT01909245|Immunologic Factors|immunologic factors|mesh-ancestor
65724834|NCT01909245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724835|NCT01909245|Hormones|hormones|mesh-ancestor
65724836|NCT01909245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65724837|NCT04481919|Diuretics|diuretics|mesh-list
65724838|NCT04481919|Natriuretic Agents|natriuretic agents|mesh-ancestor
65724839|NCT04481919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724840|NCT04459065|Nimotuzumab|nimotuzumab|mesh-list
65724841|NCT04459065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65724842|NCT04459065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724843|NCT03465969|Tacrolimus|tacrolimus|mesh-list
65724844|NCT03465969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65724845|NCT03465969|Immunologic Factors|immunologic factors|mesh-ancestor
65724846|NCT03465969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724847|NCT03465969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65724848|NCT03465969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724849|NCT03465969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724850|NCT05397795|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65724851|NCT05397795|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65724852|NCT05397795|Luteolytic Agents|luteolytic agents|mesh-ancestor
65724853|NCT05397795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65724854|NCT05397795|Contraceptive Agents|contraceptive agents|mesh-ancestor
65724855|NCT05397795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65724856|NCT05397795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724857|NCT05397795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65724858|NCT05397795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65724859|NCT05397795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724860|NCT02889159|Imiquimod|imiquimod|mesh-list
65724861|NCT02889159|Histamine|histamine|mesh-list
65724862|NCT02889159|Histamine phosphate|histamine phosphate|mesh-list
65724863|NCT02889159|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65724864|NCT02889159|Immunologic Factors|immunologic factors|mesh-ancestor
65724865|NCT02889159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724866|NCT02889159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724867|NCT02889159|Interferon Inducers|interferon inducers|mesh-ancestor
65724868|NCT02889159|Histamine Agonists|histamine agonists|mesh-ancestor
65724869|NCT02889159|Histamine Agents|histamine agents|mesh-ancestor
65724870|NCT02889159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65724871|NCT02889159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724872|NCT03130101|Insulin|insulin|mesh-list
65724873|NCT03130101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65724874|NCT03130101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724875|NCT01067521|Glatiramer Acetate|glatiramer acetate|mesh-list
65724876|NCT01067521|(T,G)-A-L|(t,g)-a-l|mesh-list
65724877|NCT01067521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65724878|NCT01067521|Immunologic Factors|immunologic factors|mesh-ancestor
65724879|NCT01067521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724880|NCT01067521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65724881|NCT01067521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65724882|NCT04311489|Ularitide|ularitide|mesh-list
65724883|NCT04311489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65724884|NCT04311489|Autonomic Agents|autonomic agents|mesh-ancestor
65724885|NCT04311489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65724886|NCT04311489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724887|NCT04311489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65724888|NCT04311489|Respiratory System Agents|respiratory system agents|mesh-ancestor
65724889|NCT04311489|Diuretics|diuretics|mesh-ancestor
65724890|NCT04311489|Natriuretic Agents|natriuretic agents|mesh-ancestor
65724891|NCT02735577|Disulfiram|disulfiram|mesh-list
65724892|NCT02735577|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65724893|NCT02735577|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65724894|NCT02735577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724895|NCT02735577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724896|NCT03642535|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65724897|NCT03642535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65724898|NCT03642535|Dermatologic Agents|dermatologic agents|mesh-ancestor
65724899|NCT05171257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65724900|NCT05171257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65724901|NCT05171257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65724902|NCT05171257|Antitubercular Agents|antitubercular agents|mesh-ancestor
65724903|NCT01068613|Tiotropium Bromide|tiotropium bromide|mesh-list
65724904|NCT01068613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65724905|NCT01068613|Autonomic Agents|autonomic agents|mesh-ancestor
65724906|NCT01068613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65724907|NCT01068613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724908|NCT01068613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65724909|NCT01068613|Respiratory System Agents|respiratory system agents|mesh-ancestor
65724910|NCT01068613|Parasympatholytics|parasympatholytics|mesh-ancestor
65724911|NCT01068613|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65724912|NCT01068613|Cholinergic Agents|cholinergic agents|mesh-ancestor
65724913|NCT01068613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65724914|NCT01068613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724915|NCT05396937|Bevacizumab|bevacizumab|mesh-list
65724916|NCT05396937|Atezolizumab|atezolizumab|mesh-list
65724917|NCT05396937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65724918|NCT05396937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724919|NCT05396937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65724920|NCT05396937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65724921|NCT05396937|Growth Substances|growth substances|mesh-ancestor
65724922|NCT05396937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724923|NCT05396937|Growth Inhibitors|growth inhibitors|mesh-ancestor
65724924|NCT03465579|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65724925|NCT03465579|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65724926|NCT03465579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724928|NCT05424315|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65724929|NCT05424315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724930|NCT05424315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65724931|NCT05424315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724932|NCT03642145|Deflazacort|deflazacort|mesh-list
65724933|NCT03642145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65724934|NCT03642145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65724935|NCT03642145|Immunologic Factors|immunologic factors|mesh-ancestor
65724936|NCT03642145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724937|NCT01064791|Mycophenolic Acid|mycophenolic acid|mesh-list
65724938|NCT01064791|Tacrolimus|tacrolimus|mesh-list
65724939|NCT01064791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65724940|NCT01064791|Immunologic Factors|immunologic factors|mesh-ancestor
65724941|NCT01064791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724942|NCT01064791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65724943|NCT01064791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724944|NCT01064791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724945|NCT01064791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65724946|NCT01064791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724947|NCT01064791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65724948|NCT01064791|Antitubercular Agents|antitubercular agents|mesh-ancestor
65724949|NCT01064791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65724950|NCT01064791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65724951|NCT03465423|Propofol|propofol|mesh-list
65724952|NCT03465423|Anesthetics|anesthetics|mesh-ancestor
65724953|NCT03465423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65724954|NCT03465423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724955|NCT03465423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65724956|NCT03465423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65724957|NCT03465423|Anesthetics, General|anesthetics, general|mesh-ancestor
65724958|NCT05161351|Vitamin D|vitamin d|mesh-list
65724959|NCT05161351|Cholecalciferol|cholecalciferol|mesh-list
65724960|NCT05161351|Baclofen|baclofen|mesh-list
65724961|NCT05161351|Vitamins|vitamins|mesh-ancestor
65724962|NCT05161351|Micronutrients|micronutrients|mesh-ancestor
65724963|NCT05161351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724964|NCT05161351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65724965|NCT05161351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65724966|NCT05161351|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65724967|NCT05161351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65724968|NCT05161351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65724969|NCT05161351|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65724970|NCT05161351|GABA Agonists|gaba agonists|mesh-ancestor
65724971|NCT05161351|GABA Agents|gaba agents|mesh-ancestor
65724972|NCT05161351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65724973|NCT05161351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724974|NCT03465345|Metformin|metformin|mesh-list
65724975|NCT03465345|Proanthocyanidin|proanthocyanidin|mesh-list
65724976|NCT03465345|Procyanidin|procyanidin|mesh-list
65724977|NCT03465345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65724978|NCT03465345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724979|NCT03465345|Antioxidants|antioxidants|mesh-ancestor
65724980|NCT03465345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724981|NCT03465345|Protective Agents|protective agents|mesh-ancestor
65724982|NCT03465345|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65724983|NCT03465345|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65724984|NCT03465345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65724985|NCT04563507|Letrozole|letrozole|mesh-list
65724986|NCT04563507|Palbociclib|palbociclib|mesh-list
65724987|NCT04563507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65724988|NCT04563507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65724989|NCT04563507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65724990|NCT04563507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65724991|NCT04563507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65724992|NCT04563507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65724993|NCT04563507|Hormone Antagonists|hormone antagonists|mesh-ancestor
65724994|NCT04563507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65724995|NCT04563507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65724996|NCT04563507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65724997|NCT02983799|Olaparib|olaparib|mesh-list
65724998|NCT02983799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65724999|NCT02983799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725000|NCT02983799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725001|NCT02983799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725002|NCT05385705|Cyclophosphamide|cyclophosphamide|mesh-list
65725003|NCT05385705|Trastuzumab|trastuzumab|mesh-list
65725004|NCT05385705|Interleukin-2|interleukin-2|mesh-list
65725005|NCT05385705|Pertuzumab|pertuzumab|mesh-list
65725006|NCT05385705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65725007|NCT05385705|Immunologic Factors|immunologic factors|mesh-ancestor
65725008|NCT05385705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725009|NCT05385705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65725010|NCT05385705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65725011|NCT05385705|Alkylating Agents|alkylating agents|mesh-ancestor
65725012|NCT05385705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725013|NCT05385705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725014|NCT05385705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65725015|NCT05385705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65725016|NCT05385705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65725017|NCT05385705|Analgesics|analgesics|mesh-ancestor
65725018|NCT05385705|Sensory System Agents|sensory system agents|mesh-ancestor
65725019|NCT05385705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65725020|NCT03912831|Cyclophosphamide|cyclophosphamide|mesh-list
65725021|NCT03912831|Fludarabine|fludarabine|mesh-list
65725022|NCT03912831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65725023|NCT03912831|Immunologic Factors|immunologic factors|mesh-ancestor
65725024|NCT03912831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725025|NCT03912831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65725026|NCT03912831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65725027|NCT03912831|Alkylating Agents|alkylating agents|mesh-ancestor
65725028|NCT03912831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725029|NCT03912831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725030|NCT03912831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65725031|NCT04373265|Pembrolizumab|pembrolizumab|mesh-list
65725032|NCT04373265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65725033|NCT04373265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725034|NCT02186847|Metformin|metformin|mesh-list
65725035|NCT02186847|Paclitaxel|paclitaxel|mesh-list
65725036|NCT02186847|Carboplatin|carboplatin|mesh-list
65725037|NCT02186847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65725038|NCT02186847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725039|NCT02186847|Tubulin Modulators|tubulin modulators|mesh-ancestor
65725040|NCT02186847|Antimitotic Agents|antimitotic agents|mesh-ancestor
65725041|NCT02186847|Mitosis Modulators|mitosis modulators|mesh-ancestor
65725042|NCT02186847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725043|NCT02186847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65725044|NCT02186847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725045|NCT01938261|Acetaminophen|acetaminophen|mesh-list
65725046|NCT01938261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65725047|NCT01938261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65725048|NCT01938261|Analgesics|analgesics|mesh-ancestor
65725049|NCT01938261|Sensory System Agents|sensory system agents|mesh-ancestor
65725050|NCT01938261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65725051|NCT01938261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725052|NCT01938261|Antipyretics|antipyretics|mesh-ancestor
65725053|NCT05274789|Dexmedetomidine|dexmedetomidine|mesh-list
65725054|NCT05274789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65725055|NCT05274789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65725056|NCT05274789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725057|NCT05274789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65725058|NCT05274789|Analgesics|analgesics|mesh-ancestor
65725059|NCT05274789|Sensory System Agents|sensory system agents|mesh-ancestor
65725060|NCT05274789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65725061|NCT05274789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65725062|NCT05274789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65725063|NCT05274789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65725064|NCT05274789|Adrenergic Agents|adrenergic agents|mesh-ancestor
65725065|NCT05274789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65040826|NCT00193388|Topotecan|topotecan|mesh-list
65725066|NCT05274789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725067|NCT02353247|Norethindrone|norethindrone|mesh-list
65725068|NCT02353247|Norethindrone Acetate|norethindrone acetate|mesh-list
65725069|NCT02353247|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65725070|NCT02353247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65725071|NCT02353247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65725072|NCT02353247|Contraceptive Agents|contraceptive agents|mesh-ancestor
65725073|NCT02353247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65725074|NCT02353247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725075|NCT02353247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65725076|NCT02353247|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65725078|NCT04343651|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65725079|NCT04343651|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65725080|NCT04343651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725081|NCT04343651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65725082|NCT04343651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65725083|NCT04343651|Antiviral Agents|antiviral agents|mesh-ancestor
65725084|NCT04343651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65725085|NCT03343431|Tenofovir|tenofovir|mesh-list
65725086|NCT03343431|Antiviral Agents|antiviral agents|mesh-list
65725087|NCT03343431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65725088|NCT03343431|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65725089|NCT03343431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65725090|NCT03343431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725091|NCT03343431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725092|NCT03343431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65725093|NCT03343431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65725094|NCT05226897|Metformin|metformin|mesh-list
65725095|NCT05226897|Dapagliflozin|dapagliflozin|mesh-list
65725096|NCT05226897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65725097|NCT05226897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725098|NCT05226897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65725099|NCT05226897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725100|NCT04453761|Vitamin B Complex|vitamin b complex|mesh-list
65725101|NCT04453761|Vitamins|vitamins|mesh-ancestor
65725102|NCT04453761|Micronutrients|micronutrients|mesh-ancestor
65725103|NCT04453761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725104|NCT03225417|Sirolimus|sirolimus|mesh-list
65725105|NCT03225417|Cyclophosphamide|cyclophosphamide|mesh-list
65725106|NCT03225417|Ixazomib|ixazomib|mesh-list
65725107|NCT03225417|Tacrolimus|tacrolimus|mesh-list
65725108|NCT03225417|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65725109|NCT03225417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65725110|NCT03225417|Immunologic Factors|immunologic factors|mesh-ancestor
65725111|NCT03225417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725112|NCT03225417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65725113|NCT03225417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65725114|NCT03225417|Alkylating Agents|alkylating agents|mesh-ancestor
65725115|NCT03225417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725116|NCT03225417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725117|NCT03225417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65725118|NCT03225417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65725119|NCT03225417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725120|NCT03225417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65725121|NCT03225417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65725122|NCT03225417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65725123|NCT03225417|Antifungal Agents|antifungal agents|mesh-ancestor
65725124|NCT03225417|Protease Inhibitors|protease inhibitors|mesh-ancestor
65725125|NCT03463317|Aspirin|aspirin|mesh-list
65725126|NCT03463317|Warfarin|warfarin|mesh-list
65725127|NCT03463317|Rivaroxaban|rivaroxaban|mesh-list
65725128|NCT03463317|Dabigatran|dabigatran|mesh-list
65725129|NCT03463317|Apixaban|apixaban|mesh-list
65725130|NCT03463317|Edoxaban|edoxaban|mesh-list
65725131|NCT03463317|Phenprocoumon|phenprocoumon|mesh-list
65725132|NCT03463317|Clopidogrel|clopidogrel|mesh-list
65725133|NCT03463317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65725134|NCT03463317|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65725135|NCT03463317|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65725136|NCT03463317|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65725137|NCT03463317|Purinergic Agents|purinergic agents|mesh-ancestor
65725138|NCT03463317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65725139|NCT03463317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725140|NCT03463317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040902|NCT00124358|Analgesics|analgesics|mesh-ancestor
65725141|NCT03463317|Anticoagulants|anticoagulants|mesh-ancestor
65725142|NCT03463317|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65725143|NCT03463317|Antithrombins|antithrombins|mesh-ancestor
65725144|NCT03463317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65725145|NCT03463317|Protease Inhibitors|protease inhibitors|mesh-ancestor
65725146|NCT03463317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725147|NCT03463317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65725148|NCT03463317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65725150|NCT03463317|Sensory System Agents|sensory system agents|mesh-ancestor
65725151|NCT03463317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65725152|NCT03463317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65725153|NCT03463317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65725154|NCT03463317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65725155|NCT03463317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65725156|NCT03463317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65725157|NCT03463317|Antipyretics|antipyretics|mesh-ancestor
65725158|NCT05049213|Povidone-Iodine|povidone-iodine|mesh-list
65725159|NCT05049213|Povidone|povidone|mesh-list
65725160|NCT05049213|Plasma Substitutes|plasma substitutes|mesh-ancestor
65725161|NCT05049213|Blood Substitutes|blood substitutes|mesh-ancestor
65725162|NCT05049213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65725163|NCT05049213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65725164|NCT02906579|Praliciguat|praliciguat|mesh-list
65725165|NCT02906579|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65725166|NCT02906579|Enzyme Activators|enzyme activators|mesh-ancestor
65725167|NCT02906579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725168|NCT02906579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65725169|NCT04975347|Naloxone|naloxone|mesh-list
65725170|NCT04975347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725171|NCT04975347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65725172|NCT04975347|Sensory System Agents|sensory system agents|mesh-ancestor
65725173|NCT04975347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65725174|NCT03463083|Fentanyl|fentanyl|mesh-list
65725175|NCT03463083|Dexmedetomidine|dexmedetomidine|mesh-list
65725176|NCT03463083|Bupivacaine|bupivacaine|mesh-list
65725177|NCT03463083|Anesthetics, Local|anesthetics, local|mesh-ancestor
65725178|NCT03463083|Anesthetics|anesthetics|mesh-ancestor
65725179|NCT03463083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65725180|NCT03463083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725181|NCT03463083|Sensory System Agents|sensory system agents|mesh-ancestor
65725182|NCT03463083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65725183|NCT03463083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65725184|NCT03463083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65725185|NCT03463083|Analgesics|analgesics|mesh-ancestor
65725186|NCT03463083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65725187|NCT03463083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65725188|NCT03463083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65725189|NCT03463083|Adrenergic Agents|adrenergic agents|mesh-ancestor
65725190|NCT03463083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65725191|NCT03463083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725192|NCT03463083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65725193|NCT03463083|Narcotics|narcotics|mesh-ancestor
65725194|NCT03463083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65725195|NCT03463083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65725196|NCT03463083|Anesthetics, General|anesthetics, general|mesh-ancestor
65725197|NCT04971837|Cannabidiol|cannabidiol|mesh-list
65725198|NCT04971837|Sorbitol|sorbitol|mesh-list
65725199|NCT04971837|Anticonvulsants|anticonvulsants|mesh-ancestor
65725200|NCT04971837|Cathartics|cathartics|mesh-ancestor
65725201|NCT04971837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65725202|NCT01328535|Temozolomide|temozolomide|mesh-list
65725203|NCT01328535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65725204|NCT01328535|Alkylating Agents|alkylating agents|mesh-ancestor
65725205|NCT01328535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725206|NCT01328535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725207|NCT03463005|Propolis|propolis|mesh-list
65725208|NCT03463005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65725209|NCT02522169|Infliximab|infliximab|mesh-list
65725210|NCT02522169|Dermatologic Agents|dermatologic agents|mesh-ancestor
65725211|NCT02522169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65725212|NCT02522169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65725213|NCT03656393|Carboplatin|carboplatin|mesh-list
65725214|NCT03656393|Vinorelbine|vinorelbine|mesh-list
65725215|NCT03656393|Gefitinib|gefitinib|mesh-list
65725216|NCT03656393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725217|NCT03656393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65725218|NCT03656393|Tubulin Modulators|tubulin modulators|mesh-ancestor
65725219|NCT03656393|Antimitotic Agents|antimitotic agents|mesh-ancestor
65725220|NCT03656393|Mitosis Modulators|mitosis modulators|mesh-ancestor
65725221|NCT03656393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725222|NCT03656393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65725223|NCT03656393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725224|NCT02979197|Celecoxib|celecoxib|mesh-list
65725225|NCT02979197|Amlodipine|amlodipine|mesh-list
65725226|NCT02979197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65725227|NCT02979197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65725228|NCT02979197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65725229|NCT02979197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725230|NCT02979197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65725231|NCT02979197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725232|NCT02979197|Vasodilator Agents|vasodilator agents|mesh-ancestor
65725233|NCT02979197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65725234|NCT02979197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65725235|NCT02979197|Analgesics|analgesics|mesh-ancestor
65725236|NCT02979197|Sensory System Agents|sensory system agents|mesh-ancestor
65725237|NCT02979197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65725238|NCT02979197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65725239|NCT02979197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65725240|NCT02979197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65725241|NCT02979197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65725242|NCT02979197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725243|NCT01837277|Efavirenz|efavirenz|mesh-list
65725244|NCT01837277|Dolutegravir|dolutegravir|mesh-list
65725245|NCT01837277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65725246|NCT01837277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65725247|NCT01837277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725248|NCT01837277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725249|NCT01837277|Antiviral Agents|antiviral agents|mesh-ancestor
65725250|NCT01837277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65725251|NCT01837277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65725252|NCT01837277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65725253|NCT01837277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65725254|NCT01837277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65725255|NCT01837277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65725256|NCT01837277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65725257|NCT01837277|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65725258|NCT01837277|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65725259|NCT01837277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65725260|NCT01837277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65725261|NCT03655535|PAZ320|paz320|mesh-list
65725262|NCT03655535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65725263|NCT03655535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725264|NCT03654365|Caffeine|caffeine|mesh-list
65725265|NCT03654365|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65725266|NCT03654365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725267|NCT03654365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65725268|NCT03654365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725269|NCT03654365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725270|NCT03654365|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65725271|NCT03654365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65725272|NCT03654365|Purinergic Agents|purinergic agents|mesh-ancestor
65725273|NCT03654365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65725274|NCT03655847|Dexmedetomidine|dexmedetomidine|mesh-list
65725275|NCT03655847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65725276|NCT03655847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65725277|NCT03655847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725278|NCT03655847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65725279|NCT03655847|Analgesics|analgesics|mesh-ancestor
65725280|NCT03655847|Sensory System Agents|sensory system agents|mesh-ancestor
65725281|NCT03655847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65725282|NCT03655847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65725283|NCT03655847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65725284|NCT03655847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65725285|NCT03655847|Adrenergic Agents|adrenergic agents|mesh-ancestor
65725286|NCT03655847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65725287|NCT03655847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725288|NCT03655457|Poractant alfa|poractant alfa|mesh-list
65725289|NCT03655457|Beractant|beractant|mesh-list
65725290|NCT03655457|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
65725291|NCT03655457|Respiratory System Agents|respiratory system agents|mesh-ancestor
65725292|NCT01066793|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65725293|NCT01066793|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65725294|NCT01066793|Antiviral Agents|antiviral agents|mesh-ancestor
65725295|NCT01066793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65725296|NCT04453371|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65725297|NCT04453371|Plasminogen|plasminogen|mesh-list
65725298|NCT04453371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65725299|NCT04453371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65725300|NCT04453371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725301|NCT02980523|Moxifloxacin|moxifloxacin|mesh-list
65725302|NCT02980523|Gatifloxacin|gatifloxacin|mesh-list
65725303|NCT02980523|Pazufloxacin|pazufloxacin|mesh-list
65725304|NCT02980523|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65725305|NCT02980523|Hyaluronic Acid|hyaluronic acid|mesh-list
65725306|NCT02980523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65725307|NCT02980523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65725308|NCT02980523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65725309|NCT02980523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65725310|NCT02980523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65725311|NCT02980523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725312|NCT02980523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725313|NCT02980523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725314|NCT02980523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725315|NCT02980523|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65725316|NCT02980523|Immunologic Factors|immunologic factors|mesh-ancestor
65725317|NCT02980523|Viscosupplements|viscosupplements|mesh-ancestor
65725318|NCT02980523|Protective Agents|protective agents|mesh-ancestor
65725319|NCT02980523|Antitubercular Agents|antitubercular agents|mesh-ancestor
65725320|NCT03468465|Solifenacin Succinate|solifenacin succinate|mesh-list
65725321|NCT03468465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65725322|NCT03468465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65725323|NCT03468465|Cholinergic Agents|cholinergic agents|mesh-ancestor
65725324|NCT03468465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65725325|NCT03468465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725326|NCT03468465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725327|NCT03468465|Urological Agents|urological agents|mesh-ancestor
65725328|NCT03460743|Vaccines|vaccines|mesh-list
65725329|NCT03460743|Hemagglutinins|hemagglutinins|mesh-list
65725330|NCT03460743|Immunologic Factors|immunologic factors|mesh-ancestor
65725331|NCT03460743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725332|NCT03460743|Agglutinins|agglutinins|mesh-ancestor
65725333|NCT02980133|Fluticasone|fluticasone|mesh-list
65725335|NCT02980133|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65725336|NCT02980133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65725337|NCT02980133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65725338|NCT02980133|Autonomic Agents|autonomic agents|mesh-ancestor
65725339|NCT02980133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65725340|NCT02980133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725341|NCT02980133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65725342|NCT02980133|Respiratory System Agents|respiratory system agents|mesh-ancestor
65725343|NCT02980133|Dermatologic Agents|dermatologic agents|mesh-ancestor
65725344|NCT02980133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65725345|NCT02980133|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65725346|NCT02980133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65725347|NCT02980133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65725348|NCT02980133|Adrenergic Agents|adrenergic agents|mesh-ancestor
65725349|NCT02980133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65725350|NCT02980133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725351|NCT03653663|Simvastatin|simvastatin|mesh-list
65725352|NCT03653663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65725353|NCT03653663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65725354|NCT03653663|Antimetabolites|antimetabolites|mesh-ancestor
65725355|NCT03653663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725356|NCT03653663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65725357|NCT03653663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65725358|NCT03653663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725359|NCT04864743|Factor VIII|factor viii|mesh-list
65725360|NCT04864743|Coagulants|coagulants|mesh-ancestor
65725361|NCT02979431|Gontivimab|gontivimab|mesh-list
65725362|NCT02979431|Antiviral Agents|antiviral agents|mesh-ancestor
65725363|NCT02979431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65725364|NCT03460275|Osimertinib|osimertinib|mesh-list
65725365|NCT03460275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725366|NCT03460275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65041126|NCT00193895|Carboplatin|carboplatin|mesh-list
65725367|NCT03460275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725368|NCT03460275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725369|NCT03468231|Leucovorin|leucovorin|mesh-list
65725370|NCT03468231|Fluorouracil|fluorouracil|mesh-list
65725371|NCT03468231|Oxaliplatin|oxaliplatin|mesh-list
65725372|NCT03468231|Sorafenib|sorafenib|mesh-list
65725373|NCT03468231|Antimetabolites|antimetabolites|mesh-ancestor
65725374|NCT03468231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725375|NCT03468231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65725376|NCT03468231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725377|NCT03468231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65725378|NCT03468231|Immunologic Factors|immunologic factors|mesh-ancestor
65725379|NCT03468231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725380|NCT03468231|Antidotes|antidotes|mesh-ancestor
65725381|NCT03468231|Protective Agents|protective agents|mesh-ancestor
65725382|NCT03468231|Vitamin B Complex|vitamin b complex|mesh-ancestor
65725383|NCT03468231|Vitamins|vitamins|mesh-ancestor
65725384|NCT03468231|Micronutrients|micronutrients|mesh-ancestor
65725385|NCT03468231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65725386|NCT03468231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725387|NCT03460041|Magnesium Sulfate|magnesium sulfate|mesh-list
65725388|NCT03460041|Bupivacaine|bupivacaine|mesh-list
65725389|NCT03460041|Anesthetics, Local|anesthetics, local|mesh-ancestor
65725390|NCT03460041|Anesthetics|anesthetics|mesh-ancestor
65725391|NCT03460041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65725392|NCT03460041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725393|NCT03460041|Sensory System Agents|sensory system agents|mesh-ancestor
65725394|NCT03460041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65725395|NCT03460041|Analgesics|analgesics|mesh-ancestor
65725396|NCT03460041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65725397|NCT03460041|Anticonvulsants|anticonvulsants|mesh-ancestor
65725398|NCT03460041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65725399|NCT03460041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65725400|NCT03460041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725401|NCT03460041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65725402|NCT03460041|Tocolytic Agents|tocolytic agents|mesh-ancestor
65725403|NCT03460041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65725404|NCT02522013|Aminophylline|aminophylline|mesh-list
65725405|NCT02522013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65725406|NCT02522013|Autonomic Agents|autonomic agents|mesh-ancestor
65725407|NCT02522013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65725408|NCT02522013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725409|NCT02522013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65725410|NCT02522013|Respiratory System Agents|respiratory system agents|mesh-ancestor
65725411|NCT02522013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65725412|NCT02522013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65725413|NCT02522013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725414|NCT02522013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725415|NCT02522013|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65725416|NCT02522013|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65725417|NCT02522013|Purinergic Agents|purinergic agents|mesh-ancestor
65725418|NCT02522013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65725419|NCT02522013|Protective Agents|protective agents|mesh-ancestor
65725420|NCT02978417|Naltrexone|naltrexone|mesh-list
65725421|NCT02978417|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65725422|NCT02978417|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65725423|NCT02978417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725424|NCT02978417|Sensory System Agents|sensory system agents|mesh-ancestor
65725425|NCT02978417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65725426|NCT03458559|Etidronic Acid|etidronic acid|mesh-list
65725427|NCT03458559|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65725428|NCT03458559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725429|NCT03458559|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65725430|NCT03458559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725431|NCT03457467|Apatinib|apatinib|mesh-list
65725432|NCT03457467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725433|NCT03457467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65725434|NCT03457467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725435|NCT03457467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725436|NCT05191875|Doxycycline|doxycycline|mesh-list
65725437|NCT05191875|Furazolidone|furazolidone|mesh-list
65725438|NCT05191875|Bismuth|bismuth|mesh-list
65725439|NCT05191875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65725440|NCT05191875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65725441|NCT05191875|Antimalarials|antimalarials|mesh-ancestor
65725442|NCT05191875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65725443|NCT05191875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65725444|NCT05191875|Antacids|antacids|mesh-ancestor
65725445|NCT05191875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725446|NCT05191875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65725447|NCT05191875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65725448|NCT05191875|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65725449|NCT05191875|Renal Agents|renal agents|mesh-ancestor
65725450|NCT05191875|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65725451|NCT05191875|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65725452|NCT05191875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725453|NCT04370145|Meropenem|meropenem|mesh-list
65725454|NCT04370145|Tinidazole|tinidazole|mesh-list
65725455|NCT04370145|Teicoplanin|teicoplanin|mesh-list
65725456|NCT04370145|Sulperazone|sulperazone|mesh-list
65725457|NCT04370145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65725458|NCT04370145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65725459|NCT04370145|Alkylating Agents|alkylating agents|mesh-ancestor
65725460|NCT04370145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725461|NCT04370145|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65725462|NCT04370145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65725463|NCT04370145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65725464|NCT04370145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65725465|NCT04370145|Renal Agents|renal agents|mesh-ancestor
65725466|NCT03453723|Lidocaine|lidocaine|mesh-list
65725467|NCT03453723|Anesthetics, Local|anesthetics, local|mesh-ancestor
65725468|NCT03453723|Anesthetics|anesthetics|mesh-ancestor
65725469|NCT03453723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65725470|NCT03453723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725471|NCT03453723|Sensory System Agents|sensory system agents|mesh-ancestor
65725472|NCT03453723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65725473|NCT03453723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65188058|NCT02718742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725474|NCT03453723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65725475|NCT03453723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65725476|NCT03453723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65725477|NCT03453723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725478|NCT04368429|Vaccines|vaccines|mesh-list
65725479|NCT04368429|Immunologic Factors|immunologic factors|mesh-ancestor
65725480|NCT04368429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725481|NCT04774965|Diphenhydramine|diphenhydramine|mesh-list
65725482|NCT04774965|Promethazine|promethazine|mesh-list
65725483|NCT04774965|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65725484|NCT04774965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65725485|NCT04774965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65725486|NCT04774965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725487|NCT04774965|Anesthetics, Local|anesthetics, local|mesh-ancestor
65725488|NCT04774965|Anesthetics|anesthetics|mesh-ancestor
65725489|NCT04774965|Sensory System Agents|sensory system agents|mesh-ancestor
65725490|NCT04774965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65725491|NCT04774965|Antiemetics|antiemetics|mesh-ancestor
65725492|NCT04774965|Autonomic Agents|autonomic agents|mesh-ancestor
65725493|NCT04774965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65725494|NCT04774965|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65725495|NCT04774965|Histamine Antagonists|histamine antagonists|mesh-ancestor
65725496|NCT04774965|Histamine Agents|histamine agents|mesh-ancestor
65725497|NCT04774965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65725498|NCT04774965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725499|NCT04774965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65725500|NCT04774965|Antipruritics|antipruritics|mesh-ancestor
65725501|NCT04774965|Dermatologic Agents|dermatologic agents|mesh-ancestor
65725502|NCT03452553|Doxorubicin|doxorubicin|mesh-list
65725503|NCT03452553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65725504|NCT03452553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725505|NCT03452553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65725506|NCT03452553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65725507|NCT03452553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725508|NCT03452553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725509|NCT03452475|Lumefantrine|lumefantrine|mesh-list
65725510|NCT03452475|Artemether|artemether|mesh-list
65725511|NCT03452475|Piperaquine|piperaquine|mesh-list
65725512|NCT03452475|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65725513|NCT03452475|Mefloquine|mefloquine|mesh-list
65725514|NCT03452475|Antimalarials|antimalarials|mesh-ancestor
65725515|NCT03452475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65725516|NCT03452475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65725517|NCT03452475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65725518|NCT04255407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65725519|NCT03451227|Dexmedetomidine|dexmedetomidine|mesh-list
65725520|NCT03451227|Remifentanil|remifentanil|mesh-list
65725521|NCT03451227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65725522|NCT03451227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65725523|NCT03451227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725524|NCT03451227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65725525|NCT03451227|Analgesics|analgesics|mesh-ancestor
65725526|NCT03451227|Sensory System Agents|sensory system agents|mesh-ancestor
65725527|NCT03451227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65725528|NCT03451227|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65725529|NCT03451227|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65725530|NCT03451227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65725531|NCT03451227|Adrenergic Agents|adrenergic agents|mesh-ancestor
65725532|NCT03451227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65725533|NCT03451227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725534|NCT03451227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65725535|NCT03451227|Narcotics|narcotics|mesh-ancestor
65725536|NCT02529813|Cyclophosphamide|cyclophosphamide|mesh-list
65725537|NCT02529813|Fludarabine|fludarabine|mesh-list
65725538|NCT02529813|Fludarabine phosphate|fludarabine phosphate|mesh-list
65725539|NCT02529813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65725540|NCT02529813|Immunologic Factors|immunologic factors|mesh-ancestor
65725541|NCT02529813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725542|NCT02529813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65725543|NCT02529813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65725544|NCT02529813|Alkylating Agents|alkylating agents|mesh-ancestor
65725545|NCT02529813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725546|NCT02529813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725547|NCT02529813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65188133|NCT04964284|Hormones|hormones|mesh-list
65725548|NCT02529813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65725549|NCT02529813|Antimetabolites|antimetabolites|mesh-ancestor
65725550|NCT05321511|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65725551|NCT05321511|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65725552|NCT05321511|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65725553|NCT05321511|Hormones|hormones|mesh-ancestor
65725554|NCT05321511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65725555|NCT05321511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725556|NCT05321511|Luteolytic Agents|luteolytic agents|mesh-ancestor
65725557|NCT05321511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65725558|NCT05321511|Contraceptive Agents|contraceptive agents|mesh-ancestor
65725559|NCT05321511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65725560|NCT05321511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65725561|NCT05321511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65725562|NCT05321511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725563|NCT02417103|Liraglutide|liraglutide|mesh-list
65725564|NCT02417103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65725565|NCT02417103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725566|NCT02417103|Incretins|incretins|mesh-ancestor
65725567|NCT02417103|Hormones|hormones|mesh-ancestor
65725568|NCT02417103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65725569|NCT02382549|Vaccines|vaccines|mesh-list
65725570|NCT02382549|Immunologic Factors|immunologic factors|mesh-ancestor
65725571|NCT02382549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725572|NCT02097225|Trametinib|trametinib|mesh-list
65725573|NCT02097225|Dabrafenib|dabrafenib|mesh-list
65725574|NCT02097225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725575|NCT02097225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65725576|NCT02097225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725577|NCT02097225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725578|NCT02958865|PF-06700841|pf-06700841|mesh-list
65725579|NCT02958865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65725580|NCT02958865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725581|NCT02958865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725582|NCT02501902|Paclitaxel|paclitaxel|mesh-list
65725583|NCT02501902|Palbociclib|palbociclib|mesh-list
65725584|NCT02501902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65725585|NCT02501902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725586|NCT02501902|Tubulin Modulators|tubulin modulators|mesh-ancestor
65725587|NCT02501902|Antimitotic Agents|antimitotic agents|mesh-ancestor
65725588|NCT02501902|Mitosis Modulators|mitosis modulators|mesh-ancestor
65725589|NCT02501902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725590|NCT02501902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65725591|NCT02501902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725592|NCT04205968|Calcium, Dietary|calcium, dietary|mesh-list
65725593|NCT04205968|Leucovorin|leucovorin|mesh-list
65725594|NCT04205968|Folic Acid|folic acid|mesh-list
65725595|NCT04205968|Paclitaxel|paclitaxel|mesh-list
65041342|NCT00206661|Molgramostim|molgramostim|mesh-list
65725597|NCT04205968|Fluorouracil|fluorouracil|mesh-list
65725598|NCT04205968|Irinotecan|irinotecan|mesh-list
65725599|NCT04205968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65725600|NCT04205968|Ramucirumab|ramucirumab|mesh-list
65725601|NCT04205968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65725602|NCT04205968|Antibodies|antibodies|mesh-list
65725603|NCT04205968|Immunoglobulins|immunoglobulins|mesh-list
65725604|NCT04205968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65725605|NCT04205968|Lexatumumab|lexatumumab|mesh-list
65725606|NCT04205968|Calcium|calcium|mesh-list
65725607|NCT04205968|Levoleucovorin|levoleucovorin|mesh-list
65725608|NCT04205968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65725609|NCT04205968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725610|NCT04205968|Tubulin Modulators|tubulin modulators|mesh-ancestor
65725611|NCT04205968|Antimitotic Agents|antimitotic agents|mesh-ancestor
65725612|NCT04205968|Mitosis Modulators|mitosis modulators|mesh-ancestor
65725613|NCT04205968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725614|NCT04205968|Immunologic Factors|immunologic factors|mesh-ancestor
65725615|NCT04205968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725616|NCT04205968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65725617|NCT04205968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65725618|NCT04205968|Antimetabolites|antimetabolites|mesh-ancestor
65725619|NCT04205968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65725620|NCT04205968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65725621|NCT04205968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65725622|NCT04205968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65725623|NCT04205968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725624|NCT04205968|Antidotes|antidotes|mesh-ancestor
65725625|NCT04205968|Protective Agents|protective agents|mesh-ancestor
65725626|NCT04205968|Vitamin B Complex|vitamin b complex|mesh-ancestor
65725627|NCT04205968|Vitamins|vitamins|mesh-ancestor
65725628|NCT04205968|Micronutrients|micronutrients|mesh-ancestor
65725629|NCT04205968|Hematinics|hematinics|mesh-ancestor
65725630|NCT05320575|Zanubrutinib|zanubrutinib|mesh-list
65725631|NCT05320575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725632|NCT05320575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65725633|NCT05320575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725634|NCT05320575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725635|NCT03448731|Doxycycline|doxycycline|mesh-list
65725636|NCT03448731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65725637|NCT03448731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65725638|NCT03448731|Antimalarials|antimalarials|mesh-ancestor
65725639|NCT03448731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65725640|NCT03448731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65725641|NCT04452669|Epoprostenol|epoprostenol|mesh-list
65725642|NCT04452669|Tezosentan|tezosentan|mesh-list
65725643|NCT04452669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65725644|NCT04452669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65725645|NCT04452669|Vasodilator Agents|vasodilator agents|mesh-ancestor
65725646|NCT03719001|Clevidipine|clevidipine|mesh-list
65725647|NCT03719001|Phenylephrine|phenylephrine|mesh-list
65725648|NCT03719001|Oxymetazoline|oxymetazoline|mesh-list
65725649|NCT03719001|Dexmedetomidine|dexmedetomidine|mesh-list
65725650|NCT03719001|Calcium|calcium|mesh-list
65725651|NCT03719001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65725652|NCT03719001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725653|NCT03719001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65725654|NCT03719001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65725655|NCT03719001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65725656|NCT03719001|Analgesics|analgesics|mesh-ancestor
65725657|NCT03719001|Sensory System Agents|sensory system agents|mesh-ancestor
65725658|NCT03719001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65725659|NCT03719001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65725660|NCT03719001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65725661|NCT03719001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65725662|NCT03719001|Adrenergic Agents|adrenergic agents|mesh-ancestor
65725663|NCT03719001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65725664|NCT03719001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725665|NCT03719001|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65725666|NCT03719001|Mydriatics|mydriatics|mesh-ancestor
65725667|NCT03719001|Autonomic Agents|autonomic agents|mesh-ancestor
65725668|NCT03719001|Sympathomimetics|sympathomimetics|mesh-ancestor
65725669|NCT03719001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65725670|NCT03719001|Nasal Decongestants|nasal decongestants|mesh-ancestor
65725671|NCT03719001|Respiratory System Agents|respiratory system agents|mesh-ancestor
65725672|NCT03719001|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65725673|NCT03719001|Protective Agents|protective agents|mesh-ancestor
65725675|NCT03719001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65725676|NCT02500732|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65725677|NCT02500732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65725678|NCT02500732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65725679|NCT02500732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65725680|NCT02500732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725681|NCT02500732|Adrenergic Agents|adrenergic agents|mesh-ancestor
65725682|NCT02500732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65725683|NCT02500732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725684|NCT04965064|Capecitabine|capecitabine|mesh-list
65725685|NCT04965064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65725686|NCT04965064|Antimetabolites|antimetabolites|mesh-ancestor
65725687|NCT04965064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725688|NCT04965064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725689|NCT02499952|Pembrolizumab|pembrolizumab|mesh-list
65725690|NCT02499952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65725691|NCT02499952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725692|NCT04964128|Insulin|insulin|mesh-list
65725693|NCT04964128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65725694|NCT04964128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725695|NCT02498392|JNJ-42165279|jnj-42165279|mesh-list
65725696|NCT02498392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725697|NCT02498392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725698|NCT03205605|Mandelic Acids|mandelic acids|mesh-list
65725699|NCT03205605|Oxybutynin|oxybutynin|mesh-list
65725700|NCT03205605|Parasympatholytics|parasympatholytics|mesh-ancestor
65725701|NCT03205605|Autonomic Agents|autonomic agents|mesh-ancestor
65725702|NCT03205605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65725703|NCT03205605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725704|NCT03205605|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65725705|NCT03205605|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65725706|NCT03205605|Cholinergic Agents|cholinergic agents|mesh-ancestor
65725707|NCT03205605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65725708|NCT03205605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725709|NCT03205605|Urological Agents|urological agents|mesh-ancestor
65725710|NCT03205605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65725711|NCT03205605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65725712|NCT03205605|Renal Agents|renal agents|mesh-ancestor
65725713|NCT05006638|Atropine|atropine|mesh-list
65725714|NCT05006638|Ondansetron|ondansetron|mesh-list
65725715|NCT05006638|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
65725716|NCT05006638|Obidoxime Chloride|obidoxime chloride|mesh-list
65725717|NCT05006638|Antiemetics|antiemetics|mesh-ancestor
65725718|NCT05006638|Autonomic Agents|autonomic agents|mesh-ancestor
65725719|NCT05006638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65725720|NCT05006638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725721|NCT05006638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65725722|NCT05006638|Antipruritics|antipruritics|mesh-ancestor
65725723|NCT05006638|Dermatologic Agents|dermatologic agents|mesh-ancestor
65725724|NCT05006638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65725725|NCT05006638|Serotonin Agents|serotonin agents|mesh-ancestor
65725726|NCT05006638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65725727|NCT05006638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725728|NCT05006638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65725729|NCT05006638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65725730|NCT05006638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65725731|NCT05006638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65725732|NCT05006638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65725733|NCT05006638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65725734|NCT05006638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65725735|NCT05006638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65725736|NCT05006638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65725737|NCT05006638|Respiratory System Agents|respiratory system agents|mesh-ancestor
65725738|NCT05006638|Mydriatics|mydriatics|mesh-ancestor
65725739|NCT05006638|Parasympatholytics|parasympatholytics|mesh-ancestor
65725740|NCT05006638|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65725741|NCT05006638|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65725742|NCT05006638|Cholinergic Agents|cholinergic agents|mesh-ancestor
65725743|NCT05006638|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65725744|NCT05006638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65725745|NCT05006638|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
65725746|NCT05006638|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
65725747|NCT02498236|Oxytocin|oxytocin|mesh-list
65725748|NCT02498236|Oxytocics|oxytocics|mesh-ancestor
65725749|NCT02498236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65725750|NCT02498236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725751|NCT01283997|Minocycline|minocycline|mesh-list
65725752|NCT01283997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65725753|NCT01283997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65725754|NCT02496676|Magnesium Sulfate|magnesium sulfate|mesh-list
65725755|NCT02496676|Analgesics|analgesics|mesh-ancestor
65725756|NCT02496676|Sensory System Agents|sensory system agents|mesh-ancestor
65725757|NCT02496676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65725758|NCT02496676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725759|NCT02496676|Anesthetics|anesthetics|mesh-ancestor
65725760|NCT02496676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65725761|NCT02496676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65725762|NCT02496676|Anticonvulsants|anticonvulsants|mesh-ancestor
65725763|NCT02496676|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65725764|NCT02496676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65725765|NCT02496676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725766|NCT02496676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65725767|NCT02496676|Tocolytic Agents|tocolytic agents|mesh-ancestor
65725768|NCT02496676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65725769|NCT04204252|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65725770|NCT04204252|Protein C Inhibitor|protein c inhibitor|mesh-list
65725771|NCT04204252|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65725772|NCT04204252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65725773|NCT04204252|Protease Inhibitors|protease inhibitors|mesh-ancestor
65725774|NCT04204252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725775|NCT04204252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725776|NCT03800602|Metformin|metformin|mesh-list
65725777|NCT03800602|Nivolumab|nivolumab|mesh-list
65725778|NCT03800602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65725779|NCT03800602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725780|NCT03800602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65725781|NCT03800602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725782|NCT03800602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65725783|NCT03800602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725784|NCT01160211|Trastuzumab|trastuzumab|mesh-list
65725785|NCT01160211|Lapatinib|lapatinib|mesh-list
65725786|NCT01160211|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65725787|NCT01160211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65725788|NCT01160211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725789|NCT01160211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65725790|NCT01160211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725791|NCT01160211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725792|NCT01160211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65725793|NCT01160211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65725794|NCT01160211|Hormone Antagonists|hormone antagonists|mesh-ancestor
65725795|NCT01160211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65725796|NCT01160211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725797|NCT03443271|Bupivacaine|bupivacaine|mesh-list
65725798|NCT03443271|Anesthetics, Local|anesthetics, local|mesh-ancestor
65725799|NCT03443271|Anesthetics|anesthetics|mesh-ancestor
65725800|NCT03443271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65725801|NCT03443271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725802|NCT03443271|Sensory System Agents|sensory system agents|mesh-ancestor
65725803|NCT03443271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65725804|NCT01064687|Metformin|metformin|mesh-list
65725805|NCT01064687|Pioglitazone|pioglitazone|mesh-list
65725806|NCT01064687|Exenatide|exenatide|mesh-list
65725807|NCT01064687|Dulaglutide|dulaglutide|mesh-list
65725808|NCT01064687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65725809|NCT01064687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725810|NCT01064687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65725811|NCT01064687|Incretins|incretins|mesh-ancestor
65725812|NCT01064687|Hormones|hormones|mesh-ancestor
65725813|NCT01064687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65725814|NCT03447873|Lamivudine|lamivudine|mesh-list
65725815|NCT03447873|Cobicistat|cobicistat|mesh-list
65725816|NCT03447873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65725817|NCT03447873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65725818|NCT03447873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725819|NCT03447873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725820|NCT03447873|Antiviral Agents|antiviral agents|mesh-ancestor
65725821|NCT03447873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65725822|NCT03447873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65725823|NCT03447873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65725824|NCT03447873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65725825|NCT03447873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65725826|NCT02493946|Botulinum Toxins|botulinum toxins|mesh-list
65725827|NCT02493946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65725828|NCT02493946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65725829|NCT02493946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65725830|NCT02493946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65725831|NCT02493946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725832|NCT02493946|Cholinergic Agents|cholinergic agents|mesh-ancestor
65725833|NCT02493946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65725834|NCT02493946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725835|NCT02493946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65725836|NCT02493946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65725837|NCT00740805|Cyclophosphamide|cyclophosphamide|mesh-list
65725838|NCT00740805|Doxorubicin|doxorubicin|mesh-list
65725839|NCT00740805|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65725840|NCT00740805|Veliparib|veliparib|mesh-list
65725841|NCT00740805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65725842|NCT00740805|Immunologic Factors|immunologic factors|mesh-ancestor
65725843|NCT00740805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725844|NCT00740805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65725845|NCT00740805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65725846|NCT00740805|Alkylating Agents|alkylating agents|mesh-ancestor
65725847|NCT00740805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725848|NCT00740805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725849|NCT00740805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65725850|NCT00740805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65725851|NCT00740805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65725852|NCT00740805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65725853|NCT00740805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725854|NCT00740805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65725855|NCT03621995|Catalase|catalase|mesh-list
65725856|NCT03621995|Antioxidants|antioxidants|mesh-ancestor
65725857|NCT03621995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725858|NCT03621995|Protective Agents|protective agents|mesh-ancestor
65725859|NCT03621995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725860|NCT03443037|Amantadine|amantadine|mesh-list
65725861|NCT03443037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65725862|NCT03443037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65725863|NCT03443037|Antiviral Agents|antiviral agents|mesh-ancestor
65725864|NCT03443037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65725865|NCT03443037|Dopamine Agents|dopamine agents|mesh-ancestor
65725866|NCT03443037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65725867|NCT03443037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725868|NCT03443037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725869|NCT03443037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65725870|NCT03443037|Analgesics|analgesics|mesh-ancestor
65725871|NCT03443037|Sensory System Agents|sensory system agents|mesh-ancestor
65725872|NCT03443037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65725873|NCT03442491|Hemostatics|hemostatics|mesh-list
65725874|NCT03442491|Coagulants|coagulants|mesh-ancestor
65725875|NCT02918279|Liraglutide|liraglutide|mesh-list
65725876|NCT02918279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65725877|NCT02918279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725878|NCT02918279|Incretins|incretins|mesh-ancestor
65725879|NCT02918279|Hormones|hormones|mesh-ancestor
65725880|NCT02918279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65725881|NCT02956837|Vaccines|vaccines|mesh-list
65725882|NCT02956837|Immunologic Factors|immunologic factors|mesh-ancestor
65725883|NCT02956837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725884|NCT03447093|Methimazole|methimazole|mesh-list
65725885|NCT03447093|Propylthiouracil|propylthiouracil|mesh-list
65725886|NCT03447093|Antithyroid Agents|antithyroid agents|mesh-ancestor
65725887|NCT03447093|Hormone Antagonists|hormone antagonists|mesh-ancestor
65725888|NCT03447093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65725889|NCT03447093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725890|NCT03447093|Antimetabolites|antimetabolites|mesh-ancestor
65725891|NCT03447093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725892|NCT03640351|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65725893|NCT03640351|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65725894|NCT03640351|Hyaluronic Acid|hyaluronic acid|mesh-list
65725895|NCT03640351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65725896|NCT03640351|Immunologic Factors|immunologic factors|mesh-ancestor
65725897|NCT03640351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725898|NCT03640351|Viscosupplements|viscosupplements|mesh-ancestor
65725899|NCT03640351|Protective Agents|protective agents|mesh-ancestor
65725901|NCT03640273|Antipruritics|antipruritics|mesh-ancestor
65725902|NCT03640273|Dermatologic Agents|dermatologic agents|mesh-ancestor
65725903|NCT03640273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65725904|NCT03640273|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65725905|NCT03640273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65725906|NCT03640273|Histamine Antagonists|histamine antagonists|mesh-ancestor
65725907|NCT03640273|Histamine Agents|histamine agents|mesh-ancestor
65725908|NCT03640273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65725909|NCT03640273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725910|NCT03640273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725911|NCT03442023|Chlorhexidine|chlorhexidine|mesh-list
65725912|NCT03442023|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65725913|NCT03442023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65725914|NCT03442023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65725915|NCT03442023|Disinfectants|disinfectants|mesh-ancestor
65725916|NCT03442023|Dermatologic Agents|dermatologic agents|mesh-ancestor
65725917|NCT01063283|Bevacizumab|bevacizumab|mesh-list
65725918|NCT01063283|Carboplatin|carboplatin|mesh-list
65725919|NCT01063283|Pemetrexed|pemetrexed|mesh-list
65725920|NCT01063283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65725921|NCT01063283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725922|NCT01063283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65725923|NCT01063283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65725924|NCT01063283|Growth Substances|growth substances|mesh-ancestor
65725925|NCT01063283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725926|NCT01063283|Growth Inhibitors|growth inhibitors|mesh-ancestor
65725927|NCT01063283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725928|NCT01063283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725929|NCT01063283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65725930|NCT01063283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65725931|NCT01062971|Timolol|timolol|mesh-list
65725932|NCT01062971|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65725933|NCT01062971|Dorzolamide|dorzolamide|mesh-list
65725934|NCT01062971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65725935|NCT01062971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65725936|NCT01062971|Adrenergic Agents|adrenergic agents|mesh-ancestor
65725937|NCT01062971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65725938|NCT01062971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725939|NCT01062971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725940|NCT01062971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65725941|NCT01062971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65725942|NCT01062971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65725943|NCT01062971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65725944|NCT01062971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65725945|NCT01062971|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65725946|NCT01062971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725947|NCT03446937|Dexamethasone|dexamethasone|mesh-list
65725948|NCT03446937|Betamethasone|betamethasone|mesh-list
65725949|NCT03446937|Betamethasone Valerate|betamethasone valerate|mesh-list
65725950|NCT03446937|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65725951|NCT03446937|Betamethasone benzoate|betamethasone benzoate|mesh-list
65725952|NCT03446937|Dexamethasone acetate|dexamethasone acetate|mesh-list
65725953|NCT03446937|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65725954|NCT03446937|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65725955|NCT03446937|BB 1101|bb 1101|mesh-list
65725956|NCT03446937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65725957|NCT03446937|Antiemetics|antiemetics|mesh-ancestor
65725958|NCT03446937|Autonomic Agents|autonomic agents|mesh-ancestor
65725959|NCT03446937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65725960|NCT03446937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725961|NCT03446937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65725962|NCT03446937|Glucocorticoids|glucocorticoids|mesh-ancestor
65725963|NCT03446937|Hormones|hormones|mesh-ancestor
65725964|NCT03446937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65725965|NCT03446937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65725966|NCT03446937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725967|NCT03446937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65725968|NCT03446937|Respiratory System Agents|respiratory system agents|mesh-ancestor
65725969|NCT03446937|Protease Inhibitors|protease inhibitors|mesh-ancestor
65725970|NCT03446937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65725971|NCT03446937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725972|NCT03652493|Carboplatin|carboplatin|mesh-list
65725973|NCT03652493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65725975|NCT03652415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65725976|NCT03652415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65725977|NCT04889079|Contraceptive Agents|contraceptive agents|mesh-list
65725978|NCT04889079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65725979|NCT04889079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725980|NCT02493868|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65725981|NCT02493868|Citalopram|citalopram|mesh-list
65725982|NCT02493868|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65725983|NCT02493868|Sertraline|sertraline|mesh-list
65725984|NCT02493868|Antidepressive Agents|antidepressive agents|mesh-list
65725985|NCT02493868|Esketamine|esketamine|mesh-list
65725986|NCT02493868|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65725987|NCT02493868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65725988|NCT02493868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65725989|NCT02493868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65725990|NCT02493868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65725991|NCT02493868|Serotonin Agents|serotonin agents|mesh-ancestor
65725992|NCT02493868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65725993|NCT02493868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65725994|NCT02493868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65725995|NCT02493868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65725996|NCT02493868|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65725997|NCT02493868|Analgesics|analgesics|mesh-ancestor
65725998|NCT02493868|Sensory System Agents|sensory system agents|mesh-ancestor
65725999|NCT02493868|Dopamine Agents|dopamine agents|mesh-ancestor
65726000|NCT03619057|Anesthetics|anesthetics|mesh-list
65726001|NCT03619057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65726002|NCT03619057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726003|NCT04451655|Insulin|insulin|mesh-list
65726004|NCT04451655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65726005|NCT04451655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726006|NCT03446625|Resveratrol|resveratrol|mesh-list
65726007|NCT03446625|Antioxidants|antioxidants|mesh-ancestor
65726008|NCT03446625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726009|NCT03446625|Protective Agents|protective agents|mesh-ancestor
65726010|NCT03446625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726011|NCT03446625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726012|NCT03446625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65726013|NCT04594005|Paclitaxel|paclitaxel|mesh-list
65726014|NCT04594005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65726015|NCT04594005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726016|NCT04594005|Tubulin Modulators|tubulin modulators|mesh-ancestor
65726017|NCT04594005|Antimitotic Agents|antimitotic agents|mesh-ancestor
65726018|NCT04594005|Mitosis Modulators|mitosis modulators|mesh-ancestor
65726019|NCT04594005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726020|NCT02516410|Ivacaftor|ivacaftor|mesh-list
65726021|NCT02516410|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65726022|NCT02516410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65726023|NCT02516410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726024|NCT04580277|Tofacitinib|tofacitinib|mesh-list
65726025|NCT04580277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65726026|NCT04580277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726027|NCT04580277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726028|NCT02493712|Mesalamine|mesalamine|mesh-list
65726029|NCT02493712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65726030|NCT02493712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65726031|NCT02493712|Analgesics|analgesics|mesh-ancestor
65726032|NCT02493712|Sensory System Agents|sensory system agents|mesh-ancestor
65726033|NCT02493712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65726034|NCT02493712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726035|NCT02493712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65726036|NCT02493712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65726037|NCT03446547|Durvalumab|durvalumab|mesh-list
65726038|NCT03446547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65726039|NCT03446547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726040|NCT02516332|Citalopram|citalopram|mesh-list
65726041|NCT02516332|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65726042|NCT02516332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65726043|NCT02516332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65726044|NCT02516332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726045|NCT02516332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65726046|NCT02516332|Serotonin Agents|serotonin agents|mesh-ancestor
65726047|NCT02516332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726048|NCT02516332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65726049|NCT02516332|Antidepressive Agents|antidepressive agents|mesh-ancestor
65726050|NCT02516332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65726051|NCT03437655|Eugenol|eugenol|mesh-list
65726052|NCT03437655|Zinc Oxide|zinc oxide|mesh-list
65726053|NCT03437655|Dermatologic Agents|dermatologic agents|mesh-ancestor
65726054|NCT03437655|Sunscreening Agents|sunscreening agents|mesh-ancestor
65726055|NCT03437655|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65726056|NCT03437655|Protective Agents|protective agents|mesh-ancestor
65726057|NCT03437655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726058|NCT03437655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65726059|NCT01062425|Temozolomide|temozolomide|mesh-list
65726060|NCT01062425|Cediranib|cediranib|mesh-list
65726061|NCT01062425|Maleic acid|maleic acid|mesh-list
65726062|NCT01062425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65726063|NCT01062425|Alkylating Agents|alkylating agents|mesh-ancestor
65726064|NCT01062425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726065|NCT01062425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726066|NCT01062425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726067|NCT01062425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65726068|NCT03437187|Analgesics|analgesics|mesh-list
65726069|NCT03437187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726070|NCT03437187|Sensory System Agents|sensory system agents|mesh-ancestor
65726071|NCT03437187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65726072|NCT02491684|Interferons|interferons|mesh-list
65726073|NCT02491684|Interferon-beta|interferon-beta|mesh-list
65726074|NCT02491684|Interferon beta-1a|interferon beta-1a|mesh-list
65726075|NCT02491684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726076|NCT02491684|Antiviral Agents|antiviral agents|mesh-ancestor
65726077|NCT02491684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65726078|NCT02491684|Immunologic Factors|immunologic factors|mesh-ancestor
65726079|NCT02491684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726080|NCT02491684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65726081|NCT04752813|Vitamin K|vitamin k|mesh-list
65726082|NCT04752813|Vitamin K 1|vitamin k 1|mesh-list
65726083|NCT04752813|Temozolomide|temozolomide|mesh-list
65726084|NCT04752813|Vitamins|vitamins|mesh-ancestor
65726085|NCT04752813|Micronutrients|micronutrients|mesh-ancestor
65726086|NCT04752813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726087|NCT04752813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65726088|NCT04752813|Alkylating Agents|alkylating agents|mesh-ancestor
65726089|NCT04752813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726090|NCT04752813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726091|NCT04752813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65726092|NCT04752813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65726093|NCT04752813|Hemostatics|hemostatics|mesh-ancestor
65726094|NCT04752813|Coagulants|coagulants|mesh-ancestor
65726095|NCT03445611|Lidocaine|lidocaine|mesh-list
65726096|NCT03445611|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65726097|NCT03445611|Anesthetics, Local|anesthetics, local|mesh-ancestor
65726098|NCT03445611|Anesthetics|anesthetics|mesh-ancestor
65726099|NCT03445611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65726100|NCT03445611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726101|NCT03445611|Sensory System Agents|sensory system agents|mesh-ancestor
65726102|NCT03445611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65726103|NCT03445611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65726104|NCT03445611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65726105|NCT03445611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65726106|NCT03445611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65726107|NCT03445611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726108|NCT04360629|Tranexamic Acid|tranexamic acid|mesh-list
65726109|NCT04360629|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65726110|NCT04360629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65726111|NCT04360629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726112|NCT04360629|Hemostatics|hemostatics|mesh-ancestor
65726113|NCT04360629|Coagulants|coagulants|mesh-ancestor
65726114|NCT04727229|Bupivacaine|bupivacaine|mesh-list
65726115|NCT04727229|Anesthetics, Local|anesthetics, local|mesh-ancestor
65726116|NCT04727229|Anesthetics|anesthetics|mesh-ancestor
65726117|NCT04727229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65726118|NCT04727229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726119|NCT04727229|Sensory System Agents|sensory system agents|mesh-ancestor
65726120|NCT04727229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65726121|NCT03436719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65726122|NCT03436719|Metronidazole|metronidazole|mesh-list
65041872|NCT00470704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726123|NCT03436719|Erythromycin|erythromycin|mesh-list
65726124|NCT03436719|Cefoperazone|cefoperazone|mesh-list
65726125|NCT03436719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65726126|NCT03436719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65726127|NCT03436719|Antitubercular Agents|antitubercular agents|mesh-ancestor
65726128|NCT03436719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65726129|NCT03436719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65726130|NCT03436719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65726131|NCT03436719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65726132|NCT03436719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726133|NCT03436719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726134|NCT01061333|Mometasone Furoate|mometasone furoate|mesh-list
65726135|NCT01061333|Nedocromil|nedocromil|mesh-list
65726136|NCT01061333|Montelukast|montelukast|mesh-list
65726137|NCT01061333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65726138|NCT01061333|Respiratory System Agents|respiratory system agents|mesh-ancestor
65726139|NCT01061333|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65726140|NCT01061333|Hormone Antagonists|hormone antagonists|mesh-ancestor
65188729|NCT04231318|Immunologic Factors|immunologic factors|mesh-ancestor
65726141|NCT01061333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65726142|NCT01061333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726143|NCT01061333|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65726144|NCT01061333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65726145|NCT01061333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726146|NCT01061333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65726147|NCT01061333|Dermatologic Agents|dermatologic agents|mesh-ancestor
65726148|NCT01061333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65726149|NCT01061333|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
65726150|NCT01061333|Immunologic Factors|immunologic factors|mesh-ancestor
65726151|NCT02489968|Empagliflozin|empagliflozin|mesh-list
65726152|NCT02489968|Linagliptin|linagliptin|mesh-list
65726153|NCT02489968|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65726154|NCT02489968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726155|NCT02489968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65726156|NCT02489968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726157|NCT02489968|Incretins|incretins|mesh-ancestor
65726158|NCT02489968|Hormones|hormones|mesh-ancestor
65726159|NCT02489968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65726160|NCT02489968|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65726161|NCT02489968|Protease Inhibitors|protease inhibitors|mesh-ancestor
65726162|NCT02489968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726163|NCT03436173|Fluoxetine|fluoxetine|mesh-list
65726164|NCT03436173|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65726165|NCT03436173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65726166|NCT03436173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65726167|NCT03436173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726168|NCT03436173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65726169|NCT03436173|Serotonin Agents|serotonin agents|mesh-ancestor
65726170|NCT03436173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726171|NCT03436173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65726172|NCT03436173|Antidepressive Agents|antidepressive agents|mesh-ancestor
65726173|NCT03436173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65726174|NCT03436173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65726175|NCT03436173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65726176|NCT03436173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726177|NCT03444831|Buspirone|buspirone|mesh-list
65726178|NCT03444831|Omeprazole|omeprazole|mesh-list
65726179|NCT03444831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65726180|NCT03444831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65726181|NCT03444831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65726182|NCT03444831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726183|NCT03444831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726184|NCT03444831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65726185|NCT03444831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65726186|NCT03444831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65726187|NCT03444831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726188|NCT03444831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65726189|NCT03444831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65726190|NCT03444831|Serotonin Agents|serotonin agents|mesh-ancestor
65726191|NCT03444831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65726192|NCT02481934|Lenalidomide|lenalidomide|mesh-list
65726193|NCT02481934|Bortezomib|bortezomib|mesh-list
65726194|NCT02481934|Immunologic Factors|immunologic factors|mesh-ancestor
65726195|NCT02481934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041950|NCT00195767|Valproic Acid|valproic acid|mesh-list
65726196|NCT02481934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65726197|NCT02481934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65726198|NCT02481934|Growth Substances|growth substances|mesh-ancestor
65726199|NCT02481934|Growth Inhibitors|growth inhibitors|mesh-ancestor
65726200|NCT02481934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726202|NCT03444519|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65726203|NCT03444519|Diuretics|diuretics|mesh-ancestor
65726204|NCT03444519|Natriuretic Agents|natriuretic agents|mesh-ancestor
65726205|NCT03444519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726206|NCT03129009|Anesthetics|anesthetics|mesh-list
65726207|NCT03129009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65726208|NCT03129009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726209|NCT02489500|Bortezomib|bortezomib|mesh-list
65726210|NCT02489500|Melphalan|melphalan|mesh-list
65726211|NCT02489500|Lenograstim|lenograstim|mesh-list
65726212|NCT02489500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726213|NCT02489500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65726214|NCT02489500|Alkylating Agents|alkylating agents|mesh-ancestor
65726215|NCT02489500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726216|NCT02489500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65726217|NCT02489500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65726218|NCT02489500|Immunologic Factors|immunologic factors|mesh-ancestor
65726219|NCT02489500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726220|NCT02489500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65726221|NCT04053959|Insulin|insulin|mesh-list
65726222|NCT04053959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65726223|NCT04053959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65726224|NCT04053959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726225|NCT03652571|Nortriptyline|nortriptyline|mesh-list
65726226|NCT03652571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65726227|NCT03652571|Antidepressive Agents|antidepressive agents|mesh-ancestor
65726228|NCT03652571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65726229|NCT03652571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65726230|NCT03652571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65726231|NCT03652571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65726232|NCT03652571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726233|NCT03652571|Adrenergic Agents|adrenergic agents|mesh-ancestor
65726234|NCT03652571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65726235|NCT03652571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726236|NCT03652103|Bupivacaine|bupivacaine|mesh-list
65726237|NCT03652103|Anesthetics, Local|anesthetics, local|mesh-ancestor
65726238|NCT03652103|Anesthetics|anesthetics|mesh-ancestor
65726239|NCT03652103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65726240|NCT03652103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726241|NCT03652103|Sensory System Agents|sensory system agents|mesh-ancestor
65726242|NCT03652103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65726243|NCT03651947|Denosumab|denosumab|mesh-list
65726244|NCT03651947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65726245|NCT03651947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726246|NCT03651557|Salicylates|salicylates|mesh-list
65726247|NCT03651557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65726248|NCT03651557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65726249|NCT03651557|Analgesics|analgesics|mesh-ancestor
65726250|NCT03651557|Sensory System Agents|sensory system agents|mesh-ancestor
65726251|NCT03651557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65726252|NCT03651557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726253|NCT03651557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65726254|NCT03651557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65726255|NCT03651557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65726256|NCT03651557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726257|NCT03651557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726258|NCT03432975|Povidone-Iodine|povidone-iodine|mesh-list
65726259|NCT03432975|Povidone|povidone|mesh-list
65726260|NCT03432975|Plasma Substitutes|plasma substitutes|mesh-ancestor
65726261|NCT03432975|Blood Substitutes|blood substitutes|mesh-ancestor
65726262|NCT03432975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65726263|NCT03432975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65726264|NCT04953130|Vaccines|vaccines|mesh-list
65726265|NCT04953130|Immunologic Factors|immunologic factors|mesh-ancestor
65726266|NCT04953130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726267|NCT02488330|Bevacizumab|bevacizumab|mesh-list
65726268|NCT02488330|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65726269|NCT02488330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65726270|NCT02488330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726271|NCT02488330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65726272|NCT02488330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65726273|NCT02488330|Growth Substances|growth substances|mesh-ancestor
65726274|NCT02488330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726275|NCT02488330|Growth Inhibitors|growth inhibitors|mesh-ancestor
65726276|NCT02488330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65726277|NCT02488330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726278|NCT02488330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726279|NCT03432663|Amiodarone|amiodarone|mesh-list
65726280|NCT03432663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65726281|NCT03432663|Vasodilator Agents|vasodilator agents|mesh-ancestor
65726282|NCT03432663|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65726283|NCT03432663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65726284|NCT03432663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726285|NCT03432663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65726286|NCT03432663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65726287|NCT03432663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65726288|NCT03432663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726289|NCT03432663|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65726290|NCT03432663|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65726291|NCT03432663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65726292|NCT04266795|Azacitidine|azacitidine|mesh-list
65726293|NCT04266795|Venetoclax|venetoclax|mesh-list
65726294|NCT04266795|Pevonedistat|pevonedistat|mesh-list
65726295|NCT04266795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65726296|NCT04266795|Antimetabolites|antimetabolites|mesh-ancestor
65726297|NCT04266795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726298|NCT04266795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726299|NCT04266795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726300|NCT03432273|Nicotine|nicotine|mesh-list
65726301|NCT03432273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65726302|NCT03432273|Autonomic Agents|autonomic agents|mesh-ancestor
65726303|NCT03432273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65726304|NCT03432273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726305|NCT03432273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65726306|NCT03432273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65726307|NCT03432273|Cholinergic Agents|cholinergic agents|mesh-ancestor
65726308|NCT03432273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65726309|NCT03432273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726310|NCT02481310|Cytarabine|cytarabine|mesh-list
65726311|NCT02481310|Prednisone|prednisone|mesh-list
65726312|NCT02481310|Hydrocortisone|hydrocortisone|mesh-list
65726313|NCT02481310|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65726314|NCT02481310|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65726315|NCT02481310|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65726316|NCT02481310|Cortisone|cortisone|mesh-list
65726317|NCT02481310|Cyclophosphamide|cyclophosphamide|mesh-list
65726318|NCT02481310|Rituximab|rituximab|mesh-list
65726319|NCT02481310|Doxorubicin|doxorubicin|mesh-list
65726320|NCT02481310|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65726321|NCT02481310|Methotrexate|methotrexate|mesh-list
65726322|NCT02481310|Etoposide|etoposide|mesh-list
65726323|NCT02481310|Vincristine|vincristine|mesh-list
65726324|NCT02481310|Etoposide phosphate|etoposide phosphate|mesh-list
65726325|NCT02481310|Ixazomib|ixazomib|mesh-list
65726326|NCT02481310|Podophyllotoxin|podophyllotoxin|mesh-list
65726327|NCT02481310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65726328|NCT02481310|Antibodies|antibodies|mesh-list
65726329|NCT02481310|Immunoglobulins|immunoglobulins|mesh-list
65726330|NCT02481310|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65726331|NCT02481310|Glycine|glycine|mesh-list
65726332|NCT02481310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65726333|NCT02481310|Immunologic Factors|immunologic factors|mesh-ancestor
65726334|NCT02481310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726335|NCT02481310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65726336|NCT02481310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65726337|NCT02481310|Alkylating Agents|alkylating agents|mesh-ancestor
65726338|NCT02481310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726339|NCT02481310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726340|NCT02481310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65726341|NCT02481310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65726342|NCT02481310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65726343|NCT02481310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65726344|NCT02481310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042098|NCT00202553|Perindopril|perindopril|mesh-list
65726345|NCT02481310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65726346|NCT02481310|Glucocorticoids|glucocorticoids|mesh-ancestor
65726348|NCT02481310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65726349|NCT02481310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65726350|NCT02481310|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65726351|NCT02481310|Abortifacient Agents|abortifacient agents|mesh-ancestor
65726352|NCT02481310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65726353|NCT02481310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65726354|NCT02481310|Antimetabolites|antimetabolites|mesh-ancestor
65726355|NCT02481310|Dermatologic Agents|dermatologic agents|mesh-ancestor
65726356|NCT02481310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65726357|NCT02481310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65726358|NCT02481310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65726359|NCT02481310|Antiviral Agents|antiviral agents|mesh-ancestor
65726360|NCT02481310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65726361|NCT02481310|Tubulin Modulators|tubulin modulators|mesh-ancestor
65726362|NCT02481310|Antimitotic Agents|antimitotic agents|mesh-ancestor
65726363|NCT02481310|Mitosis Modulators|mitosis modulators|mesh-ancestor
65726364|NCT02481310|Protease Inhibitors|protease inhibitors|mesh-ancestor
65726365|NCT02481310|Keratolytic Agents|keratolytic agents|mesh-ancestor
65726366|NCT02481310|Glycine Agents|glycine agents|mesh-ancestor
65726367|NCT02481310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65726368|NCT03432195|Donepezil|donepezil|mesh-list
65726369|NCT03432195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65726370|NCT03432195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726371|NCT03432195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726372|NCT03432195|Cholinergic Agents|cholinergic agents|mesh-ancestor
65726373|NCT03432195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65726374|NCT03432195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726375|NCT03432195|Nootropic Agents|nootropic agents|mesh-ancestor
65726376|NCT03431961|Triamcinolone|triamcinolone|mesh-list
65726377|NCT03431961|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65726378|NCT03431961|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65726379|NCT03431961|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65726380|NCT03431961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65726381|NCT03431961|Glucocorticoids|glucocorticoids|mesh-ancestor
65726382|NCT03431961|Hormones|hormones|mesh-ancestor
65726383|NCT03431961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65726384|NCT03431961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726385|NCT03431961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65726386|NCT03431961|Immunologic Factors|immunologic factors|mesh-ancestor
65726387|NCT03431961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726388|NCT03431961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726389|NCT02480764|Valsartan|valsartan|mesh-list
65726390|NCT02480764|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65726391|NCT02480764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65726392|NCT02480764|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65726393|NCT02480764|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65726394|NCT02480764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726395|NCT03434691|Remifentanil|remifentanil|mesh-list
65726396|NCT03434691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65726397|NCT03434691|Narcotics|narcotics|mesh-ancestor
65726398|NCT03434691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65726399|NCT03434691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726400|NCT03434691|Analgesics|analgesics|mesh-ancestor
65726401|NCT03434691|Sensory System Agents|sensory system agents|mesh-ancestor
65726402|NCT03434691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65726403|NCT03434613|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65726404|NCT03434613|Ezetimibe|ezetimibe|mesh-list
65726405|NCT03434613|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65726406|NCT03434613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65726407|NCT03434613|Antimetabolites|antimetabolites|mesh-ancestor
65726408|NCT03434613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726409|NCT03434613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65726410|NCT03434613|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65726411|NCT03434613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726412|NCT04953052|Imatinib Mesylate|imatinib mesylate|mesh-list
65726413|NCT04953052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726414|NCT04953052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65726415|NCT04953052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726416|NCT04953052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726417|NCT03428685|Dydrogesterone|dydrogesterone|mesh-list
65726418|NCT03428685|Progestins|progestins|mesh-ancestor
65726419|NCT03428685|Hormones|hormones|mesh-ancestor
65042183|NCT00202982|(T,G)-A-L|(t,g)-a-l|mesh-list
65726420|NCT03428685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65726421|NCT03428685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726423|NCT05665647|Itraconazole|itraconazole|mesh-list
65726424|NCT05665647|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
65726425|NCT05665647|Rifampin|rifampin|mesh-list
65726426|NCT05665647|Midazolam|midazolam|mesh-list
65726427|NCT05665647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65726428|NCT05665647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65726429|NCT05665647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65726430|NCT05665647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726431|NCT05665647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65726432|NCT05665647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65726433|NCT05665647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65726434|NCT05665647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65726435|NCT05665647|Anesthetics, General|anesthetics, general|mesh-ancestor
65726436|NCT05665647|Anesthetics|anesthetics|mesh-ancestor
65726437|NCT05665647|GABA Modulators|gaba modulators|mesh-ancestor
65726438|NCT05665647|GABA Agents|gaba agents|mesh-ancestor
65726439|NCT05665647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65726440|NCT05665647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726441|NCT05665647|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65726442|NCT05665647|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65726443|NCT05665647|Protease Inhibitors|protease inhibitors|mesh-ancestor
65726444|NCT05665647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726445|NCT05665647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65726446|NCT05665647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65726447|NCT05665647|Antiviral Agents|antiviral agents|mesh-ancestor
65726448|NCT05665647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65726449|NCT05665647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65726450|NCT05665647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65726451|NCT05665647|Antifungal Agents|antifungal agents|mesh-ancestor
65726452|NCT05665647|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65726453|NCT05665647|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65726454|NCT05665647|Hormone Antagonists|hormone antagonists|mesh-ancestor
65726455|NCT05665647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65726456|NCT05665647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65726457|NCT05665647|Antitubercular Agents|antitubercular agents|mesh-ancestor
65726458|NCT05665647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65726459|NCT05665647|Leprostatic Agents|leprostatic agents|mesh-ancestor
65726460|NCT05665647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65726461|NCT05665647|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65726462|NCT05665647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65726463|NCT05665647|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65726464|NCT05665647|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65726465|NCT05665647|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65726466|NCT05665647|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65726467|NCT03943173|Olaparib|olaparib|mesh-list
65726468|NCT03943173|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65726469|NCT03943173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726470|NCT03943173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726471|NCT03943173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726472|NCT04941196|Ticagrelor|ticagrelor|mesh-list
65726473|NCT04941196|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65726474|NCT04941196|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65726475|NCT04941196|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65726476|NCT04941196|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65726477|NCT04941196|Purinergic Agents|purinergic agents|mesh-ancestor
65726478|NCT04941196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65726479|NCT04941196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726480|NCT04941196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726481|NCT03431805|Tranexamic Acid|tranexamic acid|mesh-list
65726482|NCT03431805|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65726483|NCT03431805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65726484|NCT03431805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726485|NCT03431805|Hemostatics|hemostatics|mesh-ancestor
65726486|NCT03431805|Coagulants|coagulants|mesh-ancestor
65726487|NCT03428607|Olaparib|olaparib|mesh-list
65726488|NCT03428607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65726489|NCT03428607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726490|NCT03428607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042252|NCT00203099|Acetylcysteine|acetylcysteine|mesh-list
65726491|NCT03428607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726492|NCT02521233|Losartan|losartan|mesh-list
65726493|NCT02521233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65726494|NCT02521233|Candesartan|candesartan|mesh-list
65726495|NCT02521233|Candesartan cilexetil|candesartan cilexetil|mesh-list
65726496|NCT02521233|Chlorthalidone|chlorthalidone|mesh-list
65726497|NCT02521233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65726498|NCT02521233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65726499|NCT02521233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65726500|NCT02521233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65726501|NCT02521233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726502|NCT02521233|Diuretics|diuretics|mesh-ancestor
65726503|NCT02521233|Natriuretic Agents|natriuretic agents|mesh-ancestor
65726504|NCT02521233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726505|NCT02521233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65726506|NCT02521233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65726507|NCT03428529|Fluorouracil|fluorouracil|mesh-list
65726508|NCT03428529|Capecitabine|capecitabine|mesh-list
65726509|NCT03428529|Antimetabolites|antimetabolites|mesh-ancestor
65726510|NCT03428529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726511|NCT03428529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65726512|NCT03428529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726513|NCT03428529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65726514|NCT03428529|Immunologic Factors|immunologic factors|mesh-ancestor
65726515|NCT03428529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726516|NCT03431649|Sildenafil Citrate|sildenafil citrate|mesh-list
65726517|NCT03431649|Beraprost|beraprost|mesh-list
65726518|NCT03431649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726519|NCT03431649|Vasodilator Agents|vasodilator agents|mesh-ancestor
65726520|NCT03431649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65726521|NCT03431649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65726522|NCT03431649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726523|NCT03431649|Urological Agents|urological agents|mesh-ancestor
65726524|NCT03431649|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65726525|NCT04450095|Ambrisentan|ambrisentan|mesh-list
65726526|NCT04450095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65726527|NCT03101475|Durvalumab|durvalumab|mesh-list
65726528|NCT03101475|Tremelimumab|tremelimumab|mesh-list
65726529|NCT03101475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65726530|NCT03101475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726531|NCT01060007|Leucovorin|leucovorin|mesh-list
65726532|NCT01060007|Fluorouracil|fluorouracil|mesh-list
65726533|NCT01060007|Capecitabine|capecitabine|mesh-list
65726534|NCT01060007|Oxaliplatin|oxaliplatin|mesh-list
65726535|NCT01060007|Antimetabolites|antimetabolites|mesh-ancestor
65726536|NCT01060007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726537|NCT01060007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65726538|NCT01060007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726539|NCT01060007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65726540|NCT01060007|Immunologic Factors|immunologic factors|mesh-ancestor
65726541|NCT01060007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726542|NCT01060007|Antidotes|antidotes|mesh-ancestor
65726543|NCT01060007|Protective Agents|protective agents|mesh-ancestor
65726544|NCT01060007|Vitamin B Complex|vitamin b complex|mesh-ancestor
65726545|NCT01060007|Vitamins|vitamins|mesh-ancestor
65726546|NCT01060007|Micronutrients|micronutrients|mesh-ancestor
65726547|NCT04175925|Famotidine|famotidine|mesh-list
65726548|NCT04175925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65726549|NCT04175925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65726550|NCT04175925|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65726551|NCT04175925|Histamine Antagonists|histamine antagonists|mesh-ancestor
65726552|NCT04175925|Histamine Agents|histamine agents|mesh-ancestor
65726553|NCT04175925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65726554|NCT04175925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726555|NCT04175925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726556|NCT02971007|Fluconazole|fluconazole|mesh-list
65726557|NCT02971007|Amphotericin B|amphotericin b|mesh-list
65726558|NCT02971007|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65726559|NCT02971007|Antifungal Agents|antifungal agents|mesh-ancestor
65726560|NCT02971007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65726561|NCT02971007|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65726562|NCT02971007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65726563|NCT02971007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726564|NCT02971007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726565|NCT02971007|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65726566|NCT02971007|Hormone Antagonists|hormone antagonists|mesh-ancestor
65726567|NCT02971007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65726568|NCT02971007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726569|NCT02971007|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65726570|NCT02971007|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65726571|NCT02971007|Amebicides|amebicides|mesh-ancestor
65726572|NCT02971007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65726573|NCT02971007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65726574|NCT02971007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65726575|NCT02983461|Sildenafil Citrate|sildenafil citrate|mesh-list
65726576|NCT02983461|Vasodilator Agents|vasodilator agents|mesh-ancestor
65726577|NCT02983461|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65726578|NCT02983461|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65726579|NCT02983461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726580|NCT02983461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726581|NCT02983461|Urological Agents|urological agents|mesh-ancestor
65726582|NCT03428139|Thioctic Acid|thioctic acid|mesh-list
65726583|NCT03428139|Antioxidants|antioxidants|mesh-ancestor
65726584|NCT03428139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726585|NCT03428139|Protective Agents|protective agents|mesh-ancestor
65726586|NCT03428139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726587|NCT03428139|Vitamin B Complex|vitamin b complex|mesh-ancestor
65726588|NCT03428139|Vitamins|vitamins|mesh-ancestor
65726589|NCT03428139|Micronutrients|micronutrients|mesh-ancestor
65726590|NCT03650543|Amoxicillin|amoxicillin|mesh-list
65726591|NCT03650543|Clarithromycin|clarithromycin|mesh-list
65726592|NCT03650543|Omeprazole|omeprazole|mesh-list
65726593|NCT03650543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65726594|NCT03650543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65726595|NCT03650543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65726596|NCT03650543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65726597|NCT03650543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65726598|NCT03650543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726599|NCT03650543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726600|NCT03650543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65726601|NCT03650543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65726602|NCT03650543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65726603|NCT03650777|Warfarin|warfarin|mesh-list
65726604|NCT03650777|Anticoagulants|anticoagulants|mesh-ancestor
65726605|NCT02970305|Pimavanserin|pimavanserin|mesh-list
65726606|NCT02970305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65726607|NCT02970305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65726608|NCT02970305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65726609|NCT02970305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65726610|NCT02970305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65726611|NCT02970305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726612|NCT02970305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65726613|NCT02970305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65726614|NCT02970305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65726615|NCT02970305|Serotonin Agents|serotonin agents|mesh-ancestor
65726616|NCT02970305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65726617|NCT02970305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726618|NCT03649763|Lidocaine|lidocaine|mesh-list
65726619|NCT03649763|Bupivacaine|bupivacaine|mesh-list
65726620|NCT03649763|Anesthetics, Local|anesthetics, local|mesh-ancestor
65726621|NCT03649763|Anesthetics|anesthetics|mesh-ancestor
65726622|NCT03649763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65726623|NCT03649763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726624|NCT03649763|Sensory System Agents|sensory system agents|mesh-ancestor
65726625|NCT03649763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65726626|NCT03649763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65726627|NCT03649763|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65726628|NCT03649763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65726629|NCT03649763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65726630|NCT03649763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726631|NCT03427437|Epinephrine|epinephrine|mesh-list
65726632|NCT03427437|Racepinephrine|racepinephrine|mesh-list
65726633|NCT03427437|Bupivacaine|bupivacaine|mesh-list
65726634|NCT03427437|Epinephryl borate|epinephryl borate|mesh-list
65726635|NCT03427437|Anesthetics, Local|anesthetics, local|mesh-ancestor
65726636|NCT03427437|Anesthetics|anesthetics|mesh-ancestor
65726637|NCT03427437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65726638|NCT03427437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726639|NCT03427437|Sensory System Agents|sensory system agents|mesh-ancestor
65726640|NCT03427437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65726641|NCT03427437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65726642|NCT03427437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65726643|NCT03427437|Adrenergic Agents|adrenergic agents|mesh-ancestor
65726644|NCT03427437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65726645|NCT03427437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726646|NCT03427437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65726647|NCT03427437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65726648|NCT03427437|Autonomic Agents|autonomic agents|mesh-ancestor
65726649|NCT03427437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65726650|NCT03427437|Respiratory System Agents|respiratory system agents|mesh-ancestor
65726651|NCT03427437|Mydriatics|mydriatics|mesh-ancestor
65726652|NCT03427437|Sympathomimetics|sympathomimetics|mesh-ancestor
65726653|NCT03427437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65726654|NCT03427359|Capecitabine|capecitabine|mesh-list
65726655|NCT03427359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726656|NCT03427359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65726657|NCT03427359|Antimetabolites|antimetabolites|mesh-ancestor
65726658|NCT03427359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726659|NCT05053659|Venetoclax|venetoclax|mesh-list
65726660|NCT05053659|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
65726661|NCT05053659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726662|NCT05053659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65726663|NCT03423537|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65726664|NCT03423537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65726665|NCT03423537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726666|NCT03648125|Salicylic Acid|salicylic acid|mesh-list
65726667|NCT03648125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65726668|NCT03648125|Antifungal Agents|antifungal agents|mesh-ancestor
65726669|NCT03648125|Keratolytic Agents|keratolytic agents|mesh-ancestor
65726670|NCT03648125|Dermatologic Agents|dermatologic agents|mesh-ancestor
65726671|NCT03423225|Tacrolimus|tacrolimus|mesh-list
65726672|NCT03423225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65726673|NCT03423225|Immunologic Factors|immunologic factors|mesh-ancestor
65726674|NCT03423225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726675|NCT03423225|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65726676|NCT03423225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726677|NCT03423225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726678|NCT02521077|Ascorbic Acid|ascorbic acid|mesh-list
65726679|NCT02521077|Vitamins|vitamins|mesh-ancestor
65726680|NCT02521077|Micronutrients|micronutrients|mesh-ancestor
65726681|NCT02521077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726682|NCT02521077|Antioxidants|antioxidants|mesh-ancestor
65726683|NCT02521077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726684|NCT02521077|Protective Agents|protective agents|mesh-ancestor
65726685|NCT03564093|Dexmedetomidine|dexmedetomidine|mesh-list
65726686|NCT03564093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65726687|NCT03564093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65726688|NCT03564093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726689|NCT03564093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65726690|NCT03564093|Analgesics|analgesics|mesh-ancestor
65726691|NCT03564093|Sensory System Agents|sensory system agents|mesh-ancestor
65726692|NCT03564093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65726693|NCT03564093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65726694|NCT03564093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65726695|NCT03564093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65726696|NCT03564093|Adrenergic Agents|adrenergic agents|mesh-ancestor
65726697|NCT03564093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65726698|NCT03564093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726699|NCT03429621|Simethicone|simethicone|mesh-list
65726700|NCT03429621|Antifoaming Agents|antifoaming agents|mesh-ancestor
65726701|NCT03429621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726702|NCT03429621|Emollients|emollients|mesh-ancestor
65726703|NCT03429621|Dermatologic Agents|dermatologic agents|mesh-ancestor
65726704|NCT03426969|Mycophenolic Acid|mycophenolic acid|mesh-list
65726705|NCT03426969|Cyclophosphamide|cyclophosphamide|mesh-list
65726706|NCT03426969|Melphalan|melphalan|mesh-list
65726707|NCT03426969|Mechlorethamine|mechlorethamine|mesh-list
65726708|NCT03426969|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65726709|NCT03426969|Fludarabine|fludarabine|mesh-list
65726710|NCT03426969|Fludarabine phosphate|fludarabine phosphate|mesh-list
65726711|NCT03426969|Tacrolimus|tacrolimus|mesh-list
65726712|NCT03426969|Lenograstim|lenograstim|mesh-list
65726713|NCT03426969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65726714|NCT03426969|Immunologic Factors|immunologic factors|mesh-ancestor
65726715|NCT03426969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726716|NCT03426969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65042485|NCT00410657|Prednisone|prednisone|mesh-list
65726717|NCT03426969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65726718|NCT03426969|Alkylating Agents|alkylating agents|mesh-ancestor
65726719|NCT03426969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726720|NCT03426969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726721|NCT03426969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65726722|NCT03426969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65726723|NCT03426969|Antimetabolites|antimetabolites|mesh-ancestor
65726724|NCT03426969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65726725|NCT03426969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65726726|NCT03426969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726727|NCT03426969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65726728|NCT03426969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65726729|NCT03426969|Antitubercular Agents|antitubercular agents|mesh-ancestor
65726730|NCT03426969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65726731|NCT03426969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65726732|NCT03422445|Temozolomide|temozolomide|mesh-list
65726733|NCT03422445|Apatinib|apatinib|mesh-list
65726734|NCT03422445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65726735|NCT03422445|Alkylating Agents|alkylating agents|mesh-ancestor
65726736|NCT03422445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726737|NCT03422445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726738|NCT03422445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65726739|NCT03422445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726740|NCT03429309|Propofol|propofol|mesh-list
65726741|NCT03429309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65726742|NCT03429309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65726743|NCT03429309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726744|NCT03429309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65726745|NCT03429309|Anesthetics, General|anesthetics, general|mesh-ancestor
65726746|NCT03429309|Anesthetics|anesthetics|mesh-ancestor
65726747|NCT03429075|Citalopram|citalopram|mesh-list
65726748|NCT03429075|Psilocybin|psilocybin|mesh-list
65726749|NCT03429075|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65726750|NCT03429075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65726751|NCT03429075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65726752|NCT03429075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726753|NCT03429075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65726754|NCT03429075|Serotonin Agents|serotonin agents|mesh-ancestor
65726755|NCT03429075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726756|NCT03429075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65726757|NCT03429075|Antidepressive Agents|antidepressive agents|mesh-ancestor
65726758|NCT03429075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65726759|NCT03429075|Hallucinogens|hallucinogens|mesh-ancestor
65726760|NCT03422289|Folic Acid|folic acid|mesh-list
65726761|NCT03422289|Vitamin B Complex|vitamin b complex|mesh-list
65726762|NCT03422289|Inositol|inositol|mesh-list
65726763|NCT03422289|Hematinics|hematinics|mesh-ancestor
65726764|NCT03422289|Vitamins|vitamins|mesh-ancestor
65726765|NCT03422289|Micronutrients|micronutrients|mesh-ancestor
65726766|NCT03422289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726767|NCT03422055|Fucoidan|fucoidan|mesh-list
65726768|NCT03422055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65726769|NCT03422055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65726770|NCT03422055|Anticoagulants|anticoagulants|mesh-ancestor
65726771|NCT03422055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726772|NCT04449471|Naproxen|naproxen|mesh-list
65726773|NCT04449471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65726774|NCT04449471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65726775|NCT04449471|Analgesics|analgesics|mesh-ancestor
65726776|NCT04449471|Sensory System Agents|sensory system agents|mesh-ancestor
65726777|NCT04449471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65726778|NCT04449471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726779|NCT04449471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65726780|NCT04449471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65726781|NCT04449471|Gout Suppressants|gout suppressants|mesh-ancestor
65726782|NCT04449471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65726783|NCT04449471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726784|NCT04449471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726785|NCT03127371|Nitrous Oxide|nitrous oxide|mesh-list
65726786|NCT03127371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65726787|NCT03127371|Anesthetics, General|anesthetics, general|mesh-ancestor
65726788|NCT03127371|Anesthetics|anesthetics|mesh-ancestor
65726789|NCT03127371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65726790|NCT03127371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726791|NCT03127371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65726792|NCT03127371|Analgesics|analgesics|mesh-ancestor
65726793|NCT03127371|Sensory System Agents|sensory system agents|mesh-ancestor
65726794|NCT03127371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65726795|NCT03421821|Ropivacaine|ropivacaine|mesh-list
65726796|NCT03421821|Anesthetics, Local|anesthetics, local|mesh-ancestor
65726797|NCT03421821|Anesthetics|anesthetics|mesh-ancestor
65726798|NCT03421821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65726799|NCT03421821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726800|NCT03421821|Sensory System Agents|sensory system agents|mesh-ancestor
65726801|NCT03421821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65726802|NCT03421743|Molgramostim|molgramostim|mesh-list
65726803|NCT03421743|Sargramostim|sargramostim|mesh-list
65726804|NCT03421743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726805|NCT03421743|Immunologic Factors|immunologic factors|mesh-ancestor
65726806|NCT03421743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726807|NCT01103349|Montelukast|montelukast|mesh-list
65726808|NCT01103349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65726809|NCT01103349|Respiratory System Agents|respiratory system agents|mesh-ancestor
65726810|NCT01103349|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65726811|NCT01103349|Hormone Antagonists|hormone antagonists|mesh-ancestor
65726812|NCT01103349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65726813|NCT01103349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726814|NCT01103349|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65726815|NCT01103349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65726816|NCT01103349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726817|NCT03421275|Fentanyl|fentanyl|mesh-list
65726818|NCT03421275|Esketamine|esketamine|mesh-list
65726819|NCT03421275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65726820|NCT03421275|Narcotics|narcotics|mesh-ancestor
65726821|NCT03421275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65726822|NCT03421275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726823|NCT03421275|Analgesics|analgesics|mesh-ancestor
65726824|NCT03421275|Sensory System Agents|sensory system agents|mesh-ancestor
65726825|NCT03421275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65726826|NCT03421275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65726827|NCT03421275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65726828|NCT03421275|Anesthetics, General|anesthetics, general|mesh-ancestor
65726829|NCT03421275|Anesthetics|anesthetics|mesh-ancestor
65726830|NCT03421275|Antidepressive Agents|antidepressive agents|mesh-ancestor
65726831|NCT03421275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65726832|NCT03416517|Irinotecan|irinotecan|mesh-list
65726833|NCT03416517|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65726834|NCT03416517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65726835|NCT03416517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726836|NCT03416517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726837|NCT03416517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726838|NCT03421119|Insulin|insulin|mesh-list
65726839|NCT03421119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65726840|NCT03421119|Metformin|metformin|mesh-list
65726841|NCT03421119|Liraglutide|liraglutide|mesh-list
65726842|NCT03421119|Secretagogues|secretagogues|mesh-list
65726843|NCT03421119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65726844|NCT03421119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726845|NCT03421119|Incretins|incretins|mesh-ancestor
65726846|NCT03421119|Hormones|hormones|mesh-ancestor
65726847|NCT03421119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65726848|NCT03426033|Warfarin|warfarin|mesh-list
65726849|NCT03426033|Anticoagulants|anticoagulants|mesh-ancestor
65726850|NCT02451423|Atezolizumab|atezolizumab|mesh-list
65726851|NCT02451423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726852|NCT02432547|Aflibercept|aflibercept|mesh-list
65726853|NCT02432547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65726854|NCT02432547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65726855|NCT02432547|Growth Substances|growth substances|mesh-ancestor
65726856|NCT02432547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726857|NCT02432547|Growth Inhibitors|growth inhibitors|mesh-ancestor
65726858|NCT02432547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726859|NCT02345733|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65726860|NCT02345733|Amoxicillin|amoxicillin|mesh-list
65726861|NCT02345733|Metronidazole|metronidazole|mesh-list
65726862|NCT02345733|Doxycycline|doxycycline|mesh-list
65726863|NCT02345733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65726864|NCT02345733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65726865|NCT02345733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65726866|NCT02345733|Antimalarials|antimalarials|mesh-ancestor
65726867|NCT03415269|Ambroxol|ambroxol|mesh-list
65726868|NCT03415269|Expectorants|expectorants|mesh-ancestor
65726869|NCT03415269|Respiratory System Agents|respiratory system agents|mesh-ancestor
65726870|NCT03618589|Pregabalin|pregabalin|mesh-list
65726871|NCT03618589|Analgesics|analgesics|mesh-ancestor
65726872|NCT03618589|Sensory System Agents|sensory system agents|mesh-ancestor
65726873|NCT03618589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65726874|NCT03618589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726876|NCT03618589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65726877|NCT03618589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65726878|NCT03618589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726879|NCT03618589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65726880|NCT03618589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65726881|NCT03618589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65726882|NCT03618589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65726883|NCT03618589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65726884|NCT03127449|Aflutinib|aflutinib|mesh-list
65726885|NCT03127449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65726886|NCT03127449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65726887|NCT03127449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726888|NCT02521155|Fenbendazole|fenbendazole|mesh-list
65726889|NCT02521155|Antinematodal Agents|antinematodal agents|mesh-ancestor
65726890|NCT02521155|Anthelmintics|anthelmintics|mesh-ancestor
65726891|NCT02521155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65726892|NCT02521155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65726893|NCT03415191|Ketamine|ketamine|mesh-list
65726894|NCT03415191|Analgesics|analgesics|mesh-ancestor
65726895|NCT03415191|Sensory System Agents|sensory system agents|mesh-ancestor
65726896|NCT03415191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65726897|NCT03415191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726898|NCT03415191|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65726899|NCT03415191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65726900|NCT03415191|Anesthetics, General|anesthetics, general|mesh-ancestor
65726901|NCT03415191|Anesthetics|anesthetics|mesh-ancestor
65726902|NCT03415191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65726903|NCT03415191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65726904|NCT03415191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65726905|NCT03415191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65726906|NCT03415191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726907|NCT03419949|Pregabalin|pregabalin|mesh-list
65726908|NCT03419949|Lamotrigine|lamotrigine|mesh-list
65726909|NCT03419949|Analgesics|analgesics|mesh-ancestor
65726910|NCT03419949|Sensory System Agents|sensory system agents|mesh-ancestor
65726911|NCT03419949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65726912|NCT03419949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726913|NCT03419949|Anticonvulsants|anticonvulsants|mesh-ancestor
65726914|NCT03419949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65726915|NCT03419949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65726916|NCT03419949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726917|NCT03419949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65726918|NCT03419949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65726919|NCT03419949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65726920|NCT03419949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65726921|NCT03419949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65726922|NCT03419949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65726923|NCT03419949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65726924|NCT03414879|Lidocaine|lidocaine|mesh-list
65726925|NCT03414879|Ketamine|ketamine|mesh-list
65726926|NCT03414879|Anesthetics, Local|anesthetics, local|mesh-ancestor
65726927|NCT03414879|Anesthetics|anesthetics|mesh-ancestor
65726928|NCT03414879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65726929|NCT03414879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726930|NCT03414879|Sensory System Agents|sensory system agents|mesh-ancestor
65726931|NCT03414879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65726932|NCT03414879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65726933|NCT03414879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65726934|NCT03414879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65726935|NCT03414879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65726936|NCT03414879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65726937|NCT03414879|Analgesics|analgesics|mesh-ancestor
65726938|NCT03414879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65726939|NCT03414879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65726940|NCT03414879|Anesthetics, General|anesthetics, general|mesh-ancestor
65726941|NCT03414879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65726942|NCT03414879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65726943|NCT03414879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65726944|NCT03419715|Bimatoprost|bimatoprost|mesh-list
65726945|NCT03419715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65726946|NCT03618355|Sirolimus|sirolimus|mesh-list
65726947|NCT03618355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65726948|NCT03618355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65726949|NCT03618355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65726950|NCT03618355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726951|NCT03618355|Antifungal Agents|antifungal agents|mesh-ancestor
65726952|NCT03618355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65726953|NCT03618355|Immunologic Factors|immunologic factors|mesh-ancestor
65726954|NCT03618355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726955|NCT04448457|Sufentanil|sufentanil|mesh-list
65726956|NCT04448457|Oxycodone|oxycodone|mesh-list
65726957|NCT04448457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65726958|NCT04448457|Narcotics|narcotics|mesh-ancestor
65726959|NCT04448457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65726960|NCT04448457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726961|NCT04448457|Analgesics|analgesics|mesh-ancestor
65726962|NCT04448457|Sensory System Agents|sensory system agents|mesh-ancestor
65726963|NCT04448457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65726964|NCT04448457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65726965|NCT04448457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65726966|NCT04448457|Anesthetics, General|anesthetics, general|mesh-ancestor
65726967|NCT04448457|Anesthetics|anesthetics|mesh-ancestor
65726968|NCT05384743|Rituximab|rituximab|mesh-list
65726969|NCT05384743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65726970|NCT05384743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726971|NCT05384743|Immunologic Factors|immunologic factors|mesh-ancestor
65726972|NCT05384743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726973|NCT05384743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65726974|NCT03414333|Hormones|hormones|mesh-list
65726975|NCT03414333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65726976|NCT03414333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726977|NCT03617029|Ethiodized Oil|ethiodized oil|mesh-list
65726978|NCT03617029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65726979|NCT03616639|Morphine|morphine|mesh-list
65726980|NCT03616639|Oxycodone|oxycodone|mesh-list
65726981|NCT03616639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65726982|NCT03616639|Narcotics|narcotics|mesh-ancestor
65726983|NCT03616639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65726984|NCT03616639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726985|NCT03616639|Analgesics|analgesics|mesh-ancestor
65726986|NCT03616639|Sensory System Agents|sensory system agents|mesh-ancestor
65726987|NCT03616639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65726988|NCT03616561|Apremilast|apremilast|mesh-list
65726989|NCT03616561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65726990|NCT03616561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65726991|NCT03616561|Analgesics|analgesics|mesh-ancestor
65726992|NCT03616561|Sensory System Agents|sensory system agents|mesh-ancestor
65726993|NCT03616561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65726994|NCT03616561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65726995|NCT03616561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65726996|NCT03616561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65726997|NCT03616561|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65726998|NCT03616561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65726999|NCT03616561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727000|NCT03616561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727001|NCT03615313|Antibodies|antibodies|mesh-list
65727002|NCT03615313|Immunologic Factors|immunologic factors|mesh-ancestor
65727003|NCT03615313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727004|NCT03617575|Lactoferrin|lactoferrin|mesh-list
65727005|NCT03617575|Fesoterodine|fesoterodine|mesh-list
65727006|NCT03617575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65727007|NCT03617575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65727008|NCT03617575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65727009|NCT03617575|Cholinergic Agents|cholinergic agents|mesh-ancestor
65727010|NCT03617575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65727011|NCT03617575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727012|NCT03617575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727013|NCT03617575|Urological Agents|urological agents|mesh-ancestor
65727014|NCT02983617|Obinutuzumab|obinutuzumab|mesh-list
65727015|NCT02983617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65727016|NCT02983617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727017|NCT03616405|Amoxicillin|amoxicillin|mesh-list
65727018|NCT03616405|Tetracycline|tetracycline|mesh-list
65727019|NCT03616405|Furazolidone|furazolidone|mesh-list
65727020|NCT03616405|Rabeprazole|rabeprazole|mesh-list
65727021|NCT03616405|Bismuth|bismuth|mesh-list
65727022|NCT03616405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65042818|NCT00227136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65727023|NCT03616405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65727024|NCT03616405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65727025|NCT03616405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65727026|NCT03616405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65727027|NCT03616405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727028|NCT03616405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727029|NCT03616405|Antacids|antacids|mesh-ancestor
65727030|NCT03616405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65727031|NCT03616405|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65727032|NCT03616405|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65727033|NCT03616405|Renal Agents|renal agents|mesh-ancestor
65727034|NCT03616405|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65727035|NCT03616405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65727036|NCT03616405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65727037|NCT03616405|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65727038|NCT03419559|Durvalumab|durvalumab|mesh-list
65727039|NCT03419559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65727040|NCT03419559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727041|NCT02873689|Dexlansoprazole|dexlansoprazole|mesh-list
65727042|NCT02873689|Lansoprazole|lansoprazole|mesh-list
65727043|NCT02873689|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65727044|NCT02873689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65727045|NCT02873689|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65727046|NCT02873689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727047|NCT02873689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727048|NCT02873377|Nicotine|nicotine|mesh-list
65727049|NCT02873377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65727050|NCT02873377|Autonomic Agents|autonomic agents|mesh-ancestor
65727051|NCT02873377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65727052|NCT02873377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727053|NCT02873377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65727054|NCT02873377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65727055|NCT02873377|Cholinergic Agents|cholinergic agents|mesh-ancestor
65727056|NCT02873377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65727057|NCT02873377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727058|NCT03647579|Midazolam|midazolam|mesh-list
65727059|NCT03647579|Dexmedetomidine|dexmedetomidine|mesh-list
65727060|NCT03647579|Ketamine|ketamine|mesh-list
65727061|NCT03647579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65727062|NCT03647579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65727063|NCT03647579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727064|NCT03647579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65727065|NCT03647579|Analgesics|analgesics|mesh-ancestor
65727066|NCT03647579|Sensory System Agents|sensory system agents|mesh-ancestor
65727067|NCT03647579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65727068|NCT03647579|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65727069|NCT03647579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65727070|NCT03647579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65727071|NCT03647579|Adrenergic Agents|adrenergic agents|mesh-ancestor
65727072|NCT03647579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65727073|NCT03647579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727074|NCT03647579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65727075|NCT03647579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65727076|NCT03647579|Anesthetics, General|anesthetics, general|mesh-ancestor
65727077|NCT03647579|Anesthetics|anesthetics|mesh-ancestor
65727078|NCT03647579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65727079|NCT03647579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65727080|NCT03647579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65727081|NCT03647579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65727082|NCT03647579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65727083|NCT03647579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65727084|NCT03647579|GABA Modulators|gaba modulators|mesh-ancestor
65727085|NCT03647579|GABA Agents|gaba agents|mesh-ancestor
65727086|NCT04046861|Ascorbic Acid|ascorbic acid|mesh-list
65727087|NCT04046861|Vitamins|vitamins|mesh-ancestor
65727088|NCT04046861|Micronutrients|micronutrients|mesh-ancestor
65727089|NCT04046861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727090|NCT04046861|Antioxidants|antioxidants|mesh-ancestor
65727091|NCT04046861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727092|NCT04046861|Protective Agents|protective agents|mesh-ancestor
65727093|NCT02236741|Pramipexole|pramipexole|mesh-list
65727094|NCT02236741|Antioxidants|antioxidants|mesh-ancestor
65727095|NCT02236741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727096|NCT02236741|Protective Agents|protective agents|mesh-ancestor
65727097|NCT02236741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727098|NCT02236741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65727099|NCT02236741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65727100|NCT02236741|Dopamine Agonists|dopamine agonists|mesh-ancestor
65727101|NCT02236741|Dopamine Agents|dopamine agents|mesh-ancestor
65727102|NCT02236741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65727103|NCT03648671|Rasagiline|rasagiline|mesh-list
65727104|NCT03648671|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65727105|NCT03648671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727106|NCT03648671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727107|NCT03648671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65727108|NCT03648671|Protective Agents|protective agents|mesh-ancestor
65727109|NCT03648671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727110|NCT03647423|Cyclophosphamide|cyclophosphamide|mesh-list
65727111|NCT03647423|Cetuximab|cetuximab|mesh-list
65727112|NCT03647423|Avelumab|avelumab|mesh-list
65727113|NCT03647423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65727114|NCT03647423|Immunologic Factors|immunologic factors|mesh-ancestor
65727115|NCT03647423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727116|NCT03647423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65727117|NCT03647423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65727118|NCT03647423|Alkylating Agents|alkylating agents|mesh-ancestor
65727119|NCT03647423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727120|NCT03647423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727121|NCT03647423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65727122|NCT03647423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65727123|NCT04052711|Minocycline|minocycline|mesh-list
65727124|NCT04052711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65727125|NCT04052711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65727126|NCT03291847|Buprenorphine|buprenorphine|mesh-list
65727127|NCT03291847|Methadone|methadone|mesh-list
65727128|NCT03291847|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65727129|NCT03291847|Naloxone|naloxone|mesh-list
65727130|NCT03291847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65727131|NCT03291847|Narcotics|narcotics|mesh-ancestor
65727132|NCT03291847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65727133|NCT03291847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727134|NCT03291847|Analgesics|analgesics|mesh-ancestor
65727135|NCT03291847|Sensory System Agents|sensory system agents|mesh-ancestor
65727136|NCT03291847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65727137|NCT03291847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65727138|NCT03291847|Antitussive Agents|antitussive agents|mesh-ancestor
65727139|NCT03291847|Respiratory System Agents|respiratory system agents|mesh-ancestor
65727140|NCT04949503|Nimotuzumab|nimotuzumab|mesh-list
65727141|NCT04949503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65727142|NCT04949503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727143|NCT03621683|Antioxidants|antioxidants|mesh-list
65727144|NCT03621683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727145|NCT03621683|Protective Agents|protective agents|mesh-ancestor
65727146|NCT03621683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727147|NCT03614065|Endostar protein|endostar protein|mesh-list
65727148|NCT03614065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
65727149|NCT03614065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65727150|NCT03614065|Growth Substances|growth substances|mesh-ancestor
65727151|NCT03614065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727152|NCT03614065|Growth Inhibitors|growth inhibitors|mesh-ancestor
65727153|NCT03614065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727154|NCT03621527|Remifentanil|remifentanil|mesh-list
65727155|NCT03621527|Anesthetics|anesthetics|mesh-list
65727156|NCT03621527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65727157|NCT03621527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727158|NCT03621527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65727159|NCT03621527|Narcotics|narcotics|mesh-ancestor
65727160|NCT03621527|Analgesics|analgesics|mesh-ancestor
65727161|NCT03621527|Sensory System Agents|sensory system agents|mesh-ancestor
65727162|NCT03621527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65727163|NCT03646721|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65727164|NCT03646721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65727165|NCT03646721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727166|NCT03646721|Incretins|incretins|mesh-ancestor
65727167|NCT03646721|Hormones|hormones|mesh-ancestor
65727168|NCT03646721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65727169|NCT03646721|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65727170|NCT03646721|Protease Inhibitors|protease inhibitors|mesh-ancestor
65727171|NCT03646721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727172|NCT03646721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042894|NCT00227409|Antidotes|antidotes|mesh-ancestor
65727173|NCT03613753|Irinotecan|irinotecan|mesh-list
65727174|NCT03613753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65727175|NCT03613753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65727176|NCT03613753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727177|NCT03613753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727178|NCT03613753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727179|NCT03267433|Rituximab|rituximab|mesh-list
65727180|NCT03267433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65727181|NCT03267433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727182|NCT03267433|Immunologic Factors|immunologic factors|mesh-ancestor
65727183|NCT03267433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727184|NCT03267433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65727185|NCT04051853|Sorafenib|sorafenib|mesh-list
65727186|NCT04051853|Midazolam|midazolam|mesh-list
65727187|NCT04051853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65727188|NCT04051853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65727189|NCT04051853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65727190|NCT04051853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727191|NCT04051853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65727192|NCT04051853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65727193|NCT04051853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65727194|NCT04051853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65727195|NCT04051853|Anesthetics, General|anesthetics, general|mesh-ancestor
65727196|NCT04051853|Anesthetics|anesthetics|mesh-ancestor
65727197|NCT04051853|GABA Modulators|gaba modulators|mesh-ancestor
65727198|NCT04051853|GABA Agents|gaba agents|mesh-ancestor
65727199|NCT04051853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65727200|NCT04051853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727201|NCT04051853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727202|NCT04051853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65727203|NCT04051853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727204|NCT03605927|Sirolimus|sirolimus|mesh-list
65727205|NCT03605927|Tacrolimus|tacrolimus|mesh-list
65727206|NCT03605927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65727207|NCT03605927|Immunologic Factors|immunologic factors|mesh-ancestor
65727208|NCT03605927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727209|NCT03605927|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65727210|NCT03605927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727211|NCT03605927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727212|NCT03605927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65727213|NCT03605927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65727214|NCT03605927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65727215|NCT03605927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727216|NCT03605927|Antifungal Agents|antifungal agents|mesh-ancestor
65727217|NCT03643757|Bupivacaine|bupivacaine|mesh-list
65727218|NCT03643757|Anesthetics, Local|anesthetics, local|mesh-ancestor
65727219|NCT03643757|Anesthetics|anesthetics|mesh-ancestor
65727220|NCT03643757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65727221|NCT03643757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727222|NCT03643757|Sensory System Agents|sensory system agents|mesh-ancestor
65727223|NCT03643757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65727224|NCT03718793|Nitric Oxide|nitric oxide|mesh-list
65727225|NCT03718793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65727226|NCT03718793|Autonomic Agents|autonomic agents|mesh-ancestor
65727227|NCT03718793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65727228|NCT03718793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727229|NCT03718793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65727230|NCT03718793|Respiratory System Agents|respiratory system agents|mesh-ancestor
65727231|NCT03718793|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65727232|NCT03718793|Antioxidants|antioxidants|mesh-ancestor
65727233|NCT03718793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727234|NCT03718793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65727235|NCT03718793|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65727236|NCT03718793|Vasodilator Agents|vasodilator agents|mesh-ancestor
65727237|NCT03718793|Gasotransmitters|gasotransmitters|mesh-ancestor
65727238|NCT03718793|Protective Agents|protective agents|mesh-ancestor
65727239|NCT02962739|Tenofovir|tenofovir|mesh-list
65727240|NCT02962739|Emtricitabine|emtricitabine|mesh-list
65727241|NCT02962739|Antiviral Agents|antiviral agents|mesh-ancestor
65727242|NCT02962739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65727243|NCT02962739|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65727244|NCT02962739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65727245|NCT02962739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727246|NCT02962739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042968|NCT00204308|Tenofovir|tenofovir|mesh-list
65727247|NCT02962739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65727248|NCT02962739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65727249|NCT01344629|Telmisartan|telmisartan|mesh-list
65727250|NCT01344629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65727251|NCT01344629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65727252|NCT01344629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65727253|NCT01344629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727254|NCT03642665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65727255|NCT03642665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65727256|NCT03642665|Estradiol|estradiol|mesh-list
65727257|NCT03642665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65727258|NCT03642665|Progesterone|progesterone|mesh-list
65727259|NCT03642665|Estrogens|estrogens|mesh-ancestor
65727260|NCT03642665|Hormones|hormones|mesh-ancestor
65727261|NCT03642665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65727262|NCT03642665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727263|NCT03642665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65727264|NCT03642665|Contraceptive Agents|contraceptive agents|mesh-ancestor
65727265|NCT03642665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65727266|NCT03642665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65727267|NCT03642665|Progestins|progestins|mesh-ancestor
65727268|NCT05233163|Empagliflozin|empagliflozin|mesh-list
65727269|NCT05233163|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65727270|NCT05233163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727271|NCT05233163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65727272|NCT05233163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727273|NCT03642509|Rivaroxaban|rivaroxaban|mesh-list
65727274|NCT03642509|Apixaban|apixaban|mesh-list
65727275|NCT03642509|Edoxaban|edoxaban|mesh-list
65727276|NCT03642509|Dabigatran|dabigatran|mesh-list
65727277|NCT03642509|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65727278|NCT03642509|Antithrombins|antithrombins|mesh-ancestor
65727279|NCT03642509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65727280|NCT03642509|Protease Inhibitors|protease inhibitors|mesh-ancestor
65727281|NCT03642509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727282|NCT03642509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727283|NCT03642509|Anticoagulants|anticoagulants|mesh-ancestor
65727284|NCT03642353|Listerine|listerine|mesh-list
65727285|NCT03642353|Triclosan|triclosan|mesh-list
65727286|NCT03642353|Sodium Fluoride|sodium fluoride|mesh-list
65727287|NCT03642353|Cariostatic Agents|cariostatic agents|mesh-ancestor
65727288|NCT03642353|Protective Agents|protective agents|mesh-ancestor
65727289|NCT03642353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727290|NCT03642353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65727291|NCT03642353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65727292|NCT03642353|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65727293|NCT03642353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65727294|NCT03642353|Antimetabolites|antimetabolites|mesh-ancestor
65727295|NCT03642353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727296|NCT03642353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65727297|NCT03424707|Eperisone|eperisone|mesh-list
65727298|NCT03424707|Anticonvulsants|anticonvulsants|mesh-ancestor
65727299|NCT03424707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65727300|NCT03424707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65727301|NCT03424707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727302|NCT03424707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65727303|NCT03424707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727304|NCT03424707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65727305|NCT03424707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65727306|NCT03424707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65727307|NCT03424707|Parasympatholytics|parasympatholytics|mesh-ancestor
65727308|NCT03424707|Autonomic Agents|autonomic agents|mesh-ancestor
65727309|NCT03424707|Vasodilator Agents|vasodilator agents|mesh-ancestor
65727310|NCT05174351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65727311|NCT05174351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65727312|NCT05174351|Adrenergic Agents|adrenergic agents|mesh-ancestor
65727313|NCT05174351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65727314|NCT05174351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727315|NCT05174351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727316|NCT03418935|Niacinamide|niacinamide|mesh-list
65727317|NCT03418935|Niacin|niacin|mesh-list
65727318|NCT03418935|Nicotinic Acids|nicotinic acids|mesh-list
65727319|NCT03418935|Vitamin B Complex|vitamin b complex|mesh-ancestor
65727320|NCT03418935|Vitamins|vitamins|mesh-ancestor
65727321|NCT03418935|Micronutrients|micronutrients|mesh-ancestor
65727322|NCT03418935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043043|NCT00197834|GABA Agents|gaba agents|mesh-ancestor
65727323|NCT03418935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65727324|NCT03418935|Antimetabolites|antimetabolites|mesh-ancestor
65727325|NCT03418935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727326|NCT03418935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65727327|NCT03418935|Vasodilator Agents|vasodilator agents|mesh-ancestor
65727328|NCT03413319|Tilavonemab|tilavonemab|mesh-list
65727329|NCT03413319|Nootropic Agents|nootropic agents|mesh-ancestor
65727330|NCT03424629|Methotrexate|methotrexate|mesh-list
65727331|NCT03424629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65727332|NCT03424629|Abortifacient Agents|abortifacient agents|mesh-ancestor
65727333|NCT03424629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65727334|NCT03424629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727335|NCT03424629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65727336|NCT03424629|Antimetabolites|antimetabolites|mesh-ancestor
65727337|NCT03424629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727338|NCT03424629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727339|NCT03424629|Dermatologic Agents|dermatologic agents|mesh-ancestor
65727340|NCT03424629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727341|NCT03424629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65727342|NCT03424629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65727343|NCT03424629|Immunologic Factors|immunologic factors|mesh-ancestor
65727344|NCT03424629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65727345|NCT03424629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65727346|NCT03424473|Tucatinib|tucatinib|mesh-list
65727347|NCT03424473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727348|NCT03424473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65727349|NCT03424473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727350|NCT03424473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727351|NCT04448379|Osimertinib|osimertinib|mesh-list
65727352|NCT04448379|Afatinib|afatinib|mesh-list
65727353|NCT04448379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727354|NCT04448379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65727355|NCT04448379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727356|NCT04448379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727357|NCT04448223|Latanoprost|latanoprost|mesh-list
65727358|NCT04448223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65727359|NCT04448223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65727360|NCT03644147|Acetaminophen|acetaminophen|mesh-list
65727361|NCT03644147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65727362|NCT03644147|Analgesics|analgesics|mesh-ancestor
65727363|NCT03644147|Sensory System Agents|sensory system agents|mesh-ancestor
65727364|NCT03644147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65727365|NCT03644147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727366|NCT03644147|Antipyretics|antipyretics|mesh-ancestor
65727367|NCT02743923|Paclitaxel|paclitaxel|mesh-list
65727368|NCT02743923|Bevacizumab|bevacizumab|mesh-list
65727369|NCT02743923|Carboplatin|carboplatin|mesh-list
65727370|NCT02743923|Pemetrexed|pemetrexed|mesh-list
65727371|NCT02743923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65727372|NCT02743923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727373|NCT02743923|Tubulin Modulators|tubulin modulators|mesh-ancestor
65727374|NCT02743923|Antimitotic Agents|antimitotic agents|mesh-ancestor
65727375|NCT02743923|Mitosis Modulators|mitosis modulators|mesh-ancestor
65727376|NCT02743923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727377|NCT02743923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65727378|NCT02743923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65727379|NCT02743923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65727380|NCT02743923|Growth Substances|growth substances|mesh-ancestor
65727381|NCT02743923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727382|NCT02743923|Growth Inhibitors|growth inhibitors|mesh-ancestor
65727383|NCT02743923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727384|NCT02743923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65727385|NCT02743923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65727386|NCT01065779|Alendronate|alendronate|mesh-list
65727387|NCT01065779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65727388|NCT01065779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727389|NCT02357966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65727390|NCT02357966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65727391|NCT03570359|Interferons|interferons|mesh-list
65727392|NCT03570359|Interferon-beta|interferon-beta|mesh-list
65727393|NCT03570359|Interferon beta-1a|interferon beta-1a|mesh-list
65727394|NCT03570359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727395|NCT03570359|Antiviral Agents|antiviral agents|mesh-ancestor
65727396|NCT03570359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65727397|NCT03570359|Immunologic Factors|immunologic factors|mesh-ancestor
65727398|NCT03570359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727399|NCT03570359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65727400|NCT02358200|Paclitaxel|paclitaxel|mesh-list
65727401|NCT02358200|Carboplatin|carboplatin|mesh-list
65727402|NCT02358200|Talazoparib|talazoparib|mesh-list
65727403|NCT02358200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65727404|NCT02358200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727405|NCT02358200|Tubulin Modulators|tubulin modulators|mesh-ancestor
65727406|NCT02358200|Antimitotic Agents|antimitotic agents|mesh-ancestor
65727407|NCT02358200|Mitosis Modulators|mitosis modulators|mesh-ancestor
65727408|NCT02358200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727409|NCT02358200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65727410|NCT02358200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727411|NCT03413007|Antigen-Antibody Complex|antigen-antibody complex|mesh-list
65727412|NCT03413007|Immunologic Factors|immunologic factors|mesh-ancestor
65727413|NCT03413007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727414|NCT03127605|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65727415|NCT03127605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65727416|NCT03127605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727417|NCT03127605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65727418|NCT03112538|Insulin|insulin|mesh-list
65727419|NCT03112538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65727420|NCT03112538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65727421|NCT03112538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727422|NCT05283551|Famciclovir|famciclovir|mesh-list
65727423|NCT05283551|Antiviral Agents|antiviral agents|mesh-ancestor
65727424|NCT05283551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65727425|NCT05283551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65727426|NCT05283551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727427|NCT05283551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727428|NCT02357732|Nivolumab|nivolumab|mesh-list
65727429|NCT02357732|Trametinib|trametinib|mesh-list
65727430|NCT02357732|Dabrafenib|dabrafenib|mesh-list
65727431|NCT02357732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65727432|NCT02357732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727433|NCT02357732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65727434|NCT02357732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727435|NCT02357732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65727436|NCT02357732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727437|NCT02109081|Dexamethasone|dexamethasone|mesh-list
65727438|NCT02109081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65727439|NCT02109081|Antiemetics|antiemetics|mesh-ancestor
65727440|NCT02109081|Autonomic Agents|autonomic agents|mesh-ancestor
65727441|NCT02109081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65727442|NCT02109081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727443|NCT02109081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65727444|NCT02109081|Glucocorticoids|glucocorticoids|mesh-ancestor
65727445|NCT02109081|Hormones|hormones|mesh-ancestor
65727446|NCT02109081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65727447|NCT02109081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65727448|NCT02109081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727449|NCT03160040|Minocycline|minocycline|mesh-list
65727450|NCT03160040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65727451|NCT03160040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65727452|NCT03112148|Tofacitinib|tofacitinib|mesh-list
65727453|NCT03112148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65727454|NCT03112148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727455|NCT03112148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727456|NCT03423849|Gemcitabine|gemcitabine|mesh-list
65727457|NCT03423849|Capecitabine|capecitabine|mesh-list
65727458|NCT03423849|Vinorelbine|vinorelbine|mesh-list
65727459|NCT03423849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727460|NCT03423849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65727461|NCT03423849|Antimetabolites|antimetabolites|mesh-ancestor
65727462|NCT03423849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727463|NCT03423849|Antiviral Agents|antiviral agents|mesh-ancestor
65727464|NCT03423849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65727465|NCT03423849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727466|NCT03423849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65727467|NCT03423849|Immunologic Factors|immunologic factors|mesh-ancestor
65727468|NCT03423849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727469|NCT03423849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65727470|NCT03423849|Tubulin Modulators|tubulin modulators|mesh-ancestor
65727471|NCT03423849|Antimitotic Agents|antimitotic agents|mesh-ancestor
65727472|NCT03423849|Mitosis Modulators|mitosis modulators|mesh-ancestor
65727473|NCT02362490|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65727474|NCT02362490|Antiviral Agents|antiviral agents|mesh-ancestor
65727475|NCT02362490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65727477|NCT02362256|Naltrexone|naltrexone|mesh-list
65727478|NCT02362256|Lorazepam|lorazepam|mesh-list
65727479|NCT02362256|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65727480|NCT02362256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65727481|NCT02362256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727482|NCT02362256|Sensory System Agents|sensory system agents|mesh-ancestor
65727483|NCT02362256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65727484|NCT02362256|Analgesics|analgesics|mesh-ancestor
65727485|NCT02362256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65727486|NCT02362256|Sympatholytics|sympatholytics|mesh-ancestor
65727487|NCT02362256|Autonomic Agents|autonomic agents|mesh-ancestor
65727488|NCT02362256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65727489|NCT02362256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65727490|NCT02362256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65727491|NCT02362256|Adrenergic Agents|adrenergic agents|mesh-ancestor
65727492|NCT02362256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65727493|NCT02362256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727494|NCT02362256|Anticonvulsants|anticonvulsants|mesh-ancestor
65727495|NCT02362256|Antiemetics|antiemetics|mesh-ancestor
65727496|NCT02362256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65727497|NCT02362256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65727498|NCT02362256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65727499|NCT02362256|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65727500|NCT02362256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65727501|NCT02362256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65727502|NCT02362256|GABA Modulators|gaba modulators|mesh-ancestor
65727503|NCT02362256|GABA Agents|gaba agents|mesh-ancestor
65727504|NCT03412305|Amoxicillin|amoxicillin|mesh-list
65727505|NCT03412305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65727506|NCT03412305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65727507|NCT04259996|Estradiol|estradiol|mesh-list
65727508|NCT04259996|Progesterone|progesterone|mesh-list
65727509|NCT04259996|Estrogens|estrogens|mesh-ancestor
65727510|NCT04259996|Hormones|hormones|mesh-ancestor
65727511|NCT04259996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65727512|NCT04259996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727513|NCT04259996|Progestins|progestins|mesh-ancestor
65727514|NCT03417453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65727515|NCT03417453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65727516|NCT04795557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65727517|NCT03397875|Zinc Oxide|zinc oxide|mesh-list
65727518|NCT03397875|Dermatologic Agents|dermatologic agents|mesh-ancestor
65727519|NCT03397875|Sunscreening Agents|sunscreening agents|mesh-ancestor
65727520|NCT03397875|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65727521|NCT03397875|Protective Agents|protective agents|mesh-ancestor
65727522|NCT03397875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727523|NCT02362022|Morphine|morphine|mesh-list
65727524|NCT02362022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65727525|NCT02362022|Narcotics|narcotics|mesh-ancestor
65727526|NCT02362022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65727527|NCT02362022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727528|NCT02362022|Analgesics|analgesics|mesh-ancestor
65727529|NCT02362022|Sensory System Agents|sensory system agents|mesh-ancestor
65727530|NCT02362022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65727531|NCT03412071|Metronidazole|metronidazole|mesh-list
65727532|NCT03412071|Clindamycin|clindamycin|mesh-list
65727533|NCT03412071|Clindamycin palmitate|clindamycin palmitate|mesh-list
65727534|NCT03412071|Clindamycin phosphate|clindamycin phosphate|mesh-list
65727535|NCT03412071|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65727536|NCT03412071|Tinidazole|tinidazole|mesh-list
65727537|NCT03412071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65727538|NCT03412071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65727539|NCT03412071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65727540|NCT03412071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65727541|NCT03412071|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65727542|NCT03412071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727543|NCT03412071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727544|NCT03412071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65727545|NCT03412071|Alkylating Agents|alkylating agents|mesh-ancestor
65727546|NCT03412071|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65727547|NCT03397797|Rocuronium|rocuronium|mesh-list
65727548|NCT03397797|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65727549|NCT03397797|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65727550|NCT03397797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65727551|NCT03397797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65727552|NCT03397797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727553|NCT05170581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65727554|NCT05170581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727555|NCT05170581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727556|NCT02351882|Nabilone|nabilone|mesh-list
65727557|NCT02351882|Antiemetics|antiemetics|mesh-ancestor
65727558|NCT02351882|Autonomic Agents|autonomic agents|mesh-ancestor
65727559|NCT02351882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65727560|NCT02351882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727561|NCT02351882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65727562|NCT02351882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65727563|NCT02351882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65727564|NCT02351882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65727565|NCT02351882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65727566|NCT02356640|Levobupivacaine|levobupivacaine|mesh-list
65727567|NCT02356640|Anesthetics, Local|anesthetics, local|mesh-ancestor
65727568|NCT02356640|Anesthetics|anesthetics|mesh-ancestor
65727569|NCT02356640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65727570|NCT02356640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727571|NCT02356640|Sensory System Agents|sensory system agents|mesh-ancestor
65727572|NCT02356640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65727573|NCT05169801|Paclitaxel|paclitaxel|mesh-list
65727574|NCT05169801|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65727575|NCT05169801|Carboplatin|carboplatin|mesh-list
65727576|NCT05169801|Bevacizumab|bevacizumab|mesh-list
65727577|NCT05169801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65727578|NCT05169801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727579|NCT05169801|Tubulin Modulators|tubulin modulators|mesh-ancestor
65727580|NCT05169801|Antimitotic Agents|antimitotic agents|mesh-ancestor
65727581|NCT05169801|Mitosis Modulators|mitosis modulators|mesh-ancestor
65727582|NCT05169801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727583|NCT05169801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65727584|NCT05169801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65727585|NCT05169801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65727586|NCT05169801|Growth Substances|growth substances|mesh-ancestor
65727587|NCT05169801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727588|NCT05169801|Growth Inhibitors|growth inhibitors|mesh-ancestor
65727589|NCT04447443|Loperamide|loperamide|mesh-list
65727590|NCT04447443|Antidiarrheals|antidiarrheals|mesh-list
65727591|NCT04447443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65727592|NCT02356328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65727593|NCT02356328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65727594|NCT01345253|Belimumab|belimumab|mesh-list
65727595|NCT01345253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65727596|NCT01345253|Immunologic Factors|immunologic factors|mesh-ancestor
65727597|NCT01345253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727598|NCT03150134|Cyclosporine|cyclosporine|mesh-list
65727599|NCT03150134|Cyclosporins|cyclosporins|mesh-list
65727600|NCT03150134|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65727601|NCT03150134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727602|NCT03150134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727603|NCT03150134|Immunologic Factors|immunologic factors|mesh-ancestor
65727604|NCT03150134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727605|NCT03150134|Antifungal Agents|antifungal agents|mesh-ancestor
65727606|NCT03150134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65727607|NCT03150134|Dermatologic Agents|dermatologic agents|mesh-ancestor
65727608|NCT03150134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65727609|NCT03150134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65727610|NCT03411369|Vitamins|vitamins|mesh-list
65727611|NCT03411369|Micronutrients|micronutrients|mesh-ancestor
65727612|NCT03411369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727613|NCT04653207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65727614|NCT02351804|Dexamethasone|dexamethasone|mesh-list
65727615|NCT02351804|Ropivacaine|ropivacaine|mesh-list
65727616|NCT02351804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65727617|NCT02351804|Antiemetics|antiemetics|mesh-ancestor
65727618|NCT02351804|Autonomic Agents|autonomic agents|mesh-ancestor
65727619|NCT02351804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65727620|NCT02351804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727621|NCT02351804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65727622|NCT02351804|Glucocorticoids|glucocorticoids|mesh-ancestor
65727623|NCT02351804|Hormones|hormones|mesh-ancestor
65727624|NCT02351804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65727625|NCT02351804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65727626|NCT02351804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727627|NCT02351804|Anesthetics, Local|anesthetics, local|mesh-ancestor
65727628|NCT02351804|Anesthetics|anesthetics|mesh-ancestor
65043348|NCT00231855|Docetaxel|docetaxel|mesh-list
65727629|NCT02351804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65727630|NCT02351804|Sensory System Agents|sensory system agents|mesh-ancestor
65727631|NCT02958527|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65727632|NCT02958527|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65727633|NCT02958527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65727634|NCT02958527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65727635|NCT02958527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727636|NCT02958527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65727637|NCT02958527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727638|NCT02958527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65727639|NCT02958527|Antidepressive Agents|antidepressive agents|mesh-ancestor
65727640|NCT02958527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65727642|NCT03640403|Piperaquine|piperaquine|mesh-list
65727643|NCT03640403|Amodiaquine|amodiaquine|mesh-list
65727644|NCT03640403|Artenimol|artenimol|mesh-list
65727645|NCT03640403|Antimalarials|antimalarials|mesh-ancestor
65727646|NCT03640403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65727647|NCT03640403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65727648|NCT03640403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65727649|NCT03640403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727650|NCT03640403|Antiviral Agents|antiviral agents|mesh-ancestor
65727651|NCT03640403|Schistosomicides|schistosomicides|mesh-ancestor
65727652|NCT03640403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65727653|NCT03640403|Anthelmintics|anthelmintics|mesh-ancestor
65727654|NCT02355938|Vancomycin|vancomycin|mesh-list
65727655|NCT02355938|Fidaxomicin|fidaxomicin|mesh-list
65727656|NCT02355938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65727657|NCT02355938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65727658|NCT03397173|Ascorbic Acid|ascorbic acid|mesh-list
65727659|NCT03397173|Azacitidine|azacitidine|mesh-list
65727660|NCT03397173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65727661|NCT03397173|Antimetabolites|antimetabolites|mesh-ancestor
65727662|NCT03397173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727663|NCT03397173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727664|NCT03397173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727665|NCT03397173|Antioxidants|antioxidants|mesh-ancestor
65727666|NCT03397173|Protective Agents|protective agents|mesh-ancestor
65727667|NCT03397173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727668|NCT03397173|Vitamins|vitamins|mesh-ancestor
65727669|NCT03397173|Micronutrients|micronutrients|mesh-ancestor
65727670|NCT03640247|Acetaminophen|acetaminophen|mesh-list
65727671|NCT03640247|Ibuprofen|ibuprofen|mesh-list
65727672|NCT03640247|Oxycodone|oxycodone|mesh-list
65727673|NCT03640247|Tramadol|tramadol|mesh-list
65727674|NCT03640247|Hydrocodone|hydrocodone|mesh-list
65727675|NCT03640247|Narcotics|narcotics|mesh-list
65727676|NCT03640247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65727677|NCT03640247|Analgesics|analgesics|mesh-ancestor
65727678|NCT03640247|Sensory System Agents|sensory system agents|mesh-ancestor
65727679|NCT03640247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65727680|NCT03640247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727681|NCT03640247|Antipyretics|antipyretics|mesh-ancestor
65727682|NCT03640247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65727683|NCT03640247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65727684|NCT03640247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65727685|NCT03640247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65727686|NCT03640247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727687|NCT03640247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727688|NCT03640247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65727689|NCT03640247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65727690|NCT03640247|Antitussive Agents|antitussive agents|mesh-ancestor
65727691|NCT03640247|Respiratory System Agents|respiratory system agents|mesh-ancestor
65727692|NCT03394131|Insulin|insulin|mesh-list
65727693|NCT03394131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65727694|NCT03394131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65727695|NCT03394131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727696|NCT02360618|Metformin|metformin|mesh-list
65727697|NCT02360618|Simvastatin|simvastatin|mesh-list
65727698|NCT02360618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65727699|NCT02360618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727700|NCT02360618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65727701|NCT02360618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65727702|NCT02360618|Antimetabolites|antimetabolites|mesh-ancestor
65727703|NCT02360618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727704|NCT02360618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65727705|NCT02360618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65727706|NCT02360618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727707|NCT05214183|Rituximab|rituximab|mesh-list
65727708|NCT05214183|Acalabrutinib|acalabrutinib|mesh-list
65727709|NCT05214183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65727710|NCT05214183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727711|NCT05214183|Immunologic Factors|immunologic factors|mesh-ancestor
65727712|NCT05214183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727713|NCT05214183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65727714|NCT01344161|Vitamin D|vitamin d|mesh-list
65727715|NCT01344161|Cholecalciferol|cholecalciferol|mesh-list
65727716|NCT01344161|Vitamins|vitamins|mesh-ancestor
65727717|NCT01344161|Micronutrients|micronutrients|mesh-ancestor
65727718|NCT01344161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727719|NCT01344161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65727720|NCT01344161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65727721|NCT02451358|Vaccines|vaccines|mesh-list
65727722|NCT02451358|Immunologic Factors|immunologic factors|mesh-ancestor
65727723|NCT02451358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727724|NCT02360384|Linaclotide|linaclotide|mesh-list
65727725|NCT02360384|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65727726|NCT02360384|Enzyme Activators|enzyme activators|mesh-ancestor
65727727|NCT02360384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727728|NCT02360384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65727729|NCT03396861|Aflibercept|aflibercept|mesh-list
65727730|NCT03396861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65727731|NCT03396861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65727732|NCT03396861|Growth Substances|growth substances|mesh-ancestor
65727733|NCT03396861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727734|NCT03396861|Growth Inhibitors|growth inhibitors|mesh-ancestor
65727735|NCT03396861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727736|NCT02749721|Vortioxetine|vortioxetine|mesh-list
65727737|NCT02749721|Antidepressive Agents|antidepressive agents|mesh-ancestor
65727738|NCT02749721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65727739|NCT02749721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65727740|NCT02749721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65727741|NCT02749721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65727742|NCT02749721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727743|NCT02749721|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65727744|NCT02749721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65727745|NCT02749721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65727746|NCT02749721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727747|NCT02749721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65727748|NCT02749721|Serotonin Agents|serotonin agents|mesh-ancestor
65727749|NCT02749721|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65727750|NCT02749721|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65727751|NCT02749721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65727752|NCT02749721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65727753|NCT02351102|Valacyclovir|valacyclovir|mesh-list
65727754|NCT02351102|Antiviral Agents|antiviral agents|mesh-ancestor
65727755|NCT02351102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65727756|NCT02351024|Naproxen|naproxen|mesh-list
65727757|NCT02351024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65727758|NCT02351024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65727759|NCT02351024|Analgesics|analgesics|mesh-ancestor
65727760|NCT02351024|Sensory System Agents|sensory system agents|mesh-ancestor
65727761|NCT02351024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65727762|NCT02351024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727763|NCT02351024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65727764|NCT02351024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65727765|NCT02351024|Gout Suppressants|gout suppressants|mesh-ancestor
65727766|NCT02351024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65727767|NCT02351024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727768|NCT02351024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727769|NCT02355704|Atorvastatin|atorvastatin|mesh-list
65727770|NCT02355704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65727771|NCT02355704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65727772|NCT02355704|Antimetabolites|antimetabolites|mesh-ancestor
65727773|NCT02355704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727774|NCT02355704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65727775|NCT02355704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65727776|NCT02355704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727777|NCT03396393|Artenimol|artenimol|mesh-list
65727778|NCT03396393|Antimalarials|antimalarials|mesh-ancestor
65727779|NCT03396393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65727780|NCT03396393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65727781|NCT03396393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65727782|NCT03393819|Ethanol|ethanol|mesh-list
65727783|NCT03393819|Chlorhexidine|chlorhexidine|mesh-list
65727784|NCT03393819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65727785|NCT03393819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65727786|NCT03393819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65727787|NCT03393819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727788|NCT03393819|Disinfectants|disinfectants|mesh-ancestor
65727789|NCT03393507|Apatinib|apatinib|mesh-list
65727790|NCT03393507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727791|NCT03393507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65727792|NCT03393507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727793|NCT03393507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727794|NCT01348139|AZD-3199|azd-3199|mesh-list
65727795|NCT01348139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65727796|NCT01348139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65727797|NCT01348139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65727798|NCT01348139|Adrenergic Agents|adrenergic agents|mesh-ancestor
65727799|NCT01348139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65727800|NCT01348139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727801|NCT01348139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727802|NCT02355236|Celecoxib|celecoxib|mesh-list
65727803|NCT02355236|Naproxen|naproxen|mesh-list
65727804|NCT02355236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65727805|NCT02355236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65727806|NCT02355236|Analgesics|analgesics|mesh-ancestor
65727807|NCT02355236|Sensory System Agents|sensory system agents|mesh-ancestor
65727808|NCT02355236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65727809|NCT02355236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727810|NCT02355236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65727811|NCT02355236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65727812|NCT02355236|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65727813|NCT02355236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65727814|NCT02355236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727815|NCT02355236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727816|NCT02355236|Gout Suppressants|gout suppressants|mesh-ancestor
65727817|NCT05169255|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65727818|NCT05169255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65727819|NCT02359604|Esomeprazole|esomeprazole|mesh-list
65727820|NCT02359604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65727821|NCT02359604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65727822|NCT02359604|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65727823|NCT02359604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727824|NCT02359604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727825|NCT03410511|Nicotine|nicotine|mesh-list
65727826|NCT03410511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65727827|NCT03410511|Autonomic Agents|autonomic agents|mesh-ancestor
65727828|NCT03410511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65727829|NCT03410511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727830|NCT03410511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65727831|NCT03410511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65727832|NCT03410511|Cholinergic Agents|cholinergic agents|mesh-ancestor
65727833|NCT03410511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65727834|NCT03410511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727835|NCT05169021|Folic Acid|folic acid|mesh-list
65727836|NCT05169021|Vitamin B Complex|vitamin b complex|mesh-list
65727837|NCT05169021|Amlodipine|amlodipine|mesh-list
65727838|NCT05169021|Antihypertensive Agents|antihypertensive agents|mesh-list
65727839|NCT05169021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65727840|NCT05169021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65727841|NCT05169021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727842|NCT05169021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65727843|NCT05169021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727844|NCT05169021|Vasodilator Agents|vasodilator agents|mesh-ancestor
65727845|NCT05169021|Hematinics|hematinics|mesh-ancestor
65727846|NCT05169021|Vitamins|vitamins|mesh-ancestor
65727847|NCT05169021|Micronutrients|micronutrients|mesh-ancestor
65727848|NCT02359292|Charcoal|charcoal|mesh-list
65727849|NCT02359292|Antidotes|antidotes|mesh-ancestor
65727850|NCT02359292|Protective Agents|protective agents|mesh-ancestor
65727851|NCT02359292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727852|NCT05168787|Valsartan|valsartan|mesh-list
65727853|NCT05168787|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65727854|NCT05168787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65043572|NCT00229125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65727855|NCT05168787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65727856|NCT05168787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65727857|NCT05168787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727859|NCT02359214|Cholecalciferol|cholecalciferol|mesh-list
65727860|NCT02359214|Vitamins|vitamins|mesh-ancestor
65727861|NCT02359214|Micronutrients|micronutrients|mesh-ancestor
65727862|NCT02359214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727863|NCT02359214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65727864|NCT02359214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65727865|NCT02359370|Lidocaine|lidocaine|mesh-list
65727866|NCT02359370|Magnesium Sulfate|magnesium sulfate|mesh-list
65727867|NCT02359370|Anesthetics, Local|anesthetics, local|mesh-ancestor
65727868|NCT02359370|Anesthetics|anesthetics|mesh-ancestor
65727869|NCT02359370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65727870|NCT02359370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727871|NCT02359370|Sensory System Agents|sensory system agents|mesh-ancestor
65727872|NCT02359370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65727873|NCT02359370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65727874|NCT02359370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65727875|NCT02359370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65727876|NCT02359370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65727877|NCT02359370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727878|NCT02359370|Analgesics|analgesics|mesh-ancestor
65727879|NCT02359370|Anticonvulsants|anticonvulsants|mesh-ancestor
65727880|NCT02359370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65727881|NCT02359370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65727882|NCT02359370|Tocolytic Agents|tocolytic agents|mesh-ancestor
65727883|NCT02359370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65727884|NCT03396315|Zoledronic Acid|zoledronic acid|mesh-list
65727885|NCT03396315|Alendronate|alendronate|mesh-list
65727886|NCT03396315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65727887|NCT03396315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727888|NCT02359448|Melatonin|melatonin|mesh-list
65727889|NCT02359448|Antioxidants|antioxidants|mesh-ancestor
65727890|NCT02359448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727891|NCT02359448|Protective Agents|protective agents|mesh-ancestor
65727892|NCT02359448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727893|NCT02359448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65727894|NCT02359526|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
65727895|NCT02359526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65727896|NCT02359526|Glucocorticoids|glucocorticoids|mesh-ancestor
65727897|NCT02359526|Hormones|hormones|mesh-ancestor
65727898|NCT02359526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65727899|NCT02359526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727900|NCT03618953|Atezolizumab|atezolizumab|mesh-list
65727901|NCT03618953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727902|NCT02354768|Lanreotide|lanreotide|mesh-list
65727903|NCT02354768|Loperamide|loperamide|mesh-list
65727904|NCT02354768|Antidiarrheals|antidiarrheals|mesh-list
65727905|NCT02354768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727906|NCT02354768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65727907|NCT00000125|Antihypertensive Agents|antihypertensive agents|mesh-list
65727908|NCT00000125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65727909|NCT00000125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65727910|NCT02354612|Bevacizumab|bevacizumab|mesh-list
65727911|NCT02354612|Capecitabine|capecitabine|mesh-list
65727912|NCT02354612|Axitinib|axitinib|mesh-list
65727913|NCT02354612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65727914|NCT02354612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727915|NCT02354612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65727916|NCT02354612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65727917|NCT02354612|Growth Substances|growth substances|mesh-ancestor
65727918|NCT02354612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727919|NCT02354612|Growth Inhibitors|growth inhibitors|mesh-ancestor
65727920|NCT02354612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65727921|NCT02354612|Antimetabolites|antimetabolites|mesh-ancestor
65727922|NCT02354612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727923|NCT02354612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65727924|NCT02354612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727925|NCT02348450|Irinotecan|irinotecan|mesh-list
65727926|NCT02348450|Etoposide|etoposide|mesh-list
65727927|NCT02348450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727928|NCT02348450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65727929|NCT02348450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65727930|NCT02348450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727931|NCT02348450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727932|NCT02348450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65727933|NCT02348450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65727934|NCT03393273|Elotuzumab|elotuzumab|mesh-list
65727935|NCT03393273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727936|NCT03613597|Etoposide|etoposide|mesh-list
65727937|NCT03613597|Etoposide phosphate|etoposide phosphate|mesh-list
65727938|NCT03613597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727939|NCT03613597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65190509|NCT04956705|Micronutrients|micronutrients|mesh-ancestor
65727940|NCT03613597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65727941|NCT03613597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65727942|NCT03613597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727943|NCT03613597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727944|NCT02348372|Glycine|glycine|mesh-list
65727945|NCT02348372|Glycine Agents|glycine agents|mesh-ancestor
65727946|NCT02348372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65727947|NCT02348372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727948|NCT02348372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727949|NCT02031731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65727950|NCT02031731|Immunologic Factors|immunologic factors|mesh-ancestor
65727951|NCT02031731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727952|NCT03614533|Vaccines|vaccines|mesh-list
65727953|NCT03614533|Immunologic Factors|immunologic factors|mesh-ancestor
65727954|NCT03614533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727955|NCT03147404|Avelumab|avelumab|mesh-list
65727956|NCT03147404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65727957|NCT03147404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65727958|NCT03614455|Itraconazole|itraconazole|mesh-list
65727959|NCT03614455|Posaconazole|posaconazole|mesh-list
65727960|NCT03614455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
65727961|NCT03614455|Antifungal Agents|antifungal agents|mesh-ancestor
65727962|NCT03614455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65727963|NCT03614455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65727964|NCT03614455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65727965|NCT03614455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65727966|NCT03614455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727967|NCT03614455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65727968|NCT03614455|Hormone Antagonists|hormone antagonists|mesh-ancestor
65727969|NCT03614455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65727970|NCT03614455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727971|NCT03614455|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65727972|NCT03614455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65727973|NCT03614455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65727974|NCT03393117|Narcotics|narcotics|mesh-list
65727975|NCT03393117|Bupivacaine|bupivacaine|mesh-list
65727976|NCT03393117|Anesthetics, Local|anesthetics, local|mesh-ancestor
65727977|NCT03393117|Anesthetics|anesthetics|mesh-ancestor
65727978|NCT03393117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65727979|NCT03393117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727980|NCT03393117|Sensory System Agents|sensory system agents|mesh-ancestor
65727981|NCT03393117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65727982|NCT03393117|Analgesics|analgesics|mesh-ancestor
65727983|NCT02032303|Ticagrelor|ticagrelor|mesh-list
65727984|NCT02032303|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65727985|NCT02032303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65727986|NCT02032303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65727987|NCT02032303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65727988|NCT02032303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65727989|NCT02032303|Purinergic Agents|purinergic agents|mesh-ancestor
65727990|NCT02032303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65727991|NCT02032303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65727992|NCT02032303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727993|NCT04297293|Ramosetron|ramosetron|mesh-list
65727994|NCT04297293|Antiemetics|antiemetics|mesh-ancestor
65727995|NCT04297293|Autonomic Agents|autonomic agents|mesh-ancestor
65727996|NCT04297293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65727997|NCT04297293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65727998|NCT04297293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65727999|NCT04297293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65728000|NCT04297293|Serotonin Agents|serotonin agents|mesh-ancestor
65728001|NCT04297293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65728002|NCT04297293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728003|NCT03392961|Insulin|insulin|mesh-list
65728004|NCT03392961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65728005|NCT03392961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728006|NCT02350946|Oxytocin|oxytocin|mesh-list
65728007|NCT02350946|Oxytocics|oxytocics|mesh-ancestor
65728008|NCT02350946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65728009|NCT02350946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728010|NCT00000371|Cycloserine|cycloserine|mesh-list
65728011|NCT00000371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65728012|NCT00000371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65728013|NCT00000371|Renal Agents|renal agents|mesh-ancestor
65728014|NCT00000371|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65728015|NCT00000371|Antitubercular Agents|antitubercular agents|mesh-ancestor
65728016|NCT00000371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65728017|NCT00000371|Antimetabolites|antimetabolites|mesh-ancestor
65728018|NCT00000371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728019|NCT02350712|Carboplatin|carboplatin|mesh-list
65728020|NCT02350712|Cetuximab|cetuximab|mesh-list
65728021|NCT02350712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728022|NCT02350712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65728023|NCT02867995|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65728024|NCT02867995|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65728025|NCT03618797|Fenofibrate|fenofibrate|mesh-list
65728026|NCT03618797|Pitavastatin|pitavastatin|mesh-list
65728027|NCT03618797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65728028|NCT03618797|Antimetabolites|antimetabolites|mesh-ancestor
65728029|NCT03618797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728030|NCT03618797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65728031|NCT03618797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65728032|NCT03618797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65728033|NCT03618797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728034|NCT03149432|Gabapentin|gabapentin|mesh-list
65728035|NCT03149432|Analgesics|analgesics|mesh-ancestor
65728036|NCT03149432|Sensory System Agents|sensory system agents|mesh-ancestor
65728037|NCT03149432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65728038|NCT03149432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728039|NCT03149432|Anticonvulsants|anticonvulsants|mesh-ancestor
65728040|NCT03149432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65728041|NCT03149432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65728042|NCT03149432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65728043|NCT03149432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65728044|NCT03149432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65728045|NCT03149432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65728046|NCT03149432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65728047|NCT03149432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728048|NCT03149432|Antimanic Agents|antimanic agents|mesh-ancestor
65728049|NCT05384483|Cariprazine|cariprazine|mesh-list
65728050|NCT05384483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65728051|NCT05384483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65728052|NCT05384483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65728053|NCT05384483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728054|NCT05384483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65728055|NCT05061563|Esomeprazole|esomeprazole|mesh-list
65728056|NCT05061563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65728057|NCT05061563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65728058|NCT05061563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65728059|NCT05061563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728060|NCT05061563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728061|NCT03147092|Losartan|losartan|mesh-list
65728062|NCT03147092|Atenolol|atenolol|mesh-list
65728063|NCT03147092|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65728064|NCT03147092|Clonidine|clonidine|mesh-list
65728065|NCT03147092|Captopril|captopril|mesh-list
65728066|NCT03147092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65728067|NCT03147092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65728068|NCT03147092|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65728069|NCT03147092|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65728070|NCT03147092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728071|NCT03147092|Diuretics|diuretics|mesh-ancestor
65728072|NCT03147092|Natriuretic Agents|natriuretic agents|mesh-ancestor
65728073|NCT03147092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728074|NCT03147092|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65728075|NCT03147092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65728076|NCT03147092|Analgesics|analgesics|mesh-ancestor
65728077|NCT03147092|Sensory System Agents|sensory system agents|mesh-ancestor
65728078|NCT03147092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65728079|NCT03147092|Sympatholytics|sympatholytics|mesh-ancestor
65043872|NCT00206570|Estrogens|estrogens|mesh-ancestor
65728080|NCT03147092|Autonomic Agents|autonomic agents|mesh-ancestor
65728081|NCT03147092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65728082|NCT03147092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65728083|NCT03147092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65728084|NCT03147092|Adrenergic Agents|adrenergic agents|mesh-ancestor
65728085|NCT03147092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65728086|NCT03147092|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65728087|NCT03147092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65728088|NCT03147092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65728089|NCT03147092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65728090|NCT03147092|Protease Inhibitors|protease inhibitors|mesh-ancestor
65728091|NCT03147092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728092|NCT03149588|Propofol|propofol|mesh-list
65728093|NCT03149588|Sevoflurane|sevoflurane|mesh-list
65728094|NCT03149588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65728095|NCT03149588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65728096|NCT03149588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728097|NCT03149588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65728098|NCT03149588|Anesthetics, General|anesthetics, general|mesh-ancestor
65728099|NCT03149588|Anesthetics|anesthetics|mesh-ancestor
65728100|NCT03149588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65728101|NCT03149588|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65728102|NCT03613207|Lidocaine|lidocaine|mesh-list
65728103|NCT03613207|Prilocaine|prilocaine|mesh-list
65728104|NCT03613207|Anesthetics, Local|anesthetics, local|mesh-ancestor
65728105|NCT03613207|Anesthetics|anesthetics|mesh-ancestor
65728106|NCT03613207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65728107|NCT03613207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728108|NCT03613207|Sensory System Agents|sensory system agents|mesh-ancestor
65728109|NCT03613207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65728110|NCT03613207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65728111|NCT03613207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65728112|NCT03613207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65728113|NCT03613207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65728114|NCT03613207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728115|NCT03612739|Azacitidine|azacitidine|mesh-list
65728116|NCT03612739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65728117|NCT03612739|Antimetabolites|antimetabolites|mesh-ancestor
65728118|NCT03612739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728119|NCT03612739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728120|NCT03612739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728121|NCT02350400|Irinotecan|irinotecan|mesh-list
65728122|NCT02350400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65728123|NCT02350400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65728124|NCT02350400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728125|NCT02350400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728126|NCT02350400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728127|NCT03612817|Timolol|timolol|mesh-list
65728128|NCT03612817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65728129|NCT03612817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65728130|NCT03612817|Adrenergic Agents|adrenergic agents|mesh-ancestor
65728131|NCT03612817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65728132|NCT03612817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728133|NCT03612817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728134|NCT03612817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65728135|NCT03612817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65728136|NCT02347904|Oxaliplatin|oxaliplatin|mesh-list
65728137|NCT02347904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728138|NCT03612349|Menthol|menthol|mesh-list
65728139|NCT03612349|Antipruritics|antipruritics|mesh-ancestor
65728140|NCT03612349|Dermatologic Agents|dermatologic agents|mesh-ancestor
65728141|NCT03146858|Enoxaparin|enoxaparin|mesh-list
65728142|NCT03146858|Anticoagulants|anticoagulants|mesh-ancestor
65728143|NCT03146858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65728144|NCT03146858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65728145|NCT03146858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728146|NCT03408405|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65728147|NCT03408405|Hormones|hormones|mesh-ancestor
65728148|NCT03408405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65728149|NCT03408405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728150|NCT03408093|Interferons|interferons|mesh-list
65728151|NCT03408093|Interferon-beta|interferon-beta|mesh-list
65728152|NCT03408093|Interferon beta-1b|interferon beta-1b|mesh-list
65728153|NCT03408093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728154|NCT03408093|Antiviral Agents|antiviral agents|mesh-ancestor
65728155|NCT03408093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65728156|NCT03408093|Immunologic Factors|immunologic factors|mesh-ancestor
65728157|NCT03408093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728158|NCT03408093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65728159|NCT04679623|Midazolam|midazolam|mesh-list
65728160|NCT04679623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65728161|NCT04679623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65728162|NCT04679623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65728163|NCT04679623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728164|NCT04679623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65728165|NCT04679623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65728166|NCT04679623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65728167|NCT04679623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65728168|NCT04679623|Anesthetics, General|anesthetics, general|mesh-ancestor
65728169|NCT04679623|Anesthetics|anesthetics|mesh-ancestor
65728170|NCT04679623|GABA Modulators|gaba modulators|mesh-ancestor
65728171|NCT04679623|GABA Agents|gaba agents|mesh-ancestor
65728172|NCT04679623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65728173|NCT04679623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728174|NCT02353988|Bicalutamide|bicalutamide|mesh-list
65728175|NCT02353988|Androgen Antagonists|androgen antagonists|mesh-ancestor
65728176|NCT02353988|Hormone Antagonists|hormone antagonists|mesh-ancestor
65728177|NCT02353988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65728178|NCT02353988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728179|NCT02353988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728180|NCT03392571|Gemcitabine|gemcitabine|mesh-list
65728181|NCT03392571|Paclitaxel|paclitaxel|mesh-list
65728182|NCT03392571|Cisplatin|cisplatin|mesh-list
65728183|NCT03392571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65728184|NCT03392571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728185|NCT03392571|Tubulin Modulators|tubulin modulators|mesh-ancestor
65728186|NCT03392571|Antimitotic Agents|antimitotic agents|mesh-ancestor
65728187|NCT03392571|Mitosis Modulators|mitosis modulators|mesh-ancestor
65728188|NCT03392571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728189|NCT03392571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65728190|NCT03392571|Antimetabolites|antimetabolites|mesh-ancestor
65728191|NCT03392571|Antiviral Agents|antiviral agents|mesh-ancestor
65728192|NCT03392571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65728193|NCT03392571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728194|NCT03392571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65728195|NCT03392571|Immunologic Factors|immunologic factors|mesh-ancestor
65728196|NCT03392571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728197|NCT04656067|Tranexamic Acid|tranexamic acid|mesh-list
65728198|NCT04656067|Ethamsylate|ethamsylate|mesh-list
65728199|NCT04656067|Oxytocin|oxytocin|mesh-list
65728200|NCT04656067|Oxytocics|oxytocics|mesh-ancestor
65728201|NCT04656067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65728202|NCT04656067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728203|NCT04656067|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65728204|NCT04656067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65728205|NCT04656067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728206|NCT04656067|Hemostatics|hemostatics|mesh-ancestor
65728207|NCT04656067|Coagulants|coagulants|mesh-ancestor
65728208|NCT03612037|Thioctic Acid|thioctic acid|mesh-list
65728209|NCT03612037|Antioxidants|antioxidants|mesh-ancestor
65728210|NCT03612037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728211|NCT03612037|Protective Agents|protective agents|mesh-ancestor
65728212|NCT03612037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728213|NCT03612037|Vitamin B Complex|vitamin b complex|mesh-ancestor
65728214|NCT03612037|Vitamins|vitamins|mesh-ancestor
65728215|NCT03612037|Micronutrients|micronutrients|mesh-ancestor
65728216|NCT04447209|Chrysarobin|chrysarobin|mesh-list
65728217|NCT04447209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65728218|NCT04447209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65728219|NCT04447209|Analgesics|analgesics|mesh-ancestor
65728220|NCT04447209|Sensory System Agents|sensory system agents|mesh-ancestor
65728221|NCT04447209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65728222|NCT04447209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728223|NCT04447209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65728224|NCT04447209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65728225|NCT04199624|Omeprazole|omeprazole|mesh-list
65728226|NCT04199624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728227|NCT04199624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65728228|NCT04199624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65728229|NCT04199624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65728230|NCT04199624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728231|NCT03611491|Lidocaine|lidocaine|mesh-list
65728232|NCT03611491|Anesthetics, Local|anesthetics, local|mesh-ancestor
65728233|NCT03611491|Anesthetics|anesthetics|mesh-ancestor
65728234|NCT03611491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65728235|NCT03611491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728236|NCT03611491|Sensory System Agents|sensory system agents|mesh-ancestor
65728237|NCT03611491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65728238|NCT03611491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65728239|NCT03611491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65728240|NCT03611491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65728241|NCT03611491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65728242|NCT03611491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728243|NCT02748863|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65728244|NCT02748863|Immunologic Factors|immunologic factors|mesh-ancestor
65728245|NCT02748863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728246|NCT03611179|Bevacizumab|bevacizumab|mesh-list
65728247|NCT03611179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65728248|NCT03611179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728249|NCT03611179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65728250|NCT03611179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65728251|NCT03611179|Growth Substances|growth substances|mesh-ancestor
65728252|NCT03611179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728253|NCT03611179|Growth Inhibitors|growth inhibitors|mesh-ancestor
65728254|NCT03126123|Acetic Acid|acetic acid|mesh-list
65728255|NCT03126123|Retinol acetate|retinol acetate|mesh-list
65728256|NCT03126123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65728257|NCT03126123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65728258|NCT03126123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65728259|NCT03126123|Immunologic Factors|immunologic factors|mesh-ancestor
65728260|NCT03126123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728261|NCT03126123|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65728262|NCT03126123|Protective Agents|protective agents|mesh-ancestor
65728263|NCT03126123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728264|NCT02353676|Bupivacaine|bupivacaine|mesh-list
65728265|NCT02353676|Anesthetics, Local|anesthetics, local|mesh-ancestor
65728266|NCT02353676|Anesthetics|anesthetics|mesh-ancestor
65728267|NCT02353676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65728268|NCT02353676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728269|NCT02353676|Sensory System Agents|sensory system agents|mesh-ancestor
65728270|NCT02353676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65728271|NCT04184869|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65728272|NCT04184869|Belinostat|belinostat|mesh-list
65728273|NCT04184869|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65728274|NCT04184869|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65728275|NCT04184869|Protease Inhibitors|protease inhibitors|mesh-ancestor
65728276|NCT04184869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728277|NCT04184869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728278|NCT04184869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65728279|NCT04184869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65728280|NCT04184869|Antiviral Agents|antiviral agents|mesh-ancestor
65728281|NCT04184869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65728282|NCT04184869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728283|NCT04184869|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65728284|NCT03617471|Acetaminophen|acetaminophen|mesh-list
65728285|NCT03617471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65728286|NCT03617471|Analgesics|analgesics|mesh-ancestor
65728287|NCT03617471|Sensory System Agents|sensory system agents|mesh-ancestor
65728288|NCT03617471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65728289|NCT03617471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728290|NCT03617471|Antipyretics|antipyretics|mesh-ancestor
65728291|NCT04162873|Celecoxib|celecoxib|mesh-list
65728292|NCT04162873|Benzenesulfonamide|benzenesulfonamide|mesh-list
65728293|NCT04162873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65728294|NCT04162873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65728295|NCT04162873|Analgesics|analgesics|mesh-ancestor
65728296|NCT04162873|Sensory System Agents|sensory system agents|mesh-ancestor
65728297|NCT04162873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65728298|NCT04162873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728299|NCT04162873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65728300|NCT04162873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65728301|NCT04162873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65728302|NCT04162873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65728303|NCT04162873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728304|NCT04162873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728305|NCT04162873|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65728306|NCT05168007|Cariprazine|cariprazine|mesh-list
65728307|NCT05168007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65728308|NCT05168007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65728309|NCT05168007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65728310|NCT05168007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728311|NCT05168007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65728312|NCT02032927|Acetaminophen|acetaminophen|mesh-list
65728313|NCT02032927|Oxycodone|oxycodone|mesh-list
65728314|NCT02032927|Codeine|codeine|mesh-list
65728315|NCT02032927|Naloxone|naloxone|mesh-list
65728316|NCT02032927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65728317|NCT02032927|Analgesics|analgesics|mesh-ancestor
65728318|NCT02032927|Sensory System Agents|sensory system agents|mesh-ancestor
65728319|NCT02032927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65728320|NCT02032927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728321|NCT02032927|Antipyretics|antipyretics|mesh-ancestor
65728322|NCT02032927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65728323|NCT02032927|Narcotics|narcotics|mesh-ancestor
65728324|NCT02032927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65728325|NCT02032927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65728326|NCT02032927|Antitussive Agents|antitussive agents|mesh-ancestor
65728327|NCT02032927|Respiratory System Agents|respiratory system agents|mesh-ancestor
65728328|NCT02353598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65728329|NCT02353598|Immunologic Factors|immunologic factors|mesh-ancestor
65728330|NCT02353598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728331|NCT03392103|Raltitrexed|raltitrexed|mesh-list
65728332|NCT03392103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65728333|NCT03392103|Antimetabolites|antimetabolites|mesh-ancestor
65728334|NCT03392103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728335|NCT03392103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728336|NCT03392103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65728337|NCT03392103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728338|NCT03610945|Fluconazole|fluconazole|mesh-list
65728339|NCT03610945|Quinidine|quinidine|mesh-list
65728340|NCT03610945|Antifungal Agents|antifungal agents|mesh-ancestor
65728341|NCT03610945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65728342|NCT03610945|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65728343|NCT03610945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65728344|NCT03610945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728345|NCT03610945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728346|NCT03610945|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65728347|NCT03610945|Hormone Antagonists|hormone antagonists|mesh-ancestor
65728348|NCT03610945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65728349|NCT03610945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728350|NCT03610945|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65728351|NCT03610945|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65728352|NCT03610945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65728353|NCT03610945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65728354|NCT03610945|Adrenergic Agents|adrenergic agents|mesh-ancestor
65728355|NCT03610945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65728356|NCT03610945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65728357|NCT03610945|Antimalarials|antimalarials|mesh-ancestor
65728358|NCT03610945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65728359|NCT03610945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65728360|NCT03610945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65728361|NCT03610945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65728362|NCT03610945|Cholinergic Agents|cholinergic agents|mesh-ancestor
65728363|NCT03610945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65728364|NCT03610945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65728365|NCT03610945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65728366|NCT03610945|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65728367|NCT03616769|Antihypertensive Agents|antihypertensive agents|mesh-list
65728368|NCT03616769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65728369|NCT05167851|Lazertinib|lazertinib|mesh-list
65728370|NCT05167851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65728371|NCT05167851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728372|NCT05167851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728373|NCT02236715|Ipratropium|ipratropium|mesh-list
65728374|NCT02236715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65728375|NCT02236715|Autonomic Agents|autonomic agents|mesh-ancestor
65728376|NCT02236715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044098|NCT00230490|Pradefovir|pradefovir|mesh-list
65728377|NCT02236715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728378|NCT02236715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65728379|NCT02236715|Respiratory System Agents|respiratory system agents|mesh-ancestor
65728380|NCT02236715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65728381|NCT02236715|Cholinergic Agents|cholinergic agents|mesh-ancestor
65728382|NCT02236715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65728383|NCT02236715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728384|NCT03823365|Blinatumomab|blinatumomab|mesh-list
65728385|NCT03823365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728386|NCT03616691|Bevacizumab|bevacizumab|mesh-list
65728387|NCT03616691|Atezolizumab|atezolizumab|mesh-list
65728388|NCT03616691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65728389|NCT03616691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65728390|NCT03616691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728391|NCT03616691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65728392|NCT03616691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65728393|NCT03616691|Growth Substances|growth substances|mesh-ancestor
65728394|NCT03616691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728395|NCT03616691|Growth Inhibitors|growth inhibitors|mesh-ancestor
65728396|NCT03616691|Immunologic Factors|immunologic factors|mesh-ancestor
65728397|NCT03158168|Zinc Sulfate|zinc sulfate|mesh-list
65728398|NCT03158168|Astringents|astringents|mesh-ancestor
65728399|NCT03158168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728400|NCT03158168|Dermatologic Agents|dermatologic agents|mesh-ancestor
65728401|NCT03334253|Atropine|atropine|mesh-list
65728402|NCT03334253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65728403|NCT03334253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65728404|NCT03334253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65728405|NCT03334253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65728406|NCT03334253|Autonomic Agents|autonomic agents|mesh-ancestor
65728407|NCT03334253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65728408|NCT03334253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728409|NCT03334253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65728410|NCT03334253|Respiratory System Agents|respiratory system agents|mesh-ancestor
65728411|NCT03334253|Mydriatics|mydriatics|mesh-ancestor
65728412|NCT03334253|Parasympatholytics|parasympatholytics|mesh-ancestor
65728413|NCT03334253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65728414|NCT03334253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65728415|NCT03334253|Cholinergic Agents|cholinergic agents|mesh-ancestor
65728416|NCT03334253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65728417|NCT03334253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728418|NCT03334253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65728419|NCT02865499|Acarbose|acarbose|mesh-list
65728420|NCT02865499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65728421|NCT02865499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728422|NCT02865499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728423|NCT02865499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65728424|NCT02865499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728425|NCT03156062|Salicylic Acid|salicylic acid|mesh-list
65728426|NCT03156062|Salicylates|salicylates|mesh-list
65728427|NCT03156062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65728428|NCT03156062|Antifungal Agents|antifungal agents|mesh-ancestor
65728429|NCT03156062|Keratolytic Agents|keratolytic agents|mesh-ancestor
65728430|NCT03156062|Dermatologic Agents|dermatologic agents|mesh-ancestor
65728431|NCT03156062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65728432|NCT03156062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65728433|NCT03156062|Analgesics|analgesics|mesh-ancestor
65728434|NCT03156062|Sensory System Agents|sensory system agents|mesh-ancestor
65728435|NCT03156062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65728436|NCT03156062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728437|NCT03156062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65728438|NCT03156062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65728439|NCT03156062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65728440|NCT03156062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728441|NCT03156062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728442|NCT02568553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65728443|NCT02568553|Lenalidomide|lenalidomide|mesh-list
65728444|NCT02568553|Blinatumomab|blinatumomab|mesh-list
65728445|NCT02568553|Antibodies|antibodies|mesh-list
65728446|NCT02568553|Immunoglobulins|immunoglobulins|mesh-list
65728447|NCT02568553|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65728448|NCT02568553|Muromonab-CD3|muromonab-cd3|mesh-list
65728449|NCT02568553|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65728450|NCT02568553|Immunologic Factors|immunologic factors|mesh-ancestor
65728451|NCT02568553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728452|NCT02568553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728453|NCT02568553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65728454|NCT02568553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65728455|NCT02568553|Growth Substances|growth substances|mesh-ancestor
65728456|NCT02568553|Growth Inhibitors|growth inhibitors|mesh-ancestor
65728457|NCT02568553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65728458|NCT03404739|Ceftazidime|ceftazidime|mesh-list
65728459|NCT03404739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65728460|NCT03404739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65728461|NCT02031965|Dexamethasone|dexamethasone|mesh-list
65728462|NCT02031965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65728463|NCT02031965|Antiemetics|antiemetics|mesh-ancestor
65728464|NCT02031965|Autonomic Agents|autonomic agents|mesh-ancestor
65728465|NCT02031965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65728466|NCT02031965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728467|NCT02031965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65728468|NCT02031965|Glucocorticoids|glucocorticoids|mesh-ancestor
65728469|NCT02031965|Hormones|hormones|mesh-ancestor
65728470|NCT02031965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65728471|NCT02031965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65728472|NCT02031965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728473|NCT03149120|Nivolumab|nivolumab|mesh-list
65728474|NCT03149120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65728475|NCT03149120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728476|NCT03149120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65728477|NCT03149120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728478|NCT04849325|Sirolimus|sirolimus|mesh-list
65728479|NCT04849325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65728480|NCT04849325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65728481|NCT04849325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65728482|NCT04849325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728483|NCT04849325|Antifungal Agents|antifungal agents|mesh-ancestor
65728484|NCT04849325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65728485|NCT04849325|Immunologic Factors|immunologic factors|mesh-ancestor
65728486|NCT04849325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728487|NCT03403023|Cyclosporine|cyclosporine|mesh-list
65728488|NCT03403023|Cyclosporins|cyclosporins|mesh-list
65728489|NCT03403023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728490|NCT03403023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728491|NCT03403023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65728492|NCT03403023|Immunologic Factors|immunologic factors|mesh-ancestor
65728493|NCT03403023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728494|NCT03403023|Antifungal Agents|antifungal agents|mesh-ancestor
65728495|NCT03403023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65728496|NCT03403023|Dermatologic Agents|dermatologic agents|mesh-ancestor
65728497|NCT03403023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65728498|NCT03403023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65728499|NCT02864407|Tiotropium Bromide|tiotropium bromide|mesh-list
65728500|NCT02864407|Olodaterol|olodaterol|mesh-list
65728501|NCT02864407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65728502|NCT02864407|Autonomic Agents|autonomic agents|mesh-ancestor
65728503|NCT02864407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65728504|NCT02864407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728505|NCT02864407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65728506|NCT02864407|Respiratory System Agents|respiratory system agents|mesh-ancestor
65728507|NCT02864407|Parasympatholytics|parasympatholytics|mesh-ancestor
65728508|NCT02864407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65728509|NCT02864407|Cholinergic Agents|cholinergic agents|mesh-ancestor
65728510|NCT02864407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65728511|NCT02864407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728512|NCT03616301|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65728513|NCT03616301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65728514|NCT03616301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65728515|NCT03616301|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65728516|NCT03616301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728517|NCT03616301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728518|NCT03394989|Fluticasone|fluticasone|mesh-list
65728519|NCT03394989|Xhance|xhance|mesh-list
65728520|NCT03394989|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65728521|NCT03394989|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65728522|NCT03394989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65728523|NCT03394989|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65728524|NCT03394989|Autonomic Agents|autonomic agents|mesh-ancestor
65728525|NCT03394989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65728526|NCT03394989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728527|NCT03394989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65728528|NCT03394989|Respiratory System Agents|respiratory system agents|mesh-ancestor
65728529|NCT03394989|Dermatologic Agents|dermatologic agents|mesh-ancestor
65728530|NCT03394989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65728531|NCT03394989|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65728532|NCT03394989|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65728533|NCT03394989|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65728534|NCT03394989|Adrenergic Agents|adrenergic agents|mesh-ancestor
65728535|NCT03394989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65728536|NCT03394989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728537|NCT03394989|Glucocorticoids|glucocorticoids|mesh-ancestor
65728538|NCT03394989|Hormones|hormones|mesh-ancestor
65728539|NCT03394989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65728540|NCT03394989|Sympathomimetics|sympathomimetics|mesh-ancestor
65728541|NCT02033239|Insulin|insulin|mesh-list
65728542|NCT02033239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65728543|NCT02033239|Insulin Aspart|insulin aspart|mesh-list
65728544|NCT02033239|Insulin, Long-Acting|insulin, long-acting|mesh-list
65728545|NCT02033239|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65728546|NCT02033239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65728547|NCT02033239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728548|NCT02486302|Etanercept|etanercept|mesh-list
65728549|NCT02486302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65728550|NCT02486302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65728551|NCT02486302|Analgesics|analgesics|mesh-ancestor
65728552|NCT02486302|Sensory System Agents|sensory system agents|mesh-ancestor
65728553|NCT02486302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65728554|NCT02486302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728555|NCT02486302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65728556|NCT02486302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65728557|NCT02486302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65728558|NCT02486302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65728559|NCT02486302|Immunologic Factors|immunologic factors|mesh-ancestor
65728560|NCT02034097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65728561|NCT02034097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728562|NCT02034097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65728563|NCT02034097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728564|NCT02034097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728565|NCT03615833|Vitamin D|vitamin d|mesh-list
65728566|NCT03615833|Cholecalciferol|cholecalciferol|mesh-list
65728567|NCT03615833|Vitamins|vitamins|mesh-ancestor
65728568|NCT03615833|Micronutrients|micronutrients|mesh-ancestor
65728569|NCT03615833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728570|NCT03615833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65728571|NCT03615833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65728572|NCT02747875|Fentanyl|fentanyl|mesh-list
65728573|NCT02747875|Methadone|methadone|mesh-list
65728574|NCT02747875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65728575|NCT02747875|Narcotics|narcotics|mesh-ancestor
65728576|NCT02747875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65728577|NCT02747875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728578|NCT02747875|Analgesics|analgesics|mesh-ancestor
65728579|NCT02747875|Sensory System Agents|sensory system agents|mesh-ancestor
65728580|NCT02747875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65728581|NCT02747875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65728582|NCT02747875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65728583|NCT02747875|Anesthetics, General|anesthetics, general|mesh-ancestor
65728584|NCT02747875|Anesthetics|anesthetics|mesh-ancestor
65728585|NCT02747875|Antitussive Agents|antitussive agents|mesh-ancestor
65728586|NCT02747875|Respiratory System Agents|respiratory system agents|mesh-ancestor
65728587|NCT03394833|Polygeline|polygeline|mesh-list
65728588|NCT03394833|Plasma Substitutes|plasma substitutes|mesh-ancestor
65728589|NCT03394833|Blood Substitutes|blood substitutes|mesh-ancestor
65728590|NCT02347358|Plasminogen|plasminogen|mesh-list
65728591|NCT02347358|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65728592|NCT02347358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65728593|NCT02347358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65728594|NCT02347358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728595|NCT03610321|Gefarnate|gefarnate|mesh-list
65728596|NCT03610321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65728597|NCT03610321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65728598|NCT02236793|Becaplermin|becaplermin|mesh-list
65728599|NCT02236793|Anticoagulants|anticoagulants|mesh-ancestor
65728600|NCT02236793|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
65728601|NCT02236793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65728602|NCT02236793|Growth Substances|growth substances|mesh-ancestor
65728603|NCT02236793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728604|NCT02347046|Dotinurad|dotinurad|mesh-list
65728605|NCT02347046|Uricosuric Agents|uricosuric agents|mesh-ancestor
65728606|NCT02347046|Gout Suppressants|gout suppressants|mesh-ancestor
65728607|NCT02347046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65728609|NCT03391245|Vitamin D|vitamin d|mesh-list
65728610|NCT03391245|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65728611|NCT03391245|Calcifediol|calcifediol|mesh-list
65728612|NCT03391245|Vitamins|vitamins|mesh-ancestor
65728613|NCT03391245|Micronutrients|micronutrients|mesh-ancestor
65728614|NCT03391245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728615|NCT03391245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65728616|NCT03401619|Vitamin D|vitamin d|mesh-list
65728617|NCT03401619|Calcitonin|calcitonin|mesh-list
65728618|NCT03401619|Salmon calcitonin|salmon calcitonin|mesh-list
65728619|NCT03401619|Diphosphonates|diphosphonates|mesh-list
65728620|NCT03401619|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
65728621|NCT03401619|Katacalcin|katacalcin|mesh-list
65728622|NCT03401619|Vitamins|vitamins|mesh-ancestor
65728623|NCT03401619|Micronutrients|micronutrients|mesh-ancestor
65728624|NCT03401619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728625|NCT03401619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65728626|NCT03401619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65728627|NCT03401619|Vasodilator Agents|vasodilator agents|mesh-ancestor
65728628|NCT03399903|Mesalamine|mesalamine|mesh-list
65728629|NCT03399903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65728630|NCT03399903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65728631|NCT03399903|Analgesics|analgesics|mesh-ancestor
65728632|NCT03399903|Sensory System Agents|sensory system agents|mesh-ancestor
65728633|NCT03399903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65728634|NCT03399903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728635|NCT03399903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65728636|NCT03399903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65728637|NCT03146468|Nivolumab|nivolumab|mesh-list
65728638|NCT03146468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65728639|NCT03146468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728640|NCT03146468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65728641|NCT03146468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728642|NCT02353130|Memantine|memantine|mesh-list
65728643|NCT02353130|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65728644|NCT02353130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65728645|NCT02353130|Dopamine Agents|dopamine agents|mesh-ancestor
65728646|NCT02353130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65728647|NCT02353130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728648|NCT02353130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728649|NCT02353130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65728650|NCT02353130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65728651|NCT02033551|Paclitaxel|paclitaxel|mesh-list
65728652|NCT02033551|Carboplatin|carboplatin|mesh-list
65728653|NCT02033551|Veliparib|veliparib|mesh-list
65728654|NCT02033551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65728655|NCT02033551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728656|NCT02033551|Tubulin Modulators|tubulin modulators|mesh-ancestor
65728657|NCT02033551|Antimitotic Agents|antimitotic agents|mesh-ancestor
65728658|NCT02033551|Mitosis Modulators|mitosis modulators|mesh-ancestor
65728659|NCT02033551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728660|NCT02033551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65728661|NCT02033551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728662|NCT02450578|Atovaquone|atovaquone|mesh-list
65728663|NCT02450578|Proguanil|proguanil|mesh-list
65728664|NCT02450578|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
65728665|NCT02450578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65728666|NCT02450578|Antimalarials|antimalarials|mesh-ancestor
65728667|NCT02450578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65728668|NCT02450578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65728669|NCT02450578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728670|NCT02450578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728671|NCT02450578|Antimetabolites|antimetabolites|mesh-ancestor
65728672|NCT02346890|Sevelamer|sevelamer|mesh-list
65728673|NCT02346890|Chelating Agents|chelating agents|mesh-ancestor
65728674|NCT02346890|Sequestering Agents|sequestering agents|mesh-ancestor
65728675|NCT02346890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728676|NCT03146390|Listerine|listerine|mesh-list
65728677|NCT03146390|Sodium Fluoride|sodium fluoride|mesh-list
65728678|NCT03146390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65728679|NCT03146390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65728680|NCT03146390|Cariostatic Agents|cariostatic agents|mesh-ancestor
65728681|NCT03146390|Protective Agents|protective agents|mesh-ancestor
65728682|NCT03146390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728683|NCT02859415|Plicamycin|plicamycin|mesh-list
65728684|NCT02859415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65044470|NCT00209222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728685|NCT02859415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728686|NCT02859415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65728687|NCT02859415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728688|NCT02859415|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65728689|NCT02859415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728690|NCT02859415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728691|NCT02859415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65728693|NCT02871791|Palbociclib|palbociclib|mesh-list
65728694|NCT02871791|Exemestane|exemestane|mesh-list
65728695|NCT02871791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728696|NCT02871791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65728697|NCT02871791|Immunologic Factors|immunologic factors|mesh-ancestor
65728698|NCT02871791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728699|NCT02871791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65728700|NCT02871791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728701|NCT02871791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728702|NCT02871791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65728703|NCT02871791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65728704|NCT02871791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65728705|NCT02871791|Hormone Antagonists|hormone antagonists|mesh-ancestor
65728706|NCT02871791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65728707|NCT02346578|Flutamide|flutamide|mesh-list
65728708|NCT02346578|Androgen Antagonists|androgen antagonists|mesh-ancestor
65728709|NCT02346578|Hormone Antagonists|hormone antagonists|mesh-ancestor
65728710|NCT02346578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65728711|NCT02346578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728712|NCT02346578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65728713|NCT02346578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728714|NCT04933721|Berotralstat|berotralstat|mesh-list
65728715|NCT04933721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728716|NCT04933721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728717|NCT03112382|Vitamins|vitamins|mesh-list
65728718|NCT03112382|Vitamin A|vitamin a|mesh-list
65728719|NCT03112382|Retinol palmitate|retinol palmitate|mesh-list
65728720|NCT03112382|Micronutrients|micronutrients|mesh-ancestor
65728721|NCT03112382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728722|NCT03112382|Antioxidants|antioxidants|mesh-ancestor
65728723|NCT03112382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728724|NCT03112382|Protective Agents|protective agents|mesh-ancestor
65728725|NCT03112382|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65728726|NCT03112382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728727|NCT03399669|Gefitinib|gefitinib|mesh-list
65728728|NCT03399669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728729|NCT03399669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65728730|NCT03399669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728731|NCT03399669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728732|NCT03148574|Misoprostol|misoprostol|mesh-list
65728733|NCT03148574|Oxytocin|oxytocin|mesh-list
65728734|NCT03148574|Oxytocics|oxytocics|mesh-ancestor
65728735|NCT03148574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65728736|NCT03148574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728737|NCT03148574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65728738|NCT03148574|Abortifacient Agents|abortifacient agents|mesh-ancestor
65728739|NCT03148574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65728740|NCT03148574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65728741|NCT02343536|Prednisone|prednisone|mesh-list
65728742|NCT02343536|Cyclophosphamide|cyclophosphamide|mesh-list
65728743|NCT02343536|Rituximab|rituximab|mesh-list
65728744|NCT02343536|Vincristine|vincristine|mesh-list
65728745|NCT02343536|Azacitidine|azacitidine|mesh-list
65728746|NCT02343536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65728747|NCT02343536|Immunologic Factors|immunologic factors|mesh-ancestor
65728748|NCT02343536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728749|NCT02343536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65728750|NCT02343536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65728751|NCT02343536|Alkylating Agents|alkylating agents|mesh-ancestor
65728752|NCT02343536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728753|NCT02343536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728754|NCT02343536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65728755|NCT02343536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65728756|NCT02343536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65728757|NCT02343536|Glucocorticoids|glucocorticoids|mesh-ancestor
65728758|NCT02343536|Hormones|hormones|mesh-ancestor
65728759|NCT02343536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65728760|NCT02343536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65728761|NCT02343536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65728762|NCT02343536|Tubulin Modulators|tubulin modulators|mesh-ancestor
65728763|NCT02343536|Antimitotic Agents|antimitotic agents|mesh-ancestor
65728764|NCT02343536|Mitosis Modulators|mitosis modulators|mesh-ancestor
65728765|NCT02343536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65728766|NCT02343536|Antimetabolites|antimetabolites|mesh-ancestor
65728767|NCT02343536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728769|NCT02343614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65728770|NCT02343614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65728771|NCT02343614|Analgesics|analgesics|mesh-ancestor
65728772|NCT02343614|Sensory System Agents|sensory system agents|mesh-ancestor
65728773|NCT02343614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65728774|NCT02343614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728775|NCT02343614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65728776|NCT02343614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65728777|NCT02343614|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65728778|NCT02343614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65728779|NCT02343614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728780|NCT02343614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728781|NCT02871635|Adalimumab|adalimumab|mesh-list
65728782|NCT02871635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65728783|NCT02871635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65728784|NCT03390465|Amlodipine|amlodipine|mesh-list
65728785|NCT03390465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65728786|NCT03390465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65728787|NCT03390465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65728788|NCT03390465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65728789|NCT03390465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728790|NCT03390465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65728791|NCT03390465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728792|NCT03390465|Vasodilator Agents|vasodilator agents|mesh-ancestor
65728793|NCT03390465|Diuretics|diuretics|mesh-ancestor
65728794|NCT03390465|Natriuretic Agents|natriuretic agents|mesh-ancestor
65728795|NCT03390465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65728796|NCT03390387|Dexamethasone|dexamethasone|mesh-list
65728797|NCT03390387|Dexamethasone acetate|dexamethasone acetate|mesh-list
65728798|NCT03390387|Methylprednisolone|methylprednisolone|mesh-list
65728799|NCT03390387|Bortezomib|bortezomib|mesh-list
65728800|NCT03390387|Daunorubicin|daunorubicin|mesh-list
65728801|NCT03390387|Idarubicin|idarubicin|mesh-list
65728802|NCT03390387|BB 1101|bb 1101|mesh-list
65728803|NCT03390387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65728804|NCT03390387|Antiemetics|antiemetics|mesh-ancestor
65728805|NCT03390387|Autonomic Agents|autonomic agents|mesh-ancestor
65728806|NCT03390387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65728807|NCT03390387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728808|NCT03390387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65728809|NCT03390387|Glucocorticoids|glucocorticoids|mesh-ancestor
65728810|NCT03390387|Hormones|hormones|mesh-ancestor
65728811|NCT03390387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65728812|NCT03390387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65728813|NCT03390387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728814|NCT03390387|Protease Inhibitors|protease inhibitors|mesh-ancestor
65728815|NCT03390387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728816|NCT03390387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728817|NCT03390387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65728818|NCT03390387|Protective Agents|protective agents|mesh-ancestor
65728819|NCT03390387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65728820|NCT03390387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65728821|NCT03390387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65728822|NCT03146000|Meloxicam|meloxicam|mesh-list
65728823|NCT03146000|Lidocaine|lidocaine|mesh-list
65728824|NCT03146000|Prilocaine|prilocaine|mesh-list
65728825|NCT03146000|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65728826|NCT03146000|Anesthetics, Local|anesthetics, local|mesh-ancestor
65728827|NCT03146000|Anesthetics|anesthetics|mesh-ancestor
65728828|NCT03146000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65728829|NCT03146000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728830|NCT03146000|Sensory System Agents|sensory system agents|mesh-ancestor
65044542|NCT00411437|Cholinergic Agents|cholinergic agents|mesh-ancestor
65728831|NCT03146000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65728832|NCT03146000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65728833|NCT03146000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65728834|NCT03146000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65728835|NCT03146000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65728836|NCT03146000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728837|NCT03146000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65728838|NCT03146000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65728839|NCT03146000|Analgesics|analgesics|mesh-ancestor
65728840|NCT03146000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65728841|NCT03146000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65728842|NCT03146000|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65728843|NCT03146000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65728844|NCT03146000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728845|NCT03146000|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65728846|NCT02346188|Ferrous fumarate|ferrous fumarate|mesh-list
65728847|NCT02346188|Zinc Oxide|zinc oxide|mesh-list
65728848|NCT02346188|Trace Elements|trace elements|mesh-ancestor
65728849|NCT02346188|Micronutrients|micronutrients|mesh-ancestor
65728850|NCT02346188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728851|NCT02346188|Dermatologic Agents|dermatologic agents|mesh-ancestor
65728852|NCT02346188|Sunscreening Agents|sunscreening agents|mesh-ancestor
65728853|NCT02346188|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65728854|NCT02346188|Protective Agents|protective agents|mesh-ancestor
65728855|NCT02477332|Omalizumab|omalizumab|mesh-list
65728856|NCT02477332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65728857|NCT02477332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65728858|NCT02477332|Respiratory System Agents|respiratory system agents|mesh-ancestor
65728859|NCT02346110|Dexamethasone|dexamethasone|mesh-list
65728860|NCT02346110|Epinephrine|epinephrine|mesh-list
65728861|NCT02346110|Racepinephrine|racepinephrine|mesh-list
65728862|NCT02346110|Bupivacaine|bupivacaine|mesh-list
65728863|NCT02346110|Epinephryl borate|epinephryl borate|mesh-list
65728864|NCT02346110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65728865|NCT02346110|Antiemetics|antiemetics|mesh-ancestor
65728866|NCT02346110|Autonomic Agents|autonomic agents|mesh-ancestor
65728867|NCT02346110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65728868|NCT02346110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728869|NCT02346110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65728870|NCT02346110|Glucocorticoids|glucocorticoids|mesh-ancestor
65728871|NCT02346110|Hormones|hormones|mesh-ancestor
65728872|NCT02346110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65728873|NCT02346110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65728874|NCT02346110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728875|NCT02346110|Anesthetics, Local|anesthetics, local|mesh-ancestor
65728876|NCT02346110|Anesthetics|anesthetics|mesh-ancestor
65728877|NCT02346110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65728878|NCT02346110|Sensory System Agents|sensory system agents|mesh-ancestor
65728879|NCT02346110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65728880|NCT02346110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65728881|NCT02346110|Adrenergic Agents|adrenergic agents|mesh-ancestor
65728882|NCT02346110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65728883|NCT02346110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728884|NCT02346110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65728885|NCT02346110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65728886|NCT02346110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65728887|NCT02346110|Respiratory System Agents|respiratory system agents|mesh-ancestor
65728888|NCT02346110|Mydriatics|mydriatics|mesh-ancestor
65728889|NCT02346110|Sympathomimetics|sympathomimetics|mesh-ancestor
65728890|NCT02346110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65728891|NCT02348528|Dexamethasone|dexamethasone|mesh-list
65728892|NCT02348528|Lenalidomide|lenalidomide|mesh-list
65728893|NCT02348528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65728894|NCT02348528|Antiemetics|antiemetics|mesh-ancestor
65728895|NCT02348528|Autonomic Agents|autonomic agents|mesh-ancestor
65728896|NCT02348528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65728897|NCT02348528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728898|NCT02348528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65728899|NCT02348528|Glucocorticoids|glucocorticoids|mesh-ancestor
65728900|NCT02348528|Hormones|hormones|mesh-ancestor
65728901|NCT02348528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65728902|NCT02348528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65728903|NCT02348528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728904|NCT02348528|Immunologic Factors|immunologic factors|mesh-ancestor
65728905|NCT02348528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65728906|NCT02348528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65728907|NCT02348528|Growth Substances|growth substances|mesh-ancestor
65044623|NCT00209612|Paclitaxel|paclitaxel|mesh-list
65728908|NCT02348528|Growth Inhibitors|growth inhibitors|mesh-ancestor
65728909|NCT02342600|Trametinib|trametinib|mesh-list
65728910|NCT02342600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728911|NCT02342600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65728912|NCT02342600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728913|NCT02342600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728914|NCT03147638|Warfarin|warfarin|mesh-list
65269611|NCT02738918|Abatacept|abatacept|mesh-list
65728915|NCT03147638|Anticoagulants|anticoagulants|mesh-ancestor
65728916|NCT02342366|Sodium Oxybate|sodium oxybate|mesh-list
65728917|NCT02342366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65728918|NCT02342366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65728919|NCT02342366|Anesthetics, General|anesthetics, general|mesh-ancestor
65728920|NCT02342366|Anesthetics|anesthetics|mesh-ancestor
65728921|NCT02342366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65728922|NCT02342366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728923|NCT02862535|Oxaliplatin|oxaliplatin|mesh-list
65728924|NCT02862535|Nivolumab|nivolumab|mesh-list
65728925|NCT02862535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728926|NCT02862535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65728927|NCT02862535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65728928|NCT02862535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728929|NCT02033707|Scopolamine|scopolamine|mesh-list
65728930|NCT02033707|Hallucinogens|hallucinogens|mesh-list
65728931|NCT02033707|Nicotine|nicotine|mesh-list
65728932|NCT02033707|Histamine Antagonists|histamine antagonists|mesh-list
65728933|NCT02033707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65728934|NCT02033707|Autonomic Agents|autonomic agents|mesh-ancestor
65728935|NCT02033707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65728936|NCT02033707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728937|NCT02033707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65728938|NCT02033707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65728939|NCT02033707|Cholinergic Agents|cholinergic agents|mesh-ancestor
65728940|NCT02033707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65728941|NCT02033707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728942|NCT02033707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65728943|NCT02033707|Antiemetics|antiemetics|mesh-ancestor
65728944|NCT02033707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65728945|NCT02033707|Mydriatics|mydriatics|mesh-ancestor
65728946|NCT02033707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65728947|NCT02033707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65728948|NCT02033707|Histamine Agents|histamine agents|mesh-ancestor
65728949|NCT02033707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65728950|NCT02039336|Docetaxel|docetaxel|mesh-list
65728951|NCT02039336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728952|NCT02039336|Tubulin Modulators|tubulin modulators|mesh-ancestor
65728953|NCT02039336|Antimitotic Agents|antimitotic agents|mesh-ancestor
65728954|NCT02039336|Mitosis Modulators|mitosis modulators|mesh-ancestor
65728955|NCT02039336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728956|NCT04935476|Dapsone|dapsone|mesh-list
65728957|NCT04935476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65728958|NCT04935476|Antimalarials|antimalarials|mesh-ancestor
65728959|NCT04935476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65728960|NCT04935476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65728961|NCT04935476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65728962|NCT04935476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728963|NCT04935476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728964|NCT04935476|Leprostatic Agents|leprostatic agents|mesh-ancestor
65728965|NCT04935476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65728966|NCT02476006|Atorvastatin|atorvastatin|mesh-list
65728967|NCT02476006|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65728968|NCT02476006|Simvastatin|simvastatin|mesh-list
65728969|NCT02476006|Ezetimibe|ezetimibe|mesh-list
65728970|NCT02476006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65728971|NCT02476006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65728972|NCT02476006|Antimetabolites|antimetabolites|mesh-ancestor
65728973|NCT02476006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728974|NCT02476006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65728975|NCT02476006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65728976|NCT02476006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728977|NCT02344940|Tamoxifen|tamoxifen|mesh-list
65728978|NCT02344940|Toremifene|toremifene|mesh-list
65728979|NCT02344940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65728980|NCT02344940|Hormone Antagonists|hormone antagonists|mesh-ancestor
65728981|NCT02344940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65728982|NCT02344940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65728983|NCT02344940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65728984|NCT02344940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65728985|NCT02344940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65728986|NCT02344940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65728987|NCT02344940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65728988|NCT03615677|Esomeprazole|esomeprazole|mesh-list
65728989|NCT03615677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65728990|NCT03615677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65728991|NCT03615677|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65728992|NCT03615677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65728993|NCT03615677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65728994|NCT02344862|Dotinurad|dotinurad|mesh-list
65728995|NCT02344862|Uricosuric Agents|uricosuric agents|mesh-ancestor
65728996|NCT02344862|Gout Suppressants|gout suppressants|mesh-ancestor
65728997|NCT02344862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65728998|NCT02344862|Renal Agents|renal agents|mesh-ancestor
65728999|NCT03614429|Chlorhexidine|chlorhexidine|mesh-list
65729000|NCT03614429|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65729001|NCT03614429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65729002|NCT03614429|Disinfectants|disinfectants|mesh-ancestor
65729003|NCT03614273|Epinephrine|epinephrine|mesh-list
65729004|NCT03614273|Racepinephrine|racepinephrine|mesh-list
65729005|NCT03614273|Epinephryl borate|epinephryl borate|mesh-list
65729006|NCT03614273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65729007|NCT03614273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65729008|NCT03614273|Adrenergic Agents|adrenergic agents|mesh-ancestor
65729009|NCT03614273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65729010|NCT03614273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729011|NCT03614273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729012|NCT03614273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65729013|NCT03614273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65729014|NCT03614273|Autonomic Agents|autonomic agents|mesh-ancestor
65729015|NCT03614273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729016|NCT03614273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65729017|NCT03614273|Respiratory System Agents|respiratory system agents|mesh-ancestor
65729018|NCT03614273|Mydriatics|mydriatics|mesh-ancestor
65729019|NCT03614273|Sympathomimetics|sympathomimetics|mesh-ancestor
65729020|NCT03614273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65729021|NCT02336984|Trastuzumab|trastuzumab|mesh-list
65729022|NCT02336984|Pertuzumab|pertuzumab|mesh-list
65729023|NCT02336984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65729024|NCT02336984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729025|NCT03145610|Triclosan|triclosan|mesh-list
65729026|NCT03145610|Fluorides|fluorides|mesh-list
65729027|NCT03145610|Cariostatic Agents|cariostatic agents|mesh-ancestor
65729028|NCT03145610|Protective Agents|protective agents|mesh-ancestor
65729029|NCT03145610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729030|NCT03145610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65729031|NCT03145610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65729032|NCT03145610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65729033|NCT03145610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65729034|NCT03145610|Antimetabolites|antimetabolites|mesh-ancestor
65729035|NCT03145610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729036|NCT03145610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65729037|NCT02341586|Iron|iron|mesh-list
65729038|NCT02341586|Trace Elements|trace elements|mesh-ancestor
65729039|NCT02341586|Micronutrients|micronutrients|mesh-ancestor
65729040|NCT02341586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729041|NCT02336906|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65729042|NCT02336906|Laxatives|laxatives|mesh-ancestor
65729043|NCT02336906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65729044|NCT03613961|Anesthetics|anesthetics|mesh-list
65729045|NCT03613961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65729046|NCT03613961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729047|NCT02341352|Fluorides|fluorides|mesh-list
65729048|NCT02341352|Fluorides, Topical|fluorides, topical|mesh-list
65729049|NCT02341352|Immunoglobulins|immunoglobulins|mesh-list
65729050|NCT02341352|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65729051|NCT02341352|Antibodies|antibodies|mesh-list
65729052|NCT02341352|Cariostatic Agents|cariostatic agents|mesh-ancestor
65729053|NCT02341352|Protective Agents|protective agents|mesh-ancestor
65729054|NCT02341352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729055|NCT02341352|Immunologic Factors|immunologic factors|mesh-ancestor
65729056|NCT02344550|Everolimus|everolimus|mesh-list
65729057|NCT02344550|Letrozole|letrozole|mesh-list
65729058|NCT02344550|Leuprolide|leuprolide|mesh-list
65729059|NCT02344550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729060|NCT02344550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65729061|NCT02344550|Immunologic Factors|immunologic factors|mesh-ancestor
65729062|NCT02344550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729063|NCT02344550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65729064|NCT02344550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65044878|NCT00209924|Gaboxadol|gaboxadol|mesh-list
65729065|NCT02344550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65729066|NCT02344550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729067|NCT02344550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65729068|NCT02344550|Hormone Antagonists|hormone antagonists|mesh-ancestor
65729069|NCT02344550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65729070|NCT02344550|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65729071|NCT02344550|Fertility Agents|fertility agents|mesh-ancestor
65729072|NCT02344550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65729073|NCT02344550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65729074|NCT02419612|Dapagliflozin|dapagliflozin|mesh-list
65729075|NCT02419612|Glimepiride|glimepiride|mesh-list
65729076|NCT02419612|Saxagliptin|saxagliptin|mesh-list
65729077|NCT02419612|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65729078|NCT02419612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729079|NCT02419612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65729080|NCT02419612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729081|NCT02419612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65729082|NCT02419612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65729083|NCT02419612|Immunologic Factors|immunologic factors|mesh-ancestor
65729084|NCT02419612|Incretins|incretins|mesh-ancestor
65729085|NCT02419612|Hormones|hormones|mesh-ancestor
65729086|NCT02419612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65729087|NCT02419612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65729088|NCT02419612|Protease Inhibitors|protease inhibitors|mesh-ancestor
65729089|NCT02419612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65729090|NCT03612947|Magnesium Sulfate|magnesium sulfate|mesh-list
65729091|NCT03612947|Bupivacaine|bupivacaine|mesh-list
65729092|NCT03612947|Anesthetics, Local|anesthetics, local|mesh-ancestor
65729093|NCT03612947|Anesthetics|anesthetics|mesh-ancestor
65729094|NCT03612947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65729095|NCT03612947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729096|NCT03612947|Sensory System Agents|sensory system agents|mesh-ancestor
65729097|NCT03612947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729098|NCT03612947|Analgesics|analgesics|mesh-ancestor
65729099|NCT03612947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65729100|NCT03612947|Anticonvulsants|anticonvulsants|mesh-ancestor
65729101|NCT03612947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65729102|NCT03612947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65729103|NCT03612947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729104|NCT03612947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65729105|NCT03612947|Tocolytic Agents|tocolytic agents|mesh-ancestor
65729106|NCT03612947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65729107|NCT02344784|Methylphenidate|methylphenidate|mesh-list
65729108|NCT02344784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65729109|NCT02344784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729110|NCT02344784|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65729111|NCT02344784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65729112|NCT02344784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65729113|NCT02344784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729114|NCT02344784|Dopamine Agents|dopamine agents|mesh-ancestor
65729115|NCT02344784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65729116|NCT02447848|Sufentanil|sufentanil|mesh-list
65729117|NCT02447848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65729118|NCT02447848|Narcotics|narcotics|mesh-ancestor
65729119|NCT02447848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65729120|NCT02447848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729121|NCT02447848|Analgesics|analgesics|mesh-ancestor
65729122|NCT02447848|Sensory System Agents|sensory system agents|mesh-ancestor
65729123|NCT02447848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729124|NCT02447848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65729125|NCT02447848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65729126|NCT02447848|Anesthetics, General|anesthetics, general|mesh-ancestor
65729127|NCT02447848|Anesthetics|anesthetics|mesh-ancestor
65729128|NCT02336516|Azithromycin|azithromycin|mesh-list
65729129|NCT02336516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65729130|NCT02336516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65729131|NCT03114527|Everolimus|everolimus|mesh-list
65729132|NCT03114527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729133|NCT03114527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65729134|NCT03114527|Immunologic Factors|immunologic factors|mesh-ancestor
65729135|NCT03114527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729136|NCT03055013|Nivolumab|nivolumab|mesh-list
65729137|NCT03055013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65729138|NCT03055013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729139|NCT03055013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65729140|NCT03055013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729141|NCT05254652|Pregabalin|pregabalin|mesh-list
65729142|NCT05254652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65729143|NCT05254652|Analgesics|analgesics|mesh-ancestor
65729144|NCT05254652|Sensory System Agents|sensory system agents|mesh-ancestor
65729145|NCT05254652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729146|NCT05254652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729147|NCT05254652|Anticonvulsants|anticonvulsants|mesh-ancestor
65729148|NCT05254652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65729149|NCT05254652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65729150|NCT05254652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729151|NCT05254652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65729152|NCT05254652|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65729153|NCT05254652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65729154|NCT05254652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65729155|NCT05254652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65729156|NCT05254652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65729157|NCT05254652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65729158|NCT05254652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65729159|NCT05254652|Antidepressive Agents|antidepressive agents|mesh-ancestor
65729160|NCT05254652|Dopamine Agents|dopamine agents|mesh-ancestor
65729161|NCT02343926|Metformin|metformin|mesh-list
65729162|NCT02343926|Vildagliptin|vildagliptin|mesh-list
65729163|NCT02343926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65729164|NCT02343926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729165|NCT02343926|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65729166|NCT02343926|Protease Inhibitors|protease inhibitors|mesh-ancestor
65729167|NCT02343926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65729168|NCT02343926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729169|NCT05254574|Diclofenac|diclofenac|mesh-list
65729170|NCT05254574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65729171|NCT05254574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65729172|NCT05254574|Analgesics|analgesics|mesh-ancestor
65729173|NCT05254574|Sensory System Agents|sensory system agents|mesh-ancestor
65729174|NCT05254574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729175|NCT05254574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729176|NCT05254574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65729177|NCT05254574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65729178|NCT05254574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65729179|NCT05254574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65729180|NCT05254574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729181|NCT03112226|Estradiol|estradiol|mesh-list
65729182|NCT03112226|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
65729183|NCT03112226|Estrogens|estrogens|mesh-ancestor
65729184|NCT03112226|Hormones|hormones|mesh-ancestor
65729185|NCT03112226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65729186|NCT03112226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729187|NCT03112226|Hormone Antagonists|hormone antagonists|mesh-ancestor
65729188|NCT02343692|Pancrelipase|pancrelipase|mesh-list
65729189|NCT02343692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65729190|NCT02332616|Methylprednisolone|methylprednisolone|mesh-list
65729191|NCT02332616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65729192|NCT02332616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65729193|NCT02332616|Prednisolone|prednisolone|mesh-list
65729194|NCT02332616|Prednisolone acetate|prednisolone acetate|mesh-list
65729195|NCT02332616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65729196|NCT02332616|Prednisolone phosphate|prednisolone phosphate|mesh-list
65729197|NCT02332616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65729198|NCT02332616|Antiemetics|antiemetics|mesh-ancestor
65729199|NCT02332616|Autonomic Agents|autonomic agents|mesh-ancestor
65729200|NCT02332616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729201|NCT02332616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729202|NCT02332616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65729203|NCT02332616|Glucocorticoids|glucocorticoids|mesh-ancestor
65729204|NCT02332616|Hormones|hormones|mesh-ancestor
65729205|NCT02332616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65729206|NCT02332616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65729207|NCT02332616|Protective Agents|protective agents|mesh-ancestor
65729208|NCT02332616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65729209|NCT02332616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729210|NCT03345173|Ketamine|ketamine|mesh-list
65729211|NCT03345173|Analgesics|analgesics|mesh-ancestor
65729212|NCT03345173|Sensory System Agents|sensory system agents|mesh-ancestor
65729213|NCT03345173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729214|NCT03345173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729215|NCT03345173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65729216|NCT03345173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65729217|NCT03345173|Anesthetics, General|anesthetics, general|mesh-ancestor
65729218|NCT03345173|Anesthetics|anesthetics|mesh-ancestor
65729219|NCT03345173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65729220|NCT03345173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65729221|NCT03345173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65729222|NCT03345173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65729223|NCT03345173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729224|NCT03618173|Dexamethasone|dexamethasone|mesh-list
65729225|NCT03618173|Dexamethasone acetate|dexamethasone acetate|mesh-list
65729226|NCT03618173|BB 1101|bb 1101|mesh-list
65729227|NCT03618173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65729228|NCT03618173|Antiemetics|antiemetics|mesh-ancestor
65729229|NCT03618173|Autonomic Agents|autonomic agents|mesh-ancestor
65729230|NCT03618173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729231|NCT03618173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729232|NCT03618173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65729233|NCT03618173|Glucocorticoids|glucocorticoids|mesh-ancestor
65729234|NCT03618173|Hormones|hormones|mesh-ancestor
65729235|NCT03618173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65729236|NCT03618173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65729237|NCT03618173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729238|NCT03618173|Protease Inhibitors|protease inhibitors|mesh-ancestor
65729239|NCT03618173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65729240|NCT03618173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729241|NCT02336048|Obinutuzumab|obinutuzumab|mesh-list
65729242|NCT02336048|Chlorambucil|chlorambucil|mesh-list
65729243|NCT02336048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65729244|NCT02336048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729245|NCT02336048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65729246|NCT02336048|Alkylating Agents|alkylating agents|mesh-ancestor
65729247|NCT02336048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729248|NCT03612401|Mirabegron|mirabegron|mesh-list
65729249|NCT03612401|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65729250|NCT03612401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65729251|NCT03612401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65729252|NCT03612401|Adrenergic Agents|adrenergic agents|mesh-ancestor
65729253|NCT03612401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65729254|NCT03612401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729255|NCT03612401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729256|NCT03612401|Urological Agents|urological agents|mesh-ancestor
65729257|NCT03612323|Piroxicam|piroxicam|mesh-list
65729258|NCT03612323|Carticaine|carticaine|mesh-list
65729259|NCT03612323|Anesthetics, Local|anesthetics, local|mesh-ancestor
65729260|NCT03612323|Anesthetics|anesthetics|mesh-ancestor
65729261|NCT03612323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65729262|NCT03612323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729263|NCT03612323|Sensory System Agents|sensory system agents|mesh-ancestor
65729264|NCT03612323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729265|NCT03612323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65729266|NCT03612323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65729267|NCT03612323|Analgesics|analgesics|mesh-ancestor
65729268|NCT03612323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65729269|NCT03612323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65729270|NCT03612323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65729271|NCT03612323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65729272|NCT03612323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729273|NCT02994719|Amantadine|amantadine|mesh-list
65729274|NCT02994719|Levodopa|levodopa|mesh-list
65729275|NCT02994719|Carbidopa|carbidopa|mesh-list
65729276|NCT02994719|Pramipexole|pramipexole|mesh-list
65729277|NCT02994719|Ropinirole|ropinirole|mesh-list
65729278|NCT02994719|Entacapone|entacapone|mesh-list
65729279|NCT02994719|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65729280|NCT02994719|Tolcapone|tolcapone|mesh-list
65729281|NCT02994719|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65729282|NCT02994719|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65729283|NCT02994719|Dopamine Agents|dopamine agents|mesh-ancestor
65044989|NCT04571164|Dopamine Agents|dopamine agents|mesh-ancestor
65729284|NCT02994719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65045064|NCT02210104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65729285|NCT02994719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729286|NCT02994719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729287|NCT02994719|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65729288|NCT02994719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65729289|NCT02994719|Antioxidants|antioxidants|mesh-ancestor
65729290|NCT02994719|Protective Agents|protective agents|mesh-ancestor
65729291|NCT02994719|Dopamine Agonists|dopamine agonists|mesh-ancestor
65729292|NCT02994719|Antiviral Agents|antiviral agents|mesh-ancestor
65729293|NCT02994719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65729294|NCT02994719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65729295|NCT02994719|Analgesics|analgesics|mesh-ancestor
65729296|NCT02994719|Sensory System Agents|sensory system agents|mesh-ancestor
65729297|NCT02994719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729298|NCT02994719|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65729299|NCT02994719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65729300|NCT02994719|Immunologic Factors|immunologic factors|mesh-ancestor
65729301|NCT04356638|Midazolam|midazolam|mesh-list
65729302|NCT04356638|Dexmedetomidine|dexmedetomidine|mesh-list
65729303|NCT04356638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65729304|NCT04356638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65729305|NCT04356638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729306|NCT04356638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65729307|NCT04356638|Analgesics|analgesics|mesh-ancestor
65729308|NCT04356638|Sensory System Agents|sensory system agents|mesh-ancestor
65729309|NCT04356638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729310|NCT04356638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65729311|NCT04356638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65729312|NCT04356638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65729313|NCT04356638|Adrenergic Agents|adrenergic agents|mesh-ancestor
65729314|NCT04356638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65729315|NCT04356638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729316|NCT04356638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65729317|NCT04356638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65729318|NCT04356638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65729319|NCT04356638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65729320|NCT04356638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65729321|NCT04356638|Anesthetics, General|anesthetics, general|mesh-ancestor
65729322|NCT04356638|Anesthetics|anesthetics|mesh-ancestor
65729323|NCT04356638|GABA Modulators|gaba modulators|mesh-ancestor
65729324|NCT04356638|GABA Agents|gaba agents|mesh-ancestor
65729325|NCT04346108|Immunoglobulins|immunoglobulins|mesh-list
65729326|NCT04346108|Antibodies|antibodies|mesh-list
65729327|NCT04346108|gamma-Globulins|gamma-globulins|mesh-list
65729328|NCT04346108|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65729329|NCT04346108|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65729330|NCT04346108|Immunoglobulin G|immunoglobulin g|mesh-list
65729331|NCT04346108|Immunologic Factors|immunologic factors|mesh-ancestor
65729332|NCT04346108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729333|NCT02335736|Cetrorelix|cetrorelix|mesh-list
65729334|NCT02335736|Hormones|hormones|mesh-list
65729335|NCT02335736|Hormone Antagonists|hormone antagonists|mesh-list
65729336|NCT02335736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65729337|NCT02335736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729338|NCT02335736|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65729339|NCT02335736|Fertility Agents|fertility agents|mesh-ancestor
65729340|NCT02335736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65729341|NCT03613259|Alovudine|alovudine|mesh-list
65729342|NCT03613259|Antiviral Agents|antiviral agents|mesh-ancestor
65729343|NCT03613259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65729344|NCT02032355|Anesthetics|anesthetics|mesh-list
65729345|NCT02032355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65729346|NCT02032355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729347|NCT03095456|Tiotropium Bromide|tiotropium bromide|mesh-list
65729348|NCT03095456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65729349|NCT03095456|Autonomic Agents|autonomic agents|mesh-ancestor
65729350|NCT03095456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729351|NCT03095456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729352|NCT03095456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65729353|NCT03095456|Respiratory System Agents|respiratory system agents|mesh-ancestor
65729354|NCT03095456|Parasympatholytics|parasympatholytics|mesh-ancestor
65729355|NCT03095456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65729356|NCT03095456|Cholinergic Agents|cholinergic agents|mesh-ancestor
65729357|NCT03095456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65729358|NCT03095456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729359|NCT03612557|Penicillins|penicillins|mesh-list
65729360|NCT03612557|Penicillin G|penicillin g|mesh-list
65729361|NCT03612557|Penicillin G Benzathine|penicillin g benzathine|mesh-list
65729362|NCT03612557|Penicillin G Procaine|penicillin g procaine|mesh-list
65729363|NCT03612557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65729364|NCT03612557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65729365|NCT02340182|Metronidazole|metronidazole|mesh-list
65729366|NCT02340182|Vancomycin|vancomycin|mesh-list
65729367|NCT02340182|Ciprofloxacin|ciprofloxacin|mesh-list
65729368|NCT02340182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65729369|NCT02340182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65729370|NCT02340182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65729371|NCT02340182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65729372|NCT02340182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65729373|NCT02340182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65729374|NCT02340182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65729375|NCT02340182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729376|NCT02340182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729377|NCT02340182|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65729378|NCT02340182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65729379|NCT02339714|Loratadine|loratadine|mesh-list
65729380|NCT02339714|Antipruritics|antipruritics|mesh-ancestor
65729381|NCT02339714|Dermatologic Agents|dermatologic agents|mesh-ancestor
65729382|NCT02339714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65729383|NCT02339714|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65729384|NCT02339714|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65729385|NCT02339714|Histamine Antagonists|histamine antagonists|mesh-ancestor
65729386|NCT02339714|Histamine Agents|histamine agents|mesh-ancestor
65729387|NCT02339714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65729388|NCT02339714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729389|NCT02339714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729390|NCT02335190|Lidocaine|lidocaine|mesh-list
65729391|NCT02335190|Anesthetics, Local|anesthetics, local|mesh-ancestor
65729392|NCT02335190|Anesthetics|anesthetics|mesh-ancestor
65729393|NCT02335190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65729394|NCT02335190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729395|NCT02335190|Sensory System Agents|sensory system agents|mesh-ancestor
65729396|NCT02335190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729397|NCT02335190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65729398|NCT02335190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65729399|NCT02335190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65729400|NCT02335190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65729401|NCT02335190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729402|NCT02339324|Interferons|interferons|mesh-list
65729403|NCT02339324|Interferon-alpha|interferon-alpha|mesh-list
65729404|NCT02339324|Interferon alpha-2|interferon alpha-2|mesh-list
65729405|NCT02339324|Pembrolizumab|pembrolizumab|mesh-list
65729406|NCT02339324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65729407|NCT02339324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729408|NCT02339324|Antiviral Agents|antiviral agents|mesh-ancestor
65729409|NCT02339324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65729410|NCT02339324|Immunologic Factors|immunologic factors|mesh-ancestor
65729411|NCT02339324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729412|NCT02418754|Aflibercept|aflibercept|mesh-list
65729413|NCT02418754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65729414|NCT02418754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65729415|NCT02418754|Growth Substances|growth substances|mesh-ancestor
65729416|NCT02418754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729417|NCT02418754|Growth Inhibitors|growth inhibitors|mesh-ancestor
65729418|NCT02418754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729419|NCT02334488|Mycophenolic Acid|mycophenolic acid|mesh-list
65729420|NCT02334488|Everolimus|everolimus|mesh-list
65729421|NCT02334488|Tacrolimus|tacrolimus|mesh-list
65729422|NCT02334488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65729423|NCT02334488|Immunologic Factors|immunologic factors|mesh-ancestor
65729424|NCT02334488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729425|NCT02334488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65729426|NCT02334488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65729427|NCT02334488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729428|NCT02334488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729429|NCT02334488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65729430|NCT02334488|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65729431|NCT02334488|Antitubercular Agents|antitubercular agents|mesh-ancestor
65045138|NCT00234819|Estrogens|estrogens|mesh-list
65729432|NCT02334488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65729433|NCT02334488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65729434|NCT02862457|Paclitaxel|paclitaxel|mesh-list
65729435|NCT02862457|Cisplatin|cisplatin|mesh-list
65729436|NCT02862457|Carboplatin|carboplatin|mesh-list
65729437|NCT02862457|Pembrolizumab|pembrolizumab|mesh-list
65729438|NCT02862457|Pemetrexed|pemetrexed|mesh-list
65729439|NCT02862457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65729440|NCT02862457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729441|NCT02862457|Tubulin Modulators|tubulin modulators|mesh-ancestor
65729442|NCT02862457|Antimitotic Agents|antimitotic agents|mesh-ancestor
65729443|NCT02862457|Mitosis Modulators|mitosis modulators|mesh-ancestor
65729444|NCT02862457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729445|NCT02862457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65729446|NCT02862457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65729447|NCT02862457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65729448|NCT02862457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65729449|NCT02334254|Warfarin|warfarin|mesh-list
65729450|NCT02334254|Rivaroxaban|rivaroxaban|mesh-list
65729451|NCT02334254|Clopidogrel|clopidogrel|mesh-list
65729452|NCT02334254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65729453|NCT02334254|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65729454|NCT02334254|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65729455|NCT02334254|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65729456|NCT02334254|Purinergic Agents|purinergic agents|mesh-ancestor
65729457|NCT02334254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65729458|NCT02334254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729459|NCT02334254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729460|NCT02334254|Anticoagulants|anticoagulants|mesh-ancestor
65729461|NCT02334254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65729462|NCT02334254|Antithrombins|antithrombins|mesh-ancestor
65729463|NCT02334254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65729464|NCT02334254|Protease Inhibitors|protease inhibitors|mesh-ancestor
65729465|NCT02334254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65729466|NCT02331602|Rivaroxaban|rivaroxaban|mesh-list
65729467|NCT02331602|Dabigatran|dabigatran|mesh-list
65729468|NCT02331602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65729469|NCT02331602|Antithrombins|antithrombins|mesh-ancestor
65729470|NCT02331602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65729471|NCT02331602|Protease Inhibitors|protease inhibitors|mesh-ancestor
65729472|NCT02331602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65729473|NCT02331602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729474|NCT02331602|Anticoagulants|anticoagulants|mesh-ancestor
65729475|NCT02338934|Vitamin D|vitamin d|mesh-list
65729476|NCT02338934|Cinacalcet|cinacalcet|mesh-list
65729477|NCT02338934|Vitamins|vitamins|mesh-ancestor
65729478|NCT02338934|Micronutrients|micronutrients|mesh-ancestor
65729479|NCT02338934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729480|NCT02338934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65729481|NCT02338934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65729482|NCT02338934|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65729483|NCT02338934|Hormone Antagonists|hormone antagonists|mesh-ancestor
65729484|NCT02338934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65729485|NCT03861039|Tirzepatide|tirzepatide|mesh-list
65729486|NCT03861039|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65729487|NCT03861039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729488|NCT03861039|Incretins|incretins|mesh-ancestor
65729489|NCT03861039|Hormones|hormones|mesh-ancestor
65729490|NCT03861039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65729491|NCT02334176|Lidocaine|lidocaine|mesh-list
65729492|NCT02334176|Epinephrine|epinephrine|mesh-list
65729493|NCT02334176|Anesthetics, Local|anesthetics, local|mesh-ancestor
65729494|NCT02334176|Anesthetics|anesthetics|mesh-ancestor
65729495|NCT02334176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65729496|NCT02334176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729497|NCT02334176|Sensory System Agents|sensory system agents|mesh-ancestor
65729498|NCT02334176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729499|NCT02334176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65729500|NCT02334176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65729501|NCT02334176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65729502|NCT02334176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65729503|NCT02334176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729504|NCT02334176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65729505|NCT02334176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65729506|NCT02334176|Adrenergic Agents|adrenergic agents|mesh-ancestor
65729507|NCT02334176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65729508|NCT02334176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65729509|NCT02334176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65729510|NCT02334176|Autonomic Agents|autonomic agents|mesh-ancestor
65729511|NCT02334176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65729512|NCT02334176|Respiratory System Agents|respiratory system agents|mesh-ancestor
65729513|NCT02334176|Mydriatics|mydriatics|mesh-ancestor
65729514|NCT02334176|Sympathomimetics|sympathomimetics|mesh-ancestor
65729515|NCT02334176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65729516|NCT02338856|Beta-lapachone|beta-lapachone|mesh-list
65729517|NCT02338856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65729518|NCT02338856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65729519|NCT02338856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65729520|NCT02338856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65729521|NCT02338856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729522|NCT02338856|Antiviral Agents|antiviral agents|mesh-ancestor
65729523|NCT03609307|Bevacizumab|bevacizumab|mesh-list
65729524|NCT03609307|Propranolol|propranolol|mesh-list
65729525|NCT03609307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65729526|NCT03609307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729527|NCT03609307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65729528|NCT03609307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65729529|NCT03609307|Growth Substances|growth substances|mesh-ancestor
65729530|NCT03609307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729531|NCT03609307|Growth Inhibitors|growth inhibitors|mesh-ancestor
65729532|NCT03609307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65729533|NCT03609307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65729534|NCT03609307|Adrenergic Agents|adrenergic agents|mesh-ancestor
65729535|NCT03609307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65729536|NCT03609307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729537|NCT03609307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65729538|NCT03609307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65729539|NCT03609307|Vasodilator Agents|vasodilator agents|mesh-ancestor
65729540|NCT03399435|Epinephrine|epinephrine|mesh-list
65729541|NCT03399435|Racepinephrine|racepinephrine|mesh-list
65729542|NCT03399435|Bupivacaine|bupivacaine|mesh-list
65729543|NCT03399435|Epinephryl borate|epinephryl borate|mesh-list
65729544|NCT03399435|Neosaxitoxin|neosaxitoxin|mesh-list
65729545|NCT03399435|Anesthetics, Local|anesthetics, local|mesh-ancestor
65729546|NCT03399435|Anesthetics|anesthetics|mesh-ancestor
65729547|NCT03399435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65729548|NCT03399435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729549|NCT03399435|Sensory System Agents|sensory system agents|mesh-ancestor
65729550|NCT03399435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729551|NCT03399435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65729552|NCT03399435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65729553|NCT03399435|Adrenergic Agents|adrenergic agents|mesh-ancestor
65729554|NCT03399435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65729555|NCT03399435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729556|NCT03399435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65729557|NCT03399435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65729558|NCT03399435|Autonomic Agents|autonomic agents|mesh-ancestor
65729559|NCT03399435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65729560|NCT03399435|Respiratory System Agents|respiratory system agents|mesh-ancestor
65729561|NCT03399435|Mydriatics|mydriatics|mesh-ancestor
65729562|NCT03399435|Sympathomimetics|sympathomimetics|mesh-ancestor
65729563|NCT03399435|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65729564|NCT03399435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65729565|NCT03399435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65729566|NCT01936688|Etanercept|etanercept|mesh-list
65729567|NCT01936688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65729568|NCT01936688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65729569|NCT01936688|Analgesics|analgesics|mesh-ancestor
65729570|NCT01936688|Sensory System Agents|sensory system agents|mesh-ancestor
65729571|NCT01936688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729572|NCT01936688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729573|NCT01936688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65729574|NCT01936688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65729575|NCT01936688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65729576|NCT01936688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65729577|NCT01936688|Immunologic Factors|immunologic factors|mesh-ancestor
65729578|NCT02338544|Adapalene|adapalene|mesh-list
65729579|NCT02338544|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65729580|NCT02338544|Dermatologic Agents|dermatologic agents|mesh-ancestor
65729581|NCT02338544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65729582|NCT02338544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65729583|NCT02338544|Analgesics|analgesics|mesh-ancestor
65729584|NCT02338544|Sensory System Agents|sensory system agents|mesh-ancestor
65729585|NCT02338544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729586|NCT02338544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729587|NCT02338544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65729588|NCT02338544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65729589|NCT04446663|Paclitaxel|paclitaxel|mesh-list
65729590|NCT04446663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65729591|NCT04446663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65729592|NCT04446663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729593|NCT04446663|Tubulin Modulators|tubulin modulators|mesh-ancestor
65729594|NCT04446663|Antimitotic Agents|antimitotic agents|mesh-ancestor
65729595|NCT04446663|Mitosis Modulators|mitosis modulators|mesh-ancestor
65729596|NCT04446663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729597|NCT01861496|Cisplatin|cisplatin|mesh-list
65729598|NCT01861496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729599|NCT02520219|Endostar protein|endostar protein|mesh-list
65729600|NCT02520219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65729601|NCT02520219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65729602|NCT02520219|Growth Substances|growth substances|mesh-ancestor
65729603|NCT02520219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729604|NCT02520219|Growth Inhibitors|growth inhibitors|mesh-ancestor
65729605|NCT02520219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729606|NCT03683355|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65729607|NCT03683355|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65729608|NCT03683355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729609|NCT03394287|Apatinib|apatinib|mesh-list
65729610|NCT03394287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729611|NCT03394287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65729612|NCT03394287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65729613|NCT03394287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729614|NCT02338622|Olaparib|olaparib|mesh-list
65729615|NCT02338622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65729616|NCT02338622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65729617|NCT02338622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729618|NCT02338622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729619|NCT02338466|Tenecteplase|tenecteplase|mesh-list
65729620|NCT02338466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65729621|NCT02338466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65729622|NCT02338466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729623|NCT03394209|Oseltamivir|oseltamivir|mesh-list
65729624|NCT03394209|Favipiravir|favipiravir|mesh-list
65729625|NCT03394209|Antiviral Agents|antiviral agents|mesh-ancestor
65729626|NCT03394209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65729627|NCT03394209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65729628|NCT03394209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729629|NCT03399201|Anesthetics|anesthetics|mesh-list
65729630|NCT03399201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65729631|NCT03399201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729632|NCT02520453|Durvalumab|durvalumab|mesh-list
65729633|NCT02520453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65729634|NCT02520453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729635|NCT03389763|Remifentanil|remifentanil|mesh-list
65729636|NCT03389763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65729637|NCT03389763|Narcotics|narcotics|mesh-ancestor
65729638|NCT03389763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65729639|NCT03389763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729640|NCT03389763|Analgesics|analgesics|mesh-ancestor
65729641|NCT03389763|Sensory System Agents|sensory system agents|mesh-ancestor
65729642|NCT03389763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729643|NCT02866175|Vitamin K|vitamin k|mesh-list
65729644|NCT02866175|Edoxaban|edoxaban|mesh-list
65729645|NCT02866175|Clopidogrel|clopidogrel|mesh-list
65729646|NCT02866175|Ticagrelor|ticagrelor|mesh-list
65729647|NCT02866175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65729648|NCT02866175|Vitamins|vitamins|mesh-ancestor
65729649|NCT02866175|Micronutrients|micronutrients|mesh-ancestor
65729650|NCT02866175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729651|NCT02866175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65729652|NCT02866175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65729653|NCT02866175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65729654|NCT02866175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65729655|NCT02866175|Purinergic Agents|purinergic agents|mesh-ancestor
65729656|NCT02866175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65729657|NCT02866175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729658|NCT02866175|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65729659|NCT02866175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65729660|NCT02866175|Hemostatics|hemostatics|mesh-ancestor
65729661|NCT02866175|Coagulants|coagulants|mesh-ancestor
65729662|NCT02866175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65729664|NCT02866175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65729665|NCT02866175|Protease Inhibitors|protease inhibitors|mesh-ancestor
65729666|NCT02866175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65729667|NCT02866175|Anticoagulants|anticoagulants|mesh-ancestor
65729668|NCT02330822|Hyaluronic Acid|hyaluronic acid|mesh-list
65729669|NCT02330822|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65729670|NCT02330822|Immunologic Factors|immunologic factors|mesh-ancestor
65729671|NCT02330822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729672|NCT02330822|Viscosupplements|viscosupplements|mesh-ancestor
65729673|NCT02330822|Protective Agents|protective agents|mesh-ancestor
65729674|NCT02338310|Letrozole|letrozole|mesh-list
65729675|NCT02338310|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65729676|NCT02338310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729677|NCT02338310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65729678|NCT02338310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65729679|NCT02338310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729680|NCT02338310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65729681|NCT02338310|Hormone Antagonists|hormone antagonists|mesh-ancestor
65729682|NCT02338310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65729683|NCT02338310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729684|NCT03389607|Anesthetics|anesthetics|mesh-list
65729685|NCT03389607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65729686|NCT03389607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729687|NCT02817789|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
65729688|NCT02817789|Clopidogrel|clopidogrel|mesh-list
65729689|NCT02817789|Ticagrelor|ticagrelor|mesh-list
65729690|NCT02817789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65729691|NCT02817789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65729692|NCT02817789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65729693|NCT02817789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65729694|NCT02817789|Purinergic Agents|purinergic agents|mesh-ancestor
65729695|NCT02817789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65729696|NCT02817789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729697|NCT02817789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729698|NCT02817789|Analgesics|analgesics|mesh-ancestor
65729699|NCT02817789|Sensory System Agents|sensory system agents|mesh-ancestor
65729700|NCT02817789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729701|NCT02817789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65729702|NCT02817789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65729703|NCT02817789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65729704|NCT02817789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65729705|NCT02817789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65729706|NCT02817789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65729707|NCT05383625|Vaccines|vaccines|mesh-list
65729708|NCT05383625|Immunologic Factors|immunologic factors|mesh-ancestor
65729709|NCT05383625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729710|NCT02926859|Cannabidiol|cannabidiol|mesh-list
65729711|NCT02926859|Anticonvulsants|anticonvulsants|mesh-ancestor
65729712|NCT03389451|Edetic Acid|edetic acid|mesh-list
65729713|NCT03389451|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65729714|NCT03389451|Chelating Agents|chelating agents|mesh-ancestor
65729715|NCT03389451|Sequestering Agents|sequestering agents|mesh-ancestor
65729716|NCT03389451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729717|NCT03389451|Anticoagulants|anticoagulants|mesh-ancestor
65729718|NCT03389451|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65729719|NCT03389451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65729720|NCT03385395|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65729721|NCT03385395|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65729722|NCT03385395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65729723|NCT03385395|Protease Inhibitors|protease inhibitors|mesh-ancestor
65729724|NCT03385395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65729725|NCT03385395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729726|NCT02330120|Dexmedetomidine|dexmedetomidine|mesh-list
65729727|NCT02330120|Propofol|propofol|mesh-list
65729728|NCT02330120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65729729|NCT02330120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65729730|NCT02330120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729731|NCT02330120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65729732|NCT02330120|Anesthetics, General|anesthetics, general|mesh-ancestor
65729733|NCT02330120|Anesthetics|anesthetics|mesh-ancestor
65729734|NCT02330120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65729735|NCT02330120|Analgesics|analgesics|mesh-ancestor
65729736|NCT02330120|Sensory System Agents|sensory system agents|mesh-ancestor
65729737|NCT02330120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729738|NCT02330120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65729739|NCT02330120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65729740|NCT02330120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65729741|NCT02330120|Adrenergic Agents|adrenergic agents|mesh-ancestor
65729742|NCT02330120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65729743|NCT02330120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729745|NCT03389295|Docetaxel|docetaxel|mesh-list
65729746|NCT03389295|Fluorouracil|fluorouracil|mesh-list
65729747|NCT03389295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729748|NCT03389295|Tubulin Modulators|tubulin modulators|mesh-ancestor
65729749|NCT03389295|Antimitotic Agents|antimitotic agents|mesh-ancestor
65729750|NCT03389295|Mitosis Modulators|mitosis modulators|mesh-ancestor
65729751|NCT03389295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729752|NCT03389295|Antimetabolites|antimetabolites|mesh-ancestor
65729753|NCT03389295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65729754|NCT03389295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65729755|NCT03389295|Immunologic Factors|immunologic factors|mesh-ancestor
65729756|NCT03389295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729757|NCT03727880|Pembrolizumab|pembrolizumab|mesh-list
65729758|NCT03727880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65729759|NCT03727880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729760|NCT03398811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65729761|NCT03398811|Etonogestrel|etonogestrel|mesh-list
65729762|NCT03398811|Desogestrel|desogestrel|mesh-list
65729763|NCT03398811|Medroxyprogesterone|medroxyprogesterone|mesh-list
65729764|NCT03398811|Progesterone|progesterone|mesh-list
65729765|NCT03398811|Progestins|progestins|mesh-ancestor
65729766|NCT03398811|Hormones|hormones|mesh-ancestor
65729767|NCT03398811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65729768|NCT03398811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729769|NCT03398811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65729770|NCT03398811|Contraceptive Agents|contraceptive agents|mesh-ancestor
65729771|NCT03398811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65729772|NCT03398811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65729773|NCT03398811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65729774|NCT03398811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65729775|NCT03398811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65729776|NCT03398811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65729777|NCT03398811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65729778|NCT03398811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729779|NCT01300143|Chlorotrianisene|chlorotrianisene|mesh-list
65729780|NCT01300143|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65729781|NCT01300143|Estrogens|estrogens|mesh-ancestor
65729782|NCT01300143|Hormones|hormones|mesh-ancestor
65729783|NCT01300143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65729784|NCT01300143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729785|NCT01300143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65729786|NCT01300143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729787|NCT01336205|Naloxegol|naloxegol|mesh-list
65729788|NCT01336205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65729789|NCT01336205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729790|NCT01336205|Sensory System Agents|sensory system agents|mesh-ancestor
65729791|NCT01336205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729792|NCT02333240|Antihypertensive Agents|antihypertensive agents|mesh-list
65729793|NCT03610685|Prednisolone|prednisolone|mesh-list
65729794|NCT03610685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65729795|NCT03610685|Glucocorticoids|glucocorticoids|mesh-ancestor
65729796|NCT03610685|Hormones|hormones|mesh-ancestor
65729797|NCT03610685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65729798|NCT03610685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729799|NCT03610685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65729800|NCT03610685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729801|NCT02327234|Ibuprofen|ibuprofen|mesh-list
65729802|NCT02327234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65729803|NCT02327234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65729804|NCT02327234|Analgesics|analgesics|mesh-ancestor
65729805|NCT02327234|Sensory System Agents|sensory system agents|mesh-ancestor
65729806|NCT02327234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729807|NCT02327234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729808|NCT02327234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65729809|NCT02327234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65729810|NCT02327234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65045522|NCT02894554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65729811|NCT02327234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65729812|NCT02327234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729813|NCT01123707|Aripiprazole|aripiprazole|mesh-list
65729814|NCT01123707|Citalopram|citalopram|mesh-list
65729815|NCT01123707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65729816|NCT01123707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65729817|NCT01123707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65729818|NCT01123707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729819|NCT01123707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65729820|NCT01123707|Serotonin Agents|serotonin agents|mesh-ancestor
65729821|NCT01123707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729822|NCT01123707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65729823|NCT01123707|Antidepressive Agents|antidepressive agents|mesh-ancestor
65729824|NCT01123707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65729825|NCT01123707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65729826|NCT01123707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65729827|NCT01123707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65729828|NCT01123707|Dopamine Agonists|dopamine agonists|mesh-ancestor
65729829|NCT01123707|Dopamine Agents|dopamine agents|mesh-ancestor
65729830|NCT01123707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65729831|NCT01123707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65729832|NCT01123707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65729833|NCT01123707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65729834|NCT01123707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65729835|NCT01123707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65729836|NCT01258803|Mometasone Furoate|mometasone furoate|mesh-list
65729837|NCT01258803|Formoterol Fumarate|formoterol fumarate|mesh-list
65729838|NCT01258803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65729839|NCT01258803|Autonomic Agents|autonomic agents|mesh-ancestor
65729840|NCT01258803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729841|NCT01258803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729842|NCT01258803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65729843|NCT01258803|Respiratory System Agents|respiratory system agents|mesh-ancestor
65729844|NCT01258803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65729845|NCT01258803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65729846|NCT01258803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65729847|NCT01258803|Adrenergic Agents|adrenergic agents|mesh-ancestor
65729848|NCT01258803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65729849|NCT01258803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729850|NCT01258803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65729851|NCT01258803|Dermatologic Agents|dermatologic agents|mesh-ancestor
65729852|NCT01258803|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65729853|NCT02327156|Dexmedetomidine|dexmedetomidine|mesh-list
65729854|NCT02327156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65729855|NCT02327156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65729856|NCT02327156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729857|NCT02327156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65729858|NCT02327156|Analgesics|analgesics|mesh-ancestor
65729859|NCT02327156|Sensory System Agents|sensory system agents|mesh-ancestor
65729860|NCT02327156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729861|NCT02327156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65729862|NCT02327156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65729863|NCT02327156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65729864|NCT02327156|Adrenergic Agents|adrenergic agents|mesh-ancestor
65729865|NCT02327156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65729866|NCT02327156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729867|NCT02039804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65729868|NCT02039804|Hyaluronic Acid|hyaluronic acid|mesh-list
65729869|NCT02039804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65729870|NCT02039804|Immunologic Factors|immunologic factors|mesh-ancestor
65729871|NCT02039804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729872|NCT02039804|Viscosupplements|viscosupplements|mesh-ancestor
65729873|NCT02039804|Protective Agents|protective agents|mesh-ancestor
65729874|NCT02039804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65729875|NCT03385161|Ethanol|ethanol|mesh-list
65729876|NCT03385161|Botulinum Toxins|botulinum toxins|mesh-list
65729877|NCT03385161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65729878|NCT03385161|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65729879|NCT03385161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65729880|NCT03385161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65729881|NCT03385161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729882|NCT03385161|Cholinergic Agents|cholinergic agents|mesh-ancestor
65729883|NCT03385161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65729884|NCT03385161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729885|NCT03385161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65729886|NCT03385161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65729887|NCT03385161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65729888|NCT03385161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65729889|NCT03385161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729890|NCT02327000|Pregabalin|pregabalin|mesh-list
65729891|NCT02327000|Analgesics|analgesics|mesh-ancestor
65729892|NCT02327000|Sensory System Agents|sensory system agents|mesh-ancestor
65729893|NCT02327000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729894|NCT02327000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729895|NCT02327000|Anticonvulsants|anticonvulsants|mesh-ancestor
65729896|NCT02327000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65729897|NCT02327000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65729898|NCT02327000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729899|NCT02327000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65729900|NCT02327000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65729901|NCT02327000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65729902|NCT02327000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65729903|NCT02327000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65729904|NCT02033603|Ropivacaine|ropivacaine|mesh-list
65729905|NCT02033603|Anesthetics, Local|anesthetics, local|mesh-ancestor
65729906|NCT02033603|Anesthetics|anesthetics|mesh-ancestor
65729907|NCT02033603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65729908|NCT02033603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729909|NCT02033603|Sensory System Agents|sensory system agents|mesh-ancestor
65729910|NCT02033603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729911|NCT02326922|Levonorgestrel|levonorgestrel|mesh-list
65729912|NCT02326922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65729913|NCT02326922|Contraceptive Agents|contraceptive agents|mesh-ancestor
65729914|NCT02326922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65729915|NCT02326922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729916|NCT02326922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65729917|NCT02326922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65729918|NCT02326922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65729919|NCT00862251|Atorvastatin|atorvastatin|mesh-list
65729920|NCT00862251|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65729921|NCT00862251|Simvastatin|simvastatin|mesh-list
65729922|NCT00862251|Ezetimibe|ezetimibe|mesh-list
65729923|NCT00862251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65729924|NCT00862251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65729925|NCT00862251|Antimetabolites|antimetabolites|mesh-ancestor
65729926|NCT00862251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729927|NCT00862251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65729928|NCT00862251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65729929|NCT00862251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65729930|NCT03389139|Anesthetics|anesthetics|mesh-list
65729931|NCT03389139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65729932|NCT03389139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729933|NCT00885963|Sapacitabine|sapacitabine|mesh-list
65729934|NCT00885963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729935|NCT00725127|Aspirin|aspirin|mesh-list
65729936|NCT00725127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65729937|NCT00725127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65729938|NCT00725127|Analgesics|analgesics|mesh-ancestor
65729939|NCT00725127|Sensory System Agents|sensory system agents|mesh-ancestor
65729940|NCT00725127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65729941|NCT00725127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729942|NCT00725127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65729943|NCT00725127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65729944|NCT00725127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65729945|NCT00725127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65729946|NCT00725127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729947|NCT00725127|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65729948|NCT00725127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65729949|NCT00725127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65729950|NCT00725127|Antipyretics|antipyretics|mesh-ancestor
65729951|NCT02328950|Cytarabine|cytarabine|mesh-list
65729952|NCT02328950|Cyclophosphamide|cyclophosphamide|mesh-list
65729953|NCT02328950|Busulfan|busulfan|mesh-list
65729954|NCT02328950|Fludarabine|fludarabine|mesh-list
65729955|NCT02328950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65729956|NCT02328950|Immunologic Factors|immunologic factors|mesh-ancestor
65729957|NCT02328950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729958|NCT02328950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65729959|NCT02328950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65729960|NCT02328950|Alkylating Agents|alkylating agents|mesh-ancestor
65729961|NCT02328950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729962|NCT02328950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65729963|NCT02328950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65729964|NCT02328950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65729965|NCT02328950|Antimetabolites|antimetabolites|mesh-ancestor
65729966|NCT02328950|Antiviral Agents|antiviral agents|mesh-ancestor
65729967|NCT02328950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65729968|NCT03398577|Dapagliflozin|dapagliflozin|mesh-list
65729969|NCT03398577|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65729970|NCT03398577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729971|NCT03398577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65729972|NCT03398577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729973|NCT03389061|Sofosbuvir|sofosbuvir|mesh-list
65729974|NCT03389061|Velpatasvir|velpatasvir|mesh-list
65729975|NCT03389061|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65729976|NCT03389061|Antiviral Agents|antiviral agents|mesh-ancestor
65729977|NCT03389061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65729978|NCT05078138|Epoetin Alfa|epoetin alfa|mesh-list
65729979|NCT05078138|Hematinics|hematinics|mesh-ancestor
65729980|NCT02038868|Tamsulosin|tamsulosin|mesh-list
65729981|NCT02038868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65729982|NCT02038868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65729983|NCT02038868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65729984|NCT02038868|Adrenergic Agents|adrenergic agents|mesh-ancestor
65729985|NCT02038868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65729986|NCT02038868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729987|NCT02038868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729988|NCT02038868|Urological Agents|urological agents|mesh-ancestor
65729989|NCT02328794|Varenicline|varenicline|mesh-list
65729990|NCT02328794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65729991|NCT02328794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65729992|NCT02328794|Cholinergic Agents|cholinergic agents|mesh-ancestor
65729993|NCT02328794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65729994|NCT02328794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65729995|NCT02328794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65729996|NCT03388827|Misoprostol|misoprostol|mesh-list
65729997|NCT03388827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65729998|NCT03388827|Abortifacient Agents|abortifacient agents|mesh-ancestor
65729999|NCT03388827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65730000|NCT03388827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730001|NCT03388827|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65730002|NCT03388827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65730003|NCT03388827|Oxytocics|oxytocics|mesh-ancestor
65730004|NCT02328716|Cisplatin|cisplatin|mesh-list
65730005|NCT02328716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730006|NCT00445107|Montelukast|montelukast|mesh-list
65730007|NCT00445107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65730008|NCT00445107|Respiratory System Agents|respiratory system agents|mesh-ancestor
65730009|NCT00445107|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65730010|NCT00445107|Hormone Antagonists|hormone antagonists|mesh-ancestor
65730011|NCT00445107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65730012|NCT00445107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730013|NCT00445107|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65730014|NCT00445107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65730015|NCT00445107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730016|NCT05077592|Povidone-Iodine|povidone-iodine|mesh-list
65730017|NCT05077592|Povidone|povidone|mesh-list
65730018|NCT05077592|Plasma Substitutes|plasma substitutes|mesh-ancestor
65730019|NCT05077592|Blood Substitutes|blood substitutes|mesh-ancestor
65730020|NCT05077592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65730021|NCT05077592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65730022|NCT00038727|Metformin|metformin|mesh-list
65730023|NCT00038727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65730024|NCT00038727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730025|NCT02864381|Nivolumab|nivolumab|mesh-list
65730026|NCT02864381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65730027|NCT02864381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730028|NCT02864381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65730029|NCT02864381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730030|NCT05230472|Simvastatin|simvastatin|mesh-list
65730031|NCT05230472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65730032|NCT05230472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65730033|NCT05230472|Antimetabolites|antimetabolites|mesh-ancestor
65730034|NCT05230472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730035|NCT05230472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65730036|NCT05230472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65730037|NCT05230472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65730038|NCT03398031|Magnesium Oxide|magnesium oxide|mesh-list
65730039|NCT03398031|Antacids|antacids|mesh-ancestor
65730040|NCT03398031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730041|NCT03398031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65730042|NCT02039960|Bupropion|bupropion|mesh-list
65730043|NCT02039960|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65730044|NCT02039960|Antidepressive Agents|antidepressive agents|mesh-ancestor
65730045|NCT02039960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65730046|NCT02039960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65730047|NCT02039960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65730048|NCT02039960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65730049|NCT02039960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730050|NCT02039960|Dopamine Agents|dopamine agents|mesh-ancestor
65730051|NCT02039960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65730052|NCT02039960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730053|NCT02039960|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65730054|NCT02039960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65730055|NCT02039960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65730056|NCT05383313|Midazolam|midazolam|mesh-list
65730057|NCT05383313|Ketamine|ketamine|mesh-list
65730058|NCT05383313|Psilocybin|psilocybin|mesh-list
65730059|NCT05383313|Analgesics|analgesics|mesh-ancestor
65730060|NCT05383313|Sensory System Agents|sensory system agents|mesh-ancestor
65730061|NCT05383313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65730062|NCT05383313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730063|NCT05383313|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65730064|NCT05383313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65730065|NCT05383313|Anesthetics, General|anesthetics, general|mesh-ancestor
65730066|NCT05383313|Anesthetics|anesthetics|mesh-ancestor
65730067|NCT05383313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65730068|NCT05383313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65730069|NCT05383313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65730070|NCT05383313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65730071|NCT05383313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730072|NCT05383313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65730073|NCT05383313|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65730074|NCT05383313|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65730075|NCT05383313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65730076|NCT05383313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65730077|NCT05383313|GABA Modulators|gaba modulators|mesh-ancestor
65730078|NCT05383313|GABA Agents|gaba agents|mesh-ancestor
65730079|NCT05383313|Hallucinogens|hallucinogens|mesh-ancestor
65730080|NCT02033681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65730081|NCT03144128|Vitamin D|vitamin d|mesh-list
65730082|NCT03144128|Vitamins|vitamins|mesh-ancestor
65730083|NCT03144128|Micronutrients|micronutrients|mesh-ancestor
65730084|NCT03144128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730085|NCT03144128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65730086|NCT02326610|Hormones|hormones|mesh-list
65730087|NCT02326610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65730088|NCT02326610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730089|NCT00409773|Atorvastatin|atorvastatin|mesh-list
65730090|NCT00409773|Simvastatin|simvastatin|mesh-list
65730091|NCT00409773|Ezetimibe|ezetimibe|mesh-list
65730092|NCT00409773|Calcium|calcium|mesh-list
65730093|NCT00409773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65730094|NCT00409773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730095|NCT00409773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65730096|NCT00409773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65730097|NCT00409773|Antimetabolites|antimetabolites|mesh-ancestor
65730098|NCT00409773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730099|NCT00409773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65730100|NCT00409773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65730101|NCT00409773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65730102|NCT02326376|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65730103|NCT02326376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65730104|NCT02034422|Antioxidants|antioxidants|mesh-list
65730105|NCT02034422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730106|NCT02034422|Protective Agents|protective agents|mesh-ancestor
65730107|NCT02034422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730108|NCT02325986|Fluorouracil|fluorouracil|mesh-list
65730109|NCT02325986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730110|NCT02325986|Antimetabolites|antimetabolites|mesh-ancestor
65730111|NCT02325986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730112|NCT02325986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65730113|NCT02325986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65730114|NCT02325986|Immunologic Factors|immunologic factors|mesh-ancestor
65730115|NCT02325986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730116|NCT00398151|Montelukast|montelukast|mesh-list
65730117|NCT00398151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65730118|NCT00398151|Respiratory System Agents|respiratory system agents|mesh-ancestor
65730119|NCT00398151|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65730120|NCT00398151|Hormone Antagonists|hormone antagonists|mesh-ancestor
65730121|NCT00398151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65730122|NCT00398151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730123|NCT00398151|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65730124|NCT00398151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65730125|NCT00398151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730126|NCT03610139|Vitamin D|vitamin d|mesh-list
65730127|NCT03610139|Cholecalciferol|cholecalciferol|mesh-list
65730128|NCT03610139|Vitamins|vitamins|mesh-ancestor
65730129|NCT03610139|Micronutrients|micronutrients|mesh-ancestor
65730130|NCT03610139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730131|NCT03610139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65730132|NCT03610139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65730133|NCT02327624|Clopidogrel|clopidogrel|mesh-list
65730134|NCT02327624|Ticagrelor|ticagrelor|mesh-list
65730135|NCT02327624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65730136|NCT02327624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65730137|NCT02327624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65730138|NCT02327624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65730139|NCT02327624|Purinergic Agents|purinergic agents|mesh-ancestor
65730140|NCT02327624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65730141|NCT02327624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730142|NCT02327624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730143|NCT03388671|Bupivacaine|bupivacaine|mesh-list
65730144|NCT03388671|Anesthetics, Local|anesthetics, local|mesh-ancestor
65730145|NCT03388671|Anesthetics|anesthetics|mesh-ancestor
65730146|NCT03388671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65730147|NCT03388671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730148|NCT03388671|Sensory System Agents|sensory system agents|mesh-ancestor
65730149|NCT03388671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65730150|NCT02327936|Fesoterodine|fesoterodine|mesh-list
65730151|NCT02327936|Oxybutynin|oxybutynin|mesh-list
65730152|NCT02327936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65730153|NCT02327936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65730154|NCT02327936|Cholinergic Agents|cholinergic agents|mesh-ancestor
65730155|NCT02327936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65730156|NCT02327936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730157|NCT02327936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730158|NCT02327936|Urological Agents|urological agents|mesh-ancestor
65730159|NCT02327936|Parasympatholytics|parasympatholytics|mesh-ancestor
65730160|NCT02327936|Autonomic Agents|autonomic agents|mesh-ancestor
65730161|NCT02327936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65730162|NCT03609827|Melphalan|melphalan|mesh-list
65730163|NCT03609827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65730164|NCT03609827|Alkylating Agents|alkylating agents|mesh-ancestor
65730165|NCT03609827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730166|NCT03609827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730167|NCT03609827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65730168|NCT03609827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65730169|NCT03609827|Immunologic Factors|immunologic factors|mesh-ancestor
65730170|NCT03609827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730171|NCT02858401|Vesatolimod|vesatolimod|mesh-list
65730172|NCT02858401|Antiviral Agents|antiviral agents|mesh-ancestor
65730173|NCT02858401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65730174|NCT03144596|Tamsulosin|tamsulosin|mesh-list
65730175|NCT03144596|Alfuzosin|alfuzosin|mesh-list
65730176|NCT03144596|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65730177|NCT03144596|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65730178|NCT03144596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65730179|NCT03144596|Adrenergic Agents|adrenergic agents|mesh-ancestor
65730180|NCT03144596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65730181|NCT03144596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730182|NCT03144596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730183|NCT03144596|Urological Agents|urological agents|mesh-ancestor
65730184|NCT00127647|Montelukast|montelukast|mesh-list
65730185|NCT00127647|Pranlukast|pranlukast|mesh-list
65730186|NCT00127647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65730187|NCT00127647|Respiratory System Agents|respiratory system agents|mesh-ancestor
65730188|NCT00127647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65730189|NCT00127647|Hormone Antagonists|hormone antagonists|mesh-ancestor
65730190|NCT00127647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65730191|NCT00127647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730192|NCT00127647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65730193|NCT00127647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65730194|NCT00127647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730195|NCT02408549|Lacosamide|lacosamide|mesh-list
65730196|NCT02408549|Anticonvulsants|anticonvulsants|mesh-ancestor
65730197|NCT02408549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65730198|NCT02408549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65730199|NCT02408549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65730200|NCT02408549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730201|NCT03111446|Anesthetics|anesthetics|mesh-list
65730202|NCT03111446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65730203|NCT03111446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730204|NCT02034071|Diazoxide|diazoxide|mesh-list
65730205|NCT02034071|Choline|choline|mesh-list
65730206|NCT02034071|Lipotropic Agents|lipotropic agents|mesh-ancestor
65730207|NCT02034071|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65730208|NCT02034071|Antimetabolites|antimetabolites|mesh-ancestor
65730209|NCT02034071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730210|NCT02034071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65730211|NCT02034071|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65730212|NCT02034071|Nootropic Agents|nootropic agents|mesh-ancestor
65730213|NCT02034071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65730214|NCT02034071|Vasodilator Agents|vasodilator agents|mesh-ancestor
65730215|NCT03609359|Pembrolizumab|pembrolizumab|mesh-list
65730216|NCT03609359|Lenvatinib|lenvatinib|mesh-list
65730217|NCT03609359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65730218|NCT03609359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730219|NCT03609359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65730220|NCT03609359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65730221|NCT03609359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730222|NCT04833764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65730223|NCT04833764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65730224|NCT04833764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65730225|NCT04833764|Antimetabolites|antimetabolites|mesh-ancestor
65730226|NCT04833764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730227|NCT04833764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65730228|NCT04833764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65730229|NCT04833764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65730230|NCT03388125|Ethanolamine oleate|ethanolamine oleate|mesh-list
65730231|NCT03388125|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65730232|NCT03388125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65730233|NCT04822376|Ansuvimab|ansuvimab|mesh-list
65730234|NCT04822376|Antiviral Agents|antiviral agents|mesh-ancestor
65730235|NCT04822376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65730236|NCT05173545|Mitoxantrone|mitoxantrone|mesh-list
65730237|NCT05173545|Analgesics|analgesics|mesh-ancestor
65730238|NCT05173545|Sensory System Agents|sensory system agents|mesh-ancestor
65730239|NCT05173545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65730240|NCT05173545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730241|NCT05173545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730242|NCT05173545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65730243|NCT05173545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65730244|NCT05173545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65730245|NCT05173545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730246|NCT05383183|Choline|choline|mesh-list
65730247|NCT05383183|Lipotropic Agents|lipotropic agents|mesh-ancestor
65730248|NCT05383183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65730249|NCT05383183|Antimetabolites|antimetabolites|mesh-ancestor
65730250|NCT05383183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730251|NCT05383183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65730252|NCT05383183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65730253|NCT05383183|Nootropic Agents|nootropic agents|mesh-ancestor
65730254|NCT02327702|Emtricitabine|emtricitabine|mesh-list
65730255|NCT02327702|Antiviral Agents|antiviral agents|mesh-ancestor
65730256|NCT02327702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65730257|NCT02327702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65730258|NCT02327702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65730259|NCT02327702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65730260|NCT02327702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730261|NCT02327702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65730262|NCT02327702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65730263|NCT03609775|Ethanol|ethanol|mesh-list
65730264|NCT03609775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65730265|NCT03609775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65730266|NCT03609775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65730267|NCT03609775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730268|NCT03690765|Dydrogesterone|dydrogesterone|mesh-list
65730269|NCT03690765|Progestins|progestins|mesh-ancestor
65730270|NCT03690765|Hormones|hormones|mesh-ancestor
65730271|NCT03690765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65730272|NCT03690765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730273|NCT02033941|Phenol|phenol|mesh-list
65730274|NCT02033941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65730275|NCT02033941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65730276|NCT02033941|Disinfectants|disinfectants|mesh-ancestor
65730277|NCT02033941|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65730278|NCT02033941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65730279|NCT03143972|Dexmedetomidine|dexmedetomidine|mesh-list
65730280|NCT03143972|Remifentanil|remifentanil|mesh-list
65730281|NCT03143972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65730282|NCT03143972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65730283|NCT03143972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730284|NCT03143972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65730285|NCT03143972|Analgesics|analgesics|mesh-ancestor
65730286|NCT03143972|Sensory System Agents|sensory system agents|mesh-ancestor
65730287|NCT03143972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65730288|NCT03143972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65730289|NCT03143972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65730290|NCT03143972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65730291|NCT03143972|Adrenergic Agents|adrenergic agents|mesh-ancestor
65730292|NCT03143972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65730293|NCT03143972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730294|NCT03143972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65730295|NCT03143972|Narcotics|narcotics|mesh-ancestor
65730296|NCT02237027|Tenofovir|tenofovir|mesh-list
65730297|NCT02237027|Emtricitabine|emtricitabine|mesh-list
65730298|NCT02237027|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65730299|NCT02237027|Antiviral Agents|antiviral agents|mesh-ancestor
65730300|NCT02237027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65730301|NCT02237027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65730302|NCT02237027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65730303|NCT02237027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65730304|NCT02237027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730305|NCT02237027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65730306|NCT02237027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65730307|NCT03609125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65730308|NCT03609125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65730309|NCT03143738|Anesthetics|anesthetics|mesh-list
65730310|NCT03143738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65730311|NCT03143738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730312|NCT04393753|Avelumab|avelumab|mesh-list
65730313|NCT04393753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65730314|NCT04393753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730315|NCT04647903|Amphetamine|amphetamine|mesh-list
65730316|NCT04647903|Dextroamphetamine|dextroamphetamine|mesh-list
65730317|NCT04647903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65730318|NCT04647903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730319|NCT04647903|Sympathomimetics|sympathomimetics|mesh-ancestor
65730320|NCT04647903|Autonomic Agents|autonomic agents|mesh-ancestor
65730321|NCT04647903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65730322|NCT04647903|Dopamine Agents|dopamine agents|mesh-ancestor
65730323|NCT04647903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65730324|NCT04647903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730325|NCT04647903|Adrenergic Agents|adrenergic agents|mesh-ancestor
65730326|NCT04647903|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65730327|NCT04647903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65730328|NCT04647903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65730329|NCT04647903|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65730330|NCT01860937|Cyclophosphamide|cyclophosphamide|mesh-list
65730331|NCT01860937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65730332|NCT01860937|Immunologic Factors|immunologic factors|mesh-ancestor
65730333|NCT01860937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730334|NCT01860937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65730335|NCT01860937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65730336|NCT01860937|Alkylating Agents|alkylating agents|mesh-ancestor
65730337|NCT01860937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730338|NCT01860937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730339|NCT01860937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65730340|NCT03142256|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65730341|NCT03142256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65730342|NCT03142256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65730343|NCT03142256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65730344|NCT03142256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730345|NCT03142256|Antiviral Agents|antiviral agents|mesh-ancestor
65730346|NCT03142256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65730347|NCT03142256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65730348|NCT03142256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65730350|NCT03380403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65730351|NCT03380403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65730352|NCT03380403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65730353|NCT03380403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65730354|NCT03380403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65730355|NCT03380403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730356|NCT03380403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730357|NCT03380403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65730358|NCT03380403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65730359|NCT03380325|Iloprost|iloprost|mesh-list
65730360|NCT03380325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65730361|NCT03380325|Vasodilator Agents|vasodilator agents|mesh-ancestor
65730362|NCT02237053|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65730363|NCT02237053|Octreotide|octreotide|mesh-list
65730364|NCT02237053|Glucagon|glucagon|mesh-list
65730365|NCT02237053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730366|NCT02237053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65730367|NCT02237053|Hormones|hormones|mesh-ancestor
65730368|NCT02237053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65730369|NCT02237053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65730370|NCT02237053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730371|NCT02237131|Contraceptive Agents|contraceptive agents|mesh-list
65730372|NCT02237131|Contraceptives, Oral|contraceptives, oral|mesh-list
65730373|NCT02237131|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65730374|NCT02237131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65730375|NCT02237131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730376|NCT02237131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65730377|NCT04997174|Celecoxib|celecoxib|mesh-list
65730378|NCT04997174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65730379|NCT04997174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65730380|NCT04997174|Analgesics|analgesics|mesh-ancestor
65730381|NCT04997174|Sensory System Agents|sensory system agents|mesh-ancestor
65730382|NCT04997174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65730383|NCT04997174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730384|NCT04997174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65730385|NCT04997174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65730386|NCT04997174|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65730387|NCT04997174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65730388|NCT04997174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65730389|NCT04997174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730390|NCT02237209|Vaccines|vaccines|mesh-list
65730391|NCT02237209|Immunologic Factors|immunologic factors|mesh-ancestor
65730392|NCT02237209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730393|NCT03387111|Leucovorin|leucovorin|mesh-list
65730394|NCT03387111|Paclitaxel|paclitaxel|mesh-list
65730395|NCT03387111|Cyclophosphamide|cyclophosphamide|mesh-list
65730396|NCT03387111|Bevacizumab|bevacizumab|mesh-list
65730397|NCT03387111|Fluorouracil|fluorouracil|mesh-list
65730398|NCT03387111|Capecitabine|capecitabine|mesh-list
65730399|NCT03387111|Cetuximab|cetuximab|mesh-list
65730400|NCT03387111|Avelumab|avelumab|mesh-list
65730401|NCT03387111|Necitumumab|necitumumab|mesh-list
65730402|NCT03387111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65730403|NCT03387111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730404|NCT03387111|Tubulin Modulators|tubulin modulators|mesh-ancestor
65730405|NCT03387111|Antimitotic Agents|antimitotic agents|mesh-ancestor
65730406|NCT03387111|Mitosis Modulators|mitosis modulators|mesh-ancestor
65730407|NCT03387111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730408|NCT03387111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65730409|NCT03387111|Immunologic Factors|immunologic factors|mesh-ancestor
65730410|NCT03387111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730411|NCT03387111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65730412|NCT03387111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65730413|NCT03387111|Alkylating Agents|alkylating agents|mesh-ancestor
65730414|NCT03387111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65730415|NCT03387111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65730416|NCT03387111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65730417|NCT03387111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65730418|NCT03387111|Growth Substances|growth substances|mesh-ancestor
65730419|NCT03387111|Growth Inhibitors|growth inhibitors|mesh-ancestor
65730420|NCT03387111|Antimetabolites|antimetabolites|mesh-ancestor
65730421|NCT03387111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65730422|NCT03387111|Antidotes|antidotes|mesh-ancestor
65730423|NCT03387111|Protective Agents|protective agents|mesh-ancestor
65730424|NCT03387111|Vitamin B Complex|vitamin b complex|mesh-ancestor
65730425|NCT03387111|Vitamins|vitamins|mesh-ancestor
65730426|NCT03387111|Micronutrients|micronutrients|mesh-ancestor
65730427|NCT03608293|Dimercaprol|dimercaprol|mesh-list
65730428|NCT03608293|Chelating Agents|chelating agents|mesh-ancestor
65730429|NCT03608293|Sequestering Agents|sequestering agents|mesh-ancestor
65730430|NCT03608293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730431|NCT03608501|Thalidomide|thalidomide|mesh-list
65730432|NCT03608501|Dexamethasone|dexamethasone|mesh-list
65730433|NCT03608501|Ixazomib|ixazomib|mesh-list
65730434|NCT03608501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65730435|NCT03608501|Antiemetics|antiemetics|mesh-ancestor
65730436|NCT03608501|Autonomic Agents|autonomic agents|mesh-ancestor
65730437|NCT03608501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65730438|NCT03608501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730439|NCT03608501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65730440|NCT03608501|Glucocorticoids|glucocorticoids|mesh-ancestor
65730441|NCT03608501|Hormones|hormones|mesh-ancestor
65730442|NCT03608501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65730443|NCT03608501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65730444|NCT03608501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730445|NCT03608501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730446|NCT03608501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65730447|NCT03608501|Immunologic Factors|immunologic factors|mesh-ancestor
65730448|NCT03608501|Leprostatic Agents|leprostatic agents|mesh-ancestor
65730449|NCT03608501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65730450|NCT03608501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65730451|NCT03608501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65730452|NCT03608501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65730453|NCT03608501|Growth Substances|growth substances|mesh-ancestor
65730454|NCT03608501|Growth Inhibitors|growth inhibitors|mesh-ancestor
65730455|NCT03608501|Protease Inhibitors|protease inhibitors|mesh-ancestor
65730456|NCT03608501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65730457|NCT03608761|Rebamipide|rebamipide|mesh-list
65730458|NCT03608761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65730459|NCT03608761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65730460|NCT03608761|Antioxidants|antioxidants|mesh-ancestor
65730461|NCT03608761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730462|NCT03608761|Protective Agents|protective agents|mesh-ancestor
65730463|NCT03608761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730464|NCT03608761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65730465|NCT04554836|Cetuximab|cetuximab|mesh-list
65730466|NCT04554836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65730467|NCT04554836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730468|NCT04536272|Heparin|heparin|mesh-list
65730469|NCT04536272|Calcium heparin|calcium heparin|mesh-list
65730470|NCT04536272|Enoxaparin|enoxaparin|mesh-list
65730471|NCT04536272|Nadroparin|nadroparin|mesh-list
65730472|NCT04536272|Anticoagulants|anticoagulants|mesh-ancestor
65730473|NCT04536272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65730474|NCT04536272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65730475|NCT04536272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730476|NCT02731131|Ribavirin|ribavirin|mesh-list
65730477|NCT02731131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65730478|NCT02731131|Antimetabolites|antimetabolites|mesh-ancestor
65730479|NCT02731131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730480|NCT02731131|Antiviral Agents|antiviral agents|mesh-ancestor
65730481|NCT02731131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65730482|NCT04585724|Palbociclib|palbociclib|mesh-list
65730483|NCT04585724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730484|NCT04585724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65730485|NCT04585724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65730486|NCT04585724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730487|NCT02237261|Prednisone|prednisone|mesh-list
65730488|NCT02237261|Bortezomib|bortezomib|mesh-list
65730489|NCT02237261|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65730490|NCT02237261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65730491|NCT02237261|Glucocorticoids|glucocorticoids|mesh-ancestor
65730492|NCT02237261|Hormones|hormones|mesh-ancestor
65730493|NCT02237261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65730494|NCT02237261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730495|NCT02237261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65730496|NCT02237261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730497|NCT02237261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65730498|NCT02237261|Alkylating Agents|alkylating agents|mesh-ancestor
65730499|NCT02237261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730500|NCT03386643|Clobetasol|clobetasol|mesh-list
65730501|NCT03386643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65730502|NCT03386643|Glucocorticoids|glucocorticoids|mesh-ancestor
65730503|NCT03386643|Hormones|hormones|mesh-ancestor
65730504|NCT03386643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65730505|NCT03386643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730506|NCT05171985|Dexmedetomidine|dexmedetomidine|mesh-list
65730507|NCT05171985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65730508|NCT05171985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65730509|NCT05171985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730510|NCT05171985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65730511|NCT05171985|Analgesics|analgesics|mesh-ancestor
65730512|NCT05171985|Sensory System Agents|sensory system agents|mesh-ancestor
65730513|NCT05171985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65730514|NCT05171985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65730515|NCT05171985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65730516|NCT05171985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65730517|NCT05171985|Adrenergic Agents|adrenergic agents|mesh-ancestor
65730518|NCT05171985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65730519|NCT05171985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730520|NCT02237365|Aspirin|aspirin|mesh-list
65730521|NCT02237365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65730522|NCT02237365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65730523|NCT02237365|Analgesics|analgesics|mesh-ancestor
65730524|NCT02237365|Sensory System Agents|sensory system agents|mesh-ancestor
65730525|NCT02237365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65730526|NCT02237365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730527|NCT02237365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65730528|NCT02237365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65730529|NCT02237365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65730530|NCT02237365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65730531|NCT02237365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730532|NCT02237365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65730533|NCT02237365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65730534|NCT02237365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65730535|NCT02237365|Antipyretics|antipyretics|mesh-ancestor
65730536|NCT03383367|TEMPO|tempo|mesh-list
65730537|NCT03383367|Antioxidants|antioxidants|mesh-ancestor
65730538|NCT03383367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730539|NCT03383367|Protective Agents|protective agents|mesh-ancestor
65730540|NCT03383367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730541|NCT02856113|Alogliptin|alogliptin|mesh-list
65730542|NCT02856113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65730543|NCT02856113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730544|NCT02856113|Incretins|incretins|mesh-ancestor
65730545|NCT02856113|Hormones|hormones|mesh-ancestor
65730546|NCT02856113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65730547|NCT02856113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65730548|NCT02856113|Protease Inhibitors|protease inhibitors|mesh-ancestor
65730549|NCT02856113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65730550|NCT02856113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730551|NCT03386565|Lidocaine|lidocaine|mesh-list
65730552|NCT03386565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65046267|NCT00243789|Pentoxifylline|pentoxifylline|mesh-list
65730553|NCT03386565|Anesthetics, Local|anesthetics, local|mesh-ancestor
65730554|NCT03386565|Anesthetics|anesthetics|mesh-ancestor
65730555|NCT03386565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65730556|NCT03386565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730557|NCT03386565|Sensory System Agents|sensory system agents|mesh-ancestor
65730558|NCT03386565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65730559|NCT03386565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65730560|NCT03386565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65730561|NCT03386565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65730562|NCT03386565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65730563|NCT03386565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730564|NCT02237339|Allopurinol|allopurinol|mesh-list
65730565|NCT02237339|Antimetabolites|antimetabolites|mesh-ancestor
65730566|NCT02237339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730567|NCT02237339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65730568|NCT02237339|Gout Suppressants|gout suppressants|mesh-ancestor
65730569|NCT02237339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65730570|NCT02237339|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65730571|NCT02237339|Antioxidants|antioxidants|mesh-ancestor
65730572|NCT02237339|Protective Agents|protective agents|mesh-ancestor
65730573|NCT02237339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730574|NCT05171751|Octreotide|octreotide|mesh-list
65730575|NCT05171751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65730576|NCT05171751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65730577|NCT05171751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730578|NCT03971084|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
65730579|NCT03971084|Caseins|caseins|mesh-list
65730580|NCT03971084|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65730581|NCT03971084|Serotonin Agents|serotonin agents|mesh-ancestor
65730582|NCT03971084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65730583|NCT03971084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730584|NCT03971084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730585|NCT03971084|Chelating Agents|chelating agents|mesh-ancestor
65730586|NCT03971084|Sequestering Agents|sequestering agents|mesh-ancestor
65730587|NCT03379779|Dimercaprol|dimercaprol|mesh-list
65730588|NCT03379779|Chelating Agents|chelating agents|mesh-ancestor
65730589|NCT03379779|Sequestering Agents|sequestering agents|mesh-ancestor
65730590|NCT03379779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730591|NCT04083014|Bortezomib|bortezomib|mesh-list
65730592|NCT04083014|Antibodies|antibodies|mesh-list
65730593|NCT04083014|Immunologic Factors|immunologic factors|mesh-ancestor
65730594|NCT04083014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730595|NCT04083014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730596|NCT03563066|Benralizumab|benralizumab|mesh-list
65730597|NCT03563066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65730598|NCT03563066|Respiratory System Agents|respiratory system agents|mesh-ancestor
65730599|NCT03140384|Misoprostol|misoprostol|mesh-list
65730600|NCT03140384|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65730601|NCT03140384|Abortifacient Agents|abortifacient agents|mesh-ancestor
65730602|NCT03140384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65730603|NCT03140384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730604|NCT03140384|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65730605|NCT03140384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65730606|NCT03140384|Oxytocics|oxytocics|mesh-ancestor
65730607|NCT05117307|Bupivacaine|bupivacaine|mesh-list
65730608|NCT05117307|Anesthetics, Local|anesthetics, local|mesh-ancestor
65730609|NCT05117307|Anesthetics|anesthetics|mesh-ancestor
65730610|NCT05117307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65730611|NCT05117307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730612|NCT05117307|Sensory System Agents|sensory system agents|mesh-ancestor
65730613|NCT05117307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65730614|NCT03739268|Sevelamer|sevelamer|mesh-list
65730615|NCT03739268|Chelating Agents|chelating agents|mesh-ancestor
65730616|NCT03739268|Sequestering Agents|sequestering agents|mesh-ancestor
65730617|NCT03739268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730618|NCT02787590|Simvastatin|simvastatin|mesh-list
65730619|NCT02787590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65730620|NCT02787590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65730621|NCT02787590|Antimetabolites|antimetabolites|mesh-ancestor
65730622|NCT02787590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730623|NCT02787590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65730624|NCT02787590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65730625|NCT02787590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046333|NCT00214370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65730626|NCT04445571|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65730627|NCT04445571|Respiratory System Agents|respiratory system agents|mesh-ancestor
65730629|NCT03382743|Anesthetics, Local|anesthetics, local|mesh-ancestor
65730630|NCT03382743|Anesthetics|anesthetics|mesh-ancestor
65730631|NCT03382743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65730632|NCT03382743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730633|NCT03382743|Sensory System Agents|sensory system agents|mesh-ancestor
65730634|NCT03382743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65730635|NCT03382743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65730636|NCT03382743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65730637|NCT03382743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65730638|NCT03382743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65730639|NCT03382743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730640|NCT02854631|Prednisolone|prednisolone|mesh-list
65730641|NCT02854631|Selonsertib|selonsertib|mesh-list
65730642|NCT02854631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65730643|NCT02854631|Glucocorticoids|glucocorticoids|mesh-ancestor
65730644|NCT02854631|Hormones|hormones|mesh-ancestor
65730645|NCT02854631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65730646|NCT02854631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730647|NCT02854631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65730648|NCT02854631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730649|NCT02854631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65730650|NCT02854631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65730651|NCT02854631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730652|NCT03607643|Leucovorin|leucovorin|mesh-list
65730653|NCT03607643|Gemcitabine|gemcitabine|mesh-list
65730654|NCT03607643|Bevacizumab|bevacizumab|mesh-list
65730655|NCT03607643|Oxaliplatin|oxaliplatin|mesh-list
65730656|NCT03607643|Irinotecan|irinotecan|mesh-list
65730657|NCT03607643|Temozolomide|temozolomide|mesh-list
65730658|NCT03607643|Bortezomib|bortezomib|mesh-list
65730659|NCT03607643|Cannabidiol|cannabidiol|mesh-list
65730660|NCT03607643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65730661|NCT03607643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730662|NCT03607643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65730663|NCT03607643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65730664|NCT03607643|Growth Substances|growth substances|mesh-ancestor
65730665|NCT03607643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730666|NCT03607643|Growth Inhibitors|growth inhibitors|mesh-ancestor
65730667|NCT03607643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65730668|NCT03607643|Antimetabolites|antimetabolites|mesh-ancestor
65730669|NCT03607643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730670|NCT03607643|Antiviral Agents|antiviral agents|mesh-ancestor
65730671|NCT03607643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65730672|NCT03607643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65730673|NCT03607643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65730674|NCT03607643|Immunologic Factors|immunologic factors|mesh-ancestor
65730675|NCT03607643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65730676|NCT03607643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65730677|NCT03607643|Antidotes|antidotes|mesh-ancestor
65730678|NCT03607643|Protective Agents|protective agents|mesh-ancestor
65730679|NCT03607643|Vitamin B Complex|vitamin b complex|mesh-ancestor
65730680|NCT03607643|Vitamins|vitamins|mesh-ancestor
65730681|NCT03607643|Micronutrients|micronutrients|mesh-ancestor
65730682|NCT03607643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65730683|NCT03607643|Alkylating Agents|alkylating agents|mesh-ancestor
65730684|NCT03607643|Anticonvulsants|anticonvulsants|mesh-ancestor
65730685|NCT02855359|Prednisone|prednisone|mesh-list
65730686|NCT02855359|Cyclophosphamide|cyclophosphamide|mesh-list
65730687|NCT02855359|Rituximab|rituximab|mesh-list
65730688|NCT02855359|Doxorubicin|doxorubicin|mesh-list
65730689|NCT02855359|Vincristine|vincristine|mesh-list
65730690|NCT02855359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65730691|NCT02855359|Immunologic Factors|immunologic factors|mesh-ancestor
65730692|NCT02855359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730693|NCT02855359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65730694|NCT02855359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65730695|NCT02855359|Alkylating Agents|alkylating agents|mesh-ancestor
65730696|NCT02855359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730697|NCT02855359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730698|NCT02855359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65730699|NCT02855359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65730700|NCT02855359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65730701|NCT02855359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65046403|NCT00414531|Atorvastatin|atorvastatin|mesh-list
65730702|NCT02855359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65730703|NCT02855359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65730704|NCT02855359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65730705|NCT02855359|Glucocorticoids|glucocorticoids|mesh-ancestor
65730706|NCT02855359|Hormones|hormones|mesh-ancestor
65730707|NCT02855359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65730708|NCT02855359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65730709|NCT02855359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65730710|NCT02855359|Tubulin Modulators|tubulin modulators|mesh-ancestor
65730711|NCT02855359|Antimitotic Agents|antimitotic agents|mesh-ancestor
65730712|NCT02855359|Mitosis Modulators|mitosis modulators|mesh-ancestor
65730713|NCT05084456|Docetaxel|docetaxel|mesh-list
65730714|NCT05084456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730715|NCT05084456|Tubulin Modulators|tubulin modulators|mesh-ancestor
65730716|NCT05084456|Antimitotic Agents|antimitotic agents|mesh-ancestor
65730717|NCT05084456|Mitosis Modulators|mitosis modulators|mesh-ancestor
65730718|NCT05084456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730719|NCT03607903|Adalimumab|adalimumab|mesh-list
65730720|NCT03607903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65730721|NCT03607903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65730722|NCT04438850|Ivermectin|ivermectin|mesh-list
65730723|NCT04438850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65730724|NCT04438850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65730725|NCT03385863|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65730726|NCT03385863|Poractant alfa|poractant alfa|mesh-list
65730727|NCT03385863|Respiratory System Agents|respiratory system agents|mesh-ancestor
65730728|NCT03939026|Cyclophosphamide|cyclophosphamide|mesh-list
65730729|NCT03939026|Fludarabine|fludarabine|mesh-list
65730730|NCT03939026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65730731|NCT03939026|Immunologic Factors|immunologic factors|mesh-ancestor
65730732|NCT03939026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730733|NCT03939026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65730734|NCT03939026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65730735|NCT03939026|Alkylating Agents|alkylating agents|mesh-ancestor
65730736|NCT03939026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730737|NCT03939026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730738|NCT03939026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65730739|NCT03382587|Aflibercept|aflibercept|mesh-list
65730740|NCT03382587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65730741|NCT03382587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65730742|NCT03382587|Growth Substances|growth substances|mesh-ancestor
65730743|NCT03382587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730744|NCT03382587|Growth Inhibitors|growth inhibitors|mesh-ancestor
65730745|NCT03382587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730746|NCT03382431|PC-786|pc-786|mesh-list
65730747|NCT03382431|Antiviral Agents|antiviral agents|mesh-ancestor
65730748|NCT03382431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65730749|NCT03382431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65730750|NCT03382431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730751|NCT03141632|Dulaglutide|dulaglutide|mesh-list
65730752|NCT03141632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65730753|NCT03141632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730754|NCT04282239|Lidocaine|lidocaine|mesh-list
65730755|NCT04282239|Epinephrine|epinephrine|mesh-list
65730756|NCT04282239|Dexmedetomidine|dexmedetomidine|mesh-list
65730757|NCT04282239|Ropivacaine|ropivacaine|mesh-list
65730758|NCT04282239|Anesthetics, Local|anesthetics, local|mesh-ancestor
65730759|NCT04282239|Anesthetics|anesthetics|mesh-ancestor
65730760|NCT04282239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65730761|NCT04282239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730762|NCT04282239|Sensory System Agents|sensory system agents|mesh-ancestor
65730763|NCT04282239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65730764|NCT04282239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65730765|NCT04282239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65730766|NCT04282239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65730767|NCT04282239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65730768|NCT04282239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730769|NCT04282239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65730770|NCT04282239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65730771|NCT04282239|Analgesics|analgesics|mesh-ancestor
65730772|NCT04282239|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65730773|NCT04282239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65730774|NCT04282239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65730775|NCT04282239|Adrenergic Agents|adrenergic agents|mesh-ancestor
65730776|NCT04282239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65730777|NCT04282239|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65730778|NCT04282239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65730779|NCT04282239|Autonomic Agents|autonomic agents|mesh-ancestor
65730780|NCT04282239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65730781|NCT04282239|Respiratory System Agents|respiratory system agents|mesh-ancestor
65730782|NCT04282239|Mydriatics|mydriatics|mesh-ancestor
65730783|NCT04282239|Sympathomimetics|sympathomimetics|mesh-ancestor
65730784|NCT04282239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65730785|NCT03605173|Vitamin D|vitamin d|mesh-list
65730786|NCT03605173|Ergocalciferols|ergocalciferols|mesh-list
65730787|NCT03605173|Cholecalciferol|cholecalciferol|mesh-list
65730788|NCT03605173|Vitamins|vitamins|mesh-list
65730789|NCT03605173|Micronutrients|micronutrients|mesh-ancestor
65730790|NCT03605173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730791|NCT03605173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65730792|NCT03605173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65730793|NCT03605095|Nitroglycerin|nitroglycerin|mesh-list
65730794|NCT03605095|Vasodilator Agents|vasodilator agents|mesh-ancestor
65730795|NCT03382275|Iron|iron|mesh-list
65730796|NCT03382275|Ferric maltol|ferric maltol|mesh-list
65730797|NCT03382275|Trace Elements|trace elements|mesh-ancestor
65730798|NCT03382275|Micronutrients|micronutrients|mesh-ancestor
65730799|NCT03382275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730800|NCT03382275|Hematinics|hematinics|mesh-ancestor
65730801|NCT05080478|Clopidogrel|clopidogrel|mesh-list
65730802|NCT05080478|Ticagrelor|ticagrelor|mesh-list
65730803|NCT05080478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65730804|NCT05080478|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65730805|NCT05080478|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65730806|NCT05080478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65730807|NCT05080478|Purinergic Agents|purinergic agents|mesh-ancestor
65730808|NCT05080478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65730809|NCT05080478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730810|NCT05080478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730811|NCT03604627|Calcium|calcium|mesh-list
65730812|NCT03604627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65730813|NCT03604627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730814|NCT05082974|Varenicline|varenicline|mesh-list
65730815|NCT05082974|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65730816|NCT05082974|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65730817|NCT05082974|Cholinergic Agents|cholinergic agents|mesh-ancestor
65730818|NCT05082974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65730819|NCT05082974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730820|NCT05082974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730821|NCT03604471|Atorvastatin|atorvastatin|mesh-list
65730822|NCT03604471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65730823|NCT03604471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65730824|NCT03604471|Antimetabolites|antimetabolites|mesh-ancestor
65730825|NCT03604471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730826|NCT03604471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65730827|NCT03604471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65730828|NCT03604471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65730829|NCT03757130|Liraglutide|liraglutide|mesh-list
65730830|NCT03757130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65730831|NCT03757130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730832|NCT03757130|Incretins|incretins|mesh-ancestor
65730833|NCT03757130|Hormones|hormones|mesh-ancestor
65730834|NCT03757130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65730835|NCT02237443|Bromides|bromides|mesh-list
65730836|NCT02237443|Rocuronium|rocuronium|mesh-list
65730837|NCT02237443|Vecuronium Bromide|vecuronium bromide|mesh-list
65730838|NCT02237443|Succinylcholine|succinylcholine|mesh-list
65730839|NCT02237443|Anticonvulsants|anticonvulsants|mesh-ancestor
65730840|NCT02237443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65730841|NCT02237443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65730842|NCT02237443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65730843|NCT02237443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65730844|NCT02237443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730845|NCT02237443|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
65730846|NCT02237443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65730847|NCT02237443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65730848|NCT02237443|Cholinergic Agents|cholinergic agents|mesh-ancestor
65730849|NCT02237443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65730850|NCT02237443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730851|NCT03141398|Pancrelipase|pancrelipase|mesh-list
65730852|NCT03141398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65730853|NCT03733418|Vitamin D|vitamin d|mesh-list
65730854|NCT03733418|Cholecalciferol|cholecalciferol|mesh-list
65730855|NCT03733418|Vitamins|vitamins|mesh-ancestor
65730856|NCT03733418|Micronutrients|micronutrients|mesh-ancestor
65730857|NCT03733418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730858|NCT03733418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65730859|NCT03733418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65730860|NCT03607331|Citalopram|citalopram|mesh-list
65730861|NCT03607331|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65730862|NCT03607331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65730863|NCT03607331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65730864|NCT03607331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730865|NCT03607331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65730866|NCT03607331|Serotonin Agents|serotonin agents|mesh-ancestor
65730867|NCT03607331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730868|NCT03607331|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65730869|NCT03607331|Antidepressive Agents|antidepressive agents|mesh-ancestor
65730870|NCT03607331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65730871|NCT05082896|Anesthetics|anesthetics|mesh-list
65730872|NCT05082896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65730873|NCT05082896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730874|NCT03607955|Paclitaxel|paclitaxel|mesh-list
65730875|NCT03607955|Carboplatin|carboplatin|mesh-list
65730876|NCT03607955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65730877|NCT03607955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730878|NCT03607955|Tubulin Modulators|tubulin modulators|mesh-ancestor
65730879|NCT03607955|Antimitotic Agents|antimitotic agents|mesh-ancestor
65730880|NCT03607955|Mitosis Modulators|mitosis modulators|mesh-ancestor
65730881|NCT03607955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730882|NCT02067975|Tryptophan|tryptophan|mesh-list
65730883|NCT02067975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65730884|NCT02067975|Antidepressive Agents|antidepressive agents|mesh-ancestor
65730885|NCT02067975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65730886|NCT03143036|Thalidomide|thalidomide|mesh-list
65730887|NCT03143036|Dexamethasone|dexamethasone|mesh-list
65730888|NCT03143036|Daratumumab|daratumumab|mesh-list
65730889|NCT03143036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65730890|NCT03143036|Antiemetics|antiemetics|mesh-ancestor
65730891|NCT03143036|Autonomic Agents|autonomic agents|mesh-ancestor
65730892|NCT03143036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65730893|NCT03143036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730894|NCT03143036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65730895|NCT03143036|Glucocorticoids|glucocorticoids|mesh-ancestor
65730896|NCT03143036|Hormones|hormones|mesh-ancestor
65730897|NCT03143036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65730898|NCT03143036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65730899|NCT03143036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730900|NCT03143036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65730901|NCT03143036|Immunologic Factors|immunologic factors|mesh-ancestor
65730902|NCT03143036|Leprostatic Agents|leprostatic agents|mesh-ancestor
65730903|NCT03143036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65730904|NCT03143036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65730905|NCT03143036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65730906|NCT03143036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65730907|NCT03143036|Growth Substances|growth substances|mesh-ancestor
65730908|NCT03143036|Growth Inhibitors|growth inhibitors|mesh-ancestor
65730909|NCT03607175|Triamcinolone|triamcinolone|mesh-list
65730910|NCT03607175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65730911|NCT03607175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65730912|NCT03607175|Glucocorticoids|glucocorticoids|mesh-ancestor
65730913|NCT03607175|Hormones|hormones|mesh-ancestor
65730914|NCT03607175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65730915|NCT03607175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730916|NCT03607175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65730917|NCT03607175|Immunologic Factors|immunologic factors|mesh-ancestor
65730918|NCT05082662|Diclofenac|diclofenac|mesh-list
65730919|NCT05082662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65730920|NCT05082662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65730921|NCT05082662|Analgesics|analgesics|mesh-ancestor
65730922|NCT05082662|Sensory System Agents|sensory system agents|mesh-ancestor
65730923|NCT05082662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65730924|NCT05082662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730925|NCT05082662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65730926|NCT05082662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65730927|NCT05082662|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65730928|NCT05082662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046629|NCT00556621|Antimetabolites|antimetabolites|mesh-ancestor
65730929|NCT05082662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730931|NCT05080010|Etoposide|etoposide|mesh-list
65730932|NCT05080010|Vincristine|vincristine|mesh-list
65730933|NCT05080010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730934|NCT05080010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65730935|NCT05080010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65730936|NCT05080010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65730937|NCT05080010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65730938|NCT05080010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730939|NCT05080010|Tubulin Modulators|tubulin modulators|mesh-ancestor
65730940|NCT05080010|Antimitotic Agents|antimitotic agents|mesh-ancestor
65730941|NCT05080010|Mitosis Modulators|mitosis modulators|mesh-ancestor
65730942|NCT03385551|Estradiol|estradiol|mesh-list
65730943|NCT03385551|Estrogens|estrogens|mesh-ancestor
65730944|NCT03385551|Hormones|hormones|mesh-ancestor
65730945|NCT03385551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65730946|NCT03385551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730947|NCT03606473|Amphetamine|amphetamine|mesh-list
65730948|NCT03606473|Dextroamphetamine|dextroamphetamine|mesh-list
65730949|NCT03606473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65730950|NCT03606473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730951|NCT03606473|Sympathomimetics|sympathomimetics|mesh-ancestor
65730952|NCT03606473|Autonomic Agents|autonomic agents|mesh-ancestor
65730953|NCT03606473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65730954|NCT03606473|Dopamine Agents|dopamine agents|mesh-ancestor
65730955|NCT03606473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65730956|NCT03606473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730957|NCT03606473|Adrenergic Agents|adrenergic agents|mesh-ancestor
65730958|NCT03606473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65730959|NCT03606473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65730960|NCT03606473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65730961|NCT03606473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65730962|NCT03316274|Nivolumab|nivolumab|mesh-list
65730963|NCT03316274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65730964|NCT03316274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65730965|NCT03316274|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65730966|NCT03316274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730967|NCT03252626|Alprostadil|alprostadil|mesh-list
65730968|NCT03252626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65730969|NCT03252626|Vasodilator Agents|vasodilator agents|mesh-ancestor
65730970|NCT03252626|Urological Agents|urological agents|mesh-ancestor
65730971|NCT05072054|Atorvastatin|atorvastatin|mesh-list
65730972|NCT05072054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65730973|NCT05072054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65730974|NCT05072054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65730975|NCT05072054|Antimetabolites|antimetabolites|mesh-ancestor
65730976|NCT05072054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730977|NCT05072054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65730978|NCT05072054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65730979|NCT05072054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65730980|NCT03142880|Ropivacaine|ropivacaine|mesh-list
65730981|NCT03142880|Anesthetics, Local|anesthetics, local|mesh-ancestor
65730982|NCT03142880|Anesthetics|anesthetics|mesh-ancestor
65730983|NCT03142880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65730984|NCT03142880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65730985|NCT03142880|Sensory System Agents|sensory system agents|mesh-ancestor
65730986|NCT03142880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65730987|NCT03605537|Mometasone Furoate|mometasone furoate|mesh-list
65730988|NCT03605537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65730989|NCT03605537|Dermatologic Agents|dermatologic agents|mesh-ancestor
65730990|NCT03605537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65730991|NCT05049902|Amoxicillin|amoxicillin|mesh-list
65730992|NCT05049902|Metronidazole|metronidazole|mesh-list
65730993|NCT05049902|Clarithromycin|clarithromycin|mesh-list
65730994|NCT05049902|Tetracycline|tetracycline|mesh-list
65730995|NCT05049902|Potassium Citrate|potassium citrate|mesh-list
65730996|NCT05049902|Bismuth|bismuth|mesh-list
65730997|NCT05049902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65730998|NCT05049902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65193599|NCT02685748|Aspirin|aspirin|mesh-list
65730999|NCT05049902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65731000|NCT05049902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65731001|NCT05049902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65731002|NCT05049902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65731003|NCT05049902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731004|NCT05049902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65731005|NCT05049902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65731006|NCT05049902|Antacids|antacids|mesh-ancestor
65731007|NCT05049902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65731008|NCT05049902|Diuretics|diuretics|mesh-ancestor
65731009|NCT05049902|Natriuretic Agents|natriuretic agents|mesh-ancestor
65731010|NCT05049902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731011|NCT05049902|Expectorants|expectorants|mesh-ancestor
65731012|NCT05049902|Respiratory System Agents|respiratory system agents|mesh-ancestor
65731013|NCT05379803|Aflutinib|aflutinib|mesh-list
65731014|NCT05379803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65731015|NCT05379803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731016|NCT05379803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731017|NCT03381495|Sufentanil|sufentanil|mesh-list
65731018|NCT03381495|Ropivacaine|ropivacaine|mesh-list
65731019|NCT03381495|Anesthetics, Local|anesthetics, local|mesh-ancestor
65731020|NCT03381495|Anesthetics|anesthetics|mesh-ancestor
65731021|NCT03381495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65731022|NCT03381495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731023|NCT03381495|Sensory System Agents|sensory system agents|mesh-ancestor
65731024|NCT03381495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731025|NCT03381495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65731026|NCT03381495|Narcotics|narcotics|mesh-ancestor
65731027|NCT03381495|Analgesics|analgesics|mesh-ancestor
65731028|NCT03381495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65731029|NCT03381495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65731030|NCT03381495|Anesthetics, General|anesthetics, general|mesh-ancestor
65731031|NCT03059498|Bupivacaine|bupivacaine|mesh-list
65731032|NCT03059498|Anesthetics, Local|anesthetics, local|mesh-ancestor
65731033|NCT03059498|Anesthetics|anesthetics|mesh-ancestor
65731034|NCT03059498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65731035|NCT03059498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731036|NCT03059498|Sensory System Agents|sensory system agents|mesh-ancestor
65731037|NCT03059498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731038|NCT03264131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65731039|NCT03264131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65731040|NCT03264131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731041|NCT03142646|Cyclophosphamide|cyclophosphamide|mesh-list
65731042|NCT03142646|Fludarabine|fludarabine|mesh-list
65731043|NCT03142646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65731044|NCT03142646|Immunologic Factors|immunologic factors|mesh-ancestor
65731045|NCT03142646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731046|NCT03142646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65731047|NCT03142646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65731048|NCT03142646|Alkylating Agents|alkylating agents|mesh-ancestor
65731049|NCT03142646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731050|NCT03142646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731051|NCT03142646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65731052|NCT03541083|Blinatumomab|blinatumomab|mesh-list
65731053|NCT03541083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731054|NCT04962230|Ritonavir|ritonavir|mesh-list
65731055|NCT04962230|Carbamazepine|carbamazepine|mesh-list
65731056|NCT04962230|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65731057|NCT04962230|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65731058|NCT04962230|Protease Inhibitors|protease inhibitors|mesh-ancestor
65731059|NCT04962230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731060|NCT04962230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731061|NCT04962230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65731062|NCT04962230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65731063|NCT04962230|Antiviral Agents|antiviral agents|mesh-ancestor
65731064|NCT04962230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65731065|NCT04962230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65731066|NCT04962230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65731067|NCT04962230|Anticonvulsants|anticonvulsants|mesh-ancestor
65731068|NCT04962230|Antimanic Agents|antimanic agents|mesh-ancestor
65731069|NCT04962230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65731070|NCT04962230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65731071|NCT04962230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731072|NCT04962230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65731073|NCT04962230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65731074|NCT04962230|Analgesics|analgesics|mesh-ancestor
65731075|NCT04962230|Sensory System Agents|sensory system agents|mesh-ancestor
65731076|NCT04962230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731077|NCT04962230|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65731078|NCT04962230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65731079|NCT04962230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65731080|NCT04962230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65731081|NCT03602027|Gefitinib|gefitinib|mesh-list
65731082|NCT03602027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731083|NCT03602027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65731084|NCT03602027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731085|NCT03602027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731086|NCT03141476|Cefuroxime|cefuroxime|mesh-list
65731087|NCT03141476|Cefuroxime axetil|cefuroxime axetil|mesh-list
65731088|NCT03141476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65731089|NCT03141476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65731090|NCT03601871|Thalidomide|thalidomide|mesh-list
65731091|NCT03601871|Dexamethasone|dexamethasone|mesh-list
65731092|NCT03601871|Palonosetron|palonosetron|mesh-list
65731093|NCT03601871|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
65731094|NCT03601871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65731095|NCT03601871|Antiemetics|antiemetics|mesh-ancestor
65731096|NCT03601871|Autonomic Agents|autonomic agents|mesh-ancestor
65731097|NCT03601871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731098|NCT03601871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731099|NCT03601871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65731100|NCT03601871|Glucocorticoids|glucocorticoids|mesh-ancestor
65731101|NCT03601871|Hormones|hormones|mesh-ancestor
65731102|NCT03601871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65731103|NCT03601871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65731104|NCT03601871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731105|NCT03601871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65731106|NCT03601871|Immunologic Factors|immunologic factors|mesh-ancestor
65731107|NCT03601871|Leprostatic Agents|leprostatic agents|mesh-ancestor
65731108|NCT03601871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65731109|NCT03601871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65731110|NCT03601871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65731111|NCT03601871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65731112|NCT03601871|Growth Substances|growth substances|mesh-ancestor
65731113|NCT03601871|Growth Inhibitors|growth inhibitors|mesh-ancestor
65731114|NCT03601871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65731115|NCT03601871|Serotonin Agents|serotonin agents|mesh-ancestor
65731116|NCT03601871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65731117|NCT03601871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731118|NCT03380949|Remifentanil|remifentanil|mesh-list
65731119|NCT03380949|Analgesics, Opioid|analgesics, opioid|mesh-list
65731120|NCT03380949|Narcotics|narcotics|mesh-ancestor
65731121|NCT03380949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65731122|NCT03380949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731123|NCT03380949|Analgesics|analgesics|mesh-ancestor
65731124|NCT03380949|Sensory System Agents|sensory system agents|mesh-ancestor
65731125|NCT03380949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731126|NCT03604757|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65731127|NCT03604757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65731128|NCT03604757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731129|NCT03604679|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65731130|NCT03604679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65731131|NCT03604679|Alkylating Agents|alkylating agents|mesh-ancestor
65731132|NCT03604679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731133|NCT03604679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731134|NCT05078372|Midazolam|midazolam|mesh-list
65731135|NCT05078372|Ropivacaine|ropivacaine|mesh-list
65731136|NCT05078372|Anesthetics, Local|anesthetics, local|mesh-ancestor
65731137|NCT05078372|Anesthetics|anesthetics|mesh-ancestor
65731138|NCT05078372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65731139|NCT05078372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731140|NCT05078372|Sensory System Agents|sensory system agents|mesh-ancestor
65731141|NCT05078372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731142|NCT05078372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65731143|NCT05078372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65731144|NCT05078372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65731145|NCT05078372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65731146|NCT05078372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65731147|NCT05078372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65731148|NCT05078372|Anesthetics, General|anesthetics, general|mesh-ancestor
65731149|NCT05078372|GABA Modulators|gaba modulators|mesh-ancestor
65731150|NCT05078372|GABA Agents|gaba agents|mesh-ancestor
65731151|NCT05078372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65731152|NCT05078372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731153|NCT03380871|Carboplatin|carboplatin|mesh-list
65731154|NCT03380871|Pembrolizumab|pembrolizumab|mesh-list
65731155|NCT03380871|Pemetrexed|pemetrexed|mesh-list
65731156|NCT03380871|Poly ICLC|poly iclc|mesh-list
65731157|NCT03380871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731158|NCT03380871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65731159|NCT03380871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731160|NCT03380871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731161|NCT03380871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65731162|NCT03380871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65731163|NCT03380871|Interferon Inducers|interferon inducers|mesh-ancestor
65731164|NCT03380871|Immunologic Factors|immunologic factors|mesh-ancestor
65731165|NCT03380871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731166|NCT02237495|Dexmedetomidine|dexmedetomidine|mesh-list
65731167|NCT02237495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65731168|NCT02237495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65731169|NCT02237495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731170|NCT02237495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65731171|NCT02237495|Analgesics|analgesics|mesh-ancestor
65731172|NCT02237495|Sensory System Agents|sensory system agents|mesh-ancestor
65731173|NCT02237495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731174|NCT02237495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65731175|NCT02237495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65731176|NCT02237495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65731177|NCT02237495|Adrenergic Agents|adrenergic agents|mesh-ancestor
65731178|NCT02237495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65731179|NCT02237495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731180|NCT02486666|Enoxaparin|enoxaparin|mesh-list
65731181|NCT02486666|Enoxaparin sodium|enoxaparin sodium|mesh-list
65731182|NCT02486666|Anticoagulants|anticoagulants|mesh-ancestor
65731183|NCT02486666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65731184|NCT02486666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65731185|NCT02486666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731186|NCT02237807|Dirithromycin|dirithromycin|mesh-list
65731187|NCT02237807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65731188|NCT02237807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65731189|NCT03125187|Heparin|heparin|mesh-list
65731190|NCT03125187|Calcium heparin|calcium heparin|mesh-list
65731191|NCT03125187|Anticoagulants|anticoagulants|mesh-ancestor
65731192|NCT03125187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65731193|NCT03125187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65731194|NCT03125187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731195|NCT02038946|Nivolumab|nivolumab|mesh-list
65731196|NCT02038946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65731197|NCT02038946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731198|NCT02038946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65731199|NCT02038946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731200|NCT03377907|Lidocaine|lidocaine|mesh-list
65731201|NCT03377907|Ketamine|ketamine|mesh-list
65731202|NCT03377907|Anesthetics, Local|anesthetics, local|mesh-ancestor
65731203|NCT03377907|Anesthetics|anesthetics|mesh-ancestor
65731204|NCT03377907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65731205|NCT03377907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731206|NCT03377907|Sensory System Agents|sensory system agents|mesh-ancestor
65731207|NCT03377907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731208|NCT03377907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65731209|NCT03377907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65731210|NCT03377907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65731211|NCT03377907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65731212|NCT03377907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731213|NCT03377907|Analgesics|analgesics|mesh-ancestor
65731214|NCT03377907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65731215|NCT03377907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65731216|NCT03377907|Anesthetics, General|anesthetics, general|mesh-ancestor
65731217|NCT03377907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65731218|NCT03377907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65731219|NCT03377907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65731220|NCT03141554|Chlorhexidine|chlorhexidine|mesh-list
65731221|NCT03141554|Povidone-Iodine|povidone-iodine|mesh-list
65731222|NCT03141554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65731223|NCT03141554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65731224|NCT03141554|Disinfectants|disinfectants|mesh-ancestor
65731225|NCT03369795|Methotrexate|methotrexate|mesh-list
65731226|NCT03369795|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65731227|NCT03369795|Abortifacient Agents|abortifacient agents|mesh-ancestor
65731228|NCT03369795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65731229|NCT03369795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731230|NCT03369795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65731231|NCT03369795|Antimetabolites|antimetabolites|mesh-ancestor
65731232|NCT03369795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731233|NCT03369795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731234|NCT03369795|Dermatologic Agents|dermatologic agents|mesh-ancestor
65731235|NCT03369795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731236|NCT03369795|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65731237|NCT03369795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65731238|NCT03369795|Immunologic Factors|immunologic factors|mesh-ancestor
65731239|NCT03369795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65731240|NCT03369795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65731241|NCT03374709|Oxcarbazepine|oxcarbazepine|mesh-list
65731242|NCT03374709|Anticonvulsants|anticonvulsants|mesh-ancestor
65731243|NCT03374709|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65731244|NCT03374709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65731245|NCT03374709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65731246|NCT03374709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731247|NCT03374709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65731248|NCT03374709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65731249|NCT05393414|Acetaminophen|acetaminophen|mesh-list
65731250|NCT05393414|Ketorolac|ketorolac|mesh-list
65731251|NCT05393414|Morphine|morphine|mesh-list
65731252|NCT05393414|Analgesics, Opioid|analgesics, opioid|mesh-list
65731253|NCT05393414|Narcotics|narcotics|mesh-ancestor
65731254|NCT05393414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65731255|NCT05393414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731256|NCT05393414|Analgesics|analgesics|mesh-ancestor
65731257|NCT05393414|Sensory System Agents|sensory system agents|mesh-ancestor
65731258|NCT05393414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731259|NCT05393414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65731260|NCT05393414|Antipyretics|antipyretics|mesh-ancestor
65731261|NCT05393414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65731262|NCT05393414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65731263|NCT05393414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65731264|NCT05393414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65731265|NCT05393414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731266|NCT05393414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731267|NCT03369327|Sofosbuvir|sofosbuvir|mesh-list
65731268|NCT03369327|Antiviral Agents|antiviral agents|mesh-ancestor
65731269|NCT03369327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65731270|NCT02034500|Vaccines|vaccines|mesh-list
65731271|NCT02034500|Immunologic Factors|immunologic factors|mesh-ancestor
65731272|NCT02034500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731273|NCT03377283|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65731274|NCT03377283|Thymoglobulin|thymoglobulin|mesh-list
65731275|NCT03377283|Immunologic Factors|immunologic factors|mesh-ancestor
65731276|NCT03377283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731277|NCT03377283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65731278|NCT03955640|Olaparib|olaparib|mesh-list
65731279|NCT03955640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65731280|NCT03955640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731281|NCT03955640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731282|NCT03955640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731283|NCT03369093|Amoxicillin|amoxicillin|mesh-list
65731284|NCT03369093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65731285|NCT03369093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65731286|NCT03369015|Amphetamine|amphetamine|mesh-list
65731287|NCT03369015|Dextroamphetamine|dextroamphetamine|mesh-list
65731288|NCT03369015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65731289|NCT03369015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731290|NCT03369015|Sympathomimetics|sympathomimetics|mesh-ancestor
65731291|NCT03369015|Autonomic Agents|autonomic agents|mesh-ancestor
65731292|NCT03369015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731293|NCT03369015|Dopamine Agents|dopamine agents|mesh-ancestor
65731294|NCT03369015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65731295|NCT03369015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731296|NCT03369015|Adrenergic Agents|adrenergic agents|mesh-ancestor
65731297|NCT03369015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65731298|NCT03369015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65731299|NCT03369015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65731300|NCT03369015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65731301|NCT03890744|Docetaxel|docetaxel|mesh-list
65731302|NCT03890744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731303|NCT03890744|Tubulin Modulators|tubulin modulators|mesh-ancestor
65731304|NCT03890744|Antimitotic Agents|antimitotic agents|mesh-ancestor
65731305|NCT03890744|Mitosis Modulators|mitosis modulators|mesh-ancestor
65731306|NCT03890744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731307|NCT03374163|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65731308|NCT03374163|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65731309|NCT03374163|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65731310|NCT03374163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65731311|NCT03374007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65731312|NCT03374007|Antibodies|antibodies|mesh-list
65731313|NCT03374007|Immunoglobulins|immunoglobulins|mesh-list
65731314|NCT03374007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65731315|NCT03374007|Immunologic Factors|immunologic factors|mesh-ancestor
65731316|NCT03374007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731317|NCT03374007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731318|NCT04525521|Hand Sanitizers|hand sanitizers|mesh-list
65731319|NCT04525521|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65731320|NCT04525521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65731321|NCT04525521|Disinfectants|disinfectants|mesh-ancestor
65731322|NCT05392166|Calcium|calcium|mesh-list
65731323|NCT05392166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65731324|NCT05392166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731325|NCT02853331|Pembrolizumab|pembrolizumab|mesh-list
65731326|NCT02853331|Sunitinib|sunitinib|mesh-list
65731327|NCT02853331|Axitinib|axitinib|mesh-list
65731328|NCT02853331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65731329|NCT02853331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731330|NCT02853331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65731331|NCT02853331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65731332|NCT02853331|Growth Substances|growth substances|mesh-ancestor
65731333|NCT02853331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731334|NCT02853331|Growth Inhibitors|growth inhibitors|mesh-ancestor
65731335|NCT02853331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65731336|NCT02853331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731337|NCT02853331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731338|NCT03136640|Docetaxel|docetaxel|mesh-list
65731339|NCT03136640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731340|NCT03136640|Tubulin Modulators|tubulin modulators|mesh-ancestor
65731341|NCT03136640|Antimitotic Agents|antimitotic agents|mesh-ancestor
65731342|NCT03136640|Mitosis Modulators|mitosis modulators|mesh-ancestor
65731343|NCT03136640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731344|NCT02675439|Ipilimumab|ipilimumab|mesh-list
65731345|NCT02675439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65731346|NCT02675439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731347|NCT02675439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65731348|NCT02675439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731349|NCT03604003|Losartan|losartan|mesh-list
65731350|NCT03604003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65731351|NCT03604003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65731352|NCT03604003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65731353|NCT03604003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65731354|NCT03604003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731355|NCT03368391|Lidocaine|lidocaine|mesh-list
65731356|NCT03368391|Phenylephrine|phenylephrine|mesh-list
65731357|NCT03368391|Epinephrine|epinephrine|mesh-list
65731358|NCT03368391|Racepinephrine|racepinephrine|mesh-list
65731359|NCT03368391|Oxymetazoline|oxymetazoline|mesh-list
65731360|NCT03368391|Tetracaine|tetracaine|mesh-list
65731361|NCT03368391|Mepivacaine|mepivacaine|mesh-list
65731362|NCT03368391|Epinephryl borate|epinephryl borate|mesh-list
65731363|NCT03368391|Anesthetics, Local|anesthetics, local|mesh-ancestor
65731364|NCT03368391|Anesthetics|anesthetics|mesh-ancestor
65731365|NCT03368391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65731366|NCT03368391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731367|NCT03368391|Sensory System Agents|sensory system agents|mesh-ancestor
65731368|NCT03368391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731369|NCT03368391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65731370|NCT03368391|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65193976|NCT00640588|Adefovir|adefovir|mesh-list
65731371|NCT03368391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65731372|NCT03368391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65731373|NCT03368391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731374|NCT03368391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65731375|NCT03368391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65731376|NCT03368391|Adrenergic Agents|adrenergic agents|mesh-ancestor
65731377|NCT03368391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65731378|NCT03368391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65047076|NCT00241254|Hormones|hormones|mesh-ancestor
65731379|NCT03368391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65731380|NCT03368391|Autonomic Agents|autonomic agents|mesh-ancestor
65731381|NCT03368391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65731382|NCT03368391|Respiratory System Agents|respiratory system agents|mesh-ancestor
65731383|NCT03368391|Mydriatics|mydriatics|mesh-ancestor
65731384|NCT03368391|Sympathomimetics|sympathomimetics|mesh-ancestor
65731385|NCT03368391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65731386|NCT03368391|Nasal Decongestants|nasal decongestants|mesh-ancestor
65731387|NCT03368391|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65731388|NCT03368391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65731389|NCT03368391|Protective Agents|protective agents|mesh-ancestor
65731390|NCT03373305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65731391|NCT03373305|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65731392|NCT03373305|Lenalidomide|lenalidomide|mesh-list
65731393|NCT03373305|Piperidine|piperidine|mesh-list
65731394|NCT03373305|Antibodies|antibodies|mesh-list
65731395|NCT03373305|Immunoglobulins|immunoglobulins|mesh-list
65731396|NCT03373305|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65731397|NCT03373305|Immunoconjugates|immunoconjugates|mesh-list
65731398|NCT03373305|Immunologic Factors|immunologic factors|mesh-ancestor
65731399|NCT03373305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731400|NCT03373305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731401|NCT03373305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65731402|NCT03373305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65731403|NCT03373305|Growth Substances|growth substances|mesh-ancestor
65731404|NCT03373305|Growth Inhibitors|growth inhibitors|mesh-ancestor
65731405|NCT03373305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65731406|NCT03373305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65731407|NCT03373305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731408|NCT03373305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65731409|NCT03376737|Pemetrexed|pemetrexed|mesh-list
65731410|NCT03376737|Apatinib|apatinib|mesh-list
65731411|NCT03376737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731412|NCT03376737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731413|NCT03376737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731414|NCT03376737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65731415|NCT03376737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65731416|NCT03376737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65731417|NCT03373227|Tacrolimus|tacrolimus|mesh-list
65731418|NCT03373227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65731419|NCT03373227|Immunologic Factors|immunologic factors|mesh-ancestor
65731420|NCT03373227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731421|NCT03373227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65731422|NCT03373227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731423|NCT03373227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731424|NCT02484716|Timolol|timolol|mesh-list
65731425|NCT02484716|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65731426|NCT02484716|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65731427|NCT02484716|Adrenergic Agents|adrenergic agents|mesh-ancestor
65731428|NCT02484716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65731429|NCT02484716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731430|NCT02484716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731431|NCT02484716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65731432|NCT02484716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65731433|NCT03373149|Hormones|hormones|mesh-list
65731434|NCT03373149|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65731435|NCT03373149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65731436|NCT03373149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731437|NCT05386784|Cholecalciferol|cholecalciferol|mesh-list
65731438|NCT05386784|Vitamin D|vitamin d|mesh-list
65731439|NCT05386784|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65731440|NCT05386784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65731441|NCT05386784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731442|NCT05386784|Vitamins|vitamins|mesh-ancestor
65731443|NCT05386784|Micronutrients|micronutrients|mesh-ancestor
65731444|NCT05386784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65731445|NCT05386784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65731446|NCT05386784|Hormone Antagonists|hormone antagonists|mesh-ancestor
65731447|NCT05386784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65731448|NCT05386784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65731449|NCT05386784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65731450|NCT03602287|Lidocaine|lidocaine|mesh-list
65731451|NCT03602287|Anesthetics, Local|anesthetics, local|mesh-ancestor
65731452|NCT03602287|Anesthetics|anesthetics|mesh-ancestor
65047151|NCT00241332|Anesthetics|anesthetics|mesh-ancestor
65731454|NCT03602287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731455|NCT03602287|Sensory System Agents|sensory system agents|mesh-ancestor
65731456|NCT03602287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731457|NCT03602287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65731458|NCT03602287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65731459|NCT03602287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65731460|NCT03602287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65731461|NCT03602287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731462|NCT03137498|Ketorolac|ketorolac|mesh-list
65731463|NCT03137498|Lidocaine|lidocaine|mesh-list
65731464|NCT03137498|Prilocaine|prilocaine|mesh-list
65731465|NCT03137498|Anesthetics, Local|anesthetics, local|mesh-ancestor
65731466|NCT03137498|Anesthetics|anesthetics|mesh-ancestor
65731467|NCT03137498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65731468|NCT03137498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731469|NCT03137498|Sensory System Agents|sensory system agents|mesh-ancestor
65731470|NCT03137498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731471|NCT03137498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65731472|NCT03137498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65731473|NCT03137498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65731474|NCT03137498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65731475|NCT03137498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731476|NCT03137498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65731477|NCT03137498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65731478|NCT03137498|Analgesics|analgesics|mesh-ancestor
65731479|NCT03137498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65731480|NCT03137498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65731481|NCT03137498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65731482|NCT03137498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731483|NCT03602209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65731484|NCT03602209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65731485|NCT03367377|Insulin Glargine|insulin glargine|mesh-list
65731486|NCT03367377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65731487|NCT03367377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731488|NCT03602131|Gemcitabine|gemcitabine|mesh-list
65731489|NCT03602131|Busulfan|busulfan|mesh-list
65731490|NCT03602131|Cladribine|cladribine|mesh-list
65731491|NCT03602131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65731492|NCT03602131|Antimetabolites|antimetabolites|mesh-ancestor
65731493|NCT03602131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731494|NCT03602131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731495|NCT03602131|Antiviral Agents|antiviral agents|mesh-ancestor
65731496|NCT03602131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65731497|NCT03602131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731498|NCT03602131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65731499|NCT03602131|Immunologic Factors|immunologic factors|mesh-ancestor
65731500|NCT03602131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731501|NCT03602131|Alkylating Agents|alkylating agents|mesh-ancestor
65731502|NCT03602131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65731503|NCT03602131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65731504|NCT03606577|Dexamethasone|dexamethasone|mesh-list
65731505|NCT03606577|Lenalidomide|lenalidomide|mesh-list
65731506|NCT03606577|Daratumumab|daratumumab|mesh-list
65731507|NCT03606577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65731508|NCT03606577|Antiemetics|antiemetics|mesh-ancestor
65731509|NCT03606577|Autonomic Agents|autonomic agents|mesh-ancestor
65731510|NCT03606577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731511|NCT03606577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731512|NCT03606577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65731513|NCT03606577|Glucocorticoids|glucocorticoids|mesh-ancestor
65731514|NCT03606577|Hormones|hormones|mesh-ancestor
65731515|NCT03606577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65731516|NCT03606577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65731517|NCT03606577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731518|NCT03606577|Immunologic Factors|immunologic factors|mesh-ancestor
65731519|NCT03606577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65731520|NCT03606577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65731521|NCT03606577|Growth Substances|growth substances|mesh-ancestor
65731522|NCT03606577|Growth Inhibitors|growth inhibitors|mesh-ancestor
65731523|NCT03601975|Gemcitabine|gemcitabine|mesh-list
65731524|NCT03601975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731525|NCT03601975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65731526|NCT03601975|Antimetabolites|antimetabolites|mesh-ancestor
65731527|NCT03601975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731528|NCT03601975|Antiviral Agents|antiviral agents|mesh-ancestor
65731529|NCT03601975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65731530|NCT03601975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731531|NCT03601975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65731532|NCT03601975|Immunologic Factors|immunologic factors|mesh-ancestor
65731533|NCT03601975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731534|NCT03602911|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65731535|NCT03602911|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65731536|NCT03602911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731537|NCT03137186|Metformin|metformin|mesh-list
65731538|NCT03137186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65731539|NCT03137186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731540|NCT03601897|Paclitaxel|paclitaxel|mesh-list
65731541|NCT03601897|Rebastinib|rebastinib|mesh-list
65731542|NCT03601897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65731543|NCT03601897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731544|NCT03601897|Tubulin Modulators|tubulin modulators|mesh-ancestor
65731545|NCT03601897|Antimitotic Agents|antimitotic agents|mesh-ancestor
65731546|NCT03601897|Mitosis Modulators|mitosis modulators|mesh-ancestor
65731547|NCT03601897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731548|NCT03601897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65731549|NCT03601897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731550|NCT03137030|Acetaminophen|acetaminophen|mesh-list
65731551|NCT03137030|Hydrocodone|hydrocodone|mesh-list
65731552|NCT03137030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65731553|NCT03137030|Analgesics|analgesics|mesh-ancestor
65731554|NCT03137030|Sensory System Agents|sensory system agents|mesh-ancestor
65731555|NCT03137030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731556|NCT03137030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731557|NCT03137030|Antipyretics|antipyretics|mesh-ancestor
65731558|NCT03137030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65731559|NCT03137030|Narcotics|narcotics|mesh-ancestor
65731560|NCT03137030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65731561|NCT03137030|Antitussive Agents|antitussive agents|mesh-ancestor
65731562|NCT03137030|Respiratory System Agents|respiratory system agents|mesh-ancestor
65731563|NCT03596749|Sevelamer|sevelamer|mesh-list
65731564|NCT03596749|Chelating Agents|chelating agents|mesh-ancestor
65731565|NCT03596749|Sequestering Agents|sequestering agents|mesh-ancestor
65731566|NCT03596749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731567|NCT01595061|Gemcitabine|gemcitabine|mesh-list
65731568|NCT01595061|Cisplatin|cisplatin|mesh-list
65731569|NCT01595061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731570|NCT01595061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65731571|NCT01595061|Antimetabolites|antimetabolites|mesh-ancestor
65731572|NCT01595061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731573|NCT01595061|Antiviral Agents|antiviral agents|mesh-ancestor
65731574|NCT01595061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65731575|NCT01595061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731576|NCT01595061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65731577|NCT01595061|Immunologic Factors|immunologic factors|mesh-ancestor
65731578|NCT01595061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731579|NCT03367143|Carboplatin|carboplatin|mesh-list
65731580|NCT03367143|Etoposide|etoposide|mesh-list
65731581|NCT03367143|Lenalidomide|lenalidomide|mesh-list
65731582|NCT03367143|Ifosfamide|ifosfamide|mesh-list
65731583|NCT03367143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731584|NCT03367143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65731585|NCT03367143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65731586|NCT03367143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65731587|NCT03367143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731588|NCT03367143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731589|NCT03367143|Immunologic Factors|immunologic factors|mesh-ancestor
65731590|NCT03367143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731591|NCT03367143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65731592|NCT03367143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65731593|NCT03367143|Growth Substances|growth substances|mesh-ancestor
65731594|NCT03367143|Growth Inhibitors|growth inhibitors|mesh-ancestor
65731595|NCT03367143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65731596|NCT03367143|Alkylating Agents|alkylating agents|mesh-ancestor
65731597|NCT03372681|Antidiarrheals|antidiarrheals|mesh-list
65731598|NCT03372681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65731599|NCT04762316|Pyridoxal|pyridoxal|mesh-list
65731600|NCT04762316|Pyridoxine|pyridoxine|mesh-list
65731601|NCT04762316|Vitamin B 6|vitamin b 6|mesh-list
65731602|NCT04762316|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
65731603|NCT04762316|Vitamin B Complex|vitamin b complex|mesh-ancestor
65731604|NCT04762316|Vitamins|vitamins|mesh-ancestor
65731605|NCT04762316|Micronutrients|micronutrients|mesh-ancestor
65731606|NCT04762316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731607|NCT03372447|Thiamine|thiamine|mesh-list
65731608|NCT03372447|Pyridoxine|pyridoxine|mesh-list
65731609|NCT03372447|Hydroxocobalamin|hydroxocobalamin|mesh-list
65731610|NCT03372447|Vitamin B 12|vitamin b 12|mesh-list
65731611|NCT03372447|Vitamin B Complex|vitamin b complex|mesh-ancestor
65731612|NCT03372447|Vitamins|vitamins|mesh-ancestor
65731613|NCT03372447|Micronutrients|micronutrients|mesh-ancestor
65731614|NCT03372447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731615|NCT03372447|Hematinics|hematinics|mesh-ancestor
65731616|NCT04651166|Tranexamic Acid|tranexamic acid|mesh-list
65731617|NCT04651166|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65731618|NCT04651166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65731619|NCT04651166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731620|NCT04651166|Hemostatics|hemostatics|mesh-ancestor
65731621|NCT04651166|Coagulants|coagulants|mesh-ancestor
65731622|NCT03376191|Apatinib|apatinib|mesh-list
65731623|NCT03376191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731624|NCT03376191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65731625|NCT03376191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731626|NCT03376191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731627|NCT03366597|Sevoflurane|sevoflurane|mesh-list
65731628|NCT03366597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65731629|NCT03366597|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65731630|NCT03366597|Anesthetics, General|anesthetics, general|mesh-ancestor
65731631|NCT03366597|Anesthetics|anesthetics|mesh-ancestor
65731632|NCT03366597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65731633|NCT03366597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731634|NCT03110120|Levobupivacaine|levobupivacaine|mesh-list
65731635|NCT03110120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65731636|NCT03110120|Anesthetics, Local|anesthetics, local|mesh-ancestor
65731637|NCT03110120|Anesthetics|anesthetics|mesh-ancestor
65731638|NCT03110120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65731639|NCT03110120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731640|NCT03110120|Sensory System Agents|sensory system agents|mesh-ancestor
65731641|NCT03110120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731642|NCT03109886|Maleic acid|maleic acid|mesh-list
65731643|NCT03109886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731644|NCT03109886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731645|NCT03110198|Hydrocortisone|hydrocortisone|mesh-list
65731646|NCT03110198|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65731647|NCT03110198|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65731648|NCT03110198|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65731649|NCT03110198|Mesalamine|mesalamine|mesh-list
65731650|NCT03110198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65731651|NCT03110198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65731652|NCT03110198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65731653|NCT03110198|Analgesics|analgesics|mesh-ancestor
65731654|NCT03110198|Sensory System Agents|sensory system agents|mesh-ancestor
65731655|NCT03110198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731656|NCT03110198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731657|NCT03110198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65731658|NCT04460781|Vaccines|vaccines|mesh-list
65731659|NCT04460781|Immunologic Factors|immunologic factors|mesh-ancestor
65731660|NCT04460781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731661|NCT04427241|Amantadine|amantadine|mesh-list
65731662|NCT04427241|Cerebrolysin|cerebrolysin|mesh-list
65731663|NCT04427241|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65731664|NCT04427241|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65731665|NCT04427241|Antiviral Agents|antiviral agents|mesh-ancestor
65731666|NCT04427241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65731667|NCT04427241|Dopamine Agents|dopamine agents|mesh-ancestor
65731668|NCT04427241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65731669|NCT04427241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731670|NCT04427241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731671|NCT04427241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65731672|NCT04427241|Analgesics|analgesics|mesh-ancestor
65731673|NCT04427241|Sensory System Agents|sensory system agents|mesh-ancestor
65731674|NCT04427241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731675|NCT04427241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65731676|NCT04427241|Protective Agents|protective agents|mesh-ancestor
65731677|NCT04427241|Nootropic Agents|nootropic agents|mesh-ancestor
65731678|NCT04362488|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65731679|NCT04362488|Dermatologic Agents|dermatologic agents|mesh-ancestor
65731680|NCT04262024|Cabergoline|cabergoline|mesh-list
65731681|NCT04262024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65731682|NCT04262024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65731683|NCT04262024|Dopamine Agonists|dopamine agonists|mesh-ancestor
65731684|NCT04262024|Dopamine Agents|dopamine agents|mesh-ancestor
65731685|NCT04262024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65731686|NCT04262024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731687|NCT04262024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731688|NCT03371589|Dexamethasone|dexamethasone|mesh-list
65731689|NCT03371589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65731690|NCT03371589|Antiemetics|antiemetics|mesh-ancestor
65731691|NCT03371589|Autonomic Agents|autonomic agents|mesh-ancestor
65731692|NCT03371589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731693|NCT03371589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731694|NCT03371589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65731695|NCT03371589|Glucocorticoids|glucocorticoids|mesh-ancestor
65731696|NCT03371589|Hormones|hormones|mesh-ancestor
65731697|NCT03371589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65731698|NCT03371589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65731699|NCT03371589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731700|NCT03365817|Fentanyl|fentanyl|mesh-list
65731701|NCT03365817|Morphine|morphine|mesh-list
65731702|NCT03365817|Oxycodone|oxycodone|mesh-list
65731703|NCT03365817|Analgesics, Opioid|analgesics, opioid|mesh-list
65731704|NCT03365817|Tramadol|tramadol|mesh-list
65731705|NCT03365817|Methadone|methadone|mesh-list
65731706|NCT03365817|Narcotics|narcotics|mesh-ancestor
65731707|NCT03365817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65731708|NCT03365817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731709|NCT03365817|Analgesics|analgesics|mesh-ancestor
65731710|NCT03365817|Sensory System Agents|sensory system agents|mesh-ancestor
65731711|NCT03365817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731712|NCT03365817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65731713|NCT03365817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65731714|NCT03365817|Anesthetics, General|anesthetics, general|mesh-ancestor
65731715|NCT03365817|Anesthetics|anesthetics|mesh-ancestor
65731716|NCT03365817|Antitussive Agents|antitussive agents|mesh-ancestor
65731717|NCT03365817|Respiratory System Agents|respiratory system agents|mesh-ancestor
65731718|NCT02852005|Vaccines|vaccines|mesh-list
65731719|NCT02852005|Immunologic Factors|immunologic factors|mesh-ancestor
65731720|NCT02852005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731721|NCT03601741|Anti-Infective Agents|anti-infective agents|mesh-list
65731722|NCT03601741|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65731723|NCT03365115|Fentanyl|fentanyl|mesh-list
65731724|NCT03365115|Morphine|morphine|mesh-list
65731725|NCT03365115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65731726|NCT03365115|Narcotics|narcotics|mesh-ancestor
65731727|NCT03365115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65731728|NCT03365115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731729|NCT03365115|Analgesics|analgesics|mesh-ancestor
65731730|NCT03365115|Sensory System Agents|sensory system agents|mesh-ancestor
65731731|NCT03365115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731732|NCT03365115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65731733|NCT03365115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65731734|NCT03365115|Anesthetics, General|anesthetics, general|mesh-ancestor
65731735|NCT03365115|Anesthetics|anesthetics|mesh-ancestor
65731736|NCT02237755|Citric Acid|citric acid|mesh-list
65731737|NCT02237755|Sodium Citrate|sodium citrate|mesh-list
65731738|NCT02237755|Clomiphene|clomiphene|mesh-list
65731739|NCT02237755|Enclomiphene|enclomiphene|mesh-list
65731740|NCT02237755|Zuclomiphene|zuclomiphene|mesh-list
65731741|NCT02237755|Anticoagulants|anticoagulants|mesh-ancestor
65731742|NCT02237755|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65731743|NCT02237755|Chelating Agents|chelating agents|mesh-ancestor
65731744|NCT02237755|Sequestering Agents|sequestering agents|mesh-ancestor
65731745|NCT02237755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731746|NCT02237755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65731747|NCT02237755|Hormone Antagonists|hormone antagonists|mesh-ancestor
65731748|NCT02237755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65731749|NCT02237755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731750|NCT02237755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65731751|NCT02237755|Fertility Agents|fertility agents|mesh-ancestor
65731752|NCT02237755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65731753|NCT02237755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65731754|NCT02237755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65731755|NCT04524897|Triamcinolone|triamcinolone|mesh-list
65731756|NCT04524897|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65731757|NCT04524897|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65731758|NCT04524897|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65047463|NCT00558376|Laxatives|laxatives|mesh-ancestor
65731759|NCT04524897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65731760|NCT04524897|Glucocorticoids|glucocorticoids|mesh-ancestor
65731761|NCT04524897|Hormones|hormones|mesh-ancestor
65731762|NCT04524897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65731763|NCT04524897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731764|NCT04524897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65731765|NCT04524897|Immunologic Factors|immunologic factors|mesh-ancestor
65731766|NCT04524897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731767|NCT04524897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731768|NCT03364569|Tranexamic Acid|tranexamic acid|mesh-list
65731769|NCT03364569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65731770|NCT03364569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65731771|NCT03364569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731772|NCT03364569|Hemostatics|hemostatics|mesh-ancestor
65731773|NCT03364569|Coagulants|coagulants|mesh-ancestor
65731774|NCT03363477|Enoxaparin|enoxaparin|mesh-list
65731775|NCT03363477|Enoxaparin sodium|enoxaparin sodium|mesh-list
65731776|NCT03363477|Anticoagulants|anticoagulants|mesh-ancestor
65731777|NCT03363477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65731778|NCT03363477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65731779|NCT03363477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731780|NCT02879318|Gemcitabine|gemcitabine|mesh-list
65731781|NCT02879318|Paclitaxel|paclitaxel|mesh-list
65731782|NCT02879318|Durvalumab|durvalumab|mesh-list
65731783|NCT02879318|Tremelimumab|tremelimumab|mesh-list
65731784|NCT02879318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65731785|NCT02879318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731786|NCT02879318|Tubulin Modulators|tubulin modulators|mesh-ancestor
65731787|NCT02879318|Antimitotic Agents|antimitotic agents|mesh-ancestor
65731788|NCT02879318|Mitosis Modulators|mitosis modulators|mesh-ancestor
65731789|NCT02879318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731790|NCT02879318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65731791|NCT02879318|Antimetabolites|antimetabolites|mesh-ancestor
65731792|NCT02879318|Antiviral Agents|antiviral agents|mesh-ancestor
65731793|NCT02879318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65731794|NCT02879318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731795|NCT02879318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65731796|NCT02879318|Immunologic Factors|immunologic factors|mesh-ancestor
65731797|NCT02879318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731798|NCT02879318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65731799|NCT03593707|Metformin|metformin|mesh-list
65731800|NCT03593707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65731801|NCT03593707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731802|NCT03592537|Fentanyl|fentanyl|mesh-list
65731803|NCT03592537|Midazolam|midazolam|mesh-list
65731804|NCT03592537|Bupivacaine|bupivacaine|mesh-list
65731805|NCT03592537|Anesthetics, Local|anesthetics, local|mesh-ancestor
65731806|NCT03592537|Anesthetics|anesthetics|mesh-ancestor
65731807|NCT03592537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65731808|NCT03592537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731809|NCT03592537|Sensory System Agents|sensory system agents|mesh-ancestor
65731810|NCT03592537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731811|NCT03592537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65731812|NCT03592537|Narcotics|narcotics|mesh-ancestor
65731813|NCT03592537|Analgesics|analgesics|mesh-ancestor
65731814|NCT03592537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65731815|NCT03592537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65731816|NCT03592537|Anesthetics, General|anesthetics, general|mesh-ancestor
65731817|NCT03592537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65731818|NCT03592537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65731819|NCT03592537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65731820|NCT03592537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65731821|NCT03592537|GABA Modulators|gaba modulators|mesh-ancestor
65731822|NCT03592537|GABA Agents|gaba agents|mesh-ancestor
65731823|NCT03592537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65731824|NCT03592537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731825|NCT03362853|Moxifloxacin|moxifloxacin|mesh-list
65731826|NCT03362853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65194429|NCT02537392|Vitamins|vitamins|mesh-ancestor
65731827|NCT03362853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65731828|NCT03362853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65731829|NCT03362853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65731830|NCT03362853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731831|NCT03362853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731832|NCT03362853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731833|NCT02849743|Oxytocin|oxytocin|mesh-list
65731834|NCT02849743|Oxytocics|oxytocics|mesh-ancestor
65731835|NCT02849743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65731836|NCT02849743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047532|NCT04644094|Hormones|hormones|mesh-ancestor
65731837|NCT05063006|Methamphetamine|methamphetamine|mesh-list
65731838|NCT05063006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65731839|NCT05063006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731840|NCT05063006|Sympathomimetics|sympathomimetics|mesh-ancestor
65731841|NCT05063006|Autonomic Agents|autonomic agents|mesh-ancestor
65731842|NCT05063006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731843|NCT05063006|Dopamine Agents|dopamine agents|mesh-ancestor
65731844|NCT05063006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65731845|NCT05063006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731846|NCT05063006|Adrenergic Agents|adrenergic agents|mesh-ancestor
65731847|NCT05063006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65731848|NCT05063006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65731849|NCT05063006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65731850|NCT05063006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65731851|NCT03587077|Isosorbide|isosorbide|mesh-list
65731852|NCT03587077|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65731853|NCT03587077|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65731854|NCT03587077|Misoprostol|misoprostol|mesh-list
65731855|NCT03587077|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65731856|NCT03587077|Abortifacient Agents|abortifacient agents|mesh-ancestor
65731857|NCT03587077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65731858|NCT03587077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731859|NCT03587077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65731860|NCT03587077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65731861|NCT03587077|Oxytocics|oxytocics|mesh-ancestor
65731862|NCT03587077|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65731863|NCT03587077|Diuretics|diuretics|mesh-ancestor
65731864|NCT03587077|Natriuretic Agents|natriuretic agents|mesh-ancestor
65731865|NCT03587077|Vasodilator Agents|vasodilator agents|mesh-ancestor
65731866|NCT03587077|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65731867|NCT03587077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731868|NCT02238457|Losartan|losartan|mesh-list
65731869|NCT02238457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65731870|NCT02238457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65731871|NCT02238457|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65731872|NCT02238457|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65731873|NCT02238457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731874|NCT02238535|Iloprost|iloprost|mesh-list
65731875|NCT02238535|Warfarin|warfarin|mesh-list
65731876|NCT02238535|Anticoagulants|anticoagulants|mesh-ancestor
65731877|NCT02238535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65731878|NCT02238535|Vasodilator Agents|vasodilator agents|mesh-ancestor
65731879|NCT03362697|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65731880|NCT03362697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65731881|NCT03909074|Vaccines|vaccines|mesh-list
65731882|NCT03909074|Immunologic Factors|immunologic factors|mesh-ancestor
65731883|NCT03909074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731884|NCT03138668|Ropivacaine|ropivacaine|mesh-list
65731885|NCT03138668|Anesthetics, Local|anesthetics, local|mesh-ancestor
65731886|NCT03138668|Anesthetics|anesthetics|mesh-ancestor
65731887|NCT03138668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65731888|NCT03138668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731889|NCT03138668|Sensory System Agents|sensory system agents|mesh-ancestor
65731890|NCT03138668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731891|NCT03371043|Analgesics|analgesics|mesh-list
65731892|NCT03371043|Sensory System Agents|sensory system agents|mesh-ancestor
65731893|NCT03371043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731894|NCT03371043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731895|NCT03600961|Sirolimus|sirolimus|mesh-list
65731896|NCT03600961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65731897|NCT03600961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65731898|NCT03600961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65731899|NCT03600961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731900|NCT03600961|Antifungal Agents|antifungal agents|mesh-ancestor
65731901|NCT03600961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65731902|NCT03600961|Immunologic Factors|immunologic factors|mesh-ancestor
65731903|NCT03600961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731904|NCT05013242|Goserelin|goserelin|mesh-list
65731905|NCT05013242|Dienogest|dienogest|mesh-list
65731906|NCT05013242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65731907|NCT05013242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731908|NCT05013242|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65731909|NCT05013242|Contraceptive Agents|contraceptive agents|mesh-ancestor
65731910|NCT05013242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65731911|NCT05013242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731912|NCT05013242|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65731913|NCT05013242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65731914|NCT05013242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65731915|NCT05013242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65731916|NCT05013242|Hormone Antagonists|hormone antagonists|mesh-ancestor
65731917|NCT05013242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65731918|NCT05089604|Tacrolimus|tacrolimus|mesh-list
65731919|NCT05089604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65731920|NCT05089604|Immunologic Factors|immunologic factors|mesh-ancestor
65731921|NCT05089604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731922|NCT05089604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65731923|NCT05089604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731924|NCT05089604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731925|NCT03590275|Folfirinox|folfirinox|mesh-list
65731926|NCT03590275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731927|NCT05089448|Amlodipine|amlodipine|mesh-list
65731928|NCT05089448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65731929|NCT05089448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65731930|NCT05089448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65731931|NCT05089448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731932|NCT05089448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65731933|NCT05089448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731934|NCT05089448|Vasodilator Agents|vasodilator agents|mesh-ancestor
65731935|NCT00601003|Nifurtimox|nifurtimox|mesh-list
65731936|NCT00601003|Cyclophosphamide|cyclophosphamide|mesh-list
65731937|NCT00601003|Topotecan|topotecan|mesh-list
65731938|NCT00601003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65731939|NCT00601003|Immunologic Factors|immunologic factors|mesh-ancestor
65731940|NCT00601003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731941|NCT00601003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65731942|NCT00601003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65731943|NCT00601003|Alkylating Agents|alkylating agents|mesh-ancestor
65731944|NCT00601003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731945|NCT00601003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65731946|NCT00601003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65731947|NCT00601003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65731948|NCT00601003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65731949|NCT00601003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731950|NCT00601003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65731951|NCT00601003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65731952|NCT00601003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65731953|NCT00601003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65731954|NCT02849509|Vitamin K|vitamin k|mesh-list
65731955|NCT02849509|Dabigatran|dabigatran|mesh-list
65731956|NCT02849509|Vitamins|vitamins|mesh-ancestor
65731957|NCT02849509|Micronutrients|micronutrients|mesh-ancestor
65731958|NCT02849509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731959|NCT02849509|Antithrombins|antithrombins|mesh-ancestor
65731960|NCT02849509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65731961|NCT02849509|Protease Inhibitors|protease inhibitors|mesh-ancestor
65731962|NCT02849509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65731963|NCT02849509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731964|NCT02849509|Anticoagulants|anticoagulants|mesh-ancestor
65731965|NCT02849509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65731966|NCT02849509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65731967|NCT02849509|Hemostatics|hemostatics|mesh-ancestor
65731968|NCT02849509|Coagulants|coagulants|mesh-ancestor
65731969|NCT00151424|Olanzapine|olanzapine|mesh-list
65731970|NCT00151424|Asenapine|asenapine|mesh-list
65731971|NCT00151424|Antiemetics|antiemetics|mesh-ancestor
65731972|NCT00151424|Autonomic Agents|autonomic agents|mesh-ancestor
65731973|NCT00151424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731974|NCT00151424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731975|NCT00151424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65731976|NCT00151424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65731977|NCT00151424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65731978|NCT00151424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65731979|NCT00151424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65731980|NCT00151424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65731981|NCT00151424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65731982|NCT00151424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65731983|NCT00151424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65731984|NCT00151424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65731985|NCT00151424|Serotonin Agents|serotonin agents|mesh-ancestor
65731986|NCT03600727|Dexmedetomidine|dexmedetomidine|mesh-list
65731987|NCT03600727|Propofol|propofol|mesh-list
65731988|NCT03600727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65731989|NCT03600727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65731990|NCT03600727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65731991|NCT03600727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65731992|NCT03600727|Anesthetics, General|anesthetics, general|mesh-ancestor
65731993|NCT03600727|Anesthetics|anesthetics|mesh-ancestor
65731994|NCT03600727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65731995|NCT03600727|Analgesics|analgesics|mesh-ancestor
65731996|NCT03600727|Sensory System Agents|sensory system agents|mesh-ancestor
65731997|NCT03600727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65731998|NCT03600727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65731999|NCT03600727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65732000|NCT03600727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65732001|NCT03600727|Adrenergic Agents|adrenergic agents|mesh-ancestor
65732002|NCT03600727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65732003|NCT03600727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732004|NCT02733133|Testosterone|testosterone|mesh-list
65732005|NCT02733133|Androgens|androgens|mesh-ancestor
65732007|NCT02733133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65732008|NCT02733133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732009|NCT03464942|Atezolizumab|atezolizumab|mesh-list
65732010|NCT03464942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65732011|NCT03584893|Dehydrocholesterols|dehydrocholesterols|mesh-list
65732012|NCT03584893|Provitamins|provitamins|mesh-ancestor
65732013|NCT03584893|Vitamins|vitamins|mesh-ancestor
65732014|NCT03584893|Micronutrients|micronutrients|mesh-ancestor
65732015|NCT03584893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732016|NCT03362073|Ketamine|ketamine|mesh-list
65732017|NCT03362073|Analgesics|analgesics|mesh-ancestor
65732018|NCT03362073|Sensory System Agents|sensory system agents|mesh-ancestor
65732019|NCT03362073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732020|NCT03362073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732021|NCT03362073|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65732022|NCT03362073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65732023|NCT03362073|Anesthetics, General|anesthetics, general|mesh-ancestor
65732024|NCT03362073|Anesthetics|anesthetics|mesh-ancestor
65732025|NCT03362073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65732026|NCT03362073|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65732027|NCT03362073|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65732028|NCT03362073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65732029|NCT03362073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732030|NCT03582865|Tamoxifen|tamoxifen|mesh-list
65732031|NCT03582865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65732032|NCT03582865|Hormone Antagonists|hormone antagonists|mesh-ancestor
65732033|NCT03582865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65732034|NCT03582865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732035|NCT03582865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65732036|NCT03582865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65732037|NCT03582865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65732038|NCT03582865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65732039|NCT03582865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65732040|NCT03136406|Leucovorin|leucovorin|mesh-list
65732041|NCT03136406|Paclitaxel|paclitaxel|mesh-list
65732042|NCT03136406|Cyclophosphamide|cyclophosphamide|mesh-list
65732043|NCT03136406|Bevacizumab|bevacizumab|mesh-list
65732044|NCT03136406|Fluorouracil|fluorouracil|mesh-list
65732045|NCT03136406|Capecitabine|capecitabine|mesh-list
65732046|NCT03136406|Oxaliplatin|oxaliplatin|mesh-list
65732047|NCT03136406|Avelumab|avelumab|mesh-list
65732048|NCT03136406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65732049|NCT03136406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65732050|NCT03136406|Tubulin Modulators|tubulin modulators|mesh-ancestor
65732051|NCT03136406|Antimitotic Agents|antimitotic agents|mesh-ancestor
65732052|NCT03136406|Mitosis Modulators|mitosis modulators|mesh-ancestor
65732053|NCT03136406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732054|NCT03136406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65732055|NCT03136406|Immunologic Factors|immunologic factors|mesh-ancestor
65732056|NCT03136406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732057|NCT03136406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65732058|NCT03136406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65732059|NCT03136406|Alkylating Agents|alkylating agents|mesh-ancestor
65732060|NCT03136406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65732061|NCT03136406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65732062|NCT03136406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65047752|NCT04639804|Celecoxib|celecoxib|mesh-list
65732063|NCT03136406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65732064|NCT03136406|Growth Substances|growth substances|mesh-ancestor
65732065|NCT03136406|Growth Inhibitors|growth inhibitors|mesh-ancestor
65732066|NCT03136406|Antimetabolites|antimetabolites|mesh-ancestor
65732067|NCT03136406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65732068|NCT03136406|Antidotes|antidotes|mesh-ancestor
65732069|NCT03136406|Protective Agents|protective agents|mesh-ancestor
65732070|NCT03136406|Vitamin B Complex|vitamin b complex|mesh-ancestor
65732071|NCT03136406|Vitamins|vitamins|mesh-ancestor
65732072|NCT03136406|Micronutrients|micronutrients|mesh-ancestor
65732073|NCT03590197|Melatonin|melatonin|mesh-list
65732074|NCT03590197|Antioxidants|antioxidants|mesh-ancestor
65732075|NCT03590197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732076|NCT03590197|Protective Agents|protective agents|mesh-ancestor
65732077|NCT03590197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732078|NCT03590197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65732079|NCT05057468|Cyclosporine|cyclosporine|mesh-list
65732080|NCT05057468|Rituximab|rituximab|mesh-list
65732081|NCT05057468|Cyclosporins|cyclosporins|mesh-list
65732082|NCT05057468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65732083|NCT05057468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65732084|NCT05057468|Immunologic Factors|immunologic factors|mesh-ancestor
65732085|NCT05057468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732086|NCT05057468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65732087|NCT05057468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65732088|NCT05057468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732089|NCT05057468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65732090|NCT05057468|Antifungal Agents|antifungal agents|mesh-ancestor
65732091|NCT05057468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65732092|NCT05057468|Dermatologic Agents|dermatologic agents|mesh-ancestor
65732093|NCT05057468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65732094|NCT02518503|Atorvastatin|atorvastatin|mesh-list
65732095|NCT02518503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65732096|NCT02518503|Simvastatin|simvastatin|mesh-list
65732097|NCT02518503|Pravastatin|pravastatin|mesh-list
65732098|NCT02518503|Lovastatin|lovastatin|mesh-list
65732099|NCT02518503|L 647318|l 647318|mesh-list
65732100|NCT02518503|Dihydromevinolin|dihydromevinolin|mesh-list
65732101|NCT02518503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65732102|NCT02518503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65732103|NCT02518503|Antimetabolites|antimetabolites|mesh-ancestor
65732104|NCT02518503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732105|NCT02518503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65732106|NCT02518503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65732107|NCT02518503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65732108|NCT03600493|Lidocaine|lidocaine|mesh-list
65732109|NCT03600493|Dexmedetomidine|dexmedetomidine|mesh-list
65732110|NCT03600493|Anesthetics, Local|anesthetics, local|mesh-ancestor
65732111|NCT03600493|Anesthetics|anesthetics|mesh-ancestor
65732112|NCT03600493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65732113|NCT03600493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732114|NCT03600493|Sensory System Agents|sensory system agents|mesh-ancestor
65732115|NCT03600493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732116|NCT03600493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65732117|NCT03600493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65732118|NCT03600493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65732119|NCT03600493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65732120|NCT03600493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732121|NCT03600493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65732122|NCT03600493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65732123|NCT03600493|Analgesics|analgesics|mesh-ancestor
65732124|NCT03600493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65732125|NCT03600493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65732126|NCT03600493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65732127|NCT03600493|Adrenergic Agents|adrenergic agents|mesh-ancestor
65732128|NCT03600493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65732129|NCT03138356|Metformin|metformin|mesh-list
65732130|NCT03138356|Dapagliflozin|dapagliflozin|mesh-list
65732131|NCT03138356|Saxagliptin|saxagliptin|mesh-list
65732132|NCT03138356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65732133|NCT03138356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732134|NCT03138356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65732135|NCT03138356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732136|NCT03138356|Incretins|incretins|mesh-ancestor
65732137|NCT03138356|Hormones|hormones|mesh-ancestor
65732138|NCT03138356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65732139|NCT03138356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65732140|NCT03138356|Protease Inhibitors|protease inhibitors|mesh-ancestor
65732141|NCT03138356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65732142|NCT03137966|Deferoxamine|deferoxamine|mesh-list
65732143|NCT03137966|Siderophores|siderophores|mesh-ancestor
65732144|NCT03137966|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65732145|NCT03137966|Chelating Agents|chelating agents|mesh-ancestor
65732146|NCT03137966|Sequestering Agents|sequestering agents|mesh-ancestor
65732147|NCT03137966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732148|NCT02853305|Gemcitabine|gemcitabine|mesh-list
65732149|NCT02853305|Carboplatin|carboplatin|mesh-list
65732150|NCT02853305|Pembrolizumab|pembrolizumab|mesh-list
65732151|NCT02853305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65732152|NCT02853305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65732153|NCT02853305|Antimetabolites|antimetabolites|mesh-ancestor
65732154|NCT02853305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732155|NCT02853305|Antiviral Agents|antiviral agents|mesh-ancestor
65732156|NCT02853305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65732157|NCT02853305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65732158|NCT02853305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65732159|NCT02853305|Immunologic Factors|immunologic factors|mesh-ancestor
65732160|NCT02853305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732161|NCT02853305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65732162|NCT04521387|Hyaluronic Acid|hyaluronic acid|mesh-list
65732163|NCT04521387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65732164|NCT04521387|Immunologic Factors|immunologic factors|mesh-ancestor
65732165|NCT04521387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732166|NCT04521387|Viscosupplements|viscosupplements|mesh-ancestor
65732167|NCT04521387|Protective Agents|protective agents|mesh-ancestor
65732168|NCT03579979|Methylene Blue|methylene blue|mesh-list
65732169|NCT03579979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65732170|NCT03579979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732171|NCT04509219|Methylprednisolone|methylprednisolone|mesh-list
65732172|NCT04509219|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65732173|NCT04509219|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65732174|NCT04509219|Prednisolone|prednisolone|mesh-list
65732175|NCT04509219|Prednisolone acetate|prednisolone acetate|mesh-list
65732176|NCT04509219|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65732177|NCT04509219|Prednisolone phosphate|prednisolone phosphate|mesh-list
65732178|NCT04509219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65732179|NCT04509219|Antiemetics|antiemetics|mesh-ancestor
65732180|NCT04509219|Autonomic Agents|autonomic agents|mesh-ancestor
65732181|NCT04509219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732182|NCT04509219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732183|NCT04509219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65732184|NCT04509219|Glucocorticoids|glucocorticoids|mesh-ancestor
65732185|NCT04509219|Hormones|hormones|mesh-ancestor
65732186|NCT04509219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65732187|NCT04509219|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65732188|NCT04509219|Protective Agents|protective agents|mesh-ancestor
65732189|NCT04509219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65732190|NCT04509219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65732191|NCT04444635|Fentanyl|fentanyl|mesh-list
65732192|NCT04444635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65732193|NCT04444635|Narcotics|narcotics|mesh-ancestor
65732194|NCT04444635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65732195|NCT04444635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732196|NCT04444635|Analgesics|analgesics|mesh-ancestor
65732197|NCT04444635|Sensory System Agents|sensory system agents|mesh-ancestor
65732198|NCT04444635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732199|NCT04444635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65732200|NCT04444635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65732201|NCT04444635|Anesthetics, General|anesthetics, general|mesh-ancestor
65732202|NCT04444635|Anesthetics|anesthetics|mesh-ancestor
65732203|NCT03033446|Nivolumab|nivolumab|mesh-list
65732204|NCT03033446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65732205|NCT03033446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65732206|NCT03033446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65732207|NCT03033446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732208|NCT03579823|Adalimumab|adalimumab|mesh-list
65732209|NCT03579823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65732210|NCT03579823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65732211|NCT04444011|Amoxicillin|amoxicillin|mesh-list
65732212|NCT04444011|Clarithromycin|clarithromycin|mesh-list
65732213|NCT04444011|Bismuth|bismuth|mesh-list
65732214|NCT04444011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65732215|NCT04444011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65732216|NCT04444011|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65732218|NCT04444011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732219|NCT04444011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65732220|NCT04444011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65732221|NCT04444011|Antacids|antacids|mesh-ancestor
65732222|NCT04444011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65732223|NCT04443387|Vitamin D|vitamin d|mesh-list
65732224|NCT04443387|Vitamins|vitamins|mesh-ancestor
65732225|NCT04443387|Micronutrients|micronutrients|mesh-ancestor
65732226|NCT04443387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732227|NCT04443387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65732228|NCT02316236|Dexmedetomidine|dexmedetomidine|mesh-list
65732229|NCT02316236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65732230|NCT02316236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65732231|NCT02316236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732232|NCT02316236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65732233|NCT02316236|Analgesics|analgesics|mesh-ancestor
65732234|NCT02316236|Sensory System Agents|sensory system agents|mesh-ancestor
65732235|NCT02316236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732236|NCT02316236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65732237|NCT02316236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65732238|NCT02316236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65732239|NCT02316236|Adrenergic Agents|adrenergic agents|mesh-ancestor
65732240|NCT02316236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65732241|NCT02316236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732242|NCT04521075|Nivolumab|nivolumab|mesh-list
65732243|NCT04521075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65732244|NCT04521075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65732245|NCT04521075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65732246|NCT04521075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732247|NCT03577249|Dialysis Solutions|dialysis solutions|mesh-list
65732248|NCT03577249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65732249|NCT03601091|Midazolam|midazolam|mesh-list
65732250|NCT03601091|Dexmedetomidine|dexmedetomidine|mesh-list
65732251|NCT03601091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65732252|NCT03601091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65732253|NCT03601091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732254|NCT03601091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65732255|NCT03601091|Analgesics|analgesics|mesh-ancestor
65732256|NCT03601091|Sensory System Agents|sensory system agents|mesh-ancestor
65732257|NCT03601091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732258|NCT03601091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65732259|NCT03601091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65732260|NCT03601091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65732261|NCT03601091|Adrenergic Agents|adrenergic agents|mesh-ancestor
65732262|NCT03601091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65732263|NCT03601091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732264|NCT03601091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65732265|NCT03601091|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65732266|NCT03601091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65732267|NCT03601091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65732268|NCT03601091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65732269|NCT03601091|Anesthetics, General|anesthetics, general|mesh-ancestor
65732270|NCT03601091|Anesthetics|anesthetics|mesh-ancestor
65732271|NCT03601091|GABA Modulators|gaba modulators|mesh-ancestor
65732272|NCT03601091|GABA Agents|gaba agents|mesh-ancestor
65732273|NCT04508829|Antibodies|antibodies|mesh-list
65732274|NCT04508829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65732275|NCT04508829|Immunologic Factors|immunologic factors|mesh-ancestor
65732276|NCT04508829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732277|NCT04521309|Antibodies|antibodies|mesh-list
65732278|NCT04521309|Immunologic Factors|immunologic factors|mesh-ancestor
65732279|NCT04521309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732280|NCT02267252|Antibodies|antibodies|mesh-list
65732281|NCT02267252|Immunologic Factors|immunologic factors|mesh-ancestor
65732282|NCT02267252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732283|NCT04521153|Apatinib|apatinib|mesh-list
65732284|NCT04521153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65732285|NCT04521153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65732286|NCT04521153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65732287|NCT04521153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732288|NCT04362566|Bupivacaine|bupivacaine|mesh-list
65732289|NCT04362566|Anesthetics, Local|anesthetics, local|mesh-ancestor
65732290|NCT04362566|Anesthetics|anesthetics|mesh-ancestor
65732291|NCT04362566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65732293|NCT04362566|Sensory System Agents|sensory system agents|mesh-ancestor
65732294|NCT04362566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732295|NCT03579589|Neostigmine|neostigmine|mesh-list
65732296|NCT03579589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65732297|NCT03579589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65732298|NCT03579589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732299|NCT03579589|Cholinergic Agents|cholinergic agents|mesh-ancestor
65732300|NCT03579589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65732301|NCT03579589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732302|NCT03579589|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65732303|NCT03579589|Autonomic Agents|autonomic agents|mesh-ancestor
65732304|NCT03579589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732305|NCT03600857|Misoprostol|misoprostol|mesh-list
65732306|NCT03600857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65732307|NCT03600857|Abortifacient Agents|abortifacient agents|mesh-ancestor
65732308|NCT03600857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65732309|NCT03600857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732310|NCT03600857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65732311|NCT03600857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65732312|NCT03600857|Oxytocics|oxytocics|mesh-ancestor
65732313|NCT02229968|Aminocaproic Acid|aminocaproic acid|mesh-list
65732314|NCT02229968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65732315|NCT02229968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65732316|NCT02229968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732317|NCT02229968|Hemostatics|hemostatics|mesh-ancestor
65732318|NCT02229968|Coagulants|coagulants|mesh-ancestor
65732319|NCT03600623|Gemcitabine|gemcitabine|mesh-list
65732320|NCT03600623|Paclitaxel|paclitaxel|mesh-list
65732321|NCT03600623|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65732322|NCT03600623|Fluorouracil|fluorouracil|mesh-list
65732323|NCT03600623|Oxaliplatin|oxaliplatin|mesh-list
65732324|NCT03600623|Irinotecan|irinotecan|mesh-list
65732325|NCT03600623|Folfirinox|folfirinox|mesh-list
65732326|NCT03600623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65732327|NCT03600623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65732328|NCT03600623|Tubulin Modulators|tubulin modulators|mesh-ancestor
65732329|NCT03600623|Antimitotic Agents|antimitotic agents|mesh-ancestor
65732330|NCT03600623|Mitosis Modulators|mitosis modulators|mesh-ancestor
65732331|NCT03600623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732332|NCT03600623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65732333|NCT03600623|Antimetabolites|antimetabolites|mesh-ancestor
65732334|NCT03600623|Antiviral Agents|antiviral agents|mesh-ancestor
65732335|NCT03600623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65732336|NCT03600623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65732337|NCT03600623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65732338|NCT03600623|Immunologic Factors|immunologic factors|mesh-ancestor
65732339|NCT03600623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732340|NCT03600623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65732341|NCT03600623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65732342|NCT02848729|Acetaminophen|acetaminophen|mesh-list
65732343|NCT02848729|Morphine|morphine|mesh-list
65732344|NCT02848729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65732345|NCT02848729|Narcotics|narcotics|mesh-ancestor
65732346|NCT02848729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65732347|NCT02848729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732348|NCT02848729|Analgesics|analgesics|mesh-ancestor
65732349|NCT02848729|Sensory System Agents|sensory system agents|mesh-ancestor
65732350|NCT02848729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732351|NCT02848729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65732352|NCT02848729|Antipyretics|antipyretics|mesh-ancestor
65732353|NCT03600467|Seviteronel|seviteronel|mesh-list
65732354|NCT03600467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65732355|NCT03600467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65732356|NCT03600467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65732357|NCT03600467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732358|NCT05737784|Pramoxine|pramoxine|mesh-list
65732359|NCT05737784|Anesthetics, Local|anesthetics, local|mesh-ancestor
65732360|NCT05737784|Anesthetics|anesthetics|mesh-ancestor
65732361|NCT05737784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65732362|NCT05737784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732363|NCT05737784|Sensory System Agents|sensory system agents|mesh-ancestor
65732364|NCT05737784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65048054|NCT04626193|Antimalarials|antimalarials|mesh-ancestor
65732365|NCT04520919|Anesthetics|anesthetics|mesh-list
65732366|NCT04520919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65732367|NCT04520919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732368|NCT05737628|Rituximab|rituximab|mesh-list
65732369|NCT05737628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65732370|NCT05737628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65732371|NCT05737628|Immunologic Factors|immunologic factors|mesh-ancestor
65732372|NCT05737628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732373|NCT05737628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65732374|NCT03600311|Vitamin D|vitamin d|mesh-list
65732375|NCT03600311|Calcium|calcium|mesh-list
65732376|NCT03600311|Vitamins|vitamins|mesh-ancestor
65732377|NCT03600311|Micronutrients|micronutrients|mesh-ancestor
65732378|NCT03600311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732379|NCT03600311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65732380|NCT03600311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65732381|NCT01594580|Anti-Infective Agents|anti-infective agents|mesh-list
65732382|NCT01594580|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65732383|NCT04562324|Antipsychotic Agents|antipsychotic agents|mesh-list
65732384|NCT04562324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65732385|NCT04562324|Antidepressive Agents|antidepressive agents|mesh-list
65732386|NCT04562324|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
65732387|NCT04562324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65732388|NCT04562324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65732389|NCT04562324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65732390|NCT04562324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732391|NCT03603119|Dexamethasone|dexamethasone|mesh-list
65732392|NCT03603119|Midazolam|midazolam|mesh-list
65732393|NCT03603119|Ondansetron|ondansetron|mesh-list
65732394|NCT03603119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65732395|NCT03603119|Antiemetics|antiemetics|mesh-ancestor
65732396|NCT03603119|Autonomic Agents|autonomic agents|mesh-ancestor
65732397|NCT03603119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732398|NCT03603119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732399|NCT03603119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65732400|NCT03603119|Glucocorticoids|glucocorticoids|mesh-ancestor
65732401|NCT03603119|Hormones|hormones|mesh-ancestor
65732402|NCT03603119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65732403|NCT03603119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65732404|NCT03603119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65732405|NCT03603119|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65732406|NCT03603119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65732407|NCT03603119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65732408|NCT03603119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65732409|NCT03603119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65732410|NCT03603119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65732411|NCT03603119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65732412|NCT03603119|Anesthetics, General|anesthetics, general|mesh-ancestor
65732413|NCT03603119|Anesthetics|anesthetics|mesh-ancestor
65732414|NCT03603119|GABA Modulators|gaba modulators|mesh-ancestor
65732415|NCT03603119|GABA Agents|gaba agents|mesh-ancestor
65732416|NCT03603119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65732417|NCT03603119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732418|NCT03603119|Antipruritics|antipruritics|mesh-ancestor
65732419|NCT03603119|Dermatologic Agents|dermatologic agents|mesh-ancestor
65732420|NCT03603119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65732421|NCT03603119|Serotonin Agents|serotonin agents|mesh-ancestor
65732422|NCT03603119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65732423|NCT03356769|Aspirin|aspirin|mesh-list
65732424|NCT03356769|Anticonvulsants|anticonvulsants|mesh-list
65732425|NCT03356769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65732426|NCT03356769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65732427|NCT03356769|Analgesics|analgesics|mesh-ancestor
65732428|NCT03356769|Sensory System Agents|sensory system agents|mesh-ancestor
65732429|NCT03356769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732430|NCT03356769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732431|NCT03356769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65732432|NCT03356769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65732433|NCT03356769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65732434|NCT03356769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65732435|NCT03356769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732436|NCT03356769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65732437|NCT03356769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65732438|NCT03356769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65732439|NCT03356769|Antipyretics|antipyretics|mesh-ancestor
65732440|NCT04508439|Heparin|heparin|mesh-list
65732441|NCT04508439|Enoxaparin|enoxaparin|mesh-list
65732442|NCT04508439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65048200|NCT00220064|Irinotecan|irinotecan|mesh-list
65732443|NCT04508439|Tinzaparin|tinzaparin|mesh-list
65732444|NCT04508439|Dalteparin|dalteparin|mesh-list
65732445|NCT04508439|Anticoagulants|anticoagulants|mesh-ancestor
65732446|NCT04508439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65732447|NCT04508439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65732448|NCT04508439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732449|NCT02237651|Anesthetics|anesthetics|mesh-list
65732450|NCT02237651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65732451|NCT02237651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732452|NCT02237729|Adalimumab|adalimumab|mesh-list
65732453|NCT02237729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65732454|NCT02237729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65732455|NCT02238119|Formoterol Fumarate|formoterol fumarate|mesh-list
65732456|NCT02238119|Tiotropium Bromide|tiotropium bromide|mesh-list
65732457|NCT02238119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65732458|NCT02238119|Autonomic Agents|autonomic agents|mesh-ancestor
65732459|NCT02238119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732460|NCT02238119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732461|NCT02238119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65732462|NCT02238119|Respiratory System Agents|respiratory system agents|mesh-ancestor
65732463|NCT02238119|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65732464|NCT02238119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65732465|NCT02238119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65732466|NCT02238119|Adrenergic Agents|adrenergic agents|mesh-ancestor
65732467|NCT02238119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65732468|NCT02238119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732469|NCT02238119|Parasympatholytics|parasympatholytics|mesh-ancestor
65732470|NCT02238119|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65732471|NCT02238119|Cholinergic Agents|cholinergic agents|mesh-ancestor
65732472|NCT03354117|Meloxicam|meloxicam|mesh-list
65732473|NCT03354117|Ulipristal acetate|ulipristal acetate|mesh-list
65732474|NCT03354117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65732475|NCT03354117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65732476|NCT03354117|Analgesics|analgesics|mesh-ancestor
65732477|NCT03354117|Sensory System Agents|sensory system agents|mesh-ancestor
65732478|NCT03354117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732479|NCT03354117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732480|NCT03354117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65732481|NCT03354117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65732482|NCT03354117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65732483|NCT03354117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65732484|NCT03354117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65732485|NCT03354117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732486|NCT03354117|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65732487|NCT03354117|Contraceptive Agents|contraceptive agents|mesh-ancestor
65732488|NCT03354117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65732489|NCT03354117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65732490|NCT03360981|Incretins|incretins|mesh-list
65732491|NCT03360981|Hormones|hormones|mesh-ancestor
65732492|NCT03360981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65732493|NCT03360981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732494|NCT03597815|Aflibercept|aflibercept|mesh-list
65732495|NCT03597815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65732496|NCT03597815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65732497|NCT03597815|Growth Substances|growth substances|mesh-ancestor
65732498|NCT03597815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732499|NCT03597815|Growth Inhibitors|growth inhibitors|mesh-ancestor
65732500|NCT03597815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65732501|NCT03595085|Streptokinase|streptokinase|mesh-list
65732502|NCT03595085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65732503|NCT03595085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65732504|NCT03595085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732505|NCT00158756|Vaccines|vaccines|mesh-list
65732506|NCT00158756|Immunologic Factors|immunologic factors|mesh-ancestor
65732507|NCT00158756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732508|NCT03353883|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65732509|NCT03353883|Luteolytic Agents|luteolytic agents|mesh-ancestor
65732510|NCT03353883|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65732511|NCT03353883|Contraceptive Agents|contraceptive agents|mesh-ancestor
65732512|NCT03353883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65732513|NCT03353883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732514|NCT03353883|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65732515|NCT03353883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65732516|NCT03353883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65732518|NCT03885713|Golimumab|golimumab|mesh-list
65732519|NCT03885713|Infliximab|infliximab|mesh-list
65732520|NCT03885713|Ustekinumab|ustekinumab|mesh-list
65732521|NCT03885713|Vedolizumab|vedolizumab|mesh-list
65732522|NCT03885713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65732523|NCT03885713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65732524|NCT03885713|Dermatologic Agents|dermatologic agents|mesh-ancestor
65732525|NCT03885713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65732526|NCT03885713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65732527|NCT03885713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65732528|NCT03885713|Immunologic Factors|immunologic factors|mesh-ancestor
65732529|NCT03885713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732530|NCT04519125|Tenofovir|tenofovir|mesh-list
65732531|NCT04519125|Emtricitabine|emtricitabine|mesh-list
65732532|NCT04519125|Antiviral Agents|antiviral agents|mesh-ancestor
65732533|NCT04519125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65732534|NCT04519125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65732535|NCT04519125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65732536|NCT04519125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65732537|NCT04519125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732538|NCT04519125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65732539|NCT04519125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65732540|NCT02730195|Pioglitazone|pioglitazone|mesh-list
65732541|NCT02730195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65732542|NCT02730195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732543|NCT03360279|Paclitaxel|paclitaxel|mesh-list
65732544|NCT03360279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65732545|NCT03360279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65732546|NCT03360279|Tubulin Modulators|tubulin modulators|mesh-ancestor
65732547|NCT03360279|Antimitotic Agents|antimitotic agents|mesh-ancestor
65732548|NCT03360279|Mitosis Modulators|mitosis modulators|mesh-ancestor
65732549|NCT03360279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732550|NCT03353103|Listerine|listerine|mesh-list
65732551|NCT03353103|Fluorides|fluorides|mesh-list
65732552|NCT03353103|Sodium Fluoride|sodium fluoride|mesh-list
65732553|NCT03353103|Cariostatic Agents|cariostatic agents|mesh-ancestor
65732554|NCT03353103|Protective Agents|protective agents|mesh-ancestor
65732555|NCT03353103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732556|NCT03353103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65732557|NCT03353103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65732558|NCT03360123|Midazolam|midazolam|mesh-list
65732559|NCT03360123|Triazolam|triazolam|mesh-list
65732560|NCT03360123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65732561|NCT03360123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65732562|NCT03360123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65732563|NCT03360123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732564|NCT03360123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65732565|NCT03360123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65732566|NCT03360123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65732567|NCT03360123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65732568|NCT03360123|Anesthetics, General|anesthetics, general|mesh-ancestor
65732569|NCT03360123|Anesthetics|anesthetics|mesh-ancestor
65732570|NCT03360123|GABA Modulators|gaba modulators|mesh-ancestor
65732571|NCT03360123|GABA Agents|gaba agents|mesh-ancestor
65732572|NCT03360123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65732573|NCT03360123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732574|NCT03360045|Tranexamic Acid|tranexamic acid|mesh-list
65732575|NCT03360045|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
65732576|NCT03360045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65732577|NCT03360045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65732578|NCT03360045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732579|NCT03360045|Hemostatics|hemostatics|mesh-ancestor
65732580|NCT03360045|Coagulants|coagulants|mesh-ancestor
65732581|NCT03353025|Dopamine|dopamine|mesh-list
65732582|NCT03353025|Dopamine Agonists|dopamine agonists|mesh-list
65732583|NCT03353025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65732584|NCT03353025|Sympathomimetics|sympathomimetics|mesh-ancestor
65732585|NCT03353025|Autonomic Agents|autonomic agents|mesh-ancestor
65732586|NCT03353025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732587|NCT03353025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732588|NCT03353025|Dopamine Agents|dopamine agents|mesh-ancestor
65732589|NCT03353025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65732590|NCT03353025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732591|NCT03353025|Protective Agents|protective agents|mesh-ancestor
65732592|NCT03359967|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65732593|NCT03359967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65732594|NCT03359967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732595|NCT04506957|Chrysarobin|chrysarobin|mesh-list
65732596|NCT04506957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65732597|NCT04506957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65732598|NCT04506957|Analgesics|analgesics|mesh-ancestor
65732599|NCT04506957|Sensory System Agents|sensory system agents|mesh-ancestor
65732600|NCT04506957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732601|NCT04506957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732602|NCT04506957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65732603|NCT04506957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65732604|NCT04516395|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65732605|NCT04516395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65732606|NCT04516395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65732607|NCT04516395|Antitubercular Agents|antitubercular agents|mesh-ancestor
65732608|NCT03352947|Trametinib|trametinib|mesh-list
65732609|NCT03352947|Dabrafenib|dabrafenib|mesh-list
65732610|NCT03352947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65732611|NCT03352947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65732612|NCT03352947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65732613|NCT03352947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732614|NCT02730351|Fluticasone|fluticasone|mesh-list
65732615|NCT02730351|Xhance|xhance|mesh-list
65732616|NCT02730351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65732617|NCT02730351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65732618|NCT02730351|Autonomic Agents|autonomic agents|mesh-ancestor
65732619|NCT02730351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732620|NCT02730351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732621|NCT02730351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65732622|NCT02730351|Respiratory System Agents|respiratory system agents|mesh-ancestor
65732623|NCT02730351|Dermatologic Agents|dermatologic agents|mesh-ancestor
65732624|NCT02730351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65732625|NCT03359655|Scopolamine|scopolamine|mesh-list
65732626|NCT03359655|Bromides|bromides|mesh-list
65732627|NCT03359655|Misoprostol|misoprostol|mesh-list
65732628|NCT03359655|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65732629|NCT03359655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65732630|NCT03359655|Abortifacient Agents|abortifacient agents|mesh-ancestor
65732631|NCT03359655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65732632|NCT03359655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732633|NCT03359655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65732634|NCT03359655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65732635|NCT03359655|Oxytocics|oxytocics|mesh-ancestor
65732636|NCT03359655|Anticonvulsants|anticonvulsants|mesh-ancestor
65732637|NCT03359655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65732638|NCT03359655|Antiemetics|antiemetics|mesh-ancestor
65732639|NCT03359655|Autonomic Agents|autonomic agents|mesh-ancestor
65732640|NCT03359655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732641|NCT03359655|Mydriatics|mydriatics|mesh-ancestor
65732642|NCT03359655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65732643|NCT03359655|Cholinergic Agents|cholinergic agents|mesh-ancestor
65732644|NCT03359655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65732645|NCT03359655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732646|NCT03359655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65732647|NCT03359655|Parasympatholytics|parasympatholytics|mesh-ancestor
65732648|NCT03352869|Metformin|metformin|mesh-list
65732649|NCT03352869|Exenatide|exenatide|mesh-list
65732650|NCT03352869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65732651|NCT03352869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732652|NCT03352869|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65732653|NCT03352869|Incretins|incretins|mesh-ancestor
65732654|NCT03352869|Hormones|hormones|mesh-ancestor
65732655|NCT03352869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65732656|NCT03359499|Trimebutine|trimebutine|mesh-list
65732657|NCT03359499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65732658|NCT03359499|Parasympatholytics|parasympatholytics|mesh-ancestor
65732659|NCT03359499|Autonomic Agents|autonomic agents|mesh-ancestor
65732660|NCT03359499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732661|NCT03359499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732662|NCT03352479|Analgesics, Opioid|analgesics, opioid|mesh-list
65732663|NCT03352479|Narcotics|narcotics|mesh-ancestor
65732664|NCT03352479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65732665|NCT03352479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732666|NCT03352479|Analgesics|analgesics|mesh-ancestor
65732667|NCT03352479|Sensory System Agents|sensory system agents|mesh-ancestor
65732668|NCT03352479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732669|NCT03355053|Dexmedetomidine|dexmedetomidine|mesh-list
65732670|NCT03355053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65732671|NCT03355053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65732672|NCT03355053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732673|NCT03355053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65732674|NCT03355053|Analgesics|analgesics|mesh-ancestor
65732675|NCT03355053|Sensory System Agents|sensory system agents|mesh-ancestor
65732676|NCT03355053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732677|NCT03355053|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65732678|NCT03355053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65732679|NCT03355053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65732680|NCT03355053|Adrenergic Agents|adrenergic agents|mesh-ancestor
65732681|NCT03355053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65732682|NCT03355053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732683|NCT03354897|Torsemide|torsemide|mesh-list
65732684|NCT03354897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65732685|NCT03354897|Diuretics|diuretics|mesh-ancestor
65732686|NCT03354897|Natriuretic Agents|natriuretic agents|mesh-ancestor
65732687|NCT03354897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732688|NCT03354897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65732689|NCT03354897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65732690|NCT03354897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732691|NCT04506567|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65732692|NCT04506567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65732693|NCT04506567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732694|NCT03358953|Nicotine|nicotine|mesh-list
65732695|NCT03358953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65732696|NCT03358953|Autonomic Agents|autonomic agents|mesh-ancestor
65732697|NCT03358953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732698|NCT03358953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732699|NCT03358953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65732700|NCT03358953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65732701|NCT03358953|Cholinergic Agents|cholinergic agents|mesh-ancestor
65732702|NCT03358953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65732703|NCT03358953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732704|NCT04509999|Bicalutamide|bicalutamide|mesh-list
65732705|NCT04509999|Androgen Antagonists|androgen antagonists|mesh-ancestor
65732706|NCT04509999|Hormone Antagonists|hormone antagonists|mesh-ancestor
65732707|NCT04509999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65732708|NCT04509999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732709|NCT04509999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65732710|NCT04505943|Isoniazid|isoniazid|mesh-list
65732711|NCT04505943|Misoprostol|misoprostol|mesh-list
65732712|NCT04505943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65732713|NCT04505943|Abortifacient Agents|abortifacient agents|mesh-ancestor
65732714|NCT04505943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65732715|NCT04505943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732716|NCT04505943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65732717|NCT04505943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65732718|NCT04505943|Oxytocics|oxytocics|mesh-ancestor
65732719|NCT04505943|Antitubercular Agents|antitubercular agents|mesh-ancestor
65732720|NCT04505943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65732721|NCT04505943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65732722|NCT04505943|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65732723|NCT04505943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65732724|NCT04505943|Antimetabolites|antimetabolites|mesh-ancestor
65732725|NCT04505943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732726|NCT04505943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65732727|NCT03358719|Poly I-C|poly i-c|mesh-list
65732728|NCT03358719|Nivolumab|nivolumab|mesh-list
65732729|NCT03358719|Decitabine|decitabine|mesh-list
65732730|NCT03358719|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65732731|NCT03358719|Poly ICLC|poly iclc|mesh-list
65732732|NCT03358719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65732733|NCT03358719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65732734|NCT03358719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65195324|NCT02662660|Dipyrone|dipyrone|mesh-list
65732735|NCT03358719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732736|NCT03358719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65732737|NCT03358719|Antimetabolites|antimetabolites|mesh-ancestor
65732738|NCT03358719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65732739|NCT03358719|Interferon Inducers|interferon inducers|mesh-ancestor
65732740|NCT03358719|Immunologic Factors|immunologic factors|mesh-ancestor
65732741|NCT03358719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732742|NCT03358719|Laxatives|laxatives|mesh-ancestor
65732743|NCT03358719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65732744|NCT03358719|Antiviral Agents|antiviral agents|mesh-ancestor
65732745|NCT03358719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65732746|NCT04505475|Hemostatics|hemostatics|mesh-list
65732747|NCT04505475|Coagulants|coagulants|mesh-ancestor
65732748|NCT01376349|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65732749|NCT01376349|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65732750|NCT01376349|Immunologic Factors|immunologic factors|mesh-ancestor
65732751|NCT01376349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732752|NCT03350373|Dotinurad|dotinurad|mesh-list
65732753|NCT03350373|Uricosuric Agents|uricosuric agents|mesh-ancestor
65732754|NCT03350373|Gout Suppressants|gout suppressants|mesh-ancestor
65732755|NCT03350373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65732756|NCT03350373|Renal Agents|renal agents|mesh-ancestor
65732757|NCT03350295|Nifurtimox|nifurtimox|mesh-list
65732758|NCT03350295|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65732759|NCT03350295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65732760|NCT03350295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65732761|NCT03350295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65732762|NCT03349827|Apatinib|apatinib|mesh-list
65732763|NCT03349827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65732764|NCT03349827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65732765|NCT03349827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65732766|NCT03349827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732767|NCT04503915|Estrogens|estrogens|mesh-list
65732768|NCT04503915|Hormones|hormones|mesh-ancestor
65732769|NCT04503915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65732770|NCT04503915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732771|NCT04504851|Rifampin|rifampin|mesh-list
65732772|NCT04504851|Isoniazid|isoniazid|mesh-list
65732773|NCT04504851|Pyrazinamide|pyrazinamide|mesh-list
65732774|NCT04504851|Ethambutol|ethambutol|mesh-list
65732775|NCT04504851|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65732776|NCT04504851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65732777|NCT04504851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65732778|NCT04504851|Antimetabolites|antimetabolites|mesh-ancestor
65732779|NCT04504851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732780|NCT04504851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65732781|NCT04504851|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65732782|NCT04504851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65732783|NCT04504851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65732784|NCT04504851|Antitubercular Agents|antitubercular agents|mesh-ancestor
65732785|NCT04504851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65732786|NCT04504851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65732787|NCT04504851|Leprostatic Agents|leprostatic agents|mesh-ancestor
65732788|NCT04504851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65732789|NCT04504851|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65732790|NCT04504851|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65732791|NCT04504851|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65732792|NCT04504851|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65732793|NCT04504851|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65732794|NCT04504851|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65732795|NCT04504851|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65732796|NCT05509257|Naltrexone|naltrexone|mesh-list
65732797|NCT05509257|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65732798|NCT05509257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65732799|NCT05509257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732800|NCT05509257|Sensory System Agents|sensory system agents|mesh-ancestor
65732801|NCT05509257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732802|NCT03349359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65732803|NCT03349359|Antiviral Agents|antiviral agents|mesh-ancestor
65732804|NCT03349359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65732805|NCT03072147|Teriparatide|teriparatide|mesh-list
65732806|NCT03072147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65732807|NCT03072147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732808|NCT03072147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65732809|NCT03030261|Dexamethasone|dexamethasone|mesh-list
65732810|NCT03030261|Pomalidomide|pomalidomide|mesh-list
65732811|NCT03030261|Elotuzumab|elotuzumab|mesh-list
65732812|NCT03030261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65732813|NCT03030261|Antiemetics|antiemetics|mesh-ancestor
65732814|NCT03030261|Autonomic Agents|autonomic agents|mesh-ancestor
65732815|NCT03030261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732816|NCT03030261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732817|NCT03030261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65732818|NCT03030261|Glucocorticoids|glucocorticoids|mesh-ancestor
65048501|NCT00220649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65732819|NCT03030261|Hormones|hormones|mesh-ancestor
65732820|NCT03030261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65732821|NCT03030261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65732822|NCT03030261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65732823|NCT03030261|Immunologic Factors|immunologic factors|mesh-ancestor
65732824|NCT03030261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65732825|NCT03030261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65732826|NCT03030261|Growth Substances|growth substances|mesh-ancestor
65732827|NCT03030261|Growth Inhibitors|growth inhibitors|mesh-ancestor
65732828|NCT02176161|Metformin|metformin|mesh-list
65732829|NCT02176161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65732830|NCT02176161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732831|NCT03348735|Lidocaine|lidocaine|mesh-list
65732832|NCT03348735|Pregabalin|pregabalin|mesh-list
65732833|NCT03348735|Capsaicin|capsaicin|mesh-list
65732834|NCT03348735|Anesthetics, Local|anesthetics, local|mesh-ancestor
65732835|NCT03348735|Anesthetics|anesthetics|mesh-ancestor
65732836|NCT03348735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65732837|NCT03348735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732838|NCT03348735|Sensory System Agents|sensory system agents|mesh-ancestor
65732839|NCT03348735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732840|NCT03348735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65732841|NCT03348735|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65732842|NCT03348735|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65732843|NCT03348735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65732844|NCT03348735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732845|NCT03348735|Analgesics|analgesics|mesh-ancestor
65732846|NCT03348735|Anticonvulsants|anticonvulsants|mesh-ancestor
65732847|NCT03348735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65732848|NCT03348735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65732849|NCT03348735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65732850|NCT03348735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65732851|NCT03348735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65732852|NCT03348735|Antipruritics|antipruritics|mesh-ancestor
65732853|NCT03348735|Dermatologic Agents|dermatologic agents|mesh-ancestor
65732854|NCT01700673|Azacitidine|azacitidine|mesh-list
65732855|NCT01700673|Sargramostim|sargramostim|mesh-list
65732856|NCT01700673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65732857|NCT01700673|Antimetabolites|antimetabolites|mesh-ancestor
65732858|NCT01700673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732859|NCT01700673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65732860|NCT01700673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65732861|NCT01700673|Immunologic Factors|immunologic factors|mesh-ancestor
65732862|NCT01700673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732863|NCT03348423|Fentanyl|fentanyl|mesh-list
65732864|NCT03348423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65732865|NCT03348423|Narcotics|narcotics|mesh-ancestor
65732866|NCT03348423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65732867|NCT03348423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732868|NCT03348423|Analgesics|analgesics|mesh-ancestor
65732869|NCT03348423|Sensory System Agents|sensory system agents|mesh-ancestor
65732870|NCT03348423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732871|NCT03348423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65732872|NCT03348423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65732873|NCT03348423|Anesthetics, General|anesthetics, general|mesh-ancestor
65732874|NCT03348423|Anesthetics|anesthetics|mesh-ancestor
65732875|NCT03898154|Dexamethasone|dexamethasone|mesh-list
65732876|NCT03898154|Methylprednisolone|methylprednisolone|mesh-list
65732877|NCT03898154|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65732878|NCT03898154|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65732879|NCT03898154|Prednisolone|prednisolone|mesh-list
65732880|NCT03898154|Prednisolone acetate|prednisolone acetate|mesh-list
65732881|NCT03898154|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65732882|NCT03898154|Prednisolone phosphate|prednisolone phosphate|mesh-list
65732883|NCT03898154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65732884|NCT03898154|Antiemetics|antiemetics|mesh-ancestor
65732885|NCT03898154|Autonomic Agents|autonomic agents|mesh-ancestor
65732886|NCT03898154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732887|NCT03898154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732888|NCT03898154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65732889|NCT03898154|Glucocorticoids|glucocorticoids|mesh-ancestor
65732890|NCT03898154|Hormones|hormones|mesh-ancestor
65732891|NCT03898154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65732892|NCT03898154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65732893|NCT03898154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65732894|NCT03898154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65732895|NCT03898154|Protective Agents|protective agents|mesh-ancestor
65732897|NCT02517957|Antidiarrheals|antidiarrheals|mesh-list
65732898|NCT02517957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65732899|NCT03348267|Caseins|caseins|mesh-list
65732900|NCT03348267|Chelating Agents|chelating agents|mesh-ancestor
65732901|NCT03348267|Sequestering Agents|sequestering agents|mesh-ancestor
65732902|NCT03348267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732903|NCT03136796|Meropenem|meropenem|mesh-list
65732904|NCT03136796|Piperacillin|piperacillin|mesh-list
65732905|NCT03136796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65732906|NCT03136796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65732907|NCT05243745|Fluorides|fluorides|mesh-list
65732908|NCT05243745|Cariostatic Agents|cariostatic agents|mesh-ancestor
65732909|NCT05243745|Protective Agents|protective agents|mesh-ancestor
65732910|NCT05243745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732911|NCT04500717|Carboplatin|carboplatin|mesh-list
65732912|NCT04500717|Pemetrexed|pemetrexed|mesh-list
65732913|NCT04500717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65732914|NCT04500717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65732915|NCT04500717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732916|NCT04500717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65732917|NCT04500717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65732918|NCT01680458|Fluconazole|fluconazole|mesh-list
65732919|NCT01680458|Antifungal Agents|antifungal agents|mesh-ancestor
65732920|NCT01680458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65732921|NCT01680458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65732922|NCT01680458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65732923|NCT01680458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65732924|NCT01680458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732925|NCT01680458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65732926|NCT01680458|Hormone Antagonists|hormone antagonists|mesh-ancestor
65732927|NCT01680458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65732928|NCT01680458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732929|NCT01680458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65732930|NCT01680458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65732931|NCT03346317|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65732932|NCT03346317|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65732933|NCT03346317|Estradiol|estradiol|mesh-list
65732934|NCT03346317|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65732935|NCT03346317|Dydrogesterone|dydrogesterone|mesh-list
65732936|NCT03346317|Estrogens|estrogens|mesh-ancestor
65732937|NCT03346317|Hormones|hormones|mesh-ancestor
65732938|NCT03346317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65732939|NCT03346317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732940|NCT03346317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65732941|NCT03346317|Contraceptive Agents|contraceptive agents|mesh-ancestor
65732942|NCT03346317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65732943|NCT03346317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65732944|NCT03346317|Progestins|progestins|mesh-ancestor
65732945|NCT01550432|Acetylcysteine|acetylcysteine|mesh-list
65732946|NCT01550432|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65732947|NCT01550432|Antiviral Agents|antiviral agents|mesh-ancestor
65732948|NCT01550432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65732949|NCT01550432|Expectorants|expectorants|mesh-ancestor
65732950|NCT01550432|Respiratory System Agents|respiratory system agents|mesh-ancestor
65732951|NCT01550432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65732952|NCT01550432|Antioxidants|antioxidants|mesh-ancestor
65732953|NCT01550432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732954|NCT01550432|Protective Agents|protective agents|mesh-ancestor
65732955|NCT01550432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732956|NCT01550432|Antidotes|antidotes|mesh-ancestor
65732957|NCT04502277|Fluconazole|fluconazole|mesh-list
65732958|NCT04502277|Antifungal Agents|antifungal agents|mesh-ancestor
65732959|NCT04502277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65732960|NCT04502277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65732961|NCT04502277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65732962|NCT04502277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65732963|NCT04502277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732964|NCT04502277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65732965|NCT04502277|Hormone Antagonists|hormone antagonists|mesh-ancestor
65732966|NCT04502277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65732967|NCT04502277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048649|NCT04617652|Tocolytic Agents|tocolytic agents|mesh-ancestor
65732968|NCT04502277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65732969|NCT04502277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65732970|NCT05730608|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65732971|NCT05730608|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65732972|NCT05730608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732973|NCT02517489|Hydrocortisone|hydrocortisone|mesh-list
65732974|NCT02517489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65732975|NCT04850144|Bromides|bromides|mesh-list
65732976|NCT04850144|Tiotropium Bromide|tiotropium bromide|mesh-list
65732977|NCT04850144|Charcoal|charcoal|mesh-list
65732978|NCT04850144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65732979|NCT04850144|Autonomic Agents|autonomic agents|mesh-ancestor
65732980|NCT04850144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65732981|NCT04850144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65732982|NCT04850144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65732983|NCT04850144|Respiratory System Agents|respiratory system agents|mesh-ancestor
65732984|NCT04850144|Parasympatholytics|parasympatholytics|mesh-ancestor
65732985|NCT04850144|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65732986|NCT04850144|Cholinergic Agents|cholinergic agents|mesh-ancestor
65732987|NCT04850144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65732988|NCT04850144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732989|NCT04850144|Anticonvulsants|anticonvulsants|mesh-ancestor
65732990|NCT04850144|Antidotes|antidotes|mesh-ancestor
65732991|NCT04850144|Protective Agents|protective agents|mesh-ancestor
65732992|NCT04590794|Plasminogen|plasminogen|mesh-list
65732993|NCT04590794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65732994|NCT04590794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65732995|NCT04590794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65732996|NCT00709761|Paclitaxel|paclitaxel|mesh-list
65732997|NCT00709761|Lapatinib|lapatinib|mesh-list
65732998|NCT00709761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65732999|NCT00709761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733000|NCT00709761|Tubulin Modulators|tubulin modulators|mesh-ancestor
65733001|NCT00709761|Antimitotic Agents|antimitotic agents|mesh-ancestor
65733002|NCT00709761|Mitosis Modulators|mitosis modulators|mesh-ancestor
65733003|NCT00709761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733004|NCT00709761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65733005|NCT00709761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733006|NCT03346083|Betrixaban|betrixaban|mesh-list
65733007|NCT03346083|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65733008|NCT03346083|Antithrombins|antithrombins|mesh-ancestor
65733009|NCT03346083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65733010|NCT03346083|Protease Inhibitors|protease inhibitors|mesh-ancestor
65733011|NCT03346083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733012|NCT03346083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733013|NCT03346083|Anticoagulants|anticoagulants|mesh-ancestor
65733014|NCT05584683|Amoxicillin|amoxicillin|mesh-list
65733015|NCT05584683|Clavulanic Acid|clavulanic acid|mesh-list
65733016|NCT05584683|Clavulanic Acids|clavulanic acids|mesh-list
65733017|NCT05584683|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65733018|NCT05584683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65733019|NCT05584683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65733020|NCT05584683|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65733021|NCT05584683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733022|NCT05584683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733023|NCT02358031|Carboplatin|carboplatin|mesh-list
65733024|NCT02358031|Pembrolizumab|pembrolizumab|mesh-list
65733025|NCT02358031|Cetuximab|cetuximab|mesh-list
65733026|NCT02358031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733027|NCT02358031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65733028|NCT02516631|Misoprostol|misoprostol|mesh-list
65733029|NCT02516631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65733030|NCT02516631|Abortifacient Agents|abortifacient agents|mesh-ancestor
65733031|NCT02516631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65733032|NCT02516631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733033|NCT02516631|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65733034|NCT02516631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65733035|NCT02516631|Oxytocics|oxytocics|mesh-ancestor
65733036|NCT02516475|Zinc Sulfate|zinc sulfate|mesh-list
65733037|NCT02516475|Astringents|astringents|mesh-ancestor
65733038|NCT02516475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733039|NCT02516475|Dermatologic Agents|dermatologic agents|mesh-ancestor
65733040|NCT05083286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65733041|NCT05083286|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65733042|NCT05083286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65733043|NCT05083286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65733044|NCT05083286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048760|NCT00251082|Estradiol|estradiol|mesh-list
65733045|NCT05083286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65733046|NCT05083286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65733047|NCT05083286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733048|NCT05083286|Cholinergic Agents|cholinergic agents|mesh-ancestor
65733049|NCT05083286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65733050|NCT03423680|Aripiprazole|aripiprazole|mesh-list
65733051|NCT03423680|Antidepressive Agents|antidepressive agents|mesh-ancestor
65733052|NCT03423680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65733053|NCT03423680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65733054|NCT03423680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65733055|NCT03423680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65733056|NCT03423680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733057|NCT03423680|Dopamine Agonists|dopamine agonists|mesh-ancestor
65733058|NCT03423680|Dopamine Agents|dopamine agents|mesh-ancestor
65733059|NCT03423680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65733060|NCT03423680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733061|NCT03423680|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65733062|NCT03423680|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65733063|NCT03423680|Serotonin Agents|serotonin agents|mesh-ancestor
65733064|NCT03423680|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65733065|NCT03423680|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65733066|NCT03423680|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65733067|NCT03423680|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65733068|NCT00588991|Carboplatin|carboplatin|mesh-list
65733069|NCT00588991|Topotecan|topotecan|mesh-list
65733070|NCT00588991|Veliparib|veliparib|mesh-list
65733071|NCT00588991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733072|NCT00588991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65733073|NCT00588991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65733074|NCT00588991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733075|NCT00588991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733076|NCT00588991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65733077|NCT04443543|Fluorouracil|fluorouracil|mesh-list
65733078|NCT04443543|Capecitabine|capecitabine|mesh-list
65733079|NCT04443543|Oxaliplatin|oxaliplatin|mesh-list
65733080|NCT04443543|Irinotecan|irinotecan|mesh-list
65733081|NCT04443543|Antimetabolites|antimetabolites|mesh-ancestor
65733082|NCT04443543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733083|NCT04443543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65733084|NCT04443543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733085|NCT04443543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65733086|NCT04443543|Immunologic Factors|immunologic factors|mesh-ancestor
65733087|NCT04443543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733088|NCT04443543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65733089|NCT04443543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65733090|NCT04443543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733091|NCT02516085|Metformin|metformin|mesh-list
65733092|NCT02516085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65733093|NCT02516085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733094|NCT02515929|Proanthocyanidin|proanthocyanidin|mesh-list
65733095|NCT02515929|Procyanidin|procyanidin|mesh-list
65733096|NCT02515929|Antioxidants|antioxidants|mesh-ancestor
65733097|NCT02515929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733098|NCT02515929|Protective Agents|protective agents|mesh-ancestor
65733099|NCT02515929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733100|NCT02515929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65733101|NCT02515929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65733102|NCT02515929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65733103|NCT03347721|Lidocaine|lidocaine|mesh-list
65733104|NCT03347721|Anesthetics, Local|anesthetics, local|mesh-ancestor
65733105|NCT03347721|Anesthetics|anesthetics|mesh-ancestor
65733106|NCT03347721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65733107|NCT03347721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733108|NCT03347721|Sensory System Agents|sensory system agents|mesh-ancestor
65733109|NCT03347721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65733110|NCT03347721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65733111|NCT03347721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65733112|NCT03347721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65733113|NCT03347721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65733114|NCT03347721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733115|NCT02848651|Atezolizumab|atezolizumab|mesh-list
65733116|NCT02848651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733117|NCT00709059|Ribavirin|ribavirin|mesh-list
65733118|NCT00709059|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65733119|NCT00709059|Interferon-alpha|interferon-alpha|mesh-list
65733120|NCT00709059|Antimetabolites|antimetabolites|mesh-ancestor
65733121|NCT00709059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733122|NCT00709059|Antiviral Agents|antiviral agents|mesh-ancestor
65733123|NCT00709059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65733124|NCT00709059|Immunologic Factors|immunologic factors|mesh-ancestor
65733125|NCT00709059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733126|NCT05584137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65733127|NCT05584137|Antibodies|antibodies|mesh-list
65733128|NCT05584137|Immunoglobulins|immunoglobulins|mesh-list
65733129|NCT05584137|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65733130|NCT05584137|Immunologic Factors|immunologic factors|mesh-ancestor
65733131|NCT05584137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733132|NCT05584137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733133|NCT04500561|Gemcitabine|gemcitabine|mesh-list
65733134|NCT04500561|Oxaliplatin|oxaliplatin|mesh-list
65733135|NCT04500561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65733136|NCT04500561|Antimetabolites|antimetabolites|mesh-ancestor
65733137|NCT04500561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733138|NCT04500561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733139|NCT04500561|Antiviral Agents|antiviral agents|mesh-ancestor
65733140|NCT04500561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65733141|NCT04500561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733142|NCT04500561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65733143|NCT04500561|Immunologic Factors|immunologic factors|mesh-ancestor
65733144|NCT04500561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733145|NCT04968015|Cytarabine|cytarabine|mesh-list
65733146|NCT04968015|Venetoclax|venetoclax|mesh-list
65733147|NCT04968015|Idarubicin|idarubicin|mesh-list
65733148|NCT04968015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65733149|NCT04968015|Antimetabolites|antimetabolites|mesh-ancestor
65733150|NCT04968015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733151|NCT04968015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733152|NCT04968015|Antiviral Agents|antiviral agents|mesh-ancestor
65733153|NCT04968015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65733154|NCT04968015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65733155|NCT04968015|Immunologic Factors|immunologic factors|mesh-ancestor
65733156|NCT04968015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733157|NCT04968015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65733158|NCT04968015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65733159|NCT04968015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65733160|NCT04968015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733161|NCT05094596|Montelukast|montelukast|mesh-list
65733162|NCT05094596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65733163|NCT05094596|Respiratory System Agents|respiratory system agents|mesh-ancestor
65733164|NCT05094596|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65733165|NCT05094596|Hormone Antagonists|hormone antagonists|mesh-ancestor
65733166|NCT05094596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65733167|NCT05094596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733168|NCT05094596|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65733169|NCT05094596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65733170|NCT05094596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733171|NCT02133872|Minocycline|minocycline|mesh-list
65733172|NCT02133872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65733173|NCT02133872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65733174|NCT01678820|Metformin|metformin|mesh-list
65733175|NCT01678820|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65733176|NCT01678820|Glimepiride|glimepiride|mesh-list
65733177|NCT01678820|Simvastatin|simvastatin|mesh-list
65733178|NCT01678820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65733179|NCT01678820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733180|NCT01678820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65733181|NCT01678820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65733182|NCT01678820|Antimetabolites|antimetabolites|mesh-ancestor
65733183|NCT01678820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733184|NCT01678820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65733185|NCT01678820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65733186|NCT01678820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733187|NCT01678820|Incretins|incretins|mesh-ancestor
65733188|NCT01678820|Hormones|hormones|mesh-ancestor
65733189|NCT01678820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65733190|NCT01678820|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65733191|NCT01678820|Protease Inhibitors|protease inhibitors|mesh-ancestor
65733192|NCT01678820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65733193|NCT01678820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65733194|NCT01678820|Immunologic Factors|immunologic factors|mesh-ancestor
65733195|NCT02515695|Interferons|interferons|mesh-list
65733196|NCT02515695|Interferon-beta|interferon-beta|mesh-list
65733197|NCT02515695|Interferon beta-1a|interferon beta-1a|mesh-list
65733198|NCT02515695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733199|NCT02515695|Antiviral Agents|antiviral agents|mesh-ancestor
65733200|NCT02515695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65733201|NCT02515695|Immunologic Factors|immunologic factors|mesh-ancestor
65733202|NCT02515695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733203|NCT02515695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65733204|NCT04788615|Interferons|interferons|mesh-list
65733205|NCT04788615|Interferon-beta|interferon-beta|mesh-list
65733206|NCT04788615|Interferon beta-1a|interferon beta-1a|mesh-list
65733207|NCT04788615|Teriflunomide|teriflunomide|mesh-list
65733208|NCT04788615|Ofatumumab|ofatumumab|mesh-list
65733209|NCT04788615|Glatiramer Acetate|glatiramer acetate|mesh-list
65733210|NCT04788615|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65733211|NCT04788615|(T,G)-A-L|(t,g)-a-l|mesh-list
65733212|NCT04788615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733213|NCT04788615|Antiviral Agents|antiviral agents|mesh-ancestor
65733214|NCT04788615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65733215|NCT04788615|Immunologic Factors|immunologic factors|mesh-ancestor
65733216|NCT04788615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733217|NCT04788615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65733218|NCT04788615|Dermatologic Agents|dermatologic agents|mesh-ancestor
65733219|NCT04788615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65733220|NCT04788615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65733221|NCT04788615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65733222|NCT04788615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65733223|NCT04788615|Analgesics|analgesics|mesh-ancestor
65733224|NCT04788615|Sensory System Agents|sensory system agents|mesh-ancestor
65733225|NCT04788615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65733226|NCT04788615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65733227|NCT03346629|Misoprostol|misoprostol|mesh-list
65733228|NCT03346629|Mifepristone|mifepristone|mesh-list
65733229|NCT03346629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65733230|NCT03346629|Abortifacient Agents|abortifacient agents|mesh-ancestor
65733231|NCT03346629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65733232|NCT03346629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733233|NCT03346629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65733234|NCT03346629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65733235|NCT03346629|Oxytocics|oxytocics|mesh-ancestor
65733236|NCT03346629|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65733237|NCT03346629|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65733238|NCT03346629|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65733239|NCT03346629|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65733240|NCT03346629|Contraceptive Agents|contraceptive agents|mesh-ancestor
65733241|NCT03346629|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65733242|NCT03346629|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65733243|NCT03346629|Hormone Antagonists|hormone antagonists|mesh-ancestor
65733244|NCT03346629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65733245|NCT03346629|Luteolytic Agents|luteolytic agents|mesh-ancestor
65733246|NCT03346629|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65733247|NCT03346629|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65733248|NCT04501965|Azithromycin|azithromycin|mesh-list
65733249|NCT04501965|Hydroxychloroquine|hydroxychloroquine|mesh-list
65733250|NCT04501965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65733251|NCT04501965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65733252|NCT04501965|Antimalarials|antimalarials|mesh-ancestor
65733253|NCT04501965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65733254|NCT04501965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65733255|NCT04501965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733256|NCT04501965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733257|NCT04501965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65733258|NCT04437836|Rifampin|rifampin|mesh-list
65733259|NCT04437836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65733260|NCT04437836|Antitubercular Agents|antitubercular agents|mesh-ancestor
65733261|NCT04437836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65733262|NCT04437836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65733263|NCT04437836|Leprostatic Agents|leprostatic agents|mesh-ancestor
65195854|NCT00839527|Incretins|incretins|mesh-ancestor
65733264|NCT04437836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65733265|NCT04437836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733266|NCT04437836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733267|NCT04437836|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65733268|NCT04437836|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65733269|NCT04437836|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65733270|NCT04437836|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65733271|NCT04437836|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65733272|NCT04437836|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65733273|NCT03122067|Oxytocin|oxytocin|mesh-list
65733274|NCT03122067|Oxytocics|oxytocics|mesh-ancestor
65733275|NCT03122067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65733276|NCT03122067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733277|NCT04536194|Dopamine|dopamine|mesh-list
65733278|NCT04536194|Norepinephrine|norepinephrine|mesh-list
65733279|NCT04536194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65733280|NCT04536194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65733281|NCT04536194|Adrenergic Agents|adrenergic agents|mesh-ancestor
65733282|NCT04536194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65733283|NCT04536194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733284|NCT04536194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733285|NCT04536194|Sympathomimetics|sympathomimetics|mesh-ancestor
65733286|NCT04536194|Autonomic Agents|autonomic agents|mesh-ancestor
65733287|NCT04536194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65733288|NCT04536194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65733289|NCT04536194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65733290|NCT04536194|Dopamine Agents|dopamine agents|mesh-ancestor
65733291|NCT04536194|Protective Agents|protective agents|mesh-ancestor
65733292|NCT03122769|Metformin|metformin|mesh-list
65733293|NCT03122769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65733294|NCT03122769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733295|NCT03121833|Endostar protein|endostar protein|mesh-list
65733296|NCT03121833|Endostatins|endostatins|mesh-list
65733297|NCT03121833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65733298|NCT03121833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65733299|NCT03121833|Growth Substances|growth substances|mesh-ancestor
65733300|NCT03121833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733301|NCT03121833|Growth Inhibitors|growth inhibitors|mesh-ancestor
65733302|NCT03121833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733303|NCT03121521|Melatonin|melatonin|mesh-list
65733304|NCT03121521|Antioxidants|antioxidants|mesh-ancestor
65733305|NCT03121521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733306|NCT03121521|Protective Agents|protective agents|mesh-ancestor
65733307|NCT03121521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733308|NCT03121521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65733309|NCT03046862|Gemcitabine|gemcitabine|mesh-list
65733310|NCT03046862|Durvalumab|durvalumab|mesh-list
65733311|NCT03046862|Tremelimumab|tremelimumab|mesh-list
65733312|NCT03046862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733313|NCT03046862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65733314|NCT03046862|Antimetabolites|antimetabolites|mesh-ancestor
65733315|NCT03046862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733316|NCT03046862|Antiviral Agents|antiviral agents|mesh-ancestor
65733317|NCT03046862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65733318|NCT03046862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733319|NCT03046862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65733320|NCT03046862|Immunologic Factors|immunologic factors|mesh-ancestor
65733321|NCT03046862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733322|NCT03046862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65733323|NCT05590923|Dexamethasone|dexamethasone|mesh-list
65733324|NCT05590923|Olanzapine|olanzapine|mesh-list
65733325|NCT05590923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65733326|NCT05590923|Antiemetics|antiemetics|mesh-ancestor
65733327|NCT05590923|Autonomic Agents|autonomic agents|mesh-ancestor
65733328|NCT05590923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65733329|NCT05590923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733330|NCT05590923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65733331|NCT05590923|Glucocorticoids|glucocorticoids|mesh-ancestor
65733332|NCT05590923|Hormones|hormones|mesh-ancestor
65733333|NCT05590923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65733334|NCT05590923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65733335|NCT05590923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733336|NCT05590923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65733337|NCT05590923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65733338|NCT05590923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65733339|NCT05590923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65733340|NCT05590923|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65733341|NCT05590923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65733342|NCT05590923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65733343|NCT05590923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733344|NCT05590923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65733345|NCT05590923|Serotonin Agents|serotonin agents|mesh-ancestor
65049025|NCT00222053|Diphosphonates|diphosphonates|mesh-list
65733346|NCT00770809|Paclitaxel|paclitaxel|mesh-list
65733347|NCT00770809|Trastuzumab|trastuzumab|mesh-list
65733348|NCT00770809|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65733349|NCT00770809|Lapatinib|lapatinib|mesh-list
65733350|NCT00770809|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
65733351|NCT00770809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65733352|NCT00770809|Antibodies|antibodies|mesh-list
65733353|NCT00770809|Immunoglobulins|immunoglobulins|mesh-list
65733354|NCT00770809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65733355|NCT00770809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65733356|NCT00770809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733357|NCT00770809|Tubulin Modulators|tubulin modulators|mesh-ancestor
65733358|NCT00770809|Antimitotic Agents|antimitotic agents|mesh-ancestor
65733359|NCT00770809|Mitosis Modulators|mitosis modulators|mesh-ancestor
65733360|NCT00770809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733361|NCT00770809|Immunologic Factors|immunologic factors|mesh-ancestor
65733362|NCT00770809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733363|NCT00770809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65733364|NCT00770809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733365|NCT02643056|Panitumumab|panitumumab|mesh-list
65733366|NCT02643056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65733367|NCT02643056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733368|NCT02515617|Silver Sulfadiazine|silver sulfadiazine|mesh-list
65733369|NCT02515617|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65733370|NCT02515617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65733371|NCT04263896|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65733372|NCT04263896|Laxatives|laxatives|mesh-ancestor
65733373|NCT04263896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65733374|NCT04578639|Rituximab|rituximab|mesh-list
65733375|NCT04578639|Ocrelizumab|ocrelizumab|mesh-list
65733376|NCT04578639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65733377|NCT04578639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733378|NCT04578639|Immunologic Factors|immunologic factors|mesh-ancestor
65733379|NCT04578639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733380|NCT04578639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65733381|NCT04413422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65733382|NCT04413422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65733383|NCT04413422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733384|NCT02238145|Ipratropium|ipratropium|mesh-list
65733385|NCT02238145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65733386|NCT02238145|Autonomic Agents|autonomic agents|mesh-ancestor
65733387|NCT02238145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65733388|NCT02238145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733389|NCT02238145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65733390|NCT02238145|Respiratory System Agents|respiratory system agents|mesh-ancestor
65733391|NCT02238145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65733392|NCT02238145|Cholinergic Agents|cholinergic agents|mesh-ancestor
65733393|NCT02238145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65733394|NCT02238145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733395|NCT04550637|Apixaban|apixaban|mesh-list
65733396|NCT04550637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65733397|NCT04550637|Antithrombins|antithrombins|mesh-ancestor
65733398|NCT04550637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65733399|NCT04550637|Protease Inhibitors|protease inhibitors|mesh-ancestor
65733400|NCT04550637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733401|NCT04550637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733402|NCT04550637|Anticoagulants|anticoagulants|mesh-ancestor
65733403|NCT03345303|Bortezomib|bortezomib|mesh-list
65733404|NCT03345303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733405|NCT03574909|Aspirin|aspirin|mesh-list
65733406|NCT03574909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65733407|NCT03574909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65733408|NCT03574909|Analgesics|analgesics|mesh-ancestor
65733409|NCT03574909|Sensory System Agents|sensory system agents|mesh-ancestor
65733410|NCT03574909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65733411|NCT03574909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733412|NCT03574909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65733413|NCT03574909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65733414|NCT03574909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65733415|NCT03574909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65733416|NCT03574909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733417|NCT03574909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65733418|NCT03574909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65733419|NCT03574909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733420|NCT03574909|Antipyretics|antipyretics|mesh-ancestor
65733421|NCT02515227|Pembrolizumab|pembrolizumab|mesh-list
65733422|NCT02515227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65733423|NCT02515227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733424|NCT03579043|Cocaine|cocaine|mesh-list
65733425|NCT03579043|Anesthetics, Local|anesthetics, local|mesh-ancestor
65733426|NCT03579043|Anesthetics|anesthetics|mesh-ancestor
65733427|NCT03579043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65733428|NCT03579043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733429|NCT03579043|Sensory System Agents|sensory system agents|mesh-ancestor
65733430|NCT03579043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65733431|NCT03579043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65733432|NCT03579043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65733433|NCT03579043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65733434|NCT03579043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65733435|NCT03579043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733436|NCT03579043|Dopamine Agents|dopamine agents|mesh-ancestor
65733437|NCT03579043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65733438|NCT02187991|Paclitaxel|paclitaxel|mesh-list
65733439|NCT02187991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65733440|NCT02187991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733441|NCT02187991|Tubulin Modulators|tubulin modulators|mesh-ancestor
65733442|NCT02187991|Antimitotic Agents|antimitotic agents|mesh-ancestor
65733443|NCT02187991|Mitosis Modulators|mitosis modulators|mesh-ancestor
65733444|NCT02187991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733445|NCT02660138|Botulinum Toxins|botulinum toxins|mesh-list
65733446|NCT02660138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65733447|NCT02660138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65733448|NCT02660138|Hemagglutinins|hemagglutinins|mesh-list
65733449|NCT02660138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65733450|NCT02660138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65733451|NCT02660138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733452|NCT02660138|Cholinergic Agents|cholinergic agents|mesh-ancestor
65733453|NCT02660138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65733454|NCT02660138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733455|NCT02660138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65733456|NCT02660138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65733457|NCT02660138|Agglutinins|agglutinins|mesh-ancestor
65733458|NCT02660138|Immunologic Factors|immunologic factors|mesh-ancestor
65733459|NCT03576469|Complement C1s|complement c1s|mesh-list
65733460|NCT03576469|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
65733461|NCT03576469|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
65733462|NCT03576469|Immunologic Factors|immunologic factors|mesh-ancestor
65733463|NCT03576469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733464|NCT03576469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65733465|NCT03576469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65733466|NCT05036876|Insulin Glargine|insulin glargine|mesh-list
65733467|NCT05036876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65733468|NCT05036876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733469|NCT05097950|Acetaminophen|acetaminophen|mesh-list
65733470|NCT05097950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65733471|NCT05097950|Analgesics|analgesics|mesh-ancestor
65733472|NCT05097950|Sensory System Agents|sensory system agents|mesh-ancestor
65733473|NCT05097950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65733474|NCT05097950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733475|NCT05097950|Antipyretics|antipyretics|mesh-ancestor
65733476|NCT05097248|Doxorubicin|doxorubicin|mesh-list
65733477|NCT05097248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65733478|NCT05097248|Losartan|losartan|mesh-list
65733479|NCT05097248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65733480|NCT05097248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733481|NCT05097248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65733482|NCT05097248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65733483|NCT05097248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733484|NCT05097248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733485|NCT05097248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65733486|NCT05097248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65733487|NCT05097248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65733488|NCT05097248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65733489|NCT01603394|Pregabalin|pregabalin|mesh-list
65733490|NCT01603394|Analgesics|analgesics|mesh-ancestor
65733491|NCT01603394|Sensory System Agents|sensory system agents|mesh-ancestor
65733492|NCT01603394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65733493|NCT01603394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733494|NCT01603394|Anticonvulsants|anticonvulsants|mesh-ancestor
65733495|NCT01603394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65733496|NCT01603394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65733497|NCT01603394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733498|NCT01603394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65733499|NCT01603394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65733500|NCT01603394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65733501|NCT01603394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65733502|NCT01603394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65733504|NCT04682522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65733505|NCT04682522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65733506|NCT04682522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65733507|NCT04682522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65733508|NCT02837432|Hydrocortisone|hydrocortisone|mesh-list
65733509|NCT02837432|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65733510|NCT02837432|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65733511|NCT02837432|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65733512|NCT02837432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65733513|NCT02729025|Evolocumab|evolocumab|mesh-list
65733514|NCT02729025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65733515|NCT02729025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65733516|NCT02729025|Antimetabolites|antimetabolites|mesh-ancestor
65733517|NCT02729025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733518|NCT02729025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65733519|NCT05599971|Fluorouracil|fluorouracil|mesh-list
65733520|NCT05599971|Digoxin|digoxin|mesh-list
65733521|NCT05599971|Furosemide|furosemide|mesh-list
65733522|NCT05599971|Antimetabolites|antimetabolites|mesh-ancestor
65733523|NCT05599971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733524|NCT05599971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65733525|NCT05599971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733526|NCT05599971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65733527|NCT05599971|Immunologic Factors|immunologic factors|mesh-ancestor
65733528|NCT05599971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733529|NCT05599971|Diuretics|diuretics|mesh-ancestor
65733530|NCT05599971|Natriuretic Agents|natriuretic agents|mesh-ancestor
65733531|NCT05599971|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65733532|NCT05599971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65733533|NCT05599971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65733534|NCT05599971|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65733535|NCT05599971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733536|NCT05599971|Protective Agents|protective agents|mesh-ancestor
65733537|NCT02511873|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
65733538|NCT02511873|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65733539|NCT02511873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65733540|NCT02511873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733541|NCT02511873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733542|NCT02511795|Olaparib|olaparib|mesh-list
65733543|NCT02511795|Adavosertib|adavosertib|mesh-list
65733544|NCT02511795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65733545|NCT02511795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733546|NCT02511795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733547|NCT02511795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733548|NCT04796636|Ascorbic Acid|ascorbic acid|mesh-list
65733549|NCT04796636|Antioxidants|antioxidants|mesh-ancestor
65733550|NCT04796636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733551|NCT04796636|Protective Agents|protective agents|mesh-ancestor
65733552|NCT04796636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733553|NCT04796636|Vitamins|vitamins|mesh-ancestor
65733554|NCT04796636|Micronutrients|micronutrients|mesh-ancestor
65733555|NCT04501809|Misoprostol|misoprostol|mesh-list
65733556|NCT04501809|Oxytocin|oxytocin|mesh-list
65733557|NCT04501809|Oxytocics|oxytocics|mesh-ancestor
65733558|NCT04501809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65733559|NCT04501809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733560|NCT04501809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65733561|NCT04501809|Abortifacient Agents|abortifacient agents|mesh-ancestor
65733562|NCT04501809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65733563|NCT04501809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65733564|NCT04718636|Moxifloxacin|moxifloxacin|mesh-list
65733565|NCT04718636|Contraceptive Agents|contraceptive agents|mesh-list
65733566|NCT04718636|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65733567|NCT04718636|Contraceptives, Oral|contraceptives, oral|mesh-list
65733568|NCT04718636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65733569|NCT04718636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733570|NCT04718636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65733571|NCT04718636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65733572|NCT04718636|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65733573|NCT04718636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65733574|NCT04718636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65733575|NCT04718636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65733576|NCT04718636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65733577|NCT04718636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733578|NCT04718636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733579|NCT04718636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733580|NCT02514681|Gemcitabine|gemcitabine|mesh-list
65733581|NCT02514681|Paclitaxel|paclitaxel|mesh-list
65733582|NCT02514681|Vinorelbine|vinorelbine|mesh-list
65733583|NCT02514681|Docetaxel|docetaxel|mesh-list
65733584|NCT02514681|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65733585|NCT02514681|Capecitabine|capecitabine|mesh-list
65733586|NCT02514681|Trastuzumab|trastuzumab|mesh-list
65733587|NCT02514681|Pertuzumab|pertuzumab|mesh-list
65733588|NCT02514681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65733589|NCT02514681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733590|NCT02514681|Tubulin Modulators|tubulin modulators|mesh-ancestor
65733591|NCT02514681|Antimitotic Agents|antimitotic agents|mesh-ancestor
65733592|NCT02514681|Mitosis Modulators|mitosis modulators|mesh-ancestor
65733593|NCT02514681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733594|NCT02514681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65733595|NCT02514681|Antimetabolites|antimetabolites|mesh-ancestor
65733596|NCT02514681|Antiviral Agents|antiviral agents|mesh-ancestor
65733597|NCT02514681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65733598|NCT02514681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733599|NCT02514681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65733600|NCT02514681|Immunologic Factors|immunologic factors|mesh-ancestor
65733601|NCT02514681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733602|NCT02514681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65733603|NCT02511639|Everolimus|everolimus|mesh-list
65733604|NCT02511639|Letrozole|letrozole|mesh-list
65733605|NCT02511639|Anastrozole|anastrozole|mesh-list
65733606|NCT02511639|Exemestane|exemestane|mesh-list
65733607|NCT02511639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65733608|NCT02511639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733609|NCT02511639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65733610|NCT02511639|Immunologic Factors|immunologic factors|mesh-ancestor
65733611|NCT02511639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733612|NCT02511639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65733613|NCT02511639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733614|NCT02511639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733615|NCT02511639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65733616|NCT02511639|Hormone Antagonists|hormone antagonists|mesh-ancestor
65733617|NCT02511639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65733618|NCT02511639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65733619|NCT02511483|Propranolol|propranolol|mesh-list
65733620|NCT02511483|Morphine|morphine|mesh-list
65733621|NCT02511483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65733622|NCT02511483|Narcotics|narcotics|mesh-ancestor
65733623|NCT02511483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65733624|NCT02511483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733625|NCT02511483|Analgesics|analgesics|mesh-ancestor
65733626|NCT02511483|Sensory System Agents|sensory system agents|mesh-ancestor
65733627|NCT02511483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65733628|NCT02511483|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65733629|NCT02511483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65733630|NCT02511483|Adrenergic Agents|adrenergic agents|mesh-ancestor
65733631|NCT02511483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65733632|NCT02511483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733633|NCT02511483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65733634|NCT02511483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65733635|NCT02511483|Vasodilator Agents|vasodilator agents|mesh-ancestor
65733636|NCT04429802|Prucalopride|prucalopride|mesh-list
65733637|NCT04429802|Laxatives|laxatives|mesh-ancestor
65733638|NCT04429802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65733639|NCT04429802|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65733640|NCT04429802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65733641|NCT04429802|Serotonin Agents|serotonin agents|mesh-ancestor
65049325|NCT00222833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65733642|NCT04429802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65733643|NCT04429802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733644|NCT04429802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733645|NCT02511405|Bevacizumab|bevacizumab|mesh-list
65733646|NCT02511405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65733647|NCT02511405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733648|NCT02511405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65733649|NCT02511405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65733650|NCT02511405|Growth Substances|growth substances|mesh-ancestor
65733651|NCT02511405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733652|NCT02511405|Growth Inhibitors|growth inhibitors|mesh-ancestor
65733653|NCT04387760|Hydroxychloroquine|hydroxychloroquine|mesh-list
65733654|NCT04387760|Favipiravir|favipiravir|mesh-list
65733655|NCT04387760|Antimalarials|antimalarials|mesh-ancestor
65733656|NCT04387760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65733657|NCT04387760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65733658|NCT04387760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65733659|NCT04387760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733660|NCT04387760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733661|NCT04387760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65733662|NCT04387760|Antiviral Agents|antiviral agents|mesh-ancestor
65733663|NCT05091086|Zoledronic Acid|zoledronic acid|mesh-list
65733664|NCT05091086|Denosumab|denosumab|mesh-list
65733665|NCT05091086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65733666|NCT05091086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733667|NCT05091008|Sofosbuvir|sofosbuvir|mesh-list
65733668|NCT05091008|Ledipasvir|ledipasvir|mesh-list
65733669|NCT05091008|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
65733670|NCT05091008|Antiviral Agents|antiviral agents|mesh-ancestor
65733671|NCT05091008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65733672|NCT02918084|Letrozole|letrozole|mesh-list
65733673|NCT02918084|Anastrozole|anastrozole|mesh-list
65733674|NCT02918084|Exemestane|exemestane|mesh-list
65733675|NCT02918084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733676|NCT02918084|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65733677|NCT02918084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65733678|NCT02918084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733679|NCT02918084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733680|NCT02918084|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65733681|NCT02918084|Hormone Antagonists|hormone antagonists|mesh-ancestor
65733682|NCT02918084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65733683|NCT02918084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733684|NCT02918084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65733685|NCT01603082|Clopidogrel|clopidogrel|mesh-list
65733686|NCT01603082|Ticagrelor|ticagrelor|mesh-list
65733687|NCT01603082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65733688|NCT01603082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65733689|NCT01603082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65733690|NCT01603082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65733691|NCT01603082|Purinergic Agents|purinergic agents|mesh-ancestor
65733692|NCT01603082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65733693|NCT01603082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733694|NCT01603082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733695|NCT04499313|Dexamethasone|dexamethasone|mesh-list
65733696|NCT04499313|Methylprednisolone|methylprednisolone|mesh-list
65733697|NCT04499313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65733698|NCT04499313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65733699|NCT04499313|Prednisolone|prednisolone|mesh-list
65733700|NCT04499313|Prednisolone acetate|prednisolone acetate|mesh-list
65733701|NCT04499313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65733702|NCT04499313|Prednisolone phosphate|prednisolone phosphate|mesh-list
65733703|NCT04499313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65733704|NCT04499313|Antiemetics|antiemetics|mesh-ancestor
65733705|NCT04499313|Autonomic Agents|autonomic agents|mesh-ancestor
65733706|NCT04499313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65733707|NCT04499313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733708|NCT04499313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65733709|NCT04499313|Glucocorticoids|glucocorticoids|mesh-ancestor
65733710|NCT04499313|Hormones|hormones|mesh-ancestor
65733711|NCT04499313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65733712|NCT04499313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65733713|NCT04499313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733714|NCT04499313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65733715|NCT04499313|Protective Agents|protective agents|mesh-ancestor
65733716|NCT04134884|Talazoparib|talazoparib|mesh-list
65049395|NCT04607629|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65733717|NCT04134884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65733718|NCT04134884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733719|NCT04134884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733720|NCT04134884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733721|NCT04331756|Anesthetics|anesthetics|mesh-list
65733722|NCT04331756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65733723|NCT04331756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733724|NCT04112199|Terlipressin|terlipressin|mesh-list
65733725|NCT04112199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65733726|NCT04112199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65733727|NCT02499835|Pembrolizumab|pembrolizumab|mesh-list
65733728|NCT02499835|Immunoglobulins|immunoglobulins|mesh-list
65733729|NCT02499835|Immunoglobulin G|immunoglobulin g|mesh-list
65733730|NCT02499835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65733731|NCT02499835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733732|NCT02499835|Immunologic Factors|immunologic factors|mesh-ancestor
65733733|NCT02499835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733734|NCT02510781|Carboplatin|carboplatin|mesh-list
65733735|NCT02510781|Docetaxel|docetaxel|mesh-list
65733736|NCT02510781|Trastuzumab|trastuzumab|mesh-list
65733737|NCT02510781|Epirubicin|epirubicin|mesh-list
65733738|NCT02510781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733739|NCT02510781|Tubulin Modulators|tubulin modulators|mesh-ancestor
65733740|NCT02510781|Antimitotic Agents|antimitotic agents|mesh-ancestor
65733741|NCT02510781|Mitosis Modulators|mitosis modulators|mesh-ancestor
65733742|NCT02510781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733743|NCT02510781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65733744|NCT02510781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65733745|NCT02510781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65733746|NCT02510781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65733747|NCT02510781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733748|NCT03121599|Alovudine|alovudine|mesh-list
65733749|NCT03121599|Antiviral Agents|antiviral agents|mesh-ancestor
65733750|NCT03121599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65733751|NCT03576079|Salicylic Acid|salicylic acid|mesh-list
65733752|NCT03576079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65733753|NCT03576079|Antifungal Agents|antifungal agents|mesh-ancestor
65733754|NCT03576079|Keratolytic Agents|keratolytic agents|mesh-ancestor
65733755|NCT03576079|Dermatologic Agents|dermatologic agents|mesh-ancestor
65733756|NCT04181606|Esmolol|esmolol|mesh-list
65733757|NCT04181606|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65733758|NCT04181606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65733759|NCT04181606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65733760|NCT04181606|Adrenergic Agents|adrenergic agents|mesh-ancestor
65733761|NCT04181606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65733762|NCT04181606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733763|NCT04181606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733764|NCT04499235|Mometasone Furoate|mometasone furoate|mesh-list
65733765|NCT04499235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65733766|NCT04499235|Dermatologic Agents|dermatologic agents|mesh-ancestor
65733767|NCT04499235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65733768|NCT02510469|Apatinib|apatinib|mesh-list
65733769|NCT02510469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733770|NCT02510469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65733771|NCT02510469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733772|NCT02510469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733773|NCT05375630|Vitamin K|vitamin k|mesh-list
65733774|NCT05375630|Vitamin K 2|vitamin k 2|mesh-list
65733775|NCT05375630|Vitamins|vitamins|mesh-ancestor
65733776|NCT05375630|Micronutrients|micronutrients|mesh-ancestor
65733777|NCT05375630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733778|NCT05375630|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65733779|NCT05375630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65733780|NCT05375630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733781|NCT05375630|Hemostatics|hemostatics|mesh-ancestor
65733782|NCT05375630|Coagulants|coagulants|mesh-ancestor
65733783|NCT02510235|Hyaluronic Acid|hyaluronic acid|mesh-list
65733784|NCT02510235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65733785|NCT02510235|Immunologic Factors|immunologic factors|mesh-ancestor
65733786|NCT02510235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733787|NCT02510235|Viscosupplements|viscosupplements|mesh-ancestor
65733788|NCT02510235|Protective Agents|protective agents|mesh-ancestor
65733789|NCT05081336|Ezetimibe|ezetimibe|mesh-list
65733790|NCT05081336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65733791|NCT05081336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65733792|NCT05081336|Antimetabolites|antimetabolites|mesh-ancestor
65733793|NCT05081336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733794|NCT05081336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65733795|NCT03578497|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65733796|NCT03578497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65733797|NCT03710876|Gemcitabine|gemcitabine|mesh-list
65733798|NCT03710876|Celecoxib|celecoxib|mesh-list
65733799|NCT03710876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65733800|NCT03710876|Antimetabolites|antimetabolites|mesh-ancestor
65733801|NCT03710876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733802|NCT03710876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733803|NCT03710876|Antiviral Agents|antiviral agents|mesh-ancestor
65733804|NCT03710876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65733805|NCT03710876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733806|NCT03710876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65733807|NCT03710876|Immunologic Factors|immunologic factors|mesh-ancestor
65733808|NCT03710876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733809|NCT03710876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65733810|NCT03710876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65733811|NCT03710876|Analgesics|analgesics|mesh-ancestor
65733812|NCT03710876|Sensory System Agents|sensory system agents|mesh-ancestor
65733813|NCT03710876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65733814|NCT03710876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65733815|NCT03710876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65733816|NCT03710876|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65733817|NCT03710876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65733818|NCT02513433|Bupivacaine|bupivacaine|mesh-list
65733819|NCT02513433|Ropivacaine|ropivacaine|mesh-list
65733820|NCT02513433|Levobupivacaine|levobupivacaine|mesh-list
65733821|NCT02513433|Anesthetics, Local|anesthetics, local|mesh-ancestor
65733822|NCT02513433|Anesthetics|anesthetics|mesh-ancestor
65733823|NCT02513433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65733824|NCT02513433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733825|NCT02513433|Sensory System Agents|sensory system agents|mesh-ancestor
65733826|NCT02513433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65733827|NCT02510157|Dexamethasone|dexamethasone|mesh-list
65733828|NCT02510157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65733829|NCT02510157|Antiemetics|antiemetics|mesh-ancestor
65733830|NCT02510157|Autonomic Agents|autonomic agents|mesh-ancestor
65733831|NCT02510157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65733832|NCT02510157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733833|NCT02510157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65733834|NCT02510157|Glucocorticoids|glucocorticoids|mesh-ancestor
65733835|NCT02510157|Hormones|hormones|mesh-ancestor
65733836|NCT02510157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65733837|NCT02510157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65733838|NCT02510157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733839|NCT03345147|Vitamins|vitamins|mesh-list
65733840|NCT03345147|Vitamin A|vitamin a|mesh-list
65733841|NCT03345147|Retinol palmitate|retinol palmitate|mesh-list
65733842|NCT03345147|Micronutrients|micronutrients|mesh-ancestor
65733843|NCT03345147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733844|NCT03345147|Antioxidants|antioxidants|mesh-ancestor
65733845|NCT03345147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733846|NCT03345147|Protective Agents|protective agents|mesh-ancestor
65733847|NCT03345147|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65733848|NCT03345147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733849|NCT03662919|Adalimumab|adalimumab|mesh-list
65733850|NCT03662919|Infliximab|infliximab|mesh-list
65733851|NCT03662919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65733852|NCT03662919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65733853|NCT03662919|Dermatologic Agents|dermatologic agents|mesh-ancestor
65733854|NCT03662919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65733855|NCT05375240|Ceftriaxone|ceftriaxone|mesh-list
65733856|NCT05375240|Propranolol|propranolol|mesh-list
65733857|NCT05375240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65733858|NCT05375240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65733859|NCT05375240|Adrenergic Agents|adrenergic agents|mesh-ancestor
65733860|NCT05375240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65733861|NCT05375240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733862|NCT05375240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733863|NCT05375240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65733864|NCT05375240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65733865|NCT05375240|Vasodilator Agents|vasodilator agents|mesh-ancestor
65733866|NCT05375240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65733867|NCT05375240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65733868|NCT00406393|Sirolimus|sirolimus|mesh-list
65733869|NCT00406393|Methotrexate|methotrexate|mesh-list
65733870|NCT00406393|Tacrolimus|tacrolimus|mesh-list
65733871|NCT00406393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65049544|NCT00565123|Levofloxacin|levofloxacin|mesh-list
65733872|NCT00406393|Abortifacient Agents|abortifacient agents|mesh-ancestor
65733873|NCT00406393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65733874|NCT00406393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733875|NCT00406393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65733877|NCT00406393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733878|NCT00406393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733879|NCT00406393|Dermatologic Agents|dermatologic agents|mesh-ancestor
65733880|NCT00406393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733881|NCT00406393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65733882|NCT00406393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65733883|NCT00406393|Immunologic Factors|immunologic factors|mesh-ancestor
65733884|NCT00406393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65733885|NCT00406393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65733886|NCT00406393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65733887|NCT00406393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65733888|NCT00406393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65733889|NCT00406393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65733890|NCT00406393|Antifungal Agents|antifungal agents|mesh-ancestor
65733891|NCT02513355|Cisplatin|cisplatin|mesh-list
65733892|NCT02513355|Endostar protein|endostar protein|mesh-list
65733893|NCT02513355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733894|NCT02513355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65733895|NCT02513355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65733896|NCT02513355|Growth Substances|growth substances|mesh-ancestor
65733897|NCT02513355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733898|NCT02513355|Growth Inhibitors|growth inhibitors|mesh-ancestor
65733899|NCT03329378|Paclitaxel|paclitaxel|mesh-list
65733900|NCT03329378|Docetaxel|docetaxel|mesh-list
65733901|NCT03329378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65733902|NCT03329378|Cyclophosphamide|cyclophosphamide|mesh-list
65733903|NCT03329378|Carboplatin|carboplatin|mesh-list
65733904|NCT03329378|Doxorubicin|doxorubicin|mesh-list
65733905|NCT03329378|Trastuzumab|trastuzumab|mesh-list
65733906|NCT03329378|Pertuzumab|pertuzumab|mesh-list
65733907|NCT03329378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65733908|NCT03329378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65733909|NCT03329378|Tubulin Modulators|tubulin modulators|mesh-ancestor
65733910|NCT03329378|Antimitotic Agents|antimitotic agents|mesh-ancestor
65733911|NCT03329378|Mitosis Modulators|mitosis modulators|mesh-ancestor
65733912|NCT03329378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733913|NCT03329378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65733914|NCT03329378|Immunologic Factors|immunologic factors|mesh-ancestor
65733915|NCT03329378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733916|NCT03329378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65733917|NCT03329378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65733918|NCT03329378|Alkylating Agents|alkylating agents|mesh-ancestor
65733919|NCT03329378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65733920|NCT03329378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65733921|NCT03329378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65733922|NCT03329378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65733923|NCT03329378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733924|NCT03329378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65733925|NCT03574285|Sarpogrelate|sarpogrelate|mesh-list
65733926|NCT03574285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65733927|NCT03574285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65733928|NCT03574285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733929|NCT03574285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65733930|NCT03574285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65733931|NCT03574285|Serotonin Agents|serotonin agents|mesh-ancestor
65733932|NCT03574285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65733933|NCT03574285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733934|NCT02509923|Rabeprazole|rabeprazole|mesh-list
65733935|NCT02509923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65733936|NCT02509923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65733937|NCT02509923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65733938|NCT02509923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733939|NCT02509923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733940|NCT03578263|Oxytocin|oxytocin|mesh-list
65733941|NCT03578263|Carbetocin|carbetocin|mesh-list
65733942|NCT03578263|Ergonovine|ergonovine|mesh-list
65733943|NCT03578263|Oxytocics|oxytocics|mesh-ancestor
65733944|NCT03578263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65733945|NCT03578263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733946|NCT05099198|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65733947|NCT05099198|Glimepiride|glimepiride|mesh-list
65049619|NCT04603573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65733948|NCT05099198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65733949|NCT05099198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733950|NCT05099198|Incretins|incretins|mesh-ancestor
65733951|NCT05099198|Hormones|hormones|mesh-ancestor
65733952|NCT05099198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65733953|NCT05099198|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65733954|NCT05099198|Protease Inhibitors|protease inhibitors|mesh-ancestor
65733955|NCT05099198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733956|NCT05099198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733957|NCT05099198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65733958|NCT05099198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65733959|NCT05099198|Immunologic Factors|immunologic factors|mesh-ancestor
65733960|NCT03572257|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65733961|NCT03572257|Antidepressive Agents|antidepressive agents|mesh-ancestor
65733962|NCT03572257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65733963|NCT03572257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65733964|NCT03572257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65733965|NCT03572257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65733966|NCT03572257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733967|NCT02845375|Neostigmine|neostigmine|mesh-list
65733968|NCT02845375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65733969|NCT02845375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65733970|NCT02845375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733971|NCT02845375|Cholinergic Agents|cholinergic agents|mesh-ancestor
65733972|NCT02845375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65733973|NCT02845375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733974|NCT02845375|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65733975|NCT02845375|Autonomic Agents|autonomic agents|mesh-ancestor
65733976|NCT02845375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65733977|NCT02979860|Oxymetazoline|oxymetazoline|mesh-list
65733978|NCT02979860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65733979|NCT02979860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65733980|NCT02979860|Adrenergic Agents|adrenergic agents|mesh-ancestor
65733981|NCT02979860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65733982|NCT02979860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65733983|NCT02979860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733984|NCT02979860|Sympathomimetics|sympathomimetics|mesh-ancestor
65733985|NCT02979860|Autonomic Agents|autonomic agents|mesh-ancestor
65733986|NCT02979860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65733987|NCT02979860|Nasal Decongestants|nasal decongestants|mesh-ancestor
65733988|NCT02979860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65733989|NCT02979860|Respiratory System Agents|respiratory system agents|mesh-ancestor
65733990|NCT03344679|Magnesium Sulfate|magnesium sulfate|mesh-list
65733991|NCT03344679|Adenosine|adenosine|mesh-list
65733992|NCT03344679|Bupivacaine|bupivacaine|mesh-list
65733993|NCT03344679|Anesthetics, Local|anesthetics, local|mesh-ancestor
65733994|NCT03344679|Anesthetics|anesthetics|mesh-ancestor
65733995|NCT03344679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65733996|NCT03344679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65733997|NCT03344679|Sensory System Agents|sensory system agents|mesh-ancestor
65733998|NCT03344679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65733999|NCT03344679|Analgesics|analgesics|mesh-ancestor
65734000|NCT03344679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65734001|NCT03344679|Anticonvulsants|anticonvulsants|mesh-ancestor
65734002|NCT03344679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65734003|NCT03344679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65734004|NCT03344679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734005|NCT03344679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65734006|NCT03344679|Tocolytic Agents|tocolytic agents|mesh-ancestor
65734007|NCT03344679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65734008|NCT03344679|Vasodilator Agents|vasodilator agents|mesh-ancestor
65734009|NCT03344679|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65734010|NCT03344679|Purinergic Agonists|purinergic agonists|mesh-ancestor
65734011|NCT03344679|Purinergic Agents|purinergic agents|mesh-ancestor
65734012|NCT03344679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65734013|NCT02259829|Amlodipine|amlodipine|mesh-list
65734014|NCT02259829|Telmisartan|telmisartan|mesh-list
65734015|NCT02259829|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
65734016|NCT02259829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65734017|NCT02259829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65734018|NCT02259829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65734019|NCT02259829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734020|NCT02259829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65049701|NCT00565240|Letrozole|letrozole|mesh-list
65734021|NCT02259829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734022|NCT02259829|Vasodilator Agents|vasodilator agents|mesh-ancestor
65734023|NCT02259829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65734024|NCT02259829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65734025|NCT03344523|Iron protein succinylate|iron protein succinylate|mesh-list
65734026|NCT03344523|Hematinics|hematinics|mesh-ancestor
65734027|NCT02658734|Trastuzumab|trastuzumab|mesh-list
65734028|NCT02658734|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65734029|NCT02658734|Maytansine|maytansine|mesh-list
65734030|NCT02658734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65734031|NCT02658734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734032|NCT02658734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65734033|NCT02658734|Tubulin Modulators|tubulin modulators|mesh-ancestor
65734034|NCT02658734|Antimitotic Agents|antimitotic agents|mesh-ancestor
65734035|NCT02658734|Mitosis Modulators|mitosis modulators|mesh-ancestor
65734036|NCT02658734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734037|NCT03344445|Anesthetics|anesthetics|mesh-list
65734038|NCT03344445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65734039|NCT03344445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734040|NCT04501107|Insulin|insulin|mesh-list
65734041|NCT04501107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65734042|NCT04501107|Insulin Lispro|insulin lispro|mesh-list
65734043|NCT04501107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65734044|NCT04501107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734045|NCT03143985|Pomalidomide|pomalidomide|mesh-list
65734046|NCT03143985|Immunologic Factors|immunologic factors|mesh-ancestor
65734047|NCT03143985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734048|NCT03143985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65734049|NCT03143985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65734050|NCT03143985|Growth Substances|growth substances|mesh-ancestor
65734051|NCT03143985|Growth Inhibitors|growth inhibitors|mesh-ancestor
65734052|NCT03143985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734053|NCT02605148|Vitamin D|vitamin d|mesh-list
65734054|NCT02605148|Vitamins|vitamins|mesh-ancestor
65734055|NCT02605148|Micronutrients|micronutrients|mesh-ancestor
65734056|NCT02605148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734057|NCT02605148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65734058|NCT04497831|Morphine|morphine|mesh-list
65734059|NCT04497831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65734060|NCT04497831|Narcotics|narcotics|mesh-ancestor
65734061|NCT04497831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65734062|NCT04497831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734063|NCT04497831|Analgesics|analgesics|mesh-ancestor
65734064|NCT04497831|Sensory System Agents|sensory system agents|mesh-ancestor
65734065|NCT04497831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65734066|NCT02395640|Capecitabine|capecitabine|mesh-list
65734067|NCT02395640|Oxaliplatin|oxaliplatin|mesh-list
65734068|NCT02395640|Epirubicin|epirubicin|mesh-list
65734069|NCT02395640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65734070|NCT02395640|Antimetabolites|antimetabolites|mesh-ancestor
65734071|NCT02395640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734072|NCT02395640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734073|NCT02395640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65734074|NCT02395640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65734075|NCT02395640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65734076|NCT02395640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734077|NCT02509143|Ramosetron|ramosetron|mesh-list
65734078|NCT02509143|Antiemetics|antiemetics|mesh-list
65734079|NCT02509143|Autonomic Agents|autonomic agents|mesh-ancestor
65734080|NCT02509143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65734081|NCT02509143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734082|NCT02509143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65734083|NCT02509143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65734084|NCT02509143|Serotonin Agents|serotonin agents|mesh-ancestor
65734085|NCT02509143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65734086|NCT02509143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734087|NCT05100446|Amoxicillin|amoxicillin|mesh-list
65734088|NCT05100446|Esomeprazole|esomeprazole|mesh-list
65734089|NCT05100446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65734090|NCT05100446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65734091|NCT05100446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65734092|NCT05100446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65734093|NCT05100446|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65049770|NCT00565318|Benphothiamine|benphothiamine|mesh-list
65734094|NCT05100446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734095|NCT05100446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734096|NCT02506803|Gemcitabine|gemcitabine|mesh-list
65734097|NCT02506803|Paclitaxel|paclitaxel|mesh-list
65734098|NCT02506803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65734099|NCT02506803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734100|NCT02506803|Tubulin Modulators|tubulin modulators|mesh-ancestor
65734101|NCT02506803|Antimitotic Agents|antimitotic agents|mesh-ancestor
65734102|NCT02506803|Mitosis Modulators|mitosis modulators|mesh-ancestor
65734103|NCT02506803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734104|NCT02506803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65734105|NCT02506803|Antimetabolites|antimetabolites|mesh-ancestor
65734106|NCT02506803|Antiviral Agents|antiviral agents|mesh-ancestor
65734107|NCT02506803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65734108|NCT02506803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734109|NCT02506803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65734110|NCT02506803|Immunologic Factors|immunologic factors|mesh-ancestor
65734111|NCT02506803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734112|NCT02844439|XL647|xl647|mesh-list
65734113|NCT02844439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734114|NCT02844439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65734115|NCT02844439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734116|NCT02844439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734117|NCT04531592|Valproic Acid|valproic acid|mesh-list
65734118|NCT04531592|Anticonvulsants|anticonvulsants|mesh-ancestor
65734119|NCT04531592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734120|NCT04531592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734121|NCT04531592|GABA Agents|gaba agents|mesh-ancestor
65734122|NCT04531592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65734123|NCT04531592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734124|NCT04531592|Antimanic Agents|antimanic agents|mesh-ancestor
65734125|NCT04531592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65734126|NCT04531592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65734127|NCT04531592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65734128|NCT03571711|Meropenem|meropenem|mesh-list
65734129|NCT03571711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65734130|NCT03571711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65734131|NCT03570541|Acetaminophen|acetaminophen|mesh-list
65734132|NCT03570541|Morphine|morphine|mesh-list
65734133|NCT03570541|Ropivacaine|ropivacaine|mesh-list
65734134|NCT03570541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65734135|NCT03570541|Narcotics|narcotics|mesh-ancestor
65734136|NCT03570541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65734137|NCT03570541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734138|NCT03570541|Analgesics|analgesics|mesh-ancestor
65734139|NCT03570541|Sensory System Agents|sensory system agents|mesh-ancestor
65734140|NCT03570541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65734141|NCT03570541|Anesthetics, Local|anesthetics, local|mesh-ancestor
65734142|NCT03570541|Anesthetics|anesthetics|mesh-ancestor
65734143|NCT03570541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65734144|NCT03570541|Antipyretics|antipyretics|mesh-ancestor
65734145|NCT00708435|Protein C|protein c|mesh-list
65734146|NCT00708435|Protein S|protein s|mesh-list
65734147|NCT00708435|Anticoagulants|anticoagulants|mesh-ancestor
65734148|NCT00708435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65734149|NCT00708435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65734150|NCT00708435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734151|NCT02508753|Moxifloxacin|moxifloxacin|mesh-list
65734152|NCT02508753|Tazobactam|tazobactam|mesh-list
65734153|NCT02508753|Ceftolozane|ceftolozane|mesh-list
65734154|NCT02508753|Cephalosporins|cephalosporins|mesh-list
65734155|NCT02508753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65734156|NCT02508753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65734157|NCT02508753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65734158|NCT02508753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65734159|NCT02508753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734160|NCT02508753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734161|NCT02508753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734162|NCT02508753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65734163|NCT02506647|Insulin|insulin|mesh-list
65734164|NCT02506647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65734165|NCT02506647|Insulin Glargine|insulin glargine|mesh-list
65734166|NCT02506647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65734167|NCT02506647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734168|NCT02571530|Trastuzumab|trastuzumab|mesh-list
65734169|NCT02571530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65734170|NCT02571530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049845|NCT00414648|Antifungal Agents|antifungal agents|mesh-ancestor
65734171|NCT04379024|Bazedoxifene|bazedoxifene|mesh-list
65734172|NCT04379024|Estrogens|estrogens|mesh-list
65734173|NCT04379024|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65734174|NCT04379024|Hormones|hormones|mesh-ancestor
65734175|NCT04379024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65734176|NCT04379024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734177|NCT04379024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65734178|NCT04379024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65734179|NCT04379024|Hormone Antagonists|hormone antagonists|mesh-ancestor
65734180|NCT04379024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65734181|NCT04498689|Gemcitabine|gemcitabine|mesh-list
65734182|NCT04498689|Paclitaxel|paclitaxel|mesh-list
65734183|NCT04498689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65734184|NCT04498689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734185|NCT04498689|Tubulin Modulators|tubulin modulators|mesh-ancestor
65734186|NCT04498689|Antimitotic Agents|antimitotic agents|mesh-ancestor
65734187|NCT04498689|Mitosis Modulators|mitosis modulators|mesh-ancestor
65734188|NCT04498689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734189|NCT04498689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65734190|NCT04498689|Antimetabolites|antimetabolites|mesh-ancestor
65734191|NCT04498689|Antiviral Agents|antiviral agents|mesh-ancestor
65734192|NCT04498689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65734193|NCT04498689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734194|NCT04498689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65734195|NCT04498689|Immunologic Factors|immunologic factors|mesh-ancestor
65734196|NCT04498689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734197|NCT05103098|Misoprostol|misoprostol|mesh-list
65734198|NCT05103098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65734199|NCT05103098|Abortifacient Agents|abortifacient agents|mesh-ancestor
65734200|NCT05103098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65734201|NCT05103098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734202|NCT05103098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65734203|NCT05103098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65734204|NCT05103098|Oxytocics|oxytocics|mesh-ancestor
65734205|NCT04272008|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65734206|NCT04272008|Estradiol|estradiol|mesh-list
65734207|NCT04272008|Estrogens|estrogens|mesh-ancestor
65734208|NCT04272008|Hormones|hormones|mesh-ancestor
65734209|NCT04272008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65734210|NCT04272008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734211|NCT04272008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65734212|NCT04272008|Contraceptive Agents|contraceptive agents|mesh-ancestor
65734213|NCT04272008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65734214|NCT04272008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65734215|NCT04272008|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65734216|NCT04272008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65734217|NCT05103020|Bevacizumab|bevacizumab|mesh-list
65734218|NCT05103020|Cetuximab|cetuximab|mesh-list
65734219|NCT05103020|Oxaliplatin|oxaliplatin|mesh-list
65734220|NCT05103020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65734221|NCT05103020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734222|NCT05103020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65734223|NCT05103020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65734224|NCT05103020|Growth Substances|growth substances|mesh-ancestor
65734225|NCT05103020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734226|NCT05103020|Growth Inhibitors|growth inhibitors|mesh-ancestor
65734227|NCT02501109|Aripiprazole|aripiprazole|mesh-list
65734228|NCT02501109|Antidepressive Agents|antidepressive agents|mesh-ancestor
65734229|NCT02501109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65734230|NCT02501109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65734231|NCT02501109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65734232|NCT02501109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65734233|NCT02501109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734234|NCT02501109|Dopamine Agonists|dopamine agonists|mesh-ancestor
65734235|NCT02501109|Dopamine Agents|dopamine agents|mesh-ancestor
65734236|NCT02501109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65734237|NCT02501109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734238|NCT02501109|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65734239|NCT02501109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65734240|NCT02501109|Serotonin Agents|serotonin agents|mesh-ancestor
65734241|NCT02501109|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65734242|NCT02501109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65734243|NCT02501109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65734244|NCT02501109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65734245|NCT05060666|Ivermectin|ivermectin|mesh-list
65734246|NCT05060666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65734247|NCT05060666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65734248|NCT02506335|Cholic Acids|cholic acids|mesh-list
65049918|NCT00565708|Aspirin|aspirin|mesh-list
65734249|NCT02506335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65734251|NCT04725032|Sevoflurane|sevoflurane|mesh-list
65734252|NCT04725032|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65734253|NCT04725032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65734254|NCT04725032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734255|NCT04725032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65734256|NCT04725032|Anesthetics, General|anesthetics, general|mesh-ancestor
65734257|NCT04725032|Anesthetics|anesthetics|mesh-ancestor
65734258|NCT04725032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65734259|NCT04725032|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65734260|NCT01353859|Methotrexate|methotrexate|mesh-list
65734261|NCT01353859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65734262|NCT01353859|Abortifacient Agents|abortifacient agents|mesh-ancestor
65734263|NCT01353859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65734264|NCT01353859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734265|NCT01353859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65734266|NCT01353859|Antimetabolites|antimetabolites|mesh-ancestor
65734267|NCT01353859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734268|NCT01353859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734269|NCT01353859|Dermatologic Agents|dermatologic agents|mesh-ancestor
65734270|NCT01353859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734271|NCT01353859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65734272|NCT01353859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65734273|NCT01353859|Immunologic Factors|immunologic factors|mesh-ancestor
65734274|NCT01353859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65734275|NCT01353859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65734276|NCT02238197|Ipratropium|ipratropium|mesh-list
65734277|NCT02238197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65734278|NCT02238197|Autonomic Agents|autonomic agents|mesh-ancestor
65734279|NCT02238197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65734280|NCT02238197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734281|NCT02238197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65734282|NCT02238197|Respiratory System Agents|respiratory system agents|mesh-ancestor
65734283|NCT02238197|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65734284|NCT02238197|Cholinergic Agents|cholinergic agents|mesh-ancestor
65734285|NCT02238197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65734286|NCT02238197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734287|NCT03592199|Sunitinib|sunitinib|mesh-list
65734288|NCT03592199|Axitinib|axitinib|mesh-list
65734289|NCT03592199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734290|NCT03592199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65734291|NCT03592199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65734292|NCT03592199|Growth Substances|growth substances|mesh-ancestor
65734293|NCT03592199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734294|NCT03592199|Growth Inhibitors|growth inhibitors|mesh-ancestor
65734295|NCT03592199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65734296|NCT03592199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734297|NCT03592199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734298|NCT02245867|Antibodies|antibodies|mesh-list
65734299|NCT02245867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65734300|NCT02245867|Immunologic Factors|immunologic factors|mesh-ancestor
65734301|NCT02245867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734302|NCT03139916|Temozolomide|temozolomide|mesh-list
65734303|NCT03139916|Bavituximab|bavituximab|mesh-list
65734304|NCT03139916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65734305|NCT03139916|Alkylating Agents|alkylating agents|mesh-ancestor
65734306|NCT03139916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734307|NCT03139916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734308|NCT03139916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65734309|NCT02507583|Insulin|insulin|mesh-list
65734310|NCT02507583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65734311|NCT02507583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734312|NCT02506023|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65734313|NCT02506023|Hemostatics|hemostatics|mesh-ancestor
65734314|NCT02506023|Coagulants|coagulants|mesh-ancestor
65734315|NCT02506023|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65734316|NCT02506023|Natriuretic Agents|natriuretic agents|mesh-ancestor
65734317|NCT02506023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734318|NCT02246179|Lidocaine|lidocaine|mesh-list
65734319|NCT02246179|Epinephrine|epinephrine|mesh-list
65734320|NCT02246179|Prilocaine|prilocaine|mesh-list
65734321|NCT02246179|Carticaine|carticaine|mesh-list
65734322|NCT02246179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65734323|NCT02246179|Anesthetics, Local|anesthetics, local|mesh-ancestor
65734324|NCT02246179|Anesthetics|anesthetics|mesh-ancestor
65734325|NCT02246179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65734326|NCT02246179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734327|NCT02246179|Sensory System Agents|sensory system agents|mesh-ancestor
65734328|NCT02246179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65734329|NCT02246179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65734330|NCT02246179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65734331|NCT02246179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65734332|NCT02246179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65734333|NCT02246179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734334|NCT02246179|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65734335|NCT02246179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65734336|NCT02246179|Adrenergic Agents|adrenergic agents|mesh-ancestor
65734337|NCT02246179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65734338|NCT02246179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65734339|NCT02246179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65734341|NCT02246179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65734342|NCT02246179|Respiratory System Agents|respiratory system agents|mesh-ancestor
65734343|NCT02246179|Mydriatics|mydriatics|mesh-ancestor
65734344|NCT02246179|Sympathomimetics|sympathomimetics|mesh-ancestor
65734345|NCT02246179|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65734346|NCT02246179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65734347|NCT02238275|Telmisartan|telmisartan|mesh-list
65734348|NCT02238275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65734349|NCT02238275|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65734350|NCT02238275|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65734351|NCT02238275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734352|NCT04495101|Protease Inhibitors|protease inhibitors|mesh-list
65734353|NCT04495101|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65734354|NCT04495101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734355|NCT04495101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734356|NCT04495101|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65734357|NCT04495101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65734358|NCT04394117|Losartan|losartan|mesh-list
65734359|NCT04394117|Valsartan|valsartan|mesh-list
65734360|NCT04394117|Telmisartan|telmisartan|mesh-list
65734361|NCT04394117|Candesartan|candesartan|mesh-list
65734362|NCT04394117|Olmesartan|olmesartan|mesh-list
65734363|NCT04394117|Irbesartan|irbesartan|mesh-list
65734364|NCT04394117|Eprosartan|eprosartan|mesh-list
65734365|NCT04394117|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65734366|NCT04394117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65734367|NCT04394117|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65734368|NCT04394117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734369|NCT04394117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65734370|NCT04394117|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
65734371|NCT02500563|Caseins|caseins|mesh-list
65734372|NCT02500563|Chelating Agents|chelating agents|mesh-ancestor
65734373|NCT02500563|Sequestering Agents|sequestering agents|mesh-ancestor
65734374|NCT02500563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734375|NCT02500329|Acarbose|acarbose|mesh-list
65734376|NCT02500329|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65734377|NCT02500329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734378|NCT02500329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734379|NCT02500329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65734380|NCT02500329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734381|NCT02243137|Aspirin|aspirin|mesh-list
65734382|NCT02243137|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
65734383|NCT02243137|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65734384|NCT02243137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65734385|NCT02243137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65734386|NCT02243137|Analgesics|analgesics|mesh-ancestor
65734387|NCT02243137|Sensory System Agents|sensory system agents|mesh-ancestor
65734388|NCT02243137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65734389|NCT02243137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734390|NCT02243137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65734391|NCT02243137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65734392|NCT02243137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65734393|NCT02243137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65734394|NCT02243137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734395|NCT02243137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65734396|NCT02243137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65050068|NCT02961660|Odalasvir|odalasvir|mesh-list
65734397|NCT02243137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734398|NCT02243137|Antipyretics|antipyretics|mesh-ancestor
65734399|NCT03343977|Docetaxel|docetaxel|mesh-list
65734400|NCT03343977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734401|NCT03343977|Tubulin Modulators|tubulin modulators|mesh-ancestor
65734402|NCT03343977|Antimitotic Agents|antimitotic agents|mesh-ancestor
65734403|NCT03343977|Mitosis Modulators|mitosis modulators|mesh-ancestor
65734404|NCT03343977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734405|NCT02850965|Adalimumab|adalimumab|mesh-list
65734406|NCT02850965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65734407|NCT02850965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65734408|NCT03571087|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65734409|NCT03571087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65734410|NCT03571087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65734411|NCT03571087|Antimetabolites|antimetabolites|mesh-ancestor
65734412|NCT03571087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734413|NCT03571087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65734414|NCT03571087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65734415|NCT03571087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734416|NCT04557644|Dermatologic Agents|dermatologic agents|mesh-list
65734417|NCT01375959|Resveratrol|resveratrol|mesh-list
65734418|NCT01375959|Antioxidants|antioxidants|mesh-ancestor
65734419|NCT01375959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734420|NCT01375959|Protective Agents|protective agents|mesh-ancestor
65734421|NCT01375959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734422|NCT01375959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734423|NCT01375959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65734424|NCT02238353|Fluticasone|fluticasone|mesh-list
65734425|NCT02238353|Azelastine|azelastine|mesh-list
65734426|NCT02238353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65734427|NCT02238353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65734428|NCT02238353|Autonomic Agents|autonomic agents|mesh-ancestor
65734429|NCT02238353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65734430|NCT02238353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734431|NCT02238353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65734432|NCT02238353|Respiratory System Agents|respiratory system agents|mesh-ancestor
65734433|NCT02238353|Dermatologic Agents|dermatologic agents|mesh-ancestor
65734434|NCT02238353|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65734435|NCT02238353|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65734436|NCT02238353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734437|NCT02238353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734438|NCT02238353|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65734439|NCT02238353|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65734440|NCT02238353|Histamine Antagonists|histamine antagonists|mesh-ancestor
65734441|NCT02238353|Histamine Agents|histamine agents|mesh-ancestor
65734442|NCT02238353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65734443|NCT04482686|Vitamin D|vitamin d|mesh-list
65734444|NCT04482686|Cholecalciferol|cholecalciferol|mesh-list
65734445|NCT04482686|Vitamins|vitamins|mesh-list
65734446|NCT04482686|Ascorbic Acid|ascorbic acid|mesh-list
65734447|NCT04482686|Zinc|zinc|mesh-list
65734448|NCT04482686|Doxycycline|doxycycline|mesh-list
65734449|NCT04482686|Ivermectin|ivermectin|mesh-list
65734450|NCT04482686|Zinc Sulfate|zinc sulfate|mesh-list
65734451|NCT04482686|Micronutrients|micronutrients|mesh-ancestor
65734452|NCT04482686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734453|NCT04482686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65734454|NCT04482686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65734455|NCT04482686|Trace Elements|trace elements|mesh-ancestor
65734456|NCT04482686|Antioxidants|antioxidants|mesh-ancestor
65734457|NCT04482686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734458|NCT04482686|Protective Agents|protective agents|mesh-ancestor
65734459|NCT04482686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65734460|NCT04482686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65734461|NCT04482686|Antimalarials|antimalarials|mesh-ancestor
65734462|NCT04482686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65734463|NCT04482686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65734464|NCT04482686|Astringents|astringents|mesh-ancestor
65734465|NCT04482686|Dermatologic Agents|dermatologic agents|mesh-ancestor
65734466|NCT03580889|Atropine|atropine|mesh-list
65734467|NCT03580889|Glycopyrrolate|glycopyrrolate|mesh-list
65734468|NCT03580889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65734469|NCT03580889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65734470|NCT03580889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65734471|NCT03580889|Autonomic Agents|autonomic agents|mesh-ancestor
65734472|NCT03580889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65734473|NCT03580889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734474|NCT03580889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65734475|NCT03580889|Respiratory System Agents|respiratory system agents|mesh-ancestor
65734476|NCT03580889|Mydriatics|mydriatics|mesh-ancestor
65734477|NCT03580889|Parasympatholytics|parasympatholytics|mesh-ancestor
65734478|NCT03580889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65734479|NCT03580889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65734480|NCT03580889|Cholinergic Agents|cholinergic agents|mesh-ancestor
65734481|NCT03580889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65734482|NCT03580889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734483|NCT02500017|Melatonin|melatonin|mesh-list
65734484|NCT02500017|Antioxidants|antioxidants|mesh-ancestor
65734485|NCT02500017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734486|NCT02500017|Protective Agents|protective agents|mesh-ancestor
65734487|NCT02500017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734488|NCT02500017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65734489|NCT02505633|Lidocaine|lidocaine|mesh-list
65734490|NCT02505633|Epinephrine|epinephrine|mesh-list
65734491|NCT02505633|Racepinephrine|racepinephrine|mesh-list
65734492|NCT02505633|Epinephryl borate|epinephryl borate|mesh-list
65734493|NCT02505633|Anesthetics, Local|anesthetics, local|mesh-ancestor
65734494|NCT02505633|Anesthetics|anesthetics|mesh-ancestor
65734495|NCT02505633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65734496|NCT02505633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734497|NCT02505633|Sensory System Agents|sensory system agents|mesh-ancestor
65734498|NCT02505633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65734499|NCT02505633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65734500|NCT02505633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65734501|NCT02505633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65734502|NCT02505633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65734503|NCT02505633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734504|NCT02505633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65734505|NCT02505633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65734506|NCT02505633|Adrenergic Agents|adrenergic agents|mesh-ancestor
65734507|NCT02505633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65734508|NCT02505633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65734509|NCT02505633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65734510|NCT02505633|Autonomic Agents|autonomic agents|mesh-ancestor
65734511|NCT02505633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65734512|NCT02505633|Respiratory System Agents|respiratory system agents|mesh-ancestor
65734513|NCT02505633|Mydriatics|mydriatics|mesh-ancestor
65734514|NCT02505633|Sympathomimetics|sympathomimetics|mesh-ancestor
65734515|NCT02505633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65734516|NCT03587441|Neostigmine|neostigmine|mesh-list
65734517|NCT03587441|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65734518|NCT03587441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734519|NCT03587441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734520|NCT03587441|Cholinergic Agents|cholinergic agents|mesh-ancestor
65734521|NCT03587441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65734522|NCT03587441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734523|NCT03587441|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65734524|NCT03587441|Autonomic Agents|autonomic agents|mesh-ancestor
65734525|NCT03587441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65734526|NCT05102396|Mandelic Acids|mandelic acids|mesh-list
65734527|NCT05102396|Oxybutynin|oxybutynin|mesh-list
65734528|NCT05102396|Parasympatholytics|parasympatholytics|mesh-ancestor
65734529|NCT05102396|Autonomic Agents|autonomic agents|mesh-ancestor
65734530|NCT05102396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65734531|NCT05102396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734532|NCT05102396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65734533|NCT05102396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65734534|NCT05102396|Cholinergic Agents|cholinergic agents|mesh-ancestor
65734535|NCT05102396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65734536|NCT05102396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734537|NCT05102396|Urological Agents|urological agents|mesh-ancestor
65734538|NCT05102396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65734539|NCT05102396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65734540|NCT05102396|Renal Agents|renal agents|mesh-ancestor
65734541|NCT01165645|Ritonavir|ritonavir|mesh-list
65734542|NCT01165645|Lopinavir|lopinavir|mesh-list
65734543|NCT01165645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65734544|NCT01165645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65734545|NCT01165645|Protease Inhibitors|protease inhibitors|mesh-ancestor
65734546|NCT01165645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734547|NCT01165645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734548|NCT01165645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65734549|NCT01165645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65734550|NCT01165645|Antiviral Agents|antiviral agents|mesh-ancestor
65734551|NCT01165645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65734552|NCT01165645|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65734553|NCT01165645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65734554|NCT03579875|Methylprednisolone|methylprednisolone|mesh-list
65734555|NCT03579875|Cyclophosphamide|cyclophosphamide|mesh-list
65734556|NCT03579875|Busulfan|busulfan|mesh-list
65734557|NCT03579875|Rituximab|rituximab|mesh-list
65734558|NCT03579875|Fludarabine|fludarabine|mesh-list
65734559|NCT03579875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65734560|NCT03579875|Immunologic Factors|immunologic factors|mesh-ancestor
65734561|NCT03579875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734562|NCT03579875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65734563|NCT03579875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65734564|NCT03579875|Alkylating Agents|alkylating agents|mesh-ancestor
65734565|NCT03579875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734566|NCT03579875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734567|NCT03579875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65734568|NCT03579875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65734569|NCT03579875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65734570|NCT03579875|Antiemetics|antiemetics|mesh-ancestor
65734571|NCT03579875|Autonomic Agents|autonomic agents|mesh-ancestor
65734572|NCT03579875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65734573|NCT03579875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65734574|NCT03579875|Glucocorticoids|glucocorticoids|mesh-ancestor
65734575|NCT03579875|Hormones|hormones|mesh-ancestor
65734576|NCT03579875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65734577|NCT03579875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65734578|NCT03579875|Protective Agents|protective agents|mesh-ancestor
65734579|NCT03569995|Cytarabine|cytarabine|mesh-list
65734580|NCT03569995|Rituximab|rituximab|mesh-list
65734581|NCT03569995|Methotrexate|methotrexate|mesh-list
65734582|NCT03569995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65734583|NCT03569995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734584|NCT03569995|Immunologic Factors|immunologic factors|mesh-ancestor
65734585|NCT03569995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734586|NCT03569995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65734587|NCT03569995|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65734588|NCT03569995|Abortifacient Agents|abortifacient agents|mesh-ancestor
65734589|NCT03569995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65734590|NCT03569995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65734591|NCT03569995|Antimetabolites|antimetabolites|mesh-ancestor
65734592|NCT03569995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734593|NCT03569995|Dermatologic Agents|dermatologic agents|mesh-ancestor
65734594|NCT03569995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734595|NCT03569995|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65734596|NCT03569995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65734597|NCT03569995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65734598|NCT03569995|Antiviral Agents|antiviral agents|mesh-ancestor
65734599|NCT03569995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65734600|NCT02238431|Leuprolide|leuprolide|mesh-list
65734601|NCT02238431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65734602|NCT02238431|Fertility Agents|fertility agents|mesh-ancestor
65734603|NCT02238431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65734604|NCT02238431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734605|NCT02238431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65734606|NCT02238431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734607|NCT05122598|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
65734608|NCT05122598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734609|NCT02238509|Trastuzumab|trastuzumab|mesh-list
65734610|NCT02238509|Lapatinib|lapatinib|mesh-list
65734611|NCT02238509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65734612|NCT02238509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734613|NCT02238509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65734614|NCT02238509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734615|NCT02238509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734616|NCT03579914|Metoprolol|metoprolol|mesh-list
65197209|NCT01163786|Bortezomib|bortezomib|mesh-list
65734617|NCT03579914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65734618|NCT03579914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65734619|NCT03579914|Sympatholytics|sympatholytics|mesh-ancestor
65734620|NCT03579914|Autonomic Agents|autonomic agents|mesh-ancestor
65734621|NCT03579914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65734622|NCT03579914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734623|NCT03579914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65734624|NCT03579914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65734625|NCT03579914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65734626|NCT03579914|Adrenergic Agents|adrenergic agents|mesh-ancestor
65734627|NCT03579914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65734628|NCT03579914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734629|NCT03573037|Anticoagulants|anticoagulants|mesh-list
65734630|NCT05354635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65734631|NCT05354635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65734632|NCT03585413|Micronutrients|micronutrients|mesh-list
65734633|NCT03585413|Trace Elements|trace elements|mesh-list
65734634|NCT03585413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734635|NCT03569683|Hyaluronic Acid|hyaluronic acid|mesh-list
65734636|NCT03569683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65734637|NCT03569683|Immunologic Factors|immunologic factors|mesh-ancestor
65734638|NCT03569683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734639|NCT03569683|Viscosupplements|viscosupplements|mesh-ancestor
65734640|NCT03569683|Protective Agents|protective agents|mesh-ancestor
65734641|NCT00708201|Alvimopan|alvimopan|mesh-list
65734642|NCT00708201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65734643|NCT03572959|Triamcinolone|triamcinolone|mesh-list
65734644|NCT03572959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65734645|NCT03572959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65734646|NCT03572959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65734647|NCT03572959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65734648|NCT03572959|Glucocorticoids|glucocorticoids|mesh-ancestor
65734649|NCT03572959|Hormones|hormones|mesh-ancestor
65734650|NCT03572959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65734651|NCT03572959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734652|NCT03572959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65734653|NCT03572959|Immunologic Factors|immunologic factors|mesh-ancestor
65734654|NCT03572959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734655|NCT03572959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734656|NCT05708755|Valganciclovir|valganciclovir|mesh-list
65734657|NCT05708755|Antiviral Agents|antiviral agents|mesh-ancestor
65734658|NCT05708755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65734659|NCT02500251|Rituximab|rituximab|mesh-list
65734660|NCT02500251|Bortezomib|bortezomib|mesh-list
65734661|NCT02500251|Belimumab|belimumab|mesh-list
65734662|NCT02500251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65734663|NCT02500251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734664|NCT02500251|Immunologic Factors|immunologic factors|mesh-ancestor
65734665|NCT02500251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734666|NCT02500251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65734667|NCT02500251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65734668|NCT03568513|Curcumin|curcumin|mesh-list
65734669|NCT03568513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65734670|NCT03568513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65734671|NCT03568513|Analgesics|analgesics|mesh-ancestor
65734672|NCT03568513|Sensory System Agents|sensory system agents|mesh-ancestor
65734673|NCT03568513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65734674|NCT03568513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734675|NCT03568513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65734676|NCT03568513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65734677|NCT03568513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734678|NCT03568513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734679|NCT03568513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734680|NCT02982668|Metoclopramide|metoclopramide|mesh-list
65734681|NCT02982668|Mosapride|mosapride|mesh-list
65734682|NCT02982668|Antiemetics|antiemetics|mesh-ancestor
65734683|NCT02982668|Autonomic Agents|autonomic agents|mesh-ancestor
65734684|NCT02982668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65734685|NCT02982668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734686|NCT02982668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65734687|NCT02982668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65734688|NCT02982668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65734689|NCT02982668|Dopamine Agents|dopamine agents|mesh-ancestor
65734690|NCT02982668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65734691|NCT02982668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734692|NCT02982668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65734693|NCT02982668|Serotonin Agents|serotonin agents|mesh-ancestor
65734694|NCT02505477|Acetylcysteine|acetylcysteine|mesh-list
65734695|NCT02505477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65734696|NCT02505477|Antiviral Agents|antiviral agents|mesh-ancestor
65734697|NCT02505477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65734698|NCT02505477|Expectorants|expectorants|mesh-ancestor
65734699|NCT02505477|Respiratory System Agents|respiratory system agents|mesh-ancestor
65734700|NCT02505477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65734701|NCT02505477|Antioxidants|antioxidants|mesh-ancestor
65734702|NCT02505477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734703|NCT02505477|Protective Agents|protective agents|mesh-ancestor
65734704|NCT02505477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734705|NCT02505477|Antidotes|antidotes|mesh-ancestor
65734706|NCT02398526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65734707|NCT02398526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734708|NCT05354479|Acetaminophen|acetaminophen|mesh-list
65734709|NCT05354479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65734710|NCT05354479|Analgesics|analgesics|mesh-ancestor
65734711|NCT05354479|Sensory System Agents|sensory system agents|mesh-ancestor
65734712|NCT05354479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65734713|NCT05354479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734714|NCT05354479|Antipyretics|antipyretics|mesh-ancestor
65734715|NCT02505399|Clopidogrel|clopidogrel|mesh-list
65734716|NCT02505399|Ticagrelor|ticagrelor|mesh-list
65734717|NCT02505399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65734718|NCT02505399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65734719|NCT02505399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65734720|NCT02505399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65734721|NCT02505399|Purinergic Agents|purinergic agents|mesh-ancestor
65734722|NCT02505399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65734723|NCT02505399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734724|NCT02505399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734725|NCT02728089|Tazobactam|tazobactam|mesh-list
65734726|NCT02728089|Ceftolozane|ceftolozane|mesh-list
65734727|NCT02728089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65734728|NCT02728089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65734729|NCT02728089|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65734730|NCT02728089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734731|NCT02728089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734732|NCT05110118|Bevacizumab|bevacizumab|mesh-list
65734733|NCT05110118|Endothelial Growth Factors|endothelial growth factors|mesh-list
65734734|NCT05110118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65734735|NCT05110118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734736|NCT05110118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65734737|NCT05110118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65734738|NCT05110118|Growth Substances|growth substances|mesh-ancestor
65734739|NCT05110118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734740|NCT05110118|Growth Inhibitors|growth inhibitors|mesh-ancestor
65734741|NCT03572647|Epoetin Alfa|epoetin alfa|mesh-list
65734742|NCT03572647|Hematinics|hematinics|mesh-ancestor
65734743|NCT02495181|Aflibercept|aflibercept|mesh-list
65734744|NCT02495181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65734745|NCT02495181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65734746|NCT02495181|Growth Substances|growth substances|mesh-ancestor
65734747|NCT02495181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734748|NCT02495181|Growth Inhibitors|growth inhibitors|mesh-ancestor
65734749|NCT02495181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734750|NCT05109650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65734751|NCT05109650|Antibodies|antibodies|mesh-list
65734752|NCT05109650|Immunoglobulins|immunoglobulins|mesh-list
65734753|NCT05109650|Immunologic Factors|immunologic factors|mesh-ancestor
65734754|NCT05109650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734755|NCT02499861|Decitabine|decitabine|mesh-list
65734756|NCT02499861|Genistein|genistein|mesh-list
65734757|NCT02499861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65734758|NCT02499861|Antimetabolites|antimetabolites|mesh-ancestor
65734759|NCT02499861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734760|NCT02499861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734761|NCT02499861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734762|NCT02499861|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65734763|NCT02499861|Protective Agents|protective agents|mesh-ancestor
65734764|NCT02499861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734765|NCT02499861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65734766|NCT02499861|Phytoestrogens|phytoestrogens|mesh-ancestor
65734767|NCT02499861|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65734768|NCT02499861|Estrogens|estrogens|mesh-ancestor
65734769|NCT02499861|Hormones|hormones|mesh-ancestor
65734770|NCT02499861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65734771|NCT05505435|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65734772|NCT05505435|Medroxyprogesterone|medroxyprogesterone|mesh-list
65734773|NCT05505435|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65734774|NCT05505435|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65734775|NCT05505435|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65734776|NCT05505435|Contraceptive Agents|contraceptive agents|mesh-ancestor
65734777|NCT05505435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65734778|NCT05505435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734779|NCT05505435|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65734780|NCT05505435|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65734781|NCT05505435|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65734782|NCT05505435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65734783|NCT05505435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734784|NCT02840461|Ivermectin|ivermectin|mesh-list
65734785|NCT02840461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65734786|NCT02840461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65734787|NCT05108714|Lidocaine|lidocaine|mesh-list
65734788|NCT05108714|Anesthetics, Local|anesthetics, local|mesh-ancestor
65734789|NCT05108714|Anesthetics|anesthetics|mesh-ancestor
65734790|NCT05108714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65734791|NCT05108714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734792|NCT05108714|Sensory System Agents|sensory system agents|mesh-ancestor
65734793|NCT05108714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65734794|NCT05108714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65734795|NCT05108714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65734796|NCT05108714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65734797|NCT05108714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65734798|NCT05108714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734799|NCT02495415|Fenretinide|fenretinide|mesh-list
65734800|NCT02495415|Retinamide|retinamide|mesh-list
65734801|NCT02495415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734802|NCT02495415|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65734803|NCT02495415|Protective Agents|protective agents|mesh-ancestor
65734804|NCT02495415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734805|NCT02505009|Tenofovir|tenofovir|mesh-list
65734806|NCT02505009|Entecavir|entecavir|mesh-list
65734807|NCT02505009|Antiviral Agents|antiviral agents|mesh-ancestor
65734808|NCT02505009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65734809|NCT02505009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65734810|NCT02505009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65734811|NCT02505009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734812|NCT02505009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734813|NCT02505009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65734814|NCT02505009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65734815|NCT05353543|Antidepressive Agents|antidepressive agents|mesh-list
65734816|NCT05353543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65734817|NCT02499627|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65734818|NCT02499627|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65734819|NCT02499627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65734820|NCT02499627|Alkylating Agents|alkylating agents|mesh-ancestor
65734821|NCT02499627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734822|NCT02499627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734823|NCT02499627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65734824|NCT03567655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65734825|NCT03567655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65734826|NCT03567655|Contraceptive Agents|contraceptive agents|mesh-ancestor
65734827|NCT03567655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65734828|NCT03567655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734829|NCT03567655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65734830|NCT03567655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65734831|NCT03567655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65734832|NCT03567655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734833|NCT02505087|Acetylcysteine|acetylcysteine|mesh-list
65734834|NCT02505087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65734835|NCT02505087|Antiviral Agents|antiviral agents|mesh-ancestor
65734836|NCT02505087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65734837|NCT02505087|Expectorants|expectorants|mesh-ancestor
65734838|NCT02505087|Respiratory System Agents|respiratory system agents|mesh-ancestor
65734839|NCT02505087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65734840|NCT02505087|Antioxidants|antioxidants|mesh-ancestor
65197429|NCT02610829|Vitamin E|vitamin e|mesh-list
65734841|NCT02505087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734842|NCT02505087|Protective Agents|protective agents|mesh-ancestor
65734843|NCT02505087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734844|NCT02505087|Antidotes|antidotes|mesh-ancestor
65734845|NCT02839681|Maytansine|maytansine|mesh-list
65734846|NCT02839681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65734847|NCT02839681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734848|NCT02839681|Tubulin Modulators|tubulin modulators|mesh-ancestor
65734849|NCT02839681|Antimitotic Agents|antimitotic agents|mesh-ancestor
65734850|NCT02839681|Mitosis Modulators|mitosis modulators|mesh-ancestor
65734851|NCT02839681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734852|NCT02504463|Naltrexone|naltrexone|mesh-list
65050596|NCT04590196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65734853|NCT02504463|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65734854|NCT02504463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65734855|NCT02504463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734856|NCT02504463|Sensory System Agents|sensory system agents|mesh-ancestor
65734857|NCT02504463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65734858|NCT03566329|Lidocaine|lidocaine|mesh-list
65734859|NCT03566329|Magnesium Sulfate|magnesium sulfate|mesh-list
65734860|NCT03566329|Anesthetics, Local|anesthetics, local|mesh-ancestor
65734861|NCT03566329|Anesthetics|anesthetics|mesh-ancestor
65734862|NCT03566329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65734863|NCT03566329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734864|NCT03566329|Sensory System Agents|sensory system agents|mesh-ancestor
65734865|NCT03566329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65734866|NCT03566329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65734867|NCT03566329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65734868|NCT03566329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65734869|NCT03566329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65734870|NCT03566329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734871|NCT03566329|Analgesics|analgesics|mesh-ancestor
65734872|NCT03566329|Anticonvulsants|anticonvulsants|mesh-ancestor
65734873|NCT03566329|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65734874|NCT03566329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65734875|NCT03566329|Tocolytic Agents|tocolytic agents|mesh-ancestor
65734876|NCT03566329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65734877|NCT02499237|Zoledronic Acid|zoledronic acid|mesh-list
65734878|NCT02499237|Denosumab|denosumab|mesh-list
65734879|NCT02499237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65734880|NCT02499237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734881|NCT02499393|Magnesium Sulfate|magnesium sulfate|mesh-list
65734882|NCT02499393|Analgesics|analgesics|mesh-ancestor
65734883|NCT02499393|Sensory System Agents|sensory system agents|mesh-ancestor
65734884|NCT02499393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65734885|NCT02499393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734886|NCT02499393|Anesthetics|anesthetics|mesh-ancestor
65734887|NCT02499393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65734888|NCT02499393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65734889|NCT02499393|Anticonvulsants|anticonvulsants|mesh-ancestor
65734890|NCT02499393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65734891|NCT02499393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65734892|NCT02499393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734893|NCT02499393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65734894|NCT02499393|Tocolytic Agents|tocolytic agents|mesh-ancestor
65734895|NCT02499393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65734896|NCT02504307|Sirolimus|sirolimus|mesh-list
65734897|NCT02504307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65734898|NCT02504307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65734899|NCT02504307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65734900|NCT02504307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734901|NCT02504307|Antifungal Agents|antifungal agents|mesh-ancestor
65734902|NCT02504307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65734903|NCT02504307|Immunologic Factors|immunologic factors|mesh-ancestor
65734904|NCT02504307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734905|NCT02504229|Oxaliplatin|oxaliplatin|mesh-list
65734906|NCT02504229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734907|NCT03567343|Melatonin|melatonin|mesh-list
65734908|NCT03567343|Antioxidants|antioxidants|mesh-ancestor
65734909|NCT03567343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734910|NCT03567343|Protective Agents|protective agents|mesh-ancestor
65734911|NCT03567343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734912|NCT03567343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65734913|NCT04595864|Leucovorin|leucovorin|mesh-list
65734914|NCT04595864|Oxaliplatin|oxaliplatin|mesh-list
65734915|NCT04595864|Calcium|calcium|mesh-list
65734916|NCT04595864|Levoleucovorin|levoleucovorin|mesh-list
65734917|NCT04595864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65734918|NCT04595864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734919|NCT04595864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734920|NCT04595864|Antidotes|antidotes|mesh-ancestor
65734921|NCT04595864|Protective Agents|protective agents|mesh-ancestor
65734922|NCT04595864|Vitamin B Complex|vitamin b complex|mesh-ancestor
65734923|NCT04595864|Vitamins|vitamins|mesh-ancestor
65734924|NCT04595864|Micronutrients|micronutrients|mesh-ancestor
65734925|NCT04583462|Metformin|metformin|mesh-list
65734926|NCT04583462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65734927|NCT04583462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734928|NCT04456322|Cisplatin|cisplatin|mesh-list
65734929|NCT04456322|Nimotuzumab|nimotuzumab|mesh-list
65734930|NCT04456322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734931|NCT04456322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65734932|NCT02503761|Meropenem|meropenem|mesh-list
65734933|NCT02503761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65734934|NCT02503761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65734935|NCT04305548|Trabectedin|trabectedin|mesh-list
65734936|NCT04305548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65734937|NCT04305548|Alkylating Agents|alkylating agents|mesh-ancestor
65734938|NCT04305548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734939|NCT04305548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734940|NCT04097912|Aspirin|aspirin|mesh-list
65734941|NCT04097912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65734942|NCT04097912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65734943|NCT04097912|Analgesics|analgesics|mesh-ancestor
65734944|NCT04097912|Sensory System Agents|sensory system agents|mesh-ancestor
65734945|NCT04097912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65734946|NCT04097912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734947|NCT04097912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65734948|NCT04097912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65734949|NCT04097912|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65734950|NCT04097912|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65734951|NCT04097912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734952|NCT04097912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65734953|NCT04097912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65734954|NCT04097912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65734955|NCT04097912|Antipyretics|antipyretics|mesh-ancestor
65734956|NCT04966676|Nivolumab|nivolumab|mesh-list
65734957|NCT04966676|Ipilimumab|ipilimumab|mesh-list
65734958|NCT04966676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65734959|NCT04966676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65734960|NCT04966676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65734961|NCT04966676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734962|NCT03340779|Dobutamine|dobutamine|mesh-list
65734963|NCT03340779|Norepinephrine|norepinephrine|mesh-list
65734964|NCT03340779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65734965|NCT03340779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65734966|NCT03340779|Adrenergic Agents|adrenergic agents|mesh-ancestor
65734967|NCT03340779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65734968|NCT03340779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734969|NCT03340779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734970|NCT03340779|Sympathomimetics|sympathomimetics|mesh-ancestor
65734971|NCT03340779|Autonomic Agents|autonomic agents|mesh-ancestor
65734972|NCT03340779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65734973|NCT03340779|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65734974|NCT03340779|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65734975|NCT03340779|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65734976|NCT03340779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65734977|NCT03340779|Protective Agents|protective agents|mesh-ancestor
65734978|NCT04040738|Anesthetics|anesthetics|mesh-list
65734979|NCT04040738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65734980|NCT04040738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734981|NCT05104424|Insulin Aspart|insulin aspart|mesh-list
65734982|NCT05104424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65734983|NCT05104424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734984|NCT05087732|Lidocaine|lidocaine|mesh-list
65734985|NCT05087732|Anesthetics, Local|anesthetics, local|mesh-ancestor
65734986|NCT05087732|Anesthetics|anesthetics|mesh-ancestor
65734987|NCT05087732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65734988|NCT05087732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65734989|NCT05087732|Sensory System Agents|sensory system agents|mesh-ancestor
65734990|NCT05087732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65734991|NCT05087732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65734992|NCT05087732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65734993|NCT05087732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65734994|NCT05087732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65734995|NCT05087732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65734996|NCT03340701|Progesterone|progesterone|mesh-list
65734997|NCT03340701|Progestins|progestins|mesh-ancestor
65734998|NCT03340701|Hormones|hormones|mesh-ancestor
65734999|NCT03340701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65735000|NCT03340701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735001|NCT02498535|Nitric Oxide|nitric oxide|mesh-list
65050670|NCT00567814|Metyrapone|metyrapone|mesh-list
65735002|NCT02498535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65735003|NCT02498535|Autonomic Agents|autonomic agents|mesh-ancestor
65735004|NCT02498535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735005|NCT02498535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735006|NCT02498535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65735007|NCT02498535|Respiratory System Agents|respiratory system agents|mesh-ancestor
65735008|NCT02498535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65735009|NCT02498535|Antioxidants|antioxidants|mesh-ancestor
65735010|NCT02498535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735011|NCT02498535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65735012|NCT02498535|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65735013|NCT02498535|Vasodilator Agents|vasodilator agents|mesh-ancestor
65735014|NCT02498535|Gasotransmitters|gasotransmitters|mesh-ancestor
65735015|NCT02498535|Protective Agents|protective agents|mesh-ancestor
65735016|NCT04727138|Midazolam|midazolam|mesh-list
65735017|NCT04727138|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65735018|NCT04727138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65735019|NCT04727138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65735020|NCT04727138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735021|NCT04727138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65735022|NCT04727138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65735023|NCT04727138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65735024|NCT04727138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65735025|NCT04727138|Anesthetics, General|anesthetics, general|mesh-ancestor
65735026|NCT04727138|Anesthetics|anesthetics|mesh-ancestor
65735027|NCT04727138|GABA Modulators|gaba modulators|mesh-ancestor
65735028|NCT04727138|GABA Agents|gaba agents|mesh-ancestor
65735029|NCT04727138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65735030|NCT04727138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735031|NCT02498457|Calcium|calcium|mesh-list
65735032|NCT02498457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65735033|NCT02498457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735034|NCT02498301|Rifaximin|rifaximin|mesh-list
65735035|NCT02498301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65735036|NCT02498301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65735037|NCT02498301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65735038|NCT03343665|Nivolumab|nivolumab|mesh-list
65735039|NCT03343665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65735040|NCT03343665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735041|NCT03343665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65735042|NCT03343665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735043|NCT02733614|SRX246|srx246|mesh-list
65735044|NCT02733614|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65735045|NCT02733614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735046|NCT02733614|Natriuretic Agents|natriuretic agents|mesh-ancestor
65735047|NCT02733614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735048|NCT04674254|Bevacizumab|bevacizumab|mesh-list
65735049|NCT04674254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65735050|NCT04674254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735051|NCT04674254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65735052|NCT04674254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65735053|NCT04674254|Growth Substances|growth substances|mesh-ancestor
65735054|NCT04674254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735055|NCT04674254|Growth Inhibitors|growth inhibitors|mesh-ancestor
65735056|NCT03342807|Insulin|insulin|mesh-list
65735057|NCT03342807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65735058|NCT03342807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735059|NCT02570672|Metformin|metformin|mesh-list
65735060|NCT02570672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65735061|NCT02570672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735062|NCT03339921|Botulinum Toxins|botulinum toxins|mesh-list
65735063|NCT03339921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65735064|NCT03339921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65735065|NCT03339921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735066|NCT03339921|Cholinergic Agents|cholinergic agents|mesh-ancestor
65735067|NCT03339921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65735068|NCT03339921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735069|NCT04593914|Protective Agents|protective agents|mesh-list
65735070|NCT04593914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735071|NCT04523090|Nitazoxanide|nitazoxanide|mesh-list
65735072|NCT04523090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65735073|NCT04523090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65735074|NCT03342651|Vitamin D|vitamin d|mesh-list
65735075|NCT03342651|Vitamins|vitamins|mesh-ancestor
65735076|NCT03342651|Micronutrients|micronutrients|mesh-ancestor
65735077|NCT03342651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735078|NCT03342651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65735079|NCT04819568|Terlipressin|terlipressin|mesh-list
65735080|NCT04819568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65735081|NCT04819568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65735082|NCT02502981|Chlorthalidone|chlorthalidone|mesh-list
65735083|NCT02502981|Spironolactone|spironolactone|mesh-list
65735084|NCT02502981|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
65735085|NCT02502981|Diuretics|diuretics|mesh-list
65735086|NCT02502981|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
65735087|NCT02502981|Mineralocorticoids|mineralocorticoids|mesh-list
65735088|NCT02502981|Hormone Antagonists|hormone antagonists|mesh-ancestor
65735089|NCT02502981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65735090|NCT02502981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735091|NCT02502981|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65735092|NCT02502981|Natriuretic Agents|natriuretic agents|mesh-ancestor
65735093|NCT02502981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65735094|NCT02502981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65735095|NCT02502981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735096|NCT02502981|Hormones|hormones|mesh-ancestor
65735097|NCT04230746|Trimethoprim|trimethoprim|mesh-list
65735098|NCT04230746|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65735099|NCT04230746|Sulfamethoxazole|sulfamethoxazole|mesh-list
65735100|NCT04230746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65735101|NCT04230746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65735102|NCT04230746|Renal Agents|renal agents|mesh-ancestor
65735103|NCT04230746|Antimalarials|antimalarials|mesh-ancestor
65735104|NCT04230746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65735105|NCT04230746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65735106|NCT04230746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65735107|NCT04230746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65735108|NCT04230746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735109|NCT04230746|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65735110|NCT04230746|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65735111|NCT04230746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65735112|NCT04230746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65735113|NCT04633772|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
65735114|NCT04633772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65735115|NCT04633772|Vasodilator Agents|vasodilator agents|mesh-ancestor
65735116|NCT05111444|Paclitaxel|paclitaxel|mesh-list
65735117|NCT05111444|Capecitabine|capecitabine|mesh-list
65735118|NCT05111444|Oxaliplatin|oxaliplatin|mesh-list
65735119|NCT05111444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65735120|NCT05111444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735121|NCT05111444|Tubulin Modulators|tubulin modulators|mesh-ancestor
65735122|NCT05111444|Antimitotic Agents|antimitotic agents|mesh-ancestor
65735123|NCT05111444|Mitosis Modulators|mitosis modulators|mesh-ancestor
65735124|NCT05111444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735125|NCT05111444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65735126|NCT05111444|Antimetabolites|antimetabolites|mesh-ancestor
65735127|NCT03769688|Metronidazole|metronidazole|mesh-list
65735128|NCT03769688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65735129|NCT03769688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65735130|NCT03769688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65735131|NCT03769688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65735132|NCT02502825|Methacholine Chloride|methacholine chloride|mesh-list
65735133|NCT02502825|Miotics|miotics|mesh-ancestor
65735134|NCT02502825|Autonomic Agents|autonomic agents|mesh-ancestor
65735135|NCT02502825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735136|NCT02502825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735137|NCT02502825|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65735138|NCT02502825|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
65735139|NCT02502825|Respiratory System Agents|respiratory system agents|mesh-ancestor
65735140|NCT02502825|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65735141|NCT02502825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65735142|NCT02502825|Cholinergic Agents|cholinergic agents|mesh-ancestor
65735143|NCT02502825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65735144|NCT02502825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735145|NCT02498145|Nicotine|nicotine|mesh-list
65735146|NCT02498145|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65735147|NCT02498145|Autonomic Agents|autonomic agents|mesh-ancestor
65735148|NCT02498145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735149|NCT02498145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735150|NCT02498145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65735151|NCT02498145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65735152|NCT02498145|Cholinergic Agents|cholinergic agents|mesh-ancestor
65735153|NCT02498145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65735154|NCT02498145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735155|NCT02497911|Bupivacaine|bupivacaine|mesh-list
65735156|NCT02497911|Anesthetics, Local|anesthetics, local|mesh-ancestor
65735157|NCT02497911|Anesthetics|anesthetics|mesh-ancestor
65735158|NCT02497911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65735159|NCT02497911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735160|NCT02497911|Sensory System Agents|sensory system agents|mesh-ancestor
65735161|NCT02497911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735162|NCT02497833|Tretinoin|tretinoin|mesh-list
65735163|NCT02497833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735164|NCT02497833|Keratolytic Agents|keratolytic agents|mesh-ancestor
65735165|NCT02497833|Dermatologic Agents|dermatologic agents|mesh-ancestor
65735166|NCT02493933|Acetylcysteine|acetylcysteine|mesh-list
65735167|NCT02493933|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65735168|NCT02493933|Phytoestrogens|phytoestrogens|mesh-list
65735169|NCT02493933|Antiviral Agents|antiviral agents|mesh-ancestor
65735170|NCT02493933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65735171|NCT02493933|Expectorants|expectorants|mesh-ancestor
65735172|NCT02493933|Respiratory System Agents|respiratory system agents|mesh-ancestor
65735173|NCT02493933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65735174|NCT02493933|Antioxidants|antioxidants|mesh-ancestor
65735175|NCT02493933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735176|NCT02493933|Protective Agents|protective agents|mesh-ancestor
65735177|NCT02493933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735178|NCT02493933|Antidotes|antidotes|mesh-ancestor
65735179|NCT02493933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65735180|NCT02493933|Estrogens|estrogens|mesh-ancestor
65735181|NCT02493933|Hormones|hormones|mesh-ancestor
65735182|NCT02493933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65735183|NCT04153604|Doxycycline|doxycycline|mesh-list
65735184|NCT04153604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65735185|NCT04153604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65735186|NCT04153604|Antimalarials|antimalarials|mesh-ancestor
65735187|NCT04153604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65735188|NCT04153604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65735189|NCT03338205|Ketamine|ketamine|mesh-list
65735190|NCT03338205|Analgesics|analgesics|mesh-ancestor
65735191|NCT03338205|Sensory System Agents|sensory system agents|mesh-ancestor
65735192|NCT03338205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735193|NCT03338205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735194|NCT03338205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65735195|NCT03338205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65735196|NCT03338205|Anesthetics, General|anesthetics, general|mesh-ancestor
65735197|NCT03338205|Anesthetics|anesthetics|mesh-ancestor
65735198|NCT03338205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65735199|NCT03338205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65735200|NCT03338205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65735201|NCT03338205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65735202|NCT03338205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735203|NCT04314050|Dexmedetomidine|dexmedetomidine|mesh-list
65735204|NCT04314050|Tramadol|tramadol|mesh-list
65735205|NCT04314050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65735206|NCT04314050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65735207|NCT04314050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735208|NCT04314050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65735209|NCT04314050|Analgesics|analgesics|mesh-ancestor
65735210|NCT04314050|Sensory System Agents|sensory system agents|mesh-ancestor
65735211|NCT04314050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735212|NCT04314050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65735213|NCT04314050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65735214|NCT04314050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65735215|NCT04314050|Adrenergic Agents|adrenergic agents|mesh-ancestor
65735216|NCT04314050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65735217|NCT04314050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735218|NCT04314050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65735219|NCT04314050|Narcotics|narcotics|mesh-ancestor
65735220|NCT03343509|Metronidazole|metronidazole|mesh-list
65735221|NCT03343509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65735222|NCT03343509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65735223|NCT03343509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65735224|NCT03343509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65735225|NCT04516148|Clindamycin|clindamycin|mesh-list
65735226|NCT04516148|Clindamycin palmitate|clindamycin palmitate|mesh-list
65735227|NCT04516148|Clindamycin phosphate|clindamycin phosphate|mesh-list
65735228|NCT04516148|Cefazolin|cefazolin|mesh-list
65735229|NCT04516148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65735230|NCT04516148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65735231|NCT04516148|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65735232|NCT04516148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65735233|NCT04516148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735234|NCT02497365|Cefazolin|cefazolin|mesh-list
65735235|NCT02497365|Tobramycin|tobramycin|mesh-list
65735236|NCT02497365|Besifloxacin|besifloxacin|mesh-list
65735237|NCT02497365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65735238|NCT02497365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65735239|NCT02497365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65735240|NCT02497365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65735241|NCT02497365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65735242|NCT02497365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735243|NCT02497365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735244|NCT02497053|Pemetrexed|pemetrexed|mesh-list
65735245|NCT02497053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735246|NCT02497053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65735247|NCT02497053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735248|NCT02497053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65735249|NCT02497053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65735250|NCT03120975|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65735251|NCT03120975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65735252|NCT03337581|Dexmedetomidine|dexmedetomidine|mesh-list
65735253|NCT03337581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65735254|NCT03337581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65735255|NCT03337581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735256|NCT03337581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65735257|NCT03337581|Analgesics|analgesics|mesh-ancestor
65735258|NCT03337581|Sensory System Agents|sensory system agents|mesh-ancestor
65735259|NCT03337581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735260|NCT03337581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65735261|NCT03337581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65735262|NCT03337581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65735263|NCT03337581|Adrenergic Agents|adrenergic agents|mesh-ancestor
65735264|NCT03337581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65735265|NCT03337581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735266|NCT02496975|Cyclosporine|cyclosporine|mesh-list
65735267|NCT02496975|Cyclosporins|cyclosporins|mesh-list
65735268|NCT02496975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65735269|NCT02496975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735270|NCT02496975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65735271|NCT02496975|Immunologic Factors|immunologic factors|mesh-ancestor
65735272|NCT02496975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735273|NCT02496975|Antifungal Agents|antifungal agents|mesh-ancestor
65735274|NCT02496975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65735275|NCT02496975|Dermatologic Agents|dermatologic agents|mesh-ancestor
65735276|NCT02496975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65735277|NCT02496975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65735278|NCT03337503|Dronabinol|dronabinol|mesh-list
65735279|NCT03337503|Hallucinogens|hallucinogens|mesh-ancestor
65735280|NCT03337503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735281|NCT03337503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65735282|NCT03337503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65735283|NCT03337503|Analgesics|analgesics|mesh-ancestor
65735284|NCT03337503|Sensory System Agents|sensory system agents|mesh-ancestor
65735285|NCT03337503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735286|NCT03337503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65735287|NCT03337503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65735288|NCT03337503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65735289|NCT03337503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735290|NCT03337503|Hormones|hormones|mesh-ancestor
65735291|NCT03337503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65735292|NCT01675622|Morphine|morphine|mesh-list
65735293|NCT01675622|Oxycodone|oxycodone|mesh-list
65735294|NCT01675622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65735295|NCT01675622|Narcotics|narcotics|mesh-ancestor
65735296|NCT01675622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65735297|NCT01675622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735298|NCT01675622|Analgesics|analgesics|mesh-ancestor
65735299|NCT01675622|Sensory System Agents|sensory system agents|mesh-ancestor
65735300|NCT01675622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735301|NCT02496741|Metformin|metformin|mesh-list
65735302|NCT02496741|Chloroquine|chloroquine|mesh-list
65735303|NCT02496741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65735304|NCT02496741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735306|NCT02496741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65735307|NCT02496741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65735308|NCT02496741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65735309|NCT02496741|Antimalarials|antimalarials|mesh-ancestor
65735310|NCT02496741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65735311|NCT04496037|Rituximab|rituximab|mesh-list
65735312|NCT04496037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65735313|NCT04496037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735314|NCT04496037|Immunologic Factors|immunologic factors|mesh-ancestor
65735315|NCT04496037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735316|NCT04496037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65735317|NCT04169828|Leucovorin|leucovorin|mesh-list
65735318|NCT04169828|Folic Acid|folic acid|mesh-list
65735319|NCT04169828|Methotrexate|methotrexate|mesh-list
65735320|NCT04169828|Ondansetron|ondansetron|mesh-list
65735321|NCT04169828|Levoleucovorin|levoleucovorin|mesh-list
65735322|NCT04169828|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65735323|NCT04169828|Abortifacient Agents|abortifacient agents|mesh-ancestor
65735324|NCT04169828|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65735325|NCT04169828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735326|NCT04169828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65735327|NCT04169828|Antimetabolites|antimetabolites|mesh-ancestor
65735328|NCT04169828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735329|NCT04169828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735330|NCT04169828|Dermatologic Agents|dermatologic agents|mesh-ancestor
65735331|NCT04169828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65735332|NCT04169828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65735333|NCT04169828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65735334|NCT04169828|Immunologic Factors|immunologic factors|mesh-ancestor
65735335|NCT04169828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65735336|NCT04169828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65735337|NCT04169828|Antidotes|antidotes|mesh-ancestor
65735338|NCT04169828|Protective Agents|protective agents|mesh-ancestor
65735339|NCT04169828|Vitamin B Complex|vitamin b complex|mesh-ancestor
65735340|NCT04169828|Vitamins|vitamins|mesh-ancestor
65735341|NCT04169828|Micronutrients|micronutrients|mesh-ancestor
65735342|NCT04169828|Antiemetics|antiemetics|mesh-ancestor
65735343|NCT04169828|Autonomic Agents|autonomic agents|mesh-ancestor
65735344|NCT04169828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735345|NCT04169828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65735346|NCT04169828|Antipruritics|antipruritics|mesh-ancestor
65735347|NCT04169828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65735348|NCT04169828|Serotonin Agents|serotonin agents|mesh-ancestor
65735349|NCT04169828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65735350|NCT04169828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65735351|NCT04169828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65735352|NCT04169828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65735353|NCT04169828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65735354|NCT04169828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65735355|NCT04169828|Hematinics|hematinics|mesh-ancestor
65735356|NCT04495881|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65735357|NCT04495881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65735358|NCT04495881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735359|NCT04495881|Incretins|incretins|mesh-ancestor
65735360|NCT04495881|Hormones|hormones|mesh-ancestor
65735361|NCT04495881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65735362|NCT04495881|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65735363|NCT04495881|Protease Inhibitors|protease inhibitors|mesh-ancestor
65735364|NCT04495881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65735365|NCT04495881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735366|NCT02493465|Everolimus|everolimus|mesh-list
65735367|NCT02493465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735368|NCT02493465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65735369|NCT02493465|Immunologic Factors|immunologic factors|mesh-ancestor
65735370|NCT02493465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735371|NCT03342261|Antiviral Agents|antiviral agents|mesh-list
65735372|NCT03342261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65735373|NCT04495569|Antibodies|antibodies|mesh-list
65735374|NCT04495569|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65735375|NCT04495569|Immunologic Factors|immunologic factors|mesh-ancestor
65735376|NCT04495569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735377|NCT03337191|Morphine|morphine|mesh-list
65735378|NCT03337191|Levobupivacaine|levobupivacaine|mesh-list
65735379|NCT03337191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65735380|NCT03337191|Narcotics|narcotics|mesh-ancestor
65735381|NCT03337191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65735382|NCT03337191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735383|NCT03337191|Analgesics|analgesics|mesh-ancestor
65735384|NCT03337191|Sensory System Agents|sensory system agents|mesh-ancestor
65735385|NCT03337191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735386|NCT03337191|Anesthetics, Local|anesthetics, local|mesh-ancestor
65735387|NCT03337191|Anesthetics|anesthetics|mesh-ancestor
65735388|NCT04494243|Rabeprazole|rabeprazole|mesh-list
65735389|NCT04494243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65735390|NCT04494243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65735391|NCT04494243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65735392|NCT04494243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65735393|NCT04494243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735394|NCT03337035|Oxytocin|oxytocin|mesh-list
65735395|NCT03337035|Oxytocics|oxytocics|mesh-ancestor
65735396|NCT03337035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65735397|NCT03337035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735398|NCT03330717|Anesthetics|anesthetics|mesh-list
65735399|NCT03330717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65735400|NCT03330717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735401|NCT02655224|Relugolix|relugolix|mesh-list
65735402|NCT02655224|Androgen Antagonists|androgen antagonists|mesh-ancestor
65735403|NCT02655224|Hormone Antagonists|hormone antagonists|mesh-ancestor
65735404|NCT02655224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65735405|NCT02655224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735406|NCT04494321|Budesonide|budesonide|mesh-list
65735407|NCT04494321|Formoterol Fumarate|formoterol fumarate|mesh-list
65735408|NCT04494321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65735409|NCT04494321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65735410|NCT04494321|Autonomic Agents|autonomic agents|mesh-ancestor
65735411|NCT04494321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735412|NCT04494321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735413|NCT04494321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65735414|NCT04494321|Respiratory System Agents|respiratory system agents|mesh-ancestor
65735415|NCT04494321|Glucocorticoids|glucocorticoids|mesh-ancestor
65735416|NCT04494321|Hormones|hormones|mesh-ancestor
65735417|NCT04494321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65735418|NCT04494321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65735419|NCT04494321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65735420|NCT04494321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65735421|NCT04494321|Adrenergic Agents|adrenergic agents|mesh-ancestor
65735422|NCT04494321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65735423|NCT04494321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735424|NCT03330171|Vaccines|vaccines|mesh-list
65735425|NCT03330171|Immunologic Factors|immunologic factors|mesh-ancestor
65735426|NCT03330171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735427|NCT05118542|Methimazole|methimazole|mesh-list
65735428|NCT05118542|Propylthiouracil|propylthiouracil|mesh-list
65735429|NCT05118542|Antithyroid Agents|antithyroid agents|mesh-ancestor
65735430|NCT05118542|Hormone Antagonists|hormone antagonists|mesh-ancestor
65735431|NCT05118542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65735432|NCT05118542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735433|NCT05118542|Antimetabolites|antimetabolites|mesh-ancestor
65735434|NCT05118542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735435|NCT03336801|Propofol|propofol|mesh-list
65735436|NCT03336801|Sevoflurane|sevoflurane|mesh-list
65735437|NCT03336801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65735438|NCT03336801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65735439|NCT03336801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735440|NCT03336801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65735441|NCT03336801|Anesthetics, General|anesthetics, general|mesh-ancestor
65735442|NCT03336801|Anesthetics|anesthetics|mesh-ancestor
65735443|NCT03336801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65735444|NCT03336801|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65735445|NCT05115578|Midazolam|midazolam|mesh-list
65735446|NCT05115578|Remifentanil|remifentanil|mesh-list
65735447|NCT05115578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65735448|NCT05115578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65735449|NCT05115578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65735450|NCT05115578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735451|NCT05115578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65735452|NCT05115578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65735453|NCT05115578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65735454|NCT05115578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65735455|NCT05115578|Anesthetics, General|anesthetics, general|mesh-ancestor
65051137|NCT00223691|Mydriatics|mydriatics|mesh-ancestor
65735456|NCT05115578|Anesthetics|anesthetics|mesh-ancestor
65735457|NCT05115578|GABA Modulators|gaba modulators|mesh-ancestor
65735458|NCT05115578|GABA Agents|gaba agents|mesh-ancestor
65735459|NCT05115578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65735460|NCT05115578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735461|NCT05115578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65735462|NCT05115578|Narcotics|narcotics|mesh-ancestor
65735463|NCT05115578|Analgesics|analgesics|mesh-ancestor
65735464|NCT05115578|Sensory System Agents|sensory system agents|mesh-ancestor
65735465|NCT05115578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735466|NCT02636036|Nivolumab|nivolumab|mesh-list
65735467|NCT02636036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65735468|NCT02636036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735469|NCT02636036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65735470|NCT02636036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735471|NCT03329781|Curcumin|curcumin|mesh-list
65735472|NCT03329781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65735473|NCT03329781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65735474|NCT03329781|Analgesics|analgesics|mesh-ancestor
65735475|NCT03329781|Sensory System Agents|sensory system agents|mesh-ancestor
65735476|NCT03329781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735477|NCT03329781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735478|NCT03329781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65735479|NCT03329781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65735480|NCT03329781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735481|NCT03329781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65735482|NCT03329781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735483|NCT02437604|Fluticasone|fluticasone|mesh-list
65735484|NCT02437604|Xhance|xhance|mesh-list
65735485|NCT02437604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65735486|NCT02437604|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65735487|NCT02437604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65735488|NCT02437604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65735489|NCT02437604|Autonomic Agents|autonomic agents|mesh-ancestor
65735490|NCT02437604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735491|NCT02437604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735492|NCT02437604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65735493|NCT02437604|Respiratory System Agents|respiratory system agents|mesh-ancestor
65735494|NCT02437604|Dermatologic Agents|dermatologic agents|mesh-ancestor
65735495|NCT02437604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65735496|NCT02437604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65735497|NCT02437604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65735498|NCT02437604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65735499|NCT02437604|Adrenergic Agents|adrenergic agents|mesh-ancestor
65735500|NCT02437604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65735501|NCT02437604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735502|NCT02437604|Glucocorticoids|glucocorticoids|mesh-ancestor
65735503|NCT02437604|Hormones|hormones|mesh-ancestor
65735504|NCT02437604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65735505|NCT02437604|Sympathomimetics|sympathomimetics|mesh-ancestor
65735506|NCT03329547|Cefixime|cefixime|mesh-list
65735507|NCT03329547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65735508|NCT03329547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65735509|NCT05463627|Metformin|metformin|mesh-list
65735510|NCT05463627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65735511|NCT05463627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735512|NCT01975298|Interferons|interferons|mesh-list
65735513|NCT01975298|Interferon beta-1a|interferon beta-1a|mesh-list
65735514|NCT01975298|Interferon-beta|interferon-beta|mesh-list
65735515|NCT01975298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735516|NCT01975298|Antiviral Agents|antiviral agents|mesh-ancestor
65735517|NCT01975298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65735518|NCT01975298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65735519|NCT01975298|Immunologic Factors|immunologic factors|mesh-ancestor
65735520|NCT01975298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735521|NCT03324867|Insulin|insulin|mesh-list
65735522|NCT03324867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65735523|NCT03324867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65735524|NCT03324867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735525|NCT05084534|Midodrine|midodrine|mesh-list
65735526|NCT05084534|Sympathomimetics|sympathomimetics|mesh-ancestor
65735527|NCT05084534|Autonomic Agents|autonomic agents|mesh-ancestor
65735528|NCT05084534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735529|NCT05084534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735530|NCT05084534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65735531|NCT05084534|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65735532|NCT05084534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65735533|NCT05084534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65735534|NCT05084534|Adrenergic Agents|adrenergic agents|mesh-ancestor
65735535|NCT05084534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65735536|NCT05084534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735537|NCT04645316|Propofol|propofol|mesh-list
65735538|NCT04645316|Sevoflurane|sevoflurane|mesh-list
65735539|NCT04645316|Desflurane|desflurane|mesh-list
65735540|NCT04645316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65735541|NCT04645316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65735542|NCT04645316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735543|NCT04645316|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65735544|NCT04645316|Anesthetics, General|anesthetics, general|mesh-ancestor
65735545|NCT04645316|Anesthetics|anesthetics|mesh-ancestor
65735546|NCT04645316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65735547|NCT04645316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65735548|NCT00659126|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65735549|NCT00659126|Hematinics|hematinics|mesh-ancestor
65735550|NCT00659126|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65735551|NCT00659126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65735552|NCT04594382|Analgesics, Opioid|analgesics, opioid|mesh-list
65735553|NCT04594382|Narcotics|narcotics|mesh-ancestor
65735554|NCT04594382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65735555|NCT04594382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735556|NCT04594382|Analgesics|analgesics|mesh-ancestor
65735557|NCT04594382|Sensory System Agents|sensory system agents|mesh-ancestor
65735558|NCT04594382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735559|NCT02491515|Denosumab|denosumab|mesh-list
65735560|NCT02491515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65735561|NCT02491515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735562|NCT05113628|Methylene Blue|methylene blue|mesh-list
65735563|NCT05113628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65735564|NCT05113628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735565|NCT04247750|Sirolimus|sirolimus|mesh-list
65735566|NCT04247750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65735567|NCT04247750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65735568|NCT04247750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65735569|NCT04247750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735570|NCT04247750|Antifungal Agents|antifungal agents|mesh-ancestor
65735571|NCT04247750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65735572|NCT04247750|Immunologic Factors|immunologic factors|mesh-ancestor
65735573|NCT04247750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735574|NCT04513808|Anesthetics|anesthetics|mesh-list
65735575|NCT04513808|Propofol|propofol|mesh-list
65735576|NCT04513808|Sevoflurane|sevoflurane|mesh-list
65735577|NCT04513808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65735578|NCT04513808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735579|NCT04513808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65735580|NCT04513808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65735581|NCT04513808|Anesthetics, General|anesthetics, general|mesh-ancestor
65735582|NCT04513808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65735583|NCT04513808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65735584|NCT02493231|Ketamine|ketamine|mesh-list
65735585|NCT02493231|Nefopam|nefopam|mesh-list
65735586|NCT02493231|Analgesics|analgesics|mesh-ancestor
65735587|NCT02493231|Sensory System Agents|sensory system agents|mesh-ancestor
65735588|NCT02493231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735589|NCT02493231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735590|NCT02493231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65735591|NCT02493231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65735592|NCT02493231|Anesthetics, General|anesthetics, general|mesh-ancestor
65735593|NCT02493231|Anesthetics|anesthetics|mesh-ancestor
65735594|NCT02493231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65735595|NCT02493231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65735596|NCT02493231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65735597|NCT02493231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65735598|NCT02493231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735599|NCT02493231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65735600|NCT05112692|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65735601|NCT05112692|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65735602|NCT05112692|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65735603|NCT05112692|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65735604|NCT05112692|Cetrorelix|cetrorelix|mesh-list
65735605|NCT05112692|Menotropins|menotropins|mesh-list
65735606|NCT05112692|Estradiol|estradiol|mesh-list
65735607|NCT05112692|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65735608|NCT05112692|Progesterone|progesterone|mesh-list
65735609|NCT05112692|Dydrogesterone|dydrogesterone|mesh-list
65735610|NCT05112692|Estrogens|estrogens|mesh-ancestor
65735611|NCT05112692|Hormones|hormones|mesh-ancestor
65735612|NCT05112692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65735613|NCT05112692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735614|NCT05112692|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65735615|NCT05112692|Contraceptive Agents|contraceptive agents|mesh-ancestor
65735616|NCT05112692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65735617|NCT05112692|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65735618|NCT05112692|Progestins|progestins|mesh-ancestor
65735619|NCT05112692|Luteolytic Agents|luteolytic agents|mesh-ancestor
65735620|NCT05112692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65735621|NCT05112692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735622|NCT05112692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65735623|NCT05112692|Fertility Agents|fertility agents|mesh-ancestor
65735624|NCT05112692|Hormone Antagonists|hormone antagonists|mesh-ancestor
65735625|NCT03328533|Phenylephrine|phenylephrine|mesh-list
65735626|NCT03328533|Oxymetazoline|oxymetazoline|mesh-list
65735627|NCT03328533|Norepinephrine|norepinephrine|mesh-list
65735628|NCT03328533|Bupivacaine|bupivacaine|mesh-list
65735629|NCT03328533|Anesthetics, Local|anesthetics, local|mesh-ancestor
65735630|NCT03328533|Anesthetics|anesthetics|mesh-ancestor
65735631|NCT03328533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65735632|NCT03328533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735633|NCT03328533|Sensory System Agents|sensory system agents|mesh-ancestor
65735634|NCT03328533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735635|NCT03328533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65735636|NCT03328533|Mydriatics|mydriatics|mesh-ancestor
65735637|NCT03328533|Autonomic Agents|autonomic agents|mesh-ancestor
65735638|NCT03328533|Sympathomimetics|sympathomimetics|mesh-ancestor
65735639|NCT03328533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65735640|NCT03328533|Nasal Decongestants|nasal decongestants|mesh-ancestor
65735641|NCT03328533|Respiratory System Agents|respiratory system agents|mesh-ancestor
65735642|NCT03328533|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65735643|NCT03328533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65735644|NCT03328533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65735645|NCT03328533|Adrenergic Agents|adrenergic agents|mesh-ancestor
65735646|NCT03328533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65735647|NCT03328533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735648|NCT03328533|Protective Agents|protective agents|mesh-ancestor
65735649|NCT03324243|Cytarabine|cytarabine|mesh-list
65735650|NCT03324243|Fludarabine|fludarabine|mesh-list
65735651|NCT03324243|Crenolanib|crenolanib|mesh-list
65735652|NCT03324243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735653|NCT03324243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65735654|NCT03324243|Antimetabolites|antimetabolites|mesh-ancestor
65735655|NCT03324243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735656|NCT03324243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65735657|NCT03324243|Immunologic Factors|immunologic factors|mesh-ancestor
65735658|NCT03324243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735659|NCT03324243|Antiviral Agents|antiviral agents|mesh-ancestor
65735660|NCT03324243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65735661|NCT03328299|Dexmedetomidine|dexmedetomidine|mesh-list
65735662|NCT03328299|Bupivacaine|bupivacaine|mesh-list
65735663|NCT03328299|Anesthetics, Local|anesthetics, local|mesh-ancestor
65735664|NCT03328299|Anesthetics|anesthetics|mesh-ancestor
65735665|NCT03328299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65735666|NCT03328299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735667|NCT03328299|Sensory System Agents|sensory system agents|mesh-ancestor
65735668|NCT03328299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735669|NCT03328299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65735670|NCT03328299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65735671|NCT03328299|Analgesics|analgesics|mesh-ancestor
65735672|NCT03328299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65735673|NCT03328299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65735674|NCT03328299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65735675|NCT03328299|Adrenergic Agents|adrenergic agents|mesh-ancestor
65735676|NCT03328299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65735677|NCT03328299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735678|NCT03564301|Metronidazole|metronidazole|mesh-list
65735679|NCT03564301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65735680|NCT03564301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65735681|NCT03564301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65735682|NCT03564301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65735683|NCT05079854|Moxifloxacin|moxifloxacin|mesh-list
65051354|NCT00569335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735684|NCT05079854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65735685|NCT05079854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65735686|NCT05079854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65735687|NCT05079854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65735688|NCT05079854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65735689|NCT05079854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735690|NCT05079854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735691|NCT03327987|Vaccines|vaccines|mesh-list
65735692|NCT03327987|Immunologic Factors|immunologic factors|mesh-ancestor
65735693|NCT03327987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735694|NCT03335241|Doxorubicin|doxorubicin|mesh-list
65735695|NCT03335241|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65735696|NCT03335241|Fludarabine|fludarabine|mesh-list
65735697|NCT03335241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65735698|NCT03335241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735699|NCT03335241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65735700|NCT03335241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65735701|NCT03335241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65735702|NCT03335241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735703|NCT03327831|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65735704|NCT03327831|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65735705|NCT03327831|Dermatologic Agents|dermatologic agents|mesh-ancestor
65735706|NCT03120663|Amoxicillin|amoxicillin|mesh-list
65735707|NCT03120663|Clindamycin|clindamycin|mesh-list
65735708|NCT03120663|Meropenem|meropenem|mesh-list
65735709|NCT03120663|Tazobactam|tazobactam|mesh-list
65735710|NCT03120663|Piperacillin|piperacillin|mesh-list
65735711|NCT03120663|Clavulanic Acids|clavulanic acids|mesh-list
65735712|NCT03120663|Clavulanic Acid|clavulanic acid|mesh-list
65735713|NCT03120663|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65735714|NCT03120663|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65735715|NCT03120663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65735716|NCT03120663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65735717|NCT03120663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65735718|NCT03120663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65735719|NCT03120663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735720|NCT03120663|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65735721|NCT02578394|Methylprednisolone|methylprednisolone|mesh-list
65735722|NCT02578394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65735723|NCT02578394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65735724|NCT02578394|Prednisolone|prednisolone|mesh-list
65735725|NCT02578394|Prednisolone acetate|prednisolone acetate|mesh-list
65735726|NCT02578394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65735727|NCT02578394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65735728|NCT02578394|Prednisolone phosphate|prednisolone phosphate|mesh-list
65735729|NCT02578394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65735730|NCT02578394|Antiemetics|antiemetics|mesh-ancestor
65735731|NCT02578394|Autonomic Agents|autonomic agents|mesh-ancestor
65735732|NCT02578394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735733|NCT02578394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735734|NCT02578394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65735735|NCT02578394|Glucocorticoids|glucocorticoids|mesh-ancestor
65735736|NCT02578394|Hormones|hormones|mesh-ancestor
65735737|NCT02578394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65735738|NCT02578394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65735739|NCT02578394|Protective Agents|protective agents|mesh-ancestor
65735740|NCT02578394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65735741|NCT02578394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735742|NCT02578394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65735743|NCT04493229|Oxytocin|oxytocin|mesh-list
65735744|NCT04493229|Oxytocics|oxytocics|mesh-ancestor
65735745|NCT04493229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65735746|NCT04493229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735747|NCT03120273|Lansoprazole|lansoprazole|mesh-list
65735748|NCT03120273|Dexlansoprazole|dexlansoprazole|mesh-list
65735749|NCT03120273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65735750|NCT03120273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65735751|NCT03120273|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65735752|NCT03120273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65735753|NCT03120273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735754|NCT02122718|Allopurinol|allopurinol|mesh-list
65735755|NCT02122718|Antimetabolites|antimetabolites|mesh-ancestor
65735756|NCT02122718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735757|NCT02122718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65735758|NCT02122718|Gout Suppressants|gout suppressants|mesh-ancestor
65735759|NCT02122718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65735760|NCT02122718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65735762|NCT02122718|Protective Agents|protective agents|mesh-ancestor
65735763|NCT02122718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735764|NCT04513652|Carticaine|carticaine|mesh-list
65735765|NCT04513652|Anesthetics, Local|anesthetics, local|mesh-ancestor
65735766|NCT04513652|Anesthetics|anesthetics|mesh-ancestor
65735767|NCT04513652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65735768|NCT04513652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735769|NCT04513652|Sensory System Agents|sensory system agents|mesh-ancestor
65735770|NCT04513652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735771|NCT00706797|Etanercept|etanercept|mesh-list
65735772|NCT00706797|Methotrexate|methotrexate|mesh-list
65735773|NCT00706797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65735774|NCT00706797|Abortifacient Agents|abortifacient agents|mesh-ancestor
65735775|NCT00706797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65735776|NCT00706797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735777|NCT00706797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65735778|NCT00706797|Antimetabolites|antimetabolites|mesh-ancestor
65735779|NCT00706797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735780|NCT00706797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735781|NCT00706797|Dermatologic Agents|dermatologic agents|mesh-ancestor
65735782|NCT00706797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65735783|NCT00706797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65735784|NCT00706797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65735785|NCT00706797|Immunologic Factors|immunologic factors|mesh-ancestor
65735786|NCT00706797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65735787|NCT00706797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65735788|NCT00706797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65735789|NCT00706797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65735790|NCT00706797|Analgesics|analgesics|mesh-ancestor
65735791|NCT00706797|Sensory System Agents|sensory system agents|mesh-ancestor
65735792|NCT00706797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735793|NCT00706797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65735794|NCT00706797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65735795|NCT03323697|Citalopram|citalopram|mesh-list
65735796|NCT03323697|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65735797|NCT03323697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65735798|NCT03323697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65735799|NCT03323697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735800|NCT03323697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65735801|NCT03323697|Serotonin Agents|serotonin agents|mesh-ancestor
65735802|NCT03323697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735803|NCT03323697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65735804|NCT03323697|Antidepressive Agents|antidepressive agents|mesh-ancestor
65735805|NCT03323697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65735806|NCT00706641|Dasatinib|dasatinib|mesh-list
65735807|NCT00706641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735808|NCT00706641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65735809|NCT00706641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65735810|NCT00706641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735811|NCT03335085|Oxytocin|oxytocin|mesh-list
65735812|NCT03335085|Oxytocics|oxytocics|mesh-ancestor
65735813|NCT03335085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65735814|NCT03335085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735815|NCT03323619|Anesthetics|anesthetics|mesh-list
65735816|NCT03323619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65735817|NCT03323619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735818|NCT03323541|Lenograstim|lenograstim|mesh-list
65735819|NCT03323541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65735820|NCT03323541|Immunologic Factors|immunologic factors|mesh-ancestor
65735821|NCT03323541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735822|NCT03335007|Aceclofenac|aceclofenac|mesh-list
65735823|NCT03335007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65735824|NCT03335007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65735825|NCT03335007|Analgesics|analgesics|mesh-ancestor
65735826|NCT03335007|Sensory System Agents|sensory system agents|mesh-ancestor
65735827|NCT03335007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735828|NCT03335007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735829|NCT03335007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65735830|NCT03335007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65735831|NCT01362530|Ondansetron|ondansetron|mesh-list
65735832|NCT01362530|Aprepitant|aprepitant|mesh-list
65735833|NCT01362530|Fosaprepitant|fosaprepitant|mesh-list
65735834|NCT01362530|Antiemetics|antiemetics|mesh-ancestor
65735835|NCT01362530|Autonomic Agents|autonomic agents|mesh-ancestor
65735836|NCT01362530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735837|NCT01362530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735838|NCT01362530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65735839|NCT01362530|Antipruritics|antipruritics|mesh-ancestor
65735840|NCT01362530|Dermatologic Agents|dermatologic agents|mesh-ancestor
65735841|NCT01362530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65735842|NCT01362530|Serotonin Agents|serotonin agents|mesh-ancestor
65735843|NCT01362530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65735844|NCT01362530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735845|NCT01362530|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65735846|NCT01362530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65735847|NCT01362530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65735848|NCT01362530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65735849|NCT01362530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65735850|NCT01362530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65735851|NCT04494399|Interferons|interferons|mesh-list
65735852|NCT04494399|Ribavirin|ribavirin|mesh-list
65735853|NCT04494399|Interferon-beta|interferon-beta|mesh-list
65735854|NCT04494399|Interferon beta-1b|interferon beta-1b|mesh-list
65735855|NCT04494399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735856|NCT04494399|Antiviral Agents|antiviral agents|mesh-ancestor
65735857|NCT04494399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65735858|NCT04494399|Antimetabolites|antimetabolites|mesh-ancestor
65735859|NCT04494399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735860|NCT04494399|Immunologic Factors|immunologic factors|mesh-ancestor
65735861|NCT04494399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735862|NCT04494399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65735863|NCT03323385|Meloxicam|meloxicam|mesh-list
65735864|NCT03323385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65735865|NCT03323385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65735866|NCT03323385|Analgesics|analgesics|mesh-ancestor
65735867|NCT03323385|Sensory System Agents|sensory system agents|mesh-ancestor
65735868|NCT03323385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735869|NCT03323385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735870|NCT03323385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65735871|NCT03323385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65735872|NCT03323385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65735873|NCT03323385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65735874|NCT03323385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65735875|NCT03323385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735876|NCT01758614|Aspirin|aspirin|mesh-list
65735877|NCT01758614|Clopidogrel|clopidogrel|mesh-list
65735878|NCT01758614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65735879|NCT01758614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65735880|NCT01758614|Analgesics|analgesics|mesh-ancestor
65735881|NCT01758614|Sensory System Agents|sensory system agents|mesh-ancestor
65735882|NCT01758614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65735883|NCT01758614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735884|NCT01758614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65735885|NCT01758614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65735886|NCT01758614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65735887|NCT01758614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65735888|NCT01758614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735889|NCT01758614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65735890|NCT01758614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65735891|NCT01758614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65735892|NCT01758614|Antipyretics|antipyretics|mesh-ancestor
65735893|NCT01758614|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65735894|NCT01758614|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65735895|NCT01758614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65735896|NCT01758614|Purinergic Agents|purinergic agents|mesh-ancestor
65735897|NCT01758614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65735898|NCT02490657|Iloprost|iloprost|mesh-list
65735899|NCT02490657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65735900|NCT02490657|Vasodilator Agents|vasodilator agents|mesh-ancestor
65735901|NCT02654054|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65735902|NCT02654054|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65735903|NCT02654054|Norethindrone|norethindrone|mesh-list
65735904|NCT02654054|Norethindrone Acetate|norethindrone acetate|mesh-list
65735905|NCT02654054|Estradiol|estradiol|mesh-list
65735906|NCT02654054|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65735907|NCT02654054|Estrogens|estrogens|mesh-ancestor
65735908|NCT02654054|Hormones|hormones|mesh-ancestor
65735909|NCT02654054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65735910|NCT02654054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735911|NCT02654054|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65735912|NCT02654054|Contraceptive Agents|contraceptive agents|mesh-ancestor
65735913|NCT02654054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65735914|NCT02654054|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65735915|NCT02654054|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65735916|NCT02654054|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65735917|NCT02654054|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65735918|NCT04323566|Rituximab|rituximab|mesh-list
65735919|NCT04323566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65735920|NCT04323566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735921|NCT04323566|Immunologic Factors|immunologic factors|mesh-ancestor
65735922|NCT04323566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735923|NCT04323566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65735924|NCT03109119|Propofol|propofol|mesh-list
65735925|NCT03109119|Sevoflurane|sevoflurane|mesh-list
65735926|NCT03109119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65735927|NCT03109119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65735928|NCT03109119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735929|NCT03109119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65735930|NCT03109119|Anesthetics, General|anesthetics, general|mesh-ancestor
65735931|NCT03109119|Anesthetics|anesthetics|mesh-ancestor
65735932|NCT03109119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65735933|NCT03109119|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65735934|NCT05070104|Bevacizumab|bevacizumab|mesh-list
65735935|NCT05070104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65735936|NCT05070104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735937|NCT05070104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65735938|NCT05070104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65735939|NCT05070104|Growth Substances|growth substances|mesh-ancestor
65735940|NCT05070104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735941|NCT05070104|Growth Inhibitors|growth inhibitors|mesh-ancestor
65735942|NCT03326661|Clindamycin|clindamycin|mesh-list
65735943|NCT03326661|Clindamycin palmitate|clindamycin palmitate|mesh-list
65735944|NCT03326661|Clindamycin phosphate|clindamycin phosphate|mesh-list
65735945|NCT03326661|Penicillins|penicillins|mesh-list
65735946|NCT03326661|Penicillin V|penicillin v|mesh-list
65735947|NCT03326661|Metronidazole|metronidazole|mesh-list
65735948|NCT03326661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65735949|NCT03326661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65735950|NCT03326661|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65735951|NCT03326661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65735952|NCT03326661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735953|NCT03326661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65735954|NCT03326661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65735955|NCT05119712|Terbinafine|terbinafine|mesh-list
65735956|NCT05119712|Antifungal Agents|antifungal agents|mesh-ancestor
65735957|NCT05119712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65735958|NCT05119712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65735959|NCT05119712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735960|NCT04261478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65735961|NCT03186404|Atorvastatin|atorvastatin|mesh-list
65735962|NCT03186404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65735963|NCT03186404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65735964|NCT03186404|Antimetabolites|antimetabolites|mesh-ancestor
65735965|NCT03186404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735966|NCT03186404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65735967|NCT03186404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65735968|NCT03186404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65735969|NCT02492373|Clobetasol|clobetasol|mesh-list
65735970|NCT02492373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65735971|NCT02492373|Glucocorticoids|glucocorticoids|mesh-ancestor
65735972|NCT02492373|Hormones|hormones|mesh-ancestor
65735973|NCT02492373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65735974|NCT02492373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735975|NCT03073070|Biotin|biotin|mesh-list
65735976|NCT03073070|Vitamin B Complex|vitamin b complex|mesh-ancestor
65735977|NCT03073070|Vitamins|vitamins|mesh-ancestor
65735978|NCT03073070|Micronutrients|micronutrients|mesh-ancestor
65735979|NCT03073070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735980|NCT02905214|Sirolimus|sirolimus|mesh-list
65735981|NCT02905214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65735982|NCT02905214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65735983|NCT02905214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65735984|NCT02905214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65735985|NCT02905214|Antifungal Agents|antifungal agents|mesh-ancestor
65735986|NCT02905214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65735987|NCT02905214|Immunologic Factors|immunologic factors|mesh-ancestor
65735988|NCT02905214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735989|NCT03333603|Esomeprazole|esomeprazole|mesh-list
65735990|NCT03333603|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65735991|NCT03333603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65735992|NCT03333603|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65735993|NCT03333603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65735994|NCT03333603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65735995|NCT03333525|Insulin|insulin|mesh-list
65735996|NCT03333525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65735997|NCT03333525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65735998|NCT05463861|Lemborexant|lemborexant|mesh-list
65735999|NCT05463861|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65736000|NCT05463861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65736001|NCT05463861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736002|NCT05463861|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65736003|NCT05463861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65736004|NCT05463861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65736005|NCT05463861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736006|NCT03333369|Levodopa|levodopa|mesh-list
65736007|NCT03333369|Benserazide|benserazide|mesh-list
65736008|NCT03333369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65736009|NCT03333369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65736010|NCT03333369|Dopamine Agents|dopamine agents|mesh-ancestor
65736011|NCT03333369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65736012|NCT03333369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736013|NCT03333369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736014|NCT03333369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736015|NCT03325803|Lidocaine|lidocaine|mesh-list
65736016|NCT03325803|Prilocaine|prilocaine|mesh-list
65736017|NCT03325803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65736018|NCT03325803|Anesthetics, Local|anesthetics, local|mesh-ancestor
65736019|NCT03325803|Anesthetics|anesthetics|mesh-ancestor
65736020|NCT03325803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65736021|NCT03325803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736022|NCT03325803|Sensory System Agents|sensory system agents|mesh-ancestor
65736023|NCT03325803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65736024|NCT03325803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65736025|NCT03325803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65736026|NCT03325803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65736027|NCT03325803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65736028|NCT03325803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736029|NCT03325803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65736030|NCT03325491|Acipimox|acipimox|mesh-list
65736031|NCT03325491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65736032|NCT03325491|Antimetabolites|antimetabolites|mesh-ancestor
65736033|NCT03325491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736034|NCT03325491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65736035|NCT04150562|Avelumab|avelumab|mesh-list
65736036|NCT04150562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65736037|NCT04150562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736038|NCT03325413|Anesthetics|anesthetics|mesh-list
65736039|NCT03325413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65736040|NCT03325413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736041|NCT03325335|Midazolam|midazolam|mesh-list
65736042|NCT03325335|Remifentanil|remifentanil|mesh-list
65736043|NCT03325335|Propofol|propofol|mesh-list
65736044|NCT03325335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65736045|NCT03325335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65736046|NCT03325335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736047|NCT03325335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65736048|NCT03325335|Anesthetics, General|anesthetics, general|mesh-ancestor
65736049|NCT03325335|Anesthetics|anesthetics|mesh-ancestor
65736050|NCT03325335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65736051|NCT03325335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65736052|NCT03325335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65736053|NCT03325335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65736054|NCT03325335|GABA Modulators|gaba modulators|mesh-ancestor
65736055|NCT03325335|GABA Agents|gaba agents|mesh-ancestor
65736056|NCT03325335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65736057|NCT03325335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736058|NCT03325335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65736059|NCT03325335|Narcotics|narcotics|mesh-ancestor
65736060|NCT03325335|Analgesics|analgesics|mesh-ancestor
65051735|NCT00572689|Exenatide|exenatide|mesh-list
65736061|NCT03325335|Sensory System Agents|sensory system agents|mesh-ancestor
65736062|NCT03325335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65736063|NCT05114720|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65736064|NCT05114720|Moxifloxacin|moxifloxacin|mesh-list
65736065|NCT05114720|Cyclophosphamide|cyclophosphamide|mesh-list
65736066|NCT05114720|Docetaxel|docetaxel|mesh-list
65736067|NCT05114720|Doxorubicin|doxorubicin|mesh-list
65736068|NCT05114720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65736069|NCT05114720|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65736070|NCT05114720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65736071|NCT05114720|Immunologic Factors|immunologic factors|mesh-ancestor
65736072|NCT05114720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736073|NCT05114720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65736074|NCT05114720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65736075|NCT05114720|Alkylating Agents|alkylating agents|mesh-ancestor
65736076|NCT05114720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736077|NCT05114720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736078|NCT05114720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65736079|NCT05114720|Tubulin Modulators|tubulin modulators|mesh-ancestor
65736080|NCT05114720|Antimitotic Agents|antimitotic agents|mesh-ancestor
65736081|NCT05114720|Mitosis Modulators|mitosis modulators|mesh-ancestor
65736082|NCT05114720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65736083|NCT05114720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65736084|NCT05114720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65736085|NCT05114720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736086|NCT05114720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65736087|NCT05114720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65736088|NCT05114720|Contraceptive Agents|contraceptive agents|mesh-ancestor
65736089|NCT05114720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65736090|NCT05114720|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65736091|NCT05114720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65736092|NCT05114720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65736093|NCT04493463|Methylprednisolone|methylprednisolone|mesh-list
65736094|NCT04493463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65736095|NCT04493463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65736096|NCT04493463|Prednisolone|prednisolone|mesh-list
65736097|NCT04493463|Prednisolone acetate|prednisolone acetate|mesh-list
65736098|NCT04493463|Ropivacaine|ropivacaine|mesh-list
65736099|NCT04493463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65736100|NCT04493463|Prednisolone phosphate|prednisolone phosphate|mesh-list
65736101|NCT04493463|Anesthetics, Local|anesthetics, local|mesh-ancestor
65736102|NCT04493463|Anesthetics|anesthetics|mesh-ancestor
65736103|NCT04493463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65736104|NCT04493463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736105|NCT04493463|Sensory System Agents|sensory system agents|mesh-ancestor
65736106|NCT04493463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65736107|NCT04493463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65736108|NCT04493463|Antiemetics|antiemetics|mesh-ancestor
65736109|NCT04493463|Autonomic Agents|autonomic agents|mesh-ancestor
65736110|NCT04493463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65736111|NCT04493463|Glucocorticoids|glucocorticoids|mesh-ancestor
65736112|NCT04493463|Hormones|hormones|mesh-ancestor
65736113|NCT04493463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65736114|NCT04493463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65736115|NCT04493463|Protective Agents|protective agents|mesh-ancestor
65736116|NCT04493463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65736117|NCT04493463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736118|NCT04493073|Mitomycins|mitomycins|mesh-list
65736119|NCT04493073|Mitomycin|mitomycin|mesh-list
65736120|NCT04493073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65736121|NCT04493073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736122|NCT04493073|Alkylating Agents|alkylating agents|mesh-ancestor
65736123|NCT04493073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736124|NCT04493073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65736125|NCT04493073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736126|NCT00950846|Cyclophosphamide|cyclophosphamide|mesh-list
65736127|NCT00950846|Busulfan|busulfan|mesh-list
65736128|NCT00950846|Fludarabine|fludarabine|mesh-list
65736129|NCT00950846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65736130|NCT00950846|Immunologic Factors|immunologic factors|mesh-ancestor
65736131|NCT00950846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736132|NCT00950846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65736133|NCT00950846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65736134|NCT00950846|Alkylating Agents|alkylating agents|mesh-ancestor
65736135|NCT00950846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736136|NCT00950846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051799|NCT00225173|Gemcitabine|gemcitabine|mesh-list
65736137|NCT00950846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65736138|NCT00748904|Rifaximin|rifaximin|mesh-list
65736139|NCT00748904|Lactulose|lactulose|mesh-list
65736140|NCT00748904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65736141|NCT00748904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65736142|NCT00748904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65736143|NCT03321903|Charcoal|charcoal|mesh-list
65736144|NCT03321903|Antidotes|antidotes|mesh-ancestor
65736145|NCT03321903|Protective Agents|protective agents|mesh-ancestor
65736146|NCT03321903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736147|NCT04984616|Atorvastatin|atorvastatin|mesh-list
65736148|NCT04984616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65736149|NCT04984616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65736150|NCT04984616|Antimetabolites|antimetabolites|mesh-ancestor
65736151|NCT04984616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736152|NCT04984616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65736153|NCT04984616|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65736154|NCT04984616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736155|NCT04411550|Pertuzumab|pertuzumab|mesh-list
65736156|NCT04411550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65736157|NCT04411550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736158|NCT03321825|Lidocaine|lidocaine|mesh-list
65736159|NCT03321825|Hyaluronic Acid|hyaluronic acid|mesh-list
65736160|NCT03321825|Anesthetics, Local|anesthetics, local|mesh-ancestor
65736161|NCT03321825|Anesthetics|anesthetics|mesh-ancestor
65736162|NCT03321825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65736163|NCT03321825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736164|NCT03321825|Sensory System Agents|sensory system agents|mesh-ancestor
65736165|NCT03321825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65736166|NCT03321825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65736167|NCT03321825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65736168|NCT03321825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65736169|NCT03321825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65736170|NCT03321825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736171|NCT03321825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65736172|NCT03321825|Immunologic Factors|immunologic factors|mesh-ancestor
65736173|NCT03321825|Viscosupplements|viscosupplements|mesh-ancestor
65736174|NCT03321825|Protective Agents|protective agents|mesh-ancestor
65736175|NCT02492217|Adalimumab|adalimumab|mesh-list
65736176|NCT02492217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65736177|NCT02492217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65736178|NCT05229536|Vaccines|vaccines|mesh-list
65736179|NCT05229536|Immunologic Factors|immunologic factors|mesh-ancestor
65736180|NCT05229536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736181|NCT04810910|Molgramostim|molgramostim|mesh-list
65736182|NCT04810910|Sargramostim|sargramostim|mesh-list
65736183|NCT04810910|Immunologic Factors|immunologic factors|mesh-ancestor
65736184|NCT04810910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736185|NCT04810910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736186|NCT04562558|Leucovorin|leucovorin|mesh-list
65736187|NCT04562558|Dactinomycin|dactinomycin|mesh-list
65736188|NCT04562558|Methotrexate|methotrexate|mesh-list
65736189|NCT04562558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736190|NCT04562558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65736191|NCT04562558|Abortifacient Agents|abortifacient agents|mesh-ancestor
65736192|NCT04562558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65736193|NCT04562558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65736194|NCT04562558|Antimetabolites|antimetabolites|mesh-ancestor
65736195|NCT04562558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736196|NCT04562558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736197|NCT04562558|Dermatologic Agents|dermatologic agents|mesh-ancestor
65736198|NCT04562558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736199|NCT04562558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65736200|NCT04562558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65736201|NCT04562558|Immunologic Factors|immunologic factors|mesh-ancestor
65736202|NCT04562558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65736203|NCT04562558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65736204|NCT04562558|Antidotes|antidotes|mesh-ancestor
65736205|NCT04562558|Protective Agents|protective agents|mesh-ancestor
65736206|NCT04562558|Vitamin B Complex|vitamin b complex|mesh-ancestor
65736207|NCT04562558|Vitamins|vitamins|mesh-ancestor
65736208|NCT04562558|Micronutrients|micronutrients|mesh-ancestor
65736209|NCT04562558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65736210|NCT04562558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65736211|NCT04562558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65736212|NCT04562558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65736213|NCT03320187|Nitroglycerin|nitroglycerin|mesh-list
65736214|NCT03320187|Dinoprostone|dinoprostone|mesh-list
65736215|NCT03320187|Vasodilator Agents|vasodilator agents|mesh-ancestor
65736216|NCT03320187|Oxytocics|oxytocics|mesh-ancestor
65736217|NCT03320187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65736218|NCT03320187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736219|NCT03320109|Vitamin D|vitamin d|mesh-list
65736220|NCT03320109|Ergocalciferols|ergocalciferols|mesh-list
65736221|NCT03320109|Cholecalciferol|cholecalciferol|mesh-list
65736222|NCT03320109|Vitamins|vitamins|mesh-list
65736223|NCT03320109|Micronutrients|micronutrients|mesh-ancestor
65736224|NCT03320109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736225|NCT03320109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65736226|NCT03320109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65736227|NCT04529876|Abatacept|abatacept|mesh-list
65736228|NCT04529876|Tofacitinib|tofacitinib|mesh-list
65736229|NCT04529876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65736230|NCT04529876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736231|NCT04529876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736232|NCT04529876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65736233|NCT04529876|Immunologic Factors|immunologic factors|mesh-ancestor
65736234|NCT04529876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736235|NCT04529876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65736236|NCT04529876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65736237|NCT04529876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736238|NCT03320031|Insulin Lispro|insulin lispro|mesh-list
65736239|NCT03320031|Linagliptin|linagliptin|mesh-list
65736240|NCT03320031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65736241|NCT03320031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736242|NCT03320031|Incretins|incretins|mesh-ancestor
65736243|NCT03320031|Hormones|hormones|mesh-ancestor
65736244|NCT03320031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65736245|NCT03320031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65736246|NCT03320031|Protease Inhibitors|protease inhibitors|mesh-ancestor
65736247|NCT03320031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736248|NCT03320031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736249|NCT04510922|Droxidopa|droxidopa|mesh-list
65736250|NCT04510922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65736251|NCT04510922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65736252|NCT05465031|Valsartan|valsartan|mesh-list
65736253|NCT05465031|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65736254|NCT05465031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65736255|NCT05465031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65736256|NCT05465031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65736257|NCT05465031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736258|NCT04510844|Evolocumab|evolocumab|mesh-list
65736259|NCT04510844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65736260|NCT04510844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65736261|NCT04510844|Antimetabolites|antimetabolites|mesh-ancestor
65736262|NCT04510844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736263|NCT04510844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65736264|NCT05464953|Triamcinolone|triamcinolone|mesh-list
65736265|NCT05464953|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65736266|NCT05464953|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65736267|NCT05464953|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65736268|NCT05464953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65736269|NCT05464953|Glucocorticoids|glucocorticoids|mesh-ancestor
65736270|NCT05464953|Hormones|hormones|mesh-ancestor
65736271|NCT05464953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65736272|NCT05464953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736273|NCT05464953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65736274|NCT05464953|Immunologic Factors|immunologic factors|mesh-ancestor
65736275|NCT05464953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736276|NCT05464953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736277|NCT02491749|Anesthetics|anesthetics|mesh-list
65736278|NCT02491749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65736279|NCT02491749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736280|NCT04408898|Pembrolizumab|pembrolizumab|mesh-list
65736281|NCT04408898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65736282|NCT04408898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736283|NCT02490345|Gabapentin|gabapentin|mesh-list
65736284|NCT02490345|Analgesics|analgesics|mesh-ancestor
65736285|NCT02490345|Sensory System Agents|sensory system agents|mesh-ancestor
65736286|NCT02490345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65051947|NCT00574015|Anesthetics|anesthetics|mesh-ancestor
65736287|NCT02490345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736288|NCT02490345|Anticonvulsants|anticonvulsants|mesh-ancestor
65736289|NCT02490345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65736290|NCT02490345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65736291|NCT02490345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65736292|NCT02490345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65736293|NCT02490345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65736294|NCT02490345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65736295|NCT02490345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65736296|NCT02490345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736297|NCT02490345|Antimanic Agents|antimanic agents|mesh-ancestor
65736298|NCT03331263|Chlorhexidine|chlorhexidine|mesh-list
65736299|NCT03331263|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65736300|NCT03331263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65736301|NCT03331263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65736302|NCT03331263|Disinfectants|disinfectants|mesh-ancestor
65736303|NCT03331263|Dermatologic Agents|dermatologic agents|mesh-ancestor
65736304|NCT03319563|Epinephrine|epinephrine|mesh-list
65736305|NCT03319563|Anesthetics|anesthetics|mesh-list
65736306|NCT03319563|Anesthetics, Local|anesthetics, local|mesh-list
65736307|NCT03319563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65736308|NCT03319563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736309|NCT03319563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65736310|NCT03319563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65736311|NCT03319563|Adrenergic Agents|adrenergic agents|mesh-ancestor
65736312|NCT03319563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65736313|NCT03319563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736314|NCT03319563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65736315|NCT03319563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65736316|NCT03319563|Autonomic Agents|autonomic agents|mesh-ancestor
65736317|NCT03319563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65736318|NCT03319563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65736319|NCT03319563|Respiratory System Agents|respiratory system agents|mesh-ancestor
65736320|NCT03319563|Mydriatics|mydriatics|mesh-ancestor
65736321|NCT03319563|Sympathomimetics|sympathomimetics|mesh-ancestor
65736322|NCT03319563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65736323|NCT03319563|Sensory System Agents|sensory system agents|mesh-ancestor
65736324|NCT02484573|Propranolol|propranolol|mesh-list
65736325|NCT02484573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65736326|NCT02484573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65736327|NCT02484573|Adrenergic Agents|adrenergic agents|mesh-ancestor
65736328|NCT02484573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65736329|NCT02484573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736330|NCT02484573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736331|NCT02484573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65736332|NCT02484573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65736333|NCT02484573|Vasodilator Agents|vasodilator agents|mesh-ancestor
65736334|NCT02489955|Tobramycin|tobramycin|mesh-list
65736335|NCT02489955|Amikacin|amikacin|mesh-list
65736336|NCT02489955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65736337|NCT02489955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65736338|NCT03734744|Vitamin D|vitamin d|mesh-list
65736339|NCT03734744|Cholecalciferol|cholecalciferol|mesh-list
65736340|NCT03734744|Vitamins|vitamins|mesh-ancestor
65736341|NCT03734744|Micronutrients|micronutrients|mesh-ancestor
65736342|NCT03734744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736343|NCT03734744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65736344|NCT03734744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65736345|NCT03576716|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65736346|NCT03576716|Calcifediol|calcifediol|mesh-list
65736347|NCT03576716|Vitamins|vitamins|mesh-ancestor
65736348|NCT03576716|Micronutrients|micronutrients|mesh-ancestor
65736349|NCT03576716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736350|NCT03576716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65736351|NCT03436862|Nivolumab|nivolumab|mesh-list
65736352|NCT03436862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65736353|NCT03436862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736354|NCT03436862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65736355|NCT03436862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736356|NCT02487381|Dronabinol|dronabinol|mesh-list
65736357|NCT02487381|Cannabidiol|cannabidiol|mesh-list
65736358|NCT02487381|Anticonvulsants|anticonvulsants|mesh-ancestor
65736359|NCT02487381|Hallucinogens|hallucinogens|mesh-ancestor
65736360|NCT02487381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736361|NCT02487381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65736362|NCT02487381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65736363|NCT02487381|Analgesics|analgesics|mesh-ancestor
65736364|NCT02487381|Sensory System Agents|sensory system agents|mesh-ancestor
65052028|NCT00574600|Vaccines|vaccines|mesh-list
65736365|NCT02487381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65736366|NCT02487381|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65736367|NCT02487381|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65736368|NCT02487381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65736369|NCT02487381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736370|NCT02487381|Hormones|hormones|mesh-ancestor
65736371|NCT02487381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65736372|NCT02487849|Carboplatin|carboplatin|mesh-list
65736373|NCT02487849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736374|NCT02484339|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65736375|NCT02484339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736376|NCT04021550|Thioctic Acid|thioctic acid|mesh-list
65736377|NCT04021550|Telmisartan|telmisartan|mesh-list
65736378|NCT04021550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65736379|NCT04021550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65736380|NCT04021550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65736381|NCT04021550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736382|NCT04021550|Antioxidants|antioxidants|mesh-ancestor
65736383|NCT04021550|Protective Agents|protective agents|mesh-ancestor
65736384|NCT04021550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736385|NCT04021550|Vitamin B Complex|vitamin b complex|mesh-ancestor
65736386|NCT04021550|Vitamins|vitamins|mesh-ancestor
65736387|NCT04021550|Micronutrients|micronutrients|mesh-ancestor
65736388|NCT02489487|Ritonavir|ritonavir|mesh-list
65736389|NCT02489487|Darunavir|darunavir|mesh-list
65736390|NCT02489487|Raltegravir Potassium|raltegravir potassium|mesh-list
65736391|NCT02489487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65736392|NCT02489487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65736393|NCT02489487|Protease Inhibitors|protease inhibitors|mesh-ancestor
65736394|NCT02489487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736395|NCT02489487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736396|NCT02489487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65736397|NCT02489487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65736398|NCT02489487|Antiviral Agents|antiviral agents|mesh-ancestor
65736399|NCT02489487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65736400|NCT02489487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65736401|NCT02489487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65736402|NCT02489487|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65736403|NCT02489487|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65736404|NCT02096354|Irinotecan|irinotecan|mesh-list
65736405|NCT02096354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736406|NCT02096354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65736407|NCT02096354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65736408|NCT02096354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736409|NCT02096354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736410|NCT02487069|Cyclosporine|cyclosporine|mesh-list
65736411|NCT02487069|Mycophenolic Acid|mycophenolic acid|mesh-list
65736412|NCT02487069|Methotrexate|methotrexate|mesh-list
65736413|NCT02487069|Cyclosporins|cyclosporins|mesh-list
65736414|NCT02487069|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65736415|NCT02487069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65736416|NCT02487069|Abortifacient Agents|abortifacient agents|mesh-ancestor
65736417|NCT02487069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65736418|NCT02487069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736419|NCT02487069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65736420|NCT02487069|Antimetabolites|antimetabolites|mesh-ancestor
65736421|NCT02487069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736422|NCT02487069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736423|NCT02487069|Dermatologic Agents|dermatologic agents|mesh-ancestor
65736424|NCT02487069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736425|NCT02487069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65736426|NCT02487069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65736427|NCT02487069|Immunologic Factors|immunologic factors|mesh-ancestor
65736428|NCT02487069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65736429|NCT02487069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65736430|NCT02487069|Antifungal Agents|antifungal agents|mesh-ancestor
65736431|NCT02487069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65736432|NCT02487069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65736433|NCT02487069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65736434|NCT02487069|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65736435|NCT02487069|Antitubercular Agents|antitubercular agents|mesh-ancestor
65736436|NCT02487069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65736437|NCT03177746|Tadalafil|tadalafil|mesh-list
65736438|NCT03177746|Vasodilator Agents|vasodilator agents|mesh-ancestor
65736439|NCT03177746|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65736440|NCT03177746|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65736441|NCT03177746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736442|NCT03177746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736443|NCT03177746|Urological Agents|urological agents|mesh-ancestor
65736444|NCT02484027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65736445|NCT02484027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65736446|NCT02484027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65736447|NCT02484027|Antimetabolites|antimetabolites|mesh-ancestor
65736448|NCT02484027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736449|NCT02484027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65736450|NCT02484027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65736451|NCT02484027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736452|NCT02483715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65736453|NCT02483715|Amoxicillin|amoxicillin|mesh-list
65736454|NCT02483715|Metronidazole|metronidazole|mesh-list
65736455|NCT02483715|Tetracycline|tetracycline|mesh-list
65736456|NCT02483715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65736457|NCT02483715|Rabeprazole|rabeprazole|mesh-list
65736458|NCT02483715|Bismuth|bismuth|mesh-list
65736459|NCT02483715|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65736460|NCT02483715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65736461|NCT02483715|Antitubercular Agents|antitubercular agents|mesh-ancestor
65736462|NCT02483715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65736463|NCT02483715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65736464|NCT02483715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65736465|NCT02483715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65736466|NCT02483715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736467|NCT02483715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736468|NCT02483715|Antacids|antacids|mesh-ancestor
65736469|NCT02483715|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65736470|NCT02483793|Tamsulosin|tamsulosin|mesh-list
65736471|NCT02483793|Oxybutynin|oxybutynin|mesh-list
65736472|NCT02483793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65736473|NCT02483793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65736474|NCT02483793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65736475|NCT02483793|Adrenergic Agents|adrenergic agents|mesh-ancestor
65736476|NCT02483793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65736477|NCT02483793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736478|NCT02483793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736479|NCT02483793|Urological Agents|urological agents|mesh-ancestor
65736480|NCT02483793|Parasympatholytics|parasympatholytics|mesh-ancestor
65736481|NCT02483793|Autonomic Agents|autonomic agents|mesh-ancestor
65736482|NCT02483793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65736483|NCT02483793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65736484|NCT02483793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65736485|NCT02483793|Cholinergic Agents|cholinergic agents|mesh-ancestor
65736486|NCT03200288|Hyaluronic Acid|hyaluronic acid|mesh-list
65736487|NCT03200288|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65736488|NCT03200288|Immunologic Factors|immunologic factors|mesh-ancestor
65736489|NCT03200288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736490|NCT03200288|Viscosupplements|viscosupplements|mesh-ancestor
65199088|NCT05774067|Hemostatics|hemostatics|mesh-ancestor
65736491|NCT03200288|Protective Agents|protective agents|mesh-ancestor
65736492|NCT03318471|Magnesium Sulfate|magnesium sulfate|mesh-list
65736493|NCT03318471|Analgesics|analgesics|mesh-ancestor
65736494|NCT03318471|Sensory System Agents|sensory system agents|mesh-ancestor
65736495|NCT03318471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65736496|NCT03318471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736497|NCT03318471|Anesthetics|anesthetics|mesh-ancestor
65736498|NCT03318471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65736499|NCT03318471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65736500|NCT03318471|Anticonvulsants|anticonvulsants|mesh-ancestor
65736501|NCT03318471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65736502|NCT03318471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65736503|NCT03318471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736504|NCT03318471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65736505|NCT03318471|Tocolytic Agents|tocolytic agents|mesh-ancestor
65736506|NCT03318471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65736507|NCT04234022|Pomalidomide|pomalidomide|mesh-list
65736508|NCT04234022|Immunologic Factors|immunologic factors|mesh-ancestor
65736509|NCT04234022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736510|NCT04234022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65736511|NCT04234022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65736512|NCT04234022|Growth Substances|growth substances|mesh-ancestor
65736513|NCT04234022|Growth Inhibitors|growth inhibitors|mesh-ancestor
65736514|NCT04234022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736515|NCT02489409|Gemcitabine|gemcitabine|mesh-list
65736516|NCT02489409|Vinorelbine|vinorelbine|mesh-list
65736517|NCT02489409|Endostatins|endostatins|mesh-list
65736518|NCT02489409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65736519|NCT02489409|Antimetabolites|antimetabolites|mesh-ancestor
65736520|NCT02489409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736521|NCT02489409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736522|NCT02489409|Antiviral Agents|antiviral agents|mesh-ancestor
65736523|NCT02489409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65736524|NCT02489409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736525|NCT02489409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65736526|NCT02489409|Immunologic Factors|immunologic factors|mesh-ancestor
65736527|NCT02489409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736528|NCT02489409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65736529|NCT02489409|Tubulin Modulators|tubulin modulators|mesh-ancestor
65736530|NCT02489409|Antimitotic Agents|antimitotic agents|mesh-ancestor
65736531|NCT02489409|Mitosis Modulators|mitosis modulators|mesh-ancestor
65736532|NCT02489409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65736533|NCT02489409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65736534|NCT02489409|Growth Substances|growth substances|mesh-ancestor
65736535|NCT02489409|Growth Inhibitors|growth inhibitors|mesh-ancestor
65736536|NCT03930602|Fluvoxamine|fluvoxamine|mesh-list
65736537|NCT03930602|BMS-986165|bms-986165|mesh-list
65736538|NCT03930602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65736539|NCT03930602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65736540|NCT03930602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65736541|NCT03930602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736542|NCT03930602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65736543|NCT03930602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65736544|NCT03930602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65736545|NCT03930602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65736546|NCT03930602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736547|NCT03930602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65736548|NCT03930602|Serotonin Agents|serotonin agents|mesh-ancestor
65736549|NCT03930602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65736550|NCT03930602|Antidepressive Agents|antidepressive agents|mesh-ancestor
65736551|NCT03930602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65736552|NCT03930602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65736553|NCT03930602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736554|NCT03930602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65736555|NCT03930602|Dermatologic Agents|dermatologic agents|mesh-ancestor
65736556|NCT03930602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65736557|NCT02483871|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65736558|NCT02483871|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65736559|NCT02483871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65736560|NCT02483871|Antimetabolites|antimetabolites|mesh-ancestor
65736561|NCT02483871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736562|NCT02483871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65736563|NCT02483871|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65736564|NCT02483871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736565|NCT02489019|Fentanyl|fentanyl|mesh-list
65736566|NCT02489019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65736567|NCT02489019|Narcotics|narcotics|mesh-ancestor
65736568|NCT02489019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65736569|NCT02489019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736570|NCT02489019|Analgesics|analgesics|mesh-ancestor
65736571|NCT02489019|Sensory System Agents|sensory system agents|mesh-ancestor
65736572|NCT02489019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65736573|NCT02489019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65736574|NCT02489019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65736575|NCT02489019|Anesthetics, General|anesthetics, general|mesh-ancestor
65736576|NCT02489019|Anesthetics|anesthetics|mesh-ancestor
65736577|NCT02604446|Oxycodone|oxycodone|mesh-list
65736578|NCT02604446|Tapentadol|tapentadol|mesh-list
65736579|NCT02604446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65736580|NCT02604446|Narcotics|narcotics|mesh-ancestor
65736581|NCT02604446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65736582|NCT02604446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736583|NCT02604446|Analgesics|analgesics|mesh-ancestor
65736584|NCT02604446|Sensory System Agents|sensory system agents|mesh-ancestor
65736585|NCT02604446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65736586|NCT02604446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65736587|NCT02604446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65736588|NCT02604446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65736589|NCT02604446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736590|NCT02604446|Adrenergic Agents|adrenergic agents|mesh-ancestor
65736591|NCT02604446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65736592|NCT02847637|Factor VIII|factor viii|mesh-list
65736593|NCT02847637|Coagulants|coagulants|mesh-ancestor
65736594|NCT02652260|Tenofovir|tenofovir|mesh-list
65736595|NCT02652260|Lamivudine|lamivudine|mesh-list
65736596|NCT02652260|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65736597|NCT02652260|Antiviral Agents|antiviral agents|mesh-ancestor
65736598|NCT02652260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65736599|NCT02652260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65736600|NCT02652260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65736601|NCT02652260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736602|NCT02652260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736603|NCT02652260|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65736604|NCT02652260|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65736605|NCT01710176|Gemcitabine|gemcitabine|mesh-list
65736606|NCT01710176|Docetaxel|docetaxel|mesh-list
65736607|NCT01710176|Etoposide|etoposide|mesh-list
65736608|NCT01710176|Epirubicin|epirubicin|mesh-list
65736609|NCT01710176|Ifosfamide|ifosfamide|mesh-list
65736610|NCT01710176|Isophosphamide mustard|isophosphamide mustard|mesh-list
65736611|NCT01710176|Dacarbazine|dacarbazine|mesh-list
65736612|NCT01710176|Trabectedin|trabectedin|mesh-list
65736613|NCT01710176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65736614|NCT01710176|Antimetabolites|antimetabolites|mesh-ancestor
65736615|NCT01710176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736616|NCT01710176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736617|NCT01710176|Antiviral Agents|antiviral agents|mesh-ancestor
65736618|NCT01710176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65736619|NCT01710176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736620|NCT01710176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65736621|NCT01710176|Immunologic Factors|immunologic factors|mesh-ancestor
65736622|NCT01710176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736623|NCT01710176|Tubulin Modulators|tubulin modulators|mesh-ancestor
65736624|NCT01710176|Antimitotic Agents|antimitotic agents|mesh-ancestor
65736625|NCT01710176|Mitosis Modulators|mitosis modulators|mesh-ancestor
65736626|NCT01710176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65736627|NCT01710176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65736628|NCT01710176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65736629|NCT01710176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65736630|NCT01710176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65736631|NCT01710176|Alkylating Agents|alkylating agents|mesh-ancestor
65736632|NCT00584246|Pregabalin|pregabalin|mesh-list
65736633|NCT00584246|Analgesics|analgesics|mesh-ancestor
65736634|NCT00584246|Sensory System Agents|sensory system agents|mesh-ancestor
65736635|NCT00584246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65736636|NCT00584246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736637|NCT00584246|Anticonvulsants|anticonvulsants|mesh-ancestor
65736638|NCT00584246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65736639|NCT00584246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65736640|NCT00584246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736641|NCT00584246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65736642|NCT00584246|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65736643|NCT00584246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65736644|NCT00584246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65736645|NCT00584246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65736646|NCT05124314|Misoprostol|misoprostol|mesh-list
65736647|NCT05124314|Mifepristone|mifepristone|mesh-list
65736648|NCT05124314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65736649|NCT05124314|Abortifacient Agents|abortifacient agents|mesh-ancestor
65736650|NCT05124314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65736651|NCT05124314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736652|NCT05124314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65736653|NCT05124314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65736654|NCT05124314|Oxytocics|oxytocics|mesh-ancestor
65736655|NCT05124314|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65736656|NCT05124314|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65736657|NCT05124314|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65736658|NCT05124314|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65736659|NCT05124314|Contraceptive Agents|contraceptive agents|mesh-ancestor
65736660|NCT05124314|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65736661|NCT05124314|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65736662|NCT05124314|Hormone Antagonists|hormone antagonists|mesh-ancestor
65736663|NCT05124314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65736664|NCT05124314|Luteolytic Agents|luteolytic agents|mesh-ancestor
65736665|NCT05124314|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65736666|NCT05124314|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65736667|NCT03320967|Arginine Vasopressin|arginine vasopressin|mesh-list
65736668|NCT03320967|Hemostatics|hemostatics|mesh-ancestor
65736669|NCT03320967|Coagulants|coagulants|mesh-ancestor
65736670|NCT03320967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65736671|NCT03320967|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65736672|NCT03320967|Natriuretic Agents|natriuretic agents|mesh-ancestor
65736673|NCT03320967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736674|NCT02483325|Fludarabine|fludarabine|mesh-list
65736675|NCT02483325|Busulfan|busulfan|mesh-list
65736676|NCT02483325|Thymoglobulin|thymoglobulin|mesh-list
65736677|NCT02483325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736678|NCT02483325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736679|NCT02483325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65736680|NCT02483325|Immunologic Factors|immunologic factors|mesh-ancestor
65736681|NCT02483325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736682|NCT02483325|Alkylating Agents|alkylating agents|mesh-ancestor
65736683|NCT02483325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65736684|NCT02483325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65736685|NCT04212026|Nivolumab|nivolumab|mesh-list
65736686|NCT04212026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65736687|NCT04212026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736688|NCT04212026|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65736689|NCT04212026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736690|NCT04211090|Carboplatin|carboplatin|mesh-list
65736691|NCT04211090|Pemetrexed|pemetrexed|mesh-list
65736692|NCT04211090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736693|NCT04211090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736694|NCT04211090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736695|NCT04211090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65736696|NCT04211090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65736697|NCT02486445|Rivaroxaban|rivaroxaban|mesh-list
65736698|NCT02486445|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65736699|NCT02486445|Antithrombins|antithrombins|mesh-ancestor
65736700|NCT02486445|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65736701|NCT02486445|Protease Inhibitors|protease inhibitors|mesh-ancestor
65736702|NCT02486445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736703|NCT02486445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736704|NCT02486445|Anticoagulants|anticoagulants|mesh-ancestor
65736705|NCT02836873|Bexagliflozin|bexagliflozin|mesh-list
65736706|NCT02836873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65736707|NCT02836873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736708|NCT04538534|Nicardipine|nicardipine|mesh-list
65736709|NCT04538534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65736710|NCT04538534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65736711|NCT04538534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65736712|NCT04538534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736713|NCT04538534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65736714|NCT04538534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736715|NCT04538534|Vasodilator Agents|vasodilator agents|mesh-ancestor
65736716|NCT03318159|Posaconazole|posaconazole|mesh-list
65736717|NCT03318159|Antifungal Agents|antifungal agents|mesh-ancestor
65736718|NCT03318159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65736719|NCT03318159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65736720|NCT03318159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65736721|NCT03318159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65736722|NCT03318159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65736723|NCT03318159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65736724|NCT03318159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736725|NCT03318159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736726|NCT03318159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65736727|NCT03318159|Hormone Antagonists|hormone antagonists|mesh-ancestor
65736728|NCT03318159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65736729|NCT03318159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736730|NCT03315507|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
65736731|NCT03315507|Vasodilator Agents|vasodilator agents|mesh-ancestor
65736732|NCT02724410|Amoxicillin|amoxicillin|mesh-list
65736733|NCT02724410|Clavulanic Acid|clavulanic acid|mesh-list
65736734|NCT02724410|Clavulanic Acids|clavulanic acids|mesh-list
65736735|NCT02724410|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65736736|NCT02724410|Ertapenem|ertapenem|mesh-list
65736737|NCT02724410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65736738|NCT02724410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65736739|NCT02724410|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65736740|NCT02724410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736741|NCT02724410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736742|NCT02486601|Paclitaxel|paclitaxel|mesh-list
65736743|NCT02486601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65736744|NCT02486601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736745|NCT02486601|Tubulin Modulators|tubulin modulators|mesh-ancestor
65736746|NCT02486601|Antimitotic Agents|antimitotic agents|mesh-ancestor
65736747|NCT02486601|Mitosis Modulators|mitosis modulators|mesh-ancestor
65736748|NCT02486601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736749|NCT03564379|JNJ-42165279|jnj-42165279|mesh-list
65736750|NCT03564379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736751|NCT03564379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736752|NCT03317847|Dexamethasone|dexamethasone|mesh-list
65736753|NCT03317847|Bromfenac|bromfenac|mesh-list
65736754|NCT03317847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65736755|NCT03317847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65736756|NCT03317847|Antiemetics|antiemetics|mesh-ancestor
65736757|NCT03317847|Autonomic Agents|autonomic agents|mesh-ancestor
65736758|NCT03317847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65736759|NCT03317847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736760|NCT03317847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65736761|NCT03317847|Glucocorticoids|glucocorticoids|mesh-ancestor
65736762|NCT03317847|Hormones|hormones|mesh-ancestor
65736763|NCT03317847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65736764|NCT03317847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65736765|NCT03317847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736766|NCT03317847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65736767|NCT03317847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65736768|NCT03317847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65199389|NCT05355311|Vitamins|vitamins|mesh-ancestor
65736769|NCT03317847|Analgesics|analgesics|mesh-ancestor
65736770|NCT03317847|Sensory System Agents|sensory system agents|mesh-ancestor
65736771|NCT03317847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65736772|NCT01342081|Timolol|timolol|mesh-list
65736773|NCT01342081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65736774|NCT01342081|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65736775|NCT01342081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65736776|NCT01342081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65736777|NCT01342081|Adrenergic Agents|adrenergic agents|mesh-ancestor
65736778|NCT01342081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65736779|NCT01342081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736780|NCT01342081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736781|NCT01342081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65736782|NCT01342081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65736783|NCT03563833|Anesthetics|anesthetics|mesh-list
65736784|NCT03563833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65736785|NCT03563833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736786|NCT02483169|Aspirin|aspirin|mesh-list
65736787|NCT02483169|Cilostazol|cilostazol|mesh-list
65736788|NCT02483169|Probucol|probucol|mesh-list
65736789|NCT02483169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65736790|NCT02483169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65736791|NCT02483169|Analgesics|analgesics|mesh-ancestor
65736792|NCT02483169|Sensory System Agents|sensory system agents|mesh-ancestor
65736793|NCT02483169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65736794|NCT02483169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736795|NCT02483169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65736796|NCT02483169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65736797|NCT02483169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65736798|NCT02483169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65736799|NCT02483169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736800|NCT02483169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65736801|NCT02483169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65736802|NCT02483169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736803|NCT02483169|Antipyretics|antipyretics|mesh-ancestor
65736804|NCT02483169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65736805|NCT02483169|Autonomic Agents|autonomic agents|mesh-ancestor
65736806|NCT02483169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65736807|NCT02483169|Respiratory System Agents|respiratory system agents|mesh-ancestor
65736808|NCT02483169|Vasodilator Agents|vasodilator agents|mesh-ancestor
65736809|NCT02483169|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65736810|NCT02483169|Protective Agents|protective agents|mesh-ancestor
65736811|NCT02483169|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65736812|NCT02483169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65736813|NCT02483169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65736814|NCT02483169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65736815|NCT02483169|Antimetabolites|antimetabolites|mesh-ancestor
65736816|NCT02483169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65736817|NCT02483169|Antioxidants|antioxidants|mesh-ancestor
65736818|NCT02256800|Leucovorin|leucovorin|mesh-list
65736819|NCT02256800|Bevacizumab|bevacizumab|mesh-list
65736820|NCT02256800|Irinotecan|irinotecan|mesh-list
65736821|NCT02256800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65736822|NCT02256800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736823|NCT02256800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65736824|NCT02256800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65736825|NCT02256800|Growth Substances|growth substances|mesh-ancestor
65736826|NCT02256800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736827|NCT02256800|Growth Inhibitors|growth inhibitors|mesh-ancestor
65736828|NCT02256800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65736829|NCT02256800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65736830|NCT02256800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736831|NCT02256800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736832|NCT02256800|Antidotes|antidotes|mesh-ancestor
65199463|NCT05161936|Lumasiran|lumasiran|mesh-list
65736833|NCT02256800|Protective Agents|protective agents|mesh-ancestor
65736834|NCT02256800|Vitamin B Complex|vitamin b complex|mesh-ancestor
65736835|NCT02256800|Vitamins|vitamins|mesh-ancestor
65736836|NCT02256800|Micronutrients|micronutrients|mesh-ancestor
65736837|NCT02489097|Nitrous Oxide|nitrous oxide|mesh-list
65736838|NCT02489097|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65736839|NCT02489097|Anesthetics, General|anesthetics, general|mesh-ancestor
65736840|NCT02489097|Anesthetics|anesthetics|mesh-ancestor
65736841|NCT02489097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65736842|NCT02489097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736843|NCT02489097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65736844|NCT02489097|Analgesics|analgesics|mesh-ancestor
65736845|NCT02489097|Sensory System Agents|sensory system agents|mesh-ancestor
65736846|NCT02489097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65736847|NCT02203682|Doxycycline|doxycycline|mesh-list
65736848|NCT02203682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65736849|NCT02203682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65736850|NCT02203682|Antimalarials|antimalarials|mesh-ancestor
65736851|NCT02203682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65736852|NCT02203682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65736853|NCT01611116|Sirolimus|sirolimus|mesh-list
65736854|NCT01611116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65736855|NCT01611116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65736856|NCT01611116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65736857|NCT01611116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736858|NCT01611116|Antifungal Agents|antifungal agents|mesh-ancestor
65736859|NCT01611116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65736860|NCT01611116|Immunologic Factors|immunologic factors|mesh-ancestor
65736861|NCT01611116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736862|NCT01341457|Gemcitabine|gemcitabine|mesh-list
65736863|NCT01341457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65736864|NCT01341457|Antimetabolites|antimetabolites|mesh-ancestor
65736865|NCT01341457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736866|NCT01341457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736867|NCT01341457|Antiviral Agents|antiviral agents|mesh-ancestor
65736868|NCT01341457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65736869|NCT01341457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736870|NCT01341457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65736871|NCT01341457|Immunologic Factors|immunologic factors|mesh-ancestor
65736872|NCT01341457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736873|NCT02488473|Dexmedetomidine|dexmedetomidine|mesh-list
65736874|NCT02488473|Ropivacaine|ropivacaine|mesh-list
65736875|NCT02488473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65736876|NCT02488473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65736877|NCT02488473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736878|NCT02488473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65736879|NCT02488473|Analgesics|analgesics|mesh-ancestor
65736880|NCT02488473|Sensory System Agents|sensory system agents|mesh-ancestor
65736881|NCT02488473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65736882|NCT02488473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65736883|NCT02488473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65736884|NCT02488473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65736885|NCT02488473|Adrenergic Agents|adrenergic agents|mesh-ancestor
65736886|NCT02488473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65736887|NCT02488473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736888|NCT02488473|Anesthetics, Local|anesthetics, local|mesh-ancestor
65736889|NCT02488473|Anesthetics|anesthetics|mesh-ancestor
65736890|NCT05128292|Selenium|selenium|mesh-list
65736891|NCT05128292|Antioxidants|antioxidants|mesh-ancestor
65736892|NCT05128292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736893|NCT05128292|Protective Agents|protective agents|mesh-ancestor
65736894|NCT05128292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736895|NCT05128292|Trace Elements|trace elements|mesh-ancestor
65736896|NCT05128292|Micronutrients|micronutrients|mesh-ancestor
65736897|NCT05127980|Antibodies|antibodies|mesh-list
65736898|NCT05127980|Autoantibodies|autoantibodies|mesh-list
65736899|NCT05127980|Immunologic Factors|immunologic factors|mesh-ancestor
65736900|NCT05127980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736901|NCT03971708|Lidocaine|lidocaine|mesh-list
65736902|NCT03971708|Ropivacaine|ropivacaine|mesh-list
65736903|NCT03971708|Anesthetics, Local|anesthetics, local|mesh-ancestor
65736904|NCT03971708|Anesthetics|anesthetics|mesh-ancestor
65736905|NCT03971708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65199545|NCT05023070|Cannabidiol|cannabidiol|mesh-list
65736906|NCT03971708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736907|NCT03971708|Sensory System Agents|sensory system agents|mesh-ancestor
65736908|NCT03971708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65736909|NCT03971708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65736910|NCT03971708|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65736911|NCT03971708|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65736912|NCT03971708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65736913|NCT03971708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736914|NCT02832037|BI 425809|bi 425809|mesh-list
65736915|NCT02832037|Nootropic Agents|nootropic agents|mesh-ancestor
65736916|NCT03966014|Amoxicillin|amoxicillin|mesh-list
65736917|NCT03966014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65736918|NCT03966014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65736919|NCT02482857|Aspirin|aspirin|mesh-list
65736920|NCT02482857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65736921|NCT02482857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65736922|NCT02482857|Analgesics|analgesics|mesh-ancestor
65736923|NCT02482857|Sensory System Agents|sensory system agents|mesh-ancestor
65736924|NCT02482857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65736925|NCT02482857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736926|NCT02482857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65736927|NCT02482857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65736928|NCT02482857|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65736929|NCT02482857|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65736930|NCT02482857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736931|NCT02482857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65736932|NCT02482857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65736933|NCT02482857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736934|NCT02482857|Antipyretics|antipyretics|mesh-ancestor
65736935|NCT05463393|Xanthohumol|xanthohumol|mesh-list
65736936|NCT05463393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736937|NCT05463393|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65736938|NCT05463393|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65736939|NCT05463393|Growth Substances|growth substances|mesh-ancestor
65736940|NCT05463393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736941|NCT05463393|Growth Inhibitors|growth inhibitors|mesh-ancestor
65736942|NCT03955172|Everolimus|everolimus|mesh-list
65736943|NCT03955172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736944|NCT03955172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65736945|NCT03955172|Immunologic Factors|immunologic factors|mesh-ancestor
65736946|NCT03955172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736947|NCT04200248|Aflibercept|aflibercept|mesh-list
65736948|NCT04200248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65736949|NCT04200248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65736950|NCT04200248|Growth Substances|growth substances|mesh-ancestor
65736951|NCT04200248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736952|NCT04200248|Growth Inhibitors|growth inhibitors|mesh-ancestor
65736953|NCT04200248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65736954|NCT02480049|Montelukast|montelukast|mesh-list
65736955|NCT02480049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65736956|NCT02480049|Respiratory System Agents|respiratory system agents|mesh-ancestor
65736957|NCT02480049|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65736958|NCT02480049|Hormone Antagonists|hormone antagonists|mesh-ancestor
65736959|NCT02480049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65736960|NCT02480049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65736961|NCT02480049|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65736962|NCT02480049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65736963|NCT02480049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736964|NCT02620046|Vedolizumab|vedolizumab|mesh-list
65736965|NCT02620046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65736966|NCT02479971|Clindamycin|clindamycin|mesh-list
65736967|NCT02479971|Clindamycin palmitate|clindamycin palmitate|mesh-list
65736968|NCT02479971|Clindamycin phosphate|clindamycin phosphate|mesh-list
65736969|NCT02479971|Gentamicins|gentamicins|mesh-list
65736970|NCT02479971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65736971|NCT02479971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65736972|NCT02479971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65736973|NCT02479971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736974|NCT02479971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736975|NCT02486133|Ritonavir|ritonavir|mesh-list
65736976|NCT02486133|Darunavir|darunavir|mesh-list
65736977|NCT02486133|Tenofovir|tenofovir|mesh-list
65736978|NCT02486133|Lamivudine|lamivudine|mesh-list
65736979|NCT02486133|Emtricitabine|emtricitabine|mesh-list
65736980|NCT02486133|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65736981|NCT02486133|Dolutegravir|dolutegravir|mesh-list
65736982|NCT02486133|Abacavir|abacavir|mesh-list
65736983|NCT02486133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65736984|NCT02486133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65736985|NCT02486133|Protease Inhibitors|protease inhibitors|mesh-ancestor
65736986|NCT02486133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65736987|NCT02486133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65736988|NCT02486133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65736989|NCT02486133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65736990|NCT02486133|Antiviral Agents|antiviral agents|mesh-ancestor
65736991|NCT02486133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65736992|NCT02486133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65736993|NCT02486133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65736994|NCT02486133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65736995|NCT02486133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65736996|NCT02486133|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65736997|NCT02486133|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65736998|NCT02486055|Coenzyme Q10|coenzyme q10|mesh-list
65736999|NCT02486055|Micronutrients|micronutrients|mesh-ancestor
65737000|NCT02486055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65737001|NCT02486055|Vitamins|vitamins|mesh-ancestor
65737002|NCT02486289|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
65737003|NCT02486289|Chelating Agents|chelating agents|mesh-ancestor
65737004|NCT02486289|Sequestering Agents|sequestering agents|mesh-ancestor
65737005|NCT02486289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65737006|NCT02485821|Misoprostol|misoprostol|mesh-list
65737007|NCT02485821|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65737008|NCT02485821|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65737009|NCT02485821|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65737010|NCT02485821|Estradiol|estradiol|mesh-list
65737011|NCT02485821|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65737012|NCT02485821|Estrogens|estrogens|mesh-ancestor
65737013|NCT02485821|Hormones|hormones|mesh-ancestor
65737014|NCT02485821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65737015|NCT02485821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65737016|NCT02485821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65737017|NCT02485821|Contraceptive Agents|contraceptive agents|mesh-ancestor
65737018|NCT02485821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65737019|NCT02485821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65737020|NCT02485821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65737021|NCT02485821|Abortifacient Agents|abortifacient agents|mesh-ancestor
65737022|NCT02485821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65737023|NCT02485821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65737024|NCT02485821|Oxytocics|oxytocics|mesh-ancestor
65737025|NCT02485821|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65737026|NCT02485821|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65737027|NCT02479815|Micronutrients|micronutrients|mesh-list
65737028|NCT02479815|Trace Elements|trace elements|mesh-list
65737029|NCT02479815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65737030|NCT04119830|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
65737031|NCT04119830|Pembrolizumab|pembrolizumab|mesh-list
65737032|NCT04119830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65737033|NCT04119830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65737034|NCT04119830|Antiviral Agents|antiviral agents|mesh-ancestor
65737035|NCT04119830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65737036|NCT04049786|Metoprolol|metoprolol|mesh-list
65737037|NCT04049786|Carvedilol|carvedilol|mesh-list
65737038|NCT04049786|Midazolam|midazolam|mesh-list
65737039|NCT04049786|Simvastatin|simvastatin|mesh-list
65737040|NCT04049786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65737041|NCT04049786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65737042|NCT04049786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65737043|NCT04049786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65737044|NCT04049786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65737045|NCT04049786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65737046|NCT04049786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65737047|NCT04049786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65737048|NCT04049786|Anesthetics, General|anesthetics, general|mesh-ancestor
65737049|NCT04049786|Anesthetics|anesthetics|mesh-ancestor
65737050|NCT04049786|GABA Modulators|gaba modulators|mesh-ancestor
65737051|NCT04049786|GABA Agents|gaba agents|mesh-ancestor
65737052|NCT04049786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65737053|NCT04049786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65737054|NCT04049786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65737055|NCT04049786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65737056|NCT04049786|Antimetabolites|antimetabolites|mesh-ancestor
65737057|NCT04049786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65737058|NCT04049786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65737059|NCT04049786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65737060|NCT04049786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65737061|NCT04049786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65737062|NCT04049786|Sympatholytics|sympatholytics|mesh-ancestor
65737063|NCT04049786|Autonomic Agents|autonomic agents|mesh-ancestor
65737064|NCT04049786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65737065|NCT04049786|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65737066|NCT04049786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65737067|NCT04049786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65737068|NCT04049786|Adrenergic Agents|adrenergic agents|mesh-ancestor
65737069|NCT04049786|Antioxidants|antioxidants|mesh-ancestor
65737070|NCT04049786|Protective Agents|protective agents|mesh-ancestor
65737071|NCT04049786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65737072|NCT04049786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65737073|NCT04049786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65737074|NCT04049786|Vasodilator Agents|vasodilator agents|mesh-ancestor
65737075|NCT04049786|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65737076|NCT04049786|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65737077|NCT02482311|Adavosertib|adavosertib|mesh-list
65737078|NCT02482311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65737079|NCT02482311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65737080|NCT02482077|Sofosbuvir|sofosbuvir|mesh-list
65737081|NCT02482077|Antiviral Agents|antiviral agents|mesh-ancestor
65737082|NCT02482077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65737083|NCT03316599|Gemcitabine|gemcitabine|mesh-list
65737084|NCT03316599|Paclitaxel|paclitaxel|mesh-list
65737085|NCT03316599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65737086|NCT03316599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65737087|NCT03316599|Tubulin Modulators|tubulin modulators|mesh-ancestor
65737088|NCT03316599|Antimitotic Agents|antimitotic agents|mesh-ancestor
65737089|NCT03316599|Mitosis Modulators|mitosis modulators|mesh-ancestor
65737090|NCT03316599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65737091|NCT03316599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65737092|NCT03316599|Antimetabolites|antimetabolites|mesh-ancestor
65737093|NCT03316599|Antiviral Agents|antiviral agents|mesh-ancestor
65737094|NCT03316599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65737095|NCT03316599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65737096|NCT03316599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65737097|NCT03316599|Immunologic Factors|immunologic factors|mesh-ancestor
65737098|NCT03316599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65737099|NCT02482155|Ibuprofen|ibuprofen|mesh-list
65737100|NCT02482155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65737101|NCT02482155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65737102|NCT02482155|Analgesics|analgesics|mesh-ancestor
65737103|NCT02482155|Sensory System Agents|sensory system agents|mesh-ancestor
65737104|NCT02482155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65737105|NCT02482155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65737106|NCT02482155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65737107|NCT02482155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65737108|NCT02482155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65737109|NCT02482155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65737110|NCT02482155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65737111|NCT01675154|Orlistat|orlistat|mesh-list
65737112|NCT01675154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65737113|NCT01675154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65737114|NCT01675154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65737115|NCT01675154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65737116|NCT02485431|Deflazacort|deflazacort|mesh-list
65737117|NCT02485431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65737118|NCT02485431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65737119|NCT02485431|Immunologic Factors|immunologic factors|mesh-ancestor
65737120|NCT02485431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65737121|NCT02744755|Adalimumab|adalimumab|mesh-list
65737122|NCT02744755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65737123|NCT02744755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65737124|NCT03314493|Spironolactone|spironolactone|mesh-list
65737125|NCT03314493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65737126|NCT03314493|Hormone Antagonists|hormone antagonists|mesh-ancestor
65737127|NCT03314493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65737128|NCT03314493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65737129|NCT03314493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65737130|NCT03314493|Diuretics|diuretics|mesh-ancestor
65737131|NCT03314493|Natriuretic Agents|natriuretic agents|mesh-ancestor
65737132|NCT03829514|Fenofibrate|fenofibrate|mesh-list
65737133|NCT03829514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65737134|NCT03829514|Antimetabolites|antimetabolites|mesh-ancestor
65737135|NCT03829514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65737136|NCT03829514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65737137|NCT03801200|Apatinib|apatinib|mesh-list
65737138|NCT03801200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65737139|NCT03801200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65737140|NCT03801200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65737141|NCT03801200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65737142|NCT03801122|Tranexamic Acid|tranexamic acid|mesh-list
65737143|NCT03801122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65737144|NCT03801122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65737145|NCT03801122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65737146|NCT03801122|Hemostatics|hemostatics|mesh-ancestor
65737147|NCT03801122|Coagulants|coagulants|mesh-ancestor
65737148|NCT02485041|Mirodenafil|mirodenafil|mesh-list
65737149|NCT02485041|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65737150|NCT02485041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65737151|NCT02485041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65737152|NCT02485041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65737153|NCT02484885|Xenon|xenon|mesh-list
65737154|NCT02484885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65737155|NCT02484885|Anesthetics, General|anesthetics, general|mesh-ancestor
65737156|NCT02484885|Anesthetics|anesthetics|mesh-ancestor
65737157|NCT02484885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65737158|NCT02484885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65737159|NCT02484963|Zolpidem|zolpidem|mesh-list
65737160|NCT02484963|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65737161|NCT02484963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65737162|NCT02484963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65737163|NCT02484963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65737164|NCT02484963|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65737165|NCT02484963|GABA Agonists|gaba agonists|mesh-ancestor
65737166|NCT02484963|GABA Agents|gaba agents|mesh-ancestor
65737167|NCT02484963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65737168|NCT02484963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65737169|NCT05713773|Caffeine|caffeine|mesh-list
65737170|NCT05713773|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65737171|NCT05713773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65737172|NCT05713773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65737173|NCT05713773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65737174|NCT05713773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65737175|NCT05713773|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65737176|NCT05713773|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65737177|NCT05713773|Purinergic Agents|purinergic agents|mesh-ancestor
65737178|NCT05713773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65737179|NCT05708053|Metformin|metformin|mesh-list
65737180|NCT05708053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65737181|NCT05708053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65737182|NCT02829775|Interferons|interferons|mesh-list
65737183|NCT02829775|Interferon-alpha|interferon-alpha|mesh-list
65737184|NCT02829775|Interferon alpha-2|interferon alpha-2|mesh-list
65737185|NCT02829775|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65737186|NCT02829775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65737187|NCT02829775|Antiviral Agents|antiviral agents|mesh-ancestor
65737188|NCT02829775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65737189|NCT02829775|Immunologic Factors|immunologic factors|mesh-ancestor
65199851|NCT04084171|Insulin|insulin|mesh-list
65737190|NCT02829775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65737191|NCT02476773|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65737192|NCT02476773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65737193|NCT02476773|Immunologic Factors|immunologic factors|mesh-ancestor
65737194|NCT02476773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65737195|NCT02476773|Antacids|antacids|mesh-ancestor
65737196|NCT02476773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65737197|NCT02476773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65737198|NCT04500860|Tadalafil|tadalafil|mesh-list
65737199|NCT04500860|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65737200|NCT04500860|Vasodilator Agents|vasodilator agents|mesh-ancestor
65737201|NCT04500860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65737202|NCT04500860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65737203|NCT04500860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65737204|NCT04500860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65737205|NCT04500860|Urological Agents|urological agents|mesh-ancestor
65737206|NCT04500860|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65737207|NCT04500860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65737208|NCT04500860|Cholinergic Agents|cholinergic agents|mesh-ancestor
65737209|NCT04500860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65737210|NCT04500860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65737211|NCT02479503|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65737212|NCT02479503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65737213|NCT02479581|Floxacillin|floxacillin|mesh-list
65737214|NCT02479581|Dexamethasone|dexamethasone|mesh-list
65737215|NCT02479581|Methylprednisolone|methylprednisolone|mesh-list
65737216|NCT02479581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65737217|NCT02479581|Scopolamine|scopolamine|mesh-list
65737218|NCT02479581|Morphine|morphine|mesh-list
65737219|NCT02479581|Anesthetics|anesthetics|mesh-list
65737220|NCT02479581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65737221|NCT02479581|Antiemetics|antiemetics|mesh-ancestor
65737222|NCT02479581|Autonomic Agents|autonomic agents|mesh-ancestor
65737223|NCT02479581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65737224|NCT02479581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65737225|NCT02479581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65737226|NCT02479581|Glucocorticoids|glucocorticoids|mesh-ancestor
65737227|NCT02479581|Hormones|hormones|mesh-ancestor
65737228|NCT02479581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65737229|NCT02479581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65737230|NCT02479581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65737231|NCT02479581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65737232|NCT02479581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65737233|NCT02479581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65737234|NCT02479581|Narcotics|narcotics|mesh-ancestor
65737235|NCT02479581|Analgesics|analgesics|mesh-ancestor
65737236|NCT02479581|Sensory System Agents|sensory system agents|mesh-ancestor
65737237|NCT02479581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65737238|NCT02479581|Protective Agents|protective agents|mesh-ancestor
65737239|NCT02479581|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65737240|NCT02479581|Mydriatics|mydriatics|mesh-ancestor
65737241|NCT02479581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65737242|NCT02479581|Cholinergic Agents|cholinergic agents|mesh-ancestor
65737243|NCT02479581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65737244|NCT02479581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65737245|NCT02479581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65737246|NCT02479581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65737247|NCT02479347|Chlorhexidine|chlorhexidine|mesh-list
65737248|NCT02479347|Povidone-Iodine|povidone-iodine|mesh-list
65737249|NCT02479347|Povidone|povidone|mesh-list
65737250|NCT02479347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65737251|NCT02479347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65737252|NCT02479347|Disinfectants|disinfectants|mesh-ancestor
65737253|NCT02479347|Plasma Substitutes|plasma substitutes|mesh-ancestor
65737254|NCT02479347|Blood Substitutes|blood substitutes|mesh-ancestor
65737255|NCT05467293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65737256|NCT05467293|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65737257|NCT05125718|Anti-Infective Agents|anti-infective agents|mesh-list
65737258|NCT05125718|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65737259|NCT02481609|Acetylcysteine|acetylcysteine|mesh-list
65737260|NCT02481609|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65737261|NCT02481609|Antiviral Agents|antiviral agents|mesh-ancestor
65737262|NCT02481609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65737263|NCT02481609|Expectorants|expectorants|mesh-ancestor
65737264|NCT02481609|Respiratory System Agents|respiratory system agents|mesh-ancestor
65737265|NCT02481609|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65737266|NCT02481609|Antioxidants|antioxidants|mesh-ancestor
65737267|NCT02481609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65737268|NCT02481609|Protective Agents|protective agents|mesh-ancestor
65737269|NCT02481609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65737270|NCT02481609|Antidotes|antidotes|mesh-ancestor
65737271|NCT05373225|Acetic Acid|acetic acid|mesh-list
65737272|NCT05373225|Retinol acetate|retinol acetate|mesh-list
65737273|NCT05373225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65737274|NCT05373225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65737275|NCT05373225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65737276|NCT05373225|Immunologic Factors|immunologic factors|mesh-ancestor
65737277|NCT05373225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65737278|NCT05373225|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65737279|NCT05373225|Protective Agents|protective agents|mesh-ancestor
65737280|NCT05373225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65737282|NCT01355575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65737283|NCT01355575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65737284|NCT01355575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65737285|NCT05125640|Progesterone|progesterone|mesh-list
65737286|NCT05125640|Progestins|progestins|mesh-ancestor
65737287|NCT05125640|Hormones|hormones|mesh-ancestor
65737288|NCT05125640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65737289|NCT05125640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65737290|NCT03314259|Tamsulosin|tamsulosin|mesh-list
65737291|NCT03314259|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65737292|NCT03314259|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65737293|NCT03314259|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65737294|NCT03314259|Adrenergic Agents|adrenergic agents|mesh-ancestor
65737295|NCT03314259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65737296|NCT03314259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65737297|NCT03314259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65737298|NCT03314259|Urological Agents|urological agents|mesh-ancestor
65737299|NCT05125328|Remifentanil|remifentanil|mesh-list
65737300|NCT05125328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65737301|NCT05125328|Narcotics|narcotics|mesh-ancestor
65737302|NCT05125328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65737303|NCT05125328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65737304|NCT05125328|Analgesics|analgesics|mesh-ancestor
65737305|NCT05125328|Sensory System Agents|sensory system agents|mesh-ancestor
65737306|NCT05125328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65737307|NCT02481453|Sirolimus|sirolimus|mesh-list
65737308|NCT02481453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65737309|NCT02481453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65737310|NCT02481453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65737311|NCT02481453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65737312|NCT02481453|Antifungal Agents|antifungal agents|mesh-ancestor
65737313|NCT02481453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65737314|NCT02481453|Immunologic Factors|immunologic factors|mesh-ancestor
65737315|NCT02481453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65737316|NCT02825251|Insulin|insulin|mesh-list
65737317|NCT02825251|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65737318|NCT02825251|Insulin Aspart|insulin aspart|mesh-list
65737319|NCT02825251|Insulin, Long-Acting|insulin, long-acting|mesh-list
65737320|NCT02825251|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65737321|NCT02825251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65737322|NCT02825251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65737323|NCT03563365|Adapalene|adapalene|mesh-list
65737324|NCT03563365|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65737325|NCT03563365|Resveratrol|resveratrol|mesh-list
65737326|NCT03563365|Antioxidants|antioxidants|mesh-ancestor
65737327|NCT03563365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65737328|NCT03563365|Protective Agents|protective agents|mesh-ancestor
65737329|NCT03563365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65737330|NCT03563365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65737331|NCT03563365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65737332|NCT03563365|Dermatologic Agents|dermatologic agents|mesh-ancestor
65737333|NCT03563365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65737334|NCT03563365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65737335|NCT03563365|Analgesics|analgesics|mesh-ancestor
65737336|NCT03563365|Sensory System Agents|sensory system agents|mesh-ancestor
65737337|NCT03563365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65737338|NCT03563365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65737339|NCT03563365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65737340|NCT02475915|Tenofovir|tenofovir|mesh-list
65737341|NCT02475915|Emtricitabine|emtricitabine|mesh-list
65737342|NCT02475915|Efavirenz|efavirenz|mesh-list
65737343|NCT02475915|Maraviroc|maraviroc|mesh-list
65737344|NCT02475915|Darunavir|darunavir|mesh-list
65737345|NCT02475915|Hydroxychloroquine|hydroxychloroquine|mesh-list
65737346|NCT02475915|Vorinostat|vorinostat|mesh-list
65737347|NCT02475915|Antiviral Agents|antiviral agents|mesh-ancestor
65737348|NCT02475915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494063|NCT03743636|Niacin|niacin|mesh-list
65737349|NCT02475915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65737350|NCT02475915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65737351|NCT02475915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65737352|NCT02475915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65737353|NCT02475915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65737354|NCT02475915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65737355|NCT02475915|Antimalarials|antimalarials|mesh-ancestor
65737356|NCT02475915|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65737357|NCT02475915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65737358|NCT02475915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65737359|NCT02475915|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65737360|NCT02475915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65737361|NCT02475915|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65737362|NCT02475915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65737363|NCT02475915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65737364|NCT02475915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65737365|NCT02475915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65737366|NCT02475915|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65737367|NCT02475915|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65737368|NCT02475915|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65737369|NCT02475915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65737370|NCT02475915|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65737371|NCT02475915|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65737372|NCT02475915|Protease Inhibitors|protease inhibitors|mesh-ancestor
65737373|NCT05124457|Insulin|insulin|mesh-list
65737374|NCT05124457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65737375|NCT05124457|Insulin Detemir|insulin detemir|mesh-list
65737376|NCT05124457|Isophane Insulin, Human|isophane insulin, human|mesh-list
65737377|NCT05124457|Insulin, Isophane|insulin, isophane|mesh-list
65737378|NCT05124457|Isophane insulin, beef|isophane insulin, beef|mesh-list
65737379|NCT05124457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65737380|NCT05124457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053375|NCT00236769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65054062|NCT00202163|Testosterone|testosterone|mesh-list
65054131|NCT02962310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65054354|NCT00259428|Dronedarone|dronedarone|mesh-list
65054429|NCT04559308|Alkylating Agents|alkylating agents|mesh-ancestor
65054661|NCT04566211|Amoxicillin|amoxicillin|mesh-list
65054777|NCT04564456|Xhance|xhance|mesh-list
65054804|NCT04564144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65054877|NCT00259974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054954|NCT00233051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65055103|NCT00260364|Antiviral Agents|antiviral agents|mesh-ancestor
65055175|NCT00234026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055848|NCT02212795|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65055922|NCT02213029|Oxytocin|oxytocin|mesh-list
65056972|NCT00238082|Glucocorticoids|glucocorticoids|mesh-ancestor
65057276|NCT04534231|Nicotine|nicotine|mesh-list
65057350|NCT00238940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057495|NCT00263484|Thalidomide|thalidomide|mesh-list
65057941|NCT04720287|Bupivacaine|bupivacaine|mesh-list
65058091|NCT00240422|Ramipril|ramipril|mesh-list
65058166|NCT01649635|Hormones|hormones|mesh-ancestor
65058469|NCT00241124|Valsartan|valsartan|mesh-list
65058610|NCT04529512|Dexamethasone|dexamethasone|mesh-list
65059448|NCT00245453|Azithromycin|azithromycin|mesh-list
65059806|NCT00247208|Paclitaxel|paclitaxel|mesh-list
65060031|NCT00248261|Dopamine Agents|dopamine agents|mesh-ancestor
65060779|NCT04823065|Scopolamine|scopolamine|mesh-list
65061153|NCT05139667|Immunologic Factors|immunologic factors|mesh-ancestor
65061400|NCT01681537|Analgesics|analgesics|mesh-ancestor
65061535|NCT04527562|Antimitotic Agents|antimitotic agents|mesh-ancestor
65061611|NCT00416910|Analgesics|analgesics|mesh-ancestor
65061836|NCT01686607|Anidulafungin|anidulafungin|mesh-list
65061914|NCT00281931|Antimetabolites|antimetabolites|mesh-ancestor
65062297|NCT00288873|Vitamin D|vitamin d|mesh-list
65062432|NCT04719104|Bilirubin|bilirubin|mesh-list
65062734|NCT00256178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65062889|NCT02270749|Vitamin B Complex|vitamin b complex|mesh-ancestor
65063708|NCT00290940|Pioglitazone|pioglitazone|mesh-list
65064022|NCT00272064|Insulin|insulin|mesh-list
65064083|NCT00292071|Caspofungin|caspofungin|mesh-list
65064594|NCT00261872|Dopamine Agents|dopamine agents|mesh-ancestor
65064748|NCT00299286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064898|NCT00299754|Misoprostol|misoprostol|mesh-list
65066427|NCT00298194|Z 338|z 338|mesh-list
65066601|NCT00306774|Vitamin D|vitamin d|mesh-list
65243624|NCT00976937|Metformin|metformin|mesh-list
65244051|NCT02864927|Vaccines|vaccines|mesh-list
65244197|NCT00864513|Pemetrexed|pemetrexed|mesh-list
65244501|NCT00806923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65244502|NCT00806923|Immunologic Factors|immunologic factors|mesh-ancestor
65244503|NCT00698607|Sirolimus|sirolimus|mesh-list
65244504|NCT00698607|Everolimus|everolimus|mesh-list
65244579|NCT00800293|Betamethasone|betamethasone|mesh-list
65244580|NCT00800293|Betamethasone Valerate|betamethasone valerate|mesh-list
65244581|NCT00800293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65244582|NCT00800293|Betamethasone benzoate|betamethasone benzoate|mesh-list
65245121|NCT02612649|Ramosetron|ramosetron|mesh-list
65246597|NCT00638443|Anesthetics, Local|anesthetics, local|mesh-ancestor
65247056|NCT04029116|Fluconazole|fluconazole|mesh-list
65247199|NCT00828763|Dolutegravir|dolutegravir|mesh-list
65247570|NCT00623545|Hormones|hormones|mesh-ancestor
65247727|NCT02839122|Tadalafil|tadalafil|mesh-list
65249003|NCT05018520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249225|NCT00573937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65249316|NCT00839761|Iron|iron|mesh-list
65250123|NCT05636904|Abortifacient Agents|abortifacient agents|mesh-ancestor
65250650|NCT00853177|Lidocaine|lidocaine|mesh-list
65250734|NCT00961961|Fluoxetine|fluoxetine|mesh-list
65251026|NCT04282031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65251099|NCT02799888|Dermatologic Agents|dermatologic agents|mesh-ancestor
65251173|NCT02610153|Hemostatics|hemostatics|mesh-ancestor
65251270|NCT04235478|Hormones|hormones|mesh-ancestor
65251547|NCT02802072|Aspirin|aspirin|mesh-list
65252089|NCT00871273|Capecitabine|capecitabine|mesh-list
65252590|NCT02362997|Pembrolizumab|pembrolizumab|mesh-list
65252667|NCT02787018|Analgesics|analgesics|mesh-ancestor
65252890|NCT02784054|Melphalan|melphalan|mesh-list
65253046|NCT00878449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65253271|NCT05275686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65253803|NCT02779608|Docetaxel|docetaxel|mesh-list
65253889|NCT04227990|Docetaxel|docetaxel|mesh-list
65253946|NCT00803361|Analgesics|analgesics|mesh-ancestor
65254243|NCT02836184|Micronutrients|micronutrients|mesh-ancestor
65254244|NCT02836184|Antacids|antacids|mesh-ancestor
65254556|NCT02767674|Hormones|hormones|mesh-ancestor
65255231|NCT00887263|Budesonide|budesonide|mesh-list
65255519|NCT01786265|Leuprolide|leuprolide|mesh-list
65255747|NCT04113915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65255969|NCT00798135|Itraconazole|itraconazole|mesh-list
65256345|NCT00606229|Serotonin Agents|serotonin agents|mesh-ancestor
65256566|NCT02603991|Anticonvulsants|anticonvulsants|mesh-ancestor
65256802|NCT02540395|Hormones|hormones|mesh-ancestor
65257239|NCT04220892|Pemetrexed|pemetrexed|mesh-list
65257314|NCT02831972|Hormone Antagonists|hormone antagonists|mesh-ancestor
65257760|NCT00915915|Estrogens|estrogens|mesh-ancestor
65257832|NCT04241276|Paclitaxel|paclitaxel|mesh-list
65257908|NCT00633698|Vitamins|vitamins|mesh-ancestor
65258285|NCT00606437|Fludarabine|fludarabine|mesh-list
65258520|NCT00931645|Antiemetics|antiemetics|mesh-ancestor
65258889|NCT02819648|Hormones|hormones|mesh-ancestor
65259639|NCT05787574|Fludarabine|fludarabine|mesh-list
65259802|NCT05739136|Estradiol|estradiol|mesh-list
65259936|NCT05639972|Antiviral Agents|antiviral agents|mesh-ancestor
65259937|NCT05639972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65259938|NCT05622318|Mycophenolic Acid|mycophenolic acid|mesh-list
65259939|NCT05622318|Cyclophosphamide|cyclophosphamide|mesh-list
65259940|NCT05622318|Tacrolimus|tacrolimus|mesh-list
65259941|NCT05622318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65259942|NCT05622318|Immunologic Factors|immunologic factors|mesh-ancestor
65259943|NCT05622318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259944|NCT05622318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65259945|NCT05622318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65260012|NCT05535309|Renal Agents|renal agents|mesh-ancestor
65260310|NCT05247268|Appetite Stimulants|appetite stimulants|mesh-ancestor
65260311|NCT05247268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65260313|NCT05211804|Aflibercept|aflibercept|mesh-list
65260314|NCT05211804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260315|NCT05211804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65260316|NCT05211804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65260317|NCT05211804|Growth Substances|growth substances|mesh-ancestor
65260318|NCT05211804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260536|NCT04827056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65260537|NCT04827056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65260538|NCT04827056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260539|NCT04827056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65260540|NCT04827056|Analgesics|analgesics|mesh-ancestor
65260541|NCT04827056|Sensory System Agents|sensory system agents|mesh-ancestor
65260609|NCT04637282|Gemfibrozil|gemfibrozil|mesh-list
65260761|NCT04391764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65260771|NCT04339062|Sirolimus|sirolimus|mesh-list
65260772|NCT04339062|Prednisone|prednisone|mesh-list
65260773|NCT04339062|Everolimus|everolimus|mesh-list
65260774|NCT04339062|Cemiplimab|cemiplimab|mesh-list
65260775|NCT04339062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65260776|NCT04339062|Glucocorticoids|glucocorticoids|mesh-ancestor
65260777|NCT04339062|Hormones|hormones|mesh-ancestor
65260779|NCT04339062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260836|NCT04158141|Carboplatin|carboplatin|mesh-list
65260986|NCT03785925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65260987|NCT03785925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260988|NCT03785925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65260989|NCT03785925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260997|NCT03752398|Ipilimumab|ipilimumab|mesh-list
65260999|NCT03752398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261138|NCT03070886|Bicalutamide|bicalutamide|mesh-list
65261139|NCT03070886|Flutamide|flutamide|mesh-list
65261140|NCT03070886|Nilutamide|nilutamide|mesh-list
65261141|NCT03070886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261142|NCT03070886|Tubulin Modulators|tubulin modulators|mesh-ancestor
65261143|NCT03070886|Antimitotic Agents|antimitotic agents|mesh-ancestor
65261144|NCT03070886|Mitosis Modulators|mitosis modulators|mesh-ancestor
65261146|NCT03070886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65261291|NCT02506153|Interferons|interferons|mesh-list
65261365|NCT02160015|Growth Substances|growth substances|mesh-ancestor
65270082|NCT02716142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65270083|NCT02716142|Abortifacient Agents|abortifacient agents|mesh-ancestor
65270084|NCT02716142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65270085|NCT02716142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270086|NCT02716142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65270087|NCT02716142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65270088|NCT02716142|Oxytocics|oxytocics|mesh-ancestor
65270089|NCT03015974|Mycophenolic Acid|mycophenolic acid|mesh-list
65270091|NCT03015974|Prednisolone|prednisolone|mesh-list
65270092|NCT03015974|Deflazacort|deflazacort|mesh-list
65270093|NCT03015974|Cyclophosphamide|cyclophosphamide|mesh-list
65270094|NCT03015974|Dipyridamole|dipyridamole|mesh-list
65270095|NCT03015974|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65270096|NCT03015974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65270097|NCT03015974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65270098|NCT03015974|Immunologic Factors|immunologic factors|mesh-ancestor
65270099|NCT03015974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270100|NCT03015974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65270101|NCT03015974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65270102|NCT03015974|Alkylating Agents|alkylating agents|mesh-ancestor
65270103|NCT03015974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270104|NCT03015974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270105|NCT03015974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65270106|NCT03015974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65270107|NCT03015974|Glucocorticoids|glucocorticoids|mesh-ancestor
65270108|NCT03015974|Hormones|hormones|mesh-ancestor
65270109|NCT03015974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65270110|NCT03015974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65270111|NCT03015974|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65270112|NCT03015974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65270113|NCT03015974|Antitubercular Agents|antitubercular agents|mesh-ancestor
65270114|NCT03015974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65270115|NCT03015974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65270116|NCT03015974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270117|NCT03015974|Protease Inhibitors|protease inhibitors|mesh-ancestor
65270118|NCT03015974|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65270119|NCT03015974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65270120|NCT03015974|Vasodilator Agents|vasodilator agents|mesh-ancestor
65270121|NCT02718950|Liraglutide|liraglutide|mesh-list
65270122|NCT02718950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65270123|NCT02718950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270124|NCT02718950|Incretins|incretins|mesh-ancestor
65270125|NCT02718950|Hormones|hormones|mesh-ancestor
65270126|NCT02718950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65270127|NCT02725502|Linagliptin|linagliptin|mesh-list
65270128|NCT02725502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65270129|NCT02725502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270130|NCT02725502|Incretins|incretins|mesh-ancestor
65270131|NCT02725502|Hormones|hormones|mesh-ancestor
65270132|NCT02725502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65270133|NCT02725502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65270134|NCT02725502|Protease Inhibitors|protease inhibitors|mesh-ancestor
65270135|NCT02725502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270136|NCT02725502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270137|NCT02718716|Rozanolixizumab|rozanolixizumab|mesh-list
65270138|NCT02718716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65270139|NCT02718716|Immunologic Factors|immunologic factors|mesh-ancestor
65270140|NCT02718716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270141|NCT04153136|Valsartan|valsartan|mesh-list
65270142|NCT04153136|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65270143|NCT04153136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65270144|NCT04153136|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65270145|NCT04153136|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65270146|NCT04153136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270147|NCT01959464|Progesterone|progesterone|mesh-list
65270148|NCT01959464|Progestins|progestins|mesh-ancestor
65270149|NCT01959464|Hormones|hormones|mesh-ancestor
65270150|NCT01959464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65270151|NCT01959464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270152|NCT02718482|Gemcitabine|gemcitabine|mesh-list
65270153|NCT02718482|Docetaxel|docetaxel|mesh-list
65270154|NCT02718482|Ifosfamide|ifosfamide|mesh-list
65270155|NCT02718482|Isophosphamide mustard|isophosphamide mustard|mesh-list
65270156|NCT02718482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65270158|NCT02718482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270159|NCT02718482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270160|NCT02718482|Antiviral Agents|antiviral agents|mesh-ancestor
65270161|NCT02718482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65270162|NCT02718482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270163|NCT02718482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65270164|NCT02718482|Immunologic Factors|immunologic factors|mesh-ancestor
65270165|NCT02718482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270166|NCT02718482|Tubulin Modulators|tubulin modulators|mesh-ancestor
65270167|NCT02718482|Antimitotic Agents|antimitotic agents|mesh-ancestor
65270168|NCT02718482|Mitosis Modulators|mitosis modulators|mesh-ancestor
65270169|NCT02718482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65270170|NCT02718482|Alkylating Agents|alkylating agents|mesh-ancestor
65270171|NCT01921166|Leuprolide|leuprolide|mesh-list
65270172|NCT01921166|Clomiphene|clomiphene|mesh-list
65270173|NCT01921166|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65270174|NCT01921166|Fertility Agents|fertility agents|mesh-ancestor
65270175|NCT01921166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65270176|NCT01921166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270177|NCT01921166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65270178|NCT01921166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270179|NCT01921166|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65270180|NCT01921166|Hormone Antagonists|hormone antagonists|mesh-ancestor
65270181|NCT01921166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65270182|NCT01921166|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65270183|NCT01921166|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65270184|NCT05087030|Denosumab|denosumab|mesh-list
65270185|NCT05087030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65270186|NCT05087030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270187|NCT02717858|Liraglutide|liraglutide|mesh-list
65270188|NCT02717858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65270189|NCT02717858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270190|NCT02717858|Incretins|incretins|mesh-ancestor
65270191|NCT02717858|Hormones|hormones|mesh-ancestor
65270192|NCT02717858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65270193|NCT02725112|Pregabalin|pregabalin|mesh-list
65270194|NCT02725112|Analgesics|analgesics|mesh-ancestor
65270195|NCT02725112|Sensory System Agents|sensory system agents|mesh-ancestor
65270196|NCT02725112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65270197|NCT02725112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270198|NCT02725112|Anticonvulsants|anticonvulsants|mesh-ancestor
65270199|NCT02725112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65270200|NCT02725112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65270201|NCT02725112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270202|NCT02725112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65270203|NCT02725112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65270204|NCT02725112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65270205|NCT02725112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65270206|NCT02725112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65270207|NCT02724332|Sirolimus|sirolimus|mesh-list
65270208|NCT02724332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65270209|NCT02724332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65270210|NCT02724332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65270211|NCT02724332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270212|NCT02724332|Antifungal Agents|antifungal agents|mesh-ancestor
65270213|NCT02724332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65270214|NCT02724332|Immunologic Factors|immunologic factors|mesh-ancestor
65270215|NCT02724332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270216|NCT02717780|Fentanyl|fentanyl|mesh-list
65270217|NCT02717780|Remifentanil|remifentanil|mesh-list
65270218|NCT02717780|Sevoflurane|sevoflurane|mesh-list
65270219|NCT02717780|Desflurane|desflurane|mesh-list
65270220|NCT02717780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65270221|NCT02717780|Narcotics|narcotics|mesh-ancestor
65270222|NCT02717780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65020225|NCT05292339|Ketorolac|ketorolac|mesh-list
65270223|NCT02717780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270225|NCT02717780|Sensory System Agents|sensory system agents|mesh-ancestor
65270226|NCT02717780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65270227|NCT02717780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65270228|NCT02717780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65270229|NCT02717780|Anesthetics, General|anesthetics, general|mesh-ancestor
65270230|NCT02717780|Anesthetics|anesthetics|mesh-ancestor
65270231|NCT02717780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65270232|NCT02717780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65270233|NCT04070378|Daratumumab|daratumumab|mesh-list
65270234|NCT04070378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270235|NCT02724098|Dexmedetomidine|dexmedetomidine|mesh-list
65270236|NCT02724098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65270237|NCT02724098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65270238|NCT02724098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270239|NCT02724098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65270240|NCT02724098|Analgesics|analgesics|mesh-ancestor
65270241|NCT02724098|Sensory System Agents|sensory system agents|mesh-ancestor
65270242|NCT02724098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65270243|NCT02724098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65270244|NCT02724098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65270245|NCT02724098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65270246|NCT02724098|Adrenergic Agents|adrenergic agents|mesh-ancestor
65270247|NCT02724098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65270248|NCT02724098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270249|NCT04138316|Candesartan|candesartan|mesh-list
65270250|NCT04138316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65270251|NCT04138316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65270252|NCT04138316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65270253|NCT04138316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270254|NCT05291390|Pyronaridine|pyronaridine|mesh-list
65270255|NCT05291390|Antimalarials|antimalarials|mesh-ancestor
65270256|NCT05291390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65270257|NCT05291390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65270258|NCT05291390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65270259|NCT04189484|Evolocumab|evolocumab|mesh-list
65270260|NCT04189484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65270261|NCT04189484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65270262|NCT04189484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65270263|NCT04189484|Antimetabolites|antimetabolites|mesh-ancestor
65270264|NCT04189484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270265|NCT04189484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65270266|NCT04189484|Immunologic Factors|immunologic factors|mesh-ancestor
65270267|NCT04189484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270268|NCT00636740|Zoledronic Acid|zoledronic acid|mesh-list
65270269|NCT00636740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65270270|NCT00636740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270271|NCT02716766|Capecitabine|capecitabine|mesh-list
65270272|NCT02716766|Oxaliplatin|oxaliplatin|mesh-list
65270273|NCT02716766|Sorafenib|sorafenib|mesh-list
65270274|NCT02716766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65270275|NCT02716766|Antimetabolites|antimetabolites|mesh-ancestor
65270276|NCT02716766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270277|NCT02716766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270278|NCT02716766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65270279|NCT02716766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270280|NCT02716610|Insulin Lispro|insulin lispro|mesh-list
65270281|NCT02716610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65270282|NCT02716610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270283|NCT02694224|Paclitaxel|paclitaxel|mesh-list
65270284|NCT02694224|Cyclophosphamide|cyclophosphamide|mesh-list
65270285|NCT02694224|Epirubicin|epirubicin|mesh-list
65270286|NCT02694224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65270287|NCT02694224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270288|NCT02694224|Tubulin Modulators|tubulin modulators|mesh-ancestor
65270289|NCT02694224|Antimitotic Agents|antimitotic agents|mesh-ancestor
65270290|NCT02694224|Mitosis Modulators|mitosis modulators|mesh-ancestor
65270291|NCT02694224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020297|NCT05131386|Alkylating Agents|alkylating agents|mesh-ancestor
65020298|NCT05131386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020299|NCT05131386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020300|NCT05129332|Vitamin E|vitamin e|mesh-list
65020301|NCT05129332|Vitamins|vitamins|mesh-ancestor
65020302|NCT05129332|Micronutrients|micronutrients|mesh-ancestor
65270292|NCT02694224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65270293|NCT02694224|Immunologic Factors|immunologic factors|mesh-ancestor
65270294|NCT02694224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270295|NCT02694224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65270296|NCT02694224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65270297|NCT02694224|Alkylating Agents|alkylating agents|mesh-ancestor
65270298|NCT02694224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65270299|NCT02694224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65270300|NCT02694224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65270301|NCT02694224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65270303|NCT00782288|Digitoxin|digitoxin|mesh-list
65270304|NCT00782288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65270305|NCT00782288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65270306|NCT00782288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270307|NCT00782288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270308|NCT00782288|Protective Agents|protective agents|mesh-ancestor
65270309|NCT00782288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270310|NCT04189094|Etoposide|etoposide|mesh-list
65270311|NCT04189094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270312|NCT04189094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65270313|NCT04189094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65270314|NCT04189094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65270315|NCT04189094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270316|NCT04189094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270317|NCT02712944|Testosterone|testosterone|mesh-list
65270318|NCT02712944|Androgens|androgens|mesh-ancestor
65270319|NCT02712944|Hormones|hormones|mesh-ancestor
65270320|NCT02712944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65270321|NCT02712944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270322|NCT02712866|Vedolizumab|vedolizumab|mesh-list
65270323|NCT02712866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65270324|NCT00600483|Gentamicins|gentamicins|mesh-list
65270325|NCT00600483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65270326|NCT00600483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65270327|NCT00600483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65270328|NCT00600483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270329|NCT00600483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270330|NCT04132232|Carbon Monoxide|carbon monoxide|mesh-list
65270331|NCT04132232|Antimetabolites|antimetabolites|mesh-ancestor
65270332|NCT04132232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270333|NCT04132232|Gasotransmitters|gasotransmitters|mesh-ancestor
65270334|NCT04132232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65270335|NCT04132232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270336|NCT00649857|Cetirizine|cetirizine|mesh-list
65270337|NCT00649857|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65270338|NCT00649857|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65270339|NCT00649857|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65270340|NCT00649857|Histamine Antagonists|histamine antagonists|mesh-ancestor
65270341|NCT00649857|Histamine Agents|histamine agents|mesh-ancestor
65270342|NCT00649857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65270343|NCT00649857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270344|NCT00649857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270345|NCT00764270|Thioctic Acid|thioctic acid|mesh-list
65270346|NCT00764270|Antioxidants|antioxidants|mesh-ancestor
65270347|NCT00764270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270348|NCT00764270|Protective Agents|protective agents|mesh-ancestor
65270349|NCT00764270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270350|NCT00764270|Vitamin B Complex|vitamin b complex|mesh-ancestor
65270351|NCT00764270|Vitamins|vitamins|mesh-ancestor
65270352|NCT00764270|Micronutrients|micronutrients|mesh-ancestor
65270353|NCT00650481|Oxybutynin|oxybutynin|mesh-list
65270354|NCT00650481|Parasympatholytics|parasympatholytics|mesh-ancestor
65270355|NCT00650481|Autonomic Agents|autonomic agents|mesh-ancestor
65270356|NCT00650481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65270357|NCT00650481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270358|NCT00650481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65270359|NCT00650481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65270360|NCT00650481|Cholinergic Agents|cholinergic agents|mesh-ancestor
65270361|NCT00650481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65270362|NCT00650481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270363|NCT00650481|Urological Agents|urological agents|mesh-ancestor
65270364|NCT02712476|Furosemide|furosemide|mesh-list
65270365|NCT02712476|Mannitol|mannitol|mesh-list
65020374|NCT04933630|Norepinephrine|norepinephrine|mesh-list
65270366|NCT02712476|Diuretics|diuretics|mesh-ancestor
65270367|NCT02712476|Natriuretic Agents|natriuretic agents|mesh-ancestor
65270368|NCT02712476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270369|NCT02712476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65270370|NCT02712476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65270371|NCT02712476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270372|NCT02712476|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65270373|NCT02722538|Gemcitabine|gemcitabine|mesh-list
65270374|NCT02722538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65270375|NCT02722538|Antimetabolites|antimetabolites|mesh-ancestor
65270376|NCT02722538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270377|NCT02722538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270378|NCT02722538|Antiviral Agents|antiviral agents|mesh-ancestor
65270379|NCT02722538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65270380|NCT02722538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270381|NCT02722538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65270382|NCT02722538|Immunologic Factors|immunologic factors|mesh-ancestor
65270383|NCT02722538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270384|NCT02651727|Gemcitabine|gemcitabine|mesh-list
65270385|NCT02651727|Paclitaxel|paclitaxel|mesh-list
65270386|NCT02651727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65270387|NCT02651727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65270388|NCT02651727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270389|NCT02651727|Tubulin Modulators|tubulin modulators|mesh-ancestor
65270390|NCT02651727|Antimitotic Agents|antimitotic agents|mesh-ancestor
65270391|NCT02651727|Mitosis Modulators|mitosis modulators|mesh-ancestor
65270392|NCT02651727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270393|NCT02651727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65270394|NCT02651727|Antimetabolites|antimetabolites|mesh-ancestor
65270395|NCT02651727|Antiviral Agents|antiviral agents|mesh-ancestor
65270396|NCT02651727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65270397|NCT02651727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270398|NCT02651727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65270399|NCT02651727|Immunologic Factors|immunologic factors|mesh-ancestor
65270400|NCT02651727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270401|NCT02650791|Tranexamic Acid|tranexamic acid|mesh-list
65270402|NCT02650791|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65270403|NCT02650791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65270404|NCT02650791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270405|NCT02650791|Hemostatics|hemostatics|mesh-ancestor
65270406|NCT02650791|Coagulants|coagulants|mesh-ancestor
65270407|NCT02650713|Atezolizumab|atezolizumab|mesh-list
65270408|NCT02650713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270409|NCT02650635|Cyclophosphamide|cyclophosphamide|mesh-list
65270410|NCT02650635|Lenograstim|lenograstim|mesh-list
65270411|NCT02650635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65270412|NCT02650635|Immunologic Factors|immunologic factors|mesh-ancestor
65270413|NCT02650635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270414|NCT02650635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65270415|NCT02650635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65270416|NCT02650635|Alkylating Agents|alkylating agents|mesh-ancestor
65270417|NCT02650635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270418|NCT02650635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270419|NCT02650635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65270420|NCT02650635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65270421|NCT00650637|Calcium, Dietary|calcium, dietary|mesh-list
65270422|NCT00650637|Lamivudine|lamivudine|mesh-list
65270423|NCT00650637|Zidovudine|zidovudine|mesh-list
65270424|NCT00650637|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
65270425|NCT00650637|Nelfinavir|nelfinavir|mesh-list
65270426|NCT00650637|Calcium Carbonate|calcium carbonate|mesh-list
65270427|NCT00650637|Loperamide|loperamide|mesh-list
65270428|NCT00650637|Antidiarrheals|antidiarrheals|mesh-list
65270429|NCT00650637|Calcium|calcium|mesh-list
65270430|NCT00650637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65270431|NCT00650637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270432|NCT00650637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65270433|NCT00650637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65270434|NCT00650637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65270435|NCT00650637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270436|NCT00650637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270437|NCT00650637|Antiviral Agents|antiviral agents|mesh-ancestor
65270438|NCT00650637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65270439|NCT00650637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65270440|NCT00650637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65020448|NCT04803877|Nivolumab|nivolumab|mesh-list
65270441|NCT00650637|Antimetabolites|antimetabolites|mesh-ancestor
65270442|NCT00650637|Antacids|antacids|mesh-ancestor
65270443|NCT00650637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65270444|NCT00650637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65270445|NCT00650637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65270446|NCT00650637|Protease Inhibitors|protease inhibitors|mesh-ancestor
65270447|NCT02650479|Exenatide|exenatide|mesh-list
65270448|NCT02650479|Moxifloxacin|moxifloxacin|mesh-list
65270449|NCT02650479|Palonosetron|palonosetron|mesh-list
65270451|NCT02650479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65270452|NCT02650479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65270453|NCT02650479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65270454|NCT02650479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270455|NCT02650479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270456|NCT02650479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270457|NCT02650479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270458|NCT02650479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65270459|NCT02650479|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65270460|NCT02650479|Incretins|incretins|mesh-ancestor
65270461|NCT02650479|Hormones|hormones|mesh-ancestor
65270462|NCT02650479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65270463|NCT02650479|Antiemetics|antiemetics|mesh-ancestor
65270464|NCT02650479|Autonomic Agents|autonomic agents|mesh-ancestor
65270465|NCT02650479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65270466|NCT02650479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65270467|NCT02650479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65270468|NCT02650479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65270469|NCT02650479|Serotonin Agents|serotonin agents|mesh-ancestor
65270470|NCT02650479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65270471|NCT02722772|Etanercept|etanercept|mesh-list
65270472|NCT02722772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65270473|NCT02722772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65270474|NCT02722772|Analgesics|analgesics|mesh-ancestor
65270475|NCT02722772|Sensory System Agents|sensory system agents|mesh-ancestor
65270476|NCT02722772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65270477|NCT02722772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270478|NCT02722772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65270479|NCT02722772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65270480|NCT02722772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65270481|NCT02722772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65270482|NCT02722772|Immunologic Factors|immunologic factors|mesh-ancestor
65270483|NCT02650245|Lactulose|lactulose|mesh-list
65270484|NCT02650245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65270485|NCT00650793|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65270486|NCT00650793|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65270487|NCT00650793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65270488|NCT00650793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65270489|NCT00650793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270490|NCT00650793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65270491|NCT00650793|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65270492|NCT00650793|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65270493|NCT00650793|Serotonin Agents|serotonin agents|mesh-ancestor
65270494|NCT00650793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65270495|NCT00650793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270496|NCT00650793|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65270497|NCT00650793|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65270498|NCT00650793|Dopamine Agents|dopamine agents|mesh-ancestor
65270499|NCT00910767|Insulin|insulin|mesh-list
65270500|NCT00910767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65270501|NCT00910767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270502|NCT02722694|Methotrexate|methotrexate|mesh-list
65270503|NCT02722694|Abatacept|abatacept|mesh-list
65270504|NCT02722694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65270505|NCT02722694|Abortifacient Agents|abortifacient agents|mesh-ancestor
65270506|NCT02722694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65270507|NCT02722694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270508|NCT02722694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65270509|NCT02722694|Antimetabolites|antimetabolites|mesh-ancestor
65200591|NCT01117766|Pregabalin|pregabalin|mesh-list
65270510|NCT02722694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270511|NCT02722694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270512|NCT02722694|Dermatologic Agents|dermatologic agents|mesh-ancestor
65270513|NCT02722694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270514|NCT02722694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65020535|NCT04610658|Nivolumab|nivolumab|mesh-list
65270515|NCT02722694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65270516|NCT02722694|Immunologic Factors|immunologic factors|mesh-ancestor
65270517|NCT02722694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65270518|NCT02722694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65270519|NCT02722694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65270521|NCT00650871|Antiemetics|antiemetics|mesh-ancestor
65270522|NCT00650871|Autonomic Agents|autonomic agents|mesh-ancestor
65270523|NCT00650871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65270524|NCT00650871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270525|NCT00650871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65270526|NCT00650871|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65270527|NCT00650871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65270528|NCT00650871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270529|NCT02649621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65270530|NCT02649621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65270531|NCT02649465|Glimepiride|glimepiride|mesh-list
65270532|NCT02649465|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
65270533|NCT02649465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65270534|NCT02649465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65270535|NCT02649465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270536|NCT02649465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65270537|NCT02649465|Immunologic Factors|immunologic factors|mesh-ancestor
65270538|NCT02649465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65270539|NCT02649465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270540|NCT00651105|Vildagliptin|vildagliptin|mesh-list
65270541|NCT00651105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65270542|NCT00651105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270543|NCT00651105|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65270544|NCT00651105|Protease Inhibitors|protease inhibitors|mesh-ancestor
65270545|NCT00651105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270546|NCT00651105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270547|NCT02694146|Hylan|hylan|mesh-list
65270548|NCT02694146|Viscosupplements|viscosupplements|mesh-ancestor
65270549|NCT02694146|Protective Agents|protective agents|mesh-ancestor
65270550|NCT02694146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270551|NCT02649075|Immunoglobulins|immunoglobulins|mesh-list
65270552|NCT02649075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65270553|NCT02649075|Antibodies|antibodies|mesh-list
65270554|NCT02649075|Immunologic Factors|immunologic factors|mesh-ancestor
65270555|NCT02649075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270556|NCT02644785|Protamines|protamines|mesh-list
65270557|NCT02644785|Heparin Antagonists|heparin antagonists|mesh-ancestor
65270558|NCT02644785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270559|NCT02644785|Coagulants|coagulants|mesh-ancestor
65270560|NCT02644707|Selenium|selenium|mesh-list
65270561|NCT02644707|Antioxidants|antioxidants|mesh-ancestor
65270562|NCT02644707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270563|NCT02644707|Protective Agents|protective agents|mesh-ancestor
65270564|NCT02644707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270565|NCT02644707|Trace Elements|trace elements|mesh-ancestor
65270566|NCT02644707|Micronutrients|micronutrients|mesh-ancestor
65270567|NCT02711228|Immunoglobulins|immunoglobulins|mesh-list
65270568|NCT02711228|Antibodies|antibodies|mesh-list
65270569|NCT02711228|gamma-Globulins|gamma-globulins|mesh-list
65270570|NCT02711228|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65270571|NCT02711228|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65270572|NCT02711228|Immunologic Factors|immunologic factors|mesh-ancestor
65270573|NCT02711228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270574|NCT02644863|Paclitaxel|paclitaxel|mesh-list
65270575|NCT02644863|Cisplatin|cisplatin|mesh-list
65270576|NCT02644863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65270577|NCT02644863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270578|NCT02644863|Tubulin Modulators|tubulin modulators|mesh-ancestor
65270579|NCT02644863|Antimitotic Agents|antimitotic agents|mesh-ancestor
65270580|NCT02644863|Mitosis Modulators|mitosis modulators|mesh-ancestor
65270581|NCT02644863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270582|NCT03524235|Rituximab|rituximab|mesh-list
65270583|NCT03524235|Fludarabine|fludarabine|mesh-list
65270584|NCT03524235|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65270585|NCT03524235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65270586|NCT03524235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270587|NCT03524235|Immunologic Factors|immunologic factors|mesh-ancestor
65270588|NCT03524235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020595|NCT04511247|Sirolimus|sirolimus|mesh-list
65270589|NCT03524235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65270590|NCT03524235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270591|NCT03524235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65270592|NCT03524235|Alkylating Agents|alkylating agents|mesh-ancestor
65270594|NCT00302744|Psilocybin|psilocybin|mesh-list
65270595|NCT00302744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65270596|NCT00302744|Antimetabolites|antimetabolites|mesh-ancestor
65270597|NCT00302744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270600|NCT00302744|Vitamin B Complex|vitamin b complex|mesh-ancestor
65270601|NCT00302744|Vitamins|vitamins|mesh-ancestor
65270602|NCT00302744|Micronutrients|micronutrients|mesh-ancestor
65270603|NCT00302744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270604|NCT00302744|Hallucinogens|hallucinogens|mesh-ancestor
65270605|NCT00302744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65270606|NCT02644629|Ketamine|ketamine|mesh-list
65270607|NCT02644629|Analgesics|analgesics|mesh-ancestor
65270608|NCT02644629|Sensory System Agents|sensory system agents|mesh-ancestor
65270609|NCT02644629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65270610|NCT02644629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270611|NCT02644629|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65270612|NCT02644629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65270613|NCT02644629|Anesthetics, General|anesthetics, general|mesh-ancestor
65270614|NCT02644629|Anesthetics|anesthetics|mesh-ancestor
65270615|NCT02644629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65270616|NCT02644629|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65270617|NCT02644629|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65270618|NCT02644629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65270619|NCT02644629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270620|NCT00652665|Leflunomide|leflunomide|mesh-list
65270621|NCT00652665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270622|NCT00652665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270623|NCT00652665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65270624|NCT00652665|Immunologic Factors|immunologic factors|mesh-ancestor
65270625|NCT00652665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270626|NCT02644551|Ciclopirox|ciclopirox|mesh-list
65270627|NCT02644551|Antifungal Agents|antifungal agents|mesh-ancestor
65270628|NCT02644551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65270629|NCT02644395|Amlodipine|amlodipine|mesh-list
65270630|NCT02644395|Chlorthalidone|chlorthalidone|mesh-list
65270631|NCT02644395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65270632|NCT02644395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65270633|NCT02644395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65270634|NCT02644395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270635|NCT02644395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65270636|NCT02644395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270637|NCT02644395|Vasodilator Agents|vasodilator agents|mesh-ancestor
65270638|NCT02644395|Diuretics|diuretics|mesh-ancestor
65270639|NCT02644395|Natriuretic Agents|natriuretic agents|mesh-ancestor
65270640|NCT02644395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65270641|NCT04166565|Dexamethasone|dexamethasone|mesh-list
65270642|NCT04166565|Cyclophosphamide|cyclophosphamide|mesh-list
65270643|NCT04166565|Bortezomib|bortezomib|mesh-list
65270644|NCT04166565|Daratumumab|daratumumab|mesh-list
65270645|NCT04166565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65270646|NCT04166565|Immunologic Factors|immunologic factors|mesh-ancestor
65270647|NCT04166565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270648|NCT04166565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65270649|NCT04166565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65270650|NCT04166565|Alkylating Agents|alkylating agents|mesh-ancestor
65270651|NCT04166565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270652|NCT04166565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270653|NCT04166565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65270654|NCT04166565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65270655|NCT04166565|Antiemetics|antiemetics|mesh-ancestor
65270656|NCT04166565|Autonomic Agents|autonomic agents|mesh-ancestor
65270657|NCT04166565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65270658|NCT04166565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65270659|NCT04166565|Glucocorticoids|glucocorticoids|mesh-ancestor
65270660|NCT04166565|Hormones|hormones|mesh-ancestor
65270661|NCT04166565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65270662|NCT04166565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65020671|NCT04335669|Carboplatin|carboplatin|mesh-list
65270663|NCT02644473|Tranexamic Acid|tranexamic acid|mesh-list
65270664|NCT02644473|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65270665|NCT02644473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65270666|NCT02644473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270667|NCT02644473|Hemostatics|hemostatics|mesh-ancestor
65270668|NCT02644473|Coagulants|coagulants|mesh-ancestor
65270669|NCT02644083|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65270670|NCT02644083|Dermatologic Agents|dermatologic agents|mesh-ancestor
65270671|NCT02644083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65270672|NCT02644083|Immunologic Factors|immunologic factors|mesh-ancestor
65270673|NCT02644083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270674|NCT04005872|Calcium|calcium|mesh-list
65270675|NCT04005872|Fluorides|fluorides|mesh-list
65270676|NCT04005872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65270677|NCT04005872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270678|NCT04005872|Cariostatic Agents|cariostatic agents|mesh-ancestor
65270679|NCT04005872|Protective Agents|protective agents|mesh-ancestor
65270680|NCT00652821|Tramadol|tramadol|mesh-list
65270681|NCT00652821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65270682|NCT00652821|Narcotics|narcotics|mesh-ancestor
65270683|NCT00652821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65270684|NCT00652821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270685|NCT00652821|Analgesics|analgesics|mesh-ancestor
65270686|NCT00652821|Sensory System Agents|sensory system agents|mesh-ancestor
65270687|NCT00652821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65270688|NCT02644161|Antidepressive Agents|antidepressive agents|mesh-list
65270689|NCT02644161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65270690|NCT02710604|Tenofovir|tenofovir|mesh-list
65270691|NCT02710604|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
65270692|NCT02710604|Antiviral Agents|antiviral agents|mesh-ancestor
65270693|NCT02710604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65270694|NCT02710604|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65270695|NCT02710604|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65270696|NCT02710604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270697|NCT02710604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270698|NCT02710604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65270699|NCT02710604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65270700|NCT02535975|Metformin|metformin|mesh-list
65270701|NCT02535975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65270702|NCT02535975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270703|NCT02714036|Ibudilast|ibudilast|mesh-list
65270704|NCT02714036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65270705|NCT02714036|Autonomic Agents|autonomic agents|mesh-ancestor
65270706|NCT02714036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65270707|NCT02714036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270708|NCT02714036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65270709|NCT02714036|Respiratory System Agents|respiratory system agents|mesh-ancestor
65270710|NCT02714036|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65270711|NCT02714036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270712|NCT02714036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270713|NCT02714036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65270714|NCT02714036|Vasodilator Agents|vasodilator agents|mesh-ancestor
65270715|NCT02710448|Metformin|metformin|mesh-list
65270716|NCT02710448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65270717|NCT02710448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270718|NCT04602026|Coal Tar|coal tar|mesh-list
65270719|NCT04602026|Keratolytic Agents|keratolytic agents|mesh-ancestor
65270720|NCT04602026|Dermatologic Agents|dermatologic agents|mesh-ancestor
65270721|NCT04166253|Vitamin D|vitamin d|mesh-list
65270722|NCT04166253|Alfacalcidol|alfacalcidol|mesh-list
65270723|NCT04166253|Vitamins|vitamins|mesh-ancestor
65270724|NCT04166253|Micronutrients|micronutrients|mesh-ancestor
65270725|NCT04166253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270726|NCT04166253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65270727|NCT00653055|Cabergoline|cabergoline|mesh-list
65270728|NCT00653055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65270729|NCT00653055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65270730|NCT00653055|Dopamine Agonists|dopamine agonists|mesh-ancestor
65270731|NCT00653055|Dopamine Agents|dopamine agents|mesh-ancestor
65270732|NCT00653055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65270733|NCT00653055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270734|NCT00653055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270735|NCT02643147|Furosemide|furosemide|mesh-list
65270736|NCT02643147|Diuretics|diuretics|mesh-list
65270737|NCT02643147|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
65270738|NCT02643147|Natriuretic Agents|natriuretic agents|mesh-ancestor
65270739|NCT02643147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270740|NCT02643147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65270741|NCT02643147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270742|NCT02642913|Sorafenib|sorafenib|mesh-list
65270743|NCT02642913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270744|NCT02642913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65270745|NCT02642913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270746|NCT02642913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270749|NCT04002362|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65270750|NCT04002362|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65270751|NCT04002362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65270752|NCT04002362|Glucocorticoids|glucocorticoids|mesh-ancestor
65270753|NCT04002362|Hormones|hormones|mesh-ancestor
65270754|NCT04002362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65270755|NCT04002362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270756|NCT04002362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65270757|NCT04002362|Immunologic Factors|immunologic factors|mesh-ancestor
65270758|NCT04002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270759|NCT04002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270760|NCT04165629|Aspirin|aspirin|mesh-list
65270761|NCT04165629|Clopidogrel|clopidogrel|mesh-list
65270762|NCT04165629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65270763|NCT04165629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65270764|NCT04165629|Analgesics|analgesics|mesh-ancestor
65270765|NCT04165629|Sensory System Agents|sensory system agents|mesh-ancestor
65270766|NCT04165629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65270767|NCT04165629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270768|NCT04165629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65270769|NCT04165629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65270770|NCT04165629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65270771|NCT04165629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65270772|NCT04165629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270773|NCT04165629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65270774|NCT04165629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65270775|NCT04165629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270776|NCT04165629|Antipyretics|antipyretics|mesh-ancestor
65270777|NCT04165629|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65270778|NCT04165629|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65270779|NCT04165629|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65270780|NCT04165629|Purinergic Agents|purinergic agents|mesh-ancestor
65270781|NCT04165629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65270782|NCT02642523|Insulin|insulin|mesh-list
65270783|NCT02642523|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65270784|NCT02642523|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65270785|NCT02642523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65270786|NCT02642523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270787|NCT02642523|Natriuretic Agents|natriuretic agents|mesh-ancestor
65270788|NCT02713802|Propofol|propofol|mesh-list
65270789|NCT02713802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65270790|NCT02713802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65270791|NCT02713802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270792|NCT02713802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65270793|NCT02713802|Anesthetics, General|anesthetics, general|mesh-ancestor
65270794|NCT02713802|Anesthetics|anesthetics|mesh-ancestor
65270795|NCT02642601|Indomethacin|indomethacin|mesh-list
65270796|NCT02642601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65270797|NCT02642601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65270798|NCT02642601|Analgesics|analgesics|mesh-ancestor
65270799|NCT02642601|Sensory System Agents|sensory system agents|mesh-ancestor
65270800|NCT02642601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65270801|NCT02642601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270802|NCT02642601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65270803|NCT02642601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65270804|NCT02642601|Gout Suppressants|gout suppressants|mesh-ancestor
65270805|NCT02642601|Tocolytic Agents|tocolytic agents|mesh-ancestor
65270806|NCT02642601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65270807|NCT02642601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65270808|NCT02642601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270809|NCT02642601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270810|NCT02709902|Adapalene|adapalene|mesh-list
65270811|NCT02709902|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
65270812|NCT02709902|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65270813|NCT02709902|Dermatologic Agents|dermatologic agents|mesh-ancestor
65270814|NCT02709902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65270815|NCT02709902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65270816|NCT02709902|Analgesics|analgesics|mesh-ancestor
65270817|NCT02709902|Sensory System Agents|sensory system agents|mesh-ancestor
65270818|NCT02709902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65270819|NCT02709902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270822|NCT02709824|Chlorhexidine|chlorhexidine|mesh-list
65270823|NCT02709824|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65270824|NCT02709824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65270825|NCT02709824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65270826|NCT02709824|Disinfectants|disinfectants|mesh-ancestor
65270827|NCT02709824|Dermatologic Agents|dermatologic agents|mesh-ancestor
65270828|NCT02642367|Rocuronium|rocuronium|mesh-list
65270829|NCT02642367|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65270830|NCT02642367|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65270831|NCT02642367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65270832|NCT02642367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65270833|NCT02642367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270834|NCT00653445|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65270835|NCT00653445|Ezetimibe|ezetimibe|mesh-list
65270836|NCT00653445|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65270837|NCT00653445|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65270838|NCT00653445|Antimetabolites|antimetabolites|mesh-ancestor
65270839|NCT00653445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270840|NCT00653445|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65270841|NCT00653445|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65270842|NCT00653445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270843|NCT02641899|Acetaminophen|acetaminophen|mesh-list
65270844|NCT02641899|Exenatide|exenatide|mesh-list
65270845|NCT02641899|Digoxin|digoxin|mesh-list
65270846|NCT02641899|Lisinopril|lisinopril|mesh-list
65270847|NCT02641899|Warfarin|warfarin|mesh-list
65270848|NCT02641899|Atorvastatin|atorvastatin|mesh-list
65270849|NCT02641899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65270850|NCT02641899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65270851|NCT02641899|Antimetabolites|antimetabolites|mesh-ancestor
65270852|NCT02641899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270853|NCT02641899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65270854|NCT02641899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65270855|NCT02641899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270856|NCT02641899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65270857|NCT02641899|Analgesics|analgesics|mesh-ancestor
65270858|NCT02641899|Sensory System Agents|sensory system agents|mesh-ancestor
65270859|NCT02641899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65270860|NCT02641899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270861|NCT02641899|Antipyretics|antipyretics|mesh-ancestor
65270862|NCT02641899|Anticoagulants|anticoagulants|mesh-ancestor
65270863|NCT02641899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65270864|NCT02641899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65270865|NCT02641899|Protective Agents|protective agents|mesh-ancestor
65270866|NCT02641899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65270867|NCT02641899|Protease Inhibitors|protease inhibitors|mesh-ancestor
65270868|NCT02641899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65270869|NCT02641899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65270870|NCT02641899|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65270871|NCT02641899|Incretins|incretins|mesh-ancestor
65270872|NCT02641899|Hormones|hormones|mesh-ancestor
65270873|NCT02641899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65270874|NCT02641821|Nifedipine|nifedipine|mesh-list
65270875|NCT02641821|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65270876|NCT02641821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65270877|NCT02641821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270878|NCT02641821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65270879|NCT02641821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270880|NCT02641821|Vasodilator Agents|vasodilator agents|mesh-ancestor
65270881|NCT02641821|Tocolytic Agents|tocolytic agents|mesh-ancestor
65270882|NCT02641821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65270883|NCT01320345|Fenofibrate|fenofibrate|mesh-list
65270884|NCT01320345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65270885|NCT01320345|Antimetabolites|antimetabolites|mesh-ancestor
65270886|NCT01320345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270887|NCT01320345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65270888|NCT04164615|Capecitabine|capecitabine|mesh-list
65270889|NCT04164615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65270890|NCT04164615|Antimetabolites|antimetabolites|mesh-ancestor
65270891|NCT04164615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270892|NCT04164615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270893|NCT04164459|Latanoprost|latanoprost|mesh-list
65270894|NCT04164459|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65270895|NCT04164459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65270896|NCT04164693|Heparin|heparin|mesh-list
65270897|NCT04164693|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65270898|NCT04164693|Tinzaparin|tinzaparin|mesh-list
65270899|NCT04164693|Dalteparin|dalteparin|mesh-list
65270900|NCT04164693|Warfarin|warfarin|mesh-list
65270901|NCT04164693|Anticoagulants|anticoagulants|mesh-ancestor
65270902|NCT04164693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65270903|NCT04164693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65270904|NCT04164693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270905|NCT00602667|Cyclophosphamide|cyclophosphamide|mesh-list
65270906|NCT00602667|Cisplatin|cisplatin|mesh-list
65270907|NCT00602667|Carboplatin|carboplatin|mesh-list
65270908|NCT00602667|Methotrexate|methotrexate|mesh-list
65270909|NCT00602667|Etoposide|etoposide|mesh-list
65270910|NCT00602667|Etoposide phosphate|etoposide phosphate|mesh-list
65270911|NCT00602667|Vincristine|vincristine|mesh-list
65270912|NCT00602667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65270913|NCT00602667|Topotecan|topotecan|mesh-list
65270914|NCT00602667|Vinblastine|vinblastine|mesh-list
65270915|NCT00602667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65270916|NCT00602667|Immunologic Factors|immunologic factors|mesh-ancestor
65270917|NCT00602667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270918|NCT00602667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65270919|NCT00602667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65270920|NCT00602667|Alkylating Agents|alkylating agents|mesh-ancestor
65270921|NCT00602667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270922|NCT00602667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270923|NCT00602667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65270924|NCT00602667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65270925|NCT00602667|Abortifacient Agents|abortifacient agents|mesh-ancestor
65270926|NCT00602667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65270927|NCT00602667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65270928|NCT00602667|Antimetabolites|antimetabolites|mesh-ancestor
65270929|NCT00602667|Dermatologic Agents|dermatologic agents|mesh-ancestor
65270930|NCT00602667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270931|NCT00602667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65270932|NCT00602667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65270933|NCT00602667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65270934|NCT00602667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65270935|NCT00602667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65270936|NCT00602667|Tubulin Modulators|tubulin modulators|mesh-ancestor
65270937|NCT00602667|Antimitotic Agents|antimitotic agents|mesh-ancestor
65270938|NCT00602667|Mitosis Modulators|mitosis modulators|mesh-ancestor
65270939|NCT00602667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65270940|NCT00602667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65270941|NCT00655785|Gemcitabine|gemcitabine|mesh-list
65270942|NCT00655785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65270943|NCT00655785|Antimetabolites|antimetabolites|mesh-ancestor
65270944|NCT00655785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270945|NCT00655785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270946|NCT00655785|Antiviral Agents|antiviral agents|mesh-ancestor
65270947|NCT00655785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65270948|NCT00655785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270949|NCT00655785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65270950|NCT00655785|Immunologic Factors|immunologic factors|mesh-ancestor
65270951|NCT00655785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270952|NCT00885495|Ritonavir|ritonavir|mesh-list
65270953|NCT00885495|Darunavir|darunavir|mesh-list
65270954|NCT00885495|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65270955|NCT00885495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65270956|NCT00885495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65270957|NCT00885495|Protease Inhibitors|protease inhibitors|mesh-ancestor
65270958|NCT00885495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270959|NCT00885495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270960|NCT00885495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65270961|NCT00885495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65270962|NCT00885495|Antiviral Agents|antiviral agents|mesh-ancestor
65270963|NCT00885495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65270964|NCT00885495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65270965|NCT00885495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65270966|NCT00885495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65270967|NCT00885495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65270968|NCT00885495|Antimetabolites|antimetabolites|mesh-ancestor
65270969|NCT00885495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65270970|NCT00885495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65270972|NCT02637375|Cyclophosphamide|cyclophosphamide|mesh-list
65270973|NCT02637375|Doxorubicin|doxorubicin|mesh-list
65270974|NCT02637375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65270975|NCT02637375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270976|NCT02637375|Tubulin Modulators|tubulin modulators|mesh-ancestor
65270977|NCT02637375|Antimitotic Agents|antimitotic agents|mesh-ancestor
65270978|NCT02637375|Mitosis Modulators|mitosis modulators|mesh-ancestor
65270979|NCT02637375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270980|NCT02637375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65270981|NCT02637375|Immunologic Factors|immunologic factors|mesh-ancestor
65270982|NCT02637375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270983|NCT02637375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65270984|NCT02637375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65270985|NCT02637375|Alkylating Agents|alkylating agents|mesh-ancestor
65270986|NCT02637375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65270987|NCT02637375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65270988|NCT02637375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65270989|NCT02637375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65270990|NCT02637375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270991|NCT04163523|Zanubrutinib|zanubrutinib|mesh-list
65270992|NCT04163523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65270993|NCT04163523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65270994|NCT04163523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65270995|NCT04163523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65270996|NCT00885105|Vaccines|vaccines|mesh-list
65270997|NCT00885105|Immunologic Factors|immunologic factors|mesh-ancestor
65270998|NCT00885105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65270999|NCT02709668|Vitamin B Complex|vitamin b complex|mesh-list
65271000|NCT02709668|Vitamins|vitamins|mesh-ancestor
65271001|NCT02709668|Micronutrients|micronutrients|mesh-ancestor
65271002|NCT02709668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271003|NCT04188782|Sevoflurane|sevoflurane|mesh-list
65271004|NCT04188782|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65271005|NCT04188782|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65271006|NCT04188782|Anesthetics, General|anesthetics, general|mesh-ancestor
65271007|NCT04188782|Anesthetics|anesthetics|mesh-ancestor
65271008|NCT04188782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65271009|NCT04188782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271010|NCT02709590|Diclofenac|diclofenac|mesh-list
65271011|NCT02709590|Lidocaine|lidocaine|mesh-list
65271012|NCT02709590|Anesthetics, Local|anesthetics, local|mesh-ancestor
65271013|NCT02709590|Anesthetics|anesthetics|mesh-ancestor
65271014|NCT02709590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65271015|NCT02709590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271016|NCT02709590|Sensory System Agents|sensory system agents|mesh-ancestor
65271017|NCT02709590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65271018|NCT02709590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65271019|NCT02709590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65271020|NCT02709590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65271021|NCT02709590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65271022|NCT02709590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271023|NCT02709590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65271024|NCT02709590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65271025|NCT02709590|Analgesics|analgesics|mesh-ancestor
65271026|NCT02709590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65271027|NCT02709590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65271028|NCT02709590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65271029|NCT02709590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271030|NCT02707874|Ropivacaine|ropivacaine|mesh-list
65271031|NCT02707874|Anesthetics, Local|anesthetics, local|mesh-ancestor
65271032|NCT02707874|Anesthetics|anesthetics|mesh-ancestor
65271033|NCT02707874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65271034|NCT02707874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271035|NCT02707874|Sensory System Agents|sensory system agents|mesh-ancestor
65271036|NCT02707874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65271037|NCT02709200|Dexmedetomidine|dexmedetomidine|mesh-list
65271038|NCT02709200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65271039|NCT02709200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65271040|NCT02709200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271041|NCT02709200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65271042|NCT02709200|Analgesics|analgesics|mesh-ancestor
65271043|NCT02709200|Sensory System Agents|sensory system agents|mesh-ancestor
65271044|NCT02709200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65271045|NCT02709200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65271046|NCT02709200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65271047|NCT02709200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65271048|NCT02709200|Adrenergic Agents|adrenergic agents|mesh-ancestor
65271049|NCT02709200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65271050|NCT02709200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271051|NCT00611936|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65271052|NCT00611936|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65271053|NCT00611936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65271054|NCT00611936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65271055|NCT00611936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271056|NCT00611936|Adrenergic Agents|adrenergic agents|mesh-ancestor
65271057|NCT00611936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65271058|NCT00611936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271059|NCT02707484|Thalidomide|thalidomide|mesh-list
65271060|NCT02707484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65271061|NCT02707484|Immunologic Factors|immunologic factors|mesh-ancestor
65271062|NCT02707484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271063|NCT02707484|Leprostatic Agents|leprostatic agents|mesh-ancestor
65271064|NCT02707484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65271065|NCT02707484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65271066|NCT02707484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65271067|NCT02707484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65271068|NCT02707484|Growth Substances|growth substances|mesh-ancestor
65271069|NCT02707484|Growth Inhibitors|growth inhibitors|mesh-ancestor
65271070|NCT02707484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271071|NCT02707328|Gemcitabine|gemcitabine|mesh-list
65271072|NCT02707328|Paclitaxel|paclitaxel|mesh-list
65271073|NCT02707328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65271074|NCT02707328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271075|NCT02707328|Tubulin Modulators|tubulin modulators|mesh-ancestor
65271076|NCT02707328|Antimitotic Agents|antimitotic agents|mesh-ancestor
65271077|NCT02707328|Mitosis Modulators|mitosis modulators|mesh-ancestor
65271078|NCT02707328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271079|NCT02707328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65271080|NCT02707328|Antimetabolites|antimetabolites|mesh-ancestor
65271081|NCT02707328|Antiviral Agents|antiviral agents|mesh-ancestor
65271082|NCT02707328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65271083|NCT02707328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271084|NCT02707328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65271085|NCT02707328|Immunologic Factors|immunologic factors|mesh-ancestor
65271086|NCT02707328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271087|NCT00612638|Irinotecan|irinotecan|mesh-list
65271088|NCT00612638|Temozolomide|temozolomide|mesh-list
65271089|NCT00612638|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
65271090|NCT00612638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65271091|NCT00612638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65271092|NCT00612638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271093|NCT00612638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271094|NCT00612638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271095|NCT00612638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65271096|NCT00612638|Alkylating Agents|alkylating agents|mesh-ancestor
65271097|NCT05151848|Adalimumab|adalimumab|mesh-list
65271098|NCT05151848|Tofacitinib|tofacitinib|mesh-list
65271099|NCT05151848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65271100|NCT05151848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65271101|NCT05151848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65271102|NCT05151848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271103|NCT05151848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271104|NCT05134688|Magnesium Sulfate|magnesium sulfate|mesh-list
65271105|NCT05134688|Analgesics|analgesics|mesh-ancestor
65271106|NCT05134688|Sensory System Agents|sensory system agents|mesh-ancestor
65271107|NCT05134688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65271108|NCT05134688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271109|NCT05134688|Anesthetics|anesthetics|mesh-ancestor
65271110|NCT05134688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65271111|NCT05134688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65271112|NCT05134688|Anticonvulsants|anticonvulsants|mesh-ancestor
65271113|NCT05134688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65271114|NCT05134688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65271115|NCT05134688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271116|NCT05134688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65271117|NCT05134688|Tocolytic Agents|tocolytic agents|mesh-ancestor
65271118|NCT05134688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65271119|NCT02693288|Anesthetics|anesthetics|mesh-list
65271120|NCT02693288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65271121|NCT02693288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271122|NCT02693210|Cyclophosphamide|cyclophosphamide|mesh-list
65271124|NCT02693210|Methotrexate|methotrexate|mesh-list
65271125|NCT02693210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65271126|NCT02693210|Immunologic Factors|immunologic factors|mesh-ancestor
65271127|NCT02693210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271128|NCT02693210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65271129|NCT02693210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65271130|NCT02693210|Alkylating Agents|alkylating agents|mesh-ancestor
65271131|NCT02693210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271132|NCT02693210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271133|NCT02693210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65271134|NCT02693210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65271135|NCT02693210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65271136|NCT02693210|Abortifacient Agents|abortifacient agents|mesh-ancestor
65271137|NCT02693210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65271138|NCT02693210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65271139|NCT02693210|Antimetabolites|antimetabolites|mesh-ancestor
65271140|NCT02693210|Dermatologic Agents|dermatologic agents|mesh-ancestor
65271141|NCT02693210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271142|NCT02693210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65271143|NCT02693210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65271144|NCT05029466|Psilocybin|psilocybin|mesh-list
65271145|NCT05029466|Hallucinogens|hallucinogens|mesh-ancestor
65271146|NCT05029466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271147|NCT05029466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65271148|NCT05024006|Interferons|interferons|mesh-list
65271149|NCT05024006|Ritonavir|ritonavir|mesh-list
65271150|NCT05024006|Lopinavir|lopinavir|mesh-list
65271151|NCT05024006|Interferon-beta|interferon-beta|mesh-list
65271152|NCT05024006|Interferon beta-1a|interferon beta-1a|mesh-list
65271153|NCT05024006|Remdesivir|remdesivir|mesh-list
65271154|NCT05024006|Hydroxychloroquine|hydroxychloroquine|mesh-list
65271155|NCT05024006|Acalabrutinib|acalabrutinib|mesh-list
65271156|NCT05024006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271157|NCT05024006|Antiviral Agents|antiviral agents|mesh-ancestor
65271158|NCT05024006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65271159|NCT05024006|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65271160|NCT05024006|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65271161|NCT05024006|Protease Inhibitors|protease inhibitors|mesh-ancestor
65271162|NCT05024006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271163|NCT05024006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271164|NCT05024006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65271165|NCT05024006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65271166|NCT05024006|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65271167|NCT05024006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65271168|NCT05024006|Antimalarials|antimalarials|mesh-ancestor
65271169|NCT05024006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65271170|NCT05024006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65271171|NCT05024006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65271172|NCT05024006|Immunologic Factors|immunologic factors|mesh-ancestor
65271173|NCT05024006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271174|NCT05024006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65271175|NCT05024006|Antimetabolites|antimetabolites|mesh-ancestor
65271176|NCT02707250|Meperidine|meperidine|mesh-list
65271177|NCT02707250|Bupivacaine|bupivacaine|mesh-list
65271178|NCT02707250|Anesthetics, Local|anesthetics, local|mesh-ancestor
65271179|NCT02707250|Anesthetics|anesthetics|mesh-ancestor
65271180|NCT02707250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65271181|NCT02707250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271182|NCT02707250|Sensory System Agents|sensory system agents|mesh-ancestor
65271183|NCT02707250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65271184|NCT02707250|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65271185|NCT02707250|Narcotics|narcotics|mesh-ancestor
65271186|NCT02707250|Analgesics|analgesics|mesh-ancestor
65271187|NCT02707250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65271188|NCT03781544|Acetaminophen|acetaminophen|mesh-list
65271189|NCT03781544|Diclofenac|diclofenac|mesh-list
65271190|NCT03781544|Tramadol|tramadol|mesh-list
65271191|NCT03781544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65271192|NCT03781544|Analgesics|analgesics|mesh-ancestor
65271193|NCT03781544|Sensory System Agents|sensory system agents|mesh-ancestor
65271194|NCT03781544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65271195|NCT03781544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271196|NCT03781544|Antipyretics|antipyretics|mesh-ancestor
65271197|NCT03781544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65271198|NCT03781544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65271199|NCT03781544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65271200|NCT03781544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65271201|NCT03781544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271202|NCT03781544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271203|NCT03781544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65271205|NCT03781544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65271206|NCT02707094|Immunologic Factors|immunologic factors|mesh-list
65271207|NCT02707094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271208|NCT02707016|Sevoflurane|sevoflurane|mesh-list
65271209|NCT02707016|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65271210|NCT02707016|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65271211|NCT02707016|Anesthetics, General|anesthetics, general|mesh-ancestor
65271212|NCT02707016|Anesthetics|anesthetics|mesh-ancestor
65271213|NCT02707016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65271214|NCT02707016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271215|NCT02706704|Adalimumab|adalimumab|mesh-list
65271216|NCT02706704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65271217|NCT02706704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65271218|NCT04956146|Carboplatin|carboplatin|mesh-list
65271219|NCT04956146|Pemetrexed|pemetrexed|mesh-list
65271220|NCT04956146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271221|NCT04956146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271222|NCT04956146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271223|NCT04956146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65271224|NCT04956146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65271225|NCT00612794|Exenatide|exenatide|mesh-list
65271226|NCT00612794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65271227|NCT00612794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271228|NCT00612794|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65271229|NCT00612794|Incretins|incretins|mesh-ancestor
65271230|NCT00612794|Hormones|hormones|mesh-ancestor
65271231|NCT00612794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65271232|NCT03773276|Norepinephrine|norepinephrine|mesh-list
65271233|NCT03773276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65271234|NCT03773276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65271235|NCT03773276|Adrenergic Agents|adrenergic agents|mesh-ancestor
65271236|NCT03773276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65271237|NCT03773276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271238|NCT03773276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271239|NCT03773276|Sympathomimetics|sympathomimetics|mesh-ancestor
65271240|NCT03773276|Autonomic Agents|autonomic agents|mesh-ancestor
65271241|NCT03773276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65271242|NCT03773276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65271243|NCT02706860|Atorvastatin|atorvastatin|mesh-list
65271244|NCT02706860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65271245|NCT02706860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65271246|NCT02706860|Antimetabolites|antimetabolites|mesh-ancestor
65271247|NCT02706860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271248|NCT02706860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65271249|NCT02706860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65271250|NCT02706860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271251|NCT02706470|Cyclosporine|cyclosporine|mesh-list
65271252|NCT02706470|Cyclosporins|cyclosporins|mesh-list
65271253|NCT02706470|Dydrogesterone|dydrogesterone|mesh-list
65271254|NCT02706470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271255|NCT02706470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271256|NCT02706470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65271257|NCT02706470|Immunologic Factors|immunologic factors|mesh-ancestor
65271258|NCT02706470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271259|NCT02706470|Antifungal Agents|antifungal agents|mesh-ancestor
65271260|NCT02706470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65271261|NCT02706470|Dermatologic Agents|dermatologic agents|mesh-ancestor
65271262|NCT02706470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65271263|NCT02706470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65271264|NCT02706470|Progestins|progestins|mesh-ancestor
65271265|NCT02706470|Hormones|hormones|mesh-ancestor
65271266|NCT02706470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65271267|NCT03769766|Curcumin|curcumin|mesh-list
65021275|NCT01364051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271268|NCT03769766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65271269|NCT03769766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65271271|NCT03769766|Sensory System Agents|sensory system agents|mesh-ancestor
64468984|NCT00049036|Hormones|hormones|mesh-ancestor
65271273|NCT03769766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271274|NCT03769766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65271275|NCT03769766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65271276|NCT03769766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271277|NCT03769766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271278|NCT03769766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271279|NCT03767348|Nivolumab|nivolumab|mesh-list
65271280|NCT03767348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65271281|NCT03767348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271282|NCT03767348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65271283|NCT03767348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271284|NCT03764540|Prednisone|prednisone|mesh-list
65271285|NCT03764540|Docetaxel|docetaxel|mesh-list
65271286|NCT03764540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271287|NCT03764540|Tubulin Modulators|tubulin modulators|mesh-ancestor
65271288|NCT03764540|Antimitotic Agents|antimitotic agents|mesh-ancestor
65271289|NCT03764540|Mitosis Modulators|mitosis modulators|mesh-ancestor
65271290|NCT03764540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271291|NCT03764540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65271292|NCT03764540|Glucocorticoids|glucocorticoids|mesh-ancestor
65271293|NCT03764540|Hormones|hormones|mesh-ancestor
65271294|NCT03764540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65271295|NCT03764540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271296|NCT03764540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65271297|NCT03763370|Immunoconjugates|immunoconjugates|mesh-list
65271298|NCT03763370|Immunologic Factors|immunologic factors|mesh-ancestor
65271299|NCT03763370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271300|NCT02706236|Pancrelipase|pancrelipase|mesh-list
65271301|NCT02706236|Pancreatin|pancreatin|mesh-list
65271302|NCT02706236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65271303|NCT00613496|Irbesartan|irbesartan|mesh-list
65271304|NCT00613496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65271305|NCT00613496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65271306|NCT00613496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65271307|NCT00613496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271308|NCT04789928|Gentamicins|gentamicins|mesh-list
65271309|NCT04789928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65271310|NCT04789928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65271311|NCT04789928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65271312|NCT04789928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271313|NCT04789928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271314|NCT00612950|Glucagon|glucagon|mesh-list
65271315|NCT00612950|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
65271316|NCT00612950|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65271317|NCT00612950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65271318|NCT00612950|Hormones|hormones|mesh-ancestor
65271319|NCT00612950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65271320|NCT00612950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271321|NCT00612950|Incretins|incretins|mesh-ancestor
65271322|NCT00884793|Ritonavir|ritonavir|mesh-list
65271323|NCT00884793|Lopinavir|lopinavir|mesh-list
65271324|NCT00884793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65271325|NCT00884793|Fosamprenavir|fosamprenavir|mesh-list
65271326|NCT00884793|Raltegravir Potassium|raltegravir potassium|mesh-list
65271327|NCT00884793|Efavirenz|efavirenz|mesh-list
65271328|NCT00884793|Etravirine|etravirine|mesh-list
65271329|NCT00884793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65271330|NCT00884793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65271331|NCT00884793|Protease Inhibitors|protease inhibitors|mesh-ancestor
65271332|NCT00884793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271333|NCT00884793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271334|NCT00884793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65271335|NCT00884793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65271336|NCT00884793|Antiviral Agents|antiviral agents|mesh-ancestor
65271337|NCT00884793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65271338|NCT00884793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65271339|NCT00884793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65271340|NCT00884793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65271341|NCT00884793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65271342|NCT00884793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65271343|NCT00884793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65271344|NCT00884793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65271346|NCT00884793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65271348|NCT00884793|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65271349|NCT00656331|Amlodipine|amlodipine|mesh-list
65271350|NCT00656331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65271351|NCT00656331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65271352|NCT00656331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65271353|NCT00656331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271354|NCT00656331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65271355|NCT00656331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271356|NCT00656331|Vasodilator Agents|vasodilator agents|mesh-ancestor
65271357|NCT02636829|Calcium|calcium|mesh-list
65271358|NCT02636829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65271359|NCT02636829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271360|NCT00884325|Levocetirizine|levocetirizine|mesh-list
65271361|NCT00884325|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65271362|NCT00884325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65271363|NCT00884325|Histamine Antagonists|histamine antagonists|mesh-ancestor
65271364|NCT00884325|Histamine Agents|histamine agents|mesh-ancestor
65271365|NCT00884325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65271366|NCT00884325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271367|NCT00884325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271368|NCT00656409|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65271369|NCT00656409|Immunologic Factors|immunologic factors|mesh-ancestor
65271370|NCT00656409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271371|NCT05264558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65271372|NCT05264558|Antiviral Agents|antiviral agents|mesh-ancestor
65271373|NCT05264558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65271374|NCT04705844|Adalimumab|adalimumab|mesh-list
65271375|NCT04705844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65271376|NCT04705844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65271377|NCT00636896|Olanzapine|olanzapine|mesh-list
65271378|NCT00636896|Modafinil|modafinil|mesh-list
65271379|NCT00636896|Antiemetics|antiemetics|mesh-ancestor
65271380|NCT00636896|Autonomic Agents|autonomic agents|mesh-ancestor
65271381|NCT00636896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65271382|NCT00636896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271383|NCT00636896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65271384|NCT00636896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65271385|NCT00636896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65271386|NCT00636896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65271387|NCT00636896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65271388|NCT00636896|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65271389|NCT00636896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65271390|NCT00636896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65271391|NCT00636896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271392|NCT00636896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65271393|NCT00636896|Serotonin Agents|serotonin agents|mesh-ancestor
65271394|NCT00636896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65271395|NCT00636896|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65271396|NCT00636896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65271397|NCT00636896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65271398|NCT04470674|Carboplatin|carboplatin|mesh-list
65271399|NCT04470674|Pemetrexed|pemetrexed|mesh-list
65271400|NCT04470674|Durvalumab|durvalumab|mesh-list
65271401|NCT04470674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271402|NCT04470674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271403|NCT04470674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271404|NCT04470674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65271405|NCT04470674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65271406|NCT04470674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65271407|NCT00883779|Gemcitabine|gemcitabine|mesh-list
65271408|NCT00883779|Carboplatin|carboplatin|mesh-list
65271409|NCT00883779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65271410|NCT00883779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271411|NCT00883779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65271412|NCT00883779|Antimetabolites|antimetabolites|mesh-ancestor
65021422|NCT02914678|Anesthetics, General|anesthetics, general|mesh-ancestor
65201502|NCT03188796|Vitamin D|vitamin d|mesh-list
65271413|NCT00883779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271414|NCT00883779|Antiviral Agents|antiviral agents|mesh-ancestor
65271415|NCT00883779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65271416|NCT00883779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271417|NCT00883779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65271418|NCT00883779|Immunologic Factors|immunologic factors|mesh-ancestor
65271419|NCT00883779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271420|NCT00883779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65271421|NCT05263778|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
65271422|NCT05263778|Ezetimibe|ezetimibe|mesh-list
65271423|NCT05263778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65271424|NCT05263778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65271425|NCT05263778|Antimetabolites|antimetabolites|mesh-ancestor
65271426|NCT05263778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271427|NCT05263778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65271428|NCT05263778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271429|NCT05263778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65271430|NCT05263778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271431|NCT02693444|Lidocaine|lidocaine|mesh-list
65271432|NCT02693444|Anesthetics, Local|anesthetics, local|mesh-ancestor
65271433|NCT02693444|Anesthetics|anesthetics|mesh-ancestor
65271434|NCT02693444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65271435|NCT02693444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271436|NCT02693444|Sensory System Agents|sensory system agents|mesh-ancestor
65271437|NCT02693444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65271438|NCT02693444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65271439|NCT02693444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65271440|NCT02693444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65271441|NCT02693444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65271442|NCT02693444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271443|NCT04162743|Trazodone|trazodone|mesh-list
65271444|NCT04162743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65271445|NCT04162743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65271446|NCT04162743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65271447|NCT04162743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271448|NCT04162743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65271449|NCT04162743|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65271450|NCT04162743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65271451|NCT04162743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65271452|NCT04162743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271453|NCT04162743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65271454|NCT04162743|Serotonin Agents|serotonin agents|mesh-ancestor
65271455|NCT04162743|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65271456|NCT04162743|Antidepressive Agents|antidepressive agents|mesh-ancestor
65271457|NCT03813992|Nitroglycerin|nitroglycerin|mesh-list
65271458|NCT03813992|Vasodilator Agents|vasodilator agents|mesh-ancestor
65271459|NCT04302896|Tenofovir|tenofovir|mesh-list
65271460|NCT04302896|Lamivudine|lamivudine|mesh-list
65271461|NCT04302896|Emtricitabine|emtricitabine|mesh-list
65271462|NCT04302896|Dolutegravir|dolutegravir|mesh-list
65271463|NCT04302896|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65271464|NCT04302896|Antiviral Agents|antiviral agents|mesh-ancestor
65271465|NCT04302896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65271466|NCT04302896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65271467|NCT04302896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65271468|NCT04302896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271469|NCT04302896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271470|NCT04302896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65271471|NCT04302896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65271472|NCT04302896|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65271473|NCT04302896|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65271474|NCT00656643|Sirolimus|sirolimus|mesh-list
65271475|NCT00656643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65271476|NCT00656643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65271477|NCT00656643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65271478|NCT00656643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271479|NCT00656643|Antifungal Agents|antifungal agents|mesh-ancestor
65271480|NCT00656643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65271481|NCT00656643|Immunologic Factors|immunologic factors|mesh-ancestor
65271482|NCT00656643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271483|NCT04291820|Anesthetics|anesthetics|mesh-list
65271484|NCT04291820|Sevoflurane|sevoflurane|mesh-list
65271485|NCT04291820|Desflurane|desflurane|mesh-list
65201565|NCT04304807|Melatonin|melatonin|mesh-list
65271486|NCT04291820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65271487|NCT04291820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271488|NCT04291820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65271489|NCT04291820|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65271490|NCT04291820|Anesthetics, General|anesthetics, general|mesh-ancestor
65271491|NCT03712202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65271492|NCT03712202|Nivolumab|nivolumab|mesh-list
65271493|NCT03712202|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65271494|NCT03712202|Doxorubicin|doxorubicin|mesh-list
65271495|NCT03712202|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65271496|NCT03712202|Daunorubicin|daunorubicin|mesh-list
65271497|NCT03712202|Bleomycin|bleomycin|mesh-list
65271498|NCT03712202|Dacarbazine|dacarbazine|mesh-list
65271499|NCT03712202|Vinblastine|vinblastine|mesh-list
65271500|NCT03712202|Antibodies|antibodies|mesh-list
65271501|NCT03712202|Immunoglobulins|immunoglobulins|mesh-list
65271502|NCT03712202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65271503|NCT03712202|Immunoconjugates|immunoconjugates|mesh-list
65271504|NCT03712202|Imidazole|imidazole|mesh-list
65271505|NCT03712202|Immunologic Factors|immunologic factors|mesh-ancestor
65271506|NCT03712202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271507|NCT03712202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271508|NCT03712202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65271509|NCT03712202|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65271510|NCT03712202|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65271511|NCT03712202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271512|NCT03712202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271513|NCT03712202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65271514|NCT03712202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65271515|NCT03712202|Alkylating Agents|alkylating agents|mesh-ancestor
65271516|NCT03712202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65271517|NCT03712202|Tubulin Modulators|tubulin modulators|mesh-ancestor
65271518|NCT03712202|Antimitotic Agents|antimitotic agents|mesh-ancestor
65271519|NCT03712202|Mitosis Modulators|mitosis modulators|mesh-ancestor
65271520|NCT02635971|Gemcitabine|gemcitabine|mesh-list
65271521|NCT02635971|Oxaliplatin|oxaliplatin|mesh-list
65271522|NCT02635971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65271523|NCT02635971|Antimetabolites|antimetabolites|mesh-ancestor
65271524|NCT02635971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271525|NCT02635971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271526|NCT02635971|Antiviral Agents|antiviral agents|mesh-ancestor
65271527|NCT02635971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65271528|NCT02635971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271529|NCT02635971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65271530|NCT02635971|Immunologic Factors|immunologic factors|mesh-ancestor
65271531|NCT02635971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271532|NCT00657423|Cisplatin|cisplatin|mesh-list
65271533|NCT00657423|Docetaxel|docetaxel|mesh-list
65271534|NCT00657423|Endostar protein|endostar protein|mesh-list
65271535|NCT00657423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271536|NCT00657423|Tubulin Modulators|tubulin modulators|mesh-ancestor
65271537|NCT00657423|Antimitotic Agents|antimitotic agents|mesh-ancestor
65271538|NCT00657423|Mitosis Modulators|mitosis modulators|mesh-ancestor
65271539|NCT00657423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271540|NCT00657423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65271541|NCT00657423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65271542|NCT00657423|Growth Substances|growth substances|mesh-ancestor
65271543|NCT00657423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271544|NCT00657423|Growth Inhibitors|growth inhibitors|mesh-ancestor
65271545|NCT00911235|Fluconazole|fluconazole|mesh-list
65271546|NCT00911235|Fesoterodine|fesoterodine|mesh-list
65271547|NCT00911235|Antifungal Agents|antifungal agents|mesh-ancestor
65271548|NCT00911235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65271549|NCT00911235|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65271550|NCT00911235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65271551|NCT00911235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271552|NCT00911235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271553|NCT00911235|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65271554|NCT00911235|Hormone Antagonists|hormone antagonists|mesh-ancestor
65271555|NCT00911235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65271556|NCT00911235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271557|NCT00911235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65271558|NCT00911235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65271559|NCT00911235|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65271560|NCT00911235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65271561|NCT00911235|Cholinergic Agents|cholinergic agents|mesh-ancestor
65271562|NCT00911235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65271563|NCT00911235|Urological Agents|urological agents|mesh-ancestor
65271564|NCT00636974|Anesthetics|anesthetics|mesh-list
65271565|NCT00636974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65271566|NCT00636974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271568|NCT02535351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271569|NCT02535351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65271570|NCT02535351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65271571|NCT02535351|Growth Substances|growth substances|mesh-ancestor
65271572|NCT02535351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271573|NCT02535351|Growth Inhibitors|growth inhibitors|mesh-ancestor
65271574|NCT02535351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65271575|NCT02535351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271576|NCT02535351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271578|NCT00613964|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
65271579|NCT00613964|Natriuretic Agents|natriuretic agents|mesh-ancestor
65271580|NCT00613964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271581|NCT00613964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65271582|NCT00613964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271583|NCT05342870|Dexmedetomidine|dexmedetomidine|mesh-list
65271584|NCT05342870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65271585|NCT05342870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65271586|NCT05342870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271587|NCT05342870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65271588|NCT05342870|Analgesics|analgesics|mesh-ancestor
65271589|NCT05342870|Sensory System Agents|sensory system agents|mesh-ancestor
65271590|NCT05342870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65271591|NCT05342870|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65271592|NCT05342870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65271593|NCT05342870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65271594|NCT05342870|Adrenergic Agents|adrenergic agents|mesh-ancestor
65271595|NCT05342870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65271596|NCT05342870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271597|NCT00657579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65271598|NCT00657579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65271599|NCT05342792|Capecitabine|capecitabine|mesh-list
65271600|NCT05342792|Antibodies|antibodies|mesh-list
65271601|NCT05342792|Immunologic Factors|immunologic factors|mesh-ancestor
65271602|NCT05342792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271603|NCT05342792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65271604|NCT05342792|Antimetabolites|antimetabolites|mesh-ancestor
65271605|NCT05342792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271606|NCT05342792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271607|NCT03616886|Paclitaxel|paclitaxel|mesh-list
65271608|NCT03616886|Carboplatin|carboplatin|mesh-list
65271609|NCT03616886|Durvalumab|durvalumab|mesh-list
65271610|NCT03616886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65271611|NCT03616886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271612|NCT03616886|Tubulin Modulators|tubulin modulators|mesh-ancestor
65271613|NCT03616886|Antimitotic Agents|antimitotic agents|mesh-ancestor
65271614|NCT03616886|Mitosis Modulators|mitosis modulators|mesh-ancestor
65271615|NCT03616886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271616|NCT03616886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65271617|NCT00657891|Omalizumab|omalizumab|mesh-list
65271618|NCT00657891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65271619|NCT00657891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65271620|NCT00657891|Respiratory System Agents|respiratory system agents|mesh-ancestor
65271621|NCT05162300|Botulinum Toxins|botulinum toxins|mesh-list
65271622|NCT05162300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65271623|NCT05162300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65271624|NCT05162300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271625|NCT05162300|Cholinergic Agents|cholinergic agents|mesh-ancestor
65271626|NCT05162300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65271627|NCT05162300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271628|NCT04159077|Tamsulosin|tamsulosin|mesh-list
65271629|NCT04159077|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65271630|NCT04159077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65271631|NCT04159077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65271632|NCT04159077|Adrenergic Agents|adrenergic agents|mesh-ancestor
65271633|NCT04159077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65201700|NCT02630290|Anesthetics|anesthetics|mesh-ancestor
65271634|NCT04159077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271635|NCT04159077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271636|NCT04159077|Urological Agents|urological agents|mesh-ancestor
65271637|NCT02690480|Fulvestrant|fulvestrant|mesh-list
65271638|NCT02690480|Palbociclib|palbociclib|mesh-list
65271639|NCT02690480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65271641|NCT02690480|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65271642|NCT02690480|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65271643|NCT02690480|Hormone Antagonists|hormone antagonists|mesh-ancestor
65271644|NCT02690480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65271645|NCT02690480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271646|NCT02690480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65271647|NCT02690480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271648|NCT02690480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271649|NCT00658593|Gemcitabine|gemcitabine|mesh-list
65271650|NCT00658593|Capecitabine|capecitabine|mesh-list
65271651|NCT00658593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65271652|NCT00658593|Antimetabolites|antimetabolites|mesh-ancestor
65271653|NCT00658593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271654|NCT00658593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271655|NCT00658593|Antiviral Agents|antiviral agents|mesh-ancestor
65271656|NCT00658593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65271657|NCT00658593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271658|NCT00658593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65271659|NCT00658593|Immunologic Factors|immunologic factors|mesh-ancestor
65271660|NCT00658593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271661|NCT00880269|Panobinostat|panobinostat|mesh-list
65271662|NCT00880269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271663|NCT00880269|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65271664|NCT00880269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271665|NCT00880269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271666|NCT00880191|Dexamethasone|dexamethasone|mesh-list
65271668|NCT00880191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65271669|NCT00880191|Antiemetics|antiemetics|mesh-ancestor
65271670|NCT00880191|Autonomic Agents|autonomic agents|mesh-ancestor
65271671|NCT00880191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65271672|NCT00880191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271673|NCT00880191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65271674|NCT00880191|Glucocorticoids|glucocorticoids|mesh-ancestor
65271675|NCT00880191|Hormones|hormones|mesh-ancestor
65271676|NCT00880191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65271677|NCT00880191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65271678|NCT00880191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271679|NCT00880191|Analgesics|analgesics|mesh-ancestor
65271680|NCT00880191|Sensory System Agents|sensory system agents|mesh-ancestor
65271681|NCT00880191|Anticonvulsants|anticonvulsants|mesh-ancestor
65271682|NCT00880191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65271683|NCT00880191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65271684|NCT00880191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65271685|NCT00880191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65271686|NCT00880191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65271687|NCT00880191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65271688|NCT00880191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65271689|NCT00880191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271690|NCT00880191|Antimanic Agents|antimanic agents|mesh-ancestor
65271691|NCT00659451|Losartan|losartan|mesh-list
65271692|NCT00659451|Amlodipine|amlodipine|mesh-list
65271693|NCT00659451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65271694|NCT00659451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65271695|NCT00659451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65271696|NCT00659451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271697|NCT00659451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65271698|NCT00659451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271699|NCT00659451|Vasodilator Agents|vasodilator agents|mesh-ancestor
65271700|NCT00659451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65271701|NCT00659451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65271702|NCT00659451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65271703|NCT00911313|Metformin|metformin|mesh-list
65271704|NCT00911313|Letrozole|letrozole|mesh-list
65271705|NCT00911313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65271706|NCT00911313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271707|NCT00911313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201777|NCT00958074|Vorinostat|vorinostat|mesh-list
65271708|NCT00911313|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65021720|NCT00150527|Dexamethasone|dexamethasone|mesh-list
65271709|NCT00911313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65271710|NCT00911313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469415|NCT05815199|Nicotine|nicotine|mesh-list
65271712|NCT00911313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65271713|NCT00911313|Hormone Antagonists|hormone antagonists|mesh-ancestor
65271714|NCT00911313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65271715|NCT00659685|Ondansetron|ondansetron|mesh-list
65271716|NCT00659685|Antiemetics|antiemetics|mesh-ancestor
65271717|NCT00659685|Autonomic Agents|autonomic agents|mesh-ancestor
65271718|NCT00659685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65271719|NCT00659685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271720|NCT00659685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65271721|NCT00659685|Antipruritics|antipruritics|mesh-ancestor
65271722|NCT00659685|Dermatologic Agents|dermatologic agents|mesh-ancestor
65271723|NCT00659685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65271724|NCT00659685|Serotonin Agents|serotonin agents|mesh-ancestor
65271725|NCT00659685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65271726|NCT00659685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271727|NCT00659685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65271728|NCT00659685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65271729|NCT00659685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65271730|NCT00659685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65271731|NCT00659685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65271732|NCT00659841|Ciclesonide|ciclesonide|mesh-list
65271733|NCT00659841|Glucocorticoids|glucocorticoids|mesh-ancestor
65271734|NCT00659841|Hormones|hormones|mesh-ancestor
65271735|NCT00659841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65271736|NCT00659841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271737|NCT00659841|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65271738|NCT00659919|Trazodone|trazodone|mesh-list
65271739|NCT00659919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65271740|NCT00659919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65271741|NCT00659919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65271742|NCT00659919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271743|NCT00659919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65271744|NCT00659919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65271745|NCT00659919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65271746|NCT00659919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65271747|NCT00659919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271748|NCT00659919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65271749|NCT00659919|Serotonin Agents|serotonin agents|mesh-ancestor
65271750|NCT00659919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65271751|NCT00659919|Antidepressive Agents|antidepressive agents|mesh-ancestor
65271752|NCT00659997|Albendazole|albendazole|mesh-list
65271753|NCT00659997|Levamisole|levamisole|mesh-list
65271754|NCT00659997|Anthelmintics|anthelmintics|mesh-ancestor
65271755|NCT00659997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65271756|NCT00659997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65271757|NCT00659997|Anticestodal Agents|anticestodal agents|mesh-ancestor
65271758|NCT00659997|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65271759|NCT00659997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65271760|NCT00659997|Tubulin Modulators|tubulin modulators|mesh-ancestor
65271761|NCT00659997|Antimitotic Agents|antimitotic agents|mesh-ancestor
65271762|NCT00659997|Mitosis Modulators|mitosis modulators|mesh-ancestor
65271763|NCT00659997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271764|NCT00659997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271765|NCT00659997|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65271766|NCT00659997|Immunologic Factors|immunologic factors|mesh-ancestor
65271767|NCT00659997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271768|NCT00659997|Antinematodal Agents|antinematodal agents|mesh-ancestor
65271769|NCT00659997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65271770|NCT00660231|Gemcitabine|gemcitabine|mesh-list
65271771|NCT00660231|Bexarotene|bexarotene|mesh-list
65271772|NCT00660231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65271773|NCT00660231|Antimetabolites|antimetabolites|mesh-ancestor
65271774|NCT00660231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271775|NCT00660231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271776|NCT00660231|Antiviral Agents|antiviral agents|mesh-ancestor
65271777|NCT00660231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65271778|NCT00660231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271779|NCT00660231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65021801|NCT00164112|Azithromycin|azithromycin|mesh-list
65271780|NCT00660231|Immunologic Factors|immunologic factors|mesh-ancestor
65271781|NCT00660231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271782|NCT00597519|Cyclophosphamide|cyclophosphamide|mesh-list
65271783|NCT00597519|Fludarabine|fludarabine|mesh-list
65271785|NCT00597519|Immunologic Factors|immunologic factors|mesh-ancestor
65271786|NCT00597519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271787|NCT00597519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65271788|NCT00597519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65271789|NCT00597519|Alkylating Agents|alkylating agents|mesh-ancestor
65271790|NCT00597519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271791|NCT00597519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271792|NCT00597519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65271793|NCT00660621|Bevacizumab|bevacizumab|mesh-list
65271794|NCT00660621|Temozolomide|temozolomide|mesh-list
65271795|NCT00660621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65271796|NCT00660621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271797|NCT00660621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65271798|NCT00660621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65271799|NCT00660621|Growth Substances|growth substances|mesh-ancestor
65271800|NCT00660621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271801|NCT00660621|Growth Inhibitors|growth inhibitors|mesh-ancestor
65271802|NCT00660621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65271803|NCT00660621|Alkylating Agents|alkylating agents|mesh-ancestor
65271804|NCT00660621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271805|NCT02632305|Gemcitabine|gemcitabine|mesh-list
65271806|NCT02632305|Paclitaxel|paclitaxel|mesh-list
65271807|NCT02632305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65271808|NCT02632305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271809|NCT02632305|Tubulin Modulators|tubulin modulators|mesh-ancestor
65271810|NCT02632305|Antimitotic Agents|antimitotic agents|mesh-ancestor
65271811|NCT02632305|Mitosis Modulators|mitosis modulators|mesh-ancestor
65271812|NCT02632305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271813|NCT02632305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65271814|NCT02632305|Antimetabolites|antimetabolites|mesh-ancestor
65271815|NCT02632305|Antiviral Agents|antiviral agents|mesh-ancestor
65271816|NCT02632305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65271817|NCT02632305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271818|NCT02632305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65271819|NCT02632305|Immunologic Factors|immunologic factors|mesh-ancestor
65271820|NCT02632305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271821|NCT02631993|Furocoumarins|furocoumarins|mesh-list
65271822|NCT02631993|Dermatologic Agents|dermatologic agents|mesh-ancestor
65271823|NCT02631993|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65271824|NCT00660855|Parecoxib|parecoxib|mesh-list
65271825|NCT00660855|Valdecoxib|valdecoxib|mesh-list
65271826|NCT00660855|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65271827|NCT00660855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65271828|NCT00660855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271829|NCT00660855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271830|NCT00660855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65271831|NCT00660855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65271832|NCT00660855|Analgesics|analgesics|mesh-ancestor
65271833|NCT00660855|Sensory System Agents|sensory system agents|mesh-ancestor
65271834|NCT00660855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65271835|NCT00660855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271836|NCT00660855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65271837|NCT00660855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65271838|NCT00660933|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65271839|NCT00660933|Hematinics|hematinics|mesh-ancestor
65271840|NCT02632071|Paclitaxel|paclitaxel|mesh-list
65271841|NCT02632071|Ricolinostat|ricolinostat|mesh-list
65271842|NCT02632071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65271843|NCT02632071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271844|NCT02632071|Tubulin Modulators|tubulin modulators|mesh-ancestor
65271845|NCT02632071|Antimitotic Agents|antimitotic agents|mesh-ancestor
65271846|NCT02632071|Mitosis Modulators|mitosis modulators|mesh-ancestor
65271847|NCT02632071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271848|NCT02632071|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65271849|NCT02632071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271850|NCT00879333|Everolimus|everolimus|mesh-list
65271851|NCT00879333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271852|NCT00879333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65271853|NCT00879333|Immunologic Factors|immunologic factors|mesh-ancestor
65271854|NCT00879333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271855|NCT02630823|Paclitaxel|paclitaxel|mesh-list
65271856|NCT02630823|Carboplatin|carboplatin|mesh-list
65271857|NCT02630823|Pembrolizumab|pembrolizumab|mesh-list
64469563|NCT05814640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271858|NCT02630823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65271859|NCT02630823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271861|NCT02630823|Antimitotic Agents|antimitotic agents|mesh-ancestor
65271862|NCT02630823|Mitosis Modulators|mitosis modulators|mesh-ancestor
65271863|NCT02630823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271864|NCT02630823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65271865|NCT02630511|Mannitol|mannitol|mesh-list
65271866|NCT02630511|Methacholine Chloride|methacholine chloride|mesh-list
65271867|NCT02630511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65271868|NCT02630511|Diuretics|diuretics|mesh-ancestor
65271869|NCT02630511|Natriuretic Agents|natriuretic agents|mesh-ancestor
65271870|NCT02630511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271871|NCT02630511|Miotics|miotics|mesh-ancestor
65271872|NCT02630511|Autonomic Agents|autonomic agents|mesh-ancestor
65271873|NCT02630511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65271874|NCT02630511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65271875|NCT02630511|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
65271876|NCT02630511|Respiratory System Agents|respiratory system agents|mesh-ancestor
65271877|NCT02630511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65271878|NCT02630511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65271879|NCT02630511|Cholinergic Agents|cholinergic agents|mesh-ancestor
65271880|NCT02630511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65271881|NCT02630511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271882|NCT00666159|Pimecrolimus|pimecrolimus|mesh-list
65271883|NCT00666159|Tacrolimus|tacrolimus|mesh-list
65271884|NCT00666159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65271885|NCT00666159|Immunologic Factors|immunologic factors|mesh-ancestor
65271886|NCT00666159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271887|NCT00666159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65271888|NCT00666159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65271889|NCT00666159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271890|NCT00666159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65271891|NCT00666159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65271892|NCT00666159|Analgesics|analgesics|mesh-ancestor
65271893|NCT00666159|Sensory System Agents|sensory system agents|mesh-ancestor
65271894|NCT00666159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65271895|NCT00666159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65271896|NCT00666159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65271897|NCT00666159|Dermatologic Agents|dermatologic agents|mesh-ancestor
65271898|NCT00666393|Fentanyl|fentanyl|mesh-list
65271899|NCT00666393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65271900|NCT00666393|Narcotics|narcotics|mesh-ancestor
65271901|NCT00666393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65271902|NCT00666393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271903|NCT00666393|Analgesics|analgesics|mesh-ancestor
65271904|NCT00666393|Sensory System Agents|sensory system agents|mesh-ancestor
65271905|NCT00666393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65271906|NCT00666393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65271907|NCT00666393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65271908|NCT00666393|Anesthetics, General|anesthetics, general|mesh-ancestor
65271909|NCT00666393|Anesthetics|anesthetics|mesh-ancestor
65271910|NCT00666627|Alendronate|alendronate|mesh-list
65271911|NCT00666627|Risedronic Acid|risedronic acid|mesh-list
65271912|NCT00666627|Ibandronic Acid|ibandronic acid|mesh-list
65271913|NCT00666627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65271914|NCT00666627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271915|NCT00666627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65271916|NCT00666627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65271917|NCT00666627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271918|NCT00666627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65271919|NCT00666783|Palonosetron|palonosetron|mesh-list
65271920|NCT00666783|Granisetron|granisetron|mesh-list
65271921|NCT00666783|Antiemetics|antiemetics|mesh-ancestor
65271922|NCT00666783|Autonomic Agents|autonomic agents|mesh-ancestor
65271923|NCT00666783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65271924|NCT00666783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271925|NCT00666783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65271926|NCT00666783|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65271927|NCT00666783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65271928|NCT00666783|Serotonin Agents|serotonin agents|mesh-ancestor
65271929|NCT00666783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65271930|NCT00666783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271931|NCT00666939|Gabapentin|gabapentin|mesh-list
65271932|NCT00666939|Analgesics|analgesics|mesh-ancestor
65271933|NCT00666939|Sensory System Agents|sensory system agents|mesh-ancestor
65271934|NCT00666939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65271935|NCT00666939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271937|NCT00666939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65271938|NCT00666939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65271939|NCT00666939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65271940|NCT00666939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65271941|NCT00666939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65271942|NCT00666939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65271943|NCT00666939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65271944|NCT00666939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271945|NCT00666939|Antimanic Agents|antimanic agents|mesh-ancestor
65271946|NCT00667407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65271948|NCT00667407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65271949|NCT00667407|Autonomic Agents|autonomic agents|mesh-ancestor
65271950|NCT00667407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65271951|NCT00667407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271952|NCT00667407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65271953|NCT00667407|Respiratory System Agents|respiratory system agents|mesh-ancestor
65271954|NCT00667407|Tocolytic Agents|tocolytic agents|mesh-ancestor
65271955|NCT00667407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65271956|NCT00667407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65271957|NCT00667407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65271958|NCT00667407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65271959|NCT00667407|Adrenergic Agents|adrenergic agents|mesh-ancestor
65271960|NCT00667407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65271961|NCT00667407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271962|NCT00667485|Sirolimus|sirolimus|mesh-list
65271963|NCT00667485|Bevacizumab|bevacizumab|mesh-list
65271964|NCT00667485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65271965|NCT00667485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271966|NCT00667485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65271967|NCT00667485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65271968|NCT00667485|Growth Substances|growth substances|mesh-ancestor
65271969|NCT00667485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271970|NCT00667485|Growth Inhibitors|growth inhibitors|mesh-ancestor
65271971|NCT00667485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65271972|NCT00667485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65271973|NCT00667485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65271974|NCT00667485|Antifungal Agents|antifungal agents|mesh-ancestor
65271975|NCT00667485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65271976|NCT00667485|Immunologic Factors|immunologic factors|mesh-ancestor
65271977|NCT00667641|Paclitaxel|paclitaxel|mesh-list
65271978|NCT00667641|Bortezomib|bortezomib|mesh-list
65271979|NCT00667641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65271980|NCT00667641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65271981|NCT00667641|Tubulin Modulators|tubulin modulators|mesh-ancestor
65271982|NCT00667641|Antimitotic Agents|antimitotic agents|mesh-ancestor
65271983|NCT00667641|Mitosis Modulators|mitosis modulators|mesh-ancestor
65271984|NCT00667641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65271985|NCT00667797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65271986|NCT00667797|Albuterol|albuterol|mesh-list
65271987|NCT00667797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65271988|NCT00667797|Autonomic Agents|autonomic agents|mesh-ancestor
65271989|NCT00667797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65271990|NCT00667797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65271991|NCT00667797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65271992|NCT00667797|Respiratory System Agents|respiratory system agents|mesh-ancestor
65271993|NCT00667797|Tocolytic Agents|tocolytic agents|mesh-ancestor
65271994|NCT00667797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65271995|NCT00667797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65271996|NCT00667797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65271997|NCT00667797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65271998|NCT00667797|Adrenergic Agents|adrenergic agents|mesh-ancestor
65271999|NCT00667797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65272000|NCT00667797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272001|NCT03481556|Dexamethasone|dexamethasone|mesh-list
65272002|NCT03481556|Dexamethasone acetate|dexamethasone acetate|mesh-list
65272003|NCT03481556|Bortezomib|bortezomib|mesh-list
65272004|NCT03481556|Melphalan|melphalan|mesh-list
65272005|NCT03481556|Daratumumab|daratumumab|mesh-list
65272006|NCT03481556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65272007|NCT03481556|Antiemetics|antiemetics|mesh-ancestor
64469729|NCT05754710|Tofacitinib|tofacitinib|mesh-list
65022011|NCT00171522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272008|NCT03481556|Autonomic Agents|autonomic agents|mesh-ancestor
65272009|NCT03481556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65272010|NCT03481556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272011|NCT03481556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65272014|NCT03481556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65272015|NCT03481556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65272016|NCT03481556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272017|NCT03481556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65272018|NCT03481556|Alkylating Agents|alkylating agents|mesh-ancestor
65272019|NCT03481556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272020|NCT03481556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65272021|NCT03481556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65272022|NCT03481556|Immunologic Factors|immunologic factors|mesh-ancestor
65272023|NCT00668031|Aprotinin|aprotinin|mesh-list
65272024|NCT00668031|Hemostatics|hemostatics|mesh-ancestor
65272025|NCT00668031|Coagulants|coagulants|mesh-ancestor
65272026|NCT00668031|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65272027|NCT00668031|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65272028|NCT00668031|Protease Inhibitors|protease inhibitors|mesh-ancestor
65272029|NCT00668031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272030|NCT00668031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272031|NCT03480776|Aspirin|aspirin|mesh-list
65272032|NCT03480776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65272033|NCT03480776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65272034|NCT03480776|Analgesics|analgesics|mesh-ancestor
65272035|NCT03480776|Sensory System Agents|sensory system agents|mesh-ancestor
65272036|NCT03480776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65272037|NCT03480776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272038|NCT03480776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65272039|NCT03480776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65272040|NCT03480776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65272041|NCT03480776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65272042|NCT03480776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272043|NCT03480776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65272044|NCT03480776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65272045|NCT03480776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272046|NCT03480776|Antipyretics|antipyretics|mesh-ancestor
65272047|NCT00668109|Tadalafil|tadalafil|mesh-list
65272048|NCT00668109|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65272049|NCT00668109|Vasodilator Agents|vasodilator agents|mesh-ancestor
65272050|NCT00668109|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65272051|NCT00668109|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65272052|NCT00668109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272053|NCT00668109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272054|NCT00668109|Urological Agents|urological agents|mesh-ancestor
65272055|NCT00668343|Simvastatin|simvastatin|mesh-list
65272056|NCT00668343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65272057|NCT00668343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65272058|NCT00668343|Antimetabolites|antimetabolites|mesh-ancestor
65272059|NCT00668343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272060|NCT00668343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65272061|NCT00668343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65272062|NCT00668343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272063|NCT04717700|Dexamethasone|dexamethasone|mesh-list
65272064|NCT04717700|Lenalidomide|lenalidomide|mesh-list
65272065|NCT04717700|Bortezomib|bortezomib|mesh-list
65272066|NCT04717700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65272067|NCT04717700|Antiemetics|antiemetics|mesh-ancestor
65272068|NCT04717700|Autonomic Agents|autonomic agents|mesh-ancestor
65272069|NCT04717700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65272070|NCT04717700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272071|NCT04717700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65272072|NCT04717700|Glucocorticoids|glucocorticoids|mesh-ancestor
65272073|NCT04717700|Hormones|hormones|mesh-ancestor
65272074|NCT04717700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65272075|NCT04717700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65272076|NCT04717700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272077|NCT04717700|Immunologic Factors|immunologic factors|mesh-ancestor
65272078|NCT04717700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65272079|NCT04717700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65272080|NCT04717700|Growth Substances|growth substances|mesh-ancestor
64469801|NCT05688904|Imipramine|imipramine|mesh-list
65272082|NCT02630277|Aflibercept|aflibercept|mesh-list
65272083|NCT02630277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65272084|NCT02630277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65272085|NCT02630277|Growth Substances|growth substances|mesh-ancestor
65272086|NCT02630277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272087|NCT02630277|Growth Inhibitors|growth inhibitors|mesh-ancestor
65272088|NCT02630277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272089|NCT00668499|Pemetrexed|pemetrexed|mesh-list
65272090|NCT00668499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272091|NCT00668499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272092|NCT00668499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272093|NCT00668499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65272094|NCT00668499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65272095|NCT05201846|Insulin|insulin|mesh-list
65272096|NCT05201846|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65272097|NCT05201846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65272098|NCT05201846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272099|NCT00668967|Verapamil|verapamil|mesh-list
65272100|NCT00668967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65272101|NCT00668967|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65272102|NCT00668967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65272103|NCT00668967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272104|NCT00668967|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65272105|NCT00668967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272106|NCT00668967|Vasodilator Agents|vasodilator agents|mesh-ancestor
65272107|NCT03583658|Ambroxol|ambroxol|mesh-list
65272108|NCT03583658|Expectorants|expectorants|mesh-ancestor
65272109|NCT03583658|Respiratory System Agents|respiratory system agents|mesh-ancestor
65272110|NCT03555968|Dronabinol|dronabinol|mesh-list
65272111|NCT03555968|Hallucinogens|hallucinogens|mesh-ancestor
65272112|NCT03555968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272113|NCT03555968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65272114|NCT03555968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65272115|NCT03555968|Analgesics|analgesics|mesh-ancestor
65272116|NCT03555968|Sensory System Agents|sensory system agents|mesh-ancestor
65272117|NCT03555968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65272118|NCT03555968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65272119|NCT03555968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65272120|NCT03555968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65272121|NCT03555968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272122|NCT03555968|Hormones|hormones|mesh-ancestor
65272123|NCT03555968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65272124|NCT04593680|Tenofovir|tenofovir|mesh-list
65272125|NCT04593680|Emtricitabine|emtricitabine|mesh-list
65272126|NCT04593680|Antiviral Agents|antiviral agents|mesh-ancestor
65272127|NCT04593680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65272128|NCT04593680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65272129|NCT04593680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65272130|NCT04593680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272131|NCT04593680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272132|NCT04593680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65272133|NCT04593680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65272134|NCT00669435|Losartan|losartan|mesh-list
65272135|NCT00669435|Amlodipine|amlodipine|mesh-list
65272136|NCT00669435|Simvastatin|simvastatin|mesh-list
65272137|NCT00669435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65272138|NCT00669435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65272139|NCT00669435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65272140|NCT00669435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272141|NCT00669435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65272142|NCT00669435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272143|NCT00669435|Vasodilator Agents|vasodilator agents|mesh-ancestor
65272144|NCT00669435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65272145|NCT00669435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65272146|NCT00669435|Antimetabolites|antimetabolites|mesh-ancestor
65272147|NCT00669435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65272148|NCT00669435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65272149|NCT00669435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272150|NCT00669435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65272151|NCT00669435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65272152|NCT00669435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65272153|NCT00669591|Bavituximab|bavituximab|mesh-list
65272155|NCT00669591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65022163|NCT00171678|Diclofenac|diclofenac|mesh-list
65272156|NCT00669747|Carboplatin|carboplatin|mesh-list
65272157|NCT00669747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272158|NCT00596427|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65272159|NCT00596427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65272160|NCT00596427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65272161|NCT00596427|Antimetabolites|antimetabolites|mesh-ancestor
65272162|NCT00596427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272163|NCT00596427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65272164|NCT00670215|Ciprofloxacin|ciprofloxacin|mesh-list
65272165|NCT00670215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65272166|NCT00670215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65272167|NCT00670215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65272168|NCT00670215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65272169|NCT00670215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272170|NCT00670215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272171|NCT00670215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272172|NCT00670215|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65272173|NCT00670215|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65272174|NCT00670293|Raclopride|raclopride|mesh-list
65272175|NCT00670293|Methylphenidate|methylphenidate|mesh-list
65272176|NCT00670293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65272177|NCT00670293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272178|NCT00670293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65272179|NCT00670293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65272180|NCT00670293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65272181|NCT00670293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272182|NCT00670293|Dopamine Agents|dopamine agents|mesh-ancestor
65272183|NCT00670293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65272184|NCT00670293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65272185|NCT00670293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65272186|NCT00670293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65272187|NCT00670293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65272188|NCT00670293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65272189|NCT00670683|Insulin Detemir|insulin detemir|mesh-list
65272190|NCT00670683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65272191|NCT00670683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272192|NCT00670761|Misoprostol|misoprostol|mesh-list
65272193|NCT00670761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65272194|NCT00670761|Abortifacient Agents|abortifacient agents|mesh-ancestor
65272195|NCT00670761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65272196|NCT00670761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272197|NCT00670761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65272198|NCT00670761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65272199|NCT00670761|Oxytocics|oxytocics|mesh-ancestor
65272200|NCT04537208|Vaccines|vaccines|mesh-list
65272201|NCT04537208|Immunologic Factors|immunologic factors|mesh-ancestor
65272202|NCT04537208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272203|NCT00680433|Ketamine|ketamine|mesh-list
65272204|NCT00680433|Analgesics|analgesics|mesh-ancestor
65272205|NCT00680433|Sensory System Agents|sensory system agents|mesh-ancestor
65272206|NCT00680433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65272207|NCT00680433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272208|NCT00680433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65272209|NCT00680433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65272210|NCT00680433|Anesthetics, General|anesthetics, general|mesh-ancestor
65272211|NCT00680433|Anesthetics|anesthetics|mesh-ancestor
65272212|NCT00680433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65272213|NCT00680433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65272214|NCT00680433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65272215|NCT00680433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65272216|NCT00680433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272217|NCT03322280|Chlorotrianisene|chlorotrianisene|mesh-list
65272218|NCT03322280|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65272219|NCT03322280|Estrogens|estrogens|mesh-ancestor
65272220|NCT03322280|Hormones|hormones|mesh-ancestor
65272221|NCT03322280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65272222|NCT03322280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272223|NCT03322280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65272224|NCT03322280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272225|NCT04150965|Thalidomide|thalidomide|mesh-list
65272226|NCT04150965|Dexamethasone|dexamethasone|mesh-list
65272227|NCT04150965|Dexamethasone acetate|dexamethasone acetate|mesh-list
65272228|NCT04150965|Pomalidomide|pomalidomide|mesh-list
65272229|NCT04150965|Elotuzumab|elotuzumab|mesh-list
65272230|NCT04150965|BB 1101|bb 1101|mesh-list
65272231|NCT04150965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65272232|NCT04150965|Antiemetics|antiemetics|mesh-ancestor
65272233|NCT04150965|Autonomic Agents|autonomic agents|mesh-ancestor
65272234|NCT04150965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65272235|NCT04150965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272236|NCT04150965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65272237|NCT04150965|Glucocorticoids|glucocorticoids|mesh-ancestor
65272238|NCT04150965|Hormones|hormones|mesh-ancestor
65272239|NCT04150965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65272240|NCT04150965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65272241|NCT04150965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272242|NCT04150965|Protease Inhibitors|protease inhibitors|mesh-ancestor
65272243|NCT04150965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272244|NCT04150965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272245|NCT04150965|Immunologic Factors|immunologic factors|mesh-ancestor
65272246|NCT04150965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65272247|NCT04150965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65272248|NCT04150965|Growth Substances|growth substances|mesh-ancestor
65272249|NCT04150965|Growth Inhibitors|growth inhibitors|mesh-ancestor
65272250|NCT04150965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65272251|NCT04150965|Leprostatic Agents|leprostatic agents|mesh-ancestor
65272252|NCT04150965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65272253|NCT04150965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65272254|NCT04150575|Paclitaxel|paclitaxel|mesh-list
65272255|NCT04150575|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65272256|NCT04150575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65272257|NCT04150575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272258|NCT04150575|Tubulin Modulators|tubulin modulators|mesh-ancestor
65272259|NCT04150575|Antimitotic Agents|antimitotic agents|mesh-ancestor
65272260|NCT04150575|Mitosis Modulators|mitosis modulators|mesh-ancestor
65272261|NCT04150575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272262|NCT05345132|Magnesium Sulfate|magnesium sulfate|mesh-list
65272263|NCT05345132|Nifedipine|nifedipine|mesh-list
65272264|NCT05345132|Analgesics|analgesics|mesh-ancestor
65272265|NCT05345132|Sensory System Agents|sensory system agents|mesh-ancestor
65272266|NCT05345132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65272267|NCT05345132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272268|NCT05345132|Anesthetics|anesthetics|mesh-ancestor
65272269|NCT05345132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65272270|NCT05345132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65272271|NCT05345132|Anticonvulsants|anticonvulsants|mesh-ancestor
65272272|NCT05345132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65272273|NCT05345132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65272274|NCT05345132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272275|NCT05345132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65272276|NCT05345132|Tocolytic Agents|tocolytic agents|mesh-ancestor
65272277|NCT05345132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65272278|NCT05345132|Vasodilator Agents|vasodilator agents|mesh-ancestor
65272279|NCT04349306|Rasburicase|rasburicase|mesh-list
65272280|NCT04349306|Gout Suppressants|gout suppressants|mesh-ancestor
65272281|NCT04349306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65272282|NCT00614588|Anesthetics|anesthetics|mesh-list
65272283|NCT00614588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65272284|NCT00614588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272285|NCT03421652|Nivolumab|nivolumab|mesh-list
65272286|NCT03421652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65272287|NCT03421652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272288|NCT03421652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65272289|NCT03421652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272290|NCT02699840|Vaccines|vaccines|mesh-list
65272291|NCT02699840|Immunologic Factors|immunologic factors|mesh-ancestor
65272292|NCT02699840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272293|NCT00613808|Nitric Oxide|nitric oxide|mesh-list
65272294|NCT00613808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65272295|NCT00613808|Autonomic Agents|autonomic agents|mesh-ancestor
65272296|NCT00613808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65272297|NCT00613808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272298|NCT00613808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65272299|NCT00613808|Respiratory System Agents|respiratory system agents|mesh-ancestor
65272300|NCT00613808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65272301|NCT00613808|Antioxidants|antioxidants|mesh-ancestor
65272302|NCT00613808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272304|NCT00613808|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65272305|NCT00613808|Vasodilator Agents|vasodilator agents|mesh-ancestor
65272306|NCT00613808|Gasotransmitters|gasotransmitters|mesh-ancestor
65272307|NCT00613808|Protective Agents|protective agents|mesh-ancestor
65272308|NCT05344742|Paclitaxel|paclitaxel|mesh-list
65272309|NCT05344742|Capecitabine|capecitabine|mesh-list
65272310|NCT05344742|Mitoxantrone|mitoxantrone|mesh-list
65272311|NCT05344742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65272312|NCT05344742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272313|NCT05344742|Tubulin Modulators|tubulin modulators|mesh-ancestor
65272314|NCT05344742|Antimitotic Agents|antimitotic agents|mesh-ancestor
65272315|NCT05344742|Mitosis Modulators|mitosis modulators|mesh-ancestor
65272316|NCT05344742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272317|NCT05344742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65272318|NCT05344742|Antimetabolites|antimetabolites|mesh-ancestor
65272319|NCT05344742|Analgesics|analgesics|mesh-ancestor
65272320|NCT05344742|Sensory System Agents|sensory system agents|mesh-ancestor
65272321|NCT05344742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65272322|NCT05344742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272323|NCT05344742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65272324|NCT05344742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65272325|NCT05344742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272326|NCT02046434|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
65272327|NCT02046434|Glycerol|glycerol|mesh-list
65272328|NCT02046434|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65272329|NCT02046434|Protective Agents|protective agents|mesh-ancestor
65272330|NCT02046434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272331|NCT02046434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272332|NCT03930446|Ethanol|ethanol|mesh-list
65272333|NCT03930446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65272334|NCT03930446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65272335|NCT03930446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65272336|NCT03930446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272337|NCT00614666|Nikkomycin|nikkomycin|mesh-list
65272338|NCT00614666|Antifungal Agents|antifungal agents|mesh-ancestor
65272339|NCT00614666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65272340|NCT00614666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272341|NCT00614666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272342|NCT03794336|Aspirin|aspirin|mesh-list
65272343|NCT03794336|Metformin|metformin|mesh-list
65272344|NCT03794336|Alogliptin|alogliptin|mesh-list
65272345|NCT03794336|Acarbose|acarbose|mesh-list
65272346|NCT03794336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65272347|NCT03794336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272348|NCT03794336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65272349|NCT03794336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65272350|NCT03794336|Analgesics|analgesics|mesh-ancestor
65272351|NCT03794336|Sensory System Agents|sensory system agents|mesh-ancestor
65272352|NCT03794336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65272353|NCT03794336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65272354|NCT03794336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65272355|NCT03794336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65272356|NCT03794336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65272357|NCT03794336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272358|NCT03794336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65272359|NCT03794336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65272360|NCT03794336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272361|NCT03794336|Antipyretics|antipyretics|mesh-ancestor
65272362|NCT03794336|Incretins|incretins|mesh-ancestor
65272363|NCT03794336|Hormones|hormones|mesh-ancestor
65272364|NCT03794336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65272365|NCT03794336|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65272366|NCT03794336|Protease Inhibitors|protease inhibitors|mesh-ancestor
65272367|NCT03794336|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65272368|NCT03774914|Alemtuzumab|alemtuzumab|mesh-list
65272369|NCT03774914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65272370|NCT03774914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272371|NCT03681158|Valproic Acid|valproic acid|mesh-list
65272372|NCT03681158|Anticonvulsants|anticonvulsants|mesh-ancestor
65272373|NCT03681158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272374|NCT03681158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272375|NCT03681158|GABA Agents|gaba agents|mesh-ancestor
65272376|NCT03681158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65272378|NCT03681158|Antimanic Agents|antimanic agents|mesh-ancestor
65272379|NCT03681158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65272380|NCT03681158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65272381|NCT03681158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65272382|NCT05343806|Magnesium Sulfate|magnesium sulfate|mesh-list
65272384|NCT05343806|Analgesics|analgesics|mesh-ancestor
65272385|NCT05343806|Sensory System Agents|sensory system agents|mesh-ancestor
65272386|NCT05343806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65272387|NCT05343806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272388|NCT05343806|Anesthetics|anesthetics|mesh-ancestor
65272389|NCT05343806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65272390|NCT05343806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65272391|NCT05343806|Anticonvulsants|anticonvulsants|mesh-ancestor
65272392|NCT05343806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65272393|NCT05343806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65272394|NCT05343806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272395|NCT05343806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65272396|NCT05343806|Tocolytic Agents|tocolytic agents|mesh-ancestor
65272397|NCT05343806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65272398|NCT05343806|Vasodilator Agents|vasodilator agents|mesh-ancestor
65272399|NCT05343728|Hemostatics|hemostatics|mesh-list
65272400|NCT05343728|Coagulants|coagulants|mesh-ancestor
65272401|NCT00436748|Darbepoetin alfa|darbepoetin alfa|mesh-list
65272402|NCT00436748|Hematinics|hematinics|mesh-ancestor
65272403|NCT02704598|Warfarin|warfarin|mesh-list
65272404|NCT02704598|Rivaroxaban|rivaroxaban|mesh-list
65272405|NCT02704598|Anticoagulants|anticoagulants|mesh-ancestor
65272406|NCT02704598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65272407|NCT02704598|Antithrombins|antithrombins|mesh-ancestor
65272408|NCT02704598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65272409|NCT02704598|Protease Inhibitors|protease inhibitors|mesh-ancestor
65272410|NCT02704598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272411|NCT02704598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272412|NCT03342404|Luspatercept|luspatercept|mesh-list
65272413|NCT03342404|Hematinics|hematinics|mesh-ancestor
65272414|NCT03094052|Trastuzumab|trastuzumab|mesh-list
65272415|NCT03094052|Atropine|atropine|mesh-list
65272416|NCT03094052|Diphenoxylate|diphenoxylate|mesh-list
65272417|NCT03094052|Loperamide|loperamide|mesh-list
65272418|NCT03094052|Antidiarrheals|antidiarrheals|mesh-list
65272419|NCT03094052|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
65272420|NCT03094052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65272421|NCT03094052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272422|NCT03094052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65272423|NCT03094052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65272424|NCT03094052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65272425|NCT03094052|Autonomic Agents|autonomic agents|mesh-ancestor
65272426|NCT03094052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65272427|NCT03094052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272428|NCT03094052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65272429|NCT03094052|Respiratory System Agents|respiratory system agents|mesh-ancestor
65272430|NCT03094052|Mydriatics|mydriatics|mesh-ancestor
65272431|NCT03094052|Parasympatholytics|parasympatholytics|mesh-ancestor
65272432|NCT03094052|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65272433|NCT03094052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65272434|NCT03094052|Cholinergic Agents|cholinergic agents|mesh-ancestor
65272435|NCT03094052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65272436|NCT03094052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272437|NCT03094052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65272438|NCT03094052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65272439|NCT03094052|Narcotics|narcotics|mesh-ancestor
65272440|NCT03094052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65272441|NCT03094052|Analgesics|analgesics|mesh-ancestor
65272442|NCT03094052|Sensory System Agents|sensory system agents|mesh-ancestor
65272443|NCT05343338|Sivelestat|sivelestat|mesh-list
65272444|NCT05343338|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65272445|NCT05343338|Protease Inhibitors|protease inhibitors|mesh-ancestor
65272446|NCT05343338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272447|NCT05343338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272448|NCT02704520|Leucovorin|leucovorin|mesh-list
65272449|NCT02704520|Folic Acid|folic acid|mesh-list
65272450|NCT02704520|Fluorouracil|fluorouracil|mesh-list
65272451|NCT02704520|Capecitabine|capecitabine|mesh-list
65272452|NCT02704520|Oxaliplatin|oxaliplatin|mesh-list
65272453|NCT02704520|Levoleucovorin|levoleucovorin|mesh-list
65272454|NCT02704520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272456|NCT02704520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272457|NCT02704520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65272458|NCT02704520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272459|NCT02704520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65272460|NCT02704520|Immunologic Factors|immunologic factors|mesh-ancestor
65272461|NCT02704520|Antidotes|antidotes|mesh-ancestor
65272462|NCT02704520|Protective Agents|protective agents|mesh-ancestor
65272463|NCT02704520|Vitamin B Complex|vitamin b complex|mesh-ancestor
65272464|NCT02704520|Vitamins|vitamins|mesh-ancestor
65272465|NCT02704520|Micronutrients|micronutrients|mesh-ancestor
65272466|NCT02704520|Hematinics|hematinics|mesh-ancestor
65272467|NCT02704052|Enoxaparin|enoxaparin|mesh-list
65272468|NCT02704052|Enoxaparin sodium|enoxaparin sodium|mesh-list
65272469|NCT02704052|Anticoagulants|anticoagulants|mesh-ancestor
65272470|NCT02704052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65272471|NCT02704052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65272472|NCT02704052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272473|NCT02703896|Esomeprazole|esomeprazole|mesh-list
65272474|NCT02703896|Omeprazole|omeprazole|mesh-list
65272475|NCT02703896|Pantoprazole|pantoprazole|mesh-list
65272476|NCT02703896|Lansoprazole|lansoprazole|mesh-list
65272477|NCT02703896|Famotidine|famotidine|mesh-list
65272478|NCT02703896|Ranitidine|ranitidine|mesh-list
65272479|NCT02703896|Cimetidine|cimetidine|mesh-list
65272480|NCT02703896|Nizatidine|nizatidine|mesh-list
65272481|NCT02703896|Lafutidine|lafutidine|mesh-list
65272482|NCT02703896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65272483|NCT02703896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65272484|NCT02703896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65272485|NCT02703896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272486|NCT02703896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272487|NCT02703896|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65272488|NCT02703896|Histamine Antagonists|histamine antagonists|mesh-ancestor
65272489|NCT02703896|Histamine Agents|histamine agents|mesh-ancestor
65272490|NCT02703896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65272491|NCT02703896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272492|NCT02703896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65272493|NCT02703896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65272494|NCT02737436|Oxytocin|oxytocin|mesh-list
65272495|NCT02737436|Oxytocics|oxytocics|mesh-ancestor
65272496|NCT02737436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65272497|NCT02737436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272498|NCT03552692|Venetoclax|venetoclax|mesh-list
65272499|NCT03552692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272500|NCT00614978|Temozolomide|temozolomide|mesh-list
65272501|NCT00614978|Lapatinib|lapatinib|mesh-list
65272502|NCT00614978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65272503|NCT00614978|Alkylating Agents|alkylating agents|mesh-ancestor
65272504|NCT00614978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272505|NCT00614978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272506|NCT00614978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65272507|NCT00614978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272508|NCT03188354|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65272509|NCT03188354|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65272510|NCT03188354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272511|NCT02703740|Lidocaine|lidocaine|mesh-list
65272512|NCT02703740|Hyaluronic Acid|hyaluronic acid|mesh-list
65272513|NCT02703740|Anesthetics, Local|anesthetics, local|mesh-ancestor
65272514|NCT02703740|Anesthetics|anesthetics|mesh-ancestor
65272515|NCT02703740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65272516|NCT02703740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272517|NCT02703740|Sensory System Agents|sensory system agents|mesh-ancestor
65272518|NCT02703740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65272519|NCT02703740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65272520|NCT02703740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65272521|NCT02703740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65272522|NCT02703740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65272523|NCT02703740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272524|NCT02703740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65272525|NCT02703740|Immunologic Factors|immunologic factors|mesh-ancestor
65272526|NCT02703740|Viscosupplements|viscosupplements|mesh-ancestor
65272527|NCT02703740|Protective Agents|protective agents|mesh-ancestor
65272528|NCT00615368|Epoetin Alfa|epoetin alfa|mesh-list
65272529|NCT00615368|Hematinics|hematinics|mesh-ancestor
65272530|NCT00615446|Gemcitabine|gemcitabine|mesh-list
65272531|NCT00615446|Sunitinib|sunitinib|mesh-list
65272544|NCT00615446|Growth Substances|growth substances|mesh-ancestor
65272545|NCT00615446|Growth Inhibitors|growth inhibitors|mesh-ancestor
65272546|NCT00615446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65272547|NCT02703272|Dexamethasone|dexamethasone|mesh-list
65272549|NCT02703272|Carboplatin|carboplatin|mesh-list
65272550|NCT02703272|Etoposide|etoposide|mesh-list
65272551|NCT02703272|Vincristine|vincristine|mesh-list
65272552|NCT02703272|Ifosfamide|ifosfamide|mesh-list
65272553|NCT02703272|Idarubicin|idarubicin|mesh-list
65269620|NCT03195374|Narcotics|narcotics|mesh-ancestor
65272554|NCT02703272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65272555|NCT02703272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272556|NCT02703272|Immunologic Factors|immunologic factors|mesh-ancestor
65272557|NCT02703272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272558|NCT02703272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65272559|NCT02703272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65272560|NCT02703272|Antiemetics|antiemetics|mesh-ancestor
65272561|NCT02703272|Autonomic Agents|autonomic agents|mesh-ancestor
65272562|NCT02703272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65272563|NCT02703272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65272564|NCT02703272|Glucocorticoids|glucocorticoids|mesh-ancestor
65272565|NCT02703272|Hormones|hormones|mesh-ancestor
65272566|NCT02703272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65272567|NCT02703272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65272568|NCT02703272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65272569|NCT02703272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65272570|NCT02703272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65272571|NCT02703272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272572|NCT02703272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272573|NCT02703272|Tubulin Modulators|tubulin modulators|mesh-ancestor
65272574|NCT02703272|Antimitotic Agents|antimitotic agents|mesh-ancestor
65272575|NCT02703272|Mitosis Modulators|mitosis modulators|mesh-ancestor
65272576|NCT02703272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65272577|NCT02703272|Alkylating Agents|alkylating agents|mesh-ancestor
65272578|NCT02703272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65272579|NCT02703194|Prednisone|prednisone|mesh-list
65272580|NCT02703194|Prednisolone|prednisolone|mesh-list
65272581|NCT02703194|Leflunomide|leflunomide|mesh-list
65272582|NCT02703194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65272583|NCT02703194|Glucocorticoids|glucocorticoids|mesh-ancestor
65272584|NCT02703194|Hormones|hormones|mesh-ancestor
65272585|NCT02703194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65272586|NCT02703194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272587|NCT02703194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65272588|NCT02703194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272589|NCT02703194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272590|NCT02703194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272591|NCT02703194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65272592|NCT02703194|Immunologic Factors|immunologic factors|mesh-ancestor
65272593|NCT02402660|Vitamin A|vitamin a|mesh-list
65272594|NCT02402660|Retinol acetate|retinol acetate|mesh-list
65272595|NCT02402660|Vitamins|vitamins|mesh-ancestor
65272596|NCT02402660|Micronutrients|micronutrients|mesh-ancestor
65272599|NCT02402660|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65272600|NCT02402660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272601|NCT02402660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65272602|NCT02402660|Immunologic Factors|immunologic factors|mesh-ancestor
65272603|NCT02702960|Mycophenolic Acid|mycophenolic acid|mesh-list
65272604|NCT02702960|Prednisone|prednisone|mesh-list
65272605|NCT02702960|Cyclophosphamide|cyclophosphamide|mesh-list
65272606|NCT02702960|Fludarabine|fludarabine|mesh-list
65272607|NCT02702960|Tacrolimus|tacrolimus|mesh-list
65272608|NCT02702960|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65272609|NCT02702960|Mesna|mesna|mesh-list
65272610|NCT02702960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65272611|NCT02702960|Immunologic Factors|immunologic factors|mesh-ancestor
65272612|NCT02702960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272613|NCT02702960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65272614|NCT02702960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65272615|NCT02702960|Alkylating Agents|alkylating agents|mesh-ancestor
65272616|NCT02702960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272618|NCT02702960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65272619|NCT02702960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65272620|NCT02702960|Glucocorticoids|glucocorticoids|mesh-ancestor
65272621|NCT02702960|Hormones|hormones|mesh-ancestor
65272622|NCT02702960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65272623|NCT02702960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65272624|NCT02702960|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65272625|NCT02702960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272626|NCT02702960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65272627|NCT02702960|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65272628|NCT02702960|Antitubercular Agents|antitubercular agents|mesh-ancestor
65272629|NCT02702960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65272630|NCT02702960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65272631|NCT02702960|Protective Agents|protective agents|mesh-ancestor
65272632|NCT02699528|Methylphenidate|methylphenidate|mesh-list
65272633|NCT02699528|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65272634|NCT02699528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272635|NCT02699528|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65272636|NCT02699528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65272637|NCT02699528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65272638|NCT02699528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272639|NCT02699528|Dopamine Agents|dopamine agents|mesh-ancestor
65272640|NCT02699528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65272641|NCT04215770|Penicillins|penicillins|mesh-list
65272642|NCT04215770|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65272643|NCT04215770|Penicillin G|penicillin g|mesh-list
65272644|NCT04215770|Penicillin G Benzathine|penicillin g benzathine|mesh-list
65272645|NCT04215770|Penicillin G Procaine|penicillin g procaine|mesh-list
65272646|NCT04215770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65272647|NCT04215770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65272648|NCT04215770|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65272649|NCT04215770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272650|NCT04215770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272651|NCT02699138|Trazodone|trazodone|mesh-list
65272652|NCT02699138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65272653|NCT02699138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65272654|NCT02699138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65272655|NCT02699138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272656|NCT02699138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65272657|NCT02699138|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65272658|NCT02699138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65272659|NCT02699138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65272660|NCT02699138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272661|NCT02699138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65272662|NCT02699138|Serotonin Agents|serotonin agents|mesh-ancestor
65272663|NCT02699138|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65272664|NCT02699138|Antidepressive Agents|antidepressive agents|mesh-ancestor
65272665|NCT04215536|Empagliflozin|empagliflozin|mesh-list
65272666|NCT04215536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65272667|NCT04215536|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65272668|NCT04215536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272670|NCT04215536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272671|NCT04215536|Protease Inhibitors|protease inhibitors|mesh-ancestor
65272672|NCT04215536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272673|NCT00615134|Enfuvirtide|enfuvirtide|mesh-list
65272674|NCT00615134|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65272675|NCT00615134|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65272676|NCT00615134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272677|NCT00615134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65272678|NCT00615134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65272679|NCT00615134|Antiviral Agents|antiviral agents|mesh-ancestor
65272680|NCT00615134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65272681|NCT01831076|Tamoxifen|tamoxifen|mesh-list
65272682|NCT01831076|Exemestane|exemestane|mesh-list
65272683|NCT01831076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65272684|NCT01831076|Hormone Antagonists|hormone antagonists|mesh-ancestor
65272685|NCT01831076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65272686|NCT01831076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272687|NCT01831076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65272688|NCT01831076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272689|NCT01831076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65272690|NCT01831076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65272691|NCT01831076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65272692|NCT01831076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65272693|NCT01831076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65272694|NCT01831076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272695|NCT01831076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272696|NCT02698982|Anesthetics|anesthetics|mesh-list
65272697|NCT02698982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65272698|NCT02698982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272699|NCT00615524|Exemestane|exemestane|mesh-list
65272700|NCT00615524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272701|NCT00615524|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65272702|NCT00615524|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65272703|NCT00615524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272704|NCT00615524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272705|NCT00615524|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65272706|NCT00615524|Hormone Antagonists|hormone antagonists|mesh-ancestor
65272707|NCT00615524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65272708|NCT00615524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272709|NCT00908141|Sargramostim|sargramostim|mesh-list
65272710|NCT00908141|Immunologic Factors|immunologic factors|mesh-ancestor
65272711|NCT00908141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272712|NCT01246310|Inositol|inositol|mesh-list
65272713|NCT01246310|Vitamin B Complex|vitamin b complex|mesh-ancestor
65272714|NCT01246310|Vitamins|vitamins|mesh-ancestor
65272715|NCT01246310|Micronutrients|micronutrients|mesh-ancestor
65272716|NCT01246310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272717|NCT01773707|Abatacept|abatacept|mesh-list
65272718|NCT01773707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65272719|NCT01773707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272720|NCT01773707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272721|NCT01773707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65272722|NCT01773707|Immunologic Factors|immunologic factors|mesh-ancestor
65272723|NCT01773707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272724|NCT01773707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65272725|NCT00700076|Ketamine|ketamine|mesh-list
65272726|NCT00700076|Analgesics|analgesics|mesh-ancestor
65272727|NCT00700076|Sensory System Agents|sensory system agents|mesh-ancestor
65272728|NCT00700076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65272729|NCT00700076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272730|NCT00700076|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65272731|NCT00700076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65272732|NCT00700076|Anesthetics, General|anesthetics, general|mesh-ancestor
65272733|NCT00700076|Anesthetics|anesthetics|mesh-ancestor
65272734|NCT00700076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65272735|NCT00700076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65272736|NCT00700076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65272737|NCT00700076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65272738|NCT00700076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272739|NCT02698514|Sevoflurane|sevoflurane|mesh-list
65272740|NCT02698514|Desflurane|desflurane|mesh-list
65272741|NCT02698514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65272742|NCT02698514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65272743|NCT02698514|Anesthetics, General|anesthetics, general|mesh-ancestor
65272745|NCT02698514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65272746|NCT02698514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272747|NCT02706158|Vitamin D|vitamin d|mesh-list
65272748|NCT02706158|Calcium|calcium|mesh-list
65272749|NCT02706158|Vitamins|vitamins|mesh-ancestor
65272750|NCT02706158|Micronutrients|micronutrients|mesh-ancestor
65272751|NCT02706158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272752|NCT02706158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65272753|NCT02706158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65272754|NCT03739853|Sulfasalazine|sulfasalazine|mesh-list
65272755|NCT03739853|Adalimumab|adalimumab|mesh-list
65272756|NCT03739853|Methotrexate|methotrexate|mesh-list
65272757|NCT03739853|Leflunomide|leflunomide|mesh-list
65272758|NCT03739853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65272759|NCT03739853|Abortifacient Agents|abortifacient agents|mesh-ancestor
65272760|NCT03739853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65272761|NCT03739853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272762|NCT03739853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65272763|NCT03739853|Antimetabolites|antimetabolites|mesh-ancestor
65272764|NCT03739853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272765|NCT03739853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272766|NCT03739853|Dermatologic Agents|dermatologic agents|mesh-ancestor
65272767|NCT03739853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272768|NCT03739853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65272769|NCT03739853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65272770|NCT03739853|Immunologic Factors|immunologic factors|mesh-ancestor
65272771|NCT03739853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65272772|NCT03739853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65272773|NCT03739853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65272774|NCT03739853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65272775|NCT03739853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65272776|NCT03739853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65272777|NCT03739853|Analgesics|analgesics|mesh-ancestor
65272778|NCT03739853|Sensory System Agents|sensory system agents|mesh-ancestor
65272779|NCT03739853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65272780|NCT03739853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65272781|NCT00615602|Cyclophosphamide|cyclophosphamide|mesh-list
65272782|NCT00615602|Docetaxel|docetaxel|mesh-list
65272783|NCT00615602|Trastuzumab|trastuzumab|mesh-list
65272784|NCT00615602|Epirubicin|epirubicin|mesh-list
65272785|NCT00615602|Fluorouracil|fluorouracil|mesh-list
65272786|NCT00615602|Lenograstim|lenograstim|mesh-list
65272787|NCT00615602|Mitogens|mitogens|mesh-list
65272788|NCT00615602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65272789|NCT00615602|Immunologic Factors|immunologic factors|mesh-ancestor
65272790|NCT00615602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272791|NCT00615602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65272792|NCT00615602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65272793|NCT00615602|Alkylating Agents|alkylating agents|mesh-ancestor
65272794|NCT00615602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272795|NCT00615602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272796|NCT00615602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65272797|NCT00615602|Tubulin Modulators|tubulin modulators|mesh-ancestor
65272798|NCT00615602|Antimitotic Agents|antimitotic agents|mesh-ancestor
65272799|NCT00615602|Mitosis Modulators|mitosis modulators|mesh-ancestor
65272800|NCT00615602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65272801|NCT00615602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65272802|NCT00615602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65272803|NCT00615602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65272804|NCT00615602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272805|NCT00615602|Antimetabolites|antimetabolites|mesh-ancestor
65272806|NCT00615602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65272807|NCT00615602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65272808|NCT02698748|Chloroquine|chloroquine|mesh-list
65272809|NCT02698748|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65272810|NCT02698748|Amebicides|amebicides|mesh-ancestor
65272811|NCT02698748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65272812|NCT02698748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65272813|NCT02698748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65272814|NCT02698748|Antimalarials|antimalarials|mesh-ancestor
65272815|NCT02698748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65272816|NCT02698748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65272817|NCT02698748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65272818|NCT02698748|Analgesics|analgesics|mesh-ancestor
65272819|NCT02698748|Sensory System Agents|sensory system agents|mesh-ancestor
65272820|NCT02698748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65272821|NCT02698748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272822|NCT02698748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65272824|NCT02698748|Antinematodal Agents|antinematodal agents|mesh-ancestor
65272825|NCT02698748|Anthelmintics|anthelmintics|mesh-ancestor
65272826|NCT04750343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65272827|NCT04214990|Aspirin|aspirin|mesh-list
65272828|NCT04214990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65272829|NCT04214990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65272830|NCT04214990|Analgesics|analgesics|mesh-ancestor
65272831|NCT04214990|Sensory System Agents|sensory system agents|mesh-ancestor
65272832|NCT04214990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65272833|NCT04214990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272834|NCT04214990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65272835|NCT04214990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65272836|NCT04214990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65022827|NCT00152750|Clonidine|clonidine|mesh-list
65272837|NCT04214990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65272838|NCT04214990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272839|NCT04214990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65272840|NCT04214990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65272841|NCT04214990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272842|NCT04214990|Antipyretics|antipyretics|mesh-ancestor
65272843|NCT00615212|Rosiglitazone|rosiglitazone|mesh-list
65272844|NCT00615212|Flurbiprofen|flurbiprofen|mesh-list
65272845|NCT00615212|Midazolam|midazolam|mesh-list
65272846|NCT00615212|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65272847|NCT00615212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65272848|NCT00615212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65272849|NCT00615212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272850|NCT00615212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65272851|NCT00615212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65272852|NCT00615212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65272853|NCT00615212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65272854|NCT00615212|Anesthetics, General|anesthetics, general|mesh-ancestor
65272855|NCT00615212|Anesthetics|anesthetics|mesh-ancestor
65272856|NCT00615212|GABA Modulators|gaba modulators|mesh-ancestor
65272857|NCT00615212|GABA Agents|gaba agents|mesh-ancestor
65272858|NCT00615212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65272859|NCT00615212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272860|NCT00615212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65272861|NCT00615212|Analgesics|analgesics|mesh-ancestor
65272862|NCT00615212|Sensory System Agents|sensory system agents|mesh-ancestor
65272863|NCT00615212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65272864|NCT00615212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65272865|NCT00615212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65272866|NCT00615212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65272867|NCT00615212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65272868|NCT00615212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65272869|NCT00615212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272870|NCT02701478|Nitrous Oxide|nitrous oxide|mesh-list
65272871|NCT02701478|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65272872|NCT02701478|Anesthetics, General|anesthetics, general|mesh-ancestor
65272873|NCT02701478|Anesthetics|anesthetics|mesh-ancestor
65272874|NCT02701478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65272875|NCT02701478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272876|NCT02701478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65272877|NCT02701478|Analgesics|analgesics|mesh-ancestor
65272878|NCT02701478|Sensory System Agents|sensory system agents|mesh-ancestor
65272879|NCT02701478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65272880|NCT03314363|Trace Elements|trace elements|mesh-list
65272881|NCT03314363|Micronutrients|micronutrients|mesh-list
65272882|NCT03314363|Citric Acid|citric acid|mesh-list
65272883|NCT03314363|Sodium Citrate|sodium citrate|mesh-list
65272884|NCT03314363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272885|NCT03314363|Anticoagulants|anticoagulants|mesh-ancestor
65272886|NCT03314363|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65272887|NCT03314363|Chelating Agents|chelating agents|mesh-ancestor
65272888|NCT03314363|Sequestering Agents|sequestering agents|mesh-ancestor
65272889|NCT03314363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272890|NCT00906347|Misoprostol|misoprostol|mesh-list
65272891|NCT00906347|Oxytocin|oxytocin|mesh-list
65272892|NCT00906347|Oxytocics|oxytocics|mesh-ancestor
65272893|NCT00906347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65272894|NCT00906347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272895|NCT00906347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65272896|NCT00906347|Abortifacient Agents|abortifacient agents|mesh-ancestor
65272897|NCT00906347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65272898|NCT00906347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65272900|NCT02705768|Oxcarbazepine|oxcarbazepine|mesh-list
65272901|NCT02705768|Anticonvulsants|anticonvulsants|mesh-ancestor
65272902|NCT02705768|Antimanic Agents|antimanic agents|mesh-ancestor
65272903|NCT02705768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65272904|NCT02705768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65272905|NCT02705768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272906|NCT02705768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65272907|NCT02705768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65272908|NCT02705768|Analgesics|analgesics|mesh-ancestor
65272909|NCT02705768|Sensory System Agents|sensory system agents|mesh-ancestor
65272910|NCT02705768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65272911|NCT02705768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65272912|NCT02705768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65272913|NCT02705768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272914|NCT02705768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65272915|NCT02705768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65272916|NCT02705768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65272917|NCT00616070|Difluprednate|difluprednate|mesh-list
65272918|NCT00616070|Glucocorticoids|glucocorticoids|mesh-ancestor
65272920|NCT00616070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65272921|NCT00616070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272922|NCT03153527|Prednisone|prednisone|mesh-list
65272923|NCT03153527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65272924|NCT03153527|Glucocorticoids|glucocorticoids|mesh-ancestor
65272925|NCT03153527|Hormones|hormones|mesh-ancestor
65272926|NCT03153527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65272927|NCT03153527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272928|NCT03153527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65272929|NCT03153527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272930|NCT02705534|Ribavirin|ribavirin|mesh-list
65272931|NCT02705534|Sofosbuvir|sofosbuvir|mesh-list
65272932|NCT02705534|Ledipasvir|ledipasvir|mesh-list
65272933|NCT02705534|Antimetabolites|antimetabolites|mesh-ancestor
65272934|NCT02705534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272935|NCT02705534|Antiviral Agents|antiviral agents|mesh-ancestor
65272936|NCT02705534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65272937|NCT02701166|Bezafibrate|bezafibrate|mesh-list
65272938|NCT02701166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65272939|NCT02701166|Antimetabolites|antimetabolites|mesh-ancestor
65272940|NCT02701166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272941|NCT02701166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65272942|NCT03141203|Romidepsin|romidepsin|mesh-list
65272943|NCT03141203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65272944|NCT03141203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272945|NCT05320991|Ketamine|ketamine|mesh-list
65272946|NCT05320991|Analgesics|analgesics|mesh-ancestor
65272947|NCT05320991|Sensory System Agents|sensory system agents|mesh-ancestor
65272948|NCT05320991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65272949|NCT05320991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272950|NCT05320991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65272951|NCT05320991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65272952|NCT05320991|Anesthetics, General|anesthetics, general|mesh-ancestor
65272953|NCT05320991|Anesthetics|anesthetics|mesh-ancestor
65272954|NCT05320991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65272955|NCT05320991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65272956|NCT05320991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65272957|NCT05320991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65272958|NCT05320991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272959|NCT04215614|Lidocaine|lidocaine|mesh-list
65272960|NCT04215614|Bupivacaine|bupivacaine|mesh-list
65272961|NCT04215614|Anesthetics, Local|anesthetics, local|mesh-ancestor
65272962|NCT04215614|Anesthetics|anesthetics|mesh-ancestor
65272963|NCT04215614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65272964|NCT04215614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272965|NCT04215614|Sensory System Agents|sensory system agents|mesh-ancestor
65272966|NCT04215614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65272967|NCT04215614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65272968|NCT04215614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65272969|NCT04215614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65272971|NCT04215614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272972|NCT00906035|Aspirin|aspirin|mesh-list
65272973|NCT00906035|Dipyridamole|dipyridamole|mesh-list
65272974|NCT00906035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65272975|NCT00906035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65272976|NCT00906035|Analgesics|analgesics|mesh-ancestor
65272977|NCT00906035|Sensory System Agents|sensory system agents|mesh-ancestor
65272978|NCT00906035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65272979|NCT00906035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272980|NCT00906035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65272981|NCT00906035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65272982|NCT00906035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65272983|NCT00906035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65272984|NCT00906035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65272985|NCT00906035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65272986|NCT00906035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65272987|NCT00906035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65272988|NCT00906035|Antipyretics|antipyretics|mesh-ancestor
65272989|NCT00906035|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65272990|NCT00906035|Vasodilator Agents|vasodilator agents|mesh-ancestor
65272991|NCT02698280|Bevacizumab|bevacizumab|mesh-list
65272992|NCT02698280|Nimustine|nimustine|mesh-list
65272993|NCT02698280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65272994|NCT02698280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65272995|NCT02698280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65272996|NCT02698280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65272997|NCT02698280|Growth Substances|growth substances|mesh-ancestor
65272998|NCT02698280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65272999|NCT02698280|Growth Inhibitors|growth inhibitors|mesh-ancestor
65273000|NCT03087773|Empagliflozin|empagliflozin|mesh-list
65273001|NCT03087773|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65273002|NCT03087773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273003|NCT03087773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65273004|NCT03087773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273005|NCT02705612|Nimotuzumab|nimotuzumab|mesh-list
65273006|NCT02705612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269622|NCT03195374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273007|NCT02705612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65273008|NCT05333159|Dapagliflozin|dapagliflozin|mesh-list
65273009|NCT05333159|Empagliflozin|empagliflozin|mesh-list
65273010|NCT05333159|Canagliflozin|canagliflozin|mesh-list
65273011|NCT05333159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65273012|NCT05333159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273013|NCT05333159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65273014|NCT05333159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273015|NCT03654989|Treprostinil|treprostinil|mesh-list
65273016|NCT03654989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65273017|NCT02698124|Decitabine|decitabine|mesh-list
65273018|NCT02698124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65273019|NCT02698124|Antimetabolites|antimetabolites|mesh-ancestor
65273020|NCT02698124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273021|NCT02698124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273022|NCT02698124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273023|NCT00905489|Nevirapine|nevirapine|mesh-list
65273024|NCT00905489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65273025|NCT00905489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65273026|NCT00905489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65273027|NCT00905489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273028|NCT00905489|Antiviral Agents|antiviral agents|mesh-ancestor
65273029|NCT00905489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65273030|NCT00905489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65273031|NCT00905489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65273032|NCT00905489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65273033|NCT00905489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65273034|NCT02705378|Naloxegol|naloxegol|mesh-list
65273035|NCT02705378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65273036|NCT02705378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273037|NCT02705378|Sensory System Agents|sensory system agents|mesh-ancestor
65273038|NCT02705378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65273039|NCT03059147|Nivolumab|nivolumab|mesh-list
65273040|NCT03059147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65273041|NCT03059147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273042|NCT03059147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65273071|NCT05182658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273073|NCT05182658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273074|NCT04214054|Calcium|calcium|mesh-list
65273075|NCT04214054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65273076|NCT04214054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65273077|NCT02909036|Melphalan|melphalan|mesh-list
65273078|NCT02909036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65273079|NCT02909036|Alkylating Agents|alkylating agents|mesh-ancestor
65273080|NCT02909036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65273081|NCT02909036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65273082|NCT02909036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65273083|NCT02909036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65273084|NCT02909036|Immunologic Factors|immunologic factors|mesh-ancestor
64388929|NCT02442817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64388930|NCT02442817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64388931|NCT02442817|Protease Inhibitors|protease inhibitors|mesh-ancestor
64388932|NCT02442817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472936|NCT02025010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472945|NCT02020694|Vitamins|vitamins|mesh-list
64857643|NCT01736670|Hormones|hormones|mesh-ancestor
64472946|NCT02020694|Micronutrients|micronutrients|mesh-ancestor
64472950|NCT02019875|Clarithromycin|clarithromycin|mesh-list
64572269|NCT01459679|Dermatologic Agents|dermatologic agents|mesh-ancestor
64572652|NCT04856124|Esketamine|esketamine|mesh-list
65274263|NCT02686476|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64473009|NCT01726582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64860755|NCT01756417|Metformin|metformin|mesh-list
64629905|NCT04883242|Hormones|hormones|mesh-ancestor
64861506|NCT01760226|Prednisone|prednisone|mesh-list
64861754|NCT01761149|Narcotics|narcotics|mesh-ancestor
64861902|NCT01762150|Sorafenib|sorafenib|mesh-list
64575743|NCT00176917|Busulfan|busulfan|mesh-list
64473056|NCT01701674|Antiviral Agents|antiviral agents|mesh-ancestor
64473058|NCT01686126|Metformin|metformin|mesh-list
64862513|NCT01765452|Clopidogrel|clopidogrel|mesh-list
64862768|NCT01766843|Charcoal|charcoal|mesh-list
64576774|NCT04799184|Epinephryl borate|epinephryl borate|mesh-list
64864809|NCT01780883|Protective Agents|protective agents|mesh-ancestor
64864922|NCT01781988|Gemcitabine|gemcitabine|mesh-list
64473095|NCT01208662|Dexamethasone|dexamethasone|mesh-list
64577152|NCT04091022|Analgesics|analgesics|mesh-ancestor
64577227|NCT03794388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64869521|NCT01824251|Immunoglobulins|immunoglobulins|mesh-list
64577974|NCT03086993|Melphalan|melphalan|mesh-list
64871502|NCT01846026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64871503|NCT01846026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64871504|NCT01846117|Vitamin D|vitamin d|mesh-list
64871505|NCT01846117|Secoisolariciresinol|secoisolariciresinol|mesh-list
64871506|NCT01846117|Vitamins|vitamins|mesh-ancestor
64871507|NCT01846117|Micronutrients|micronutrients|mesh-ancestor
64871508|NCT01846117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871510|NCT01846117|Phytoestrogens|phytoestrogens|mesh-ancestor
64874125|NCT01863147|Acarbose|acarbose|mesh-list
64578794|NCT03089567|Listerine|listerine|mesh-list
64473111|NCT01208662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64874677|NCT01867255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64579244|NCT03089333|Glyburide|glyburide|mesh-list
64579317|NCT00227617|Leucovorin|leucovorin|mesh-list
64875672|NCT01872754|Narcotics|narcotics|mesh-ancestor
64876011|NCT01874574|Triamcinolone|triamcinolone|mesh-list
64876592|NCT01879033|Insulin|insulin|mesh-list
64473123|NCT00837616|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64473135|NCT00694850|Enzyme Activators|enzyme activators|mesh-ancestor
64580567|NCT01666314|Hormones|hormones|mesh-ancestor
64580672|NCT04639843|Cc-486|cc-486|mesh-list
64878359|NCT01897051|Rifaximin|rifaximin|mesh-list
64473139|NCT00460486|Formaldehyde|formaldehyde|mesh-list
64581470|NCT01438424|Entecavir|entecavir|mesh-list
64473146|NCT00378105|Antiemetics|antiemetics|mesh-ancestor
64881394|NCT01918254|Paclitaxel|paclitaxel|mesh-list
64473150|NCT00378105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64473151|NCT00378105|Glucocorticoids|glucocorticoids|mesh-ancestor
64582736|NCT01770483|Antimetabolites|antimetabolites|mesh-ancestor
64582813|NCT00267059|Lenalidomide|lenalidomide|mesh-list
64582885|NCT00267293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742499|NCT00005081|Carmustine|carmustine|mesh-list
64473159|NCT00378105|Growth Substances|growth substances|mesh-ancestor
64584086|NCT00328861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64473161|NCT00139477|Metformin|metformin|mesh-list
64473164|NCT00082706|Leucovorin|leucovorin|mesh-list
64473165|NCT00082706|Gemcitabine|gemcitabine|mesh-list
64473166|NCT00082706|Cisplatin|cisplatin|mesh-list
64746474|NCT01572792|Bromides|bromides|mesh-list
64747939|NCT01428258|Coal Tar|coal tar|mesh-list
64748852|NCT03592836|Furosemide|furosemide|mesh-list
64749642|NCT04140318|Paclitaxel|paclitaxel|mesh-list
64473178|NCT00082706|Antidotes|antidotes|mesh-ancestor
64749787|NCT04147572|Parasympatholytics|parasympatholytics|mesh-ancestor
64749788|NCT04147572|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64473181|NCT00082706|Vitamins|vitamins|mesh-ancestor
64750988|NCT03817320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64473183|NCT00004935|Trastuzumab|trastuzumab|mesh-list
64587062|NCT00384449|Ranibizumab|ranibizumab|mesh-list
64587211|NCT01796899|Anticonvulsants|anticonvulsants|mesh-ancestor
64752138|NCT03292926|BB 1101|bb 1101|mesh-list
64473189|NCT00119158|Tacrolimus|tacrolimus|mesh-list
64473191|NCT00119158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64755573|NCT02442180|Protective Agents|protective agents|mesh-ancestor
64589300|NCT04028804|Deoxyglucose|deoxyglucose|mesh-list
64589526|NCT04193852|Contraceptive Agents|contraceptive agents|mesh-ancestor
64589599|NCT00553969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64757077|NCT00195702|Adalimumab|adalimumab|mesh-list
64369080|NCT03221569|Anesthetics, General|anesthetics, general|mesh-ancestor
64757452|NCT04752852|Hormones|hormones|mesh-ancestor
64758005|NCT00335478|Daptomycin|daptomycin|mesh-list
64760083|NCT00527124|Docetaxel|docetaxel|mesh-list
64591467|NCT00578305|Micronutrients|micronutrients|mesh-ancestor
64591541|NCT00505895|Melphalan|melphalan|mesh-list
64591834|NCT03029780|Nivolumab|nivolumab|mesh-list
64592059|NCT00630253|Antiemetics|antiemetics|mesh-ancestor
64592282|NCT03152942|Hormones|hormones|mesh-ancestor
64764498|NCT03014778|Povidone|povidone|mesh-list
64473244|NCT00218062|Autonomic Agents|autonomic agents|mesh-ancestor
65203181|NCT00952068|Tramadol|tramadol|mesh-list
64765681|NCT00666978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64593632|NCT03610490|Analgesics|analgesics|mesh-ancestor
64766774|NCT00803010|Sirolimus|sirolimus|mesh-list
64594001|NCT00692185|Serotonin Agents|serotonin agents|mesh-ancestor
64473248|NCT00218062|Adrenergic Agents|adrenergic agents|mesh-ancestor
64594519|NCT00595231|Rufinamide|rufinamide|mesh-list
64380345|NCT05696613|Rituximab|rituximab|mesh-list
64768647|NCT01051440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768648|NCT01051440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64768649|NCT01051440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64768650|NCT01051440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64768651|NCT01051440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768653|NCT01051440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64768654|NCT01051596|Temozolomide|temozolomide|mesh-list
64768655|NCT01051596|Veliparib|veliparib|mesh-list
64768656|NCT01051596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64768657|NCT01051596|Alkylating Agents|alkylating agents|mesh-ancestor
64768658|NCT01051596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768659|NCT01051596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768660|NCT01051596|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64768726|NCT05821712|Sodium Fluoride|sodium fluoride|mesh-list
64768727|NCT05821712|Cariostatic Agents|cariostatic agents|mesh-ancestor
64594597|NCT03478514|Palbociclib|palbociclib|mesh-list
64768879|NCT05821075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64768880|NCT05821075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768881|NCT05821075|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64768882|NCT05821075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768883|NCT05821075|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64768884|NCT05821075|Protective Agents|protective agents|mesh-ancestor
64768885|NCT05821075|Nootropic Agents|nootropic agents|mesh-ancestor
64768886|NCT05821062|Aspirin|aspirin|mesh-list
64768887|NCT05821062|Clopidogrel|clopidogrel|mesh-list
64768888|NCT05821062|Ticagrelor|ticagrelor|mesh-list
64768889|NCT05821062|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64768890|NCT05821062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64594666|NCT00597493|Temozolomide|temozolomide|mesh-list
64473252|NCT00218062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64473254|NCT00121186|Fludarabine phosphate|fludarabine phosphate|mesh-list
64594975|NCT05362799|Metformin|metformin|mesh-list
64473255|NCT00121186|Fludarabine|fludarabine|mesh-list
64770380|NCT03781817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64770381|NCT03781817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64473256|NCT00121186|Melphalan|melphalan|mesh-list
64772041|NCT01263132|Thiamine|thiamine|mesh-list
64773234|NCT01479348|Antimetabolites|antimetabolites|mesh-ancestor
64773414|NCT01529502|Antioxidants|antioxidants|mesh-ancestor
64514749|NCT02127723|Protective Agents|protective agents|mesh-ancestor
64336902|NCT02440009|Hormones|hormones|mesh-ancestor
64596952|NCT05688020|Mydriatics|mydriatics|mesh-ancestor
64473270|NCT00121186|Immunologic Factors|immunologic factors|mesh-ancestor
64304109|NCT03067688|Vasodilator Agents|vasodilator agents|mesh-ancestor
64473283|NCT00121810|Antitubercular Agents|antitubercular agents|mesh-ancestor
64597901|NCT03339596|Epoetin Alfa|epoetin alfa|mesh-list
64484237|NCT01751113|Glucocorticoids|glucocorticoids|mesh-ancestor
64310473|NCT05028608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64473290|NCT00121810|Immunologic Factors|immunologic factors|mesh-ancestor
64473291|NCT00121810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473294|NCT00053014|Fludarabine|fludarabine|mesh-list
64473295|NCT00053014|Cyclosporins|cyclosporins|mesh-list
64473302|NCT00053014|Antifungal Agents|antifungal agents|mesh-ancestor
64598860|NCT04399226|Dexmedetomidine|dexmedetomidine|mesh-list
64398761|NCT03148561|Misoprostol|misoprostol|mesh-list
64399225|NCT05005715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64473305|NCT00053014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64399905|NCT05075863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400093|NCT04654429|Antipruritics|antipruritics|mesh-ancestor
64599235|NCT00592943|Modafinil|modafinil|mesh-list
64400471|NCT03071705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514752|NCT05586711|Hormones|hormones|mesh-ancestor
65066972|NCT00313950|Vaccines|vaccines|mesh-list
65067171|NCT00308451|Biotin|biotin|mesh-list
65067194|NCT00274118|Telmisartan|telmisartan|mesh-list
65067337|NCT00308763|Bupropion|bupropion|mesh-list
65067480|NCT00277589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65067791|NCT00418860|Antipyretics|antipyretics|mesh-ancestor
65067857|NCT00316329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65067935|NCT00279734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068159|NCT00280787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64473615|NCT01790594|Antiemetics|antiemetics|mesh-ancestor
65495836|NCT04181008|Amiloride|amiloride|mesh-list
65496054|NCT01149408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496426|NCT03898752|Vitamins|vitamins|mesh-ancestor
65496564|NCT01153386|Treprostinil|treprostinil|mesh-list
65497438|NCT01581840|Panitumumab|panitumumab|mesh-list
65497512|NCT01269528|Antioxidants|antioxidants|mesh-ancestor
65497589|NCT01269138|Thrombin|thrombin|mesh-list
65497952|NCT05834244|Venetoclax|venetoclax|mesh-list
65498037|NCT05829356|Vaccines|vaccines|mesh-list
65498396|NCT05594680|Methotrexate|methotrexate|mesh-list
65498472|NCT05578976|Glucocorticoids|glucocorticoids|mesh-ancestor
65068319|NCT00281567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65499017|NCT04872608|Letrozole|letrozole|mesh-list
65499291|NCT04525014|Irinotecan|irinotecan|mesh-list
65499893|NCT03485287|Adrenergic Agents|adrenergic agents|mesh-ancestor
65500263|NCT02427568|Adrenergic Agents|adrenergic agents|mesh-ancestor
65500514|NCT01665794|Hormones|hormones|mesh-ancestor
65274124|NCT02687178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65274125|NCT02687178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274126|NCT02687178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65274127|NCT02687178|Diuretics|diuretics|mesh-ancestor
65274128|NCT02687178|Natriuretic Agents|natriuretic agents|mesh-ancestor
65274129|NCT03711318|Buprenorphine|buprenorphine|mesh-list
65274130|NCT03711318|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65274131|NCT03711318|Naloxone|naloxone|mesh-list
65274132|NCT03711318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65274133|NCT03711318|Narcotics|narcotics|mesh-ancestor
65274134|NCT03711318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65274135|NCT03711318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274136|NCT03711318|Analgesics|analgesics|mesh-ancestor
65274137|NCT03711318|Sensory System Agents|sensory system agents|mesh-ancestor
65274138|NCT03711318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65274139|NCT03711318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65274140|NCT03535116|Ketorolac|ketorolac|mesh-list
65274141|NCT03535116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65274142|NCT03535116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65274143|NCT03535116|Analgesics|analgesics|mesh-ancestor
65274144|NCT03535116|Sensory System Agents|sensory system agents|mesh-ancestor
65274145|NCT03535116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65274146|NCT03535116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274147|NCT03535116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65274148|NCT03535116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65274149|NCT03535116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65274150|NCT03535116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274151|NCT03535116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274152|NCT03704298|Cyclophosphamide|cyclophosphamide|mesh-list
65274153|NCT03704298|Fludarabine|fludarabine|mesh-list
65274154|NCT03704298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65274155|NCT03704298|Immunologic Factors|immunologic factors|mesh-ancestor
65274156|NCT03704298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274157|NCT03704298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65274158|NCT03704298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65274159|NCT03704298|Alkylating Agents|alkylating agents|mesh-ancestor
65274160|NCT03704298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274161|NCT03704298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274162|NCT03704298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65274163|NCT02687100|Beclomethasone|beclomethasone|mesh-list
65274164|NCT02687100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65274165|NCT02687100|Glucocorticoids|glucocorticoids|mesh-ancestor
65274166|NCT02687100|Hormones|hormones|mesh-ancestor
65274167|NCT02687100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65262253|NCT00609557|Dopamine Agents|dopamine agents|mesh-ancestor
65262254|NCT05122481|Ascorbic Acid|ascorbic acid|mesh-list
65262256|NCT05122481|Micronutrients|micronutrients|mesh-ancestor
65262257|NCT05122481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262258|NCT05122481|Antioxidants|antioxidants|mesh-ancestor
65262259|NCT05122481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262260|NCT05122481|Protective Agents|protective agents|mesh-ancestor
65262261|NCT00937417|Docetaxel|docetaxel|mesh-list
65262262|NCT00937417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262263|NCT00937417|Tubulin Modulators|tubulin modulators|mesh-ancestor
65262264|NCT00937417|Antimitotic Agents|antimitotic agents|mesh-ancestor
65262265|NCT00937417|Mitosis Modulators|mitosis modulators|mesh-ancestor
65262266|NCT00937417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262267|NCT02728440|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65262268|NCT02728440|Menotropins|menotropins|mesh-list
65262269|NCT02728440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65262270|NCT02728440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262271|NCT02728440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65262272|NCT02728440|Fertility Agents|fertility agents|mesh-ancestor
65262273|NCT05358912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65262274|NCT04261517|Hydroxychloroquine|hydroxychloroquine|mesh-list
65262275|NCT04261517|Antimalarials|antimalarials|mesh-ancestor
65262276|NCT04261517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65262277|NCT04261517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65262278|NCT04261517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65262279|NCT04261517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262280|NCT04261517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262281|NCT04261517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65262282|NCT00930865|Dapagliflozin|dapagliflozin|mesh-list
65262283|NCT00930865|Bumetanide|bumetanide|mesh-list
65262284|NCT00930865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65262285|NCT00930865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262286|NCT00930865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65262287|NCT00930865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262288|NCT00930865|Diuretics|diuretics|mesh-ancestor
65262289|NCT00930865|Natriuretic Agents|natriuretic agents|mesh-ancestor
65262290|NCT00930865|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65262291|NCT00930865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65262292|NCT00930943|Oxymorphone|oxymorphone|mesh-list
65262293|NCT00930943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65262294|NCT00930943|Narcotics|narcotics|mesh-ancestor
65262295|NCT00930943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65262296|NCT00930943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262297|NCT00930943|Analgesics|analgesics|mesh-ancestor
65262298|NCT00930943|Sensory System Agents|sensory system agents|mesh-ancestor
65262299|NCT00930943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262300|NCT00930943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65262301|NCT02737800|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65262302|NCT02737800|Luteolytic Agents|luteolytic agents|mesh-ancestor
65262303|NCT02737800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65262304|NCT02737800|Contraceptive Agents|contraceptive agents|mesh-ancestor
65262305|NCT02737800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65262306|NCT02737800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262307|NCT02737800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65262308|NCT02737800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65262309|NCT02737800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262310|NCT00934531|Donepezil|donepezil|mesh-list
65262311|NCT00934531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65262312|NCT00934531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262313|NCT00934531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262314|NCT00934531|Cholinergic Agents|cholinergic agents|mesh-ancestor
65262315|NCT00934531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65262316|NCT00934531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262317|NCT00934531|Nootropic Agents|nootropic agents|mesh-ancestor
65262318|NCT00931021|Nicotine|nicotine|mesh-list
65262319|NCT00931021|Varenicline|varenicline|mesh-list
65262320|NCT00931021|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65262321|NCT00931021|Autonomic Agents|autonomic agents|mesh-ancestor
65262322|NCT00931021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262323|NCT00931021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262324|NCT00931021|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65262325|NCT00931021|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65012557|NCT00506272|Insulin|insulin|mesh-list
65262326|NCT00931021|Cholinergic Agents|cholinergic agents|mesh-ancestor
65262327|NCT00931021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65262328|NCT00931021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262329|NCT00937807|Sevoflurane|sevoflurane|mesh-list
65262330|NCT00937807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65262331|NCT00937807|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65262332|NCT00937807|Anesthetics, General|anesthetics, general|mesh-ancestor
65262333|NCT00937807|Anesthetics|anesthetics|mesh-ancestor
65262334|NCT00937807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65262335|NCT00937807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262336|NCT00934687|Botulinum Toxins|botulinum toxins|mesh-list
65262337|NCT00934687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65262338|NCT00934687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65262339|NCT00934687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65262340|NCT00934687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65262341|NCT00934687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262342|NCT00934687|Cholinergic Agents|cholinergic agents|mesh-ancestor
65262343|NCT00934687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65262344|NCT00934687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262345|NCT00934687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65262346|NCT00934687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262347|NCT02808728|Bupivacaine|bupivacaine|mesh-list
65262348|NCT02808728|Ropivacaine|ropivacaine|mesh-list
65262349|NCT02808728|Anesthetics, Local|anesthetics, local|mesh-ancestor
65262350|NCT02808728|Anesthetics|anesthetics|mesh-ancestor
65262351|NCT02808728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65262352|NCT02808728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262353|NCT02808728|Sensory System Agents|sensory system agents|mesh-ancestor
65262354|NCT02808728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262355|NCT05331053|Atorvastatin|atorvastatin|mesh-list
65262356|NCT05331053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65262357|NCT05331053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65262358|NCT05331053|Antimetabolites|antimetabolites|mesh-ancestor
65262359|NCT05331053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262360|NCT05331053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65262361|NCT05331053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65262362|NCT05331053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262363|NCT02732730|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65262364|NCT02732730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65262365|NCT02732730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65262366|NCT02732730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262367|NCT02732730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262368|NCT02732730|Antiviral Agents|antiviral agents|mesh-ancestor
65262369|NCT02732730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65262370|NCT02732730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65262371|NCT02732730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65262372|NCT04996667|Nitric Oxide|nitric oxide|mesh-list
65262373|NCT04996667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65262374|NCT04996667|Autonomic Agents|autonomic agents|mesh-ancestor
65262375|NCT04996667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262376|NCT04996667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262377|NCT04996667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65262378|NCT04996667|Respiratory System Agents|respiratory system agents|mesh-ancestor
65262379|NCT04996667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65262380|NCT04996667|Antioxidants|antioxidants|mesh-ancestor
65262381|NCT04996667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262382|NCT04996667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65262383|NCT04996667|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65262384|NCT04996667|Vasodilator Agents|vasodilator agents|mesh-ancestor
65262385|NCT04996667|Gasotransmitters|gasotransmitters|mesh-ancestor
65262386|NCT04996667|Protective Agents|protective agents|mesh-ancestor
65262387|NCT00929669|Pasireotide|pasireotide|mesh-list
65262389|NCT00929669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65262390|NCT00929669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262391|NCT02804360|Dexamethasone|dexamethasone|mesh-list
65262392|NCT02804360|Dexamethasone acetate|dexamethasone acetate|mesh-list
65262393|NCT02804360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65262394|NCT02804360|Antiemetics|antiemetics|mesh-ancestor
65262395|NCT02804360|Autonomic Agents|autonomic agents|mesh-ancestor
65262396|NCT02804360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262397|NCT02804360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262398|NCT02804360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65262399|NCT02804360|Glucocorticoids|glucocorticoids|mesh-ancestor
65262400|NCT02804360|Hormones|hormones|mesh-ancestor
65262401|NCT02804360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65262402|NCT02804360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65262403|NCT02804360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262404|NCT02727738|Selenium|selenium|mesh-list
65262405|NCT02727738|Methimazole|methimazole|mesh-list
65262406|NCT02727738|Antioxidants|antioxidants|mesh-ancestor
65262407|NCT02727738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262408|NCT02727738|Protective Agents|protective agents|mesh-ancestor
65262409|NCT02727738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262410|NCT02727738|Trace Elements|trace elements|mesh-ancestor
65262411|NCT02727738|Micronutrients|micronutrients|mesh-ancestor
65262412|NCT02727738|Antithyroid Agents|antithyroid agents|mesh-ancestor
65262413|NCT02727738|Hormone Antagonists|hormone antagonists|mesh-ancestor
65262414|NCT02727738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65262415|NCT02732418|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65262416|NCT02732418|Contraceptive Agents|contraceptive agents|mesh-list
65262417|NCT02732418|Medroxyprogesterone|medroxyprogesterone|mesh-list
65262418|NCT02732418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65262419|NCT02732418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262420|NCT02732418|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65262421|NCT02732418|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65262422|NCT02732418|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65262423|NCT02732418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65262424|NCT02732418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262425|NCT02732418|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65262426|NCT02732418|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65262427|NCT02732418|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65262428|NCT02811692|Aflibercept|aflibercept|mesh-list
65262429|NCT02811692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65262430|NCT02811692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65262431|NCT02811692|Growth Substances|growth substances|mesh-ancestor
65262432|NCT02811692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262433|NCT02811692|Growth Inhibitors|growth inhibitors|mesh-ancestor
65262434|NCT02811692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262435|NCT04004078|Antifungal Agents|antifungal agents|mesh-list
65262436|NCT04004078|Clotrimazole|clotrimazole|mesh-list
65262437|NCT04004078|Miconazole|miconazole|mesh-list
65262438|NCT04004078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65262439|NCT04004078|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65262440|NCT04004078|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65262441|NCT04004078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65262442|NCT04004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262443|NCT04004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262444|NCT04004078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65262445|NCT04004078|Hormone Antagonists|hormone antagonists|mesh-ancestor
65262446|NCT04004078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65262447|NCT04004078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262448|NCT04004078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65262449|NCT04004078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65262450|NCT02732262|Oxycodone|oxycodone|mesh-list
65262451|NCT02732262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65262452|NCT02732262|Narcotics|narcotics|mesh-ancestor
65262453|NCT02732262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65262454|NCT02732262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262455|NCT02732262|Analgesics|analgesics|mesh-ancestor
65262456|NCT02732262|Sensory System Agents|sensory system agents|mesh-ancestor
65262457|NCT02732262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262458|NCT00926393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65262459|NCT00926393|Antidepressive Agents|antidepressive agents|mesh-ancestor
65262460|NCT00926393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65262461|NCT00926393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65262462|NCT00926393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65262463|NCT00926393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65262464|NCT00926393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262465|NCT02737254|Oxytocin|oxytocin|mesh-list
65262466|NCT02737254|Oxytocics|oxytocics|mesh-ancestor
65262467|NCT02737254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65262468|NCT02737254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262469|NCT00938197|Amlodipine|amlodipine|mesh-list
65262470|NCT00938197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65262471|NCT00938197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65068358|NCT00317538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65262472|NCT00938197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65262473|NCT00938197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262474|NCT00938197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65262475|NCT00938197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262476|NCT00938197|Vasodilator Agents|vasodilator agents|mesh-ancestor
65262477|NCT02727504|Dobutamine|dobutamine|mesh-list
65262478|NCT02727504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65262479|NCT02727504|Sympathomimetics|sympathomimetics|mesh-ancestor
65262480|NCT02727504|Autonomic Agents|autonomic agents|mesh-ancestor
65262481|NCT02727504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262482|NCT02727504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262483|NCT02727504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65262484|NCT02727504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65262485|NCT02727504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65262486|NCT02727504|Adrenergic Agents|adrenergic agents|mesh-ancestor
65262487|NCT02727504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65262488|NCT02727504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262489|NCT02727504|Protective Agents|protective agents|mesh-ancestor
65262490|NCT02727348|Anesthetics|anesthetics|mesh-list
65262491|NCT02727348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65262492|NCT02727348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262493|NCT02804126|Acetaminophen|acetaminophen|mesh-list
65262494|NCT02804126|Dipyrone|dipyrone|mesh-list
65262495|NCT02804126|Ketoprofen|ketoprofen|mesh-list
65262496|NCT02804126|Morphine|morphine|mesh-list
65262497|NCT02804126|Bupivacaine|bupivacaine|mesh-list
65262498|NCT02804126|Anesthetics, Local|anesthetics, local|mesh-ancestor
65262499|NCT02804126|Anesthetics|anesthetics|mesh-ancestor
65262500|NCT02804126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65262501|NCT02804126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262502|NCT02804126|Sensory System Agents|sensory system agents|mesh-ancestor
65262503|NCT02804126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262504|NCT02804126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65262505|NCT02804126|Narcotics|narcotics|mesh-ancestor
65262506|NCT02804126|Analgesics|analgesics|mesh-ancestor
65262507|NCT02804126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65262508|NCT02804126|Antipyretics|antipyretics|mesh-ancestor
65262509|NCT02804126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65262510|NCT02804126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65262511|NCT02804126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65262512|NCT02804126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65262513|NCT02804126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262514|NCT02804126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262515|NCT04013815|Ropivacaine|ropivacaine|mesh-list
65262516|NCT04013815|Anesthetics, Local|anesthetics, local|mesh-ancestor
65262517|NCT04013815|Anesthetics|anesthetics|mesh-ancestor
65262518|NCT04013815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65262519|NCT04013815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262520|NCT04013815|Sensory System Agents|sensory system agents|mesh-ancestor
65262521|NCT04013815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262522|NCT00610103|Apomorphine|apomorphine|mesh-list
65262523|NCT00610103|Emetics|emetics|mesh-ancestor
65262524|NCT00610103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262525|NCT00610103|Autonomic Agents|autonomic agents|mesh-ancestor
65262526|NCT00610103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262527|NCT00610103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65262528|NCT00610103|Dopamine Agonists|dopamine agonists|mesh-ancestor
65262529|NCT00610103|Dopamine Agents|dopamine agents|mesh-ancestor
65262530|NCT00610103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65262531|NCT00610103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262532|NCT05624190|Plasminogen|plasminogen|mesh-list
65262533|NCT05624190|Tenecteplase|tenecteplase|mesh-list
65262534|NCT05624190|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65262535|NCT05624190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65262536|NCT05624190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65262537|NCT05624190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262538|NCT00938353|Beclomethasone|beclomethasone|mesh-list
65262539|NCT00938353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65262540|NCT00938353|Glucocorticoids|glucocorticoids|mesh-ancestor
65262541|NCT00938353|Hormones|hormones|mesh-ancestor
65262542|NCT00938353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65262543|NCT00938353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262544|NCT00938353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65262545|NCT00938353|Respiratory System Agents|respiratory system agents|mesh-ancestor
65262546|NCT04259333|Acetaminophen|acetaminophen|mesh-list
65262547|NCT04259333|Celecoxib|celecoxib|mesh-list
65262548|NCT04259333|Codeine|codeine|mesh-list
65262549|NCT04259333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65262550|NCT04259333|Analgesics|analgesics|mesh-ancestor
65262552|NCT04259333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262553|NCT04259333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262554|NCT04259333|Antipyretics|antipyretics|mesh-ancestor
65262555|NCT04259333|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65262556|NCT04259333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65262557|NCT04259333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65262558|NCT04259333|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65262559|NCT04259333|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65262560|NCT04259333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262561|NCT04259333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262562|NCT04259333|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65262563|NCT04259333|Narcotics|narcotics|mesh-ancestor
65262564|NCT04259333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65262565|NCT04259333|Antitussive Agents|antitussive agents|mesh-ancestor
65262566|NCT04259333|Respiratory System Agents|respiratory system agents|mesh-ancestor
65262567|NCT02721420|Piperaquine|piperaquine|mesh-list
65262568|NCT02721420|Artenimol|artenimol|mesh-list
65262569|NCT02721420|Antimalarials|antimalarials|mesh-ancestor
65262570|NCT02721420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65262571|NCT02721420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65262572|NCT02721420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65262573|NCT00608699|Niacin|niacin|mesh-list
65262574|NCT00608699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65262575|NCT00608699|Antimetabolites|antimetabolites|mesh-ancestor
65262576|NCT00608699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262577|NCT00608699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65262578|NCT00608699|Vasodilator Agents|vasodilator agents|mesh-ancestor
65262579|NCT00608699|Vitamin B Complex|vitamin b complex|mesh-ancestor
65262580|NCT00608699|Vitamins|vitamins|mesh-ancestor
65262581|NCT00608699|Micronutrients|micronutrients|mesh-ancestor
65262582|NCT00608699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262583|NCT05193396|Hydrocortisone|hydrocortisone|mesh-list
65262584|NCT05193396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65262585|NCT02726490|Metformin|metformin|mesh-list
65262586|NCT02726490|Glyburide|glyburide|mesh-list
65262587|NCT02726490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65262588|NCT02726490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262589|NCT02726646|Doxycycline|doxycycline|mesh-list
65262590|NCT02726646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65262591|NCT02726646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65262592|NCT02726646|Antimalarials|antimalarials|mesh-ancestor
65262593|NCT02726646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65262594|NCT02726646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65262595|NCT02803892|Vildagliptin|vildagliptin|mesh-list
65262596|NCT02803892|Sirolimus|sirolimus|mesh-list
65262597|NCT02803892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65262598|NCT02803892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65262599|NCT02803892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65262600|NCT02803892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262601|NCT02803892|Antifungal Agents|antifungal agents|mesh-ancestor
65262602|NCT02803892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65262603|NCT02803892|Immunologic Factors|immunologic factors|mesh-ancestor
65262604|NCT02803892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262605|NCT02803892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65262606|NCT02803892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65262607|NCT02803892|Protease Inhibitors|protease inhibitors|mesh-ancestor
65262608|NCT02803892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262609|NCT02803892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262610|NCT02803502|Thrombin|thrombin|mesh-list
65262611|NCT02803502|Hemostatics|hemostatics|mesh-ancestor
65262612|NCT02803502|Coagulants|coagulants|mesh-ancestor
65262613|NCT02721186|Piperaquine|piperaquine|mesh-list
65262614|NCT02721186|Primaquine|primaquine|mesh-list
65262615|NCT02721186|Artenimol|artenimol|mesh-list
65262616|NCT02721186|Antimalarials|antimalarials|mesh-ancestor
65262617|NCT02721186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65262618|NCT02721186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65262619|NCT02721186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65262620|NCT02716428|Ribavirin|ribavirin|mesh-list
65262621|NCT02716428|Antimetabolites|antimetabolites|mesh-ancestor
65262622|NCT02716428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262623|NCT02716428|Antiviral Agents|antiviral agents|mesh-ancestor
65262624|NCT02716428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65262625|NCT05511428|Daratumumab|daratumumab|mesh-list
65012857|NCT00143702|Antiviral Agents|antiviral agents|mesh-ancestor
65262626|NCT05511428|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65262627|NCT05511428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262628|NCT05511428|Immunologic Factors|immunologic factors|mesh-ancestor
65262629|NCT05511428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262630|NCT00931463|Ritonavir|ritonavir|mesh-list
65262631|NCT00931463|Lopinavir|lopinavir|mesh-list
65262632|NCT00931463|Raltegravir Potassium|raltegravir potassium|mesh-list
65262633|NCT00931463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65262634|NCT00931463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65262635|NCT00931463|Protease Inhibitors|protease inhibitors|mesh-ancestor
65262636|NCT00931463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262637|NCT00931463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262638|NCT00931463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65262639|NCT00931463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65262640|NCT00931463|Antiviral Agents|antiviral agents|mesh-ancestor
65262641|NCT00931463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65262642|NCT00931463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65262643|NCT00931463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65262644|NCT00931463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65262645|NCT00931463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65262646|NCT03974594|Trifluridine|trifluridine|mesh-list
65262647|NCT03974594|Antimetabolites|antimetabolites|mesh-ancestor
65262648|NCT03974594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262649|NCT03974594|Antiviral Agents|antiviral agents|mesh-ancestor
65262650|NCT03974594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65262651|NCT03964688|Ascorbic Acid|ascorbic acid|mesh-list
65262652|NCT03964688|Vitamins|vitamins|mesh-ancestor
65262653|NCT03964688|Micronutrients|micronutrients|mesh-ancestor
65262654|NCT03964688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262655|NCT03964688|Antioxidants|antioxidants|mesh-ancestor
65262656|NCT03964688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262657|NCT03964688|Protective Agents|protective agents|mesh-ancestor
65262658|NCT00929201|Metformin|metformin|mesh-list
65262659|NCT00929201|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65262660|NCT00929201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65262661|NCT00929201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262662|NCT00929201|Incretins|incretins|mesh-ancestor
65262663|NCT00929201|Hormones|hormones|mesh-ancestor
65262664|NCT00929201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65262665|NCT00929201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65262666|NCT00929201|Protease Inhibitors|protease inhibitors|mesh-ancestor
65262667|NCT00929201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262668|NCT00929201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262669|NCT02800772|Acetic Acid|acetic acid|mesh-list
65262670|NCT02800772|Retinol acetate|retinol acetate|mesh-list
65262671|NCT02800772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65262672|NCT02800772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65262673|NCT02800772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65262674|NCT02800772|Immunologic Factors|immunologic factors|mesh-ancestor
65262675|NCT02800772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262676|NCT02800772|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65262677|NCT02800772|Protective Agents|protective agents|mesh-ancestor
65262678|NCT02800772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262679|NCT02773212|Amphetamine|amphetamine|mesh-list
65262680|NCT02773212|Dextroamphetamine|dextroamphetamine|mesh-list
65262681|NCT02773212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65262682|NCT02773212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262683|NCT02773212|Sympathomimetics|sympathomimetics|mesh-ancestor
65262684|NCT02773212|Autonomic Agents|autonomic agents|mesh-ancestor
65262685|NCT02773212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262686|NCT02773212|Dopamine Agents|dopamine agents|mesh-ancestor
65262687|NCT02773212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65262688|NCT02773212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262689|NCT02773212|Adrenergic Agents|adrenergic agents|mesh-ancestor
65262690|NCT02773212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65262691|NCT02773212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65262692|NCT02773212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65262693|NCT02773212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65262694|NCT00610493|Sirolimus|sirolimus|mesh-list
65262695|NCT00610493|Bevacizumab|bevacizumab|mesh-list
65262696|NCT00610493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65012929|NCT00156312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65012930|NCT00156312|Tubulin Modulators|tubulin modulators|mesh-ancestor
65012931|NCT00156312|Antimitotic Agents|antimitotic agents|mesh-ancestor
65012932|NCT00156312|Mitosis Modulators|mitosis modulators|mesh-ancestor
65012933|NCT00156312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012934|NCT00156312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65012936|NCT00506701|Tadalafil|tadalafil|mesh-list
65262697|NCT00610493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262698|NCT00610493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65262699|NCT00610493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65262700|NCT00610493|Growth Substances|growth substances|mesh-ancestor
65262701|NCT00610493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262702|NCT00610493|Growth Inhibitors|growth inhibitors|mesh-ancestor
65262703|NCT00610493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65262704|NCT00610493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65262705|NCT00610493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65262706|NCT00610493|Antifungal Agents|antifungal agents|mesh-ancestor
65262707|NCT00610493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65262708|NCT00610493|Immunologic Factors|immunologic factors|mesh-ancestor
65262709|NCT02716272|Nivolumab|nivolumab|mesh-list
65262710|NCT02716272|Ipilimumab|ipilimumab|mesh-list
65262711|NCT02716272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65262712|NCT02716272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262713|NCT02716272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65203772|NCT03082755|Gabapentin|gabapentin|mesh-list
65262714|NCT02716272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262715|NCT02720406|Ketamine|ketamine|mesh-list
65262716|NCT02720406|Analgesics|analgesics|mesh-ancestor
65262717|NCT02720406|Sensory System Agents|sensory system agents|mesh-ancestor
65262718|NCT02720406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262719|NCT02720406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262720|NCT02720406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65262721|NCT02720406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65262722|NCT02720406|Anesthetics, General|anesthetics, general|mesh-ancestor
65262723|NCT02720406|Anesthetics|anesthetics|mesh-ancestor
65262724|NCT02720406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65262725|NCT02720406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65262726|NCT02720406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65262727|NCT02720406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65262728|NCT02720406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262729|NCT05504876|Midazolam|midazolam|mesh-list
65262730|NCT05504876|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65262731|NCT05504876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65262732|NCT05504876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65262733|NCT05504876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262734|NCT05504876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65262735|NCT05504876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65262736|NCT05504876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65262737|NCT05504876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65262738|NCT05504876|Anesthetics, General|anesthetics, general|mesh-ancestor
65262739|NCT05504876|Anesthetics|anesthetics|mesh-ancestor
65262740|NCT05504876|GABA Modulators|gaba modulators|mesh-ancestor
65262741|NCT05504876|GABA Agents|gaba agents|mesh-ancestor
65262742|NCT05504876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65262743|NCT05504876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262744|NCT02802722|Vitamin D|vitamin d|mesh-list
65262745|NCT02802722|Cholecalciferol|cholecalciferol|mesh-list
65262746|NCT02802722|Vitamins|vitamins|mesh-ancestor
65262747|NCT02802722|Micronutrients|micronutrients|mesh-ancestor
65262748|NCT02802722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262749|NCT02802722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65262750|NCT02802722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65262751|NCT02802644|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65262752|NCT02802644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65262753|NCT02802644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262754|NCT02802644|Incretins|incretins|mesh-ancestor
65262755|NCT02802644|Hormones|hormones|mesh-ancestor
65262756|NCT02802644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65262757|NCT02802644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65262758|NCT02802644|Protease Inhibitors|protease inhibitors|mesh-ancestor
65262759|NCT02802644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262760|NCT02802644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262761|NCT02744976|Metformin|metformin|mesh-list
65262762|NCT02744976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65262763|NCT02744976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262765|NCT00928889|Nateglinide|nateglinide|mesh-list
65262766|NCT00928889|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65262767|NCT00928889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262768|NCT00928889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262769|NCT00928889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65262770|NCT00928889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013011|NCT00144287|Ritonavir|ritonavir|mesh-list
65262771|NCT02725398|Scopolamine|scopolamine|mesh-list
65262772|NCT02725398|Bromides|bromides|mesh-list
65262773|NCT02725398|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65262774|NCT02725398|Anticonvulsants|anticonvulsants|mesh-ancestor
65262775|NCT02725398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65262776|NCT02725398|Antiemetics|antiemetics|mesh-ancestor
65262777|NCT02725398|Autonomic Agents|autonomic agents|mesh-ancestor
65262778|NCT02725398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262779|NCT02725398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262780|NCT02725398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65262781|NCT02725398|Mydriatics|mydriatics|mesh-ancestor
65262782|NCT02725398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65262783|NCT02725398|Cholinergic Agents|cholinergic agents|mesh-ancestor
65262784|NCT02725398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65262785|NCT02725398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262786|NCT02725398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65262787|NCT02725398|Parasympatholytics|parasympatholytics|mesh-ancestor
65262788|NCT04906902|Acalabrutinib|acalabrutinib|mesh-list
65262789|NCT04906902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262790|NCT02795546|Alendronate|alendronate|mesh-list
65262791|NCT02795546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65262792|NCT02795546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262793|NCT03978091|Ceftazidime|ceftazidime|mesh-list
65262794|NCT03978091|Avibactam|avibactam|mesh-list
65262795|NCT03978091|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
65262796|NCT03978091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65262797|NCT03978091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65262798|NCT03978091|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65262799|NCT03978091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262800|NCT03978091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262801|NCT00610571|Temozolomide|temozolomide|mesh-list
65262802|NCT00610571|Topotecan|topotecan|mesh-list
65262803|NCT00610571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65262804|NCT00610571|Alkylating Agents|alkylating agents|mesh-ancestor
65262805|NCT00610571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262806|NCT00610571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262807|NCT00610571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65262808|NCT00610571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65262809|NCT00610571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262810|NCT02725242|Budesonide|budesonide|mesh-list
65262811|NCT02725242|Formoterol Fumarate|formoterol fumarate|mesh-list
65262812|NCT02725242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65262813|NCT02725242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65262814|NCT02725242|Autonomic Agents|autonomic agents|mesh-ancestor
65262815|NCT02725242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262816|NCT02725242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262817|NCT02725242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65262818|NCT02725242|Respiratory System Agents|respiratory system agents|mesh-ancestor
65262819|NCT02725242|Glucocorticoids|glucocorticoids|mesh-ancestor
65262820|NCT02725242|Hormones|hormones|mesh-ancestor
65262821|NCT02725242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65262822|NCT02725242|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65262823|NCT02725242|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65262824|NCT02725242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65262825|NCT02725242|Adrenergic Agents|adrenergic agents|mesh-ancestor
65262826|NCT02725242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65262827|NCT02725242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262828|NCT00564733|Gemcitabine|gemcitabine|mesh-list
65262829|NCT00564733|Paclitaxel|paclitaxel|mesh-list
65262830|NCT00564733|Docetaxel|docetaxel|mesh-list
65262831|NCT00564733|Carboplatin|carboplatin|mesh-list
65262832|NCT00564733|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65262833|NCT00564733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65262834|NCT00564733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262835|NCT00564733|Tubulin Modulators|tubulin modulators|mesh-ancestor
65262836|NCT00564733|Antimitotic Agents|antimitotic agents|mesh-ancestor
65262837|NCT00564733|Mitosis Modulators|mitosis modulators|mesh-ancestor
65262838|NCT00564733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262839|NCT00564733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65262840|NCT00564733|Antimetabolites|antimetabolites|mesh-ancestor
65262841|NCT00564733|Antiviral Agents|antiviral agents|mesh-ancestor
65262842|NCT00564733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65262843|NCT00564733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262844|NCT00564733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65262845|NCT00564733|Immunologic Factors|immunologic factors|mesh-ancestor
65262846|NCT00564733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262847|NCT00564733|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65262848|NCT02725164|Nitrous Oxide|nitrous oxide|mesh-list
65262849|NCT02725164|Sevoflurane|sevoflurane|mesh-list
65262850|NCT02725164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65262851|NCT02725164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65262852|NCT02725164|Anesthetics, General|anesthetics, general|mesh-ancestor
65262853|NCT02725164|Anesthetics|anesthetics|mesh-ancestor
65262854|NCT02725164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65262855|NCT02725164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262856|NCT02725164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65262857|NCT02725164|Analgesics|analgesics|mesh-ancestor
65262858|NCT02725164|Sensory System Agents|sensory system agents|mesh-ancestor
65262859|NCT02725164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262860|NCT02800694|Fentanyl|fentanyl|mesh-list
65262861|NCT02800694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65262862|NCT02800694|Narcotics|narcotics|mesh-ancestor
65262863|NCT02800694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65262864|NCT02800694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262865|NCT02800694|Analgesics|analgesics|mesh-ancestor
65262866|NCT02800694|Sensory System Agents|sensory system agents|mesh-ancestor
65262867|NCT02800694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262868|NCT02800694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65262869|NCT02800694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65262870|NCT02800694|Anesthetics, General|anesthetics, general|mesh-ancestor
65262871|NCT02800694|Anesthetics|anesthetics|mesh-ancestor
65262872|NCT00931385|Formoterol Fumarate|formoterol fumarate|mesh-list
65262873|NCT00931385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65262874|NCT00931385|Autonomic Agents|autonomic agents|mesh-ancestor
65262875|NCT00931385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262876|NCT00931385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262877|NCT00931385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65262878|NCT00931385|Respiratory System Agents|respiratory system agents|mesh-ancestor
65262879|NCT00931385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65262880|NCT00931385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65262881|NCT00931385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65262882|NCT00931385|Adrenergic Agents|adrenergic agents|mesh-ancestor
65262883|NCT00931385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65262884|NCT00931385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262885|NCT00938509|Ibuprofen|ibuprofen|mesh-list
65262886|NCT00938509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65262887|NCT00938509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65262888|NCT00938509|Analgesics|analgesics|mesh-ancestor
65262889|NCT00938509|Sensory System Agents|sensory system agents|mesh-ancestor
65262890|NCT00938509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262891|NCT00938509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262892|NCT00938509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65262893|NCT00938509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65262894|NCT00938509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65262895|NCT00938509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262896|NCT00938509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262897|NCT02724618|Curcumin|curcumin|mesh-list
65262898|NCT02724618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65262899|NCT02724618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65262900|NCT02724618|Analgesics|analgesics|mesh-ancestor
65262901|NCT02724618|Sensory System Agents|sensory system agents|mesh-ancestor
65262902|NCT02724618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262903|NCT02724618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262904|NCT02724618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65262905|NCT02724618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65262906|NCT02724618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262907|NCT02724618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262908|NCT02724618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262909|NCT02801786|Tamoxifen|tamoxifen|mesh-list
65262910|NCT02801786|Lidocaine|lidocaine|mesh-list
65262911|NCT02801786|Anesthetics, Local|anesthetics, local|mesh-ancestor
65262912|NCT02801786|Anesthetics|anesthetics|mesh-ancestor
65262913|NCT02801786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65262914|NCT02801786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262915|NCT02801786|Sensory System Agents|sensory system agents|mesh-ancestor
65262916|NCT02801786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262917|NCT02801786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65262918|NCT02801786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65262919|NCT02801786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65262920|NCT02801786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65013161|NCT05148637|Lidocaine|lidocaine|mesh-list
65262921|NCT02801786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262922|NCT02801786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65262923|NCT02801786|Hormone Antagonists|hormone antagonists|mesh-ancestor
65262924|NCT02801786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65262925|NCT02801786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65262926|NCT02801786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262927|NCT02801786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65204000|NCT05034783|Exenatide|exenatide|mesh-list
65262928|NCT02801786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65262929|NCT02801786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65262930|NCT04258553|Antioxidants|antioxidants|mesh-list
65262931|NCT04258553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262932|NCT04258553|Protective Agents|protective agents|mesh-ancestor
65262933|NCT04258553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262934|NCT00938743|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65262935|NCT00938743|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65262936|NCT00938743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65262937|NCT00938743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65262938|NCT00938743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262939|NCT00938743|Adrenergic Agents|adrenergic agents|mesh-ancestor
65262940|NCT00938743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65262941|NCT00938743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262942|NCT02719392|Acetylcysteine|acetylcysteine|mesh-list
65262943|NCT02719392|Minocycline|minocycline|mesh-list
65262944|NCT02719392|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65262945|NCT02719392|Antiviral Agents|antiviral agents|mesh-ancestor
65262946|NCT02719392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65262947|NCT02719392|Expectorants|expectorants|mesh-ancestor
65262948|NCT02719392|Respiratory System Agents|respiratory system agents|mesh-ancestor
65262949|NCT02719392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65262950|NCT02719392|Antioxidants|antioxidants|mesh-ancestor
65262951|NCT02719392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262952|NCT02719392|Protective Agents|protective agents|mesh-ancestor
65262953|NCT02719392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262954|NCT02719392|Antidotes|antidotes|mesh-ancestor
65262955|NCT02719392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65262956|NCT02802098|Bevacizumab|bevacizumab|mesh-list
65262957|NCT02802098|Durvalumab|durvalumab|mesh-list
65262958|NCT02802098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65262959|NCT02802098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262960|NCT02802098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65262961|NCT02802098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65262962|NCT02802098|Growth Substances|growth substances|mesh-ancestor
65262963|NCT02802098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262964|NCT02802098|Growth Inhibitors|growth inhibitors|mesh-ancestor
65262965|NCT00938821|Morphine|morphine|mesh-list
65262966|NCT00938821|Bupivacaine|bupivacaine|mesh-list
65013235|NCT05143762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013236|NCT05143762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65013237|NCT05143762|Analgesics|analgesics|mesh-ancestor
65013238|NCT05143762|Sensory System Agents|sensory system agents|mesh-ancestor
65013239|NCT05143762|Antipyretics|antipyretics|mesh-ancestor
65013240|NCT00148356|Paclitaxel|paclitaxel|mesh-list
65013241|NCT00148356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65013242|NCT00148356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013243|NCT00148356|Tubulin Modulators|tubulin modulators|mesh-ancestor
65013244|NCT00148356|Antimitotic Agents|antimitotic agents|mesh-ancestor
65013245|NCT00148356|Mitosis Modulators|mitosis modulators|mesh-ancestor
65013246|NCT00148356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013247|NCT00424281|PENTA|penta|mesh-list
65013248|NCT00424281|Fondaparinux|fondaparinux|mesh-list
65013249|NCT00424281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65013250|NCT00424281|Antithrombins|antithrombins|mesh-ancestor
65013251|NCT00424281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65013252|NCT00424281|Protease Inhibitors|protease inhibitors|mesh-ancestor
65013253|NCT00424281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013254|NCT00424281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013255|NCT00424281|Anticoagulants|anticoagulants|mesh-ancestor
65013256|NCT00424281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65013257|NCT00424281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65013258|NCT00148395|Gemcitabine|gemcitabine|mesh-list
65013259|NCT00148395|Carboplatin|carboplatin|mesh-list
65013260|NCT00148395|Ifosfamide|ifosfamide|mesh-list
65013261|NCT00148395|Mitomycins|mitomycins|mesh-list
65013262|NCT00148395|Mitomycin|mitomycin|mesh-list
65013263|NCT00148395|Vinorelbine|vinorelbine|mesh-list
65262968|NCT00938821|Anesthetics|anesthetics|mesh-ancestor
65262969|NCT00938821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65262970|NCT00938821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262971|NCT00938821|Sensory System Agents|sensory system agents|mesh-ancestor
65262972|NCT00938821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262973|NCT00938821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65262974|NCT00938821|Narcotics|narcotics|mesh-ancestor
65262975|NCT00938821|Analgesics|analgesics|mesh-ancestor
65262976|NCT04013581|Empagliflozin|empagliflozin|mesh-list
65204074|NCT04286529|Calcitriol|calcitriol|mesh-list
65262977|NCT04013581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65262978|NCT04013581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262979|NCT04013581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65262980|NCT04013581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262981|NCT02715960|Vitamin A|vitamin a|mesh-list
65262982|NCT02715960|Tretinoin|tretinoin|mesh-list
65262983|NCT02715960|Acitretin|acitretin|mesh-list
65262984|NCT02715960|Vitamins|vitamins|mesh-ancestor
65262985|NCT02715960|Micronutrients|micronutrients|mesh-ancestor
65262986|NCT02715960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262987|NCT02715960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262988|NCT02715960|Keratolytic Agents|keratolytic agents|mesh-ancestor
65262989|NCT02715960|Dermatologic Agents|dermatologic agents|mesh-ancestor
65262990|NCT03983018|Rituximab|rituximab|mesh-list
65262991|NCT03983018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65262992|NCT03983018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262993|NCT03983018|Immunologic Factors|immunologic factors|mesh-ancestor
65262994|NCT03983018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262995|NCT03983018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65262996|NCT02794922|Vitamin B Complex|vitamin b complex|mesh-list
65262997|NCT02794922|Vitamins|vitamins|mesh-ancestor
65262998|NCT02794922|Micronutrients|micronutrients|mesh-ancestor
65262999|NCT02794922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263000|NCT00935467|Saxagliptin|saxagliptin|mesh-list
65263001|NCT00935467|Incretins|incretins|mesh-ancestor
65263002|NCT00935467|Hormones|hormones|mesh-ancestor
65263003|NCT00935467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65263004|NCT00935467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263005|NCT00935467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65263006|NCT00935467|Protease Inhibitors|protease inhibitors|mesh-ancestor
65263007|NCT00935467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263008|NCT00935467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263009|NCT00935467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65263010|NCT00935545|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65263011|NCT00935545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65263012|NCT00935545|Immunologic Factors|immunologic factors|mesh-ancestor
65263013|NCT00935545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263014|NCT04235816|Azithromycin|azithromycin|mesh-list
65263015|NCT04235816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65263016|NCT04235816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263017|NCT00936013|Oseltamivir|oseltamivir|mesh-list
65263018|NCT00936013|Antiviral Agents|antiviral agents|mesh-ancestor
65263019|NCT00936013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263020|NCT00936013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263021|NCT00936013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263022|NCT00936091|Vitamin A|vitamin a|mesh-list
65263023|NCT00936091|Vitamins|vitamins|mesh-ancestor
65263024|NCT00936091|Micronutrients|micronutrients|mesh-ancestor
65263025|NCT00936091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263026|NCT00563797|Mecamylamine|mecamylamine|mesh-list
65263027|NCT00563797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65263028|NCT00563797|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
65263029|NCT00563797|Autonomic Agents|autonomic agents|mesh-ancestor
65263030|NCT00563797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65263031|NCT00563797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263032|NCT00563797|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65263033|NCT00563797|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65263034|NCT00563797|Cholinergic Agents|cholinergic agents|mesh-ancestor
65263035|NCT00563797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65263036|NCT00563797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263038|NCT01192698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65263039|NCT01192698|Antiviral Agents|antiviral agents|mesh-ancestor
65263040|NCT01192698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263041|NCT04014361|Itraconazole|itraconazole|mesh-list
65263042|NCT04014361|Antifungal Agents|antifungal agents|mesh-ancestor
65263043|NCT04014361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263044|NCT04014361|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65263045|NCT04014361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65263046|NCT04014361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263047|NCT04014361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263048|NCT04014361|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65263049|NCT04014361|Hormone Antagonists|hormone antagonists|mesh-ancestor
65263050|NCT04014361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65263051|NCT04014361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846859|NCT05291195|Eusol|eusol|mesh-list
65263052|NCT04014361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65263053|NCT00771927|Lacosamide|lacosamide|mesh-list
65263054|NCT00771927|Anticonvulsants|anticonvulsants|mesh-ancestor
65263055|NCT00771927|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65263056|NCT00771927|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65263057|NCT00771927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65263058|NCT00771927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263059|NCT02715492|Enoxaparin|enoxaparin|mesh-list
65263060|NCT02715492|Anticoagulants|anticoagulants|mesh-ancestor
65263061|NCT02715492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65263062|NCT02715492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65263063|NCT02715492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263064|NCT03940196|Paclitaxel|paclitaxel|mesh-list
65263065|NCT03940196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65263066|NCT03940196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65263067|NCT03940196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65263068|NCT03940196|Tubulin Modulators|tubulin modulators|mesh-ancestor
65263069|NCT03940196|Antimitotic Agents|antimitotic agents|mesh-ancestor
65263070|NCT03940196|Mitosis Modulators|mitosis modulators|mesh-ancestor
65263071|NCT03940196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263072|NCT03988179|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
65263073|NCT03988179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263074|NCT03988179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263075|NCT03988179|Cholinergic Agents|cholinergic agents|mesh-ancestor
65263076|NCT03988179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65263077|NCT03988179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263078|NCT02724150|Omeprazole|omeprazole|mesh-list
65263079|NCT02724150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65263080|NCT02724150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65263081|NCT02724150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65263082|NCT02724150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263083|NCT02724150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263084|NCT00936247|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65263085|NCT04042740|Ribavirin|ribavirin|mesh-list
65263086|NCT04042740|Antimetabolites|antimetabolites|mesh-ancestor
65263087|NCT04042740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263088|NCT04042740|Antiviral Agents|antiviral agents|mesh-ancestor
65263089|NCT04042740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263090|NCT02715336|Leuprolide|leuprolide|mesh-list
65263091|NCT02715336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65263092|NCT02715336|Fertility Agents|fertility agents|mesh-ancestor
65263093|NCT02715336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65263094|NCT02715336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263095|NCT02715336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65263096|NCT02715336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65263097|NCT02794610|Tacrolimus|tacrolimus|mesh-list
65263098|NCT02794610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65263099|NCT02794610|Immunologic Factors|immunologic factors|mesh-ancestor
65263100|NCT02794610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263101|NCT02794610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65263102|NCT02794610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479563|NCT01870297|Hormones|hormones|mesh-ancestor
65263103|NCT02794610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263105|NCT02799758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65263106|NCT02799758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65263107|NCT02799758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65263108|NCT02799758|Antimetabolites|antimetabolites|mesh-ancestor
65263109|NCT02799758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263110|NCT02799758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263111|NCT02799758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65263112|NCT00938899|Simeprevir|simeprevir|mesh-list
65263113|NCT00938899|Antiviral Agents|antiviral agents|mesh-ancestor
65263114|NCT00938899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263115|NCT00938899|Protease Inhibitors|protease inhibitors|mesh-ancestor
65263116|NCT00938899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263117|NCT00938899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263118|NCT03259165|Diuretics|diuretics|mesh-list
65263119|NCT03259165|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
65263120|NCT03259165|Natriuretic Agents|natriuretic agents|mesh-ancestor
65263121|NCT03259165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263122|NCT03259165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65263123|NCT03259165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263124|NCT04013659|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65263125|NCT04013659|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65263126|NCT04013659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263127|NCT00939133|Tretinoin|tretinoin|mesh-list
65263128|NCT00939133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65263129|NCT00939133|Keratolytic Agents|keratolytic agents|mesh-ancestor
65263130|NCT00939133|Dermatologic Agents|dermatologic agents|mesh-ancestor
65263131|NCT02799446|Reslizumab|reslizumab|mesh-list
65263132|NCT02799446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65263133|NCT02799446|Respiratory System Agents|respiratory system agents|mesh-ancestor
65263134|NCT00564889|Dexamethasone|dexamethasone|mesh-list
65263135|NCT00564889|Cyclophosphamide|cyclophosphamide|mesh-list
65263136|NCT00564889|Lenalidomide|lenalidomide|mesh-list
65263137|NCT00564889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65263138|NCT00564889|Immunologic Factors|immunologic factors|mesh-ancestor
65263139|NCT00564889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263140|NCT00564889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65263141|NCT00564889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65263142|NCT00564889|Alkylating Agents|alkylating agents|mesh-ancestor
65263143|NCT00564889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263144|NCT00564889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65263145|NCT00564889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65263146|NCT00564889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65263147|NCT00564889|Antiemetics|antiemetics|mesh-ancestor
65263148|NCT00564889|Autonomic Agents|autonomic agents|mesh-ancestor
65263149|NCT00564889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65263150|NCT00564889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65263151|NCT00564889|Glucocorticoids|glucocorticoids|mesh-ancestor
65263152|NCT00564889|Hormones|hormones|mesh-ancestor
65263153|NCT00564889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65263154|NCT00564889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65263155|NCT00564889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65263156|NCT00564889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65263157|NCT00564889|Growth Substances|growth substances|mesh-ancestor
65263158|NCT00564889|Growth Inhibitors|growth inhibitors|mesh-ancestor
65263159|NCT02790164|Rocuronium|rocuronium|mesh-list
65263160|NCT02790164|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65263161|NCT02790164|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65263162|NCT02790164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65263163|NCT02790164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65263164|NCT02790164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263165|NCT00939757|Mirabegron|mirabegron|mesh-list
65263166|NCT00939757|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65263167|NCT00939757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65263168|NCT00939757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65263169|NCT00939757|Adrenergic Agents|adrenergic agents|mesh-ancestor
65263170|NCT00939757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65263171|NCT00939757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263172|NCT00939757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263173|NCT00939757|Urological Agents|urological agents|mesh-ancestor
65263174|NCT05415644|Metformin|metformin|mesh-list
65263175|NCT05415644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65263176|NCT05415644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263177|NCT00939835|Dexetimide|dexetimide|mesh-list
65263178|NCT00939835|Citalopram|citalopram|mesh-list
65263179|NCT00939835|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65263180|NCT00939835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65263181|NCT00939835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65263182|NCT00939835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263183|NCT00939835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65263184|NCT00939835|Serotonin Agents|serotonin agents|mesh-ancestor
65263185|NCT00939835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263186|NCT00939835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65263187|NCT00939835|Antidepressive Agents|antidepressive agents|mesh-ancestor
65263188|NCT00939835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65263189|NCT00939835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65263190|NCT00939835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65263191|NCT00939835|Parasympatholytics|parasympatholytics|mesh-ancestor
65263192|NCT00939835|Autonomic Agents|autonomic agents|mesh-ancestor
65263193|NCT00939835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65263194|NCT00939835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65263195|NCT00939835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65263196|NCT00939835|Cholinergic Agents|cholinergic agents|mesh-ancestor
65263197|NCT02690012|Magnesium citrate|magnesium citrate|mesh-list
65263198|NCT02690012|Magnesium Oxide|magnesium oxide|mesh-list
65263199|NCT02690012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263200|NCT02690012|Cathartics|cathartics|mesh-ancestor
65263201|NCT02690012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65263203|NCT02793986|Dexmedetomidine|dexmedetomidine|mesh-list
65263204|NCT02793986|Propofol|propofol|mesh-list
65263205|NCT02793986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65263206|NCT02793986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65263207|NCT02793986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263208|NCT02793986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65263209|NCT02793986|Anesthetics, General|anesthetics, general|mesh-ancestor
65263210|NCT02793986|Anesthetics|anesthetics|mesh-ancestor
65263211|NCT02793986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65263212|NCT02793986|Analgesics|analgesics|mesh-ancestor
65263213|NCT02793986|Sensory System Agents|sensory system agents|mesh-ancestor
65263214|NCT02793986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65263215|NCT02793986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65263216|NCT02793986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65263217|NCT02793986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65263218|NCT02793986|Adrenergic Agents|adrenergic agents|mesh-ancestor
65263219|NCT02793986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65263220|NCT02793986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263221|NCT00940069|Pemetrexed|pemetrexed|mesh-list
65263222|NCT00940069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65263223|NCT00940069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263224|NCT00940069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263225|NCT00940069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65263226|NCT00940069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65263227|NCT00940303|Leucovorin|leucovorin|mesh-list
65263228|NCT00940303|Bevacizumab|bevacizumab|mesh-list
65263229|NCT00940303|Oxaliplatin|oxaliplatin|mesh-list
65263230|NCT00940303|Irinotecan|irinotecan|mesh-list
65263231|NCT00940303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65263232|NCT00940303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65263233|NCT00940303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65263234|NCT00940303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65263235|NCT00940303|Growth Substances|growth substances|mesh-ancestor
65263236|NCT00940303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263237|NCT00940303|Growth Inhibitors|growth inhibitors|mesh-ancestor
65263238|NCT00940303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65263239|NCT00940303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65263240|NCT00940303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263241|NCT00940303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263242|NCT00940303|Antidotes|antidotes|mesh-ancestor
65263243|NCT00940303|Protective Agents|protective agents|mesh-ancestor
65263244|NCT00940303|Vitamin B Complex|vitamin b complex|mesh-ancestor
65263245|NCT00940303|Vitamins|vitamins|mesh-ancestor
65263246|NCT00940303|Micronutrients|micronutrients|mesh-ancestor
65263247|NCT02794220|Nicotine|nicotine|mesh-list
65263248|NCT02794220|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65263249|NCT02794220|Autonomic Agents|autonomic agents|mesh-ancestor
65263250|NCT02794220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65263251|NCT02794220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263252|NCT02794220|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65263253|NCT02794220|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65263254|NCT02794220|Cholinergic Agents|cholinergic agents|mesh-ancestor
65263255|NCT02794220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65263256|NCT02794220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263257|NCT00941083|Raltegravir Potassium|raltegravir potassium|mesh-list
65263258|NCT00941083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65263259|NCT00941083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65263260|NCT00941083|Antiviral Agents|antiviral agents|mesh-ancestor
65263261|NCT00941083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263262|NCT00941083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65263263|NCT00941083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65263264|NCT00941083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263265|NCT00941083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013542|NCT05591144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65263266|NCT04143594|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65263267|NCT04143594|Antiviral Agents|antiviral agents|mesh-ancestor
65263268|NCT04143594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263269|NCT04143594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65263270|NCT04143594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65263271|NCT04143594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263272|NCT04143594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263273|NCT04143594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65263274|NCT04143594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65263276|NCT04405999|Expectorants|expectorants|mesh-ancestor
65263277|NCT04405999|Respiratory System Agents|respiratory system agents|mesh-ancestor
65263278|NCT02793908|Progesterone|progesterone|mesh-list
65263279|NCT02793908|Progestins|progestins|mesh-ancestor
65263280|NCT02793908|Hormones|hormones|mesh-ancestor
65263281|NCT02793908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65263282|NCT02793908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263283|NCT02789930|Anesthetics|anesthetics|mesh-list
65263284|NCT02789930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65263285|NCT02789930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263286|NCT00560833|Mirtazapine|mirtazapine|mesh-list
65263287|NCT00560833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263288|NCT00560833|Antidepressive Agents|antidepressive agents|mesh-ancestor
65263289|NCT00560833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65263290|NCT00560833|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65263291|NCT00560833|Histamine Antagonists|histamine antagonists|mesh-ancestor
65263292|NCT00560833|Histamine Agents|histamine agents|mesh-ancestor
65263293|NCT00560833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65263294|NCT00560833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263295|NCT00560833|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65263296|NCT00560833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65263297|NCT00560833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65263298|NCT00560833|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65263299|NCT00560833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65263300|NCT00560833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65263301|NCT00560833|Adrenergic Agents|adrenergic agents|mesh-ancestor
65263302|NCT00560833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65263303|NCT00560833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65263304|NCT00560833|Serotonin Agents|serotonin agents|mesh-ancestor
65263305|NCT00560833|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65263306|NCT02723760|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
65263307|NCT02723760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65263308|NCT02723760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263309|NCT00941161|Metformin|metformin|mesh-list
65263310|NCT00941161|Glimepiride|glimepiride|mesh-list
65263311|NCT00941161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65263312|NCT00941161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263313|NCT00941161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65263314|NCT00941161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65263315|NCT00941161|Immunologic Factors|immunologic factors|mesh-ancestor
65263316|NCT00944515|Azithromycin|azithromycin|mesh-list
65263317|NCT00944515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65263318|NCT00944515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263319|NCT00771654|Phentermine|phentermine|mesh-list
65263320|NCT00771654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65263321|NCT00771654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263322|NCT00771654|Appetite Depressants|appetite depressants|mesh-ancestor
65263323|NCT00771654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65263324|NCT00771654|Sympathomimetics|sympathomimetics|mesh-ancestor
65263325|NCT00771654|Autonomic Agents|autonomic agents|mesh-ancestor
65263326|NCT00771654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65263327|NCT00771654|Adrenergic Agents|adrenergic agents|mesh-ancestor
65263328|NCT00771654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65263329|NCT00771654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263330|NCT00941239|Metformin|metformin|mesh-list
65263331|NCT00941239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65263332|NCT00941239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263333|NCT04235426|Vitamin B 12|vitamin b 12|mesh-list
65263334|NCT04235426|Hydroxocobalamin|hydroxocobalamin|mesh-list
65263335|NCT04235426|Diclofenac|diclofenac|mesh-list
65263336|NCT04235426|Vitamins|vitamins|mesh-ancestor
65263337|NCT04235426|Micronutrients|micronutrients|mesh-ancestor
65263338|NCT04235426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263339|NCT04235426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65263340|NCT04235426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65263341|NCT04235426|Analgesics|analgesics|mesh-ancestor
65263342|NCT04235426|Sensory System Agents|sensory system agents|mesh-ancestor
65263343|NCT04235426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65263344|NCT04235426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65263345|NCT04235426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65263346|NCT04235426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65263347|NCT04235426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263348|NCT04235426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263349|NCT04235426|Vitamin B Complex|vitamin b complex|mesh-ancestor
65263350|NCT04235426|Hematinics|hematinics|mesh-ancestor
65263351|NCT02793440|Cortivazol|cortivazol|mesh-list
65263352|NCT02793440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65263353|NCT02723838|Gemcitabine|gemcitabine|mesh-list
65263354|NCT02723838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65263355|NCT02723838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65263356|NCT02723838|Antimetabolites|antimetabolites|mesh-ancestor
65263357|NCT02723838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263358|NCT02723838|Antiviral Agents|antiviral agents|mesh-ancestor
65263359|NCT02723838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263360|NCT02723838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263361|NCT02723838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65263362|NCT02723838|Immunologic Factors|immunologic factors|mesh-ancestor
65263363|NCT02723838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263364|NCT02789150|Norepinephrine|norepinephrine|mesh-list
65263365|NCT02789150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65263366|NCT02789150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65263367|NCT02789150|Adrenergic Agents|adrenergic agents|mesh-ancestor
65263368|NCT02789150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65263369|NCT02789150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263370|NCT02789150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263371|NCT02789150|Sympathomimetics|sympathomimetics|mesh-ancestor
65263372|NCT02789150|Autonomic Agents|autonomic agents|mesh-ancestor
65263373|NCT02789150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65263374|NCT02789150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65263375|NCT02715024|Tamsulosin|tamsulosin|mesh-list
65263376|NCT02715024|Solifenacin Succinate|solifenacin succinate|mesh-list
65263377|NCT02715024|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65263378|NCT02715024|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65263379|NCT02715024|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65263380|NCT02715024|Adrenergic Agents|adrenergic agents|mesh-ancestor
65263381|NCT02715024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65263382|NCT02715024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263383|NCT02715024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263384|NCT02715024|Urological Agents|urological agents|mesh-ancestor
65263385|NCT02715024|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65263386|NCT02715024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65263387|NCT02715024|Cholinergic Agents|cholinergic agents|mesh-ancestor
65263388|NCT02798744|Empagliflozin|empagliflozin|mesh-list
65263389|NCT02798744|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65263390|NCT02798744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263391|NCT02798744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65263392|NCT02798744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263393|NCT00925769|Bevacizumab|bevacizumab|mesh-list
65263394|NCT00925769|Capecitabine|capecitabine|mesh-list
65263395|NCT00925769|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65263396|NCT00925769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65263397|NCT00925769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65263398|NCT00925769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65263399|NCT00925769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65263400|NCT00925769|Growth Substances|growth substances|mesh-ancestor
65263401|NCT00925769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263402|NCT00925769|Growth Inhibitors|growth inhibitors|mesh-ancestor
65263403|NCT00925769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65263404|NCT00925769|Antimetabolites|antimetabolites|mesh-ancestor
65263405|NCT00925769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263406|NCT00925769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65263407|NCT00925769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263408|NCT00770913|Rabeprazole|rabeprazole|mesh-list
65263409|NCT00770913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65263410|NCT00770913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65263411|NCT00770913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65263412|NCT00770913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263413|NCT00770913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263414|NCT00562861|Lamotrigine|lamotrigine|mesh-list
65263415|NCT00562861|Carbamazepine|carbamazepine|mesh-list
65263416|NCT00562861|Valproic Acid|valproic acid|mesh-list
65263417|NCT00562861|Citalopram|citalopram|mesh-list
65263418|NCT00562861|Anticonvulsants|anticonvulsants|mesh-ancestor
65263419|NCT00562861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65263420|NCT00562861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65263421|NCT00562861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263422|NCT00562861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65263423|NCT00562861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263424|NCT00562861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65263425|NCT00562861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65263426|NCT00562861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65263427|NCT00562861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65263428|NCT00562861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65263429|NCT00562861|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65263430|NCT00562861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65263431|NCT00562861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65263432|NCT00562861|Serotonin Agents|serotonin agents|mesh-ancestor
65263433|NCT00562861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65263434|NCT00562861|Antidepressive Agents|antidepressive agents|mesh-ancestor
65263435|NCT00562861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65263436|NCT00562861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263437|NCT00562861|GABA Agents|gaba agents|mesh-ancestor
65263438|NCT00562861|Antimanic Agents|antimanic agents|mesh-ancestor
65263439|NCT00562861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65263440|NCT00562861|Analgesics|analgesics|mesh-ancestor
65263441|NCT00562861|Sensory System Agents|sensory system agents|mesh-ancestor
65263442|NCT00562861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65263443|NCT00562861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65263444|NCT02723448|Aclarubicin|aclarubicin|mesh-list
65263445|NCT02723448|Aclacinomycins|aclacinomycins|mesh-list
65263446|NCT02723448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65263447|NCT02723448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65263448|NCT02723448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65263449|NCT02723448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65263450|NCT02723448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263451|NCT02723448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263452|NCT02723448|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65263453|NCT02723448|Immunologic Factors|immunologic factors|mesh-ancestor
65263454|NCT02723448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263455|NCT02798510|Gemcitabine|gemcitabine|mesh-list
65263456|NCT02798510|Capecitabine|capecitabine|mesh-list
65263457|NCT02798510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65263458|NCT02798510|Antimetabolites|antimetabolites|mesh-ancestor
65263459|NCT02798510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263460|NCT02798510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65263461|NCT02798510|Antiviral Agents|antiviral agents|mesh-ancestor
65263462|NCT02798510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263463|NCT02798510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263464|NCT02798510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65263465|NCT02798510|Immunologic Factors|immunologic factors|mesh-ancestor
65263466|NCT02798510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263467|NCT00941473|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65263468|NCT00941473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65263469|NCT00941473|Glucocorticoids|glucocorticoids|mesh-ancestor
65263470|NCT00941473|Hormones|hormones|mesh-ancestor
65263471|NCT00941473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65263472|NCT00941473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263473|NCT00941473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65263474|NCT00941473|Immunologic Factors|immunologic factors|mesh-ancestor
65263475|NCT04258475|Raltegravir Potassium|raltegravir potassium|mesh-list
65263476|NCT04258475|Calcium|calcium|mesh-list
65263477|NCT04258475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65263478|NCT04258475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263479|NCT04258475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65263480|NCT04258475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65263481|NCT04258475|Antiviral Agents|antiviral agents|mesh-ancestor
65263482|NCT04258475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263483|NCT04258475|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65263484|NCT04258475|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65263485|NCT04258475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263486|NCT04258475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263487|NCT03944954|Dronabinol|dronabinol|mesh-list
65263488|NCT03944954|Hallucinogens|hallucinogens|mesh-ancestor
65263489|NCT03944954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263490|NCT03944954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65263491|NCT03944954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65263492|NCT03944954|Analgesics|analgesics|mesh-ancestor
65263493|NCT03944954|Sensory System Agents|sensory system agents|mesh-ancestor
65263494|NCT03944954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65263495|NCT03944954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65263496|NCT03944954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65263497|NCT03944954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65263498|NCT03944954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263499|NCT03944954|Hormones|hormones|mesh-ancestor
65263500|NCT03944954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65263501|NCT00609011|Temozolomide|temozolomide|mesh-list
65263502|NCT00609011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65263503|NCT00609011|Alkylating Agents|alkylating agents|mesh-ancestor
65263504|NCT00609011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263505|NCT00609011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65263506|NCT00770679|Atorvastatin|atorvastatin|mesh-list
65263507|NCT00770679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65263508|NCT00770679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65263509|NCT00770679|Antimetabolites|antimetabolites|mesh-ancestor
65263510|NCT00770679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263511|NCT00770679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65263512|NCT00770679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65263513|NCT00770679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263514|NCT04042116|Nivolumab|nivolumab|mesh-list
65263515|NCT04042116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65263516|NCT04042116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65263517|NCT04042116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65263518|NCT04042116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263519|NCT04260581|Amantadine|amantadine|mesh-list
65263520|NCT04260581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65263521|NCT04260581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65263522|NCT04260581|Antiviral Agents|antiviral agents|mesh-ancestor
65263523|NCT04260581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263524|NCT04260581|Dopamine Agents|dopamine agents|mesh-ancestor
65263525|NCT04260581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65263526|NCT04260581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263527|NCT04260581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263528|NCT04260581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65263530|NCT04260581|Sensory System Agents|sensory system agents|mesh-ancestor
65263531|NCT04260581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65263532|NCT00770367|Pioglitazone|pioglitazone|mesh-list
65263533|NCT00770367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65263534|NCT00770367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263535|NCT00941785|Amodiaquine|amodiaquine|mesh-list
65263536|NCT00941785|Antimalarials|antimalarials|mesh-ancestor
65263537|NCT00941785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65263538|NCT00941785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65263539|NCT00941785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263540|NCT05502081|Remdesivir|remdesivir|mesh-list
65263541|NCT05502081|Favipiravir|favipiravir|mesh-list
65263542|NCT05502081|Antimetabolites|antimetabolites|mesh-ancestor
65263543|NCT05502081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263544|NCT05502081|Antiviral Agents|antiviral agents|mesh-ancestor
65263545|NCT05502081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263546|NCT02793050|Trabectedin|trabectedin|mesh-list
65263547|NCT02793050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65263548|NCT02793050|Alkylating Agents|alkylating agents|mesh-ancestor
65263549|NCT02793050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263550|NCT02793050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65263551|NCT04964843|Acetylcysteine|acetylcysteine|mesh-list
65263552|NCT04964843|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65263553|NCT04964843|Antiviral Agents|antiviral agents|mesh-ancestor
65263554|NCT04964843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263555|NCT04964843|Expectorants|expectorants|mesh-ancestor
65263556|NCT04964843|Respiratory System Agents|respiratory system agents|mesh-ancestor
65263557|NCT04964843|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65263558|NCT04964843|Antioxidants|antioxidants|mesh-ancestor
65263559|NCT04964843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263560|NCT04964843|Protective Agents|protective agents|mesh-ancestor
65263561|NCT04964843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263562|NCT04964843|Antidotes|antidotes|mesh-ancestor
65263563|NCT00942253|Dopamine|dopamine|mesh-list
65013850|NCT04697641|Z 338|z 338|mesh-list
65263564|NCT00942253|Dopamine Agonists|dopamine agonists|mesh-list
65263565|NCT00942253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65263566|NCT00942253|Sympathomimetics|sympathomimetics|mesh-ancestor
65263567|NCT00942253|Autonomic Agents|autonomic agents|mesh-ancestor
65263568|NCT00942253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65263569|NCT00942253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263570|NCT00942253|Dopamine Agents|dopamine agents|mesh-ancestor
65263571|NCT00942253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65263572|NCT00942253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263573|NCT00942253|Protective Agents|protective agents|mesh-ancestor
65263574|NCT02792816|Artesunate|artesunate|mesh-list
65263575|NCT02792816|Artemether|artemether|mesh-list
65263576|NCT02792816|Piperaquine|piperaquine|mesh-list
65263577|NCT02792816|Artenimol|artenimol|mesh-list
65263578|NCT02792816|Mefloquine|mefloquine|mesh-list
65263579|NCT02792816|Antimalarials|antimalarials|mesh-list
65263580|NCT02792816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65263581|NCT02792816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65263582|NCT02792816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263583|NCT02792816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65263584|NCT02792816|Antiviral Agents|antiviral agents|mesh-ancestor
65263585|NCT02792816|Schistosomicides|schistosomicides|mesh-ancestor
65263586|NCT02792816|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65263587|NCT02792816|Anthelmintics|anthelmintics|mesh-ancestor
65263588|NCT00940381|Sirolimus|sirolimus|mesh-list
65263589|NCT00940381|Cetuximab|cetuximab|mesh-list
65263590|NCT00940381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65263591|NCT00940381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65263592|NCT00940381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65263593|NCT00940381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263594|NCT00940381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65263595|NCT00940381|Antifungal Agents|antifungal agents|mesh-ancestor
65263596|NCT00940381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65263597|NCT00940381|Immunologic Factors|immunologic factors|mesh-ancestor
65263598|NCT00940381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263599|NCT00637988|Aspirin|aspirin|mesh-list
65263600|NCT00637988|Rofecoxib|rofecoxib|mesh-list
65263601|NCT00637988|Esomeprazole|esomeprazole|mesh-list
65263602|NCT00637988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65263603|NCT00637988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65263604|NCT00637988|Analgesics|analgesics|mesh-ancestor
65263605|NCT00637988|Sensory System Agents|sensory system agents|mesh-ancestor
65263606|NCT00637988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65068389|NCT00281996|Gemcitabine|gemcitabine|mesh-list
65263607|NCT00637988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263609|NCT00637988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65263610|NCT00637988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65263611|NCT00637988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65263612|NCT00637988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263613|NCT00637988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65263614|NCT00637988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65263615|NCT00637988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263616|NCT00637988|Antipyretics|antipyretics|mesh-ancestor
65263617|NCT00637988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65263618|NCT00637988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65263619|NCT00637988|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65263620|NCT00637988|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65263621|NCT04258163|Gemcitabine|gemcitabine|mesh-list
65263622|NCT04258163|Capecitabine|capecitabine|mesh-list
65263623|NCT04258163|Doxorubicin|doxorubicin|mesh-list
65263624|NCT04258163|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65263625|NCT04258163|Letrozole|letrozole|mesh-list
65263626|NCT04258163|Fulvestrant|fulvestrant|mesh-list
65263627|NCT04258163|Anastrozole|anastrozole|mesh-list
65263628|NCT04258163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65263629|NCT04258163|Antimetabolites|antimetabolites|mesh-ancestor
65263630|NCT04258163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263631|NCT04258163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65263632|NCT04258163|Antiviral Agents|antiviral agents|mesh-ancestor
65263633|NCT04258163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263634|NCT04258163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263635|NCT04258163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65263636|NCT04258163|Immunologic Factors|immunologic factors|mesh-ancestor
65263637|NCT04258163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263638|NCT04258163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65263639|NCT04258163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65263640|NCT04258163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65263641|NCT04258163|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65263642|NCT04258163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65263643|NCT04258163|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65263644|NCT04258163|Hormone Antagonists|hormone antagonists|mesh-ancestor
65263645|NCT04258163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65263646|NCT04258163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65263647|NCT04258163|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65263648|NCT00942487|Nebivolol|nebivolol|mesh-list
65263649|NCT00942487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65263650|NCT00942487|Vasodilator Agents|vasodilator agents|mesh-ancestor
65263651|NCT00942487|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65263652|NCT00942487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65263653|NCT00942487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65263654|NCT00942487|Adrenergic Agents|adrenergic agents|mesh-ancestor
65263655|NCT00942487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65263656|NCT00942487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263657|NCT00942487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263658|NCT00611039|Ritonavir|ritonavir|mesh-list
65263659|NCT00611039|Darunavir|darunavir|mesh-list
65263660|NCT00611039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65263661|NCT00611039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65263662|NCT00611039|Protease Inhibitors|protease inhibitors|mesh-ancestor
65263663|NCT00611039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263664|NCT00611039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263665|NCT00611039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65263666|NCT00611039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65263667|NCT00611039|Antiviral Agents|antiviral agents|mesh-ancestor
65263668|NCT00611039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263669|NCT00611039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65263670|NCT00611039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65263671|NCT00942565|Acetaminophen|acetaminophen|mesh-list
65263672|NCT00942565|Tramadol|tramadol|mesh-list
65263673|NCT00942565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65263674|NCT00942565|Analgesics|analgesics|mesh-ancestor
65263675|NCT00942565|Sensory System Agents|sensory system agents|mesh-ancestor
65263676|NCT00942565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65263677|NCT00942565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263678|NCT00942565|Antipyretics|antipyretics|mesh-ancestor
65263679|NCT00942565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65263680|NCT00942565|Narcotics|narcotics|mesh-ancestor
65263681|NCT00942565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65263682|NCT00945373|Calcium Dobesilate|calcium dobesilate|mesh-list
65263684|NCT00945373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65263685|NCT00945373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263686|NCT00945373|Hemostatics|hemostatics|mesh-ancestor
65263687|NCT00945373|Coagulants|coagulants|mesh-ancestor
65263688|NCT04100655|Molgramostim|molgramostim|mesh-list
65263689|NCT04100655|Estradiol|estradiol|mesh-list
65263690|NCT04100655|Sargramostim|sargramostim|mesh-list
65263691|NCT04100655|Estrogens|estrogens|mesh-ancestor
65263692|NCT04100655|Hormones|hormones|mesh-ancestor
65263693|NCT04100655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65263694|NCT04100655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263695|NCT04100655|Immunologic Factors|immunologic factors|mesh-ancestor
65263696|NCT04100655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65263697|NCT00556933|Mycophenolic Acid|mycophenolic acid|mesh-list
65263698|NCT00556933|Sirolimus|sirolimus|mesh-list
65263699|NCT00556933|Tacrolimus|tacrolimus|mesh-list
65263700|NCT00556933|Thymoglobulin|thymoglobulin|mesh-list
65263701|NCT00556933|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65263702|NCT00556933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65263703|NCT00556933|Immunologic Factors|immunologic factors|mesh-ancestor
65263704|NCT00556933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263705|NCT00556933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65263706|NCT00556933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263707|NCT00556933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263708|NCT00556933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65263709|NCT00556933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65263710|NCT00556933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65263711|NCT00556933|Antitubercular Agents|antitubercular agents|mesh-ancestor
65263712|NCT00556933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65263713|NCT00556933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263714|NCT00556933|Antifungal Agents|antifungal agents|mesh-ancestor
65263715|NCT02792426|Nicotine|nicotine|mesh-list
65263716|NCT02792426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65263717|NCT02792426|Autonomic Agents|autonomic agents|mesh-ancestor
65014001|NCT00470353|Vitamin D|vitamin d|mesh-list
65263718|NCT02792426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65263719|NCT02792426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263721|NCT02792426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65263722|NCT02792426|Cholinergic Agents|cholinergic agents|mesh-ancestor
65263723|NCT02792426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65263724|NCT02792426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263725|NCT00770211|Botulinum Toxins|botulinum toxins|mesh-list
65263726|NCT00770211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65263727|NCT00770211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65263728|NCT00770211|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65204830|NCT02851212|Metformin|metformin|mesh-list
65263729|NCT00770211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65263730|NCT00770211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65263731|NCT00770211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263732|NCT00770211|Cholinergic Agents|cholinergic agents|mesh-ancestor
65263733|NCT00770211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65263734|NCT00770211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263735|NCT00770211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65263736|NCT00770211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65263737|NCT02792036|Carboplatin|carboplatin|mesh-list
65263738|NCT02792036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65263739|NCT00945529|Nitric Oxide|nitric oxide|mesh-list
65263740|NCT00945529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65263741|NCT00945529|Autonomic Agents|autonomic agents|mesh-ancestor
65263742|NCT00945529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65263743|NCT00945529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263744|NCT00945529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65263745|NCT00945529|Respiratory System Agents|respiratory system agents|mesh-ancestor
65263746|NCT00945529|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65263747|NCT00945529|Antioxidants|antioxidants|mesh-ancestor
65263748|NCT00945529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263749|NCT00945529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65263750|NCT00945529|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65263751|NCT00945529|Vasodilator Agents|vasodilator agents|mesh-ancestor
65263752|NCT00945529|Gasotransmitters|gasotransmitters|mesh-ancestor
65263753|NCT00945529|Protective Agents|protective agents|mesh-ancestor
65263754|NCT02797340|Metformin|metformin|mesh-list
65263755|NCT02797340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65263756|NCT02797340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263757|NCT00928187|Ritonavir|ritonavir|mesh-list
65263758|NCT00928187|Lopinavir|lopinavir|mesh-list
65263759|NCT00928187|Darunavir|darunavir|mesh-list
65263760|NCT00928187|Tenofovir|tenofovir|mesh-list
65263761|NCT00928187|Emtricitabine|emtricitabine|mesh-list
65263762|NCT00928187|Abacavir|abacavir|mesh-list
65263763|NCT00928187|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65263764|NCT00928187|Didanosine|didanosine|mesh-list
65263765|NCT00928187|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65263766|NCT00928187|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65263767|NCT00928187|Protease Inhibitors|protease inhibitors|mesh-ancestor
65263768|NCT00928187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263769|NCT00928187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263770|NCT00928187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65263771|NCT00928187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65263772|NCT00928187|Antiviral Agents|antiviral agents|mesh-ancestor
65263773|NCT00928187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263774|NCT00928187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65263775|NCT00928187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65263776|NCT00928187|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65263777|NCT00928187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65263778|NCT00928187|Antimetabolites|antimetabolites|mesh-ancestor
65263779|NCT04235270|Tadalafil|tadalafil|mesh-list
65263780|NCT04235270|Macitentan|macitentan|mesh-list
65263781|NCT04235270|Vasodilator Agents|vasodilator agents|mesh-ancestor
65263782|NCT04235270|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65263783|NCT04235270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65263784|NCT04235270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263785|NCT04235270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263786|NCT04235270|Urological Agents|urological agents|mesh-ancestor
65263787|NCT04235270|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65263788|NCT04235270|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65263789|NCT04235270|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65263790|NCT04256525|Aspirin|aspirin|mesh-list
65263791|NCT04256525|Heparin|heparin|mesh-list
65263792|NCT04256525|Rivaroxaban|rivaroxaban|mesh-list
65014071|NCT00335920|Glucocorticoids|glucocorticoids|mesh-ancestor
65263793|NCT04256525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65263794|NCT04256525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65263796|NCT04256525|Sensory System Agents|sensory system agents|mesh-ancestor
65263797|NCT04256525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65263798|NCT04256525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263799|NCT04256525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65263800|NCT04256525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65263801|NCT04256525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65263802|NCT04256525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65263803|NCT04256525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263804|NCT04256525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65263805|NCT04256525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65263806|NCT04256525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263807|NCT04256525|Antipyretics|antipyretics|mesh-ancestor
65263808|NCT04256525|Anticoagulants|anticoagulants|mesh-ancestor
65263809|NCT04256525|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65263810|NCT04256525|Antithrombins|antithrombins|mesh-ancestor
65263811|NCT04256525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65263812|NCT04256525|Protease Inhibitors|protease inhibitors|mesh-ancestor
65263813|NCT02791958|Ramipril|ramipril|mesh-list
65263814|NCT02791958|Atorvastatin|atorvastatin|mesh-list
65263815|NCT02791958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65263816|NCT02791958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65263817|NCT02791958|Antimetabolites|antimetabolites|mesh-ancestor
65263818|NCT02791958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263819|NCT02791958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65263820|NCT02791958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65263821|NCT02791958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263822|NCT02791958|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65263823|NCT02791958|Protease Inhibitors|protease inhibitors|mesh-ancestor
65263824|NCT02791958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65263825|NCT02601651|Lidocaine|lidocaine|mesh-list
65263826|NCT02601651|Anesthetics, Local|anesthetics, local|mesh-ancestor
65263827|NCT02601651|Anesthetics|anesthetics|mesh-ancestor
65263828|NCT02601651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65263829|NCT02601651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263830|NCT02601651|Sensory System Agents|sensory system agents|mesh-ancestor
65263831|NCT02601651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65263832|NCT02601651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65263833|NCT02601651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65263834|NCT02601651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65263835|NCT02601651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65263836|NCT02601651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263837|NCT00943267|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
65263838|NCT00943267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263839|NCT00945919|Oxymorphone|oxymorphone|mesh-list
65263840|NCT00945919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65263841|NCT00945919|Narcotics|narcotics|mesh-ancestor
65263842|NCT00945919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65263843|NCT00945919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263844|NCT00945919|Analgesics|analgesics|mesh-ancestor
65263845|NCT00945919|Sensory System Agents|sensory system agents|mesh-ancestor
65263846|NCT00945919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65263847|NCT00945919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65263848|NCT00945997|Misoprostol|misoprostol|mesh-list
65263849|NCT00945997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65263850|NCT00945997|Abortifacient Agents|abortifacient agents|mesh-ancestor
65263851|NCT00945997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65263852|NCT00945997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263853|NCT00945997|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65263854|NCT00945997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65263855|NCT00945997|Oxytocics|oxytocics|mesh-ancestor
65263856|NCT00943345|Indomethacin|indomethacin|mesh-list
65263857|NCT00943345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65263858|NCT00943345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65263859|NCT00943345|Analgesics|analgesics|mesh-ancestor
65263860|NCT00943345|Sensory System Agents|sensory system agents|mesh-ancestor
65263861|NCT00943345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65263862|NCT00943345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263863|NCT00943345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65263864|NCT00943345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65263865|NCT00943345|Gout Suppressants|gout suppressants|mesh-ancestor
65263866|NCT00943345|Tocolytic Agents|tocolytic agents|mesh-ancestor
65263867|NCT00943345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65263868|NCT00943345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65263869|NCT00943345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263870|NCT00943345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263871|NCT02797028|Allopurinol|allopurinol|mesh-list
65263872|NCT02797028|Antimetabolites|antimetabolites|mesh-ancestor
65263873|NCT02797028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263874|NCT02797028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263875|NCT02797028|Gout Suppressants|gout suppressants|mesh-ancestor
65263876|NCT02797028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65263877|NCT02797028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65263878|NCT02797028|Antioxidants|antioxidants|mesh-ancestor
65263879|NCT02797028|Protective Agents|protective agents|mesh-ancestor
65263880|NCT02797028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263881|NCT00916461|Minocycline|minocycline|mesh-list
65263882|NCT00916461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65263883|NCT00916461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263884|NCT04260035|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
65263885|NCT04260035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65263886|NCT04260035|Vasodilator Agents|vasodilator agents|mesh-ancestor
65263887|NCT04260035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65263888|NCT04260035|Protective Agents|protective agents|mesh-ancestor
65263889|NCT04260035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263890|NCT00768651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65263891|NCT00768651|Pantoprazole|pantoprazole|mesh-list
65263892|NCT00768651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65263893|NCT00768651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263894|NCT00768651|Incretins|incretins|mesh-ancestor
65263895|NCT00768651|Hormones|hormones|mesh-ancestor
65263896|NCT00768651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65263897|NCT00768651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65263898|NCT00768651|Protease Inhibitors|protease inhibitors|mesh-ancestor
65263899|NCT00768651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263900|NCT00768651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263901|NCT00768651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65263902|NCT00768651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65263903|NCT00768651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65263904|NCT05378750|Diuretics|diuretics|mesh-list
65263905|NCT05378750|Natriuretic Agents|natriuretic agents|mesh-ancestor
65263906|NCT05378750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263907|NCT00943501|Liraglutide|liraglutide|mesh-list
65263908|NCT00943501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65263909|NCT00943501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263910|NCT00943501|Incretins|incretins|mesh-ancestor
65263911|NCT00943501|Hormones|hormones|mesh-ancestor
65263912|NCT00943501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65263913|NCT04258241|Bupivacaine|bupivacaine|mesh-list
65263914|NCT04258241|Anesthetics, Local|anesthetics, local|mesh-list
65263915|NCT04258241|Anesthetics|anesthetics|mesh-list
65263916|NCT04258241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65263917|NCT04258241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65263918|NCT04258241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263919|NCT04258241|Sensory System Agents|sensory system agents|mesh-ancestor
65263920|NCT04258241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65263921|NCT02796794|Genistein|genistein|mesh-list
65263922|NCT02796794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65263923|NCT02796794|Protective Agents|protective agents|mesh-ancestor
65263924|NCT02796794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263925|NCT02796794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65263926|NCT02796794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65263927|NCT02796794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263928|NCT02796794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263929|NCT02796794|Phytoestrogens|phytoestrogens|mesh-ancestor
65263930|NCT02796794|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65263931|NCT02796794|Estrogens|estrogens|mesh-ancestor
65263932|NCT02796794|Hormones|hormones|mesh-ancestor
65263933|NCT02796794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65263934|NCT04097613|Povidone-Iodine|povidone-iodine|mesh-list
65263935|NCT04097613|Budesonide|budesonide|mesh-list
65263936|NCT04097613|Povidone|povidone|mesh-list
65263937|NCT04097613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65263938|NCT04097613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65263939|NCT04097613|Autonomic Agents|autonomic agents|mesh-ancestor
65263940|NCT04097613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65263941|NCT04097613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263942|NCT04097613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65263943|NCT04097613|Respiratory System Agents|respiratory system agents|mesh-ancestor
65263944|NCT04097613|Glucocorticoids|glucocorticoids|mesh-ancestor
65263945|NCT04097613|Hormones|hormones|mesh-ancestor
65263946|NCT04097613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65263947|NCT04097613|Plasma Substitutes|plasma substitutes|mesh-ancestor
65263948|NCT04097613|Blood Substitutes|blood substitutes|mesh-ancestor
65263949|NCT04097613|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65263950|NCT04097613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263951|NCT00946387|Ondansetron|ondansetron|mesh-list
65263952|NCT00946387|Antiemetics|antiemetics|mesh-ancestor
65263953|NCT00946387|Autonomic Agents|autonomic agents|mesh-ancestor
65263954|NCT00946387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65263955|NCT00946387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263956|NCT00946387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65263957|NCT00946387|Antipruritics|antipruritics|mesh-ancestor
65263958|NCT00946387|Dermatologic Agents|dermatologic agents|mesh-ancestor
65263959|NCT00946387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65263960|NCT00946387|Serotonin Agents|serotonin agents|mesh-ancestor
65263961|NCT00946387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65263962|NCT00946387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263963|NCT00946387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65263964|NCT00946387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65263965|NCT00946387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65263966|NCT00946387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65263967|NCT00946387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65263968|NCT00916695|Everolimus|everolimus|mesh-list
65263969|NCT00916695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65263970|NCT00916695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65263971|NCT00916695|Immunologic Factors|immunologic factors|mesh-ancestor
65263972|NCT00916695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263973|NCT00946465|Ramipril|ramipril|mesh-list
65263974|NCT00946465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65263975|NCT00946465|Protease Inhibitors|protease inhibitors|mesh-ancestor
65263976|NCT00946465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263977|NCT00946465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263978|NCT00946465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65263979|NCT00946621|Ramipril|ramipril|mesh-list
65263980|NCT00946621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65263981|NCT00946621|Protease Inhibitors|protease inhibitors|mesh-ancestor
65263982|NCT00946621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65263983|NCT00946621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65263984|NCT00946621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65263985|NCT02600793|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
65263986|NCT02600793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65263987|NCT02600793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65263988|NCT04235894|Propofol|propofol|mesh-list
65263989|NCT04235894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65263990|NCT04235894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65263991|NCT04235894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263992|NCT04235894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65263993|NCT04235894|Anesthetics, General|anesthetics, general|mesh-ancestor
65263994|NCT04235894|Anesthetics|anesthetics|mesh-ancestor
65263995|NCT04096599|Fluorides|fluorides|mesh-list
65263996|NCT04096599|Cariostatic Agents|cariostatic agents|mesh-ancestor
65263997|NCT04096599|Protective Agents|protective agents|mesh-ancestor
65263998|NCT04096599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65263999|NCT00923351|Vaccines|vaccines|mesh-list
65264000|NCT00923351|Immunologic Factors|immunologic factors|mesh-ancestor
65264001|NCT00923351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264002|NCT02788292|Acetylcysteine|acetylcysteine|mesh-list
65264003|NCT02788292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65264004|NCT02788292|Antiviral Agents|antiviral agents|mesh-ancestor
65264005|NCT02788292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65264006|NCT02788292|Expectorants|expectorants|mesh-ancestor
65264007|NCT02788292|Respiratory System Agents|respiratory system agents|mesh-ancestor
65264008|NCT02788292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65264009|NCT02788292|Antioxidants|antioxidants|mesh-ancestor
65264010|NCT02788292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264011|NCT02788292|Protective Agents|protective agents|mesh-ancestor
65264012|NCT02788292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264013|NCT02788292|Antidotes|antidotes|mesh-ancestor
65264015|NCT00944359|Trace Elements|trace elements|mesh-ancestor
65264016|NCT00944359|Micronutrients|micronutrients|mesh-ancestor
65264017|NCT00944359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264018|NCT02791256|Ribavirin|ribavirin|mesh-list
65264019|NCT02791256|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65264021|NCT02791256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264022|NCT02791256|Antiviral Agents|antiviral agents|mesh-ancestor
65264023|NCT02791256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65264024|NCT04258007|Neostigmine|neostigmine|mesh-list
65264025|NCT04258007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65264026|NCT04258007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65264027|NCT04258007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264028|NCT04258007|Cholinergic Agents|cholinergic agents|mesh-ancestor
65264029|NCT04258007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65264030|NCT04258007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264031|NCT04258007|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65264032|NCT04258007|Autonomic Agents|autonomic agents|mesh-ancestor
65264033|NCT04258007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264034|NCT02787824|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65264035|NCT02787824|Hematinics|hematinics|mesh-ancestor
65264036|NCT02796950|Acipimox|acipimox|mesh-list
65264037|NCT02796950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65264038|NCT02796950|Antimetabolites|antimetabolites|mesh-ancestor
65264039|NCT02796950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264040|NCT02796950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65264041|NCT00755079|Adrenergic Agents|adrenergic agents|mesh-list
65264042|NCT00755079|Adrenergic Agonists|adrenergic agonists|mesh-list
65264043|NCT00755079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65264044|NCT00755079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264045|NCT00755079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264046|NCT00950209|Heparin|heparin|mesh-list
65264047|NCT00950209|Anticoagulants|anticoagulants|mesh-ancestor
65264048|NCT00950209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65264049|NCT00950209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65264050|NCT00950209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264051|NCT05370326|Analgesics, Opioid|analgesics, opioid|mesh-list
65264052|NCT05370326|Narcotics|narcotics|mesh-ancestor
65264053|NCT05370326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65264054|NCT05370326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264055|NCT05370326|Analgesics|analgesics|mesh-ancestor
65264056|NCT05370326|Sensory System Agents|sensory system agents|mesh-ancestor
65264057|NCT05370326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264058|NCT00947323|Simvastatin|simvastatin|mesh-list
65264059|NCT00947323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65264060|NCT00947323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65264061|NCT00947323|Antimetabolites|antimetabolites|mesh-ancestor
65264062|NCT00947323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264063|NCT00947323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65264064|NCT00947323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65264065|NCT00947323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65264066|NCT04236050|Rocuronium|rocuronium|mesh-list
65264067|NCT04236050|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65264068|NCT04236050|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65264069|NCT04236050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65264070|NCT04236050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264071|NCT04236050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264072|NCT02790632|Nimodipine|nimodipine|mesh-list
65264073|NCT02790632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65264074|NCT02790632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65264075|NCT02790632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65264076|NCT02790632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264077|NCT02790632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65264078|NCT02790632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264079|NCT02790632|Vasodilator Agents|vasodilator agents|mesh-ancestor
65264080|NCT03633110|Pembrolizumab|pembrolizumab|mesh-list
65264081|NCT03633110|Nivolumab|nivolumab|mesh-list
65264082|NCT03633110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65264083|NCT03633110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264084|NCT03633110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65264085|NCT03633110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264086|NCT02788136|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65264087|NCT02788136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65264088|NCT02788136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264089|NCT02788058|Gefitinib|gefitinib|mesh-list
65264090|NCT02788058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264091|NCT02788058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65264092|NCT02788058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65264093|NCT02788058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264094|NCT04200092|Granisetron|granisetron|mesh-list
65264095|NCT04200092|Antiemetics|antiemetics|mesh-ancestor
65264096|NCT04200092|Autonomic Agents|autonomic agents|mesh-ancestor
65264097|NCT04200092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264098|NCT04200092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264099|NCT04200092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65264100|NCT04200092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65264101|NCT04200092|Serotonin Agents|serotonin agents|mesh-ancestor
65264102|NCT04200092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65264103|NCT04200092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264104|NCT00754065|Moxifloxacin|moxifloxacin|mesh-list
65264106|NCT00754065|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65264107|NCT00754065|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65264108|NCT00754065|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65264109|NCT00754065|Estradiol|estradiol|mesh-list
65264110|NCT00754065|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65264111|NCT00754065|Estrogens|estrogens|mesh-ancestor
65264112|NCT00754065|Hormones|hormones|mesh-ancestor
65264113|NCT00754065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65264114|NCT00754065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264115|NCT00754065|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65264116|NCT00754065|Contraceptive Agents|contraceptive agents|mesh-ancestor
65264117|NCT00754065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65264118|NCT00754065|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65264119|NCT00754065|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65264120|NCT00754065|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65264121|NCT00754065|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65264122|NCT00754065|Hormone Antagonists|hormone antagonists|mesh-ancestor
65264123|NCT00754065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65264124|NCT00754065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264125|NCT00754065|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65264126|NCT00754065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65264127|NCT00754065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65264128|NCT00754065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65264129|NCT00754065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65264130|NCT00754065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65264131|NCT00754065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264133|NCT02787746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65264134|NCT02787746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65264135|NCT02787746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264136|NCT02787746|Cholinergic Agents|cholinergic agents|mesh-ancestor
65264137|NCT02787746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65264138|NCT02787746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264139|NCT02787746|Nootropic Agents|nootropic agents|mesh-ancestor
65264140|NCT03254654|Apatinib|apatinib|mesh-list
65264141|NCT03254654|Vinorelbine|vinorelbine|mesh-list
65264142|NCT03254654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264143|NCT03254654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65264144|NCT03254654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65264145|NCT03254654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264146|NCT03254654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65264147|NCT03254654|Tubulin Modulators|tubulin modulators|mesh-ancestor
65264148|NCT03254654|Antimitotic Agents|antimitotic agents|mesh-ancestor
65264149|NCT03254654|Mitosis Modulators|mitosis modulators|mesh-ancestor
65264150|NCT02785718|Hemostatics|hemostatics|mesh-list
65264151|NCT02785718|Coagulants|coagulants|mesh-ancestor
65264152|NCT04094805|Calcitriol|calcitriol|mesh-list
65264153|NCT04094805|Dexamethasone|dexamethasone|mesh-list
65264154|NCT04094805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65264155|NCT04094805|Antiemetics|antiemetics|mesh-ancestor
65264156|NCT04094805|Autonomic Agents|autonomic agents|mesh-ancestor
65264157|NCT04094805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264158|NCT04094805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264159|NCT04094805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65264160|NCT04094805|Glucocorticoids|glucocorticoids|mesh-ancestor
65264161|NCT04094805|Hormones|hormones|mesh-ancestor
65264162|NCT04094805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65264163|NCT04094805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65264164|NCT04094805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264165|NCT04094805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65264166|NCT04094805|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65264167|NCT04094805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65264168|NCT04094805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264169|NCT04094805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65264171|NCT04094805|Micronutrients|micronutrients|mesh-ancestor
65264172|NCT04094805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65264173|NCT04094727|Lumefantrine|lumefantrine|mesh-list
65264174|NCT04094727|Artemether|artemether|mesh-list
65264175|NCT04094727|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65264176|NCT04094727|Antimalarials|antimalarials|mesh-ancestor
65264177|NCT04094727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65264178|NCT04094727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65264179|NCT04094727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65264180|NCT00638066|Botulinum Toxins|botulinum toxins|mesh-list
65264181|NCT00638066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65264182|NCT00638066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65264183|NCT00638066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65264184|NCT00638066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65264185|NCT00638066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264186|NCT00638066|Cholinergic Agents|cholinergic agents|mesh-ancestor
65264187|NCT00638066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65264188|NCT00638066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264189|NCT00638066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65264190|NCT00638066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264191|NCT02786732|Ustekinumab|ustekinumab|mesh-list
65264192|NCT02786732|Brodalumab|brodalumab|mesh-list
65264193|NCT02786732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65264194|NCT02786732|Dermatologic Agents|dermatologic agents|mesh-ancestor
65264195|NCT02786732|Immunologic Factors|immunologic factors|mesh-ancestor
65264196|NCT02786732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264197|NCT02785250|Cyclophosphamide|cyclophosphamide|mesh-list
65264198|NCT02785250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65264199|NCT02785250|Immunologic Factors|immunologic factors|mesh-ancestor
65264200|NCT02785250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264201|NCT02785250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65264202|NCT02785250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65264203|NCT02785250|Alkylating Agents|alkylating agents|mesh-ancestor
65264204|NCT02785250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264205|NCT02785250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264206|NCT02785250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65264207|NCT03110822|Methylprednisolone|methylprednisolone|mesh-list
65264208|NCT03110822|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65264209|NCT03110822|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65264210|NCT03110822|Prednisolone|prednisolone|mesh-list
65264211|NCT03110822|Prednisolone acetate|prednisolone acetate|mesh-list
65264212|NCT03110822|Lenalidomide|lenalidomide|mesh-list
65264213|NCT03110822|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65264214|NCT03110822|Prednisolone phosphate|prednisolone phosphate|mesh-list
65264215|NCT03110822|Immunologic Factors|immunologic factors|mesh-ancestor
65264216|NCT03110822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264217|NCT03110822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65264218|NCT03110822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65264219|NCT03110822|Growth Substances|growth substances|mesh-ancestor
65264220|NCT03110822|Growth Inhibitors|growth inhibitors|mesh-ancestor
65264221|NCT03110822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264222|NCT03110822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65264223|NCT03110822|Antiemetics|antiemetics|mesh-ancestor
65264224|NCT03110822|Autonomic Agents|autonomic agents|mesh-ancestor
65264225|NCT03110822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264226|NCT03110822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65264227|NCT03110822|Glucocorticoids|glucocorticoids|mesh-ancestor
65264228|NCT03110822|Hormones|hormones|mesh-ancestor
65264229|NCT03110822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65264230|NCT03110822|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65264231|NCT03110822|Protective Agents|protective agents|mesh-ancestor
65264232|NCT03110822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65264233|NCT02787356|Lidocaine|lidocaine|mesh-list
65264234|NCT02787356|Anesthetics, Local|anesthetics, local|mesh-ancestor
65264235|NCT02787356|Anesthetics|anesthetics|mesh-ancestor
65264236|NCT02787356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65264237|NCT02787356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264238|NCT02787356|Sensory System Agents|sensory system agents|mesh-ancestor
65264239|NCT02787356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264240|NCT02787356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65264241|NCT02787356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65264242|NCT02787356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65264243|NCT02787356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65264244|NCT02787356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264245|NCT02787278|Otaplimastat|otaplimastat|mesh-list
65264246|NCT02787278|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65264247|NCT02787278|Protective Agents|protective agents|mesh-ancestor
65264248|NCT02787278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264249|NCT03083678|Afatinib|afatinib|mesh-list
65264250|NCT03083678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264251|NCT03083678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65264252|NCT03083678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65264253|NCT03083678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264254|NCT04232150|Midazolam|midazolam|mesh-list
65264255|NCT04232150|Anesthetics|anesthetics|mesh-list
65264256|NCT04232150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65264257|NCT04232150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264258|NCT04232150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65264259|NCT04232150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65264260|NCT04232150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65264261|NCT04232150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65264262|NCT04232150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65264263|NCT04232150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65264264|NCT04232150|Anesthetics, General|anesthetics, general|mesh-ancestor
65068408|NCT00317733|Ketoprofen|ketoprofen|mesh-list
65264266|NCT04232150|GABA Agents|gaba agents|mesh-ancestor
65264267|NCT04232150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65264268|NCT04232150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264269|NCT04197752|Anesthetics|anesthetics|mesh-list
65264270|NCT04197752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65264271|NCT04197752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264273|NCT02336750|Fosaprepitant|fosaprepitant|mesh-list
65264274|NCT02336750|Mirtazapine|mirtazapine|mesh-list
65264275|NCT02336750|Antiemetics|antiemetics|mesh-ancestor
65264276|NCT02336750|Autonomic Agents|autonomic agents|mesh-ancestor
65264277|NCT02336750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264278|NCT02336750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264279|NCT02336750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65264280|NCT02336750|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65264281|NCT02336750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65264282|NCT02336750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264283|NCT02336750|Antidepressive Agents|antidepressive agents|mesh-ancestor
65264284|NCT02336750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65264285|NCT02336750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65264286|NCT02336750|Histamine Antagonists|histamine antagonists|mesh-ancestor
65264287|NCT02336750|Histamine Agents|histamine agents|mesh-ancestor
65264288|NCT02336750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65264289|NCT02336750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65264290|NCT02336750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65264291|NCT02336750|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65264292|NCT02336750|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65264293|NCT02336750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65264294|NCT02336750|Adrenergic Agents|adrenergic agents|mesh-ancestor
65264295|NCT02336750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65264296|NCT02336750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65264297|NCT02336750|Serotonin Agents|serotonin agents|mesh-ancestor
65264298|NCT02336750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65264299|NCT02784392|Metoclopramide|metoclopramide|mesh-list
65264300|NCT02784392|Antiemetics|antiemetics|mesh-ancestor
65264301|NCT02784392|Autonomic Agents|autonomic agents|mesh-ancestor
65264302|NCT02784392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264303|NCT02784392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264304|NCT02784392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65264305|NCT02784392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65264306|NCT02784392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65264307|NCT02784392|Dopamine Agents|dopamine agents|mesh-ancestor
65264308|NCT02784392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65264309|NCT02784392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264310|NCT00634556|Levodopa|levodopa|mesh-list
65264311|NCT00634556|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
65264312|NCT00634556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65264313|NCT00634556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65264314|NCT00634556|Dopamine Agents|dopamine agents|mesh-ancestor
65264315|NCT00634556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65014594|NCT00509470|Diuretics|diuretics|mesh-ancestor
65264316|NCT00634556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264317|NCT00634556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264318|NCT02784080|Isoantibodies|isoantibodies|mesh-list
65264319|NCT02784080|Immunologic Factors|immunologic factors|mesh-ancestor
65264320|NCT02784080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264321|NCT02784860|Lidocaine|lidocaine|mesh-list
65264322|NCT02784860|Anesthetics, Local|anesthetics, local|mesh-ancestor
65264323|NCT02784860|Anesthetics|anesthetics|mesh-ancestor
65264324|NCT02784860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65264325|NCT02784860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264326|NCT02784860|Sensory System Agents|sensory system agents|mesh-ancestor
65264327|NCT02784860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264328|NCT02784860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65264329|NCT02784860|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65264330|NCT02784860|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65264331|NCT02784860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65264332|NCT02784860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264333|NCT02783924|Cholecalciferol|cholecalciferol|mesh-list
65264334|NCT02783924|Vitamin D|vitamin d|mesh-list
65264335|NCT02783924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65264336|NCT02783924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264337|NCT02783924|Vitamins|vitamins|mesh-ancestor
65264338|NCT02783924|Micronutrients|micronutrients|mesh-ancestor
65264339|NCT02783924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65264340|NCT02783846|Dexmedetomidine|dexmedetomidine|mesh-list
65264341|NCT02783846|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65264342|NCT02783846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65264343|NCT02783846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264344|NCT02783846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65264345|NCT02783846|Analgesics|analgesics|mesh-ancestor
65264346|NCT02783846|Sensory System Agents|sensory system agents|mesh-ancestor
65264347|NCT02783846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264348|NCT02783846|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65264349|NCT02783846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65264350|NCT02783846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65264351|NCT02783846|Adrenergic Agents|adrenergic agents|mesh-ancestor
65264352|NCT02783846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65264353|NCT02783846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264354|NCT02783378|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
65264355|NCT02783378|Antacids|antacids|mesh-ancestor
65264356|NCT02783378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264357|NCT02783378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65264358|NCT05237726|Heparin|heparin|mesh-list
65264359|NCT05237726|Enoxaparin|enoxaparin|mesh-list
65264360|NCT05237726|Calcium heparin|calcium heparin|mesh-list
65264361|NCT05237726|Enoxaparin sodium|enoxaparin sodium|mesh-list
65264362|NCT05237726|Anticoagulants|anticoagulants|mesh-ancestor
65264363|NCT05237726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65264364|NCT05237726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65264365|NCT05237726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264366|NCT02783144|Dexamethasone|dexamethasone|mesh-list
65264367|NCT02783144|Dexamethasone acetate|dexamethasone acetate|mesh-list
65264368|NCT02783144|BB 1101|bb 1101|mesh-list
65264369|NCT02783144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65264370|NCT02783144|Antiemetics|antiemetics|mesh-ancestor
65264371|NCT02783144|Autonomic Agents|autonomic agents|mesh-ancestor
65264372|NCT02783144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264373|NCT02783144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264374|NCT02783144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65264375|NCT02783144|Glucocorticoids|glucocorticoids|mesh-ancestor
65264376|NCT02783144|Hormones|hormones|mesh-ancestor
65264377|NCT02783144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65264378|NCT02783144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65264379|NCT02783144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264380|NCT02783144|Protease Inhibitors|protease inhibitors|mesh-ancestor
65264381|NCT02783144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65264382|NCT02783144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264383|NCT05260320|Anesthetics|anesthetics|mesh-list
65264384|NCT05260320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65264385|NCT05260320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264386|NCT02783222|Paclitaxel|paclitaxel|mesh-list
65264387|NCT02783222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65264388|NCT02783222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264392|NCT02783222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264393|NCT02689856|Hydrocortisone|hydrocortisone|mesh-list
65264394|NCT02689856|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65264395|NCT02689856|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65264396|NCT02689856|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65264397|NCT02689856|Lidocaine|lidocaine|mesh-list
65264398|NCT02689856|Anesthetics, Local|anesthetics, local|mesh-ancestor
65264399|NCT02689856|Anesthetics|anesthetics|mesh-ancestor
65264400|NCT02689856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65264401|NCT02689856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264402|NCT02689856|Sensory System Agents|sensory system agents|mesh-ancestor
65264403|NCT02689856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264404|NCT02689856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65264405|NCT02689856|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65264406|NCT02689856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65264407|NCT02689856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65264408|NCT02689856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264409|NCT02689856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65264413|NCT02722902|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65264414|NCT02722902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65264415|NCT02722902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65264416|NCT02722902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65264417|NCT05206448|Letrozole|letrozole|mesh-list
65264418|NCT05206448|Clomiphene|clomiphene|mesh-list
65264419|NCT05206448|Enclomiphene|enclomiphene|mesh-list
65264420|NCT05206448|Zuclomiphene|zuclomiphene|mesh-list
65264421|NCT05206448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264422|NCT05206448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264423|NCT05206448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65264424|NCT05206448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65264425|NCT05206448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65264426|NCT05206448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65264427|NCT05206448|Hormone Antagonists|hormone antagonists|mesh-ancestor
65264428|NCT05206448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65264429|NCT05206448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264430|NCT05206448|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65264431|NCT05206448|Fertility Agents|fertility agents|mesh-ancestor
65264432|NCT05206448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65264433|NCT05206448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65264434|NCT05206448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65264435|NCT02722746|Epinephrine|epinephrine|mesh-list
65264436|NCT02722746|Ropivacaine|ropivacaine|mesh-list
65264437|NCT02722746|Anesthetics, Local|anesthetics, local|mesh-ancestor
65264438|NCT02722746|Anesthetics|anesthetics|mesh-ancestor
65264439|NCT02722746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65264440|NCT02722746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264441|NCT02722746|Sensory System Agents|sensory system agents|mesh-ancestor
65264442|NCT02722746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264443|NCT02722746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65264444|NCT02722746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65264445|NCT02722746|Adrenergic Agents|adrenergic agents|mesh-ancestor
65264446|NCT02722746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65264447|NCT02722746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264448|NCT02722746|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65264449|NCT02722746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65264450|NCT02722746|Autonomic Agents|autonomic agents|mesh-ancestor
65264451|NCT02722746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65264452|NCT02722746|Respiratory System Agents|respiratory system agents|mesh-ancestor
65264453|NCT02722746|Mydriatics|mydriatics|mesh-ancestor
65264454|NCT02722746|Sympathomimetics|sympathomimetics|mesh-ancestor
65264455|NCT02722746|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65264456|NCT02784626|Dexmedetomidine|dexmedetomidine|mesh-list
65264457|NCT02784626|Propofol|propofol|mesh-list
65264458|NCT02784626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65264459|NCT02784626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65264460|NCT02784626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264461|NCT02784626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65264462|NCT02784626|Anesthetics, General|anesthetics, general|mesh-ancestor
65264463|NCT02784626|Anesthetics|anesthetics|mesh-ancestor
65264464|NCT02784626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65264465|NCT02784626|Analgesics|analgesics|mesh-ancestor
65264466|NCT02784626|Sensory System Agents|sensory system agents|mesh-ancestor
65264467|NCT02784626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264468|NCT02784626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65264469|NCT02784626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65264470|NCT02784626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65264471|NCT02784626|Adrenergic Agents|adrenergic agents|mesh-ancestor
65264472|NCT02784626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65264473|NCT02784626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264474|NCT02782754|Cyclophosphamide|cyclophosphamide|mesh-list
65264475|NCT02782754|Carboplatin|carboplatin|mesh-list
65264476|NCT02782754|Etoposide|etoposide|mesh-list
65264477|NCT02782754|Bleomycin|bleomycin|mesh-list
65264478|NCT02782754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65264479|NCT02782754|Immunologic Factors|immunologic factors|mesh-ancestor
65264480|NCT02782754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264481|NCT02782754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65264482|NCT02782754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65264483|NCT02782754|Alkylating Agents|alkylating agents|mesh-ancestor
65264484|NCT02782754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264485|NCT02782754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264486|NCT02782754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65264487|NCT02782754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65264488|NCT02782754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65264489|NCT02782754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65264490|NCT02782754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65264491|NCT02782754|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65264492|NCT00634634|Sorafenib|sorafenib|mesh-list
65264493|NCT00634634|Letrozole|letrozole|mesh-list
65264494|NCT00634634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264495|NCT00634634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65264496|NCT00634634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65264497|NCT00634634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264498|NCT00634634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65264499|NCT00634634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65264500|NCT00634634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65264501|NCT00634634|Hormone Antagonists|hormone antagonists|mesh-ancestor
65264502|NCT00634634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65264503|NCT00634634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264504|NCT03539822|Durvalumab|durvalumab|mesh-list
65264505|NCT03539822|Tremelimumab|tremelimumab|mesh-list
65264506|NCT03539822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65264507|NCT03539822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65264508|NCT03539822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264509|NCT03539822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264510|NCT05341076|Oxytocin|oxytocin|mesh-list
65264511|NCT05341076|Oxytocics|oxytocics|mesh-ancestor
65264512|NCT05341076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65264513|NCT05341076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264514|NCT05133518|Midazolam|midazolam|mesh-list
65264515|NCT05133518|Ketamine|ketamine|mesh-list
65264516|NCT05133518|Analgesics|analgesics|mesh-ancestor
65264517|NCT05133518|Sensory System Agents|sensory system agents|mesh-ancestor
65264518|NCT05133518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264519|NCT05133518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264520|NCT05133518|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65264521|NCT05133518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65264522|NCT05133518|Anesthetics, General|anesthetics, general|mesh-ancestor
65264523|NCT05133518|Anesthetics|anesthetics|mesh-ancestor
65264524|NCT05133518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65264525|NCT05133518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65264526|NCT05133518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65264527|NCT05133518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65264528|NCT05133518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264529|NCT05133518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65264530|NCT05133518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65264531|NCT05133518|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65264532|NCT05133518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65264533|NCT05133518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65264534|NCT05133518|GABA Modulators|gaba modulators|mesh-ancestor
65264535|NCT05133518|GABA Agents|gaba agents|mesh-ancestor
65014812|NCT02953015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65264536|NCT02714712|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65264537|NCT02714712|Antiviral Agents|antiviral agents|mesh-ancestor
65264538|NCT02714712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65264539|NCT02714166|Sunscreening Agents|sunscreening agents|mesh-list
65264540|NCT02714166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65264541|NCT02714166|Protective Agents|protective agents|mesh-ancestor
65264542|NCT02714166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264543|NCT02714166|Dermatologic Agents|dermatologic agents|mesh-ancestor
65264544|NCT04231682|Denosumab|denosumab|mesh-list
65264545|NCT04231682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65264546|NCT04231682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264547|NCT02722356|Oxytocin|oxytocin|mesh-list
65264548|NCT02722356|Oxytocics|oxytocics|mesh-ancestor
65264549|NCT02722356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65264550|NCT02722356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264551|NCT00753675|Gemcitabine|gemcitabine|mesh-list
65264552|NCT00753675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65264553|NCT00753675|Antimetabolites|antimetabolites|mesh-ancestor
65264554|NCT00753675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264555|NCT00753675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264556|NCT00753675|Antiviral Agents|antiviral agents|mesh-ancestor
65264557|NCT00753675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64481014|NCT00655642|Antipruritics|antipruritics|mesh-ancestor
65264558|NCT00753675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65264559|NCT00753675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65264560|NCT00753675|Immunologic Factors|immunologic factors|mesh-ancestor
65264561|NCT00753675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264562|NCT05224050|Nicotine|nicotine|mesh-list
65264563|NCT05224050|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65264564|NCT05224050|Autonomic Agents|autonomic agents|mesh-ancestor
65264565|NCT05224050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264566|NCT05224050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264567|NCT05224050|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65264568|NCT05224050|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65264569|NCT05224050|Cholinergic Agents|cholinergic agents|mesh-ancestor
65264570|NCT05224050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65264571|NCT05224050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264572|NCT05131178|Bupivacaine|bupivacaine|mesh-list
65264573|NCT05131178|Anesthetics, Local|anesthetics, local|mesh-ancestor
65264574|NCT05131178|Anesthetics|anesthetics|mesh-ancestor
65264575|NCT05131178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65264576|NCT05131178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264577|NCT05131178|Sensory System Agents|sensory system agents|mesh-ancestor
65264578|NCT05131178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264579|NCT02546934|Gemcitabine|gemcitabine|mesh-list
65264580|NCT02546934|Cisplatin|cisplatin|mesh-list
65264581|NCT02546934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264582|NCT02546934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65264583|NCT02546934|Antimetabolites|antimetabolites|mesh-ancestor
65264584|NCT02546934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264585|NCT02546934|Antiviral Agents|antiviral agents|mesh-ancestor
65264586|NCT02546934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65264587|NCT02546934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65264588|NCT02546934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65264589|NCT02546934|Immunologic Factors|immunologic factors|mesh-ancestor
65264590|NCT02546934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264591|NCT00586521|Factor VIII|factor viii|mesh-list
65264592|NCT00586521|Coagulants|coagulants|mesh-ancestor
65264593|NCT02782286|Ketorolac|ketorolac|mesh-list
65264594|NCT02782286|Morphine|morphine|mesh-list
65264595|NCT02782286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65264596|NCT02782286|Narcotics|narcotics|mesh-ancestor
65264597|NCT02782286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65264598|NCT02782286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264599|NCT02782286|Analgesics|analgesics|mesh-ancestor
65264600|NCT02782286|Sensory System Agents|sensory system agents|mesh-ancestor
65264601|NCT02782286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264602|NCT02782286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65264603|NCT02782286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65264604|NCT02782286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65264605|NCT02782286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65264606|NCT02782286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65264607|NCT02782286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65264608|NCT02782286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264609|NCT04231448|Prednisone|prednisone|mesh-list
65264610|NCT04231448|Cyclophosphamide|cyclophosphamide|mesh-list
65264611|NCT04231448|Rituximab|rituximab|mesh-list
65014868|NCT00150384|Amlodipine|amlodipine|mesh-list
65264612|NCT04231448|Doxorubicin|doxorubicin|mesh-list
65264613|NCT04231448|Vincristine|vincristine|mesh-list
65264614|NCT04231448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65264615|NCT04231448|Immunologic Factors|immunologic factors|mesh-ancestor
65264616|NCT04231448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264617|NCT04231448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65264618|NCT04231448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65264619|NCT04231448|Alkylating Agents|alkylating agents|mesh-ancestor
65264620|NCT04231448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264621|NCT04231448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264622|NCT04231448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65264623|NCT04231448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65264624|NCT04231448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65264625|NCT04231448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65264626|NCT04231448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65264627|NCT04231448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65264628|NCT04231448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65264629|NCT04231448|Glucocorticoids|glucocorticoids|mesh-ancestor
65264630|NCT04231448|Hormones|hormones|mesh-ancestor
65264631|NCT04231448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65264632|NCT04231448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65264633|NCT04231448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65264634|NCT04231448|Tubulin Modulators|tubulin modulators|mesh-ancestor
65264635|NCT04231448|Antimitotic Agents|antimitotic agents|mesh-ancestor
65264636|NCT04231448|Mitosis Modulators|mitosis modulators|mesh-ancestor
65264637|NCT02600247|Acetaminophen|acetaminophen|mesh-list
65264638|NCT02600247|Celecoxib|celecoxib|mesh-list
65264639|NCT02600247|Pregabalin|pregabalin|mesh-list
65264640|NCT02600247|Oxycodone|oxycodone|mesh-list
65264641|NCT02600247|Tramadol|tramadol|mesh-list
65264642|NCT02600247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65264643|NCT02600247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65264644|NCT02600247|Analgesics|analgesics|mesh-ancestor
65264645|NCT02600247|Sensory System Agents|sensory system agents|mesh-ancestor
65264646|NCT02600247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264647|NCT02600247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264648|NCT02600247|Antipyretics|antipyretics|mesh-ancestor
65264649|NCT02600247|Anticonvulsants|anticonvulsants|mesh-ancestor
65264650|NCT02600247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65264651|NCT02600247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65264652|NCT02600247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264653|NCT02600247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65264654|NCT02600247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65264655|NCT02600247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65264656|NCT02600247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65264657|NCT02600247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65264658|NCT02600247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65264659|NCT02600247|Narcotics|narcotics|mesh-ancestor
65264660|NCT02600247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65264661|NCT02600247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65264662|NCT02600247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65264663|NCT02600247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65264664|NCT02600247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65264665|NCT02600247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65264666|NCT02600247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65264667|NCT02600247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65264668|NCT02600247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65264669|NCT02600247|Antidepressive Agents|antidepressive agents|mesh-ancestor
65264670|NCT02600247|Dopamine Agents|dopamine agents|mesh-ancestor
65264671|NCT05453253|Vaccines|vaccines|mesh-list
65264672|NCT05453253|Immunologic Factors|immunologic factors|mesh-ancestor
65264673|NCT05453253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264674|NCT04229498|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65264675|NCT04229498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65264676|NCT02717052|Ketamine|ketamine|mesh-list
65264677|NCT02717052|Esketamine|esketamine|mesh-list
65264678|NCT02717052|Analgesics|analgesics|mesh-ancestor
65264679|NCT02717052|Sensory System Agents|sensory system agents|mesh-ancestor
65264680|NCT02717052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264681|NCT02717052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264682|NCT02717052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65264683|NCT02717052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65264684|NCT02717052|Anesthetics, General|anesthetics, general|mesh-ancestor
65264685|NCT02717052|Anesthetics|anesthetics|mesh-ancestor
65264686|NCT02717052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65264687|NCT02717052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65264688|NCT02717052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65264689|NCT02717052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65264690|NCT02717052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264691|NCT02717052|Antidepressive Agents|antidepressive agents|mesh-ancestor
65264692|NCT02717052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65264693|NCT05342558|Fluticasone|fluticasone|mesh-list
65264694|NCT05342558|Xhance|xhance|mesh-list
65264695|NCT05342558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65264696|NCT05342558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65264697|NCT05342558|Autonomic Agents|autonomic agents|mesh-ancestor
65264698|NCT05342558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264699|NCT05342558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264700|NCT05342558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65264701|NCT05342558|Respiratory System Agents|respiratory system agents|mesh-ancestor
65264702|NCT05342558|Dermatologic Agents|dermatologic agents|mesh-ancestor
65264703|NCT05342558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65264705|NCT00923273|Vitamin B 12|vitamin b 12|mesh-list
65264706|NCT00923273|Sirolimus|sirolimus|mesh-list
65264707|NCT00923273|Dexamethasone|dexamethasone|mesh-list
65264708|NCT00923273|Pemetrexed|pemetrexed|mesh-list
65264709|NCT00923273|Vitamins|vitamins|mesh-ancestor
65264710|NCT00923273|Micronutrients|micronutrients|mesh-ancestor
65264711|NCT00923273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264712|NCT00923273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65264713|NCT00923273|Antiemetics|antiemetics|mesh-ancestor
65264714|NCT00923273|Autonomic Agents|autonomic agents|mesh-ancestor
65264715|NCT00923273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264716|NCT00923273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65264717|NCT00923273|Glucocorticoids|glucocorticoids|mesh-ancestor
65264718|NCT00923273|Hormones|hormones|mesh-ancestor
65264719|NCT00923273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65264720|NCT00923273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65264721|NCT00923273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264722|NCT00923273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65264723|NCT00923273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264724|NCT00923273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65264725|NCT00923273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65264726|NCT00923273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65264727|NCT00923273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65264728|NCT00923273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65264729|NCT00923273|Antifungal Agents|antifungal agents|mesh-ancestor
65264730|NCT00923273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65264731|NCT00923273|Immunologic Factors|immunologic factors|mesh-ancestor
65264732|NCT00923273|Hematinics|hematinics|mesh-ancestor
65264733|NCT00923273|Vitamin B Complex|vitamin b complex|mesh-ancestor
65264734|NCT04231370|Lenalidomide|lenalidomide|mesh-list
65264735|NCT04231370|Immunologic Factors|immunologic factors|mesh-ancestor
65264736|NCT04231370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264737|NCT04231370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65264738|NCT04231370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65264739|NCT04231370|Growth Substances|growth substances|mesh-ancestor
65264740|NCT04231370|Growth Inhibitors|growth inhibitors|mesh-ancestor
65264741|NCT04231370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264742|NCT05340530|Meropenem|meropenem|mesh-list
65264743|NCT05340530|Avibactam|avibactam|mesh-list
65264744|NCT05340530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65264745|NCT05340530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65264746|NCT05340530|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65264747|NCT05340530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65264748|NCT05340530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264749|NCT00634712|Candesartan|candesartan|mesh-list
65264750|NCT00634712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65264751|NCT00634712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65264752|NCT00634712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65264753|NCT00634712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264754|NCT00923195|Aldesleukin|aldesleukin|mesh-list
65264755|NCT00923195|Cyclophosphamide|cyclophosphamide|mesh-list
65264756|NCT00923195|Fludarabine|fludarabine|mesh-list
65264757|NCT00923195|Interleukin-2|interleukin-2|mesh-list
65264758|NCT00923195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65264759|NCT00923195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65264760|NCT00923195|Immunologic Factors|immunologic factors|mesh-ancestor
65264761|NCT00923195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015006|NCT00510367|Immunologic Factors|immunologic factors|mesh-ancestor
65264762|NCT00923195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65264763|NCT00923195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65264764|NCT00923195|Alkylating Agents|alkylating agents|mesh-ancestor
65264765|NCT00923195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264766|NCT00923195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264767|NCT00923195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65264768|NCT00923195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65264769|NCT00923195|Analgesics|analgesics|mesh-ancestor
65264770|NCT00923195|Sensory System Agents|sensory system agents|mesh-ancestor
65264771|NCT00923195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264772|NCT00923195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65264773|NCT00923195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65264774|NCT00923195|Antiviral Agents|antiviral agents|mesh-ancestor
65264775|NCT00923195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65264776|NCT00923195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65264777|NCT02721888|Liraglutide|liraglutide|mesh-list
65264778|NCT02721888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65264779|NCT02721888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264781|NCT02721888|Hormones|hormones|mesh-ancestor
65264782|NCT02721888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65264783|NCT04256057|Magnesium Sulfate|magnesium sulfate|mesh-list
65264784|NCT04256057|Analgesics|analgesics|mesh-ancestor
65264785|NCT04256057|Sensory System Agents|sensory system agents|mesh-ancestor
65264786|NCT04256057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264787|NCT04256057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264788|NCT04256057|Anesthetics|anesthetics|mesh-ancestor
65264789|NCT04256057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65264790|NCT04256057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65264791|NCT04256057|Anticonvulsants|anticonvulsants|mesh-ancestor
65264792|NCT04256057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65264793|NCT04256057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65264794|NCT04256057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264795|NCT04256057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65264796|NCT04256057|Tocolytic Agents|tocolytic agents|mesh-ancestor
65264797|NCT04256057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65264798|NCT04189302|Pyrithione zinc|pyrithione zinc|mesh-list
65264799|NCT04189302|Keratolytic Agents|keratolytic agents|mesh-ancestor
65264800|NCT04189302|Dermatologic Agents|dermatologic agents|mesh-ancestor
65264801|NCT02714010|Gefitinib|gefitinib|mesh-list
65264802|NCT02714010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264803|NCT02714010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65264804|NCT02714010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65264805|NCT02714010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264806|NCT00917241|Dexamethasone|dexamethasone|mesh-list
65264807|NCT00917241|Methimazole|methimazole|mesh-list
65264808|NCT00917241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65264809|NCT00917241|Antiemetics|antiemetics|mesh-ancestor
65264810|NCT00917241|Autonomic Agents|autonomic agents|mesh-ancestor
65264811|NCT00917241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264812|NCT00917241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264813|NCT00917241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65264814|NCT00917241|Glucocorticoids|glucocorticoids|mesh-ancestor
65264815|NCT00917241|Hormones|hormones|mesh-ancestor
65264816|NCT00917241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65264817|NCT00917241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65264818|NCT00917241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264819|NCT00917241|Antithyroid Agents|antithyroid agents|mesh-ancestor
65264820|NCT00917241|Hormone Antagonists|hormone antagonists|mesh-ancestor
65264821|NCT00919061|Gemcitabine|gemcitabine|mesh-list
65264822|NCT00919061|Sorafenib|sorafenib|mesh-list
65264823|NCT00919061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264824|NCT00919061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65264825|NCT00919061|Antimetabolites|antimetabolites|mesh-ancestor
65264826|NCT00919061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264827|NCT00919061|Antiviral Agents|antiviral agents|mesh-ancestor
65264828|NCT00919061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65264829|NCT00919061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65264830|NCT00919061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65264831|NCT00919061|Immunologic Factors|immunologic factors|mesh-ancestor
65264832|NCT00919061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264833|NCT00919061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65264834|NCT05106296|Cyclophosphamide|cyclophosphamide|mesh-list
65264835|NCT05106296|Etoposide|etoposide|mesh-list
65264836|NCT05106296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65264837|NCT05106296|Immunologic Factors|immunologic factors|mesh-ancestor
65015081|NCT00150579|Dopamine Agents|dopamine agents|mesh-ancestor
65264838|NCT05106296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264839|NCT05106296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65264840|NCT05106296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65264841|NCT05106296|Alkylating Agents|alkylating agents|mesh-ancestor
65264842|NCT05106296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264843|NCT05106296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264844|NCT05106296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65264845|NCT05106296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65264846|NCT05106296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65264847|NCT05106296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65264848|NCT05106296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65264850|NCT02598687|Carboplatin|carboplatin|mesh-list
65264851|NCT02598687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65264852|NCT02598687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264853|NCT02598687|Tubulin Modulators|tubulin modulators|mesh-ancestor
65264854|NCT02598687|Antimitotic Agents|antimitotic agents|mesh-ancestor
65264855|NCT02598687|Mitosis Modulators|mitosis modulators|mesh-ancestor
65264856|NCT02598687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264857|NCT05338190|Rituximab|rituximab|mesh-list
65264858|NCT05338190|Belimumab|belimumab|mesh-list
65264859|NCT05338190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65264860|NCT05338190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264861|NCT05338190|Immunologic Factors|immunologic factors|mesh-ancestor
65264862|NCT05338190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264863|NCT05338190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65264864|NCT05338190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65264865|NCT04908605|Melatonin|melatonin|mesh-list
65264866|NCT04908605|Mirtazapine|mirtazapine|mesh-list
65264867|NCT04908605|Antioxidants|antioxidants|mesh-ancestor
65264868|NCT04908605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264869|NCT04908605|Protective Agents|protective agents|mesh-ancestor
65264870|NCT04908605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264871|NCT04908605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65264872|NCT04908605|Antidepressive Agents|antidepressive agents|mesh-ancestor
65264873|NCT04908605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65264874|NCT04908605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65264875|NCT04908605|Histamine Antagonists|histamine antagonists|mesh-ancestor
65264876|NCT04908605|Histamine Agents|histamine agents|mesh-ancestor
65264877|NCT04908605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65264878|NCT04908605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65264879|NCT04908605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65264880|NCT04908605|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65264881|NCT04908605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65264882|NCT04908605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65264883|NCT04908605|Adrenergic Agents|adrenergic agents|mesh-ancestor
65264884|NCT04908605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65264885|NCT04908605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65264886|NCT04908605|Serotonin Agents|serotonin agents|mesh-ancestor
65264887|NCT04908605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65264888|NCT02782208|Acipimox|acipimox|mesh-list
65264889|NCT02782208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65264890|NCT02782208|Antimetabolites|antimetabolites|mesh-ancestor
65264891|NCT02782208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264892|NCT02782208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65264893|NCT02598453|Ibandronic Acid|ibandronic acid|mesh-list
65264894|NCT02598453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65264895|NCT02598453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264896|NCT00611286|Sirolimus|sirolimus|mesh-list
65264897|NCT00611286|Paclitaxel|paclitaxel|mesh-list
65264898|NCT00611286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65264899|NCT00611286|Everolimus|everolimus|mesh-list
65264900|NCT00611286|Clopidogrel|clopidogrel|mesh-list
65264901|NCT00611286|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
65264902|NCT00611286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65264903|NCT00611286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65264904|NCT00611286|Tubulin Modulators|tubulin modulators|mesh-ancestor
65264905|NCT00611286|Antimitotic Agents|antimitotic agents|mesh-ancestor
65264906|NCT00611286|Mitosis Modulators|mitosis modulators|mesh-ancestor
65264907|NCT00611286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264908|NCT00611286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65264909|NCT00611286|Immunologic Factors|immunologic factors|mesh-ancestor
65264910|NCT00611286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264911|NCT00611286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65264912|NCT00611286|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65264913|NCT00611286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65264914|NCT00611286|Purinergic Agents|purinergic agents|mesh-ancestor
65264915|NCT00611286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65264916|NCT00611286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65264917|NCT00611286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65264918|NCT00611286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65264919|NCT00611286|Antifungal Agents|antifungal agents|mesh-ancestor
65264920|NCT04257851|Sumatriptan|sumatriptan|mesh-list
65264921|NCT04257851|Theophylline|theophylline|mesh-list
65264922|NCT04257851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65264923|NCT04257851|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65264924|NCT04257851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65264925|NCT04257851|Serotonin Agents|serotonin agents|mesh-ancestor
65264926|NCT04257851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65264927|NCT04257851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264928|NCT04257851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264929|NCT04257851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65264930|NCT04257851|Autonomic Agents|autonomic agents|mesh-ancestor
65264931|NCT04257851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264932|NCT04257851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65264933|NCT04257851|Respiratory System Agents|respiratory system agents|mesh-ancestor
65264934|NCT04257851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65264935|NCT04257851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65264936|NCT04257851|Vasodilator Agents|vasodilator agents|mesh-ancestor
65264937|NCT04257851|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65264938|NCT04257851|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65264939|NCT04257851|Purinergic Agents|purinergic agents|mesh-ancestor
65264940|NCT02780102|Methylphenidate|methylphenidate|mesh-list
65264941|NCT02780102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65264942|NCT02780102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264943|NCT02780102|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65264944|NCT02780102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65264945|NCT02780102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65264946|NCT02780102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264947|NCT02780102|Dopamine Agents|dopamine agents|mesh-ancestor
65264948|NCT02780102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65264949|NCT04197050|Valsartan|valsartan|mesh-list
65264950|NCT04197050|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65264951|NCT04197050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65264952|NCT04197050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65264953|NCT04197050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65264954|NCT04197050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264955|NCT04090047|Itraconazole|itraconazole|mesh-list
65264956|NCT04090047|PF-06700841|pf-06700841|mesh-list
65264957|NCT04090047|Antifungal Agents|antifungal agents|mesh-ancestor
65264958|NCT04090047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65264959|NCT04090047|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65264960|NCT04090047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65264961|NCT04090047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65264962|NCT04090047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264963|NCT04090047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65264964|NCT04090047|Hormone Antagonists|hormone antagonists|mesh-ancestor
65264965|NCT04090047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65264966|NCT04090047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264967|NCT04090047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65264968|NCT04090047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65264969|NCT02782052|Bromides|bromides|mesh-list
65264970|NCT02782052|Albuterol|albuterol|mesh-list
65264971|NCT02782052|Ipratropium|ipratropium|mesh-list
65264972|NCT02782052|Anticonvulsants|anticonvulsants|mesh-ancestor
65264973|NCT02782052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65264974|NCT02782052|Autonomic Agents|autonomic agents|mesh-ancestor
65264975|NCT02782052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65264976|NCT02782052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65264977|NCT02782052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65264978|NCT02782052|Respiratory System Agents|respiratory system agents|mesh-ancestor
65264979|NCT02782052|Tocolytic Agents|tocolytic agents|mesh-ancestor
65264980|NCT02782052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65264981|NCT02782052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65264982|NCT02782052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65264983|NCT02782052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65264984|NCT02782052|Adrenergic Agents|adrenergic agents|mesh-ancestor
65264985|NCT02782052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65264986|NCT02782052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264987|NCT02782052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65264988|NCT02782052|Cholinergic Agents|cholinergic agents|mesh-ancestor
65264989|NCT02708628|Heparin|heparin|mesh-list
65264990|NCT02708628|Allantoin|allantoin|mesh-list
65264991|NCT02708628|Anticoagulants|anticoagulants|mesh-ancestor
65264992|NCT02708628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65264993|NCT02708628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65264994|NCT02708628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65264995|NCT02708628|Dermatologic Agents|dermatologic agents|mesh-ancestor
65264996|NCT00746733|Amphetamine|amphetamine|mesh-list
65264997|NCT00746733|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65264998|NCT00746733|Adderall|adderall|mesh-list
65264999|NCT00746733|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65265000|NCT00746733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265001|NCT00746733|Sympathomimetics|sympathomimetics|mesh-ancestor
65265002|NCT00746733|Autonomic Agents|autonomic agents|mesh-ancestor
65265003|NCT00746733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65265004|NCT00746733|Dopamine Agents|dopamine agents|mesh-ancestor
65265005|NCT00746733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65265006|NCT00746733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265007|NCT00746733|Adrenergic Agents|adrenergic agents|mesh-ancestor
65265008|NCT00746733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65265009|NCT00746733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65265010|NCT00746733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65265011|NCT00746733|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65265012|NCT00636870|Fexofenadine|fexofenadine|mesh-list
65265013|NCT00636870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65265014|NCT00636870|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65265015|NCT00636870|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65265016|NCT00636870|Histamine Antagonists|histamine antagonists|mesh-ancestor
65265017|NCT00636870|Histamine Agents|histamine agents|mesh-ancestor
65265018|NCT00636870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65265019|NCT00636870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265020|NCT00636870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265021|NCT00634790|Alprazolam|alprazolam|mesh-list
65265022|NCT00634790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65265023|NCT00634790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65265024|NCT00634790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265025|NCT00634790|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65265026|NCT00634790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65265027|NCT00634790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65265028|NCT00634790|GABA Modulators|gaba modulators|mesh-ancestor
65265029|NCT00634790|GABA Agents|gaba agents|mesh-ancestor
65265030|NCT00634790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65265031|NCT00634790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265032|NCT04831151|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
65265033|NCT04831151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265034|NCT04831151|Androgen Antagonists|androgen antagonists|mesh-ancestor
65265035|NCT04831151|Hormone Antagonists|hormone antagonists|mesh-ancestor
65265036|NCT04831151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65265037|NCT00917397|Sertraline|sertraline|mesh-list
65265038|NCT00917397|Antidepressive Agents|antidepressive agents|mesh-ancestor
65265039|NCT00917397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65265040|NCT00917397|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65265041|NCT00917397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65265042|NCT00917397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65265043|NCT00917397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265044|NCT00917397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65265045|NCT00917397|Serotonin Agents|serotonin agents|mesh-ancestor
65265046|NCT00917397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265047|NCT02708160|Fluorides|fluorides|mesh-list
65265048|NCT02708160|Cariostatic Agents|cariostatic agents|mesh-ancestor
65265049|NCT02708160|Protective Agents|protective agents|mesh-ancestor
65265050|NCT02708160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265051|NCT04257461|Capecitabine|capecitabine|mesh-list
65265052|NCT04257461|Oxaliplatin|oxaliplatin|mesh-list
65265053|NCT04257461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65265054|NCT04257461|Antimetabolites|antimetabolites|mesh-ancestor
65265055|NCT04257461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265056|NCT04257461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265057|NCT02712528|Sufentanil|sufentanil|mesh-list
65265058|NCT02712528|Remifentanil|remifentanil|mesh-list
65265059|NCT02712528|Sevoflurane|sevoflurane|mesh-list
65265060|NCT02712528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65265062|NCT02712528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65265063|NCT02712528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265064|NCT02712528|Analgesics|analgesics|mesh-ancestor
65265065|NCT02712528|Sensory System Agents|sensory system agents|mesh-ancestor
65265066|NCT02712528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65265067|NCT02712528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65265068|NCT02712528|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65265069|NCT02712528|Anesthetics, General|anesthetics, general|mesh-ancestor
65265070|NCT02712528|Anesthetics|anesthetics|mesh-ancestor
65265071|NCT02712528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65265072|NCT02712528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65265073|NCT04089657|Apatinib|apatinib|mesh-list
65265074|NCT04089657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265075|NCT04089657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65265076|NCT04089657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65265077|NCT04089657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265078|NCT02713074|Povidone-Iodine|povidone-iodine|mesh-list
65265079|NCT02713074|Povidone|povidone|mesh-list
65265080|NCT02713074|Plasma Substitutes|plasma substitutes|mesh-ancestor
65265081|NCT02713074|Blood Substitutes|blood substitutes|mesh-ancestor
65265082|NCT02713074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65265083|NCT02713074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65265084|NCT00637793|(S)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|(s)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|mesh-list
65265085|NCT00637793|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65265086|NCT00637793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65265087|NCT00637793|Cholinergic Agents|cholinergic agents|mesh-ancestor
65265088|NCT00637793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65265089|NCT00637793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265090|NCT00637793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265091|NCT00745875|Pemetrexed|pemetrexed|mesh-list
65265092|NCT00745875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265093|NCT00745875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65265094|NCT00745875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265095|NCT00745875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65265096|NCT00745875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65265097|NCT04089813|Metformin|metformin|mesh-list
65265098|NCT04089813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65265099|NCT04089813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265100|NCT00555217|Losartan|losartan|mesh-list
65265101|NCT00555217|Lisinopril|lisinopril|mesh-list
65265102|NCT00555217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65265103|NCT00555217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65265104|NCT00555217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65265105|NCT00555217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65265106|NCT00555217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265107|NCT00555217|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65265108|NCT00555217|Protease Inhibitors|protease inhibitors|mesh-ancestor
65265109|NCT00555217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65265110|NCT00555217|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65265111|NCT00555217|Protective Agents|protective agents|mesh-ancestor
65265112|NCT00555217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265113|NCT02711904|Remifentanil|remifentanil|mesh-list
65265114|NCT02711904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65265115|NCT02711904|Narcotics|narcotics|mesh-ancestor
65265116|NCT02711904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65265117|NCT02711904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265118|NCT02711904|Analgesics|analgesics|mesh-ancestor
65265119|NCT02711904|Sensory System Agents|sensory system agents|mesh-ancestor
65265120|NCT02711904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65265121|NCT05326490|Metformin|metformin|mesh-list
65265122|NCT05326490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65265123|NCT05326490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265124|NCT02693808|Hyaluronic Acid|hyaluronic acid|mesh-list
65265125|NCT02693808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65265126|NCT02693808|Immunologic Factors|immunologic factors|mesh-ancestor
65265127|NCT02693808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265128|NCT02693808|Viscosupplements|viscosupplements|mesh-ancestor
65265129|NCT02693808|Protective Agents|protective agents|mesh-ancestor
65265130|NCT02711982|Methylprednisolone|methylprednisolone|mesh-list
65265131|NCT02711982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65265132|NCT02711982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65265133|NCT02711982|Prednisolone|prednisolone|mesh-list
65265134|NCT02711982|Prednisolone acetate|prednisolone acetate|mesh-list
65015375|NCT02951962|Antimetabolites|antimetabolites|mesh-ancestor
65265135|NCT02711982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65265136|NCT02711982|Prednisolone phosphate|prednisolone phosphate|mesh-list
65265137|NCT02711982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65265139|NCT02711982|Autonomic Agents|autonomic agents|mesh-ancestor
65265140|NCT02711982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65265141|NCT02711982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265142|NCT02711982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65265143|NCT02711982|Glucocorticoids|glucocorticoids|mesh-ancestor
65265144|NCT02711982|Hormones|hormones|mesh-ancestor
65265145|NCT02711982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65265146|NCT02711982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65265147|NCT02711982|Protective Agents|protective agents|mesh-ancestor
65265148|NCT02711982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65265149|NCT02711982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265150|NCT00745095|Neostigmine|neostigmine|mesh-list
65265151|NCT00745095|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65265152|NCT00745095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65265153|NCT00745095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265154|NCT00745095|Cholinergic Agents|cholinergic agents|mesh-ancestor
65265155|NCT00745095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65265156|NCT00745095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265157|NCT00745095|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65265158|NCT00745095|Autonomic Agents|autonomic agents|mesh-ancestor
65265159|NCT00745095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65265160|NCT05181462|Gemcitabine|gemcitabine|mesh-list
65265161|NCT05181462|Carboplatin|carboplatin|mesh-list
65265162|NCT05181462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265163|NCT05181462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65265164|NCT05181462|Antimetabolites|antimetabolites|mesh-ancestor
65265165|NCT05181462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265166|NCT05181462|Antiviral Agents|antiviral agents|mesh-ancestor
65265167|NCT05181462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65265168|NCT05181462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65265169|NCT05181462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65265170|NCT05181462|Immunologic Factors|immunologic factors|mesh-ancestor
65265171|NCT05181462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265172|NCT00612612|Rituximab|rituximab|mesh-list
65265173|NCT00612612|Fludarabine|fludarabine|mesh-list
65265174|NCT00612612|Fludarabine phosphate|fludarabine phosphate|mesh-list
65265175|NCT00612612|Obatoclax|obatoclax|mesh-list
65265176|NCT00612612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65265177|NCT00612612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265178|NCT00612612|Immunologic Factors|immunologic factors|mesh-ancestor
65265179|NCT00612612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265180|NCT00612612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65265181|NCT00612612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65265182|NCT00612612|Antimetabolites|antimetabolites|mesh-ancestor
65265183|NCT00612612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265184|NCT00612612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65265185|NCT00612612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65265186|NCT03822468|Letrozole|letrozole|mesh-list
65265187|NCT03822468|Anastrozole|anastrozole|mesh-list
65265188|NCT03822468|Goserelin|goserelin|mesh-list
65265189|NCT03822468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265190|NCT03822468|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65265191|NCT03822468|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65265192|NCT03822468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65265193|NCT03822468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265194|NCT03822468|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65265195|NCT03822468|Hormone Antagonists|hormone antagonists|mesh-ancestor
65265196|NCT03822468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65265197|NCT03822468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265198|NCT03822468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65265199|NCT00947713|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65265200|NCT00947713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65265201|NCT00947713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265202|NCT00940693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65265203|NCT00940693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65265204|NCT00940693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65265205|NCT00940693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65265206|NCT00940693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015443|NCT04695613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65265207|NCT00940693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65265208|NCT00940693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265210|NCT00940693|Sensory System Agents|sensory system agents|mesh-ancestor
65265211|NCT00940693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65265212|NCT00940693|Antidepressive Agents|antidepressive agents|mesh-ancestor
65265213|NCT00940693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65265214|NCT00940693|Dopamine Agents|dopamine agents|mesh-ancestor
65265215|NCT02598063|Lamivudine|lamivudine|mesh-list
65265216|NCT02598063|Adefovir|adefovir|mesh-list
65265217|NCT02598063|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65265218|NCT02598063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65265219|NCT02598063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65265220|NCT02598063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65265221|NCT02598063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65265222|NCT02598063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265223|NCT02598063|Antiviral Agents|antiviral agents|mesh-ancestor
65265224|NCT02598063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65265225|NCT02598063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65265226|NCT02598063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65265227|NCT02707458|Probucol|probucol|mesh-list
65265228|NCT02707458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65265229|NCT02707458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65265230|NCT02707458|Antimetabolites|antimetabolites|mesh-ancestor
65265231|NCT02707458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265232|NCT02707458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65265233|NCT02707458|Antioxidants|antioxidants|mesh-ancestor
65265234|NCT02707458|Protective Agents|protective agents|mesh-ancestor
65265235|NCT02707458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265236|NCT00950677|Exenatide|exenatide|mesh-list
65265237|NCT00950677|Pramlintide|pramlintide|mesh-list
65265238|NCT00950677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65265239|NCT00950677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265240|NCT00950677|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65265241|NCT00950677|Incretins|incretins|mesh-ancestor
65265242|NCT00950677|Hormones|hormones|mesh-ancestor
65265243|NCT00950677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65265244|NCT05174598|Calcitriol|calcitriol|mesh-list
65265245|NCT05174598|Calcipotriene|calcipotriene|mesh-list
65265246|NCT05174598|Dermatologic Agents|dermatologic agents|mesh-ancestor
65265247|NCT05174598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65265248|NCT05174598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265249|NCT05174598|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65265250|NCT05174598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65265251|NCT05174598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265252|NCT05174598|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65265253|NCT05174598|Vitamins|vitamins|mesh-ancestor
65265254|NCT05174598|Micronutrients|micronutrients|mesh-ancestor
65265255|NCT05174598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65265256|NCT00554515|Aldesleukin|aldesleukin|mesh-list
65265257|NCT00554515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265258|NCT00554515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65265259|NCT00554515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65265260|NCT00554515|Antiviral Agents|antiviral agents|mesh-ancestor
65265261|NCT00554515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65265262|NCT05341856|Isosorbide|isosorbide|mesh-list
65265263|NCT05341856|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65265264|NCT05341856|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65265265|NCT05341856|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65265266|NCT05341856|Diuretics|diuretics|mesh-ancestor
65265267|NCT05341856|Natriuretic Agents|natriuretic agents|mesh-ancestor
65265268|NCT05341856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265269|NCT05341856|Vasodilator Agents|vasodilator agents|mesh-ancestor
65265270|NCT05341856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65265271|NCT05341856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265272|NCT00951223|Interferons|interferons|mesh-list
65265273|NCT00951223|Interferon alfacon-1|interferon alfacon-1|mesh-list
65265274|NCT00951223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265275|NCT00951223|Antiviral Agents|antiviral agents|mesh-ancestor
65265276|NCT00951223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65265277|NCT02711592|Analgesics|analgesics|mesh-list
65265278|NCT02711592|Sensory System Agents|sensory system agents|mesh-ancestor
65265279|NCT02711592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65265280|NCT02711592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265281|NCT00948103|Nitrous Oxide|nitrous oxide|mesh-list
65265282|NCT00948103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65265283|NCT00948103|Anesthetics, General|anesthetics, general|mesh-ancestor
65265284|NCT00948103|Anesthetics|anesthetics|mesh-ancestor
65265285|NCT00948103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65265286|NCT00948103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265287|NCT00948103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65265288|NCT00948103|Analgesics|analgesics|mesh-ancestor
65265289|NCT00948103|Sensory System Agents|sensory system agents|mesh-ancestor
65265290|NCT00948103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65265291|NCT02012114|Cysteamine|cysteamine|mesh-list
65265292|NCT02012114|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
65265293|NCT02012114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265294|NCT05301205|Gabapentin|gabapentin|mesh-list
65265295|NCT05301205|Analgesics|analgesics|mesh-ancestor
65265296|NCT05301205|Sensory System Agents|sensory system agents|mesh-ancestor
65265297|NCT05301205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65265298|NCT05301205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265299|NCT05301205|Anticonvulsants|anticonvulsants|mesh-ancestor
65265300|NCT05301205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65265301|NCT05301205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65265302|NCT05301205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65265303|NCT05301205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65265304|NCT05301205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65265305|NCT05301205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65265306|NCT05301205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65265307|NCT05301205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265308|NCT05301205|Antimanic Agents|antimanic agents|mesh-ancestor
65265309|NCT02707224|Candesartan|candesartan|mesh-list
65265310|NCT02707224|Candesartan cilexetil|candesartan cilexetil|mesh-list
65265311|NCT02707224|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65265312|NCT02707224|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65265313|NCT02707224|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65265314|NCT02707224|Antimetabolites|antimetabolites|mesh-ancestor
65265315|NCT02707224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265316|NCT02707224|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65265317|NCT02707224|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65265318|NCT02707224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65265319|NCT02707224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65265320|NCT02707224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65265321|NCT02707224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65265322|NCT04229264|Apixaban|apixaban|mesh-list
65265323|NCT04229264|Clopidogrel|clopidogrel|mesh-list
65265324|NCT04229264|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65265325|NCT04229264|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65265326|NCT04229264|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65265327|NCT04229264|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65265328|NCT04229264|Purinergic Agents|purinergic agents|mesh-ancestor
65265329|NCT04229264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65265330|NCT04229264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265331|NCT04229264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265332|NCT04229264|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65265333|NCT04229264|Antithrombins|antithrombins|mesh-ancestor
65265334|NCT04229264|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65265335|NCT04229264|Protease Inhibitors|protease inhibitors|mesh-ancestor
65265336|NCT04229264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65265337|NCT04229264|Anticoagulants|anticoagulants|mesh-ancestor
65265338|NCT02597829|Certolizumab Pegol|certolizumab pegol|mesh-list
65265339|NCT02597829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65265340|NCT02597829|Immunologic Factors|immunologic factors|mesh-ancestor
65265341|NCT02597829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265342|NCT02597829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65265343|NCT02711202|Sirolimus|sirolimus|mesh-list
65265344|NCT02711202|Alemtuzumab|alemtuzumab|mesh-list
65265345|NCT02711202|Infliximab|infliximab|mesh-list
65265346|NCT02711202|Tacrolimus|tacrolimus|mesh-list
65265347|NCT02711202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65265348|NCT02711202|Immunologic Factors|immunologic factors|mesh-ancestor
65265349|NCT02711202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265350|NCT02711202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65265351|NCT02711202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65265352|NCT02711202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265353|NCT02711202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65265354|NCT02711202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65265355|NCT02711202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65265356|NCT02711202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265357|NCT02711202|Antifungal Agents|antifungal agents|mesh-ancestor
65265358|NCT02711202|Dermatologic Agents|dermatologic agents|mesh-ancestor
65265359|NCT02711202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65265360|NCT02711202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65265361|NCT02711202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65265362|NCT02711358|Indomethacin|indomethacin|mesh-list
65265363|NCT02711358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65265364|NCT02711358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65265365|NCT02711358|Analgesics|analgesics|mesh-ancestor
65265366|NCT02711358|Sensory System Agents|sensory system agents|mesh-ancestor
65265367|NCT02711358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65265368|NCT02711358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265369|NCT02711358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65265370|NCT02711358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65265371|NCT02711358|Gout Suppressants|gout suppressants|mesh-ancestor
65265372|NCT02711358|Tocolytic Agents|tocolytic agents|mesh-ancestor
65265373|NCT02711358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65265374|NCT02711358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65265375|NCT02711358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65265376|NCT02711358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265377|NCT04962152|Nalbuphine|nalbuphine|mesh-list
65265378|NCT04962152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65265379|NCT04962152|Narcotics|narcotics|mesh-ancestor
65265380|NCT04962152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65265381|NCT04962152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265382|NCT04962152|Analgesics|analgesics|mesh-ancestor
65265383|NCT04962152|Sensory System Agents|sensory system agents|mesh-ancestor
65265384|NCT04962152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65265385|NCT00744627|Vortioxetine|vortioxetine|mesh-list
65265386|NCT00744627|Antidepressive Agents|antidepressive agents|mesh-ancestor
65265387|NCT00744627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65265388|NCT00744627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65265389|NCT00744627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65265390|NCT00744627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65265391|NCT00744627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265392|NCT00744627|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65265393|NCT00744627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65265394|NCT00744627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65265395|NCT00744627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265396|NCT00744627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65265397|NCT00744627|Serotonin Agents|serotonin agents|mesh-ancestor
65265398|NCT00744627|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65265399|NCT00744627|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65265400|NCT00744627|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65265401|NCT00744627|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65265402|NCT04942886|Entecavir|entecavir|mesh-list
65265403|NCT04942886|Antiviral Agents|antiviral agents|mesh-ancestor
65265404|NCT04942886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65265405|NCT00951847|Oxcarbazepine|oxcarbazepine|mesh-list
65265406|NCT00951847|Anticonvulsants|anticonvulsants|mesh-ancestor
65265407|NCT00951847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65265408|NCT00951847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65265409|NCT00951847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65265410|NCT00951847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265411|NCT00951847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65265412|NCT00951847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65265413|NCT02711280|Propofol|propofol|mesh-list
65265414|NCT02711280|Sevoflurane|sevoflurane|mesh-list
65265415|NCT02711280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65265416|NCT02711280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65265417|NCT02711280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265418|NCT02711280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65265419|NCT02711280|Anesthetics, General|anesthetics, general|mesh-ancestor
65265420|NCT02711280|Anesthetics|anesthetics|mesh-ancestor
65265421|NCT02711280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65265422|NCT02711280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65265423|NCT00948493|Insulin|insulin|mesh-list
65265424|NCT00948493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65265425|NCT00948493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65265427|NCT00952003|Bevacizumab|bevacizumab|mesh-list
65265428|NCT00952003|Docetaxel|docetaxel|mesh-list
65265429|NCT00952003|Oxaliplatin|oxaliplatin|mesh-list
65265430|NCT00952003|Irinotecan|irinotecan|mesh-list
65265431|NCT00952003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65265432|NCT00952003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265433|NCT00952003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65265434|NCT00952003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65265436|NCT00952003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265437|NCT00952003|Growth Inhibitors|growth inhibitors|mesh-ancestor
65265438|NCT00952003|Tubulin Modulators|tubulin modulators|mesh-ancestor
65265439|NCT00952003|Antimitotic Agents|antimitotic agents|mesh-ancestor
65265440|NCT00952003|Mitosis Modulators|mitosis modulators|mesh-ancestor
65265441|NCT00952003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265442|NCT00952003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65265443|NCT00952003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65265444|NCT00952003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65265445|NCT00612144|Metformin|metformin|mesh-list
65265446|NCT00612144|Glimepiride|glimepiride|mesh-list
65265447|NCT00612144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65265448|NCT00612144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265449|NCT00612144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65265450|NCT00612144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65265451|NCT00612144|Immunologic Factors|immunologic factors|mesh-ancestor
65265452|NCT02597361|Irbesartan|irbesartan|mesh-list
65265453|NCT02597361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65265454|NCT02597361|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65265455|NCT02597361|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65265456|NCT02597361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265457|NCT00562627|Ketorolac|ketorolac|mesh-list
65265458|NCT00562627|Epinephrine|epinephrine|mesh-list
65265459|NCT00562627|Racepinephrine|racepinephrine|mesh-list
65265460|NCT00562627|Fentanyl|fentanyl|mesh-list
65265461|NCT00562627|Morphine|morphine|mesh-list
65265462|NCT00562627|Bupivacaine|bupivacaine|mesh-list
65265463|NCT00562627|Ropivacaine|ropivacaine|mesh-list
65265464|NCT00562627|Epinephryl borate|epinephryl borate|mesh-list
65265465|NCT00562627|Anesthetics, Local|anesthetics, local|mesh-ancestor
65265466|NCT00562627|Anesthetics|anesthetics|mesh-ancestor
65265467|NCT00562627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65265468|NCT00562627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265469|NCT00562627|Sensory System Agents|sensory system agents|mesh-ancestor
65265470|NCT00562627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65265471|NCT00562627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65265472|NCT00562627|Narcotics|narcotics|mesh-ancestor
65265473|NCT00562627|Analgesics|analgesics|mesh-ancestor
65265474|NCT00562627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65265475|NCT00562627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65265476|NCT00562627|Anesthetics, General|anesthetics, general|mesh-ancestor
65265477|NCT00562627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65265478|NCT00562627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65265479|NCT00562627|Adrenergic Agents|adrenergic agents|mesh-ancestor
65265480|NCT00562627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65265481|NCT00562627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265482|NCT00562627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65265483|NCT00562627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65265484|NCT00562627|Autonomic Agents|autonomic agents|mesh-ancestor
65265485|NCT00562627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65265486|NCT00562627|Respiratory System Agents|respiratory system agents|mesh-ancestor
65265487|NCT00562627|Mydriatics|mydriatics|mesh-ancestor
65265488|NCT00562627|Sympathomimetics|sympathomimetics|mesh-ancestor
65265489|NCT00562627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65265490|NCT00562627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65265491|NCT00562627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65265492|NCT00562627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65265493|NCT00562627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65265494|NCT00562627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65265495|NCT00562627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65265496|NCT02597283|Sirolimus|sirolimus|mesh-list
65265497|NCT02597283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65265498|NCT02597283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65265499|NCT02597283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65265500|NCT02597283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265501|NCT02597283|Antifungal Agents|antifungal agents|mesh-ancestor
65265502|NCT02597283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65265503|NCT02597283|Immunologic Factors|immunologic factors|mesh-ancestor
65265504|NCT02597283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265505|NCT00948649|Varenicline|varenicline|mesh-list
65265506|NCT00948649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65265507|NCT00948649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65265508|NCT00948649|Cholinergic Agents|cholinergic agents|mesh-ancestor
65265509|NCT00948649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65265510|NCT00948649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015714|NCT00166413|Thalidomide|thalidomide|mesh-list
65265512|NCT00952159|Tramadol|tramadol|mesh-list
65265513|NCT00952159|O-demethyltramadol|o-demethyltramadol|mesh-list
65265514|NCT00952159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65265515|NCT00952159|Narcotics|narcotics|mesh-ancestor
65265516|NCT00952159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65265517|NCT00952159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265518|NCT00952159|Analgesics|analgesics|mesh-ancestor
65265519|NCT00952159|Sensory System Agents|sensory system agents|mesh-ancestor
65265520|NCT00952159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65265521|NCT00948727|Cyclosporine|cyclosporine|mesh-list
65265522|NCT00948727|Cyclosporins|cyclosporins|mesh-list
65265523|NCT00948727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65265524|NCT00948727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265525|NCT00948727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65265526|NCT00948727|Immunologic Factors|immunologic factors|mesh-ancestor
65265527|NCT00948727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265528|NCT00948727|Antifungal Agents|antifungal agents|mesh-ancestor
65265529|NCT00948727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65265530|NCT00948727|Dermatologic Agents|dermatologic agents|mesh-ancestor
65265531|NCT00948727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65265532|NCT00948727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65265533|NCT02778776|Metformin|metformin|mesh-list
65265534|NCT02778776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65265535|NCT02778776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265536|NCT00948805|Goserelin|goserelin|mesh-list
65265537|NCT00948805|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65265538|NCT00948805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65265539|NCT00948805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265540|NCT00948805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65265541|NCT00948805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265542|NCT02710656|Paclitaxel|paclitaxel|mesh-list
65265543|NCT02710656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65265544|NCT02710656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265545|NCT02710656|Tubulin Modulators|tubulin modulators|mesh-ancestor
65265546|NCT02710656|Antimitotic Agents|antimitotic agents|mesh-ancestor
65265547|NCT02710656|Mitosis Modulators|mitosis modulators|mesh-ancestor
65265548|NCT02710656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265549|NCT02780882|Pasireotide|pasireotide|mesh-list
65265550|NCT02780882|Hormones|hormones|mesh-ancestor
65265551|NCT02780882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65265552|NCT02780882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265553|NCT02710266|Gabexate|gabexate|mesh-list
65265554|NCT02710266|Anticoagulants|anticoagulants|mesh-ancestor
65265555|NCT02710266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65265556|NCT02710266|Protease Inhibitors|protease inhibitors|mesh-ancestor
65265557|NCT02710266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65265558|NCT02710266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265559|NCT00562159|Fluticasone|fluticasone|mesh-list
65265560|NCT00562159|Xhance|xhance|mesh-list
65265561|NCT00562159|Mometasone Furoate|mometasone furoate|mesh-list
65265562|NCT00562159|Loratadine|loratadine|mesh-list
65265563|NCT00562159|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
65265564|NCT00562159|Prednisone|prednisone|mesh-list
65265565|NCT00562159|Albuterol|albuterol|mesh-list
65265566|NCT00562159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65265567|NCT00562159|Glucocorticoids|glucocorticoids|mesh-ancestor
65265568|NCT00562159|Hormones|hormones|mesh-ancestor
65265569|NCT00562159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65265570|NCT00562159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265571|NCT00562159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65265572|NCT00562159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265573|NCT00562159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65265574|NCT00562159|Autonomic Agents|autonomic agents|mesh-ancestor
65265575|NCT00562159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65265576|NCT00562159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65265577|NCT00562159|Respiratory System Agents|respiratory system agents|mesh-ancestor
65265578|NCT00562159|Dermatologic Agents|dermatologic agents|mesh-ancestor
65265579|NCT00562159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65265580|NCT00562159|Tocolytic Agents|tocolytic agents|mesh-ancestor
65265581|NCT00562159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65265582|NCT00562159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65265583|NCT00562159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65265584|NCT00562159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65265585|NCT00562159|Adrenergic Agents|adrenergic agents|mesh-ancestor
65265586|NCT00562159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65265587|NCT00562159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265588|NCT00562159|Antipruritics|antipruritics|mesh-ancestor
65265589|NCT00562159|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65265590|NCT00562159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65265591|NCT00562159|Histamine Antagonists|histamine antagonists|mesh-ancestor
65265592|NCT00562159|Histamine Agents|histamine agents|mesh-ancestor
65265593|NCT00562159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65265594|NCT00562159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65265595|NCT00562159|Analgesics|analgesics|mesh-ancestor
65265596|NCT00562159|Sensory System Agents|sensory system agents|mesh-ancestor
65265597|NCT00562159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65265598|NCT02710110|Capsaicin|capsaicin|mesh-list
65265599|NCT02710110|Antipruritics|antipruritics|mesh-ancestor
65265600|NCT02710110|Dermatologic Agents|dermatologic agents|mesh-ancestor
65265601|NCT02710110|Sensory System Agents|sensory system agents|mesh-ancestor
65265602|NCT02710110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65265603|NCT02710110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265604|NCT00952627|Pycnogenols|pycnogenols|mesh-list
65265605|NCT00952627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65265606|NCT00952627|Immunologic Factors|immunologic factors|mesh-ancestor
65265607|NCT00952627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265608|NCT00952627|Antioxidants|antioxidants|mesh-ancestor
65265609|NCT00952627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265610|NCT00952627|Protective Agents|protective agents|mesh-ancestor
65265611|NCT00952627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65265612|NCT00611676|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65265613|NCT00611676|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65265614|NCT00611676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65265615|NCT00611676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65265616|NCT00611676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265617|NCT00611676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65265618|NCT00611676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265619|NCT00611676|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65265620|NCT00611676|Antidepressive Agents|antidepressive agents|mesh-ancestor
65265621|NCT00611676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65265622|NCT04848714|Antivenins|antivenins|mesh-list
65265623|NCT04848714|Immunologic Factors|immunologic factors|mesh-ancestor
65265624|NCT04848714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265625|NCT00952861|Doxycycline|doxycycline|mesh-list
65265626|NCT00952861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65265627|NCT00952861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65265628|NCT00952861|Antimalarials|antimalarials|mesh-ancestor
65265629|NCT00952861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65265630|NCT00952861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65265631|NCT05137730|Parathyroid Hormone|parathyroid hormone|mesh-list
65265632|NCT05137730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265633|NCT05137730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65265634|NCT04889066|Durvalumab|durvalumab|mesh-list
65265635|NCT04889066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65265636|NCT04889066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265637|NCT04223778|Islatravir|islatravir|mesh-list
65265638|NCT04223778|Antiviral Agents|antiviral agents|mesh-ancestor
65265639|NCT04223778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65265640|NCT04223778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65265641|NCT04223778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068449|NCT00282386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65265642|NCT04223778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65265643|NCT04223778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65265644|NCT04223778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65265645|NCT05109416|Bupivacaine|bupivacaine|mesh-list
65265646|NCT05109416|Anesthetics, Local|anesthetics, local|mesh-ancestor
65265647|NCT05109416|Anesthetics|anesthetics|mesh-ancestor
65265648|NCT05109416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65265649|NCT05109416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265650|NCT05109416|Sensory System Agents|sensory system agents|mesh-ancestor
65265651|NCT05109416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65265652|NCT04074564|Apatinib|apatinib|mesh-list
65265653|NCT04074564|Antibodies|antibodies|mesh-list
65265654|NCT04074564|Immunologic Factors|immunologic factors|mesh-ancestor
65265655|NCT04074564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265656|NCT04074564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265657|NCT04074564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65265658|NCT04074564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015878|NCT00517582|Icatibant|icatibant|mesh-list
65265659|NCT04074564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265660|NCT02778308|Gemcitabine|gemcitabine|mesh-list
65265661|NCT02778308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265662|NCT02778308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65265663|NCT02778308|Antimetabolites|antimetabolites|mesh-ancestor
65265664|NCT02778308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265665|NCT02778308|Antiviral Agents|antiviral agents|mesh-ancestor
65265666|NCT02778308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65265667|NCT02778308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65265668|NCT02778308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65265669|NCT02778308|Immunologic Factors|immunologic factors|mesh-ancestor
65265670|NCT02778308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265671|NCT02776202|Mycophenolic Acid|mycophenolic acid|mesh-list
65265672|NCT02776202|Sirolimus|sirolimus|mesh-list
65265673|NCT02776202|Fludarabine|fludarabine|mesh-list
65265674|NCT02776202|Fludarabine phosphate|fludarabine phosphate|mesh-list
65265675|NCT02776202|Melphalan|melphalan|mesh-list
65265676|NCT02776202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265677|NCT02776202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65265678|NCT02776202|Antimetabolites|antimetabolites|mesh-ancestor
65265679|NCT02776202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265680|NCT02776202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65265681|NCT02776202|Immunologic Factors|immunologic factors|mesh-ancestor
65265682|NCT02776202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265683|NCT02776202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65265684|NCT02776202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65265685|NCT02776202|Antitubercular Agents|antitubercular agents|mesh-ancestor
65265686|NCT02776202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65265687|NCT02776202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65265688|NCT02776202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65265689|NCT02776202|Antifungal Agents|antifungal agents|mesh-ancestor
65265690|NCT02776202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65265691|NCT02776202|Alkylating Agents|alkylating agents|mesh-ancestor
65265692|NCT02776202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65265693|NCT00921557|Vitamin D|vitamin d|mesh-list
65265694|NCT00921557|Alendronate|alendronate|mesh-list
65265695|NCT00921557|Calcium Carbonate|calcium carbonate|mesh-list
65265696|NCT00921557|Calcium|calcium|mesh-list
65265697|NCT00921557|Vitamins|vitamins|mesh-ancestor
65265698|NCT00921557|Micronutrients|micronutrients|mesh-ancestor
65265699|NCT00921557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265700|NCT00921557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65265701|NCT00921557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65265702|NCT00921557|Antacids|antacids|mesh-ancestor
65265703|NCT00921557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265704|NCT00921557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65265705|NCT00611754|Fluorouracil|fluorouracil|mesh-list
65265706|NCT00611754|Oxaliplatin|oxaliplatin|mesh-list
65265707|NCT00611754|Antimetabolites|antimetabolites|mesh-ancestor
65265708|NCT00611754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265709|NCT00611754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65265710|NCT00611754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265711|NCT00611754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65265712|NCT00611754|Immunologic Factors|immunologic factors|mesh-ancestor
65265713|NCT00611754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265714|NCT00550615|Dasatinib|dasatinib|mesh-list
65265715|NCT00550615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265716|NCT00550615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65265717|NCT00550615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65265718|NCT00550615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265719|NCT02709720|Cisplatin|cisplatin|mesh-list
65265720|NCT02709720|Vinorelbine|vinorelbine|mesh-list
65265721|NCT02709720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265722|NCT02709720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65265723|NCT02709720|Tubulin Modulators|tubulin modulators|mesh-ancestor
65265724|NCT02709720|Antimitotic Agents|antimitotic agents|mesh-ancestor
65265725|NCT02709720|Mitosis Modulators|mitosis modulators|mesh-ancestor
65265726|NCT02709720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265727|NCT02779634|Coenzyme Q10|coenzyme q10|mesh-list
65265728|NCT02779634|Micronutrients|micronutrients|mesh-ancestor
65265729|NCT02779634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265730|NCT02779634|Vitamins|vitamins|mesh-ancestor
65265731|NCT04255589|Ethanol|ethanol|mesh-list
65265732|NCT04255589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65015935|NCT02957903|Ropivacaine|ropivacaine|mesh-list
65265733|NCT04255589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65265734|NCT04255589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65265735|NCT04255589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265736|NCT00744471|Tanezumab|tanezumab|mesh-list
65265737|NCT00744471|Analgesics|analgesics|mesh-ancestor
65265738|NCT00744471|Sensory System Agents|sensory system agents|mesh-ancestor
65265739|NCT00744471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65265740|NCT00744471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265741|NCT02776436|Dexamethasone|dexamethasone|mesh-list
65265742|NCT02776436|Prednisone|prednisone|mesh-list
65265743|NCT02776436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65265744|NCT02776436|Antiemetics|antiemetics|mesh-ancestor
65265745|NCT02776436|Autonomic Agents|autonomic agents|mesh-ancestor
65265746|NCT02776436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65265747|NCT02776436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265748|NCT02776436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65265749|NCT02776436|Glucocorticoids|glucocorticoids|mesh-ancestor
65265750|NCT02776436|Hormones|hormones|mesh-ancestor
65265751|NCT02776436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65265752|NCT02776436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65265753|NCT02776436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265754|NCT02775968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65265755|NCT02775968|Azithromycin|azithromycin|mesh-list
65265756|NCT02775968|Ceftriaxone|ceftriaxone|mesh-list
65265757|NCT02775968|Erythromycin|erythromycin|mesh-list
65265758|NCT02775968|Cephalosporins|cephalosporins|mesh-list
65265759|NCT02775968|Cefamandole|cefamandole|mesh-list
65265760|NCT02775968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65265761|NCT02775968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65265762|NCT02775968|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65265763|NCT02775968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65265764|NCT02775968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265765|NCT02775734|Acetylcysteine|acetylcysteine|mesh-list
65265766|NCT02775734|Clomiphene|clomiphene|mesh-list
65265767|NCT02775734|Enclomiphene|enclomiphene|mesh-list
65265768|NCT02775734|Zuclomiphene|zuclomiphene|mesh-list
65265769|NCT02775734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65265770|NCT02775734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265771|NCT02775734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65265772|NCT02775734|Hormone Antagonists|hormone antagonists|mesh-ancestor
65265773|NCT02775734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65265774|NCT02775734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265775|NCT02775734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65265776|NCT02775734|Fertility Agents|fertility agents|mesh-ancestor
65265777|NCT02775734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65265778|NCT02775734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65265779|NCT02775734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65265780|NCT02775734|Antiviral Agents|antiviral agents|mesh-ancestor
65265781|NCT02775734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65265782|NCT02775734|Expectorants|expectorants|mesh-ancestor
65265783|NCT02775734|Respiratory System Agents|respiratory system agents|mesh-ancestor
65265784|NCT02775734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65265785|NCT02775734|Antioxidants|antioxidants|mesh-ancestor
65265786|NCT02775734|Protective Agents|protective agents|mesh-ancestor
65265787|NCT02775734|Antidotes|antidotes|mesh-ancestor
65265788|NCT02772926|Benphothiamine|benphothiamine|mesh-list
65265789|NCT02772926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65265790|NCT02772926|Immunologic Factors|immunologic factors|mesh-ancestor
65265791|NCT02772926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265792|NCT02772926|Chelating Agents|chelating agents|mesh-ancestor
65265793|NCT02772926|Sequestering Agents|sequestering agents|mesh-ancestor
65265794|NCT02772926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265795|NCT02709564|Misoprostol|misoprostol|mesh-list
65265796|NCT02709564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65265797|NCT02709564|Abortifacient Agents|abortifacient agents|mesh-ancestor
65265798|NCT02709564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65265799|NCT02709564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265800|NCT02709564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65265801|NCT02709564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65265802|NCT02709564|Oxytocics|oxytocics|mesh-ancestor
65265804|NCT04688814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65265805|NCT04688814|Narcotics|narcotics|mesh-ancestor
65265806|NCT04688814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65265807|NCT04688814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265808|NCT04688814|Analgesics|analgesics|mesh-ancestor
65265809|NCT04688814|Sensory System Agents|sensory system agents|mesh-ancestor
65265810|NCT04688814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65265811|NCT00744237|Metoprolol|metoprolol|mesh-list
65265812|NCT00744237|Nebivolol|nebivolol|mesh-list
65265813|NCT00744237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65265814|NCT00744237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65265816|NCT00744237|Autonomic Agents|autonomic agents|mesh-ancestor
65265817|NCT00744237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65265818|NCT00744237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265819|NCT00744237|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65265820|NCT00744237|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65265821|NCT00744237|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65265822|NCT00744237|Adrenergic Agents|adrenergic agents|mesh-ancestor
65265823|NCT00744237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65265824|NCT00744237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265825|NCT00744237|Vasodilator Agents|vasodilator agents|mesh-ancestor
65265826|NCT00744237|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65265827|NCT00744237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65265828|NCT00744237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65265829|NCT04821284|Leucovorin|leucovorin|mesh-list
65265830|NCT04821284|Gemcitabine|gemcitabine|mesh-list
65265831|NCT04821284|Paclitaxel|paclitaxel|mesh-list
65265832|NCT04821284|Fluorouracil|fluorouracil|mesh-list
65265833|NCT04821284|Oxaliplatin|oxaliplatin|mesh-list
65265834|NCT04821284|Irinotecan|irinotecan|mesh-list
65265835|NCT04821284|Calcium|calcium|mesh-list
65265836|NCT04821284|Levoleucovorin|levoleucovorin|mesh-list
65265837|NCT04821284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65265838|NCT04821284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265839|NCT04821284|Tubulin Modulators|tubulin modulators|mesh-ancestor
65265840|NCT04821284|Antimitotic Agents|antimitotic agents|mesh-ancestor
65265841|NCT04821284|Mitosis Modulators|mitosis modulators|mesh-ancestor
65265842|NCT04821284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265843|NCT04821284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65265844|NCT04821284|Antimetabolites|antimetabolites|mesh-ancestor
65265845|NCT04821284|Antiviral Agents|antiviral agents|mesh-ancestor
65265846|NCT04821284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65265847|NCT04821284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65265848|NCT04821284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65265849|NCT04821284|Immunologic Factors|immunologic factors|mesh-ancestor
65265850|NCT04821284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265851|NCT04821284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65265852|NCT04821284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65265853|NCT04821284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65265854|NCT04821284|Antidotes|antidotes|mesh-ancestor
65265855|NCT04821284|Protective Agents|protective agents|mesh-ancestor
65265856|NCT04821284|Vitamin B Complex|vitamin b complex|mesh-ancestor
65265857|NCT04821284|Vitamins|vitamins|mesh-ancestor
65265858|NCT04821284|Micronutrients|micronutrients|mesh-ancestor
65265859|NCT05260554|Fosfomycin|fosfomycin|mesh-list
65265860|NCT05260554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65265861|NCT05260554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65265862|NCT04089345|Ustekinumab|ustekinumab|mesh-list
65265863|NCT04089345|Dermatologic Agents|dermatologic agents|mesh-ancestor
65265864|NCT02693574|Amoxicillin|amoxicillin|mesh-list
65265865|NCT02693574|Clarithromycin|clarithromycin|mesh-list
65265867|NCT02693574|Ofloxacin|ofloxacin|mesh-list
65265868|NCT02693574|Esomeprazole|esomeprazole|mesh-list
65265869|NCT02693574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65265870|NCT02693574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65265871|NCT02693574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65265872|NCT02693574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65265873|NCT02693574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65265874|NCT02693574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65265875|NCT02693574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265876|NCT02693574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65265877|NCT02693574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65265878|NCT02693574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65265879|NCT02693574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65265880|NCT02693574|Renal Agents|renal agents|mesh-ancestor
65265881|NCT02693574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65265882|NCT02693574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65265883|NCT02693574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265884|NCT02693574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65265885|NCT04179266|Ketamine|ketamine|mesh-list
65265886|NCT04179266|Analgesics|analgesics|mesh-ancestor
65265887|NCT04179266|Sensory System Agents|sensory system agents|mesh-ancestor
65265888|NCT04179266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65265889|NCT04179266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265890|NCT04179266|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65265891|NCT04179266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65265892|NCT04179266|Anesthetics, General|anesthetics, general|mesh-ancestor
65265893|NCT04179266|Anesthetics|anesthetics|mesh-ancestor
65265894|NCT04179266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65265895|NCT04179266|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65265896|NCT04179266|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65265897|NCT04179266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65265898|NCT04179266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265899|NCT00743145|Naltrexone|naltrexone|mesh-list
65265900|NCT00743145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65265901|NCT00743145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65265902|NCT00743145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265903|NCT00743145|Sensory System Agents|sensory system agents|mesh-ancestor
65265904|NCT00743145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65265905|NCT04875728|Cefazolin|cefazolin|mesh-list
65265906|NCT04875728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65265907|NCT04875728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65265908|NCT00611910|Sirolimus|sirolimus|mesh-list
65265909|NCT00611910|Paclitaxel|paclitaxel|mesh-list
65265910|NCT00611910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65265911|NCT00611910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265912|NCT00611910|Tubulin Modulators|tubulin modulators|mesh-ancestor
65265913|NCT00611910|Antimitotic Agents|antimitotic agents|mesh-ancestor
65265914|NCT00611910|Mitosis Modulators|mitosis modulators|mesh-ancestor
65265915|NCT00611910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265916|NCT00611910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65265917|NCT00611910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65265918|NCT00611910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65265919|NCT00611910|Antifungal Agents|antifungal agents|mesh-ancestor
65265920|NCT00611910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65265921|NCT00611910|Immunologic Factors|immunologic factors|mesh-ancestor
65265922|NCT00611910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265923|NCT00920855|Bortezomib|bortezomib|mesh-list
65265924|NCT00920855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65265925|NCT00920855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265926|NCT00920855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65265927|NCT00920855|Alkylating Agents|alkylating agents|mesh-ancestor
65265928|NCT00920855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265929|NCT02775500|Apremilast|apremilast|mesh-list
65265930|NCT02775500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65265931|NCT02775500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65265932|NCT02775500|Analgesics|analgesics|mesh-ancestor
65265933|NCT02775500|Sensory System Agents|sensory system agents|mesh-ancestor
65265934|NCT02775500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65265935|NCT02775500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265936|NCT02775500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65265937|NCT02775500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65265938|NCT02775500|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65265939|NCT02775500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65265940|NCT02775500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65269749|NCT02728622|Mitosis Modulators|mitosis modulators|mesh-ancestor
65265941|NCT02775500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265942|NCT04251845|Melatonin|melatonin|mesh-list
65265943|NCT04251845|Antioxidants|antioxidants|mesh-ancestor
65265944|NCT04251845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265945|NCT04251845|Protective Agents|protective agents|mesh-ancestor
65265946|NCT04251845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265947|NCT04251845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65265948|NCT05207358|Mycophenolic Acid|mycophenolic acid|mesh-list
65265949|NCT05207358|Cyclophosphamide|cyclophosphamide|mesh-list
65265950|NCT05207358|Rituximab|rituximab|mesh-list
65265951|NCT05207358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65265952|NCT05207358|Immunologic Factors|immunologic factors|mesh-ancestor
65265953|NCT05207358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265954|NCT05207358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65265955|NCT05207358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65265956|NCT05207358|Alkylating Agents|alkylating agents|mesh-ancestor
65265957|NCT05207358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265958|NCT05207358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265959|NCT05207358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65265960|NCT05207358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65265961|NCT05207358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65265962|NCT05207358|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65265963|NCT05207358|Antitubercular Agents|antitubercular agents|mesh-ancestor
65265964|NCT05207358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65265965|NCT05207358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65265967|NCT04256993|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65265968|NCT04256993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65265969|NCT05387031|Ustekinumab|ustekinumab|mesh-list
65265970|NCT05387031|Dermatologic Agents|dermatologic agents|mesh-ancestor
65265971|NCT04570644|Ibuprofen|ibuprofen|mesh-list
65265972|NCT04570644|Cromolyn Sodium|cromolyn sodium|mesh-list
65265973|NCT04570644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65265974|NCT04570644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65265975|NCT04570644|Analgesics|analgesics|mesh-ancestor
65265976|NCT04570644|Sensory System Agents|sensory system agents|mesh-ancestor
65265977|NCT04570644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65265978|NCT04570644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265979|NCT04570644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65265980|NCT04570644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65265981|NCT04570644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65265982|NCT04570644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65265983|NCT04570644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265984|NCT04570644|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
65265985|NCT04570644|Immunologic Factors|immunologic factors|mesh-ancestor
65265986|NCT04570644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65265987|NCT04570644|Respiratory System Agents|respiratory system agents|mesh-ancestor
65265988|NCT02775110|Natalizumab|natalizumab|mesh-list
65265989|NCT02775110|Immunologic Factors|immunologic factors|mesh-ancestor
65265990|NCT02775110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265991|NCT02775266|Thioctic Acid|thioctic acid|mesh-list
65265992|NCT02775266|Antioxidants|antioxidants|mesh-ancestor
65265993|NCT02775266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65265994|NCT02775266|Protective Agents|protective agents|mesh-ancestor
65265995|NCT02775266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65265996|NCT02775266|Vitamin B Complex|vitamin b complex|mesh-ancestor
65265997|NCT02775266|Vitamins|vitamins|mesh-ancestor
65265998|NCT02775266|Micronutrients|micronutrients|mesh-ancestor
65265999|NCT01524926|Crizotinib|crizotinib|mesh-list
65266000|NCT01524926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65266001|NCT01524926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65266002|NCT01524926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65269761|NCT02728622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65266003|NCT01524926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266004|NCT03738228|Cisplatin|cisplatin|mesh-list
65266005|NCT03738228|Atezolizumab|atezolizumab|mesh-list
65266006|NCT03738228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65266007|NCT03738228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65266008|NCT03738228|Immunologic Factors|immunologic factors|mesh-ancestor
65266009|NCT03738228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266010|NCT04756232|Mecamylamine|mecamylamine|mesh-list
65266011|NCT04756232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65266012|NCT04756232|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
65266013|NCT04756232|Autonomic Agents|autonomic agents|mesh-ancestor
65266014|NCT04756232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65266015|NCT04756232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266016|NCT04756232|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65266017|NCT04756232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65266018|NCT04756232|Cholinergic Agents|cholinergic agents|mesh-ancestor
65266019|NCT04756232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65266020|NCT04756232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266022|NCT02774876|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65266023|NCT02774876|Hormones|hormones|mesh-list
65266024|NCT02774876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65266025|NCT02774876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266026|NCT02774876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65266027|NCT04225364|Paclitaxel|paclitaxel|mesh-list
65266028|NCT04225364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65266029|NCT04225364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65266030|NCT04225364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65266031|NCT04225364|Tubulin Modulators|tubulin modulators|mesh-ancestor
65266032|NCT04225364|Antimitotic Agents|antimitotic agents|mesh-ancestor
65266033|NCT04225364|Mitosis Modulators|mitosis modulators|mesh-ancestor
65266034|NCT04225364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266035|NCT02771834|Vitamin D|vitamin d|mesh-list
65266036|NCT02771834|Vitamins|vitamins|mesh-ancestor
65266037|NCT02771834|Micronutrients|micronutrients|mesh-ancestor
65266038|NCT02771834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016194|NCT04457180|Repaglinide|repaglinide|mesh-list
65266039|NCT02771834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65266040|NCT02774564|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65266041|NCT02774564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65266042|NCT02774564|Immunologic Factors|immunologic factors|mesh-ancestor
65266043|NCT02774564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266044|NCT02774564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65266045|NCT02774564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65266046|NCT02774564|Dopamine Agonists|dopamine agonists|mesh-ancestor
65266047|NCT02774564|Dopamine Agents|dopamine agents|mesh-ancestor
65266048|NCT02774564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65266049|NCT02774564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266051|NCT00613470|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65266052|NCT00613470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65266053|NCT00613470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65069550|NCT00288002|Tubulin Modulators|tubulin modulators|mesh-ancestor
65266054|NCT00613470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069625|NCT00288236|Rimonabant|rimonabant|mesh-list
65266055|NCT00613470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65266056|NCT00613470|Serotonin Agents|serotonin agents|mesh-ancestor
65266057|NCT00613470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266058|NCT00613470|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65266059|NCT00613470|Antidepressive Agents|antidepressive agents|mesh-ancestor
65266060|NCT00613470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65266061|NCT02771912|Propofol|propofol|mesh-list
65266062|NCT02771912|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65266063|NCT02771912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65266064|NCT02771912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65266065|NCT02771912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266066|NCT02771912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65266067|NCT02771912|Anesthetics, General|anesthetics, general|mesh-ancestor
65266068|NCT02771912|Anesthetics|anesthetics|mesh-ancestor
65266069|NCT02771912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65266070|NCT02771912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65266071|NCT02771912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65266072|NCT00741819|Treprostinil|treprostinil|mesh-list
65266073|NCT00741819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65266074|NCT04457466|Mitogens|mitogens|mesh-list
65266075|NCT04457466|Mitosis Modulators|mitosis modulators|mesh-ancestor
65266076|NCT04457466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266077|NCT04954742|Riociguat|riociguat|mesh-list
65266078|NCT04954742|Enzyme Activators|enzyme activators|mesh-ancestor
65266079|NCT04954742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266080|NCT02774096|Xenon|xenon|mesh-list
65266081|NCT02774096|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65266082|NCT02774096|Anesthetics, General|anesthetics, general|mesh-ancestor
65266083|NCT02774096|Anesthetics|anesthetics|mesh-ancestor
65266084|NCT02774096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65266085|NCT02774096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266086|NCT04181385|Bromocriptine|bromocriptine|mesh-list
65266087|NCT04181385|Olanzapine|olanzapine|mesh-list
65266088|NCT04181385|Antiemetics|antiemetics|mesh-ancestor
65266089|NCT04181385|Autonomic Agents|autonomic agents|mesh-ancestor
65266090|NCT04181385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65266091|NCT04181385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266092|NCT04181385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65266093|NCT04181385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65266094|NCT04181385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65266095|NCT04181385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65266096|NCT04181385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65266097|NCT04181385|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65266098|NCT04181385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65266099|NCT04181385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65266100|NCT04181385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266101|NCT04181385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65266102|NCT04181385|Serotonin Agents|serotonin agents|mesh-ancestor
65266103|NCT04181385|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65266104|NCT04181385|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65266105|NCT04181385|Hormone Antagonists|hormone antagonists|mesh-ancestor
65070107|NCT00303576|Dapivirine|dapivirine|mesh-list
65266106|NCT04181385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65266107|NCT04181385|Dopamine Agonists|dopamine agonists|mesh-ancestor
65266108|NCT04181385|Dopamine Agents|dopamine agents|mesh-ancestor
65266109|NCT00924443|Clofarabine|clofarabine|mesh-list
65266110|NCT00924443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65266111|NCT00924443|Antimetabolites|antimetabolites|mesh-ancestor
65266112|NCT00924443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266113|NCT00924443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65266114|NCT02677155|Rituximab|rituximab|mesh-list
65266116|NCT02677155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65266117|NCT02677155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65266118|NCT02677155|Immunologic Factors|immunologic factors|mesh-ancestor
65266119|NCT02677155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266120|NCT02677155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65266121|NCT02537691|Theophylline|theophylline|mesh-list
65266122|NCT02537691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65266123|NCT02537691|Autonomic Agents|autonomic agents|mesh-ancestor
65070541|NCT00304629|Autonomic Agents|autonomic agents|mesh-ancestor
65266125|NCT02537691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266126|NCT02537691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65266127|NCT02537691|Respiratory System Agents|respiratory system agents|mesh-ancestor
65266128|NCT02537691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65266129|NCT02537691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266130|NCT02537691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266131|NCT02537691|Vasodilator Agents|vasodilator agents|mesh-ancestor
65266132|NCT02537691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65266133|NCT02537691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65266134|NCT02537691|Purinergic Agents|purinergic agents|mesh-ancestor
65266135|NCT02537691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65266136|NCT04225052|Varenicline|varenicline|mesh-list
65266137|NCT04225052|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65266138|NCT04225052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65266139|NCT04225052|Cholinergic Agents|cholinergic agents|mesh-ancestor
65266140|NCT04225052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65266141|NCT04225052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266142|NCT04225052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266143|NCT04255121|Lidocaine|lidocaine|mesh-list
65266144|NCT04255121|Epinephrine|epinephrine|mesh-list
65266145|NCT04255121|Racepinephrine|racepinephrine|mesh-list
65266146|NCT04255121|Epinephryl borate|epinephryl borate|mesh-list
65266147|NCT04255121|Anesthetics, Local|anesthetics, local|mesh-ancestor
65266148|NCT04255121|Anesthetics|anesthetics|mesh-ancestor
65266149|NCT04255121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65266150|NCT04255121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266151|NCT04255121|Sensory System Agents|sensory system agents|mesh-ancestor
65070660|NCT00304980|Lumefantrine|lumefantrine|mesh-list
65266152|NCT04255121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65266153|NCT04255121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65266154|NCT04255121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65266155|NCT04255121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65266156|NCT04255121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65266157|NCT04255121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266158|NCT04255121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65266159|NCT04255121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65266160|NCT04255121|Adrenergic Agents|adrenergic agents|mesh-ancestor
65266161|NCT04255121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65266162|NCT04255121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65266163|NCT04255121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65266164|NCT04255121|Autonomic Agents|autonomic agents|mesh-ancestor
65266165|NCT04255121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65266166|NCT04255121|Respiratory System Agents|respiratory system agents|mesh-ancestor
65266167|NCT04255121|Mydriatics|mydriatics|mesh-ancestor
65266168|NCT04255121|Sympathomimetics|sympathomimetics|mesh-ancestor
65266169|NCT04255121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65266170|NCT03521232|Niclosamide|niclosamide|mesh-list
65266171|NCT03521232|Anticestodal Agents|anticestodal agents|mesh-ancestor
65266172|NCT03521232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65266173|NCT03521232|Anthelmintics|anthelmintics|mesh-ancestor
65266174|NCT03521232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65266175|NCT03521232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65266176|NCT03521232|Antinematodal Agents|antinematodal agents|mesh-ancestor
65266177|NCT00924287|Aldesleukin|aldesleukin|mesh-list
65266178|NCT00924287|Cyclophosphamide|cyclophosphamide|mesh-list
65266179|NCT00924287|Fludarabine|fludarabine|mesh-list
65070737|NCT00294164|Hormones|hormones|mesh-list
65266180|NCT00924287|Interleukin-2|interleukin-2|mesh-list
65266182|NCT00924287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65266183|NCT00924287|Immunologic Factors|immunologic factors|mesh-ancestor
65266184|NCT00924287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266185|NCT00924287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65266186|NCT00924287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65266187|NCT00924287|Alkylating Agents|alkylating agents|mesh-ancestor
65266188|NCT00924287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266189|NCT00924287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65266190|NCT00924287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65266191|NCT00924287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65266192|NCT00924287|Analgesics|analgesics|mesh-ancestor
65266193|NCT00924287|Sensory System Agents|sensory system agents|mesh-ancestor
65266194|NCT00924287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65266195|NCT00924287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65266196|NCT00924287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65266197|NCT00924287|Antiviral Agents|antiviral agents|mesh-ancestor
65266198|NCT00924287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65266199|NCT00924287|Protective Agents|protective agents|mesh-ancestor
65266200|NCT02696954|Lumefantrine|lumefantrine|mesh-list
65266201|NCT02696954|Artemether|artemether|mesh-list
65266202|NCT02696954|Primaquine|primaquine|mesh-list
65266203|NCT02696954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65266204|NCT02696954|Amodiaquine|amodiaquine|mesh-list
65266205|NCT02696954|Antimalarials|antimalarials|mesh-ancestor
65266206|NCT02696954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65266207|NCT02696954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65266208|NCT02696954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65266209|NCT02677077|Natalizumab|natalizumab|mesh-list
65266210|NCT02677077|Immunologic Factors|immunologic factors|mesh-ancestor
65266211|NCT02677077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266212|NCT02771600|Anesthetics|anesthetics|mesh-list
65266213|NCT02771600|Anesthetics, Local|anesthetics, local|mesh-list
65266214|NCT02771600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65266215|NCT02771600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266216|NCT02771600|Sensory System Agents|sensory system agents|mesh-ancestor
65266217|NCT02771600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65266218|NCT02773316|Morphine|morphine|mesh-list
65266219|NCT02773316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65266220|NCT02773316|Narcotics|narcotics|mesh-ancestor
65266221|NCT02773316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65266222|NCT02773316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266223|NCT02773316|Analgesics|analgesics|mesh-ancestor
65266224|NCT02773316|Sensory System Agents|sensory system agents|mesh-ancestor
65266225|NCT02773316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65266226|NCT00642681|Insulin|insulin|mesh-list
65266227|NCT00642681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65266228|NCT00642681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266229|NCT02773550|Prednisone|prednisone|mesh-list
65266230|NCT02773550|Bortezomib|bortezomib|mesh-list
65266231|NCT02773550|Melphalan|melphalan|mesh-list
65266232|NCT02773550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65266233|NCT02773550|Glucocorticoids|glucocorticoids|mesh-ancestor
65274168|NCT02687100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266235|NCT02773550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65266236|NCT02773550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266237|NCT02773550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65266238|NCT02773550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65266239|NCT02773550|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65266240|NCT02773550|Alkylating Agents|alkylating agents|mesh-ancestor
65266241|NCT02773550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266242|NCT02773550|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65266243|NCT02773550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65266244|NCT02773550|Immunologic Factors|immunologic factors|mesh-ancestor
65266245|NCT02773472|Morphine|morphine|mesh-list
65266246|NCT02773472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65266247|NCT02773472|Narcotics|narcotics|mesh-ancestor
65266248|NCT02773472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65266249|NCT02773472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266250|NCT02773472|Analgesics|analgesics|mesh-ancestor
65266251|NCT02773472|Sensory System Agents|sensory system agents|mesh-ancestor
65266252|NCT02773472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65266253|NCT04891770|Tenofovir|tenofovir|mesh-list
65266254|NCT04891770|Nivolumab|nivolumab|mesh-list
65266255|NCT04891770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65266256|NCT04891770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65266257|NCT04891770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65266258|NCT04891770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266259|NCT04891770|Antiviral Agents|antiviral agents|mesh-ancestor
65266260|NCT04891770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65266261|NCT04891770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65266262|NCT04891770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65266263|NCT04891770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016351|NCT00521482|Thalidomide|thalidomide|mesh-list
65266264|NCT04891770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65266265|NCT04891770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65266266|NCT00637871|Tamoxifen|tamoxifen|mesh-list
65266268|NCT00637871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65266269|NCT00637871|Hormone Antagonists|hormone antagonists|mesh-ancestor
65266270|NCT00637871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65266271|NCT00637871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266272|NCT00637871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65266273|NCT00637871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65266274|NCT00637871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65266275|NCT00637871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65266276|NCT00637871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65266277|NCT00637871|Androgen Antagonists|androgen antagonists|mesh-ancestor
65266278|NCT00635258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65266279|NCT00635258|Ganirelix|ganirelix|mesh-list
65266280|NCT00635258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65266281|NCT00635258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266282|NCT00635258|Luteolytic Agents|luteolytic agents|mesh-ancestor
65266283|NCT00635258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65266284|NCT00635258|Contraceptive Agents|contraceptive agents|mesh-ancestor
65266285|NCT00635258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65266286|NCT00635258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65266287|NCT00635258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65266288|NCT00635258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65266289|NCT00635258|Hormone Antagonists|hormone antagonists|mesh-ancestor
65266290|NCT00642837|Acetaminophen|acetaminophen|mesh-list
65266291|NCT00642837|Tramadol|tramadol|mesh-list
65266292|NCT00642837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65266293|NCT00642837|Analgesics|analgesics|mesh-ancestor
65266294|NCT00642837|Sensory System Agents|sensory system agents|mesh-ancestor
65266295|NCT00642837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65072684|NCT00333021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65266296|NCT00642837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266297|NCT00642837|Antipyretics|antipyretics|mesh-ancestor
65266298|NCT00642837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65266299|NCT00642837|Narcotics|narcotics|mesh-ancestor
65266300|NCT00642837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65266301|NCT02776748|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65266302|NCT02776748|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65266303|NCT02776748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65266305|NCT02776748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266306|NCT02776748|Antiviral Agents|antiviral agents|mesh-ancestor
65266307|NCT02776748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65266308|NCT02776748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65266309|NCT02776748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65266310|NCT02676609|Insulin|insulin|mesh-list
65266311|NCT02676609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65266312|NCT02676609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266313|NCT00642915|Insulin Glargine|insulin glargine|mesh-list
65266314|NCT00642915|Glimepiride|glimepiride|mesh-list
65266315|NCT00642915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65266316|NCT00642915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266317|NCT00642915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65266318|NCT00642915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65073217|NCT00334464|Warfarin|warfarin|mesh-list
65266319|NCT00642915|Immunologic Factors|immunologic factors|mesh-ancestor
65266320|NCT02676297|Tiotropium Bromide|tiotropium bromide|mesh-list
65266321|NCT02676297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65266324|NCT02676297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266325|NCT02676297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65266326|NCT02676297|Respiratory System Agents|respiratory system agents|mesh-ancestor
65266327|NCT02676297|Parasympatholytics|parasympatholytics|mesh-ancestor
65266328|NCT02676297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65266329|NCT02676297|Cholinergic Agents|cholinergic agents|mesh-ancestor
65266330|NCT02676297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65266331|NCT02676297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266333|NCT02696720|Anesthetics, Local|anesthetics, local|mesh-ancestor
65266334|NCT02696720|Anesthetics|anesthetics|mesh-ancestor
65266335|NCT02696720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65266336|NCT02696720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266337|NCT02696720|Sensory System Agents|sensory system agents|mesh-ancestor
65266338|NCT02696720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65266339|NCT02696720|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65266340|NCT02696720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65266341|NCT02696720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65266342|NCT02696720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65266343|NCT02696720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073697|NCT00418535|Cisplatin|cisplatin|mesh-list
65266345|NCT00643071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65266346|NCT00643071|Immunologic Factors|immunologic factors|mesh-ancestor
65266347|NCT00643071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266348|NCT00643071|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65266349|NCT00643071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274169|NCT02687100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65074057|NCT00309374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65266350|NCT00643071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266351|NCT03728634|Vitamin A|vitamin a|mesh-list
65266352|NCT03728634|Vitamins|vitamins|mesh-ancestor
65266353|NCT03728634|Micronutrients|micronutrients|mesh-ancestor
65074278|NCT00310232|Epoetin Alfa|epoetin alfa|mesh-list
65266354|NCT03728634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266356|NCT02767310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65266357|NCT02767310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65266358|NCT02767310|Antimetabolites|antimetabolites|mesh-ancestor
65074499|NCT00311636|Antimetabolites|antimetabolites|mesh-ancestor
65266359|NCT02767310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266360|NCT02767310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65274170|NCT02687100|Respiratory System Agents|respiratory system agents|mesh-ancestor
65266361|NCT02767310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65074794|NCT00343668|Irinotecan|irinotecan|mesh-list
65266362|NCT02767310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266363|NCT04353414|Bupivacaine|bupivacaine|mesh-list
65266364|NCT04353414|Anesthetics, Local|anesthetics, local|mesh-ancestor
65266365|NCT04353414|Anesthetics|anesthetics|mesh-ancestor
65266366|NCT04353414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65266367|NCT04353414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266368|NCT04353414|Sensory System Agents|sensory system agents|mesh-ancestor
65266369|NCT04353414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65266371|NCT00643149|Azithromycin|azithromycin|mesh-list
65266372|NCT00643149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65075173|NCT00348894|Reboxetine|reboxetine|mesh-list
65266373|NCT00643149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65266374|NCT05141682|Azacitidine|azacitidine|mesh-list
65266375|NCT05141682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65274171|NCT05662098|Hydroxyurea|hydroxyurea|mesh-list
65075468|NCT00344955|Atorvastatin|atorvastatin|mesh-list
65266377|NCT05141682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075543|NCT00317408|Cytarabine|cytarabine|mesh-list
65266378|NCT05141682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65266379|NCT05141682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266381|NCT00643227|Clarithromycin|clarithromycin|mesh-list
65266382|NCT00643227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65075686|NCT00345501|Iloprost|iloprost|mesh-list
65266383|NCT00643227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65266384|NCT00643227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65266385|NCT00643227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266386|NCT00643227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266387|NCT00643227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65266388|NCT00643227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65266389|NCT00613392|Antioxidants|antioxidants|mesh-list
65266390|NCT00613392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266391|NCT00613392|Protective Agents|protective agents|mesh-ancestor
65075821|NCT00318383|Vaccines|vaccines|mesh-list
65266392|NCT00613392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266393|NCT02537457|Rivaroxaban|rivaroxaban|mesh-list
65266394|NCT02537457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65266395|NCT02537457|Antithrombins|antithrombins|mesh-ancestor
65266396|NCT02537457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65266397|NCT02537457|Protease Inhibitors|protease inhibitors|mesh-ancestor
65266398|NCT02537457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266399|NCT02537457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266400|NCT02537457|Anticoagulants|anticoagulants|mesh-ancestor
65266401|NCT02762864|Clopidogrel|clopidogrel|mesh-list
65266402|NCT02762864|Ticagrelor|ticagrelor|mesh-list
65266403|NCT02762864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266404|NCT02762864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266405|NCT02762864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65266406|NCT02762864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65266407|NCT02762864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65266408|NCT02762864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65266409|NCT02762864|Purinergic Agents|purinergic agents|mesh-ancestor
65266410|NCT02762864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65266411|NCT02767154|Mannitol|mannitol|mesh-list
65266412|NCT02767154|Dextrans|dextrans|mesh-list
65016482|NCT00523120|Diclofenac|diclofenac|mesh-list
65266413|NCT02767154|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65266414|NCT02767154|Diuretics|diuretics|mesh-ancestor
65266415|NCT02767154|Natriuretic Agents|natriuretic agents|mesh-ancestor
65266416|NCT02767154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266417|NCT02767154|Anticoagulants|anticoagulants|mesh-ancestor
65266418|NCT02767154|Plasma Substitutes|plasma substitutes|mesh-ancestor
65266419|NCT02767154|Blood Substitutes|blood substitutes|mesh-ancestor
65076163|NCT00351585|Vildagliptin|vildagliptin|mesh-list
65266420|NCT02767232|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65266421|NCT02767232|Plasminogen|plasminogen|mesh-list
65266422|NCT02767232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65076238|NCT00321191|Analgesics|analgesics|mesh-ancestor
65266423|NCT02767232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65266424|NCT02767232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266425|NCT02767076|Anesthetics|anesthetics|mesh-list
65076381|NCT00352599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266426|NCT02767076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65266427|NCT02767076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274172|NCT05662098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076599|NCT00331851|Metformin|metformin|mesh-list
65266429|NCT02766764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65274173|NCT05662098|Antisickling Agents|antisickling agents|mesh-ancestor
65266430|NCT02766764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266431|NCT04313088|Eluxadoline|eluxadoline|mesh-list
65207520|NCT04133974|Narcotics|narcotics|mesh-ancestor
65266432|NCT04313088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65266433|NCT04658654|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
65266434|NCT04658654|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65266435|NCT04658654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076977|NCT00325793|Nicardipine|nicardipine|mesh-list
65266436|NCT04658654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274174|NCT05662098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266438|NCT04891068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65266439|NCT04891068|Antimetabolites|antimetabolites|mesh-ancestor
65266440|NCT04891068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077259|NCT00425724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65266442|NCT04891068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266443|NCT02770508|Ritonavir|ritonavir|mesh-list
65266444|NCT02770508|Darunavir|darunavir|mesh-list
65266445|NCT02770508|Tenofovir|tenofovir|mesh-list
65266446|NCT02770508|Lamivudine|lamivudine|mesh-list
65266447|NCT02770508|Emtricitabine|emtricitabine|mesh-list
65266448|NCT02770508|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65266449|NCT02770508|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65266450|NCT02770508|Protease Inhibitors|protease inhibitors|mesh-ancestor
65266451|NCT02770508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266452|NCT02770508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266453|NCT02770508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65266454|NCT02770508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65266455|NCT02770508|Antiviral Agents|antiviral agents|mesh-ancestor
65266456|NCT02770508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65266457|NCT02770508|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65266458|NCT02770508|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65266459|NCT02770508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65077771|NCT01055886|Nicotine|nicotine|mesh-list
65266460|NCT02770508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65266461|NCT02762942|Misoprostol|misoprostol|mesh-list
65266462|NCT02762942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65266463|NCT02762942|Abortifacient Agents|abortifacient agents|mesh-ancestor
65266464|NCT02762942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65077981|NCT00327587|Vasodilator Agents|vasodilator agents|mesh-ancestor
65266465|NCT02762942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266466|NCT02762942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65266467|NCT02762942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65266468|NCT02762942|Oxytocics|oxytocics|mesh-ancestor
65078227|NCT00434031|Docetaxel|docetaxel|mesh-list
65266471|NCT02770430|Dermatologic Agents|dermatologic agents|mesh-ancestor
65266472|NCT02770430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65266473|NCT02770430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65266474|NCT02770430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65266475|NCT02770430|Immunologic Factors|immunologic factors|mesh-ancestor
65266476|NCT02770430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266477|NCT00918203|Paclitaxel|paclitaxel|mesh-list
65266479|NCT00918203|Olaratumab|olaratumab|mesh-list
65078416|NCT00330239|Paroxetine|paroxetine|mesh-list
65266480|NCT00918203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65266481|NCT00918203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65266482|NCT00918203|Tubulin Modulators|tubulin modulators|mesh-ancestor
65266483|NCT00918203|Antimitotic Agents|antimitotic agents|mesh-ancestor
65266484|NCT00918203|Mitosis Modulators|mitosis modulators|mesh-ancestor
65016557|NCT02952157|Lidocaine|lidocaine|mesh-list
65266485|NCT00918203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266486|NCT00644319|Ibuprofen|ibuprofen|mesh-list
65266487|NCT00644319|Morphine|morphine|mesh-list
65266488|NCT00644319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65266489|NCT00644319|Narcotics|narcotics|mesh-ancestor
65266490|NCT00644319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65266491|NCT00644319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266493|NCT00644319|Sensory System Agents|sensory system agents|mesh-ancestor
65266494|NCT00644319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65266495|NCT00644319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65266496|NCT00644319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65266497|NCT00644319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65266498|NCT00644319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65266499|NCT00644319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65266500|NCT00644319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266501|NCT00644319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266502|NCT04224116|Tranexamic Acid|tranexamic acid|mesh-list
65266503|NCT04224116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65266504|NCT04224116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65266505|NCT04224116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266506|NCT04224116|Hemostatics|hemostatics|mesh-ancestor
65079521|NCT00335270|Ritonavir|ritonavir|mesh-list
65266508|NCT02672709|Apixaban|apixaban|mesh-list
65266509|NCT02672709|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65266510|NCT02672709|Antithrombins|antithrombins|mesh-ancestor
65266511|NCT02672709|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65266512|NCT02672709|Protease Inhibitors|protease inhibitors|mesh-ancestor
65266513|NCT02672709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266514|NCT02672709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266515|NCT02672709|Anticoagulants|anticoagulants|mesh-ancestor
65266516|NCT02770274|Aspirin|aspirin|mesh-list
65266517|NCT02770274|Cilostazol|cilostazol|mesh-list
65079799|NCT00336791|Alkylating Agents|alkylating agents|mesh-ancestor
65266518|NCT02770274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65266519|NCT02770274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65266521|NCT02770274|Sensory System Agents|sensory system agents|mesh-ancestor
65266522|NCT02770274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65266523|NCT02770274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266524|NCT02770274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65266525|NCT02770274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65266526|NCT02770274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65266527|NCT02770274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65079871|NCT00337298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079942|NCT00444834|Antioxidants|antioxidants|mesh-ancestor
65266528|NCT02770274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080025|NCT00338273|Aripiprazole|aripiprazole|mesh-list
65266529|NCT02770274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65266530|NCT02770274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65266531|NCT02770274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266532|NCT02770274|Antipyretics|antipyretics|mesh-ancestor
65266533|NCT02770274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65080303|NCT00340691|Doxycycline|doxycycline|mesh-list
65266534|NCT02770274|Autonomic Agents|autonomic agents|mesh-ancestor
65266535|NCT02770274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65266536|NCT02770274|Respiratory System Agents|respiratory system agents|mesh-ancestor
65266537|NCT02770274|Vasodilator Agents|vasodilator agents|mesh-ancestor
65080377|NCT00341432|Autonomic Agents|autonomic agents|mesh-ancestor
65266538|NCT02770274|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65266539|NCT02770274|Protective Agents|protective agents|mesh-ancestor
65266540|NCT02770274|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65266541|NCT02770274|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65266542|NCT00910221|Atorvastatin|atorvastatin|mesh-list
65266543|NCT00910221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65266544|NCT00910221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65266545|NCT00910221|Antimetabolites|antimetabolites|mesh-ancestor
65266546|NCT00910221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266547|NCT00910221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65266548|NCT00910221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65266549|NCT00910221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266550|NCT04657562|Tacrolimus|tacrolimus|mesh-list
65266551|NCT04657562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65266552|NCT04657562|Immunologic Factors|immunologic factors|mesh-ancestor
65266553|NCT04657562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266555|NCT04657562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080964|NCT00448461|Heparin|heparin|mesh-list
65266556|NCT04657562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266557|NCT05252117|Mepivacaine|mepivacaine|mesh-list
65266558|NCT05252117|Carticaine|carticaine|mesh-list
65266559|NCT05252117|Anesthetics, Local|anesthetics, local|mesh-ancestor
65266560|NCT05252117|Anesthetics|anesthetics|mesh-ancestor
65266561|NCT05252117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65266562|NCT05252117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266563|NCT05252117|Sensory System Agents|sensory system agents|mesh-ancestor
65266564|NCT05252117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65266565|NCT04224350|Tacrolimus|tacrolimus|mesh-list
65266566|NCT04224350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65266567|NCT04224350|Immunologic Factors|immunologic factors|mesh-ancestor
65266568|NCT04224350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266569|NCT04224350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65266570|NCT04224350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266571|NCT04224350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266572|NCT02770716|Terlipressin|terlipressin|mesh-list
65266573|NCT02770716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65266574|NCT02770716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65266575|NCT04846829|Citalopram|citalopram|mesh-list
65266576|NCT04846829|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65266577|NCT04846829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65266578|NCT04846829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65266579|NCT04846829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266580|NCT04846829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65266581|NCT04846829|Serotonin Agents|serotonin agents|mesh-ancestor
65266582|NCT04846829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266583|NCT04846829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65266584|NCT04846829|Antidepressive Agents|antidepressive agents|mesh-ancestor
65266585|NCT04846829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65266586|NCT02672241|Temozolomide|temozolomide|mesh-list
65266587|NCT02672241|Nimotuzumab|nimotuzumab|mesh-list
65266588|NCT02672241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65266589|NCT02672241|Alkylating Agents|alkylating agents|mesh-ancestor
65081683|NCT00421460|Hormones|hormones|mesh-ancestor
65266590|NCT02672241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266591|NCT02672241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65266592|NCT02672241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65266593|NCT04177875|Paclitaxel|paclitaxel|mesh-list
65266594|NCT04177875|Docetaxel|docetaxel|mesh-list
65266595|NCT04177875|Cisplatin|cisplatin|mesh-list
65266596|NCT04177875|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65266597|NCT04177875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65266598|NCT04177875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65266599|NCT04177875|Tubulin Modulators|tubulin modulators|mesh-ancestor
65266600|NCT04177875|Antimitotic Agents|antimitotic agents|mesh-ancestor
65266601|NCT04177875|Mitosis Modulators|mitosis modulators|mesh-ancestor
65081892|NCT00351143|Fluticasone|fluticasone|mesh-list
65266602|NCT04177875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266604|NCT00917579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65266605|NCT00917579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65266606|NCT00917579|Antimetabolites|antimetabolites|mesh-ancestor
65266607|NCT00917579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266608|NCT00917579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65266609|NCT00917579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65266610|NCT00917579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266611|NCT03808740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65081956|NCT00458055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65266612|NCT03808740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65266613|NCT03808740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65082022|NCT00450957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65266614|NCT03808740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65266615|NCT03808740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266616|NCT03808740|Adrenergic Agents|adrenergic agents|mesh-ancestor
65266617|NCT03808740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65266618|NCT03808740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266620|NCT02766140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65266621|NCT02766140|Tubulin Modulators|tubulin modulators|mesh-ancestor
65266622|NCT02766140|Antimitotic Agents|antimitotic agents|mesh-ancestor
65266623|NCT02766140|Mitosis Modulators|mitosis modulators|mesh-ancestor
65266624|NCT02766140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266625|NCT04177641|Antioxidants|antioxidants|mesh-list
65266626|NCT04177641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266627|NCT04177641|Protective Agents|protective agents|mesh-ancestor
65266628|NCT04177641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266629|NCT04178109|Acetaminophen|acetaminophen|mesh-list
65266630|NCT04178109|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65266631|NCT04178109|Tramadol|tramadol|mesh-list
65266632|NCT04178109|Ropivacaine|ropivacaine|mesh-list
65266633|NCT04178109|Levobupivacaine|levobupivacaine|mesh-list
65266634|NCT04178109|Anesthetics, Local|anesthetics, local|mesh-ancestor
65266635|NCT04178109|Anesthetics|anesthetics|mesh-ancestor
65266636|NCT04178109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65016696|NCT00524095|Xhance|xhance|mesh-list
65266637|NCT04178109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266638|NCT04178109|Sensory System Agents|sensory system agents|mesh-ancestor
65266639|NCT04178109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65266640|NCT04178109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65266641|NCT04178109|Analgesics|analgesics|mesh-ancestor
65266642|NCT04178109|Antipyretics|antipyretics|mesh-ancestor
65266643|NCT04178109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65266645|NCT04178109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65266646|NCT04178109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65266647|NCT04178109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65266648|NCT00644475|Candesartan|candesartan|mesh-list
65266649|NCT00644475|Imidapril|imidapril|mesh-list
65266650|NCT00644475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65266651|NCT00644475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65266652|NCT00644475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65266653|NCT00644475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266654|NCT00644475|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65266655|NCT00644475|Protease Inhibitors|protease inhibitors|mesh-ancestor
65266656|NCT00644475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266657|NCT04177719|Oxytocin|oxytocin|mesh-list
65266658|NCT04177719|Oxytocics|oxytocics|mesh-ancestor
65266659|NCT04177719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65266660|NCT04177719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266661|NCT00644553|Amoxicillin|amoxicillin|mesh-list
65082662|NCT00468234|Nicotine|nicotine|mesh-list
65266662|NCT00644553|Clarithromycin|clarithromycin|mesh-list
65266663|NCT00644553|Clavulanic Acid|clavulanic acid|mesh-list
65082725|NCT00468429|Growth Inhibitors|growth inhibitors|mesh-ancestor
65082797|NCT00427271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266664|NCT00644553|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65266665|NCT00644553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65266666|NCT00644553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65266667|NCT00644553|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65266668|NCT00644553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266669|NCT00644553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266670|NCT00644553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65266671|NCT00644553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65266672|NCT00644553|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65266673|NCT02762474|Paclitaxel|paclitaxel|mesh-list
65266674|NCT02762474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65266675|NCT02762474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65266676|NCT02762474|Tubulin Modulators|tubulin modulators|mesh-ancestor
65266677|NCT02762474|Antimitotic Agents|antimitotic agents|mesh-ancestor
65266678|NCT02762474|Mitosis Modulators|mitosis modulators|mesh-ancestor
65266679|NCT02762474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266680|NCT00915473|Methylprednisolone|methylprednisolone|mesh-list
65266681|NCT00915473|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65266682|NCT00915473|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65266683|NCT00915473|Prednisolone|prednisolone|mesh-list
65266684|NCT00915473|Prednisolone acetate|prednisolone acetate|mesh-list
65266685|NCT00915473|Lidocaine|lidocaine|mesh-list
65266686|NCT00915473|Bupivacaine|bupivacaine|mesh-list
65266687|NCT00915473|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65266688|NCT00915473|Prednisolone phosphate|prednisolone phosphate|mesh-list
65266689|NCT00915473|Anesthetics, Local|anesthetics, local|mesh-ancestor
65266690|NCT00915473|Anesthetics|anesthetics|mesh-ancestor
65266691|NCT00915473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65266692|NCT00915473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266693|NCT00915473|Sensory System Agents|sensory system agents|mesh-ancestor
65266694|NCT00915473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65266695|NCT00915473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65266696|NCT00915473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65082986|NCT00460512|Serotonin Agents|serotonin agents|mesh-ancestor
65266697|NCT00915473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65266698|NCT00915473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65266699|NCT00915473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266701|NCT00915473|Antiemetics|antiemetics|mesh-ancestor
65083135|NCT04704245|Emollients|emollients|mesh-ancestor
65266702|NCT00915473|Autonomic Agents|autonomic agents|mesh-ancestor
65083209|NCT00430118|Antiviral Agents|antiviral agents|mesh-ancestor
65266703|NCT00915473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65266704|NCT00915473|Glucocorticoids|glucocorticoids|mesh-ancestor
65266705|NCT00915473|Hormones|hormones|mesh-ancestor
65083360|NCT00431054|Docetaxel|docetaxel|mesh-list
65083421|NCT00462111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083502|NCT00471159|Docetaxel|docetaxel|mesh-list
65266706|NCT00915473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65266707|NCT00915473|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65266708|NCT00915473|Protective Agents|protective agents|mesh-ancestor
65266709|NCT00915473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65016742|NCT00167739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65266710|NCT00915473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083720|NCT00432653|Rituximab|rituximab|mesh-list
65266713|NCT04691726|Morphine|morphine|mesh-list
65266714|NCT04691726|Anesthetics, Local|anesthetics, local|mesh-ancestor
65266715|NCT04691726|Anesthetics|anesthetics|mesh-ancestor
65083858|NCT00433121|Olanzapine|olanzapine|mesh-list
65266716|NCT04691726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65083933|NCT00433316|Anesthetics, Local|anesthetics, local|mesh-ancestor
65266717|NCT04691726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266718|NCT04691726|Sensory System Agents|sensory system agents|mesh-ancestor
65266719|NCT04691726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65266720|NCT04691726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65084078|NCT01050764|Vidarabine|vidarabine|mesh-list
65266721|NCT04691726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65266722|NCT04691726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65266723|NCT04691726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65266724|NCT04691726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266725|NCT04691726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65266726|NCT04691726|Narcotics|narcotics|mesh-ancestor
65266727|NCT04691726|Analgesics|analgesics|mesh-ancestor
65266728|NCT04691726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65266729|NCT04691726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65266730|NCT04691726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65084590|NCT00481884|Petrolatum|petrolatum|mesh-list
65266731|NCT04691726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65266732|NCT04691726|Antipyretics|antipyretics|mesh-ancestor
65266734|NCT00614328|Baclofen|baclofen|mesh-list
65266735|NCT00614328|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65266736|NCT00614328|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65084731|NCT00437996|Analgesics|analgesics|mesh-ancestor
65266737|NCT00614328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084878|NCT00438386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65266738|NCT00614328|Sensory System Agents|sensory system agents|mesh-ancestor
65266739|NCT00614328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65266740|NCT00614328|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65266741|NCT00614328|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65266742|NCT00614328|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65266743|NCT00614328|GABA Agonists|gaba agonists|mesh-ancestor
65266744|NCT00614328|GABA Agents|gaba agents|mesh-ancestor
65266745|NCT00614328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65085238|NCT03277248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65266746|NCT00614328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266747|NCT04177173|Methotrexate|methotrexate|mesh-list
65266749|NCT04177173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65266750|NCT04177173|Abortifacient Agents|abortifacient agents|mesh-ancestor
65266751|NCT04177173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65266752|NCT04177173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266753|NCT04177173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65266754|NCT04177173|Antimetabolites|antimetabolites|mesh-ancestor
65266755|NCT04177173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266756|NCT04177173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65266757|NCT04177173|Dermatologic Agents|dermatologic agents|mesh-ancestor
65266758|NCT04177173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266759|NCT04177173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65266760|NCT04177173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65266761|NCT04177173|Immunologic Factors|immunologic factors|mesh-ancestor
65266762|NCT04177173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65266763|NCT04177173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65266764|NCT04177173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65266765|NCT04177173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65266766|NCT04177173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65266767|NCT04177173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65266768|NCT04224818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65266769|NCT04224818|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65266770|NCT04224818|Luteolytic Agents|luteolytic agents|mesh-ancestor
65266771|NCT04224818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65266772|NCT04224818|Contraceptive Agents|contraceptive agents|mesh-ancestor
65266773|NCT04224818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65266774|NCT04224818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266775|NCT04224818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65266776|NCT04224818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65266777|NCT04224818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65266778|NCT03651804|Acetaminophen|acetaminophen|mesh-list
65266779|NCT03651804|Diphosphonates|diphosphonates|mesh-list
65266780|NCT03651804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65085582|NCT03279341|Bisacodyl|bisacodyl|mesh-list
65085653|NCT00477711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65266781|NCT03651804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65266782|NCT03651804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65266783|NCT03651804|Analgesics|analgesics|mesh-ancestor
65266784|NCT03651804|Sensory System Agents|sensory system agents|mesh-ancestor
65266785|NCT03651804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65266786|NCT03651804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266787|NCT03651804|Antipyretics|antipyretics|mesh-ancestor
65266788|NCT03651804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65266789|NCT03651804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65266791|NCT00917267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65266792|NCT00917267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266793|NCT00917267|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65266794|NCT00917267|Incretins|incretins|mesh-ancestor
65266795|NCT00917267|Hormones|hormones|mesh-ancestor
65266796|NCT00917267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65266797|NCT02670759|Bupivacaine|bupivacaine|mesh-list
65266798|NCT02670759|Anesthetics, Local|anesthetics, local|mesh-ancestor
65266799|NCT02670759|Anesthetics|anesthetics|mesh-ancestor
65086166|NCT00441909|UC-781|uc-781|mesh-list
65266800|NCT02670759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65266801|NCT02670759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266802|NCT02670759|Sensory System Agents|sensory system agents|mesh-ancestor
65266803|NCT02670759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65266805|NCT00644943|Cefdinir|cefdinir|mesh-list
65086314|NCT00442221|Serotonin Agents|serotonin agents|mesh-ancestor
65266806|NCT00644943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65266807|NCT00644943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65266808|NCT02762006|Durvalumab|durvalumab|mesh-list
65266809|NCT02762006|Tremelimumab|tremelimumab|mesh-list
65266810|NCT02762006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65266811|NCT02762006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65266813|NCT02769884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65266815|NCT05213507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65266816|NCT05213507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65266817|NCT02670603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65266818|NCT04253873|Temozolomide|temozolomide|mesh-list
65266819|NCT04253873|Apatinib|apatinib|mesh-list
65266820|NCT04253873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65266821|NCT04253873|Alkylating Agents|alkylating agents|mesh-ancestor
65266822|NCT04253873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266823|NCT04253873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65266824|NCT04253873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65266826|NCT05147727|Fluconazole|fluconazole|mesh-list
65266827|NCT05147727|Antifungal Agents|antifungal agents|mesh-ancestor
65266828|NCT05147727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65266829|NCT05147727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65266830|NCT05147727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65266831|NCT05147727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266832|NCT05147727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266833|NCT05147727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65266834|NCT05147727|Hormone Antagonists|hormone antagonists|mesh-ancestor
65086882|NCT00458315|Paclitaxel|paclitaxel|mesh-list
65086950|NCT00488163|Adrenergic Agents|adrenergic agents|mesh-ancestor
65266835|NCT05147727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65087023|NCT00495183|Biperiden|biperiden|mesh-list
65266836|NCT05147727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266837|NCT05147727|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65266838|NCT05147727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65266839|NCT02765594|Hydroxychloroquine|hydroxychloroquine|mesh-list
65266840|NCT02765594|Valsartan|valsartan|mesh-list
65266841|NCT02765594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65266842|NCT02765594|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65266843|NCT02765594|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65266844|NCT02765594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266845|NCT02765594|Antimalarials|antimalarials|mesh-ancestor
65266846|NCT02765594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65266847|NCT02765594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65266848|NCT02765594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65266849|NCT02765594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266850|NCT02765594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65266851|NCT00920699|Ubiquinone|ubiquinone|mesh-list
65266853|NCT00920699|Micronutrients|micronutrients|mesh-ancestor
65266854|NCT00920699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266855|NCT00920699|Vitamins|vitamins|mesh-ancestor
65266856|NCT02670135|Triclosan|triclosan|mesh-list
65087684|NCT00490464|Nicardipine|nicardipine|mesh-list
65087756|NCT00497562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65266857|NCT02670135|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65266858|NCT02670135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65266859|NCT02670135|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65266860|NCT02670135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65266862|NCT02670135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266863|NCT02670135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65266865|NCT02769494|Flavin Mononucleotide|flavin mononucleotide|mesh-list
65266866|NCT02769494|Mesalamine|mesalamine|mesh-list
65266867|NCT02769494|Vitamin B Complex|vitamin b complex|mesh-ancestor
65266868|NCT02769494|Vitamins|vitamins|mesh-ancestor
65266869|NCT02769494|Micronutrients|micronutrients|mesh-ancestor
65266870|NCT02769494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266871|NCT02769494|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65266872|NCT02769494|Dermatologic Agents|dermatologic agents|mesh-ancestor
65266873|NCT02769494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65088344|NCT00492219|Cimetidine|cimetidine|mesh-list
65266875|NCT02769494|Analgesics|analgesics|mesh-ancestor
65088562|NCT05653453|Tubulin Modulators|tubulin modulators|mesh-ancestor
65266876|NCT02769494|Sensory System Agents|sensory system agents|mesh-ancestor
65266877|NCT02769494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65266878|NCT02769494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65266879|NCT02769494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65266880|NCT02769572|Diclofenac|diclofenac|mesh-list
65266881|NCT02769572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65266882|NCT02769572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65266883|NCT02769572|Analgesics|analgesics|mesh-ancestor
65266884|NCT02769572|Sensory System Agents|sensory system agents|mesh-ancestor
65089004|NCT00500409|Vitamin D|vitamin d|mesh-list
65266885|NCT02769572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65266886|NCT02769572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266887|NCT02769572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65266888|NCT02769572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65266889|NCT02769572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65266890|NCT02769572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266891|NCT02769572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266892|NCT05116293|Acetaminophen|acetaminophen|mesh-list
65266893|NCT05116293|Digoxin|digoxin|mesh-list
65266894|NCT05116293|Midazolam|midazolam|mesh-list
65266895|NCT05116293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65266896|NCT05116293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65266897|NCT05116293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65266898|NCT05116293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266899|NCT05116293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65266900|NCT05116293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65266901|NCT05116293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65266902|NCT05116293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65266903|NCT05116293|Anesthetics, General|anesthetics, general|mesh-ancestor
65266904|NCT05116293|Anesthetics|anesthetics|mesh-ancestor
65266905|NCT05116293|GABA Modulators|gaba modulators|mesh-ancestor
65266906|NCT05116293|GABA Agents|gaba agents|mesh-ancestor
65266907|NCT05116293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65089207|NCT00500955|Rosiglitazone|rosiglitazone|mesh-list
65089282|NCT04697732|Anesthetics|anesthetics|mesh-list
65266908|NCT05116293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266909|NCT05116293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65266910|NCT05116293|Analgesics|analgesics|mesh-ancestor
65266911|NCT05116293|Sensory System Agents|sensory system agents|mesh-ancestor
65266912|NCT05116293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65089533|NCT00623077|Mesna|mesna|mesh-list
65266913|NCT05116293|Antipyretics|antipyretics|mesh-ancestor
65266914|NCT05116293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65089566|NCT00623155|Pyrimethamine|pyrimethamine|mesh-list
65266915|NCT05116293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65266916|NCT05116293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266917|NCT05116293|Protective Agents|protective agents|mesh-ancestor
65266918|NCT02669589|Heparin|heparin|mesh-list
65266919|NCT02669589|Anticoagulants|anticoagulants|mesh-ancestor
65089783|NCT00601978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65266920|NCT02669589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266921|NCT02669589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65266922|NCT02669589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65266923|NCT02765204|Dapagliflozin|dapagliflozin|mesh-list
65266924|NCT02765204|Saxagliptin|saxagliptin|mesh-list
65266925|NCT02765204|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65266926|NCT02765204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266927|NCT02765204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65266929|NCT02765204|Incretins|incretins|mesh-ancestor
65266930|NCT02765204|Hormones|hormones|mesh-ancestor
65266931|NCT02765204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65266932|NCT02765204|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65266933|NCT02765204|Protease Inhibitors|protease inhibitors|mesh-ancestor
65266934|NCT02765204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266935|NCT00920387|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
65266936|NCT00920387|Hallucinogens|hallucinogens|mesh-ancestor
65090433|NCT04325776|Zoledronic Acid|zoledronic acid|mesh-list
65266937|NCT00920387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266938|NCT00920387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65266939|NCT00920387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65266940|NCT00920387|Serotonin Agents|serotonin agents|mesh-ancestor
65266941|NCT00920387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65266942|NCT00920387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266943|NCT00920387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65266944|NCT03342456|Amoxicillin|amoxicillin|mesh-list
65266945|NCT03342456|Doxycycline|doxycycline|mesh-list
65266946|NCT03342456|Furazolidone|furazolidone|mesh-list
65266947|NCT03342456|Potassium Citrate|potassium citrate|mesh-list
65266948|NCT03342456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266949|NCT03342456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65266950|NCT03342456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65266951|NCT03342456|Antimalarials|antimalarials|mesh-ancestor
65266952|NCT03342456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65266953|NCT03342456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65266954|NCT03342456|Diuretics|diuretics|mesh-ancestor
65266955|NCT03342456|Natriuretic Agents|natriuretic agents|mesh-ancestor
65266956|NCT03342456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266957|NCT03342456|Expectorants|expectorants|mesh-ancestor
65090940|NCT01315249|Glucocorticoids|glucocorticoids|mesh-ancestor
65266958|NCT03342456|Respiratory System Agents|respiratory system agents|mesh-ancestor
65266959|NCT03342456|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65266960|NCT03342456|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65266961|NCT03342456|Renal Agents|renal agents|mesh-ancestor
65266962|NCT03342456|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65091087|NCT04515147|Vaccines|vaccines|mesh-list
65266963|NCT03342456|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65266964|NCT03342456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266965|NCT04666649|Venetoclax|venetoclax|mesh-list
65266967|NCT02669277|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65266968|NCT02669277|gamma-Globulins|gamma-globulins|mesh-list
65266969|NCT02669277|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65266970|NCT02669277|Immunologic Factors|immunologic factors|mesh-ancestor
65266971|NCT02669277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266972|NCT02769104|Docetaxel|docetaxel|mesh-list
65266973|NCT02769104|Letrozole|letrozole|mesh-list
65266974|NCT02769104|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65266975|NCT02769104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65266976|NCT02769104|Tubulin Modulators|tubulin modulators|mesh-ancestor
65266977|NCT02769104|Antimitotic Agents|antimitotic agents|mesh-ancestor
65266978|NCT02769104|Mitosis Modulators|mitosis modulators|mesh-ancestor
65091814|NCT00488189|Piperacillin|piperacillin|mesh-list
65266979|NCT02769104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65266980|NCT02769104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65266981|NCT02769104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65266982|NCT02769104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65092034|NCT01303861|Bupropion|bupropion|mesh-list
65266983|NCT02769104|Hormone Antagonists|hormone antagonists|mesh-ancestor
65092104|NCT00484055|Gentamicins|gentamicins|mesh-list
65266984|NCT02769104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65266985|NCT02769104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266986|NCT02545842|Insulin Glargine|insulin glargine|mesh-list
65266987|NCT02545842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65092470|NCT04513509|Metoprolol|metoprolol|mesh-list
65266988|NCT02545842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65266989|NCT00645255|Sibutramine|sibutramine|mesh-list
65266990|NCT00645255|Antidepressive Agents|antidepressive agents|mesh-ancestor
65266991|NCT00645255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65092623|NCT00485550|Dopamine Agents|dopamine agents|mesh-ancestor
65266992|NCT00645255|Appetite Depressants|appetite depressants|mesh-ancestor
65266993|NCT00645255|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65092759|NCT00485823|Olanzapine|olanzapine|mesh-list
65266995|NCT04679012|Cyclophosphamide|cyclophosphamide|mesh-list
65266996|NCT04679012|Rituximab|rituximab|mesh-list
65266997|NCT04679012|Doxorubicin|doxorubicin|mesh-list
65266998|NCT04679012|Etoposide|etoposide|mesh-list
65266999|NCT04679012|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65092904|NCT00486317|Calcitonin|calcitonin|mesh-list
65267000|NCT04679012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65267001|NCT04679012|Immunologic Factors|immunologic factors|mesh-ancestor
65092972|NCT04511637|Rivaroxaban|rivaroxaban|mesh-list
65267002|NCT04679012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267004|NCT04679012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65267006|NCT04679012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267007|NCT04679012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093338|NCT01300351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267008|NCT04679012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65267009|NCT04679012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65267010|NCT04679012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65093489|NCT01242306|Acetylcholine|acetylcholine|mesh-list
65267011|NCT04679012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65267012|NCT04679012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65267013|NCT04679012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267014|NCT04679012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65267015|NCT04679012|Glucocorticoids|glucocorticoids|mesh-ancestor
65093708|NCT00492518|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65267017|NCT04679012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65093787|NCT00495872|Growth Substances|growth substances|mesh-ancestor
65267018|NCT04679012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65267019|NCT04679012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65267021|NCT00910455|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65267022|NCT00910455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267023|NCT00910455|Natriuretic Agents|natriuretic agents|mesh-ancestor
65267024|NCT00910455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267025|NCT02765126|Vaccines|vaccines|mesh-list
65267026|NCT02765126|Immunologic Factors|immunologic factors|mesh-ancestor
65267027|NCT02765126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267028|NCT02668965|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65267029|NCT02668965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65267030|NCT02668965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267032|NCT00916721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65267033|NCT00916721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65267034|NCT00916721|Adrenergic Agents|adrenergic agents|mesh-ancestor
65267035|NCT00916721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65267036|NCT00916721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267037|NCT00916721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267038|NCT00916721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65267039|NCT00916721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65267040|NCT00916721|Vasodilator Agents|vasodilator agents|mesh-ancestor
65267041|NCT00613782|Methyltestosterone|methyltestosterone|mesh-list
65267042|NCT00613782|Testosterone|testosterone|mesh-list
65267043|NCT00613782|Testosterone undecanoate|testosterone undecanoate|mesh-list
65267044|NCT00613782|Testosterone enanthate|testosterone enanthate|mesh-list
65267045|NCT00613782|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65267046|NCT00613782|Androgens|androgens|mesh-ancestor
65267047|NCT00613782|Hormones|hormones|mesh-ancestor
65274175|NCT05662098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267048|NCT00613782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65267049|NCT00613782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267050|NCT00613782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65267051|NCT00613782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267052|NCT00613782|Anabolic Agents|anabolic agents|mesh-ancestor
65267053|NCT02764736|Atorvastatin|atorvastatin|mesh-list
65267054|NCT02764736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65267055|NCT02764736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65267056|NCT02764736|Antimetabolites|antimetabolites|mesh-ancestor
65267057|NCT02764736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267058|NCT02764736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65267059|NCT02764736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65267060|NCT02764736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267061|NCT00646737|Mycophenolic Acid|mycophenolic acid|mesh-list
65267062|NCT00646737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65094641|NCT05145270|Dexetimide|dexetimide|mesh-list
65267063|NCT00646737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267064|NCT00646737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65267065|NCT00646737|Antitubercular Agents|antitubercular agents|mesh-ancestor
65267066|NCT00646737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65267067|NCT00646737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65267068|NCT00646737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267069|NCT00646737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267071|NCT00646815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65267072|NCT00646815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267073|NCT00915005|Paclitaxel|paclitaxel|mesh-list
65267074|NCT00915005|Carboplatin|carboplatin|mesh-list
65267075|NCT00915005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65094999|NCT00507585|Antidotes|antidotes|mesh-ancestor
65267076|NCT00915005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267077|NCT00915005|Tubulin Modulators|tubulin modulators|mesh-ancestor
65267078|NCT00915005|Antimitotic Agents|antimitotic agents|mesh-ancestor
65267079|NCT00915005|Mitosis Modulators|mitosis modulators|mesh-ancestor
65267080|NCT00915005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267081|NCT00910533|Ceftriaxone|ceftriaxone|mesh-list
65267082|NCT00910533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65267083|NCT00910533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65267084|NCT02696642|Maytansine|maytansine|mesh-list
65267086|NCT02696642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095434|NCT01248611|Anesthetics|anesthetics|mesh-ancestor
65267088|NCT02696642|Antimitotic Agents|antimitotic agents|mesh-ancestor
65267089|NCT02696642|Mitosis Modulators|mitosis modulators|mesh-ancestor
65267090|NCT02696642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267091|NCT00647049|Cytarabine|cytarabine|mesh-list
65267092|NCT00647049|Rituximab|rituximab|mesh-list
65267093|NCT00647049|Methotrexate|methotrexate|mesh-list
65267094|NCT00647049|Thiotepa|thiotepa|mesh-list
65267095|NCT00647049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65267096|NCT00647049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267097|NCT00647049|Immunologic Factors|immunologic factors|mesh-ancestor
65095653|NCT03459417|Analgesics|analgesics|mesh-ancestor
65267098|NCT00647049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267099|NCT00647049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65267100|NCT00647049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65267101|NCT00647049|Abortifacient Agents|abortifacient agents|mesh-ancestor
65267102|NCT00647049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65096026|NCT00512811|Furosemide|furosemide|mesh-list
65267103|NCT00647049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65267104|NCT00647049|Antimetabolites|antimetabolites|mesh-ancestor
65267105|NCT00647049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267106|NCT00647049|Dermatologic Agents|dermatologic agents|mesh-ancestor
65267107|NCT00647049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267108|NCT00647049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65096105|NCT00513981|Antimetabolites|antimetabolites|mesh-ancestor
65267109|NCT00647049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65096172|NCT01244984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65267110|NCT00647049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65267111|NCT00647049|Antiviral Agents|antiviral agents|mesh-ancestor
65267112|NCT00647049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65267113|NCT00647049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65096321|NCT00516009|Hormones|hormones|mesh-ancestor
65267114|NCT00647049|Alkylating Agents|alkylating agents|mesh-ancestor
65267115|NCT00647049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65267116|NCT02696330|Enoxaparin|enoxaparin|mesh-list
65267117|NCT02696330|Clopidogrel|clopidogrel|mesh-list
65267118|NCT02696330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65267119|NCT02696330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65267120|NCT02696330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65267121|NCT02696330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65267122|NCT02696330|Purinergic Agents|purinergic agents|mesh-ancestor
65267123|NCT02696330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65267124|NCT02696330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096828|NCT04510337|Analgesics|analgesics|mesh-ancestor
65267125|NCT02696330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267126|NCT02696330|Anticoagulants|anticoagulants|mesh-ancestor
65267128|NCT02696330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65267129|NCT04172727|Bupivacaine|bupivacaine|mesh-list
65267130|NCT04172727|Anesthetics, Local|anesthetics, local|mesh-ancestor
65267131|NCT04172727|Anesthetics|anesthetics|mesh-ancestor
65267132|NCT04172727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65267133|NCT04172727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267134|NCT04172727|Sensory System Agents|sensory system agents|mesh-ancestor
65267135|NCT04172727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65267136|NCT04648319|Nivolumab|nivolumab|mesh-list
65267137|NCT04648319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65267138|NCT04648319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267139|NCT04648319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65267140|NCT04648319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267142|NCT00647127|Buprenorphine|buprenorphine|mesh-list
65267143|NCT00647127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65267144|NCT00647127|Narcotics|narcotics|mesh-ancestor
65208269|NCT01074008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65267145|NCT00647127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65267146|NCT00647127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267147|NCT00647127|Analgesics|analgesics|mesh-ancestor
65267148|NCT00647127|Sensory System Agents|sensory system agents|mesh-ancestor
65267149|NCT00647127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65267150|NCT00647127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65267151|NCT00647127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65267152|NCT00647127|Anesthetics, General|anesthetics, general|mesh-ancestor
65267153|NCT00647127|Anesthetics|anesthetics|mesh-ancestor
65267154|NCT00647127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65267155|NCT04736745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65267156|NCT04736745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65267157|NCT04736745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65267158|NCT04736745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267159|NCT04736745|Cholinergic Agents|cholinergic agents|mesh-ancestor
65267160|NCT04736745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65267161|NCT04736745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267162|NCT04750070|Dopamine|dopamine|mesh-list
65267163|NCT04750070|Epinephrine|epinephrine|mesh-list
65267164|NCT04750070|Racepinephrine|racepinephrine|mesh-list
65267165|NCT04750070|Epinephryl borate|epinephryl borate|mesh-list
65267166|NCT04750070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65267167|NCT04750070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65267168|NCT04750070|Adrenergic Agents|adrenergic agents|mesh-ancestor
65267169|NCT04750070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65267170|NCT04750070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267171|NCT04750070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267172|NCT04750070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65267173|NCT04750070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65267174|NCT04750070|Autonomic Agents|autonomic agents|mesh-ancestor
65267175|NCT04750070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65267176|NCT04750070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65267177|NCT04750070|Respiratory System Agents|respiratory system agents|mesh-ancestor
65267178|NCT04750070|Mydriatics|mydriatics|mesh-ancestor
65267179|NCT04750070|Sympathomimetics|sympathomimetics|mesh-ancestor
65097228|NCT02955251|Nivolumab|nivolumab|mesh-list
65267180|NCT04750070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65267181|NCT04750070|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65267182|NCT04750070|Dopamine Agents|dopamine agents|mesh-ancestor
65097311|NCT00505700|Cytarabine|cytarabine|mesh-list
65267184|NCT02763722|Emollients|emollients|mesh-list
65267185|NCT02763722|Dermatologic Agents|dermatologic agents|mesh-ancestor
65267186|NCT01143246|Terlipressin|terlipressin|mesh-list
65267187|NCT01143246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65097369|NCT04514081|Decitabine|decitabine|mesh-list
65267188|NCT01143246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65267189|NCT00647673|Verapamil|verapamil|mesh-list
65267190|NCT00647673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65097438|NCT02598557|Exemestane|exemestane|mesh-list
65267191|NCT00647673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65097589|NCT05146778|Analgesics|analgesics|mesh-ancestor
65267192|NCT00647673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65267193|NCT00647673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267194|NCT00647673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65267195|NCT00647673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267196|NCT00647673|Vasodilator Agents|vasodilator agents|mesh-ancestor
65267197|NCT00561925|Nevirapine|nevirapine|mesh-list
65267198|NCT00561925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65097802|NCT05148767|Irinotecan|irinotecan|mesh-list
65267199|NCT00561925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65267200|NCT00561925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267201|NCT00561925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267202|NCT00561925|Antiviral Agents|antiviral agents|mesh-ancestor
65267203|NCT00561925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65267204|NCT00561925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65267205|NCT00561925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64740391|NCT00002945|Melphalan|melphalan|mesh-list
65098247|NCT02276690|Hepcidins|hepcidins|mesh-list
65267207|NCT00561925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65267208|NCT02760992|Baclofen|baclofen|mesh-list
65267209|NCT02760992|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65267210|NCT02760992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267211|NCT02760992|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65267212|NCT02760992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65267213|NCT02760992|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65267214|NCT02760992|GABA Agonists|gaba agonists|mesh-ancestor
65267215|NCT02760992|GABA Agents|gaba agents|mesh-ancestor
65267216|NCT02760992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65267217|NCT02760992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267219|NCT04172259|Docetaxel|docetaxel|mesh-list
65267221|NCT04172259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65267222|NCT04172259|Trastuzumab|trastuzumab|mesh-list
65267223|NCT04172259|Epirubicin|epirubicin|mesh-list
65267224|NCT04172259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65267225|NCT04172259|Immunologic Factors|immunologic factors|mesh-ancestor
65267226|NCT04172259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267227|NCT04172259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65098984|NCT01356966|Folic Acid|folic acid|mesh-list
65267229|NCT04172259|Alkylating Agents|alkylating agents|mesh-ancestor
65267230|NCT04172259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267231|NCT04172259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267232|NCT04172259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65267233|NCT04172259|Tubulin Modulators|tubulin modulators|mesh-ancestor
65267234|NCT04172259|Antimitotic Agents|antimitotic agents|mesh-ancestor
65267235|NCT04172259|Mitosis Modulators|mitosis modulators|mesh-ancestor
65267236|NCT04172259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65267237|NCT04172259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65267238|NCT04172259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65267239|NCT04172259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267240|NCT04172259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65267242|NCT00647751|Anticonvulsants|anticonvulsants|mesh-ancestor
65267243|NCT00647751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65267244|NCT00647751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65267245|NCT00647751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267246|NCT00647751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65267247|NCT00647751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267248|NCT00647751|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65267249|NCT00647751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65267250|NCT00647751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65267251|NCT00647751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65267252|NCT00647751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65267253|NCT02536989|Omeprazole|omeprazole|mesh-list
65267254|NCT02536989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65267255|NCT02536989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65267256|NCT02536989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65267257|NCT02536989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267258|NCT02536989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267259|NCT00647829|Valdecoxib|valdecoxib|mesh-list
65267260|NCT00647829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65267261|NCT00647829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65267262|NCT00647829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267263|NCT00647829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267264|NCT00647829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65267265|NCT00647829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65267266|NCT00647829|Analgesics|analgesics|mesh-ancestor
65267267|NCT00647829|Sensory System Agents|sensory system agents|mesh-ancestor
65267268|NCT00647829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65267269|NCT00647829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267270|NCT00647829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65267271|NCT00647829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65267272|NCT02517918|Zoledronic Acid|zoledronic acid|mesh-list
65267273|NCT02517918|Sirolimus|sirolimus|mesh-list
65267274|NCT02517918|Methotrexate|methotrexate|mesh-list
65267275|NCT02517918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65267276|NCT02517918|Abortifacient Agents|abortifacient agents|mesh-ancestor
65099083|NCT02951897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267277|NCT02517918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65267278|NCT02517918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267279|NCT02517918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65274176|NCT05662098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65267281|NCT02517918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267282|NCT02517918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267283|NCT02517918|Dermatologic Agents|dermatologic agents|mesh-ancestor
65267284|NCT02517918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267285|NCT02517918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65099524|NCT00514748|Analgesics|analgesics|mesh-ancestor
65274178|NCT02153645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65267286|NCT02517918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65267287|NCT02517918|Immunologic Factors|immunologic factors|mesh-ancestor
65267288|NCT02517918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65267289|NCT02517918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65208424|NCT02836743|Melatonin|melatonin|mesh-list
65099807|NCT02951117|Glucocorticoids|glucocorticoids|mesh-ancestor
65267290|NCT02517918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65267291|NCT02517918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65267292|NCT02517918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65267293|NCT02517918|Antifungal Agents|antifungal agents|mesh-ancestor
65267294|NCT02517918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65267295|NCT00647907|Voriconazole|voriconazole|mesh-list
65267296|NCT00647907|Antifungal Agents|antifungal agents|mesh-ancestor
65267297|NCT00647907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65267298|NCT00647907|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65267299|NCT00647907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65267300|NCT00647907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274179|NCT02153645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65267301|NCT00647907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267302|NCT00647907|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65267303|NCT00647907|Hormone Antagonists|hormone antagonists|mesh-ancestor
65267304|NCT00647907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65267305|NCT00647907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267306|NCT00647907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65267307|NCT04017546|Venetoclax|venetoclax|mesh-list
65267308|NCT04017546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267311|NCT04003818|Teicoplanin|teicoplanin|mesh-list
65267312|NCT04003818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65267313|NCT04003818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65267314|NCT00949663|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
65267315|NCT00949663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65267316|NCT00949663|Incretins|incretins|mesh-ancestor
65267317|NCT00949663|Hormones|hormones|mesh-ancestor
65267318|NCT00949663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65267319|NCT00949663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267320|NCT00647985|Fexofenadine|fexofenadine|mesh-list
65267321|NCT00647985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65267322|NCT00647985|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65267323|NCT00647985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65267324|NCT00647985|Histamine Antagonists|histamine antagonists|mesh-ancestor
65267325|NCT00647985|Histamine Agents|histamine agents|mesh-ancestor
65267326|NCT00647985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65267327|NCT00647985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267328|NCT00647985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267329|NCT02664051|Cromolyn Sodium|cromolyn sodium|mesh-list
65267330|NCT02664051|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
65267331|NCT02664051|Immunologic Factors|immunologic factors|mesh-ancestor
65267332|NCT02664051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267333|NCT02664051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65267334|NCT02664051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65267335|NCT02664051|Respiratory System Agents|respiratory system agents|mesh-ancestor
65267336|NCT00648063|Letrozole|letrozole|mesh-list
65267337|NCT00648063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267338|NCT00648063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65274180|NCT02153645|Antiviral Agents|antiviral agents|mesh-ancestor
65267340|NCT00648063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267341|NCT00648063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267342|NCT00648063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65267343|NCT00648063|Hormone Antagonists|hormone antagonists|mesh-ancestor
65267344|NCT00648063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65267345|NCT00648063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267346|NCT00648141|Celecoxib|celecoxib|mesh-list
65267347|NCT00648141|Diclofenac|diclofenac|mesh-list
65267348|NCT00648141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65267349|NCT00648141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65267350|NCT00648141|Analgesics|analgesics|mesh-ancestor
65267351|NCT00648141|Sensory System Agents|sensory system agents|mesh-ancestor
65267352|NCT00648141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65267353|NCT00648141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267354|NCT00648141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65267355|NCT00648141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65267356|NCT00648141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65267357|NCT00648141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65267358|NCT00648141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267359|NCT00648141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267360|NCT00953641|Misoprostol|misoprostol|mesh-list
65267361|NCT00953641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65267362|NCT00953641|Abortifacient Agents|abortifacient agents|mesh-ancestor
65101239|NCT04288323|Chelating Agents|chelating agents|mesh-ancestor
65267364|NCT00953641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267365|NCT00953641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65267366|NCT00953641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65267367|NCT00953641|Oxytocics|oxytocics|mesh-ancestor
65267368|NCT02763098|Remifentanil|remifentanil|mesh-list
65267369|NCT02763098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65267370|NCT02763098|Narcotics|narcotics|mesh-ancestor
65267371|NCT02763098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65267372|NCT02763098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267373|NCT02763098|Analgesics|analgesics|mesh-ancestor
65101456|NCT02927886|Botulinum Toxins|botulinum toxins|mesh-list
65101532|NCT02927379|Analgesics|analgesics|mesh-ancestor
65267375|NCT02763098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65267376|NCT00648219|Olmesartan|olmesartan|mesh-list
65267377|NCT00648219|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65267378|NCT00648219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65267379|NCT00648219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65267380|NCT00648219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65267381|NCT00648219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267383|NCT00648297|Bendroflumethiazide|bendroflumethiazide|mesh-list
65267384|NCT00648297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65267385|NCT00648297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65267386|NCT00648297|Adrenergic Agents|adrenergic agents|mesh-ancestor
65101809|NCT04107675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65267387|NCT00648297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65267388|NCT00648297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267389|NCT00648297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102036|NCT02944292|Anesthetics, General|anesthetics, general|mesh-ancestor
65267390|NCT00648297|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65102110|NCT02922387|Varenicline|varenicline|mesh-list
65267391|NCT00648297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65267392|NCT00648297|Sympatholytics|sympatholytics|mesh-ancestor
65267393|NCT00648297|Autonomic Agents|autonomic agents|mesh-ancestor
65267394|NCT00648297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65267395|NCT00648297|Diuretics|diuretics|mesh-ancestor
65102331|NCT05319899|Choline|choline|mesh-list
65267396|NCT00648297|Natriuretic Agents|natriuretic agents|mesh-ancestor
65267397|NCT00648297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65267398|NCT00648297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65267399|NCT00648453|Clopidogrel|clopidogrel|mesh-list
65102478|NCT02941562|Leucovorin|leucovorin|mesh-list
65267400|NCT00648453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65267401|NCT00648453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65267402|NCT00648453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65267403|NCT00648453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65102626|NCT02919462|Cisplatin|cisplatin|mesh-list
65267404|NCT00648453|Purinergic Agents|purinergic agents|mesh-ancestor
65267405|NCT00648453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65267406|NCT00648453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267407|NCT00648453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267409|NCT00549445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65267410|NCT00549445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65267411|NCT00637026|Gefitinib|gefitinib|mesh-list
65267412|NCT00637026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102846|NCT01294579|Ofatumumab|ofatumumab|mesh-list
65267413|NCT00637026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65267414|NCT00637026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267415|NCT00637026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267416|NCT00649155|Ciprofloxacin|ciprofloxacin|mesh-list
65267417|NCT00649155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65267418|NCT00649155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65102994|NCT02937662|Cytarabine|cytarabine|mesh-list
65267419|NCT00649155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65267420|NCT00649155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65103066|NCT02937779|Antiviral Agents|antiviral agents|mesh-ancestor
65267421|NCT00649155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267422|NCT00649155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267423|NCT00649155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267424|NCT00649155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65267425|NCT00649155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65267427|NCT02758340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65267428|NCT02758340|Abortifacient Agents|abortifacient agents|mesh-ancestor
65267429|NCT02758340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65267430|NCT02758340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267431|NCT02758340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65267432|NCT02758340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65267433|NCT02758340|Oxytocics|oxytocics|mesh-ancestor
65267434|NCT02768168|Dezocine|dezocine|mesh-list
65267435|NCT02768168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65267436|NCT02768168|Narcotics|narcotics|mesh-ancestor
65267437|NCT02768168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65267438|NCT02768168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267439|NCT02768168|Analgesics|analgesics|mesh-ancestor
65267440|NCT02768168|Sensory System Agents|sensory system agents|mesh-ancestor
65267441|NCT02768168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65267442|NCT03739554|Venetoclax|venetoclax|mesh-list
65267443|NCT03739554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267444|NCT02659683|Esomeprazole|esomeprazole|mesh-list
65267445|NCT02659683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65267446|NCT02659683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65267447|NCT02659683|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65267448|NCT02659683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267449|NCT02659683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267451|NCT04701476|Tirapazamine|tirapazamine|mesh-list
65267452|NCT04701476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65267453|NCT04701476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267454|NCT05343702|Rocuronium|rocuronium|mesh-list
65267455|NCT05343702|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65267473|NCT02659761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65267476|NCT05343546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65267477|NCT05343546|Contraceptive Agents|contraceptive agents|mesh-ancestor
65267478|NCT05343546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65267479|NCT05343546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267480|NCT05343546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65267481|NCT05343546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65267482|NCT05343546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65267483|NCT05343546|Trace Elements|trace elements|mesh-ancestor
65267484|NCT05343546|Micronutrients|micronutrients|mesh-ancestor
65267485|NCT02659917|Methamphetamine|methamphetamine|mesh-list
65267486|NCT02659917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65267487|NCT02659917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267488|NCT02659917|Sympathomimetics|sympathomimetics|mesh-ancestor
65267489|NCT02659917|Autonomic Agents|autonomic agents|mesh-ancestor
65267490|NCT02659917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65267491|NCT02659917|Dopamine Agents|dopamine agents|mesh-ancestor
65267492|NCT02659917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65274181|NCT02153645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65274182|NCT02153645|Dopamine Agents|dopamine agents|mesh-ancestor
65267493|NCT02659917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267494|NCT02659917|Adrenergic Agents|adrenergic agents|mesh-ancestor
65267495|NCT02659917|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65267496|NCT02659917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65267497|NCT02659917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65267498|NCT02659917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65104452|NCT05466279|Anesthetics|anesthetics|mesh-ancestor
65267499|NCT00954265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65104523|NCT02932254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65104595|NCT02919332|Deoxyglucose|deoxyglucose|mesh-list
65267500|NCT00954265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65267501|NCT00954265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267502|NCT02659527|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65267503|NCT02659527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65267504|NCT02659527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104843|NCT00532662|Ketamine|ketamine|mesh-list
65267505|NCT04500236|Anesthetics|anesthetics|mesh-list
65104906|NCT05467319|Hematinics|hematinics|mesh-ancestor
65104967|NCT00532454|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65267506|NCT04500236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65267507|NCT04500236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267526|NCT05343312|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65267527|NCT05343312|Antimalarials|antimalarials|mesh-ancestor
65267528|NCT05343312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65267529|NCT05343312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65267530|NCT05343312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65267531|NCT02658825|Moxifloxacin|moxifloxacin|mesh-list
65267532|NCT02658825|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65267533|NCT02658825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65267534|NCT02658825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65267535|NCT02658825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65267536|NCT02658825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65267537|NCT02658825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267538|NCT02658825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267539|NCT02658825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267540|NCT02658825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65267541|NCT02658825|Contraceptive Agents|contraceptive agents|mesh-ancestor
65267542|NCT02658825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65267543|NCT02658825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267544|NCT02658825|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65267545|NCT02658825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65267546|NCT02658825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65267548|NCT00649233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65267549|NCT00649233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65267550|NCT00649233|Diuretics|diuretics|mesh-ancestor
65267551|NCT00649233|Natriuretic Agents|natriuretic agents|mesh-ancestor
65267552|NCT00649233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267553|NCT00649233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65267554|NCT00649233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65267555|NCT00649233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267556|NCT00649233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65267557|NCT00649233|Sympatholytics|sympatholytics|mesh-ancestor
65267558|NCT00649233|Autonomic Agents|autonomic agents|mesh-ancestor
65267559|NCT00649233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65267560|NCT00649233|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65267561|NCT00649233|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65267562|NCT00649233|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65267564|NCT00649233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65267565|NCT00954811|Progesterone|progesterone|mesh-list
65267566|NCT00954811|Progestins|progestins|mesh-ancestor
65267567|NCT00954811|Hormones|hormones|mesh-ancestor
65267568|NCT00954811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65267569|NCT00954811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267570|NCT00954889|Tamsulosin|tamsulosin|mesh-list
65267571|NCT00954889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65267572|NCT00954889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65267573|NCT00954889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65267574|NCT00954889|Adrenergic Agents|adrenergic agents|mesh-ancestor
65267575|NCT00954889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65267576|NCT00954889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267577|NCT00954889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267578|NCT00954889|Urological Agents|urological agents|mesh-ancestor
65267579|NCT03666000|Cyclophosphamide|cyclophosphamide|mesh-list
65267580|NCT03666000|Fludarabine|fludarabine|mesh-list
65267581|NCT03666000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65267582|NCT03666000|Immunologic Factors|immunologic factors|mesh-ancestor
65267583|NCT03666000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267584|NCT03666000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65267585|NCT03666000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65267586|NCT03666000|Alkylating Agents|alkylating agents|mesh-ancestor
65105993|NCT00624130|Dacuronium|dacuronium|mesh-list
65267587|NCT03666000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267588|NCT03666000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267589|NCT03666000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65267590|NCT02692248|Gemcitabine|gemcitabine|mesh-list
65267591|NCT02692248|Dexamethasone|dexamethasone|mesh-list
65267593|NCT02692248|Oxaliplatin|oxaliplatin|mesh-list
65106255|NCT05466305|Cobalt|cobalt|mesh-list
65267594|NCT02692248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65267595|NCT02692248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267596|NCT02692248|Immunologic Factors|immunologic factors|mesh-ancestor
65267597|NCT02692248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267598|NCT02692248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65267599|NCT02692248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65267600|NCT02692248|Antiemetics|antiemetics|mesh-ancestor
65267601|NCT02692248|Autonomic Agents|autonomic agents|mesh-ancestor
65267602|NCT02692248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65106405|NCT02503839|Etoricoxib|etoricoxib|mesh-list
65267603|NCT02692248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65017607|NCT00144833|Ritonavir|ritonavir|mesh-list
65267604|NCT02692248|Glucocorticoids|glucocorticoids|mesh-ancestor
65267605|NCT02692248|Hormones|hormones|mesh-ancestor
65267606|NCT02692248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65267607|NCT02692248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65267608|NCT02692248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65267609|NCT02692248|Antimetabolites|antimetabolites|mesh-ancestor
65267610|NCT02692248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267611|NCT02692248|Antiviral Agents|antiviral agents|mesh-ancestor
65106760|NCT00552500|GABA Agents|gaba agents|mesh-ancestor
65106833|NCT04362527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65267612|NCT02692248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65107021|NCT05003089|Hormones|hormones|mesh-ancestor
65267613|NCT02692248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107066|NCT04005053|Acetylcysteine|acetylcysteine|mesh-list
65267614|NCT02692248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65267616|NCT04370509|Axitinib|axitinib|mesh-list
65267617|NCT04370509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65267618|NCT04370509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267619|NCT04370509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65107266|NCT02605421|Melphalan|melphalan|mesh-list
65267620|NCT04370509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267621|NCT04370509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267622|NCT04477772|Antibodies|antibodies|mesh-list
65267623|NCT04477772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65267624|NCT04477772|Immunologic Factors|immunologic factors|mesh-ancestor
65267625|NCT04477772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267626|NCT02851290|Anesthetics|anesthetics|mesh-list
65267627|NCT02851290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65267628|NCT02851290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267629|NCT02757404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65267630|NCT02757404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65267631|NCT02757404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65267632|NCT02757404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267633|NCT02757404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65267634|NCT02757404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65274183|NCT02153645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65267635|NCT02757404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267636|NCT02757404|Cholinergic Agents|cholinergic agents|mesh-ancestor
65267637|NCT02757404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65267638|NCT00955045|Istradefylline|istradefylline|mesh-list
65267639|NCT00955045|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
65267640|NCT00955045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65267641|NCT00955045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65267642|NCT00955045|Purinergic Agents|purinergic agents|mesh-ancestor
65267643|NCT00955045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65267644|NCT00955045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267645|NCT00955045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267646|NCT00601107|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
65267647|NCT00601107|Vitamins|vitamins|mesh-ancestor
65267648|NCT00601107|Micronutrients|micronutrients|mesh-ancestor
65267649|NCT00601107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267650|NCT00601107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65267651|NCT00957385|Lenalidomide|lenalidomide|mesh-list
65267652|NCT00957385|Immunologic Factors|immunologic factors|mesh-ancestor
65267653|NCT00957385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267654|NCT00957385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65267655|NCT00957385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65267656|NCT00957385|Growth Substances|growth substances|mesh-ancestor
65267657|NCT00957385|Growth Inhibitors|growth inhibitors|mesh-ancestor
65267658|NCT00957385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267659|NCT04169841|Durvalumab|durvalumab|mesh-list
65267660|NCT04169841|Olaparib|olaparib|mesh-list
65267661|NCT04169841|Tremelimumab|tremelimumab|mesh-list
65267662|NCT04169841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65267663|NCT04169841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267664|NCT04169841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65267665|NCT04169841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267666|NCT04169841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267667|NCT02462538|Imatinib Mesylate|imatinib mesylate|mesh-list
65267668|NCT02462538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65267669|NCT02462538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267670|NCT02462538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65267671|NCT02462538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108126|NCT02623439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65267672|NCT02462538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267673|NCT02462538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65267674|NCT02752646|Ketorolac|ketorolac|mesh-list
65267675|NCT02752646|Nepafenac|nepafenac|mesh-list
65267676|NCT02752646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65267677|NCT02752646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65267678|NCT02752646|Analgesics|analgesics|mesh-ancestor
65267679|NCT02752646|Sensory System Agents|sensory system agents|mesh-ancestor
65267680|NCT02752646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65108261|NCT00546546|Methotrexate|methotrexate|mesh-list
65267681|NCT02752646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267682|NCT02752646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65267683|NCT02752646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65267684|NCT02752646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65267685|NCT02752646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267686|NCT02752646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267687|NCT04169919|Povidone-Iodine|povidone-iodine|mesh-list
65267688|NCT04169919|Povidone|povidone|mesh-list
65267689|NCT04169919|Plasma Substitutes|plasma substitutes|mesh-ancestor
65267690|NCT04169919|Blood Substitutes|blood substitutes|mesh-ancestor
65267691|NCT04169919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65267692|NCT04169919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65267693|NCT02757248|Romidepsin|romidepsin|mesh-list
65267694|NCT02757248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65108540|NCT03809442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65267695|NCT02757248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267696|NCT00649311|Losartan|losartan|mesh-list
65267697|NCT00649311|Eplerenone|eplerenone|mesh-list
65267698|NCT00649311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65267699|NCT00649311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65267700|NCT00649311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65267701|NCT00649311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65267702|NCT00649311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267703|NCT00649311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65267704|NCT00649311|Hormone Antagonists|hormone antagonists|mesh-ancestor
65267705|NCT00649311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65267706|NCT00649311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267707|NCT00649311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65267709|NCT00649311|Natriuretic Agents|natriuretic agents|mesh-ancestor
65267710|NCT02704494|Losartan|losartan|mesh-list
65267711|NCT02704494|Resveratrol|resveratrol|mesh-list
65267712|NCT02704494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65267713|NCT02704494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65267714|NCT02704494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65267715|NCT02704494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65267716|NCT02704494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267717|NCT02704494|Antioxidants|antioxidants|mesh-ancestor
65267718|NCT02704494|Protective Agents|protective agents|mesh-ancestor
65267719|NCT02704494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267720|NCT02704494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267721|NCT02704494|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65267722|NCT00649467|Topiramate|topiramate|mesh-list
65267723|NCT00649467|Anticonvulsants|anticonvulsants|mesh-ancestor
65108887|NCT02899169|Tretinoin|tretinoin|mesh-list
65267724|NCT00649467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65267725|NCT00649467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267726|NCT00649545|Adalimumab|adalimumab|mesh-list
65108960|NCT00549120|Autonomic Agents|autonomic agents|mesh-ancestor
65267727|NCT00649545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65267728|NCT00649545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65267729|NCT04169763|Nelfinavir|nelfinavir|mesh-list
65267730|NCT04169763|Cisplatin|cisplatin|mesh-list
65267731|NCT04169763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267732|NCT04169763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65267733|NCT04169763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65267734|NCT04169763|Protease Inhibitors|protease inhibitors|mesh-ancestor
65267735|NCT04169763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267736|NCT04169763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267737|NCT04169763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65267738|NCT04169763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65267739|NCT04169763|Antiviral Agents|antiviral agents|mesh-ancestor
65267740|NCT04169763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65267741|NCT00635414|Esomeprazole|esomeprazole|mesh-list
65109468|NCT00550992|Hormones|hormones|mesh-ancestor
65267742|NCT00635414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65109544|NCT00551343|Hormones|hormones|mesh-ancestor
65267743|NCT00635414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65267744|NCT00635414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65267745|NCT00635414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109616|NCT05427617|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65267746|NCT00635414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267747|NCT02658435|Tafenoquine|tafenoquine|mesh-list
65267748|NCT02658435|Antimalarials|antimalarials|mesh-ancestor
65267749|NCT02658435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65267751|NCT02658435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65267752|NCT02756546|Hydroxychloroquine|hydroxychloroquine|mesh-list
65267753|NCT02756546|Hydrocortisone|hydrocortisone|mesh-list
65267754|NCT02756546|Cyclophosphamide|cyclophosphamide|mesh-list
65267756|NCT02756546|Immunologic Factors|immunologic factors|mesh-ancestor
65267757|NCT02756546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267758|NCT02756546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65267759|NCT02756546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65267760|NCT02756546|Alkylating Agents|alkylating agents|mesh-ancestor
65267761|NCT02756546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267762|NCT02756546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267763|NCT02756546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65267764|NCT02756546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65267765|NCT02756546|Antimalarials|antimalarials|mesh-ancestor
65267766|NCT02756546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65109901|NCT04116528|Ketamine|ketamine|mesh-list
65267767|NCT02756546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65267768|NCT02756546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65267769|NCT02756546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109966|NCT05255367|Phenol|phenol|mesh-list
65267770|NCT02752724|Ketamine|ketamine|mesh-list
65267771|NCT02752724|Methohexital|methohexital|mesh-list
65267772|NCT02752724|Analgesics|analgesics|mesh-ancestor
65267773|NCT02752724|Sensory System Agents|sensory system agents|mesh-ancestor
65267774|NCT02752724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65267775|NCT02752724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110114|NCT05093205|Anesthetics|anesthetics|mesh-ancestor
65267777|NCT02752724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65267778|NCT02752724|Anesthetics, General|anesthetics, general|mesh-ancestor
65267779|NCT02752724|Anesthetics|anesthetics|mesh-ancestor
65110200|NCT05073627|Dabigatran|dabigatran|mesh-list
65267780|NCT02752724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65267781|NCT02752724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65267782|NCT02752724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65267783|NCT02752724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65110332|NCT00554528|Meloxicam|meloxicam|mesh-list
65267784|NCT02752724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267785|NCT00649623|Olmesartan|olmesartan|mesh-list
65110454|NCT04678076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65110455|NCT04678076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110456|NCT04678076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110457|NCT02257619|Docetaxel|docetaxel|mesh-list
65110458|NCT02257619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110459|NCT02257619|Tubulin Modulators|tubulin modulators|mesh-ancestor
65110460|NCT02257619|Antimitotic Agents|antimitotic agents|mesh-ancestor
65110461|NCT02257619|Mitosis Modulators|mitosis modulators|mesh-ancestor
65110463|NCT04891302|Clevudine|clevudine|mesh-list
65267786|NCT00649623|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65267788|NCT00649623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65267789|NCT00649623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65267790|NCT00649623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267791|NCT02756312|Anesthetics|anesthetics|mesh-list
65110826|NCT04638309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267792|NCT02756312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65267793|NCT02756312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267795|NCT02657187|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65111052|NCT00557180|Parasympatholytics|parasympatholytics|mesh-ancestor
65267796|NCT02657187|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65267797|NCT02657187|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65267798|NCT02657187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65267799|NCT02657187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267802|NCT00649779|Autonomic Agents|autonomic agents|mesh-ancestor
65267803|NCT00649779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65111418|NCT00541125|Bevacizumab|bevacizumab|mesh-list
65267804|NCT00649779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267805|NCT00649779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65267806|NCT00649779|Respiratory System Agents|respiratory system agents|mesh-ancestor
65267807|NCT00649779|Tocolytic Agents|tocolytic agents|mesh-ancestor
65267808|NCT00649779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65267809|NCT00649779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65267810|NCT00649779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65267811|NCT00649779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65267812|NCT00649779|Adrenergic Agents|adrenergic agents|mesh-ancestor
65267813|NCT00649779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65267814|NCT00649779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267815|NCT00615186|Temozolomide|temozolomide|mesh-list
65267816|NCT00615186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65267817|NCT00615186|Alkylating Agents|alkylating agents|mesh-ancestor
65111494|NCT03096249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65111554|NCT00541554|Antidepressive Agents|antidepressive agents|mesh-ancestor
65111625|NCT02546583|Bumetanide|bumetanide|mesh-list
65267818|NCT00615186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267819|NCT00615186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267820|NCT00616044|Anesthetics|anesthetics|mesh-list
65267821|NCT00616044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65267822|NCT00616044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267824|NCT02536911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111923|NCT00557960|Amphetamine|amphetamine|mesh-list
65267825|NCT02536911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267826|NCT04221152|Empagliflozin|empagliflozin|mesh-list
65111997|NCT00543933|Antioxidants|antioxidants|mesh-ancestor
65267827|NCT04221152|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65267828|NCT04221152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267829|NCT04221152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65267830|NCT04221152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112217|NCT01237951|Antimetabolites|antimetabolites|mesh-ancestor
65267831|NCT02656563|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65267832|NCT02656563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267833|NCT02756000|Dobutamine|dobutamine|mesh-list
65267834|NCT02756000|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65267836|NCT02756000|Autonomic Agents|autonomic agents|mesh-ancestor
65267837|NCT02756000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65112435|NCT04646876|Magnesium Sulfate|magnesium sulfate|mesh-list
65267838|NCT02756000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267839|NCT02756000|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65112583|NCT00558818|Antiviral Agents|antiviral agents|mesh-ancestor
65112657|NCT04643483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65267840|NCT02756000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65267841|NCT02756000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65267842|NCT02756000|Adrenergic Agents|adrenergic agents|mesh-ancestor
65267843|NCT02756000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65112807|NCT04640324|Protective Agents|protective agents|mesh-ancestor
65267844|NCT02756000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112894|NCT01236001|Lacosamide|lacosamide|mesh-list
65267846|NCT02759510|Phenylephrine|phenylephrine|mesh-list
65267847|NCT02759510|Oxymetazoline|oxymetazoline|mesh-list
65267848|NCT02759510|Norepinephrine|norepinephrine|mesh-list
65267849|NCT02759510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65267850|NCT02759510|Mydriatics|mydriatics|mesh-ancestor
65267851|NCT02759510|Autonomic Agents|autonomic agents|mesh-ancestor
65267852|NCT02759510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65267853|NCT02759510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267854|NCT02759510|Sympathomimetics|sympathomimetics|mesh-ancestor
65267855|NCT02759510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65267856|NCT02759510|Nasal Decongestants|nasal decongestants|mesh-ancestor
65267857|NCT02759510|Respiratory System Agents|respiratory system agents|mesh-ancestor
65267858|NCT02759510|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65267859|NCT02759510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65267861|NCT02759510|Adrenergic Agents|adrenergic agents|mesh-ancestor
65113173|NCT01227967|Analgesics|analgesics|mesh-ancestor
65267862|NCT02759510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65267863|NCT02759510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113239|NCT02904369|Tenofovir|tenofovir|mesh-list
65267864|NCT02759510|Protective Agents|protective agents|mesh-ancestor
65267865|NCT04220528|Capecitabine|capecitabine|mesh-list
65267866|NCT04220528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65267867|NCT04220528|Antimetabolites|antimetabolites|mesh-ancestor
65267868|NCT04220528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267869|NCT04220528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267870|NCT02759042|Leronlimab|leronlimab|mesh-list
65267871|NCT02759042|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65267872|NCT02759042|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65267873|NCT02759042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267874|NCT02759042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65267875|NCT02759042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65267876|NCT02759042|Antiviral Agents|antiviral agents|mesh-ancestor
65267877|NCT02759042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65267878|NCT02755532|Bupivacaine|bupivacaine|mesh-list
65267879|NCT02755532|Anesthetics, Local|anesthetics, local|mesh-ancestor
65267880|NCT02755532|Anesthetics|anesthetics|mesh-ancestor
65267881|NCT02755532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65267882|NCT02755532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267883|NCT02755532|Sensory System Agents|sensory system agents|mesh-ancestor
65267884|NCT02755532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65267885|NCT02755376|Hyaluronic Acid|hyaluronic acid|mesh-list
65267886|NCT02755376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65267887|NCT02755376|Immunologic Factors|immunologic factors|mesh-ancestor
65267888|NCT02755376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267889|NCT02755376|Viscosupplements|viscosupplements|mesh-ancestor
65267890|NCT02755376|Protective Agents|protective agents|mesh-ancestor
65267891|NCT02752334|Magnesium Sulfate|magnesium sulfate|mesh-list
65267892|NCT02752334|Bupivacaine|bupivacaine|mesh-list
65267893|NCT02752334|Anesthetics, Local|anesthetics, local|mesh-ancestor
65267894|NCT02752334|Anesthetics|anesthetics|mesh-ancestor
65267895|NCT02752334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65267896|NCT02752334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267897|NCT02752334|Sensory System Agents|sensory system agents|mesh-ancestor
65267898|NCT02752334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65267899|NCT02752334|Analgesics|analgesics|mesh-ancestor
65267900|NCT02752334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65267901|NCT02752334|Anticonvulsants|anticonvulsants|mesh-ancestor
65267902|NCT02752334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65267903|NCT02752334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65267904|NCT02752334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267905|NCT02752334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65267906|NCT02752334|Tocolytic Agents|tocolytic agents|mesh-ancestor
65267907|NCT02752334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65267908|NCT02755298|Acetazolamide|acetazolamide|mesh-list
65267909|NCT02755298|Anticonvulsants|anticonvulsants|mesh-ancestor
65267910|NCT02755298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65267911|NCT02755298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267912|NCT02755298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267913|NCT02755298|Diuretics|diuretics|mesh-ancestor
65267914|NCT02755298|Natriuretic Agents|natriuretic agents|mesh-ancestor
65267915|NCT02755298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267916|NCT02755142|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65114093|NCT05368441|Midazolam|midazolam|mesh-list
65267917|NCT02755142|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65267918|NCT02755142|Dermatologic Agents|dermatologic agents|mesh-ancestor
65267919|NCT02759198|Celecoxib|celecoxib|mesh-list
65267920|NCT02759198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65267921|NCT02759198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65267922|NCT02759198|Analgesics|analgesics|mesh-ancestor
65267923|NCT02759198|Sensory System Agents|sensory system agents|mesh-ancestor
65267924|NCT02759198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65267925|NCT02759198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267926|NCT02759198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65267927|NCT02759198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65267928|NCT02759198|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65267929|NCT02759198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65267930|NCT02759198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267931|NCT02759198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267933|NCT04220606|Vasodilator Agents|vasodilator agents|mesh-ancestor
65267934|NCT02755064|Erythromycin|erythromycin|mesh-list
65267935|NCT02755064|Erythromycin Estolate|erythromycin estolate|mesh-list
65267936|NCT02755064|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65267937|NCT02755064|Erythromycin stearate|erythromycin stearate|mesh-list
65267938|NCT02755064|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
65267939|NCT02755064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65267940|NCT02755064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65267941|NCT02755064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65267942|NCT02755064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65267943|NCT02755064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267944|NCT02755064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267946|NCT00003042|Paclitaxel|paclitaxel|mesh-list
65267947|NCT00003042|Cyclophosphamide|cyclophosphamide|mesh-list
65267948|NCT00003042|Doxorubicin|doxorubicin|mesh-list
65267949|NCT00003042|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65267950|NCT00003042|Melphalan|melphalan|mesh-list
65115040|NCT02153502|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65267951|NCT00003042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65267952|NCT00003042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65267953|NCT00003042|Tubulin Modulators|tubulin modulators|mesh-ancestor
65267954|NCT00003042|Antimitotic Agents|antimitotic agents|mesh-ancestor
65267955|NCT00003042|Mitosis Modulators|mitosis modulators|mesh-ancestor
65115328|NCT01658826|Valacyclovir|valacyclovir|mesh-list
65115401|NCT01632228|Growth Inhibitors|growth inhibitors|mesh-ancestor
65267956|NCT00003042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65267957|NCT00003042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65115629|NCT02010333|Benzyl Alcohol|benzyl alcohol|mesh-list
65267958|NCT00003042|Immunologic Factors|immunologic factors|mesh-ancestor
65267959|NCT00003042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267960|NCT00003042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65267961|NCT00003042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65267962|NCT00003042|Alkylating Agents|alkylating agents|mesh-ancestor
65267963|NCT00003042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65267964|NCT00003042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65267965|NCT00003042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65267966|NCT00003042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65267967|NCT00003042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267968|NCT00003042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65267969|NCT00003042|Hormone Antagonists|hormone antagonists|mesh-ancestor
65116069|NCT01184989|Dabigatran|dabigatran|mesh-list
65116076|NCT04674423|Tenofovir|tenofovir|mesh-list
65116140|NCT01904409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65267970|NCT00003042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65267971|NCT00003042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65267972|NCT00003042|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65267973|NCT00003042|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65267974|NCT00003042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65267975|NCT02754596|Timolol|timolol|mesh-list
65267976|NCT02754596|Travoprost|travoprost|mesh-list
65267977|NCT02754596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65267978|NCT02754596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65116512|NCT04545866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65267979|NCT02754596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116594|NCT01718145|Ribavirin|ribavirin|mesh-list
65267980|NCT02754596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65116659|NCT00532142|Triamcinolone|triamcinolone|mesh-list
65267981|NCT02754596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65267982|NCT02754596|Adrenergic Agents|adrenergic agents|mesh-ancestor
65116731|NCT04668417|Vaccines|vaccines|mesh-list
65267983|NCT02754596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65267984|NCT02754596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267985|NCT02754596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65267986|NCT02754596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65267987|NCT02706054|Meloxicam|meloxicam|mesh-list
65267988|NCT02706054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65117028|NCT01184053|Arsenic Trioxide|arsenic trioxide|mesh-list
65267989|NCT02706054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65267990|NCT02706054|Analgesics|analgesics|mesh-ancestor
65117107|NCT03580148|Cortisone|cortisone|mesh-list
65267991|NCT02706054|Sensory System Agents|sensory system agents|mesh-ancestor
65267992|NCT02706054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65267993|NCT02706054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65267994|NCT02706054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65267995|NCT02706054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65267996|NCT02706054|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65267997|NCT02706054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65267998|NCT02706054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65267999|NCT02706054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268000|NCT02705976|Warfarin|warfarin|mesh-list
65268001|NCT02705976|Anticoagulants|anticoagulants|mesh-ancestor
65268002|NCT02752412|Insulin|insulin|mesh-list
65268003|NCT02752412|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65268004|NCT02752412|Metformin|metformin|mesh-list
65268005|NCT02752412|Insulin Glargine|insulin glargine|mesh-list
65268006|NCT02752412|Lixisenatide|lixisenatide|mesh-list
65268007|NCT02752412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65268008|NCT02752412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268009|NCT02705820|Pembrolizumab|pembrolizumab|mesh-list
65268010|NCT02705820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65268011|NCT02705820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268012|NCT02703090|Remifentanil|remifentanil|mesh-list
65268013|NCT02703090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65268014|NCT02703090|Narcotics|narcotics|mesh-ancestor
65268015|NCT02703090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65268016|NCT02703090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268017|NCT02703090|Analgesics|analgesics|mesh-ancestor
65268018|NCT02703090|Sensory System Agents|sensory system agents|mesh-ancestor
65268019|NCT02703090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65268020|NCT02754362|Bevacizumab|bevacizumab|mesh-list
65268021|NCT02754362|Poly ICLC|poly iclc|mesh-list
65268022|NCT02754362|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
65268023|NCT02754362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
65268024|NCT02754362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65268025|NCT02754362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268026|NCT02754362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65268027|NCT02754362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65117374|NCT03245021|Rituximab|rituximab|mesh-list
65268028|NCT02754362|Growth Substances|growth substances|mesh-ancestor
65268029|NCT02754362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268030|NCT02754362|Growth Inhibitors|growth inhibitors|mesh-ancestor
65268031|NCT02754362|Interferon Inducers|interferon inducers|mesh-ancestor
65268032|NCT02754362|Immunologic Factors|immunologic factors|mesh-ancestor
65268033|NCT03373188|Nivolumab|nivolumab|mesh-list
65268034|NCT03373188|Ipilimumab|ipilimumab|mesh-list
65268035|NCT03373188|Antibodies|antibodies|mesh-list
65268036|NCT03373188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65268037|NCT03373188|Immunologic Factors|immunologic factors|mesh-ancestor
65268038|NCT03373188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268039|NCT03373188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65268040|NCT03373188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268041|NCT03373188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65268042|NCT03373188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268043|NCT02698098|Methadone|methadone|mesh-list
65268044|NCT02698098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65268046|NCT02698098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65118122|NCT02301234|Celecoxib|celecoxib|mesh-list
65268048|NCT02698098|Analgesics|analgesics|mesh-ancestor
65268049|NCT02698098|Sensory System Agents|sensory system agents|mesh-ancestor
65268050|NCT02698098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65268051|NCT02698098|Antitussive Agents|antitussive agents|mesh-ancestor
65118406|NCT04638582|Paclitaxel|paclitaxel|mesh-list
65268052|NCT02698098|Respiratory System Agents|respiratory system agents|mesh-ancestor
65268054|NCT04220996|Antidepressive Agents|antidepressive agents|mesh-ancestor
65268055|NCT04220996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65268056|NCT04220996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65268057|NCT04220996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65268058|NCT04220996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65268059|NCT04220996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268060|NCT04220996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65268061|NCT04220996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65268062|NCT04220996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65268063|NCT04220996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268064|NCT04220996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65268066|NCT04220996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65268067|NCT04220996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65268068|NCT04220996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65268069|NCT04220996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65268070|NCT02702700|Verteporfin|verteporfin|mesh-list
65268071|NCT02702700|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65268072|NCT02702700|Dermatologic Agents|dermatologic agents|mesh-ancestor
65268073|NCT02702622|Provitamins|provitamins|mesh-list
65268074|NCT02702622|Beta Carotene|beta carotene|mesh-list
65268076|NCT02702622|Micronutrients|micronutrients|mesh-ancestor
65268077|NCT02702622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268078|NCT04214808|Dutasteride|dutasteride|mesh-list
65268079|NCT04214808|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65268080|NCT04214808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65268081|NCT04214808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268082|NCT04214808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268083|NCT04214808|Hormone Antagonists|hormone antagonists|mesh-ancestor
65268084|NCT04214808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65268085|NCT04214808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268086|NCT02705508|Gemcitabine|gemcitabine|mesh-list
65268087|NCT02705508|Etoposide|etoposide|mesh-list
65268088|NCT02705508|Etoposide phosphate|etoposide phosphate|mesh-list
65268089|NCT02705508|Pegaspargase|pegaspargase|mesh-list
65268090|NCT02705508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65268091|NCT02705508|Antimetabolites|antimetabolites|mesh-ancestor
65268092|NCT02705508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268093|NCT02705508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268094|NCT02705508|Antiviral Agents|antiviral agents|mesh-ancestor
65268096|NCT02705508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268097|NCT02705508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65268098|NCT02705508|Immunologic Factors|immunologic factors|mesh-ancestor
65119113|NCT05557877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268099|NCT02705508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268100|NCT02705508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65268101|NCT02705508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65268102|NCT02705508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65268103|NCT02702778|Prednisone|prednisone|mesh-list
65268104|NCT02702778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65268105|NCT02702778|Glucocorticoids|glucocorticoids|mesh-ancestor
65268106|NCT02702778|Hormones|hormones|mesh-ancestor
65119186|NCT05325866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119187|NCT05308446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65119188|NCT05308446|Nivolumab|nivolumab|mesh-list
65119189|NCT05308446|Cetuximab|cetuximab|mesh-list
65119190|NCT05308446|Antibodies|antibodies|mesh-list
65119191|NCT05308446|Immunoglobulins|immunoglobulins|mesh-list
65119192|NCT05308446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65119193|NCT05308446|Immunologic Factors|immunologic factors|mesh-ancestor
65119194|NCT05308446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119195|NCT05308446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119196|NCT05308446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65119197|NCT05308446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274184|NCT02153645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268107|NCT02702778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65268108|NCT02702778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268109|NCT02702778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65268110|NCT02702778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268112|NCT02753738|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65268113|NCT02753738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65268114|NCT02753738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65119336|NCT05058287|Methylprednisolone|methylprednisolone|mesh-list
65268115|NCT02753738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268117|NCT02753738|Serotonin Agents|serotonin agents|mesh-ancestor
65119405|NCT04963296|Hormones|hormones|mesh-ancestor
65268118|NCT02753738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268119|NCT02753738|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65268120|NCT02753738|Antidepressive Agents|antidepressive agents|mesh-ancestor
65268122|NCT02751632|Fluoxetine|fluoxetine|mesh-list
65119468|NCT04919226|Leucovorin|leucovorin|mesh-list
65268123|NCT02751632|Antidepressive Agents|antidepressive agents|mesh-list
65268124|NCT02751632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65268125|NCT02751632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65268126|NCT02751632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65268127|NCT02751632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268128|NCT02751632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65268129|NCT02751632|Serotonin Agents|serotonin agents|mesh-ancestor
65119542|NCT04813653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268130|NCT02751632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268131|NCT02751632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65268132|NCT02751632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65268133|NCT02751632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65119623|NCT04766723|Botulinum Toxins|botulinum toxins|mesh-list
65268134|NCT02751632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65268135|NCT02751632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268136|NCT04805268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65268137|NCT04805268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65119809|NCT04415060|Isoflurane|isoflurane|mesh-list
65268138|NCT04805268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268139|NCT02751476|Disinfectants|disinfectants|mesh-list
65268140|NCT02751476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65268142|NCT02705664|Bifonazole|bifonazole|mesh-list
65268143|NCT02705664|Antifungal Agents|antifungal agents|mesh-ancestor
65268144|NCT02705664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65268145|NCT02753426|Doxycycline|doxycycline|mesh-list
65268146|NCT02753426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65268147|NCT02753426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65268148|NCT02753426|Antimalarials|antimalarials|mesh-ancestor
65268149|NCT02753426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65268150|NCT02753426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65268151|NCT04219124|Dapagliflozin|dapagliflozin|mesh-list
65268152|NCT04219124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65268153|NCT04219124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268154|NCT04219124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65268155|NCT04219124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268156|NCT02702076|Apomorphine|apomorphine|mesh-list
65268157|NCT02702076|Emetics|emetics|mesh-ancestor
65268158|NCT02702076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268159|NCT02702076|Autonomic Agents|autonomic agents|mesh-ancestor
65268160|NCT02702076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65268161|NCT02702076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65268162|NCT02702076|Dopamine Agonists|dopamine agonists|mesh-ancestor
65268163|NCT02702076|Dopamine Agents|dopamine agents|mesh-ancestor
65268164|NCT02702076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65268165|NCT02702076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268166|NCT02751398|Dapagliflozin|dapagliflozin|mesh-list
65268167|NCT02751398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65268168|NCT02751398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268169|NCT02751398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65268170|NCT02751398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268171|NCT02753114|Ketamine|ketamine|mesh-list
65268172|NCT02753114|Analgesics|analgesics|mesh-ancestor
65268173|NCT02753114|Sensory System Agents|sensory system agents|mesh-ancestor
65268174|NCT02753114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65268175|NCT02753114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268176|NCT02753114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65268177|NCT02753114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65268178|NCT02753114|Anesthetics, General|anesthetics, general|mesh-ancestor
65268179|NCT02753114|Anesthetics|anesthetics|mesh-ancestor
65120107|NCT03433807|Idebenone|idebenone|mesh-list
65268180|NCT02753114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65268181|NCT02753114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65268182|NCT02753114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65120152|NCT03266783|Rivaroxaban|rivaroxaban|mesh-list
65268183|NCT02753114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65268184|NCT02753114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268186|NCT03288324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65268187|NCT03288324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268188|NCT03288324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268189|NCT05324748|Methylprednisolone|methylprednisolone|mesh-list
65268190|NCT05324748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65268191|NCT05324748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65268192|NCT05324748|Prednisolone|prednisolone|mesh-list
65268193|NCT05324748|Prednisolone acetate|prednisolone acetate|mesh-list
65268194|NCT05324748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65268195|NCT05324748|Prednisolone phosphate|prednisolone phosphate|mesh-list
65268196|NCT05324748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65268197|NCT05324748|Antiemetics|antiemetics|mesh-ancestor
65268198|NCT05324748|Autonomic Agents|autonomic agents|mesh-ancestor
65018205|NCT00529360|Clofarabine|clofarabine|mesh-list
65268199|NCT05324748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65268200|NCT05324748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268201|NCT05324748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65268202|NCT05324748|Glucocorticoids|glucocorticoids|mesh-ancestor
65268203|NCT05324748|Hormones|hormones|mesh-ancestor
65268204|NCT05324748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65268205|NCT05324748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65268206|NCT05324748|Protective Agents|protective agents|mesh-ancestor
65268207|NCT05324748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65268208|NCT05324748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268209|NCT02705274|Bevacizumab|bevacizumab|mesh-list
65268210|NCT02705274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65268211|NCT02705274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268212|NCT02705274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65268213|NCT02705274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65268214|NCT02705274|Growth Substances|growth substances|mesh-ancestor
65120532|NCT00545246|Docetaxel|docetaxel|mesh-list
65268215|NCT02705274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268216|NCT02705274|Growth Inhibitors|growth inhibitors|mesh-ancestor
65268217|NCT00914849|Plerixafor|plerixafor|mesh-list
65268218|NCT00914849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65268219|NCT00914849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65268220|NCT00914849|Antiviral Agents|antiviral agents|mesh-ancestor
65268221|NCT00914849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65268222|NCT02704962|Olanzapine|olanzapine|mesh-list
65268223|NCT02704962|Antiemetics|antiemetics|mesh-ancestor
65268224|NCT02704962|Autonomic Agents|autonomic agents|mesh-ancestor
65268225|NCT02704962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65120626|NCT00545675|Anticonvulsants|anticonvulsants|mesh-ancestor
65268226|NCT02704962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268227|NCT02704962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65268228|NCT02704962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65268229|NCT02704962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65268230|NCT02704962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65268231|NCT02704962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65120906|NCT00549068|Risedronic Acid|risedronic acid|mesh-list
65268232|NCT02704962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65268233|NCT02704962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65268234|NCT02704962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65268235|NCT02704962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268236|NCT02704962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65268237|NCT02704962|Serotonin Agents|serotonin agents|mesh-ancestor
65268238|NCT00631943|Pregabalin|pregabalin|mesh-list
65268239|NCT00631943|Analgesics|analgesics|mesh-ancestor
65268240|NCT00631943|Sensory System Agents|sensory system agents|mesh-ancestor
65268241|NCT00631943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65268242|NCT00631943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268243|NCT00631943|Anticonvulsants|anticonvulsants|mesh-ancestor
65268244|NCT00631943|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65268245|NCT00631943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65120982|NCT04643691|Diuretics|diuretics|mesh-ancestor
65268246|NCT00631943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268247|NCT00631943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65268248|NCT00631943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65268249|NCT00631943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65268250|NCT00631943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65268251|NCT00631943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65268252|NCT05429684|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65268254|NCT05429684|Trastuzumab|trastuzumab|mesh-list
65268255|NCT05429684|Everolimus|everolimus|mesh-list
65268257|NCT05429684|Palbociclib|palbociclib|mesh-list
65268258|NCT05429684|Pertuzumab|pertuzumab|mesh-list
65121287|NCT05408312|Vaccines|vaccines|mesh-list
65268260|NCT05429684|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65268262|NCT05429684|Tubulin Modulators|tubulin modulators|mesh-ancestor
65268263|NCT05429684|Antimitotic Agents|antimitotic agents|mesh-ancestor
65268264|NCT05429684|Mitosis Modulators|mitosis modulators|mesh-ancestor
65121555|NCT01214239|Protease Inhibitors|protease inhibitors|mesh-ancestor
65268265|NCT05429684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268266|NCT05429684|Immunologic Factors|immunologic factors|mesh-ancestor
65268267|NCT05429684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268268|NCT05429684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65268269|NCT05429684|Antimetabolites|antimetabolites|mesh-ancestor
65268270|NCT05429684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65268271|NCT05429684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65268272|NCT05429684|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65268273|NCT05429684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65018285|NCT02942212|Nicotine|nicotine|mesh-list
65268274|NCT05429684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268275|NCT05429684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65268276|NCT05429684|Hormone Antagonists|hormone antagonists|mesh-ancestor
65268277|NCT05429684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65268278|NCT05429684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65268279|NCT05324592|Aflibercept|aflibercept|mesh-list
65268280|NCT05324592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65268281|NCT05324592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65268282|NCT05324592|Growth Substances|growth substances|mesh-ancestor
65268283|NCT05324592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268284|NCT05324592|Growth Inhibitors|growth inhibitors|mesh-ancestor
65268285|NCT05324592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268286|NCT04433858|Psilocybin|psilocybin|mesh-list
65268287|NCT04433858|Hallucinogens|hallucinogens|mesh-ancestor
65268288|NCT04433858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268289|NCT04433858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65268290|NCT02750696|Acetaminophen|acetaminophen|mesh-list
65268292|NCT02750696|Codeine|codeine|mesh-list
65268293|NCT02750696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65268295|NCT02750696|Sensory System Agents|sensory system agents|mesh-ancestor
65268296|NCT02750696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65268297|NCT02750696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268298|NCT02750696|Antipyretics|antipyretics|mesh-ancestor
65122266|NCT04622397|Tranexamic Acid|tranexamic acid|mesh-list
65268299|NCT02750696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65268300|NCT02750696|Narcotics|narcotics|mesh-ancestor
65268301|NCT02750696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65268302|NCT02750696|Antitussive Agents|antitussive agents|mesh-ancestor
65268303|NCT02750696|Respiratory System Agents|respiratory system agents|mesh-ancestor
65268304|NCT02695550|Conteltinib|conteltinib|mesh-list
65268305|NCT02695550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65268306|NCT02695550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268307|NCT02695550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268308|NCT00912743|Olaparib|olaparib|mesh-list
65268309|NCT00912743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65268310|NCT00912743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122624|NCT01165996|Decitabine|decitabine|mesh-list
65268311|NCT00912743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268312|NCT00912743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268313|NCT04432610|Nebivolol|nebivolol|mesh-list
65268314|NCT04432610|Bisoprolol|bisoprolol|mesh-list
65268315|NCT04432610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65268316|NCT04432610|Vasodilator Agents|vasodilator agents|mesh-ancestor
65268317|NCT04432610|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65268318|NCT04432610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65268319|NCT04432610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65268320|NCT04432610|Adrenergic Agents|adrenergic agents|mesh-ancestor
65268321|NCT04432610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65268322|NCT04432610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268323|NCT04432610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268324|NCT04432610|Sympatholytics|sympatholytics|mesh-ancestor
65268325|NCT04432610|Autonomic Agents|autonomic agents|mesh-ancestor
65268326|NCT04432610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122914|NCT04617015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65268327|NCT04432610|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65268328|NCT04432610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65123061|NCT04934228|Clonidine|clonidine|mesh-list
65268330|NCT04643093|Ezetimibe|ezetimibe|mesh-list
65268331|NCT04643093|Pitavastatin|pitavastatin|mesh-list
65268332|NCT04643093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65268334|NCT04643093|Antimetabolites|antimetabolites|mesh-ancestor
65268335|NCT04643093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123355|NCT02179151|Growth Inhibitors|growth inhibitors|mesh-ancestor
65268336|NCT04643093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65268337|NCT04643093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65268339|NCT00914459|Factor VIII|factor viii|mesh-list
65268340|NCT00914459|Coagulants|coagulants|mesh-ancestor
65268341|NCT02701608|Levofloxacin|levofloxacin|mesh-list
65268342|NCT02701608|Ofloxacin|ofloxacin|mesh-list
65268343|NCT02701608|Rifampin|rifampin|mesh-list
65268344|NCT02701608|Fluoroquinolones|fluoroquinolones|mesh-list
65123726|NCT00561132|Antacids|antacids|mesh-ancestor
65268345|NCT02701608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65268346|NCT02701608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65018357|NCT02277067|Carbetocin|carbetocin|mesh-list
65268347|NCT02701608|Renal Agents|renal agents|mesh-ancestor
65268348|NCT02701608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65268349|NCT02701608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65268351|NCT02701608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274185|NCT02153645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268352|NCT02701608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268353|NCT02701608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268354|NCT02701608|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65268355|NCT02701608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65268356|NCT02701608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65268357|NCT02701608|Antitubercular Agents|antitubercular agents|mesh-ancestor
65268358|NCT02701608|Leprostatic Agents|leprostatic agents|mesh-ancestor
65268359|NCT02701608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65124374|NCT01563731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65268360|NCT02701608|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65268361|NCT02701608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65268362|NCT02701608|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65268363|NCT02701608|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65268364|NCT02701608|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65268365|NCT02701608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65268367|NCT00635960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65124816|NCT01159171|Bevacizumab|bevacizumab|mesh-list
65268368|NCT00635960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268369|NCT05429294|Paclitaxel|paclitaxel|mesh-list
65268370|NCT05429294|Trastuzumab|trastuzumab|mesh-list
65268371|NCT05429294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65268372|NCT05429294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268373|NCT05429294|Tubulin Modulators|tubulin modulators|mesh-ancestor
65268374|NCT05429294|Antimitotic Agents|antimitotic agents|mesh-ancestor
65268375|NCT05429294|Mitosis Modulators|mitosis modulators|mesh-ancestor
65124889|NCT00561119|Gemcitabine|gemcitabine|mesh-list
65268376|NCT05429294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125030|NCT04628624|Protective Agents|protective agents|mesh-ancestor
65268377|NCT05429294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65268378|NCT04219046|Naloxegol|naloxegol|mesh-list
65268379|NCT04219046|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65268380|NCT04219046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268381|NCT04219046|Sensory System Agents|sensory system agents|mesh-ancestor
65268382|NCT04219046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65268383|NCT00912509|Riboflavin|riboflavin|mesh-list
65268384|NCT00912509|Vitamin B Complex|vitamin b complex|mesh-ancestor
65268385|NCT00912509|Vitamins|vitamins|mesh-ancestor
65268386|NCT00912509|Micronutrients|micronutrients|mesh-ancestor
65268387|NCT00912509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268388|NCT00912509|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65268389|NCT00912509|Dermatologic Agents|dermatologic agents|mesh-ancestor
65268392|NCT02873598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65268393|NCT02873598|Folfirinox|folfirinox|mesh-list
65268394|NCT02873598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65268395|NCT02873598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268396|NCT02873598|Tubulin Modulators|tubulin modulators|mesh-ancestor
65268397|NCT02873598|Antimitotic Agents|antimitotic agents|mesh-ancestor
65268398|NCT02873598|Mitosis Modulators|mitosis modulators|mesh-ancestor
65268399|NCT02873598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268400|NCT02873598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65268401|NCT02873598|Antimetabolites|antimetabolites|mesh-ancestor
65268402|NCT02873598|Antiviral Agents|antiviral agents|mesh-ancestor
65268403|NCT02873598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65268404|NCT02873598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268405|NCT02873598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65268406|NCT02873598|Immunologic Factors|immunologic factors|mesh-ancestor
65125463|NCT04590612|Carbidopa|carbidopa|mesh-list
65268407|NCT02873598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125528|NCT04313218|Misoprostol|misoprostol|mesh-list
65268408|NCT02749994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65268409|NCT02749994|Ezetimibe|ezetimibe|mesh-list
65268410|NCT02749994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65268411|NCT02749994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65125706|NCT01152190|Tadalafil|tadalafil|mesh-list
65268412|NCT02749994|Antimetabolites|antimetabolites|mesh-ancestor
65274186|NCT02153645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65274187|NCT02153645|Analgesics|analgesics|mesh-ancestor
65125891|NCT04587843|Naltrexone|naltrexone|mesh-list
65268413|NCT02749994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125971|NCT00562835|Hormones|hormones|mesh-ancestor
65268414|NCT02749994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65268415|NCT02749994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65126044|NCT04618952|Calcium|calcium|mesh-list
65268417|NCT04417049|Pentoxifylline|pentoxifylline|mesh-list
65126182|NCT04617782|Cholinergic Agents|cholinergic agents|mesh-ancestor
65268418|NCT04417049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65268419|NCT04417049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268420|NCT04417049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126329|NCT00563069|GABA Modulators|gaba modulators|mesh-ancestor
65126428|NCT00563303|Hydrocortisone|hydrocortisone|mesh-list
65268421|NCT04417049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65018433|NCT02940379|Anesthetics|anesthetics|mesh-ancestor
65268422|NCT04417049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65268423|NCT04417049|Protective Agents|protective agents|mesh-ancestor
65268424|NCT04417049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268425|NCT04417049|Vasodilator Agents|vasodilator agents|mesh-ancestor
65268426|NCT04417049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65268427|NCT04417049|Antioxidants|antioxidants|mesh-ancestor
65268429|NCT04911062|Bupivacaine|bupivacaine|mesh-list
65268430|NCT04911062|Anesthetics, Local|anesthetics, local|mesh-ancestor
65268431|NCT04911062|Anesthetics|anesthetics|mesh-ancestor
65126757|NCT01149460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65126758|NCT00575523|Atropine|atropine|mesh-list
65268432|NCT04911062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65268433|NCT04911062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268434|NCT04911062|Sensory System Agents|sensory system agents|mesh-ancestor
65268435|NCT04911062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65268436|NCT04911062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65268437|NCT04911062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65268438|NCT04911062|Adrenergic Agents|adrenergic agents|mesh-ancestor
64769348|NCT05398484|Niacin|niacin|mesh-list
65268439|NCT04911062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65274188|NCT02153645|Sensory System Agents|sensory system agents|mesh-ancestor
65274189|NCT02153645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65268440|NCT04911062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127196|NCT01147744|Xhance|xhance|mesh-list
65268441|NCT04911062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65127257|NCT00578097|Botulinum Toxins|botulinum toxins|mesh-list
65274190|NCT02688738|Doxycycline|doxycycline|mesh-list
65268442|NCT04911062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65268443|NCT04911062|Autonomic Agents|autonomic agents|mesh-ancestor
65127460|NCT04591457|Insulin|insulin|mesh-list
65268444|NCT04911062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65127524|NCT04590638|Mydriatics|mydriatics|mesh-ancestor
65268445|NCT04911062|Respiratory System Agents|respiratory system agents|mesh-ancestor
65268446|NCT04911062|Mydriatics|mydriatics|mesh-ancestor
65268447|NCT04911062|Sympathomimetics|sympathomimetics|mesh-ancestor
65268448|NCT04911062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65268449|NCT02862210|Lithium Carbonate|lithium carbonate|mesh-list
65268450|NCT02862210|Antidepressive Agents|antidepressive agents|mesh-ancestor
65268451|NCT02862210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65268452|NCT02862210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127720|NCT04593654|Tinzaparin|tinzaparin|mesh-list
65268453|NCT02862210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268454|NCT02862210|Antimanic Agents|antimanic agents|mesh-ancestor
65268455|NCT02862210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65268456|NCT02862210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64770557|NCT03093909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268457|NCT02862210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268458|NCT05323422|Ketamine|ketamine|mesh-list
65268459|NCT05323422|Analgesics|analgesics|mesh-ancestor
65128168|NCT00568763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128243|NCT00569699|Growth Substances|growth substances|mesh-ancestor
65128246|NCT00569816|Sevoflurane|sevoflurane|mesh-list
65128317|NCT00584376|Analgesics|analgesics|mesh-ancestor
65268460|NCT05323422|Sensory System Agents|sensory system agents|mesh-ancestor
65268461|NCT05323422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65268462|NCT05323422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128537|NCT01142596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65268463|NCT05323422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65128640|NCT00585741|Alovudine|alovudine|mesh-list
65268464|NCT05323422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65128735|NCT01138657|Prednisone|prednisone|mesh-list
65268465|NCT05323422|Anesthetics, General|anesthetics, general|mesh-ancestor
65268466|NCT05323422|Anesthetics|anesthetics|mesh-ancestor
65128987|NCT00199797|Antidotes|antidotes|mesh-ancestor
65268467|NCT05323422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65268468|NCT05323422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65268469|NCT05323422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65268470|NCT05323422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65274191|NCT02688738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65274192|NCT02688738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65129512|NCT00564512|Rituximab|rituximab|mesh-list
65268471|NCT05323422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268474|NCT02700906|Anesthetics|anesthetics|mesh-ancestor
65268475|NCT02700906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65268476|NCT02700906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274195|NCT02688738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65268477|NCT02700906|Sensory System Agents|sensory system agents|mesh-ancestor
65268478|NCT02700906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65268479|NCT02700906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65274196|NCT00639366|Trastuzumab|trastuzumab|mesh-list
65130537|NCT03452696|Calcium|calcium|mesh-list
65130610|NCT04312204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274197|NCT00639366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65130756|NCT00587873|Immunologic Factors|immunologic factors|mesh-ancestor
65130831|NCT01083810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268480|NCT02700906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65268481|NCT02700906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65130988|NCT03452306|Metformin|metformin|mesh-list
65131051|NCT01085097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65131276|NCT04565184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65131350|NCT03453164|Nivolumab|nivolumab|mesh-list
65268482|NCT02700906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65268483|NCT02700906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268484|NCT00636038|Beta Carotene|beta carotene|mesh-list
65268485|NCT00636038|Carotenoids|carotenoids|mesh-list
65268487|NCT00636038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131743|NCT04559568|Midazolam|midazolam|mesh-list
65268488|NCT00636038|Protective Agents|protective agents|mesh-ancestor
65268489|NCT00636038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131869|NCT00476606|Ritonavir|ritonavir|mesh-list
65268490|NCT00636038|Provitamins|provitamins|mesh-ancestor
65268491|NCT00636038|Vitamins|vitamins|mesh-ancestor
65268492|NCT00636038|Micronutrients|micronutrients|mesh-ancestor
65268493|NCT04723004|Bevacizumab|bevacizumab|mesh-list
65268494|NCT04723004|Sorafenib|sorafenib|mesh-list
65268495|NCT04723004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65268496|NCT04723004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268497|NCT04723004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65268498|NCT04723004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65268499|NCT04723004|Growth Substances|growth substances|mesh-ancestor
65268500|NCT04723004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268501|NCT04723004|Growth Inhibitors|growth inhibitors|mesh-ancestor
65268502|NCT04723004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65132158|NCT00478595|Hormones|hormones|mesh-ancestor
65268503|NCT04723004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132376|NCT01086410|Dermatologic Agents|dermatologic agents|mesh-ancestor
65132525|NCT01083602|Autonomic Agents|autonomic agents|mesh-ancestor
65268504|NCT04723004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268505|NCT04213716|Calcium, Dietary|calcium, dietary|mesh-list
65268507|NCT04213716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65268508|NCT04213716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268509|NCT04213716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65268510|NCT04218890|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
65268511|NCT04218890|Thromboplastin|thromboplastin|mesh-list
65268512|NCT04218890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65268513|NCT04218890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65268514|NCT04218890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268515|NCT04218890|Hemostatics|hemostatics|mesh-ancestor
65268516|NCT04218890|Coagulants|coagulants|mesh-ancestor
65268517|NCT04218890|Anticoagulants|anticoagulants|mesh-ancestor
65268518|NCT04218890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65268519|NCT04218890|Protease Inhibitors|protease inhibitors|mesh-ancestor
65268520|NCT04218890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268521|NCT04218890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65268522|NCT04218890|Antithrombins|antithrombins|mesh-ancestor
65268523|NCT00636116|Antivenins|antivenins|mesh-list
65268524|NCT00636116|Immunologic Factors|immunologic factors|mesh-ancestor
65268525|NCT00636116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268526|NCT04772196|Vitamin D|vitamin d|mesh-list
65268527|NCT04772196|Cholecalciferol|cholecalciferol|mesh-list
65268528|NCT04772196|Vitamins|vitamins|mesh-ancestor
65268529|NCT04772196|Micronutrients|micronutrients|mesh-ancestor
65268530|NCT04772196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268531|NCT04772196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65268532|NCT04772196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65268533|NCT05428670|Rituximab|rituximab|mesh-list
65268534|NCT05428670|Lenalidomide|lenalidomide|mesh-list
65268535|NCT05428670|Zanubrutinib|zanubrutinib|mesh-list
65268536|NCT05428670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65268537|NCT05428670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268538|NCT05428670|Immunologic Factors|immunologic factors|mesh-ancestor
65268539|NCT05428670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268540|NCT05428670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65132674|NCT00177216|Antidepressive Agents|antidepressive agents|mesh-ancestor
65268541|NCT05428670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65268542|NCT05428670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65268543|NCT05428670|Growth Substances|growth substances|mesh-ancestor
65268545|NCT05428670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65268546|NCT05428670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268547|NCT05428670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268548|NCT00635726|Gemcitabine|gemcitabine|mesh-list
65268549|NCT00635726|Cisplatin|cisplatin|mesh-list
65268550|NCT00635726|Doxorubicin|doxorubicin|mesh-list
65268551|NCT00635726|Methotrexate|methotrexate|mesh-list
65268552|NCT00635726|Vinblastine|vinblastine|mesh-list
65268553|NCT00635726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268554|NCT00635726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65268555|NCT00635726|Antimetabolites|antimetabolites|mesh-ancestor
65268556|NCT00635726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268557|NCT00635726|Antiviral Agents|antiviral agents|mesh-ancestor
65268558|NCT00635726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65268559|NCT00635726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268560|NCT00635726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65268561|NCT00635726|Immunologic Factors|immunologic factors|mesh-ancestor
65268562|NCT00635726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268563|NCT00635726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65268564|NCT00635726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65268565|NCT00635726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65268566|NCT00635726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65268567|NCT00635726|Abortifacient Agents|abortifacient agents|mesh-ancestor
65268568|NCT00635726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65268569|NCT00635726|Dermatologic Agents|dermatologic agents|mesh-ancestor
65018582|NCT00169572|Hormones|hormones|mesh-ancestor
65268570|NCT00635726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65268571|NCT00635726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65268572|NCT00635726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65268573|NCT00635726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65268574|NCT00635726|Tubulin Modulators|tubulin modulators|mesh-ancestor
65268575|NCT00635726|Antimitotic Agents|antimitotic agents|mesh-ancestor
65268576|NCT00635726|Mitosis Modulators|mitosis modulators|mesh-ancestor
65268577|NCT02749292|Rituximab|rituximab|mesh-list
65268578|NCT02749292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65268579|NCT02749292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268580|NCT02749292|Immunologic Factors|immunologic factors|mesh-ancestor
65268581|NCT02749292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268582|NCT02749292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65268583|NCT04217096|Paclitaxel|paclitaxel|mesh-list
65133117|NCT02210117|Nivolumab|nivolumab|mesh-list
65268584|NCT04217096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65268585|NCT04217096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268586|NCT04217096|Tubulin Modulators|tubulin modulators|mesh-ancestor
65268587|NCT04217096|Antimitotic Agents|antimitotic agents|mesh-ancestor
65268588|NCT04217096|Mitosis Modulators|mitosis modulators|mesh-ancestor
65268589|NCT04217096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268590|NCT04219982|Scopolamine|scopolamine|mesh-list
65268591|NCT04219982|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65268592|NCT04219982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65268593|NCT04219982|Antiemetics|antiemetics|mesh-ancestor
65268594|NCT04219982|Autonomic Agents|autonomic agents|mesh-ancestor
65134056|NCT04544163|Sensory System Agents|sensory system agents|mesh-ancestor
65134202|NCT02216331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65268595|NCT04219982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65268596|NCT04219982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268597|NCT04219982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65268599|NCT04219982|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65134500|NCT04530903|Clonidine|clonidine|mesh-list
65268600|NCT04219982|Cholinergic Agents|cholinergic agents|mesh-ancestor
65134649|NCT00580814|Methylphenidate|methylphenidate|mesh-list
65268601|NCT04219982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65268602|NCT04219982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268603|NCT04219982|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65268604|NCT04219982|Parasympatholytics|parasympatholytics|mesh-ancestor
65268605|NCT02700438|Nitroglycerin|nitroglycerin|mesh-list
65268606|NCT02700438|Vasodilator Agents|vasodilator agents|mesh-ancestor
65268607|NCT04216706|Calcium Channel Blockers|calcium channel blockers|mesh-list
65268608|NCT04216706|Sympatholytics|sympatholytics|mesh-list
65268609|NCT04216706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65268610|NCT04216706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134720|NCT00581009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65268611|NCT04216706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65134892|NCT02219178|Bortezomib|bortezomib|mesh-list
65134944|NCT02219412|Aspirin|aspirin|mesh-list
65268612|NCT04216706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268613|NCT04216706|Autonomic Agents|autonomic agents|mesh-ancestor
65268614|NCT04216706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65268616|NCT00913835|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65135380|NCT04549844|Bupivacaine|bupivacaine|mesh-list
65135454|NCT02214368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65135603|NCT01181011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65268618|NCT00913835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65135748|NCT04545788|Antitubercular Agents|antitubercular agents|mesh-ancestor
65268619|NCT00913835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268620|NCT00913835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65268621|NCT00913835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65268622|NCT00913835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135973|NCT02214992|Protease Inhibitors|protease inhibitors|mesh-ancestor
65268623|NCT00913835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268624|NCT05322720|Paclitaxel|paclitaxel|mesh-list
65268625|NCT05322720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65268626|NCT05322720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65268627|NCT05322720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268628|NCT05322720|Tubulin Modulators|tubulin modulators|mesh-ancestor
65268629|NCT05322720|Antimitotic Agents|antimitotic agents|mesh-ancestor
65136190|NCT01180660|Anesthetics|anesthetics|mesh-ancestor
65136263|NCT01649037|Mydriatics|mydriatics|mesh-ancestor
65268630|NCT05322720|Mitosis Modulators|mitosis modulators|mesh-ancestor
65136345|NCT01179919|Oseltamivir|oseltamivir|mesh-list
65136408|NCT01200589|Rituximab|rituximab|mesh-list
65268631|NCT05322720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268632|NCT04213170|Bevacizumab|bevacizumab|mesh-list
65136629|NCT04531397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65268633|NCT04213170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65136781|NCT01685892|Venetoclax|venetoclax|mesh-list
65268634|NCT04213170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268635|NCT04213170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65268636|NCT04213170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65268637|NCT04213170|Growth Substances|growth substances|mesh-ancestor
65268638|NCT04213170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268639|NCT04213170|Growth Inhibitors|growth inhibitors|mesh-ancestor
65268640|NCT05322564|Opiate Alkaloids|opiate alkaloids|mesh-list
65268641|NCT05322564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65268642|NCT05322564|Narcotics|narcotics|mesh-ancestor
65268643|NCT05322564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65268644|NCT05322564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268645|NCT05322564|Analgesics|analgesics|mesh-ancestor
65268646|NCT05322564|Sensory System Agents|sensory system agents|mesh-ancestor
65268647|NCT05322564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65268648|NCT02749136|Gemcitabine|gemcitabine|mesh-list
65268650|NCT02749136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65268651|NCT02749136|Antimetabolites|antimetabolites|mesh-ancestor
65268652|NCT02749136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268653|NCT02749136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268654|NCT02749136|Antiviral Agents|antiviral agents|mesh-ancestor
65268655|NCT02749136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65268656|NCT02749136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137284|NCT03016338|Niraparib|niraparib|mesh-list
65268657|NCT02749136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65268658|NCT02749136|Immunologic Factors|immunologic factors|mesh-ancestor
65137651|NCT01643135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268659|NCT02749136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268661|NCT00631631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65268662|NCT00631631|Immunologic Factors|immunologic factors|mesh-ancestor
65137875|NCT01644071|Autonomic Agents|autonomic agents|mesh-ancestor
65268664|NCT02999022|Lithium Carbonate|lithium carbonate|mesh-list
65268665|NCT02999022|Antidepressive Agents|antidepressive agents|mesh-ancestor
65268666|NCT02999022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65268667|NCT02999022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268668|NCT02999022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268670|NCT02999022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65138391|NCT01608945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65268671|NCT02999022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65268672|NCT02999022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268673|NCT04238741|Anesthetics|anesthetics|mesh-list
65268674|NCT04238741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65268675|NCT04238741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268676|NCT02691858|Hydrocortisone|hydrocortisone|mesh-list
65268677|NCT02691858|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65268678|NCT02691858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65268679|NCT04218500|Niacinamide|niacinamide|mesh-list
65268680|NCT04218500|Niacin|niacin|mesh-list
65268681|NCT04218500|Nicotinic Acids|nicotinic acids|mesh-list
65268682|NCT04218500|Vitamin B Complex|vitamin b complex|mesh-ancestor
65268683|NCT04218500|Vitamins|vitamins|mesh-ancestor
65268684|NCT04218500|Micronutrients|micronutrients|mesh-ancestor
65268685|NCT04218500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268686|NCT04218500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65268687|NCT04218500|Antimetabolites|antimetabolites|mesh-ancestor
65268688|NCT04218500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139081|NCT01687127|Folic Acid|folic acid|mesh-list
65139194|NCT01687868|Dexmedetomidine|dexmedetomidine|mesh-list
65139272|NCT01689896|Testosterone|testosterone|mesh-list
65139341|NCT05653401|Anticonvulsants|anticonvulsants|mesh-ancestor
65268689|NCT04218500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65268690|NCT04218500|Vasodilator Agents|vasodilator agents|mesh-ancestor
65268691|NCT04264208|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65139713|NCT01340664|Metformin|metformin|mesh-list
65268692|NCT04264208|Bombesin|bombesin|mesh-list
65268693|NCT04264208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65268694|NCT04264208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139940|NCT04389294|Antibodies|antibodies|mesh-list
65140014|NCT04328883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65268695|NCT04264208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65268696|NCT04264208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268697|NCT05412056|Metformin|metformin|mesh-list
65268698|NCT05412056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65140234|NCT04367688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268699|NCT05412056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140468|NCT01602302|Adalimumab|adalimumab|mesh-list
65268701|NCT04453046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65140613|NCT00592566|Glucocorticoids|glucocorticoids|mesh-ancestor
65268702|NCT04453046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268704|NCT04216628|Oxytocics|oxytocics|mesh-ancestor
65268706|NCT04216628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268707|NCT05411978|Ubiquinone|ubiquinone|mesh-list
65268708|NCT05411978|Idebenone|idebenone|mesh-list
65268709|NCT05411978|Antioxidants|antioxidants|mesh-ancestor
65268710|NCT05411978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268711|NCT05411978|Protective Agents|protective agents|mesh-ancestor
65268712|NCT05411978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268713|NCT05411978|Micronutrients|micronutrients|mesh-ancestor
65268714|NCT00617370|Paclitaxel|paclitaxel|mesh-list
65268715|NCT00617370|Cyclophosphamide|cyclophosphamide|mesh-list
65268716|NCT00617370|Epirubicin|epirubicin|mesh-list
65268717|NCT00617370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65268718|NCT00617370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268719|NCT00617370|Tubulin Modulators|tubulin modulators|mesh-ancestor
65268720|NCT00617370|Antimitotic Agents|antimitotic agents|mesh-ancestor
65268721|NCT00617370|Mitosis Modulators|mitosis modulators|mesh-ancestor
65141049|NCT00595140|Dopamine Agents|dopamine agents|mesh-ancestor
65268722|NCT00617370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141136|NCT02271464|Antimetabolites|antimetabolites|mesh-ancestor
65268723|NCT00617370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65268724|NCT00617370|Immunologic Factors|immunologic factors|mesh-ancestor
65141448|NCT01335698|Ritonavir|ritonavir|mesh-list
65268725|NCT00617370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141640|NCT01326702|Veliparib|veliparib|mesh-list
65268726|NCT00617370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65268727|NCT00617370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65268728|NCT00617370|Alkylating Agents|alkylating agents|mesh-ancestor
65141933|NCT00598572|Deferoxamine|deferoxamine|mesh-list
65268729|NCT00617370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65142003|NCT00623220|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65268730|NCT00617370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65268731|NCT00617370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65268732|NCT00617370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65268733|NCT00617370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268734|NCT02699658|Levofloxacin|levofloxacin|mesh-list
65268735|NCT02699658|Ofloxacin|ofloxacin|mesh-list
65268736|NCT02699658|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65142370|NCT04327232|Diuretics|diuretics|mesh-ancestor
65268737|NCT02699658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65268738|NCT02699658|Renal Agents|renal agents|mesh-ancestor
65268739|NCT02699658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65268740|NCT02699658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65142737|NCT02878291|Vaccines|vaccines|mesh-list
65268741|NCT02699658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65268742|NCT02699658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274198|NCT00639366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142961|NCT01101841|Serotonin Agents|serotonin agents|mesh-ancestor
65274199|NCT02686710|Propofol|propofol|mesh-list
65143184|NCT02890875|Heparin|heparin|mesh-list
65143259|NCT01170364|Appetite Depressants|appetite depressants|mesh-ancestor
65268743|NCT02699658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268744|NCT02699658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143704|NCT02875873|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65143782|NCT01102972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143855|NCT04296253|Mitogens|mitogens|mesh-list
65143927|NCT04325061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65144077|NCT00594269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144147|NCT00596297|Growth Substances|growth substances|mesh-ancestor
65268745|NCT02699658|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65268746|NCT02699658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65268748|NCT04218734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65268749|NCT04218734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268750|NCT04066478|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65144676|NCT01035463|Antimetabolites|antimetabolites|mesh-ancestor
65268752|NCT04066478|Immunologic Factors|immunologic factors|mesh-ancestor
65268753|NCT04066478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268754|NCT04496063|Ustekinumab|ustekinumab|mesh-list
65268755|NCT04496063|Dermatologic Agents|dermatologic agents|mesh-ancestor
65268756|NCT04032626|Lenalidomide|lenalidomide|mesh-list
65268757|NCT04032626|Immunologic Factors|immunologic factors|mesh-ancestor
65144897|NCT01320683|Oxaliplatin|oxaliplatin|mesh-list
65268758|NCT04032626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144975|NCT01313663|Pemetrexed|pemetrexed|mesh-list
65268759|NCT04032626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65268760|NCT04032626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65145263|NCT01091428|Paclitaxel|paclitaxel|mesh-list
65145338|NCT01023217|Lamivudine|lamivudine|mesh-list
65268761|NCT04032626|Growth Substances|growth substances|mesh-ancestor
65145556|NCT02872597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65268763|NCT04032626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268764|NCT04214106|Thiamine|thiamine|mesh-list
65268765|NCT04214106|Vitamin B Complex|vitamin b complex|mesh-ancestor
65268766|NCT04214106|Vitamins|vitamins|mesh-ancestor
65145782|NCT04306666|Anesthetics|anesthetics|mesh-list
65268767|NCT04214106|Micronutrients|micronutrients|mesh-ancestor
65146004|NCT01016977|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65268768|NCT04214106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146107|NCT01012219|Niacin|niacin|mesh-list
65146153|NCT01011673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65268769|NCT02747732|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65268770|NCT02747732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268771|NCT02747732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65268773|NCT02747732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268774|NCT02695862|Terlipressin|terlipressin|mesh-list
65268775|NCT02695862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65268776|NCT02695862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65268777|NCT00617448|Anesthetics|anesthetics|mesh-list
65268778|NCT00617448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65146303|NCT01004185|Analgesics|analgesics|mesh-ancestor
65268779|NCT00617448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268780|NCT04308863|Chitosan|chitosan|mesh-list
65146597|NCT04978545|Chlorhexidine|chlorhexidine|mesh-list
65268781|NCT04308863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268782|NCT04308863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65268783|NCT04308863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65268784|NCT04308863|Antimetabolites|antimetabolites|mesh-ancestor
65268785|NCT04308863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65268786|NCT04308863|Chelating Agents|chelating agents|mesh-ancestor
65268787|NCT04308863|Sequestering Agents|sequestering agents|mesh-ancestor
65146747|NCT02866071|Ketamine|ketamine|mesh-list
65268788|NCT04308863|Hemostatics|hemostatics|mesh-ancestor
65268789|NCT04308863|Coagulants|coagulants|mesh-ancestor
65268790|NCT00615810|Efavirenz|efavirenz|mesh-list
65268791|NCT00615810|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65268792|NCT00615810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65268793|NCT00615810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65268794|NCT00615810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268795|NCT00615810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268796|NCT00615810|Antiviral Agents|antiviral agents|mesh-ancestor
65268797|NCT00615810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65268798|NCT00615810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65268799|NCT00615810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65268800|NCT00615810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65268801|NCT00615810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65268802|NCT00615810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65268803|NCT00615810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65268804|NCT00615810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65268805|NCT00615810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65268806|NCT03355157|Tamoxifen|tamoxifen|mesh-list
65268807|NCT03355157|Paclitaxel|paclitaxel|mesh-list
65268808|NCT03355157|Vinorelbine|vinorelbine|mesh-list
65210072|NCT04241523|Lenvatinib|lenvatinib|mesh-list
65268809|NCT03355157|Capecitabine|capecitabine|mesh-list
65268810|NCT03355157|Letrozole|letrozole|mesh-list
65268811|NCT03355157|Epirubicin|epirubicin|mesh-list
65268812|NCT03355157|Fulvestrant|fulvestrant|mesh-list
65268813|NCT03355157|Palbociclib|palbociclib|mesh-list
65268814|NCT03355157|Exemestane|exemestane|mesh-list
65268815|NCT03355157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65268816|NCT03355157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268817|NCT03355157|Tubulin Modulators|tubulin modulators|mesh-ancestor
65268818|NCT03355157|Antimitotic Agents|antimitotic agents|mesh-ancestor
65268819|NCT03355157|Mitosis Modulators|mitosis modulators|mesh-ancestor
65268820|NCT03355157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268821|NCT03355157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65268822|NCT03355157|Antimetabolites|antimetabolites|mesh-ancestor
65268823|NCT03355157|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65268824|NCT03355157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65268825|NCT03355157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268826|NCT03355157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65268827|NCT03355157|Hormone Antagonists|hormone antagonists|mesh-ancestor
65268828|NCT03355157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65268829|NCT03355157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268830|NCT03355157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65268831|NCT03355157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65268832|NCT03355157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65146952|NCT01296672|Finasteride|finasteride|mesh-list
65146961|NCT01254669|Vaccines|vaccines|mesh-list
65268833|NCT03355157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65268834|NCT03355157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65268835|NCT03355157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65268836|NCT03355157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65268837|NCT03355157|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65268838|NCT03355157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65268840|NCT04215432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65268841|NCT03324035|Tramadol|tramadol|mesh-list
65268842|NCT03324035|Amitriptyline|amitriptyline|mesh-list
65268843|NCT03324035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65268844|NCT03324035|Narcotics|narcotics|mesh-ancestor
65268845|NCT03324035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65268846|NCT03324035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268847|NCT03324035|Analgesics|analgesics|mesh-ancestor
65268848|NCT03324035|Sensory System Agents|sensory system agents|mesh-ancestor
65268849|NCT03324035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65268850|NCT03324035|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65268851|NCT03324035|Antidepressive Agents|antidepressive agents|mesh-ancestor
65268852|NCT03324035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65268853|NCT03324035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65268854|NCT03324035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65268855|NCT03324035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65268856|NCT03324035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65268857|NCT03324035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268858|NCT03324035|Adrenergic Agents|adrenergic agents|mesh-ancestor
65268859|NCT03324035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65268860|NCT00616746|Ethanol|ethanol|mesh-list
65268861|NCT00616746|Nicotine|nicotine|mesh-list
65268862|NCT00616746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65268863|NCT00616746|Autonomic Agents|autonomic agents|mesh-ancestor
65268864|NCT00616746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65268865|NCT00616746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268866|NCT00616746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65268867|NCT00616746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65268868|NCT00616746|Cholinergic Agents|cholinergic agents|mesh-ancestor
65268869|NCT00616746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65268870|NCT00616746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268871|NCT00616746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65268872|NCT00616746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65268873|NCT00616746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65268874|NCT00777582|Olaparib|olaparib|mesh-list
65268875|NCT00777582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65268876|NCT00777582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268877|NCT00777582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268878|NCT00777582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268879|NCT00632255|Imatinib Mesylate|imatinib mesylate|mesh-list
65268880|NCT00632255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268881|NCT00632255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65268882|NCT00632255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268883|NCT00632255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268884|NCT04677504|Gemcitabine|gemcitabine|mesh-list
65268885|NCT04677504|Bevacizumab|bevacizumab|mesh-list
65268886|NCT04677504|Atezolizumab|atezolizumab|mesh-list
65268887|NCT04677504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65268888|NCT04677504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268889|NCT04677504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65268890|NCT04677504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65268891|NCT04677504|Growth Substances|growth substances|mesh-ancestor
65268892|NCT04677504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268894|NCT04677504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65268895|NCT04677504|Antimetabolites|antimetabolites|mesh-ancestor
65274201|NCT02686710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65268896|NCT04677504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268897|NCT04677504|Antiviral Agents|antiviral agents|mesh-ancestor
65268898|NCT04677504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65268899|NCT04677504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268900|NCT04677504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65268901|NCT04677504|Immunologic Factors|immunologic factors|mesh-ancestor
65268902|NCT05271578|Nicotine|nicotine|mesh-list
65268903|NCT05271578|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65268904|NCT05271578|Autonomic Agents|autonomic agents|mesh-ancestor
65268905|NCT05271578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65268906|NCT05271578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268907|NCT05271578|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65268908|NCT05271578|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65268909|NCT05271578|Cholinergic Agents|cholinergic agents|mesh-ancestor
65268910|NCT05271578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65268911|NCT05271578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268912|NCT04203485|Paclitaxel|paclitaxel|mesh-list
65268913|NCT04203485|Carboplatin|carboplatin|mesh-list
65268914|NCT04203485|Pemetrexed|pemetrexed|mesh-list
65268915|NCT04203485|Apatinib|apatinib|mesh-list
65268916|NCT04203485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65268917|NCT04203485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268918|NCT04203485|Tubulin Modulators|tubulin modulators|mesh-ancestor
65268919|NCT04203485|Antimitotic Agents|antimitotic agents|mesh-ancestor
65268920|NCT04203485|Mitosis Modulators|mitosis modulators|mesh-ancestor
65268921|NCT04203485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268922|NCT04203485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65268923|NCT04203485|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65268924|NCT04203485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65268925|NCT04203485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65268926|NCT03851627|Methyltestosterone|methyltestosterone|mesh-list
65268927|NCT03851627|Testosterone|testosterone|mesh-list
65268928|NCT03851627|Testosterone undecanoate|testosterone undecanoate|mesh-list
65268929|NCT03851627|Testosterone enanthate|testosterone enanthate|mesh-list
65268930|NCT03851627|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65268931|NCT03851627|Androgens|androgens|mesh-ancestor
65147568|NCT01029652|Immunologic Factors|immunologic factors|mesh-ancestor
65274202|NCT02686710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65274203|NCT02686710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274204|NCT02686710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65268933|NCT03851627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65268934|NCT03851627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147942|NCT01299896|Dopamine Agents|dopamine agents|mesh-ancestor
65268935|NCT03851627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65148086|NCT01056718|Adrenergic Agents|adrenergic agents|mesh-ancestor
65148090|NCT01298570|Leucovorin|leucovorin|mesh-list
65268936|NCT03851627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268938|NCT03116126|Guanfacine|guanfacine|mesh-list
65274205|NCT02686710|Anesthetics, General|anesthetics, general|mesh-ancestor
65268940|NCT03116126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65268941|NCT03116126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65148682|NCT01002547|Antioxidants|antioxidants|mesh-ancestor
65268942|NCT03116126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65268943|NCT03116126|Adrenergic Agents|adrenergic agents|mesh-ancestor
65148912|NCT01221753|Carboplatin|carboplatin|mesh-list
65268944|NCT03116126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65148979|NCT01219959|Icodextrin|icodextrin|mesh-list
65274207|NCT02686710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65268945|NCT03116126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268946|NCT03116126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018947|NCT00169845|Provitamins|provitamins|mesh-ancestor
65268948|NCT02983682|Anesthetics, Local|anesthetics, local|mesh-ancestor
65268949|NCT02983682|Anesthetics|anesthetics|mesh-ancestor
65268950|NCT02983682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65268951|NCT02983682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268952|NCT02983682|Sensory System Agents|sensory system agents|mesh-ancestor
65268953|NCT02983682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65149570|NCT01003990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65268954|NCT02983682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65149793|NCT01001572|Amlodipine|amlodipine|mesh-list
65149866|NCT01206777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65268955|NCT02983682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65268956|NCT02983682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65150014|NCT01198509|Vancomycin|vancomycin|mesh-list
65268957|NCT02983682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65150231|NCT01193283|Immunologic Factors|immunologic factors|mesh-ancestor
65150455|NCT05661227|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65150527|NCT02890589|Immunologic Factors|immunologic factors|mesh-ancestor
65268958|NCT02983682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150610|NCT01300247|Fludarabine|fludarabine|mesh-list
65268959|NCT00910247|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
65150680|NCT04315935|Fentanyl|fentanyl|mesh-list
65268960|NCT00910247|Anticonvulsants|anticonvulsants|mesh-ancestor
65150826|NCT04046107|Cemiplimab|cemiplimab|mesh-list
65274208|NCT02686710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65268961|NCT00910247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65274209|NCT01818167|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65268962|NCT00910247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65274210|NCT01818167|Dermatologic Agents|dermatologic agents|mesh-ancestor
65268963|NCT00910247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65151494|NCT02889692|Gefitinib|gefitinib|mesh-list
65274211|NCT01773083|Heparin|heparin|mesh-list
65268964|NCT00910247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151712|NCT01288079|Analgesics|analgesics|mesh-ancestor
65268965|NCT04217798|Etoposide|etoposide|mesh-list
65268966|NCT04217798|Niraparib|niraparib|mesh-list
65274213|NCT01773083|Anticoagulants|anticoagulants|mesh-ancestor
65274214|NCT01773083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65268967|NCT04217798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65268968|NCT04217798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152238|NCT02856919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65268969|NCT04217798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65152459|NCT01809691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268970|NCT04217798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65152532|NCT01154673|Lopinavir|lopinavir|mesh-list
65268971|NCT04217798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274215|NCT01773083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65152902|NCT00489307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65152975|NCT01146873|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65153049|NCT02852083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65153192|NCT00602173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153341|NCT00605995|Simvastatin|simvastatin|mesh-list
65153417|NCT02851303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65268972|NCT04217798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268973|NCT04217798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65268974|NCT02742038|Fluorides|fluorides|mesh-list
65268975|NCT02742038|Fluorides, Topical|fluorides, topical|mesh-list
65268976|NCT02742038|Cariostatic Agents|cariostatic agents|mesh-ancestor
65268977|NCT02742038|Protective Agents|protective agents|mesh-ancestor
65268978|NCT02742038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268980|NCT02022098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65268981|NCT02746250|Amitriptyline|amitriptyline|mesh-list
65268983|NCT02746250|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
65268984|NCT02746250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65268985|NCT02746250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65268986|NCT02746250|Analgesics|analgesics|mesh-ancestor
65268987|NCT02746250|Sensory System Agents|sensory system agents|mesh-ancestor
65268988|NCT02746250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65154602|NCT00925015|Irinotecan|irinotecan|mesh-list
65154672|NCT01212588|Luteolytic Agents|luteolytic agents|mesh-ancestor
65268991|NCT02746250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65268992|NCT02746250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65154972|NCT01283009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155124|NCT01266161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155200|NCT01263197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65155286|NCT05241275|Xenon|xenon|mesh-list
65155347|NCT03192215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268993|NCT02746250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65268994|NCT02746250|Adrenergic Agents|adrenergic agents|mesh-ancestor
65268995|NCT02746250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65268996|NCT02741960|Metformin|metformin|mesh-list
65155573|NCT04310631|Ranibizumab|ranibizumab|mesh-list
65268997|NCT02741960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65268998|NCT02741960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65268999|NCT00910091|Megestrol|megestrol|mesh-list
65155788|NCT01121913|Trazodone|trazodone|mesh-list
65269000|NCT00910091|Megestrol Acetate|megestrol acetate|mesh-list
65269001|NCT00910091|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65269002|NCT00910091|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65156235|NCT00629278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65156308|NCT05625308|Viscosupplements|viscosupplements|mesh-ancestor
65269003|NCT00910091|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65269004|NCT00910091|Contraceptive Agents|contraceptive agents|mesh-ancestor
65269005|NCT00910091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65269006|NCT00910091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269007|NCT00910091|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65269008|NCT00910091|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65269009|NCT00910091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65269010|NCT00910091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269011|NCT00910091|Appetite Stimulants|appetite stimulants|mesh-ancestor
65269012|NCT00910091|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65269013|NCT04216550|Apatinib|apatinib|mesh-list
65269014|NCT04216550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269015|NCT04216550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65269016|NCT04216550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156386|NCT03918278|Antimetabolites|antimetabolites|mesh-ancestor
65156448|NCT02867332|Interleukin-2|interleukin-2|mesh-list
65269017|NCT04216550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269018|NCT01442792|Rivaroxaban|rivaroxaban|mesh-list
65156672|NCT01204710|Analgesics|analgesics|mesh-ancestor
65269019|NCT01442792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65269020|NCT01442792|Antithrombins|antithrombins|mesh-ancestor
65269021|NCT01442792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65269022|NCT01442792|Protease Inhibitors|protease inhibitors|mesh-ancestor
65269023|NCT01442792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65269024|NCT01442792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269025|NCT01442792|Anticoagulants|anticoagulants|mesh-ancestor
65269026|NCT00909857|Dienogest|dienogest|mesh-list
65269027|NCT00909857|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65269028|NCT00909857|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65269029|NCT00909857|Levonorgestrel|levonorgestrel|mesh-list
65156974|NCT01109979|Diuretics|diuretics|mesh-ancestor
65269030|NCT00909857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65157104|NCT01100853|Naltrexone|naltrexone|mesh-list
65269031|NCT00909857|Estradiol|estradiol|mesh-list
65269032|NCT00909857|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65269033|NCT00909857|Estrogens|estrogens|mesh-ancestor
65157478|NCT00977938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65157550|NCT00910663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157623|NCT02888327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65157697|NCT02866396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65157771|NCT00977080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65269035|NCT00909857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65157920|NCT02864602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269036|NCT00909857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269037|NCT00909857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65269038|NCT00909857|Contraceptive Agents|contraceptive agents|mesh-ancestor
65269039|NCT00909857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65269040|NCT00909857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65269041|NCT00909857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65269042|NCT00909857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65269043|NCT00909857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65158231|NCT00903331|Macitentan|macitentan|mesh-list
65269044|NCT00909857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65269045|NCT00909857|Hormone Antagonists|hormone antagonists|mesh-ancestor
65269046|NCT00909857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65269047|NCT00909857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269048|NCT00911807|Cerebrolysin|cerebrolysin|mesh-list
65269049|NCT00911807|Donepezil|donepezil|mesh-list
65269050|NCT00911807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65269051|NCT00911807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65269052|NCT00911807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269053|NCT00911807|Cholinergic Agents|cholinergic agents|mesh-ancestor
65269054|NCT00911807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65269055|NCT00911807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269056|NCT00911807|Nootropic Agents|nootropic agents|mesh-ancestor
65158426|NCT02875587|Calcium|calcium|mesh-list
65269058|NCT00911807|Protective Agents|protective agents|mesh-ancestor
65269059|NCT04127981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65269060|NCT04127981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65269061|NCT04127981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269062|NCT04117763|Empagliflozin|empagliflozin|mesh-list
65269063|NCT04117763|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65269064|NCT04117763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269065|NCT04117763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65269066|NCT04117763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269068|NCT04117451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65269069|NCT03690089|Atropine|atropine|mesh-list
65158564|NCT00626769|Genistein|genistein|mesh-list
65269070|NCT03690089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65158637|NCT04753749|Antipyretics|antipyretics|mesh-ancestor
65269071|NCT03690089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65269072|NCT03690089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65269073|NCT03690089|Autonomic Agents|autonomic agents|mesh-ancestor
65159074|NCT02845843|Lopinavir|lopinavir|mesh-list
65159154|NCT00901927|Analgesics|analgesics|mesh-ancestor
65159221|NCT00779545|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65159297|NCT02839135|Cholinergic Agents|cholinergic agents|mesh-ancestor
65269074|NCT03690089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65269075|NCT03690089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269076|NCT03690089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65269077|NCT03690089|Respiratory System Agents|respiratory system agents|mesh-ancestor
65159678|NCT05197192|Venetoclax|venetoclax|mesh-list
65269078|NCT03690089|Mydriatics|mydriatics|mesh-ancestor
65269079|NCT03690089|Parasympatholytics|parasympatholytics|mesh-ancestor
65159824|NCT04400929|Molgramostim|molgramostim|mesh-list
65159976|NCT00964678|Antioxidants|antioxidants|mesh-ancestor
65160046|NCT00630214|Antacids|antacids|mesh-ancestor
65269080|NCT03690089|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65160194|NCT02861482|Carboprost tromethamine|carboprost tromethamine|mesh-list
65269081|NCT03690089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65269082|NCT03690089|Cholinergic Agents|cholinergic agents|mesh-ancestor
65269083|NCT03690089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65160499|NCT04281628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65160570|NCT00889603|Cholinergic Agents|cholinergic agents|mesh-ancestor
65160642|NCT02826031|Immunologic Factors|immunologic factors|mesh-ancestor
65269084|NCT03690089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269086|NCT03812588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65269087|NCT03812588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65269088|NCT03812588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65269089|NCT03812588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269090|NCT03812588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65269091|NCT03812588|Serotonin Agents|serotonin agents|mesh-ancestor
65269092|NCT03812588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269093|NCT03812588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65160796|NCT02822131|Sevelamer|sevelamer|mesh-list
65019099|NCT00148148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65269094|NCT03812588|Antidepressive Agents|antidepressive agents|mesh-ancestor
65269095|NCT03812588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65269097|NCT02387099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269098|NCT02387099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65269099|NCT02387099|Immunologic Factors|immunologic factors|mesh-ancestor
65161748|NCT04278040|Melphalan|melphalan|mesh-list
65269101|NCT02745860|Selexipag|selexipag|mesh-list
65269102|NCT02745860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65269103|NCT04788641|Cyclosporine|cyclosporine|mesh-list
65269104|NCT04788641|Tacrolimus|tacrolimus|mesh-list
65269105|NCT04788641|Cyclosporins|cyclosporins|mesh-list
65162120|NCT02805829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162194|NCT02799589|Anesthetics, Local|anesthetics, local|mesh-ancestor
65162269|NCT02799277|Testosterone|testosterone|mesh-list
65162345|NCT02797717|Doxorubicin|doxorubicin|mesh-list
65269106|NCT04788641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65269107|NCT04788641|Immunologic Factors|immunologic factors|mesh-ancestor
65269108|NCT04788641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269109|NCT04788641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65269111|NCT04788641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269112|NCT04788641|Antifungal Agents|antifungal agents|mesh-ancestor
65269113|NCT04788641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65269114|NCT04788641|Dermatologic Agents|dermatologic agents|mesh-ancestor
65269115|NCT04788641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65269117|NCT04331288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65269118|NCT04331288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65269119|NCT04331288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65269120|NCT04331288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269121|NCT02745470|Lixisenatide|lixisenatide|mesh-list
65269122|NCT02745470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65163080|NCT04975555|Siltuximab|siltuximab|mesh-list
65269123|NCT02745470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163305|NCT02772601|Anesthetics|anesthetics|mesh-ancestor
65269125|NCT02741414|Amoxicillin|amoxicillin|mesh-list
65269126|NCT02741414|Metronidazole|metronidazole|mesh-list
65269127|NCT02741414|Clarithromycin|clarithromycin|mesh-list
65269128|NCT02741414|Levofloxacin|levofloxacin|mesh-list
65269129|NCT02741414|Ofloxacin|ofloxacin|mesh-list
65269130|NCT02741414|Tetracycline|tetracycline|mesh-list
65269131|NCT02741414|Furazolidone|furazolidone|mesh-list
65269132|NCT02741414|Esomeprazole|esomeprazole|mesh-list
65163449|NCT04224103|Nitric Oxide|nitric oxide|mesh-list
65163525|NCT02770885|Dulaglutide|dulaglutide|mesh-list
65269133|NCT02741414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65269134|NCT02741414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65269135|NCT02741414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65269136|NCT02741414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65269137|NCT02741414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65269138|NCT02741414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65164122|NCT02855632|Estrogens|estrogens|mesh-list
65269139|NCT02741414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65269140|NCT02741414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269141|NCT02741414|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65269142|NCT02741414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65269143|NCT02741414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65269144|NCT02741414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65269145|NCT02741414|Renal Agents|renal agents|mesh-ancestor
65269146|NCT02741414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65269147|NCT02741414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65269148|NCT02741414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269149|NCT02741414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65269150|NCT02741414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65164424|NCT01189890|Glimepiride|glimepiride|mesh-list
65164571|NCT05381038|Antimetabolites|antimetabolites|mesh-ancestor
65269152|NCT02741414|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65269153|NCT02736500|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65269154|NCT02736500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65269155|NCT02736500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269156|NCT05629598|Epoetin Alfa|epoetin alfa|mesh-list
65269157|NCT05629598|Hematinics|hematinics|mesh-ancestor
65269158|NCT02744690|Mitomycins|mitomycins|mesh-list
65269159|NCT02744690|Mitomycin|mitomycin|mesh-list
65269160|NCT02744690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65269162|NCT02744690|Alkylating Agents|alkylating agents|mesh-ancestor
65269163|NCT02744690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269164|NCT02744690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65165091|NCT02753647|Hormones|hormones|mesh-ancestor
65269166|NCT02736266|Pembrolizumab|pembrolizumab|mesh-list
65269167|NCT02736266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65269168|NCT02736266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269170|NCT02736032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65269172|NCT02736032|Estradiol|estradiol|mesh-list
65165832|NCT02743975|Growth Substances|growth substances|mesh-ancestor
65269173|NCT02736032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65269175|NCT02736032|Estrogens|estrogens|mesh-ancestor
65166199|NCT02718469|Vaccines|vaccines|mesh-list
65166273|NCT02724163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65166274|NCT02724163|Immunologic Factors|immunologic factors|mesh-ancestor
65166275|NCT02724163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166276|NCT02724163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65166277|NCT02724163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65166278|NCT02724163|Alkylating Agents|alkylating agents|mesh-ancestor
65166279|NCT02724163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166280|NCT02724163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166281|NCT02724163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65269177|NCT02736032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65269178|NCT02736032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269179|NCT02736032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65269180|NCT02736032|Contraceptive Agents|contraceptive agents|mesh-ancestor
65269181|NCT02736032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65166807|NCT05079061|Oxytocics|oxytocics|mesh-ancestor
65269182|NCT02736032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65269183|NCT02736032|Progestins|progestins|mesh-ancestor
65269184|NCT02736032|Luteolytic Agents|luteolytic agents|mesh-ancestor
65167026|NCT05264077|Midazolam|midazolam|mesh-list
65269185|NCT02736032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65167182|NCT00935818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167338|NCT04264624|Erythritol|erythritol|mesh-list
65167409|NCT05198791|Eplerenone|eplerenone|mesh-list
65269186|NCT02736032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167589|NCT04205565|Oxiracetam|oxiracetam|mesh-list
65269189|NCT02744768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167705|NCT05345119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65167851|NCT02964013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65167852|NCT02964013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65167853|NCT02964013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168002|NCT00848731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65168148|NCT01012713|Micronutrients|micronutrients|mesh-ancestor
65269190|NCT02744768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65168517|NCT02700217|Anesthetics, Local|anesthetics, local|mesh-ancestor
65269191|NCT02744768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168820|NCT02052193|Dabrafenib|dabrafenib|mesh-list
65168906|NCT00516373|Olaparib|olaparib|mesh-list
65269192|NCT02744768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169109|NCT00621907|Levobupivacaine|levobupivacaine|mesh-list
65269193|NCT00909779|Formoterol Fumarate|formoterol fumarate|mesh-list
64812480|NCT01463735|Vitamin E|vitamin e|mesh-list
65269195|NCT00909779|Autonomic Agents|autonomic agents|mesh-ancestor
65269196|NCT00909779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170387|NCT00992589|Rabeprazole|rabeprazole|mesh-list
65170464|NCT01196429|Tubulin Modulators|tubulin modulators|mesh-ancestor
65269197|NCT00909779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171070|NCT01180049|Antifungal Agents|antifungal agents|mesh-ancestor
65269198|NCT00909779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65171143|NCT01149486|Diuretics|diuretics|mesh-ancestor
65171293|NCT00640705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65171380|NCT00931918|Glucocorticoids|glucocorticoids|mesh-ancestor
65171572|NCT00975195|Xhance|xhance|mesh-list
65269199|NCT00909779|Respiratory System Agents|respiratory system agents|mesh-ancestor
65172215|NCT05332444|Antacids|antacids|mesh-ancestor
65172349|NCT00976209|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65172430|NCT04177303|Metformin|metformin|mesh-list
65172729|NCT02886299|Simvastatin|simvastatin|mesh-list
65172953|NCT02862327|Anesthetics|anesthetics|mesh-ancestor
65173025|NCT02863809|Riboflavin|riboflavin|mesh-list
65173100|NCT01225562|Purinergic Agents|purinergic agents|mesh-ancestor
65269200|NCT00909779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65173561|NCT01217060|Docetaxel|docetaxel|mesh-list
65173632|NCT02664649|Apixaban|apixaban|mesh-list
65269201|NCT00909779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65269202|NCT00909779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65269203|NCT00909779|Adrenergic Agents|adrenergic agents|mesh-ancestor
65269204|NCT00909779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65269205|NCT00909779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269206|NCT04096391|Analgesics|analgesics|mesh-list
65269207|NCT04096391|Sensory System Agents|sensory system agents|mesh-ancestor
65269208|NCT04096391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65269209|NCT04096391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269210|NCT02744378|Clobetasol|clobetasol|mesh-list
65174367|NCT02658721|Mydriatics|mydriatics|mesh-ancestor
65269212|NCT02744378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65269213|NCT02744378|Immunologic Factors|immunologic factors|mesh-ancestor
65174815|NCT00920140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65269214|NCT02744378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269215|NCT02744378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65269216|NCT02744378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175115|NCT01168973|Docetaxel|docetaxel|mesh-list
65175258|NCT02647489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65269217|NCT02744378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175561|NCT02639767|Pemetrexed|pemetrexed|mesh-list
65175650|NCT01119846|Incretins|incretins|mesh-ancestor
65175861|NCT00654277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65269218|NCT02744378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65269219|NCT02744378|Glucocorticoids|glucocorticoids|mesh-ancestor
65269221|NCT02744378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65269222|NCT04318730|Apatinib|apatinib|mesh-list
65269223|NCT04318730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269224|NCT04318730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65269225|NCT04318730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176082|NCT02645461|Palmidrol|palmidrol|mesh-list
65176381|NCT03302728|Lenalidomide|lenalidomide|mesh-list
65176459|NCT01605253|Eszopiclone|eszopiclone|mesh-list
65176531|NCT00953667|Vitamins|vitamins|mesh-ancestor
65176608|NCT00903760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176682|NCT04221568|Fentanyl|fentanyl|mesh-list
65269226|NCT04318730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269227|NCT00632333|Fluorouracil|fluorouracil|mesh-list
65269228|NCT00632333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269229|NCT00632333|Antimetabolites|antimetabolites|mesh-ancestor
65269230|NCT00632333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269231|NCT00632333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65269232|NCT00632333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65269233|NCT00632333|Immunologic Factors|immunologic factors|mesh-ancestor
65269234|NCT00632333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269235|NCT02744456|Losartan|losartan|mesh-list
65269236|NCT02744456|Amlodipine|amlodipine|mesh-list
65269237|NCT02744456|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65269238|NCT02744456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65269239|NCT02744456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65177129|NCT01996605|Oxytocin|oxytocin|mesh-list
65269240|NCT02744456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65269241|NCT02744456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269242|NCT02744456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65269243|NCT02744456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269244|NCT02744456|Vasodilator Agents|vasodilator agents|mesh-ancestor
65269245|NCT02744456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65269246|NCT02744456|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65269247|NCT02744456|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65269248|NCT02744456|Diuretics|diuretics|mesh-ancestor
65269249|NCT02744456|Natriuretic Agents|natriuretic agents|mesh-ancestor
65177333|NCT00885703|Deoxycholic Acid|deoxycholic acid|mesh-list
65269250|NCT02744456|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65269251|NCT02744222|Interferons|interferons|mesh-list
65269252|NCT02744222|Interferon-beta|interferon-beta|mesh-list
65269253|NCT02744222|Interferon beta-1a|interferon beta-1a|mesh-list
65269254|NCT02744222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269255|NCT02744222|Antiviral Agents|antiviral agents|mesh-ancestor
65269256|NCT02744222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65269257|NCT02744222|Immunologic Factors|immunologic factors|mesh-ancestor
65269258|NCT02744222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269259|NCT02744222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65269260|NCT02741024|Artesunate|artesunate|mesh-list
65269261|NCT02741024|Lumefantrine|lumefantrine|mesh-list
65269262|NCT02741024|Artemether|artemether|mesh-list
65269263|NCT02741024|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65269264|NCT02741024|Amodiaquine|amodiaquine|mesh-list
65269265|NCT02741024|Antimalarials|antimalarials|mesh-ancestor
65269266|NCT02741024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65269267|NCT02741024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65269268|NCT02741024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65269269|NCT02741024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269270|NCT02741024|Antiviral Agents|antiviral agents|mesh-ancestor
65269271|NCT02741024|Schistosomicides|schistosomicides|mesh-ancestor
65269272|NCT02741024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65269273|NCT02741024|Anthelmintics|anthelmintics|mesh-ancestor
65269274|NCT02735876|Rituximab|rituximab|mesh-list
65269275|NCT02735876|Acalabrutinib|acalabrutinib|mesh-list
65269276|NCT02735876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65177537|NCT02634463|Olanzapine|olanzapine|mesh-list
65269277|NCT02735876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269278|NCT02735876|Immunologic Factors|immunologic factors|mesh-ancestor
65269279|NCT02735876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269280|NCT02735876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65269281|NCT00910871|Bedaquiline|bedaquiline|mesh-list
65269282|NCT00910871|Antitubercular Agents|antitubercular agents|mesh-ancestor
65269283|NCT00910871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65269284|NCT00910871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65269285|NCT04346654|Dexamethasone|dexamethasone|mesh-list
65269286|NCT04346654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65269287|NCT04346654|Antiemetics|antiemetics|mesh-ancestor
65269288|NCT04346654|Autonomic Agents|autonomic agents|mesh-ancestor
65269289|NCT04346654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65269290|NCT04346654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269291|NCT04346654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65269292|NCT04346654|Glucocorticoids|glucocorticoids|mesh-ancestor
65269293|NCT04346654|Hormones|hormones|mesh-ancestor
65269294|NCT04346654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65269295|NCT04346654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65269296|NCT04346654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269297|NCT04230707|Melatonin|melatonin|mesh-list
65269298|NCT04230707|Antioxidants|antioxidants|mesh-ancestor
65269299|NCT04230707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269300|NCT04230707|Protective Agents|protective agents|mesh-ancestor
65269301|NCT04230707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269302|NCT04230707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65269303|NCT03943667|Gemcitabine|gemcitabine|mesh-list
65269304|NCT03943667|Paclitaxel|paclitaxel|mesh-list
65269305|NCT03943667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65269306|NCT03943667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269307|NCT03943667|Tubulin Modulators|tubulin modulators|mesh-ancestor
65269308|NCT03943667|Antimitotic Agents|antimitotic agents|mesh-ancestor
65269309|NCT03943667|Mitosis Modulators|mitosis modulators|mesh-ancestor
65269310|NCT03943667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711254|NCT05593939|Niacin|niacin|mesh-list
65269311|NCT03943667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65269312|NCT03943667|Antimetabolites|antimetabolites|mesh-ancestor
65269313|NCT03943667|Antiviral Agents|antiviral agents|mesh-ancestor
65177712|NCT03612466|Plerixafor|plerixafor|mesh-list
65269314|NCT03943667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65269315|NCT03943667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65269316|NCT03943667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65269317|NCT03943667|Immunologic Factors|immunologic factors|mesh-ancestor
65269318|NCT03943667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269319|NCT02735798|Trastuzumab|trastuzumab|mesh-list
65269320|NCT02735798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65269321|NCT02735798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269322|NCT02740712|Vitamin K|vitamin k|mesh-list
65269323|NCT02740712|Rucaparib|rucaparib|mesh-list
65269324|NCT02740712|Digoxin|digoxin|mesh-list
65269325|NCT02740712|Midazolam|midazolam|mesh-list
65269326|NCT02740712|Caffeine|caffeine|mesh-list
65269327|NCT02740712|Omeprazole|omeprazole|mesh-list
65269328|NCT02740712|Warfarin|warfarin|mesh-list
65269329|NCT02740712|Vitamins|vitamins|mesh-ancestor
65269330|NCT02740712|Micronutrients|micronutrients|mesh-ancestor
65269331|NCT02740712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269332|NCT02740712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65269333|NCT02740712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65269334|NCT02740712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65269335|NCT02740712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65269336|NCT02740712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65269337|NCT02740712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65269338|NCT02740712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65269339|NCT02740712|Anesthetics, General|anesthetics, general|mesh-ancestor
65269340|NCT02740712|Anesthetics|anesthetics|mesh-ancestor
65269341|NCT02740712|GABA Modulators|gaba modulators|mesh-ancestor
65269342|NCT02740712|GABA Agents|gaba agents|mesh-ancestor
65269343|NCT02740712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65269344|NCT02740712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269345|NCT02740712|Anticoagulants|anticoagulants|mesh-ancestor
65269346|NCT02740712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65269347|NCT02740712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65269348|NCT02740712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177790|NCT00895414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65269349|NCT02740712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65269350|NCT02740712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65269351|NCT02740712|Purinergic Agents|purinergic agents|mesh-ancestor
65269352|NCT02740712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65269353|NCT02740712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65269354|NCT02740712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65269355|NCT02740712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65269356|NCT02740712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65269357|NCT02740712|Protective Agents|protective agents|mesh-ancestor
65269358|NCT02740712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65269359|NCT02740712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65269360|NCT02740712|Hemostatics|hemostatics|mesh-ancestor
65269361|NCT02740712|Coagulants|coagulants|mesh-ancestor
65269362|NCT02740712|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65269363|NCT02740712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269364|NCT03760718|Chloroprocaine|chloroprocaine|mesh-list
65269365|NCT03760718|Procaine|procaine|mesh-list
65269366|NCT03760718|Anesthetics, Local|anesthetics, local|mesh-ancestor
65269367|NCT03760718|Anesthetics|anesthetics|mesh-ancestor
65269368|NCT03760718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65269369|NCT03760718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269370|NCT03760718|Sensory System Agents|sensory system agents|mesh-ancestor
65269371|NCT03760718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65269372|NCT05590286|Amoxicillin|amoxicillin|mesh-list
65269373|NCT05590286|Esomeprazole|esomeprazole|mesh-list
65269374|NCT05590286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65269375|NCT05590286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65269376|NCT05590286|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65269377|NCT05590286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65269378|NCT05590286|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65269379|NCT05590286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65269380|NCT05590286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269381|NCT05580029|Triamcinolone|triamcinolone|mesh-list
65269382|NCT05580029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65269383|NCT05580029|Glucocorticoids|glucocorticoids|mesh-ancestor
65269385|NCT05580029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65269386|NCT05580029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269387|NCT03724994|Gemcitabine|gemcitabine|mesh-list
65269388|NCT03724994|Paclitaxel|paclitaxel|mesh-list
65269389|NCT03724994|Fluorouracil|fluorouracil|mesh-list
65269390|NCT03724994|Folfirinox|folfirinox|mesh-list
65269391|NCT03724994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65269392|NCT03724994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269393|NCT03724994|Tubulin Modulators|tubulin modulators|mesh-ancestor
65269394|NCT03724994|Antimitotic Agents|antimitotic agents|mesh-ancestor
65269395|NCT03724994|Mitosis Modulators|mitosis modulators|mesh-ancestor
65269396|NCT03724994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269397|NCT03724994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65269398|NCT03724994|Antimetabolites|antimetabolites|mesh-ancestor
65269399|NCT03724994|Antiviral Agents|antiviral agents|mesh-ancestor
65269400|NCT03724994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65269401|NCT03724994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65269403|NCT03724994|Immunologic Factors|immunologic factors|mesh-ancestor
65269404|NCT03724994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269405|NCT02735330|Ethanol|ethanol|mesh-list
65269406|NCT02735330|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65269407|NCT02735330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65269408|NCT02735330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65269409|NCT02735330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269410|NCT02631941|Budesonide|budesonide|mesh-list
65269411|NCT02631941|Formoterol Fumarate|formoterol fumarate|mesh-list
65269412|NCT02631941|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65269413|NCT02631941|Charcoal|charcoal|mesh-list
65269414|NCT02631941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65269415|NCT02631941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65269416|NCT02631941|Autonomic Agents|autonomic agents|mesh-ancestor
65269417|NCT02631941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65269418|NCT02631941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269419|NCT02631941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65269420|NCT02631941|Respiratory System Agents|respiratory system agents|mesh-ancestor
65269421|NCT02631941|Glucocorticoids|glucocorticoids|mesh-ancestor
65269422|NCT02631941|Hormones|hormones|mesh-ancestor
65269423|NCT02631941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65269424|NCT02631941|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65269425|NCT02631941|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65269426|NCT02631941|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65269427|NCT02631941|Adrenergic Agents|adrenergic agents|mesh-ancestor
65269428|NCT02631941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65269429|NCT02631941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269430|NCT02631941|Antidotes|antidotes|mesh-ancestor
65269431|NCT02631941|Protective Agents|protective agents|mesh-ancestor
65269432|NCT02690987|Exenatide|exenatide|mesh-list
65269433|NCT02690987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65178347|NCT04249804|Tocolytic Agents|tocolytic agents|mesh-ancestor
65269434|NCT02690987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269435|NCT02690987|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65269436|NCT02690987|Incretins|incretins|mesh-ancestor
65269437|NCT02690987|Hormones|hormones|mesh-ancestor
65269438|NCT02690987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65269439|NCT02740166|Propranolol|propranolol|mesh-list
65269440|NCT02740166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65269441|NCT02740166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65269442|NCT02740166|Adrenergic Agents|adrenergic agents|mesh-ancestor
65269443|NCT02740166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65269444|NCT02740166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269445|NCT02740166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269446|NCT02740166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65269447|NCT02740166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65269448|NCT02740166|Vasodilator Agents|vasodilator agents|mesh-ancestor
65269449|NCT02735018|Epinephrine|epinephrine|mesh-list
65269450|NCT02735018|Racepinephrine|racepinephrine|mesh-list
65269451|NCT02735018|Epinephryl borate|epinephryl borate|mesh-list
65269452|NCT02735018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65269453|NCT02735018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65269454|NCT02735018|Adrenergic Agents|adrenergic agents|mesh-ancestor
65269455|NCT02735018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65269456|NCT02735018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269457|NCT02735018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269458|NCT02735018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65269459|NCT02735018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65269460|NCT02735018|Autonomic Agents|autonomic agents|mesh-ancestor
65269461|NCT02735018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65269462|NCT02735018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65269463|NCT02735018|Respiratory System Agents|respiratory system agents|mesh-ancestor
65269464|NCT02735018|Mydriatics|mydriatics|mesh-ancestor
65269465|NCT02735018|Sympathomimetics|sympathomimetics|mesh-ancestor
65269466|NCT02735018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65269467|NCT00908375|Pregabalin|pregabalin|mesh-list
65269468|NCT00908375|Analgesics|analgesics|mesh-ancestor
65269469|NCT00908375|Sensory System Agents|sensory system agents|mesh-ancestor
65178414|NCT00658099|Insulin|insulin|mesh-list
65269470|NCT00908375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65269471|NCT00908375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269472|NCT00908375|Anticonvulsants|anticonvulsants|mesh-ancestor
65269473|NCT00908375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65269474|NCT00908375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65269475|NCT00908375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269476|NCT00908375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65269477|NCT00908375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65269478|NCT00908375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65269479|NCT00908375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65269480|NCT00908375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65269482|NCT04247867|Cathartics|cathartics|mesh-ancestor
65269483|NCT04247867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65269484|NCT02731664|Glucagon|glucagon|mesh-list
65269485|NCT02731664|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65269486|NCT02731664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65269487|NCT02731664|Hormones|hormones|mesh-ancestor
65269488|NCT02731664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65269489|NCT02731664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269490|NCT02731664|Incretins|incretins|mesh-ancestor
65269491|NCT02543255|Prednisone|prednisone|mesh-list
65269492|NCT02543255|Leuprolide|leuprolide|mesh-list
65269493|NCT02543255|Abiraterone Acetate|abiraterone acetate|mesh-list
65269494|NCT02543255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65269495|NCT02543255|Glucocorticoids|glucocorticoids|mesh-ancestor
65269496|NCT02543255|Hormones|hormones|mesh-ancestor
65269497|NCT02543255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65269498|NCT02543255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269499|NCT02543255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65269500|NCT02543255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269501|NCT02543255|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65269502|NCT02543255|Fertility Agents|fertility agents|mesh-ancestor
65269503|NCT02543255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65269504|NCT02543255|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65269505|NCT02543255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65269506|NCT02543255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269507|NCT02543255|Hormone Antagonists|hormone antagonists|mesh-ancestor
65269508|NCT02543255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65269509|NCT02695004|Donepezil|donepezil|mesh-list
65269510|NCT02695004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65269511|NCT02695004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65269512|NCT02695004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269513|NCT02695004|Cholinergic Agents|cholinergic agents|mesh-ancestor
65269514|NCT02695004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65269515|NCT02695004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269516|NCT02695004|Nootropic Agents|nootropic agents|mesh-ancestor
65269517|NCT00909389|Simvastatin|simvastatin|mesh-list
65269518|NCT00909389|Ezetimibe|ezetimibe|mesh-list
65269519|NCT00909389|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
65269520|NCT00909389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65269521|NCT00909389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65269522|NCT00909389|Antimetabolites|antimetabolites|mesh-ancestor
65269523|NCT00909389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269524|NCT00909389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65269525|NCT00909389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65269526|NCT00909389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65269528|NCT00910715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65269529|NCT00910715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65269530|NCT00910715|Antimalarials|antimalarials|mesh-ancestor
65269531|NCT00910715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65269532|NCT00910715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65269533|NCT02731430|Morphine|morphine|mesh-list
65269534|NCT02731430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65269535|NCT02731430|Narcotics|narcotics|mesh-ancestor
65269536|NCT02731430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65269537|NCT02731430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269538|NCT02731430|Analgesics|analgesics|mesh-ancestor
65178920|NCT02885441|Analgesics|analgesics|mesh-ancestor
65178989|NCT01159769|Analgesics|analgesics|mesh-ancestor
65179061|NCT02831686|Antiemetics|antiemetics|mesh-ancestor
65179133|NCT04201054|Hormone Antagonists|hormone antagonists|mesh-ancestor
65179209|NCT02832700|Caseins|caseins|mesh-list
65269539|NCT02731430|Sensory System Agents|sensory system agents|mesh-ancestor
65269540|NCT02731430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65269541|NCT04232969|Exenatide|exenatide|mesh-list
65269542|NCT04232969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65269543|NCT04232969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269544|NCT04232969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65269545|NCT04232969|Incretins|incretins|mesh-ancestor
65269546|NCT04232969|Hormones|hormones|mesh-ancestor
65019556|NCT00170859|Everolimus|everolimus|mesh-list
65269547|NCT04232969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65269548|NCT03364868|Insulin|insulin|mesh-list
65269549|NCT03364868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65269550|NCT03364868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269551|NCT03695510|Pembrolizumab|pembrolizumab|mesh-list
65269552|NCT03695510|Afatinib|afatinib|mesh-list
65269553|NCT03695510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65269554|NCT03695510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269555|NCT03695510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65269556|NCT03695510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65269557|NCT03695510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269558|NCT02731040|Ibandronic Acid|ibandronic acid|mesh-list
65269559|NCT02731040|Zoledronic Acid|zoledronic acid|mesh-list
65269560|NCT02731040|Diphosphonates|diphosphonates|mesh-list
65269561|NCT02731040|Etidronic Acid|etidronic acid|mesh-list
65269562|NCT02731040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65269563|NCT02731040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269565|NCT05501600|Anesthetics, Local|anesthetics, local|mesh-ancestor
65269566|NCT05501600|Anesthetics|anesthetics|mesh-ancestor
65269567|NCT05501600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65269568|NCT05501600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269569|NCT05501600|Sensory System Agents|sensory system agents|mesh-ancestor
65269570|NCT05501600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65269571|NCT05501600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65269572|NCT05501600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65269573|NCT05501600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65269574|NCT05501600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65269575|NCT05501600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269576|NCT02734160|Durvalumab|durvalumab|mesh-list
65269577|NCT02734160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65269578|NCT02734160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269579|NCT02730572|Methylphenidate|methylphenidate|mesh-list
65269580|NCT02730572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65269581|NCT02730572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269582|NCT02730572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65269583|NCT02730572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65179640|NCT05117736|Valsartan|valsartan|mesh-list
65179759|NCT02825290|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65269584|NCT02730572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65179984|NCT00945945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65180135|NCT02824666|Fallypride|fallypride|mesh-list
65180282|NCT02824042|Antimitotic Agents|antimitotic agents|mesh-ancestor
65180357|NCT01200758|Prednisolone|prednisolone|mesh-list
65180359|NCT01200758|Rituximab|rituximab|mesh-list
65180431|NCT00675649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65180668|NCT04745728|Hormones|hormones|mesh-ancestor
65180730|NCT05658640|Alkylating Agents|alkylating agents|mesh-ancestor
65180878|NCT04547140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181035|NCT00681967|Gefitinib|gefitinib|mesh-list
65181479|NCT02880462|Protective Agents|protective agents|mesh-ancestor
65269585|NCT02730572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181784|NCT00684229|Anesthetics|anesthetics|mesh-list
65182002|NCT00694837|Nelfinavir|nelfinavir|mesh-list
65269587|NCT02730572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65269588|NCT04225988|Tacrolimus|tacrolimus|mesh-list
65269589|NCT04225988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65269590|NCT04225988|Immunologic Factors|immunologic factors|mesh-ancestor
65269591|NCT04225988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269592|NCT04225988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65269593|NCT04225988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182610|NCT02793388|Primaquine|primaquine|mesh-list
65183126|NCT01145417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269594|NCT04225988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183355|NCT05308420|Morphine|morphine|mesh-list
65183585|NCT02782078|Rifampin|rifampin|mesh-list
65183875|NCT01078974|Antiemetics|antiemetics|mesh-ancestor
65269596|NCT02730026|Omeprazole|omeprazole|mesh-list
65269597|NCT02730026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65184269|NCT01194830|Hormones|hormones|mesh-ancestor
65184319|NCT04823052|Anticonvulsants|anticonvulsants|mesh-ancestor
65269598|NCT02730026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65184542|NCT01076010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184700|NCT02776540|Antipyretics|antipyretics|mesh-ancestor
65184767|NCT04121611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65269599|NCT02730026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65184991|NCT02769130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65269601|NCT02730026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185291|NCT05655728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65185366|NCT00861757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65185442|NCT01130051|Colchicine|colchicine|mesh-list
65185515|NCT01182194|Hormone Antagonists|hormone antagonists|mesh-ancestor
65185664|NCT01186328|Glucocorticoids|glucocorticoids|mesh-ancestor
65269602|NCT02730026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65185880|NCT01181102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186104|NCT02758990|Cholecalciferol|cholecalciferol|mesh-list
65269603|NCT02730026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65269604|NCT02730026|Analgesics|analgesics|mesh-ancestor
65186636|NCT04801368|Anesthetics|anesthetics|mesh-list
65186864|NCT04216888|Anesthetics|anesthetics|mesh-ancestor
65187165|NCT00856297|Vaccines|vaccines|mesh-list
65187241|NCT02736682|Metronidazole|metronidazole|mesh-list
65187382|NCT05626348|Antimalarials|antimalarials|mesh-ancestor
65187564|NCT02731378|Iron|iron|mesh-list
65187606|NCT00847015|Immunologic Factors|immunologic factors|mesh-ancestor
65187762|NCT01042392|Protease Inhibitors|protease inhibitors|mesh-ancestor
65269605|NCT02730026|Sensory System Agents|sensory system agents|mesh-ancestor
65188220|NCT02714842|Diclofenac|diclofenac|mesh-list
65188280|NCT03998176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65188355|NCT02712346|Ambrisentan|ambrisentan|mesh-list
65188430|NCT02710162|Capsaicin|capsaicin|mesh-list
65188505|NCT05380713|Durvalumab|durvalumab|mesh-list
65188576|NCT00607581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65188577|NCT00607581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65188578|NCT00607581|Alkylating Agents|alkylating agents|mesh-ancestor
65188579|NCT00607581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188580|NCT00607581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188581|NCT00607581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65188582|NCT00607581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65269606|NCT02730026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65188872|NCT00625547|Dopamine Agonists|dopamine agonists|mesh-ancestor
65269607|NCT02730026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269608|NCT02730026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65189092|NCT01119131|Calcium|calcium|mesh-list
65269609|NCT02730026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65189240|NCT04120870|Ketamine|ketamine|mesh-list
65189687|NCT04142086|Vaccines|vaccines|mesh-list
65189985|NCT05101629|Pembrolizumab|pembrolizumab|mesh-list
65190281|NCT00627666|Methotrexate|methotrexate|mesh-list
65190358|NCT04216186|Adrenergic Agents|adrenergic agents|mesh-ancestor
65190583|NCT02700568|Axitinib|axitinib|mesh-list
65190884|NCT00924729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191186|NCT00628290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65269610|NCT02730026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65191412|NCT04256733|Capsaicin|capsaicin|mesh-list
65191706|NCT00700297|Colchicine|colchicine|mesh-list
65191782|NCT00831181|Vitamins|vitamins|mesh-ancestor
65191929|NCT04213378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192157|NCT00631527|Androgen Antagonists|androgen antagonists|mesh-ancestor
65192230|NCT04209166|Serotonin Agents|serotonin agents|mesh-ancestor
65192307|NCT04648540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65192383|NCT04208776|Adrenergic Agents|adrenergic agents|mesh-ancestor
65192458|NCT00618046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65269612|NCT02738918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65192856|NCT01178138|Prazosin|prazosin|mesh-list
65192986|NCT00619996|Tubulin Modulators|tubulin modulators|mesh-ancestor
65193062|NCT02691442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65193294|NCT04521946|Antimetabolites|antimetabolites|mesh-ancestor
65193674|NCT02073838|Antiviral Agents|antiviral agents|mesh-ancestor
65193900|NCT02682082|Sensory System Agents|sensory system agents|mesh-ancestor
65194050|NCT04182568|Alkylating Agents|alkylating agents|mesh-ancestor
65194509|NCT04177342|Fentanyl|fentanyl|mesh-list
65195103|NCT02663830|Fertility Agents|fertility agents|mesh-ancestor
65195176|NCT00647608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195926|NCT04116931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65196230|NCT00700921|Lovastatin|lovastatin|mesh-list
65196302|NCT02650102|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65196452|NCT02644954|Metformin|metformin|mesh-list
65196595|NCT02613247|Hylan|hylan|mesh-list
65196920|NCT00848965|Xhance|xhance|mesh-list
65197354|NCT00824473|Azelastine|azelastine|mesh-list
65197579|NCT00813943|Alkylating Agents|alkylating agents|mesh-ancestor
65269613|NCT02738918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198268|NCT04156984|Golimumab|golimumab|mesh-list
65198638|NCT00629382|Polymyxins|polymyxins|mesh-list
65198729|NCT01120184|Paclitaxel|paclitaxel|mesh-list
65198879|NCT00974922|Vitamin D|vitamin d|mesh-list
65198937|NCT00970944|Amantadine|amantadine|mesh-list
65199085|NCT05774067|Autonomic Agents|autonomic agents|mesh-ancestor
65199086|NCT05774067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65199087|NCT05774067|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65199089|NCT05774067|Coagulants|coagulants|mesh-ancestor
65199090|NCT05774067|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65199091|NCT05774067|Natriuretic Agents|natriuretic agents|mesh-ancestor
65199168|NCT05670106|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65199169|NCT05670106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65199170|NCT05670106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199171|NCT05661851|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65199172|NCT05661851|Lubricant Eye Drops|lubricant eye drops|mesh-list
65199173|NCT05661851|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65199174|NCT05659654|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65199191|NCT05620784|Furosemide|furosemide|mesh-list
65199235|NCT05575063|Hyaluronic Acid|hyaluronic acid|mesh-list
65199310|NCT05480384|Nivolumab|nivolumab|mesh-list
65199382|NCT05362955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65199383|NCT05362955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199384|NCT05362955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65199385|NCT05362955|Immunologic Factors|immunologic factors|mesh-ancestor
65199386|NCT05362955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199387|NCT05355311|Acetylcarnitine|acetylcarnitine|mesh-list
65199388|NCT05355311|Vitamin B Complex|vitamin b complex|mesh-ancestor
65199390|NCT05355311|Micronutrients|micronutrients|mesh-ancestor
65199392|NCT05355311|Nootropic Agents|nootropic agents|mesh-ancestor
65199464|NCT05161936|Renal Agents|renal agents|mesh-ancestor
65199472|NCT05143424|Morphine|morphine|mesh-list
65199473|NCT05143424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65199474|NCT05143424|Narcotics|narcotics|mesh-ancestor
65199475|NCT05143424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65199476|NCT05143424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199477|NCT05143424|Analgesics|analgesics|mesh-ancestor
65199478|NCT05143424|Sensory System Agents|sensory system agents|mesh-ancestor
65199479|NCT05143424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65199480|NCT05142696|Carboplatin|carboplatin|mesh-list
65199481|NCT05142696|Etoposide|etoposide|mesh-list
65199493|NCT05137067|Cisplatin|cisplatin|mesh-list
65199535|NCT05027945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199536|NCT05027945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199537|NCT05027945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65199612|NCT04901702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65199613|NCT04901702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65199699|NCT04680975|Belumosudil|belumosudil|mesh-list
65199700|NCT04680975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65199701|NCT04680975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199702|NCT04680975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199703|NCT04663555|Dexamethasone|dexamethasone|mesh-list
65199704|NCT04663555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65199705|NCT04663555|Antiemetics|antiemetics|mesh-ancestor
65199706|NCT04663555|Autonomic Agents|autonomic agents|mesh-ancestor
65199707|NCT04663555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65199708|NCT04663555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199709|NCT04663555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65199710|NCT04663555|Glucocorticoids|glucocorticoids|mesh-ancestor
65199711|NCT04663555|Hormones|hormones|mesh-ancestor
65199715|NCT04637763|Cyclophosphamide|cyclophosphamide|mesh-list
65199761|NCT04496024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65269614|NCT02738918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200209|NCT03009981|Androgen Antagonists|androgen antagonists|mesh-ancestor
65200288|NCT02587195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65200657|NCT00915525|Botulinum Toxins|botulinum toxins|mesh-list
65200806|NCT00625352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65269615|NCT02738918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65269616|NCT02738918|Immunologic Factors|immunologic factors|mesh-ancestor
65201327|NCT03328026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201941|NCT00809341|Glucocorticoids|glucocorticoids|mesh-ancestor
65269617|NCT02738918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202152|NCT00908583|Methylprednisolone|methylprednisolone|mesh-list
65269618|NCT02738918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65269619|NCT03195374|Analgesics, Opioid|analgesics, opioid|mesh-list
65269621|NCT03195374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65202894|NCT02607631|Pembrolizumab|pembrolizumab|mesh-list
65202984|NCT05734495|Venetoclax|venetoclax|mesh-list
65019625|NCT00163761|Gemcitabine|gemcitabine|mesh-list
65269623|NCT03195374|Analgesics|analgesics|mesh-ancestor
65269625|NCT03195374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65269626|NCT02739386|Ipilimumab|ipilimumab|mesh-list
65269627|NCT02739386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65269628|NCT02739386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269629|NCT02739386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65269630|NCT02739386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269631|NCT00636428|Midazolam|midazolam|mesh-list
65269632|NCT00636428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65269633|NCT00636428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65269634|NCT00636428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65269635|NCT00636428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269636|NCT00636428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65269637|NCT00636428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65269638|NCT00636428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65269639|NCT00636428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65269640|NCT00636428|Anesthetics, General|anesthetics, general|mesh-ancestor
65269641|NCT00636428|Anesthetics|anesthetics|mesh-ancestor
65203703|NCT00954174|Paclitaxel|paclitaxel|mesh-list
65203839|NCT00904839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203840|NCT04985955|Tofacitinib|tofacitinib|mesh-list
65203841|NCT04985955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65203842|NCT04985955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203843|NCT04985955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203844|NCT02821923|Erythritol|erythritol|mesh-list
65203845|NCT02821923|Vasodilator Agents|vasodilator agents|mesh-ancestor
65269642|NCT00636428|GABA Modulators|gaba modulators|mesh-ancestor
65269643|NCT00636428|GABA Agents|gaba agents|mesh-ancestor
65204669|NCT00938886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65204744|NCT00604578|Pioglitazone|pioglitazone|mesh-list
65205039|NCT00684112|Antimanic Agents|antimanic agents|mesh-ancestor
65205115|NCT05382390|Decitabine|decitabine|mesh-list
65205267|NCT00606450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65205494|NCT00673270|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65269644|NCT00636428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65269645|NCT00636428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269646|NCT02729870|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65269647|NCT02729870|Laxatives|laxatives|mesh-ancestor
65269648|NCT02729870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65269649|NCT05628662|Insulin|insulin|mesh-list
65205570|NCT02629042|Prednisolone|prednisolone|mesh-list
65269650|NCT05628662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65269651|NCT05628662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269652|NCT02694848|Aspirin|aspirin|mesh-list
65269653|NCT02694848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65269654|NCT02694848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65269655|NCT02694848|Analgesics|analgesics|mesh-ancestor
65269656|NCT02694848|Sensory System Agents|sensory system agents|mesh-ancestor
65269657|NCT02694848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65269658|NCT02694848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269659|NCT02694848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65269660|NCT02694848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65269661|NCT02694848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65269662|NCT02694848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65269663|NCT02694848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269664|NCT02694848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65269665|NCT02694848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65269666|NCT02694848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65269667|NCT02694848|Antipyretics|antipyretics|mesh-ancestor
65269668|NCT02729324|Protective Agents|protective agents|mesh-list
65269669|NCT02729324|Radiation-Protective Agents|radiation-protective agents|mesh-list
65269670|NCT02729324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269671|NCT02733458|Gemcitabine|gemcitabine|mesh-list
65269672|NCT02733458|Dexamethasone|dexamethasone|mesh-list
65269673|NCT02733458|Etoposide|etoposide|mesh-list
65269674|NCT02733458|Pegaspargase|pegaspargase|mesh-list
65269675|NCT02733458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65269676|NCT02733458|Antiemetics|antiemetics|mesh-ancestor
65269677|NCT02733458|Autonomic Agents|autonomic agents|mesh-ancestor
65269678|NCT02733458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65269679|NCT02733458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269680|NCT02733458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65269681|NCT02733458|Glucocorticoids|glucocorticoids|mesh-ancestor
65269682|NCT02733458|Hormones|hormones|mesh-ancestor
65269683|NCT02733458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65269684|NCT02733458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65269685|NCT02733458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269686|NCT02733458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65269687|NCT02733458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269688|NCT02733458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65269689|NCT02733458|Antimetabolites|antimetabolites|mesh-ancestor
65269690|NCT02733458|Antiviral Agents|antiviral agents|mesh-ancestor
65205771|NCT00674596|Ramipril|ramipril|mesh-list
65205818|NCT00696202|Contraceptive Agents|contraceptive agents|mesh-ancestor
65205971|NCT02623114|Dopamine Agents|dopamine agents|mesh-ancestor
65206275|NCT04133506|Aspirin|aspirin|mesh-list
65206338|NCT00927186|Teriparatide|teriparatide|mesh-list
65206495|NCT00608946|Copper|copper|mesh-list
65269691|NCT02733458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65269692|NCT02733458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65269693|NCT02733458|Immunologic Factors|immunologic factors|mesh-ancestor
65269694|NCT02733458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65269695|NCT02733458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65019696|NCT04688632|Contraceptive Agents|contraceptive agents|mesh-ancestor
65269696|NCT02733458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65269697|NCT03658772|Pembrolizumab|pembrolizumab|mesh-list
65269698|NCT03658772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65269699|NCT03658772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269700|NCT02729012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65269701|NCT02728856|Sunscreening Agents|sunscreening agents|mesh-list
65269702|NCT02728856|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65269703|NCT02728856|Protective Agents|protective agents|mesh-ancestor
65269704|NCT02728856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269705|NCT02728856|Dermatologic Agents|dermatologic agents|mesh-ancestor
65269706|NCT02728934|Golimumab|golimumab|mesh-list
65269707|NCT02728934|Infliximab|infliximab|mesh-list
65269708|NCT02728934|Dermatologic Agents|dermatologic agents|mesh-ancestor
65269709|NCT02728934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65269710|NCT02728934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65269711|NCT02728934|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65269712|NCT02728934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65269713|NCT02728934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65269714|NCT02728934|Immunologic Factors|immunologic factors|mesh-ancestor
65269715|NCT02728934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269716|NCT04179500|Moxifloxacin|moxifloxacin|mesh-list
65269717|NCT04179500|Pyrazinamide|pyrazinamide|mesh-list
65269718|NCT04179500|Bedaquiline|bedaquiline|mesh-list
65269719|NCT04179500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65269720|NCT04179500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65269721|NCT04179500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65269722|NCT04179500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65269723|NCT04179500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65269724|NCT04179500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269725|NCT04179500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269726|NCT04179500|Antitubercular Agents|antitubercular agents|mesh-ancestor
65269727|NCT02728700|Mycophenolic Acid|mycophenolic acid|mesh-list
65269728|NCT02728700|Sirolimus|sirolimus|mesh-list
65269729|NCT02728700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65269730|NCT02728700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269731|NCT02728700|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65269732|NCT02728700|Antitubercular Agents|antitubercular agents|mesh-ancestor
65269733|NCT02728700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65269734|NCT02728700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65269735|NCT02728700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65269736|NCT02728700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269737|NCT02728700|Antifungal Agents|antifungal agents|mesh-ancestor
65269738|NCT02728700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65269739|NCT02728700|Immunologic Factors|immunologic factors|mesh-ancestor
65269740|NCT02728700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269741|NCT02728622|Tamoxifen|tamoxifen|mesh-list
65269742|NCT02728622|Paclitaxel|paclitaxel|mesh-list
65269743|NCT02728622|Doxorubicin|doxorubicin|mesh-list
65269744|NCT02728622|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65269745|NCT02728622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65269746|NCT02728622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269747|NCT02728622|Tubulin Modulators|tubulin modulators|mesh-ancestor
65206821|NCT00866788|Omalizumab|omalizumab|mesh-list
65269748|NCT02728622|Antimitotic Agents|antimitotic agents|mesh-ancestor
65269750|NCT02728622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269751|NCT02728622|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65269752|NCT02728622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65269753|NCT02728622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65269754|NCT02728622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65269755|NCT02728622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65269756|NCT02728622|Hormone Antagonists|hormone antagonists|mesh-ancestor
65269757|NCT02728622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65269758|NCT02728622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269759|NCT02728622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65269760|NCT02728622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65269762|NCT02728622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65269763|NCT02728466|Proanthocyanidin|proanthocyanidin|mesh-list
65269764|NCT02728466|Procyanidin|procyanidin|mesh-list
65269765|NCT02728466|Antioxidants|antioxidants|mesh-ancestor
65269766|NCT02728466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269767|NCT02728466|Protective Agents|protective agents|mesh-ancestor
65269768|NCT02728466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269769|NCT02728466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65269770|NCT02728466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65269771|NCT02728466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65019772|NCT05786339|Irbesartan|irbesartan|mesh-list
65269773|NCT02733380|Dexamethasone|dexamethasone|mesh-list
65269774|NCT02733380|Doxorubicin|doxorubicin|mesh-list
65269775|NCT02733380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65269776|NCT02733380|Vinorelbine|vinorelbine|mesh-list
65269777|NCT02733380|Mitoxantrone|mitoxantrone|mesh-list
65269778|NCT02733380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65269779|NCT02733380|Antiemetics|antiemetics|mesh-ancestor
65269780|NCT02733380|Autonomic Agents|autonomic agents|mesh-ancestor
65269781|NCT02733380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65207219|NCT00857818|Risperidone|risperidone|mesh-list
65207291|NCT00857584|Antidepressive Agents|antidepressive agents|mesh-ancestor
65207665|NCT00855166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207906|NCT00899847|Analgesics|analgesics|mesh-ancestor
65208191|NCT04988256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65208493|NCT05304663|Alkylating Agents|alkylating agents|mesh-ancestor
65269782|NCT02733380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208794|NCT02831205|Cobalt|cobalt|mesh-list
65208869|NCT00837148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65269783|NCT02733380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65209245|NCT05253066|Goserelin|goserelin|mesh-list
65269784|NCT02733380|Glucocorticoids|glucocorticoids|mesh-ancestor
65269785|NCT02733380|Hormones|hormones|mesh-ancestor
65269786|NCT02733380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65209320|NCT00707278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209393|NCT00626600|Analgesics|analgesics|mesh-ancestor
65209612|NCT00784927|Dexamethasone|dexamethasone|mesh-list
65209767|NCT00587431|Hormones|hormones|mesh-ancestor
65269787|NCT02733380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65210144|NCT02612272|Ketorolac|ketorolac|mesh-list
65269788|NCT02733380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269789|NCT02733380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65210667|NCT05658861|Chelating Agents|chelating agents|mesh-ancestor
65269790|NCT02733380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65210889|NCT02237508|Hormones|hormones|mesh-ancestor
65210961|NCT02812719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65211120|NCT04321395|Vigabatrin|vigabatrin|mesh-list
65269791|NCT02733380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65211333|NCT00819052|Nevirapine|nevirapine|mesh-list
65328224|NCT04067817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328226|NCT00740636|Temozolomide|temozolomide|mesh-list
65328227|NCT00740636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65328228|NCT00740636|Alkylating Agents|alkylating agents|mesh-ancestor
65269792|NCT02733380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328229|NCT00740636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328483|NCT00739934|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65328485|NCT00723411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65328486|NCT00723411|Immunologic Factors|immunologic factors|mesh-ancestor
64714625|NCT02858713|Betamethasone benzoate|betamethasone benzoate|mesh-list
65328643|NCT00724035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328644|NCT04126824|Triamcinolone|triamcinolone|mesh-list
65328645|NCT04126824|Bupivacaine|bupivacaine|mesh-list
65328646|NCT04126824|Anesthetics, Local|anesthetics, local|mesh-ancestor
65328647|NCT04126824|Anesthetics|anesthetics|mesh-ancestor
65328648|NCT04126824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65328649|NCT04126824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328650|NCT04126824|Sensory System Agents|sensory system agents|mesh-ancestor
65328651|NCT04126824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65328652|NCT04126824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64714785|NCT03100123|Aspirin|aspirin|mesh-list
65328785|NCT00920088|Anesthetics, General|anesthetics, general|mesh-ancestor
65328786|NCT00920088|Anesthetics|anesthetics|mesh-ancestor
65328787|NCT00920088|GABA Modulators|gaba modulators|mesh-ancestor
65328863|NCT04657068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65328864|NCT04657068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65328865|NCT04657068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65328866|NCT04689828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65328867|NCT04689828|177Lu-PSMA-617|177lu-psma-617|mesh-list
65328868|NCT04689828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65328869|NCT04689828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328870|NCT00794417|Pemetrexed|pemetrexed|mesh-list
65328871|NCT00794417|Aflibercept|aflibercept|mesh-list
65328872|NCT00794417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328873|NCT00794417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328874|NCT00794417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329289|NCT00727935|Lidocaine|lidocaine|mesh-list
65329290|NCT00727935|Ropivacaine|ropivacaine|mesh-list
65329291|NCT00727935|Anesthetics, Local|anesthetics, local|mesh-ancestor
65329292|NCT00727935|Anesthetics|anesthetics|mesh-ancestor
65329293|NCT00727935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65329294|NCT00727935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329295|NCT00727935|Sensory System Agents|sensory system agents|mesh-ancestor
65329296|NCT00727935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65329297|NCT00727935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65329298|NCT00727935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65329299|NCT00727935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65329300|NCT00727935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65329301|NCT00727935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329302|NCT00728013|Atorvastatin|atorvastatin|mesh-list
65329303|NCT00728013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65329304|NCT00728013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65329305|NCT00728013|Antimetabolites|antimetabolites|mesh-ancestor
65329306|NCT00728013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329307|NCT00728013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65329308|NCT00728013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65329309|NCT00728013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329310|NCT00577707|Pemetrexed|pemetrexed|mesh-list
65329311|NCT00577707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65329312|NCT00577707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333796|NCT04323956|Cyclophosphamide|cyclophosphamide|mesh-list
65333797|NCT04323956|Rituximab|rituximab|mesh-list
65333798|NCT04323956|Doxorubicin|doxorubicin|mesh-list
65333799|NCT04323956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65083687|NCT00471549|Simvastatin|simvastatin|mesh-list
65333800|NCT04323956|Vincristine|vincristine|mesh-list
65333801|NCT04323956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65333802|NCT04323956|Antibodies|antibodies|mesh-list
65333803|NCT04323956|Immunoglobulins|immunoglobulins|mesh-list
65333804|NCT04323956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65333805|NCT04323956|Lenograstim|lenograstim|mesh-list
65333806|NCT04323956|Immunoconjugates|immunoconjugates|mesh-list
65333807|NCT04323956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65333808|NCT04323956|Immunologic Factors|immunologic factors|mesh-ancestor
65333809|NCT04323956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333810|NCT04323956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65333811|NCT04323956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65333812|NCT04323956|Alkylating Agents|alkylating agents|mesh-ancestor
65333813|NCT04323956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211488|NCT00762463|Celecoxib|celecoxib|mesh-list
65333814|NCT04323956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333815|NCT04323956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65333816|NCT04323956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65333817|NCT04323956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65333818|NCT04323956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65333819|NCT04323956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333820|NCT04323956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65333821|NCT04323956|Glucocorticoids|glucocorticoids|mesh-ancestor
65333822|NCT04323956|Hormones|hormones|mesh-ancestor
65333823|NCT04323956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65333824|NCT04323956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65333825|NCT04323956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65333826|NCT04323956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65333912|NCT00767481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333913|NCT04305236|Fulvestrant|fulvestrant|mesh-list
64327757|NCT02170805|Anticoagulants|anticoagulants|mesh-ancestor
64327758|NCT00606697|Vofopitant|vofopitant|mesh-list
65333922|NCT00671931|Propofol|propofol|mesh-list
65333923|NCT00671931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65333924|NCT00671931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65333925|NCT00671931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333926|NCT00671931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65333927|NCT00671931|Anesthetics, General|anesthetics, general|mesh-ancestor
65333928|NCT00671931|Anesthetics|anesthetics|mesh-ancestor
65333929|NCT00671931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65333930|NCT00671931|Analgesics|analgesics|mesh-ancestor
65333931|NCT00671931|Sensory System Agents|sensory system agents|mesh-ancestor
65333932|NCT00671931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333933|NCT00671931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65333934|NCT00671931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65333935|NCT00671931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65333936|NCT00671931|Adrenergic Agents|adrenergic agents|mesh-ancestor
65333937|NCT00671931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65333938|NCT00671931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333939|NCT00767559|PENTA|penta|mesh-list
65333940|NCT00767559|Warfarin|warfarin|mesh-list
65333941|NCT00767559|Fondaparinux|fondaparinux|mesh-list
65333942|NCT00767559|Anticoagulants|anticoagulants|mesh-ancestor
65333943|NCT00767559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65333944|NCT00767559|Antithrombins|antithrombins|mesh-ancestor
65333945|NCT00767559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65333946|NCT00767559|Protease Inhibitors|protease inhibitors|mesh-ancestor
65333947|NCT00767559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333948|NCT00767559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333949|NCT00767559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65333963|NCT00767715|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65333964|NCT00767715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65333965|NCT00767715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65333966|NCT00767715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333967|NCT00767715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65333968|NCT00767715|Serotonin Agents|serotonin agents|mesh-ancestor
65333969|NCT00767715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65333970|NCT00767715|Dopamine Agents|dopamine agents|mesh-ancestor
65333971|NCT00767715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65333972|NCT00762957|Metformin|metformin|mesh-list
65333973|NCT00762957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65333974|NCT00762957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333975|NCT00759993|Chromium|chromium|mesh-list
65333976|NCT00759993|Trace Elements|trace elements|mesh-ancestor
65333977|NCT00759993|Micronutrients|micronutrients|mesh-ancestor
65333978|NCT00759993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333979|NCT00673881|Choline|choline|mesh-list
65333980|NCT00673881|Fenofibrate|fenofibrate|mesh-list
65333981|NCT00673881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65333982|NCT00673881|Antimetabolites|antimetabolites|mesh-ancestor
65333983|NCT00673881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333984|NCT00673881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65333985|NCT00673881|Lipotropic Agents|lipotropic agents|mesh-ancestor
65333986|NCT00673881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65333987|NCT00673881|Nootropic Agents|nootropic agents|mesh-ancestor
65333988|NCT00763347|Alogliptin|alogliptin|mesh-list
65333989|NCT00763347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65333990|NCT00763347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333991|NCT00763347|Incretins|incretins|mesh-ancestor
65333992|NCT00763347|Hormones|hormones|mesh-ancestor
65211557|NCT02805231|Vitamin D|vitamin d|mesh-list
65333993|NCT00763347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65333994|NCT00763347|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64719706|NCT00000224|Analgesics|analgesics|mesh-ancestor
65334005|NCT00767871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334006|NCT00767871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65334007|NCT00767871|Antidepressive Agents|antidepressive agents|mesh-ancestor
65334008|NCT00767871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65334009|NCT00760149|Rifampin|rifampin|mesh-list
65334010|NCT00760149|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65334011|NCT00760149|Antitubercular Agents|antitubercular agents|mesh-ancestor
65334012|NCT00760149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65334013|NCT00760149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65334014|NCT00760149|Leprostatic Agents|leprostatic agents|mesh-ancestor
65334015|NCT00760149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65334016|NCT00760149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334017|NCT00760149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334018|NCT00760149|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65334019|NCT00760149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65334020|NCT00760149|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65334021|NCT00760149|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65334022|NCT00760149|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65334023|NCT00760149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65334024|NCT00671853|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65334025|NCT00671853|Antidepressive Agents|antidepressive agents|mesh-ancestor
65334026|NCT00671853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65334027|NCT00671853|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65334028|NCT00671853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65334029|NCT00671853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65334030|NCT00671853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334031|NCT00768183|Ethanol|ethanol|mesh-list
65334036|NCT00768183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334037|NCT00768183|Analgesics|analgesics|mesh-ancestor
65334038|NCT00768183|Sensory System Agents|sensory system agents|mesh-ancestor
65334039|NCT00768183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65334040|NCT00768183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65334041|NCT00768183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65334042|NCT02557581|Terbutaline|terbutaline|mesh-list
65334043|NCT02557581|Clenbuterol|clenbuterol|mesh-list
65334044|NCT02557581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65334045|NCT02557581|Autonomic Agents|autonomic agents|mesh-ancestor
65334046|NCT02557581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65334047|NCT02557581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334048|NCT02557581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65334049|NCT02557581|Respiratory System Agents|respiratory system agents|mesh-ancestor
65334050|NCT02557581|Sympathomimetics|sympathomimetics|mesh-ancestor
65334051|NCT02557581|Tocolytic Agents|tocolytic agents|mesh-ancestor
65334052|NCT02557581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65334053|NCT02557581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65334054|NCT02557581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65334055|NCT02557581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65334056|NCT02557581|Adrenergic Agents|adrenergic agents|mesh-ancestor
65334057|NCT02557581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65334058|NCT02557581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334059|NCT04077944|Trace Elements|trace elements|mesh-list
65334060|NCT04077944|Micronutrients|micronutrients|mesh-list
65334061|NCT04077944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334063|NCT02558751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65334064|NCT02558751|Immunologic Factors|immunologic factors|mesh-ancestor
65334065|NCT02558751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334117|NCT02582372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65334118|NCT02582372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334119|NCT02582372|Sensory System Agents|sensory system agents|mesh-ancestor
65334120|NCT02582372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65334121|NCT02582372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65334122|NCT02582372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65334123|NCT02582372|Analgesics|analgesics|mesh-ancestor
65334124|NCT02582372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65334125|NCT02582372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65334126|NCT02582372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65334127|NCT02582372|Adrenergic Agents|adrenergic agents|mesh-ancestor
65334128|NCT02582372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65334129|NCT02582372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334130|NCT02582372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65334131|NCT02582372|Narcotics|narcotics|mesh-ancestor
65334132|NCT02582372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65334133|NCT02582372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65334134|NCT02582372|Anesthetics, General|anesthetics, general|mesh-ancestor
65334135|NCT00768729|Sirolimus|sirolimus|mesh-list
65334136|NCT00768729|Azathioprine|azathioprine|mesh-list
65334137|NCT00768729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65334138|NCT00768729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65334139|NCT00768729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65334140|NCT00768729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64719747|NCT00000242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65334173|NCT04077398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65334174|NCT04077398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334225|NCT04610528|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
65334226|NCT04610528|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65334227|NCT04610528|Immunologic Factors|immunologic factors|mesh-ancestor
65334228|NCT04610528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334229|NCT04610528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65334230|NCT04610528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334231|NCT00570921|Everolimus|everolimus|mesh-list
65334232|NCT00570921|Fulvestrant|fulvestrant|mesh-list
64327816|NCT00603577|Xaliproden|xaliproden|mesh-list
64327820|NCT00603577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64327821|NCT00603577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334238|NCT00570921|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65334239|NCT00570921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65334240|NCT00570921|Hormone Antagonists|hormone antagonists|mesh-ancestor
65334241|NCT00570921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65334242|NCT04076930|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65334243|NCT04076930|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65334244|NCT04076930|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65334245|NCT04076930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334246|NCT04076930|Protease Inhibitors|protease inhibitors|mesh-ancestor
65334247|NCT04609904|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65334248|NCT04609904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65334249|NCT04609904|Respiratory System Agents|respiratory system agents|mesh-ancestor
65334251|NCT04048317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65334252|NCT04048317|Ethiodized Oil|ethiodized oil|mesh-list
65334253|NCT04048317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65334254|NCT04048317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334255|NCT04048317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65334256|NCT04048317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65334257|NCT04048317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334258|NCT04048317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334259|NCT04353986|Sofosbuvir|sofosbuvir|mesh-list
65334260|NCT04353986|Ledipasvir|ledipasvir|mesh-list
65334261|NCT04353986|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
65334262|NCT04353986|Antiviral Agents|antiviral agents|mesh-ancestor
65334263|NCT04353986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65334264|NCT00670449|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65334265|NCT00670449|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65334266|NCT00670449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334267|NCT00670449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65334268|NCT00670449|Immunologic Factors|immunologic factors|mesh-ancestor
65334269|NCT00670449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327823|NCT02178293|Ketoprofen|ketoprofen|mesh-list
64327830|NCT02178293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64327831|NCT02178293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327832|NCT02178293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64327833|NCT02178293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64383142|NCT02569437|Fluticasone|fluticasone|mesh-list
64383143|NCT02569437|Doxycycline|doxycycline|mesh-list
65334274|NCT00771147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334275|NCT04155710|Interleukin-2|interleukin-2|mesh-list
65334276|NCT04155710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334277|NCT04155710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65334278|NCT04155710|Analgesics|analgesics|mesh-ancestor
65334279|NCT04155710|Sensory System Agents|sensory system agents|mesh-ancestor
65334280|NCT04155710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65334281|NCT04155710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334282|NCT00775047|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65211721|NCT04235985|Chlorhexidine|chlorhexidine|mesh-list
65334283|NCT00775047|Medroxyprogesterone|medroxyprogesterone|mesh-list
65334284|NCT00775047|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65334285|NCT00775047|Contraceptive Agents|contraceptive agents|mesh-ancestor
65334286|NCT00775047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65334287|NCT00775047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334288|NCT00775047|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65334289|NCT00775047|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65334290|NCT00775047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65334291|NCT00775047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334292|NCT00775047|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65334293|NCT00775047|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65334294|NCT00775047|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65334295|NCT00775125|Ritonavir|ritonavir|mesh-list
65334296|NCT00775125|Darunavir|darunavir|mesh-list
65334297|NCT00775125|Fosamprenavir|fosamprenavir|mesh-list
65334298|NCT00775125|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65334299|NCT00775125|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65334300|NCT00775125|Protease Inhibitors|protease inhibitors|mesh-ancestor
65334301|NCT00775125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334302|NCT00775125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334303|NCT00775125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65334304|NCT00775125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65334305|NCT00775125|Antiviral Agents|antiviral agents|mesh-ancestor
65334306|NCT00775125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65334307|NCT00775125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64383144|NCT02569437|Methylprednisolone|methylprednisolone|mesh-list
65334327|NCT00764439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334329|NCT04130516|Antibodies|antibodies|mesh-list
65334330|NCT04130516|Immunologic Factors|immunologic factors|mesh-ancestor
65334331|NCT04130516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334332|NCT04130516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65334333|NCT04130516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334334|NCT00771303|Fibrin fragment D|fibrin fragment d|mesh-list
65334335|NCT00771303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65334336|NCT00771303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64327836|NCT02178293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334364|NCT00775359|Antimetabolites|antimetabolites|mesh-ancestor
65334365|NCT00775359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334366|NCT00775359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64719853|NCT00001934|Daclizumab|daclizumab|mesh-list
65334398|NCT02557269|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65334399|NCT02557269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334400|NCT02557269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334401|NCT02557269|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65334402|NCT02557269|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65334403|NCT02557269|Histamine Antagonists|histamine antagonists|mesh-ancestor
65334404|NCT02557269|Histamine Agents|histamine agents|mesh-ancestor
65334488|NCT02580344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65334489|NCT02580344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65334490|NCT02580344|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65334491|NCT02580344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334492|NCT02580344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334494|NCT00779649|Cathartics|cathartics|mesh-ancestor
65334495|NCT00779649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65334496|NCT00779649|Laxatives|laxatives|mesh-ancestor
65334497|NCT00776217|Loratadine|loratadine|mesh-list
65334498|NCT00776217|Antipruritics|antipruritics|mesh-ancestor
65334499|NCT00776217|Dermatologic Agents|dermatologic agents|mesh-ancestor
65334500|NCT00776217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65334501|NCT00776217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65334502|NCT00776217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65334503|NCT00776217|Histamine Antagonists|histamine antagonists|mesh-ancestor
65334504|NCT00776217|Histamine Agents|histamine agents|mesh-ancestor
65334505|NCT00776217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65334506|NCT00776217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334507|NCT00776217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334508|NCT04990232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65334509|NCT04990232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65334510|NCT00667875|Naltrexone|naltrexone|mesh-list
65334511|NCT00667875|Aripiprazole|aripiprazole|mesh-list
65334512|NCT00667875|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65334513|NCT00667875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65211784|NCT05804903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334514|NCT00667875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334515|NCT00667875|Sensory System Agents|sensory system agents|mesh-ancestor
64713093|NCT03199040|Durvalumab|durvalumab|mesh-list
64713094|NCT03199040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64713095|NCT03199040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334529|NCT00667875|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65334530|NCT00667875|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65334531|NCT00667875|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65334532|NCT00667875|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65334533|NCT02579642|Ketamine|ketamine|mesh-list
65334534|NCT02579642|Analgesics|analgesics|mesh-ancestor
65334535|NCT02579642|Sensory System Agents|sensory system agents|mesh-ancestor
65334536|NCT02579642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65334537|NCT02579642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334538|NCT02579642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65334539|NCT02579642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65334540|NCT02579642|Anesthetics, General|anesthetics, general|mesh-ancestor
65334541|NCT02579642|Anesthetics|anesthetics|mesh-ancestor
65334542|NCT02579642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65334543|NCT02579642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65334544|NCT02579642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65334545|NCT02579642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65334546|NCT02579642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334547|NCT00779805|Pseudoephedrine|pseudoephedrine|mesh-list
64719920|NCT00001964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64719921|NCT00001964|Immunologic Factors|immunologic factors|mesh-ancestor
64719922|NCT00001964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719923|NCT00001964|Antifungal Agents|antifungal agents|mesh-ancestor
64719924|NCT00001964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719925|NCT00001964|Dermatologic Agents|dermatologic agents|mesh-ancestor
64719926|NCT00001964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64719933|NCT03801265|Sensory System Agents|sensory system agents|mesh-ancestor
64719934|NCT03801265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719937|NCT00000290|Anesthetics|anesthetics|mesh-ancestor
64719938|NCT00000290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64719939|NCT00000290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334635|NCT00772551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65334637|NCT00772551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65334638|NCT00772551|Antiviral Agents|antiviral agents|mesh-ancestor
65334639|NCT00772551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65334640|NCT00772551|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65334641|NCT00772551|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65334642|NCT00772551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334643|NCT00776841|Cholic Acids|cholic acids|mesh-list
65334644|NCT00776841|Bile Acids and Salts|bile acids and salts|mesh-list
65334645|NCT00776841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65334646|NCT02556879|Liver Extracts|liver extracts|mesh-list
65334647|NCT02556879|Antibodies|antibodies|mesh-list
65334648|NCT02556879|Immunologic Factors|immunologic factors|mesh-ancestor
65334649|NCT02556879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334650|NCT02556879|Hematinics|hematinics|mesh-ancestor
65334651|NCT00772863|Docetaxel|docetaxel|mesh-list
65334652|NCT00772863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334653|NCT00772863|Tubulin Modulators|tubulin modulators|mesh-ancestor
65334654|NCT00772863|Antimitotic Agents|antimitotic agents|mesh-ancestor
65334655|NCT00772863|Mitosis Modulators|mitosis modulators|mesh-ancestor
65334656|NCT00772863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334657|NCT04075760|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65334658|NCT04075760|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65334659|NCT04075760|Adrenergic Agents|adrenergic agents|mesh-ancestor
65334660|NCT04075760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65334661|NCT04075760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334662|NCT04075760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334663|NCT00667719|Amlodipine|amlodipine|mesh-list
64327940|NCT00829023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64327941|NCT02178683|Mycophenolic Acid|mycophenolic acid|mesh-list
64327942|NCT02178683|Tacrolimus|tacrolimus|mesh-list
65334693|NCT00669669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65334694|NCT00669669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334695|NCT02579564|Gemcitabine|gemcitabine|mesh-list
65334696|NCT02579564|Paclitaxel|paclitaxel|mesh-list
65334697|NCT02579564|Vinorelbine|vinorelbine|mesh-list
65334698|NCT02579564|Pemetrexed|pemetrexed|mesh-list
65334703|NCT02579564|Tubulin Modulators|tubulin modulators|mesh-ancestor
65334704|NCT02579564|Antimitotic Agents|antimitotic agents|mesh-ancestor
65211856|NCT05804305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65211857|NCT05804305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65211858|NCT05804305|Oxytocics|oxytocics|mesh-ancestor
65211875|NCT05804032|Dexamethasone|dexamethasone|mesh-list
65211876|NCT05804032|Lenalidomide|lenalidomide|mesh-list
65211877|NCT05804032|Bortezomib|bortezomib|mesh-list
65211878|NCT05804032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65211879|NCT05804032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65211880|NCT05804032|Antiemetics|antiemetics|mesh-ancestor
65211881|NCT05804032|Autonomic Agents|autonomic agents|mesh-ancestor
65211882|NCT05804032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65211883|NCT05804032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211884|NCT05804032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65211885|NCT05804032|Glucocorticoids|glucocorticoids|mesh-ancestor
65211886|NCT05804032|Hormones|hormones|mesh-ancestor
65211887|NCT05804032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65211888|NCT05804032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65211895|NCT05803941|177Lu-PSMA-617|177lu-psma-617|mesh-list
65334705|NCT02579564|Mitosis Modulators|mitosis modulators|mesh-ancestor
65334706|NCT02579564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334707|NCT02579564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65334708|NCT02579564|Antimetabolites|antimetabolites|mesh-ancestor
65334709|NCT02579564|Antiviral Agents|antiviral agents|mesh-ancestor
65334710|NCT02579564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65334711|NCT02579564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334712|NCT02579564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65334713|NCT02579564|Immunologic Factors|immunologic factors|mesh-ancestor
65334714|NCT02579564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334715|NCT02579564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65334716|NCT02579564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65334717|NCT02579564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65334718|NCT02579564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65334719|NCT02579564|Growth Substances|growth substances|mesh-ancestor
65334720|NCT02579564|Growth Inhibitors|growth inhibitors|mesh-ancestor
65334721|NCT00467779|Midazolam|midazolam|mesh-list
65334722|NCT00467779|Dextromethorphan|dextromethorphan|mesh-list
65334723|NCT00467779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65334724|NCT00467779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65334725|NCT00467779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65334726|NCT00467779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334727|NCT00467779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65334728|NCT00467779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65334729|NCT00467779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65334730|NCT00467779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64713212|NCT03007147|Asparaginase|asparaginase|mesh-list
64713213|NCT03007147|Mercaptopurine|mercaptopurine|mesh-list
65334738|NCT00467779|Respiratory System Agents|respiratory system agents|mesh-ancestor
65334739|NCT00467779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65334740|NCT00467779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65334741|NCT03704480|Durvalumab|durvalumab|mesh-list
65334742|NCT03704480|Tremelimumab|tremelimumab|mesh-list
65334743|NCT03704480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65334744|NCT03704480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334745|NCT03699254|Valganciclovir|valganciclovir|mesh-list
65334746|NCT03699254|Ganciclovir|ganciclovir|mesh-list
65334747|NCT03699254|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65334748|NCT03699254|Antiviral Agents|antiviral agents|mesh-ancestor
65334749|NCT03699254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65334750|NCT03699254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65211932|NCT05803642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65334751|NCT03699254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334752|NCT03699254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334753|NCT00570687|Insulin|insulin|mesh-list
65334754|NCT00570687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65334755|NCT00570687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334756|NCT01021891|Insulin|insulin|mesh-list
65334757|NCT01021891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65334758|NCT01021891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334759|NCT01029223|Metoprolol|metoprolol|mesh-list
65334760|NCT01029223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65334761|NCT01029223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65334762|NCT01029223|Sympatholytics|sympatholytics|mesh-ancestor
65334763|NCT01029223|Autonomic Agents|autonomic agents|mesh-ancestor
65334764|NCT01029223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65334765|NCT01029223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334797|NCT03410654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65334798|NCT03410654|Immunologic Factors|immunologic factors|mesh-ancestor
65334799|NCT03410654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334800|NCT03410654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65334801|NCT03410654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334802|NCT03410654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334803|NCT04006262|Nivolumab|nivolumab|mesh-list
65334804|NCT04006262|Ipilimumab|ipilimumab|mesh-list
65334805|NCT04006262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65334806|NCT04006262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334807|NCT04006262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65334832|NCT03385928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334834|NCT03385928|Coagulants|coagulants|mesh-ancestor
65334835|NCT05673980|Vitamin D|vitamin d|mesh-list
65334836|NCT05673980|Cholecalciferol|cholecalciferol|mesh-list
65334837|NCT05673980|Ergocalciferols|ergocalciferols|mesh-list
65334838|NCT05673980|Vitamins|vitamins|mesh-ancestor
65334839|NCT05673980|Micronutrients|micronutrients|mesh-ancestor
65334840|NCT05673980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334841|NCT05673980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65334842|NCT05673980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65334843|NCT02581124|Lapatinib|lapatinib|mesh-list
65334844|NCT02581124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334845|NCT02581124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65334846|NCT02581124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334847|NCT02581124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334848|NCT02580968|Flunarizine|flunarizine|mesh-list
65334849|NCT02580968|Anticonvulsants|anticonvulsants|mesh-ancestor
65334850|NCT02580968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65334851|NCT02580968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65334852|NCT02580968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334853|NCT02580968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65334854|NCT02580968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334855|NCT02580968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65334856|NCT02580968|Histamine Antagonists|histamine antagonists|mesh-ancestor
65334857|NCT02580968|Histamine Agents|histamine agents|mesh-ancestor
65334858|NCT02580968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65334859|NCT02580968|Vasodilator Agents|vasodilator agents|mesh-ancestor
65334860|NCT00441103|Interferon beta-1a|interferon beta-1a|mesh-list
65334861|NCT00441103|Interferon-beta|interferon-beta|mesh-list
65334862|NCT00441103|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65334863|NCT00441103|Immunologic Factors|immunologic factors|mesh-ancestor
65334894|NCT00433537|Dexamethasone|dexamethasone|mesh-list
65334895|NCT00433537|Cyclophosphamide|cyclophosphamide|mesh-list
65334896|NCT00433537|Rituximab|rituximab|mesh-list
65334897|NCT00433537|Doxorubicin|doxorubicin|mesh-list
65334898|NCT00433537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65334899|NCT00433537|Vincristine|vincristine|mesh-list
65334900|NCT00433537|Bortezomib|bortezomib|mesh-list
65334901|NCT00433537|Lenograstim|lenograstim|mesh-list
65334902|NCT00433537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65334903|NCT00433537|Immunologic Factors|immunologic factors|mesh-ancestor
65334904|NCT00433537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334905|NCT00433537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65334906|NCT00433537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65334907|NCT00433537|Alkylating Agents|alkylating agents|mesh-ancestor
65334908|NCT00433537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334909|NCT00433537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334910|NCT00433537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64720052|NCT00001082|Antiviral Agents|antiviral agents|mesh-ancestor
65334974|NCT00777933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65334975|NCT00773331|Epoetin Alfa|epoetin alfa|mesh-list
65334976|NCT00773331|Hematinics|hematinics|mesh-ancestor
65334977|NCT00778011|Ondansetron|ondansetron|mesh-list
64720103|NCT03799783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65335009|NCT00433381|Antibodies|antibodies|mesh-list
65335010|NCT00433381|Immunoglobulins|immunoglobulins|mesh-list
65335011|NCT00433381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65335012|NCT00433381|Immunoglobulin G|immunoglobulin g|mesh-list
65335013|NCT00433381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335014|NCT00433381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65335015|NCT00433381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65335016|NCT00433381|Growth Substances|growth substances|mesh-ancestor
65335033|NCT00781131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65335034|NCT00781131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335035|NCT00781131|Anticonvulsants|anticonvulsants|mesh-ancestor
65335036|NCT00781131|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65335037|NCT00781131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65335038|NCT00781131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335039|NCT00781131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65335040|NCT00781131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65335041|NCT00781131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65335042|NCT00781131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65335043|NCT00781131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65335044|NCT00778245|Cefprozil|cefprozil|mesh-list
65335045|NCT00778245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65335046|NCT00778245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64328078|NCT02741713|Racepinephrine|racepinephrine|mesh-list
65335063|NCT00666705|Maraviroc|maraviroc|mesh-list
65335064|NCT00666705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65335065|NCT00666705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65335066|NCT00666705|Antiviral Agents|antiviral agents|mesh-ancestor
65335067|NCT00666705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335068|NCT00666705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65335069|NCT00666705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65335070|NCT00666705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335071|NCT00666705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335072|NCT00666705|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65335073|NCT00666705|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65335074|NCT00666705|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65335075|NCT04047849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65335076|NCT04047849|Amoxicillin|amoxicillin|mesh-list
65335077|NCT04047849|Azithromycin|azithromycin|mesh-list
65335078|NCT04047849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335079|NCT00778557|Cefprozil|cefprozil|mesh-list
65335080|NCT00778557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65335081|NCT00778557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335082|NCT00778713|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65335083|NCT00778713|Fosinopril|fosinopril|mesh-list
65335084|NCT00778713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65335085|NCT00778713|Diuretics|diuretics|mesh-ancestor
65335086|NCT00778713|Natriuretic Agents|natriuretic agents|mesh-ancestor
65335087|NCT00778713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335088|NCT00778713|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65335089|NCT00778713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65335090|NCT00778713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335091|NCT00778713|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65335092|NCT00778713|Protease Inhibitors|protease inhibitors|mesh-ancestor
65335093|NCT00778713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335094|NCT00781287|Raltegravir Potassium|raltegravir potassium|mesh-list
65335095|NCT00781287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65335096|NCT00781287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65335097|NCT00781287|Antiviral Agents|antiviral agents|mesh-ancestor
65335098|NCT00781287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335099|NCT00781287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65335100|NCT00781287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65335101|NCT00781287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335102|NCT00781287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335103|NCT00774111|Dolutegravir|dolutegravir|mesh-list
65335104|NCT00774111|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65335105|NCT00774111|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65335106|NCT00774111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335107|NCT00774111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335108|NCT00774111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65335109|NCT00774111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65335110|NCT00774111|Antiviral Agents|antiviral agents|mesh-ancestor
65335111|NCT00774111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65212087|NCT05802056|Antidotes|antidotes|mesh-ancestor
65335112|NCT00778791|Metformin|metformin|mesh-list
65335113|NCT00778791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65335114|NCT00778791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335115|NCT00774189|Clarithromycin|clarithromycin|mesh-list
65335116|NCT00774189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65335117|NCT00774189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335120|NCT00774189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335121|NCT00774189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65335122|NCT00774189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65335124|NCT00774423|Anticonvulsants|anticonvulsants|mesh-ancestor
65335125|NCT00774423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65335126|NCT00774423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65335127|NCT00774423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65335128|NCT00774423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335129|NCT00774423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335130|NCT00774423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65335131|NCT00774423|Protective Agents|protective agents|mesh-ancestor
65335132|NCT00781521|Ofloxacin|ofloxacin|mesh-list
65335133|NCT00781521|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65335134|NCT00781521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335135|NCT00781521|Renal Agents|renal agents|mesh-ancestor
65335136|NCT00781521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65335137|NCT00781521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65335138|NCT00781521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65335139|NCT00781521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335140|NCT00781521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335141|NCT00781521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335142|NCT00781521|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65335143|NCT00781521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65335144|NCT00774501|Anesthetics|anesthetics|mesh-list
65335145|NCT00774501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65335146|NCT00774501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335147|NCT00784485|Omalizumab|omalizumab|mesh-list
65335148|NCT00784485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65335149|NCT00784485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64713330|NCT02989597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65335183|NCT00774813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65335184|NCT00774813|Antidepressive Agents|antidepressive agents|mesh-ancestor
65335185|NCT00774813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65335186|NCT00784797|Oxytocin|oxytocin|mesh-list
65335187|NCT00784797|Mifepristone|mifepristone|mesh-list
65335188|NCT00784797|Oxytocics|oxytocics|mesh-ancestor
65335189|NCT00784797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65335192|NCT00784797|Abortifacient Agents|abortifacient agents|mesh-ancestor
65335193|NCT00784797|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65335194|NCT00784797|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65335195|NCT00784797|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65335196|NCT00784797|Contraceptive Agents|contraceptive agents|mesh-ancestor
65335197|NCT00784797|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65335198|NCT00784797|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65335199|NCT00784797|Hormone Antagonists|hormone antagonists|mesh-ancestor
65335200|NCT00784797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65335201|NCT00784797|Luteolytic Agents|luteolytic agents|mesh-ancestor
65335202|NCT00784797|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65335203|NCT00784797|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65335204|NCT00774969|Metronidazole|metronidazole|mesh-list
65335205|NCT00774969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335206|NCT00774969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65335207|NCT00774969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65335208|NCT00774969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65335209|NCT00785109|Vitamin K|vitamin k|mesh-list
65335210|NCT00785109|Vitamins|vitamins|mesh-ancestor
65335211|NCT00785109|Micronutrients|micronutrients|mesh-ancestor
65335212|NCT00785109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335213|NCT00785109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65335214|NCT00785109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65335215|NCT00785109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335216|NCT00785109|Hemostatics|hemostatics|mesh-ancestor
65335217|NCT00785109|Coagulants|coagulants|mesh-ancestor
65335218|NCT00662025|Capecitabine|capecitabine|mesh-list
65335219|NCT00662025|Sunitinib|sunitinib|mesh-list
65335220|NCT00662025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65085087|NCT00475917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212158|NCT05768711|Venetoclax|venetoclax|mesh-list
65335221|NCT00662025|Antimetabolites|antimetabolites|mesh-ancestor
65335222|NCT00662025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335223|NCT00662025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335224|NCT00662025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64713333|NCT02989597|Anesthetics|anesthetics|mesh-ancestor
65335252|NCT00782301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335254|NCT00782301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65335255|NCT00782301|Antiviral Agents|antiviral agents|mesh-ancestor
65335256|NCT00782301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335257|NCT00782301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65335258|NCT00782301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65335259|NCT00782301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65335260|NCT00782301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335261|NCT00785421|Leucovorin|leucovorin|mesh-list
65335262|NCT00785421|Folic Acid|folic acid|mesh-list
65335263|NCT00785421|Gemcitabine|gemcitabine|mesh-list
65335264|NCT00785421|Cisplatin|cisplatin|mesh-list
65335265|NCT00785421|Enoxaparin|enoxaparin|mesh-list
65335266|NCT00785421|Enoxaparin sodium|enoxaparin sodium|mesh-list
65335267|NCT00785421|Levoleucovorin|levoleucovorin|mesh-list
65335268|NCT00785421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64720213|NCT04103515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335306|NCT00790413|Alkylating Agents|alkylating agents|mesh-ancestor
64720233|NCT00002036|Immune Sera|immune sera|mesh-list
65335334|NCT00440947|Antimetabolites|antimetabolites|mesh-ancestor
65335335|NCT00790881|Lumefantrine|lumefantrine|mesh-list
65335336|NCT00790881|Artemether|artemether|mesh-list
65335337|NCT00790881|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65335338|NCT00790881|Antimalarials|antimalarials|mesh-ancestor
65335339|NCT00790881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65335340|NCT00790881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65335341|NCT00790881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335342|NCT01029769|Olanzapine|olanzapine|mesh-list
65335345|NCT01029769|Autonomic Agents|autonomic agents|mesh-ancestor
65335346|NCT01029769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65335347|NCT01029769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335348|NCT01029769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65335349|NCT01029769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65335350|NCT01029769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65335351|NCT01029769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65335352|NCT01029769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65335353|NCT01029769|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65335354|NCT01029769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65335355|NCT01029769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65335356|NCT01029769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335357|NCT01029769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65335358|NCT01029769|Serotonin Agents|serotonin agents|mesh-ancestor
65335359|NCT01029769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65335360|NCT01029769|Dopamine Agents|dopamine agents|mesh-ancestor
65335361|NCT01029769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65335362|NCT01029769|Antidepressive Agents|antidepressive agents|mesh-ancestor
65335363|NCT02557945|Gabapentin|gabapentin|mesh-list
65335364|NCT02557945|Analgesics|analgesics|mesh-ancestor
65335365|NCT02557945|Sensory System Agents|sensory system agents|mesh-ancestor
65335366|NCT02557945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65335367|NCT02557945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335368|NCT02557945|Anticonvulsants|anticonvulsants|mesh-ancestor
65335369|NCT02557945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65335370|NCT02557945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65335371|NCT02557945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65335372|NCT02557945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65335373|NCT02557945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65335374|NCT02557945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65335375|NCT02557945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65335376|NCT02557945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335377|NCT02557945|Antimanic Agents|antimanic agents|mesh-ancestor
64328290|NCT02176187|Respiratory System Agents|respiratory system agents|mesh-ancestor
64328291|NCT02176187|Sympathomimetics|sympathomimetics|mesh-ancestor
64328292|NCT02176187|Tocolytic Agents|tocolytic agents|mesh-ancestor
64328293|NCT02176187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65335451|NCT02555943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65335452|NCT02555943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65335453|NCT02555943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65335454|NCT02555943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65212236|NCT05701917|Heparin|heparin|mesh-list
65335455|NCT00782847|Cyproterone Acetate|cyproterone acetate|mesh-list
65335457|NCT00782847|Androgen Antagonists|androgen antagonists|mesh-ancestor
65335458|NCT00782847|Hormone Antagonists|hormone antagonists|mesh-ancestor
65335459|NCT00782847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65335460|NCT00782847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335461|NCT00782847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335462|NCT00782847|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65335463|NCT00782847|Contraceptive Agents|contraceptive agents|mesh-ancestor
65335464|NCT00782847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65335465|NCT00785967|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65335466|NCT00785967|Immunologic Factors|immunologic factors|mesh-ancestor
65335467|NCT00785967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335468|NCT00440557|Epoetin Alfa|epoetin alfa|mesh-list
65335469|NCT00440557|Hematinics|hematinics|mesh-ancestor
65335470|NCT05673590|Docetaxel|docetaxel|mesh-list
65335471|NCT05673590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335472|NCT05673590|Tubulin Modulators|tubulin modulators|mesh-ancestor
65335473|NCT05673590|Antimitotic Agents|antimitotic agents|mesh-ancestor
65335474|NCT05673590|Mitosis Modulators|mitosis modulators|mesh-ancestor
65335475|NCT05673590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335476|NCT03139370|Cyclophosphamide|cyclophosphamide|mesh-list
65335477|NCT03139370|Fludarabine|fludarabine|mesh-list
65335478|NCT03139370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65335479|NCT03139370|Immunologic Factors|immunologic factors|mesh-ancestor
65335480|NCT03139370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335481|NCT03139370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65335482|NCT03139370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65335483|NCT03139370|Alkylating Agents|alkylating agents|mesh-ancestor
65335484|NCT03139370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335536|NCT00582608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335537|NCT00582608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335538|NCT02400242|Dexamethasone|dexamethasone|mesh-list
64328310|NCT02176733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335626|NCT00427999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65335627|NCT00427999|Glucocorticoids|glucocorticoids|mesh-ancestor
65335628|NCT00427999|Hormones|hormones|mesh-ancestor
65335629|NCT00427999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65335630|NCT00427999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65335631|NCT00427999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335632|NCT00427999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65335633|NCT00427999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65335634|NCT00427999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720410|NCT00002096|Didanosine|didanosine|mesh-list
65335668|NCT03840902|Mitosis Modulators|mitosis modulators|mesh-ancestor
65335669|NCT03840902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335670|NCT03840902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65335671|NCT03840902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65335672|NCT03840902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335673|NCT03840902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65335674|NCT03840902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65335675|NCT03840902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64720441|NCT00002108|Lamivudine|lamivudine|mesh-list
65335708|NCT01566487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65335709|NCT01566487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65335710|NCT01566487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335711|NCT02576288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65335712|NCT02576288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65335713|NCT02576288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335714|NCT02576288|Incretins|incretins|mesh-ancestor
65335715|NCT02576288|Hormones|hormones|mesh-ancestor
65335729|NCT00432991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65335730|NCT00432991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65335731|NCT00432991|Adrenergic Agents|adrenergic agents|mesh-ancestor
65335732|NCT00432991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65335733|NCT00432991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335735|NCT00580970|L 647318|l 647318|mesh-list
65335736|NCT00580970|Dihydromevinolin|dihydromevinolin|mesh-list
65335737|NCT00580970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65335738|NCT00580970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65335739|NCT00580970|Antimetabolites|antimetabolites|mesh-ancestor
65335740|NCT00580970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335741|NCT00580970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65212310|NCT05627232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335742|NCT00580970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65335743|NCT00580970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335744|NCT01030081|Amlodipine|amlodipine|mesh-list
65335745|NCT01030081|Nifedipine|nifedipine|mesh-list
65335746|NCT01030081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65335776|NCT02576366|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65335777|NCT02576366|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65335778|NCT02576366|Antifungal Agents|antifungal agents|mesh-ancestor
65335779|NCT02576366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65335780|NCT02576366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65335781|NCT02576366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65335782|NCT02576366|Hormone Antagonists|hormone antagonists|mesh-ancestor
65335783|NCT02576366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65335784|NCT02576366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335785|NCT02576366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65335786|NCT01030237|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64383009|NCT02414165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64383010|NCT02414165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64383011|NCT02414165|Growth Substances|growth substances|mesh-ancestor
65335787|NCT01030237|Lubricant Eye Drops|lubricant eye drops|mesh-list
65335788|NCT01030237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65335790|NCT04046679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65335791|NCT04046679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335792|NCT00786279|Ethanol|ethanol|mesh-list
65335793|NCT00786279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65335794|NCT00786279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335795|NCT00786279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65335796|NCT00786279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335797|NCT00791193|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65335798|NCT00791193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65335799|NCT00791193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65335800|NCT00791193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65335801|NCT00791193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335802|NCT00791193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65335803|NCT00791193|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65335804|NCT00791193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65335805|NCT00791193|Serotonin Agents|serotonin agents|mesh-ancestor
65335806|NCT00791193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65335807|NCT00791193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335808|NCT00791193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65335809|NCT00791193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65335810|NCT00791193|Dopamine Agents|dopamine agents|mesh-ancestor
65335811|NCT00791271|Interferons|interferons|mesh-list
65335812|NCT00791271|Interferon-alpha|interferon-alpha|mesh-list
65335813|NCT00791271|Interferon alpha-2|interferon alpha-2|mesh-list
65335814|NCT00791271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65335815|NCT00791271|Decitabine|decitabine|mesh-list
65335816|NCT00791271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335817|NCT00791271|Antiviral Agents|antiviral agents|mesh-ancestor
65335818|NCT00791271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335819|NCT00791271|Immunologic Factors|immunologic factors|mesh-ancestor
65335820|NCT00791271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335821|NCT00791271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65335822|NCT00791271|Antimetabolites|antimetabolites|mesh-ancestor
64383012|NCT02414165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335850|NCT00786513|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65335851|NCT00791505|Ciprofloxacin|ciprofloxacin|mesh-list
65335852|NCT00791505|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65335853|NCT00791505|Fluoroquinolones|fluoroquinolones|mesh-list
65335854|NCT00791505|Trimethoprim|trimethoprim|mesh-list
65335855|NCT00791505|Sulfamethoxazole|sulfamethoxazole|mesh-list
65335856|NCT00791505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65335857|NCT00791505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335858|NCT00791505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65335859|NCT00791505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65335860|NCT00791505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335861|NCT00791505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335862|NCT00791505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335863|NCT00791505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65335864|NCT00791505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64459823|NCT04804540|Vedolizumab|vedolizumab|mesh-list
65212388|NCT05577715|Farletuzumab|farletuzumab|mesh-list
65212389|NCT05577715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212390|NCT05566795|Antineoplastic Agents|antineoplastic agents|mesh-list
65335871|NCT00791505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65335872|NCT00791505|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65335873|NCT00791505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65335874|NCT02598960|Nivolumab|nivolumab|mesh-list
65335875|NCT02598960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65335876|NCT02598960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335877|NCT02598960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65335878|NCT02598960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335879|NCT00426361|Vaccines|vaccines|mesh-list
65335880|NCT00426361|Immunologic Factors|immunologic factors|mesh-ancestor
65335881|NCT00426361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335882|NCT00665847|Etravirine|etravirine|mesh-list
65335883|NCT00665847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65335884|NCT00665847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65335885|NCT00665847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335886|NCT00665847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335887|NCT00665847|Antiviral Agents|antiviral agents|mesh-ancestor
65335888|NCT00665847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335889|NCT01030393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65335890|NCT01030393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65335891|NCT01030393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335892|NCT00783081|Cilostazol|cilostazol|mesh-list
65335893|NCT00783081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65335894|NCT00783081|Autonomic Agents|autonomic agents|mesh-ancestor
65335895|NCT00783081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65085760|NCT00478374|Doxorubicin|doxorubicin|mesh-list
65335896|NCT00783081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335897|NCT00783081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65335898|NCT00783081|Respiratory System Agents|respiratory system agents|mesh-ancestor
65335899|NCT00783081|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65335900|NCT00783081|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65335928|NCT02535078|Durvalumab|durvalumab|mesh-list
65335929|NCT02535078|Tremelimumab|tremelimumab|mesh-list
65335930|NCT02535078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65335931|NCT02535078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335932|NCT00425503|Bortezomib|bortezomib|mesh-list
65335969|NCT00791739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335970|NCT00791739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65335979|NCT00791739|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65335981|NCT00791895|Insulin Aspart|insulin aspart|mesh-list
65335982|NCT00791895|Biphasic Insulins|biphasic insulins|mesh-list
65335983|NCT00791895|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65335984|NCT00791895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65335985|NCT00791895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335986|NCT02503722|Osimertinib|osimertinib|mesh-list
65335987|NCT02503722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335988|NCT02503722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65335989|NCT02503722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335990|NCT02503722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335991|NCT00430573|Cycloserine|cycloserine|mesh-list
65335992|NCT00430573|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65335993|NCT00430573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335994|NCT00430573|Renal Agents|renal agents|mesh-ancestor
65335995|NCT00430573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65335996|NCT00430573|Antitubercular Agents|antitubercular agents|mesh-ancestor
65335997|NCT00430573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65335998|NCT00430573|Antimetabolites|antimetabolites|mesh-ancestor
65335999|NCT00430573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336000|NCT00783393|Temozolomide|temozolomide|mesh-list
65336001|NCT00783393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65336002|NCT00783393|Alkylating Agents|alkylating agents|mesh-ancestor
65336003|NCT00783393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336004|NCT00783393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336005|NCT00783471|Docetaxel|docetaxel|mesh-list
65336006|NCT00783471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65336007|NCT00783471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336008|NCT00783471|Tubulin Modulators|tubulin modulators|mesh-ancestor
65336009|NCT00783471|Antimitotic Agents|antimitotic agents|mesh-ancestor
65269793|NCT02733380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336010|NCT00783471|Mitosis Modulators|mitosis modulators|mesh-ancestor
65336011|NCT00783471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336012|NCT00783471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65336013|NCT00783471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336014|NCT02460900|Varenicline|varenicline|mesh-list
65336015|NCT02460900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65336016|NCT02460900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65336017|NCT02460900|Cholinergic Agents|cholinergic agents|mesh-ancestor
65336018|NCT02460900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65336019|NCT02460900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336020|NCT02460900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336021|NCT00787371|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65336022|NCT00787371|Interferon-alpha|interferon-alpha|mesh-list
65336023|NCT00787371|Antiviral Agents|antiviral agents|mesh-ancestor
65336024|NCT00787371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65336025|NCT00787371|Immunologic Factors|immunologic factors|mesh-ancestor
65336026|NCT00787371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336027|NCT02075840|Crizotinib|crizotinib|mesh-list
65336028|NCT02075840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336029|NCT02075840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65336030|NCT02075840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336031|NCT02075840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336032|NCT02554695|Denosumab|denosumab|mesh-list
65336033|NCT02554695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65336034|NCT02554695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336035|NCT00792363|Irinotecan|irinotecan|mesh-list
65336036|NCT00792363|Panitumumab|panitumumab|mesh-list
65336037|NCT00792363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65336056|NCT04895280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65336057|NCT04895280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336058|NCT04895280|Sensory System Agents|sensory system agents|mesh-ancestor
65336059|NCT04895280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65336060|NCT04895280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65336061|NCT04895280|Glucocorticoids|glucocorticoids|mesh-ancestor
65336062|NCT04895280|Hormones|hormones|mesh-ancestor
65336063|NCT04895280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65336064|NCT04895280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65336065|NCT04895280|Immunologic Factors|immunologic factors|mesh-ancestor
65336066|NCT04895280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336067|NCT04895280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336068|NCT04895280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65336069|NCT04895280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65336070|NCT04895280|Analgesics|analgesics|mesh-ancestor
65336071|NCT04895280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65336072|NCT04895280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65336073|NCT03994783|Methylprednisolone|methylprednisolone|mesh-list
65336074|NCT03994783|Rituximab|rituximab|mesh-list
65336108|NCT01937468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336109|NCT00663117|Naltrexone|naltrexone|mesh-list
65336110|NCT00663117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65336111|NCT00663117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65336112|NCT00663117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336113|NCT00663117|Sensory System Agents|sensory system agents|mesh-ancestor
65336114|NCT00663117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65336115|NCT04072328|Midazolam|midazolam|mesh-list
65336116|NCT04072328|Propofol|propofol|mesh-list
65336117|NCT04072328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64720665|NCT00000626|Bleomycin|bleomycin|mesh-list
65336135|NCT00784017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336136|NCT04074122|Adenosine|adenosine|mesh-list
65336137|NCT04074122|Isoproterenol|isoproterenol|mesh-list
65336138|NCT04074122|Epinephrine|epinephrine|mesh-list
65336139|NCT04074122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65336140|NCT04074122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65336141|NCT04074122|Adrenergic Agents|adrenergic agents|mesh-ancestor
65336142|NCT04074122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65336143|NCT04074122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336144|NCT04074122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336145|NCT04074122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65336146|NCT04074122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65336147|NCT04074122|Autonomic Agents|autonomic agents|mesh-ancestor
65336148|NCT04074122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65336149|NCT04074122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65212554|NCT05459571|Hormones|hormones|mesh-ancestor
65336150|NCT04074122|Respiratory System Agents|respiratory system agents|mesh-ancestor
65336151|NCT04074122|Mydriatics|mydriatics|mesh-ancestor
65336152|NCT04074122|Sympathomimetics|sympathomimetics|mesh-ancestor
65336153|NCT04074122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64720696|NCT04713254|GABA Modulators|gaba modulators|mesh-ancestor
64720697|NCT04713254|GABA Agents|gaba agents|mesh-ancestor
65336155|NCT04074122|Sensory System Agents|sensory system agents|mesh-ancestor
65336156|NCT04074122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65336157|NCT04074122|Vasodilator Agents|vasodilator agents|mesh-ancestor
65336158|NCT04074122|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65336159|NCT04074122|Purinergic Agonists|purinergic agonists|mesh-ancestor
65336160|NCT04074122|Purinergic Agents|purinergic agents|mesh-ancestor
65336161|NCT04074122|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65336162|NCT04074122|Protective Agents|protective agents|mesh-ancestor
65336164|NCT02578550|Emtricitabine|emtricitabine|mesh-list
65336165|NCT02578550|Darunavir|darunavir|mesh-list
65336166|NCT02578550|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65336167|NCT02578550|Cobicistat|cobicistat|mesh-list
65336168|NCT02578550|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65336169|NCT02578550|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
65336170|NCT02578550|Antiviral Agents|antiviral agents|mesh-ancestor
65336171|NCT02578550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65336172|NCT02578550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65336173|NCT02578550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65336174|NCT02578550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336175|NCT02578550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336176|NCT02578550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65336177|NCT02578550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65336178|NCT02578550|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65336179|NCT02578550|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65336180|NCT02578550|Protease Inhibitors|protease inhibitors|mesh-ancestor
65336181|NCT02578550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65336182|NCT02578550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65336183|NCT00788463|Beclomethasone|beclomethasone|mesh-list
65336184|NCT00788463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65336185|NCT00788463|Glucocorticoids|glucocorticoids|mesh-ancestor
65336186|NCT00788463|Hormones|hormones|mesh-ancestor
65336187|NCT00788463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65336188|NCT00788463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336189|NCT00788463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64713668|NCT02016924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65336218|NCT04941144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336219|NCT00661089|Botulinum Toxins|botulinum toxins|mesh-list
65336220|NCT00661089|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65336221|NCT00661089|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65336222|NCT00661089|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65336223|NCT00661089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65336224|NCT00661089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336225|NCT00661089|Cholinergic Agents|cholinergic agents|mesh-ancestor
65336226|NCT00661089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65336227|NCT00661089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720712|NCT04713254|Autonomic Agents|autonomic agents|mesh-ancestor
64720718|NCT00002156|Ganciclovir|ganciclovir|mesh-list
65336255|NCT00582426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336256|NCT00709982|Folic Acid|folic acid|mesh-list
65336257|NCT00709982|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65336258|NCT00709982|Norgestimate|norgestimate|mesh-list
65336259|NCT00709982|Estradiol|estradiol|mesh-list
65336260|NCT00709982|Estrogens|estrogens|mesh-ancestor
65336261|NCT00709982|Hormones|hormones|mesh-ancestor
65336262|NCT00709982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65336263|NCT00709982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336264|NCT00709982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65336265|NCT00709982|Contraceptive Agents|contraceptive agents|mesh-ancestor
65336266|NCT00709982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65336267|NCT00709982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65336268|NCT00709982|Hematinics|hematinics|mesh-ancestor
65336269|NCT00709982|Vitamin B Complex|vitamin b complex|mesh-ancestor
65336270|NCT00709982|Vitamins|vitamins|mesh-ancestor
65336271|NCT00709982|Micronutrients|micronutrients|mesh-ancestor
65336272|NCT00709982|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65336273|NCT00709982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65086140|NCT00441870|Folic Acid|folic acid|mesh-list
65336274|NCT00709982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65336304|NCT00711074|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
65336305|NCT00711074|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65336306|NCT00711074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336307|NCT00711074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65336308|NCT00711074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65336309|NCT00711074|Antiviral Agents|antiviral agents|mesh-ancestor
65336310|NCT00711074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65336311|NCT00711308|Vitamin K|vitamin k|mesh-list
65336312|NCT00711308|Tinzaparin|tinzaparin|mesh-list
65336313|NCT00711308|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65336314|NCT00711308|Dalteparin|dalteparin|mesh-list
65336315|NCT00711308|Acenocoumarol|acenocoumarol|mesh-list
65336316|NCT00711308|Vitamins|vitamins|mesh-ancestor
65336317|NCT00711308|Micronutrients|micronutrients|mesh-ancestor
65336318|NCT00711308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336319|NCT00711308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65336320|NCT00711308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65336321|NCT00711308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336322|NCT00711308|Hemostatics|hemostatics|mesh-ancestor
65336323|NCT00711308|Coagulants|coagulants|mesh-ancestor
65336324|NCT00711308|Anticoagulants|anticoagulants|mesh-ancestor
65336330|NCT02601911|Analgesics|analgesics|mesh-ancestor
65336331|NCT02601911|Sensory System Agents|sensory system agents|mesh-ancestor
65336332|NCT02601911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65336333|NCT02601911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336334|NCT02601911|Antipyretics|antipyretics|mesh-ancestor
65336335|NCT02601911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65336336|NCT02601911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65336337|NCT02601911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65336338|NCT02601911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65336339|NCT02601911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336340|NCT02601911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336341|NCT00711620|Thymalfasin|thymalfasin|mesh-list
65336342|NCT00711620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65336343|NCT00711620|Immunologic Factors|immunologic factors|mesh-ancestor
65336344|NCT00711620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336345|NCT00581828|Vitamin D|vitamin d|mesh-list
65336346|NCT00581828|Ergocalciferols|ergocalciferols|mesh-list
65086209|NCT00479739|Adrenergic Agents|adrenergic agents|mesh-ancestor
65336347|NCT00581828|Cholecalciferol|cholecalciferol|mesh-list
65336348|NCT00581828|Vitamins|vitamins|mesh-list
65336349|NCT00581828|Micronutrients|micronutrients|mesh-ancestor
65336350|NCT00581828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336351|NCT00581828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65336352|NCT00581828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65336353|NCT02577614|Coagulants|coagulants|mesh-list
65336354|NCT02577614|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
65336355|NCT02577458|Everolimus|everolimus|mesh-list
65336356|NCT02577458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336357|NCT02577458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65336358|NCT02577458|Immunologic Factors|immunologic factors|mesh-ancestor
65336359|NCT02577458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336360|NCT00767039|Poractant alfa|poractant alfa|mesh-list
65336361|NCT00767039|Beractant|beractant|mesh-list
65336362|NCT00767039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
65336363|NCT00767039|Respiratory System Agents|respiratory system agents|mesh-ancestor
65336364|NCT01572506|Biotin|biotin|mesh-list
65336365|NCT01572506|Vitamin B Complex|vitamin b complex|mesh-ancestor
65336366|NCT01572506|Vitamins|vitamins|mesh-ancestor
65336367|NCT01572506|Micronutrients|micronutrients|mesh-ancestor
65336368|NCT01572506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336369|NCT00662649|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65336370|NCT00662649|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65336371|NCT00662649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336372|NCT00662649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65336373|NCT00662649|Immunologic Factors|immunologic factors|mesh-ancestor
65336374|NCT00662649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336375|NCT02577770|Caffeine|caffeine|mesh-list
65336376|NCT02577770|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65336377|NCT02577770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336378|NCT02577770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65336379|NCT02577770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336380|NCT02577770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336381|NCT02577770|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65336382|NCT02577770|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65336383|NCT02577770|Purinergic Agents|purinergic agents|mesh-ancestor
65336384|NCT02577770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65336385|NCT00129896|Docetaxel|docetaxel|mesh-list
65336386|NCT00129896|Doxorubicin|doxorubicin|mesh-list
65336387|NCT00129896|Trastuzumab|trastuzumab|mesh-list
65336388|NCT00129896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336389|NCT00129896|Tubulin Modulators|tubulin modulators|mesh-ancestor
65336390|NCT00129896|Antimitotic Agents|antimitotic agents|mesh-ancestor
65336391|NCT00129896|Mitosis Modulators|mitosis modulators|mesh-ancestor
65336392|NCT00129896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336393|NCT00129896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65336394|NCT00129896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65336395|NCT00129896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65336427|NCT00711698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65336428|NCT00795171|Docetaxel|docetaxel|mesh-list
65336429|NCT00795171|Sunitinib|sunitinib|mesh-list
65336430|NCT00795171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336431|NCT00795171|Tubulin Modulators|tubulin modulators|mesh-ancestor
65336432|NCT00795171|Antimitotic Agents|antimitotic agents|mesh-ancestor
65336433|NCT00795171|Mitosis Modulators|mitosis modulators|mesh-ancestor
65336434|NCT00795171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336435|NCT00795171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65336436|NCT00795171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65336437|NCT00795171|Growth Substances|growth substances|mesh-ancestor
65336438|NCT00795171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336439|NCT00795171|Growth Inhibitors|growth inhibitors|mesh-ancestor
64720870|NCT00000698|Ganciclovir|ganciclovir|mesh-list
65336496|NCT03015792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65336497|NCT03015792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336498|NCT03015792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65336500|NCT03015792|Hormones|hormones|mesh-ancestor
65336501|NCT03015792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65336502|NCT03015792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65336503|NCT03015792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336504|NCT03015792|Protease Inhibitors|protease inhibitors|mesh-ancestor
65336505|NCT03015792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336613|NCT02577068|Analgesics|analgesics|mesh-ancestor
65336614|NCT02577068|Sensory System Agents|sensory system agents|mesh-ancestor
65336615|NCT02577068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65336616|NCT02577068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336617|NCT02577068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65336618|NCT02577068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65336619|NCT02577068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65336620|NCT00582114|Atenolol|atenolol|mesh-list
65336621|NCT00582114|Lisinopril|lisinopril|mesh-list
65336622|NCT00582114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65336623|NCT00582114|Protease Inhibitors|protease inhibitors|mesh-ancestor
65336650|NCT00581360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336652|NCT01650792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65336653|NCT01650792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65336654|NCT01650792|Analgesics|analgesics|mesh-ancestor
65336655|NCT01650792|Sensory System Agents|sensory system agents|mesh-ancestor
65336656|NCT01650792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65336657|NCT01650792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336658|NCT01650792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65336659|NCT01650792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65336660|NCT01650792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65336661|NCT01650792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65336662|NCT01650792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336663|NCT01650792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65336664|NCT01650792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65336665|NCT01650792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336666|NCT01650792|Antipyretics|antipyretics|mesh-ancestor
65336667|NCT00660387|Levodopa|levodopa|mesh-list
65336668|NCT00660387|Carbidopa|carbidopa|mesh-list
65336669|NCT00660387|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65336670|NCT00660387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65336671|NCT00660387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65336672|NCT00660387|Dopamine Agents|dopamine agents|mesh-ancestor
65336673|NCT00660387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65336674|NCT00660387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336675|NCT00660387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336676|NCT00660387|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65336677|NCT00660387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336678|NCT00660387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65336679|NCT00660387|Immunologic Factors|immunologic factors|mesh-ancestor
65336680|NCT00660387|Dopamine Agonists|dopamine agonists|mesh-ancestor
65336681|NCT00582738|Everolimus|everolimus|mesh-list
65336682|NCT00582738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336683|NCT00582738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65336684|NCT00582738|Immunologic Factors|immunologic factors|mesh-ancestor
65336685|NCT00582738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336686|NCT00713336|Moxifloxacin|moxifloxacin|mesh-list
65336687|NCT00713336|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65336688|NCT00713336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65336689|NCT00713336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65336690|NCT00713336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65336691|NCT00713336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65336692|NCT00713336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336693|NCT00713336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336694|NCT00713336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336695|NCT00713336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65336696|NCT00713336|Contraceptive Agents|contraceptive agents|mesh-ancestor
65336697|NCT00713336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65336698|NCT00713336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336699|NCT00713336|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65336700|NCT00713336|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65336701|NCT00713336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65336702|NCT00789711|Insulin|insulin|mesh-list
65336703|NCT00789711|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65336704|NCT00789711|Insulin Aspart|insulin aspart|mesh-list
65336705|NCT00789711|Insulin Detemir|insulin detemir|mesh-list
65336706|NCT00789711|Biphasic Insulins|biphasic insulins|mesh-list
65336707|NCT00789711|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65336708|NCT00789711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65336709|NCT00789711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336728|NCT00800553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65336729|NCT00800553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336730|NCT00800553|Nootropic Agents|nootropic agents|mesh-ancestor
65336731|NCT00793767|Epoetin Alfa|epoetin alfa|mesh-list
65336732|NCT00793767|Hematinics|hematinics|mesh-ancestor
65336733|NCT00796029|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65336734|NCT00796029|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65336735|NCT00796029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65336736|NCT00796029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65336737|NCT00796029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336738|NCT00796029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65336739|NCT00796029|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65336757|NCT00793845|Alkylating Agents|alkylating agents|mesh-ancestor
65336758|NCT00793845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336759|NCT00793845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336760|NCT00793845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65336761|NCT00793845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65336762|NCT00793845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65336763|NCT00793845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65336764|NCT00793845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336765|NCT00800709|Memantine|memantine|mesh-list
65336766|NCT00800709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65336767|NCT00800709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65336768|NCT00800709|Dopamine Agents|dopamine agents|mesh-ancestor
65336769|NCT00800709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65336770|NCT00800709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336771|NCT00800709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336772|NCT00800709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65336773|NCT00800709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65336774|NCT00793923|Dexamethasone|dexamethasone|mesh-list
65336775|NCT00793923|Ranibizumab|ranibizumab|mesh-list
65336776|NCT00793923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65336777|NCT00793923|Antiemetics|antiemetics|mesh-ancestor
65336778|NCT00793923|Autonomic Agents|autonomic agents|mesh-ancestor
65336779|NCT00793923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65336780|NCT00793923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336836|NCT00800787|Immunologic Factors|immunologic factors|mesh-ancestor
65336837|NCT00800787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336838|NCT04073550|Topotecan|topotecan|mesh-list
65336839|NCT04073550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65336840|NCT04073550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65336841|NCT04073550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336842|NCT04073550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336843|NCT04073550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336844|NCT02576600|Remifentanil|remifentanil|mesh-list
65336845|NCT02576600|Propofol|propofol|mesh-list
65336846|NCT02576600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65336847|NCT02576600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65336848|NCT02576600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336849|NCT02576600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65336850|NCT02576600|Anesthetics, General|anesthetics, general|mesh-ancestor
65336851|NCT02576600|Anesthetics|anesthetics|mesh-ancestor
65336852|NCT02576600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65336853|NCT02576600|Narcotics|narcotics|mesh-ancestor
65336854|NCT02576600|Analgesics|analgesics|mesh-ancestor
64721118|NCT04070287|Antibodies|antibodies|mesh-list
65336898|NCT02573714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65336899|NCT02573714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336900|NCT02573714|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65336901|NCT02573714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65336902|NCT02573714|Anesthetics, General|anesthetics, general|mesh-ancestor
65336903|NCT02573714|Anesthetics|anesthetics|mesh-ancestor
65336904|NCT02573714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65336905|NCT02573714|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65336906|NCT02573714|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65336907|NCT02573714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65336908|NCT02573714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336909|NCT00794235|Sorafenib|sorafenib|mesh-list
65336910|NCT00794235|Dacarbazine|dacarbazine|mesh-list
65336911|NCT00794235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336912|NCT00794235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65336913|NCT00794235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336914|NCT00794235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336915|NCT00794235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65336916|NCT00794235|Alkylating Agents|alkylating agents|mesh-ancestor
65336917|NCT00800943|Alemtuzumab|alemtuzumab|mesh-list
65336918|NCT00800943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64329027|NCT02256683|Anticoagulants|anticoagulants|mesh-ancestor
65336965|NCT00581100|Immunologic Factors|immunologic factors|mesh-ancestor
65336966|NCT00579098|Atorvastatin|atorvastatin|mesh-list
65336967|NCT00579098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65336968|NCT00579098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65336969|NCT00579098|Antimetabolites|antimetabolites|mesh-ancestor
65337052|NCT00801411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337053|NCT00801411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337054|NCT00801411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65337055|NCT00801411|Tubulin Modulators|tubulin modulators|mesh-ancestor
65337056|NCT00801411|Antimitotic Agents|antimitotic agents|mesh-ancestor
65337057|NCT00801411|Mitosis Modulators|mitosis modulators|mesh-ancestor
65337058|NCT00801411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65337059|NCT00801411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65337060|NCT00801411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65337061|NCT00801411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337062|NCT00794859|Sorafenib|sorafenib|mesh-list
65337063|NCT00794859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337064|NCT00794859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65337065|NCT00794859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337066|NCT00794859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337067|NCT04940013|Misoprostol|misoprostol|mesh-list
65337068|NCT04940013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65337069|NCT04940013|Abortifacient Agents|abortifacient agents|mesh-ancestor
65337070|NCT04940013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65337071|NCT04940013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337072|NCT04940013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65337104|NCT00714740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337105|NCT00714740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337106|NCT00714740|Diuretics|diuretics|mesh-ancestor
65337107|NCT00714740|Natriuretic Agents|natriuretic agents|mesh-ancestor
65337108|NCT00714740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337109|NCT00659529|Sildenafil Citrate|sildenafil citrate|mesh-list
65337110|NCT00659529|Vasodilator Agents|vasodilator agents|mesh-ancestor
65337111|NCT00659529|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65337112|NCT00659529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65337113|NCT00659529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337114|NCT00659529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337115|NCT00659529|Urological Agents|urological agents|mesh-ancestor
65212922|NCT05009069|Fluorouracil|fluorouracil|mesh-list
65337153|NCT00843934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65337154|NCT00843934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65337155|NCT00843934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65337156|NCT00843934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337160|NCT00805701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65337161|NCT00805701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337162|NCT00805701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337163|NCT00805701|Hormone Antagonists|hormone antagonists|mesh-ancestor
65337164|NCT00805701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65337165|NCT00805701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337166|NCT04042948|Acetaminophen|acetaminophen|mesh-list
65337167|NCT04042948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65337168|NCT04042948|Analgesics|analgesics|mesh-ancestor
65337169|NCT04042948|Sensory System Agents|sensory system agents|mesh-ancestor
65337170|NCT04042948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65337171|NCT04042948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337172|NCT04042948|Antipyretics|antipyretics|mesh-ancestor
65337173|NCT00765245|Rituximab|rituximab|mesh-list
65337174|NCT00765245|Lenalidomide|lenalidomide|mesh-list
65337175|NCT00765245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65337176|NCT00765245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337177|NCT00765245|Immunologic Factors|immunologic factors|mesh-ancestor
65337178|NCT00765245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337179|NCT00765245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65337180|NCT00765245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65337181|NCT00765245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65337182|NCT00765245|Growth Substances|growth substances|mesh-ancestor
65337183|NCT00765245|Growth Inhibitors|growth inhibitors|mesh-ancestor
65337185|NCT00801879|Calcium|calcium|mesh-list
65337186|NCT00801879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65337187|NCT00801879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337188|NCT00801879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65337189|NCT00801879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65337190|NCT00801879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64495004|NCT05431920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65337203|NCT00718484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65337205|NCT00841126|Iron|iron|mesh-list
65337206|NCT00841126|Trace Elements|trace elements|mesh-ancestor
65337207|NCT00841126|Micronutrients|micronutrients|mesh-ancestor
65337208|NCT00841126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337209|NCT00805857|Tipranavir|tipranavir|mesh-list
65337210|NCT00805857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65337211|NCT00805857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65337212|NCT00805857|Antiviral Agents|antiviral agents|mesh-ancestor
65337213|NCT00805857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65337214|NCT00801957|Hydrocortisone|hydrocortisone|mesh-list
65337215|NCT00801957|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65337216|NCT00801957|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65337217|NCT00801957|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65337218|NCT00801957|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
65337219|NCT00801957|Tacrolimus|tacrolimus|mesh-list
65337220|NCT00801957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65337221|NCT00801957|Immunologic Factors|immunologic factors|mesh-ancestor
65337222|NCT00801957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337223|NCT00801957|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65337224|NCT00801957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337225|NCT00801957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337226|NCT00801957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65337248|NCT02573558|Sensory System Agents|sensory system agents|mesh-ancestor
65337249|NCT02573558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65337250|NCT02573558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65337251|NCT02573558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65337252|NCT02573558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65337253|NCT02573558|Adrenergic Agents|adrenergic agents|mesh-ancestor
65337254|NCT02573558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65337255|NCT02573558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337257|NCT00656799|Rocuronium|rocuronium|mesh-list
65337258|NCT00656799|Anticonvulsants|anticonvulsants|mesh-ancestor
65337259|NCT00656799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65337260|NCT00656799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65337267|NCT00844012|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65337268|NCT00844012|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65212993|NCT04952389|Glucocorticoids|glucocorticoids|mesh-ancestor
65337270|NCT00844012|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65337271|NCT00844012|Estrogens|estrogens|mesh-ancestor
65337272|NCT00844012|Hormones|hormones|mesh-ancestor
65337273|NCT00844012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65337274|NCT00844012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337275|NCT00844012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65337276|NCT00844012|Contraceptive Agents|contraceptive agents|mesh-ancestor
65337277|NCT00844012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65337278|NCT00844012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65337279|NCT02574962|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65337280|NCT02574962|Hormones|hormones|mesh-ancestor
65337281|NCT02574962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65337282|NCT02574962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337283|NCT00802035|Baclofen|baclofen|mesh-list
65337284|NCT00802035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65337285|NCT00802035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337286|NCT00802035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65337287|NCT00802035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65337288|NCT00802035|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65337289|NCT00802035|GABA Agonists|gaba agonists|mesh-ancestor
65337290|NCT00802035|GABA Agents|gaba agents|mesh-ancestor
65337291|NCT00802035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65337292|NCT00802035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337293|NCT00836212|Efavirenz|efavirenz|mesh-list
65337325|NCT00782717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337326|NCT00782717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65337327|NCT00782717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337328|NCT00782717|Antiemetics|antiemetics|mesh-ancestor
65337329|NCT00782717|Autonomic Agents|autonomic agents|mesh-ancestor
65337330|NCT00782717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65337331|NCT00782717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65337332|NCT00782717|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65337333|NCT00782717|Protective Agents|protective agents|mesh-ancestor
64721314|NCT00002282|Clotrimazole|clotrimazole|mesh-list
65337336|NCT00782717|Analgesics|analgesics|mesh-ancestor
65337337|NCT00782717|Sensory System Agents|sensory system agents|mesh-ancestor
65337338|NCT00782717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65337339|NCT00656175|Raltegravir Potassium|raltegravir potassium|mesh-list
65337340|NCT00656175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65337341|NCT00656175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65337342|NCT00656175|Antiviral Agents|antiviral agents|mesh-ancestor
65337343|NCT00656175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65337344|NCT00656175|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65337345|NCT00656175|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65337346|NCT00656175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337347|NCT00656175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337348|NCT02601677|Fluoxetine|fluoxetine|mesh-list
65337349|NCT02601677|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65337350|NCT02601677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65337351|NCT02601677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65337352|NCT02601677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337353|NCT02601677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65337354|NCT02601677|Serotonin Agents|serotonin agents|mesh-ancestor
65337355|NCT02601677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337356|NCT02601677|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65337357|NCT02601677|Antidepressive Agents|antidepressive agents|mesh-ancestor
65337358|NCT02601677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65337359|NCT02601677|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65337360|NCT02601677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65337361|NCT02601677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337362|NCT04558112|Levodopa|levodopa|mesh-list
65337363|NCT04558112|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65337364|NCT04558112|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65337365|NCT04558112|Dopamine Agents|dopamine agents|mesh-ancestor
65337366|NCT04558112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65337367|NCT04558112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337368|NCT04558112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337383|NCT00656019|Micronutrients|micronutrients|mesh-ancestor
65337384|NCT00656019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337385|NCT00656019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65337386|NCT00656019|Dermatologic Agents|dermatologic agents|mesh-ancestor
65337387|NCT00841438|Abciximab|abciximab|mesh-list
65337388|NCT00841438|Anticoagulants|anticoagulants|mesh-ancestor
65337389|NCT00841438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65337390|NCT00841594|Nitroglycerin|nitroglycerin|mesh-list
65337391|NCT00841594|Vasodilator Agents|vasodilator agents|mesh-ancestor
65337392|NCT04068974|Apatinib|apatinib|mesh-list
65337393|NCT04068974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337394|NCT04068974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65337395|NCT04068974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337396|NCT04068974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337397|NCT00836368|Vitamin E|vitamin e|mesh-list
65337398|NCT00836368|Tocopherols|tocopherols|mesh-list
65337399|NCT00836368|Tocotrienols|tocotrienols|mesh-list
65337400|NCT00836368|alpha-Tocopherol|alpha-tocopherol|mesh-list
65337401|NCT00836368|gamma-Tocopherol|gamma-tocopherol|mesh-list
65337403|NCT00836368|Micronutrients|micronutrients|mesh-ancestor
65337404|NCT00836368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329186|NCT02181335|Hormones|hormones|mesh-ancestor
64329188|NCT00517153|Miglustat|miglustat|mesh-list
65337420|NCT00718796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337421|NCT00718796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65337422|NCT00718796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65337423|NCT00718796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337424|NCT00718796|Vitamins|vitamins|mesh-ancestor
65337425|NCT00718796|Micronutrients|micronutrients|mesh-ancestor
65337426|NCT00718796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337427|NCT00844168|Sorafenib|sorafenib|mesh-list
65337428|NCT00844168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337429|NCT00844168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65337430|NCT00844168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337431|NCT00844168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337432|NCT02573168|Psychotropic Drugs|psychotropic drugs|mesh-list
65337433|NCT00764465|Ritonavir|ritonavir|mesh-list
65337434|NCT00764465|Fosamprenavir|fosamprenavir|mesh-list
65337435|NCT00764465|Maraviroc|maraviroc|mesh-list
65337436|NCT00764465|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65337437|NCT00764465|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65337438|NCT00764465|Protease Inhibitors|protease inhibitors|mesh-ancestor
65337439|NCT00764465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337440|NCT00764465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337441|NCT00764465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65337442|NCT00764465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65337443|NCT00764465|Antiviral Agents|antiviral agents|mesh-ancestor
64721370|NCT00378313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64329200|NCT00359437|Satavaptan|satavaptan|mesh-list
65337460|NCT00655863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337462|NCT04263922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65337463|NCT04263922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65337464|NCT04263922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65337465|NCT04263922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337466|NCT00718952|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65337467|NCT00718952|Vasodilator Agents|vasodilator agents|mesh-ancestor
65337468|NCT00718952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65337469|NCT00718952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65337470|NCT00718952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337471|NCT00718952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337472|NCT00718952|Urological Agents|urological agents|mesh-ancestor
65337473|NCT00781937|Liraglutide|liraglutide|mesh-list
65337474|NCT00781937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65337475|NCT00781937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329208|NCT05064449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65337540|NCT04100759|Urological Agents|urological agents|mesh-ancestor
65337541|NCT00836914|Idelalisib|idelalisib|mesh-list
65337542|NCT00836914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337543|NCT00836914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337544|NCT00836914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337545|NCT00844402|Atorvastatin|atorvastatin|mesh-list
65337546|NCT00844402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65337562|NCT00806247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65337563|NCT00806247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65337564|NCT00806247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337565|NCT00806247|Adrenergic Agents|adrenergic agents|mesh-ancestor
65337566|NCT00806247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65337567|NCT00797745|Ritonavir|ritonavir|mesh-list
65337568|NCT00797745|Ribavirin|ribavirin|mesh-list
65337569|NCT00797745|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65337570|NCT00797745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65337571|NCT00797745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65337572|NCT00797745|Protease Inhibitors|protease inhibitors|mesh-ancestor
65337573|NCT00797745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337574|NCT00797745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337575|NCT00797745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65337576|NCT00797745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65337577|NCT00797745|Antiviral Agents|antiviral agents|mesh-ancestor
65337578|NCT00797745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65337579|NCT00797745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65337580|NCT00797745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65337581|NCT00797745|Antimetabolites|antimetabolites|mesh-ancestor
65337582|NCT00659373|Tamoxifen|tamoxifen|mesh-list
65337583|NCT00659373|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65337584|NCT00659373|Exemestane|exemestane|mesh-list
65337585|NCT00659373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65337586|NCT00659373|Hormone Antagonists|hormone antagonists|mesh-ancestor
65337587|NCT00659373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64721435|NCT02589145|Hormones|hormones|mesh-ancestor
65337598|NCT00659373|Luteolytic Agents|luteolytic agents|mesh-ancestor
65337599|NCT00659373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65337600|NCT00659373|Contraceptive Agents|contraceptive agents|mesh-ancestor
65337601|NCT00659373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65337602|NCT00659373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65337603|NCT00842452|Topotecan|topotecan|mesh-list
65337604|NCT00842452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65337605|NCT00842452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65337606|NCT00842452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337607|NCT00842452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337608|NCT00842452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337609|NCT02552745|Parecoxib|parecoxib|mesh-list
65337610|NCT02552745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65337611|NCT02552745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65337612|NCT02552745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337613|NCT02552745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337614|NCT02552745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65337615|NCT02552745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65337616|NCT02552745|Analgesics|analgesics|mesh-ancestor
65337617|NCT02552745|Sensory System Agents|sensory system agents|mesh-ancestor
65337618|NCT02552745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65337619|NCT02552745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337620|NCT02552745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65337621|NCT02552745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65337622|NCT02547844|Tenofovir|tenofovir|mesh-list
65337623|NCT02547844|Efavirenz|efavirenz|mesh-list
65337683|NCT00709436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65337684|NCT00709436|Anesthetics, General|anesthetics, general|mesh-ancestor
65337685|NCT00709436|Anesthetics|anesthetics|mesh-ancestor
65337686|NCT00709436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65337687|NCT00709436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65337688|NCT00709436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65337689|NCT00709436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65337690|NCT00709436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337692|NCT00844792|Cholecalciferol|cholecalciferol|mesh-list
65337713|NCT00719420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65337714|NCT00719420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65337715|NCT00719420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65337716|NCT00719420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65337717|NCT00719420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65337718|NCT00719420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65337719|NCT00719420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65337720|NCT00719420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337721|NCT00719420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495079|NCT03466320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337793|NCT00792948|Dexamethasone acetate|dexamethasone acetate|mesh-list
65337794|NCT00792948|Prednisone|prednisone|mesh-list
65337795|NCT00792948|Methylprednisolone|methylprednisolone|mesh-list
65337796|NCT00792948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65337797|NCT00792948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65337798|NCT00792948|Prednisolone|prednisolone|mesh-list
65337799|NCT00792948|Prednisolone acetate|prednisolone acetate|mesh-list
65337800|NCT00792948|Cortisone|cortisone|mesh-list
65337801|NCT00792948|Cyclophosphamide|cyclophosphamide|mesh-list
65337802|NCT00792948|Doxorubicin|doxorubicin|mesh-list
65337803|NCT00792948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65337804|NCT00792948|Methotrexate|methotrexate|mesh-list
65337805|NCT00792948|Etoposide|etoposide|mesh-list
65337806|NCT00792948|Vincristine|vincristine|mesh-list
65213221|NCT04428866|Glucagon|glucagon|mesh-list
65337807|NCT00792948|Etoposide phosphate|etoposide phosphate|mesh-list
65337808|NCT00792948|Dasatinib|dasatinib|mesh-list
65337809|NCT00792948|Podophyllotoxin|podophyllotoxin|mesh-list
65337810|NCT00792948|Tacrolimus|tacrolimus|mesh-list
65337811|NCT00792948|Lenograstim|lenograstim|mesh-list
65337812|NCT00792948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65337813|NCT00792948|Prednisolone phosphate|prednisolone phosphate|mesh-list
65337814|NCT00792948|BB 1101|bb 1101|mesh-list
65337815|NCT00792948|Calcium|calcium|mesh-list
65337816|NCT00792948|Levoleucovorin|levoleucovorin|mesh-list
65337817|NCT00792948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65337818|NCT00792948|Immunologic Factors|immunologic factors|mesh-ancestor
65337819|NCT00792948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337820|NCT00792948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65337821|NCT00792948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65337822|NCT00792948|Alkylating Agents|alkylating agents|mesh-ancestor
65337823|NCT00792948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337824|NCT00792948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337825|NCT00792948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65337826|NCT00792948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65337827|NCT00792948|Antiemetics|antiemetics|mesh-ancestor
65337828|NCT00792948|Autonomic Agents|autonomic agents|mesh-ancestor
65337829|NCT00792948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65337830|NCT00792948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65337831|NCT00792948|Glucocorticoids|glucocorticoids|mesh-ancestor
65337832|NCT00792948|Hormones|hormones|mesh-ancestor
65337833|NCT00792948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65337834|NCT00792948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65337835|NCT00792948|Protease Inhibitors|protease inhibitors|mesh-ancestor
65337836|NCT00792948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337837|NCT00792948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65337838|NCT00792948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65337839|NCT00792948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65337840|NCT00792948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65337841|NCT00792948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65337842|NCT00792948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65337843|NCT00792948|Abortifacient Agents|abortifacient agents|mesh-ancestor
65337844|NCT00792948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65337845|NCT00792948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65337846|NCT00792948|Antimetabolites|antimetabolites|mesh-ancestor
65337847|NCT00792948|Dermatologic Agents|dermatologic agents|mesh-ancestor
65337882|NCT04766229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65337883|NCT04766229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337884|NCT04766229|Antimanic Agents|antimanic agents|mesh-ancestor
65337885|NCT04766229|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65337886|NCT04766229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65337887|NCT04766229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65337888|NCT04766229|Serotonin Agents|serotonin agents|mesh-ancestor
65337889|NCT04766229|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65337898|NCT04068506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65337899|NCT04068506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65337900|NCT04068506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65337901|NCT04068506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65337902|NCT04068506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65337903|NCT04068506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65337904|NCT04068506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337905|NCT04068506|Antimanic Agents|antimanic agents|mesh-ancestor
65337906|NCT00803907|Imiquimod|imiquimod|mesh-list
65337907|NCT00803907|Immunologic Factors|immunologic factors|mesh-list
65337908|NCT00803907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65337909|NCT00803907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337910|NCT00803907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337911|NCT00803907|Interferon Inducers|interferon inducers|mesh-ancestor
65337912|NCT00843154|Candesartan|candesartan|mesh-list
65337913|NCT00843154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65337914|NCT00843154|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65337915|NCT00843154|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65337916|NCT00843154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337917|NCT00429793|Sirolimus|sirolimus|mesh-list
65337918|NCT00429793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65337919|NCT00429793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65337920|NCT00429793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65337921|NCT00429793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337922|NCT00429793|Antifungal Agents|antifungal agents|mesh-ancestor
65337923|NCT00429793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65337924|NCT00429793|Immunologic Factors|immunologic factors|mesh-ancestor
64329428|NCT02384343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65337952|NCT04069208|Antimetabolites|antimetabolites|mesh-ancestor
65337953|NCT04069208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337954|NCT04069208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337955|NCT04069208|Antiviral Agents|antiviral agents|mesh-ancestor
65337956|NCT04069208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65337957|NCT04069208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65337958|NCT04069208|Immunologic Factors|immunologic factors|mesh-ancestor
65337959|NCT04069208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337960|NCT04069208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65337961|NCT04069208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65337962|NCT04069208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65337963|NCT04069208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337965|NCT00845104|Rituximab|rituximab|mesh-list
65337966|NCT00845104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65337967|NCT00845104|Fludarabine|fludarabine|mesh-list
65337968|NCT00845104|Fludarabine phosphate|fludarabine phosphate|mesh-list
65337969|NCT00845104|Antibodies|antibodies|mesh-list
65338030|NCT00578864|Etoposide|etoposide|mesh-list
65338031|NCT00578864|Etoposide phosphate|etoposide phosphate|mesh-list
65338032|NCT00578864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65338033|NCT00578864|Immunologic Factors|immunologic factors|mesh-ancestor
65338034|NCT00578864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338035|NCT00578864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65338036|NCT00578864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65338037|NCT00578864|Alkylating Agents|alkylating agents|mesh-ancestor
65338038|NCT00578864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460959|NCT01677754|Memantine|memantine|mesh-list
65338062|NCT00717470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338063|NCT00717470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65338064|NCT00717470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338065|NCT00717470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65338066|NCT00717470|Immunologic Factors|immunologic factors|mesh-ancestor
65338067|NCT00717470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65338068|NCT00717470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338069|NCT00717470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338070|NCT00717470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65338087|NCT00631566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338088|NCT00631566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338089|NCT00631566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65338090|NCT00631566|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65338091|NCT00631566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65338092|NCT00631566|Antimetabolites|antimetabolites|mesh-ancestor
65338093|NCT00631566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65338095|NCT00722852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65338096|NCT00722852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65338097|NCT00722852|Analgesics|analgesics|mesh-ancestor
65338098|NCT00722852|Sensory System Agents|sensory system agents|mesh-ancestor
65338099|NCT00722852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65338100|NCT00722852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338101|NCT00722852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65338102|NCT00722852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65338103|NCT00722852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65338104|NCT00722852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338105|NCT00722852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338106|NCT05657444|Tenecteplase|tenecteplase|mesh-list
65338107|NCT05657444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65338108|NCT05657444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65338109|NCT05657444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338110|NCT01410942|Methylphenidate|methylphenidate|mesh-list
64721710|NCT00002456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329489|NCT02298868|Baclofen|baclofen|mesh-list
65338188|NCT00417079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338189|NCT00417079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65338220|NCT01037491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65338222|NCT01037491|Analgesics|analgesics|mesh-ancestor
65338223|NCT01037491|Sensory System Agents|sensory system agents|mesh-ancestor
65338224|NCT01037491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65338225|NCT01037491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338226|NCT01037491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65213371|NCT04114136|Metformin|metformin|mesh-list
65338227|NCT01037491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65338228|NCT01037491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65338229|NCT01037491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65338230|NCT01037491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721748|NCT00002474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338282|NCT02576340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65338283|NCT02576340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65338284|NCT02576340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338285|NCT02576340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65338286|NCT02576340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338287|NCT02576340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65338288|NCT02576340|Parasympatholytics|parasympatholytics|mesh-ancestor
65338289|NCT02576340|Autonomic Agents|autonomic agents|mesh-ancestor
65338290|NCT02576340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65338291|NCT02576340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65338292|NCT02576340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65338293|NCT02576340|Cholinergic Agents|cholinergic agents|mesh-ancestor
65338294|NCT02576340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65338295|NCT02578602|Edetic Acid|edetic acid|mesh-list
65338296|NCT02578602|Pentetic Acid|pentetic acid|mesh-list
65338297|NCT02578602|Antidotes|antidotes|mesh-ancestor
65338298|NCT02578602|Protective Agents|protective agents|mesh-ancestor
65338299|NCT02578602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338300|NCT02578602|Chelating Agents|chelating agents|mesh-ancestor
65338301|NCT02578602|Sequestering Agents|sequestering agents|mesh-ancestor
65338302|NCT02578602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338303|NCT02578602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65338304|NCT02578602|Anticoagulants|anticoagulants|mesh-ancestor
65338305|NCT02578602|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65338306|NCT00128856|Gemcitabine|gemcitabine|mesh-list
65338308|NCT00128856|Doxorubicin|doxorubicin|mesh-list
65338309|NCT00128856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65338310|NCT00128856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338311|NCT00128856|Tubulin Modulators|tubulin modulators|mesh-ancestor
65338312|NCT00128856|Antimitotic Agents|antimitotic agents|mesh-ancestor
65338313|NCT00128856|Mitosis Modulators|mitosis modulators|mesh-ancestor
64721799|NCT00002498|Mitoxantrone|mitoxantrone|mesh-list
65338335|NCT00709488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338336|NCT00709488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65338337|NCT00709488|Dermatologic Agents|dermatologic agents|mesh-ancestor
65338338|NCT00714246|Carboplatin|carboplatin|mesh-list
65338339|NCT00714246|Docetaxel|docetaxel|mesh-list
65338340|NCT00714246|Bortezomib|bortezomib|mesh-list
65338341|NCT00714246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338342|NCT00714246|Tubulin Modulators|tubulin modulators|mesh-ancestor
65338343|NCT00714246|Antimitotic Agents|antimitotic agents|mesh-ancestor
65338345|NCT00714246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338347|NCT00416455|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65338348|NCT00416455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338349|NCT00415909|Imatinib Mesylate|imatinib mesylate|mesh-list
65338350|NCT00415909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338351|NCT00415909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65338352|NCT00415909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338353|NCT00415909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338354|NCT00709644|Folic Acid|folic acid|mesh-list
65338355|NCT00709644|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65338356|NCT00709644|Norgestimate|norgestimate|mesh-list
65338357|NCT00709644|Estradiol|estradiol|mesh-list
65338358|NCT00709644|Estrogens|estrogens|mesh-ancestor
65338359|NCT00709644|Hormones|hormones|mesh-ancestor
65338360|NCT00709644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65338361|NCT00709644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338362|NCT00709644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65338363|NCT00709644|Contraceptive Agents|contraceptive agents|mesh-ancestor
65338364|NCT00709644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65338365|NCT00709644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65338366|NCT00709644|Hematinics|hematinics|mesh-ancestor
65338367|NCT00709644|Vitamin B Complex|vitamin b complex|mesh-ancestor
65338368|NCT00709644|Vitamins|vitamins|mesh-ancestor
65338369|NCT00709644|Micronutrients|micronutrients|mesh-ancestor
65338370|NCT00709644|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65338371|NCT00709644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65338372|NCT00709644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65338373|NCT00415597|Naltrexone|naltrexone|mesh-list
65338374|NCT00415597|Morphine|morphine|mesh-list
65213459|NCT03867500|Niacin|niacin|mesh-list
65338375|NCT00415597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65338376|NCT00415597|Narcotics|narcotics|mesh-ancestor
65338377|NCT00415597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65338410|NCT02575638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65338411|NCT02575638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65338412|NCT02575638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338413|NCT02575638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338414|NCT02573610|Levofloxacin|levofloxacin|mesh-list
65338415|NCT02573610|Ofloxacin|ofloxacin|mesh-list
65338416|NCT02573610|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65338417|NCT02573610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65338418|NCT02573610|Renal Agents|renal agents|mesh-ancestor
65338419|NCT02573610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65338420|NCT02573610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65338421|NCT02573610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65338422|NCT02573610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338423|NCT02573610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338453|NCT00710268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65338455|NCT00710268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338456|NCT02575248|Dienogest|dienogest|mesh-list
65338457|NCT02575248|Clomiphene|clomiphene|mesh-list
65338458|NCT02575248|Enclomiphene|enclomiphene|mesh-list
65338459|NCT02575248|Zuclomiphene|zuclomiphene|mesh-list
65338460|NCT02575248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65338461|NCT02575248|Hormone Antagonists|hormone antagonists|mesh-ancestor
65338462|NCT02575248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65338463|NCT02575248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338464|NCT02575248|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65338465|NCT02575248|Fertility Agents|fertility agents|mesh-ancestor
65338466|NCT02575248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64721861|NCT00002516|Ifosfamide|ifosfamide|mesh-list
65338468|NCT02575248|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65338469|NCT02575248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65338471|NCT02575248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65338472|NCT02575248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65338473|NCT02575248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65338474|NCT02575248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65338475|NCT02575248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65338476|NCT02575248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338477|NCT02575170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65338478|NCT00710736|Fluorouracil|fluorouracil|mesh-list
65338479|NCT00710736|Capecitabine|capecitabine|mesh-list
65338480|NCT00710736|Antimetabolites|antimetabolites|mesh-ancestor
65338481|NCT00710736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338482|NCT00710736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65338483|NCT00710736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338484|NCT00710736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65338485|NCT00710736|Immunologic Factors|immunologic factors|mesh-ancestor
65338486|NCT00710736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338487|NCT00620542|Atorvastatin|atorvastatin|mesh-list
65338488|NCT00620542|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65338489|NCT00620542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65338490|NCT00620542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65338491|NCT00620542|Antimetabolites|antimetabolites|mesh-ancestor
65338492|NCT00620542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338493|NCT00620542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65338494|NCT00620542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65338495|NCT00620542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338496|NCT04070742|Minocycline|minocycline|mesh-list
65338497|NCT04070742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65338498|NCT04070742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65338499|NCT00851344|Cetirizine|cetirizine|mesh-list
65338500|NCT00851344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65338528|NCT05810792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338529|NCT05810792|Histamine Agonists|histamine agonists|mesh-ancestor
65338530|NCT05810792|Histamine Agents|histamine agents|mesh-ancestor
65338531|NCT05810792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65338532|NCT05810792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338533|NCT05810649|Hyaluronic Acid|hyaluronic acid|mesh-list
65338534|NCT05810649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65338535|NCT05810649|Immunologic Factors|immunologic factors|mesh-ancestor
65338536|NCT05810649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338537|NCT05810649|Viscosupplements|viscosupplements|mesh-ancestor
65338538|NCT05810649|Protective Agents|protective agents|mesh-ancestor
65338539|NCT05810571|Morphine|morphine|mesh-list
65338540|NCT05810571|Remifentanil|remifentanil|mesh-list
65338541|NCT05810571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65338542|NCT05810571|Narcotics|narcotics|mesh-ancestor
65338543|NCT05810571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65338544|NCT05810571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338545|NCT05810571|Analgesics|analgesics|mesh-ancestor
65338546|NCT05810571|Sensory System Agents|sensory system agents|mesh-ancestor
65338547|NCT05810571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65338548|NCT05810558|Glycine|glycine|mesh-list
65338611|NCT05809609|Ketamine|ketamine|mesh-list
65338612|NCT05809609|Analgesics|analgesics|mesh-ancestor
65338614|NCT05809609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65338615|NCT05809609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338616|NCT05809609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65338617|NCT05809609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65338618|NCT05809609|Anesthetics, General|anesthetics, general|mesh-ancestor
65338619|NCT05809609|Anesthetics|anesthetics|mesh-ancestor
65338620|NCT05809609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65338621|NCT05809609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65338637|NCT05809518|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65338638|NCT05809518|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65338639|NCT05809518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65338640|NCT05809518|Adrenergic Agents|adrenergic agents|mesh-ancestor
65338641|NCT05809518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65338642|NCT05809518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338643|NCT05809414|Amantadine|amantadine|mesh-list
65338644|NCT05809414|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65338645|NCT05809414|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65338646|NCT05809414|Antiviral Agents|antiviral agents|mesh-ancestor
65338647|NCT05809414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65338648|NCT05809414|Dopamine Agents|dopamine agents|mesh-ancestor
65338649|NCT05809414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65338650|NCT05809414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338651|NCT05809414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338652|NCT05809414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65338653|NCT05809414|Analgesics|analgesics|mesh-ancestor
65338654|NCT05809414|Sensory System Agents|sensory system agents|mesh-ancestor
65338655|NCT05809414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65338656|NCT05809336|Pembrolizumab|pembrolizumab|mesh-list
65338657|NCT05809336|Atezolizumab|atezolizumab|mesh-list
65338658|NCT05809336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65338659|NCT05809336|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65338704|NCT05809011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65338705|NCT05809011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338706|NCT05809011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65338707|NCT05809011|Glucocorticoids|glucocorticoids|mesh-ancestor
65338723|NCT05808946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338724|NCT05808946|Vitamin B Complex|vitamin b complex|mesh-ancestor
65338726|NCT05808946|Micronutrients|micronutrients|mesh-ancestor
65338727|NCT05808881|Naloxone|naloxone|mesh-list
65338728|NCT05808881|Nalmefene|nalmefene|mesh-list
65338729|NCT05808881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65338730|NCT05808881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338731|NCT05808881|Sensory System Agents|sensory system agents|mesh-ancestor
65338732|NCT05808881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65338733|NCT05806567|Belumosudil|belumosudil|mesh-list
65338734|NCT05806567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65338735|NCT05806567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338736|NCT05806567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338737|NCT05806346|Tranexamic Acid|tranexamic acid|mesh-list
65338738|NCT05806346|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65338739|NCT05806346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64329720|NCT00317395|Protease Inhibitors|protease inhibitors|mesh-ancestor
64329722|NCT02383563|Metformin|metformin|mesh-list
65338764|NCT05792540|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65338765|NCT05792540|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65338768|NCT05781711|Carbidopa|carbidopa|mesh-list
65338769|NCT05781711|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65338770|NCT05781711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65338771|NCT05781711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338772|NCT05781711|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65338773|NCT05781711|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65338774|NCT05781711|Dopamine Agents|dopamine agents|mesh-ancestor
65338775|NCT05781711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65269794|NCT02733380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65269795|NCT02733380|Tubulin Modulators|tubulin modulators|mesh-ancestor
65269796|NCT02733380|Antimitotic Agents|antimitotic agents|mesh-ancestor
65269797|NCT02733380|Mitosis Modulators|mitosis modulators|mesh-ancestor
65269798|NCT02733380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65269799|NCT02733380|Immunologic Factors|immunologic factors|mesh-ancestor
65269800|NCT02733380|Leprostatic Agents|leprostatic agents|mesh-ancestor
65338776|NCT05781711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338777|NCT05781711|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65338778|NCT05781711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338779|NCT05781711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65338780|NCT05781711|Immunologic Factors|immunologic factors|mesh-ancestor
65338781|NCT05781711|Dopamine Agonists|dopamine agonists|mesh-ancestor
65338782|NCT05764876|Azithromycin|azithromycin|mesh-list
65338783|NCT05764876|Linezolid|linezolid|mesh-list
65338784|NCT05764876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65338785|NCT05764876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65338786|NCT05764876|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65338787|NCT05764876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338788|NCT05764876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338789|NCT05737576|Insulin Aspart|insulin aspart|mesh-list
65338819|NCT05716763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65338820|NCT05716503|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65338821|NCT05716503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65338822|NCT05716009|Gemtuzumab|gemtuzumab|mesh-list
65338847|NCT05706753|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65338849|NCT05706753|Hormones|hormones|mesh-ancestor
65338865|NCT05696938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338866|NCT05696938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65338867|NCT05696938|Vasodilator Agents|vasodilator agents|mesh-ancestor
65338868|NCT05695508|Dexamethasone|dexamethasone|mesh-list
65338869|NCT05695508|Lenalidomide|lenalidomide|mesh-list
65338870|NCT05695508|Bortezomib|bortezomib|mesh-list
65338871|NCT05695508|Daratumumab|daratumumab|mesh-list
65338872|NCT05695508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65338873|NCT05695508|Antiemetics|antiemetics|mesh-ancestor
65338874|NCT05695508|Autonomic Agents|autonomic agents|mesh-ancestor
65338875|NCT05695508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65338876|NCT05695508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338877|NCT05695508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65338878|NCT05695508|Glucocorticoids|glucocorticoids|mesh-ancestor
65338879|NCT05695508|Hormones|hormones|mesh-ancestor
65338880|NCT05695508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65338881|NCT05695508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64329768|NCT00315757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338942|NCT05663866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65338943|NCT05663866|Antimetabolites|antimetabolites|mesh-ancestor
65338944|NCT05663866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338945|NCT05663866|Dermatologic Agents|dermatologic agents|mesh-ancestor
65338946|NCT05663866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338947|NCT05663866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65338948|NCT05663866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65338949|NCT05663866|Immunologic Factors|immunologic factors|mesh-ancestor
65338950|NCT05663866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64722068|NCT00002570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338972|NCT05643573|Apixaban|apixaban|mesh-list
65338973|NCT05643573|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65338974|NCT05643573|Antithrombins|antithrombins|mesh-ancestor
65338975|NCT05643573|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65338976|NCT05643573|Protease Inhibitors|protease inhibitors|mesh-ancestor
65338977|NCT05643573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338978|NCT05643573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338979|NCT05643573|Anticoagulants|anticoagulants|mesh-ancestor
65338980|NCT05642767|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65338981|NCT05642767|Cetrimonium|cetrimonium|mesh-list
64722081|NCT00002576|Mitoxantrone|mitoxantrone|mesh-list
64495650|NCT01206478|Megestrol|megestrol|mesh-list
65339074|NCT05596383|Vitamin D|vitamin d|mesh-list
65339075|NCT05596383|Vitamins|vitamins|mesh-ancestor
65339076|NCT05596383|Micronutrients|micronutrients|mesh-ancestor
65213663|NCT03386539|Antitubercular Agents|antitubercular agents|mesh-ancestor
65339077|NCT05596383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339078|NCT05596383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65339079|NCT05594745|Lifitegrast|lifitegrast|mesh-list
65339080|NCT05594745|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65339081|NCT05594745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65339110|NCT05569954|Immunologic Factors|immunologic factors|mesh-ancestor
65339111|NCT05569954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339112|NCT05568953|Vaccines|vaccines|mesh-list
65339113|NCT05568953|Immunologic Factors|immunologic factors|mesh-ancestor
65339114|NCT05568953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339115|NCT05564052|Rituximab|rituximab|mesh-list
65339116|NCT05564052|Lenalidomide|lenalidomide|mesh-list
65339117|NCT05564052|Bortezomib|bortezomib|mesh-list
65339118|NCT05564052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65339119|NCT05564052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339120|NCT05564052|Immunologic Factors|immunologic factors|mesh-ancestor
65339121|NCT05564052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339122|NCT05564052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65339123|NCT05564052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65339124|NCT05564052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65339125|NCT05564052|Growth Substances|growth substances|mesh-ancestor
65339126|NCT05564052|Growth Inhibitors|growth inhibitors|mesh-ancestor
65339127|NCT05564039|Dulaglutide|dulaglutide|mesh-list
65339128|NCT05564039|Tirzepatide|tirzepatide|mesh-list
64722154|NCT02239627|Clonidine|clonidine|mesh-list
65339162|NCT05553132|Coagulants|coagulants|mesh-ancestor
65339163|NCT05551936|Rituximab|rituximab|mesh-list
65339164|NCT05551936|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65339165|NCT05551936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65339166|NCT05551936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339167|NCT05551936|Immunologic Factors|immunologic factors|mesh-ancestor
65339168|NCT05551936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339169|NCT05551936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64722168|NCT05750576|Chlorhexidine|chlorhexidine|mesh-list
65339202|NCT05521087|Fludarabine|fludarabine|mesh-list
65339203|NCT05521087|Vincristine|vincristine|mesh-list
65339204|NCT05521087|Pegaspargase|pegaspargase|mesh-list
65339205|NCT05521087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65339206|NCT05521087|Antiemetics|antiemetics|mesh-ancestor
65339207|NCT05521087|Autonomic Agents|autonomic agents|mesh-ancestor
65339208|NCT05521087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65339209|NCT05521087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339210|NCT05521087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65339211|NCT05521087|Glucocorticoids|glucocorticoids|mesh-ancestor
65339212|NCT05521087|Hormones|hormones|mesh-ancestor
65339239|NCT05510089|Antiviral Agents|antiviral agents|mesh-ancestor
65339240|NCT05510089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65339241|NCT05510089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65339242|NCT05510089|Immunologic Factors|immunologic factors|mesh-ancestor
65339243|NCT05510089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339244|NCT05505552|Vitamin K|vitamin k|mesh-list
65339245|NCT05505552|Vitamin K 1|vitamin k 1|mesh-list
65339246|NCT05505552|Vitamins|vitamins|mesh-ancestor
65339247|NCT05505552|Micronutrients|micronutrients|mesh-ancestor
65339248|NCT05505552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339249|NCT05505552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65339250|NCT05505552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65339251|NCT05505552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339252|NCT05505552|Hemostatics|hemostatics|mesh-ancestor
65339253|NCT05505552|Coagulants|coagulants|mesh-ancestor
65339254|NCT05498428|Carboplatin|carboplatin|mesh-list
65339255|NCT05498428|Pemetrexed|pemetrexed|mesh-list
65339256|NCT05498428|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
65339257|NCT05498428|Heparin|heparin|mesh-list
65339258|NCT05498428|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65339259|NCT05498428|Tinzaparin|tinzaparin|mesh-list
65339294|NCT05467891|Letrozole|letrozole|mesh-list
65339295|NCT05467891|Fulvestrant|fulvestrant|mesh-list
65339296|NCT05467891|Anastrozole|anastrozole|mesh-list
65339297|NCT05467891|Exemestane|exemestane|mesh-list
65339298|NCT05467891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339299|NCT05467891|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65339300|NCT05467891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65339301|NCT05467891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339302|NCT05467891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722293|NCT00002630|Melphalan|melphalan|mesh-list
65339360|NCT05408091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339362|NCT05396014|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65339363|NCT05396014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65339364|NCT05396014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65339365|NCT05396014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339366|NCT05396014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65339375|NCT05395195|Hematinics|hematinics|mesh-ancestor
65339376|NCT05391360|Entecavir|entecavir|mesh-list
65339377|NCT05391360|Antiviral Agents|antiviral agents|mesh-ancestor
65339378|NCT05391360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65339379|NCT05388669|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
65339380|NCT05388669|Lazertinib|lazertinib|mesh-list
65339381|NCT05388669|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65339382|NCT05388669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65339383|NCT05388669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339384|NCT05388669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339385|NCT05388669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65339386|NCT05388669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339387|NCT05388669|Immunologic Factors|immunologic factors|mesh-ancestor
65339388|NCT05388669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339389|NCT05379595|Leucovorin|leucovorin|mesh-list
65339390|NCT05379595|Fluorouracil|fluorouracil|mesh-list
65339391|NCT05379595|Oxaliplatin|oxaliplatin|mesh-list
65339392|NCT05379595|Irinotecan|irinotecan|mesh-list
65339393|NCT05379595|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
65339394|NCT05379595|Antimetabolites|antimetabolites|mesh-ancestor
65339395|NCT05379595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339396|NCT05379595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65339397|NCT05379595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339398|NCT05379595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65339399|NCT05379595|Immunologic Factors|immunologic factors|mesh-ancestor
65339400|NCT05379595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339401|NCT05379595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64330071|NCT00004093|Vinorelbine|vinorelbine|mesh-list
64330072|NCT00004093|Carboplatin|carboplatin|mesh-list
65339433|NCT05366764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65339434|NCT05366764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339435|NCT05366166|Cisplatin|cisplatin|mesh-list
65339436|NCT05366166|Pembrolizumab|pembrolizumab|mesh-list
65339437|NCT05366166|Olaparib|olaparib|mesh-list
65339438|NCT05366166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339439|NCT05366166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65339440|NCT05366166|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65339441|NCT05366166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089285|NCT00501267|Oxybutynin|oxybutynin|mesh-list
65339442|NCT05366166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339443|NCT05360160|Venetoclax|venetoclax|mesh-list
65339444|NCT05360160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339492|NCT05314933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65339494|NCT05303090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339495|NCT05303090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65339496|NCT05303090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339497|NCT05303090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339498|NCT05275023|Tenofovir|tenofovir|mesh-list
65339499|NCT05275023|Entecavir|entecavir|mesh-list
65339500|NCT05275023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65339501|NCT05275023|Antiviral Agents|antiviral agents|mesh-ancestor
65339502|NCT05275023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65339503|NCT05275023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64722376|NCT01402531|Bevacizumab|bevacizumab|mesh-list
65339504|NCT05275023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65339506|NCT05275023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339507|NCT05275023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65339508|NCT05275023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65339509|NCT05275023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339510|NCT05260606|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65339511|NCT05260606|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65339512|NCT05260606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339513|NCT05255601|Nivolumab|nivolumab|mesh-list
65339514|NCT05255601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65339515|NCT05255601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089365|NCT01246284|Hormones|hormones|mesh-ancestor
65339516|NCT05255601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65339517|NCT05255601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339518|NCT05252533|Ustekinumab|ustekinumab|mesh-list
65339519|NCT05252533|Dermatologic Agents|dermatologic agents|mesh-ancestor
65339520|NCT05250973|Dexamethasone|dexamethasone|mesh-list
65339521|NCT05250973|Cyclophosphamide|cyclophosphamide|mesh-list
65339522|NCT05250973|Bortezomib|bortezomib|mesh-list
65339523|NCT05250973|Daratumumab|daratumumab|mesh-list
65339524|NCT05250973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65339525|NCT05250973|Immunologic Factors|immunologic factors|mesh-ancestor
65339526|NCT05250973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339527|NCT05250973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65339528|NCT05250973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65339529|NCT05250973|Alkylating Agents|alkylating agents|mesh-ancestor
65339530|NCT05250973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339531|NCT05250973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339532|NCT05250973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65339533|NCT05250973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65339534|NCT05250973|Antiemetics|antiemetics|mesh-ancestor
65339535|NCT05250973|Autonomic Agents|autonomic agents|mesh-ancestor
65339536|NCT05250973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65339537|NCT05250973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65339538|NCT05250973|Glucocorticoids|glucocorticoids|mesh-ancestor
65339539|NCT05250973|Hormones|hormones|mesh-ancestor
65339540|NCT05250973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65339541|NCT05250973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65339558|NCT05225363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65339559|NCT05225363|Immunologic Factors|immunologic factors|mesh-ancestor
65339560|NCT05225363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339561|NCT05225363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65339562|NCT05225363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65339563|NCT05225363|Alkylating Agents|alkylating agents|mesh-ancestor
65339564|NCT05225363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339565|NCT05225363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339566|NCT05225363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65339567|NCT05222932|Avelumab|avelumab|mesh-list
65339568|NCT05222932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65339569|NCT05222932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339570|NCT05216419|Cholecalciferol|cholecalciferol|mesh-list
65339571|NCT05216419|Vitamin D|vitamin d|mesh-list
65339572|NCT05216419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65339573|NCT05216419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339574|NCT05216419|Vitamins|vitamins|mesh-ancestor
65339575|NCT05216419|Micronutrients|micronutrients|mesh-ancestor
65339576|NCT05216419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65339577|NCT05213208|Propofol|propofol|mesh-list
65339578|NCT05213208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65339579|NCT05213208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64722418|NCT00002684|Paclitaxel|paclitaxel|mesh-list
64722419|NCT00002684|Ifosfamide|ifosfamide|mesh-list
65339612|NCT05171075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65339613|NCT05171075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339614|NCT05171049|Apixaban|apixaban|mesh-list
65339615|NCT05171049|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65339616|NCT05171049|Antithrombins|antithrombins|mesh-ancestor
65339617|NCT05171049|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65339618|NCT05171049|Protease Inhibitors|protease inhibitors|mesh-ancestor
65339619|NCT05171049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339620|NCT05171049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339621|NCT05171049|Anticoagulants|anticoagulants|mesh-ancestor
65339622|NCT05170399|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65339623|NCT05170399|Immunologic Factors|immunologic factors|mesh-ancestor
64722428|NCT02972918|Simendan|simendan|mesh-list
65339654|NCT05112939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339711|NCT05080946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339712|NCT05080946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65339713|NCT05080946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65339714|NCT05080946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65339715|NCT05080946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65339716|NCT05080946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339717|NCT05080946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65339718|NCT05080946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65339719|NCT05080946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339720|NCT05080946|Antipyretics|antipyretics|mesh-ancestor
65339721|NCT05071664|Golimumab|golimumab|mesh-list
65339722|NCT05071664|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65339723|NCT05071664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65339724|NCT05071664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65339725|NCT05071664|Immunologic Factors|immunologic factors|mesh-ancestor
65339726|NCT05071664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339727|NCT05070403|Afatinib|afatinib|mesh-list
65339728|NCT05070403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339729|NCT05070403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65213895|NCT02625961|Pembrolizumab|pembrolizumab|mesh-list
65339730|NCT05070403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339731|NCT05070403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339732|NCT05068752|Sorafenib|sorafenib|mesh-list
65339733|NCT05068752|Vemurafenib|vemurafenib|mesh-list
65339734|NCT05068752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339735|NCT05068752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65339736|NCT05068752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339737|NCT05068752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339738|NCT05052879|Tadalafil|tadalafil|mesh-list
65339739|NCT05052879|Vasodilator Agents|vasodilator agents|mesh-ancestor
65089577|NCT00623155|Renal Agents|renal agents|mesh-ancestor
65339740|NCT05052879|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65339741|NCT05052879|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65339742|NCT05052879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339743|NCT05052879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339765|NCT05043805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65339766|NCT05043805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339767|NCT05043805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339768|NCT05042687|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
64330189|NCT02378415|Sensory System Agents|sensory system agents|mesh-ancestor
65339795|NCT05039619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339796|NCT05039619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339798|NCT05039619|Autonomic Agents|autonomic agents|mesh-ancestor
65339799|NCT05039619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65339800|NCT05039619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65339801|NCT05039619|Protective Agents|protective agents|mesh-ancestor
65339802|NCT05039619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65339803|NCT05039619|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65339804|NCT05039619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65339805|NCT05039619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65339806|NCT05039619|Anesthetics, Local|anesthetics, local|mesh-ancestor
65339807|NCT05039619|Anesthetics|anesthetics|mesh-ancestor
65339808|NCT05039619|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65339809|NCT05039619|Histamine Antagonists|histamine antagonists|mesh-ancestor
65339810|NCT05039619|Histamine Agents|histamine agents|mesh-ancestor
65339811|NCT05039619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65339812|NCT05039619|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65339813|NCT05039619|Antipruritics|antipruritics|mesh-ancestor
65339814|NCT05039619|Dermatologic Agents|dermatologic agents|mesh-ancestor
65339815|NCT05036109|Aspirin|aspirin|mesh-list
65339816|NCT05036109|Vitamin D|vitamin d|mesh-list
65339817|NCT05036109|Vitamins|vitamins|mesh-ancestor
65089651|NCT00501696|Naltrexone|naltrexone|mesh-list
65339818|NCT05036109|Micronutrients|micronutrients|mesh-ancestor
65339825|NCT05036109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65339826|NCT05036109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65339827|NCT05036109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65339828|NCT05036109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65339829|NCT05036109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65339830|NCT05036109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339831|NCT05036109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65339832|NCT05036109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65339833|NCT05036109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339834|NCT05036109|Antipyretics|antipyretics|mesh-ancestor
65339835|NCT05033483|Ferrous fumarate|ferrous fumarate|mesh-list
65339836|NCT05033483|Trace Elements|trace elements|mesh-ancestor
65339837|NCT05033483|Micronutrients|micronutrients|mesh-ancestor
65339838|NCT05033483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339839|NCT04999969|Gemcitabine|gemcitabine|mesh-list
65339840|NCT04999969|Paclitaxel|paclitaxel|mesh-list
65339841|NCT04999969|Durvalumab|durvalumab|mesh-list
65339842|NCT04999969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65339843|NCT04999969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339844|NCT04999969|Tubulin Modulators|tubulin modulators|mesh-ancestor
65339845|NCT04999969|Antimitotic Agents|antimitotic agents|mesh-ancestor
65339846|NCT04999969|Mitosis Modulators|mitosis modulators|mesh-ancestor
65339847|NCT04999969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339848|NCT04999969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65339849|NCT04999969|Antimetabolites|antimetabolites|mesh-ancestor
65339850|NCT04999969|Antiviral Agents|antiviral agents|mesh-ancestor
65339851|NCT04999969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65339852|NCT04999969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339853|NCT04999969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65339854|NCT04999969|Immunologic Factors|immunologic factors|mesh-ancestor
65213967|NCT02231879|Antiviral Agents|antiviral agents|mesh-ancestor
65339855|NCT04999969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339856|NCT04999969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65339857|NCT04988295|Carboplatin|carboplatin|mesh-list
65339858|NCT04988295|Pemetrexed|pemetrexed|mesh-list
65339859|NCT04988295|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
65339860|NCT04988295|Lazertinib|lazertinib|mesh-list
65339861|NCT04988295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339862|NCT04988295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339863|NCT04988295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339864|NCT04988295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65339865|NCT04988295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65339866|NCT04988295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65339867|NCT04988295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65339868|NCT04982913|Oseltamivir|oseltamivir|mesh-list
65339869|NCT04982913|Antiviral Agents|antiviral agents|mesh-ancestor
65339870|NCT04982913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65339871|NCT04982913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339872|NCT04982913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339873|NCT04981899|Carboplatin|carboplatin|mesh-list
65339874|NCT04981899|Nivolumab|nivolumab|mesh-list
65339875|NCT04981899|Etoposide|etoposide|mesh-list
65339876|NCT04981899|Ifosfamide|ifosfamide|mesh-list
65339877|NCT04981899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339878|NCT04981899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65339879|NCT04981899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65339880|NCT04981899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339881|NCT04981899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65339882|NCT04981899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65339883|NCT04981899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65339884|NCT04981899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339885|NCT04981899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65339886|NCT04981899|Alkylating Agents|alkylating agents|mesh-ancestor
65339887|NCT04977830|Xenon|xenon|mesh-list
64383013|NCT02414165|Growth Inhibitors|growth inhibitors|mesh-ancestor
64383014|NCT02414165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64383015|NCT02414165|Alkylating Agents|alkylating agents|mesh-ancestor
64383016|NCT02414165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383017|NCT02414165|Antifungal Agents|antifungal agents|mesh-ancestor
64383018|NCT02414165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65339888|NCT04977830|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65339889|NCT04977830|Anesthetics, General|anesthetics, general|mesh-ancestor
65339890|NCT04977830|Anesthetics|anesthetics|mesh-ancestor
65339891|NCT04977830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65339892|NCT04977830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339893|NCT04936542|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65339894|NCT04936542|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65339895|NCT04936542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65339896|NCT04936542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339897|NCT04936542|Cholinergic Agents|cholinergic agents|mesh-ancestor
65339898|NCT04936542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65339899|NCT04936542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339900|NCT04929600|Amlodipine|amlodipine|mesh-list
65339901|NCT04929600|Valsartan|valsartan|mesh-list
65339902|NCT04929600|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65339903|NCT04929600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65339904|NCT04929600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65339905|NCT04929600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65339906|NCT04929600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339907|NCT04929600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65339908|NCT04929600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339909|NCT04929600|Vasodilator Agents|vasodilator agents|mesh-ancestor
65339910|NCT04929600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65339911|NCT04929600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65339912|NCT04925648|Dasatinib|dasatinib|mesh-list
65339913|NCT04925648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339914|NCT04925648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65339915|NCT04925648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339916|NCT04925648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339917|NCT04904536|Atorvastatin|atorvastatin|mesh-list
65339918|NCT04904536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65339919|NCT04904536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65339920|NCT04904536|Antimetabolites|antimetabolites|mesh-ancestor
65339921|NCT04904536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339922|NCT04904536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65339956|NCT04849364|Atezolizumab|atezolizumab|mesh-list
65339957|NCT04849364|Talazoparib|talazoparib|mesh-list
65339958|NCT04849364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65339959|NCT04849364|Antimetabolites|antimetabolites|mesh-ancestor
65339960|NCT04849364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339961|NCT04849364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339962|NCT04849364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65339963|NCT04849364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339964|NCT04848337|Pembrolizumab|pembrolizumab|mesh-list
65339965|NCT04848337|Lenvatinib|lenvatinib|mesh-list
65339966|NCT04848337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65339967|NCT04848337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339968|NCT04848337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65339969|NCT04848337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339970|NCT04848337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339971|NCT04824417|Itraconazole|itraconazole|mesh-list
65339972|NCT04824417|Voriconazole|voriconazole|mesh-list
65339973|NCT04824417|Antifungal Agents|antifungal agents|mesh-ancestor
65339974|NCT04824417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65339975|NCT04824417|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65339976|NCT04824417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65339977|NCT04824417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339978|NCT04824417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339979|NCT04824417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64330330|NCT03601455|Durvalumab|durvalumab|mesh-list
64330331|NCT03601455|Ipilimumab|ipilimumab|mesh-list
65339981|NCT04824417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65339982|NCT04824417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339983|NCT04824417|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65339984|NCT04720781|Esomeprazole|esomeprazole|mesh-list
65339985|NCT04720781|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65339986|NCT04720781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65339987|NCT04720781|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65339988|NCT04720781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339989|NCT04720781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339990|NCT04702880|Carboplatin|carboplatin|mesh-list
65339991|NCT04702880|Nivolumab|nivolumab|mesh-list
65339992|NCT04702880|Etoposide|etoposide|mesh-list
65339993|NCT04702880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339994|NCT04702880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65339995|NCT04702880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65339996|NCT04702880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339997|NCT04702880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65339998|NCT04702880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65339999|NCT04702880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65340000|NCT04702880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340001|NCT04692623|Insulin|insulin|mesh-list
65340002|NCT04692623|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65340003|NCT04692623|Moxifloxacin|moxifloxacin|mesh-list
65340004|NCT04692623|Gemifloxacin|gemifloxacin|mesh-list
65340005|NCT04692623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65340006|NCT04692623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340007|NCT04692623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65340008|NCT04692623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65340009|NCT04692623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65340010|NCT04692623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65340011|NCT04692623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340012|NCT04692623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340013|NCT04692623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340014|NCT04690608|Triamcinolone|triamcinolone|mesh-list
65340015|NCT04690608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65340016|NCT04690608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65340021|NCT04690608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65340022|NCT04690608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340024|NCT04690608|Immunologic Factors|immunologic factors|mesh-ancestor
65340025|NCT04690608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340026|NCT04690608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340027|NCT04684238|Midazolam|midazolam|mesh-list
65340028|NCT04684238|Isoflurane|isoflurane|mesh-list
65340029|NCT04684238|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65340030|NCT04684238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65340031|NCT04684238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65340032|NCT04684238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340033|NCT04684238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65340034|NCT04684238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65340035|NCT04684238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65340036|NCT04684238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65340037|NCT04684238|Anesthetics, General|anesthetics, general|mesh-ancestor
65340038|NCT04684238|Anesthetics|anesthetics|mesh-ancestor
65340039|NCT04684238|GABA Modulators|gaba modulators|mesh-ancestor
65340040|NCT04684238|GABA Agents|gaba agents|mesh-ancestor
65340041|NCT04684238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65340042|NCT04684238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340043|NCT04684238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65340044|NCT04629248|Acetaminophen|acetaminophen|mesh-list
65340045|NCT04629248|Diphenhydramine|diphenhydramine|mesh-list
65340046|NCT04629248|Promethazine|promethazine|mesh-list
65340047|NCT04629248|Methylprednisolone|methylprednisolone|mesh-list
65340048|NCT04629248|Obinutuzumab|obinutuzumab|mesh-list
65340049|NCT04629248|Tacrolimus|tacrolimus|mesh-list
65340050|NCT04629248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65340051|NCT04629248|Immunologic Factors|immunologic factors|mesh-ancestor
65340052|NCT04629248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340053|NCT04629248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65340154|NCT04560127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340155|NCT04560127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340156|NCT04553536|Sufentanil|sufentanil|mesh-list
65340157|NCT04553536|Remifentanil|remifentanil|mesh-list
65340158|NCT04553536|Dsuvia|dsuvia|mesh-list
65340159|NCT04553536|Bromides|bromides|mesh-list
65340160|NCT04553536|Propofol|propofol|mesh-list
65340161|NCT04553536|Esketamine|esketamine|mesh-list
65340162|NCT04553536|Rocuronium|rocuronium|mesh-list
65340163|NCT04553536|Cisatracurium|cisatracurium|mesh-list
65340164|NCT04553536|Atracurium|atracurium|mesh-list
65340165|NCT04553536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65340166|NCT04553536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65340167|NCT04553536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340168|NCT04553536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65340169|NCT04553536|Anesthetics, General|anesthetics, general|mesh-ancestor
65340170|NCT04553536|Anesthetics|anesthetics|mesh-ancestor
65340171|NCT04553536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65340172|NCT04553536|Narcotics|narcotics|mesh-ancestor
65340173|NCT04553536|Analgesics|analgesics|mesh-ancestor
65340244|NCT04485130|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65340245|NCT04485130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340246|NCT04485130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340247|NCT04484818|Leuprolide|leuprolide|mesh-list
65340248|NCT04484818|Goserelin|goserelin|mesh-list
65340249|NCT04484818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65340250|NCT04484818|Tryptophan|tryptophan|mesh-list
65340251|NCT04484818|Androgen Antagonists|androgen antagonists|mesh-list
65340252|NCT04484818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65340253|NCT04484818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722774|NCT05749016|Paclitaxel|paclitaxel|mesh-list
65340256|NCT04484818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65340257|NCT04484818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65340258|NCT04484818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340259|NCT04484818|Luteolytic Agents|luteolytic agents|mesh-ancestor
65340260|NCT04484818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65340261|NCT04484818|Contraceptive Agents|contraceptive agents|mesh-ancestor
65340262|NCT04484818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65340263|NCT04484818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65340264|NCT04484818|Antidepressive Agents|antidepressive agents|mesh-ancestor
65340265|NCT04484818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65340266|NCT04484818|Hormone Antagonists|hormone antagonists|mesh-ancestor
65340268|NCT04480502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65340269|NCT04480502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340270|NCT04480502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65340271|NCT04480502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340272|NCT04447092|Leucovorin|leucovorin|mesh-list
65340273|NCT04447092|Gemcitabine|gemcitabine|mesh-list
65340274|NCT04447092|Paclitaxel|paclitaxel|mesh-list
65340275|NCT04447092|Pembrolizumab|pembrolizumab|mesh-list
65340276|NCT04447092|Oxaliplatin|oxaliplatin|mesh-list
65340277|NCT04447092|Irinotecan|irinotecan|mesh-list
65340278|NCT04447092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65340279|NCT04447092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340280|NCT04447092|Tubulin Modulators|tubulin modulators|mesh-ancestor
65340281|NCT04447092|Antimitotic Agents|antimitotic agents|mesh-ancestor
65269801|NCT02733380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65340282|NCT04447092|Mitosis Modulators|mitosis modulators|mesh-ancestor
65340283|NCT04447092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340284|NCT04447092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65340285|NCT04447092|Antimetabolites|antimetabolites|mesh-ancestor
65340286|NCT04447092|Antiviral Agents|antiviral agents|mesh-ancestor
65340287|NCT04447092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64495938|NCT03449940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65340334|NCT04306900|Docetaxel|docetaxel|mesh-list
65340335|NCT04306900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65340336|NCT04306900|Pembrolizumab|pembrolizumab|mesh-list
65340337|NCT04306900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65340338|NCT04306900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340339|NCT04306900|Tubulin Modulators|tubulin modulators|mesh-ancestor
65340340|NCT04306900|Antimitotic Agents|antimitotic agents|mesh-ancestor
65340341|NCT04306900|Mitosis Modulators|mitosis modulators|mesh-ancestor
65340342|NCT04306900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340343|NCT04306900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65340344|NCT04306900|Antimetabolites|antimetabolites|mesh-ancestor
65340345|NCT04306900|Antiviral Agents|antiviral agents|mesh-ancestor
65340346|NCT04306900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65340347|NCT04306900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64495958|NCT01230502|Antitubercular Agents|antitubercular agents|mesh-ancestor
65340428|NCT04216524|Doxorubicin|doxorubicin|mesh-list
65340429|NCT04216524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65340430|NCT04216524|Methotrexate|methotrexate|mesh-list
65340431|NCT04216524|Vincristine|vincristine|mesh-list
65340432|NCT04216524|Daunorubicin|daunorubicin|mesh-list
65340433|NCT04216524|Venetoclax|venetoclax|mesh-list
65340434|NCT04216524|Mercaptopurine|mercaptopurine|mesh-list
65340435|NCT04216524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65340436|NCT04216524|Antibodies|antibodies|mesh-list
65340437|NCT04216524|Immunoglobulins|immunoglobulins|mesh-list
65340438|NCT04216524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65340439|NCT04216524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65340440|NCT04216524|Prednisolone phosphate|prednisolone phosphate|mesh-list
65340441|NCT04216524|BB 1101|bb 1101|mesh-list
65340442|NCT04216524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65340443|NCT04216524|Immunologic Factors|immunologic factors|mesh-ancestor
65340444|NCT04216524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340445|NCT04216524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65340446|NCT04216524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65340447|NCT04216524|Alkylating Agents|alkylating agents|mesh-ancestor
65340448|NCT04216524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340449|NCT04216524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340450|NCT04216524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65340451|NCT04216524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65340452|NCT04216524|Antiemetics|antiemetics|mesh-ancestor
65340453|NCT04216524|Autonomic Agents|autonomic agents|mesh-ancestor
65340454|NCT04216524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65340455|NCT04216524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65340456|NCT04216524|Glucocorticoids|glucocorticoids|mesh-ancestor
65340457|NCT04216524|Hormones|hormones|mesh-ancestor
65340458|NCT04216524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65340459|NCT04216524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65340460|NCT04216524|Protease Inhibitors|protease inhibitors|mesh-ancestor
65340461|NCT04216524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340462|NCT04216524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65340463|NCT04216524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65340494|NCT04191499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340495|NCT04191499|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65340496|NCT04191499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65340497|NCT04191499|Hormone Antagonists|hormone antagonists|mesh-ancestor
65340498|NCT04191499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65340499|NCT04191499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340500|NCT04191499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65340501|NCT04191499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340502|NCT04191499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340504|NCT04177758|Vitamins|vitamins|mesh-ancestor
65340505|NCT04177758|Micronutrients|micronutrients|mesh-ancestor
65340506|NCT04177758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722867|NCT01692691|Dacarbazine|dacarbazine|mesh-list
65340546|NCT04147208|Protease Inhibitors|protease inhibitors|mesh-ancestor
65340547|NCT04147208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340548|NCT04147208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214283|NCT02793765|Docetaxel|docetaxel|mesh-list
65340549|NCT04147208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65340550|NCT04147208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65340551|NCT04147208|Antiviral Agents|antiviral agents|mesh-ancestor
65340552|NCT04147208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65340553|NCT04147208|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65340554|NCT04147208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65340555|NCT04140487|Azacitidine|azacitidine|mesh-list
65340557|NCT04140487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65340558|NCT04140487|Antimetabolites|antimetabolites|mesh-ancestor
65340559|NCT04140487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340560|NCT04140487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340561|NCT04140487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340562|NCT04136756|Rituximab|rituximab|mesh-list
65340563|NCT04136756|Daratumumab|daratumumab|mesh-list
65340564|NCT04136756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64496094|NCT01234870|Adenosine|adenosine|mesh-list
65340585|NCT04003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340586|NCT04003103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65340587|NCT04003103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65340588|NCT04003103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65340589|NCT03999216|Diuretics|diuretics|mesh-list
65340590|NCT03999216|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
65340591|NCT03999216|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
65340592|NCT03999216|Natriuretic Agents|natriuretic agents|mesh-ancestor
65340593|NCT03999216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340594|NCT03999216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65340595|NCT03999216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340596|NCT03996850|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
65340624|NCT03942328|Immunologic Factors|immunologic factors|mesh-ancestor
65340625|NCT03942328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340626|NCT03941587|Aflibercept|aflibercept|mesh-list
65340627|NCT03941587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65340628|NCT03941587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65340629|NCT03941587|Growth Substances|growth substances|mesh-ancestor
65340630|NCT03941587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340631|NCT03941587|Growth Inhibitors|growth inhibitors|mesh-ancestor
65340632|NCT03941587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340659|NCT03913104|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65340660|NCT03913104|Hormone Antagonists|hormone antagonists|mesh-ancestor
65340661|NCT03913104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65340662|NCT03913104|Luteolytic Agents|luteolytic agents|mesh-ancestor
65340663|NCT03913104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65340664|NCT03913104|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65340665|NCT03884556|Gemcitabine|gemcitabine|mesh-list
65340666|NCT03884556|Paclitaxel|paclitaxel|mesh-list
65340667|NCT03884556|Pembrolizumab|pembrolizumab|mesh-list
65340668|NCT03884556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65340669|NCT03884556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340670|NCT03884556|Tubulin Modulators|tubulin modulators|mesh-ancestor
65340671|NCT03884556|Antimitotic Agents|antimitotic agents|mesh-ancestor
65340672|NCT03884556|Mitosis Modulators|mitosis modulators|mesh-ancestor
65340673|NCT03884556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340674|NCT03884556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65340675|NCT03884556|Antimetabolites|antimetabolites|mesh-ancestor
65340676|NCT03884556|Antiviral Agents|antiviral agents|mesh-ancestor
65340677|NCT03884556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65340678|NCT03884556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340679|NCT03884556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65340680|NCT03884556|Immunologic Factors|immunologic factors|mesh-ancestor
65340681|NCT03884556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340682|NCT03884556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65340683|NCT03879629|Carvedilol|carvedilol|mesh-list
65340684|NCT03879629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65340685|NCT03879629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64330590|NCT02202239|Cisatracurium|cisatracurium|mesh-list
64330591|NCT02202239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64496165|NCT03444636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65340711|NCT03825536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340713|NCT03825536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65340714|NCT03825536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65340780|NCT03579784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65340781|NCT03579784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340782|NCT03579784|Tubulin Modulators|tubulin modulators|mesh-ancestor
65340783|NCT03579784|Antimitotic Agents|antimitotic agents|mesh-ancestor
65340784|NCT03579784|Mitosis Modulators|mitosis modulators|mesh-ancestor
65340785|NCT03579784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340786|NCT03579784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65340787|NCT03579784|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65340788|NCT03579784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340807|NCT03553563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65340808|NCT03553563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340809|NCT03553563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340810|NCT03542760|Methylene Blue|methylene blue|mesh-list
65340811|NCT03542760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340812|NCT03542760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340813|NCT03530397|Paclitaxel|paclitaxel|mesh-list
65340814|NCT03530397|Carboplatin|carboplatin|mesh-list
65340815|NCT03530397|Pembrolizumab|pembrolizumab|mesh-list
65340816|NCT03530397|Pemetrexed|pemetrexed|mesh-list
65340817|NCT03530397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65340818|NCT03530397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340819|NCT03530397|Tubulin Modulators|tubulin modulators|mesh-ancestor
65340820|NCT03530397|Antimitotic Agents|antimitotic agents|mesh-ancestor
65340858|NCT03374085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340859|NCT03374085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65340861|NCT03374085|Hormones|hormones|mesh-ancestor
65340862|NCT03374085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65340863|NCT03374085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65340864|NCT03374085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340865|NCT03368547|Edetic Acid|edetic acid|mesh-list
65340866|NCT03368547|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65340867|NCT03368547|Chelating Agents|chelating agents|mesh-ancestor
65340868|NCT03368547|Sequestering Agents|sequestering agents|mesh-ancestor
65340869|NCT03368547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340870|NCT03368547|Anticoagulants|anticoagulants|mesh-ancestor
65340871|NCT03368547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65340872|NCT03368547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65340873|NCT03217227|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65340874|NCT03217227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340875|NCT03217227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340876|NCT03217227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340877|NCT03217227|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65340878|NCT03152903|BCG Vaccine|bcg vaccine|mesh-list
64723034|NCT01583647|Nicotinic Acids|nicotinic acids|mesh-list
64723035|NCT01583647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65340941|NCT02940925|Immunologic Factors|immunologic factors|mesh-ancestor
65340942|NCT02940925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340943|NCT02915705|Vitamin D|vitamin d|mesh-list
65340944|NCT02915705|Vitamins|vitamins|mesh-ancestor
65340945|NCT02915705|Micronutrients|micronutrients|mesh-ancestor
65340946|NCT02915705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340947|NCT02915705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65340948|NCT02891278|Cytarabine|cytarabine|mesh-list
65340949|NCT02891278|Sertraline|sertraline|mesh-list
65340950|NCT02891278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65340951|NCT02891278|Antimetabolites|antimetabolites|mesh-ancestor
65340952|NCT02891278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723057|NCT04403516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65341003|NCT02366494|Bicalutamide|bicalutamide|mesh-list
65341004|NCT02366494|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65341005|NCT02366494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341006|NCT02366494|Tubulin Modulators|tubulin modulators|mesh-ancestor
65341007|NCT02366494|Antimitotic Agents|antimitotic agents|mesh-ancestor
65341008|NCT02366494|Mitosis Modulators|mitosis modulators|mesh-ancestor
65341009|NCT02366494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341010|NCT02366494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65341011|NCT02366494|Fertility Agents|fertility agents|mesh-ancestor
65341012|NCT02366494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65341013|NCT02366494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341014|NCT02366494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65341015|NCT02366494|Androgen Antagonists|androgen antagonists|mesh-ancestor
65341016|NCT02366494|Hormone Antagonists|hormone antagonists|mesh-ancestor
65341017|NCT02366494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65341039|NCT02157610|Cholinergic Agents|cholinergic agents|mesh-ancestor
65341040|NCT02157610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65214432|NCT00905424|Dopamine Agents|dopamine agents|mesh-ancestor
65341041|NCT02157610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341042|NCT02138617|Leucovorin|leucovorin|mesh-list
65341043|NCT02138617|Bevacizumab|bevacizumab|mesh-list
65341044|NCT02138617|Fluorouracil|fluorouracil|mesh-list
65341045|NCT02138617|Irinotecan|irinotecan|mesh-list
65341046|NCT02138617|Levoleucovorin|levoleucovorin|mesh-list
65341047|NCT02138617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65341048|NCT02138617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341049|NCT02138617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65341050|NCT02138617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65341051|NCT02138617|Growth Substances|growth substances|mesh-ancestor
65341052|NCT02138617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341053|NCT02138617|Growth Inhibitors|growth inhibitors|mesh-ancestor
65341054|NCT02138617|Antimetabolites|antimetabolites|mesh-ancestor
65341055|NCT02138617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723101|NCT05296759|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65341085|NCT02078869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341086|NCT02070705|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65341087|NCT02070705|Hematinics|hematinics|mesh-ancestor
65341088|NCT02070705|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65341089|NCT02070705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65341090|NCT02031419|Rituximab|rituximab|mesh-list
65341091|NCT02031419|Spebrutinib|spebrutinib|mesh-list
64723115|NCT05296759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65341360|NCT02575092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341361|NCT02575092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341362|NCT02575092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65341363|NCT02575092|Protease Inhibitors|protease inhibitors|mesh-ancestor
65341364|NCT02575092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65341366|NCT04097470|Midostaurin|midostaurin|mesh-list
65341367|NCT04097470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65341368|NCT04097470|Antimetabolites|antimetabolites|mesh-ancestor
65341369|NCT04097470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341370|NCT04097470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341371|NCT04097470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341372|NCT04097470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65341373|NCT04041934|Tryptophan|tryptophan|mesh-list
65341374|NCT04041934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65341375|NCT04041934|Antidepressive Agents|antidepressive agents|mesh-ancestor
65341376|NCT04041934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65341377|NCT00851734|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65341378|NCT00851734|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65341379|NCT00845572|Risperidone|risperidone|mesh-list
65341380|NCT00845572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65341381|NCT00845572|Serotonin Agents|serotonin agents|mesh-ancestor
65341382|NCT00845572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65341383|NCT00845572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341384|NCT00845572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341385|NCT00845572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65341386|NCT00845572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65341387|NCT00845572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65341388|NCT00845572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65341389|NCT00845572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65341390|NCT00845572|Dopamine Agents|dopamine agents|mesh-ancestor
65341391|NCT00711906|Pyrimethamine|pyrimethamine|mesh-list
65341392|NCT00711906|Sulfadoxine|sulfadoxine|mesh-list
65341393|NCT00711906|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65341394|NCT00711906|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65341395|NCT00711906|Antimalarials|antimalarials|mesh-ancestor
65341396|NCT00711906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65341397|NCT00711906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65341398|NCT00711906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65341399|NCT00711906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65341400|NCT00711906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341401|NCT00711906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341402|NCT00711906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65341403|NCT00711906|Renal Agents|renal agents|mesh-ancestor
65341404|NCT00711906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65341405|NCT04502550|Propofol|propofol|mesh-list
65341406|NCT04502550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65341407|NCT04502550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65341408|NCT04502550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341409|NCT04502550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65341410|NCT04502550|Anesthetics, General|anesthetics, general|mesh-ancestor
65341411|NCT04502550|Anesthetics|anesthetics|mesh-ancestor
65341412|NCT04227184|Trospium chloride|trospium chloride|mesh-list
65341413|NCT04227184|Parasympatholytics|parasympatholytics|mesh-ancestor
65341414|NCT04227184|Autonomic Agents|autonomic agents|mesh-ancestor
65341415|NCT04227184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65341416|NCT04227184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341417|NCT04227184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65341418|NCT04227184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65341419|NCT04227184|Cholinergic Agents|cholinergic agents|mesh-ancestor
65341420|NCT04227184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65341421|NCT04227184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342496|NCT02571140|Parathyroid Hormone|parathyroid hormone|mesh-list
65342497|NCT02571140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65342498|NCT02571140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342499|NCT02571140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65342500|NCT00723216|Enoxaparin|enoxaparin|mesh-list
65342501|NCT00723216|Anticoagulants|anticoagulants|mesh-ancestor
65342502|NCT00723216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65342503|NCT00723216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65342504|NCT00723216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342505|NCT00724178|Vitamin D|vitamin d|mesh-list
65342506|NCT00724178|Cholecalciferol|cholecalciferol|mesh-list
65342507|NCT00724178|Calcium Carbonate|calcium carbonate|mesh-list
65342508|NCT00724178|Calcium|calcium|mesh-list
65342509|NCT00724178|Vitamins|vitamins|mesh-ancestor
65342510|NCT00724178|Micronutrients|micronutrients|mesh-ancestor
65342511|NCT00724178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342512|NCT00724178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65342513|NCT00724178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65342514|NCT00724178|Antacids|antacids|mesh-ancestor
65342515|NCT00724178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342516|NCT00724178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65342517|NCT02546050|Metformin|metformin|mesh-list
65342518|NCT02546050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65342519|NCT02546050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342520|NCT04800224|Propolis|propolis|mesh-list
65342521|NCT04800224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65342522|NCT00718146|Vaccines|vaccines|mesh-list
65342523|NCT00718146|Immunologic Factors|immunologic factors|mesh-ancestor
65342524|NCT00718146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342525|NCT00860626|Interferons|interferons|mesh-list
65342526|NCT00860626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342527|NCT00860626|Antiviral Agents|antiviral agents|mesh-ancestor
65342528|NCT00860626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65342529|NCT00724256|Ceftibuten|ceftibuten|mesh-list
65342530|NCT00724256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65342531|NCT00724256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65342532|NCT04742660|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
65092335|NCT00484926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342533|NCT04742660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65342534|NCT01005914|Cytarabine|cytarabine|mesh-list
65342535|NCT01005914|Dexamethasone|dexamethasone|mesh-list
65342536|NCT01005914|Methylprednisolone|methylprednisolone|mesh-list
65342537|NCT01005914|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65342538|NCT01005914|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65342539|NCT01005914|Cyclophosphamide|cyclophosphamide|mesh-list
65342540|NCT01005914|Doxorubicin|doxorubicin|mesh-list
65342541|NCT01005914|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65342542|NCT01005914|Methotrexate|methotrexate|mesh-list
65342543|NCT01005914|Vincristine|vincristine|mesh-list
65342544|NCT01005914|Imatinib Mesylate|imatinib mesylate|mesh-list
65342545|NCT01005914|Asparaginase|asparaginase|mesh-list
65342546|NCT01005914|Pegaspargase|pegaspargase|mesh-list
65342547|NCT01005914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65342548|NCT01005914|Immunologic Factors|immunologic factors|mesh-ancestor
65342549|NCT01005914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342550|NCT01005914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65342551|NCT01005914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65342552|NCT01005914|Alkylating Agents|alkylating agents|mesh-ancestor
65342553|NCT01005914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342554|NCT01005914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342555|NCT01005914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65342556|NCT01005914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65342557|NCT01005914|Antiemetics|antiemetics|mesh-ancestor
65342558|NCT01005914|Autonomic Agents|autonomic agents|mesh-ancestor
65342559|NCT01005914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65342560|NCT01005914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65342561|NCT01005914|Glucocorticoids|glucocorticoids|mesh-ancestor
65269802|NCT02733380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65342562|NCT01005914|Hormones|hormones|mesh-ancestor
65342563|NCT01005914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65342564|NCT01005914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65343030|NCT03491540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65343031|NCT03491540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343032|NCT03491540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343033|NCT03491540|Laxatives|laxatives|mesh-ancestor
65343034|NCT03491540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65343035|NCT03491540|Amebicides|amebicides|mesh-ancestor
65343036|NCT03491540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65343037|NCT03491540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65343038|NCT03491540|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65343039|NCT00854932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65343040|NCT00854932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65343041|NCT00861874|Sirolimus|sirolimus|mesh-list
65343042|NCT00861874|Decitabine|decitabine|mesh-list
65343043|NCT00861874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65343044|NCT00861874|Antimetabolites|antimetabolites|mesh-ancestor
65343045|NCT00861874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343046|NCT00861874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343047|NCT00861874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343048|NCT00861874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65343049|NCT00861874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65343050|NCT00861874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65343051|NCT00861874|Antifungal Agents|antifungal agents|mesh-ancestor
65343052|NCT00861874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65343053|NCT00861874|Immunologic Factors|immunologic factors|mesh-ancestor
65343054|NCT00861874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343055|NCT05372874|Antiviral Agents|antiviral agents|mesh-list
65343056|NCT05372874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65343057|NCT04067856|Dexamethasone|dexamethasone|mesh-list
65343058|NCT04067856|Bevacizumab|bevacizumab|mesh-list
65343059|NCT04067856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65343060|NCT04067856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343061|NCT04067856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65343062|NCT04067856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65343900|NCT04066088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343901|NCT00733148|Insulin|insulin|mesh-list
65343902|NCT00733148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65343903|NCT00733148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344210|NCT00808743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65344211|NCT00869596|Fluticasone|fluticasone|mesh-list
65344212|NCT00869596|Xhance|xhance|mesh-list
65344213|NCT00869596|Albuterol|albuterol|mesh-list
65344214|NCT00869596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65344215|NCT00869596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65344216|NCT00869596|Autonomic Agents|autonomic agents|mesh-ancestor
65344217|NCT00869596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65344218|NCT00869596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344219|NCT00869596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65344220|NCT00869596|Respiratory System Agents|respiratory system agents|mesh-ancestor
65344221|NCT00869596|Dermatologic Agents|dermatologic agents|mesh-ancestor
65344222|NCT00869596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65344223|NCT00869596|Tocolytic Agents|tocolytic agents|mesh-ancestor
65344224|NCT00869596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65344225|NCT00869596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65275329|NCT00642798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275330|NCT05364996|Dimercaprol|dimercaprol|mesh-list
65275331|NCT05364996|Chelating Agents|chelating agents|mesh-ancestor
65275332|NCT05364996|Sequestering Agents|sequestering agents|mesh-ancestor
65275333|NCT05364996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275334|NCT00643734|Azithromycin|azithromycin|mesh-list
65275335|NCT00643734|Levofloxacin|levofloxacin|mesh-list
65275336|NCT00643734|Ofloxacin|ofloxacin|mesh-list
65275337|NCT00643734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65275338|NCT00643734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65275339|NCT00643734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65275503|NCT00644982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65275505|NCT00644982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727951|NCT00003602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65275539|NCT00644670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65275540|NCT00644670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65275541|NCT00644670|Antimetabolites|antimetabolites|mesh-ancestor
65275542|NCT00644670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275543|NCT00644670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64727990|NCT00003614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65275885|NCT00647712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275886|NCT00647712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275888|NCT00647712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65275889|NCT00647712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275890|NCT00647712|Antimanic Agents|antimanic agents|mesh-ancestor
65275891|NCT00647712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65275892|NCT00647712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65275893|NCT00647712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65275894|NCT04173390|Pregabalin|pregabalin|mesh-list
65275895|NCT04173390|Analgesics|analgesics|mesh-ancestor
65275943|NCT02665416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275944|NCT02665416|Growth Inhibitors|growth inhibitors|mesh-ancestor
65275945|NCT00646620|Fluticasone|fluticasone|mesh-list
65275946|NCT00646620|Budesonide|budesonide|mesh-list
65275947|NCT00646620|Albuterol|albuterol|mesh-list
65275948|NCT00646620|Formoterol Fumarate|formoterol fumarate|mesh-list
65275949|NCT00646620|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65275950|NCT00646620|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65275951|NCT00646620|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65275952|NCT00646620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65276044|NCT00648414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276045|NCT00648414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65276046|NCT00648414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65276047|NCT00648414|Anesthetics, General|anesthetics, general|mesh-ancestor
65276048|NCT00648414|Anesthetics|anesthetics|mesh-ancestor
65276049|NCT04558866|Methyltestosterone|methyltestosterone|mesh-list
65276050|NCT04558866|Testosterone|testosterone|mesh-list
65276051|NCT04558866|Testosterone undecanoate|testosterone undecanoate|mesh-list
65276052|NCT04558866|Testosterone enanthate|testosterone enanthate|mesh-list
65276053|NCT04558866|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65276055|NCT04558866|Hormones|hormones|mesh-ancestor
65276056|NCT04558866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65276057|NCT04558866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276058|NCT04558866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65276059|NCT04558866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276060|NCT04558866|Anabolic Agents|anabolic agents|mesh-ancestor
65276061|NCT02663700|Artesunate|artesunate|mesh-list
65276062|NCT02663700|Antimalarials|antimalarials|mesh-ancestor
65276063|NCT02663700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65276064|NCT02663700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65276065|NCT02663700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65276066|NCT02663700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276067|NCT02663700|Antiviral Agents|antiviral agents|mesh-ancestor
65276068|NCT02663700|Schistosomicides|schistosomicides|mesh-ancestor
65276115|NCT02664012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276117|NCT02664012|Dermatologic Agents|dermatologic agents|mesh-ancestor
65276118|NCT00895037|Factor VIII|factor viii|mesh-list
65276119|NCT00895037|Coagulants|coagulants|mesh-ancestor
65276120|NCT04170504|Methotrexate|methotrexate|mesh-list
65276121|NCT04170504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65276122|NCT04170504|Abortifacient Agents|abortifacient agents|mesh-ancestor
65276123|NCT04170504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65276124|NCT04170504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276125|NCT04170504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65276126|NCT04170504|Antimetabolites|antimetabolites|mesh-ancestor
65276127|NCT04170504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276128|NCT04170504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276129|NCT04170504|Dermatologic Agents|dermatologic agents|mesh-ancestor
65276130|NCT04170504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728573|NCT05501665|Deoxyglucose|deoxyglucose|mesh-list
65276381|NCT04169256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276382|NCT04169256|Sensory System Agents|sensory system agents|mesh-ancestor
65276383|NCT04169256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276385|NCT02658396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276386|NCT02661438|Ciprofloxacin|ciprofloxacin|mesh-list
65276387|NCT02661438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65276388|NCT02661438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65276389|NCT02661438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65276390|NCT02661438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65276391|NCT02661438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276392|NCT02661438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276393|NCT02661438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276394|NCT02661438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65214726|NCT00903630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65276395|NCT02661438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65276396|NCT00894803|Eptifibatide|eptifibatide|mesh-list
65276397|NCT00894803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65276398|NCT00601458|Naproxen|naproxen|mesh-list
65276399|NCT00601458|Pregabalin|pregabalin|mesh-list
65276400|NCT00601458|Analgesics|analgesics|mesh-ancestor
65276401|NCT00601458|Sensory System Agents|sensory system agents|mesh-ancestor
65276402|NCT00601458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276403|NCT00601458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276404|NCT00601458|Anticonvulsants|anticonvulsants|mesh-ancestor
65276405|NCT00601458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65276406|NCT00601458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65276407|NCT00601458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276408|NCT00601458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65276409|NCT00601458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65276410|NCT00601458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65276411|NCT00601458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65276412|NCT00601458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65276413|NCT00601458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65276414|NCT00601458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65276415|NCT00601458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65276416|NCT00601458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65276417|NCT00601458|Gout Suppressants|gout suppressants|mesh-ancestor
65276418|NCT00601458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65276419|NCT00601458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276420|NCT02660736|rGLP-1 protein|rglp-1 protein|mesh-list
65276421|NCT02660736|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65276422|NCT02660736|Incretins|incretins|mesh-ancestor
65276423|NCT02660736|Hormones|hormones|mesh-ancestor
65276424|NCT02660736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65276425|NCT02660736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276426|NCT00649584|Gemcitabine|gemcitabine|mesh-list
65276427|NCT00649584|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65276428|NCT00649584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65276429|NCT00649584|Antimetabolites|antimetabolites|mesh-ancestor
65276430|NCT00649584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276431|NCT00649584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276432|NCT00649584|Antiviral Agents|antiviral agents|mesh-ancestor
65276433|NCT00649584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65276434|NCT00649584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276435|NCT00649584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65276436|NCT00649584|Immunologic Factors|immunologic factors|mesh-ancestor
65276437|NCT00649584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276438|NCT00649584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65276439|NCT02141282|Venetoclax|venetoclax|mesh-list
65276440|NCT02141282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276619|NCT00600756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65276620|NCT00600756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65276621|NCT00600756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65276622|NCT00600756|Dopamine Agents|dopamine agents|mesh-ancestor
65276623|NCT00600756|Antidepressive Agents|antidepressive agents|mesh-ancestor
65276624|NCT04865042|Gabapentin|gabapentin|mesh-list
65276625|NCT04865042|Analgesics|analgesics|mesh-ancestor
65276626|NCT04865042|Sensory System Agents|sensory system agents|mesh-ancestor
65276627|NCT04865042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276628|NCT04865042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276629|NCT04865042|Anticonvulsants|anticonvulsants|mesh-ancestor
65276630|NCT04865042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65276631|NCT04865042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64729082|NCT00004934|Paclitaxel|paclitaxel|mesh-list
65276789|NCT04246697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276790|NCT02830139|Capecitabine|capecitabine|mesh-list
65276791|NCT02830139|Oxaliplatin|oxaliplatin|mesh-list
65276792|NCT02830139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276793|NCT02830139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65276836|NCT04724720|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65276837|NCT04724720|Histamine Antagonists|histamine antagonists|mesh-ancestor
65276839|NCT04724720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65276840|NCT04724720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276841|NCT04724720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276842|NCT02833103|Pinaverium|pinaverium|mesh-list
65276843|NCT02833103|Bromides|bromides|mesh-list
65276844|NCT02833103|Anticonvulsants|anticonvulsants|mesh-ancestor
65276845|NCT02833103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65269803|NCT02733380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65276846|NCT02833103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65276847|NCT02833103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276848|NCT02833103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65276849|NCT02833103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276850|NCT02833103|Parasympatholytics|parasympatholytics|mesh-ancestor
65276851|NCT02833103|Autonomic Agents|autonomic agents|mesh-ancestor
65276852|NCT02833103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276853|NCT02648490|Acetaminophen|acetaminophen|mesh-list
65276854|NCT02648490|Diphenhydramine|diphenhydramine|mesh-list
65276855|NCT02648490|Promethazine|promethazine|mesh-list
65276856|NCT02648490|Dexamethasone|dexamethasone|mesh-list
65276857|NCT02648490|Ondansetron|ondansetron|mesh-list
65276858|NCT02648490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65276859|NCT02648490|Antiemetics|antiemetics|mesh-ancestor
65276860|NCT02648490|Autonomic Agents|autonomic agents|mesh-ancestor
65276861|NCT02648490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276862|NCT02648490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276863|NCT02648490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65276864|NCT02648490|Glucocorticoids|glucocorticoids|mesh-ancestor
65276865|NCT02648490|Hormones|hormones|mesh-ancestor
65276866|NCT02648490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65276867|NCT02648490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65276868|NCT02648490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276869|NCT02648490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65276870|NCT02648490|Analgesics|analgesics|mesh-ancestor
65276871|NCT02648490|Sensory System Agents|sensory system agents|mesh-ancestor
65276872|NCT02648490|Antipyretics|antipyretics|mesh-ancestor
65276873|NCT02648490|Antipruritics|antipruritics|mesh-ancestor
65276874|NCT02648490|Dermatologic Agents|dermatologic agents|mesh-ancestor
65276875|NCT02648490|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65276876|NCT02648490|Serotonin Agents|serotonin agents|mesh-ancestor
65276877|NCT02648490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65276878|NCT02648490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276879|NCT02648490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65276880|NCT02648490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65276881|NCT02648490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65276882|NCT02648490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65276883|NCT02648490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65276884|NCT02648490|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65276885|NCT02648490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64729313|NCT00003824|Cephalexin|cephalexin|mesh-list
65276918|NCT00650520|Dopamine Agonists|dopamine agonists|mesh-ancestor
65276919|NCT00650520|Dopamine Agents|dopamine agents|mesh-ancestor
65276920|NCT00650520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65276921|NCT00650520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276922|NCT04244981|Thrombin|thrombin|mesh-list
65276923|NCT04244981|Hemostatics|hemostatics|mesh-ancestor
65276924|NCT04244981|Coagulants|coagulants|mesh-ancestor
65276925|NCT00621218|Tretinoin|tretinoin|mesh-list
65276926|NCT00621218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276927|NCT00621218|Keratolytic Agents|keratolytic agents|mesh-ancestor
65276985|NCT00621998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65276986|NCT00621998|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65276987|NCT00621998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65276988|NCT00621998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64729440|NCT00004442|Cathartics|cathartics|mesh-ancestor
65277026|NCT03845166|Atezolizumab|atezolizumab|mesh-list
65277027|NCT03845166|Avelumab|avelumab|mesh-list
65277028|NCT03845166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65277029|NCT03845166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65277030|NCT02829359|Entecavir|entecavir|mesh-list
65277031|NCT02829359|Antiviral Agents|antiviral agents|mesh-ancestor
65277032|NCT02829359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65277033|NCT02650752|Capecitabine|capecitabine|mesh-list
65277034|NCT02650752|Lapatinib|lapatinib|mesh-list
65277035|NCT02650752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65277036|NCT02650752|Antimetabolites|antimetabolites|mesh-ancestor
65277037|NCT02650752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277038|NCT02650752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65277039|NCT02650752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65277040|NCT02650752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277041|NCT02832713|Botulinum Toxins|botulinum toxins|mesh-list
65277042|NCT02832713|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65277043|NCT02832713|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65277044|NCT02832713|Hyaluronic Acid|hyaluronic acid|mesh-list
65277045|NCT02832713|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65277046|NCT02832713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65277047|NCT02832713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277048|NCT02832713|Cholinergic Agents|cholinergic agents|mesh-ancestor
65277049|NCT02832713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65277050|NCT02832713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277051|NCT02832713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65277052|NCT02832713|Immunologic Factors|immunologic factors|mesh-ancestor
65277053|NCT02832713|Viscosupplements|viscosupplements|mesh-ancestor
65277054|NCT02832713|Protective Agents|protective agents|mesh-ancestor
65277055|NCT02832713|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65277056|NCT02832713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277057|NCT02832635|Temozolomide|temozolomide|mesh-list
65277594|NCT02646072|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65277595|NCT02646072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65277596|NCT02646072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65277597|NCT02646072|Analgesics|analgesics|mesh-ancestor
65277598|NCT02646072|Sensory System Agents|sensory system agents|mesh-ancestor
65277599|NCT02646072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277600|NCT02646072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277601|NCT02646072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65277602|NCT02646072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65277603|NCT02646072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65277604|NCT02646072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277605|NCT02646072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277606|NCT05074355|Azacitidine|azacitidine|mesh-list
65277607|NCT05074355|Venetoclax|venetoclax|mesh-list
65277608|NCT05074355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65277609|NCT05074355|Antimetabolites|antimetabolites|mesh-ancestor
65277610|NCT05074355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277611|NCT05074355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65277612|NCT05074355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277613|NCT02654106|Temozolomide|temozolomide|mesh-list
65277614|NCT02654106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65277615|NCT02654106|Alkylating Agents|alkylating agents|mesh-ancestor
65277616|NCT02654106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277617|NCT02654106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65277618|NCT04243733|Pemetrexed|pemetrexed|mesh-list
65277619|NCT04243733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65277620|NCT04243733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277621|NCT04243733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277622|NCT04243733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65277623|NCT04243733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65277624|NCT03434366|Dexmedetomidine|dexmedetomidine|mesh-list
65277625|NCT03434366|Ketamine|ketamine|mesh-list
65277626|NCT03434366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65277627|NCT03434366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65277628|NCT03434366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277629|NCT03434366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65277630|NCT03434366|Analgesics|analgesics|mesh-ancestor
65277631|NCT03434366|Sensory System Agents|sensory system agents|mesh-ancestor
65277632|NCT03434366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277633|NCT03434366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65277634|NCT03434366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65277635|NCT03434366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65277636|NCT03434366|Adrenergic Agents|adrenergic agents|mesh-ancestor
65277637|NCT03434366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65277638|NCT03434366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277639|NCT03434366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65277640|NCT03434366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65277641|NCT03434366|Anesthetics, General|anesthetics, general|mesh-ancestor
65277642|NCT03434366|Anesthetics|anesthetics|mesh-ancestor
65277643|NCT03434366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65277644|NCT03434366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65277645|NCT04167228|Ceftazidime|ceftazidime|mesh-list
65277646|NCT04167228|Avibactam|avibactam|mesh-list
65277647|NCT04167228|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
65277648|NCT04167228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65277649|NCT04167228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65277650|NCT04167228|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65278069|NCT04876937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65278070|NCT04876937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65278071|NCT04876937|Adrenergic Agents|adrenergic agents|mesh-ancestor
65214954|NCT01029782|Renal Agents|renal agents|mesh-ancestor
65278072|NCT04876937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65278073|NCT04876937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278074|NCT05660993|Nivolumab|nivolumab|mesh-list
65278075|NCT05660993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65278076|NCT05660993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65278077|NCT05660993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65278078|NCT05660993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278079|NCT00633659|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65278080|NCT00633659|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65278081|NCT00633659|Plasma Substitutes|plasma substitutes|mesh-ancestor
65278082|NCT00633659|Blood Substitutes|blood substitutes|mesh-ancestor
65278083|NCT04241705|Lumefantrine|lumefantrine|mesh-list
65278084|NCT04241705|Artemether|artemether|mesh-list
65278085|NCT04241705|Primaquine|primaquine|mesh-list
65278086|NCT04241705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65278087|NCT04241705|Antimalarials|antimalarials|mesh-ancestor
65278088|NCT04241705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65278089|NCT04241705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65278090|NCT04241705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65278091|NCT04243109|Dexamethasone|dexamethasone|mesh-list
65278092|NCT04243109|Cyclophosphamide|cyclophosphamide|mesh-list
65278093|NCT04243109|Pomalidomide|pomalidomide|mesh-list
65278094|NCT04243109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65278095|NCT04243109|Immunologic Factors|immunologic factors|mesh-ancestor
65278096|NCT04243109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278097|NCT04243109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65278098|NCT04243109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65278099|NCT04243109|Alkylating Agents|alkylating agents|mesh-ancestor
65278100|NCT04243109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278101|NCT04243109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65278102|NCT04243109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65278103|NCT04243109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65278104|NCT04243109|Antiemetics|antiemetics|mesh-ancestor
65278105|NCT04243109|Autonomic Agents|autonomic agents|mesh-ancestor
65278106|NCT04243109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65278107|NCT04243109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65278108|NCT04243109|Glucocorticoids|glucocorticoids|mesh-ancestor
65278109|NCT04243109|Hormones|hormones|mesh-ancestor
65278110|NCT04243109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65278111|NCT04243109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65278112|NCT04243109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65278113|NCT04243109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65278114|NCT04243109|Growth Substances|growth substances|mesh-ancestor
65278115|NCT04243109|Growth Inhibitors|growth inhibitors|mesh-ancestor
65278116|NCT04165902|Hyaluronic Acid|hyaluronic acid|mesh-list
65278117|NCT04165902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65278118|NCT04165902|Immunologic Factors|immunologic factors|mesh-ancestor
65278237|NCT02642874|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65278238|NCT02642874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65278239|NCT02642874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65278240|NCT00653874|Bilirubin|bilirubin|mesh-list
65278241|NCT00653874|Antioxidants|antioxidants|mesh-ancestor
65278242|NCT00653874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278243|NCT00653874|Protective Agents|protective agents|mesh-ancestor
65278244|NCT00653874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278245|NCT04224701|Vaccines|vaccines|mesh-list
65278246|NCT04224701|Immunologic Factors|immunologic factors|mesh-ancestor
65278247|NCT04224701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278248|NCT00653952|Paclitaxel|paclitaxel|mesh-list
65278249|NCT00653952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65278250|NCT00653952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65278251|NCT00653952|Tubulin Modulators|tubulin modulators|mesh-ancestor
65278252|NCT00653952|Antimitotic Agents|antimitotic agents|mesh-ancestor
65278312|NCT04907279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278313|NCT04907279|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65278314|NCT04907279|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65278315|NCT04907279|Serotonin Agents|serotonin agents|mesh-ancestor
65278316|NCT04907279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65278317|NCT04907279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65278318|NCT04907279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65278319|NCT04907279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65278320|NCT02642718|Ketorolac|ketorolac|mesh-list
65278595|NCT04763135|Citalopram|citalopram|mesh-list
65278596|NCT04763135|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65215031|NCT00221988|Levetiracetam|levetiracetam|mesh-list
65278597|NCT04763135|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65278598|NCT04763135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65278599|NCT04763135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278600|NCT04763135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65278601|NCT04763135|Serotonin Agents|serotonin agents|mesh-ancestor
65278602|NCT04763135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278603|NCT04763135|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65278604|NCT04763135|Antidepressive Agents|antidepressive agents|mesh-ancestor
65278605|NCT04763135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65278606|NCT04763135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65278607|NCT04763135|Histamine Antagonists|histamine antagonists|mesh-ancestor
65278608|NCT04763135|Histamine Agents|histamine agents|mesh-ancestor
65278609|NCT04763135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65278610|NCT04763135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65278611|NCT04763135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65278612|NCT04763135|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65278613|NCT04763135|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65278614|NCT04763135|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65278615|NCT04763135|Adrenergic Agents|adrenergic agents|mesh-ancestor
65278616|NCT04763135|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65279047|NCT00639938|Immunologic Factors|immunologic factors|mesh-ancestor
65279048|NCT00639938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279049|NCT00639938|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65279050|NCT00639938|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65279051|NCT00639938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279052|NCT00639938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279053|NCT00639938|Antiviral Agents|antiviral agents|mesh-ancestor
64470749|NCT05048797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279171|NCT02683070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65279172|NCT02683070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279173|NCT02683070|Sensory System Agents|sensory system agents|mesh-ancestor
65279174|NCT02683070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65279175|NCT02683070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65279176|NCT02683070|Narcotics|narcotics|mesh-ancestor
65279177|NCT02683070|Analgesics|analgesics|mesh-ancestor
65279178|NCT02685176|Charcoal|charcoal|mesh-list
65279179|NCT02685176|Antidotes|antidotes|mesh-ancestor
65279180|NCT02685176|Protective Agents|protective agents|mesh-ancestor
65279181|NCT02685176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279182|NCT05664074|Ketorolac|ketorolac|mesh-list
65279183|NCT05664074|Indomethacin|indomethacin|mesh-list
65279184|NCT05664074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65279185|NCT05664074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65279186|NCT05664074|Analgesics|analgesics|mesh-ancestor
65279187|NCT05664074|Sensory System Agents|sensory system agents|mesh-ancestor
65279188|NCT05664074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65279189|NCT05664074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279190|NCT05664074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65279191|NCT05664074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65279192|NCT05664074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65279193|NCT05664074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279339|NCT00683319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731770|NCT00003625|Cyclosporine|cyclosporine|mesh-list
64731771|NCT00003625|Etoposide|etoposide|mesh-list
64320145|NCT02183701|Natriuretic Agents|natriuretic agents|mesh-ancestor
64320146|NCT02183701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320147|NCT02183701|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64320148|NCT02183701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64320149|NCT02183779|Fluconazole|fluconazole|mesh-list
64320150|NCT02183779|Antifungal Agents|antifungal agents|mesh-ancestor
64383019|NCT02414165|Antimetabolites|antimetabolites|mesh-ancestor
64383020|NCT02094898|Ketamine|ketamine|mesh-list
64383021|NCT02094898|Analgesics|analgesics|mesh-ancestor
64383022|NCT02094898|Sensory System Agents|sensory system agents|mesh-ancestor
64383023|NCT02094898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64383024|NCT02094898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383025|NCT02094898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64383026|NCT02094898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64383027|NCT02094898|Anesthetics, General|anesthetics, general|mesh-ancestor
64383028|NCT02094898|Anesthetics|anesthetics|mesh-ancestor
64383029|NCT02094898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64383049|NCT02414009|Fluorouracil|fluorouracil|mesh-list
64383054|NCT02414009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383055|NCT02414009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64383056|NCT02414009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383057|NCT02414009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64383058|NCT02414009|Immunologic Factors|immunologic factors|mesh-ancestor
64383059|NCT02414009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383060|NCT02414009|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64383061|NCT02414009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64383062|NCT02414009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383063|NCT02414009|Antidotes|antidotes|mesh-ancestor
64383064|NCT02414009|Protective Agents|protective agents|mesh-ancestor
64383065|NCT02414009|Vitamin B Complex|vitamin b complex|mesh-ancestor
64383066|NCT02414009|Vitamins|vitamins|mesh-ancestor
64383067|NCT02414009|Micronutrients|micronutrients|mesh-ancestor
64383068|NCT02414009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64383069|NCT02414009|Alkylating Agents|alkylating agents|mesh-ancestor
64383070|NCT02413853|Leucovorin|leucovorin|mesh-list
64383071|NCT02413853|Bevacizumab|bevacizumab|mesh-list
64383072|NCT02413853|Fluorouracil|fluorouracil|mesh-list
64383073|NCT02413853|Oxaliplatin|oxaliplatin|mesh-list
64383135|NCT02412917|Valacyclovir|valacyclovir|mesh-list
64383136|NCT02412917|Antiviral Agents|antiviral agents|mesh-ancestor
64383137|NCT02412917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64383138|NCT02412683|Oxaliplatin|oxaliplatin|mesh-list
64383139|NCT02412683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279400|NCT00683943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64731772|NCT00003625|Vincristine|vincristine|mesh-list
65279450|NCT02810015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279451|NCT02810015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65279452|NCT02810015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65279453|NCT02809781|Etanercept|etanercept|mesh-list
65279454|NCT02809781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65279455|NCT02809781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65279456|NCT02809781|Analgesics|analgesics|mesh-ancestor
65279457|NCT02809781|Sensory System Agents|sensory system agents|mesh-ancestor
65279458|NCT02809781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65279459|NCT02809781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279460|NCT02809781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65279461|NCT02809781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65279462|NCT02809781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65279463|NCT02809781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65279464|NCT02809781|Immunologic Factors|immunologic factors|mesh-ancestor
65279465|NCT02809937|Dexmedetomidine|dexmedetomidine|mesh-list
65279466|NCT02809937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65279467|NCT02809937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65279468|NCT02809937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279469|NCT02809937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65279470|NCT02809937|Analgesics|analgesics|mesh-ancestor
65279471|NCT02809937|Sensory System Agents|sensory system agents|mesh-ancestor
65279472|NCT02809937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65279473|NCT02809937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65279474|NCT02809937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65279475|NCT02809937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65279476|NCT02809937|Adrenergic Agents|adrenergic agents|mesh-ancestor
65279541|NCT02812199|Respiratory System Agents|respiratory system agents|mesh-ancestor
65279542|NCT02812199|Mydriatics|mydriatics|mesh-ancestor
65279543|NCT02812199|Sympathomimetics|sympathomimetics|mesh-ancestor
65279544|NCT02812199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65279546|NCT02812043|Antifungal Agents|antifungal agents|mesh-ancestor
65279547|NCT02812043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65279548|NCT02808767|Ticagrelor|ticagrelor|mesh-list
65279549|NCT02808767|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65279550|NCT02808767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65279551|NCT02808767|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65279552|NCT02808767|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65279553|NCT02808767|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65279554|NCT02808767|Purinergic Agents|purinergic agents|mesh-ancestor
65279555|NCT02808767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65279556|NCT02808767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279557|NCT02808767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279558|NCT02812355|Heparin|heparin|mesh-list
65279559|NCT02812355|Anticoagulants|anticoagulants|mesh-ancestor
65279560|NCT02812355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65279561|NCT02812355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65279562|NCT02812355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279563|NCT02811731|Amlodipine|amlodipine|mesh-list
65279564|NCT02811731|Candesartan|candesartan|mesh-list
65269804|NCT02733380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65279565|NCT02811731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65029550|NCT02579473|Dopamine Agents|dopamine agents|mesh-ancestor
65029554|NCT02578732|Leucovorin|leucovorin|mesh-list
65279566|NCT02811731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65279567|NCT02811731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65279568|NCT02811731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279569|NCT02811731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65279570|NCT02811731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279571|NCT02811731|Vasodilator Agents|vasodilator agents|mesh-ancestor
65279572|NCT02811731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65280717|NCT02635230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65280718|NCT02635230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65280719|NCT02635230|Analgesics|analgesics|mesh-ancestor
65280720|NCT02635230|Sensory System Agents|sensory system agents|mesh-ancestor
65280721|NCT02635230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280722|NCT02635230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280723|NCT02635230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65280724|NCT02635230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65280725|NCT02635230|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65280726|NCT02635230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65280727|NCT02635230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280728|NCT02635230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65280729|NCT02635230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65280730|NCT02635230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280731|NCT02635230|Antipyretics|antipyretics|mesh-ancestor
65280732|NCT00964015|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65280733|NCT00964015|Plasma Substitutes|plasma substitutes|mesh-ancestor
65280734|NCT00964015|Blood Substitutes|blood substitutes|mesh-ancestor
65280735|NCT02673632|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65280736|NCT02673632|Luteolytic Agents|luteolytic agents|mesh-ancestor
65280737|NCT02673632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65280738|NCT02673632|Contraceptive Agents|contraceptive agents|mesh-ancestor
65280739|NCT02673632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65280740|NCT02673632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280741|NCT02673632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65280742|NCT02673632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65280743|NCT02673632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030756|NCT00177060|Hydromorphone|hydromorphone|mesh-list
65280744|NCT04009525|Cyclosporine|cyclosporine|mesh-list
65280745|NCT04009525|Mycophenolic Acid|mycophenolic acid|mesh-list
65280746|NCT04009525|Cyclophosphamide|cyclophosphamide|mesh-list
65280747|NCT04009525|Busulfan|busulfan|mesh-list
65280748|NCT04009525|Methotrexate|methotrexate|mesh-list
65280749|NCT04009525|Fludarabine|fludarabine|mesh-list
65280750|NCT04009525|Tacrolimus|tacrolimus|mesh-list
65280751|NCT04009525|Cyclosporins|cyclosporins|mesh-list
65280752|NCT04009525|Thymoglobulin|thymoglobulin|mesh-list
65280753|NCT04009525|Basiliximab|basiliximab|mesh-list
65280754|NCT04009525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65280755|NCT04009525|Immunologic Factors|immunologic factors|mesh-ancestor
65280756|NCT04009525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280757|NCT04009525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65280758|NCT04009525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65280759|NCT04009525|Alkylating Agents|alkylating agents|mesh-ancestor
65280760|NCT04009525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280761|NCT04009525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280762|NCT04009525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65280763|NCT04009525|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65280764|NCT04009525|Abortifacient Agents|abortifacient agents|mesh-ancestor
65280765|NCT04009525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65280766|NCT04009525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65280767|NCT04009525|Antimetabolites|antimetabolites|mesh-ancestor
65280768|NCT04009525|Dermatologic Agents|dermatologic agents|mesh-ancestor
65280769|NCT04009525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280770|NCT04009525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65280771|NCT04009525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65280772|NCT04009525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65280773|NCT04009525|Antifungal Agents|antifungal agents|mesh-ancestor
65280774|NCT04009525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65280775|NCT04009525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65280776|NCT04009525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65280777|NCT04009525|Antitubercular Agents|antitubercular agents|mesh-ancestor
65280778|NCT04009525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65280779|NCT04032366|Nitric Oxide|nitric oxide|mesh-list
65280780|NCT04032366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65280781|NCT04032366|Autonomic Agents|autonomic agents|mesh-ancestor
65280782|NCT04032366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280783|NCT04032366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280784|NCT04032366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65280785|NCT04032366|Respiratory System Agents|respiratory system agents|mesh-ancestor
65280859|NCT00546637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280861|NCT00690885|Interferons|interferons|mesh-list
65280862|NCT00690885|Interferon-alpha|interferon-alpha|mesh-list
65280863|NCT00690885|Interferon alpha-2|interferon alpha-2|mesh-list
65280864|NCT00690885|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65280865|NCT00690885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280866|NCT00690885|Antiviral Agents|antiviral agents|mesh-ancestor
65280867|NCT00690885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65280868|NCT00690885|Immunologic Factors|immunologic factors|mesh-ancestor
65280869|NCT00690885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280870|NCT04138719|Paclitaxel|paclitaxel|mesh-list
65280871|NCT04138719|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65280872|NCT04138719|Carboplatin|carboplatin|mesh-list
65280873|NCT04138719|Epirubicin|epirubicin|mesh-list
65280874|NCT04138719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65280875|NCT04138719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280876|NCT04138719|Tubulin Modulators|tubulin modulators|mesh-ancestor
65280877|NCT04138719|Antimitotic Agents|antimitotic agents|mesh-ancestor
65280878|NCT04138719|Mitosis Modulators|mitosis modulators|mesh-ancestor
65280879|NCT04138719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280880|NCT04138719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65280881|NCT04138719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65280882|NCT04138719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65280883|NCT04138719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280884|NCT02790203|Celecoxib|celecoxib|mesh-list
65280885|NCT02790203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65280886|NCT02790203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65280887|NCT02790203|Analgesics|analgesics|mesh-ancestor
65280888|NCT02790203|Sensory System Agents|sensory system agents|mesh-ancestor
65280889|NCT02790203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280890|NCT02790203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280891|NCT02790203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65280892|NCT02790203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65280893|NCT02790203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65280894|NCT02790203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65280895|NCT02790203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280896|NCT02790203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280897|NCT02816567|Sufentanil|sufentanil|mesh-list
65280898|NCT02816567|Propofol|propofol|mesh-list
65280899|NCT02816567|Cisatracurium|cisatracurium|mesh-list
65280900|NCT02816567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65280901|NCT02816567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65280902|NCT02816567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280903|NCT02816567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65280904|NCT02816567|Anesthetics, General|anesthetics, general|mesh-ancestor
65280905|NCT02816567|Anesthetics|anesthetics|mesh-ancestor
65280906|NCT02816567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65280907|NCT02816567|Narcotics|narcotics|mesh-ancestor
65280908|NCT02816567|Analgesics|analgesics|mesh-ancestor
65280909|NCT02816567|Sensory System Agents|sensory system agents|mesh-ancestor
65280910|NCT02816567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280911|NCT02816567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65280912|NCT02816567|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65280913|NCT02816567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65280914|NCT00657774|Prednisone|prednisone|mesh-list
65280915|NCT00657774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65280916|NCT00657774|Glucocorticoids|glucocorticoids|mesh-ancestor
65280917|NCT00657774|Hormones|hormones|mesh-ancestor
65280918|NCT00657774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65280919|NCT00657774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280920|NCT00657774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65280921|NCT00657774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280922|NCT04138485|Immunoglobulins|immunoglobulins|mesh-list
65280923|NCT04138485|Immunologic Factors|immunologic factors|mesh-ancestor
65280924|NCT04138485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280925|NCT02789969|Fentanyl|fentanyl|mesh-list
65280926|NCT02789969|Hydromorphone|hydromorphone|mesh-list
65280927|NCT02789969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65280928|NCT02789969|Narcotics|narcotics|mesh-ancestor
65281432|NCT00960349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215328|NCT04197219|Axitinib|axitinib|mesh-list
65281433|NCT00960349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65281435|NCT05375903|Imiquimod|imiquimod|mesh-list
65281436|NCT05375903|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65281437|NCT05375903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65281438|NCT05375903|Immunologic Factors|immunologic factors|mesh-ancestor
65281448|NCT02670434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281449|NCT02670434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65281450|NCT00965653|Folic Acid|folic acid|mesh-list
65281451|NCT00965653|Methotrexate|methotrexate|mesh-list
65281452|NCT00965653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65281453|NCT00965653|Abortifacient Agents|abortifacient agents|mesh-ancestor
65281454|NCT00965653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65281455|NCT00965653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281456|NCT00965653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65281457|NCT00965653|Antimetabolites|antimetabolites|mesh-ancestor
65281458|NCT00965653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281459|NCT00965653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281460|NCT00965653|Dermatologic Agents|dermatologic agents|mesh-ancestor
65281461|NCT00965653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281462|NCT00965653|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65281463|NCT00965653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65281464|NCT00965653|Immunologic Factors|immunologic factors|mesh-ancestor
65281465|NCT00965653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65281466|NCT00965653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65281467|NCT00965653|Hematinics|hematinics|mesh-ancestor
65281468|NCT00965653|Vitamin B Complex|vitamin b complex|mesh-ancestor
65281469|NCT00965653|Vitamins|vitamins|mesh-ancestor
65281470|NCT00965653|Micronutrients|micronutrients|mesh-ancestor
65281471|NCT00644696|Cefixime|cefixime|mesh-list
65281472|NCT00644696|Cefpodoxime|cefpodoxime|mesh-list
65281473|NCT00644696|Irinotecan|irinotecan|mesh-list
65281474|NCT00644696|Bortezomib|bortezomib|mesh-list
65281475|NCT00644696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65281476|NCT00644696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65281477|NCT00644696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281478|NCT00644696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281479|NCT00644696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281480|NCT00644696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65281481|NCT00644696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65281482|NCT00960739|Topotecan|topotecan|mesh-list
65281483|NCT00960739|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65281484|NCT00960739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65281485|NCT00960739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65281486|NCT00960739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281487|NCT00960739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281488|NCT00960739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281489|NCT00960739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65281490|NCT00659022|Bevacizumab|bevacizumab|mesh-list
65281491|NCT00659022|Capecitabine|capecitabine|mesh-list
65281492|NCT00659022|Oxaliplatin|oxaliplatin|mesh-list
65281493|NCT00659022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65281494|NCT00659022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281495|NCT00659022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65281496|NCT00659022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65281497|NCT00659022|Growth Substances|growth substances|mesh-ancestor
65281498|NCT00659022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281499|NCT00659022|Growth Inhibitors|growth inhibitors|mesh-ancestor
65281500|NCT00659022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65281501|NCT00659022|Antimetabolites|antimetabolites|mesh-ancestor
65281502|NCT00659022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281503|NCT02788643|Dimercaprol|dimercaprol|mesh-list
65281504|NCT02788643|Chelating Agents|chelating agents|mesh-ancestor
65281641|NCT00645086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65281642|NCT00645086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65281643|NCT00645086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65281644|NCT00645086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281645|NCT00645086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281646|NCT00645086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65281647|NCT00645086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65281648|NCT05238649|Vaccines|vaccines|mesh-list
65281649|NCT05238649|Immunologic Factors|immunologic factors|mesh-ancestor
65281650|NCT05238649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281651|NCT02792153|Estradiol|estradiol|mesh-list
65281652|NCT02792153|Estrogens|estrogens|mesh-ancestor
65281653|NCT02792153|Hormones|hormones|mesh-ancestor
65269805|NCT02733380|Growth Substances|growth substances|mesh-ancestor
65215412|NCT02601235|Histamine Agents|histamine agents|mesh-ancestor
65281654|NCT02792153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65281655|NCT02792153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281656|NCT00644540|Vaccines|vaccines|mesh-list
65281657|NCT00644540|Immunologic Factors|immunologic factors|mesh-ancestor
65281658|NCT00644540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281659|NCT02669732|Firuglipel|firuglipel|mesh-list
65281660|NCT02669732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65281661|NCT02669732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281662|NCT05003245|Ranibizumab|ranibizumab|mesh-list
65281663|NCT05003245|Antibodies|antibodies|mesh-list
65281664|NCT05003245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65281665|NCT05003245|Mitogens|mitogens|mesh-list
65281666|NCT05003245|Endothelial Growth Factors|endothelial growth factors|mesh-list
65281667|NCT05003245|Immunologic Factors|immunologic factors|mesh-ancestor
65281668|NCT05003245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281669|NCT05003245|Mitosis Modulators|mitosis modulators|mesh-ancestor
65281670|NCT05003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281671|NCT05003245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65281672|NCT05003245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65281673|NCT05003245|Growth Substances|growth substances|mesh-ancestor
65281674|NCT05003245|Growth Inhibitors|growth inhibitors|mesh-ancestor
65281675|NCT05003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281676|NCT05367089|Fluconazole|fluconazole|mesh-list
65281677|NCT05367089|Antifungal Agents|antifungal agents|mesh-ancestor
65281678|NCT05367089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65281679|NCT05367089|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65281680|NCT05367089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65281681|NCT05367089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281682|NCT05367089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281683|NCT05367089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65281684|NCT05367089|Hormone Antagonists|hormone antagonists|mesh-ancestor
65281685|NCT05367089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65281686|NCT05367089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281687|NCT05367089|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65281688|NCT05367089|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65281689|NCT02671058|Hydrocortisone|hydrocortisone|mesh-list
65281690|NCT02671058|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65281691|NCT02671058|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65281692|NCT02671058|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65281693|NCT02671058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65281694|NCT02791919|Cytarabine|cytarabine|mesh-list
65281695|NCT02791919|Fludarabine|fludarabine|mesh-list
65281696|NCT02791919|Fludarabine phosphate|fludarabine phosphate|mesh-list
65281697|NCT02791919|Lenograstim|lenograstim|mesh-list
65281698|NCT02791919|Adavosertib|adavosertib|mesh-list
65281699|NCT02791919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281700|NCT02791919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65281701|NCT02791919|Antimetabolites|antimetabolites|mesh-ancestor
65281702|NCT02791919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281836|NCT00910442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65281924|NCT03938857|Sensory System Agents|sensory system agents|mesh-ancestor
65281925|NCT03938857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281926|NCT03938857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65281927|NCT03938857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65281928|NCT03938857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65281929|NCT03938857|Adrenergic Agents|adrenergic agents|mesh-ancestor
65281930|NCT03938857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65281931|NCT03938857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734234|NCT02119026|Bevacizumab|bevacizumab|mesh-list
65281991|NCT02668172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65281992|NCT02668172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281994|NCT00660270|Interferons|interferons|mesh-list
65281995|NCT00660270|Interferon-alpha|interferon-alpha|mesh-list
65281996|NCT00660270|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65281997|NCT00660270|Fluorouracil|fluorouracil|mesh-list
65281998|NCT00660270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281999|NCT00660270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65282000|NCT00660270|Antimetabolites|antimetabolites|mesh-ancestor
65282001|NCT00660270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282002|NCT00660270|Antiviral Agents|antiviral agents|mesh-ancestor
65282003|NCT00660270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65282004|NCT00660270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282005|NCT00660270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65282006|NCT00660270|Immunologic Factors|immunologic factors|mesh-ancestor
65282007|NCT00660270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282008|NCT04032132|Curcumin|curcumin|mesh-list
65282009|NCT04032132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65282010|NCT04032132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65282011|NCT04032132|Analgesics|analgesics|mesh-ancestor
65282012|NCT04032132|Sensory System Agents|sensory system agents|mesh-ancestor
65282013|NCT04032132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65282014|NCT04032132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282015|NCT04032132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65282016|NCT04032132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65282017|NCT04032132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282018|NCT04032132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282019|NCT04032132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282020|NCT00967057|Dexamethasone|dexamethasone|mesh-list
65032028|NCT00553618|Aldesleukin|aldesleukin|mesh-list
65282022|NCT00967057|Vincristine|vincristine|mesh-list
65282023|NCT00967057|Asparaginase|asparaginase|mesh-list
65282024|NCT00967057|Mitoxantrone|mitoxantrone|mesh-list
65282025|NCT00967057|Idarubicin|idarubicin|mesh-list
65282026|NCT00967057|Pegaspargase|pegaspargase|mesh-list
65282027|NCT00967057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65282028|NCT00967057|Antiemetics|antiemetics|mesh-ancestor
65282029|NCT00967057|Autonomic Agents|autonomic agents|mesh-ancestor
65282030|NCT00967057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65282031|NCT00967057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282032|NCT00967057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65282065|NCT02633514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282066|NCT02633514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282067|NCT00656214|Lycopene|lycopene|mesh-list
65282068|NCT00656214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65282069|NCT00656214|Antioxidants|antioxidants|mesh-ancestor
65282070|NCT00656214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282071|NCT00656214|Protective Agents|protective agents|mesh-ancestor
65282072|NCT00656214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282215|NCT00660582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65282216|NCT00660582|Antidotes|antidotes|mesh-ancestor
65282217|NCT00660582|Protective Agents|protective agents|mesh-ancestor
65282218|NCT00660582|Vitamin B Complex|vitamin b complex|mesh-ancestor
65282219|NCT00660582|Vitamins|vitamins|mesh-ancestor
65282220|NCT00660582|Micronutrients|micronutrients|mesh-ancestor
65282221|NCT00660582|Hematinics|hematinics|mesh-ancestor
65282222|NCT00646802|Progesterone|progesterone|mesh-list
65282223|NCT00646802|Progestins|progestins|mesh-ancestor
65282224|NCT00646802|Hormones|hormones|mesh-ancestor
65282225|NCT00646802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65282226|NCT00646802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282227|NCT00968383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65282228|NCT00968383|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65282229|NCT00968383|Adrenergic Agents|adrenergic agents|mesh-list
65282230|NCT00968383|Adrenergic Antagonists|adrenergic antagonists|mesh-list
65282231|NCT00968383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65282232|NCT00968383|Protease Inhibitors|protease inhibitors|mesh-ancestor
65282233|NCT00968383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282234|NCT00968383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282235|NCT00968383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65282236|NCT00968383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282237|NCT03568097|Avelumab|avelumab|mesh-list
65282238|NCT03568097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65282239|NCT03568097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282240|NCT00657228|Heparin|heparin|mesh-list
65282241|NCT00657228|Anticoagulants|anticoagulants|mesh-ancestor
65282242|NCT00657228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65282243|NCT00657228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65282244|NCT00657228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282245|NCT02666534|Lidocaine|lidocaine|mesh-list
65282246|NCT02666534|Prilocaine|prilocaine|mesh-list
65282247|NCT02666534|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65282248|NCT02666534|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65282249|NCT02666534|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65282718|NCT00647660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65282720|NCT00647660|Natriuretic Agents|natriuretic agents|mesh-ancestor
65282721|NCT00647660|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65282722|NCT00647660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65282723|NCT00634595|Paclitaxel|paclitaxel|mesh-list
65282724|NCT00634595|Cisplatin|cisplatin|mesh-list
65282725|NCT00634595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65282726|NCT00634595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282727|NCT00634595|Tubulin Modulators|tubulin modulators|mesh-ancestor
65282728|NCT00634595|Antimitotic Agents|antimitotic agents|mesh-ancestor
65282729|NCT00634595|Mitosis Modulators|mitosis modulators|mesh-ancestor
65282730|NCT00634595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282731|NCT00647738|Baclofen|baclofen|mesh-list
65282732|NCT00647738|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65282733|NCT00647738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282734|NCT00647738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65282735|NCT00647738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65282736|NCT00647738|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65282737|NCT00647738|GABA Agonists|gaba agonists|mesh-ancestor
65282738|NCT00647738|GABA Agents|gaba agents|mesh-ancestor
65282739|NCT00647738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65282740|NCT00647738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282741|NCT04008511|Capecitabine|capecitabine|mesh-list
65282742|NCT04008511|Oxaliplatin|oxaliplatin|mesh-list
65282743|NCT04008511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65282744|NCT04008511|Antimetabolites|antimetabolites|mesh-ancestor
65282745|NCT04008511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282746|NCT04008511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282747|NCT00979537|Nisoldipine|nisoldipine|mesh-list
65282748|NCT00979537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65282749|NCT00979537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65282750|NCT00979537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65282751|NCT00979537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282752|NCT00979537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65282753|NCT00979537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282754|NCT00979537|Vasodilator Agents|vasodilator agents|mesh-ancestor
65282755|NCT00692055|Naproxen|naproxen|mesh-list
65282756|NCT00692055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65282757|NCT00692055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65282758|NCT00692055|Analgesics|analgesics|mesh-ancestor
65282759|NCT00692055|Sensory System Agents|sensory system agents|mesh-ancestor
65282760|NCT00692055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65282761|NCT00692055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282762|NCT00692055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65282763|NCT00692055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65282764|NCT00692055|Gout Suppressants|gout suppressants|mesh-ancestor
65282765|NCT00692055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65282766|NCT00692055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282767|NCT00692055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282768|NCT04033250|Bisacodyl|bisacodyl|mesh-list
65282769|NCT04033250|Picosulfate sodium|picosulfate sodium|mesh-list
65282770|NCT04033250|Magnesium Oxide|magnesium oxide|mesh-list
65282771|NCT04033250|Sodium Citrate|sodium citrate|mesh-list
65282772|NCT04033250|Citric Acid|citric acid|mesh-list
65282773|NCT04033250|Cathartics|cathartics|mesh-ancestor
65282774|NCT04033250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65282775|NCT04033250|Laxatives|laxatives|mesh-ancestor
65282776|NCT04033250|Anticoagulants|anticoagulants|mesh-ancestor
65282777|NCT04033250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65282904|NCT02785055|Anesthetics|anesthetics|mesh-ancestor
65282905|NCT02785055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65282906|NCT02785055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282907|NCT02785055|Sensory System Agents|sensory system agents|mesh-ancestor
65282908|NCT02785055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65282909|NCT02785055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65282910|NCT02785055|Narcotics|narcotics|mesh-ancestor
65282911|NCT02785055|Analgesics|analgesics|mesh-ancestor
65282912|NCT02624661|Glycerol|glycerol|mesh-list
65282913|NCT02624661|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65282914|NCT02624661|Protective Agents|protective agents|mesh-ancestor
65282915|NCT02624661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282916|NCT00648050|Verapamil|verapamil|mesh-list
65282917|NCT00648050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65282918|NCT00648050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65282919|NCT00648050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65282920|NCT00648050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282921|NCT00648050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65282922|NCT00648050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282923|NCT00648050|Vasodilator Agents|vasodilator agents|mesh-ancestor
65282924|NCT00692757|Povidone-Iodine|povidone-iodine|mesh-list
65282925|NCT00692757|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65282926|NCT00692757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65282927|NCT02624505|Albuterol|albuterol|mesh-list
65282928|NCT02624505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65282929|NCT02624505|Autonomic Agents|autonomic agents|mesh-ancestor
65282930|NCT02624505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65282931|NCT02624505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282932|NCT02624505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65282933|NCT02624505|Respiratory System Agents|respiratory system agents|mesh-ancestor
65282934|NCT02624505|Tocolytic Agents|tocolytic agents|mesh-ancestor
65283014|NCT04230083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283015|NCT04230083|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65283016|NCT04230083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65283017|NCT04230083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65283018|NCT04230083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65283019|NCT04230083|Hormone Antagonists|hormone antagonists|mesh-ancestor
65283020|NCT04230083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65283021|NCT04230083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65283022|NCT04230083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283023|NCT04230083|Androgens|androgens|mesh-ancestor
65283024|NCT04230083|Hormones|hormones|mesh-ancestor
65283059|NCT05221151|Autonomic Agents|autonomic agents|mesh-ancestor
65283060|NCT05221151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65283061|NCT05221151|Antipruritics|antipruritics|mesh-ancestor
65283062|NCT05221151|Dermatologic Agents|dermatologic agents|mesh-ancestor
65283063|NCT05221151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65283064|NCT05221151|Serotonin Agents|serotonin agents|mesh-ancestor
65283065|NCT05221151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65283066|NCT05221151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65283067|NCT04008043|Acetaminophen|acetaminophen|mesh-list
65283139|NCT00693615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283140|NCT02663960|Citric Acid|citric acid|mesh-list
65283141|NCT02663960|Sodium Citrate|sodium citrate|mesh-list
65283142|NCT02663960|Anticoagulants|anticoagulants|mesh-ancestor
65283143|NCT02663960|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65283144|NCT02663960|Chelating Agents|chelating agents|mesh-ancestor
65283145|NCT02663960|Sequestering Agents|sequestering agents|mesh-ancestor
65283146|NCT02663960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283147|NCT00693771|Insulin Glargine|insulin glargine|mesh-list
65283148|NCT00693771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65283335|NCT00980239|Irinotecan|irinotecan|mesh-list
65283336|NCT00980239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65283337|NCT00980239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283338|NCT00980239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65283339|NCT00980239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65283340|NCT00980239|Growth Substances|growth substances|mesh-ancestor
65283341|NCT00980239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283342|NCT00980239|Growth Inhibitors|growth inhibitors|mesh-ancestor
65283343|NCT00980239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65283344|NCT00980239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65283345|NCT00980239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283346|NCT00980239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283347|NCT02665832|Amlodipine|amlodipine|mesh-list
65283348|NCT02665832|Olmesartan|olmesartan|mesh-list
65283349|NCT02665832|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65283350|NCT02665832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65283351|NCT02665832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65283394|NCT05341817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283395|NCT05341817|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65283396|NCT05341817|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65283397|NCT05341817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283398|NCT05341817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283399|NCT05341817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65283400|NCT05341817|Hormone Antagonists|hormone antagonists|mesh-ancestor
65283401|NCT05341817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64735693|NCT01980888|Alkylating Agents|alkylating agents|mesh-ancestor
65283427|NCT00980473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283428|NCT00980473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283429|NCT00980473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65283430|NCT00980473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65283431|NCT02784743|Ivermectin|ivermectin|mesh-list
65283432|NCT02784743|Albendazole|albendazole|mesh-list
65283433|NCT02784743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65283434|NCT02784743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65269806|NCT02733380|Growth Inhibitors|growth inhibitors|mesh-ancestor
65283435|NCT02784743|Anthelmintics|anthelmintics|mesh-ancestor
65283436|NCT02784743|Anticestodal Agents|anticestodal agents|mesh-ancestor
65283437|NCT02784743|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65283438|NCT02784743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65283439|NCT02784743|Tubulin Modulators|tubulin modulators|mesh-ancestor
65283440|NCT02784743|Antimitotic Agents|antimitotic agents|mesh-ancestor
65283441|NCT02784743|Mitosis Modulators|mitosis modulators|mesh-ancestor
65283442|NCT02784743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283443|NCT02784743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033429|NCT00554827|Vitamins|vitamins|mesh-list
65283444|NCT05341583|Ensartinib|ensartinib|mesh-list
65283445|NCT05341583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283446|NCT05341583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65283447|NCT05341583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283448|NCT05341583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283449|NCT00980551|Carboplatin|carboplatin|mesh-list
65283482|NCT04008979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283484|NCT04008979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65283485|NCT04008979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283486|NCT04008979|Antipyretics|antipyretics|mesh-ancestor
65283487|NCT05263583|Bromides|bromides|mesh-list
65283488|NCT05263583|Anticonvulsants|anticonvulsants|mesh-ancestor
65283489|NCT00970879|Mefloquine|mefloquine|mesh-list
65283490|NCT00970879|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65283491|NCT00970879|Antimalarials|antimalarials|mesh-ancestor
65284325|NCT03335488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284326|NCT03335488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284327|NCT02623504|Carbamazepine|carbamazepine|mesh-list
65284328|NCT02623504|Anticonvulsants|anticonvulsants|mesh-ancestor
65284329|NCT02623504|Antimanic Agents|antimanic agents|mesh-ancestor
65284330|NCT02623504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65284331|NCT02623504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65284332|NCT02623504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284333|NCT02623504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65284334|NCT02623504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65284335|NCT02623504|Analgesics|analgesics|mesh-ancestor
65284336|NCT02623504|Sensory System Agents|sensory system agents|mesh-ancestor
65284337|NCT02623504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65284338|NCT02623504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65284339|NCT02623504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65284340|NCT02623504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284341|NCT02623504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65284342|NCT02623504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65284343|NCT02777723|Hyaluronic Acid|hyaluronic acid|mesh-list
65284344|NCT02777723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65284345|NCT02777723|Immunologic Factors|immunologic factors|mesh-ancestor
65284917|NCT00582166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65284919|NCT00582166|Immunologic Factors|immunologic factors|mesh-ancestor
65284920|NCT00582166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284921|NCT00582166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65284922|NCT02775539|Mirabegron|mirabegron|mesh-list
65284923|NCT02775539|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65284924|NCT02775539|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65284925|NCT02775539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64515156|NCT04607122|Landiolol|landiolol|mesh-list
64516145|NCT03289338|Prednisolone|prednisolone|mesh-list
65286434|NCT00664170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286435|NCT00664170|Tubulin Modulators|tubulin modulators|mesh-ancestor
65286436|NCT00664170|Antimitotic Agents|antimitotic agents|mesh-ancestor
65286437|NCT00664170|Mitosis Modulators|mitosis modulators|mesh-ancestor
65286438|NCT00664170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286440|NCT02758067|Brexpiprazole|brexpiprazole|mesh-list
65286441|NCT02758067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65286442|NCT02758067|Serotonin Agents|serotonin agents|mesh-ancestor
65036428|NCT00575419|Antiviral Agents|antiviral agents|mesh-ancestor
65286443|NCT02758067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65286444|NCT02758067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286445|NCT02758067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286446|NCT02758067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65286447|NCT02758067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65286448|NCT02758067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65286449|NCT02758067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65286450|NCT02758067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65286452|NCT02758067|Dopamine Agonists|dopamine agonists|mesh-ancestor
65215785|NCT02780505|Ascorbic Acid|ascorbic acid|mesh-list
65286453|NCT00664248|Clindamycin|clindamycin|mesh-list
65286454|NCT00664248|Clindamycin palmitate|clindamycin palmitate|mesh-list
65286455|NCT00664248|Clindamycin phosphate|clindamycin phosphate|mesh-list
65286456|NCT00664248|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65286457|NCT00664248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65286458|NCT00664248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65286459|NCT00664248|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65286460|NCT00664248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286461|NCT00664248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286462|NCT00664248|Dermatologic Agents|dermatologic agents|mesh-ancestor
65286463|NCT00579670|Ziprasidone|ziprasidone|mesh-list
65286464|NCT00579670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65286465|NCT00579670|Serotonin Agents|serotonin agents|mesh-ancestor
65286466|NCT00579670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65286467|NCT00579670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286468|NCT00579670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286469|NCT00579670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65286470|NCT00579670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65286471|NCT00579670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65286472|NCT00579670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65286473|NCT00579670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65286474|NCT00579670|Dopamine Agents|dopamine agents|mesh-ancestor
65286475|NCT00669786|Menotropins|menotropins|mesh-list
65286476|NCT00669786|Hormones|hormones|mesh-list
65286477|NCT00669786|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65286478|NCT00669786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65286479|NCT00669786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286480|NCT00669786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65286481|NCT00669786|Fertility Agents|fertility agents|mesh-ancestor
65286482|NCT00669786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65286483|NCT02760953|Epirubicin|epirubicin|mesh-list
65286484|NCT02760953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65286485|NCT02760953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286486|NCT02760953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65286487|NCT02760953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65286488|NCT02760953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286489|NCT02760953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286490|NCT02630004|Melatonin|melatonin|mesh-list
65286491|NCT02630004|Antioxidants|antioxidants|mesh-ancestor
65286492|NCT02630004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286493|NCT02630004|Protective Agents|protective agents|mesh-ancestor
65286494|NCT02630004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516714|NCT03269760|GABA Agents|gaba agents|mesh-ancestor
65287660|NCT02628522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65287661|NCT02628522|Adrenergic Agents|adrenergic agents|mesh-ancestor
65287662|NCT02628522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65287663|NCT02628522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65287664|NCT02628522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65287665|NCT02628522|Autonomic Agents|autonomic agents|mesh-ancestor
65288648|NCT05590117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288649|NCT05590117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65288650|NCT05590117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65288651|NCT05590117|Vasodilator Agents|vasodilator agents|mesh-ancestor
65288652|NCT05590117|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65288654|NCT00636311|Gemcitabine|gemcitabine|mesh-list
65288655|NCT00636311|Bortezomib|bortezomib|mesh-list
65288656|NCT00636311|Vinorelbine|vinorelbine|mesh-list
65288657|NCT00636311|Ifosfamide|ifosfamide|mesh-list
65288658|NCT00636311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65288659|NCT00636311|Antimetabolites|antimetabolites|mesh-ancestor
65288660|NCT00636311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288661|NCT00636311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288662|NCT00636311|Antiviral Agents|antiviral agents|mesh-ancestor
65288663|NCT00636311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65288664|NCT00636311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288665|NCT00636311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65288666|NCT00636311|Immunologic Factors|immunologic factors|mesh-ancestor
65288667|NCT00636311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288668|NCT00636311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65288669|NCT00636311|Tubulin Modulators|tubulin modulators|mesh-ancestor
65288670|NCT00636311|Antimitotic Agents|antimitotic agents|mesh-ancestor
65288671|NCT00636311|Mitosis Modulators|mitosis modulators|mesh-ancestor
65288672|NCT00636311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65288673|NCT00636311|Alkylating Agents|alkylating agents|mesh-ancestor
65269807|NCT02733380|Analgesics|analgesics|mesh-ancestor
65288712|NCT00673218|Respiratory System Agents|respiratory system agents|mesh-ancestor
65288713|NCT00673296|Bevacizumab|bevacizumab|mesh-list
65288714|NCT00673296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65288755|NCT00683202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288757|NCT00683202|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65288758|NCT00683202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288759|NCT00683202|Antipyretics|antipyretics|mesh-ancestor
65288760|NCT00679536|Fludarabine|fludarabine|mesh-list
65288761|NCT00679536|Busulfan|busulfan|mesh-list
65288762|NCT00679536|Thymoglobulin|thymoglobulin|mesh-list
65289134|NCT00690300|Antimitotic Agents|antimitotic agents|mesh-ancestor
65289135|NCT00690300|Mitosis Modulators|mitosis modulators|mesh-ancestor
65289136|NCT00690300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289138|NCT02741219|Dexmedetomidine|dexmedetomidine|mesh-list
65289139|NCT02741219|Dsuvia|dsuvia|mesh-list
65289140|NCT02741219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65289141|NCT02741219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65289142|NCT02741219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289143|NCT02741219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65039124|NCT00188669|Micronutrients|micronutrients|mesh-ancestor
65289144|NCT02741219|Analgesics|analgesics|mesh-ancestor
65289145|NCT02741219|Sensory System Agents|sensory system agents|mesh-ancestor
65289146|NCT02741219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65289147|NCT02741219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65289148|NCT02741219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65289149|NCT02741219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65289150|NCT02741219|Adrenergic Agents|adrenergic agents|mesh-ancestor
65289151|NCT02741219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65289152|NCT02741219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289153|NCT02741219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65289154|NCT02741219|Narcotics|narcotics|mesh-ancestor
65289155|NCT02741219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65289156|NCT02741219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65289157|NCT02741219|Anesthetics, General|anesthetics, general|mesh-ancestor
65289158|NCT02741219|Anesthetics|anesthetics|mesh-ancestor
65289159|NCT00690534|Insulin|insulin|mesh-list
65289160|NCT00690534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65289161|NCT00690534|Nitroprusside|nitroprusside|mesh-list
65289162|NCT00690534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65289163|NCT00690534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289164|NCT00690534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65289165|NCT00690534|Vasodilator Agents|vasodilator agents|mesh-ancestor
65289166|NCT00690534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65289167|NCT00690534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289168|NCT00991705|Atorvastatin|atorvastatin|mesh-list
65289169|NCT00991705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65289170|NCT00991705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65289171|NCT00991705|Antimetabolites|antimetabolites|mesh-ancestor
65289172|NCT00991705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289173|NCT00991705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65289174|NCT00991705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65289175|NCT00991705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289176|NCT02735837|Doxycycline|doxycycline|mesh-list
65289177|NCT02735837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65289178|NCT02735837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65289179|NCT02735837|Antimalarials|antimalarials|mesh-ancestor
65289180|NCT02735837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65289181|NCT02735837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65289182|NCT02625558|Riociguat|riociguat|mesh-list
65289183|NCT02625558|Enzyme Activators|enzyme activators|mesh-ancestor
65289184|NCT02625558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289185|NCT00685230|Antivenins|antivenins|mesh-list
65289186|NCT00685230|Immunologic Factors|immunologic factors|mesh-ancestor
65289187|NCT00685230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289188|NCT05455879|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65289189|NCT05455879|Respiratory System Agents|respiratory system agents|mesh-ancestor
65289190|NCT00991783|Digoxin|digoxin|mesh-list
65289191|NCT00991783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65289192|NCT00991783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65289193|NCT00991783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289194|NCT00991783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289195|NCT00991783|Protective Agents|protective agents|mesh-ancestor
65289196|NCT00991783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289197|NCT00690768|Bevacizumab|bevacizumab|mesh-list
65289522|NCT00691236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289524|NCT04137978|Diuretics|diuretics|mesh-ancestor
65289525|NCT04137978|Natriuretic Agents|natriuretic agents|mesh-ancestor
65289526|NCT04137978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289527|NCT04137978|Expectorants|expectorants|mesh-ancestor
65289528|NCT04137978|Respiratory System Agents|respiratory system agents|mesh-ancestor
65289529|NCT05408065|Triamcinolone|triamcinolone|mesh-list
65289530|NCT05408065|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65289531|NCT05408065|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65289532|NCT05408065|Cortisone|cortisone|mesh-list
65289533|NCT05408065|Hyaluronic Acid|hyaluronic acid|mesh-list
64519744|NCT03225924|Glucocorticoids|glucocorticoids|mesh-ancestor
65289884|NCT03579316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65289886|NCT03579316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520080|NCT02054338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290082|NCT00723268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290083|NCT00723268|Gout Suppressants|gout suppressants|mesh-ancestor
65290084|NCT00723268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65290085|NCT00723268|Tubulin Modulators|tubulin modulators|mesh-ancestor
65290086|NCT00723268|Antimitotic Agents|antimitotic agents|mesh-ancestor
65290087|NCT00723268|Mitosis Modulators|mitosis modulators|mesh-ancestor
65290088|NCT00723268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290089|NCT00874770|Ribavirin|ribavirin|mesh-list
65290090|NCT00874770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65290091|NCT00874770|Antimetabolites|antimetabolites|mesh-ancestor
65290092|NCT00874770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290093|NCT00874770|Antiviral Agents|antiviral agents|mesh-ancestor
65290094|NCT00874770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290095|NCT00536263|Interferons|interferons|mesh-list
65290096|NCT00536263|Interferon-alpha|interferon-alpha|mesh-list
65290097|NCT00536263|Interferon alpha-2|interferon alpha-2|mesh-list
65290098|NCT00536263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65290099|NCT00536263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290100|NCT00536263|Antiviral Agents|antiviral agents|mesh-ancestor
65290101|NCT00536263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290102|NCT00536263|Immunologic Factors|immunologic factors|mesh-ancestor
65290103|NCT00536263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290104|NCT00578344|Cyclophosphamide|cyclophosphamide|mesh-list
65290105|NCT00578344|Busulfan|busulfan|mesh-list
65290106|NCT00578344|Alemtuzumab|alemtuzumab|mesh-list
65290107|NCT00578344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65290108|NCT00578344|Immunologic Factors|immunologic factors|mesh-ancestor
65290109|NCT00578344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290110|NCT00578344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65290111|NCT00578344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65290112|NCT00578344|Alkylating Agents|alkylating agents|mesh-ancestor
65290113|NCT00578344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290114|NCT00578344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290115|NCT00578344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65290239|NCT00686556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65290240|NCT00686556|Alkylating Agents|alkylating agents|mesh-ancestor
65290241|NCT00686556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290242|NCT00686556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290243|NCT00686556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65290244|NCT00686556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290245|NCT00686556|Antifungal Agents|antifungal agents|mesh-ancestor
65290246|NCT00686556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290974|NCT04001725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290975|NCT04001725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65290976|NCT00713674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65290977|NCT00713674|Mupirocin|mupirocin|mesh-list
65290978|NCT00713674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290979|NCT00713674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65290980|NCT00713674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290981|NCT00713674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290982|NCT00885482|Ritonavir|ritonavir|mesh-list
65290983|NCT00885482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65290984|NCT00885482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65290985|NCT00885482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65290986|NCT00885482|Protease Inhibitors|protease inhibitors|mesh-ancestor
65290987|NCT00885482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290988|NCT00885482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290989|NCT00885482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65290990|NCT00885482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65290991|NCT00885482|Antiviral Agents|antiviral agents|mesh-ancestor
65290992|NCT00885482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290993|NCT00885482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65290994|NCT00885482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65290995|NCT04139226|CC-11050|cc-11050|mesh-list
65290996|NCT04139226|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65290997|NCT04139226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65290998|NCT04139226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290999|NCT04139226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291000|NCT05366062|Cyclophosphamide|cyclophosphamide|mesh-list
65291001|NCT05366062|Pembrolizumab|pembrolizumab|mesh-list
65291002|NCT05366062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65291003|NCT05366062|Immunologic Factors|immunologic factors|mesh-ancestor
65291004|NCT05366062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291005|NCT05366062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65291006|NCT05366062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65291007|NCT05366062|Alkylating Agents|alkylating agents|mesh-ancestor
65344924|NCT00864058|Sensory System Agents|sensory system agents|mesh-ancestor
65291044|NCT00653744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65291045|NCT00653744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65291246|NCT04350190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291247|NCT04350190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291249|NCT02721173|Clindamycin palmitate|clindamycin palmitate|mesh-list
65291250|NCT02721173|Clindamycin phosphate|clindamycin phosphate|mesh-list
65291251|NCT02721173|Adapalene|adapalene|mesh-list
65291252|NCT02721173|Tazarotene|tazarotene|mesh-list
65291253|NCT02721173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65291254|NCT02721173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65291255|NCT02721173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65291256|NCT02721173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291257|NCT02721173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521447|NCT02449278|Glucocorticoids|glucocorticoids|mesh-ancestor
65291408|NCT00995293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291410|NCT00995293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65291411|NCT00995293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65291412|NCT00995293|Immunologic Factors|immunologic factors|mesh-ancestor
65291413|NCT00995293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291436|NCT00689208|Autonomic Agents|autonomic agents|mesh-ancestor
65291437|NCT00689208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65291438|NCT00689208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291439|NCT00689208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65291440|NCT00689208|Respiratory System Agents|respiratory system agents|mesh-ancestor
65291441|NCT00689208|Mydriatics|mydriatics|mesh-ancestor
65291442|NCT00689208|Parasympatholytics|parasympatholytics|mesh-ancestor
65291443|NCT00689208|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65291444|NCT00689208|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65291445|NCT00689208|Cholinergic Agents|cholinergic agents|mesh-ancestor
65291446|NCT00689208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65291447|NCT00689208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291448|NCT00689208|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65291449|NCT00689208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291450|NCT00689208|Miotics|miotics|mesh-ancestor
65291451|NCT00726466|Ranibizumab|ranibizumab|mesh-list
65291452|NCT00726466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65291453|NCT00726466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65291454|NCT00726466|Growth Substances|growth substances|mesh-ancestor
65291455|NCT00726466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291456|NCT00726466|Growth Inhibitors|growth inhibitors|mesh-ancestor
65291457|NCT00726466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291458|NCT02694263|Pioglitazone|pioglitazone|mesh-list
65291459|NCT02694263|Glimepiride|glimepiride|mesh-list
65291460|NCT02694263|Canagliflozin|canagliflozin|mesh-list
65291461|NCT02694263|Repaglinide|repaglinide|mesh-list
65291462|NCT02694263|Gliclazide|gliclazide|mesh-list
65291463|NCT02694263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65291464|NCT02694263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291465|NCT02694263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65291466|NCT02694263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65291467|NCT02694263|Immunologic Factors|immunologic factors|mesh-ancestor
65041420|NCT00125684|Analgesics|analgesics|mesh-ancestor
65291468|NCT02694263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65291469|NCT02694263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291470|NCT04139070|Bleomycin|bleomycin|mesh-list
65291471|NCT04139070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65291472|NCT04139070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291473|NCT00693030|Sirolimus|sirolimus|mesh-list
65291474|NCT00693030|Paclitaxel|paclitaxel|mesh-list
65291475|NCT00693030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65216083|NCT02721342|Ramipril|ramipril|mesh-list
65291476|NCT00693030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291477|NCT00693030|Tubulin Modulators|tubulin modulators|mesh-ancestor
65291478|NCT00693030|Antimitotic Agents|antimitotic agents|mesh-ancestor
65291479|NCT00693030|Mitosis Modulators|mitosis modulators|mesh-ancestor
65291480|NCT00693030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291481|NCT00693030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65291482|NCT00693030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65291483|NCT00693030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65291484|NCT00693030|Antifungal Agents|antifungal agents|mesh-ancestor
65291485|NCT00693030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65291486|NCT00693030|Immunologic Factors|immunologic factors|mesh-ancestor
65291487|NCT00693030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291488|NCT00653822|Alefacept|alefacept|mesh-list
65291489|NCT00653822|Dermatologic Agents|dermatologic agents|mesh-ancestor
65291490|NCT00653822|Immunologic Factors|immunologic factors|mesh-ancestor
65291491|NCT00653822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291492|NCT04137276|Vitamins|vitamins|mesh-list
65291493|NCT04137276|Thiamine|thiamine|mesh-list
65291494|NCT04137276|Vitamin B Complex|vitamin b complex|mesh-list
65291495|NCT04137276|Micronutrients|micronutrients|mesh-ancestor
65291496|NCT04137276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291497|NCT03448666|Pembrolizumab|pembrolizumab|mesh-list
65291498|NCT03448666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65291499|NCT03448666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291500|NCT02723981|Vitamins|vitamins|mesh-list
65291501|NCT02723981|Vitamin K|vitamin k|mesh-list
65291502|NCT02723981|Rivaroxaban|rivaroxaban|mesh-list
65291503|NCT02723981|Dabigatran|dabigatran|mesh-list
65291504|NCT02723981|Anticoagulants|anticoagulants|mesh-list
65291505|NCT02723981|Clopidogrel|clopidogrel|mesh-list
65291506|NCT02723981|Micronutrients|micronutrients|mesh-ancestor
65291507|NCT02723981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291595|NCT00675714|Ketoconazole|ketoconazole|mesh-list
65291596|NCT00675714|Methyltestosterone|methyltestosterone|mesh-list
65291597|NCT00675714|Propranolol|propranolol|mesh-list
65291598|NCT00675714|Metoprolol|metoprolol|mesh-list
65291599|NCT00675714|Hormones|hormones|mesh-list
65291600|NCT00675714|Testosterone|testosterone|mesh-list
65291601|NCT00675714|Testosterone undecanoate|testosterone undecanoate|mesh-list
65291602|NCT00675714|Testosterone enanthate|testosterone enanthate|mesh-list
65291603|NCT00675714|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65291604|NCT00675714|Oxandrolone|oxandrolone|mesh-list
65291605|NCT00675714|Nandrolone|nandrolone|mesh-list
65291606|NCT00675714|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
65291607|NCT00675714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65291608|NCT00675714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291609|NCT00675714|Androgens|androgens|mesh-ancestor
65291610|NCT00675714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65291611|NCT00675714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291612|NCT00675714|Anabolic Agents|anabolic agents|mesh-ancestor
65291613|NCT00675714|Antifungal Agents|antifungal agents|mesh-ancestor
65291614|NCT00675714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65291615|NCT00675714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65291616|NCT00675714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65291617|NCT00675714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291618|NCT00675714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291619|NCT00675714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65291620|NCT00675714|Hormone Antagonists|hormone antagonists|mesh-ancestor
65291621|NCT00675714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65291622|NCT00675714|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65291624|NCT00675714|Adrenergic Agents|adrenergic agents|mesh-ancestor
65291625|NCT00675714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65291626|NCT00675714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65291627|NCT00675714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65291628|NCT00675714|Vasodilator Agents|vasodilator agents|mesh-ancestor
65291629|NCT00675714|Sympatholytics|sympatholytics|mesh-ancestor
65291630|NCT00675714|Autonomic Agents|autonomic agents|mesh-ancestor
65291631|NCT00675714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65291632|NCT00675714|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65291633|NCT00675714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65291634|NCT00675714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65291635|NCT00675714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65291636|NCT00656240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65291637|NCT00656240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65291638|NCT05290727|Hyaluronic Acid|hyaluronic acid|mesh-list
65291639|NCT05290727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65291640|NCT05290727|Immunologic Factors|immunologic factors|mesh-ancestor
65291641|NCT05290727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291642|NCT05290727|Viscosupplements|viscosupplements|mesh-ancestor
65291643|NCT05290727|Protective Agents|protective agents|mesh-ancestor
65291644|NCT00729976|Ibuprofen|ibuprofen|mesh-list
65291645|NCT00729976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65291646|NCT00729976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65291647|NCT00729976|Analgesics|analgesics|mesh-ancestor
65291648|NCT00729976|Sensory System Agents|sensory system agents|mesh-ancestor
65291649|NCT00729976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65291650|NCT00729976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291651|NCT00729976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65291652|NCT00729976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65292930|NCT02715167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65292931|NCT02715167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65292932|NCT02715167|Autonomic Agents|autonomic agents|mesh-ancestor
65292933|NCT02715167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65344928|NCT00864058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65293228|NCT01004497|Antiviral Agents|antiviral agents|mesh-ancestor
65293229|NCT01004497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65293230|NCT01004497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65293231|NCT01004497|Tubulin Modulators|tubulin modulators|mesh-ancestor
65293232|NCT01004497|Antimitotic Agents|antimitotic agents|mesh-ancestor
65293233|NCT01004497|Mitosis Modulators|mitosis modulators|mesh-ancestor
65293234|NCT01004497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65293235|NCT01004497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65293236|NCT01004497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65293237|NCT01004497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65293238|NCT01004497|Analgesics|analgesics|mesh-ancestor
65293239|NCT01004497|Sensory System Agents|sensory system agents|mesh-ancestor
65293240|NCT02713841|Insulin|insulin|mesh-list
65293241|NCT02713841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65293242|NCT02713841|Insulin Lispro|insulin lispro|mesh-list
65293243|NCT02713841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65293244|NCT02713841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293246|NCT01004575|Chromium|chromium|mesh-list
65293247|NCT01004575|Trace Elements|trace elements|mesh-ancestor
65293248|NCT01004575|Micronutrients|micronutrients|mesh-ancestor
65293568|NCT02638922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65293569|NCT02638922|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65293570|NCT02638922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65293571|NCT02638922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65293573|NCT01005199|Sorafenib|sorafenib|mesh-list
65293574|NCT01005199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293575|NCT01005199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65293576|NCT01005199|Immunologic Factors|immunologic factors|mesh-ancestor
65293577|NCT01005199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293578|NCT01005199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65293579|NCT01005199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293580|NCT01005199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293581|NCT02711189|Oxytocin|oxytocin|mesh-list
65293582|NCT02711189|Oxytocics|oxytocics|mesh-ancestor
65293583|NCT02711189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65293584|NCT02711189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293585|NCT02635802|Lidocaine|lidocaine|mesh-list
65293586|NCT02635802|Midazolam|midazolam|mesh-list
65293587|NCT02635802|Remifentanil|remifentanil|mesh-list
65293588|NCT02635802|Anesthetics, Local|anesthetics, local|mesh-ancestor
65293589|NCT02635802|Anesthetics|anesthetics|mesh-ancestor
65293590|NCT02635802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65293591|NCT02635802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293592|NCT02635802|Sensory System Agents|sensory system agents|mesh-ancestor
65293593|NCT02635802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65293594|NCT02635802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65293595|NCT02635802|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65293596|NCT02635802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65293597|NCT02635802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65293598|NCT02635802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293599|NCT02635802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65293600|NCT02635802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65293601|NCT02635802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65293602|NCT02635802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65293603|NCT02635802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65293604|NCT02635802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65293605|NCT02635802|Anesthetics, General|anesthetics, general|mesh-ancestor
65293606|NCT02635802|GABA Modulators|gaba modulators|mesh-ancestor
65293607|NCT02635802|GABA Agents|gaba agents|mesh-ancestor
65216229|NCT02776137|Docetaxel|docetaxel|mesh-list
65293608|NCT02635802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65293609|NCT02635802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65293610|NCT02635802|Narcotics|narcotics|mesh-ancestor
65293611|NCT02635802|Analgesics|analgesics|mesh-ancestor
65293612|NCT00853749|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65293613|NCT00853749|Immunologic Factors|immunologic factors|mesh-ancestor
65293614|NCT00853749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293615|NCT03940703|Osimertinib|osimertinib|mesh-list
65293616|NCT03940703|Tepotinib|tepotinib|mesh-list
65293617|NCT03940703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293618|NCT03940703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65293619|NCT03940703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293620|NCT03940703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293621|NCT00657410|Dexamethasone|dexamethasone|mesh-list
65293622|NCT00657410|Prednisone|prednisone|mesh-list
65293623|NCT00657410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65293624|NCT00657410|Antiemetics|antiemetics|mesh-ancestor
65293625|NCT00657410|Autonomic Agents|autonomic agents|mesh-ancestor
65293626|NCT00657410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65293627|NCT00657410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293628|NCT00657410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65293629|NCT00657410|Glucocorticoids|glucocorticoids|mesh-ancestor
65293630|NCT00657410|Hormones|hormones|mesh-ancestor
65293631|NCT00657410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65293632|NCT00657410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65293633|NCT00657410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293634|NCT01009021|Diclofenac|diclofenac|mesh-list
65293635|NCT01009021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65293636|NCT01009021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65293637|NCT01009021|Analgesics|analgesics|mesh-ancestor
65293638|NCT01009021|Sensory System Agents|sensory system agents|mesh-ancestor
64523823|NCT02414568|Vinblastine|vinblastine|mesh-list
65293839|NCT01006525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293841|NCT01006681|MF59 oil emulsion|mf59 oil emulsion|mesh-list
65293842|NCT01006681|Immunologic Factors|immunologic factors|mesh-ancestor
65293843|NCT01006681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293844|NCT01006681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65293845|NCT05733403|Norepinephrine|norepinephrine|mesh-list
65293846|NCT05733403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65293847|NCT05733403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65293848|NCT05733403|Adrenergic Agents|adrenergic agents|mesh-ancestor
65293849|NCT05733403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65293850|NCT05733403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524069|NCT00363376|Zonisamide|zonisamide|mesh-list
65295702|NCT00827775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65295703|NCT00827775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65295704|NCT02544308|Dexamethasone|dexamethasone|mesh-list
65295987|NCT00865098|Cetuximab|cetuximab|mesh-list
65295988|NCT00865098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65295989|NCT00865098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295990|NCT00880100|Pancrelipase|pancrelipase|mesh-list
65295991|NCT00880100|Pancreatin|pancreatin|mesh-list
65295992|NCT00880100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65295993|NCT00729898|Insulin Aspart|insulin aspart|mesh-list
65295994|NCT00729898|Biphasic Insulins|biphasic insulins|mesh-list
65295995|NCT00729898|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65295996|NCT00729898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65295997|NCT00729898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296536|NCT00881504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65296537|NCT00881504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65296539|NCT00881504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296540|NCT00881504|Growth Inhibitors|growth inhibitors|mesh-ancestor
65296541|NCT00660764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65296542|NCT00660764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65296543|NCT00660764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65296544|NCT00660764|Antimetabolites|antimetabolites|mesh-ancestor
65296545|NCT00660764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296546|NCT00660764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65296547|NCT00660764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65296548|NCT00660764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296549|NCT02131493|Gemcitabine|gemcitabine|mesh-list
65296550|NCT02131493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65296551|NCT02131493|Antimetabolites|antimetabolites|mesh-ancestor
65296552|NCT02131493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216309|NCT03205956|Levodopa|levodopa|mesh-list
65296553|NCT02131493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296554|NCT02131493|Antiviral Agents|antiviral agents|mesh-ancestor
65296555|NCT02131493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65296556|NCT02131493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296557|NCT02131493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65296558|NCT02131493|Immunologic Factors|immunologic factors|mesh-ancestor
65296559|NCT02131493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296560|NCT02096159|Trimethoprim|trimethoprim|mesh-list
65296825|NCT04215731|Vitamins|vitamins|mesh-ancestor
65296826|NCT04215731|Micronutrients|micronutrients|mesh-ancestor
65296973|NCT05740618|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65296974|NCT05740618|Diuretics|diuretics|mesh-ancestor
64527298|NCT01555073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65297196|NCT02701673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64527352|NCT04410211|GABA Modulators|gaba modulators|mesh-ancestor
65297581|NCT02700893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65297582|NCT02700893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65297583|NCT02700893|Cholinergic Agents|cholinergic agents|mesh-ancestor
65297584|NCT02700893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65297585|NCT02700893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297586|NCT02700893|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65297587|NCT02700893|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65297588|NCT02700893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65297589|NCT02700893|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65298014|NCT02727907|Immunologic Factors|immunologic factors|mesh-ancestor
65298015|NCT02727907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298016|NCT02727907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65298017|NCT00663728|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65298018|NCT00663728|Vasodilator Agents|vasodilator agents|mesh-ancestor
65298019|NCT00663728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65298020|NCT00663728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65298021|NCT00663728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298060|NCT01009879|Sensory System Agents|sensory system agents|mesh-ancestor
65298061|NCT01009879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65298062|NCT01009879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298063|NCT01009879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65298064|NCT01009879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65298065|NCT01009879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65298066|NCT01009879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65298067|NCT01009879|Immunologic Factors|immunologic factors|mesh-ancestor
65298068|NCT01009957|Everolimus|everolimus|mesh-list
65298069|NCT01009957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298070|NCT01009957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65298071|NCT01009957|Immunologic Factors|immunologic factors|mesh-ancestor
65298072|NCT01009957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298073|NCT04062370|Ranibizumab|ranibizumab|mesh-list
65298074|NCT04062370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65298075|NCT04062370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65298076|NCT04062370|Growth Substances|growth substances|mesh-ancestor
65298077|NCT04062370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298078|NCT04062370|Growth Inhibitors|growth inhibitors|mesh-ancestor
65298079|NCT04062370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298080|NCT01015183|Zinc Sulfate|zinc sulfate|mesh-list
65298081|NCT01015183|Astringents|astringents|mesh-ancestor
65298082|NCT01015183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298083|NCT01015183|Dermatologic Agents|dermatologic agents|mesh-ancestor
65298084|NCT00856284|Metformin|metformin|mesh-list
65298085|NCT00856284|Alogliptin|alogliptin|mesh-list
65298086|NCT00856284|Glipizide|glipizide|mesh-list
65298087|NCT00856284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65298088|NCT00856284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298089|NCT00856284|Incretins|incretins|mesh-ancestor
65298090|NCT00856284|Hormones|hormones|mesh-ancestor
65298091|NCT00856284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65298092|NCT00856284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65298093|NCT00856284|Protease Inhibitors|protease inhibitors|mesh-ancestor
65298094|NCT00856284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298095|NCT00856284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298096|NCT05057494|Venetoclax|venetoclax|mesh-list
65298097|NCT05057494|Obinutuzumab|obinutuzumab|mesh-list
65298098|NCT05057494|Acalabrutinib|acalabrutinib|mesh-list
65298099|NCT05057494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298100|NCT05057494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65298101|NCT00510289|Sorafenib|sorafenib|mesh-list
65298102|NCT00510289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298103|NCT00510289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65269808|NCT02733380|Sensory System Agents|sensory system agents|mesh-ancestor
65298104|NCT00510289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298105|NCT00510289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298106|NCT01013155|Perindopril|perindopril|mesh-list
65298107|NCT01013155|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65298108|NCT01013155|Protease Inhibitors|protease inhibitors|mesh-ancestor
65298109|NCT01013155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298110|NCT01013155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298111|NCT01013155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65298112|NCT00663806|Ciprofloxacin|ciprofloxacin|mesh-list
65298113|NCT00663806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65298114|NCT00663806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65298115|NCT00663806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65298116|NCT00663806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65298117|NCT00663806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298118|NCT00663806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298119|NCT00663806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298120|NCT00663806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65298149|NCT00675896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298150|NCT01015417|Amoxicillin|amoxicillin|mesh-list
65298151|NCT01015417|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65298152|NCT01015417|Clavulanic Acids|clavulanic acids|mesh-list
65298153|NCT01015417|Clavulanic Acid|clavulanic acid|mesh-list
65298154|NCT01015417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65298155|NCT01015417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65298156|NCT01015417|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65298157|NCT01015417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298158|NCT01015417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298159|NCT04061824|Olmesartan|olmesartan|mesh-list
65298160|NCT04061824|Angiotensin II|angiotensin ii|mesh-list
65298161|NCT04061824|Giapreza|giapreza|mesh-list
65298162|NCT04061824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65298163|NCT04061824|Angiotensinogen|angiotensinogen|mesh-list
65298164|NCT04061824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65298165|NCT04061824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65298297|NCT00699894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65298298|NCT00699894|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65298299|NCT00664196|Hormones|hormones|mesh-list
65298300|NCT00664196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65298301|NCT00664196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298302|NCT00616499|Gefitinib|gefitinib|mesh-list
65298303|NCT00616499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298304|NCT00616499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65298305|NCT00616499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298306|NCT00616499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298307|NCT05317936|Venetoclax|venetoclax|mesh-list
65298308|NCT05317936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298309|NCT02614248|Protective Agents|protective agents|mesh-list
65298310|NCT02614248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298311|NCT00491179|Interferons|interferons|mesh-list
65298312|NCT00491179|Ribavirin|ribavirin|mesh-list
65298313|NCT00491179|Interferon-alpha|interferon-alpha|mesh-list
65298314|NCT00491179|Interferon alpha-2|interferon alpha-2|mesh-list
65298315|NCT00491179|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65298316|NCT00491179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298317|NCT00491179|Antiviral Agents|antiviral agents|mesh-ancestor
65298318|NCT00491179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65298319|NCT00491179|Antimetabolites|antimetabolites|mesh-ancestor
65298320|NCT00491179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298321|NCT00491179|Immunologic Factors|immunologic factors|mesh-ancestor
65298322|NCT00491179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298323|NCT04155476|Nitroglycerin|nitroglycerin|mesh-list
65298324|NCT04155476|Vasodilator Agents|vasodilator agents|mesh-ancestor
65298325|NCT04502095|Levofloxacin|levofloxacin|mesh-list
65298326|NCT04502095|Ofloxacin|ofloxacin|mesh-list
65298327|NCT04502095|Trimethoprim|trimethoprim|mesh-list
65298328|NCT04502095|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65298329|NCT04502095|Nitrofurantoin|nitrofurantoin|mesh-list
65298330|NCT04502095|Clindamycin|clindamycin|mesh-list
65298331|NCT04502095|Ertapenem|ertapenem|mesh-list
65298332|NCT04502095|Sulfamethoxazole|sulfamethoxazole|mesh-list
65298333|NCT04502095|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65298334|NCT04502095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65298335|NCT04502095|Renal Agents|renal agents|mesh-ancestor
65298336|NCT04502095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65298337|NCT04502095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65298338|NCT04502095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65298339|NCT04502095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298340|NCT04502095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298341|NCT04502095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298342|NCT04502095|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65298343|NCT04502095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65298344|NCT04502095|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65298345|NCT04502095|Antimalarials|antimalarials|mesh-ancestor
65298346|NCT04502095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65298347|NCT04502095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65298348|NCT04502095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65298349|NCT04502095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65298350|NCT04502095|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65298351|NCT05301322|Vaccines|vaccines|mesh-list
65298352|NCT05301322|Immunologic Factors|immunologic factors|mesh-ancestor
65298353|NCT05301322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298354|NCT00674102|Vadimezan|vadimezan|mesh-list
65298355|NCT00674102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298356|NCT00503581|Megestrol|megestrol|mesh-list
65298971|NCT00619697|Biphasic Insulins|biphasic insulins|mesh-list
65494080|NCT03701763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65048868|NCT00563485|Doxazosin|doxazosin|mesh-list
65298972|NCT00619697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65298973|NCT00619697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64529154|NCT01790997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65300017|NCT00049595|Cyclophosphamide|cyclophosphamide|mesh-list
65300019|NCT00049595|Doxorubicin|doxorubicin|mesh-list
65300020|NCT00049595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65300021|NCT00049595|Etoposide|etoposide|mesh-list
65300022|NCT00049595|Vincristine|vincristine|mesh-list
65300023|NCT00049595|Bleomycin|bleomycin|mesh-list
65300024|NCT00049595|Vinblastine|vinblastine|mesh-list
65300115|NCT00686816|Antimetabolites|antimetabolites|mesh-ancestor
65300116|NCT00686816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300117|NCT00686816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65300118|NCT05368181|Methylprednisolone|methylprednisolone|mesh-list
65300119|NCT05368181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65300120|NCT05368181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65300121|NCT05368181|Prednisolone|prednisolone|mesh-list
65300122|NCT05368181|Prednisolone acetate|prednisolone acetate|mesh-list
65300123|NCT05368181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65300124|NCT05368181|Prednisolone phosphate|prednisolone phosphate|mesh-list
65300125|NCT05368181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65300126|NCT05368181|Antiemetics|antiemetics|mesh-ancestor
65300127|NCT05368181|Autonomic Agents|autonomic agents|mesh-ancestor
65300128|NCT05368181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65300129|NCT05368181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300130|NCT05368181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65300131|NCT05368181|Glucocorticoids|glucocorticoids|mesh-ancestor
65300132|NCT05368181|Hormones|hormones|mesh-ancestor
65300133|NCT05368181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65300134|NCT05368181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65300135|NCT05368181|Protective Agents|protective agents|mesh-ancestor
65300136|NCT05368181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65300137|NCT05368181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300138|NCT05662163|Anesthetics|anesthetics|mesh-list
65300139|NCT05662163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65300140|NCT05662163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300141|NCT02666105|Exemestane|exemestane|mesh-list
64530201|NCT05799144|Vaccines|vaccines|mesh-list
65300636|NCT01946711|Autonomic Agents|autonomic agents|mesh-ancestor
65300637|NCT01946711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65300638|NCT01946711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300639|NCT01946711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65300640|NCT01946711|Respiratory System Agents|respiratory system agents|mesh-ancestor
65300641|NCT01946711|Glucocorticoids|glucocorticoids|mesh-ancestor
65300642|NCT01946711|Hormones|hormones|mesh-ancestor
65300643|NCT01946711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65300644|NCT00693446|Sirolimus|sirolimus|mesh-list
65300645|NCT00693446|Tacrolimus|tacrolimus|mesh-list
65300646|NCT00693446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65300647|NCT00693446|Immunologic Factors|immunologic factors|mesh-ancestor
65300648|NCT00693446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300649|NCT00693446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65300650|NCT00693446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300651|NCT00693446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300652|NCT00693446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65300653|NCT00693446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65300654|NCT00693446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65300655|NCT00693446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300656|NCT00693446|Antifungal Agents|antifungal agents|mesh-ancestor
65300657|NCT00693524|Mycophenolic Acid|mycophenolic acid|mesh-list
65300658|NCT00693524|Prednisone|prednisone|mesh-list
65300659|NCT00693524|Tacrolimus|tacrolimus|mesh-list
65300660|NCT00693524|Daclizumab|daclizumab|mesh-list
65300661|NCT00693524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65300662|NCT00693524|Glucocorticoids|glucocorticoids|mesh-ancestor
65300663|NCT00693524|Hormones|hormones|mesh-ancestor
65300664|NCT00693524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65300665|NCT00693524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300666|NCT00693524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65300667|NCT00693524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300668|NCT00693524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65300669|NCT00693524|Immunologic Factors|immunologic factors|mesh-ancestor
65300670|NCT00693524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65300671|NCT00693524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300672|NCT00693524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530680|NCT05338320|Fentanyl|fentanyl|mesh-list
65300686|NCT00682214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65300687|NCT04137380|Mirikizumab|mirikizumab|mesh-list
65300688|NCT04137380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65300689|NCT04137380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65300690|NCT04137380|Analgesics|analgesics|mesh-ancestor
65300691|NCT04137380|Sensory System Agents|sensory system agents|mesh-ancestor
65300692|NCT04137380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65300693|NCT04137380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300694|NCT04137380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65300695|NCT04137380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65300696|NCT04137380|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65300697|NCT04137380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65300698|NCT00693680|Imipramine|imipramine|mesh-list
65300699|NCT00693680|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65300700|NCT00693680|Antidepressive Agents|antidepressive agents|mesh-ancestor
65300701|NCT00693680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65300702|NCT00693680|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65300703|NCT00693680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65300704|NCT00693680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65300705|NCT00693680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300706|NCT00693680|Adrenergic Agents|adrenergic agents|mesh-ancestor
65300707|NCT00693680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65300708|NCT00693680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300709|NCT00682292|Thymoglobulin|thymoglobulin|mesh-list
65300710|NCT00682292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65300711|NCT00682292|Daclizumab|daclizumab|mesh-list
65300712|NCT00682292|Immunologic Factors|immunologic factors|mesh-ancestor
65300713|NCT00682292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300714|NCT00682292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65300715|NCT00810069|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65300716|NCT00810069|Citalopram|citalopram|mesh-list
65300717|NCT00810069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65300718|NCT00810069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65300719|NCT00810069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65300720|NCT00810069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300721|NCT00810069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65300722|NCT00810069|Serotonin Agents|serotonin agents|mesh-ancestor
65300723|NCT00810069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300724|NCT00810069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65300725|NCT00810069|Antidepressive Agents|antidepressive agents|mesh-ancestor
65300726|NCT00810069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65300727|NCT00810069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65300728|NCT00810069|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65300729|NCT00810069|Analgesics|analgesics|mesh-ancestor
65300730|NCT00810069|Sensory System Agents|sensory system agents|mesh-ancestor
65300731|NCT00810069|Dopamine Agents|dopamine agents|mesh-ancestor
65300732|NCT00693758|Adenosine|adenosine|mesh-list
65300733|NCT00693758|Analgesics|analgesics|mesh-ancestor
65300734|NCT00693758|Sensory System Agents|sensory system agents|mesh-ancestor
65302365|NCT00602537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65302366|NCT00602537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65216604|NCT02767245|Vitamins|vitamins|mesh-ancestor
65302367|NCT00602537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302368|NCT00602537|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65302369|NCT00602537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65302370|NCT00602537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65302371|NCT00602537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65302372|NCT00602537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65302373|NCT02688803|Paclitaxel|paclitaxel|mesh-list
65302374|NCT02688803|Docetaxel|docetaxel|mesh-list
65302375|NCT02688803|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65302376|NCT02688803|Cyclophosphamide|cyclophosphamide|mesh-list
65302377|NCT02688803|Doxorubicin|doxorubicin|mesh-list
65302378|NCT02688803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65302379|NCT02688803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65302380|NCT02688803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302381|NCT02688803|Tubulin Modulators|tubulin modulators|mesh-ancestor
65302382|NCT02688803|Antimitotic Agents|antimitotic agents|mesh-ancestor
65302383|NCT02688803|Mitosis Modulators|mitosis modulators|mesh-ancestor
65302384|NCT02688803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302385|NCT02688803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65302386|NCT02688803|Immunologic Factors|immunologic factors|mesh-ancestor
65302387|NCT02688803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302388|NCT02688803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65302389|NCT02688803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65302390|NCT02688803|Alkylating Agents|alkylating agents|mesh-ancestor
65302391|NCT02688803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65302392|NCT02688803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65302393|NCT02688803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65302394|NCT02688803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65302395|NCT02688803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302396|NCT02684669|Naloxone|naloxone|mesh-list
65302397|NCT02684669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65302398|NCT02684669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302399|NCT02684669|Sensory System Agents|sensory system agents|mesh-ancestor
65302400|NCT02684669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65302401|NCT02976935|Xenon|xenon|mesh-list
65302402|NCT02976935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65302403|NCT02976935|Anesthetics, General|anesthetics, general|mesh-ancestor
65302404|NCT02976935|Anesthetics|anesthetics|mesh-ancestor
65302405|NCT02976935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65302406|NCT02976935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302407|NCT00861614|Ipilimumab|ipilimumab|mesh-list
65302408|NCT00861614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65302409|NCT00861614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302410|NCT00861614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65302411|NCT00861614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302412|NCT00861380|Vaccines|vaccines|mesh-list
65302413|NCT00861380|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65302414|NCT00861380|Immunologic Factors|immunologic factors|mesh-ancestor
65302415|NCT00861380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302416|NCT00495391|Ribavirin|ribavirin|mesh-list
65302417|NCT00495391|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65302418|NCT00495391|Nitazoxanide|nitazoxanide|mesh-list
65302419|NCT00495391|Antimetabolites|antimetabolites|mesh-ancestor
65302420|NCT00495391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302421|NCT00495391|Antiviral Agents|antiviral agents|mesh-ancestor
65052308|NCT03450499|Sensory System Agents|sensory system agents|mesh-ancestor
65302422|NCT00495391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65302423|NCT00495391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65302424|NCT04378621|Adalimumab|adalimumab|mesh-list
65302425|NCT04378621|Etanercept|etanercept|mesh-list
65302426|NCT04378621|Golimumab|golimumab|mesh-list
65302427|NCT04378621|Infliximab|infliximab|mesh-list
65302428|NCT04378621|Certolizumab Pegol|certolizumab pegol|mesh-list
65302429|NCT04378621|Tofacitinib|tofacitinib|mesh-list
65302430|NCT04378621|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
65302431|NCT04378621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65302432|NCT04378621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65302433|NCT04378621|Dermatologic Agents|dermatologic agents|mesh-ancestor
65302434|NCT04378621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64532454|NCT02372292|Furosemide|furosemide|mesh-list
65303037|NCT04102319|Hepcidins|hepcidins|mesh-list
65303038|NCT04102319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65303039|NCT00743860|Darapladib|darapladib|mesh-list
65303040|NCT00743860|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
65303041|NCT00743860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303042|NCT00743860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303043|NCT00747526|Rabeprazole|rabeprazole|mesh-list
65303044|NCT00747526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65303045|NCT00747526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64533068|NCT00323739|Growth Substances|growth substances|mesh-ancestor
65303265|NCT04181489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65303266|NCT04181489|Alkylating Agents|alkylating agents|mesh-ancestor
65303267|NCT04181489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303268|NCT04181489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303269|NCT04181489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65303270|NCT04181489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65303271|NCT04181489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65303272|NCT04181489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65303273|NCT04181489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65303274|NCT04181489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303275|NCT04181489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65303642|NCT00643877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303643|NCT02674295|Esketamine|esketamine|mesh-list
65303644|NCT02674295|Antidepressive Agents|antidepressive agents|mesh-ancestor
65303645|NCT02674295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65303646|NCT04179071|Famotidine|famotidine|mesh-list
65303647|NCT04179071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65303648|NCT04179071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65303649|NCT04179071|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65303650|NCT04179071|Histamine Antagonists|histamine antagonists|mesh-ancestor
65303651|NCT04179071|Histamine Agents|histamine agents|mesh-ancestor
65303652|NCT04179071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65303653|NCT04179071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303654|NCT04179071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303655|NCT02674139|Copper|copper|mesh-list
65303656|NCT02674139|Trace Elements|trace elements|mesh-ancestor
65303657|NCT02674139|Micronutrients|micronutrients|mesh-ancestor
65303658|NCT02674139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303659|NCT00644033|Frovatriptan|frovatriptan|mesh-list
65303660|NCT00644033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65303661|NCT00644033|Serotonin Agents|serotonin agents|mesh-ancestor
65303662|NCT00644033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65303663|NCT00644033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303664|NCT00644033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303682|NCT00484315|Paclitaxel|paclitaxel|mesh-list
65303683|NCT00484315|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65303684|NCT00484315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65303685|NCT00484315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303686|NCT00484315|Tubulin Modulators|tubulin modulators|mesh-ancestor
65303687|NCT00484315|Antimitotic Agents|antimitotic agents|mesh-ancestor
65303688|NCT00484315|Mitosis Modulators|mitosis modulators|mesh-ancestor
65303689|NCT00484315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303690|NCT01019083|Zinc|zinc|mesh-list
65303691|NCT01019083|Albendazole|albendazole|mesh-list
65303692|NCT01019083|Secnidazole|secnidazole|mesh-list
65303693|NCT01019083|Zinc Sulfate|zinc sulfate|mesh-list
65303694|NCT01019083|Trace Elements|trace elements|mesh-ancestor
65303695|NCT01019083|Micronutrients|micronutrients|mesh-ancestor
65303696|NCT01019083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303697|NCT01019083|Anthelmintics|anthelmintics|mesh-ancestor
65303698|NCT01019083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65303699|NCT01019083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65303700|NCT01019083|Anticestodal Agents|anticestodal agents|mesh-ancestor
65303701|NCT01019083|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65303702|NCT01019083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65303703|NCT01019083|Tubulin Modulators|tubulin modulators|mesh-ancestor
65303704|NCT01019083|Antimitotic Agents|antimitotic agents|mesh-ancestor
65303705|NCT01019083|Mitosis Modulators|mitosis modulators|mesh-ancestor
65303706|NCT01019083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303707|NCT01019083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303708|NCT01019083|Astringents|astringents|mesh-ancestor
65303709|NCT01019083|Dermatologic Agents|dermatologic agents|mesh-ancestor
65303710|NCT00463801|Daptomycin|daptomycin|mesh-list
65303711|NCT00463801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65303712|NCT00463801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65303713|NCT02672345|Sevoflurane|sevoflurane|mesh-list
65303714|NCT02672345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65303715|NCT02672345|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65303716|NCT02672345|Anesthetics, General|anesthetics, general|mesh-ancestor
65303717|NCT02672345|Anesthetics|anesthetics|mesh-ancestor
65303718|NCT02672345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65216765|NCT00746785|Olanzapine|olanzapine|mesh-list
65303719|NCT02672345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303720|NCT02537249|Dexmedetomidine|dexmedetomidine|mesh-list
65303721|NCT02537249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65303722|NCT02537249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65303723|NCT02537249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303724|NCT02537249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65303725|NCT02537249|Analgesics|analgesics|mesh-ancestor
65303726|NCT02537249|Sensory System Agents|sensory system agents|mesh-ancestor
65303727|NCT02537249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65303728|NCT02537249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65303729|NCT02537249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65303730|NCT02537249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65304492|NCT02655029|Indapamide|indapamide|mesh-list
65304493|NCT02655029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65304494|NCT02655029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65304495|NCT02655029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65304496|NCT02655029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304497|NCT02655029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65304498|NCT02655029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304605|NCT00650195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65304606|NCT00650195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304607|NCT04170959|Metformin|metformin|mesh-list
65305363|NCT02649101|Growth Substances|growth substances|mesh-ancestor
65305364|NCT02649101|Growth Inhibitors|growth inhibitors|mesh-ancestor
65305365|NCT02649101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305366|NCT00700154|Insulin|insulin|mesh-list
65305367|NCT00700154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65305368|NCT00700154|Insulin Aspart|insulin aspart|mesh-list
65305780|NCT00744640|Antiviral Agents|antiviral agents|mesh-ancestor
65305781|NCT00744640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65305782|NCT00744640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305783|NCT00744640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65305784|NCT00744640|Immunologic Factors|immunologic factors|mesh-ancestor
65305785|NCT00744640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305786|NCT00848718|Paclitaxel|paclitaxel|mesh-list
65305787|NCT00848718|Docetaxel|docetaxel|mesh-list
65305788|NCT00848718|Carboplatin|carboplatin|mesh-list
65305789|NCT00848718|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65305790|NCT00848718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64535660|NCT00464685|Hormones|hormones|mesh-ancestor
65305865|NCT00744718|Bevacizumab|bevacizumab|mesh-list
65305866|NCT00744718|Carboplatin|carboplatin|mesh-list
65305867|NCT00744718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65305868|NCT00744718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305869|NCT00744718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64535748|NCT04081337|Tirzepatide|tirzepatide|mesh-list
65305913|NCT00749710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65305914|NCT00749710|Purinergic Agents|purinergic agents|mesh-ancestor
65305915|NCT00749710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65305916|NCT00749710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305917|NCT00749710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305918|NCT00749866|Gentamicins|gentamicins|mesh-list
65305919|NCT00749866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65305920|NCT00749866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65305921|NCT00749866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65305922|NCT00749866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305923|NCT00749866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305926|NCT04058236|Blood Substitutes|blood substitutes|mesh-ancestor
65305927|NCT00742066|Felodipine|felodipine|mesh-list
65305928|NCT00742066|Irbesartan|irbesartan|mesh-list
65305929|NCT00742066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65305930|NCT00742066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65305931|NCT00742066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65305932|NCT00742066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305933|NCT00742066|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65055835|NCT02212639|Digoxin|digoxin|mesh-list
65305934|NCT00742066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65305935|NCT00742066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65305936|NCT00742066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65305937|NCT00742066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305938|NCT00742066|Vasodilator Agents|vasodilator agents|mesh-ancestor
65305939|NCT00742144|Ofatumumab|ofatumumab|mesh-list
65305940|NCT00742144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305941|NCT00845676|Interferons|interferons|mesh-list
65305942|NCT00845676|Ribavirin|ribavirin|mesh-list
65305943|NCT00845676|Interferon-alpha|interferon-alpha|mesh-list
65305944|NCT00845676|Interferon alpha-2|interferon alpha-2|mesh-list
65305945|NCT00845676|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65305946|NCT00845676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305947|NCT00845676|Antiviral Agents|antiviral agents|mesh-ancestor
65305948|NCT00845676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65305949|NCT00845676|Antimetabolites|antimetabolites|mesh-ancestor
65305950|NCT00845676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305951|NCT00845676|Immunologic Factors|immunologic factors|mesh-ancestor
65305952|NCT00845676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305953|NCT00742300|Cyclophosphamide|cyclophosphamide|mesh-list
65305954|NCT00742300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65305955|NCT00742300|Immunologic Factors|immunologic factors|mesh-ancestor
65305956|NCT00742300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305957|NCT00742300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65305958|NCT00742300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65305959|NCT00742300|Alkylating Agents|alkylating agents|mesh-ancestor
65305960|NCT00742300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305961|NCT00742300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305962|NCT00742300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65305963|NCT02611908|Obinutuzumab|obinutuzumab|mesh-list
65305964|NCT02611908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65305965|NCT02611908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305966|NCT02561884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65305967|NCT02561884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65305968|NCT02561884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65305969|NCT02561884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65305970|NCT02561884|Antimetabolites|antimetabolites|mesh-ancestor
65305971|NCT02561884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305972|NCT02561884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65305973|NCT02561884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65305974|NCT02561884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305975|NCT02561884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65305976|NCT02561884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65305977|NCT02561884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65305978|NCT00655655|Everolimus|everolimus|mesh-list
65305979|NCT00655655|Vatalanib|vatalanib|mesh-list
65305980|NCT00655655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305981|NCT00655655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65305982|NCT00655655|Immunologic Factors|immunologic factors|mesh-ancestor
65305983|NCT00655655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305984|NCT00655655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65305985|NCT00655655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305986|NCT00655655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305987|NCT00844896|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
65305988|NCT00844896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305989|NCT00844896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305990|NCT05483400|Atezolizumab|atezolizumab|mesh-list
65305991|NCT05483400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305992|NCT00837330|Ranibizumab|ranibizumab|mesh-list
65305993|NCT00837330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65305994|NCT00837330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65305995|NCT00837330|Growth Substances|growth substances|mesh-ancestor
65306109|NCT02638415|Adrenergic Agents|adrenergic agents|mesh-ancestor
65306110|NCT02638415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65306111|NCT02638415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306112|NCT02638415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306113|NCT02638415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65306114|NCT02638415|Antioxidants|antioxidants|mesh-ancestor
65306115|NCT02638415|Protective Agents|protective agents|mesh-ancestor
65306116|NCT02638415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65306117|NCT02638415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65306118|NCT02638415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65306119|NCT02638415|Vasodilator Agents|vasodilator agents|mesh-ancestor
65306120|NCT02638415|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65306121|NCT02638415|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65306122|NCT00703872|Interferons|interferons|mesh-list
65306123|NCT00703872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306124|NCT00703872|Antiviral Agents|antiviral agents|mesh-ancestor
65306125|NCT00703872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65306126|NCT00689026|Lubiprostone|lubiprostone|mesh-list
65306127|NCT00689026|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65306223|NCT00656123|Alkylating Agents|alkylating agents|mesh-ancestor
65306224|NCT00656123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306225|NCT00656123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306226|NCT00656123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65306227|NCT04163471|Hemostatics|hemostatics|mesh-list
65306228|NCT04163471|Coagulants|coagulants|mesh-ancestor
65306229|NCT00657449|Valdecoxib|valdecoxib|mesh-list
65306230|NCT00657449|Rofecoxib|rofecoxib|mesh-list
65306231|NCT00657449|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65306232|NCT00657449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65306233|NCT00657449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306234|NCT00657449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306235|NCT00657449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65306236|NCT00657449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65306261|NCT00911261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65306263|NCT00686374|Adalimumab|adalimumab|mesh-list
65306264|NCT00686374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65306265|NCT00686374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65306266|NCT00750178|Vorinostat|vorinostat|mesh-list
65306267|NCT00750178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306268|NCT00750178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65306269|NCT00750178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306270|NCT00750178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306271|NCT00750334|Clofarabine|clofarabine|mesh-list
65306272|NCT00750334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65306273|NCT00750334|Antimetabolites|antimetabolites|mesh-ancestor
65306274|NCT00750334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306275|NCT00750334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306276|NCT00745186|Glucagon|glucagon|mesh-list
65306277|NCT00745186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65306278|NCT00745186|Hormones|hormones|mesh-ancestor
65306279|NCT00745186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65306280|NCT00745186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306281|NCT00750724|Hyaluronic Acid|hyaluronic acid|mesh-list
65306282|NCT00750724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65306283|NCT00750724|Immunologic Factors|immunologic factors|mesh-ancestor
65306284|NCT00750724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306285|NCT00750724|Viscosupplements|viscosupplements|mesh-ancestor
64536136|NCT01472965|Ethanol|ethanol|mesh-list
65306317|NCT00751504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65306318|NCT00751504|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65306319|NCT00751504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65306320|NCT00751504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65306321|NCT00751504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306322|NCT00576628|Epoetin Alfa|epoetin alfa|mesh-list
65306323|NCT00576628|Hematinics|hematinics|mesh-ancestor
65306324|NCT00683878|Pioglitazone|pioglitazone|mesh-list
65306325|NCT00683878|Dapagliflozin|dapagliflozin|mesh-list
64536205|NCT01472185|Ranolazine|ranolazine|mesh-list
65306652|NCT04158167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306653|NCT00659555|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65306654|NCT00659555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65306655|NCT02635607|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65306656|NCT02635607|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65306657|NCT02635607|Ganirelix|ganirelix|mesh-list
65306658|NCT02635607|Luteolytic Agents|luteolytic agents|mesh-ancestor
65306659|NCT02635607|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65306660|NCT02635607|Contraceptive Agents|contraceptive agents|mesh-ancestor
65306661|NCT02635607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65306662|NCT02635607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307144|NCT02631239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65307145|NCT02631239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307146|NCT02631239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65307498|NCT00665327|Levofloxacin|levofloxacin|mesh-list
65307499|NCT00665327|Ofloxacin|ofloxacin|mesh-list
65307500|NCT00665327|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65307501|NCT00665327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65307502|NCT00665327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65307503|NCT00665327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65307504|NCT00665327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65307505|NCT00665327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307506|NCT00665327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307507|NCT00665327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307508|NCT00665327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65307509|NCT00665327|Contraceptive Agents|contraceptive agents|mesh-ancestor
65307510|NCT00665327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65307511|NCT00665327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307512|NCT00665327|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65307513|NCT00665327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65307514|NCT00665327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65307515|NCT00665327|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65307516|NCT00665327|Renal Agents|renal agents|mesh-ancestor
65307517|NCT00665327|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65307518|NCT00665327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65307519|NCT00823836|Ropinirole|ropinirole|mesh-list
65307520|NCT00823836|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65307521|NCT00823836|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65307522|NCT00823836|Dopamine Agonists|dopamine agonists|mesh-ancestor
65307523|NCT00823836|Dopamine Agents|dopamine agents|mesh-ancestor
65307524|NCT00823836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65307525|NCT00823836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307526|NCT00823836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307527|NCT04154735|Rifaximin|rifaximin|mesh-list
65307528|NCT04154735|Cyclophosphamide|cyclophosphamide|mesh-list
65307529|NCT04154735|Fludarabine|fludarabine|mesh-list
65307530|NCT04154735|Alemtuzumab|alemtuzumab|mesh-list
65307531|NCT04154735|Tacrolimus|tacrolimus|mesh-list
65307532|NCT04154735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65307533|NCT04154735|Immunologic Factors|immunologic factors|mesh-ancestor
65307534|NCT04154735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307535|NCT04154735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65307536|NCT04154735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65307537|NCT04154735|Alkylating Agents|alkylating agents|mesh-ancestor
65307538|NCT04154735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307539|NCT04154735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307540|NCT04154735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65307541|NCT04154735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65307542|NCT04154735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307543|NCT04154735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65307544|NCT04154735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65307545|NCT04154735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65307546|NCT04154735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65307547|NCT00705042|Etanercept|etanercept|mesh-list
65307548|NCT00705042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65307549|NCT00705042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65307550|NCT00705042|Analgesics|analgesics|mesh-ancestor
65307551|NCT00705042|Sensory System Agents|sensory system agents|mesh-ancestor
65307552|NCT00705042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65307553|NCT00705042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308438|NCT02560870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65308439|NCT02560870|Disinfectants|disinfectants|mesh-ancestor
65308440|NCT02560870|Dermatologic Agents|dermatologic agents|mesh-ancestor
65308441|NCT04050826|Lidocaine|lidocaine|mesh-list
65308442|NCT04050826|Prilocaine|prilocaine|mesh-list
65308443|NCT04050826|Anesthetics, Local|anesthetics, local|mesh-ancestor
65308444|NCT04050826|Anesthetics|anesthetics|mesh-ancestor
65308445|NCT04050826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64538243|NCT00610311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65308738|NCT05747469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65308739|NCT05747469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65308740|NCT05747469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65308741|NCT05747469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65308742|NCT05747469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65308743|NCT05747469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308923|NCT04741438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309019|NCT02558452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65309020|NCT02558452|Immunologic Factors|immunologic factors|mesh-ancestor
65309021|NCT02558452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309022|NCT02558452|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65309023|NCT02558452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309024|NCT02558452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309026|NCT00762736|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65309027|NCT00762736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65309028|NCT00762736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309055|NCT02813824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309056|NCT02813824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65309057|NCT02813824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65309059|NCT02813824|Antipyretics|antipyretics|mesh-ancestor
65309060|NCT00673894|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65309061|NCT00673894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65309062|NCT00673894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309063|NCT00673894|Incretins|incretins|mesh-ancestor
65309064|NCT00673894|Hormones|hormones|mesh-ancestor
65309065|NCT00673894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65309066|NCT00673894|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65309067|NCT00673894|Protease Inhibitors|protease inhibitors|mesh-ancestor
65309068|NCT00673894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309069|NCT00673894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309070|NCT00763204|Betamethasone|betamethasone|mesh-list
65309071|NCT00763204|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65309072|NCT00763204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65309073|NCT00763204|Glucocorticoids|glucocorticoids|mesh-ancestor
65309281|NCT02557984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65309282|NCT02557984|Dopamine Agents|dopamine agents|mesh-ancestor
65309283|NCT02557984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65309284|NCT02557984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309285|NCT02557984|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65309286|NCT02557984|Antidepressive Agents|antidepressive agents|mesh-ancestor
65309287|NCT00759928|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65309288|NCT00759928|Sorafenib|sorafenib|mesh-list
65309289|NCT00759928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65309357|NCT00670306|Fertility Agents|fertility agents|mesh-ancestor
65309358|NCT00670306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65309359|NCT00670306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309360|NCT00670306|Hormone Antagonists|hormone antagonists|mesh-ancestor
65309361|NCT00670306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65309362|NCT00709254|Fentanyl|fentanyl|mesh-list
65309363|NCT00709254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65309364|NCT00709254|Narcotics|narcotics|mesh-ancestor
65309365|NCT00709254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65059280|NCT00244556|Analgesics|analgesics|mesh-ancestor
65309366|NCT00709254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309367|NCT00709254|Analgesics|analgesics|mesh-ancestor
65309368|NCT00709254|Sensory System Agents|sensory system agents|mesh-ancestor
64539137|NCT01418365|Metronidazole|metronidazole|mesh-list
65309445|NCT00766402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65309446|NCT00766402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309447|NCT00766402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309448|NCT00766402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65309449|NCT00766402|Narcotics|narcotics|mesh-ancestor
65309450|NCT00766402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65309451|NCT00771706|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65309452|NCT00771706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309453|NCT00771706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309454|NCT00760864|Methotrexate|methotrexate|mesh-list
65309455|NCT00760864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65309456|NCT00760864|Abortifacient Agents|abortifacient agents|mesh-ancestor
65309457|NCT00760864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65309458|NCT00760864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309459|NCT00760864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65309460|NCT00760864|Antimetabolites|antimetabolites|mesh-ancestor
65309461|NCT00760864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309462|NCT00760864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65309463|NCT00760864|Dermatologic Agents|dermatologic agents|mesh-ancestor
65309464|NCT00760864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309465|NCT00760864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65309466|NCT00760864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65309467|NCT00760864|Immunologic Factors|immunologic factors|mesh-ancestor
65309481|NCT00772174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309483|NCT00772564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65309484|NCT00772564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65309485|NCT00772564|Antimetabolites|antimetabolites|mesh-ancestor
65309486|NCT00772564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309487|NCT00772564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65309488|NCT00772564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65309489|NCT00772564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309490|NCT00766870|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65309491|NCT00766870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65309492|NCT00766870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65309493|NCT00766870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65309494|NCT00766870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309495|NCT00766870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65309496|NCT00766870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309497|NCT00766870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65309498|NCT00766870|Antidepressive Agents|antidepressive agents|mesh-ancestor
65309499|NCT00766870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65309500|NCT00772720|Raltegravir Potassium|raltegravir potassium|mesh-list
65309501|NCT00772720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65309502|NCT00772720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65309503|NCT00772720|Antiviral Agents|antiviral agents|mesh-ancestor
65309504|NCT00772720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65309505|NCT00772720|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65309506|NCT00772720|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65309507|NCT00772720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309508|NCT00772720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309509|NCT00775294|Maraviroc|maraviroc|mesh-list
65309510|NCT00775294|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65309511|NCT00775294|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65309512|NCT00775294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309513|NCT00775294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65309514|NCT00775294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65309515|NCT00775294|Antiviral Agents|antiviral agents|mesh-ancestor
65309516|NCT00775294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65309517|NCT00775294|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65309519|NCT00772798|Carboplatin|carboplatin|mesh-list
65309520|NCT00772798|Vorinostat|vorinostat|mesh-list
65309521|NCT00772798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65309522|NCT00772798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65309523|NCT00772798|Tubulin Modulators|tubulin modulators|mesh-ancestor
65309524|NCT00772798|Antimitotic Agents|antimitotic agents|mesh-ancestor
65309525|NCT00772798|Mitosis Modulators|mitosis modulators|mesh-ancestor
65309526|NCT00772798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309527|NCT00772798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65309528|NCT00772798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309529|NCT00570778|Glycopyrrolate|glycopyrrolate|mesh-list
65309544|NCT00775372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65309545|NCT00668746|Minocycline|minocycline|mesh-list
65309546|NCT00668746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65309547|NCT00668746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65309548|NCT04047940|Metformin|metformin|mesh-list
65309549|NCT04047940|Valsartan|valsartan|mesh-list
65309550|NCT04047940|Atorvastatin|atorvastatin|mesh-list
65309551|NCT04047940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65309552|NCT04047940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309553|NCT04047940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65309554|NCT04047940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65309555|NCT04047940|Antimetabolites|antimetabolites|mesh-ancestor
65309556|NCT04047940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309557|NCT04047940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65309558|NCT04047940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65309559|NCT04047940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309560|NCT04047940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65309561|NCT04047940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65309562|NCT04047940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65309563|NCT00773188|Bevacizumab|bevacizumab|mesh-list
65309564|NCT00773188|Vinorelbine|vinorelbine|mesh-list
65309565|NCT00773188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65309566|NCT00773188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65309567|NCT00773188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65309568|NCT00773188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65309569|NCT00773188|Growth Substances|growth substances|mesh-ancestor
65309570|NCT00773188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309571|NCT00773188|Growth Inhibitors|growth inhibitors|mesh-ancestor
65309572|NCT00773188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65309573|NCT00773188|Tubulin Modulators|tubulin modulators|mesh-ancestor
65309574|NCT00773188|Antimitotic Agents|antimitotic agents|mesh-ancestor
65309575|NCT00773188|Mitosis Modulators|mitosis modulators|mesh-ancestor
65309576|NCT00773188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309577|NCT00767260|Insulin|insulin|mesh-list
65309578|NCT00767260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65309579|NCT00767260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309580|NCT00767494|Travoprost|travoprost|mesh-list
65309581|NCT00767494|Brinzolamide|brinzolamide|mesh-list
65309582|NCT00767494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65309583|NCT00767494|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65309584|NCT00767494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309585|NCT00767494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217207|NCT02752113|Hormones|hormones|mesh-ancestor
65309586|NCT00773578|Nitric Oxide|nitric oxide|mesh-list
65309587|NCT00773578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65309588|NCT00773578|Autonomic Agents|autonomic agents|mesh-ancestor
65309597|NCT00773578|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65309598|NCT00773578|Vasodilator Agents|vasodilator agents|mesh-ancestor
65309599|NCT00773578|Gasotransmitters|gasotransmitters|mesh-ancestor
65309600|NCT00773578|Protective Agents|protective agents|mesh-ancestor
65309602|NCT00775762|Clopidogrel|clopidogrel|mesh-list
65309603|NCT00775762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65309604|NCT00775762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65309605|NCT00775762|Analgesics|analgesics|mesh-ancestor
65309606|NCT00775762|Sensory System Agents|sensory system agents|mesh-ancestor
65309607|NCT00775762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65309608|NCT00775762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309609|NCT00775762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65309610|NCT00775762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65309611|NCT00775762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65309612|NCT00775762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65309613|NCT00775762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309614|NCT00775762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65309615|NCT00775762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65309616|NCT00775762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309617|NCT00775762|Antipyretics|antipyretics|mesh-ancestor
65309618|NCT00775762|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65309619|NCT00775762|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65309620|NCT00775762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65309621|NCT00775762|Purinergic Agents|purinergic agents|mesh-ancestor
65309622|NCT00775762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65309623|NCT00775840|Candesartan|candesartan|mesh-list
65309624|NCT00775840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65309625|NCT00775840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65309626|NCT00775840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65309627|NCT00775840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309628|NCT00775918|Doxycycline|doxycycline|mesh-list
65309629|NCT00775918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65309630|NCT00775918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65309631|NCT00775918|Antimalarials|antimalarials|mesh-ancestor
65309632|NCT00775918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65309633|NCT00775918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65309634|NCT00775996|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
65309635|NCT00775996|Anticonvulsants|anticonvulsants|mesh-ancestor
65309636|NCT00775996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65309637|NCT00775996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65309638|NCT00775996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65309639|NCT00775996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309640|NCT00775996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65309641|NCT00775996|GABA Modulators|gaba modulators|mesh-ancestor
65309642|NCT00775996|GABA Agents|gaba agents|mesh-ancestor
65309643|NCT00775996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65309644|NCT00775996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309645|NCT00773812|Mecamylamine|mecamylamine|mesh-list
65309646|NCT00773812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65309647|NCT00773812|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
65309648|NCT00773812|Autonomic Agents|autonomic agents|mesh-ancestor
65309649|NCT00773812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65309650|NCT00773812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309651|NCT00773812|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65309652|NCT00773812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65309653|NCT00773812|Cholinergic Agents|cholinergic agents|mesh-ancestor
65309662|NCT00767728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059562|NCT00284193|Hemostatics|hemostatics|mesh-ancestor
65309663|NCT00767728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65309664|NCT00767728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65309666|NCT00776074|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65309667|NCT00776074|Fertility Agents|fertility agents|mesh-ancestor
65309668|NCT00776074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65309669|NCT00776074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309670|NCT00776074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65309671|NCT00776074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65309672|NCT02628587|Clopidogrel|clopidogrel|mesh-list
65309673|NCT02628587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65309674|NCT02628587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65309675|NCT02628587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65217295|NCT04554771|Paclitaxel|paclitaxel|mesh-list
65309676|NCT02628587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65309677|NCT02628587|Purinergic Agents|purinergic agents|mesh-ancestor
65309678|NCT02628587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65309679|NCT02628587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309680|NCT02628587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309681|NCT02634437|Ulipristal acetate|ulipristal acetate|mesh-list
65309682|NCT02634437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65309683|NCT02634437|Contraceptive Agents|contraceptive agents|mesh-ancestor
65309684|NCT02634437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65309685|NCT02634437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309686|NCT02634437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65309687|NCT00668200|Vitamin D|vitamin d|mesh-list
65309688|NCT00668200|Zoledronic Acid|zoledronic acid|mesh-list
65309689|NCT00668200|Calcium|calcium|mesh-list
65309690|NCT00668200|Vitamins|vitamins|mesh-ancestor
65309691|NCT00668200|Micronutrients|micronutrients|mesh-ancestor
65309692|NCT00668200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309693|NCT00668200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65309694|NCT00668200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65309695|NCT00679601|Tavaborole|tavaborole|mesh-list
65309696|NCT00679601|Antifungal Agents|antifungal agents|mesh-ancestor
65309697|NCT00679601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65309698|NCT00675779|Atorvastatin|atorvastatin|mesh-list
65309699|NCT00675779|Contraceptive Agents|contraceptive agents|mesh-list
65309700|NCT00675779|Contraceptives, Oral|contraceptives, oral|mesh-list
65309701|NCT00675779|Dacuronium|dacuronium|mesh-list
65309702|NCT00675779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65309703|NCT00675779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65309704|NCT00675779|Antimetabolites|antimetabolites|mesh-ancestor
65309705|NCT00675779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309706|NCT00675779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65309707|NCT00675779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65309708|NCT00675779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309709|NCT00675779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65309710|NCT00675779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309711|NCT00675779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65309712|NCT00675779|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65309713|NCT00675779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65309714|NCT00675779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65309715|NCT00675779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65309716|NCT00774280|Cyclophosphamide|cyclophosphamide|mesh-list
65309717|NCT00774280|Busulfan|busulfan|mesh-list
65309718|NCT00774280|Fludarabine|fludarabine|mesh-list
64539466|NCT00656487|Hormones|hormones|mesh-ancestor
65309731|NCT00774358|Aldesleukin|aldesleukin|mesh-list
65309732|NCT00774358|Interleukin-2|interleukin-2|mesh-list
65309733|NCT00774358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65309734|NCT00774358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65309735|NCT00774358|Analgesics|analgesics|mesh-ancestor
65309736|NCT00774358|Sensory System Agents|sensory system agents|mesh-ancestor
65059642|NCT00284271|Hormones|hormones|mesh-ancestor
65309737|NCT00774358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65309738|NCT00774358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309739|NCT00774358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65309740|NCT00774358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65309741|NCT00774358|Antiviral Agents|antiviral agents|mesh-ancestor
65309742|NCT00774358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65309744|NCT02627417|Prednisone|prednisone|mesh-list
65309745|NCT02627417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65309746|NCT02627417|Glucocorticoids|glucocorticoids|mesh-ancestor
65309747|NCT02627417|Hormones|hormones|mesh-ancestor
65309748|NCT02627417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65309749|NCT02627417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309750|NCT02627417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65309751|NCT02627417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65309752|NCT02627417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65309753|NCT02627417|Antimalarials|antimalarials|mesh-ancestor
65309754|NCT02627417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65309755|NCT02627417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65309756|NCT02627417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65309757|NCT02627417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309758|NCT02627417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309759|NCT02627417|Leprostatic Agents|leprostatic agents|mesh-ancestor
65309760|NCT02627417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65309761|NCT00679679|Metformin|metformin|mesh-list
65309762|NCT00679679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65309763|NCT00679679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309764|NCT00838578|Irinotecan|irinotecan|mesh-list
65309765|NCT00838578|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65309766|NCT00838578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65309767|NCT00838578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309768|NCT00838578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309769|NCT00838578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65309770|NCT02634515|Insulin|insulin|mesh-list
65309771|NCT02634515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65309772|NCT02634515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65309773|NCT02634515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309774|NCT00705900|Calcipotriene|calcipotriene|mesh-list
65309775|NCT00705900|Dermatologic Agents|dermatologic agents|mesh-ancestor
65309776|NCT00679835|Daptomycin|daptomycin|mesh-list
65309777|NCT00679835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65309778|NCT00679835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65309779|NCT00774904|Losartan|losartan|mesh-list
65309780|NCT00774904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65309781|NCT00774904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64539529|NCT01442155|Oxaliplatin|oxaliplatin|mesh-list
65309815|NCT00881621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65309816|NCT00881621|Antimetabolites|antimetabolites|mesh-ancestor
65309817|NCT00881621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309818|NCT00881621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310416|NCT00780598|Tosedostat|tosedostat|mesh-list
65310417|NCT00780598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310418|NCT00780598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310419|NCT00780754|Dutasteride|dutasteride|mesh-list
65310420|NCT00780754|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65310421|NCT00780754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65310422|NCT00780754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310423|NCT00780754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310424|NCT00780754|Hormone Antagonists|hormone antagonists|mesh-ancestor
65310425|NCT00780754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65310426|NCT00780754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310427|NCT00780832|Caffeine|caffeine|mesh-list
65310428|NCT00780832|Cholinergic Antagonists|cholinergic antagonists|mesh-list
65310429|NCT00780832|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65310430|NCT00780832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310431|NCT00780832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65310432|NCT00780832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310433|NCT00780832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310434|NCT00780832|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65310435|NCT00780832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65310436|NCT00780832|Purinergic Agents|purinergic agents|mesh-ancestor
65310437|NCT00780832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65310438|NCT00780832|Cholinergic Agents|cholinergic agents|mesh-ancestor
65310439|NCT00597701|Lorazepam|lorazepam|mesh-list
65310440|NCT00597701|Baclofen|baclofen|mesh-list
65310441|NCT00597701|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65310442|NCT00597701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310443|NCT00597701|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65310444|NCT00597701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65310445|NCT00597701|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65310446|NCT00597701|GABA Agonists|gaba agonists|mesh-ancestor
65310447|NCT00597701|GABA Agents|gaba agents|mesh-ancestor
65310448|NCT00597701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65310449|NCT00597701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310450|NCT00597701|Anticonvulsants|anticonvulsants|mesh-ancestor
65310451|NCT00597701|Antiemetics|antiemetics|mesh-ancestor
65310452|NCT00597701|Autonomic Agents|autonomic agents|mesh-ancestor
65310453|NCT00597701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65310454|NCT00597701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65310455|NCT00597701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65310456|NCT00597701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65310457|NCT00597701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65310458|NCT00597701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65310459|NCT00597701|GABA Modulators|gaba modulators|mesh-ancestor
65310460|NCT02556658|Anesthetics|anesthetics|mesh-list
65310461|NCT02556658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65310462|NCT02556658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310463|NCT00682721|Valacyclovir|valacyclovir|mesh-list
65310464|NCT00682721|Antiviral Agents|antiviral agents|mesh-ancestor
65310465|NCT00682721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65310466|NCT02556814|Dexamethasone|dexamethasone|mesh-list
65310467|NCT02556814|Caffeic acid|caffeic acid|mesh-list
65310468|NCT02556814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65310469|NCT02556814|Antiemetics|antiemetics|mesh-ancestor
65310470|NCT02556814|Autonomic Agents|autonomic agents|mesh-ancestor
65310471|NCT02556814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65310472|NCT02556814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310473|NCT02556814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65310474|NCT02556814|Glucocorticoids|glucocorticoids|mesh-ancestor
65310475|NCT02556814|Hormones|hormones|mesh-ancestor
65310476|NCT02556814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65344939|NCT00864136|Contraceptive Agents|contraceptive agents|mesh-ancestor
65310640|NCT00667420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310641|NCT00667420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65310642|NCT00667420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65310643|NCT00667420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65310644|NCT00667420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310844|NCT00778414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310845|NCT00778414|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65310846|NCT00769288|2'-fluoro-5-ethylarabinosyluracil|2'-fluoro-5-ethylarabinosyluracil|mesh-list
65310847|NCT00769288|Deoxyuridine|deoxyuridine|mesh-list
65310848|NCT00769288|Antimetabolites|antimetabolites|mesh-ancestor
65310849|NCT00769288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310850|NCT00769288|Antiviral Agents|antiviral agents|mesh-ancestor
65310851|NCT00769288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65310852|NCT00769288|Growth Inhibitors|growth inhibitors|mesh-ancestor
65310853|NCT00769288|Growth Substances|growth substances|mesh-ancestor
65310854|NCT00769288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310855|NCT00912938|Zoledronic Acid|zoledronic acid|mesh-list
65310923|NCT00769522|Immunologic Factors|immunologic factors|mesh-ancestor
65310924|NCT00769522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310925|NCT00769522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65310926|NCT00769522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65310927|NCT00769522|Alkylating Agents|alkylating agents|mesh-ancestor
65310928|NCT00769522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310929|NCT00769522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310930|NCT00769522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64540679|NCT00601965|Serotonin Agents|serotonin agents|mesh-ancestor
65310966|NCT00782548|Analgesics|analgesics|mesh-ancestor
65310967|NCT00782548|Sensory System Agents|sensory system agents|mesh-ancestor
65310968|NCT00782548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65310969|NCT00689195|Curcumin|curcumin|mesh-list
64540717|NCT00602355|Sertraline|sertraline|mesh-list
65311001|NCT00691067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65311002|NCT00691067|Contraceptive Agents|contraceptive agents|mesh-ancestor
65311003|NCT00691067|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65311004|NCT00691067|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65311005|NCT00691067|Hormone Antagonists|hormone antagonists|mesh-ancestor
65311006|NCT00691067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65311007|NCT00691067|Luteolytic Agents|luteolytic agents|mesh-ancestor
65311040|NCT02624453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311041|NCT02624453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65311042|NCT02624453|Hormone Antagonists|hormone antagonists|mesh-ancestor
65311043|NCT02624453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65311044|NCT02624453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311045|NCT02624453|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65311046|NCT02624453|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65311047|NCT02624453|Antiviral Agents|antiviral agents|mesh-ancestor
65311048|NCT00819234|Pramlintide|pramlintide|mesh-list
65311049|NCT00819234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65311082|NCT00667342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65311083|NCT00667342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65311084|NCT00667342|Antimetabolites|antimetabolites|mesh-ancestor
65311085|NCT00667342|Dermatologic Agents|dermatologic agents|mesh-ancestor
65311086|NCT00667342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65311087|NCT00667342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65311088|NCT00667342|Immunologic Factors|immunologic factors|mesh-ancestor
65311089|NCT00667342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65311090|NCT00667342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65311091|NCT00667342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64540835|NCT05392374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311128|NCT02555800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65311129|NCT02555800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65217507|NCT04217421|Antimetabolites|antimetabolites|mesh-ancestor
65311160|NCT00783250|Parasympatholytics|parasympatholytics|mesh-ancestor
65311161|NCT00783250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65311162|NCT00783250|Cholinergic Agents|cholinergic agents|mesh-ancestor
65311163|NCT00783250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65311164|NCT00783250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311166|NCT00783250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65311167|NCT00783250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65311168|NCT00783250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65311169|NCT00783250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65311170|NCT00783250|Adrenergic Agents|adrenergic agents|mesh-ancestor
65311171|NCT02555644|Cetuximab|cetuximab|mesh-list
65311172|NCT02555644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311173|NCT02555644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65311174|NCT00871403|Pemetrexed|pemetrexed|mesh-list
65311249|NCT05298683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65311250|NCT05298683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311251|NCT05298683|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65311252|NCT05298683|Antipruritics|antipruritics|mesh-ancestor
65311345|NCT01022983|Vasodilator Agents|vasodilator agents|mesh-ancestor
65311346|NCT01022983|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65311347|NCT01022983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65311348|NCT01022983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311349|NCT01022983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311350|NCT01022983|Protective Agents|protective agents|mesh-ancestor
65311351|NCT01022983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311353|NCT00912860|Interferon-beta|interferon-beta|mesh-list
65311354|NCT00912860|Interferon beta-1a|interferon beta-1a|mesh-list
65311355|NCT00912860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311356|NCT00912860|Antiviral Agents|antiviral agents|mesh-ancestor
65311357|NCT00912860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65311358|NCT00912860|Immunologic Factors|immunologic factors|mesh-ancestor
65311359|NCT00912860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311360|NCT00912860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65311361|NCT02623673|Dexamethasone|dexamethasone|mesh-list
65311362|NCT02623673|Bevacizumab|bevacizumab|mesh-list
65311363|NCT02623673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65311364|NCT02623673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311365|NCT02623673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65311366|NCT02623673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65311367|NCT02623673|Growth Substances|growth substances|mesh-ancestor
65311368|NCT02623673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311369|NCT02623673|Growth Inhibitors|growth inhibitors|mesh-ancestor
65311370|NCT02623673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65311371|NCT02623673|Antiemetics|antiemetics|mesh-ancestor
65311372|NCT02623673|Autonomic Agents|autonomic agents|mesh-ancestor
65311373|NCT02623673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65311406|NCT00783484|GABA Modulators|gaba modulators|mesh-ancestor
65311407|NCT00783484|GABA Agents|gaba agents|mesh-ancestor
65311408|NCT00783484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65311409|NCT00783484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311410|NCT00783484|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65311411|NCT00783484|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65311412|NCT00783484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65311413|NCT00783484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65311414|NCT00783484|Antiviral Agents|antiviral agents|mesh-ancestor
65311415|NCT00783484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541176|NCT03113994|Antacids|antacids|mesh-ancestor
65311444|NCT00873119|Carboplatin|carboplatin|mesh-list
65311445|NCT00873119|Belinostat|belinostat|mesh-list
65311446|NCT00873119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65311447|NCT00873119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311448|NCT00873119|Tubulin Modulators|tubulin modulators|mesh-ancestor
65311449|NCT00873119|Antimitotic Agents|antimitotic agents|mesh-ancestor
65311450|NCT00873119|Mitosis Modulators|mitosis modulators|mesh-ancestor
65311451|NCT00873119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311452|NCT00873119|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65311453|NCT00873119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311454|NCT00661726|Decitabine|decitabine|mesh-list
65311455|NCT00661726|Azacitidine|azacitidine|mesh-list
65311456|NCT00661726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65311457|NCT00661726|Antimetabolites|antimetabolites|mesh-ancestor
65311458|NCT00661726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311459|NCT00661726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311460|NCT00661726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541256|NCT04766827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311603|NCT00696215|Rasagiline|rasagiline|mesh-list
65311604|NCT00696215|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65311605|NCT00696215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311606|NCT00696215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311607|NCT00696215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65311608|NCT00696215|Protective Agents|protective agents|mesh-ancestor
65311609|NCT00696215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311610|NCT00784186|Misoprostol|misoprostol|mesh-list
65311611|NCT00784186|Mifepristone|mifepristone|mesh-list
65311612|NCT00784186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65311613|NCT00784186|Abortifacient Agents|abortifacient agents|mesh-ancestor
65311614|NCT00784186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65311615|NCT00784186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541371|NCT05089344|Clomiphene|clomiphene|mesh-list
65311650|NCT00785122|Immunologic Factors|immunologic factors|mesh-ancestor
65311651|NCT00785122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311652|NCT00785122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65311653|NCT00785122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65311654|NCT00785122|Alkylating Agents|alkylating agents|mesh-ancestor
64541410|NCT04726098|Autonomic Agents|autonomic agents|mesh-ancestor
65311680|NCT00790114|Anesthetics, General|anesthetics, general|mesh-ancestor
65311681|NCT00790114|Anesthetics|anesthetics|mesh-ancestor
65311682|NCT00790114|GABA Modulators|gaba modulators|mesh-ancestor
65311683|NCT00790114|GABA Agents|gaba agents|mesh-ancestor
65311684|NCT00790114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65311685|NCT00790114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311686|NCT00790114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65311687|NCT00790114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65311688|NCT00790114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311689|NCT00790114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65311690|NCT00790114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65311691|NCT00790114|Purinergic Agents|purinergic agents|mesh-ancestor
65311692|NCT01023139|Sibutramine|sibutramine|mesh-list
65311693|NCT01023139|Antidepressive Agents|antidepressive agents|mesh-ancestor
65311694|NCT01023139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65311695|NCT01023139|Appetite Depressants|appetite depressants|mesh-ancestor
65311696|NCT01023139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65311697|NCT00459043|Docetaxel|docetaxel|mesh-list
65311698|NCT00459043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311699|NCT00459043|Tubulin Modulators|tubulin modulators|mesh-ancestor
65311700|NCT00459043|Antimitotic Agents|antimitotic agents|mesh-ancestor
65311701|NCT00459043|Mitosis Modulators|mitosis modulators|mesh-ancestor
65311702|NCT00459043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311703|NCT00795262|Thioctic Acid|thioctic acid|mesh-list
65311704|NCT00795262|Quinapril|quinapril|mesh-list
65311705|NCT00795262|Antioxidants|antioxidants|mesh-ancestor
65311727|NCT02611518|Metformin|metformin|mesh-list
65311728|NCT02611518|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65311729|NCT02611518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65311730|NCT02611518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311731|NCT02611518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65311732|NCT02611518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65311733|NCT02611518|Antimetabolites|antimetabolites|mesh-ancestor
65311734|NCT02611518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311735|NCT02611518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65311736|NCT02611518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65311737|NCT02611518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311738|NCT01023607|Atorvastatin|atorvastatin|mesh-list
65311739|NCT01023607|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65311740|NCT01023607|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65311741|NCT01023607|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65311742|NCT01023607|Antimetabolites|antimetabolites|mesh-ancestor
65311743|NCT01023607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311744|NCT01023607|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65311745|NCT01023607|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65311746|NCT01023607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311747|NCT00665002|Sargramostim|sargramostim|mesh-list
65311748|NCT00665002|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65311749|NCT00665002|Immunologic Factors|immunologic factors|mesh-ancestor
65311750|NCT00665002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311751|NCT00665002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65311752|NCT00660010|Leuprolide|leuprolide|mesh-list
65311753|NCT00660010|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65311754|NCT00660010|Fertility Agents|fertility agents|mesh-ancestor
65311755|NCT00660010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65311756|NCT00660010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311757|NCT00660010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65311758|NCT00660010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311890|NCT04135781|Antimitotic Agents|antimitotic agents|mesh-ancestor
65311891|NCT04135781|Mitosis Modulators|mitosis modulators|mesh-ancestor
65311892|NCT04135781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311893|NCT04135781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65311894|NCT04135781|Antimetabolites|antimetabolites|mesh-ancestor
65311895|NCT04135313|Capecitabine|capecitabine|mesh-list
65311896|NCT04135313|Oxaliplatin|oxaliplatin|mesh-list
65311995|NCT04676958|Micronutrients|micronutrients|mesh-ancestor
65311996|NCT04676958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311997|NCT04676958|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65311998|NCT04676958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64541797|NCT01396057|Dexamethasone|dexamethasone|mesh-list
65312056|NCT00786058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312057|NCT00871169|Oxaliplatin|oxaliplatin|mesh-list
65312058|NCT00871169|Irinotecan|irinotecan|mesh-list
65312059|NCT00871169|Cetuximab|cetuximab|mesh-list
65312060|NCT00871169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312061|NCT00871169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65312062|NCT00871169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65312063|NCT00871169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312064|NCT00871169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312065|NCT00871169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65312066|NCT00791284|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65312067|NCT00791284|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65312068|NCT00791284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65312069|NCT00791284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65312070|NCT00791284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312071|NCT00791284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65312072|NCT00791284|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65312073|NCT00791284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65312074|NCT00791284|Serotonin Agents|serotonin agents|mesh-ancestor
65312075|NCT00791284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65312076|NCT00791284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312077|NCT00791284|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65312078|NCT00791284|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65312079|NCT00791284|Dopamine Agents|dopamine agents|mesh-ancestor
65312080|NCT00814632|Apremilast|apremilast|mesh-list
65312081|NCT00814632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65312082|NCT00814632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65312083|NCT00814632|Analgesics|analgesics|mesh-ancestor
65312084|NCT00814632|Sensory System Agents|sensory system agents|mesh-ancestor
65312085|NCT00814632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64541818|NCT04011163|Narcotics|narcotics|mesh-ancestor
65312219|NCT00797056|Purinergic Agents|purinergic agents|mesh-ancestor
65312220|NCT00797056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65312221|NCT00593957|Dextromethorphan|dextromethorphan|mesh-list
65312222|NCT00593957|Antitussive Agents|antitussive agents|mesh-ancestor
65312223|NCT00593957|Respiratory System Agents|respiratory system agents|mesh-ancestor
65312224|NCT00593957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65312225|NCT00593957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65312226|NCT00593957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65312263|NCT00851084|Growth Substances|growth substances|mesh-ancestor
65312264|NCT00851084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312342|NCT00693251|Everolimus|everolimus|mesh-list
65312343|NCT00693251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65312344|NCT00693251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312345|NCT00693251|Tubulin Modulators|tubulin modulators|mesh-ancestor
65312346|NCT00693251|Antimitotic Agents|antimitotic agents|mesh-ancestor
65312347|NCT00693251|Mitosis Modulators|mitosis modulators|mesh-ancestor
65312348|NCT00693251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312349|NCT00693251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65312350|NCT00693251|Immunologic Factors|immunologic factors|mesh-ancestor
65312411|NCT04030988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312413|NCT00703352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65312414|NCT00703352|Hormone Antagonists|hormone antagonists|mesh-ancestor
65312415|NCT00703352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65312416|NCT00703352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312417|NCT00703352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65312418|NCT00703352|Diuretics|diuretics|mesh-ancestor
65312419|NCT00703352|Natriuretic Agents|natriuretic agents|mesh-ancestor
65312420|NCT00703352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65217730|NCT02745093|Hormone Antagonists|hormone antagonists|mesh-ancestor
65312421|NCT00703430|Memantine|memantine|mesh-list
65312422|NCT00703430|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65312423|NCT00703430|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65312424|NCT00703430|Dopamine Agents|dopamine agents|mesh-ancestor
65312425|NCT00703430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65344943|NCT00864136|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65312548|NCT00809328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65312549|NCT00809328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65312551|NCT00798148|Etoposide|etoposide|mesh-list
65312552|NCT00798148|Melphalan|melphalan|mesh-list
65312553|NCT00798148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312554|NCT00798148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65312555|NCT00798148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65312556|NCT00798148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65312557|NCT00798148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312558|NCT00798148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312590|NCT00798460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312592|NCT00798460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65312593|NCT00798460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65312594|NCT00798460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65312595|NCT02615873|Levodopa|levodopa|mesh-list
65312596|NCT02615873|Carbidopa|carbidopa|mesh-list
65312597|NCT02615873|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65312598|NCT02615873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65312599|NCT02615873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65312600|NCT02615873|Dopamine Agents|dopamine agents|mesh-ancestor
65312601|NCT02615873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65312632|NCT00659230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65312633|NCT00659230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312634|NCT00659230|Protective Agents|protective agents|mesh-ancestor
65312635|NCT00809094|Acetylcysteine|acetylcysteine|mesh-list
65312636|NCT00809094|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65312637|NCT00809094|Antiviral Agents|antiviral agents|mesh-ancestor
65312638|NCT00809094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65312639|NCT00809094|Expectorants|expectorants|mesh-ancestor
65312640|NCT00809094|Respiratory System Agents|respiratory system agents|mesh-ancestor
65312641|NCT00809094|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65312642|NCT00809094|Antioxidants|antioxidants|mesh-ancestor
65312643|NCT00809094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312644|NCT00809094|Protective Agents|protective agents|mesh-ancestor
65312770|NCT02615561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312772|NCT00793234|Anticoagulants|anticoagulants|mesh-ancestor
65312773|NCT00793234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65312774|NCT00793234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65312775|NCT00793234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312776|NCT00697775|Vaccines|vaccines|mesh-list
65312777|NCT00697775|Immunologic Factors|immunologic factors|mesh-ancestor
65312778|NCT00697775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312779|NCT04133051|Bupivacaine|bupivacaine|mesh-list
65312780|NCT04133051|Anesthetics, Local|anesthetics, local|mesh-ancestor
65312781|NCT04133051|Anesthetics|anesthetics|mesh-ancestor
65312782|NCT04133051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65312783|NCT04133051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312784|NCT04133051|Sensory System Agents|sensory system agents|mesh-ancestor
65312785|NCT04133051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65312786|NCT00788242|Insulin|insulin|mesh-list
65312787|NCT00788242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65312788|NCT00788242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312789|NCT04031027|Apremilast|apremilast|mesh-list
65312790|NCT04031027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65312791|NCT04031027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65312792|NCT04031027|Analgesics|analgesics|mesh-ancestor
65312793|NCT04031027|Sensory System Agents|sensory system agents|mesh-ancestor
65312794|NCT04031027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65312795|NCT04031027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312796|NCT04031027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65312797|NCT04031027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65312798|NCT04031027|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64542546|NCT01409837|Lisinopril|lisinopril|mesh-list
65312860|NCT00914004|Adrenergic Agents|adrenergic agents|mesh-ancestor
65312861|NCT00914004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65312862|NCT00914004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312863|NCT00867113|Imatinib Mesylate|imatinib mesylate|mesh-list
65312864|NCT00867113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269809|NCT02737670|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
65269810|NCT02737670|Anticoagulants|anticoagulants|mesh-ancestor
65269811|NCT02737670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65269812|NCT02737670|Antimetabolites|antimetabolites|mesh-ancestor
65269813|NCT02737670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269814|NCT02737670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65269815|NCT02737670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65269816|NCT02737670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65269817|NCT02737670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65269818|NCT02737670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269819|NCT02728310|Levobupivacaine|levobupivacaine|mesh-list
65269820|NCT02728310|Anesthetics, Local|anesthetics, local|mesh-ancestor
65269821|NCT02728310|Anesthetics|anesthetics|mesh-ancestor
65269822|NCT02728310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65269823|NCT02728310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269824|NCT02728310|Sensory System Agents|sensory system agents|mesh-ancestor
65269825|NCT02728310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65269826|NCT00636584|Nitroprusside|nitroprusside|mesh-list
65269827|NCT00636584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65269828|NCT00636584|Vasodilator Agents|vasodilator agents|mesh-ancestor
65269829|NCT00636584|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65269830|NCT00636584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269831|NCT02732756|Oxymetazoline|oxymetazoline|mesh-list
65312865|NCT00867113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65312866|NCT00867113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312867|NCT00867113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312868|NCT02608710|Verinurad|verinurad|mesh-list
65312869|NCT02608710|Gout Suppressants|gout suppressants|mesh-ancestor
65312870|NCT02608710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65312871|NCT04030260|Antibodies|antibodies|mesh-list
65312872|NCT04030260|Immunoglobulins|immunoglobulins|mesh-list
65312873|NCT04030260|Immunologic Factors|immunologic factors|mesh-ancestor
65312874|NCT04030260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312875|NCT00697385|Tranexamic Acid|tranexamic acid|mesh-list
65312876|NCT00697385|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65312877|NCT00697385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65312878|NCT00697385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312879|NCT00697385|Hemostatics|hemostatics|mesh-ancestor
64542632|NCT04044131|Sorbitol|sorbitol|mesh-list
65312916|NCT05754684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65312918|NCT05754684|Diuretics|diuretics|mesh-ancestor
65312919|NCT05754684|Natriuretic Agents|natriuretic agents|mesh-ancestor
65312920|NCT00694187|Zaleplon|zaleplon|mesh-list
65312921|NCT00694187|Anticonvulsants|anticonvulsants|mesh-ancestor
65312990|NCT00871871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312991|NCT00871871|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65312992|NCT00871871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65312993|NCT00871871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312994|NCT00871871|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65312995|NCT00871871|Vasodilator Agents|vasodilator agents|mesh-ancestor
65312996|NCT00871871|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65269832|NCT02732756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65312998|NCT02608788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65312999|NCT02608788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65313244|NCT00663052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313245|NCT00663052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313246|NCT00663052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65313247|NCT00663052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65313248|NCT00663052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65313249|NCT00663052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65313250|NCT00663052|Immunologic Factors|immunologic factors|mesh-ancestor
65313251|NCT05599880|Bortezomib|bortezomib|mesh-list
65313252|NCT05599880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313253|NCT00707252|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64542992|NCT02471118|Adalimumab|adalimumab|mesh-list
65313318|NCT00591006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313319|NCT00591006|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65313320|NCT00591006|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65313321|NCT00788398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65313323|NCT00844844|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65313324|NCT00844844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65313360|NCT00836810|Prednisone|prednisone|mesh-list
65313361|NCT00836810|Prednisolone|prednisolone|mesh-list
65313362|NCT00836810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65313363|NCT00836810|Glucocorticoids|glucocorticoids|mesh-ancestor
65313364|NCT00836810|Hormones|hormones|mesh-ancestor
64543103|NCT05102058|Dexmedetomidine|dexmedetomidine|mesh-list
65313453|NCT04130477|Trace Elements|trace elements|mesh-ancestor
65313454|NCT04130477|Micronutrients|micronutrients|mesh-ancestor
65313455|NCT04130477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313456|NCT00794326|Dialysis Solutions|dialysis solutions|mesh-list
65313457|NCT00794326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65313458|NCT00702728|Furosemide|furosemide|mesh-list
65313459|NCT00702728|Diuretics|diuretics|mesh-ancestor
65313460|NCT00702728|Natriuretic Agents|natriuretic agents|mesh-ancestor
65313549|NCT00794638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313550|NCT00801580|Doxorubicin|doxorubicin|mesh-list
65313551|NCT00801580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65313552|NCT00801580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65313553|NCT00801580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313554|NCT00801580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65313555|NCT00801580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65313556|NCT00801580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313557|NCT00801580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313558|NCT04951492|Olaparib|olaparib|mesh-list
65313559|NCT04951492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65313560|NCT04951492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313561|NCT04951492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313562|NCT04951492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313563|NCT00805194|Docetaxel|docetaxel|mesh-list
65313564|NCT00805194|Nintedanib|nintedanib|mesh-list
65313565|NCT00805194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313566|NCT00805194|Tubulin Modulators|tubulin modulators|mesh-ancestor
65313567|NCT00805194|Antimitotic Agents|antimitotic agents|mesh-ancestor
65313568|NCT00805194|Mitosis Modulators|mitosis modulators|mesh-ancestor
65313569|NCT00805194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313570|NCT00805194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65313571|NCT00805194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313572|NCT00657046|Droxidopa|droxidopa|mesh-list
65313573|NCT00657046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65313574|NCT00657046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64714158|NCT02831569|Loxoprofen|loxoprofen|mesh-list
65313701|NCT00652834|Mycophenolic Acid|mycophenolic acid|mesh-list
65313702|NCT00652834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65313703|NCT00652834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313704|NCT00652834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65313705|NCT00652834|Antitubercular Agents|antitubercular agents|mesh-ancestor
65313706|NCT00652834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65313707|NCT00652834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65313708|NCT00652834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313709|NCT00652834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313710|NCT00825812|Atropine|atropine|mesh-list
65313711|NCT00825812|Neostigmine|neostigmine|mesh-list
65313712|NCT00825812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65313713|NCT00825812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65313714|NCT00825812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65313715|NCT00825812|Autonomic Agents|autonomic agents|mesh-ancestor
65269833|NCT02732756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65217936|NCT03673527|Tacrolimus|tacrolimus|mesh-list
65313716|NCT00825812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313747|NCT05746572|Hallucinogens|hallucinogens|mesh-ancestor
65313748|NCT05746572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313749|NCT05746572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65313750|NCT05746572|Serotonin Agents|serotonin agents|mesh-ancestor
65313751|NCT05746572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65313752|NCT05746572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313753|NCT05746572|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65313754|NCT05746572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65313755|NCT05746572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65313756|NCT05746572|Adrenergic Agents|adrenergic agents|mesh-ancestor
65313757|NCT00802828|Famotidine|famotidine|mesh-list
65313758|NCT00802828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65313759|NCT00802828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65313760|NCT00802828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65313793|NCT00803374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65313794|NCT00803374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313795|NCT00803374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65313796|NCT00803374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313797|NCT00803374|Immunologic Factors|immunologic factors|mesh-ancestor
65313798|NCT00803374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313800|NCT00803530|Antioxidants|antioxidants|mesh-ancestor
65313801|NCT00803530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313802|NCT00803530|Protective Agents|protective agents|mesh-ancestor
64543592|NCT04022473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65313868|NCT05753436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65313869|NCT05753436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65313870|NCT05753436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313871|NCT05753436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313872|NCT05753436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313873|NCT05753280|Vitamin D|vitamin d|mesh-list
65313874|NCT05753280|Vitamins|vitamins|mesh-ancestor
65313875|NCT05753280|Micronutrients|micronutrients|mesh-ancestor
65313876|NCT05753280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313877|NCT05753280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65313878|NCT05739942|Temozolomide|temozolomide|mesh-list
65313879|NCT05739942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65313880|NCT05739942|Alkylating Agents|alkylating agents|mesh-ancestor
64543675|NCT04716114|Cytarabine|cytarabine|mesh-list
65313907|NCT00708344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65313908|NCT00708344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313909|NCT00708344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65313910|NCT00708344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65313911|NCT00866333|Entinostat|entinostat|mesh-list
65313912|NCT00866333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313913|NCT00866333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65313914|NCT00866333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313915|NCT00866333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313916|NCT00834080|Naltrexone|naltrexone|mesh-list
65313917|NCT00834080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65313918|NCT00834080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65313919|NCT00834080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313920|NCT00834080|Sensory System Agents|sensory system agents|mesh-ancestor
65313921|NCT00834080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313922|NCT00823472|Ganirelix|ganirelix|mesh-list
65313923|NCT00823472|Hormone Antagonists|hormone antagonists|mesh-ancestor
65313924|NCT00823472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65313925|NCT00823472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313926|NCT04118699|Rifaximin|rifaximin|mesh-list
64543712|NCT04025593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65313961|NCT00652366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65313962|NCT00841568|Tolvaptan|tolvaptan|mesh-list
65313963|NCT00841568|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65313964|NCT00841568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543774|NCT03022123|Prednisone|prednisone|mesh-list
65313989|NCT00699881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65313990|NCT00699881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313992|NCT00708578|Insulin Glargine|insulin glargine|mesh-list
65313993|NCT00708578|Glimepiride|glimepiride|mesh-list
65313994|NCT00708578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65269834|NCT02732756|Adrenergic Agents|adrenergic agents|mesh-ancestor
65313995|NCT00708578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313996|NCT00708578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65313997|NCT00708578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65313998|NCT00708578|Immunologic Factors|immunologic factors|mesh-ancestor
65313999|NCT00704678|Sevelamer|sevelamer|mesh-list
65314000|NCT00704678|Chelating Agents|chelating agents|mesh-ancestor
65314001|NCT00704678|Sequestering Agents|sequestering agents|mesh-ancestor
65314002|NCT00704678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314003|NCT00708656|Mesalamine|mesalamine|mesh-list
65314004|NCT00708656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65314005|NCT00708656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65063913|NCT01332292|Xhance|xhance|mesh-list
65063967|NCT00291759|Tamoxifen|tamoxifen|mesh-list
65314006|NCT00708656|Analgesics|analgesics|mesh-ancestor
65314007|NCT00708656|Sensory System Agents|sensory system agents|mesh-ancestor
65314008|NCT00708656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65314009|NCT00708656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314010|NCT00708656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65314011|NCT00708656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65314012|NCT00913328|Montelukast|montelukast|mesh-list
65314013|NCT00913328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65314014|NCT00913328|Respiratory System Agents|respiratory system agents|mesh-ancestor
65314037|NCT03307785|Growth Substances|growth substances|mesh-ancestor
65314038|NCT03307785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314039|NCT03307785|Growth Inhibitors|growth inhibitors|mesh-ancestor
65314040|NCT03307785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314041|NCT03307785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65314042|NCT03307785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65314043|NCT03307785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65314044|NCT00804310|Lapatinib|lapatinib|mesh-list
65314045|NCT00804310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314046|NCT00804310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65314047|NCT00804310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314048|NCT00804310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314049|NCT04118777|Ropivacaine|ropivacaine|mesh-list
65314050|NCT04118777|Anesthetics, Local|anesthetics, local|mesh-ancestor
65314051|NCT04118777|Anesthetics|anesthetics|mesh-ancestor
65314052|NCT04118777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65314053|NCT04118777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314054|NCT04118777|Sensory System Agents|sensory system agents|mesh-ancestor
65314055|NCT04118777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65314056|NCT00708812|Paclitaxel|paclitaxel|mesh-list
65314057|NCT00708812|Carboplatin|carboplatin|mesh-list
65314058|NCT00708812|Endostar protein|endostar protein|mesh-list
65314059|NCT00708812|Endostatins|endostatins|mesh-list
65314060|NCT00708812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65314061|NCT00708812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314062|NCT00708812|Tubulin Modulators|tubulin modulators|mesh-ancestor
65314063|NCT00708812|Antimitotic Agents|antimitotic agents|mesh-ancestor
65314064|NCT00708812|Mitosis Modulators|mitosis modulators|mesh-ancestor
64543846|NCT00723099|Fludarabine phosphate|fludarabine phosphate|mesh-list
65314095|NCT00822770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65314097|NCT00822770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314098|NCT00822770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65314099|NCT00822770|Immunologic Factors|immunologic factors|mesh-ancestor
65314100|NCT00822770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314101|NCT00822770|Antiviral Agents|antiviral agents|mesh-ancestor
65314102|NCT00822770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65314103|NCT00822770|Alkylating Agents|alkylating agents|mesh-ancestor
65314104|NCT00822770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65314105|NCT00822770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65314127|NCT02607111|Tinzaparin|tinzaparin|mesh-list
65314128|NCT02607111|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65314129|NCT02607111|Anticoagulants|anticoagulants|mesh-ancestor
65314130|NCT02607111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65314131|NCT02607111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65314132|NCT02607111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314133|NCT00703196|Folic Acid|folic acid|mesh-list
65314134|NCT00703196|Hematinics|hematinics|mesh-ancestor
65314135|NCT00703196|Vitamin B Complex|vitamin b complex|mesh-ancestor
65314136|NCT00703196|Vitamins|vitamins|mesh-ancestor
65314137|NCT00703196|Micronutrients|micronutrients|mesh-ancestor
65314138|NCT00703196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314139|NCT00913250|Interferon beta-1a|interferon beta-1a|mesh-list
65314140|NCT00913250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65314141|NCT00913250|Immunologic Factors|immunologic factors|mesh-ancestor
65314142|NCT00913250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314143|NCT00913250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314144|NCT00913250|Antiviral Agents|antiviral agents|mesh-ancestor
65314145|NCT00913250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65314146|NCT00914277|Sildenafil Citrate|sildenafil citrate|mesh-list
65314147|NCT00914277|Vasodilator Agents|vasodilator agents|mesh-ancestor
65314148|NCT00914277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65314149|NCT00914277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65314150|NCT00914277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314151|NCT00914277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314152|NCT00914277|Urological Agents|urological agents|mesh-ancestor
65314153|NCT00704756|Ribavirin|ribavirin|mesh-list
65314154|NCT00704756|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65314155|NCT00704756|Interferon-alpha|interferon-alpha|mesh-list
65314156|NCT00704756|Antimetabolites|antimetabolites|mesh-ancestor
65314157|NCT00704756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314158|NCT00704756|Antiviral Agents|antiviral agents|mesh-ancestor
65314247|NCT00839306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65314248|NCT00839306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65314249|NCT00839306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314250|NCT00839306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314251|NCT00839306|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65314252|NCT00839306|Histamine Antagonists|histamine antagonists|mesh-ancestor
65314253|NCT00839306|Histamine Agents|histamine agents|mesh-ancestor
65314254|NCT00839306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64544047|NCT04144933|Gabapentin|gabapentin|mesh-list
65314287|NCT03553836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314288|NCT02607774|Midazolam|midazolam|mesh-list
65314289|NCT02607774|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65314290|NCT02607774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65314291|NCT02607774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65314292|NCT02607774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314293|NCT02607774|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65314294|NCT02607774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65314295|NCT02607774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65314296|NCT02607774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65314297|NCT02607774|Anesthetics, General|anesthetics, general|mesh-ancestor
65314298|NCT02607774|Anesthetics|anesthetics|mesh-ancestor
65314330|NCT00803712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65314331|NCT00803712|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65314332|NCT00803712|Hormone Antagonists|hormone antagonists|mesh-ancestor
65314333|NCT00803712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65314334|NCT00803634|Antihypertensive Agents|antihypertensive agents|mesh-list
65314336|NCT00803634|Nitroprusside|nitroprusside|mesh-list
65314337|NCT00803634|Nicardipine|nicardipine|mesh-list
65314338|NCT00803634|Clevidipine|clevidipine|mesh-list
65314339|NCT00803634|Isosorbide|isosorbide|mesh-list
65314340|NCT00803634|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65314341|NCT00803634|Nitroglycerin|nitroglycerin|mesh-list
65314342|NCT00803634|Vasodilator Agents|vasodilator agents|mesh-ancestor
65314343|NCT00803634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64544134|NCT04143685|Oxytocin|oxytocin|mesh-list
65314374|NCT02611466|Analgesics|analgesics|mesh-ancestor
65314375|NCT02611466|Sensory System Agents|sensory system agents|mesh-ancestor
65314376|NCT02611466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65314377|NCT02611466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314378|NCT02611466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65314379|NCT02611466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65314380|NCT02611466|Gout Suppressants|gout suppressants|mesh-ancestor
65314381|NCT02611466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65314382|NCT02611466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314383|NCT02611466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314384|NCT02688270|Nitroglycerin|nitroglycerin|mesh-list
65314385|NCT02688270|Vasodilator Agents|vasodilator agents|mesh-ancestor
64544183|NCT04917588|Lidocaine|lidocaine|mesh-list
65314449|NCT00806286|Antimitotic Agents|antimitotic agents|mesh-ancestor
65314450|NCT00806286|Mitosis Modulators|mitosis modulators|mesh-ancestor
65314451|NCT00806286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314452|NCT03537924|Acetazolamide|acetazolamide|mesh-list
65314453|NCT03537924|Anticonvulsants|anticonvulsants|mesh-ancestor
65314454|NCT03537924|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65314455|NCT03537924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314456|NCT03537924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314457|NCT03537924|Diuretics|diuretics|mesh-ancestor
65314458|NCT03537924|Natriuretic Agents|natriuretic agents|mesh-ancestor
65064343|NCT01330459|Lorazepam|lorazepam|mesh-list
65218166|NCT00734851|Docetaxel|docetaxel|mesh-list
65314459|NCT03537924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314461|NCT00590538|Genistein|genistein|mesh-list
65314462|NCT00590538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314463|NCT00590538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65314464|NCT00590538|Protective Agents|protective agents|mesh-ancestor
65314465|NCT00590538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314466|NCT00590538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65314467|NCT00590538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314468|NCT00590538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314469|NCT00590538|Phytoestrogens|phytoestrogens|mesh-ancestor
65314470|NCT00590538|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65314532|NCT04110873|Micronutrients|micronutrients|mesh-ancestor
65064460|NCT00293163|Hylan|hylan|mesh-list
65314533|NCT04110873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314534|NCT02604615|Capecitabine|capecitabine|mesh-list
65314535|NCT02604615|Oxaliplatin|oxaliplatin|mesh-list
65314536|NCT02604615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65314537|NCT02604615|Antimetabolites|antimetabolites|mesh-ancestor
65314538|NCT02604615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314539|NCT02604615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314540|NCT00796107|Letrozole|letrozole|mesh-list
65314541|NCT00796107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314542|NCT00796107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65314543|NCT00796107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65314544|NCT00796107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314545|NCT00796107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314546|NCT00796107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65314547|NCT00796107|Hormone Antagonists|hormone antagonists|mesh-ancestor
65314548|NCT00796107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65314549|NCT00796107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314550|NCT00805740|Caspofungin|caspofungin|mesh-list
65314551|NCT00805740|Anidulafungin|anidulafungin|mesh-list
65314552|NCT00805740|Antifungal Agents|antifungal agents|mesh-ancestor
65314581|NCT01227876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314582|NCT00795639|Sitaxsentan|sitaxsentan|mesh-list
65314583|NCT00795639|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65314584|NCT00795639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314585|NCT05297292|Ranibizumab|ranibizumab|mesh-list
65314586|NCT05297292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65314587|NCT05297292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65314588|NCT05297292|Growth Substances|growth substances|mesh-ancestor
65314589|NCT05297292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314590|NCT05297292|Growth Inhibitors|growth inhibitors|mesh-ancestor
65314591|NCT05297292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314592|NCT02604459|Fentanyl|fentanyl|mesh-list
65314593|NCT02604459|Anesthetics|anesthetics|mesh-list
65314594|NCT02604459|Propofol|propofol|mesh-list
65314595|NCT02604459|Sevoflurane|sevoflurane|mesh-list
65314596|NCT02604459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65314597|NCT02604459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314598|NCT02604459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65314599|NCT02604459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65314626|NCT02607072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314627|NCT02607072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65314628|NCT02607072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65314630|NCT02607072|Antipyretics|antipyretics|mesh-ancestor
65314631|NCT04110093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65314632|NCT04110093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314633|NCT04110093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314634|NCT03161652|Ranibizumab|ranibizumab|mesh-list
65314635|NCT03161652|Dopamine|dopamine|mesh-list
65314636|NCT03161652|Sulpiride|sulpiride|mesh-list
65314637|NCT03161652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65314638|NCT03161652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65314639|NCT03161652|Growth Substances|growth substances|mesh-ancestor
65314640|NCT03161652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314641|NCT03161652|Growth Inhibitors|growth inhibitors|mesh-ancestor
65314642|NCT03161652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314643|NCT03161652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65314644|NCT03161652|Sympathomimetics|sympathomimetics|mesh-ancestor
65314645|NCT03161652|Autonomic Agents|autonomic agents|mesh-ancestor
65314646|NCT03161652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65314677|NCT04109859|Methylene Blue|methylene blue|mesh-list
65314678|NCT04109859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218238|NCT02737527|Levobupivacaine|levobupivacaine|mesh-list
65314679|NCT04109859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314680|NCT00790023|Ciclesonide|ciclesonide|mesh-list
65314681|NCT00790023|Glucocorticoids|glucocorticoids|mesh-ancestor
65314682|NCT00790023|Hormones|hormones|mesh-ancestor
65314683|NCT00790023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65314684|NCT00790023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314685|NCT00790023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65314686|NCT00588822|Rituximab|rituximab|mesh-list
65314687|NCT00588822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65314688|NCT00588822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314742|NCT03746275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65314743|NCT03746275|Analgesics|analgesics|mesh-ancestor
65314744|NCT03746275|Sensory System Agents|sensory system agents|mesh-ancestor
65314745|NCT03746275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65314746|NCT03746275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314747|NCT03746275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65314748|NCT03746275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65314749|NCT03746275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65314750|NCT03746275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65314751|NCT03746275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314752|NCT03746275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65314753|NCT03746275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65314754|NCT03746275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314755|NCT03746275|Antipyretics|antipyretics|mesh-ancestor
65314756|NCT03746275|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65314757|NCT03746275|Antithrombins|antithrombins|mesh-ancestor
65314758|NCT03746275|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65314760|NCT03746275|Anticoagulants|anticoagulants|mesh-ancestor
65314761|NCT01026415|Rifampin|rifampin|mesh-list
65314762|NCT01026415|Ketoconazole|ketoconazole|mesh-list
65314763|NCT01026415|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65314764|NCT01026415|Midazolam|midazolam|mesh-list
65314787|NCT01026415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65314788|NCT01026415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65314789|NCT01026415|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65314790|NCT01026415|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65314791|NCT01026415|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65314792|NCT01026415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65314793|NCT01026415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65314794|NCT01026415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314795|NCT01026415|Immunologic Factors|immunologic factors|mesh-ancestor
65314796|NCT01026415|Antifungal Agents|antifungal agents|mesh-ancestor
65314797|NCT01026415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65314798|NCT01026415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65314799|NCT01026415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65314800|NCT01026415|Hormone Antagonists|hormone antagonists|mesh-ancestor
65314801|NCT01026415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65314802|NCT01026415|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65314803|NCT01026727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65314804|NCT01026727|Antiviral Agents|antiviral agents|mesh-ancestor
65314805|NCT01026727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65314807|NCT02604966|Antimalarials|antimalarials|mesh-ancestor
65314808|NCT02604966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65314809|NCT02604966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65314810|NCT02604966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65314811|NCT02604966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314812|NCT02604966|Antiviral Agents|antiviral agents|mesh-ancestor
65314813|NCT02604966|Schistosomicides|schistosomicides|mesh-ancestor
65314814|NCT02604966|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65314815|NCT02604966|Anthelmintics|anthelmintics|mesh-ancestor
65314848|NCT00802074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314849|NCT00802074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314850|NCT00802074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65314851|NCT00802074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65314852|NCT00802074|Antiviral Agents|antiviral agents|mesh-ancestor
65314853|NCT00802074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65314854|NCT00802074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65314855|NCT00802074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65314856|NCT00802074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65314857|NCT00802074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65314858|NCT04112394|Anesthetics|anesthetics|mesh-list
65314859|NCT04112394|Anesthetics, Local|anesthetics, local|mesh-list
65218300|NCT04089163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65314929|NCT00449761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314930|NCT00800982|Etanercept|etanercept|mesh-list
65314931|NCT00800982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65314932|NCT00800982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64544727|NCT05583175|Venetoclax|venetoclax|mesh-list
65314963|NCT01026961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314964|NCT01026961|Antipyretics|antipyretics|mesh-ancestor
65314965|NCT01026961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314966|NCT01026961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65314967|NCT01026961|Mydriatics|mydriatics|mesh-ancestor
65314968|NCT01026961|Autonomic Agents|autonomic agents|mesh-ancestor
65314969|NCT01026961|Sympathomimetics|sympathomimetics|mesh-ancestor
65314970|NCT01026961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65314971|NCT01026961|Nasal Decongestants|nasal decongestants|mesh-ancestor
65314972|NCT01026961|Respiratory System Agents|respiratory system agents|mesh-ancestor
65314973|NCT01026961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65314974|NCT01026961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65314975|NCT01026961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65314976|NCT01026961|Adrenergic Agents|adrenergic agents|mesh-ancestor
65314977|NCT01026961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65315005|NCT03849313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65315006|NCT04111614|Tofacitinib|tofacitinib|mesh-list
65315007|NCT04111614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65315008|NCT04111614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315009|NCT04111614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315010|NCT01023919|Sirolimus|sirolimus|mesh-list
65315011|NCT01023919|Paclitaxel|paclitaxel|mesh-list
65315012|NCT01023919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65315013|NCT01023919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315014|NCT01023919|Tubulin Modulators|tubulin modulators|mesh-ancestor
65315015|NCT01023919|Antimitotic Agents|antimitotic agents|mesh-ancestor
65315016|NCT01023919|Mitosis Modulators|mitosis modulators|mesh-ancestor
65315017|NCT01023919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315018|NCT01023919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65315019|NCT01023919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65315020|NCT01023919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65315021|NCT01023919|Antifungal Agents|antifungal agents|mesh-ancestor
65315022|NCT01023919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65315023|NCT01023919|Immunologic Factors|immunologic factors|mesh-ancestor
65315024|NCT01023919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315025|NCT04028622|Anesthetics|anesthetics|mesh-list
65315026|NCT04028622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65315027|NCT04028622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315028|NCT00830804|Ritonavir|ritonavir|mesh-list
65315029|NCT00830804|Darunavir|darunavir|mesh-list
65315063|NCT05756348|Protective Agents|protective agents|mesh-list
65315064|NCT05756348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315065|NCT00913874|Valproic Acid|valproic acid|mesh-list
65315066|NCT00913874|Anticonvulsants|anticonvulsants|mesh-ancestor
65315067|NCT00913874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315068|NCT00913874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315069|NCT00913874|GABA Agents|gaba agents|mesh-ancestor
65315070|NCT00913874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65315124|NCT02605434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315125|NCT02605434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315126|NCT02605434|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65315127|NCT02605434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315128|NCT02605434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65315129|NCT02605434|Immunologic Factors|immunologic factors|mesh-ancestor
65315130|NCT02605434|Dopamine Agonists|dopamine agonists|mesh-ancestor
65315132|NCT00863681|Enzyme Activators|enzyme activators|mesh-ancestor
65315133|NCT00863681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315134|NCT05758298|Nicotine|nicotine|mesh-list
65315135|NCT05758298|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65315136|NCT05758298|Autonomic Agents|autonomic agents|mesh-ancestor
65315137|NCT05758298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65315138|NCT05758298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315139|NCT05758298|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65315140|NCT05758298|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65315141|NCT05758298|Cholinergic Agents|cholinergic agents|mesh-ancestor
65315142|NCT05758298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65315143|NCT05758298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315144|NCT00789321|Amlodipine|amlodipine|mesh-list
65218374|NCT00734071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65315145|NCT00789321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65315146|NCT00789321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65315147|NCT00789321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65315148|NCT00789321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315149|NCT00789321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65315150|NCT00789321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315183|NCT00591734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65315184|NCT00591734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65315185|NCT00591734|Growth Substances|growth substances|mesh-ancestor
65315186|NCT00591734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315187|NCT00591734|Growth Inhibitors|growth inhibitors|mesh-ancestor
65315188|NCT00591734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65315189|NCT00591734|Immunologic Factors|immunologic factors|mesh-ancestor
65315190|NCT00848549|Carbamazepine|carbamazepine|mesh-list
65315191|NCT00848549|Zonisamide|zonisamide|mesh-list
65315218|NCT04116359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65315219|NCT04116359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65315220|NCT04116359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65315221|NCT04116359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315222|NCT04116359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315223|NCT04116359|Keratolytic Agents|keratolytic agents|mesh-ancestor
65315224|NCT04116359|Dermatologic Agents|dermatologic agents|mesh-ancestor
65315225|NCT04116359|Tubulin Modulators|tubulin modulators|mesh-ancestor
65315226|NCT04116359|Antimitotic Agents|antimitotic agents|mesh-ancestor
65315227|NCT04116359|Mitosis Modulators|mitosis modulators|mesh-ancestor
65315228|NCT04118153|Abatacept|abatacept|mesh-list
65315229|NCT04118153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65315230|NCT04118153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315231|NCT04118153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315232|NCT04118153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65315233|NCT04118153|Immunologic Factors|immunologic factors|mesh-ancestor
65315234|NCT04118153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315235|NCT04118153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65315236|NCT00848393|Fentanyl|fentanyl|mesh-list
65315237|NCT00848393|Dexmedetomidine|dexmedetomidine|mesh-list
65315238|NCT00848393|Citric Acid|citric acid|mesh-list
65315239|NCT00848393|Sodium Citrate|sodium citrate|mesh-list
65315272|NCT00815516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65315273|NCT00815516|Antifungal Agents|antifungal agents|mesh-ancestor
65315274|NCT00815516|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65315275|NCT00815516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65315276|NCT00705926|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65315277|NCT00705926|Antiviral Agents|antiviral agents|mesh-ancestor
65315278|NCT00705926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65315279|NCT00787917|Omalizumab|omalizumab|mesh-list
65315280|NCT00787917|Itraconazole|itraconazole|mesh-list
65315281|NCT00787917|Antifungal Agents|antifungal agents|mesh-ancestor
65315282|NCT00787917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65315283|NCT00787917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65315349|NCT00787527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65315350|NCT00787527|Tubulin Modulators|tubulin modulators|mesh-ancestor
65315351|NCT00787527|Antimitotic Agents|antimitotic agents|mesh-ancestor
65315352|NCT00787527|Mitosis Modulators|mitosis modulators|mesh-ancestor
65315353|NCT00787527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65315354|NCT00804388|Vitamin E|vitamin e|mesh-list
65315355|NCT00804388|Vitamins|vitamins|mesh-ancestor
65315356|NCT00804388|Micronutrients|micronutrients|mesh-ancestor
65315357|NCT00804388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315358|NCT00804388|Antioxidants|antioxidants|mesh-ancestor
65315359|NCT00804388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315360|NCT00804388|Protective Agents|protective agents|mesh-ancestor
65315385|NCT00448435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65315386|NCT00448435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65315387|NCT00448435|Autonomic Agents|autonomic agents|mesh-ancestor
65315388|NCT00448435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65315389|NCT00448435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315390|NCT00448435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65315391|NCT00448435|Respiratory System Agents|respiratory system agents|mesh-ancestor
65315392|NCT00448435|Dermatologic Agents|dermatologic agents|mesh-ancestor
65315393|NCT00448435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65315394|NCT00448435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65315395|NCT00448435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65315396|NCT00448435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65315397|NCT00448435|Adrenergic Agents|adrenergic agents|mesh-ancestor
65315398|NCT00448435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65315399|NCT00448435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315400|NCT00448435|Glucocorticoids|glucocorticoids|mesh-ancestor
65315401|NCT00448435|Hormones|hormones|mesh-ancestor
65315402|NCT00448435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65315403|NCT00448435|Sympathomimetics|sympathomimetics|mesh-ancestor
65315404|NCT00804622|Tenofovir|tenofovir|mesh-list
65315405|NCT00804622|Telbivudine|telbivudine|mesh-list
65315406|NCT00804622|Antiviral Agents|antiviral agents|mesh-ancestor
65315407|NCT00804622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65315408|NCT00804622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65315409|NCT00804622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65315410|NCT00804622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315411|NCT00804622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315412|NCT00804622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65315413|NCT00804622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65315476|NCT00807196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315477|NCT00807196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315478|NCT00807196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65315479|NCT00807196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65315481|NCT00448123|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65315482|NCT00448123|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65315483|NCT00448123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65315484|NCT00448123|Adrenergic Agents|adrenergic agents|mesh-ancestor
65315485|NCT00448123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65315486|NCT00448123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545277|NCT03583021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65315511|NCT00805090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315512|NCT00805090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65315513|NCT00805090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65315514|NCT00805090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65315515|NCT00805090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315516|NCT00805090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315517|NCT00805090|Antifungal Agents|antifungal agents|mesh-ancestor
65315518|NCT00805090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65315519|NCT00805090|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65315520|NCT00805090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65315521|NCT00805090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65315522|NCT00805090|Hormone Antagonists|hormone antagonists|mesh-ancestor
65315523|NCT00805090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65315524|NCT00805090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65315526|NCT00810862|Lactitol|lactitol|mesh-list
65315527|NCT00810862|Cathartics|cathartics|mesh-ancestor
65315528|NCT00810862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65315529|NCT00810862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65315530|NCT00810862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65315531|NCT00810862|Analgesics|analgesics|mesh-ancestor
65315532|NCT00810862|Sensory System Agents|sensory system agents|mesh-ancestor
65315533|NCT00810862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65315534|NCT00810862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315535|NCT00810862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65315536|NCT00810862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65066804|NCT00272597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65066805|NCT00272597|Dopamine Agents|dopamine agents|mesh-ancestor
65315583|NCT00447265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65315585|NCT00447265|Sensory System Agents|sensory system agents|mesh-ancestor
65315586|NCT00447265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65315587|NCT00447265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315588|NCT00447265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65315589|NCT00447265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65315590|NCT00447265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65315591|NCT00447265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65315592|NCT00447265|Immunologic Factors|immunologic factors|mesh-ancestor
65315593|NCT03641755|Olaparib|olaparib|mesh-list
65315594|NCT03641755|Sapacitabine|sapacitabine|mesh-list
65315595|NCT03641755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65315596|NCT03641755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315597|NCT03641755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315598|NCT03641755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315599|NCT00657358|Lidocaine|lidocaine|mesh-list
65315600|NCT00657358|Anesthetics, Local|anesthetics, local|mesh-ancestor
65315601|NCT00657358|Anesthetics|anesthetics|mesh-ancestor
65218520|NCT01026194|Pioglitazone|pioglitazone|mesh-list
65315602|NCT00657358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65315603|NCT00657358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315604|NCT00657358|Sensory System Agents|sensory system agents|mesh-ancestor
65315605|NCT00657358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65315606|NCT00657358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65315607|NCT00657358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65315608|NCT00657358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65315609|NCT00657358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65315610|NCT00657358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315611|NCT00457639|Cholic Acids|cholic acids|mesh-list
65315612|NCT00457639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65315613|NCT00800202|Paclitaxel|paclitaxel|mesh-list
65315614|NCT00800202|Bevacizumab|bevacizumab|mesh-list
65315641|NCT00811096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65315642|NCT00811096|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65315643|NCT05146804|Sulforaphane|sulforaphane|mesh-list
65315644|NCT05146804|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65315645|NCT05146804|Protective Agents|protective agents|mesh-ancestor
65315646|NCT05146804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315647|NCT05146804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315648|NCT00655486|Lacosamide|lacosamide|mesh-list
65315649|NCT00655486|Anticonvulsants|anticonvulsants|mesh-ancestor
65315650|NCT00655486|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65315651|NCT00655486|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65315652|NCT00655486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65315653|NCT00655486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315654|NCT04111302|Dezocine|dezocine|mesh-list
65315655|NCT04111302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65315656|NCT04111302|Narcotics|narcotics|mesh-ancestor
65315657|NCT04111302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65315658|NCT04111302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315659|NCT04111302|Analgesics|analgesics|mesh-ancestor
65315660|NCT04111302|Sensory System Agents|sensory system agents|mesh-ancestor
65315661|NCT04111302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65315662|NCT04111848|Ketamine|ketamine|mesh-list
65315663|NCT04111848|Analgesics|analgesics|mesh-ancestor
65315720|NCT00805558|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65315721|NCT00805558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65315722|NCT00805558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65315747|NCT02604186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65315748|NCT02604186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65315749|NCT02604186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315750|NCT02604186|Cholinergic Agents|cholinergic agents|mesh-ancestor
65315751|NCT02604186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65315752|NCT02604186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315753|NCT01024543|Phenylephrine|phenylephrine|mesh-list
65315754|NCT01024543|Oxymetazoline|oxymetazoline|mesh-list
65315755|NCT01024543|Angiotensin II|angiotensin ii|mesh-list
65315756|NCT01024543|Giapreza|giapreza|mesh-list
65315757|NCT01024543|Angiotensinogen|angiotensinogen|mesh-list
65315758|NCT01024543|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65315759|NCT01024543|Mydriatics|mydriatics|mesh-ancestor
65315760|NCT01024543|Autonomic Agents|autonomic agents|mesh-ancestor
65315761|NCT01024543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65315762|NCT01024543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315763|NCT01024543|Sympathomimetics|sympathomimetics|mesh-ancestor
65315764|NCT01024543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65315765|NCT01024543|Nasal Decongestants|nasal decongestants|mesh-ancestor
65315766|NCT01024543|Respiratory System Agents|respiratory system agents|mesh-ancestor
65315767|NCT01024543|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65315768|NCT01024543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65315769|NCT01024543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65315770|NCT01024543|Adrenergic Agents|adrenergic agents|mesh-ancestor
65315771|NCT01024543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65493917|NCT03930680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493918|NCT03930680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493919|NCT03930680|Protective Agents|protective agents|mesh-ancestor
65493920|NCT03930680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493921|NCT03930680|Antimitotic Agents|antimitotic agents|mesh-ancestor
65493922|NCT03930680|Mitosis Modulators|mitosis modulators|mesh-ancestor
65493923|NCT03913559|Acetaminophen|acetaminophen|mesh-list
65315785|NCT00811408|Cidofovir|cidofovir|mesh-list
65315786|NCT00811408|Carboplatin|carboplatin|mesh-list
65315787|NCT00811408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315788|NCT00811408|Antiviral Agents|antiviral agents|mesh-ancestor
64545683|NCT01671787|Tenofovir|tenofovir|mesh-list
65315817|NCT00855335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65315818|NCT00855335|Antiviral Agents|antiviral agents|mesh-ancestor
65315819|NCT00855335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65315820|NCT00855335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65315821|NCT00855335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65315822|NCT00855335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65315823|NCT00855335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65315824|NCT00811486|Spironolactone|spironolactone|mesh-list
65315825|NCT00811486|Conivaptan|conivaptan|mesh-list
65315826|NCT00811486|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65315827|NCT00811486|Hormone Antagonists|hormone antagonists|mesh-ancestor
65315828|NCT00811486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65315829|NCT00811486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315830|NCT00811486|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65315831|NCT00811486|Diuretics|diuretics|mesh-ancestor
65315832|NCT00811486|Natriuretic Agents|natriuretic agents|mesh-ancestor
65315833|NCT00811486|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65315890|NCT00446641|Respiratory System Agents|respiratory system agents|mesh-ancestor
65315891|NCT00446641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65315892|NCT00446641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65315893|NCT00446641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315894|NCT00446641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65315895|NCT00446641|Vasodilator Agents|vasodilator agents|mesh-ancestor
65315896|NCT00446641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65315897|NCT00446641|Protective Agents|protective agents|mesh-ancestor
65315898|NCT00446641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65315899|NCT00446641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65315900|NCT00446641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315901|NCT00646282|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
65315926|NCT00446563|Amlodipine|amlodipine|mesh-list
65315927|NCT00446563|Valsartan|valsartan|mesh-list
65315928|NCT00446563|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65315929|NCT00446563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65315930|NCT00446563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65315931|NCT00446563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65315932|NCT00446563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315933|NCT00446563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65315934|NCT00446563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315935|NCT00446563|Vasodilator Agents|vasodilator agents|mesh-ancestor
65315936|NCT00446563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65315937|NCT00446563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65315938|NCT00446563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65315939|NCT00446563|Diuretics|diuretics|mesh-ancestor
65315940|NCT00446563|Natriuretic Agents|natriuretic agents|mesh-ancestor
65315941|NCT00446563|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65315942|NCT00650806|Canagliflozin|canagliflozin|mesh-list
65315943|NCT00650806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65315944|NCT00650806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315945|NCT00650806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65315946|NCT00650806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315947|NCT00863057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65315948|NCT00863057|Methadone|methadone|mesh-list
65315949|NCT00863057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64545824|NCT01675128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315984|NCT00829166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315985|NCT00829166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315986|NCT00829166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65315987|NCT00829166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65315989|NCT00829166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65315990|NCT00829166|Tubulin Modulators|tubulin modulators|mesh-ancestor
65315991|NCT00829166|Antimitotic Agents|antimitotic agents|mesh-ancestor
65316022|NCT00814528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316023|NCT00814528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316024|NCT00814528|Interferon Inducers|interferon inducers|mesh-ancestor
65316026|NCT00814606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65316027|NCT00814606|Antimetabolites|antimetabolites|mesh-ancestor
65316028|NCT00814606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316029|NCT00814606|Antiviral Agents|antiviral agents|mesh-ancestor
65316030|NCT00814606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65316031|NCT00814762|Vaccines|vaccines|mesh-list
65218668|NCT02734173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65316032|NCT00814762|Immunologic Factors|immunologic factors|mesh-ancestor
65316033|NCT00814762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316034|NCT00654238|Sorafenib|sorafenib|mesh-list
65316035|NCT00654238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316036|NCT00654238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65316037|NCT00654238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316093|NCT04113954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65316094|NCT00812344|Ketoconazole|ketoconazole|mesh-list
65316095|NCT00812344|Antifungal Agents|antifungal agents|mesh-ancestor
65316096|NCT00812344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65316097|NCT00812344|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65316098|NCT00812344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65316099|NCT00812344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316100|NCT00812344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316101|NCT00812344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65316102|NCT00812344|Hormone Antagonists|hormone antagonists|mesh-ancestor
65316103|NCT00812344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65316104|NCT00812344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316105|NCT00812344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65316106|NCT00446251|Mycophenolic Acid|mycophenolic acid|mesh-list
65316107|NCT00446251|Rituximab|rituximab|mesh-list
65316108|NCT00446251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65316109|NCT00446251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316110|NCT00446251|Immunologic Factors|immunologic factors|mesh-ancestor
65316111|NCT00446251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316112|NCT00446251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65316113|NCT00446251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65316114|NCT00446251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65316115|NCT00446251|Antitubercular Agents|antitubercular agents|mesh-ancestor
65316116|NCT00446251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65316117|NCT00446251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65316118|NCT00446251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316119|NCT00446251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316120|NCT00812422|Ibuprofen|ibuprofen|mesh-list
65316121|NCT00812422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65316122|NCT00812422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65316123|NCT00812422|Analgesics|analgesics|mesh-ancestor
65316124|NCT00812422|Sensory System Agents|sensory system agents|mesh-ancestor
65316125|NCT00812422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65316126|NCT00812422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546005|NCT01675999|Antidotes|antidotes|mesh-ancestor
65316151|NCT00812578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65316152|NCT00796224|Azithromycin|azithromycin|mesh-list
65316153|NCT00796224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65316154|NCT00796224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65316155|NCT00808366|Antifungal Agents|antifungal agents|mesh-list
65316156|NCT00808366|Clotrimazole|clotrimazole|mesh-list
65316157|NCT00808366|Miconazole|miconazole|mesh-list
65316158|NCT00808366|Keratolytic Agents|keratolytic agents|mesh-list
65316159|NCT00808366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65316160|NCT00808366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65316161|NCT00808366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65316162|NCT00808366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65316163|NCT00808366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316164|NCT00808366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316165|NCT00808366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65316166|NCT00808366|Hormone Antagonists|hormone antagonists|mesh-ancestor
65316167|NCT00808366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65316168|NCT00808366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316169|NCT00808366|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65316170|NCT00808366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65316171|NCT00808366|Dermatologic Agents|dermatologic agents|mesh-ancestor
65316172|NCT04045522|Zoledronic Acid|zoledronic acid|mesh-list
64546064|NCT03841357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65316203|NCT04111380|Tubulin Modulators|tubulin modulators|mesh-ancestor
65316204|NCT04111380|Antimitotic Agents|antimitotic agents|mesh-ancestor
65316205|NCT04111380|Mitosis Modulators|mitosis modulators|mesh-ancestor
65316206|NCT04111380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316208|NCT04117919|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65316209|NCT04117919|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65316210|NCT04117919|Hydrocortisone|hydrocortisone|mesh-list
65218746|NCT02596555|Protease Inhibitors|protease inhibitors|mesh-ancestor
65316211|NCT04117919|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65316212|NCT04117919|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65316213|NCT04117919|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65316214|NCT04117919|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65316215|NCT04117919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65316280|NCT05645406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316281|NCT05645406|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65316283|NCT05645406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65316284|NCT05645406|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65316285|NCT00795600|Insulin|insulin|mesh-list
65316286|NCT00795600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65316287|NCT00795600|Insulin Detemir|insulin detemir|mesh-list
65316288|NCT00795600|Isophane Insulin, Human|isophane insulin, human|mesh-list
65316289|NCT00795600|Insulin, Isophane|insulin, isophane|mesh-list
65316290|NCT00795600|Isophane insulin, beef|isophane insulin, beef|mesh-list
65316291|NCT00795600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65316292|NCT00795600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316303|NCT00795132|Immunologic Factors|immunologic factors|mesh-ancestor
65316304|NCT00795132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316305|NCT00795132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316306|NCT00795132|Antifungal Agents|antifungal agents|mesh-ancestor
65316307|NCT00795132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65316308|NCT00795132|Dermatologic Agents|dermatologic agents|mesh-ancestor
65316309|NCT00795132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65316310|NCT00795132|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65316311|NCT00795132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65316312|NCT00795132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65316313|NCT00795132|Antitubercular Agents|antitubercular agents|mesh-ancestor
65316314|NCT00795132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65316315|NCT00795132|Alkylating Agents|alkylating agents|mesh-ancestor
65316316|NCT00795132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65316317|NCT00795132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65316319|NCT02604420|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65316320|NCT02604420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65316321|NCT02604420|Immunologic Factors|immunologic factors|mesh-ancestor
65316322|NCT02604420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316323|NCT04110210|Morphine|morphine|mesh-list
65316324|NCT04110210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65316325|NCT04110210|Narcotics|narcotics|mesh-ancestor
65316326|NCT04110210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64979075|NCT00274495|Rosiglitazone|rosiglitazone|mesh-list
65316360|NCT00646906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316361|NCT00646906|Antipyretics|antipyretics|mesh-ancestor
65316362|NCT00813436|Oxytocin|oxytocin|mesh-list
65316363|NCT00813436|Oxytocics|oxytocics|mesh-ancestor
65316364|NCT00813436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65316365|NCT00813436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316366|NCT00808678|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65316367|NCT00808678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65316368|NCT00808678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65316397|NCT00829010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316398|NCT00644332|Ranolazine|ranolazine|mesh-list
65316399|NCT00644332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65316400|NCT00644332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65316401|NCT00644332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316402|NCT00808912|Sildenafil Citrate|sildenafil citrate|mesh-list
65316403|NCT00808912|Vasodilator Agents|vasodilator agents|mesh-ancestor
65316404|NCT00808912|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65316405|NCT00808912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65316406|NCT00808912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316407|NCT00808912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316408|NCT00808912|Urological Agents|urological agents|mesh-ancestor
65316409|NCT02551042|Factor VIII|factor viii|mesh-list
65316410|NCT02551042|Coagulants|coagulants|mesh-ancestor
65316411|NCT00445939|Adalimumab|adalimumab|mesh-list
65316503|NCT00455923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316504|NCT00455923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65316505|NCT00455923|Respiratory System Agents|respiratory system agents|mesh-ancestor
65316506|NCT00455923|Glucocorticoids|glucocorticoids|mesh-ancestor
65316507|NCT00455923|Hormones|hormones|mesh-ancestor
65316508|NCT00455923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65316509|NCT00455923|Sympathomimetics|sympathomimetics|mesh-ancestor
65316510|NCT00455923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65316511|NCT00455923|Dermatologic Agents|dermatologic agents|mesh-ancestor
65218818|NCT00809926|Valsartan|valsartan|mesh-list
65316512|NCT00455923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65316513|NCT00642616|Insulin|insulin|mesh-list
65316600|NCT00642460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65316601|NCT00642460|Analgesics|analgesics|mesh-ancestor
65316602|NCT00642460|Sensory System Agents|sensory system agents|mesh-ancestor
65316603|NCT00642460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65316604|NCT00814658|Nimodipine|nimodipine|mesh-list
65316605|NCT00814658|Galantamine|galantamine|mesh-list
65316606|NCT00814658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65316607|NCT00814658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316608|NCT00814658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316609|NCT00814658|Cholinergic Agents|cholinergic agents|mesh-ancestor
65316610|NCT00814658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65316611|NCT00814658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316612|NCT00814658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65316613|NCT00814658|Autonomic Agents|autonomic agents|mesh-ancestor
65316614|NCT00814658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65316615|NCT00814658|Nootropic Agents|nootropic agents|mesh-ancestor
65316616|NCT00814658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65316617|NCT00814658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65316618|NCT00814658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65316619|NCT00814658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65316620|NCT00814658|Vasodilator Agents|vasodilator agents|mesh-ancestor
65316621|NCT00816634|Paclitaxel|paclitaxel|mesh-list
65316622|NCT00816634|Capecitabine|capecitabine|mesh-list
65316623|NCT00816634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65316624|NCT00816634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316649|NCT00643162|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65316650|NCT00643162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65316651|NCT00643162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65316652|NCT00643162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316654|NCT00643162|Serotonin Agents|serotonin agents|mesh-ancestor
65316655|NCT00643162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316656|NCT00643162|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65316657|NCT00643162|Antidepressive Agents|antidepressive agents|mesh-ancestor
65316658|NCT00643162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65316659|NCT00814502|Zolpidem|zolpidem|mesh-list
65316660|NCT00814502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65316661|NCT00814502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65316662|NCT00814502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65316663|NCT00814502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316664|NCT00814502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65316665|NCT00814502|GABA Agonists|gaba agonists|mesh-ancestor
65316666|NCT00814502|GABA Agents|gaba agents|mesh-ancestor
65316667|NCT00814502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65316668|NCT00814502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316669|NCT00653224|Levocetirizine|levocetirizine|mesh-list
65316670|NCT00653224|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65316671|NCT00653224|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65316672|NCT00653224|Histamine Antagonists|histamine antagonists|mesh-ancestor
65316673|NCT00653224|Histamine Agents|histamine agents|mesh-ancestor
65316753|NCT00818350|Growth Inhibitors|growth inhibitors|mesh-ancestor
65316754|NCT00818350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65316755|NCT00818350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316756|NCT00818350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316757|NCT00810602|Vorinostat|vorinostat|mesh-list
65316758|NCT00810602|Tacrolimus|tacrolimus|mesh-list
65316759|NCT00810602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65316760|NCT00810602|Immunologic Factors|immunologic factors|mesh-ancestor
65316761|NCT00810602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316762|NCT00810602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65316763|NCT00810602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316764|NCT00810602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316765|NCT00810602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316766|NCT00810602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65316767|NCT00816868|Capecitabine|capecitabine|mesh-list
65316768|NCT00816868|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65316769|NCT00816868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65316770|NCT00816868|Antimetabolites|antimetabolites|mesh-ancestor
65316771|NCT00816868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316772|NCT00816868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316773|NCT00816868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65316774|NCT00816868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316775|NCT05500586|Glucagon|glucagon|mesh-list
65316776|NCT05500586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65316777|NCT05500586|Hormones|hormones|mesh-ancestor
65316778|NCT05500586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65316779|NCT05500586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316844|NCT00455533|Mitosis Modulators|mitosis modulators|mesh-ancestor
65316845|NCT00455533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316846|NCT00455533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65316847|NCT00455533|Immunologic Factors|immunologic factors|mesh-ancestor
65316848|NCT00455533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316849|NCT00455533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65316850|NCT00455533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65316851|NCT00455533|Alkylating Agents|alkylating agents|mesh-ancestor
65316852|NCT00455533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65316853|NCT00455533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65316854|NCT00455533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65316855|NCT00455533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65316856|NCT00455533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316857|NCT05227742|Psilocybin|psilocybin|mesh-list
65316858|NCT05227742|Hallucinogens|hallucinogens|mesh-ancestor
65316859|NCT05227742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316860|NCT05227742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65316861|NCT00818584|Micafungin|micafungin|mesh-list
65316862|NCT00818584|Antifungal Agents|antifungal agents|mesh-ancestor
65316863|NCT00818584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65316896|NCT04581382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316897|NCT00818818|Meglumine Antimoniate|meglumine antimoniate|mesh-list
65316898|NCT00818818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65316899|NCT00818818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65316900|NCT00818818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65316902|NCT03840811|Ceftriaxone|ceftriaxone|mesh-list
65316903|NCT03840811|Cefixime|cefixime|mesh-list
65316904|NCT03840811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65316905|NCT03840811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65316906|NCT03840811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65316907|NCT03840811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65316908|NCT03840811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316953|NCT00627016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65316954|NCT00627016|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65316955|NCT00627016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316956|NCT00627016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316958|NCT00794664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65316959|NCT00794664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65316960|NCT00794664|Antimetabolites|antimetabolites|mesh-ancestor
65316961|NCT00794664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316962|NCT00794664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65316963|NCT00444535|Bevacizumab|bevacizumab|mesh-list
65316964|NCT00444535|Lapatinib|lapatinib|mesh-list
65316965|NCT00444535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65316966|NCT00444535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316967|NCT00444535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65316968|NCT00444535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65316969|NCT00444535|Growth Substances|growth substances|mesh-ancestor
65316970|NCT00444535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316971|NCT00444535|Growth Inhibitors|growth inhibitors|mesh-ancestor
65316972|NCT00444535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65316973|NCT00444535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316974|NCT00444535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316975|NCT04110288|Paclitaxel|paclitaxel|mesh-list
65316976|NCT04110288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65316977|NCT04110288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316978|NCT04110288|Tubulin Modulators|tubulin modulators|mesh-ancestor
65316979|NCT04110288|Antimitotic Agents|antimitotic agents|mesh-ancestor
65316980|NCT04110288|Mitosis Modulators|mitosis modulators|mesh-ancestor
65316981|NCT04110288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316982|NCT00826306|Sunscreening Agents|sunscreening agents|mesh-list
65316983|NCT00826306|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64311743|NCT03555929|Glucocorticoids|glucocorticoids|mesh-ancestor
65317054|NCT00807014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65317082|NCT04109742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317084|NCT00813488|Oxycodone|oxycodone|mesh-list
65317085|NCT00813488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65317086|NCT00813488|Narcotics|narcotics|mesh-ancestor
65317087|NCT00813488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65317088|NCT00813488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317089|NCT00813488|Analgesics|analgesics|mesh-ancestor
65317090|NCT00813488|Sensory System Agents|sensory system agents|mesh-ancestor
65317091|NCT00813488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317092|NCT00813488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65317093|NCT00813488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65317094|NCT00813488|Anesthetics, General|anesthetics, general|mesh-ancestor
65317095|NCT00813488|Anesthetics|anesthetics|mesh-ancestor
65317096|NCT00797316|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65317097|NCT00797316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65317098|NCT00797316|Diuretics|diuretics|mesh-ancestor
65317099|NCT00797316|Natriuretic Agents|natriuretic agents|mesh-ancestor
65317100|NCT00797316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317125|NCT04107480|Protective Agents|protective agents|mesh-ancestor
65317126|NCT00915408|Dexamethasone|dexamethasone|mesh-list
65317127|NCT00915408|Cyclophosphamide|cyclophosphamide|mesh-list
65317128|NCT00915408|Lenalidomide|lenalidomide|mesh-list
65317129|NCT00915408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65317130|NCT00915408|Immunologic Factors|immunologic factors|mesh-ancestor
65317131|NCT00915408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317132|NCT00915408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65317133|NCT00915408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65317134|NCT00915408|Alkylating Agents|alkylating agents|mesh-ancestor
65317135|NCT00915408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317136|NCT00915408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317137|NCT00915408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65317138|NCT00915408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65317139|NCT00915408|Antiemetics|antiemetics|mesh-ancestor
65317140|NCT00915408|Autonomic Agents|autonomic agents|mesh-ancestor
65317141|NCT00915408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317142|NCT00915408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65317143|NCT00915408|Glucocorticoids|glucocorticoids|mesh-ancestor
65317144|NCT00915408|Hormones|hormones|mesh-ancestor
65317145|NCT00915408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65317146|NCT00915408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65317147|NCT00915408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65317148|NCT00915408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65317201|NCT00806624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317202|NCT00806624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317203|NCT00624832|Omalizumab|omalizumab|mesh-list
65317204|NCT00624832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65317205|NCT00624832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65317206|NCT00624832|Respiratory System Agents|respiratory system agents|mesh-ancestor
65317207|NCT05753150|Primaquine|primaquine|mesh-list
65317208|NCT05753150|Tafenoquine|tafenoquine|mesh-list
65317209|NCT05753150|Antimalarials|antimalarials|mesh-ancestor
65317210|NCT05753150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65317211|NCT05753150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65317239|NCT04029428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317240|NCT04029428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65317241|NCT04029428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65317242|NCT04029428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317244|NCT00819520|Malathion|malathion|mesh-list
65317245|NCT00819520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65317246|NCT00819520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65317247|NCT00819520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65317248|NCT00819520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317249|NCT00819520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317250|NCT00819520|Cholinergic Agents|cholinergic agents|mesh-ancestor
65317251|NCT00819520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65317252|NCT00819520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317253|NCT00631696|Pregabalin|pregabalin|mesh-list
65317254|NCT00631696|Analgesics|analgesics|mesh-ancestor
65317255|NCT00631696|Sensory System Agents|sensory system agents|mesh-ancestor
65317256|NCT00631696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317257|NCT00631696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317258|NCT00631696|Anticonvulsants|anticonvulsants|mesh-ancestor
65317259|NCT00631696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65317260|NCT00631696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65317283|NCT04375384|Cetuximab|cetuximab|mesh-list
65317284|NCT04375384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65317285|NCT04375384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317286|NCT02549326|Vitamin D|vitamin d|mesh-list
65317287|NCT02549326|Cholecalciferol|cholecalciferol|mesh-list
65317288|NCT02549326|Vitamins|vitamins|mesh-ancestor
65317289|NCT02549326|Micronutrients|micronutrients|mesh-ancestor
65317290|NCT02549326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317291|NCT02549326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65317292|NCT02549326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65317293|NCT00819676|Nitric Oxide|nitric oxide|mesh-list
65317294|NCT00819676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65317295|NCT00819676|Autonomic Agents|autonomic agents|mesh-ancestor
65317296|NCT00819676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317297|NCT00819676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317298|NCT00819676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65317299|NCT00819676|Respiratory System Agents|respiratory system agents|mesh-ancestor
65317300|NCT00819676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65317301|NCT00819676|Antioxidants|antioxidants|mesh-ancestor
65317302|NCT00819676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317303|NCT00819676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65317304|NCT00819676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65317305|NCT00819676|Vasodilator Agents|vasodilator agents|mesh-ancestor
65317306|NCT00819676|Gasotransmitters|gasotransmitters|mesh-ancestor
65317307|NCT00819676|Protective Agents|protective agents|mesh-ancestor
65317308|NCT00827320|Levetiracetam|levetiracetam|mesh-list
65317309|NCT00827320|Anticonvulsants|anticonvulsants|mesh-ancestor
65317310|NCT00827320|Nootropic Agents|nootropic agents|mesh-ancestor
65317311|NCT00819754|Bevacizumab|bevacizumab|mesh-list
65317344|NCT00827554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65317345|NCT00827554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65317346|NCT00827554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317348|NCT00847145|Immunologic Factors|immunologic factors|mesh-ancestor
65317349|NCT00847145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317350|NCT00701597|Bosentan|bosentan|mesh-list
65317351|NCT00701597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65317375|NCT00862823|Antiviral Agents|antiviral agents|mesh-ancestor
65317376|NCT00862823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65317377|NCT00862823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65317378|NCT00862823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65317379|NCT00862823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317380|NCT00862823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317381|NCT00862823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65317382|NCT00862823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65317383|NCT00862823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65317384|NCT00862823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65317385|NCT00862823|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65317386|NCT00862823|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65317387|NCT00862823|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65317388|NCT00862823|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65317390|NCT00790842|Lenalidomide|lenalidomide|mesh-list
65317391|NCT00790842|Heparin|heparin|mesh-list
65317392|NCT00790842|Calcium heparin|calcium heparin|mesh-list
65317393|NCT00790842|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65317394|NCT00790842|Tinzaparin|tinzaparin|mesh-list
65317395|NCT00790842|Dalteparin|dalteparin|mesh-list
65317396|NCT00790842|Anticoagulants|anticoagulants|mesh-list
65317397|NCT00790842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65317398|NCT00790842|Antiemetics|antiemetics|mesh-ancestor
65317399|NCT00790842|Autonomic Agents|autonomic agents|mesh-ancestor
65317400|NCT00790842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317401|NCT00790842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317467|NCT00790452|Antipyretics|antipyretics|mesh-ancestor
65317468|NCT00823030|Lidocaine|lidocaine|mesh-list
65317469|NCT00823030|Anesthetics, Local|anesthetics, local|mesh-ancestor
65317470|NCT00823030|Anesthetics|anesthetics|mesh-ancestor
65317471|NCT00823030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65317472|NCT00823030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317473|NCT00823030|Sensory System Agents|sensory system agents|mesh-ancestor
65317474|NCT00823030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317475|NCT00823030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65317476|NCT00823030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65317477|NCT00823030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65317478|NCT00823030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64547380|NCT03508921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65317534|NCT00624052|Telmisartan|telmisartan|mesh-list
65317535|NCT00624052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65317536|NCT00624052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65317537|NCT00624052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65317538|NCT00624052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317539|NCT00624052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65219114|NCT00811252|Dopamine Agents|dopamine agents|mesh-ancestor
65219115|NCT00811252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65219116|NCT00811252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65219117|NCT00811252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65317540|NCT00624052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317541|NCT00624052|Vasodilator Agents|vasodilator agents|mesh-ancestor
65317542|NCT00624052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65317543|NCT00624052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65317544|NCT00821080|Sirolimus|sirolimus|mesh-list
64547462|NCT03809325|Serotonin Agents|serotonin agents|mesh-ancestor
65317571|NCT02548936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65317572|NCT02548936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317573|NCT00828802|Lenalidomide|lenalidomide|mesh-list
65317574|NCT00828802|Decitabine|decitabine|mesh-list
65317575|NCT00828802|Immunologic Factors|immunologic factors|mesh-ancestor
65317576|NCT00828802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317577|NCT00828802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65317578|NCT00828802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65317579|NCT00828802|Growth Substances|growth substances|mesh-ancestor
65317580|NCT00828802|Growth Inhibitors|growth inhibitors|mesh-ancestor
65317581|NCT00828802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317582|NCT00828802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65317583|NCT00828802|Antimetabolites|antimetabolites|mesh-ancestor
65317584|NCT00828802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317585|NCT00828802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317586|NCT00785577|Pregabalin|pregabalin|mesh-list
65317587|NCT00785577|Analgesics|analgesics|mesh-ancestor
65317588|NCT00785577|Sensory System Agents|sensory system agents|mesh-ancestor
64547496|NCT03807999|Gemcitabine|gemcitabine|mesh-list
65317620|NCT02548780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317621|NCT02548780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65317622|NCT02548780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65317623|NCT02548780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317624|NCT02548780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317625|NCT04105023|Genistein|genistein|mesh-list
65317626|NCT04105023|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65317627|NCT04105023|Protective Agents|protective agents|mesh-ancestor
65317628|NCT04105023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317629|NCT04105023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547537|NCT04273737|Analgesics|analgesics|mesh-ancestor
65317904|NCT04102176|Cariostatic Agents|cariostatic agents|mesh-ancestor
65317905|NCT04102176|Protective Agents|protective agents|mesh-ancestor
65317906|NCT04102176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317907|NCT00783432|Azelastine|azelastine|mesh-list
65317908|NCT00783432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65317909|NCT00783432|Autonomic Agents|autonomic agents|mesh-ancestor
65317910|NCT00783432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317911|NCT00783432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317965|NCT00774852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317967|NCT00774852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65317968|NCT00774852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65317969|NCT00774852|Glucocorticoids|glucocorticoids|mesh-ancestor
65317970|NCT00774852|Hormones|hormones|mesh-ancestor
64547857|NCT00088465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65318002|NCT04105764|Rocuronium|rocuronium|mesh-list
65318003|NCT04105764|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
65318004|NCT04105764|Anticonvulsants|anticonvulsants|mesh-ancestor
65318005|NCT04105764|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65318006|NCT04105764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65318007|NCT04105764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65318008|NCT04105764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067977|NCT00316563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65318009|NCT00781326|Nimodipine|nimodipine|mesh-list
65318010|NCT00781326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65318011|NCT00781326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65318012|NCT00781326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65318115|NCT00825058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318116|NCT00825058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65318152|NCT00773292|Immunologic Factors|immunologic factors|mesh-ancestor
65318153|NCT00773292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318154|NCT00773292|Antifungal Agents|antifungal agents|mesh-ancestor
65219190|NCT02723487|Bupivacaine|bupivacaine|mesh-list
65318155|NCT00773292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65318156|NCT00773292|Dermatologic Agents|dermatologic agents|mesh-ancestor
65318157|NCT00773292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64548047|NCT01479374|Analgesics|analgesics|mesh-ancestor
65318189|NCT00833404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318191|NCT00621322|Immunologic Factors|immunologic factors|mesh-ancestor
65318192|NCT00621322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318193|NCT00839488|Pantoprazole|pantoprazole|mesh-list
65318194|NCT00839488|Famotidine|famotidine|mesh-list
65318195|NCT00839488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65318196|NCT00839488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65318197|NCT00839488|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65318198|NCT00839488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318199|NCT00839488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318200|NCT00839488|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65318201|NCT00839488|Histamine Antagonists|histamine antagonists|mesh-ancestor
64548095|NCT01500434|Aspirin|aspirin|mesh-list
65318328|NCT00840346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318329|NCT04105140|Oxytocin|oxytocin|mesh-list
65318330|NCT04105140|Oxytocics|oxytocics|mesh-ancestor
65318331|NCT04105140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65318332|NCT04105140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318333|NCT00840580|Moxifloxacin|moxifloxacin|mesh-list
65318334|NCT00840580|Levofloxacin|levofloxacin|mesh-list
65318335|NCT00840580|Ofloxacin|ofloxacin|mesh-list
65318428|NCT00701909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65318430|NCT00701909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65318431|NCT00701909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318432|NCT00701909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65318433|NCT00701909|Narcotics|narcotics|mesh-ancestor
65318434|NCT00699023|Simvastatin|simvastatin|mesh-list
65318435|NCT00699023|Ezetimibe|ezetimibe|mesh-list
65318436|NCT00699023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64548277|NCT01478828|Antimetabolites|antimetabolites|mesh-ancestor
65318514|NCT00784719|Antifungal Agents|antifungal agents|mesh-ancestor
65318515|NCT00784719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65318516|NCT00784719|Dermatologic Agents|dermatologic agents|mesh-ancestor
65318517|NCT00784719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65318518|NCT00784719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65318519|NCT00784719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65318520|NCT00852917|Tramadol|tramadol|mesh-list
65318521|NCT00852917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65318522|NCT00852917|Narcotics|narcotics|mesh-ancestor
65318523|NCT00852917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65318524|NCT00852917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318525|NCT00852917|Analgesics|analgesics|mesh-ancestor
65318526|NCT00852917|Sensory System Agents|sensory system agents|mesh-ancestor
65318527|NCT00852917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65318528|NCT00700583|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65318529|NCT00700583|Terazosin|terazosin|mesh-list
65318530|NCT00700583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65318531|NCT00700583|Diuretics|diuretics|mesh-ancestor
65318532|NCT00700583|Natriuretic Agents|natriuretic agents|mesh-ancestor
65318533|NCT00700583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318534|NCT00700583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65318535|NCT00700583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65318630|NCT00861341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318631|NCT00861341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65318632|NCT00861341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65318633|NCT00861341|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65318634|NCT00861341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65318635|NCT00861341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318636|NCT00861341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65318637|NCT00861341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65318638|NCT00861341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318639|NCT00861341|Antipyretics|antipyretics|mesh-ancestor
65318640|NCT00861341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65318641|NCT00766467|Modafinil|modafinil|mesh-list
65318642|NCT00766467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65318643|NCT00766467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318644|NCT00766467|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65318645|NCT00766467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65318646|NCT00766467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65318837|NCT00849017|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65318838|NCT00849017|Incretins|incretins|mesh-ancestor
65219266|NCT02722083|Antipruritics|antipruritics|mesh-ancestor
65318839|NCT00849017|Hormones|hormones|mesh-ancestor
65318840|NCT00849017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65318841|NCT00849017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319019|NCT00703625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319020|NCT00703625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65319021|NCT00703625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319022|NCT00703625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65319023|NCT00703625|Antifungal Agents|antifungal agents|mesh-ancestor
65319024|NCT00703625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65319025|NCT00703625|Immunologic Factors|immunologic factors|mesh-ancestor
65319026|NCT00703625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319027|NCT00703703|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65319028|NCT00703703|Darifenacin|darifenacin|mesh-list
65319029|NCT00703703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65319030|NCT00703703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65319031|NCT00703703|Cholinergic Agents|cholinergic agents|mesh-ancestor
65319032|NCT00703703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65319033|NCT00703703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319034|NCT00703703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319035|NCT00703703|Urological Agents|urological agents|mesh-ancestor
65319036|NCT00859313|Sufentanil|sufentanil|mesh-list
65319037|NCT00859313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65319038|NCT00859313|Narcotics|narcotics|mesh-ancestor
65319039|NCT00859313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65319040|NCT00859313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319041|NCT00859313|Analgesics|analgesics|mesh-ancestor
65319042|NCT00859313|Sensory System Agents|sensory system agents|mesh-ancestor
65319043|NCT00859313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65319044|NCT00859313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65319045|NCT00859313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65319046|NCT00859313|Anesthetics, General|anesthetics, general|mesh-ancestor
65319047|NCT00859313|Anesthetics|anesthetics|mesh-ancestor
65319048|NCT02611973|Aspirin|aspirin|mesh-list
65319049|NCT02611973|Hydroxyurea|hydroxyurea|mesh-list
65319050|NCT02611973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65319051|NCT02611973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65319052|NCT02611973|Analgesics|analgesics|mesh-ancestor
65319120|NCT04104984|Tocolytic Agents|tocolytic agents|mesh-list
65319121|NCT04104984|Progesterone|progesterone|mesh-list
65319122|NCT04104984|Progestins|progestins|mesh-ancestor
65319123|NCT04104984|Hormones|hormones|mesh-ancestor
65319124|NCT04104984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65319125|NCT04104984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319126|NCT04104984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65319127|NCT00767520|Dasatinib|dasatinib|mesh-list
65319128|NCT00767520|Exemestane|exemestane|mesh-list
65319129|NCT00767520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319130|NCT00767520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65319131|NCT00767520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319132|NCT00767520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319133|NCT00767520|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65319134|NCT00767520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65319135|NCT00767520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65319136|NCT00767520|Hormone Antagonists|hormone antagonists|mesh-ancestor
65319137|NCT00767520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65319138|NCT00767520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319139|NCT00858845|Clonidine|clonidine|mesh-list
65319140|NCT00858845|Analgesics|analgesics|mesh-ancestor
65319141|NCT00858845|Sensory System Agents|sensory system agents|mesh-ancestor
65319347|NCT00818519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319348|NCT00818519|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65319350|NCT00818519|Natriuretic Agents|natriuretic agents|mesh-ancestor
65319351|NCT00827567|Everolimus|everolimus|mesh-list
65319352|NCT00827567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319353|NCT00827567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65319354|NCT00827567|Immunologic Factors|immunologic factors|mesh-ancestor
65319355|NCT00827567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319356|NCT00765102|Bortezomib|bortezomib|mesh-list
65319468|NCT00752856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65319469|NCT00752856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65319470|NCT00752856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65319471|NCT00752856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65319472|NCT00752856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65319473|NCT00752856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65319474|NCT00752856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65319475|NCT00752856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65319476|NCT00752856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65319477|NCT00752856|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65319478|NCT00752856|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65319480|NCT00805142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65319481|NCT00805142|Narcotics|narcotics|mesh-ancestor
65319482|NCT00805142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65319483|NCT00805142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319484|NCT00805142|Analgesics|analgesics|mesh-ancestor
65319485|NCT00805142|Sensory System Agents|sensory system agents|mesh-ancestor
65319486|NCT00805142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65319487|NCT00805142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65319488|NCT00805142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65319489|NCT00805142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65319490|NCT00805142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319491|NCT00805142|Adrenergic Agents|adrenergic agents|mesh-ancestor
65319492|NCT00805142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65319493|NCT00761631|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65319494|NCT00761631|Immunologic Factors|immunologic factors|mesh-ancestor
65319495|NCT00761631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319496|NCT03684980|Leucovorin|leucovorin|mesh-list
65319497|NCT03684980|Rituximab|rituximab|mesh-list
65319498|NCT03684980|Methotrexate|methotrexate|mesh-list
65319499|NCT03684980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65319500|NCT03684980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319501|NCT03684980|Immunologic Factors|immunologic factors|mesh-ancestor
65319502|NCT03684980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319503|NCT03684980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65319504|NCT03684980|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65319505|NCT03684980|Abortifacient Agents|abortifacient agents|mesh-ancestor
65319506|NCT03684980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65319507|NCT03684980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65319508|NCT03684980|Antimetabolites|antimetabolites|mesh-ancestor
65319648|NCT00752622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65319649|NCT00752622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65319650|NCT00754650|Bevacizumab|bevacizumab|mesh-list
65319651|NCT00754650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65319652|NCT00754650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319653|NCT00754650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65319654|NCT00754650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65319655|NCT00754650|Growth Substances|growth substances|mesh-ancestor
65319656|NCT00754650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319657|NCT00754650|Growth Inhibitors|growth inhibitors|mesh-ancestor
65319658|NCT02611271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65319659|NCT02611271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319660|NCT00825305|Vaccines|vaccines|mesh-list
65319661|NCT00825305|Immunologic Factors|immunologic factors|mesh-ancestor
65319662|NCT00825305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319663|NCT00754572|Methotrexate|methotrexate|mesh-list
65319664|NCT00754572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65319665|NCT00754572|Abortifacient Agents|abortifacient agents|mesh-ancestor
65319666|NCT00754572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65319667|NCT00754572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319668|NCT00754572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65319669|NCT00754572|Antimetabolites|antimetabolites|mesh-ancestor
65319670|NCT00754572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319671|NCT00754572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319672|NCT00754572|Dermatologic Agents|dermatologic agents|mesh-ancestor
65319673|NCT00754572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319674|NCT00754572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65320342|NCT00751101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65320343|NCT00751101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320344|NCT00751101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65320345|NCT00751101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65320346|NCT00751101|Cholinergic Agents|cholinergic agents|mesh-ancestor
65320347|NCT00751101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65320348|NCT00751101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320350|NCT04092309|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65320351|NCT04092309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65320352|NCT04092309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64550245|NCT00818337|Aspirin|aspirin|mesh-list
65321158|NCT05728736|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65321159|NCT05728736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65321160|NCT05728736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65321161|NCT05728736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321162|NCT00809783|Tanezumab|tanezumab|mesh-list
65321163|NCT00809783|Analgesics|analgesics|mesh-ancestor
65321164|NCT00809783|Sensory System Agents|sensory system agents|mesh-ancestor
65321165|NCT00809783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65321166|NCT00809783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321167|NCT05675462|Lenvatinib|lenvatinib|mesh-list
65321168|NCT05675462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321169|NCT05675462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65321310|NCT03236324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65321311|NCT03236324|Autonomic Agents|autonomic agents|mesh-ancestor
65321312|NCT03236324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65321313|NCT03236324|Respiratory System Agents|respiratory system agents|mesh-ancestor
65321314|NCT03236324|Mydriatics|mydriatics|mesh-ancestor
65321315|NCT03236324|Sympathomimetics|sympathomimetics|mesh-ancestor
65321316|NCT03236324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65321317|NCT03229850|Insulin Lispro|insulin lispro|mesh-list
65321318|NCT03229850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65321319|NCT03229850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321320|NCT05720390|Quinine|quinine|mesh-list
65321321|NCT05720390|Antimalarials|antimalarials|mesh-ancestor
65321322|NCT05720390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65321323|NCT05720390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65321324|NCT05720390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65321325|NCT05720390|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65321326|NCT05720390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321327|NCT05720390|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65321328|NCT05720390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65321329|NCT05720390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65321330|NCT05720390|Analgesics|analgesics|mesh-ancestor
65321331|NCT05720390|Sensory System Agents|sensory system agents|mesh-ancestor
65321332|NCT00742560|Dexamethasone|dexamethasone|mesh-list
65321333|NCT00742560|Dexamethasone acetate|dexamethasone acetate|mesh-list
65321334|NCT00742560|Lenalidomide|lenalidomide|mesh-list
65321335|NCT00742560|Elotuzumab|elotuzumab|mesh-list
65321336|NCT00742560|BB 1101|bb 1101|mesh-list
65321337|NCT00742560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65321338|NCT00742560|Antiemetics|antiemetics|mesh-ancestor
65321339|NCT00742560|Autonomic Agents|autonomic agents|mesh-ancestor
65321340|NCT00742560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65321341|NCT00742560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321342|NCT00742560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65321343|NCT00742560|Glucocorticoids|glucocorticoids|mesh-ancestor
65321344|NCT00742560|Hormones|hormones|mesh-ancestor
65321345|NCT00742560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65321346|NCT00742560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65321347|NCT00742560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321348|NCT00742560|Protease Inhibitors|protease inhibitors|mesh-ancestor
65321349|NCT00742560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65321350|NCT00742560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321351|NCT00742560|Immunologic Factors|immunologic factors|mesh-ancestor
65321352|NCT00742560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65321353|NCT00742560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65321354|NCT00742560|Growth Substances|growth substances|mesh-ancestor
65321355|NCT00742560|Growth Inhibitors|growth inhibitors|mesh-ancestor
65321356|NCT02604914|Levodopa|levodopa|mesh-list
65321357|NCT02604914|Carbidopa|carbidopa|mesh-list
65321358|NCT02604914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65321359|NCT02604914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65321360|NCT02604914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65321361|NCT02604914|Dopamine Agents|dopamine agents|mesh-ancestor
65321362|NCT02604914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65321363|NCT02604914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321364|NCT02604914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321365|NCT02604914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65321366|NCT02604914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65321367|NCT02604914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65321368|NCT02604914|Immunologic Factors|immunologic factors|mesh-ancestor
65321369|NCT02604914|Dopamine Agonists|dopamine agonists|mesh-ancestor
65321370|NCT00796718|Capecitabine|capecitabine|mesh-list
65321371|NCT00796718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65321372|NCT00796718|Antimetabolites|antimetabolites|mesh-ancestor
65321373|NCT00796718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269835|NCT02732756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65321374|NCT00796718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321375|NCT00745368|Raltegravir Potassium|raltegravir potassium|mesh-list
65321376|NCT00745368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65321377|NCT00745368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65321378|NCT00745368|Antiviral Agents|antiviral agents|mesh-ancestor
65321379|NCT00745368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65321380|NCT00745368|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65321381|NCT00745368|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65322025|NCT01020331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65322027|NCT00738894|Dipyridamole|dipyridamole|mesh-list
65322028|NCT00738894|Clopidogrel|clopidogrel|mesh-list
65322029|NCT00738894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322030|NCT00738894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322031|NCT00738894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65322032|NCT00738894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322033|NCT00738894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65322034|NCT00738894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65322035|NCT00738894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65322036|NCT00738894|Purinergic Agents|purinergic agents|mesh-ancestor
65322037|NCT00738894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64551803|NCT03882996|Antimetabolites|antimetabolites|mesh-ancestor
64991242|NCT04609046|Nivolumab|nivolumab|mesh-list
65324087|NCT05561673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65324088|NCT04101500|Aminophylline|aminophylline|mesh-list
65324089|NCT04101500|Bromides|bromides|mesh-list
65324090|NCT04101500|Ipratropium|ipratropium|mesh-list
65324091|NCT04101500|Anticonvulsants|anticonvulsants|mesh-ancestor
65324092|NCT04101500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65324093|NCT04101500|Autonomic Agents|autonomic agents|mesh-ancestor
65324094|NCT04101500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324095|NCT04101500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324096|NCT04101500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65324097|NCT04101500|Respiratory System Agents|respiratory system agents|mesh-ancestor
65324098|NCT04101500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65324099|NCT04101500|Cholinergic Agents|cholinergic agents|mesh-ancestor
65324100|NCT04101500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65324101|NCT04101500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324102|NCT04101500|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65324103|NCT04101500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65324104|NCT04101500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65324105|NCT04101500|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65324106|NCT04101500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65324144|NCT04081077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65324145|NCT04081077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65324146|NCT04081077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324208|NCT04101578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65324209|NCT04101578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65324211|NCT04101578|Hormones|hormones|mesh-ancestor
65324392|NCT00761150|Hydrocodone|hydrocodone|mesh-list
65324393|NCT00761150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65324394|NCT00761150|Analgesics|analgesics|mesh-ancestor
65324395|NCT00761150|Sensory System Agents|sensory system agents|mesh-ancestor
65324396|NCT00761150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324397|NCT00761150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324398|NCT00761150|Antipyretics|antipyretics|mesh-ancestor
65324399|NCT00761150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65324400|NCT00761150|Narcotics|narcotics|mesh-ancestor
65324401|NCT00761150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65324402|NCT00761150|Antitussive Agents|antitussive agents|mesh-ancestor
65324403|NCT00761150|Respiratory System Agents|respiratory system agents|mesh-ancestor
65324404|NCT00583557|Belimumab|belimumab|mesh-list
65324405|NCT00583557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65324406|NCT00583557|Immunologic Factors|immunologic factors|mesh-ancestor
65324407|NCT00583557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324408|NCT00586820|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
65324409|NCT00586820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65324410|NCT00586820|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65324411|NCT00586820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324412|NCT00760838|Azithromycin|azithromycin|mesh-list
65324413|NCT00760838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65382185|NCT00841802|Prednisone|prednisone|mesh-list
65382186|NCT00841802|Glucocorticoids|glucocorticoids|mesh-list
65382187|NCT00841802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65382188|NCT00841802|Hormones|hormones|mesh-ancestor
65219567|NCT00736255|Dopamine Agents|dopamine agents|mesh-ancestor
65382189|NCT00841802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65382190|NCT00841802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382191|NCT00841802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65382192|NCT00841802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382193|NCT00621140|Linagliptin|linagliptin|mesh-list
64774791|NCT01729494|Hormones|hormones|mesh-ancestor
65382530|NCT04893291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65382531|NCT04893291|Immunologic Factors|immunologic factors|mesh-ancestor
65382532|NCT04893291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382533|NCT04893291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65382534|NCT04893291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65382535|NCT04893291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65382536|NCT04893291|Antifungal Agents|antifungal agents|mesh-ancestor
65382537|NCT00620750|Naltrexone|naltrexone|mesh-list
65382538|NCT00620750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65382539|NCT00620750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65382540|NCT00620750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382541|NCT00620750|Sensory System Agents|sensory system agents|mesh-ancestor
65382542|NCT00620750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65382543|NCT04867707|Zanamivir|zanamivir|mesh-list
65382544|NCT04867707|Antiviral Agents|antiviral agents|mesh-ancestor
65382545|NCT04867707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65382575|NCT01564251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65382576|NCT01564251|Immunologic Factors|immunologic factors|mesh-ancestor
65382577|NCT01564251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382578|NCT01564251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65382579|NCT00508144|Pemetrexed|pemetrexed|mesh-list
65382580|NCT00508144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382581|NCT00508144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382582|NCT00508144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382583|NCT00508144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65382584|NCT00508144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65382585|NCT05357547|Buspirone|buspirone|mesh-list
65382586|NCT05357547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65382587|NCT05357547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65382588|NCT05357547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65382589|NCT05357547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775184|NCT01785186|Pyridoxine|pyridoxine|mesh-list
65132232|NCT01089608|Azithromycin|azithromycin|mesh-list
65382648|NCT01011166|Ribavirin|ribavirin|mesh-list
65382649|NCT01011166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65382650|NCT01011166|Antimetabolites|antimetabolites|mesh-ancestor
65382651|NCT01011166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382652|NCT01011166|Antiviral Agents|antiviral agents|mesh-ancestor
65382653|NCT01011166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65382654|NCT00621842|Lamotrigine|lamotrigine|mesh-list
65382655|NCT00621842|Anticonvulsants|anticonvulsants|mesh-list
65382656|NCT00621842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64775258|NCT01791972|Albuterol|albuterol|mesh-list
65382710|NCT00844688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65382712|NCT04541680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382713|NCT04541680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65382714|NCT04541680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382715|NCT04541680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382716|NCT00855530|Amibegron|amibegron|mesh-list
65382717|NCT00855530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65382718|NCT00855530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65382719|NCT00855530|Adrenergic Agents|adrenergic agents|mesh-ancestor
65382720|NCT00855530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65132321|NCT01087970|Carboplatin|carboplatin|mesh-list
65382721|NCT00855530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382722|NCT00855530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382724|NCT00855608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65382725|NCT00855608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65382726|NCT00851864|Tinzaparin|tinzaparin|mesh-list
65382727|NCT00851864|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65382728|NCT00851864|Dalteparin|dalteparin|mesh-list
65382729|NCT00851864|Anticoagulants|anticoagulants|mesh-ancestor
65382730|NCT00851864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65382731|NCT00851864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65382732|NCT00851864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382733|NCT00851942|Cosyntropin|cosyntropin|mesh-list
65382734|NCT00851942|Hormones|hormones|mesh-ancestor
65382735|NCT00851942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65219640|NCT02713191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65382736|NCT00851942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382737|NCT00503776|Amifostine|amifostine|mesh-list
65382772|NCT00845156|Protective Agents|protective agents|mesh-ancestor
65382773|NCT00845156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382774|NCT00845156|Vitamin B Complex|vitamin b complex|mesh-ancestor
65382775|NCT00845156|Vitamins|vitamins|mesh-ancestor
65382776|NCT00845156|Micronutrients|micronutrients|mesh-ancestor
65382777|NCT03262935|Capecitabine|capecitabine|mesh-list
65382778|NCT03262935|Trastuzumab|trastuzumab|mesh-list
65382779|NCT03262935|Vinorelbine|vinorelbine|mesh-list
65382841|NCT00992121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382874|NCT02773485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382875|NCT04042220|Glucocorticoids|glucocorticoids|mesh-list
65382876|NCT04042220|Hormones|hormones|mesh-ancestor
65382877|NCT04042220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65382878|NCT04042220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382879|NCT00992355|Tobramycin|tobramycin|mesh-list
65382880|NCT00992355|Dexamethasone|dexamethasone|mesh-list
65382881|NCT00992355|Dexamethasone acetate|dexamethasone acetate|mesh-list
65382882|NCT00992355|Ketorolac|ketorolac|mesh-list
65382883|NCT00992355|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65382884|NCT00992355|BB 1101|bb 1101|mesh-list
64775472|NCT01835262|Ketamine|ketamine|mesh-list
65383066|NCT00845780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65383067|NCT00845780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383068|NCT00845780|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65383069|NCT00845780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65383070|NCT00845780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65383071|NCT00845780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383072|NCT00845780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65383073|NCT00845780|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65383074|NCT00845780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65383075|NCT00853502|Methyltestosterone|methyltestosterone|mesh-list
65383076|NCT00853502|Testosterone|testosterone|mesh-list
65383077|NCT00853502|Testosterone undecanoate|testosterone undecanoate|mesh-list
65383078|NCT00853502|Testosterone enanthate|testosterone enanthate|mesh-list
65383079|NCT00853502|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65383080|NCT00853502|Androgens|androgens|mesh-ancestor
65383081|NCT00853502|Hormones|hormones|mesh-ancestor
65383168|NCT02590133|Growth Inhibitors|growth inhibitors|mesh-ancestor
65383169|NCT00854204|Darunavir|darunavir|mesh-list
65132755|NCT04571489|Gemcitabine|gemcitabine|mesh-list
65383170|NCT00854204|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65383171|NCT00854204|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65383172|NCT00854204|Protease Inhibitors|protease inhibitors|mesh-ancestor
65383173|NCT00854204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383174|NCT00854204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383175|NCT00854204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65383176|NCT00854204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65383177|NCT00854204|Antiviral Agents|antiviral agents|mesh-ancestor
65383178|NCT00854204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65383179|NCT00857870|Metformin|metformin|mesh-list
65383406|NCT00862628|Rebamipide|rebamipide|mesh-list
65383407|NCT00862628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65383408|NCT00862628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65383409|NCT00862628|Antioxidants|antioxidants|mesh-ancestor
65383410|NCT00862628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383411|NCT00862628|Protective Agents|protective agents|mesh-ancestor
65383446|NCT04041362|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65383447|NCT04041362|UB-421|ub-421|mesh-list
65383448|NCT04041362|Antiviral Agents|antiviral agents|mesh-ancestor
65383449|NCT04041362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65383450|NCT00850850|Physostigmine|physostigmine|mesh-list
65383451|NCT00850850|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64776052|NCT02718066|Nivolumab|nivolumab|mesh-list
65383502|NCT00502996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65383503|NCT00502996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65383504|NCT00502996|Antimetabolites|antimetabolites|mesh-ancestor
65383505|NCT00502996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383506|NCT00502996|Dermatologic Agents|dermatologic agents|mesh-ancestor
65383507|NCT00502996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383508|NCT00502996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65383509|NCT00502996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65383510|NCT00502996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65383511|NCT00865436|Metformin|metformin|mesh-list
65383512|NCT00865436|Glyburide|glyburide|mesh-list
65383513|NCT00865436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65383514|NCT00865436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383515|NCT00715403|Nintedanib|nintedanib|mesh-list
65383516|NCT00715403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383517|NCT00715403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65383518|NCT00715403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383519|NCT00715403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383520|NCT01013584|Cholecalciferol|cholecalciferol|mesh-list
65383521|NCT01013584|Vitamin D|vitamin d|mesh-list
65383522|NCT01013584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64776105|NCT01887132|Nootropic Agents|nootropic agents|mesh-ancestor
65383617|NCT00864890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65383618|NCT00864890|Antidepressive Agents|antidepressive agents|mesh-ancestor
65383619|NCT00864890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65383620|NCT00864890|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65383621|NCT00864890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65383622|NCT00864890|Parasympatholytics|parasympatholytics|mesh-ancestor
65383623|NCT00864890|Autonomic Agents|autonomic agents|mesh-ancestor
65383624|NCT00864890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65383625|NCT00864890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65383626|NCT00864890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65383678|NCT00871052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383679|NCT00871052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65383680|NCT00871052|Dermatologic Agents|dermatologic agents|mesh-ancestor
65383681|NCT00502840|Rituximab|rituximab|mesh-list
65383682|NCT00502840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65383683|NCT00502840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383684|NCT00502840|Immunologic Factors|immunologic factors|mesh-ancestor
65383685|NCT00502840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383686|NCT00502840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65383687|NCT00514540|Carboplatin|carboplatin|mesh-list
65383688|NCT00514540|Docetaxel|docetaxel|mesh-list
65383689|NCT00514540|Etoposide|etoposide|mesh-list
65383690|NCT00514540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383691|NCT00514540|Tubulin Modulators|tubulin modulators|mesh-ancestor
65383692|NCT00514540|Antimitotic Agents|antimitotic agents|mesh-ancestor
65383693|NCT00514540|Mitosis Modulators|mitosis modulators|mesh-ancestor
65383694|NCT00514540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383695|NCT00514540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65383696|NCT00514540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65383697|NCT00514540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65133291|NCT04560218|Oxytocics|oxytocics|mesh-ancestor
65383698|NCT00514540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383699|NCT00506662|Insulin|insulin|mesh-list
64776271|NCT01933464|Cromolyn Sodium|cromolyn sodium|mesh-list
65383733|NCT04615624|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65383734|NCT04615624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65383735|NCT04615624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383736|NCT00713609|Clindamycin|clindamycin|mesh-list
65383737|NCT00713609|Clindamycin palmitate|clindamycin palmitate|mesh-list
65383738|NCT00713609|Clindamycin phosphate|clindamycin phosphate|mesh-list
65383739|NCT00713609|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65383740|NCT00713609|Tazarotene|tazarotene|mesh-list
65383741|NCT00713609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65383742|NCT00713609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65383743|NCT00713609|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65383780|NCT05330429|Growth Inhibitors|growth inhibitors|mesh-ancestor
65383781|NCT05330429|Antimetabolites|antimetabolites|mesh-ancestor
64776359|NCT01955382|Antimalarials|antimalarials|mesh-ancestor
65383809|NCT05238233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65383810|NCT05238233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383811|NCT05238233|Mydriatics|mydriatics|mesh-ancestor
65383812|NCT05238233|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65383813|NCT05238233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65383814|NCT05238233|Anesthetics, Local|anesthetics, local|mesh-ancestor
65383815|NCT05238233|Anesthetics|anesthetics|mesh-ancestor
65383816|NCT05238233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65383817|NCT05238233|Sensory System Agents|sensory system agents|mesh-ancestor
65383818|NCT05232851|Pembrolizumab|pembrolizumab|mesh-list
65383820|NCT05232851|Immunologic Factors|immunologic factors|mesh-ancestor
65383821|NCT05232851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383822|NCT05232851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65383823|NCT05232851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383824|NCT05311475|Mometasone Furoate|mometasone furoate|mesh-list
65383825|NCT05311475|Azelastine|azelastine|mesh-list
65383826|NCT05311475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65383827|NCT05311475|Dermatologic Agents|dermatologic agents|mesh-ancestor
65383828|NCT05311475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65383829|NCT05311475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65383830|NCT05311475|Autonomic Agents|autonomic agents|mesh-ancestor
65383831|NCT05311475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776400|NCT05739786|Vitamin D|vitamin d|mesh-list
65383860|NCT04083209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383861|NCT04083209|Analgesics|analgesics|mesh-ancestor
65383862|NCT04083209|Sensory System Agents|sensory system agents|mesh-ancestor
65383863|NCT04083209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65383864|NCT00864968|Nabumetone|nabumetone|mesh-list
65383865|NCT00864968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65383866|NCT00864968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65383867|NCT00864968|Analgesics|analgesics|mesh-ancestor
65383868|NCT00864968|Sensory System Agents|sensory system agents|mesh-ancestor
65383869|NCT00864968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65383870|NCT00864968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383871|NCT00864968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65383872|NCT00864968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65383873|NCT00864968|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65383874|NCT00864968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65383875|NCT00864968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776456|NCT05737680|Colchicine|colchicine|mesh-list
65383907|NCT05113745|Reboxetine|reboxetine|mesh-list
65383908|NCT05113745|Antidepressive Agents|antidepressive agents|mesh-ancestor
65383909|NCT05113745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65383910|NCT05113745|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65383911|NCT05113745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65383912|NCT05113745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65383913|NCT05113745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383914|NCT05113745|Adrenergic Agents|adrenergic agents|mesh-ancestor
65383951|NCT05355597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65383952|NCT05355597|Adrenergic Agents|adrenergic agents|mesh-ancestor
65383953|NCT05355597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64776536|NCT05721144|Autonomic Agents|autonomic agents|mesh-ancestor
65384018|NCT00876824|Amebicides|amebicides|mesh-ancestor
65384019|NCT00876824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65384020|NCT00876824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65384021|NCT00876824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65384022|NCT00876824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65384023|NCT00876824|Antifungal Agents|antifungal agents|mesh-ancestor
65384024|NCT00866684|Cyclosporine|cyclosporine|mesh-list
65384025|NCT00866684|Sirolimus|sirolimus|mesh-list
65384026|NCT00866684|Azathioprine|azathioprine|mesh-list
65384027|NCT00866684|Tacrolimus|tacrolimus|mesh-list
65384028|NCT00866684|Cyclosporins|cyclosporins|mesh-list
65384029|NCT00866684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65384030|NCT00866684|Immunologic Factors|immunologic factors|mesh-ancestor
65384031|NCT00866684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384120|NCT05355441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384122|NCT05155436|Telmisartan|telmisartan|mesh-list
65384123|NCT05155436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65384124|NCT05155436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65384125|NCT05155436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65384126|NCT05155436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384127|NCT05155436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65384128|NCT05155436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384129|NCT05155436|Vasodilator Agents|vasodilator agents|mesh-ancestor
65384235|NCT00872144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384236|NCT05018585|Cholecalciferol|cholecalciferol|mesh-list
65384237|NCT05018585|Vitamin D|vitamin d|mesh-list
65384238|NCT05018585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65384239|NCT05018585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65384262|NCT00867152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65384263|NCT00867152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65384264|NCT00867152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65384265|NCT00867152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65384266|NCT00867152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65384267|NCT00867152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65384268|NCT00867152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65384324|NCT04083911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65384325|NCT04083911|Antimetabolites|antimetabolites|mesh-ancestor
65384326|NCT04083911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388328|NCT02354027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65384338|NCT04083911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65384339|NCT00995241|Raltegravir Potassium|raltegravir potassium|mesh-list
65384340|NCT00995241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65219885|NCT02776527|Apatinib|apatinib|mesh-list
65384341|NCT00995241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65384342|NCT00995241|Antiviral Agents|antiviral agents|mesh-ancestor
65384343|NCT00995241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65384344|NCT00995241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65384345|NCT00995241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65384346|NCT00995241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384347|NCT00995241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384348|NCT00994383|Morphine|morphine|mesh-list
65384349|NCT00994383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65384350|NCT00994383|Narcotics|narcotics|mesh-ancestor
65384351|NCT00994383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65384352|NCT00994383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384353|NCT00994383|Analgesics|analgesics|mesh-ancestor
65384354|NCT00994383|Sensory System Agents|sensory system agents|mesh-ancestor
65384355|NCT00994383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65384356|NCT02588417|Dexamethasone|dexamethasone|mesh-list
65384357|NCT02588417|Levobupivacaine|levobupivacaine|mesh-list
65384358|NCT02588417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65384359|NCT02588417|Antiemetics|antiemetics|mesh-ancestor
65384360|NCT02588417|Autonomic Agents|autonomic agents|mesh-ancestor
65384361|NCT02588417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65384362|NCT02588417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384363|NCT02588417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65384364|NCT02588417|Glucocorticoids|glucocorticoids|mesh-ancestor
65384365|NCT02588417|Hormones|hormones|mesh-ancestor
65384366|NCT02588417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65384367|NCT02588417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64776858|NCT02723994|Doxorubicin|doxorubicin|mesh-list
64388342|NCT02353715|Hormone Antagonists|hormone antagonists|mesh-ancestor
65384427|NCT00994617|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65384428|NCT00994617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65384429|NCT00995397|Chlorpheniramine|chlorpheniramine|mesh-list
65384430|NCT00995397|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
65384431|NCT00995397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65384432|NCT00995397|Histamine Antagonists|histamine antagonists|mesh-ancestor
65384433|NCT00995397|Histamine Agents|histamine agents|mesh-ancestor
64776881|NCT02723994|Hormones|hormones|mesh-ancestor
65384442|NCT00919451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384443|NCT00919451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384444|NCT00919451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65384445|NCT00919451|Immunologic Factors|immunologic factors|mesh-ancestor
65384446|NCT00919451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384447|NCT00919451|Antifungal Agents|antifungal agents|mesh-ancestor
65384448|NCT00919451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65384449|NCT00919451|Dermatologic Agents|dermatologic agents|mesh-ancestor
65384450|NCT00919451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65384451|NCT00919451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65384452|NCT03016312|Atezolizumab|atezolizumab|mesh-list
65384453|NCT03016312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384454|NCT05059223|Reboxetine|reboxetine|mesh-list
65384455|NCT05059223|Antidepressive Agents|antidepressive agents|mesh-ancestor
65384457|NCT05059223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65384458|NCT05059223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65384459|NCT05059223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65384460|NCT05059223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384461|NCT05059223|Adrenergic Agents|adrenergic agents|mesh-ancestor
65384462|NCT05059223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65384463|NCT05059223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384464|NCT00919607|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65384465|NCT00919607|Antidepressive Agents|antidepressive agents|mesh-ancestor
65384466|NCT00919607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65384467|NCT00919607|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65384468|NCT00919607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65384469|NCT00919607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65384470|NCT00919607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384471|NCT01014052|Retinol acetate|retinol acetate|mesh-list
65384472|NCT01014052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65384473|NCT01014052|Immunologic Factors|immunologic factors|mesh-ancestor
65384474|NCT01014052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388373|NCT03155477|Cholecalciferol|cholecalciferol|mesh-list
65384488|NCT01015300|Bevacizumab|bevacizumab|mesh-list
65384489|NCT01015300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65384490|NCT01015300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384491|NCT01015300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65219939|NCT02710305|Antiemetics|antiemetics|mesh-ancestor
65384492|NCT01015300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65384493|NCT01015300|Growth Substances|growth substances|mesh-ancestor
65384494|NCT01015300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384495|NCT01015300|Growth Inhibitors|growth inhibitors|mesh-ancestor
65384496|NCT01015456|Mycophenolic Acid|mycophenolic acid|mesh-list
65384497|NCT01015456|Cyclophosphamide|cyclophosphamide|mesh-list
65384498|NCT01015456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65384499|NCT01015456|Immunologic Factors|immunologic factors|mesh-ancestor
65384500|NCT01015456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384501|NCT01015456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65384502|NCT01015456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65384503|NCT01015456|Alkylating Agents|alkylating agents|mesh-ancestor
65384504|NCT01015456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384505|NCT01015456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384506|NCT01015456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65384507|NCT01015456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64388383|NCT02349581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64388385|NCT02349581|Sensory System Agents|sensory system agents|mesh-ancestor
65384546|NCT00491764|Terbinafine|terbinafine|mesh-list
65384547|NCT00491764|Antifungal Agents|antifungal agents|mesh-ancestor
65384548|NCT00491764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65384549|NCT00491764|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65384550|NCT00491764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65384551|NCT00491764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65384552|NCT00491764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65384553|NCT00491764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65384554|NCT00491764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384555|NCT00491764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384556|NCT00491764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65384557|NCT00491764|Hormone Antagonists|hormone antagonists|mesh-ancestor
65384558|NCT00491764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65384559|NCT00491764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384560|NCT02586311|Amlodipine|amlodipine|mesh-list
65384561|NCT02586311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65384562|NCT02586311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65384563|NCT02586311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65384564|NCT02586311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384565|NCT02586311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65384566|NCT02586311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384567|NCT02586311|Vasodilator Agents|vasodilator agents|mesh-ancestor
65384568|NCT05557721|Lidocaine|lidocaine|mesh-list
65384569|NCT05557721|Anesthetics, Local|anesthetics, local|mesh-ancestor
64388427|NCT02349113|Estrogens|estrogens|mesh-list
65384620|NCT00878540|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65384621|NCT00878540|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65384622|NCT00878540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65384623|NCT00878540|Adrenergic Agents|adrenergic agents|mesh-ancestor
65384624|NCT00878540|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65384625|NCT00878540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65384626|NCT00878540|Serotonin Agents|serotonin agents|mesh-ancestor
65384627|NCT00878540|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65384628|NCT04018274|Levonorgestrel|levonorgestrel|mesh-list
65384629|NCT04018274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65384630|NCT04018274|Contraceptive Agents|contraceptive agents|mesh-list
65384631|NCT04018274|Contraceptives, Oral|contraceptives, oral|mesh-list
65384632|NCT04018274|Estradiol|estradiol|mesh-list
65384659|NCT00491530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65384661|NCT00491530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384662|NCT00491530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65384663|NCT00491530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65384664|NCT00491530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384665|NCT00617240|Metformin|metformin|mesh-list
65384666|NCT00617240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65384667|NCT00617240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384668|NCT00615290|Tipranavir|tipranavir|mesh-list
65384669|NCT00615290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65384670|NCT00615290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65384671|NCT00615290|Antiviral Agents|antiviral agents|mesh-ancestor
65384672|NCT00615290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65384673|NCT02587169|Doxorubicin|doxorubicin|mesh-list
65384674|NCT02587169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65134257|NCT04542252|Cyclosporine|cyclosporine|mesh-list
64388482|NCT02343419|Miotics|miotics|mesh-ancestor
65220023|NCT02716857|Oxycodone|oxycodone|mesh-list
65384699|NCT00868010|Cholinergic Agents|cholinergic agents|mesh-ancestor
65384700|NCT00868010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65384701|NCT00868010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384702|NCT00868010|Nootropic Agents|nootropic agents|mesh-ancestor
65384703|NCT05683301|Amlodipine|amlodipine|mesh-list
65384704|NCT05683301|Perindopril|perindopril|mesh-list
65384705|NCT05683301|Indapamide|indapamide|mesh-list
65384706|NCT05683301|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
65384707|NCT05683301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65384708|NCT05683301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65384709|NCT05683301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65384710|NCT05683301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384711|NCT05683301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65384712|NCT05683301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384713|NCT05683301|Vasodilator Agents|vasodilator agents|mesh-ancestor
65384714|NCT05683301|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65384715|NCT05683301|Protease Inhibitors|protease inhibitors|mesh-ancestor
65384716|NCT05683301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384717|NCT05683301|Diuretics|diuretics|mesh-ancestor
65384718|NCT05683301|Natriuretic Agents|natriuretic agents|mesh-ancestor
65384719|NCT05683301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65384720|NCT04770623|Docetaxel|docetaxel|mesh-list
65384721|NCT04770623|Irinotecan|irinotecan|mesh-list
65384722|NCT04770623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384723|NCT04770623|Tubulin Modulators|tubulin modulators|mesh-ancestor
65384724|NCT04770623|Antimitotic Agents|antimitotic agents|mesh-ancestor
65384725|NCT04770623|Mitosis Modulators|mitosis modulators|mesh-ancestor
65384726|NCT04770623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384727|NCT04770623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65384728|NCT04770623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65384729|NCT04770623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384730|NCT05653661|Paclitaxel|paclitaxel|mesh-list
65384731|NCT05653661|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65384732|NCT05653661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65384733|NCT05653661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384734|NCT05653661|Tubulin Modulators|tubulin modulators|mesh-ancestor
65384735|NCT05653661|Antimitotic Agents|antimitotic agents|mesh-ancestor
65384869|NCT00920153|Ifosfamide|ifosfamide|mesh-list
65384870|NCT00920153|Dacarbazine|dacarbazine|mesh-list
65384871|NCT00920153|Carmustine|carmustine|mesh-list
65384872|NCT00920153|Bleomycin|bleomycin|mesh-list
65384873|NCT00920153|Vindesine|vindesine|mesh-list
65384874|NCT00920153|Mitoguazone|mitoguazone|mesh-list
65384875|NCT00920153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65384876|NCT00920153|Antiemetics|antiemetics|mesh-ancestor
64777093|NCT01984398|Anticoagulants|anticoagulants|mesh-ancestor
64777094|NCT01984398|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64388583|NCT02340455|Pregabalin|pregabalin|mesh-list
65385037|NCT03084237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65385038|NCT00996021|Moxifloxacin|moxifloxacin|mesh-list
65385039|NCT00996021|Dolutegravir|dolutegravir|mesh-list
65385040|NCT00996021|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65385041|NCT00996021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65385042|NCT00996021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65385043|NCT00996021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65385044|NCT00996021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65385045|NCT00996021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385046|NCT00996021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385047|NCT00996021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385048|NCT00996021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65385049|NCT00996021|Contraceptive Agents|contraceptive agents|mesh-ancestor
65134634|NCT04577846|Cephalexin|cephalexin|mesh-list
65385050|NCT00996021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65385051|NCT00996021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385167|NCT00532779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65385168|NCT00532779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385169|NCT00532779|Dopamine Agents|dopamine agents|mesh-ancestor
65385170|NCT00532779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65385171|NCT00532779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65385172|NCT00532779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65385173|NCT00532779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385174|NCT00500266|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65385175|NCT00500266|Immunologic Factors|immunologic factors|mesh-ancestor
65385176|NCT00500266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385177|NCT00996411|Salvinorin A|salvinorin a|mesh-list
65385178|NCT00996411|Hallucinogens|hallucinogens|mesh-ancestor
65385179|NCT00996411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385180|NCT00996411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65385181|NCT00996567|Cetuximab|cetuximab|mesh-list
65385182|NCT00996567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65385183|NCT00996567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385184|NCT04120805|Hemostatics|hemostatics|mesh-list
65385185|NCT04120805|Coagulants|coagulants|mesh-ancestor
65385186|NCT02852655|Pembrolizumab|pembrolizumab|mesh-list
65385187|NCT02852655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65385188|NCT02852655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385189|NCT00500110|Docetaxel|docetaxel|mesh-list
65385190|NCT00500110|Imatinib Mesylate|imatinib mesylate|mesh-list
65385191|NCT00500110|Leuprolide|leuprolide|mesh-list
65385192|NCT00500110|Goserelin|goserelin|mesh-list
65385276|NCT02582177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65385278|NCT02582177|Autonomic Agents|autonomic agents|mesh-ancestor
65385279|NCT02582177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385280|NCT02582177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385281|NCT02582177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65385311|NCT02626715|Immunologic Factors|immunologic factors|mesh-ancestor
65385312|NCT02626715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385368|NCT00997347|Misoprostol|misoprostol|mesh-list
65385369|NCT00997347|Mifepristone|mifepristone|mesh-list
65385370|NCT00997347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65385371|NCT00997347|Abortifacient Agents|abortifacient agents|mesh-ancestor
65385372|NCT00997347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65385373|NCT00997347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385374|NCT00997347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65385375|NCT00997347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65385376|NCT00997347|Oxytocics|oxytocics|mesh-ancestor
65385377|NCT00997347|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65385378|NCT00997347|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65385379|NCT00997347|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64388805|NCT03112031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65385574|NCT04166110|Autonomic Agents|autonomic agents|mesh-ancestor
65385575|NCT04166110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385577|NCT04166110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65385578|NCT04166110|Respiratory System Agents|respiratory system agents|mesh-ancestor
65385580|NCT04276259|Buprenorphine|buprenorphine|mesh-list
65385581|NCT04276259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65385582|NCT04276259|Narcotics|narcotics|mesh-ancestor
65385583|NCT04276259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65385584|NCT04276259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385585|NCT04276259|Analgesics|analgesics|mesh-ancestor
65385586|NCT04276259|Sensory System Agents|sensory system agents|mesh-ancestor
65385587|NCT04276259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385588|NCT04276259|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65385589|NCT04276259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65385590|NCT00499486|Sirolimus|sirolimus|mesh-list
65385591|NCT00499486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65385592|NCT00499486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65385593|NCT00499486|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65385594|NCT00499486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385595|NCT00499486|Antifungal Agents|antifungal agents|mesh-ancestor
65385596|NCT00499486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65385597|NCT00499486|Immunologic Factors|immunologic factors|mesh-ancestor
65385598|NCT00499486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385599|NCT05057117|Botulinum Toxins|botulinum toxins|mesh-list
65385600|NCT05057117|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65385601|NCT05057117|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65385602|NCT05057117|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64388891|NCT02709889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388892|NCT03189901|Simendan|simendan|mesh-list
65385633|NCT01014520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65385634|NCT01014520|Adrenergic Agents|adrenergic agents|mesh-ancestor
65385636|NCT01016002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385637|NCT01016002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65385638|NCT01016002|Dermatologic Agents|dermatologic agents|mesh-ancestor
65385639|NCT01019434|Sirolimus|sirolimus|mesh-list
65385640|NCT01019434|Temozolomide|temozolomide|mesh-list
65385641|NCT01019434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65385642|NCT01019434|Alkylating Agents|alkylating agents|mesh-ancestor
65385643|NCT01019434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385644|NCT01019434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385672|NCT01019590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65385673|NCT01019590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65385675|NCT03775421|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65385676|NCT03775421|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65385677|NCT03775421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385678|NCT03775421|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65385679|NCT00532155|Dexamethasone|dexamethasone|mesh-list
65385680|NCT00532155|Docetaxel|docetaxel|mesh-list
65385681|NCT00532155|Aflibercept|aflibercept|mesh-list
65385682|NCT00532155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65385683|NCT00532155|Antiemetics|antiemetics|mesh-ancestor
65385684|NCT00532155|Autonomic Agents|autonomic agents|mesh-ancestor
65385685|NCT00532155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385686|NCT00532155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385687|NCT00532155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65385688|NCT00532155|Glucocorticoids|glucocorticoids|mesh-ancestor
65385689|NCT00532155|Hormones|hormones|mesh-ancestor
64777479|NCT02062710|Histamine Agents|histamine agents|mesh-ancestor
65385713|NCT00205777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65385714|NCT00205777|Hormone Antagonists|hormone antagonists|mesh-ancestor
65385715|NCT00205777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65385716|NCT00205777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385717|NCT00205777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65385718|NCT03762395|CXA-10|cxa-10|mesh-list
65385719|NCT03762395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65385730|NCT01014832|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65385731|NCT01014832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65385732|NCT01014832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385733|NCT03996473|Pembrolizumab|pembrolizumab|mesh-list
65385734|NCT03996473|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65385735|NCT03996473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65385736|NCT03996473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385737|NCT01000545|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
65385738|NCT01000545|Anticoagulants|anticoagulants|mesh-ancestor
65385739|NCT01000545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65385740|NCT01000545|Antimetabolites|antimetabolites|mesh-ancestor
65385741|NCT01000545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385742|NCT01000545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65385743|NCT01000545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65385744|NCT01000545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65385745|NCT01000545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65385746|NCT01000545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385747|NCT03992729|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65385748|NCT03992729|Immunologic Factors|immunologic factors|mesh-ancestor
65385749|NCT03992729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385750|NCT00483574|Vaccines|vaccines|mesh-list
65385751|NCT00483574|Immunologic Factors|immunologic factors|mesh-ancestor
65385752|NCT00483574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385753|NCT01000623|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65385754|NCT01000623|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65385755|NCT01000623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65385756|NCT01000623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64388952|NCT02437045|Tazobactam|tazobactam|mesh-list
64388953|NCT02437045|Piperacillin|piperacillin|mesh-list
65385765|NCT00998439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385766|NCT00998439|Tubulin Modulators|tubulin modulators|mesh-ancestor
65385767|NCT00998439|Antimitotic Agents|antimitotic agents|mesh-ancestor
65385768|NCT00998439|Mitosis Modulators|mitosis modulators|mesh-ancestor
65385769|NCT00998439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385770|NCT03996772|Rivaroxaban|rivaroxaban|mesh-list
65385771|NCT03996772|Apixaban|apixaban|mesh-list
65385772|NCT03996772|Edoxaban|edoxaban|mesh-list
65385773|NCT03996772|Dabigatran|dabigatran|mesh-list
65385774|NCT03996772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65385775|NCT03996772|Antithrombins|antithrombins|mesh-ancestor
65385776|NCT03996772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65385777|NCT03996772|Protease Inhibitors|protease inhibitors|mesh-ancestor
65385778|NCT03996772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385779|NCT03996772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385780|NCT03996772|Anticoagulants|anticoagulants|mesh-ancestor
65385781|NCT01000779|Propranolol|propranolol|mesh-list
65385782|NCT01000779|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65385783|NCT01000779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65385784|NCT01000779|Adrenergic Agents|adrenergic agents|mesh-ancestor
65385785|NCT01000779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65385786|NCT01000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385787|NCT01000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385788|NCT01000779|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65385789|NCT01000779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65385790|NCT01000779|Vasodilator Agents|vasodilator agents|mesh-ancestor
65385791|NCT01000857|Paroxetine|paroxetine|mesh-list
65385792|NCT01000857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65385793|NCT01000857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64388968|NCT05233735|Betamethasone|betamethasone|mesh-list
65385856|NCT03944915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385857|NCT03944915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65385885|NCT05228249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65385886|NCT05228249|Antimetabolites|antimetabolites|mesh-ancestor
65385887|NCT05228249|Antiviral Agents|antiviral agents|mesh-ancestor
65385888|NCT05228249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65385889|NCT05228249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65385890|NCT05228249|Immunologic Factors|immunologic factors|mesh-ancestor
65385891|NCT05228249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385892|NCT05228249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65385893|NCT05228249|Alkylating Agents|alkylating agents|mesh-ancestor
65385894|NCT05228249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65385895|NCT05228249|Keratolytic Agents|keratolytic agents|mesh-ancestor
65385896|NCT05228249|Dermatologic Agents|dermatologic agents|mesh-ancestor
65385897|NCT05228249|Tubulin Modulators|tubulin modulators|mesh-ancestor
65385898|NCT05228249|Antimitotic Agents|antimitotic agents|mesh-ancestor
65385899|NCT05228249|Mitosis Modulators|mitosis modulators|mesh-ancestor
65385900|NCT05228249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65385901|NCT02580227|Tranexamic Acid|tranexamic acid|mesh-list
65385902|NCT02580227|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65385903|NCT02580227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65385904|NCT02580227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385905|NCT02580227|Hemostatics|hemostatics|mesh-ancestor
65385906|NCT02580227|Coagulants|coagulants|mesh-ancestor
65385907|NCT04218695|Ceftriaxone|ceftriaxone|mesh-list
65385985|NCT01005147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385987|NCT01005147|Coagulants|coagulants|mesh-ancestor
65385988|NCT03603899|Xenon|xenon|mesh-list
65385989|NCT03603899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65385990|NCT03603899|Anesthetics, General|anesthetics, general|mesh-ancestor
65385991|NCT03603899|Anesthetics|anesthetics|mesh-ancestor
65385992|NCT03603899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65385993|NCT03603899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385994|NCT01001871|Vitamins|vitamins|mesh-list
65385995|NCT01001871|Micronutrients|micronutrients|mesh-ancestor
65385996|NCT01001871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385997|NCT01005303|Vitamin D|vitamin d|mesh-list
65385998|NCT01005303|Cholecalciferol|cholecalciferol|mesh-list
65385999|NCT01005303|Vitamins|vitamins|mesh-ancestor
65386000|NCT01005303|Micronutrients|micronutrients|mesh-ancestor
64777619|NCT02160990|Hormones|hormones|mesh-ancestor
64777621|NCT02164422|Guanfacine|guanfacine|mesh-list
65386037|NCT05733741|Benoxinate|benoxinate|mesh-list
65386038|NCT05733741|Hyaluronic Acid|hyaluronic acid|mesh-list
65386039|NCT05733741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65386040|NCT05733741|Immunologic Factors|immunologic factors|mesh-ancestor
65386041|NCT05733741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386160|NCT00868634|Vinorelbine|vinorelbine|mesh-list
65386180|NCT05232357|Protective Agents|protective agents|mesh-ancestor
65386181|NCT05232357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386182|NCT05232357|Antioxidants|antioxidants|mesh-ancestor
65386183|NCT05232357|Antitubercular Agents|antitubercular agents|mesh-ancestor
65386184|NCT05232357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65386185|NCT05232357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65386186|NCT05232357|Chelating Agents|chelating agents|mesh-ancestor
65386187|NCT05232357|Sequestering Agents|sequestering agents|mesh-ancestor
65386188|NCT00879476|Ramipril|ramipril|mesh-list
65386189|NCT00879476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65386190|NCT00879476|Protease Inhibitors|protease inhibitors|mesh-ancestor
65386191|NCT00879476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386192|NCT00879476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389128|NCT02335151|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65386214|NCT03595553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65386215|NCT03595553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65386216|NCT03595553|Anthelmintics|anthelmintics|mesh-ancestor
65386217|NCT03595553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65386218|NCT00874172|Analgesics|analgesics|mesh-list
65386219|NCT00874172|Sensory System Agents|sensory system agents|mesh-ancestor
65386220|NCT00874172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65386221|NCT00874172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386222|NCT00614822|Bevacizumab|bevacizumab|mesh-list
65386223|NCT00614822|Carboplatin|carboplatin|mesh-list
65386224|NCT00614822|Pemetrexed|pemetrexed|mesh-list
65386225|NCT00614822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65386226|NCT00614822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386227|NCT00614822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65386228|NCT00614822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65386255|NCT00869180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65386256|NCT00869180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386257|NCT00869180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65386259|NCT00869180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65386296|NCT00880178|Vitamin B Complex|vitamin b complex|mesh-ancestor
65386297|NCT00880178|Vitamins|vitamins|mesh-ancestor
65386298|NCT00880178|Micronutrients|micronutrients|mesh-ancestor
65386299|NCT00880178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386320|NCT04194203|Growth Inhibitors|growth inhibitors|mesh-ancestor
65386321|NCT04194203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386322|NCT04194203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65386323|NCT04194203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65386324|NCT05172401|Triamcinolone|triamcinolone|mesh-list
65386325|NCT05172401|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65386326|NCT05172401|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65386327|NCT05172401|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65386328|NCT05172401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65386329|NCT05172401|Glucocorticoids|glucocorticoids|mesh-ancestor
65386331|NCT05172401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65386332|NCT05172401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386333|NCT05172401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65386334|NCT05172401|Immunologic Factors|immunologic factors|mesh-ancestor
65386358|NCT01006863|Respiratory System Agents|respiratory system agents|mesh-ancestor
65386359|NCT01006863|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65386360|NCT01006863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65386362|NCT01006863|Adrenergic Agents|adrenergic agents|mesh-ancestor
65386363|NCT01006863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65386364|NCT01006863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386365|NCT01006863|Protective Agents|protective agents|mesh-ancestor
65386366|NCT01006863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65386367|NCT03535727|Gemcitabine|gemcitabine|mesh-list
65386368|NCT03535727|Paclitaxel|paclitaxel|mesh-list
65386369|NCT03535727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65386370|NCT03535727|Cisplatin|cisplatin|mesh-list
65386371|NCT03535727|Capecitabine|capecitabine|mesh-list
65386372|NCT03535727|Irinotecan|irinotecan|mesh-list
65386373|NCT03535727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65386374|NCT03535727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386375|NCT03535727|Tubulin Modulators|tubulin modulators|mesh-ancestor
65386376|NCT03535727|Antimitotic Agents|antimitotic agents|mesh-ancestor
64777758|NCT02214420|Antiviral Agents|antiviral agents|mesh-ancestor
65386404|NCT00142909|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65386405|NCT00142909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386406|NCT00142909|Sensory System Agents|sensory system agents|mesh-ancestor
65386407|NCT00142909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65386408|NCT00142909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65386409|NCT00142909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65386410|NCT00142909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65386411|NCT00142909|Adrenergic Agents|adrenergic agents|mesh-ancestor
65386412|NCT00142909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65386413|NCT00142909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386415|NCT01007019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65386416|NCT01007019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65386417|NCT01007019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65386418|NCT01007019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386419|NCT01007019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386420|NCT05633979|Trastuzumab|trastuzumab|mesh-list
64777766|NCT02215200|Immunologic Factors|immunologic factors|mesh-ancestor
65386440|NCT00205699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65386441|NCT00205699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65386442|NCT00205699|Dopamine Agents|dopamine agents|mesh-ancestor
65386443|NCT00205699|Antiemetics|antiemetics|mesh-ancestor
65386444|NCT00205699|Autonomic Agents|autonomic agents|mesh-ancestor
65386445|NCT00205699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65386446|NCT00205699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65386447|NCT00205699|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65386448|NCT00205699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65386449|NCT00205699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65386450|NCT00205699|Antidepressive Agents|antidepressive agents|mesh-ancestor
65386451|NCT00205699|Dopamine Agonists|dopamine agonists|mesh-ancestor
65220398|NCT02607436|Aspirin|aspirin|mesh-list
65386452|NCT00205699|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65386453|NCT00205699|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65386454|NCT00205699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65386455|NCT00205699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65386466|NCT03498521|Atezolizumab|atezolizumab|mesh-list
65386467|NCT03498521|Olaparib|olaparib|mesh-list
65386468|NCT03498521|Pertuzumab|pertuzumab|mesh-list
65386469|NCT03498521|Vemurafenib|vemurafenib|mesh-list
65386470|NCT03498521|Ivosidenib|ivosidenib|mesh-list
65386471|NCT03498521|Entrectinib|entrectinib|mesh-list
65386472|NCT03498521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386473|NCT03498521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386474|NCT03498521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65386475|NCT03498521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65386476|NCT03498521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65386477|NCT03498521|Growth Substances|growth substances|mesh-ancestor
65386478|NCT03498521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386479|NCT03498521|Growth Inhibitors|growth inhibitors|mesh-ancestor
65386480|NCT03498521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65386481|NCT03498521|Antimetabolites|antimetabolites|mesh-ancestor
65386482|NCT03498521|Antiviral Agents|antiviral agents|mesh-ancestor
65386483|NCT03498521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65386484|NCT03498521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386485|NCT03498521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65386486|NCT03498521|Immunologic Factors|immunologic factors|mesh-ancestor
65386487|NCT03498521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65386488|NCT03498521|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65386489|NCT03850691|Aldesleukin|aldesleukin|mesh-list
65386490|NCT03850691|Nivolumab|nivolumab|mesh-list
65386491|NCT03850691|Ipilimumab|ipilimumab|mesh-list
65386492|NCT03850691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65386493|NCT03850691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386529|NCT04994223|Protease Inhibitors|protease inhibitors|mesh-ancestor
65386530|NCT04994223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386531|NCT04994223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386583|NCT03443765|Antibodies|antibodies|mesh-list
65386584|NCT03443765|Vitamins|vitamins|mesh-ancestor
65386585|NCT03443765|Micronutrients|micronutrients|mesh-ancestor
65386586|NCT03443765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386587|NCT03443765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65386588|NCT03443765|Immunologic Factors|immunologic factors|mesh-ancestor
65386589|NCT03441893|Nitazoxanide|nitazoxanide|mesh-list
65386590|NCT03441893|Mesalamine|mesalamine|mesh-list
65386591|NCT03441893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65386592|NCT03441893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65386593|NCT03441893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65386594|NCT03441893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65386595|NCT03441893|Analgesics|analgesics|mesh-ancestor
65386596|NCT03441893|Sensory System Agents|sensory system agents|mesh-ancestor
65386597|NCT03441893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65386598|NCT03441893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386599|NCT03441893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65386600|NCT03441893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65386628|NCT02758847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65386630|NCT02758847|Tubulin Modulators|tubulin modulators|mesh-ancestor
65386631|NCT02758847|Antimitotic Agents|antimitotic agents|mesh-ancestor
65136208|NCT01202227|Anticonvulsants|anticonvulsants|mesh-ancestor
65386632|NCT02758847|Mitosis Modulators|mitosis modulators|mesh-ancestor
65386633|NCT02758847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386634|NCT01016860|Irinotecan|irinotecan|mesh-list
65386635|NCT01016860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65386636|NCT01016860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65386637|NCT01016860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386638|NCT01016860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386668|NCT05127304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386670|NCT05127304|Respiratory System Agents|respiratory system agents|mesh-ancestor
65386671|NCT05127304|Parasympatholytics|parasympatholytics|mesh-ancestor
65386672|NCT05127304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65386673|NCT05127304|Cholinergic Agents|cholinergic agents|mesh-ancestor
65386674|NCT05127304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65386675|NCT05127304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386676|NCT05127304|Anticonvulsants|anticonvulsants|mesh-ancestor
65386677|NCT00880412|Etazolate|etazolate|mesh-list
65386678|NCT00880412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65269836|NCT02732756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269837|NCT02732756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269838|NCT02732756|Sympathomimetics|sympathomimetics|mesh-ancestor
65269839|NCT02732756|Autonomic Agents|autonomic agents|mesh-ancestor
65269840|NCT02732756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65269841|NCT02732756|Nasal Decongestants|nasal decongestants|mesh-ancestor
65386679|NCT00880412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386680|NCT00880412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386681|NCT00880412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65386682|NCT00880412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65386683|NCT00880412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65386684|NCT00880412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386685|NCT00880412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65386725|NCT01020214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65386726|NCT01020214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386727|NCT01020214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65386728|NCT01020214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65386730|NCT03970824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65386731|NCT03970824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65386732|NCT00933894|Citalopram|citalopram|mesh-list
65386733|NCT00933894|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65386734|NCT00933894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65386735|NCT00933894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65386736|NCT00933894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386737|NCT00933894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65386738|NCT00933894|Serotonin Agents|serotonin agents|mesh-ancestor
65386739|NCT00933894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386740|NCT00933894|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65386741|NCT00933894|Antidepressive Agents|antidepressive agents|mesh-ancestor
65386742|NCT00933894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65386743|NCT00564486|Acetaminophen|acetaminophen|mesh-list
64777907|NCT02251938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65386766|NCT00480532|Estrogens|estrogens|mesh-ancestor
65386767|NCT00480532|Hormones|hormones|mesh-ancestor
65386768|NCT00480532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65386769|NCT00480532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386770|NCT00480532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65386771|NCT00480532|Contraceptive Agents|contraceptive agents|mesh-ancestor
65386772|NCT00480532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65386773|NCT00480532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65386774|NCT00480532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65386775|NCT00480532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65386776|NCT00480532|Antimalarials|antimalarials|mesh-ancestor
65386777|NCT00480532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64389361|NCT02328443|Rifampin|rifampin|mesh-list
65386813|NCT01020292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65386814|NCT01020292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65386841|NCT04014192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386842|NCT04014192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65386843|NCT04014192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386844|NCT00935610|Caseins|caseins|mesh-list
64389386|NCT02328443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65386855|NCT04074473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386856|NCT04074473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386857|NCT04074473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65386858|NCT04074473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65386859|NCT04074473|Vasodilator Agents|vasodilator agents|mesh-ancestor
65386861|NCT03356483|Nicotinic Acids|nicotinic acids|mesh-list
65386862|NCT03356483|Psilocybin|psilocybin|mesh-list
65386863|NCT03356483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65386864|NCT03356483|Antimetabolites|antimetabolites|mesh-ancestor
65386865|NCT03356483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386866|NCT03356483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65386867|NCT03356483|Vasodilator Agents|vasodilator agents|mesh-ancestor
65386868|NCT03356483|Vitamin B Complex|vitamin b complex|mesh-ancestor
65386869|NCT03356483|Vitamins|vitamins|mesh-ancestor
65386870|NCT03356483|Micronutrients|micronutrients|mesh-ancestor
65220538|NCT04028596|Acetaminophen|acetaminophen|mesh-list
65386871|NCT03356483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386872|NCT03356483|Hallucinogens|hallucinogens|mesh-ancestor
65386873|NCT03356483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65386874|NCT03093480|Factor VIII|factor viii|mesh-list
65386875|NCT03093480|Coagulants|coagulants|mesh-ancestor
65386876|NCT02578511|Ixazomib|ixazomib|mesh-list
65386877|NCT02578511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386878|NCT02578511|Protease Inhibitors|protease inhibitors|mesh-ancestor
65386879|NCT02578511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386880|NCT02578511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386903|NCT00203047|Immunologic Factors|immunologic factors|mesh-ancestor
65386904|NCT00203047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65386905|NCT00203047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65386906|NCT00870038|Paclitaxel|paclitaxel|mesh-list
65386907|NCT00870038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65386908|NCT00870038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386909|NCT00870038|Tubulin Modulators|tubulin modulators|mesh-ancestor
65386910|NCT00870038|Antimitotic Agents|antimitotic agents|mesh-ancestor
65386911|NCT00870038|Mitosis Modulators|mitosis modulators|mesh-ancestor
65386912|NCT00870038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386913|NCT04074551|Losartan|losartan|mesh-list
65386914|NCT04074551|Amlodipine|amlodipine|mesh-list
65386915|NCT04074551|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65386916|NCT04074551|Ezetimibe|ezetimibe|mesh-list
65386917|NCT04074551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65386918|NCT04074551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65386919|NCT04074551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65386920|NCT04074551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386921|NCT04074551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65386922|NCT04074551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386951|NCT03713294|Ichthammol|ichthammol|mesh-list
65386952|NCT03713294|BB 1101|bb 1101|mesh-list
65386953|NCT03713294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65386954|NCT03713294|Antiemetics|antiemetics|mesh-ancestor
65386955|NCT03713294|Autonomic Agents|autonomic agents|mesh-ancestor
65386956|NCT03713294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65386957|NCT03713294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386958|NCT03713294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65386959|NCT03713294|Glucocorticoids|glucocorticoids|mesh-ancestor
65386960|NCT03713294|Hormones|hormones|mesh-ancestor
65386961|NCT03713294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65386962|NCT03713294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65386963|NCT03713294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386964|NCT03713294|Protease Inhibitors|protease inhibitors|mesh-ancestor
65386965|NCT03713294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386966|NCT03713294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386967|NCT03713294|Immunologic Factors|immunologic factors|mesh-ancestor
65386968|NCT03713294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65386969|NCT03713294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65386970|NCT03713294|Growth Substances|growth substances|mesh-ancestor
65386971|NCT03713294|Growth Inhibitors|growth inhibitors|mesh-ancestor
65386972|NCT03713294|Dermatologic Agents|dermatologic agents|mesh-ancestor
65387004|NCT00874562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387005|NCT00874562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65387006|NCT00874562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387007|NCT00874562|Antifungal Agents|antifungal agents|mesh-ancestor
65387008|NCT00874562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65387009|NCT00874562|Immunologic Factors|immunologic factors|mesh-ancestor
65387010|NCT00874562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387012|NCT00201643|Betamethasone|betamethasone|mesh-list
65387013|NCT00201643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65387014|NCT00201643|Antiemetics|antiemetics|mesh-ancestor
65387015|NCT00201643|Autonomic Agents|autonomic agents|mesh-ancestor
65387017|NCT00201643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387018|NCT00201643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65387019|NCT00201643|Glucocorticoids|glucocorticoids|mesh-ancestor
65387020|NCT00201643|Hormones|hormones|mesh-ancestor
64777997|NCT02282514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65387054|NCT00883064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387055|NCT00883064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65387056|NCT00883064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65387057|NCT00883064|Protective Agents|protective agents|mesh-ancestor
65387058|NCT00883064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387059|NCT01077505|Contraceptive Agents|contraceptive agents|mesh-list
65387116|NCT04489628|Vitamin D|vitamin d|mesh-list
65387117|NCT04489628|Cholecalciferol|cholecalciferol|mesh-list
65387118|NCT04489628|Vitamins|vitamins|mesh-ancestor
65387119|NCT04489628|Micronutrients|micronutrients|mesh-ancestor
65387120|NCT04489628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387121|NCT04489628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65387122|NCT04489628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65387123|NCT00130039|Cilostazol|cilostazol|mesh-list
65387124|NCT00130039|Clopidogrel|clopidogrel|mesh-list
65387125|NCT00130039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65387126|NCT00130039|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65387127|NCT00130039|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65387128|NCT00130039|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64778045|NCT02284854|Antimanic Agents|antimanic agents|mesh-ancestor
64389493|NCT03144713|Midodrine|midodrine|mesh-list
65387144|NCT00130039|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65387145|NCT00130039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387146|NCT00875030|Artesunate|artesunate|mesh-list
65387147|NCT00875030|Antimalarials|antimalarials|mesh-ancestor
65387148|NCT00875030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65387149|NCT00875030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65387150|NCT00875030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387151|NCT00875030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387152|NCT00875030|Antiviral Agents|antiviral agents|mesh-ancestor
65387153|NCT00875030|Schistosomicides|schistosomicides|mesh-ancestor
65387154|NCT00875030|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65387155|NCT00875030|Anthelmintics|anthelmintics|mesh-ancestor
65387156|NCT00883298|Bevacizumab|bevacizumab|mesh-list
65387157|NCT00883298|Temozolomide|temozolomide|mesh-list
65387158|NCT00883298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65387159|NCT00883298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387160|NCT00883298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65136728|NCT04530500|Androgens|androgens|mesh-list
65387161|NCT00883298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65387189|NCT01017640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65387190|NCT01017640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387191|NCT01017640|Alkylating Agents|alkylating agents|mesh-ancestor
65387192|NCT01017640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387193|NCT01017640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65387194|NCT01017640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387195|NCT01017640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65387196|NCT00614120|Metformin|metformin|mesh-list
65387197|NCT00614120|Liraglutide|liraglutide|mesh-list
65387209|NCT00496054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387210|NCT05014646|Cholestyramine Resin|cholestyramine resin|mesh-list
65387211|NCT05014646|Leflunomide|leflunomide|mesh-list
65387212|NCT05014646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387213|NCT05014646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387214|NCT05014646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65387215|NCT05014646|Immunologic Factors|immunologic factors|mesh-ancestor
65387216|NCT05014646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387217|NCT05014646|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65387218|NCT05014646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65387219|NCT05014646|Antimetabolites|antimetabolites|mesh-ancestor
65387220|NCT05014646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65387221|NCT00495820|Methylphenidate|methylphenidate|mesh-list
65387222|NCT00495820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65387223|NCT00495820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387224|NCT00495820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65387225|NCT00495820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65387226|NCT00495820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65387227|NCT00495820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387228|NCT00495820|Dopamine Agents|dopamine agents|mesh-ancestor
65387229|NCT00495820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65387230|NCT04387240|Artesunate|artesunate|mesh-list
65387231|NCT04387240|Artemisinins|artemisinins|mesh-list
64389532|NCT02430259|Isoniazid|isoniazid|mesh-list
65387265|NCT00613574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65387267|NCT00613574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65387268|NCT00613574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387269|NCT00613574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65387270|NCT00613574|Respiratory System Agents|respiratory system agents|mesh-ancestor
65387271|NCT00613574|Parasympatholytics|parasympatholytics|mesh-ancestor
65387272|NCT00613574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65387273|NCT00613574|Cholinergic Agents|cholinergic agents|mesh-ancestor
65387274|NCT00613574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65387275|NCT00613574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220688|NCT04114630|Erenumab|erenumab|mesh-list
64778094|NCT02287350|Analgesics|analgesics|mesh-ancestor
65387309|NCT00881738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65136874|NCT01686789|Interferons|interferons|mesh-list
65387311|NCT00613106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65387312|NCT00613106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65387313|NCT00613106|Analgesics|analgesics|mesh-ancestor
65387314|NCT00613106|Sensory System Agents|sensory system agents|mesh-ancestor
65387315|NCT00613106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65387316|NCT00613106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387419|NCT00923390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387420|NCT00885794|Ranibizumab|ranibizumab|mesh-list
65387421|NCT00885794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65387422|NCT00885794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65387423|NCT00885794|Growth Substances|growth substances|mesh-ancestor
65387424|NCT00885794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387425|NCT00885794|Growth Inhibitors|growth inhibitors|mesh-ancestor
65387426|NCT00885794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387427|NCT00888602|Psyllium|psyllium|mesh-list
65387428|NCT00888602|Calcium polycarbophil|calcium polycarbophil|mesh-list
65387429|NCT00888602|Cathartics|cathartics|mesh-ancestor
65387430|NCT00888602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65387431|NCT00888602|Antidiarrheals|antidiarrheals|mesh-ancestor
65387432|NCT00885872|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65387433|NCT00885872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65387434|NCT00885872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65387435|NCT00885872|Antimetabolites|antimetabolites|mesh-ancestor
65387436|NCT00885872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387437|NCT00885872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65387438|NCT00885872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65387439|NCT00885872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387493|NCT00889148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65387494|NCT00889148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65387495|NCT00889148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65387496|NCT00889148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65387497|NCT00889148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65387498|NCT00889148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65387499|NCT00889148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387500|NCT00889148|Antimanic Agents|antimanic agents|mesh-ancestor
65387501|NCT00936156|Carboplatin|carboplatin|mesh-list
65387502|NCT00936156|Etoposide|etoposide|mesh-list
65387503|NCT00936156|Thiotepa|thiotepa|mesh-list
65387504|NCT00936156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387505|NCT00936156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65387506|NCT00936156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65387507|NCT00936156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65387508|NCT00936156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387509|NCT00936156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387510|NCT00936156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65387511|NCT00936156|Alkylating Agents|alkylating agents|mesh-ancestor
65387512|NCT00936156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65387513|NCT00936156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65387514|NCT00936156|Immunologic Factors|immunologic factors|mesh-ancestor
65387515|NCT00936156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387516|NCT00129961|Cyclosporine|cyclosporine|mesh-list
65387517|NCT00129961|Sirolimus|sirolimus|mesh-list
65387518|NCT00129961|Tacrolimus|tacrolimus|mesh-list
65387519|NCT00129961|Cyclosporins|cyclosporins|mesh-list
65387546|NCT00936234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387547|NCT00936234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387548|NCT00886028|Doxorubicin|doxorubicin|mesh-list
65387549|NCT00886028|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65387550|NCT00886028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387551|NCT00886028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65387552|NCT00886028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65387553|NCT00886028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65387554|NCT00886028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387555|NCT00886028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387556|NCT00936546|Rituximab|rituximab|mesh-list
65387557|NCT00936546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65387558|NCT00936546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387559|NCT00936546|Immunologic Factors|immunologic factors|mesh-ancestor
65387560|NCT00936546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387561|NCT00936546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65387562|NCT00936624|Montelukast|montelukast|mesh-list
65387563|NCT00936624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65387564|NCT00936624|Respiratory System Agents|respiratory system agents|mesh-ancestor
65387565|NCT00936624|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65387566|NCT00936624|Hormone Antagonists|hormone antagonists|mesh-ancestor
64778219|NCT02322528|Loteprednol Etabonate|loteprednol etabonate|mesh-list
65387580|NCT00138151|Antimitotic Agents|antimitotic agents|mesh-ancestor
65387581|NCT00138151|Mitosis Modulators|mitosis modulators|mesh-ancestor
65387582|NCT00138151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387583|NCT00138151|Antiviral Agents|antiviral agents|mesh-ancestor
65387584|NCT00138151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387585|NCT00138151|Immunologic Factors|immunologic factors|mesh-ancestor
65387586|NCT00138151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387587|NCT00138151|Dermatologic Agents|dermatologic agents|mesh-ancestor
65387588|NCT02543060|Fluorides|fluorides|mesh-list
65387589|NCT02543060|Tin Fluorides|tin fluorides|mesh-list
65387590|NCT02543060|Cariostatic Agents|cariostatic agents|mesh-ancestor
65387591|NCT02543060|Protective Agents|protective agents|mesh-ancestor
65387592|NCT02543060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387593|NCT00889616|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65387594|NCT00889616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65387595|NCT00889616|Immunologic Factors|immunologic factors|mesh-ancestor
65387596|NCT00889616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387597|NCT00889616|Antacids|antacids|mesh-ancestor
65387598|NCT00889616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387599|NCT00889616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65387600|NCT02581631|Nivolumab|nivolumab|mesh-list
65387601|NCT02581631|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65387602|NCT02581631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65387603|NCT02581631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387604|NCT02581631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64389697|NCT04996199|Analgesics|analgesics|mesh-ancestor
65387639|NCT00886106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65387640|NCT00886106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387641|NCT00886106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65387642|NCT00886106|Narcotics|narcotics|mesh-ancestor
65387643|NCT00886106|Analgesics|analgesics|mesh-ancestor
65387644|NCT00886106|Sensory System Agents|sensory system agents|mesh-ancestor
65387645|NCT00886106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65387646|NCT00889694|Sulfasalazine|sulfasalazine|mesh-list
65387647|NCT00889694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387648|NCT00889694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65387681|NCT02578043|Dermatologic Agents|dermatologic agents|mesh-ancestor
65387682|NCT00889850|Esomeprazole|esomeprazole|mesh-list
65387683|NCT00889850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65387684|NCT00889850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65387685|NCT00889850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65387686|NCT00889850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387687|NCT00889850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387688|NCT04074317|Insulin|insulin|mesh-list
65387689|NCT04074317|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65387690|NCT04074317|Pramlintide|pramlintide|mesh-list
65387691|NCT04074317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64778272|NCT02351700|Ibuprofen|ibuprofen|mesh-list
65066838|NCT00272714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65066839|NCT00272714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066840|NCT00272714|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65066841|NCT00272714|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65066843|NCT00272753|Albuterol|albuterol|mesh-list
65066844|NCT00272753|Formoterol Fumarate|formoterol fumarate|mesh-list
65066845|NCT00272753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65066846|NCT00272753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65066847|NCT00272753|Autonomic Agents|autonomic agents|mesh-ancestor
65066848|NCT00272753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64508269|NCT02467686|Tamoxifen|tamoxifen|mesh-list
65066849|NCT00272753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066850|NCT00272753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65066851|NCT00272753|Respiratory System Agents|respiratory system agents|mesh-ancestor
65066852|NCT00272753|Glucocorticoids|glucocorticoids|mesh-ancestor
65066853|NCT00272753|Hormones|hormones|mesh-ancestor
65066854|NCT00272753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64389746|NCT02707861|Ibalizumab|ibalizumab|mesh-list
65387709|NCT03263429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65387710|NCT03263429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65387711|NCT03263429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387712|NCT03263429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387713|NCT03263429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387714|NCT03263429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65387715|NCT00609674|Fluticasone|fluticasone|mesh-list
65387716|NCT00609674|Xhance|xhance|mesh-list
65387717|NCT00609674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65387718|NCT00609674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65387719|NCT00609674|Autonomic Agents|autonomic agents|mesh-ancestor
65387720|NCT00609674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65387721|NCT00609674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387722|NCT00609674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64778311|NCT02359110|Gabapentin|gabapentin|mesh-list
65387747|NCT00890318|Ketoconazole|ketoconazole|mesh-list
65387748|NCT00890318|Antifungal Agents|antifungal agents|mesh-ancestor
65387749|NCT00890318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387750|NCT00890318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65387784|NCT02542748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65387785|NCT02542748|Adrenergic Agents|adrenergic agents|mesh-ancestor
65387786|NCT02542748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65387787|NCT02542748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778351|NCT02374398|Hemostatics|hemostatics|mesh-ancestor
65387808|NCT02542592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65387809|NCT02542592|Glucocorticoids|glucocorticoids|mesh-ancestor
65387810|NCT02542592|Hormones|hormones|mesh-ancestor
65387811|NCT02542592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65387812|NCT02542592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65387813|NCT02542592|Protective Agents|protective agents|mesh-ancestor
65387814|NCT02542592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65387815|NCT02542592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387816|NCT03178487|Upadacitinib|upadacitinib|mesh-list
65387817|NCT03178487|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65387818|NCT03178487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64389812|NCT02432365|Tubulin Modulators|tubulin modulators|mesh-ancestor
65493971|NCT03913559|Histamine Agents|histamine agents|mesh-ancestor
65493972|NCT03913559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65493973|NCT03913559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65493974|NCT03913559|Antipruritics|antipruritics|mesh-ancestor
65493975|NCT03913559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65493976|NCT03913559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65493978|NCT03900754|Oxytocics|oxytocics|mesh-ancestor
65066879|NCT00272831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387834|NCT00528957|Tenofovir|tenofovir|mesh-list
65387835|NCT00528957|Zidovudine|zidovudine|mesh-list
65387836|NCT00528957|Stavudine|stavudine|mesh-list
65387837|NCT00528957|Antiviral Agents|antiviral agents|mesh-ancestor
65387838|NCT00528957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387839|NCT00528957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65387840|NCT00528957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65387841|NCT00528957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387842|NCT00528957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387843|NCT00528957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65387869|NCT00890786|Growth Substances|growth substances|mesh-ancestor
65387870|NCT00890786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387871|NCT00890786|Growth Inhibitors|growth inhibitors|mesh-ancestor
65387872|NCT00890786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65387873|NCT00890786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65387874|NCT00890786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387875|NCT00890786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387876|NCT00890786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65387877|NCT00890786|Alkylating Agents|alkylating agents|mesh-ancestor
65387878|NCT00560508|Pramipexole|pramipexole|mesh-list
65387879|NCT00560508|Antioxidants|antioxidants|mesh-ancestor
65387880|NCT00560508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387881|NCT00560508|Protective Agents|protective agents|mesh-ancestor
65387882|NCT00560508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387883|NCT00560508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65387884|NCT00560508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65387885|NCT00560508|Dopamine Agonists|dopamine agonists|mesh-ancestor
65387886|NCT00560508|Dopamine Agents|dopamine agents|mesh-ancestor
65387887|NCT00560508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65387888|NCT00890942|Naloxone|naloxone|mesh-list
65387889|NCT00890942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65387890|NCT00890942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389840|NCT03143933|Analgesics|analgesics|mesh-ancestor
65387960|NCT00609518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65387961|NCT00609518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65387962|NCT00609518|Hematinics|hematinics|mesh-ancestor
65387963|NCT01008111|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65387964|NCT01008111|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65220913|NCT03387657|Diuretics|diuretics|mesh-ancestor
65387965|NCT01008111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387966|NCT00886496|Lectins|lectins|mesh-list
64389941|NCT02431975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64389942|NCT02431975|Antiviral Agents|antiviral agents|mesh-ancestor
65388009|NCT00886574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65388010|NCT00886574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388011|NCT00886574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65388012|NCT00886574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65388013|NCT00886574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65388014|NCT00886574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65388015|NCT00886574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388016|NCT00886574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65388017|NCT00886574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65388018|NCT00886574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388019|NCT00886574|Antipyretics|antipyretics|mesh-ancestor
65388020|NCT00886574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65388021|NCT00886574|Autonomic Agents|autonomic agents|mesh-ancestor
65388022|NCT00886574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65388023|NCT00886574|Respiratory System Agents|respiratory system agents|mesh-ancestor
65388024|NCT00886574|Vasodilator Agents|vasodilator agents|mesh-ancestor
65388025|NCT00886574|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65388026|NCT00886574|Protective Agents|protective agents|mesh-ancestor
65388027|NCT00886574|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65388028|NCT00886574|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65388029|NCT00611858|Fluorouracil|fluorouracil|mesh-list
65388030|NCT00611858|Cetuximab|cetuximab|mesh-list
65388031|NCT00611858|Antimetabolites|antimetabolites|mesh-ancestor
65388032|NCT00611858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388033|NCT00611858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65388034|NCT00611858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388035|NCT00611858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65388036|NCT00611858|Immunologic Factors|immunologic factors|mesh-ancestor
65388037|NCT00611858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388038|NCT00611858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65388039|NCT00137449|Sunitinib|sunitinib|mesh-list
65388040|NCT00137449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388041|NCT00137449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64389943|NCT02431975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65388076|NCT00892112|Immunologic Factors|immunologic factors|mesh-ancestor
65388077|NCT00892112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388078|NCT00892112|Blood Substitutes|blood substitutes|mesh-ancestor
65388079|NCT00887120|Ritonavir|ritonavir|mesh-list
65388080|NCT00887120|Lopinavir|lopinavir|mesh-list
65388081|NCT00887120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65388131|NCT00608894|Antimetabolites|antimetabolites|mesh-ancestor
65388132|NCT00608894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65388133|NCT00608894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65388134|NCT00892346|Thalidomide|thalidomide|mesh-list
65388135|NCT00892346|Melphalan|melphalan|mesh-list
65388136|NCT00892346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65388137|NCT00892346|Alkylating Agents|alkylating agents|mesh-ancestor
65388138|NCT00892346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388139|NCT00892346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388140|NCT00892346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65388141|NCT00892346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65388142|NCT00892346|Immunologic Factors|immunologic factors|mesh-ancestor
65388143|NCT00892346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388144|NCT00892346|Leprostatic Agents|leprostatic agents|mesh-ancestor
65388145|NCT00892346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65388146|NCT00892346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65388147|NCT00892346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65388148|NCT00892346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65388149|NCT00892346|Growth Substances|growth substances|mesh-ancestor
65388150|NCT00892346|Growth Inhibitors|growth inhibitors|mesh-ancestor
65388151|NCT00892424|Sorafenib|sorafenib|mesh-list
65388152|NCT00892424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388153|NCT00892424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65388182|NCT00191113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65388183|NCT00191113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388184|NCT03965052|Travoprost|travoprost|mesh-list
65388185|NCT03965052|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65388186|NCT03965052|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65388187|NCT03965052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65388188|NCT00892658|Sorafenib|sorafenib|mesh-list
65388189|NCT00892658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65269842|NCT02732756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65220980|NCT00720109|Methotrexate|methotrexate|mesh-list
65388190|NCT00892658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65388191|NCT00892658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388192|NCT00892658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388193|NCT00892736|Veliparib|veliparib|mesh-list
65388194|NCT00892736|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65388195|NCT00892736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388196|NCT00892736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388197|NCT00892736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388198|NCT03966235|Melatonin|melatonin|mesh-list
65388199|NCT03966235|Antioxidants|antioxidants|mesh-ancestor
65388225|NCT00606320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65388226|NCT00606320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65388227|NCT00606320|Serotonin Agents|serotonin agents|mesh-ancestor
65388228|NCT00606320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65388229|NCT00606320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65388230|NCT00606320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65388231|NCT00606320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65388232|NCT03966079|Plasminogen|plasminogen|mesh-list
65388233|NCT03966079|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65388234|NCT03966079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65388235|NCT03966079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65388236|NCT03966079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388237|NCT02540486|Insulin Glargine|insulin glargine|mesh-list
65388238|NCT02540486|Insulin, Long-Acting|insulin, long-acting|mesh-list
65388239|NCT02540486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65388240|NCT02540486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388241|NCT03966859|Atorvastatin|atorvastatin|mesh-list
65388242|NCT03966859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65388243|NCT03966859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65388244|NCT03966859|Antimetabolites|antimetabolites|mesh-ancestor
64778626|NCT04711824|Cisplatin|cisplatin|mesh-list
65388276|NCT00895778|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65388277|NCT00895778|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65388279|NCT00895778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65388280|NCT00895778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388281|NCT00187135|Fentanyl|fentanyl|mesh-list
65388282|NCT00187135|Propofol|propofol|mesh-list
65388283|NCT00187135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65388284|NCT00187135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65388285|NCT00187135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388316|NCT00560352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388317|NCT00560352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65388318|NCT00560352|Glucocorticoids|glucocorticoids|mesh-ancestor
65388320|NCT00560352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65388321|NCT00560352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65388322|NCT00560352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388323|NCT00560352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65388324|NCT00560352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388325|NCT00560352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388326|NCT00892892|Nitrendipine|nitrendipine|mesh-list
65388327|NCT00892892|Rilmenidine|rilmenidine|mesh-list
65388328|NCT00892892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65388329|NCT00892892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65388330|NCT00892892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65388331|NCT00892892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388332|NCT00892892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65388333|NCT00892892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388334|NCT00892892|Vasodilator Agents|vasodilator agents|mesh-ancestor
65388386|NCT00896558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65388387|NCT00896558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388388|NCT00896558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65388389|NCT00896558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65388390|NCT00896558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65388391|NCT00896558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65388392|NCT00896558|Anesthetics, General|anesthetics, general|mesh-ancestor
65388393|NCT00896558|Anesthetics|anesthetics|mesh-ancestor
65388394|NCT00896558|GABA Modulators|gaba modulators|mesh-ancestor
65388395|NCT00896558|GABA Agents|gaba agents|mesh-ancestor
65388396|NCT00896558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65221057|NCT02590627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65388397|NCT00896558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388398|NCT00943176|Modafinil|modafinil|mesh-list
65388399|NCT00943176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65388400|NCT00943176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388401|NCT00943176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65388402|NCT00943176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65388403|NCT00943176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64778725|NCT02834052|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65388432|NCT00940524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65388434|NCT00940524|Dermatologic Agents|dermatologic agents|mesh-ancestor
65388435|NCT00940524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388436|NCT00940524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64778741|NCT02828358|Dexamethasone acetate|dexamethasone acetate|mesh-list
64778742|NCT02828358|Prednisolone|prednisolone|mesh-list
64778743|NCT02828358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65388460|NCT00943410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388462|NCT00896948|Immunologic Factors|immunologic factors|mesh-ancestor
65388463|NCT00896948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388464|NCT00186121|Anastrozole|anastrozole|mesh-list
65388465|NCT00186121|Goserelin|goserelin|mesh-list
65388466|NCT00186121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65388467|NCT00186121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388468|NCT00186121|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65388469|NCT00186121|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65388470|NCT00186121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388471|NCT00186121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388472|NCT00186121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65388473|NCT00186121|Hormone Antagonists|hormone antagonists|mesh-ancestor
64778753|NCT02828358|Methotrexate|methotrexate|mesh-list
65388500|NCT00186043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65388501|NCT00186043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65388502|NCT00186043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65388503|NCT00186043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388504|NCT01076491|Mannitol|mannitol|mesh-list
65388505|NCT01076491|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65388506|NCT01076491|Diuretics|diuretics|mesh-ancestor
65388507|NCT01076491|Natriuretic Agents|natriuretic agents|mesh-ancestor
65388508|NCT01076491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388509|NCT00127933|Capecitabine|capecitabine|mesh-list
65388510|NCT00127933|Docetaxel|docetaxel|mesh-list
65388511|NCT00127933|Trastuzumab|trastuzumab|mesh-list
65388512|NCT00127933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65388513|NCT00127933|Antimetabolites|antimetabolites|mesh-ancestor
65138122|NCT01681979|Xhance|xhance|mesh-list
65493979|NCT03900754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65388514|NCT00127933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388515|NCT00127933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388516|NCT00127933|Tubulin Modulators|tubulin modulators|mesh-ancestor
65388517|NCT00127933|Antimitotic Agents|antimitotic agents|mesh-ancestor
65388518|NCT00127933|Mitosis Modulators|mitosis modulators|mesh-ancestor
65388519|NCT00127933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65388555|NCT05225961|Analgesics|analgesics|mesh-ancestor
65388556|NCT05225961|Sensory System Agents|sensory system agents|mesh-ancestor
64778812|NCT02828358|Hematinics|hematinics|mesh-ancestor
65388588|NCT00945360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65388589|NCT00945360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388592|NCT00943566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65388593|NCT00943566|Narcotics|narcotics|mesh-ancestor
65388594|NCT00943566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65388595|NCT00943566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388622|NCT00943956|Leuprolide|leuprolide|mesh-list
65388623|NCT00943956|Bicalutamide|bicalutamide|mesh-list
65388624|NCT00943956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388625|NCT00943956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65388626|NCT00943956|Immunologic Factors|immunologic factors|mesh-ancestor
65388627|NCT00943956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388628|NCT00943956|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65388629|NCT00943956|Fertility Agents|fertility agents|mesh-ancestor
65388630|NCT00943956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65388631|NCT00943956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65388632|NCT00943956|Androgen Antagonists|androgen antagonists|mesh-ancestor
65388633|NCT00943956|Hormone Antagonists|hormone antagonists|mesh-ancestor
65388634|NCT00943956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65221134|NCT02606032|Metronidazole|metronidazole|mesh-list
65388635|NCT00944346|Metformin|metformin|mesh-list
65388636|NCT00944346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65388637|NCT00944346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388638|NCT04115319|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65388639|NCT04115319|Antidepressive Agents|antidepressive agents|mesh-ancestor
65388640|NCT04115319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65388641|NCT04115319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65388642|NCT04115319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65388643|NCT04115319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65388644|NCT04115319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388665|NCT00940836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65388667|NCT00940836|Adrenergic Agents|adrenergic agents|mesh-ancestor
65388668|NCT00940836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65388669|NCT00940836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388670|NCT00940836|Protective Agents|protective agents|mesh-ancestor
65388671|NCT00940836|Antipruritics|antipruritics|mesh-ancestor
65388672|NCT00940836|Dermatologic Agents|dermatologic agents|mesh-ancestor
65388673|NCT00940836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65388674|NCT00940836|Histamine Antagonists|histamine antagonists|mesh-ancestor
65388675|NCT00940836|Histamine Agents|histamine agents|mesh-ancestor
65388676|NCT00940836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65388677|NCT00940914|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|mesh-list
65388678|NCT00940914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65388679|NCT00940914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388680|NCT00944424|Vitamin D|vitamin d|mesh-list
65388681|NCT00944424|Ergocalciferols|ergocalciferols|mesh-list
65388682|NCT00944424|Cholecalciferol|cholecalciferol|mesh-list
65388683|NCT00944424|Vitamins|vitamins|mesh-list
65388684|NCT00944424|Docetaxel|docetaxel|mesh-list
65388685|NCT00944424|Micronutrients|micronutrients|mesh-ancestor
65388686|NCT00944424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778922|NCT05722002|Antipyretics|antipyretics|mesh-ancestor
65388710|NCT00944502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65388711|NCT00944502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388712|NCT00944502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65388713|NCT00944502|Glucocorticoids|glucocorticoids|mesh-ancestor
65388714|NCT00944502|Hormones|hormones|mesh-ancestor
65388715|NCT00944502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65388716|NCT00944502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65388717|NCT00944502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388718|NCT00949962|Leuprolide|leuprolide|mesh-list
65388719|NCT00949962|Androgen Antagonists|androgen antagonists|mesh-list
65388720|NCT00949962|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65388721|NCT00949962|Fertility Agents|fertility agents|mesh-ancestor
65388722|NCT00949962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65388723|NCT00949962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388724|NCT00949962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65388725|NCT00949962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388726|NCT00949962|Hormone Antagonists|hormone antagonists|mesh-ancestor
65388727|NCT00949962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65388728|NCT00946374|Cyclosporine|cyclosporine|mesh-list
65388729|NCT00946374|Doxorubicin|doxorubicin|mesh-list
65388730|NCT00946374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65388731|NCT00946374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388732|NCT00946374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65388733|NCT00946374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65388734|NCT00946374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066880|NCT00416468|Valsartan|valsartan|mesh-list
65388762|NCT00950196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388764|NCT00950196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65388765|NCT00950196|Analgesics|analgesics|mesh-ancestor
65388766|NCT00950196|Sensory System Agents|sensory system agents|mesh-ancestor
65388767|NCT00950196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65388768|NCT01565109|Docetaxel|docetaxel|mesh-list
65388769|NCT01565109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388770|NCT01565109|Tubulin Modulators|tubulin modulators|mesh-ancestor
65388771|NCT01565109|Antimitotic Agents|antimitotic agents|mesh-ancestor
65388772|NCT01565109|Mitosis Modulators|mitosis modulators|mesh-ancestor
65388773|NCT01565109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778955|NCT05719506|Ketamine|ketamine|mesh-list
65388803|NCT00521001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388804|NCT00134563|Teriflunomide|teriflunomide|mesh-list
65388805|NCT00134563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65388806|NCT00134563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65388807|NCT00134563|Analgesics|analgesics|mesh-ancestor
65388808|NCT00134563|Sensory System Agents|sensory system agents|mesh-ancestor
65388809|NCT00134563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65388810|NCT00134563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388811|NCT00134563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65388812|NCT00134563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65388813|NCT00134563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65388814|NCT00134563|Immunologic Factors|immunologic factors|mesh-ancestor
65388815|NCT03966547|Anesthetics|anesthetics|mesh-list
65388816|NCT03966547|Anesthetics, Local|anesthetics, local|mesh-list
65388817|NCT03966547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65388818|NCT03966547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388852|NCT00520845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65388854|NCT00520845|Analgesics|analgesics|mesh-ancestor
65388855|NCT00520845|Sensory System Agents|sensory system agents|mesh-ancestor
65388856|NCT00520845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65388857|NCT00520845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388858|NCT00520845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65388891|NCT00520767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65388892|NCT00520767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65388894|NCT00520767|Protease Inhibitors|protease inhibitors|mesh-ancestor
65388895|NCT00520767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388896|NCT00520767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388897|NCT00520767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65388898|NCT00520767|Alkylating Agents|alkylating agents|mesh-ancestor
64779030|NCT05715840|Growth Substances|growth substances|mesh-ancestor
65388925|NCT01017796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388927|NCT01017796|Vitamins|vitamins|mesh-ancestor
65388928|NCT01017796|Micronutrients|micronutrients|mesh-ancestor
65388929|NCT01783535|Cyclophosphamide|cyclophosphamide|mesh-list
65388930|NCT01783535|Carboplatin|carboplatin|mesh-list
65388931|NCT01783535|Doxorubicin|doxorubicin|mesh-list
65388932|NCT01783535|Etoposide|etoposide|mesh-list
65388933|NCT01783535|Vincristine|vincristine|mesh-list
65388934|NCT01783535|Topotecan|topotecan|mesh-list
65388935|NCT01783535|Lenograstim|lenograstim|mesh-list
65388936|NCT01783535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65388937|NCT01783535|Immunologic Factors|immunologic factors|mesh-ancestor
65388938|NCT01783535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388939|NCT01783535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65388940|NCT01783535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65388941|NCT01783535|Alkylating Agents|alkylating agents|mesh-ancestor
65388942|NCT01783535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388943|NCT01783535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388944|NCT01783535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65388945|NCT01783535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65388946|NCT01783535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65388947|NCT01783535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65388948|NCT01783535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388949|NCT01783535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65388986|NCT00524589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65388987|NCT00524589|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65388988|NCT00524589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65389022|NCT00127855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389023|NCT00493636|Gemcitabine|gemcitabine|mesh-list
65389024|NCT00493636|Capecitabine|capecitabine|mesh-list
65389025|NCT00493636|Sorafenib|sorafenib|mesh-list
65389026|NCT00493636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65389027|NCT00493636|Antimetabolites|antimetabolites|mesh-ancestor
65389028|NCT00493636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389029|NCT00493636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389030|NCT00493636|Antiviral Agents|antiviral agents|mesh-ancestor
65389031|NCT00493636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65389081|NCT00133705|Luteolytic Agents|luteolytic agents|mesh-ancestor
65389082|NCT00133705|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65389083|NCT00133705|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65389084|NCT00132769|MK 0873|mk 0873|mesh-list
65389085|NCT00132769|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65389086|NCT00132769|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65389087|NCT00132769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389088|NCT00132769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389089|NCT02500407|Atezolizumab|atezolizumab|mesh-list
65389090|NCT02500407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389091|NCT02478255|Xenon|xenon|mesh-list
65389092|NCT02478255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65269843|NCT02732756|Respiratory System Agents|respiratory system agents|mesh-ancestor
65221290|NCT04301336|Zinc|zinc|mesh-list
65389093|NCT02478255|Anesthetics, General|anesthetics, general|mesh-ancestor
65389094|NCT02478255|Anesthetics|anesthetics|mesh-ancestor
65389095|NCT02478255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65389096|NCT02478255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389097|NCT00132691|Cyclosporine|cyclosporine|mesh-list
65389098|NCT00132691|Mycophenolic Acid|mycophenolic acid|mesh-list
65389099|NCT00132691|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
65389100|NCT00132691|Cyclophosphamide|cyclophosphamide|mesh-list
65389101|NCT00132691|Chlorambucil|chlorambucil|mesh-list
65389102|NCT00132691|Methotrexate|methotrexate|mesh-list
65389103|NCT00132691|Azathioprine|azathioprine|mesh-list
65389104|NCT00132691|Infliximab|infliximab|mesh-list
65389105|NCT00132691|Tacrolimus|tacrolimus|mesh-list
65389106|NCT00132691|Cyclosporins|cyclosporins|mesh-list
65389107|NCT00132691|Daclizumab|daclizumab|mesh-list
65389108|NCT00132691|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65389109|NCT00132691|Alkylating Agents|alkylating agents|mesh-list
65389110|NCT00132691|Immunologic Factors|immunologic factors|mesh-ancestor
65389111|NCT00132691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389112|NCT00132691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65389113|NCT00132691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65389114|NCT00132691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389116|NCT00132691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65389117|NCT00132691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65389118|NCT00132691|Abortifacient Agents|abortifacient agents|mesh-ancestor
65389119|NCT00132691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65389120|NCT00132691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65389121|NCT00132691|Antimetabolites|antimetabolites|mesh-ancestor
65389154|NCT00125359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389155|NCT00125359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389156|NCT00524043|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65389157|NCT00524043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65389158|NCT00524043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65389159|NCT00524043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65389160|NCT00524043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389161|NCT00524043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65389162|NCT00524043|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65389163|NCT00524043|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65389173|NCT00523419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389174|NCT00523419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389175|NCT00523419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389176|NCT00523419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65389177|NCT00523419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65389178|NCT03868059|Methyltestosterone|methyltestosterone|mesh-list
65389179|NCT03868059|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65389180|NCT03868059|Testosterone|testosterone|mesh-list
65389181|NCT03868059|Testosterone undecanoate|testosterone undecanoate|mesh-list
65389182|NCT03868059|Testosterone enanthate|testosterone enanthate|mesh-list
65389183|NCT03868059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65389184|NCT03868059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066881|NCT00416468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65389185|NCT03868059|Anabolic Agents|anabolic agents|mesh-ancestor
65389186|NCT03868059|Hormones|hormones|mesh-ancestor
65389187|NCT03868059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65389188|NCT03868059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389189|NCT03868059|Androgens|androgens|mesh-ancestor
65389190|NCT04028115|Ixazomib|ixazomib|mesh-list
65389191|NCT04028115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389192|NCT04028115|Protease Inhibitors|protease inhibitors|mesh-ancestor
65389193|NCT04028115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389194|NCT04028115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389195|NCT03865407|Allopurinol|allopurinol|mesh-list
65389196|NCT03865407|Antimetabolites|antimetabolites|mesh-ancestor
65389197|NCT03865407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389198|NCT03865407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389199|NCT03865407|Gout Suppressants|gout suppressants|mesh-ancestor
65389200|NCT03865407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65389201|NCT03865407|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65389202|NCT03865407|Antioxidants|antioxidants|mesh-ancestor
65389203|NCT03865407|Protective Agents|protective agents|mesh-ancestor
65389263|NCT01074619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389264|NCT01074619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269844|NCT02732522|Misoprostol|misoprostol|mesh-list
65389265|NCT01074619|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65389266|NCT01074619|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65389268|NCT00183625|Risperidone|risperidone|mesh-list
65389269|NCT00183625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65389270|NCT00183625|Serotonin Agents|serotonin agents|mesh-ancestor
65389271|NCT00183625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65389272|NCT00183625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389273|NCT00183625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389274|NCT00183625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65389275|NCT00183625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65389276|NCT00183625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65389277|NCT00183625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65389278|NCT00183625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65389279|NCT00183625|Dopamine Agents|dopamine agents|mesh-ancestor
65389280|NCT00183625|Antiemetics|antiemetics|mesh-ancestor
65389281|NCT00183625|Autonomic Agents|autonomic agents|mesh-ancestor
65389282|NCT00183625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389283|NCT00183625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65389284|NCT00183625|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65389315|NCT02576327|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65389316|NCT02576327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65389317|NCT02576327|Serotonin Agents|serotonin agents|mesh-ancestor
65389318|NCT00183391|Methylphenidate|methylphenidate|mesh-list
65389319|NCT00183391|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65389320|NCT00183391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65389321|NCT00183391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389322|NCT00183391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65389323|NCT00183391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65389324|NCT00183391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65389325|NCT00183391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389326|NCT00183391|Dopamine Agents|dopamine agents|mesh-ancestor
65389327|NCT00183391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65389328|NCT00183391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65389365|NCT03997006|Protective Agents|protective agents|mesh-ancestor
65389366|NCT02281955|Cisplatin|cisplatin|mesh-list
65389367|NCT02281955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389399|NCT00182689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65389401|NCT00182689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389402|NCT02578121|Dexamethasone|dexamethasone|mesh-list
65389403|NCT02578121|Pomalidomide|pomalidomide|mesh-list
65389404|NCT02578121|Ixazomib|ixazomib|mesh-list
65389405|NCT02578121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65389406|NCT02578121|Antiemetics|antiemetics|mesh-ancestor
65389407|NCT02578121|Autonomic Agents|autonomic agents|mesh-ancestor
65389408|NCT02578121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389409|NCT02578121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389410|NCT02578121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65389411|NCT02578121|Glucocorticoids|glucocorticoids|mesh-ancestor
65389412|NCT02578121|Hormones|hormones|mesh-ancestor
65389432|NCT00487240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389433|NCT00487240|Coagulants|coagulants|mesh-ancestor
65389434|NCT02577809|Indomethacin|indomethacin|mesh-list
65389435|NCT02577809|Fentanyl|fentanyl|mesh-list
65389436|NCT02577809|Morphine|morphine|mesh-list
65389437|NCT02577809|Bupivacaine|bupivacaine|mesh-list
65389438|NCT02577809|Anesthetics, Local|anesthetics, local|mesh-ancestor
65389439|NCT02577809|Anesthetics|anesthetics|mesh-ancestor
65389440|NCT02577809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65389441|NCT02577809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389442|NCT02577809|Sensory System Agents|sensory system agents|mesh-ancestor
65389443|NCT02577809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389444|NCT02577809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65389445|NCT02577809|Narcotics|narcotics|mesh-ancestor
65389446|NCT02577809|Analgesics|analgesics|mesh-ancestor
65389447|NCT02577809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65389448|NCT02577809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65389449|NCT02577809|Anesthetics, General|anesthetics, general|mesh-ancestor
65389450|NCT02577809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65389451|NCT02577809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65389452|NCT02577809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65389453|NCT02577809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65389454|NCT02577809|Gout Suppressants|gout suppressants|mesh-ancestor
65389455|NCT02577809|Tocolytic Agents|tocolytic agents|mesh-ancestor
65389456|NCT02577809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65221433|NCT02281084|Durvalumab|durvalumab|mesh-list
65389457|NCT02577809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65389458|NCT02577809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389459|NCT02577809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389479|NCT00487084|Anesthetics|anesthetics|mesh-ancestor
65389480|NCT00487084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65389481|NCT00487084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389482|NCT00487084|Sensory System Agents|sensory system agents|mesh-ancestor
65389483|NCT00487084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389484|NCT00487084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65389485|NCT00487084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65389486|NCT00487084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65389487|NCT00487084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65389488|NCT00487084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389489|NCT00487084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65389491|NCT00487084|Analgesics|analgesics|mesh-ancestor
65389492|NCT00466726|Sargramostim|sargramostim|mesh-list
65389493|NCT00466726|Immunologic Factors|immunologic factors|mesh-ancestor
65389494|NCT00466726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389495|NCT01721291|Albuterol|albuterol|mesh-list
65389496|NCT01721291|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65389497|NCT01721291|Autonomic Agents|autonomic agents|mesh-ancestor
65389498|NCT01721291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389499|NCT01721291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389500|NCT01721291|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65389501|NCT01721291|Respiratory System Agents|respiratory system agents|mesh-ancestor
65389502|NCT01721291|Tocolytic Agents|tocolytic agents|mesh-ancestor
65389503|NCT01721291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65389504|NCT01721291|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65389505|NCT01721291|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65389506|NCT01721291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65389507|NCT01721291|Adrenergic Agents|adrenergic agents|mesh-ancestor
65389508|NCT01721291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64779461|NCT04509414|Analgesics|analgesics|mesh-ancestor
65389537|NCT02199665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389539|NCT01021696|Pregabalin|pregabalin|mesh-list
65389540|NCT01021696|Morphine|morphine|mesh-list
65389541|NCT01021696|Buprenorphine|buprenorphine|mesh-list
65389542|NCT01021696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65389543|NCT01021696|Narcotics|narcotics|mesh-ancestor
65389544|NCT01021696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65389545|NCT01021696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389546|NCT01021696|Analgesics|analgesics|mesh-ancestor
65389547|NCT01021696|Sensory System Agents|sensory system agents|mesh-ancestor
65389548|NCT01021696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389549|NCT01021696|Anticonvulsants|anticonvulsants|mesh-ancestor
65389550|NCT01021696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65389551|NCT01021696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65389620|NCT03850444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65389621|NCT00469456|Memantine|memantine|mesh-list
65389622|NCT00469456|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65389623|NCT00469456|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65389624|NCT00469456|Dopamine Agents|dopamine agents|mesh-ancestor
65389625|NCT00469456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65389626|NCT00469456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389627|NCT00469456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389628|NCT00469456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65389629|NCT00469456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65389663|NCT03987022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65389665|NCT03987022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65389666|NCT03987022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65389667|NCT03987022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65389668|NCT03987022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389669|NCT03987022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389670|NCT03987022|Antipyretics|antipyretics|mesh-ancestor
65389671|NCT01025128|Vitamin D|vitamin d|mesh-list
65389701|NCT01412333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65389702|NCT02577185|Botulinum Toxins|botulinum toxins|mesh-list
65389703|NCT02577185|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65389704|NCT02577185|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65389705|NCT02577185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65389706|NCT02577185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65389707|NCT02577185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389708|NCT02577185|Cholinergic Agents|cholinergic agents|mesh-ancestor
65221507|NCT02604940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65389709|NCT02577185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65389710|NCT02577185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389711|NCT02577185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65389712|NCT02577185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389713|NCT00519285|Prednisone|prednisone|mesh-list
65389714|NCT00519285|Prednisolone|prednisolone|mesh-list
65389715|NCT00519285|Docetaxel|docetaxel|mesh-list
65389716|NCT00519285|Aflibercept|aflibercept|mesh-list
65389717|NCT00519285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389718|NCT00519285|Tubulin Modulators|tubulin modulators|mesh-ancestor
65389752|NCT05212857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65389753|NCT05212857|Luteolytic Agents|luteolytic agents|mesh-ancestor
65389754|NCT05212857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65389755|NCT05212857|Contraceptive Agents|contraceptive agents|mesh-ancestor
65389756|NCT05212857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65389758|NCT02099123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65389790|NCT00463840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389792|NCT00129389|Cyclophosphamide|cyclophosphamide|mesh-list
65389793|NCT00129389|Doxorubicin|doxorubicin|mesh-list
65389794|NCT00129389|Fluorouracil|fluorouracil|mesh-list
65389795|NCT00129389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65389796|NCT00129389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389797|NCT00129389|Tubulin Modulators|tubulin modulators|mesh-ancestor
65389798|NCT00129389|Antimitotic Agents|antimitotic agents|mesh-ancestor
65389799|NCT00129389|Mitosis Modulators|mitosis modulators|mesh-ancestor
64779655|NCT03535272|Antidiarrheals|antidiarrheals|mesh-ancestor
65389827|NCT00468052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65389828|NCT00468052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389829|NCT00468052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65389830|NCT00468052|Narcotics|narcotics|mesh-ancestor
65389831|NCT00468052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65389832|NCT00468052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65389833|NCT00468052|Anesthetics, General|anesthetics, general|mesh-ancestor
65389834|NCT00468052|Anesthetics|anesthetics|mesh-ancestor
65389835|NCT00453310|Sunitinib|sunitinib|mesh-list
65389836|NCT00453310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389837|NCT00453310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65389838|NCT00453310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65389839|NCT00453310|Growth Substances|growth substances|mesh-ancestor
65389840|NCT00453310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389841|NCT00453310|Growth Inhibitors|growth inhibitors|mesh-ancestor
65389842|NCT00453310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65389843|NCT00453310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389844|NCT00453310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389845|NCT04711343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65389875|NCT02578277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65389876|NCT00555906|Dexamethasone|dexamethasone|mesh-list
65389877|NCT00555906|Bortezomib|bortezomib|mesh-list
65389878|NCT00555906|Palbociclib|palbociclib|mesh-list
65389879|NCT00555906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65389880|NCT00555906|Antiemetics|antiemetics|mesh-ancestor
65389881|NCT00555906|Autonomic Agents|autonomic agents|mesh-ancestor
65389882|NCT00555906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389883|NCT00555906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389884|NCT00555906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65389885|NCT00555906|Glucocorticoids|glucocorticoids|mesh-ancestor
65389886|NCT00555906|Hormones|hormones|mesh-ancestor
65389887|NCT00555906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65389888|NCT00555906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64779706|NCT03367572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65389951|NCT03958656|Cyclophosphamide|cyclophosphamide|mesh-list
65389952|NCT03958656|Fludarabine|fludarabine|mesh-list
65389953|NCT03958656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65389954|NCT03958656|Immunologic Factors|immunologic factors|mesh-ancestor
65389955|NCT03958656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389956|NCT03958656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65389957|NCT03958656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65389958|NCT03958656|Alkylating Agents|alkylating agents|mesh-ancestor
65389959|NCT03958656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389960|NCT03958656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389961|NCT03958656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65389962|NCT00561912|Interferons|interferons|mesh-list
65389963|NCT00561912|Interferon-alpha|interferon-alpha|mesh-list
65389964|NCT00561912|Interferon alpha-2|interferon alpha-2|mesh-list
65389997|NCT00946608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65221593|NCT00714259|Fludarabine|fludarabine|mesh-list
65389998|NCT00946608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389999|NCT00946608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390000|NCT00463684|Vaccines|vaccines|mesh-list
65390001|NCT00463684|Immunologic Factors|immunologic factors|mesh-ancestor
65390002|NCT00463684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390003|NCT00463606|Calcium, Dietary|calcium, dietary|mesh-list
65390004|NCT00463606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65390005|NCT00463606|Fenofibric acid|fenofibric acid|mesh-list
65390034|NCT00950586|Respiratory System Agents|respiratory system agents|mesh-ancestor
65390035|NCT00950586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65390036|NCT00950586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65390037|NCT00950586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65390038|NCT00950586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390039|NCT00950586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390041|NCT00467896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65390042|NCT00467896|Vasodilator Agents|vasodilator agents|mesh-ancestor
65390043|NCT00946686|Leflunomide|leflunomide|mesh-list
65390044|NCT00946686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390045|NCT00946686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390046|NCT00946686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65390047|NCT00946686|Immunologic Factors|immunologic factors|mesh-ancestor
65390048|NCT00946686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390049|NCT02531737|Docetaxel|docetaxel|mesh-list
65390050|NCT02531737|Nintedanib|nintedanib|mesh-list
65390051|NCT02531737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390052|NCT02531737|Tubulin Modulators|tubulin modulators|mesh-ancestor
65390053|NCT02531737|Antimitotic Agents|antimitotic agents|mesh-ancestor
65390074|NCT00467740|Olodaterol|olodaterol|mesh-list
65390075|NCT00467740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65390076|NCT00467740|Autonomic Agents|autonomic agents|mesh-ancestor
65390077|NCT00467740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65390078|NCT00467740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390079|NCT00467740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65390080|NCT00467740|Respiratory System Agents|respiratory system agents|mesh-ancestor
65390081|NCT00710099|Sildenafil Citrate|sildenafil citrate|mesh-list
65390082|NCT00710099|Vasodilator Agents|vasodilator agents|mesh-ancestor
65390083|NCT00710099|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65390084|NCT00710099|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65390085|NCT00710099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390086|NCT00710099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390087|NCT00710099|Urological Agents|urological agents|mesh-ancestor
65390088|NCT03944044|Acetaminophen|acetaminophen|mesh-list
65390089|NCT03944044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65390090|NCT03944044|Analgesics|analgesics|mesh-ancestor
65390091|NCT03944044|Sensory System Agents|sensory system agents|mesh-ancestor
65390092|NCT03944044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65390093|NCT03944044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390094|NCT03944044|Antipyretics|antipyretics|mesh-ancestor
65390095|NCT00714623|Sirolimus|sirolimus|mesh-list
65390096|NCT00714623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65390097|NCT00714623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65390098|NCT00714623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65390099|NCT00714623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390100|NCT00714623|Antifungal Agents|antifungal agents|mesh-ancestor
65390101|NCT00714623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65390102|NCT00714623|Immunologic Factors|immunologic factors|mesh-ancestor
65390103|NCT00714623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390104|NCT01022476|Raltegravir Potassium|raltegravir potassium|mesh-list
65390105|NCT01022476|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65390106|NCT01022476|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65390107|NCT01022476|Antiviral Agents|antiviral agents|mesh-ancestor
65390108|NCT01022476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65390139|NCT00946764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65390140|NCT00946764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390142|NCT00946764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65390143|NCT00946764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390144|NCT00950820|Capecitabine|capecitabine|mesh-list
65390145|NCT00950820|Oxaliplatin|oxaliplatin|mesh-list
65390146|NCT00950820|Panitumumab|panitumumab|mesh-list
65390147|NCT00950820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65390148|NCT00950820|Antimetabolites|antimetabolites|mesh-ancestor
65390149|NCT00950820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390150|NCT00950820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390187|NCT00467584|Antipyretics|antipyretics|mesh-ancestor
65269845|NCT02732522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65390188|NCT02574611|Glycopyrrolate|glycopyrrolate|mesh-list
65390219|NCT00168103|Immunologic Factors|immunologic factors|mesh-ancestor
65390220|NCT00168103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390221|NCT00168103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65390222|NCT00168103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65390223|NCT00463060|Sunitinib|sunitinib|mesh-list
65390224|NCT00463060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390225|NCT00463060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65390226|NCT00463060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65390227|NCT00463060|Growth Substances|growth substances|mesh-ancestor
65390228|NCT00463060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390229|NCT00463060|Growth Inhibitors|growth inhibitors|mesh-ancestor
65390230|NCT00463060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65390290|NCT00947076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390292|NCT00462982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390293|NCT00462982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65390294|NCT00462982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65390295|NCT00462982|Growth Substances|growth substances|mesh-ancestor
65390296|NCT00462982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390297|NCT00462982|Growth Inhibitors|growth inhibitors|mesh-ancestor
65390298|NCT00462982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65390299|NCT00462982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390300|NCT00462982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390301|NCT02573597|Sufentanil|sufentanil|mesh-list
65390302|NCT02573597|Bupivacaine|bupivacaine|mesh-list
65390303|NCT02573597|Anesthetics, Local|anesthetics, local|mesh-ancestor
65390304|NCT02573597|Anesthetics|anesthetics|mesh-ancestor
65390305|NCT02573597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65139885|NCT02893371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65390306|NCT02573597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390307|NCT02573597|Sensory System Agents|sensory system agents|mesh-ancestor
65390308|NCT02573597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65390309|NCT02573597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65390310|NCT02573597|Narcotics|narcotics|mesh-ancestor
65390311|NCT02573597|Analgesics|analgesics|mesh-ancestor
64780025|NCT02422290|Anesthetics|anesthetics|mesh-ancestor
65390344|NCT00714857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65390345|NCT00714857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390347|NCT00714857|Analgesics|analgesics|mesh-ancestor
65390348|NCT00714857|Sensory System Agents|sensory system agents|mesh-ancestor
65390349|NCT00714857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65390350|NCT00714857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65390351|NCT00714857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65390352|NCT00714857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65390353|NCT00714857|Adrenergic Agents|adrenergic agents|mesh-ancestor
65390354|NCT00714857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65390355|NCT00714857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390420|NCT00947388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390421|NCT00947388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65390422|NCT00947388|Alkylating Agents|alkylating agents|mesh-ancestor
65390423|NCT00947388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390424|NCT00951600|Oxcarbazepine|oxcarbazepine|mesh-list
65390425|NCT00951600|Anticonvulsants|anticonvulsants|mesh-ancestor
65390426|NCT00951600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65390427|NCT00951600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65390428|NCT00951600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65390429|NCT00951600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390430|NCT00951600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65390431|NCT00951600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65390432|NCT03910985|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
65390433|NCT03910985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64780116|NCT02462382|Ropivacaine|ropivacaine|mesh-list
65390462|NCT00718757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65390463|NCT00718757|Tubulin Modulators|tubulin modulators|mesh-ancestor
65390464|NCT00718757|Antimitotic Agents|antimitotic agents|mesh-ancestor
65390465|NCT00718757|Mitosis Modulators|mitosis modulators|mesh-ancestor
65390466|NCT00947466|Buprenorphine|buprenorphine|mesh-list
65390467|NCT00947466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65390468|NCT00947466|Narcotics|narcotics|mesh-ancestor
65390469|NCT00947466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65390470|NCT00947466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390471|NCT00947466|Analgesics|analgesics|mesh-ancestor
65390472|NCT00947466|Sensory System Agents|sensory system agents|mesh-ancestor
65390473|NCT00947466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65390474|NCT00947466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65390475|NCT00951834|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65390476|NCT00951834|Antioxidants|antioxidants|mesh-ancestor
65390477|NCT00951834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390478|NCT00951834|Protective Agents|protective agents|mesh-ancestor
65390479|NCT00951834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390480|NCT00951834|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64780144|NCT02464176|Anesthetics|anesthetics|mesh-ancestor
65390513|NCT04011930|Calcitriol|calcitriol|mesh-list
65390514|NCT04011930|Vitamins|vitamins|mesh-ancestor
65390515|NCT04011930|Micronutrients|micronutrients|mesh-ancestor
65390516|NCT04011930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390517|NCT04011930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65390518|NCT04011930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65390519|NCT04011930|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65390520|NCT04011930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65390521|NCT04011930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390522|NCT04011930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65390551|NCT00549198|Efavirenz|efavirenz|mesh-list
65390552|NCT00549198|Abacavir|abacavir|mesh-list
65390553|NCT00549198|Antiviral Agents|antiviral agents|mesh-ancestor
65390554|NCT00549198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65390555|NCT00549198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65390556|NCT00549198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65390557|NCT00549198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390558|NCT00549198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390559|NCT00549198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65390560|NCT00549198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65390561|NCT00549198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65390562|NCT00549198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65390563|NCT00549198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65390564|NCT00549198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65390565|NCT00549198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65390566|NCT00549198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65390567|NCT00506415|Rivastigmine|rivastigmine|mesh-list
65390568|NCT00506415|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65390569|NCT00506415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390599|NCT00510783|Levetiracetam|levetiracetam|mesh-list
65390600|NCT00510783|Anticonvulsants|anticonvulsants|mesh-ancestor
65390601|NCT00510783|Nootropic Agents|nootropic agents|mesh-ancestor
65390602|NCT00510783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65390603|NCT00510783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65390604|NCT00510783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65390605|NCT00510783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390606|NCT00510783|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65390607|NCT00510783|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65390608|NCT00952302|Iron|iron|mesh-list
65390609|NCT00952302|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65390610|NCT00952302|Trace Elements|trace elements|mesh-ancestor
65390611|NCT00952302|Micronutrients|micronutrients|mesh-ancestor
65390612|NCT00952302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390613|NCT00952302|Hematinics|hematinics|mesh-ancestor
65390614|NCT00518973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65390642|NCT01012479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65390644|NCT01012479|Natriuretic Agents|natriuretic agents|mesh-ancestor
65390645|NCT01012479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390646|NCT01012479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65390647|NCT01012479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65390648|NCT01012479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390649|NCT01012479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65390650|NCT01012479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65390651|NCT02541734|Exenatide|exenatide|mesh-list
65390652|NCT02541734|Polygeline|polygeline|mesh-list
65390653|NCT02541734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65390654|NCT02541734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390655|NCT02541734|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65390656|NCT02541734|Incretins|incretins|mesh-ancestor
65390657|NCT02541734|Hormones|hormones|mesh-ancestor
65390658|NCT02541734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65390659|NCT02541734|Plasma Substitutes|plasma substitutes|mesh-ancestor
65390660|NCT02541734|Blood Substitutes|blood substitutes|mesh-ancestor
65269846|NCT02732522|Abortifacient Agents|abortifacient agents|mesh-ancestor
65390661|NCT00462670|Tolvaptan|tolvaptan|mesh-list
65390662|NCT00462670|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64780253|NCT02492802|Posaconazole|posaconazole|mesh-list
65390732|NCT03753555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390733|NCT03753555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65390734|NCT03753555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65390735|NCT03753555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390737|NCT03753555|Protective Agents|protective agents|mesh-ancestor
65390738|NCT00606086|Interferons|interferons|mesh-list
65390739|NCT00606086|Ribavirin|ribavirin|mesh-list
65390740|NCT00606086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65390741|NCT00606086|Interferon-alpha|interferon-alpha|mesh-list
65390742|NCT00606086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390770|NCT00715637|Antimetabolites|antimetabolites|mesh-ancestor
65390771|NCT00715637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390772|NCT00715637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390773|NCT00715637|Antiviral Agents|antiviral agents|mesh-ancestor
65390774|NCT00715637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65390775|NCT00715637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65390776|NCT00715637|Immunologic Factors|immunologic factors|mesh-ancestor
65390777|NCT00715637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390778|NCT00715637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65390779|NCT00715637|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65390780|NCT00715637|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65390781|NCT00715637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390782|NCT05300490|Prednisolone|prednisolone|mesh-list
65390783|NCT05300490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65390784|NCT05300490|Glucocorticoids|glucocorticoids|mesh-ancestor
65390785|NCT05300490|Hormones|hormones|mesh-ancestor
65390786|NCT05300490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65390787|NCT05300490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390788|NCT05300490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65390789|NCT05300490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390790|NCT00893594|Naproxen|naproxen|mesh-list
65390791|NCT00893594|Sumatriptan|sumatriptan|mesh-list
65390823|NCT00953394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390825|NCT00953394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65390826|NCT00953394|Immunologic Factors|immunologic factors|mesh-ancestor
65390827|NCT00953394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390828|NCT00720161|Metformin|metformin|mesh-list
65390829|NCT00720161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65390830|NCT00720161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390831|NCT00898508|Antibodies|antibodies|mesh-list
65390832|NCT00898508|Immunologic Factors|immunologic factors|mesh-ancestor
65390897|NCT04070495|Leprostatic Agents|leprostatic agents|mesh-ancestor
65390898|NCT04070495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65390899|NCT04070495|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65390900|NCT04070495|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65390901|NCT04070495|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65390902|NCT04070495|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65390903|NCT04070495|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65390904|NCT04070495|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65390906|NCT00712439|Analgesics|analgesics|mesh-ancestor
65390907|NCT00712439|Sensory System Agents|sensory system agents|mesh-ancestor
65390908|NCT00712439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65390909|NCT00712439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390910|NCT00712439|Anticonvulsants|anticonvulsants|mesh-ancestor
65390911|NCT00712439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65390912|NCT00712439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65390913|NCT00712439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65390914|NCT00712439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65390915|NCT00712439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65390974|NCT00606008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65390975|NCT00606008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65390976|NCT00606008|Growth Substances|growth substances|mesh-ancestor
65390977|NCT00606008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390978|NCT00606008|Growth Inhibitors|growth inhibitors|mesh-ancestor
65390979|NCT00606008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65390980|NCT00606008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390981|NCT00606008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390982|NCT00461812|Mometasone Furoate|mometasone furoate|mesh-list
65390983|NCT00461812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65390984|NCT00461812|Dermatologic Agents|dermatologic agents|mesh-ancestor
65390985|NCT00461812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65390986|NCT00721331|Mometasone Furoate|mometasone furoate|mesh-list
65140561|NCT04310254|Antidotes|antidotes|mesh-ancestor
65390988|NCT00721331|Nortriptyline|nortriptyline|mesh-list
65390989|NCT00721331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64780472|NCT02542410|Dopamine Agents|dopamine agents|mesh-ancestor
65391020|NCT01027546|Coagulants|coagulants|mesh-ancestor
65391021|NCT00115063|Orlistat|orlistat|mesh-list
65391022|NCT00115063|Sibutramine|sibutramine|mesh-list
65391023|NCT00115063|Diethylpropion|diethylpropion|mesh-list
65391024|NCT00115063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391025|NCT00115063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391026|NCT00115063|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65391027|NCT00115063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65391028|NCT00115063|Antidepressive Agents|antidepressive agents|mesh-ancestor
65391029|NCT00115063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65391030|NCT00115063|Appetite Depressants|appetite depressants|mesh-ancestor
65391031|NCT01026064|Azithromycin|azithromycin|mesh-list
65391062|NCT00461500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391064|NCT00893906|Immunologic Factors|immunologic factors|mesh-ancestor
65391065|NCT00893906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391066|NCT00721487|Fluconazole|fluconazole|mesh-list
65391067|NCT00721487|Antifungal Agents|antifungal agents|mesh-ancestor
65391068|NCT00721487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65391069|NCT00721487|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65391070|NCT00721487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65391071|NCT00721487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391072|NCT00721487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391073|NCT00721487|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65391074|NCT00721487|Hormone Antagonists|hormone antagonists|mesh-ancestor
64780513|NCT02560038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391105|NCT01022632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65391106|NCT01022632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65391107|NCT01022632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391108|NCT01022632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65391109|NCT01022632|Serotonin Agents|serotonin agents|mesh-ancestor
65391110|NCT01022632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391111|NCT01022632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65391112|NCT01022632|Antidepressive Agents|antidepressive agents|mesh-ancestor
65391113|NCT01022632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65391114|NCT01022632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65391115|NCT01022632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65391116|NCT01022632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391117|NCT01022632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65391118|NCT01022632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65391144|NCT00451204|(T,G)-A-L|(t,g)-a-l|mesh-list
65391145|NCT00451204|Hormones|hormones|mesh-ancestor
65391146|NCT00451204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65391147|NCT00451204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391148|NCT00451204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65391149|NCT00451204|Immunologic Factors|immunologic factors|mesh-ancestor
65391150|NCT00451204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65391151|NCT00451204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65391152|NCT00721877|Resveratrol|resveratrol|mesh-list
65391153|NCT00721877|Antioxidants|antioxidants|mesh-ancestor
65391154|NCT00721877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391155|NCT00721877|Protective Agents|protective agents|mesh-ancestor
65391156|NCT00721877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391157|NCT00721877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391158|NCT00721877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65391159|NCT03537586|Adenosine|adenosine|mesh-list
65391160|NCT03537586|Heparin|heparin|mesh-list
65391161|NCT03537586|Bivalirudin|bivalirudin|mesh-list
65391162|NCT03537586|Anticoagulants|anticoagulants|mesh-ancestor
65391163|NCT03537586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65391164|NCT03537586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65391165|NCT03537586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391166|NCT03537586|Analgesics|analgesics|mesh-ancestor
65391167|NCT03537586|Sensory System Agents|sensory system agents|mesh-ancestor
65391168|NCT03537586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391206|NCT04920149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65391207|NCT04920149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65391241|NCT02573051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65391242|NCT02573051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391243|NCT02573051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65391244|NCT02573051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65391245|NCT02573051|Oxytocics|oxytocics|mesh-ancestor
65391246|NCT02573051|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65391247|NCT02573051|Diuretics|diuretics|mesh-ancestor
65391248|NCT02573051|Natriuretic Agents|natriuretic agents|mesh-ancestor
65391249|NCT02573051|Vasodilator Agents|vasodilator agents|mesh-ancestor
65391250|NCT02573051|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65391279|NCT00605306|Mometasone Furoate|mometasone furoate|mesh-list
65391280|NCT00605306|Maleic acid|maleic acid|mesh-list
65391281|NCT00605306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391282|NCT00605306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391283|NCT00605306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65391284|NCT00605306|Dermatologic Agents|dermatologic agents|mesh-ancestor
65391285|NCT00605306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65391286|NCT00905918|Vitamin E|vitamin e|mesh-list
65140863|NCT00594126|Imetelstat|imetelstat|mesh-list
65391287|NCT00905918|Vitamins|vitamins|mesh-ancestor
65391288|NCT00905918|Micronutrients|micronutrients|mesh-ancestor
65391289|NCT00905918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391290|NCT00905918|Antioxidants|antioxidants|mesh-ancestor
65391291|NCT00905918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391292|NCT00905918|Protective Agents|protective agents|mesh-ancestor
65391293|NCT00894608|Letrozole|letrozole|mesh-list
65391294|NCT00894608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391295|NCT00894608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65391296|NCT00894608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65391297|NCT00894608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780643|NCT05248152|Analgesics|analgesics|mesh-ancestor
65391329|NCT02573987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391330|NCT02573987|Sensory System Agents|sensory system agents|mesh-ancestor
65391331|NCT02573987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391332|NCT02573987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65391333|NCT02573987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65391334|NCT02573987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65391335|NCT02573987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65391336|NCT02573987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391337|NCT02573987|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65391338|NCT02573987|Anesthetics, General|anesthetics, general|mesh-ancestor
65391373|NCT00713687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391374|NCT00713687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65391375|NCT00713687|Immunologic Factors|immunologic factors|mesh-ancestor
65391376|NCT00713687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391377|NCT02540876|Ilorasertib|ilorasertib|mesh-list
65391378|NCT02540876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391379|NCT02540876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65391433|NCT00894998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65391434|NCT00894998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391436|NCT00713921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65391437|NCT00713921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65391438|NCT00713921|Cholinergic Agents|cholinergic agents|mesh-ancestor
65391439|NCT00713921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65391440|NCT00713921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391441|NCT00713921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391442|NCT00713921|Urological Agents|urological agents|mesh-ancestor
65391443|NCT00713999|Praziquantel|praziquantel|mesh-list
65391444|NCT00713999|Anthelmintics|anthelmintics|mesh-ancestor
65391445|NCT00713999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65391446|NCT00713999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65391447|NCT04072601|Atorvastatin|atorvastatin|mesh-list
65391448|NCT04072601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65391449|NCT04072601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65391450|NCT04072601|Antimetabolites|antimetabolites|mesh-ancestor
65391451|NCT04072601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391452|NCT04072601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65391453|NCT04072601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65391454|NCT04072601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391455|NCT00717821|Epoetin Alfa|epoetin alfa|mesh-list
65391456|NCT00717821|Darbepoetin alfa|darbepoetin alfa|mesh-list
65391457|NCT00717821|Hematinics|hematinics|mesh-ancestor
65391458|NCT03476369|Fentanyl|fentanyl|mesh-list
65391459|NCT03476369|Ticagrelor|ticagrelor|mesh-list
65391460|NCT03476369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65391461|NCT03476369|Narcotics|narcotics|mesh-ancestor
65391462|NCT03476369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64780724|NCT02056236|Midazolam|midazolam|mesh-list
65391497|NCT00450814|Immunologic Factors|immunologic factors|mesh-ancestor
65391498|NCT00450814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391499|NCT00450814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65391500|NCT00450814|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65391501|NCT00450814|Alkylating Agents|alkylating agents|mesh-ancestor
64780791|NCT03560466|Prednisone|prednisone|mesh-list
65391564|NCT00450658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391565|NCT00450658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391566|NCT00450658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65391567|NCT00450658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65391568|NCT00450658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65391569|NCT00450658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391570|NCT00450658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391571|NCT02572505|Tenofovir|tenofovir|mesh-list
65391572|NCT02572505|Emtricitabine|emtricitabine|mesh-list
65391573|NCT02572505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65391574|NCT02572505|Antiviral Agents|antiviral agents|mesh-ancestor
65391575|NCT02572505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65391576|NCT02572505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65391577|NCT02572505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65391578|NCT02572505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391579|NCT02572505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391580|NCT02572505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65391620|NCT01010295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65391621|NCT01010295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391649|NCT02570789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391650|NCT02570789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391651|NCT00604214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
65391652|NCT00604214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65391653|NCT00450580|Ritonavir|ritonavir|mesh-list
65391654|NCT00450580|Fosamprenavir|fosamprenavir|mesh-list
65391655|NCT00450580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65391656|NCT00450580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65391657|NCT00450580|Protease Inhibitors|protease inhibitors|mesh-ancestor
65391658|NCT00450580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391659|NCT00450580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391660|NCT00450580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65391661|NCT00450580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65391662|NCT00450580|Antiviral Agents|antiviral agents|mesh-ancestor
65391663|NCT00450580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65391664|NCT00450580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65391665|NCT00450580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65391697|NCT05277974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65391699|NCT00504777|Rituximab|rituximab|mesh-list
65391700|NCT00504777|Methotrexate|methotrexate|mesh-list
65391701|NCT00504777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65391702|NCT00504777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391703|NCT00504777|Immunologic Factors|immunologic factors|mesh-ancestor
65391704|NCT00504777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391705|NCT00504777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65391706|NCT00504777|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65391707|NCT00504777|Abortifacient Agents|abortifacient agents|mesh-ancestor
65391708|NCT00504777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65391709|NCT00504777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65391742|NCT01078519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391743|NCT01078519|Sensory System Agents|sensory system agents|mesh-ancestor
65391744|NCT01078519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391746|NCT02539316|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65391747|NCT02539316|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65391748|NCT02539316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65391749|NCT03968185|Analgesics|analgesics|mesh-list
65391750|NCT03968185|Sensory System Agents|sensory system agents|mesh-ancestor
65391751|NCT03968185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780918|NCT05419674|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65391784|NCT01074697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65391786|NCT01074697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65391787|NCT01074697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65391788|NCT05124275|Pilocarpine|pilocarpine|mesh-list
65391789|NCT05124275|Miotics|miotics|mesh-ancestor
65391790|NCT05124275|Autonomic Agents|autonomic agents|mesh-ancestor
65391791|NCT05124275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391792|NCT05124275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391793|NCT05124275|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65391822|NCT00114127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391823|NCT00114127|Antidepressive Agents|antidepressive agents|mesh-ancestor
65391824|NCT00114127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65391825|NCT00114127|Dopamine Agents|dopamine agents|mesh-ancestor
65391826|NCT00902954|Letrozole|letrozole|mesh-list
65391827|NCT00902954|Anastrozole|anastrozole|mesh-list
65391828|NCT00902954|Exemestane|exemestane|mesh-list
65391829|NCT00902954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391830|NCT00902954|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65391831|NCT00902954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65391832|NCT00902954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391833|NCT00902954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391834|NCT00902954|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65391835|NCT00902954|Hormone Antagonists|hormone antagonists|mesh-ancestor
65391836|NCT00902954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65391837|NCT00902954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391873|NCT00908336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391874|NCT00908414|TMC-310911|tmc-310911|mesh-list
65391875|NCT00908414|Protease Inhibitors|protease inhibitors|mesh-ancestor
65391876|NCT00908414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391877|NCT00908414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391878|NCT01074853|Propranolol|propranolol|mesh-list
65391894|NCT00725777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65391896|NCT00165841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65391897|NCT00165841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65391898|NCT00165841|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65391899|NCT00165841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391900|NCT00165841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391901|NCT00907166|Gemcitabine|gemcitabine|mesh-list
65391902|NCT00907166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65391903|NCT00907166|Antimetabolites|antimetabolites|mesh-ancestor
65391904|NCT00907166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391905|NCT00907166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391906|NCT00907166|Antiviral Agents|antiviral agents|mesh-ancestor
65391907|NCT00907166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65391908|NCT00907166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391909|NCT00907166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65391910|NCT00907166|Immunologic Factors|immunologic factors|mesh-ancestor
65391911|NCT00907166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391912|NCT04984811|Atezolizumab|atezolizumab|mesh-list
65391913|NCT04984811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391914|NCT00460798|Sunitinib|sunitinib|mesh-list
65391915|NCT00460798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391916|NCT00460798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65391917|NCT00460798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65391918|NCT00460798|Growth Substances|growth substances|mesh-ancestor
65391919|NCT00460798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391920|NCT00460798|Growth Inhibitors|growth inhibitors|mesh-ancestor
65391921|NCT00460798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65391922|NCT00460798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391923|NCT00460798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391924|NCT03513406|Glycopyrrolate|glycopyrrolate|mesh-list
65391925|NCT03513406|Neostigmine|neostigmine|mesh-list
65391926|NCT03513406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65391927|NCT03513406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391928|NCT03513406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391929|NCT03513406|Cholinergic Agents|cholinergic agents|mesh-ancestor
65391930|NCT03513406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65391931|NCT03513406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391932|NCT03513406|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65391933|NCT03513406|Autonomic Agents|autonomic agents|mesh-ancestor
65391934|NCT03513406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391935|NCT03513406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65391936|NCT03513406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65391937|NCT03513406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65391964|NCT00603980|GABA Modulators|gaba modulators|mesh-ancestor
65391965|NCT00603980|GABA Agents|gaba agents|mesh-ancestor
65391966|NCT00603980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65391967|NCT00603980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391968|NCT01028404|Insulin|insulin|mesh-list
65391969|NCT01028404|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65391970|NCT01028404|Insulin Aspart|insulin aspart|mesh-list
65391971|NCT01028404|Insulin, Long-Acting|insulin, long-acting|mesh-list
65391972|NCT01028404|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65391973|NCT01028404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65391974|NCT01028404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391975|NCT00727103|Varenicline|varenicline|mesh-list
65391976|NCT00727103|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65391977|NCT00727103|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65391978|NCT00727103|Cholinergic Agents|cholinergic agents|mesh-ancestor
65391979|NCT00727103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65391980|NCT00727103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391981|NCT00727103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391982|NCT01028482|Sertraline|sertraline|mesh-list
65391983|NCT01028482|Antidepressive Agents|antidepressive agents|mesh-ancestor
65391984|NCT01028482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65392022|NCT00903188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65392057|NCT00907400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65392059|NCT00907400|Analgesics|analgesics|mesh-ancestor
65392060|NCT00907400|Sensory System Agents|sensory system agents|mesh-ancestor
65392061|NCT00907400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65392062|NCT00907400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781115|NCT02632812|Rebamipide|rebamipide|mesh-list
65392086|NCT00730067|Vasodilator Agents|vasodilator agents|mesh-ancestor
65392087|NCT00730067|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65392088|NCT00730067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65392089|NCT00730067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392090|NCT00730067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392091|NCT00730067|Urological Agents|urological agents|mesh-ancestor
65392092|NCT02538224|Doxycycline|doxycycline|mesh-list
65392093|NCT02538224|Ketoprofen|ketoprofen|mesh-list
65392094|NCT02538224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65392095|NCT02538224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65392096|NCT02538224|Antimalarials|antimalarials|mesh-ancestor
65392097|NCT02538224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65392098|NCT02538224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65392099|NCT02538224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65392100|NCT02538224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65392101|NCT02538224|Analgesics|analgesics|mesh-ancestor
65392102|NCT02538224|Sensory System Agents|sensory system agents|mesh-ancestor
65392103|NCT02538224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65392104|NCT02538224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392105|NCT02538224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65392106|NCT02538224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65392107|NCT02538224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65392108|NCT02538224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392109|NCT02538224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066885|NCT00307944|Pantoprazole|pantoprazole|mesh-list
65392110|NCT02538302|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65392111|NCT02538302|Oxybutynin|oxybutynin|mesh-list
65392112|NCT02538302|Parasympatholytics|parasympatholytics|mesh-ancestor
65392149|NCT00509067|Dopamine Agents|dopamine agents|mesh-ancestor
65392150|NCT00509067|Antiemetics|antiemetics|mesh-ancestor
65392151|NCT00509067|Autonomic Agents|autonomic agents|mesh-ancestor
65392152|NCT00509067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65392153|NCT00509067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65392154|NCT00509067|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65392187|NCT00730223|Antiviral Agents|antiviral agents|mesh-ancestor
65392188|NCT00730223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65392189|NCT00730223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65392190|NCT00730223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65392191|NCT00730223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65392192|NCT00730223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65392193|NCT00730223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65392194|NCT00730223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65392195|NCT00730223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64781227|NCT04511052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392268|NCT02570243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65392269|NCT02570243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392270|NCT00927212|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
65392271|NCT00927212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65392273|NCT00927212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392303|NCT00728195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65392304|NCT00728195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65392305|NCT00728195|Dopamine Agents|dopamine agents|mesh-ancestor
65392306|NCT04390217|Tranexamic Acid|tranexamic acid|mesh-list
65392307|NCT04390217|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65392308|NCT04390217|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65222263|NCT02704923|Atropine|atropine|mesh-list
65392309|NCT04390217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392310|NCT04390217|Hemostatics|hemostatics|mesh-ancestor
65392311|NCT04390217|Coagulants|coagulants|mesh-ancestor
65392312|NCT00927524|Insulin|insulin|mesh-list
65392313|NCT00927524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65392314|NCT00927524|Insulin glulisine|insulin glulisine|mesh-list
65392315|NCT00927524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65392316|NCT00927524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392317|NCT00728273|Micronutrients|micronutrients|mesh-list
65392318|NCT00728273|Trace Elements|trace elements|mesh-list
65392338|NCT00730535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65392339|NCT00730535|Cholinergic Agents|cholinergic agents|mesh-ancestor
65392340|NCT00730535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65392341|NCT00730535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392342|NCT00730535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392343|NCT00730535|Urological Agents|urological agents|mesh-ancestor
65392344|NCT00904202|Lidocaine|lidocaine|mesh-list
65392345|NCT00904202|Gabapentin|gabapentin|mesh-list
65392346|NCT00904202|Anesthetics, Local|anesthetics, local|mesh-ancestor
65392347|NCT00904202|Anesthetics|anesthetics|mesh-ancestor
65392348|NCT00904202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65392349|NCT00904202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392350|NCT00904202|Sensory System Agents|sensory system agents|mesh-ancestor
65392351|NCT00904202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65392352|NCT00904202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65392353|NCT00904202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65392354|NCT00904202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65392355|NCT00904202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65392356|NCT00904202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392357|NCT00904202|Analgesics|analgesics|mesh-ancestor
65392358|NCT00904202|Anticonvulsants|anticonvulsants|mesh-ancestor
65392359|NCT00904202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65392360|NCT00904202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65392361|NCT00904202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65392362|NCT00904202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65392363|NCT00904202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65392364|NCT00904202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65392365|NCT00904202|Antimanic Agents|antimanic agents|mesh-ancestor
65392366|NCT00927836|Lenograstim|lenograstim|mesh-list
65392367|NCT00927836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65392368|NCT00927836|Immunologic Factors|immunologic factors|mesh-ancestor
65392369|NCT00927836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392370|NCT00904280|Oxymorphone|oxymorphone|mesh-list
65392371|NCT00904280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65392372|NCT00904280|Narcotics|narcotics|mesh-ancestor
65392373|NCT00904280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65392374|NCT00904280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392396|NCT00928148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65392397|NCT00928148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392399|NCT00928148|Autonomic Agents|autonomic agents|mesh-ancestor
65392400|NCT00928148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65392401|NCT00928148|Dopamine Agents|dopamine agents|mesh-ancestor
65392402|NCT00928148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65392403|NCT00928148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392404|NCT00928148|Adrenergic Agents|adrenergic agents|mesh-ancestor
65392405|NCT00928148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65392406|NCT00928148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65392407|NCT00928148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65392408|NCT00928148|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65392409|NCT02430077|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
65392410|NCT02430077|Cathartics|cathartics|mesh-ancestor
65392411|NCT02430077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65141980|NCT01326546|Entecavir|entecavir|mesh-list
65392412|NCT00904436|Ipratropium|ipratropium|mesh-list
65392413|NCT00904436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65392414|NCT00904436|Autonomic Agents|autonomic agents|mesh-ancestor
65392415|NCT00904436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65392416|NCT00904436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392417|NCT00904436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65392418|NCT00904436|Respiratory System Agents|respiratory system agents|mesh-ancestor
65392419|NCT00904436|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65392420|NCT00904436|Cholinergic Agents|cholinergic agents|mesh-ancestor
65392421|NCT00904436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65222329|NCT02703363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65392422|NCT00904436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392423|NCT00728585|Mitogens|mitogens|mesh-list
65392424|NCT00728585|Mitosis Modulators|mitosis modulators|mesh-ancestor
64781371|NCT02655354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65392460|NCT00729287|Antioxidants|antioxidants|mesh-ancestor
65392461|NCT00729287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392462|NCT00729287|Protective Agents|protective agents|mesh-ancestor
65392463|NCT00729287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392497|NCT00568178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65392498|NCT00568178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392500|NCT00568178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65392501|NCT00568178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65392502|NCT00568178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65392503|NCT00568178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392504|NCT00568178|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65392505|NCT00568178|Protease Inhibitors|protease inhibitors|mesh-ancestor
65392539|NCT02538926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65392540|NCT02538926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65392541|NCT02538926|Alkylating Agents|alkylating agents|mesh-ancestor
65392542|NCT02538926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392543|NCT02538926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392544|NCT02538926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65392545|NCT02538926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65392546|NCT02538926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65392547|NCT02538926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65392548|NCT02538926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392549|NCT02538926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65392550|NCT02538926|Glucocorticoids|glucocorticoids|mesh-ancestor
65392578|NCT00904904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65392581|NCT00731861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65392582|NCT00731861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392583|NCT00731861|Tubulin Modulators|tubulin modulators|mesh-ancestor
65392584|NCT00731861|Antimitotic Agents|antimitotic agents|mesh-ancestor
65392585|NCT00731861|Mitosis Modulators|mitosis modulators|mesh-ancestor
65392586|NCT00731861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392587|NCT00731861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65392588|NCT00731861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392589|NCT00567476|Omalizumab|omalizumab|mesh-list
65392590|NCT00567476|Terbutaline|terbutaline|mesh-list
65392591|NCT00567476|Adrenergic Agents|adrenergic agents|mesh-list
65392592|NCT00567476|Adrenergic Agonists|adrenergic agonists|mesh-list
65392593|NCT00567476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65392594|NCT00567476|Autonomic Agents|autonomic agents|mesh-ancestor
65392595|NCT00567476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65392596|NCT00567476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392597|NCT00567476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65392598|NCT00567476|Respiratory System Agents|respiratory system agents|mesh-ancestor
64781497|NCT02695290|Afatinib|afatinib|mesh-list
65392628|NCT04018703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65392629|NCT04018703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65392630|NCT04018703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65392631|NCT04018703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65392632|NCT04018703|Adrenergic Agents|adrenergic agents|mesh-ancestor
65392633|NCT04018703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65392634|NCT04018703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392635|NCT04018703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65392636|NCT04018703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65392637|NCT04018703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65392638|NCT04018703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65392639|NCT04018703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65392640|NCT04018703|Anesthetics, General|anesthetics, general|mesh-ancestor
65392666|NCT00733889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65392668|NCT00733889|Immunologic Factors|immunologic factors|mesh-ancestor
65392669|NCT00733889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392670|NCT00733889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65392671|NCT00733967|Varenicline|varenicline|mesh-list
65392672|NCT00733967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65392673|NCT00733967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65392674|NCT00733967|Cholinergic Agents|cholinergic agents|mesh-ancestor
65392675|NCT00733967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65269847|NCT02732522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65269848|NCT02732522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392676|NCT00733967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392677|NCT00733967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392678|NCT04650243|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65392679|NCT04650243|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65392680|NCT04650243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65392681|NCT00738569|Raltegravir Potassium|raltegravir potassium|mesh-list
65392682|NCT00738569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65392683|NCT00738569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65392684|NCT00738569|Antiviral Agents|antiviral agents|mesh-ancestor
65392685|NCT00738569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65392686|NCT00738569|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65392687|NCT00738569|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65392688|NCT00738569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392689|NCT00738569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392721|NCT00732485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65392722|NCT00732485|Antimetabolites|antimetabolites|mesh-ancestor
65392723|NCT00732485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392724|NCT00732485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65392725|NCT02569073|Dronabinol|dronabinol|mesh-list
65392726|NCT02569073|Hallucinogens|hallucinogens|mesh-ancestor
65392727|NCT02569073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392728|NCT02569073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65392729|NCT02569073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65392730|NCT02569073|Analgesics|analgesics|mesh-ancestor
65392731|NCT02569073|Sensory System Agents|sensory system agents|mesh-ancestor
65392732|NCT02569073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65392761|NCT00734123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65392762|NCT00734123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65392763|NCT00734123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392764|NCT00734123|Antipyretics|antipyretics|mesh-ancestor
65392765|NCT00734123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65392766|NCT00734123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65392767|NCT00734123|Antimetabolites|antimetabolites|mesh-ancestor
65392768|NCT00734123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65392769|NCT00734123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65392770|NCT00734123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65392771|NCT00734123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65392772|NCT00734123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65392773|NCT00734123|Purinergic Agents|purinergic agents|mesh-ancestor
65392774|NCT00734123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65392775|NCT00734123|Protease Inhibitors|protease inhibitors|mesh-ancestor
65392776|NCT00734123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65392777|NCT00734123|Natriuretic Agents|natriuretic agents|mesh-ancestor
65392846|NCT01327781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65392847|NCT01327781|Hormone Antagonists|hormone antagonists|mesh-ancestor
65392848|NCT01327781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65392849|NCT01327781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392850|NCT01327781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65392851|NCT01327781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392887|NCT00515619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392888|NCT01815359|Leucovorin|leucovorin|mesh-list
65392889|NCT01815359|Mitomycins|mitomycins|mesh-list
65392890|NCT01815359|Mitomycin|mitomycin|mesh-list
65392914|NCT00733265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392915|NCT00733265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392917|NCT00112489|Carboplatin|carboplatin|mesh-list
65392918|NCT00112489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65392919|NCT00112489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392920|NCT00112489|Tubulin Modulators|tubulin modulators|mesh-ancestor
65392921|NCT00112489|Antimitotic Agents|antimitotic agents|mesh-ancestor
65392922|NCT00112489|Mitosis Modulators|mitosis modulators|mesh-ancestor
65392923|NCT00112489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392924|NCT01023100|Tofacitinib|tofacitinib|mesh-list
65392925|NCT01023100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65392926|NCT01023100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392995|NCT00735527|Antiemetics|antiemetics|mesh-ancestor
65392996|NCT00735527|Autonomic Agents|autonomic agents|mesh-ancestor
65392997|NCT00735527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65392998|NCT00735527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222485|NCT05065021|Paclitaxel|paclitaxel|mesh-list
65392999|NCT00735527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65393000|NCT00735527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64781751|NCT04495608|Fluconazole|fluconazole|mesh-list
65393031|NCT00507429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393032|NCT00507429|Tubulin Modulators|tubulin modulators|mesh-ancestor
65393033|NCT00507429|Antimitotic Agents|antimitotic agents|mesh-ancestor
65393034|NCT00507429|Mitosis Modulators|mitosis modulators|mesh-ancestor
65393035|NCT00507429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393036|NCT01011621|Prednisolone|prednisolone|mesh-list
65393037|NCT01011621|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65393038|NCT01011621|Methylprednisolone|methylprednisolone|mesh-list
65393039|NCT01011621|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65393040|NCT01011621|Prednisolone acetate|prednisolone acetate|mesh-list
65393041|NCT01011621|Betamethasone|betamethasone|mesh-list
65393042|NCT01011621|Betamethasone Valerate|betamethasone valerate|mesh-list
65393043|NCT01011621|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65393044|NCT01011621|Betamethasone benzoate|betamethasone benzoate|mesh-list
65393045|NCT01011621|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65393046|NCT01011621|Prednisolone phosphate|prednisolone phosphate|mesh-list
65393047|NCT01011621|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65393115|NCT00515073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65393116|NCT00515073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393148|NCT00740519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65393149|NCT00740519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393151|NCT00514917|Leuprolide|leuprolide|mesh-list
65393152|NCT00514917|Bicalutamide|bicalutamide|mesh-list
65393153|NCT00514917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393154|NCT00514917|Tubulin Modulators|tubulin modulators|mesh-ancestor
65393155|NCT00514917|Antimitotic Agents|antimitotic agents|mesh-ancestor
65393156|NCT00514917|Mitosis Modulators|mitosis modulators|mesh-ancestor
65393157|NCT00514917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393158|NCT00514917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65393159|NCT00514917|Fertility Agents|fertility agents|mesh-ancestor
65393160|NCT00514917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65393161|NCT00514917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393226|NCT00736541|Antidotes|antidotes|mesh-ancestor
65393227|NCT00736541|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65393228|NCT00736541|Protease Inhibitors|protease inhibitors|mesh-ancestor
65393229|NCT00736541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393230|NCT00096265|Temozolomide|temozolomide|mesh-list
65393231|NCT00096265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65393232|NCT00096265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65393233|NCT00096265|Alkylating Agents|alkylating agents|mesh-ancestor
65393234|NCT00096265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393235|NCT00096265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393236|NCT00096265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65393237|NCT00096265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781893|NCT05447364|Pregabalin|pregabalin|mesh-list
65393272|NCT00741221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65393273|NCT00741221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65393274|NCT00741221|Growth Substances|growth substances|mesh-ancestor
65393275|NCT00741221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393276|NCT00741221|Growth Inhibitors|growth inhibitors|mesh-ancestor
65393277|NCT00741221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781918|NCT05430750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65393305|NCT00567398|Icodextrin|icodextrin|mesh-list
65393306|NCT00567398|Dialysis Solutions|dialysis solutions|mesh-ancestor
65393307|NCT00567398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65393308|NCT00448708|Paclitaxel|paclitaxel|mesh-list
65393309|NCT00448708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65393310|NCT00448708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65393311|NCT00448708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393312|NCT00448708|Tubulin Modulators|tubulin modulators|mesh-ancestor
65393313|NCT00448708|Antimitotic Agents|antimitotic agents|mesh-ancestor
65393314|NCT00448708|Mitosis Modulators|mitosis modulators|mesh-ancestor
65393315|NCT00448708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393316|NCT00925028|Warfarin|warfarin|mesh-list
65393317|NCT00925028|Anticoagulants|anticoagulants|mesh-ancestor
65393318|NCT00905216|Heparin|heparin|mesh-list
65393319|NCT00905216|Calcium heparin|calcium heparin|mesh-list
65393320|NCT00905216|Anticoagulants|anticoagulants|mesh-ancestor
65393321|NCT00905216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65393322|NCT00905216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65393323|NCT00905216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393324|NCT00929630|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65269849|NCT02732522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65269850|NCT02732522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65269852|NCT02732678|Propranolol|propranolol|mesh-list
65269853|NCT02732678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65393361|NCT02568995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65393362|NCT02568995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393363|NCT02568995|Sensory System Agents|sensory system agents|mesh-ancestor
65393364|NCT02568995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65393391|NCT00930098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393393|NCT00905684|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65393394|NCT00905684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65393395|NCT00905684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393396|NCT00905762|Moxifloxacin|moxifloxacin|mesh-list
65393397|NCT00905762|Gatifloxacin|gatifloxacin|mesh-list
65393398|NCT00905762|Besifloxacin|besifloxacin|mesh-list
65393399|NCT00905762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65393400|NCT00905762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65393401|NCT00905762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65393402|NCT00905762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65393403|NCT00905762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393404|NCT00905762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393405|NCT00905762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393406|NCT00905762|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65393407|NCT00905762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65393408|NCT00930332|Methadone|methadone|mesh-list
65393409|NCT00930332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65393410|NCT00930332|Narcotics|narcotics|mesh-ancestor
65393411|NCT00930332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64781983|NCT04715646|Brivaracetam|brivaracetam|mesh-list
65393443|NCT02568839|Antimitotic Agents|antimitotic agents|mesh-ancestor
65393444|NCT02568839|Mitosis Modulators|mitosis modulators|mesh-ancestor
65393445|NCT02568839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393446|NCT02568839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65393447|NCT00930488|Moxifloxacin|moxifloxacin|mesh-list
65393448|NCT00930488|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65393449|NCT00930488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65393450|NCT00930488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65393451|NCT00930488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65393452|NCT00930488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65393453|NCT00930488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393454|NCT00930488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393455|NCT00930488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393456|NCT00930488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65393492|NCT00567164|Hormone Antagonists|hormone antagonists|mesh-ancestor
65393493|NCT00567164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65393494|NCT00567164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393495|NCT00567164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65393496|NCT00567164|Diuretics|diuretics|mesh-ancestor
65393529|NCT04063865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65393530|NCT04063865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393531|NCT04063865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393532|NCT04063865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393533|NCT00713219|Docetaxel|docetaxel|mesh-list
65393534|NCT00713219|Cetuximab|cetuximab|mesh-list
65393535|NCT00713219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393536|NCT00713219|Tubulin Modulators|tubulin modulators|mesh-ancestor
65393537|NCT00713219|Antimitotic Agents|antimitotic agents|mesh-ancestor
65393538|NCT00713219|Mitosis Modulators|mitosis modulators|mesh-ancestor
65393539|NCT00713219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782095|NCT03737604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64782096|NCT03737604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393549|NCT05661461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65393550|NCT05661461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65393551|NCT05661461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65393552|NCT05661461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393553|NCT05661461|Antifungal Agents|antifungal agents|mesh-ancestor
65393554|NCT05661461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65393555|NCT05661461|Immunologic Factors|immunologic factors|mesh-ancestor
65269854|NCT02732678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65269855|NCT02732678|Adrenergic Agents|adrenergic agents|mesh-ancestor
65269856|NCT02732678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65269857|NCT02732678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65269858|NCT02732678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65269859|NCT02732678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65269860|NCT02732678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65222634|NCT00776230|Vaccines|vaccines|mesh-list
65393556|NCT05661461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393557|NCT00931736|Rifampin|rifampin|mesh-list
65393558|NCT00931736|Isoniazid|isoniazid|mesh-list
65393559|NCT00931736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65393560|NCT00931736|Antitubercular Agents|antitubercular agents|mesh-ancestor
65393561|NCT00931736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65393562|NCT00931736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65393563|NCT00931736|Leprostatic Agents|leprostatic agents|mesh-ancestor
65393564|NCT00931736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65393565|NCT00931736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393566|NCT00931736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393567|NCT00931736|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65393568|NCT00931736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65393569|NCT00931736|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65393570|NCT00931736|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65393571|NCT00931736|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65393572|NCT00931736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65393573|NCT00931736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65393574|NCT00931736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65393575|NCT00931736|Antimetabolites|antimetabolites|mesh-ancestor
65393576|NCT00931736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65393577|NCT02567981|Vitamin A|vitamin a|mesh-list
65393578|NCT02567981|Micronutrients|micronutrients|mesh-list
65393579|NCT02567981|Trace Elements|trace elements|mesh-list
65393580|NCT02567981|Vitamins|vitamins|mesh-ancestor
65393581|NCT02567981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393582|NCT00737555|Tosedostat|tosedostat|mesh-list
65393583|NCT00737555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782097|NCT03737604|Sensory System Agents|sensory system agents|mesh-ancestor
64393512|NCT03115255|Growth Inhibitors|growth inhibitors|mesh-ancestor
65393614|NCT00926354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393615|NCT00926354|Antiviral Agents|antiviral agents|mesh-ancestor
65393616|NCT00926354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65393617|NCT00712985|Zoledronic Acid|zoledronic acid|mesh-list
65393618|NCT00712985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65393619|NCT00712985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393620|NCT05518877|Ketamine|ketamine|mesh-list
65393621|NCT05518877|Analgesics|analgesics|mesh-ancestor
65393622|NCT05518877|Sensory System Agents|sensory system agents|mesh-ancestor
65393623|NCT05518877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550742|NCT04399525|Cetirizine|cetirizine|mesh-list
65393645|NCT00700115|Raltegravir Potassium|raltegravir potassium|mesh-list
65393646|NCT00700115|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65393647|NCT00700115|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65393648|NCT00700115|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65393649|NCT00700115|Protease Inhibitors|protease inhibitors|mesh-ancestor
65393650|NCT00700115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393651|NCT00700115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393652|NCT00700115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65393653|NCT00700115|Antiviral Agents|antiviral agents|mesh-ancestor
65393654|NCT00700115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65393655|NCT00700115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65393656|NCT00700115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65393657|NCT00700115|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65393658|NCT00700115|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65393659|NCT05556473|Tryptophan|tryptophan|mesh-list
65393660|NCT05556473|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65393661|NCT05556473|Antidepressive Agents|antidepressive agents|mesh-ancestor
65393662|NCT05556473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65393663|NCT05097599|Trastuzumab|trastuzumab|mesh-list
65393684|NCT05095259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65393685|NCT05095259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65393686|NCT05095259|Respiratory System Agents|respiratory system agents|mesh-ancestor
65393687|NCT05095259|Mydriatics|mydriatics|mesh-ancestor
65393688|NCT05095259|Sympathomimetics|sympathomimetics|mesh-ancestor
65393689|NCT05095259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65393690|NCT05095259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65393691|NCT05095259|Hormones|hormones|mesh-ancestor
65393692|NCT05095259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65393693|NCT00566852|Memantine|memantine|mesh-list
65393694|NCT00566852|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65393695|NCT00566852|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65393696|NCT00566852|Dopamine Agents|dopamine agents|mesh-ancestor
65393697|NCT00566852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65393698|NCT00566852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393699|NCT00566852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393700|NCT00566852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64782143|NCT02952924|Midazolam|midazolam|mesh-list
65393723|NCT00936962|Immunologic Factors|immunologic factors|mesh-ancestor
65393724|NCT00936962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393725|NCT00514683|Nintedanib|nintedanib|mesh-list
65393726|NCT00514683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393727|NCT00514683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65393728|NCT00514683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393729|NCT00514683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393730|NCT00566696|Mycophenolic Acid|mycophenolic acid|mesh-list
65393731|NCT00566696|Cyclophosphamide|cyclophosphamide|mesh-list
65393732|NCT00566696|Melphalan|melphalan|mesh-list
65393733|NCT00566696|Mechlorethamine|mechlorethamine|mesh-list
65393734|NCT00566696|Thiotepa|thiotepa|mesh-list
65393735|NCT00566696|Rituximab|rituximab|mesh-list
65393736|NCT00566696|Fludarabine|fludarabine|mesh-list
65393737|NCT00566696|Alemtuzumab|alemtuzumab|mesh-list
65393738|NCT00566696|Thymoglobulin|thymoglobulin|mesh-list
65393739|NCT00566696|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65393740|NCT00566696|Muromonab-CD3|muromonab-cd3|mesh-list
65393741|NCT00566696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65393742|NCT00566696|Immunologic Factors|immunologic factors|mesh-ancestor
65393743|NCT00566696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393744|NCT00566696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65393745|NCT00566696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65393746|NCT00566696|Alkylating Agents|alkylating agents|mesh-ancestor
65393747|NCT00566696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393748|NCT00566696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393749|NCT00566696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65393750|NCT00566696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65393751|NCT00566696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65393752|NCT00566696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65393786|NCT00937664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65393788|NCT00937664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393789|NCT00937664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393790|NCT00937664|Antiviral Agents|antiviral agents|mesh-ancestor
65393791|NCT00937664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65393792|NCT00937664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782199|NCT05453448|Tenofovir|tenofovir|mesh-list
65393828|NCT01023334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65393829|NCT01023334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393830|NCT01023334|Sensory System Agents|sensory system agents|mesh-ancestor
65393831|NCT01023334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65393832|NCT01023334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64782220|NCT05354466|Cholinergic Agents|cholinergic agents|mesh-ancestor
65393842|NCT00938522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65393843|NCT00938522|Respiratory System Agents|respiratory system agents|mesh-ancestor
65393844|NCT00938522|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65393845|NCT00938522|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65393846|NCT00938522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393847|NCT00938522|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65393848|NCT00938522|Vasodilator Agents|vasodilator agents|mesh-ancestor
65393849|NCT00938522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65393850|NCT00938522|Protective Agents|protective agents|mesh-ancestor
65393851|NCT00938522|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65393852|NCT00938522|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65393853|NCT00938522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393854|NCT00938600|Vitamin D|vitamin d|mesh-list
65393855|NCT00938600|Ergocalciferols|ergocalciferols|mesh-list
65393856|NCT00938600|Cholecalciferol|cholecalciferol|mesh-list
65393857|NCT00938600|Vitamins|vitamins|mesh-list
65393858|NCT00938600|Micronutrients|micronutrients|mesh-ancestor
65393859|NCT00938600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393860|NCT00938600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65393861|NCT00938600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65393862|NCT00503685|Cetuximab|cetuximab|mesh-list
65393863|NCT00503685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65393864|NCT00503685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393865|NCT00712673|Metformin|metformin|mesh-list
65393866|NCT00712673|Lixisenatide|lixisenatide|mesh-list
65393867|NCT00712673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65393868|NCT00712673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393869|NCT01562990|Gemcitabine|gemcitabine|mesh-list
65393870|NCT01562990|Rituximab|rituximab|mesh-list
65393871|NCT01562990|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65393872|NCT01562990|Oxaliplatin|oxaliplatin|mesh-list
64782266|NCT04674462|Immunologic Factors|immunologic factors|mesh-ancestor
64393675|NCT04299113|Vinorelbine|vinorelbine|mesh-list
65393931|NCT00933452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65393932|NCT00933452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65393933|NCT00933452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65393934|NCT00933452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393935|NCT00933452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65393936|NCT00933452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393938|NCT00933452|Sensory System Agents|sensory system agents|mesh-ancestor
65393939|NCT00933452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65393940|NCT00933452|Antidepressive Agents|antidepressive agents|mesh-ancestor
65393941|NCT00933452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65393942|NCT00933452|Dopamine Agents|dopamine agents|mesh-ancestor
65393943|NCT00447694|Deferasirox|deferasirox|mesh-list
65393944|NCT00447694|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64782289|NCT03341676|Hormones|hormones|mesh-ancestor
65393977|NCT00933998|Micronutrients|micronutrients|mesh-ancestor
65393978|NCT00933998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393979|NCT00447226|Lapatinib|lapatinib|mesh-list
65393980|NCT00447226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393981|NCT00447226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65393982|NCT00447226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393983|NCT00447226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393984|NCT03360916|Atorvastatin|atorvastatin|mesh-list
65393985|NCT03360916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65393986|NCT03360916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65393987|NCT03360916|Antimetabolites|antimetabolites|mesh-ancestor
65393988|NCT03360916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393989|NCT03360916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65393990|NCT03360916|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65394024|NCT00577031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65394025|NCT00577031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65394026|NCT00577031|Growth Substances|growth substances|mesh-ancestor
65394027|NCT00577031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394028|NCT00577031|Growth Inhibitors|growth inhibitors|mesh-ancestor
65394029|NCT00565448|Docetaxel|docetaxel|mesh-list
65394030|NCT00565448|Fluorouracil|fluorouracil|mesh-list
65394031|NCT00565448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394032|NCT00565448|Tubulin Modulators|tubulin modulators|mesh-ancestor
65394033|NCT00565448|Antimitotic Agents|antimitotic agents|mesh-ancestor
65066886|NCT00307944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65394062|NCT00934154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65394063|NCT00934154|Glucocorticoids|glucocorticoids|mesh-ancestor
65394064|NCT00934154|Hormones|hormones|mesh-ancestor
65394065|NCT00934154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65394066|NCT00934154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65394067|NCT00934154|Leprostatic Agents|leprostatic agents|mesh-ancestor
65394068|NCT00934154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65394069|NCT00934154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65394070|NCT00934154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65394071|NCT00934154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65394072|NCT00934154|Growth Substances|growth substances|mesh-ancestor
65394073|NCT00934154|Growth Inhibitors|growth inhibitors|mesh-ancestor
65394074|NCT00446446|Panitumumab|panitumumab|mesh-list
65394075|NCT00446446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64782387|NCT02747628|Antioxidants|antioxidants|mesh-ancestor
65394107|NCT00934232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394109|NCT00934232|Immunologic Factors|immunologic factors|mesh-ancestor
65269861|NCT02732678|Vasodilator Agents|vasodilator agents|mesh-ancestor
65394110|NCT00934232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394111|NCT00934232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65394112|NCT00934232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394113|NCT00934232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65394114|NCT01013571|Insulin|insulin|mesh-list
65394115|NCT01013571|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65394116|NCT01013571|Insulin Glargine|insulin glargine|mesh-list
65394209|NCT04948463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394210|NCT04948463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394211|NCT04948463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394212|NCT04948463|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65394246|NCT00492297|Alkylating Agents|alkylating agents|mesh-ancestor
65394247|NCT00697073|Idebenone|idebenone|mesh-list
65394248|NCT00697073|Antioxidants|antioxidants|mesh-ancestor
65394249|NCT00697073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394250|NCT00697073|Protective Agents|protective agents|mesh-ancestor
65394251|NCT00697073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394284|NCT00934466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65394285|NCT00934466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65394286|NCT00934466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65394287|NCT00934466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394288|NCT00934466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394289|NCT00921245|Darifenacin|darifenacin|mesh-list
65394290|NCT00921245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65394291|NCT00921245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65394292|NCT00921245|Cholinergic Agents|cholinergic agents|mesh-ancestor
65394293|NCT00921245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65394294|NCT00921245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782561|NCT05273814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394327|NCT00940238|Cholinergic Agents|cholinergic agents|mesh-ancestor
65394328|NCT04013438|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65394329|NCT04013438|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65394330|NCT04013438|Saw palmetto extract|saw palmetto extract|mesh-list
65394331|NCT04013438|Estradiol|estradiol|mesh-list
65394332|NCT04013438|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65394333|NCT04013438|Estrogens|estrogens|mesh-ancestor
65394334|NCT04013438|Hormones|hormones|mesh-ancestor
64782590|NCT03845010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394369|NCT00111007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394371|NCT00699335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65394373|NCT00699335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65394374|NCT00699335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394375|NCT00699335|Analgesics|analgesics|mesh-ancestor
65394438|NCT00939848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394439|NCT00939848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65394442|NCT00935558|Anastrozole|anastrozole|mesh-list
65394443|NCT00935558|Letrozole|letrozole|mesh-list
65394444|NCT00935558|Lactitol|lactitol|mesh-list
65394445|NCT00935558|Vaccines|vaccines|mesh-list
65394446|NCT00935558|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65394447|NCT00935558|Immunologic Factors|immunologic factors|mesh-ancestor
64782677|NCT04527900|Tubulin Modulators|tubulin modulators|mesh-ancestor
65394512|NCT00936182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65394513|NCT00936182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394514|NCT00936182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394515|NCT00936182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65394516|NCT00936182|Hormone Antagonists|hormone antagonists|mesh-ancestor
65394615|NCT04061057|Anesthetics|anesthetics|mesh-ancestor
65394616|NCT04061057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65394617|NCT04061057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394618|NCT04061057|Sensory System Agents|sensory system agents|mesh-ancestor
65394619|NCT04061057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65394620|NCT04061057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65394621|NCT04061057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65394622|NCT04061057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65394623|NCT04061057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65394624|NCT04061057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394625|NCT00921167|Bevacizumab|bevacizumab|mesh-list
65394626|NCT00921167|Irinotecan|irinotecan|mesh-list
65394627|NCT00921167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65394628|NCT00921167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394629|NCT00921167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65394657|NCT05472779|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65394658|NCT05472779|Contraceptive Agents|contraceptive agents|mesh-ancestor
65394659|NCT05472779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65394660|NCT05472779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65394662|NCT02565953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65394663|NCT02565953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394664|NCT02565953|Tubulin Modulators|tubulin modulators|mesh-ancestor
65394665|NCT02565953|Antimitotic Agents|antimitotic agents|mesh-ancestor
65394666|NCT02565953|Mitosis Modulators|mitosis modulators|mesh-ancestor
65394667|NCT02565953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394668|NCT00562718|Capecitabine|capecitabine|mesh-list
65394669|NCT00562718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65394670|NCT00562718|Antimetabolites|antimetabolites|mesh-ancestor
65394671|NCT00562718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394672|NCT00562718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782872|NCT02845752|Bromides|bromides|mesh-list
65394771|NCT01029418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394772|NCT04060979|Nitric Oxide|nitric oxide|mesh-list
65394773|NCT04060979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65394774|NCT04060979|Autonomic Agents|autonomic agents|mesh-ancestor
65394775|NCT04060979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65394776|NCT04060979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394777|NCT04060979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65394778|NCT04060979|Respiratory System Agents|respiratory system agents|mesh-ancestor
65394779|NCT04060979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65394780|NCT04060979|Antioxidants|antioxidants|mesh-ancestor
65394781|NCT04060979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394782|NCT04060979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65394783|NCT04060979|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65394823|NCT00561470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394884|NCT00694109|Antimetabolites|antimetabolites|mesh-ancestor
65394885|NCT00694109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394886|NCT00694109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65394887|NCT03070301|Everolimus|everolimus|mesh-list
65394888|NCT03070301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394889|NCT03070301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65394890|NCT03070301|Immunologic Factors|immunologic factors|mesh-ancestor
65394891|NCT03070301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394892|NCT00940862|Adalimumab|adalimumab|mesh-list
65394893|NCT00940862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65394894|NCT00940862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65394895|NCT03068741|Ceftriaxone|ceftriaxone|mesh-list
64783046|NCT02912364|Anticonvulsants|anticonvulsants|mesh-ancestor
65394966|NCT03817853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65394967|NCT03817853|Protective Agents|protective agents|mesh-ancestor
65394968|NCT03817853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65394969|NCT00944840|Amodiaquine|amodiaquine|mesh-list
65394970|NCT00944840|Antimalarials|antimalarials|mesh-ancestor
65394971|NCT00944840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65394972|NCT00944840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65394973|NCT00944840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65395008|NCT04012268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395009|NCT04012268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65395010|NCT04012268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65395011|NCT04012268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395041|NCT01024192|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65395043|NCT01024192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65395044|NCT01024192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395045|NCT01024192|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65395046|NCT01024192|GABA Agonists|gaba agonists|mesh-ancestor
65395047|NCT01024192|GABA Agents|gaba agents|mesh-ancestor
65395048|NCT01024192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65395049|NCT01024192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395050|NCT01024270|Misoprostol|misoprostol|mesh-list
65395051|NCT01024270|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65395052|NCT01024270|Abortifacient Agents|abortifacient agents|mesh-ancestor
65395053|NCT01024270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65395054|NCT01024270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395055|NCT01024270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65395056|NCT01024270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65395057|NCT01024270|Oxytocics|oxytocics|mesh-ancestor
65395058|NCT00944996|Citalopram|citalopram|mesh-list
65395059|NCT00944996|Fluoxetine|fluoxetine|mesh-list
65395095|NCT01031212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65395096|NCT01031212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395135|NCT00941174|Levoleucovorin|levoleucovorin|mesh-list
65395136|NCT00941174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65395172|NCT03172936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65395173|NCT03172936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395174|NCT03172936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395176|NCT01030042|Oxaliplatin|oxaliplatin|mesh-list
65395177|NCT01030042|Irinotecan|irinotecan|mesh-list
65395239|NCT01030510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65395240|NCT01030510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65395241|NCT01030510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65395242|NCT01030510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65395243|NCT01030510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395244|NCT04813822|Miconazole|miconazole|mesh-list
65395245|NCT04813822|Clotrimazole|clotrimazole|mesh-list
65395246|NCT04813822|Bromides|bromides|mesh-list
65395247|NCT04813822|Anticonvulsants|anticonvulsants|mesh-ancestor
65395248|NCT04813822|Antifungal Agents|antifungal agents|mesh-ancestor
65395249|NCT04813822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65395250|NCT04813822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65395251|NCT04813822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65395252|NCT04813822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395253|NCT04813822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395254|NCT04813822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65395255|NCT04813822|Hormone Antagonists|hormone antagonists|mesh-ancestor
65395256|NCT04813822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65395257|NCT04813822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395258|NCT04813822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64783312|NCT03036384|Morphine|morphine|mesh-list
65395289|NCT00952016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65395291|NCT00952094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65395292|NCT00952094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395293|NCT00952094|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65395294|NCT00952094|Hormone Antagonists|hormone antagonists|mesh-ancestor
65395295|NCT00952094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65395296|NCT00942344|Losartan|losartan|mesh-list
65395297|NCT00942344|Amlodipine|amlodipine|mesh-list
65395298|NCT00942344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65395299|NCT00942344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64783338|NCT03044418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65395331|NCT00952796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65395332|NCT00952796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65395333|NCT00952796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65395334|NCT00952796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65395335|NCT00952796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395336|NCT00952796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395337|NCT00952796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395338|NCT00952796|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65395339|NCT00952952|Mesalamine|mesalamine|mesh-list
65395340|NCT00952952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65395341|NCT00952952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65395342|NCT00952952|Analgesics|analgesics|mesh-ancestor
65395377|NCT00120289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65395378|NCT00120289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395379|NCT00120289|Vasodilator Agents|vasodilator agents|mesh-ancestor
65395380|NCT00120289|Vitamin B Complex|vitamin b complex|mesh-ancestor
65395381|NCT00120289|Vitamins|vitamins|mesh-ancestor
65395382|NCT00120289|Micronutrients|micronutrients|mesh-ancestor
65395416|NCT00954278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395418|NCT00550446|Tofacitinib|tofacitinib|mesh-list
65395419|NCT00550446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65395420|NCT00550446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65395421|NCT00550446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65395422|NCT00550446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395459|NCT00949182|Alkylating Agents|alkylating agents|mesh-ancestor
65395460|NCT00949182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65395461|NCT00436618|Everolimus|everolimus|mesh-list
65395498|NCT04011878|Mitomycin|mitomycin|mesh-list
65395499|NCT04011878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65395500|NCT04011878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395501|NCT04011878|Alkylating Agents|alkylating agents|mesh-ancestor
65395502|NCT04011878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395673|NCT00549900|Immunologic Factors|immunologic factors|mesh-ancestor
65269862|NCT02727608|Eculizumab|eculizumab|mesh-list
65395674|NCT00549900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395675|NCT00435994|Epinephrine|epinephrine|mesh-list
65395676|NCT00435994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65395677|NCT00435994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65395678|NCT00435994|Adrenergic Agents|adrenergic agents|mesh-ancestor
65395679|NCT00435994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65395680|NCT00435994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395681|NCT00435994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395682|NCT00435994|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65395683|NCT00435994|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65395684|NCT00435994|Autonomic Agents|autonomic agents|mesh-ancestor
65395685|NCT00435994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65395686|NCT00435994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65395687|NCT00435994|Respiratory System Agents|respiratory system agents|mesh-ancestor
65395688|NCT00435994|Mydriatics|mydriatics|mesh-ancestor
65395689|NCT00435994|Sympathomimetics|sympathomimetics|mesh-ancestor
65395717|NCT05100654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65395718|NCT05100654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65395719|NCT05100654|Antimalarials|antimalarials|mesh-ancestor
65395720|NCT05100654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65395721|NCT05100654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65395722|NCT05100654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65395723|NCT05100654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65395724|NCT05100654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395725|NCT05100654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395726|NCT05100654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395727|NCT05100654|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65395728|NCT05100654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65395729|NCT05100654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65395730|NCT05100654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65395731|NCT05100654|Renal Agents|renal agents|mesh-ancestor
65395733|NCT00096031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65395734|NCT00096031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395735|NCT00118417|Clonazepam|clonazepam|mesh-list
65395809|NCT00549848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65395810|NCT00549848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65395811|NCT00549848|Antimetabolites|antimetabolites|mesh-ancestor
65395812|NCT00549848|Dermatologic Agents|dermatologic agents|mesh-ancestor
65395813|NCT00549848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65395814|NCT00549848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64783701|NCT00151398|Donepezil|donepezil|mesh-list
65395847|NCT00454636|Oxaliplatin|oxaliplatin|mesh-list
65395848|NCT00454636|Epirubicin|epirubicin|mesh-list
65395849|NCT00454636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395850|NCT00454636|Tubulin Modulators|tubulin modulators|mesh-ancestor
65395851|NCT00454636|Antimitotic Agents|antimitotic agents|mesh-ancestor
65395852|NCT00454636|Mitosis Modulators|mitosis modulators|mesh-ancestor
65395853|NCT00454636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395854|NCT00454636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65395855|NCT00454636|Antimetabolites|antimetabolites|mesh-ancestor
65395856|NCT00454636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65395886|NCT00956046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395887|NCT00454246|Epoetin Alfa|epoetin alfa|mesh-list
65395888|NCT00454246|Darbepoetin alfa|darbepoetin alfa|mesh-list
65395889|NCT00454246|Hematinics|hematinics|mesh-ancestor
65395890|NCT00434590|Mycophenolic Acid|mycophenolic acid|mesh-list
65395891|NCT00434590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65395892|NCT00434590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395893|NCT00434590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65395894|NCT00434590|Antitubercular Agents|antitubercular agents|mesh-ancestor
65395895|NCT00434590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65395896|NCT00434590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65395897|NCT00434590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395898|NCT00434590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395900|NCT00956202|Immunologic Factors|immunologic factors|mesh-ancestor
65395901|NCT00956202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395902|NCT00695903|Vancomycin|vancomycin|mesh-list
65395925|NCT00548262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395926|NCT00548262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65395927|NCT02565173|Timolol|timolol|mesh-list
65395928|NCT02565173|Adenosine|adenosine|mesh-list
65395929|NCT02565173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65395930|NCT02565173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65395931|NCT02565173|Adrenergic Agents|adrenergic agents|mesh-ancestor
65223150|NCT02584075|Hormones|hormones|mesh-ancestor
65395932|NCT02565173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65395933|NCT02565173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395934|NCT02565173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395935|NCT02565173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65395936|NCT02565173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65395980|NCT00095173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395981|NCT00095173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395982|NCT00095173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65395983|NCT00095173|Immunologic Factors|immunologic factors|mesh-ancestor
65395984|NCT00095173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395985|NCT00095173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65395986|NCT03704753|Ropivacaine|ropivacaine|mesh-list
65395987|NCT03704753|Anesthetics, Local|anesthetics, local|mesh-ancestor
65395988|NCT03704753|Anesthetics|anesthetics|mesh-ancestor
65395989|NCT03704753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65395990|NCT03704753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395991|NCT03704753|Sensory System Agents|sensory system agents|mesh-ancestor
65395992|NCT03704753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65395993|NCT00690443|Atorvastatin|atorvastatin|mesh-list
65395994|NCT00690443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65395995|NCT00690443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65395996|NCT00690443|Antimetabolites|antimetabolites|mesh-ancestor
65395997|NCT00690443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395998|NCT00690443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65395999|NCT00690443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65396035|NCT01084057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396037|NCT01084057|Antimitotic Agents|antimitotic agents|mesh-ancestor
65396038|NCT01084057|Mitosis Modulators|mitosis modulators|mesh-ancestor
65396039|NCT03954444|Phenylephrine|phenylephrine|mesh-list
65396072|NCT03953820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65396074|NCT03953820|Anesthetics|anesthetics|mesh-ancestor
65396075|NCT03953820|GABA Modulators|gaba modulators|mesh-ancestor
65396076|NCT03953820|GABA Agents|gaba agents|mesh-ancestor
65396077|NCT03953820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65396078|NCT03953820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396079|NCT02611037|Gemcitabine|gemcitabine|mesh-list
65396080|NCT02611037|Methotrexate|methotrexate|mesh-list
65396081|NCT02611037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396082|NCT02611037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65396088|NCT02611037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65396089|NCT02611037|Immunologic Factors|immunologic factors|mesh-ancestor
65396090|NCT02611037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396091|NCT02611037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65396092|NCT02611037|Abortifacient Agents|abortifacient agents|mesh-ancestor
65396093|NCT02611037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65396094|NCT02611037|Dermatologic Agents|dermatologic agents|mesh-ancestor
65396095|NCT02611037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65396096|NCT02611037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65396097|NCT02611037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65396098|NCT03678636|Anti-Infective Agents|anti-infective agents|mesh-list
65396099|NCT03678636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65396101|NCT04492956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65396102|NCT04492956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65396103|NCT04492956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65396104|NCT04492956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396105|NCT04492956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65396106|NCT04492956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65396107|NCT04492956|Dopamine Agents|dopamine agents|mesh-ancestor
65396108|NCT04492956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65396109|NCT04492956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396110|NCT01084213|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65396111|NCT01084213|Antimalarials|antimalarials|mesh-ancestor
65396112|NCT01084213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65396113|NCT01084213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65396114|NCT01084213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65396115|NCT00742937|Vitamin A|vitamin a|mesh-list
65396116|NCT00742937|Vitamins|vitamins|mesh-ancestor
65396117|NCT00742937|Micronutrients|micronutrients|mesh-ancestor
65396118|NCT00742937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396145|NCT00427648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65396146|NCT00427648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65396147|NCT00427648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65223223|NCT04624243|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65223224|NCT04624243|Dopamine Agents|dopamine agents|mesh-ancestor
65223225|NCT02585011|Epinephrine|epinephrine|mesh-list
65223226|NCT02585011|Ropivacaine|ropivacaine|mesh-list
65223227|NCT02585011|Anesthetics, Local|anesthetics, local|mesh-ancestor
65223228|NCT02585011|Anesthetics|anesthetics|mesh-ancestor
65396148|NCT00427648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64783872|NCT03340350|Minocycline|minocycline|mesh-list
65396175|NCT02153177|Antitussive Agents|antitussive agents|mesh-ancestor
65396176|NCT02153177|Respiratory System Agents|respiratory system agents|mesh-ancestor
65396177|NCT00743327|Pioglitazone|pioglitazone|mesh-list
65396178|NCT00743327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65396179|NCT00743327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396180|NCT02564861|DS-1971a|ds-1971a|mesh-list
65396181|NCT02564861|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64783882|NCT03341910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396211|NCT00433966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396212|NCT00433966|Tubulin Modulators|tubulin modulators|mesh-ancestor
65396213|NCT00433966|Antimitotic Agents|antimitotic agents|mesh-ancestor
65396214|NCT00433966|Mitosis Modulators|mitosis modulators|mesh-ancestor
65396215|NCT00433966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396216|NCT00433966|Anticoagulants|anticoagulants|mesh-ancestor
65396217|NCT00433966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65396218|NCT00433966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65396219|NCT00433966|Antithrombins|antithrombins|mesh-ancestor
65396220|NCT00433966|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65396221|NCT00433966|Protease Inhibitors|protease inhibitors|mesh-ancestor
65396222|NCT00433966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396223|NCT03463265|Sirolimus|sirolimus|mesh-list
65396224|NCT03463265|Bevacizumab|bevacizumab|mesh-list
65396225|NCT03463265|Temozolomide|temozolomide|mesh-list
65396226|NCT03463265|Lomustine|lomustine|mesh-list
65396227|NCT03463265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65396228|NCT03463265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396229|NCT03463265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65396230|NCT03463265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65396231|NCT03463265|Growth Substances|growth substances|mesh-ancestor
65396232|NCT03463265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396233|NCT03463265|Growth Inhibitors|growth inhibitors|mesh-ancestor
65396234|NCT03463265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65396235|NCT03463265|Alkylating Agents|alkylating agents|mesh-ancestor
65396290|NCT05300360|Purinergic Agents|purinergic agents|mesh-ancestor
65396325|NCT00955526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65396326|NCT00955526|Purinergic Agents|purinergic agents|mesh-ancestor
65396327|NCT00955526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65396328|NCT00955526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396329|NCT00955526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396330|NCT00955604|Rasagiline|rasagiline|mesh-list
65396331|NCT00955604|Antidepressive Agents|antidepressive agents|mesh-list
65396332|NCT00955604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65396333|NCT00955604|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65396334|NCT00955604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396335|NCT00955604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396336|NCT00955604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65396337|NCT00955604|Protective Agents|protective agents|mesh-ancestor
65396338|NCT00955604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396339|NCT00962286|Furosemide|furosemide|mesh-list
65396340|NCT00962286|Diuretics|diuretics|mesh-ancestor
65396341|NCT00962286|Natriuretic Agents|natriuretic agents|mesh-ancestor
65396342|NCT00962286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396343|NCT00962286|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65396344|NCT00962286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65396345|NCT00962286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396346|NCT00691301|Pemetrexed|pemetrexed|mesh-list
65396347|NCT00691301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396348|NCT00691301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396349|NCT00691301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396350|NCT00691301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65396351|NCT00691301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65396352|NCT05277480|Apatinib|apatinib|mesh-list
65396353|NCT05277480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396412|NCT00775229|Naltrexone|naltrexone|mesh-list
65396413|NCT00775229|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64783989|NCT03459612|Antipruritics|antipruritics|mesh-ancestor
65396449|NCT00653159|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65396450|NCT00653159|Trace Elements|trace elements|mesh-ancestor
65396451|NCT00653159|Micronutrients|micronutrients|mesh-ancestor
65396452|NCT03047070|Lidocaine|lidocaine|mesh-list
65396453|NCT03047070|Anesthetics, Local|anesthetics, local|mesh-ancestor
65396454|NCT03047070|Anesthetics|anesthetics|mesh-ancestor
65396455|NCT03047070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65396456|NCT03047070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396457|NCT03047070|Sensory System Agents|sensory system agents|mesh-ancestor
65396458|NCT03047070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65396459|NCT03047070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65396460|NCT03047070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65396461|NCT03047070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65396462|NCT03047070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65396463|NCT03047070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396464|NCT00948272|Vaccines|vaccines|mesh-list
65396465|NCT00948272|Immunologic Factors|immunologic factors|mesh-ancestor
65396466|NCT00948272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396467|NCT00957554|Amlodipine|amlodipine|mesh-list
65396468|NCT00957554|Irbesartan|irbesartan|mesh-list
65146044|NCT00628459|Micronutrients|micronutrients|mesh-list
65396469|NCT00957554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65396470|NCT00957554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65396471|NCT00957554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65396472|NCT00957554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396473|NCT00957554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65396474|NCT00957554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396475|NCT00957554|Vasodilator Agents|vasodilator agents|mesh-ancestor
65396476|NCT00957554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65396477|NCT00957554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65396479|NCT03024684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65396480|NCT03024684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65396506|NCT00744185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65396507|NCT00744185|Vasodilator Agents|vasodilator agents|mesh-ancestor
65396509|NCT02897778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396510|NCT02897778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65396511|NCT02897778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396512|NCT02897778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396513|NCT01084291|Vaccines|vaccines|mesh-list
65396514|NCT01084291|Immunologic Factors|immunologic factors|mesh-ancestor
65396515|NCT01084291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396516|NCT00741767|Fluticasone|fluticasone|mesh-list
65396517|NCT00741767|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65396518|NCT00741767|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65396519|NCT00741767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65396520|NCT00741767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65396521|NCT00741767|Autonomic Agents|autonomic agents|mesh-ancestor
65396522|NCT00741767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65396533|NCT00741767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396535|NCT00741767|Hormones|hormones|mesh-ancestor
65396536|NCT00741767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65396537|NCT00741767|Sympathomimetics|sympathomimetics|mesh-ancestor
65396538|NCT05317403|Cytarabine|cytarabine|mesh-list
65396539|NCT05317403|Fludarabine|fludarabine|mesh-list
65396540|NCT05317403|Venetoclax|venetoclax|mesh-list
65396541|NCT05317403|Vorinostat|vorinostat|mesh-list
65396542|NCT05317403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396543|NCT05317403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65396544|NCT05317403|Antimetabolites|antimetabolites|mesh-ancestor
65396545|NCT05317403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396546|NCT05317403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65396547|NCT05317403|Immunologic Factors|immunologic factors|mesh-ancestor
65396548|NCT05317403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396549|NCT05317403|Antiviral Agents|antiviral agents|mesh-ancestor
65396550|NCT05317403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65396551|NCT05317403|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65396552|NCT05317403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396553|NCT00741845|Metronidazole|metronidazole|mesh-list
65396554|NCT00741845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65396558|NCT00746447|Mesalamine|mesalamine|mesh-list
65396559|NCT00746447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65396560|NCT00746447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65223374|NCT04332211|Autonomic Agents|autonomic agents|mesh-ancestor
65396561|NCT00746447|Analgesics|analgesics|mesh-ancestor
65396562|NCT00746447|Sensory System Agents|sensory system agents|mesh-ancestor
65396563|NCT00746447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65396564|NCT00746447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396565|NCT00746447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65396566|NCT00746447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65396567|NCT00744419|Pantoprazole|pantoprazole|mesh-list
65396568|NCT00744419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65396569|NCT00744419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65396570|NCT00744419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65396571|NCT00744419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396572|NCT00744419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396573|NCT00742157|Hormones|hormones|mesh-list
65396574|NCT00742157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65396575|NCT00742157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396576|NCT00549302|Tadalafil|tadalafil|mesh-list
65396577|NCT00549302|Vasodilator Agents|vasodilator agents|mesh-ancestor
65396578|NCT00549302|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65396579|NCT00549302|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65396580|NCT00549302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396581|NCT00549302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396582|NCT00549302|Urological Agents|urological agents|mesh-ancestor
65396583|NCT04277858|Cisplatin|cisplatin|mesh-list
65396584|NCT04277858|Docetaxel|docetaxel|mesh-list
65396585|NCT04277858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396586|NCT04277858|Tubulin Modulators|tubulin modulators|mesh-ancestor
65396587|NCT04277858|Antimitotic Agents|antimitotic agents|mesh-ancestor
65396588|NCT04277858|Mitosis Modulators|mitosis modulators|mesh-ancestor
65396589|NCT04277858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396590|NCT00957866|Interferons|interferons|mesh-list
65396591|NCT00957866|Ribavirin|ribavirin|mesh-list
65396592|NCT00957866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395452|NCT02669407|Anesthetics|anesthetics|mesh-list
65396622|NCT00958100|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65396623|NCT00958100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65396624|NCT00958100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396625|NCT00958100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396626|NCT00958100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65396627|NCT00958100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65396704|NCT00949130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396705|NCT02815592|Carboplatin|carboplatin|mesh-list
65396706|NCT02815592|Etoposide|etoposide|mesh-list
65396707|NCT02815592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396708|NCT02815592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65396709|NCT02815592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65396710|NCT02815592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65396711|NCT02815592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396712|NCT02815592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396713|NCT04010318|Anesthetics|anesthetics|mesh-list
65396714|NCT04010318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65396715|NCT04010318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396716|NCT00108355|Octreotide|octreotide|mesh-list
65396717|NCT00108355|Midodrine|midodrine|mesh-list
65396718|NCT00108355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65396719|NCT00108355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65396720|NCT00108355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396721|NCT00108355|Sympathomimetics|sympathomimetics|mesh-ancestor
65396722|NCT00108355|Autonomic Agents|autonomic agents|mesh-ancestor
65396723|NCT00108355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65396724|NCT00108355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396725|NCT00108355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65396726|NCT00108355|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65396727|NCT00108355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65396728|NCT00108355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65396729|NCT00108355|Adrenergic Agents|adrenergic agents|mesh-ancestor
65396730|NCT00108355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65396731|NCT00108355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396732|NCT05351606|Bupropion|bupropion|mesh-list
65396733|NCT05351606|Nicotine|nicotine|mesh-list
65396734|NCT05351606|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65396735|NCT05351606|Autonomic Agents|autonomic agents|mesh-ancestor
65396736|NCT05351606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65396737|NCT05351606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223449|NCT02874989|Antioxidants|antioxidants|mesh-ancestor
65396738|NCT05351606|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65396807|NCT02465138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396809|NCT00968994|Emollients|emollients|mesh-ancestor
65396810|NCT00968994|Dermatologic Agents|dermatologic agents|mesh-ancestor
65396811|NCT00969072|Dutasteride|dutasteride|mesh-list
65396812|NCT00969072|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65396813|NCT00969072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65396814|NCT00969072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396815|NCT00969072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396816|NCT00969072|Hormone Antagonists|hormone antagonists|mesh-ancestor
65396817|NCT00969072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65396818|NCT00969072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396819|NCT00094861|Paclitaxel|paclitaxel|mesh-list
65396820|NCT00094861|Carboplatin|carboplatin|mesh-list
65396821|NCT00094861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65396822|NCT00094861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396823|NCT00094861|Tubulin Modulators|tubulin modulators|mesh-ancestor
65396824|NCT00094861|Antimitotic Agents|antimitotic agents|mesh-ancestor
65396836|NCT00963534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65396837|NCT00963534|Growth Substances|growth substances|mesh-ancestor
65396838|NCT00963534|Growth Inhibitors|growth inhibitors|mesh-ancestor
65396839|NCT00963534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65396840|NCT00963534|Alkylating Agents|alkylating agents|mesh-ancestor
65396841|NCT00963534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396842|NCT00963690|Hemostatics|hemostatics|mesh-list
65396843|NCT00963690|Coagulants|coagulants|mesh-ancestor
65146408|NCT01003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396845|NCT01079767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65396846|NCT01079767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65396847|NCT01079767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65396848|NCT01079767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396849|NCT01079767|Antifungal Agents|antifungal agents|mesh-ancestor
65396850|NCT01079767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65396851|NCT01079767|Immunologic Factors|immunologic factors|mesh-ancestor
65396852|NCT01079767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396853|NCT00969306|Chloroquine|chloroquine|mesh-list
65396854|NCT00969306|Amebicides|amebicides|mesh-ancestor
65396855|NCT00969306|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65396856|NCT00969306|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65396857|NCT00969306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65396858|NCT00969306|Antimalarials|antimalarials|mesh-ancestor
65396859|NCT00969306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65396860|NCT00963768|Canagliflozin|canagliflozin|mesh-list
64784193|NCT03889158|Vitamins|vitamins|mesh-ancestor
64784194|NCT03889158|Micronutrients|micronutrients|mesh-ancestor
64395547|NCT05403749|Aflibercept|aflibercept|mesh-list
65396879|NCT00963846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65396880|NCT00963846|Protective Agents|protective agents|mesh-ancestor
65396881|NCT00969696|Galantamine|galantamine|mesh-list
65396882|NCT00969696|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65396883|NCT00969696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396884|NCT00969696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396885|NCT00969696|Cholinergic Agents|cholinergic agents|mesh-ancestor
65396886|NCT00969696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65396887|NCT00969696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396888|NCT00969696|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65396889|NCT00969696|Autonomic Agents|autonomic agents|mesh-ancestor
65396890|NCT00969696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65396891|NCT00969696|Nootropic Agents|nootropic agents|mesh-ancestor
65396892|NCT00958854|Thalidomide|thalidomide|mesh-list
65396893|NCT00958854|Cyclophosphamide|cyclophosphamide|mesh-list
65396894|NCT00958854|Fludarabine|fludarabine|mesh-list
65396895|NCT00958854|Fludarabine phosphate|fludarabine phosphate|mesh-list
65396896|NCT00958854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65396897|NCT00958854|Immunologic Factors|immunologic factors|mesh-ancestor
65396898|NCT00958854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396899|NCT00958854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65396900|NCT00958854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65396901|NCT00958854|Alkylating Agents|alkylating agents|mesh-ancestor
64784201|NCT04138758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396936|NCT00969852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65396937|NCT00969852|Serotonin Agents|serotonin agents|mesh-ancestor
65396938|NCT00969852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396939|NCT00426556|Paclitaxel|paclitaxel|mesh-list
65396940|NCT00426556|Trastuzumab|trastuzumab|mesh-list
65396941|NCT00426556|Everolimus|everolimus|mesh-list
65396942|NCT00426556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65396943|NCT00426556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396944|NCT00426556|Tubulin Modulators|tubulin modulators|mesh-ancestor
65396945|NCT00426556|Antimitotic Agents|antimitotic agents|mesh-ancestor
65396946|NCT00426556|Mitosis Modulators|mitosis modulators|mesh-ancestor
65396947|NCT00426556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396948|NCT00426556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65396949|NCT00426556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65396950|NCT00426556|Immunologic Factors|immunologic factors|mesh-ancestor
65396951|NCT00426556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396952|NCT00107653|Ribavirin|ribavirin|mesh-list
65396953|NCT00107653|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65396954|NCT00107653|Interferon-alpha|interferon-alpha|mesh-list
65396955|NCT00107653|Antimetabolites|antimetabolites|mesh-ancestor
65396956|NCT00107653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396957|NCT00107653|Antiviral Agents|antiviral agents|mesh-ancestor
65396958|NCT00107653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65396959|NCT00107653|Immunologic Factors|immunologic factors|mesh-ancestor
65396960|NCT00107653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396961|NCT03950856|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65396962|NCT03950856|Immunologic Factors|immunologic factors|mesh-ancestor
65396963|NCT03950856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396964|NCT00970008|CD59 Antigens|cd59 antigens|mesh-list
65396965|NCT00970008|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64784230|NCT04511520|Trimetazidine|trimetazidine|mesh-list
65397008|NCT00746681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65397010|NCT00746837|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
65397011|NCT00746837|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65397012|NCT00746837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397013|NCT00746837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65397014|NCT00746837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65397015|NCT00746837|Antiviral Agents|antiviral agents|mesh-ancestor
65397016|NCT00746837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65397017|NCT00749099|Pancrelipase|pancrelipase|mesh-list
65397018|NCT00749099|Pancreatin|pancreatin|mesh-list
65397019|NCT00749099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65397020|NCT00959400|Fentanyl|fentanyl|mesh-list
65397021|NCT00959400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65397022|NCT00959400|Narcotics|narcotics|mesh-ancestor
65397023|NCT00959400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65397024|NCT00959400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397025|NCT00959400|Analgesics|analgesics|mesh-ancestor
65397026|NCT00959400|Sensory System Agents|sensory system agents|mesh-ancestor
65397027|NCT00959400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65397028|NCT00959400|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65397029|NCT00959400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65397030|NCT00959400|Anesthetics, General|anesthetics, general|mesh-ancestor
65397054|NCT00959478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397055|NCT00959478|Gasotransmitters|gasotransmitters|mesh-ancestor
65397056|NCT00959478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65397057|NCT00959478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397058|NCT00964626|Paclitaxel|paclitaxel|mesh-list
65397059|NCT00964626|Cisplatin|cisplatin|mesh-list
65397060|NCT00964626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65397061|NCT00964626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397062|NCT00964626|Tubulin Modulators|tubulin modulators|mesh-ancestor
65397063|NCT00964626|Antimitotic Agents|antimitotic agents|mesh-ancestor
65397109|NCT02562053|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65397110|NCT00746993|Contraceptive Agents|contraceptive agents|mesh-list
65397111|NCT00746993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65397112|NCT00746993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397113|NCT04060043|Goserelin|goserelin|mesh-list
65397114|NCT04060043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65397115|NCT04060043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397116|NCT00553358|Paclitaxel|paclitaxel|mesh-list
65397117|NCT00553358|Trastuzumab|trastuzumab|mesh-list
65397118|NCT00553358|Lapatinib|lapatinib|mesh-list
65397119|NCT00553358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65397120|NCT00553358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397121|NCT00553358|Tubulin Modulators|tubulin modulators|mesh-ancestor
65397122|NCT00553358|Antimitotic Agents|antimitotic agents|mesh-ancestor
65397123|NCT00553358|Mitosis Modulators|mitosis modulators|mesh-ancestor
65397132|NCT00744809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65397133|NCT00744809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65397134|NCT00744809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65397135|NCT00744809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397136|NCT00744809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397137|NCT00744809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397138|NCT00744809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65397139|NCT00744809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65397140|NCT00744809|Antiviral Agents|antiviral agents|mesh-ancestor
65397141|NCT00744809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65397142|NCT00744809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65397143|NCT00744809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65397144|NCT00744809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65397145|NCT00744809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65397146|NCT00744809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65397147|NCT00744809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65397148|NCT00744809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65397149|NCT00744887|Darunavir|darunavir|mesh-list
65397150|NCT00744887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65397151|NCT00744887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65397152|NCT00744887|Protease Inhibitors|protease inhibitors|mesh-ancestor
65397153|NCT00744887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397154|NCT00744887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397155|NCT00744887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65397156|NCT00744887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65397157|NCT00744887|Antiviral Agents|antiviral agents|mesh-ancestor
65397158|NCT00744887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65397159|NCT02286830|Zoledronic Acid|zoledronic acid|mesh-list
64395635|NCT05304845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65397165|NCT00749567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397166|NCT00749567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65397167|NCT00749567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65397169|NCT00749567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397170|NCT00749567|Growth Inhibitors|growth inhibitors|mesh-ancestor
65397171|NCT00749567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65397172|NCT00749567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397173|NCT00749567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397174|NCT04010942|Metformin|metformin|mesh-list
65397175|NCT04010942|Clomiphene|clomiphene|mesh-list
65397176|NCT04010942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65397177|NCT04010942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397178|NCT04010942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65397179|NCT04010942|Hormone Antagonists|hormone antagonists|mesh-ancestor
65397180|NCT04010942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65397181|NCT04010942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65397182|NCT04010942|Fertility Agents|fertility agents|mesh-ancestor
65397183|NCT04010942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65397184|NCT04010942|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65397185|NCT04010942|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65397186|NCT00949364|Pomalidomide|pomalidomide|mesh-list
65397187|NCT00949364|Immunologic Factors|immunologic factors|mesh-ancestor
65397188|NCT00949364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397189|NCT00949364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65397190|NCT00949364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65397191|NCT00949364|Growth Substances|growth substances|mesh-ancestor
65397192|NCT00949364|Growth Inhibitors|growth inhibitors|mesh-ancestor
65397193|NCT00949364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397200|NCT00689117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65397201|NCT00689117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397202|NCT00689117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397203|NCT00689117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397204|NCT00689117|Keratolytic Agents|keratolytic agents|mesh-ancestor
65397205|NCT00689117|Dermatologic Agents|dermatologic agents|mesh-ancestor
65397207|NCT00949442|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65397208|NCT00949442|Insulin Glargine|insulin glargine|mesh-list
65397209|NCT00949442|Glimepiride|glimepiride|mesh-list
65397210|NCT00949442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65397211|NCT00949442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397212|NCT00949442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65397213|NCT00949442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65397214|NCT00949442|Immunologic Factors|immunologic factors|mesh-ancestor
65397215|NCT00749723|Carboplatin|carboplatin|mesh-list
65397216|NCT00749723|Etoposide|etoposide|mesh-list
65397217|NCT00749723|Etoposide phosphate|etoposide phosphate|mesh-list
65397219|NCT00749723|Thiotepa|thiotepa|mesh-list
65397220|NCT00749723|Trofosfamide|trofosfamide|mesh-list
65223677|NCT04078399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397221|NCT00749723|Cyclophosphamide|cyclophosphamide|mesh-list
65397222|NCT00749723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397223|NCT00749723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65397224|NCT00749723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65397225|NCT00749723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65397226|NCT00749723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397227|NCT00749723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397228|NCT00749723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65397229|NCT00749723|Alkylating Agents|alkylating agents|mesh-ancestor
65397230|NCT00749723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65397231|NCT00749723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65397232|NCT00749723|Immunologic Factors|immunologic factors|mesh-ancestor
65397233|NCT00749723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397234|NCT00749723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64324436|NCT03922880|Ipilimumab|ipilimumab|mesh-list
65397249|NCT00688103|Dermatologic Agents|dermatologic agents|mesh-ancestor
65397250|NCT00688103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397251|NCT00688103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65397252|NCT00688103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65397253|NCT00688103|Immunologic Factors|immunologic factors|mesh-ancestor
65397254|NCT00688103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65397255|NCT00688103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65397256|NCT00688103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65397257|NCT00688103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65397258|NCT00688103|Analgesics|analgesics|mesh-ancestor
65397259|NCT00688103|Sensory System Agents|sensory system agents|mesh-ancestor
65397260|NCT00688103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65397261|NCT00688103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65397262|NCT00688103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65397263|NCT00949598|Tamoxifen|tamoxifen|mesh-list
65397264|NCT00949598|Letrozole|letrozole|mesh-list
65397265|NCT00949598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397266|NCT00949598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397267|NCT00949598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65397268|NCT00949598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65397269|NCT00949598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397270|NCT00949598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65397271|NCT00949598|Hormone Antagonists|hormone antagonists|mesh-ancestor
65397272|NCT00949598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65397273|NCT00949598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397274|NCT00949598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64784341|NCT03933774|Tretinoin|tretinoin|mesh-list
65397278|NCT00964704|Bevacizumab|bevacizumab|mesh-list
65397279|NCT00964704|Trastuzumab|trastuzumab|mesh-list
65397280|NCT00964704|Docetaxel|docetaxel|mesh-list
65397281|NCT00964704|Capecitabine|capecitabine|mesh-list
65397282|NCT00964704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65397283|NCT00964704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397284|NCT00964704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65397285|NCT00964704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65397286|NCT00964704|Growth Substances|growth substances|mesh-ancestor
65397287|NCT00964704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397288|NCT00964704|Growth Inhibitors|growth inhibitors|mesh-ancestor
65397289|NCT00964704|Tubulin Modulators|tubulin modulators|mesh-ancestor
65397290|NCT00964704|Antimitotic Agents|antimitotic agents|mesh-ancestor
65397291|NCT00964704|Mitosis Modulators|mitosis modulators|mesh-ancestor
65397292|NCT00964704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397293|NCT00964704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65397295|NCT00686855|Dexamethasone|dexamethasone|mesh-list
65397296|NCT00686855|Tacrolimus|tacrolimus|mesh-list
65397297|NCT00686855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65397298|NCT00686855|Antiemetics|antiemetics|mesh-ancestor
65397299|NCT00686855|Autonomic Agents|autonomic agents|mesh-ancestor
65397300|NCT00686855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65397301|NCT00686855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397302|NCT00686855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65397303|NCT00686855|Glucocorticoids|glucocorticoids|mesh-ancestor
65397304|NCT00686855|Hormones|hormones|mesh-ancestor
65397305|NCT00686855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65397306|NCT00686855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65397307|NCT00686855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397308|NCT00686855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65397309|NCT00686855|Immunologic Factors|immunologic factors|mesh-ancestor
65397310|NCT00686855|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65397311|NCT00686855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397312|NCT00686855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397328|NCT00949832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65397329|NCT03797066|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65397330|NCT03797066|Antiviral Agents|antiviral agents|mesh-ancestor
65397331|NCT03797066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65397332|NCT00745199|Cromolyn Sodium|cromolyn sodium|mesh-list
65397333|NCT00745199|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
65397334|NCT00745199|Immunologic Factors|immunologic factors|mesh-ancestor
65397335|NCT00745199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397336|NCT00745199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65397337|NCT00745199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65397338|NCT00745199|Respiratory System Agents|respiratory system agents|mesh-ancestor
65397339|NCT00961844|Temozolomide|temozolomide|mesh-list
65397340|NCT00961844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65397341|NCT00961844|Alkylating Agents|alkylating agents|mesh-ancestor
65397361|NCT04009772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65397363|NCT04009772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65397364|NCT00959582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65397365|NCT00959582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65397366|NCT00959582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066887|NCT00307944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65397367|NCT00962156|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65397368|NCT00962156|Plasma Substitutes|plasma substitutes|mesh-ancestor
65397369|NCT00962156|Blood Substitutes|blood substitutes|mesh-ancestor
65397370|NCT01563068|Calcipotriene|calcipotriene|mesh-list
65397371|NCT01563068|Dermatologic Agents|dermatologic agents|mesh-ancestor
65397372|NCT00747305|Sunitinib|sunitinib|mesh-list
65397373|NCT00747305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397394|NCT00747383|Hormones|hormones|mesh-ancestor
65397395|NCT00747383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65397396|NCT00747383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65397397|NCT00747383|Protease Inhibitors|protease inhibitors|mesh-ancestor
65397398|NCT00747383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397399|NCT00747383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397400|NCT00747383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65397401|NCT00747383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65397402|NCT00747383|Immunologic Factors|immunologic factors|mesh-ancestor
65397403|NCT00106639|Tacrolimus|tacrolimus|mesh-list
65397404|NCT00106639|Tofacitinib|tofacitinib|mesh-list
65397405|NCT00106639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65397406|NCT00106639|Immunologic Factors|immunologic factors|mesh-ancestor
65397407|NCT00106639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397408|NCT00106639|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64784381|NCT03849690|Esomeprazole|esomeprazole|mesh-list
65397474|NCT00962312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65397475|NCT00962312|Antimetabolites|antimetabolites|mesh-ancestor
65397476|NCT00962312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397477|NCT00962312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397478|NCT00962312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65397479|NCT00962312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397480|NCT00960518|Adefovir|adefovir|mesh-list
65397481|NCT00960518|Antiviral Agents|antiviral agents|mesh-ancestor
65397482|NCT00960518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65397483|NCT00960518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65397484|NCT00960518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65397498|NCT00960830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65397499|NCT00960830|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65397500|NCT00960830|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65397501|NCT00960830|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65397502|NCT00960830|Adrenergic Agents|adrenergic agents|mesh-ancestor
65397503|NCT00960830|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65397504|NCT00960830|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65397505|NCT00960830|Serotonin Agents|serotonin agents|mesh-ancestor
65397506|NCT00960830|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65397507|NCT00962624|Vaccines|vaccines|mesh-list
65397508|NCT00962624|Immunologic Factors|immunologic factors|mesh-ancestor
65397509|NCT00962624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397510|NCT00105235|Cyclosporine|cyclosporine|mesh-list
65397511|NCT00105235|Mycophenolic Acid|mycophenolic acid|mesh-list
65397512|NCT00105235|Alemtuzumab|alemtuzumab|mesh-list
65397513|NCT00105235|Tacrolimus|tacrolimus|mesh-list
65397514|NCT00105235|Cyclosporins|cyclosporins|mesh-list
65397515|NCT00105235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65397516|NCT00105235|Immunologic Factors|immunologic factors|mesh-ancestor
65397517|NCT00105235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397518|NCT00105235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65397519|NCT00105235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397520|NCT00105235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397521|NCT00105235|Antifungal Agents|antifungal agents|mesh-ancestor
65397522|NCT00105235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65397554|NCT01087099|Antimitotic Agents|antimitotic agents|mesh-ancestor
65397555|NCT01087099|Mitosis Modulators|mitosis modulators|mesh-ancestor
65397556|NCT01087099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397557|NCT01087099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397559|NCT03946124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65397560|NCT03946124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65397561|NCT03946124|Cholinergic Agents|cholinergic agents|mesh-ancestor
65397562|NCT03946124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65397563|NCT03946124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397564|NCT03946124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397565|NCT03946124|Urological Agents|urological agents|mesh-ancestor
65397566|NCT00686543|Posaconazole|posaconazole|mesh-list
65397567|NCT00686543|Antifungal Agents|antifungal agents|mesh-ancestor
65397568|NCT00686543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65397569|NCT00686543|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65397570|NCT00686543|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65397571|NCT00686543|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65397572|NCT00686543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65397573|NCT00686543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65397574|NCT00686543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397575|NCT00686543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397576|NCT00686543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65397577|NCT00686543|Hormone Antagonists|hormone antagonists|mesh-ancestor
65397578|NCT00686543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65397579|NCT00686543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397580|NCT00750113|Telmisartan|telmisartan|mesh-list
65397581|NCT00750113|Nifedipine|nifedipine|mesh-list
65397582|NCT00750113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65397583|NCT00750113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65397584|NCT00750113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65397585|NCT00750113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397586|NCT00750113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65397587|NCT00750113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65397593|NCT00745511|Bevacizumab|bevacizumab|mesh-list
65397594|NCT00745511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65397595|NCT00745511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397596|NCT00745511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65397597|NCT00745511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65397598|NCT00745511|Growth Substances|growth substances|mesh-ancestor
65397599|NCT00745511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397600|NCT00745511|Growth Inhibitors|growth inhibitors|mesh-ancestor
65397601|NCT00545688|Docetaxel|docetaxel|mesh-list
65397602|NCT00545688|Trastuzumab|trastuzumab|mesh-list
65397603|NCT00545688|Pertuzumab|pertuzumab|mesh-list
65397604|NCT00545688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397605|NCT00545688|Tubulin Modulators|tubulin modulators|mesh-ancestor
65397606|NCT00545688|Antimitotic Agents|antimitotic agents|mesh-ancestor
65397607|NCT00545688|Mitosis Modulators|mitosis modulators|mesh-ancestor
65397608|NCT00545688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397609|NCT00545688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65397610|NCT00502203|Paclitaxel|paclitaxel|mesh-list
65397611|NCT00502203|Carboplatin|carboplatin|mesh-list
65397612|NCT00502203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65397613|NCT00502203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397614|NCT00502203|Tubulin Modulators|tubulin modulators|mesh-ancestor
65397615|NCT00502203|Antimitotic Agents|antimitotic agents|mesh-ancestor
65397616|NCT00502203|Mitosis Modulators|mitosis modulators|mesh-ancestor
65397617|NCT00502203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397618|NCT00546078|Vaccines|vaccines|mesh-list
65397619|NCT00546078|Immunologic Factors|immunologic factors|mesh-ancestor
65397620|NCT00546078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397621|NCT00967772|Naftopidil|naftopidil|mesh-list
65397622|NCT00967772|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65397623|NCT00967772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65397624|NCT00967772|Adrenergic Agents|adrenergic agents|mesh-ancestor
65397625|NCT00967772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65269863|NCT02727608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65397671|NCT00968240|Growth Inhibitors|growth inhibitors|mesh-ancestor
65397672|NCT00501969|Rotigotine|rotigotine|mesh-list
65397673|NCT00501969|Dopamine Agonists|dopamine agonists|mesh-ancestor
65397674|NCT00501969|Dopamine Agents|dopamine agents|mesh-ancestor
65397675|NCT00501969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65397676|NCT00501969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397677|NCT00501969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397678|NCT03942042|Ixekizumab|ixekizumab|mesh-list
65397679|NCT03942042|Dermatologic Agents|dermatologic agents|mesh-ancestor
64395788|NCT01228331|Abortifacient Agents|abortifacient agents|mesh-ancestor
64395789|NCT01228331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65397682|NCT00968396|Alkylating Agents|alkylating agents|mesh-ancestor
65397683|NCT00968396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397684|NCT00968396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397685|NCT00968396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65397686|NCT00968396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65397687|NCT00968396|Immunologic Factors|immunologic factors|mesh-ancestor
65397688|NCT00968396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397690|NCT04008732|Vasodilator Agents|vasodilator agents|mesh-ancestor
65397691|NCT04699604|Levocetirizine|levocetirizine|mesh-list
65397692|NCT04699604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65397693|NCT04699604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65397694|NCT04699604|Histamine Antagonists|histamine antagonists|mesh-ancestor
65397695|NCT04699604|Histamine Agents|histamine agents|mesh-ancestor
65397696|NCT04699604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65397697|NCT04699604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397698|NCT04699604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397699|NCT01013727|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
65397700|NCT01013727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65397701|NCT01013727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397702|NCT05299580|Trametinib|trametinib|mesh-list
65397703|NCT05299580|Dabrafenib|dabrafenib|mesh-list
65397704|NCT05299580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397705|NCT05299580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65397706|NCT05299580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397707|NCT05299580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397708|NCT01013805|Leucovorin|leucovorin|mesh-list
65397709|NCT01013805|Fluorouracil|fluorouracil|mesh-list
65397710|NCT01013805|Oxaliplatin|oxaliplatin|mesh-list
65397711|NCT01013805|Antimetabolites|antimetabolites|mesh-ancestor
65397712|NCT01013805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397713|NCT01013805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65397714|NCT01013805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397715|NCT01013805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65397733|NCT00104299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65397734|NCT00104299|Alkylating Agents|alkylating agents|mesh-ancestor
65397735|NCT00104299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397736|NCT00104299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397737|NCT00104299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65147310|NCT01072630|Modafinil|modafinil|mesh-list
65397738|NCT00104299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65397739|NCT00104299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65397740|NCT00104299|Hormones|hormones|mesh-ancestor
65397741|NCT00104299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65397742|NCT00104299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65397743|NCT00104299|Antiemetics|antiemetics|mesh-ancestor
65397744|NCT00104299|Autonomic Agents|autonomic agents|mesh-ancestor
65397745|NCT00104299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65397746|NCT00104299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65397747|NCT00104299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65397748|NCT00104299|Protective Agents|protective agents|mesh-ancestor
65397749|NCT00104299|Antimetabolites|antimetabolites|mesh-ancestor
65397750|NCT00104299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65397751|NCT05196308|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65397752|NCT05196308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65397753|NCT05196308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65397754|NCT05196308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397755|NCT05196308|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64784508|NCT02966184|Tocolytic Agents|tocolytic agents|mesh-ancestor
65397762|NCT00082381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65397763|NCT00082381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397764|NCT00082381|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65223977|NCT01001702|Serotonin Agents|serotonin agents|mesh-ancestor
65397765|NCT00082381|Incretins|incretins|mesh-ancestor
65397766|NCT00082381|Hormones|hormones|mesh-ancestor
65397767|NCT00082381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65397768|NCT00964106|Rosiglitazone|rosiglitazone|mesh-list
65397769|NCT00964106|Rifampin|rifampin|mesh-list
65397770|NCT00964106|Fluconazole|fluconazole|mesh-list
65397771|NCT00964106|Ketoconazole|ketoconazole|mesh-list
65397772|NCT00964106|Flurbiprofen|flurbiprofen|mesh-list
65397773|NCT00964106|Midazolam|midazolam|mesh-list
65397774|NCT00964106|Dextromethorphan|dextromethorphan|mesh-list
65397775|NCT00964106|Caffeine|caffeine|mesh-list
65397776|NCT00964106|Omeprazole|omeprazole|mesh-list
65397777|NCT00964106|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65397778|NCT00964106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65397779|NCT00964106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65397780|NCT00964106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65397781|NCT00964106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397782|NCT00964106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65397783|NCT00964106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65397784|NCT00964106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65397785|NCT00964106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65397786|NCT00964106|Anesthetics, General|anesthetics, general|mesh-ancestor
65397787|NCT00964106|Anesthetics|anesthetics|mesh-ancestor
65397788|NCT00964106|GABA Modulators|gaba modulators|mesh-ancestor
65397789|NCT00964106|GABA Agents|gaba agents|mesh-ancestor
65397790|NCT00964106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65397791|NCT00964106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397813|NCT00964106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65397814|NCT00964106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65397815|NCT00964106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65397816|NCT00964106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65397817|NCT00964106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65397818|NCT00964106|Antifungal Agents|antifungal agents|mesh-ancestor
65397819|NCT00964106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65397820|NCT00964106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65397821|NCT00964106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65397822|NCT00964106|Hormone Antagonists|hormone antagonists|mesh-ancestor
65397823|NCT00964106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65397824|NCT00964106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65397825|NCT00964106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65397826|NCT00964106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65397827|NCT00964106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65397828|NCT00964106|Antitussive Agents|antitussive agents|mesh-ancestor
65397829|NCT00964106|Respiratory System Agents|respiratory system agents|mesh-ancestor
64784524|NCT02744352|Anesthetics, Local|anesthetics, local|mesh-ancestor
64784525|NCT02744352|Anesthetics|anesthetics|mesh-ancestor
65397856|NCT00545844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65397857|NCT00545844|Hormone Antagonists|hormone antagonists|mesh-ancestor
64395828|NCT02047097|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64395859|NCT00416351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65397895|NCT02976909|Tubulin Modulators|tubulin modulators|mesh-ancestor
65397896|NCT02976909|Antimitotic Agents|antimitotic agents|mesh-ancestor
65397897|NCT02976909|Mitosis Modulators|mitosis modulators|mesh-ancestor
65397898|NCT02976909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397899|NCT02976909|Antimetabolites|antimetabolites|mesh-ancestor
65397900|NCT02976909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65397901|NCT02976909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65397902|NCT02976909|Immunologic Factors|immunologic factors|mesh-ancestor
65397903|NCT02976909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397904|NCT02878083|Adalimumab|adalimumab|mesh-list
65397905|NCT02878083|Vedolizumab|vedolizumab|mesh-list
65397906|NCT02878083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65397907|NCT02878083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65397908|NCT02878083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65397909|NCT00093145|Paclitaxel|paclitaxel|mesh-list
65397910|NCT00093145|Carboplatin|carboplatin|mesh-list
65397911|NCT00093145|Trastuzumab|trastuzumab|mesh-list
65397912|NCT00093145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65397913|NCT00093145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65397914|NCT00093145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397915|NCT00093145|Tubulin Modulators|tubulin modulators|mesh-ancestor
65397916|NCT00093145|Antimitotic Agents|antimitotic agents|mesh-ancestor
65397917|NCT00093145|Mitosis Modulators|mitosis modulators|mesh-ancestor
65397918|NCT00093145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325365|NCT00777608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325366|NCT00777608|Cholinergic Agents|cholinergic agents|mesh-ancestor
65325367|NCT00777608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65325368|NCT00777608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325369|NCT00777608|Nootropic Agents|nootropic agents|mesh-ancestor
65325370|NCT00792935|Metformin|metformin|mesh-list
65177146|NCT00630981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65177147|NCT00630981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65177148|NCT00952341|Dexamethasone|dexamethasone|mesh-list
65177149|NCT00952341|Dexamethasone acetate|dexamethasone acetate|mesh-list
65177150|NCT00952341|Aprepitant|aprepitant|mesh-list
65177151|NCT00952341|Fosaprepitant|fosaprepitant|mesh-list
65177152|NCT00952341|Granisetron|granisetron|mesh-list
65177153|NCT00952341|BB 1101|bb 1101|mesh-list
65177154|NCT00952341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65177155|NCT00952341|Antiemetics|antiemetics|mesh-ancestor
65177156|NCT00952341|Autonomic Agents|autonomic agents|mesh-ancestor
65177157|NCT00952341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65177158|NCT00952341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177159|NCT00952341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65177160|NCT00952341|Glucocorticoids|glucocorticoids|mesh-ancestor
65177161|NCT00952341|Hormones|hormones|mesh-ancestor
65177162|NCT00952341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65177163|NCT00952341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65177164|NCT00952341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177165|NCT00952341|Protease Inhibitors|protease inhibitors|mesh-ancestor
65177166|NCT00952341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177167|NCT00952341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177168|NCT00952341|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65177169|NCT00952341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65177170|NCT00952341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65177171|NCT00952341|Serotonin Agents|serotonin agents|mesh-ancestor
65177172|NCT02845024|Doxycycline|doxycycline|mesh-list
65177173|NCT02845024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65177174|NCT02845024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65177175|NCT02845024|Antimalarials|antimalarials|mesh-ancestor
65177176|NCT02845024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65177177|NCT02845024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65177178|NCT05242120|Anesthetics|anesthetics|mesh-list
65177179|NCT05242120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65177180|NCT05242120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177181|NCT01909089|Chloroprocaine|chloroprocaine|mesh-list
65177182|NCT01909089|Anesthetics, Local|anesthetics, local|mesh-ancestor
64945623|NCT05402553|Serotonin Agents|serotonin agents|mesh-ancestor
64710697|NCT05828966|Anesthetics|anesthetics|mesh-ancestor
64710698|NCT05828966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64710699|NCT05828966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64710700|NCT05828966|Anticonvulsants|anticonvulsants|mesh-ancestor
64710701|NCT05828966|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64710702|NCT05828966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65177183|NCT01909089|Anesthetics|anesthetics|mesh-ancestor
65177184|NCT01909089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65177185|NCT01909089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177186|NCT01909089|Sensory System Agents|sensory system agents|mesh-ancestor
65177187|NCT01909089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65177189|NCT02844790|Insulin Aspart|insulin aspart|mesh-list
65177190|NCT02844790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65177191|NCT02844790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177192|NCT02856243|Antiviral Agents|antiviral agents|mesh-list
65177193|NCT02856243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65177194|NCT04410328|Aspirin|aspirin|mesh-list
65177195|NCT04410328|Dipyridamole|dipyridamole|mesh-list
65177196|NCT04410328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65177197|NCT04410328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65177198|NCT04410328|Analgesics|analgesics|mesh-ancestor
65177199|NCT04410328|Sensory System Agents|sensory system agents|mesh-ancestor
65177200|NCT04410328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65177201|NCT04410328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177202|NCT04410328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65177203|NCT04410328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65177204|NCT04410328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65325371|NCT00792935|Glimepiride|glimepiride|mesh-list
65325372|NCT00792935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65325373|NCT00792935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325374|NCT00792935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65325375|NCT00792935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65325376|NCT00792935|Immunologic Factors|immunologic factors|mesh-ancestor
65325377|NCT03904563|Bevacizumab|bevacizumab|mesh-list
65325378|NCT03904563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65177205|NCT04410328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65177206|NCT04410328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177207|NCT04410328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65177208|NCT04410328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65177209|NCT04410328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177218|NCT02852577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177219|NCT02852577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65177220|NCT02852577|Serotonin Agents|serotonin agents|mesh-ancestor
65177221|NCT02852577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177222|NCT02852577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65177223|NCT02852577|Antidepressive Agents|antidepressive agents|mesh-ancestor
65177224|NCT02852577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65177225|NCT02852577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65177226|NCT02852577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65177227|NCT02852577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177228|NCT02852577|Anticonvulsants|anticonvulsants|mesh-ancestor
65177229|NCT02852577|GABA Modulators|gaba modulators|mesh-ancestor
65177231|NCT00902044|Cyclophosphamide|cyclophosphamide|mesh-list
65177232|NCT00902044|Fludarabine|fludarabine|mesh-list
65177233|NCT00902044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65177234|NCT00902044|Immunologic Factors|immunologic factors|mesh-ancestor
65177235|NCT00902044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177236|NCT00902044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65177237|NCT00902044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65177238|NCT00902044|Alkylating Agents|alkylating agents|mesh-ancestor
65177239|NCT00902044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177240|NCT00902044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177241|NCT00902044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65177242|NCT04201990|Apatinib|apatinib|mesh-list
65177243|NCT04201990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177244|NCT04201990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65177245|NCT04201990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177246|NCT04201990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177247|NCT00632866|Hydroxychloroquine|hydroxychloroquine|mesh-list
65177248|NCT00632866|Antimalarials|antimalarials|mesh-ancestor
65177249|NCT00632866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65177250|NCT00632866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65177251|NCT00632866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65177252|NCT00632866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177253|NCT00632866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177254|NCT00632866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65177255|NCT00901186|Ranibizumab|ranibizumab|mesh-list
65177256|NCT00901186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64710789|NCT05828147|Rituximab|rituximab|mesh-list
65177257|NCT00901186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65177258|NCT00901186|Growth Substances|growth substances|mesh-ancestor
65177259|NCT00901186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177260|NCT00901186|Growth Inhibitors|growth inhibitors|mesh-ancestor
65177261|NCT00901186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177262|NCT05040880|Telmisartan|telmisartan|mesh-list
65177263|NCT05040880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65177264|NCT05040880|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65177265|NCT05040880|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65177266|NCT05040880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177267|NCT04073290|Rifaximin|rifaximin|mesh-list
65177268|NCT04073290|Lactulose|lactulose|mesh-list
65177269|NCT04073290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65177270|NCT04073290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65325379|NCT03904563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325380|NCT03904563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65325381|NCT03904563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65325382|NCT03904563|Growth Substances|growth substances|mesh-ancestor
65325383|NCT03904563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325384|NCT03904563|Growth Inhibitors|growth inhibitors|mesh-ancestor
65325385|NCT00770510|Zolpidem|zolpidem|mesh-list
65325386|NCT00770510|Eszopiclone|eszopiclone|mesh-list
65325387|NCT00770510|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65325388|NCT00770510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65177271|NCT04073290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65177272|NCT03763162|Dexamethasone|dexamethasone|mesh-list
65177273|NCT03763162|Dexamethasone acetate|dexamethasone acetate|mesh-list
65177274|NCT03763162|Bortezomib|bortezomib|mesh-list
65177275|NCT03763162|Daratumumab|daratumumab|mesh-list
65177276|NCT03763162|Ixazomib|ixazomib|mesh-list
65177284|NCT03763162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177285|NCT03763162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65177286|NCT03763162|Glucocorticoids|glucocorticoids|mesh-ancestor
65177287|NCT03763162|Hormones|hormones|mesh-ancestor
65177288|NCT03763162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65177289|NCT03763162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65177290|NCT03763162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177291|NCT03763162|Protease Inhibitors|protease inhibitors|mesh-ancestor
65177292|NCT03763162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177293|NCT03763162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177294|NCT03763162|Dermatologic Agents|dermatologic agents|mesh-ancestor
65177295|NCT03763162|Glycine Agents|glycine agents|mesh-ancestor
65177296|NCT03763162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65177297|NCT03936790|Fentanyl|fentanyl|mesh-list
65177298|NCT03936790|Ropivacaine|ropivacaine|mesh-list
65177299|NCT03936790|Anesthetics, Local|anesthetics, local|mesh-ancestor
65177300|NCT03936790|Anesthetics|anesthetics|mesh-ancestor
65177301|NCT03936790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65177302|NCT03936790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177303|NCT03936790|Sensory System Agents|sensory system agents|mesh-ancestor
65177304|NCT03936790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65177305|NCT03936790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64819848|NCT01507597|Glucagon|glucagon|mesh-list
65177306|NCT03936790|Narcotics|narcotics|mesh-ancestor
65177308|NCT03936790|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65177309|NCT03936790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65177310|NCT03936790|Anesthetics, General|anesthetics, general|mesh-ancestor
65177311|NCT04782700|Prednisone|prednisone|mesh-list
65177312|NCT04782700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65177313|NCT04782700|Glucocorticoids|glucocorticoids|mesh-ancestor
65177314|NCT04782700|Hormones|hormones|mesh-ancestor
65177315|NCT04782700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65177316|NCT04782700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177317|NCT04782700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65177318|NCT04782700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177319|NCT03711448|Prednisone|prednisone|mesh-list
65177320|NCT03711448|Ustekinumab|ustekinumab|mesh-list
65177321|NCT03711448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65177322|NCT03711448|Glucocorticoids|glucocorticoids|mesh-ancestor
65177323|NCT03711448|Hormones|hormones|mesh-ancestor
65177324|NCT03711448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65177325|NCT03711448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177326|NCT03711448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65177327|NCT03711448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177328|NCT03711448|Dermatologic Agents|dermatologic agents|mesh-ancestor
65177329|NCT00885703|Fluconazole|fluconazole|mesh-list
65177330|NCT00885703|Amphotericin B|amphotericin b|mesh-list
65177331|NCT00885703|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64710845|NCT05827549|Blinatumomab|blinatumomab|mesh-list
65177332|NCT00885703|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
65177334|NCT00885703|Antifungal Agents|antifungal agents|mesh-ancestor
65325389|NCT00770510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65325390|NCT00770510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325391|NCT00770510|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64555009|NCT04196231|Insulin|insulin|mesh-list
65177335|NCT00885703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65177336|NCT00885703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65177337|NCT00885703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65177338|NCT00885703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177339|NCT00885703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177340|NCT00885703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65177341|NCT00885703|Hormone Antagonists|hormone antagonists|mesh-ancestor
65177342|NCT00885703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65177343|NCT00885703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177344|NCT00885703|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65177345|NCT00885703|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65177355|NCT02642419|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65177356|NCT02642419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65177357|NCT02642419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65177358|NCT02642419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65177359|NCT02642419|Analgesics|analgesics|mesh-ancestor
65177360|NCT02642419|Sensory System Agents|sensory system agents|mesh-ancestor
65177361|NCT02642419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65177362|NCT02642419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177363|NCT02642419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65177364|NCT02642419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65177365|NCT02642419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65177366|NCT02642419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65177367|NCT02642419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177368|NCT02642419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65177369|NCT02642419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177370|NCT02642419|Antipyretics|antipyretics|mesh-ancestor
65177371|NCT02642419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65177372|NCT02642419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65177373|NCT02642419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65177374|NCT02642419|Purinergic Agents|purinergic agents|mesh-ancestor
65177375|NCT02642419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65177376|NCT02642419|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65177377|NCT02642419|Antithrombins|antithrombins|mesh-ancestor
65177378|NCT02642419|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65177379|NCT02642419|Protease Inhibitors|protease inhibitors|mesh-ancestor
64819945|NCT01508104|Everolimus|everolimus|mesh-list
65177380|NCT02642419|Anticoagulants|anticoagulants|mesh-ancestor
65177381|NCT00901576|Methylphenidate|methylphenidate|mesh-list
65177382|NCT00901576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65177383|NCT00901576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177384|NCT00901576|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65177385|NCT00901576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65177386|NCT00901576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65177387|NCT00901576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177388|NCT00901576|Dopamine Agents|dopamine agents|mesh-ancestor
65177389|NCT00901576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65177390|NCT00655837|Gemcitabine|gemcitabine|mesh-list
65177392|NCT00655837|Dacetuzumab|dacetuzumab|mesh-list
65177393|NCT00655837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65177394|NCT00655837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177395|NCT00655837|Immunologic Factors|immunologic factors|mesh-ancestor
65177396|NCT00655837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177397|NCT00655837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65177398|NCT00655837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65177399|NCT00655837|Antimetabolites|antimetabolites|mesh-ancestor
65177400|NCT00655837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177401|NCT00655837|Antiviral Agents|antiviral agents|mesh-ancestor
65177402|NCT00655837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65177403|NCT00655837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177404|NCT00655837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65177405|NCT00655915|Betamethasone|betamethasone|mesh-list
65177406|NCT00655915|Lidocaine|lidocaine|mesh-list
65177407|NCT00655915|Anesthetics, Local|anesthetics, local|mesh-ancestor
65325392|NCT00770510|GABA Agonists|gaba agonists|mesh-ancestor
65325393|NCT00770510|GABA Agents|gaba agents|mesh-ancestor
65325394|NCT00770510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65325395|NCT00770510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325396|NCT04077255|Paclitaxel|paclitaxel|mesh-list
65325397|NCT04077255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65325398|NCT04077255|Antibodies|antibodies|mesh-list
65177408|NCT00655915|Anesthetics|anesthetics|mesh-ancestor
65177409|NCT00655915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65177410|NCT00655915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177411|NCT00655915|Sensory System Agents|sensory system agents|mesh-ancestor
65177412|NCT00655915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65177417|NCT00655915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177418|NCT00655915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65177419|NCT00655915|Glucocorticoids|glucocorticoids|mesh-ancestor
65177420|NCT00655915|Hormones|hormones|mesh-ancestor
65177421|NCT00655915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65177422|NCT00655915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65177423|NCT00655915|Respiratory System Agents|respiratory system agents|mesh-ancestor
65177424|NCT02637193|Moxifloxacin|moxifloxacin|mesh-list
65177425|NCT02637193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65177426|NCT02637193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65177427|NCT02637193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65177428|NCT02637193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65177429|NCT02637193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65177430|NCT02637193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177431|NCT02637193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177432|NCT02637193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177433|NCT02637193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177434|NCT02637193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65177435|NCT02637193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65177436|NCT02637193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65177437|NCT02637193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65177438|NCT02637193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65177439|NCT02637193|Antidepressive Agents|antidepressive agents|mesh-ancestor
65177440|NCT02637193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65177441|NCT00656773|Sufentanil|sufentanil|mesh-list
65177442|NCT00656773|Morphine|morphine|mesh-list
65177443|NCT00656773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65177444|NCT00656773|Narcotics|narcotics|mesh-ancestor
65177445|NCT00656773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65177446|NCT00656773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177447|NCT00656773|Analgesics|analgesics|mesh-ancestor
65177448|NCT00656773|Sensory System Agents|sensory system agents|mesh-ancestor
65177449|NCT00656773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65177450|NCT00656773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65177451|NCT00656773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64820000|NCT01508286|Ribavirin|ribavirin|mesh-list
65177452|NCT00656773|Anesthetics, General|anesthetics, general|mesh-ancestor
65177453|NCT00656773|Anesthetics|anesthetics|mesh-ancestor
65177455|NCT00882583|Cetuximab|cetuximab|mesh-list
65177456|NCT00882583|Dasatinib|dasatinib|mesh-list
65177457|NCT00882583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64710996|NCT05786066|Anesthetics|anesthetics|mesh-ancestor
65177458|NCT00882583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65177459|NCT00882583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65177460|NCT00882583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177461|NCT00882583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177462|NCT04481308|Fentanyl|fentanyl|mesh-list
65177463|NCT04481308|Propofol|propofol|mesh-list
65177464|NCT04481308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65177465|NCT04481308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65177466|NCT04481308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177467|NCT04481308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65177468|NCT04481308|Anesthetics, General|anesthetics, general|mesh-ancestor
65177469|NCT04481308|Anesthetics|anesthetics|mesh-ancestor
65177470|NCT04481308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65177471|NCT04481308|Narcotics|narcotics|mesh-ancestor
65177472|NCT04481308|Analgesics|analgesics|mesh-ancestor
65325399|NCT04077255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65325400|NCT04077255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325401|NCT04077255|Tubulin Modulators|tubulin modulators|mesh-ancestor
65325402|NCT04077255|Antimitotic Agents|antimitotic agents|mesh-ancestor
65325403|NCT04077255|Mitosis Modulators|mitosis modulators|mesh-ancestor
65325404|NCT04077255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325405|NCT04077255|Immunologic Factors|immunologic factors|mesh-ancestor
65325406|NCT04077255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325407|NCT00770432|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65177473|NCT04481308|Sensory System Agents|sensory system agents|mesh-ancestor
65177474|NCT04481308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65177475|NCT04481308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65177476|NCT02634541|Adalimumab|adalimumab|mesh-list
65177477|NCT02634541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65177478|NCT02634541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65177479|NCT04475848|Midazolam|midazolam|mesh-list
65177480|NCT04475848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65177481|NCT04475848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65177482|NCT04475848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65177486|NCT04475848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65177487|NCT04475848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65177488|NCT04475848|Anesthetics, General|anesthetics, general|mesh-ancestor
65177489|NCT04475848|Anesthetics|anesthetics|mesh-ancestor
65177490|NCT04475848|GABA Modulators|gaba modulators|mesh-ancestor
65177491|NCT04475848|GABA Agents|gaba agents|mesh-ancestor
65177492|NCT04475848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65177493|NCT04475848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177494|NCT00599521|Adapalene|adapalene|mesh-list
65177495|NCT00599521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65177496|NCT00599521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65177497|NCT00599521|Analgesics|analgesics|mesh-ancestor
65177498|NCT00599521|Sensory System Agents|sensory system agents|mesh-ancestor
65177499|NCT00599521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65177500|NCT00599521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177501|NCT00599521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65177502|NCT00599521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65177503|NCT00599521|Dermatologic Agents|dermatologic agents|mesh-ancestor
65177504|NCT04201678|Anesthetics|anesthetics|mesh-list
65177505|NCT04201678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65177506|NCT04201678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177507|NCT00653341|Insulin|insulin|mesh-list
65177508|NCT00653341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65177509|NCT00653341|Insulin Glargine|insulin glargine|mesh-list
65177510|NCT00653341|Isophane Insulin, Human|isophane insulin, human|mesh-list
65177511|NCT00653341|Insulin, Isophane|insulin, isophane|mesh-list
65177512|NCT00653341|Isophane insulin, beef|isophane insulin, beef|mesh-list
65177513|NCT00653341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65177514|NCT00653341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177515|NCT02642263|Carbetocin|carbetocin|mesh-list
65177516|NCT02642263|Oxytocics|oxytocics|mesh-ancestor
65177517|NCT02642263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65177518|NCT02642263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177519|NCT00779740|Mometasone Furoate|mometasone furoate|mesh-list
65177520|NCT00779740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65177521|NCT00779740|Dermatologic Agents|dermatologic agents|mesh-ancestor
65177522|NCT00779740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65177523|NCT02636803|Albendazole|albendazole|mesh-list
65177524|NCT02636803|Oxfendazole|oxfendazole|mesh-list
65177525|NCT02636803|Anthelmintics|anthelmintics|mesh-ancestor
65177526|NCT02636803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65177527|NCT02636803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65177528|NCT02636803|Anticestodal Agents|anticestodal agents|mesh-ancestor
65177529|NCT02636803|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65177530|NCT02636803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65177531|NCT02636803|Tubulin Modulators|tubulin modulators|mesh-ancestor
65177532|NCT02636803|Antimitotic Agents|antimitotic agents|mesh-ancestor
65177533|NCT02636803|Mitosis Modulators|mitosis modulators|mesh-ancestor
65325408|NCT00770432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65325409|NCT00770432|Laxatives|laxatives|mesh-ancestor
65325410|NCT00770432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65325411|NCT00792701|Gemcitabine|gemcitabine|mesh-list
65325412|NCT00792701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325413|NCT00792701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65177534|NCT02636803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177535|NCT02636803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177536|NCT02636803|Antinematodal Agents|antinematodal agents|mesh-ancestor
65177538|NCT02634463|Risperidone|risperidone|mesh-list
65177539|NCT02634463|Aripiprazole|aripiprazole|mesh-list
65177540|NCT02634463|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65177541|NCT02634463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65177542|NCT02634463|Serotonin Agents|serotonin agents|mesh-ancestor
65177543|NCT02634463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65177544|NCT02634463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177545|NCT02634463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177546|NCT02634463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65177547|NCT02634463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65177548|NCT02634463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65177549|NCT02634463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65177550|NCT02634463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65177551|NCT02634463|Dopamine Agents|dopamine agents|mesh-ancestor
65177552|NCT02634463|Antiemetics|antiemetics|mesh-ancestor
65177553|NCT02634463|Autonomic Agents|autonomic agents|mesh-ancestor
65177554|NCT02634463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65177555|NCT02634463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65177556|NCT02634463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65177557|NCT02634463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65177562|NCT02634463|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65177563|NCT02634463|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65177564|NCT02634463|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65177565|NCT00882115|Sulforaphane|sulforaphane|mesh-list
65177566|NCT00882115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65177567|NCT00882115|Protective Agents|protective agents|mesh-ancestor
65177568|NCT00882115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177569|NCT00882115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177570|NCT00653419|Buspirone|buspirone|mesh-list
65177571|NCT00653419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65177572|NCT00653419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65177573|NCT00653419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65177574|NCT00653419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177575|NCT00653419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65177576|NCT00653419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65177577|NCT00653419|Serotonin Agents|serotonin agents|mesh-ancestor
65177578|NCT00653419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65177579|NCT00653419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177580|NCT00884377|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
65177581|NCT00884377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65177582|NCT00884377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65177583|NCT00884377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65177584|NCT00884377|Schistosomicides|schistosomicides|mesh-ancestor
65177585|NCT00884377|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65177586|NCT00884377|Anthelmintics|anthelmintics|mesh-ancestor
65177587|NCT00656929|Vitamin D|vitamin d|mesh-list
65177588|NCT00656929|Cholecalciferol|cholecalciferol|mesh-list
65177589|NCT00656929|Vitamins|vitamins|mesh-ancestor
65177590|NCT00656929|Micronutrients|micronutrients|mesh-ancestor
65177591|NCT00656929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177592|NCT00656929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65177593|NCT00656929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65177594|NCT00884221|Menotropins|menotropins|mesh-list
65177595|NCT00884221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65177596|NCT00884221|Fertility Agents|fertility agents|mesh-ancestor
65177597|NCT00884221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65177598|NCT00884221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177599|NCT02153632|Amantadine|amantadine|mesh-list
65177600|NCT02153632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65177601|NCT02153632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65177602|NCT02153632|Antiviral Agents|antiviral agents|mesh-ancestor
65325414|NCT00792701|Antimetabolites|antimetabolites|mesh-ancestor
65325415|NCT00792701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325416|NCT00792701|Antiviral Agents|antiviral agents|mesh-ancestor
65325417|NCT00792701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65325418|NCT00792701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325419|NCT00792701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65177603|NCT02153632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65177604|NCT02153632|Dopamine Agents|dopamine agents|mesh-ancestor
65177605|NCT02153632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65177606|NCT02153632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177607|NCT02153632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177608|NCT02153632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65177609|NCT02153632|Analgesics|analgesics|mesh-ancestor
65177610|NCT02153632|Sensory System Agents|sensory system agents|mesh-ancestor
65177611|NCT02153632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65177612|NCT01934452|Sunitinib|sunitinib|mesh-list
65177613|NCT01934452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177614|NCT01934452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65177615|NCT01934452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65177616|NCT01934452|Growth Substances|growth substances|mesh-ancestor
65177617|NCT01934452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177618|NCT01934452|Growth Inhibitors|growth inhibitors|mesh-ancestor
65177619|NCT01934452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65177620|NCT01934452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177621|NCT01934452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177622|NCT03524326|Cetuximab|cetuximab|mesh-list
65177623|NCT03524326|Lenvatinib|lenvatinib|mesh-list
65177624|NCT03524326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65177625|NCT03524326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177626|NCT03524326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65177627|NCT03524326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177628|NCT03524326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177637|NCT01236430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177639|NCT00726856|Fenofibrate|fenofibrate|mesh-list
65177640|NCT00726856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65177641|NCT00726856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65177642|NCT00726856|Antimetabolites|antimetabolites|mesh-ancestor
65177643|NCT00726856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177644|NCT00726856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65177645|NCT00651274|Ezetimibe|ezetimibe|mesh-list
65177646|NCT00651274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65177647|NCT00651274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65177648|NCT00651274|Antimetabolites|antimetabolites|mesh-ancestor
65177649|NCT00651274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177650|NCT00651274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65177651|NCT04608448|Sirolimus|sirolimus|mesh-list
65177652|NCT04608448|Petrolatum|petrolatum|mesh-list
65177653|NCT04608448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65177654|NCT04608448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65177655|NCT04608448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65177656|NCT04608448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177657|NCT04608448|Antifungal Agents|antifungal agents|mesh-ancestor
65177658|NCT04608448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65177659|NCT04608448|Immunologic Factors|immunologic factors|mesh-ancestor
65177660|NCT04608448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177661|NCT04608448|Emollients|emollients|mesh-ancestor
65177662|NCT04608448|Dermatologic Agents|dermatologic agents|mesh-ancestor
65177663|NCT00212836|Olanzapine|olanzapine|mesh-list
65177664|NCT00212836|Asenapine|asenapine|mesh-list
65177665|NCT00212836|Antiemetics|antiemetics|mesh-ancestor
65177666|NCT00212836|Autonomic Agents|autonomic agents|mesh-ancestor
65177667|NCT00212836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65177668|NCT00212836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177669|NCT00212836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65177670|NCT00212836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65177671|NCT00212836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65177672|NCT00212836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65177673|NCT00212836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65177674|NCT00212836|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65325420|NCT00792701|Immunologic Factors|immunologic factors|mesh-ancestor
65325421|NCT00792701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325422|NCT03772353|Letrozole|letrozole|mesh-list
65325423|NCT03772353|Fulvestrant|fulvestrant|mesh-list
65325424|NCT03772353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325425|NCT03772353|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65325426|NCT03772353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65177675|NCT00212836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65177676|NCT00212836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65177677|NCT00212836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177678|NCT00212836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65177679|NCT00212836|Serotonin Agents|serotonin agents|mesh-ancestor
65177680|NCT00805324|Desloratadine|desloratadine|mesh-list
65177681|NCT00805324|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65177682|NCT00805324|Cholinergic Agents|cholinergic agents|mesh-ancestor
65177683|NCT00805324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65177684|NCT00805324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177685|NCT00805324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177686|NCT00805324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65177687|NCT00805324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65177688|NCT00805324|Histamine Antagonists|histamine antagonists|mesh-ancestor
65177689|NCT00805324|Histamine Agents|histamine agents|mesh-ancestor
65177690|NCT00157924|Atorvastatin|atorvastatin|mesh-list
65177691|NCT00157924|Simvastatin|simvastatin|mesh-list
65177692|NCT00157924|Ezetimibe|ezetimibe|mesh-list
65177693|NCT00157924|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65177694|NCT00157924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65177695|NCT00157924|Antimetabolites|antimetabolites|mesh-ancestor
65177702|NCT00794794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65177703|NCT00794794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65177704|NCT00794794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65177705|NCT00794794|Histamine Antagonists|histamine antagonists|mesh-ancestor
65177706|NCT00794794|Histamine Agents|histamine agents|mesh-ancestor
65177707|NCT00794794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65177708|NCT00794794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177709|NCT00794794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177710|NCT00794794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65177711|NCT00794794|Cholinergic Agents|cholinergic agents|mesh-ancestor
65177713|NCT03612466|Calcium Carbonate|calcium carbonate|mesh-list
65177714|NCT03612466|Calcium|calcium|mesh-list
65177715|NCT03612466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65177716|NCT03612466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177717|NCT03612466|Antacids|antacids|mesh-ancestor
65177718|NCT03612466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177719|NCT03612466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65177720|NCT03612466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65177721|NCT03612466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65177722|NCT03612466|Antiviral Agents|antiviral agents|mesh-ancestor
65177723|NCT03612466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65177724|NCT00142558|Indomethacin|indomethacin|mesh-list
65177725|NCT00142558|Etoricoxib|etoricoxib|mesh-list
65177726|NCT00142558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177727|NCT00142558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177728|NCT00142558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65177729|NCT00142558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65177730|NCT00142558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65177731|NCT00142558|Analgesics|analgesics|mesh-ancestor
65177732|NCT00142558|Sensory System Agents|sensory system agents|mesh-ancestor
65177733|NCT00142558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65177734|NCT00142558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65177735|NCT00142558|Gout Suppressants|gout suppressants|mesh-ancestor
65177736|NCT00142558|Tocolytic Agents|tocolytic agents|mesh-ancestor
65177737|NCT00142558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65177738|NCT00142558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65177739|NCT00142558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177740|NCT00142558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65177741|NCT02842294|Bevacizumab|bevacizumab|mesh-list
65177742|NCT02842294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65325427|NCT03772353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325428|NCT03772353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325429|NCT03772353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65177743|NCT02842294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177744|NCT02842294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65177745|NCT02842294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65177746|NCT02842294|Growth Substances|growth substances|mesh-ancestor
65177747|NCT02842294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177748|NCT02842294|Growth Inhibitors|growth inhibitors|mesh-ancestor
65177749|NCT02841982|Morphine|morphine|mesh-list
65177750|NCT02841982|Ropivacaine|ropivacaine|mesh-list
65177751|NCT02841982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65177752|NCT02841982|Narcotics|narcotics|mesh-ancestor
65177753|NCT02841982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65177754|NCT02841982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177755|NCT02841982|Analgesics|analgesics|mesh-ancestor
65177756|NCT02841982|Sensory System Agents|sensory system agents|mesh-ancestor
65177757|NCT02841982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65177758|NCT02841982|Anesthetics, Local|anesthetics, local|mesh-ancestor
65177759|NCT02841982|Anesthetics|anesthetics|mesh-ancestor
65177760|NCT02843698|Dexmedetomidine|dexmedetomidine|mesh-list
65177761|NCT02843698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65177762|NCT02843698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65177763|NCT02843698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177764|NCT02843698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65177769|NCT02843698|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65177771|NCT02843698|Adrenergic Agents|adrenergic agents|mesh-ancestor
65177772|NCT02843698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65177773|NCT02843698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177774|NCT00690898|Lanreotide|lanreotide|mesh-list
65177775|NCT00690898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177776|NCT02841202|Contraceptive Agents|contraceptive agents|mesh-list
65177777|NCT02841202|Contraceptives, Oral|contraceptives, oral|mesh-list
65177778|NCT02841202|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65177779|NCT02841202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65177780|NCT02841202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177781|NCT02841202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65177782|NCT00895414|Doxorubicin|doxorubicin|mesh-list
65177783|NCT00895414|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65177784|NCT00895414|Enalapril|enalapril|mesh-list
65177785|NCT00895414|Enalaprilat|enalaprilat|mesh-list
65177786|NCT00895414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65177787|NCT00895414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177788|NCT00895414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65177789|NCT00895414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65177791|NCT00895414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177792|NCT00895414|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65177793|NCT00895414|Protease Inhibitors|protease inhibitors|mesh-ancestor
65177794|NCT00895414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65177795|NCT01822288|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65177796|NCT01822288|Tibolone|tibolone|mesh-list
65177797|NCT01822288|Medroxyprogesterone|medroxyprogesterone|mesh-list
65177798|NCT01822288|Estradiol|estradiol|mesh-list
65177799|NCT01822288|Estrogens|estrogens|mesh-ancestor
65177800|NCT01822288|Hormones|hormones|mesh-ancestor
65177801|NCT01822288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65177802|NCT01822288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177803|NCT01822288|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65177804|NCT01822288|Contraceptive Agents|contraceptive agents|mesh-ancestor
65177805|NCT01822288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65177806|NCT01822288|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65177807|NCT01822288|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65177808|NCT01822288|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65177809|NCT01822288|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65177810|NCT01822288|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65177811|NCT01822288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65177812|NCT01822288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177813|NCT01822288|Androgen Antagonists|androgen antagonists|mesh-ancestor
65177814|NCT01822288|Hormone Antagonists|hormone antagonists|mesh-ancestor
65177815|NCT01822288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65177816|NCT01822288|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65325430|NCT03772353|Hormone Antagonists|hormone antagonists|mesh-ancestor
65325431|NCT03772353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65325432|NCT03772353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325433|NCT03772353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65325434|NCT03772353|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65325435|NCT05559983|Aluminum phosphate|aluminum phosphate|mesh-list
65325436|NCT05559983|Vaccines|vaccines|mesh-list
64555047|NCT04195373|Antimetabolites|antimetabolites|mesh-ancestor
65177817|NCT01822288|Anabolic Agents|anabolic agents|mesh-ancestor
65177818|NCT01328626|Venetoclax|venetoclax|mesh-list
65177819|NCT01328626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177820|NCT01212770|Thalidomide|thalidomide|mesh-list
65177821|NCT01212770|Apremilast|apremilast|mesh-list
65177822|NCT01212770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65177823|NCT01212770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65177824|NCT01212770|Analgesics|analgesics|mesh-ancestor
65177825|NCT01212770|Sensory System Agents|sensory system agents|mesh-ancestor
65177826|NCT01212770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65177827|NCT01212770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711448|NCT05400369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65177828|NCT01212770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65177829|NCT01212770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65177830|NCT01212770|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65177831|NCT01212770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64820375|NCT01510613|Autonomic Agents|autonomic agents|mesh-ancestor
65177832|NCT01212770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177833|NCT01212770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177841|NCT01212770|Growth Substances|growth substances|mesh-ancestor
65177842|NCT01212770|Growth Inhibitors|growth inhibitors|mesh-ancestor
65177843|NCT01212770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177844|NCT05334316|Dexamethasone|dexamethasone|mesh-list
65177845|NCT05334316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65177846|NCT05334316|Antiemetics|antiemetics|mesh-ancestor
65177847|NCT05334316|Autonomic Agents|autonomic agents|mesh-ancestor
65177848|NCT05334316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65177849|NCT05334316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177850|NCT05334316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65177851|NCT05334316|Glucocorticoids|glucocorticoids|mesh-ancestor
65177853|NCT05334316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65177854|NCT05334316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65177855|NCT05334316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177856|NCT00598273|Darbepoetin alfa|darbepoetin alfa|mesh-list
65177857|NCT00598273|Hematinics|hematinics|mesh-ancestor
65177858|NCT02636491|Insulin|insulin|mesh-list
65177859|NCT02636491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65177860|NCT02636491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65177861|NCT02636491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177862|NCT00657007|Belimumab|belimumab|mesh-list
65177863|NCT00657007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65177864|NCT00657007|Immunologic Factors|immunologic factors|mesh-ancestor
65177865|NCT00657007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177866|NCT04318652|Methylprednisolone|methylprednisolone|mesh-list
65177867|NCT04318652|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65177868|NCT04318652|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65177869|NCT04318652|Prednisolone|prednisolone|mesh-list
65177870|NCT04318652|Prednisolone acetate|prednisolone acetate|mesh-list
65177871|NCT04318652|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65177872|NCT04318652|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65177873|NCT04318652|Prednisolone phosphate|prednisolone phosphate|mesh-list
65177874|NCT04318652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65177875|NCT04318652|Antiemetics|antiemetics|mesh-ancestor
65177876|NCT04318652|Autonomic Agents|autonomic agents|mesh-ancestor
65177877|NCT04318652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65177878|NCT04318652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177879|NCT04318652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65177880|NCT04318652|Glucocorticoids|glucocorticoids|mesh-ancestor
65177881|NCT04318652|Hormones|hormones|mesh-ancestor
65222847|NCT02586181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65325437|NCT05559983|Immunologic Factors|immunologic factors|mesh-ancestor
65325438|NCT05559983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325439|NCT05559983|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65325440|NCT05559983|Antacids|antacids|mesh-ancestor
65325441|NCT05559983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177882|NCT04318652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65177883|NCT04318652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65177884|NCT04318652|Protective Agents|protective agents|mesh-ancestor
65177885|NCT04318652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65177886|NCT04318652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177887|NCT04318652|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65177888|NCT02633995|Anesthetics|anesthetics|mesh-list
65177889|NCT02633995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65177890|NCT02633995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177891|NCT02633683|Gabapentin|gabapentin|mesh-list
65177892|NCT02633683|Analgesics|analgesics|mesh-ancestor
65177893|NCT02633683|Sensory System Agents|sensory system agents|mesh-ancestor
65177894|NCT02633683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65177895|NCT02633683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177896|NCT02633683|Anticonvulsants|anticonvulsants|mesh-ancestor
65177897|NCT02633683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65177898|NCT02633683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65177899|NCT02633683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65177900|NCT02633683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65177901|NCT02633683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65177902|NCT02633683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65177903|NCT02633683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65177907|NCT01211522|Haloperidol decanoate|haloperidol decanoate|mesh-list
65177908|NCT01211522|Ziprasidone|ziprasidone|mesh-list
65177909|NCT01211522|Antiemetics|antiemetics|mesh-ancestor
65177910|NCT01211522|Autonomic Agents|autonomic agents|mesh-ancestor
65177911|NCT01211522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65177912|NCT01211522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177913|NCT01211522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65177914|NCT01211522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65177915|NCT01211522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65177916|NCT01211522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65177917|NCT01211522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65177918|NCT01211522|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65177919|NCT01211522|Dopamine Agents|dopamine agents|mesh-ancestor
65177920|NCT01211522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65177921|NCT01211522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177922|NCT01211522|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65177923|NCT01211522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65177924|NCT01211522|Serotonin Agents|serotonin agents|mesh-ancestor
65177925|NCT05404724|Itraconazole|itraconazole|mesh-list
65177926|NCT05404724|Antifungal Agents|antifungal agents|mesh-ancestor
65177927|NCT05404724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65177928|NCT05404724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65177929|NCT05404724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65177930|NCT05404724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177931|NCT05404724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177932|NCT05404724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65177933|NCT05404724|Hormone Antagonists|hormone antagonists|mesh-ancestor
65177934|NCT05404724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65177935|NCT05404724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177936|NCT05404724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65177937|NCT03314935|Leucovorin|leucovorin|mesh-list
65177938|NCT03314935|Gemcitabine|gemcitabine|mesh-list
65177939|NCT03314935|Paclitaxel|paclitaxel|mesh-list
65177940|NCT03314935|Fluorouracil|fluorouracil|mesh-list
65177941|NCT03314935|Oxaliplatin|oxaliplatin|mesh-list
65177942|NCT03314935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65177943|NCT03314935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177944|NCT03314935|Tubulin Modulators|tubulin modulators|mesh-ancestor
65177945|NCT03314935|Antimitotic Agents|antimitotic agents|mesh-ancestor
65177946|NCT03314935|Mitosis Modulators|mitosis modulators|mesh-ancestor
65177947|NCT03314935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325442|NCT05559983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65325443|NCT03765567|Vancomycin|vancomycin|mesh-list
65325444|NCT03765567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65325445|NCT03765567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65325446|NCT00777296|Amikacin|amikacin|mesh-list
65325447|NCT00777296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65325448|NCT00777296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65177948|NCT03314935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65177949|NCT03314935|Antimetabolites|antimetabolites|mesh-ancestor
65177950|NCT03314935|Antiviral Agents|antiviral agents|mesh-ancestor
65177951|NCT03314935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65177952|NCT03314935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177953|NCT03314935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65177954|NCT03314935|Immunologic Factors|immunologic factors|mesh-ancestor
65177955|NCT03314935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177956|NCT03314935|Antidotes|antidotes|mesh-ancestor
65177957|NCT03314935|Protective Agents|protective agents|mesh-ancestor
65177958|NCT03314935|Vitamin B Complex|vitamin b complex|mesh-ancestor
65177959|NCT03314935|Vitamins|vitamins|mesh-ancestor
65177960|NCT03314935|Micronutrients|micronutrients|mesh-ancestor
65177961|NCT02633761|Misoprostol|misoprostol|mesh-list
65177962|NCT02633761|Mifepristone|mifepristone|mesh-list
64711599|NCT05322252|Mifepristone|mifepristone|mesh-list
65177963|NCT02633761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65177964|NCT02633761|Abortifacient Agents|abortifacient agents|mesh-ancestor
65177965|NCT02633761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65177966|NCT02633761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177967|NCT02633761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65177968|NCT02633761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65177969|NCT02633761|Oxytocics|oxytocics|mesh-ancestor
65177970|NCT02633761|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65177971|NCT02633761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65177972|NCT02633761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65177973|NCT02633761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65177974|NCT02633761|Contraceptive Agents|contraceptive agents|mesh-ancestor
65177975|NCT02633761|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65177980|NCT02633761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65177981|NCT02633761|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65177982|NCT02633839|Carbidopa|carbidopa|mesh-list
65177983|NCT02633839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65177984|NCT02633839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65177985|NCT02633839|Dopamine Agents|dopamine agents|mesh-ancestor
65177986|NCT02633839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65177987|NCT02633839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177988|NCT02633839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177989|NCT02633839|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65177990|NCT02633839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177991|NCT02632903|Zoledronic Acid|zoledronic acid|mesh-list
65177992|NCT02632903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65177993|NCT02632903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177994|NCT00657397|Methadone|methadone|mesh-list
65177995|NCT00657397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65177996|NCT00657397|Narcotics|narcotics|mesh-ancestor
65177997|NCT00657397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65177998|NCT00657397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177999|NCT00657397|Analgesics|analgesics|mesh-ancestor
65178000|NCT00657397|Sensory System Agents|sensory system agents|mesh-ancestor
65178001|NCT00657397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65178002|NCT00657397|Antitussive Agents|antitussive agents|mesh-ancestor
65178003|NCT00657397|Respiratory System Agents|respiratory system agents|mesh-ancestor
65178004|NCT04160611|Midazolam|midazolam|mesh-list
65178005|NCT04160611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65178006|NCT04160611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65178007|NCT04160611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65178008|NCT04160611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178009|NCT04160611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65178010|NCT04160611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65178011|NCT04160611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65178012|NCT04160611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65178013|NCT04160611|Anesthetics, General|anesthetics, general|mesh-ancestor
65325449|NCT00756470|Paclitaxel|paclitaxel|mesh-list
65325450|NCT00756470|Cyclophosphamide|cyclophosphamide|mesh-list
65325451|NCT00756470|Fluorouracil|fluorouracil|mesh-list
65325452|NCT00756470|Epirubicin|epirubicin|mesh-list
65325453|NCT00756470|Lapatinib|lapatinib|mesh-list
64555066|NCT04194905|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65178014|NCT04160611|Anesthetics|anesthetics|mesh-ancestor
65178015|NCT04160611|GABA Modulators|gaba modulators|mesh-ancestor
65178016|NCT04160611|GABA Agents|gaba agents|mesh-ancestor
65178017|NCT04160611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65178018|NCT04160611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178019|NCT04161001|Amlodipine|amlodipine|mesh-list
65178020|NCT04161001|Olmesartan|olmesartan|mesh-list
65178021|NCT04161001|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65178022|NCT04161001|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
65178023|NCT04161001|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65178024|NCT04161001|Ezetimibe|ezetimibe|mesh-list
65178025|NCT04161001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65178026|NCT04161001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65178027|NCT04161001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65178028|NCT04161001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178029|NCT04161001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65178030|NCT04161001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178031|NCT04161001|Vasodilator Agents|vasodilator agents|mesh-ancestor
65178032|NCT04161001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65178033|NCT04161001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65178034|NCT04161001|Antimetabolites|antimetabolites|mesh-ancestor
65178035|NCT04161001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65178036|NCT04161001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65178037|NCT04161001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178038|NCT04161001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65178039|NCT04161001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65178040|NCT00881569|Efatutazone|efatutazone|mesh-list
65178041|NCT00881569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178042|NCT00657163|Fluoxetine|fluoxetine|mesh-list
65178043|NCT00657163|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65178044|NCT00657163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65178053|NCT00657163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65178054|NCT00657163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64820616|NCT01511692|Hormones|hormones|mesh-ancestor
65178055|NCT00657163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178056|NCT02636101|Betamethasone|betamethasone|mesh-list
65178057|NCT02636101|Betamethasone Valerate|betamethasone valerate|mesh-list
65178058|NCT02636101|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65178059|NCT02636101|Betamethasone benzoate|betamethasone benzoate|mesh-list
65178060|NCT02636101|Calcipotriene|calcipotriene|mesh-list
65178061|NCT02636101|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65178062|NCT02636101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65178063|NCT02636101|Glucocorticoids|glucocorticoids|mesh-ancestor
65178064|NCT02636101|Hormones|hormones|mesh-ancestor
65178065|NCT02636101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65178066|NCT02636101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178067|NCT02636101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65178068|NCT02636101|Respiratory System Agents|respiratory system agents|mesh-ancestor
65178069|NCT02636101|Dermatologic Agents|dermatologic agents|mesh-ancestor
65178070|NCT00657475|Heparin|heparin|mesh-list
65178071|NCT00657475|Calcium heparin|calcium heparin|mesh-list
65178072|NCT00657475|Anticoagulants|anticoagulants|mesh-ancestor
65178073|NCT00657475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65178074|NCT00657475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65178075|NCT00657475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178076|NCT00657319|Insulin Aspart|insulin aspart|mesh-list
65178077|NCT00657319|Biphasic Insulins|biphasic insulins|mesh-list
65178078|NCT00657319|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65178079|NCT00657319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65178080|NCT00657319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178081|NCT04159597|Upadacitinib|upadacitinib|mesh-list
65178082|NCT04159597|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65178083|NCT04159597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65178084|NCT04159597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325454|NCT00756470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65325455|NCT00756470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325456|NCT00756470|Tubulin Modulators|tubulin modulators|mesh-ancestor
65325457|NCT00756470|Antimitotic Agents|antimitotic agents|mesh-ancestor
65325458|NCT00756470|Mitosis Modulators|mitosis modulators|mesh-ancestor
65325459|NCT00756470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325460|NCT00756470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65325461|NCT00756470|Immunologic Factors|immunologic factors|mesh-ancestor
65325462|NCT00756470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325463|NCT00756470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65178085|NCT04159597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178086|NCT04159597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65178087|NCT00661219|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65178088|NCT00661219|Vasodilator Agents|vasodilator agents|mesh-ancestor
65178089|NCT00661219|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65178090|NCT00661219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65178091|NCT00661219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178092|NCT00661219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178093|NCT00661219|Urological Agents|urological agents|mesh-ancestor
65178094|NCT02382406|Paclitaxel|paclitaxel|mesh-list
65178095|NCT02382406|Carboplatin|carboplatin|mesh-list
65178096|NCT02382406|Pembrolizumab|pembrolizumab|mesh-list
65178097|NCT02382406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65178098|NCT02382406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178099|NCT02382406|Tubulin Modulators|tubulin modulators|mesh-ancestor
65178100|NCT02382406|Antimitotic Agents|antimitotic agents|mesh-ancestor
65178101|NCT02382406|Mitosis Modulators|mitosis modulators|mesh-ancestor
65178102|NCT02382406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178103|NCT02382406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65178104|NCT00665743|Naproxen|naproxen|mesh-list
65178105|NCT00665743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65178106|NCT00665743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65178107|NCT00665743|Analgesics|analgesics|mesh-ancestor
65178114|NCT00665743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65178115|NCT00665743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178116|NCT00665743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178117|NCT00661297|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65178118|NCT00661297|Vasodilator Agents|vasodilator agents|mesh-ancestor
65178119|NCT00661297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65178120|NCT00661297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65178121|NCT00661297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178122|NCT00661297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178123|NCT00661297|Urological Agents|urological agents|mesh-ancestor
65178124|NCT00879775|Sodium Benzoate|sodium benzoate|mesh-list
65178125|NCT00879775|Caffeine|caffeine|mesh-list
65178126|NCT00879775|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65178127|NCT00879775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178128|NCT00879775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65178129|NCT00879775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178130|NCT00879775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178131|NCT00879775|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65178132|NCT00879775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65178133|NCT00879775|Purinergic Agents|purinergic agents|mesh-ancestor
65178134|NCT00879775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65178135|NCT00879775|Antifungal Agents|antifungal agents|mesh-ancestor
65178136|NCT00879775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65178137|NCT00894790|Celecoxib|celecoxib|mesh-list
65178138|NCT00894790|Diclofenac|diclofenac|mesh-list
65178139|NCT00894790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65178140|NCT00894790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65178141|NCT00894790|Analgesics|analgesics|mesh-ancestor
65178142|NCT00894790|Sensory System Agents|sensory system agents|mesh-ancestor
65325464|NCT00756470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65325465|NCT00756470|Alkylating Agents|alkylating agents|mesh-ancestor
65325466|NCT00756470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65325467|NCT00756470|Antimetabolites|antimetabolites|mesh-ancestor
65325468|NCT00756470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65178143|NCT00894790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65178144|NCT00894790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178145|NCT00894790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65178146|NCT00894790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65178147|NCT00894790|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65178148|NCT00894790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65178149|NCT00894790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178150|NCT00894790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178151|NCT00665977|Triamcinolone|triamcinolone|mesh-list
65178152|NCT00665977|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65178153|NCT00665977|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65178154|NCT00665977|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65178155|NCT00665977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65178156|NCT00665977|Glucocorticoids|glucocorticoids|mesh-ancestor
65178157|NCT00665977|Hormones|hormones|mesh-ancestor
65178158|NCT00665977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65178159|NCT00665977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178160|NCT00665977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65178161|NCT00665977|Immunologic Factors|immunologic factors|mesh-ancestor
65178162|NCT00665977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178163|NCT00665977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178164|NCT00666055|Ritonavir|ritonavir|mesh-list
65178165|NCT00666055|Lopinavir|lopinavir|mesh-list
65178166|NCT00666055|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65178167|NCT00666055|Tenofovir|tenofovir|mesh-list
65178168|NCT00666055|Lamivudine|lamivudine|mesh-list
65178169|NCT00666055|Zidovudine|zidovudine|mesh-list
65178170|NCT00666055|Emtricitabine|emtricitabine|mesh-list
65178171|NCT00666055|Raltegravir Potassium|raltegravir potassium|mesh-list
65178172|NCT00666055|Maraviroc|maraviroc|mesh-list
65178173|NCT00666055|Efavirenz|efavirenz|mesh-list
65178174|NCT00666055|Etravirine|etravirine|mesh-list
65178175|NCT00666055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65178176|NCT00666055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65178177|NCT00666055|Protease Inhibitors|protease inhibitors|mesh-ancestor
65178185|NCT00666055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65178186|NCT00666055|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65178187|NCT00666055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65178188|NCT00666055|Antimetabolites|antimetabolites|mesh-ancestor
65178189|NCT00666055|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65178190|NCT00666055|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65178191|NCT00666055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65178192|NCT00666055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65178193|NCT00666055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65178194|NCT00666055|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65178195|NCT00666055|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65178196|NCT00666055|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65178197|NCT00666055|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65178198|NCT00666055|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65178200|NCT00661375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178201|NCT00661375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65178202|NCT00661375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178203|NCT00661375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178204|NCT00911287|Oxymorphone|oxymorphone|mesh-list
65178205|NCT00911287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65178206|NCT00911287|Narcotics|narcotics|mesh-ancestor
65178207|NCT00911287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65178208|NCT00911287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178209|NCT00911287|Analgesics|analgesics|mesh-ancestor
65178210|NCT00911287|Sensory System Agents|sensory system agents|mesh-ancestor
65178211|NCT00911287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65178212|NCT00911287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65178213|NCT04494880|Bupivacaine|bupivacaine|mesh-list
65178214|NCT04494880|Anesthetics, Local|anesthetics, local|mesh-ancestor
65178215|NCT04494880|Anesthetics|anesthetics|mesh-ancestor
65325469|NCT00756470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65325470|NCT00756470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65325471|NCT00756470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65325472|NCT00756470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325473|NCT00756470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65325474|NCT00756314|Contraceptive Agents|contraceptive agents|mesh-list
64555085|NCT00013611|Analgesics|analgesics|mesh-ancestor
65178216|NCT04494880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65178217|NCT04494880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178218|NCT04494880|Sensory System Agents|sensory system agents|mesh-ancestor
65178219|NCT04494880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65178220|NCT02631031|Valsartan|valsartan|mesh-list
65178221|NCT02631031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65178222|NCT02631031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65178223|NCT02631031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65178224|NCT02631031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178225|NCT02839408|Azithromycin|azithromycin|mesh-list
65178226|NCT02839408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65178227|NCT02839408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65178228|NCT02837614|Acetaminophen|acetaminophen|mesh-list
65178229|NCT02837614|Amoxicillin|amoxicillin|mesh-list
65178230|NCT02837614|Dexamethasone|dexamethasone|mesh-list
65178231|NCT02837614|Dexamethasone acetate|dexamethasone acetate|mesh-list
65178232|NCT02837614|BB 1101|bb 1101|mesh-list
65178233|NCT02837614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65178234|NCT02837614|Antiemetics|antiemetics|mesh-ancestor
65178235|NCT02837614|Autonomic Agents|autonomic agents|mesh-ancestor
65178236|NCT02837614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65178237|NCT02837614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178238|NCT02837614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65178239|NCT02837614|Glucocorticoids|glucocorticoids|mesh-ancestor
65178240|NCT02837614|Hormones|hormones|mesh-ancestor
65178241|NCT02837614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65178242|NCT02837614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65178243|NCT02837614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178249|NCT02837614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65178250|NCT02837614|Analgesics|analgesics|mesh-ancestor
65178251|NCT02837614|Sensory System Agents|sensory system agents|mesh-ancestor
65178252|NCT02837614|Antipyretics|antipyretics|mesh-ancestor
65178253|NCT02839486|Vancomycin|vancomycin|mesh-list
65178254|NCT02839486|Cefoxitin|cefoxitin|mesh-list
65178255|NCT02839486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65178256|NCT02839486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65178257|NCT00879229|Ambrisentan|ambrisentan|mesh-list
65178258|NCT00879229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65178259|NCT04249570|Povidone-Iodine|povidone-iodine|mesh-list
65178260|NCT04249570|Povidone|povidone|mesh-list
65178261|NCT04249570|Plasma Substitutes|plasma substitutes|mesh-ancestor
65178262|NCT04249570|Blood Substitutes|blood substitutes|mesh-ancestor
65178263|NCT04249570|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65178264|NCT04249570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65178265|NCT02837770|Diclofenac|diclofenac|mesh-list
65178266|NCT02837770|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65178267|NCT02837770|Lubricant Eye Drops|lubricant eye drops|mesh-list
65178268|NCT02837770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65178269|NCT02837770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65178270|NCT02837770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65178271|NCT02837770|Analgesics|analgesics|mesh-ancestor
65178272|NCT02837770|Sensory System Agents|sensory system agents|mesh-ancestor
65178273|NCT02837770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65178274|NCT02837770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178275|NCT02837770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65178276|NCT02837770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65178277|NCT02837770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65178278|NCT02837770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178279|NCT02837770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178280|NCT00878995|Methyltestosterone|methyltestosterone|mesh-list
65178281|NCT00878995|Testosterone|testosterone|mesh-list
65178282|NCT00878995|Testosterone undecanoate|testosterone undecanoate|mesh-list
65178283|NCT00878995|Testosterone enanthate|testosterone enanthate|mesh-list
65325475|NCT00756314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65325476|NCT00756314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325477|NCT00727506|Afatinib|afatinib|mesh-list
65325478|NCT00727506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325479|NCT00727506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65325480|NCT00727506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325481|NCT00727506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325482|NCT00789815|Midazolam|midazolam|mesh-list
65325483|NCT00789815|Propofol|propofol|mesh-list
65325484|NCT00789815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65325485|NCT00789815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65325486|NCT00789815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325487|NCT00789815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65325488|NCT00789815|Anesthetics, General|anesthetics, general|mesh-ancestor
65325489|NCT00789815|Anesthetics|anesthetics|mesh-ancestor
65325490|NCT00789815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65325491|NCT00789815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65325492|NCT00789815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65325493|NCT00789815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65325494|NCT00789815|GABA Modulators|gaba modulators|mesh-ancestor
65325495|NCT00789815|GABA Agents|gaba agents|mesh-ancestor
65325496|NCT00789815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65325497|NCT00789815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325498|NCT00721578|Voriconazole|voriconazole|mesh-list
65325499|NCT00721578|Antifungal Agents|antifungal agents|mesh-ancestor
65325500|NCT00721578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65178284|NCT00878995|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65178285|NCT00878995|Androgens|androgens|mesh-ancestor
65178286|NCT00878995|Hormones|hormones|mesh-ancestor
65178287|NCT00878995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65178288|NCT00878995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178289|NCT00878995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65178290|NCT00878995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178291|NCT00878995|Anabolic Agents|anabolic agents|mesh-ancestor
65178292|NCT02837146|Methotrexate|methotrexate|mesh-list
65178293|NCT02837146|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65178294|NCT02837146|Abortifacient Agents|abortifacient agents|mesh-ancestor
65178295|NCT02837146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65178296|NCT02837146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178297|NCT02837146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65178298|NCT02837146|Antimetabolites|antimetabolites|mesh-ancestor
65178299|NCT02837146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178300|NCT02837146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178301|NCT02837146|Dermatologic Agents|dermatologic agents|mesh-ancestor
65178302|NCT02837146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178303|NCT02837146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65178304|NCT02837146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65178305|NCT02837146|Immunologic Factors|immunologic factors|mesh-ancestor
65178306|NCT02837146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65325501|NCT00721578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65325502|NCT00721578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65325503|NCT00721578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325504|NCT00721578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555115|NCT04192643|Hemostatics|hemostatics|mesh-ancestor
65178307|NCT02837146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65178308|NCT00657865|Ramipril|ramipril|mesh-list
65178309|NCT00657865|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65178310|NCT00657865|Protease Inhibitors|protease inhibitors|mesh-ancestor
65178311|NCT00657865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178312|NCT00657865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178313|NCT00657865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65178320|NCT00661765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178321|NCT00657943|Insulin|insulin|mesh-list
65178322|NCT00657943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65178323|NCT00657943|Metformin|metformin|mesh-list
65178324|NCT00657943|Insulin Aspart|insulin aspart|mesh-list
65178325|NCT00657943|Insulin, Long-Acting|insulin, long-acting|mesh-list
65178326|NCT00657943|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65178327|NCT00657943|Insulin Detemir|insulin detemir|mesh-list
65178328|NCT00657943|Protamines|protamines|mesh-list
65178329|NCT00657943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65178330|NCT00657943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178331|NCT00657943|Heparin Antagonists|heparin antagonists|mesh-ancestor
65178332|NCT00657943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178333|NCT00657943|Coagulants|coagulants|mesh-ancestor
65178334|NCT04249804|Magnesium Sulfate|magnesium sulfate|mesh-list
65178335|NCT04249804|Analgesics|analgesics|mesh-ancestor
65178336|NCT04249804|Sensory System Agents|sensory system agents|mesh-ancestor
65178337|NCT04249804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65178338|NCT04249804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178339|NCT04249804|Anesthetics|anesthetics|mesh-ancestor
65178340|NCT04249804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65178341|NCT04249804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65178342|NCT04249804|Anticonvulsants|anticonvulsants|mesh-ancestor
65178343|NCT04249804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65178344|NCT04249804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64712054|NCT04838301|Pregnanolone|pregnanolone|mesh-list
64712055|NCT04838301|Anesthetics|anesthetics|mesh-ancestor
64712056|NCT04838301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65178345|NCT04249804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178346|NCT04249804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65178348|NCT04249804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65178349|NCT02631109|Methylprednisolone|methylprednisolone|mesh-list
65178350|NCT02631109|Doxorubicin|doxorubicin|mesh-list
65178351|NCT02631109|Etoposide|etoposide|mesh-list
65178352|NCT02631109|Pegaspargase|pegaspargase|mesh-list
65178353|NCT02631109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65178354|NCT02631109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178355|NCT02631109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65178356|NCT02631109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65178357|NCT02631109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178358|NCT02631109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178359|NCT02631109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65178360|NCT02631109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65178361|NCT02631109|Antiemetics|antiemetics|mesh-ancestor
65178362|NCT02631109|Autonomic Agents|autonomic agents|mesh-ancestor
65178363|NCT02631109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65178364|NCT02631109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178365|NCT02631109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65178366|NCT02631109|Glucocorticoids|glucocorticoids|mesh-ancestor
65178367|NCT02631109|Hormones|hormones|mesh-ancestor
65178368|NCT02631109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65178369|NCT02631109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65178370|NCT02631109|Protective Agents|protective agents|mesh-ancestor
65178371|NCT02630485|Inositol|inositol|mesh-list
65178372|NCT02630485|Letrozole|letrozole|mesh-list
65178373|NCT02630485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178374|NCT02630485|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65325505|NCT00721578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65066808|NCT00272636|Vasodilator Agents|vasodilator agents|mesh-ancestor
65325506|NCT00721578|Hormone Antagonists|hormone antagonists|mesh-ancestor
65325507|NCT00721578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65325509|NCT00721578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65325510|NCT00789737|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65325511|NCT00789737|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65325512|NCT00789737|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65325513|NCT00789737|Antimetabolites|antimetabolites|mesh-ancestor
65178375|NCT02630485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65178376|NCT02630485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178377|NCT02630485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178378|NCT02630485|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65178379|NCT02630485|Hormone Antagonists|hormone antagonists|mesh-ancestor
65178380|NCT02630485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65178383|NCT02630485|Vitamins|vitamins|mesh-ancestor
65178384|NCT02630485|Micronutrients|micronutrients|mesh-ancestor
65178385|NCT00894556|Sumatriptan|sumatriptan|mesh-list
65178386|NCT00894556|Rizatriptan|rizatriptan|mesh-list
65178387|NCT00894556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65178388|NCT00894556|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65178389|NCT00894556|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65178390|NCT00894556|Serotonin Agents|serotonin agents|mesh-ancestor
65178391|NCT00894556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65178392|NCT00894556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178393|NCT00894556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178394|NCT01210352|Oxymorphone|oxymorphone|mesh-list
65178395|NCT01210352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65178396|NCT01210352|Narcotics|narcotics|mesh-ancestor
65178397|NCT01210352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65178398|NCT01210352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178399|NCT01210352|Analgesics|analgesics|mesh-ancestor
65178400|NCT01210352|Sensory System Agents|sensory system agents|mesh-ancestor
65178401|NCT01210352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65178402|NCT01210352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65178403|NCT04250506|Moxifloxacin|moxifloxacin|mesh-list
65178404|NCT04250506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65178405|NCT04250506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65178406|NCT04250506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65178407|NCT04250506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65178408|NCT04250506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178409|NCT04250506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178410|NCT04250506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178411|NCT00662077|Ibandronic Acid|ibandronic acid|mesh-list
65178412|NCT00662077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65178413|NCT00662077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178415|NCT00658099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65178416|NCT00658099|Insulin Detemir|insulin detemir|mesh-list
65178417|NCT00658099|Isophane Insulin, Human|isophane insulin, human|mesh-list
65178418|NCT00658099|Insulin, Isophane|insulin, isophane|mesh-list
65178419|NCT00658099|Isophane insulin, beef|isophane insulin, beef|mesh-list
65178420|NCT00658099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65178421|NCT00658099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178422|NCT00658177|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65178423|NCT00658177|Vasodilator Agents|vasodilator agents|mesh-ancestor
65178424|NCT00658177|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65178425|NCT00658177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65178426|NCT00658177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178427|NCT00658177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178428|NCT00658177|Urological Agents|urological agents|mesh-ancestor
65178429|NCT00658255|Budesonide|budesonide|mesh-list
65178430|NCT00658255|Formoterol Fumarate|formoterol fumarate|mesh-list
65178431|NCT00658255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65178432|NCT00658255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65178433|NCT00658255|Autonomic Agents|autonomic agents|mesh-ancestor
65325514|NCT00789737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325515|NCT00789737|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65325516|NCT04019574|Moxifloxacin|moxifloxacin|mesh-list
65325517|NCT04019574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65325518|NCT04019574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65325519|NCT04019574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65325520|NCT04019574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65325521|NCT04019574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325522|NCT04019574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325523|NCT04019574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325524|NCT04166487|Paclitaxel|paclitaxel|mesh-list
65325525|NCT04166487|Carboplatin|carboplatin|mesh-list
65325526|NCT04166487|Pembrolizumab|pembrolizumab|mesh-list
65325527|NCT04166487|Pemetrexed|pemetrexed|mesh-list
65325528|NCT04166487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65325529|NCT04166487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325530|NCT04166487|Tubulin Modulators|tubulin modulators|mesh-ancestor
65178434|NCT00658255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65178435|NCT00658255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178436|NCT00658255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65178437|NCT00658255|Respiratory System Agents|respiratory system agents|mesh-ancestor
65178438|NCT00658255|Glucocorticoids|glucocorticoids|mesh-ancestor
65178439|NCT00658255|Hormones|hormones|mesh-ancestor
65178440|NCT00658255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65178441|NCT00658255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65178442|NCT00658255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65178443|NCT00658255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65178444|NCT00658255|Adrenergic Agents|adrenergic agents|mesh-ancestor
65178445|NCT00658255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65178446|NCT00658255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178447|NCT02836288|Ketamine|ketamine|mesh-list
65178448|NCT02836288|Analgesics|analgesics|mesh-ancestor
65178449|NCT02836288|Sensory System Agents|sensory system agents|mesh-ancestor
65178450|NCT02836288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65178451|NCT02836288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178452|NCT02836288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65178453|NCT02836288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65178454|NCT02836288|Anesthetics, General|anesthetics, general|mesh-ancestor
65178457|NCT02836288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65178458|NCT02836288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65178459|NCT02836288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65178460|NCT02836288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178461|NCT00658645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65178462|NCT00658645|Antidepressive Agents|antidepressive agents|mesh-ancestor
65178463|NCT00658645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65178464|NCT00658645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65178465|NCT00658645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65178466|NCT00658645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65178467|NCT00658645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178469|NCT01208402|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65178470|NCT01208402|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65178471|NCT01208402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65178472|NCT01208402|Adrenergic Agents|adrenergic agents|mesh-ancestor
65178473|NCT01208402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65178474|NCT01208402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178475|NCT01208402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325531|NCT04166487|Antimitotic Agents|antimitotic agents|mesh-ancestor
65325532|NCT04166487|Mitosis Modulators|mitosis modulators|mesh-ancestor
65325533|NCT04166487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325534|NCT04166487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65178476|NCT01208324|Estrogens|estrogens|mesh-list
65178477|NCT01208324|Hormones|hormones|mesh-ancestor
65178478|NCT01208324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65178479|NCT01208324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178480|NCT02838940|Cefazolin|cefazolin|mesh-list
65178481|NCT02838940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65178482|NCT02838940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65178483|NCT05416658|Antipsychotic Agents|antipsychotic agents|mesh-list
65178484|NCT05416658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65178485|NCT05416658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65178486|NCT05416658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178487|NCT05416658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65178488|NCT02835742|Sargramostim|sargramostim|mesh-list
65178489|NCT02835742|Immunologic Factors|immunologic factors|mesh-ancestor
65178490|NCT02835742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178491|NCT05326360|Ramosetron|ramosetron|mesh-list
65178492|NCT05326360|Antiemetics|antiemetics|mesh-ancestor
65178493|NCT05326360|Autonomic Agents|autonomic agents|mesh-ancestor
65178494|NCT05326360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65178495|NCT05326360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178496|NCT05326360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65178497|NCT05326360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65178498|NCT05326360|Serotonin Agents|serotonin agents|mesh-ancestor
65178499|NCT05326360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65178500|NCT05326360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178501|NCT00666601|Tedizolid phosphate|tedizolid phosphate|mesh-list
65178502|NCT00666601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65178503|NCT00666601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65178504|NCT01207388|Blinatumomab|blinatumomab|mesh-list
65178505|NCT01207388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178507|NCT02835664|Niacin|niacin|mesh-list
65178508|NCT02835664|Nicotinic Acids|nicotinic acids|mesh-list
65178509|NCT02835664|Vitamin B Complex|vitamin b complex|mesh-ancestor
65178510|NCT02835664|Vitamins|vitamins|mesh-ancestor
65178511|NCT02835664|Micronutrients|micronutrients|mesh-ancestor
65178512|NCT02835664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178513|NCT02835664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65178514|NCT02835664|Antimetabolites|antimetabolites|mesh-ancestor
65178515|NCT02835664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178516|NCT02835664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65178517|NCT02835664|Vasodilator Agents|vasodilator agents|mesh-ancestor
65178518|NCT02838472|Ascorbic Acid|ascorbic acid|mesh-list
65178519|NCT02838472|Vitamins|vitamins|mesh-ancestor
65178520|NCT02838472|Micronutrients|micronutrients|mesh-ancestor
65178521|NCT02838472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178522|NCT02838472|Antioxidants|antioxidants|mesh-ancestor
65178523|NCT02838472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178524|NCT02838472|Protective Agents|protective agents|mesh-ancestor
65178525|NCT00666991|Paclitaxel|paclitaxel|mesh-list
65178526|NCT00666991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65178527|NCT00666991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178528|NCT00666991|Tubulin Modulators|tubulin modulators|mesh-ancestor
65178534|NCT00667147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178535|NCT00667147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65178536|NCT00667147|Tubulin Modulators|tubulin modulators|mesh-ancestor
65178537|NCT00667147|Antimitotic Agents|antimitotic agents|mesh-ancestor
65178538|NCT00667147|Mitosis Modulators|mitosis modulators|mesh-ancestor
65178539|NCT00667147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178540|NCT02835586|Paclitaxel|paclitaxel|mesh-list
65178541|NCT02835586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65178542|NCT02835586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178543|NCT02835586|Tubulin Modulators|tubulin modulators|mesh-ancestor
65178544|NCT02835586|Antimitotic Agents|antimitotic agents|mesh-ancestor
65178545|NCT02835586|Mitosis Modulators|mitosis modulators|mesh-ancestor
65178546|NCT02835586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178547|NCT00667303|Antibodies|antibodies|mesh-list
65178548|NCT00667303|Immunologic Factors|immunologic factors|mesh-ancestor
65178549|NCT00667303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325535|NCT04166487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325536|NCT04166487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65325537|NCT04166487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65325538|NCT00792467|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
65325539|NCT00792467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65325540|NCT00792467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325541|NCT00792467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325542|NCT00585468|Mycophenolic Acid|mycophenolic acid|mesh-list
65325543|NCT00585468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65325544|NCT00585468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325545|NCT00585468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65325546|NCT00585468|Antitubercular Agents|antitubercular agents|mesh-ancestor
65325547|NCT00585468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65325548|NCT00585468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65325549|NCT00585468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325550|NCT00585468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325551|NCT05600387|Empagliflozin|empagliflozin|mesh-list
65325552|NCT05600387|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65325553|NCT05600387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325554|NCT05600387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65325555|NCT05600387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325556|NCT03725007|Upadacitinib|upadacitinib|mesh-list
65325557|NCT03725007|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65178550|NCT02838238|Capecitabine|capecitabine|mesh-list
65178551|NCT02838238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65178552|NCT02838238|Antimetabolites|antimetabolites|mesh-ancestor
65178553|NCT02838238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178554|NCT02838238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178555|NCT00667537|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65178556|NCT00667537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178557|NCT00667771|Naltrexone|naltrexone|mesh-list
65178558|NCT00667771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65178559|NCT00667771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65178560|NCT00667771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178561|NCT00667771|Sensory System Agents|sensory system agents|mesh-ancestor
65178562|NCT00667771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65178563|NCT01206764|Everolimus|everolimus|mesh-list
65178564|NCT01206764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178565|NCT01206764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65178566|NCT01206764|Immunologic Factors|immunologic factors|mesh-ancestor
65178567|NCT01206764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178568|NCT00667927|Cyclophosphamide|cyclophosphamide|mesh-list
65178569|NCT00667927|Busulfan|busulfan|mesh-list
65178570|NCT00667927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65178571|NCT00667927|Immunologic Factors|immunologic factors|mesh-ancestor
65178572|NCT00667927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178573|NCT00667927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65178574|NCT00667927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65178575|NCT00667927|Alkylating Agents|alkylating agents|mesh-ancestor
65222848|NCT02586181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65325558|NCT03725007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65325559|NCT03725007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325560|NCT03725007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325561|NCT03725007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65325562|NCT00721110|Lidocaine|lidocaine|mesh-list
65325563|NCT00721110|Ketamine|ketamine|mesh-list
64555173|NCT00919191|Adapalene|adapalene|mesh-list
65178576|NCT00667927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178577|NCT00667927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178578|NCT00667927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65178579|NCT00668005|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65178580|NCT00668005|Vasodilator Agents|vasodilator agents|mesh-ancestor
65178581|NCT00668005|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65178582|NCT00668005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65178583|NCT00668005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178584|NCT00668005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178585|NCT00668005|Urological Agents|urological agents|mesh-ancestor
65178586|NCT00668239|Triamcinolone|triamcinolone|mesh-list
65178587|NCT00668239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65178588|NCT00668239|Glucocorticoids|glucocorticoids|mesh-ancestor
65178589|NCT00668239|Hormones|hormones|mesh-ancestor
65178590|NCT00668239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65178591|NCT00668239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178592|NCT02631499|Epirubicin|epirubicin|mesh-list
65178593|NCT02631499|Ethiodized Oil|ethiodized oil|mesh-list
65178594|NCT02631499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65178595|NCT02631499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178596|NCT02631499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65178597|NCT02631499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65178598|NCT02631499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178608|NCT00662233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178609|NCT00662233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65178610|NCT00662233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65178611|NCT00662233|Alkylating Agents|alkylating agents|mesh-ancestor
65178612|NCT00662233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178613|NCT00662233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178614|NCT00662233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65178615|NCT00662233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65178616|NCT00662233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65178617|NCT00662233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65178618|NCT00662233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178619|NCT00662233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65178620|NCT00662233|Tubulin Modulators|tubulin modulators|mesh-ancestor
65178621|NCT00662233|Antimitotic Agents|antimitotic agents|mesh-ancestor
65178622|NCT00662233|Mitosis Modulators|mitosis modulators|mesh-ancestor
65178623|NCT00658957|Gentamicins|gentamicins|mesh-list
65178624|NCT00658957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65178625|NCT00658957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65178626|NCT00658957|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65178627|NCT00658957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178628|NCT00658957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178629|NCT00662467|Aspirin|aspirin|mesh-list
65178630|NCT00662467|Warfarin|warfarin|mesh-list
65178631|NCT00662467|Clopidogrel|clopidogrel|mesh-list
65178632|NCT00662467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65178633|NCT00662467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65178634|NCT00662467|Analgesics|analgesics|mesh-ancestor
65178635|NCT00662467|Sensory System Agents|sensory system agents|mesh-ancestor
65178636|NCT00662467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65178637|NCT00662467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178638|NCT00662467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65178639|NCT00662467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65178640|NCT00662467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65178641|NCT00662467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65178642|NCT00662467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178643|NCT00662467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65178644|NCT00662467|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65325564|NCT00721110|Anesthetics, Local|anesthetics, local|mesh-ancestor
65325565|NCT00721110|Anesthetics|anesthetics|mesh-ancestor
65325566|NCT00721110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65325567|NCT00721110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325568|NCT00721110|Sensory System Agents|sensory system agents|mesh-ancestor
65325569|NCT00721110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65325570|NCT00721110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65325571|NCT00721110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65325572|NCT00721110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65325573|NCT00721110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65325574|NCT00721110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325575|NCT00721110|Analgesics|analgesics|mesh-ancestor
65325576|NCT00721110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65325577|NCT00721110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65325578|NCT00721110|Anesthetics, General|anesthetics, general|mesh-ancestor
65075542|NCT00317408|Leucovorin|leucovorin|mesh-list
65178645|NCT00662467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178646|NCT00662467|Antipyretics|antipyretics|mesh-ancestor
65178647|NCT00662467|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65178648|NCT00662467|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65178649|NCT00662467|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65178650|NCT00662467|Purinergic Agents|purinergic agents|mesh-ancestor
65178651|NCT00662467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65178652|NCT00662467|Anticoagulants|anticoagulants|mesh-ancestor
65178653|NCT00668941|Vitamin D|vitamin d|mesh-list
65178654|NCT00668941|Cholecalciferol|cholecalciferol|mesh-list
65178655|NCT00668941|Alendronate|alendronate|mesh-list
65178656|NCT00668941|Teriparatide|teriparatide|mesh-list
65178657|NCT00668941|Calcium|calcium|mesh-list
65178658|NCT00668941|Vitamins|vitamins|mesh-ancestor
65178659|NCT00668941|Micronutrients|micronutrients|mesh-ancestor
65178660|NCT00668941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945632|NCT05379322|Etanercept|etanercept|mesh-list
65178661|NCT00668941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65178662|NCT00668941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65178663|NCT00894322|Exenatide|exenatide|mesh-list
65178664|NCT00894322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65178665|NCT00894322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178671|NCT05323708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65178672|NCT05323708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178673|NCT00633412|Esomeprazole|esomeprazole|mesh-list
65178674|NCT00633412|Ranitidine|ranitidine|mesh-list
65178675|NCT00633412|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65178676|NCT00633412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65178677|NCT00633412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65178678|NCT00633412|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65178679|NCT00633412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178680|NCT00633412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178681|NCT00633412|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65178682|NCT00633412|Histamine Antagonists|histamine antagonists|mesh-ancestor
65178683|NCT00633412|Histamine Agents|histamine agents|mesh-ancestor
65178684|NCT00633412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65178685|NCT00633412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178686|NCT04250116|Apixaban|apixaban|mesh-list
65178687|NCT04250116|Clopidogrel|clopidogrel|mesh-list
65178688|NCT04250116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65178689|NCT04250116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65178690|NCT04250116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65178691|NCT04250116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65325579|NCT00721110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65325580|NCT00721110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65325581|NCT00721110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65325582|NCT05073237|Bazedoxifene|bazedoxifene|mesh-list
65325584|NCT05073237|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65325585|NCT05073237|Hormones|hormones|mesh-ancestor
65325586|NCT05073237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65325587|NCT05073237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325588|NCT05073237|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65325589|NCT05073237|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65325590|NCT05073237|Hormone Antagonists|hormone antagonists|mesh-ancestor
65178692|NCT04250116|Purinergic Agents|purinergic agents|mesh-ancestor
65178693|NCT04250116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65178694|NCT04250116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178695|NCT04250116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178696|NCT04250116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65178697|NCT04250116|Antithrombins|antithrombins|mesh-ancestor
65178698|NCT04250116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65178699|NCT04250116|Protease Inhibitors|protease inhibitors|mesh-ancestor
65178700|NCT04250116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178701|NCT04250116|Anticoagulants|anticoagulants|mesh-ancestor
65178702|NCT00659113|Tegafur|tegafur|mesh-list
65178703|NCT00659113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178704|NCT00659113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65178705|NCT00659113|Antimetabolites|antimetabolites|mesh-ancestor
65178706|NCT00659113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178707|NCT00662779|Formoterol Fumarate|formoterol fumarate|mesh-list
65178708|NCT00662779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65178709|NCT00662779|Autonomic Agents|autonomic agents|mesh-ancestor
65178710|NCT00662779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65178711|NCT00662779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178712|NCT00662779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65178713|NCT00662779|Respiratory System Agents|respiratory system agents|mesh-ancestor
65178714|NCT00662779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65178715|NCT00662779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65178716|NCT00662779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65178717|NCT00662779|Adrenergic Agents|adrenergic agents|mesh-ancestor
65178718|NCT00662779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64945633|NCT05379322|Golimumab|golimumab|mesh-list
65178719|NCT00662779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178720|NCT02630095|Nadroparin|nadroparin|mesh-list
65178721|NCT02630095|Warfarin|warfarin|mesh-list
65178722|NCT02630095|Calcium|calcium|mesh-list
65178723|NCT02630095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65178724|NCT02630095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178725|NCT02630095|Anticoagulants|anticoagulants|mesh-ancestor
65178726|NCT02630095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65178727|NCT02630095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65178728|NCT02630095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178729|NCT00669487|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65178730|NCT00669487|Lamivudine|lamivudine|mesh-list
65178731|NCT00669487|Stavudine|stavudine|mesh-list
65178732|NCT00669487|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65178733|NCT00669487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65178734|NCT00669487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178743|NCT00669565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178744|NCT00669643|Rifampin|rifampin|mesh-list
65178745|NCT00669643|Dapsone|dapsone|mesh-list
65178746|NCT00669643|Clofazimine|clofazimine|mesh-list
65178747|NCT00669643|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65178748|NCT00669643|Antitubercular Agents|antitubercular agents|mesh-ancestor
65178749|NCT00669643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65325591|NCT05073237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65325592|NCT02592096|Carbamide Peroxide|carbamide peroxide|mesh-list
65325593|NCT02592096|Pazufloxacin|pazufloxacin|mesh-list
65325594|NCT02592096|Fluoroquinolones|fluoroquinolones|mesh-list
65325595|NCT02592096|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65178750|NCT00669643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65178751|NCT00669643|Leprostatic Agents|leprostatic agents|mesh-ancestor
65178752|NCT00669643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65178753|NCT00669643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178754|NCT00669643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178755|NCT00669643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65178756|NCT00669643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65178757|NCT00669643|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65178758|NCT00669643|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65178759|NCT00669643|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65178760|NCT00669643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65178761|NCT00669643|Antimalarials|antimalarials|mesh-ancestor
65178762|NCT00669643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65178763|NCT00669643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65178764|NCT00669643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65178765|NCT00669643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65178766|NCT00669721|Heparin|heparin|mesh-list
65178767|NCT00669721|Calcium heparin|calcium heparin|mesh-list
65178768|NCT00669721|Nadroparin|nadroparin|mesh-list
65178769|NCT00669721|Anticoagulants|anticoagulants|mesh-ancestor
65178770|NCT00669721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65178771|NCT00669721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65178772|NCT00669721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178773|NCT00894166|Bupropion|bupropion|mesh-list
65178774|NCT00894166|Nicotine|nicotine|mesh-list
65178775|NCT00894166|Varenicline|varenicline|mesh-list
65178776|NCT00894166|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65178777|NCT00894166|Autonomic Agents|autonomic agents|mesh-ancestor
65178778|NCT00894166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65178779|NCT00894166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178780|NCT00894166|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65178781|NCT00894166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65178782|NCT00894166|Cholinergic Agents|cholinergic agents|mesh-ancestor
65178783|NCT00894166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65178784|NCT00894166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178785|NCT00894166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65178786|NCT00894166|Antidepressive Agents|antidepressive agents|mesh-ancestor
65178787|NCT00894166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65178788|NCT00894166|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65178789|NCT00894166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65178790|NCT00894166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65178791|NCT00894166|Dopamine Agents|dopamine agents|mesh-ancestor
65178792|NCT00894166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65178793|NCT00894166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65178794|NCT00894166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178795|NCT00659503|Ciclesonide|ciclesonide|mesh-list
65178796|NCT00659503|Glucocorticoids|glucocorticoids|mesh-ancestor
65178797|NCT00659503|Hormones|hormones|mesh-ancestor
65178798|NCT00659503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65178799|NCT00659503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178800|NCT00659503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65178801|NCT00670345|Tranexamic Acid|tranexamic acid|mesh-list
65178805|NCT00670345|Hemostatics|hemostatics|mesh-ancestor
65178807|NCT04153981|Insulin Glargine|insulin glargine|mesh-list
65178808|NCT04153981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65178809|NCT04153981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178810|NCT00670423|Sirolimus|sirolimus|mesh-list
65178811|NCT00670423|Bortezomib|bortezomib|mesh-list
65178812|NCT00670423|Tacrolimus|tacrolimus|mesh-list
65178813|NCT00670423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65178814|NCT00670423|Immunologic Factors|immunologic factors|mesh-ancestor
65178815|NCT00670423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178816|NCT00670423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65178817|NCT00670423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178818|NCT00670423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325596|NCT02592096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65325597|NCT02592096|Antitubercular Agents|antitubercular agents|mesh-ancestor
65325598|NCT02592096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65325599|NCT02592096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65178819|NCT00670423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178820|NCT00670423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65178821|NCT00670423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65178822|NCT00670423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65178823|NCT00670423|Antifungal Agents|antifungal agents|mesh-ancestor
65178824|NCT00659659|Benralizumab|benralizumab|mesh-list
65178825|NCT00659659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65178826|NCT00659659|Respiratory System Agents|respiratory system agents|mesh-ancestor
65178827|NCT00670501|Vitamin D|vitamin d|mesh-list
65178828|NCT00670501|Teriparatide|teriparatide|mesh-list
65178829|NCT00670501|Calcium|calcium|mesh-list
65178830|NCT00670501|Vitamins|vitamins|mesh-ancestor
65178831|NCT00670501|Micronutrients|micronutrients|mesh-ancestor
65178832|NCT00670501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178833|NCT00670501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65178834|NCT00670501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65178835|NCT00663247|Mesalamine|mesalamine|mesh-list
65178836|NCT00663247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65178837|NCT00663247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65178838|NCT00663247|Analgesics|analgesics|mesh-ancestor
65178839|NCT00663247|Sensory System Agents|sensory system agents|mesh-ancestor
65178840|NCT00663247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65178841|NCT00663247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178842|NCT00663247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65178843|NCT00663247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65178844|NCT01163747|Methotrexate|methotrexate|mesh-list
65178845|NCT01163747|Vaccines|vaccines|mesh-list
65178846|NCT01163747|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65178847|NCT01163747|Immunologic Factors|immunologic factors|mesh-ancestor
65178848|NCT01163747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178849|NCT01163747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65178850|NCT01163747|Abortifacient Agents|abortifacient agents|mesh-ancestor
65178851|NCT01163747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65178852|NCT01163747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65178853|NCT01163747|Antimetabolites|antimetabolites|mesh-ancestor
65178854|NCT01163747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178855|NCT01163747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178856|NCT01163747|Dermatologic Agents|dermatologic agents|mesh-ancestor
65178857|NCT01163747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178858|NCT01163747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65178859|NCT01163747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65178860|NCT01163747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65178861|NCT01163747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65178862|NCT00670657|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65178863|NCT00670657|Antifungal Agents|antifungal agents|mesh-ancestor
65178864|NCT00670657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65178865|NCT00670657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65178866|NCT00670657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65178867|NCT05657015|Simvastatin|simvastatin|mesh-list
65178868|NCT05657015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65178869|NCT05657015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65178870|NCT05657015|Antimetabolites|antimetabolites|mesh-ancestor
65178871|NCT05657015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178872|NCT05657015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65178873|NCT05657015|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65178879|NCT02887313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178880|NCT02887313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65178881|NCT02887313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178882|NCT02887313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65178883|NCT02887313|Immunologic Factors|immunologic factors|mesh-ancestor
65178884|NCT02887313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178885|NCT02887313|Antidotes|antidotes|mesh-ancestor
65178886|NCT02887313|Protective Agents|protective agents|mesh-ancestor
65178887|NCT02887313|Vitamin B Complex|vitamin b complex|mesh-ancestor
65178888|NCT02887313|Vitamins|vitamins|mesh-ancestor
65178889|NCT02887313|Micronutrients|micronutrients|mesh-ancestor
65178890|NCT01206140|Sirolimus|sirolimus|mesh-list
65325600|NCT02592096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65325601|NCT02592096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325602|NCT02592096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325603|NCT02592096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325604|NCT02592096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65325605|NCT00791999|Certolizumab Pegol|certolizumab pegol|mesh-list
65325606|NCT00791999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65325607|NCT00791999|Immunologic Factors|immunologic factors|mesh-ancestor
65325608|NCT00791999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325609|NCT00791999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65325610|NCT04085484|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
65325611|NCT04085484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65325612|NCT04033263|Fluorides|fluorides|mesh-list
65325613|NCT04033263|Cariostatic Agents|cariostatic agents|mesh-ancestor
65325614|NCT04033263|Protective Agents|protective agents|mesh-ancestor
65325615|NCT04033263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325616|NCT04075227|Loteprednol Etabonate|loteprednol etabonate|mesh-list
65325617|NCT04075227|Dexamethasone|dexamethasone|mesh-list
65325618|NCT04075227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65325619|NCT04075227|Antiemetics|antiemetics|mesh-ancestor
65178891|NCT01206140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65178892|NCT01206140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65178893|NCT01206140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65178894|NCT01206140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178895|NCT01206140|Antifungal Agents|antifungal agents|mesh-ancestor
65178896|NCT01206140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65178897|NCT01206140|Immunologic Factors|immunologic factors|mesh-ancestor
65178898|NCT01206140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178899|NCT01162421|Adalimumab|adalimumab|mesh-list
65178900|NCT01162421|Methotrexate|methotrexate|mesh-list
65178901|NCT01162421|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65178902|NCT01162421|Abortifacient Agents|abortifacient agents|mesh-ancestor
65178903|NCT01162421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65178904|NCT01162421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178905|NCT01162421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65178906|NCT01162421|Antimetabolites|antimetabolites|mesh-ancestor
65178907|NCT01162421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178908|NCT01162421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178909|NCT01162421|Dermatologic Agents|dermatologic agents|mesh-ancestor
65178910|NCT01162421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178911|NCT01162421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65178912|NCT01162421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65178913|NCT01162421|Immunologic Factors|immunologic factors|mesh-ancestor
65178914|NCT01162421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65178915|NCT01162421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65178916|NCT01162421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65178917|NCT02885441|Ketorolac|ketorolac|mesh-list
65178918|NCT02885441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65178919|NCT02885441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65178921|NCT02885441|Sensory System Agents|sensory system agents|mesh-ancestor
65178922|NCT02885441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65178923|NCT02885441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178924|NCT02885441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65178925|NCT02885441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65325620|NCT04075227|Autonomic Agents|autonomic agents|mesh-ancestor
65325621|NCT04075227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65325622|NCT04075227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325623|NCT04075227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65325624|NCT04075227|Glucocorticoids|glucocorticoids|mesh-ancestor
65325625|NCT04075227|Hormones|hormones|mesh-ancestor
65325626|NCT04075227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64555214|NCT03962465|Antiviral Agents|antiviral agents|mesh-ancestor
65178926|NCT02885441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65178927|NCT02885441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178928|NCT02885441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178929|NCT02885597|Methotrexate|methotrexate|mesh-list
65178930|NCT02885597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65178931|NCT02885597|Abortifacient Agents|abortifacient agents|mesh-ancestor
65178932|NCT02885597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65178933|NCT02885597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178934|NCT02885597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65178935|NCT02885597|Antimetabolites|antimetabolites|mesh-ancestor
65178936|NCT02885597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178937|NCT02885597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178938|NCT02885597|Dermatologic Agents|dermatologic agents|mesh-ancestor
65178939|NCT02885597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178940|NCT02885597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65178941|NCT02885597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65178942|NCT02885597|Immunologic Factors|immunologic factors|mesh-ancestor
65178943|NCT02885597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65178944|NCT02885597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65178945|NCT01188551|Fentanyl|fentanyl|mesh-list
65178946|NCT01188551|Midazolam|midazolam|mesh-list
65178951|NCT01188551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65178953|NCT01188551|Sensory System Agents|sensory system agents|mesh-ancestor
65178954|NCT01188551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65178955|NCT01188551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65178956|NCT01188551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65178957|NCT01188551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65178958|NCT01188551|Adrenergic Agents|adrenergic agents|mesh-ancestor
65178959|NCT01188551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65178960|NCT01188551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178961|NCT01188551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65178962|NCT01188551|Narcotics|narcotics|mesh-ancestor
65178963|NCT01188551|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65178964|NCT01188551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65178965|NCT01188551|Anesthetics, General|anesthetics, general|mesh-ancestor
65178966|NCT01188551|Anesthetics|anesthetics|mesh-ancestor
65178967|NCT01188551|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65178968|NCT01188551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65178969|NCT01188551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65178970|NCT01188551|GABA Modulators|gaba modulators|mesh-ancestor
65178971|NCT01188551|GABA Agents|gaba agents|mesh-ancestor
65178972|NCT01161407|Calcium Carbonate|calcium carbonate|mesh-list
65178973|NCT01161407|Calcium|calcium|mesh-list
65178974|NCT01161407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65178975|NCT01161407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178976|NCT01161407|Antacids|antacids|mesh-ancestor
65178977|NCT01161407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178978|NCT01161407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65178979|NCT01161173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65178980|NCT01161173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65178981|NCT01161173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65178982|NCT01161173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178983|NCT01161173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178984|NCT01159769|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
65178985|NCT01159769|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65178986|NCT01159769|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65178987|NCT01159769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65178988|NCT01159769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65325627|NCT04075227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65325628|NCT04075227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325629|NCT04075227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65325630|NCT00585078|Capecitabine|capecitabine|mesh-list
65178990|NCT01159769|Sensory System Agents|sensory system agents|mesh-ancestor
65178991|NCT01159769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65178992|NCT01159769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178993|NCT01159769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65178994|NCT01159769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65178995|NCT01159769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65178996|NCT01159769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65178997|NCT01159769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65178998|NCT01159769|Histamine Antagonists|histamine antagonists|mesh-ancestor
65178999|NCT01159769|Histamine Agents|histamine agents|mesh-ancestor
65179000|NCT01159769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65179001|NCT01159769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179002|NCT01185821|Siponimod|siponimod|mesh-list
65179003|NCT01185821|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65179004|NCT01185821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179005|NCT01185821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65179006|NCT01185821|Immunologic Factors|immunologic factors|mesh-ancestor
65179007|NCT01185821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179008|NCT00893464|Ixazomib|ixazomib|mesh-list
65179009|NCT00893464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179010|NCT00893464|Protease Inhibitors|protease inhibitors|mesh-ancestor
65179011|NCT00893464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179012|NCT00893464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179013|NCT00891904|Cetuximab|cetuximab|mesh-list
65179014|NCT00891904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65179015|NCT00891904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179016|NCT02834260|Dexamethasone|dexamethasone|mesh-list
65179026|NCT02834260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65179027|NCT02834260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179028|NCT01157351|Olanzapine|olanzapine|mesh-list
65179029|NCT01157351|Risperidone|risperidone|mesh-list
65179030|NCT01157351|Aripiprazole|aripiprazole|mesh-list
65179031|NCT01157351|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65179032|NCT01157351|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65179033|NCT01157351|Perphenazine|perphenazine|mesh-list
65179034|NCT01157351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65179035|NCT01157351|Serotonin Agents|serotonin agents|mesh-ancestor
65179036|NCT01157351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65179037|NCT01157351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179038|NCT01157351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179039|NCT01157351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65179040|NCT01157351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65179041|NCT01157351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65179042|NCT01157351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65179043|NCT01157351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65179044|NCT01157351|Dopamine Agents|dopamine agents|mesh-ancestor
65179045|NCT01157351|Antiemetics|antiemetics|mesh-ancestor
65179046|NCT01157351|Autonomic Agents|autonomic agents|mesh-ancestor
65179047|NCT01157351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179048|NCT01157351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65179049|NCT01157351|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65179050|NCT01157351|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65179051|NCT01157351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65179052|NCT01157351|Antidepressive Agents|antidepressive agents|mesh-ancestor
65179053|NCT01157351|Dopamine Agonists|dopamine agonists|mesh-ancestor
65179054|NCT01157351|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65179055|NCT01157351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65179056|NCT01157351|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65179057|NCT01157351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65179058|NCT02831686|Dexamethasone|dexamethasone|mesh-list
65179059|NCT02831686|Ixazomib|ixazomib|mesh-list
65179060|NCT02831686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65179062|NCT02831686|Autonomic Agents|autonomic agents|mesh-ancestor
65179063|NCT02831686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179064|NCT02831686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179065|NCT02831686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65179066|NCT02831686|Glucocorticoids|glucocorticoids|mesh-ancestor
65325631|NCT00585078|Oxaliplatin|oxaliplatin|mesh-list
65325632|NCT00585078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65325633|NCT00585078|Antimetabolites|antimetabolites|mesh-ancestor
65325634|NCT00585078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325635|NCT00585078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325636|NCT00720876|Rituximab|rituximab|mesh-list
65325637|NCT00720876|Vorinostat|vorinostat|mesh-list
64555224|NCT05021406|Carvedilol|carvedilol|mesh-list
65179067|NCT02831686|Hormones|hormones|mesh-ancestor
65179068|NCT02831686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65179069|NCT02831686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65179070|NCT02831686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179071|NCT02831686|Protease Inhibitors|protease inhibitors|mesh-ancestor
65179072|NCT02831686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179073|NCT02831686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179074|NCT00633490|Apatinib|apatinib|mesh-list
65179075|NCT00633490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179076|NCT00633490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65179077|NCT00633490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179078|NCT00633490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179079|NCT02831374|Anesthetics|anesthetics|mesh-list
65179080|NCT02831374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65179088|NCT02831218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179089|NCT02831218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179091|NCT02831218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65179092|NCT02831218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65179093|NCT02831218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65179094|NCT02831218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179095|NCT02831218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65179096|NCT02831218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65179097|NCT02831218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179098|NCT02831218|Antipyretics|antipyretics|mesh-ancestor
65179099|NCT02831218|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65179100|NCT02831218|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65179101|NCT02831218|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65179102|NCT02831218|Purinergic Agents|purinergic agents|mesh-ancestor
65179103|NCT02831218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65179104|NCT02833480|Fluticasone|fluticasone|mesh-list
65179105|NCT02833480|Budesonide|budesonide|mesh-list
65179106|NCT02833480|Formoterol Fumarate|formoterol fumarate|mesh-list
65179107|NCT02833480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65179108|NCT02833480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65179109|NCT02833480|Autonomic Agents|autonomic agents|mesh-ancestor
65179110|NCT02833480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179111|NCT02833480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179112|NCT02833480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65179113|NCT02833480|Respiratory System Agents|respiratory system agents|mesh-ancestor
65179114|NCT02833480|Dermatologic Agents|dermatologic agents|mesh-ancestor
65179115|NCT02833480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65179116|NCT02833480|Glucocorticoids|glucocorticoids|mesh-ancestor
65179117|NCT02833480|Hormones|hormones|mesh-ancestor
65179118|NCT02833480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65179119|NCT02833480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65179120|NCT02833480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65179121|NCT02833480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65179122|NCT02833480|Adrenergic Agents|adrenergic agents|mesh-ancestor
65179123|NCT02833480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65179124|NCT02833480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179125|NCT04201054|Fluconazole|fluconazole|mesh-list
65179126|NCT04201054|Antifungal Agents|antifungal agents|mesh-ancestor
65179127|NCT04201054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65179128|NCT04201054|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65179129|NCT04201054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65179130|NCT04201054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179131|NCT04201054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712958|NCT03625687|Antiviral Agents|antiviral agents|mesh-list
65325638|NCT00720876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65325639|NCT00720876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325640|NCT00720876|Immunologic Factors|immunologic factors|mesh-ancestor
65325641|NCT00720876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325642|NCT00720876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65325643|NCT00720876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65325644|NCT00720876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325645|NCT00720876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325646|NCT00789581|Paclitaxel|paclitaxel|mesh-list
65325647|NCT00789581|Cyclophosphamide|cyclophosphamide|mesh-list
65325648|NCT00789581|Doxorubicin|doxorubicin|mesh-list
64555226|NCT05021406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65179132|NCT04201054|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65179134|NCT04201054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65179135|NCT04201054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179136|NCT04201054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65179137|NCT04201054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65179138|NCT01157117|Omalizumab|omalizumab|mesh-list
65179139|NCT01157117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65179140|NCT01157117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65179141|NCT01157117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65179142|NCT01157117|Respiratory System Agents|respiratory system agents|mesh-ancestor
65179143|NCT01157117|Immunologic Factors|immunologic factors|mesh-ancestor
65179144|NCT01157117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179145|NCT00891202|Eliglustat|eliglustat|mesh-list
65179146|NCT00891202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179151|NCT02830906|Autonomic Agents|autonomic agents|mesh-ancestor
65179152|NCT02830906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179153|NCT02830906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179154|NCT02830906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65179155|NCT02830906|Antipruritics|antipruritics|mesh-ancestor
65179156|NCT02830906|Dermatologic Agents|dermatologic agents|mesh-ancestor
65179157|NCT02830906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65179158|NCT02830906|Serotonin Agents|serotonin agents|mesh-ancestor
65179159|NCT02830906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65179160|NCT02830906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179161|NCT02830906|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65179162|NCT02830906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65179163|NCT02830906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65179164|NCT02830906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65179165|NCT02830906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65179166|NCT02832778|Tenofovir|tenofovir|mesh-list
65179167|NCT02832778|Lamivudine|lamivudine|mesh-list
65179168|NCT02832778|Zidovudine|zidovudine|mesh-list
65179169|NCT02832778|Emtricitabine|emtricitabine|mesh-list
65179170|NCT02832778|Efavirenz|efavirenz|mesh-list
65179171|NCT02832778|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
65179172|NCT02832778|Isoniazid|isoniazid|mesh-list
65179173|NCT02832778|Antiviral Agents|antiviral agents|mesh-ancestor
65179174|NCT02832778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65179175|NCT02832778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65179176|NCT02832778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65179177|NCT02832778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179178|NCT02832778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179179|NCT02832778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65179180|NCT02832778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65179182|NCT02832778|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65179183|NCT02832778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65179184|NCT02832778|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65179185|NCT02832778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65179186|NCT02832778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65179187|NCT02832778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65325649|NCT00789581|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65325650|NCT00789581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65325651|NCT00789581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325652|NCT00789581|Tubulin Modulators|tubulin modulators|mesh-ancestor
65325653|NCT00789581|Antimitotic Agents|antimitotic agents|mesh-ancestor
65325654|NCT00789581|Mitosis Modulators|mitosis modulators|mesh-ancestor
65325655|NCT00789581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325656|NCT00789581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65325657|NCT00789581|Immunologic Factors|immunologic factors|mesh-ancestor
65325658|NCT00789581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325659|NCT00789581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65325660|NCT00789581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65325661|NCT00789581|Alkylating Agents|alkylating agents|mesh-ancestor
65325662|NCT00789581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65325663|NCT00789581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65325664|NCT00789581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65325665|NCT00789581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65325666|NCT00789581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325667|NCT00717756|Lenalidomide|lenalidomide|mesh-list
65325668|NCT00717756|Immunologic Factors|immunologic factors|mesh-ancestor
65325669|NCT00717756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325670|NCT00717756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65325671|NCT00717756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65325672|NCT00717756|Growth Substances|growth substances|mesh-ancestor
64555240|NCT04766177|Bumetanide|bumetanide|mesh-list
65179188|NCT02832778|Antitubercular Agents|antitubercular agents|mesh-ancestor
65179189|NCT02832778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65179190|NCT02832778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65179191|NCT02832778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65179192|NCT02832778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65179193|NCT01185509|Trastuzumab|trastuzumab|mesh-list
65179194|NCT01185509|Vinorelbine|vinorelbine|mesh-list
65179195|NCT01185509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65179196|NCT01185509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179197|NCT01185509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65179198|NCT01185509|Tubulin Modulators|tubulin modulators|mesh-ancestor
65179199|NCT01185509|Antimitotic Agents|antimitotic agents|mesh-ancestor
65179200|NCT01185509|Mitosis Modulators|mitosis modulators|mesh-ancestor
65179201|NCT01185509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179202|NCT04247230|Tetracaine|tetracaine|mesh-list
65179203|NCT04247230|Anesthetics, Local|anesthetics, local|mesh-ancestor
65179204|NCT04247230|Anesthetics|anesthetics|mesh-ancestor
65179205|NCT04247230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65179206|NCT04247230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179207|NCT04247230|Sensory System Agents|sensory system agents|mesh-ancestor
65179208|NCT04247230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179210|NCT02832700|Chelating Agents|chelating agents|mesh-ancestor
65179211|NCT02832700|Sequestering Agents|sequestering agents|mesh-ancestor
65179212|NCT02832700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325673|NCT00717756|Growth Inhibitors|growth inhibitors|mesh-ancestor
65325674|NCT00717756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325675|NCT04111289|Tirofiban|tirofiban|mesh-list
65325676|NCT04111289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65325677|NCT04111289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64555259|NCT05016180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179213|NCT02831842|Bevacizumab|bevacizumab|mesh-list
65179214|NCT02831842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65179215|NCT02831842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179216|NCT02831842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65179217|NCT02831842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65179218|NCT02831842|Growth Substances|growth substances|mesh-ancestor
65179219|NCT02831842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179225|NCT02830126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65179226|NCT02830126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179227|NCT02828566|Ketamine|ketamine|mesh-list
65179228|NCT02828566|Analgesics|analgesics|mesh-ancestor
65179229|NCT02828566|Sensory System Agents|sensory system agents|mesh-ancestor
65179230|NCT02828566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179231|NCT02828566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179232|NCT02828566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65179233|NCT02828566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65179234|NCT02828566|Anesthetics, General|anesthetics, general|mesh-ancestor
65179235|NCT02828566|Anesthetics|anesthetics|mesh-ancestor
65179236|NCT02828566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65179237|NCT02828566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65179238|NCT02828566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65179239|NCT02828566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65179240|NCT02828566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179241|NCT04245046|Amlodipine|amlodipine|mesh-list
65179242|NCT04245046|Candesartan|candesartan|mesh-list
65179243|NCT04245046|Atorvastatin|atorvastatin|mesh-list
65179244|NCT04245046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65179245|NCT04245046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65179246|NCT04245046|Antimetabolites|antimetabolites|mesh-ancestor
65179247|NCT04245046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179248|NCT04245046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65179249|NCT04245046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65179250|NCT04245046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179251|NCT04245046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65179252|NCT04245046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65179253|NCT04245046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65179254|NCT04245046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65179255|NCT04245046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179256|NCT04245046|Vasodilator Agents|vasodilator agents|mesh-ancestor
65179257|NCT04245046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65179258|NCT04245046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65179259|NCT02828176|Anesthetics|anesthetics|mesh-list
65179260|NCT02828176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65179261|NCT02828176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179262|NCT00633568|Cisplatin|cisplatin|mesh-list
65179263|NCT00633568|Docetaxel|docetaxel|mesh-list
65179264|NCT00633568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179265|NCT00633568|Tubulin Modulators|tubulin modulators|mesh-ancestor
65179266|NCT00633568|Antimitotic Agents|antimitotic agents|mesh-ancestor
65179267|NCT00633568|Mitosis Modulators|mitosis modulators|mesh-ancestor
65179268|NCT00633568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179269|NCT02829424|Methotrexate|methotrexate|mesh-list
65179270|NCT02829424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65179271|NCT02829424|Abortifacient Agents|abortifacient agents|mesh-ancestor
65179272|NCT02829424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65179273|NCT02829424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179274|NCT02829424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65179275|NCT02829424|Antimetabolites|antimetabolites|mesh-ancestor
65179276|NCT02829424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179277|NCT02829424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179278|NCT02829424|Dermatologic Agents|dermatologic agents|mesh-ancestor
65179279|NCT02829424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325678|NCT04111289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325679|NCT04111289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65325680|NCT04108637|Penicillins|penicillins|mesh-list
65325681|NCT04108637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65325682|NCT04108637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65179280|NCT02829424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65179281|NCT02829424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65179283|NCT02829424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65179284|NCT02829424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65179285|NCT02829346|Tranexamic Acid|tranexamic acid|mesh-list
65179286|NCT02829346|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65179287|NCT02829346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65179288|NCT02829346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179289|NCT02829346|Hemostatics|hemostatics|mesh-ancestor
65179298|NCT05210764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65179299|NCT05210764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65179300|NCT05210764|Anesthetics, General|anesthetics, general|mesh-ancestor
65179301|NCT05210764|Analgesics|analgesics|mesh-ancestor
65179302|NCT05210764|Sensory System Agents|sensory system agents|mesh-ancestor
65179303|NCT05210764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179304|NCT05210764|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65179305|NCT05210764|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65179306|NCT05210764|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65179307|NCT05210764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65179308|NCT05210764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179309|NCT05210764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65179310|NCT05210764|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65179311|NCT05210764|Antidepressive Agents|antidepressive agents|mesh-ancestor
65179312|NCT05210764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65179313|NCT00889720|Varenicline|varenicline|mesh-list
65179314|NCT00889720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65179315|NCT00889720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65179316|NCT00889720|Cholinergic Agents|cholinergic agents|mesh-ancestor
65179317|NCT00889720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65179318|NCT00889720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179319|NCT00889720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179320|NCT01116648|Olaparib|olaparib|mesh-list
65179321|NCT01116648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65179322|NCT01116648|Cediranib|cediranib|mesh-list
65179323|NCT01116648|Maleic acid|maleic acid|mesh-list
65179324|NCT01116648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179325|NCT01116648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179326|NCT01116648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179327|NCT01116648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65179328|NCT04243954|Morphine|morphine|mesh-list
65179329|NCT04243954|Hydromorphone|hydromorphone|mesh-list
65179330|NCT04243954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65179331|NCT04243954|Narcotics|narcotics|mesh-ancestor
65179332|NCT04243954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65179333|NCT04243954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179334|NCT04243954|Analgesics|analgesics|mesh-ancestor
65179335|NCT04243954|Sensory System Agents|sensory system agents|mesh-ancestor
65179336|NCT04243954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179337|NCT02827942|Amoxicillin|amoxicillin|mesh-list
65179338|NCT02827942|Metronidazole|metronidazole|mesh-list
65179339|NCT02827942|Clarithromycin|clarithromycin|mesh-list
65179340|NCT02827942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65179341|NCT02827942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65179342|NCT02827942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65179343|NCT02827942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65179344|NCT02827942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65179345|NCT02827942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179346|NCT02827942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179347|NCT02827942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65179348|NCT02827942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65179349|NCT00889252|Ketotifen|ketotifen|mesh-list
65179350|NCT00889252|Antipruritics|antipruritics|mesh-ancestor
65179351|NCT00889252|Dermatologic Agents|dermatologic agents|mesh-ancestor
65179352|NCT00889252|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65325683|NCT05674539|Vidarabine|vidarabine|mesh-list
65325684|NCT05674539|Fludarabine|fludarabine|mesh-list
65325685|NCT05674539|Fludarabine phosphate|fludarabine phosphate|mesh-list
65325686|NCT05674539|Melphalan|melphalan|mesh-list
65325687|NCT05674539|Busulfan|busulfan|mesh-list
65325688|NCT05674539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179353|NCT00889252|Histamine Antagonists|histamine antagonists|mesh-ancestor
65179354|NCT00889252|Histamine Agents|histamine agents|mesh-ancestor
65179355|NCT00889252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65179356|NCT00889252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179357|NCT00889252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179358|NCT00889252|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65179364|NCT00670813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65179365|NCT00670813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179366|NCT01110330|Ketoconazole|ketoconazole|mesh-list
65179367|NCT01110330|Antifungal Agents|antifungal agents|mesh-ancestor
65179368|NCT01110330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65179369|NCT01110330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65179370|NCT01110330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65179371|NCT01110330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179372|NCT01110330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179373|NCT01110330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65179374|NCT01110330|Hormone Antagonists|hormone antagonists|mesh-ancestor
65179375|NCT01110330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65179376|NCT01110330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179377|NCT01110330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65179378|NCT00663481|Leucovorin|leucovorin|mesh-list
65179379|NCT00663481|Antidotes|antidotes|mesh-ancestor
65179380|NCT00663481|Protective Agents|protective agents|mesh-ancestor
65179381|NCT00663481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179382|NCT00663481|Vitamin B Complex|vitamin b complex|mesh-ancestor
65179383|NCT00663481|Vitamins|vitamins|mesh-ancestor
65179384|NCT00663481|Micronutrients|micronutrients|mesh-ancestor
65179385|NCT04308954|Flumazenil|flumazenil|mesh-list
65179386|NCT04308954|Antidotes|antidotes|mesh-ancestor
65179387|NCT04308954|Protective Agents|protective agents|mesh-ancestor
65179388|NCT04308954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179389|NCT04308954|GABA Modulators|gaba modulators|mesh-ancestor
65179390|NCT04308954|GABA Agents|gaba agents|mesh-ancestor
65179391|NCT04308954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65179392|NCT04308954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179393|NCT00596947|Mycophenolic Acid|mycophenolic acid|mesh-list
65179394|NCT00596947|Prednisone|prednisone|mesh-list
65179395|NCT00596947|Methylprednisolone|methylprednisolone|mesh-list
65179396|NCT00596947|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65179397|NCT00596947|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65179398|NCT00596947|Prednisolone|prednisolone|mesh-list
65179399|NCT00596947|Prednisolone acetate|prednisolone acetate|mesh-list
65179400|NCT00596947|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65179401|NCT00596947|Prednisolone phosphate|prednisolone phosphate|mesh-list
65179402|NCT00596947|Tacrolimus|tacrolimus|mesh-list
65179403|NCT00596947|Thymoglobulin|thymoglobulin|mesh-list
65179404|NCT00596947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65179405|NCT00596947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65179406|NCT00596947|Glucocorticoids|glucocorticoids|mesh-ancestor
65179407|NCT00596947|Hormones|hormones|mesh-ancestor
65179408|NCT00596947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65179409|NCT00596947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179410|NCT00596947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65179411|NCT00596947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179412|NCT00596947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65179413|NCT00596947|Immunologic Factors|immunologic factors|mesh-ancestor
65179414|NCT00596947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65179415|NCT00596947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179416|NCT00596947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179417|NCT00596947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65179418|NCT00596947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65179419|NCT00596947|Antitubercular Agents|antitubercular agents|mesh-ancestor
65179420|NCT00596947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65179421|NCT00596947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65325689|NCT05674539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65325690|NCT05674539|Antimetabolites|antimetabolites|mesh-ancestor
65325691|NCT05674539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325692|NCT05674539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65325693|NCT05674539|Immunologic Factors|immunologic factors|mesh-ancestor
65325694|NCT05674539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325695|NCT05674539|Antiviral Agents|antiviral agents|mesh-ancestor
65179422|NCT00596947|Antiemetics|antiemetics|mesh-ancestor
65179423|NCT00596947|Autonomic Agents|autonomic agents|mesh-ancestor
65179424|NCT00596947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179425|NCT00596947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65179426|NCT00596947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65179427|NCT00596947|Protective Agents|protective agents|mesh-ancestor
65179428|NCT04155697|Hand Sanitizers|hand sanitizers|mesh-list
65179433|NCT04155697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65179434|NCT04155697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179436|NCT00663559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179437|NCT00663559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65179438|NCT00663559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65179439|NCT00663559|Growth Substances|growth substances|mesh-ancestor
65179440|NCT00663559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179441|NCT00663559|Growth Inhibitors|growth inhibitors|mesh-ancestor
65179442|NCT00663559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65179443|NCT00663559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179444|NCT00663559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179445|NCT04158349|Oxaliplatin|oxaliplatin|mesh-list
65179446|NCT04158349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179447|NCT00888940|Ecallantide|ecallantide|mesh-list
65179448|NCT00888940|Tranexamic Acid|tranexamic acid|mesh-list
65179449|NCT00888940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65179450|NCT00888940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65179451|NCT00888940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179452|NCT00888940|Hemostatics|hemostatics|mesh-ancestor
65179453|NCT00888940|Coagulants|coagulants|mesh-ancestor
65179454|NCT00888940|Analgesics|analgesics|mesh-ancestor
65179455|NCT00888940|Sensory System Agents|sensory system agents|mesh-ancestor
65179456|NCT00888940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179457|NCT00888940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179458|NCT00888940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65179459|NCT00888940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65179460|NCT00888940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65179461|NCT00888940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65179462|NCT02826070|Adefovir|adefovir|mesh-list
65179463|NCT02826070|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65179464|NCT02826070|Telbivudine|telbivudine|mesh-list
65179465|NCT02826070|Antiviral Agents|antiviral agents|mesh-ancestor
65179466|NCT02826070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65179467|NCT02826070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65179468|NCT02826070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65179469|NCT02826070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179470|NCT02826070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179471|NCT02826226|Bronchodilator Agents|bronchodilator agents|mesh-list
65179472|NCT02826226|Autonomic Agents|autonomic agents|mesh-ancestor
65179473|NCT02826226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179474|NCT02826226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179475|NCT02826226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65179476|NCT02826226|Respiratory System Agents|respiratory system agents|mesh-ancestor
65179477|NCT00671203|Erythromycin|erythromycin|mesh-list
65179478|NCT00671203|Erythromycin Estolate|erythromycin estolate|mesh-list
65179479|NCT00671203|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65179480|NCT00671203|Erythromycin stearate|erythromycin stearate|mesh-list
65179481|NCT00671203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65179482|NCT00671203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65179483|NCT00671203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65179484|NCT00671203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65179485|NCT00671203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179486|NCT00671203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325696|NCT05674539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65325697|NCT05674539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65325698|NCT05674539|Alkylating Agents|alkylating agents|mesh-ancestor
65325699|NCT05674539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65325700|NCT00717522|Pomalidomide|pomalidomide|mesh-list
65325701|NCT00717522|Immunologic Factors|immunologic factors|mesh-ancestor
65325702|NCT00717522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325703|NCT00717522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65325704|NCT00717522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65325705|NCT00717522|Growth Substances|growth substances|mesh-ancestor
65325706|NCT00717522|Growth Inhibitors|growth inhibitors|mesh-ancestor
65179487|NCT04157803|Acetic Acid|acetic acid|mesh-list
65179488|NCT04157803|Retinol acetate|retinol acetate|mesh-list
65179489|NCT04157803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65179490|NCT04157803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65179491|NCT04157803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65179492|NCT04157803|Immunologic Factors|immunologic factors|mesh-ancestor
65179493|NCT04157803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179494|NCT04157803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65179495|NCT04157803|Protective Agents|protective agents|mesh-ancestor
65179496|NCT04157803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179497|NCT04157959|Febuxostat|febuxostat|mesh-list
65179498|NCT04157959|Gout Suppressants|gout suppressants|mesh-ancestor
65179499|NCT04157959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65179500|NCT00660283|Temozolomide|temozolomide|mesh-list
65179509|NCT00663949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179511|NCT00663949|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65179512|NCT00663949|Protective Agents|protective agents|mesh-ancestor
65179513|NCT00663949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179514|NCT00663949|Vasodilator Agents|vasodilator agents|mesh-ancestor
65179515|NCT00663949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65179516|NCT00663949|Antioxidants|antioxidants|mesh-ancestor
65179517|NCT00663949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65179518|NCT00663949|Protease Inhibitors|protease inhibitors|mesh-ancestor
65179519|NCT00663949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65179520|NCT00888238|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65179521|NCT00888238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65179522|NCT00888238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179523|NCT00888238|Incretins|incretins|mesh-ancestor
65179524|NCT00888238|Hormones|hormones|mesh-ancestor
65179525|NCT00888238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65179526|NCT00888238|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65179527|NCT00888238|Protease Inhibitors|protease inhibitors|mesh-ancestor
65179528|NCT00888238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179529|NCT00888238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179530|NCT05660356|Hormones|hormones|mesh-list
65179531|NCT05660356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65179532|NCT05660356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179533|NCT02825914|Caseins|caseins|mesh-list
65179534|NCT02825914|Chelating Agents|chelating agents|mesh-ancestor
65179535|NCT02825914|Sequestering Agents|sequestering agents|mesh-ancestor
65179536|NCT02825914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179537|NCT00671281|Tranexamic Acid|tranexamic acid|mesh-list
65179538|NCT00671281|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65179539|NCT00671281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65179540|NCT00671281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179541|NCT00671281|Hemostatics|hemostatics|mesh-ancestor
65179542|NCT00671281|Coagulants|coagulants|mesh-ancestor
65179543|NCT04155229|Acetaminophen|acetaminophen|mesh-list
65179544|NCT04155229|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65179545|NCT04155229|Oxycodone|oxycodone|mesh-list
65179546|NCT04155229|Hydrocodone|hydrocodone|mesh-list
65179547|NCT04155229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65179548|NCT04155229|Analgesics|analgesics|mesh-ancestor
65325707|NCT00717522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325708|NCT00791921|Certolizumab Pegol|certolizumab pegol|mesh-list
65325709|NCT00791921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65325710|NCT00791921|Immunologic Factors|immunologic factors|mesh-ancestor
65325711|NCT00791921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179549|NCT04155229|Sensory System Agents|sensory system agents|mesh-ancestor
65179550|NCT04155229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179551|NCT04155229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179552|NCT04155229|Antipyretics|antipyretics|mesh-ancestor
65179553|NCT04155229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64822109|NCT01519401|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65179554|NCT04155229|Narcotics|narcotics|mesh-ancestor
65179555|NCT04155229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65179556|NCT04155229|Antitussive Agents|antitussive agents|mesh-ancestor
64713418|NCT02785952|Nivolumab|nivolumab|mesh-list
64713419|NCT02785952|Ipilimumab|ipilimumab|mesh-list
64713420|NCT02785952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65179570|NCT04153201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179571|NCT04153201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65179572|NCT05660278|Caseins|caseins|mesh-list
65179573|NCT05660278|Chelating Agents|chelating agents|mesh-ancestor
65179574|NCT05660278|Sequestering Agents|sequestering agents|mesh-ancestor
65179575|NCT05660278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179576|NCT04153123|Epinephrine|epinephrine|mesh-list
65179577|NCT04153123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65179578|NCT04153123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65179579|NCT04153123|Adrenergic Agents|adrenergic agents|mesh-ancestor
65179580|NCT04153123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65179581|NCT04153123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179582|NCT04153123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179583|NCT04153123|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65179584|NCT04153123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65179585|NCT04153123|Autonomic Agents|autonomic agents|mesh-ancestor
65179586|NCT04153123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179587|NCT04153123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65179588|NCT04153123|Respiratory System Agents|respiratory system agents|mesh-ancestor
65179589|NCT04153123|Mydriatics|mydriatics|mesh-ancestor
65179590|NCT04153123|Sympathomimetics|sympathomimetics|mesh-ancestor
65179591|NCT04153123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65179592|NCT00671593|Phenol|phenol|mesh-list
65179593|NCT00671593|Glycerol|glycerol|mesh-list
65179594|NCT00671593|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65179595|NCT00671593|Protective Agents|protective agents|mesh-ancestor
65179596|NCT00671593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179597|NCT00671593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65179598|NCT00671593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65179599|NCT00671593|Disinfectants|disinfectants|mesh-ancestor
65179600|NCT00671593|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65179601|NCT00671593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65179602|NCT01104870|Treprostinil|treprostinil|mesh-list
65179603|NCT01104870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65179604|NCT02632279|Tryptophan|tryptophan|mesh-list
65179605|NCT02632279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65179606|NCT02632279|Antidepressive Agents|antidepressive agents|mesh-ancestor
65179607|NCT02632279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65179608|NCT00664417|Vaccines|vaccines|mesh-list
65179609|NCT00664417|Immunologic Factors|immunologic factors|mesh-ancestor
65179610|NCT00664417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179611|NCT04031755|Minocycline|minocycline|mesh-list
65179612|NCT04031755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65179613|NCT04031755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65179614|NCT01104792|Cariprazine|cariprazine|mesh-list
65179615|NCT01104792|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65179616|NCT01104792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65179625|NCT01205126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179626|NCT01205126|Analgesics|analgesics|mesh-ancestor
65179627|NCT01205126|Sensory System Agents|sensory system agents|mesh-ancestor
65179628|NCT01205126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179629|NCT02629627|Metformin|metformin|mesh-list
65179630|NCT02629627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65179631|NCT02629627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179633|NCT00946647|Panobinostat|panobinostat|mesh-list
65222849|NCT02586181|Vitamin B Complex|vitamin b complex|mesh-ancestor
65325712|NCT00791921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65325713|NCT04106843|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65325714|NCT04106843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325715|NCT04106843|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65325716|NCT03475953|Avelumab|avelumab|mesh-list
65325717|NCT03475953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65325718|NCT03475953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65325719|NCT03475953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325720|NCT03475953|Immunologic Factors|immunologic factors|mesh-ancestor
65325721|NCT03475953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325722|NCT00582933|Vidarabine|vidarabine|mesh-list
65325723|NCT00582933|Fludarabine|fludarabine|mesh-list
65325724|NCT00582933|Fludarabine phosphate|fludarabine phosphate|mesh-list
65325725|NCT00582933|Melphalan|melphalan|mesh-list
65325726|NCT00582933|Busulfan|busulfan|mesh-list
65325727|NCT00582933|Lenograstim|lenograstim|mesh-list
65325728|NCT00582933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325729|NCT00582933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65325730|NCT00582933|Antimetabolites|antimetabolites|mesh-ancestor
65325731|NCT00582933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555295|NCT05015322|Glucocorticoids|glucocorticoids|mesh-ancestor
65179634|NCT00946647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65179635|NCT00946647|Antimetabolites|antimetabolites|mesh-ancestor
65179636|NCT00946647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179637|NCT00946647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179638|NCT00946647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179639|NCT00946647|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65179641|NCT05117736|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65179642|NCT05117736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65179643|NCT05117736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65179644|NCT05117736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65179645|NCT05117736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179646|NCT04157491|Antibodies|antibodies|mesh-list
65179647|NCT04157491|Immunologic Factors|immunologic factors|mesh-ancestor
65179648|NCT04157491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179649|NCT00660751|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65179650|NCT00660751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65179651|NCT00660751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65179652|NCT00660751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65179653|NCT00660751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179654|NCT00660751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65179655|NCT00660751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179656|NCT00660751|Analgesics|analgesics|mesh-ancestor
65179657|NCT00660751|Sensory System Agents|sensory system agents|mesh-ancestor
65179658|NCT00660751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179659|NCT00660751|Antidepressive Agents|antidepressive agents|mesh-ancestor
65179660|NCT00660751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65179661|NCT00660751|Dopamine Agents|dopamine agents|mesh-ancestor
65179662|NCT00664963|Sirolimus|sirolimus|mesh-list
65179663|NCT00664963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65179664|NCT00664963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65179665|NCT00664963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65222850|NCT02586181|Hematinics|hematinics|mesh-ancestor
65325732|NCT00582933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65325733|NCT00582933|Immunologic Factors|immunologic factors|mesh-ancestor
65325734|NCT00582933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325735|NCT00582933|Antiviral Agents|antiviral agents|mesh-ancestor
65325736|NCT00582933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65325737|NCT00582933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65325738|NCT00582933|Alkylating Agents|alkylating agents|mesh-ancestor
65325739|NCT00582933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64555315|NCT00919503|Fludarabine phosphate|fludarabine phosphate|mesh-list
64555316|NCT00919503|Fludarabine|fludarabine|mesh-list
65179666|NCT00664963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179667|NCT00664963|Antifungal Agents|antifungal agents|mesh-ancestor
65179668|NCT00664963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65179669|NCT00664963|Immunologic Factors|immunologic factors|mesh-ancestor
65179670|NCT00664963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179671|NCT00672295|Paclitaxel|paclitaxel|mesh-list
65179672|NCT00672295|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65179673|NCT00672295|Carboplatin|carboplatin|mesh-list
65179674|NCT00672295|Dasatinib|dasatinib|mesh-list
65179675|NCT00672295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65179676|NCT00672295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179677|NCT00672295|Tubulin Modulators|tubulin modulators|mesh-ancestor
65179678|NCT00672295|Antimitotic Agents|antimitotic agents|mesh-ancestor
65179679|NCT00672295|Mitosis Modulators|mitosis modulators|mesh-ancestor
65179680|NCT00672295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179681|NCT00672295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64713602|NCT02185560|Sorafenib|sorafenib|mesh-list
65179682|NCT00672295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179683|NCT00665041|Quinagolide|quinagolide|mesh-list
65179689|NCT04152655|Coenzyme Q10|coenzyme q10|mesh-list
65179690|NCT04152655|Idebenone|idebenone|mesh-list
65179691|NCT04152655|Micronutrients|micronutrients|mesh-ancestor
65179692|NCT04152655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179693|NCT04152655|Vitamins|vitamins|mesh-ancestor
65179694|NCT04152655|Antioxidants|antioxidants|mesh-ancestor
65179695|NCT04152655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179696|NCT04152655|Protective Agents|protective agents|mesh-ancestor
65179697|NCT00665119|Remifentanil|remifentanil|mesh-list
65179698|NCT00665119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65179699|NCT00665119|Narcotics|narcotics|mesh-ancestor
65179700|NCT00665119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65179701|NCT00665119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179702|NCT00665119|Analgesics|analgesics|mesh-ancestor
65179703|NCT00665119|Sensory System Agents|sensory system agents|mesh-ancestor
65179704|NCT00665119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179705|NCT00887224|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65179706|NCT00887224|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65179707|NCT00887224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65179708|NCT00887224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65179709|NCT00887224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179710|NCT00887224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65179711|NCT00887224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179712|NCT00887224|Antidepressive Agents|antidepressive agents|mesh-ancestor
65179713|NCT00887224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65179714|NCT00672763|Calcium, Dietary|calcium, dietary|mesh-list
65179715|NCT00672763|Vitamin D|vitamin d|mesh-list
65179716|NCT00672763|Ergocalciferols|ergocalciferols|mesh-list
65179717|NCT00672763|Cholecalciferol|cholecalciferol|mesh-list
65179718|NCT00672763|Vitamins|vitamins|mesh-list
65179719|NCT00672763|Calcium|calcium|mesh-list
65179720|NCT00672763|Micronutrients|micronutrients|mesh-ancestor
65179721|NCT00672763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179722|NCT00672763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65179723|NCT00672763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65179724|NCT04154449|Insulin|insulin|mesh-list
65179725|NCT04154449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65179726|NCT04154449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325740|NCT00582933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65325741|NCT00791765|Etanercept|etanercept|mesh-list
65325742|NCT00791765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65325743|NCT00791765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65325744|NCT00791765|Analgesics|analgesics|mesh-ancestor
65325745|NCT00791765|Sensory System Agents|sensory system agents|mesh-ancestor
65325746|NCT00791765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65325747|NCT00791765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325748|NCT00791765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64555325|NCT00919503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64555328|NCT00919503|Antimetabolites|antimetabolites|mesh-ancestor
65179727|NCT00661063|Clonidine|clonidine|mesh-list
65179728|NCT00661063|Ketamine|ketamine|mesh-list
65179729|NCT00661063|Analgesics|analgesics|mesh-ancestor
65179730|NCT00661063|Sensory System Agents|sensory system agents|mesh-ancestor
65179731|NCT00661063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179732|NCT00661063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179733|NCT00661063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65179734|NCT00661063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65179735|NCT00661063|Anesthetics, General|anesthetics, general|mesh-ancestor
65179736|NCT00661063|Anesthetics|anesthetics|mesh-ancestor
65179737|NCT00661063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65179738|NCT00661063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65179739|NCT00661063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65179740|NCT00661063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65179741|NCT00661063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179742|NCT00661063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65179743|NCT00661063|Sympatholytics|sympatholytics|mesh-ancestor
65179744|NCT00661063|Autonomic Agents|autonomic agents|mesh-ancestor
65179745|NCT00661063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65179746|NCT00661063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65179747|NCT00661063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65179748|NCT00661063|Adrenergic Agents|adrenergic agents|mesh-ancestor
65179749|NCT00672919|Pioglitazone|pioglitazone|mesh-list
65179750|NCT00672919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65179751|NCT00672919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179752|NCT01109316|Insulin|insulin|mesh-list
65179753|NCT01109316|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65179754|NCT01109316|Insulin Aspart|insulin aspart|mesh-list
65179766|NCT02825290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65179767|NCT02825290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179768|NCT00675961|Naltrexone|naltrexone|mesh-list
65179769|NCT00675961|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65179770|NCT00675961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65179771|NCT00675961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179772|NCT00675961|Sensory System Agents|sensory system agents|mesh-ancestor
65179773|NCT00675961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179774|NCT00887068|Azacitidine|azacitidine|mesh-list
65179775|NCT00887068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65179776|NCT00887068|Antimetabolites|antimetabolites|mesh-ancestor
65179777|NCT00887068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179778|NCT00887068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179779|NCT00887068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179780|NCT00941031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65179781|NCT00941031|Immunologic Factors|immunologic factors|mesh-ancestor
65179782|NCT00941031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179783|NCT00886834|Misoprostol|misoprostol|mesh-list
65179784|NCT00886834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65179785|NCT00886834|Abortifacient Agents|abortifacient agents|mesh-ancestor
65179786|NCT00886834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65179787|NCT00886834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179788|NCT00886834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65179789|NCT00886834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65179790|NCT00886834|Oxytocics|oxytocics|mesh-ancestor
65179791|NCT00880009|Letrozole|letrozole|mesh-list
65325749|NCT00791765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65325750|NCT00791765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65325751|NCT00791765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65325752|NCT00791765|Immunologic Factors|immunologic factors|mesh-ancestor
65325753|NCT03648021|Acetaminophen|acetaminophen|mesh-list
65325754|NCT03648021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65325755|NCT03648021|Analgesics|analgesics|mesh-ancestor
65325756|NCT03648021|Sensory System Agents|sensory system agents|mesh-ancestor
64555333|NCT00919503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64320443|NCT02752633|Antioxidants|antioxidants|mesh-ancestor
65179792|NCT00880009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179793|NCT00880009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65179794|NCT00880009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65179795|NCT00880009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179796|NCT00880009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179797|NCT00880009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65179798|NCT00880009|Hormone Antagonists|hormone antagonists|mesh-ancestor
65179799|NCT00880009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65179800|NCT00880009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179801|NCT00676039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65179802|NCT00676039|Citalopram|citalopram|mesh-list
65179803|NCT00676039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65179804|NCT00676039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65179805|NCT00676039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65179806|NCT00676039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179807|NCT00676039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65179808|NCT00676039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179809|NCT00676039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65179810|NCT00676039|Antidepressive Agents|antidepressive agents|mesh-ancestor
65179811|NCT00676039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65179812|NCT00676039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65179813|NCT00676039|Serotonin Agents|serotonin agents|mesh-ancestor
65179814|NCT01104636|Varenicline|varenicline|mesh-list
65179815|NCT01104636|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65179816|NCT01104636|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65179817|NCT01104636|Cholinergic Agents|cholinergic agents|mesh-ancestor
65179818|NCT01104636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65179822|NCT04931602|Vitamins|vitamins|mesh-ancestor
65179823|NCT04931602|Micronutrients|micronutrients|mesh-ancestor
65179824|NCT04931602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179825|NCT04931602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65179826|NCT04157257|Tenofovir|tenofovir|mesh-list
65179827|NCT04157257|Entecavir|entecavir|mesh-list
65179828|NCT04157257|Antiviral Agents|antiviral agents|mesh-ancestor
65179829|NCT04157257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65179830|NCT04157257|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65179831|NCT04157257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65179832|NCT04157257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179833|NCT04157257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179834|NCT04157257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65179835|NCT04157257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65179836|NCT04152889|Docetaxel|docetaxel|mesh-list
65179837|NCT04152889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179838|NCT04152889|Tubulin Modulators|tubulin modulators|mesh-ancestor
65179839|NCT04152889|Antimitotic Agents|antimitotic agents|mesh-ancestor
65179840|NCT04152889|Mitosis Modulators|mitosis modulators|mesh-ancestor
65179841|NCT04152889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179842|NCT00602511|Thalidomide|thalidomide|mesh-list
65179843|NCT00602511|Bortezomib|bortezomib|mesh-list
65179844|NCT00602511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179845|NCT00602511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65179846|NCT00602511|Immunologic Factors|immunologic factors|mesh-ancestor
65179847|NCT00602511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179848|NCT00602511|Leprostatic Agents|leprostatic agents|mesh-ancestor
65179849|NCT00602511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65325757|NCT03648021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65325758|NCT03648021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325759|NCT03648021|Antipyretics|antipyretics|mesh-ancestor
65325760|NCT00789191|Metformin|metformin|mesh-list
65325761|NCT00789191|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65325762|NCT00789191|Insulin Detemir|insulin detemir|mesh-list
65325763|NCT00789191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65325764|NCT00789191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325765|NCT00789191|Incretins|incretins|mesh-ancestor
65179850|NCT00602511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65179851|NCT00602511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65179852|NCT00602511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65179853|NCT00602511|Growth Substances|growth substances|mesh-ancestor
65179854|NCT00602511|Growth Inhibitors|growth inhibitors|mesh-ancestor
65179855|NCT02826616|Trimetazidine|trimetazidine|mesh-list
65179856|NCT02826616|Vasodilator Agents|vasodilator agents|mesh-ancestor
65179857|NCT00676117|Loxoprofen|loxoprofen|mesh-list
65179858|NCT00676117|Esomeprazole|esomeprazole|mesh-list
65179859|NCT00676117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65179860|NCT00676117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65179861|NCT00676117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65179862|NCT00676117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179863|NCT00676117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179864|NCT00676117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65179865|NCT00676117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65179866|NCT00676117|Analgesics|analgesics|mesh-ancestor
65179867|NCT00676117|Sensory System Agents|sensory system agents|mesh-ancestor
65179868|NCT00676117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179869|NCT00676117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179870|NCT00676117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65179871|NCT00676117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65179872|NCT01104558|Bisoprolol|bisoprolol|mesh-list
65179873|NCT01104558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65179874|NCT01104558|Sympatholytics|sympatholytics|mesh-ancestor
65179875|NCT01104558|Autonomic Agents|autonomic agents|mesh-ancestor
65179876|NCT01104558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179877|NCT01104558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179878|NCT01104558|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65179879|NCT01104558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65179880|NCT01104558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65179881|NCT01104558|Adrenergic Agents|adrenergic agents|mesh-ancestor
65179882|NCT01104558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65179883|NCT01104558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179884|NCT00602589|Levofloxacin|levofloxacin|mesh-list
65179885|NCT00602589|Ofloxacin|ofloxacin|mesh-list
65179886|NCT00602589|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65179887|NCT00602589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65179888|NCT00602589|Renal Agents|renal agents|mesh-ancestor
65179889|NCT00602589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65179890|NCT00602589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65179891|NCT00602589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65179896|NCT00602589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65179897|NCT04270071|Nitroglycerin|nitroglycerin|mesh-list
65179898|NCT04270071|Vasodilator Agents|vasodilator agents|mesh-ancestor
65179899|NCT02856087|Remifentanil|remifentanil|mesh-list
65179900|NCT02856087|Naloxone|naloxone|mesh-list
65179901|NCT02856087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65179902|NCT02856087|Narcotics|narcotics|mesh-ancestor
65179903|NCT02856087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65179904|NCT02856087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179905|NCT02856087|Analgesics|analgesics|mesh-ancestor
65179906|NCT02856087|Sensory System Agents|sensory system agents|mesh-ancestor
65179907|NCT02856087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179908|NCT02856087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65179909|NCT00676429|Ziprasidone|ziprasidone|mesh-list
65179910|NCT00676429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65179911|NCT00676429|Serotonin Agents|serotonin agents|mesh-ancestor
65179912|NCT00676429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65325766|NCT00789191|Hormones|hormones|mesh-ancestor
65325767|NCT00789191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65325768|NCT00789191|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65325769|NCT00789191|Protease Inhibitors|protease inhibitors|mesh-ancestor
65325770|NCT00789191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325771|NCT00789191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325772|NCT02603315|Mitogens|mitogens|mesh-list
65325773|NCT02603315|Endothelial Growth Factors|endothelial growth factors|mesh-list
65325774|NCT02603315|Mitosis Modulators|mitosis modulators|mesh-ancestor
65325775|NCT02603315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325776|NCT02603315|Growth Substances|growth substances|mesh-ancestor
65325777|NCT02603315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325778|NCT00789035|Metformin|metformin|mesh-list
65325779|NCT00789035|Empagliflozin|empagliflozin|mesh-list
65325780|NCT00789035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65325781|NCT00789035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325782|NCT00789035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65325783|NCT00789035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325784|NCT04108013|Paclitaxel|paclitaxel|mesh-list
65325785|NCT04108013|Carboplatin|carboplatin|mesh-list
65325786|NCT04108013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65325787|NCT04108013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325788|NCT04108013|Tubulin Modulators|tubulin modulators|mesh-ancestor
65325789|NCT04108013|Antimitotic Agents|antimitotic agents|mesh-ancestor
65179913|NCT00676429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179914|NCT00676429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179915|NCT00676429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65179916|NCT00676429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65179917|NCT00676429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65179918|NCT00676429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65179919|NCT00676429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65179920|NCT00676429|Dopamine Agents|dopamine agents|mesh-ancestor
65179921|NCT02629315|Formaldehyde|formaldehyde|mesh-list
65179922|NCT02629315|Disinfectants|disinfectants|mesh-ancestor
65179923|NCT02629315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65179924|NCT01204658|Vaccines|vaccines|mesh-list
65179925|NCT01204658|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65179926|NCT01204658|Immunologic Factors|immunologic factors|mesh-ancestor
65179927|NCT01204658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179928|NCT00951483|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65179929|NCT00951483|Antidepressive Agents|antidepressive agents|mesh-ancestor
65179930|NCT00951483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65179931|NCT00951483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65179932|NCT00951483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65179933|NCT00951483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65179934|NCT00951483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179935|NCT01104246|Testosterone|testosterone|mesh-list
65179936|NCT01104246|Androgens|androgens|mesh-ancestor
65179937|NCT01104246|Hormones|hormones|mesh-ancestor
65222851|NCT03181035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
65325790|NCT04108013|Mitosis Modulators|mitosis modulators|mesh-ancestor
65325791|NCT04108013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325792|NCT04105985|Oxymetazoline|oxymetazoline|mesh-list
65325793|NCT04105985|Tetracaine|tetracaine|mesh-list
65325794|NCT04105985|Carticaine|carticaine|mesh-list
65325795|NCT04105985|Anesthetics, Local|anesthetics, local|mesh-ancestor
65325796|NCT04105985|Anesthetics|anesthetics|mesh-ancestor
65325797|NCT04105985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64555368|NCT03092076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555369|NCT04193501|Melatonin|melatonin|mesh-list
64555370|NCT04193501|Antioxidants|antioxidants|mesh-ancestor
64555371|NCT04193501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555372|NCT04193501|Protective Agents|protective agents|mesh-ancestor
64555373|NCT04193501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320479|NCT04411862|Nootropic Agents|nootropic agents|mesh-ancestor
65179938|NCT01104246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65179939|NCT01104246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179940|NCT00676741|Insulin|insulin|mesh-list
65179941|NCT00676741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65179942|NCT00676741|Insulin Aspart|insulin aspart|mesh-list
65179943|NCT00676741|Insulin, Long-Acting|insulin, long-acting|mesh-list
65179944|NCT00676741|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65179945|NCT00676741|Insulin Detemir|insulin detemir|mesh-list
65179946|NCT00676741|Biphasic Insulins|biphasic insulins|mesh-list
65179947|NCT00676741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65179948|NCT00676741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65179949|NCT00676741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179950|NCT01103778|Bortezomib|bortezomib|mesh-list
65179951|NCT01103778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179952|NCT00673621|Albuterol|albuterol|mesh-list
65179953|NCT00673621|Methacholine Chloride|methacholine chloride|mesh-list
65179954|NCT00673621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179955|NCT00673621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65179956|NCT00673621|Autonomic Agents|autonomic agents|mesh-ancestor
65179957|NCT00673621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179958|NCT00673621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65179959|NCT00673621|Respiratory System Agents|respiratory system agents|mesh-ancestor
65179960|NCT00673621|Tocolytic Agents|tocolytic agents|mesh-ancestor
65179961|NCT00673621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65179962|NCT00673621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65179966|NCT00673621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65179967|NCT00673621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179968|NCT00673621|Miotics|miotics|mesh-ancestor
65179969|NCT00673621|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65179970|NCT00673621|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
65179971|NCT00673621|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65179972|NCT00673621|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65179973|NCT00673621|Cholinergic Agents|cholinergic agents|mesh-ancestor
65179974|NCT02627053|Rivaroxaban|rivaroxaban|mesh-list
65179975|NCT02627053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65179976|NCT02627053|Antithrombins|antithrombins|mesh-ancestor
65179977|NCT02627053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65179978|NCT02627053|Protease Inhibitors|protease inhibitors|mesh-ancestor
65179979|NCT02627053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179980|NCT02627053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179981|NCT02627053|Anticoagulants|anticoagulants|mesh-ancestor
65179982|NCT00945945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65179983|NCT00945945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65179985|NCT00945945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65222852|NCT03181035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65325798|NCT04105985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325799|NCT04105985|Sensory System Agents|sensory system agents|mesh-ancestor
65325800|NCT04105985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65325801|NCT04105985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65325802|NCT04105985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65325803|NCT04105985|Adrenergic Agents|adrenergic agents|mesh-ancestor
65325804|NCT04105985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65325805|NCT04105985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555374|NCT04193501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64555375|NCT04374279|Bicalutamide|bicalutamide|mesh-list
65179986|NCT00945945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179987|NCT00945945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65179988|NCT00945945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179989|NCT00945945|Analgesics|analgesics|mesh-ancestor
65179990|NCT00945945|Sensory System Agents|sensory system agents|mesh-ancestor
65179991|NCT00945945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179992|NCT00945945|Antidepressive Agents|antidepressive agents|mesh-ancestor
65179993|NCT00945945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65179994|NCT00945945|Dopamine Agents|dopamine agents|mesh-ancestor
65179995|NCT01112982|Colchicine|colchicine|mesh-list
65179996|NCT01112982|Febuxostat|febuxostat|mesh-list
65179997|NCT01112982|Gout Suppressants|gout suppressants|mesh-ancestor
65179998|NCT01112982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65179999|NCT01112982|Tubulin Modulators|tubulin modulators|mesh-ancestor
65180000|NCT01112982|Antimitotic Agents|antimitotic agents|mesh-ancestor
65180001|NCT01112982|Mitosis Modulators|mitosis modulators|mesh-ancestor
65180002|NCT01112982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180003|NCT01112982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180004|NCT01203878|Imiquimod|imiquimod|mesh-list
65180005|NCT01203878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65180006|NCT01203878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65180007|NCT01203878|Immunologic Factors|immunologic factors|mesh-ancestor
65180008|NCT01203878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180009|NCT01203878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180010|NCT01203878|Interferon Inducers|interferon inducers|mesh-ancestor
65180011|NCT01203878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65180012|NCT01203878|Dermatologic Agents|dermatologic agents|mesh-ancestor
65180013|NCT00676819|Insulin|insulin|mesh-list
65180014|NCT00676819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65180015|NCT00676819|Insulin Aspart|insulin aspart|mesh-list
65180016|NCT00676819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65180017|NCT00676819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180018|NCT00625794|Nicotine|nicotine|mesh-list
65180019|NCT00625794|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65180020|NCT00625794|Autonomic Agents|autonomic agents|mesh-ancestor
65180021|NCT00625794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65180022|NCT00625794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180023|NCT00625794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65180024|NCT00625794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65180025|NCT00625794|Cholinergic Agents|cholinergic agents|mesh-ancestor
65180026|NCT00625794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65180027|NCT00625794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180028|NCT01203098|Enoxaparin|enoxaparin|mesh-list
65180029|NCT01203098|Enoxaparin sodium|enoxaparin sodium|mesh-list
65180030|NCT01203098|Edoxaban|edoxaban|mesh-list
65180031|NCT01203098|Anticoagulants|anticoagulants|mesh-ancestor
65180032|NCT01203098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65180033|NCT01203098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65180034|NCT01203098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180035|NCT01203098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65180036|NCT01203098|Antithrombins|antithrombins|mesh-ancestor
65180037|NCT01203098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65180044|NCT00945555|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65180045|NCT00945555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65180046|NCT01108458|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65325806|NCT04105985|Sympathomimetics|sympathomimetics|mesh-ancestor
65325807|NCT04105985|Autonomic Agents|autonomic agents|mesh-ancestor
65325808|NCT04105985|Nasal Decongestants|nasal decongestants|mesh-ancestor
65325809|NCT04105985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65325810|NCT04105985|Respiratory System Agents|respiratory system agents|mesh-ancestor
65325811|NCT04074213|Clozapine|clozapine|mesh-list
65325812|NCT04074213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65325813|NCT04074213|Serotonin Agents|serotonin agents|mesh-ancestor
65325814|NCT04074213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65325815|NCT04074213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325816|NCT04074213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325817|NCT04074213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65325818|NCT04074213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65325819|NCT04074213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65325820|NCT04074213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65325821|NCT04074213|GABA Antagonists|gaba antagonists|mesh-ancestor
65325822|NCT04074213|GABA Agents|gaba agents|mesh-ancestor
65325823|NCT04110587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65325824|NCT04110587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65325825|NCT04110587|Analgesics|analgesics|mesh-list
65325826|NCT04110587|Hyaluronic Acid|hyaluronic acid|mesh-list
65325827|NCT04110587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65325828|NCT04110587|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65325829|NCT04110587|Immunologic Factors|immunologic factors|mesh-ancestor
65325830|NCT04110587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325831|NCT04110587|Viscosupplements|viscosupplements|mesh-ancestor
65325832|NCT04110587|Protective Agents|protective agents|mesh-ancestor
64555381|NCT03957551|Pembrolizumab|pembrolizumab|mesh-list
65180047|NCT01108458|Pertuzumab|pertuzumab|mesh-list
65180048|NCT01108458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180049|NCT01108458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65180050|NCT01108458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180051|NCT01108458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180052|NCT01108458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65180053|NCT04318262|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65180054|NCT04318262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65180055|NCT00680485|Ketoconazole|ketoconazole|mesh-list
65180056|NCT00680485|Antifungal Agents|antifungal agents|mesh-ancestor
65180057|NCT00680485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65180058|NCT00680485|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65180059|NCT00680485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65180060|NCT00680485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180061|NCT00680485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180062|NCT00680485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65180063|NCT00680485|Hormone Antagonists|hormone antagonists|mesh-ancestor
65180064|NCT00680485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65180065|NCT00680485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325833|NCT04110587|Sensory System Agents|sensory system agents|mesh-ancestor
65325834|NCT04110587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65325835|NCT03616587|Everolimus|everolimus|mesh-list
65325836|NCT03616587|Palbociclib|palbociclib|mesh-list
65325837|NCT03616587|Anastrozole|anastrozole|mesh-list
65325838|NCT03616587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325839|NCT03616587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65325840|NCT03616587|Immunologic Factors|immunologic factors|mesh-ancestor
64555407|NCT00211757|Anticonvulsants|anticonvulsants|mesh-ancestor
64555408|NCT00211757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555409|NCT00211757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555410|NCT00211757|GABA Agents|gaba agents|mesh-ancestor
65180066|NCT00680485|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65180067|NCT00680563|Epoetin Alfa|epoetin alfa|mesh-list
65180068|NCT00680563|Hematinics|hematinics|mesh-ancestor
65180069|NCT01108068|Lithium Carbonate|lithium carbonate|mesh-list
65180070|NCT01108068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180071|NCT01108068|Antidepressive Agents|antidepressive agents|mesh-ancestor
65180072|NCT01108068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65180073|NCT01108068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180074|NCT01108068|Antimanic Agents|antimanic agents|mesh-ancestor
65180075|NCT01108068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65180076|NCT01108068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65180077|NCT01108068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180078|NCT00680641|Simvastatin|simvastatin|mesh-list
65180079|NCT00680641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65180080|NCT00680641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65180081|NCT00680641|Antimetabolites|antimetabolites|mesh-ancestor
65180082|NCT00680641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822643|NCT01522989|Fluorouracil|fluorouracil|mesh-list
65180083|NCT00680641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65180084|NCT00680641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65180085|NCT00680641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180086|NCT01201850|Bevacizumab|bevacizumab|mesh-list
65180087|NCT01201850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65180088|NCT01201850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180089|NCT01201850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65180090|NCT01201850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65180091|NCT01201850|Growth Substances|growth substances|mesh-ancestor
65180092|NCT01201850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180093|NCT01201850|Growth Inhibitors|growth inhibitors|mesh-ancestor
65180094|NCT04980144|Lubricant Eye Drops|lubricant eye drops|mesh-list
65180095|NCT04980144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65180096|NCT04980144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65180097|NCT02825056|Morphine|morphine|mesh-list
65180098|NCT02825056|Bupivacaine|bupivacaine|mesh-list
65180099|NCT02825056|Anesthetics, Local|anesthetics, local|mesh-ancestor
65180100|NCT02825056|Anesthetics|anesthetics|mesh-ancestor
65180101|NCT02825056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65180102|NCT02825056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180103|NCT02825056|Sensory System Agents|sensory system agents|mesh-ancestor
65180104|NCT02825056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65180105|NCT02825056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65180106|NCT02825056|Narcotics|narcotics|mesh-ancestor
65180127|NCT01200992|Mitomycins|mitomycins|mesh-list
65180128|NCT01200992|Mitomycin|mitomycin|mesh-list
65180129|NCT01200992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65180130|NCT01200992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180131|NCT01200992|Alkylating Agents|alkylating agents|mesh-ancestor
65180132|NCT01200992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180133|NCT01200992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65180134|NCT01200992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180136|NCT02824666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65180137|NCT02824666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65325841|NCT03616587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325842|NCT03616587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65325843|NCT03616587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325844|NCT03616587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325845|NCT03616587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65325846|NCT03616587|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65325847|NCT03616587|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65180138|NCT02824666|Dopamine Agents|dopamine agents|mesh-ancestor
65180139|NCT02824666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65180140|NCT02824666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180141|NCT02824666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180142|NCT00674167|Docetaxel|docetaxel|mesh-list
65180143|NCT00674167|Capecitabine|capecitabine|mesh-list
65180144|NCT00674167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180145|NCT00674167|Tubulin Modulators|tubulin modulators|mesh-ancestor
65180146|NCT00674167|Antimitotic Agents|antimitotic agents|mesh-ancestor
65180147|NCT00674167|Mitosis Modulators|mitosis modulators|mesh-ancestor
65180148|NCT00674167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180149|NCT00674167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65180150|NCT00674167|Antimetabolites|antimetabolites|mesh-ancestor
65180151|NCT00912145|Alprazolam|alprazolam|mesh-list
65180152|NCT00912145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65180153|NCT00912145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65180154|NCT00912145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180155|NCT00912145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65180156|NCT00912145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65180157|NCT00912145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65180158|NCT00912145|GABA Modulators|gaba modulators|mesh-ancestor
65180159|NCT00912145|GABA Agents|gaba agents|mesh-ancestor
65180161|NCT00912145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180162|NCT02824510|Insulin|insulin|mesh-list
65180163|NCT02824510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65180164|NCT02824510|Insulin Aspart|insulin aspart|mesh-list
65180168|NCT00674245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65180169|NCT00674245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65180170|NCT00674245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65180171|NCT00674245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180172|NCT00674245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180173|NCT00878215|Liver Extracts|liver extracts|mesh-list
65180174|NCT00878215|Hematinics|hematinics|mesh-ancestor
65180175|NCT02628847|Sildenafil Citrate|sildenafil citrate|mesh-list
65180176|NCT02628847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180177|NCT02628847|Vasodilator Agents|vasodilator agents|mesh-ancestor
65180178|NCT02628847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65180179|NCT02628847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65180180|NCT02628847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180181|NCT02628847|Urological Agents|urological agents|mesh-ancestor
65180182|NCT00677443|Capecitabine|capecitabine|mesh-list
65180183|NCT00677443|Oxaliplatin|oxaliplatin|mesh-list
65180184|NCT00677443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65180185|NCT00677443|Antimetabolites|antimetabolites|mesh-ancestor
65180186|NCT00677443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180187|NCT00677443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180188|NCT00674557|Exemestane|exemestane|mesh-list
65180189|NCT00674557|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
65180190|NCT00674557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180191|NCT00674557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65180192|NCT00674557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65180193|NCT00674557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180194|NCT00674557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180195|NCT00674557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65180196|NCT00674557|Hormone Antagonists|hormone antagonists|mesh-ancestor
65180197|NCT00674557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65180198|NCT00674557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180199|NCT00674557|Chelating Agents|chelating agents|mesh-ancestor
65180200|NCT00674557|Sequestering Agents|sequestering agents|mesh-ancestor
65325848|NCT03616587|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65325849|NCT03616587|Hormone Antagonists|hormone antagonists|mesh-ancestor
65325850|NCT03616587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65325851|NCT02658279|Pembrolizumab|pembrolizumab|mesh-list
65325852|NCT02658279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65325853|NCT02658279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325854|NCT03534453|Olaparib|olaparib|mesh-list
64555416|NCT00211757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64555417|NCT04373967|Metformin|metformin|mesh-list
64555418|NCT04373967|Liraglutide|liraglutide|mesh-list
64555419|NCT04373967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64555420|NCT04373967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555422|NCT04373967|Hormones|hormones|mesh-ancestor
64555423|NCT04373967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64555424|NCT04026191|Hyaluronic Acid|hyaluronic acid|mesh-list
65180201|NCT00674557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65180202|NCT00674557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65180203|NCT00674557|Growth Substances|growth substances|mesh-ancestor
65180204|NCT00674557|Growth Inhibitors|growth inhibitors|mesh-ancestor
65180205|NCT00677521|Acarbose|acarbose|mesh-list
65180206|NCT00677521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65180207|NCT00677521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180208|NCT00677521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180209|NCT00677521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65180210|NCT00677521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180211|NCT00674713|Ondansetron|ondansetron|mesh-list
65180212|NCT00674713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65180213|NCT00674713|Antiemetics|antiemetics|mesh-ancestor
65180214|NCT00674713|Autonomic Agents|autonomic agents|mesh-ancestor
65180215|NCT00674713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65180216|NCT00674713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180217|NCT00674713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65180218|NCT00674713|Antipruritics|antipruritics|mesh-ancestor
65180219|NCT00674713|Dermatologic Agents|dermatologic agents|mesh-ancestor
65180220|NCT00674713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65180221|NCT00674713|Serotonin Agents|serotonin agents|mesh-ancestor
65180222|NCT00674713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65180223|NCT00674713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180224|NCT00674713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65180225|NCT00674713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65180226|NCT00674713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65180227|NCT00674713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65180228|NCT00674713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65180229|NCT04241380|Heparin|heparin|mesh-list
65180230|NCT04241380|Anticoagulants|anticoagulants|mesh-list
65180231|NCT04241380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65180232|NCT04241380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65180233|NCT04241380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64822785|NCT01523379|Parecoxib|parecoxib|mesh-list
65180234|NCT04241380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180235|NCT02824354|Nalmefene|nalmefene|mesh-list
65180236|NCT02824354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65180246|NCT00677755|Mifepristone|mifepristone|mesh-list
65180247|NCT00677755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65180248|NCT00677755|Abortifacient Agents|abortifacient agents|mesh-ancestor
65180249|NCT00677755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65180250|NCT00677755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180251|NCT00677755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65180252|NCT00677755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65180253|NCT00677755|Oxytocics|oxytocics|mesh-ancestor
65325855|NCT03534453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65325856|NCT03534453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325857|NCT03534453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325858|NCT03534453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325859|NCT04074915|Chlorhexidine|chlorhexidine|mesh-list
65325860|NCT04074915|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65325861|NCT04074915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65325862|NCT04074915|Disinfectants|disinfectants|mesh-ancestor
64555425|NCT04026191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64555426|NCT04026191|Immunologic Factors|immunologic factors|mesh-ancestor
64555427|NCT04026191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555428|NCT04026191|Viscosupplements|viscosupplements|mesh-ancestor
64555429|NCT04026191|Protective Agents|protective agents|mesh-ancestor
64555430|NCT04022057|Ropivacaine|ropivacaine|mesh-list
64555431|NCT04022057|Anesthetics, Local|anesthetics, local|mesh-ancestor
65180254|NCT00677755|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65180255|NCT00677755|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65180256|NCT00677755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65180257|NCT00677755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65180258|NCT00677755|Contraceptive Agents|contraceptive agents|mesh-ancestor
65180259|NCT00677755|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65180260|NCT00677755|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65180261|NCT00677755|Hormone Antagonists|hormone antagonists|mesh-ancestor
65180262|NCT00677755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65180263|NCT00677755|Luteolytic Agents|luteolytic agents|mesh-ancestor
65180264|NCT00677755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65180265|NCT00677755|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65180266|NCT02824042|Itraconazole|itraconazole|mesh-list
65180267|NCT02824042|Maytansine|maytansine|mesh-list
65180268|NCT02824042|Antifungal Agents|antifungal agents|mesh-ancestor
65180269|NCT02824042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65180270|NCT02824042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65180271|NCT02824042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65180272|NCT02824042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180273|NCT02824042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180274|NCT02824042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65180275|NCT02824042|Hormone Antagonists|hormone antagonists|mesh-ancestor
65180276|NCT02824042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65180277|NCT02824042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180278|NCT02824042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65180279|NCT02824042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65180280|NCT02824042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180281|NCT02824042|Tubulin Modulators|tubulin modulators|mesh-ancestor
65180283|NCT02824042|Mitosis Modulators|mitosis modulators|mesh-ancestor
65180284|NCT00675181|Melatonin|melatonin|mesh-list
65180285|NCT00675181|Antioxidants|antioxidants|mesh-ancestor
65180286|NCT00675181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180287|NCT00675181|Protective Agents|protective agents|mesh-ancestor
65180288|NCT00675181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180289|NCT00675181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65180290|NCT04241458|Midazolam|midazolam|mesh-list
65180291|NCT04241458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65180292|NCT04241458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65180293|NCT04241458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65325863|NCT02579733|Azathioprine|azathioprine|mesh-list
65325864|NCT02579733|Antimetabolites|antimetabolites|mesh-ancestor
65325865|NCT02579733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325866|NCT02579733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65325867|NCT02579733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325868|NCT02579733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65325869|NCT02579733|Immunologic Factors|immunologic factors|mesh-ancestor
65325870|NCT02579733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325871|NCT02579733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64555432|NCT04022057|Anesthetics|anesthetics|mesh-ancestor
64555433|NCT04022057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64555434|NCT04022057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555435|NCT04022057|Sensory System Agents|sensory system agents|mesh-ancestor
64555437|NCT00921843|Methadone|methadone|mesh-list
65180294|NCT04241458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180295|NCT04241458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65180296|NCT04241458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65180297|NCT04241458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65180298|NCT04241458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65180299|NCT04241458|Anesthetics, General|anesthetics, general|mesh-ancestor
65180300|NCT04241458|Anesthetics|anesthetics|mesh-ancestor
65180301|NCT04241458|GABA Modulators|gaba modulators|mesh-ancestor
65180306|NCT00681343|Thymoglobulin|thymoglobulin|mesh-list
65180307|NCT00681343|Daclizumab|daclizumab|mesh-list
65180308|NCT00681343|Immunologic Factors|immunologic factors|mesh-ancestor
65180309|NCT00681343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180310|NCT00681343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65180311|NCT00681343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65180312|NCT00681343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180313|NCT02823808|Glimepiride|glimepiride|mesh-list
65180314|NCT02823808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65180315|NCT02823808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65180316|NCT02823808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180317|NCT02823808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65180318|NCT02823808|Immunologic Factors|immunologic factors|mesh-ancestor
65180319|NCT04151719|Bromides|bromides|mesh-list
65180320|NCT04151719|Methylnaltrexone|methylnaltrexone|mesh-list
65180321|NCT04151719|Anticonvulsants|anticonvulsants|mesh-ancestor
65180322|NCT04151719|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65180323|NCT04151719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180324|NCT04151719|Sensory System Agents|sensory system agents|mesh-ancestor
65180325|NCT04151719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65180326|NCT02822482|Cetuximab|cetuximab|mesh-list
65180327|NCT02822482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65180328|NCT02822482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180329|NCT00675493|Insulin Aspart|insulin aspart|mesh-list
65180330|NCT00675493|Biphasic Insulins|biphasic insulins|mesh-list
65180331|NCT00675493|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65180332|NCT00675493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65180333|NCT00675493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180334|NCT04240834|Aspirin|aspirin|mesh-list
65180335|NCT04240834|Ticagrelor|ticagrelor|mesh-list
65180336|NCT04240834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65180337|NCT04240834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65180338|NCT04240834|Analgesics|analgesics|mesh-ancestor
65180339|NCT04240834|Sensory System Agents|sensory system agents|mesh-ancestor
65180340|NCT04240834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65180341|NCT04240834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180342|NCT04240834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65180343|NCT04240834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65180344|NCT04240834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65180345|NCT04240834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65325872|NCT03326193|Bevacizumab|bevacizumab|mesh-list
65325873|NCT03326193|Niraparib|niraparib|mesh-list
65325874|NCT03326193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65325875|NCT03326193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325876|NCT03326193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65325877|NCT03326193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65325878|NCT03326193|Growth Substances|growth substances|mesh-ancestor
65325879|NCT03326193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325880|NCT03326193|Growth Inhibitors|growth inhibitors|mesh-ancestor
64555441|NCT00921843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555442|NCT00921843|Analgesics|analgesics|mesh-ancestor
64555443|NCT00921843|Sensory System Agents|sensory system agents|mesh-ancestor
64555444|NCT00921843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64555445|NCT00921843|Antitussive Agents|antitussive agents|mesh-ancestor
64555446|NCT00921843|Respiratory System Agents|respiratory system agents|mesh-ancestor
64555447|NCT04020653|Ferrous citrate|ferrous citrate|mesh-list
64555448|NCT04020653|Lumefantrine|lumefantrine|mesh-list
64320546|NCT05509946|Pregabalin|pregabalin|mesh-list
65180346|NCT04240834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180347|NCT04240834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65180348|NCT04240834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65180349|NCT04240834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180350|NCT04240834|Antipyretics|antipyretics|mesh-ancestor
65180351|NCT04240834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65180352|NCT04240834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65180353|NCT04240834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65180354|NCT04240834|Purinergic Agents|purinergic agents|mesh-ancestor
65180355|NCT04240834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65180356|NCT01200758|Prednisone|prednisone|mesh-list
65180358|NCT01200758|Cyclophosphamide|cyclophosphamide|mesh-list
65180360|NCT01200758|Doxorubicin|doxorubicin|mesh-list
65180361|NCT01200758|Vincristine|vincristine|mesh-list
65180362|NCT01200758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65180363|NCT01200758|Immunologic Factors|immunologic factors|mesh-ancestor
65180364|NCT01200758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180365|NCT01200758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65180366|NCT01200758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65180367|NCT01200758|Alkylating Agents|alkylating agents|mesh-ancestor
65180368|NCT01200758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180369|NCT01200758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180370|NCT01200758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65180371|NCT01200758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65180372|NCT01200758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65180373|NCT01200758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65180374|NCT01200758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65180377|NCT01200758|Glucocorticoids|glucocorticoids|mesh-ancestor
65180378|NCT01200758|Hormones|hormones|mesh-ancestor
65180379|NCT01200758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65180380|NCT01200758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65180381|NCT01200758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65180382|NCT01200758|Tubulin Modulators|tubulin modulators|mesh-ancestor
65180383|NCT01200758|Antimitotic Agents|antimitotic agents|mesh-ancestor
65180384|NCT01200758|Mitosis Modulators|mitosis modulators|mesh-ancestor
65180385|NCT02823106|Verapamil|verapamil|mesh-list
65180386|NCT02823106|Choline|choline|mesh-list
65180387|NCT02823106|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
65075844|NCT00346047|Narcotics|narcotics|mesh-ancestor
65325881|NCT03326193|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65325882|NCT03326193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325883|NCT03326193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325884|NCT02517099|Azithromycin|azithromycin|mesh-list
65325885|NCT02517099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65180388|NCT02823106|Lipotropic Agents|lipotropic agents|mesh-ancestor
65180389|NCT02823106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65180390|NCT02823106|Antimetabolites|antimetabolites|mesh-ancestor
65180391|NCT02823106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180392|NCT02823106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65180393|NCT02823106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65180394|NCT02823106|Nootropic Agents|nootropic agents|mesh-ancestor
65180395|NCT02823106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65180396|NCT02823106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65180397|NCT02823106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65180398|NCT02823106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65180399|NCT02823106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180400|NCT02823106|Vasodilator Agents|vasodilator agents|mesh-ancestor
65180401|NCT02821858|Odalasvir|odalasvir|mesh-list
65180402|NCT02821858|Antiviral Agents|antiviral agents|mesh-ancestor
65180403|NCT02821858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65180404|NCT00876343|Aripiprazole|aripiprazole|mesh-list
65180405|NCT00876343|Antidepressive Agents|antidepressive agents|mesh-ancestor
65180406|NCT00876343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65180407|NCT00876343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65180408|NCT00876343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65180409|NCT00876343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65180410|NCT00876343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180411|NCT00876343|Dopamine Agonists|dopamine agonists|mesh-ancestor
65180412|NCT00876343|Dopamine Agents|dopamine agents|mesh-ancestor
65180413|NCT00876343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65180414|NCT00876343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180415|NCT00876343|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65180416|NCT00876343|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65180417|NCT00876343|Serotonin Agents|serotonin agents|mesh-ancestor
65180418|NCT00876343|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65180419|NCT00876343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65180420|NCT00876343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65180421|NCT00876343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65180422|NCT02627989|Diflucortolone valerate|diflucortolone valerate|mesh-list
65180423|NCT02627989|Diflucortolone|diflucortolone|mesh-list
65180424|NCT02627989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65180425|NCT02627989|Glucocorticoids|glucocorticoids|mesh-ancestor
65180426|NCT02627989|Hormones|hormones|mesh-ancestor
65180427|NCT02627989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65180428|NCT02627989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180429|NCT00675649|Golimumab|golimumab|mesh-list
65180430|NCT00675649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65180432|NCT00675649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65180433|NCT00675649|Immunologic Factors|immunologic factors|mesh-ancestor
65180434|NCT00675649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180435|NCT01107912|Clopidogrel|clopidogrel|mesh-list
65180436|NCT01107912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65180437|NCT01107912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65180438|NCT01107912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65180439|NCT01107912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65180440|NCT01107912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65180441|NCT01107912|Purinergic Agents|purinergic agents|mesh-ancestor
65180442|NCT01107912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65180443|NCT01107912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180444|NCT01107912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180445|NCT00678145|Epinephrine|epinephrine|mesh-list
65180446|NCT00678145|Morphine|morphine|mesh-list
65180447|NCT00678145|Naloxone|naloxone|mesh-list
65180448|NCT00678145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180450|NCT00678145|Narcotics|narcotics|mesh-ancestor
65325886|NCT02517099|Beclomethasone|beclomethasone|mesh-list
65325887|NCT02517099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65325888|NCT02517099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65325889|NCT02517099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65325890|NCT02517099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325891|NCT02517099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325892|NCT02517099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65325893|NCT02517099|Glucocorticoids|glucocorticoids|mesh-ancestor
65325894|NCT02517099|Hormones|hormones|mesh-ancestor
64555453|NCT04020653|Citric Acid|citric acid|mesh-list
64555454|NCT04020653|Sodium Citrate|sodium citrate|mesh-list
64555455|NCT04020653|Anticoagulants|anticoagulants|mesh-ancestor
64555456|NCT04020653|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64555457|NCT04020653|Chelating Agents|chelating agents|mesh-ancestor
64555458|NCT04020653|Sequestering Agents|sequestering agents|mesh-ancestor
64555459|NCT04020653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555460|NCT04020653|Antimalarials|antimalarials|mesh-ancestor
64320555|NCT05509946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65180451|NCT00678145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65180452|NCT00678145|Analgesics|analgesics|mesh-ancestor
65180453|NCT00678145|Sensory System Agents|sensory system agents|mesh-ancestor
65180454|NCT00678145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65180455|NCT00678145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65180456|NCT00678145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65180457|NCT00678145|Adrenergic Agents|adrenergic agents|mesh-ancestor
65180458|NCT00678145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65180459|NCT00678145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180460|NCT00678145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65180461|NCT00678145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65180462|NCT00678145|Autonomic Agents|autonomic agents|mesh-ancestor
65180463|NCT00678145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65180464|NCT00678145|Respiratory System Agents|respiratory system agents|mesh-ancestor
65180465|NCT00678145|Mydriatics|mydriatics|mesh-ancestor
65180466|NCT00678145|Sympathomimetics|sympathomimetics|mesh-ancestor
65180467|NCT00678145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65180468|NCT00678145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65180469|NCT02879916|Levobupivacaine|levobupivacaine|mesh-list
65180470|NCT02879916|Anesthetics, Local|anesthetics, local|mesh-ancestor
65180471|NCT02879916|Anesthetics|anesthetics|mesh-ancestor
65180472|NCT02879916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65180473|NCT02879916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180474|NCT02879916|Sensory System Agents|sensory system agents|mesh-ancestor
65180475|NCT02879916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65180476|NCT02690506|Pregabalin|pregabalin|mesh-list
65180477|NCT02690506|Analgesics|analgesics|mesh-ancestor
65180478|NCT02690506|Sensory System Agents|sensory system agents|mesh-ancestor
65180479|NCT02690506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65180480|NCT02690506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180481|NCT02690506|Anticonvulsants|anticonvulsants|mesh-ancestor
65180482|NCT02690506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65180483|NCT02690506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65180484|NCT02690506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180485|NCT02690506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65180486|NCT02690506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65180487|NCT02690506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65325895|NCT02517099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65325896|NCT02517099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325897|NCT02517099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65325898|NCT02517099|Respiratory System Agents|respiratory system agents|mesh-ancestor
65325899|NCT02478099|Atezolizumab|atezolizumab|mesh-list
65325900|NCT02478099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325901|NCT02473263|Ceftriaxone|ceftriaxone|mesh-list
64555461|NCT04020653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64555462|NCT04020653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64555463|NCT04020653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64555464|NCT04020653|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64555465|NCT04020653|Dermatologic Agents|dermatologic agents|mesh-ancestor
64555466|NCT04020653|Trace Elements|trace elements|mesh-ancestor
65180488|NCT02690506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65180489|NCT02690506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65180490|NCT04310280|Insulin Glargine|insulin glargine|mesh-list
65180491|NCT04310280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65180492|NCT04310280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180493|NCT04239586|Glyburide|glyburide|mesh-list
65180494|NCT04239586|Glipizide|glipizide|mesh-list
65180495|NCT04239586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65180496|NCT04239586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180497|NCT02628613|Paclitaxel|paclitaxel|mesh-list
65180498|NCT02628613|Vinorelbine|vinorelbine|mesh-list
65180499|NCT02628613|Epirubicin|epirubicin|mesh-list
65180500|NCT02628613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65180501|NCT02628613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180502|NCT02628613|Tubulin Modulators|tubulin modulators|mesh-ancestor
65180503|NCT02628613|Antimitotic Agents|antimitotic agents|mesh-ancestor
65180504|NCT02628613|Mitosis Modulators|mitosis modulators|mesh-ancestor
65180505|NCT02628613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180506|NCT02628613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65180507|NCT02628613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65180508|NCT02628613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65180509|NCT02628613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180510|NCT01100034|Etanercept|etanercept|mesh-list
65180511|NCT01100034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65180512|NCT01100034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65180513|NCT01100034|Analgesics|analgesics|mesh-ancestor
65180514|NCT01100034|Sensory System Agents|sensory system agents|mesh-ancestor
65180515|NCT01100034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65180516|NCT01100034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180517|NCT01100034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65180518|NCT01100034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65180519|NCT01100034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65180520|NCT01100034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65180521|NCT01100034|Immunologic Factors|immunologic factors|mesh-ancestor
65180522|NCT04148833|Paclitaxel|paclitaxel|mesh-list
65180523|NCT04148833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65180528|NCT04148833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180529|NCT02821546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65180530|NCT02821468|Acetaminophen|acetaminophen|mesh-list
65180531|NCT02821468|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
65180532|NCT02821468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65180533|NCT02821468|Analgesics|analgesics|mesh-ancestor
65180534|NCT02821468|Sensory System Agents|sensory system agents|mesh-ancestor
65180535|NCT02821468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65325902|NCT02473263|Tazobactam|tazobactam|mesh-list
65325903|NCT02473263|Piperacillin|piperacillin|mesh-list
65325904|NCT02473263|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65325905|NCT02473263|Hydrocortisone|hydrocortisone|mesh-list
65325906|NCT02473263|Norepinephrine|norepinephrine|mesh-list
65325907|NCT02473263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65325908|NCT02473263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65325909|NCT02473263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65325910|NCT02473263|Adrenergic Agents|adrenergic agents|mesh-ancestor
64555467|NCT04020653|Micronutrients|micronutrients|mesh-ancestor
64555468|NCT04020653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555469|NCT05008458|Arginine Vasopressin|arginine vasopressin|mesh-list
64555470|NCT05008458|Hemostatics|hemostatics|mesh-ancestor
64555471|NCT05008458|Coagulants|coagulants|mesh-ancestor
64555472|NCT05008458|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65180536|NCT02821468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180537|NCT02821468|Antipyretics|antipyretics|mesh-ancestor
65180538|NCT02821468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65180539|NCT02821468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180540|NCT02821468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180541|NCT02821468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65180542|NCT02821468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65180543|NCT02821468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65180544|NCT04964622|Ibuprofen|ibuprofen|mesh-list
65180545|NCT04964622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65180546|NCT04964622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65180547|NCT04964622|Analgesics|analgesics|mesh-ancestor
65180548|NCT04964622|Sensory System Agents|sensory system agents|mesh-ancestor
65180549|NCT04964622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65180550|NCT04964622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180551|NCT04964622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65180552|NCT04964622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65180553|NCT04964622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65180554|NCT04964622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180555|NCT04964622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180556|NCT04769050|Docetaxel|docetaxel|mesh-list
65180557|NCT04769050|Capecitabine|capecitabine|mesh-list
65180558|NCT04769050|Trastuzumab|trastuzumab|mesh-list
65180559|NCT04769050|Pertuzumab|pertuzumab|mesh-list
65180560|NCT04769050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180561|NCT04769050|Tubulin Modulators|tubulin modulators|mesh-ancestor
65180562|NCT04769050|Antimitotic Agents|antimitotic agents|mesh-ancestor
65180563|NCT04769050|Mitosis Modulators|mitosis modulators|mesh-ancestor
65180564|NCT04769050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180565|NCT04769050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65180566|NCT04769050|Antimetabolites|antimetabolites|mesh-ancestor
65180567|NCT04769050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65180568|NCT02821390|Nepafenac|nepafenac|mesh-list
65180569|NCT02821390|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65180570|NCT02821390|Lubricant Eye Drops|lubricant eye drops|mesh-list
65180571|NCT02821390|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65180572|NCT02821390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65180573|NCT02821390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65180574|NCT02821390|Analgesics|analgesics|mesh-ancestor
65180575|NCT02821390|Sensory System Agents|sensory system agents|mesh-ancestor
65180576|NCT02821390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65180577|NCT02821390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180578|NCT02821390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65180579|NCT02821390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65180580|NCT02821312|DA-8010|da-8010|mesh-list
65180581|NCT02821312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65180582|NCT02821312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65325911|NCT02473263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65325912|NCT02473263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325913|NCT02473263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325914|NCT02473263|Sympathomimetics|sympathomimetics|mesh-ancestor
65325915|NCT02473263|Autonomic Agents|autonomic agents|mesh-ancestor
65325916|NCT02473263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65325917|NCT02473263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64555476|NCT02080637|Ambrisentan|ambrisentan|mesh-list
64555477|NCT02080637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64555478|NCT05019690|Paclitaxel|paclitaxel|mesh-list
64555479|NCT05019690|Apatinib|apatinib|mesh-list
64555480|NCT05019690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64555481|NCT05019690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64555482|NCT05019690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555483|NCT05019690|Tubulin Modulators|tubulin modulators|mesh-ancestor
64555484|NCT05019690|Antimitotic Agents|antimitotic agents|mesh-ancestor
65180583|NCT02821312|Cholinergic Agents|cholinergic agents|mesh-ancestor
65180584|NCT02821312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65180585|NCT02821312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180586|NCT02821312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180587|NCT02821156|Nitric Oxide|nitric oxide|mesh-list
65180588|NCT02821156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65180589|NCT02821156|Autonomic Agents|autonomic agents|mesh-ancestor
65180590|NCT02821156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65180591|NCT02821156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180592|NCT02821156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65180593|NCT02821156|Respiratory System Agents|respiratory system agents|mesh-ancestor
65180594|NCT02821156|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65180603|NCT02820922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65180604|NCT02820922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180605|NCT00633958|Alovudine|alovudine|mesh-list
65180606|NCT00633958|Antiviral Agents|antiviral agents|mesh-ancestor
65180607|NCT00633958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65180608|NCT02820688|Bupivacaine|bupivacaine|mesh-list
65180609|NCT02820688|Prilocaine|prilocaine|mesh-list
65180610|NCT02820688|Anesthetics, Local|anesthetics, local|mesh-ancestor
65180611|NCT02820688|Anesthetics|anesthetics|mesh-ancestor
65180612|NCT02820688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65180613|NCT02820688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180614|NCT02820688|Sensory System Agents|sensory system agents|mesh-ancestor
65180615|NCT02820688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65180616|NCT02818816|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65180617|NCT02818816|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65180618|NCT02818816|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65180619|NCT02818816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65180620|NCT02818816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65180621|NCT02818816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65180622|NCT02818816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65180623|NCT02818816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65180624|NCT02818816|Adrenergic Agents|adrenergic agents|mesh-ancestor
65180625|NCT02818816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65180626|NCT02818816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180627|NCT02818816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180628|NCT02818816|Laxatives|laxatives|mesh-ancestor
65180629|NCT02818816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65180630|NCT02820610|Magnesium Sulfate|magnesium sulfate|mesh-list
65180631|NCT02820610|Dexmedetomidine|dexmedetomidine|mesh-list
65325918|NCT02473263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65325919|NCT02473263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65325920|NCT02473263|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65325921|NCT02473263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325922|NCT03249831|Mycophenolic Acid|mycophenolic acid|mesh-list
65325923|NCT03249831|Cyclophosphamide|cyclophosphamide|mesh-list
65325924|NCT03249831|Pentostatin|pentostatin|mesh-list
65325925|NCT03249831|Tacrolimus|tacrolimus|mesh-list
65325926|NCT03249831|Thymoglobulin|thymoglobulin|mesh-list
65325927|NCT03249831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64555485|NCT05019690|Mitosis Modulators|mitosis modulators|mesh-ancestor
64555486|NCT05019690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555487|NCT05019690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64555488|NCT05019690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555489|NCT04029467|Dexmedetomidine|dexmedetomidine|mesh-list
64555490|NCT04029467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64555491|NCT04029467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65180632|NCT02820610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65180633|NCT02820610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65180634|NCT02820610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180635|NCT02820610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65180636|NCT02820610|Analgesics|analgesics|mesh-ancestor
65180637|NCT02820610|Sensory System Agents|sensory system agents|mesh-ancestor
65180638|NCT02820610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65180639|NCT02820610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65180640|NCT02820610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65180641|NCT02820610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65180642|NCT02820610|Adrenergic Agents|adrenergic agents|mesh-ancestor
65180643|NCT02820610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65180644|NCT02820610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180645|NCT02820610|Anesthetics|anesthetics|mesh-ancestor
65180646|NCT02820610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65180647|NCT02820610|Anticonvulsants|anticonvulsants|mesh-ancestor
65180648|NCT02820610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65180649|NCT02820610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65180650|NCT02820610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65180651|NCT02820610|Tocolytic Agents|tocolytic agents|mesh-ancestor
65180652|NCT02820610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65180653|NCT04745728|Prednisone|prednisone|mesh-list
65180654|NCT04745728|Cyclophosphamide|cyclophosphamide|mesh-list
65180655|NCT04745728|Rituximab|rituximab|mesh-list
65180656|NCT04745728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65180657|NCT04745728|Immunologic Factors|immunologic factors|mesh-ancestor
65180658|NCT04745728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180659|NCT04745728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65180660|NCT04745728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65180661|NCT04745728|Alkylating Agents|alkylating agents|mesh-ancestor
65180669|NCT04745728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65180670|NCT04745728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65180672|NCT02818660|Hormones|hormones|mesh-ancestor
65180673|NCT02818660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65180674|NCT02818660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180675|NCT01107444|Docetaxel|docetaxel|mesh-list
65180676|NCT01107444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180677|NCT01107444|Tubulin Modulators|tubulin modulators|mesh-ancestor
65180678|NCT01107444|Antimitotic Agents|antimitotic agents|mesh-ancestor
65180679|NCT01107444|Mitosis Modulators|mitosis modulators|mesh-ancestor
65180680|NCT01107444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325928|NCT03249831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65325929|NCT03249831|Immunologic Factors|immunologic factors|mesh-ancestor
65325930|NCT03249831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325931|NCT03249831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65325932|NCT03249831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65325933|NCT03249831|Alkylating Agents|alkylating agents|mesh-ancestor
65325934|NCT03249831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555493|NCT04029467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64555494|NCT04029467|Analgesics|analgesics|mesh-ancestor
64555495|NCT04029467|Sensory System Agents|sensory system agents|mesh-ancestor
64555496|NCT04029467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64555497|NCT04029467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64320592|NCT02187445|Hormones|hormones|mesh-ancestor
65180681|NCT04238806|Desflurane|desflurane|mesh-list
64823236|NCT01526083|Lacosamide|lacosamide|mesh-list
65180682|NCT04238806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65180683|NCT04238806|Anesthetics, General|anesthetics, general|mesh-ancestor
65180684|NCT04238806|Anesthetics|anesthetics|mesh-ancestor
65180685|NCT04238806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65180686|NCT04238806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180687|NCT00876187|Naproxen|naproxen|mesh-list
65180688|NCT00876187|Tanezumab|tanezumab|mesh-list
65180689|NCT00876187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65180690|NCT00876187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65180691|NCT00876187|Analgesics|analgesics|mesh-ancestor
65180692|NCT00876187|Sensory System Agents|sensory system agents|mesh-ancestor
65180693|NCT00876187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65180694|NCT00876187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180695|NCT00876187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65180696|NCT00876187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65180697|NCT00876187|Gout Suppressants|gout suppressants|mesh-ancestor
65180698|NCT00876187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65180699|NCT00876187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180700|NCT00876187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180701|NCT04238884|Voriconazole|voriconazole|mesh-list
65180702|NCT04238884|Antifungal Agents|antifungal agents|mesh-ancestor
65180703|NCT04238884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65180704|NCT04238884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65180705|NCT04238884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65180706|NCT04238884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180707|NCT04238884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180708|NCT04238884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65180709|NCT04238884|Hormone Antagonists|hormone antagonists|mesh-ancestor
65180710|NCT04238884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65180711|NCT04238884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180712|NCT04238884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65180713|NCT01102374|Vitamin D|vitamin d|mesh-list
65180714|NCT01102374|Ergocalciferols|ergocalciferols|mesh-list
65180715|NCT01102374|Cholecalciferol|cholecalciferol|mesh-list
65180716|NCT01102374|Vitamins|vitamins|mesh-list
65180717|NCT01102374|Micronutrients|micronutrients|mesh-ancestor
65180718|NCT01102374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180719|NCT01102374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65180720|NCT01102374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65180721|NCT05658640|Cytarabine|cytarabine|mesh-list
65180722|NCT05658640|Dexamethasone|dexamethasone|mesh-list
65180723|NCT05658640|Cyclophosphamide|cyclophosphamide|mesh-list
65325935|NCT03249831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325936|NCT03249831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65325937|NCT03249831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65325938|NCT03249831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325939|NCT03249831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65325940|NCT03249831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65325941|NCT03249831|Antitubercular Agents|antitubercular agents|mesh-ancestor
65325942|NCT03249831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64555498|NCT04029467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65180724|NCT05658640|Trametinib|trametinib|mesh-list
65180725|NCT05658640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65180726|NCT05658640|Immunologic Factors|immunologic factors|mesh-ancestor
65180727|NCT05658640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180728|NCT05658640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65180737|NCT05658640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65180738|NCT05658640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65180739|NCT05658640|Glucocorticoids|glucocorticoids|mesh-ancestor
65180740|NCT05658640|Hormones|hormones|mesh-ancestor
65180741|NCT05658640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65180742|NCT05658640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65180743|NCT05658640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65180744|NCT05658640|Antimetabolites|antimetabolites|mesh-ancestor
65180745|NCT05658640|Antiviral Agents|antiviral agents|mesh-ancestor
65180746|NCT05658640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65180747|NCT05658640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65180748|NCT05658640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180749|NCT02818270|Acetylcysteine|acetylcysteine|mesh-list
65180750|NCT02818270|Albuterol|albuterol|mesh-list
65180751|NCT02818270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65180752|NCT02818270|Antiviral Agents|antiviral agents|mesh-ancestor
65180753|NCT02818270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65180754|NCT02818270|Expectorants|expectorants|mesh-ancestor
65180755|NCT02818270|Respiratory System Agents|respiratory system agents|mesh-ancestor
65180756|NCT02818270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65180757|NCT02818270|Antioxidants|antioxidants|mesh-ancestor
65180758|NCT02818270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180759|NCT02818270|Protective Agents|protective agents|mesh-ancestor
65180760|NCT02818270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180761|NCT02818270|Antidotes|antidotes|mesh-ancestor
65180762|NCT02818270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65180763|NCT02818270|Autonomic Agents|autonomic agents|mesh-ancestor
65180764|NCT02818270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65180765|NCT02818270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65180766|NCT02818270|Tocolytic Agents|tocolytic agents|mesh-ancestor
65180767|NCT02818270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65180768|NCT02818270|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65180769|NCT02818270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65180770|NCT02818270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65180771|NCT02818270|Adrenergic Agents|adrenergic agents|mesh-ancestor
65180772|NCT02818270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65180773|NCT02879760|Pembrolizumab|pembrolizumab|mesh-list
65180774|NCT02879760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65180775|NCT02879760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180776|NCT02818348|Darunavir|darunavir|mesh-list
65180777|NCT02818348|Cobicistat|cobicistat|mesh-list
65180778|NCT02818348|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
65180779|NCT02818348|Etravirine|etravirine|mesh-list
65180780|NCT02818348|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65180781|NCT02818348|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65180782|NCT02818348|Protease Inhibitors|protease inhibitors|mesh-ancestor
65180783|NCT02818348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180784|NCT02818348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180785|NCT02818348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65180786|NCT02818348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65180787|NCT02818348|Antiviral Agents|antiviral agents|mesh-ancestor
65180788|NCT02818348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65180789|NCT02818348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65325943|NCT03249831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65325944|NCT03249831|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65325945|NCT03222609|Navitoclax|navitoclax|mesh-list
65325946|NCT03222609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325947|NCT00437203|Gemcitabine|gemcitabine|mesh-list
65325948|NCT00437203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65325949|NCT00437203|Antimetabolites|antimetabolites|mesh-ancestor
65180790|NCT02818348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65180791|NCT02818348|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65180792|NCT02818348|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65180793|NCT00634192|Tobramycin|tobramycin|mesh-list
65180794|NCT00634192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65180795|NCT00634192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65180796|NCT00684463|Palonosetron|palonosetron|mesh-list
65180797|NCT00684463|Antiemetics|antiemetics|mesh-ancestor
65180798|NCT00684463|Autonomic Agents|autonomic agents|mesh-ancestor
65180802|NCT00684463|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65180803|NCT00684463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65180804|NCT00684463|Serotonin Agents|serotonin agents|mesh-ancestor
65180805|NCT00684463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65180806|NCT00684463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180807|NCT00678457|Ondansetron|ondansetron|mesh-list
65180808|NCT00678457|Olanzapine|olanzapine|mesh-list
65180809|NCT00678457|Antiemetics|antiemetics|mesh-ancestor
65180810|NCT00678457|Autonomic Agents|autonomic agents|mesh-ancestor
65180811|NCT00678457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65180812|NCT00678457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180813|NCT00678457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65180814|NCT00678457|Antipruritics|antipruritics|mesh-ancestor
65180815|NCT00678457|Dermatologic Agents|dermatologic agents|mesh-ancestor
65180816|NCT00678457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65180817|NCT00678457|Serotonin Agents|serotonin agents|mesh-ancestor
65180818|NCT00678457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65180819|NCT00678457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180820|NCT00678457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65180821|NCT00678457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65180822|NCT00678457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65180823|NCT00678457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65180824|NCT00678457|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65180825|NCT00678457|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65180826|NCT00678457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65180827|NCT00678457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65180828|NCT00678613|Norfloxacin|norfloxacin|mesh-list
65180829|NCT00678613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65180830|NCT00678613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65180831|NCT00678613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65180832|NCT00678613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65180833|NCT00678613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180834|NCT00678613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180835|NCT00678613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180836|NCT00678613|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65180837|NCT00678613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65180838|NCT00678769|Sirolimus|sirolimus|mesh-list
65180839|NCT00678769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65180840|NCT00678769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65180841|NCT00678769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65180842|NCT00678769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65180843|NCT00678769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180844|NCT00678769|Antifungal Agents|antifungal agents|mesh-ancestor
65180845|NCT00678769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65180846|NCT00678769|Immunologic Factors|immunologic factors|mesh-ancestor
65180847|NCT00678769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180848|NCT04146883|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65180849|NCT04146883|Cephalexin|cephalexin|mesh-list
65180850|NCT04146883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65180851|NCT02817256|Vitamins|vitamins|mesh-list
65180852|NCT02817256|Micronutrients|micronutrients|mesh-ancestor
65180853|NCT02817256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180854|NCT02817100|Itraconazole|itraconazole|mesh-list
65325950|NCT00437203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325951|NCT00437203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325952|NCT00437203|Antiviral Agents|antiviral agents|mesh-ancestor
65325953|NCT00437203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65325954|NCT00437203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325955|NCT00437203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65325956|NCT00437203|Immunologic Factors|immunologic factors|mesh-ancestor
65325957|NCT00437203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325958|NCT02419287|Crizotinib|crizotinib|mesh-list
65325959|NCT02419287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180855|NCT02817100|Antifungal Agents|antifungal agents|mesh-ancestor
65180856|NCT02817100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65180857|NCT02817100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65180858|NCT02817100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65180859|NCT02817100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180860|NCT02817100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180861|NCT02817100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65180862|NCT02817100|Hormone Antagonists|hormone antagonists|mesh-ancestor
65180863|NCT02817100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65180864|NCT02817100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180865|NCT02817100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65180866|NCT00684853|Bevacizumab|bevacizumab|mesh-list
65180867|NCT00684853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65180868|NCT00684853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180874|NCT02816476|Daratumumab|daratumumab|mesh-list
65180875|NCT02816476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180876|NCT04547140|Protease Inhibitors|protease inhibitors|mesh-list
65180877|NCT04547140|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65180879|NCT04547140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180880|NCT04547140|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65180881|NCT04547140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65180882|NCT00679159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65180883|NCT00679159|Immunologic Factors|immunologic factors|mesh-ancestor
65180884|NCT00679159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180885|NCT00685009|Hormones|hormones|mesh-list
65180886|NCT00685009|Progesterone|progesterone|mesh-list
65180887|NCT00685009|Estrogens|estrogens|mesh-list
65180888|NCT00685009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65180889|NCT00685009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180890|NCT00685009|Progestins|progestins|mesh-ancestor
65180891|NCT00679237|Metformin|metformin|mesh-list
65180892|NCT00679237|Glimepiride|glimepiride|mesh-list
65180893|NCT00679237|Ezetimibe|ezetimibe|mesh-list
65180894|NCT00679237|Diuretics|diuretics|mesh-list
65180895|NCT00679237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65180896|NCT00679237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180897|NCT00679237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65180898|NCT00679237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65180899|NCT00679237|Antimetabolites|antimetabolites|mesh-ancestor
65180900|NCT00679237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180901|NCT00679237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65180902|NCT00679237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64823457|NCT01526850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180903|NCT00679237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65180904|NCT00679237|Immunologic Factors|immunologic factors|mesh-ancestor
65180905|NCT00679237|Natriuretic Agents|natriuretic agents|mesh-ancestor
65180906|NCT00681733|Pioglitazone|pioglitazone|mesh-list
65180907|NCT00681733|Pentoxifylline|pentoxifylline|mesh-list
65180908|NCT00681733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65180909|NCT00681733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180910|NCT00681733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65180911|NCT00681733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180912|NCT00681733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180913|NCT00681733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65325960|NCT02419287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65325961|NCT02419287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325962|NCT02419287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325963|NCT00437125|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65325964|NCT00437125|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65325965|NCT00437125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65325966|NCT00437125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65180914|NCT00681733|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65180915|NCT00681733|Protective Agents|protective agents|mesh-ancestor
65180916|NCT00681733|Vasodilator Agents|vasodilator agents|mesh-ancestor
65180917|NCT00681733|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65180918|NCT00681733|Antioxidants|antioxidants|mesh-ancestor
65180919|NCT00679315|Alfuzosin|alfuzosin|mesh-list
65180920|NCT00679315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65180921|NCT00679315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65180922|NCT00679315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65180923|NCT00679315|Adrenergic Agents|adrenergic agents|mesh-ancestor
65180924|NCT00679315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65180925|NCT00679315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180926|NCT00679315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180927|NCT00679315|Urological Agents|urological agents|mesh-ancestor
65180928|NCT05652400|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65180929|NCT05652400|Antiviral Agents|antiviral agents|mesh-ancestor
65180930|NCT05652400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65180931|NCT01098474|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65180932|NCT01098474|Immunologic Factors|immunologic factors|mesh-ancestor
65180933|NCT01098474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180934|NCT00633802|Risperidone|risperidone|mesh-list
65180935|NCT00633802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65180936|NCT00633802|Serotonin Agents|serotonin agents|mesh-ancestor
65180937|NCT00633802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65180938|NCT00633802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180942|NCT00633802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65180944|NCT00633802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65180945|NCT00633802|Dopamine Agents|dopamine agents|mesh-ancestor
65180946|NCT04460248|Rituximab|rituximab|mesh-list
65180947|NCT04460248|Lenalidomide|lenalidomide|mesh-list
65180948|NCT04460248|Zanubrutinib|zanubrutinib|mesh-list
65180949|NCT04460248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65180950|NCT04460248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180951|NCT04460248|Immunologic Factors|immunologic factors|mesh-ancestor
65180952|NCT04460248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180953|NCT04460248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65180954|NCT04460248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65180955|NCT04460248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65180956|NCT04460248|Growth Substances|growth substances|mesh-ancestor
65180957|NCT04460248|Growth Inhibitors|growth inhibitors|mesh-ancestor
65180958|NCT04460248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65180959|NCT04460248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180960|NCT04460248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180961|NCT05658874|Methenamine|methenamine|mesh-list
65180962|NCT05658874|Methenamine hippurate|methenamine hippurate|mesh-list
65180963|NCT05658874|Methenamine mandelate|methenamine mandelate|mesh-list
65180964|NCT05658874|Gabapentin|gabapentin|mesh-list
65180965|NCT05658874|Amitriptyline|amitriptyline|mesh-list
65180966|NCT05658874|Mirabegron|mirabegron|mesh-list
65180967|NCT05658874|Oxybutynin|oxybutynin|mesh-list
65180968|NCT05658874|Estrogens|estrogens|mesh-list
65180969|NCT05658874|Analgesics|analgesics|mesh-ancestor
65180970|NCT05658874|Sensory System Agents|sensory system agents|mesh-ancestor
65180971|NCT05658874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65180972|NCT05658874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180973|NCT05658874|Anticonvulsants|anticonvulsants|mesh-ancestor
65180974|NCT05658874|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65180975|NCT05658874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65180976|NCT05658874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65180977|NCT05658874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65325967|NCT00437125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325968|NCT00437125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65325969|NCT00437125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325970|NCT00437125|Analgesics|analgesics|mesh-ancestor
65325971|NCT00437125|Sensory System Agents|sensory system agents|mesh-ancestor
64555526|NCT03402087|Immunologic Factors|immunologic factors|mesh-ancestor
65180978|NCT05658874|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65180979|NCT05658874|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65180980|NCT05658874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65180981|NCT05658874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180982|NCT05658874|Antimanic Agents|antimanic agents|mesh-ancestor
65180983|NCT05658874|Hormones|hormones|mesh-ancestor
65180984|NCT05658874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65180985|NCT05658874|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65180986|NCT05658874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65180987|NCT05658874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65180988|NCT05658874|Adrenergic Agents|adrenergic agents|mesh-ancestor
65180989|NCT05658874|Urological Agents|urological agents|mesh-ancestor
65180990|NCT05658874|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65180991|NCT05658874|Antidepressive Agents|antidepressive agents|mesh-ancestor
65180992|NCT05658874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65180993|NCT05658874|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65180994|NCT05658874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65180995|NCT05658874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65180996|NCT05658874|Parasympatholytics|parasympatholytics|mesh-ancestor
65180997|NCT05658874|Autonomic Agents|autonomic agents|mesh-ancestor
65180998|NCT05658874|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65180999|NCT05658874|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65181000|NCT05658874|Cholinergic Agents|cholinergic agents|mesh-ancestor
65181001|NCT05658874|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65181002|NCT05658874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65181003|NCT05658874|Renal Agents|renal agents|mesh-ancestor
65181004|NCT05658874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65181005|NCT01106898|Paclitaxel|paclitaxel|mesh-list
65181006|NCT01106898|Cyclophosphamide|cyclophosphamide|mesh-list
65181007|NCT01106898|Trastuzumab|trastuzumab|mesh-list
65181008|NCT01106898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65181009|NCT01106898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181010|NCT01106898|Tubulin Modulators|tubulin modulators|mesh-ancestor
65181011|NCT01106898|Antimitotic Agents|antimitotic agents|mesh-ancestor
65181017|NCT01106898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65181018|NCT01106898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65181019|NCT01106898|Alkylating Agents|alkylating agents|mesh-ancestor
65181020|NCT01106898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65181021|NCT01106898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65181022|NCT04425538|Infliximab|infliximab|mesh-list
65181023|NCT04425538|Dermatologic Agents|dermatologic agents|mesh-ancestor
65181024|NCT04425538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65181025|NCT04425538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65181026|NCT02627521|Ticagrelor|ticagrelor|mesh-list
65181027|NCT02627521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65181028|NCT02627521|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65181029|NCT02627521|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65181030|NCT02627521|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65181031|NCT02627521|Purinergic Agents|purinergic agents|mesh-ancestor
65181032|NCT02627521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65181033|NCT02627521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181034|NCT02627521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181036|NCT00681967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181037|NCT00681967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65181038|NCT00681967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181039|NCT00681967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181040|NCT04239118|Hemostatics|hemostatics|mesh-list
65181041|NCT04239118|Coagulants|coagulants|mesh-ancestor
65181042|NCT04139941|Antibodies|antibodies|mesh-list
65181043|NCT04139941|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
65181044|NCT04139941|Immunologic Factors|immunologic factors|mesh-ancestor
65325972|NCT00437125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65325973|NCT00437125|Antidepressive Agents|antidepressive agents|mesh-ancestor
65325974|NCT00437125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65325975|NCT00437125|Dopamine Agents|dopamine agents|mesh-ancestor
65325976|NCT01028287|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65325977|NCT01028287|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
65325978|NCT01028287|beta-Endorphin|beta-endorphin|mesh-list
65181045|NCT04139941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181046|NCT02814994|Respiratory System Agents|respiratory system agents|mesh-list
65181047|NCT00875017|Sevelamer|sevelamer|mesh-list
65181048|NCT00875017|Chelating Agents|chelating agents|mesh-ancestor
65181049|NCT00875017|Sequestering Agents|sequestering agents|mesh-ancestor
65181050|NCT00875017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181051|NCT00679705|Atosiban|atosiban|mesh-list
65181052|NCT00679705|Ritodrine|ritodrine|mesh-list
65181053|NCT00679705|Hormone Antagonists|hormone antagonists|mesh-ancestor
65181054|NCT00679705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65181055|NCT00679705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181056|NCT00679705|Tocolytic Agents|tocolytic agents|mesh-ancestor
65181057|NCT00679705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65181058|NCT00679705|Sympathomimetics|sympathomimetics|mesh-ancestor
65181059|NCT00679705|Autonomic Agents|autonomic agents|mesh-ancestor
65181060|NCT00679705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65181061|NCT00679705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65181062|NCT00679705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65181063|NCT00679705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65181064|NCT00679705|Adrenergic Agents|adrenergic agents|mesh-ancestor
65181065|NCT00679705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65181066|NCT00679705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181067|NCT00685633|Bicalutamide|bicalutamide|mesh-list
65181068|NCT00685633|Androgen Antagonists|androgen antagonists|mesh-ancestor
65181069|NCT00685633|Hormone Antagonists|hormone antagonists|mesh-ancestor
65181070|NCT00685633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65181071|NCT00685633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181072|NCT00685633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181073|NCT04371952|Doxycycline|doxycycline|mesh-list
65181074|NCT04371952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65181075|NCT04371952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65181076|NCT04371952|Antimalarials|antimalarials|mesh-ancestor
65181077|NCT04371952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65181078|NCT04371952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65181079|NCT04329832|Azithromycin|azithromycin|mesh-list
65181080|NCT04329832|Hydroxychloroquine|hydroxychloroquine|mesh-list
65181081|NCT04329832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65181083|NCT04329832|Antimalarials|antimalarials|mesh-ancestor
65181084|NCT04329832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65181085|NCT04329832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65181086|NCT04329832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181087|NCT04329832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181088|NCT04329832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65181089|NCT04237246|Tacrolimus|tacrolimus|mesh-list
65181090|NCT04237246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65181091|NCT04237246|Immunologic Factors|immunologic factors|mesh-ancestor
65181092|NCT04237246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181093|NCT04237246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65181094|NCT04237246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181095|NCT04237246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181096|NCT00680095|Tavaborole|tavaborole|mesh-list
65181097|NCT00680095|Antifungal Agents|antifungal agents|mesh-ancestor
65181098|NCT00680095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65181099|NCT02814058|Zolpidem|zolpidem|mesh-list
65181100|NCT02814058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65181101|NCT02814058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65181102|NCT02814058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65181103|NCT02814058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181104|NCT02814058|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65181105|NCT02814058|GABA Agonists|gaba agonists|mesh-ancestor
65181106|NCT02814058|GABA Agents|gaba agents|mesh-ancestor
65325979|NCT01028287|Hormones|hormones|mesh-ancestor
65325980|NCT01028287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65325981|NCT01028287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325982|NCT01028287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65325983|NCT01028287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325984|NCT01028443|Cyclosporine|cyclosporine|mesh-list
65325985|NCT01028443|Antifungal Agents|antifungal agents|mesh-ancestor
65181107|NCT02814058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65181108|NCT02814058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181109|NCT00680173|Interferons|interferons|mesh-list
65181110|NCT00680173|Ribavirin|ribavirin|mesh-list
65181111|NCT00680173|Interferon-alpha|interferon-alpha|mesh-list
65181112|NCT00680173|Interferon alpha-2|interferon alpha-2|mesh-list
65181113|NCT00680173|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65181114|NCT00680173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181115|NCT00680173|Antiviral Agents|antiviral agents|mesh-ancestor
65181116|NCT00680173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65181117|NCT00680173|Antimetabolites|antimetabolites|mesh-ancestor
65181118|NCT00680173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181119|NCT00680173|Immunologic Factors|immunologic factors|mesh-ancestor
65181120|NCT00680173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181121|NCT00682279|Topotecan|topotecan|mesh-list
65181122|NCT00682279|Lapatinib|lapatinib|mesh-list
65181123|NCT00682279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65181124|NCT00682279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65181125|NCT00682279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181126|NCT00682279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181127|NCT00682279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181128|NCT00682279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65181129|NCT02811484|Dapagliflozin|dapagliflozin|mesh-list
65181130|NCT02811484|Exenatide|exenatide|mesh-list
65181131|NCT02811484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65181132|NCT02811484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181133|NCT02811484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65181134|NCT02811484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181136|NCT02811484|Incretins|incretins|mesh-ancestor
65181137|NCT02811484|Hormones|hormones|mesh-ancestor
65181138|NCT02811484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65181139|NCT00686179|Moxifloxacin|moxifloxacin|mesh-list
65181140|NCT00686179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65181141|NCT00686179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65181142|NCT00686179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65181143|NCT00686179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65181144|NCT00686179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181145|NCT00686179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181146|NCT00686179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181147|NCT00922597|Factor VIII|factor viii|mesh-list
65181148|NCT00922597|Coagulants|coagulants|mesh-ancestor
65181149|NCT00874939|Donepezil|donepezil|mesh-list
65181150|NCT00874939|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65181151|NCT00874939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181152|NCT00874939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181153|NCT00874939|Cholinergic Agents|cholinergic agents|mesh-ancestor
65181154|NCT00874939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65181155|NCT00874939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181156|NCT00874939|Nootropic Agents|nootropic agents|mesh-ancestor
65181157|NCT00634348|Aripiprazole|aripiprazole|mesh-list
65181161|NCT00634348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65181162|NCT00634348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65181163|NCT00634348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65181164|NCT00634348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181165|NCT00634348|Dopamine Agonists|dopamine agonists|mesh-ancestor
65181166|NCT00634348|Dopamine Agents|dopamine agents|mesh-ancestor
65181167|NCT00634348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65181168|NCT00634348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181169|NCT00634348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65181170|NCT00634348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65325986|NCT01028443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65325987|NCT01028443|Dermatologic Agents|dermatologic agents|mesh-ancestor
65325988|NCT01028443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325989|NCT01028443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325990|NCT01028443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65325991|NCT01028443|Immunologic Factors|immunologic factors|mesh-ancestor
65325992|NCT01028443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325993|NCT01028443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65181171|NCT00634348|Serotonin Agents|serotonin agents|mesh-ancestor
65181172|NCT00634348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65181173|NCT00634348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65181174|NCT00634348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65181175|NCT00634348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65181177|NCT00680329|Travoprost|travoprost|mesh-list
65181178|NCT00680329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65181179|NCT00680329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65181180|NCT00680329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65181181|NCT00680329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65181182|NCT00680329|Adrenergic Agents|adrenergic agents|mesh-ancestor
65181183|NCT00680329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65181184|NCT00680329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181185|NCT00680329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181186|NCT00680329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65181187|NCT00680329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65181188|NCT01185353|Methotrexate|methotrexate|mesh-list
65181189|NCT01185353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65181190|NCT01185353|Abortifacient Agents|abortifacient agents|mesh-ancestor
65181191|NCT01185353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65181192|NCT01185353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181193|NCT01185353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65181194|NCT01185353|Antimetabolites|antimetabolites|mesh-ancestor
65181195|NCT01185353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181196|NCT01185353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181197|NCT01185353|Dermatologic Agents|dermatologic agents|mesh-ancestor
65181198|NCT01185353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181199|NCT01185353|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65181200|NCT01185353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65181201|NCT01185353|Immunologic Factors|immunologic factors|mesh-ancestor
65181202|NCT01185353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65181203|NCT01185353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65181204|NCT02811016|Budesonide|budesonide|mesh-list
65181205|NCT02811016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65181206|NCT02811016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65181207|NCT02811016|Autonomic Agents|autonomic agents|mesh-ancestor
65181208|NCT02811016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65181209|NCT02811016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181210|NCT02811016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65181211|NCT02811016|Respiratory System Agents|respiratory system agents|mesh-ancestor
65181212|NCT02811016|Glucocorticoids|glucocorticoids|mesh-ancestor
65181213|NCT02811016|Hormones|hormones|mesh-ancestor
65181214|NCT02811016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65181215|NCT00690313|Moxifloxacin|moxifloxacin|mesh-list
65181216|NCT00690313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65181217|NCT00690313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65181218|NCT00690313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65181219|NCT00690313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65181220|NCT00690313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65181221|NCT00690313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181222|NCT00690313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181223|NCT00690313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181224|NCT00690313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65181225|NCT00690313|Contraceptive Agents|contraceptive agents|mesh-ancestor
65181226|NCT00690313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65181227|NCT00690313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181232|NCT04237480|Ergocalciferols|ergocalciferols|mesh-list
65325994|NCT01028443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65325995|NCT03116997|Glycopyrrolate|glycopyrrolate|mesh-list
65325996|NCT03116997|Neostigmine|neostigmine|mesh-list
65325997|NCT03116997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65325998|NCT03116997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325999|NCT03116997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326000|NCT03116997|Cholinergic Agents|cholinergic agents|mesh-ancestor
65181233|NCT04237480|Cholecalciferol|cholecalciferol|mesh-list
65181234|NCT04237480|Vitamins|vitamins|mesh-list
65181235|NCT04237480|Micronutrients|micronutrients|mesh-ancestor
65181236|NCT04237480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181237|NCT04237480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65181238|NCT04237480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65181239|NCT02813356|Naloxegol|naloxegol|mesh-list
65181240|NCT02813356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65181241|NCT02813356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181242|NCT02813356|Sensory System Agents|sensory system agents|mesh-ancestor
65181243|NCT02813356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65181244|NCT02810782|Morphine|morphine|mesh-list
65181245|NCT02810782|Phenobarbital|phenobarbital|mesh-list
65181246|NCT02810782|Chlorpromazine|chlorpromazine|mesh-list
65181247|NCT02810782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65181248|NCT02810782|Narcotics|narcotics|mesh-ancestor
65181249|NCT02810782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65181250|NCT02810782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181251|NCT02810782|Analgesics|analgesics|mesh-ancestor
65181252|NCT02810782|Sensory System Agents|sensory system agents|mesh-ancestor
65181253|NCT02810782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65181254|NCT02810782|Anticonvulsants|anticonvulsants|mesh-ancestor
65181255|NCT02810782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65181256|NCT02810782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65181257|NCT02810782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65181258|NCT02810782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65181259|NCT02810782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181260|NCT02810782|GABA Modulators|gaba modulators|mesh-ancestor
65181261|NCT02810782|GABA Agents|gaba agents|mesh-ancestor
65181262|NCT02810782|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65181263|NCT02810782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65181264|NCT02810782|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65181265|NCT02810782|Antiemetics|antiemetics|mesh-ancestor
65181266|NCT02810782|Autonomic Agents|autonomic agents|mesh-ancestor
65181267|NCT02810782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65181268|NCT02810782|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65181269|NCT02810782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65181270|NCT02810782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65181271|NCT02810782|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65181272|NCT02810782|Dopamine Agents|dopamine agents|mesh-ancestor
65181273|NCT02810548|Mitogens|mitogens|mesh-list
65181274|NCT02810548|Mitosis Modulators|mitosis modulators|mesh-ancestor
65181275|NCT02810548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181276|NCT01155869|Naltrexone|naltrexone|mesh-list
65181277|NCT01155869|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65181278|NCT01155869|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65181279|NCT01155869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181280|NCT01155869|Sensory System Agents|sensory system agents|mesh-ancestor
65181281|NCT01155869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65181282|NCT00687037|Cetylpyridinium|cetylpyridinium|mesh-list
65181283|NCT00687037|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65181284|NCT00687037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65181285|NCT02625415|Vitamins|vitamins|mesh-list
65181286|NCT02625415|Vitamin B 6|vitamin b 6|mesh-list
65181287|NCT02625415|Pyridoxal|pyridoxal|mesh-list
65181288|NCT02625415|Pyridoxine|pyridoxine|mesh-list
65181289|NCT02625415|Vitamin B Complex|vitamin b complex|mesh-list
65181290|NCT02625415|Micronutrients|micronutrients|mesh-ancestor
65181291|NCT02625415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181292|NCT02809768|Itraconazole|itraconazole|mesh-list
65181293|NCT02809768|Fluconazole|fluconazole|mesh-list
65181294|NCT02809768|Rifampin|rifampin|mesh-list
65181295|NCT02809768|Antifungal Agents|antifungal agents|mesh-ancestor
65181296|NCT02809768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65326001|NCT03116997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65326002|NCT03116997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326003|NCT03116997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65326004|NCT03116997|Autonomic Agents|autonomic agents|mesh-ancestor
65326005|NCT03116997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65326006|NCT03116997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65181297|NCT02809768|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65181298|NCT02809768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65181299|NCT02809768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181300|NCT02809768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181301|NCT02809768|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65181303|NCT02809768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65181304|NCT02809768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181305|NCT02809768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65181306|NCT02809768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65181307|NCT02809768|Antitubercular Agents|antitubercular agents|mesh-ancestor
65181308|NCT02809768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65181309|NCT02809768|Leprostatic Agents|leprostatic agents|mesh-ancestor
65181310|NCT02809768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65181311|NCT02809768|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65181312|NCT02809768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65181313|NCT02809768|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65181314|NCT02809768|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65181315|NCT02809768|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65181316|NCT02809768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65181317|NCT02809768|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65181318|NCT02809768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65181319|NCT04237090|Diphenhydramine|diphenhydramine|mesh-list
65181320|NCT04237090|Promethazine|promethazine|mesh-list
65181321|NCT04237090|Cetirizine|cetirizine|mesh-list
65181322|NCT04237090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65181323|NCT04237090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65181324|NCT04237090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65181325|NCT04237090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181326|NCT04237090|Anesthetics, Local|anesthetics, local|mesh-ancestor
65181327|NCT04237090|Anesthetics|anesthetics|mesh-ancestor
65181328|NCT04237090|Sensory System Agents|sensory system agents|mesh-ancestor
65181329|NCT04237090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65181331|NCT04237090|Autonomic Agents|autonomic agents|mesh-ancestor
65181332|NCT04237090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65181333|NCT04237090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65181334|NCT04237090|Histamine Antagonists|histamine antagonists|mesh-ancestor
65181335|NCT04237090|Histamine Agents|histamine agents|mesh-ancestor
65181336|NCT04237090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65181337|NCT04237090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181338|NCT04237090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65181339|NCT04237090|Antipruritics|antipruritics|mesh-ancestor
65181340|NCT04237090|Dermatologic Agents|dermatologic agents|mesh-ancestor
65181341|NCT04237090|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65181342|NCT00690781|Caseins|caseins|mesh-list
65181343|NCT00690781|Chelating Agents|chelating agents|mesh-ancestor
65181344|NCT00690781|Sequestering Agents|sequestering agents|mesh-ancestor
65181345|NCT00690781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181346|NCT00682825|Anesthetics|anesthetics|mesh-list
65181347|NCT00682825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
65181348|NCT00682825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65181349|NCT00682825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181350|NCT00682825|Anesthetics, General|anesthetics, general|mesh-ancestor
65181351|NCT04187248|Asparaginase|asparaginase|mesh-list
65181352|NCT04187248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181353|NCT00912379|Chrysarobin|chrysarobin|mesh-list
65181354|NCT00912379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65181355|NCT00912379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65181356|NCT00912379|Analgesics|analgesics|mesh-ancestor
64823915|NCT01529164|Vitamins|vitamins|mesh-ancestor
65181357|NCT00912379|Sensory System Agents|sensory system agents|mesh-ancestor
65326007|NCT03116997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65326008|NCT03116997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65326009|NCT02600780|Allopurinol|allopurinol|mesh-list
65326010|NCT02600780|Febuxostat|febuxostat|mesh-list
65326011|NCT02600780|Antimetabolites|antimetabolites|mesh-ancestor
65326012|NCT02600780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326013|NCT02600780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326014|NCT02600780|Gout Suppressants|gout suppressants|mesh-ancestor
65181358|NCT00912379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65181359|NCT00912379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181360|NCT00912379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65181361|NCT00912379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65181362|NCT02809378|Remifentanil|remifentanil|mesh-list
65181363|NCT02809378|Thiopental|thiopental|mesh-list
65181364|NCT02809378|Palonosetron|palonosetron|mesh-list
65181365|NCT02809378|Propofol|propofol|mesh-list
65181366|NCT02809378|Sevoflurane|sevoflurane|mesh-list
65181367|NCT02809378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65181368|NCT02809378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65181369|NCT02809378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181370|NCT02809378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65181371|NCT02809378|Anesthetics, General|anesthetics, general|mesh-ancestor
65181372|NCT02809378|Anesthetics|anesthetics|mesh-ancestor
65181373|NCT02809378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65181374|NCT02809378|Narcotics|narcotics|mesh-ancestor
65181375|NCT02809378|Analgesics|analgesics|mesh-ancestor
65181377|NCT02809378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65181378|NCT02809378|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65181379|NCT02809378|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65181380|NCT02809378|Antiemetics|antiemetics|mesh-ancestor
65181381|NCT02809378|Autonomic Agents|autonomic agents|mesh-ancestor
65181382|NCT02809378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65181383|NCT02809378|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65181384|NCT02809378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65181385|NCT02809378|Serotonin Agents|serotonin agents|mesh-ancestor
65181386|NCT02809378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65181387|NCT02809378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181388|NCT02809378|Anticonvulsants|anticonvulsants|mesh-ancestor
65181389|NCT02809378|GABA Modulators|gaba modulators|mesh-ancestor
65181390|NCT02809378|GABA Agents|gaba agents|mesh-ancestor
65181391|NCT00683059|Paclitaxel|paclitaxel|mesh-list
65181392|NCT00683059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65181393|NCT00683059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181394|NCT00683059|Tubulin Modulators|tubulin modulators|mesh-ancestor
65181395|NCT00683059|Antimitotic Agents|antimitotic agents|mesh-ancestor
65181396|NCT00683059|Mitosis Modulators|mitosis modulators|mesh-ancestor
65181397|NCT00683059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181398|NCT00683137|Valdecoxib|valdecoxib|mesh-list
65181399|NCT00683137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65181400|NCT00683137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65181401|NCT00683137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181402|NCT00683137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181403|NCT00683137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65181404|NCT00683137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65181405|NCT00683137|Analgesics|analgesics|mesh-ancestor
65181406|NCT00683137|Sensory System Agents|sensory system agents|mesh-ancestor
65181407|NCT00683137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65181408|NCT00683137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181409|NCT00683137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65181410|NCT00683137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65181411|NCT02809456|Nicorandil|nicorandil|mesh-list
65181412|NCT02809456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65181413|NCT02809456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65181414|NCT02809456|Vasodilator Agents|vasodilator agents|mesh-ancestor
65181415|NCT02809456|Vitamin B Complex|vitamin b complex|mesh-ancestor
65181416|NCT02809456|Vitamins|vitamins|mesh-ancestor
65181417|NCT02809456|Micronutrients|micronutrients|mesh-ancestor
65181418|NCT02809456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181419|NCT05576740|Contraceptive Agents|contraceptive agents|mesh-list
65181420|NCT05576740|Hormones|hormones|mesh-list
65326015|NCT02600780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65326016|NCT02600780|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65326017|NCT02600780|Antioxidants|antioxidants|mesh-ancestor
65326018|NCT02600780|Protective Agents|protective agents|mesh-ancestor
65326019|NCT02600780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326020|NCT00582309|Insulin|insulin|mesh-list
65326021|NCT00582309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65326022|NCT00582309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64555571|NCT04020809|Atezolizumab|atezolizumab|mesh-list
65181421|NCT05576740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65181422|NCT05576740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181423|NCT05576740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65181424|NCT04139629|Antibodies|antibodies|mesh-list
65181425|NCT04139629|Immunologic Factors|immunologic factors|mesh-ancestor
65181426|NCT04139629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181427|NCT02813044|Anesthetics|anesthetics|mesh-list
65181428|NCT02813044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65181429|NCT02813044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181430|NCT04236778|Vancomycin|vancomycin|mesh-list
65181431|NCT04236778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65181432|NCT04236778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65181433|NCT02812888|Propranolol|propranolol|mesh-list
65181434|NCT02812888|Methimazole|methimazole|mesh-list
65181435|NCT02812888|Propylthiouracil|propylthiouracil|mesh-list
65181436|NCT02812888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65181437|NCT02812888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65181438|NCT02812888|Adrenergic Agents|adrenergic agents|mesh-ancestor
65181439|NCT02812888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65181440|NCT02812888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181441|NCT02812888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181442|NCT02812888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65181443|NCT02812888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65181444|NCT02812888|Vasodilator Agents|vasodilator agents|mesh-ancestor
65181445|NCT02812888|Antithyroid Agents|antithyroid agents|mesh-ancestor
65181446|NCT02812888|Hormone Antagonists|hormone antagonists|mesh-ancestor
65181447|NCT02812888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65181448|NCT02812888|Antimetabolites|antimetabolites|mesh-ancestor
65181449|NCT00687661|Diphosphonates|diphosphonates|mesh-list
65181456|NCT00687817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181457|NCT00687817|Tubulin Modulators|tubulin modulators|mesh-ancestor
65181458|NCT00687817|Antimitotic Agents|antimitotic agents|mesh-ancestor
65181459|NCT00687817|Mitosis Modulators|mitosis modulators|mesh-ancestor
65181460|NCT00687817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181461|NCT00687817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65181462|NCT02808988|Zoledronic Acid|zoledronic acid|mesh-list
65181463|NCT02808988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65181464|NCT02808988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181465|NCT02625805|Methylphenidate|methylphenidate|mesh-list
65181466|NCT02625805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65181467|NCT02625805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181468|NCT02625805|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65181469|NCT02625805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65181470|NCT02625805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65181471|NCT02625805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181472|NCT02625805|Dopamine Agents|dopamine agents|mesh-ancestor
65181473|NCT02625805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65181474|NCT00688207|Rosiglitazone|rosiglitazone|mesh-list
65181475|NCT00688207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65181476|NCT00688207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181477|NCT02880462|Sulforaphane|sulforaphane|mesh-list
65181478|NCT02880462|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65181480|NCT02880462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181481|NCT02880462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181482|NCT00688363|Chrysarobin|chrysarobin|mesh-list
65181483|NCT00688363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65181484|NCT00688363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65326023|NCT00582309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326024|NCT00443053|PENTA|penta|mesh-list
65326025|NCT00443053|Fondaparinux|fondaparinux|mesh-list
65326026|NCT00443053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65181485|NCT00688363|Analgesics|analgesics|mesh-ancestor
65181486|NCT00688363|Sensory System Agents|sensory system agents|mesh-ancestor
65181487|NCT00688363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65181488|NCT00688363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181489|NCT00688363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65181490|NCT00688363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65181491|NCT02812654|Doxorubicin|doxorubicin|mesh-list
65181492|NCT02812654|Ifosfamide|ifosfamide|mesh-list
65181493|NCT02812654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65181494|NCT02812654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181495|NCT02812654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65181496|NCT02812654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65181497|NCT02812654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181498|NCT02812654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181499|NCT02812654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65181500|NCT02812654|Alkylating Agents|alkylating agents|mesh-ancestor
65181501|NCT02809066|Calcium, Dietary|calcium, dietary|mesh-list
65181502|NCT02809066|Calcium|calcium|mesh-list
65181503|NCT02809066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65181504|NCT02809066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181505|NCT02809066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65181506|NCT01097694|Imatinib Mesylate|imatinib mesylate|mesh-list
65181507|NCT01097694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181508|NCT01097694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65181509|NCT01097694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181510|NCT01097694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181511|NCT00688987|Hydrocortisone|hydrocortisone|mesh-list
65181512|NCT00688987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65181513|NCT02808676|Vitamin D|vitamin d|mesh-list
65181514|NCT02808676|Cholecalciferol|cholecalciferol|mesh-list
65181515|NCT02808676|Vitamins|vitamins|mesh-ancestor
65181516|NCT02808676|Micronutrients|micronutrients|mesh-ancestor
65181517|NCT02808676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181518|NCT02808676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65181522|NCT00690937|Chelating Agents|chelating agents|mesh-ancestor
65181523|NCT00690937|Sequestering Agents|sequestering agents|mesh-ancestor
65181524|NCT00690937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181525|NCT00690937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65181526|NCT00690937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65181527|NCT00690937|Antimetabolites|antimetabolites|mesh-ancestor
65181528|NCT00690937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65181529|NCT00689143|Sargramostim|sargramostim|mesh-list
65181530|NCT00689143|Immunologic Factors|immunologic factors|mesh-ancestor
65181531|NCT00689143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181532|NCT00912457|Donepezil|donepezil|mesh-list
65181533|NCT00912457|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65181534|NCT00912457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181535|NCT00912457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181536|NCT00912457|Cholinergic Agents|cholinergic agents|mesh-ancestor
65181537|NCT00912457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65181538|NCT00912457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181539|NCT00912457|Nootropic Agents|nootropic agents|mesh-ancestor
65181540|NCT04200586|Dapagliflozin|dapagliflozin|mesh-list
65181541|NCT04200586|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65181542|NCT04200586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181543|NCT04200586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65181544|NCT04200586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181545|NCT02625103|Clozapine|clozapine|mesh-list
65181546|NCT02625103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65181547|NCT02625103|Serotonin Agents|serotonin agents|mesh-ancestor
65181548|NCT02625103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65181549|NCT02625103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181550|NCT02625103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181551|NCT02625103|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65181552|NCT02625103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65181553|NCT02625103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65181554|NCT02625103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65181555|NCT02625103|GABA Antagonists|gaba antagonists|mesh-ancestor
65326027|NCT00443053|Antithrombins|antithrombins|mesh-ancestor
65326028|NCT00443053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65326029|NCT00443053|Protease Inhibitors|protease inhibitors|mesh-ancestor
65326030|NCT00443053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326031|NCT00443053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326032|NCT00443053|Anticoagulants|anticoagulants|mesh-ancestor
65326033|NCT00443053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65181556|NCT02625103|GABA Agents|gaba agents|mesh-ancestor
65181557|NCT01155479|Rasagiline|rasagiline|mesh-list
65181558|NCT01155479|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65181559|NCT01155479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181560|NCT01155479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181561|NCT01155479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65181562|NCT01155479|Protective Agents|protective agents|mesh-ancestor
65181563|NCT01155479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181564|NCT02807272|Tipifarnib|tipifarnib|mesh-list
65181565|NCT02807272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181566|NCT02807194|Anesthetics|anesthetics|mesh-list
65181567|NCT02807194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65181568|NCT02807194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181569|NCT00912535|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65181570|NCT00912535|Antidepressive Agents|antidepressive agents|mesh-ancestor
65181571|NCT00912535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65181572|NCT00912535|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65181573|NCT00912535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65181574|NCT00912535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65181575|NCT00912535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181576|NCT02625727|Hyaluronic Acid|hyaluronic acid|mesh-list
65181577|NCT02625727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65181578|NCT02625727|Immunologic Factors|immunologic factors|mesh-ancestor
65181579|NCT02625727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181580|NCT02625727|Viscosupplements|viscosupplements|mesh-ancestor
65181581|NCT02625727|Protective Agents|protective agents|mesh-ancestor
65181582|NCT02807116|Rifampin|rifampin|mesh-list
65181583|NCT02807116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65181584|NCT02807116|Antitubercular Agents|antitubercular agents|mesh-ancestor
65181585|NCT02807116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65181586|NCT02807116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65181587|NCT02807116|Leprostatic Agents|leprostatic agents|mesh-ancestor
65181588|NCT02807116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65181589|NCT02807116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181590|NCT02807116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181594|NCT02807116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65181595|NCT02807116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65181596|NCT02807116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65181597|NCT04313699|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65181598|NCT04313699|Antiviral Agents|antiviral agents|mesh-ancestor
65181599|NCT04313699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65181600|NCT05605366|Minocycline|minocycline|mesh-list
65181601|NCT05605366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65181602|NCT05605366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65181603|NCT01155167|Lidocaine|lidocaine|mesh-list
65181604|NCT01155167|Nitroglycerin|nitroglycerin|mesh-list
65181605|NCT01155167|Anesthetics, Local|anesthetics, local|mesh-ancestor
65181606|NCT01155167|Anesthetics|anesthetics|mesh-ancestor
65181607|NCT01155167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65181608|NCT01155167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181609|NCT01155167|Sensory System Agents|sensory system agents|mesh-ancestor
65181610|NCT01155167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65181611|NCT01155167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65181612|NCT01155167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65181613|NCT01155167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65181614|NCT01155167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65181615|NCT01155167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181616|NCT01155167|Vasodilator Agents|vasodilator agents|mesh-ancestor
65181617|NCT05238155|Antimetabolites|antimetabolites|mesh-list
65181618|NCT05238155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181619|NCT01106586|Ritonavir|ritonavir|mesh-list
65326034|NCT00443053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65326035|NCT00720798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65326036|NCT00720798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65326037|NCT00720798|Antirheumatic Agents|antirheumatic agents|mesh-list
65326038|NCT00720798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65326039|NCT00720798|Analgesics|analgesics|mesh-ancestor
65326040|NCT00720798|Sensory System Agents|sensory system agents|mesh-ancestor
65326041|NCT00720798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65326042|NCT00720798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326043|NCT01816971|Dexamethasone|dexamethasone|mesh-list
65181620|NCT01106586|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65181621|NCT01106586|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65181622|NCT01106586|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65181623|NCT01106586|Protease Inhibitors|protease inhibitors|mesh-ancestor
65181624|NCT01106586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181625|NCT01106586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181626|NCT01106586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65181627|NCT01106586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65181628|NCT01106586|Antiviral Agents|antiviral agents|mesh-ancestor
65181629|NCT01106586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65181630|NCT01106586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65181631|NCT01106586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65181632|NCT00683995|Fentanyl|fentanyl|mesh-list
65181633|NCT00683995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65181634|NCT00683995|Narcotics|narcotics|mesh-ancestor
65181635|NCT00683995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65181636|NCT00683995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181637|NCT00683995|Analgesics|analgesics|mesh-ancestor
65181638|NCT00683995|Sensory System Agents|sensory system agents|mesh-ancestor
65181639|NCT00683995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65181640|NCT00683995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65181641|NCT00683995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65181642|NCT00683995|Anesthetics, General|anesthetics, general|mesh-ancestor
65181643|NCT00683995|Anesthetics|anesthetics|mesh-ancestor
65181644|NCT02806882|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
65181645|NCT02806882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65181646|NCT02806882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65181647|NCT02884817|Listerine|listerine|mesh-list
65181648|NCT02884817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65181649|NCT02884817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65181650|NCT02806804|Vaccines|vaccines|mesh-list
65181651|NCT02806804|Immunologic Factors|immunologic factors|mesh-ancestor
65181652|NCT02806804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181653|NCT02879292|Anesthetics|anesthetics|mesh-list
65181654|NCT02879292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65181655|NCT02879292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181656|NCT02806648|Palbociclib|palbociclib|mesh-list
65181657|NCT02806648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181658|NCT02806648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65181659|NCT02806648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181660|NCT02806648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181668|NCT00689845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65181670|NCT00689845|Etoposide|etoposide|mesh-list
65181671|NCT00689845|Vincristine|vincristine|mesh-list
65181672|NCT00689845|Bleomycin|bleomycin|mesh-list
65181673|NCT00689845|Etoposide phosphate|etoposide phosphate|mesh-list
65181674|NCT00689845|Vindesine|vindesine|mesh-list
65181675|NCT00689845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65181676|NCT00689845|Immunologic Factors|immunologic factors|mesh-ancestor
65181677|NCT00689845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181678|NCT00689845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65181679|NCT00689845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65181680|NCT00689845|Alkylating Agents|alkylating agents|mesh-ancestor
65181681|NCT00689845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326044|NCT01816971|Lenalidomide|lenalidomide|mesh-list
65326045|NCT01816971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65326046|NCT01816971|Antiemetics|antiemetics|mesh-ancestor
65326047|NCT01816971|Autonomic Agents|autonomic agents|mesh-ancestor
65326048|NCT01816971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65181682|NCT00689845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181683|NCT00689845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65181684|NCT00689845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65181685|NCT00689845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65181686|NCT00689845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65181687|NCT00689845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65181688|NCT00689845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181689|NCT00689845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65181690|NCT00689845|Glucocorticoids|glucocorticoids|mesh-ancestor
65181691|NCT00689845|Hormones|hormones|mesh-ancestor
65181692|NCT00689845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65181693|NCT00689845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65181694|NCT00689845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65181695|NCT00689845|Abortifacient Agents|abortifacient agents|mesh-ancestor
65181696|NCT00689845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65181697|NCT00689845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65181698|NCT00689845|Antimetabolites|antimetabolites|mesh-ancestor
65181699|NCT00689845|Dermatologic Agents|dermatologic agents|mesh-ancestor
65181700|NCT00689845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65181701|NCT00689845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65181702|NCT00689845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65181703|NCT00689845|Antiviral Agents|antiviral agents|mesh-ancestor
65181704|NCT00689845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65181705|NCT00689845|Tubulin Modulators|tubulin modulators|mesh-ancestor
65181706|NCT00689845|Antimitotic Agents|antimitotic agents|mesh-ancestor
65181707|NCT00689845|Mitosis Modulators|mitosis modulators|mesh-ancestor
65181708|NCT00624767|Insulin|insulin|mesh-list
65181709|NCT00624767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65181710|NCT00624767|Insulin Aspart|insulin aspart|mesh-list
65181711|NCT00624767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65181712|NCT00624767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181713|NCT02806492|Phenylephrine|phenylephrine|mesh-list
65181714|NCT02806492|Oxymetazoline|oxymetazoline|mesh-list
65181715|NCT02806492|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65181716|NCT02806492|Mydriatics|mydriatics|mesh-ancestor
65181717|NCT02806492|Autonomic Agents|autonomic agents|mesh-ancestor
65181718|NCT02806492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65181719|NCT02806492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181720|NCT02806492|Sympathomimetics|sympathomimetics|mesh-ancestor
65181721|NCT02806492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65181722|NCT02806492|Nasal Decongestants|nasal decongestants|mesh-ancestor
65181723|NCT02806492|Respiratory System Agents|respiratory system agents|mesh-ancestor
65181724|NCT02806492|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65181725|NCT02806492|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65181726|NCT02806492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65181727|NCT02806492|Adrenergic Agents|adrenergic agents|mesh-ancestor
65181728|NCT02806492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65181729|NCT02806492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181730|NCT02806492|Protective Agents|protective agents|mesh-ancestor
65181731|NCT00691405|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65181732|NCT00691405|Formoterol Fumarate|formoterol fumarate|mesh-list
65181737|NCT00691405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65181738|NCT00691405|Respiratory System Agents|respiratory system agents|mesh-ancestor
65181739|NCT00691405|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65181740|NCT00691405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65181742|NCT00691405|Adrenergic Agents|adrenergic agents|mesh-ancestor
65181743|NCT00691405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65181744|NCT00691405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181745|NCT01106430|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65181746|NCT01106430|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65181747|NCT01106430|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65181748|NCT01106430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65181749|NCT01106430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65181750|NCT01106430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326049|NCT01816971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326050|NCT01816971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65326051|NCT01816971|Glucocorticoids|glucocorticoids|mesh-ancestor
65326052|NCT01816971|Hormones|hormones|mesh-ancestor
65326053|NCT01816971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65326054|NCT01816971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65326055|NCT01816971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486106|NCT04553263|Naltrexone|naltrexone|mesh-list
65181751|NCT01106430|Adrenergic Agents|adrenergic agents|mesh-ancestor
65181752|NCT01106430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65181753|NCT01106430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181754|NCT01106430|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65181755|NCT01106430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65181756|NCT01106430|Dopamine Agents|dopamine agents|mesh-ancestor
65181757|NCT02804776|Gefitinib|gefitinib|mesh-list
65181758|NCT02804776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181759|NCT02804776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65181760|NCT02804776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181761|NCT02804776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181762|NCT01154153|Loratadine|loratadine|mesh-list
65181763|NCT01154153|Triamcinolone|triamcinolone|mesh-list
65181764|NCT01154153|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65181765|NCT01154153|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65181766|NCT01154153|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65181767|NCT01154153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65181768|NCT01154153|Glucocorticoids|glucocorticoids|mesh-ancestor
65181769|NCT01154153|Hormones|hormones|mesh-ancestor
65181770|NCT01154153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65181771|NCT01154153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181772|NCT01154153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65181773|NCT01154153|Immunologic Factors|immunologic factors|mesh-ancestor
65181774|NCT01154153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181775|NCT01154153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181776|NCT01154153|Antipruritics|antipruritics|mesh-ancestor
65181777|NCT01154153|Dermatologic Agents|dermatologic agents|mesh-ancestor
65181778|NCT01154153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65181779|NCT01154153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65181780|NCT01154153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65181781|NCT01154153|Histamine Antagonists|histamine antagonists|mesh-ancestor
65181782|NCT01154153|Histamine Agents|histamine agents|mesh-ancestor
65181783|NCT01154153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65181785|NCT00684229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65181786|NCT00684229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181787|NCT00874237|Moxifloxacin|moxifloxacin|mesh-list
65181788|NCT00874237|Loxapine|loxapine|mesh-list
65181789|NCT00874237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65181790|NCT00874237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65181791|NCT00874237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65181792|NCT00874237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65181793|NCT00874237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181794|NCT00874237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181795|NCT00874237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181796|NCT00874237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181797|NCT00874237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65181798|NCT00874237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65181799|NCT00874237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65181800|NCT00874237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65181801|NCT00874237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65181810|NCT02805946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65181811|NCT02805946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65181812|NCT02805946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181813|NCT02805946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181814|NCT02805946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65181815|NCT02805946|Hormone Antagonists|hormone antagonists|mesh-ancestor
65181816|NCT02805946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65326056|NCT01816971|Immunologic Factors|immunologic factors|mesh-ancestor
65326057|NCT01816971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65326058|NCT01816971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65326059|NCT01816971|Growth Substances|growth substances|mesh-ancestor
65326060|NCT01816971|Growth Inhibitors|growth inhibitors|mesh-ancestor
65326061|NCT01021267|Saw palmetto extract|saw palmetto extract|mesh-list
65326062|NCT01021267|Urological Agents|urological agents|mesh-ancestor
65326063|NCT00717366|Epoetin Alfa|epoetin alfa|mesh-list
65181817|NCT02805946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181819|NCT02804386|Antiviral Agents|antiviral agents|mesh-ancestor
65181820|NCT02804386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65181821|NCT02805868|Siltuximab|siltuximab|mesh-list
65181822|NCT02805868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65181823|NCT02805868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181824|NCT02805868|Immunologic Factors|immunologic factors|mesh-ancestor
65181825|NCT02805868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181826|NCT00684385|Gefitinib|gefitinib|mesh-list
65181827|NCT00684385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181828|NCT00684385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65181829|NCT00684385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181830|NCT00684385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181831|NCT02690038|Immunoglobulins|immunoglobulins|mesh-list
65181832|NCT02690038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65181833|NCT02690038|Antibodies|antibodies|mesh-list
65181834|NCT02690038|gamma-Globulins|gamma-globulins|mesh-list
65181835|NCT02690038|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65181836|NCT02690038|Immunologic Factors|immunologic factors|mesh-ancestor
65181837|NCT02690038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181838|NCT00691795|Clonidine|clonidine|mesh-list
65181839|NCT00691795|Fentanyl|fentanyl|mesh-list
65181840|NCT00691795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65181841|NCT00691795|Narcotics|narcotics|mesh-ancestor
65181842|NCT00691795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65181843|NCT00691795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181844|NCT00691795|Analgesics|analgesics|mesh-ancestor
65181845|NCT00691795|Sensory System Agents|sensory system agents|mesh-ancestor
65181846|NCT00691795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65181847|NCT00691795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65181848|NCT00691795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65181849|NCT00691795|Anesthetics, General|anesthetics, general|mesh-ancestor
65181850|NCT00691795|Anesthetics|anesthetics|mesh-ancestor
65181851|NCT00691795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65181852|NCT00691795|Sympatholytics|sympatholytics|mesh-ancestor
65181853|NCT00691795|Autonomic Agents|autonomic agents|mesh-ancestor
65181854|NCT00691795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65181855|NCT00691795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65181856|NCT00691795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65181857|NCT00691795|Adrenergic Agents|adrenergic agents|mesh-ancestor
65181858|NCT00691795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65181859|NCT00691795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181861|NCT02805556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65181862|NCT02805556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65181863|NCT02805556|Antiviral Agents|antiviral agents|mesh-ancestor
65181864|NCT02805556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65181865|NCT02805556|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65181866|NCT02805556|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65181867|NCT02805556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181868|NCT04032964|Doxorubicin|doxorubicin|mesh-list
65181869|NCT04032964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65181870|NCT04032964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181875|NCT00694291|Sorafenib|sorafenib|mesh-list
65181876|NCT00694291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181877|NCT00694291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65181878|NCT00694291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181879|NCT00694291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181880|NCT01153763|Dabrafenib|dabrafenib|mesh-list
65181881|NCT01153763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181882|NCT01153763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65181883|NCT01153763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326064|NCT00717366|Hematinics|hematinics|mesh-ancestor
65326065|NCT02939989|Ribavirin|ribavirin|mesh-list
65326066|NCT02939989|Sofosbuvir|sofosbuvir|mesh-list
65326067|NCT02939989|Antimetabolites|antimetabolites|mesh-ancestor
65326068|NCT02939989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326069|NCT02939989|Antiviral Agents|antiviral agents|mesh-ancestor
65326070|NCT02939989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65326071|NCT04096742|Tretinoin|tretinoin|mesh-list
65181884|NCT01153763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181885|NCT00691873|Omalizumab|omalizumab|mesh-list
65181886|NCT00691873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65181887|NCT00691873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65181888|NCT00691873|Respiratory System Agents|respiratory system agents|mesh-ancestor
65181889|NCT05538052|Lidocaine|lidocaine|mesh-list
65181890|NCT05538052|Tramadol|tramadol|mesh-list
65181891|NCT05538052|Anesthetics, Local|anesthetics, local|mesh-ancestor
65181892|NCT05538052|Anesthetics|anesthetics|mesh-ancestor
65181893|NCT05538052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65181894|NCT05538052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181895|NCT05538052|Sensory System Agents|sensory system agents|mesh-ancestor
65181896|NCT05538052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65181897|NCT05538052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65181898|NCT05538052|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65181899|NCT05538052|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65181900|NCT05538052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65181901|NCT05538052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181902|NCT05538052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65181903|NCT05538052|Narcotics|narcotics|mesh-ancestor
65181904|NCT05538052|Analgesics|analgesics|mesh-ancestor
65181905|NCT00691951|Budesonide|budesonide|mesh-list
65181906|NCT00691951|Formoterol Fumarate|formoterol fumarate|mesh-list
65181907|NCT00691951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65181908|NCT00691951|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65181909|NCT00691951|Autonomic Agents|autonomic agents|mesh-ancestor
65181910|NCT00691951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65181911|NCT00691951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181912|NCT00691951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65181913|NCT00691951|Respiratory System Agents|respiratory system agents|mesh-ancestor
65181914|NCT00691951|Glucocorticoids|glucocorticoids|mesh-ancestor
65181915|NCT00691951|Hormones|hormones|mesh-ancestor
65181916|NCT00691951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65181917|NCT00691951|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65181918|NCT00691951|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65181919|NCT00691951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65181920|NCT00691951|Adrenergic Agents|adrenergic agents|mesh-ancestor
65181921|NCT00691951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65181922|NCT00691951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181923|NCT04316351|Pemetrexed|pemetrexed|mesh-list
65181924|NCT04316351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181925|NCT04316351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181926|NCT04316351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181927|NCT04316351|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65181928|NCT04316351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65181929|NCT02625337|Pembrolizumab|pembrolizumab|mesh-list
65181930|NCT02625337|Trametinib|trametinib|mesh-list
65181931|NCT02625337|Dabrafenib|dabrafenib|mesh-list
65181932|NCT02625337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65181933|NCT02625337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181934|NCT02625337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65181935|NCT02625337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181936|NCT02625337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181937|NCT04236310|Trastuzumab|trastuzumab|mesh-list
65181938|NCT04236310|Anastrozole|anastrozole|mesh-list
65181939|NCT04236310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65181940|NCT04236310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181945|NCT04236310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181946|NCT04236310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65181947|NCT04236310|Hormone Antagonists|hormone antagonists|mesh-ancestor
65326072|NCT04096742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326073|NCT04096742|Keratolytic Agents|keratolytic agents|mesh-ancestor
65326074|NCT04096742|Dermatologic Agents|dermatologic agents|mesh-ancestor
65326075|NCT04085640|Ropivacaine|ropivacaine|mesh-list
65326076|NCT04085640|Anesthetics, Local|anesthetics, local|mesh-ancestor
65326077|NCT04085640|Anesthetics|anesthetics|mesh-ancestor
65181948|NCT04236310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65181949|NCT04236310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181950|NCT02621515|Nivolumab|nivolumab|mesh-list
65181951|NCT02621515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65181952|NCT02621515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181953|NCT02621515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65181954|NCT02621515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181955|NCT02803918|Metformin|metformin|mesh-list
65181956|NCT02803918|Lixisenatide|lixisenatide|mesh-list
65181958|NCT02803918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181959|NCT02805010|Abatacept|abatacept|mesh-list
65181960|NCT02805010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65181961|NCT02805010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181962|NCT02805010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181963|NCT02805010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65181964|NCT02805010|Immunologic Factors|immunologic factors|mesh-ancestor
65181965|NCT02805010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181966|NCT02805010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65181967|NCT02800408|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
65181968|NCT02800408|Provitamins|provitamins|mesh-ancestor
65181969|NCT02800408|Vitamins|vitamins|mesh-ancestor
65181970|NCT02800408|Micronutrients|micronutrients|mesh-ancestor
65181971|NCT02800408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181972|NCT00692263|Tramadol|tramadol|mesh-list
65181973|NCT00692263|Citalopram|citalopram|mesh-list
65181974|NCT00692263|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65181975|NCT00692263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65181976|NCT00692263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65181977|NCT00692263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181978|NCT00692263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65181979|NCT00692263|Serotonin Agents|serotonin agents|mesh-ancestor
65181980|NCT00692263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181981|NCT00692263|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65181982|NCT00692263|Antidepressive Agents|antidepressive agents|mesh-ancestor
65181983|NCT00692263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65181984|NCT00692263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65181985|NCT00692263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65181986|NCT00692263|Narcotics|narcotics|mesh-ancestor
65181987|NCT00692263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65181988|NCT00692263|Analgesics|analgesics|mesh-ancestor
65181989|NCT00692263|Sensory System Agents|sensory system agents|mesh-ancestor
65181990|NCT02800486|Cetuximab|cetuximab|mesh-list
65181991|NCT02800486|Mannitol|mannitol|mesh-list
65181992|NCT02800486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65181993|NCT02800486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65181994|NCT02800486|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65181995|NCT02800486|Diuretics|diuretics|mesh-ancestor
65181996|NCT02800486|Natriuretic Agents|natriuretic agents|mesh-ancestor
65181997|NCT02800486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181998|NCT00694759|Metformin|metformin|mesh-list
65181999|NCT00694759|Pioglitazone|pioglitazone|mesh-list
65182000|NCT00694759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65182001|NCT00694759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182003|NCT00694837|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65182004|NCT00694837|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65182005|NCT00694837|Protease Inhibitors|protease inhibitors|mesh-ancestor
65182006|NCT00694837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182007|NCT00694837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182008|NCT00694837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65182009|NCT00694837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65182010|NCT00694837|Antiviral Agents|antiviral agents|mesh-ancestor
65182011|NCT00694837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65182012|NCT02800252|Aspirin|aspirin|mesh-list
65182013|NCT02800252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65182017|NCT02800252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65326078|NCT04085640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65326079|NCT04085640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326080|NCT04085640|Sensory System Agents|sensory system agents|mesh-ancestor
65326081|NCT04085640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65326082|NCT01031719|Vaccines|vaccines|mesh-list
65326083|NCT01031719|Immunologic Factors|immunologic factors|mesh-ancestor
65182018|NCT02800252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182019|NCT02800252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65182020|NCT02800252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65182021|NCT02800252|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65182022|NCT02800252|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65182023|NCT02800252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182024|NCT02800252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65182025|NCT02800252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65182026|NCT02800252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182027|NCT02800252|Antipyretics|antipyretics|mesh-ancestor
65182028|NCT02621359|Doxycycline|doxycycline|mesh-list
65182029|NCT02621359|Levofloxacin|levofloxacin|mesh-list
65182030|NCT02621359|Ofloxacin|ofloxacin|mesh-list
65182031|NCT02621359|Nitazoxanide|nitazoxanide|mesh-list
65182032|NCT02621359|Omeprazole|omeprazole|mesh-list
65182033|NCT02621359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65182034|NCT02621359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65182035|NCT02621359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65182036|NCT02621359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182037|NCT02621359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182038|NCT02621359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65182039|NCT02621359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65182040|NCT02621359|Antimalarials|antimalarials|mesh-ancestor
65182041|NCT02621359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65182042|NCT02621359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65182043|NCT02621359|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65182044|NCT02621359|Renal Agents|renal agents|mesh-ancestor
65182045|NCT02621359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65182046|NCT02621359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65182047|NCT02621359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182048|NCT02621359|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65182049|NCT02621359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65182050|NCT01152437|Cetuximab|cetuximab|mesh-list
65182051|NCT01152437|Afatinib|afatinib|mesh-list
65182052|NCT01152437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65182053|NCT01152437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182054|NCT01152437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65182055|NCT01152437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182056|NCT01152437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182057|NCT02800174|Clopidogrel|clopidogrel|mesh-list
65182058|NCT02800174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65182059|NCT02800174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182060|NCT02800174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182061|NCT02800174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65182062|NCT02800174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65182063|NCT02800174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65182064|NCT02800174|Purinergic Agents|purinergic agents|mesh-ancestor
65182065|NCT02800174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65182066|NCT02800330|Esomeprazole|esomeprazole|mesh-list
65182067|NCT02800330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65182068|NCT02800330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65182069|NCT02800330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65182070|NCT02800330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182071|NCT02800330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182072|NCT02799862|Paclitaxel|paclitaxel|mesh-list
65182073|NCT02799862|Carboplatin|carboplatin|mesh-list
65182074|NCT02799862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65182075|NCT02799862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182076|NCT02799862|Tubulin Modulators|tubulin modulators|mesh-ancestor
65182077|NCT02799862|Antimitotic Agents|antimitotic agents|mesh-ancestor
65182078|NCT02799862|Mitosis Modulators|mitosis modulators|mesh-ancestor
65182079|NCT02799862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326084|NCT01031719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326085|NCT00723606|Haloperidol|haloperidol|mesh-list
65326086|NCT00723606|Haloperidol decanoate|haloperidol decanoate|mesh-list
65326087|NCT00723606|Ziprasidone|ziprasidone|mesh-list
65326088|NCT00723606|Antiemetics|antiemetics|mesh-ancestor
65326089|NCT00723606|Autonomic Agents|autonomic agents|mesh-ancestor
65326090|NCT00723606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65182080|NCT01151579|Albuterol|albuterol|mesh-list
65182081|NCT01151579|Ipratropium|ipratropium|mesh-list
65182082|NCT01151579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65182083|NCT01151579|Autonomic Agents|autonomic agents|mesh-ancestor
65182084|NCT01151579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65182085|NCT01151579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182090|NCT01151579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65182091|NCT01151579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65182092|NCT01151579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65182093|NCT01151579|Adrenergic Agents|adrenergic agents|mesh-ancestor
65182094|NCT01151579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65182095|NCT01151579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182096|NCT01151579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65182097|NCT01151579|Cholinergic Agents|cholinergic agents|mesh-ancestor
65182098|NCT00694915|BCG Vaccine|bcg vaccine|mesh-list
65182099|NCT00694915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65182100|NCT00694915|Immunologic Factors|immunologic factors|mesh-ancestor
65182101|NCT00694915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182102|NCT01097616|Suvorexant|suvorexant|mesh-list
65182103|NCT01097616|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65182104|NCT01097616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65182105|NCT01097616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65182106|NCT01097616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182107|NCT01097616|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65182108|NCT01097616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65182109|NCT01097616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182110|NCT00695071|Itraconazole|itraconazole|mesh-list
65182111|NCT00695071|Antifungal Agents|antifungal agents|mesh-ancestor
65182112|NCT00695071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65182113|NCT00695071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65182114|NCT00695071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65182115|NCT00695071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182116|NCT00695071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182117|NCT00695071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65182118|NCT00695071|Hormone Antagonists|hormone antagonists|mesh-ancestor
65182119|NCT00695071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65182120|NCT00695071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182121|NCT00695071|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65182122|NCT02803216|Amoxicillin|amoxicillin|mesh-list
65182123|NCT02803216|Clarithromycin|clarithromycin|mesh-list
65182124|NCT02803216|Omeprazole|omeprazole|mesh-list
65182125|NCT02803216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65182126|NCT02803216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65182127|NCT02803216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65182128|NCT02803216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65182129|NCT02803216|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65182130|NCT02803216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182131|NCT02803216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182132|NCT02803216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65182133|NCT02803216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65182134|NCT02803216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65182135|NCT02799316|Antibodies|antibodies|mesh-list
65182136|NCT02799316|Immunologic Factors|immunologic factors|mesh-ancestor
65182137|NCT02799316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182138|NCT02620969|Dialysis Solutions|dialysis solutions|mesh-list
65182139|NCT02620969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65182140|NCT02799238|Temozolomide|temozolomide|mesh-list
65182141|NCT02799238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65182142|NCT02799238|Alkylating Agents|alkylating agents|mesh-ancestor
65182143|NCT02799238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326091|NCT00723606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326092|NCT00723606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65326093|NCT00723606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65326094|NCT00723606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65326095|NCT00723606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65326096|NCT00723606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65326097|NCT00723606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65326098|NCT00723606|Dopamine Agents|dopamine agents|mesh-ancestor
65326099|NCT00723606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65326100|NCT00723606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182144|NCT02799238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182145|NCT02620813|Tretinoin|tretinoin|mesh-list
65182146|NCT02620813|Isotretinoin|isotretinoin|mesh-list
65182147|NCT02620813|Dermatologic Agents|dermatologic agents|mesh-ancestor
65182148|NCT02620813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182149|NCT02620813|Keratolytic Agents|keratolytic agents|mesh-ancestor
65182150|NCT00692731|Caffeine|caffeine|mesh-list
65182151|NCT00692731|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65182152|NCT00692731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182153|NCT00692731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65182154|NCT00692731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182158|NCT00692731|Purinergic Agents|purinergic agents|mesh-ancestor
65182159|NCT00692731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65182160|NCT02624401|Dexmedetomidine|dexmedetomidine|mesh-list
65182161|NCT02624401|Ketamine|ketamine|mesh-list
65182162|NCT02624401|Propofol|propofol|mesh-list
65182163|NCT02624401|Sevoflurane|sevoflurane|mesh-list
65182164|NCT02624401|Esketamine|esketamine|mesh-list
65182165|NCT02624401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65182166|NCT02624401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65182167|NCT02624401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182168|NCT02624401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65182169|NCT02624401|Anesthetics, General|anesthetics, general|mesh-ancestor
65182170|NCT02624401|Anesthetics|anesthetics|mesh-ancestor
65182171|NCT02624401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65182172|NCT02624401|Analgesics|analgesics|mesh-ancestor
65182173|NCT02624401|Sensory System Agents|sensory system agents|mesh-ancestor
65182174|NCT02624401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65182175|NCT02624401|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65182176|NCT02624401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65182177|NCT02624401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65182178|NCT02624401|Adrenergic Agents|adrenergic agents|mesh-ancestor
65182179|NCT02624401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65182180|NCT02624401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182181|NCT02624401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65182182|NCT02624401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65182183|NCT02624401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65182184|NCT02624401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65182185|NCT02624401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65182186|NCT02624401|Antidepressive Agents|antidepressive agents|mesh-ancestor
65182188|NCT02802748|Letrozole|letrozole|mesh-list
65182189|NCT02802748|Vinorelbine|vinorelbine|mesh-list
65182190|NCT02802748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182191|NCT02802748|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65182192|NCT02802748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65182193|NCT02802748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182194|NCT02802748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182195|NCT02802748|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65182196|NCT02802748|Hormone Antagonists|hormone antagonists|mesh-ancestor
65182197|NCT02802748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65182198|NCT02802748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182199|NCT02802748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65182200|NCT02802748|Tubulin Modulators|tubulin modulators|mesh-ancestor
65182201|NCT02802748|Antimitotic Agents|antimitotic agents|mesh-ancestor
65326101|NCT00723606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65326102|NCT00723606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65326103|NCT00723606|Serotonin Agents|serotonin agents|mesh-ancestor
65326104|NCT01021501|Nifedipine|nifedipine|mesh-list
65326105|NCT01021501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64555657|NCT03953261|Curcumin|curcumin|mesh-list
65182202|NCT02802748|Mitosis Modulators|mitosis modulators|mesh-ancestor
65182203|NCT05502250|Gemcitabine|gemcitabine|mesh-list
65182204|NCT05502250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182205|NCT05502250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65182206|NCT05502250|Antimetabolites|antimetabolites|mesh-ancestor
65182207|NCT05502250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182208|NCT05502250|Antiviral Agents|antiviral agents|mesh-ancestor
65182209|NCT05502250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65182210|NCT05502250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182211|NCT05502250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65182212|NCT05502250|Immunologic Factors|immunologic factors|mesh-ancestor
65182213|NCT05502250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182214|NCT02798068|Methylprednisolone|methylprednisolone|mesh-list
65182215|NCT02798068|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65182216|NCT02798068|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65182217|NCT02798068|Prednisolone|prednisolone|mesh-list
65182218|NCT02798068|Prednisolone acetate|prednisolone acetate|mesh-list
65182219|NCT02798068|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65182220|NCT02798068|Prednisolone phosphate|prednisolone phosphate|mesh-list
65182221|NCT02798068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65182222|NCT02798068|Antiemetics|antiemetics|mesh-ancestor
65182223|NCT02798068|Autonomic Agents|autonomic agents|mesh-ancestor
65182224|NCT02798068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65182225|NCT02798068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182226|NCT02798068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65182229|NCT02798068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65182230|NCT02798068|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65182231|NCT02798068|Protective Agents|protective agents|mesh-ancestor
65182232|NCT02798068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65182233|NCT02798068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182234|NCT00593827|Epothilones|epothilones|mesh-list
65182235|NCT00593827|Tubulin Modulators|tubulin modulators|mesh-ancestor
65182236|NCT00593827|Antimitotic Agents|antimitotic agents|mesh-ancestor
65182237|NCT00593827|Mitosis Modulators|mitosis modulators|mesh-ancestor
65182238|NCT00593827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182239|NCT00593827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182241|NCT04135885|Hematinics|hematinics|mesh-ancestor
65182242|NCT04135885|Vitamin B Complex|vitamin b complex|mesh-ancestor
65182243|NCT04135885|Vitamins|vitamins|mesh-ancestor
65182244|NCT04135885|Micronutrients|micronutrients|mesh-ancestor
65182245|NCT04135885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182246|NCT00693043|Lidocaine|lidocaine|mesh-list
65182247|NCT00693043|Anesthetics, Local|anesthetics, local|mesh-ancestor
65182248|NCT00693043|Anesthetics|anesthetics|mesh-ancestor
65182249|NCT00693043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65182250|NCT00693043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182251|NCT00693043|Sensory System Agents|sensory system agents|mesh-ancestor
65182252|NCT00693043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65182253|NCT00693043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65182254|NCT00693043|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64824820|NCT01533870|Rifampin|rifampin|mesh-list
65182255|NCT00693043|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65182256|NCT00693043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65182257|NCT00693043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182259|NCT00695929|Milrinone|milrinone|mesh-list
65182260|NCT00695929|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65182261|NCT00695929|Vasodilator Agents|vasodilator agents|mesh-ancestor
65182262|NCT00695929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65182263|NCT00695929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65182264|NCT00695929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182265|NCT00695929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182266|NCT00695929|Protective Agents|protective agents|mesh-ancestor
65182267|NCT00695929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182268|NCT00695929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65326106|NCT01021501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65326107|NCT01021501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326108|NCT01021501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65326109|NCT01021501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182269|NCT04235296|Mitogens|mitogens|mesh-list
65182270|NCT04235296|Mitosis Modulators|mitosis modulators|mesh-ancestor
65182271|NCT04235296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182272|NCT02620501|Lidocaine|lidocaine|mesh-list
65182273|NCT02620501|Anesthetics, Local|anesthetics, local|mesh-ancestor
65182274|NCT02620501|Anesthetics|anesthetics|mesh-ancestor
65182275|NCT02620501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65182276|NCT02620501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182277|NCT02620501|Sensory System Agents|sensory system agents|mesh-ancestor
65182278|NCT02620501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65182279|NCT02620501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65182280|NCT02620501|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65182281|NCT02620501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65182282|NCT02620501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65182283|NCT02620501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182284|NCT00693121|Amantadine|amantadine|mesh-list
65182285|NCT00693121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65182286|NCT00693121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65182287|NCT00693121|Antiviral Agents|antiviral agents|mesh-ancestor
65182288|NCT00693121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65182289|NCT00693121|Dopamine Agents|dopamine agents|mesh-ancestor
65182290|NCT00693121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65182291|NCT00693121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182292|NCT00693121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182293|NCT00693121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65182294|NCT00693121|Analgesics|analgesics|mesh-ancestor
65182295|NCT00693121|Sensory System Agents|sensory system agents|mesh-ancestor
65182296|NCT00693121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65182297|NCT02620423|Leucovorin|leucovorin|mesh-list
65182298|NCT02620423|Gemcitabine|gemcitabine|mesh-list
65182299|NCT02620423|Fluorouracil|fluorouracil|mesh-list
65182303|NCT02620423|Antimetabolites|antimetabolites|mesh-ancestor
65182304|NCT02620423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182305|NCT02620423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182306|NCT02620423|Antiviral Agents|antiviral agents|mesh-ancestor
65182307|NCT02620423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65182308|NCT02620423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182309|NCT02620423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65182310|NCT02620423|Immunologic Factors|immunologic factors|mesh-ancestor
65182311|NCT02620423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182312|NCT02620423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65182313|NCT02620423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65182314|NCT02620423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65182315|NCT02620423|Antidotes|antidotes|mesh-ancestor
65182316|NCT02620423|Protective Agents|protective agents|mesh-ancestor
65182317|NCT02620423|Vitamin B Complex|vitamin b complex|mesh-ancestor
65182318|NCT02620423|Vitamins|vitamins|mesh-ancestor
65182319|NCT02620423|Micronutrients|micronutrients|mesh-ancestor
65182320|NCT00696007|Gemcitabine|gemcitabine|mesh-list
65182321|NCT00696007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182322|NCT00696007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65182323|NCT00696007|Antimetabolites|antimetabolites|mesh-ancestor
65182324|NCT00696007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182325|NCT00696007|Antiviral Agents|antiviral agents|mesh-ancestor
65182326|NCT00696007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65182327|NCT00696007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182328|NCT00696007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65182329|NCT00696007|Immunologic Factors|immunologic factors|mesh-ancestor
64824898|NCT01534455|Lapatinib|lapatinib|mesh-list
65182330|NCT00696007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182332|NCT02624089|Anesthetics, Local|anesthetics, local|mesh-ancestor
65182333|NCT02624089|Anesthetics|anesthetics|mesh-ancestor
65182334|NCT02624089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65182335|NCT02624089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182336|NCT02624089|Sensory System Agents|sensory system agents|mesh-ancestor
65326110|NCT01021501|Vasodilator Agents|vasodilator agents|mesh-ancestor
65326111|NCT01021501|Tocolytic Agents|tocolytic agents|mesh-ancestor
65326112|NCT01021501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65326114|NCT01021579|Simvastatin|simvastatin|mesh-list
65326115|NCT01021579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65326116|NCT01021579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326117|NCT01021579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65326118|NCT01021579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65326119|NCT01021579|Antimetabolites|antimetabolites|mesh-ancestor
65182337|NCT02624089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65182338|NCT02796196|Coal Tar|coal tar|mesh-list
65182339|NCT02796196|Keratolytic Agents|keratolytic agents|mesh-ancestor
65182340|NCT02796196|Dermatologic Agents|dermatologic agents|mesh-ancestor
65182341|NCT00693199|Amlodipine|amlodipine|mesh-list
65182342|NCT00693199|Prazosin|prazosin|mesh-list
65182343|NCT00693199|Terazosin|terazosin|mesh-list
65182344|NCT00693199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65182345|NCT00693199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65182346|NCT00693199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65182347|NCT00693199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182348|NCT00693199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65182349|NCT00693199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182350|NCT00693199|Vasodilator Agents|vasodilator agents|mesh-ancestor
65182351|NCT00693199|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65182352|NCT00693199|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65182353|NCT00693199|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65182354|NCT00693199|Adrenergic Agents|adrenergic agents|mesh-ancestor
65182355|NCT00693199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65182356|NCT00693199|Urological Agents|urological agents|mesh-ancestor
65182357|NCT02795884|Cisplatin|cisplatin|mesh-list
65182358|NCT02795884|Pemetrexed|pemetrexed|mesh-list
65182359|NCT02795884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65182360|NCT02795884|Vinorelbine|vinorelbine|mesh-list
65182361|NCT02795884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182362|NCT02795884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182363|NCT02795884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182364|NCT02795884|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65182365|NCT02795884|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65182366|NCT02795884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65182367|NCT02795884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65182368|NCT02795884|Tubulin Modulators|tubulin modulators|mesh-ancestor
65182369|NCT02795884|Antimitotic Agents|antimitotic agents|mesh-ancestor
65182370|NCT02795884|Mitosis Modulators|mitosis modulators|mesh-ancestor
65182371|NCT02795572|Vitamin D|vitamin d|mesh-list
65182372|NCT02795572|Vitamins|vitamins|mesh-list
65182373|NCT02795572|Vitamin B 12|vitamin b 12|mesh-list
65182374|NCT02795572|Vitamin B 6|vitamin b 6|mesh-list
65182388|NCT05445778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182389|NCT05445778|Growth Inhibitors|growth inhibitors|mesh-ancestor
65182390|NCT05445778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65182391|NCT05445778|Tubulin Modulators|tubulin modulators|mesh-ancestor
65182392|NCT05445778|Antimitotic Agents|antimitotic agents|mesh-ancestor
65182393|NCT05445778|Mitosis Modulators|mitosis modulators|mesh-ancestor
65182394|NCT05445778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182395|NCT02801188|Dexmedetomidine|dexmedetomidine|mesh-list
65182396|NCT02801188|Bupivacaine|bupivacaine|mesh-list
65182397|NCT02801188|Anesthetics, Local|anesthetics, local|mesh-ancestor
65182398|NCT02801188|Anesthetics|anesthetics|mesh-ancestor
65182399|NCT02801188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65182400|NCT02801188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182401|NCT02801188|Sensory System Agents|sensory system agents|mesh-ancestor
64824973|NCT01534884|Rituximab|rituximab|mesh-list
65182402|NCT02801188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65182403|NCT02801188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65182404|NCT02801188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65182405|NCT02801188|Analgesics|analgesics|mesh-ancestor
65182406|NCT02801188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65182407|NCT02801188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65326120|NCT01021579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326121|NCT01021579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65326122|NCT01021579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65326123|NCT01021579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326124|NCT01031875|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64555677|NCT03079050|Lansoprazole|lansoprazole|mesh-list
65182408|NCT02801188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65182409|NCT02801188|Adrenergic Agents|adrenergic agents|mesh-ancestor
65182410|NCT02801188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65182411|NCT02801188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182412|NCT02801032|Tadalafil|tadalafil|mesh-list
65182413|NCT02801032|Vasodilator Agents|vasodilator agents|mesh-ancestor
65182414|NCT02801032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65182415|NCT02801032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65182416|NCT02801032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182417|NCT02801032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182418|NCT02801032|Urological Agents|urological agents|mesh-ancestor
65182419|NCT05442190|Hypericin|hypericin|mesh-list
65182420|NCT05442190|Antidepressive Agents|antidepressive agents|mesh-ancestor
65182421|NCT05442190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65182422|NCT05442190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182423|NCT05442190|Antiviral Agents|antiviral agents|mesh-ancestor
65182424|NCT05442190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65182425|NCT05442190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182426|NCT05442190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182427|NCT05442190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65182428|NCT05442190|Immunologic Factors|immunologic factors|mesh-ancestor
65182429|NCT05442190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182430|NCT02689960|Prednisone|prednisone|mesh-list
65182431|NCT02689960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65182432|NCT02689960|Glucocorticoids|glucocorticoids|mesh-ancestor
65182433|NCT02689960|Hormones|hormones|mesh-ancestor
65182434|NCT02689960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65182435|NCT02689960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182436|NCT02689960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65182443|NCT01150097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65182444|NCT01150097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182445|NCT01150097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182446|NCT01150097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182447|NCT02794948|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65182448|NCT02794948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65182449|NCT02794948|Immunologic Factors|immunologic factors|mesh-ancestor
65182450|NCT02794948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182451|NCT01149863|Plerixafor|plerixafor|mesh-list
65182452|NCT01149863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65182453|NCT01149863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65182454|NCT01149863|Antiviral Agents|antiviral agents|mesh-ancestor
65182455|NCT01149863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65182456|NCT02794792|Metformin|metformin|mesh-list
65182457|NCT02794792|Ipragliflozin|ipragliflozin|mesh-list
65182458|NCT02794792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65182459|NCT02794792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182460|NCT02794792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65182461|NCT02794792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182462|NCT01149473|Losartan|losartan|mesh-list
65182463|NCT01149473|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65182464|NCT01149473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65182465|NCT01149473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65182466|NCT01149473|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65182467|NCT01149473|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65182468|NCT01149473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182469|NCT01149473|Diuretics|diuretics|mesh-ancestor
65182470|NCT01149473|Natriuretic Agents|natriuretic agents|mesh-ancestor
65182471|NCT01149473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182472|NCT01149473|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65182473|NCT01149473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65182474|NCT00872989|Docetaxel|docetaxel|mesh-list
65326125|NCT01031875|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65326126|NCT01031875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326127|NCT01021735|Adalimumab|adalimumab|mesh-list
65326128|NCT01021735|Etanercept|etanercept|mesh-list
65326129|NCT01021735|Rituximab|rituximab|mesh-list
65326130|NCT01021735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65326131|NCT01021735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182475|NCT00872989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182476|NCT00872989|Tubulin Modulators|tubulin modulators|mesh-ancestor
65182477|NCT00872989|Antimitotic Agents|antimitotic agents|mesh-ancestor
65182478|NCT00872989|Mitosis Modulators|mitosis modulators|mesh-ancestor
65182479|NCT00872989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182480|NCT02794714|Rocuronium|rocuronium|mesh-list
65182481|NCT02794714|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65182482|NCT02794714|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65182483|NCT02794714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65182484|NCT02794714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65182485|NCT02794714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182486|NCT01148771|Ertapenem|ertapenem|mesh-list
65182487|NCT01148771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65182488|NCT01148771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65182489|NCT01148693|Gentamicins|gentamicins|mesh-list
65182490|NCT01148693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65182491|NCT01148693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65182492|NCT01148693|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65182493|NCT01148693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182494|NCT01148693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182495|NCT00693355|Butyric Acid|butyric acid|mesh-list
65182496|NCT00693355|Histamine Antagonists|histamine antagonists|mesh-ancestor
65182497|NCT00693355|Histamine Agents|histamine agents|mesh-ancestor
65182498|NCT00693355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65182499|NCT00693355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182500|NCT00693355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182501|NCT00693433|Sirolimus|sirolimus|mesh-list
65182502|NCT00693433|Dexamethasone|dexamethasone|mesh-list
65182503|NCT00693433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65182504|NCT00693433|Antiemetics|antiemetics|mesh-ancestor
65182505|NCT00693433|Autonomic Agents|autonomic agents|mesh-ancestor
65182506|NCT00693433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65182511|NCT00693433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65182513|NCT00693433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182514|NCT00693433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65182515|NCT00693433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65182516|NCT00693433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65182517|NCT00693433|Antifungal Agents|antifungal agents|mesh-ancestor
65182518|NCT00693433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65182519|NCT00693433|Immunologic Factors|immunologic factors|mesh-ancestor
65182520|NCT05414422|Ketamine|ketamine|mesh-list
65182521|NCT05414422|Analgesics|analgesics|mesh-ancestor
65182522|NCT05414422|Sensory System Agents|sensory system agents|mesh-ancestor
65182523|NCT05414422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65182524|NCT05414422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182525|NCT05414422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65182526|NCT05414422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65182527|NCT05414422|Anesthetics, General|anesthetics, general|mesh-ancestor
65182528|NCT05414422|Anesthetics|anesthetics|mesh-ancestor
65182529|NCT05414422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65182530|NCT05414422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65182531|NCT05414422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65182532|NCT05414422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65182533|NCT05414422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182534|NCT00872599|Fenofibrate|fenofibrate|mesh-list
65182535|NCT00872599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65182536|NCT00872599|Antimetabolites|antimetabolites|mesh-ancestor
65182537|NCT00872599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182538|NCT00872599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65182539|NCT02623621|Bevacizumab|bevacizumab|mesh-list
65182540|NCT02623621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65326132|NCT01021735|Immunologic Factors|immunologic factors|mesh-ancestor
65326133|NCT01021735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326134|NCT01021735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65326135|NCT01021735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65326136|NCT01021735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65326137|NCT01021735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65182541|NCT02623621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182542|NCT02623621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65182543|NCT02623621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65182544|NCT02623621|Growth Substances|growth substances|mesh-ancestor
65182545|NCT02623621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182546|NCT02623621|Growth Inhibitors|growth inhibitors|mesh-ancestor
65182547|NCT00693589|Folic Acid|folic acid|mesh-list
65182548|NCT00693589|Vitamin B 12|vitamin b 12|mesh-list
65182549|NCT00693589|Hydroxocobalamin|hydroxocobalamin|mesh-list
65182550|NCT00693589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65182551|NCT00693589|Vitamins|vitamins|mesh-ancestor
65182552|NCT00693589|Micronutrients|micronutrients|mesh-ancestor
65182553|NCT00693589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182554|NCT00693589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64825112|NCT01535781|Hemostatics|hemostatics|mesh-ancestor
65182555|NCT00693589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65182556|NCT00693589|Antimetabolites|antimetabolites|mesh-ancestor
65182557|NCT00693589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182558|NCT00693589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65182559|NCT00693589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65182560|NCT00693589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182561|NCT00693589|Hematinics|hematinics|mesh-ancestor
65182562|NCT00693589|Vitamin B Complex|vitamin b complex|mesh-ancestor
65182563|NCT01148537|Moxifloxacin|moxifloxacin|mesh-list
65182564|NCT01148537|Buprenorphine|buprenorphine|mesh-list
65182565|NCT01148537|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65182566|NCT01148537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65182567|NCT01148537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65182568|NCT01148537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65182569|NCT01148537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65182570|NCT01148537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182571|NCT01148537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182572|NCT01148537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182573|NCT01148537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65182574|NCT01148537|Contraceptive Agents|contraceptive agents|mesh-ancestor
64956063|NCT00424333|Insulin|insulin|mesh-list
65182579|NCT01148537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65182580|NCT01148537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65182581|NCT01148537|Narcotics|narcotics|mesh-ancestor
65182582|NCT01148537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65182583|NCT01148537|Analgesics|analgesics|mesh-ancestor
65182584|NCT01148537|Sensory System Agents|sensory system agents|mesh-ancestor
65182585|NCT01148537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65182586|NCT01148537|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65182587|NCT02793544|Mycophenolic Acid|mycophenolic acid|mesh-list
65182588|NCT02793544|Sirolimus|sirolimus|mesh-list
65182589|NCT02793544|Cyclophosphamide|cyclophosphamide|mesh-list
65182590|NCT02793544|Busulfan|busulfan|mesh-list
65182591|NCT02793544|Fludarabine|fludarabine|mesh-list
65182592|NCT02793544|Mesna|mesna|mesh-list
65182593|NCT02793544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65182594|NCT02793544|Immunologic Factors|immunologic factors|mesh-ancestor
65182595|NCT02793544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182596|NCT02793544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65182597|NCT02793544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65182598|NCT02793544|Alkylating Agents|alkylating agents|mesh-ancestor
65182599|NCT02793544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182600|NCT02793544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182601|NCT02793544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65182602|NCT02793544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65182603|NCT02793544|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65182604|NCT02793544|Antitubercular Agents|antitubercular agents|mesh-ancestor
65182605|NCT02793544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65182606|NCT02793544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65326138|NCT01021735|Analgesics|analgesics|mesh-ancestor
65326139|NCT01021735|Sensory System Agents|sensory system agents|mesh-ancestor
65326140|NCT01021735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65326141|NCT01021735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65326142|NCT01021735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65326143|NCT00442351|Mometasone Furoate|mometasone furoate|mesh-list
64555693|NCT03834129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65182607|NCT02793544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182608|NCT02793544|Antifungal Agents|antifungal agents|mesh-ancestor
65182609|NCT02793544|Protective Agents|protective agents|mesh-ancestor
65182611|NCT02793388|Antimalarials|antimalarials|mesh-ancestor
65182612|NCT02793388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65182613|NCT02793388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65182614|NCT02793388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65182615|NCT02689882|Niacinamide|niacinamide|mesh-list
65182616|NCT02689882|Niacin|niacin|mesh-list
65182617|NCT02689882|Nicotinic Acids|nicotinic acids|mesh-list
65182618|NCT02689882|Vitamin B Complex|vitamin b complex|mesh-ancestor
65182619|NCT02689882|Vitamins|vitamins|mesh-ancestor
65182620|NCT02689882|Micronutrients|micronutrients|mesh-ancestor
65182621|NCT02689882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182622|NCT02689882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65182623|NCT02689882|Antimetabolites|antimetabolites|mesh-ancestor
65182624|NCT02689882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182625|NCT02689882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65182626|NCT02689882|Vasodilator Agents|vasodilator agents|mesh-ancestor
65182627|NCT02789644|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65182628|NCT02789644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65182629|NCT02789644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65182630|NCT04234594|Panitumumab|panitumumab|mesh-list
65182631|NCT04234594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65182632|NCT04234594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182633|NCT04233346|Ponatinib|ponatinib|mesh-list
65182634|NCT04233346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182635|NCT04233346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65182636|NCT04233346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182637|NCT04233346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182638|NCT01148459|Vaccines|vaccines|mesh-list
65182639|NCT01148459|Immunologic Factors|immunologic factors|mesh-ancestor
65182640|NCT01148459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182641|NCT03913234|Trastuzumab|trastuzumab|mesh-list
65182642|NCT03913234|Letrozole|letrozole|mesh-list
65182643|NCT03913234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65182644|NCT03913234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182645|NCT03913234|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65182646|NCT03913234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65182647|NCT03913234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182648|NCT03913234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182651|NCT03913234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65182653|NCT03854500|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65182654|NCT03854500|Tenecteplase|tenecteplase|mesh-list
65182655|NCT03854500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65182656|NCT03854500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65182657|NCT03854500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182658|NCT02789332|Paclitaxel|paclitaxel|mesh-list
65182659|NCT02789332|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65182660|NCT02789332|Cyclophosphamide|cyclophosphamide|mesh-list
65182661|NCT02789332|Carboplatin|carboplatin|mesh-list
65182662|NCT02789332|Epirubicin|epirubicin|mesh-list
65182663|NCT02789332|Olaparib|olaparib|mesh-list
65182664|NCT02789332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65182665|NCT02789332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182666|NCT02789332|Tubulin Modulators|tubulin modulators|mesh-ancestor
65182667|NCT02789332|Antimitotic Agents|antimitotic agents|mesh-ancestor
65182668|NCT02789332|Mitosis Modulators|mitosis modulators|mesh-ancestor
65182669|NCT02789332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182670|NCT02789332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65182671|NCT02789332|Immunologic Factors|immunologic factors|mesh-ancestor
65182672|NCT02789332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182673|NCT02789332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65326144|NCT00442351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65326145|NCT00442351|Dermatologic Agents|dermatologic agents|mesh-ancestor
65326146|NCT00442351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65326147|NCT00436501|Docetaxel|docetaxel|mesh-list
65326148|NCT00436501|Aflibercept|aflibercept|mesh-list
65326149|NCT00436501|Endothelial Growth Factors|endothelial growth factors|mesh-list
65326150|NCT00436501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326151|NCT00436501|Tubulin Modulators|tubulin modulators|mesh-ancestor
65326152|NCT00436501|Antimitotic Agents|antimitotic agents|mesh-ancestor
65326153|NCT00436501|Mitosis Modulators|mitosis modulators|mesh-ancestor
65326154|NCT00436501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326155|NCT00436501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65326156|NCT00436501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65326157|NCT00436501|Growth Substances|growth substances|mesh-ancestor
65326158|NCT00436501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326159|NCT00436501|Growth Inhibitors|growth inhibitors|mesh-ancestor
65326160|NCT00755846|Alogliptin|alogliptin|mesh-list
65326161|NCT00755846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65326162|NCT00755846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326163|NCT00755846|Incretins|incretins|mesh-ancestor
65326164|NCT00755846|Hormones|hormones|mesh-ancestor
65326165|NCT00755846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65182674|NCT02789332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65182675|NCT02789332|Alkylating Agents|alkylating agents|mesh-ancestor
65182676|NCT02789332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65182677|NCT02789332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65182678|NCT02789332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65182679|NCT02789332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65182680|NCT02789332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182681|NCT02789332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65182682|NCT02792140|Naltrexone|naltrexone|mesh-list
65182683|NCT02792140|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65182684|NCT02792140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65182685|NCT02792140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182686|NCT02792140|Sensory System Agents|sensory system agents|mesh-ancestor
65182687|NCT02792140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65182688|NCT02791594|Pembrolizumab|pembrolizumab|mesh-list
65182689|NCT02791594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65182690|NCT02791594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182691|NCT04234516|Morphine|morphine|mesh-list
65182692|NCT04234516|Buprenorphine|buprenorphine|mesh-list
65182693|NCT04234516|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65182694|NCT04234516|Naloxone|naloxone|mesh-list
65182695|NCT04234516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65182696|NCT04234516|Narcotics|narcotics|mesh-ancestor
65182697|NCT04234516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65182698|NCT04234516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182699|NCT04234516|Analgesics|analgesics|mesh-ancestor
65182700|NCT04234516|Sensory System Agents|sensory system agents|mesh-ancestor
65182701|NCT04234516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65182702|NCT04234516|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65182703|NCT02789566|Primaquine|primaquine|mesh-list
65182704|NCT02789566|Antimalarials|antimalarials|mesh-ancestor
65182705|NCT02789566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65326166|NCT00755846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65326167|NCT00755846|Protease Inhibitors|protease inhibitors|mesh-ancestor
65326168|NCT00755846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326169|NCT00755846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326170|NCT03850093|Bisoprolol|bisoprolol|mesh-list
65326171|NCT03850093|Gabapentin|gabapentin|mesh-list
65326172|NCT03850093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326173|NCT03850093|Analgesics|analgesics|mesh-ancestor
65182706|NCT02789566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64825263|NCT01536613|Insulin Aspart|insulin aspart|mesh-list
65182707|NCT02789566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65182708|NCT00697021|Aspirin|aspirin|mesh-list
65182709|NCT00697021|Clopidogrel|clopidogrel|mesh-list
65182710|NCT00697021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65182711|NCT00697021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65182712|NCT00697021|Analgesics|analgesics|mesh-ancestor
65182713|NCT00697021|Sensory System Agents|sensory system agents|mesh-ancestor
65182714|NCT00697021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65182715|NCT00697021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182716|NCT00697021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65182717|NCT00697021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65182718|NCT00697021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65182719|NCT00697021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65182720|NCT00697021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182727|NCT00697021|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65182728|NCT00697021|Purinergic Agents|purinergic agents|mesh-ancestor
65182729|NCT00697021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65182730|NCT02620345|Dydrogesterone|dydrogesterone|mesh-list
65182731|NCT02620345|Progestins|progestins|mesh-ancestor
65182732|NCT02620345|Hormones|hormones|mesh-ancestor
65182733|NCT02620345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65182734|NCT02620345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182735|NCT00696163|Insulin Aspart|insulin aspart|mesh-list
65182736|NCT00696163|Biphasic Insulins|biphasic insulins|mesh-list
65182737|NCT00696163|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65182738|NCT00696163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65182739|NCT00696163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182740|NCT02790580|Cyclophosphamide|cyclophosphamide|mesh-list
65182741|NCT02790580|Doxorubicin|doxorubicin|mesh-list
65182742|NCT02790580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65182743|NCT02790580|Sunitinib|sunitinib|mesh-list
65182744|NCT02790580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65182745|NCT02790580|Immunologic Factors|immunologic factors|mesh-ancestor
65182746|NCT02790580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182747|NCT02790580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65182748|NCT02790580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65182749|NCT02790580|Alkylating Agents|alkylating agents|mesh-ancestor
65182750|NCT02790580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182751|NCT02790580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182752|NCT02790580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65182753|NCT02790580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65182754|NCT02790580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65182755|NCT02790580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65182756|NCT02790580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182757|NCT02790580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65182758|NCT02790580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65182759|NCT02790580|Growth Substances|growth substances|mesh-ancestor
65182760|NCT02790580|Growth Inhibitors|growth inhibitors|mesh-ancestor
65182761|NCT02790580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65182762|NCT02788864|Piperaquine|piperaquine|mesh-list
65182763|NCT02788864|Antimalarials|antimalarials|mesh-ancestor
65182764|NCT02788864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65182765|NCT02788864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65182766|NCT02788864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65182767|NCT02788786|Chlorhexidine|chlorhexidine|mesh-list
65182768|NCT02788786|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65182769|NCT02788786|Cetylpyridinium|cetylpyridinium|mesh-list
65182770|NCT02788786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65326174|NCT03850093|Sensory System Agents|sensory system agents|mesh-ancestor
65326175|NCT03850093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65326176|NCT03850093|Anticonvulsants|anticonvulsants|mesh-ancestor
65326177|NCT03850093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65326178|NCT03850093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65326179|NCT03850093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65182771|NCT02788786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65182772|NCT02788786|Disinfectants|disinfectants|mesh-ancestor
65182773|NCT02788786|Dermatologic Agents|dermatologic agents|mesh-ancestor
65182774|NCT02623465|Insulin Lispro|insulin lispro|mesh-list
65182775|NCT02623465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65182776|NCT02623465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182777|NCT00693979|Paclitaxel|paclitaxel|mesh-list
65182778|NCT00693979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65182779|NCT00693979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182780|NCT00693979|Tubulin Modulators|tubulin modulators|mesh-ancestor
65182781|NCT00693979|Antimitotic Agents|antimitotic agents|mesh-ancestor
65182782|NCT00693979|Mitosis Modulators|mitosis modulators|mesh-ancestor
65182783|NCT00693979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182784|NCT04232800|Riboflavin|riboflavin|mesh-list
65182785|NCT04232800|Vitamins|vitamins|mesh-ancestor
65182786|NCT04232800|Micronutrients|micronutrients|mesh-ancestor
65182787|NCT04232800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182788|NCT04232800|Vitamin B Complex|vitamin b complex|mesh-ancestor
65182789|NCT04232800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65182790|NCT04232800|Dermatologic Agents|dermatologic agents|mesh-ancestor
65182795|NCT02788240|Terlipressin|terlipressin|mesh-list
65182796|NCT02788240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65182797|NCT02788240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65182798|NCT02788240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65182799|NCT02788240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65182800|NCT04134715|Contraceptive Agents|contraceptive agents|mesh-list
65182801|NCT04134715|Contraceptives, Oral|contraceptives, oral|mesh-list
65182802|NCT04134715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65182803|NCT04134715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182804|NCT04134715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65182805|NCT02884115|Penicillins|penicillins|mesh-list
65182806|NCT02884115|Penicillin G Benzathine|penicillin g benzathine|mesh-list
65182807|NCT02884115|Penicillin G|penicillin g|mesh-list
65182808|NCT02884115|Penicillin G Procaine|penicillin g procaine|mesh-list
65182809|NCT02884115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65182810|NCT02884115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65182811|NCT01190813|Levodopa|levodopa|mesh-list
65182812|NCT01190813|Carbidopa|carbidopa|mesh-list
65182813|NCT01190813|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65182814|NCT01190813|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65182815|NCT01190813|Dopamine Agents|dopamine agents|mesh-ancestor
65182816|NCT01190813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65182817|NCT01190813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182818|NCT01190813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182819|NCT01190813|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65182820|NCT01190813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182821|NCT03641326|Sunitinib|sunitinib|mesh-list
65182822|NCT03641326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182823|NCT03641326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65182824|NCT03641326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65182825|NCT03641326|Growth Substances|growth substances|mesh-ancestor
65182826|NCT03641326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182827|NCT03641326|Growth Inhibitors|growth inhibitors|mesh-ancestor
65182828|NCT03641326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65182829|NCT03641326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182830|NCT03641326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182831|NCT00870727|Aripiprazole|aripiprazole|mesh-list
65182832|NCT00870727|Antidepressive Agents|antidepressive agents|mesh-ancestor
65182833|NCT00870727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65182834|NCT00870727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65182835|NCT00870727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65182836|NCT00870727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65182837|NCT00870727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182838|NCT00870727|Dopamine Agonists|dopamine agonists|mesh-ancestor
65326180|NCT03850093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65326181|NCT03850093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65326182|NCT03850093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65326183|NCT03850093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65326184|NCT03850093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326185|NCT03850093|Antimanic Agents|antimanic agents|mesh-ancestor
65326186|NCT03850093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65326187|NCT03850093|Sympatholytics|sympatholytics|mesh-ancestor
65326188|NCT03850093|Autonomic Agents|autonomic agents|mesh-ancestor
65326189|NCT03850093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65326190|NCT03850093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65326191|NCT03850093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65326192|NCT03850093|Adrenergic Agents|adrenergic agents|mesh-ancestor
65326193|NCT00442117|Mometasone Furoate|mometasone furoate|mesh-list
65326194|NCT00442117|Budesonide|budesonide|mesh-list
65326195|NCT00442117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65326196|NCT00442117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65182839|NCT00870727|Dopamine Agents|dopamine agents|mesh-ancestor
65182840|NCT00870727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65182841|NCT00870727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182842|NCT00870727|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65182843|NCT00870727|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65182844|NCT00870727|Serotonin Agents|serotonin agents|mesh-ancestor
65182845|NCT00870727|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65182846|NCT00870727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65182847|NCT00870727|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65182848|NCT00870727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65182849|NCT02787928|Hydromorphone|hydromorphone|mesh-list
65182850|NCT02787928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65182851|NCT02787928|Narcotics|narcotics|mesh-ancestor
65182852|NCT02787928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65182853|NCT02787928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182854|NCT02787928|Analgesics|analgesics|mesh-ancestor
65182855|NCT02787928|Sensory System Agents|sensory system agents|mesh-ancestor
65182856|NCT02787928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65182857|NCT02617069|Botulinum Toxins|botulinum toxins|mesh-list
65182858|NCT02617069|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65182859|NCT02617069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65182860|NCT02617069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182861|NCT02617069|Cholinergic Agents|cholinergic agents|mesh-ancestor
65182862|NCT02617069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65182872|NCT01147055|Antitubercular Agents|antitubercular agents|mesh-ancestor
65182873|NCT01147055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65182874|NCT01147055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65182875|NCT01147055|Leprostatic Agents|leprostatic agents|mesh-ancestor
65182876|NCT01147055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65182877|NCT01147055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182878|NCT01147055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182879|NCT01147055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65182880|NCT01147055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65182881|NCT01147055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65182882|NCT01147055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65182883|NCT01147055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65182884|NCT01147055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65182885|NCT01147055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326197|NCT00442117|Autonomic Agents|autonomic agents|mesh-ancestor
65326198|NCT00442117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65326199|NCT00442117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326200|NCT00442117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65326201|NCT00442117|Respiratory System Agents|respiratory system agents|mesh-ancestor
65326202|NCT00442117|Glucocorticoids|glucocorticoids|mesh-ancestor
65326203|NCT00442117|Hormones|hormones|mesh-ancestor
65326204|NCT00442117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65326205|NCT00442117|Dermatologic Agents|dermatologic agents|mesh-ancestor
65326206|NCT00442117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65326207|NCT05457998|Flutemetamol|flutemetamol|mesh-list
65182886|NCT01147055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65182887|NCT02623231|Citalopram|citalopram|mesh-list
65182888|NCT02623231|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65182889|NCT02623231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65182890|NCT02623231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65182891|NCT02623231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182892|NCT02623231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65182893|NCT02623231|Serotonin Agents|serotonin agents|mesh-ancestor
65182894|NCT02623231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182895|NCT02623231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65182896|NCT02623231|Antidepressive Agents|antidepressive agents|mesh-ancestor
65182897|NCT02623231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65182898|NCT02623153|Docetaxel|docetaxel|mesh-list
65182899|NCT02623153|Capecitabine|capecitabine|mesh-list
65182900|NCT02623153|Oxaliplatin|oxaliplatin|mesh-list
65182901|NCT02623153|Tegafur|tegafur|mesh-list
65182902|NCT02623153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182903|NCT02623153|Tubulin Modulators|tubulin modulators|mesh-ancestor
65182904|NCT02623153|Antimitotic Agents|antimitotic agents|mesh-ancestor
65182905|NCT02623153|Mitosis Modulators|mitosis modulators|mesh-ancestor
65182906|NCT02623153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182907|NCT02623153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65182908|NCT02623153|Antimetabolites|antimetabolites|mesh-ancestor
65182909|NCT02616913|Moxifloxacin|moxifloxacin|mesh-list
65182910|NCT02616913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65182911|NCT02616913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65182912|NCT02616913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65182913|NCT02616913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65182914|NCT02616913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182915|NCT02616913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182916|NCT02616913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182917|NCT02884037|Rifaximin|rifaximin|mesh-list
65182918|NCT02884037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65182919|NCT02884037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65182920|NCT02884037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65182921|NCT04233502|Melatonin|melatonin|mesh-list
65182922|NCT04233502|Antioxidants|antioxidants|mesh-ancestor
65182923|NCT04233502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182924|NCT04233502|Protective Agents|protective agents|mesh-ancestor
65182925|NCT04233502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182926|NCT04233502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65182927|NCT00696475|Diazoxide|diazoxide|mesh-list
65182928|NCT00696475|Choline|choline|mesh-list
65182929|NCT00696475|Lipotropic Agents|lipotropic agents|mesh-ancestor
65182930|NCT00696475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65182931|NCT00696475|Antimetabolites|antimetabolites|mesh-ancestor
65182941|NCT03628066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182942|NCT03628066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65182943|NCT03628066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65182944|NCT03628066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182945|NCT03628066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182946|NCT03628066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65182947|NCT03628066|Hormone Antagonists|hormone antagonists|mesh-ancestor
65326208|NCT05457998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65326209|NCT05457998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326210|NCT00752726|Orlistat|orlistat|mesh-list
64487677|NCT01706198|Xhance|xhance|mesh-list
65182948|NCT03628066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65182949|NCT03628066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182950|NCT03628066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65182951|NCT03628066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65182952|NCT00625079|Sildenafil Citrate|sildenafil citrate|mesh-list
65182953|NCT00625079|Vasodilator Agents|vasodilator agents|mesh-ancestor
65182954|NCT00625079|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65182955|NCT00625079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65182956|NCT00625079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182957|NCT00625079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182958|NCT00625079|Urological Agents|urological agents|mesh-ancestor
65182959|NCT02786992|Misoprostol|misoprostol|mesh-list
65182960|NCT02786992|Oxytocin|oxytocin|mesh-list
65182961|NCT02786992|Carbetocin|carbetocin|mesh-list
65182962|NCT02786992|Oxytocics|oxytocics|mesh-ancestor
65182963|NCT02786992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65182964|NCT02786992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182965|NCT02786992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65182966|NCT02786992|Abortifacient Agents|abortifacient agents|mesh-ancestor
65182967|NCT02786992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65182968|NCT02786992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65182969|NCT04232644|Amphetamine|amphetamine|mesh-list
65182970|NCT04232644|Dextroamphetamine|dextroamphetamine|mesh-list
65182971|NCT04232644|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65182972|NCT04232644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182973|NCT04232644|Sympathomimetics|sympathomimetics|mesh-ancestor
65182974|NCT04232644|Autonomic Agents|autonomic agents|mesh-ancestor
65182975|NCT04232644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65182976|NCT04232644|Dopamine Agents|dopamine agents|mesh-ancestor
65182977|NCT04232644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65182978|NCT04232644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182979|NCT04232644|Adrenergic Agents|adrenergic agents|mesh-ancestor
65182980|NCT04232644|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65182981|NCT04232644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65182982|NCT04232644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65182983|NCT04232644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65182984|NCT03557788|Rifaximin|rifaximin|mesh-list
65182985|NCT03557788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65182986|NCT03557788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65182987|NCT03557788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65182988|NCT04133155|Gemcitabine|gemcitabine|mesh-list
65182989|NCT04133155|Paclitaxel|paclitaxel|mesh-list
65182990|NCT04133155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65182991|NCT04133155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182992|NCT04133155|Tubulin Modulators|tubulin modulators|mesh-ancestor
65182993|NCT04133155|Antimitotic Agents|antimitotic agents|mesh-ancestor
65182994|NCT04133155|Mitosis Modulators|mitosis modulators|mesh-ancestor
65182995|NCT04133155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182996|NCT04133155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65182997|NCT04133155|Antimetabolites|antimetabolites|mesh-ancestor
65183002|NCT04133155|Immunologic Factors|immunologic factors|mesh-ancestor
65183003|NCT04133155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183004|NCT01190267|Asenapine|asenapine|mesh-list
65183005|NCT01190267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64825564|NCT01538459|Hormones|hormones|mesh-ancestor
65183006|NCT01190267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65183007|NCT01190267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65183008|NCT01190267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183009|NCT01190267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65183010|NCT00869089|Apremilast|apremilast|mesh-list
65183011|NCT00869089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65183012|NCT00869089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65183013|NCT00869089|Analgesics|analgesics|mesh-ancestor
65183014|NCT00869089|Sensory System Agents|sensory system agents|mesh-ancestor
65183015|NCT00869089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183016|NCT00869089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183017|NCT00869089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65326211|NCT00752726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326212|NCT00752726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326213|NCT00752726|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65183018|NCT00869089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65183019|NCT00869089|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65183020|NCT00869089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65183021|NCT00869089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183022|NCT00869089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183023|NCT02616367|Bupivacaine|bupivacaine|mesh-list
65183024|NCT02616367|Ropivacaine|ropivacaine|mesh-list
65183025|NCT02616367|Anesthetics, Local|anesthetics, local|mesh-ancestor
65183026|NCT02616367|Anesthetics|anesthetics|mesh-ancestor
65183027|NCT02616367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65183028|NCT02616367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183029|NCT02616367|Sensory System Agents|sensory system agents|mesh-ancestor
65183030|NCT02616367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183031|NCT04200040|Dacarbazine|dacarbazine|mesh-list
65183032|NCT04200040|Molgramostim|molgramostim|mesh-list
65183033|NCT04200040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65183034|NCT04200040|Alkylating Agents|alkylating agents|mesh-ancestor
65183035|NCT04200040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183036|NCT04200040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183037|NCT04232722|Sorafenib|sorafenib|mesh-list
65183038|NCT04232722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183039|NCT04232722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65183040|NCT04232722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183041|NCT04232722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183042|NCT02622685|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65183043|NCT02622685|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65183044|NCT02622685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65183045|NCT02622607|Zoledronic Acid|zoledronic acid|mesh-list
65183046|NCT02622607|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65183047|NCT02622607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183048|NCT02787226|Bupivacaine|bupivacaine|mesh-list
65183049|NCT02787226|Anesthetics, Local|anesthetics, local|mesh-ancestor
65183050|NCT02787226|Anesthetics|anesthetics|mesh-ancestor
65183051|NCT02787226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65183052|NCT02787226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183053|NCT02787226|Sensory System Agents|sensory system agents|mesh-ancestor
65183054|NCT02787226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183056|NCT00697567|Immunologic Factors|immunologic factors|mesh-ancestor
65183057|NCT00697567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183058|NCT02616289|Emollients|emollients|mesh-list
65183059|NCT02616289|Dermatologic Agents|dermatologic agents|mesh-ancestor
65183060|NCT01145495|Rituximab|rituximab|mesh-list
65183061|NCT01145495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65183062|NCT01145495|Lenalidomide|lenalidomide|mesh-list
65183063|NCT01145495|Antibodies|antibodies|mesh-list
65183064|NCT01145495|Immunoglobulins|immunoglobulins|mesh-list
65183065|NCT01145495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65183066|NCT01145495|Immunologic Factors|immunologic factors|mesh-ancestor
65183067|NCT01145495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183068|NCT01145495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183069|NCT01145495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65183073|NCT01145495|Growth Inhibitors|growth inhibitors|mesh-ancestor
65183075|NCT03421756|Alemtuzumab|alemtuzumab|mesh-list
65183076|NCT03421756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65183077|NCT03421756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65183078|NCT03421756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65183079|NCT03421756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183080|NCT03421756|Antifungal Agents|antifungal agents|mesh-ancestor
65183081|NCT03421756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65183082|NCT03421756|Immunologic Factors|immunologic factors|mesh-ancestor
65183083|NCT03421756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183084|NCT03421756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65183085|NCT00870103|Moxifloxacin|moxifloxacin|mesh-list
65183086|NCT00870103|Dexamethasone|dexamethasone|mesh-list
65183087|NCT00870103|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65183088|NCT00870103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65183089|NCT00870103|Antiemetics|antiemetics|mesh-ancestor
65183090|NCT00870103|Autonomic Agents|autonomic agents|mesh-ancestor
65183091|NCT00870103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65326214|NCT00752726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65326215|NCT04072497|Vaccines|vaccines|mesh-list
65326216|NCT04072497|Immunologic Factors|immunologic factors|mesh-ancestor
65326217|NCT04072497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326218|NCT04072263|Interferons|interferons|mesh-list
65326219|NCT04072263|Interferon-alpha|interferon-alpha|mesh-list
65326220|NCT04072263|Interferon alpha-2|interferon alpha-2|mesh-list
65183092|NCT00870103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183093|NCT00870103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65183094|NCT00870103|Glucocorticoids|glucocorticoids|mesh-ancestor
65183095|NCT00870103|Hormones|hormones|mesh-ancestor
65183096|NCT00870103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65183097|NCT00870103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65183098|NCT00870103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183099|NCT00870103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65183100|NCT00870103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65183101|NCT00870103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65183102|NCT00870103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65183103|NCT00870103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183104|NCT00870103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183105|NCT00870103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65183106|NCT03365752|Anesthetics|anesthetics|mesh-list
65183107|NCT03365752|Mepivacaine|mepivacaine|mesh-list
65183108|NCT03365752|Chloroprocaine|chloroprocaine|mesh-list
65183109|NCT03365752|Anesthetics, General|anesthetics, general|mesh-list
65183110|NCT03365752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65183111|NCT03365752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183112|NCT03365752|Anesthetics, Local|anesthetics, local|mesh-ancestor
65183113|NCT03365752|Sensory System Agents|sensory system agents|mesh-ancestor
65183114|NCT03365752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183115|NCT02785666|Ribavirin|ribavirin|mesh-list
65183116|NCT02785666|Grazoprevir|grazoprevir|mesh-list
65183117|NCT02785666|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65183118|NCT02785666|Antimetabolites|antimetabolites|mesh-ancestor
65183119|NCT02785666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183120|NCT02785666|Antiviral Agents|antiviral agents|mesh-ancestor
65183121|NCT02785666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65183122|NCT01145417|Pregabalin|pregabalin|mesh-list
65183123|NCT01145417|Analgesics|analgesics|mesh-ancestor
65183124|NCT01145417|Sensory System Agents|sensory system agents|mesh-ancestor
65183125|NCT01145417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183127|NCT01145417|Anticonvulsants|anticonvulsants|mesh-ancestor
65183128|NCT01145417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65183129|NCT01145417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65183130|NCT01145417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183131|NCT01145417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65183132|NCT01145417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65183133|NCT01145417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65183134|NCT01145417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65183135|NCT01145417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65183136|NCT04232332|Mitogens|mitogens|mesh-list
65183137|NCT04232332|Mitosis Modulators|mitosis modulators|mesh-ancestor
65183138|NCT04232332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183139|NCT02785276|Ropivacaine|ropivacaine|mesh-list
65183140|NCT02785276|Anesthetics, Local|anesthetics, local|mesh-ancestor
65183141|NCT02785276|Anesthetics|anesthetics|mesh-ancestor
65183142|NCT02785276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65183147|NCT04316039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65183149|NCT04316039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183150|NCT04316039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183151|NCT00696631|Dronedarone|dronedarone|mesh-list
65183152|NCT00696631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65183153|NCT02615977|Ethanol|ethanol|mesh-list
65183154|NCT02615977|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65183155|NCT02615977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65183156|NCT02615977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65183157|NCT02615977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183158|NCT01189487|Ampicillin|ampicillin|mesh-list
65183159|NCT01189487|Sulbactam|sulbactam|mesh-list
65326221|NCT04072263|Paclitaxel|paclitaxel|mesh-list
65326222|NCT04072263|Carboplatin|carboplatin|mesh-list
65326223|NCT04072263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65326224|NCT04072263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326225|NCT04072263|Tubulin Modulators|tubulin modulators|mesh-ancestor
65326226|NCT04072263|Antimitotic Agents|antimitotic agents|mesh-ancestor
65326227|NCT04072263|Mitosis Modulators|mitosis modulators|mesh-ancestor
65183160|NCT01189487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65183161|NCT01189487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65183162|NCT01189487|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65183163|NCT01189487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183164|NCT01189487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183165|NCT02621905|Itraconazole|itraconazole|mesh-list
65183166|NCT02621905|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
65183167|NCT02621905|Antifungal Agents|antifungal agents|mesh-ancestor
65183168|NCT02621905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65183169|NCT02621905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65183170|NCT02621905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65183171|NCT02621905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183172|NCT02621905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183173|NCT02621905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65183174|NCT02621905|Hormone Antagonists|hormone antagonists|mesh-ancestor
65183175|NCT02621905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65183176|NCT02621905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183177|NCT02621905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65183178|NCT01106352|Docetaxel|docetaxel|mesh-list
65183179|NCT01106352|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65183180|NCT01106352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183181|NCT01106352|Tubulin Modulators|tubulin modulators|mesh-ancestor
65183182|NCT01106352|Antimitotic Agents|antimitotic agents|mesh-ancestor
65183183|NCT01106352|Mitosis Modulators|mitosis modulators|mesh-ancestor
65183184|NCT01106352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183185|NCT01144403|Cyclophosphamide|cyclophosphamide|mesh-list
65183186|NCT01144403|Rituximab|rituximab|mesh-list
65183187|NCT01144403|Fludarabine|fludarabine|mesh-list
65183188|NCT01144403|Mitoxantrone|mitoxantrone|mesh-list
65183189|NCT01144403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65183190|NCT01144403|Immunologic Factors|immunologic factors|mesh-ancestor
65183191|NCT01144403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183192|NCT01144403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65183193|NCT01144403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65183194|NCT01144403|Alkylating Agents|alkylating agents|mesh-ancestor
65183195|NCT01144403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183196|NCT01144403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183197|NCT01144403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65183198|NCT01144403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65183199|NCT01144403|Analgesics|analgesics|mesh-ancestor
65183200|NCT01144403|Sensory System Agents|sensory system agents|mesh-ancestor
65183201|NCT01144403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183202|NCT01144403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65183203|NCT01144403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65183204|NCT01144403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183205|NCT03071926|Doxorubicin|doxorubicin|mesh-list
65183206|NCT03071926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65183207|NCT03071926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65183208|NCT03071926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183209|NCT03071926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65183210|NCT03071926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65183211|NCT03071926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183217|NCT02883647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65183218|NCT02883647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65183219|NCT02883647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183220|NCT02883647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183221|NCT02883647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65183222|NCT02883647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65183223|NCT02621827|Calcifediol|calcifediol|mesh-list
65183224|NCT02621827|Vitamins|vitamins|mesh-ancestor
65183225|NCT02621827|Micronutrients|micronutrients|mesh-ancestor
65326228|NCT04072263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326229|NCT04072263|Antiviral Agents|antiviral agents|mesh-ancestor
65326230|NCT04072263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65326231|NCT04072263|Immunologic Factors|immunologic factors|mesh-ancestor
65326232|NCT04072263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326233|NCT00441727|Esomeprazole|esomeprazole|mesh-list
65183226|NCT02621827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183227|NCT02621827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65183228|NCT01143389|Riboflavin|riboflavin|mesh-list
65183229|NCT01143389|Vitamin B Complex|vitamin b complex|mesh-ancestor
65183230|NCT01143389|Vitamins|vitamins|mesh-ancestor
65183231|NCT01143389|Micronutrients|micronutrients|mesh-ancestor
65183232|NCT01143389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183233|NCT01143389|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65183234|NCT01143389|Dermatologic Agents|dermatologic agents|mesh-ancestor
65183236|NCT00868231|Tiotropium Bromide|tiotropium bromide|mesh-list
65183237|NCT00868231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65183238|NCT00868231|Autonomic Agents|autonomic agents|mesh-ancestor
65183239|NCT00868231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183240|NCT00868231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183241|NCT00868231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65183242|NCT00868231|Respiratory System Agents|respiratory system agents|mesh-ancestor
65183243|NCT00868231|Parasympatholytics|parasympatholytics|mesh-ancestor
65183244|NCT00868231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65183245|NCT00868231|Cholinergic Agents|cholinergic agents|mesh-ancestor
65183246|NCT00868231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65183247|NCT00868231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183248|NCT00868231|Anticonvulsants|anticonvulsants|mesh-ancestor
65183249|NCT04231864|Durvalumab|durvalumab|mesh-list
65183250|NCT04231864|Immunoglobulins|immunoglobulins|mesh-list
65183251|NCT04231864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65183252|NCT04231864|Immunoglobulin G|immunoglobulin g|mesh-list
65183253|NCT04231864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65183254|NCT04231864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183255|NCT04231864|Immunologic Factors|immunologic factors|mesh-ancestor
65183256|NCT04231864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183257|NCT01101438|Metformin|metformin|mesh-list
65183258|NCT01101438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65183259|NCT01101438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183260|NCT02992522|Lenalidomide|lenalidomide|mesh-list
65183261|NCT02992522|Venetoclax|venetoclax|mesh-list
65183262|NCT02992522|Obinutuzumab|obinutuzumab|mesh-list
65183263|NCT02992522|Immunologic Factors|immunologic factors|mesh-ancestor
65183264|NCT02992522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183265|NCT02992522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65183266|NCT02992522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65183267|NCT02992522|Growth Substances|growth substances|mesh-ancestor
65183268|NCT02992522|Growth Inhibitors|growth inhibitors|mesh-ancestor
65183269|NCT02992522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183270|NCT02992522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65183271|NCT01143077|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65183272|NCT01143077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65183273|NCT01143077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65183274|NCT01143077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65183275|NCT01143077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183276|NCT01143077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65183277|NCT01143077|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65183278|NCT01143077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65183279|NCT01143077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65183280|NCT01143077|Adrenergic Agents|adrenergic agents|mesh-ancestor
65183281|NCT01143077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65183282|NCT01143077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183283|NCT01143077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65183290|NCT02786446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65183291|NCT02786446|Lidocaine|lidocaine|mesh-list
65183292|NCT02786446|Anesthetics, Local|anesthetics, local|mesh-ancestor
65183293|NCT02786446|Anesthetics|anesthetics|mesh-ancestor
65183294|NCT02786446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65183295|NCT02786446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326234|NCT00441727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65326235|NCT00441727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65326236|NCT00441727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65326237|NCT00441727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326238|NCT00441727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326239|NCT00770120|Everolimus|everolimus|mesh-list
65326240|NCT00770120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326241|NCT00770120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65326242|NCT00770120|Immunologic Factors|immunologic factors|mesh-ancestor
65326243|NCT00770120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326244|NCT03996655|Neostigmine|neostigmine|mesh-list
64555786|NCT02242383|Telmisartan|telmisartan|mesh-list
65183296|NCT02786446|Sensory System Agents|sensory system agents|mesh-ancestor
65183297|NCT02786446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183298|NCT02786446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65183299|NCT02786446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65183300|NCT02786446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65183301|NCT02786446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65183302|NCT02786446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183303|NCT02786446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65183304|NCT02786446|Analgesics|analgesics|mesh-ancestor
65183305|NCT02786446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65183306|NCT02786446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64825876|NCT01539720|Levonorgestrel|levonorgestrel|mesh-list
65183307|NCT02786446|Gout Suppressants|gout suppressants|mesh-ancestor
65183308|NCT02786446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65183310|NCT02619019|Dexamethasone|dexamethasone|mesh-list
65183311|NCT02619019|Meperidine|meperidine|mesh-list
65183312|NCT02619019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65183313|NCT02619019|Antiemetics|antiemetics|mesh-ancestor
65183314|NCT02619019|Autonomic Agents|autonomic agents|mesh-ancestor
65183315|NCT02619019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183316|NCT02619019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183317|NCT02619019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65183318|NCT02619019|Glucocorticoids|glucocorticoids|mesh-ancestor
65183319|NCT02619019|Hormones|hormones|mesh-ancestor
65183320|NCT02619019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65183321|NCT02619019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65183322|NCT02619019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183323|NCT02619019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65183324|NCT02619019|Narcotics|narcotics|mesh-ancestor
65183325|NCT02619019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65183326|NCT02619019|Analgesics|analgesics|mesh-ancestor
65183327|NCT02619019|Sensory System Agents|sensory system agents|mesh-ancestor
65183328|NCT02619019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65183329|NCT02957032|Cytarabine|cytarabine|mesh-list
65183330|NCT02957032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65183331|NCT02957032|Antimetabolites|antimetabolites|mesh-ancestor
65183332|NCT02957032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183333|NCT02957032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183334|NCT02957032|Antiviral Agents|antiviral agents|mesh-ancestor
65183335|NCT02957032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65183336|NCT02957032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65183337|NCT02957032|Immunologic Factors|immunologic factors|mesh-ancestor
65183338|NCT02957032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183339|NCT02947516|Liver Extracts|liver extracts|mesh-list
65183340|NCT02947516|Hematinics|hematinics|mesh-ancestor
65183341|NCT01096446|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65183342|NCT01096446|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
65183343|NCT01096446|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65183344|NCT01096446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65183345|NCT00864721|Sunitinib|sunitinib|mesh-list
65183346|NCT00864721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183347|NCT00864721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65326245|NCT03996655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65326246|NCT03996655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326247|NCT03996655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326248|NCT03996655|Cholinergic Agents|cholinergic agents|mesh-ancestor
65326249|NCT03996655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65326250|NCT03996655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326251|NCT03996655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65183348|NCT00864721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65183349|NCT00864721|Growth Substances|growth substances|mesh-ancestor
65183350|NCT00864721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183351|NCT00864721|Growth Inhibitors|growth inhibitors|mesh-ancestor
65183352|NCT00864721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65183353|NCT00864721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183358|NCT05308420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65183359|NCT05308420|Narcotics|narcotics|mesh-ancestor
65183360|NCT05308420|Analgesics|analgesics|mesh-ancestor
65183361|NCT05308420|Sensory System Agents|sensory system agents|mesh-ancestor
65183362|NCT05308420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183363|NCT02897050|Cyclophosphamide|cyclophosphamide|mesh-list
65183364|NCT02897050|Docetaxel|docetaxel|mesh-list
65183365|NCT02897050|Fluorouracil|fluorouracil|mesh-list
65183366|NCT02897050|Capecitabine|capecitabine|mesh-list
65183367|NCT02897050|Epirubicin|epirubicin|mesh-list
65183368|NCT02897050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65183369|NCT02897050|Immunologic Factors|immunologic factors|mesh-ancestor
65183370|NCT02897050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183371|NCT02897050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65183372|NCT02897050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65183373|NCT02897050|Alkylating Agents|alkylating agents|mesh-ancestor
65183374|NCT02897050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183375|NCT02897050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183376|NCT02897050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65183377|NCT02897050|Tubulin Modulators|tubulin modulators|mesh-ancestor
65183378|NCT02897050|Antimitotic Agents|antimitotic agents|mesh-ancestor
65183379|NCT02897050|Mitosis Modulators|mitosis modulators|mesh-ancestor
65183380|NCT02897050|Antimetabolites|antimetabolites|mesh-ancestor
65183381|NCT02897050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65183382|NCT02897050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65183383|NCT02897050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65183384|NCT02897050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65183385|NCT02897050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183386|NCT01095666|Metformin|metformin|mesh-list
65183387|NCT01095666|Pioglitazone|pioglitazone|mesh-list
65183388|NCT01095666|Dapagliflozin|dapagliflozin|mesh-list
65183389|NCT01095666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65183390|NCT01095666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183391|NCT01095666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65183392|NCT01095666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183393|NCT01100658|Methylphenidate|methylphenidate|mesh-list
65183394|NCT01100658|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65183395|NCT01100658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183396|NCT01100658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65183397|NCT01100658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65183398|NCT01100658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65183399|NCT01100658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183400|NCT01100658|Dopamine Agents|dopamine agents|mesh-ancestor
65183401|NCT01100658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65183402|NCT05276908|Bupivacaine|bupivacaine|mesh-list
65183403|NCT05276908|Anesthetics|anesthetics|mesh-list
65183404|NCT05276908|Anesthetics, Local|anesthetics, local|mesh-ancestor
65183405|NCT05276908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65183406|NCT05276908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183407|NCT05276908|Sensory System Agents|sensory system agents|mesh-ancestor
65183408|NCT05276908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183409|NCT02785978|Levodopa|levodopa|mesh-list
65183410|NCT02785978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65183411|NCT02785978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65183412|NCT02785978|Dopamine Agents|dopamine agents|mesh-ancestor
65326252|NCT03996655|Autonomic Agents|autonomic agents|mesh-ancestor
65326253|NCT03996655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65326254|NCT01032109|Bevacizumab|bevacizumab|mesh-list
65326255|NCT01032109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65326256|NCT01032109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326257|NCT01032109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64555796|NCT04366089|Azithromycin|azithromycin|mesh-list
65183413|NCT02785978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65183414|NCT02785978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183415|NCT02785978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183416|NCT02786212|Dexmedetomidine|dexmedetomidine|mesh-list
65183417|NCT02786212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65183418|NCT02786212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65183419|NCT02786212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183420|NCT02786212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65183421|NCT02786212|Analgesics|analgesics|mesh-ancestor
65183422|NCT02786212|Sensory System Agents|sensory system agents|mesh-ancestor
65183423|NCT02786212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183424|NCT02786212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65183430|NCT05273710|Folic Acid|folic acid|mesh-list
65183431|NCT05273710|Hematinics|hematinics|mesh-ancestor
65183432|NCT05273710|Vitamin B Complex|vitamin b complex|mesh-ancestor
65183433|NCT05273710|Vitamins|vitamins|mesh-ancestor
65183434|NCT05273710|Micronutrients|micronutrients|mesh-ancestor
65183435|NCT05273710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183436|NCT02784808|Antirheumatic Agents|antirheumatic agents|mesh-list
65183437|NCT02784652|Zoledronic Acid|zoledronic acid|mesh-list
65183438|NCT02784652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65183439|NCT02784652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183440|NCT01100502|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65183441|NCT01100502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65183442|NCT01100502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183443|NCT02784340|Dexamethasone|dexamethasone|mesh-list
65183444|NCT02784340|Dexamethasone acetate|dexamethasone acetate|mesh-list
65183445|NCT02784340|Bupivacaine|bupivacaine|mesh-list
65183446|NCT02784340|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65183447|NCT02784340|BB 1101|bb 1101|mesh-list
65183448|NCT02784340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65183449|NCT02784340|Antiemetics|antiemetics|mesh-ancestor
65183450|NCT02784340|Autonomic Agents|autonomic agents|mesh-ancestor
65183451|NCT02784340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183452|NCT02784340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183453|NCT02784340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65183454|NCT02784340|Glucocorticoids|glucocorticoids|mesh-ancestor
65183455|NCT02784340|Hormones|hormones|mesh-ancestor
65183456|NCT02784340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65183457|NCT02784340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65183458|NCT02784340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183460|NCT02784340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183461|NCT02784340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183462|NCT02784340|Anesthetics, Local|anesthetics, local|mesh-ancestor
65183463|NCT02784340|Anesthetics|anesthetics|mesh-ancestor
65183464|NCT02784340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65183465|NCT02784340|Sensory System Agents|sensory system agents|mesh-ancestor
65183466|NCT02389036|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65183467|NCT02389036|Ciprofloxacin|ciprofloxacin|mesh-list
65183468|NCT02389036|Ceftriaxone|ceftriaxone|mesh-list
65183469|NCT02389036|Tobramycin|tobramycin|mesh-list
65183470|NCT02389036|Colistin|colistin|mesh-list
65183471|NCT02389036|Nystatin|nystatin|mesh-list
65183472|NCT02389036|Cefotaxime|cefotaxime|mesh-list
65183473|NCT02389036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65183474|NCT02389036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65183475|NCT02389036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65183476|NCT02389036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183477|NCT02389036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183478|NCT02389036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183479|NCT02389036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65183480|NCT02389036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65326258|NCT01032109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65326259|NCT01032109|Growth Substances|growth substances|mesh-ancestor
65326260|NCT01032109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326261|NCT01032109|Growth Inhibitors|growth inhibitors|mesh-ancestor
65326263|NCT04100330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65326264|NCT04100330|Antimetabolites|antimetabolites|mesh-ancestor
65326265|NCT04100330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183481|NCT02389036|Antifungal Agents|antifungal agents|mesh-ancestor
65183482|NCT02389036|Ionophores|ionophores|mesh-ancestor
65183483|NCT02389036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65183484|NCT02878512|Anesthetics|anesthetics|mesh-list
65183485|NCT02878512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65183486|NCT02878512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183487|NCT01094886|Rivaroxaban|rivaroxaban|mesh-list
65183488|NCT01094886|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65183489|NCT01094886|Antithrombins|antithrombins|mesh-ancestor
65183490|NCT01094886|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65183491|NCT01094886|Protease Inhibitors|protease inhibitors|mesh-ancestor
65183492|NCT01094886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183493|NCT01094886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183494|NCT01094886|Anticoagulants|anticoagulants|mesh-ancestor
65183495|NCT01094808|Pregabalin|pregabalin|mesh-list
65183496|NCT01094808|Analgesics|analgesics|mesh-ancestor
65183497|NCT01094808|Sensory System Agents|sensory system agents|mesh-ancestor
65183500|NCT01094808|Anticonvulsants|anticonvulsants|mesh-ancestor
65183501|NCT01094808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65183502|NCT01094808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65183503|NCT01094808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183504|NCT01094808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65183505|NCT01094808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65183506|NCT01094808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65183507|NCT01094808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65183508|NCT01094808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65183509|NCT00864253|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65183510|NCT00864253|Dacarbazine|dacarbazine|mesh-list
65183511|NCT00864253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183512|NCT00864253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65183513|NCT00864253|Alkylating Agents|alkylating agents|mesh-ancestor
65183514|NCT00864253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183515|NCT02782312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65183516|NCT02782312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65183517|NCT02782312|Autonomic Agents|autonomic agents|mesh-ancestor
65183518|NCT02782312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183519|NCT02782312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183520|NCT02782312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65183521|NCT02782312|Respiratory System Agents|respiratory system agents|mesh-ancestor
65183522|NCT02782312|Glucocorticoids|glucocorticoids|mesh-ancestor
65183523|NCT02782312|Hormones|hormones|mesh-ancestor
65183524|NCT02782312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65183525|NCT02782312|Sympathomimetics|sympathomimetics|mesh-ancestor
65183526|NCT04229758|Anticoagulants|anticoagulants|mesh-list
65183527|NCT00698425|Citric Acid|citric acid|mesh-list
65183528|NCT00698425|Sodium Citrate|sodium citrate|mesh-list
65183529|NCT00698425|Anticoagulants|anticoagulants|mesh-ancestor
65183530|NCT00698425|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65183531|NCT00698425|Chelating Agents|chelating agents|mesh-ancestor
64826092|NCT01540877|Antipruritics|antipruritics|mesh-ancestor
65183532|NCT00698425|Sequestering Agents|sequestering agents|mesh-ancestor
65183533|NCT00698425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183534|NCT05342272|Lactoferrin|lactoferrin|mesh-list
65183535|NCT05342272|Muramidase|muramidase|mesh-list
65183536|NCT05342272|Betaine|betaine|mesh-list
65183537|NCT05342272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65183538|NCT05342272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65183539|NCT05342272|Lipotropic Agents|lipotropic agents|mesh-ancestor
65183540|NCT05342272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65183541|NCT05342272|Antimetabolites|antimetabolites|mesh-ancestor
65326266|NCT04100330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326267|NCT04100330|Antiviral Agents|antiviral agents|mesh-ancestor
65326268|NCT04100330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65326269|NCT04100330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65326270|NCT04100330|Immunologic Factors|immunologic factors|mesh-ancestor
65326271|NCT04100330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326272|NCT00436345|Remifentanil|remifentanil|mesh-list
65326273|NCT00436345|Propofol|propofol|mesh-list
65326274|NCT00436345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65183542|NCT05342272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183543|NCT05342272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65183544|NCT04230460|Ethanol|ethanol|mesh-list
65183545|NCT04230460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65183546|NCT04230460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65183547|NCT04230460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65183548|NCT04230460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183549|NCT02783638|Pregabalin|pregabalin|mesh-list
65183550|NCT02783638|Analgesics|analgesics|mesh-ancestor
65183551|NCT02783638|Sensory System Agents|sensory system agents|mesh-ancestor
65183552|NCT02783638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183553|NCT02783638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183554|NCT02783638|Anticonvulsants|anticonvulsants|mesh-ancestor
65183555|NCT02783638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65183556|NCT02783638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65183557|NCT02783638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183558|NCT02783638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65183559|NCT02783638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65183560|NCT02783638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65183561|NCT02783638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65183562|NCT02783638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65183563|NCT04230070|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65183564|NCT04230070|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65183565|NCT04230070|Levonorgestrel|levonorgestrel|mesh-list
65183566|NCT04230070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65183567|NCT04230070|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65183568|NCT04230070|Estradiol|estradiol|mesh-list
65183576|NCT04230070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65183577|NCT04230070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65183578|NCT04230070|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65183579|NCT04230070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65183580|NCT04230070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65183581|NCT04230070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65183582|NCT02782078|Clindamycin|clindamycin|mesh-list
65183583|NCT02782078|Clindamycin palmitate|clindamycin palmitate|mesh-list
65183584|NCT02782078|Clindamycin phosphate|clindamycin phosphate|mesh-list
65183586|NCT02782078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65183587|NCT02782078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65183588|NCT02782078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65183589|NCT02782078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183590|NCT02782078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183591|NCT02782078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65183592|NCT02782078|Antitubercular Agents|antitubercular agents|mesh-ancestor
65183593|NCT02782078|Leprostatic Agents|leprostatic agents|mesh-ancestor
65183594|NCT02782078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65183595|NCT02782078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65183596|NCT02782078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65183597|NCT02782078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65183598|NCT02782078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65183599|NCT02782078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65183600|NCT02782078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65183601|NCT01293682|Calcitriol|calcitriol|mesh-list
65183602|NCT01293682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65183603|NCT01293682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183604|NCT01293682|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65326275|NCT00436345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65326276|NCT00436345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326277|NCT00436345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65326278|NCT00436345|Anesthetics, General|anesthetics, general|mesh-ancestor
65326279|NCT00436345|Anesthetics|anesthetics|mesh-ancestor
65326280|NCT00436345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65326281|NCT00436345|Narcotics|narcotics|mesh-ancestor
65326282|NCT00436345|Analgesics|analgesics|mesh-ancestor
65326283|NCT00436345|Sensory System Agents|sensory system agents|mesh-ancestor
65326284|NCT00436345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183605|NCT01293682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65183606|NCT01293682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183607|NCT01293682|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65183608|NCT01293682|Vitamins|vitamins|mesh-ancestor
65183609|NCT01293682|Micronutrients|micronutrients|mesh-ancestor
65183610|NCT01293682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65183611|NCT00864097|Diclofenac|diclofenac|mesh-list
65183612|NCT00864097|Tanezumab|tanezumab|mesh-list
65183613|NCT00864097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65183614|NCT00864097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65183615|NCT00864097|Analgesics|analgesics|mesh-ancestor
65183616|NCT00864097|Sensory System Agents|sensory system agents|mesh-ancestor
65183617|NCT00864097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183618|NCT00864097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183619|NCT00864097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65183620|NCT00864097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65183621|NCT00864097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65183622|NCT00864097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183623|NCT00864097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183624|NCT02782624|Empagliflozin|empagliflozin|mesh-list
65183625|NCT02782624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65183626|NCT02782624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183627|NCT02782624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65183628|NCT02782624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183629|NCT02781766|Thrombin|thrombin|mesh-list
65183630|NCT02781766|Hemostatics|hemostatics|mesh-ancestor
65183631|NCT02781766|Coagulants|coagulants|mesh-ancestor
65183632|NCT00887536|Cyclophosphamide|cyclophosphamide|mesh-list
65183633|NCT00887536|Bevacizumab|bevacizumab|mesh-list
65183634|NCT00887536|Docetaxel|docetaxel|mesh-list
65183635|NCT00887536|Doxorubicin|doxorubicin|mesh-list
65183642|NCT00887536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183643|NCT00887536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183644|NCT00887536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65183645|NCT00887536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65183646|NCT00887536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65183647|NCT00887536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65183648|NCT00887536|Growth Substances|growth substances|mesh-ancestor
65183649|NCT00887536|Growth Inhibitors|growth inhibitors|mesh-ancestor
65183650|NCT00887536|Tubulin Modulators|tubulin modulators|mesh-ancestor
65183651|NCT00887536|Antimitotic Agents|antimitotic agents|mesh-ancestor
65183652|NCT00887536|Mitosis Modulators|mitosis modulators|mesh-ancestor
65183653|NCT00887536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65183654|NCT00887536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65183655|NCT00887536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65183656|NCT00887536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183657|NCT02614339|Metformin|metformin|mesh-list
65183658|NCT02614339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65183659|NCT02614339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183660|NCT02618395|Hydrocodone|hydrocodone|mesh-list
65183661|NCT02618395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65183662|NCT02618395|Narcotics|narcotics|mesh-ancestor
65183663|NCT02618395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65183664|NCT02618395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183665|NCT02618395|Analgesics|analgesics|mesh-ancestor
65183666|NCT02618395|Sensory System Agents|sensory system agents|mesh-ancestor
65326285|NCT00916448|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65326286|NCT00916448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65326287|NCT00916448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65326288|NCT00916448|Protease Inhibitors|protease inhibitors|mesh-ancestor
65326289|NCT00916448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326290|NCT00916448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183667|NCT02618395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183668|NCT02618395|Antitussive Agents|antitussive agents|mesh-ancestor
65183669|NCT02618395|Respiratory System Agents|respiratory system agents|mesh-ancestor
65183670|NCT01183013|Pioglitazone|pioglitazone|mesh-list
65183671|NCT01183013|Linagliptin|linagliptin|mesh-list
65183672|NCT01183013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65183673|NCT01183013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183674|NCT01183013|Incretins|incretins|mesh-ancestor
65183675|NCT01183013|Hormones|hormones|mesh-ancestor
65183676|NCT01183013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65183677|NCT01183013|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65183678|NCT01183013|Protease Inhibitors|protease inhibitors|mesh-ancestor
65183679|NCT01183013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183680|NCT01183013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183681|NCT04229212|Cimetidine|cimetidine|mesh-list
65183682|NCT04229212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65183683|NCT04229212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65183684|NCT04229212|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65183685|NCT04229212|Histamine Antagonists|histamine antagonists|mesh-ancestor
65183686|NCT04229212|Histamine Agents|histamine agents|mesh-ancestor
65183687|NCT04229212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65183688|NCT04229212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183689|NCT04229212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183690|NCT04229212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65183691|NCT04229212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65183692|NCT04229212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183693|NCT02615041|Meropenem|meropenem|mesh-list
65183694|NCT02615041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65183695|NCT02615041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65183696|NCT04229602|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65183697|NCT04229602|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65183698|NCT04229602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65183699|NCT04229602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65183700|NCT04229602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183701|NCT04229602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65183702|NCT04229602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183704|NCT04229602|Antidepressive Agents|antidepressive agents|mesh-ancestor
65183706|NCT05298163|Calcitriol|calcitriol|mesh-list
65183707|NCT05298163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65183708|NCT05298163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183709|NCT05298163|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65183710|NCT05298163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65183711|NCT05298163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183712|NCT05298163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65183713|NCT05298163|Vitamins|vitamins|mesh-ancestor
65183714|NCT05298163|Micronutrients|micronutrients|mesh-ancestor
65183715|NCT05298163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65183716|NCT01141283|Buprenorphine|buprenorphine|mesh-list
65183717|NCT01141283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65183718|NCT01141283|Narcotics|narcotics|mesh-ancestor
65183719|NCT01141283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65183720|NCT01141283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183721|NCT01141283|Analgesics|analgesics|mesh-ancestor
65183722|NCT01141283|Sensory System Agents|sensory system agents|mesh-ancestor
65183723|NCT01141283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183724|NCT01141283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65183725|NCT05340946|Anesthetics|anesthetics|mesh-list
65183726|NCT05340946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65183727|NCT05340946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183728|NCT00863707|Regadenoson|regadenoson|mesh-list
65326291|NCT00916448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65326292|NCT00916448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65326293|NCT00916448|Antiviral Agents|antiviral agents|mesh-ancestor
65326294|NCT00916448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65326295|NCT01032187|Amphotericin B|amphotericin b|mesh-list
65326296|NCT01032187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65326297|NCT01032187|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
65326298|NCT01032187|Meglumine Antimoniate|meglumine antimoniate|mesh-list
65326299|NCT01032187|Deoxycholic Acid|deoxycholic acid|mesh-list
65326300|NCT01032187|Amebicides|amebicides|mesh-ancestor
65326301|NCT01032187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65326302|NCT01032187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65326303|NCT01032187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65183729|NCT00863707|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65183730|NCT00863707|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65183731|NCT00863707|Purinergic Agonists|purinergic agonists|mesh-ancestor
65183732|NCT00863707|Purinergic Agents|purinergic agents|mesh-ancestor
65183733|NCT00863707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65183734|NCT00863707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183735|NCT00863707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183736|NCT05340634|Contraceptive Agents|contraceptive agents|mesh-list
65183737|NCT05340634|Contraceptives, Oral|contraceptives, oral|mesh-list
65183738|NCT05340634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65183739|NCT05340634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183740|NCT05340634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65183741|NCT05367479|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65183742|NCT05367479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65183743|NCT04187807|Melatonin|melatonin|mesh-list
65183744|NCT04187807|Antioxidants|antioxidants|mesh-ancestor
65183745|NCT04187807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183746|NCT04187807|Protective Agents|protective agents|mesh-ancestor
65183747|NCT04187807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183748|NCT04187807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65183749|NCT01094184|Paclitaxel|paclitaxel|mesh-list
65183750|NCT01094184|Docetaxel|docetaxel|mesh-list
65183751|NCT01094184|Bevacizumab|bevacizumab|mesh-list
65183752|NCT01094184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65183753|NCT01094184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183754|NCT01094184|Tubulin Modulators|tubulin modulators|mesh-ancestor
65183755|NCT01094184|Antimitotic Agents|antimitotic agents|mesh-ancestor
65183756|NCT01094184|Mitosis Modulators|mitosis modulators|mesh-ancestor
65183757|NCT01094184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183758|NCT01094184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65183759|NCT01094184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65183760|NCT01094184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65183761|NCT01094184|Growth Substances|growth substances|mesh-ancestor
65183762|NCT01094184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183763|NCT01094184|Growth Inhibitors|growth inhibitors|mesh-ancestor
65183764|NCT00697879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65183765|NCT00697879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183766|NCT00697879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183767|NCT01134731|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65183768|NCT01134731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65183769|NCT01134731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183770|NCT01134731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65183771|NCT01134731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65183772|NCT01134731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183773|NCT01134731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65183775|NCT01134731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65183776|NCT01134731|Serotonin Agents|serotonin agents|mesh-ancestor
65183777|NCT01134731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65183778|NCT01134731|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65326304|NCT01032187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65326305|NCT01032187|Antifungal Agents|antifungal agents|mesh-ancestor
65326306|NCT01032187|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65326307|NCT01032187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65326308|NCT03361345|Tranexamic Acid|tranexamic acid|mesh-list
65326309|NCT03361345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65326310|NCT03361345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64555837|NCT04999878|Etoposide|etoposide|mesh-list
65183779|NCT01134731|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65183780|NCT01134731|Dopamine Agents|dopamine agents|mesh-ancestor
65183781|NCT04132063|Levetiracetam|levetiracetam|mesh-list
65183782|NCT04132063|Anticonvulsants|anticonvulsants|mesh-ancestor
65183783|NCT04132063|Nootropic Agents|nootropic agents|mesh-ancestor
65183784|NCT02618317|Minocycline|minocycline|mesh-list
65183785|NCT02618317|Heparin|heparin|mesh-list
65183786|NCT02618317|Anticoagulants|anticoagulants|mesh-ancestor
65183787|NCT02618317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183788|NCT02618317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65183789|NCT02618317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65183790|NCT02618317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65183791|NCT02618317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65183792|NCT01140503|Apremilast|apremilast|mesh-list
65183793|NCT01140503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65183794|NCT01140503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65183795|NCT01140503|Analgesics|analgesics|mesh-ancestor
65183796|NCT01140503|Sensory System Agents|sensory system agents|mesh-ancestor
65183797|NCT01140503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183798|NCT01140503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183799|NCT01140503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65183800|NCT01140503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65183801|NCT01140503|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65183802|NCT01140503|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65183803|NCT01140503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183804|NCT01140503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183805|NCT02689726|Imiquimod|imiquimod|mesh-list
65183806|NCT02689726|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65183807|NCT02689726|Immunologic Factors|immunologic factors|mesh-ancestor
65183808|NCT02689726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183809|NCT02689726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183810|NCT02689726|Interferon Inducers|interferon inducers|mesh-ancestor
65183811|NCT00863317|Montelukast|montelukast|mesh-list
65183812|NCT00863317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65183813|NCT00863317|Respiratory System Agents|respiratory system agents|mesh-ancestor
65183814|NCT00863317|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65183815|NCT00863317|Hormone Antagonists|hormone antagonists|mesh-ancestor
65183816|NCT00863317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65183817|NCT00863317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183818|NCT00863317|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65183819|NCT00863317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65183820|NCT00863317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183821|NCT02744092|Enoxaparin|enoxaparin|mesh-list
65183822|NCT02744092|Dalteparin|dalteparin|mesh-list
65183823|NCT02744092|PENTA|penta|mesh-list
65183824|NCT02744092|Warfarin|warfarin|mesh-list
65183825|NCT02744092|Rivaroxaban|rivaroxaban|mesh-list
65183826|NCT02744092|Dabigatran|dabigatran|mesh-list
65183827|NCT02744092|Apixaban|apixaban|mesh-list
65183828|NCT02744092|Edoxaban|edoxaban|mesh-list
65183829|NCT02744092|Fondaparinux|fondaparinux|mesh-list
64826393|NCT01542710|Timolol|timolol|mesh-list
65183830|NCT02744092|Anticoagulants|anticoagulants|mesh-ancestor
65183831|NCT02744092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65183832|NCT02744092|Antithrombins|antithrombins|mesh-ancestor
65183833|NCT02744092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65183834|NCT02744092|Protease Inhibitors|protease inhibitors|mesh-ancestor
65183835|NCT02744092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183836|NCT02744092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183837|NCT02744092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65183838|NCT02744092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65183839|NCT01200368|Vaccines|vaccines|mesh-list
65326311|NCT03361345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326312|NCT03361345|Hemostatics|hemostatics|mesh-ancestor
65326313|NCT03361345|Coagulants|coagulants|mesh-ancestor
65326314|NCT00769184|Clobetasol|clobetasol|mesh-list
65326315|NCT00769184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65326316|NCT00769184|Glucocorticoids|glucocorticoids|mesh-ancestor
65326317|NCT00769184|Hormones|hormones|mesh-ancestor
65326318|NCT00769184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64555847|NCT04999878|Hormones|hormones|mesh-ancestor
65183840|NCT01200368|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65183841|NCT01200368|Immunologic Factors|immunologic factors|mesh-ancestor
65183842|NCT01200368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183843|NCT04125121|Propofol|propofol|mesh-list
65183844|NCT04125121|Sevoflurane|sevoflurane|mesh-list
65183845|NCT04125121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65183846|NCT04125121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65183847|NCT04125121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183848|NCT04125121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65183852|NCT04125121|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65183853|NCT01079130|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65183854|NCT01079130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65183855|NCT01079130|Autonomic Agents|autonomic agents|mesh-ancestor
65183856|NCT01079130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183857|NCT01079130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183858|NCT01079130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65183859|NCT01079130|Respiratory System Agents|respiratory system agents|mesh-ancestor
65183860|NCT01079130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65183861|NCT01079130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65183862|NCT01079130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65183863|NCT01079130|Adrenergic Agents|adrenergic agents|mesh-ancestor
65183864|NCT01079130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65183865|NCT01079130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183866|NCT01078974|Dexamethasone|dexamethasone|mesh-list
65183867|NCT01078974|Rituximab|rituximab|mesh-list
65183868|NCT01078974|Pomalidomide|pomalidomide|mesh-list
65183869|NCT01078974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64498618|NCT04602221|Anticonvulsants|anticonvulsants|mesh-ancestor
65183870|NCT01078974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183871|NCT01078974|Immunologic Factors|immunologic factors|mesh-ancestor
65183872|NCT01078974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183873|NCT01078974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65183874|NCT01078974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65183876|NCT01078974|Autonomic Agents|autonomic agents|mesh-ancestor
65183877|NCT01078974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183878|NCT01078974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65183879|NCT01078974|Glucocorticoids|glucocorticoids|mesh-ancestor
65183880|NCT01078974|Hormones|hormones|mesh-ancestor
65183881|NCT01078974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65183882|NCT01078974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65183883|NCT01078974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65183884|NCT01078974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65183885|NCT01078974|Growth Substances|growth substances|mesh-ancestor
65183886|NCT01078974|Growth Inhibitors|growth inhibitors|mesh-ancestor
65183887|NCT04307082|Ibrexafungerp|ibrexafungerp|mesh-list
65183888|NCT04307082|Antifungal Agents|antifungal agents|mesh-ancestor
65183889|NCT04307082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65183890|NCT02878200|Piperaquine|piperaquine|mesh-list
65183891|NCT02878200|Artenimol|artenimol|mesh-list
65183892|NCT02878200|Antimalarials|antimalarials|mesh-ancestor
65183893|NCT02878200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65183894|NCT02878200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65183895|NCT02878200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65183896|NCT04302012|Mydriatics|mydriatics|mesh-list
65183897|NCT04302012|Autonomic Agents|autonomic agents|mesh-ancestor
65183898|NCT04302012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183899|NCT04302012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183900|NCT00869557|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65326319|NCT00769184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326320|NCT00768560|Nifedipine|nifedipine|mesh-list
65326321|NCT00768560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65326322|NCT00768560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65326323|NCT00768560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326324|NCT00768560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64555852|NCT04999878|Antimetabolites|antimetabolites|mesh-ancestor
65183901|NCT00869557|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65183902|NCT00869557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65183903|NCT00869557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65183905|NCT00869557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183906|NCT00869557|Antiviral Agents|antiviral agents|mesh-ancestor
65183907|NCT00869557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65183908|NCT00869557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65183909|NCT00869557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65183910|NCT02781064|Atorvastatin|atorvastatin|mesh-list
65183911|NCT02781064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65183912|NCT02781064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65183913|NCT02781064|Antimetabolites|antimetabolites|mesh-ancestor
65183914|NCT02781064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183915|NCT02781064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65183916|NCT02781064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65183917|NCT02781064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183918|NCT04205682|Cannabidiol|cannabidiol|mesh-list
65183919|NCT04205682|Anticonvulsants|anticonvulsants|mesh-ancestor
65183920|NCT01134263|Vaccines|vaccines|mesh-list
65183924|NCT01199822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183925|NCT01096056|Vaccines|vaccines|mesh-list
65183926|NCT01096056|Immunologic Factors|immunologic factors|mesh-ancestor
65183927|NCT01096056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183928|NCT00866359|Apremilast|apremilast|mesh-list
65183929|NCT00866359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65183930|NCT00866359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65183931|NCT00866359|Analgesics|analgesics|mesh-ancestor
65183932|NCT00866359|Sensory System Agents|sensory system agents|mesh-ancestor
65183933|NCT00866359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183934|NCT00866359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183935|NCT00866359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65183936|NCT00866359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65183937|NCT00866359|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65183938|NCT00866359|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65183939|NCT00866359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183940|NCT00866359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183941|NCT01199198|Tolvaptan|tolvaptan|mesh-list
65183942|NCT01199198|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65183943|NCT01199198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183944|NCT01199198|Natriuretic Agents|natriuretic agents|mesh-ancestor
65183945|NCT01199198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183946|NCT05089708|Trifarotene|trifarotene|mesh-list
65183947|NCT05089708|Dermatologic Agents|dermatologic agents|mesh-ancestor
65183948|NCT01095978|Clarithromycin|clarithromycin|mesh-list
65183949|NCT01095978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65183950|NCT01095978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65183951|NCT01095978|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65183952|NCT01095978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183953|NCT01095978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183954|NCT01095978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65183955|NCT01095978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65183956|NCT01134107|Insulin|insulin|mesh-list
65183957|NCT01134107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65183958|NCT01134107|Insulin Aspart|insulin aspart|mesh-list
65183959|NCT01134107|Insulin Lispro|insulin lispro|mesh-list
65183960|NCT01134107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65183961|NCT01134107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183962|NCT01198574|Vitamins|vitamins|mesh-list
65326325|NCT00768560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326326|NCT00768560|Vasodilator Agents|vasodilator agents|mesh-ancestor
65326327|NCT00768560|Tocolytic Agents|tocolytic agents|mesh-ancestor
65326328|NCT00768560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65183963|NCT01198574|Folic Acid|folic acid|mesh-list
65183964|NCT01198574|Vitamin A|vitamin a|mesh-list
65183965|NCT01198574|Iron|iron|mesh-list
65183966|NCT01198574|Retinol palmitate|retinol palmitate|mesh-list
65183967|NCT01198574|Micronutrients|micronutrients|mesh-ancestor
65183968|NCT01198574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183969|NCT01198574|Trace Elements|trace elements|mesh-ancestor
65183970|NCT01198574|Hematinics|hematinics|mesh-ancestor
65183971|NCT01198574|Vitamin B Complex|vitamin b complex|mesh-ancestor
65183972|NCT01198574|Antioxidants|antioxidants|mesh-ancestor
65183973|NCT01198574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183974|NCT01198574|Protective Agents|protective agents|mesh-ancestor
65183975|NCT01198574|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65183976|NCT01198574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183977|NCT02580994|Carboplatin|carboplatin|mesh-list
65183978|NCT02580994|Pembrolizumab|pembrolizumab|mesh-list
65183979|NCT02580994|Etoposide|etoposide|mesh-list
65183980|NCT02580994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183981|NCT02580994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65183982|NCT02580994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65183983|NCT02580994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65183984|NCT02580994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65183985|NCT02580994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183986|NCT02580994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183987|NCT01198028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65183988|NCT01198028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65183989|NCT01198028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65183990|NCT01198028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183991|NCT01198028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183993|NCT01092780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65183994|NCT01092780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183999|NCT05338606|Bimatoprost|bimatoprost|mesh-list
65184000|NCT05338606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65184001|NCT01092702|Varenicline|varenicline|mesh-list
65184002|NCT01092702|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65184003|NCT01092702|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65184004|NCT01092702|Cholinergic Agents|cholinergic agents|mesh-ancestor
65184005|NCT01092702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65184006|NCT01092702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184007|NCT01092702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184008|NCT01092546|Flutemetamol|flutemetamol|mesh-list
65184009|NCT01092546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65184010|NCT01092546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184011|NCT02779348|Warfarin|warfarin|mesh-list
65184012|NCT02779348|Anticoagulants|anticoagulants|mesh-ancestor
65184013|NCT02779582|Progesterone|progesterone|mesh-list
65184014|NCT02779582|Progestins|progestins|mesh-ancestor
65184015|NCT02779582|Hormones|hormones|mesh-ancestor
65184016|NCT02779582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65184017|NCT02779582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184018|NCT04878432|Azacitidine|azacitidine|mesh-list
65184019|NCT04878432|Decitabine|decitabine|mesh-list
64498770|NCT01845077|Incretins|incretins|mesh-ancestor
65184020|NCT04878432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65184021|NCT04878432|Antimetabolites|antimetabolites|mesh-ancestor
65184022|NCT04878432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184023|NCT04878432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184024|NCT04878432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184025|NCT00634894|Letrozole|letrozole|mesh-list
65184026|NCT00634894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184027|NCT00634894|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65184028|NCT00634894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65184029|NCT00634894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184030|NCT00634894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184031|NCT00634894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65184032|NCT00634894|Hormone Antagonists|hormone antagonists|mesh-ancestor
65184033|NCT00634894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65326329|NCT00468559|Esomeprazole|esomeprazole|mesh-list
65326330|NCT00468559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65326331|NCT00468559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65326332|NCT00468559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65076293|NCT00352092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
65326333|NCT00468559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326334|NCT00468559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326335|NCT00754442|Teriparatide|teriparatide|mesh-list
64555862|NCT02242929|Imiquimod|imiquimod|mesh-list
65184034|NCT00634894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184035|NCT02779270|Sunscreening Agents|sunscreening agents|mesh-list
65184036|NCT02779270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65184037|NCT02779270|Protective Agents|protective agents|mesh-ancestor
65184038|NCT02779270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184039|NCT02779270|Dermatologic Agents|dermatologic agents|mesh-ancestor
65184040|NCT01078662|Olaparib|olaparib|mesh-list
65184041|NCT01078662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65184042|NCT01078662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184043|NCT01078662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184044|NCT01078662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184045|NCT04227886|Capecitabine|capecitabine|mesh-list
65184046|NCT04227886|Irinotecan|irinotecan|mesh-list
65184047|NCT04227886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65184048|NCT04227886|Antimetabolites|antimetabolites|mesh-ancestor
65184049|NCT04227886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184050|NCT04227886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184051|NCT04227886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65184052|NCT04227886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65184053|NCT04227886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184054|NCT02200978|Cytarabine|cytarabine|mesh-list
65184055|NCT02200978|Methotrexate|methotrexate|mesh-list
65184056|NCT02200978|Mercaptopurine|mercaptopurine|mesh-list
65184057|NCT02200978|Mitoxantrone|mitoxantrone|mesh-list
65184058|NCT02200978|Tretinoin|tretinoin|mesh-list
65184059|NCT02200978|Arsenic Trioxide|arsenic trioxide|mesh-list
65184060|NCT02200978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65184061|NCT02200978|Abortifacient Agents|abortifacient agents|mesh-ancestor
65184062|NCT02200978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65184063|NCT02200978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184067|NCT02200978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184068|NCT02200978|Dermatologic Agents|dermatologic agents|mesh-ancestor
65184069|NCT02200978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184070|NCT02200978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65184071|NCT02200978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65184072|NCT02200978|Immunologic Factors|immunologic factors|mesh-ancestor
65184073|NCT02200978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65184074|NCT02200978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65184075|NCT02200978|Antiviral Agents|antiviral agents|mesh-ancestor
65184076|NCT02200978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65184077|NCT02200978|Analgesics|analgesics|mesh-ancestor
65184078|NCT02200978|Sensory System Agents|sensory system agents|mesh-ancestor
65184079|NCT02200978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184080|NCT02200978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65184081|NCT02200978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65184082|NCT02200978|Keratolytic Agents|keratolytic agents|mesh-ancestor
65184083|NCT02779192|Ebselen|ebselen|mesh-list
65184084|NCT02779192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65184085|NCT02779192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65184086|NCT02779192|Analgesics|analgesics|mesh-ancestor
65184087|NCT02779192|Sensory System Agents|sensory system agents|mesh-ancestor
65184088|NCT02779192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184089|NCT02779192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184090|NCT02779192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65184091|NCT02779192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65184092|NCT02779192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65184093|NCT02779192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65184094|NCT02779192|Antioxidants|antioxidants|mesh-ancestor
65184095|NCT02779192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326336|NCT00754442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65326337|NCT00754442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326338|NCT00754442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65326339|NCT00754052|Donepezil|donepezil|mesh-list
65326340|NCT00754052|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65326341|NCT00754052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184096|NCT02779192|Protective Agents|protective agents|mesh-ancestor
65184097|NCT02779192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65184098|NCT02779192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184099|NCT02779192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65184100|NCT05020210|Sivelestat|sivelestat|mesh-list
65184101|NCT05020210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65184102|NCT05020210|Protease Inhibitors|protease inhibitors|mesh-ancestor
65184103|NCT05020210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184104|NCT05020210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184105|NCT04227808|Lenvatinib|lenvatinib|mesh-list
65184106|NCT04227808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184107|NCT04227808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65184108|NCT04227808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184109|NCT04227808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184110|NCT05017246|Lidocaine|lidocaine|mesh-list
65184111|NCT05017246|Morphine|morphine|mesh-list
65184112|NCT05017246|Bupivacaine|bupivacaine|mesh-list
65184113|NCT05017246|Anesthetics, Local|anesthetics, local|mesh-ancestor
65184114|NCT05017246|Anesthetics|anesthetics|mesh-ancestor
65184115|NCT05017246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65184116|NCT05017246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184117|NCT05017246|Sensory System Agents|sensory system agents|mesh-ancestor
65184118|NCT05017246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184119|NCT05017246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65184120|NCT05017246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65184121|NCT05017246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65184122|NCT05017246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65184123|NCT05017246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184124|NCT05017246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65184125|NCT05017246|Narcotics|narcotics|mesh-ancestor
65184126|NCT05017246|Analgesics|analgesics|mesh-ancestor
64826698|NCT01544634|Hormones|hormones|mesh-ancestor
65184127|NCT01091454|Cisplatin|cisplatin|mesh-list
65184128|NCT01091454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184129|NCT01140347|Ramucirumab|ramucirumab|mesh-list
65184130|NCT01140347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184132|NCT04227652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65184133|NCT04227652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65184134|NCT04227652|Analgesics|analgesics|mesh-ancestor
65184135|NCT04227652|Sensory System Agents|sensory system agents|mesh-ancestor
65184139|NCT04227652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65184140|NCT04227652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65184141|NCT04227652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184142|NCT04227652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184143|NCT02883569|Ibuprofen|ibuprofen|mesh-list
65184144|NCT02883569|Aceclofenac|aceclofenac|mesh-list
65184145|NCT02883569|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
65184146|NCT02883569|Tramadol|tramadol|mesh-list
65184147|NCT02883569|Codeine|codeine|mesh-list
65184148|NCT02883569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65184149|NCT02883569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65184150|NCT02883569|Analgesics|analgesics|mesh-ancestor
65184151|NCT02883569|Sensory System Agents|sensory system agents|mesh-ancestor
65184152|NCT02883569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184153|NCT02883569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184154|NCT02883569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65184155|NCT02883569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65184156|NCT02883569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65184157|NCT02883569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184158|NCT02883569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184159|NCT02883569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65184160|NCT02883569|Narcotics|narcotics|mesh-ancestor
65184161|NCT02883569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65326342|NCT00754052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326343|NCT00754052|Cholinergic Agents|cholinergic agents|mesh-ancestor
65326344|NCT00754052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65326345|NCT00754052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326346|NCT00754052|Nootropic Agents|nootropic agents|mesh-ancestor
65326347|NCT04095182|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
65326348|NCT04095182|Anticonvulsants|anticonvulsants|mesh-ancestor
65184162|NCT02883569|Antitussive Agents|antitussive agents|mesh-ancestor
65184163|NCT02883569|Respiratory System Agents|respiratory system agents|mesh-ancestor
65184164|NCT02883023|Bleomycin|bleomycin|mesh-list
65184165|NCT02883023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65184166|NCT02883023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184167|NCT02778958|Acetaminophen|acetaminophen|mesh-list
65184168|NCT02778958|Ibuprofen|ibuprofen|mesh-list
65184169|NCT02778958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65184170|NCT02778958|Analgesics|analgesics|mesh-ancestor
65184171|NCT02778958|Sensory System Agents|sensory system agents|mesh-ancestor
65184172|NCT02778958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184173|NCT02778958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184174|NCT02778958|Antipyretics|antipyretics|mesh-ancestor
65184175|NCT02778958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65184176|NCT02778958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65184177|NCT02778958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65184178|NCT02778958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65184179|NCT02778958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184180|NCT02778958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184181|NCT01197560|Gemcitabine|gemcitabine|mesh-list
65184182|NCT01197560|Rituximab|rituximab|mesh-list
65184183|NCT01197560|Oxaliplatin|oxaliplatin|mesh-list
65184184|NCT01197560|Etoposide|etoposide|mesh-list
65184185|NCT01197560|Lenalidomide|lenalidomide|mesh-list
65184186|NCT01197560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65184187|NCT01197560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184188|NCT01197560|Immunologic Factors|immunologic factors|mesh-ancestor
65184189|NCT01197560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184190|NCT01197560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65184191|NCT01197560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65184192|NCT01197560|Antimetabolites|antimetabolites|mesh-ancestor
65184193|NCT01197560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184194|NCT01197560|Antiviral Agents|antiviral agents|mesh-ancestor
65184195|NCT01197560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65184196|NCT01197560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184197|NCT01197560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65184198|NCT01197560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65184199|NCT01197560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65184200|NCT01197560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65184201|NCT01197560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65184202|NCT01197560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64826770|NCT01544907|Paclitaxel|paclitaxel|mesh-list
65184203|NCT01197560|Growth Substances|growth substances|mesh-ancestor
65184204|NCT01197560|Growth Inhibitors|growth inhibitors|mesh-ancestor
65184205|NCT04940572|Valproic Acid|valproic acid|mesh-list
65184206|NCT04940572|Anticonvulsants|anticonvulsants|mesh-ancestor
65184207|NCT04940572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184214|NCT04940572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65184215|NCT04940572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65184216|NCT01196078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65184217|NCT01196078|Vinorelbine|vinorelbine|mesh-list
65184218|NCT01196078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184219|NCT01196078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65184220|NCT01196078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184221|NCT01196078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184222|NCT01196078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65184223|NCT01196078|Tubulin Modulators|tubulin modulators|mesh-ancestor
65184224|NCT01196078|Antimitotic Agents|antimitotic agents|mesh-ancestor
65184225|NCT01196078|Mitosis Modulators|mitosis modulators|mesh-ancestor
65184226|NCT05314660|Fluorides|fluorides|mesh-list
65184227|NCT05314660|Cariostatic Agents|cariostatic agents|mesh-ancestor
65184228|NCT05314660|Protective Agents|protective agents|mesh-ancestor
65326349|NCT04095182|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65326350|NCT04095182|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65326351|NCT04095182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65326352|NCT04095182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326353|NCT00753896|Exenatide|exenatide|mesh-list
65326354|NCT00753896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65184229|NCT05314660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184230|NCT04920292|Oxfendazole|oxfendazole|mesh-list
65184231|NCT04920292|Anthelmintics|anthelmintics|mesh-ancestor
65184232|NCT04920292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65184233|NCT04920292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65184234|NCT04920292|Antinematodal Agents|antinematodal agents|mesh-ancestor
65184235|NCT04317872|Dexamethasone|dexamethasone|mesh-list
65184236|NCT04317872|Dexamethasone acetate|dexamethasone acetate|mesh-list
65184237|NCT04317872|BB 1101|bb 1101|mesh-list
65184238|NCT04317872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65184239|NCT04317872|Antiemetics|antiemetics|mesh-ancestor
65184240|NCT04317872|Autonomic Agents|autonomic agents|mesh-ancestor
65184241|NCT04317872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184242|NCT04317872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184243|NCT04317872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65184244|NCT04317872|Glucocorticoids|glucocorticoids|mesh-ancestor
65184245|NCT04317872|Hormones|hormones|mesh-ancestor
65184246|NCT04317872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65184247|NCT04317872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65184248|NCT04317872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184249|NCT04317872|Protease Inhibitors|protease inhibitors|mesh-ancestor
65184250|NCT04317872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184251|NCT04317872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184252|NCT01132547|Cyproheptadine|cyproheptadine|mesh-list
65184253|NCT01132547|Antipruritics|antipruritics|mesh-ancestor
65184254|NCT01132547|Dermatologic Agents|dermatologic agents|mesh-ancestor
65184255|NCT01132547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65184256|NCT01132547|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65184257|NCT01132547|Histamine Antagonists|histamine antagonists|mesh-ancestor
65184258|NCT01132547|Histamine Agents|histamine agents|mesh-ancestor
65184259|NCT01132547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65184260|NCT01132547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184261|NCT01132547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184262|NCT01132547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65184263|NCT01132547|Serotonin Agents|serotonin agents|mesh-ancestor
65184264|NCT01132547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65184265|NCT01194830|Linagliptin|linagliptin|mesh-list
65184266|NCT01194830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65184267|NCT01194830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184268|NCT01194830|Incretins|incretins|mesh-ancestor
65184270|NCT01194830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65184271|NCT01194830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65184272|NCT01194830|Protease Inhibitors|protease inhibitors|mesh-ancestor
65184273|NCT01194830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184274|NCT01194830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184275|NCT02778178|Clonidine|clonidine|mesh-list
65184276|NCT02778178|Ropivacaine|ropivacaine|mesh-list
65184277|NCT02778178|Anesthetics, Local|anesthetics, local|mesh-ancestor
65184279|NCT02778178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65184280|NCT02778178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184282|NCT02778178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184283|NCT02778178|Analgesics|analgesics|mesh-ancestor
65184284|NCT02778178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65184285|NCT02778178|Sympatholytics|sympatholytics|mesh-ancestor
65184286|NCT02778178|Autonomic Agents|autonomic agents|mesh-ancestor
65184287|NCT02778178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65184288|NCT02778178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65184289|NCT02778178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65184290|NCT02778178|Adrenergic Agents|adrenergic agents|mesh-ancestor
65184291|NCT02778178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65184292|NCT02778178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184293|NCT01194440|Zoledronic Acid|zoledronic acid|mesh-list
65326355|NCT00753896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326356|NCT00753896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65326357|NCT00753896|Incretins|incretins|mesh-ancestor
65326358|NCT00753896|Hormones|hormones|mesh-ancestor
64555892|NCT05006898|Cholinergic Agents|cholinergic agents|mesh-ancestor
65184294|NCT01194440|Letrozole|letrozole|mesh-list
65184295|NCT01194440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184296|NCT01194440|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65184297|NCT01194440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65184298|NCT01194440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184299|NCT01194440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184300|NCT01194440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65184301|NCT01194440|Hormone Antagonists|hormone antagonists|mesh-ancestor
65184302|NCT01194440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65184303|NCT01194440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184304|NCT01194440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65184305|NCT04823052|Sulindac|sulindac|mesh-list
65184306|NCT04823052|Gaboxadol|gaboxadol|mesh-list
65184307|NCT04823052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65184308|NCT04823052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65184309|NCT04823052|Analgesics|analgesics|mesh-ancestor
65184310|NCT04823052|Sensory System Agents|sensory system agents|mesh-ancestor
65184311|NCT04823052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184312|NCT04823052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184313|NCT04823052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65184314|NCT04823052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65184315|NCT04823052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184316|NCT04823052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65184317|NCT04823052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64499071|NCT01389856|Bosentan|bosentan|mesh-list
65184318|NCT04823052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184320|NCT04823052|GABA Agonists|gaba agonists|mesh-ancestor
65184321|NCT04823052|GABA Agents|gaba agents|mesh-ancestor
65184322|NCT04823052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65184323|NCT04815720|Pembrolizumab|pembrolizumab|mesh-list
65184324|NCT04815720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65184325|NCT04815720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184326|NCT00951015|Efavirenz|efavirenz|mesh-list
65184327|NCT00951015|Dolutegravir|dolutegravir|mesh-list
65184328|NCT00951015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65184329|NCT00951015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65184330|NCT00951015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184331|NCT00951015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184332|NCT00951015|Antiviral Agents|antiviral agents|mesh-ancestor
65184333|NCT00951015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65184334|NCT00951015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65184335|NCT00951015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65184336|NCT00951015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65184337|NCT00951015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65184338|NCT00951015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65184339|NCT00951015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65184340|NCT00951015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65184341|NCT00951015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65184342|NCT00951015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65184343|NCT00951015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65184344|NCT02777866|Bupivacaine|bupivacaine|mesh-list
65184345|NCT02777866|Anesthetics, Local|anesthetics, local|mesh-ancestor
65184346|NCT02777866|Anesthetics|anesthetics|mesh-ancestor
65184347|NCT02777866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65184348|NCT02777866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184354|NCT00626262|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65184355|NCT00626262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184356|NCT00626262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184357|NCT02876796|Firsocostat|firsocostat|mesh-list
65184358|NCT02876796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184359|NCT02876796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184360|NCT01193660|Epoetin Alfa|epoetin alfa|mesh-list
65184361|NCT01193660|Hematinics|hematinics|mesh-ancestor
65184362|NCT02777788|Gemcitabine|gemcitabine|mesh-list
65184363|NCT02777788|Paclitaxel|paclitaxel|mesh-list
65184364|NCT02777788|Vinorelbine|vinorelbine|mesh-list
65326359|NCT00753896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65326360|NCT05430152|Naltrexone|naltrexone|mesh-list
65326361|NCT05430152|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65326362|NCT05430152|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65184365|NCT02777788|Docetaxel|docetaxel|mesh-list
65184366|NCT02777788|Carboplatin|carboplatin|mesh-list
65184367|NCT02777788|Pemetrexed|pemetrexed|mesh-list
65184368|NCT02777788|Cisplatin|cisplatin|mesh-list
65184369|NCT02777788|Nedaplatin|nedaplatin|mesh-list
65184370|NCT02777788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65184371|NCT02777788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184372|NCT02777788|Tubulin Modulators|tubulin modulators|mesh-ancestor
65184373|NCT02777788|Antimitotic Agents|antimitotic agents|mesh-ancestor
65184374|NCT02777788|Mitosis Modulators|mitosis modulators|mesh-ancestor
65184375|NCT02777788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184376|NCT02777788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65184377|NCT02777788|Antimetabolites|antimetabolites|mesh-ancestor
65184378|NCT02777788|Antiviral Agents|antiviral agents|mesh-ancestor
65184379|NCT02777788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65184380|NCT02777788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184381|NCT02777788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65184382|NCT02777788|Immunologic Factors|immunologic factors|mesh-ancestor
65184383|NCT02777788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184384|NCT02777788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65184385|NCT02777788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65184386|NCT01076166|Clarithromycin|clarithromycin|mesh-list
65184387|NCT01076166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65184388|NCT01076166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65184389|NCT01076166|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65184390|NCT01076166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184391|NCT01076166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184392|NCT01076166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65184393|NCT01076166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65184394|NCT02777710|Durvalumab|durvalumab|mesh-list
65184395|NCT02777710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65184396|NCT02777710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184397|NCT01193582|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65184398|NCT01193582|Immunologic Factors|immunologic factors|mesh-ancestor
65184399|NCT01193582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184400|NCT00602901|Naproxen|naproxen|mesh-list
65184401|NCT00602901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65184402|NCT00602901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65184403|NCT00602901|Analgesics|analgesics|mesh-ancestor
65184404|NCT00602901|Sensory System Agents|sensory system agents|mesh-ancestor
65184405|NCT00602901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184406|NCT00602901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184407|NCT00602901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65184408|NCT00602901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65184409|NCT00602901|Gout Suppressants|gout suppressants|mesh-ancestor
65184410|NCT00602901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65184411|NCT00602901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184412|NCT00602901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184413|NCT01076088|Metformin|metformin|mesh-list
65184414|NCT01076088|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65184415|NCT01076088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65184416|NCT01076088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184417|NCT01076088|Incretins|incretins|mesh-ancestor
65184418|NCT01076088|Hormones|hormones|mesh-ancestor
65184419|NCT01076088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65184431|NCT02777320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184432|NCT02777320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65184433|NCT02777320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65184434|NCT02777320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65184435|NCT02777320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184436|NCT02777320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184437|NCT02777320|Antipyretics|antipyretics|mesh-ancestor
65184438|NCT01193348|Eculizumab|eculizumab|mesh-list
65184439|NCT01193348|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65184440|NCT01193348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65184441|NCT01193348|Immunologic Factors|immunologic factors|mesh-ancestor
65326363|NCT05430152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326364|NCT05430152|Sensory System Agents|sensory system agents|mesh-ancestor
65326365|NCT05430152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65326366|NCT02927067|Valganciclovir|valganciclovir|mesh-list
65326367|NCT02927067|Maribavir|maribavir|mesh-list
65326368|NCT02927067|Antiviral Agents|antiviral agents|mesh-ancestor
65326369|NCT02927067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65326370|NCT02600468|Abatacept|abatacept|mesh-list
65326371|NCT02600468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64555899|NCT02243241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184442|NCT01193348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184443|NCT00945321|Aprepitant|aprepitant|mesh-list
65184444|NCT00945321|Fosaprepitant|fosaprepitant|mesh-list
65184445|NCT00945321|Antiemetics|antiemetics|mesh-ancestor
65184446|NCT00945321|Autonomic Agents|autonomic agents|mesh-ancestor
65184447|NCT00945321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184448|NCT00945321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184449|NCT00945321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65184450|NCT00945321|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65184451|NCT00945321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65184452|NCT00945321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184453|NCT02776228|Brotizolam|brotizolam|mesh-list
65184454|NCT02776228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64383210|NCT03175679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64383211|NCT03175679|Analgesics|analgesics|mesh-ancestor
65184455|NCT02776228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65184456|NCT02776228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184457|NCT04872790|Prednisone|prednisone|mesh-list
65184458|NCT04872790|Cortisone|cortisone|mesh-list
65184459|NCT04872790|Rituximab|rituximab|mesh-list
65184460|NCT04872790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65184461|NCT04872790|Methotrexate|methotrexate|mesh-list
65184462|NCT04872790|Venetoclax|venetoclax|mesh-list
65184463|NCT04872790|Dasatinib|dasatinib|mesh-list
65184464|NCT04872790|Antibodies|antibodies|mesh-list
65184465|NCT04872790|Immunoglobulins|immunoglobulins|mesh-list
65184466|NCT04872790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65184467|NCT04872790|Immunologic Factors|immunologic factors|mesh-ancestor
65184468|NCT04872790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184469|NCT04872790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184470|NCT04872790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65184471|NCT04872790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65184472|NCT04872790|Glucocorticoids|glucocorticoids|mesh-ancestor
65184473|NCT04872790|Hormones|hormones|mesh-ancestor
65184474|NCT04872790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65184475|NCT04872790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65184476|NCT04872790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65184477|NCT04872790|Abortifacient Agents|abortifacient agents|mesh-ancestor
65184478|NCT04872790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65184479|NCT04872790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65184480|NCT04872790|Antimetabolites|antimetabolites|mesh-ancestor
65184481|NCT04872790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184482|NCT04872790|Dermatologic Agents|dermatologic agents|mesh-ancestor
65184483|NCT04872790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184484|NCT04872790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65184485|NCT04872790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65184486|NCT04872790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65184487|NCT04872790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65184488|NCT05382728|Osimertinib|osimertinib|mesh-list
65184489|NCT05382728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184490|NCT05382728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65184491|NCT05382728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184492|NCT05382728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184493|NCT00944697|Oxycodone|oxycodone|mesh-list
65184494|NCT00944697|Naloxone|naloxone|mesh-list
65184495|NCT00944697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65184496|NCT00944697|Narcotics|narcotics|mesh-ancestor
65184497|NCT00944697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65326372|NCT02600468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326373|NCT02600468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184498|NCT00944697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184499|NCT00944697|Analgesics|analgesics|mesh-ancestor
65184500|NCT00944697|Sensory System Agents|sensory system agents|mesh-ancestor
65184501|NCT00944697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184502|NCT00944697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65184503|NCT01192178|Fluticasone|fluticasone|mesh-list
65184505|NCT01192178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64827081|NCT01547377|Zinc|zinc|mesh-list
65184506|NCT01192178|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65184507|NCT01192178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65184508|NCT01192178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65184510|NCT01192178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184511|NCT01192178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184512|NCT01192178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65184513|NCT01192178|Respiratory System Agents|respiratory system agents|mesh-ancestor
65184514|NCT01192178|Dermatologic Agents|dermatologic agents|mesh-ancestor
65184515|NCT01192178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65184516|NCT01192178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65184517|NCT01192178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65184518|NCT01192178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65184519|NCT01192178|Adrenergic Agents|adrenergic agents|mesh-ancestor
65184520|NCT01192178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65184521|NCT01192178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184522|NCT01192178|Glucocorticoids|glucocorticoids|mesh-ancestor
65184523|NCT01192178|Hormones|hormones|mesh-ancestor
65184524|NCT01192178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65184525|NCT01192178|Sympathomimetics|sympathomimetics|mesh-ancestor
65184526|NCT04193566|Dapagliflozin|dapagliflozin|mesh-list
65184527|NCT04193566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64383212|NCT03175679|Sensory System Agents|sensory system agents|mesh-ancestor
65184531|NCT00869401|Temozolomide|temozolomide|mesh-list
65184532|NCT00869401|Dasatinib|dasatinib|mesh-list
65184533|NCT00869401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65184534|NCT00869401|Alkylating Agents|alkylating agents|mesh-ancestor
65184535|NCT00869401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184536|NCT00869401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184537|NCT00869401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65184538|NCT00869401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184539|NCT01076010|Sorafenib|sorafenib|mesh-list
65184540|NCT01076010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184541|NCT01076010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65184543|NCT01076010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184544|NCT04225780|Ganciclovir|ganciclovir|mesh-list
65184545|NCT04225780|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65184546|NCT04225780|Antiviral Agents|antiviral agents|mesh-ancestor
65184547|NCT04225780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65184548|NCT04225780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65184549|NCT04225780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184550|NCT04225780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184551|NCT04045171|Tacrolimus|tacrolimus|mesh-list
65184552|NCT04045171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65184553|NCT04045171|Immunologic Factors|immunologic factors|mesh-ancestor
65184554|NCT04045171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184555|NCT04045171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65184556|NCT04045171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184557|NCT04045171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184558|NCT01075152|Lamivudine|lamivudine|mesh-list
65184559|NCT01075152|Zidovudine|zidovudine|mesh-list
65184560|NCT01075152|Efavirenz|efavirenz|mesh-list
65184561|NCT01075152|Stavudine|stavudine|mesh-list
65184562|NCT01075152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65184563|NCT01075152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65184564|NCT01075152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184565|NCT01075152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184566|NCT01075152|Antiviral Agents|antiviral agents|mesh-ancestor
65184567|NCT01075152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65184568|NCT01075152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65184569|NCT01075152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65184570|NCT01075152|Antimetabolites|antimetabolites|mesh-ancestor
65184571|NCT01075152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65326374|NCT02600468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65326375|NCT02600468|Immunologic Factors|immunologic factors|mesh-ancestor
65326376|NCT02600468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326377|NCT02600468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65326378|NCT02598596|Azathioprine|azathioprine|mesh-list
65326379|NCT02598596|Antimetabolites|antimetabolites|mesh-ancestor
64555910|NCT03076320|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65184572|NCT01075152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65184573|NCT01075152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65184574|NCT01075152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65184575|NCT01075152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65184576|NCT01075152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65184577|NCT04134637|Bupivacaine|bupivacaine|mesh-list
64827173|NCT01548118|Vaccines|vaccines|mesh-list
65184578|NCT04134637|Anesthetics, Local|anesthetics, local|mesh-ancestor
65184580|NCT04134637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65184581|NCT04134637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184582|NCT04134637|Sensory System Agents|sensory system agents|mesh-ancestor
65184583|NCT04134637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184584|NCT02617849|Paclitaxel|paclitaxel|mesh-list
65184585|NCT02617849|Carboplatin|carboplatin|mesh-list
65184586|NCT02617849|Pembrolizumab|pembrolizumab|mesh-list
65184587|NCT02617849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65184588|NCT02617849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184589|NCT02617849|Tubulin Modulators|tubulin modulators|mesh-ancestor
65184590|NCT02617849|Antimitotic Agents|antimitotic agents|mesh-ancestor
65184591|NCT02617849|Mitosis Modulators|mitosis modulators|mesh-ancestor
65184592|NCT02617849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184593|NCT02617849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65184594|NCT00950859|Dolutegravir|dolutegravir|mesh-list
65184595|NCT00950859|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65184596|NCT00950859|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65184597|NCT00950859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184598|NCT00950859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184601|NCT00950859|Antiviral Agents|antiviral agents|mesh-ancestor
65184602|NCT00950859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65184603|NCT02775292|Aldesleukin|aldesleukin|mesh-list
65184604|NCT02775292|Cyclophosphamide|cyclophosphamide|mesh-list
65184605|NCT02775292|Nivolumab|nivolumab|mesh-list
65184606|NCT02775292|Fludarabine|fludarabine|mesh-list
65184607|NCT02775292|Fludarabine phosphate|fludarabine phosphate|mesh-list
65184608|NCT02775292|Interleukin-2|interleukin-2|mesh-list
65184609|NCT02775292|Vaccines|vaccines|mesh-list
65184610|NCT02775292|Immunologic Factors|immunologic factors|mesh-ancestor
65184611|NCT02775292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184612|NCT02775292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65184613|NCT02775292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65184614|NCT02775292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65184615|NCT02775292|Alkylating Agents|alkylating agents|mesh-ancestor
65184616|NCT02775292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184617|NCT02775292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184618|NCT02775292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65184619|NCT02775292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65184620|NCT02775292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65184621|NCT02775292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65184622|NCT02775292|Antimetabolites|antimetabolites|mesh-ancestor
65184623|NCT02775292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65184624|NCT02775292|Analgesics|analgesics|mesh-ancestor
65184625|NCT02775292|Sensory System Agents|sensory system agents|mesh-ancestor
65184626|NCT02775292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184627|NCT02775292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65184628|NCT02775292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65184629|NCT02775292|Antiviral Agents|antiviral agents|mesh-ancestor
65184630|NCT02775292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65184631|NCT00862849|Insulin|insulin|mesh-list
65184632|NCT00862849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65184633|NCT00862849|Insulin Lispro|insulin lispro|mesh-list
65184634|NCT00862849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65184635|NCT00862849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184636|NCT01090050|Naproxen|naproxen|mesh-list
65326380|NCT02598596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326381|NCT02598596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65326382|NCT02598596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326383|NCT02598596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64555920|NCT04365309|Aspirin|aspirin|mesh-list
65184637|NCT01090050|Sumatriptan|sumatriptan|mesh-list
65184638|NCT01090050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65184639|NCT01090050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65184640|NCT01090050|Analgesics|analgesics|mesh-ancestor
65184641|NCT01090050|Sensory System Agents|sensory system agents|mesh-ancestor
65184642|NCT01090050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184643|NCT01090050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184644|NCT01090050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65184645|NCT01090050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65184646|NCT01090050|Gout Suppressants|gout suppressants|mesh-ancestor
65184647|NCT01090050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65184648|NCT01090050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184649|NCT01090050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184650|NCT01090050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65184651|NCT01090050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65184652|NCT01090050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65184653|NCT01090050|Serotonin Agents|serotonin agents|mesh-ancestor
65184654|NCT01090050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65184655|NCT02775370|Apatinib|apatinib|mesh-list
65184656|NCT02775370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184657|NCT02775370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65184658|NCT02775370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184659|NCT02775370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184660|NCT04225468|Analgesics, Opioid|analgesics, opioid|mesh-list
65184661|NCT04225468|Narcotics|narcotics|mesh-ancestor
65184662|NCT04225468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65184663|NCT04225468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184664|NCT04225468|Analgesics|analgesics|mesh-ancestor
65184665|NCT04225468|Sensory System Agents|sensory system agents|mesh-ancestor
65184666|NCT04225468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184667|NCT02855307|Insulin|insulin|mesh-list
65184668|NCT02855307|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65184669|NCT02855307|Hormones|hormones|mesh-list
65184670|NCT02855307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65184671|NCT02855307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184672|NCT02855307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65184673|NCT01077960|Hormones|hormones|mesh-list
65184677|NCT04269369|Antimetabolites|antimetabolites|mesh-ancestor
65184678|NCT04269369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184679|NCT04269369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65184680|NCT04269369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184681|NCT04269369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65184682|NCT04269369|Immunologic Factors|immunologic factors|mesh-ancestor
65184683|NCT04269369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184684|NCT02776540|Aspirin|aspirin|mesh-list
65184685|NCT02776540|Clopidogrel|clopidogrel|mesh-list
65184686|NCT02776540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65184687|NCT02776540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65184688|NCT02776540|Analgesics|analgesics|mesh-ancestor
65184689|NCT02776540|Sensory System Agents|sensory system agents|mesh-ancestor
65184690|NCT02776540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184691|NCT02776540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184692|NCT02776540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65184693|NCT02776540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65184694|NCT02776540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65184695|NCT02776540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65184696|NCT02776540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184697|NCT02776540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65184698|NCT02776540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65184699|NCT02776540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184701|NCT02776540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65184702|NCT02776540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65184703|NCT02776540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65326384|NCT02598596|Immunologic Factors|immunologic factors|mesh-ancestor
65326385|NCT02598596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326386|NCT02598596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65326387|NCT01771107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65326388|NCT01771107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65326389|NCT01771107|Doxorubicin|doxorubicin|mesh-list
65326390|NCT01771107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65326391|NCT01771107|Dacarbazine|dacarbazine|mesh-list
65326392|NCT01771107|Vinblastine|vinblastine|mesh-list
65326393|NCT01771107|Antibodies|antibodies|mesh-list
65326394|NCT01771107|Immunoglobulins|immunoglobulins|mesh-list
65326395|NCT01771107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65326396|NCT01771107|Immunoconjugates|immunoconjugates|mesh-list
65326397|NCT01771107|Imidazole|imidazole|mesh-list
65326398|NCT01771107|Immunologic Factors|immunologic factors|mesh-ancestor
65326399|NCT01771107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326400|NCT01771107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326401|NCT01771107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65326402|NCT01771107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65326403|NCT01771107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65326404|NCT01771107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555922|NCT04365309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65184704|NCT02776540|Purinergic Agents|purinergic agents|mesh-ancestor
65184705|NCT02776540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65184706|NCT02878122|Carboplatin|carboplatin|mesh-list
65184707|NCT02878122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184708|NCT04807348|Metformin|metformin|mesh-list
65184709|NCT04807348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65184710|NCT04807348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184711|NCT04224922|Paclitaxel|paclitaxel|mesh-list
65184712|NCT04224922|Cyclophosphamide|cyclophosphamide|mesh-list
65184713|NCT04224922|Epirubicin|epirubicin|mesh-list
65184714|NCT04224922|Carboplatin|carboplatin|mesh-list
65184715|NCT04224922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65184716|NCT04224922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184717|NCT04224922|Tubulin Modulators|tubulin modulators|mesh-ancestor
65184718|NCT04224922|Antimitotic Agents|antimitotic agents|mesh-ancestor
65184719|NCT04224922|Mitosis Modulators|mitosis modulators|mesh-ancestor
65184720|NCT04224922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184721|NCT04224922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65184722|NCT04224922|Immunologic Factors|immunologic factors|mesh-ancestor
65184723|NCT04224922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184724|NCT04224922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65184725|NCT04224922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65184726|NCT04224922|Alkylating Agents|alkylating agents|mesh-ancestor
65184727|NCT04224922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64827290|NCT01548794|Lidocaine|lidocaine|mesh-list
65184728|NCT04224922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65184729|NCT04224922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65184730|NCT04224922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65184731|NCT04224922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184733|NCT02877888|Fluorides, Topical|fluorides, topical|mesh-list
65184734|NCT02877888|Cariostatic Agents|cariostatic agents|mesh-ancestor
65184735|NCT02877888|Protective Agents|protective agents|mesh-ancestor
65184736|NCT02877888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184737|NCT02772640|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65184738|NCT02772640|Ezetimibe|ezetimibe|mesh-list
65326405|NCT01771107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326406|NCT01771107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65326407|NCT01771107|Alkylating Agents|alkylating agents|mesh-ancestor
65326408|NCT01771107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65326409|NCT01771107|Tubulin Modulators|tubulin modulators|mesh-ancestor
64490122|NCT04367818|Anesthetics|anesthetics|mesh-list
65184739|NCT02772640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65184740|NCT02772640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65184741|NCT02772640|Antimetabolites|antimetabolites|mesh-ancestor
65184742|NCT02772640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184743|NCT02772640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65184744|NCT02772640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65184745|NCT02772640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184751|NCT00866281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65184752|NCT00866281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184753|NCT00866281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184754|NCT04121611|Aspirin|aspirin|mesh-list
65184755|NCT04121611|Heparin|heparin|mesh-list
65184756|NCT04121611|Calcium heparin|calcium heparin|mesh-list
65184757|NCT04121611|Anticoagulants|anticoagulants|mesh-ancestor
65184758|NCT04121611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65184759|NCT04121611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65184760|NCT04121611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184761|NCT04121611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65184762|NCT04121611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65184763|NCT04121611|Analgesics|analgesics|mesh-ancestor
65184764|NCT04121611|Sensory System Agents|sensory system agents|mesh-ancestor
65184765|NCT04121611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184766|NCT04121611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184768|NCT04121611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65184769|NCT04121611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65184770|NCT04121611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65184771|NCT04121611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184772|NCT04121611|Antipyretics|antipyretics|mesh-ancestor
65184773|NCT02771860|Denosumab|denosumab|mesh-list
65184774|NCT02771860|Calcium|calcium|mesh-list
65184775|NCT02771860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65184776|NCT02771860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184777|NCT02771860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65184778|NCT02771782|Vaccines|vaccines|mesh-list
65184779|NCT02771782|BCG Vaccine|bcg vaccine|mesh-list
65184780|NCT02771782|Immunologic Factors|immunologic factors|mesh-ancestor
65184781|NCT02771782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184782|NCT02771782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65184783|NCT02771392|Tetracaine|tetracaine|mesh-list
65184784|NCT02771392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65184785|NCT02771392|Anesthetics, Local|anesthetics, local|mesh-ancestor
65184786|NCT02771392|Anesthetics|anesthetics|mesh-ancestor
65184787|NCT02771392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65184788|NCT02771392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184789|NCT02771392|Sensory System Agents|sensory system agents|mesh-ancestor
65184790|NCT02771392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184791|NCT02771704|Iodine|iodine|mesh-list
65184792|NCT02771704|Chlorhexidine|chlorhexidine|mesh-list
65184793|NCT02771704|Fluorides|fluorides|mesh-list
65184794|NCT02771704|Cariostatic Agents|cariostatic agents|mesh-ancestor
65184795|NCT02771704|Protective Agents|protective agents|mesh-ancestor
65184796|NCT02771704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184797|NCT02771704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65184798|NCT02771704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65184799|NCT02771704|Disinfectants|disinfectants|mesh-ancestor
65184800|NCT02771704|Trace Elements|trace elements|mesh-ancestor
65184801|NCT02771704|Micronutrients|micronutrients|mesh-ancestor
65184802|NCT02771314|Osimertinib|osimertinib|mesh-list
65184803|NCT02771314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184804|NCT02771314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65184805|NCT02771314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184806|NCT02771314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184807|NCT02771158|Midodrine|midodrine|mesh-list
65326410|NCT01771107|Antimitotic Agents|antimitotic agents|mesh-ancestor
65326411|NCT01771107|Mitosis Modulators|mitosis modulators|mesh-ancestor
65326412|NCT00586508|Bevacizumab|bevacizumab|mesh-list
65326413|NCT00586508|Anticonvulsants|anticonvulsants|mesh-list
65326414|NCT00586508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65326415|NCT00586508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326416|NCT00586508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65326417|NCT00586508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65326418|NCT00586508|Growth Substances|growth substances|mesh-ancestor
65184808|NCT02771158|Sympathomimetics|sympathomimetics|mesh-ancestor
65184809|NCT02771158|Autonomic Agents|autonomic agents|mesh-ancestor
65184810|NCT02771158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184811|NCT02771158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184812|NCT02771158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65184813|NCT02771158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65184814|NCT02771158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65184815|NCT02771158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65184816|NCT02771158|Adrenergic Agents|adrenergic agents|mesh-ancestor
65184817|NCT02771158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65184818|NCT02771158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184823|NCT02770690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65184824|NCT02770690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184825|NCT02770690|Sensory System Agents|sensory system agents|mesh-ancestor
65184826|NCT02770690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184827|NCT02770690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65184828|NCT02770690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65184829|NCT02770690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65184830|NCT02770690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65184831|NCT02770690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184832|NCT02770378|Ritonavir|ritonavir|mesh-list
65184833|NCT02770378|Itraconazole|itraconazole|mesh-list
65184834|NCT02770378|Minocycline|minocycline|mesh-list
65184835|NCT02770378|Celecoxib|celecoxib|mesh-list
65184836|NCT02770378|Temozolomide|temozolomide|mesh-list
65184837|NCT02770378|Auranofin|auranofin|mesh-list
65184838|NCT02770378|Captopril|captopril|mesh-list
65184839|NCT02770378|Disulfiram|disulfiram|mesh-list
65184840|NCT02770378|Aprepitant|aprepitant|mesh-list
65184841|NCT02770378|Sertraline|sertraline|mesh-list
65184842|NCT02770378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65184843|NCT02770378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65184844|NCT02770378|Protease Inhibitors|protease inhibitors|mesh-ancestor
65184845|NCT02770378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184846|NCT02770378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184847|NCT02770378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65184848|NCT02770378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65184849|NCT02770378|Antiviral Agents|antiviral agents|mesh-ancestor
65184850|NCT02770378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65184851|NCT02770378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65184852|NCT02770378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65184853|NCT02770378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65184854|NCT02770378|Alkylating Agents|alkylating agents|mesh-ancestor
65184855|NCT02770378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184856|NCT02770378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65184857|NCT02770378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65184858|NCT02770378|Analgesics|analgesics|mesh-ancestor
65184859|NCT02770378|Sensory System Agents|sensory system agents|mesh-ancestor
65184860|NCT02770378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184861|NCT02770378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184862|NCT02770378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65184863|NCT02770378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65184864|NCT02770378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65184865|NCT02770378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65184866|NCT02770378|Antifungal Agents|antifungal agents|mesh-ancestor
65184867|NCT02770378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65184868|NCT02770378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65326419|NCT00586508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326420|NCT00586508|Growth Inhibitors|growth inhibitors|mesh-ancestor
65326421|NCT00581919|Acetylcarnitine|acetylcarnitine|mesh-list
65326422|NCT00581919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326423|NCT00581919|Vitamin B Complex|vitamin b complex|mesh-ancestor
65326424|NCT00581919|Vitamins|vitamins|mesh-ancestor
65326425|NCT00581919|Micronutrients|micronutrients|mesh-ancestor
65326426|NCT00581919|Nootropic Agents|nootropic agents|mesh-ancestor
65326427|NCT00723528|Ustekinumab|ustekinumab|mesh-list
65326428|NCT00723528|Dermatologic Agents|dermatologic agents|mesh-ancestor
65184869|NCT02770378|Hormone Antagonists|hormone antagonists|mesh-ancestor
65184870|NCT02770378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65184871|NCT02770378|Antidepressive Agents|antidepressive agents|mesh-ancestor
65184872|NCT02770378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65184873|NCT02770378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65184874|NCT02770378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65184875|NCT02770378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65184876|NCT02770378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65184877|NCT02770378|Serotonin Agents|serotonin agents|mesh-ancestor
65184878|NCT02770378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64827446|NCT01549600|Psyllium|psyllium|mesh-list
65184879|NCT02770378|Antiemetics|antiemetics|mesh-ancestor
65184880|NCT02770378|Autonomic Agents|autonomic agents|mesh-ancestor
65184881|NCT02770378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65184882|NCT02770378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65184883|NCT02770378|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65184884|NCT02770378|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65184885|NCT02770378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65184886|NCT02770378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65184887|NCT02770222|Rifampin|rifampin|mesh-list
65184888|NCT02770222|Selexipag|selexipag|mesh-list
65184889|NCT02770222|Gemfibrozil|gemfibrozil|mesh-list
65184890|NCT02770222|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65184897|NCT02770222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184898|NCT02770222|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65184899|NCT02770222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65184900|NCT02770222|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65184901|NCT02770222|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65184902|NCT02770222|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65184903|NCT02770222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65184904|NCT02770222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65184905|NCT02770222|Antimetabolites|antimetabolites|mesh-ancestor
65184906|NCT02770222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65184907|NCT02770222|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65184908|NCT02770222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65184909|NCT02770222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65184910|NCT00943917|Exenatide|exenatide|mesh-list
65184911|NCT00943917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65184912|NCT00943917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184913|NCT00943917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65184914|NCT00943917|Incretins|incretins|mesh-ancestor
65184915|NCT00943917|Hormones|hormones|mesh-ancestor
65184916|NCT00943917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65184917|NCT02769832|Gemcitabine|gemcitabine|mesh-list
65184918|NCT02769832|Paclitaxel|paclitaxel|mesh-list
65184919|NCT02769832|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65184920|NCT02769832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65184921|NCT02769832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184922|NCT02769832|Tubulin Modulators|tubulin modulators|mesh-ancestor
65184923|NCT02769832|Antimitotic Agents|antimitotic agents|mesh-ancestor
65184924|NCT02769832|Mitosis Modulators|mitosis modulators|mesh-ancestor
65184925|NCT02769832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184926|NCT02769832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65184927|NCT02769832|Antimetabolites|antimetabolites|mesh-ancestor
65184928|NCT02769832|Antiviral Agents|antiviral agents|mesh-ancestor
65326429|NCT02892123|Paclitaxel|paclitaxel|mesh-list
65326430|NCT02892123|Vinorelbine|vinorelbine|mesh-list
65326431|NCT02892123|Capecitabine|capecitabine|mesh-list
65326432|NCT02892123|Tucatinib|tucatinib|mesh-list
65326433|NCT02892123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65326434|NCT02892123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326435|NCT02892123|Tubulin Modulators|tubulin modulators|mesh-ancestor
64555967|NCT02243553|Anesthetics|anesthetics|mesh-ancestor
65184929|NCT02769832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65184930|NCT02769832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184931|NCT02769832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65184932|NCT02769832|Immunologic Factors|immunologic factors|mesh-ancestor
65184933|NCT02769832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184934|NCT02876250|Cyclosporine|cyclosporine|mesh-list
65184935|NCT02876250|Cyclosporins|cyclosporins|mesh-list
65184936|NCT02876250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184937|NCT02876250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184938|NCT02876250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65184939|NCT02876250|Immunologic Factors|immunologic factors|mesh-ancestor
65184940|NCT02876250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184941|NCT02876250|Antifungal Agents|antifungal agents|mesh-ancestor
65184942|NCT02876250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65184943|NCT02876250|Dermatologic Agents|dermatologic agents|mesh-ancestor
65184944|NCT02876250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65184945|NCT02876250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65184946|NCT02769910|Capsaicin|capsaicin|mesh-list
65184947|NCT02769910|Antipruritics|antipruritics|mesh-ancestor
65184948|NCT02769910|Dermatologic Agents|dermatologic agents|mesh-ancestor
65184949|NCT02769910|Sensory System Agents|sensory system agents|mesh-ancestor
65184950|NCT02769910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184951|NCT02769910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184952|NCT02876484|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
64827531|NCT01550146|BB 1101|bb 1101|mesh-list
65184953|NCT02876484|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65184954|NCT02876484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65184955|NCT02876484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65184956|NCT02876484|Antimetabolites|antimetabolites|mesh-ancestor
65184957|NCT02876484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184962|NCT02876094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65184963|NCT02876094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65184964|NCT02876094|Analgesics|analgesics|mesh-ancestor
65184965|NCT02876094|Sensory System Agents|sensory system agents|mesh-ancestor
65184966|NCT02876094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184967|NCT02876094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184968|NCT02876094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65184969|NCT02876094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65184970|NCT02876094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65184971|NCT02876094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65184972|NCT02876094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184973|NCT02876094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184974|NCT00603135|Levetiracetam|levetiracetam|mesh-list
65184975|NCT00603135|Anticonvulsants|anticonvulsants|mesh-ancestor
65184976|NCT00603135|Nootropic Agents|nootropic agents|mesh-ancestor
65184977|NCT02769286|Osimertinib|osimertinib|mesh-list
65184978|NCT02769286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184979|NCT02769286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65184980|NCT02769286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184981|NCT02769286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184982|NCT02855073|Hyaluronic Acid|hyaluronic acid|mesh-list
65184983|NCT02855073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65184984|NCT02855073|Immunologic Factors|immunologic factors|mesh-ancestor
65184985|NCT02855073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184986|NCT02855073|Viscosupplements|viscosupplements|mesh-ancestor
65184987|NCT02855073|Protective Agents|protective agents|mesh-ancestor
65184988|NCT02769130|Losartan|losartan|mesh-list
65184989|NCT02769130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65184990|NCT02769130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65184992|NCT02769130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65184993|NCT02769130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184994|NCT02768740|Hydrocortisone|hydrocortisone|mesh-list
65326436|NCT02892123|Antimitotic Agents|antimitotic agents|mesh-ancestor
65326437|NCT02892123|Mitosis Modulators|mitosis modulators|mesh-ancestor
65326438|NCT02892123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326439|NCT02892123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65184995|NCT02768740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65184996|NCT02768740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65184997|NCT02768740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65184998|NCT02768740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65184999|NCT02851095|Metformin|metformin|mesh-list
65185000|NCT02851095|Canagliflozin|canagliflozin|mesh-list
65185001|NCT02851095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65185002|NCT02851095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185003|NCT02851095|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65185004|NCT02851095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185005|NCT00580047|Calcium, Dietary|calcium, dietary|mesh-list
65185006|NCT00580047|Vitamin D|vitamin d|mesh-list
65185007|NCT00580047|Zoledronic Acid|zoledronic acid|mesh-list
65185008|NCT00580047|Alendronate|alendronate|mesh-list
65185009|NCT00580047|Calcium Carbonate|calcium carbonate|mesh-list
65185010|NCT00580047|Calcium|calcium|mesh-list
65185011|NCT00580047|Vitamins|vitamins|mesh-ancestor
65185012|NCT00580047|Micronutrients|micronutrients|mesh-ancestor
65185013|NCT00580047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185014|NCT00580047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65185015|NCT00580047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65185016|NCT00580047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185017|NCT00580047|Antacids|antacids|mesh-ancestor
65185018|NCT00580047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65185019|NCT01074450|Pramipexole|pramipexole|mesh-list
65185020|NCT01074450|Antioxidants|antioxidants|mesh-ancestor
65185021|NCT01074450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185022|NCT01074450|Protective Agents|protective agents|mesh-ancestor
65185023|NCT01074450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185024|NCT01074450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65185025|NCT01074450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64827597|NCT01550640|Remifentanil|remifentanil|mesh-list
65185026|NCT01074450|Dopamine Agonists|dopamine agonists|mesh-ancestor
65185027|NCT01074450|Dopamine Agents|dopamine agents|mesh-ancestor
65185028|NCT01074450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65185030|NCT02768116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65185031|NCT02768116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65185034|NCT02768116|Antifungal Agents|antifungal agents|mesh-ancestor
65185035|NCT02768116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65185036|NCT02768116|Immunologic Factors|immunologic factors|mesh-ancestor
65185037|NCT02768116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185038|NCT00635284|Sirolimus|sirolimus|mesh-list
65185039|NCT00635284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65185040|NCT00635284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65185041|NCT00635284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65185042|NCT00635284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185043|NCT00635284|Antifungal Agents|antifungal agents|mesh-ancestor
65185044|NCT00635284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65185045|NCT00635284|Immunologic Factors|immunologic factors|mesh-ancestor
65185046|NCT00635284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185047|NCT00699049|Solifenacin Succinate|solifenacin succinate|mesh-list
65185048|NCT00699049|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
65185049|NCT00699049|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65185050|NCT00699049|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65185051|NCT00699049|Cholinergic Agents|cholinergic agents|mesh-ancestor
65185052|NCT00699049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65185053|NCT00699049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185054|NCT00699049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185055|NCT00699049|Urological Agents|urological agents|mesh-ancestor
65185056|NCT00699049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65185057|NCT00699049|Adrenergic Agents|adrenergic agents|mesh-ancestor
65185058|NCT04131283|Epinephrine|epinephrine|mesh-list
65185059|NCT04131283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65185060|NCT04131283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65185061|NCT04131283|Adrenergic Agents|adrenergic agents|mesh-ancestor
65185062|NCT04131283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65185063|NCT04131283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326440|NCT02892123|Antimetabolites|antimetabolites|mesh-ancestor
65326441|NCT02892123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65326442|NCT02892123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326443|NCT00751790|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65326444|NCT00751790|Luteolytic Agents|luteolytic agents|mesh-ancestor
65326445|NCT00751790|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65326446|NCT00751790|Contraceptive Agents|contraceptive agents|mesh-ancestor
65326447|NCT00751790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65326448|NCT00751790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326449|NCT00751790|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64490602|NCT03420963|Etoposide|etoposide|mesh-list
65185064|NCT04131283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185065|NCT04131283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65185066|NCT04131283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65185067|NCT04131283|Autonomic Agents|autonomic agents|mesh-ancestor
65185068|NCT04131283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65185069|NCT04131283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65185070|NCT04131283|Respiratory System Agents|respiratory system agents|mesh-ancestor
65185071|NCT04131283|Mydriatics|mydriatics|mesh-ancestor
65185072|NCT04131283|Sympathomimetics|sympathomimetics|mesh-ancestor
65185073|NCT04131283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65185074|NCT00943761|Interferons|interferons|mesh-list
65185075|NCT00943761|Ribavirin|ribavirin|mesh-list
65185076|NCT00943761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185077|NCT00943761|Antiviral Agents|antiviral agents|mesh-ancestor
65185078|NCT00943761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65185079|NCT00943761|Antimetabolites|antimetabolites|mesh-ancestor
65185080|NCT00943761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185081|NCT02617771|Vitamin D|vitamin d|mesh-list
65185082|NCT02617771|Cholecalciferol|cholecalciferol|mesh-list
65185083|NCT02617771|Vitamins|vitamins|mesh-ancestor
65185084|NCT02617771|Micronutrients|micronutrients|mesh-ancestor
65185085|NCT02617771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185086|NCT02617771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65185087|NCT02617771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65185088|NCT02696590|Vitamin D|vitamin d|mesh-list
65185089|NCT02696590|Cholecalciferol|cholecalciferol|mesh-list
65185090|NCT02696590|Vitamins|vitamins|mesh-ancestor
65185091|NCT02696590|Micronutrients|micronutrients|mesh-ancestor
65185092|NCT02696590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185093|NCT02696590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65185094|NCT02696590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65185095|NCT02617459|Betaxolol|betaxolol|mesh-list
65185096|NCT02617459|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65185097|NCT02617459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65185098|NCT02617459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65185099|NCT02617459|Sympatholytics|sympatholytics|mesh-ancestor
65185100|NCT02617459|Autonomic Agents|autonomic agents|mesh-ancestor
65185101|NCT02617459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65185102|NCT02617459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185103|NCT02617459|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65185104|NCT02617459|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65185105|NCT02617459|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65185112|NCT02854995|Hormones|hormones|mesh-ancestor
65185113|NCT02854995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65185114|NCT02854995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185115|NCT02696512|Thioctic Acid|thioctic acid|mesh-list
65185116|NCT02696512|Minocycline|minocycline|mesh-list
65185117|NCT02696512|Lamotrigine|lamotrigine|mesh-list
65185118|NCT02696512|Flumazenil|flumazenil|mesh-list
65185119|NCT02696512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65185120|NCT02696512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65185121|NCT02696512|Anticonvulsants|anticonvulsants|mesh-ancestor
65185122|NCT02696512|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65185123|NCT02696512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65326450|NCT00751790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65326451|NCT00751790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326452|NCT04020536|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65326453|NCT04020536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65326454|NCT00916760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65185124|NCT02696512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185125|NCT02696512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65185126|NCT02696512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185127|NCT02696512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65185128|NCT02696512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65185129|NCT02696512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65185130|NCT02696512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65185131|NCT02696512|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65185132|NCT02696512|Antioxidants|antioxidants|mesh-ancestor
65185133|NCT02696512|Protective Agents|protective agents|mesh-ancestor
65185134|NCT02696512|Vitamin B Complex|vitamin b complex|mesh-ancestor
65185135|NCT02696512|Vitamins|vitamins|mesh-ancestor
65185136|NCT02696512|Micronutrients|micronutrients|mesh-ancestor
65185137|NCT02696512|Antidotes|antidotes|mesh-ancestor
65185138|NCT02696512|GABA Modulators|gaba modulators|mesh-ancestor
65185139|NCT02696512|GABA Agents|gaba agents|mesh-ancestor
65185140|NCT02696512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65185141|NCT00949533|Oseltamivir|oseltamivir|mesh-list
65185142|NCT00949533|Antiviral Agents|antiviral agents|mesh-ancestor
65185143|NCT00949533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65185144|NCT00949533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65185145|NCT00949533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185146|NCT02767258|Lubricant Eye Drops|lubricant eye drops|mesh-list
65185147|NCT02767258|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65185148|NCT02767258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65185149|NCT02854761|Vitamin D|vitamin d|mesh-list
65185150|NCT02854761|Vitamins|vitamins|mesh-ancestor
65185151|NCT02854761|Micronutrients|micronutrients|mesh-ancestor
65185152|NCT02854761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185153|NCT02854761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65185154|NCT00866047|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65185155|NCT00866047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65185156|NCT00866047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185157|NCT01706692|Cyclosporine|cyclosporine|mesh-list
65185158|NCT01706692|Adalimumab|adalimumab|mesh-list
65185159|NCT01706692|Etanercept|etanercept|mesh-list
65185160|NCT01706692|Methotrexate|methotrexate|mesh-list
65185161|NCT01706692|Infliximab|infliximab|mesh-list
65185162|NCT01706692|Ustekinumab|ustekinumab|mesh-list
65185163|NCT01706692|Cyclosporins|cyclosporins|mesh-list
65185164|NCT01706692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65185165|NCT01706692|Abortifacient Agents|abortifacient agents|mesh-ancestor
65185166|NCT01706692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65185167|NCT01706692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185168|NCT01706692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65185169|NCT01706692|Antimetabolites|antimetabolites|mesh-ancestor
65185170|NCT01706692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185171|NCT01706692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185172|NCT01706692|Dermatologic Agents|dermatologic agents|mesh-ancestor
65185173|NCT01706692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65185174|NCT01706692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65185175|NCT01706692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65185176|NCT01706692|Immunologic Factors|immunologic factors|mesh-ancestor
65185177|NCT01706692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65185185|NCT01706692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65185186|NCT01706692|Analgesics|analgesics|mesh-ancestor
65185187|NCT01706692|Sensory System Agents|sensory system agents|mesh-ancestor
65185188|NCT01706692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65185189|NCT00869323|Rituximab|rituximab|mesh-list
65185190|NCT00869323|Bortezomib|bortezomib|mesh-list
65185191|NCT00869323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65185192|NCT00869323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185193|NCT00869323|Immunologic Factors|immunologic factors|mesh-ancestor
65185194|NCT00869323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185195|NCT00869323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65185196|NCT02767102|Melatonin|melatonin|mesh-list
65185197|NCT02767102|Antioxidants|antioxidants|mesh-ancestor
65185198|NCT02767102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326455|NCT00916760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65326456|NCT00916760|Immunologic Factors|immunologic factors|mesh-ancestor
65326457|NCT00916760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326458|NCT00916760|Antacids|antacids|mesh-ancestor
65326459|NCT00916760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326460|NCT00916760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65326461|NCT05442554|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65326462|NCT05442554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65326463|NCT05442554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326464|NCT00723450|Lamotrigine|lamotrigine|mesh-list
65326465|NCT00723450|Anticonvulsants|anticonvulsants|mesh-ancestor
65326466|NCT00723450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65326467|NCT00723450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65326468|NCT00723450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326469|NCT00723450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65326470|NCT00723450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326471|NCT00723450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65326472|NCT00723450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65185199|NCT02767102|Protective Agents|protective agents|mesh-ancestor
65185200|NCT02767102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185201|NCT02767102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65185202|NCT02774902|Clarithromycin|clarithromycin|mesh-list
65185203|NCT02774902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65185204|NCT02774902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65185205|NCT02774902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65185206|NCT02774902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65185207|NCT02774902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185208|NCT02774902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65185209|NCT02774902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65185210|NCT02767024|Nitroprusside|nitroprusside|mesh-list
65185211|NCT02767024|Dobutamine|dobutamine|mesh-list
65185212|NCT02767024|Furosemide|furosemide|mesh-list
65185213|NCT02767024|Diuretics|diuretics|mesh-ancestor
65185214|NCT02767024|Natriuretic Agents|natriuretic agents|mesh-ancestor
65185215|NCT02767024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185216|NCT02767024|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65185217|NCT02767024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65185218|NCT02767024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185219|NCT02767024|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65185220|NCT02767024|Sympathomimetics|sympathomimetics|mesh-ancestor
65185221|NCT02767024|Autonomic Agents|autonomic agents|mesh-ancestor
65185222|NCT02767024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65185223|NCT02767024|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65185224|NCT02767024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65185225|NCT02767024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65185226|NCT02767024|Adrenergic Agents|adrenergic agents|mesh-ancestor
65185227|NCT02767024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65185228|NCT02767024|Protective Agents|protective agents|mesh-ancestor
65185229|NCT02767024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65185230|NCT02767024|Vasodilator Agents|vasodilator agents|mesh-ancestor
65185231|NCT02767024|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65185232|NCT02774200|Apatinib|apatinib|mesh-list
65185233|NCT02774200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185234|NCT02774200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65185235|NCT02774200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326473|NCT00723450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65326474|NCT00723450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65326475|NCT00723450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65326476|NCT02599532|Apixaban|apixaban|mesh-list
65326477|NCT02599532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65326478|NCT02599532|Antithrombins|antithrombins|mesh-ancestor
65326479|NCT02599532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65326480|NCT02599532|Protease Inhibitors|protease inhibitors|mesh-ancestor
65326481|NCT02599532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326482|NCT02599532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185236|NCT02774200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185237|NCT02766634|Lenograstim|lenograstim|mesh-list
65185238|NCT02766634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65185239|NCT02766634|Immunologic Factors|immunologic factors|mesh-ancestor
65185240|NCT02766634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185241|NCT02774044|Beractant|beractant|mesh-list
65185242|NCT02774044|Goat lung surfactant extract|goat lung surfactant extract|mesh-list
65185243|NCT02774044|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
65185244|NCT02774044|Respiratory System Agents|respiratory system agents|mesh-ancestor
65185251|NCT02766556|Analgesics|analgesics|mesh-ancestor
65185252|NCT02766556|Sensory System Agents|sensory system agents|mesh-ancestor
65185253|NCT02766556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65185254|NCT02766556|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65185255|NCT02766556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64827819|NCT01552018|Protease Inhibitors|protease inhibitors|mesh-ancestor
65185256|NCT02766556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65185257|NCT02766556|Adrenergic Agents|adrenergic agents|mesh-ancestor
65185258|NCT02766556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65185259|NCT02766556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185260|NCT02766556|Anesthetics, Local|anesthetics, local|mesh-ancestor
65185261|NCT02766556|Anesthetics|anesthetics|mesh-ancestor
65185262|NCT01191944|Pramipexole|pramipexole|mesh-list
65185263|NCT01191944|Antioxidants|antioxidants|mesh-ancestor
65185264|NCT01191944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185265|NCT01191944|Protective Agents|protective agents|mesh-ancestor
65185266|NCT01191944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185267|NCT01191944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65185268|NCT01191944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65185269|NCT01191944|Dopamine Agonists|dopamine agonists|mesh-ancestor
65185270|NCT01191944|Dopamine Agents|dopamine agents|mesh-ancestor
65185271|NCT01191944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65185272|NCT00940875|Gemcitabine|gemcitabine|mesh-list
65185273|NCT00940875|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65185274|NCT00940875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65185275|NCT00940875|Antimetabolites|antimetabolites|mesh-ancestor
65185276|NCT00940875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185277|NCT00940875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185278|NCT00940875|Antiviral Agents|antiviral agents|mesh-ancestor
65185279|NCT00940875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65185280|NCT00940875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65185281|NCT00940875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65185282|NCT00940875|Immunologic Factors|immunologic factors|mesh-ancestor
65185283|NCT00940875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185284|NCT00940875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65185285|NCT02766322|Ethanol|ethanol|mesh-list
65185286|NCT02766322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65185287|NCT02766322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65185288|NCT02766322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65185289|NCT02766322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185290|NCT05655728|Metformin|metformin|mesh-list
65185292|NCT05655728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185293|NCT00940485|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65185294|NCT00940485|Entecavir|entecavir|mesh-list
65185295|NCT00940485|Antiviral Agents|antiviral agents|mesh-ancestor
65185296|NCT00940485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65326483|NCT02599532|Anticoagulants|anticoagulants|mesh-ancestor
65326484|NCT04085094|Pilocarpine|pilocarpine|mesh-list
65326485|NCT04085094|Miotics|miotics|mesh-ancestor
65326486|NCT04085094|Autonomic Agents|autonomic agents|mesh-ancestor
65326487|NCT04085094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65326488|NCT04085094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326489|NCT04085094|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65326490|NCT04085094|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65185297|NCT04317248|Cyclophosphamide|cyclophosphamide|mesh-list
65185298|NCT04317248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65185299|NCT04317248|Immunologic Factors|immunologic factors|mesh-ancestor
65185300|NCT04317248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185301|NCT04317248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65185302|NCT04317248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65185303|NCT04317248|Alkylating Agents|alkylating agents|mesh-ancestor
65185304|NCT04317248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185305|NCT04317248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185306|NCT04317248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65185307|NCT05655338|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65185308|NCT05655338|Amoxicillin|amoxicillin|mesh-list
65185309|NCT05655338|Metronidazole|metronidazole|mesh-list
65185310|NCT05655338|Anti-Infective Agents|anti-infective agents|mesh-list
65185311|NCT05655338|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65185312|NCT05655338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65185313|NCT01132313|Ribavirin|ribavirin|mesh-list
65185314|NCT01132313|Antimetabolites|antimetabolites|mesh-ancestor
65185320|NCT05658146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65185321|NCT00422565|Sirolimus|sirolimus|mesh-list
65185322|NCT00422565|Paclitaxel|paclitaxel|mesh-list
65185323|NCT00422565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65185324|NCT00422565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185325|NCT00422565|Tubulin Modulators|tubulin modulators|mesh-ancestor
65185326|NCT00422565|Antimitotic Agents|antimitotic agents|mesh-ancestor
65185327|NCT00422565|Mitosis Modulators|mitosis modulators|mesh-ancestor
65185328|NCT00422565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185329|NCT00422565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65185330|NCT00422565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65185331|NCT00422565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64827903|NCT01552798|Antipyretics|antipyretics|mesh-ancestor
65185332|NCT00422565|Antifungal Agents|antifungal agents|mesh-ancestor
65185333|NCT00422565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65185334|NCT00422565|Immunologic Factors|immunologic factors|mesh-ancestor
65185335|NCT00422565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185336|NCT04316936|Dexamethasone|dexamethasone|mesh-list
65185337|NCT04316936|Prednisolone|prednisolone|mesh-list
65185338|NCT04316936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65185339|NCT04316936|Methylprednisolone|methylprednisolone|mesh-list
65185340|NCT04316936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65185341|NCT04316936|Prednisolone acetate|prednisolone acetate|mesh-list
65185342|NCT04316936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65185343|NCT04316936|Prednisolone phosphate|prednisolone phosphate|mesh-list
65185344|NCT04316936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65185345|NCT04316936|Antiemetics|antiemetics|mesh-ancestor
65185346|NCT04316936|Autonomic Agents|autonomic agents|mesh-ancestor
65185347|NCT04316936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65185348|NCT04316936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185349|NCT04316936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65185350|NCT04316936|Glucocorticoids|glucocorticoids|mesh-ancestor
65185351|NCT04316936|Hormones|hormones|mesh-ancestor
65185352|NCT04316936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65185353|NCT04316936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65185354|NCT04316936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185355|NCT04316936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65185356|NCT04316936|Protective Agents|protective agents|mesh-ancestor
65185357|NCT00861757|Tadalafil|tadalafil|mesh-list
65185358|NCT00861757|Tamsulosin|tamsulosin|mesh-list
65185359|NCT00861757|Vasodilator Agents|vasodilator agents|mesh-ancestor
65185360|NCT00861757|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65185361|NCT00861757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65185362|NCT00861757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326491|NCT04085094|Cholinergic Agents|cholinergic agents|mesh-ancestor
65326492|NCT04085094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65326493|NCT04085094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326494|NCT00751400|Naproxen|naproxen|mesh-list
65326495|NCT00751400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65326496|NCT00751400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65326497|NCT00751400|Analgesics|analgesics|mesh-ancestor
65326498|NCT00751400|Sensory System Agents|sensory system agents|mesh-ancestor
65185363|NCT00861757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185364|NCT00861757|Urological Agents|urological agents|mesh-ancestor
65185365|NCT00861757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65185367|NCT00861757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65185368|NCT00861757|Adrenergic Agents|adrenergic agents|mesh-ancestor
65185369|NCT00861757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65185370|NCT00861757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185371|NCT02762812|Infliximab|infliximab|mesh-list
65185372|NCT02762812|Dermatologic Agents|dermatologic agents|mesh-ancestor
65185373|NCT02762812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65185374|NCT02762812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65185376|NCT02762890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65185377|NCT02762890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65185378|NCT02762890|Trace Elements|trace elements|mesh-ancestor
65185379|NCT02762890|Micronutrients|micronutrients|mesh-ancestor
65185380|NCT02762890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185381|NCT02613715|Ethanol|ethanol|mesh-list
65185382|NCT02613715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65185383|NCT02613715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65185384|NCT02613715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65185385|NCT02613715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185392|NCT02762656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65185393|NCT02762656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65185394|NCT02762656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65185395|NCT02762656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65185396|NCT02762656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65185397|NCT02762656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185398|NCT00637325|Trastuzumab|trastuzumab|mesh-list
65185399|NCT00637325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65185400|NCT00637325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185402|NCT02762344|Anticoagulants|anticoagulants|mesh-ancestor
65185403|NCT02762344|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65185404|NCT02762344|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65185405|NCT02762344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185406|NCT04663282|Insulin|insulin|mesh-list
65185407|NCT04663282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65185408|NCT04663282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185409|NCT01130597|Spironolactone|spironolactone|mesh-list
65185410|NCT01130597|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65185411|NCT01130597|Hormone Antagonists|hormone antagonists|mesh-ancestor
65185412|NCT01130597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65185413|NCT01130597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185414|NCT01130597|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65185415|NCT01130597|Diuretics|diuretics|mesh-ancestor
65185416|NCT01130597|Natriuretic Agents|natriuretic agents|mesh-ancestor
65185417|NCT00939003|Adalimumab|adalimumab|mesh-list
65185418|NCT00939003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65185419|NCT00939003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65185420|NCT01188668|Aripiprazole|aripiprazole|mesh-list
65185421|NCT01188668|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65185422|NCT01188668|Antidepressive Agents|antidepressive agents|mesh-ancestor
65185423|NCT01188668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65185424|NCT01188668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65185425|NCT01188668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65185426|NCT01188668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65185427|NCT01188668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185428|NCT01188668|Dopamine Agonists|dopamine agonists|mesh-ancestor
65326499|NCT00751400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65326500|NCT00751400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326501|NCT00751400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65326502|NCT00751400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65326503|NCT00751400|Gout Suppressants|gout suppressants|mesh-ancestor
64556029|NCT05006664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65185429|NCT01188668|Dopamine Agents|dopamine agents|mesh-ancestor
65185430|NCT01188668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65185431|NCT01188668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185432|NCT01188668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65185433|NCT01188668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65185434|NCT01188668|Serotonin Agents|serotonin agents|mesh-ancestor
65185435|NCT01188668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65185436|NCT01188668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65185437|NCT01188668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65185438|NCT01188668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64500204|NCT01447888|Narcotics|narcotics|mesh-ancestor
65185439|NCT01188668|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65185440|NCT01188668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65185441|NCT01188668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65185443|NCT01130051|Gout Suppressants|gout suppressants|mesh-ancestor
65185444|NCT01130051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65185445|NCT01130051|Tubulin Modulators|tubulin modulators|mesh-ancestor
65185446|NCT01130051|Antimitotic Agents|antimitotic agents|mesh-ancestor
65185447|NCT01130051|Mitosis Modulators|mitosis modulators|mesh-ancestor
65185448|NCT01130051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185449|NCT01130051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185450|NCT00865189|Leucovorin|leucovorin|mesh-list
65185451|NCT00865189|Folic Acid|folic acid|mesh-list
65185452|NCT00865189|Bevacizumab|bevacizumab|mesh-list
65185453|NCT00865189|Fluorouracil|fluorouracil|mesh-list
65185459|NCT00865189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65185460|NCT00865189|Growth Substances|growth substances|mesh-ancestor
65185461|NCT00865189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185462|NCT00865189|Growth Inhibitors|growth inhibitors|mesh-ancestor
65185463|NCT00865189|Antimetabolites|antimetabolites|mesh-ancestor
65185464|NCT00865189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185465|NCT00865189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65185466|NCT00865189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65185467|NCT00865189|Immunologic Factors|immunologic factors|mesh-ancestor
65185468|NCT00865189|Antidotes|antidotes|mesh-ancestor
65185469|NCT00865189|Protective Agents|protective agents|mesh-ancestor
65185470|NCT00865189|Vitamin B Complex|vitamin b complex|mesh-ancestor
65185472|NCT00865189|Micronutrients|micronutrients|mesh-ancestor
65185473|NCT00865189|Hematinics|hematinics|mesh-ancestor
65185474|NCT05362292|Mirabegron|mirabegron|mesh-list
65185475|NCT05362292|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65185476|NCT05362292|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65185477|NCT05362292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65185478|NCT05362292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65185479|NCT05362292|Adrenergic Agents|adrenergic agents|mesh-ancestor
65185480|NCT05362292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65185481|NCT05362292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185482|NCT05362292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185484|NCT05362292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65185485|NCT05362292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65185486|NCT05362292|Cholinergic Agents|cholinergic agents|mesh-ancestor
65185487|NCT00698269|Insulin|insulin|mesh-list
65185488|NCT00698269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65185489|NCT00698269|Insulin Aspart|insulin aspart|mesh-list
65185490|NCT00698269|Insulin, Long-Acting|insulin, long-acting|mesh-list
65185491|NCT00698269|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65185492|NCT00698269|Insulin Detemir|insulin detemir|mesh-list
65185493|NCT00698269|Biphasic Insulins|biphasic insulins|mesh-list
65185494|NCT00698269|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65185495|NCT00698269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65185496|NCT00698269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185497|NCT01182194|Drospirenone|drospirenone|mesh-list
65326504|NCT00751400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65326505|NCT00751400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326506|NCT00751400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326507|NCT05420948|Paclitaxel|paclitaxel|mesh-list
65326508|NCT05420948|Carboplatin|carboplatin|mesh-list
65326509|NCT05420948|Pembrolizumab|pembrolizumab|mesh-list
64556037|NCT04346901|Methimazole|methimazole|mesh-list
65185498|NCT01182194|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65185499|NCT01182194|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65185500|NCT01182194|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65185501|NCT01182194|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65185502|NCT01182194|Estradiol|estradiol|mesh-list
65185503|NCT01182194|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65185504|NCT01182194|Estrogens|estrogens|mesh-ancestor
65185505|NCT01182194|Hormones|hormones|mesh-ancestor
65185506|NCT01182194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65185507|NCT01182194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185508|NCT01182194|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65185509|NCT01182194|Contraceptive Agents|contraceptive agents|mesh-ancestor
65185510|NCT01182194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65185511|NCT01182194|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65185512|NCT01182194|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65185513|NCT01182194|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65185514|NCT01182194|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65185516|NCT01182194|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65185517|NCT01182194|Diuretics|diuretics|mesh-ancestor
65185518|NCT01182194|Natriuretic Agents|natriuretic agents|mesh-ancestor
65185519|NCT01181726|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65185520|NCT01181726|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65185521|NCT01181726|Norethindrone|norethindrone|mesh-list
65185522|NCT01181726|Norethindrone Acetate|norethindrone acetate|mesh-list
65185523|NCT01181726|Estradiol|estradiol|mesh-list
65185524|NCT01181726|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65185525|NCT01181726|Estrogens|estrogens|mesh-ancestor
65185526|NCT01181726|Hormones|hormones|mesh-ancestor
65185531|NCT01181726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65185532|NCT01181726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65185533|NCT01181726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65185534|NCT01181726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65185535|NCT01181726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65185536|NCT01137071|Antibodies|antibodies|mesh-list
65185537|NCT01137071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65185538|NCT01137071|Immunologic Factors|immunologic factors|mesh-ancestor
65185539|NCT01137071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185540|NCT00603759|Celecoxib|celecoxib|mesh-list
65185541|NCT00603759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65185542|NCT00603759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65185543|NCT00603759|Analgesics|analgesics|mesh-ancestor
65185544|NCT00603759|Sensory System Agents|sensory system agents|mesh-ancestor
65185545|NCT00603759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65185546|NCT00603759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185547|NCT00603759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65185548|NCT00603759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65185549|NCT00603759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65185550|NCT00603759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65185551|NCT00603759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65185552|NCT00603759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185553|NCT04130815|Furosemide|furosemide|mesh-list
65185554|NCT04130815|Diuretics|diuretics|mesh-ancestor
65185555|NCT04130815|Natriuretic Agents|natriuretic agents|mesh-ancestor
65185556|NCT04130815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185557|NCT04130815|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65185558|NCT04130815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65185559|NCT04130815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185560|NCT04256265|Risdiplam|risdiplam|mesh-list
65185561|NCT04256265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65185562|NCT04256265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65185563|NCT04256265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185564|NCT04312061|Tramadol|tramadol|mesh-list
65326510|NCT05420948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65326511|NCT05420948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326512|NCT05420948|Tubulin Modulators|tubulin modulators|mesh-ancestor
65326513|NCT05420948|Antimitotic Agents|antimitotic agents|mesh-ancestor
65326514|NCT05420948|Mitosis Modulators|mitosis modulators|mesh-ancestor
65326515|NCT05420948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326516|NCT05420948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65326517|NCT00585312|Celecoxib|celecoxib|mesh-list
65326518|NCT00585312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65185565|NCT04312061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65185566|NCT04312061|Narcotics|narcotics|mesh-ancestor
65185567|NCT04312061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65185568|NCT04312061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185569|NCT04312061|Analgesics|analgesics|mesh-ancestor
65185570|NCT04312061|Sensory System Agents|sensory system agents|mesh-ancestor
65185571|NCT04312061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65185572|NCT00860743|Antioxidants|antioxidants|mesh-list
65185573|NCT00860743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185574|NCT00860743|Protective Agents|protective agents|mesh-ancestor
65185575|NCT00860743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185576|NCT01186796|Fulvestrant|fulvestrant|mesh-list
65185577|NCT01186796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65185578|NCT01186796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185579|NCT01186796|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65185580|NCT01186796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65185581|NCT01186796|Hormone Antagonists|hormone antagonists|mesh-ancestor
65185582|NCT01186796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65185583|NCT01186796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185584|NCT05383131|Pirfenidone|pirfenidone|mesh-list
65185585|NCT05383131|Nintedanib|nintedanib|mesh-list
65185586|NCT05383131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185587|NCT05383131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65185588|NCT05383131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65185589|NCT05383131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185591|NCT05383131|Sensory System Agents|sensory system agents|mesh-ancestor
65185592|NCT05383131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65185593|NCT05383131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185594|NCT05383131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65185599|NCT02761486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65185600|NCT02761486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65185602|NCT02761486|Sensory System Agents|sensory system agents|mesh-ancestor
65185603|NCT02761486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65185604|NCT02761486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185605|NCT02761486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65185606|NCT02761486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65185607|NCT02761486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65185608|NCT02761486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65185609|NCT02761486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185610|NCT02761486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65185611|NCT02761486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65185612|NCT02761486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65185613|NCT02761486|Antipyretics|antipyretics|mesh-ancestor
65185614|NCT02882789|Delpazolid|delpazolid|mesh-list
65185615|NCT02882789|Oxazolidinones|oxazolidinones|mesh-list
65185616|NCT02882789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65185617|NCT02882789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65185618|NCT02882789|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65185619|NCT02882789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65185620|NCT02882789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185621|NCT00940017|Voriconazole|voriconazole|mesh-list
65185622|NCT00940017|Anidulafungin|anidulafungin|mesh-list
65185623|NCT00940017|Antifungal Agents|antifungal agents|mesh-ancestor
65185624|NCT00940017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65326519|NCT00585312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65326520|NCT00585312|Analgesics|analgesics|mesh-ancestor
65326521|NCT00585312|Sensory System Agents|sensory system agents|mesh-ancestor
65326522|NCT00585312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65326523|NCT00585312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326524|NCT00585312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65326525|NCT00585312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65326526|NCT00585312|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65326527|NCT00585312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65326528|NCT00585312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326529|NCT00585312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185625|NCT00940017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65185626|NCT00940017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65185627|NCT00940017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65185628|NCT00940017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185629|NCT00940017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65185630|NCT00940017|Hormone Antagonists|hormone antagonists|mesh-ancestor
65185631|NCT00940017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65185632|NCT00940017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185633|NCT00940017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65185634|NCT01129583|Botulinum Toxins|botulinum toxins|mesh-list
65185635|NCT01129583|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65185636|NCT01129583|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65185637|NCT01129583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65185638|NCT01129583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65185639|NCT01129583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185640|NCT01129583|Cholinergic Agents|cholinergic agents|mesh-ancestor
65185641|NCT01129583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65185642|NCT01129583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185643|NCT01129583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65185644|NCT01129583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65185646|NCT01186328|Prednisone|prednisone|mesh-list
65185647|NCT01186328|Hydrocortisone|hydrocortisone|mesh-list
65185648|NCT01186328|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65185649|NCT01186328|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65185650|NCT01186328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65185651|NCT01186328|Cortisone|cortisone|mesh-list
65185652|NCT01186328|Doxorubicin|doxorubicin|mesh-list
65185653|NCT01186328|Methotrexate|methotrexate|mesh-list
65185654|NCT01186328|Vincristine|vincristine|mesh-list
65185655|NCT01186328|Asparaginase|asparaginase|mesh-list
65185656|NCT01186328|Pegaspargase|pegaspargase|mesh-list
65185657|NCT01186328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65185658|NCT01186328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185659|NCT01186328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65185660|NCT01186328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65185661|NCT01186328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65185662|NCT01186328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185663|NCT01186328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65185665|NCT01186328|Hormones|hormones|mesh-ancestor
65185666|NCT01186328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65185669|NCT01186328|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65185670|NCT01186328|Abortifacient Agents|abortifacient agents|mesh-ancestor
65185671|NCT01186328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65185672|NCT01186328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65185673|NCT01186328|Antimetabolites|antimetabolites|mesh-ancestor
65185674|NCT01186328|Dermatologic Agents|dermatologic agents|mesh-ancestor
65185675|NCT01186328|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65185676|NCT01186328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65185677|NCT01186328|Immunologic Factors|immunologic factors|mesh-ancestor
65185678|NCT01186328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65326530|NCT00753506|Artemisinins|artemisinins|mesh-list
65326531|NCT00753506|Artemisinin|artemisinin|mesh-list
65326532|NCT00753506|Antimalarials|antimalarials|mesh-ancestor
65326533|NCT00753506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65326534|NCT00753506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65326535|NCT00753506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65326536|NCT00720096|Doxorubicin|doxorubicin|mesh-list
65326537|NCT00720096|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65326538|NCT00720096|Topotecan|topotecan|mesh-list
65326539|NCT00720096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65326540|NCT00720096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326541|NCT00720096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64556058|NCT02245269|Tipranavir|tipranavir|mesh-list
65185679|NCT01186328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65185680|NCT01186328|Antiviral Agents|antiviral agents|mesh-ancestor
65185681|NCT01186328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65185682|NCT01186328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65185683|NCT01186328|Tubulin Modulators|tubulin modulators|mesh-ancestor
65185684|NCT01186328|Antimitotic Agents|antimitotic agents|mesh-ancestor
65185685|NCT01186328|Mitosis Modulators|mitosis modulators|mesh-ancestor
65185686|NCT00848497|Methyltestosterone|methyltestosterone|mesh-list
65185687|NCT00848497|Sildenafil Citrate|sildenafil citrate|mesh-list
65185688|NCT00848497|Testosterone|testosterone|mesh-list
65185689|NCT00848497|Testosterone undecanoate|testosterone undecanoate|mesh-list
65185690|NCT00848497|Testosterone enanthate|testosterone enanthate|mesh-list
65185691|NCT00848497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65185692|NCT00848497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185693|NCT00848497|Androgens|androgens|mesh-ancestor
65185694|NCT00848497|Hormones|hormones|mesh-ancestor
65185695|NCT00848497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65185696|NCT00848497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185697|NCT00848497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65185698|NCT00848497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185699|NCT00848497|Anabolic Agents|anabolic agents|mesh-ancestor
65185700|NCT00848497|Vasodilator Agents|vasodilator agents|mesh-ancestor
65185701|NCT00848497|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65185702|NCT00848497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65185703|NCT00848497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65185704|NCT00848497|Urological Agents|urological agents|mesh-ancestor
65185705|NCT02763592|Lidocaine|lidocaine|mesh-list
65185706|NCT02763592|Anesthetics, Local|anesthetics, local|mesh-ancestor
65185707|NCT02763592|Anesthetics|anesthetics|mesh-ancestor
65185708|NCT02763592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65185709|NCT02763592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185710|NCT02763592|Sensory System Agents|sensory system agents|mesh-ancestor
65185711|NCT02763592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65185712|NCT02763592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65185713|NCT02763592|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65185714|NCT02763592|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65185715|NCT02763592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65185716|NCT02763592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185717|NCT01185782|Gonadotropins, Pituitary|gonadotropins, pituitary|mesh-list
65185718|NCT01185782|Hormones|hormones|mesh-list
65185719|NCT01185782|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65185720|NCT01185782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65185721|NCT01185782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185722|NCT01185782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65185723|NCT01185782|Fertility Agents|fertility agents|mesh-ancestor
65185724|NCT01185782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65185725|NCT01185782|Fertility Agents, Male|fertility agents, male|mesh-ancestor
65185726|NCT02761174|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65185727|NCT02761174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65185728|NCT02761174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65326542|NCT00720096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65326543|NCT00720096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326544|NCT00720096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326545|NCT00720096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65326546|NCT04086108|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
65326547|NCT04086108|GABA Agents|gaba agents|mesh-ancestor
65326548|NCT04086108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64556070|NCT02245269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65185729|NCT02761174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65185730|NCT02761174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65185731|NCT02761174|Adrenergic Agents|adrenergic agents|mesh-ancestor
65185732|NCT02761174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65185733|NCT02761174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185734|NCT02761174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185735|NCT02882555|Capsaicin|capsaicin|mesh-list
65185736|NCT02882555|Antipruritics|antipruritics|mesh-ancestor
65185737|NCT02882555|Dermatologic Agents|dermatologic agents|mesh-ancestor
65185743|NCT00699361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65185744|NCT00699361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65185745|NCT00699361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65185746|NCT00699361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185747|NCT01185704|Cetrorelix|cetrorelix|mesh-list
65185748|NCT01185704|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65185749|NCT01185704|Hormones|hormones|mesh-list
65185750|NCT01185704|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65185751|NCT01185704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65185752|NCT01185704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185753|NCT01185704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65185754|NCT01185704|Fertility Agents|fertility agents|mesh-ancestor
65185755|NCT01185704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65185756|NCT01185704|Hormone Antagonists|hormone antagonists|mesh-ancestor
65185757|NCT01128959|Carbamazepine|carbamazepine|mesh-list
65185758|NCT01128959|Anticonvulsants|anticonvulsants|mesh-ancestor
65185759|NCT01128959|Antimanic Agents|antimanic agents|mesh-ancestor
65185760|NCT01128959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65185761|NCT01128959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65185762|NCT01128959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185763|NCT01128959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65185764|NCT01128959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65185765|NCT01128959|Analgesics|analgesics|mesh-ancestor
65185766|NCT01128959|Sensory System Agents|sensory system agents|mesh-ancestor
65185767|NCT01128959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65185768|NCT01128959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65185769|NCT01128959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65185770|NCT01128959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185771|NCT01128959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65185772|NCT01128959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65185773|NCT04119739|Ibuprofen|ibuprofen|mesh-list
65185774|NCT04119739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65185775|NCT04119739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64828348|NCT01556334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65185776|NCT04119739|Analgesics|analgesics|mesh-ancestor
65185777|NCT04119739|Sensory System Agents|sensory system agents|mesh-ancestor
65185778|NCT04119739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65185779|NCT04119739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185780|NCT04119739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65185781|NCT04119739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65185782|NCT04119739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65185783|NCT04119739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65185784|NCT04119739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185785|NCT00859573|Modafinil|modafinil|mesh-list
65185786|NCT00859573|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65185787|NCT00859573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185788|NCT00859573|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65185789|NCT00859573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65326549|NCT04086108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326550|NCT04086108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326551|NCT02577783|Dexamethasone|dexamethasone|mesh-list
65326552|NCT02577783|Dexamethasone acetate|dexamethasone acetate|mesh-list
65326553|NCT02577783|Doxorubicin|doxorubicin|mesh-list
65326554|NCT02577783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65326555|NCT02577783|BB 1101|bb 1101|mesh-list
65326556|NCT02577783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65326557|NCT02577783|Antiemetics|antiemetics|mesh-ancestor
64556076|NCT04364139|Metoprolol|metoprolol|mesh-list
65185790|NCT00859573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65185791|NCT00859573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185792|NCT02758444|Micronutrients|micronutrients|mesh-list
65185793|NCT02758444|Trace Elements|trace elements|mesh-list
65185794|NCT02758444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185795|NCT01185548|Tolbutamide|tolbutamide|mesh-list
65185796|NCT01185548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65185797|NCT01185548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185798|NCT01128569|Fluticasone|fluticasone|mesh-list
65185799|NCT01128569|Xhance|xhance|mesh-list
65185800|NCT01128569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65185801|NCT01128569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65185802|NCT01128569|Autonomic Agents|autonomic agents|mesh-ancestor
65185803|NCT01128569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65185804|NCT01128569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185805|NCT01128569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65185813|NCT02883179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65185815|NCT02883179|Anesthetics|anesthetics|mesh-ancestor
65185816|NCT02883179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65185817|NCT02883179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185818|NCT02883179|Sensory System Agents|sensory system agents|mesh-ancestor
65185819|NCT02883179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65185820|NCT02883179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65185821|NCT02883179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65185822|NCT02883179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65185823|NCT02883179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65185824|NCT02883179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185825|NCT02883179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65185826|NCT02758366|Doxorubicin|doxorubicin|mesh-list
65185827|NCT02758366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65185828|NCT02758366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185829|NCT02758366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65185830|NCT02758366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65185831|NCT02758366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65185832|NCT02758366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185833|NCT04577326|Cyclophosphamide|cyclophosphamide|mesh-list
65185834|NCT04577326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65185835|NCT04577326|Immunologic Factors|immunologic factors|mesh-ancestor
65185836|NCT04577326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185837|NCT04577326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65185838|NCT04577326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65185839|NCT04577326|Alkylating Agents|alkylating agents|mesh-ancestor
65185840|NCT04577326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185841|NCT04577326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185842|NCT04577326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65185843|NCT00637403|Megestrol|megestrol|mesh-list
65185844|NCT00637403|Megestrol Acetate|megestrol acetate|mesh-list
65185845|NCT00637403|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65185846|NCT00637403|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65185847|NCT00637403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64828422|NCT01556815|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65185848|NCT00637403|Contraceptive Agents|contraceptive agents|mesh-ancestor
65185849|NCT00637403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65185850|NCT00637403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185851|NCT00637403|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65326558|NCT02577783|Autonomic Agents|autonomic agents|mesh-ancestor
65326559|NCT02577783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65076517|NCT00323375|Chloroquine|chloroquine|mesh-list
65326560|NCT02577783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326561|NCT02577783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65326562|NCT02577783|Glucocorticoids|glucocorticoids|mesh-ancestor
65326563|NCT02577783|Hormones|hormones|mesh-ancestor
65326564|NCT02577783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65326565|NCT02577783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65326566|NCT02577783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326567|NCT02577783|Protease Inhibitors|protease inhibitors|mesh-ancestor
65185852|NCT00637403|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65185853|NCT00637403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65185854|NCT00637403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185855|NCT00637403|Appetite Stimulants|appetite stimulants|mesh-ancestor
65185856|NCT00637403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65185857|NCT01185080|Adenosine|adenosine|mesh-list
65185858|NCT01185080|Analgesics|analgesics|mesh-ancestor
65185859|NCT01185080|Sensory System Agents|sensory system agents|mesh-ancestor
65185860|NCT01185080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65185861|NCT01185080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185862|NCT01185080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65185863|NCT01185080|Vasodilator Agents|vasodilator agents|mesh-ancestor
65185864|NCT01185080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65185865|NCT01185080|Purinergic Agonists|purinergic agonists|mesh-ancestor
65185866|NCT01185080|Purinergic Agents|purinergic agents|mesh-ancestor
65185867|NCT01185080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65185868|NCT01185080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185869|NCT01181102|Enoxaparin|enoxaparin|mesh-list
65185870|NCT01181102|Enoxaparin sodium|enoxaparin sodium|mesh-list
65185871|NCT01181102|Edoxaban|edoxaban|mesh-list
65185872|NCT01181102|Anticoagulants|anticoagulants|mesh-ancestor
65185873|NCT01181102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65185883|NCT00858637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65185884|NCT00858637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65185885|NCT00858637|Antimetabolites|antimetabolites|mesh-ancestor
65185886|NCT00858637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185887|NCT00858637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65185888|NCT00858637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65185889|NCT00858637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65185890|NCT00858637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65185891|NCT02760316|Prednisolone|prednisolone|mesh-list
65185892|NCT02760316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65185893|NCT02760316|Methylprednisolone|methylprednisolone|mesh-list
65185894|NCT02760316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65185895|NCT02760316|Prednisolone acetate|prednisolone acetate|mesh-list
65185896|NCT02760316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65185897|NCT02760316|Prednisolone phosphate|prednisolone phosphate|mesh-list
65185898|NCT02760316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65185899|NCT02760316|Glucocorticoids|glucocorticoids|mesh-ancestor
65185900|NCT02760316|Hormones|hormones|mesh-ancestor
65185901|NCT02760316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65185902|NCT02760316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185903|NCT02760316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65185904|NCT02760316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185905|NCT02760316|Antiemetics|antiemetics|mesh-ancestor
65185906|NCT02760316|Autonomic Agents|autonomic agents|mesh-ancestor
65185907|NCT02760316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65185908|NCT02760316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65185909|NCT02760316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65185910|NCT02760316|Protective Agents|protective agents|mesh-ancestor
65185911|NCT00858403|Dasatinib|dasatinib|mesh-list
65185912|NCT00858403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185913|NCT00858403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65326568|NCT02577783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326569|NCT02577783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326570|NCT02577783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65326571|NCT02577783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65326572|NCT02577783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65326573|NCT00918450|Navitoclax|navitoclax|mesh-list
65326574|NCT00918450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185914|NCT00858403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65185915|NCT00858403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185916|NCT02760472|SMOFlipid|smoflipid|mesh-list
65185917|NCT02760472|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65185918|NCT02760472|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65185919|NCT02760472|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65185920|NCT00858247|Vitamin D|vitamin d|mesh-list
65185921|NCT00858247|Cholecalciferol|cholecalciferol|mesh-list
65185922|NCT00858247|Vitamins|vitamins|mesh-ancestor
65185923|NCT00858247|Micronutrients|micronutrients|mesh-ancestor
65185924|NCT00858247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185925|NCT00858247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65185926|NCT00858247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65185927|NCT04480918|Ketamine|ketamine|mesh-list
65185928|NCT04480918|Esketamine|esketamine|mesh-list
65185929|NCT04480918|Analgesics|analgesics|mesh-ancestor
65185930|NCT04480918|Sensory System Agents|sensory system agents|mesh-ancestor
65185931|NCT04480918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65185932|NCT04480918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185933|NCT04480918|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65185934|NCT04480918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65185935|NCT04480918|Anesthetics, General|anesthetics, general|mesh-ancestor
65185936|NCT04480918|Anesthetics|anesthetics|mesh-ancestor
65185937|NCT04480918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65185938|NCT04480918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65185939|NCT04480918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65185940|NCT04480918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65185941|NCT04480918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185947|NCT04222348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185949|NCT04222114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65185950|NCT00838435|Verapamil|verapamil|mesh-list
65185951|NCT00838435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65185952|NCT00838435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65185953|NCT00838435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65185954|NCT00838435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185955|NCT00838435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65185956|NCT00838435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185957|NCT00838435|Vasodilator Agents|vasodilator agents|mesh-ancestor
65185958|NCT02757508|Vitamins|vitamins|mesh-list
65185959|NCT02757508|Micronutrients|micronutrients|mesh-ancestor
65185960|NCT02757508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185961|NCT04568902|Histamine Antagonists|histamine antagonists|mesh-list
65185962|NCT04568902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
65185963|NCT04568902|Histamine Agents|histamine agents|mesh-ancestor
65185964|NCT04568902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65185965|NCT04568902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185966|NCT04568902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185967|NCT02757196|Methylprednisolone|methylprednisolone|mesh-list
65185968|NCT02757196|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65185969|NCT02757196|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65185970|NCT02757196|Prednisolone|prednisolone|mesh-list
65185971|NCT02757196|Prednisolone acetate|prednisolone acetate|mesh-list
65185972|NCT02757196|Rituximab|rituximab|mesh-list
65185973|NCT02757196|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65185974|NCT02757196|Prednisolone phosphate|prednisolone phosphate|mesh-list
65185975|NCT02757196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65185976|NCT02757196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185977|NCT02757196|Immunologic Factors|immunologic factors|mesh-ancestor
65185978|NCT02757196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185979|NCT02757196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65326575|NCT02591628|Chlorthalidone|chlorthalidone|mesh-list
65326576|NCT02591628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65326577|NCT02591628|Diuretics|diuretics|mesh-ancestor
65326578|NCT02591628|Natriuretic Agents|natriuretic agents|mesh-ancestor
65326579|NCT02591628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326580|NCT02591628|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65326581|NCT02591628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65326582|NCT02591628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326583|NCT04090112|Lidocaine|lidocaine|mesh-list
65326584|NCT04090112|Anesthetics, Local|anesthetics, local|mesh-ancestor
65326585|NCT04090112|Anesthetics|anesthetics|mesh-ancestor
65185980|NCT02757196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65185981|NCT02757196|Antiemetics|antiemetics|mesh-ancestor
65185982|NCT02757196|Autonomic Agents|autonomic agents|mesh-ancestor
65185983|NCT02757196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65185984|NCT02757196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65185985|NCT02757196|Glucocorticoids|glucocorticoids|mesh-ancestor
65185986|NCT02757196|Hormones|hormones|mesh-ancestor
65185987|NCT02757196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65185988|NCT02757196|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65185989|NCT02757196|Protective Agents|protective agents|mesh-ancestor
65185990|NCT02757196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65185991|NCT04403698|Alendronate|alendronate|mesh-list
65185992|NCT04403698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65185993|NCT04403698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185994|NCT02759926|Quinine|quinine|mesh-list
65185995|NCT02759926|Denatonium|denatonium|mesh-list
65185996|NCT02759926|Antimalarials|antimalarials|mesh-ancestor
65185997|NCT02759926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65185998|NCT02759926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65185999|NCT02759926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65186000|NCT02759926|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65186001|NCT02759926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186002|NCT02759926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65186003|NCT02759926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65186004|NCT02759926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65186005|NCT02759926|Analgesics|analgesics|mesh-ancestor
65186006|NCT02759926|Sensory System Agents|sensory system agents|mesh-ancestor
65186007|NCT02759926|Aversive Agents|aversive agents|mesh-ancestor
65186008|NCT02759926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186009|NCT02759926|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
65186010|NCT04221256|Citalopram|citalopram|mesh-list
65186011|NCT04221256|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65186012|NCT04221256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65186017|NCT04221256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186018|NCT04221256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65186019|NCT04221256|Antidepressive Agents|antidepressive agents|mesh-ancestor
65186020|NCT04221256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65186021|NCT00838201|Denosumab|denosumab|mesh-list
65186022|NCT00838201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65186023|NCT00838201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186024|NCT00837967|Terbutaline|terbutaline|mesh-list
65186025|NCT00837967|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65186026|NCT00837967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65186027|NCT00837967|Respiratory System Agents|respiratory system agents|mesh-ancestor
65186028|NCT00837967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65186029|NCT00837967|Autonomic Agents|autonomic agents|mesh-ancestor
65186030|NCT00837967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65186031|NCT00837967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186032|NCT00837967|Sympathomimetics|sympathomimetics|mesh-ancestor
65186033|NCT00837967|Tocolytic Agents|tocolytic agents|mesh-ancestor
65186034|NCT00837967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65186035|NCT00837967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65186036|NCT00837967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65326586|NCT04090112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65326587|NCT04090112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326588|NCT04090112|Sensory System Agents|sensory system agents|mesh-ancestor
65326589|NCT04090112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65326590|NCT04090112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65186037|NCT00837967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65186038|NCT00837967|Adrenergic Agents|adrenergic agents|mesh-ancestor
65186039|NCT00837967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65186040|NCT00837967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186041|NCT02759614|Bevacizumab|bevacizumab|mesh-list
65186042|NCT02759614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65186043|NCT02759614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65186044|NCT02759614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186045|NCT02759614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65186046|NCT02759614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65186047|NCT02759614|Growth Substances|growth substances|mesh-ancestor
65186048|NCT02759614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186049|NCT02759614|Growth Inhibitors|growth inhibitors|mesh-ancestor
65186050|NCT02759614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65186051|NCT02759614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186052|NCT02759614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186053|NCT02757040|Arsenic Trioxide|arsenic trioxide|mesh-list
65186054|NCT02757040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186055|NCT02759224|Irsogladine|irsogladine|mesh-list
65186056|NCT02759224|Lafutidine|lafutidine|mesh-list
65186057|NCT02759224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186058|NCT02759224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65186059|NCT02759224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65186060|NCT02759224|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65186061|NCT02759224|Histamine Antagonists|histamine antagonists|mesh-ancestor
65186062|NCT02759224|Histamine Agents|histamine agents|mesh-ancestor
65186063|NCT02759224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65186064|NCT02759224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186065|NCT02759224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186066|NCT02759224|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65186067|NCT02759224|Protective Agents|protective agents|mesh-ancestor
65186068|NCT02759224|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65186069|NCT02756728|Melphalan|melphalan|mesh-list
65186070|NCT02756728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65186071|NCT02756728|Alkylating Agents|alkylating agents|mesh-ancestor
65186072|NCT02756728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186073|NCT02756728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186074|NCT02756728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65186075|NCT02756728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65186076|NCT02756728|Immunologic Factors|immunologic factors|mesh-ancestor
65186077|NCT02756728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186078|NCT04586920|Itraconazole|itraconazole|mesh-list
65186079|NCT04586920|Midazolam|midazolam|mesh-list
65186080|NCT04586920|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65186081|NCT04586920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65186087|NCT04586920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65186088|NCT04586920|Anesthetics, General|anesthetics, general|mesh-ancestor
65186089|NCT04586920|Anesthetics|anesthetics|mesh-ancestor
65186090|NCT04586920|GABA Modulators|gaba modulators|mesh-ancestor
65186091|NCT04586920|GABA Agents|gaba agents|mesh-ancestor
65186092|NCT04586920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65186093|NCT04586920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186094|NCT04586920|Antifungal Agents|antifungal agents|mesh-ancestor
65186095|NCT04586920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65186096|NCT04586920|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65186097|NCT04586920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65186098|NCT04586920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186099|NCT04586920|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65186100|NCT04586920|Hormone Antagonists|hormone antagonists|mesh-ancestor
65186101|NCT04586920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65186102|NCT04586920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65186103|NCT02758990|Vitamin D|vitamin d|mesh-list
65186105|NCT02758990|Vitamins|vitamins|mesh-list
65186106|NCT02758990|Ascorbic Acid|ascorbic acid|mesh-list
65326591|NCT04090112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65326592|NCT04090112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65326593|NCT04090112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64556115|NCT00923949|Pioglitazone|pioglitazone|mesh-list
65186107|NCT02758990|Vitamin E|vitamin e|mesh-list
65186108|NCT02758990|Tocopherols|tocopherols|mesh-list
65186109|NCT02758990|Vitamin A|vitamin a|mesh-list
65186110|NCT02758990|Niacinamide|niacinamide|mesh-list
65186111|NCT02758990|Niacin|niacin|mesh-list
65186112|NCT02758990|Nicotinic Acids|nicotinic acids|mesh-list
65186113|NCT02758990|Pyridoxine|pyridoxine|mesh-list
65186114|NCT02758990|Pyridoxal|pyridoxal|mesh-list
65186115|NCT02758990|Vitamin B 6|vitamin b 6|mesh-list
65186116|NCT02758990|Caffeine|caffeine|mesh-list
65186117|NCT02758990|Micronutrients|micronutrients|mesh-ancestor
65186118|NCT02758990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186119|NCT02758990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65186120|NCT02758990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65186121|NCT02758990|Antioxidants|antioxidants|mesh-ancestor
65186122|NCT02758990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186123|NCT02758990|Protective Agents|protective agents|mesh-ancestor
65186124|NCT02758990|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65186125|NCT02758990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65186126|NCT02758990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186127|NCT02758990|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65186128|NCT02758990|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65186129|NCT02758990|Purinergic Agents|purinergic agents|mesh-ancestor
65186130|NCT02758990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65186131|NCT02758990|Vitamin B Complex|vitamin b complex|mesh-ancestor
65186132|NCT02758990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65186133|NCT02758990|Antimetabolites|antimetabolites|mesh-ancestor
65186134|NCT02758990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65186135|NCT02758990|Vasodilator Agents|vasodilator agents|mesh-ancestor
65186136|NCT02756104|Vitamin D|vitamin d|mesh-list
65186137|NCT02756104|Vitamins|vitamins|mesh-ancestor
65186138|NCT02756104|Micronutrients|micronutrients|mesh-ancestor
65186139|NCT02756104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186140|NCT02756104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65186141|NCT02756026|Micronutrients|micronutrients|mesh-list
65186142|NCT02756026|Trace Elements|trace elements|mesh-list
65186143|NCT02756026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186144|NCT02755714|Bromides|bromides|mesh-list
65186145|NCT02755714|Ipratropium|ipratropium|mesh-list
65186146|NCT02755714|Anticonvulsants|anticonvulsants|mesh-ancestor
65186147|NCT02755714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65186148|NCT02755714|Autonomic Agents|autonomic agents|mesh-ancestor
65186149|NCT02755714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65186150|NCT02755714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186151|NCT02755714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65186152|NCT02755714|Respiratory System Agents|respiratory system agents|mesh-ancestor
65186153|NCT02755714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65186154|NCT02755714|Cholinergic Agents|cholinergic agents|mesh-ancestor
65186155|NCT02755714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65186157|NCT02758522|Insulin|insulin|mesh-list
65186158|NCT02758522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65186159|NCT02758522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65186160|NCT02758522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186161|NCT00942357|Paclitaxel|paclitaxel|mesh-list
65186162|NCT00942357|Cisplatin|cisplatin|mesh-list
65186163|NCT00942357|Carboplatin|carboplatin|mesh-list
65186164|NCT00942357|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65186165|NCT00942357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65186166|NCT00942357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186167|NCT00942357|Tubulin Modulators|tubulin modulators|mesh-ancestor
65186168|NCT00942357|Antimitotic Agents|antimitotic agents|mesh-ancestor
65186169|NCT00942357|Mitosis Modulators|mitosis modulators|mesh-ancestor
65186170|NCT00942357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186171|NCT04583956|Remdesivir|remdesivir|mesh-list
65186172|NCT04583956|Antimetabolites|antimetabolites|mesh-ancestor
65186173|NCT04583956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186174|NCT04583956|Antiviral Agents|antiviral agents|mesh-ancestor
65186175|NCT04583956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65186176|NCT02752828|Insulin|insulin|mesh-list
65186177|NCT02752828|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65186178|NCT02752828|Insulin Glargine|insulin glargine|mesh-list
65186179|NCT02752828|Lixisenatide|lixisenatide|mesh-list
65326594|NCT04090112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326595|NCT00747344|Ustekinumab|ustekinumab|mesh-list
65326596|NCT00747344|Dermatologic Agents|dermatologic agents|mesh-ancestor
65326597|NCT00580983|Paclitaxel|paclitaxel|mesh-list
65326598|NCT00580983|Carboplatin|carboplatin|mesh-list
65186180|NCT02752828|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65186181|NCT02752828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186182|NCT02753062|Rituximab|rituximab|mesh-list
65186183|NCT02753062|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65186184|NCT02753062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65186185|NCT02753062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186186|NCT02753062|Immunologic Factors|immunologic factors|mesh-ancestor
65186187|NCT02753062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186188|NCT02753062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65186189|NCT02753062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65186190|NCT02753062|Alkylating Agents|alkylating agents|mesh-ancestor
65186191|NCT02753062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186192|NCT02752204|Rituximab|rituximab|mesh-list
65186193|NCT02752204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65186194|NCT02752204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186195|NCT02752204|Immunologic Factors|immunologic factors|mesh-ancestor
65186196|NCT02752204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186197|NCT02752204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65186198|NCT04220398|Hormones|hormones|mesh-list
65186199|NCT04220398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65186200|NCT04220398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186201|NCT04220632|Prednisone|prednisone|mesh-list
65186202|NCT04220632|Methylprednisolone|methylprednisolone|mesh-list
65186203|NCT04220632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65186204|NCT04220632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65186205|NCT04220632|Prednisolone|prednisolone|mesh-list
65186206|NCT04220632|Prednisolone acetate|prednisolone acetate|mesh-list
65186207|NCT04220632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65186208|NCT04220632|Prednisolone phosphate|prednisolone phosphate|mesh-list
65186209|NCT04220632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65186210|NCT04220632|Glucocorticoids|glucocorticoids|mesh-ancestor
65186211|NCT04220632|Hormones|hormones|mesh-ancestor
65186212|NCT04220632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65186213|NCT04220632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186214|NCT04220632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65186215|NCT04220632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186216|NCT04220632|Antiemetics|antiemetics|mesh-ancestor
65186217|NCT04220632|Autonomic Agents|autonomic agents|mesh-ancestor
65186218|NCT04220632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65186219|NCT04220632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65186220|NCT04220632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65186221|NCT04220632|Protective Agents|protective agents|mesh-ancestor
65186222|NCT00939627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65186223|NCT00939627|Cetuximab|cetuximab|mesh-list
65186224|NCT00939627|Sorafenib|sorafenib|mesh-list
65186225|NCT00939627|Antibodies|antibodies|mesh-list
65186226|NCT00939627|Immunoglobulins|immunoglobulins|mesh-list
65186227|NCT00939627|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65186228|NCT00939627|Immunologic Factors|immunologic factors|mesh-ancestor
65186229|NCT00939627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186230|NCT00939627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186235|NCT05382741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65186236|NCT05382741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186238|NCT04220476|Palbociclib|palbociclib|mesh-list
65186239|NCT04220476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186240|NCT04220476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65186241|NCT04220476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65186242|NCT04220476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186243|NCT04220476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186244|NCT04220476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65186245|NCT04220476|Hormone Antagonists|hormone antagonists|mesh-ancestor
65186246|NCT04220476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65186247|NCT04220476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186248|NCT04220476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65186249|NCT02695810|Metformin|metformin|mesh-list
65186250|NCT02695810|Dapagliflozin|dapagliflozin|mesh-list
65326599|NCT00580983|Fluorouracil|fluorouracil|mesh-list
65326600|NCT00580983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65326601|NCT00580983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326602|NCT00580983|Tubulin Modulators|tubulin modulators|mesh-ancestor
65326603|NCT00580983|Antimitotic Agents|antimitotic agents|mesh-ancestor
65326604|NCT00580983|Mitosis Modulators|mitosis modulators|mesh-ancestor
65326605|NCT00580983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326606|NCT00580983|Antimetabolites|antimetabolites|mesh-ancestor
65186251|NCT02695810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65186252|NCT02695810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186253|NCT02695810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65186254|NCT02695810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186255|NCT02753764|Prednisone|prednisone|mesh-list
65186256|NCT02753764|AZD7624|azd7624|mesh-list
65186257|NCT02753764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65186258|NCT02753764|Glucocorticoids|glucocorticoids|mesh-ancestor
65186260|NCT02753764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65186261|NCT02753764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186262|NCT02753764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65186263|NCT02753764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186264|NCT02753764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65186265|NCT02753764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186266|NCT02753764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186267|NCT02695654|Clonidine|clonidine|mesh-list
65186268|NCT02695654|Levobupivacaine|levobupivacaine|mesh-list
65186269|NCT02695654|Analgesics|analgesics|mesh-ancestor
65186270|NCT02695654|Sensory System Agents|sensory system agents|mesh-ancestor
65186271|NCT02695654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65186272|NCT02695654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186273|NCT02695654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65186274|NCT02695654|Sympatholytics|sympatholytics|mesh-ancestor
65186275|NCT02695654|Autonomic Agents|autonomic agents|mesh-ancestor
65186276|NCT02695654|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65186277|NCT02695654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65186278|NCT02695654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65186279|NCT02695654|Adrenergic Agents|adrenergic agents|mesh-ancestor
65186280|NCT02695654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65186281|NCT02695654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186282|NCT02695654|Anesthetics, Local|anesthetics, local|mesh-ancestor
65186283|NCT02695654|Anesthetics|anesthetics|mesh-ancestor
65186284|NCT02695654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65186285|NCT02696122|Anesthetics|anesthetics|mesh-list
65186286|NCT02696122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65186287|NCT02696122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186288|NCT01135511|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65186289|NCT01135511|Tofacitinib|tofacitinib|mesh-list
65186290|NCT01135511|Hyaluronic Acid|hyaluronic acid|mesh-list
65186291|NCT01135511|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65186292|NCT01135511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65186293|NCT01135511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186294|NCT01135511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186295|NCT01135511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65186296|NCT01135511|Immunologic Factors|immunologic factors|mesh-ancestor
65186297|NCT01135511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186298|NCT01135511|Viscosupplements|viscosupplements|mesh-ancestor
65186299|NCT01135511|Protective Agents|protective agents|mesh-ancestor
65186300|NCT02753140|Docetaxel|docetaxel|mesh-list
65186305|NCT02753140|Mitosis Modulators|mitosis modulators|mesh-ancestor
65186306|NCT02753140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186307|NCT02753140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65186308|NCT02753218|Midazolam|midazolam|mesh-list
65186309|NCT02753218|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65186310|NCT02753218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65186311|NCT02753218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65186312|NCT02753218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326607|NCT00580983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65326608|NCT00580983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65326609|NCT00580983|Immunologic Factors|immunologic factors|mesh-ancestor
65326610|NCT00580983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326611|NCT02576223|Ropivacaine|ropivacaine|mesh-list
65326612|NCT02576223|Anesthetics, Local|anesthetics, local|mesh-ancestor
65326613|NCT02576223|Anesthetics|anesthetics|mesh-ancestor
65326614|NCT02576223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65186313|NCT02753218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65186314|NCT02753218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65186315|NCT02753218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65186316|NCT02753218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65186317|NCT02753218|Anesthetics, General|anesthetics, general|mesh-ancestor
65186318|NCT02753218|Anesthetics|anesthetics|mesh-ancestor
65186319|NCT02753218|GABA Modulators|gaba modulators|mesh-ancestor
65186320|NCT02753218|GABA Agents|gaba agents|mesh-ancestor
65186321|NCT02753218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65186322|NCT02753218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186323|NCT05429554|Vildagliptin|vildagliptin|mesh-list
65186324|NCT05429554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65186325|NCT05429554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186326|NCT05429554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65186327|NCT05429554|Protease Inhibitors|protease inhibitors|mesh-ancestor
65186328|NCT05429554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186329|NCT05429554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186330|NCT05429086|Propofol|propofol|mesh-list
65186331|NCT05429086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65186332|NCT05429086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65186333|NCT05429086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186334|NCT05429086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65186335|NCT05429086|Anesthetics, General|anesthetics, general|mesh-ancestor
65186336|NCT05429086|Anesthetics|anesthetics|mesh-ancestor
65186337|NCT00638248|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
65186338|NCT00638248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65186339|NCT00638248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65186340|NCT00638248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186341|NCT05422144|Anti-Infective Agents|anti-infective agents|mesh-list
65186342|NCT05422144|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65186343|NCT01180790|Interferons|interferons|mesh-list
65186344|NCT01180790|Ribavirin|ribavirin|mesh-list
65186345|NCT01180790|Interferon-alpha|interferon-alpha|mesh-list
65186346|NCT01180790|Interferon alpha-2|interferon alpha-2|mesh-list
65186347|NCT01180790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65186348|NCT01180790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186349|NCT01180790|Antiviral Agents|antiviral agents|mesh-ancestor
65186350|NCT01180790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65186351|NCT01180790|Antimetabolites|antimetabolites|mesh-ancestor
65186352|NCT01180790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186353|NCT01180790|Immunologic Factors|immunologic factors|mesh-ancestor
65186354|NCT01180790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186355|NCT01184846|Immunoglobulins|immunoglobulins|mesh-list
65186356|NCT01184846|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65186357|NCT01184846|Antibodies|antibodies|mesh-list
65186358|NCT01184846|Immunologic Factors|immunologic factors|mesh-ancestor
65186359|NCT01184846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186360|NCT01191086|Topiramate|topiramate|mesh-list
65186361|NCT01191086|Anticonvulsants|anticonvulsants|mesh-ancestor
65186362|NCT01191086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65186363|NCT01191086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186364|NCT01191008|Timolol|timolol|mesh-list
65186365|NCT01191008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65186366|NCT01191008|Latanoprost|latanoprost|mesh-list
65186367|NCT01191008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65186368|NCT01191008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186369|NCT01191008|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65186370|NCT01191008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65186371|NCT01191008|Adrenergic Agents|adrenergic agents|mesh-ancestor
65186372|NCT01191008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65186383|NCT05318560|Lidocaine|lidocaine|mesh-list
65326615|NCT02576223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326616|NCT02576223|Sensory System Agents|sensory system agents|mesh-ancestor
65326617|NCT02576223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65326618|NCT02309931|Antidiarrheals|antidiarrheals|mesh-list
65326619|NCT02309931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65326620|NCT02577393|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65326621|NCT02577393|Antioxidants|antioxidants|mesh-ancestor
65326622|NCT02577393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326623|NCT02577393|Protective Agents|protective agents|mesh-ancestor
65326624|NCT02577393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326625|NCT02577393|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65326626|NCT02577393|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65186384|NCT05318560|Anesthetics, Local|anesthetics, local|mesh-ancestor
65186385|NCT05318560|Anesthetics|anesthetics|mesh-ancestor
65186386|NCT05318560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65186387|NCT05318560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186388|NCT05318560|Sensory System Agents|sensory system agents|mesh-ancestor
65186389|NCT05318560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65186390|NCT05318560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65186391|NCT05318560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65186392|NCT05318560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65186393|NCT05318560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65186394|NCT05318560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186395|NCT04171258|Botulinum Toxins|botulinum toxins|mesh-list
65186396|NCT04171258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65186397|NCT04171258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65186398|NCT04171258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65186399|NCT04171258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65186400|NCT04171258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186401|NCT04171258|Cholinergic Agents|cholinergic agents|mesh-ancestor
65186402|NCT04171258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65186403|NCT04171258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186404|NCT04171258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65186405|NCT04171258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65186406|NCT01086384|Fluticasone|fluticasone|mesh-list
65186407|NCT01086384|Xhance|xhance|mesh-list
65186408|NCT01086384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65186409|NCT01086384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65186410|NCT01086384|Autonomic Agents|autonomic agents|mesh-ancestor
65186411|NCT01086384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65186412|NCT01086384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186413|NCT01086384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65186414|NCT01086384|Respiratory System Agents|respiratory system agents|mesh-ancestor
65186415|NCT01086384|Dermatologic Agents|dermatologic agents|mesh-ancestor
65186416|NCT01086384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65186417|NCT04115644|Triamcinolone|triamcinolone|mesh-list
65186418|NCT04115644|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65186419|NCT04115644|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65186420|NCT04115644|Ketorolac|ketorolac|mesh-list
65186421|NCT04115644|Bupivacaine|bupivacaine|mesh-list
65186422|NCT04115644|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65186423|NCT04115644|Anesthetics, Local|anesthetics, local|mesh-ancestor
65186424|NCT04115644|Anesthetics|anesthetics|mesh-ancestor
65186425|NCT04115644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65186426|NCT04115644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186427|NCT04115644|Sensory System Agents|sensory system agents|mesh-ancestor
65186428|NCT04115644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65186429|NCT04115644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65186430|NCT04115644|Glucocorticoids|glucocorticoids|mesh-ancestor
65186431|NCT04115644|Hormones|hormones|mesh-ancestor
65186432|NCT04115644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65186433|NCT04115644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65326627|NCT02577393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326628|NCT02577393|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65326629|NCT02597114|Insulin|insulin|mesh-list
65326630|NCT02597114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65326631|NCT02597114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65326632|NCT02597114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326633|NCT00716976|Sodium thiosulfate|sodium thiosulfate|mesh-list
65326634|NCT00716976|Antidotes|antidotes|mesh-ancestor
65076590|NCT00323843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65326635|NCT00716976|Protective Agents|protective agents|mesh-ancestor
65326636|NCT00716976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326637|NCT00716976|Antioxidants|antioxidants|mesh-ancestor
65326638|NCT00716976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326639|NCT00716976|Antitubercular Agents|antitubercular agents|mesh-ancestor
65326640|NCT00716976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65326641|NCT00716976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65326642|NCT00716976|Chelating Agents|chelating agents|mesh-ancestor
65326643|NCT00716976|Sequestering Agents|sequestering agents|mesh-ancestor
65326644|NCT00743444|Lesogaberan|lesogaberan|mesh-list
65326645|NCT00743444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65186434|NCT04115644|Immunologic Factors|immunologic factors|mesh-ancestor
65186435|NCT04115644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186437|NCT04115644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65186439|NCT04115644|Analgesics|analgesics|mesh-ancestor
65186440|NCT04115644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65186441|NCT04115644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65186442|NCT00635986|Fentanyl|fentanyl|mesh-list
65186443|NCT00635986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65186444|NCT00635986|Narcotics|narcotics|mesh-ancestor
65186445|NCT00635986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65186446|NCT00635986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186447|NCT00635986|Analgesics|analgesics|mesh-ancestor
65186448|NCT00635986|Sensory System Agents|sensory system agents|mesh-ancestor
65186449|NCT00635986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65186450|NCT00635986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65186451|NCT00635986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65186452|NCT00635986|Anesthetics, General|anesthetics, general|mesh-ancestor
65186453|NCT00635986|Anesthetics|anesthetics|mesh-ancestor
65186454|NCT04799626|Levofloxacin|levofloxacin|mesh-list
65186455|NCT04799626|Ofloxacin|ofloxacin|mesh-list
65186457|NCT04799626|Tazobactam|tazobactam|mesh-list
65186458|NCT04799626|Piperacillin|piperacillin|mesh-list
65186459|NCT04799626|Tigecycline|tigecycline|mesh-list
65186460|NCT04799626|Biapenem|biapenem|mesh-list
65186461|NCT04799626|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65186462|NCT04799626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65186463|NCT04799626|Renal Agents|renal agents|mesh-ancestor
65186464|NCT04799626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65186465|NCT04799626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65186466|NCT04799626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65186467|NCT04799626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186468|NCT04799626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186469|NCT04799626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186470|NCT04799626|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65186471|NCT04799626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65186472|NCT04799626|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65186473|NCT04799626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65186474|NCT00636064|Parecoxib|parecoxib|mesh-list
65326646|NCT00743444|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65326647|NCT00743444|GABA Agonists|gaba agonists|mesh-ancestor
65326648|NCT00743444|GABA Agents|gaba agents|mesh-ancestor
65326649|NCT00743444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65326650|NCT00743444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326651|NCT00743444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326652|NCT00743366|Riboflavin|riboflavin|mesh-list
65326653|NCT00743366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65326654|NCT00743366|Antidepressive Agents|antidepressive agents|mesh-ancestor
65326655|NCT00743366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65326656|NCT00743366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65326657|NCT00743366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65186475|NCT00636064|Valdecoxib|valdecoxib|mesh-list
65186476|NCT00636064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65186477|NCT00636064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65186478|NCT00636064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186479|NCT00636064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186480|NCT00636064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65186481|NCT00636064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65186482|NCT00636064|Analgesics|analgesics|mesh-ancestor
65186483|NCT00636064|Sensory System Agents|sensory system agents|mesh-ancestor
65186484|NCT00636064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65186485|NCT00636064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186486|NCT00636064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65186487|NCT00636064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65186488|NCT02751034|Lidocaine|lidocaine|mesh-list
65186489|NCT02751034|Anesthetics, Local|anesthetics, local|mesh-ancestor
65186490|NCT02751034|Anesthetics|anesthetics|mesh-ancestor
65186491|NCT02751034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65186492|NCT02751034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186493|NCT02751034|Sensory System Agents|sensory system agents|mesh-ancestor
65186494|NCT02751034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65186495|NCT02751034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65186496|NCT02751034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65186497|NCT02751034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65186498|NCT02751034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65186499|NCT02751034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186500|NCT04217668|Isosorbide|isosorbide|mesh-list
65186501|NCT04217668|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65186502|NCT04217668|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65186503|NCT04217668|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65186504|NCT04217668|Diuretics|diuretics|mesh-ancestor
65186505|NCT04217668|Natriuretic Agents|natriuretic agents|mesh-ancestor
65186506|NCT04217668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186507|NCT04217668|Vasodilator Agents|vasodilator agents|mesh-ancestor
65186508|NCT04217668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65186509|NCT04217668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186515|NCT01127165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65186516|NCT01127165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186517|NCT04335292|Pemetrexed|pemetrexed|mesh-list
65186518|NCT04335292|Osimertinib|osimertinib|mesh-list
65186519|NCT04335292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186520|NCT04335292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186521|NCT04335292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186522|NCT04335292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65186523|NCT04335292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65186524|NCT04335292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65186525|NCT04278508|Progesterone|progesterone|mesh-list
65186526|NCT04278508|Progestins|progestins|mesh-ancestor
65186527|NCT04278508|Hormones|hormones|mesh-ancestor
65186528|NCT04278508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64829093|NCT05372393|Anesthetics|anesthetics|mesh-list
65326658|NCT00743366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65326659|NCT00743366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326660|NCT00743366|Vitamin B Complex|vitamin b complex|mesh-ancestor
65326661|NCT00743366|Vitamins|vitamins|mesh-ancestor
65326662|NCT00743366|Micronutrients|micronutrients|mesh-ancestor
65326663|NCT00743366|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65326664|NCT00743366|Dermatologic Agents|dermatologic agents|mesh-ancestor
65326665|NCT01760655|Mycophenolic Acid|mycophenolic acid|mesh-list
65186529|NCT04278508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186531|NCT05382351|Entecavir|entecavir|mesh-list
65186532|NCT05382351|Antiviral Agents|antiviral agents|mesh-ancestor
65186533|NCT05382351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65186534|NCT05382351|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65186535|NCT05382351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65186536|NCT05382351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186537|NCT05382351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186538|NCT05382351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65186539|NCT05382351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65186540|NCT04218760|Isosorbide|isosorbide|mesh-list
65186541|NCT04218760|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65186542|NCT04218760|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65186543|NCT04218760|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65186544|NCT04218760|Diuretics|diuretics|mesh-ancestor
65186545|NCT04218760|Natriuretic Agents|natriuretic agents|mesh-ancestor
65186546|NCT04218760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186547|NCT04218760|Vasodilator Agents|vasodilator agents|mesh-ancestor
65186548|NCT04218760|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65186549|NCT04218760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186550|NCT02750254|Plerixafor|plerixafor|mesh-list
65186551|NCT02750254|Cyclophosphamide|cyclophosphamide|mesh-list
65186552|NCT02750254|Melphalan|melphalan|mesh-list
65186553|NCT02750254|Busulfan|busulfan|mesh-list
65186554|NCT02750254|Fludarabine|fludarabine|mesh-list
65186555|NCT02750254|Fludarabine phosphate|fludarabine phosphate|mesh-list
65186556|NCT02750254|Azacitidine|azacitidine|mesh-list
65186557|NCT02750254|Lenograstim|lenograstim|mesh-list
65186558|NCT02750254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65186559|NCT02750254|Immunologic Factors|immunologic factors|mesh-ancestor
65186560|NCT02750254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186561|NCT02750254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65186562|NCT02750254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65186563|NCT02750254|Alkylating Agents|alkylating agents|mesh-ancestor
65186564|NCT02750254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186565|NCT02750254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186566|NCT02750254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65186567|NCT02750254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65186568|NCT02750254|Antimetabolites|antimetabolites|mesh-ancestor
65186569|NCT02750254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186570|NCT02750254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65186571|NCT02750254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65186572|NCT02750254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65186573|NCT02750254|Antiviral Agents|antiviral agents|mesh-ancestor
65186574|NCT02750254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65186575|NCT00941655|Leucovorin|leucovorin|mesh-list
65186576|NCT00941655|Fluorouracil|fluorouracil|mesh-list
65186577|NCT00941655|Oxaliplatin|oxaliplatin|mesh-list
65186578|NCT00941655|Irinotecan|irinotecan|mesh-list
65186579|NCT00941655|Antimetabolites|antimetabolites|mesh-ancestor
65186580|NCT00941655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186581|NCT00941655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65186586|NCT00941655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65186587|NCT00941655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65186588|NCT00941655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186589|NCT00941655|Antidotes|antidotes|mesh-ancestor
65186590|NCT00941655|Protective Agents|protective agents|mesh-ancestor
65186591|NCT00941655|Vitamin B Complex|vitamin b complex|mesh-ancestor
65186592|NCT00941655|Vitamins|vitamins|mesh-ancestor
65186593|NCT00941655|Micronutrients|micronutrients|mesh-ancestor
65186594|NCT00605787|1-(carboxymethylthio)tetradecane|1-(carboxymethylthio)tetradecane|mesh-list
65186595|NCT00605787|Antioxidants|antioxidants|mesh-ancestor
65326666|NCT01760655|Cyclophosphamide|cyclophosphamide|mesh-list
65326667|NCT01760655|Busulfan|busulfan|mesh-list
65326668|NCT01760655|Methyl Methanesulfonate|methyl methanesulfonate|mesh-list
65326669|NCT01760655|Fludarabine|fludarabine|mesh-list
65326670|NCT01760655|Fludarabine phosphate|fludarabine phosphate|mesh-list
65326671|NCT01760655|Tacrolimus|tacrolimus|mesh-list
65326672|NCT01760655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65326673|NCT01760655|Immunologic Factors|immunologic factors|mesh-ancestor
65326674|NCT01760655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326675|NCT01760655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65326676|NCT01760655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65326677|NCT01760655|Alkylating Agents|alkylating agents|mesh-ancestor
65326678|NCT01760655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326679|NCT01760655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326680|NCT01760655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65326681|NCT01760655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65186596|NCT00605787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186597|NCT00605787|Protective Agents|protective agents|mesh-ancestor
65186598|NCT00605787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186599|NCT00605787|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65186600|NCT00936117|Posaconazole|posaconazole|mesh-list
65186601|NCT00936117|Antifungal Agents|antifungal agents|mesh-ancestor
65186602|NCT00936117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65186603|NCT00936117|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65186604|NCT00936117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65186605|NCT00936117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65186606|NCT00936117|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65186607|NCT00936117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65186608|NCT00936117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186609|NCT00936117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186610|NCT00936117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65186611|NCT00936117|Hormone Antagonists|hormone antagonists|mesh-ancestor
65186612|NCT00936117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65186613|NCT00936117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186614|NCT04267653|Lactoferrin|lactoferrin|mesh-list
65186615|NCT04267653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65186616|NCT04088500|Nivolumab|nivolumab|mesh-list
65186617|NCT04088500|Ipilimumab|ipilimumab|mesh-list
65186618|NCT04088500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65186619|NCT04088500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186620|NCT04088500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65186621|NCT04088500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186622|NCT01082874|Clonidine|clonidine|mesh-list
65186623|NCT01082874|Analgesics|analgesics|mesh-ancestor
65186624|NCT01082874|Sensory System Agents|sensory system agents|mesh-ancestor
65186625|NCT01082874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65186626|NCT01082874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186627|NCT01082874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186628|NCT01082874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65186629|NCT01082874|Sympatholytics|sympatholytics|mesh-ancestor
65186630|NCT01082874|Autonomic Agents|autonomic agents|mesh-ancestor
65186631|NCT01082874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65186632|NCT01082874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65186633|NCT01082874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65186634|NCT01082874|Adrenergic Agents|adrenergic agents|mesh-ancestor
65186635|NCT01082874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65186637|NCT04801368|Anesthetics, Local|anesthetics, local|mesh-list
65326682|NCT01760655|Antimetabolites|antimetabolites|mesh-ancestor
65326683|NCT01760655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65326684|NCT01760655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65326685|NCT01760655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326686|NCT01760655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65326687|NCT01760655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65326688|NCT01760655|Antitubercular Agents|antitubercular agents|mesh-ancestor
65326689|NCT01760655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65186638|NCT04801368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65186639|NCT04801368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186640|NCT04801368|Sensory System Agents|sensory system agents|mesh-ancestor
65186641|NCT04801368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65186642|NCT00607503|Terbutaline|terbutaline|mesh-list
65186643|NCT00607503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65186644|NCT00607503|Autonomic Agents|autonomic agents|mesh-ancestor
65186645|NCT00607503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65186646|NCT00607503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186647|NCT00607503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65186648|NCT00607503|Respiratory System Agents|respiratory system agents|mesh-ancestor
65186649|NCT00607503|Sympathomimetics|sympathomimetics|mesh-ancestor
65186650|NCT00607503|Tocolytic Agents|tocolytic agents|mesh-ancestor
65186651|NCT00607503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65186652|NCT00607503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65186657|NCT00607503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186659|NCT04217512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65186660|NCT04217512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65186661|NCT04217512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65186662|NCT04217512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186663|NCT04217512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186664|NCT01079988|Cyclosporine|cyclosporine|mesh-list
65186665|NCT01079988|Methotrexate|methotrexate|mesh-list
65186666|NCT01079988|Cyclosporins|cyclosporins|mesh-list
65186667|NCT01079988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65186668|NCT01079988|Abortifacient Agents|abortifacient agents|mesh-ancestor
65186669|NCT01079988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65186670|NCT01079988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186671|NCT01079988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65186672|NCT01079988|Antimetabolites|antimetabolites|mesh-ancestor
65186673|NCT01079988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186674|NCT01079988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186675|NCT01079988|Dermatologic Agents|dermatologic agents|mesh-ancestor
65186676|NCT01079988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186677|NCT01079988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65186678|NCT01079988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65186679|NCT01079988|Immunologic Factors|immunologic factors|mesh-ancestor
64829248|NCT04410406|Ivermectin|ivermectin|mesh-list
65186680|NCT01079988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65186681|NCT01079988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65186682|NCT01079988|Antifungal Agents|antifungal agents|mesh-ancestor
65186683|NCT01079988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65186684|NCT01079988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65186685|NCT03974152|Nicotine|nicotine|mesh-list
65186686|NCT03974152|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65186687|NCT03974152|Autonomic Agents|autonomic agents|mesh-ancestor
65186688|NCT03974152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65186689|NCT03974152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186690|NCT03974152|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65186691|NCT03974152|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65186692|NCT03974152|Cholinergic Agents|cholinergic agents|mesh-ancestor
65186693|NCT03974152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65186694|NCT03974152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186695|NCT02876718|Rivaroxaban|rivaroxaban|mesh-list
65186696|NCT02876718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65186697|NCT02876718|Antithrombins|antithrombins|mesh-ancestor
65186698|NCT02876718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65186699|NCT02876718|Protease Inhibitors|protease inhibitors|mesh-ancestor
65186700|NCT02876718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326690|NCT00743288|Melphalan|melphalan|mesh-list
65326691|NCT00743288|Panobinostat|panobinostat|mesh-list
65326692|NCT00743288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65326693|NCT00743288|Alkylating Agents|alkylating agents|mesh-ancestor
65326694|NCT00743288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326695|NCT00743288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326696|NCT00743288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65326697|NCT00743288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65326698|NCT00743288|Immunologic Factors|immunologic factors|mesh-ancestor
65326699|NCT00743288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326700|NCT00743288|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65326701|NCT00743288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326702|NCT02579187|Anesthetics|anesthetics|mesh-list
65326703|NCT02579187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65326704|NCT02579187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326705|NCT02598440|Alendronate|alendronate|mesh-list
65326706|NCT02598440|Ibandronic Acid|ibandronic acid|mesh-list
65326707|NCT02598440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65326708|NCT02598440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326709|NCT00750308|Ramipril|ramipril|mesh-list
65186701|NCT02876718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186702|NCT02876718|Anticoagulants|anticoagulants|mesh-ancestor
65186703|NCT03508570|Nivolumab|nivolumab|mesh-list
65186704|NCT03508570|Ipilimumab|ipilimumab|mesh-list
65186705|NCT03508570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65186706|NCT03508570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186707|NCT03508570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65186708|NCT03508570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186709|NCT01074216|Vitamin D|vitamin d|mesh-list
65186710|NCT01074216|Ergocalciferols|ergocalciferols|mesh-list
65186711|NCT01074216|Cholecalciferol|cholecalciferol|mesh-list
65186712|NCT01074216|Vitamins|vitamins|mesh-list
65186713|NCT01074216|Micronutrients|micronutrients|mesh-ancestor
65186714|NCT01074216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186715|NCT01074216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65186716|NCT01074216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65186717|NCT03141034|Irinotecan|irinotecan|mesh-list
65186718|NCT03141034|Ramucirumab|ramucirumab|mesh-list
65186719|NCT03141034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65186720|NCT03141034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65186721|NCT03141034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186722|NCT03141034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186728|NCT02499562|Entecavir|entecavir|mesh-list
65186729|NCT02499562|Antiviral Agents|antiviral agents|mesh-ancestor
65186730|NCT02499562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65186731|NCT04304430|Dapagliflozin|dapagliflozin|mesh-list
65186732|NCT04304430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65186733|NCT04304430|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65186734|NCT04304430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186735|NCT04304430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65186736|NCT04304430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186737|NCT04304430|Protease Inhibitors|protease inhibitors|mesh-ancestor
65186738|NCT04304430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186739|NCT02875002|Belinostat|belinostat|mesh-list
65186740|NCT02875002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326710|NCT00750308|Tadalafil|tadalafil|mesh-list
65326711|NCT00750308|Vasodilator Agents|vasodilator agents|mesh-ancestor
65326712|NCT00750308|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65326713|NCT00750308|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65326714|NCT00750308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326715|NCT00750308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326716|NCT00750308|Urological Agents|urological agents|mesh-ancestor
65326717|NCT00750308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65326718|NCT00750308|Protease Inhibitors|protease inhibitors|mesh-ancestor
65326719|NCT00750308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65326720|NCT05392790|Calcium|calcium|mesh-list
65326721|NCT05392790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65326722|NCT05392790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326723|NCT02597036|Zansecimab|zansecimab|mesh-list
65326724|NCT02597036|Paclitaxel|paclitaxel|mesh-list
65326725|NCT02597036|Ramucirumab|ramucirumab|mesh-list
65326726|NCT02597036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65326727|NCT02597036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186741|NCT02875002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65186742|NCT02875002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186743|NCT02875002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186744|NCT02749396|Interferons|interferons|mesh-list
65186745|NCT02749396|Interferon-beta|interferon-beta|mesh-list
65186746|NCT02749396|Interferon beta-1a|interferon beta-1a|mesh-list
65186747|NCT02749396|Interferon beta-1b|interferon beta-1b|mesh-list
65186748|NCT02749396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186749|NCT02749396|Antiviral Agents|antiviral agents|mesh-ancestor
65186750|NCT02749396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65186751|NCT02749396|Immunologic Factors|immunologic factors|mesh-ancestor
65186752|NCT02749396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186753|NCT02749396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65186754|NCT04745910|Rasburicase|rasburicase|mesh-list
65186755|NCT04745910|Uric Acid|uric acid|mesh-list
65186756|NCT04745910|Gout Suppressants|gout suppressants|mesh-ancestor
65186757|NCT04745910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65186758|NCT04745910|Antioxidants|antioxidants|mesh-ancestor
65186759|NCT04745910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186760|NCT04745910|Protective Agents|protective agents|mesh-ancestor
65186761|NCT04745910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186762|NCT02749162|Acetaminophen|acetaminophen|mesh-list
65186763|NCT02749162|Dexamethasone|dexamethasone|mesh-list
65186764|NCT02749162|Lidocaine|lidocaine|mesh-list
65186765|NCT02749162|Morphine|morphine|mesh-list
65186766|NCT02749162|Ropivacaine|ropivacaine|mesh-list
65186767|NCT02749162|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65186768|NCT02749162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65186769|NCT02749162|Antiemetics|antiemetics|mesh-ancestor
65186770|NCT02749162|Autonomic Agents|autonomic agents|mesh-ancestor
65186771|NCT02749162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65186772|NCT02749162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186773|NCT02749162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65186774|NCT02749162|Glucocorticoids|glucocorticoids|mesh-ancestor
65186775|NCT02749162|Hormones|hormones|mesh-ancestor
65186776|NCT02749162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65186777|NCT02749162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65186778|NCT02749162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186779|NCT02749162|Anesthetics, Local|anesthetics, local|mesh-ancestor
65186780|NCT02749162|Anesthetics|anesthetics|mesh-ancestor
65326728|NCT02597036|Tubulin Modulators|tubulin modulators|mesh-ancestor
65326729|NCT02597036|Antimitotic Agents|antimitotic agents|mesh-ancestor
65326730|NCT02597036|Mitosis Modulators|mitosis modulators|mesh-ancestor
65326731|NCT02597036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326732|NCT02597036|Antiviral Agents|antiviral agents|mesh-ancestor
65326733|NCT02597036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65326734|NCT04071639|Ubiquinone|ubiquinone|mesh-list
65186781|NCT02749162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65186782|NCT02749162|Sensory System Agents|sensory system agents|mesh-ancestor
65186783|NCT02749162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65186784|NCT02749162|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65186785|NCT02749162|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65186786|NCT02749162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65186787|NCT02749162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186788|NCT02749162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65186789|NCT02749162|Narcotics|narcotics|mesh-ancestor
65186790|NCT02749162|Analgesics|analgesics|mesh-ancestor
65186791|NCT02749162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65186792|NCT02749162|Antipyretics|antipyretics|mesh-ancestor
65186793|NCT02041234|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65186794|NCT02041234|Liraglutide|liraglutide|mesh-list
65186795|NCT02041234|Empagliflozin|empagliflozin|mesh-list
65186807|NCT02041234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186808|NCT02041234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186809|NCT02041234|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65186810|NCT02041234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65186811|NCT02695732|Carvedilol|carvedilol|mesh-list
65186812|NCT02695732|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65186813|NCT02695732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65186814|NCT02695732|Adrenergic Agents|adrenergic agents|mesh-ancestor
65186815|NCT02695732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65186816|NCT02695732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186817|NCT02695732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186818|NCT02695732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65186819|NCT02695732|Antioxidants|antioxidants|mesh-ancestor
65186820|NCT02695732|Protective Agents|protective agents|mesh-ancestor
65186821|NCT02695732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65186822|NCT02695732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65186823|NCT02695732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65186824|NCT02695732|Vasodilator Agents|vasodilator agents|mesh-ancestor
65186825|NCT02695732|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65186826|NCT02695732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65186827|NCT02751268|Ropivacaine|ropivacaine|mesh-list
65186828|NCT02751268|Anesthetics, Local|anesthetics, local|mesh-ancestor
64829397|NCT03691714|Cetuximab|cetuximab|mesh-list
65186829|NCT02751268|Anesthetics|anesthetics|mesh-ancestor
65186830|NCT02751268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65186831|NCT02751268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186832|NCT02751268|Sensory System Agents|sensory system agents|mesh-ancestor
65186833|NCT02751268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65186834|NCT02748772|Thalidomide|thalidomide|mesh-list
65186835|NCT02748772|Endostar protein|endostar protein|mesh-list
65186836|NCT02748772|Endostatins|endostatins|mesh-list
65186837|NCT02748772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65186838|NCT02748772|Immunologic Factors|immunologic factors|mesh-ancestor
65186839|NCT02748772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186840|NCT02748772|Leprostatic Agents|leprostatic agents|mesh-ancestor
65186841|NCT02748772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65186842|NCT02748772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65186843|NCT02748772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65186844|NCT02748772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65186845|NCT02748772|Growth Substances|growth substances|mesh-ancestor
65186846|NCT02748772|Growth Inhibitors|growth inhibitors|mesh-ancestor
65186847|NCT02748772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186848|NCT04406272|Bevacizumab|bevacizumab|mesh-list
65186849|NCT04406272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65186850|NCT04406272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186851|NCT04406272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65326735|NCT04071639|Haloperidol|haloperidol|mesh-list
65326736|NCT04071639|Risperidone|risperidone|mesh-list
65326737|NCT04071639|Haloperidol decanoate|haloperidol decanoate|mesh-list
65326738|NCT04071639|Sertraline|sertraline|mesh-list
65326739|NCT04071639|Tetrabenazine|tetrabenazine|mesh-list
65326740|NCT04071639|Idebenone|idebenone|mesh-list
65326741|NCT04071639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65326742|NCT04071639|Serotonin Agents|serotonin agents|mesh-ancestor
65326743|NCT04071639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65326744|NCT04071639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326745|NCT04071639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186852|NCT04406272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65186855|NCT04406272|Growth Inhibitors|growth inhibitors|mesh-ancestor
65186856|NCT04216888|Ketamine|ketamine|mesh-list
65186857|NCT04216888|Analgesics|analgesics|mesh-ancestor
65186858|NCT04216888|Sensory System Agents|sensory system agents|mesh-ancestor
65186859|NCT04216888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65186860|NCT04216888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186861|NCT04216888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65186862|NCT04216888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65186863|NCT04216888|Anesthetics, General|anesthetics, general|mesh-ancestor
65186865|NCT04216888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65186866|NCT04216888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65186867|NCT04216888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65186868|NCT04216888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65186869|NCT04216888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186870|NCT02746744|Rituximab|rituximab|mesh-list
65186871|NCT02746744|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65186872|NCT02746744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65186873|NCT02746744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186874|NCT02746744|Immunologic Factors|immunologic factors|mesh-ancestor
65186875|NCT02746744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186876|NCT02746744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65186877|NCT02746744|Dermatologic Agents|dermatologic agents|mesh-ancestor
65186878|NCT02746744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65186879|NCT02748304|Aspirin|aspirin|mesh-list
65186880|NCT02748304|Sorafenib|sorafenib|mesh-list
65186881|NCT02748304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65186882|NCT02748304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65186883|NCT02748304|Analgesics|analgesics|mesh-ancestor
65186884|NCT02748304|Sensory System Agents|sensory system agents|mesh-ancestor
65186885|NCT02748304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65186886|NCT02748304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186887|NCT02748304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65186888|NCT02748304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65186889|NCT02748304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65186890|NCT02748304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65186891|NCT02748304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186892|NCT02748304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65186893|NCT02748304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65186894|NCT02748304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186895|NCT02748304|Antipyretics|antipyretics|mesh-ancestor
65186896|NCT02748304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186897|NCT02748304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65186898|NCT02746276|Metronidazole|metronidazole|mesh-list
65186899|NCT02746276|Ceftriaxone|ceftriaxone|mesh-list
65186900|NCT02746276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65186901|NCT02746276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65186902|NCT02746276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65186903|NCT02746276|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65186904|NCT02745886|Metformin|metformin|mesh-list
65186905|NCT02745886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65186906|NCT02745886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186907|NCT05629234|Osimertinib|osimertinib|mesh-list
65186908|NCT05629234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186909|NCT05629234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65326746|NCT04071639|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65326747|NCT04071639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65326748|NCT04071639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65326749|NCT04071639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65326750|NCT04071639|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65326751|NCT04071639|Dopamine Agents|dopamine agents|mesh-ancestor
65326752|NCT04071639|Antidepressive Agents|antidepressive agents|mesh-ancestor
65326753|NCT04071639|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65326754|NCT04071639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65326755|NCT04071639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65326756|NCT04071639|Antiemetics|antiemetics|mesh-ancestor
65186910|NCT05629234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186911|NCT05629234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186913|NCT02742142|Cariostatic Agents|cariostatic agents|mesh-ancestor
65186914|NCT02742142|Protective Agents|protective agents|mesh-ancestor
65186915|NCT02742142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186916|NCT00636298|Bevacizumab|bevacizumab|mesh-list
65186917|NCT00636298|Cetuximab|cetuximab|mesh-list
65186918|NCT00636298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65186919|NCT00636298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186920|NCT00636298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65186921|NCT00636298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65186922|NCT00636298|Growth Substances|growth substances|mesh-ancestor
65186923|NCT00636298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186924|NCT00636298|Growth Inhibitors|growth inhibitors|mesh-ancestor
65186925|NCT02744716|Aspirin|aspirin|mesh-list
65186926|NCT02744716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65186927|NCT02744716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65186934|NCT02744716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65186935|NCT02744716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65186936|NCT02744716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186937|NCT02744716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65186938|NCT02744716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65186939|NCT02744716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186940|NCT02744716|Antipyretics|antipyretics|mesh-ancestor
65186941|NCT02744872|Felodipine|felodipine|mesh-list
65186942|NCT02744872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65186943|NCT02744872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65186944|NCT02744872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65186945|NCT02744872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65186946|NCT02744872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186947|NCT02744872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65186948|NCT02744872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186949|NCT02744872|Vasodilator Agents|vasodilator agents|mesh-ancestor
65186950|NCT02744638|Metronidazole|metronidazole|mesh-list
65186951|NCT02744638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65186952|NCT02744638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65186953|NCT02744638|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65186954|NCT02744638|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65186955|NCT02740894|Gefitinib|gefitinib|mesh-list
65186956|NCT02740894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186957|NCT02740894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65186958|NCT02740894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186959|NCT02740894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186960|NCT00857389|Cyclophosphamide|cyclophosphamide|mesh-list
65186961|NCT00857389|Busulfan|busulfan|mesh-list
65186962|NCT00857389|Thiotepa|thiotepa|mesh-list
65186963|NCT00857389|Methotrexate|methotrexate|mesh-list
65186964|NCT00857389|Clofarabine|clofarabine|mesh-list
65186965|NCT00857389|Tacrolimus|tacrolimus|mesh-list
65186966|NCT00857389|Thymoglobulin|thymoglobulin|mesh-list
65186967|NCT00857389|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65186968|NCT00857389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65186969|NCT00857389|Immunologic Factors|immunologic factors|mesh-ancestor
65186970|NCT00857389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326757|NCT04071639|Autonomic Agents|autonomic agents|mesh-ancestor
65326758|NCT04071639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65326759|NCT04071639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65326760|NCT04071639|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65326761|NCT04071639|Antioxidants|antioxidants|mesh-ancestor
65326762|NCT04071639|Protective Agents|protective agents|mesh-ancestor
65326763|NCT04071639|Micronutrients|micronutrients|mesh-ancestor
65326764|NCT04071639|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65326765|NCT04071639|Adrenergic Agents|adrenergic agents|mesh-ancestor
65326766|NCT04089176|Oxytocin|oxytocin|mesh-list
65326767|NCT04089176|Carbetocin|carbetocin|mesh-list
65326768|NCT04089176|Oxytocics|oxytocics|mesh-ancestor
65326769|NCT04089176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65326770|NCT04089176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326771|NCT02577159|Dapagliflozin|dapagliflozin|mesh-list
65326772|NCT02577159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65326773|NCT02577159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326774|NCT02577159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65326775|NCT02577159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326776|NCT00749684|Interferons|interferons|mesh-list
65326777|NCT00749684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326778|NCT00749684|Antiviral Agents|antiviral agents|mesh-ancestor
65326779|NCT00749684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65326780|NCT02575755|Azithromycin|azithromycin|mesh-list
65326781|NCT02575755|Pyrimethamine|pyrimethamine|mesh-list
65326782|NCT02575755|Piperaquine|piperaquine|mesh-list
65326783|NCT02575755|Sulfadoxine|sulfadoxine|mesh-list
65326784|NCT02575755|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65326785|NCT02575755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65186971|NCT00857389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65186972|NCT00857389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65186973|NCT00857389|Alkylating Agents|alkylating agents|mesh-ancestor
65186974|NCT00857389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186975|NCT00857389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186976|NCT00857389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65186977|NCT00857389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65186978|NCT00857389|Abortifacient Agents|abortifacient agents|mesh-ancestor
65186979|NCT00857389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65186980|NCT00857389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64829539|NCT02909686|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65186981|NCT00857389|Antimetabolites|antimetabolites|mesh-ancestor
65186983|NCT00857389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186984|NCT00857389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65186985|NCT00857389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65186986|NCT00857389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65186987|NCT02744482|Risedronic Acid|risedronic acid|mesh-list
65186988|NCT02744482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65326786|NCT02575755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65326787|NCT02575755|Antimalarials|antimalarials|mesh-ancestor
65326788|NCT02575755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65326789|NCT02575755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65326790|NCT02575755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65326791|NCT02575755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326792|NCT02575755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326793|NCT02575755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65326794|NCT02575755|Renal Agents|renal agents|mesh-ancestor
65326795|NCT00746798|Vaccines|vaccines|mesh-list
64556296|NCT04912596|Miotics|miotics|mesh-ancestor
65186989|NCT02744482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65186990|NCT02744482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186991|NCT02744482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65186992|NCT02744482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186993|NCT02744482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65186994|NCT01071798|Rituximab|rituximab|mesh-list
65186995|NCT01071798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65186999|NCT01071798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65187000|NCT00857311|Vaccines|vaccines|mesh-list
65187001|NCT00857311|Immunologic Factors|immunologic factors|mesh-ancestor
65187002|NCT00857311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187003|NCT02874768|Dexmedetomidine|dexmedetomidine|mesh-list
65187004|NCT02874768|Propofol|propofol|mesh-list
65187005|NCT02874768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65187006|NCT02874768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65187007|NCT02874768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187008|NCT02874768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65187009|NCT02874768|Anesthetics, General|anesthetics, general|mesh-ancestor
65187010|NCT02874768|Anesthetics|anesthetics|mesh-ancestor
65187011|NCT02874768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65187012|NCT02874768|Analgesics|analgesics|mesh-ancestor
65187013|NCT02874768|Sensory System Agents|sensory system agents|mesh-ancestor
65187014|NCT02874768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65187015|NCT02874768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65187016|NCT02874768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65187017|NCT02874768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65187018|NCT02874768|Adrenergic Agents|adrenergic agents|mesh-ancestor
65187019|NCT02874768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65187020|NCT02874768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187021|NCT00857233|Memantine|memantine|mesh-list
65187022|NCT00857233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65187023|NCT00857233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65187024|NCT00857233|Dopamine Agents|dopamine agents|mesh-ancestor
65187025|NCT00857233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65187026|NCT00857233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187027|NCT00857233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187028|NCT00857233|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65187029|NCT00857233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65187030|NCT02740426|Pirarubicin|pirarubicin|mesh-list
65187031|NCT02740426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187032|NCT02743234|Vancomycin|vancomycin|mesh-list
65187033|NCT02743234|Fidaxomicin|fidaxomicin|mesh-list
65187034|NCT02743234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65187035|NCT02743234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65187036|NCT02740270|Spartalizumab|spartalizumab|mesh-list
65187037|NCT02740270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65187038|NCT02740270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187039|NCT02740270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187040|NCT00856843|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65187041|NCT00856843|Laxatives|laxatives|mesh-ancestor
65187042|NCT00856843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65187043|NCT02740192|Bupivacaine|bupivacaine|mesh-list
65187044|NCT02740192|Ropivacaine|ropivacaine|mesh-list
65187045|NCT02740192|Anesthetics, Local|anesthetics, local|mesh-ancestor
65326796|NCT00746798|Immunologic Factors|immunologic factors|mesh-ancestor
65326797|NCT00746798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326798|NCT00716274|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65326799|NCT00716274|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65326800|NCT00716274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65326801|NCT00716274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65326802|NCT00716274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326803|NCT00716274|Adrenergic Agents|adrenergic agents|mesh-ancestor
65326804|NCT00716274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65326805|NCT00716274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326806|NCT01298193|Phenothiazine|phenothiazine|mesh-list
65326807|NCT01298193|Droperidol|droperidol|mesh-list
65326808|NCT01298193|Haloperidol|haloperidol|mesh-list
65326809|NCT01298193|Aprepitant|aprepitant|mesh-list
65187046|NCT02740192|Anesthetics|anesthetics|mesh-ancestor
65187047|NCT02740192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65187048|NCT02740192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187049|NCT02740192|Sensory System Agents|sensory system agents|mesh-ancestor
65187050|NCT02740192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65187051|NCT02743390|Infliximab|infliximab|mesh-list
65187052|NCT02743390|Dermatologic Agents|dermatologic agents|mesh-ancestor
65187053|NCT02743390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65187054|NCT02743390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65187055|NCT00856609|Exenatide|exenatide|mesh-list
65187056|NCT00856609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65187057|NCT00856609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187058|NCT00856609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65187059|NCT00856609|Incretins|incretins|mesh-ancestor
65187060|NCT00856609|Hormones|hormones|mesh-ancestor
65187061|NCT00856609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65187062|NCT02739958|Propofol|propofol|mesh-list
65187063|NCT02739958|Isoflurane|isoflurane|mesh-list
65187064|NCT02739958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65187065|NCT02739958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65187066|NCT02739958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187067|NCT02739958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65187068|NCT02739958|Anesthetics, General|anesthetics, general|mesh-ancestor
65187069|NCT02739958|Anesthetics|anesthetics|mesh-ancestor
65187093|NCT00856375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187095|NCT00856375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65187096|NCT01070784|Budesonide|budesonide|mesh-list
65187097|NCT01070784|Formoterol Fumarate|formoterol fumarate|mesh-list
65187098|NCT01070784|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65187099|NCT01070784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65187100|NCT01070784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65187101|NCT01070784|Autonomic Agents|autonomic agents|mesh-ancestor
65187102|NCT01070784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65187103|NCT01070784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187104|NCT01070784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65187105|NCT01070784|Respiratory System Agents|respiratory system agents|mesh-ancestor
65187106|NCT01070784|Glucocorticoids|glucocorticoids|mesh-ancestor
65187107|NCT01070784|Hormones|hormones|mesh-ancestor
65187108|NCT01070784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65187109|NCT01070784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65187110|NCT01070784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65187111|NCT01070784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65187112|NCT01070784|Adrenergic Agents|adrenergic agents|mesh-ancestor
65187113|NCT01070784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65187114|NCT01070784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187115|NCT02694874|Rosiglitazone|rosiglitazone|mesh-list
65187116|NCT02694874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65326810|NCT01298193|Metoclopramide|metoclopramide|mesh-list
65326811|NCT01298193|Domperidone|domperidone|mesh-list
65326812|NCT01298193|Alizapride|alizapride|mesh-list
65326813|NCT01298193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
65326814|NCT01298193|Antiemetics|antiemetics|mesh-ancestor
65326815|NCT01298193|Autonomic Agents|autonomic agents|mesh-ancestor
65326816|NCT01298193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65326817|NCT01298193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326818|NCT01298193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65326819|NCT01298193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65326820|NCT01298193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64493298|NCT03819465|Paclitaxel|paclitaxel|mesh-list
65187117|NCT02694874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187118|NCT00837577|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65187119|NCT00837577|Voglibose|voglibose|mesh-list
65187124|NCT00837577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65187125|NCT00837577|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65187126|NCT00837577|Protease Inhibitors|protease inhibitors|mesh-ancestor
65187127|NCT00837577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187128|NCT00837577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187129|NCT00837577|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65187130|NCT01070550|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65187132|NCT01070550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65187133|NCT04189900|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65187134|NCT04189900|Luteolytic Agents|luteolytic agents|mesh-ancestor
65187135|NCT04189900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65187136|NCT04189900|Contraceptive Agents|contraceptive agents|mesh-ancestor
65187137|NCT04189900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65187138|NCT04189900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187139|NCT04189900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65187140|NCT04189900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65187141|NCT04189900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187142|NCT00848107|Treprostinil|treprostinil|mesh-list
65187143|NCT00848107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65187144|NCT03823768|Tacrolimus|tacrolimus|mesh-list
65187145|NCT03823768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65187146|NCT03823768|Immunologic Factors|immunologic factors|mesh-ancestor
65187147|NCT03823768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187148|NCT03823768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65187149|NCT03823768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187150|NCT03823768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187151|NCT04030741|Metronidazole|metronidazole|mesh-list
65187152|NCT04030741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65187153|NCT04030741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65187154|NCT04030741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65187155|NCT04030741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65187156|NCT02736760|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65187157|NCT02736760|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65187158|NCT02736760|Dermatologic Agents|dermatologic agents|mesh-ancestor
65187159|NCT05620108|Rocuronium|rocuronium|mesh-list
65187160|NCT05620108|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65187161|NCT05620108|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65187162|NCT05620108|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65187163|NCT05620108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65187164|NCT05620108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187166|NCT00856297|Immunologic Factors|immunologic factors|mesh-ancestor
65187167|NCT00856297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187168|NCT02736604|Nitrous Oxide|nitrous oxide|mesh-list
65187169|NCT02736604|Anesthetics|anesthetics|mesh-list
65187170|NCT02736604|Sevoflurane|sevoflurane|mesh-list
65187171|NCT02736604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65187172|NCT02736604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187173|NCT02736604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65326821|NCT01298193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326822|NCT01298193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65326823|NCT01298193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65326824|NCT01298193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65326825|NCT01298193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65326826|NCT01298193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65326827|NCT01298193|Dopamine Agents|dopamine agents|mesh-ancestor
65326828|NCT01298193|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65326829|NCT01298193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65326830|NCT01298193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65326831|NCT01298193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65326832|NCT01298193|Serotonin Agents|serotonin agents|mesh-ancestor
65326833|NCT01298193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65326834|NCT01298193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65187174|NCT02736604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65187175|NCT02736604|Anesthetics, General|anesthetics, general|mesh-ancestor
65187176|NCT02736604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65187177|NCT02736604|Analgesics|analgesics|mesh-ancestor
65187178|NCT02736604|Sensory System Agents|sensory system agents|mesh-ancestor
65187179|NCT02736604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65187180|NCT02613013|Proxymetacaine|proxymetacaine|mesh-list
65187181|NCT02613013|Pilocarpine|pilocarpine|mesh-list
65187182|NCT02613013|Miotics|miotics|mesh-ancestor
65187183|NCT02613013|Autonomic Agents|autonomic agents|mesh-ancestor
65187184|NCT02613013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65187185|NCT02613013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187186|NCT02613013|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65187187|NCT02613013|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65187188|NCT02613013|Cholinergic Agents|cholinergic agents|mesh-ancestor
65187189|NCT02613013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65187190|NCT02613013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187191|NCT02613013|Anesthetics, Local|anesthetics, local|mesh-ancestor
65187197|NCT04306510|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65187198|NCT04306510|Immunologic Factors|immunologic factors|mesh-ancestor
65187199|NCT04306510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187200|NCT02611921|Ketamine|ketamine|mesh-list
65187201|NCT02611921|Analgesics|analgesics|mesh-ancestor
65187202|NCT02611921|Sensory System Agents|sensory system agents|mesh-ancestor
65187203|NCT02611921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65187204|NCT02611921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187205|NCT02611921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65187206|NCT02611921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65187207|NCT02611921|Anesthetics, General|anesthetics, general|mesh-ancestor
65187208|NCT02611921|Anesthetics|anesthetics|mesh-ancestor
65187209|NCT02611921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65187210|NCT02611921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65187211|NCT02611921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65187212|NCT02611921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65187213|NCT02611921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187214|NCT02736448|Capecitabine|capecitabine|mesh-list
65187215|NCT02736448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65187216|NCT02736448|Antimetabolites|antimetabolites|mesh-ancestor
65187217|NCT02736448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187218|NCT02736448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187219|NCT00703651|Vaccines|vaccines|mesh-list
65187220|NCT00703651|Immunologic Factors|immunologic factors|mesh-ancestor
65187221|NCT00703651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187222|NCT01046136|Phenylpropanolamine|phenylpropanolamine|mesh-list
65187223|NCT01046136|Guaifenesin|guaifenesin|mesh-list
65187224|NCT01046136|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
65187225|NCT01046136|Expectorants|expectorants|mesh-ancestor
65326835|NCT01298193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65326836|NCT02590536|Sildenafil Citrate|sildenafil citrate|mesh-list
65326837|NCT02590536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326838|NCT02590536|Vasodilator Agents|vasodilator agents|mesh-ancestor
65326839|NCT02590536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65326840|NCT02590536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64556340|NCT04024241|Analgesics|analgesics|mesh-ancestor
65187226|NCT01046136|Respiratory System Agents|respiratory system agents|mesh-ancestor
65187227|NCT01046136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65187228|NCT01046136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65187229|NCT01046136|Adrenergic Agents|adrenergic agents|mesh-ancestor
65187230|NCT01046136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65187231|NCT01046136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187232|NCT01046136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187233|NCT01046136|Appetite Depressants|appetite depressants|mesh-ancestor
65187234|NCT01046136|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65187235|NCT01046136|Sympathomimetics|sympathomimetics|mesh-ancestor
65187236|NCT01046136|Autonomic Agents|autonomic agents|mesh-ancestor
65187237|NCT01046136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65187238|NCT01046136|Nasal Decongestants|nasal decongestants|mesh-ancestor
65187239|NCT01046136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65187240|NCT02736682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65187242|NCT02736682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65187243|NCT02736682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65187244|NCT02736682|Antitubercular Agents|antitubercular agents|mesh-ancestor
65187245|NCT02736682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65187246|NCT02736682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65187247|NCT00701155|Insulin Detemir|insulin detemir|mesh-list
65187248|NCT00701155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65187249|NCT00701155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187250|NCT02874690|Methylphenidate|methylphenidate|mesh-list
65187251|NCT02874690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65187252|NCT02874690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187253|NCT02874690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65187254|NCT02874690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65187255|NCT02874690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65187256|NCT02874690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187257|NCT02874690|Dopamine Agents|dopamine agents|mesh-ancestor
65187258|NCT02874690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65187259|NCT04304352|Cyclophosphamide|cyclophosphamide|mesh-list
65187260|NCT04304352|Capecitabine|capecitabine|mesh-list
65187261|NCT04304352|Vinorelbine|vinorelbine|mesh-list
65187262|NCT04304352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65187267|NCT04304352|Alkylating Agents|alkylating agents|mesh-ancestor
65187268|NCT04304352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187269|NCT04304352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187270|NCT04304352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65187271|NCT04304352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65187272|NCT04304352|Antimetabolites|antimetabolites|mesh-ancestor
65187273|NCT04304352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65187274|NCT04304352|Tubulin Modulators|tubulin modulators|mesh-ancestor
65187275|NCT04304352|Antimitotic Agents|antimitotic agents|mesh-ancestor
65187276|NCT04304352|Mitosis Modulators|mitosis modulators|mesh-ancestor
65187277|NCT02738632|Amlodipine|amlodipine|mesh-list
65187278|NCT02738632|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65187279|NCT02738632|Telmisartan|telmisartan|mesh-list
65187280|NCT02738632|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
65187281|NCT02738632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65187282|NCT02738632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65187283|NCT02738632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65187284|NCT02738632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187285|NCT02738632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65187286|NCT02738632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187287|NCT02738632|Vasodilator Agents|vasodilator agents|mesh-ancestor
65187288|NCT02738632|Diuretics|diuretics|mesh-ancestor
65187289|NCT02738632|Natriuretic Agents|natriuretic agents|mesh-ancestor
65187290|NCT02738632|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65326841|NCT02590536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326842|NCT02590536|Urological Agents|urological agents|mesh-ancestor
65326843|NCT04086264|Azacitidine|azacitidine|mesh-list
65326844|NCT04086264|Decitabine|decitabine|mesh-list
65326845|NCT04086264|Venetoclax|venetoclax|mesh-list
65326846|NCT04086264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65326847|NCT04086264|Antimetabolites|antimetabolites|mesh-ancestor
65326848|NCT04086264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187291|NCT02738632|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65187292|NCT02738632|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65187293|NCT01070394|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65187294|NCT01070394|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65187295|NCT01070394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187296|NCT01070394|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65187297|NCT01070394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65187298|NCT01070394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65187299|NCT01070394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187300|NCT01070394|Dopamine Agents|dopamine agents|mesh-ancestor
65187301|NCT01070394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65187302|NCT00703807|Everolimus|everolimus|mesh-list
65187303|NCT00703807|Topotecan|topotecan|mesh-list
65187304|NCT00703807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187305|NCT00703807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65187306|NCT00703807|Immunologic Factors|immunologic factors|mesh-ancestor
65187307|NCT00703807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502046|NCT03005002|Durvalumab|durvalumab|mesh-list
65187308|NCT00703807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65187309|NCT00703807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65187310|NCT00703807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187311|NCT00703807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187312|NCT03649438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65187313|NCT03649438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187314|NCT03649438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187315|NCT03649438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187316|NCT03649438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65187317|NCT00701233|Botulinum Toxins|botulinum toxins|mesh-list
65187318|NCT00701233|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65187319|NCT00701233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65187320|NCT00701233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187321|NCT00701233|Cholinergic Agents|cholinergic agents|mesh-ancestor
65187322|NCT00701233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65187323|NCT00701233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187324|NCT03633058|Ketamine|ketamine|mesh-list
65187325|NCT03633058|Analgesics|analgesics|mesh-ancestor
65187326|NCT03633058|Sensory System Agents|sensory system agents|mesh-ancestor
65187327|NCT03633058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65187328|NCT03633058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187329|NCT03633058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65187334|NCT03633058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65187335|NCT03633058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65187336|NCT03633058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65187337|NCT03633058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187338|NCT01070316|Everolimus|everolimus|mesh-list
65187339|NCT01070316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187340|NCT01070316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65187341|NCT01070316|Immunologic Factors|immunologic factors|mesh-ancestor
65187342|NCT01070316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187343|NCT02737774|Carboplatin|carboplatin|mesh-list
65187344|NCT02737774|Pemetrexed|pemetrexed|mesh-list
65187345|NCT02737774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187346|NCT02737774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187347|NCT02737774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187348|NCT02737774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65187349|NCT02737774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65187350|NCT02735590|Isoniazid|isoniazid|mesh-list
65187351|NCT02735590|Rifapentine|rifapentine|mesh-list
65326849|NCT04086264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326850|NCT04086264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326851|NCT04756401|Dexamethasone|dexamethasone|mesh-list
65326852|NCT04756401|Dexamethasone acetate|dexamethasone acetate|mesh-list
65326853|NCT04756401|Daratumumab|daratumumab|mesh-list
65326854|NCT04756401|Ichthammol|ichthammol|mesh-list
65187352|NCT02735590|Antitubercular Agents|antitubercular agents|mesh-ancestor
65187353|NCT02735590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65187354|NCT02735590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65187355|NCT02735590|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65187356|NCT02735590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65187357|NCT02735590|Antimetabolites|antimetabolites|mesh-ancestor
65187358|NCT02735590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187359|NCT02735590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65187360|NCT02735590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65187361|NCT02735590|Leprostatic Agents|leprostatic agents|mesh-ancestor
65187362|NCT05626348|Hydroxychloroquine|hydroxychloroquine|mesh-list
65187363|NCT05626348|Adalimumab|adalimumab|mesh-list
65187364|NCT05626348|Methotrexate|methotrexate|mesh-list
65187365|NCT05626348|Leflunomide|leflunomide|mesh-list
65187366|NCT05626348|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65187367|NCT05626348|Abortifacient Agents|abortifacient agents|mesh-ancestor
65187368|NCT05626348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65187369|NCT05626348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187370|NCT05626348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65187371|NCT05626348|Antimetabolites|antimetabolites|mesh-ancestor
65187372|NCT05626348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187373|NCT05626348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187374|NCT05626348|Dermatologic Agents|dermatologic agents|mesh-ancestor
65187375|NCT05626348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187376|NCT05626348|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65187377|NCT05626348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65187378|NCT05626348|Immunologic Factors|immunologic factors|mesh-ancestor
65187379|NCT05626348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65187380|NCT05626348|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65187381|NCT05626348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65187383|NCT05626348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65187384|NCT05626348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65187385|NCT05626348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65187386|NCT02737696|Analgesics, Opioid|analgesics, opioid|mesh-list
65187387|NCT02737696|Narcotics|narcotics|mesh-ancestor
65187388|NCT02737696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65187389|NCT02737696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187390|NCT02737696|Analgesics|analgesics|mesh-ancestor
65187391|NCT02737696|Sensory System Agents|sensory system agents|mesh-ancestor
65187392|NCT02737696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65187393|NCT02737228|Gemcitabine|gemcitabine|mesh-list
65187394|NCT02737228|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65187395|NCT02737228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65187396|NCT02737228|Antimetabolites|antimetabolites|mesh-ancestor
65187397|NCT02737228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187398|NCT02737228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187399|NCT02737228|Antiviral Agents|antiviral agents|mesh-ancestor
65187400|NCT02737228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65187401|NCT02737228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187404|NCT02737228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187405|NCT02737228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65187406|NCT01126541|Rituximab|rituximab|mesh-list
65187407|NCT01126541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65187408|NCT01126541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187409|NCT01126541|Immunologic Factors|immunologic factors|mesh-ancestor
65187410|NCT01126541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187411|NCT01126541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65187412|NCT02737150|Anesthetics|anesthetics|mesh-list
65187413|NCT02737150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65187414|NCT02737150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187415|NCT02735356|Itraconazole|itraconazole|mesh-list
65187416|NCT02735356|Antifungal Agents|antifungal agents|mesh-ancestor
65187417|NCT02735356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65187418|NCT02735356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65187419|NCT02735356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65326855|NCT04756401|BB 1101|bb 1101|mesh-list
65326856|NCT04756401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65326857|NCT04756401|Antiemetics|antiemetics|mesh-ancestor
65326858|NCT04756401|Autonomic Agents|autonomic agents|mesh-ancestor
65326859|NCT04756401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65326860|NCT04756401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326861|NCT04756401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65326862|NCT04756401|Glucocorticoids|glucocorticoids|mesh-ancestor
65326863|NCT04756401|Hormones|hormones|mesh-ancestor
65187420|NCT02735356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187421|NCT02735356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187422|NCT02735356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65187423|NCT02735356|Hormone Antagonists|hormone antagonists|mesh-ancestor
65187424|NCT02735356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65187425|NCT02735356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187426|NCT02735356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65187427|NCT00625469|Bosentan|bosentan|mesh-list
65187429|NCT00625469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65187430|NCT00625469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187431|NCT05577910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65187432|NCT05577910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65187433|NCT00637481|Atorvastatin|atorvastatin|mesh-list
65187434|NCT00637481|Calcium|calcium|mesh-list
65187435|NCT00637481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65187436|NCT00637481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187437|NCT00637481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65187438|NCT00637481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65187439|NCT00637481|Antimetabolites|antimetabolites|mesh-ancestor
65187440|NCT00637481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187441|NCT00637481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65187442|NCT00637481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65187443|NCT00637481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187444|NCT04278898|Acetylcysteine|acetylcysteine|mesh-list
65187445|NCT04278898|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65187446|NCT04278898|Antiviral Agents|antiviral agents|mesh-ancestor
65187447|NCT04278898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65187448|NCT04278898|Expectorants|expectorants|mesh-ancestor
65187449|NCT04278898|Respiratory System Agents|respiratory system agents|mesh-ancestor
65187450|NCT04278898|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65187451|NCT04278898|Antioxidants|antioxidants|mesh-ancestor
65187452|NCT04278898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187453|NCT04278898|Protective Agents|protective agents|mesh-ancestor
65187454|NCT04278898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187455|NCT04278898|Antidotes|antidotes|mesh-ancestor
65187456|NCT00637559|Esomeprazole|esomeprazole|mesh-list
65187457|NCT00637559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65187458|NCT00637559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65187459|NCT00637559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65187460|NCT00637559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187461|NCT00637559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187462|NCT00836875|Voriconazole|voriconazole|mesh-list
65187463|NCT00836875|Antifungal Agents|antifungal agents|mesh-ancestor
65187464|NCT00836875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65187465|NCT00836875|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65187466|NCT00836875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65187467|NCT00836875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187468|NCT00836875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187469|NCT00836875|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65187470|NCT00836875|Hormone Antagonists|hormone antagonists|mesh-ancestor
65187471|NCT00836875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65187472|NCT00836875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187476|NCT01125917|Buprenorphine|buprenorphine|mesh-list
65187477|NCT01125917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65187478|NCT01125917|Narcotics|narcotics|mesh-ancestor
65187479|NCT01125917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65076821|NCT00324623|Cyclophosphamide|cyclophosphamide|mesh-list
65326864|NCT04756401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65326865|NCT04756401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65326867|NCT04756401|Protease Inhibitors|protease inhibitors|mesh-ancestor
65187480|NCT01125917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187481|NCT01125917|Analgesics|analgesics|mesh-ancestor
65187482|NCT01125917|Sensory System Agents|sensory system agents|mesh-ancestor
65187483|NCT01125917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65187484|NCT01125917|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65187485|NCT02732236|Rituximab|rituximab|mesh-list
65187486|NCT02732236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65187487|NCT02732236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187488|NCT02732236|Immunologic Factors|immunologic factors|mesh-ancestor
65187489|NCT02732236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187490|NCT02732236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65187491|NCT01121549|Exemestane|exemestane|mesh-list
65187492|NCT01121549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187493|NCT01121549|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65187494|NCT01121549|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65187495|NCT01121549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187496|NCT01121549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187497|NCT01121549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65187498|NCT01121549|Hormone Antagonists|hormone antagonists|mesh-ancestor
65187499|NCT01121549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64830065|NCT01571609|Insulin|insulin|mesh-list
65187500|NCT01121549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187501|NCT00847405|Sumatriptan|sumatriptan|mesh-list
65187502|NCT00847405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65187503|NCT00847405|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65187504|NCT00847405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65187505|NCT00847405|Serotonin Agents|serotonin agents|mesh-ancestor
65187506|NCT00847405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65187507|NCT00847405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187508|NCT00847405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187509|NCT02731846|Fluticasone|fluticasone|mesh-list
65187510|NCT02731846|Xhance|xhance|mesh-list
65187511|NCT02731846|Albuterol|albuterol|mesh-list
65187512|NCT02731846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65187513|NCT02731846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65187514|NCT02731846|Autonomic Agents|autonomic agents|mesh-ancestor
65187515|NCT02731846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65187516|NCT02731846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187517|NCT02731846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65187518|NCT02731846|Respiratory System Agents|respiratory system agents|mesh-ancestor
65187519|NCT02731846|Dermatologic Agents|dermatologic agents|mesh-ancestor
65187520|NCT02731846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65187521|NCT02731846|Tocolytic Agents|tocolytic agents|mesh-ancestor
65187522|NCT02731846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65187523|NCT02731846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65187524|NCT02731846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65187525|NCT02731846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65187526|NCT02731846|Adrenergic Agents|adrenergic agents|mesh-ancestor
65187527|NCT02731846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65187528|NCT02731846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187529|NCT04248712|Loratadine|loratadine|mesh-list
65187530|NCT04248712|Famotidine|famotidine|mesh-list
65187531|NCT04248712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65187532|NCT04248712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65187533|NCT04248712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65187534|NCT04248712|Histamine Antagonists|histamine antagonists|mesh-ancestor
65187535|NCT04248712|Histamine Agents|histamine agents|mesh-ancestor
65187536|NCT04248712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65187537|NCT04248712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187538|NCT04248712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187539|NCT04248712|Antipruritics|antipruritics|mesh-ancestor
65187540|NCT04248712|Dermatologic Agents|dermatologic agents|mesh-ancestor
65187541|NCT04248712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65187542|NCT04248712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65187543|NCT04248712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65187544|NCT02734732|Ciprofloxacin|ciprofloxacin|mesh-list
65326868|NCT04756401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326869|NCT04756401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326870|NCT04756401|Dermatologic Agents|dermatologic agents|mesh-ancestor
65326871|NCT00719862|Azelastine|azelastine|mesh-list
65326872|NCT00719862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65326873|NCT00719862|Autonomic Agents|autonomic agents|mesh-ancestor
65326874|NCT00719862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65187550|NCT02734732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65187551|NCT02734732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187552|NCT02734732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187553|NCT02734732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187554|NCT02734732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65187555|NCT02734732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65187556|NCT02734732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65187557|NCT02734732|Renal Agents|renal agents|mesh-ancestor
65187558|NCT02734732|Antimalarials|antimalarials|mesh-ancestor
65187559|NCT02734732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65187560|NCT02734732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65187561|NCT02734732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65187562|NCT02734732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65187563|NCT02734732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65187565|NCT02731378|Dextrans|dextrans|mesh-list
65187566|NCT02731378|Epoetin Alfa|epoetin alfa|mesh-list
65187567|NCT02731378|Iron-Dextran Complex|iron-dextran complex|mesh-list
65187568|NCT02731378|Trace Elements|trace elements|mesh-ancestor
65187569|NCT02731378|Micronutrients|micronutrients|mesh-ancestor
65187570|NCT02731378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187571|NCT02731378|Hematinics|hematinics|mesh-ancestor
65187572|NCT02731378|Anticoagulants|anticoagulants|mesh-ancestor
65187573|NCT02731378|Plasma Substitutes|plasma substitutes|mesh-ancestor
65187574|NCT02731378|Blood Substitutes|blood substitutes|mesh-ancestor
65187575|NCT02731534|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64830138|NCT01571921|Vitamins|vitamins|mesh-ancestor
65187576|NCT02731534|Hematinics|hematinics|mesh-ancestor
65187577|NCT02734420|Tolonium Chloride|tolonium chloride|mesh-list
65187578|NCT02734420|Hemostatics|hemostatics|mesh-ancestor
65187579|NCT02734420|Coagulants|coagulants|mesh-ancestor
65187580|NCT02734420|Heparin Antagonists|heparin antagonists|mesh-ancestor
65187581|NCT02734420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187582|NCT00704275|Cyclosporine|cyclosporine|mesh-list
65187583|NCT00704275|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65187584|NCT00704275|Cyclosporins|cyclosporins|mesh-list
65187585|NCT00704275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187586|NCT00704275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187587|NCT00704275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65187588|NCT00704275|Immunologic Factors|immunologic factors|mesh-ancestor
65187589|NCT00704275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187590|NCT00704275|Antifungal Agents|antifungal agents|mesh-ancestor
65187591|NCT00704275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65187592|NCT00704275|Dermatologic Agents|dermatologic agents|mesh-ancestor
65187593|NCT00704275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65187594|NCT00704275|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65187595|NCT00704275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65187596|NCT00847015|Gemcitabine|gemcitabine|mesh-list
65187597|NCT00847015|Sunitinib|sunitinib|mesh-list
65187598|NCT00847015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187599|NCT00847015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65187600|NCT00847015|Antimetabolites|antimetabolites|mesh-ancestor
65187601|NCT00847015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187602|NCT00847015|Antiviral Agents|antiviral agents|mesh-ancestor
65187603|NCT00847015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65187604|NCT00847015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187605|NCT00847015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65187607|NCT00847015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187608|NCT00847015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65187609|NCT00847015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65187610|NCT00847015|Growth Substances|growth substances|mesh-ancestor
65187611|NCT00847015|Growth Inhibitors|growth inhibitors|mesh-ancestor
65187612|NCT00847015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65187613|NCT00627354|Prednisone|prednisone|mesh-list
65326875|NCT00719862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326876|NCT00719862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65326877|NCT00719862|Respiratory System Agents|respiratory system agents|mesh-ancestor
65326878|NCT00719862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65326879|NCT00719862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326880|NCT00719862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187614|NCT00627354|Etoposide|etoposide|mesh-list
65187615|NCT00627354|Vinorelbine|vinorelbine|mesh-list
65187616|NCT00627354|Mitoxantrone|mitoxantrone|mesh-list
65187617|NCT00627354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65187618|NCT00627354|Glucocorticoids|glucocorticoids|mesh-ancestor
65187619|NCT00627354|Hormones|hormones|mesh-ancestor
65187626|NCT00627354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65187627|NCT00627354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187628|NCT00627354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187629|NCT00627354|Tubulin Modulators|tubulin modulators|mesh-ancestor
65187630|NCT00627354|Antimitotic Agents|antimitotic agents|mesh-ancestor
65187631|NCT00627354|Mitosis Modulators|mitosis modulators|mesh-ancestor
65187632|NCT00627354|Analgesics|analgesics|mesh-ancestor
65187633|NCT00627354|Sensory System Agents|sensory system agents|mesh-ancestor
65187634|NCT00627354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65187635|NCT00704431|Darapladib|darapladib|mesh-list
65187636|NCT00704431|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
65187637|NCT00704431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187638|NCT00704431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187639|NCT02734186|Praziquantel|praziquantel|mesh-list
65187640|NCT02734186|Anthelmintics|anthelmintics|mesh-ancestor
65187641|NCT02734186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65187642|NCT02734186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65187643|NCT00704509|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65187644|NCT00704509|Antidepressive Agents|antidepressive agents|mesh-ancestor
65187645|NCT00704509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65187646|NCT00704509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65187647|NCT00704509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65187648|NCT00704509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65187649|NCT00704509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187650|NCT02733952|Tranexamic Acid|tranexamic acid|mesh-list
65187651|NCT02733952|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65187652|NCT02733952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65187653|NCT02733952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187654|NCT02733952|Hemostatics|hemostatics|mesh-ancestor
65187655|NCT02733952|Coagulants|coagulants|mesh-ancestor
65187656|NCT02733640|Pantoprazole|pantoprazole|mesh-list
65187657|NCT02733640|Ranitidine|ranitidine|mesh-list
65187658|NCT02733640|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65187659|NCT02733640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65187660|NCT02733640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65187661|NCT02733640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65187662|NCT02733640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187663|NCT02733640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187664|NCT02733640|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65187665|NCT02733640|Histamine Antagonists|histamine antagonists|mesh-ancestor
65187666|NCT02733640|Histamine Agents|histamine agents|mesh-ancestor
65187667|NCT02733640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65187668|NCT02733640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187669|NCT02730676|Menthol|menthol|mesh-list
65187670|NCT02730676|Antipruritics|antipruritics|mesh-ancestor
65187671|NCT02730676|Dermatologic Agents|dermatologic agents|mesh-ancestor
65187672|NCT00855595|Metronidazole|metronidazole|mesh-list
65187673|NCT00855595|Doxycycline|doxycycline|mesh-list
65187674|NCT00855595|Azelaic acid|azelaic acid|mesh-list
65187675|NCT00855595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65187676|NCT00855595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65187677|NCT00855595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65187678|NCT00855595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65187679|NCT00855595|Antimalarials|antimalarials|mesh-ancestor
65187680|NCT00855595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187681|NCT00855595|Dermatologic Agents|dermatologic agents|mesh-ancestor
65187682|NCT05433532|Azacitidine|azacitidine|mesh-list
65187683|NCT05433532|Venetoclax|venetoclax|mesh-list
65187684|NCT05433532|HH-GV-678|hh-gv-678|mesh-list
65187685|NCT05433532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65326881|NCT00719862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65326882|NCT00719862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65326883|NCT00719862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65326884|NCT00719862|Histamine Antagonists|histamine antagonists|mesh-ancestor
65326885|NCT00719862|Histamine Agents|histamine agents|mesh-ancestor
65326886|NCT00719862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65326887|NCT02578953|Dutasteride|dutasteride|mesh-list
65187686|NCT05433532|Antimetabolites|antimetabolites|mesh-ancestor
65187687|NCT05433532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187688|NCT05433532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187690|NCT05433532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65187691|NCT00855439|Exenatide|exenatide|mesh-list
65187692|NCT00855439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65187693|NCT00855439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187694|NCT00855439|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65187695|NCT00855439|Incretins|incretins|mesh-ancestor
65187696|NCT00855439|Hormones|hormones|mesh-ancestor
65187697|NCT00855439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65187698|NCT01064856|Adalimumab|adalimumab|mesh-list
65187699|NCT01064856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65187700|NCT01064856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65187701|NCT02730442|Fluconazole|fluconazole|mesh-list
65187702|NCT02730442|Antifungal Agents|antifungal agents|mesh-list
65187703|NCT02730442|Clotrimazole|clotrimazole|mesh-list
65187704|NCT02730442|Miconazole|miconazole|mesh-list
65187705|NCT02730442|Olorofim|olorofim|mesh-list
65187706|NCT02730442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65187707|NCT02730442|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65187708|NCT02730442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65187709|NCT02730442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187710|NCT02730442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187711|NCT02730442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65187712|NCT02730442|Hormone Antagonists|hormone antagonists|mesh-ancestor
65187713|NCT02730442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65187714|NCT02730442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187715|NCT02730442|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65187716|NCT02730442|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65187717|NCT02730442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65187718|NCT02730442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65187719|NCT02733874|Betamethasone|betamethasone|mesh-list
65187720|NCT02733874|Clobetasol|clobetasol|mesh-list
65187721|NCT02733874|Calcipotriene|calcipotriene|mesh-list
65187722|NCT02733874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65187723|NCT02733874|Glucocorticoids|glucocorticoids|mesh-ancestor
65187724|NCT02733874|Hormones|hormones|mesh-ancestor
65187725|NCT02733874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65187726|NCT02733874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187727|NCT02733874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65187728|NCT02733874|Respiratory System Agents|respiratory system agents|mesh-ancestor
65187729|NCT02733874|Dermatologic Agents|dermatologic agents|mesh-ancestor
65187730|NCT02730364|Acetaminophen|acetaminophen|mesh-list
65187731|NCT02730364|Pheniramine|pheniramine|mesh-list
65187732|NCT02730364|Phenylephrine|phenylephrine|mesh-list
65187733|NCT02730364|Oxymetazoline|oxymetazoline|mesh-list
65187734|NCT02730364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187735|NCT02730364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65187736|NCT02730364|Analgesics|analgesics|mesh-ancestor
65187737|NCT02730364|Sensory System Agents|sensory system agents|mesh-ancestor
65187738|NCT02730364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65187739|NCT02730364|Antipyretics|antipyretics|mesh-ancestor
65187740|NCT02730364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187741|NCT02730364|Protective Agents|protective agents|mesh-ancestor
65187742|NCT02730364|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65187743|NCT02730364|Mydriatics|mydriatics|mesh-ancestor
65187744|NCT02730364|Autonomic Agents|autonomic agents|mesh-ancestor
65187745|NCT02730364|Sympathomimetics|sympathomimetics|mesh-ancestor
65187746|NCT02730364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65187747|NCT02730364|Nasal Decongestants|nasal decongestants|mesh-ancestor
65187748|NCT02730364|Respiratory System Agents|respiratory system agents|mesh-ancestor
65326888|NCT02578953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65326889|NCT02578953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65326890|NCT02578953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326891|NCT02578953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326892|NCT02578953|Hormone Antagonists|hormone antagonists|mesh-ancestor
65326893|NCT02578953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65326894|NCT02578953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326895|NCT02578719|Bupivacaine|bupivacaine|mesh-list
65326896|NCT02578719|Anesthetics, Local|anesthetics, local|mesh-ancestor
65326897|NCT02578719|Anesthetics|anesthetics|mesh-ancestor
65326898|NCT02578719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65326899|NCT02578719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326900|NCT02578719|Sensory System Agents|sensory system agents|mesh-ancestor
65326901|NCT02578719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65187749|NCT02730364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65187750|NCT02730364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65187751|NCT02730364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65187752|NCT02730364|Adrenergic Agents|adrenergic agents|mesh-ancestor
65187753|NCT02730364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65187754|NCT02730364|Antipruritics|antipruritics|mesh-ancestor
65187755|NCT02730364|Dermatologic Agents|dermatologic agents|mesh-ancestor
65187756|NCT02730364|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65187757|NCT02730364|Histamine Antagonists|histamine antagonists|mesh-ancestor
65187758|NCT02730364|Histamine Agents|histamine agents|mesh-ancestor
65187759|NCT02730364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65187761|NCT01042392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65187763|NCT01042392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187764|NCT01042392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187765|NCT01042392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65187769|NCT00704665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65187770|NCT00704665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65187771|NCT00913315|Tamsulosin|tamsulosin|mesh-list
65187772|NCT00913315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65187773|NCT00913315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65187774|NCT00913315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65187775|NCT00913315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65187776|NCT00913315|Adrenergic Agents|adrenergic agents|mesh-ancestor
65187777|NCT00913315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65187778|NCT00913315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187779|NCT00913315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187780|NCT00913315|Urological Agents|urological agents|mesh-ancestor
65187781|NCT00913315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65187782|NCT00913315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65187783|NCT00913315|Cholinergic Agents|cholinergic agents|mesh-ancestor
65187784|NCT00701857|Pemetrexed|pemetrexed|mesh-list
65187785|NCT00701857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187786|NCT00701857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187787|NCT00701857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187788|NCT00701857|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65187789|NCT00701857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65187790|NCT02729662|Tolvaptan|tolvaptan|mesh-list
65187791|NCT02729662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65187792|NCT02729662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187793|NCT02729662|Natriuretic Agents|natriuretic agents|mesh-ancestor
65187794|NCT02729662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187795|NCT02733250|Paclitaxel|paclitaxel|mesh-list
65187796|NCT02733250|Pembrolizumab|pembrolizumab|mesh-list
65326902|NCT00742508|Carvedilol|carvedilol|mesh-list
65326903|NCT00742508|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65326904|NCT00742508|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65326905|NCT00742508|Adrenergic Agents|adrenergic agents|mesh-ancestor
65326906|NCT00742508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65326907|NCT00742508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326908|NCT00742508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326909|NCT00742508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65326910|NCT00742508|Antioxidants|antioxidants|mesh-ancestor
65326911|NCT00742508|Protective Agents|protective agents|mesh-ancestor
65326912|NCT00742508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65326913|NCT00742508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65326914|NCT00742508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65326915|NCT00742508|Vasodilator Agents|vasodilator agents|mesh-ancestor
65326916|NCT00742508|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65326917|NCT00742508|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65326918|NCT02590614|Vitamin D|vitamin d|mesh-list
65326919|NCT02590614|Vitamins|vitamins|mesh-ancestor
65187797|NCT02733250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65187798|NCT02733250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187799|NCT02733250|Tubulin Modulators|tubulin modulators|mesh-ancestor
65187800|NCT02733250|Antimitotic Agents|antimitotic agents|mesh-ancestor
65187801|NCT02733250|Mitosis Modulators|mitosis modulators|mesh-ancestor
65187802|NCT02733250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187803|NCT02733250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65187804|NCT03188068|Sirolimus|sirolimus|mesh-list
64830366|NCT01572805|Melatonin|melatonin|mesh-list
65187805|NCT03188068|Prednisolone|prednisolone|mesh-list
65187806|NCT03188068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65187807|NCT03188068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65187808|NCT03188068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65187809|NCT03188068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187810|NCT03188068|Antifungal Agents|antifungal agents|mesh-ancestor
65187811|NCT03188068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65187812|NCT03188068|Immunologic Factors|immunologic factors|mesh-ancestor
65187813|NCT03188068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187814|NCT03188068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65187815|NCT03188068|Glucocorticoids|glucocorticoids|mesh-ancestor
65187816|NCT03188068|Hormones|hormones|mesh-ancestor
65187817|NCT03188068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65187818|NCT03188068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65187819|NCT01064310|Sunitinib|sunitinib|mesh-list
65187820|NCT01064310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187821|NCT01064310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65187822|NCT01064310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65187823|NCT01064310|Growth Substances|growth substances|mesh-ancestor
65187824|NCT01064310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187825|NCT01064310|Growth Inhibitors|growth inhibitors|mesh-ancestor
65187826|NCT01064310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65187827|NCT01064310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187828|NCT01064310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187829|NCT02726854|Apatinib|apatinib|mesh-list
65187830|NCT02726854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187831|NCT02726854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65187832|NCT02726854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326920|NCT02590614|Micronutrients|micronutrients|mesh-ancestor
65326921|NCT02590614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326922|NCT02590614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65326923|NCT02575443|Rocuronium|rocuronium|mesh-list
65326924|NCT02575443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65326925|NCT02575443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65326926|NCT02575443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65326927|NCT02575443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65326928|NCT02575443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326929|NCT05382650|Immunoglobulins|immunoglobulins|mesh-list
65326930|NCT05382650|Antibodies|antibodies|mesh-list
65326931|NCT05382650|gamma-Globulins|gamma-globulins|mesh-list
65326932|NCT05382650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65326933|NCT05382650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65326934|NCT05382650|Immunologic Factors|immunologic factors|mesh-ancestor
65326935|NCT05382650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326936|NCT02596334|Lamivudine|lamivudine|mesh-list
65326937|NCT02596334|Abacavir|abacavir|mesh-list
65326938|NCT02596334|Dolutegravir|dolutegravir|mesh-list
65326939|NCT02596334|Triumeq|triumeq|mesh-list
65187833|NCT02726854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187834|NCT02728492|Gemcitabine|gemcitabine|mesh-list
65187835|NCT02728492|Paclitaxel|paclitaxel|mesh-list
65187845|NCT02728492|Antiviral Agents|antiviral agents|mesh-ancestor
65187846|NCT02728492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65187847|NCT02728492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187848|NCT02728492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65187849|NCT02728492|Immunologic Factors|immunologic factors|mesh-ancestor
65187850|NCT02728492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187851|NCT02726308|Dexamethasone|dexamethasone|mesh-list
65187852|NCT02726308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65187853|NCT02726308|Antiemetics|antiemetics|mesh-ancestor
65187854|NCT02726308|Autonomic Agents|autonomic agents|mesh-ancestor
65187855|NCT02726308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65187856|NCT02726308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187857|NCT02726308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65187858|NCT02726308|Glucocorticoids|glucocorticoids|mesh-ancestor
65187859|NCT02726308|Hormones|hormones|mesh-ancestor
65187860|NCT02726308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65187861|NCT02726308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65187862|NCT02726308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187863|NCT01037244|Udenafil|udenafil|mesh-list
65187864|NCT01037244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65187865|NCT01037244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65187866|NCT01037244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187867|NCT01037244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187868|NCT03100786|Dexamethasone|dexamethasone|mesh-list
65187869|NCT03100786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65187870|NCT03100786|Antiemetics|antiemetics|mesh-ancestor
65187871|NCT03100786|Autonomic Agents|autonomic agents|mesh-ancestor
65187872|NCT03100786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65187873|NCT03100786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187874|NCT03100786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65187875|NCT03100786|Glucocorticoids|glucocorticoids|mesh-ancestor
65187876|NCT03100786|Hormones|hormones|mesh-ancestor
65187877|NCT03100786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65187878|NCT03100786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65326940|NCT02596334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65326941|NCT02596334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65326942|NCT02596334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326943|NCT02596334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326944|NCT02596334|Antiviral Agents|antiviral agents|mesh-ancestor
65326945|NCT02596334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65326946|NCT02596334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65326947|NCT02596334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65187879|NCT03100786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187880|NCT00627432|Gemcitabine|gemcitabine|mesh-list
65187881|NCT00627432|Oxaliplatin|oxaliplatin|mesh-list
65187882|NCT00627432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65187883|NCT00627432|Antimetabolites|antimetabolites|mesh-ancestor
65187884|NCT00627432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187885|NCT00627432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187886|NCT00627432|Antiviral Agents|antiviral agents|mesh-ancestor
65187887|NCT00627432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65187888|NCT00627432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187889|NCT00627432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65187890|NCT00627432|Immunologic Factors|immunologic factors|mesh-ancestor
65187891|NCT00627432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187892|NCT02727712|Anesthetics|anesthetics|mesh-list
65187893|NCT02727712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65187894|NCT02727712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187895|NCT01042236|Fesoterodine|fesoterodine|mesh-list
65187896|NCT01042236|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65187897|NCT01042236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65187898|NCT01042236|Cholinergic Agents|cholinergic agents|mesh-ancestor
65187899|NCT01042236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65187900|NCT01042236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187931|NCT02720926|Capecitabine|capecitabine|mesh-list
65187932|NCT02720926|Oxaliplatin|oxaliplatin|mesh-list
65187933|NCT02720926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65187934|NCT02720926|Antimetabolites|antimetabolites|mesh-ancestor
65187935|NCT02720926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187936|NCT02720926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187937|NCT00854581|Interferons|interferons|mesh-list
65187938|NCT00854581|Interferon-alpha|interferon-alpha|mesh-list
65187939|NCT00854581|Interferon alpha-2|interferon alpha-2|mesh-list
65187940|NCT00854581|Zidovudine|zidovudine|mesh-list
65187941|NCT00854581|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65187942|NCT00854581|Valproic Acid|valproic acid|mesh-list
65187943|NCT00854581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187947|NCT00854581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187949|NCT00854581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187950|NCT00854581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65187951|NCT00854581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65187952|NCT00854581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187953|NCT00854581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65187954|NCT00854581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65187955|NCT00854581|Anticonvulsants|anticonvulsants|mesh-ancestor
65187956|NCT00854581|GABA Agents|gaba agents|mesh-ancestor
65187957|NCT00854581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65187958|NCT00854581|Antimanic Agents|antimanic agents|mesh-ancestor
65187959|NCT00854581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65187960|NCT00854581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65187961|NCT00854581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65187962|NCT02720692|Meloxicam|meloxicam|mesh-list
65187963|NCT02720692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65187964|NCT02720692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65187965|NCT02720692|Analgesics|analgesics|mesh-ancestor
65187966|NCT02720692|Sensory System Agents|sensory system agents|mesh-ancestor
65187967|NCT02720692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65187968|NCT02720692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187969|NCT02720692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65187970|NCT02720692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65326948|NCT02596334|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65326949|NCT02596334|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65326950|NCT00719706|Acetylcarnitine|acetylcarnitine|mesh-list
65326951|NCT00719706|Vitamin B Complex|vitamin b complex|mesh-ancestor
65326952|NCT00719706|Vitamins|vitamins|mesh-ancestor
65326953|NCT00719706|Micronutrients|micronutrients|mesh-ancestor
65326954|NCT00719706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326955|NCT00719706|Nootropic Agents|nootropic agents|mesh-ancestor
65187971|NCT02720692|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65187972|NCT02720692|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65187973|NCT02720692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187974|NCT02720692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187975|NCT02720458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65187976|NCT02720458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65187977|NCT02720458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187978|NCT00833911|Tramadol|tramadol|mesh-list
65187979|NCT00833911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65187980|NCT00833911|Narcotics|narcotics|mesh-ancestor
65187981|NCT00833911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65187982|NCT00833911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187983|NCT00833911|Analgesics|analgesics|mesh-ancestor
65187984|NCT00833911|Sensory System Agents|sensory system agents|mesh-ancestor
65187985|NCT00833911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65187986|NCT02719756|Metformin|metformin|mesh-list
65187987|NCT02719756|Dapagliflozin|dapagliflozin|mesh-list
65187988|NCT02719756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65187989|NCT02719756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187990|NCT02719756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65187991|NCT02719756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187992|NCT01125293|Rituximab|rituximab|mesh-list
65187993|NCT01125293|Everolimus|everolimus|mesh-list
65187994|NCT01125293|Bortezomib|bortezomib|mesh-list
65187995|NCT01125293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65187996|NCT01125293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187997|NCT01125293|Immunologic Factors|immunologic factors|mesh-ancestor
65187998|NCT01125293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187999|NCT01125293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65188000|NCT01125293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65188001|NCT02719834|Acetaminophen|acetaminophen|mesh-list
65188002|NCT02719834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65188003|NCT02719834|Analgesics|analgesics|mesh-ancestor
65188004|NCT02719834|Sensory System Agents|sensory system agents|mesh-ancestor
65188005|NCT02719834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65188006|NCT02719834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188007|NCT02719834|Antipyretics|antipyretics|mesh-ancestor
65188008|NCT02719210|Mannitol|mannitol|mesh-list
65188009|NCT02719210|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65188010|NCT02719210|Diuretics|diuretics|mesh-ancestor
65188011|NCT02719210|Natriuretic Agents|natriuretic agents|mesh-ancestor
65188012|NCT02719210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188013|NCT02719132|Metformin|metformin|mesh-list
65188014|NCT02719132|Dapagliflozin|dapagliflozin|mesh-list
65188015|NCT02719132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65188016|NCT02719132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188022|NCT02718820|Tubulin Modulators|tubulin modulators|mesh-ancestor
65188023|NCT02718820|Antimitotic Agents|antimitotic agents|mesh-ancestor
65188024|NCT02718820|Mitosis Modulators|mitosis modulators|mesh-ancestor
65188025|NCT02718820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188026|NCT02718820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65188027|NCT02718976|Lidocaine|lidocaine|mesh-list
65188028|NCT02718976|Epinephrine|epinephrine|mesh-list
65188029|NCT02718976|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
64830598|NCT01575301|Exenatide|exenatide|mesh-list
65188030|NCT02718976|Anesthetics, Local|anesthetics, local|mesh-ancestor
65188031|NCT02718976|Anesthetics|anesthetics|mesh-ancestor
65188032|NCT02718976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65188033|NCT02718976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188034|NCT02718976|Sensory System Agents|sensory system agents|mesh-ancestor
65188035|NCT02718976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65326956|NCT02575521|Dexmedetomidine|dexmedetomidine|mesh-list
65326957|NCT02575521|Propofol|propofol|mesh-list
65326958|NCT02575521|Sevoflurane|sevoflurane|mesh-list
65326959|NCT02575521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65326960|NCT02575521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65326961|NCT02575521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65326962|NCT02575521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65188036|NCT02718976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65188037|NCT02718976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65188038|NCT02718976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65188039|NCT02718976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65188040|NCT02718976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188041|NCT02718976|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65188042|NCT02718976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65188043|NCT02718976|Adrenergic Agents|adrenergic agents|mesh-ancestor
65188044|NCT02718976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65188045|NCT02718976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65188046|NCT02718976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65188047|NCT02718976|Autonomic Agents|autonomic agents|mesh-ancestor
65188048|NCT02718976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65188049|NCT02718976|Respiratory System Agents|respiratory system agents|mesh-ancestor
65188050|NCT02718976|Mydriatics|mydriatics|mesh-ancestor
65188051|NCT02718976|Sympathomimetics|sympathomimetics|mesh-ancestor
65188052|NCT02718976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65188053|NCT02718976|Chelating Agents|chelating agents|mesh-ancestor
65188054|NCT02718976|Sequestering Agents|sequestering agents|mesh-ancestor
65188055|NCT02718742|Paclitaxel|paclitaxel|mesh-list
65188056|NCT02718742|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65188057|NCT02718742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65188059|NCT02718742|Tubulin Modulators|tubulin modulators|mesh-ancestor
65188060|NCT02718742|Antimitotic Agents|antimitotic agents|mesh-ancestor
65188061|NCT02718742|Mitosis Modulators|mitosis modulators|mesh-ancestor
65188062|NCT02718742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188063|NCT02717884|Cytarabine|cytarabine|mesh-list
65188064|NCT02717884|Tretinoin|tretinoin|mesh-list
65188065|NCT02717884|Tranylcypromine|tranylcypromine|mesh-list
65188066|NCT02717884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65188067|NCT02717884|Antimetabolites|antimetabolites|mesh-ancestor
65188068|NCT02717884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188069|NCT02717884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188070|NCT02717884|Antiviral Agents|antiviral agents|mesh-ancestor
65188071|NCT02717884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65188072|NCT02717884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65188073|NCT02717884|Immunologic Factors|immunologic factors|mesh-ancestor
65188074|NCT02717884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188075|NCT02717884|Keratolytic Agents|keratolytic agents|mesh-ancestor
65188076|NCT02717884|Dermatologic Agents|dermatologic agents|mesh-ancestor
65188077|NCT02717884|Antidepressive Agents|antidepressive agents|mesh-ancestor
65188078|NCT02717884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65188079|NCT02717884|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65188080|NCT02717884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188081|NCT02717884|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65188082|NCT02717884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65188083|NCT02717884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65188084|NCT02717572|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65188085|NCT02717572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65188097|NCT01121393|Immunologic Factors|immunologic factors|mesh-ancestor
65188098|NCT01121393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188099|NCT01121393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65188100|NCT02882477|Metformin|metformin|mesh-list
65188101|NCT02882477|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65188102|NCT02882477|Acetylcysteine|acetylcysteine|mesh-list
65188103|NCT02882477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65188104|NCT02882477|Deferiprone|deferiprone|mesh-list
65188105|NCT02882477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65188106|NCT02882477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188107|NCT02882477|Incretins|incretins|mesh-ancestor
65188109|NCT02882477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65188110|NCT02882477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65326963|NCT02575521|Anesthetics, General|anesthetics, general|mesh-ancestor
65326964|NCT02575521|Anesthetics|anesthetics|mesh-ancestor
65326965|NCT02575521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65326966|NCT02575521|Analgesics|analgesics|mesh-ancestor
65326967|NCT02575521|Sensory System Agents|sensory system agents|mesh-ancestor
65326968|NCT02575521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65326969|NCT02575521|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65326970|NCT02575521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65326971|NCT02575521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65326972|NCT02575521|Adrenergic Agents|adrenergic agents|mesh-ancestor
65326973|NCT02575521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65326974|NCT02575521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326975|NCT02575521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65188111|NCT02882477|Protease Inhibitors|protease inhibitors|mesh-ancestor
65188112|NCT02882477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188113|NCT02882477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188114|NCT02882477|Antiviral Agents|antiviral agents|mesh-ancestor
65188115|NCT02882477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65188116|NCT02882477|Expectorants|expectorants|mesh-ancestor
65188117|NCT02882477|Respiratory System Agents|respiratory system agents|mesh-ancestor
65188118|NCT02882477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65188119|NCT02882477|Antioxidants|antioxidants|mesh-ancestor
65188120|NCT02882477|Protective Agents|protective agents|mesh-ancestor
65188121|NCT02882477|Antidotes|antidotes|mesh-ancestor
65188122|NCT02882477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65188123|NCT02882477|Chelating Agents|chelating agents|mesh-ancestor
65188124|NCT02882477|Sequestering Agents|sequestering agents|mesh-ancestor
65188125|NCT04163224|Imidacloprid|imidacloprid|mesh-list
65188126|NCT04163224|Cholinergic Agents|cholinergic agents|mesh-ancestor
65188127|NCT04163224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65188128|NCT04163224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188129|NCT04163224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188130|NCT02716792|Ibandronic Acid|ibandronic acid|mesh-list
65188131|NCT02716792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65188132|NCT02716792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188134|NCT04964284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65188135|NCT04964284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188136|NCT02716090|Adapalene|adapalene|mesh-list
65188137|NCT02716090|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65188138|NCT02716090|Dermatologic Agents|dermatologic agents|mesh-ancestor
65188139|NCT02716090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65188140|NCT02716090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65188141|NCT02716090|Analgesics|analgesics|mesh-ancestor
65188142|NCT02716090|Sensory System Agents|sensory system agents|mesh-ancestor
65188143|NCT02716090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65188144|NCT02716090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188145|NCT02716090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65188146|NCT02716090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65188147|NCT01227616|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65188148|NCT01227616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65188149|NCT01227616|Hematinics|hematinics|mesh-ancestor
65188150|NCT01227616|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65188157|NCT02714998|Abortifacient Agents|abortifacient agents|mesh-ancestor
65188158|NCT02714998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65188159|NCT02714998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188160|NCT02714998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65188161|NCT02714998|Antimetabolites|antimetabolites|mesh-ancestor
65188162|NCT02714998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188163|NCT02714998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188164|NCT02714998|Dermatologic Agents|dermatologic agents|mesh-ancestor
65326976|NCT02575521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65326977|NCT02576457|BMS-936559|bms-936559|mesh-list
65326978|NCT02576457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65326979|NCT02576457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326980|NCT05276102|Emollients|emollients|mesh-list
65326981|NCT05276102|Dermatologic Agents|dermatologic agents|mesh-ancestor
65326982|NCT02596100|Betrixaban|betrixaban|mesh-list
65326983|NCT02596100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65326984|NCT02596100|Antithrombins|antithrombins|mesh-ancestor
64556473|NCT04148261|Mydriatics|mydriatics|mesh-ancestor
65188165|NCT02714998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188166|NCT02714998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65188167|NCT02714998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65188168|NCT02714998|Immunologic Factors|immunologic factors|mesh-ancestor
65188169|NCT02714998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65188170|NCT02714998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65188171|NCT00765310|Thioctic Acid|thioctic acid|mesh-list
65188172|NCT00765310|Antioxidants|antioxidants|mesh-ancestor
65188173|NCT00765310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188174|NCT00765310|Protective Agents|protective agents|mesh-ancestor
65188175|NCT00765310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188176|NCT00765310|Vitamin B Complex|vitamin b complex|mesh-ancestor
65188178|NCT00765310|Micronutrients|micronutrients|mesh-ancestor
65188179|NCT02715154|Dexmedetomidine|dexmedetomidine|mesh-list
65188180|NCT02715154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65188181|NCT02715154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65188182|NCT02715154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188183|NCT02715154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65188184|NCT02715154|Analgesics|analgesics|mesh-ancestor
65188185|NCT02715154|Sensory System Agents|sensory system agents|mesh-ancestor
65188186|NCT02715154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65188187|NCT02715154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65188188|NCT02715154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65188189|NCT02715154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65188190|NCT02715154|Adrenergic Agents|adrenergic agents|mesh-ancestor
65188191|NCT02715154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65188192|NCT02715154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188193|NCT02715232|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65188194|NCT02715232|Cyproterone Acetate|cyproterone acetate|mesh-list
65188195|NCT02715232|Lynestrenol|lynestrenol|mesh-list
65188196|NCT02715232|Estradiol|estradiol|mesh-list
65188197|NCT02715232|Testosterone|testosterone|mesh-list
65188198|NCT02715232|Cyproterone|cyproterone|mesh-list
65188199|NCT02715232|Estrogens|estrogens|mesh-ancestor
65188200|NCT02715232|Hormones|hormones|mesh-ancestor
65188201|NCT02715232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65188202|NCT02715232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188203|NCT02715232|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65188204|NCT02715232|Contraceptive Agents|contraceptive agents|mesh-ancestor
65188205|NCT02715232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65188206|NCT02715232|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65188207|NCT02715232|Androgens|androgens|mesh-ancestor
65188208|NCT02715232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65188209|NCT02715232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188210|NCT02715232|Luteolytic Agents|luteolytic agents|mesh-ancestor
65188211|NCT02715232|Androgen Antagonists|androgen antagonists|mesh-ancestor
65188212|NCT02715232|Hormone Antagonists|hormone antagonists|mesh-ancestor
65188213|NCT02715232|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65188214|NCT02715232|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65188215|NCT02715232|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65188216|NCT02715232|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65188217|NCT02693860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65188218|NCT02693860|Immunologic Factors|immunologic factors|mesh-ancestor
65188219|NCT02693860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188230|NCT02714842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188231|NCT02714842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188232|NCT02714530|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65326985|NCT02596100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65326986|NCT02596100|Protease Inhibitors|protease inhibitors|mesh-ancestor
65326987|NCT02596100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326988|NCT02596100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188233|NCT02714530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188234|NCT02714530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65188235|NCT02714530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188236|NCT02714530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188237|NCT02713750|Contraceptive Agents|contraceptive agents|mesh-list
65188238|NCT02713750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65188239|NCT02713750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188240|NCT04738162|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65188241|NCT04738162|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65188242|NCT04738162|Dermatologic Agents|dermatologic agents|mesh-ancestor
65188243|NCT04000906|Paclitaxel|paclitaxel|mesh-list
65188244|NCT04000906|Cisplatin|cisplatin|mesh-list
65188245|NCT04000906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65188246|NCT04000906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188247|NCT04000906|Tubulin Modulators|tubulin modulators|mesh-ancestor
65188248|NCT04000906|Antimitotic Agents|antimitotic agents|mesh-ancestor
65188249|NCT04000906|Mitosis Modulators|mitosis modulators|mesh-ancestor
65188250|NCT04000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188251|NCT00636766|Metformin|metformin|mesh-list
65188252|NCT00636766|Rosiglitazone|rosiglitazone|mesh-list
65188253|NCT00636766|Rimonabant|rimonabant|mesh-list
64830823|NCT01576770|Lidocaine|lidocaine|mesh-list
65188254|NCT00636766|Atorvastatin|atorvastatin|mesh-list
65188255|NCT00636766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65188256|NCT00636766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188257|NCT00636766|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65188258|NCT00636766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65188259|NCT00636766|Antimetabolites|antimetabolites|mesh-ancestor
65188260|NCT00636766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188261|NCT00636766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65188262|NCT00636766|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65188263|NCT00636766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188264|NCT00636766|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65188265|NCT00636766|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65188266|NCT00636766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65188267|NCT00636766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65188268|NCT00636766|Hormones|hormones|mesh-ancestor
65188269|NCT00636766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65188270|NCT03998176|Tenofovir|tenofovir|mesh-list
65188271|NCT03998176|Emtricitabine|emtricitabine|mesh-list
65188272|NCT03998176|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65188273|NCT03998176|Antiviral Agents|antiviral agents|mesh-ancestor
65188274|NCT03998176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65188275|NCT03998176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65188276|NCT03998176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65188277|NCT03998176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188278|NCT03998176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188279|NCT03998176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64503026|NCT03355638|Analgesics|analgesics|mesh-ancestor
65188281|NCT02713282|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65188282|NCT02713282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65188283|NCT02713282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65188284|NCT02713282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65188287|NCT02713282|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65188288|NCT02713282|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65188289|NCT02713282|Serotonin Agents|serotonin agents|mesh-ancestor
65188290|NCT02713282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65188291|NCT02713282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188292|NCT02713282|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65188293|NCT02713282|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65188294|NCT02713282|Dopamine Agents|dopamine agents|mesh-ancestor
65188295|NCT00611416|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65188296|NCT00611416|Caffeine|caffeine|mesh-list
65188297|NCT00611416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65188298|NCT00611416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188299|NCT00611416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65326989|NCT02596100|Anticoagulants|anticoagulants|mesh-ancestor
65326990|NCT01192971|Apatinib|apatinib|mesh-list
65326991|NCT01192971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65326992|NCT01192971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65326993|NCT01192971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65326994|NCT01192971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65326995|NCT00719472|Antipyretics|antipyretics|mesh-list
65326996|NCT00719472|Prednisone|prednisone|mesh-list
65326997|NCT00719472|Cyclophosphamide|cyclophosphamide|mesh-list
65326998|NCT00719472|Rituximab|rituximab|mesh-list
65326999|NCT00719472|Doxorubicin|doxorubicin|mesh-list
65188300|NCT00611416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188301|NCT00611416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188302|NCT00611416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65188303|NCT00611416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65188304|NCT00611416|Purinergic Agents|purinergic agents|mesh-ancestor
65188305|NCT00611416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65188306|NCT00611416|Antioxidants|antioxidants|mesh-ancestor
65188307|NCT00611416|Protective Agents|protective agents|mesh-ancestor
65188308|NCT00611416|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65188309|NCT00611416|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65188310|NCT00611416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188311|NCT00611416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65188312|NCT02712658|Terbutaline|terbutaline|mesh-list
65188313|NCT02712658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65188314|NCT02712658|Autonomic Agents|autonomic agents|mesh-ancestor
65188315|NCT02712658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65188316|NCT02712658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188317|NCT02712658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65188318|NCT02712658|Respiratory System Agents|respiratory system agents|mesh-ancestor
65188319|NCT02712658|Sympathomimetics|sympathomimetics|mesh-ancestor
65188320|NCT02712658|Tocolytic Agents|tocolytic agents|mesh-ancestor
65188321|NCT02712658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65188322|NCT02712658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65188323|NCT02712658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65188324|NCT02712658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65188325|NCT02712658|Adrenergic Agents|adrenergic agents|mesh-ancestor
65188326|NCT02712658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65188327|NCT02712658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830883|NCT01577199|Fertility Agents|fertility agents|mesh-ancestor
65188328|NCT00611494|Mycophenolic Acid|mycophenolic acid|mesh-list
65188329|NCT00611494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65188330|NCT00611494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188331|NCT00611494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65188332|NCT00611494|Antitubercular Agents|antitubercular agents|mesh-ancestor
65188333|NCT00611494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65188334|NCT00611494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65188335|NCT00611494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188336|NCT00611494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188337|NCT02712502|Amoxicillin|amoxicillin|mesh-list
65188338|NCT02712502|Levofloxacin|levofloxacin|mesh-list
65188340|NCT02712502|Clavulanic Acid|clavulanic acid|mesh-list
65188341|NCT02712502|Clavulanic Acids|clavulanic acids|mesh-list
65188342|NCT02712502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65188343|NCT02712502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65188344|NCT02712502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65188345|NCT02712502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65188346|NCT02712502|Renal Agents|renal agents|mesh-ancestor
65188347|NCT02712502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65188348|NCT02712502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65188349|NCT02712502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188350|NCT02712502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188351|NCT02712502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503098|NCT03350334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65188352|NCT02712502|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65327000|NCT00719472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65327001|NCT00719472|Vincristine|vincristine|mesh-list
65327002|NCT00719472|Analgesics|analgesics|mesh-list
65327003|NCT00719472|Histamine Antagonists|histamine antagonists|mesh-list
65327004|NCT00719472|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
65327005|NCT00719472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65327006|NCT00719472|Immunologic Factors|immunologic factors|mesh-ancestor
65327007|NCT00719472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327008|NCT00719472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65327009|NCT00719472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65327010|NCT00719472|Alkylating Agents|alkylating agents|mesh-ancestor
65188353|NCT02712502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65188354|NCT02712502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65188361|NCT04617028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188362|NCT04617028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65188363|NCT02711410|Clopidogrel|clopidogrel|mesh-list
65188364|NCT02711410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65188365|NCT02711410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65188366|NCT02711410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65188367|NCT02711410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65188368|NCT02711410|Purinergic Agents|purinergic agents|mesh-ancestor
65188369|NCT02711410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65188370|NCT02711410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188371|NCT02711410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188372|NCT02711176|Amoxicillin|amoxicillin|mesh-list
65188373|NCT02711176|Clarithromycin|clarithromycin|mesh-list
65188374|NCT02711176|Tinidazole|tinidazole|mesh-list
65188375|NCT02711176|Esomeprazole|esomeprazole|mesh-list
65188376|NCT02711176|Lansoprazole|lansoprazole|mesh-list
65188377|NCT02711176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65188378|NCT02711176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65188379|NCT02711176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65188380|NCT02711176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65188381|NCT02711176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65188382|NCT02711176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188383|NCT02711176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188384|NCT02711176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65188385|NCT02711176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65188386|NCT02711176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65188387|NCT02711176|Alkylating Agents|alkylating agents|mesh-ancestor
65188388|NCT02711176|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65188389|NCT02711176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65188390|NCT02711176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65188391|NCT00611650|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65188392|NCT00611650|Antioxidants|antioxidants|mesh-ancestor
65188393|NCT00611650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188394|NCT00611650|Protective Agents|protective agents|mesh-ancestor
65188395|NCT00611650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188396|NCT00611650|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65188397|NCT00611650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65188398|NCT00611650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188399|NCT00611650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65188400|NCT02710552|Amlodipine|amlodipine|mesh-list
65188401|NCT02710552|Antihypertensive Agents|antihypertensive agents|mesh-list
65188402|NCT02710552|Perindopril|perindopril|mesh-list
65188403|NCT02710552|Indapamide|indapamide|mesh-list
65188404|NCT02710552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65188405|NCT02710552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65188406|NCT02710552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188407|NCT02710552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65188408|NCT02710552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188409|NCT02710552|Vasodilator Agents|vasodilator agents|mesh-ancestor
65188410|NCT02710552|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65327011|NCT00719472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327012|NCT00719472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327013|NCT00719472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65076969|NCT00325715|Esomeprazole|esomeprazole|mesh-list
65327014|NCT00719472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65327015|NCT00719472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65327016|NCT00719472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65327017|NCT00719472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65327018|NCT00719472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327019|NCT00719472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65327020|NCT00719472|Glucocorticoids|glucocorticoids|mesh-ancestor
65188411|NCT02710552|Protease Inhibitors|protease inhibitors|mesh-ancestor
65188412|NCT02710552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188413|NCT02710552|Diuretics|diuretics|mesh-ancestor
65188414|NCT02710552|Natriuretic Agents|natriuretic agents|mesh-ancestor
65188415|NCT02710552|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65188416|NCT02710396|Paclitaxel|paclitaxel|mesh-list
65188417|NCT02710396|Carboplatin|carboplatin|mesh-list
65188418|NCT02710396|Pembrolizumab|pembrolizumab|mesh-list
65188419|NCT02710396|Pemetrexed|pemetrexed|mesh-list
65188420|NCT02710396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65188421|NCT02710396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188422|NCT02710396|Tubulin Modulators|tubulin modulators|mesh-ancestor
65188423|NCT02710396|Antimitotic Agents|antimitotic agents|mesh-ancestor
65188424|NCT02710396|Mitosis Modulators|mitosis modulators|mesh-ancestor
65188425|NCT02710396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188429|NCT02710396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65188431|NCT02710162|Antipruritics|antipruritics|mesh-ancestor
65188432|NCT02710162|Dermatologic Agents|dermatologic agents|mesh-ancestor
65188433|NCT02710162|Sensory System Agents|sensory system agents|mesh-ancestor
65188434|NCT02710162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65188435|NCT02710162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188436|NCT00611728|Irinotecan|irinotecan|mesh-list
65188437|NCT00611728|Sunitinib|sunitinib|mesh-list
65188438|NCT00611728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65188439|NCT00611728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65188440|NCT00611728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188441|NCT00611728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188442|NCT00611728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188443|NCT00611728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65188444|NCT00611728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65188445|NCT00611728|Growth Substances|growth substances|mesh-ancestor
65188446|NCT00611728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188447|NCT00611728|Growth Inhibitors|growth inhibitors|mesh-ancestor
65188448|NCT00611728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65188449|NCT02709304|Lidocaine|lidocaine|mesh-list
65188450|NCT02709304|Anesthetics, Local|anesthetics, local|mesh-ancestor
65188451|NCT02709304|Anesthetics|anesthetics|mesh-ancestor
65188452|NCT02709304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65188453|NCT02709304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188454|NCT02709304|Sensory System Agents|sensory system agents|mesh-ancestor
65188455|NCT02709304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65188456|NCT02709304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65188457|NCT02709304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65188458|NCT02709304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65188459|NCT02709304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65188460|NCT02709304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188461|NCT04189666|Melatonin|melatonin|mesh-list
65188462|NCT04189666|Rivastigmine|rivastigmine|mesh-list
65188463|NCT04189666|Antioxidants|antioxidants|mesh-ancestor
65188464|NCT04189666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188465|NCT04189666|Protective Agents|protective agents|mesh-ancestor
65188466|NCT04189666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327022|NCT00719472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65327023|NCT00719472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65327024|NCT00719472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65327025|NCT00719472|Tubulin Modulators|tubulin modulators|mesh-ancestor
65327026|NCT00719472|Antimitotic Agents|antimitotic agents|mesh-ancestor
65188467|NCT04189666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65188468|NCT04189666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65188469|NCT04189666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188470|NCT04189666|Cholinergic Agents|cholinergic agents|mesh-ancestor
65188471|NCT04189666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65188472|NCT04189666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65188473|NCT03944512|Pravastatin|pravastatin|mesh-list
65188474|NCT03944512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65188475|NCT03944512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65188476|NCT03944512|Antimetabolites|antimetabolites|mesh-ancestor
65188477|NCT03944512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188478|NCT03944512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65188479|NCT03944512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65188480|NCT03944512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188481|NCT00937521|Antipyretics|antipyretics|mesh-list
65188482|NCT00937521|Vaccines|vaccines|mesh-list
65188483|NCT00937521|Immunologic Factors|immunologic factors|mesh-ancestor
65188484|NCT00937521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188485|NCT02709382|Tazobactam|tazobactam|mesh-list
65188486|NCT02709382|Cefepime|cefepime|mesh-list
65188487|NCT02709382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65188488|NCT02709382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65188489|NCT02709382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65188490|NCT02709382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188491|NCT02709382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188492|NCT02708992|Azithromycin|azithromycin|mesh-list
65188493|NCT02708992|Cefixime|cefixime|mesh-list
65188494|NCT02708992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65188495|NCT02708992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65188496|NCT00611962|Paclitaxel|paclitaxel|mesh-list
65188497|NCT00611962|Oxaliplatin|oxaliplatin|mesh-list
65188498|NCT00611962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65188523|NCT00606099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65188524|NCT00606099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188525|NCT00606099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188526|NCT00935883|Eculizumab|eculizumab|mesh-list
65188527|NCT00935883|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65188528|NCT00935883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65188529|NCT00935883|Immunologic Factors|immunologic factors|mesh-ancestor
65188530|NCT00935883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188531|NCT02708446|Misoprostol|misoprostol|mesh-list
65188532|NCT02708446|Mifepristone|mifepristone|mesh-list
65188533|NCT02708446|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65188534|NCT02708446|Abortifacient Agents|abortifacient agents|mesh-ancestor
65188535|NCT02708446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65188536|NCT02708446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188537|NCT02708446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65188538|NCT02708446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65188539|NCT02708446|Oxytocics|oxytocics|mesh-ancestor
65188540|NCT02708446|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65188541|NCT02708446|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65188542|NCT02708446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65188543|NCT02708446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65188544|NCT02708446|Contraceptive Agents|contraceptive agents|mesh-ancestor
65188545|NCT02708446|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65188546|NCT02708446|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65188547|NCT02708446|Hormone Antagonists|hormone antagonists|mesh-ancestor
65188548|NCT02708446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65188554|NCT05378919|Fluorouracil|fluorouracil|mesh-list
65188555|NCT05378919|Oxaliplatin|oxaliplatin|mesh-list
65188556|NCT05378919|Levoleucovorin|levoleucovorin|mesh-list
65188557|NCT05378919|Antimetabolites|antimetabolites|mesh-ancestor
65188558|NCT05378919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327027|NCT00719472|Mitosis Modulators|mitosis modulators|mesh-ancestor
65327028|NCT00719472|Sensory System Agents|sensory system agents|mesh-ancestor
65327029|NCT00719472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65327030|NCT00719472|Histamine Agents|histamine agents|mesh-ancestor
65327031|NCT00719472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65327032|NCT00579501|Dexamethasone|dexamethasone|mesh-list
65327033|NCT00579501|Trabectedin|trabectedin|mesh-list
65327034|NCT00579501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65327035|NCT00579501|Antiemetics|antiemetics|mesh-ancestor
64329358|NCT00393991|Xhance|xhance|mesh-list
65188559|NCT05378919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65188560|NCT05378919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188561|NCT05378919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65188562|NCT05378919|Immunologic Factors|immunologic factors|mesh-ancestor
65188563|NCT05378919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188564|NCT05378919|Hematinics|hematinics|mesh-ancestor
65188565|NCT05378919|Vitamin B Complex|vitamin b complex|mesh-ancestor
65188566|NCT05378919|Vitamins|vitamins|mesh-ancestor
65188567|NCT05378919|Micronutrients|micronutrients|mesh-ancestor
65188568|NCT05378919|Antidotes|antidotes|mesh-ancestor
65188569|NCT05378919|Protective Agents|protective agents|mesh-ancestor
65188570|NCT00607581|Dexamethasone|dexamethasone|mesh-list
65188571|NCT00607581|Cyclophosphamide|cyclophosphamide|mesh-list
65188572|NCT00607581|Lenalidomide|lenalidomide|mesh-list
65188573|NCT00607581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65188574|NCT00607581|Immunologic Factors|immunologic factors|mesh-ancestor
65188575|NCT00607581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188583|NCT00607581|Antiemetics|antiemetics|mesh-ancestor
65188584|NCT00607581|Autonomic Agents|autonomic agents|mesh-ancestor
65188585|NCT00607581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65188586|NCT00607581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65188587|NCT00607581|Glucocorticoids|glucocorticoids|mesh-ancestor
65188588|NCT00607581|Hormones|hormones|mesh-ancestor
65188589|NCT00607581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65188590|NCT00607581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65188591|NCT00607581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65188592|NCT00607581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65188593|NCT00607581|Growth Substances|growth substances|mesh-ancestor
65188594|NCT00607581|Growth Inhibitors|growth inhibitors|mesh-ancestor
65188595|NCT02707900|Vorinostat|vorinostat|mesh-list
65188596|NCT02707900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188597|NCT02707900|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65188598|NCT02707900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188599|NCT02707900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188600|NCT05380479|Megestrol|megestrol|mesh-list
65188601|NCT05380479|Megestrol Acetate|megestrol acetate|mesh-list
65188602|NCT05380479|Mirtazapine|mirtazapine|mesh-list
65188603|NCT05380479|Antidepressive Agents|antidepressive agents|mesh-ancestor
65188604|NCT05380479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65188605|NCT05380479|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65188606|NCT05380479|Histamine Antagonists|histamine antagonists|mesh-ancestor
65188607|NCT05380479|Histamine Agents|histamine agents|mesh-ancestor
65188608|NCT05380479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65188609|NCT05380479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188610|NCT05380479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188611|NCT05380479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65188612|NCT05380479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65188613|NCT05380479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65188614|NCT05380479|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65188615|NCT05380479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65188616|NCT05380479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65188617|NCT05380479|Adrenergic Agents|adrenergic agents|mesh-ancestor
65188618|NCT05380479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65188619|NCT05380479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65188620|NCT05380479|Serotonin Agents|serotonin agents|mesh-ancestor
65188621|NCT05380479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65188622|NCT05380479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65188623|NCT05380479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65327036|NCT00579501|Autonomic Agents|autonomic agents|mesh-ancestor
65327037|NCT00579501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65327038|NCT00579501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327039|NCT00579501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65327040|NCT00579501|Glucocorticoids|glucocorticoids|mesh-ancestor
65327041|NCT00579501|Hormones|hormones|mesh-ancestor
65327042|NCT00579501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65327043|NCT00579501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65327044|NCT00579501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327045|NCT00579501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65327046|NCT00579501|Alkylating Agents|alkylating agents|mesh-ancestor
65188624|NCT05380479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65188625|NCT05380479|Contraceptive Agents|contraceptive agents|mesh-ancestor
65188626|NCT05380479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65188627|NCT05380479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65188633|NCT00936975|Listerine|listerine|mesh-list
65188634|NCT00936975|Fluorides|fluorides|mesh-list
65188635|NCT00936975|Sodium Fluoride|sodium fluoride|mesh-list
65188636|NCT00936975|Cariostatic Agents|cariostatic agents|mesh-ancestor
65188637|NCT00936975|Protective Agents|protective agents|mesh-ancestor
65188638|NCT00936975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188639|NCT00936975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65188640|NCT00936975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65188649|NCT02707120|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65188650|NCT02707120|Lubricant Eye Drops|lubricant eye drops|mesh-list
65188651|NCT02707120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65188652|NCT02693470|Ustekinumab|ustekinumab|mesh-list
65188653|NCT02693470|Dermatologic Agents|dermatologic agents|mesh-ancestor
65188654|NCT00936897|Denosumab|denosumab|mesh-list
65188655|NCT00936897|Ibandronic Acid|ibandronic acid|mesh-list
65188656|NCT00936897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65188657|NCT00936897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188658|NCT05265676|Enoxaparin|enoxaparin|mesh-list
65188659|NCT05265676|Enoxaparin sodium|enoxaparin sodium|mesh-list
65188660|NCT05265676|Anticoagulants|anticoagulants|mesh-ancestor
65188661|NCT05265676|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65188662|NCT05265676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65188663|NCT05265676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188664|NCT00606333|Sirolimus|sirolimus|mesh-list
65188665|NCT00606333|Paclitaxel|paclitaxel|mesh-list
65188666|NCT00606333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65188667|NCT00606333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65188668|NCT00606333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188669|NCT00606333|Tubulin Modulators|tubulin modulators|mesh-ancestor
65188670|NCT00606333|Antimitotic Agents|antimitotic agents|mesh-ancestor
65188671|NCT00606333|Mitosis Modulators|mitosis modulators|mesh-ancestor
65188672|NCT00606333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188673|NCT00606333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65188674|NCT00606333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65188675|NCT00606333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65188676|NCT00606333|Antifungal Agents|antifungal agents|mesh-ancestor
65188677|NCT00606333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65188678|NCT00606333|Immunologic Factors|immunologic factors|mesh-ancestor
65188679|NCT00606333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188680|NCT05265442|Methadone|methadone|mesh-list
65188681|NCT05265442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65188682|NCT05265442|Narcotics|narcotics|mesh-ancestor
65188683|NCT05265442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65188684|NCT05265442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188685|NCT05265442|Analgesics|analgesics|mesh-ancestor
65188686|NCT05265442|Sensory System Agents|sensory system agents|mesh-ancestor
65188687|NCT05265442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65188688|NCT05265442|Antitussive Agents|antitussive agents|mesh-ancestor
65188689|NCT05265442|Respiratory System Agents|respiratory system agents|mesh-ancestor
65188690|NCT00606411|Topiramate|topiramate|mesh-list
65327047|NCT00579501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327048|NCT02598362|Ciprofloxacin|ciprofloxacin|mesh-list
65327049|NCT02598362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65327050|NCT02598362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65327051|NCT02598362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65327052|NCT02598362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65327053|NCT02598362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327054|NCT02598362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327055|NCT02598362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327056|NCT02598362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64556535|NCT04991298|Analgesics|analgesics|mesh-ancestor
65188691|NCT00606411|Anticonvulsants|anticonvulsants|mesh-ancestor
65188692|NCT00606411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65188693|NCT00606411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188694|NCT00607737|Insulin Detemir|insulin detemir|mesh-list
65188695|NCT00607737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65188696|NCT00607737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188697|NCT01120691|Glycopyrrolate|glycopyrrolate|mesh-list
65188698|NCT01120691|Albuterol|albuterol|mesh-list
65188699|NCT01120691|Tiotropium Bromide|tiotropium bromide|mesh-list
65188700|NCT01120691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65188701|NCT01120691|Autonomic Agents|autonomic agents|mesh-ancestor
64831265|NCT01579110|Levamisole|levamisole|mesh-list
65188702|NCT01120691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65188703|NCT01120691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188704|NCT01120691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65188705|NCT01120691|Respiratory System Agents|respiratory system agents|mesh-ancestor
65188706|NCT01120691|Parasympatholytics|parasympatholytics|mesh-ancestor
65188715|NCT01120691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65188716|NCT01120691|Adrenergic Agents|adrenergic agents|mesh-ancestor
65188717|NCT01120691|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65188718|NCT01120691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65188719|NCT04231318|Triamcinolone|triamcinolone|mesh-list
65188720|NCT04231318|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65188721|NCT04231318|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65188722|NCT04231318|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65188723|NCT04231318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65188724|NCT04231318|Glucocorticoids|glucocorticoids|mesh-ancestor
65188725|NCT04231318|Hormones|hormones|mesh-ancestor
65188726|NCT04231318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65188727|NCT04231318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188728|NCT04231318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65188730|NCT04231318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188731|NCT04231318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188732|NCT00612274|Sirolimus|sirolimus|mesh-list
65188733|NCT00612274|Methotrexate|methotrexate|mesh-list
65188734|NCT00612274|Tacrolimus|tacrolimus|mesh-list
65188735|NCT00612274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65188736|NCT00612274|Abortifacient Agents|abortifacient agents|mesh-ancestor
65188737|NCT00612274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65188738|NCT00612274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188739|NCT00612274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65188740|NCT00612274|Antimetabolites|antimetabolites|mesh-ancestor
65188741|NCT00612274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188742|NCT00612274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188743|NCT00612274|Dermatologic Agents|dermatologic agents|mesh-ancestor
65188744|NCT00612274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188745|NCT00612274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65188746|NCT00612274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65188747|NCT00612274|Immunologic Factors|immunologic factors|mesh-ancestor
65188748|NCT00612274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65188749|NCT00612274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65188750|NCT00612274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65327057|NCT02598362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65327058|NCT02576301|Cytarabine|cytarabine|mesh-list
65327059|NCT02576301|Combretastatin|combretastatin|mesh-list
65327060|NCT02576301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65327061|NCT02576301|Antimetabolites|antimetabolites|mesh-ancestor
65327062|NCT02576301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327063|NCT02576301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327064|NCT02576301|Antiviral Agents|antiviral agents|mesh-ancestor
65188751|NCT00612274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65188752|NCT00612274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65188753|NCT00612274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65188754|NCT00612274|Antifungal Agents|antifungal agents|mesh-ancestor
65188755|NCT05263882|Gemcitabine|gemcitabine|mesh-list
65188756|NCT05263882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65188757|NCT05263882|Antimetabolites|antimetabolites|mesh-ancestor
65188758|NCT05263882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188759|NCT05263882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188760|NCT05263882|Antiviral Agents|antiviral agents|mesh-ancestor
65188761|NCT05263882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65188762|NCT05263882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188763|NCT05263882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65188764|NCT05263882|Immunologic Factors|immunologic factors|mesh-ancestor
65188765|NCT05263882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188766|NCT02724904|Methotrexate|methotrexate|mesh-list
65188767|NCT02724904|Fludarabine|fludarabine|mesh-list
65188768|NCT02724904|Thiotepa|thiotepa|mesh-list
65188769|NCT02724904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65188770|NCT02724904|Abortifacient Agents|abortifacient agents|mesh-ancestor
65188771|NCT02724904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65188772|NCT02724904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188787|NCT00935493|Guanfacine|guanfacine|mesh-list
65188788|NCT00935493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65188789|NCT00935493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65188790|NCT00935493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65188791|NCT00935493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65188792|NCT00935493|Adrenergic Agents|adrenergic agents|mesh-ancestor
65188793|NCT00935493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65188794|NCT00935493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188795|NCT00935493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188796|NCT05380245|Clarithromycin|clarithromycin|mesh-list
65188797|NCT05380245|Voriconazole|voriconazole|mesh-list
64945985|NCT04859296|Hormones|hormones|mesh-ancestor
65188798|NCT05380245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65188799|NCT05380245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65188800|NCT05380245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65188801|NCT05380245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188802|NCT05380245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188803|NCT05380245|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65188804|NCT05380245|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65188805|NCT05380245|Antifungal Agents|antifungal agents|mesh-ancestor
65188806|NCT05380245|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65188807|NCT05380245|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65188808|NCT05380245|Hormone Antagonists|hormone antagonists|mesh-ancestor
65188809|NCT05380245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65188810|NCT05380245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188811|NCT04267497|Amphotericin B|amphotericin b|mesh-list
65188812|NCT04267497|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65188813|NCT04267497|Amebicides|amebicides|mesh-ancestor
65188814|NCT04267497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65188815|NCT04267497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65188816|NCT04267497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65188817|NCT04267497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65188818|NCT04267497|Antifungal Agents|antifungal agents|mesh-ancestor
65188819|NCT00935259|Simvastatin|simvastatin|mesh-list
65188820|NCT00935259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65188821|NCT00935259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65188822|NCT00935259|Antimetabolites|antimetabolites|mesh-ancestor
65327065|NCT02576301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65327066|NCT02576301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65327067|NCT02576301|Immunologic Factors|immunologic factors|mesh-ancestor
65327068|NCT02576301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327069|NCT02576301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65327070|NCT02576301|Tubulin Modulators|tubulin modulators|mesh-ancestor
65327071|NCT02576301|Antimitotic Agents|antimitotic agents|mesh-ancestor
65327072|NCT02576301|Mitosis Modulators|mitosis modulators|mesh-ancestor
65327073|NCT04086186|Bupivacaine|bupivacaine|mesh-list
65327074|NCT04086186|Anesthetics, Local|anesthetics, local|mesh-ancestor
65327075|NCT04086186|Anesthetics|anesthetics|mesh-ancestor
65327076|NCT04086186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64556552|NCT04361175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556553|NCT04361175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65188823|NCT00935259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188824|NCT00935259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65188825|NCT00935259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65188826|NCT00935259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188827|NCT02937766|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
65188839|NCT00607971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188840|NCT00607971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188842|NCT02724358|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65188843|NCT02724358|Estrogens|estrogens|mesh-ancestor
65188844|NCT02724358|Hormones|hormones|mesh-ancestor
65188845|NCT02724358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65188846|NCT02724358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188847|NCT02724358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65188848|NCT02724358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188849|NCT02724202|Curcumin|curcumin|mesh-list
65188850|NCT02724202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65188851|NCT02724202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65188853|NCT02724202|Sensory System Agents|sensory system agents|mesh-ancestor
65188854|NCT02724202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65188855|NCT02724202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188856|NCT02724202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65188857|NCT02724202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65188858|NCT02724202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188859|NCT02724202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188860|NCT02724202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188861|NCT00605397|Trastuzumab|trastuzumab|mesh-list
65188862|NCT00605397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65188863|NCT00605397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188864|NCT00625547|Levodopa|levodopa|mesh-list
65188865|NCT00625547|Cabergoline|cabergoline|mesh-list
65188866|NCT00625547|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65188867|NCT00625547|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65188868|NCT00625547|Dopamine Agents|dopamine agents|mesh-ancestor
65188869|NCT00625547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65188870|NCT00625547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188871|NCT00625547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188873|NCT05241340|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65188874|NCT05241340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188875|NCT05241340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188876|NCT02724046|Ciprofloxacin|ciprofloxacin|mesh-list
65188877|NCT02724046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65188878|NCT02724046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65188879|NCT02724046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65188880|NCT02724046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65188881|NCT02724046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327077|NCT04086186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327078|NCT04086186|Sensory System Agents|sensory system agents|mesh-ancestor
65327079|NCT04086186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65327080|NCT00741338|Cyclosporine|cyclosporine|mesh-list
65327081|NCT00741338|Azathioprine|azathioprine|mesh-list
65327082|NCT00741338|Cyclosporins|cyclosporins|mesh-list
65327083|NCT00741338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327084|NCT00741338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327085|NCT00741338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65327086|NCT00741338|Immunologic Factors|immunologic factors|mesh-ancestor
65327087|NCT00741338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327088|NCT00741338|Antifungal Agents|antifungal agents|mesh-ancestor
65327089|NCT00741338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65327090|NCT00741338|Dermatologic Agents|dermatologic agents|mesh-ancestor
65327091|NCT00741338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65327092|NCT00741338|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64556576|NCT04368585|TEMPO|tempo|mesh-list
65188882|NCT02724046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188883|NCT02724046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188884|NCT02724046|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65188885|NCT02724046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65188886|NCT01124045|Prednisolone|prednisolone|mesh-list
65188887|NCT01124045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65188888|NCT01124045|Methylprednisolone|methylprednisolone|mesh-list
65188889|NCT01124045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65188890|NCT01124045|Prednisolone acetate|prednisolone acetate|mesh-list
65188891|NCT01124045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65188898|NCT01124045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188899|NCT01124045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65188901|NCT01124045|Antiemetics|antiemetics|mesh-ancestor
65188902|NCT01124045|Autonomic Agents|autonomic agents|mesh-ancestor
65188903|NCT01124045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65188904|NCT01124045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65188905|NCT01124045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65188906|NCT01124045|Protective Agents|protective agents|mesh-ancestor
65188907|NCT01123889|Lidocaine|lidocaine|mesh-list
65188908|NCT01123889|Ropivacaine|ropivacaine|mesh-list
65188909|NCT01123889|Anesthetics, Local|anesthetics, local|mesh-ancestor
65188910|NCT01123889|Anesthetics|anesthetics|mesh-ancestor
65188911|NCT01123889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65188912|NCT01123889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188913|NCT01123889|Sensory System Agents|sensory system agents|mesh-ancestor
65188914|NCT01123889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65188915|NCT01123889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65188916|NCT01123889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65188917|NCT01123889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65188918|NCT01123889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65188919|NCT01123889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188920|NCT02723968|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65188921|NCT00606957|Vitamin D|vitamin d|mesh-list
65188922|NCT00606957|Cholecalciferol|cholecalciferol|mesh-list
65188923|NCT00606957|Vitamins|vitamins|mesh-ancestor
65188924|NCT00606957|Micronutrients|micronutrients|mesh-ancestor
64831480|NCT01582438|Citric Acid|citric acid|mesh-list
65188925|NCT00606957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188926|NCT00606957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65188927|NCT00606957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65188928|NCT00934947|Propranolol|propranolol|mesh-list
65188929|NCT00934947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65327093|NCT00741338|Antimetabolites|antimetabolites|mesh-ancestor
65327094|NCT00741338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65327095|NCT00741338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327096|NCT02598830|Vitamin D|vitamin d|mesh-list
65327097|NCT02598830|Cholecalciferol|cholecalciferol|mesh-list
65327098|NCT02598830|Vitamins|vitamins|mesh-ancestor
65327099|NCT02598830|Micronutrients|micronutrients|mesh-ancestor
65327100|NCT02598830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327101|NCT02598830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64556579|NCT04368585|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65188930|NCT00934947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65188931|NCT00934947|Adrenergic Agents|adrenergic agents|mesh-ancestor
65188932|NCT00934947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65188933|NCT00934947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188934|NCT00934947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188935|NCT00934947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65188936|NCT00934947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65188937|NCT00934947|Vasodilator Agents|vasodilator agents|mesh-ancestor
65188939|NCT02723578|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65188940|NCT02723578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188941|NCT02723578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188942|NCT02723578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188943|NCT02723578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65188944|NCT02723578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65188945|NCT02723578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65188946|NCT04189198|Bupivacaine|bupivacaine|mesh-list
65188947|NCT04189198|Carticaine|carticaine|mesh-list
65188948|NCT04189198|Anesthetics, Local|anesthetics, local|mesh-ancestor
65188949|NCT04189198|Anesthetics|anesthetics|mesh-ancestor
65188950|NCT04189198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65188951|NCT04189198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188952|NCT04189198|Sensory System Agents|sensory system agents|mesh-ancestor
65188953|NCT04189198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65188954|NCT00608361|Dasatinib|dasatinib|mesh-list
65188955|NCT00608361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188956|NCT00608361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65188957|NCT00608361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188958|NCT00608361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188959|NCT02723500|Xenon|xenon|mesh-list
65188963|NCT02723500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65188964|NCT02723500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188966|NCT00934791|Sirolimus|sirolimus|mesh-list
65188967|NCT00934791|Prednisone|prednisone|mesh-list
65188968|NCT00934791|Tacrolimus|tacrolimus|mesh-list
65188969|NCT00934791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65188970|NCT00934791|Glucocorticoids|glucocorticoids|mesh-ancestor
65188971|NCT00934791|Hormones|hormones|mesh-ancestor
65188972|NCT00934791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65188973|NCT00934791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188974|NCT00934791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65188975|NCT00934791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188976|NCT00934791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65188977|NCT00934791|Immunologic Factors|immunologic factors|mesh-ancestor
65188978|NCT00934791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65188979|NCT00934791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188980|NCT00934791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188981|NCT00934791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65188982|NCT00934791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65188983|NCT00934791|Antitubercular Agents|antitubercular agents|mesh-ancestor
65188984|NCT00934791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65188985|NCT00934791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65188986|NCT00934791|Antifungal Agents|antifungal agents|mesh-ancestor
65188987|NCT00607035|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65188988|NCT00607035|Olmesartan|olmesartan|mesh-list
65188989|NCT00607035|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65327102|NCT02598830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65327103|NCT02578251|Acetaminophen|acetaminophen|mesh-list
65327104|NCT02578251|Meperidine|meperidine|mesh-list
65327105|NCT02578251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65327106|NCT02578251|Analgesics|analgesics|mesh-ancestor
65327107|NCT02578251|Sensory System Agents|sensory system agents|mesh-ancestor
65327108|NCT02578251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65327109|NCT02578251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327110|NCT02578251|Antipyretics|antipyretics|mesh-ancestor
65327111|NCT02578251|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65327112|NCT02578251|Narcotics|narcotics|mesh-ancestor
65327113|NCT02578251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65327114|NCT02578251|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65327115|NCT05285358|Gemcitabine|gemcitabine|mesh-list
65327116|NCT05285358|Paclitaxel|paclitaxel|mesh-list
65327117|NCT05285358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65327118|NCT05285358|Cisplatin|cisplatin|mesh-list
65327119|NCT05285358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65327120|NCT05285358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327121|NCT05285358|Tubulin Modulators|tubulin modulators|mesh-ancestor
64556588|NCT04368585|Antacids|antacids|mesh-ancestor
65188990|NCT00607035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65188991|NCT00607035|Diuretics|diuretics|mesh-ancestor
65188992|NCT00607035|Natriuretic Agents|natriuretic agents|mesh-ancestor
65188993|NCT00607035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188994|NCT00607035|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65188995|NCT00607035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65188996|NCT00607035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188997|NCT00607035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64831556|NCT01587339|Pregabalin|pregabalin|mesh-list
65188999|NCT02723266|Tin Fluorides|tin fluorides|mesh-list
65189000|NCT02723266|Cariostatic Agents|cariostatic agents|mesh-ancestor
65189001|NCT02723266|Protective Agents|protective agents|mesh-ancestor
65189002|NCT02723266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189003|NCT02722954|Pembrolizumab|pembrolizumab|mesh-list
65189004|NCT02722954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65189005|NCT02722954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189006|NCT00625859|Bupropion|bupropion|mesh-list
65189007|NCT00625859|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65189008|NCT00625859|Antidepressive Agents|antidepressive agents|mesh-ancestor
65189009|NCT00625859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65189010|NCT00625859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65189011|NCT00625859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65189012|NCT00625859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65189013|NCT00625859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189014|NCT00625859|Dopamine Agents|dopamine agents|mesh-ancestor
65189015|NCT00625859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65189016|NCT00625859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189017|NCT00625859|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65189018|NCT00625859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65189019|NCT00625859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189020|NCT02691195|Ropivacaine|ropivacaine|mesh-list
65189021|NCT02691195|Anesthetics, Local|anesthetics, local|mesh-list
65189022|NCT02691195|Anesthetics|anesthetics|mesh-list
65189023|NCT02691195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65327122|NCT05285358|Antimitotic Agents|antimitotic agents|mesh-ancestor
65327123|NCT05285358|Mitosis Modulators|mitosis modulators|mesh-ancestor
65327124|NCT05285358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327125|NCT05285358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65327126|NCT05285358|Antimetabolites|antimetabolites|mesh-ancestor
65327127|NCT05285358|Antiviral Agents|antiviral agents|mesh-ancestor
65327128|NCT05285358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65189024|NCT02691195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189025|NCT02691195|Sensory System Agents|sensory system agents|mesh-ancestor
65189026|NCT02691195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65189027|NCT03808090|Calcium|calcium|mesh-list
65189028|NCT03808090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65189029|NCT03808090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189030|NCT01111019|Hormones|hormones|mesh-list
65189033|NCT02883400|Spironolactone|spironolactone|mesh-list
65189034|NCT02883400|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65189035|NCT02883400|Hormone Antagonists|hormone antagonists|mesh-ancestor
65189036|NCT02883400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65189037|NCT02883400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189038|NCT02883400|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65189039|NCT02883400|Diuretics|diuretics|mesh-ancestor
65189040|NCT02883400|Natriuretic Agents|natriuretic agents|mesh-ancestor
65189041|NCT01119287|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
65189042|NCT01119287|Dexamethasone|dexamethasone|mesh-list
65189043|NCT01119287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65189044|NCT01119287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65189045|NCT01119287|Antiemetics|antiemetics|mesh-ancestor
65189046|NCT01119287|Autonomic Agents|autonomic agents|mesh-ancestor
65189047|NCT01119287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65189048|NCT01119287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189049|NCT01119287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65189050|NCT01119287|Glucocorticoids|glucocorticoids|mesh-ancestor
65189052|NCT01119287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65189053|NCT01119287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65189054|NCT01119287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189055|NCT01119287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65189056|NCT01119287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65189057|NCT01119287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65189058|NCT01119287|Analgesics|analgesics|mesh-ancestor
65189059|NCT01119287|Sensory System Agents|sensory system agents|mesh-ancestor
65189060|NCT01119287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65189061|NCT01119287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65189062|NCT01119287|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65189063|NCT01119287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65189064|NCT01119287|Histamine Antagonists|histamine antagonists|mesh-ancestor
65189065|NCT01119287|Histamine Agents|histamine agents|mesh-ancestor
65189066|NCT01119287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65189067|NCT01119287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189068|NCT01110707|Hormones|hormones|mesh-list
65189069|NCT01110707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65189070|NCT01110707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65189071|NCT01110707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189072|NCT04931368|Rituximab|rituximab|mesh-list
65189073|NCT04931368|Methotrexate|methotrexate|mesh-list
65189074|NCT04931368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65189075|NCT04931368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189076|NCT04931368|Immunologic Factors|immunologic factors|mesh-ancestor
65189077|NCT04931368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189078|NCT04931368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65189079|NCT04931368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65189080|NCT04931368|Abortifacient Agents|abortifacient agents|mesh-ancestor
65189081|NCT04931368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65189082|NCT04931368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65189083|NCT04931368|Antimetabolites|antimetabolites|mesh-ancestor
65189084|NCT04931368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189085|NCT04931368|Dermatologic Agents|dermatologic agents|mesh-ancestor
65327129|NCT05285358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327130|NCT05285358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65327131|NCT05285358|Immunologic Factors|immunologic factors|mesh-ancestor
65327132|NCT05285358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327133|NCT00746330|Mometasone Furoate|mometasone furoate|mesh-list
65327134|NCT00746330|Formoterol Fumarate|formoterol fumarate|mesh-list
65327135|NCT00746330|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65327136|NCT00746330|Autonomic Agents|autonomic agents|mesh-ancestor
65327137|NCT00746330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65327138|NCT00746330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327139|NCT00746330|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65327140|NCT00746330|Respiratory System Agents|respiratory system agents|mesh-ancestor
65327141|NCT00746330|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65327142|NCT00746330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65327143|NCT00746330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65327144|NCT00746330|Adrenergic Agents|adrenergic agents|mesh-ancestor
65327145|NCT00746330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64556616|NCT04361409|Antiviral Agents|antiviral agents|mesh-ancestor
65189086|NCT04931368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189087|NCT04931368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65189088|NCT04931368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65189089|NCT04931368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65189090|NCT01119131|Vitamin D|vitamin d|mesh-list
65189091|NCT01119131|Cholecalciferol|cholecalciferol|mesh-list
65189093|NCT01119131|Vitamins|vitamins|mesh-ancestor
65189094|NCT01119131|Micronutrients|micronutrients|mesh-ancestor
65189095|NCT01119131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189096|NCT01119131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65189097|NCT01119131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65189098|NCT00636922|Everolimus|everolimus|mesh-list
65189099|NCT00636922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189100|NCT00636922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65189101|NCT00636922|Immunologic Factors|immunologic factors|mesh-ancestor
65189103|NCT02722096|Lidocaine|lidocaine|mesh-list
65189104|NCT02722096|Ropivacaine|ropivacaine|mesh-list
65189105|NCT02722096|Anesthetics|anesthetics|mesh-list
65189106|NCT02722096|Anesthetics, Local|anesthetics, local|mesh-ancestor
65189107|NCT02722096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65189108|NCT02722096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189109|NCT02722096|Sensory System Agents|sensory system agents|mesh-ancestor
65189110|NCT02722096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65189111|NCT02722096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65189112|NCT02722096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65189113|NCT02722096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65189114|NCT02722096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65189115|NCT02722096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189116|NCT04862962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65189117|NCT04862962|Ezetimibe|ezetimibe|mesh-list
65189118|NCT04862962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65189119|NCT04862962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65189120|NCT04862962|Antimetabolites|antimetabolites|mesh-ancestor
65189121|NCT04862962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189122|NCT04862962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65189123|NCT04862962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65189124|NCT04862962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189125|NCT01118975|Lapatinib|lapatinib|mesh-list
65189126|NCT01118975|Vorinostat|vorinostat|mesh-list
65327146|NCT00746330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327147|NCT00746330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65327148|NCT00746330|Dermatologic Agents|dermatologic agents|mesh-ancestor
65327149|NCT00746330|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65327150|NCT02590224|Glycine|glycine|mesh-list
65327151|NCT02590224|Glycine Agents|glycine agents|mesh-ancestor
65327152|NCT02590224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65327153|NCT02590224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327154|NCT02590224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327155|NCT00709449|Papaverine|papaverine|mesh-list
65327156|NCT00709449|Moxaverine|moxaverine|mesh-list
65327157|NCT00709449|Parasympatholytics|parasympatholytics|mesh-ancestor
65327158|NCT00709449|Autonomic Agents|autonomic agents|mesh-ancestor
65327159|NCT00709449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65189127|NCT01118975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189128|NCT01118975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65189129|NCT01118975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189130|NCT01118975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189131|NCT01118975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65189132|NCT02721940|Zoledronic Acid|zoledronic acid|mesh-list
65189133|NCT02721940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65189134|NCT02721940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189135|NCT04829422|Lazertinib|lazertinib|mesh-list
65189136|NCT04829422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65189137|NCT04829422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189138|NCT04829422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189139|NCT02721862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65189140|NCT02721862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65189141|NCT02721862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65189142|NCT00612898|Lamivudine|lamivudine|mesh-list
65189143|NCT00612898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65189144|NCT00612898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65189146|NCT00612898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189147|NCT00612898|Antiviral Agents|antiviral agents|mesh-ancestor
65189148|NCT00612898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65189149|NCT00612898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65189150|NCT00612898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65189151|NCT01118663|Acetylcysteine|acetylcysteine|mesh-list
65189152|NCT01118663|Edetic Acid|edetic acid|mesh-list
65189153|NCT01118663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65189154|NCT01118663|Pentetic Acid|pentetic acid|mesh-list
65189155|NCT01118663|Antiviral Agents|antiviral agents|mesh-ancestor
65189156|NCT01118663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65189157|NCT01118663|Expectorants|expectorants|mesh-ancestor
65189158|NCT01118663|Respiratory System Agents|respiratory system agents|mesh-ancestor
65189159|NCT01118663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65189160|NCT01118663|Antioxidants|antioxidants|mesh-ancestor
65189161|NCT01118663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189162|NCT01118663|Protective Agents|protective agents|mesh-ancestor
65189163|NCT01118663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189164|NCT01118663|Antidotes|antidotes|mesh-ancestor
65189165|NCT01118663|Anticoagulants|anticoagulants|mesh-ancestor
65189166|NCT01118663|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65189167|NCT01118663|Chelating Agents|chelating agents|mesh-ancestor
65189168|NCT01118663|Sequestering Agents|sequestering agents|mesh-ancestor
65189169|NCT01118663|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65189170|NCT01118351|Sunitinib|sunitinib|mesh-list
65189171|NCT01118351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189172|NCT01118351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65189173|NCT01118351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65189174|NCT01118351|Growth Substances|growth substances|mesh-ancestor
65327160|NCT00709449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327161|NCT00709449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65327162|NCT00709449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327163|NCT00709449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327164|NCT00709449|Vasodilator Agents|vasodilator agents|mesh-ancestor
65327165|NCT00709449|Urological Agents|urological agents|mesh-ancestor
65327166|NCT00746252|Risperidone|risperidone|mesh-list
65327167|NCT00746252|Aripiprazole|aripiprazole|mesh-list
65327168|NCT00746252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65327169|NCT00746252|Serotonin Agents|serotonin agents|mesh-ancestor
64556645|NCT05620641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64556646|NCT05620641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65189175|NCT01118351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189176|NCT01118351|Growth Inhibitors|growth inhibitors|mesh-ancestor
65189181|NCT02693392|Metformin|metformin|mesh-list
65189182|NCT02693392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65189183|NCT02693392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189184|NCT04175626|Sirolimus|sirolimus|mesh-list
65189185|NCT04175626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65189186|NCT04175626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65189187|NCT04175626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65189188|NCT04175626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189189|NCT04175626|Antifungal Agents|antifungal agents|mesh-ancestor
65189190|NCT04175626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65189191|NCT04175626|Immunologic Factors|immunologic factors|mesh-ancestor
65189192|NCT04175626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189193|NCT00613054|Imatinib Mesylate|imatinib mesylate|mesh-list
65189194|NCT00613054|Hydroxyurea|hydroxyurea|mesh-list
65189195|NCT00613054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189196|NCT00613054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65189197|NCT00613054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189198|NCT00613054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189199|NCT00613054|Antisickling Agents|antisickling agents|mesh-ancestor
65189200|NCT00613054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65189201|NCT00613132|Everolimus|everolimus|mesh-list
65189202|NCT00613132|Imatinib Mesylate|imatinib mesylate|mesh-list
65189203|NCT00613132|Hydroxyurea|hydroxyurea|mesh-list
65189204|NCT00613132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189205|NCT00613132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65189206|NCT00613132|Immunologic Factors|immunologic factors|mesh-ancestor
65189207|NCT00613132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189208|NCT00613132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65189209|NCT00613132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189210|NCT00613132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189211|NCT00613132|Antisickling Agents|antisickling agents|mesh-ancestor
65189212|NCT00613132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65189213|NCT03917914|Bisoprolol|bisoprolol|mesh-list
65189214|NCT03917914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65189215|NCT03917914|Sympatholytics|sympatholytics|mesh-ancestor
65189216|NCT03917914|Autonomic Agents|autonomic agents|mesh-ancestor
65189217|NCT03917914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65189218|NCT03917914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831785|NCT01591031|Anesthetics|anesthetics|mesh-ancestor
65189219|NCT03917914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65189220|NCT03917914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65189221|NCT03917914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65189222|NCT03917914|Adrenergic Agents|adrenergic agents|mesh-ancestor
65189223|NCT03917914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65189224|NCT03917914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189225|NCT04558216|Rifampin|rifampin|mesh-list
65189226|NCT04558216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65189227|NCT04558216|Antitubercular Agents|antitubercular agents|mesh-ancestor
65189228|NCT04558216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65327170|NCT00746252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65327171|NCT00746252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327172|NCT00746252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327173|NCT00746252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65327174|NCT00746252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65327175|NCT00746252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65327176|NCT00746252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65327177|NCT00746252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65327178|NCT00746252|Dopamine Agents|dopamine agents|mesh-ancestor
65327179|NCT00746252|Antidepressive Agents|antidepressive agents|mesh-ancestor
65189229|NCT04558216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65189230|NCT04558216|Leprostatic Agents|leprostatic agents|mesh-ancestor
65189231|NCT04558216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65189232|NCT04558216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189233|NCT04558216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189234|NCT04558216|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65189235|NCT04558216|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65189236|NCT04558216|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65189237|NCT04558216|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65189238|NCT04558216|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65189239|NCT04558216|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65189241|NCT04120870|Etomidate|etomidate|mesh-list
65189242|NCT04120870|Analgesics|analgesics|mesh-ancestor
65189243|NCT04120870|Sensory System Agents|sensory system agents|mesh-ancestor
65189244|NCT04120870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65189245|NCT04120870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189252|NCT04120870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65189254|NCT04120870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189255|NCT04120870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65189256|NCT03747562|Gabapentin|gabapentin|mesh-list
65189257|NCT03747562|Analgesics|analgesics|mesh-ancestor
65189258|NCT03747562|Sensory System Agents|sensory system agents|mesh-ancestor
65189259|NCT03747562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65189260|NCT03747562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189261|NCT03747562|Anticonvulsants|anticonvulsants|mesh-ancestor
65189262|NCT03747562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65189263|NCT03747562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65189264|NCT03747562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65189265|NCT03747562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65189266|NCT03747562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65189267|NCT03747562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65189268|NCT03747562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65189269|NCT03747562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189270|NCT03747562|Antimanic Agents|antimanic agents|mesh-ancestor
65189271|NCT03747484|Interferons|interferons|mesh-list
65189272|NCT03747484|Interferon-gamma|interferon-gamma|mesh-list
65189273|NCT03747484|Pembrolizumab|pembrolizumab|mesh-list
65189274|NCT03747484|Avelumab|avelumab|mesh-list
65189275|NCT03747484|Immunoglobulins|immunoglobulins|mesh-list
65189276|NCT03747484|Immunoglobulin G|immunoglobulin g|mesh-list
65189277|NCT03747484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65189278|NCT03747484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65189279|NCT03747484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189280|NCT03747484|Antiviral Agents|antiviral agents|mesh-ancestor
65189281|NCT03747484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65189282|NCT03747484|Immunologic Factors|immunologic factors|mesh-ancestor
65189283|NCT03747484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189284|NCT01109849|Methylphenidate|methylphenidate|mesh-list
65189285|NCT01109849|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
65189286|NCT01109849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189287|NCT01109849|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65189288|NCT01109849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65327180|NCT00746252|Dopamine Agonists|dopamine agonists|mesh-ancestor
65327181|NCT00746252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65327182|NCT00746252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65327183|NCT00746252|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65327184|NCT00746252|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65327185|NCT02574975|Budesonide|budesonide|mesh-list
65327186|NCT02574975|Adenosine|adenosine|mesh-list
65327187|NCT02574975|Formoterol Fumarate|formoterol fumarate|mesh-list
65327188|NCT02574975|Methacholine Chloride|methacholine chloride|mesh-list
65327189|NCT02574975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65327190|NCT02574975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65327191|NCT02574975|Autonomic Agents|autonomic agents|mesh-ancestor
65327192|NCT02574975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65327193|NCT02574975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327194|NCT02574975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65189289|NCT01109849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65189290|NCT01109849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831857|NCT01591226|Diuretics|diuretics|mesh-ancestor
65189291|NCT01109849|Dopamine Agents|dopamine agents|mesh-ancestor
65189292|NCT01109849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65189293|NCT01061736|Folic Acid|folic acid|mesh-list
65189294|NCT01061736|Methotrexate|methotrexate|mesh-list
65189295|NCT01061736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65189296|NCT01061736|Abortifacient Agents|abortifacient agents|mesh-ancestor
65189297|NCT01061736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65189298|NCT01061736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189299|NCT01061736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65189300|NCT01061736|Antimetabolites|antimetabolites|mesh-ancestor
65189301|NCT01061736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189302|NCT01061736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189303|NCT01061736|Dermatologic Agents|dermatologic agents|mesh-ancestor
65189304|NCT01061736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189305|NCT01061736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65189306|NCT01061736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65189307|NCT01061736|Immunologic Factors|immunologic factors|mesh-ancestor
65189308|NCT01061736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65189309|NCT01061736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65189310|NCT01061736|Hematinics|hematinics|mesh-ancestor
65189311|NCT01061736|Vitamin B Complex|vitamin b complex|mesh-ancestor
65189312|NCT01061736|Vitamins|vitamins|mesh-ancestor
65189320|NCT02874378|Sensory System Agents|sensory system agents|mesh-ancestor
65189321|NCT02874378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65189322|NCT02874378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65189323|NCT02874378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65189324|NCT02874378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65189325|NCT02874378|Adrenergic Agents|adrenergic agents|mesh-ancestor
65189326|NCT02874378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65189327|NCT02874378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189328|NCT01117181|Methylphenidate|methylphenidate|mesh-list
65189329|NCT01117181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65189330|NCT01117181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189331|NCT01117181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65189332|NCT01117181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65189333|NCT01117181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65189334|NCT01117181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189335|NCT01117181|Dopamine Agents|dopamine agents|mesh-ancestor
65189336|NCT01117181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65189337|NCT02881619|Etodolac|etodolac|mesh-list
65189338|NCT02881619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65327195|NCT02574975|Respiratory System Agents|respiratory system agents|mesh-ancestor
65327196|NCT02574975|Glucocorticoids|glucocorticoids|mesh-ancestor
65327197|NCT02574975|Hormones|hormones|mesh-ancestor
65327198|NCT02574975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65327199|NCT02574975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65327200|NCT02574975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65327201|NCT02574975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65327202|NCT02574975|Adrenergic Agents|adrenergic agents|mesh-ancestor
65327203|NCT02574975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65327204|NCT02574975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327205|NCT02574975|Analgesics|analgesics|mesh-ancestor
65189339|NCT02881619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65189340|NCT02881619|Analgesics|analgesics|mesh-ancestor
65189341|NCT02881619|Sensory System Agents|sensory system agents|mesh-ancestor
65189342|NCT02881619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65189343|NCT02881619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189344|NCT02881619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65189345|NCT02881619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65189346|NCT02881619|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65189347|NCT02881619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65189348|NCT02881619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189349|NCT02881619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189350|NCT04303806|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65189351|NCT04303806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65189352|NCT04303806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65189353|NCT04303806|Antimetabolites|antimetabolites|mesh-ancestor
65189354|NCT04303806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189355|NCT04303806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65189356|NCT04303806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65189357|NCT04303806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189358|NCT02882087|Methotrexate|methotrexate|mesh-list
65189359|NCT02882087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65189360|NCT02882087|Abortifacient Agents|abortifacient agents|mesh-ancestor
65189361|NCT02882087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65189362|NCT02882087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831931|NCT01592019|Diclofenac|diclofenac|mesh-list
65189363|NCT02882087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65189364|NCT02882087|Antimetabolites|antimetabolites|mesh-ancestor
65189365|NCT02882087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189366|NCT02882087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189367|NCT02882087|Dermatologic Agents|dermatologic agents|mesh-ancestor
65189368|NCT02882087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189369|NCT02882087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65189370|NCT02882087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65189371|NCT02882087|Immunologic Factors|immunologic factors|mesh-ancestor
65189372|NCT02882087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65189373|NCT02882087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65189374|NCT04303884|Pembrolizumab|pembrolizumab|mesh-list
65189375|NCT04303884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65189376|NCT04303884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189377|NCT01040130|Olodaterol|olodaterol|mesh-list
65189384|NCT00932451|Crizotinib|crizotinib|mesh-list
65189385|NCT00932451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189386|NCT00932451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65189387|NCT00932451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189388|NCT00932451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189389|NCT01039584|Butoconazole|butoconazole|mesh-list
65189390|NCT01039584|Antifungal Agents|antifungal agents|mesh-ancestor
65189391|NCT01039584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65189392|NCT05297682|Propofol|propofol|mesh-list
65189393|NCT05297682|Anesthetics|anesthetics|mesh-ancestor
65189394|NCT05297682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65327206|NCT02574975|Sensory System Agents|sensory system agents|mesh-ancestor
65327207|NCT02574975|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65327208|NCT02574975|Vasodilator Agents|vasodilator agents|mesh-ancestor
65327209|NCT02574975|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65327210|NCT02574975|Purinergic Agonists|purinergic agonists|mesh-ancestor
65327211|NCT02574975|Purinergic Agents|purinergic agents|mesh-ancestor
65327212|NCT02574975|Miotics|miotics|mesh-ancestor
65189395|NCT05297682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189396|NCT05297682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65189397|NCT05297682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65189398|NCT05297682|Anesthetics, General|anesthetics, general|mesh-ancestor
65189399|NCT01108055|Paclitaxel|paclitaxel|mesh-list
65189400|NCT01108055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65189401|NCT01108055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189402|NCT01108055|Tubulin Modulators|tubulin modulators|mesh-ancestor
65189403|NCT01108055|Antimitotic Agents|antimitotic agents|mesh-ancestor
65189404|NCT01108055|Mitosis Modulators|mitosis modulators|mesh-ancestor
65189405|NCT01108055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189406|NCT00609375|Cefepime|cefepime|mesh-list
65189407|NCT00609375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65189408|NCT00609375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65189409|NCT01107899|Clopidogrel|clopidogrel|mesh-list
65189410|NCT01107899|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65189411|NCT01107899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65189412|NCT01107899|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65189413|NCT01107899|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65189414|NCT01107899|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65189415|NCT01107899|Purinergic Agents|purinergic agents|mesh-ancestor
65189416|NCT01107899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65189417|NCT01107899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189418|NCT01107899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189419|NCT01107743|Amlodipine|amlodipine|mesh-list
65189420|NCT01107743|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
65189421|NCT01107743|Atorvastatin|atorvastatin|mesh-list
65189422|NCT01107743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65189423|NCT01107743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65189424|NCT01107743|Antimetabolites|antimetabolites|mesh-ancestor
65189425|NCT01107743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189426|NCT01107743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65189427|NCT01107743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65189428|NCT01107743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189429|NCT01107743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65189430|NCT01107743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65189431|NCT01107743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65189432|NCT01107743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65189433|NCT01107743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189434|NCT01107743|Vasodilator Agents|vasodilator agents|mesh-ancestor
65189435|NCT01059864|Atorvastatin|atorvastatin|mesh-list
65189436|NCT01059864|Tofacitinib|tofacitinib|mesh-list
65189437|NCT01059864|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65189438|NCT01059864|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65189439|NCT01059864|Antimetabolites|antimetabolites|mesh-ancestor
65189440|NCT01059864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189441|NCT01059864|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65189442|NCT01059864|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65189443|NCT01059864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189444|NCT01059864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65189449|NCT04302402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65189450|NCT04302402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65189451|NCT04302402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65189453|NCT03931408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65189454|NCT03931408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65189455|NCT03931408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65189456|NCT03931408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189457|NCT03931408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189458|NCT03398824|Metformin|metformin|mesh-list
65327213|NCT02574975|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65327214|NCT02574975|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
65327215|NCT02574975|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65327216|NCT02574975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65327217|NCT02574975|Cholinergic Agents|cholinergic agents|mesh-ancestor
65327218|NCT00718770|Bexarotene|bexarotene|mesh-list
65327219|NCT00718770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327220|NCT04084158|Paclitaxel|paclitaxel|mesh-list
65327221|NCT04084158|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64556694|NCT04990752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65189459|NCT03398824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65189460|NCT03398824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189461|NCT01033734|Oseltamivir|oseltamivir|mesh-list
65189462|NCT01033734|Antiviral Agents|antiviral agents|mesh-ancestor
65189463|NCT01033734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65189464|NCT01033734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189465|NCT01033734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189466|NCT03792256|Cytarabine|cytarabine|mesh-list
65189467|NCT03792256|Prednisone|prednisone|mesh-list
65189468|NCT03792256|Prednisolone|prednisolone|mesh-list
65189469|NCT03792256|Hydrocortisone|hydrocortisone|mesh-list
65189470|NCT03792256|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65189471|NCT03792256|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65189472|NCT03792256|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65189473|NCT03792256|Doxorubicin|doxorubicin|mesh-list
65189474|NCT03792256|Methotrexate|methotrexate|mesh-list
65189475|NCT03792256|Vincristine|vincristine|mesh-list
65189476|NCT03792256|Palbociclib|palbociclib|mesh-list
65189477|NCT03792256|Pegaspargase|pegaspargase|mesh-list
65189478|NCT03792256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65189479|NCT03792256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189480|NCT03792256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65189481|NCT03792256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65189482|NCT03792256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189483|NCT03792256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189484|NCT03792256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65189485|NCT03792256|Glucocorticoids|glucocorticoids|mesh-ancestor
65189486|NCT03792256|Hormones|hormones|mesh-ancestor
65189487|NCT03792256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65189488|NCT03792256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189489|NCT03792256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65189490|NCT03792256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65189491|NCT03792256|Abortifacient Agents|abortifacient agents|mesh-ancestor
65189492|NCT03792256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65189493|NCT03792256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65189494|NCT03792256|Antimetabolites|antimetabolites|mesh-ancestor
65189495|NCT03792256|Dermatologic Agents|dermatologic agents|mesh-ancestor
65189496|NCT03792256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65189497|NCT03792256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65189498|NCT03792256|Immunologic Factors|immunologic factors|mesh-ancestor
65189499|NCT03792256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65189500|NCT03792256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65189501|NCT03792256|Antiviral Agents|antiviral agents|mesh-ancestor
65189502|NCT03792256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65189503|NCT03792256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65189504|NCT03792256|Tubulin Modulators|tubulin modulators|mesh-ancestor
65189505|NCT03792256|Antimitotic Agents|antimitotic agents|mesh-ancestor
65189506|NCT03792256|Mitosis Modulators|mitosis modulators|mesh-ancestor
65189507|NCT03792256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65189508|NCT00613288|Testosterone|testosterone|mesh-list
65189509|NCT00613288|Androgens|androgens|mesh-ancestor
65189510|NCT00613288|Hormones|hormones|mesh-ancestor
65189511|NCT00613288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65189512|NCT00613288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189513|NCT03711838|Acetylcysteine|acetylcysteine|mesh-list
65189514|NCT03711838|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65189515|NCT03711838|Antiviral Agents|antiviral agents|mesh-ancestor
65327222|NCT04084158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65327223|NCT04084158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327224|NCT04084158|Tubulin Modulators|tubulin modulators|mesh-ancestor
65327225|NCT04084158|Antimitotic Agents|antimitotic agents|mesh-ancestor
65327226|NCT04084158|Mitosis Modulators|mitosis modulators|mesh-ancestor
65327227|NCT04084158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327228|NCT00714519|Castor Oil|castor oil|mesh-list
65327229|NCT00714519|Cathartics|cathartics|mesh-ancestor
65327230|NCT00714519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65327231|NCT00714948|Gemcitabine|gemcitabine|mesh-list
65327232|NCT00714948|Sorafenib|sorafenib|mesh-list
65327233|NCT00714948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189516|NCT03711838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65189517|NCT03711838|Expectorants|expectorants|mesh-ancestor
65189521|NCT03711838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189522|NCT03711838|Protective Agents|protective agents|mesh-ancestor
65189523|NCT03711838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189524|NCT03711838|Antidotes|antidotes|mesh-ancestor
65189525|NCT04275778|Hydroxychloroquine|hydroxychloroquine|mesh-list
65189526|NCT04275778|Antimalarials|antimalarials|mesh-ancestor
65189527|NCT04275778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65189528|NCT04275778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65189529|NCT04275778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65189530|NCT04275778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189531|NCT04275778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189532|NCT04275778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65189533|NCT01115855|Eplerenone|eplerenone|mesh-list
65189534|NCT01115855|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65189535|NCT01115855|Hormone Antagonists|hormone antagonists|mesh-ancestor
65189536|NCT01115855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65189537|NCT01115855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189538|NCT01115855|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65189539|NCT01115855|Diuretics|diuretics|mesh-ancestor
65189540|NCT01115855|Natriuretic Agents|natriuretic agents|mesh-ancestor
65189541|NCT01115855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65189542|NCT03615508|Phenylephrine|phenylephrine|mesh-list
65189543|NCT03615508|Oxymetazoline|oxymetazoline|mesh-list
65189544|NCT03615508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65189545|NCT03615508|Mydriatics|mydriatics|mesh-ancestor
65189546|NCT03615508|Autonomic Agents|autonomic agents|mesh-ancestor
65189547|NCT03615508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65189548|NCT03615508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189549|NCT03615508|Sympathomimetics|sympathomimetics|mesh-ancestor
65189550|NCT03615508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65189551|NCT03615508|Nasal Decongestants|nasal decongestants|mesh-ancestor
65189552|NCT03615508|Respiratory System Agents|respiratory system agents|mesh-ancestor
65189553|NCT03615508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65189554|NCT03615508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65189555|NCT03615508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65189556|NCT03615508|Adrenergic Agents|adrenergic agents|mesh-ancestor
65189557|NCT03615508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65189558|NCT03615508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189559|NCT03615508|Protective Agents|protective agents|mesh-ancestor
65189560|NCT02880995|Amisulpride|amisulpride|mesh-list
65189561|NCT02880995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65189562|NCT02880995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65189563|NCT02880995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65189564|NCT02880995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189565|NCT02880995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65189566|NCT02880995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65189567|NCT02880995|Dopamine Agents|dopamine agents|mesh-ancestor
65189568|NCT02880995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65189569|NCT02880995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189570|NCT02880995|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65327234|NCT00714948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65327235|NCT00714948|Antimetabolites|antimetabolites|mesh-ancestor
65327236|NCT00714948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327237|NCT00714948|Antiviral Agents|antiviral agents|mesh-ancestor
65327238|NCT00714948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65327239|NCT00714948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327240|NCT00714948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65327241|NCT00714948|Immunologic Factors|immunologic factors|mesh-ancestor
65327242|NCT00714948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327243|NCT00714948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65327244|NCT00714714|Adapalene|adapalene|mesh-list
65327245|NCT00714714|Tretinoin|tretinoin|mesh-list
65327246|NCT00714714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65327247|NCT00714714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65327248|NCT00714714|Analgesics|analgesics|mesh-ancestor
65327249|NCT00714714|Sensory System Agents|sensory system agents|mesh-ancestor
65327250|NCT00714714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65327251|NCT00714714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327252|NCT00714714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65327253|NCT00714714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65327254|NCT00714714|Dermatologic Agents|dermatologic agents|mesh-ancestor
65327255|NCT00714714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327256|NCT00714714|Keratolytic Agents|keratolytic agents|mesh-ancestor
65327257|NCT00441337|Nivolumab|nivolumab|mesh-list
65189571|NCT02880995|Antidepressive Agents|antidepressive agents|mesh-ancestor
65189572|NCT03522064|Carboplatin|carboplatin|mesh-list
65189573|NCT03522064|Methyltestosterone|methyltestosterone|mesh-list
65189574|NCT03522064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65189575|NCT03522064|Testosterone|testosterone|mesh-list
65189576|NCT03522064|Testosterone undecanoate|testosterone undecanoate|mesh-list
65189577|NCT03522064|Testosterone enanthate|testosterone enanthate|mesh-list
65189578|NCT03522064|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65189579|NCT03522064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189580|NCT03522064|Androgens|androgens|mesh-ancestor
65189581|NCT03522064|Hormones|hormones|mesh-ancestor
65189582|NCT03522064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65189583|NCT03522064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189584|NCT03522064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65189585|NCT03522064|Anabolic Agents|anabolic agents|mesh-ancestor
65189586|NCT04310579|Midazolam|midazolam|mesh-list
65189587|NCT04310579|Oxycodone|oxycodone|mesh-list
65189588|NCT04310579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65189589|NCT04310579|Paroxetine|paroxetine|mesh-list
65189590|NCT04310579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65189598|NCT04310579|Anesthetics, General|anesthetics, general|mesh-ancestor
65189599|NCT04310579|Anesthetics|anesthetics|mesh-ancestor
65189600|NCT04310579|GABA Modulators|gaba modulators|mesh-ancestor
65189601|NCT04310579|GABA Agents|gaba agents|mesh-ancestor
65189602|NCT04310579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65189603|NCT04310579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189604|NCT04310579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65189605|NCT04310579|Narcotics|narcotics|mesh-ancestor
65189606|NCT04310579|Analgesics|analgesics|mesh-ancestor
65189607|NCT04310579|Sensory System Agents|sensory system agents|mesh-ancestor
65327258|NCT00441337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65327259|NCT00441337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327260|NCT00441337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65327261|NCT00441337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327262|NCT00578877|Nonoxynol|nonoxynol|mesh-list
65327263|NCT00578877|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
65327264|NCT00578877|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
65327265|NCT00578877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327266|NCT00578877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65327267|NCT00578877|Contraceptive Agents|contraceptive agents|mesh-ancestor
65327268|NCT00578877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65327269|NCT00578877|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65327270|NCT02573727|Terlipressin|terlipressin|mesh-list
65327271|NCT02573727|Epinephrine|epinephrine|mesh-list
65327272|NCT02573727|Racepinephrine|racepinephrine|mesh-list
65327273|NCT02573727|Norepinephrine|norepinephrine|mesh-list
65327274|NCT02573727|Epinephryl borate|epinephryl borate|mesh-list
65189608|NCT04310579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65189609|NCT04310579|Antidepressive Agents|antidepressive agents|mesh-ancestor
65189610|NCT04310579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65189611|NCT04310579|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65189612|NCT04310579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65189613|NCT04310579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65189614|NCT04310579|Serotonin Agents|serotonin agents|mesh-ancestor
65189615|NCT04310579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65189616|NCT04310579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65189617|NCT04310579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65189618|NCT04310579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189619|NCT05244538|Remifentanil|remifentanil|mesh-list
65189620|NCT05244538|Propofol|propofol|mesh-list
65189621|NCT05244538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65189622|NCT05244538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65189623|NCT05244538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189624|NCT05244538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65189625|NCT05244538|Anesthetics, General|anesthetics, general|mesh-ancestor
65189626|NCT05244538|Anesthetics|anesthetics|mesh-ancestor
65189627|NCT05244538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65189628|NCT05244538|Narcotics|narcotics|mesh-ancestor
65189629|NCT05244538|Analgesics|analgesics|mesh-ancestor
65189630|NCT05244538|Sensory System Agents|sensory system agents|mesh-ancestor
65189631|NCT05244538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65189632|NCT03638128|Denosumab|denosumab|mesh-list
65189633|NCT03638128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65189634|NCT03638128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189635|NCT05042440|Factor VIII|factor viii|mesh-list
65189636|NCT05042440|BAX 855|bax 855|mesh-list
65189637|NCT05042440|Coagulants|coagulants|mesh-ancestor
65189638|NCT03481660|Aflibercept|aflibercept|mesh-list
65189639|NCT03481660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65189640|NCT03481660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65189641|NCT03481660|Growth Substances|growth substances|mesh-ancestor
65189642|NCT03481660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189643|NCT03481660|Growth Inhibitors|growth inhibitors|mesh-ancestor
65189644|NCT03481660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189645|NCT05345236|Aflibercept|aflibercept|mesh-list
65189646|NCT05345236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65189647|NCT05345236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65189648|NCT05345236|Growth Substances|growth substances|mesh-ancestor
65189649|NCT05345236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189650|NCT05345236|Growth Inhibitors|growth inhibitors|mesh-ancestor
65327275|NCT02573727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65327276|NCT02573727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65327277|NCT02573727|Adrenergic Agents|adrenergic agents|mesh-ancestor
65327278|NCT02573727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65327279|NCT02573727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327280|NCT02573727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327281|NCT02573727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65327282|NCT02573727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65327283|NCT02573727|Autonomic Agents|autonomic agents|mesh-ancestor
65327284|NCT02573727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65327285|NCT02573727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65189651|NCT05345236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189652|NCT02692534|Cocaine|cocaine|mesh-list
65189653|NCT02692534|Anesthetics, Local|anesthetics, local|mesh-ancestor
65189654|NCT02692534|Anesthetics|anesthetics|mesh-ancestor
65189655|NCT02692534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65189656|NCT02692534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189657|NCT02692534|Sensory System Agents|sensory system agents|mesh-ancestor
65189658|NCT02692534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65189659|NCT02692534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65189668|NCT00614536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65189669|NCT00614536|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65189670|NCT00614536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189671|NCT00614536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189672|NCT04333654|Hydroxychloroquine|hydroxychloroquine|mesh-list
65189673|NCT04333654|Antimalarials|antimalarials|mesh-ancestor
65189674|NCT04333654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65189675|NCT04333654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65189676|NCT04333654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65189677|NCT04333654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189678|NCT04333654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189679|NCT04333654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65189680|NCT01059630|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65189681|NCT01059630|Obinutuzumab|obinutuzumab|mesh-list
65189682|NCT01059630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65189683|NCT01059630|Alkylating Agents|alkylating agents|mesh-ancestor
65189684|NCT01059630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189685|NCT01059630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189686|NCT01059630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65189688|NCT04142086|Immunologic Factors|immunologic factors|mesh-ancestor
65189689|NCT04142086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189690|NCT03664882|Fexofenadine|fexofenadine|mesh-list
65189691|NCT03664882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65189692|NCT03664882|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65189693|NCT03664882|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65189694|NCT03664882|Histamine Antagonists|histamine antagonists|mesh-ancestor
65189695|NCT03664882|Histamine Agents|histamine agents|mesh-ancestor
65189696|NCT03664882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65189697|NCT03664882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189698|NCT03664882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189699|NCT03951142|Losartan|losartan|mesh-list
65189700|NCT03951142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65189701|NCT03951142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65189702|NCT03951142|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65189703|NCT03951142|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65189704|NCT03951142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189705|NCT03903016|Insulin|insulin|mesh-list
65189706|NCT03903016|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65189707|NCT03903016|Insulin Lispro|insulin lispro|mesh-list
65189708|NCT03903016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65189709|NCT03903016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189710|NCT03514732|Melatonin|melatonin|mesh-list
65327286|NCT02573727|Respiratory System Agents|respiratory system agents|mesh-ancestor
65327287|NCT02573727|Mydriatics|mydriatics|mesh-ancestor
65327288|NCT02573727|Sympathomimetics|sympathomimetics|mesh-ancestor
65327289|NCT02573727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65327290|NCT02573727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65327291|NCT00709683|Insulin Aspart|insulin aspart|mesh-list
65327292|NCT00709683|Biphasic Insulins|biphasic insulins|mesh-list
65327293|NCT00709683|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65189711|NCT03514732|Antioxidants|antioxidants|mesh-ancestor
65189712|NCT03514732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189713|NCT03514732|Protective Agents|protective agents|mesh-ancestor
65189714|NCT03514732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189715|NCT03514732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65189716|NCT03800836|Paclitaxel|paclitaxel|mesh-list
65189717|NCT03800836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65189718|NCT03800836|Atezolizumab|atezolizumab|mesh-list
65189719|NCT03800836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65189720|NCT03800836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189721|NCT03800836|Tubulin Modulators|tubulin modulators|mesh-ancestor
65189722|NCT03800836|Antimitotic Agents|antimitotic agents|mesh-ancestor
65189723|NCT03800836|Mitosis Modulators|mitosis modulators|mesh-ancestor
65189724|NCT03800836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189725|NCT01976182|Cyclophosphamide|cyclophosphamide|mesh-list
65189728|NCT01976182|Immunologic Factors|immunologic factors|mesh-ancestor
65189729|NCT01976182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189730|NCT01976182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65189731|NCT01976182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65189732|NCT01976182|Alkylating Agents|alkylating agents|mesh-ancestor
65189733|NCT01976182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189734|NCT01976182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189735|NCT01976182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65189736|NCT01976182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65189737|NCT01976182|Abortifacient Agents|abortifacient agents|mesh-ancestor
65189738|NCT01976182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65189739|NCT01976182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65189740|NCT01976182|Antimetabolites|antimetabolites|mesh-ancestor
65189741|NCT01976182|Dermatologic Agents|dermatologic agents|mesh-ancestor
65189742|NCT01976182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189743|NCT01976182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65189744|NCT01976182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65189745|NCT00932373|Trastuzumab|trastuzumab|mesh-list
65189746|NCT00932373|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65189747|NCT00932373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65189748|NCT00932373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189749|NCT00932373|Tubulin Modulators|tubulin modulators|mesh-ancestor
65189750|NCT00932373|Antimitotic Agents|antimitotic agents|mesh-ancestor
65189751|NCT00932373|Mitosis Modulators|mitosis modulators|mesh-ancestor
65189752|NCT00932373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189753|NCT04265001|Hyaluronic Acid|hyaluronic acid|mesh-list
65189754|NCT04265001|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65189755|NCT04265001|Immunologic Factors|immunologic factors|mesh-ancestor
65189756|NCT04265001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189757|NCT04265001|Viscosupplements|viscosupplements|mesh-ancestor
65189758|NCT04265001|Protective Agents|protective agents|mesh-ancestor
65189760|NCT00608595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65189761|NCT00608595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65189762|NCT00608595|Analgesics|analgesics|mesh-ancestor
65189763|NCT00608595|Sensory System Agents|sensory system agents|mesh-ancestor
65189764|NCT00608595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65189765|NCT00608595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189766|NCT00608595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65189767|NCT00608595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65189768|NCT00608595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65189769|NCT00608595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65189770|NCT00608595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327294|NCT00709683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65327295|NCT00709683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327296|NCT00918840|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65327297|NCT00918840|Antiviral Agents|antiviral agents|mesh-ancestor
65327298|NCT00918840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65327299|NCT00918528|Mitomycins|mitomycins|mesh-list
65327300|NCT00918528|Mitomycin|mitomycin|mesh-list
65327301|NCT00918528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65327302|NCT00918528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327303|NCT00918528|Alkylating Agents|alkylating agents|mesh-ancestor
65327304|NCT00918528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189771|NCT00608595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189772|NCT03761134|Metformin|metformin|mesh-list
65189773|NCT03761134|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65189774|NCT03761134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65189775|NCT03761134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189776|NCT03761134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65189777|NCT03761134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189778|NCT01055496|Gemcitabine|gemcitabine|mesh-list
65189779|NCT01055496|Dexamethasone|dexamethasone|mesh-list
65189780|NCT01055496|Prednisone|prednisone|mesh-list
65189781|NCT01055496|Cyclophosphamide|cyclophosphamide|mesh-list
65189782|NCT01055496|Rituximab|rituximab|mesh-list
65189783|NCT01055496|Vincristine|vincristine|mesh-list
65189784|NCT01055496|Cisplatin|cisplatin|mesh-list
65189785|NCT01055496|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65189786|NCT01055496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65189787|NCT01055496|Immunologic Factors|immunologic factors|mesh-ancestor
65189788|NCT01055496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189789|NCT01055496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65189790|NCT01055496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65189791|NCT01055496|Alkylating Agents|alkylating agents|mesh-ancestor
65189792|NCT01055496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189793|NCT01055496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189794|NCT01055496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65189795|NCT01055496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65189796|NCT01055496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65189803|NCT01055496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65189804|NCT01055496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65189805|NCT01055496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65189806|NCT01055496|Antimetabolites|antimetabolites|mesh-ancestor
65189807|NCT01055496|Antiviral Agents|antiviral agents|mesh-ancestor
65189808|NCT01055496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65189809|NCT01055496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189810|NCT01055496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65189811|NCT01055496|Tubulin Modulators|tubulin modulators|mesh-ancestor
65189812|NCT01055496|Antimitotic Agents|antimitotic agents|mesh-ancestor
65189814|NCT01055496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65189815|NCT03436498|Insulin|insulin|mesh-list
65189816|NCT03436498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65189817|NCT03436498|Insulin Aspart|insulin aspart|mesh-list
65189818|NCT03436498|Insulin, Long-Acting|insulin, long-acting|mesh-list
65189819|NCT03436498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65189820|NCT03436498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65189821|NCT03436498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189822|NCT03435952|Doxycycline|doxycycline|mesh-list
65189823|NCT03435952|Pembrolizumab|pembrolizumab|mesh-list
65189824|NCT03435952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65189825|NCT03435952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189826|NCT03435952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65189827|NCT03435952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65189828|NCT03435952|Antimalarials|antimalarials|mesh-ancestor
65189829|NCT03435952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65327305|NCT00918528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65327306|NCT00918528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327307|NCT00468481|Drospirenone|drospirenone|mesh-list
65327308|NCT00468481|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65327309|NCT00468481|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65327310|NCT00468481|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65327311|NCT00468481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65327312|NCT00468481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65327313|NCT00468481|Contraceptive Agents|contraceptive agents|mesh-ancestor
65327314|NCT00468481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64556779|NCT00934635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65189830|NCT03435952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65189831|NCT04262193|Suvorexant|suvorexant|mesh-list
65189832|NCT04262193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65189833|NCT04262193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65189834|NCT04262193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65189835|NCT04262193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189836|NCT04262193|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65189837|NCT04262193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65189838|NCT04262193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189839|NCT00609531|Citalopram|citalopram|mesh-list
65189840|NCT00609531|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65189841|NCT00609531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65189842|NCT00609531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65189843|NCT00609531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189844|NCT00609531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65189845|NCT00609531|Serotonin Agents|serotonin agents|mesh-ancestor
65189846|NCT00609531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189847|NCT00609531|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65189848|NCT00609531|Antidepressive Agents|antidepressive agents|mesh-ancestor
65189849|NCT00609531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65189850|NCT03406000|Insulin Glargine|insulin glargine|mesh-list
65189851|NCT03406000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65189852|NCT03406000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189853|NCT01052844|Gabapentin|gabapentin|mesh-list
65189854|NCT01052844|Analgesics|analgesics|mesh-ancestor
65189855|NCT01052844|Sensory System Agents|sensory system agents|mesh-ancestor
65189856|NCT01052844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65189857|NCT01052844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189858|NCT01052844|Anticonvulsants|anticonvulsants|mesh-ancestor
65189859|NCT01052844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65189860|NCT01052844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65189861|NCT01052844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65189862|NCT01052844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65189863|NCT01052844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65189864|NCT01052844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65189865|NCT01052844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65189866|NCT01052844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189871|NCT01049412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65189872|NCT01049412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189874|NCT02584426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65189875|NCT02584426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65189876|NCT00934089|Latanoprost|latanoprost|mesh-list
65189877|NCT00934089|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65189878|NCT00934089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65189879|NCT01032174|Azithromycin|azithromycin|mesh-list
65189880|NCT01032174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65189881|NCT01032174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65189882|NCT02704780|Misoprostol|misoprostol|mesh-list
65189883|NCT02704780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65189884|NCT02704780|Abortifacient Agents|abortifacient agents|mesh-ancestor
65327315|NCT00468481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327316|NCT00468481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65327317|NCT00468481|Estrogens|estrogens|mesh-ancestor
65327318|NCT00468481|Hormones|hormones|mesh-ancestor
65327319|NCT00468481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65327320|NCT00468481|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65327321|NCT00468481|Hormone Antagonists|hormone antagonists|mesh-ancestor
65327322|NCT00468481|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65327323|NCT00468481|Diuretics|diuretics|mesh-ancestor
65327324|NCT00468481|Natriuretic Agents|natriuretic agents|mesh-ancestor
65327325|NCT02574819|Methylnaltrexone|methylnaltrexone|mesh-list
65327326|NCT02574819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65327327|NCT02574819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327328|NCT02574819|Sensory System Agents|sensory system agents|mesh-ancestor
65327329|NCT02574819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65327330|NCT00709839|Hydrocortisone|hydrocortisone|mesh-list
65327331|NCT00709839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65327332|NCT03949153|Nivolumab|nivolumab|mesh-list
65327333|NCT03949153|Ipilimumab|ipilimumab|mesh-list
65327334|NCT03949153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65189885|NCT02704780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65189886|NCT02704780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189887|NCT02704780|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65189888|NCT02704780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65189889|NCT02704780|Oxytocics|oxytocics|mesh-ancestor
65189890|NCT02704546|Methylphenidate|methylphenidate|mesh-list
65189891|NCT02704546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65189892|NCT02704546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189893|NCT02704546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65189894|NCT02704546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65189895|NCT02704546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65189896|NCT02704546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189897|NCT02704546|Dopamine Agents|dopamine agents|mesh-ancestor
65189898|NCT02704546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65189899|NCT01032018|Bupropion|bupropion|mesh-list
65189900|NCT01032018|Citalopram|citalopram|mesh-list
65189901|NCT01032018|Sertraline|sertraline|mesh-list
65189902|NCT01032018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65189903|NCT01032018|Antidepressive Agents|antidepressive agents|mesh-ancestor
65189904|NCT01032018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65189905|NCT01032018|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65189906|NCT01032018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65189907|NCT01032018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65189908|NCT01032018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189909|NCT01032018|Dopamine Agents|dopamine agents|mesh-ancestor
65189910|NCT01032018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65189911|NCT01032018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189912|NCT01032018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65189913|NCT01032018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65189914|NCT01032018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189915|NCT01032018|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65189916|NCT01032018|Serotonin Agents|serotonin agents|mesh-ancestor
65189917|NCT02330926|Ibuprofen|ibuprofen|mesh-list
65327335|NCT03949153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327336|NCT03949153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65327337|NCT03949153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327338|NCT00709917|Repaglinide|repaglinide|mesh-list
65327339|NCT00709917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65327340|NCT00709917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327341|NCT02574741|Aripiprazole|aripiprazole|mesh-list
65327342|NCT02574741|Antidepressive Agents|antidepressive agents|mesh-ancestor
65327343|NCT02574741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65327344|NCT02574741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65327345|NCT02574741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65327346|NCT02574741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64556809|NCT04355949|Folic Acid|folic acid|mesh-list
64556810|NCT04355949|Vitamin B 12|vitamin b 12|mesh-list
64556811|NCT04355949|Hydroxocobalamin|hydroxocobalamin|mesh-list
65189918|NCT02330926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65189919|NCT02330926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65189920|NCT02330926|Analgesics|analgesics|mesh-ancestor
65189921|NCT02330926|Sensory System Agents|sensory system agents|mesh-ancestor
65189922|NCT02330926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65189923|NCT02330926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189924|NCT02330926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65189925|NCT02330926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65189926|NCT02330926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65189927|NCT02330926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189928|NCT02330926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189929|NCT03606694|Metformin|metformin|mesh-list
65189930|NCT03606694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65189931|NCT03606694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189932|NCT00927069|Adalimumab|adalimumab|mesh-list
65189933|NCT00927069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65189934|NCT00927069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65189935|NCT01031628|Imatinib Mesylate|imatinib mesylate|mesh-list
65189936|NCT01031628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189937|NCT01031628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65189938|NCT01031628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189945|NCT00608673|Betamethasone benzoate|betamethasone benzoate|mesh-list
65189946|NCT00608673|Pimecrolimus|pimecrolimus|mesh-list
65189947|NCT00608673|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65189948|NCT00608673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65189949|NCT00608673|Glucocorticoids|glucocorticoids|mesh-ancestor
65189950|NCT00608673|Hormones|hormones|mesh-ancestor
65189951|NCT00608673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65189952|NCT00608673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189953|NCT00608673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65189954|NCT00608673|Respiratory System Agents|respiratory system agents|mesh-ancestor
65189955|NCT00608673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65189956|NCT00608673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65189957|NCT00608673|Analgesics|analgesics|mesh-ancestor
65189958|NCT00608673|Sensory System Agents|sensory system agents|mesh-ancestor
65189959|NCT00608673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65189960|NCT00608673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64832535|NCT01595399|Atropine|atropine|mesh-list
65189961|NCT00608673|Dermatologic Agents|dermatologic agents|mesh-ancestor
65189962|NCT00608673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65189963|NCT00608673|Immunologic Factors|immunologic factors|mesh-ancestor
65189964|NCT00608673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65189965|NCT00608673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189966|NCT00608673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189967|NCT04263519|Tacrolimus|tacrolimus|mesh-list
65189968|NCT04263519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65327347|NCT02574741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327348|NCT02574741|Dopamine Agonists|dopamine agonists|mesh-ancestor
65327349|NCT02574741|Dopamine Agents|dopamine agents|mesh-ancestor
65327350|NCT02574741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65327351|NCT02574741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556823|NCT05580887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189969|NCT04263519|Immunologic Factors|immunologic factors|mesh-ancestor
65189970|NCT04263519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189971|NCT04263519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65189972|NCT04263519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189973|NCT04263519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189974|NCT00637767|Melphalan|melphalan|mesh-list
65189975|NCT00637767|Antibodies|antibodies|mesh-list
65189976|NCT00637767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65189977|NCT00637767|Immunologic Factors|immunologic factors|mesh-ancestor
65189978|NCT00637767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189979|NCT00637767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65189980|NCT00637767|Alkylating Agents|alkylating agents|mesh-ancestor
65189981|NCT00637767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189982|NCT00637767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189983|NCT00637767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65189984|NCT00637767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65189986|NCT05101629|Lenvatinib|lenvatinib|mesh-list
65189987|NCT05101629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65189988|NCT05101629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189989|NCT05101629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65189990|NCT05101629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189991|NCT05101629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189992|NCT00609999|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65189993|NCT00609999|Dasatinib|dasatinib|mesh-list
65189994|NCT00609999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189995|NCT00609999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65189996|NCT00609999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189997|NCT00609999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189998|NCT00627250|Amantadine|amantadine|mesh-list
65189999|NCT00627250|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65190000|NCT00627250|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65190001|NCT00627250|Antiviral Agents|antiviral agents|mesh-ancestor
65190002|NCT00627250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65190003|NCT00627250|Dopamine Agents|dopamine agents|mesh-ancestor
65190004|NCT00627250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65190005|NCT00627250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190006|NCT00627250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190009|NCT00627250|Sensory System Agents|sensory system agents|mesh-ancestor
65190010|NCT00627250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190011|NCT04300374|Anesthetics|anesthetics|mesh-list
65190012|NCT04300374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65190013|NCT04300374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190014|NCT02703376|Prednisone|prednisone|mesh-list
65190015|NCT02703376|Prednisolone|prednisolone|mesh-list
65190016|NCT02703376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65190017|NCT02703376|Glucocorticoids|glucocorticoids|mesh-ancestor
65190018|NCT02703376|Hormones|hormones|mesh-ancestor
65190019|NCT02703376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65190020|NCT02703376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190021|NCT02703376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65190022|NCT02703376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190023|NCT00610077|Letrozole|letrozole|mesh-list
65190024|NCT00610077|Clomiphene|clomiphene|mesh-list
65190025|NCT00610077|Enclomiphene|enclomiphene|mesh-list
65190026|NCT00610077|Zuclomiphene|zuclomiphene|mesh-list
65190027|NCT00610077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190028|NCT00610077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190029|NCT00610077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65190030|NCT00610077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65190031|NCT00610077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190032|NCT00610077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65190033|NCT00610077|Hormone Antagonists|hormone antagonists|mesh-ancestor
65327352|NCT02574741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64670480|NCT03978767|Oxycodone|oxycodone|mesh-list
65190034|NCT00610077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65190035|NCT00610077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190036|NCT00610077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65190037|NCT00610077|Fertility Agents|fertility agents|mesh-ancestor
65190038|NCT00610077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65190039|NCT00610077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65190040|NCT00610077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65190041|NCT00823576|Ropivacaine|ropivacaine|mesh-list
65190042|NCT00823576|Anesthetics, Local|anesthetics, local|mesh-ancestor
65190043|NCT00823576|Anesthetics|anesthetics|mesh-ancestor
65190044|NCT00823576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65190045|NCT00823576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190046|NCT00823576|Sensory System Agents|sensory system agents|mesh-ancestor
65190047|NCT00823576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190048|NCT01028352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65190049|NCT01028352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65190050|NCT01028352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65190051|NCT01028352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65190052|NCT01028352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190053|NCT01028352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65190054|NCT01028352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190055|NCT01028352|Analgesics|analgesics|mesh-ancestor
65190056|NCT01028352|Sensory System Agents|sensory system agents|mesh-ancestor
65190057|NCT01028352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190058|NCT01028352|Antidepressive Agents|antidepressive agents|mesh-ancestor
65190059|NCT01028352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65190060|NCT01028352|Dopamine Agents|dopamine agents|mesh-ancestor
65190061|NCT03172780|Diclofenac|diclofenac|mesh-list
65190062|NCT03172780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65190063|NCT03172780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65190064|NCT03172780|Analgesics|analgesics|mesh-ancestor
65190065|NCT03172780|Sensory System Agents|sensory system agents|mesh-ancestor
65190066|NCT03172780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190067|NCT03172780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190068|NCT03172780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65190069|NCT03172780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65190070|NCT03172780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65190071|NCT03172780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190072|NCT03172780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190073|NCT05011617|Anesthetics|anesthetics|mesh-list
65190074|NCT05011617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65190075|NCT05011617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190076|NCT03169972|Factor VIII|factor viii|mesh-list
65190077|NCT03169972|BAX 855|bax 855|mesh-list
65190078|NCT03169972|Coagulants|coagulants|mesh-ancestor
65190086|NCT00926367|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65190088|NCT00926367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190089|NCT00926367|Dermatologic Agents|dermatologic agents|mesh-ancestor
65190090|NCT00926367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65190091|NCT00926367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65190092|NCT00926367|Analgesics|analgesics|mesh-ancestor
65190093|NCT00926367|Sensory System Agents|sensory system agents|mesh-ancestor
65190094|NCT00926367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190095|NCT00926367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190096|NCT00926367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65190097|NCT00926367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65190098|NCT04261023|Abatacept|abatacept|mesh-list
65190099|NCT04261023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65190100|NCT04261023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190101|NCT04261023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190102|NCT04261023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65190103|NCT04261023|Immunologic Factors|immunologic factors|mesh-ancestor
65190104|NCT04261023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190105|NCT04261023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65190106|NCT01114529|Cyclosporine|cyclosporine|mesh-list
65190107|NCT01114529|Everolimus|everolimus|mesh-list
65190108|NCT01114529|Tacrolimus|tacrolimus|mesh-list
65190109|NCT01114529|Cyclosporins|cyclosporins|mesh-list
65190110|NCT01114529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64556831|NCT05580887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65327353|NCT02574741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65327354|NCT02574741|Serotonin Agents|serotonin agents|mesh-ancestor
65327355|NCT02574741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65327356|NCT02574741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65327357|NCT02574741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65327358|NCT02574741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65327359|NCT00468169|Cetuximab|cetuximab|mesh-list
65327360|NCT00468169|Hydroxyurea|hydroxyurea|mesh-list
65190111|NCT01114529|Immunologic Factors|immunologic factors|mesh-ancestor
65190112|NCT01114529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190113|NCT01114529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65190114|NCT01114529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190115|NCT01114529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190116|NCT01114529|Antifungal Agents|antifungal agents|mesh-ancestor
65190117|NCT01114529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65190118|NCT01114529|Dermatologic Agents|dermatologic agents|mesh-ancestor
65190119|NCT01114529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65190120|NCT01114529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190121|NCT00926289|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65190122|NCT00926289|Telmisartan|telmisartan|mesh-list
65190123|NCT00926289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65190124|NCT00926289|Diuretics|diuretics|mesh-ancestor
65190125|NCT00926289|Natriuretic Agents|natriuretic agents|mesh-ancestor
65190126|NCT00926289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190127|NCT00926289|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65190128|NCT00926289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65190129|NCT00926289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190130|NCT00926289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65190131|NCT00926289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65190132|NCT04309643|Levonorgestrel|levonorgestrel|mesh-list
65190133|NCT04309643|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65190134|NCT04309643|Contraceptive Agents|contraceptive agents|mesh-list
65190135|NCT04309643|Contraceptives, Oral|contraceptives, oral|mesh-list
65190136|NCT04309643|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65190137|NCT04309643|Estradiol|estradiol|mesh-list
65190138|NCT04309643|Estrogens|estrogens|mesh-ancestor
65190139|NCT04309643|Hormones|hormones|mesh-ancestor
65190140|NCT04309643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65190141|NCT04309643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190142|NCT04309643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65190143|NCT04309643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65190144|NCT04309643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65190145|NCT04309643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65190146|NCT04309643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65190150|NCT05006417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190151|NCT05006417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65190152|NCT05006417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65190153|NCT05006417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190155|NCT05006417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65190156|NCT03188146|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65190157|NCT03188146|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65190158|NCT03188146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65190159|NCT04259073|Pregabalin|pregabalin|mesh-list
65190160|NCT04259073|Analgesics|analgesics|mesh-ancestor
65190161|NCT04259073|Sensory System Agents|sensory system agents|mesh-ancestor
65190162|NCT04259073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190163|NCT04259073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190164|NCT04259073|Anticonvulsants|anticonvulsants|mesh-ancestor
65190165|NCT04259073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65190166|NCT04259073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65190167|NCT04259073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190168|NCT04259073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65190169|NCT04259073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65327361|NCT00468169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327362|NCT00468169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65327363|NCT00468169|Antisickling Agents|antisickling agents|mesh-ancestor
65327364|NCT00468169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327365|NCT00468169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327366|NCT00468169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65190170|NCT04259073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65190171|NCT04259073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65190172|NCT04259073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65190173|NCT00609063|Atorvastatin|atorvastatin|mesh-list
65190174|NCT00609063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65190175|NCT00609063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65190176|NCT00609063|Antimetabolites|antimetabolites|mesh-ancestor
65190177|NCT00609063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190178|NCT00609063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65190179|NCT00609063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65190180|NCT00609063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190181|NCT01114373|Melatonin|melatonin|mesh-list
65190182|NCT01114373|Antioxidants|antioxidants|mesh-ancestor
64832761|NCT01596413|Antiemetics|antiemetics|mesh-ancestor
65190183|NCT01114373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190184|NCT01114373|Protective Agents|protective agents|mesh-ancestor
65190185|NCT01114373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190186|NCT01114373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65190187|NCT00925899|Melatonin|melatonin|mesh-list
65190188|NCT00925899|Antioxidants|antioxidants|mesh-ancestor
65190189|NCT00925899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190190|NCT00925899|Protective Agents|protective agents|mesh-ancestor
65190191|NCT00925899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190192|NCT00925899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65190193|NCT02601586|Oxycodone|oxycodone|mesh-list
65190194|NCT02601586|Levodopa|levodopa|mesh-list
65190195|NCT02601586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65190196|NCT02601586|Narcotics|narcotics|mesh-ancestor
65190197|NCT02601586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65190198|NCT02601586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190199|NCT02601586|Analgesics|analgesics|mesh-ancestor
65190200|NCT02601586|Sensory System Agents|sensory system agents|mesh-ancestor
65190201|NCT02601586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190202|NCT02601586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65190203|NCT02601586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65190204|NCT02601586|Dopamine Agents|dopamine agents|mesh-ancestor
65190205|NCT02601586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65190206|NCT02601586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190207|NCT00609141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65190208|NCT00609141|Immunologic Factors|immunologic factors|mesh-ancestor
65190209|NCT00609141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190210|NCT01114217|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65190211|NCT01114217|Hematinics|hematinics|mesh-ancestor
65190212|NCT01114217|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65190213|NCT01114217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65190214|NCT01030536|Immunotoxin HA22|immunotoxin ha22|mesh-list
65190215|NCT01030536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190223|NCT02549170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190224|NCT01030458|Amlodipine|amlodipine|mesh-list
65190225|NCT01030458|Valsartan|valsartan|mesh-list
65190226|NCT01030458|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65190227|NCT01030458|Bisoprolol|bisoprolol|mesh-list
65190228|NCT01030458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65190229|NCT01030458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65190230|NCT01030458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65190231|NCT01030458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190232|NCT01030458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65190233|NCT01030458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190234|NCT01030458|Vasodilator Agents|vasodilator agents|mesh-ancestor
65190235|NCT01030458|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65190236|NCT01030458|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65327367|NCT05251974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65327368|NCT05251974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65327369|NCT05251974|Adrenergic Agents|adrenergic agents|mesh-ancestor
65327370|NCT05251974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65327371|NCT05251974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327372|NCT05251974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327373|NCT02589444|Vitamin D|vitamin d|mesh-list
65327374|NCT02589444|Cholecalciferol|cholecalciferol|mesh-list
65327375|NCT02589444|Vitamins|vitamins|mesh-ancestor
65327376|NCT02589444|Micronutrients|micronutrients|mesh-ancestor
64556840|NCT04994262|Antipruritics|antipruritics|mesh-ancestor
65190237|NCT01030458|Diuretics|diuretics|mesh-ancestor
65190238|NCT01030458|Natriuretic Agents|natriuretic agents|mesh-ancestor
65190239|NCT01030458|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65190240|NCT01030458|Sympatholytics|sympatholytics|mesh-ancestor
65190241|NCT01030458|Autonomic Agents|autonomic agents|mesh-ancestor
65190242|NCT01030458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190243|NCT01030458|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65190244|NCT01030458|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65190245|NCT01030458|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65190246|NCT01030458|Adrenergic Agents|adrenergic agents|mesh-ancestor
65190247|NCT01030458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65190248|NCT02702674|Propranolol|propranolol|mesh-list
65190249|NCT02702674|Oxytocin|oxytocin|mesh-list
65190250|NCT02702674|Oxytocics|oxytocics|mesh-ancestor
65190251|NCT02702674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65190252|NCT02702674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190253|NCT02702674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65190254|NCT02702674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65190255|NCT02702674|Adrenergic Agents|adrenergic agents|mesh-ancestor
65190256|NCT02702674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65190257|NCT02702674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190258|NCT02702674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65190259|NCT02702674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65190260|NCT02702674|Vasodilator Agents|vasodilator agents|mesh-ancestor
65190261|NCT01114139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65190262|NCT01114139|Hematinics|hematinics|mesh-ancestor
65190263|NCT01114139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65190264|NCT01114139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65190265|NCT01027884|Idebenone|idebenone|mesh-list
65190266|NCT01027884|Antioxidants|antioxidants|mesh-ancestor
65190267|NCT01027884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190268|NCT01027884|Protective Agents|protective agents|mesh-ancestor
65190269|NCT01027884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190270|NCT02699008|Clopidogrel|clopidogrel|mesh-list
65190271|NCT02699008|Ticagrelor|ticagrelor|mesh-list
65190272|NCT02699008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65190273|NCT02699008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65190274|NCT02699008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65190275|NCT02699008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65190276|NCT02699008|Purinergic Agents|purinergic agents|mesh-ancestor
65190277|NCT02699008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65190278|NCT02699008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190279|NCT02699008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190280|NCT00627666|Leucovorin|leucovorin|mesh-list
65190282|NCT00627666|Fludarabine phosphate|fludarabine phosphate|mesh-list
65190283|NCT00627666|Fludarabine|fludarabine|mesh-list
65190284|NCT00627666|Busulfan|busulfan|mesh-list
65190285|NCT00627666|Calcium|calcium|mesh-list
65190286|NCT00627666|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65190292|NCT00627666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65190293|NCT00627666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65190294|NCT00627666|Antimetabolites|antimetabolites|mesh-ancestor
65190295|NCT00627666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190296|NCT00627666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327377|NCT02589444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327378|NCT02589444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65327379|NCT02589444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65327380|NCT05325684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65327381|NCT05325684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327382|NCT05325684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327383|NCT00435487|Heparin|heparin|mesh-list
65327384|NCT00435487|Calcium heparin|calcium heparin|mesh-list
65327385|NCT00435487|Dalteparin|dalteparin|mesh-list
65327386|NCT00435487|Tinzaparin|tinzaparin|mesh-list
65327387|NCT00435487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65327388|NCT00435487|Anticoagulants|anticoagulants|mesh-ancestor
65327389|NCT00435487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65327390|NCT00435487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65327391|NCT00435487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327392|NCT02589678|Vaccines|vaccines|mesh-list
65327393|NCT02589678|Immunologic Factors|immunologic factors|mesh-ancestor
65327394|NCT02589678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327395|NCT05328258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65327396|NCT05328258|Luteolytic Agents|luteolytic agents|mesh-ancestor
65327397|NCT05328258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65190297|NCT00627666|Dermatologic Agents|dermatologic agents|mesh-ancestor
65190298|NCT00627666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190299|NCT00627666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65190300|NCT00627666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65190301|NCT00627666|Immunologic Factors|immunologic factors|mesh-ancestor
65190302|NCT00627666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65190303|NCT00627666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65190304|NCT00627666|Antidotes|antidotes|mesh-ancestor
65190305|NCT00627666|Protective Agents|protective agents|mesh-ancestor
65190306|NCT00627666|Vitamin B Complex|vitamin b complex|mesh-ancestor
65190307|NCT00627666|Vitamins|vitamins|mesh-ancestor
65190308|NCT00627666|Micronutrients|micronutrients|mesh-ancestor
65190309|NCT00627666|Alkylating Agents|alkylating agents|mesh-ancestor
65190310|NCT00627666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65190311|NCT00627666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65190312|NCT01022580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65190313|NCT01022580|Calfactant|calfactant|mesh-list
65190314|NCT01022580|Respiratory System Agents|respiratory system agents|mesh-ancestor
65190315|NCT02698930|Dexmedetomidine|dexmedetomidine|mesh-list
65190316|NCT02698930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65190317|NCT02698930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65190318|NCT02698930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190319|NCT02698930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65190320|NCT02698930|Analgesics|analgesics|mesh-ancestor
65190321|NCT02698930|Sensory System Agents|sensory system agents|mesh-ancestor
65190322|NCT02698930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190323|NCT02698930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65190324|NCT02698930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65190325|NCT02698930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65190326|NCT02698930|Adrenergic Agents|adrenergic agents|mesh-ancestor
65190327|NCT02698930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65190328|NCT02698930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190329|NCT01107353|Imipramine|imipramine|mesh-list
65327398|NCT05328258|Contraceptive Agents|contraceptive agents|mesh-ancestor
65327399|NCT05328258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65327400|NCT05328258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327401|NCT05328258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65327402|NCT05328258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65327403|NCT05328258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190330|NCT01107353|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65190331|NCT01107353|Antidepressive Agents|antidepressive agents|mesh-ancestor
65190332|NCT01107353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65190333|NCT01107353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65190334|NCT01107353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65190335|NCT01107353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65190336|NCT01107353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190337|NCT01107353|Adrenergic Agents|adrenergic agents|mesh-ancestor
65190338|NCT01107353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65190339|NCT01107353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190340|NCT02702206|Triamcinolone|triamcinolone|mesh-list
65190341|NCT02702206|Hyaluronic Acid|hyaluronic acid|mesh-list
65190342|NCT02702206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65190343|NCT02702206|Glucocorticoids|glucocorticoids|mesh-ancestor
65190344|NCT02702206|Hormones|hormones|mesh-ancestor
65190345|NCT02702206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65190346|NCT02702206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190347|NCT02702206|Immunologic Factors|immunologic factors|mesh-ancestor
65190348|NCT02702206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65190349|NCT02702206|Viscosupplements|viscosupplements|mesh-ancestor
65190350|NCT02702206|Protective Agents|protective agents|mesh-ancestor
65190351|NCT04216186|Ubiquinone|ubiquinone|mesh-list
65190352|NCT04216186|Coenzyme Q10|coenzyme q10|mesh-list
65190353|NCT04216186|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65190354|NCT04216186|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65190355|NCT04216186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65190360|NCT04216186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190361|NCT04216186|Micronutrients|micronutrients|mesh-ancestor
65190362|NCT04216186|Vitamins|vitamins|mesh-ancestor
65190363|NCT01989598|Trametinib|trametinib|mesh-list
65190364|NCT01989598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190365|NCT01989598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65190366|NCT01989598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190367|NCT01989598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190368|NCT04214938|Lidocaine|lidocaine|mesh-list
65190369|NCT04214938|Xylometazoline|xylometazoline|mesh-list
65190370|NCT04214938|Anesthetics, Local|anesthetics, local|mesh-ancestor
65190371|NCT04214938|Anesthetics|anesthetics|mesh-ancestor
65190372|NCT04214938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65190373|NCT04214938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190374|NCT04214938|Sensory System Agents|sensory system agents|mesh-ancestor
65190375|NCT04214938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190376|NCT04214938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65190377|NCT04214938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65190378|NCT04214938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65190379|NCT04214938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65190380|NCT04214938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190381|NCT04214938|Nasal Decongestants|nasal decongestants|mesh-ancestor
65190382|NCT04214938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65190383|NCT04214938|Respiratory System Agents|respiratory system agents|mesh-ancestor
65190384|NCT00615160|Dacarbazine|dacarbazine|mesh-list
65190385|NCT00615160|Vatalanib|vatalanib|mesh-list
65190386|NCT00615160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65190387|NCT00615160|Alkylating Agents|alkylating agents|mesh-ancestor
65190388|NCT00615160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190389|NCT00615160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190390|NCT00615160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65190391|NCT00615160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190392|NCT01112267|Acetaminophen|acetaminophen|mesh-list
65190393|NCT01112267|Tramadol|tramadol|mesh-list
65190394|NCT01112267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65190395|NCT01112267|Analgesics|analgesics|mesh-ancestor
65327404|NCT02591004|Nifedipine|nifedipine|mesh-list
65327405|NCT02591004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65327406|NCT02591004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65327407|NCT02591004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327408|NCT02591004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65327409|NCT02591004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190396|NCT01112267|Sensory System Agents|sensory system agents|mesh-ancestor
65190397|NCT01112267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190398|NCT01112267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190399|NCT01112267|Antipyretics|antipyretics|mesh-ancestor
65190400|NCT01112267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65190401|NCT01112267|Narcotics|narcotics|mesh-ancestor
65190402|NCT01112267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65190403|NCT00925587|Darbepoetin alfa|darbepoetin alfa|mesh-list
65190404|NCT00925587|Hematinics|hematinics|mesh-ancestor
65190405|NCT02698306|Dexamethasone|dexamethasone|mesh-list
65190406|NCT02698306|Diclofenac|diclofenac|mesh-list
65190407|NCT02698306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65190408|NCT02698306|Antiemetics|antiemetics|mesh-ancestor
65190409|NCT02698306|Autonomic Agents|autonomic agents|mesh-ancestor
65190410|NCT02698306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190411|NCT02698306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190412|NCT02698306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65190413|NCT02698306|Glucocorticoids|glucocorticoids|mesh-ancestor
65190414|NCT02698306|Hormones|hormones|mesh-ancestor
65190415|NCT02698306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65190416|NCT02698306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65190417|NCT02698306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190418|NCT02698306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65190419|NCT02698306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65190420|NCT02698306|Analgesics|analgesics|mesh-ancestor
65190421|NCT02698306|Sensory System Agents|sensory system agents|mesh-ancestor
65190422|NCT02698306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65190423|NCT02698306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65190424|NCT02698306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190425|NCT02698306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190426|NCT02698228|Morphine|morphine|mesh-list
65190427|NCT02698228|Bupivacaine|bupivacaine|mesh-list
65190428|NCT02698228|Anesthetics, Local|anesthetics, local|mesh-ancestor
65190433|NCT02698228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190434|NCT02698228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65190435|NCT02698228|Narcotics|narcotics|mesh-ancestor
65190436|NCT02698228|Analgesics|analgesics|mesh-ancestor
65190437|NCT02702128|Tranexamic Acid|tranexamic acid|mesh-list
65190438|NCT02702128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65190439|NCT02702128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65190440|NCT02702128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190441|NCT02702128|Hemostatics|hemostatics|mesh-ancestor
65190442|NCT02702128|Coagulants|coagulants|mesh-ancestor
65190443|NCT00610545|Atorvastatin|atorvastatin|mesh-list
65190444|NCT00610545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65190445|NCT00610545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65190446|NCT00610545|Antimetabolites|antimetabolites|mesh-ancestor
65190447|NCT00610545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190448|NCT00610545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65190449|NCT00610545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65190450|NCT00610545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190451|NCT00193414|Gemcitabine|gemcitabine|mesh-list
65190453|NCT00193414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65190454|NCT00193414|Antimetabolites|antimetabolites|mesh-ancestor
65190455|NCT00193414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190456|NCT00193414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190457|NCT00193414|Antiviral Agents|antiviral agents|mesh-ancestor
65190458|NCT00193414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65190459|NCT00193414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190460|NCT00193414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65190461|NCT00193414|Immunologic Factors|immunologic factors|mesh-ancestor
65190462|NCT00193414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190463|NCT00193414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65327410|NCT02591004|Vasodilator Agents|vasodilator agents|mesh-ancestor
65327411|NCT02591004|Tocolytic Agents|tocolytic agents|mesh-ancestor
65327412|NCT02591004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65327413|NCT05310786|Analgesics, Opioid|analgesics, opioid|mesh-list
65327414|NCT05310786|Narcotics|narcotics|mesh-ancestor
65327415|NCT05310786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65327416|NCT05310786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327417|NCT05310786|Analgesics|analgesics|mesh-ancestor
65327418|NCT05310786|Sensory System Agents|sensory system agents|mesh-ancestor
65327419|NCT05310786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65327420|NCT04085562|Amlodipine|amlodipine|mesh-list
65327421|NCT04085562|Bisoprolol|bisoprolol|mesh-list
65327422|NCT04085562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65327423|NCT04085562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65327424|NCT04085562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65327425|NCT04085562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327426|NCT04085562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65327427|NCT04085562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327428|NCT04085562|Vasodilator Agents|vasodilator agents|mesh-ancestor
65327429|NCT04085562|Sympatholytics|sympatholytics|mesh-ancestor
65327430|NCT04085562|Autonomic Agents|autonomic agents|mesh-ancestor
64556884|NCT03076710|Sensory System Agents|sensory system agents|mesh-ancestor
65190464|NCT00193414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65190465|NCT04260711|Interferons|interferons|mesh-list
65190466|NCT04260711|Teriflunomide|teriflunomide|mesh-list
65190467|NCT04260711|Glatiramer Acetate|glatiramer acetate|mesh-list
65190468|NCT04260711|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65190469|NCT04260711|(T,G)-A-L|(t,g)-a-l|mesh-list
65190470|NCT04260711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190471|NCT04260711|Antiviral Agents|antiviral agents|mesh-ancestor
65190472|NCT04260711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65190473|NCT04260711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65190474|NCT04260711|Immunologic Factors|immunologic factors|mesh-ancestor
65190475|NCT04260711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190476|NCT04260711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65190477|NCT04260711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65190478|NCT04260711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65190479|NCT04260711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65190480|NCT04260711|Analgesics|analgesics|mesh-ancestor
65190481|NCT04260711|Sensory System Agents|sensory system agents|mesh-ancestor
65190482|NCT04260711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190483|NCT04260711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65190484|NCT04260711|Dermatologic Agents|dermatologic agents|mesh-ancestor
65190485|NCT00610623|Azithromycin|azithromycin|mesh-list
65190486|NCT00610623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65190487|NCT00610623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65190489|NCT02697838|Apatinib|apatinib|mesh-list
65190490|NCT02697838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65190491|NCT02697838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190492|NCT02697838|Tubulin Modulators|tubulin modulators|mesh-ancestor
65190493|NCT02697838|Antimitotic Agents|antimitotic agents|mesh-ancestor
65190494|NCT02697838|Mitosis Modulators|mitosis modulators|mesh-ancestor
65190495|NCT02697838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190496|NCT02697838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65327431|NCT04085562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65327432|NCT04085562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65190497|NCT02697838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190498|NCT00928707|Hydroxyurea|hydroxyurea|mesh-list
65190499|NCT00928707|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
65190500|NCT00928707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190501|NCT00928707|Antisickling Agents|antisickling agents|mesh-ancestor
65190519|NCT02705950|GABA Agonists|gaba agonists|mesh-ancestor
65190520|NCT02705950|GABA Agents|gaba agents|mesh-ancestor
65190521|NCT02705950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65190522|NCT02705950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190523|NCT04951323|Vaccines|vaccines|mesh-list
65190524|NCT04951323|Immunologic Factors|immunologic factors|mesh-ancestor
65190525|NCT04951323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190526|NCT02705872|Sufentanil|sufentanil|mesh-list
65190527|NCT02705872|Dsuvia|dsuvia|mesh-list
65190528|NCT02705872|Levobupivacaine|levobupivacaine|mesh-list
65190529|NCT02705872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65190530|NCT02705872|Narcotics|narcotics|mesh-ancestor
65190531|NCT02705872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65190532|NCT02705872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190533|NCT02705872|Analgesics|analgesics|mesh-ancestor
65190534|NCT02705872|Sensory System Agents|sensory system agents|mesh-ancestor
65190535|NCT02705872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190536|NCT02705872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65190537|NCT02705872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65190538|NCT02705872|Anesthetics, General|anesthetics, general|mesh-ancestor
65190539|NCT02705872|Anesthetics|anesthetics|mesh-ancestor
65190540|NCT02705872|Anesthetics, Local|anesthetics, local|mesh-ancestor
65190541|NCT02701348|Letrozole|letrozole|mesh-list
65190542|NCT02701348|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65190543|NCT02701348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190544|NCT02701348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65190545|NCT02701348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190546|NCT02701348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190547|NCT02701348|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65190548|NCT02701348|Hormone Antagonists|hormone antagonists|mesh-ancestor
65190549|NCT02701348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65190550|NCT02701348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190551|NCT05324800|Turmeric extract|turmeric extract|mesh-list
65190552|NCT05324800|Antioxidants|antioxidants|mesh-ancestor
65190553|NCT05324800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190554|NCT05324800|Protective Agents|protective agents|mesh-ancestor
65190555|NCT05324800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190556|NCT04258371|Dapagliflozin|dapagliflozin|mesh-list
65190557|NCT04258371|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65190558|NCT04258371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190559|NCT04258371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64833144|NCT01597895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65190566|NCT03367156|Ichthammol|ichthammol|mesh-list
65190567|NCT03367156|BB 1101|bb 1101|mesh-list
65190568|NCT03367156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65190569|NCT03367156|Antiemetics|antiemetics|mesh-ancestor
65190570|NCT03367156|Autonomic Agents|autonomic agents|mesh-ancestor
65190571|NCT03367156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190572|NCT03367156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190573|NCT03367156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65190574|NCT03367156|Glucocorticoids|glucocorticoids|mesh-ancestor
65190575|NCT03367156|Hormones|hormones|mesh-ancestor
65190576|NCT03367156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65190577|NCT03367156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65190578|NCT03367156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190579|NCT03367156|Protease Inhibitors|protease inhibitors|mesh-ancestor
65190580|NCT03367156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190581|NCT03367156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190582|NCT03367156|Dermatologic Agents|dermatologic agents|mesh-ancestor
65190584|NCT02700568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190585|NCT02700568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65190586|NCT02700568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190587|NCT02700568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190588|NCT00925353|Lidocaine|lidocaine|mesh-list
65190589|NCT00925353|Anesthetics, Local|anesthetics, local|mesh-ancestor
65190590|NCT00925353|Anesthetics|anesthetics|mesh-ancestor
65327433|NCT04085562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65327434|NCT04085562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65327435|NCT04085562|Adrenergic Agents|adrenergic agents|mesh-ancestor
65327436|NCT04085562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65327437|NCT05048238|Tofacitinib|tofacitinib|mesh-list
65327438|NCT05048238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65327439|NCT05048238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327440|NCT05048238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190591|NCT00925353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65190592|NCT00925353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190593|NCT00925353|Sensory System Agents|sensory system agents|mesh-ancestor
65190594|NCT00925353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190595|NCT00925353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65190596|NCT00925353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65190597|NCT00925353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65190598|NCT00925353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65190599|NCT00925353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190600|NCT02705482|Durvalumab|durvalumab|mesh-list
65190601|NCT02705482|Tremelimumab|tremelimumab|mesh-list
65190602|NCT02705482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65190603|NCT02705482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190604|NCT02705638|Rituximab|rituximab|mesh-list
65190605|NCT02705638|Lenalidomide|lenalidomide|mesh-list
65190606|NCT02705638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65190607|NCT02705638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190608|NCT02705638|Immunologic Factors|immunologic factors|mesh-ancestor
65190609|NCT02705638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190610|NCT02705638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65190611|NCT02705638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65190612|NCT02705638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65190613|NCT02705638|Growth Substances|growth substances|mesh-ancestor
65190614|NCT02705638|Growth Inhibitors|growth inhibitors|mesh-ancestor
65190615|NCT02691910|Chloroquine|chloroquine|mesh-list
65190616|NCT02691910|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65190617|NCT02691910|Primaquine|primaquine|mesh-list
65190618|NCT02691910|Amebicides|amebicides|mesh-ancestor
65190619|NCT02691910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65190620|NCT02691910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65190621|NCT02691910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65190622|NCT02691910|Antimalarials|antimalarials|mesh-ancestor
65190623|NCT02691910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65190624|NCT02691910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65190625|NCT02691910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65190626|NCT02691910|Analgesics|analgesics|mesh-ancestor
65190627|NCT02691910|Sensory System Agents|sensory system agents|mesh-ancestor
65190628|NCT02691910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190629|NCT02691910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190630|NCT02691910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65190635|NCT02705014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65190637|NCT02704624|Vitamin D|vitamin d|mesh-list
65190638|NCT02704624|Vitamins|vitamins|mesh-ancestor
65190639|NCT02704624|Micronutrients|micronutrients|mesh-ancestor
65190640|NCT02704624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190641|NCT02704624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65190642|NCT02700022|Prednisone|prednisone|mesh-list
65190643|NCT02700022|Cyclophosphamide|cyclophosphamide|mesh-list
65190644|NCT02700022|Doxorubicin|doxorubicin|mesh-list
65190645|NCT02700022|Etoposide|etoposide|mesh-list
65190646|NCT02700022|Vincristine|vincristine|mesh-list
65190647|NCT02700022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65190648|NCT02700022|Immunologic Factors|immunologic factors|mesh-ancestor
65190649|NCT02700022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190650|NCT02700022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65190651|NCT02700022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65190652|NCT02700022|Alkylating Agents|alkylating agents|mesh-ancestor
65190653|NCT02700022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190654|NCT02700022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327441|NCT05683626|Adalimumab|adalimumab|mesh-list
65327442|NCT05683626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65327443|NCT05683626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65327444|NCT04082988|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65327445|NCT04082988|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65327446|NCT04082988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327447|NCT05168202|Azacitidine|azacitidine|mesh-list
64556918|NCT04355247|Methylprednisolone|methylprednisolone|mesh-list
65190655|NCT02700022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65190656|NCT02700022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65190657|NCT02700022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65190658|NCT02700022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65190659|NCT02700022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190660|NCT02700022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65190661|NCT02700022|Glucocorticoids|glucocorticoids|mesh-ancestor
65190662|NCT02700022|Hormones|hormones|mesh-ancestor
65190663|NCT02700022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65190664|NCT02700022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65190665|NCT02700022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65190666|NCT02700022|Tubulin Modulators|tubulin modulators|mesh-ancestor
65190667|NCT02700022|Antimitotic Agents|antimitotic agents|mesh-ancestor
65190668|NCT02700022|Mitosis Modulators|mitosis modulators|mesh-ancestor
65190669|NCT02699710|Folic Acid|folic acid|mesh-list
65190670|NCT02699710|Methotrexate|methotrexate|mesh-list
65190671|NCT02699710|Rabeprazole|rabeprazole|mesh-list
65190672|NCT02699710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65190673|NCT02699710|Abortifacient Agents|abortifacient agents|mesh-ancestor
65190674|NCT02699710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65190675|NCT02699710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190676|NCT02699710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65190677|NCT02699710|Antimetabolites|antimetabolites|mesh-ancestor
65190678|NCT02699710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190679|NCT02699710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190680|NCT02699710|Dermatologic Agents|dermatologic agents|mesh-ancestor
65190681|NCT02699710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190682|NCT02699710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65190683|NCT02699710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65190684|NCT02699710|Immunologic Factors|immunologic factors|mesh-ancestor
65190685|NCT02699710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65190686|NCT02699710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65190687|NCT02699710|Hematinics|hematinics|mesh-ancestor
65190688|NCT02699710|Vitamin B Complex|vitamin b complex|mesh-ancestor
65190689|NCT02699710|Vitamins|vitamins|mesh-ancestor
65190690|NCT02699710|Micronutrients|micronutrients|mesh-ancestor
65190691|NCT02699710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65190692|NCT02699710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65190693|NCT02699710|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65190694|NCT04214626|Prednisone|prednisone|mesh-list
65190695|NCT04214626|Cyclophosphamide|cyclophosphamide|mesh-list
65190696|NCT04214626|Rituximab|rituximab|mesh-list
65190697|NCT04214626|Methotrexate|methotrexate|mesh-list
65190698|NCT04214626|Vincristine|vincristine|mesh-list
65190699|NCT04214626|Lenalidomide|lenalidomide|mesh-list
65190700|NCT04214626|Epirubicin|epirubicin|mesh-list
65190701|NCT04214626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65190702|NCT04214626|Immunologic Factors|immunologic factors|mesh-ancestor
65190703|NCT04214626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190704|NCT04214626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65190708|NCT04214626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190709|NCT04214626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65190710|NCT04214626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65190711|NCT04214626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65190712|NCT04214626|Glucocorticoids|glucocorticoids|mesh-ancestor
65190714|NCT04214626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65190715|NCT04214626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65190716|NCT04214626|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65190717|NCT04214626|Abortifacient Agents|abortifacient agents|mesh-ancestor
65190718|NCT04214626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65190719|NCT04214626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65327448|NCT05168202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65327449|NCT05168202|Antimetabolites|antimetabolites|mesh-ancestor
65327450|NCT05168202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327451|NCT05168202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327452|NCT05168202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327453|NCT02588196|Dexamethasone|dexamethasone|mesh-list
65327454|NCT02588196|Dexamethasone acetate|dexamethasone acetate|mesh-list
65327455|NCT02588196|BB 1101|bb 1101|mesh-list
65190720|NCT04214626|Antimetabolites|antimetabolites|mesh-ancestor
65190721|NCT04214626|Dermatologic Agents|dermatologic agents|mesh-ancestor
65190722|NCT04214626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190723|NCT04214626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65190724|NCT04214626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65190725|NCT04214626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65190726|NCT04214626|Tubulin Modulators|tubulin modulators|mesh-ancestor
65190727|NCT04214626|Antimitotic Agents|antimitotic agents|mesh-ancestor
65190728|NCT04214626|Mitosis Modulators|mitosis modulators|mesh-ancestor
65190729|NCT04214626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65190730|NCT04214626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65190731|NCT04214626|Growth Substances|growth substances|mesh-ancestor
65190732|NCT04214626|Growth Inhibitors|growth inhibitors|mesh-ancestor
65190733|NCT04214626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65190734|NCT04214626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65190735|NCT04214626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65190736|NCT03140488|Oxytocin|oxytocin|mesh-list
65190737|NCT03140488|Oxytocics|oxytocics|mesh-ancestor
65190738|NCT03140488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65190739|NCT03140488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190740|NCT00616408|Octreotide|octreotide|mesh-list
65190741|NCT00616408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65190742|NCT00616408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65190743|NCT00616408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190744|NCT02691754|Acetaminophen|acetaminophen|mesh-list
65190745|NCT02691754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65190746|NCT02691754|Analgesics|analgesics|mesh-ancestor
65190747|NCT02691754|Sensory System Agents|sensory system agents|mesh-ancestor
65190748|NCT02691754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190749|NCT02691754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190750|NCT02691754|Antipyretics|antipyretics|mesh-ancestor
65190751|NCT02691676|Plasma-lyte 148|plasma-lyte 148|mesh-list
65190752|NCT02691676|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65190753|NCT02691676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65190754|NCT05321602|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65190755|NCT05321602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65190756|NCT05321602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65190757|NCT05321602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65190758|NCT05321602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190759|NCT05321602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65190760|NCT05321602|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65190761|NCT05321602|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65190762|NCT05321602|Serotonin Agents|serotonin agents|mesh-ancestor
65190763|NCT05321602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65190764|NCT05321602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190765|NCT05321602|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65190766|NCT05321602|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65190767|NCT05321602|Dopamine Agents|dopamine agents|mesh-ancestor
65190768|NCT01106651|Canagliflozin|canagliflozin|mesh-list
65190769|NCT01106651|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65190770|NCT01106651|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65190771|NCT01106651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190772|NCT01106651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190773|NCT00637078|Amlodipine|amlodipine|mesh-list
65190774|NCT00637078|Spironolactone|spironolactone|mesh-list
65190776|NCT00637078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65190777|NCT00637078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65190778|NCT00637078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190779|NCT00637078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65327456|NCT02588196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65327457|NCT02588196|Antiemetics|antiemetics|mesh-ancestor
65327458|NCT02588196|Autonomic Agents|autonomic agents|mesh-ancestor
65190780|NCT00637078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190781|NCT00637078|Vasodilator Agents|vasodilator agents|mesh-ancestor
65190782|NCT00637078|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65190783|NCT00637078|Hormone Antagonists|hormone antagonists|mesh-ancestor
65190784|NCT00637078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65190785|NCT00637078|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65190787|NCT00637078|Natriuretic Agents|natriuretic agents|mesh-ancestor
65190788|NCT00625781|Insulin|insulin|mesh-list
65190789|NCT00625781|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65190790|NCT00625781|Insulin Aspart|insulin aspart|mesh-list
65190791|NCT00625781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65190792|NCT00625781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190793|NCT01027650|Dexamethasone|dexamethasone|mesh-list
65190794|NCT01027650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65190795|NCT01027650|Antiemetics|antiemetics|mesh-ancestor
65190796|NCT01027650|Autonomic Agents|autonomic agents|mesh-ancestor
65190797|NCT01027650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190798|NCT01027650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190799|NCT01027650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65190800|NCT01027650|Glucocorticoids|glucocorticoids|mesh-ancestor
65190801|NCT01027650|Hormones|hormones|mesh-ancestor
65190802|NCT01027650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65190803|NCT01027650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65190804|NCT01027650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190805|NCT00616876|Lactulose|lactulose|mesh-list
65190806|NCT00616876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65190807|NCT01106027|Eculizumab|eculizumab|mesh-list
65190808|NCT01106027|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65190809|NCT01106027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65190810|NCT01106027|Immunologic Factors|immunologic factors|mesh-ancestor
65190811|NCT01106027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190812|NCT01027416|Tamoxifen|tamoxifen|mesh-list
65190813|NCT01027416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65190814|NCT01027416|Hormone Antagonists|hormone antagonists|mesh-ancestor
65190815|NCT01027416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65190816|NCT01027416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190817|NCT01027416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65190818|NCT01027416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190819|NCT01027416|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65190820|NCT01027416|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65190821|NCT01027416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65190822|NCT05026203|Midazolam|midazolam|mesh-list
65190823|NCT05026203|Ketamine|ketamine|mesh-list
65190824|NCT05026203|Analgesics|analgesics|mesh-ancestor
65190825|NCT05026203|Sensory System Agents|sensory system agents|mesh-ancestor
65190826|NCT05026203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190827|NCT05026203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190828|NCT05026203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65190829|NCT05026203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65190830|NCT05026203|Anesthetics, General|anesthetics, general|mesh-ancestor
65190831|NCT05026203|Anesthetics|anesthetics|mesh-ancestor
65190832|NCT05026203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65190833|NCT05026203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65190834|NCT05026203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65190835|NCT05026203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65190836|NCT05026203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190837|NCT05026203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65190838|NCT05026203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65190839|NCT05026203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65190840|NCT05026203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65190841|NCT05026203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65190842|NCT05026203|GABA Modulators|gaba modulators|mesh-ancestor
65190843|NCT05026203|GABA Agents|gaba agents|mesh-ancestor
65190844|NCT01015638|Clindamycin|clindamycin|mesh-list
65190845|NCT01015638|Clindamycin palmitate|clindamycin palmitate|mesh-list
65190846|NCT01015638|Clindamycin phosphate|clindamycin phosphate|mesh-list
65190847|NCT01015638|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65190852|NCT01015638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190854|NCT00627744|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65327459|NCT02588196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65327460|NCT02588196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327461|NCT02588196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65327462|NCT02588196|Glucocorticoids|glucocorticoids|mesh-ancestor
65327463|NCT02588196|Hormones|hormones|mesh-ancestor
65327464|NCT02588196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65190855|NCT00627744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65190856|NCT00627744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190857|NCT00627744|Incretins|incretins|mesh-ancestor
65190858|NCT00627744|Hormones|hormones|mesh-ancestor
65190859|NCT00627744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65190860|NCT00627744|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65190861|NCT00627744|Protease Inhibitors|protease inhibitors|mesh-ancestor
65190862|NCT00627744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190863|NCT00627744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190864|NCT01105091|Epoprostenol|epoprostenol|mesh-list
65190865|NCT01105091|Tezosentan|tezosentan|mesh-list
65190866|NCT01105091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65190867|NCT01105091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65190868|NCT01105091|Vasodilator Agents|vasodilator agents|mesh-ancestor
65190869|NCT00628056|Perhexiline|perhexiline|mesh-list
65190870|NCT00628056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65190871|NCT00628056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65190872|NCT00628056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190873|NCT00628056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65190874|NCT00628056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190875|NCT00628056|Vasodilator Agents|vasodilator agents|mesh-ancestor
65190876|NCT00924729|Moxifloxacin|moxifloxacin|mesh-list
65190877|NCT00924729|Besifloxacin|besifloxacin|mesh-list
65190878|NCT00924729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65190879|NCT00924729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65190880|NCT00924729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65190881|NCT00924729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65190882|NCT00924729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65190883|NCT00924729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65190885|NCT00924729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190886|NCT00924729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190887|NCT01099709|Oxycodone|oxycodone|mesh-list
65190888|NCT01099709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65190889|NCT01099709|Narcotics|narcotics|mesh-ancestor
65190890|NCT01099709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65190891|NCT01099709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190892|NCT01099709|Analgesics|analgesics|mesh-ancestor
65190893|NCT01099709|Sensory System Agents|sensory system agents|mesh-ancestor
65190894|NCT01099709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190895|NCT04907019|Rifampin|rifampin|mesh-list
65190896|NCT04907019|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65190897|NCT04907019|Antitubercular Agents|antitubercular agents|mesh-ancestor
65190898|NCT04907019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65190899|NCT04907019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65190900|NCT04907019|Leprostatic Agents|leprostatic agents|mesh-ancestor
65190901|NCT04907019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65190902|NCT04907019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190903|NCT04907019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190904|NCT04907019|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65190905|NCT04907019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65190906|NCT04907019|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65190907|NCT04907019|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65190908|NCT04907019|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65190909|NCT04907019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65190910|NCT01022424|Tolvaptan|tolvaptan|mesh-list
65190911|NCT01022424|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65190912|NCT01022424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190913|NCT01022424|Natriuretic Agents|natriuretic agents|mesh-ancestor
65190914|NCT01022424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190915|NCT05329857|Metformin|metformin|mesh-list
65327465|NCT02588196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65077411|NCT05453045|Albendazole|albendazole|mesh-list
65327466|NCT02588196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327467|NCT02588196|Protease Inhibitors|protease inhibitors|mesh-ancestor
65327468|NCT02588196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327469|NCT02588196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190916|NCT05329857|Vildagliptin|vildagliptin|mesh-list
65190927|NCT04981041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65190928|NCT04981041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65190929|NCT04981041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65190930|NCT04981041|Purinergic Agents|purinergic agents|mesh-ancestor
65190931|NCT04981041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65190932|NCT04981041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190933|NCT04981041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190934|NCT01026948|Dinoprostone|dinoprostone|mesh-list
65190935|NCT01026948|Oxytocics|oxytocics|mesh-ancestor
65190936|NCT01026948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65190937|NCT01026948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190938|NCT01104779|Cariprazine|cariprazine|mesh-list
65190939|NCT01104779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65190940|NCT01104779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65190941|NCT01104779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65190942|NCT01104779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190943|NCT01104779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65190944|NCT00918957|Tobramycin|tobramycin|mesh-list
65190945|NCT00918957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65190946|NCT00918957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65190947|NCT04308161|Vitamin D|vitamin d|mesh-list
65190948|NCT04308161|Miconazole|miconazole|mesh-list
65190949|NCT04308161|Vitamins|vitamins|mesh-ancestor
65190950|NCT04308161|Micronutrients|micronutrients|mesh-ancestor
65190951|NCT04308161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190952|NCT04308161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65190953|NCT04308161|Antifungal Agents|antifungal agents|mesh-ancestor
65190954|NCT04308161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65190955|NCT04308161|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65190956|NCT04308161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65190957|NCT04308161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190958|NCT04308161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190959|NCT04308161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65190960|NCT04308161|Hormone Antagonists|hormone antagonists|mesh-ancestor
65190961|NCT04308161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65190962|NCT04308161|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65190963|NCT04308161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65190964|NCT04939467|Pirfenidone|pirfenidone|mesh-list
65190965|NCT04939467|Nintedanib|nintedanib|mesh-list
65190966|NCT04939467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65190967|NCT04939467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65190968|NCT04939467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190969|NCT04939467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190970|NCT04939467|Analgesics|analgesics|mesh-ancestor
65190971|NCT04939467|Sensory System Agents|sensory system agents|mesh-ancestor
65190972|NCT04939467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190973|NCT04939467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190974|NCT04939467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65190975|NCT04939467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65190976|NCT04939467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65190977|NCT04939467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65190978|NCT01015560|Antibodies|antibodies|mesh-list
65190979|NCT01015560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65190983|NCT04253223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65190984|NCT04253223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190985|NCT00918879|Saxagliptin|saxagliptin|mesh-list
65190986|NCT00918879|Incretins|incretins|mesh-ancestor
65190987|NCT00918879|Hormones|hormones|mesh-ancestor
65190988|NCT00918879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65190989|NCT00918879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327470|NCT02588820|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65327471|NCT02588820|Antiviral Agents|antiviral agents|mesh-ancestor
65327472|NCT02588820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65327474|NCT00579345|Immunologic Factors|immunologic factors|mesh-ancestor
65327475|NCT00579345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327476|NCT00715377|Benztropine|benztropine|mesh-list
65327477|NCT00715377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65327478|NCT00715377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65327479|NCT00715377|Parasympatholytics|parasympatholytics|mesh-ancestor
65327480|NCT00715377|Autonomic Agents|autonomic agents|mesh-ancestor
65327481|NCT00715377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65327482|NCT00715377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327483|NCT00715377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65327484|NCT00715377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65327485|NCT00715377|Cholinergic Agents|cholinergic agents|mesh-ancestor
65327486|NCT00715377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65327487|NCT00715377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327488|NCT00715377|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65327489|NCT00715377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65327490|NCT00715377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65327491|NCT00715377|Dopamine Agents|dopamine agents|mesh-ancestor
65327492|NCT05023980|Rituximab|rituximab|mesh-list
65327493|NCT05023980|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65327494|NCT05023980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64321999|NCT02231281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190990|NCT00918879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65190991|NCT00918879|Protease Inhibitors|protease inhibitors|mesh-ancestor
65190992|NCT00918879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190993|NCT00918879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190994|NCT00918879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65190995|NCT01026792|Sirolimus|sirolimus|mesh-list
65190996|NCT01026792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65190997|NCT01026792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65190998|NCT01026792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65190999|NCT01026792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191000|NCT01026792|Antifungal Agents|antifungal agents|mesh-ancestor
65191001|NCT01026792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65191002|NCT01026792|Immunologic Factors|immunologic factors|mesh-ancestor
65191003|NCT01026792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191004|NCT01026324|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
65191005|NCT01026324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65191006|NCT01026324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191007|NCT01026324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191008|NCT04300686|Adalimumab|adalimumab|mesh-list
65191009|NCT04300686|Antibodies|antibodies|mesh-list
65191010|NCT04300686|Immunoglobulins|immunoglobulins|mesh-list
65191011|NCT04300686|Immunologic Factors|immunologic factors|mesh-ancestor
65191012|NCT04300686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191013|NCT04300686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65327495|NCT05023980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327496|NCT05023980|Immunologic Factors|immunologic factors|mesh-ancestor
65327497|NCT05023980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327498|NCT05023980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65327499|NCT05023980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65327500|NCT05023980|Alkylating Agents|alkylating agents|mesh-ancestor
65327501|NCT05023980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327502|NCT00715455|Heparin|heparin|mesh-list
65327503|NCT00715455|Calcium heparin|calcium heparin|mesh-list
65327504|NCT00715455|Anticoagulants|anticoagulants|mesh-ancestor
65327505|NCT00715455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65327506|NCT00715455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65327507|NCT00715455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327508|NCT02574663|Leucovorin|leucovorin|mesh-list
65327509|NCT02574663|Folic Acid|folic acid|mesh-list
65327510|NCT02574663|Gemcitabine|gemcitabine|mesh-list
65327511|NCT02574663|Paclitaxel|paclitaxel|mesh-list
65327512|NCT02574663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65327513|NCT02574663|Bevacizumab|bevacizumab|mesh-list
65327514|NCT02574663|Fluorouracil|fluorouracil|mesh-list
65327515|NCT02574663|Oxaliplatin|oxaliplatin|mesh-list
65327516|NCT02574663|Levoleucovorin|levoleucovorin|mesh-list
65327517|NCT02574663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65327518|NCT02574663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327519|NCT02574663|Tubulin Modulators|tubulin modulators|mesh-ancestor
65327520|NCT02574663|Antimitotic Agents|antimitotic agents|mesh-ancestor
65191014|NCT04300686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65191015|NCT01098539|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65191016|NCT01098539|rGLP-1 protein|rglp-1 protein|mesh-list
65191017|NCT01098539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65191018|NCT01098539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191019|NCT01098539|Incretins|incretins|mesh-ancestor
65191020|NCT01098539|Hormones|hormones|mesh-ancestor
65191021|NCT01098539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65191022|NCT01098539|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65191023|NCT01098539|Protease Inhibitors|protease inhibitors|mesh-ancestor
65191024|NCT01098539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191025|NCT01098539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191026|NCT04922723|Daratumumab|daratumumab|mesh-list
65191027|NCT04922723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191028|NCT01098461|rGLP-1 protein|rglp-1 protein|mesh-list
65191029|NCT01098461|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65191030|NCT01098461|Incretins|incretins|mesh-ancestor
65191031|NCT01098461|Hormones|hormones|mesh-ancestor
65191032|NCT01098461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65191033|NCT01098461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191034|NCT01098305|Varenicline|varenicline|mesh-list
65191035|NCT01098305|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65191036|NCT01098305|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65191037|NCT01098305|Cholinergic Agents|cholinergic agents|mesh-ancestor
65191038|NCT01098305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65327521|NCT02574663|Mitosis Modulators|mitosis modulators|mesh-ancestor
65327522|NCT02574663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327523|NCT02574663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65327524|NCT02574663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65327525|NCT02574663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65327526|NCT02574663|Growth Substances|growth substances|mesh-ancestor
65191039|NCT01098305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191040|NCT01098305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191041|NCT00833833|Aspirin|aspirin|mesh-list
65191042|NCT00833833|Dexamethasone|dexamethasone|mesh-list
65191043|NCT00833833|Dexamethasone acetate|dexamethasone acetate|mesh-list
65191044|NCT00833833|Pomalidomide|pomalidomide|mesh-list
65191045|NCT00833833|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65191046|NCT00833833|BB 1101|bb 1101|mesh-list
65191047|NCT00833833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65191048|NCT00833833|Antiemetics|antiemetics|mesh-ancestor
65191049|NCT00833833|Autonomic Agents|autonomic agents|mesh-ancestor
65191050|NCT00833833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65191051|NCT00833833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191052|NCT00833833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65191057|NCT00833833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191058|NCT00833833|Protease Inhibitors|protease inhibitors|mesh-ancestor
65191059|NCT00833833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191060|NCT00833833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191061|NCT00833833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65191062|NCT00833833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65191063|NCT00833833|Analgesics|analgesics|mesh-ancestor
65191064|NCT00833833|Sensory System Agents|sensory system agents|mesh-ancestor
65191065|NCT00833833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65191066|NCT00833833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65191067|NCT00833833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65191068|NCT00833833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65191069|NCT00833833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65191070|NCT00833833|Antipyretics|antipyretics|mesh-ancestor
65191071|NCT00833833|Immunologic Factors|immunologic factors|mesh-ancestor
65191072|NCT00833833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65191073|NCT00833833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65191074|NCT00833833|Growth Substances|growth substances|mesh-ancestor
65191075|NCT00833833|Growth Inhibitors|growth inhibitors|mesh-ancestor
65191076|NCT01098071|Mometasone Furoate|mometasone furoate|mesh-list
65191077|NCT01098071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65191078|NCT01098071|Dermatologic Agents|dermatologic agents|mesh-ancestor
65191079|NCT01098071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65191080|NCT02612545|Piperaquine|piperaquine|mesh-list
65191081|NCT02612545|Artenimol|artenimol|mesh-list
65191082|NCT02612545|Mefloquine|mefloquine|mesh-list
65191083|NCT02612545|Antimalarials|antimalarials|mesh-ancestor
65191084|NCT02612545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65191085|NCT02612545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65191086|NCT02612545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65191087|NCT00704743|Calpastatin|calpastatin|mesh-list
65191088|NCT00704743|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65191089|NCT00704743|Protease Inhibitors|protease inhibitors|mesh-ancestor
65191090|NCT00704743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191091|NCT00704743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191093|NCT01097057|Rituximab|rituximab|mesh-list
65191094|NCT01097057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65191095|NCT01097057|Carboplatin|carboplatin|mesh-list
65191096|NCT01097057|Etoposide|etoposide|mesh-list
65191097|NCT01097057|Etoposide phosphate|etoposide phosphate|mesh-list
65191098|NCT01097057|Ifosfamide|ifosfamide|mesh-list
65191099|NCT01097057|Isophosphamide mustard|isophosphamide mustard|mesh-list
65191100|NCT01097057|Podophyllotoxin|podophyllotoxin|mesh-list
65191101|NCT01097057|Antibodies|antibodies|mesh-list
65191102|NCT01097057|Immunoglobulins|immunoglobulins|mesh-list
65191103|NCT01097057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65191104|NCT01097057|Lenograstim|lenograstim|mesh-list
65191105|NCT01097057|Immunologic Factors|immunologic factors|mesh-ancestor
65191106|NCT01097057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191107|NCT01097057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191108|NCT01097057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65327527|NCT02574663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327528|NCT02574663|Growth Inhibitors|growth inhibitors|mesh-ancestor
65327529|NCT02574663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65327530|NCT02574663|Antimetabolites|antimetabolites|mesh-ancestor
65327531|NCT02574663|Antiviral Agents|antiviral agents|mesh-ancestor
65327532|NCT02574663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65327533|NCT02574663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327534|NCT02574663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65327535|NCT02574663|Immunologic Factors|immunologic factors|mesh-ancestor
65327536|NCT02574663|Antidotes|antidotes|mesh-ancestor
65327537|NCT02574663|Protective Agents|protective agents|mesh-ancestor
65327538|NCT02574663|Vitamin B Complex|vitamin b complex|mesh-ancestor
65327539|NCT02574663|Vitamins|vitamins|mesh-ancestor
65191109|NCT01097057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65191110|NCT01097057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65191111|NCT01097057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65191112|NCT01097057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191113|NCT01097057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191114|NCT01097057|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65191115|NCT01097057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65191116|NCT01097057|Alkylating Agents|alkylating agents|mesh-ancestor
65191117|NCT01097057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65191118|NCT01097057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65191119|NCT01097057|Antiviral Agents|antiviral agents|mesh-ancestor
65191120|NCT01097057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65191121|NCT01097057|Keratolytic Agents|keratolytic agents|mesh-ancestor
65191122|NCT01097057|Dermatologic Agents|dermatologic agents|mesh-ancestor
65191123|NCT01097057|Tubulin Modulators|tubulin modulators|mesh-ancestor
65191124|NCT01097057|Antimitotic Agents|antimitotic agents|mesh-ancestor
65191125|NCT01097057|Mitosis Modulators|mitosis modulators|mesh-ancestor
65191126|NCT02612701|Nicotine|nicotine|mesh-list
65191127|NCT02612701|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65191138|NCT01096667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65191139|NCT01096667|Diuretics|diuretics|mesh-ancestor
65191140|NCT01096667|Natriuretic Agents|natriuretic agents|mesh-ancestor
65191141|NCT01096667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191142|NCT01096667|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65191143|NCT01096667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65191144|NCT01096667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191145|NCT01096667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65191146|NCT01096667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65191147|NCT01014624|Clopidogrel|clopidogrel|mesh-list
65191148|NCT01014624|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65191149|NCT01014624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65191150|NCT01014624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65191151|NCT01014624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65191152|NCT01014624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65191153|NCT01014624|Purinergic Agents|purinergic agents|mesh-ancestor
65191154|NCT01014624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65191155|NCT01014624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191156|NCT01014624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191157|NCT01021878|Icodextrin|icodextrin|mesh-list
65191158|NCT01021878|Dialysis Solutions|dialysis solutions|mesh-ancestor
65191159|NCT01021878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65191160|NCT02872428|Valproic Acid|valproic acid|mesh-list
65191161|NCT02872428|Anticonvulsants|anticonvulsants|mesh-ancestor
65191162|NCT02872428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191163|NCT02872428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191164|NCT02872428|GABA Agents|gaba agents|mesh-ancestor
65191165|NCT02872428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65191166|NCT02872428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191167|NCT02872428|Antimanic Agents|antimanic agents|mesh-ancestor
65327540|NCT02574663|Micronutrients|micronutrients|mesh-ancestor
65327541|NCT02574663|Hematinics|hematinics|mesh-ancestor
65327542|NCT04069845|Doxorubicin|doxorubicin|mesh-list
65327543|NCT04069845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65327544|NCT04069845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65327545|NCT04069845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327546|NCT04069845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65327547|NCT04069845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65327548|NCT04069845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327549|NCT04069845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327550|NCT05158140|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65327551|NCT05158140|Immunologic Factors|immunologic factors|mesh-ancestor
65327552|NCT05158140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327553|NCT00710229|Bevacizumab|bevacizumab|mesh-list
65327554|NCT00710229|Ranibizumab|ranibizumab|mesh-list
65327555|NCT00710229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65327556|NCT00710229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557005|NCT05583071|Rituximab|rituximab|mesh-list
65191168|NCT02872428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65191169|NCT02872428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65191170|NCT02872428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65191171|NCT02873364|Vitamin D|vitamin d|mesh-list
65191172|NCT02873364|Ergocalciferols|ergocalciferols|mesh-list
65191173|NCT02873364|Cholecalciferol|cholecalciferol|mesh-list
65191174|NCT02873364|Vitamins|vitamins|mesh-list
65191175|NCT02873364|Micronutrients|micronutrients|mesh-ancestor
65191176|NCT02873364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191177|NCT02873364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65191178|NCT02873364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65191179|NCT00628290|Cannabidiol|cannabidiol|mesh-list
65191180|NCT00628290|Amisulpride|amisulpride|mesh-list
65191181|NCT00628290|Anticonvulsants|anticonvulsants|mesh-ancestor
65191182|NCT00628290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65191183|NCT00628290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65191184|NCT00628290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65191185|NCT00628290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191187|NCT00628290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65191188|NCT00628290|Dopamine Agents|dopamine agents|mesh-ancestor
65191189|NCT00628290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65191190|NCT00628290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191191|NCT00628290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65191192|NCT00628290|Antidepressive Agents|antidepressive agents|mesh-ancestor
65191199|NCT04559412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191200|NCT04559412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65191201|NCT04559412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65191202|NCT04559412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65191203|NCT04559412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65191204|NCT04559412|Immunologic Factors|immunologic factors|mesh-ancestor
65191205|NCT02871882|Bile Acids and Salts|bile acids and salts|mesh-list
65191206|NCT02871882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65191207|NCT00854113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65191208|NCT00854113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191209|NCT00854113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65191210|NCT00854113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191211|NCT02872584|Prednisone|prednisone|mesh-list
65191212|NCT02872584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65191213|NCT02872584|Glucocorticoids|glucocorticoids|mesh-ancestor
65191214|NCT02872584|Hormones|hormones|mesh-ancestor
65327557|NCT00710229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65327558|NCT00710229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65327559|NCT00710229|Growth Substances|growth substances|mesh-ancestor
65327560|NCT00710229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327561|NCT00710229|Growth Inhibitors|growth inhibitors|mesh-ancestor
65327562|NCT00715689|Hormones|hormones|mesh-list
65327563|NCT00715689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65327564|NCT00715689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327565|NCT00919542|Cyclosporine|cyclosporine|mesh-list
65327566|NCT00919542|Prednisolone|prednisolone|mesh-list
65327567|NCT00919542|Cyclosporins|cyclosporins|mesh-list
65327568|NCT00919542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327569|NCT00919542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327570|NCT00919542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65327571|NCT00919542|Immunologic Factors|immunologic factors|mesh-ancestor
65327572|NCT00919542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327573|NCT00919542|Antifungal Agents|antifungal agents|mesh-ancestor
65327574|NCT00919542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65327575|NCT00919542|Dermatologic Agents|dermatologic agents|mesh-ancestor
65327576|NCT00919542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65191215|NCT02872584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65191216|NCT02872584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191217|NCT02872584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65191218|NCT02872584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191219|NCT00704821|Docetaxel|docetaxel|mesh-list
65191220|NCT00704821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191221|NCT00704821|Tubulin Modulators|tubulin modulators|mesh-ancestor
65191222|NCT00704821|Antimitotic Agents|antimitotic agents|mesh-ancestor
65191223|NCT00704821|Mitosis Modulators|mitosis modulators|mesh-ancestor
65191224|NCT00704821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191225|NCT00704899|Amitriptyline|amitriptyline|mesh-list
65191226|NCT00704899|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65191227|NCT00704899|Antidepressive Agents|antidepressive agents|mesh-ancestor
65191228|NCT00704899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65191229|NCT00704899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65191230|NCT00704899|Analgesics|analgesics|mesh-ancestor
65191231|NCT00704899|Sensory System Agents|sensory system agents|mesh-ancestor
65191232|NCT00704899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65191233|NCT00704899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191234|NCT00704899|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65191235|NCT00704899|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65191236|NCT00704899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65191237|NCT00704899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191238|NCT00704899|Adrenergic Agents|adrenergic agents|mesh-ancestor
65191239|NCT00704899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65191240|NCT01104701|Exenatide|exenatide|mesh-list
65191241|NCT01104701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65191242|NCT01104701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191243|NCT01104701|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65191244|NCT01104701|Incretins|incretins|mesh-ancestor
65191245|NCT01104701|Hormones|hormones|mesh-ancestor
65191246|NCT01104701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65191247|NCT00833755|Ketamine|ketamine|mesh-list
65327577|NCT00919542|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65327578|NCT00919542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65327579|NCT00919542|Glucocorticoids|glucocorticoids|mesh-ancestor
65327580|NCT00919542|Hormones|hormones|mesh-ancestor
65327581|NCT00919542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65327582|NCT00919542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65327583|NCT00919542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327584|NCT04240626|Acetaminophen|acetaminophen|mesh-list
65327585|NCT04240626|Scopolamine|scopolamine|mesh-list
65327586|NCT04240626|Oxycodone|oxycodone|mesh-list
65327587|NCT04240626|Gabapentin|gabapentin|mesh-list
65327588|NCT04240626|Hydromorphone|hydromorphone|mesh-list
65327589|NCT04240626|Hydrocodone|hydrocodone|mesh-list
65327590|NCT04240626|Bupivacaine|bupivacaine|mesh-list
65191248|NCT00833755|Analgesics|analgesics|mesh-ancestor
65191249|NCT00833755|Sensory System Agents|sensory system agents|mesh-ancestor
65191250|NCT00833755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65191251|NCT00833755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191252|NCT00833755|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65191253|NCT00833755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65191254|NCT00833755|Anesthetics, General|anesthetics, general|mesh-ancestor
65191255|NCT00833755|Anesthetics|anesthetics|mesh-ancestor
65191256|NCT00833755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64948456|NCT04081389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191257|NCT00833755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65191258|NCT00833755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65191259|NCT00833755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65191264|NCT01021332|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65191265|NCT01021332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65191266|NCT01021332|Adrenergic Agents|adrenergic agents|mesh-ancestor
65191267|NCT01021332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65191268|NCT01021332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191269|NCT01021332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191270|NCT01021332|Urological Agents|urological agents|mesh-ancestor
65191271|NCT01021332|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65191272|NCT01021332|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65191273|NCT01021332|Cholinergic Agents|cholinergic agents|mesh-ancestor
65191274|NCT00923091|Amlodipine|amlodipine|mesh-list
65191275|NCT00923091|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65191276|NCT00923091|Olmesartan|olmesartan|mesh-list
65191277|NCT00923091|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65191278|NCT00923091|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
65191279|NCT00923091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65191280|NCT00923091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65191281|NCT00923091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65191282|NCT00923091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191283|NCT00923091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65191284|NCT00923091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191285|NCT00923091|Vasodilator Agents|vasodilator agents|mesh-ancestor
65191286|NCT00923091|Diuretics|diuretics|mesh-ancestor
65191287|NCT00923091|Natriuretic Agents|natriuretic agents|mesh-ancestor
65191288|NCT00923091|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65191289|NCT00923091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65191290|NCT00923091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65191291|NCT00853957|Amlodipine|amlodipine|mesh-list
65191292|NCT00853957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65191293|NCT00853957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65191294|NCT00853957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65191295|NCT00853957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191296|NCT00853957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65191297|NCT00853957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327591|NCT04240626|Cyclobenzaprine|cyclobenzaprine|mesh-list
65327592|NCT04240626|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65327593|NCT04240626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65327594|NCT04240626|Analgesics|analgesics|mesh-ancestor
65191298|NCT00853957|Vasodilator Agents|vasodilator agents|mesh-ancestor
65191299|NCT01021020|Colchicine|colchicine|mesh-list
65191300|NCT01021020|Probenecid|probenecid|mesh-list
65191301|NCT01021020|Gout Suppressants|gout suppressants|mesh-ancestor
65191302|NCT01021020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65191303|NCT01021020|Tubulin Modulators|tubulin modulators|mesh-ancestor
65191304|NCT01021020|Antimitotic Agents|antimitotic agents|mesh-ancestor
65191305|NCT01021020|Mitosis Modulators|mitosis modulators|mesh-ancestor
65191306|NCT01021020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191307|NCT01021020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191308|NCT01021020|Uricosuric Agents|uricosuric agents|mesh-ancestor
65191309|NCT01021020|Renal Agents|renal agents|mesh-ancestor
65191311|NCT00833053|Infliximab|infliximab|mesh-list
65191312|NCT00833053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65191313|NCT00833053|Abortifacient Agents|abortifacient agents|mesh-ancestor
65191314|NCT00833053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65191315|NCT00833053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191316|NCT00833053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65191317|NCT00833053|Antimetabolites|antimetabolites|mesh-ancestor
65191318|NCT00833053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191319|NCT00833053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191320|NCT00833053|Dermatologic Agents|dermatologic agents|mesh-ancestor
65191321|NCT00833053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191322|NCT00833053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65191323|NCT00833053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65191324|NCT00833053|Immunologic Factors|immunologic factors|mesh-ancestor
65191325|NCT00833053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65191326|NCT00833053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65191327|NCT00833053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65191328|NCT01020786|Carboplatin|carboplatin|mesh-list
65191329|NCT01020786|Pemetrexed|pemetrexed|mesh-list
65191332|NCT01020786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191333|NCT01020786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65191334|NCT01020786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65191335|NCT00918645|Calcium|calcium|mesh-list
65191336|NCT00918645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65191337|NCT00918645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191338|NCT01020474|Pregabalin|pregabalin|mesh-list
65191339|NCT01020474|Analgesics|analgesics|mesh-ancestor
65191340|NCT01020474|Sensory System Agents|sensory system agents|mesh-ancestor
65191341|NCT01020474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65191342|NCT01020474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191343|NCT01020474|Anticonvulsants|anticonvulsants|mesh-ancestor
65191344|NCT01020474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65191345|NCT01020474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65191346|NCT01020474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191347|NCT01020474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65191348|NCT01020474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65191349|NCT01020474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65191350|NCT01020474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65191351|NCT01020474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65191352|NCT02872818|Metformin|metformin|mesh-list
65191353|NCT02872818|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65191354|NCT02872818|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65191355|NCT02872818|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65191356|NCT02872818|Medroxyprogesterone|medroxyprogesterone|mesh-list
65191357|NCT02872818|Estradiol|estradiol|mesh-list
65191358|NCT02872818|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65191359|NCT02872818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65191360|NCT02872818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191361|NCT02872818|Estrogens|estrogens|mesh-ancestor
65191362|NCT02872818|Hormones|hormones|mesh-ancestor
65191363|NCT02872818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65191364|NCT02872818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65191365|NCT02872818|Contraceptive Agents|contraceptive agents|mesh-ancestor
65191366|NCT02872818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65191367|NCT02872818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65327595|NCT04240626|Sensory System Agents|sensory system agents|mesh-ancestor
65327596|NCT04240626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65327597|NCT04240626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327598|NCT04240626|Antipyretics|antipyretics|mesh-ancestor
65327599|NCT04240626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65327600|NCT04240626|Narcotics|narcotics|mesh-ancestor
65327601|NCT04240626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65327602|NCT04240626|Anticonvulsants|anticonvulsants|mesh-ancestor
65191368|NCT02872818|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65191369|NCT02872818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65191370|NCT02872818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65191371|NCT02872818|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65191372|NCT02872818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65191373|NCT02872818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191374|NCT00922779|Ribavirin|ribavirin|mesh-list
65191375|NCT00922779|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65191376|NCT00922779|Antimetabolites|antimetabolites|mesh-ancestor
65191377|NCT00922779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191378|NCT00922779|Antiviral Agents|antiviral agents|mesh-ancestor
65191379|NCT00922779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65191380|NCT04528680|Paclitaxel|paclitaxel|mesh-list
65191381|NCT04528680|Carboplatin|carboplatin|mesh-list
65191382|NCT04528680|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65191383|NCT04528680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65191384|NCT04528680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191385|NCT04528680|Tubulin Modulators|tubulin modulators|mesh-ancestor
65191386|NCT04528680|Antimitotic Agents|antimitotic agents|mesh-ancestor
65191387|NCT04528680|Mitosis Modulators|mitosis modulators|mesh-ancestor
65191388|NCT04528680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191389|NCT04570410|Gemcitabine|gemcitabine|mesh-list
65191390|NCT04570410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191391|NCT04570410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65191392|NCT04570410|Antimetabolites|antimetabolites|mesh-ancestor
65191393|NCT04570410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191394|NCT04570410|Antiviral Agents|antiviral agents|mesh-ancestor
65191395|NCT04570410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65191396|NCT04570410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191397|NCT04570410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65191398|NCT04570410|Immunologic Factors|immunologic factors|mesh-ancestor
65191399|NCT04570410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191408|NCT04203771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65191409|NCT04203771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65191410|NCT04203771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191411|NCT04203771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191413|NCT04256733|Antipruritics|antipruritics|mesh-ancestor
65191414|NCT04256733|Dermatologic Agents|dermatologic agents|mesh-ancestor
65191415|NCT04256733|Sensory System Agents|sensory system agents|mesh-ancestor
65191416|NCT04256733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65191417|NCT04256733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191419|NCT01025232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65191420|NCT01025232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65191421|NCT01025232|Growth Substances|growth substances|mesh-ancestor
65191422|NCT01025232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191423|NCT01025232|Growth Inhibitors|growth inhibitors|mesh-ancestor
65191424|NCT01025232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191425|NCT05321199|Tranexamic Acid|tranexamic acid|mesh-list
65191426|NCT05321199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65191427|NCT05321199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65191428|NCT05321199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191429|NCT05321199|Hemostatics|hemostatics|mesh-ancestor
65191430|NCT05321199|Coagulants|coagulants|mesh-ancestor
65191431|NCT04300452|Carbetocin|carbetocin|mesh-list
65191432|NCT04300452|Ergonovine|ergonovine|mesh-list
65191433|NCT04300452|Oxytocics|oxytocics|mesh-ancestor
65191434|NCT04300452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65191435|NCT04300452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191436|NCT01025154|Cytarabine|cytarabine|mesh-list
65191437|NCT01025154|Clofarabine|clofarabine|mesh-list
65327603|NCT04240626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65327604|NCT04240626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65327605|NCT04240626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65327606|NCT04240626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65327607|NCT04240626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65191438|NCT01025154|Idarubicin|idarubicin|mesh-list
65191439|NCT01025154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65191440|NCT01025154|Antimetabolites|antimetabolites|mesh-ancestor
65191441|NCT01025154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191442|NCT01025154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191443|NCT01025154|Antiviral Agents|antiviral agents|mesh-ancestor
65191444|NCT01025154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65191445|NCT01025154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65191446|NCT01025154|Immunologic Factors|immunologic factors|mesh-ancestor
65191447|NCT01025154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191448|NCT01025154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65191449|NCT01025154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65191450|NCT01025154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65191451|NCT01025154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191452|NCT04252365|Pembrolizumab|pembrolizumab|mesh-list
65191453|NCT04252365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65191454|NCT04252365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191455|NCT04252443|Analgesics, Opioid|analgesics, opioid|mesh-list
65191456|NCT04252443|Analgesics|analgesics|mesh-list
65191457|NCT04252443|Narcotics|narcotics|mesh-ancestor
65191458|NCT04252443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65191459|NCT04252443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191460|NCT04252443|Sensory System Agents|sensory system agents|mesh-ancestor
65191461|NCT04252443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65191462|NCT00832819|Paclitaxel|paclitaxel|mesh-list
65191463|NCT00832819|Carboplatin|carboplatin|mesh-list
65191464|NCT00832819|Lenvatinib|lenvatinib|mesh-list
65191465|NCT00832819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65191466|NCT00832819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191467|NCT00832819|Tubulin Modulators|tubulin modulators|mesh-ancestor
65191468|NCT00832819|Antimitotic Agents|antimitotic agents|mesh-ancestor
65191477|NCT05527483|Listerine|listerine|mesh-list
65191478|NCT05527483|Fluorides|fluorides|mesh-list
65191479|NCT05527483|Sodium Fluoride|sodium fluoride|mesh-list
65191480|NCT05527483|Cariostatic Agents|cariostatic agents|mesh-ancestor
65191481|NCT05527483|Protective Agents|protective agents|mesh-ancestor
65191482|NCT05527483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191483|NCT05527483|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65191484|NCT05527483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65191485|NCT00853723|Teriparatide|teriparatide|mesh-list
65191486|NCT00853723|Hormones|hormones|mesh-list
65191487|NCT00853723|Parathyroid Hormone|parathyroid hormone|mesh-list
65191488|NCT00853723|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
65191489|NCT00853723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65191490|NCT00853723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191491|NCT00853723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65191492|NCT00853723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65191493|NCT00918255|Adalimumab|adalimumab|mesh-list
65191494|NCT00918255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65191495|NCT00918255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65191496|NCT01096589|Monensin|monensin|mesh-list
65191497|NCT01096589|Antifungal Agents|antifungal agents|mesh-ancestor
65191498|NCT01096589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65191499|NCT01096589|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65191500|NCT01096589|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65191501|NCT01096589|Coccidiostats|coccidiostats|mesh-ancestor
65191502|NCT01096589|Proton Ionophores|proton ionophores|mesh-ancestor
65191503|NCT01096589|Uncoupling Agents|uncoupling agents|mesh-ancestor
65191504|NCT01096589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191505|NCT01096589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191506|NCT01096589|Ionophores|ionophores|mesh-ancestor
65191507|NCT01096589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65191508|NCT01096589|Sodium Ionophores|sodium ionophores|mesh-ancestor
65191509|NCT04252521|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65191510|NCT04252521|Ketoprofen|ketoprofen|mesh-list
65191511|NCT04252521|Metoclopramide|metoclopramide|mesh-list
65191512|NCT04252521|Antiemetics|antiemetics|mesh-ancestor
65327608|NCT04240626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65327609|NCT04240626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327610|NCT04240626|Antimanic Agents|antimanic agents|mesh-ancestor
65327611|NCT04240626|Anesthetics, Local|anesthetics, local|mesh-ancestor
65327612|NCT04240626|Anesthetics|anesthetics|mesh-ancestor
65327613|NCT04240626|Antiemetics|antiemetics|mesh-ancestor
65327614|NCT04240626|Autonomic Agents|autonomic agents|mesh-ancestor
65191513|NCT04252521|Autonomic Agents|autonomic agents|mesh-ancestor
65191514|NCT04252521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65191515|NCT04252521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191516|NCT04252521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65191517|NCT04252521|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65191518|NCT04252521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65191519|NCT04252521|Dopamine Agents|dopamine agents|mesh-ancestor
65191520|NCT04252521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65191521|NCT04252521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191522|NCT04252521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65191523|NCT04252521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65191524|NCT04252521|Analgesics|analgesics|mesh-ancestor
65191525|NCT04252521|Sensory System Agents|sensory system agents|mesh-ancestor
65191526|NCT04252521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65191527|NCT04252521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65191528|NCT04252521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65191529|NCT04252521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191530|NCT00845065|Ribavirin|ribavirin|mesh-list
65191531|NCT00845065|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65191532|NCT00845065|Antimetabolites|antimetabolites|mesh-ancestor
65191533|NCT00845065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191534|NCT00845065|Antiviral Agents|antiviral agents|mesh-ancestor
65191535|NCT00845065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65191536|NCT04772001|Carboplatin|carboplatin|mesh-list
65191543|NCT00702091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191544|NCT00702091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65191546|NCT00832585|Dermatologic Agents|dermatologic agents|mesh-ancestor
65191547|NCT00832585|Immunologic Factors|immunologic factors|mesh-ancestor
65191548|NCT00832585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191549|NCT00918567|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65191550|NCT00918567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65191551|NCT00918567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65191552|NCT00918567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65191553|NCT00918567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191554|NCT00918567|Adrenergic Agents|adrenergic agents|mesh-ancestor
64948745|NCT03292458|Anesthetics|anesthetics|mesh-ancestor
65191555|NCT00918567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65191556|NCT00918567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191557|NCT05252325|Lidocaine|lidocaine|mesh-list
65191558|NCT05252325|Hyaluronic Acid|hyaluronic acid|mesh-list
65191559|NCT05252325|Anesthetics, Local|anesthetics, local|mesh-ancestor
65191560|NCT05252325|Anesthetics|anesthetics|mesh-ancestor
65191561|NCT05252325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65191562|NCT05252325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191563|NCT05252325|Sensory System Agents|sensory system agents|mesh-ancestor
65191564|NCT05252325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65191565|NCT05252325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65191566|NCT05252325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65191567|NCT05252325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65191568|NCT05252325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65191569|NCT05252325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191570|NCT05252325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65191571|NCT05252325|Immunologic Factors|immunologic factors|mesh-ancestor
65191572|NCT05252325|Viscosupplements|viscosupplements|mesh-ancestor
65191573|NCT05252325|Protective Agents|protective agents|mesh-ancestor
65191574|NCT01024920|Sunitinib|sunitinib|mesh-list
65191575|NCT01024920|Nintedanib|nintedanib|mesh-list
65191576|NCT01024920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191577|NCT01024920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65191578|NCT01024920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65191579|NCT01024920|Growth Substances|growth substances|mesh-ancestor
65327615|NCT04240626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65077560|NCT00432549|Serotonin Agents|serotonin agents|mesh-ancestor
65327616|NCT04240626|Antitussive Agents|antitussive agents|mesh-ancestor
65327617|NCT04240626|Respiratory System Agents|respiratory system agents|mesh-ancestor
65327618|NCT04240626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65327619|NCT04240626|Mydriatics|mydriatics|mesh-ancestor
64557067|NCT04143191|Sorafenib|sorafenib|mesh-list
65191580|NCT01024920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191581|NCT01024920|Growth Inhibitors|growth inhibitors|mesh-ancestor
65191582|NCT01024920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65191583|NCT01024920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191584|NCT01024920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191585|NCT00832117|Cisplatin|cisplatin|mesh-list
65191586|NCT00832117|Epothilones|epothilones|mesh-list
65191587|NCT00832117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191588|NCT00832117|Tubulin Modulators|tubulin modulators|mesh-ancestor
65191589|NCT00832117|Antimitotic Agents|antimitotic agents|mesh-ancestor
65191590|NCT00832117|Mitosis Modulators|mitosis modulators|mesh-ancestor
65191591|NCT00832117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191592|NCT02872272|Amikacin|amikacin|mesh-list
65191593|NCT02872272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65191594|NCT02872272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65191595|NCT00831493|Vorinostat|vorinostat|mesh-list
65191596|NCT00831493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191597|NCT00831493|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65191598|NCT00831493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191599|NCT00831493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191601|NCT00705445|Trace Elements|trace elements|mesh-list
65191602|NCT00705445|Micronutrients|micronutrients|mesh-list
65191603|NCT00705445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191604|NCT01104155|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65191605|NCT01104155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191614|NCT02879981|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65191615|NCT02879981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65191616|NCT02879981|Renal Agents|renal agents|mesh-ancestor
65191617|NCT02879981|Antimalarials|antimalarials|mesh-ancestor
65191618|NCT02879981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65191619|NCT02879981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65191620|NCT02879981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65191621|NCT02879981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191622|NCT02879981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191623|NCT02879981|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65191624|NCT02879981|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65191625|NCT02879981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65191626|NCT02879981|Expectorants|expectorants|mesh-ancestor
65191627|NCT02879981|Respiratory System Agents|respiratory system agents|mesh-ancestor
65191628|NCT02879981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65191629|NCT02879981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65191630|NCT02879981|Adrenergic Agents|adrenergic agents|mesh-ancestor
65191631|NCT02879981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65191632|NCT02879981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191633|NCT02879981|Appetite Depressants|appetite depressants|mesh-ancestor
65191634|NCT02879981|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65191635|NCT02879981|Sympathomimetics|sympathomimetics|mesh-ancestor
65191636|NCT02879981|Autonomic Agents|autonomic agents|mesh-ancestor
65191637|NCT02879981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65191638|NCT02879981|Nasal Decongestants|nasal decongestants|mesh-ancestor
65191639|NCT02879981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65191640|NCT04307693|Ritonavir|ritonavir|mesh-list
65191641|NCT04307693|Lopinavir|lopinavir|mesh-list
65191642|NCT04307693|Hydroxychloroquine|hydroxychloroquine|mesh-list
65191643|NCT04307693|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65191644|NCT04307693|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65191645|NCT04307693|Protease Inhibitors|protease inhibitors|mesh-ancestor
65191646|NCT04307693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191647|NCT04307693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191648|NCT04307693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65191649|NCT04307693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65191650|NCT04307693|Antiviral Agents|antiviral agents|mesh-ancestor
65191651|NCT04307693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65327620|NCT04240626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65327621|NCT04240626|Cholinergic Agents|cholinergic agents|mesh-ancestor
65327622|NCT04240626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65191652|NCT04307693|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65191653|NCT04307693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65191654|NCT04307693|Antimalarials|antimalarials|mesh-ancestor
65191655|NCT04307693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65191656|NCT04307693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65191657|NCT04307693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65191658|NCT02878421|Nicotine|nicotine|mesh-list
65191659|NCT02878421|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65191660|NCT02878421|Autonomic Agents|autonomic agents|mesh-ancestor
65191661|NCT02878421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65191662|NCT02878421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191663|NCT02878421|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65191664|NCT02878421|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65191665|NCT02878421|Cholinergic Agents|cholinergic agents|mesh-ancestor
65191666|NCT02878421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65191667|NCT02878421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191668|NCT01019694|Albuterol|albuterol|mesh-list
65191669|NCT01019694|Ipratropium|ipratropium|mesh-list
65191670|NCT01019694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65191671|NCT01019694|Autonomic Agents|autonomic agents|mesh-ancestor
65191672|NCT01019694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65191673|NCT01019694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191674|NCT01019694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65191686|NCT00831415|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65191687|NCT00831415|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65191688|NCT00831415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65191689|NCT00831415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65191690|NCT00831415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191691|NCT00831415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65191692|NCT00831415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191693|NCT00831415|Antidepressive Agents|antidepressive agents|mesh-ancestor
65191694|NCT00831415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65191696|NCT01095653|Dapagliflozin|dapagliflozin|mesh-list
65191697|NCT01095653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65191698|NCT01095653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191699|NCT01095653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65191700|NCT01095653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191701|NCT00920907|Ipilimumab|ipilimumab|mesh-list
65191702|NCT00920907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65191703|NCT00920907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191704|NCT00920907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65191705|NCT00920907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191707|NCT00700297|Gout Suppressants|gout suppressants|mesh-ancestor
65191708|NCT00700297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65191709|NCT00700297|Tubulin Modulators|tubulin modulators|mesh-ancestor
65191710|NCT00700297|Antimitotic Agents|antimitotic agents|mesh-ancestor
65191711|NCT00700297|Mitosis Modulators|mitosis modulators|mesh-ancestor
65191712|NCT00700297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191713|NCT00700297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191714|NCT04307147|Capecitabine|capecitabine|mesh-list
65191715|NCT04307147|Vinorelbine|vinorelbine|mesh-list
65191716|NCT04307147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65191717|NCT04307147|Antimetabolites|antimetabolites|mesh-ancestor
65191718|NCT04307147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191719|NCT04307147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191720|NCT04307147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65191721|NCT04307147|Tubulin Modulators|tubulin modulators|mesh-ancestor
65191722|NCT04307147|Antimitotic Agents|antimitotic agents|mesh-ancestor
65191723|NCT04307147|Mitosis Modulators|mitosis modulators|mesh-ancestor
65191724|NCT00844831|Lubiprostone|lubiprostone|mesh-list
65191725|NCT00844831|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65191726|NCT00844831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65191727|NCT00844831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191728|NCT00920829|Naltrexone|naltrexone|mesh-list
65191729|NCT00920829|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65191730|NCT00920829|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65327623|NCT04240626|Parasympatholytics|parasympatholytics|mesh-ancestor
65327624|NCT04240626|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65327625|NCT04240626|Antidepressive Agents|antidepressive agents|mesh-ancestor
65327626|NCT04240626|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65327627|NCT04240626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65327628|NCT00719121|Adapalene|adapalene|mesh-list
65327629|NCT00719121|R 115866|r 115866|mesh-list
65327630|NCT00719121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65327631|NCT00719121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65327632|NCT00719121|Analgesics|analgesics|mesh-ancestor
65327633|NCT00719121|Sensory System Agents|sensory system agents|mesh-ancestor
65327634|NCT00719121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65327635|NCT00719121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327636|NCT00719121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65327637|NCT00719121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65327638|NCT00719121|Dermatologic Agents|dermatologic agents|mesh-ancestor
65327639|NCT00719121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65327640|NCT00719121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557083|NCT04461288|Nicotine|nicotine|mesh-list
65191731|NCT00920829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191732|NCT00920829|Sensory System Agents|sensory system agents|mesh-ancestor
65191733|NCT00920829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65191734|NCT05010876|Icatibant|icatibant|mesh-list
65191735|NCT05010876|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
65191740|NCT05010876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65191741|NCT05010876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191742|NCT05010876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65191743|NCT05010876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65191744|NCT05010876|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
65191745|NCT05010876|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
65191746|NCT05010876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191747|NCT05010876|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65191748|NCT05010876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65191749|NCT05010876|Immunologic Factors|immunologic factors|mesh-ancestor
65191750|NCT04307069|Oxytocin|oxytocin|mesh-list
65191751|NCT04307069|Oxytocics|oxytocics|mesh-ancestor
65191752|NCT04307069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65191753|NCT04307069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191754|NCT04251741|Adalimumab|adalimumab|mesh-list
65191755|NCT04251741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65191756|NCT04251741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65191757|NCT02878265|Vitamins|vitamins|mesh-list
65191758|NCT02878265|Vitamin A|vitamin a|mesh-list
65191759|NCT02878265|Zinc|zinc|mesh-list
64834360|NCT03274414|Cisplatin|cisplatin|mesh-list
65191760|NCT02878265|Retinol palmitate|retinol palmitate|mesh-list
65191761|NCT02878265|Micronutrients|micronutrients|mesh-ancestor
65191762|NCT02878265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191763|NCT02878265|Trace Elements|trace elements|mesh-ancestor
65191764|NCT02878265|Antioxidants|antioxidants|mesh-ancestor
65191765|NCT02878265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191766|NCT02878265|Protective Agents|protective agents|mesh-ancestor
65191767|NCT02878265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65191768|NCT02878265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191769|NCT00831181|Leucovorin|leucovorin|mesh-list
65191770|NCT00831181|Fluorouracil|fluorouracil|mesh-list
65191771|NCT00831181|Oxaliplatin|oxaliplatin|mesh-list
65191772|NCT00831181|Antimetabolites|antimetabolites|mesh-ancestor
65327641|NCT00719121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327642|NCT00719199|Cetuximab|cetuximab|mesh-list
65327643|NCT00719199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65327644|NCT00719199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327645|NCT02589288|Ropivacaine|ropivacaine|mesh-list
65327646|NCT02589288|Anesthetics, Local|anesthetics, local|mesh-ancestor
65327647|NCT02589288|Anesthetics|anesthetics|mesh-ancestor
65327648|NCT02589288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65327649|NCT02589288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327650|NCT02589288|Sensory System Agents|sensory system agents|mesh-ancestor
65327651|NCT02589288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65327652|NCT00716001|Acetylcysteine|acetylcysteine|mesh-list
65327653|NCT00716001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65327654|NCT00716001|Antiviral Agents|antiviral agents|mesh-ancestor
65327655|NCT00716001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65327656|NCT00716001|Expectorants|expectorants|mesh-ancestor
65327657|NCT00716001|Respiratory System Agents|respiratory system agents|mesh-ancestor
65327658|NCT00716001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65327659|NCT00716001|Antioxidants|antioxidants|mesh-ancestor
65327660|NCT00716001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327661|NCT00716001|Protective Agents|protective agents|mesh-ancestor
65327662|NCT00716001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327663|NCT00716001|Antidotes|antidotes|mesh-ancestor
65327664|NCT05136846|Paclitaxel|paclitaxel|mesh-list
65327665|NCT05136846|Carboplatin|carboplatin|mesh-list
65327666|NCT05136846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65327667|NCT05136846|Durvalumab|durvalumab|mesh-list
65327668|NCT05136846|Papaverine|papaverine|mesh-list
65327669|NCT05136846|Immunoglobulins|immunoglobulins|mesh-list
65191773|NCT00831181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191774|NCT00831181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65191775|NCT00831181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191776|NCT00831181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65191777|NCT00831181|Immunologic Factors|immunologic factors|mesh-ancestor
65191778|NCT00831181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191779|NCT00831181|Antidotes|antidotes|mesh-ancestor
65191780|NCT00831181|Protective Agents|protective agents|mesh-ancestor
65191781|NCT00831181|Vitamin B Complex|vitamin b complex|mesh-ancestor
65191783|NCT00831181|Micronutrients|micronutrients|mesh-ancestor
65191784|NCT01023672|Modafinil|modafinil|mesh-list
65191785|NCT01023672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65191786|NCT01023672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191787|NCT01023672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65191788|NCT01023672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65191789|NCT01023672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65191790|NCT01023672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191791|NCT00705835|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65327670|NCT05136846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65327671|NCT05136846|Immunoglobulin G|immunoglobulin g|mesh-list
65327672|NCT05136846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65327673|NCT05136846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327674|NCT05136846|Tubulin Modulators|tubulin modulators|mesh-ancestor
65327675|NCT05136846|Antimitotic Agents|antimitotic agents|mesh-ancestor
65327676|NCT05136846|Mitosis Modulators|mitosis modulators|mesh-ancestor
65327677|NCT05136846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327678|NCT05136846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65327679|NCT05136846|Immunologic Factors|immunologic factors|mesh-ancestor
65327680|NCT05136846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327681|NCT05136846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65327682|NCT05136846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327683|NCT05136846|Vasodilator Agents|vasodilator agents|mesh-ancestor
65327684|NCT05136846|Urological Agents|urological agents|mesh-ancestor
65327685|NCT00710619|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
65191792|NCT00705835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65191793|NCT00705835|Immunologic Factors|immunologic factors|mesh-ancestor
65191794|NCT00705835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191795|NCT00705835|Antacids|antacids|mesh-ancestor
65191796|NCT00705835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191797|NCT00705835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65191798|NCT00702637|Modafinil|modafinil|mesh-list
65191799|NCT00702637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65191800|NCT00702637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191801|NCT00702637|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65191802|NCT00702637|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65191803|NCT00702637|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65191804|NCT00702637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191805|NCT04786275|Fentanyl|fentanyl|mesh-list
65191806|NCT04786275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65191810|NCT04786275|Analgesics|analgesics|mesh-ancestor
65191811|NCT04786275|Sensory System Agents|sensory system agents|mesh-ancestor
65191812|NCT04786275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65191813|NCT04786275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65191814|NCT04786275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65191815|NCT04786275|Anesthetics, General|anesthetics, general|mesh-ancestor
65191816|NCT04786275|Anesthetics|anesthetics|mesh-ancestor
65191817|NCT00844753|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65191818|NCT00844753|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65191819|NCT00844753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65191820|NCT00844753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65191821|NCT00844753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191822|NCT00844753|Adrenergic Agents|adrenergic agents|mesh-ancestor
65191823|NCT00844753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65191824|NCT00844753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191825|NCT05525611|Cabergoline|cabergoline|mesh-list
65191826|NCT05525611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65191827|NCT05525611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65191828|NCT05525611|Dopamine Agonists|dopamine agonists|mesh-ancestor
65191829|NCT05525611|Dopamine Agents|dopamine agents|mesh-ancestor
65191830|NCT05525611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65191831|NCT05525611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191832|NCT05525611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834430|NCT05704894|Epoetin Alfa|epoetin alfa|mesh-list
65191833|NCT00917553|Doxycycline|doxycycline|mesh-list
65191834|NCT00917553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65327686|NCT00710619|Coagulants|coagulants|mesh-ancestor
65327687|NCT05192460|Vaccines|vaccines|mesh-list
65327688|NCT05192460|Immunologic Factors|immunologic factors|mesh-ancestor
65327689|NCT05192460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327690|NCT00719433|Armin|armin|mesh-list
65327691|NCT00719433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65327692|NCT00719433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64672898|NCT00357461|Ipilimumab|ipilimumab|mesh-list
65191835|NCT00917553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65191836|NCT00917553|Antimalarials|antimalarials|mesh-ancestor
65191837|NCT00917553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65191838|NCT00917553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65191839|NCT04255251|Fluorides|fluorides|mesh-list
65191840|NCT04255251|Fluorides, Topical|fluorides, topical|mesh-list
65191841|NCT04255251|Cariostatic Agents|cariostatic agents|mesh-ancestor
65191842|NCT04255251|Protective Agents|protective agents|mesh-ancestor
65191843|NCT04255251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191844|NCT01018680|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65191845|NCT01018680|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65191846|NCT01018680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65191847|NCT01018680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65191848|NCT01018680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191849|NCT01018680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65191850|NCT01018680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191851|NCT01018680|Analgesics|analgesics|mesh-ancestor
65191852|NCT01018680|Sensory System Agents|sensory system agents|mesh-ancestor
65191853|NCT01018680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65191854|NCT01018680|Antidepressive Agents|antidepressive agents|mesh-ancestor
65191855|NCT01018680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65191856|NCT01018680|Dopamine Agents|dopamine agents|mesh-ancestor
65191857|NCT04255017|Ritonavir|ritonavir|mesh-list
65191858|NCT04255017|Lopinavir|lopinavir|mesh-list
65191859|NCT04255017|Oseltamivir|oseltamivir|mesh-list
65191860|NCT04255017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65191861|NCT04255017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65191862|NCT04255017|Protease Inhibitors|protease inhibitors|mesh-ancestor
65191863|NCT04255017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191864|NCT04255017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191865|NCT04255017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65191866|NCT04255017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65191867|NCT04255017|Antiviral Agents|antiviral agents|mesh-ancestor
65191868|NCT04255017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65191869|NCT04255017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65191870|NCT04255017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65191871|NCT04592991|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
65191872|NCT04592991|Chelating Agents|chelating agents|mesh-ancestor
65191873|NCT04592991|Sequestering Agents|sequestering agents|mesh-ancestor
65191874|NCT04592991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191875|NCT01017120|Tazarotene|tazarotene|mesh-list
65191876|NCT01017120|Dermatologic Agents|dermatologic agents|mesh-ancestor
65191882|NCT02872038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65191883|NCT00627900|Sirolimus|sirolimus|mesh-list
65191884|NCT00627900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65191885|NCT00627900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65191886|NCT00627900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65191887|NCT00627900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191888|NCT00627900|Antifungal Agents|antifungal agents|mesh-ancestor
65191889|NCT00627900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65191890|NCT00627900|Immunologic Factors|immunologic factors|mesh-ancestor
65191891|NCT00627900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191892|NCT02996110|Nivolumab|nivolumab|mesh-list
65191893|NCT02996110|Ipilimumab|ipilimumab|mesh-list
65191894|NCT02996110|Linrodostat|linrodostat|mesh-list
65191895|NCT02996110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65191896|NCT02996110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191897|NCT02996110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65191898|NCT02996110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191899|NCT02996110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191900|NCT01103063|Azithromycin|azithromycin|mesh-list
65191901|NCT01103063|Chloroquine|chloroquine|mesh-list
65327693|NCT00719433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327694|NCT00719433|Cholinergic Agents|cholinergic agents|mesh-ancestor
65327695|NCT00719433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65327696|NCT00719433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327697|NCT04978272|Piperaquine|piperaquine|mesh-list
65327698|NCT04978272|Artenimol|artenimol|mesh-list
65191902|NCT01103063|Pyrimethamine|pyrimethamine|mesh-list
65191903|NCT01103063|Sulfadoxine|sulfadoxine|mesh-list
65191904|NCT01103063|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65191905|NCT01103063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65191906|NCT01103063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65191907|NCT01103063|Amebicides|amebicides|mesh-ancestor
65191908|NCT01103063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65191909|NCT01103063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65191910|NCT01103063|Antimalarials|antimalarials|mesh-ancestor
65191911|NCT01103063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65191912|NCT01103063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65191913|NCT01103063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191914|NCT01103063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191915|NCT01103063|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65191916|NCT01103063|Renal Agents|renal agents|mesh-ancestor
65191917|NCT02987998|Pembrolizumab|pembrolizumab|mesh-list
65191918|NCT02987998|Etoposide|etoposide|mesh-list
65191919|NCT02987998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191920|NCT02987998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65191921|NCT02987998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65191922|NCT02987998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65191923|NCT02987998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65191924|NCT02987998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191925|NCT02987998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191926|NCT04213378|Paclitaxel|paclitaxel|mesh-list
65191927|NCT04213378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65191928|NCT04213378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64949126|NCT00018902|Fluoxetine|fluoxetine|mesh-list
65191930|NCT04213378|Tubulin Modulators|tubulin modulators|mesh-ancestor
65191931|NCT04213378|Antimitotic Agents|antimitotic agents|mesh-ancestor
65191932|NCT04213378|Mitosis Modulators|mitosis modulators|mesh-ancestor
65191933|NCT04213378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191934|NCT04213924|Ibuprofen|ibuprofen|mesh-list
65191935|NCT04213924|Lidocaine|lidocaine|mesh-list
65191936|NCT04213924|Bupivacaine|bupivacaine|mesh-list
65191937|NCT04213924|Anesthetics, Local|anesthetics, local|mesh-ancestor
65191938|NCT04213924|Anesthetics|anesthetics|mesh-ancestor
65191939|NCT04213924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65191940|NCT04213924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191941|NCT04213924|Sensory System Agents|sensory system agents|mesh-ancestor
65191942|NCT04213924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65191943|NCT04213924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65191944|NCT04213924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65191945|NCT04213924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65191946|NCT04213924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65191947|NCT04213924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191948|NCT04213924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65191964|NCT01091675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65191965|NCT01091675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65191966|NCT01091675|Analgesics|analgesics|mesh-ancestor
65191967|NCT01091675|Sensory System Agents|sensory system agents|mesh-ancestor
65191968|NCT01091675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65191969|NCT01091675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191970|NCT01091675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65191971|NCT01091675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65191972|NCT01091675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65191973|NCT01091675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65191974|NCT01091675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191975|NCT01091675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191976|NCT02739412|Aldesleukin|aldesleukin|mesh-list
65191977|NCT02739412|Interleukin-2|interleukin-2|mesh-list
65191978|NCT02739412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327699|NCT04978272|Antimalarials|antimalarials|mesh-ancestor
65327700|NCT04978272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65327701|NCT04978272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65327702|NCT04978272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65327703|NCT04973124|Dexmedetomidine|dexmedetomidine|mesh-list
65327704|NCT04973124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65327705|NCT04973124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65191979|NCT02739412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65191980|NCT02739412|Analgesics|analgesics|mesh-ancestor
65191981|NCT02739412|Sensory System Agents|sensory system agents|mesh-ancestor
65191982|NCT02739412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65191983|NCT02739412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834584|NCT05504486|Brexpiprazole|brexpiprazole|mesh-list
65191985|NCT02739412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65191986|NCT02739412|Antiviral Agents|antiviral agents|mesh-ancestor
65191987|NCT02739412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65191988|NCT04213612|Cyclophosphamide|cyclophosphamide|mesh-list
65191989|NCT04213612|Doxorubicin|doxorubicin|mesh-list
65191990|NCT04213612|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65191991|NCT04213612|Vincristine|vincristine|mesh-list
65191992|NCT04213612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65191993|NCT04213612|Immunologic Factors|immunologic factors|mesh-ancestor
65191994|NCT04213612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191995|NCT04213612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65191996|NCT04213612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65191997|NCT04213612|Alkylating Agents|alkylating agents|mesh-ancestor
65191998|NCT04213612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191999|NCT04213612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192000|NCT04213612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65192001|NCT04213612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65192002|NCT04213612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65192003|NCT04213612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65192004|NCT04213612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192005|NCT04213612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65192006|NCT04213612|Tubulin Modulators|tubulin modulators|mesh-ancestor
65192007|NCT04213612|Antimitotic Agents|antimitotic agents|mesh-ancestor
65192008|NCT04213612|Mitosis Modulators|mitosis modulators|mesh-ancestor
65192009|NCT01091519|Fesoterodine|fesoterodine|mesh-list
65192010|NCT01091519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65192011|NCT01091519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65192014|NCT01091519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192015|NCT01091519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192016|NCT01091519|Urological Agents|urological agents|mesh-ancestor
65192017|NCT02703220|Acetazolamide|acetazolamide|mesh-list
65192018|NCT02703220|Finasteride|finasteride|mesh-list
65192019|NCT02703220|Anticonvulsants|anticonvulsants|mesh-ancestor
65192020|NCT02703220|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65192021|NCT02703220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192022|NCT02703220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192023|NCT02703220|Diuretics|diuretics|mesh-ancestor
65192024|NCT02703220|Natriuretic Agents|natriuretic agents|mesh-ancestor
65192025|NCT02703220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192026|NCT02703220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65192027|NCT02703220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65192028|NCT02703220|Hormone Antagonists|hormone antagonists|mesh-ancestor
65192029|NCT02703220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65192030|NCT02703220|Urological Agents|urological agents|mesh-ancestor
65192031|NCT02878031|Amoxicillin|amoxicillin|mesh-list
65192032|NCT02878031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65192033|NCT02878031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65192034|NCT02879669|Cyclophosphamide|cyclophosphamide|mesh-list
65192035|NCT02879669|Carboplatin|carboplatin|mesh-list
65192036|NCT02879669|Pemetrexed|pemetrexed|mesh-list
65192037|NCT02879669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65192038|NCT02879669|Immunologic Factors|immunologic factors|mesh-ancestor
65192039|NCT02879669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192040|NCT02879669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65192041|NCT02879669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65192042|NCT02879669|Alkylating Agents|alkylating agents|mesh-ancestor
65327706|NCT04973124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327707|NCT04973124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65327708|NCT04973124|Analgesics|analgesics|mesh-ancestor
65327709|NCT04973124|Sensory System Agents|sensory system agents|mesh-ancestor
65327710|NCT04973124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65327711|NCT04973124|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65327712|NCT04973124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65327713|NCT04973124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65327714|NCT04973124|Adrenergic Agents|adrenergic agents|mesh-ancestor
65327715|NCT04973124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65327716|NCT04973124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327717|NCT04971720|Valsartan|valsartan|mesh-list
64557148|NCT04140461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64557149|NCT04140461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65192043|NCT02879669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192044|NCT02879669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192045|NCT02879669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65192046|NCT02879669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192047|NCT02879669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65192048|NCT02879669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65192049|NCT00516724|Paclitaxel|paclitaxel|mesh-list
65192050|NCT00516724|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65192051|NCT00516724|Carboplatin|carboplatin|mesh-list
65192052|NCT00516724|Olaparib|olaparib|mesh-list
65192053|NCT00516724|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65192054|NCT00516724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65192055|NCT00516724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192056|NCT00516724|Tubulin Modulators|tubulin modulators|mesh-ancestor
65192057|NCT00516724|Antimitotic Agents|antimitotic agents|mesh-ancestor
65192058|NCT00516724|Mitosis Modulators|mitosis modulators|mesh-ancestor
65192059|NCT00516724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192060|NCT00516724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192061|NCT04875533|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65192062|NCT04875533|Immunologic Factors|immunologic factors|mesh-ancestor
65192063|NCT04875533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192064|NCT00918333|Everolimus|everolimus|mesh-list
65192065|NCT00918333|Panobinostat|panobinostat|mesh-list
65192066|NCT00918333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65192067|NCT00918333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192068|NCT00918333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65192069|NCT00918333|Immunologic Factors|immunologic factors|mesh-ancestor
65192070|NCT00918333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192071|NCT00918333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192072|NCT00918333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192073|NCT01090973|Panobinostat|panobinostat|mesh-list
65192074|NCT01090973|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65192075|NCT01090973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192076|NCT01090973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192077|NCT01090973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192078|NCT02607904|Cannabidiol|cannabidiol|mesh-list
65192079|NCT02607904|Anticonvulsants|anticonvulsants|mesh-ancestor
65192080|NCT05295394|Lamivudine|lamivudine|mesh-list
65192081|NCT05295394|Dolutegravir|dolutegravir|mesh-list
65192082|NCT05295394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65192083|NCT05295394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65192084|NCT05295394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192088|NCT05295394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65192089|NCT05295394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65192090|NCT05295394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65192091|NCT05295394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65327718|NCT04971720|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65327719|NCT04971720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65327720|NCT04971720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65327721|NCT04971720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65327722|NCT04971720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327723|NCT00711165|Mometasone Furoate|mometasone furoate|mesh-list
65327724|NCT00711165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65327725|NCT00711165|Dermatologic Agents|dermatologic agents|mesh-ancestor
65327726|NCT00711165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65327727|NCT00719745|Tacrolimus|tacrolimus|mesh-list
65327728|NCT00719745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65327729|NCT00719745|Immunologic Factors|immunologic factors|mesh-ancestor
65327730|NCT00719745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327731|NCT00719745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65327732|NCT00719745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327733|NCT00719745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327734|NCT02587416|Atorvastatin|atorvastatin|mesh-list
65327735|NCT02587416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65327736|NCT02587416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65327737|NCT02587416|Antimetabolites|antimetabolites|mesh-ancestor
65327738|NCT02587416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327739|NCT02587416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65327740|NCT02587416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65327741|NCT02587416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327742|NCT00719823|Maraviroc|maraviroc|mesh-list
65327743|NCT00719823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65327744|NCT00719823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65327745|NCT00719823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327746|NCT00719823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65327747|NCT00719823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65327748|NCT00719823|Antiviral Agents|antiviral agents|mesh-ancestor
65327749|NCT00719823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65327750|NCT00719823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65327751|NCT00919776|Cyclosporine|cyclosporine|mesh-list
65327752|NCT00919776|Prednisolone|prednisolone|mesh-list
65327753|NCT00919776|Cyclosporins|cyclosporins|mesh-list
65192092|NCT02871648|Fludrocortisone|fludrocortisone|mesh-list
65327754|NCT00919776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327755|NCT00919776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327756|NCT00919776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65327757|NCT00919776|Immunologic Factors|immunologic factors|mesh-ancestor
65327758|NCT00919776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327759|NCT00919776|Antifungal Agents|antifungal agents|mesh-ancestor
65327760|NCT00919776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65327761|NCT00919776|Dermatologic Agents|dermatologic agents|mesh-ancestor
65327762|NCT00919776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65327763|NCT00919776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65327764|NCT00919776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65327765|NCT00919776|Glucocorticoids|glucocorticoids|mesh-ancestor
65327766|NCT00919776|Hormones|hormones|mesh-ancestor
65327767|NCT00919776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65327768|NCT00919776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65327769|NCT00919776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327770|NCT00720135|Rituximab|rituximab|mesh-list
65327771|NCT00720135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65327772|NCT00720135|Interleukin-2|interleukin-2|mesh-list
65327773|NCT00720135|Antibodies|antibodies|mesh-list
65327774|NCT00720135|Immunoglobulins|immunoglobulins|mesh-list
65327775|NCT00720135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65327776|NCT00720135|Immunologic Factors|immunologic factors|mesh-ancestor
65192093|NCT02871648|Eplerenone|eplerenone|mesh-list
65192094|NCT02871648|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65192095|NCT02871648|Hormone Antagonists|hormone antagonists|mesh-ancestor
65192096|NCT02871648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65192097|NCT02871648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192098|NCT02871648|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65192099|NCT02871648|Diuretics|diuretics|mesh-ancestor
65192100|NCT02871648|Natriuretic Agents|natriuretic agents|mesh-ancestor
65192101|NCT02871648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65192102|NCT02871648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65192103|NCT00637845|Esomeprazole|esomeprazole|mesh-list
65192104|NCT00637845|Lansoprazole|lansoprazole|mesh-list
65192105|NCT00637845|Dexlansoprazole|dexlansoprazole|mesh-list
65192106|NCT00637845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65192107|NCT00637845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65192108|NCT00637845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65192109|NCT00637845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192110|NCT00637845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192111|NCT04738695|Antibodies|antibodies|mesh-list
65192112|NCT04738695|Immunologic Factors|immunologic factors|mesh-ancestor
65192113|NCT04738695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192114|NCT02497300|Amiloride|amiloride|mesh-list
65192115|NCT02497300|Spironolactone|spironolactone|mesh-list
65192116|NCT02497300|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65192117|NCT02497300|Hormone Antagonists|hormone antagonists|mesh-ancestor
65192118|NCT02497300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65192119|NCT02497300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192120|NCT02497300|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65192121|NCT02497300|Diuretics|diuretics|mesh-ancestor
65327777|NCT00720135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327778|NCT00720135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327779|NCT00720135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65327780|NCT00720135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65327781|NCT00720135|Analgesics|analgesics|mesh-ancestor
65327782|NCT00720135|Sensory System Agents|sensory system agents|mesh-ancestor
65327783|NCT00720135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65327784|NCT02588118|Propofol|propofol|mesh-list
65327785|NCT02588118|Cisatracurium|cisatracurium|mesh-list
65327786|NCT02588118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65327787|NCT02588118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65327788|NCT02588118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327789|NCT02588118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65327790|NCT02588118|Anesthetics, General|anesthetics, general|mesh-ancestor
65327791|NCT02588118|Anesthetics|anesthetics|mesh-ancestor
65327792|NCT02588118|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65192122|NCT02497300|Natriuretic Agents|natriuretic agents|mesh-ancestor
65192123|NCT02497300|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65192124|NCT02497300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65192125|NCT02497300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65192126|NCT02497300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192127|NCT02497300|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65192128|NCT04254471|Carboplatin|carboplatin|mesh-list
65192129|NCT04254471|Etoposide|etoposide|mesh-list
65192130|NCT04254471|Rabeprazole|rabeprazole|mesh-list
65192131|NCT04254471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192132|NCT04254471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65192133|NCT04254471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65192134|NCT04254471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65192135|NCT04254471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192136|NCT04254471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192137|NCT04254471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65192138|NCT04254471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65192139|NCT04254471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65192141|NCT00631527|Leuprolide|leuprolide|mesh-list
65192142|NCT00631527|Goserelin|goserelin|mesh-list
65192143|NCT00631527|Bicalutamide|bicalutamide|mesh-list
65192144|NCT00631527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192145|NCT00631527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65192146|NCT00631527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65192147|NCT00631527|Growth Substances|growth substances|mesh-ancestor
65192148|NCT00631527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192149|NCT00631527|Growth Inhibitors|growth inhibitors|mesh-ancestor
65192150|NCT00631527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65192151|NCT00631527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192152|NCT00631527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192153|NCT00631527|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65192154|NCT00631527|Fertility Agents|fertility agents|mesh-ancestor
65192155|NCT00631527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65192156|NCT00631527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65192161|NCT00620620|Anticonvulsants|anticonvulsants|mesh-ancestor
65192162|NCT00620620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65192163|NCT00620620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65192164|NCT00620620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192165|NCT00620620|GABA Modulators|gaba modulators|mesh-ancestor
65192166|NCT00620620|GABA Agents|gaba agents|mesh-ancestor
65192167|NCT00620620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65192168|NCT00620620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327793|NCT02588118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65327794|NCT02588118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65327795|NCT00716391|Cisplatin|cisplatin|mesh-list
65327796|NCT00716391|Cetuximab|cetuximab|mesh-list
65327797|NCT00716391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327798|NCT00716391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65327799|NCT00716469|Talaporfin|talaporfin|mesh-list
65327800|NCT00716469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327801|NCT00716469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65327802|NCT00716469|Dermatologic Agents|dermatologic agents|mesh-ancestor
65327803|NCT04082598|Amoxicillin|amoxicillin|mesh-list
65327804|NCT04082598|Clavulanic Acid|clavulanic acid|mesh-list
65327805|NCT04082598|Clavulanic Acids|clavulanic acids|mesh-list
65327806|NCT04082598|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65327807|NCT04082598|Lactoferrin|lactoferrin|mesh-list
65327808|NCT04082598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65327809|NCT04082598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65327810|NCT04082598|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65327811|NCT04082598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327812|NCT04082598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327813|NCT03895203|Adalimumab|adalimumab|mesh-list
65327814|NCT03895203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65327815|NCT03895203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65327816|NCT04958226|Midazolam|midazolam|mesh-list
65327817|NCT04958226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65192170|NCT00916383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65192171|NCT00916383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192172|NCT00916383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192173|NCT00916383|Cholinergic Agents|cholinergic agents|mesh-ancestor
65192174|NCT00916383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65192175|NCT00916383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192176|NCT00916383|Nootropic Agents|nootropic agents|mesh-ancestor
65192177|NCT00617500|Hormones|hormones|mesh-list
65192178|NCT00617500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65192179|NCT00617500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192180|NCT04254081|Lidocaine|lidocaine|mesh-list
65192181|NCT04254081|Buprenorphine|buprenorphine|mesh-list
65192182|NCT04254081|Anesthetics, Local|anesthetics, local|mesh-ancestor
65192183|NCT04254081|Anesthetics|anesthetics|mesh-ancestor
65192184|NCT04254081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65192185|NCT04254081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192186|NCT04254081|Sensory System Agents|sensory system agents|mesh-ancestor
65192187|NCT04254081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192188|NCT04254081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65192189|NCT04254081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65192190|NCT04254081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65192191|NCT04254081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65192192|NCT04254081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192193|NCT04254081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65192194|NCT04254081|Narcotics|narcotics|mesh-ancestor
65192195|NCT04254081|Analgesics|analgesics|mesh-ancestor
65327818|NCT04958226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65327819|NCT04958226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65327820|NCT04958226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327821|NCT04958226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65327822|NCT04958226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65327823|NCT04958226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65327824|NCT04958226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65327825|NCT04958226|Anesthetics, General|anesthetics, general|mesh-ancestor
65327826|NCT04958226|Anesthetics|anesthetics|mesh-ancestor
65327827|NCT04958226|GABA Modulators|gaba modulators|mesh-ancestor
65327828|NCT04958226|GABA Agents|gaba agents|mesh-ancestor
65327829|NCT04958226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65327830|NCT04958226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327831|NCT00716547|Celecoxib|celecoxib|mesh-list
65327832|NCT00716547|Ketoprofen|ketoprofen|mesh-list
65327833|NCT00716547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65327834|NCT00716547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65327835|NCT00716547|Analgesics|analgesics|mesh-ancestor
65327836|NCT00716547|Sensory System Agents|sensory system agents|mesh-ancestor
65327837|NCT00716547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65327838|NCT00716547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327839|NCT00716547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65327840|NCT00716547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65327841|NCT00716547|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65327842|NCT00716547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65327843|NCT00716547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066809|NCT00272636|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65327844|NCT00716547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327845|NCT02573025|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65327846|NCT02573025|Interferon-alpha|interferon-alpha|mesh-list
65327847|NCT02573025|Interferon alpha-2|interferon alpha-2|mesh-list
65327848|NCT02573025|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65327849|NCT02573025|Antiviral Agents|antiviral agents|mesh-ancestor
65327850|NCT02573025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65327851|NCT02573025|Immunologic Factors|immunologic factors|mesh-ancestor
65327852|NCT02573025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327853|NCT02573025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327854|NCT00720291|Metronidazole|metronidazole|mesh-list
65327855|NCT00720291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65327856|NCT00720291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65327857|NCT00720291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65327858|NCT00720291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65327859|NCT00578643|Cyclosporine|cyclosporine|mesh-list
65327860|NCT00578643|Cyclophosphamide|cyclophosphamide|mesh-list
65327861|NCT00578643|Busulfan|busulfan|mesh-list
65327862|NCT00578643|Fludarabine|fludarabine|mesh-list
65327863|NCT00578643|Alemtuzumab|alemtuzumab|mesh-list
65327864|NCT00578643|Cyclosporins|cyclosporins|mesh-list
65327865|NCT00578643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65327866|NCT00578643|Immunologic Factors|immunologic factors|mesh-ancestor
65327867|NCT00578643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327868|NCT00578643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65327869|NCT00578643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65327870|NCT00578643|Alkylating Agents|alkylating agents|mesh-ancestor
65327871|NCT00578643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327872|NCT00578643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327873|NCT00578643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65327874|NCT00578643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327875|NCT00578643|Antifungal Agents|antifungal agents|mesh-ancestor
65327876|NCT00578643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65327877|NCT00578643|Dermatologic Agents|dermatologic agents|mesh-ancestor
65327878|NCT00578643|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65327879|NCT00578643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65327880|NCT04082286|Antibodies|antibodies|mesh-list
65327881|NCT04082286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65327882|NCT04082286|Immunologic Factors|immunologic factors|mesh-ancestor
65327883|NCT04082286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327884|NCT00720447|Cytarabine|cytarabine|mesh-list
65192196|NCT04254081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65192197|NCT04209478|Morphine|morphine|mesh-list
65192198|NCT04209478|Tramadol|tramadol|mesh-list
65192199|NCT04209478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65192200|NCT04209478|Narcotics|narcotics|mesh-ancestor
65192201|NCT04209478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65192202|NCT04209478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192203|NCT04209478|Analgesics|analgesics|mesh-ancestor
65192204|NCT04209478|Sensory System Agents|sensory system agents|mesh-ancestor
65192205|NCT04209478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192206|NCT05252715|Vaccines|vaccines|mesh-list
65192207|NCT05252715|Immunologic Factors|immunologic factors|mesh-ancestor
65192208|NCT05252715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192209|NCT04209166|Norepinephrine|norepinephrine|mesh-list
65192210|NCT04209166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65192211|NCT04209166|Serotonin|serotonin|mesh-list
65192212|NCT04209166|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65192213|NCT04209166|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
65327885|NCT00720447|Etoposide|etoposide|mesh-list
65327886|NCT00720447|Melphalan|melphalan|mesh-list
65327887|NCT00720447|Alemtuzumab|alemtuzumab|mesh-list
65327888|NCT00720447|Carmustine|carmustine|mesh-list
65327889|NCT00720447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65327890|NCT00720447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327891|NCT00720447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65327892|NCT00720447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65327893|NCT00720447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327894|NCT00720447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327895|NCT00720447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65327896|NCT00720447|Antimetabolites|antimetabolites|mesh-ancestor
65192214|NCT04209166|Antidepressive Agents|antidepressive agents|mesh-ancestor
65192215|NCT04209166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65192216|NCT04209166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65192217|NCT04209166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65192218|NCT04209166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65192219|NCT04209166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192220|NCT04209166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65192221|NCT04209166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65192222|NCT04209166|Adrenergic Agents|adrenergic agents|mesh-ancestor
65192223|NCT04209166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65192224|NCT04209166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192225|NCT04209166|Sympathomimetics|sympathomimetics|mesh-ancestor
65192226|NCT04209166|Autonomic Agents|autonomic agents|mesh-ancestor
65192227|NCT04209166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192228|NCT04209166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65192234|NCT04766008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65192235|NCT04766008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192236|NCT00916149|Lamotrigine|lamotrigine|mesh-list
65192237|NCT00916149|Levetiracetam|levetiracetam|mesh-list
65192238|NCT00916149|Anticonvulsants|anticonvulsants|mesh-ancestor
65192239|NCT00916149|Nootropic Agents|nootropic agents|mesh-ancestor
65192240|NCT00916149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65192241|NCT00916149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65192242|NCT00916149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192243|NCT00916149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65192244|NCT00916149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192245|NCT00916149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65192246|NCT00916149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65192247|NCT00916149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65192248|NCT00916149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65192249|NCT00916149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65192250|NCT00617656|Gemcitabine|gemcitabine|mesh-list
65192251|NCT00617656|Cisplatin|cisplatin|mesh-list
65192252|NCT00617656|Docetaxel|docetaxel|mesh-list
65192253|NCT00617656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192254|NCT00617656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65192255|NCT00617656|Antimetabolites|antimetabolites|mesh-ancestor
65192256|NCT00617656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192257|NCT00617656|Antiviral Agents|antiviral agents|mesh-ancestor
65192258|NCT00617656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65192259|NCT00617656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192260|NCT00617656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65192261|NCT00617656|Immunologic Factors|immunologic factors|mesh-ancestor
65192262|NCT00617656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192263|NCT00617656|Tubulin Modulators|tubulin modulators|mesh-ancestor
65192264|NCT00617656|Antimitotic Agents|antimitotic agents|mesh-ancestor
65192265|NCT00617656|Mitosis Modulators|mitosis modulators|mesh-ancestor
65192266|NCT00175162|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
65192267|NCT00175162|Vasodilator Agents|vasodilator agents|mesh-ancestor
65192268|NCT00175162|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65192269|NCT00175162|Protective Agents|protective agents|mesh-ancestor
65192270|NCT00175162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327897|NCT00720447|Antiviral Agents|antiviral agents|mesh-ancestor
65327898|NCT00720447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65327899|NCT00720447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65327900|NCT00720447|Immunologic Factors|immunologic factors|mesh-ancestor
65327901|NCT00720447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327902|NCT00720447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65327903|NCT00720447|Alkylating Agents|alkylating agents|mesh-ancestor
65327904|NCT00720447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65327905|NCT00720447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65327906|NCT04828824|Moxifloxacin|moxifloxacin|mesh-list
64557332|NCT03834363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65192271|NCT04648540|Acetaminophen|acetaminophen|mesh-list
65192272|NCT04648540|Celecoxib|celecoxib|mesh-list
65192273|NCT04648540|Ketorolac|ketorolac|mesh-list
65192274|NCT04648540|Lidocaine|lidocaine|mesh-list
65192275|NCT04648540|Pregabalin|pregabalin|mesh-list
65192276|NCT04648540|Fentanyl|fentanyl|mesh-list
65192277|NCT04648540|Dexmedetomidine|dexmedetomidine|mesh-list
65192278|NCT04648540|Morphine|morphine|mesh-list
65192279|NCT04648540|Anesthetics, Local|anesthetics, local|mesh-ancestor
65192280|NCT04648540|Anesthetics|anesthetics|mesh-ancestor
65192281|NCT04648540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65192282|NCT04648540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192283|NCT04648540|Sensory System Agents|sensory system agents|mesh-ancestor
65192284|NCT04648540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192285|NCT04648540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65192286|NCT04648540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65192287|NCT04648540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65192288|NCT04648540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65192289|NCT04648540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192290|NCT04648540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65192291|NCT04648540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65192292|NCT04648540|Analgesics|analgesics|mesh-ancestor
65192293|NCT04648540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65192294|NCT04648540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65192295|NCT04648540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65192296|NCT04648540|Adrenergic Agents|adrenergic agents|mesh-ancestor
65192297|NCT04648540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65192298|NCT04648540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65192299|NCT04648540|Narcotics|narcotics|mesh-ancestor
65192300|NCT04648540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65192301|NCT04648540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65192302|NCT04648540|Anesthetics, General|anesthetics, general|mesh-ancestor
65192309|NCT04648540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65192310|NCT04648540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65192311|NCT04648540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65192312|NCT04648540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65192313|NCT04648540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65192314|NCT04648540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65192315|NCT04648540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192316|NCT04213222|Bevacizumab|bevacizumab|mesh-list
65192317|NCT04213222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65192318|NCT04213222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192319|NCT04213222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65192320|NCT04213222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65192321|NCT04213222|Growth Substances|growth substances|mesh-ancestor
65192322|NCT04213222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192323|NCT04213222|Growth Inhibitors|growth inhibitors|mesh-ancestor
65192324|NCT00621166|Ritonavir|ritonavir|mesh-list
65192325|NCT00621166|Lopinavir|lopinavir|mesh-list
65192326|NCT00621166|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65192327|NCT00621166|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65192328|NCT00621166|Protease Inhibitors|protease inhibitors|mesh-ancestor
65192329|NCT00621166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192330|NCT00621166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327907|NCT04828824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65327908|NCT04828824|Norgestimate|norgestimate|mesh-list
65327909|NCT04828824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65327910|NCT04828824|Estradiol|estradiol|mesh-list
65327911|NCT04828824|Estrogens|estrogens|mesh-ancestor
65327912|NCT04828824|Hormones|hormones|mesh-ancestor
65327913|NCT04828824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65192331|NCT00621166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65192332|NCT00621166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65192333|NCT00621166|Antiviral Agents|antiviral agents|mesh-ancestor
65192334|NCT00621166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65192335|NCT00621166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65192336|NCT00621166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65192337|NCT04555798|Meropenem|meropenem|mesh-list
65192338|NCT04555798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65192339|NCT04555798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65192340|NCT00617968|Docetaxel|docetaxel|mesh-list
65192341|NCT00617968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192342|NCT00617968|Tubulin Modulators|tubulin modulators|mesh-ancestor
65192343|NCT00617968|Antimitotic Agents|antimitotic agents|mesh-ancestor
65192344|NCT00617968|Mitosis Modulators|mitosis modulators|mesh-ancestor
65192345|NCT00617968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192346|NCT00621400|Dexamethasone|dexamethasone|mesh-list
65192347|NCT00621400|Lenalidomide|lenalidomide|mesh-list
65192348|NCT00621400|Melphalan|melphalan|mesh-list
65192349|NCT00621400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65192350|NCT00621400|Antiemetics|antiemetics|mesh-ancestor
65192351|NCT00621400|Autonomic Agents|autonomic agents|mesh-ancestor
65192352|NCT00621400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192353|NCT00621400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192354|NCT00621400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65192355|NCT00621400|Glucocorticoids|glucocorticoids|mesh-ancestor
65192356|NCT00621400|Hormones|hormones|mesh-ancestor
65192357|NCT00621400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65192358|NCT00621400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65192359|NCT00621400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192360|NCT00621400|Immunologic Factors|immunologic factors|mesh-ancestor
65192362|NCT00621400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65192363|NCT00621400|Growth Substances|growth substances|mesh-ancestor
65192364|NCT00621400|Growth Inhibitors|growth inhibitors|mesh-ancestor
65192365|NCT00621400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65192366|NCT00621400|Alkylating Agents|alkylating agents|mesh-ancestor
65192367|NCT00621400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192368|NCT00621400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65192369|NCT00621400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65192370|NCT04208854|Vinorelbine|vinorelbine|mesh-list
65192371|NCT04208854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65192372|NCT04208854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192373|NCT04208854|Tubulin Modulators|tubulin modulators|mesh-ancestor
65192374|NCT04208854|Antimitotic Agents|antimitotic agents|mesh-ancestor
65192375|NCT04208854|Mitosis Modulators|mitosis modulators|mesh-ancestor
65192382|NCT04208776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65192384|NCT04208776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65192385|NCT04208776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192386|NCT04208776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192387|NCT04208776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65192388|NCT04208776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65192389|NCT04208776|Vasodilator Agents|vasodilator agents|mesh-ancestor
65192390|NCT04208776|Sympathomimetics|sympathomimetics|mesh-ancestor
65192391|NCT04208776|Autonomic Agents|autonomic agents|mesh-ancestor
65192392|NCT04208776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192393|NCT04208776|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65192394|NCT04208776|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65192395|NCT04208776|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65192396|NCT04208776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65192397|NCT02879435|Bupivacaine|bupivacaine|mesh-list
65192398|NCT02879435|Anesthetics, Local|anesthetics, local|mesh-ancestor
65192399|NCT02879435|Anesthetics|anesthetics|mesh-ancestor
65192400|NCT02879435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65327914|NCT04828824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327915|NCT04828824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65327916|NCT04828824|Contraceptive Agents|contraceptive agents|mesh-ancestor
65327917|NCT04828824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65327918|NCT04828824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65327919|NCT04828824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65327920|NCT04828824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65327921|NCT04828824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65327922|NCT04828824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65327923|NCT04828824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65192401|NCT02879435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192402|NCT02879435|Sensory System Agents|sensory system agents|mesh-ancestor
65192403|NCT02879435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192404|NCT02879513|Paclitaxel|paclitaxel|mesh-list
65192405|NCT02879513|Cyclophosphamide|cyclophosphamide|mesh-list
65192406|NCT02879513|Epirubicin|epirubicin|mesh-list
65192407|NCT02879513|Fluorouracil|fluorouracil|mesh-list
65192408|NCT02879513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65192409|NCT02879513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192410|NCT02879513|Tubulin Modulators|tubulin modulators|mesh-ancestor
65192411|NCT02879513|Antimitotic Agents|antimitotic agents|mesh-ancestor
65192412|NCT02879513|Mitosis Modulators|mitosis modulators|mesh-ancestor
65192413|NCT02879513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192414|NCT02879513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65192415|NCT02879513|Immunologic Factors|immunologic factors|mesh-ancestor
65192416|NCT02879513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192417|NCT02879513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65192418|NCT02879513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65192419|NCT02879513|Alkylating Agents|alkylating agents|mesh-ancestor
65192420|NCT02879513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65192421|NCT02879513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65192422|NCT02879513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65192423|NCT02879513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65192424|NCT02879513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192425|NCT02879513|Antimetabolites|antimetabolites|mesh-ancestor
65192426|NCT02879513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65192427|NCT00621478|Diazepam|diazepam|mesh-list
65192428|NCT00621478|Lorazepam|lorazepam|mesh-list
65192429|NCT00621478|Anticonvulsants|anticonvulsants|mesh-ancestor
65192430|NCT00621478|Antiemetics|antiemetics|mesh-ancestor
65192431|NCT00621478|Autonomic Agents|autonomic agents|mesh-ancestor
65192432|NCT00621478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192433|NCT00621478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192434|NCT00621478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65192435|NCT00621478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65192436|NCT00621478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65192437|NCT00621478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65192438|NCT00621478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65192439|NCT00621478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65192440|NCT00621478|GABA Modulators|gaba modulators|mesh-ancestor
65192441|NCT00621478|GABA Agents|gaba agents|mesh-ancestor
65192442|NCT00621478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65192443|NCT00621478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192444|NCT00621478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65192445|NCT00621478|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65192446|NCT00621478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65192467|NCT04308551|Analgesics|analgesics|mesh-ancestor
65192468|NCT04308551|Sensory System Agents|sensory system agents|mesh-ancestor
65192469|NCT04308551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192470|NCT04308551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192471|NCT04308551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65192472|NCT04308551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65192473|NCT04308551|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65192474|NCT04308551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65327924|NCT04828824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65327925|NCT04828824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65327926|NCT04828824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327927|NCT04828824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327928|NCT04828824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327929|NCT04828824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65327930|NCT00578565|Rituximab|rituximab|mesh-list
64557359|NCT05702957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192475|NCT04308551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192476|NCT04308551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65192477|NCT04308551|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65192478|NCT04308551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192479|NCT04308551|Antipyretics|antipyretics|mesh-ancestor
65192480|NCT04306913|Cardioplegic Solutions|cardioplegic solutions|mesh-list
65192481|NCT04306913|Esmolol|esmolol|mesh-list
65192482|NCT04306913|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65192483|NCT04306913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65192484|NCT04306913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65192485|NCT04306913|Adrenergic Agents|adrenergic agents|mesh-ancestor
65192486|NCT04306913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65192487|NCT04306913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192488|NCT04306913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192489|NCT04306913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65192490|NCT02299414|Antihypertensive Agents|antihypertensive agents|mesh-list
65192491|NCT02299414|Nifedipine|nifedipine|mesh-list
65192492|NCT02299414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65192493|NCT02299414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65192494|NCT02299414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192495|NCT02299414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65192496|NCT02299414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192497|NCT02299414|Vasodilator Agents|vasodilator agents|mesh-ancestor
65192498|NCT02299414|Tocolytic Agents|tocolytic agents|mesh-ancestor
65192502|NCT01016262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65192503|NCT01016262|Analgesics|analgesics|mesh-ancestor
65192504|NCT01016262|Sensory System Agents|sensory system agents|mesh-ancestor
65192505|NCT01016262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192506|NCT01016262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192507|NCT01016262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65192508|NCT01016262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65192509|NCT00625937|Docetaxel|docetaxel|mesh-list
65192510|NCT00625937|Tegafur|tegafur|mesh-list
65192511|NCT00625937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192512|NCT00625937|Tubulin Modulators|tubulin modulators|mesh-ancestor
65192513|NCT00625937|Antimitotic Agents|antimitotic agents|mesh-ancestor
65192514|NCT00625937|Mitosis Modulators|mitosis modulators|mesh-ancestor
65192515|NCT00625937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192516|NCT00625937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65192517|NCT00625937|Antimetabolites|antimetabolites|mesh-ancestor
65192518|NCT01001910|Carboplatin|carboplatin|mesh-list
65192519|NCT01001910|Pemetrexed|pemetrexed|mesh-list
65192520|NCT01001910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192521|NCT01001910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192522|NCT01001910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192523|NCT01001910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65192524|NCT01001910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65192525|NCT04308317|Tetrandrine|tetrandrine|mesh-list
65192526|NCT04308317|Antimalarials|antimalarials|mesh-ancestor
65192527|NCT04308317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65192528|NCT04308317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65192529|NCT04308317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65192530|NCT04308317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65192531|NCT04308317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192532|NCT04308317|Antiviral Agents|antiviral agents|mesh-ancestor
65192533|NCT04308317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65192534|NCT04308317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65327931|NCT00578565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65327932|NCT00578565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327933|NCT00578565|Immunologic Factors|immunologic factors|mesh-ancestor
65327934|NCT00578565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327935|NCT00578565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65327936|NCT02572089|Naloxone|naloxone|mesh-list
65327937|NCT02572089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65327938|NCT02572089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327939|NCT02572089|Sensory System Agents|sensory system agents|mesh-ancestor
65327940|NCT02572089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65327941|NCT02588742|Melatonin|melatonin|mesh-list
65327942|NCT02588742|Antioxidants|antioxidants|mesh-ancestor
65327943|NCT02588742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327944|NCT02588742|Protective Agents|protective agents|mesh-ancestor
65327945|NCT02588742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327946|NCT02588742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65327947|NCT00720603|Plerixafor|plerixafor|mesh-list
65327948|NCT00720603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64557366|NCT05702957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65192535|NCT04308317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192536|NCT04308317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65192537|NCT04308317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192538|NCT04308317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65192539|NCT04308317|Immunologic Factors|immunologic factors|mesh-ancestor
65192540|NCT01009554|Listerine|listerine|mesh-list
65192541|NCT01009554|Fluorides|fluorides|mesh-list
65192542|NCT01009554|Sodium Fluoride|sodium fluoride|mesh-list
65192543|NCT01009554|Cariostatic Agents|cariostatic agents|mesh-ancestor
65192544|NCT01009554|Protective Agents|protective agents|mesh-ancestor
65192545|NCT01009554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192546|NCT01009554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65192547|NCT01009554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65192548|NCT04211896|Nivolumab|nivolumab|mesh-list
65192549|NCT04211896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65192550|NCT04211896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192551|NCT04211896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65192552|NCT04211896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192553|NCT04188184|Epinephrine|epinephrine|mesh-list
65192554|NCT04188184|Tranexamic Acid|tranexamic acid|mesh-list
65192555|NCT04188184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65192556|NCT04188184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65192557|NCT04188184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192558|NCT04188184|Hemostatics|hemostatics|mesh-ancestor
65192559|NCT04188184|Coagulants|coagulants|mesh-ancestor
65192560|NCT04188184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65192561|NCT04188184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65192562|NCT04188184|Adrenergic Agents|adrenergic agents|mesh-ancestor
65192563|NCT04188184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65192564|NCT04188184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192565|NCT04188184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65192566|NCT04188184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65192567|NCT04188184|Autonomic Agents|autonomic agents|mesh-ancestor
65192568|NCT04188184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192569|NCT04188184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65192570|NCT04188184|Respiratory System Agents|respiratory system agents|mesh-ancestor
65192576|NCT02296684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327949|NCT00720603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65327950|NCT00720603|Antiviral Agents|antiviral agents|mesh-ancestor
65327951|NCT00720603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65327952|NCT04936854|Sirolimus|sirolimus|mesh-list
65327953|NCT04936854|Methylprednisolone|methylprednisolone|mesh-list
65327954|NCT04936854|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65327955|NCT04936854|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65327956|NCT04936854|Prednisolone|prednisolone|mesh-list
65327957|NCT04936854|Prednisolone acetate|prednisolone acetate|mesh-list
65327958|NCT04936854|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65327959|NCT04936854|Prednisolone phosphate|prednisolone phosphate|mesh-list
65327960|NCT04936854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65327961|NCT04936854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65327962|NCT04936854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65327963|NCT04936854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327964|NCT04936854|Antifungal Agents|antifungal agents|mesh-ancestor
65327965|NCT04936854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65327966|NCT04936854|Immunologic Factors|immunologic factors|mesh-ancestor
65327967|NCT04936854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65327968|NCT04936854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65327969|NCT04936854|Antiemetics|antiemetics|mesh-ancestor
65327970|NCT04936854|Autonomic Agents|autonomic agents|mesh-ancestor
65327971|NCT04936854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65327972|NCT04936854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65327973|NCT04936854|Glucocorticoids|glucocorticoids|mesh-ancestor
65327974|NCT04936854|Hormones|hormones|mesh-ancestor
65192577|NCT02296684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65192578|NCT01006590|Metformin|metformin|mesh-list
65192579|NCT01006590|Saxagliptin|saxagliptin|mesh-list
65192580|NCT01006590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65192581|NCT01006590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192582|NCT01006590|Incretins|incretins|mesh-ancestor
65192583|NCT01006590|Hormones|hormones|mesh-ancestor
65192584|NCT01006590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64835190|NCT02650271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192585|NCT01006590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65192586|NCT01006590|Protease Inhibitors|protease inhibitors|mesh-ancestor
65192587|NCT01006590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192588|NCT01006590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192589|NCT04212832|Bupivacaine|bupivacaine|mesh-list
65192590|NCT04212832|Anesthetics, Local|anesthetics, local|mesh-ancestor
65192591|NCT04212832|Anesthetics|anesthetics|mesh-ancestor
65192592|NCT04212832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65192593|NCT04212832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192594|NCT04212832|Sensory System Agents|sensory system agents|mesh-ancestor
65192595|NCT04212832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192596|NCT00621790|Fenoldopam|fenoldopam|mesh-list
65192597|NCT00621790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65192598|NCT00621790|Vasodilator Agents|vasodilator agents|mesh-ancestor
65192599|NCT00621790|Dopamine Agonists|dopamine agonists|mesh-ancestor
65192600|NCT00621790|Dopamine Agents|dopamine agents|mesh-ancestor
65192601|NCT00621790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65327975|NCT04936854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65327976|NCT04936854|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65327977|NCT04936854|Protective Agents|protective agents|mesh-ancestor
65327978|NCT04936854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65327979|NCT00711789|Angiotensin II|angiotensin ii|mesh-list
65327980|NCT00711789|Giapreza|giapreza|mesh-list
65327981|NCT00711789|Angiotensinogen|angiotensinogen|mesh-list
65327982|NCT00711789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65327983|NCT00711789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65327984|NCT00711789|Protease Inhibitors|protease inhibitors|mesh-ancestor
65327985|NCT00711789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65327986|NCT00711789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327987|NCT00741260|Capecitabine|capecitabine|mesh-list
65327988|NCT00741260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65327989|NCT00741260|Antimetabolites|antimetabolites|mesh-ancestor
65327990|NCT00741260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65327991|NCT00741260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65327992|NCT02587260|Clopidogrel|clopidogrel|mesh-list
65327993|NCT02587260|Ticagrelor|ticagrelor|mesh-list
65327994|NCT02587260|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65327995|NCT02587260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65327996|NCT02587260|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65327997|NCT02587260|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65327998|NCT02587260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65327999|NCT02587260|Purinergic Agents|purinergic agents|mesh-ancestor
65328000|NCT02587260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64557392|NCT03461445|Tacrolimus|tacrolimus|mesh-list
65192602|NCT00621790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192603|NCT00621790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192604|NCT00618124|Capecitabine|capecitabine|mesh-list
65192605|NCT00618124|Sunitinib|sunitinib|mesh-list
65192606|NCT00618124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65192607|NCT00618124|Antimetabolites|antimetabolites|mesh-ancestor
65192608|NCT00618124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192609|NCT00618124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192610|NCT00618124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65192611|NCT00618124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65192612|NCT00618124|Growth Substances|growth substances|mesh-ancestor
65192613|NCT00618124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192614|NCT00618124|Growth Inhibitors|growth inhibitors|mesh-ancestor
65192615|NCT00618124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65192616|NCT00618124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192617|NCT05063656|Gabapentin|gabapentin|mesh-list
65192618|NCT05063656|Analgesics|analgesics|mesh-ancestor
65192619|NCT05063656|Sensory System Agents|sensory system agents|mesh-ancestor
65192620|NCT05063656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192621|NCT05063656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328001|NCT02587260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328002|NCT02587260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328003|NCT02596256|Docetaxel|docetaxel|mesh-list
65328004|NCT02596256|Apatinib|apatinib|mesh-list
65328005|NCT02596256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328006|NCT02596256|Tubulin Modulators|tubulin modulators|mesh-ancestor
65328007|NCT02596256|Antimitotic Agents|antimitotic agents|mesh-ancestor
65328008|NCT02596256|Mitosis Modulators|mitosis modulators|mesh-ancestor
65328009|NCT02596256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328010|NCT02596256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65328011|NCT02596256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328012|NCT04089722|Deoxycholic Acid|deoxycholic acid|mesh-list
65328013|NCT04089722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65328014|NCT04089722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65328015|NCT00717561|Amoxicillin|amoxicillin|mesh-list
65328016|NCT00717561|Azithromycin|azithromycin|mesh-list
65328017|NCT00717561|Moxifloxacin|moxifloxacin|mesh-list
65328018|NCT00717561|Clarithromycin|clarithromycin|mesh-list
65328019|NCT00717561|Ceftriaxone|ceftriaxone|mesh-list
65328020|NCT00717561|Clavulanic Acid|clavulanic acid|mesh-list
65328021|NCT00717561|Clavulanic Acids|clavulanic acids|mesh-list
65328022|NCT00717561|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65192622|NCT05063656|Anticonvulsants|anticonvulsants|mesh-ancestor
65192623|NCT05063656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65192624|NCT05063656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65192625|NCT05063656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65192626|NCT05063656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65192627|NCT05063656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65192628|NCT05063656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65192629|NCT05063656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65192630|NCT05063656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192631|NCT05063656|Antimanic Agents|antimanic agents|mesh-ancestor
65192632|NCT00621868|Ipragliflozin|ipragliflozin|mesh-list
65192633|NCT00621868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65192634|NCT00621868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192635|NCT00621868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65192636|NCT00621868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192637|NCT01882660|Decitabine|decitabine|mesh-list
65192638|NCT01882660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65192639|NCT01882660|Antimetabolites|antimetabolites|mesh-ancestor
65192640|NCT01882660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192644|NCT01001832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65192645|NCT01001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192646|NCT01001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192647|NCT01001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65192648|NCT01001832|Immunologic Factors|immunologic factors|mesh-ancestor
65192649|NCT01001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192650|NCT01001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65192651|NCT01001598|Danazol|danazol|mesh-list
65192652|NCT01001598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65192653|NCT01001598|Hormone Antagonists|hormone antagonists|mesh-ancestor
65192654|NCT01001598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65192655|NCT01001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328023|NCT00717561|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65328024|NCT00717561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65328025|NCT00717561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65328026|NCT00717561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65328027|NCT00717561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65328028|NCT00717561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328029|NCT00717561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328030|NCT00717561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328031|NCT00717561|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65328032|NCT00717561|Contraceptive Agents|contraceptive agents|mesh-ancestor
65328033|NCT00717561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65328034|NCT00717561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328035|NCT00717561|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65328036|NCT00717561|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65328037|NCT00717561|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65328038|NCT00717561|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65328039|NCT00717561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65328040|NCT00717561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65328041|NCT00717561|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65328042|NCT00720915|Anticoagulants|anticoagulants|mesh-list
65328043|NCT00720915|Fibrin fragment D|fibrin fragment d|mesh-list
65328044|NCT00720915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65328045|NCT00720915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65328046|NCT00720915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328047|NCT00720915|Hemostatics|hemostatics|mesh-ancestor
65328048|NCT00720915|Coagulants|coagulants|mesh-ancestor
65328049|NCT00712101|Abciximab|abciximab|mesh-list
65328050|NCT00712101|Anticoagulants|anticoagulants|mesh-ancestor
65192656|NCT01006356|Hydromorphone|hydromorphone|mesh-list
65192657|NCT01006356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65192658|NCT01006356|Narcotics|narcotics|mesh-ancestor
65192659|NCT01006356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65192660|NCT01006356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192661|NCT01006356|Analgesics|analgesics|mesh-ancestor
65192662|NCT01006356|Sensory System Agents|sensory system agents|mesh-ancestor
65192663|NCT01006356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192664|NCT01089725|Tanezumab|tanezumab|mesh-list
65192665|NCT01089725|Analgesics|analgesics|mesh-ancestor
65192666|NCT01089725|Sensory System Agents|sensory system agents|mesh-ancestor
65192667|NCT01089725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192668|NCT01089725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192669|NCT01190930|Calcium, Dietary|calcium, dietary|mesh-list
65192670|NCT01190930|Leucovorin|leucovorin|mesh-list
65192671|NCT01190930|Folic Acid|folic acid|mesh-list
65192672|NCT01190930|Cytarabine|cytarabine|mesh-list
65192673|NCT01190930|Dexamethasone|dexamethasone|mesh-list
65192674|NCT01190930|Dexamethasone acetate|dexamethasone acetate|mesh-list
65328051|NCT00712101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65328052|NCT00712257|Heparin|heparin|mesh-list
65328053|NCT00712257|Anticoagulants|anticoagulants|mesh-ancestor
65328054|NCT00712257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65328055|NCT00712257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65328056|NCT00712257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328057|NCT00740792|Fluticasone|fluticasone|mesh-list
65328058|NCT00740792|Xhance|xhance|mesh-list
65328059|NCT00740792|Azelastine|azelastine|mesh-list
65328060|NCT00740792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65328061|NCT00740792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65328062|NCT00740792|Autonomic Agents|autonomic agents|mesh-ancestor
65328063|NCT00740792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65328064|NCT00740792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328065|NCT00740792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65328066|NCT00740792|Respiratory System Agents|respiratory system agents|mesh-ancestor
65328067|NCT00740792|Dermatologic Agents|dermatologic agents|mesh-ancestor
65328068|NCT00740792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65328069|NCT00740792|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65328070|NCT00740792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328071|NCT00740792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328072|NCT00740792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65192675|NCT01190930|Cyclophosphamide|cyclophosphamide|mesh-list
65192676|NCT01190930|Doxorubicin|doxorubicin|mesh-list
65192677|NCT01190930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65192678|NCT01190930|Methotrexate|methotrexate|mesh-list
65192679|NCT01190930|Vincristine|vincristine|mesh-list
65192680|NCT01190930|Asparaginase|asparaginase|mesh-list
65192681|NCT01190930|Mercaptopurine|mercaptopurine|mesh-list
65192682|NCT01190930|Pegaspargase|pegaspargase|mesh-list
65192683|NCT01190930|Thioguanine|thioguanine|mesh-list
65192684|NCT01190930|BB 1101|bb 1101|mesh-list
65192685|NCT01190930|Calcium|calcium|mesh-list
65192686|NCT01190930|2-Aminopurine|2-aminopurine|mesh-list
65192687|NCT01190930|Levoleucovorin|levoleucovorin|mesh-list
65192688|NCT01190930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65192689|NCT01190930|Immunologic Factors|immunologic factors|mesh-ancestor
65192690|NCT01190930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192691|NCT01190930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65192692|NCT01190930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65192693|NCT01190930|Alkylating Agents|alkylating agents|mesh-ancestor
65192694|NCT01190930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192695|NCT01190930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192696|NCT01190930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65192697|NCT01190930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65192698|NCT01190930|Antiemetics|antiemetics|mesh-ancestor
65192699|NCT01190930|Autonomic Agents|autonomic agents|mesh-ancestor
65192700|NCT01190930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192701|NCT01190930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65192702|NCT01190930|Glucocorticoids|glucocorticoids|mesh-ancestor
65192703|NCT01190930|Hormones|hormones|mesh-ancestor
65192704|NCT01190930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65192705|NCT01190930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65192706|NCT01190930|Protease Inhibitors|protease inhibitors|mesh-ancestor
65192707|NCT01190930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328073|NCT00740792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65328074|NCT00740792|Histamine Antagonists|histamine antagonists|mesh-ancestor
65328075|NCT00740792|Histamine Agents|histamine agents|mesh-ancestor
65328076|NCT00740792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65328077|NCT00721305|Lovastatin|lovastatin|mesh-list
65328078|NCT00721305|L 647318|l 647318|mesh-list
65328079|NCT00721305|Dihydromevinolin|dihydromevinolin|mesh-list
65328080|NCT00721305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65328081|NCT00721305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65328082|NCT00721305|Antimetabolites|antimetabolites|mesh-ancestor
65328083|NCT00721305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328084|NCT00721305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65328085|NCT00721305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65328086|NCT00721305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328087|NCT00717951|Capecitabine|capecitabine|mesh-list
65328088|NCT00717951|Docetaxel|docetaxel|mesh-list
65328089|NCT00717951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328090|NCT00717951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65328091|NCT00717951|Antimetabolites|antimetabolites|mesh-ancestor
65328092|NCT00717951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328093|NCT00717951|Tubulin Modulators|tubulin modulators|mesh-ancestor
65328094|NCT00717951|Antimitotic Agents|antimitotic agents|mesh-ancestor
65328095|NCT00717951|Mitosis Modulators|mitosis modulators|mesh-ancestor
65328096|NCT02572947|Dolutegravir|dolutegravir|mesh-list
65328097|NCT02572947|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65328098|NCT02572947|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65328099|NCT02572947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328100|NCT02572947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328101|NCT02572947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65328102|NCT02572947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65328103|NCT02572947|Antiviral Agents|antiviral agents|mesh-ancestor
65328104|NCT02572947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65192708|NCT01190930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65192709|NCT01190930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65192710|NCT01190930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65192711|NCT01190930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65192712|NCT01190930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65192713|NCT01190930|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65192714|NCT01190930|Abortifacient Agents|abortifacient agents|mesh-ancestor
65192715|NCT01190930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65192721|NCT01190930|Antiviral Agents|antiviral agents|mesh-ancestor
65192722|NCT01190930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65192723|NCT01190930|Antidotes|antidotes|mesh-ancestor
65192724|NCT01190930|Protective Agents|protective agents|mesh-ancestor
65328105|NCT00712491|Sirolimus|sirolimus|mesh-list
65328106|NCT00712491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65328107|NCT00712491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65328108|NCT00712491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65328109|NCT00712491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328110|NCT00712491|Antifungal Agents|antifungal agents|mesh-ancestor
65328111|NCT00712491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65328112|NCT00712491|Immunologic Factors|immunologic factors|mesh-ancestor
65328113|NCT00712491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328114|NCT04083066|Cytarabine|cytarabine|mesh-list
65328115|NCT04083066|Dexamethasone|dexamethasone|mesh-list
65328116|NCT04083066|Rituximab|rituximab|mesh-list
65328117|NCT04083066|Methotrexate|methotrexate|mesh-list
64714302|NCT00374959|Ceftriaxone|ceftriaxone|mesh-list
65192725|NCT01190930|Vitamin B Complex|vitamin b complex|mesh-ancestor
65192726|NCT01190930|Vitamins|vitamins|mesh-ancestor
65192727|NCT01190930|Micronutrients|micronutrients|mesh-ancestor
65192728|NCT01190930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65192729|NCT01190930|Tubulin Modulators|tubulin modulators|mesh-ancestor
65192730|NCT01190930|Antimitotic Agents|antimitotic agents|mesh-ancestor
65192731|NCT01190930|Mitosis Modulators|mitosis modulators|mesh-ancestor
65192732|NCT01190930|Hematinics|hematinics|mesh-ancestor
65192733|NCT00619216|Mycophenolic Acid|mycophenolic acid|mesh-list
65192734|NCT00619216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65192735|NCT00619216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192736|NCT00619216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65192737|NCT00619216|Antitubercular Agents|antitubercular agents|mesh-ancestor
65192738|NCT00619216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65192739|NCT00619216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65192740|NCT00619216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192741|NCT00619216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192742|NCT00619372|Muromonab-CD3|muromonab-cd3|mesh-list
65192743|NCT00619372|Immunologic Factors|immunologic factors|mesh-ancestor
65192744|NCT00619372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192745|NCT00619372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65192746|NCT00618202|Balsalazide|balsalazide|mesh-list
65192747|NCT00618202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65192748|NCT00618202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65192749|NCT00618202|Analgesics|analgesics|mesh-ancestor
65192750|NCT00618202|Sensory System Agents|sensory system agents|mesh-ancestor
65192751|NCT00618202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192752|NCT00618202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192753|NCT00618202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65192754|NCT00618202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65192755|NCT00618202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65192756|NCT00626015|Temozolomide|temozolomide|mesh-list
65192757|NCT00626015|Daclizumab|daclizumab|mesh-list
65192758|NCT00626015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65192759|NCT00626015|Alkylating Agents|alkylating agents|mesh-ancestor
65192760|NCT00626015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192761|NCT00626015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192762|NCT00626015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65192763|NCT00626015|Immunologic Factors|immunologic factors|mesh-ancestor
65192764|NCT00626015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192765|NCT05662306|Aripiprazole|aripiprazole|mesh-list
65192766|NCT05662306|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
65192767|NCT05662306|Antidepressive Agents|antidepressive agents|mesh-ancestor
65192768|NCT05662306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65192769|NCT05662306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65192770|NCT05662306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65192771|NCT05662306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65192772|NCT05662306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192773|NCT05662306|Dopamine Agonists|dopamine agonists|mesh-ancestor
65192774|NCT05662306|Dopamine Agents|dopamine agents|mesh-ancestor
65328118|NCT04083066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65328119|NCT04083066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328120|NCT04083066|Immunologic Factors|immunologic factors|mesh-ancestor
65328121|NCT04083066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328122|NCT04083066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65328123|NCT04083066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65328124|NCT04083066|Antiemetics|antiemetics|mesh-ancestor
65328125|NCT04083066|Autonomic Agents|autonomic agents|mesh-ancestor
65328126|NCT04083066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65328127|NCT04083066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65328128|NCT04083066|Glucocorticoids|glucocorticoids|mesh-ancestor
65328129|NCT04083066|Hormones|hormones|mesh-ancestor
65328130|NCT04083066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65328131|NCT04083066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65328132|NCT04083066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65328133|NCT04083066|Abortifacient Agents|abortifacient agents|mesh-ancestor
65328134|NCT04083066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65328135|NCT04083066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65328136|NCT04083066|Antimetabolites|antimetabolites|mesh-ancestor
65328137|NCT04083066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328138|NCT04083066|Dermatologic Agents|dermatologic agents|mesh-ancestor
65328139|NCT04083066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328140|NCT04083066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65328141|NCT04083066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65328142|NCT04083066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65328143|NCT04083066|Antiviral Agents|antiviral agents|mesh-ancestor
65192775|NCT05662306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65192776|NCT05662306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192777|NCT05662306|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65192778|NCT05662306|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65192779|NCT05662306|Serotonin Agents|serotonin agents|mesh-ancestor
65192780|NCT05662306|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65192781|NCT05662306|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65192782|NCT05662306|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65192783|NCT05662306|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65192784|NCT00618280|Nicotine|nicotine|mesh-list
65192785|NCT00618280|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65192790|NCT00618280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65192791|NCT00618280|Cholinergic Agents|cholinergic agents|mesh-ancestor
65192792|NCT00618280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65192793|NCT00618280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192794|NCT01101191|Oxycodone|oxycodone|mesh-list
65192795|NCT01101191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65192796|NCT01101191|Narcotics|narcotics|mesh-ancestor
65192797|NCT01101191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65192798|NCT01101191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192799|NCT01101191|Analgesics|analgesics|mesh-ancestor
64714345|NCT02997722|Ketamine|ketamine|mesh-list
65328144|NCT04083066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65328145|NCT05683782|Chitosan|chitosan|mesh-list
65328146|NCT05683782|Epoetin Alfa|epoetin alfa|mesh-list
65328147|NCT05683782|Hematinics|hematinics|mesh-ancestor
65328148|NCT05683782|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65328149|NCT05683782|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65328150|NCT05683782|Antimetabolites|antimetabolites|mesh-ancestor
65328151|NCT05683782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328152|NCT05683782|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65328154|NCT05683782|Sequestering Agents|sequestering agents|mesh-ancestor
65328155|NCT05683782|Hemostatics|hemostatics|mesh-ancestor
65328156|NCT05683782|Coagulants|coagulants|mesh-ancestor
65328157|NCT00740714|Vitamins|vitamins|mesh-list
65328158|NCT00740714|Vitamin E|vitamin e|mesh-list
65192800|NCT01101191|Sensory System Agents|sensory system agents|mesh-ancestor
65192801|NCT01101191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192802|NCT00622258|Everolimus|everolimus|mesh-list
65192803|NCT00622258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192804|NCT00622258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65192805|NCT00622258|Immunologic Factors|immunologic factors|mesh-ancestor
65192806|NCT00622258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192807|NCT01812616|Nabiximols|nabiximols|mesh-list
65192808|NCT01812616|Analgesics|analgesics|mesh-ancestor
65192809|NCT01812616|Sensory System Agents|sensory system agents|mesh-ancestor
65192810|NCT01812616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192811|NCT01812616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835422|NCT03161353|Tamoxifen|tamoxifen|mesh-list
65192813|NCT00618358|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
65192814|NCT00618358|Hemostatics|hemostatics|mesh-ancestor
65192815|NCT00618358|Coagulants|coagulants|mesh-ancestor
65192816|NCT03664180|Heparin|heparin|mesh-list
65192817|NCT03664180|Calcium heparin|calcium heparin|mesh-list
65192818|NCT03664180|Enoxaparin|enoxaparin|mesh-list
65192819|NCT03664180|Hirudins|hirudins|mesh-list
65192820|NCT03664180|Enoxaparin sodium|enoxaparin sodium|mesh-list
65192821|NCT03664180|Bivalirudin|bivalirudin|mesh-list
65192822|NCT03664180|Anticoagulants|anticoagulants|mesh-ancestor
65192823|NCT03664180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65192824|NCT03664180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65192825|NCT03664180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192826|NCT03664180|Antithrombins|antithrombins|mesh-ancestor
65192827|NCT03664180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65192828|NCT03664180|Protease Inhibitors|protease inhibitors|mesh-ancestor
65192829|NCT03664180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192830|NCT01178762|Azithromycin|azithromycin|mesh-list
65192831|NCT01178762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65192832|NCT01178762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65192833|NCT03563560|Cytarabine|cytarabine|mesh-list
65192834|NCT03563560|Mitoxantrone|mitoxantrone|mesh-list
65192835|NCT03563560|Alvocidib|alvocidib|mesh-list
65192836|NCT03563560|Daunorubicin|daunorubicin|mesh-list
65192837|NCT03563560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65192838|NCT03563560|Antimetabolites|antimetabolites|mesh-ancestor
65192839|NCT03563560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192840|NCT03563560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192841|NCT03563560|Antiviral Agents|antiviral agents|mesh-ancestor
65192842|NCT03563560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65192843|NCT03563560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65192844|NCT03563560|Immunologic Factors|immunologic factors|mesh-ancestor
65192845|NCT03563560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192846|NCT03563560|Analgesics|analgesics|mesh-ancestor
65192847|NCT03563560|Sensory System Agents|sensory system agents|mesh-ancestor
65192848|NCT03563560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192849|NCT03563560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65192850|NCT03563560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65192851|NCT03563560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328159|NCT00740714|Tocopherols|tocopherols|mesh-list
65328160|NCT00740714|Tocotrienols|tocotrienols|mesh-list
65328161|NCT00740714|alpha-Tocopherol|alpha-tocopherol|mesh-list
65328162|NCT00740714|Coenzyme Q10|coenzyme q10|mesh-list
65328163|NCT00740714|Ubiquinone|ubiquinone|mesh-list
65328164|NCT00740714|Micronutrients|micronutrients|mesh-ancestor
65192852|NCT03563560|Growth Inhibitors|growth inhibitors|mesh-ancestor
65192853|NCT03563560|Growth Substances|growth substances|mesh-ancestor
65192854|NCT03563560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65192855|NCT03563560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65192857|NCT01178138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65192858|NCT01178138|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65192859|NCT01178138|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65192860|NCT01178138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65192862|NCT01178138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65192863|NCT01178138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192864|NCT01178138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192866|NCT01190228|Immunologic Factors|immunologic factors|mesh-ancestor
65192867|NCT01190228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192868|NCT01009086|Ustekinumab|ustekinumab|mesh-list
65192869|NCT01009086|Dermatologic Agents|dermatologic agents|mesh-ancestor
65192870|NCT01190150|Tranexamic Acid|tranexamic acid|mesh-list
65192871|NCT01190150|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65192872|NCT01190150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65192873|NCT01190150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192874|NCT01190150|Hemostatics|hemostatics|mesh-ancestor
65192875|NCT01190150|Coagulants|coagulants|mesh-ancestor
65192876|NCT04315688|Insulin|insulin|mesh-list
65192877|NCT04315688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65192878|NCT04315688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192879|NCT05210062|Succinylcholine|succinylcholine|mesh-list
65192880|NCT05210062|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
65192881|NCT05210062|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65192882|NCT05210062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65192883|NCT05210062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192884|NCT05210062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192885|NCT01001520|Tolcapone|tolcapone|mesh-list
65192886|NCT01001520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65192887|NCT01001520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65192888|NCT01001520|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65192889|NCT01001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192890|NCT01001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192891|NCT00619840|Methylphenidate|methylphenidate|mesh-list
65192892|NCT00619840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65192893|NCT00619840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192894|NCT00619840|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65192895|NCT00619840|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65192896|NCT00619840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65192897|NCT00619840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192898|NCT00619840|Dopamine Agents|dopamine agents|mesh-ancestor
65192899|NCT00619840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65192900|NCT01189604|Propofol|propofol|mesh-list
65192901|NCT01189604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65192902|NCT01189604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65192903|NCT01189604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192904|NCT01189604|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65192905|NCT01189604|Anesthetics, General|anesthetics, general|mesh-ancestor
65192906|NCT01189604|Anesthetics|anesthetics|mesh-ancestor
65192907|NCT02697058|Calcium, Dietary|calcium, dietary|mesh-list
65192908|NCT02697058|Leucovorin|leucovorin|mesh-list
65192909|NCT02697058|Fluorouracil|fluorouracil|mesh-list
65192910|NCT02697058|Calcium|calcium|mesh-list
65192911|NCT02697058|Levoleucovorin|levoleucovorin|mesh-list
65192912|NCT02697058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65192913|NCT02697058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192914|NCT02697058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65192915|NCT02697058|Antimetabolites|antimetabolites|mesh-ancestor
65192916|NCT02697058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192917|NCT02697058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65192918|NCT02697058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328165|NCT00740714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328166|NCT00740714|Antioxidants|antioxidants|mesh-ancestor
65328167|NCT00740714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328168|NCT00740714|Protective Agents|protective agents|mesh-ancestor
65328169|NCT00721773|Valsartan|valsartan|mesh-list
65328170|NCT00721773|Benazepril|benazepril|mesh-list
65328171|NCT00721773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65328172|NCT00721773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65328173|NCT00721773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65328174|NCT00721773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328175|NCT00721773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65328176|NCT00721773|Protease Inhibitors|protease inhibitors|mesh-ancestor
65328177|NCT00721773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328178|NCT05676684|Dapagliflozin|dapagliflozin|mesh-list
65192919|NCT02697058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65192920|NCT02697058|Immunologic Factors|immunologic factors|mesh-ancestor
65192921|NCT02697058|Antidotes|antidotes|mesh-ancestor
65192922|NCT02697058|Protective Agents|protective agents|mesh-ancestor
65192923|NCT02697058|Vitamin B Complex|vitamin b complex|mesh-ancestor
65192924|NCT02697058|Vitamins|vitamins|mesh-ancestor
65192925|NCT02697058|Micronutrients|micronutrients|mesh-ancestor
65192926|NCT00622414|Aflibercept|aflibercept|mesh-list
65192927|NCT00622414|Endothelial Growth Factors|endothelial growth factors|mesh-list
65192928|NCT00622414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65192929|NCT00622414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65192930|NCT00622414|Growth Substances|growth substances|mesh-ancestor
65192931|NCT00622414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192932|NCT00622414|Growth Inhibitors|growth inhibitors|mesh-ancestor
65192933|NCT00622414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192934|NCT01008696|Rabeprazole|rabeprazole|mesh-list
65192950|NCT01955980|Glucocorticoids|glucocorticoids|mesh-ancestor
65192952|NCT01955980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65192953|NCT02870478|Atropine|atropine|mesh-list
65192954|NCT02870478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65192955|NCT02870478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65192956|NCT02870478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65192957|NCT02870478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65192958|NCT02870478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65192959|NCT02870478|Autonomic Agents|autonomic agents|mesh-ancestor
65192960|NCT02870478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192961|NCT02870478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192962|NCT02870478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65192963|NCT02870478|Respiratory System Agents|respiratory system agents|mesh-ancestor
65192964|NCT02870478|Mydriatics|mydriatics|mesh-ancestor
64835571|NCT02702492|Niacin|niacin|mesh-list
65192966|NCT02870478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65192967|NCT02870478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65192968|NCT02870478|Cholinergic Agents|cholinergic agents|mesh-ancestor
65192969|NCT02870478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65192970|NCT02870478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192971|NCT04296162|Capecitabine|capecitabine|mesh-list
65192972|NCT04296162|Trastuzumab|trastuzumab|mesh-list
65192973|NCT04296162|Vinorelbine|vinorelbine|mesh-list
65192974|NCT04296162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65192975|NCT04296162|Antimetabolites|antimetabolites|mesh-ancestor
65192976|NCT04296162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192977|NCT04296162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192978|NCT04296162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65192979|NCT04296162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65192980|NCT04296162|Tubulin Modulators|tubulin modulators|mesh-ancestor
65192981|NCT04296162|Antimitotic Agents|antimitotic agents|mesh-ancestor
65328179|NCT05676684|Spironolactone|spironolactone|mesh-list
65328180|NCT05676684|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65328181|NCT05676684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328182|NCT05676684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65328183|NCT05676684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328184|NCT05676684|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65328185|NCT05676684|Hormone Antagonists|hormone antagonists|mesh-ancestor
65328186|NCT05676684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65328187|NCT05676684|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65328188|NCT05676684|Diuretics|diuretics|mesh-ancestor
65192982|NCT04296162|Mitosis Modulators|mitosis modulators|mesh-ancestor
65192983|NCT00619996|Docetaxel|docetaxel|mesh-list
65192984|NCT00619996|Sorafenib|sorafenib|mesh-list
65192985|NCT00619996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192987|NCT00619996|Antimitotic Agents|antimitotic agents|mesh-ancestor
65192988|NCT00619996|Mitosis Modulators|mitosis modulators|mesh-ancestor
65192989|NCT00619996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192990|NCT00619996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65192991|NCT00619996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192992|NCT02870790|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65192993|NCT02870790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65192994|NCT02870790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65192999|NCT02870790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65193000|NCT02870790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65193001|NCT00622570|Pentobarbital|pentobarbital|mesh-list
65193002|NCT00622570|Thiopental|thiopental|mesh-list
65193003|NCT00622570|Anticonvulsants|anticonvulsants|mesh-ancestor
65193004|NCT00622570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65193005|NCT00622570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65193006|NCT00622570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193007|NCT00622570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65193008|NCT00622570|Anesthetics, General|anesthetics, general|mesh-ancestor
65193009|NCT00622570|Anesthetics|anesthetics|mesh-ancestor
65193010|NCT00622570|GABA Modulators|gaba modulators|mesh-ancestor
65193011|NCT00622570|GABA Agents|gaba agents|mesh-ancestor
65193012|NCT00622570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65193013|NCT00622570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193014|NCT00622570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65193015|NCT00890266|Riboflavin|riboflavin|mesh-list
65193016|NCT00890266|Vitamin B Complex|vitamin b complex|mesh-ancestor
65193017|NCT00890266|Vitamins|vitamins|mesh-ancestor
65193018|NCT00890266|Micronutrients|micronutrients|mesh-ancestor
65193019|NCT00890266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193020|NCT00890266|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65193021|NCT00890266|Dermatologic Agents|dermatologic agents|mesh-ancestor
65193022|NCT01430572|Everolimus|everolimus|mesh-list
65193023|NCT01430572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193024|NCT01430572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65193025|NCT01430572|Immunologic Factors|immunologic factors|mesh-ancestor
65193026|NCT01430572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193027|NCT01370512|Droxidopa|droxidopa|mesh-list
65193028|NCT01370512|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
65193029|NCT01370512|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65193030|NCT01370512|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65193031|NCT01370512|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65193032|NCT01370512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193033|NCT01370512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193034|NCT01370512|Cholinergic Agents|cholinergic agents|mesh-ancestor
65193035|NCT01370512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65193036|NCT01370512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193037|NCT01176968|Eplerenone|eplerenone|mesh-list
65193038|NCT01176968|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65193039|NCT01176968|Hormone Antagonists|hormone antagonists|mesh-ancestor
65328189|NCT05676684|Natriuretic Agents|natriuretic agents|mesh-ancestor
65328190|NCT04070469|Amoxicillin|amoxicillin|mesh-list
65328191|NCT04070469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65328192|NCT04070469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65328193|NCT00712647|Beta Carotene|beta carotene|mesh-list
65328194|NCT00712647|Vitamin A|vitamin a|mesh-list
65328195|NCT00712647|Carotenoids|carotenoids|mesh-list
65328196|NCT00712647|Antioxidants|antioxidants|mesh-ancestor
65328197|NCT00712647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328198|NCT00712647|Protective Agents|protective agents|mesh-ancestor
65328199|NCT00712647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328200|NCT00712647|Provitamins|provitamins|mesh-ancestor
65328201|NCT00712647|Vitamins|vitamins|mesh-ancestor
65328202|NCT00712647|Micronutrients|micronutrients|mesh-ancestor
65328203|NCT00788957|Panitumumab|panitumumab|mesh-list
65328204|NCT00788957|Rilotumumab|rilotumumab|mesh-list
65328205|NCT00788957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65328206|NCT00788957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328207|NCT04067817|Phenylephrine|phenylephrine|mesh-list
65328208|NCT04067817|Oxymetazoline|oxymetazoline|mesh-list
65328209|NCT04067817|Norepinephrine|norepinephrine|mesh-list
65328210|NCT04067817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65328211|NCT04067817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65328212|NCT04067817|Mydriatics|mydriatics|mesh-ancestor
65328213|NCT04067817|Autonomic Agents|autonomic agents|mesh-ancestor
65328214|NCT04067817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65328215|NCT04067817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328216|NCT04067817|Sympathomimetics|sympathomimetics|mesh-ancestor
65328217|NCT04067817|Nasal Decongestants|nasal decongestants|mesh-ancestor
65328218|NCT04067817|Respiratory System Agents|respiratory system agents|mesh-ancestor
65328219|NCT04067817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65328220|NCT04067817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65328221|NCT04067817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65328222|NCT04067817|Adrenergic Agents|adrenergic agents|mesh-ancestor
65328223|NCT04067817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65078156|NCT00328874|Vitamins|vitamins|mesh-ancestor
65328225|NCT04067817|Protective Agents|protective agents|mesh-ancestor
65328230|NCT00740636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328232|NCT02603159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65328233|NCT02603159|Antimetabolites|antimetabolites|mesh-ancestor
65328234|NCT02603159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328235|NCT02603159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328236|NCT02595554|Paclitaxel|paclitaxel|mesh-list
65328237|NCT02595554|Cisplatin|cisplatin|mesh-list
65328238|NCT02595554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65328239|NCT02595554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328240|NCT02595554|Tubulin Modulators|tubulin modulators|mesh-ancestor
65328241|NCT02595554|Antimitotic Agents|antimitotic agents|mesh-ancestor
65328242|NCT02595554|Mitosis Modulators|mitosis modulators|mesh-ancestor
64714424|NCT03117140|Clonidine|clonidine|mesh-list
65193040|NCT01176968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65193041|NCT01176968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193042|NCT01176968|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65193043|NCT01176968|Diuretics|diuretics|mesh-ancestor
65193044|NCT01176968|Natriuretic Agents|natriuretic agents|mesh-ancestor
65193045|NCT01176968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65193046|NCT02697370|Factor VIII|factor viii|mesh-list
65193047|NCT02697370|Coagulants|coagulants|mesh-ancestor
65193048|NCT02691442|Epinephrine|epinephrine|mesh-list
65193049|NCT02691442|Ropivacaine|ropivacaine|mesh-list
65193050|NCT02691442|Levobupivacaine|levobupivacaine|mesh-list
65193051|NCT02691442|Anesthetics, Local|anesthetics, local|mesh-ancestor
65193052|NCT02691442|Anesthetics|anesthetics|mesh-ancestor
65193053|NCT02691442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65193054|NCT02691442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193055|NCT02691442|Sensory System Agents|sensory system agents|mesh-ancestor
65193056|NCT02691442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65193057|NCT02691442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65193058|NCT02691442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65193059|NCT02691442|Adrenergic Agents|adrenergic agents|mesh-ancestor
65193060|NCT02691442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65193061|NCT02691442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193063|NCT02691442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65193064|NCT02691442|Autonomic Agents|autonomic agents|mesh-ancestor
65193065|NCT02691442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65193066|NCT02691442|Respiratory System Agents|respiratory system agents|mesh-ancestor
65193067|NCT02691442|Mydriatics|mydriatics|mesh-ancestor
65193068|NCT02691442|Sympathomimetics|sympathomimetics|mesh-ancestor
65193076|NCT02687854|Apixaban|apixaban|mesh-list
65193077|NCT02687854|Vitamins|vitamins|mesh-ancestor
65193078|NCT02687854|Micronutrients|micronutrients|mesh-ancestor
65193079|NCT02687854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193080|NCT02687854|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65193081|NCT02687854|Antithrombins|antithrombins|mesh-ancestor
65193082|NCT02687854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65193083|NCT02687854|Protease Inhibitors|protease inhibitors|mesh-ancestor
65193084|NCT02687854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193085|NCT02687854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193086|NCT02687854|Anticoagulants|anticoagulants|mesh-ancestor
65193087|NCT02687854|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65193088|NCT02687854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65193089|NCT02687854|Hemostatics|hemostatics|mesh-ancestor
65193090|NCT02687854|Coagulants|coagulants|mesh-ancestor
65193091|NCT01005966|Listerine|listerine|mesh-list
65193092|NCT01005966|Fluorides|fluorides|mesh-list
65193093|NCT01005966|Sodium Fluoride|sodium fluoride|mesh-list
65193094|NCT01005966|Fluorophosphate|fluorophosphate|mesh-list
65193095|NCT01005966|Cariostatic Agents|cariostatic agents|mesh-ancestor
65193096|NCT01005966|Protective Agents|protective agents|mesh-ancestor
65193097|NCT01005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193098|NCT01005966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65193099|NCT01005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65328243|NCT02595554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328244|NCT04069065|Tacrolimus|tacrolimus|mesh-list
65328245|NCT04069065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65328246|NCT04069065|Immunologic Factors|immunologic factors|mesh-ancestor
65328247|NCT04069065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328248|NCT04069065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65328249|NCT04069065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328250|NCT04069065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193100|NCT00628680|Heparin|heparin|mesh-list
65193101|NCT00628680|Anticoagulants|anticoagulants|mesh-ancestor
65193102|NCT00628680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65193103|NCT00628680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65193104|NCT00628680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193105|NCT00603304|Saw palmetto extract|saw palmetto extract|mesh-list
65193106|NCT00603304|Urological Agents|urological agents|mesh-ancestor
65193107|NCT01176032|Losartan|losartan|mesh-list
65193108|NCT01176032|Amlodipine|amlodipine|mesh-list
65193109|NCT01176032|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65193110|NCT01176032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65193111|NCT01176032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65193112|NCT01176032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65193113|NCT01176032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193114|NCT01176032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65193115|NCT01176032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193116|NCT01176032|Vasodilator Agents|vasodilator agents|mesh-ancestor
65193117|NCT01176032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65193118|NCT01176032|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65193119|NCT01176032|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65193121|NCT01176032|Natriuretic Agents|natriuretic agents|mesh-ancestor
65193122|NCT01176032|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65193123|NCT01008618|Fentanyl|fentanyl|mesh-list
65193124|NCT01008618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65193125|NCT01008618|Narcotics|narcotics|mesh-ancestor
65193126|NCT01008618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65193127|NCT01008618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193128|NCT01008618|Analgesics|analgesics|mesh-ancestor
65193129|NCT01008618|Sensory System Agents|sensory system agents|mesh-ancestor
65193130|NCT01008618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65193131|NCT01008618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65193132|NCT01008618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65193133|NCT01008618|Anesthetics, General|anesthetics, general|mesh-ancestor
65193134|NCT01008618|Anesthetics|anesthetics|mesh-ancestor
65193135|NCT01001208|Etanercept|etanercept|mesh-list
65193136|NCT01001208|Methotrexate|methotrexate|mesh-list
65193137|NCT01001208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65193138|NCT01001208|Abortifacient Agents|abortifacient agents|mesh-ancestor
65193139|NCT01001208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65193140|NCT01001208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193146|NCT01001208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193147|NCT01001208|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65193148|NCT01001208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65193149|NCT01001208|Immunologic Factors|immunologic factors|mesh-ancestor
65193150|NCT01001208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65193151|NCT01001208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65193152|NCT01001208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65193153|NCT01001208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65193154|NCT01001208|Analgesics|analgesics|mesh-ancestor
65193155|NCT01001208|Sensory System Agents|sensory system agents|mesh-ancestor
65193156|NCT01001208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65193157|NCT01001208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65193158|NCT01001208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65193159|NCT01000974|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65193160|NCT01000974|Immunologic Factors|immunologic factors|mesh-ancestor
65193161|NCT01000974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193162|NCT01193842|Prednisone|prednisone|mesh-list
65193163|NCT01193842|Cortisone|cortisone|mesh-list
65328251|NCT04070391|Vitamin B 6|vitamin b 6|mesh-list
65328252|NCT04070391|Pyridoxal|pyridoxal|mesh-list
65328253|NCT04070391|Pyridoxine|pyridoxine|mesh-list
65328254|NCT04070391|Vitamins|vitamins|mesh-ancestor
65328255|NCT04070391|Micronutrients|micronutrients|mesh-ancestor
65328256|NCT04070391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328257|NCT04070391|Vitamin B Complex|vitamin b complex|mesh-ancestor
65328258|NCT05615051|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65328259|NCT05615051|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65328260|NCT05615051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65328261|NCT00795509|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65328262|NCT00795509|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65328263|NCT00795509|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65328264|NCT00795509|Cholinergic Agents|cholinergic agents|mesh-ancestor
65328265|NCT00795509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65328266|NCT00795509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328267|NCT00795509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328268|NCT00795509|Urological Agents|urological agents|mesh-ancestor
65328269|NCT02603003|Pemetrexed|pemetrexed|mesh-list
65328270|NCT02603003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328271|NCT02603003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193164|NCT01193842|Cyclophosphamide|cyclophosphamide|mesh-list
65193165|NCT01193842|Rituximab|rituximab|mesh-list
65193166|NCT01193842|Doxorubicin|doxorubicin|mesh-list
65193167|NCT01193842|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65193168|NCT01193842|Etoposide|etoposide|mesh-list
65193169|NCT01193842|Vincristine|vincristine|mesh-list
65193170|NCT01193842|Etoposide phosphate|etoposide phosphate|mesh-list
65193171|NCT01193842|Vorinostat|vorinostat|mesh-list
65193172|NCT01193842|Podophyllotoxin|podophyllotoxin|mesh-list
65193173|NCT01193842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65193174|NCT01193842|Antibodies|antibodies|mesh-list
65193175|NCT01193842|Immunoglobulins|immunoglobulins|mesh-list
65193176|NCT01193842|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65193177|NCT01193842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65193178|NCT01193842|Immunologic Factors|immunologic factors|mesh-ancestor
65193179|NCT01193842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193180|NCT01193842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65193181|NCT01193842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65193182|NCT01193842|Alkylating Agents|alkylating agents|mesh-ancestor
65193183|NCT01193842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193184|NCT01193842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193185|NCT01193842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65193186|NCT01193842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65193187|NCT01193842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65193188|NCT01193842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65193189|NCT01193842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193190|NCT01193842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65193191|NCT01193842|Glucocorticoids|glucocorticoids|mesh-ancestor
65193192|NCT01193842|Hormones|hormones|mesh-ancestor
65193193|NCT01193842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65193194|NCT01193842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65193195|NCT01193842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65193197|NCT01193842|Antimitotic Agents|antimitotic agents|mesh-ancestor
65193198|NCT01193842|Mitosis Modulators|mitosis modulators|mesh-ancestor
65193199|NCT01193842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65193200|NCT01193842|Keratolytic Agents|keratolytic agents|mesh-ancestor
65328272|NCT02603003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328273|NCT02603003|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65328274|NCT02603003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65328275|NCT04106297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65328276|NCT02603081|Ebselen|ebselen|mesh-list
65328277|NCT02603081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65328278|NCT02603081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65328279|NCT02603081|Analgesics|analgesics|mesh-ancestor
65328280|NCT02603081|Sensory System Agents|sensory system agents|mesh-ancestor
65328281|NCT02603081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65328282|NCT02603081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328283|NCT02603081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65328284|NCT02603081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65328285|NCT02603081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65328286|NCT02603081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65328287|NCT02603081|Antioxidants|antioxidants|mesh-ancestor
65328288|NCT02603081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328289|NCT02603081|Protective Agents|protective agents|mesh-ancestor
65328290|NCT02603081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65328291|NCT02603081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328292|NCT02603081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65328293|NCT05656599|Letermovir|letermovir|mesh-list
65328294|NCT05656599|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65328295|NCT05656599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328296|NCT05656599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328297|NCT05656599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328298|NCT05656599|Antiviral Agents|antiviral agents|mesh-ancestor
65328299|NCT05656599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65328300|NCT00787787|Capecitabine|capecitabine|mesh-list
65328301|NCT00787787|Sunitinib|sunitinib|mesh-list
65328302|NCT00787787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65193201|NCT01193842|Dermatologic Agents|dermatologic agents|mesh-ancestor
65193202|NCT04401774|Nivolumab|nivolumab|mesh-list
65193203|NCT04401774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65193204|NCT04401774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193205|NCT04401774|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65193206|NCT04401774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193207|NCT01004406|Atorvastatin|atorvastatin|mesh-list
65193208|NCT01004406|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65193209|NCT01004406|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65193210|NCT01004406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65193211|NCT01004406|Antimetabolites|antimetabolites|mesh-ancestor
65328303|NCT00787787|Antimetabolites|antimetabolites|mesh-ancestor
65328304|NCT00787787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328305|NCT00787787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328306|NCT00787787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65328307|NCT00787787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65328308|NCT00787787|Growth Substances|growth substances|mesh-ancestor
65328309|NCT00787787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328310|NCT00787787|Growth Inhibitors|growth inhibitors|mesh-ancestor
65328311|NCT00787787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65328312|NCT00787787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328313|NCT05590793|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65328314|NCT05590793|Luteolytic Agents|luteolytic agents|mesh-ancestor
65328315|NCT05590793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65328316|NCT05590793|Contraceptive Agents|contraceptive agents|mesh-ancestor
65193217|NCT01093612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65193218|NCT01093612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193219|NCT01093612|Trace Elements|trace elements|mesh-ancestor
65193220|NCT01093612|Micronutrients|micronutrients|mesh-ancestor
65193221|NCT01093612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193223|NCT01182350|Temozolomide|temozolomide|mesh-list
65193224|NCT01182350|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65193225|NCT01182350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65193226|NCT01182350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193227|NCT01182350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65193228|NCT01182350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65193229|NCT01182350|Growth Substances|growth substances|mesh-ancestor
65193230|NCT01182350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193231|NCT01182350|Growth Inhibitors|growth inhibitors|mesh-ancestor
65193232|NCT01182350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65193233|NCT01182350|Alkylating Agents|alkylating agents|mesh-ancestor
65193234|NCT01182350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193235|NCT01182350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65193236|NCT01182350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193237|NCT00603538|Paclitaxel|paclitaxel|mesh-list
65193238|NCT00603538|Carboplatin|carboplatin|mesh-list
65193239|NCT00603538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65193240|NCT00603538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193241|NCT00603538|Tubulin Modulators|tubulin modulators|mesh-ancestor
65193242|NCT00603538|Antimitotic Agents|antimitotic agents|mesh-ancestor
65193243|NCT00603538|Mitosis Modulators|mitosis modulators|mesh-ancestor
65193244|NCT00603538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193245|NCT04185766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65193246|NCT02537860|Fentanyl|fentanyl|mesh-list
65193247|NCT02537860|Bupivacaine|bupivacaine|mesh-list
65193248|NCT02537860|Anesthetics, Local|anesthetics, local|mesh-ancestor
65193249|NCT02537860|Anesthetics|anesthetics|mesh-ancestor
65193250|NCT02537860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65193251|NCT02537860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193252|NCT02537860|Sensory System Agents|sensory system agents|mesh-ancestor
65193253|NCT02537860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65193254|NCT02537860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65193255|NCT02537860|Narcotics|narcotics|mesh-ancestor
65193256|NCT02537860|Analgesics|analgesics|mesh-ancestor
65193257|NCT02537860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65193258|NCT02537860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65193259|NCT02537860|Anesthetics, General|anesthetics, general|mesh-ancestor
65193260|NCT03844750|Pembrolizumab|pembrolizumab|mesh-list
65193261|NCT03844750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65193262|NCT03844750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193263|NCT03797014|Tenofovir|tenofovir|mesh-list
65193264|NCT03797014|Emtricitabine|emtricitabine|mesh-list
65328317|NCT05590793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65328318|NCT05590793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328319|NCT05590793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65328320|NCT05590793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65328321|NCT05590793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328323|NCT00722475|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65328324|NCT00722475|Antibodies|antibodies|mesh-list
65328325|NCT00722475|gamma-Globulins|gamma-globulins|mesh-list
65328326|NCT00722475|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65328327|NCT00722475|Immunologic Factors|immunologic factors|mesh-ancestor
65328328|NCT00722475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328329|NCT05549297|Pembrolizumab|pembrolizumab|mesh-list
65328330|NCT05549297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65328331|NCT05549297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328332|NCT00915239|Pantoprazole|pantoprazole|mesh-list
65328333|NCT00915239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65328334|NCT00915239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65328335|NCT00915239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65328336|NCT00915239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64714496|NCT03070730|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65193265|NCT03797014|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65193266|NCT03797014|Antiviral Agents|antiviral agents|mesh-ancestor
65193267|NCT03797014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65193268|NCT03797014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65193269|NCT03797014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65193270|NCT03797014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193271|NCT03797014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193272|NCT03797014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65193273|NCT03797014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65193274|NCT04521946|Mycophenolic Acid|mycophenolic acid|mesh-list
65193275|NCT04521946|Fludarabine|fludarabine|mesh-list
65193276|NCT04521946|Fludarabine phosphate|fludarabine phosphate|mesh-list
65193277|NCT04521946|Etoposide|etoposide|mesh-list
65193278|NCT04521946|Etoposide phosphate|etoposide phosphate|mesh-list
65193279|NCT04521946|Melphalan|melphalan|mesh-list
65193280|NCT04521946|Mechlorethamine|mechlorethamine|mesh-list
65193281|NCT04521946|Thiotepa|thiotepa|mesh-list
65193282|NCT04521946|Podophyllotoxin|podophyllotoxin|mesh-list
65193283|NCT04521946|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65193293|NCT04521946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65193295|NCT04521946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193297|NCT04521946|Immunologic Factors|immunologic factors|mesh-ancestor
65193298|NCT04521946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193299|NCT04521946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65193300|NCT04521946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65193301|NCT04521946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65193302|NCT04521946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193303|NCT04521946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65193304|NCT04521946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65193305|NCT04521946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65193306|NCT04521946|Antitubercular Agents|antitubercular agents|mesh-ancestor
65193307|NCT04521946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65193308|NCT04521946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65193309|NCT04521946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65328337|NCT00915239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328338|NCT03481569|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65328339|NCT03481569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65328340|NCT00722631|Pioglitazone|pioglitazone|mesh-list
65328341|NCT00722631|Glimepiride|glimepiride|mesh-list
65328342|NCT00722631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65328343|NCT00722631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328344|NCT00722631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65328345|NCT00722631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65328346|NCT00722631|Immunologic Factors|immunologic factors|mesh-ancestor
65328347|NCT02604095|Melatonin|melatonin|mesh-list
65328348|NCT02604095|Antioxidants|antioxidants|mesh-ancestor
65328349|NCT02604095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328350|NCT02604095|Protective Agents|protective agents|mesh-ancestor
65193310|NCT04521946|Alkylating Agents|alkylating agents|mesh-ancestor
65193311|NCT04521946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65193312|NCT04521946|Keratolytic Agents|keratolytic agents|mesh-ancestor
65193313|NCT04521946|Dermatologic Agents|dermatologic agents|mesh-ancestor
65193314|NCT04521946|Tubulin Modulators|tubulin modulators|mesh-ancestor
65193315|NCT04521946|Antimitotic Agents|antimitotic agents|mesh-ancestor
65193316|NCT04521946|Mitosis Modulators|mitosis modulators|mesh-ancestor
65193317|NCT01162304|Oxycodone|oxycodone|mesh-list
65193318|NCT01162304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65193319|NCT01162304|Narcotics|narcotics|mesh-ancestor
65193320|NCT01162304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65193321|NCT01162304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193322|NCT01162304|Analgesics|analgesics|mesh-ancestor
65193323|NCT01162304|Sensory System Agents|sensory system agents|mesh-ancestor
65193324|NCT01162304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65193325|NCT04515394|Cetuximab|cetuximab|mesh-list
65193326|NCT04515394|Tepotinib|tepotinib|mesh-list
65193327|NCT04515394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65193328|NCT04515394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193329|NCT04206176|Ticagrelor|ticagrelor|mesh-list
65193330|NCT04206176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65193331|NCT04206176|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65193332|NCT04206176|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65193333|NCT04206176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65193334|NCT04206176|Purinergic Agents|purinergic agents|mesh-ancestor
65193335|NCT04206176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65193336|NCT04206176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193337|NCT04206176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193338|NCT01175018|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65193339|NCT01175018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65193340|NCT00638326|Clopidogrel|clopidogrel|mesh-list
65193341|NCT00638326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65193342|NCT00638326|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65193343|NCT00638326|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65193344|NCT00638326|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65193345|NCT00638326|Purinergic Agents|purinergic agents|mesh-ancestor
65193346|NCT00638326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65193347|NCT00638326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193348|NCT00638326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193350|NCT04314674|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65193351|NCT04314674|Diuretics|diuretics|mesh-ancestor
65193356|NCT00639262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65193357|NCT00639262|Alkylating Agents|alkylating agents|mesh-ancestor
65193358|NCT00639262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193359|NCT00639262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193360|NCT00639262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65328351|NCT02604095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328352|NCT02604095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65328353|NCT02571543|Ibuprofen|ibuprofen|mesh-list
65328354|NCT02571543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65328355|NCT02571543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65328356|NCT02571543|Analgesics|analgesics|mesh-ancestor
65328357|NCT02571543|Sensory System Agents|sensory system agents|mesh-ancestor
65328358|NCT02571543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65328359|NCT02571543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328360|NCT02571543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65328361|NCT02571543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65328362|NCT02571543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65328363|NCT02571543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328364|NCT02571543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328365|NCT00713193|Cyclosporine|cyclosporine|mesh-list
65328366|NCT00713193|Prednisone|prednisone|mesh-list
65328367|NCT00713193|Cyclosporins|cyclosporins|mesh-list
65328368|NCT00713193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65328369|NCT00713193|Glucocorticoids|glucocorticoids|mesh-ancestor
65328370|NCT00713193|Hormones|hormones|mesh-ancestor
65328371|NCT00713193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65328372|NCT00713193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328373|NCT00713193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65328374|NCT00713193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328375|NCT00713193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328376|NCT00713193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328377|NCT00713193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65193361|NCT00639262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193362|NCT02885558|Efonidipine|efonidipine|mesh-list
65193363|NCT02885558|Nifedipine|nifedipine|mesh-list
65193364|NCT02885558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65193365|NCT02885558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65193366|NCT02885558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950544|NCT00023660|Celecoxib|celecoxib|mesh-list
65193367|NCT02885558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65193368|NCT02885558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193369|NCT02885558|Vasodilator Agents|vasodilator agents|mesh-ancestor
65193370|NCT02885558|Tocolytic Agents|tocolytic agents|mesh-ancestor
65193371|NCT02885558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65193372|NCT02885558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65193373|NCT02885558|Diuretics|diuretics|mesh-ancestor
65193374|NCT02885558|Natriuretic Agents|natriuretic agents|mesh-ancestor
65193375|NCT04186702|Ranibizumab|ranibizumab|mesh-list
65193376|NCT04186702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65193377|NCT04186702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65193378|NCT04186702|Growth Substances|growth substances|mesh-ancestor
65193379|NCT04186702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328378|NCT00713193|Immunologic Factors|immunologic factors|mesh-ancestor
65328379|NCT00713193|Antifungal Agents|antifungal agents|mesh-ancestor
65328380|NCT00713193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65328381|NCT00713193|Dermatologic Agents|dermatologic agents|mesh-ancestor
65328382|NCT00713193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65328383|NCT00713193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65328385|NCT04107779|Nicotine|nicotine|mesh-list
65193380|NCT04186702|Growth Inhibitors|growth inhibitors|mesh-ancestor
65193381|NCT04186702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193382|NCT01008150|Paclitaxel|paclitaxel|mesh-list
65193383|NCT01008150|Cyclophosphamide|cyclophosphamide|mesh-list
65193384|NCT01008150|Doxorubicin|doxorubicin|mesh-list
65193385|NCT01008150|Trastuzumab|trastuzumab|mesh-list
65193386|NCT01008150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65193387|NCT01008150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193388|NCT01008150|Tubulin Modulators|tubulin modulators|mesh-ancestor
65193389|NCT01008150|Antimitotic Agents|antimitotic agents|mesh-ancestor
65193390|NCT01008150|Mitosis Modulators|mitosis modulators|mesh-ancestor
65193391|NCT01008150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193392|NCT01008150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65193393|NCT01008150|Immunologic Factors|immunologic factors|mesh-ancestor
65193394|NCT01008150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193395|NCT01008150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65193396|NCT01008150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65193397|NCT01008150|Alkylating Agents|alkylating agents|mesh-ancestor
65193398|NCT01008150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65193399|NCT01008150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65193400|NCT01008150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65193401|NCT01008150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65193402|NCT01008150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193403|NCT01008150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65193404|NCT04186936|Simethicone|simethicone|mesh-list
65193405|NCT04186936|Loperamide|loperamide|mesh-list
65193406|NCT04186936|Antidiarrheals|antidiarrheals|mesh-list
65193407|NCT04186936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65193408|NCT04186936|Antifoaming Agents|antifoaming agents|mesh-ancestor
65193409|NCT04186936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193410|NCT04186936|Emollients|emollients|mesh-ancestor
65193411|NCT04186936|Dermatologic Agents|dermatologic agents|mesh-ancestor
65193412|NCT02689180|Furosemide|furosemide|mesh-list
65193413|NCT02689180|Diuretics|diuretics|mesh-ancestor
65193414|NCT02689180|Natriuretic Agents|natriuretic agents|mesh-ancestor
65193415|NCT02689180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193416|NCT02689180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65193417|NCT02689180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65193418|NCT02689180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193419|NCT02689336|Temozolomide|temozolomide|mesh-list
65193420|NCT02689336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65193421|NCT02689336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65193422|NCT02689336|Alkylating Agents|alkylating agents|mesh-ancestor
65193425|NCT02689336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65193426|NCT02689336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193428|NCT03650764|Ramucirumab|ramucirumab|mesh-list
65193429|NCT03650764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65193430|NCT03650764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193431|NCT02685592|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65193432|NCT02685592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65193433|NCT02685592|Dermatologic Agents|dermatologic agents|mesh-ancestor
65193434|NCT01007448|Bexarotene|bexarotene|mesh-list
65193435|NCT01007448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193436|NCT02686684|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65193437|NCT02686684|Dermatologic Agents|dermatologic agents|mesh-ancestor
65193438|NCT02686684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65193439|NCT02686684|Immunologic Factors|immunologic factors|mesh-ancestor
65193440|NCT02686684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193441|NCT04294056|Propofol|propofol|mesh-list
65193442|NCT04294056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65193443|NCT04294056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65193444|NCT04294056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193445|NCT04294056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65328386|NCT04107779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65328387|NCT04107779|Autonomic Agents|autonomic agents|mesh-ancestor
65328388|NCT04107779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65328389|NCT04107779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328390|NCT04107779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65328391|NCT04107779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65328392|NCT04107779|Cholinergic Agents|cholinergic agents|mesh-ancestor
65328393|NCT04107779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65328394|NCT04107779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328395|NCT04107779|Antipruritics|antipruritics|mesh-ancestor
65328396|NCT04107779|Dermatologic Agents|dermatologic agents|mesh-ancestor
65328397|NCT04067505|Nadroparin|nadroparin|mesh-list
65328398|NCT04067505|Warfarin|warfarin|mesh-list
65193446|NCT04294056|Anesthetics, General|anesthetics, general|mesh-ancestor
65193447|NCT04294056|Anesthetics|anesthetics|mesh-ancestor
65193448|NCT04187014|Tranexamic Acid|tranexamic acid|mesh-list
65193449|NCT04187014|Aminocaproic Acid|aminocaproic acid|mesh-list
65193450|NCT04187014|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65193451|NCT04187014|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65193452|NCT04187014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193453|NCT04187014|Hemostatics|hemostatics|mesh-ancestor
65193454|NCT04187014|Coagulants|coagulants|mesh-ancestor
65193455|NCT02686840|Misoprostol|misoprostol|mesh-list
65193456|NCT02686840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65193457|NCT02686840|Abortifacient Agents|abortifacient agents|mesh-ancestor
65193458|NCT02686840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65193459|NCT02686840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193460|NCT02686840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65193461|NCT02686840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65193462|NCT02686840|Oxytocics|oxytocics|mesh-ancestor
65193463|NCT02689024|Acetaminophen|acetaminophen|mesh-list
65193464|NCT02689024|Dipyrone|dipyrone|mesh-list
65193465|NCT02689024|Ibuprofen|ibuprofen|mesh-list
65193466|NCT02689024|Diclofenac|diclofenac|mesh-list
65193467|NCT02689024|Naproxen|naproxen|mesh-list
65193468|NCT02689024|Fentanyl|fentanyl|mesh-list
65193469|NCT02689024|Morphine|morphine|mesh-list
65193470|NCT02689024|Bupivacaine|bupivacaine|mesh-list
65193471|NCT02689024|Ropivacaine|ropivacaine|mesh-list
65193472|NCT02689024|Levobupivacaine|levobupivacaine|mesh-list
65193473|NCT02689024|Anesthetics, Local|anesthetics, local|mesh-ancestor
65193474|NCT02689024|Anesthetics|anesthetics|mesh-ancestor
65193475|NCT02689024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65193476|NCT02689024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193477|NCT02689024|Sensory System Agents|sensory system agents|mesh-ancestor
65193478|NCT02689024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65193479|NCT02689024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65193480|NCT02689024|Narcotics|narcotics|mesh-ancestor
65193481|NCT02689024|Analgesics|analgesics|mesh-ancestor
65193482|NCT02689024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65193483|NCT02689024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65193484|NCT02689024|Anesthetics, General|anesthetics, general|mesh-ancestor
65193485|NCT02689024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65193486|NCT02689024|Antipyretics|antipyretics|mesh-ancestor
65193487|NCT02689024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65193488|NCT02689024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65193489|NCT02689024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65193490|NCT02689024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65193491|NCT02689024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193492|NCT02689024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193493|NCT02689024|Gout Suppressants|gout suppressants|mesh-ancestor
65193494|NCT00638482|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65193495|NCT00638482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65193496|NCT00638482|Diuretics|diuretics|mesh-ancestor
65193497|NCT00638482|Natriuretic Agents|natriuretic agents|mesh-ancestor
65193498|NCT00638482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193502|NCT00638560|Vitamins|vitamins|mesh-list
65328399|NCT04067505|Rivaroxaban|rivaroxaban|mesh-list
65328400|NCT04067505|Anticoagulants|anticoagulants|mesh-ancestor
65328401|NCT04067505|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65328402|NCT04067505|Antithrombins|antithrombins|mesh-ancestor
65328403|NCT04067505|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65328404|NCT04067505|Protease Inhibitors|protease inhibitors|mesh-ancestor
65328405|NCT04067505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328406|NCT04067505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328407|NCT04067505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65328408|NCT04067505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65328409|NCT00794963|Metformin|metformin|mesh-list
65328410|NCT00794963|Orlistat|orlistat|mesh-list
65328411|NCT00794963|Irbesartan|irbesartan|mesh-list
65328412|NCT00794963|Fenofibrate|fenofibrate|mesh-list
65328413|NCT00794963|Pravastatin|pravastatin|mesh-list
65328414|NCT00794963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65328415|NCT00794963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328416|NCT00794963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65328417|NCT00794963|Antimetabolites|antimetabolites|mesh-ancestor
64714574|NCT03071744|Anesthetics|anesthetics|mesh-ancestor
65193503|NCT00638560|Vitamin E|vitamin e|mesh-list
65193504|NCT00638560|Antioxidants|antioxidants|mesh-list
65193505|NCT00638560|Micronutrients|micronutrients|mesh-ancestor
65193506|NCT00638560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193507|NCT00638560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193508|NCT00638560|Protective Agents|protective agents|mesh-ancestor
65193509|NCT00638638|Abciximab|abciximab|mesh-list
65193510|NCT00638638|Anticoagulants|anticoagulants|mesh-ancestor
65193511|NCT00638638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65193512|NCT02684812|Tranexamic Acid|tranexamic acid|mesh-list
65193513|NCT02684812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65193514|NCT02684812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65193515|NCT02684812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193516|NCT02684812|Hemostatics|hemostatics|mesh-ancestor
65193517|NCT02684812|Coagulants|coagulants|mesh-ancestor
65193518|NCT04203160|Gemcitabine|gemcitabine|mesh-list
65193519|NCT04203160|Cisplatin|cisplatin|mesh-list
65193520|NCT04203160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193521|NCT04203160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65193522|NCT04203160|Antimetabolites|antimetabolites|mesh-ancestor
65193523|NCT04203160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193524|NCT04203160|Antiviral Agents|antiviral agents|mesh-ancestor
65193525|NCT04203160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65193526|NCT04203160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193527|NCT04203160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65193528|NCT04203160|Immunologic Factors|immunologic factors|mesh-ancestor
65193529|NCT04203160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193530|NCT01004250|Bevacizumab|bevacizumab|mesh-list
65193531|NCT01004250|Pemetrexed|pemetrexed|mesh-list
65193532|NCT01004250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65193533|NCT01004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193534|NCT01004250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65193535|NCT01004250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65193536|NCT01004250|Growth Substances|growth substances|mesh-ancestor
65193537|NCT01004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193538|NCT01004250|Growth Inhibitors|growth inhibitors|mesh-ancestor
65193539|NCT01004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193540|NCT01004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193541|NCT01004250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65328418|NCT00794963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328419|NCT00794963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65328420|NCT00794963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65328421|NCT00794963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65328422|NCT00794963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328423|NCT00794963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65328424|NCT00794963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65328425|NCT00794963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65328426|NCT00794963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65328427|NCT00713271|AZD-3199|azd-3199|mesh-list
65328428|NCT00713271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65328429|NCT00713271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65328430|NCT00713271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65328431|NCT00713271|Adrenergic Agents|adrenergic agents|mesh-ancestor
65328432|NCT00713271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65328433|NCT00713271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328434|NCT00713271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328435|NCT05673135|Antihypertensive Agents|antihypertensive agents|mesh-list
65328436|NCT00722709|Ropivacaine|ropivacaine|mesh-list
65328437|NCT00722709|Anesthetics, Local|anesthetics, local|mesh-ancestor
65328438|NCT00722709|Anesthetics|anesthetics|mesh-ancestor
65328439|NCT00722709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65328440|NCT00722709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328441|NCT00722709|Sensory System Agents|sensory system agents|mesh-ancestor
65328442|NCT00722709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65328443|NCT04105205|Apramycin|apramycin|mesh-list
65328444|NCT04105205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65328445|NCT04105205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65328446|NCT00794573|Varenicline|varenicline|mesh-list
65328447|NCT00794573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65328448|NCT00794573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65328449|NCT00794573|Cholinergic Agents|cholinergic agents|mesh-ancestor
65328450|NCT00794573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64714590|NCT05404334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193542|NCT01004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65193543|NCT02688634|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65193544|NCT02688634|Amoxicillin|amoxicillin|mesh-list
65193545|NCT02688634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65193546|NCT00639496|Acetylcysteine|acetylcysteine|mesh-list
65328451|NCT00794573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328452|NCT00794573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328453|NCT05061654|Tazobactam|tazobactam|mesh-list
65328454|NCT05061654|Ceftolozane|ceftolozane|mesh-list
65328455|NCT05061654|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
65328456|NCT05061654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65328457|NCT05061654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65328458|NCT05061654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65328459|NCT05061654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328460|NCT05061654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328461|NCT05061654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65328462|NCT05061654|Renal Agents|renal agents|mesh-ancestor
65328463|NCT04070079|Tenofovir|tenofovir|mesh-list
65328464|NCT04070079|Antiviral Agents|antiviral agents|mesh-ancestor
65328465|NCT04070079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65328466|NCT04070079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65328467|NCT04070079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65328468|NCT04070079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328469|NCT04070079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328470|NCT04070079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65328471|NCT04070079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65328472|NCT00739934|Voriconazole|voriconazole|mesh-list
65328473|NCT00739934|Antifungal Agents|antifungal agents|mesh-ancestor
65328474|NCT00739934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65328475|NCT00739934|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65328476|NCT00739934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65328477|NCT00739934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328478|NCT00739934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328479|NCT00739934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65328480|NCT00739934|Hormone Antagonists|hormone antagonists|mesh-ancestor
65328481|NCT00739934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65328482|NCT00739934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328484|NCT00723411|Aluminum sulfate|aluminum sulfate|mesh-list
65328487|NCT00723411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328488|NCT02586636|Metformin|metformin|mesh-list
65328489|NCT02586636|Omeprazole|omeprazole|mesh-list
65328490|NCT02586636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65328491|NCT02586636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328492|NCT02586636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65193547|NCT00639496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65193548|NCT00639496|Antiviral Agents|antiviral agents|mesh-ancestor
65193549|NCT00639496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65193550|NCT00639496|Expectorants|expectorants|mesh-ancestor
65193551|NCT00639496|Respiratory System Agents|respiratory system agents|mesh-ancestor
65193552|NCT00639496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65193553|NCT00639496|Antioxidants|antioxidants|mesh-ancestor
65193554|NCT00639496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193555|NCT00639496|Protective Agents|protective agents|mesh-ancestor
65193556|NCT00639496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193557|NCT00639496|Antidotes|antidotes|mesh-ancestor
65193558|NCT02688400|Celecoxib|celecoxib|mesh-list
65193559|NCT02688400|Diacetylrhein|diacetylrhein|mesh-list
65193560|NCT02688400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65193561|NCT02688400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65193562|NCT02688400|Analgesics|analgesics|mesh-ancestor
65193563|NCT02688400|Sensory System Agents|sensory system agents|mesh-ancestor
65193564|NCT02688400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65193565|NCT02688400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193566|NCT02688400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65193567|NCT02688400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65193568|NCT02688400|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65193569|NCT02688400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65193570|NCT02688400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193576|NCT00639574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65193577|NCT00639574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193578|NCT02685046|Imatinib Mesylate|imatinib mesylate|mesh-list
65193579|NCT02685046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193580|NCT02685046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65193581|NCT02685046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193582|NCT02685046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193583|NCT01004172|Bevacizumab|bevacizumab|mesh-list
65193584|NCT01004172|Trastuzumab|trastuzumab|mesh-list
65193585|NCT01004172|Carboplatin|carboplatin|mesh-list
65193586|NCT01004172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65193587|NCT01004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193588|NCT01004172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65193589|NCT01004172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65193590|NCT01004172|Growth Substances|growth substances|mesh-ancestor
65193591|NCT01004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193592|NCT01004172|Growth Inhibitors|growth inhibitors|mesh-ancestor
65193593|NCT02688322|Sulbactam|sulbactam|mesh-list
65193594|NCT02688322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65193595|NCT02688322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65193596|NCT02688322|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65193597|NCT02688322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193598|NCT02688322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193600|NCT02685748|Pantoprazole|pantoprazole|mesh-list
65193601|NCT02685748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65193602|NCT02685748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65193603|NCT02685748|Analgesics|analgesics|mesh-ancestor
65193604|NCT02685748|Sensory System Agents|sensory system agents|mesh-ancestor
65193605|NCT02685748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65193606|NCT02685748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193607|NCT02685748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65193608|NCT02685748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65193609|NCT02685748|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65193610|NCT02685748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65193611|NCT02685748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193612|NCT02685748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65193613|NCT02685748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65193614|NCT02685748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193615|NCT02685748|Antipyretics|antipyretics|mesh-ancestor
65193616|NCT02685748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65328493|NCT02586636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65328494|NCT02586636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65328495|NCT02586636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328496|NCT02586636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328497|NCT00713739|Prazosin|prazosin|mesh-list
65328498|NCT00713739|Doxazosin|doxazosin|mesh-list
65328499|NCT00713739|Nifedipine|nifedipine|mesh-list
65328500|NCT00713739|Alfuzosin|alfuzosin|mesh-list
65328501|NCT00713739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65328502|NCT00713739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65328503|NCT00713739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675012|NCT02988908|Donepezil|donepezil|mesh-list
65193617|NCT02685748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65193618|NCT02685748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65193619|NCT02685670|Cyclophosphamide|cyclophosphamide|mesh-list
65193620|NCT02685670|Fludarabine|fludarabine|mesh-list
65193621|NCT02685670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65193622|NCT02685670|Immunologic Factors|immunologic factors|mesh-ancestor
65193623|NCT02685670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193624|NCT02685670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65193625|NCT02685670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65193626|NCT02685670|Alkylating Agents|alkylating agents|mesh-ancestor
65193627|NCT02685670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193628|NCT02685670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193629|NCT02685670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65193630|NCT02687932|Valsartan|valsartan|mesh-list
65193631|NCT02687932|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65193632|NCT02687932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65193633|NCT02687932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65193634|NCT02687932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65193635|NCT02687932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193636|NCT00641602|Esomeprazole|esomeprazole|mesh-list
65193637|NCT00641602|Lansoprazole|lansoprazole|mesh-list
65193638|NCT00641602|Dexlansoprazole|dexlansoprazole|mesh-list
65193639|NCT00641602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65193640|NCT00641602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65193648|NCT05663944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65193649|NCT05663944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193650|NCT05663944|Antifungal Agents|antifungal agents|mesh-ancestor
65193651|NCT05663944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65193652|NCT05663944|Immunologic Factors|immunologic factors|mesh-ancestor
65193653|NCT05663944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193654|NCT05663944|Hematinics|hematinics|mesh-ancestor
65193655|NCT02682862|Bromides|bromides|mesh-list
65193656|NCT02682862|Tiotropium Bromide|tiotropium bromide|mesh-list
65193657|NCT02682862|Olodaterol|olodaterol|mesh-list
65193658|NCT02682862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65193659|NCT02682862|Autonomic Agents|autonomic agents|mesh-ancestor
65193660|NCT02682862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65193661|NCT02682862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193662|NCT02682862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65193663|NCT02682862|Respiratory System Agents|respiratory system agents|mesh-ancestor
65193664|NCT02682862|Parasympatholytics|parasympatholytics|mesh-ancestor
65193665|NCT02682862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65193666|NCT02682862|Cholinergic Agents|cholinergic agents|mesh-ancestor
65193667|NCT02682862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65193668|NCT02682862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193669|NCT02682862|Anticonvulsants|anticonvulsants|mesh-ancestor
65193670|NCT02073838|Ribavirin|ribavirin|mesh-list
65193671|NCT02073838|Decitabine|decitabine|mesh-list
65193672|NCT02073838|Antimetabolites|antimetabolites|mesh-ancestor
65193673|NCT02073838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193675|NCT02073838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65193676|NCT02073838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65328504|NCT00713739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65328505|NCT00713739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328506|NCT00713739|Vasodilator Agents|vasodilator agents|mesh-ancestor
65328507|NCT00713739|Tocolytic Agents|tocolytic agents|mesh-ancestor
65328508|NCT00713739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65328509|NCT00713739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65328510|NCT00713739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65328511|NCT00713739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65328512|NCT00713739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65328513|NCT00713739|Adrenergic Agents|adrenergic agents|mesh-ancestor
65328514|NCT00713739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65328515|NCT00713739|Urological Agents|urological agents|mesh-ancestor
65328516|NCT02595476|Remifentanil|remifentanil|mesh-list
65328517|NCT02595476|Propofol|propofol|mesh-list
65328518|NCT02595476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65328519|NCT02595476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65328520|NCT02595476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328521|NCT02595476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65328522|NCT02595476|Anesthetics, General|anesthetics, general|mesh-ancestor
65328523|NCT02595476|Anesthetics|anesthetics|mesh-ancestor
65328524|NCT02595476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65328525|NCT02595476|Narcotics|narcotics|mesh-ancestor
65328526|NCT02595476|Analgesics|analgesics|mesh-ancestor
65328527|NCT02595476|Sensory System Agents|sensory system agents|mesh-ancestor
65328528|NCT02595476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65328529|NCT02586402|Epoetin Alfa|epoetin alfa|mesh-list
65193677|NCT02073838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193678|NCT02073838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193679|NCT00640198|Memantine|memantine|mesh-list
65193680|NCT00640198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65193681|NCT00640198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65193682|NCT00640198|Dopamine Agents|dopamine agents|mesh-ancestor
65193683|NCT00640198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65193684|NCT00640198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193685|NCT00640198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193686|NCT00640198|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65193687|NCT00640198|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65193688|NCT02031250|Carboplatin|carboplatin|mesh-list
65193689|NCT02031250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193690|NCT04293822|Cetirizine|cetirizine|mesh-list
65193691|NCT04293822|Minoxidil|minoxidil|mesh-list
65193692|NCT04293822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65193693|NCT04293822|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65193694|NCT04293822|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65193695|NCT04293822|Histamine Antagonists|histamine antagonists|mesh-ancestor
65193696|NCT04293822|Histamine Agents|histamine agents|mesh-ancestor
65193697|NCT04293822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65193698|NCT04293822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193699|NCT04293822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328530|NCT02586402|Hematinics|hematinics|mesh-ancestor
65328531|NCT00734630|Losartan|losartan|mesh-list
65328532|NCT00734630|Lisinopril|lisinopril|mesh-list
65328533|NCT00734630|Nebivolol|nebivolol|mesh-list
65328534|NCT00734630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65328535|NCT00734630|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65328536|NCT00734630|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65328537|NCT00734630|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65328538|NCT00734630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328539|NCT00734630|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65328540|NCT00734630|Protease Inhibitors|protease inhibitors|mesh-ancestor
65328541|NCT00734630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328542|NCT00734630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65328543|NCT00734630|Protective Agents|protective agents|mesh-ancestor
65328544|NCT00734630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328545|NCT00734630|Vasodilator Agents|vasodilator agents|mesh-ancestor
65328546|NCT00734630|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65328547|NCT00734630|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65328548|NCT00734630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65328549|NCT00734630|Adrenergic Agents|adrenergic agents|mesh-ancestor
65328550|NCT00734630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65328551|NCT05636514|Decitabine|decitabine|mesh-list
65328552|NCT05636514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65328553|NCT05636514|Antimetabolites|antimetabolites|mesh-ancestor
65328554|NCT05636514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193700|NCT04293822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65193701|NCT04293822|Vasodilator Agents|vasodilator agents|mesh-ancestor
65193702|NCT02680600|Cefepime|cefepime|mesh-list
65193703|NCT02680600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65193704|NCT02680600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65193705|NCT02680678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65193706|NCT04182724|Paclitaxel|paclitaxel|mesh-list
65193707|NCT04182724|Apatinib|apatinib|mesh-list
65193708|NCT04182724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65193709|NCT04182724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193710|NCT04182724|Tubulin Modulators|tubulin modulators|mesh-ancestor
65193711|NCT04182724|Antimitotic Agents|antimitotic agents|mesh-ancestor
65193715|NCT04182724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193717|NCT04184518|Cediranib|cediranib|mesh-list
65193718|NCT04184518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65193719|NCT04184518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193720|NCT04184518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193721|NCT04184518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193722|NCT04184518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65193723|NCT01174238|Paclitaxel|paclitaxel|mesh-list
65193724|NCT01174238|Carboplatin|carboplatin|mesh-list
65193725|NCT01174238|Axitinib|axitinib|mesh-list
65193726|NCT01174238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65193727|NCT01174238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193728|NCT01174238|Tubulin Modulators|tubulin modulators|mesh-ancestor
65193729|NCT01174238|Antimitotic Agents|antimitotic agents|mesh-ancestor
65328555|NCT05636514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328556|NCT05636514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328557|NCT02586246|Certolizumab Pegol|certolizumab pegol|mesh-list
65328558|NCT02586246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65328559|NCT02586246|Immunologic Factors|immunologic factors|mesh-ancestor
65328560|NCT02586246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328561|NCT02586246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65328562|NCT00920244|Atropine|atropine|mesh-list
65328563|NCT00920244|Amiodarone|amiodarone|mesh-list
65328564|NCT00920244|Epinephrine|epinephrine|mesh-list
65328565|NCT00920244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65328566|NCT00920244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65328567|NCT00920244|Adrenergic Agents|adrenergic agents|mesh-ancestor
65328568|NCT00920244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65328569|NCT00920244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714742|NCT02953873|Antiemetics|antiemetics|mesh-ancestor
65193730|NCT01174238|Mitosis Modulators|mitosis modulators|mesh-ancestor
65193731|NCT01174238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193732|NCT01174238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65193733|NCT01174238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193734|NCT05663710|Nivolumab|nivolumab|mesh-list
65193735|NCT05663710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65193736|NCT05663710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193737|NCT05663710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65193738|NCT05663710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193739|NCT02928406|Atezolizumab|atezolizumab|mesh-list
65193740|NCT02928406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193741|NCT04315454|Levobupivacaine|levobupivacaine|mesh-list
65193742|NCT04315454|Anesthetics, Local|anesthetics, local|mesh-ancestor
65193743|NCT04315454|Anesthetics|anesthetics|mesh-ancestor
65193744|NCT04315454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65193745|NCT04315454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193746|NCT04315454|Sensory System Agents|sensory system agents|mesh-ancestor
64950915|NCT00395174|Hemagglutinins|hemagglutinins|mesh-list
65193747|NCT04315454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65193748|NCT01161446|Antibodies|antibodies|mesh-list
65193749|NCT01161446|Immunoglobulins|immunoglobulins|mesh-list
65193750|NCT01161446|Immunologic Factors|immunologic factors|mesh-ancestor
65193751|NCT01161446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193752|NCT00641680|Fluticasone|fluticasone|mesh-list
65193753|NCT00641680|Xhance|xhance|mesh-list
65193754|NCT00641680|Budesonide|budesonide|mesh-list
65193755|NCT00641680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65193756|NCT00641680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65193757|NCT00641680|Autonomic Agents|autonomic agents|mesh-ancestor
65193758|NCT00641680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65193759|NCT00641680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193760|NCT00641680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65193761|NCT00641680|Respiratory System Agents|respiratory system agents|mesh-ancestor
65193762|NCT00641680|Dermatologic Agents|dermatologic agents|mesh-ancestor
65193763|NCT00641680|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65193764|NCT00641680|Glucocorticoids|glucocorticoids|mesh-ancestor
65193765|NCT00641680|Hormones|hormones|mesh-ancestor
65193766|NCT00641680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65193767|NCT01174004|Pimavanserin|pimavanserin|mesh-list
65193768|NCT01174004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65193769|NCT01174004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65193770|NCT01174004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65193771|NCT01174004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65193772|NCT01174004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65193773|NCT01174004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328570|NCT00920244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328571|NCT00920244|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65328572|NCT00920244|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65328573|NCT00920244|Autonomic Agents|autonomic agents|mesh-ancestor
65328574|NCT00920244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65328575|NCT00920244|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65328576|NCT00920244|Respiratory System Agents|respiratory system agents|mesh-ancestor
65328577|NCT00920244|Mydriatics|mydriatics|mesh-ancestor
65328578|NCT00920244|Sympathomimetics|sympathomimetics|mesh-ancestor
65328579|NCT00920244|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65328580|NCT00920244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65328581|NCT00920244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65328582|NCT00920244|Parasympatholytics|parasympatholytics|mesh-ancestor
65328583|NCT00920244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65328584|NCT00920244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65328585|NCT00920244|Cholinergic Agents|cholinergic agents|mesh-ancestor
65328586|NCT00920244|Vasodilator Agents|vasodilator agents|mesh-ancestor
65328587|NCT00920244|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65328588|NCT00920244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65328589|NCT00920244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65193774|NCT01174004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65193775|NCT01174004|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65193776|NCT01174004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65193777|NCT01174004|Serotonin Agents|serotonin agents|mesh-ancestor
65193778|NCT01174004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65193779|NCT01174004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193780|NCT01173692|Minocycline|minocycline|mesh-list
65193781|NCT01173692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65193782|NCT01173692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65193785|NCT00641758|Immunologic Factors|immunologic factors|mesh-ancestor
65193786|NCT00641758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193788|NCT00641758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193789|NCT00641758|Protective Agents|protective agents|mesh-ancestor
65193790|NCT00641758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65193791|NCT00640276|Pitavastatin|pitavastatin|mesh-list
65193792|NCT00640276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65193793|NCT00640276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65193794|NCT00640276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65193795|NCT00640276|Antimetabolites|antimetabolites|mesh-ancestor
65193796|NCT00640276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193797|NCT00640276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193798|NCT00640276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65193799|NCT02680132|Esomeprazole|esomeprazole|mesh-list
65193800|NCT02680132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65193802|NCT02680132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65193803|NCT02680132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193804|NCT02680132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193805|NCT02683564|Infliximab|infliximab|mesh-list
65193806|NCT02683564|Dermatologic Agents|dermatologic agents|mesh-ancestor
65193807|NCT02683564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65193808|NCT02683564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65193809|NCT01101035|Allopurinol|allopurinol|mesh-list
65193810|NCT01101035|Febuxostat|febuxostat|mesh-list
65193811|NCT01101035|Antimetabolites|antimetabolites|mesh-ancestor
65328590|NCT00920244|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65328591|NCT00920244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65328592|NCT00920244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328593|NCT00920244|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65328594|NCT00920244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65328595|NCT00920244|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65328596|NCT00578175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64714763|NCT00375596|Histamine Agents|histamine agents|mesh-ancestor
65193812|NCT01101035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193813|NCT01101035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193814|NCT01101035|Gout Suppressants|gout suppressants|mesh-ancestor
65193815|NCT01101035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65193816|NCT01101035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65193817|NCT01101035|Antioxidants|antioxidants|mesh-ancestor
65193818|NCT01101035|Protective Agents|protective agents|mesh-ancestor
65193819|NCT01101035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193820|NCT01160822|Naproxen|naproxen|mesh-list
65193821|NCT01160822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65193822|NCT01160822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65193823|NCT01160822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65193824|NCT01160822|Analgesics|analgesics|mesh-ancestor
65193825|NCT01160822|Sensory System Agents|sensory system agents|mesh-ancestor
65193826|NCT01160822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65193827|NCT01160822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193828|NCT01160822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65193829|NCT01160822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65193830|NCT01160822|Gout Suppressants|gout suppressants|mesh-ancestor
65193831|NCT01160822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65193832|NCT01160822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193833|NCT01160822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193834|NCT01160822|Immunologic Factors|immunologic factors|mesh-ancestor
65193835|NCT01006980|Dacarbazine|dacarbazine|mesh-list
65193836|NCT01006980|Vemurafenib|vemurafenib|mesh-list
65193837|NCT01006980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65193838|NCT01006980|Alkylating Agents|alkylating agents|mesh-ancestor
65193839|NCT01006980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193840|NCT01006980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193841|NCT01006980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65193842|NCT01006980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193843|NCT04296240|Capecitabine|capecitabine|mesh-list
65193844|NCT04296240|Oxaliplatin|oxaliplatin|mesh-list
65193845|NCT04296240|Antiemetics|antiemetics|mesh-list
65193846|NCT04296240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65193847|NCT04296240|Antimetabolites|antimetabolites|mesh-ancestor
65193848|NCT04296240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193849|NCT04296240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193850|NCT04296240|Autonomic Agents|autonomic agents|mesh-ancestor
65193851|NCT04296240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65193852|NCT04296240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193853|NCT04296240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65193854|NCT04205058|Caffeine|caffeine|mesh-list
65193855|NCT04205058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65193856|NCT04205058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193860|NCT04205058|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65193861|NCT04205058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65193862|NCT04205058|Purinergic Agents|purinergic agents|mesh-ancestor
65193863|NCT04205058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65193864|NCT04183738|Ritonavir|ritonavir|mesh-list
65193865|NCT04183738|Darunavir|darunavir|mesh-list
65193866|NCT04183738|Dolutegravir|dolutegravir|mesh-list
65193867|NCT04183738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65193868|NCT04183738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65193869|NCT04183738|Protease Inhibitors|protease inhibitors|mesh-ancestor
65193870|NCT04183738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328597|NCT00578175|Immunologic Factors|immunologic factors|mesh-ancestor
65328598|NCT00578175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328599|NCT00723879|Ribavirin|ribavirin|mesh-list
65328600|NCT00723879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65328601|NCT00723879|Antimetabolites|antimetabolites|mesh-ancestor
65328602|NCT00723879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328603|NCT00723879|Antiviral Agents|antiviral agents|mesh-ancestor
65328604|NCT00723879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65328606|NCT03907605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65328607|NCT03907605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328608|NCT00435409|Capecitabine|capecitabine|mesh-list
65328609|NCT00435409|Sunitinib|sunitinib|mesh-list
65193871|NCT04183738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193872|NCT04183738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65193873|NCT04183738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65193874|NCT04183738|Antiviral Agents|antiviral agents|mesh-ancestor
65193875|NCT04183738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65193876|NCT04183738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65193877|NCT04183738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65193878|NCT04183738|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65193879|NCT04183738|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65193880|NCT04204980|Daratumumab|daratumumab|mesh-list
65193881|NCT04204980|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65193882|NCT04204980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193883|NCT04204980|Immunologic Factors|immunologic factors|mesh-ancestor
65193884|NCT04204980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193885|NCT05664568|Amoxicillin|amoxicillin|mesh-list
65193886|NCT05664568|Clavulanic Acid|clavulanic acid|mesh-list
65193887|NCT05664568|Clavulanic Acids|clavulanic acids|mesh-list
65193888|NCT05664568|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65193889|NCT05664568|Cephalexin|cephalexin|mesh-list
65193890|NCT05664568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65193891|NCT05664568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65193892|NCT05664568|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65193893|NCT05664568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193894|NCT05664568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193895|NCT02682082|Bupivacaine|bupivacaine|mesh-list
65193896|NCT02682082|Anesthetics, Local|anesthetics, local|mesh-ancestor
65193897|NCT02682082|Anesthetics|anesthetics|mesh-ancestor
65193898|NCT02682082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65193899|NCT02682082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193901|NCT02682082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65193902|NCT00640432|Celecoxib|celecoxib|mesh-list
65193903|NCT00640432|Diclofenac|diclofenac|mesh-list
65193904|NCT00640432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65193905|NCT00640432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65193906|NCT00640432|Analgesics|analgesics|mesh-ancestor
65193907|NCT00640432|Sensory System Agents|sensory system agents|mesh-ancestor
65193908|NCT00640432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65193909|NCT00640432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193910|NCT00640432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65193911|NCT00640432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65193912|NCT00640432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65193913|NCT00640432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65193914|NCT00640432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193915|NCT00640432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193916|NCT02679664|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65193917|NCT02679664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65193918|NCT02679664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65193919|NCT02679664|Antimetabolites|antimetabolites|mesh-ancestor
65193920|NCT02679664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193921|NCT02679664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65328610|NCT00435409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65328611|NCT00435409|Antimetabolites|antimetabolites|mesh-ancestor
65328612|NCT00435409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328613|NCT00435409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328614|NCT00435409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65328615|NCT00435409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65328616|NCT00435409|Growth Substances|growth substances|mesh-ancestor
65328617|NCT00435409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328618|NCT00435409|Growth Inhibitors|growth inhibitors|mesh-ancestor
65328619|NCT00435409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65328620|NCT00435409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328621|NCT00724035|Fentanyl|fentanyl|mesh-list
65328622|NCT00724035|Midazolam|midazolam|mesh-list
65328623|NCT00724035|Analgesics|analgesics|mesh-list
65328624|NCT00724035|Anesthetics|anesthetics|mesh-list
65328625|NCT00724035|Ropivacaine|ropivacaine|mesh-list
65328626|NCT00724035|Anesthetics, Local|anesthetics, local|mesh-list
65328627|NCT00724035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65328628|NCT00724035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328629|NCT00724035|Sensory System Agents|sensory system agents|mesh-ancestor
65328630|NCT00724035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65328631|NCT00724035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65328632|NCT00724035|Narcotics|narcotics|mesh-ancestor
65328633|NCT00724035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65328634|NCT00724035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65328635|NCT00724035|Anesthetics, General|anesthetics, general|mesh-ancestor
65328636|NCT00724035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65328637|NCT00724035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65328638|NCT00724035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65328639|NCT00724035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65328640|NCT00724035|GABA Modulators|gaba modulators|mesh-ancestor
65328641|NCT00724035|GABA Agents|gaba agents|mesh-ancestor
65328642|NCT00724035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65328653|NCT04126824|Glucocorticoids|glucocorticoids|mesh-ancestor
65328654|NCT04126824|Hormones|hormones|mesh-ancestor
65328655|NCT04126824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65328656|NCT00724113|Lidocaine|lidocaine|mesh-list
65328657|NCT00724113|Anesthetics, Local|anesthetics, local|mesh-ancestor
65328658|NCT00724113|Anesthetics|anesthetics|mesh-ancestor
65328659|NCT00724113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65328660|NCT00724113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328661|NCT00724113|Sensory System Agents|sensory system agents|mesh-ancestor
65328662|NCT00724113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65328663|NCT00724113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65328664|NCT00724113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65193922|NCT02679664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65193923|NCT02679664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193924|NCT00641212|Budesonide|budesonide|mesh-list
65193925|NCT00641212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65193926|NCT00641212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65193927|NCT00641212|Autonomic Agents|autonomic agents|mesh-ancestor
65193928|NCT00641212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65193931|NCT00641212|Respiratory System Agents|respiratory system agents|mesh-ancestor
65193932|NCT00641212|Glucocorticoids|glucocorticoids|mesh-ancestor
65193933|NCT00641212|Hormones|hormones|mesh-ancestor
65193934|NCT00641212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65193935|NCT04183192|Reslizumab|reslizumab|mesh-list
65193936|NCT04183192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65193937|NCT04183192|Respiratory System Agents|respiratory system agents|mesh-ancestor
65193938|NCT02681848|Nicotine|nicotine|mesh-list
65193939|NCT02681848|Varenicline|varenicline|mesh-list
65193940|NCT02681848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65193941|NCT02681848|Autonomic Agents|autonomic agents|mesh-ancestor
65193942|NCT02681848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65193943|NCT02681848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193944|NCT02681848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65193945|NCT02681848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65193946|NCT02681848|Cholinergic Agents|cholinergic agents|mesh-ancestor
65193947|NCT02681848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65193948|NCT02681848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193949|NCT00997386|Melphalan|melphalan|mesh-list
65193950|NCT00997386|Busulfan|busulfan|mesh-list
65193951|NCT00997386|Alemtuzumab|alemtuzumab|mesh-list
65193952|NCT00997386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65193953|NCT00997386|Alkylating Agents|alkylating agents|mesh-ancestor
65193954|NCT00997386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193955|NCT00997386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193956|NCT00997386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65193957|NCT00997386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65193958|NCT00997386|Immunologic Factors|immunologic factors|mesh-ancestor
65193959|NCT00997386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193960|NCT00997386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65193961|NCT02679820|Copper|copper|mesh-list
65193962|NCT02679820|Trace Elements|trace elements|mesh-ancestor
65193963|NCT02679820|Micronutrients|micronutrients|mesh-ancestor
65193964|NCT02679820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193965|NCT00641914|Budesonide|budesonide|mesh-list
65193966|NCT00641914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65193967|NCT00641914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65193968|NCT00641914|Autonomic Agents|autonomic agents|mesh-ancestor
65193969|NCT00641914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65193970|NCT00641914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193971|NCT00641914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65193972|NCT00641914|Respiratory System Agents|respiratory system agents|mesh-ancestor
65193973|NCT00641914|Glucocorticoids|glucocorticoids|mesh-ancestor
65193974|NCT00641914|Hormones|hormones|mesh-ancestor
65328665|NCT00724113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65328666|NCT00724113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65328667|NCT00724113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328668|NCT04070001|Ibuprofen|ibuprofen|mesh-list
65328669|NCT04070001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65328670|NCT04070001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65328671|NCT04070001|Analgesics|analgesics|mesh-ancestor
65193975|NCT00641914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65193977|NCT00640588|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65193978|NCT00640588|Telbivudine|telbivudine|mesh-list
65193979|NCT00640588|Antiviral Agents|antiviral agents|mesh-ancestor
65193980|NCT00640588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65193981|NCT00640588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65193982|NCT00640588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65193983|NCT00640588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193984|NCT00640588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193985|NCT05663398|Ibuprofen|ibuprofen|mesh-list
65193986|NCT05663398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65193987|NCT05663398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65193988|NCT05663398|Analgesics|analgesics|mesh-ancestor
65193989|NCT05663398|Sensory System Agents|sensory system agents|mesh-ancestor
65193990|NCT05663398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65193991|NCT05663398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193992|NCT05663398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65193993|NCT05663398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65193994|NCT05663398|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65193995|NCT05663398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193996|NCT05663398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193997|NCT00640744|Atorvastatin|atorvastatin|mesh-list
65193998|NCT00640744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65193999|NCT00640744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65194000|NCT00640744|Antimetabolites|antimetabolites|mesh-ancestor
65194001|NCT00640744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194002|NCT00640744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65194006|NCT02678104|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65194007|NCT02678104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65194008|NCT02678104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65194009|NCT02678104|Disinfectants|disinfectants|mesh-ancestor
65194010|NCT02678104|Dermatologic Agents|dermatologic agents|mesh-ancestor
65194011|NCT02681536|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65194012|NCT02681536|Contraceptive Agents|contraceptive agents|mesh-list
65194013|NCT02681536|Contraceptives, Oral|contraceptives, oral|mesh-list
65194014|NCT02681536|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65194015|NCT02681536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65194016|NCT02681536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194017|NCT02681536|Luteolytic Agents|luteolytic agents|mesh-ancestor
65194018|NCT02681536|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65194019|NCT02681536|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65194020|NCT02681536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65194021|NCT02681536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194022|NCT04183114|Vaccines|vaccines|mesh-list
65194023|NCT04183114|Immunologic Factors|immunologic factors|mesh-ancestor
65194024|NCT04183114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194026|NCT00996996|Tositumomab I-131|tositumomab i-131|mesh-list
65194027|NCT00996996|Antibodies|antibodies|mesh-list
65194028|NCT00996996|Immunoglobulins|immunoglobulins|mesh-list
65194029|NCT00996996|Immunologic Factors|immunologic factors|mesh-ancestor
65194030|NCT00996996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194031|NCT00996996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65194032|NCT00996996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65194033|NCT00996996|Trace Elements|trace elements|mesh-ancestor
65194034|NCT00996996|Micronutrients|micronutrients|mesh-ancestor
65194035|NCT00996996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194036|NCT04182568|Paclitaxel|paclitaxel|mesh-list
65194037|NCT04182568|Docetaxel|docetaxel|mesh-list
65194038|NCT04182568|Cyclophosphamide|cyclophosphamide|mesh-list
65194039|NCT04182568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65328672|NCT04070001|Sensory System Agents|sensory system agents|mesh-ancestor
65328673|NCT04070001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65328674|NCT04070001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328675|NCT04070001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65328676|NCT04070001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65328677|NCT04070001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65328678|NCT04070001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328679|NCT04070001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328680|NCT00435019|Insulin|insulin|mesh-list
65328681|NCT00435019|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65328682|NCT00435019|Insulin Aspart|insulin aspart|mesh-list
65328683|NCT00435019|Insulin Detemir|insulin detemir|mesh-list
64714848|NCT03098420|Antiemetics|antiemetics|mesh-ancestor
65194040|NCT04182568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194041|NCT04182568|Tubulin Modulators|tubulin modulators|mesh-ancestor
65194042|NCT04182568|Antimitotic Agents|antimitotic agents|mesh-ancestor
65194043|NCT04182568|Mitosis Modulators|mitosis modulators|mesh-ancestor
65194044|NCT04182568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194045|NCT04182568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65194046|NCT04182568|Immunologic Factors|immunologic factors|mesh-ancestor
65194047|NCT04182568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194048|NCT04182568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65194049|NCT04182568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65194051|NCT04182568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65194052|NCT00641446|Budesonide|budesonide|mesh-list
65194053|NCT00641446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65194054|NCT00641446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65194055|NCT00641446|Autonomic Agents|autonomic agents|mesh-ancestor
65194056|NCT00641446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65194057|NCT00641446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194058|NCT00641446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65194059|NCT00641446|Respiratory System Agents|respiratory system agents|mesh-ancestor
65194060|NCT00641446|Glucocorticoids|glucocorticoids|mesh-ancestor
65194061|NCT00641446|Hormones|hormones|mesh-ancestor
65194062|NCT00641446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65194063|NCT02678182|Capecitabine|capecitabine|mesh-list
65194064|NCT02678182|Trastuzumab|trastuzumab|mesh-list
65194065|NCT02678182|Durvalumab|durvalumab|mesh-list
65194066|NCT02678182|Ramucirumab|ramucirumab|mesh-list
65194067|NCT02678182|Rucaparib|rucaparib|mesh-list
65194068|NCT02678182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65194069|NCT02678182|Antimetabolites|antimetabolites|mesh-ancestor
65194070|NCT02678182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194071|NCT02678182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194072|NCT02678182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65194073|NCT02678182|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65194074|NCT02678182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194075|NCT02679040|Trastuzumab|trastuzumab|mesh-list
65194076|NCT02679040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65194081|NCT05663242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65194082|NCT05663242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194083|NCT05663242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65194084|NCT05663242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65194085|NCT05663242|Anesthetics, General|anesthetics, general|mesh-ancestor
65194086|NCT05663242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65194087|NCT05663242|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65194088|NCT05663164|Thiamine|thiamine|mesh-list
65194089|NCT05663164|Vitamins|vitamins|mesh-ancestor
65194090|NCT05663164|Micronutrients|micronutrients|mesh-ancestor
65194091|NCT05663164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194092|NCT05663164|Vitamin B Complex|vitamin b complex|mesh-ancestor
65194093|NCT02537470|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
65328684|NCT00435019|Isophane Insulin, Human|isophane insulin, human|mesh-list
65328685|NCT00435019|Insulin, Isophane|insulin, isophane|mesh-list
65328686|NCT00435019|Isophane insulin, beef|isophane insulin, beef|mesh-list
65328687|NCT00435019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65328688|NCT00435019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328689|NCT00724581|Amiodarone|amiodarone|mesh-list
65328690|NCT00724581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65328691|NCT00724581|Vasodilator Agents|vasodilator agents|mesh-ancestor
65328692|NCT00724581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65328693|NCT00724581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65328694|NCT00724581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328695|NCT00724581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65328696|NCT00724581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65328697|NCT00724581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65328698|NCT00724581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328699|NCT00724581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65328700|NCT00724581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65328701|NCT00724581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65328702|NCT02570841|Capsaicin|capsaicin|mesh-list
65328703|NCT02570841|Antipruritics|antipruritics|mesh-ancestor
65328704|NCT02570841|Dermatologic Agents|dermatologic agents|mesh-ancestor
65328705|NCT02570841|Sensory System Agents|sensory system agents|mesh-ancestor
65328706|NCT02570841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65328707|NCT02570841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328708|NCT04067037|Vincristine|vincristine|mesh-list
65194094|NCT02537470|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65194095|NCT02537470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194096|NCT02537470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65194097|NCT02537470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194098|NCT02678728|Dexmedetomidine|dexmedetomidine|mesh-list
65194099|NCT02678728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65194100|NCT02678728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65194101|NCT02678728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836698|NCT01614405|Ritonavir|ritonavir|mesh-list
65194102|NCT02678728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65194104|NCT02678728|Sensory System Agents|sensory system agents|mesh-ancestor
65194105|NCT02678728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65194106|NCT02678728|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65194107|NCT02678728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65194108|NCT02678728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65194109|NCT02678728|Adrenergic Agents|adrenergic agents|mesh-ancestor
65194110|NCT02678728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65194111|NCT02678728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194112|NCT04180072|Bevacizumab|bevacizumab|mesh-list
65194113|NCT04180072|Atezolizumab|atezolizumab|mesh-list
65194114|NCT04180072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65328709|NCT04067037|Epirubicin|epirubicin|mesh-list
65328710|NCT04067037|Dacarbazine|dacarbazine|mesh-list
65328711|NCT04067037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65328712|NCT04067037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328713|NCT04067037|Tubulin Modulators|tubulin modulators|mesh-ancestor
65328714|NCT04067037|Antimitotic Agents|antimitotic agents|mesh-ancestor
65328715|NCT04067037|Mitosis Modulators|mitosis modulators|mesh-ancestor
65328716|NCT04067037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328717|NCT04067037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65328718|NCT04067037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65328719|NCT04067037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65328720|NCT04067037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328721|NCT04067037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65328722|NCT04067037|Alkylating Agents|alkylating agents|mesh-ancestor
65328723|NCT04730544|Nivolumab|nivolumab|mesh-list
65328724|NCT04730544|Ipilimumab|ipilimumab|mesh-list
65328725|NCT04730544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65328726|NCT04730544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328727|NCT04730544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65328728|NCT04730544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328729|NCT04666038|Rituximab|rituximab|mesh-list
65328730|NCT04666038|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65194115|NCT04180072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194116|NCT04180072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65194117|NCT04180072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65194118|NCT04180072|Growth Substances|growth substances|mesh-ancestor
65194119|NCT04180072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194120|NCT04180072|Growth Inhibitors|growth inhibitors|mesh-ancestor
65194121|NCT02678650|Anesthetics|anesthetics|mesh-list
65194122|NCT02678650|Propofol|propofol|mesh-list
65194123|NCT02678650|Isoflurane|isoflurane|mesh-list
65194124|NCT02678650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65194125|NCT02678650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194126|NCT02678650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65194127|NCT02678650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65194128|NCT02678650|Anesthetics, General|anesthetics, general|mesh-ancestor
65194129|NCT02678650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65194130|NCT04180150|Entecavir|entecavir|mesh-list
65194131|NCT04180150|Antiviral Agents|antiviral agents|mesh-ancestor
65194132|NCT04180150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65194133|NCT02678338|Magrolimab|magrolimab|mesh-list
65194134|NCT02678338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65194135|NCT02678338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194136|NCT00642226|Triamcinolone|triamcinolone|mesh-list
65194137|NCT00642226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65194138|NCT00642226|Glucocorticoids|glucocorticoids|mesh-ancestor
65194139|NCT00642226|Hormones|hormones|mesh-ancestor
65194140|NCT00642226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65194141|NCT00642226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194142|NCT05511610|Sevoflurane|sevoflurane|mesh-list
65194143|NCT05511610|Desflurane|desflurane|mesh-list
65194144|NCT05511610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65194145|NCT05511610|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65194146|NCT05511610|Anesthetics, General|anesthetics, general|mesh-ancestor
65194147|NCT05511610|Anesthetics|anesthetics|mesh-ancestor
65328731|NCT04666038|Idelalisib|idelalisib|mesh-list
65328732|NCT04666038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65328733|NCT04666038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328734|NCT04666038|Immunologic Factors|immunologic factors|mesh-ancestor
65328735|NCT04666038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328736|NCT04666038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65328737|NCT04666038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65328738|NCT04666038|Alkylating Agents|alkylating agents|mesh-ancestor
65328739|NCT04666038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328740|NCT04666038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328741|NCT00577863|Teriparatide|teriparatide|mesh-list
65328742|NCT00577863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65328743|NCT00577863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328744|NCT00577863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65328745|NCT04663308|Volixibat|volixibat|mesh-list
65328746|NCT04663308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65328747|NCT04956627|Itraconazole|itraconazole|mesh-list
65328748|NCT04956627|Phenytoin|phenytoin|mesh-list
65328749|NCT04956627|Gemfibrozil|gemfibrozil|mesh-list
65328750|NCT04956627|Antifungal Agents|antifungal agents|mesh-ancestor
65194148|NCT05511610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65194149|NCT05511610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194153|NCT02675530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65194154|NCT02675530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194155|NCT02675530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65194156|NCT02675530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65194157|NCT02675530|Anesthetics, General|anesthetics, general|mesh-ancestor
65194158|NCT02675530|Anesthetics|anesthetics|mesh-ancestor
65194159|NCT02675530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65194160|NCT02675530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65194161|NCT02675530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65194162|NCT02675530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65194163|NCT02675530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194164|NCT02675374|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
65194165|NCT02675374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65194166|NCT02675374|Histamine Antagonists|histamine antagonists|mesh-ancestor
65194167|NCT02675374|Histamine Agents|histamine agents|mesh-ancestor
65194168|NCT02675374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65194169|NCT02675374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194170|NCT02675374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194171|NCT02678260|Spartalizumab|spartalizumab|mesh-list
65194172|NCT02678260|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65194173|NCT02678260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836779|NCT01615081|Insulin|insulin|mesh-list
65194174|NCT02678260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194175|NCT05488366|Pembrolizumab|pembrolizumab|mesh-list
65194176|NCT05488366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65194177|NCT05488366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194178|NCT04179604|Simendan|simendan|mesh-list
65194179|NCT04179604|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65194180|NCT04179604|Vasodilator Agents|vasodilator agents|mesh-ancestor
65194181|NCT04179604|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65194182|NCT04179604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65194183|NCT04179604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328751|NCT04956627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65328752|NCT04956627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65078675|NCT00431145|Niacin|niacin|mesh-list
65328753|NCT04956627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65328754|NCT04956627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328755|NCT04956627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328756|NCT04956627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65328757|NCT04956627|Hormone Antagonists|hormone antagonists|mesh-ancestor
65328758|NCT04956627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65328759|NCT04956627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328760|NCT04956627|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65328761|NCT04956627|Anticonvulsants|anticonvulsants|mesh-ancestor
65328762|NCT04956627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65328763|NCT04956627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65328764|NCT04956627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65328765|NCT04956627|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65328766|NCT04956627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65328767|NCT04956627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65328768|NCT04956627|Antimetabolites|antimetabolites|mesh-ancestor
65328769|NCT04956627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65328770|NCT04956627|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65328771|NCT00920088|Ritonavir|ritonavir|mesh-list
65328772|NCT00920088|Lopinavir|lopinavir|mesh-list
65328773|NCT00920088|Darunavir|darunavir|mesh-list
65328774|NCT00920088|Flurbiprofen|flurbiprofen|mesh-list
65328775|NCT00920088|Midazolam|midazolam|mesh-list
65328776|NCT00920088|Dextromethorphan|dextromethorphan|mesh-list
65328777|NCT00920088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65328778|NCT00920088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65328779|NCT00920088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65328780|NCT00920088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328781|NCT00920088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65328782|NCT00920088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65328783|NCT00920088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65328784|NCT00920088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65328788|NCT00920088|GABA Agents|gaba agents|mesh-ancestor
65328789|NCT00920088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65328790|NCT00920088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328791|NCT00920088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65328792|NCT00920088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65328793|NCT00920088|Protease Inhibitors|protease inhibitors|mesh-ancestor
65328794|NCT00920088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328795|NCT00920088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65328796|NCT00920088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65328797|NCT00920088|Antiviral Agents|antiviral agents|mesh-ancestor
65328798|NCT00920088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65328799|NCT00920088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65328800|NCT00920088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65328801|NCT00920088|Antitussive Agents|antitussive agents|mesh-ancestor
65328802|NCT00920088|Respiratory System Agents|respiratory system agents|mesh-ancestor
65328803|NCT00920088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65328804|NCT00920088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65328805|NCT00920088|Analgesics|analgesics|mesh-ancestor
65328806|NCT00920088|Sensory System Agents|sensory system agents|mesh-ancestor
65328807|NCT00920088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65328808|NCT00920088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65328809|NCT00920088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65328810|NCT00920088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65328811|NCT00920088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65328812|NCT00920088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65328813|NCT04018833|Ranibizumab|ranibizumab|mesh-list
65328814|NCT04018833|Aflibercept|aflibercept|mesh-list
65328815|NCT04018833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64714964|NCT00422708|Anesthetics|anesthetics|mesh-list
65194184|NCT04179604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194185|NCT04179604|Protective Agents|protective agents|mesh-ancestor
65194186|NCT04179604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194187|NCT02675140|Vitamins|vitamins|mesh-list
65194188|NCT02675140|Vitamin A|vitamin a|mesh-list
65194189|NCT02675140|Albendazole|albendazole|mesh-list
65194190|NCT02675140|Retinol palmitate|retinol palmitate|mesh-list
65194191|NCT02675140|Micronutrients|micronutrients|mesh-ancestor
65194192|NCT02675140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194193|NCT02675140|Antioxidants|antioxidants|mesh-ancestor
65194194|NCT02675140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194195|NCT02675140|Protective Agents|protective agents|mesh-ancestor
65194196|NCT02675140|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65194197|NCT02675140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194198|NCT02675140|Anthelmintics|anthelmintics|mesh-ancestor
65194199|NCT02675140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65194200|NCT02675140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65328816|NCT04018833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65328817|NCT04018833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65328818|NCT04018833|Growth Substances|growth substances|mesh-ancestor
65328819|NCT04018833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328820|NCT04018833|Growth Inhibitors|growth inhibitors|mesh-ancestor
65328821|NCT04018833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328822|NCT04066803|Folic Acid|folic acid|mesh-list
65328823|NCT04066803|Hematinics|hematinics|mesh-ancestor
65328824|NCT04066803|Vitamin B Complex|vitamin b complex|mesh-ancestor
65328825|NCT04066803|Vitamins|vitamins|mesh-ancestor
65328826|NCT04066803|Micronutrients|micronutrients|mesh-ancestor
65328827|NCT04066803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328828|NCT04921371|Listerine|listerine|mesh-list
65328829|NCT04921371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65328830|NCT04921371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65194201|NCT02675140|Anticestodal Agents|anticestodal agents|mesh-ancestor
65194202|NCT02675140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65194203|NCT02675140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65194204|NCT02675140|Tubulin Modulators|tubulin modulators|mesh-ancestor
65194205|NCT02675140|Antimitotic Agents|antimitotic agents|mesh-ancestor
65194206|NCT02675140|Mitosis Modulators|mitosis modulators|mesh-ancestor
65194207|NCT02674906|Heparin|heparin|mesh-list
65194208|NCT02674906|Calcium heparin|calcium heparin|mesh-list
65194209|NCT02674906|Anticoagulants|anticoagulants|mesh-list
65194210|NCT02674906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194211|NCT02674906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65194212|NCT02674906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65194213|NCT01160744|Gemcitabine|gemcitabine|mesh-list
65194214|NCT01160744|Carboplatin|carboplatin|mesh-list
65194215|NCT01160744|Pemetrexed|pemetrexed|mesh-list
65194216|NCT01160744|Ramucirumab|ramucirumab|mesh-list
65194217|NCT01160744|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65194218|NCT01160744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194219|NCT01160744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65194220|NCT01160744|Antimetabolites|antimetabolites|mesh-ancestor
65194221|NCT01160744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194222|NCT01160744|Antiviral Agents|antiviral agents|mesh-ancestor
65194229|NCT01160744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65194230|NCT02677246|Denosumab|denosumab|mesh-list
65194231|NCT02677246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65194232|NCT02677246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194233|NCT01160354|Plerixafor|plerixafor|mesh-list
65194234|NCT01160354|Clofarabine|clofarabine|mesh-list
65194235|NCT01160354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65194236|NCT01160354|Antimetabolites|antimetabolites|mesh-ancestor
65194237|NCT01160354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194238|NCT01160354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194239|NCT01160354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65194240|NCT01160354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65194241|NCT01160354|Antiviral Agents|antiviral agents|mesh-ancestor
65194242|NCT01160354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65194243|NCT04178512|Dexamethasone|dexamethasone|mesh-list
65194244|NCT04178512|Dexamethasone acetate|dexamethasone acetate|mesh-list
65194245|NCT04178512|Fentanyl|fentanyl|mesh-list
65194246|NCT04178512|BB 1101|bb 1101|mesh-list
65194247|NCT04178512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65194248|NCT04178512|Antiemetics|antiemetics|mesh-ancestor
65194249|NCT04178512|Autonomic Agents|autonomic agents|mesh-ancestor
65194250|NCT04178512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65194251|NCT04178512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194252|NCT04178512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65194253|NCT04178512|Glucocorticoids|glucocorticoids|mesh-ancestor
65194254|NCT04178512|Hormones|hormones|mesh-ancestor
65194255|NCT04178512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65328831|NCT00725439|R 115866|r 115866|mesh-list
65328832|NCT00725439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65328833|NCT00725439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328834|NCT00725439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328835|NCT03205761|Olaparib|olaparib|mesh-list
65328836|NCT03205761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65328837|NCT03205761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328838|NCT03205761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328839|NCT03205761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328840|NCT00725517|Icodextrin|icodextrin|mesh-list
65328841|NCT00725517|Dialysis Solutions|dialysis solutions|mesh-ancestor
65328842|NCT00725517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65328843|NCT04066881|Vaccines|vaccines|mesh-list
65328844|NCT04066881|Immunologic Factors|immunologic factors|mesh-ancestor
65328845|NCT04066881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328846|NCT04620291|UB-421|ub-421|mesh-list
65328847|NCT04620291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65328848|NCT04620291|Antiviral Agents|antiviral agents|mesh-ancestor
65328849|NCT04620291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65328850|NCT04657068|Gemcitabine|gemcitabine|mesh-list
65328851|NCT04657068|Irinotecan|irinotecan|mesh-list
65328852|NCT04657068|Camptothecin|camptothecin|mesh-list
65328853|NCT04657068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65328854|NCT04657068|Antimetabolites|antimetabolites|mesh-ancestor
65328855|NCT04657068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328856|NCT04657068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328857|NCT04657068|Antiviral Agents|antiviral agents|mesh-ancestor
65328858|NCT04657068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65328859|NCT04657068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328860|NCT04657068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65328861|NCT04657068|Immunologic Factors|immunologic factors|mesh-ancestor
65328862|NCT04657068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328875|NCT00794417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65328876|NCT00794417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65328877|NCT00794417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65328878|NCT00794417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65328879|NCT00794417|Growth Substances|growth substances|mesh-ancestor
65328880|NCT00794417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328881|NCT00794417|Growth Inhibitors|growth inhibitors|mesh-ancestor
65328882|NCT04483206|Melphalan|melphalan|mesh-list
65328883|NCT04483206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65328884|NCT04483206|Alkylating Agents|alkylating agents|mesh-ancestor
65328885|NCT04483206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328886|NCT04483206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65328887|NCT04483206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65328888|NCT04483206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65328889|NCT04483206|Immunologic Factors|immunologic factors|mesh-ancestor
65328890|NCT04483206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328891|NCT00725829|Simvastatin|simvastatin|mesh-list
65328892|NCT00725829|Ezetimibe|ezetimibe|mesh-list
65328893|NCT00725829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65194256|NCT04178512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65194257|NCT04178512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194258|NCT04178512|Protease Inhibitors|protease inhibitors|mesh-ancestor
65194259|NCT04178512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194260|NCT04178512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194261|NCT04178512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65194262|NCT04178512|Narcotics|narcotics|mesh-ancestor
65194263|NCT04178512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65194264|NCT04178512|Analgesics|analgesics|mesh-ancestor
65194265|NCT04178512|Sensory System Agents|sensory system agents|mesh-ancestor
65194266|NCT04178512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65194267|NCT04178512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65194268|NCT04178512|Anesthetics, General|anesthetics, general|mesh-ancestor
65194269|NCT04178512|Anesthetics|anesthetics|mesh-ancestor
65194270|NCT01160198|Ascorbic Acid|ascorbic acid|mesh-list
65194271|NCT01160198|Chelating Agents|chelating agents|mesh-list
65194272|NCT01160198|Glycine|glycine|mesh-list
65194273|NCT01160198|Sequestering Agents|sequestering agents|mesh-ancestor
65194274|NCT01160198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194275|NCT01160198|Glycine Agents|glycine agents|mesh-ancestor
65194276|NCT01160198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65194277|NCT01160198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194278|NCT01160198|Antioxidants|antioxidants|mesh-ancestor
65194279|NCT01160198|Protective Agents|protective agents|mesh-ancestor
65194280|NCT01160198|Vitamins|vitamins|mesh-ancestor
65194281|NCT01160198|Micronutrients|micronutrients|mesh-ancestor
65194282|NCT02676934|Anesthetics|anesthetics|mesh-list
65194283|NCT02676934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65194284|NCT02676934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194285|NCT05351086|Dihydroergotamine|dihydroergotamine|mesh-list
65194286|NCT05351086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65194287|NCT05351086|Dopamine Agonists|dopamine agonists|mesh-ancestor
65194288|NCT05351086|Dopamine Agents|dopamine agents|mesh-ancestor
65194289|NCT05351086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65194290|NCT05351086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194291|NCT05351086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194292|NCT05351086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65194293|NCT05351086|Analgesics|analgesics|mesh-ancestor
65328894|NCT00725829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65328895|NCT00725829|Antimetabolites|antimetabolites|mesh-ancestor
65328896|NCT00725829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328897|NCT00725829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65328898|NCT00725829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65328899|NCT00725829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328900|NCT00794339|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65194298|NCT02885168|Protein C|protein c|mesh-list
65194299|NCT02885168|Oxymetazoline|oxymetazoline|mesh-list
65194300|NCT02885168|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65194301|NCT02885168|Mydriatics|mydriatics|mesh-ancestor
65194302|NCT02885168|Autonomic Agents|autonomic agents|mesh-ancestor
65194303|NCT02885168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65194304|NCT02885168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194305|NCT02885168|Sympathomimetics|sympathomimetics|mesh-ancestor
65194306|NCT02885168|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65194307|NCT02885168|Nasal Decongestants|nasal decongestants|mesh-ancestor
65194308|NCT02885168|Respiratory System Agents|respiratory system agents|mesh-ancestor
65194309|NCT02885168|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65194310|NCT02885168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65194311|NCT02885168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65194312|NCT02885168|Adrenergic Agents|adrenergic agents|mesh-ancestor
65194313|NCT02885168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65194314|NCT02885168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194315|NCT02885168|Protective Agents|protective agents|mesh-ancestor
65194316|NCT02885168|Anticoagulants|anticoagulants|mesh-ancestor
65194317|NCT02885168|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65194318|NCT02885168|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65194319|NCT02885168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65194320|NCT01159574|Clarithromycin|clarithromycin|mesh-list
65194321|NCT01159574|Dexamethasone|dexamethasone|mesh-list
65194322|NCT01159574|Pomalidomide|pomalidomide|mesh-list
65194323|NCT01159574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65194324|NCT01159574|Antiemetics|antiemetics|mesh-ancestor
65194325|NCT01159574|Autonomic Agents|autonomic agents|mesh-ancestor
65194326|NCT01159574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65194327|NCT01159574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194328|NCT01159574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65194329|NCT01159574|Glucocorticoids|glucocorticoids|mesh-ancestor
65194330|NCT01159574|Hormones|hormones|mesh-ancestor
65194331|NCT01159574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65194332|NCT01159574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65194333|NCT01159574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194334|NCT01159574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65194335|NCT01159574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65194336|NCT01159574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65194337|NCT01159574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194338|NCT01159574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194339|NCT01159574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65194340|NCT01159574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65194341|NCT01159574|Immunologic Factors|immunologic factors|mesh-ancestor
65194342|NCT01159574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65194343|NCT01159574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65194344|NCT01159574|Growth Substances|growth substances|mesh-ancestor
65194345|NCT01159574|Growth Inhibitors|growth inhibitors|mesh-ancestor
65194346|NCT01158950|Tolcapone|tolcapone|mesh-list
65194347|NCT01158950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65194348|NCT01158950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65194349|NCT01158950|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65194350|NCT01158950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194351|NCT01158950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194352|NCT00910234|Epoetin Alfa|epoetin alfa|mesh-list
65194353|NCT00910234|Hematinics|hematinics|mesh-ancestor
65194354|NCT05652322|Furosemide|furosemide|mesh-list
65194355|NCT05652322|Diuretics|diuretics|mesh-ancestor
65194356|NCT05652322|Natriuretic Agents|natriuretic agents|mesh-ancestor
65194357|NCT05652322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328901|NCT00794339|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65328902|NCT00794339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078836|NCT00332345|Timolol|timolol|mesh-list
65328903|NCT02583438|Saxagliptin|saxagliptin|mesh-list
65328904|NCT02583438|Incretins|incretins|mesh-ancestor
65328905|NCT02583438|Hormones|hormones|mesh-ancestor
65328906|NCT02583438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65328907|NCT02583438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328908|NCT02583438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65194358|NCT05652322|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65194359|NCT05652322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65194360|NCT05652322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194361|NCT01172288|Acetylcysteine|acetylcysteine|mesh-list
65194362|NCT01172288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65194363|NCT01172288|Antiviral Agents|antiviral agents|mesh-ancestor
65194364|NCT01172288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65194365|NCT01172288|Expectorants|expectorants|mesh-ancestor
65194369|NCT01172288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194371|NCT01172288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194372|NCT01172288|Antidotes|antidotes|mesh-ancestor
65194373|NCT02676622|Aldesleukin|aldesleukin|mesh-list
65194374|NCT02676622|Cyclophosphamide|cyclophosphamide|mesh-list
65194375|NCT02676622|Thymoglobulin|thymoglobulin|mesh-list
65194376|NCT02676622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65194377|NCT02676622|Immunologic Factors|immunologic factors|mesh-ancestor
65194378|NCT02676622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194379|NCT02676622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65194380|NCT02676622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65194381|NCT02676622|Alkylating Agents|alkylating agents|mesh-ancestor
65194382|NCT02676622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194383|NCT02676622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194384|NCT02676622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65194385|NCT02676622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65194386|NCT02676622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65194387|NCT02676622|Antiviral Agents|antiviral agents|mesh-ancestor
65194388|NCT02676622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65194389|NCT00644020|Fluorouracil|fluorouracil|mesh-list
65194390|NCT00644020|Mitomycins|mitomycins|mesh-list
65194391|NCT00644020|Mitomycin|mitomycin|mesh-list
65194392|NCT00644020|Antimetabolites|antimetabolites|mesh-ancestor
65194393|NCT00644020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194394|NCT00644020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65194395|NCT00644020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194396|NCT00644020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65194397|NCT00644020|Immunologic Factors|immunologic factors|mesh-ancestor
65194398|NCT00644020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194399|NCT00644020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65194400|NCT00644020|Alkylating Agents|alkylating agents|mesh-ancestor
65194401|NCT00644020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65194402|NCT00644020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194403|NCT04178980|Simvastatin|simvastatin|mesh-list
65194404|NCT04178980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65194405|NCT04178980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64836999|NCT01616615|Aspirin|aspirin|mesh-list
65194406|NCT04178980|Antimetabolites|antimetabolites|mesh-ancestor
65194407|NCT04178980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194408|NCT04178980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65194409|NCT04178980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65194410|NCT04178980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194411|NCT02674048|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65194412|NCT02674048|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65194413|NCT02674048|Dermatologic Agents|dermatologic agents|mesh-ancestor
65194414|NCT02672566|Enoxaparin|enoxaparin|mesh-list
65194415|NCT02672566|Anticoagulants|anticoagulants|mesh-ancestor
65194416|NCT02672566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65194417|NCT02672566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65328909|NCT02583438|Protease Inhibitors|protease inhibitors|mesh-ancestor
65328910|NCT02583438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328911|NCT02583438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328912|NCT02583438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65328913|NCT02603861|Modafinil|modafinil|mesh-list
65328914|NCT02603861|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65194418|NCT02672566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194419|NCT02672488|Metformin|metformin|mesh-list
65194420|NCT02672488|Sorafenib|sorafenib|mesh-list
65194421|NCT02672488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65194422|NCT02672488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194423|NCT02672488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194424|NCT02672488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65194425|NCT02672488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194426|NCT02672488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194427|NCT02537392|Folic Acid|folic acid|mesh-list
65194428|NCT02537392|Vitamin B Complex|vitamin b complex|mesh-list
65194430|NCT02537392|Micronutrients|micronutrients|mesh-ancestor
65194431|NCT02537392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194432|NCT02537392|Hematinics|hematinics|mesh-ancestor
65194433|NCT02673814|Durvalumab|durvalumab|mesh-list
65194434|NCT02673814|Bavituximab|bavituximab|mesh-list
65194435|NCT02673814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65194436|NCT02673814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194437|NCT00644176|Azithromycin|azithromycin|mesh-list
65194438|NCT00644176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65194446|NCT04178200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194447|NCT04178200|Sensory System Agents|sensory system agents|mesh-ancestor
65194448|NCT04178200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65194449|NCT04178200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65194450|NCT04178200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65194451|NCT04178200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65194452|NCT04178200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65194453|NCT04178200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194454|NCT02537158|Sorafenib|sorafenib|mesh-list
65194455|NCT02537158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194456|NCT02537158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65194457|NCT02537158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194458|NCT02537158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194459|NCT02676154|Fesoterodine|fesoterodine|mesh-list
65194460|NCT02676154|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65194461|NCT02676154|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65194462|NCT02676154|Cholinergic Agents|cholinergic agents|mesh-ancestor
65194463|NCT02676154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65194464|NCT02676154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194465|NCT02676154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194466|NCT02676154|Urological Agents|urological agents|mesh-ancestor
65194467|NCT02676310|Bimatoprost|bimatoprost|mesh-list
65194468|NCT02676310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65194469|NCT04177186|Botulinum Toxins|botulinum toxins|mesh-list
65194470|NCT04177186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65194471|NCT04177186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65194472|NCT04177186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194473|NCT04177186|Cholinergic Agents|cholinergic agents|mesh-ancestor
65194474|NCT04177186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65194475|NCT04177186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194476|NCT04180384|Paclitaxel|paclitaxel|mesh-list
65194477|NCT04180384|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65194478|NCT04180384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65194479|NCT04180384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194480|NCT04180384|Tubulin Modulators|tubulin modulators|mesh-ancestor
65194481|NCT04180384|Antimitotic Agents|antimitotic agents|mesh-ancestor
65194482|NCT04180384|Mitosis Modulators|mitosis modulators|mesh-ancestor
65194483|NCT04180384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194485|NCT00643240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65194486|NCT00643240|Immunologic Factors|immunologic factors|mesh-ancestor
65194487|NCT00643240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328915|NCT02603861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328916|NCT02603861|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65194488|NCT02671708|Cyclophosphamide|cyclophosphamide|mesh-list
65194489|NCT02671708|Busulfan|busulfan|mesh-list
65194490|NCT02671708|Idarubicin|idarubicin|mesh-list
65194491|NCT02671708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65194492|NCT02671708|Immunologic Factors|immunologic factors|mesh-ancestor
65194493|NCT02671708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194494|NCT02671708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65194495|NCT02671708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65194496|NCT02671708|Alkylating Agents|alkylating agents|mesh-ancestor
65194497|NCT02671708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194498|NCT02671708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194499|NCT02671708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65194500|NCT02671708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65194501|NCT02671708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65194502|NCT02671708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65194503|NCT02671708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194504|NCT05280340|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65194505|NCT05280340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65194506|NCT04176328|Teicoplanin|teicoplanin|mesh-list
65194511|NCT04177342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65194513|NCT04177342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65194514|NCT04177342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194515|NCT04177342|Analgesics|analgesics|mesh-ancestor
65194516|NCT04177342|Sensory System Agents|sensory system agents|mesh-ancestor
65194517|NCT04177342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65194518|NCT04177342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65194519|NCT04177342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65194520|NCT04177342|Anesthetics, General|anesthetics, general|mesh-ancestor
65194521|NCT04177342|Anesthetics|anesthetics|mesh-ancestor
65194522|NCT05243524|Cyclophosphamide|cyclophosphamide|mesh-list
65194523|NCT05243524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65194524|NCT05243524|Immunologic Factors|immunologic factors|mesh-ancestor
65194525|NCT05243524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194526|NCT05243524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65194527|NCT05243524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65194528|NCT05243524|Alkylating Agents|alkylating agents|mesh-ancestor
65194529|NCT05243524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194530|NCT05243524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194531|NCT05243524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65194532|NCT04175158|Bevacizumab|bevacizumab|mesh-list
65194533|NCT04175158|Endothelial Growth Factors|endothelial growth factors|mesh-list
65194534|NCT04175158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65194535|NCT04175158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194536|NCT04175158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65194537|NCT04175158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65194538|NCT04175158|Growth Substances|growth substances|mesh-ancestor
65194539|NCT04175158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194540|NCT04175158|Growth Inhibitors|growth inhibitors|mesh-ancestor
65194541|NCT02671318|Sirolimus|sirolimus|mesh-list
65194542|NCT02671318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65194543|NCT02671318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65194544|NCT02671318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65194545|NCT02671318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194546|NCT02671318|Antifungal Agents|antifungal agents|mesh-ancestor
65194547|NCT02671318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65194548|NCT02671318|Immunologic Factors|immunologic factors|mesh-ancestor
65194549|NCT02671318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194550|NCT00644722|Pyrithione zinc|pyrithione zinc|mesh-list
65194551|NCT00644722|Keratolytic Agents|keratolytic agents|mesh-ancestor
65194552|NCT00644722|Dermatologic Agents|dermatologic agents|mesh-ancestor
64837150|NCT01617538|Atorvastatin|atorvastatin|mesh-list
65194553|NCT02668588|Octreotide|octreotide|mesh-list
65194554|NCT02668588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65194555|NCT02668588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65194556|NCT02668588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194557|NCT02671084|Sevoflurane|sevoflurane|mesh-list
65194558|NCT02671084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65194559|NCT02671084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65194560|NCT02671084|Anesthetics, General|anesthetics, general|mesh-ancestor
65194561|NCT02671084|Anesthetics|anesthetics|mesh-ancestor
65328917|NCT02603861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65328918|NCT02603861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65328919|NCT02603861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328920|NCT02569905|Flurbiprofen|flurbiprofen|mesh-list
65328921|NCT02569905|Parecoxib|parecoxib|mesh-list
65328922|NCT02569905|Analgesics|analgesics|mesh-ancestor
65328923|NCT02569905|Sensory System Agents|sensory system agents|mesh-ancestor
65328924|NCT02569905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65328925|NCT02569905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328926|NCT02569905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64715089|NCT02161146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65194562|NCT02671084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65194563|NCT02671084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194564|NCT00644800|Ziprasidone|ziprasidone|mesh-list
65194565|NCT00644800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65194566|NCT00644800|Serotonin Agents|serotonin agents|mesh-ancestor
65194567|NCT00644800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65194568|NCT00644800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194569|NCT00644800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194570|NCT00644800|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65194571|NCT00644800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65194572|NCT00644800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65194573|NCT00644800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65194574|NCT00644800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65194575|NCT00644800|Dopamine Agents|dopamine agents|mesh-ancestor
65194576|NCT02670616|Prednisolone|prednisolone|mesh-list
65194577|NCT02670616|Cyclophosphamide|cyclophosphamide|mesh-list
65194578|NCT02670616|Rituximab|rituximab|mesh-list
65194579|NCT02670616|Doxorubicin|doxorubicin|mesh-list
65194580|NCT02670616|Vincristine|vincristine|mesh-list
65194584|NCT02670616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65194585|NCT02670616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65194586|NCT02670616|Alkylating Agents|alkylating agents|mesh-ancestor
65194587|NCT02670616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194588|NCT02670616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194589|NCT02670616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65194590|NCT02670616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65194591|NCT02670616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65194592|NCT02670616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65194593|NCT02670616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65194594|NCT02670616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194595|NCT02670616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65194596|NCT02670616|Tubulin Modulators|tubulin modulators|mesh-ancestor
65194597|NCT02670616|Antimitotic Agents|antimitotic agents|mesh-ancestor
65194598|NCT02670616|Mitosis Modulators|mitosis modulators|mesh-ancestor
65194599|NCT02670616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65194600|NCT02670616|Glucocorticoids|glucocorticoids|mesh-ancestor
65194601|NCT02670616|Hormones|hormones|mesh-ancestor
65194602|NCT02670616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65194603|NCT02670616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65194604|NCT00645502|Risperidone|risperidone|mesh-list
65194605|NCT00645502|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65194606|NCT00645502|Serotonin Agents|serotonin agents|mesh-ancestor
65194607|NCT00645502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65194608|NCT00645502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194609|NCT00645502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194610|NCT00645502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65194611|NCT00645502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65194612|NCT00645502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65194613|NCT00645502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65194614|NCT00645502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65194615|NCT00645502|Dopamine Agents|dopamine agents|mesh-ancestor
65328927|NCT02569905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65328928|NCT02569905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65328929|NCT02569905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65328930|NCT02569905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65328931|NCT02569905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328932|NCT02569905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328933|NCT02569905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65328934|NCT02603783|Capsaicin|capsaicin|mesh-list
65328935|NCT02603783|Antipruritics|antipruritics|mesh-ancestor
65328936|NCT02603783|Dermatologic Agents|dermatologic agents|mesh-ancestor
65328937|NCT02603783|Sensory System Agents|sensory system agents|mesh-ancestor
65328938|NCT02603783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65328939|NCT02603783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328940|NCT04254627|Etanercept|etanercept|mesh-list
65328941|NCT04254627|Mifepristone|mifepristone|mesh-list
65328942|NCT04254627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65328943|NCT04254627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65328944|NCT04254627|Analgesics|analgesics|mesh-ancestor
65328945|NCT04254627|Sensory System Agents|sensory system agents|mesh-ancestor
65328946|NCT04254627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65328947|NCT04254627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328948|NCT04254627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65328949|NCT04254627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65328950|NCT04254627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65328951|NCT04254627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65328952|NCT04254627|Immunologic Factors|immunologic factors|mesh-ancestor
65328953|NCT04254627|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65328954|NCT04254627|Abortifacient Agents|abortifacient agents|mesh-ancestor
64715098|NCT03447782|Sensory System Agents|sensory system agents|mesh-ancestor
65194616|NCT00644956|Sildenafil Citrate|sildenafil citrate|mesh-list
65194617|NCT00644956|Tadalafil|tadalafil|mesh-list
65194618|NCT00644956|Vasodilator Agents|vasodilator agents|mesh-ancestor
65194619|NCT00644956|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65194620|NCT00644956|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65194621|NCT00644956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194622|NCT00644956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194623|NCT00644956|Urological Agents|urological agents|mesh-ancestor
65194624|NCT04175002|Progesterone|progesterone|mesh-list
65194625|NCT04175002|Progestins|progestins|mesh-ancestor
65194626|NCT04175002|Hormones|hormones|mesh-ancestor
65194627|NCT04175002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65194628|NCT04175002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194629|NCT02670772|Tenofovir|tenofovir|mesh-list
65194630|NCT02670772|Stavudine|stavudine|mesh-list
65194631|NCT02670772|Antiviral Agents|antiviral agents|mesh-ancestor
65194632|NCT02670772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65328955|NCT04254627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65328956|NCT04254627|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65328957|NCT04254627|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65328958|NCT04254627|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65328959|NCT04254627|Contraceptive Agents|contraceptive agents|mesh-ancestor
65328960|NCT04254627|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65328961|NCT04254627|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65328962|NCT04254627|Hormone Antagonists|hormone antagonists|mesh-ancestor
65328963|NCT04254627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65328964|NCT04254627|Luteolytic Agents|luteolytic agents|mesh-ancestor
65328965|NCT04254627|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65194633|NCT02670772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65194634|NCT02670772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65194635|NCT02670772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194636|NCT02670772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194637|NCT02670772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65194638|NCT02670772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65194639|NCT02670772|Antimetabolites|antimetabolites|mesh-ancestor
65194640|NCT02667730|Acetaminophen|acetaminophen|mesh-list
65194641|NCT02667730|Celecoxib|celecoxib|mesh-list
65194642|NCT02667730|Naproxen|naproxen|mesh-list
65194643|NCT02667730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65194644|NCT02667730|Analgesics|analgesics|mesh-ancestor
65194645|NCT02667730|Sensory System Agents|sensory system agents|mesh-ancestor
65194646|NCT02667730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65194647|NCT02667730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194648|NCT02667730|Antipyretics|antipyretics|mesh-ancestor
65194649|NCT02667730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65194650|NCT02667730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65194651|NCT02667730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65194652|NCT02667730|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65194658|NCT04294992|Antiemetics|antiemetics|mesh-ancestor
65194659|NCT04294992|Autonomic Agents|autonomic agents|mesh-ancestor
65194660|NCT04294992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65194661|NCT04294992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194662|NCT04294992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65194663|NCT04294992|Antipruritics|antipruritics|mesh-ancestor
65194664|NCT04294992|Dermatologic Agents|dermatologic agents|mesh-ancestor
65194665|NCT04294992|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65194666|NCT04294992|Serotonin Agents|serotonin agents|mesh-ancestor
65194667|NCT04294992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65194668|NCT04294992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194669|NCT04294992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65194670|NCT04294992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65194671|NCT04294992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65194672|NCT04294992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65194673|NCT04294992|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65194674|NCT00628914|Dexetimide|dexetimide|mesh-list
65194675|NCT00628914|Eszopiclone|eszopiclone|mesh-list
65194676|NCT00628914|Citalopram|citalopram|mesh-list
65194677|NCT00628914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65194678|NCT00628914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65194679|NCT00628914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65194680|NCT00628914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194681|NCT00628914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65194682|NCT00628914|Serotonin Agents|serotonin agents|mesh-ancestor
65194683|NCT00628914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194684|NCT00628914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65194685|NCT00628914|Antidepressive Agents|antidepressive agents|mesh-ancestor
65194686|NCT00628914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65194687|NCT00628914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65328966|NCT04254627|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65328967|NCT04110275|Plasminogen|plasminogen|mesh-list
65328968|NCT04110275|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65328969|NCT04110275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65328970|NCT04110275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65328971|NCT04110275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328972|NCT04250883|Iodine|iodine|mesh-list
65328973|NCT04250883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65328974|NCT04250883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65078906|NCT00431769|Bortezomib|bortezomib|mesh-list
65328976|NCT04250883|Micronutrients|micronutrients|mesh-ancestor
65328977|NCT04250883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328978|NCT04469634|Antibodies|antibodies|mesh-list
65194688|NCT00628914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65194689|NCT00628914|Parasympatholytics|parasympatholytics|mesh-ancestor
65194690|NCT00628914|Autonomic Agents|autonomic agents|mesh-ancestor
65194691|NCT00628914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65194692|NCT00628914|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65194693|NCT00628914|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65194694|NCT00628914|Cholinergic Agents|cholinergic agents|mesh-ancestor
65194695|NCT00628914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65194696|NCT00628914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65194697|NCT02870634|Copper|copper|mesh-list
65194698|NCT02870634|Trace Elements|trace elements|mesh-ancestor
65194699|NCT02870634|Micronutrients|micronutrients|mesh-ancestor
65194700|NCT02870634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194701|NCT00645580|Fluvoxamine|fluvoxamine|mesh-list
65194702|NCT00645580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65194703|NCT00645580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65194704|NCT00645580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65194705|NCT00645580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194706|NCT00645580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65194707|NCT00645580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65194708|NCT00645580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65194709|NCT00645580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65194710|NCT00645580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194711|NCT00645580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65194712|NCT00645580|Serotonin Agents|serotonin agents|mesh-ancestor
65194713|NCT00645580|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65194714|NCT00645580|Antidepressive Agents|antidepressive agents|mesh-ancestor
65194715|NCT00645580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65194716|NCT00645580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65194717|NCT00645580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194718|NCT00645580|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65194719|NCT02670304|Aspirin|aspirin|mesh-list
65194720|NCT02670304|Letrozole|letrozole|mesh-list
65194721|NCT02670304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65194724|NCT02670304|Sensory System Agents|sensory system agents|mesh-ancestor
65194725|NCT02670304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65194726|NCT02670304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194727|NCT02670304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65194728|NCT02670304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65194729|NCT02670304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65194730|NCT02670304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65194731|NCT02670304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194732|NCT02670304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65194733|NCT02670304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65194734|NCT02670304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194736|NCT02670304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194737|NCT02670304|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65194738|NCT02670304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65194739|NCT02670304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65328979|NCT04469634|Immunologic Factors|immunologic factors|mesh-ancestor
65328980|NCT04469634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328981|NCT04209543|Progesterone|progesterone|mesh-list
65328982|NCT04209543|Progestins|progestins|mesh-ancestor
65328983|NCT04209543|Hormones|hormones|mesh-ancestor
65328984|NCT04209543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65328985|NCT04209543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328986|NCT04465500|Androgens|androgens|mesh-list
65328987|NCT04465500|Hormones|hormones|mesh-ancestor
65328988|NCT04465500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65328989|NCT04465500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65328990|NCT04080726|Esomeprazole|esomeprazole|mesh-list
65328991|NCT04080726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65328992|NCT04080726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65328993|NCT04080726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65328994|NCT04080726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65328995|NCT04080726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65328996|NCT04639986|Gemcitabine|gemcitabine|mesh-list
65328997|NCT04639986|Capecitabine|capecitabine|mesh-list
65328998|NCT04639986|Vinorelbine|vinorelbine|mesh-list
65328999|NCT04639986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65329000|NCT04639986|Antimetabolites|antimetabolites|mesh-ancestor
65329001|NCT04639986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329002|NCT04639986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329003|NCT04639986|Antiviral Agents|antiviral agents|mesh-ancestor
65329004|NCT04639986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65329005|NCT04639986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715150|NCT05324384|Sirolimus|sirolimus|mesh-list
65194740|NCT02670304|Hormone Antagonists|hormone antagonists|mesh-ancestor
65194741|NCT02670304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65194742|NCT00998946|Vitamins|vitamins|mesh-list
65194743|NCT00998946|Folic Acid|folic acid|mesh-list
65194744|NCT00998946|Vitamin B 12|vitamin b 12|mesh-list
65194745|NCT00998946|Vitamin B Complex|vitamin b complex|mesh-list
65194746|NCT00998946|10-deazaaminopterin|10-deazaaminopterin|mesh-list
65194747|NCT00998946|Micronutrients|micronutrients|mesh-ancestor
65194748|NCT00998946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194749|NCT00998946|Hematinics|hematinics|mesh-ancestor
65194750|NCT00998946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194751|NCT00998946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65194752|NCT00998946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194753|NCT00998946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194754|NCT02670070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65194755|NCT02670070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65194756|NCT02670070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65194757|NCT02670070|Antimetabolites|antimetabolites|mesh-ancestor
65194758|NCT02670070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329006|NCT04639986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65329007|NCT04639986|Immunologic Factors|immunologic factors|mesh-ancestor
65329008|NCT04639986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329009|NCT04639986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65329010|NCT04639986|Tubulin Modulators|tubulin modulators|mesh-ancestor
65329011|NCT04639986|Antimitotic Agents|antimitotic agents|mesh-ancestor
65329012|NCT04639986|Mitosis Modulators|mitosis modulators|mesh-ancestor
65329013|NCT04126317|Aflibercept|aflibercept|mesh-list
65329014|NCT04126317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65329015|NCT04126317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65329016|NCT04126317|Growth Substances|growth substances|mesh-ancestor
65329017|NCT04126317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329018|NCT04126317|Growth Inhibitors|growth inhibitors|mesh-ancestor
65329019|NCT04126317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329020|NCT02583516|Vemurafenib|vemurafenib|mesh-list
65329021|NCT02583516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329022|NCT02583516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65329023|NCT02583516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329024|NCT02583516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329025|NCT00790907|Heparin|heparin|mesh-list
65329026|NCT00790907|PENTA|penta|mesh-list
65329027|NCT00790907|Fondaparinux|fondaparinux|mesh-list
65329028|NCT00790907|Anticoagulants|anticoagulants|mesh-ancestor
65329029|NCT00790907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65329030|NCT00790907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65329031|NCT00790907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329032|NCT00790907|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65329033|NCT00790907|Antithrombins|antithrombins|mesh-ancestor
65329034|NCT00790907|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65329035|NCT00790907|Protease Inhibitors|protease inhibitors|mesh-ancestor
65329036|NCT00790907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329037|NCT05429268|Lenalidomide|lenalidomide|mesh-list
64715176|NCT04736810|Antiviral Agents|antiviral agents|mesh-ancestor
65194759|NCT02670070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65194760|NCT02670070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65194761|NCT02670070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194762|NCT00645034|Sildenafil Citrate|sildenafil citrate|mesh-list
65194763|NCT00645034|Vasodilator Agents|vasodilator agents|mesh-ancestor
65194764|NCT00645034|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65194765|NCT00645034|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65194766|NCT00645034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194767|NCT00645034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194768|NCT00645034|Urological Agents|urological agents|mesh-ancestor
65194769|NCT04173832|Amantadine|amantadine|mesh-list
65329038|NCT05429268|Immunologic Factors|immunologic factors|mesh-ancestor
65329039|NCT05429268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329040|NCT05429268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65329041|NCT05429268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65329042|NCT05429268|Growth Substances|growth substances|mesh-ancestor
65329043|NCT05429268|Growth Inhibitors|growth inhibitors|mesh-ancestor
65329044|NCT05429268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329045|NCT03109353|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65329046|NCT03109353|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65329047|NCT03109353|Dermatologic Agents|dermatologic agents|mesh-ancestor
65329048|NCT04066179|Prednisolone|prednisolone|mesh-list
65329049|NCT04066179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65329050|NCT04066179|Glucocorticoids|glucocorticoids|mesh-ancestor
65329051|NCT04066179|Hormones|hormones|mesh-ancestor
65329052|NCT04066179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65194770|NCT04173832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65194771|NCT04173832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65194772|NCT04173832|Antiviral Agents|antiviral agents|mesh-ancestor
65194773|NCT04173832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65194774|NCT04173832|Dopamine Agents|dopamine agents|mesh-ancestor
65194775|NCT04173832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65194776|NCT04173832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194777|NCT04173832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194778|NCT04173832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65194779|NCT04173832|Analgesics|analgesics|mesh-ancestor
65194780|NCT04173832|Sensory System Agents|sensory system agents|mesh-ancestor
64837373|NCT01618760|Risperidone|risperidone|mesh-list
65194781|NCT04173832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65194782|NCT00645658|Testosterone|testosterone|mesh-list
65194783|NCT00645658|Androgens|androgens|mesh-ancestor
65194784|NCT00645658|Hormones|hormones|mesh-ancestor
65194785|NCT00645658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65194786|NCT00645658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194787|NCT02666170|Thioctic Acid|thioctic acid|mesh-list
65194788|NCT02666170|Antioxidants|antioxidants|mesh-ancestor
65194789|NCT02666170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194790|NCT02666170|Protective Agents|protective agents|mesh-ancestor
65194791|NCT02666170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194792|NCT02666170|Vitamin B Complex|vitamin b complex|mesh-ancestor
65194793|NCT02666170|Vitamins|vitamins|mesh-ancestor
65194798|NCT02667262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194800|NCT02667262|Sensory System Agents|sensory system agents|mesh-ancestor
65194801|NCT02667262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65194802|NCT00646126|Artesunate|artesunate|mesh-list
65194803|NCT00646126|Pyrimethamine|pyrimethamine|mesh-list
65194804|NCT00646126|Sulfadoxine|sulfadoxine|mesh-list
65194805|NCT00646126|Antimalarials|antimalarials|mesh-ancestor
65194806|NCT00646126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65194807|NCT00646126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65194808|NCT00646126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65194809|NCT00646126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194810|NCT00646126|Antiviral Agents|antiviral agents|mesh-ancestor
65194811|NCT00646126|Schistosomicides|schistosomicides|mesh-ancestor
65194812|NCT00646126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65194813|NCT00646126|Anthelmintics|anthelmintics|mesh-ancestor
65194814|NCT00646126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65194815|NCT00646126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194816|NCT00646126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194817|NCT00646126|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65194818|NCT00646126|Renal Agents|renal agents|mesh-ancestor
65194819|NCT02537080|Nimodipine|nimodipine|mesh-list
65194820|NCT02537080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65329053|NCT04066179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329054|NCT04066179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65329055|NCT04066179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329056|NCT04110119|Diclofenac|diclofenac|mesh-list
65329057|NCT04110119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65329058|NCT04110119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65329059|NCT04110119|Analgesics|analgesics|mesh-ancestor
65329060|NCT04110119|Sensory System Agents|sensory system agents|mesh-ancestor
65329061|NCT04110119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65329062|NCT04110119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329063|NCT04110119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65329064|NCT04110119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65329065|NCT04110119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64715217|NCT02002130|Aluminum sulfate|aluminum sulfate|mesh-list
65194821|NCT02537080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65194822|NCT02537080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65194823|NCT02537080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194824|NCT02537080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65194825|NCT02537080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194826|NCT02537080|Vasodilator Agents|vasodilator agents|mesh-ancestor
65194827|NCT02667496|Sargramostim|sargramostim|mesh-list
65194828|NCT02667496|Immunologic Factors|immunologic factors|mesh-ancestor
65194829|NCT02667496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194830|NCT00645112|Azithromycin|azithromycin|mesh-list
65194831|NCT00645112|Cefdinir|cefdinir|mesh-list
65194832|NCT00645112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65194833|NCT00645112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65194834|NCT02666092|Antibodies|antibodies|mesh-list
65194835|NCT02666092|Immunologic Factors|immunologic factors|mesh-ancestor
65194836|NCT02666092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194837|NCT00645814|Adalimumab|adalimumab|mesh-list
65194838|NCT00645814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65194839|NCT00645814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65194840|NCT04174378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65194841|NCT04174378|Luteolytic Agents|luteolytic agents|mesh-ancestor
65194842|NCT04174378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65194843|NCT04174378|Contraceptive Agents|contraceptive agents|mesh-ancestor
65194844|NCT04174378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65194845|NCT04174378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194846|NCT04174378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65194847|NCT04174378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65194848|NCT04174378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194849|NCT00645892|Adalimumab|adalimumab|mesh-list
65194850|NCT00645892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65194851|NCT00645892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65194852|NCT00645190|Galantamine|galantamine|mesh-list
65194853|NCT00645190|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65194854|NCT00645190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194855|NCT00645190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194856|NCT00645190|Cholinergic Agents|cholinergic agents|mesh-ancestor
65194857|NCT00645190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65194858|NCT00645190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194859|NCT00645190|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65194860|NCT00645190|Autonomic Agents|autonomic agents|mesh-ancestor
65194861|NCT00645190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65194862|NCT00645190|Nootropic Agents|nootropic agents|mesh-ancestor
65194864|NCT00910390|Plant Growth Regulators|plant growth regulators|mesh-ancestor
65194865|NCT00910390|Growth Substances|growth substances|mesh-ancestor
65194866|NCT00910390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194867|NCT02665936|Dexamethasone|dexamethasone|mesh-list
65194873|NCT02665936|Autonomic Agents|autonomic agents|mesh-ancestor
65329066|NCT04110119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329067|NCT04110119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329068|NCT00726687|Capecitabine|capecitabine|mesh-list
65329069|NCT00726687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65329070|NCT00726687|Antimetabolites|antimetabolites|mesh-ancestor
65329071|NCT00726687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329072|NCT00726687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329073|NCT00727077|Interferons|interferons|mesh-list
65329074|NCT00727077|Ribavirin|ribavirin|mesh-list
65329075|NCT00727077|Interferon-alpha|interferon-alpha|mesh-list
65329076|NCT00727077|Interferon alpha-2|interferon alpha-2|mesh-list
64715231|NCT01306994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65194874|NCT02665936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65194875|NCT02665936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194876|NCT02665936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65194877|NCT02665936|Glucocorticoids|glucocorticoids|mesh-ancestor
65194878|NCT02665936|Hormones|hormones|mesh-ancestor
65194879|NCT02665936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65194880|NCT02665936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65194881|NCT02665936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194882|NCT02665936|Protease Inhibitors|protease inhibitors|mesh-ancestor
65194883|NCT02665936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194884|NCT02665936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194885|NCT02665936|Anesthetics, Local|anesthetics, local|mesh-ancestor
65194886|NCT02665936|Anesthetics|anesthetics|mesh-ancestor
65194887|NCT02665936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65194888|NCT02665936|Sensory System Agents|sensory system agents|mesh-ancestor
65194889|NCT02665780|Cetylpyridinium|cetylpyridinium|mesh-list
65194890|NCT02665780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65194891|NCT02665780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65194892|NCT04292886|Tamoxifen|tamoxifen|mesh-list
65194893|NCT04292886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194894|NCT04292886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65194895|NCT04292886|Hormone Antagonists|hormone antagonists|mesh-ancestor
65194896|NCT04292886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65194897|NCT04292886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65194898|NCT04292886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194899|NCT04292886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65194900|NCT04292886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65194901|NCT04292886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65194902|NCT04292418|Mycophenolic Acid|mycophenolic acid|mesh-list
65194903|NCT04292418|Tacrolimus|tacrolimus|mesh-list
65194904|NCT04292418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65194905|NCT04292418|Immunologic Factors|immunologic factors|mesh-ancestor
65194906|NCT04292418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194907|NCT04292418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65194908|NCT04292418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194909|NCT04292418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194910|NCT04292418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65194911|NCT04292418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194912|NCT04292418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65194913|NCT04292418|Antitubercular Agents|antitubercular agents|mesh-ancestor
65194914|NCT04292418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65194915|NCT04292418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65194916|NCT02666716|Fluconazole|fluconazole|mesh-list
65194917|NCT02666716|Antifungal Agents|antifungal agents|mesh-ancestor
65194918|NCT02666716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65194919|NCT02666716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65194920|NCT02666716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65194921|NCT02666716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329077|NCT00727077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329078|NCT00727077|Antiviral Agents|antiviral agents|mesh-ancestor
65329079|NCT00727077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65329080|NCT00727077|Antimetabolites|antimetabolites|mesh-ancestor
65329081|NCT00727077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329082|NCT00727077|Immunologic Factors|immunologic factors|mesh-ancestor
65329083|NCT00727077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329084|NCT02585388|Letrozole|letrozole|mesh-list
65329085|NCT02585388|Vinorelbine|vinorelbine|mesh-list
65329086|NCT02585388|Anastrozole|anastrozole|mesh-list
65329087|NCT02585388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329088|NCT02585388|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65329089|NCT02585388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65329090|NCT02585388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329091|NCT02585388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329092|NCT02585388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65329093|NCT02585388|Hormone Antagonists|hormone antagonists|mesh-ancestor
65329094|NCT02585388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65329095|NCT02585388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329096|NCT02585388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65329097|NCT02585388|Tubulin Modulators|tubulin modulators|mesh-ancestor
65329098|NCT02585388|Antimitotic Agents|antimitotic agents|mesh-ancestor
65329099|NCT02585388|Mitosis Modulators|mitosis modulators|mesh-ancestor
65329100|NCT02585388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65329101|NCT04080336|Misoprostol|misoprostol|mesh-list
65329102|NCT04080336|Dinoprostone|dinoprostone|mesh-list
65329103|NCT04080336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65329104|NCT04080336|Abortifacient Agents|abortifacient agents|mesh-ancestor
65329105|NCT04080336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65329106|NCT04080336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329107|NCT04080336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65329108|NCT04080336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65329109|NCT04080336|Oxytocics|oxytocics|mesh-ancestor
65329110|NCT00793871|Sunitinib|sunitinib|mesh-list
65329111|NCT00793871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329112|NCT00793871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64715241|NCT02979301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65194922|NCT02666716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329113|NCT00793871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65329114|NCT00793871|Growth Substances|growth substances|mesh-ancestor
65329115|NCT00793871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329116|NCT00793871|Growth Inhibitors|growth inhibitors|mesh-ancestor
65329117|NCT00793871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65329118|NCT00793871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329119|NCT00793871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329120|NCT05466474|Dacarbazine|dacarbazine|mesh-list
65329121|NCT05466474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65329122|NCT05466474|Alkylating Agents|alkylating agents|mesh-ancestor
65329123|NCT05466474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329124|NCT05466474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079060|NCT00435981|Antacids|antacids|mesh-ancestor
65329125|NCT00727233|Sorafenib|sorafenib|mesh-list
65329126|NCT00727233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329127|NCT00727233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64715277|NCT05113004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65194923|NCT02666716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65194924|NCT02666716|Hormone Antagonists|hormone antagonists|mesh-ancestor
65194925|NCT02666716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65194926|NCT02666716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194927|NCT02666716|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65194928|NCT02666716|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65194929|NCT04064476|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65194930|NCT04064476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65194931|NCT04064476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65194932|NCT04064476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65194933|NCT04064476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194934|NCT04064476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65194935|NCT04064476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65194944|NCT02669368|Rocuronium|rocuronium|mesh-list
65194945|NCT02669368|Analgesics|analgesics|mesh-ancestor
65194946|NCT02669368|Sensory System Agents|sensory system agents|mesh-ancestor
65194947|NCT02669368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65194948|NCT02669368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194949|NCT02669368|Anesthetics|anesthetics|mesh-ancestor
65194950|NCT02669368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65194951|NCT02669368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65194952|NCT02669368|Anticonvulsants|anticonvulsants|mesh-ancestor
65194953|NCT02669368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65194954|NCT02669368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65194955|NCT02669368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194956|NCT02669368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65194957|NCT02669368|Tocolytic Agents|tocolytic agents|mesh-ancestor
65194958|NCT02669368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65194959|NCT02669368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65194960|NCT02669368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65194961|NCT02669368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65194962|NCT00645268|Sildenafil Citrate|sildenafil citrate|mesh-list
65194963|NCT00645268|Vasodilator Agents|vasodilator agents|mesh-ancestor
65194964|NCT00645268|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65194965|NCT00645268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65194966|NCT00645268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194967|NCT00645268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329128|NCT00727233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329129|NCT00727233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329130|NCT04105283|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
65329131|NCT04105283|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65329132|NCT04105283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329133|NCT04066257|Metronidazole|metronidazole|mesh-list
65329134|NCT04066257|Tetracycline|tetracycline|mesh-list
65329135|NCT04066257|Bismuth|bismuth|mesh-list
65329136|NCT04066257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65329137|NCT04066257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65194968|NCT00645268|Urological Agents|urological agents|mesh-ancestor
65194969|NCT02666014|Neostigmine|neostigmine|mesh-list
65194970|NCT02666014|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65194971|NCT02666014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194972|NCT02666014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194973|NCT02666014|Cholinergic Agents|cholinergic agents|mesh-ancestor
65194974|NCT02666014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65194975|NCT02666014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194976|NCT02666014|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65194977|NCT02666014|Autonomic Agents|autonomic agents|mesh-ancestor
65194978|NCT02666014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65194979|NCT02665702|Cisplatin|cisplatin|mesh-list
65194980|NCT02665702|Vinorelbine|vinorelbine|mesh-list
65194981|NCT02665702|Endostar protein|endostar protein|mesh-list
65194982|NCT02665702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194983|NCT02665702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65194984|NCT02665702|Tubulin Modulators|tubulin modulators|mesh-ancestor
65194985|NCT02665702|Antimitotic Agents|antimitotic agents|mesh-ancestor
65194986|NCT02665702|Mitosis Modulators|mitosis modulators|mesh-ancestor
65194987|NCT02665702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194988|NCT02665702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65194989|NCT02665702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65194990|NCT02665702|Growth Substances|growth substances|mesh-ancestor
65194991|NCT02665702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194992|NCT02665702|Growth Inhibitors|growth inhibitors|mesh-ancestor
65194993|NCT00646750|Rituximab|rituximab|mesh-list
65194994|NCT00646750|Melphalan|melphalan|mesh-list
65194995|NCT00646750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65194996|NCT00646750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194997|NCT00646750|Immunologic Factors|immunologic factors|mesh-ancestor
65194998|NCT00646750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194999|NCT00646750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65195000|NCT00646750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65195001|NCT00646750|Alkylating Agents|alkylating agents|mesh-ancestor
65195002|NCT00646750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195009|NCT00646516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65195010|NCT00646516|Autonomic Agents|autonomic agents|mesh-ancestor
65195011|NCT00646516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195012|NCT00646516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195013|NCT00646516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65195014|NCT00646516|Respiratory System Agents|respiratory system agents|mesh-ancestor
65195015|NCT00646516|Glucocorticoids|glucocorticoids|mesh-ancestor
65195017|NCT00646516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65195018|NCT00646516|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65195019|NCT00646516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65195020|NCT00646516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65195021|NCT00646516|Adrenergic Agents|adrenergic agents|mesh-ancestor
65195022|NCT00646516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195023|NCT00646516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195024|NCT02665624|Calcium, Dietary|calcium, dietary|mesh-list
65195025|NCT02665624|Sennosides|sennosides|mesh-list
65195026|NCT02665624|Senna Extract|senna extract|mesh-list
65195027|NCT02665624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65195028|NCT02665624|Calcium|calcium|mesh-list
65329138|NCT04066257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65329139|NCT04066257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65329140|NCT04066257|Antacids|antacids|mesh-ancestor
65329141|NCT04066257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329142|NCT04066257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65329143|NCT04066257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65329144|NCT04066257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329145|NCT03655821|Pemetrexed|pemetrexed|mesh-list
65329146|NCT03655821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329147|NCT03655821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329148|NCT03655821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329149|NCT03655821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65329150|NCT03655821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65329151|NCT04524702|Gemcitabine|gemcitabine|mesh-list
65329152|NCT04524702|Hydroxychloroquine|hydroxychloroquine|mesh-list
65329153|NCT04524702|Paclitaxel|paclitaxel|mesh-list
65329154|NCT04524702|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65329155|NCT04524702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65329156|NCT04524702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329157|NCT04524702|Tubulin Modulators|tubulin modulators|mesh-ancestor
65329158|NCT04524702|Antimitotic Agents|antimitotic agents|mesh-ancestor
64715304|NCT05271240|Bevacizumab|bevacizumab|mesh-list
65195029|NCT02665624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65195030|NCT02665624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195031|NCT02665624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65195032|NCT02665624|Laxatives|laxatives|mesh-ancestor
65195033|NCT02665624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65195034|NCT02665624|Cathartics|cathartics|mesh-ancestor
65195035|NCT00646594|Fluticasone|fluticasone|mesh-list
65195036|NCT00646594|Budesonide|budesonide|mesh-list
65195037|NCT00646594|Formoterol Fumarate|formoterol fumarate|mesh-list
65195038|NCT00646594|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65195039|NCT00646594|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65195040|NCT00646594|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65195041|NCT00646594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65195042|NCT00646594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65195043|NCT00646594|Autonomic Agents|autonomic agents|mesh-ancestor
65195044|NCT00646594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195045|NCT00646594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195046|NCT00646594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65195047|NCT00646594|Respiratory System Agents|respiratory system agents|mesh-ancestor
65195048|NCT00646594|Dermatologic Agents|dermatologic agents|mesh-ancestor
65195049|NCT00646594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65195050|NCT00646594|Glucocorticoids|glucocorticoids|mesh-ancestor
65195051|NCT00646594|Hormones|hormones|mesh-ancestor
65195052|NCT00646594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65195053|NCT00646594|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65195054|NCT00646594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65195055|NCT00646594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65195056|NCT00646594|Adrenergic Agents|adrenergic agents|mesh-ancestor
65195057|NCT00646594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195058|NCT00646594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195059|NCT00646594|Sympathomimetics|sympathomimetics|mesh-ancestor
65329159|NCT04524702|Mitosis Modulators|mitosis modulators|mesh-ancestor
65329160|NCT04524702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329161|NCT04524702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65329162|NCT04524702|Antimetabolites|antimetabolites|mesh-ancestor
65329163|NCT04524702|Antiviral Agents|antiviral agents|mesh-ancestor
65329164|NCT04524702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65329165|NCT04524702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329166|NCT04524702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65329167|NCT04524702|Immunologic Factors|immunologic factors|mesh-ancestor
65329168|NCT04524702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329169|NCT04524702|Antimalarials|antimalarials|mesh-ancestor
64715323|NCT02988349|Listerine|listerine|mesh-list
65195060|NCT00646984|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65195061|NCT00646984|Antiviral Agents|antiviral agents|mesh-ancestor
65195062|NCT00646984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65195063|NCT04773184|Capsaicin|capsaicin|mesh-list
65195064|NCT04773184|Antipruritics|antipruritics|mesh-ancestor
65195065|NCT04773184|Dermatologic Agents|dermatologic agents|mesh-ancestor
65195066|NCT04773184|Sensory System Agents|sensory system agents|mesh-ancestor
65195067|NCT04773184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195068|NCT04773184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195069|NCT00647140|Levodopa|levodopa|mesh-list
65195073|NCT00647140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195074|NCT00647140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65195075|NCT00647140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65195077|NCT00647218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65195078|NCT00647218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65195079|NCT00647218|Tubulin Modulators|tubulin modulators|mesh-ancestor
65195080|NCT00647218|Antimitotic Agents|antimitotic agents|mesh-ancestor
65195081|NCT00647218|Mitosis Modulators|mitosis modulators|mesh-ancestor
65195082|NCT00647218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195083|NCT00994890|Tanezumab|tanezumab|mesh-list
65195084|NCT00994890|Analgesics|analgesics|mesh-ancestor
65195085|NCT00994890|Sensory System Agents|sensory system agents|mesh-ancestor
65195086|NCT00994890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195087|NCT00994890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195088|NCT02663830|Sildenafil Citrate|sildenafil citrate|mesh-list
65195089|NCT02663830|Clomiphene|clomiphene|mesh-list
65195090|NCT02663830|Enclomiphene|enclomiphene|mesh-list
65195091|NCT02663830|Zuclomiphene|zuclomiphene|mesh-list
65195092|NCT02663830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195093|NCT02663830|Vasodilator Agents|vasodilator agents|mesh-ancestor
65195094|NCT02663830|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65195095|NCT02663830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65195096|NCT02663830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65195097|NCT02663830|Urological Agents|urological agents|mesh-ancestor
65195098|NCT02663830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65195099|NCT02663830|Hormone Antagonists|hormone antagonists|mesh-ancestor
65195100|NCT02663830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65195101|NCT02663830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195102|NCT02663830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65195104|NCT02663830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65195105|NCT02663830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65195106|NCT02663830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65195107|NCT00648544|Pravastatin|pravastatin|mesh-list
65195108|NCT00648544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65195109|NCT00648544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65195110|NCT00648544|Antimetabolites|antimetabolites|mesh-ancestor
65195111|NCT00648544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195112|NCT00648544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65195113|NCT00648544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65195114|NCT00648544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65195115|NCT00648622|Carvedilol|carvedilol|mesh-list
65329170|NCT04524702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65329171|NCT04524702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65329172|NCT04524702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65329173|NCT00730197|Albuterol|albuterol|mesh-list
65329174|NCT00730197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65329175|NCT00730197|Autonomic Agents|autonomic agents|mesh-ancestor
65329176|NCT00730197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65329177|NCT00730197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329178|NCT00730197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65329179|NCT00730197|Respiratory System Agents|respiratory system agents|mesh-ancestor
65329180|NCT00730197|Tocolytic Agents|tocolytic agents|mesh-ancestor
65329181|NCT00730197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64715344|NCT02187744|Carboplatin|carboplatin|mesh-list
65195116|NCT00648622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65195117|NCT00648622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65195118|NCT00648622|Adrenergic Agents|adrenergic agents|mesh-ancestor
65195119|NCT00648622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195120|NCT00648622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195121|NCT00648622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195122|NCT00648622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65195123|NCT00648622|Antioxidants|antioxidants|mesh-ancestor
65195124|NCT00648622|Protective Agents|protective agents|mesh-ancestor
65195125|NCT00648622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65195126|NCT00648622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65195127|NCT00648622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65195128|NCT00648622|Vasodilator Agents|vasodilator agents|mesh-ancestor
65195129|NCT00648622|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65195130|NCT00648622|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65195131|NCT00994422|Ivermectin|ivermectin|mesh-list
65195132|NCT00994422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65195133|NCT00994422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65195134|NCT00648778|Loxapine|loxapine|mesh-list
65195135|NCT00648778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65195136|NCT00648778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65195137|NCT00648778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65195138|NCT00648778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195139|NCT00648778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65195140|NCT00648778|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65195144|NCT00645424|Atorvastatin|atorvastatin|mesh-list
65195145|NCT00645424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65195146|NCT00645424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65195147|NCT00645424|Antimetabolites|antimetabolites|mesh-ancestor
65195148|NCT00645424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195149|NCT00645424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65195150|NCT00645424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65195151|NCT00645424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65195152|NCT04172740|Calcium|calcium|mesh-list
65195153|NCT04172740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65195154|NCT04172740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195155|NCT02663596|Vancomycin|vancomycin|mesh-list
65195156|NCT02663596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65195157|NCT02663596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65195158|NCT00647530|Fluorouracil|fluorouracil|mesh-list
65195159|NCT00647530|Capecitabine|capecitabine|mesh-list
65195160|NCT00647530|Oxaliplatin|oxaliplatin|mesh-list
65195161|NCT00647530|Panitumumab|panitumumab|mesh-list
65195162|NCT00647530|Antimetabolites|antimetabolites|mesh-ancestor
65195163|NCT00647530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195164|NCT00647530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65195165|NCT00647530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65195166|NCT00647530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65195167|NCT00647530|Immunologic Factors|immunologic factors|mesh-ancestor
65195168|NCT00647530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329182|NCT00730197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65329183|NCT00730197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65329184|NCT00730197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65329185|NCT00730197|Adrenergic Agents|adrenergic agents|mesh-ancestor
65329186|NCT00730197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65329187|NCT00730197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329188|NCT00727545|Chelating Agents|chelating agents|mesh-list
65329189|NCT00727545|Sequestering Agents|sequestering agents|mesh-ancestor
65329190|NCT00727545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329191|NCT02582892|Vitamin D|vitamin d|mesh-list
65329192|NCT02582892|Vitamins|vitamins|mesh-ancestor
65329193|NCT02582892|Micronutrients|micronutrients|mesh-ancestor
65329194|NCT02582892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329195|NCT02582892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65329196|NCT00730509|Vitamin B 12|vitamin b 12|mesh-list
65329197|NCT00730509|Hydroxocobalamin|hydroxocobalamin|mesh-list
65329198|NCT00730509|Vitamins|vitamins|mesh-ancestor
65329199|NCT00730509|Micronutrients|micronutrients|mesh-ancestor
65329200|NCT00730509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329201|NCT00730509|Vitamin B Complex|vitamin b complex|mesh-ancestor
65329202|NCT00730509|Hematinics|hematinics|mesh-ancestor
65329203|NCT02582736|Methotrimeprazine|methotrimeprazine|mesh-list
65329204|NCT02582736|Haloperidol|haloperidol|mesh-list
65329205|NCT02582736|Pimozide|pimozide|mesh-list
65329206|NCT02582736|Olanzapine|olanzapine|mesh-list
65329207|NCT02582736|Chlorpromazine|chlorpromazine|mesh-list
65329208|NCT02582736|Trifluoperazine|trifluoperazine|mesh-list
65329209|NCT02582736|Risperidone|risperidone|mesh-list
65329210|NCT02582736|Aripiprazole|aripiprazole|mesh-list
65329211|NCT02582736|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65329212|NCT02582736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65329213|NCT02582736|Ziprasidone|ziprasidone|mesh-list
65329214|NCT02582736|Antipsychotic Agents|antipsychotic agents|mesh-list
65329215|NCT02582736|Clozapine|clozapine|mesh-list
65329216|NCT02582736|Loxapine|loxapine|mesh-list
65329217|NCT02582736|Perphenazine|perphenazine|mesh-list
65329218|NCT02582736|Fluphenazine|fluphenazine|mesh-list
65329219|NCT02582736|Thioridazine|thioridazine|mesh-list
65329220|NCT02582736|Flupenthixol|flupenthixol|mesh-list
65329221|NCT02582736|Clopenthixol|clopenthixol|mesh-list
65195169|NCT00647530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65195170|NCT00647608|Propranolol|propranolol|mesh-list
65195171|NCT00647608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65329222|NCT02582736|Chlorprothixene|chlorprothixene|mesh-list
65329223|NCT02582736|Fluspirilene|fluspirilene|mesh-list
65329224|NCT02582736|Thiothixene|thiothixene|mesh-list
65329225|NCT02582736|Mesoridazine|mesoridazine|mesh-list
65329226|NCT02582736|Chlormezanone|chlormezanone|mesh-list
65329227|NCT02582736|Tetrabenazine|tetrabenazine|mesh-list
65329228|NCT02582736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65329229|NCT02582736|Serotonin Agents|serotonin agents|mesh-ancestor
65329230|NCT02582736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65329231|NCT02582736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329232|NCT02582736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329233|NCT02582736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64715380|NCT03163303|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65195172|NCT00647608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65195173|NCT00647608|Adrenergic Agents|adrenergic agents|mesh-ancestor
65195174|NCT00647608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195175|NCT00647608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195177|NCT00647608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65195178|NCT00647608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65195179|NCT00647608|Vasodilator Agents|vasodilator agents|mesh-ancestor
65195180|NCT02663440|Temozolomide|temozolomide|mesh-list
65195181|NCT02663440|Molgramostim|molgramostim|mesh-list
65195182|NCT02663440|Sargramostim|sargramostim|mesh-list
65195183|NCT02663440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65195184|NCT02663440|Alkylating Agents|alkylating agents|mesh-ancestor
65195185|NCT02663440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195186|NCT02663440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65195187|NCT02663440|Immunologic Factors|immunologic factors|mesh-ancestor
65195188|NCT02663440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195189|NCT04171180|Budesonide|budesonide|mesh-list
65195190|NCT04171180|Formoterol Fumarate|formoterol fumarate|mesh-list
65195191|NCT04171180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65195192|NCT04171180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65195193|NCT04171180|Autonomic Agents|autonomic agents|mesh-ancestor
65195194|NCT04171180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195195|NCT04171180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195196|NCT04171180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65195197|NCT04171180|Respiratory System Agents|respiratory system agents|mesh-ancestor
65195198|NCT04171180|Glucocorticoids|glucocorticoids|mesh-ancestor
65195199|NCT04171180|Hormones|hormones|mesh-ancestor
65195200|NCT04171180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65195201|NCT04171180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65195202|NCT04171180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65195203|NCT04171180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65195204|NCT04171180|Adrenergic Agents|adrenergic agents|mesh-ancestor
65195205|NCT04171180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195206|NCT04171180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195207|NCT02660008|Glucagon|glucagon|mesh-list
65195208|NCT02660008|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65195209|NCT02660008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65195210|NCT02660008|Hormones|hormones|mesh-ancestor
65195211|NCT02660008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65195212|NCT02660008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195216|NCT00649168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65195217|NCT00649168|Hormone Antagonists|hormone antagonists|mesh-ancestor
65195218|NCT00649168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65195219|NCT00649168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195220|NCT00649168|Dopamine Agonists|dopamine agonists|mesh-ancestor
65195221|NCT00649168|Dopamine Agents|dopamine agents|mesh-ancestor
65195222|NCT00649168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195223|NCT00649168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195224|NCT02663206|Botulinum Toxins|botulinum toxins|mesh-list
65329234|NCT02582736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65329235|NCT02582736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65329236|NCT02582736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65329237|NCT02582736|Dopamine Agents|dopamine agents|mesh-ancestor
65329238|NCT02582736|Antiemetics|antiemetics|mesh-ancestor
65329239|NCT02582736|Autonomic Agents|autonomic agents|mesh-ancestor
65329240|NCT02582736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195225|NCT02663206|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65195226|NCT02663206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65195227|NCT02663206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195228|NCT02663206|Cholinergic Agents|cholinergic agents|mesh-ancestor
65195229|NCT02663206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195230|NCT02663206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195231|NCT02663284|Ropivacaine|ropivacaine|mesh-list
65195232|NCT02663284|Anesthetics, Local|anesthetics, local|mesh-ancestor
65195233|NCT02663284|Anesthetics|anesthetics|mesh-ancestor
65195234|NCT02663284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65195235|NCT02663284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195236|NCT02663284|Sensory System Agents|sensory system agents|mesh-ancestor
65195237|NCT02663284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195238|NCT00647686|Fentanyl|fentanyl|mesh-list
65195239|NCT00647686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65195240|NCT00647686|Narcotics|narcotics|mesh-ancestor
65195241|NCT00647686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65195242|NCT00647686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195243|NCT00647686|Analgesics|analgesics|mesh-ancestor
65195244|NCT00647686|Sensory System Agents|sensory system agents|mesh-ancestor
65195245|NCT00647686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195246|NCT00647686|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65195247|NCT00647686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65195248|NCT00647686|Anesthetics, General|anesthetics, general|mesh-ancestor
65195249|NCT00647686|Anesthetics|anesthetics|mesh-ancestor
65195250|NCT02663050|Diclofenac|diclofenac|mesh-list
65195251|NCT02663050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65195252|NCT02663050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65195253|NCT02663050|Analgesics|analgesics|mesh-ancestor
65195254|NCT02663050|Sensory System Agents|sensory system agents|mesh-ancestor
65195255|NCT02663050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195256|NCT02663050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195257|NCT02663050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65195258|NCT02663050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65195259|NCT02663050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65195260|NCT02663050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65195261|NCT02663050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195262|NCT00648856|Sertraline|sertraline|mesh-list
65195263|NCT00648856|Antidepressive Agents|antidepressive agents|mesh-ancestor
65195264|NCT00648856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65195265|NCT00648856|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65195266|NCT00648856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65195267|NCT00648856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65195268|NCT00648856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195269|NCT00648856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195270|NCT00648856|Serotonin Agents|serotonin agents|mesh-ancestor
65195271|NCT00648856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195272|NCT01171976|Ranibizumab|ranibizumab|mesh-list
65195273|NCT01171976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65195274|NCT01171976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65195275|NCT01171976|Growth Substances|growth substances|mesh-ancestor
65195276|NCT01171976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195277|NCT01171976|Growth Inhibitors|growth inhibitors|mesh-ancestor
65195278|NCT01171976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65195279|NCT00996216|Antiviral Agents|antiviral agents|mesh-list
65195280|NCT00996216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65195281|NCT00647842|Fentanyl|fentanyl|mesh-list
65195282|NCT00647842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65195283|NCT00647842|Narcotics|narcotics|mesh-ancestor
65195284|NCT00647842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65195306|NCT02662894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65329241|NCT02582736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65329242|NCT02582736|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65329243|NCT02582736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65329244|NCT02582736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65329245|NCT02582736|Antidepressive Agents|antidepressive agents|mesh-ancestor
65329246|NCT02582736|Dopamine Agonists|dopamine agonists|mesh-ancestor
65329247|NCT02582736|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65329248|NCT02582736|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65329249|NCT02582736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65329250|NCT02582736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65329251|NCT02582736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65329252|NCT02582736|GABA Antagonists|gaba antagonists|mesh-ancestor
65329253|NCT02582736|GABA Agents|gaba agents|mesh-ancestor
65195307|NCT02662894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65195308|NCT02662894|Antimetabolites|antimetabolites|mesh-ancestor
65195309|NCT02662894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195310|NCT02662894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65195311|NCT02662894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65195312|NCT02662894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65195313|NCT02662894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65195314|NCT02662894|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65195315|NCT02662894|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65195316|NCT04291794|Propofol|propofol|mesh-list
65195317|NCT04291794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65195318|NCT04291794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65195319|NCT04291794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195320|NCT04291794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65195321|NCT04291794|Anesthetics, General|anesthetics, general|mesh-ancestor
65195322|NCT04291794|Anesthetics|anesthetics|mesh-ancestor
65195323|NCT02662660|Acetaminophen|acetaminophen|mesh-list
65195325|NCT02662660|Bupivacaine|bupivacaine|mesh-list
65195326|NCT02662660|Levobupivacaine|levobupivacaine|mesh-list
65195327|NCT02662660|Anesthetics, Local|anesthetics, local|mesh-ancestor
65195328|NCT02662660|Anesthetics|anesthetics|mesh-ancestor
65195329|NCT02662660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65195330|NCT02662660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195331|NCT02662660|Sensory System Agents|sensory system agents|mesh-ancestor
65195332|NCT02662660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195333|NCT02662660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65195334|NCT02662660|Analgesics|analgesics|mesh-ancestor
65195335|NCT02662660|Antipyretics|antipyretics|mesh-ancestor
65195336|NCT02662660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65195337|NCT02662660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65195338|NCT02662660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65195339|NCT02868606|Insulin|insulin|mesh-list
64321372|NCT05508152|Amoxicillin|amoxicillin|mesh-list
65195349|NCT00830869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65195350|NCT00830869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195351|NCT02662504|Cisplatin|cisplatin|mesh-list
65195352|NCT02662504|Pemetrexed|pemetrexed|mesh-list
65195353|NCT02662504|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
65195354|NCT02662504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65195355|NCT02662504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65195356|NCT02662504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195357|NCT02662504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65195358|NCT02662504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65195359|NCT02662504|Dermatologic Agents|dermatologic agents|mesh-ancestor
65195360|NCT02662504|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65195361|NCT00648934|Topiramate|topiramate|mesh-list
65195362|NCT00648934|Anticonvulsants|anticonvulsants|mesh-ancestor
65195363|NCT00648934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65329254|NCT02582736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65329255|NCT02582736|Adrenergic Agents|adrenergic agents|mesh-ancestor
65329256|NCT02582736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65329257|NCT02582736|Analgesics|analgesics|mesh-ancestor
65329258|NCT02582736|Sensory System Agents|sensory system agents|mesh-ancestor
65329259|NCT02582736|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65329260|NCT02582736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65329261|NCT02582736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65329262|NCT04019652|Moxifloxacin|moxifloxacin|mesh-list
65329263|NCT04019652|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65329264|NCT04019652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65195364|NCT00648934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195365|NCT02659228|Anesthetics|anesthetics|mesh-list
65195366|NCT02659228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
65195367|NCT02659228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65195368|NCT02659228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195369|NCT02659228|Anesthetics, General|anesthetics, general|mesh-ancestor
65195370|NCT00844519|Maraviroc|maraviroc|mesh-list
65195371|NCT00844519|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65195372|NCT00844519|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65195373|NCT00844519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195374|NCT00844519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65195375|NCT00844519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65195376|NCT00844519|Antiviral Agents|antiviral agents|mesh-ancestor
65195377|NCT00844519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65195378|NCT00844519|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65195379|NCT00702793|Varenicline|varenicline|mesh-list
65195380|NCT00702793|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65195381|NCT00702793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65195382|NCT00702793|Cholinergic Agents|cholinergic agents|mesh-ancestor
65195383|NCT00702793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195384|NCT00702793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195385|NCT00702793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195386|NCT02662426|Oseltamivir|oseltamivir|mesh-list
65195387|NCT02662426|Antiviral Agents|antiviral agents|mesh-ancestor
65195388|NCT02662426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65195389|NCT02662426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65195390|NCT02662426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195391|NCT00994110|Pasireotide|pasireotide|mesh-list
65195392|NCT00994110|Hormones|hormones|mesh-ancestor
65195393|NCT00994110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65195394|NCT00994110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195395|NCT02662348|Aldesleukin|aldesleukin|mesh-list
65195396|NCT02662348|Interleukin-2|interleukin-2|mesh-list
65195397|NCT02662348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65195398|NCT02662348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65195399|NCT02662348|Analgesics|analgesics|mesh-ancestor
64952528|NCT02969733|Lidocaine|lidocaine|mesh-list
65195400|NCT02662348|Sensory System Agents|sensory system agents|mesh-ancestor
65195401|NCT02662348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195402|NCT02662348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195403|NCT02662348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65195404|NCT02662348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65195405|NCT02662348|Antiviral Agents|antiviral agents|mesh-ancestor
65195406|NCT02662348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65195419|NCT00629148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65195420|NCT00629148|Tubulin Modulators|tubulin modulators|mesh-ancestor
65195421|NCT00629148|Antimitotic Agents|antimitotic agents|mesh-ancestor
65195422|NCT00629148|Mitosis Modulators|mitosis modulators|mesh-ancestor
65195424|NCT01157234|Nebivolol|nebivolol|mesh-list
65195425|NCT01157234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65195426|NCT01157234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65195427|NCT01157234|Sympatholytics|sympatholytics|mesh-ancestor
65195428|NCT01157234|Autonomic Agents|autonomic agents|mesh-ancestor
65195429|NCT01157234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65329265|NCT04019652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65329266|NCT04019652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65329267|NCT04019652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65329268|NCT04019652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329269|NCT04019652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329270|NCT04019652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329271|NCT04019652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65329272|NCT04019652|Contraceptive Agents|contraceptive agents|mesh-ancestor
65329273|NCT04019652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65329274|NCT04019652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329275|NCT04019652|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65329276|NCT04019652|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65329277|NCT04019652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65329278|NCT00735345|Docetaxel|docetaxel|mesh-list
65329279|NCT00735345|Cetuximab|cetuximab|mesh-list
65329280|NCT00735345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329281|NCT00735345|Tubulin Modulators|tubulin modulators|mesh-ancestor
65329282|NCT00735345|Antimitotic Agents|antimitotic agents|mesh-ancestor
65329283|NCT00735345|Mitosis Modulators|mitosis modulators|mesh-ancestor
65329284|NCT00735345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329285|NCT00735345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65329286|NCT00735501|Insulin Detemir|insulin detemir|mesh-list
65329287|NCT00735501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65329288|NCT00735501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329313|NCT00577707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329314|NCT00577707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329315|NCT00577707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65329316|NCT00577707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65329317|NCT00577707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65329318|NCT00730821|Nintedanib|nintedanib|mesh-list
65329319|NCT00730821|Afatinib|afatinib|mesh-list
65329320|NCT00730821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329321|NCT00730821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65329322|NCT00730821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329323|NCT00730821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329324|NCT00728559|Bupivacaine|bupivacaine|mesh-list
65329325|NCT00728559|Anesthetics, Local|anesthetics, local|mesh-ancestor
65329326|NCT00728559|Anesthetics|anesthetics|mesh-ancestor
65329327|NCT00728559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65329328|NCT00728559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329329|NCT00728559|Sensory System Agents|sensory system agents|mesh-ancestor
65329330|NCT00728559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65329331|NCT00735813|Heparin|heparin|mesh-list
65329332|NCT00735813|Anticoagulants|anticoagulants|mesh-ancestor
65329333|NCT00735813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65329334|NCT00735813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65329335|NCT00735813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329336|NCT04064619|Solifenacin Succinate|solifenacin succinate|mesh-list
65329337|NCT04064619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65329338|NCT04064619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65329339|NCT04064619|Cholinergic Agents|cholinergic agents|mesh-ancestor
65329340|NCT04064619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65329341|NCT04064619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329342|NCT04064619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329343|NCT04064619|Urological Agents|urological agents|mesh-ancestor
65329344|NCT00730977|Mannitol|mannitol|mesh-list
65329345|NCT00730977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65329346|NCT00730977|Diuretics|diuretics|mesh-ancestor
64715470|NCT03085147|Olaparib|olaparib|mesh-list
65195430|NCT01157234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195431|NCT01157234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65195432|NCT01157234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65195433|NCT01157234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65195434|NCT01157234|Adrenergic Agents|adrenergic agents|mesh-ancestor
65329347|NCT00730977|Natriuretic Agents|natriuretic agents|mesh-ancestor
65329348|NCT00730977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329349|NCT00728715|Budesonide|budesonide|mesh-list
65329350|NCT00728715|Formoterol Fumarate|formoterol fumarate|mesh-list
65329351|NCT00728715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65329352|NCT00728715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65329353|NCT00728715|Autonomic Agents|autonomic agents|mesh-ancestor
65329354|NCT00728715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65329355|NCT00728715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329356|NCT00728715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65329357|NCT00728715|Respiratory System Agents|respiratory system agents|mesh-ancestor
65329358|NCT00728715|Glucocorticoids|glucocorticoids|mesh-ancestor
65329359|NCT00728715|Hormones|hormones|mesh-ancestor
65195435|NCT01157234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195436|NCT01157234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195437|NCT01157234|Vasodilator Agents|vasodilator agents|mesh-ancestor
65195438|NCT01157234|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65195439|NCT01157234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65195440|NCT01157234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65195441|NCT04170790|Saxagliptin|saxagliptin|mesh-list
65195442|NCT04170790|Sildenafil Citrate|sildenafil citrate|mesh-list
65195443|NCT04170790|Vasodilator Agents|vasodilator agents|mesh-ancestor
65195444|NCT04170790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65195445|NCT04170790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65195446|NCT04170790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65195447|NCT04170790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195448|NCT04170790|Urological Agents|urological agents|mesh-ancestor
65195449|NCT04170790|Incretins|incretins|mesh-ancestor
65195450|NCT04170790|Hormones|hormones|mesh-ancestor
65195451|NCT04170790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64838041|NCT01622439|Prednisone|prednisone|mesh-list
65195452|NCT04170790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195453|NCT04170790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65195454|NCT04170790|Protease Inhibitors|protease inhibitors|mesh-ancestor
65195455|NCT04170790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65195456|NCT00995670|Sevoflurane|sevoflurane|mesh-list
65195457|NCT00995670|Simvastatin|simvastatin|mesh-list
65195458|NCT00995670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195459|NCT00995670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65195460|NCT00995670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65195461|NCT00995670|Antimetabolites|antimetabolites|mesh-ancestor
65195462|NCT00995670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195463|NCT00995670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65195464|NCT00995670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65195465|NCT00995670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65195466|NCT00995670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65195467|NCT00995670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65195470|NCT00995670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65195472|NCT02658838|Calcium heparin|calcium heparin|mesh-list
65195473|NCT02658838|Enoxaparin|enoxaparin|mesh-list
65195474|NCT02658838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65195475|NCT02658838|Tinzaparin|tinzaparin|mesh-list
65195476|NCT02658838|Dalteparin|dalteparin|mesh-list
65195477|NCT02658838|Enoxaparin sodium|enoxaparin sodium|mesh-list
65195478|NCT02658838|Ticagrelor|ticagrelor|mesh-list
65195479|NCT02658838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65195480|NCT02658838|Anticoagulants|anticoagulants|mesh-ancestor
65195481|NCT02658838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65195482|NCT02658838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65195483|NCT02658838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195484|NCT02658838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65195485|NCT02658838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65329360|NCT00728715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65329361|NCT00728715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65329362|NCT00728715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65329363|NCT00728715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65329364|NCT00728715|Adrenergic Agents|adrenergic agents|mesh-ancestor
65329365|NCT00728715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65329366|NCT00728715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329367|NCT00731289|Triamcinolone|triamcinolone|mesh-list
65329368|NCT00731289|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65329369|NCT00731289|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65329370|NCT00731289|Hyaluronic Acid|hyaluronic acid|mesh-list
65329371|NCT00731289|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65329372|NCT00731289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65329373|NCT00731289|Glucocorticoids|glucocorticoids|mesh-ancestor
65329374|NCT00731289|Hormones|hormones|mesh-ancestor
65329375|NCT00731289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65329376|NCT00731289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329377|NCT00731289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65329378|NCT00731289|Immunologic Factors|immunologic factors|mesh-ancestor
65195486|NCT02658838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65195487|NCT02658838|Purinergic Agents|purinergic agents|mesh-ancestor
65195488|NCT02658838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195489|NCT02658838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195490|NCT04292808|Methoxyflurane|methoxyflurane|mesh-list
65195491|NCT04292808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65195492|NCT04292808|Anesthetics, General|anesthetics, general|mesh-ancestor
65195493|NCT04292808|Anesthetics|anesthetics|mesh-ancestor
65195494|NCT04292808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65195495|NCT04292808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195496|NCT00648076|Valproic Acid|valproic acid|mesh-list
65195497|NCT00648076|Anticonvulsants|anticonvulsants|mesh-ancestor
65195498|NCT00648076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65195499|NCT00648076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195500|NCT00648076|GABA Agents|gaba agents|mesh-ancestor
65195501|NCT00648076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195502|NCT00648076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195503|NCT00648076|Antimanic Agents|antimanic agents|mesh-ancestor
65195504|NCT00648076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65195505|NCT00648076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65195506|NCT00648076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65195507|NCT00649012|Pioglitazone|pioglitazone|mesh-list
65195508|NCT00649012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65195509|NCT00649012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195510|NCT04685590|Dasatinib|dasatinib|mesh-list
65195511|NCT04685590|Quercetin|quercetin|mesh-list
65195512|NCT04685590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65195513|NCT04685590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65195514|NCT04685590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65195515|NCT04685590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195516|NCT04685590|Antioxidants|antioxidants|mesh-ancestor
65195517|NCT04685590|Protective Agents|protective agents|mesh-ancestor
65195518|NCT04685590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195519|NCT04170088|Tranexamic Acid|tranexamic acid|mesh-list
65195520|NCT04170088|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65195521|NCT04170088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65329379|NCT00731289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329380|NCT00731289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329381|NCT00731289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65329382|NCT00731289|Viscosupplements|viscosupplements|mesh-ancestor
65329383|NCT00731289|Protective Agents|protective agents|mesh-ancestor
65329384|NCT00736515|Insulin|insulin|mesh-list
65329385|NCT00736515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65329386|NCT00736515|Insulin Glargine|insulin glargine|mesh-list
65329387|NCT00736515|Gliclazide|gliclazide|mesh-list
65329388|NCT00736515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65329389|NCT00736515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329390|NCT00045201|Irinotecan|irinotecan|mesh-list
65329391|NCT00045201|Camptothecin|camptothecin|mesh-list
65329392|NCT00045201|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64715531|NCT02221284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65195522|NCT04170088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195523|NCT04170088|Hemostatics|hemostatics|mesh-ancestor
65195524|NCT04170088|Coagulants|coagulants|mesh-ancestor
65195525|NCT00648154|Letrozole|letrozole|mesh-list
65195526|NCT00648154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65195527|NCT00648154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65195528|NCT00648154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65195530|NCT00648154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195531|NCT00648154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65195532|NCT00648154|Hormone Antagonists|hormone antagonists|mesh-ancestor
65195533|NCT00648154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65195534|NCT00648154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195535|NCT02664142|Anesthetics|anesthetics|mesh-list
65195536|NCT02664142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65195537|NCT02664142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195538|NCT04169854|Lidocaine|lidocaine|mesh-list
65195539|NCT04169854|Anesthetics, Local|anesthetics, local|mesh-ancestor
65195540|NCT04169854|Anesthetics|anesthetics|mesh-ancestor
65195541|NCT04169854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65195542|NCT04169854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195546|NCT04169854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65195547|NCT04169854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65195548|NCT04169854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65195549|NCT04169854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195550|NCT02661100|Pembrolizumab|pembrolizumab|mesh-list
65195551|NCT02661100|Poly ICLC|poly iclc|mesh-list
65195552|NCT02661100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65195553|NCT02661100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65195554|NCT02661100|Interferon Inducers|interferon inducers|mesh-ancestor
65195555|NCT02661100|Immunologic Factors|immunologic factors|mesh-ancestor
65195556|NCT02661100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195557|NCT00601354|Orlistat|orlistat|mesh-list
65195558|NCT00601354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65195559|NCT00601354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195560|NCT00601354|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65195561|NCT00601354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65195562|NCT02660866|Vorapaxar|vorapaxar|mesh-list
65195563|NCT02660866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65195564|NCT00853099|Adalimumab|adalimumab|mesh-list
65195565|NCT00853099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65195566|NCT00853099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65195567|NCT00648310|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65195568|NCT00648310|Estrogens|estrogens|mesh-list
65195569|NCT00648310|Hormones|hormones|mesh-ancestor
65195570|NCT00648310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65195571|NCT00648310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195572|NCT00648310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65329393|NCT00045201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65329394|NCT00045201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65329395|NCT00045201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329396|NCT00045201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329397|NCT00045201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329398|NCT00045201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65329399|NCT00045201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65329400|NCT00731367|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65329401|NCT00731367|Laxatives|laxatives|mesh-ancestor
65329402|NCT00731367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65329403|NCT00731523|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65329404|NCT00731523|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65329405|NCT00731523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329406|NCT00731523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65329407|NCT00731523|Immunologic Factors|immunologic factors|mesh-ancestor
65329408|NCT00731523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329409|NCT05601531|Calcitriol|calcitriol|mesh-list
65329410|NCT05601531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65329411|NCT05601531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329412|NCT05601531|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65329413|NCT05601531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65329414|NCT05601531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329415|NCT05601531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65329416|NCT05601531|Vitamins|vitamins|mesh-ancestor
65329417|NCT05601531|Micronutrients|micronutrients|mesh-ancestor
65329418|NCT05601531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65329419|NCT02569125|Everolimus|everolimus|mesh-list
65329420|NCT02569125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329421|NCT02569125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65329422|NCT02569125|Immunologic Factors|immunologic factors|mesh-ancestor
65329423|NCT02569125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329424|NCT00731601|Pantoprazole|pantoprazole|mesh-list
65329425|NCT00731601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65329426|NCT00731601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65329427|NCT00731601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65329428|NCT00731601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329429|NCT00731601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329430|NCT00736905|Rilpivirine|rilpivirine|mesh-list
65329431|NCT00736905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65329432|NCT00736905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65329433|NCT00736905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329434|NCT00736905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329435|NCT00736905|Antiviral Agents|antiviral agents|mesh-ancestor
65329436|NCT00736905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65329437|NCT00736905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65329438|NCT00736905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65329439|NCT00736983|Ciprofloxacin|ciprofloxacin|mesh-list
65329440|NCT00736983|Adalimumab|adalimumab|mesh-list
65329441|NCT00736983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64715578|NCT04356716|Vasodilator Agents|vasodilator agents|mesh-ancestor
65195573|NCT00648310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65195574|NCT00648310|Cholinergic Agents|cholinergic agents|mesh-ancestor
65195575|NCT00648310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195576|NCT00648310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195577|NCT00648310|Urological Agents|urological agents|mesh-ancestor
65195578|NCT00702871|Ranitidine|ranitidine|mesh-list
65195579|NCT00702871|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65195580|NCT00702871|Sucralfate|sucralfate|mesh-list
65195581|NCT00702871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65195582|NCT00702871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65195583|NCT00702871|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65195584|NCT00702871|Histamine Antagonists|histamine antagonists|mesh-ancestor
65195585|NCT00702871|Histamine Agents|histamine agents|mesh-ancestor
65195586|NCT00702871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195587|NCT00702871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195588|NCT00702871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195589|NCT00830167|Pregabalin|pregabalin|mesh-list
65195590|NCT00830167|Analgesics|analgesics|mesh-ancestor
65195591|NCT00830167|Sensory System Agents|sensory system agents|mesh-ancestor
65195592|NCT00830167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195593|NCT00830167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195594|NCT00830167|Anticonvulsants|anticonvulsants|mesh-ancestor
65195595|NCT00830167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65195596|NCT00830167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65195597|NCT00830167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195598|NCT00830167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65195599|NCT00830167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65195600|NCT00830167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64838191|NCT01623401|Tedizolid|tedizolid|mesh-list
65195601|NCT00830167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65195602|NCT00830167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65195603|NCT04160052|Azacitidine|azacitidine|mesh-list
65195604|NCT04160052|Venetoclax|venetoclax|mesh-list
65195605|NCT04160052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65195606|NCT04160052|Antimetabolites|antimetabolites|mesh-ancestor
65195607|NCT04160052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195608|NCT04160052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65195609|NCT04160052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65195610|NCT00992394|Etanercept|etanercept|mesh-list
65195611|NCT00992394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65195612|NCT00992394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65195613|NCT00992394|Analgesics|analgesics|mesh-ancestor
65195621|NCT00992394|Immunologic Factors|immunologic factors|mesh-ancestor
65195622|NCT00829933|Warfarin|warfarin|mesh-list
65195623|NCT00829933|Edoxaban|edoxaban|mesh-list
65195624|NCT00829933|Anticoagulants|anticoagulants|mesh-ancestor
65195625|NCT00829933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65195626|NCT00829933|Antithrombins|antithrombins|mesh-ancestor
65329442|NCT00736983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65329443|NCT00736983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65329444|NCT00736983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65329445|NCT00736983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65329446|NCT00736983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65329447|NCT00736983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329448|NCT00736983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677715|NCT00002043|Dapsone|dapsone|mesh-list
65195627|NCT00829933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65195628|NCT00829933|Protease Inhibitors|protease inhibitors|mesh-ancestor
65195629|NCT00829933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65195630|NCT00829933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195631|NCT01170962|Ribavirin|ribavirin|mesh-list
65195632|NCT01170962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65195633|NCT01170962|Antimetabolites|antimetabolites|mesh-ancestor
65195634|NCT01170962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195635|NCT01170962|Antiviral Agents|antiviral agents|mesh-ancestor
65195636|NCT01170962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65195637|NCT00843193|Fluticasone|fluticasone|mesh-list
65195638|NCT00843193|Xhance|xhance|mesh-list
65195639|NCT00843193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65195640|NCT00843193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65195641|NCT00843193|Autonomic Agents|autonomic agents|mesh-ancestor
65195642|NCT00843193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195643|NCT00843193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195644|NCT00843193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65195645|NCT00843193|Respiratory System Agents|respiratory system agents|mesh-ancestor
65195646|NCT00843193|Dermatologic Agents|dermatologic agents|mesh-ancestor
65195647|NCT00843193|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65195648|NCT00853021|Aldesleukin|aldesleukin|mesh-list
65195649|NCT00853021|Bevacizumab|bevacizumab|mesh-list
65195650|NCT00853021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65195651|NCT00853021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65195652|NCT00853021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65195653|NCT00853021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65195654|NCT00853021|Growth Substances|growth substances|mesh-ancestor
65195655|NCT00853021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195656|NCT00853021|Growth Inhibitors|growth inhibitors|mesh-ancestor
65195657|NCT00853021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65195658|NCT00853021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65195659|NCT00853021|Antiviral Agents|antiviral agents|mesh-ancestor
65195660|NCT00853021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65195661|NCT00913237|Desipramine|desipramine|mesh-list
65195662|NCT00913237|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65195663|NCT00913237|Antidepressive Agents|antidepressive agents|mesh-ancestor
65195664|NCT00913237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65195665|NCT00913237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65195666|NCT00913237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195667|NCT00913237|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65195668|NCT00913237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65195669|NCT00913237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65195670|NCT00913237|Adrenergic Agents|adrenergic agents|mesh-ancestor
65195671|NCT00913237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195672|NCT00913237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195673|NCT05367284|Testosterone|testosterone|mesh-list
64838267|NCT01623921|Analgesics|analgesics|mesh-ancestor
65195674|NCT05367284|Androgens|androgens|mesh-ancestor
65195675|NCT05367284|Hormones|hormones|mesh-ancestor
65195676|NCT05367284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65195677|NCT05367284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195678|NCT00843115|Donepezil|donepezil|mesh-list
65195679|NCT00843115|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65195680|NCT00843115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65195681|NCT00843115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195689|NCT01156376|Protective Agents|protective agents|mesh-ancestor
65195690|NCT01156376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195691|NCT01156376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65329449|NCT00736983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329450|NCT00736983|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65329451|NCT00736983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65329452|NCT00729339|Mosapride|mosapride|mesh-list
65329453|NCT00729339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65329454|NCT00729339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65329455|NCT00729339|Serotonin Agents|serotonin agents|mesh-ancestor
65329456|NCT00729339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195692|NCT01156376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65195693|NCT01156142|Doxepin|doxepin|mesh-list
65195694|NCT01156142|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65195695|NCT01156142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65195696|NCT01156142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65195697|NCT01156142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195698|NCT01156142|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65195699|NCT01156142|Antidepressive Agents|antidepressive agents|mesh-ancestor
65195700|NCT01156142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65195701|NCT01156142|Histamine Antagonists|histamine antagonists|mesh-ancestor
65195702|NCT01156142|Histamine Agents|histamine agents|mesh-ancestor
65195703|NCT01156142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195704|NCT01156142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195705|NCT00842257|Panitumumab|panitumumab|mesh-list
65195706|NCT00842257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65195707|NCT00842257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65195708|NCT00706069|Capecitabine|capecitabine|mesh-list
65195709|NCT00706069|Vinorelbine|vinorelbine|mesh-list
65195710|NCT00706069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65195711|NCT00706069|Antimetabolites|antimetabolites|mesh-ancestor
65195712|NCT00706069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195713|NCT00706069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65195714|NCT00706069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65195715|NCT00706069|Tubulin Modulators|tubulin modulators|mesh-ancestor
65195716|NCT00706069|Antimitotic Agents|antimitotic agents|mesh-ancestor
65195717|NCT00706069|Mitosis Modulators|mitosis modulators|mesh-ancestor
65195718|NCT01155284|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65195719|NCT01155284|Lansoprazole|lansoprazole|mesh-list
65195720|NCT01155284|Dexlansoprazole|dexlansoprazole|mesh-list
65195721|NCT01155284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65195722|NCT01155284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195723|NCT01155284|Incretins|incretins|mesh-ancestor
65195724|NCT01155284|Hormones|hormones|mesh-ancestor
65195725|NCT01155284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65195726|NCT01155284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65195727|NCT01155284|Protease Inhibitors|protease inhibitors|mesh-ancestor
65195728|NCT01155284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65195729|NCT01155284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195730|NCT01155284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65195731|NCT01155284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65195732|NCT01155284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65195733|NCT00852397|Apixaban|apixaban|mesh-list
65195734|NCT00852397|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65195735|NCT00852397|Antithrombins|antithrombins|mesh-ancestor
65195736|NCT00852397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65195737|NCT00852397|Protease Inhibitors|protease inhibitors|mesh-ancestor
65195738|NCT00852397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65195739|NCT00852397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195740|NCT00852397|Anticoagulants|anticoagulants|mesh-ancestor
65195741|NCT00852241|Hyaluronic Acid|hyaluronic acid|mesh-list
65195742|NCT00852241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65195743|NCT00852241|Immunologic Factors|immunologic factors|mesh-ancestor
65195744|NCT00852241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195745|NCT00852241|Viscosupplements|viscosupplements|mesh-ancestor
65195746|NCT00852241|Protective Agents|protective agents|mesh-ancestor
65195747|NCT02612233|Pregabalin|pregabalin|mesh-list
65195748|NCT02612233|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65195749|NCT02612233|Analgesics|analgesics|mesh-ancestor
65195750|NCT02612233|Sensory System Agents|sensory system agents|mesh-ancestor
65329457|NCT00729339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329458|NCT00729339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329459|NCT00737139|Epinephrine|epinephrine|mesh-list
65329460|NCT00737139|Bupivacaine|bupivacaine|mesh-list
65329461|NCT00737139|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65329462|NCT00737139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65329463|NCT00737139|Adrenergic Agents|adrenergic agents|mesh-ancestor
65329464|NCT00737139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65329465|NCT00737139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329466|NCT00737139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329467|NCT00737139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65329468|NCT00737139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65329469|NCT00737139|Autonomic Agents|autonomic agents|mesh-ancestor
65329470|NCT00737139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65329471|NCT00737139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65329472|NCT00737139|Respiratory System Agents|respiratory system agents|mesh-ancestor
65329473|NCT00737139|Mydriatics|mydriatics|mesh-ancestor
64715603|NCT01801189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715604|NCT01801189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715605|NCT01801189|Anticonvulsants|anticonvulsants|mesh-ancestor
64715606|NCT01801189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64715607|NCT01801189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65195751|NCT02612233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195756|NCT02612233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195757|NCT02612233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65195758|NCT02612233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65195759|NCT02612233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65195760|NCT02612233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65195761|NCT02612233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65195762|NCT02612233|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65195763|NCT02612233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65195764|NCT02612233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195765|NCT02612233|Antidepressive Agents|antidepressive agents|mesh-ancestor
65195766|NCT02612233|Dopamine Agents|dopamine agents|mesh-ancestor
65195767|NCT01169636|Carboplatin|carboplatin|mesh-list
65195768|NCT01169636|Etoposide|etoposide|mesh-list
65195769|NCT01169636|Ifosfamide|ifosfamide|mesh-list
65195770|NCT01169636|Panobinostat|panobinostat|mesh-list
65195771|NCT01169636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65195772|NCT01169636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65195773|NCT01169636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65195774|NCT01169636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65195775|NCT01169636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65195776|NCT01169636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195777|NCT01169636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65195778|NCT01169636|Alkylating Agents|alkylating agents|mesh-ancestor
65195779|NCT01169636|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65195780|NCT00706225|Bazedoxifene|bazedoxifene|mesh-list
65195781|NCT00706225|Estrogens|estrogens|mesh-list
65195782|NCT00706225|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65329474|NCT00737139|Sympathomimetics|sympathomimetics|mesh-ancestor
65329475|NCT00737139|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65329476|NCT00737139|Anesthetics, Local|anesthetics, local|mesh-ancestor
65329477|NCT00737139|Anesthetics|anesthetics|mesh-ancestor
65329478|NCT00737139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65329479|NCT00737139|Sensory System Agents|sensory system agents|mesh-ancestor
65329480|NCT00732147|Pramlintide|pramlintide|mesh-list
64677886|NCT00001383|Paclitaxel|paclitaxel|mesh-list
65195783|NCT00706225|Hormones|hormones|mesh-ancestor
65195784|NCT00706225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65195785|NCT00706225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195786|NCT00706225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65195787|NCT00706225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65195788|NCT00706225|Hormone Antagonists|hormone antagonists|mesh-ancestor
65195789|NCT00706225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65195790|NCT04117009|Remifentanil|remifentanil|mesh-list
65195791|NCT04117009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65195792|NCT04117009|Narcotics|narcotics|mesh-ancestor
65195793|NCT04117009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65195794|NCT04117009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195795|NCT04117009|Analgesics|analgesics|mesh-ancestor
65195796|NCT04117009|Sensory System Agents|sensory system agents|mesh-ancestor
65195797|NCT04117009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195798|NCT04117243|Misoprostol|misoprostol|mesh-list
65195799|NCT04117243|Tranexamic Acid|tranexamic acid|mesh-list
65195800|NCT04117243|Oxytocin|oxytocin|mesh-list
65195801|NCT04117243|Oxytocics|oxytocics|mesh-ancestor
65195802|NCT04117243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65195803|NCT04117243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195804|NCT04117243|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65195805|NCT04117243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65195806|NCT04117243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195807|NCT04117243|Hemostatics|hemostatics|mesh-ancestor
65195808|NCT04117243|Coagulants|coagulants|mesh-ancestor
65195809|NCT04117243|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65195810|NCT04117243|Abortifacient Agents|abortifacient agents|mesh-ancestor
65195811|NCT04117243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65195812|NCT04117243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65195813|NCT01169558|Bevacizumab|bevacizumab|mesh-list
65195814|NCT01169558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65195815|NCT01169558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65195816|NCT01169558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65195817|NCT01169558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65195818|NCT01169558|Growth Substances|growth substances|mesh-ancestor
65195819|NCT01169558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195820|NCT01169558|Growth Inhibitors|growth inhibitors|mesh-ancestor
65195821|NCT00700687|Aspirin|aspirin|mesh-list
64838413|NCT01624714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65195827|NCT00700687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195828|NCT00700687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195829|NCT00700687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65195830|NCT00700687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65195831|NCT00700687|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65195832|NCT00700687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65195833|NCT00700687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195834|NCT00700687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65195835|NCT00700687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65195836|NCT00700687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65195837|NCT00700687|Antipyretics|antipyretics|mesh-ancestor
65195838|NCT00700687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65195839|NCT00840463|Ambrisentan|ambrisentan|mesh-list
65195840|NCT00840463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65195841|NCT00700765|Insulin Detemir|insulin detemir|mesh-list
65195842|NCT00700765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65195843|NCT00700765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195844|NCT00839527|Metformin|metformin|mesh-list
65195845|NCT00839527|Pioglitazone|pioglitazone|mesh-list
65195846|NCT00839527|Glimepiride|glimepiride|mesh-list
65195847|NCT00839527|rGLP-1 protein|rglp-1 protein|mesh-list
65329481|NCT00732147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65329482|NCT00732147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329483|NCT02569515|Epoetin Alfa|epoetin alfa|mesh-list
65329484|NCT02569515|Hematinics|hematinics|mesh-ancestor
65329485|NCT00737373|Leucovorin|leucovorin|mesh-list
65329486|NCT00737373|Folic Acid|folic acid|mesh-list
65329487|NCT00737373|Docetaxel|docetaxel|mesh-list
65329488|NCT00737373|Fluorouracil|fluorouracil|mesh-list
65195848|NCT00839527|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65195849|NCT00839527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65195850|NCT00839527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195851|NCT00839527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65195852|NCT00839527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65195853|NCT00839527|Immunologic Factors|immunologic factors|mesh-ancestor
65195855|NCT00839527|Hormones|hormones|mesh-ancestor
65195856|NCT00839527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65195857|NCT00706927|Timolol|timolol|mesh-list
65195858|NCT00706927|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65195859|NCT00706927|Latanoprost|latanoprost|mesh-list
65195860|NCT00706927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65195861|NCT00706927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65195862|NCT00706927|Adrenergic Agents|adrenergic agents|mesh-ancestor
65195863|NCT00706927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195864|NCT00706927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195865|NCT00706927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195866|NCT00706927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65195867|NCT00706927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65195868|NCT00706927|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65195869|NCT00706927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65195870|NCT00706927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65195871|NCT00706927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65195872|NCT00706927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65195873|NCT00707083|Dexamethasone|dexamethasone|mesh-list
65195874|NCT00707083|Methotrexate|methotrexate|mesh-list
65195875|NCT00707083|Vincristine|vincristine|mesh-list
65195876|NCT00707083|Mercaptopurine|mercaptopurine|mesh-list
65195877|NCT00707083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65195878|NCT00707083|Antiemetics|antiemetics|mesh-ancestor
65195879|NCT00707083|Autonomic Agents|autonomic agents|mesh-ancestor
65195880|NCT00707083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195881|NCT00707083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195882|NCT00707083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65195883|NCT00707083|Glucocorticoids|glucocorticoids|mesh-ancestor
65195884|NCT00707083|Hormones|hormones|mesh-ancestor
65195885|NCT00707083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65195886|NCT00707083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65195887|NCT00707083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65195888|NCT00707083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65195889|NCT00707083|Abortifacient Agents|abortifacient agents|mesh-ancestor
65195890|NCT00707083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65195891|NCT00707083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65195892|NCT00707083|Antimetabolites|antimetabolites|mesh-ancestor
65195893|NCT00707083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195895|NCT00707083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65195896|NCT00707083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65195897|NCT00707083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65195898|NCT00707083|Immunologic Factors|immunologic factors|mesh-ancestor
65195899|NCT00707083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65195900|NCT00707083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65195901|NCT00707083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65195902|NCT00707083|Tubulin Modulators|tubulin modulators|mesh-ancestor
65195903|NCT00707083|Antimitotic Agents|antimitotic agents|mesh-ancestor
65195904|NCT00707083|Mitosis Modulators|mitosis modulators|mesh-ancestor
65195905|NCT05500261|Dexmedetomidine|dexmedetomidine|mesh-list
65195906|NCT05500261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65195907|NCT05500261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65195908|NCT05500261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195909|NCT05500261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65195910|NCT05500261|Analgesics|analgesics|mesh-ancestor
65329489|NCT00737373|Oxaliplatin|oxaliplatin|mesh-list
65329490|NCT00737373|Levoleucovorin|levoleucovorin|mesh-list
65329491|NCT00737373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65195911|NCT05500261|Sensory System Agents|sensory system agents|mesh-ancestor
65195912|NCT05500261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195913|NCT05500261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65195914|NCT05500261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65195915|NCT05500261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65195916|NCT05500261|Adrenergic Agents|adrenergic agents|mesh-ancestor
65195917|NCT05500261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195918|NCT05500261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195919|NCT04116931|Clopidogrel|clopidogrel|mesh-list
65195920|NCT04116931|Ticagrelor|ticagrelor|mesh-list
65195921|NCT04116931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65195922|NCT04116931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65195923|NCT04116931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65195924|NCT04116931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65195925|NCT04116931|Purinergic Agents|purinergic agents|mesh-ancestor
65195927|NCT04116931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195928|NCT04116931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195929|NCT00600886|Octreotide|octreotide|mesh-list
65195930|NCT00600886|Pasireotide|pasireotide|mesh-list
65195931|NCT00600886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65195932|NCT00600886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65195933|NCT00600886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65195934|NCT00600886|Hormones|hormones|mesh-ancestor
65195935|NCT00600886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65195936|NCT00600886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195937|NCT00649324|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65195938|NCT00649324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65195939|NCT00649324|Diuretics|diuretics|mesh-ancestor
65195940|NCT00649324|Natriuretic Agents|natriuretic agents|mesh-ancestor
65195941|NCT00649324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195942|NCT00649324|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65195943|NCT00649324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65195944|NCT00649324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195945|NCT00648388|Cilostazol|cilostazol|mesh-list
65195946|NCT00648388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65195947|NCT00648388|Autonomic Agents|autonomic agents|mesh-ancestor
65195948|NCT00648388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195949|NCT00648388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195950|NCT00648388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65195951|NCT00648388|Respiratory System Agents|respiratory system agents|mesh-ancestor
65195952|NCT00648388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65195953|NCT00648388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65195954|NCT00648388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195955|NCT00648388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65195956|NCT00648388|Vasodilator Agents|vasodilator agents|mesh-ancestor
65195957|NCT00648388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65195958|NCT00648388|Protective Agents|protective agents|mesh-ancestor
65195959|NCT00648388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65195960|NCT00648388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65195961|NCT00648388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65195962|NCT02658760|Dexmedetomidine|dexmedetomidine|mesh-list
65195963|NCT02658760|Bupivacaine|bupivacaine|mesh-list
65195964|NCT02658760|Anesthetics, Local|anesthetics, local|mesh-ancestor
65195965|NCT02658760|Anesthetics|anesthetics|mesh-ancestor
65195969|NCT02658760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195970|NCT02658760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65195971|NCT02658760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65195972|NCT02658760|Analgesics|analgesics|mesh-ancestor
65195973|NCT02658760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65195974|NCT02658760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65195975|NCT02658760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65195976|NCT02658760|Adrenergic Agents|adrenergic agents|mesh-ancestor
65195977|NCT02658760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195978|NCT02658760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195979|NCT02536690|Midazolam|midazolam|mesh-list
65195980|NCT02536690|Remifentanil|remifentanil|mesh-list
65195981|NCT02536690|Propofol|propofol|mesh-list
65195982|NCT02536690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65329492|NCT00737373|Tubulin Modulators|tubulin modulators|mesh-ancestor
65329493|NCT00737373|Antimitotic Agents|antimitotic agents|mesh-ancestor
65329494|NCT00737373|Mitosis Modulators|mitosis modulators|mesh-ancestor
65329495|NCT00737373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329496|NCT00737373|Antimetabolites|antimetabolites|mesh-ancestor
65329497|NCT00737373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65329498|NCT00737373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65329499|NCT00737373|Immunologic Factors|immunologic factors|mesh-ancestor
65329500|NCT00737373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329501|NCT00737373|Antidotes|antidotes|mesh-ancestor
65329502|NCT00737373|Protective Agents|protective agents|mesh-ancestor
65329503|NCT00737373|Vitamin B Complex|vitamin b complex|mesh-ancestor
65079424|NCT00436839|Antimitotic Agents|antimitotic agents|mesh-ancestor
65329504|NCT00737373|Vitamins|vitamins|mesh-ancestor
65329505|NCT00737373|Micronutrients|micronutrients|mesh-ancestor
65329506|NCT00737373|Hematinics|hematinics|mesh-ancestor
65329507|NCT00729495|Celecoxib|celecoxib|mesh-list
65329508|NCT00729495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65329509|NCT00729495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65329510|NCT00729495|Analgesics|analgesics|mesh-ancestor
65329511|NCT00729495|Sensory System Agents|sensory system agents|mesh-ancestor
65329512|NCT00729495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65329513|NCT00729495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329514|NCT00729495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65329515|NCT00729495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65329516|NCT00729495|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65329517|NCT00729495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65329518|NCT00729495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329519|NCT00729495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329520|NCT00737685|Cyclophosphamide|cyclophosphamide|mesh-list
65329521|NCT00737685|Fludarabine|fludarabine|mesh-list
65195983|NCT02536690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65195984|NCT02536690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195985|NCT02536690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65195986|NCT02536690|Anesthetics, General|anesthetics, general|mesh-ancestor
65195987|NCT02536690|Anesthetics|anesthetics|mesh-ancestor
65195988|NCT02536690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65195989|NCT02536690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65195990|NCT02536690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65195991|NCT02536690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65195992|NCT02536690|GABA Modulators|gaba modulators|mesh-ancestor
65195993|NCT02536690|GABA Agents|gaba agents|mesh-ancestor
65195994|NCT02536690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195995|NCT02536690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329522|NCT00737685|Thymoglobulin|thymoglobulin|mesh-list
65329523|NCT00737685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65329524|NCT00737685|Immunologic Factors|immunologic factors|mesh-ancestor
65329525|NCT00737685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329526|NCT00737685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65329527|NCT00737685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65329528|NCT00737685|Alkylating Agents|alkylating agents|mesh-ancestor
65329529|NCT00737685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329530|NCT00737685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329531|NCT00737685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65329532|NCT00732537|Nitric Oxide|nitric oxide|mesh-list
65329533|NCT00732537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65329534|NCT00732537|Autonomic Agents|autonomic agents|mesh-ancestor
65329535|NCT00732537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65329536|NCT00732537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329537|NCT00732537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65329538|NCT00732537|Respiratory System Agents|respiratory system agents|mesh-ancestor
65329539|NCT00732537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65329540|NCT00732537|Antioxidants|antioxidants|mesh-ancestor
64715665|NCT03202550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195996|NCT02536690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65195997|NCT02536690|Narcotics|narcotics|mesh-ancestor
65195998|NCT02536690|Analgesics|analgesics|mesh-ancestor
65195999|NCT02536690|Sensory System Agents|sensory system agents|mesh-ancestor
65196000|NCT02536690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65196001|NCT00649090|Exemestane|exemestane|mesh-list
65196002|NCT00649090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196003|NCT00649090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65196004|NCT00649090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65196005|NCT00649090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196006|NCT00649090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196007|NCT00649090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65196008|NCT00649090|Hormone Antagonists|hormone antagonists|mesh-ancestor
65196009|NCT00649090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65196010|NCT00649090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196011|NCT00838903|Metformin|metformin|mesh-list
65196012|NCT00838903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65196013|NCT00838903|Glimepiride|glimepiride|mesh-list
65196014|NCT00838903|rGLP-1 protein|rglp-1 protein|mesh-list
65196015|NCT00838903|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65196016|NCT00838903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65196017|NCT00838903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196018|NCT00838903|Incretins|incretins|mesh-ancestor
65196019|NCT00838903|Hormones|hormones|mesh-ancestor
65196020|NCT00838903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65196021|NCT00838903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65196022|NCT00838903|Protease Inhibitors|protease inhibitors|mesh-ancestor
65196023|NCT00838903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196024|NCT00838903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196025|NCT00838903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65196026|NCT00838903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65196027|NCT00838903|Immunologic Factors|immunologic factors|mesh-ancestor
65196028|NCT00648466|Sumatriptan|sumatriptan|mesh-list
65196029|NCT00648466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65329541|NCT00732537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329542|NCT00732537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65329543|NCT00732537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65329544|NCT00732537|Vasodilator Agents|vasodilator agents|mesh-ancestor
65329545|NCT00732537|Gasotransmitters|gasotransmitters|mesh-ancestor
64678166|NCT00002301|Antiviral Agents|antiviral agents|mesh-ancestor
65196030|NCT00648466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65196031|NCT00648466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65196032|NCT00648466|Serotonin Agents|serotonin agents|mesh-ancestor
65196033|NCT00648466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65196034|NCT00648466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196035|NCT00648466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196036|NCT00649402|Amlodipine|amlodipine|mesh-list
65196037|NCT00649402|Benazepril|benazepril|mesh-list
65196042|NCT00649402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65196043|NCT00649402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196045|NCT00649402|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65196046|NCT00649402|Protease Inhibitors|protease inhibitors|mesh-ancestor
65196047|NCT00649402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196048|NCT04477486|Venetoclax|venetoclax|mesh-list
65196049|NCT04477486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196050|NCT00649480|Balsalazide|balsalazide|mesh-list
65196051|NCT00649480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65196052|NCT00649480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65196053|NCT00649480|Analgesics|analgesics|mesh-ancestor
65196054|NCT00649480|Sensory System Agents|sensory system agents|mesh-ancestor
65196055|NCT00649480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65196056|NCT00649480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196057|NCT00649480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65196058|NCT00649480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65196059|NCT00649480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65196060|NCT02656342|Cycloserine|cycloserine|mesh-list
65196061|NCT02656342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65196062|NCT02656342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65196063|NCT02656342|Renal Agents|renal agents|mesh-ancestor
65196064|NCT02656342|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65196065|NCT02656342|Antitubercular Agents|antitubercular agents|mesh-ancestor
65196066|NCT02656342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65196067|NCT02656342|Antimetabolites|antimetabolites|mesh-ancestor
65196068|NCT02656342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196070|NCT04169464|Antiviral Agents|antiviral agents|mesh-ancestor
65196071|NCT04169464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65196072|NCT00650416|Carvedilol|carvedilol|mesh-list
65196073|NCT00650416|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65196074|NCT00650416|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65196075|NCT00650416|Adrenergic Agents|adrenergic agents|mesh-ancestor
65196076|NCT00650416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65196077|NCT00650416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196078|NCT00650416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196079|NCT00650416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65196080|NCT00650416|Antioxidants|antioxidants|mesh-ancestor
65196081|NCT00650416|Protective Agents|protective agents|mesh-ancestor
65196082|NCT00650416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65196083|NCT00650416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65196084|NCT00650416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65196085|NCT00650416|Vasodilator Agents|vasodilator agents|mesh-ancestor
65196086|NCT00650416|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65196087|NCT00650416|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65196088|NCT00649948|Metformin|metformin|mesh-list
65196089|NCT00649948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65196090|NCT00649948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196091|NCT04167982|Isotretinoin|isotretinoin|mesh-list
65196092|NCT04167982|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65196093|NCT04167982|Dermatologic Agents|dermatologic agents|mesh-ancestor
65196094|NCT04167982|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65196095|NCT00649558|Pioglitazone|pioglitazone|mesh-list
65196096|NCT00649558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65196097|NCT00649558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329546|NCT00732537|Protective Agents|protective agents|mesh-ancestor
65329547|NCT00732693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65329548|NCT00732693|Norethindrone|norethindrone|mesh-list
65329549|NCT00732693|Norethindrone Acetate|norethindrone acetate|mesh-list
65329550|NCT00732693|Estradiol|estradiol|mesh-list
65329551|NCT00732693|Progesterone|progesterone|mesh-list
65329552|NCT00732693|Estrogens|estrogens|mesh-ancestor
65329553|NCT00732693|Hormones|hormones|mesh-ancestor
65196098|NCT02658526|Anesthetics|anesthetics|mesh-list
65196099|NCT02658526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65196100|NCT02658526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196101|NCT00650494|Valacyclovir|valacyclovir|mesh-list
65196102|NCT00650494|Antiviral Agents|antiviral agents|mesh-ancestor
65196103|NCT00650494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65196104|NCT02655874|Vaccines|vaccines|mesh-list
65196105|NCT02655874|Immunologic Factors|immunologic factors|mesh-ancestor
65196106|NCT02655874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196107|NCT00828139|Aflibercept|aflibercept|mesh-list
65196108|NCT00828139|Topotecan|topotecan|mesh-list
64838711|NCT01627236|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65196124|NCT02658214|Leucovorin|leucovorin|mesh-list
65196125|NCT02658214|Folic Acid|folic acid|mesh-list
65196126|NCT02658214|Gemcitabine|gemcitabine|mesh-list
65196127|NCT02658214|Paclitaxel|paclitaxel|mesh-list
65196128|NCT02658214|Etoposide|etoposide|mesh-list
65196129|NCT02658214|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65196130|NCT02658214|Carboplatin|carboplatin|mesh-list
65196131|NCT02658214|Fluorouracil|fluorouracil|mesh-list
65196132|NCT02658214|Oxaliplatin|oxaliplatin|mesh-list
65196133|NCT02658214|Durvalumab|durvalumab|mesh-list
65196134|NCT02658214|Tremelimumab|tremelimumab|mesh-list
65196135|NCT02658214|Levoleucovorin|levoleucovorin|mesh-list
65196136|NCT02658214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65196137|NCT02658214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196138|NCT02658214|Tubulin Modulators|tubulin modulators|mesh-ancestor
65196139|NCT02658214|Antimitotic Agents|antimitotic agents|mesh-ancestor
65196140|NCT02658214|Mitosis Modulators|mitosis modulators|mesh-ancestor
65196141|NCT02658214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196142|NCT02658214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65196143|NCT02658214|Antimetabolites|antimetabolites|mesh-ancestor
65196144|NCT02658214|Antiviral Agents|antiviral agents|mesh-ancestor
65196145|NCT02658214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65196146|NCT02658214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196147|NCT02658214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65196148|NCT02658214|Immunologic Factors|immunologic factors|mesh-ancestor
65196149|NCT02658214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196150|NCT02658214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65196151|NCT02658214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65196152|NCT02658214|Antidotes|antidotes|mesh-ancestor
65196153|NCT02658214|Protective Agents|protective agents|mesh-ancestor
65196154|NCT02658214|Vitamin B Complex|vitamin b complex|mesh-ancestor
65196155|NCT02658214|Vitamins|vitamins|mesh-ancestor
65196156|NCT02658214|Micronutrients|micronutrients|mesh-ancestor
65196157|NCT02658214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65196158|NCT02658214|Hematinics|hematinics|mesh-ancestor
65196159|NCT04169230|Citalopram|citalopram|mesh-list
65196160|NCT04169230|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65196161|NCT04169230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65196162|NCT04169230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65196163|NCT04169230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196164|NCT04169230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65196165|NCT04169230|Serotonin Agents|serotonin agents|mesh-ancestor
65196166|NCT04169230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196167|NCT04169230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65196168|NCT04169230|Antidepressive Agents|antidepressive agents|mesh-ancestor
65196172|NCT04201756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65196173|NCT04201756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196174|NCT04201756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196175|NCT02651350|Methylprednisolone|methylprednisolone|mesh-list
65196176|NCT02651350|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65196177|NCT02651350|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65196178|NCT02651350|Prednisolone|prednisolone|mesh-list
65196179|NCT02651350|Prednisolone acetate|prednisolone acetate|mesh-list
65329554|NCT00732693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65329555|NCT00732693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329556|NCT00732693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65329557|NCT00732693|Contraceptive Agents|contraceptive agents|mesh-ancestor
65329558|NCT00732693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65329559|NCT00732693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65329560|NCT00732693|Progestins|progestins|mesh-ancestor
65329561|NCT00732693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65329562|NCT00732693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65329563|NCT00732693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65329564|NCT00729963|Sibutramine|sibutramine|mesh-list
65329565|NCT00729963|Antidepressive Agents|antidepressive agents|mesh-ancestor
65329566|NCT00729963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65329567|NCT00729963|Appetite Depressants|appetite depressants|mesh-ancestor
65329568|NCT00729963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65329569|NCT00737997|Morphine|morphine|mesh-list
64715704|NCT02076217|Copper|copper|mesh-list
65196180|NCT02651350|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65196181|NCT02651350|Prednisolone phosphate|prednisolone phosphate|mesh-list
65196182|NCT02651350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65196183|NCT02651350|Antiemetics|antiemetics|mesh-ancestor
65196184|NCT02651350|Autonomic Agents|autonomic agents|mesh-ancestor
65196185|NCT02651350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65196186|NCT02651350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196187|NCT02651350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65196188|NCT02651350|Glucocorticoids|glucocorticoids|mesh-ancestor
65196189|NCT02651350|Hormones|hormones|mesh-ancestor
65196190|NCT02651350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65196191|NCT02651350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65196192|NCT02651350|Protective Agents|protective agents|mesh-ancestor
65196193|NCT02651350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65196194|NCT02651350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196195|NCT02658292|Naftifine|naftifine|mesh-list
65196196|NCT02658292|Antifungal Agents|antifungal agents|mesh-ancestor
65196197|NCT02658292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65196198|NCT02651038|Micafungin|micafungin|mesh-list
65196199|NCT02651038|Antifungal Agents|antifungal agents|mesh-ancestor
64838786|NCT01627431|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65196200|NCT02651038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65196201|NCT00650026|Adalimumab|adalimumab|mesh-list
65196202|NCT00650026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65196203|NCT00650026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65196204|NCT00838513|Eculizumab|eculizumab|mesh-list
65196205|NCT00838513|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65196206|NCT00838513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65196207|NCT00838513|Immunologic Factors|immunologic factors|mesh-ancestor
65196208|NCT00838513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196209|NCT00649636|Fluoxetine|fluoxetine|mesh-list
65196210|NCT00649636|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65196211|NCT00649636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65196212|NCT00649636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65196213|NCT00649636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196214|NCT00649636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65196215|NCT00649636|Serotonin Agents|serotonin agents|mesh-ancestor
65196216|NCT00649636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196217|NCT00649636|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65196218|NCT00649636|Antidepressive Agents|antidepressive agents|mesh-ancestor
65196219|NCT00649636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65329570|NCT00737997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65329571|NCT00737997|Narcotics|narcotics|mesh-ancestor
65329572|NCT00737997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65329573|NCT00737997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329574|NCT00737997|Analgesics|analgesics|mesh-ancestor
65329575|NCT00737997|Sensory System Agents|sensory system agents|mesh-ancestor
65329576|NCT00737997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65329577|NCT00732927|Aspirin|aspirin|mesh-list
65329578|NCT00732927|Parnaparin|parnaparin|mesh-list
65329579|NCT00732927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65329580|NCT00732927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65329581|NCT00732927|Analgesics|analgesics|mesh-ancestor
65329582|NCT00732927|Sensory System Agents|sensory system agents|mesh-ancestor
65329583|NCT00732927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65329584|NCT00732927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329585|NCT00732927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65329586|NCT00732927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65196220|NCT00649636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65196221|NCT00649636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65196222|NCT00649636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196223|NCT04030663|Nitroglycerin|nitroglycerin|mesh-list
65196224|NCT04030663|Papaverine|papaverine|mesh-list
65196225|NCT04030663|Vasodilator Agents|vasodilator agents|mesh-ancestor
65196226|NCT04030663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65196227|NCT04030663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196228|NCT04030663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196229|NCT04030663|Urological Agents|urological agents|mesh-ancestor
65196231|NCT00700921|L 647318|l 647318|mesh-list
65196232|NCT00700921|Dihydromevinolin|dihydromevinolin|mesh-list
65196233|NCT00700921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65196234|NCT00700921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65196235|NCT00700921|Antimetabolites|antimetabolites|mesh-ancestor
65196236|NCT00700921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196237|NCT00700921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65196238|NCT00700921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65196239|NCT00700921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196240|NCT00850993|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
65196241|NCT00850993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196250|NCT02657512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196251|NCT02657512|Anticoagulants|anticoagulants|mesh-ancestor
65196252|NCT02657512|Antidotes|antidotes|mesh-ancestor
65196253|NCT02657512|Protective Agents|protective agents|mesh-ancestor
65196254|NCT02657512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196255|NCT00818779|Amlodipine|amlodipine|mesh-list
65196256|NCT00818779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65196257|NCT00818779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65196258|NCT00818779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65196259|NCT00818779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196260|NCT00818779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65196261|NCT00818779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196262|NCT00818779|Vasodilator Agents|vasodilator agents|mesh-ancestor
65196263|NCT00649714|Zonisamide|zonisamide|mesh-list
65196264|NCT00649714|Anticonvulsants|anticonvulsants|mesh-ancestor
65196265|NCT00649714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65196266|NCT00649714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65196267|NCT00649714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196268|NCT00649714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65329587|NCT00732927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65329588|NCT00732927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65329589|NCT00732927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329590|NCT00732927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65329591|NCT00732927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65329592|NCT00732927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329593|NCT00732927|Antipyretics|antipyretics|mesh-ancestor
65329594|NCT00732927|Anticoagulants|anticoagulants|mesh-ancestor
65329595|NCT00733083|Dexamethasone|dexamethasone|mesh-list
65329596|NCT00733083|Morphine|morphine|mesh-list
65329597|NCT00733083|Oxycodone|oxycodone|mesh-list
65196269|NCT00649714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196270|NCT00600028|Thalidomide|thalidomide|mesh-list
65196271|NCT00600028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65196272|NCT00600028|Immunologic Factors|immunologic factors|mesh-ancestor
65196273|NCT00600028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196274|NCT00600028|Leprostatic Agents|leprostatic agents|mesh-ancestor
65196275|NCT00600028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65196276|NCT00600028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65196277|NCT00600028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65196278|NCT00600028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65196279|NCT00600028|Growth Substances|growth substances|mesh-ancestor
65196280|NCT00600028|Growth Inhibitors|growth inhibitors|mesh-ancestor
65196281|NCT00600028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196282|NCT02650102|Olanzapine|olanzapine|mesh-list
65196283|NCT02650102|Risperidone|risperidone|mesh-list
65196284|NCT02650102|Aripiprazole|aripiprazole|mesh-list
65196285|NCT02650102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65196286|NCT02650102|Ziprasidone|ziprasidone|mesh-list
65196287|NCT02650102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65196288|NCT02650102|Serotonin Agents|serotonin agents|mesh-ancestor
65196289|NCT02650102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65196290|NCT02650102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196291|NCT02650102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196292|NCT02650102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65196293|NCT02650102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65196294|NCT02650102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65196295|NCT02650102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65196296|NCT02650102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65196297|NCT02650102|Dopamine Agents|dopamine agents|mesh-ancestor
65196298|NCT02650102|Antiemetics|antiemetics|mesh-ancestor
65196299|NCT02650102|Autonomic Agents|autonomic agents|mesh-ancestor
65196300|NCT02650102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65196301|NCT02650102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65196303|NCT02650102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65196304|NCT02650102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65196305|NCT02650102|Antidepressive Agents|antidepressive agents|mesh-ancestor
65196306|NCT02650102|Dopamine Agonists|dopamine agonists|mesh-ancestor
65196307|NCT02650102|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65196308|NCT02650102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65196309|NCT02650102|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65196333|NCT00910780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196334|NCT00910780|Dopamine Agonists|dopamine agonists|mesh-ancestor
65196335|NCT00910780|Dopamine Agents|dopamine agents|mesh-ancestor
65196336|NCT00910780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65196337|NCT00910780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196338|NCT00910780|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65196339|NCT00910780|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65196340|NCT00910780|Serotonin Agents|serotonin agents|mesh-ancestor
65196341|NCT00910780|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65196342|NCT00910780|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65196343|NCT00910780|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65196344|NCT00910780|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65196345|NCT00910780|Antiemetics|antiemetics|mesh-ancestor
65196346|NCT00910780|Autonomic Agents|autonomic agents|mesh-ancestor
65329598|NCT00733083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65329599|NCT00733083|Antiemetics|antiemetics|mesh-ancestor
65329600|NCT00733083|Autonomic Agents|autonomic agents|mesh-ancestor
65329601|NCT00733083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65329602|NCT00733083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329603|NCT00733083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65329604|NCT00733083|Glucocorticoids|glucocorticoids|mesh-ancestor
65329605|NCT00733083|Hormones|hormones|mesh-ancestor
65329606|NCT00733083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65329607|NCT00733083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65329608|NCT00733083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329609|NCT00733083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65329610|NCT00733083|Narcotics|narcotics|mesh-ancestor
65329611|NCT00733083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65329612|NCT00733083|Analgesics|analgesics|mesh-ancestor
65329613|NCT00733083|Sensory System Agents|sensory system agents|mesh-ancestor
65329614|NCT00712335|Fluticasone|fluticasone|mesh-list
65329615|NCT00712335|Xhance|xhance|mesh-list
65329616|NCT00712335|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65329617|NCT00712335|Montelukast|montelukast|mesh-list
65196347|NCT00910780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65196348|NCT00910780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65196349|NCT00910780|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65196350|NCT00910780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65196351|NCT00910780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65196352|NCT02656810|Teriparatide|teriparatide|mesh-list
65196353|NCT02656810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65196354|NCT02656810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196355|NCT02656810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65196356|NCT02649478|Fluticasone|fluticasone|mesh-list
65196357|NCT02649478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65196358|NCT02649478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65196359|NCT02649478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65196360|NCT02649478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65196361|NCT02649478|Autonomic Agents|autonomic agents|mesh-ancestor
65196362|NCT02649478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65196367|NCT02649478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65196368|NCT02649478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65196369|NCT02649478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65196370|NCT02649478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65196371|NCT02649478|Adrenergic Agents|adrenergic agents|mesh-ancestor
65196372|NCT02649478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65196373|NCT02649478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196374|NCT02649478|Glucocorticoids|glucocorticoids|mesh-ancestor
65196376|NCT02649478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65196377|NCT02649478|Sympathomimetics|sympathomimetics|mesh-ancestor
65196378|NCT04167592|Benzydamine|benzydamine|mesh-list
65196379|NCT04167592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65196380|NCT04168294|Propofol|propofol|mesh-list
65196381|NCT04168294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65196382|NCT04168294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65196383|NCT04168294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196384|NCT04168294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65196385|NCT04168294|Anesthetics, General|anesthetics, general|mesh-ancestor
65196386|NCT04168294|Anesthetics|anesthetics|mesh-ancestor
65329618|NCT00712335|Leukotriene Antagonists|leukotriene antagonists|mesh-list
65329619|NCT00712335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65329620|NCT00712335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65329621|NCT00712335|Autonomic Agents|autonomic agents|mesh-ancestor
65329622|NCT00712335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65329623|NCT00712335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329624|NCT00712335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65329625|NCT00712335|Respiratory System Agents|respiratory system agents|mesh-ancestor
65329626|NCT00712335|Dermatologic Agents|dermatologic agents|mesh-ancestor
65329627|NCT00712335|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65329628|NCT00712335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65329629|NCT00712335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65196387|NCT04168138|Cytarabine|cytarabine|mesh-list
65196388|NCT04168138|Decitabine|decitabine|mesh-list
65196389|NCT04168138|Aclarubicin|aclarubicin|mesh-list
65196390|NCT04168138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65196391|NCT04168138|Antimetabolites|antimetabolites|mesh-ancestor
65196392|NCT04168138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196393|NCT04168138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196394|NCT04168138|Antiviral Agents|antiviral agents|mesh-ancestor
65196395|NCT04168138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65196396|NCT04168138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65196397|NCT04168138|Immunologic Factors|immunologic factors|mesh-ancestor
65196398|NCT04168138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196399|NCT04168138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196400|NCT04168138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65196401|NCT04168138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65196402|NCT04168138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65196403|NCT04059562|Irinotecan|irinotecan|mesh-list
65196404|NCT04059562|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65196405|NCT04059562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65196406|NCT04059562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196407|NCT04059562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196408|NCT04059562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196409|NCT00649870|Valacyclovir|valacyclovir|mesh-list
65196410|NCT00649870|Antiviral Agents|antiviral agents|mesh-ancestor
65196411|NCT00649870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65196412|NCT04167280|Ipratropium|ipratropium|mesh-list
65196413|NCT04167280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65196414|NCT04167280|Autonomic Agents|autonomic agents|mesh-ancestor
65196415|NCT04167280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65196416|NCT04167280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196417|NCT04167280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65196418|NCT04167280|Respiratory System Agents|respiratory system agents|mesh-ancestor
65196419|NCT04167280|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65196420|NCT04167280|Cholinergic Agents|cholinergic agents|mesh-ancestor
65196421|NCT04167280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65196422|NCT04167280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196423|NCT02648854|Metformin|metformin|mesh-list
65196424|NCT02648854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65196425|NCT02648854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196426|NCT03978520|Upadacitinib|upadacitinib|mesh-list
65196427|NCT03978520|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65196428|NCT03978520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65196429|NCT03978520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196430|NCT03978520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196431|NCT03978520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65196432|NCT02652598|Tolcapone|tolcapone|mesh-list
65196433|NCT02652598|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65196438|NCT02648776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65196439|NCT02648776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65196440|NCT02648776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196441|NCT02648464|Hydroxychloroquine|hydroxychloroquine|mesh-list
65329630|NCT00712335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65329631|NCT00712335|Adrenergic Agents|adrenergic agents|mesh-ancestor
65329632|NCT00712335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65329633|NCT00712335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329634|NCT00712335|Hormone Antagonists|hormone antagonists|mesh-ancestor
65329635|NCT00712335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65329636|NCT00712335|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65329637|NCT00712335|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65329638|NCT00738621|Dexamethasone|dexamethasone|mesh-list
65329639|NCT00738621|Dexamethasone acetate|dexamethasone acetate|mesh-list
65329640|NCT00738621|Ondansetron|ondansetron|mesh-list
65329641|NCT00738621|Aprepitant|aprepitant|mesh-list
65329642|NCT00738621|Fosaprepitant|fosaprepitant|mesh-list
65329643|NCT00738621|BB 1101|bb 1101|mesh-list
65329644|NCT00738621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65329645|NCT00738621|Antiemetics|antiemetics|mesh-ancestor
65329646|NCT00738621|Autonomic Agents|autonomic agents|mesh-ancestor
65329647|NCT00738621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65329648|NCT00738621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715771|NCT03296072|Fluorides|fluorides|mesh-list
65196442|NCT02648464|Antimalarials|antimalarials|mesh-ancestor
65196443|NCT02648464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65196444|NCT02648464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65196445|NCT02648464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65196446|NCT02648464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196447|NCT02648464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196448|NCT02648464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65196449|NCT02645032|Vaccines|vaccines|mesh-list
65196450|NCT02645032|Immunologic Factors|immunologic factors|mesh-ancestor
65196451|NCT02645032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196453|NCT02644954|Calcipotriene|calcipotriene|mesh-list
65196454|NCT02644954|Coal Tar|coal tar|mesh-list
65196455|NCT02644954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65196456|NCT02644954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196457|NCT02644954|Dermatologic Agents|dermatologic agents|mesh-ancestor
65196458|NCT02644954|Keratolytic Agents|keratolytic agents|mesh-ancestor
65196459|NCT00650338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65196460|NCT00650338|Latanoprost|latanoprost|mesh-list
65196461|NCT00650338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65196462|NCT02644720|Dexamethasone|dexamethasone|mesh-list
65196463|NCT02644720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65196464|NCT02644720|Antiemetics|antiemetics|mesh-ancestor
65196465|NCT02644720|Autonomic Agents|autonomic agents|mesh-ancestor
65196466|NCT02644720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65196467|NCT02644720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196468|NCT02644720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65196469|NCT02644720|Glucocorticoids|glucocorticoids|mesh-ancestor
65196470|NCT02644720|Hormones|hormones|mesh-ancestor
65196471|NCT02644720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65196472|NCT02644720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65196473|NCT02644720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196474|NCT03542266|Azacitidine|azacitidine|mesh-list
65196475|NCT03542266|Cc-486|cc-486|mesh-list
65196476|NCT03542266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65196477|NCT03542266|Antimetabolites|antimetabolites|mesh-ancestor
65196478|NCT03542266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196479|NCT03542266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196480|NCT03542266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329649|NCT00738621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65329650|NCT00738621|Glucocorticoids|glucocorticoids|mesh-ancestor
65329651|NCT00738621|Hormones|hormones|mesh-ancestor
65329652|NCT00738621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65329653|NCT00738621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65329654|NCT00738621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329655|NCT00738621|Protease Inhibitors|protease inhibitors|mesh-ancestor
65329656|NCT00738621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329657|NCT00738621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329658|NCT00738621|Antipruritics|antipruritics|mesh-ancestor
65329659|NCT00738621|Dermatologic Agents|dermatologic agents|mesh-ancestor
65329660|NCT00738621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65329661|NCT00738621|Serotonin Agents|serotonin agents|mesh-ancestor
65329662|NCT00738621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65329663|NCT00738621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65329664|NCT00738621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64715789|NCT03185065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64715795|NCT03185065|Antiviral Agents|antiviral agents|mesh-ancestor
65196481|NCT00652600|Propranolol|propranolol|mesh-list
65196482|NCT00652600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65196483|NCT00652600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65196484|NCT00652600|Adrenergic Agents|adrenergic agents|mesh-ancestor
65196485|NCT00652600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65196486|NCT00652600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196487|NCT00652600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196488|NCT00652600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65196489|NCT00652600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65196490|NCT00652600|Vasodilator Agents|vasodilator agents|mesh-ancestor
65196491|NCT03201250|Dexamethasone|dexamethasone|mesh-list
65196492|NCT03201250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65196493|NCT03201250|Antiemetics|antiemetics|mesh-ancestor
65196494|NCT03201250|Autonomic Agents|autonomic agents|mesh-ancestor
65196495|NCT03201250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65196496|NCT03201250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196497|NCT03201250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65196498|NCT03201250|Glucocorticoids|glucocorticoids|mesh-ancestor
65196499|NCT03201250|Hormones|hormones|mesh-ancestor
65196500|NCT03201250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65196501|NCT03201250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65196502|NCT03201250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196503|NCT04166578|Lidocaine|lidocaine|mesh-list
65196504|NCT04166578|Anesthetics, Local|anesthetics, local|mesh-ancestor
65196506|NCT04166578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65196513|NCT04166578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65196514|NCT04166578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196515|NCT04166734|Pembrolizumab|pembrolizumab|mesh-list
65196516|NCT04166734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65196517|NCT04166734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196518|NCT00651352|Nicotine|nicotine|mesh-list
65196519|NCT00651352|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65196520|NCT00651352|Autonomic Agents|autonomic agents|mesh-ancestor
65196521|NCT00651352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65196522|NCT00651352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196523|NCT00651352|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65196524|NCT00651352|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65196525|NCT00651352|Cholinergic Agents|cholinergic agents|mesh-ancestor
65196526|NCT00651352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65329665|NCT00738621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65329666|NCT00738621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65329667|NCT00738621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65329668|NCT00738621|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65329669|NCT00733239|Cycloserine|cycloserine|mesh-list
65329670|NCT00733239|Verapamil|verapamil|mesh-list
65329671|NCT00733239|Diltiazem|diltiazem|mesh-list
65329672|NCT00733239|Isradipine|isradipine|mesh-list
65329673|NCT00733239|Nifedipine|nifedipine|mesh-list
65329674|NCT00733239|Gabapentin|gabapentin|mesh-list
65329675|NCT00733239|Naloxone|naloxone|mesh-list
65329676|NCT00733239|Analgesics|analgesics|mesh-ancestor
65329677|NCT00733239|Sensory System Agents|sensory system agents|mesh-ancestor
65329678|NCT00733239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65329679|NCT00733239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329680|NCT00733239|Anticonvulsants|anticonvulsants|mesh-ancestor
65329681|NCT00733239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65329682|NCT00733239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65329683|NCT00733239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65196527|NCT00651352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196528|NCT02641210|Albendazole|albendazole|mesh-list
65196529|NCT02641210|Anthelmintics|anthelmintics|mesh-ancestor
65196530|NCT02641210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65196531|NCT02641210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65196532|NCT02641210|Anticestodal Agents|anticestodal agents|mesh-ancestor
65196533|NCT02641210|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65196534|NCT02641210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65196535|NCT02641210|Tubulin Modulators|tubulin modulators|mesh-ancestor
65196536|NCT02641210|Antimitotic Agents|antimitotic agents|mesh-ancestor
65196537|NCT02641210|Mitosis Modulators|mitosis modulators|mesh-ancestor
65196538|NCT02641210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196539|NCT02641210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196540|NCT02644408|Megestrol|megestrol|mesh-list
65196541|NCT02644408|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65196542|NCT02644408|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65196543|NCT02644408|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65196544|NCT02644408|Contraceptive Agents|contraceptive agents|mesh-ancestor
65196545|NCT02644408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65196546|NCT02644408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196547|NCT02644408|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65196548|NCT02644408|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65196549|NCT02644408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65196550|NCT02644408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196551|NCT05758597|Midazolam|midazolam|mesh-list
65196552|NCT05758597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65196553|NCT05758597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65196554|NCT05758597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65196555|NCT05758597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196556|NCT05758597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65196557|NCT05758597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65196558|NCT05758597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65196559|NCT05758597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65196560|NCT05758597|Anesthetics, General|anesthetics, general|mesh-ancestor
65196561|NCT05758597|Anesthetics|anesthetics|mesh-ancestor
65196562|NCT05758597|GABA Modulators|gaba modulators|mesh-ancestor
65196563|NCT05758597|GABA Agents|gaba agents|mesh-ancestor
65196564|NCT05758597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65196565|NCT05758597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196566|NCT02644486|Irbesartan|irbesartan|mesh-list
65329684|NCT00733239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65329685|NCT00733239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65329686|NCT00733239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65329687|NCT00733239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65329688|NCT00733239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329689|NCT00733239|Antimanic Agents|antimanic agents|mesh-ancestor
65329690|NCT00733239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65329691|NCT00733239|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65329692|NCT00733239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65329693|NCT00733239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65329694|NCT00733239|Vasodilator Agents|vasodilator agents|mesh-ancestor
65196567|NCT02644486|Sevelamer|sevelamer|mesh-list
65196568|NCT02644486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65196569|NCT02644486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65196570|NCT02644486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65196571|NCT02644486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196572|NCT02644486|Chelating Agents|chelating agents|mesh-ancestor
65196573|NCT02644486|Sequestering Agents|sequestering agents|mesh-ancestor
65196590|NCT04165174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196591|NCT04165174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196592|NCT04165174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65196593|NCT04165174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196594|NCT04165174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196596|NCT02613247|Viscosupplements|viscosupplements|mesh-ancestor
65196597|NCT02613247|Protective Agents|protective agents|mesh-ancestor
65196598|NCT02613247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196599|NCT02641132|Mitomycins|mitomycins|mesh-list
65196600|NCT02641132|Mitomycin|mitomycin|mesh-list
65196601|NCT02641132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65196602|NCT02641132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196603|NCT02641132|Alkylating Agents|alkylating agents|mesh-ancestor
65196604|NCT02641132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196605|NCT02641132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65196606|NCT02641132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196607|NCT00653614|Drospirenone|drospirenone|mesh-list
65196608|NCT00653614|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65196609|NCT00653614|Hormone Antagonists|hormone antagonists|mesh-ancestor
65196610|NCT00653614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65196611|NCT00653614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196612|NCT00653614|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65196613|NCT00653614|Diuretics|diuretics|mesh-ancestor
65196614|NCT00653614|Natriuretic Agents|natriuretic agents|mesh-ancestor
65196615|NCT02644252|Tocotrienols|tocotrienols|mesh-list
65196616|NCT02644252|Vitamin E|vitamin e|mesh-list
65196617|NCT02644252|Tocopherols|tocopherols|mesh-list
65196618|NCT02644252|Carboplatin|carboplatin|mesh-list
65196619|NCT02644252|Vinorelbine|vinorelbine|mesh-list
65196620|NCT02644252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196621|NCT02644252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65196622|NCT02644252|Tubulin Modulators|tubulin modulators|mesh-ancestor
65196623|NCT02644252|Antimitotic Agents|antimitotic agents|mesh-ancestor
65196624|NCT02644252|Mitosis Modulators|mitosis modulators|mesh-ancestor
65196625|NCT02644252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196626|NCT02644252|Antioxidants|antioxidants|mesh-ancestor
65196627|NCT02644252|Protective Agents|protective agents|mesh-ancestor
65196628|NCT02644252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196629|NCT02644252|Vitamins|vitamins|mesh-ancestor
65196630|NCT02644252|Micronutrients|micronutrients|mesh-ancestor
65196631|NCT00818389|Riluzole|riluzole|mesh-list
65196632|NCT00818389|Lithium Carbonate|lithium carbonate|mesh-list
65196633|NCT00818389|Antidepressive Agents|antidepressive agents|mesh-ancestor
65196638|NCT00818389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65329695|NCT00733239|Tocolytic Agents|tocolytic agents|mesh-ancestor
65329696|NCT00733239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65329697|NCT00733239|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65329698|NCT00733239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65329699|NCT00733239|Renal Agents|renal agents|mesh-ancestor
65329700|NCT00733239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65329701|NCT00733239|Antitubercular Agents|antitubercular agents|mesh-ancestor
65329702|NCT00733239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65329703|NCT00733239|Antimetabolites|antimetabolites|mesh-ancestor
65329704|NCT00733239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65329705|NCT00733239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65329706|NCT00738153|Insulin Detemir|insulin detemir|mesh-list
65329707|NCT00738153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65329708|NCT00738153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329709|NCT04065165|Lanreotide|lanreotide|mesh-list
65329710|NCT04065165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329711|NCT00577629|Cytarabine|cytarabine|mesh-list
65196639|NCT00818389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65196640|NCT00818389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196641|NCT00818389|Anticonvulsants|anticonvulsants|mesh-ancestor
65196642|NCT00818389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65196643|NCT00818389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65196644|NCT00818389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65196645|NCT00818389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65196646|NCT00818389|Protective Agents|protective agents|mesh-ancestor
65196647|NCT02640976|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65196648|NCT02640976|Cetrorelix|cetrorelix|mesh-list
65196649|NCT02640976|Menotropins|menotropins|mesh-list
65196650|NCT02640976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65196651|NCT02640976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196652|NCT02640976|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65196653|NCT02640976|Fertility Agents|fertility agents|mesh-ancestor
65196654|NCT02640976|Hormone Antagonists|hormone antagonists|mesh-ancestor
65196655|NCT02640976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65196656|NCT02644018|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
65196657|NCT02644018|Antiviral Agents|antiviral agents|mesh-ancestor
65196658|NCT02644018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65196659|NCT02647918|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65196660|NCT02647918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65196661|NCT02647918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196662|NCT02647918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65196663|NCT02647918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196664|NCT03130036|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65196665|NCT03130036|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65196666|NCT03130036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196668|NCT02535988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65196669|NCT02535988|Immunologic Factors|immunologic factors|mesh-ancestor
65196670|NCT02535988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196671|NCT02640898|Docetaxel|docetaxel|mesh-list
65196672|NCT02640898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196673|NCT02640898|Tubulin Modulators|tubulin modulators|mesh-ancestor
65196674|NCT02640898|Antimitotic Agents|antimitotic agents|mesh-ancestor
65196675|NCT02640898|Mitosis Modulators|mitosis modulators|mesh-ancestor
65196676|NCT02640898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196677|NCT02535910|Vitamin D|vitamin d|mesh-list
65196678|NCT02535910|Cholecalciferol|cholecalciferol|mesh-list
65196679|NCT02535910|Calcifediol|calcifediol|mesh-list
65196680|NCT02535910|Vitamins|vitamins|mesh-ancestor
65329712|NCT00577629|Cyclophosphamide|cyclophosphamide|mesh-list
65329713|NCT00577629|Rituximab|rituximab|mesh-list
65329714|NCT00577629|Doxorubicin|doxorubicin|mesh-list
65329715|NCT00577629|Etoposide|etoposide|mesh-list
65329716|NCT00577629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65329717|NCT00577629|Immunologic Factors|immunologic factors|mesh-ancestor
65329718|NCT00577629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329719|NCT00577629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65329720|NCT00577629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65329721|NCT00577629|Alkylating Agents|alkylating agents|mesh-ancestor
65329722|NCT00577629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329723|NCT00577629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329724|NCT00577629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65329725|NCT00577629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65196681|NCT02535910|Micronutrients|micronutrients|mesh-ancestor
65196682|NCT02535910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196683|NCT02535910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65196684|NCT02535910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65196685|NCT00849901|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65196686|NCT00849901|Fluoxetine|fluoxetine|mesh-list
65196687|NCT00849901|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65196688|NCT00849901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65196689|NCT00849901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65196690|NCT00849901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196691|NCT00849901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65196692|NCT00849901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196693|NCT00849901|Analgesics|analgesics|mesh-ancestor
65196694|NCT00849901|Sensory System Agents|sensory system agents|mesh-ancestor
65196695|NCT00849901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65196696|NCT00849901|Antidepressive Agents|antidepressive agents|mesh-ancestor
65196697|NCT00849901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65196698|NCT00849901|Dopamine Agents|dopamine agents|mesh-ancestor
65196699|NCT00849901|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65196700|NCT00849901|Serotonin Agents|serotonin agents|mesh-ancestor
65196701|NCT00849901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65196704|NCT00849901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196706|NCT02641054|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65196707|NCT02641054|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65196708|NCT02641054|Dopamine Agents|dopamine agents|mesh-ancestor
65196709|NCT02641054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65196710|NCT02641054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196711|NCT02641054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196712|NCT02643784|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65196713|NCT02643784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65196714|NCT02643784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65196715|NCT02643784|Antimetabolites|antimetabolites|mesh-ancestor
65196716|NCT02643784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196717|NCT02643784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65196718|NCT02643784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65196719|NCT02643784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196720|NCT04166890|Epinephrine|epinephrine|mesh-list
65196721|NCT04166890|Carticaine|carticaine|mesh-list
65196722|NCT04166890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65196723|NCT04166890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65196724|NCT04166890|Adrenergic Agents|adrenergic agents|mesh-ancestor
65196725|NCT04166890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65196726|NCT04166890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196727|NCT04166890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329726|NCT00577629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65329727|NCT00577629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65329728|NCT00577629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65329729|NCT00577629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329730|NCT00577629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65329731|NCT00577629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65329732|NCT00577629|Antimetabolites|antimetabolites|mesh-ancestor
65329733|NCT00577629|Antiviral Agents|antiviral agents|mesh-ancestor
65329734|NCT00577629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65329735|NCT00733317|Budesonide|budesonide|mesh-list
65329736|NCT00733317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65329737|NCT00733317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65329738|NCT00733317|Autonomic Agents|autonomic agents|mesh-ancestor
65329739|NCT00733317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65196728|NCT04166890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65196729|NCT04166890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65196730|NCT04166890|Autonomic Agents|autonomic agents|mesh-ancestor
65196731|NCT04166890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65196732|NCT04166890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65196733|NCT04166890|Respiratory System Agents|respiratory system agents|mesh-ancestor
65196734|NCT04166890|Mydriatics|mydriatics|mesh-ancestor
65196735|NCT04166890|Sympathomimetics|sympathomimetics|mesh-ancestor
65196736|NCT04166890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65196737|NCT04166890|Anesthetics, Local|anesthetics, local|mesh-ancestor
65196738|NCT04166890|Anesthetics|anesthetics|mesh-ancestor
65196739|NCT04166890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65196740|NCT04166890|Sensory System Agents|sensory system agents|mesh-ancestor
65196741|NCT00652912|Clonazepam|clonazepam|mesh-list
65196742|NCT00652912|Anticonvulsants|anticonvulsants|mesh-ancestor
65196743|NCT00652912|GABA Modulators|gaba modulators|mesh-ancestor
65196744|NCT00652912|GABA Agents|gaba agents|mesh-ancestor
65196745|NCT00652912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65196746|NCT00652912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196747|NCT00652912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196748|NCT00707473|Cisplatin|cisplatin|mesh-list
65196749|NCT00707473|Carboplatin|carboplatin|mesh-list
65196750|NCT00707473|Docetaxel|docetaxel|mesh-list
65196751|NCT00707473|Fluorouracil|fluorouracil|mesh-list
65196752|NCT00707473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196753|NCT00707473|Tubulin Modulators|tubulin modulators|mesh-ancestor
65196754|NCT00707473|Antimitotic Agents|antimitotic agents|mesh-ancestor
65196755|NCT00707473|Mitosis Modulators|mitosis modulators|mesh-ancestor
65196756|NCT00707473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196757|NCT00707473|Antimetabolites|antimetabolites|mesh-ancestor
65196758|NCT00707473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65196759|NCT00707473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65196760|NCT00707473|Immunologic Factors|immunologic factors|mesh-ancestor
65196761|NCT00707473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196762|NCT01168232|Epothilones|epothilones|mesh-list
65196763|NCT01168232|Epothilone B|epothilone b|mesh-list
65196764|NCT01168232|Tubulin Modulators|tubulin modulators|mesh-ancestor
65196765|NCT01168232|Antimitotic Agents|antimitotic agents|mesh-ancestor
65196766|NCT01168232|Mitosis Modulators|mitosis modulators|mesh-ancestor
65196767|NCT01168232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196768|NCT01168232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196769|NCT00817531|Dasatinib|dasatinib|mesh-list
65196770|NCT00817531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196771|NCT00817531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65196772|NCT00817531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196773|NCT00817531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196774|NCT00651586|Ciprofloxacin|ciprofloxacin|mesh-list
65196779|NCT00651586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65196780|NCT00651586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65329740|NCT00733317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329741|NCT00733317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65329742|NCT00733317|Respiratory System Agents|respiratory system agents|mesh-ancestor
65329743|NCT00733317|Glucocorticoids|glucocorticoids|mesh-ancestor
65329744|NCT00733317|Hormones|hormones|mesh-ancestor
64715878|NCT03297944|GABA Agonists|gaba agonists|mesh-ancestor
65196781|NCT00651586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65196782|NCT00651586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196783|NCT00651586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196784|NCT00651586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196785|NCT00651586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65196786|NCT00651586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65196788|NCT02640508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196789|NCT02640508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65196790|NCT02640508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196791|NCT02640508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196792|NCT05312606|Chlorhexidine|chlorhexidine|mesh-list
65196793|NCT05312606|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65196794|NCT05312606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65196795|NCT05312606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65196796|NCT05312606|Disinfectants|disinfectants|mesh-ancestor
65196797|NCT05312606|Dermatologic Agents|dermatologic agents|mesh-ancestor
65196798|NCT05259566|Menthol|menthol|mesh-list
65196799|NCT05259566|Antipruritics|antipruritics|mesh-ancestor
65196800|NCT05259566|Dermatologic Agents|dermatologic agents|mesh-ancestor
65196801|NCT02643550|Cetuximab|cetuximab|mesh-list
65196802|NCT02643550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65196803|NCT02643550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196804|NCT00817063|Alitretinoin|alitretinoin|mesh-list
65196805|NCT00817063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196806|NCT00817063|Dermatologic Agents|dermatologic agents|mesh-ancestor
65196807|NCT04313270|Evolocumab|evolocumab|mesh-list
65196808|NCT04313270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65196809|NCT04313270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65196810|NCT04313270|Antimetabolites|antimetabolites|mesh-ancestor
65196811|NCT04313270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196812|NCT04313270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65196813|NCT02640118|Lixisenatide|lixisenatide|mesh-list
65196814|NCT02640118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65196815|NCT02640118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196816|NCT00826267|Trastuzumab|trastuzumab|mesh-list
65196817|NCT00826267|Lapatinib|lapatinib|mesh-list
65196818|NCT00826267|Afatinib|afatinib|mesh-list
65196819|NCT00826267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65196820|NCT00826267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196821|NCT00826267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65196822|NCT00826267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196823|NCT00826267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196824|NCT00653848|Docetaxel|docetaxel|mesh-list
65196825|NCT00653848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196826|NCT00653848|Tubulin Modulators|tubulin modulators|mesh-ancestor
65196827|NCT00653848|Antimitotic Agents|antimitotic agents|mesh-ancestor
65196828|NCT00653848|Mitosis Modulators|mitosis modulators|mesh-ancestor
65196829|NCT00653848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196830|NCT00707551|Ketoconazole|ketoconazole|mesh-list
65196831|NCT00707551|Verapamil|verapamil|mesh-list
65196832|NCT00707551|Antifungal Agents|antifungal agents|mesh-ancestor
65196833|NCT00707551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65196834|NCT00707551|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65196835|NCT00707551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65196836|NCT00707551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196837|NCT00707551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196838|NCT00707551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65196839|NCT00707551|Hormone Antagonists|hormone antagonists|mesh-ancestor
65196840|NCT00707551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65196841|NCT00707551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196842|NCT00707551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65196843|NCT00707551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65196844|NCT00707551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65329745|NCT00733317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65329746|NCT02568735|Etoricoxib|etoricoxib|mesh-list
65329747|NCT02568735|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65329748|NCT02568735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65329749|NCT02568735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65329750|NCT02568735|Analgesics|analgesics|mesh-ancestor
65329751|NCT02568735|Sensory System Agents|sensory system agents|mesh-ancestor
65329752|NCT02568735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65329753|NCT02568735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321582|NCT02209909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196848|NCT00986154|Heparin|heparin|mesh-list
65196849|NCT00986154|Calcium heparin|calcium heparin|mesh-list
65196850|NCT00986154|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65196851|NCT00986154|Tinzaparin|tinzaparin|mesh-list
65196852|NCT00986154|Dalteparin|dalteparin|mesh-list
65196853|NCT00986154|Warfarin|warfarin|mesh-list
65196854|NCT00986154|Edoxaban|edoxaban|mesh-list
65196855|NCT00986154|Anticoagulants|anticoagulants|mesh-ancestor
65196856|NCT00986154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65196857|NCT00986154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65196858|NCT00986154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196859|NCT00986154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65196860|NCT00986154|Antithrombins|antithrombins|mesh-ancestor
65196861|NCT00986154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65196862|NCT00986154|Protease Inhibitors|protease inhibitors|mesh-ancestor
65196863|NCT00986154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196864|NCT00653926|Epinephrine|epinephrine|mesh-list
65196865|NCT00653926|Ropivacaine|ropivacaine|mesh-list
65196866|NCT00653926|Anesthetics, Local|anesthetics, local|mesh-ancestor
65196867|NCT00653926|Anesthetics|anesthetics|mesh-ancestor
65196868|NCT00653926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65196869|NCT00653926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196870|NCT00653926|Sensory System Agents|sensory system agents|mesh-ancestor
65196871|NCT00653926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65196872|NCT00653926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65196873|NCT00653926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65196874|NCT00653926|Adrenergic Agents|adrenergic agents|mesh-ancestor
65196875|NCT00653926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65196876|NCT00653926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196877|NCT00653926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65196878|NCT00653926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65196879|NCT00653926|Autonomic Agents|autonomic agents|mesh-ancestor
65196880|NCT00653926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65196881|NCT00653926|Respiratory System Agents|respiratory system agents|mesh-ancestor
65196882|NCT00653926|Mydriatics|mydriatics|mesh-ancestor
65196883|NCT00653926|Sympathomimetics|sympathomimetics|mesh-ancestor
65196884|NCT00653926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65196885|NCT02613091|Clemastine|clemastine|mesh-list
65196886|NCT02613091|Antipruritics|antipruritics|mesh-ancestor
65196887|NCT02613091|Dermatologic Agents|dermatologic agents|mesh-ancestor
65196888|NCT02613091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65196889|NCT02613091|Histamine Antagonists|histamine antagonists|mesh-ancestor
65196890|NCT02613091|Histamine Agents|histamine agents|mesh-ancestor
65196891|NCT02613091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65196892|NCT02613091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196893|NCT02613091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196894|NCT02613091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65196895|NCT02639806|Lidocaine|lidocaine|mesh-list
65196896|NCT02639806|Sevoflurane|sevoflurane|mesh-list
65196897|NCT02639806|Anesthetics, Local|anesthetics, local|mesh-ancestor
65196898|NCT02639806|Anesthetics|anesthetics|mesh-ancestor
65196899|NCT02639806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65196900|NCT02639806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196901|NCT02639806|Sensory System Agents|sensory system agents|mesh-ancestor
65196902|NCT02639806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65196903|NCT02639806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65196904|NCT02639806|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65329754|NCT02568735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65329755|NCT02568735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65329756|NCT02568735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65329757|NCT02568735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65329758|NCT02568735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329759|NCT02568735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329760|NCT00733473|Budesonide|budesonide|mesh-list
65329761|NCT00733473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65329762|NCT00733473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65329763|NCT00733473|Autonomic Agents|autonomic agents|mesh-ancestor
65329764|NCT00733473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65329765|NCT00733473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196905|NCT02639806|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65196906|NCT02639806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65196907|NCT02639806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196908|NCT02639806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65196909|NCT02639806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65196910|NCT02639806|Anesthetics, General|anesthetics, general|mesh-ancestor
65196911|NCT02646904|Beclomethasone|beclomethasone|mesh-list
65196912|NCT02646904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65196913|NCT02646904|Glucocorticoids|glucocorticoids|mesh-ancestor
65196914|NCT02646904|Hormones|hormones|mesh-ancestor
65196915|NCT02646904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65196916|NCT02646904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196917|NCT02646904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65196932|NCT00654082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65196933|NCT00654082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65196934|NCT00654082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196935|NCT00654082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196936|NCT00654082|Urological Agents|urological agents|mesh-ancestor
65196938|NCT00654160|Fluorouracil|fluorouracil|mesh-list
65196939|NCT00654160|Irinotecan|irinotecan|mesh-list
65196940|NCT00654160|Calcium|calcium|mesh-list
65196941|NCT00654160|Levoleucovorin|levoleucovorin|mesh-list
65196942|NCT00654160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65196943|NCT00654160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196944|NCT00654160|Antimetabolites|antimetabolites|mesh-ancestor
65196945|NCT00654160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196946|NCT00654160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65196947|NCT00654160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196948|NCT00654160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65196949|NCT00654160|Immunologic Factors|immunologic factors|mesh-ancestor
65196950|NCT00654160|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65196951|NCT00654160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65196952|NCT00654160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196953|NCT00654160|Antidotes|antidotes|mesh-ancestor
65196954|NCT00654160|Protective Agents|protective agents|mesh-ancestor
65196955|NCT00654160|Vitamin B Complex|vitamin b complex|mesh-ancestor
65196957|NCT00654160|Micronutrients|micronutrients|mesh-ancestor
65196958|NCT02642380|Dexamethasone|dexamethasone|mesh-list
65196959|NCT02642380|Dexamethasone acetate|dexamethasone acetate|mesh-list
65196960|NCT02642380|BB 1101|bb 1101|mesh-list
65196961|NCT02642380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65196962|NCT02642380|Antiemetics|antiemetics|mesh-ancestor
65196963|NCT02642380|Autonomic Agents|autonomic agents|mesh-ancestor
65196964|NCT02642380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65196965|NCT02642380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196966|NCT02642380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65196967|NCT02642380|Glucocorticoids|glucocorticoids|mesh-ancestor
65196968|NCT02642380|Hormones|hormones|mesh-ancestor
65196969|NCT02642380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65196970|NCT02642380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65329766|NCT00733473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65329767|NCT00733473|Respiratory System Agents|respiratory system agents|mesh-ancestor
65329768|NCT00733473|Glucocorticoids|glucocorticoids|mesh-ancestor
65329769|NCT00733473|Hormones|hormones|mesh-ancestor
65329770|NCT00733473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65329771|NCT00710385|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65329772|NCT00710385|Buprenorphine|buprenorphine|mesh-list
65329774|NCT00710385|Naloxone|naloxone|mesh-list
65329775|NCT00710385|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65329776|NCT00710385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329777|NCT00710385|Sensory System Agents|sensory system agents|mesh-ancestor
65329778|NCT00710385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65329779|NCT00710385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65329780|NCT00710385|Narcotics|narcotics|mesh-ancestor
65329781|NCT00710385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65196971|NCT02642380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196972|NCT02642380|Protease Inhibitors|protease inhibitors|mesh-ancestor
65196973|NCT02642380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196974|NCT02642380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196975|NCT01154036|Atorvastatin|atorvastatin|mesh-list
65196976|NCT01154036|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65196977|NCT01154036|Ezetimibe|ezetimibe|mesh-list
65196978|NCT01154036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65196979|NCT01154036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65196980|NCT01154036|Antimetabolites|antimetabolites|mesh-ancestor
65196981|NCT01154036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197007|NCT01166438|Botulinum Toxins|botulinum toxins|mesh-list
65197008|NCT01166438|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65197009|NCT01166438|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65197010|NCT01166438|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65197011|NCT01166438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65197012|NCT01166438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197013|NCT01166438|Cholinergic Agents|cholinergic agents|mesh-ancestor
65197014|NCT01166438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65197015|NCT01166438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197016|NCT01166438|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65197017|NCT01166438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65197018|NCT01166438|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65197019|NCT01166438|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65197020|NCT01166438|Urological Agents|urological agents|mesh-ancestor
65197021|NCT01166438|Parasympatholytics|parasympatholytics|mesh-ancestor
65197022|NCT01166438|Autonomic Agents|autonomic agents|mesh-ancestor
65197023|NCT00707707|Paclitaxel|paclitaxel|mesh-list
65197024|NCT00707707|Olaparib|olaparib|mesh-list
65197025|NCT00707707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65197026|NCT00707707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197027|NCT00707707|Tubulin Modulators|tubulin modulators|mesh-ancestor
65197028|NCT00707707|Antimitotic Agents|antimitotic agents|mesh-ancestor
65197029|NCT00707707|Mitosis Modulators|mitosis modulators|mesh-ancestor
64321606|NCT04476992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197042|NCT00707785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197044|NCT00599638|Analgesics|analgesics|mesh-ancestor
65197045|NCT00599638|Sensory System Agents|sensory system agents|mesh-ancestor
65197046|NCT00599638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65197047|NCT00599638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197048|NCT00599638|Anticonvulsants|anticonvulsants|mesh-ancestor
65197049|NCT00599638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65197050|NCT00599638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65197051|NCT00599638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329782|NCT00710385|Analgesics|analgesics|mesh-ancestor
65329783|NCT04063527|Paclitaxel|paclitaxel|mesh-list
65329784|NCT04063527|Carboplatin|carboplatin|mesh-list
65329785|NCT04063527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65329786|NCT04063527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329787|NCT04063527|Tubulin Modulators|tubulin modulators|mesh-ancestor
65329788|NCT04063527|Antimitotic Agents|antimitotic agents|mesh-ancestor
65329789|NCT04063527|Mitosis Modulators|mitosis modulators|mesh-ancestor
65329790|NCT04063527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329791|NCT00738777|Tamoxifen|tamoxifen|mesh-list
65329792|NCT00738777|Fulvestrant|fulvestrant|mesh-list
65329793|NCT00738777|Anastrozole|anastrozole|mesh-list
65329794|NCT00738777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65329795|NCT00738777|Hormone Antagonists|hormone antagonists|mesh-ancestor
65329796|NCT00738777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65329797|NCT00738777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197052|NCT00599638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65197053|NCT00599638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65197054|NCT00599638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65197055|NCT00599638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65197056|NCT00599638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65197057|NCT02642146|Calcium Channel Blockers|calcium channel blockers|mesh-list
65197058|NCT02642146|Vasodilator Agents|vasodilator agents|mesh-list
65197059|NCT02642146|Calcium|calcium|mesh-list
65197060|NCT02642146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
65197061|NCT02642146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65197062|NCT02642146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197063|NCT02642146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65197064|NCT02642146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197065|NCT02642146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197066|NCT00654394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65197067|NCT00654394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65197068|NCT00654394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65197069|NCT00654394|Antimetabolites|antimetabolites|mesh-ancestor
65197070|NCT00654394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197071|NCT00654394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65197072|NCT00654394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65197073|NCT00654394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197074|NCT00653302|Metformin|metformin|mesh-list
65197075|NCT00653302|Insulin Glargine|insulin glargine|mesh-list
65197076|NCT00653302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65197077|NCT00653302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197078|NCT02638870|Amitriptyline|amitriptyline|mesh-list
65197079|NCT02638870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65197080|NCT02638870|Antidepressive Agents|antidepressive agents|mesh-ancestor
65197081|NCT02638870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65197082|NCT02638870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65197083|NCT02638870|Analgesics|analgesics|mesh-ancestor
65197084|NCT02638870|Sensory System Agents|sensory system agents|mesh-ancestor
65197085|NCT02638870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65197086|NCT02638870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197087|NCT02638870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65197088|NCT02638870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65197089|NCT02638870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65197090|NCT02638870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197091|NCT02638870|Adrenergic Agents|adrenergic agents|mesh-ancestor
65197092|NCT02638870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65197102|NCT00653380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65329798|NCT00738777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65329799|NCT00738777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329800|NCT00738777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65329801|NCT00738777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65329802|NCT00738777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65329803|NCT00738777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65329804|NCT00738777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65329805|NCT00738777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65329806|NCT00738777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329807|NCT00738777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329808|NCT00733785|Rosiglitazone|rosiglitazone|mesh-list
65329809|NCT00733785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65329810|NCT00733785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197104|NCT00653380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65197105|NCT00653380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65197106|NCT02646592|Alfentanil|alfentanil|mesh-list
65197107|NCT02646592|Propofol|propofol|mesh-list
65197108|NCT02646592|Sevoflurane|sevoflurane|mesh-list
65197109|NCT02646592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65197110|NCT02646592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65197111|NCT02646592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197112|NCT02646592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65197113|NCT02646592|Anesthetics, General|anesthetics, general|mesh-ancestor
65197114|NCT02646592|Anesthetics|anesthetics|mesh-ancestor
65197115|NCT02646592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65197116|NCT02646592|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65197117|NCT02646592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65197118|NCT02646592|Narcotics|narcotics|mesh-ancestor
65197119|NCT02646592|Analgesics|analgesics|mesh-ancestor
65197120|NCT02646592|Sensory System Agents|sensory system agents|mesh-ancestor
65197121|NCT02646592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65197122|NCT02646670|Ranibizumab|ranibizumab|mesh-list
65197123|NCT02646670|Aflibercept|aflibercept|mesh-list
65197124|NCT02646670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65197125|NCT02646670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65197126|NCT02646670|Growth Substances|growth substances|mesh-ancestor
65197127|NCT02646670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197128|NCT02646670|Growth Inhibitors|growth inhibitors|mesh-ancestor
65197129|NCT02646670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197130|NCT00651976|Letrozole|letrozole|mesh-list
65197131|NCT00651976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197132|NCT00651976|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65197133|NCT00651976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65197134|NCT00651976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197135|NCT00651976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197136|NCT00651976|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65197137|NCT00651976|Hormone Antagonists|hormone antagonists|mesh-ancestor
65197138|NCT00651976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65197139|NCT00651976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197140|NCT01166282|Adalimumab|adalimumab|mesh-list
65197141|NCT01166282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65197142|NCT01166282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65197143|NCT01153724|Fluconazole|fluconazole|mesh-list
65197144|NCT01153724|Antifungal Agents|antifungal agents|mesh-ancestor
65197145|NCT01153724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65197146|NCT01153724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65197147|NCT01153724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65197148|NCT01153724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197149|NCT01153724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197150|NCT01153724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65329811|NCT04063449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65329812|NCT04063449|Endostar protein|endostar protein|mesh-list
65329813|NCT04063449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329814|NCT04063449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329815|NCT04063449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65329816|NCT04063449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65329817|NCT04063449|Growth Substances|growth substances|mesh-ancestor
65197151|NCT01153724|Hormone Antagonists|hormone antagonists|mesh-ancestor
65197152|NCT01153724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65197153|NCT01153724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197154|NCT01153724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65197155|NCT01153724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65197156|NCT02884388|Anesthetics|anesthetics|mesh-list
65197157|NCT02884388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65197168|NCT01152788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197169|NCT01165424|Mometasone Furoate|mometasone furoate|mesh-list
65197170|NCT01165424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65197171|NCT01165424|Dermatologic Agents|dermatologic agents|mesh-ancestor
65197172|NCT01165424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65197174|NCT00598702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65197175|NCT00598702|Analgesics|analgesics|mesh-ancestor
65197176|NCT00598702|Sensory System Agents|sensory system agents|mesh-ancestor
65197177|NCT00598702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65197178|NCT00598702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197179|NCT00598702|Antipyretics|antipyretics|mesh-ancestor
65197180|NCT01148810|Siponimod|siponimod|mesh-list
65197181|NCT01148810|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65197182|NCT01148810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197183|NCT01148810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65197184|NCT01148810|Immunologic Factors|immunologic factors|mesh-ancestor
65197185|NCT01148810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197186|NCT02884310|Remifentanil|remifentanil|mesh-list
65197187|NCT02884310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65197188|NCT02884310|Narcotics|narcotics|mesh-ancestor
65197189|NCT02884310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65197190|NCT02884310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197191|NCT02884310|Analgesics|analgesics|mesh-ancestor
65197192|NCT02884310|Sensory System Agents|sensory system agents|mesh-ancestor
65197193|NCT02884310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65197194|NCT01164956|Methylphenidate|methylphenidate|mesh-list
65197195|NCT01164956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65197196|NCT01164956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197197|NCT01164956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65197198|NCT01164956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65197199|NCT01164956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65197200|NCT01164956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197201|NCT01164956|Dopamine Agents|dopamine agents|mesh-ancestor
65197202|NCT01164956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65197203|NCT01151540|Rufinamide|rufinamide|mesh-list
65197204|NCT01151540|Anticonvulsants|anticonvulsants|mesh-ancestor
65197205|NCT01151540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65197206|NCT01151540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65197207|NCT01151540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65197208|NCT01151540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197210|NCT01163786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197211|NCT05367362|Minocycline|minocycline|mesh-list
65197212|NCT05367362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65197213|NCT05367362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65197214|NCT00984282|Sorafenib|sorafenib|mesh-list
65197215|NCT00984282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197216|NCT00984282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65197217|NCT00984282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197218|NCT00984282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197219|NCT04187196|Propofol|propofol|mesh-list
65197220|NCT04187196|Methohexital|methohexital|mesh-list
65329818|NCT04063449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329819|NCT04063449|Growth Inhibitors|growth inhibitors|mesh-ancestor
65329820|NCT00700011|Clofarabine|clofarabine|mesh-list
65329821|NCT00700011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65329822|NCT00700011|Antimetabolites|antimetabolites|mesh-ancestor
65329823|NCT00700011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329824|NCT00700011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197221|NCT04187196|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65197230|NCT04292184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197231|NCT04292184|Antioxidants|antioxidants|mesh-ancestor
65197232|NCT04292184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197233|NCT04292184|Antitubercular Agents|antitubercular agents|mesh-ancestor
65197234|NCT04292184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65197235|NCT04292184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65197236|NCT04292184|Chelating Agents|chelating agents|mesh-ancestor
65197237|NCT04292184|Sequestering Agents|sequestering agents|mesh-ancestor
65197238|NCT01147640|Metronidazole|metronidazole|mesh-list
65197239|NCT01147640|Meropenem|meropenem|mesh-list
65197240|NCT01147640|Tazobactam|tazobactam|mesh-list
65197241|NCT01147640|Ceftolozane|ceftolozane|mesh-list
65197242|NCT01147640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65197243|NCT01147640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65197244|NCT01147640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65197245|NCT01147640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65197246|NCT01147640|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65197247|NCT01147640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197248|NCT01147640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197249|NCT02867982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65197250|NCT02867982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65197251|NCT01121900|Trazodone|trazodone|mesh-list
65197252|NCT01121900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65197253|NCT01121900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64839843|NCT01634698|Antioxidants|antioxidants|mesh-ancestor
65197254|NCT01121900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65197255|NCT01121900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197256|NCT01121900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65197257|NCT01121900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65197258|NCT01121900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65197259|NCT01121900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65197260|NCT01121900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197261|NCT01121900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65197262|NCT01121900|Serotonin Agents|serotonin agents|mesh-ancestor
65197263|NCT01121900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65197264|NCT01121900|Antidepressive Agents|antidepressive agents|mesh-ancestor
65197265|NCT01121666|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65197266|NCT01121666|Hormones|hormones|mesh-ancestor
65197267|NCT01121666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65197268|NCT01121666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197269|NCT00984126|Factor VIII|factor viii|mesh-list
65197270|NCT00984126|Coagulants|coagulants|mesh-ancestor
65197271|NCT02868996|Kallikreins|kallikreins|mesh-list
65197272|NCT02868996|Coagulants|coagulants|mesh-ancestor
65197273|NCT02868996|Fertility Agents, Male|fertility agents, male|mesh-ancestor
65197274|NCT02868996|Fertility Agents|fertility agents|mesh-ancestor
65197275|NCT02868996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65197276|NCT02868996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197277|NCT00629226|Cetuximab|cetuximab|mesh-list
65197278|NCT00629226|Bortezomib|bortezomib|mesh-list
65197279|NCT00629226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197280|NCT00629226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65197281|NCT00629304|Antithrombin III|antithrombin iii|mesh-list
65197282|NCT00629304|Antithrombins|antithrombins|mesh-list
65197283|NCT00629304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65197284|NCT00629304|Protease Inhibitors|protease inhibitors|mesh-ancestor
65197285|NCT00629304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197286|NCT00629304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197287|NCT00629304|Anticoagulants|anticoagulants|mesh-ancestor
65197288|NCT05297929|Irbesartan|irbesartan|mesh-list
65329825|NCT05512767|Capecitabine|capecitabine|mesh-list
65329826|NCT05512767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65329827|NCT05512767|Antimetabolites|antimetabolites|mesh-ancestor
65329828|NCT05512767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329829|NCT05512767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329830|NCT02567955|Vaccines|vaccines|mesh-list
65329831|NCT02567955|Immunologic Factors|immunologic factors|mesh-ancestor
65329832|NCT02567955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329833|NCT02568423|Mirikizumab|mirikizumab|mesh-list
65329834|NCT02568423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65329835|NCT02568423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65329836|NCT02568423|Analgesics|analgesics|mesh-ancestor
65329837|NCT02568423|Sensory System Agents|sensory system agents|mesh-ancestor
65329838|NCT02568423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65329839|NCT02568423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329840|NCT02568423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65329841|NCT02568423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65197289|NCT05297929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65197298|NCT05269615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65197299|NCT05269615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65197300|NCT05269615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65197301|NCT05269615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197302|NCT00982644|Insulin|insulin|mesh-list
65197303|NCT00982644|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65197304|NCT00982644|Insulin Glargine|insulin glargine|mesh-list
65197305|NCT00982644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65197306|NCT00982644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197307|NCT00815659|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65197308|NCT00815659|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65197309|NCT00815659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65197310|NCT00815659|Antimetabolites|antimetabolites|mesh-ancestor
65197311|NCT00815659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197312|NCT00815659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65197313|NCT00815659|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65197314|NCT00815659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197315|NCT02867904|Methylprednisolone|methylprednisolone|mesh-list
65197316|NCT02867904|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65197317|NCT02867904|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65197318|NCT02867904|Prednisolone|prednisolone|mesh-list
65197319|NCT02867904|Prednisolone acetate|prednisolone acetate|mesh-list
65197320|NCT02867904|Bupivacaine|bupivacaine|mesh-list
65197321|NCT02867904|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65197322|NCT02867904|Prednisolone phosphate|prednisolone phosphate|mesh-list
65197323|NCT02867904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65197324|NCT02867904|Antiemetics|antiemetics|mesh-ancestor
65197325|NCT02867904|Autonomic Agents|autonomic agents|mesh-ancestor
65197326|NCT02867904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65197327|NCT02867904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197328|NCT02867904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65197329|NCT02867904|Glucocorticoids|glucocorticoids|mesh-ancestor
65197330|NCT02867904|Hormones|hormones|mesh-ancestor
65197331|NCT02867904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65197332|NCT02867904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65197333|NCT02867904|Protective Agents|protective agents|mesh-ancestor
65197334|NCT02867904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65197335|NCT02867904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197336|NCT02867904|Anesthetics, Local|anesthetics, local|mesh-ancestor
65197337|NCT02867904|Anesthetics|anesthetics|mesh-ancestor
65329842|NCT02568423|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65329843|NCT02568423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65329844|NCT00921063|Alprazolam|alprazolam|mesh-list
65329845|NCT00921063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65329846|NCT00921063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65329847|NCT00921063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329848|NCT00921063|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65329849|NCT00921063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65329850|NCT00921063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65329851|NCT00921063|GABA Modulators|gaba modulators|mesh-ancestor
65329852|NCT00921063|GABA Agents|gaba agents|mesh-ancestor
65329853|NCT00921063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65197338|NCT02867904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65197339|NCT02867904|Sensory System Agents|sensory system agents|mesh-ancestor
65197340|NCT04290936|Tenofovir|tenofovir|mesh-list
65197341|NCT04290936|Antiviral Agents|antiviral agents|mesh-ancestor
65197342|NCT04290936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65197343|NCT04290936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65197344|NCT04290936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65197345|NCT04290936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197346|NCT04290936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197347|NCT04290936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65197348|NCT04290936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65197349|NCT00707941|Oseltamivir|oseltamivir|mesh-list
65197350|NCT00707941|Antiviral Agents|antiviral agents|mesh-ancestor
65197351|NCT00707941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65197352|NCT00707941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197353|NCT00707941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197355|NCT00824473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65197366|NCT00824473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65197367|NCT00824473|Histamine Antagonists|histamine antagonists|mesh-ancestor
65197368|NCT00824473|Histamine Agents|histamine agents|mesh-ancestor
65197369|NCT00824473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65197370|NCT02867280|Sorafenib|sorafenib|mesh-list
65197371|NCT02867280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197372|NCT02867280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65197373|NCT02867280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197374|NCT02867280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197375|NCT04290390|Itraconazole|itraconazole|mesh-list
65197376|NCT04290390|Rifampin|rifampin|mesh-list
65197377|NCT04290390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65197378|NCT04290390|Estradiol|estradiol|mesh-list
65197379|NCT04290390|Estrogens|estrogens|mesh-ancestor
65197380|NCT04290390|Hormones|hormones|mesh-ancestor
65197381|NCT04290390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65197382|NCT04290390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197383|NCT04290390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65197384|NCT04290390|Contraceptive Agents|contraceptive agents|mesh-ancestor
65197385|NCT04290390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65197386|NCT04290390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65197387|NCT04290390|Antifungal Agents|antifungal agents|mesh-ancestor
65197388|NCT04290390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65197389|NCT04290390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65197390|NCT04290390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65197391|NCT04290390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197392|NCT04290390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197393|NCT04290390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65197394|NCT04290390|Hormone Antagonists|hormone antagonists|mesh-ancestor
65197395|NCT04290390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65197396|NCT04290390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65197397|NCT04290390|Antitubercular Agents|antitubercular agents|mesh-ancestor
65197398|NCT04290390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65197399|NCT04290390|Leprostatic Agents|leprostatic agents|mesh-ancestor
65329854|NCT00921063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329855|NCT00707031|Metformin|metformin|mesh-list
65329856|NCT00707031|Exenatide|exenatide|mesh-list
65329857|NCT00707031|Lixisenatide|lixisenatide|mesh-list
65329858|NCT00707031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65329859|NCT00707031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329860|NCT00707031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65329861|NCT00707031|Incretins|incretins|mesh-ancestor
65329862|NCT00707031|Hormones|hormones|mesh-ancestor
65329863|NCT00707031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65329864|NCT00711477|Naltrexone|naltrexone|mesh-list
65329865|NCT00711477|Bupropion|bupropion|mesh-list
65329866|NCT00711477|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65329867|NCT00711477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65329868|NCT00711477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329869|NCT00711477|Sensory System Agents|sensory system agents|mesh-ancestor
65329870|NCT00711477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65329871|NCT00711477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65329872|NCT00711477|Antidepressive Agents|antidepressive agents|mesh-ancestor
65329873|NCT00711477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65329874|NCT00711477|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65329875|NCT00711477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65329876|NCT00711477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65197400|NCT04290390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64839996|NCT01635751|Anticonvulsants|anticonvulsants|mesh-ancestor
65197401|NCT04290390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65197402|NCT04290390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65197403|NCT04290390|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65197404|NCT04290390|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65197405|NCT04290390|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65197406|NCT04290390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65197407|NCT04290390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65197408|NCT04290390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65197409|NCT04290858|Nitric Oxide|nitric oxide|mesh-list
65197410|NCT04290858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65197411|NCT04290858|Autonomic Agents|autonomic agents|mesh-ancestor
65197412|NCT04290858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65197413|NCT04290858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197414|NCT04290858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65197415|NCT04290858|Respiratory System Agents|respiratory system agents|mesh-ancestor
65197416|NCT04290858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65197436|NCT02610829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197437|NCT02610829|Antioxidants|antioxidants|mesh-ancestor
65197438|NCT02610829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197439|NCT02610829|Protective Agents|protective agents|mesh-ancestor
65197440|NCT04104672|Gemcitabine|gemcitabine|mesh-list
65197441|NCT04104672|Paclitaxel|paclitaxel|mesh-list
65197442|NCT04104672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65197443|NCT04104672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197444|NCT04104672|Tubulin Modulators|tubulin modulators|mesh-ancestor
65197445|NCT04104672|Antimitotic Agents|antimitotic agents|mesh-ancestor
65329877|NCT00711477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329878|NCT00711477|Dopamine Agents|dopamine agents|mesh-ancestor
65329879|NCT00711477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65329880|NCT00711477|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65329881|NCT00711477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65329882|NCT00711477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329883|NCT00734474|Metformin|metformin|mesh-list
65197446|NCT04104672|Mitosis Modulators|mitosis modulators|mesh-ancestor
65197447|NCT04104672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197448|NCT04104672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65197449|NCT04104672|Antimetabolites|antimetabolites|mesh-ancestor
65197450|NCT04104672|Antiviral Agents|antiviral agents|mesh-ancestor
65197451|NCT04104672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65197452|NCT04104672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197453|NCT04104672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65197454|NCT04104672|Immunologic Factors|immunologic factors|mesh-ancestor
65197455|NCT04104672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197456|NCT02865564|Gentamicins|gentamicins|mesh-list
65197457|NCT02865564|Ampicillin|ampicillin|mesh-list
65197458|NCT02865564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65197459|NCT02865564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65197460|NCT02865564|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65197461|NCT02865564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197462|NCT02865564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197463|NCT00814879|Raltegravir Potassium|raltegravir potassium|mesh-list
65197464|NCT00814879|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65197465|NCT00814879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65197466|NCT00814879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65197467|NCT00814879|Antiviral Agents|antiviral agents|mesh-ancestor
65197468|NCT00814879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65197469|NCT00814879|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65197470|NCT00814879|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65197471|NCT00814879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197472|NCT00814879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197473|NCT00814879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65197474|NCT00814879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65197484|NCT00814801|Autonomic Agents|autonomic agents|mesh-ancestor
65197485|NCT00814801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65197486|NCT00814801|Nootropic Agents|nootropic agents|mesh-ancestor
65197487|NCT00653458|Ondansetron|ondansetron|mesh-list
65197488|NCT00653458|Antiemetics|antiemetics|mesh-ancestor
65197489|NCT00653458|Autonomic Agents|autonomic agents|mesh-ancestor
65197490|NCT00653458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65197491|NCT00653458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197492|NCT00653458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65197493|NCT00653458|Antipruritics|antipruritics|mesh-ancestor
65197494|NCT00653458|Dermatologic Agents|dermatologic agents|mesh-ancestor
65197495|NCT00653458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65197496|NCT00653458|Serotonin Agents|serotonin agents|mesh-ancestor
65197497|NCT00653458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65197498|NCT00653458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197499|NCT00653458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65197500|NCT00653458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65197501|NCT00653458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65197502|NCT00653458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65197503|NCT00653458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65197504|NCT02708836|Anesthetics|anesthetics|mesh-list
65197505|NCT02708836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65197506|NCT02708836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197508|NCT00708565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65197509|NCT00708565|Vasodilator Agents|vasodilator agents|mesh-ancestor
65197510|NCT03315910|Nicotine|nicotine|mesh-list
65197511|NCT03315910|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65197512|NCT03315910|Autonomic Agents|autonomic agents|mesh-ancestor
65197513|NCT03315910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65197514|NCT03315910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197515|NCT03315910|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65197516|NCT03315910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65329884|NCT00734474|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65329885|NCT00734474|Dulaglutide|dulaglutide|mesh-list
65329886|NCT00734474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65329887|NCT00734474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329888|NCT00734474|Incretins|incretins|mesh-ancestor
65329889|NCT00734474|Hormones|hormones|mesh-ancestor
65329890|NCT00734474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65329891|NCT00734474|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65329892|NCT00734474|Protease Inhibitors|protease inhibitors|mesh-ancestor
65329893|NCT00734474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329894|NCT00734474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329895|NCT00583362|Belimumab|belimumab|mesh-list
65329896|NCT00583362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65329897|NCT00583362|Immunologic Factors|immunologic factors|mesh-ancestor
65329898|NCT00583362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329899|NCT00577473|Mesalamine|mesalamine|mesh-list
65329900|NCT00577473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65329901|NCT00577473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65329902|NCT00577473|Analgesics|analgesics|mesh-ancestor
65329903|NCT00577473|Sensory System Agents|sensory system agents|mesh-ancestor
65197517|NCT03315910|Cholinergic Agents|cholinergic agents|mesh-ancestor
65197518|NCT03315910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65197519|NCT03315910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197520|NCT00812461|Nalmefene|nalmefene|mesh-list
65197521|NCT00812461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65197522|NCT00812461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197523|NCT00812461|Sensory System Agents|sensory system agents|mesh-ancestor
65197524|NCT00812461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65197525|NCT00599326|Deferasirox|deferasirox|mesh-list
65197526|NCT00599326|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65197527|NCT00599326|Chelating Agents|chelating agents|mesh-ancestor
65197528|NCT00599326|Sequestering Agents|sequestering agents|mesh-ancestor
65197529|NCT00599326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197530|NCT00978432|Everolimus|everolimus|mesh-list
65197531|NCT00978432|Panobinostat|panobinostat|mesh-list
65197532|NCT00978432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197533|NCT00978432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65197534|NCT00978432|Immunologic Factors|immunologic factors|mesh-ancestor
65197535|NCT00978432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197536|NCT00978432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65197537|NCT00978432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197538|NCT00978432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197539|NCT05756569|Pembrolizumab|pembrolizumab|mesh-list
65197540|NCT05756569|Immunoconjugates|immunoconjugates|mesh-list
65197541|NCT05756569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65197553|NCT04166812|Antioxidants|antioxidants|mesh-ancestor
65197554|NCT04166812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197555|NCT04166812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65197556|NCT04166812|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65197557|NCT04166812|Vasodilator Agents|vasodilator agents|mesh-ancestor
65197558|NCT04166812|Gasotransmitters|gasotransmitters|mesh-ancestor
65197559|NCT04166812|Protective Agents|protective agents|mesh-ancestor
65197560|NCT02435212|Deferasirox|deferasirox|mesh-list
65197561|NCT02435212|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65197562|NCT02435212|Chelating Agents|chelating agents|mesh-ancestor
65329904|NCT00577473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65329905|NCT00577473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329906|NCT00577473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65329907|NCT00577473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65329908|NCT00740103|Semapimod|semapimod|mesh-list
65329909|NCT00740103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65329910|NCT00740103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65329911|NCT00740103|Analgesics|analgesics|mesh-ancestor
65329912|NCT00740103|Sensory System Agents|sensory system agents|mesh-ancestor
64679818|NCT05751044|Hormones|hormones|mesh-ancestor
65197563|NCT02435212|Sequestering Agents|sequestering agents|mesh-ancestor
65197564|NCT02435212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197565|NCT00708799|Azithromycin|azithromycin|mesh-list
65197566|NCT00708799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65197567|NCT00708799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65197568|NCT02610127|Factor VIII|factor viii|mesh-list
65197569|NCT02610127|Coagulants|coagulants|mesh-ancestor
65197570|NCT00814333|Thrombin|thrombin|mesh-list
65197571|NCT00814333|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
65197572|NCT00814333|Hemostatics|hemostatics|mesh-ancestor
65197573|NCT00814333|Coagulants|coagulants|mesh-ancestor
65197574|NCT01147250|Lixisenatide|lixisenatide|mesh-list
65197575|NCT01147250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65197576|NCT01147250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197577|NCT00813943|Temozolomide|temozolomide|mesh-list
65197578|NCT00813943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65197580|NCT00813943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197581|NCT00813943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197582|NCT00821509|Disinfectants|disinfectants|mesh-list
65197583|NCT00821509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65197584|NCT01134614|Ipilimumab|ipilimumab|mesh-list
65197585|NCT01134614|Sargramostim|sargramostim|mesh-list
65197586|NCT01134614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65197587|NCT01134614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197588|NCT01134614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65197589|NCT01134614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197590|NCT01134614|Immunologic Factors|immunologic factors|mesh-ancestor
65197591|NCT01134614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197592|NCT00913861|Fentanyl|fentanyl|mesh-list
65197593|NCT00913861|Propofol|propofol|mesh-list
65197594|NCT00913861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65197595|NCT00913861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65197596|NCT00913861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197597|NCT00913861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65197598|NCT00913861|Anesthetics, General|anesthetics, general|mesh-ancestor
65197599|NCT00913861|Anesthetics|anesthetics|mesh-ancestor
65197600|NCT00913861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65197601|NCT00913861|Narcotics|narcotics|mesh-ancestor
65197602|NCT00913861|Analgesics|analgesics|mesh-ancestor
65197603|NCT00913861|Sensory System Agents|sensory system agents|mesh-ancestor
65197604|NCT00913861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65197605|NCT00913861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65197606|NCT00709189|Folic Acid|folic acid|mesh-list
65197607|NCT00709189|Norgestimate|norgestimate|mesh-list
65197608|NCT00709189|Estradiol|estradiol|mesh-list
65197626|NCT00709267|Vitamins|vitamins|mesh-ancestor
65197627|NCT00709267|Micronutrients|micronutrients|mesh-ancestor
65197628|NCT00709267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197629|NCT00591565|Acamprosate|acamprosate|mesh-list
64840220|NCT01636596|Insulin Lispro|insulin lispro|mesh-list
65197630|NCT00591565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65197631|NCT00978120|Vaccines|vaccines|mesh-list
65197632|NCT00978120|Immunologic Factors|immunologic factors|mesh-ancestor
65197633|NCT00978120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197634|NCT01133756|Gemcitabine|gemcitabine|mesh-list
65197635|NCT01133756|Carboplatin|carboplatin|mesh-list
65197636|NCT01133756|Lenvatinib|lenvatinib|mesh-list
65197637|NCT01133756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197638|NCT01133756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65329913|NCT00740103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65329914|NCT00740103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329915|NCT00740103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65329916|NCT00740103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65329917|NCT00740103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65329918|NCT00740103|Immunologic Factors|immunologic factors|mesh-ancestor
65197639|NCT01133756|Antimetabolites|antimetabolites|mesh-ancestor
65197640|NCT01133756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197641|NCT01133756|Antiviral Agents|antiviral agents|mesh-ancestor
65197642|NCT01133756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65197643|NCT01133756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197644|NCT01133756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65197645|NCT01133756|Immunologic Factors|immunologic factors|mesh-ancestor
65197646|NCT01133756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197647|NCT01133756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65197648|NCT01133678|Paclitaxel|paclitaxel|mesh-list
65197649|NCT01133678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65197650|NCT01133678|Cisplatin|cisplatin|mesh-list
65197651|NCT01133678|Cetuximab|cetuximab|mesh-list
65197652|NCT01133678|Everolimus|everolimus|mesh-list
65197653|NCT01133678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65197654|NCT01133678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197655|NCT01133678|Tubulin Modulators|tubulin modulators|mesh-ancestor
65197656|NCT01133678|Antimitotic Agents|antimitotic agents|mesh-ancestor
65197657|NCT01133678|Mitosis Modulators|mitosis modulators|mesh-ancestor
65197658|NCT01133678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197659|NCT01133678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65197660|NCT01133678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65197661|NCT01133678|Immunologic Factors|immunologic factors|mesh-ancestor
65197662|NCT01133678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197663|NCT00652132|Sodium thiosulfate|sodium thiosulfate|mesh-list
65197664|NCT00652132|Antidotes|antidotes|mesh-ancestor
65197665|NCT00652132|Protective Agents|protective agents|mesh-ancestor
65197666|NCT00652132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197667|NCT00652132|Antioxidants|antioxidants|mesh-ancestor
65197668|NCT00652132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197685|NCT00655174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65197686|NCT00655174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65197687|NCT00655174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65197688|NCT00655174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65197689|NCT00655174|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65197690|NCT00655174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65197691|NCT00655174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197692|NCT00655174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65197693|NCT00655018|Ascorbic Acid|ascorbic acid|mesh-list
65197694|NCT00655018|Tocopherols|tocopherols|mesh-list
65197695|NCT00655018|Vitamin E|vitamin e|mesh-list
65197696|NCT00655018|alpha-Tocopherol|alpha-tocopherol|mesh-list
65197697|NCT00655018|Vitamins|vitamins|mesh-ancestor
65197698|NCT00655018|Micronutrients|micronutrients|mesh-ancestor
65197699|NCT00655018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197700|NCT00655018|Antioxidants|antioxidants|mesh-ancestor
65197701|NCT00655018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197702|NCT00655018|Protective Agents|protective agents|mesh-ancestor
65197703|NCT02635750|Donepezil|donepezil|mesh-list
65197704|NCT02635750|BI 409306|bi 409306|mesh-list
65197705|NCT02635750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64840296|NCT01636999|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65197706|NCT02635750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197707|NCT02635750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197708|NCT02635750|Cholinergic Agents|cholinergic agents|mesh-ancestor
65197709|NCT02635750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65197710|NCT02635750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197711|NCT02635750|Nootropic Agents|nootropic agents|mesh-ancestor
65197712|NCT02635750|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65197713|NCT04164238|Paclitaxel|paclitaxel|mesh-list
65197714|NCT04164238|Carboplatin|carboplatin|mesh-list
65197715|NCT04164238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65197716|NCT04164238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197717|NCT04164238|Tubulin Modulators|tubulin modulators|mesh-ancestor
65329919|NCT05714865|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65329920|NCT05714865|Respiratory System Agents|respiratory system agents|mesh-ancestor
65329921|NCT02583828|Cyclophosphamide|cyclophosphamide|mesh-list
65329922|NCT02583828|Letrozole|letrozole|mesh-list
65329923|NCT02583828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65329924|NCT02583828|Immunologic Factors|immunologic factors|mesh-ancestor
65329925|NCT02583828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329926|NCT02583828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65329927|NCT02583828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65329928|NCT02583828|Alkylating Agents|alkylating agents|mesh-ancestor
65329929|NCT02583828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329930|NCT02583828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329931|NCT02583828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65329932|NCT02583828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65329933|NCT02583828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65329934|NCT02583828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329935|NCT02583828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65329936|NCT02583828|Hormone Antagonists|hormone antagonists|mesh-ancestor
65329937|NCT02583828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65329938|NCT02568111|Interferons|interferons|mesh-list
65329939|NCT02568111|Interferon-beta|interferon-beta|mesh-list
65329940|NCT02568111|Interferon beta-1a|interferon beta-1a|mesh-list
64680020|NCT05429762|Maytansine|maytansine|mesh-list
65197718|NCT04164238|Antimitotic Agents|antimitotic agents|mesh-ancestor
65197719|NCT04164238|Mitosis Modulators|mitosis modulators|mesh-ancestor
65197720|NCT04164238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197721|NCT02645734|Bevacizumab|bevacizumab|mesh-list
65197722|NCT02645734|Aflibercept|aflibercept|mesh-list
65197723|NCT02645734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65197724|NCT02645734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197725|NCT02645734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65197726|NCT02645734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65197731|NCT01133522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65197732|NCT01133522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65197733|NCT01133522|Antimetabolites|antimetabolites|mesh-ancestor
65197734|NCT01133522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197735|NCT01133522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65197736|NCT00682318|Ethanol|ethanol|mesh-list
65197737|NCT00682318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65197738|NCT00682318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65197739|NCT00682318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65197740|NCT00682318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197741|NCT02881892|Dialysis Solutions|dialysis solutions|mesh-list
65197742|NCT02881892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65197743|NCT00655252|Everolimus|everolimus|mesh-list
65197744|NCT00655252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197745|NCT00655252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65197746|NCT00655252|Immunologic Factors|immunologic factors|mesh-ancestor
65197747|NCT00655252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197748|NCT00883090|Fibrinolysin|fibrinolysin|mesh-list
65197749|NCT00883090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65197750|NCT00883090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65329941|NCT02568111|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65329942|NCT02568111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329943|NCT02568111|Antiviral Agents|antiviral agents|mesh-ancestor
65329944|NCT02568111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65329945|NCT02568111|Immunologic Factors|immunologic factors|mesh-ancestor
65329946|NCT02568111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197751|NCT00883090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197752|NCT02645656|Curcumin|curcumin|mesh-list
65197753|NCT02645656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65197754|NCT02645656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65197755|NCT02645656|Analgesics|analgesics|mesh-ancestor
65197756|NCT02645656|Sensory System Agents|sensory system agents|mesh-ancestor
65197757|NCT02645656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65197758|NCT02645656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197759|NCT02645656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65197760|NCT02645656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65197761|NCT02645656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197762|NCT02645656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197763|NCT02645656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197764|NCT01132820|Cediranib|cediranib|mesh-list
65197765|NCT01132820|Maleic acid|maleic acid|mesh-list
65197766|NCT01132820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197767|NCT01132820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197768|NCT01132820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197769|NCT01132820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65197770|NCT00655330|Valsartan|valsartan|mesh-list
65197771|NCT00655330|Probucol|probucol|mesh-list
65197772|NCT00655330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65197773|NCT00655330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65197774|NCT00655330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65197775|NCT00655330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197776|NCT00655330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65197777|NCT00655330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65197778|NCT00655330|Antimetabolites|antimetabolites|mesh-ancestor
65197779|NCT00655330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64840383|NCT01637376|Temoporfin|temoporfin|mesh-list
65197780|NCT00655330|Antioxidants|antioxidants|mesh-ancestor
65197781|NCT00655330|Protective Agents|protective agents|mesh-ancestor
65197782|NCT00655330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197783|NCT00655408|Iron|iron|mesh-list
65197784|NCT00655408|Trace Elements|trace elements|mesh-ancestor
65197785|NCT00655408|Micronutrients|micronutrients|mesh-ancestor
65197786|NCT00655408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197787|NCT04163536|Methylprednisolone|methylprednisolone|mesh-list
65197788|NCT04163536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65197789|NCT04163536|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65197790|NCT04163536|Prednisolone|prednisolone|mesh-list
65197791|NCT04163536|Prednisolone acetate|prednisolone acetate|mesh-list
65197792|NCT04163536|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65197793|NCT04163536|Prednisolone phosphate|prednisolone phosphate|mesh-list
65197794|NCT04163536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65197795|NCT04163536|Antiemetics|antiemetics|mesh-ancestor
65197796|NCT04163536|Autonomic Agents|autonomic agents|mesh-ancestor
65197803|NCT04163536|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65197804|NCT04163536|Protective Agents|protective agents|mesh-ancestor
65197805|NCT04163536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65197806|NCT04163536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197807|NCT00652288|Insulin|insulin|mesh-list
65197808|NCT00652288|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65197809|NCT00652288|Insulin Glargine|insulin glargine|mesh-list
65197810|NCT00652288|Insulin Aspart|insulin aspart|mesh-list
65197811|NCT00652288|Insulin, Long-Acting|insulin, long-acting|mesh-list
65197812|NCT00652288|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65197813|NCT00652288|Insulin Lispro|insulin lispro|mesh-list
65197814|NCT00652288|Insulin Detemir|insulin detemir|mesh-list
65197815|NCT00652288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65197816|NCT00652288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197817|NCT00911092|Fluorouracil|fluorouracil|mesh-list
65197818|NCT00911092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197819|NCT00911092|Antimetabolites|antimetabolites|mesh-ancestor
65197820|NCT00911092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329947|NCT02568111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65329948|NCT02568111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65329949|NCT02568111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65329950|NCT02568111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65329951|NCT02568111|Adrenergic Agents|adrenergic agents|mesh-ancestor
65329952|NCT02568111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65329953|NCT02568111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329954|NCT02568111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65197821|NCT00911092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65197822|NCT00911092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65197823|NCT00911092|Immunologic Factors|immunologic factors|mesh-ancestor
65197824|NCT00911092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197825|NCT02635360|Pembrolizumab|pembrolizumab|mesh-list
65197826|NCT02635360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197827|NCT02635360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65197828|NCT02635282|Fentanyl|fentanyl|mesh-list
65197829|NCT02635282|Midazolam|midazolam|mesh-list
65197830|NCT02635282|Ketamine|ketamine|mesh-list
65197831|NCT02635282|Analgesics|analgesics|mesh-ancestor
65197832|NCT02635282|Sensory System Agents|sensory system agents|mesh-ancestor
65197833|NCT02635282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65197834|NCT02635282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197835|NCT02635282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65197836|NCT02635282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65197837|NCT02635282|Anesthetics, General|anesthetics, general|mesh-ancestor
65197838|NCT02635282|Anesthetics|anesthetics|mesh-ancestor
65197839|NCT02635282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65197840|NCT02635282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65197841|NCT02635282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65197842|NCT02635282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65197843|NCT02635282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197844|NCT02635282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65197845|NCT02635282|Narcotics|narcotics|mesh-ancestor
65197846|NCT02635282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65197847|NCT02635282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65197848|NCT02635282|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65197849|NCT02635282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65197850|NCT02635282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65197851|NCT02635282|GABA Modulators|gaba modulators|mesh-ancestor
65197852|NCT02635282|GABA Agents|gaba agents|mesh-ancestor
65197853|NCT00655798|Antioxidants|antioxidants|mesh-list
65197854|NCT00655798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197855|NCT00655798|Protective Agents|protective agents|mesh-ancestor
65197856|NCT00655798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197857|NCT02637700|Immunoglobulins|immunoglobulins|mesh-list
65197858|NCT02637700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65197859|NCT02637700|Antibodies|antibodies|mesh-list
65197860|NCT02637700|gamma-Globulins|gamma-globulins|mesh-list
65197861|NCT02637700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65197862|NCT02637700|Immunologic Factors|immunologic factors|mesh-ancestor
65197863|NCT02637700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197864|NCT02637466|Vortioxetine|vortioxetine|mesh-list
65197865|NCT02637466|Antidepressive Agents|antidepressive agents|mesh-ancestor
65197866|NCT02637466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65197871|NCT02637466|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65197872|NCT02637466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65197873|NCT02637466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65197874|NCT02637466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197875|NCT02637466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65197876|NCT02637466|Serotonin Agents|serotonin agents|mesh-ancestor
65197877|NCT02637466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65197878|NCT02637466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65197879|NCT02637466|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65197880|NCT02637466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65197881|NCT02634970|Ranibizumab|ranibizumab|mesh-list
65197882|NCT02634970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65329955|NCT05711667|Acetic Acid|acetic acid|mesh-list
65329956|NCT05711667|Letermovir|letermovir|mesh-list
65329957|NCT05711667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65329958|NCT05711667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65329959|NCT05711667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329960|NCT05711667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65329961|NCT05711667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329962|NCT05711667|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65329963|NCT05711667|Antiviral Agents|antiviral agents|mesh-ancestor
65329964|NCT04384692|Mycophenolic Acid|mycophenolic acid|mesh-list
65329965|NCT04384692|Cyclophosphamide|cyclophosphamide|mesh-list
65329966|NCT04384692|Melphalan|melphalan|mesh-list
65329967|NCT04384692|Busulfan|busulfan|mesh-list
65329968|NCT04384692|Mechlorethamine|mechlorethamine|mesh-list
65329969|NCT04384692|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65329970|NCT04384692|Methotrexate|methotrexate|mesh-list
65329971|NCT04384692|Fludarabine|fludarabine|mesh-list
65329972|NCT04384692|Tacrolimus|tacrolimus|mesh-list
65329973|NCT04384692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65329974|NCT04384692|Immunologic Factors|immunologic factors|mesh-ancestor
65329975|NCT04384692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65329976|NCT04384692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65329977|NCT04384692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65329978|NCT04384692|Alkylating Agents|alkylating agents|mesh-ancestor
65329979|NCT04384692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197883|NCT02634970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65197884|NCT02634970|Growth Substances|growth substances|mesh-ancestor
65197885|NCT02634970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197886|NCT02634970|Growth Inhibitors|growth inhibitors|mesh-ancestor
65197887|NCT02634970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197888|NCT00885352|Metformin|metformin|mesh-list
65197889|NCT00885352|Pioglitazone|pioglitazone|mesh-list
65197890|NCT00885352|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65197891|NCT00885352|Glipizide|glipizide|mesh-list
65197892|NCT00885352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65197893|NCT00885352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197894|NCT00885352|Incretins|incretins|mesh-ancestor
65197895|NCT00885352|Hormones|hormones|mesh-ancestor
65197896|NCT00885352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65197897|NCT00885352|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65197898|NCT00885352|Protease Inhibitors|protease inhibitors|mesh-ancestor
65197899|NCT00885352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197900|NCT00885352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197901|NCT00656032|Cinacalcet|cinacalcet|mesh-list
65197902|NCT00656032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65197903|NCT00656032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197904|NCT00656032|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65197905|NCT00656032|Hormone Antagonists|hormone antagonists|mesh-ancestor
65197906|NCT00656032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65197907|NCT00885118|Empagliflozin|empagliflozin|mesh-list
65197908|NCT00885118|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65329980|NCT04384692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65329981|NCT04384692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65329982|NCT04384692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65329983|NCT04384692|Abortifacient Agents|abortifacient agents|mesh-ancestor
65329984|NCT04384692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65329985|NCT04384692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65329986|NCT04384692|Antimetabolites|antimetabolites|mesh-ancestor
65329987|NCT04384692|Dermatologic Agents|dermatologic agents|mesh-ancestor
65329988|NCT04384692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65329989|NCT04384692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65329990|NCT04384692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65329991|NCT04384692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65329992|NCT04384692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65197909|NCT00885118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197910|NCT00885118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65197911|NCT00885118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197912|NCT00656812|Rituximab|rituximab|mesh-list
65197913|NCT00656812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65197914|NCT00656812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197915|NCT00656812|Immunologic Factors|immunologic factors|mesh-ancestor
65197916|NCT00656812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197917|NCT00656812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65197918|NCT00656110|Ethanol|ethanol|mesh-list
65197919|NCT00656110|Methylprednisolone|methylprednisolone|mesh-list
65197920|NCT00656110|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65197921|NCT00656110|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65197922|NCT00656110|Prednisolone|prednisolone|mesh-list
65197923|NCT00656110|Prednisolone acetate|prednisolone acetate|mesh-list
65197924|NCT00656110|Lidocaine|lidocaine|mesh-list
65197925|NCT00656110|Bupivacaine|bupivacaine|mesh-list
65197926|NCT00656110|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65197927|NCT00656110|Prednisolone phosphate|prednisolone phosphate|mesh-list
65197928|NCT00656110|Anesthetics, Local|anesthetics, local|mesh-ancestor
65197929|NCT00656110|Anesthetics|anesthetics|mesh-ancestor
65197930|NCT00656110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65197931|NCT00656110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197932|NCT00656110|Sensory System Agents|sensory system agents|mesh-ancestor
65197933|NCT00656110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65197934|NCT00656110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65197935|NCT00656110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65197941|NCT00656110|Autonomic Agents|autonomic agents|mesh-ancestor
65197942|NCT00656110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65197943|NCT00656110|Glucocorticoids|glucocorticoids|mesh-ancestor
65197944|NCT00656110|Hormones|hormones|mesh-ancestor
65197945|NCT00656110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65197946|NCT00656110|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65197947|NCT00656110|Protective Agents|protective agents|mesh-ancestor
65197948|NCT00656110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65197949|NCT00656110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197950|NCT00656110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65197951|NCT00656110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65197952|NCT00656188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65197953|NCT00656188|Vasodilator Agents|vasodilator agents|mesh-ancestor
65197954|NCT00656188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65197955|NCT00656188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65197956|NCT00656188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197957|NCT00656188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197958|NCT00656188|Urological Agents|urological agents|mesh-ancestor
65197959|NCT00880906|Fluticasone|fluticasone|mesh-list
65197960|NCT00880906|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65197961|NCT00880906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65329993|NCT04384692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65329994|NCT04384692|Antitubercular Agents|antitubercular agents|mesh-ancestor
65329995|NCT04384692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65329996|NCT04384692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65329997|NCT00785291|Paclitaxel|paclitaxel|mesh-list
65329998|NCT00785291|Epothilones|epothilones|mesh-list
65329999|NCT00785291|Epothilone B|epothilone b|mesh-list
65330000|NCT00785291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65330001|NCT00785291|Bevacizumab|bevacizumab|mesh-list
65330002|NCT00785291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65330003|NCT00785291|Endothelial Growth Factors|endothelial growth factors|mesh-list
65330004|NCT00785291|Antibodies|antibodies|mesh-list
65330005|NCT00785291|Immunoglobulins|immunoglobulins|mesh-list
65330006|NCT00785291|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65330007|NCT00785291|Immunoglobulin G|immunoglobulin g|mesh-list
65330008|NCT00785291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65330009|NCT00785291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330010|NCT00785291|Tubulin Modulators|tubulin modulators|mesh-ancestor
64716114|NCT03239522|Glycine|glycine|mesh-list
65197962|NCT00880906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65197963|NCT00880906|Autonomic Agents|autonomic agents|mesh-ancestor
65197964|NCT00880906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65197965|NCT00880906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197966|NCT00880906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65197967|NCT00880906|Respiratory System Agents|respiratory system agents|mesh-ancestor
65197968|NCT00880906|Dermatologic Agents|dermatologic agents|mesh-ancestor
65197969|NCT00880906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65197970|NCT00880906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197971|NCT00880906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197972|NCT04160026|Pyrimethamine|pyrimethamine|mesh-list
65197973|NCT04160026|Piperaquine|piperaquine|mesh-list
65197974|NCT04160026|Sulfadoxine|sulfadoxine|mesh-list
65197975|NCT04160026|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65197976|NCT04160026|Antimalarials|antimalarials|mesh-ancestor
65197977|NCT04160026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65197978|NCT04160026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65197979|NCT04160026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65197980|NCT04160026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65197981|NCT04160026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197982|NCT04160026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197983|NCT04160026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65197984|NCT04160026|Renal Agents|renal agents|mesh-ancestor
65197985|NCT04159870|Rifaximin|rifaximin|mesh-list
65197986|NCT04159870|Norfloxacin|norfloxacin|mesh-list
65197987|NCT04159870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65197988|NCT04159870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65197989|NCT04159870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65197990|NCT04159870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65197991|NCT04159870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65197992|NCT04159870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197993|NCT04159870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197994|NCT04159870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197995|NCT04159870|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65197996|NCT04159870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65197997|NCT00657514|Ranolazine|ranolazine|mesh-list
65197998|NCT00657514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65197999|NCT00657514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65198000|NCT00657514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330011|NCT00785291|Antimitotic Agents|antimitotic agents|mesh-ancestor
65330012|NCT00785291|Mitosis Modulators|mitosis modulators|mesh-ancestor
65330013|NCT00785291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330014|NCT00785291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65330015|NCT00785291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65330016|NCT00785291|Growth Substances|growth substances|mesh-ancestor
64716128|NCT03242408|Hormones|hormones|mesh-ancestor
65198001|NCT00656266|Mycophenolic Acid|mycophenolic acid|mesh-list
65198002|NCT00656266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65198003|NCT00656266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198004|NCT00656266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65198005|NCT00656266|Antitubercular Agents|antitubercular agents|mesh-ancestor
65198011|NCT00882310|Capecitabine|capecitabine|mesh-list
65198012|NCT00882310|Docetaxel|docetaxel|mesh-list
65198013|NCT00882310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65198014|NCT00882310|Antimetabolites|antimetabolites|mesh-ancestor
65198015|NCT00882310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198016|NCT00882310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198017|NCT00882310|Antiviral Agents|antiviral agents|mesh-ancestor
65198018|NCT00882310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65198019|NCT00882310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198020|NCT00882310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65198021|NCT00882310|Immunologic Factors|immunologic factors|mesh-ancestor
65198022|NCT00882310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198023|NCT00882310|Tubulin Modulators|tubulin modulators|mesh-ancestor
65198024|NCT00882310|Antimitotic Agents|antimitotic agents|mesh-ancestor
65198025|NCT00882310|Mitosis Modulators|mitosis modulators|mesh-ancestor
65198026|NCT00884650|Analgesics|analgesics|mesh-list
65198027|NCT00884650|Sensory System Agents|sensory system agents|mesh-ancestor
65198028|NCT00884650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65198029|NCT00884650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198030|NCT02636842|Aripiprazole|aripiprazole|mesh-list
65198031|NCT02636842|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
65198032|NCT02636842|Antidepressive Agents|antidepressive agents|mesh-ancestor
65198033|NCT02636842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65198034|NCT02636842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65198035|NCT02636842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65198036|NCT02636842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65198037|NCT02636842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198038|NCT02636842|Dopamine Agonists|dopamine agonists|mesh-ancestor
65198039|NCT02636842|Dopamine Agents|dopamine agents|mesh-ancestor
65198040|NCT02636842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65198041|NCT02636842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198042|NCT02636842|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65198043|NCT02636842|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65198044|NCT02636842|Serotonin Agents|serotonin agents|mesh-ancestor
65198045|NCT02636842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65198046|NCT02636842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65198047|NCT02636842|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65198048|NCT02636842|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65198049|NCT04161976|Insulin Lispro|insulin lispro|mesh-list
65198050|NCT04161976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65198051|NCT04161976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198052|NCT00656422|Insulin|insulin|mesh-list
65198053|NCT00656422|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65198054|NCT00656422|Insulin Detemir|insulin detemir|mesh-list
65198055|NCT00656422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65198056|NCT00656422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198057|NCT02634034|Pitavastatin|pitavastatin|mesh-list
65198058|NCT02634034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65198059|NCT02634034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65198060|NCT02634034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65198061|NCT02634034|Antimetabolites|antimetabolites|mesh-ancestor
65198062|NCT02634034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198063|NCT02634034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198064|NCT02634034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65198065|NCT00657748|Triacetin|triacetin|mesh-list
65198066|NCT00657748|Lithium Carbonate|lithium carbonate|mesh-list
65198067|NCT00657748|Antidepressive Agents|antidepressive agents|mesh-ancestor
65330017|NCT00785291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330018|NCT00785291|Growth Inhibitors|growth inhibitors|mesh-ancestor
65330019|NCT00785291|Immunologic Factors|immunologic factors|mesh-ancestor
65330020|NCT00740259|Flunarizine|flunarizine|mesh-list
65330021|NCT00740259|Anticonvulsants|anticonvulsants|mesh-ancestor
64716135|NCT03211117|Docetaxel|docetaxel|mesh-list
65198068|NCT00657748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65198069|NCT00657748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198070|NCT00657748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198071|NCT00657748|Antimanic Agents|antimanic agents|mesh-ancestor
65198072|NCT00657748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65198073|NCT00657748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65198074|NCT00657748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198075|NCT00657748|Antifungal Agents|antifungal agents|mesh-ancestor
65198080|NCT04161586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65198081|NCT04161586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198082|NCT04161586|Sensory System Agents|sensory system agents|mesh-ancestor
65198083|NCT04161586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65198084|NCT02636218|Ketamine|ketamine|mesh-list
65198085|NCT02636218|Analgesics|analgesics|mesh-ancestor
65198086|NCT02636218|Sensory System Agents|sensory system agents|mesh-ancestor
65198087|NCT02636218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65198088|NCT02636218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198089|NCT02636218|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65198090|NCT02636218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65198091|NCT02636218|Anesthetics, General|anesthetics, general|mesh-ancestor
65198092|NCT02636218|Anesthetics|anesthetics|mesh-ancestor
65198093|NCT02636218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65198094|NCT02636218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65198095|NCT02636218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65198096|NCT02636218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65198097|NCT02636218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198098|NCT04161508|Glycopyrrolate|glycopyrrolate|mesh-list
65198099|NCT04161508|Neostigmine|neostigmine|mesh-list
65198100|NCT04161508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65198101|NCT04161508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198102|NCT04161508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198103|NCT04161508|Cholinergic Agents|cholinergic agents|mesh-ancestor
65198104|NCT04161508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65198105|NCT04161508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198106|NCT04161508|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65198107|NCT04161508|Autonomic Agents|autonomic agents|mesh-ancestor
65198108|NCT04161508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65198109|NCT04161508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65198110|NCT04161508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65198111|NCT04161508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65198112|NCT00598078|Sodium Oxybate|sodium oxybate|mesh-list
65198113|NCT00598078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65198114|NCT00598078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65198115|NCT00598078|Anesthetics, General|anesthetics, general|mesh-ancestor
65198116|NCT00598078|Anesthetics|anesthetics|mesh-ancestor
65198117|NCT00598078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65198118|NCT00598078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198119|NCT00883558|Insulin|insulin|mesh-list
65198120|NCT00883558|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65198121|NCT00883558|Insulin Glargine|insulin glargine|mesh-list
65198122|NCT00883558|Insulin Lispro|insulin lispro|mesh-list
65198123|NCT00883558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65198124|NCT00883558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198125|NCT04162834|Papaverine|papaverine|mesh-list
65198126|NCT04162834|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65198127|NCT04162834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198128|NCT04162834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198129|NCT04162834|Vasodilator Agents|vasodilator agents|mesh-ancestor
65198130|NCT04162834|Urological Agents|urological agents|mesh-ancestor
65198131|NCT00657904|Bicalutamide|bicalutamide|mesh-list
65198132|NCT00657904|Androgen Antagonists|androgen antagonists|mesh-ancestor
65198133|NCT00657904|Hormone Antagonists|hormone antagonists|mesh-ancestor
65198134|NCT00657904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65330022|NCT00740259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65330023|NCT00740259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65330024|NCT00740259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330025|NCT00740259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65330026|NCT00740259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330027|NCT00740259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65198135|NCT00657904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198136|NCT00657904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198137|NCT02633878|Progesterone|progesterone|mesh-list
65198138|NCT02633878|Progestins|progestins|mesh-ancestor
65198139|NCT02633878|Hormones|hormones|mesh-ancestor
65198140|NCT02633878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65198141|NCT02633878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198142|NCT00597766|Triamcinolone|triamcinolone|mesh-list
65198143|NCT00597766|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65198144|NCT00597766|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65198145|NCT00597766|Lidocaine|lidocaine|mesh-list
65198146|NCT00597766|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65198147|NCT00597766|Anesthetics, Local|anesthetics, local|mesh-ancestor
65198153|NCT00597766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65198154|NCT00597766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64840752|NCT01638962|Antipyretics|antipyretics|mesh-ancestor
65198155|NCT00597766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65198156|NCT00597766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65198157|NCT00597766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198158|NCT00597766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65198159|NCT00597766|Glucocorticoids|glucocorticoids|mesh-ancestor
65198160|NCT00597766|Hormones|hormones|mesh-ancestor
65198161|NCT00597766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65198162|NCT00597766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65198163|NCT00597766|Immunologic Factors|immunologic factors|mesh-ancestor
65198164|NCT00597766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198165|NCT04161274|Silver Nitrate|silver nitrate|mesh-list
65198166|NCT04161274|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65198167|NCT04161274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65198168|NCT00657982|Everolimus|everolimus|mesh-list
65198169|NCT00657982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198170|NCT00657982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65198171|NCT00657982|Immunologic Factors|immunologic factors|mesh-ancestor
65198172|NCT00657982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198173|NCT04159246|Sofosbuvir|sofosbuvir|mesh-list
65198174|NCT04159246|Antiviral Agents|antiviral agents|mesh-ancestor
65198175|NCT04159246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65198176|NCT00979992|Sunitinib|sunitinib|mesh-list
65198177|NCT00979992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198178|NCT00979992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65198179|NCT00979992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65198180|NCT00979992|Growth Substances|growth substances|mesh-ancestor
65198181|NCT00979992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198182|NCT00979992|Growth Inhibitors|growth inhibitors|mesh-ancestor
65198183|NCT00979992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65198184|NCT00979992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198185|NCT00979992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198186|NCT01079741|Poly I-C|poly i-c|mesh-list
65198187|NCT01079741|Mineral Oil|mineral oil|mesh-list
65198188|NCT01079741|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65198189|NCT01079741|Poly ICLC|poly iclc|mesh-list
65198190|NCT01079741|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65198191|NCT01079741|Freund's Adjuvant|freund's adjuvant|mesh-list
65198192|NCT01079741|Interferon Inducers|interferon inducers|mesh-ancestor
65198193|NCT01079741|Immunologic Factors|immunologic factors|mesh-ancestor
65198194|NCT01079741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198195|NCT01079741|Laxatives|laxatives|mesh-ancestor
65198196|NCT01079741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65198197|NCT01079741|Antiviral Agents|antiviral agents|mesh-ancestor
65198198|NCT01079741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65198199|NCT01079741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65198200|NCT01079741|Emollients|emollients|mesh-ancestor
65198201|NCT01079741|Dermatologic Agents|dermatologic agents|mesh-ancestor
65330028|NCT00740259|Histamine Antagonists|histamine antagonists|mesh-ancestor
65330029|NCT00740259|Histamine Agents|histamine agents|mesh-ancestor
65330030|NCT00740259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65330031|NCT00740259|Vasodilator Agents|vasodilator agents|mesh-ancestor
65330032|NCT05700045|Dexmedetomidine|dexmedetomidine|mesh-list
64716147|NCT03211117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198202|NCT02877641|Vitamin D|vitamin d|mesh-list
65198203|NCT02877641|Cholecalciferol|cholecalciferol|mesh-list
65198204|NCT02877641|Vitamins|vitamins|mesh-list
65198205|NCT02877641|Micronutrients|micronutrients|mesh-ancestor
65198206|NCT02877641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198207|NCT02877641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65198208|NCT02877641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65198209|NCT04074330|Rituximab|rituximab|mesh-list
65198210|NCT04074330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65198211|NCT04074330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198212|NCT04074330|Immunologic Factors|immunologic factors|mesh-ancestor
65198213|NCT04074330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198214|NCT04074330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65198215|NCT01079663|Chlorhexidine|chlorhexidine|mesh-list
65198216|NCT01079663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65198217|NCT01079663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65198218|NCT01079663|Disinfectants|disinfectants|mesh-ancestor
65198237|NCT02865174|Tranexamic Acid|tranexamic acid|mesh-list
65198238|NCT02865174|Thrombin|thrombin|mesh-list
65198239|NCT02865174|Anticoagulants|anticoagulants|mesh-ancestor
65198240|NCT02865174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65198241|NCT02865174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65198242|NCT02865174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198243|NCT02865174|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65198244|NCT02865174|Hemostatics|hemostatics|mesh-ancestor
65198245|NCT02865174|Coagulants|coagulants|mesh-ancestor
65198246|NCT02865174|Antidepressive Agents|antidepressive agents|mesh-ancestor
65198247|NCT02865174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65198248|NCT02865174|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65198249|NCT02865174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198250|NCT02865174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65198251|NCT02865174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65198252|NCT02865174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65198253|NCT02865174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198254|NCT00879814|Vaccines|vaccines|mesh-list
65198255|NCT00879814|Immunologic Factors|immunologic factors|mesh-ancestor
65198256|NCT00879814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198257|NCT02633176|Docetaxel|docetaxel|mesh-list
65198258|NCT02633176|Capecitabine|capecitabine|mesh-list
65198259|NCT02633176|Cetuximab|cetuximab|mesh-list
65198260|NCT02633176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198261|NCT02633176|Tubulin Modulators|tubulin modulators|mesh-ancestor
65198262|NCT02633176|Antimitotic Agents|antimitotic agents|mesh-ancestor
65198263|NCT02633176|Mitosis Modulators|mitosis modulators|mesh-ancestor
65198264|NCT02633176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198265|NCT02633176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65198266|NCT02633176|Antimetabolites|antimetabolites|mesh-ancestor
65198267|NCT02633176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65198269|NCT04156984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65198270|NCT04156984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65198271|NCT04156984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65198272|NCT04156984|Immunologic Factors|immunologic factors|mesh-ancestor
65198273|NCT04156984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198274|NCT04158778|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65198275|NCT04158778|Hallucinogens|hallucinogens|mesh-ancestor
65198276|NCT04158778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198277|NCT04158778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65198278|NCT04158778|Serotonin Agents|serotonin agents|mesh-ancestor
65198279|NCT04158778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65198280|NCT04158778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198292|NCT01078805|Teriparatide|teriparatide|mesh-list
65198293|NCT01078805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65198294|NCT01078805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198295|NCT01078805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65198296|NCT00820027|Ibuprofen|ibuprofen|mesh-list
65330033|NCT05700045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65330034|NCT05700045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65330035|NCT05700045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330036|NCT05700045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65330037|NCT05700045|Analgesics|analgesics|mesh-ancestor
65330038|NCT05700045|Sensory System Agents|sensory system agents|mesh-ancestor
65330039|NCT05700045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65330040|NCT05700045|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65330041|NCT05700045|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65330042|NCT05700045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65330043|NCT05700045|Adrenergic Agents|adrenergic agents|mesh-ancestor
65330044|NCT05700045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65330045|NCT05700045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330046|NCT04063839|Sofosbuvir|sofosbuvir|mesh-list
64716150|NCT00376285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64716151|NCT00376285|Antimetabolites|antimetabolites|mesh-ancestor
65198297|NCT00820027|Etoricoxib|etoricoxib|mesh-list
65198298|NCT00820027|Morphine|morphine|mesh-list
65198299|NCT00820027|Oxycodone|oxycodone|mesh-list
65198300|NCT00820027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65198301|NCT00820027|Narcotics|narcotics|mesh-ancestor
65198302|NCT00820027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65198303|NCT00820027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198304|NCT00820027|Analgesics|analgesics|mesh-ancestor
65198305|NCT00820027|Sensory System Agents|sensory system agents|mesh-ancestor
65198306|NCT00820027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65198307|NCT00820027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65198308|NCT00820027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65198309|NCT00820027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65198310|NCT00820027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65198311|NCT00820027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65198312|NCT00820027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198313|NCT00820027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198314|NCT00820027|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65198315|NCT02876549|Chloroquine|chloroquine|mesh-list
65198316|NCT02876549|Primaquine|primaquine|mesh-list
65198317|NCT02876549|Amebicides|amebicides|mesh-ancestor
65198318|NCT02876549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65198319|NCT02876549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65198320|NCT02876549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65198321|NCT02876549|Antimalarials|antimalarials|mesh-ancestor
65198322|NCT02876549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65198323|NCT00913549|Clemastine|clemastine|mesh-list
65198324|NCT00913549|Antipruritics|antipruritics|mesh-ancestor
65198325|NCT00913549|Dermatologic Agents|dermatologic agents|mesh-ancestor
65198326|NCT00913549|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65198327|NCT00913549|Histamine Antagonists|histamine antagonists|mesh-ancestor
65198328|NCT00913549|Histamine Agents|histamine agents|mesh-ancestor
65198329|NCT00913549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65198330|NCT00913549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198331|NCT00913549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198332|NCT00913549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65198333|NCT01076153|Clarithromycin|clarithromycin|mesh-list
65198334|NCT01076153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65198335|NCT01076153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65198336|NCT01076153|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65198337|NCT01076153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198338|NCT01076153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198339|NCT01076153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65330047|NCT04063839|Grazoprevir|grazoprevir|mesh-list
65330048|NCT04063839|Ledipasvir|ledipasvir|mesh-list
65330049|NCT04063839|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65330050|NCT04063839|Antiviral Agents|antiviral agents|mesh-ancestor
65330051|NCT04063839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65330052|NCT04079088|Interferons|interferons|mesh-list
65330053|NCT04079088|Interferon-beta|interferon-beta|mesh-list
65330054|NCT04079088|Glatiramer Acetate|glatiramer acetate|mesh-list
65330055|NCT04079088|(T,G)-A-L|(t,g)-a-l|mesh-list
65330056|NCT04079088|Interferon beta-1b|interferon beta-1b|mesh-list
65330057|NCT04079088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330058|NCT04079088|Antiviral Agents|antiviral agents|mesh-ancestor
65330059|NCT04079088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65330060|NCT04079088|Immunologic Factors|immunologic factors|mesh-ancestor
65330061|NCT04079088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330062|NCT04079088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65330063|NCT04079088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65330064|NCT04079088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65330065|NCT00785213|Rosiglitazone|rosiglitazone|mesh-list
65330066|NCT00785213|Quinine|quinine|mesh-list
65330067|NCT00785213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65330068|NCT00785213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330069|NCT00785213|Antimalarials|antimalarials|mesh-ancestor
65330070|NCT00785213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65330071|NCT00785213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65330072|NCT00785213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65330073|NCT00785213|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65330074|NCT00785213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65330075|NCT00785213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65198340|NCT01076153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65198341|NCT01076075|Metformin|metformin|mesh-list
65198342|NCT01076075|Pioglitazone|pioglitazone|mesh-list
65198343|NCT01076075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65198344|NCT01076075|Glimepiride|glimepiride|mesh-list
65198354|NCT01076075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198356|NCT01076075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65198357|NCT01076075|Immunologic Factors|immunologic factors|mesh-ancestor
65198358|NCT01075763|Interferons|interferons|mesh-list
65198359|NCT01075763|Interferon-beta|interferon-beta|mesh-list
65198360|NCT01075763|Interferon beta-1a|interferon beta-1a|mesh-list
65198361|NCT01075763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198362|NCT01075763|Antiviral Agents|antiviral agents|mesh-ancestor
65198363|NCT01075763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65198364|NCT01075763|Immunologic Factors|immunologic factors|mesh-ancestor
65198365|NCT01075763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198366|NCT01075763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65198367|NCT00881530|Metformin|metformin|mesh-list
65198368|NCT00881530|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65198369|NCT00881530|Empagliflozin|empagliflozin|mesh-list
65198370|NCT00881530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65198371|NCT00881530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330076|NCT00785213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65330077|NCT00785213|Analgesics|analgesics|mesh-ancestor
65330078|NCT00785213|Sensory System Agents|sensory system agents|mesh-ancestor
65330079|NCT02583594|Loratadine|loratadine|mesh-list
65330080|NCT02583594|Acyclovir|acyclovir|mesh-list
65330081|NCT02583594|Methylprednisolone|methylprednisolone|mesh-list
65330082|NCT02583594|Alemtuzumab|alemtuzumab|mesh-list
65330083|NCT02583594|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
65330084|NCT02583594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65330085|NCT02583594|Antiemetics|antiemetics|mesh-ancestor
65330086|NCT02583594|Autonomic Agents|autonomic agents|mesh-ancestor
65330087|NCT02583594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65330088|NCT02583594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330089|NCT02583594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65330090|NCT02583594|Glucocorticoids|glucocorticoids|mesh-ancestor
65330091|NCT02583594|Hormones|hormones|mesh-ancestor
65330092|NCT02583594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65330093|NCT02583594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65330094|NCT02583594|Protective Agents|protective agents|mesh-ancestor
64716191|NCT03249272|Adenosine|adenosine|mesh-list
65198372|NCT00881530|Incretins|incretins|mesh-ancestor
65198373|NCT00881530|Hormones|hormones|mesh-ancestor
65198374|NCT00881530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65198375|NCT00881530|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65198376|NCT00881530|Protease Inhibitors|protease inhibitors|mesh-ancestor
65198377|NCT00881530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198378|NCT00881530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198379|NCT00881530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65198380|NCT02632474|Tenofovir|tenofovir|mesh-list
65198381|NCT02632474|Lamivudine|lamivudine|mesh-list
65198382|NCT02632474|Efavirenz|efavirenz|mesh-list
64840982|NCT01642979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65198383|NCT02632474|Antiviral Agents|antiviral agents|mesh-ancestor
65198384|NCT02632474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65198385|NCT02632474|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65198386|NCT02632474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65198387|NCT02632474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198388|NCT02632474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198389|NCT02632474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65198390|NCT02632474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65198391|NCT02632474|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65198392|NCT02632474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65198393|NCT02632474|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65198394|NCT02632474|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65198395|NCT02632474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65198396|NCT02632474|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65198397|NCT04156750|Metformin|metformin|mesh-list
65198398|NCT04156750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65198399|NCT04156750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198400|NCT02877173|Alprostadil|alprostadil|mesh-list
65198401|NCT02877173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65198402|NCT02877173|Vasodilator Agents|vasodilator agents|mesh-ancestor
65198403|NCT02877173|Urological Agents|urological agents|mesh-ancestor
65198404|NCT04305743|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65198405|NCT04305743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65198406|NCT04305743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65198407|NCT04305743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65330095|NCT02583594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330096|NCT02583594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65330097|NCT02583594|Antiviral Agents|antiviral agents|mesh-ancestor
65330098|NCT02583594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65330099|NCT02583594|Antipruritics|antipruritics|mesh-ancestor
65330100|NCT02583594|Dermatologic Agents|dermatologic agents|mesh-ancestor
65330101|NCT02583594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65330102|NCT02583594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65330103|NCT02583594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65330104|NCT02583594|Histamine Antagonists|histamine antagonists|mesh-ancestor
65330105|NCT02583594|Histamine Agents|histamine agents|mesh-ancestor
65330106|NCT02583594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65198408|NCT04305743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198416|NCT00661180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65198417|NCT00661180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198418|NCT00661180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198419|NCT01078571|Adalimumab|adalimumab|mesh-list
65198420|NCT01078571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65198421|NCT01078571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65198422|NCT04160416|Capecitabine|capecitabine|mesh-list
65198423|NCT04160416|Oxaliplatin|oxaliplatin|mesh-list
65198424|NCT04160416|Irinotecan|irinotecan|mesh-list
65198425|NCT04160416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65198426|NCT04160416|Antimetabolites|antimetabolites|mesh-ancestor
65198427|NCT04160416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198428|NCT04160416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198429|NCT04160416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65198430|NCT04160416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65198431|NCT04160416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198432|NCT00661336|Melphalan|melphalan|mesh-list
65198433|NCT00661336|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
65198434|NCT00661336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65198435|NCT00661336|Alkylating Agents|alkylating agents|mesh-ancestor
65198436|NCT00661336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198437|NCT00661336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198438|NCT00661336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65198439|NCT00661336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65198440|NCT00661336|Immunologic Factors|immunologic factors|mesh-ancestor
65198441|NCT00661336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198442|NCT00661336|Antimetabolites|antimetabolites|mesh-ancestor
65198443|NCT00661336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65198444|NCT00661336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198445|NCT00661336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65198446|NCT00661336|Protective Agents|protective agents|mesh-ancestor
65198447|NCT04158700|Pembrolizumab|pembrolizumab|mesh-list
65198448|NCT04158700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65198449|NCT04158700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198450|NCT00657202|Ranibizumab|ranibizumab|mesh-list
65198451|NCT00657202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65198452|NCT00657202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65198453|NCT00657202|Growth Substances|growth substances|mesh-ancestor
65198454|NCT00657202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198455|NCT00657202|Growth Inhibitors|growth inhibitors|mesh-ancestor
65198456|NCT00657202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198457|NCT00626483|Basiliximab|basiliximab|mesh-list
65198458|NCT00626483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65198459|NCT00626483|Immunologic Factors|immunologic factors|mesh-ancestor
65198460|NCT00626483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198461|NCT00626717|Riboflavin|riboflavin|mesh-list
65198462|NCT00626717|Vitamin B Complex|vitamin b complex|mesh-ancestor
65198463|NCT00626717|Vitamins|vitamins|mesh-ancestor
65198464|NCT00626717|Micronutrients|micronutrients|mesh-ancestor
65198465|NCT00626717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198466|NCT00626717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65330107|NCT02583594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330108|NCT00740415|Dexamethasone|dexamethasone|mesh-list
65330109|NCT00740415|Rituximab|rituximab|mesh-list
65330110|NCT00740415|Bortezomib|bortezomib|mesh-list
65330111|NCT00740415|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65330112|NCT00740415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65330113|NCT00740415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330114|NCT00740415|Immunologic Factors|immunologic factors|mesh-ancestor
64716223|NCT04761822|Vaccines|vaccines|mesh-list
65198467|NCT00626717|Dermatologic Agents|dermatologic agents|mesh-ancestor
65198468|NCT04156204|Tacrolimus|tacrolimus|mesh-list
65198469|NCT04156204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65198470|NCT04156204|Immunologic Factors|immunologic factors|mesh-ancestor
65198471|NCT04156204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198472|NCT04156204|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65198473|NCT04156204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198474|NCT04156204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198475|NCT02631694|Propranolol|propranolol|mesh-list
65198476|NCT02631694|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65198482|NCT02631694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65198483|NCT02631694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65198484|NCT02631694|Vasodilator Agents|vasodilator agents|mesh-ancestor
65198486|NCT04305587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65198487|NCT04305587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65198488|NCT04305587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65198489|NCT04305587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65198490|NCT04305587|Purinergic Agents|purinergic agents|mesh-ancestor
65198491|NCT04305587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65198492|NCT04305587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198493|NCT04305587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198494|NCT00658840|Capecitabine|capecitabine|mesh-list
65198495|NCT00658840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65198496|NCT00658840|Antimetabolites|antimetabolites|mesh-ancestor
65198497|NCT00658840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198498|NCT00658840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198499|NCT00658918|Ciclesonide|ciclesonide|mesh-list
65198500|NCT00658918|Glucocorticoids|glucocorticoids|mesh-ancestor
65198501|NCT00658918|Hormones|hormones|mesh-ancestor
65198502|NCT00658918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65198503|NCT00658918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198504|NCT00658918|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65198505|NCT02876081|Afatinib|afatinib|mesh-list
65198506|NCT02876081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198507|NCT02876081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65198508|NCT02876081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198509|NCT02876081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198510|NCT02631616|Somatostatin|somatostatin|mesh-list
65198511|NCT02631616|Hormones|hormones|mesh-ancestor
65198512|NCT02631616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65198513|NCT02631616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198514|NCT00661648|Pancrelipase|pancrelipase|mesh-list
65198515|NCT00661648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65198516|NCT00659074|Ondansetron|ondansetron|mesh-list
65198517|NCT00659074|Antiemetics|antiemetics|mesh-ancestor
65198518|NCT00659074|Autonomic Agents|autonomic agents|mesh-ancestor
65198519|NCT00659074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65198520|NCT00659074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198521|NCT00659074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65198522|NCT00659074|Antipruritics|antipruritics|mesh-ancestor
65198523|NCT00659074|Dermatologic Agents|dermatologic agents|mesh-ancestor
65198524|NCT00659074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65198525|NCT00659074|Serotonin Agents|serotonin agents|mesh-ancestor
65198526|NCT00659074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65198527|NCT00659074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198528|NCT00659074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65198529|NCT00659074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65330115|NCT00740415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330116|NCT00740415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65330117|NCT00740415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65330118|NCT00740415|Antiemetics|antiemetics|mesh-ancestor
65330119|NCT00740415|Autonomic Agents|autonomic agents|mesh-ancestor
65330120|NCT00740415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65330121|NCT00740415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65330122|NCT00740415|Glucocorticoids|glucocorticoids|mesh-ancestor
65198530|NCT00659074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65198531|NCT00659074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65198532|NCT00659074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65198533|NCT01077713|Gemcitabine|gemcitabine|mesh-list
65198535|NCT01077713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65198536|NCT01077713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198537|NCT01077713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65198538|NCT01077713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65198539|NCT01077713|Growth Substances|growth substances|mesh-ancestor
65198540|NCT01077713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198541|NCT01077713|Growth Inhibitors|growth inhibitors|mesh-ancestor
65198542|NCT01077713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65198543|NCT01077713|Antimetabolites|antimetabolites|mesh-ancestor
65198544|NCT01077713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198553|NCT00813709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198554|NCT00813709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198555|NCT00813709|Antiviral Agents|antiviral agents|mesh-ancestor
65198556|NCT00813709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65198557|NCT01077323|Exenatide|exenatide|mesh-list
65198558|NCT01077323|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65198559|NCT01077323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198560|NCT01077323|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65198561|NCT01077323|Incretins|incretins|mesh-ancestor
65198562|NCT01077323|Hormones|hormones|mesh-ancestor
65198563|NCT01077323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65198564|NCT03870438|Lamivudine|lamivudine|mesh-list
65198565|NCT03870438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65198566|NCT03870438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65198567|NCT03870438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198568|NCT03870438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198569|NCT03870438|Antiviral Agents|antiviral agents|mesh-ancestor
65198570|NCT03870438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65198571|NCT03870438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65198572|NCT03870438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65198573|NCT02865018|Cetirizine|cetirizine|mesh-list
65198574|NCT02865018|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65198575|NCT02865018|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65198576|NCT02865018|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65198577|NCT02865018|Histamine Antagonists|histamine antagonists|mesh-ancestor
65198578|NCT02865018|Histamine Agents|histamine agents|mesh-ancestor
65198579|NCT02865018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65198580|NCT02865018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198581|NCT02865018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198582|NCT05758831|Rituximab|rituximab|mesh-list
65198583|NCT05758831|Ocrelizumab|ocrelizumab|mesh-list
65198584|NCT05758831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65198585|NCT05758831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198586|NCT05758831|Immunologic Factors|immunologic factors|mesh-ancestor
65198587|NCT05758831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198588|NCT05758831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65198589|NCT04287894|Pemetrexed|pemetrexed|mesh-list
65198590|NCT04287894|Durvalumab|durvalumab|mesh-list
65198591|NCT04287894|Tremelimumab|tremelimumab|mesh-list
65198592|NCT04287894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198593|NCT04287894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198594|NCT04287894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198595|NCT04287894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65198596|NCT04287894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65198597|NCT04287894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65330123|NCT00740415|Hormones|hormones|mesh-ancestor
65330124|NCT00740415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65330125|NCT00740415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65330126|NCT00740415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65198598|NCT04287426|Remifentanil|remifentanil|mesh-list
65198599|NCT04287426|Rocuronium|rocuronium|mesh-list
65198600|NCT04287426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65198601|NCT04287426|Narcotics|narcotics|mesh-ancestor
65198602|NCT04287426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65198603|NCT04287426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198604|NCT04287426|Analgesics|analgesics|mesh-ancestor
65198605|NCT04287426|Sensory System Agents|sensory system agents|mesh-ancestor
65198606|NCT04287426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64841208|NCT01650441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65198607|NCT04287426|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65198608|NCT04287426|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65198609|NCT04287426|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65198610|NCT04047576|Sirolimus|sirolimus|mesh-list
65198611|NCT04047576|Prednisone|prednisone|mesh-list
65198612|NCT04047576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65198615|NCT04047576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65198617|NCT04047576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65198618|NCT04047576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198619|NCT04047576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65198620|NCT04047576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65198621|NCT04047576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65198622|NCT04047576|Antifungal Agents|antifungal agents|mesh-ancestor
65198623|NCT04047576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65198624|NCT04047576|Immunologic Factors|immunologic factors|mesh-ancestor
65198625|NCT00976950|Ritonavir|ritonavir|mesh-list
65198626|NCT00976950|Tipranavir|tipranavir|mesh-list
65198627|NCT00976950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65198628|NCT00976950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65198629|NCT00976950|Protease Inhibitors|protease inhibitors|mesh-ancestor
65198630|NCT00976950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198631|NCT00976950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198632|NCT00976950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65198633|NCT00976950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65198634|NCT00976950|Antiviral Agents|antiviral agents|mesh-ancestor
65198635|NCT00976950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65198636|NCT00976950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65198637|NCT00976950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65198639|NCT00629382|Polymyxin B|polymyxin b|mesh-list
65198640|NCT00629382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65198641|NCT00629382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65198642|NCT02866032|Ciclopirox|ciclopirox|mesh-list
65198643|NCT02866032|Antifungal Agents|antifungal agents|mesh-ancestor
65198644|NCT02866032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65198645|NCT00976716|Celecoxib|celecoxib|mesh-list
65198646|NCT00976716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65198647|NCT00976716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65198648|NCT00976716|Analgesics|analgesics|mesh-ancestor
65198649|NCT00976716|Sensory System Agents|sensory system agents|mesh-ancestor
65198650|NCT00976716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65198651|NCT00976716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198652|NCT00976716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65198653|NCT00976716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65198654|NCT00976716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65198655|NCT00976716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65198656|NCT00976716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198657|NCT00976716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198658|NCT00973674|Estrogens|estrogens|mesh-list
65198659|NCT00973674|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65198660|NCT00973674|Hormones|hormones|mesh-ancestor
65198661|NCT00973674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65198662|NCT00973674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198663|NCT00819091|Linagliptin|linagliptin|mesh-list
65198664|NCT00819091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65198665|NCT00819091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198666|NCT00819091|Incretins|incretins|mesh-ancestor
65330127|NCT00740415|Alkylating Agents|alkylating agents|mesh-ancestor
65330128|NCT00740415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330129|NCT00734162|Tenofovir|tenofovir|mesh-list
65330130|NCT00734162|Antiviral Agents|antiviral agents|mesh-ancestor
65330131|NCT00734162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65330132|NCT00734162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65330133|NCT00734162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65330134|NCT00734162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330135|NCT00734162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330136|NCT00734162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65330137|NCT00734162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65198667|NCT00819091|Hormones|hormones|mesh-ancestor
65198668|NCT00819091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65198669|NCT00819091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65198670|NCT00819091|Protease Inhibitors|protease inhibitors|mesh-ancestor
65198671|NCT00819091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198672|NCT00819091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198673|NCT02864784|Calcium Carbonate|calcium carbonate|mesh-list
65198674|NCT02864784|Calcium|calcium|mesh-list
65198675|NCT02864784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65198676|NCT02864784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198677|NCT02864784|Antacids|antacids|mesh-ancestor
65198678|NCT02864784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198679|NCT02864784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65198680|NCT03829254|Pembrolizumab|pembrolizumab|mesh-list
65198681|NCT03829254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65198682|NCT03829254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198683|NCT00819013|Vaccines|vaccines|mesh-list
65198684|NCT00819013|Immunologic Factors|immunologic factors|mesh-ancestor
65198685|NCT00819013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198690|NCT04868773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65198691|NCT04868461|Caseins|caseins|mesh-list
65198692|NCT04868461|Chelating Agents|chelating agents|mesh-ancestor
65198693|NCT04868461|Sequestering Agents|sequestering agents|mesh-ancestor
65198694|NCT04868461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198695|NCT02865642|Citalopram|citalopram|mesh-list
65198696|NCT02865642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65198697|NCT02865642|Serotonin|serotonin|mesh-list
65198698|NCT02865642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65198699|NCT02865642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65198700|NCT02865642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198701|NCT02865642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65198702|NCT02865642|Serotonin Agents|serotonin agents|mesh-ancestor
65198703|NCT02865642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198704|NCT02865642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65198705|NCT02865642|Antidepressive Agents|antidepressive agents|mesh-ancestor
65198706|NCT02865642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65198707|NCT02865642|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65198708|NCT03762564|Paclitaxel|paclitaxel|mesh-list
65198709|NCT03762564|Ramucirumab|ramucirumab|mesh-list
65198710|NCT03762564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65198711|NCT03762564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198712|NCT03762564|Tubulin Modulators|tubulin modulators|mesh-ancestor
65198713|NCT03762564|Antimitotic Agents|antimitotic agents|mesh-ancestor
65198714|NCT03762564|Mitosis Modulators|mitosis modulators|mesh-ancestor
65198715|NCT03762564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198716|NCT00629616|Fulvestrant|fulvestrant|mesh-list
65198717|NCT00629616|Anastrozole|anastrozole|mesh-list
65198718|NCT00629616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65198719|NCT00629616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198720|NCT00629616|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65198721|NCT00629616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65330138|NCT04342572|Melphalan|melphalan|mesh-list
65330139|NCT04342572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65330140|NCT04342572|Alkylating Agents|alkylating agents|mesh-ancestor
65330141|NCT04342572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330142|NCT04342572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330143|NCT04342572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65330144|NCT04342572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65198722|NCT00629616|Hormone Antagonists|hormone antagonists|mesh-ancestor
65198723|NCT00629616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65198724|NCT00629616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198725|NCT00629616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65198726|NCT00629616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65198727|NCT00629616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198728|NCT00629616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198730|NCT01120184|Maytansine|maytansine|mesh-list
65198731|NCT01120184|Docetaxel|docetaxel|mesh-list
65198732|NCT01120184|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65198733|NCT01120184|Trastuzumab|trastuzumab|mesh-list
65198734|NCT01120184|Pertuzumab|pertuzumab|mesh-list
65198735|NCT01120184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65198736|NCT01120184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198737|NCT01120184|Tubulin Modulators|tubulin modulators|mesh-ancestor
65198738|NCT01120184|Antimitotic Agents|antimitotic agents|mesh-ancestor
65198739|NCT01120184|Mitosis Modulators|mitosis modulators|mesh-ancestor
65198740|NCT01120184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198741|NCT01120184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65198742|NCT01120028|Sirolimus|sirolimus|mesh-list
65198743|NCT01120028|Alemtuzumab|alemtuzumab|mesh-list
65198744|NCT01120028|Tacrolimus|tacrolimus|mesh-list
65198745|NCT01120028|Basiliximab|basiliximab|mesh-list
65198746|NCT01120028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65198747|NCT01120028|Immunologic Factors|immunologic factors|mesh-ancestor
65198748|NCT01120028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198749|NCT01120028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65198750|NCT01120028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198751|NCT01120028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198752|NCT01120028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65198753|NCT01120028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65198754|NCT01120028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65198755|NCT01120028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198756|NCT01120028|Antifungal Agents|antifungal agents|mesh-ancestor
65198757|NCT01120028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65198764|NCT00878800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65198765|NCT00878800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198766|NCT00878800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198767|NCT00878800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65198768|NCT00662272|Vaccines|vaccines|mesh-list
65198769|NCT00662272|Immunologic Factors|immunologic factors|mesh-ancestor
65198770|NCT00662272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198771|NCT04158856|Trastuzumab|trastuzumab|mesh-list
65198772|NCT04158856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65198773|NCT04158856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198774|NCT01119950|Glycopyrrolate|glycopyrrolate|mesh-list
65198775|NCT01119950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65198776|NCT01119950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65198777|NCT01119950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65198778|NCT01119950|Cholinergic Agents|cholinergic agents|mesh-ancestor
65198779|NCT01119950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65198780|NCT01119950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198781|NCT01119950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198782|NCT02882828|Tacrolimus|tacrolimus|mesh-list
65198783|NCT02882828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65198784|NCT02882828|Immunologic Factors|immunologic factors|mesh-ancestor
65198785|NCT02882828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198786|NCT02882828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65198787|NCT02882828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198788|NCT02882828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330145|NCT04342572|Immunologic Factors|immunologic factors|mesh-ancestor
65330146|NCT04342572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330147|NCT00740493|Warfarin|warfarin|mesh-list
65330148|NCT00740493|Anticoagulants|anticoagulants|mesh-ancestor
65330149|NCT00740571|Pregabalin|pregabalin|mesh-list
65330150|NCT00740571|Amitriptyline|amitriptyline|mesh-list
65330151|NCT00740571|Analgesics|analgesics|mesh-ancestor
65330152|NCT00740571|Sensory System Agents|sensory system agents|mesh-ancestor
65198789|NCT02882126|Treprostinil|treprostinil|mesh-list
65198790|NCT02882126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65198791|NCT01145222|Midazolam|midazolam|mesh-list
65198792|NCT01145222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65198793|NCT01145222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65198794|NCT01145222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65198795|NCT01145222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198796|NCT01145222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65198797|NCT01145222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65198798|NCT01145222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65198799|NCT01145222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65198800|NCT01145222|Anesthetics, General|anesthetics, general|mesh-ancestor
65198801|NCT01145222|Anesthetics|anesthetics|mesh-ancestor
65198802|NCT01145222|GABA Modulators|gaba modulators|mesh-ancestor
65198803|NCT01145222|GABA Agents|gaba agents|mesh-ancestor
65198804|NCT01145222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65198805|NCT01145222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198806|NCT01145066|Borage oil|borage oil|mesh-list
65198807|NCT01145066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65198808|NCT01132118|Hydroxychloroquine|hydroxychloroquine|mesh-list
65198809|NCT01132118|Antimalarials|antimalarials|mesh-ancestor
65198810|NCT01132118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65198811|NCT01132118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65198812|NCT01132118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65198813|NCT01132118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198814|NCT01132118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198815|NCT01132118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65198816|NCT00637442|Galantamine|galantamine|mesh-list
65198817|NCT00637442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65198818|NCT00637442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198819|NCT00637442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198820|NCT00637442|Cholinergic Agents|cholinergic agents|mesh-ancestor
65198821|NCT00637442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65198822|NCT00637442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198823|NCT00637442|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65198824|NCT00637442|Autonomic Agents|autonomic agents|mesh-ancestor
65198825|NCT00637442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65198826|NCT00637442|Nootropic Agents|nootropic agents|mesh-ancestor
65198827|NCT00969618|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65198837|NCT02864472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65198838|NCT02864472|Growth Substances|growth substances|mesh-ancestor
65198839|NCT02864472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198840|NCT02864472|Growth Inhibitors|growth inhibitors|mesh-ancestor
65198841|NCT02864472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198842|NCT00975000|Cinacalcet|cinacalcet|mesh-list
65198843|NCT00975000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65198844|NCT00975000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198845|NCT00975000|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65198846|NCT00975000|Hormone Antagonists|hormone antagonists|mesh-ancestor
65198847|NCT00975000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65198848|NCT02863614|Ibuprofen|ibuprofen|mesh-list
65198849|NCT02863614|Lorazepam|lorazepam|mesh-list
65198850|NCT02863614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65198851|NCT02863614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65198852|NCT02863614|Analgesics|analgesics|mesh-ancestor
65198853|NCT02863614|Sensory System Agents|sensory system agents|mesh-ancestor
65198854|NCT02863614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65198855|NCT02863614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198856|NCT02863614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65198857|NCT02863614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65198858|NCT02863614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65198859|NCT02863614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330153|NCT00740571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65330154|NCT00740571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330155|NCT00740571|Anticonvulsants|anticonvulsants|mesh-ancestor
64324551|NCT02268565|Aspirin|aspirin|mesh-list
65198860|NCT02863614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198861|NCT02863614|Anticonvulsants|anticonvulsants|mesh-ancestor
65198862|NCT02863614|Antiemetics|antiemetics|mesh-ancestor
65198863|NCT02863614|Autonomic Agents|autonomic agents|mesh-ancestor
65198864|NCT02863614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65198865|NCT02863614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65198866|NCT02863614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65198867|NCT02863614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65198868|NCT02863614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65198869|NCT02863614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65198870|NCT02863614|GABA Modulators|gaba modulators|mesh-ancestor
65198871|NCT02863614|GABA Agents|gaba agents|mesh-ancestor
65198872|NCT02863614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65198873|NCT02864550|Doxycycline|doxycycline|mesh-list
65198874|NCT02864550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65198875|NCT02864550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65198876|NCT02864550|Antimalarials|antimalarials|mesh-ancestor
65198877|NCT02864550|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65198878|NCT02864550|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65198880|NCT00974922|Cholecalciferol|cholecalciferol|mesh-list
65198881|NCT00974922|Vitamins|vitamins|mesh-ancestor
65198882|NCT00974922|Micronutrients|micronutrients|mesh-ancestor
65198883|NCT00974922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198884|NCT00974922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65198885|NCT00974922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65198886|NCT00972504|Cetirizine|cetirizine|mesh-list
65198887|NCT00972504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65198888|NCT00972504|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65198889|NCT00972504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65198890|NCT00972504|Histamine Antagonists|histamine antagonists|mesh-ancestor
65198891|NCT00972504|Histamine Agents|histamine agents|mesh-ancestor
65198892|NCT00972504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65198895|NCT00969150|Milnacipran|milnacipran|mesh-list
65198896|NCT00969150|Levomilnacipran|levomilnacipran|mesh-list
65198897|NCT00969150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65198898|NCT00969150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65198899|NCT00969150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65198900|NCT00969150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198901|NCT00969150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65198902|NCT00969150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198903|NCT00969150|Antidepressive Agents|antidepressive agents|mesh-ancestor
65198904|NCT00969150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65198905|NCT00969150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65198906|NCT00969150|Analgesics|analgesics|mesh-ancestor
65198907|NCT00969150|Sensory System Agents|sensory system agents|mesh-ancestor
65198908|NCT00969150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65198909|NCT03925194|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65198911|NCT00974220|Fentanyl|fentanyl|mesh-list
65198912|NCT00974220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65198913|NCT00974220|Narcotics|narcotics|mesh-ancestor
65198914|NCT00974220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65198915|NCT00974220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198916|NCT00974220|Analgesics|analgesics|mesh-ancestor
65198917|NCT00974220|Sensory System Agents|sensory system agents|mesh-ancestor
65198918|NCT00974220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65198919|NCT00974220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65198920|NCT00974220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65198921|NCT00974220|Anesthetics, General|anesthetics, general|mesh-ancestor
65198922|NCT00974220|Anesthetics|anesthetics|mesh-ancestor
65198923|NCT00971178|Dexmedetomidine|dexmedetomidine|mesh-list
65198924|NCT00971178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65198925|NCT00971178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65198926|NCT00971178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198927|NCT00971178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65198928|NCT00971178|Analgesics|analgesics|mesh-ancestor
65198929|NCT00971178|Sensory System Agents|sensory system agents|mesh-ancestor
65198930|NCT00971178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65330156|NCT00740571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65330157|NCT00740571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65330158|NCT00740571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330159|NCT00740571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65330160|NCT00740571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65330161|NCT00740571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65330162|NCT00740571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65198931|NCT00971178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65198932|NCT00971178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65198933|NCT00971178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65198934|NCT00971178|Adrenergic Agents|adrenergic agents|mesh-ancestor
65198935|NCT00971178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65198936|NCT00971178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198938|NCT00970944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65198939|NCT00970944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65198940|NCT00970944|Antiviral Agents|antiviral agents|mesh-ancestor
65198941|NCT00970944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65198942|NCT00970944|Dopamine Agents|dopamine agents|mesh-ancestor
65198943|NCT00970944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65198944|NCT00970944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198945|NCT00970944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198946|NCT00970944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65198947|NCT00970944|Analgesics|analgesics|mesh-ancestor
65198948|NCT00970944|Sensory System Agents|sensory system agents|mesh-ancestor
65198949|NCT00970944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65198950|NCT05780723|Mesalamine|mesalamine|mesh-list
65198951|NCT05780723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65198952|NCT05780723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65198953|NCT05780723|Analgesics|analgesics|mesh-ancestor
65198954|NCT05780723|Sensory System Agents|sensory system agents|mesh-ancestor
65198955|NCT05780723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65198956|NCT05780723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198957|NCT05780723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65198958|NCT05780723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65198959|NCT05780710|Antihypertensive Agents|antihypertensive agents|mesh-list
65198960|NCT05780515|Immunoglobulins|immunoglobulins|mesh-list
65198961|NCT05780515|Immunoglobulin G|immunoglobulin g|mesh-list
65198962|NCT05780515|Immunologic Factors|immunologic factors|mesh-ancestor
65198963|NCT05780515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198964|NCT05780489|Estradiol|estradiol|mesh-list
65198965|NCT05780489|Progesterone|progesterone|mesh-list
65198968|NCT05780489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65198969|NCT05780489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198970|NCT05780489|Progestins|progestins|mesh-ancestor
65198971|NCT05780320|Amiodarone|amiodarone|mesh-list
65198972|NCT05780320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65198973|NCT05780320|Vasodilator Agents|vasodilator agents|mesh-ancestor
65198974|NCT05780320|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65198975|NCT05780320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65198976|NCT05780320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198977|NCT05780320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65198978|NCT05780320|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65198979|NCT05780320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65198980|NCT05780320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198981|NCT05780320|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65198982|NCT05780320|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65198983|NCT05780320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65198984|NCT05780307|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65198985|NCT05780307|Immunologic Factors|immunologic factors|mesh-ancestor
65198986|NCT05780307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198987|NCT05780294|Asparaginase|asparaginase|mesh-list
65198988|NCT05780294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198989|NCT05780229|Analgesics|analgesics|mesh-list
65198990|NCT05780229|Sensory System Agents|sensory system agents|mesh-ancestor
65198991|NCT05780229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65330163|NCT00740571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65330164|NCT00740571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65330165|NCT00740571|Antidepressive Agents|antidepressive agents|mesh-ancestor
65330166|NCT00740571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65330167|NCT00740571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65330168|NCT00740571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65330169|NCT00740571|Adrenergic Agents|adrenergic agents|mesh-ancestor
65330170|NCT00740571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65330171|NCT02593526|Bumetanide|bumetanide|mesh-list
65330172|NCT02593526|Dialysis Solutions|dialysis solutions|mesh-list
65330173|NCT02593526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64716271|NCT03357614|Clavulanic Acid|clavulanic acid|mesh-list
65198992|NCT05780229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198993|NCT05780216|Harmine|harmine|mesh-list
65198994|NCT05780216|Hallucinogens|hallucinogens|mesh-ancestor
65198995|NCT05780216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198996|NCT05780216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65198997|NCT05780216|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65198998|NCT05780216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198999|NCT05780216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199000|NCT05780151|Insulin Glargine|insulin glargine|mesh-list
65199001|NCT05780151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65199002|NCT05780151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199003|NCT05780086|Icodextrin|icodextrin|mesh-list
65199004|NCT05780086|Dialysis Solutions|dialysis solutions|mesh-ancestor
65199005|NCT05780086|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65199006|NCT05780073|Dasatinib|dasatinib|mesh-list
65199007|NCT05780073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199008|NCT05780073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64504162|NCT02514330|Vitamins|vitamins|mesh-ancestor
65199009|NCT05780073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199010|NCT05780073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199011|NCT05779644|Metformin|metformin|mesh-list
65199012|NCT05779644|Liraglutide|liraglutide|mesh-list
65199013|NCT05779644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65199014|NCT05779644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199015|NCT05779644|Incretins|incretins|mesh-ancestor
65199016|NCT05779644|Hormones|hormones|mesh-ancestor
65199017|NCT05779644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65199018|NCT05779514|Mirabegron|mirabegron|mesh-list
65199019|NCT05779514|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65199020|NCT05779514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65199021|NCT05779514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65199022|NCT05779514|Adrenergic Agents|adrenergic agents|mesh-ancestor
65199023|NCT05779514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65199024|NCT05779514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199025|NCT05779514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199026|NCT05779514|Urological Agents|urological agents|mesh-ancestor
65199027|NCT05779423|Nivolumab|nivolumab|mesh-list
65199028|NCT05779423|Ipilimumab|ipilimumab|mesh-list
65199029|NCT05779423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65199030|NCT05779423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199031|NCT05779423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65199032|NCT05779423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199033|NCT05779410|Vitamin D|vitamin d|mesh-list
65199034|NCT05779410|Ergocalciferols|ergocalciferols|mesh-list
65199035|NCT05779410|Cholecalciferol|cholecalciferol|mesh-list
65199036|NCT05779410|Vitamins|vitamins|mesh-list
65199037|NCT05779410|Micronutrients|micronutrients|mesh-ancestor
65199038|NCT05779410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199052|NCT05779059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65199053|NCT05779059|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65199054|NCT05779059|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65199055|NCT05779059|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65330174|NCT02593526|Diuretics|diuretics|mesh-ancestor
65330175|NCT02593526|Natriuretic Agents|natriuretic agents|mesh-ancestor
65330176|NCT02593526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330177|NCT02593526|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65330178|NCT02593526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65199056|NCT05779059|Purinergic Agents|purinergic agents|mesh-ancestor
65199057|NCT05779059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65199058|NCT05779059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199059|NCT05779059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199061|NCT05779020|Immunologic Factors|immunologic factors|mesh-ancestor
65199062|NCT05779020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199064|NCT05778422|Anesthetics, Local|anesthetics, local|mesh-list
65199065|NCT05778422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65199066|NCT05778422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199067|NCT05778422|Sensory System Agents|sensory system agents|mesh-ancestor
65199068|NCT05778422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65199069|NCT05774366|Desflurane|desflurane|mesh-list
65199070|NCT05774366|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65199071|NCT05774366|Anesthetics, General|anesthetics, general|mesh-ancestor
65199072|NCT05774366|Anesthetics|anesthetics|mesh-ancestor
65199073|NCT05774366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65199074|NCT05774366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199075|NCT05774067|Terlipressin|terlipressin|mesh-list
65199076|NCT05774067|Vasopressins|vasopressins|mesh-list
65199077|NCT05774067|Norepinephrine|norepinephrine|mesh-list
65199078|NCT05774067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65199079|NCT05774067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65199080|NCT05774067|Adrenergic Agents|adrenergic agents|mesh-ancestor
65199081|NCT05774067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65199082|NCT05774067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199083|NCT05774067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199084|NCT05774067|Sympathomimetics|sympathomimetics|mesh-ancestor
65199092|NCT05774067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65199093|NCT05769842|Propofol|propofol|mesh-list
65199094|NCT05769842|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65199095|NCT05769842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65199096|NCT05769842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199097|NCT05769842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65199098|NCT05769842|Anesthetics, General|anesthetics, general|mesh-ancestor
65199099|NCT05769842|Anesthetics|anesthetics|mesh-ancestor
65199100|NCT05768932|Paclitaxel|paclitaxel|mesh-list
65199101|NCT05768932|Carboplatin|carboplatin|mesh-list
65199102|NCT05768932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65199103|NCT05768932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199104|NCT05768932|Tubulin Modulators|tubulin modulators|mesh-ancestor
65199105|NCT05768932|Antimitotic Agents|antimitotic agents|mesh-ancestor
65199106|NCT05768932|Mitosis Modulators|mitosis modulators|mesh-ancestor
65199107|NCT05768932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199114|NCT05747794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65199115|NCT05747794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199116|NCT05747794|Tubulin Modulators|tubulin modulators|mesh-ancestor
65199117|NCT05747794|Antimitotic Agents|antimitotic agents|mesh-ancestor
65199118|NCT05747794|Mitosis Modulators|mitosis modulators|mesh-ancestor
65199119|NCT05747794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199120|NCT05739929|Colchicine|colchicine|mesh-list
65199121|NCT05739929|Gout Suppressants|gout suppressants|mesh-ancestor
65199122|NCT05739929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65199123|NCT05739929|Tubulin Modulators|tubulin modulators|mesh-ancestor
65199124|NCT05739929|Antimitotic Agents|antimitotic agents|mesh-ancestor
65199125|NCT05739929|Mitosis Modulators|mitosis modulators|mesh-ancestor
65199126|NCT05739929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199127|NCT05739929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199128|NCT05712265|Fluvoxamine|fluvoxamine|mesh-list
65199129|NCT05712265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65199130|NCT05712265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65199131|NCT05712265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65199132|NCT05712265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199133|NCT05712265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65199134|NCT05712265|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65330179|NCT02593526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330180|NCT04339140|Zafirlukast|zafirlukast|mesh-list
65330181|NCT04339140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65330182|NCT04339140|Respiratory System Agents|respiratory system agents|mesh-ancestor
65330183|NCT04339140|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65330184|NCT04339140|Hormone Antagonists|hormone antagonists|mesh-ancestor
64716287|NCT03357614|Uricosuric Agents|uricosuric agents|mesh-ancestor
65199135|NCT05712265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65199136|NCT05712265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65199137|NCT05712265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199138|NCT05712265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65199139|NCT05712265|Serotonin Agents|serotonin agents|mesh-ancestor
65199140|NCT05712265|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65199141|NCT05712265|Antidepressive Agents|antidepressive agents|mesh-ancestor
65199142|NCT05712265|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65199143|NCT05712265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65199144|NCT05712265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199145|NCT05712265|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65199146|NCT05699252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65199147|NCT05699252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65199148|NCT05699252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199149|NCT05695261|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65199150|NCT05695261|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65199151|NCT05695261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65199152|NCT05695261|Antitubercular Agents|antitubercular agents|mesh-ancestor
65199175|NCT05659654|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65199176|NCT05659654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65199177|NCT05637060|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65199178|NCT05637060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65199179|NCT05637060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65199180|NCT05637060|Antimetabolites|antimetabolites|mesh-ancestor
65199181|NCT05637060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199182|NCT05637060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65199183|NCT05637060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65199184|NCT05637060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199185|NCT05635604|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
65199186|NCT05635604|Growth Substances|growth substances|mesh-ancestor
65199187|NCT05635604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199188|NCT05635604|Vasodilator Agents|vasodilator agents|mesh-ancestor
65199189|NCT05635604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65199190|NCT05635604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199192|NCT05620784|Diuretics|diuretics|mesh-list
65199193|NCT05620784|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
65199194|NCT05620784|Natriuretic Agents|natriuretic agents|mesh-ancestor
65199195|NCT05620784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199196|NCT05620784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65199199|NCT05617859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199200|NCT05617859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65199201|NCT05617859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199202|NCT05617859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199203|NCT05616494|Docetaxel|docetaxel|mesh-list
65199204|NCT05616494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199205|NCT05616494|Tubulin Modulators|tubulin modulators|mesh-ancestor
65199206|NCT05616494|Antimitotic Agents|antimitotic agents|mesh-ancestor
65199207|NCT05616494|Mitosis Modulators|mitosis modulators|mesh-ancestor
65199208|NCT05616494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199210|NCT05614609|Anesthetics, Local|anesthetics, local|mesh-ancestor
65199211|NCT05614609|Anesthetics|anesthetics|mesh-ancestor
65199212|NCT05614609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65199213|NCT05614609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199214|NCT05614609|Sensory System Agents|sensory system agents|mesh-ancestor
65199215|NCT05614609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65199216|NCT05614609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65330185|NCT04339140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65330186|NCT04339140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330187|NCT00784979|Immunoglobulins|immunoglobulins|mesh-list
65330188|NCT00784979|Immunologic Factors|immunologic factors|mesh-ancestor
65330189|NCT00784979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330190|NCT02595242|Prednisone|prednisone|mesh-list
65330191|NCT02595242|Cyclophosphamide|cyclophosphamide|mesh-list
65330192|NCT02595242|Vincristine|vincristine|mesh-list
65330193|NCT02595242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65330194|NCT02595242|Immunologic Factors|immunologic factors|mesh-ancestor
65330195|NCT02595242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330196|NCT02595242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65330197|NCT02595242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65199217|NCT05614609|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65199218|NCT05614609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65199219|NCT05614609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65199220|NCT05614609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199221|NCT05605093|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
65199222|NCT05605093|Protease Inhibitors|protease inhibitors|mesh-list
65199223|NCT05605093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199224|NCT05605093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199225|NCT05605093|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65199226|NCT05605093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65199227|NCT05605093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65199228|NCT05605093|Antiviral Agents|antiviral agents|mesh-ancestor
65199229|NCT05605093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65199230|NCT05598957|Vitamin D|vitamin d|mesh-list
65199231|NCT05598957|Vitamins|vitamins|mesh-ancestor
65199232|NCT05598957|Micronutrients|micronutrients|mesh-ancestor
65199233|NCT05598957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199234|NCT05598957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65199236|NCT05575063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65199237|NCT05575063|Immunologic Factors|immunologic factors|mesh-ancestor
65199238|NCT05575063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199239|NCT05575063|Viscosupplements|viscosupplements|mesh-ancestor
65199240|NCT05575063|Protective Agents|protective agents|mesh-ancestor
65199241|NCT05567068|Mesalamine|mesalamine|mesh-list
65199242|NCT05567068|Atorvastatin|atorvastatin|mesh-list
65199243|NCT05567068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65199244|NCT05567068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65199245|NCT05567068|Antimetabolites|antimetabolites|mesh-ancestor
65199246|NCT05567068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199247|NCT05567068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65199248|NCT05567068|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65199249|NCT05567068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199250|NCT05567068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65199251|NCT05567068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65199252|NCT05567068|Analgesics|analgesics|mesh-ancestor
65199253|NCT05567068|Sensory System Agents|sensory system agents|mesh-ancestor
65199254|NCT05567068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65199255|NCT05567068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199256|NCT05567068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65199257|NCT05567068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65199258|NCT05565001|Cromakalim|cromakalim|mesh-list
65199259|NCT05565001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65199260|NCT05565001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65199261|NCT05565001|Autonomic Agents|autonomic agents|mesh-ancestor
65199262|NCT05565001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65199263|NCT05565001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199264|NCT05565001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65199265|NCT05565001|Respiratory System Agents|respiratory system agents|mesh-ancestor
65330198|NCT02595242|Alkylating Agents|alkylating agents|mesh-ancestor
65330199|NCT02595242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330200|NCT02595242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330201|NCT02595242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65330202|NCT02595242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65330203|NCT02595242|Glucocorticoids|glucocorticoids|mesh-ancestor
65330204|NCT02595242|Hormones|hormones|mesh-ancestor
65330205|NCT02595242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65330206|NCT02595242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65199266|NCT05565001|Parasympatholytics|parasympatholytics|mesh-ancestor
65199267|NCT05565001|Vasodilator Agents|vasodilator agents|mesh-ancestor
65199268|NCT05561062|Atorvastatin|atorvastatin|mesh-list
65199269|NCT05561062|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65199270|NCT05561062|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65199274|NCT05561062|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65199276|NCT05550402|Bromides|bromides|mesh-list
65199277|NCT05550402|Albuterol|albuterol|mesh-list
65199278|NCT05550402|Ipratropium|ipratropium|mesh-list
64841891|NCT01653717|Antimetabolites|antimetabolites|mesh-ancestor
65199279|NCT05550402|Anticonvulsants|anticonvulsants|mesh-ancestor
65199280|NCT05550402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65199282|NCT05550402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65199283|NCT05550402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199284|NCT05550402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65199285|NCT05550402|Respiratory System Agents|respiratory system agents|mesh-ancestor
65199286|NCT05550402|Tocolytic Agents|tocolytic agents|mesh-ancestor
65199287|NCT05550402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65199288|NCT05550402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65199289|NCT05550402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65199290|NCT05550402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65199291|NCT05550402|Adrenergic Agents|adrenergic agents|mesh-ancestor
65199292|NCT05550402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65199293|NCT05550402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199294|NCT05550402|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65199295|NCT05550402|Cholinergic Agents|cholinergic agents|mesh-ancestor
65199296|NCT05518149|Aticaprant|aticaprant|mesh-list
65199297|NCT05518149|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65199298|NCT05518149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199299|NCT05518149|Sensory System Agents|sensory system agents|mesh-ancestor
65199300|NCT05518149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65199301|NCT05500508|Eflornithine|eflornithine|mesh-list
65199302|NCT05500508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199303|NCT05500508|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65199304|NCT05500508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65199305|NCT05500508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65199306|NCT05500508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65199307|NCT05500508|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
65199308|NCT05500508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199309|NCT05500508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199311|NCT05480384|Trastuzumab|trastuzumab|mesh-list
65199312|NCT05480384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65199313|NCT05480384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199314|NCT05480384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65199315|NCT05480384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199316|NCT05458102|Voriconazole|voriconazole|mesh-list
65199317|NCT05458102|Cobicistat|cobicistat|mesh-list
65199318|NCT05458102|Rifabutin|rifabutin|mesh-list
65199319|NCT05458102|Vesatolimod|vesatolimod|mesh-list
65199320|NCT05458102|Antifungal Agents|antifungal agents|mesh-ancestor
65199321|NCT05458102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65199322|NCT05458102|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65199323|NCT05458102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65199324|NCT05458102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199325|NCT05458102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199326|NCT05458102|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65330207|NCT02595242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65330208|NCT02595242|Tubulin Modulators|tubulin modulators|mesh-ancestor
65330209|NCT02595242|Antimitotic Agents|antimitotic agents|mesh-ancestor
65330210|NCT02595242|Mitosis Modulators|mitosis modulators|mesh-ancestor
65330211|NCT04487106|Azacitidine|azacitidine|mesh-list
65330212|NCT04487106|Venetoclax|venetoclax|mesh-list
65330213|NCT04487106|Trametinib|trametinib|mesh-list
65330214|NCT04487106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65330215|NCT04487106|Antimetabolites|antimetabolites|mesh-ancestor
65330216|NCT04487106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330217|NCT04487106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330218|NCT04487106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330219|NCT04487106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65330220|NCT00740883|Warfarin|warfarin|mesh-list
65330221|NCT00740883|Anticoagulants|anticoagulants|mesh-ancestor
65330222|NCT02568033|Paclitaxel|paclitaxel|mesh-list
65330223|NCT02568033|Docetaxel|docetaxel|mesh-list
65330224|NCT02568033|Carboplatin|carboplatin|mesh-list
65330225|NCT02568033|Pemetrexed|pemetrexed|mesh-list
65330226|NCT02568033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65330227|NCT02568033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330228|NCT02568033|Tubulin Modulators|tubulin modulators|mesh-ancestor
65330229|NCT02568033|Antimitotic Agents|antimitotic agents|mesh-ancestor
64716312|NCT00376376|Renal Agents|renal agents|mesh-ancestor
65199327|NCT05458102|Hormone Antagonists|hormone antagonists|mesh-ancestor
65199328|NCT05458102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65199329|NCT05458102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199330|NCT05458102|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65199331|NCT05458102|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65199332|NCT05458102|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65199333|NCT05458102|Antiviral Agents|antiviral agents|mesh-ancestor
65199334|NCT05458102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65199335|NCT05458102|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65199336|NCT05458102|Antitubercular Agents|antitubercular agents|mesh-ancestor
65199337|NCT05444946|Itraconazole|itraconazole|mesh-list
65199338|NCT05444946|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
65199339|NCT05444946|Prednisone|prednisone|mesh-list
65199340|NCT05444946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65199341|NCT05444946|Glucocorticoids|glucocorticoids|mesh-ancestor
65199342|NCT05444946|Hormones|hormones|mesh-ancestor
65199344|NCT05444946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199345|NCT05444946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65199346|NCT05444946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199347|NCT05444946|Antifungal Agents|antifungal agents|mesh-ancestor
65199348|NCT05444946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65199349|NCT05444946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65199350|NCT05444946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65199351|NCT05444946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199352|NCT05444946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199353|NCT05444946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65199354|NCT05444946|Hormone Antagonists|hormone antagonists|mesh-ancestor
65199355|NCT05444946|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65199356|NCT05409157|Bisacodyl|bisacodyl|mesh-list
65199357|NCT05409157|Cathartics|cathartics|mesh-ancestor
65330230|NCT02568033|Mitosis Modulators|mitosis modulators|mesh-ancestor
65330231|NCT02568033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330232|NCT02568033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330233|NCT02568033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65330234|NCT02568033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65330235|NCT00582972|Omeprazole|omeprazole|mesh-list
65330236|NCT00582972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65330237|NCT00582972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65199358|NCT05409157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65199359|NCT05409157|Laxatives|laxatives|mesh-ancestor
65199360|NCT05380856|Neurotransmitter Agents|neurotransmitter agents|mesh-list
65199361|NCT05380856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199362|NCT05380856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199363|NCT05377242|Curcumin|curcumin|mesh-list
65199364|NCT05377242|Resveratrol|resveratrol|mesh-list
65199365|NCT05377242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65199366|NCT05377242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65199367|NCT05377242|Analgesics|analgesics|mesh-ancestor
65199368|NCT05377242|Sensory System Agents|sensory system agents|mesh-ancestor
65199369|NCT05377242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65199370|NCT05377242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199371|NCT05377242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65199372|NCT05377242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65199373|NCT05377242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199374|NCT05377242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199375|NCT05377242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199376|NCT05377242|Antioxidants|antioxidants|mesh-ancestor
65199377|NCT05377242|Protective Agents|protective agents|mesh-ancestor
65199378|NCT05377242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65199379|NCT05362955|Fluorouracil|fluorouracil|mesh-list
65199380|NCT05362955|Antimetabolites|antimetabolites|mesh-ancestor
65199381|NCT05362955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199391|NCT05355311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199393|NCT05311033|Tranexamic Acid|tranexamic acid|mesh-list
65199394|NCT05311033|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65199395|NCT05311033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65199396|NCT05311033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199397|NCT05311033|Hemostatics|hemostatics|mesh-ancestor
65199398|NCT05311033|Coagulants|coagulants|mesh-ancestor
65199399|NCT05281562|Ascorbic Acid|ascorbic acid|mesh-list
65199400|NCT05281562|Vitamins|vitamins|mesh-ancestor
65199401|NCT05281562|Micronutrients|micronutrients|mesh-ancestor
65199402|NCT05281562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199403|NCT05281562|Antioxidants|antioxidants|mesh-ancestor
65199404|NCT05281562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199405|NCT05281562|Protective Agents|protective agents|mesh-ancestor
65199406|NCT05276596|Norepinephrine|norepinephrine|mesh-list
65199407|NCT05276596|Ephedrine|ephedrine|mesh-list
65199408|NCT05276596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65199409|NCT05276596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65199410|NCT05276596|Adrenergic Agents|adrenergic agents|mesh-ancestor
65199411|NCT05276596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65199412|NCT05276596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199413|NCT05276596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199414|NCT05276596|Sympathomimetics|sympathomimetics|mesh-ancestor
65199415|NCT05276596|Autonomic Agents|autonomic agents|mesh-ancestor
65199416|NCT05276596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65199417|NCT05276596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65199418|NCT05276596|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65199419|NCT05269706|Cannabidiol|cannabidiol|mesh-list
65199420|NCT05269706|Anticonvulsants|anticonvulsants|mesh-ancestor
65199427|NCT05241262|Acetylcysteine|acetylcysteine|mesh-list
65199428|NCT05241262|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65199429|NCT05241262|Antiviral Agents|antiviral agents|mesh-ancestor
65199430|NCT05241262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65199431|NCT05241262|Expectorants|expectorants|mesh-ancestor
65199434|NCT05241262|Antioxidants|antioxidants|mesh-ancestor
65199435|NCT05241262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330238|NCT00582972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65330239|NCT00582972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330240|NCT00582972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330241|NCT05224401|Amoxicillin|amoxicillin|mesh-list
65330242|NCT05224401|Ciprofloxacin|ciprofloxacin|mesh-list
65330243|NCT05224401|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65330244|NCT05224401|Clavulanic Acids|clavulanic acids|mesh-list
65330245|NCT05224401|Clavulanic Acid|clavulanic acid|mesh-list
65330246|NCT05224401|Ertapenem|ertapenem|mesh-list
65330247|NCT05224401|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
65330248|NCT05224401|Trimethoprim|trimethoprim|mesh-list
65330249|NCT05224401|Sulfamethoxazole|sulfamethoxazole|mesh-list
65330250|NCT05224401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65330251|NCT05224401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65330252|NCT05224401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65330253|NCT05224401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65199436|NCT05241262|Protective Agents|protective agents|mesh-ancestor
65199437|NCT05241262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199438|NCT05241262|Antidotes|antidotes|mesh-ancestor
65199440|NCT05188677|Immunologic Factors|immunologic factors|mesh-ancestor
65199441|NCT05188677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199445|NCT05178849|Anesthetics|anesthetics|mesh-list
65199446|NCT05178849|Anesthetics, Local|anesthetics, local|mesh-list
65199447|NCT05178849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65199448|NCT05178849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199449|NCT05178849|Sensory System Agents|sensory system agents|mesh-ancestor
65199450|NCT05178849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65199482|NCT05142696|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
65199483|NCT05142696|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65199484|NCT05142696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199485|NCT05142696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65199486|NCT05142696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65199487|NCT05142696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65199488|NCT05142696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199489|NCT05142696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199490|NCT05142696|Chelating Agents|chelating agents|mesh-ancestor
65199491|NCT05142696|Sequestering Agents|sequestering agents|mesh-ancestor
65199492|NCT05142696|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65199494|NCT05137067|Docetaxel|docetaxel|mesh-list
65199495|NCT05137067|Antineoplastic Agents|antineoplastic agents|mesh-list
65199496|NCT05137067|Tubulin Modulators|tubulin modulators|mesh-ancestor
65199497|NCT05137067|Antimitotic Agents|antimitotic agents|mesh-ancestor
65199498|NCT05137067|Mitosis Modulators|mitosis modulators|mesh-ancestor
65199499|NCT05137067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199500|NCT05126238|Lithium Carbonate|lithium carbonate|mesh-list
65199501|NCT05126238|Antidepressive Agents|antidepressive agents|mesh-ancestor
65199502|NCT05126238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65199503|NCT05126238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842114|NCT01655199|Albuterol|albuterol|mesh-list
65199504|NCT05126238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199505|NCT05126238|Antimanic Agents|antimanic agents|mesh-ancestor
65199506|NCT05126238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65199507|NCT05126238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65199508|NCT05126238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199509|NCT05108649|Nicotine|nicotine|mesh-list
65199510|NCT05108649|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65199511|NCT05108649|Autonomic Agents|autonomic agents|mesh-ancestor
65199512|NCT05108649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65199513|NCT05108649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330254|NCT05224401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330255|NCT05224401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330256|NCT05224401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330257|NCT05224401|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65330258|NCT05224401|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65330259|NCT05224401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65330260|NCT05224401|Renal Agents|renal agents|mesh-ancestor
65330261|NCT05224401|Antimalarials|antimalarials|mesh-ancestor
65330262|NCT05224401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64682679|NCT01919606|Bupivacaine|bupivacaine|mesh-list
65199514|NCT05108649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65199515|NCT05108649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65199516|NCT05108649|Cholinergic Agents|cholinergic agents|mesh-ancestor
65199517|NCT05108649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65199518|NCT05108649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199519|NCT05050916|Vitamin D|vitamin d|mesh-list
65199520|NCT05050916|Vitamins|vitamins|mesh-ancestor
65199521|NCT05050916|Micronutrients|micronutrients|mesh-ancestor
65199522|NCT05050916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199523|NCT05050916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65199524|NCT05027945|Mycophenolic Acid|mycophenolic acid|mesh-list
65199525|NCT05027945|Sirolimus|sirolimus|mesh-list
65199526|NCT05027945|Cyclophosphamide|cyclophosphamide|mesh-list
65199527|NCT05027945|Busulfan|busulfan|mesh-list
65199528|NCT05027945|Fludarabine|fludarabine|mesh-list
65199529|NCT05027945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65199530|NCT05027945|Immunologic Factors|immunologic factors|mesh-ancestor
65199531|NCT05027945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199532|NCT05027945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65199533|NCT05027945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65199534|NCT05027945|Alkylating Agents|alkylating agents|mesh-ancestor
65199538|NCT05027945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65199539|NCT05027945|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65199540|NCT05027945|Antitubercular Agents|antitubercular agents|mesh-ancestor
65199541|NCT05027945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65199542|NCT05027945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65199547|NCT05003713|Prednisone|prednisone|mesh-list
65199548|NCT05003713|Cortisone|cortisone|mesh-list
65199549|NCT05003713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65199550|NCT05003713|Glucocorticoids|glucocorticoids|mesh-ancestor
65199551|NCT05003713|Hormones|hormones|mesh-ancestor
65199552|NCT05003713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65199553|NCT05003713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199554|NCT05003713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65199555|NCT05003713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199556|NCT04990128|Triamcinolone|triamcinolone|mesh-list
65199557|NCT04990128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65199558|NCT04990128|Glucocorticoids|glucocorticoids|mesh-ancestor
65199559|NCT04990128|Hormones|hormones|mesh-ancestor
65199560|NCT04990128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65199561|NCT04990128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199566|NCT04907370|Gemcitabine|gemcitabine|mesh-list
65199567|NCT04907370|Cisplatin|cisplatin|mesh-list
65199568|NCT04907370|Antibodies|antibodies|mesh-list
65199569|NCT04907370|Antibodies, Blocking|antibodies, blocking|mesh-list
65199570|NCT04907370|Immunologic Factors|immunologic factors|mesh-ancestor
65199571|NCT04907370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199572|NCT04907370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199573|NCT04907370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65199574|NCT04907370|Antimetabolites|antimetabolites|mesh-ancestor
65199575|NCT04907370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199576|NCT04907370|Antiviral Agents|antiviral agents|mesh-ancestor
65199577|NCT04907370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65199578|NCT04907370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842196|NCT01655641|Hemostatics|hemostatics|mesh-ancestor
65199579|NCT04907370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65199580|NCT04903054|Mycophenolic Acid|mycophenolic acid|mesh-list
65330263|NCT05224401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65330264|NCT05224401|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65330265|NCT05224401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65330266|NCT05224401|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65330267|NCT05224401|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65330268|NCT00918086|Vitamin D|vitamin d|mesh-list
65330269|NCT00918086|Vitamins|vitamins|mesh-ancestor
65330270|NCT00918086|Micronutrients|micronutrients|mesh-ancestor
65330271|NCT00918086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330272|NCT00918086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65330273|NCT02567487|Levobupivacaine|levobupivacaine|mesh-list
65330274|NCT02567487|Anesthetics, Local|anesthetics, local|mesh-ancestor
64716352|NCT02177838|Cetuximab|cetuximab|mesh-list
65199581|NCT04903054|Prednisone|prednisone|mesh-list
65199582|NCT04903054|Methylprednisolone|methylprednisolone|mesh-list
65199584|NCT04903054|Thymoglobulin|thymoglobulin|mesh-list
65199585|NCT04903054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65199586|NCT04903054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65199587|NCT04903054|Glucocorticoids|glucocorticoids|mesh-ancestor
65199588|NCT04903054|Hormones|hormones|mesh-ancestor
65199589|NCT04903054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65199590|NCT04903054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199591|NCT04903054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65199592|NCT04903054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199593|NCT04903054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65199594|NCT04903054|Immunologic Factors|immunologic factors|mesh-ancestor
65199595|NCT04903054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65199596|NCT04903054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199597|NCT04903054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199598|NCT04903054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65199599|NCT04903054|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65199600|NCT04903054|Antitubercular Agents|antitubercular agents|mesh-ancestor
65199601|NCT04903054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65199602|NCT04903054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65199603|NCT04903054|Antiemetics|antiemetics|mesh-ancestor
65199604|NCT04903054|Autonomic Agents|autonomic agents|mesh-ancestor
65199605|NCT04903054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65199606|NCT04903054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65199607|NCT04903054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65199608|NCT04903054|Protective Agents|protective agents|mesh-ancestor
65199609|NCT04901702|Irinotecan|irinotecan|mesh-list
65199610|NCT04901702|Temozolomide|temozolomide|mesh-list
65199611|NCT04901702|Talazoparib|talazoparib|mesh-list
65199614|NCT04901702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199615|NCT04901702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199616|NCT04901702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199617|NCT04901702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65199618|NCT04901702|Alkylating Agents|alkylating agents|mesh-ancestor
65199619|NCT04901702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65199620|NCT04897321|Cyclophosphamide|cyclophosphamide|mesh-list
65199621|NCT04897321|Fludarabine|fludarabine|mesh-list
65199622|NCT04897321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65199623|NCT04897321|Immunologic Factors|immunologic factors|mesh-ancestor
65199624|NCT04897321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199625|NCT04897321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65199626|NCT04897321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65199627|NCT04897321|Alkylating Agents|alkylating agents|mesh-ancestor
65199628|NCT04897321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199629|NCT04897321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199630|NCT04897321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65199632|NCT04879225|Antipruritics|antipruritics|mesh-ancestor
65199633|NCT04879225|Dermatologic Agents|dermatologic agents|mesh-ancestor
65199634|NCT04838613|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65199635|NCT04838613|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65330275|NCT02567487|Anesthetics|anesthetics|mesh-ancestor
65330276|NCT02567487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65330277|NCT02567487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330278|NCT02567487|Sensory System Agents|sensory system agents|mesh-ancestor
65330279|NCT02567487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65330280|NCT04317066|Pembrolizumab|pembrolizumab|mesh-list
65330281|NCT04317066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65330282|NCT04317066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330283|NCT04366908|Calcifediol|calcifediol|mesh-list
65330284|NCT04366908|Vitamins|vitamins|mesh-ancestor
65330285|NCT04366908|Micronutrients|micronutrients|mesh-ancestor
65330286|NCT04366908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330287|NCT04366908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65330288|NCT00711243|Docetaxel|docetaxel|mesh-list
65330289|NCT00711243|Fluorouracil|fluorouracil|mesh-list
65330290|NCT00711243|Oxaliplatin|oxaliplatin|mesh-list
65330291|NCT00711243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330292|NCT00711243|Tubulin Modulators|tubulin modulators|mesh-ancestor
65199636|NCT04838613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199637|NCT04834557|Digoxin|digoxin|mesh-list
65199638|NCT04834557|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65199639|NCT04834557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65199640|NCT04834557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65199641|NCT04834557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199642|NCT04834557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199643|NCT04834557|Protective Agents|protective agents|mesh-ancestor
65199644|NCT04834557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199645|NCT04834557|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65199646|NCT04834557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65199647|NCT04825093|Vitamin D|vitamin d|mesh-list
65199648|NCT04825093|Vitamins|vitamins|mesh-ancestor
65199649|NCT04825093|Micronutrients|micronutrients|mesh-ancestor
65199650|NCT04825093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199651|NCT04825093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65199652|NCT04793152|Vancomycin|vancomycin|mesh-list
65199653|NCT04793152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65199654|NCT04793152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65199655|NCT04770493|Lamotrigine|lamotrigine|mesh-list
65199656|NCT04770493|Anticonvulsants|anticonvulsants|mesh-ancestor
64842259|NCT01655862|Cholinergic Agents|cholinergic agents|mesh-ancestor
65199657|NCT04770493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65199658|NCT04770493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65199659|NCT04770493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199660|NCT04770493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65199661|NCT04770493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199662|NCT04770493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65199663|NCT04770493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65199664|NCT04770493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65199665|NCT04770493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65199666|NCT04770493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65199667|NCT04765059|Cisplatin|cisplatin|mesh-list
65199668|NCT04765059|Carboplatin|carboplatin|mesh-list
65199669|NCT04765059|Pemetrexed|pemetrexed|mesh-list
65199670|NCT04765059|Osimertinib|osimertinib|mesh-list
65199671|NCT04765059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199672|NCT04765059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199673|NCT04765059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199674|NCT04765059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65330293|NCT00711243|Antimitotic Agents|antimitotic agents|mesh-ancestor
65330294|NCT00711243|Mitosis Modulators|mitosis modulators|mesh-ancestor
65330295|NCT00711243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330296|NCT00711243|Antimetabolites|antimetabolites|mesh-ancestor
65330297|NCT00711243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65330298|NCT00711243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64682886|NCT01925144|Omeprazole|omeprazole|mesh-list
65199675|NCT04765059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65199676|NCT04765059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65199677|NCT04741464|Tinzaparin|tinzaparin|mesh-list
65199678|NCT04741464|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65199679|NCT04741464|Dalteparin|dalteparin|mesh-list
65199680|NCT04741464|Anticoagulants|anticoagulants|mesh-ancestor
65199681|NCT04741464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65199682|NCT04741464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65199683|NCT04741464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199712|NCT04663555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65199713|NCT04663555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65199714|NCT04663555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199716|NCT04637763|Fludarabine|fludarabine|mesh-list
65199717|NCT04637763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65199718|NCT04637763|Immunologic Factors|immunologic factors|mesh-ancestor
65199719|NCT04637763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199720|NCT04637763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65199721|NCT04637763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65199722|NCT04637763|Alkylating Agents|alkylating agents|mesh-ancestor
65199723|NCT04637763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199724|NCT04637763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199725|NCT04637763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65199731|NCT04565288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65199732|NCT04565288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199733|NCT04565288|Adrenergic Agents|adrenergic agents|mesh-ancestor
65199734|NCT04565288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65199735|NCT04565288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199736|NCT04501861|Vasopressins|vasopressins|mesh-list
65199737|NCT04501861|Arginine Vasopressin|arginine vasopressin|mesh-list
65199738|NCT04501861|Norepinephrine|norepinephrine|mesh-list
65199739|NCT04501861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65199740|NCT04501861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65199741|NCT04501861|Adrenergic Agents|adrenergic agents|mesh-ancestor
65199742|NCT04501861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65199743|NCT04501861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199744|NCT04501861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199745|NCT04501861|Sympathomimetics|sympathomimetics|mesh-ancestor
65199746|NCT04501861|Autonomic Agents|autonomic agents|mesh-ancestor
65199747|NCT04501861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65199748|NCT04501861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65199749|NCT04501861|Hemostatics|hemostatics|mesh-ancestor
65199750|NCT04501861|Coagulants|coagulants|mesh-ancestor
65199751|NCT04501861|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65199752|NCT04501861|Natriuretic Agents|natriuretic agents|mesh-ancestor
65199753|NCT04496024|Ofloxacin|ofloxacin|mesh-list
65199754|NCT04496024|Levofloxacin|levofloxacin|mesh-list
65199755|NCT04496024|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65199756|NCT04496024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65199757|NCT04496024|Renal Agents|renal agents|mesh-ancestor
65199758|NCT04496024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65199759|NCT04496024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65199760|NCT04496024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65199762|NCT04496024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199763|NCT04496024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199764|NCT04496024|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65199765|NCT04496024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65199766|NCT04425473|Esketamine|esketamine|mesh-list
65199767|NCT04425473|Antidepressive Agents|antidepressive agents|mesh-ancestor
65199768|NCT04425473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65199769|NCT04387071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65330299|NCT00711243|Immunologic Factors|immunologic factors|mesh-ancestor
65330300|NCT00711243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330301|NCT04366518|Scopolamine|scopolamine|mesh-list
65330302|NCT04366518|Rivastigmine|rivastigmine|mesh-list
65330303|NCT04366518|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65199770|NCT04387071|Antibodies|antibodies|mesh-list
65199771|NCT04387071|Immunoglobulins|immunoglobulins|mesh-list
65199772|NCT04387071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65199773|NCT04387071|Immunologic Factors|immunologic factors|mesh-ancestor
65199774|NCT04387071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199775|NCT04387071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199776|NCT04350502|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65199777|NCT04350502|Amoxicillin|amoxicillin|mesh-list
65199778|NCT04350502|Clavulanic Acids|clavulanic acids|mesh-list
65199779|NCT04350502|Clavulanic Acid|clavulanic acid|mesh-list
65199780|NCT04350502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65199781|NCT04350502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65199782|NCT04350502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199783|NCT04350502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199784|NCT04350502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65199785|NCT04300920|Acetylcysteine|acetylcysteine|mesh-list
65199786|NCT04300920|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65199787|NCT04300920|Antiviral Agents|antiviral agents|mesh-ancestor
65199788|NCT04300920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65199789|NCT04300920|Expectorants|expectorants|mesh-ancestor
65199790|NCT04300920|Respiratory System Agents|respiratory system agents|mesh-ancestor
65199791|NCT04300920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65199792|NCT04300920|Antioxidants|antioxidants|mesh-ancestor
65199793|NCT04300920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199794|NCT04300920|Protective Agents|protective agents|mesh-ancestor
65199795|NCT04300920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199796|NCT04300920|Antidotes|antidotes|mesh-ancestor
65199797|NCT04252768|Paclitaxel|paclitaxel|mesh-list
65199803|NCT04252768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199805|NCT04222010|Ropivacaine|ropivacaine|mesh-list
65199806|NCT04222010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65199807|NCT04222010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199808|NCT04222010|Anesthetics, Local|anesthetics, local|mesh-ancestor
65199809|NCT04222010|Sensory System Agents|sensory system agents|mesh-ancestor
65199810|NCT04222010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65199811|NCT04200651|Dexamethasone|dexamethasone|mesh-list
65199812|NCT04200651|Prednisolone|prednisolone|mesh-list
65199813|NCT04200651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65199814|NCT04200651|Methylprednisolone|methylprednisolone|mesh-list
65199815|NCT04200651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65199816|NCT04200651|Prednisolone acetate|prednisolone acetate|mesh-list
65199817|NCT04200651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65199818|NCT04200651|Prednisolone phosphate|prednisolone phosphate|mesh-list
65199819|NCT04200651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65199820|NCT04200651|Antiemetics|antiemetics|mesh-ancestor
65199821|NCT04200651|Autonomic Agents|autonomic agents|mesh-ancestor
65199822|NCT04200651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65199823|NCT04200651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199824|NCT04200651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65199825|NCT04200651|Glucocorticoids|glucocorticoids|mesh-ancestor
65199826|NCT04200651|Hormones|hormones|mesh-ancestor
65199827|NCT04200651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65199828|NCT04200651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65199829|NCT04200651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199830|NCT04200651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65199831|NCT04200651|Protective Agents|protective agents|mesh-ancestor
65199832|NCT04150900|Pembrolizumab|pembrolizumab|mesh-list
65199833|NCT04150900|Bavituximab|bavituximab|mesh-list
65199834|NCT04150900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65199835|NCT04150900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199836|NCT04129515|Pembrolizumab|pembrolizumab|mesh-list
65199837|NCT04129515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65199838|NCT04129515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199839|NCT04098081|Gemcitabine|gemcitabine|mesh-list
65199840|NCT04098081|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
65199841|NCT04098081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65330304|NCT04366518|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65199842|NCT04098081|Antimetabolites|antimetabolites|mesh-ancestor
65199843|NCT04098081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199844|NCT04098081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199845|NCT04098081|Antiviral Agents|antiviral agents|mesh-ancestor
65199846|NCT04098081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65199847|NCT04098081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199848|NCT04098081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65199849|NCT04098081|Immunologic Factors|immunologic factors|mesh-ancestor
65199850|NCT04098081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199852|NCT04084171|Pancrelipase|pancrelipase|mesh-list
65199853|NCT04084171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65199854|NCT04084171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199855|NCT04084171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65199856|NCT04055428|Valsartan|valsartan|mesh-list
65199857|NCT04055428|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65199858|NCT04055428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65199859|NCT04055428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65199860|NCT04055428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65199861|NCT04055428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199862|NCT04047706|Nivolumab|nivolumab|mesh-list
65199863|NCT04047706|Temozolomide|temozolomide|mesh-list
65199864|NCT04047706|Linrodostat|linrodostat|mesh-list
65199865|NCT04047706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65199866|NCT04047706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199871|NCT04047706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199872|NCT04034251|Paclitaxel|paclitaxel|mesh-list
65199873|NCT04034251|Capecitabine|capecitabine|mesh-list
65199874|NCT04034251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65199875|NCT04034251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199876|NCT04034251|Tubulin Modulators|tubulin modulators|mesh-ancestor
65199877|NCT04034251|Antimitotic Agents|antimitotic agents|mesh-ancestor
65199878|NCT04034251|Mitosis Modulators|mitosis modulators|mesh-ancestor
65199879|NCT04034251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199880|NCT04034251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65199881|NCT04034251|Antimetabolites|antimetabolites|mesh-ancestor
65199882|NCT03997123|Paclitaxel|paclitaxel|mesh-list
65199883|NCT03997123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65199884|NCT03997123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199885|NCT03997123|Tubulin Modulators|tubulin modulators|mesh-ancestor
65199886|NCT03997123|Antimitotic Agents|antimitotic agents|mesh-ancestor
65199887|NCT03997123|Mitosis Modulators|mitosis modulators|mesh-ancestor
65199888|NCT03997123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199889|NCT03983824|Cytarabine|cytarabine|mesh-list
65199890|NCT03983824|Etoposide|etoposide|mesh-list
65199891|NCT03983824|Mitoxantrone|mitoxantrone|mesh-list
65199892|NCT03983824|Etoposide phosphate|etoposide phosphate|mesh-list
65199893|NCT03983824|Peposertib|peposertib|mesh-list
65199894|NCT03983824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65199895|NCT03983824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199896|NCT03983824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65199897|NCT03983824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65199898|NCT03983824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199899|NCT03983824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199900|NCT03983824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65199901|NCT03983824|Antimetabolites|antimetabolites|mesh-ancestor
65199902|NCT03983824|Antiviral Agents|antiviral agents|mesh-ancestor
65199903|NCT03983824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65199904|NCT03983824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65199905|NCT03983824|Immunologic Factors|immunologic factors|mesh-ancestor
65199906|NCT03983824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199907|NCT03983824|Analgesics|analgesics|mesh-ancestor
65199908|NCT03983824|Sensory System Agents|sensory system agents|mesh-ancestor
65199909|NCT03983824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65199910|NCT03983824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65199911|NCT03967249|Octreotide|octreotide|mesh-list
65199912|NCT03967249|Lanreotide|lanreotide|mesh-list
65199913|NCT03967249|Somatostatin|somatostatin|mesh-list
65199914|NCT03967249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65199915|NCT03967249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65199916|NCT03967249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199917|NCT03967249|Hormones|hormones|mesh-ancestor
65199918|NCT03967249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65199919|NCT03967249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330305|NCT04366518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330306|NCT04366518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330307|NCT04366518|Cholinergic Agents|cholinergic agents|mesh-ancestor
65330308|NCT04366518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64716388|NCT03581084|Protective Agents|protective agents|mesh-ancestor
65199920|NCT03935139|Glycerol|glycerol|mesh-list
65199921|NCT03935139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65199922|NCT03935139|Protective Agents|protective agents|mesh-ancestor
65199923|NCT03935139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199924|NCT03927079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65199925|NCT03927079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65199926|NCT03927079|Dimercaprol|dimercaprol|mesh-list
65199927|NCT03927079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65199928|NCT03927079|Antitubercular Agents|antitubercular agents|mesh-ancestor
65199929|NCT03927079|Chelating Agents|chelating agents|mesh-ancestor
65199930|NCT03927079|Sequestering Agents|sequestering agents|mesh-ancestor
65199931|NCT03927079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199932|NCT03926403|Anesthetics|anesthetics|mesh-list
65199933|NCT03926403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65199934|NCT03926403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199935|NCT03884101|Paclitaxel|paclitaxel|mesh-list
65199936|NCT03884101|Carboplatin|carboplatin|mesh-list
65199937|NCT03884101|Pembrolizumab|pembrolizumab|mesh-list
65199938|NCT03884101|Lenvatinib|lenvatinib|mesh-list
65199941|NCT03884101|Tubulin Modulators|tubulin modulators|mesh-ancestor
65199942|NCT03884101|Antimitotic Agents|antimitotic agents|mesh-ancestor
65199943|NCT03884101|Mitosis Modulators|mitosis modulators|mesh-ancestor
65199944|NCT03884101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199945|NCT03884101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65199946|NCT03884101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65199947|NCT03884101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199948|NCT03871621|Metformin|metformin|mesh-list
65199949|NCT03871621|Dapagliflozin|dapagliflozin|mesh-list
65199950|NCT03871621|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
65199951|NCT03871621|Meglitinide|meglitinide|mesh-list
65199952|NCT03871621|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65199953|NCT03871621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199954|NCT03871621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65199955|NCT03871621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199956|NCT03867188|Bupivacaine|bupivacaine|mesh-list
65199957|NCT03867188|Anesthetics, Local|anesthetics, local|mesh-ancestor
65199958|NCT03867188|Anesthetics|anesthetics|mesh-ancestor
65199959|NCT03867188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65199960|NCT03867188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199961|NCT03867188|Sensory System Agents|sensory system agents|mesh-ancestor
65199962|NCT03867188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65199963|NCT03796884|Linaclotide|linaclotide|mesh-list
65199964|NCT03796884|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65199965|NCT03796884|Enzyme Activators|enzyme activators|mesh-ancestor
65199966|NCT03796884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199967|NCT03796884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65199968|NCT03753074|Tenofovir|tenofovir|mesh-list
65199969|NCT03753074|Antiviral Agents|antiviral agents|mesh-ancestor
65199970|NCT03753074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65199971|NCT03753074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65199972|NCT03753074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65199973|NCT03753074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199974|NCT03753074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199975|NCT03753074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65199976|NCT03753074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65199977|NCT03745040|Bupivacaine|bupivacaine|mesh-list
65199978|NCT03745040|Anesthetics, Local|anesthetics, local|mesh-ancestor
65199979|NCT03745040|Anesthetics|anesthetics|mesh-ancestor
65199980|NCT03745040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65199981|NCT03745040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199982|NCT03745040|Sensory System Agents|sensory system agents|mesh-ancestor
65199983|NCT03745040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65199984|NCT03740737|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65199985|NCT03740737|Hormones|hormones|mesh-ancestor
65330309|NCT04366518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330310|NCT04366518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65330311|NCT04366518|Protective Agents|protective agents|mesh-ancestor
65330312|NCT04366518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65330313|NCT04366518|Antiemetics|antiemetics|mesh-ancestor
65330314|NCT04366518|Autonomic Agents|autonomic agents|mesh-ancestor
65330315|NCT04366518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65330316|NCT04366518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65330317|NCT04366518|Mydriatics|mydriatics|mesh-ancestor
65199986|NCT03740737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65199987|NCT03740737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199988|NCT03686345|Midostaurin|midostaurin|mesh-list
65199989|NCT03686345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199990|NCT03686345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65199991|NCT03686345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199992|NCT03686345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199993|NCT03671967|Meropenem|meropenem|mesh-list
65199994|NCT03671967|Tazobactam|tazobactam|mesh-list
65199995|NCT03671967|Piperacillin|piperacillin|mesh-list
65199996|NCT03671967|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65199997|NCT03671967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65199998|NCT03671967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65199999|NCT03671967|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65200000|NCT03671967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200001|NCT03671967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200002|NCT03657810|Acetaminophen|acetaminophen|mesh-list
65200003|NCT03657810|Promethazine|promethazine|mesh-list
65200004|NCT03657810|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65200005|NCT03657810|Hydrocodone|hydrocodone|mesh-list
65200006|NCT03657810|Oxycodone|oxycodone|mesh-list
65200007|NCT03657810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65200008|NCT03657810|Analgesics|analgesics|mesh-ancestor
65200009|NCT03657810|Sensory System Agents|sensory system agents|mesh-ancestor
65200010|NCT03657810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65200013|NCT03657810|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65200015|NCT03657810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65200016|NCT03657810|Antitussive Agents|antitussive agents|mesh-ancestor
65200017|NCT03657810|Respiratory System Agents|respiratory system agents|mesh-ancestor
65200018|NCT03657810|Antipruritics|antipruritics|mesh-ancestor
65200019|NCT03657810|Dermatologic Agents|dermatologic agents|mesh-ancestor
65200020|NCT03657810|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65200021|NCT03657810|Histamine Antagonists|histamine antagonists|mesh-ancestor
65200022|NCT03657810|Histamine Agents|histamine agents|mesh-ancestor
65200023|NCT03657810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65200024|NCT03657810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200025|NCT03657810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65200026|NCT03657810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65200027|NCT03657810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65200028|NCT03657810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65200029|NCT03640026|Tacrolimus|tacrolimus|mesh-list
65200030|NCT03640026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65200031|NCT03640026|Immunologic Factors|immunologic factors|mesh-ancestor
65200032|NCT03640026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200033|NCT03640026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65200034|NCT03640026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200035|NCT03640026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200036|NCT03638297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
65200037|NCT03638297|Antibodies|antibodies|mesh-list
65200038|NCT03638297|Immunologic Factors|immunologic factors|mesh-ancestor
65200039|NCT03638297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200040|NCT03638297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200041|NCT03638297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200042|NCT03638297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65200043|NCT03638297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65200044|NCT03638297|Analgesics|analgesics|mesh-ancestor
65200045|NCT03638297|Sensory System Agents|sensory system agents|mesh-ancestor
65330318|NCT04366518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65330319|NCT04366518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65330320|NCT04366518|Parasympatholytics|parasympatholytics|mesh-ancestor
65330321|NCT00733226|Broncho-Vaxom|broncho-vaxom|mesh-list
65330322|NCT00733226|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65330323|NCT00733226|Immunologic Factors|immunologic factors|mesh-ancestor
65200046|NCT03638297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65200047|NCT03638297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65200048|NCT03638297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65200049|NCT03544736|Paclitaxel|paclitaxel|mesh-list
65200050|NCT03544736|Carboplatin|carboplatin|mesh-list
65200051|NCT03544736|Nivolumab|nivolumab|mesh-list
65200052|NCT03544736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65200053|NCT03544736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200054|NCT03544736|Tubulin Modulators|tubulin modulators|mesh-ancestor
65200055|NCT03544736|Antimitotic Agents|antimitotic agents|mesh-ancestor
65200056|NCT03544736|Mitosis Modulators|mitosis modulators|mesh-ancestor
65200057|NCT03544736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200058|NCT03544736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65200059|NCT03544736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65200060|NCT03533010|Vitamin D|vitamin d|mesh-list
65200061|NCT03533010|Vitamins|vitamins|mesh-ancestor
65200062|NCT03533010|Micronutrients|micronutrients|mesh-ancestor
65200063|NCT03533010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200064|NCT03533010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65200065|NCT03409198|Cyclophosphamide|cyclophosphamide|mesh-list
65200066|NCT03409198|Doxorubicin|doxorubicin|mesh-list
65200067|NCT03409198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65200068|NCT03409198|Nivolumab|nivolumab|mesh-list
65200069|NCT03409198|Ipilimumab|ipilimumab|mesh-list
65200070|NCT03409198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65200071|NCT03409198|Immunologic Factors|immunologic factors|mesh-ancestor
65200072|NCT03409198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200073|NCT03409198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65200074|NCT03409198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65200075|NCT03409198|Alkylating Agents|alkylating agents|mesh-ancestor
65200076|NCT03409198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200077|NCT03409198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200078|NCT03409198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65200079|NCT03409198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65200080|NCT03409198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65200081|NCT03409198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65200082|NCT03409198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200083|NCT03409198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65200086|NCT03382548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65200087|NCT03382548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65200088|NCT03382548|Antitubercular Agents|antitubercular agents|mesh-ancestor
65200089|NCT03326245|Methylphenidate|methylphenidate|mesh-list
65200090|NCT03326245|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65200091|NCT03326245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200092|NCT03326245|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65200093|NCT03326245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65200094|NCT03326245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65200095|NCT03326245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200096|NCT03326245|Dopamine Agents|dopamine agents|mesh-ancestor
65200097|NCT03326245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65200098|NCT03321656|Tacrolimus|tacrolimus|mesh-list
65200099|NCT03321656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65200100|NCT03321656|Immunologic Factors|immunologic factors|mesh-ancestor
65200101|NCT03321656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200102|NCT03321656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65200103|NCT03321656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200104|NCT03321656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200105|NCT03289962|Atezolizumab|atezolizumab|mesh-list
65200106|NCT03289962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200108|NCT03280563|Bevacizumab|bevacizumab|mesh-list
65200109|NCT03280563|Atezolizumab|atezolizumab|mesh-list
65200110|NCT03280563|Fulvestrant|fulvestrant|mesh-list
65200111|NCT03280563|Exemestane|exemestane|mesh-list
65200112|NCT03280563|Entinostat|entinostat|mesh-list
65200113|NCT03280563|Antibodies|antibodies|mesh-list
65330324|NCT00733226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330325|NCT04076436|Fosfomycin|fosfomycin|mesh-list
65330326|NCT04076436|Lactams|lactams|mesh-list
65330327|NCT04076436|beta-Lactams|beta-lactams|mesh-list
65330328|NCT04076436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65330329|NCT04076436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65330330|NCT05526417|Coal Tar|coal tar|mesh-list
65330331|NCT05526417|Keratolytic Agents|keratolytic agents|mesh-ancestor
65330332|NCT05526417|Dermatologic Agents|dermatologic agents|mesh-ancestor
65330333|NCT04096170|Lidocaine|lidocaine|mesh-list
65330334|NCT04096170|Anesthetics, Local|anesthetics, local|mesh-ancestor
65200114|NCT03280563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65200115|NCT03280563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200116|NCT03280563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65200117|NCT03280563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65200118|NCT03280563|Growth Substances|growth substances|mesh-ancestor
65200119|NCT03280563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200120|NCT03280563|Growth Inhibitors|growth inhibitors|mesh-ancestor
65200121|NCT03280563|Immunologic Factors|immunologic factors|mesh-ancestor
65200122|NCT03280563|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65200123|NCT03280563|Hormone Antagonists|hormone antagonists|mesh-ancestor
65200124|NCT03280563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65200125|NCT03280563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65200126|NCT03280563|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65200127|NCT03280563|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65200128|NCT03280563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65200129|NCT03280563|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65200130|NCT03280563|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65200131|NCT03280563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65200132|NCT03280563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200133|NCT03280563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200134|NCT03280563|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65200135|NCT03277638|Pembrolizumab|pembrolizumab|mesh-list
65200136|NCT03277638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65200137|NCT03277638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200138|NCT03236987|Azithromycin|azithromycin|mesh-list
65200139|NCT03236987|Clarithromycin|clarithromycin|mesh-list
65200140|NCT03236987|Rifampin|rifampin|mesh-list
65200141|NCT03236987|Ethambutol|ethambutol|mesh-list
65200142|NCT03236987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65200143|NCT03236987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65200144|NCT03236987|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65200145|NCT03236987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200146|NCT03236987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200147|NCT03236987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65200148|NCT03236987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65200149|NCT03236987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65200150|NCT03236987|Antitubercular Agents|antitubercular agents|mesh-ancestor
65200151|NCT03236987|Leprostatic Agents|leprostatic agents|mesh-ancestor
65200152|NCT03236987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65200153|NCT03236987|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65200154|NCT03236987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65200155|NCT03236987|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65200157|NCT03236987|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65200158|NCT03236987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65200159|NCT03094637|Pembrolizumab|pembrolizumab|mesh-list
65200160|NCT03094637|Azacitidine|azacitidine|mesh-list
65200161|NCT03094637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65200162|NCT03094637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200163|NCT03094637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65200164|NCT03094637|Antimetabolites|antimetabolites|mesh-ancestor
65200165|NCT03094637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200166|NCT03094637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200167|NCT03055507|Acetaminophen|acetaminophen|mesh-list
65330335|NCT04096170|Anesthetics|anesthetics|mesh-ancestor
65330336|NCT04096170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65330337|NCT04096170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330338|NCT04096170|Sensory System Agents|sensory system agents|mesh-ancestor
64683467|NCT01704781|Lenalidomide|lenalidomide|mesh-list
65200168|NCT03055507|Ibuprofen|ibuprofen|mesh-list
65200169|NCT03055507|Oxycodone|oxycodone|mesh-list
65200170|NCT03055507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65200171|NCT03055507|Analgesics|analgesics|mesh-ancestor
65200172|NCT03055507|Sensory System Agents|sensory system agents|mesh-ancestor
65200173|NCT03055507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65200174|NCT03055507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200175|NCT03055507|Antipyretics|antipyretics|mesh-ancestor
65200176|NCT03055507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65200177|NCT03055507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65200178|NCT03055507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65200179|NCT03055507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65200180|NCT03055507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200181|NCT03055507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200182|NCT03055507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65200183|NCT03055507|Narcotics|narcotics|mesh-ancestor
65200184|NCT03055507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65200185|NCT03038256|Capecitabine|capecitabine|mesh-list
65200186|NCT03038256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65200187|NCT03038256|Antimetabolites|antimetabolites|mesh-ancestor
65200188|NCT03038256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200189|NCT03038256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200190|NCT03009981|Prednisone|prednisone|mesh-list
65200191|NCT03009981|Leuprolide|leuprolide|mesh-list
65200192|NCT03009981|Abiraterone Acetate|abiraterone acetate|mesh-list
65200193|NCT03009981|Bicalutamide|bicalutamide|mesh-list
65200194|NCT03009981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65200195|NCT03009981|Glucocorticoids|glucocorticoids|mesh-ancestor
65200196|NCT03009981|Hormones|hormones|mesh-ancestor
65200197|NCT03009981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65200198|NCT03009981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200199|NCT03009981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65200200|NCT03009981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200201|NCT03009981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65200202|NCT03009981|Fertility Agents|fertility agents|mesh-ancestor
65200203|NCT03009981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65200204|NCT03009981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65200205|NCT03009981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200206|NCT03009981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200207|NCT03009981|Hormone Antagonists|hormone antagonists|mesh-ancestor
65200208|NCT03009981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65200210|NCT02927301|Atezolizumab|atezolizumab|mesh-list
65200211|NCT02927301|Antibodies|antibodies|mesh-list
65200212|NCT02927301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65200213|NCT02927301|Immunologic Factors|immunologic factors|mesh-ancestor
65200214|NCT02927301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200215|NCT02927301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200216|NCT02870738|Triamcinolone|triamcinolone|mesh-list
65200217|NCT02870738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65200218|NCT02870738|Glucocorticoids|glucocorticoids|mesh-ancestor
65200219|NCT02870738|Hormones|hormones|mesh-ancestor
65200220|NCT02870738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65200221|NCT02870738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200222|NCT02841995|Belumosudil|belumosudil|mesh-list
65200223|NCT02841995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65200224|NCT02841995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200225|NCT02841995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200226|NCT02789982|Propranolol|propranolol|mesh-list
65200227|NCT02789982|Adrenergic Agents|adrenergic agents|mesh-list
65200228|NCT02789982|Adrenergic Antagonists|adrenergic antagonists|mesh-list
65200229|NCT02789982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65200230|NCT02789982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65200234|NCT02789982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65200235|NCT02789982|Vasodilator Agents|vasodilator agents|mesh-ancestor
65200236|NCT02684058|Carboplatin|carboplatin|mesh-list
65200237|NCT02684058|Vincristine|vincristine|mesh-list
65200239|NCT02684058|Dabrafenib|dabrafenib|mesh-list
65330339|NCT04096170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65330340|NCT04096170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64716417|NCT03383588|Mydriatics|mydriatics|mesh-ancestor
65200240|NCT02684058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200241|NCT02684058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65200242|NCT02684058|Tubulin Modulators|tubulin modulators|mesh-ancestor
65200243|NCT02684058|Antimitotic Agents|antimitotic agents|mesh-ancestor
65200244|NCT02684058|Mitosis Modulators|mitosis modulators|mesh-ancestor
65200245|NCT02684058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200246|NCT02684058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65200247|NCT02684058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200248|NCT02667886|Axitinib|axitinib|mesh-list
65200249|NCT02667886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200250|NCT02667886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65200251|NCT02667886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200252|NCT02667886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200253|NCT02623972|Cyclophosphamide|cyclophosphamide|mesh-list
65200254|NCT02623972|Doxorubicin|doxorubicin|mesh-list
65200255|NCT02623972|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65200256|NCT02623972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65200257|NCT02623972|Immunologic Factors|immunologic factors|mesh-ancestor
65200258|NCT02623972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200259|NCT02623972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65200260|NCT02623972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65200261|NCT02623972|Alkylating Agents|alkylating agents|mesh-ancestor
65200262|NCT02623972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200263|NCT02623972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200264|NCT02623972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65200265|NCT02623972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65200266|NCT02623972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65200267|NCT02623972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65200268|NCT02623972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200269|NCT02614066|Cyclophosphamide|cyclophosphamide|mesh-list
65200270|NCT02614066|Fludarabine|fludarabine|mesh-list
65200271|NCT02614066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65200272|NCT02614066|Immunologic Factors|immunologic factors|mesh-ancestor
65200273|NCT02614066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200274|NCT02614066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65200275|NCT02614066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65200276|NCT02614066|Alkylating Agents|alkylating agents|mesh-ancestor
65200277|NCT02614066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200278|NCT02614066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200279|NCT02614066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65200280|NCT02587195|Teriflunomide|teriflunomide|mesh-list
65200281|NCT02587195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65200282|NCT02587195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65200283|NCT02587195|Analgesics|analgesics|mesh-ancestor
65200284|NCT02587195|Sensory System Agents|sensory system agents|mesh-ancestor
65200285|NCT02587195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65200286|NCT02587195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200287|NCT02587195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65200289|NCT02587195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65200290|NCT02587195|Immunologic Factors|immunologic factors|mesh-ancestor
65200291|NCT02582008|Bupropion|bupropion|mesh-list
65200292|NCT02582008|Nicotine|nicotine|mesh-list
65200293|NCT02582008|Varenicline|varenicline|mesh-list
65200294|NCT02582008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65200295|NCT02582008|Autonomic Agents|autonomic agents|mesh-ancestor
65200296|NCT02582008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65200297|NCT02582008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200298|NCT02582008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65200299|NCT02582008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65200300|NCT02582008|Cholinergic Agents|cholinergic agents|mesh-ancestor
65200301|NCT02582008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65200302|NCT02582008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200305|NCT02582008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65200306|NCT02582008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65200307|NCT02582008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65200308|NCT02582008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65200309|NCT02582008|Dopamine Agents|dopamine agents|mesh-ancestor
65200310|NCT02582008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65330341|NCT04096170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65330342|NCT04096170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65330343|NCT04096170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65330344|NCT04096170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716420|NCT03388268|Vancomycin|vancomycin|mesh-list
65200311|NCT02582008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65200312|NCT02582008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200313|NCT02502799|Methylphenidate|methylphenidate|mesh-list
65200314|NCT02502799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65200315|NCT02502799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200316|NCT02502799|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65200317|NCT02502799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65200318|NCT02502799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65200319|NCT02502799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200320|NCT02502799|Dopamine Agents|dopamine agents|mesh-ancestor
65200321|NCT02502799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65200322|NCT02135133|Ofatumumab|ofatumumab|mesh-list
65200323|NCT02135133|Idelalisib|idelalisib|mesh-list
65200324|NCT02135133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200325|NCT02135133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200326|NCT02135133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200327|NCT01993836|Anesthetics|anesthetics|mesh-list
65200328|NCT01993836|Propofol|propofol|mesh-list
65200329|NCT01993836|Isoflurane|isoflurane|mesh-list
64842932|NCT01659099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65200330|NCT01993836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65200331|NCT01993836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200332|NCT01993836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65200333|NCT01993836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65200334|NCT01993836|Anesthetics, General|anesthetics, general|mesh-ancestor
65200335|NCT01993836|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65200336|NCT01818739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65200337|NCT01717586|Pravastatin|pravastatin|mesh-list
65200338|NCT01717586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65200339|NCT01717586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65200340|NCT01717586|Antimetabolites|antimetabolites|mesh-ancestor
65200341|NCT01717586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200342|NCT01717586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65200343|NCT01717586|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65200344|NCT01717586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200345|NCT01665677|Atorvastatin|atorvastatin|mesh-list
65200346|NCT01665677|Calcium|calcium|mesh-list
65200347|NCT01665677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65200348|NCT01665677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200349|NCT01665677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65200350|NCT01665677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65200351|NCT01665677|Antimetabolites|antimetabolites|mesh-ancestor
65200352|NCT01665677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200353|NCT01665677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65200354|NCT01665677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65200355|NCT01665677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200356|NCT01523977|Prednisone|prednisone|mesh-list
65200357|NCT01523977|Doxorubicin|doxorubicin|mesh-list
65200358|NCT01523977|Dexrazoxane|dexrazoxane|mesh-list
65200359|NCT01523977|Vincristine|vincristine|mesh-list
65200360|NCT01523977|Everolimus|everolimus|mesh-list
65200361|NCT01523977|Asparaginase|asparaginase|mesh-list
65200362|NCT01523977|Pegaspargase|pegaspargase|mesh-list
65200363|NCT01523977|Razoxane|razoxane|mesh-list
65200364|NCT01523977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65200365|NCT01523977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200366|NCT01523977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65200367|NCT01523977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65200368|NCT01523977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200369|NCT01523977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200370|NCT01523977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65200371|NCT01523977|Glucocorticoids|glucocorticoids|mesh-ancestor
65200372|NCT01523977|Hormones|hormones|mesh-ancestor
65200373|NCT01523977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65330346|NCT00741117|Antioxidants|antioxidants|mesh-ancestor
65330347|NCT00741117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330348|NCT00741117|Protective Agents|protective agents|mesh-ancestor
65200376|NCT01523977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65200377|NCT01523977|Tubulin Modulators|tubulin modulators|mesh-ancestor
65200378|NCT01523977|Antimitotic Agents|antimitotic agents|mesh-ancestor
65200379|NCT01523977|Mitosis Modulators|mitosis modulators|mesh-ancestor
65200380|NCT01523977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65200381|NCT01523977|Immunologic Factors|immunologic factors|mesh-ancestor
65200382|NCT01523977|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65200383|NCT01523977|Protective Agents|protective agents|mesh-ancestor
65200384|NCT01107717|Metformin|metformin|mesh-list
65200385|NCT01107717|Pioglitazone|pioglitazone|mesh-list
65200386|NCT01107717|Exenatide|exenatide|mesh-list
65200387|NCT01107717|Glyburide|glyburide|mesh-list
65200388|NCT01107717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65200389|NCT01107717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200390|NCT01107717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65200391|NCT01107717|Incretins|incretins|mesh-ancestor
65200392|NCT01107717|Hormones|hormones|mesh-ancestor
65200393|NCT01107717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65200394|NCT00782574|Olaparib|olaparib|mesh-list
65200395|NCT00782574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200396|NCT00782574|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65200397|NCT00782574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200398|NCT00782574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200399|NCT00753545|Olaparib|olaparib|mesh-list
65200400|NCT00753545|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65200401|NCT00753545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200402|NCT00753545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200403|NCT00753545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843012|NCT01659372|Naproxen|naproxen|mesh-list
65200404|NCT00635362|Levonorgestrel|levonorgestrel|mesh-list
65200405|NCT00635362|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65200406|NCT00635362|Contraceptive Agents|contraceptive agents|mesh-ancestor
65200407|NCT00635362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65200408|NCT00635362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200409|NCT00635362|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65200410|NCT00635362|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65200411|NCT00635362|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65200412|NCT00408447|Fludarabine|fludarabine|mesh-list
65200414|NCT00408447|Alemtuzumab|alemtuzumab|mesh-list
65200415|NCT00408447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200416|NCT00408447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200417|NCT00408447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65200418|NCT00408447|Immunologic Factors|immunologic factors|mesh-ancestor
65200419|NCT00408447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200420|NCT00408447|Alkylating Agents|alkylating agents|mesh-ancestor
65200421|NCT00408447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65200422|NCT00408447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65200423|NCT00408447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65200424|NCT00278915|Fulvestrant|fulvestrant|mesh-list
65200425|NCT00278915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65200426|NCT00278915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200427|NCT00278915|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65200428|NCT00278915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65200429|NCT00278915|Hormone Antagonists|hormone antagonists|mesh-ancestor
65200430|NCT00278915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65200431|NCT00278915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200432|NCT04285320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65200433|NCT04285320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65200434|NCT04285320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65200435|NCT04285320|Antitubercular Agents|antitubercular agents|mesh-ancestor
65200436|NCT00970632|Tadalafil|tadalafil|mesh-list
65200437|NCT00970632|Tamsulosin|tamsulosin|mesh-list
65200438|NCT00970632|Vasodilator Agents|vasodilator agents|mesh-ancestor
65200439|NCT00970632|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65200440|NCT00970632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65200441|NCT00970632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200442|NCT00970632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200443|NCT00970632|Urological Agents|urological agents|mesh-ancestor
65330349|NCT00741117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330350|NCT00732992|Pemetrexed|pemetrexed|mesh-list
65330351|NCT00732992|Sunitinib|sunitinib|mesh-list
65330352|NCT00732992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330353|NCT00732992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330354|NCT00732992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330355|NCT00732992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65200444|NCT00970632|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65200445|NCT00970632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65200448|NCT00970632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65200449|NCT00970632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200451|NCT01144364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65200452|NCT01144364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200453|NCT01144364|Immunologic Factors|immunologic factors|mesh-ancestor
65200454|NCT01144364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200455|NCT01144364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65200456|NCT00965094|Mycophenolic Acid|mycophenolic acid|mesh-list
65200457|NCT00965094|Everolimus|everolimus|mesh-list
65200458|NCT00965094|Tacrolimus|tacrolimus|mesh-list
65200459|NCT00965094|Basiliximab|basiliximab|mesh-list
65200460|NCT00965094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65200461|NCT00965094|Immunologic Factors|immunologic factors|mesh-ancestor
65200462|NCT00965094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200463|NCT00965094|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65200464|NCT00965094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200465|NCT00965094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200466|NCT00965094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200467|NCT00965094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65200468|NCT00965094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65200469|NCT00965094|Antitubercular Agents|antitubercular agents|mesh-ancestor
65200470|NCT00965094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65200471|NCT00965094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65200472|NCT01131182|Metformin|metformin|mesh-list
65200473|NCT01131182|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65200474|NCT01131182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65200475|NCT01131182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200476|NCT01131182|Incretins|incretins|mesh-ancestor
65200477|NCT01131182|Hormones|hormones|mesh-ancestor
65200478|NCT01131182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65200479|NCT01131182|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65200480|NCT01131182|Protease Inhibitors|protease inhibitors|mesh-ancestor
65200481|NCT01131182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200482|NCT01131182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200483|NCT01131104|Sildenafil Citrate|sildenafil citrate|mesh-list
65200484|NCT01131104|Tadalafil|tadalafil|mesh-list
65200485|NCT01131104|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65200486|NCT01131104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
65200487|NCT01131104|Vasodilator Agents|vasodilator agents|mesh-ancestor
65200488|NCT01131104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65200489|NCT01131104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200490|NCT01131104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200491|NCT01131104|Urological Agents|urological agents|mesh-ancestor
65200492|NCT04264884|Daratumumab|daratumumab|mesh-list
65200493|NCT04264884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200494|NCT01118780|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65200495|NCT01118780|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65200496|NCT01118780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65200497|NCT01118780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65200498|NCT01118780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200499|NCT01118780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65200500|NCT01118780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200501|NCT01118780|Analgesics|analgesics|mesh-ancestor
65200502|NCT01118780|Sensory System Agents|sensory system agents|mesh-ancestor
65200503|NCT01118780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65200504|NCT01118780|Antidepressive Agents|antidepressive agents|mesh-ancestor
65200505|NCT01118780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65200506|NCT01118780|Dopamine Agents|dopamine agents|mesh-ancestor
65330356|NCT00732992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65330357|NCT00732992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65330358|NCT00732992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65330359|NCT00732992|Growth Substances|growth substances|mesh-ancestor
65330360|NCT00732992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330361|NCT00732992|Growth Inhibitors|growth inhibitors|mesh-ancestor
65330362|NCT00732992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65330363|NCT00741195|Bevacizumab|bevacizumab|mesh-list
65330364|NCT00741195|Docetaxel|docetaxel|mesh-list
64716434|NCT03588806|Oxycodone|oxycodone|mesh-list
65200507|NCT00629928|Esomeprazole|esomeprazole|mesh-list
65200508|NCT00629928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65200509|NCT00629928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65200510|NCT00629928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65200511|NCT00629928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200512|NCT00629928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200513|NCT00964782|Sildenafil Citrate|sildenafil citrate|mesh-list
65200514|NCT00964782|Vasodilator Agents|vasodilator agents|mesh-ancestor
65200515|NCT00964782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65200516|NCT00964782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65200517|NCT00964782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200519|NCT00964782|Urological Agents|urological agents|mesh-ancestor
65200520|NCT02882984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65200521|NCT02882984|Gefitinib|gefitinib|mesh-list
65200522|NCT02882984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200523|NCT02882984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65200524|NCT02882984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200525|NCT02882984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200526|NCT00966654|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65200527|NCT00966654|Incretins|incretins|mesh-ancestor
65200528|NCT00966654|Hormones|hormones|mesh-ancestor
65200529|NCT00966654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65200530|NCT00966654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200531|NCT00625196|Fluticasone|fluticasone|mesh-list
65200532|NCT00625196|Xhance|xhance|mesh-list
65200533|NCT00625196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65200534|NCT00625196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65200535|NCT00625196|Autonomic Agents|autonomic agents|mesh-ancestor
65200536|NCT00625196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65200537|NCT00625196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200538|NCT00625196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65200539|NCT00625196|Respiratory System Agents|respiratory system agents|mesh-ancestor
65200540|NCT00625196|Dermatologic Agents|dermatologic agents|mesh-ancestor
65200541|NCT00625196|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65200542|NCT03262116|Insulin|insulin|mesh-list
65200543|NCT03262116|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65200544|NCT03262116|Insulin Lispro|insulin lispro|mesh-list
65200545|NCT03262116|Insulin Aspart|insulin aspart|mesh-list
65200546|NCT03262116|Pancrelipase|pancrelipase|mesh-list
65200547|NCT03262116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65200548|NCT03262116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200549|NCT03262116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65200550|NCT01130168|Amlodipine|amlodipine|mesh-list
65200551|NCT01130168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65200552|NCT01130168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65200553|NCT01130168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65200554|NCT01130168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200555|NCT01130168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65200556|NCT01130168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200557|NCT01130168|Vasodilator Agents|vasodilator agents|mesh-ancestor
65200558|NCT04284852|Niraparib|niraparib|mesh-list
65200559|NCT04284852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65200560|NCT04284852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200561|NCT04284852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200562|NCT04284852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200563|NCT04283292|Capsaicin|capsaicin|mesh-list
65330365|NCT00741195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65330366|NCT00741195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330367|NCT00741195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65330368|NCT00741195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65330369|NCT00741195|Growth Substances|growth substances|mesh-ancestor
65330370|NCT00741195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330371|NCT00741195|Growth Inhibitors|growth inhibitors|mesh-ancestor
65330372|NCT00741195|Tubulin Modulators|tubulin modulators|mesh-ancestor
65200564|NCT04283292|Antipruritics|antipruritics|mesh-ancestor
65200565|NCT04283292|Dermatologic Agents|dermatologic agents|mesh-ancestor
65200566|NCT04283292|Sensory System Agents|sensory system agents|mesh-ancestor
65200567|NCT04283292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65200568|NCT04283292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200569|NCT01144052|Interferons|interferons|mesh-list
65200570|NCT01144052|Interferon-beta|interferon-beta|mesh-list
65200571|NCT01144052|Natalizumab|natalizumab|mesh-list
65200572|NCT01144052|Interferon beta-1b|interferon beta-1b|mesh-list
65200573|NCT01144052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200574|NCT01144052|Antiviral Agents|antiviral agents|mesh-ancestor
65200575|NCT01144052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65200576|NCT01144052|Immunologic Factors|immunologic factors|mesh-ancestor
65200577|NCT01144052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200578|NCT01144052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65200579|NCT04283526|Decitabine|decitabine|mesh-list
65200580|NCT04283526|Spartalizumab|spartalizumab|mesh-list
65200581|NCT04283526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65200582|NCT04283526|Antimetabolites|antimetabolites|mesh-ancestor
65200583|NCT04283526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200584|NCT04283526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200585|NCT04283526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200586|NCT04283526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65200587|NCT01118312|Mometasone Furoate|mometasone furoate|mesh-list
65200588|NCT01118312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65200589|NCT01118312|Dermatologic Agents|dermatologic agents|mesh-ancestor
65200590|NCT01118312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65200592|NCT01117766|Analgesics|analgesics|mesh-ancestor
65200593|NCT01117766|Sensory System Agents|sensory system agents|mesh-ancestor
65200595|NCT01117766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200597|NCT01117766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65200598|NCT01117766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65200599|NCT01117766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200600|NCT01117766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65200601|NCT01117766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65200602|NCT01117766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65200603|NCT01117766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65200604|NCT01117766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65200605|NCT04312880|Tranexamic Acid|tranexamic acid|mesh-list
65200606|NCT04312880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65200607|NCT04312880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65200608|NCT04312880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200609|NCT04312880|Hemostatics|hemostatics|mesh-ancestor
65200610|NCT04312880|Coagulants|coagulants|mesh-ancestor
65200611|NCT01117454|Flecainide|flecainide|mesh-list
65200612|NCT01117454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65200613|NCT01117454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65200614|NCT01117454|Adrenergic Agents|adrenergic agents|mesh-ancestor
65200615|NCT01117454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65200616|NCT01117454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200617|NCT01117454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200618|NCT01117454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65200619|NCT01117454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65200620|NCT01117454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65200621|NCT01117454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65200622|NCT01129622|Letrozole|letrozole|mesh-list
65200623|NCT01129622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200624|NCT01129622|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65330373|NCT00741195|Antimitotic Agents|antimitotic agents|mesh-ancestor
65330374|NCT00741195|Mitosis Modulators|mitosis modulators|mesh-ancestor
65330375|NCT00741195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330376|NCT05338632|Naloxone|naloxone|mesh-list
65330377|NCT05338632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65330378|NCT05338632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330379|NCT05338632|Sensory System Agents|sensory system agents|mesh-ancestor
65330380|NCT05338632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65330381|NCT00732758|Vitamin D|vitamin d|mesh-list
65200625|NCT01129622|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65200626|NCT01129622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200627|NCT01129622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200628|NCT01129622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65200629|NCT01129622|Hormone Antagonists|hormone antagonists|mesh-ancestor
65200630|NCT01129622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65200631|NCT01129622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200632|NCT01128842|Capecitabine|capecitabine|mesh-list
65200633|NCT01128842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65200634|NCT01128842|Antimetabolites|antimetabolites|mesh-ancestor
65200635|NCT01128842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200636|NCT01128842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200637|NCT00625274|Esomeprazole|esomeprazole|mesh-list
65200638|NCT00625274|Pantoprazole|pantoprazole|mesh-list
65200639|NCT00625274|Lansoprazole|lansoprazole|mesh-list
65200640|NCT00625274|Dexlansoprazole|dexlansoprazole|mesh-list
65200641|NCT00625274|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65200642|NCT00625274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65200643|NCT00625274|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65200644|NCT00625274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200645|NCT00625274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200646|NCT03624036|Cyclophosphamide|cyclophosphamide|mesh-list
65200647|NCT03624036|Fludarabine|fludarabine|mesh-list
65200648|NCT03624036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65200649|NCT03624036|Immunologic Factors|immunologic factors|mesh-ancestor
65200650|NCT03624036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200651|NCT03624036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65200652|NCT03624036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65200653|NCT03624036|Alkylating Agents|alkylating agents|mesh-ancestor
65200654|NCT03624036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200655|NCT03624036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200656|NCT03624036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65200658|NCT00915525|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65200659|NCT00915525|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65200660|NCT00915525|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65200661|NCT00915525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65200662|NCT00915525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200663|NCT00915525|Cholinergic Agents|cholinergic agents|mesh-ancestor
65200664|NCT00915525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64322167|NCT02144753|Cathartics|cathartics|mesh-ancestor
65200667|NCT00915525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65200668|NCT04669041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65200670|NCT04669041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65200671|NCT04669041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65200672|NCT04669041|Antimetabolites|antimetabolites|mesh-ancestor
65200673|NCT04669041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200674|NCT04669041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65200675|NCT04669041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65200676|NCT04669041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200677|NCT05132595|Ketorolac|ketorolac|mesh-list
65200678|NCT05132595|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65200679|NCT05132595|Esketamine|esketamine|mesh-list
65200680|NCT05132595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65200681|NCT05132595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65200682|NCT05132595|Analgesics|analgesics|mesh-ancestor
65200683|NCT05132595|Sensory System Agents|sensory system agents|mesh-ancestor
65330382|NCT00732758|Cholecalciferol|cholecalciferol|mesh-list
65330383|NCT00732758|Vitamins|vitamins|mesh-ancestor
65330384|NCT00732758|Micronutrients|micronutrients|mesh-ancestor
65330385|NCT00732758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330386|NCT00732758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65200684|NCT05132595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65200685|NCT05132595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200686|NCT05132595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65200687|NCT05132595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65200688|NCT05132595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65200689|NCT05132595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200690|NCT05132595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200691|NCT05132595|Antidepressive Agents|antidepressive agents|mesh-ancestor
65200692|NCT05132595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65200693|NCT01074047|Azacitidine|azacitidine|mesh-list
65200694|NCT01074047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65200695|NCT01074047|Antimetabolites|antimetabolites|mesh-ancestor
65200696|NCT01074047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200697|NCT01074047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200698|NCT01074047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200699|NCT01142726|Methotrexate|methotrexate|mesh-list
65200700|NCT01142726|Abatacept|abatacept|mesh-list
65200701|NCT01142726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65200702|NCT01142726|Abortifacient Agents|abortifacient agents|mesh-ancestor
65200703|NCT01142726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65200704|NCT01142726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200705|NCT01142726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65200707|NCT01142726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200708|NCT01142726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200709|NCT01142726|Dermatologic Agents|dermatologic agents|mesh-ancestor
65200710|NCT01142726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200711|NCT01142726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65200712|NCT01142726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65200713|NCT01142726|Immunologic Factors|immunologic factors|mesh-ancestor
65200714|NCT01142726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65200715|NCT01142726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65200716|NCT01142726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65200717|NCT04472637|Atorvastatin|atorvastatin|mesh-list
65200718|NCT04472637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65200719|NCT04472637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65200720|NCT04472637|Antimetabolites|antimetabolites|mesh-ancestor
65200721|NCT04472637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200722|NCT04472637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65200723|NCT04472637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65200724|NCT04472637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200725|NCT01142336|Simvastatin|simvastatin|mesh-list
65200726|NCT01142336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65200727|NCT01142336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65200728|NCT01142336|Antimetabolites|antimetabolites|mesh-ancestor
65200729|NCT01142336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200730|NCT01142336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65200731|NCT01142336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65200732|NCT01142336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200733|NCT00915681|Silybin|silybin|mesh-list
65200734|NCT00915681|Protective Agents|protective agents|mesh-ancestor
65200735|NCT00915681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200736|NCT00915681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65200740|NCT01128296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65200741|NCT01128296|Antimetabolites|antimetabolites|mesh-ancestor
65200742|NCT01128296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200743|NCT01128296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200744|NCT01128296|Antiviral Agents|antiviral agents|mesh-ancestor
65200745|NCT01128296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65200746|NCT01128296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200747|NCT01128296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65200748|NCT01128296|Immunologic Factors|immunologic factors|mesh-ancestor
65200749|NCT01128296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200750|NCT01128296|Antimalarials|antimalarials|mesh-ancestor
65330387|NCT00732758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65330388|NCT04082754|Antibodies|antibodies|mesh-list
65330389|NCT04082754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65330390|NCT04082754|Immunologic Factors|immunologic factors|mesh-ancestor
65200751|NCT01128296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65200752|NCT01128296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65200753|NCT01128296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65200755|NCT05082909|Uricosuric Agents|uricosuric agents|mesh-ancestor
65200756|NCT05082909|Gout Suppressants|gout suppressants|mesh-ancestor
65200757|NCT05082909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65200758|NCT05082909|Renal Agents|renal agents|mesh-ancestor
65200759|NCT04253145|Atezolizumab|atezolizumab|mesh-list
65200760|NCT04253145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200761|NCT04240509|Tenofovir|tenofovir|mesh-list
65200762|NCT04240509|Emtricitabine|emtricitabine|mesh-list
65200763|NCT04240509|Antiviral Agents|antiviral agents|mesh-ancestor
65200764|NCT04240509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65200765|NCT04240509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65200766|NCT04240509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65200767|NCT04240509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200768|NCT04240509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200769|NCT04240509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65200770|NCT04240509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65200771|NCT04450329|Aflibercept|aflibercept|mesh-list
65200772|NCT04450329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65200773|NCT04450329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65200774|NCT04450329|Growth Substances|growth substances|mesh-ancestor
65200775|NCT04450329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200776|NCT04450329|Growth Inhibitors|growth inhibitors|mesh-ancestor
65200777|NCT04450329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200779|NCT01115738|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65200780|NCT01115738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65200781|NCT01115738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65200782|NCT01115738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65200783|NCT01115738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65200784|NCT01115738|Purinergic Agents|purinergic agents|mesh-ancestor
65200785|NCT01115738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65200786|NCT01115738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200787|NCT01115738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200788|NCT00632073|Maleic acid|maleic acid|mesh-list
65200789|NCT00632073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200790|NCT00632073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200791|NCT01141478|Sorafenib|sorafenib|mesh-list
65200792|NCT01141478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200793|NCT01141478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65200794|NCT01141478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200795|NCT01141478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200796|NCT01114880|Adalimumab|adalimumab|mesh-list
65200797|NCT01114880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65200798|NCT01114880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65200799|NCT00625352|Gemcitabine|gemcitabine|mesh-list
65200800|NCT00625352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65200801|NCT00625352|Antimetabolites|antimetabolites|mesh-ancestor
65200802|NCT00625352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200803|NCT00625352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200804|NCT00625352|Antiviral Agents|antiviral agents|mesh-ancestor
65200805|NCT00625352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65200807|NCT00625352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65200808|NCT00625352|Immunologic Factors|immunologic factors|mesh-ancestor
65200809|NCT00625352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200810|NCT04539873|Colchicine|colchicine|mesh-list
65200811|NCT04539873|Gout Suppressants|gout suppressants|mesh-ancestor
65200816|NCT04539873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200817|NCT04539873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200819|NCT02861040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65200820|NCT02861040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200821|NCT02861040|Tubulin Modulators|tubulin modulators|mesh-ancestor
65200822|NCT02861040|Antimitotic Agents|antimitotic agents|mesh-ancestor
65200823|NCT02861040|Mitosis Modulators|mitosis modulators|mesh-ancestor
65200824|NCT02861040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200825|NCT04646187|Adalimumab|adalimumab|mesh-list
65330391|NCT04082754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330392|NCT00741351|Fentanyl|fentanyl|mesh-list
65330393|NCT00741351|Remifentanil|remifentanil|mesh-list
65330394|NCT00741351|Propofol|propofol|mesh-list
65330395|NCT00741351|Sevoflurane|sevoflurane|mesh-list
65330396|NCT00741351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65330397|NCT00741351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65330398|NCT00741351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330399|NCT00741351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65330400|NCT00741351|Anesthetics, General|anesthetics, general|mesh-ancestor
65330401|NCT00741351|Anesthetics|anesthetics|mesh-ancestor
65330402|NCT00741351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65330403|NCT00741351|Narcotics|narcotics|mesh-ancestor
65330404|NCT00741351|Analgesics|analgesics|mesh-ancestor
65330405|NCT00741351|Sensory System Agents|sensory system agents|mesh-ancestor
65200826|NCT04646187|Infliximab|infliximab|mesh-list
65200827|NCT04646187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65200828|NCT04646187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65200829|NCT04646187|Dermatologic Agents|dermatologic agents|mesh-ancestor
65200830|NCT04646187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65200831|NCT04282902|Pirfenidone|pirfenidone|mesh-list
65200832|NCT04282902|Analgesics|analgesics|mesh-ancestor
65200833|NCT04282902|Sensory System Agents|sensory system agents|mesh-ancestor
65200834|NCT04282902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65200835|NCT04282902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200836|NCT04282902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65200837|NCT04282902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65200838|NCT04282902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65200839|NCT04282902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65200840|NCT04282902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200841|NCT02860962|Dextromethorphan|dextromethorphan|mesh-list
65200842|NCT02860962|Antitussive Agents|antitussive agents|mesh-ancestor
65200843|NCT02860962|Respiratory System Agents|respiratory system agents|mesh-ancestor
65200844|NCT02860962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65200845|NCT02860962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65200846|NCT02860962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65200847|NCT02860962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200848|NCT02860962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200849|NCT04432623|Benserazide|benserazide|mesh-list
65200850|NCT04432623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65200851|NCT04432623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65200852|NCT04432623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200853|NCT04432623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200854|NCT04432623|Dopamine Agents|dopamine agents|mesh-ancestor
65200855|NCT04432623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65200856|NCT04432623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200857|NCT04177953|Carboplatin|carboplatin|mesh-list
65200858|NCT04177953|Nivolumab|nivolumab|mesh-list
65200859|NCT04177953|Pemetrexed|pemetrexed|mesh-list
65200860|NCT04177953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200861|NCT04177953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65200862|NCT04177953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65200863|NCT04177953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200864|NCT04177953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200865|NCT04177953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65200866|NCT04177953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65200867|NCT00878722|Idarubicin|idarubicin|mesh-list
65200868|NCT00878722|Belinostat|belinostat|mesh-list
65200869|NCT00878722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65200870|NCT00878722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200871|NCT00878722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65200872|NCT00878722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65200873|NCT00878722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330406|NCT00741351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65330407|NCT00741351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65330408|NCT00741351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65330409|NCT00741351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65330410|NCT02582190|Colchicine|colchicine|mesh-list
65330411|NCT02582190|Gout Suppressants|gout suppressants|mesh-ancestor
65330412|NCT02582190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65330413|NCT02582190|Tubulin Modulators|tubulin modulators|mesh-ancestor
65330414|NCT02582190|Antimitotic Agents|antimitotic agents|mesh-ancestor
65330415|NCT02582190|Mitosis Modulators|mitosis modulators|mesh-ancestor
65200874|NCT00878722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200875|NCT00878722|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65200876|NCT03432897|Olaparib|olaparib|mesh-list
65200877|NCT03432897|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65200878|NCT03432897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200879|NCT03432897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200880|NCT03432897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200881|NCT00659386|Immunoglobulins|immunoglobulins|mesh-list
65200883|NCT00659386|Antibodies|antibodies|mesh-list
65200884|NCT00659386|gamma-Globulins|gamma-globulins|mesh-list
65200885|NCT00659386|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65200886|NCT00659386|Immunologic Factors|immunologic factors|mesh-ancestor
65200887|NCT00659386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200888|NCT04160325|Azathioprine|azathioprine|mesh-list
65200889|NCT04160325|Antimetabolites|antimetabolites|mesh-ancestor
65200890|NCT04160325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200891|NCT04160325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65200892|NCT04160325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200893|NCT04160325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65200894|NCT04160325|Immunologic Factors|immunologic factors|mesh-ancestor
65200895|NCT04160325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200896|NCT04160325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65200897|NCT04155814|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65200898|NCT04155814|Hematinics|hematinics|mesh-ancestor
65200899|NCT04547439|Melatonin|melatonin|mesh-list
65200900|NCT04547439|Antioxidants|antioxidants|mesh-ancestor
65200901|NCT04547439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200902|NCT04547439|Protective Agents|protective agents|mesh-ancestor
65200903|NCT04547439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200904|NCT04547439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65200905|NCT04158076|Amlodipine|amlodipine|mesh-list
65200906|NCT04158076|Telmisartan|telmisartan|mesh-list
65200907|NCT04158076|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
65200908|NCT04158076|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65200909|NCT04158076|Ezetimibe|ezetimibe|mesh-list
65200910|NCT04158076|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65200911|NCT04158076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65200912|NCT04158076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65200913|NCT04158076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200914|NCT04158076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65200915|NCT04158076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200916|NCT04158076|Vasodilator Agents|vasodilator agents|mesh-ancestor
65200917|NCT04158076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65200918|NCT04158076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65200919|NCT04158076|Antimetabolites|antimetabolites|mesh-ancestor
65200920|NCT04158076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65200921|NCT04158076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65200922|NCT04158076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200923|NCT04158076|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64843528|NCT01662622|Anesthetics|anesthetics|mesh-ancestor
65200924|NCT04158076|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65200925|NCT04413201|Osimertinib|osimertinib|mesh-list
65200926|NCT04413201|Afatinib|afatinib|mesh-list
65200927|NCT04413201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200928|NCT04413201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65330416|NCT02582190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330417|NCT02582190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330418|NCT00699153|Loteprednol Etabonate|loteprednol etabonate|mesh-list
65330419|NCT00699153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65330420|NCT04277442|Nivolumab|nivolumab|mesh-list
65330421|NCT04277442|Decitabine|decitabine|mesh-list
65330422|NCT04277442|Venetoclax|venetoclax|mesh-list
65330423|NCT04277442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65330424|NCT04277442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330425|NCT04277442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65330426|NCT04277442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330427|NCT04277442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65330428|NCT04277442|Antimetabolites|antimetabolites|mesh-ancestor
65330429|NCT04277442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330430|NCT05742243|Insulin|insulin|mesh-list
65330431|NCT05742243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65200929|NCT04413201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200930|NCT04413201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200931|NCT00961350|Aspirin|aspirin|mesh-list
65200932|NCT00961350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65200933|NCT00961350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65200934|NCT00961350|Analgesics|analgesics|mesh-ancestor
65200935|NCT00961350|Sensory System Agents|sensory system agents|mesh-ancestor
65200936|NCT00961350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65200937|NCT00961350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200938|NCT00961350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65200939|NCT00961350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65200940|NCT00961350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65200941|NCT00961350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65200942|NCT00961350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200943|NCT00961350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65200944|NCT00961350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65200945|NCT00961350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200946|NCT00961350|Antipyretics|antipyretics|mesh-ancestor
65200947|NCT03537690|Paclitaxel|paclitaxel|mesh-list
65200948|NCT03537690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65200949|NCT03537690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65200950|NCT03537690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200951|NCT03537690|Tubulin Modulators|tubulin modulators|mesh-ancestor
65200952|NCT03537690|Antimitotic Agents|antimitotic agents|mesh-ancestor
65200953|NCT03537690|Mitosis Modulators|mitosis modulators|mesh-ancestor
64322209|NCT05079217|Immunologic Factors|immunologic factors|mesh-ancestor
65200957|NCT04032184|Fluorides|fluorides|mesh-list
65200958|NCT04032184|Cariostatic Agents|cariostatic agents|mesh-ancestor
65200959|NCT04032184|Protective Agents|protective agents|mesh-ancestor
65200960|NCT04032184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200961|NCT04032184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65200962|NCT04032184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65200963|NCT04032184|Disinfectants|disinfectants|mesh-ancestor
65200964|NCT04032184|Dermatologic Agents|dermatologic agents|mesh-ancestor
65200965|NCT04246437|Carbidopa|carbidopa|mesh-list
65200966|NCT04246437|Entacapone|entacapone|mesh-list
65200967|NCT04246437|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65200968|NCT04246437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65200969|NCT04246437|Dopamine Agents|dopamine agents|mesh-ancestor
65200970|NCT04246437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65200971|NCT04246437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200972|NCT04246437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200973|NCT04246437|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65330432|NCT05742243|Abatacept|abatacept|mesh-list
65330433|NCT05742243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65330434|NCT05742243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330435|NCT05742243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65330436|NCT05742243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716504|NCT03398330|Oxycodone|oxycodone|mesh-list
65200974|NCT04246437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200975|NCT04246437|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65200976|NCT00662896|Ibuprofen|ibuprofen|mesh-list
65200977|NCT00662896|Naproxen|naproxen|mesh-list
65200978|NCT00662896|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
65200979|NCT00662896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65200980|NCT00662896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65200981|NCT00662896|Analgesics|analgesics|mesh-ancestor
65200982|NCT00662896|Sensory System Agents|sensory system agents|mesh-ancestor
65200983|NCT00662896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65200984|NCT00662896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200985|NCT00662896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65200986|NCT00662896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65200987|NCT00662896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65200988|NCT00662896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65200989|NCT00662896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200990|NCT00662896|Gout Suppressants|gout suppressants|mesh-ancestor
65200991|NCT00662896|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65200992|NCT00963924|Cycloserine|cycloserine|mesh-list
65200993|NCT00963924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65200994|NCT00963924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65200995|NCT00963924|Renal Agents|renal agents|mesh-ancestor
65200996|NCT00963924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65200997|NCT00963924|Antitubercular Agents|antitubercular agents|mesh-ancestor
65200998|NCT00963924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65200999|NCT00963924|Antimetabolites|antimetabolites|mesh-ancestor
65201000|NCT00963924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201001|NCT04155658|Fluorides|fluorides|mesh-list
65201002|NCT04155658|Cariostatic Agents|cariostatic agents|mesh-ancestor
65201003|NCT04155658|Protective Agents|protective agents|mesh-ancestor
65201004|NCT04155658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201005|NCT02861976|Analgesics, Opioid|analgesics, opioid|mesh-list
65201006|NCT02861976|Narcotics|narcotics|mesh-ancestor
65201007|NCT02861976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65201008|NCT02861976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201009|NCT02861976|Analgesics|analgesics|mesh-ancestor
65201010|NCT02861976|Sensory System Agents|sensory system agents|mesh-ancestor
65201011|NCT02861976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65201012|NCT00666484|Prednisolone|prednisolone|mesh-list
65201013|NCT00666484|Cyclophosphamide|cyclophosphamide|mesh-list
65201014|NCT00666484|Doxorubicin|doxorubicin|mesh-list
65201015|NCT00666484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65201016|NCT00666484|Etoposide|etoposide|mesh-list
65201017|NCT00666484|Vincristine|vincristine|mesh-list
65201018|NCT00666484|Procarbazine|procarbazine|mesh-list
65201019|NCT00666484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65201020|NCT00666484|Immunologic Factors|immunologic factors|mesh-ancestor
65201021|NCT00666484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201022|NCT00666484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65201023|NCT00666484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65201024|NCT00666484|Alkylating Agents|alkylating agents|mesh-ancestor
65201025|NCT00666484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201026|NCT00666484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201029|NCT00666484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65201030|NCT00666484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65201031|NCT00666484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201032|NCT00666484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65201033|NCT00666484|Tubulin Modulators|tubulin modulators|mesh-ancestor
65201034|NCT00666484|Antimitotic Agents|antimitotic agents|mesh-ancestor
65201035|NCT00666484|Mitosis Modulators|mitosis modulators|mesh-ancestor
65201036|NCT00666484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65201037|NCT00666484|Glucocorticoids|glucocorticoids|mesh-ancestor
65201038|NCT00666484|Hormones|hormones|mesh-ancestor
65201039|NCT00666484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65330437|NCT05742243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330438|NCT05742243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65330439|NCT05742243|Immunologic Factors|immunologic factors|mesh-ancestor
65330440|NCT05742243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65330441|NCT04076748|Sufentanil|sufentanil|mesh-list
65330442|NCT04076748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65330443|NCT04076748|Narcotics|narcotics|mesh-ancestor
64716509|NCT03398330|Analgesics|analgesics|mesh-ancestor
65201040|NCT00666484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65201041|NCT01126736|Pemetrexed|pemetrexed|mesh-list
65201042|NCT01126736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201043|NCT01126736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201044|NCT01126736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201045|NCT01126736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65201046|NCT01126736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65201047|NCT04328337|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65201048|NCT04328337|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65201049|NCT04328337|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65201050|NCT04328337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65201051|NCT00663130|Tadalafil|tadalafil|mesh-list
65201052|NCT00663130|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65201053|NCT00663130|Vasodilator Agents|vasodilator agents|mesh-ancestor
65201054|NCT00663130|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65201055|NCT00663130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65201056|NCT00663130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201057|NCT00663130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201058|NCT00663130|Urological Agents|urological agents|mesh-ancestor
65201059|NCT00965562|Fluoxetine|fluoxetine|mesh-list
65201060|NCT00965562|Calcium|calcium|mesh-list
65201061|NCT00965562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65201062|NCT00965562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201063|NCT00965562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65201064|NCT00965562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65201065|NCT00965562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65201066|NCT00965562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201067|NCT00965562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65201068|NCT00965562|Serotonin Agents|serotonin agents|mesh-ancestor
65201069|NCT00965562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65201070|NCT00965562|Antidepressive Agents|antidepressive agents|mesh-ancestor
65201071|NCT00965562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65201072|NCT00965562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65201073|NCT00965562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65201074|NCT00965562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201075|NCT00659698|Pancrelipase|pancrelipase|mesh-list
65201076|NCT00659698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65201077|NCT00666796|Ethanol|ethanol|mesh-list
65201078|NCT00666796|Gabapentin|gabapentin|mesh-list
65201079|NCT00666796|Analgesics|analgesics|mesh-ancestor
65201080|NCT00666796|Sensory System Agents|sensory system agents|mesh-ancestor
65201081|NCT00666796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65201082|NCT00666796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201083|NCT00666796|Anticonvulsants|anticonvulsants|mesh-ancestor
65201084|NCT00666796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65201085|NCT00666796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65201086|NCT00666796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65201087|NCT00666796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65201088|NCT00666796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65201089|NCT00666796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65201090|NCT00666796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65201091|NCT00666796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201092|NCT00666796|Antimanic Agents|antimanic agents|mesh-ancestor
65201093|NCT00666796|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65201094|NCT00666796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65201095|NCT00912093|Icatibant|icatibant|mesh-list
65201096|NCT00912093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65201097|NCT00912093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65201101|NCT00912093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330444|NCT04076748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65330445|NCT04076748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330446|NCT04076748|Analgesics|analgesics|mesh-ancestor
65330447|NCT04076748|Sensory System Agents|sensory system agents|mesh-ancestor
65330448|NCT04076748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65330449|NCT04076748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65330450|NCT04076748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65330451|NCT04076748|Anesthetics, General|anesthetics, general|mesh-ancestor
65330452|NCT04076748|Anesthetics|anesthetics|mesh-ancestor
65330453|NCT00711087|Botulinum Toxins|botulinum toxins|mesh-list
65330454|NCT00711087|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65330455|NCT00711087|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65330456|NCT00711087|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65330457|NCT00711087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65330458|NCT00711087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330459|NCT00711087|Cholinergic Agents|cholinergic agents|mesh-ancestor
64716524|NCT03403712|Hormones|hormones|mesh-ancestor
65201102|NCT00912093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65201104|NCT00912093|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
65201105|NCT00912093|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
65201106|NCT00912093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201107|NCT00912093|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65201108|NCT00912093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65201109|NCT00912093|Immunologic Factors|immunologic factors|mesh-ancestor
65201110|NCT00659776|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65201111|NCT00659776|Hematinics|hematinics|mesh-ancestor
65201112|NCT00659776|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65201113|NCT00659776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65201114|NCT03500484|Liraglutide|liraglutide|mesh-list
65201115|NCT03500484|Glucagon|glucagon|mesh-list
65201116|NCT03500484|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65201117|NCT03500484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65201118|NCT03500484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201119|NCT03500484|Incretins|incretins|mesh-ancestor
65201120|NCT03500484|Hormones|hormones|mesh-ancestor
65201121|NCT03500484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65201122|NCT03500484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65201123|NCT03929601|Rituximab|rituximab|mesh-list
65201124|NCT03929601|Abatacept|abatacept|mesh-list
65201125|NCT03929601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65201126|NCT03929601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201127|NCT03929601|Immunologic Factors|immunologic factors|mesh-ancestor
65201128|NCT03929601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201129|NCT03929601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65201130|NCT03929601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65201131|NCT03929601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201132|NCT03929601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65201133|NCT02631460|Carboplatin|carboplatin|mesh-list
65201134|NCT02631460|Pemetrexed|pemetrexed|mesh-list
65201135|NCT02631460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201136|NCT02631460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201137|NCT02631460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201138|NCT02631460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65201139|NCT02631460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65201140|NCT04282824|Edetic Acid|edetic acid|mesh-list
65201141|NCT04282824|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65201142|NCT04282824|Chelating Agents|chelating agents|mesh-ancestor
65330460|NCT00711087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65330461|NCT00711087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330462|NCT00711087|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65330463|NCT00711087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65330464|NCT04272606|Tranexamic Acid|tranexamic acid|mesh-list
65330465|NCT04272606|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65330466|NCT04272606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65330467|NCT04272606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330468|NCT04272606|Hemostatics|hemostatics|mesh-ancestor
65330469|NCT04272606|Coagulants|coagulants|mesh-ancestor
65330470|NCT04262466|Pembrolizumab|pembrolizumab|mesh-list
65330471|NCT04262466|Atezolizumab|atezolizumab|mesh-list
64716533|NCT03404648|Choline|choline|mesh-list
65201143|NCT04282824|Sequestering Agents|sequestering agents|mesh-ancestor
65201144|NCT04282824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201145|NCT04282824|Anticoagulants|anticoagulants|mesh-ancestor
65201146|NCT04282824|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65201147|NCT04282824|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65201148|NCT00663286|Clindamycin|clindamycin|mesh-list
65201149|NCT00663286|Clindamycin palmitate|clindamycin palmitate|mesh-list
65201150|NCT00663286|Clindamycin phosphate|clindamycin phosphate|mesh-list
65201151|NCT00663286|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65201152|NCT00663286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65201153|NCT00663286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65201154|NCT00663286|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65201155|NCT00663286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201156|NCT00663286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201157|NCT00663286|Dermatologic Agents|dermatologic agents|mesh-ancestor
65201158|NCT03854019|Quinidine|quinidine|mesh-list
65201159|NCT03854019|Dextromethorphan|dextromethorphan|mesh-list
65201160|NCT03854019|Antitussive Agents|antitussive agents|mesh-ancestor
65201161|NCT03854019|Respiratory System Agents|respiratory system agents|mesh-ancestor
65201162|NCT03854019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65201163|NCT03854019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65201164|NCT03854019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65201165|NCT03854019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201166|NCT03854019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201167|NCT03854019|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65201168|NCT03854019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65201172|NCT03854019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65201173|NCT03854019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65201174|NCT03854019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65201175|NCT03854019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201176|NCT03854019|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65201177|NCT03854019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65201178|NCT03854019|Cholinergic Agents|cholinergic agents|mesh-ancestor
65201179|NCT03854019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65201180|NCT03854019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65201181|NCT03854019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65201182|NCT03854019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65201183|NCT03854019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65201185|NCT03237702|Antioxidants|antioxidants|mesh-ancestor
65201186|NCT03237702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201187|NCT03237702|Protective Agents|protective agents|mesh-ancestor
65201188|NCT03237702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201189|NCT00667108|Gabapentin|gabapentin|mesh-list
65201190|NCT00667108|Analgesics|analgesics|mesh-ancestor
65201191|NCT00667108|Sensory System Agents|sensory system agents|mesh-ancestor
65201192|NCT00667108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65201193|NCT00667108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201194|NCT00667108|Anticonvulsants|anticonvulsants|mesh-ancestor
65201195|NCT00667108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65330472|NCT04262466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65330473|NCT04262466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330474|NCT04255602|Ticagrelor|ticagrelor|mesh-list
65330475|NCT04255602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65330476|NCT04255602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65330477|NCT04255602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65330478|NCT04255602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65330479|NCT04255602|Purinergic Agents|purinergic agents|mesh-ancestor
65330480|NCT04255602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64716540|NCT03404648|Nootropic Agents|nootropic agents|mesh-ancestor
65201196|NCT00667108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65201197|NCT00667108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65201198|NCT00667108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65201199|NCT00667108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65201200|NCT00667108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65201201|NCT00667108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65201202|NCT00667108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201203|NCT00667108|Antimanic Agents|antimanic agents|mesh-ancestor
65201204|NCT00961116|Fenofibrate|fenofibrate|mesh-list
65201205|NCT00961116|Fenofibric acid|fenofibric acid|mesh-list
65201206|NCT00961116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65201207|NCT00961116|Antimetabolites|antimetabolites|mesh-ancestor
65201208|NCT00961116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201209|NCT00961116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65201210|NCT00961116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65201211|NCT04158388|Tryptophan|tryptophan|mesh-list
65201212|NCT04158388|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65201213|NCT04158388|Antidepressive Agents|antidepressive agents|mesh-ancestor
65201214|NCT04158388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65201215|NCT04283058|Ketamine|ketamine|mesh-list
65201216|NCT04283058|Anesthetics|anesthetics|mesh-list
65201217|NCT04283058|Analgesics|analgesics|mesh-ancestor
65201218|NCT04283058|Sensory System Agents|sensory system agents|mesh-ancestor
65201219|NCT04283058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65201220|NCT04283058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201221|NCT04283058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65201222|NCT04283058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65201223|NCT04283058|Anesthetics, General|anesthetics, general|mesh-ancestor
65201224|NCT04283058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65201225|NCT04283058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65201226|NCT04283058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65201227|NCT04283058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65201228|NCT04283058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201229|NCT00631995|Vaccines|vaccines|mesh-list
65201230|NCT00631995|Immunologic Factors|immunologic factors|mesh-ancestor
65201231|NCT00631995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201232|NCT00663442|Methylphenidate|methylphenidate|mesh-list
65201233|NCT00663442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65201234|NCT00663442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201235|NCT00663442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65201236|NCT00663442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65201237|NCT00663442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65201238|NCT00663442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201242|NCT00912015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65201243|NCT00912015|Narcotics|narcotics|mesh-ancestor
65201244|NCT00912015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65201245|NCT00912015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201246|NCT00912015|Analgesics|analgesics|mesh-ancestor
65201247|NCT00912015|Sensory System Agents|sensory system agents|mesh-ancestor
65201248|NCT00912015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65201249|NCT00960804|Tanezumab|tanezumab|mesh-list
65201250|NCT00960804|Analgesics|analgesics|mesh-ancestor
65201251|NCT00960804|Sensory System Agents|sensory system agents|mesh-ancestor
65330481|NCT04255602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330482|NCT04255602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330483|NCT00738530|Interferons|interferons|mesh-list
65330484|NCT00738530|Interferon-alpha|interferon-alpha|mesh-list
65330485|NCT00738530|Interferon alpha-2|interferon alpha-2|mesh-list
65330486|NCT00738530|Bevacizumab|bevacizumab|mesh-list
64716550|NCT03413618|Antithrombins|antithrombins|mesh-ancestor
65201252|NCT00960804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65201253|NCT00960804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201254|NCT01126580|Metformin|metformin|mesh-list
65201255|NCT01126580|Dulaglutide|dulaglutide|mesh-list
65201256|NCT01126580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65201257|NCT01126580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201258|NCT00911157|Heparin|heparin|mesh-list
65201259|NCT00911157|Calcium heparin|calcium heparin|mesh-list
65201261|NCT00911157|Fondaparinux|fondaparinux|mesh-list
65201262|NCT00911157|Anticoagulants|anticoagulants|mesh-ancestor
65201263|NCT00911157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65201264|NCT00911157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65201265|NCT00911157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201266|NCT00911157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65201267|NCT00911157|Antithrombins|antithrombins|mesh-ancestor
65201268|NCT00911157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65201269|NCT00911157|Protease Inhibitors|protease inhibitors|mesh-ancestor
65201270|NCT00911157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201271|NCT00960570|Efavirenz|efavirenz|mesh-list
65201272|NCT00960570|Fenofibric acid|fenofibric acid|mesh-list
65201273|NCT00960570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65201274|NCT00960570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65201275|NCT00960570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201276|NCT00960570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201277|NCT00960570|Antiviral Agents|antiviral agents|mesh-ancestor
65201278|NCT00960570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65201279|NCT00960570|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65201280|NCT00960570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65201281|NCT00960570|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65201282|NCT00960570|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65201283|NCT00960570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65201284|NCT00960570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65201285|NCT00960570|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65201286|NCT00960570|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65201287|NCT00960570|Antimetabolites|antimetabolites|mesh-ancestor
65201288|NCT00960570|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65201289|NCT04204278|Hyaluronic Acid|hyaluronic acid|mesh-list
65201290|NCT04204278|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65201291|NCT04204278|Immunologic Factors|immunologic factors|mesh-ancestor
65201292|NCT04204278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201293|NCT04204278|Viscosupplements|viscosupplements|mesh-ancestor
65201294|NCT04204278|Protective Agents|protective agents|mesh-ancestor
65201295|NCT00625430|Fludarabine|fludarabine|mesh-list
65201296|NCT00625430|Fludarabine phosphate|fludarabine phosphate|mesh-list
65201297|NCT00625430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201298|NCT00625430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65201299|NCT00625430|Antimetabolites|antimetabolites|mesh-ancestor
65201300|NCT00625430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201301|NCT00625430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65201302|NCT00625430|Immunologic Factors|immunologic factors|mesh-ancestor
65201303|NCT00625430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201304|NCT04282746|Ketamine|ketamine|mesh-list
65201305|NCT04282746|Analgesics|analgesics|mesh-ancestor
65201306|NCT04282746|Sensory System Agents|sensory system agents|mesh-ancestor
65201307|NCT04282746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65201308|NCT04282746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201309|NCT04282746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65201310|NCT04282746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65201311|NCT04282746|Anesthetics, General|anesthetics, general|mesh-ancestor
65201312|NCT04282746|Anesthetics|anesthetics|mesh-ancestor
65201313|NCT04282746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65330487|NCT00738530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65330488|NCT00738530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330489|NCT00738530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65330490|NCT00738530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65201317|NCT04282746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201318|NCT03328026|Interferons|interferons|mesh-list
65201319|NCT03328026|Cyclophosphamide|cyclophosphamide|mesh-list
65201320|NCT03328026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65201321|NCT03328026|Immunologic Factors|immunologic factors|mesh-ancestor
65201322|NCT03328026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201323|NCT03328026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65201324|NCT03328026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65201325|NCT03328026|Alkylating Agents|alkylating agents|mesh-ancestor
65201326|NCT03328026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201328|NCT03328026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65201329|NCT03328026|Antiviral Agents|antiviral agents|mesh-ancestor
65201330|NCT03328026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65201332|NCT03773445|Antibodies|antibodies|mesh-list
65201333|NCT03773445|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65201334|NCT03773445|Immunologic Factors|immunologic factors|mesh-ancestor
65201335|NCT03773445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201336|NCT03773445|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65201337|NCT03773445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65201338|NCT03773445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65201339|NCT00630084|Interferons|interferons|mesh-list
65201340|NCT00630084|Ribavirin|ribavirin|mesh-list
65201341|NCT00630084|Interferon-alpha|interferon-alpha|mesh-list
65201342|NCT00630084|Interferon alpha-2|interferon alpha-2|mesh-list
65201343|NCT00630084|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65201344|NCT00630084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201345|NCT00630084|Antiviral Agents|antiviral agents|mesh-ancestor
65201346|NCT00630084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65201347|NCT00630084|Antimetabolites|antimetabolites|mesh-ancestor
65201348|NCT00630084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201349|NCT00630084|Immunologic Factors|immunologic factors|mesh-ancestor
65201350|NCT00630084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201351|NCT01126424|Solifenacin Succinate|solifenacin succinate|mesh-list
65201352|NCT01126424|Oxybutynin|oxybutynin|mesh-list
65201353|NCT01126424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65201354|NCT01126424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65201355|NCT01126424|Cholinergic Agents|cholinergic agents|mesh-ancestor
65201356|NCT01126424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65201357|NCT01126424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201358|NCT01126424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201359|NCT01126424|Urological Agents|urological agents|mesh-ancestor
65201360|NCT01126424|Parasympatholytics|parasympatholytics|mesh-ancestor
65201361|NCT01126424|Autonomic Agents|autonomic agents|mesh-ancestor
65201362|NCT01126424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65201363|NCT04204902|Tepotinib|tepotinib|mesh-list
65201364|NCT04204902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201365|NCT01126268|Retapamulin|retapamulin|mesh-list
65201366|NCT01126268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65201367|NCT01126268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65201368|NCT04284150|Midazolam|midazolam|mesh-list
65201369|NCT04284150|Dexmedetomidine|dexmedetomidine|mesh-list
65201370|NCT04284150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65201371|NCT04284150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65201372|NCT04284150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201373|NCT04284150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65201374|NCT04284150|Analgesics|analgesics|mesh-ancestor
65201375|NCT04284150|Sensory System Agents|sensory system agents|mesh-ancestor
65201376|NCT04284150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65201377|NCT04284150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65201378|NCT04284150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65201379|NCT04284150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65201380|NCT04284150|Adrenergic Agents|adrenergic agents|mesh-ancestor
65201381|NCT04284150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65201382|NCT04284150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201383|NCT04284150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65201384|NCT04284150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65201385|NCT04284150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65330491|NCT00738530|Growth Substances|growth substances|mesh-ancestor
65330492|NCT00738530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330493|NCT00738530|Growth Inhibitors|growth inhibitors|mesh-ancestor
65330494|NCT00738530|Antiviral Agents|antiviral agents|mesh-ancestor
65330495|NCT00738530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65330496|NCT00738530|Immunologic Factors|immunologic factors|mesh-ancestor
65330498|NCT04077684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330499|NCT04077684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65330500|NCT04077684|Analgesics|analgesics|mesh-ancestor
65330501|NCT04077684|Sensory System Agents|sensory system agents|mesh-ancestor
65330502|NCT04077684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65330503|NCT04077684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330504|NCT00711009|Ritonavir|ritonavir|mesh-list
65330505|NCT00711009|Lopinavir|lopinavir|mesh-list
65330506|NCT00711009|Tenofovir|tenofovir|mesh-list
65330507|NCT00711009|Emtricitabine|emtricitabine|mesh-list
65330508|NCT00711009|Raltegravir Potassium|raltegravir potassium|mesh-list
64716563|NCT03523988|Antipyretics|antipyretics|mesh-ancestor
65201386|NCT04284150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65201387|NCT04284150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65201388|NCT04284150|Anesthetics, General|anesthetics, general|mesh-ancestor
65201390|NCT04284150|GABA Modulators|gaba modulators|mesh-ancestor
65201391|NCT04284150|GABA Agents|gaba agents|mesh-ancestor
65201392|NCT03311334|Pembrolizumab|pembrolizumab|mesh-list
65201393|NCT03311334|Nivolumab|nivolumab|mesh-list
65201394|NCT03311334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65201395|NCT03311334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201396|NCT03311334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65201397|NCT03311334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201398|NCT04313036|Defibrotide|defibrotide|mesh-list
65201399|NCT04313036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65201400|NCT04313036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65201401|NCT04313036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201402|NCT04313036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65201403|NCT00879658|Siponimod|siponimod|mesh-list
65201404|NCT00879658|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65201405|NCT00879658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201406|NCT00879658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65201407|NCT00879658|Immunologic Factors|immunologic factors|mesh-ancestor
65201408|NCT00879658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201409|NCT00959946|Capecitabine|capecitabine|mesh-list
65201410|NCT00959946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65201411|NCT00959946|Antimetabolites|antimetabolites|mesh-ancestor
65201412|NCT00959946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201413|NCT00959946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201414|NCT00667264|Ropivacaine|ropivacaine|mesh-list
65201415|NCT00667264|Anesthetics, Local|anesthetics, local|mesh-ancestor
65201416|NCT00667264|Anesthetics|anesthetics|mesh-ancestor
65201417|NCT00667264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65201418|NCT00667264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201419|NCT00667264|Sensory System Agents|sensory system agents|mesh-ancestor
65201420|NCT00667264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65201421|NCT00660244|Anastrozole|anastrozole|mesh-list
65201422|NCT00660244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65201423|NCT00660244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201424|NCT00660244|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65201425|NCT00660244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65201426|NCT00660244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330509|NCT00711009|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65330510|NCT00711009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65330511|NCT00711009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65330512|NCT00711009|Protease Inhibitors|protease inhibitors|mesh-ancestor
65201427|NCT00660244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201428|NCT00660244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65201429|NCT00660244|Hormone Antagonists|hormone antagonists|mesh-ancestor
65201430|NCT00660244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65201431|NCT00660244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201432|NCT04282200|Ketorolac|ketorolac|mesh-list
65201433|NCT04282200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65201434|NCT04282200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65201435|NCT04282200|Analgesics|analgesics|mesh-ancestor
65201436|NCT04282200|Sensory System Agents|sensory system agents|mesh-ancestor
65201437|NCT04282200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65201438|NCT04282200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201439|NCT04282200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65201440|NCT04282200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65201441|NCT04282200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65201442|NCT04282200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201443|NCT04282200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201444|NCT00667498|Metformin|metformin|mesh-list
65201445|NCT00667498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65201446|NCT00667498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201447|NCT00667966|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65201448|NCT00667966|Vasodilator Agents|vasodilator agents|mesh-ancestor
65201449|NCT00667966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65201450|NCT00667966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65201451|NCT00667966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201452|NCT00667966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201453|NCT00667966|Urological Agents|urological agents|mesh-ancestor
65201454|NCT04283916|Botulinum Toxins|botulinum toxins|mesh-list
65201455|NCT04283916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65201456|NCT04283916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65201457|NCT04283916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201458|NCT04283916|Cholinergic Agents|cholinergic agents|mesh-ancestor
65201462|NCT00911937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65201463|NCT00911937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65201464|NCT00911937|Cholinergic Agents|cholinergic agents|mesh-ancestor
65201465|NCT00911937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65201466|NCT00911937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201467|NCT00911937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201468|NCT00911937|Urological Agents|urological agents|mesh-ancestor
65201469|NCT00663598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65201470|NCT00663598|Vasodilator Agents|vasodilator agents|mesh-ancestor
65201471|NCT00663598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65201472|NCT00663598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65201473|NCT00663598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201474|NCT00663598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201475|NCT00663598|Urological Agents|urological agents|mesh-ancestor
65201477|NCT02946996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65201478|NCT02946996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201479|NCT04166877|Magnesium Sulfate|magnesium sulfate|mesh-list
65201480|NCT04166877|Analgesics|analgesics|mesh-ancestor
65201481|NCT04166877|Sensory System Agents|sensory system agents|mesh-ancestor
65201482|NCT04166877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65201483|NCT04166877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201484|NCT04166877|Anesthetics|anesthetics|mesh-ancestor
65201485|NCT04166877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65201486|NCT04166877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65201487|NCT04166877|Anticonvulsants|anticonvulsants|mesh-ancestor
65201488|NCT04166877|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65201489|NCT04166877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65201490|NCT04166877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201491|NCT04166877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65201492|NCT04166877|Tocolytic Agents|tocolytic agents|mesh-ancestor
65330513|NCT00711009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330514|NCT00711009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330515|NCT00711009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65330516|NCT00711009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65330517|NCT00711009|Antiviral Agents|antiviral agents|mesh-ancestor
65330518|NCT00711009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64716584|NCT03528512|Anesthetics, General|anesthetics, general|mesh-ancestor
65201493|NCT04166877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65201494|NCT02859480|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65201495|NCT02859480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65201496|NCT02859480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65201497|NCT02859480|Antimetabolites|antimetabolites|mesh-ancestor
65201498|NCT02859480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201499|NCT02859480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65201500|NCT02859480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65201501|NCT02859480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201503|NCT03188796|Cholecalciferol|cholecalciferol|mesh-list
65201504|NCT03188796|Vitamins|vitamins|mesh-ancestor
65201505|NCT03188796|Micronutrients|micronutrients|mesh-ancestor
65201506|NCT03188796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201507|NCT03188796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65201508|NCT03188796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65201509|NCT03164928|Denosumab|denosumab|mesh-list
65201510|NCT03164928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65201511|NCT03164928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201512|NCT01076543|Sirolimus|sirolimus|mesh-list
65201513|NCT01076543|Lenalidomide|lenalidomide|mesh-list
65201514|NCT01076543|Immunologic Factors|immunologic factors|mesh-ancestor
65201515|NCT01076543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201516|NCT01076543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65201517|NCT01076543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65201518|NCT01076543|Growth Substances|growth substances|mesh-ancestor
65201519|NCT01076543|Growth Inhibitors|growth inhibitors|mesh-ancestor
65201520|NCT01076543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201521|NCT01076543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65201522|NCT01076543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65201523|NCT01076543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65201524|NCT01076543|Antifungal Agents|antifungal agents|mesh-ancestor
65201525|NCT01076543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65201526|NCT00668044|Ciprofloxacin|ciprofloxacin|mesh-list
65201527|NCT00668044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65201528|NCT00668044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65201529|NCT00668044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65201530|NCT00668044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65201531|NCT00668044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201534|NCT00668044|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65201535|NCT00668044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65201537|NCT02860494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201538|NCT02860494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65201539|NCT02860494|Immunologic Factors|immunologic factors|mesh-ancestor
65201540|NCT02860494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201541|NCT00663832|Panobinostat|panobinostat|mesh-list
65201542|NCT00663832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201543|NCT00663832|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65201544|NCT00663832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201545|NCT00663832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201546|NCT04281576|Capecitabine|capecitabine|mesh-list
65201547|NCT04281576|Oxaliplatin|oxaliplatin|mesh-list
65201548|NCT04281576|Trastuzumab|trastuzumab|mesh-list
65201549|NCT04281576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65201550|NCT04281576|Antimetabolites|antimetabolites|mesh-ancestor
65201551|NCT04281576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201552|NCT04281576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201553|NCT04281576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65201554|NCT00668122|Ciprofloxacin|ciprofloxacin|mesh-list
65201555|NCT00668122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65201556|NCT00668122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65330519|NCT00711009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65330520|NCT00711009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65330521|NCT00711009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65330522|NCT00711009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65330523|NCT00711009|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65201557|NCT00668122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65201558|NCT00668122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65201559|NCT00668122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201560|NCT00668122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201561|NCT00668122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201562|NCT00668122|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65201563|NCT00668122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65201564|NCT04304807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65201566|NCT04304807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65201567|NCT04304807|Antioxidants|antioxidants|mesh-ancestor
65201568|NCT04304807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201569|NCT04304807|Protective Agents|protective agents|mesh-ancestor
65201570|NCT04304807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201571|NCT04304807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65201572|NCT04280874|Dinoprostone|dinoprostone|mesh-list
65201573|NCT04280874|Oxytocics|oxytocics|mesh-ancestor
65201574|NCT04280874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65201575|NCT04280874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201576|NCT00663910|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65201577|NCT00663910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65201578|NCT00663910|Dermatologic Agents|dermatologic agents|mesh-ancestor
65201579|NCT04157998|Metoclopramide|metoclopramide|mesh-list
65201580|NCT04157998|Antiemetics|antiemetics|mesh-ancestor
65201581|NCT04157998|Autonomic Agents|autonomic agents|mesh-ancestor
65201582|NCT04157998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65201583|NCT04157998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201584|NCT04157998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65201585|NCT04157998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65201586|NCT04157998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65201587|NCT04157998|Dopamine Agents|dopamine agents|mesh-ancestor
65201588|NCT04157998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65201589|NCT04157998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201590|NCT01072877|Polidocanol|polidocanol|mesh-list
65201591|NCT01072877|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65201592|NCT01072877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65201593|NCT00630474|Xylometazoline|xylometazoline|mesh-list
64844216|NCT01667692|Azithromycin|azithromycin|mesh-list
65201594|NCT00630474|Nasal Decongestants|nasal decongestants|mesh-ancestor
65201595|NCT00630474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65201596|NCT00630474|Respiratory System Agents|respiratory system agents|mesh-ancestor
65201597|NCT00957528|Methyltestosterone|methyltestosterone|mesh-list
65201598|NCT00957528|Testosterone|testosterone|mesh-list
65201599|NCT00957528|Testosterone undecanoate|testosterone undecanoate|mesh-list
65201600|NCT00957528|Testosterone enanthate|testosterone enanthate|mesh-list
65201601|NCT00957528|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65201602|NCT00957528|Androgens|androgens|mesh-ancestor
65201603|NCT00957528|Hormones|hormones|mesh-ancestor
65201606|NCT00957528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65201607|NCT00957528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201608|NCT00957528|Anabolic Agents|anabolic agents|mesh-ancestor
65201609|NCT02857062|Emollients|emollients|mesh-list
65201610|NCT02857062|Dermatologic Agents|dermatologic agents|mesh-ancestor
65201611|NCT00958776|Peramivir|peramivir|mesh-list
65201612|NCT00958776|Antiviral Agents|antiviral agents|mesh-ancestor
65201613|NCT00958776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65201614|NCT00958776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201615|NCT00958776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201616|NCT02858856|Juzentaihoto|juzentaihoto|mesh-list
65201617|NCT02858856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201618|NCT02858856|Mitogens|mitogens|mesh-ancestor
65201619|NCT02858856|Mitosis Modulators|mitosis modulators|mesh-ancestor
65201620|NCT02858856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201621|NCT02858622|Fentanyl|fentanyl|mesh-list
65201622|NCT02858622|Meperidine|meperidine|mesh-list
65201623|NCT02858622|Bupivacaine|bupivacaine|mesh-list
65330524|NCT00711009|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65330525|NCT05674656|Dolutegravir|dolutegravir|mesh-list
65330526|NCT05674656|Rilpivirine|rilpivirine|mesh-list
65330527|NCT05674656|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
65330528|NCT05674656|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65330529|NCT05674656|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65330530|NCT05674656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201624|NCT02858622|Anesthetics, Local|anesthetics, local|mesh-ancestor
65201625|NCT02858622|Anesthetics|anesthetics|mesh-ancestor
65201626|NCT02858622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65201627|NCT02858622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201628|NCT02858622|Sensory System Agents|sensory system agents|mesh-ancestor
65201629|NCT02858622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65201630|NCT02858622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65201631|NCT02858622|Narcotics|narcotics|mesh-ancestor
65201632|NCT02858622|Analgesics|analgesics|mesh-ancestor
65201633|NCT02858622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65201634|NCT02858622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65201635|NCT02858622|Anesthetics, General|anesthetics, general|mesh-ancestor
65201636|NCT02191566|Oxaliplatin|oxaliplatin|mesh-list
65201637|NCT02191566|Tegafur|tegafur|mesh-list
65201638|NCT02191566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201639|NCT02191566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65201640|NCT02191566|Antimetabolites|antimetabolites|mesh-ancestor
65201641|NCT02191566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201642|NCT00596830|Paclitaxel|paclitaxel|mesh-list
65201643|NCT00596830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65201644|NCT00596830|Carboplatin|carboplatin|mesh-list
65201645|NCT00596830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65201646|NCT00596830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201647|NCT00596830|Tubulin Modulators|tubulin modulators|mesh-ancestor
65201648|NCT00596830|Antimitotic Agents|antimitotic agents|mesh-ancestor
65201649|NCT00596830|Mitosis Modulators|mitosis modulators|mesh-ancestor
65201650|NCT00596830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201651|NCT00957372|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
65201652|NCT00957372|Anticonvulsants|anticonvulsants|mesh-ancestor
65201653|NCT00957372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65201654|NCT00957372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65201655|NCT00957372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65201656|NCT00957372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201657|NCT04270968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65201658|NCT05143164|Gentamicins|gentamicins|mesh-list
65201659|NCT05143164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65201660|NCT05143164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65201661|NCT05143164|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65201662|NCT05143164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201663|NCT05143164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201664|NCT00664144|Rasburicase|rasburicase|mesh-list
65201665|NCT00664144|Gout Suppressants|gout suppressants|mesh-ancestor
65201666|NCT00664144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65201667|NCT02819856|Ebselen|ebselen|mesh-list
65201668|NCT02819856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64844290|NCT01668121|Hormones|hormones|mesh-ancestor
65201669|NCT02819856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65201671|NCT02819856|Sensory System Agents|sensory system agents|mesh-ancestor
65201672|NCT02819856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65201673|NCT02819856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201674|NCT02819856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65201675|NCT02819856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65201676|NCT02819856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65201679|NCT02819856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201681|NCT02819856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65201682|NCT02819856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201683|NCT02819856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65201684|NCT02630290|Dexmedetomidine|dexmedetomidine|mesh-list
65201685|NCT02630290|Ropivacaine|ropivacaine|mesh-list
65201686|NCT02630290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65201687|NCT02630290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65330531|NCT05674656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330532|NCT05674656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65330533|NCT05674656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65330534|NCT05674656|Antiviral Agents|antiviral agents|mesh-ancestor
65330535|NCT05674656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64716602|NCT02133924|Natalizumab|natalizumab|mesh-list
65201688|NCT02630290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201689|NCT02630290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65201690|NCT02630290|Analgesics|analgesics|mesh-ancestor
65201691|NCT02630290|Sensory System Agents|sensory system agents|mesh-ancestor
65201692|NCT02630290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65201693|NCT02630290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65201694|NCT02630290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65201695|NCT02630290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65201696|NCT02630290|Adrenergic Agents|adrenergic agents|mesh-ancestor
65201697|NCT02630290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65201698|NCT02630290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201699|NCT02630290|Anesthetics, Local|anesthetics, local|mesh-ancestor
65201701|NCT04155190|Veratrum Alkaloids|veratrum alkaloids|mesh-list
65201702|NCT04155190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65201703|NCT02856906|Salicylic Acid|salicylic acid|mesh-list
65201704|NCT02856906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65201705|NCT02856906|Antifungal Agents|antifungal agents|mesh-ancestor
65201706|NCT02856906|Keratolytic Agents|keratolytic agents|mesh-ancestor
65201707|NCT02856906|Dermatologic Agents|dermatologic agents|mesh-ancestor
65201708|NCT00668356|Didanosine|didanosine|mesh-list
65201709|NCT00668356|Antimetabolites|antimetabolites|mesh-ancestor
65201710|NCT00668356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201711|NCT00668356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65201712|NCT00668356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65201713|NCT00668356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201714|NCT00668356|Antiviral Agents|antiviral agents|mesh-ancestor
65201715|NCT00668356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65201716|NCT00668356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65201717|NCT00668356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65201718|NCT00664222|Furosemide|furosemide|mesh-list
65201719|NCT00664222|Spironolactone|spironolactone|mesh-list
65201720|NCT00664222|Diuretics|diuretics|mesh-ancestor
65201721|NCT00664222|Natriuretic Agents|natriuretic agents|mesh-ancestor
65201722|NCT00664222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201723|NCT00664222|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65201724|NCT00664222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65201725|NCT00664222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201726|NCT00664222|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65201727|NCT00664222|Hormone Antagonists|hormone antagonists|mesh-ancestor
65201728|NCT00664222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65201729|NCT00664222|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65201730|NCT02554812|Avelumab|avelumab|mesh-list
65201731|NCT02554812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65201732|NCT02554812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201733|NCT00952614|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
65201734|NCT00952614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65201735|NCT00952614|Glucocorticoids|glucocorticoids|mesh-ancestor
65201736|NCT00952614|Hormones|hormones|mesh-ancestor
65201737|NCT00952614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65201738|NCT00952614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201739|NCT00911859|Prednisone|prednisone|mesh-list
65201740|NCT00911859|Bortezomib|bortezomib|mesh-list
65201741|NCT00911859|Melphalan|melphalan|mesh-list
65201742|NCT00911859|Siltuximab|siltuximab|mesh-list
65201743|NCT00911859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65201744|NCT00911859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65201745|NCT00911859|Glucocorticoids|glucocorticoids|mesh-ancestor
65201746|NCT00911859|Hormones|hormones|mesh-ancestor
65201747|NCT00911859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65201748|NCT00911859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201749|NCT00911859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65201752|NCT00911859|Alkylating Agents|alkylating agents|mesh-ancestor
65330536|NCT05674656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65330537|NCT05674656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65330538|NCT02567799|Paclitaxel|paclitaxel|mesh-list
65330539|NCT02567799|Carboplatin|carboplatin|mesh-list
65330540|NCT02567799|Genistein|genistein|mesh-list
65330541|NCT02567799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65330542|NCT02567799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330543|NCT02567799|Tubulin Modulators|tubulin modulators|mesh-ancestor
65330544|NCT02567799|Antimitotic Agents|antimitotic agents|mesh-ancestor
65330545|NCT02567799|Mitosis Modulators|mitosis modulators|mesh-ancestor
65330546|NCT02567799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330547|NCT02567799|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65330548|NCT02567799|Protective Agents|protective agents|mesh-ancestor
65330549|NCT02567799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330550|NCT02567799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65330551|NCT02567799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330552|NCT02567799|Phytoestrogens|phytoestrogens|mesh-ancestor
65330553|NCT02567799|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65330554|NCT02567799|Estrogens|estrogens|mesh-ancestor
65330555|NCT02567799|Hormones|hormones|mesh-ancestor
65330556|NCT02567799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65330557|NCT04032990|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
65330558|NCT04032990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65330559|NCT04032990|Immunologic Factors|immunologic factors|mesh-ancestor
65330560|NCT04032990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330561|NCT00921219|Ivermectin|ivermectin|mesh-list
65330562|NCT00921219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65330563|NCT00921219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65201753|NCT00911859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201754|NCT00911859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65201755|NCT00911859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65201756|NCT00911859|Immunologic Factors|immunologic factors|mesh-ancestor
65201757|NCT00955968|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65201758|NCT00955968|Antiviral Agents|antiviral agents|mesh-ancestor
65201759|NCT00955968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65201760|NCT02725593|Dapagliflozin|dapagliflozin|mesh-list
65201761|NCT02725593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65201762|NCT02725593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201763|NCT02725593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65201764|NCT02725593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201765|NCT00911625|Insulin|insulin|mesh-list
65201766|NCT00911625|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65201767|NCT00911625|Insulin Glargine|insulin glargine|mesh-list
65201768|NCT00911625|Insulin glulisine|insulin glulisine|mesh-list
65201769|NCT00911625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65201770|NCT00911625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330564|NCT02567331|Capecitabine|capecitabine|mesh-list
65330565|NCT02567331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65330566|NCT02567331|Antimetabolites|antimetabolites|mesh-ancestor
65330567|NCT02567331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330568|NCT02567331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330569|NCT00577005|Levetiracetam|levetiracetam|mesh-list
65330570|NCT00577005|Anticonvulsants|anticonvulsants|mesh-ancestor
65330571|NCT00577005|Nootropic Agents|nootropic agents|mesh-ancestor
65330572|NCT02581566|Dexmedetomidine|dexmedetomidine|mesh-list
65330573|NCT02581566|Bupivacaine|bupivacaine|mesh-list
65201771|NCT00596752|Alprostadil|alprostadil|mesh-list
65201772|NCT00596752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65201773|NCT00596752|Vasodilator Agents|vasodilator agents|mesh-ancestor
65201774|NCT00596752|Urological Agents|urological agents|mesh-ancestor
65201775|NCT04151277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65201776|NCT04151277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201778|NCT00958074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201779|NCT00958074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65201780|NCT00958074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201781|NCT00958074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201782|NCT00660868|Pentoxifylline|pentoxifylline|mesh-list
65201783|NCT00660868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65201784|NCT00660868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201785|NCT00660868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201786|NCT00660868|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65201787|NCT00660868|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65201788|NCT00660868|Protective Agents|protective agents|mesh-ancestor
65201789|NCT00660868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201790|NCT00660868|Vasodilator Agents|vasodilator agents|mesh-ancestor
65201791|NCT00660868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65201792|NCT00660868|Antioxidants|antioxidants|mesh-ancestor
65201793|NCT00664690|Celecoxib|celecoxib|mesh-list
65201794|NCT00664690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65201795|NCT00664690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65201796|NCT00664690|Analgesics|analgesics|mesh-ancestor
65201797|NCT00664690|Sensory System Agents|sensory system agents|mesh-ancestor
65201798|NCT00664690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65201799|NCT00664690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201800|NCT00664690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65201801|NCT00664690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65201802|NCT00664690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65201803|NCT00664690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65201804|NCT00664690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201805|NCT00664690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201806|NCT00809965|Rivaroxaban|rivaroxaban|mesh-list
65201807|NCT00809965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65201808|NCT00809965|Antithrombins|antithrombins|mesh-ancestor
65201809|NCT00809965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65201810|NCT00809965|Protease Inhibitors|protease inhibitors|mesh-ancestor
65201811|NCT00809965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201812|NCT00809965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201813|NCT00809965|Anticoagulants|anticoagulants|mesh-ancestor
65201814|NCT04338165|Evolocumab|evolocumab|mesh-list
65201815|NCT04338165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65201816|NCT04338165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65201817|NCT04338165|Antimetabolites|antimetabolites|mesh-ancestor
65201818|NCT04338165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201819|NCT04338165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65201820|NCT00664846|Aspirin|aspirin|mesh-list
65201821|NCT00664846|Clopidogrel|clopidogrel|mesh-list
65201822|NCT00664846|Atorvastatin|atorvastatin|mesh-list
65201823|NCT00664846|Simvastatin|simvastatin|mesh-list
65201831|NCT00664846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65201832|NCT00664846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65201833|NCT00664846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65201834|NCT00664846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330574|NCT02581566|Anesthetics, Local|anesthetics, local|mesh-ancestor
65330575|NCT02581566|Anesthetics|anesthetics|mesh-ancestor
65330576|NCT02581566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65330577|NCT02581566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330578|NCT02581566|Sensory System Agents|sensory system agents|mesh-ancestor
64716646|NCT03538808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65201835|NCT00664846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65201836|NCT00664846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65201837|NCT00664846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201838|NCT00664846|Antipyretics|antipyretics|mesh-ancestor
65201839|NCT00664846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65201840|NCT00664846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65201841|NCT00664846|Antimetabolites|antimetabolites|mesh-ancestor
65201842|NCT00664846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65201843|NCT00664846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65201844|NCT00664846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65201845|NCT00664846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65201846|NCT00664846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65201847|NCT00664846|Purinergic Agents|purinergic agents|mesh-ancestor
65201848|NCT00664846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65201849|NCT00913783|Clomipramine|clomipramine|mesh-list
65201850|NCT00913783|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65201851|NCT00913783|Antidepressive Agents|antidepressive agents|mesh-ancestor
65201852|NCT00913783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65201853|NCT00913783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65201854|NCT00913783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65201855|NCT00913783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65201856|NCT00913783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201857|NCT00913783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65201858|NCT00913783|Serotonin Agents|serotonin agents|mesh-ancestor
65201859|NCT00913783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201860|NCT00661102|Capecitabine|capecitabine|mesh-list
65201861|NCT00661102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65201862|NCT00661102|Antimetabolites|antimetabolites|mesh-ancestor
65201863|NCT00661102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201864|NCT00661102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201865|NCT00669370|Docetaxel|docetaxel|mesh-list
65201866|NCT00669370|Capecitabine|capecitabine|mesh-list
65201867|NCT00669370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201868|NCT00669370|Tubulin Modulators|tubulin modulators|mesh-ancestor
65201869|NCT00669370|Antimitotic Agents|antimitotic agents|mesh-ancestor
65201870|NCT00669370|Mitosis Modulators|mitosis modulators|mesh-ancestor
65201871|NCT00669370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201872|NCT00669370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65201873|NCT00669370|Antimetabolites|antimetabolites|mesh-ancestor
65201874|NCT00665314|Plerixafor|plerixafor|mesh-list
65201875|NCT00665314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65201876|NCT00665314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65201877|NCT00665314|Antiviral Agents|antiviral agents|mesh-ancestor
65201878|NCT00665314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65201879|NCT04154722|Azithromycin|azithromycin|mesh-list
65201880|NCT04154722|Meropenem|meropenem|mesh-list
65201881|NCT04154722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65201882|NCT04154722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65201883|NCT02631928|Insulin|insulin|mesh-list
65201884|NCT02631928|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65201885|NCT02631928|Biphasic Insulins|biphasic insulins|mesh-list
65201886|NCT02631928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65201887|NCT02631928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201888|NCT00632385|Eletriptan|eletriptan|mesh-list
65201889|NCT00632385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65201890|NCT00632385|Serotonin Agents|serotonin agents|mesh-ancestor
65201891|NCT00632385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65201910|NCT04164979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201911|NCT04669717|Amoxicillin|amoxicillin|mesh-list
65201912|NCT04669717|Azithromycin|azithromycin|mesh-list
65201913|NCT04669717|Metronidazole|metronidazole|mesh-list
65201914|NCT04669717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65201915|NCT04669717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65201916|NCT04669717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65201917|NCT04669717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65330579|NCT02581566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65330580|NCT02581566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65330581|NCT02581566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65330582|NCT02581566|Analgesics|analgesics|mesh-ancestor
64716651|NCT00377000|Clindamycin phosphate|clindamycin phosphate|mesh-list
65201918|NCT00809341|Prednisone|prednisone|mesh-list
65201919|NCT00809341|Cyclophosphamide|cyclophosphamide|mesh-list
65201920|NCT00809341|Ifosfamide|ifosfamide|mesh-list
65201921|NCT00809341|Rituximab|rituximab|mesh-list
65201922|NCT00809341|Carboplatin|carboplatin|mesh-list
65201923|NCT00809341|Doxorubicin|doxorubicin|mesh-list
65201924|NCT00809341|Etoposide|etoposide|mesh-list
65201925|NCT00809341|Vincristine|vincristine|mesh-list
65201926|NCT00809341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65201927|NCT00809341|Immunologic Factors|immunologic factors|mesh-ancestor
65201928|NCT00809341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201929|NCT00809341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65201930|NCT00809341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65201931|NCT00809341|Alkylating Agents|alkylating agents|mesh-ancestor
65201932|NCT00809341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201933|NCT00809341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201934|NCT00809341|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65201935|NCT00809341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65201936|NCT00809341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65201937|NCT00809341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65201938|NCT00809341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65201939|NCT00809341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201940|NCT00809341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65201942|NCT00809341|Hormones|hormones|mesh-ancestor
65201943|NCT00809341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65201944|NCT00809341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65201945|NCT00809341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65201946|NCT00809341|Tubulin Modulators|tubulin modulators|mesh-ancestor
65201947|NCT00809341|Antimitotic Agents|antimitotic agents|mesh-ancestor
65201948|NCT00809341|Mitosis Modulators|mitosis modulators|mesh-ancestor
65201949|NCT02609581|Immunologic Factors|immunologic factors|mesh-list
65201953|NCT00811135|Capecitabine|capecitabine|mesh-list
65201954|NCT00811135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65201955|NCT00811135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201956|NCT00811135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65201957|NCT00811135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65201958|NCT00811135|Growth Substances|growth substances|mesh-ancestor
65201959|NCT00811135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201960|NCT00811135|Growth Inhibitors|growth inhibitors|mesh-ancestor
65201961|NCT00811135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65201962|NCT00811135|Antimetabolites|antimetabolites|mesh-ancestor
65201963|NCT00811135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201964|NCT00811057|Indomethacin|indomethacin|mesh-list
65201965|NCT00811057|Magnesium Sulfate|magnesium sulfate|mesh-list
65201966|NCT00811057|Nifedipine|nifedipine|mesh-list
65201967|NCT00811057|Analgesics|analgesics|mesh-ancestor
65201968|NCT00811057|Sensory System Agents|sensory system agents|mesh-ancestor
65201969|NCT00811057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844592|NCT01670370|Antiviral Agents|antiviral agents|mesh-ancestor
65201970|NCT00811057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201972|NCT00811057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65201973|NCT00811057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65201974|NCT00811057|Anticonvulsants|anticonvulsants|mesh-ancestor
65201975|NCT00811057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65201976|NCT00811057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65201977|NCT00811057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201978|NCT00811057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65201979|NCT00811057|Tocolytic Agents|tocolytic agents|mesh-ancestor
65201980|NCT00811057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65201981|NCT00811057|Vasodilator Agents|vasodilator agents|mesh-ancestor
65201982|NCT00811057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65201983|NCT00811057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65201984|NCT00811057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65201985|NCT00811057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65201986|NCT00811057|Gout Suppressants|gout suppressants|mesh-ancestor
65330583|NCT02581566|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65330584|NCT02581566|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65330585|NCT02581566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65330586|NCT02581566|Adrenergic Agents|adrenergic agents|mesh-ancestor
65330587|NCT02581566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65330588|NCT02581566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330589|NCT04003506|Bupivacaine|bupivacaine|mesh-list
65330590|NCT04003506|Anesthetics, Local|anesthetics, local|mesh-ancestor
65330591|NCT04003506|Anesthetics|anesthetics|mesh-ancestor
65330592|NCT04003506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65330593|NCT04003506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330594|NCT04003506|Sensory System Agents|sensory system agents|mesh-ancestor
65330595|NCT04003506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65330596|NCT00698841|Cetuximab|cetuximab|mesh-list
65330597|NCT00698841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65330598|NCT00698841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330599|NCT00577395|Risedronic Acid|risedronic acid|mesh-list
65330600|NCT00577395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65330601|NCT00577395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65330602|NCT00577395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330603|NCT00577395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65330604|NCT00577395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330605|NCT00577395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65330606|NCT04062357|Lidocaine|lidocaine|mesh-list
64716661|NCT04501640|Mirabegron|mirabegron|mesh-list
65201987|NCT00811057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65201988|NCT00811057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65201989|NCT00879970|Vitamin D|vitamin d|mesh-list
65201990|NCT00879970|Pioglitazone|pioglitazone|mesh-list
65201991|NCT00879970|Rosiglitazone|rosiglitazone|mesh-list
65201992|NCT00879970|Vitamins|vitamins|mesh-ancestor
65201993|NCT00879970|Micronutrients|micronutrients|mesh-ancestor
65201994|NCT00879970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201995|NCT00879970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65201996|NCT00879970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65201997|NCT00808639|Doxorubicin|doxorubicin|mesh-list
65201998|NCT00808639|Methotrexate|methotrexate|mesh-list
65201999|NCT00808639|Vinblastine|vinblastine|mesh-list
65202000|NCT00808639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507137|NCT02474706|Imipenem|imipenem|mesh-list
65202001|NCT00808639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65202002|NCT00808639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65202003|NCT00808639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65202004|NCT00808639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202005|NCT00808639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202006|NCT00808639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65202007|NCT00808639|Abortifacient Agents|abortifacient agents|mesh-ancestor
65202008|NCT00808639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65202009|NCT00808639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330607|NCT04062357|Anesthetics, Local|anesthetics, local|mesh-ancestor
65330608|NCT04062357|Anesthetics|anesthetics|mesh-ancestor
65330609|NCT04062357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65330610|NCT04062357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330611|NCT04062357|Sensory System Agents|sensory system agents|mesh-ancestor
65330612|NCT04062357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65330613|NCT04062357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65330614|NCT04062357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65330615|NCT04062357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65330616|NCT04062357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64716679|NCT03633344|Micronutrients|micronutrients|mesh-ancestor
65202010|NCT00808639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65202011|NCT00808639|Antimetabolites|antimetabolites|mesh-ancestor
65202012|NCT00808639|Dermatologic Agents|dermatologic agents|mesh-ancestor
65202013|NCT00808639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65202014|NCT00808639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65202015|NCT00808639|Immunologic Factors|immunologic factors|mesh-ancestor
65202016|NCT00808639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65202017|NCT00808639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65202018|NCT00808639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65202019|NCT00808639|Tubulin Modulators|tubulin modulators|mesh-ancestor
65202020|NCT00808639|Antimitotic Agents|antimitotic agents|mesh-ancestor
65202021|NCT00808639|Mitosis Modulators|mitosis modulators|mesh-ancestor
65202024|NCT00910299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65202025|NCT00910299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65202026|NCT00910299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65202027|NCT00910299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65202028|NCT00910299|Purinergic Agents|purinergic agents|mesh-ancestor
65202029|NCT00910299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65202030|NCT00910299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202031|NCT00910299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202032|NCT03007329|Dapagliflozin|dapagliflozin|mesh-list
65202033|NCT03007329|Exenatide|exenatide|mesh-list
65202034|NCT03007329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65202035|NCT03007329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202036|NCT03007329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65202037|NCT03007329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202038|NCT03007329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65202039|NCT03007329|Incretins|incretins|mesh-ancestor
65202040|NCT03007329|Hormones|hormones|mesh-ancestor
65202041|NCT03007329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65202042|NCT04072341|Propolis|propolis|mesh-list
65202043|NCT04072341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65202044|NCT04030039|Interferons|interferons|mesh-list
65202045|NCT04030039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202046|NCT04030039|Antiviral Agents|antiviral agents|mesh-ancestor
65202047|NCT04030039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65202048|NCT02628574|Gemcitabine|gemcitabine|mesh-list
65202049|NCT02628574|Pembrolizumab|pembrolizumab|mesh-list
65202050|NCT02628574|Nivolumab|nivolumab|mesh-list
65202051|NCT02628574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65202052|NCT02628574|Antimetabolites|antimetabolites|mesh-ancestor
65202053|NCT02628574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202054|NCT02628574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202055|NCT02628574|Antiviral Agents|antiviral agents|mesh-ancestor
65202056|NCT02628574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65202057|NCT02628574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202058|NCT02628574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65202059|NCT02628574|Immunologic Factors|immunologic factors|mesh-ancestor
65202060|NCT02628574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202061|NCT02628574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65202062|NCT02628574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65330617|NCT04062357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330618|NCT04482309|Trastuzumab|trastuzumab|mesh-list
65330619|NCT04482309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64716688|NCT04749810|Eculizumab|eculizumab|mesh-list
65202063|NCT00596362|Bevacizumab|bevacizumab|mesh-list
65202064|NCT00596362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65202065|NCT00596362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202066|NCT00596362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65202067|NCT00596362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65202068|NCT00596362|Growth Substances|growth substances|mesh-ancestor
65202069|NCT00596362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202070|NCT00596362|Growth Inhibitors|growth inhibitors|mesh-ancestor
65202071|NCT00669994|Ciprofloxacin|ciprofloxacin|mesh-list
65202072|NCT00669994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65202073|NCT00669994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65202074|NCT00669994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65202075|NCT00669994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65202076|NCT00669994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202077|NCT00669994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202078|NCT00669994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202079|NCT00669994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65202080|NCT00669994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65202081|NCT02790723|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65202082|NCT02790723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65202083|NCT00676156|Thioctic Acid|thioctic acid|mesh-list
65202084|NCT00676156|Antioxidants|antioxidants|mesh-ancestor
65202085|NCT00676156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202086|NCT00676156|Protective Agents|protective agents|mesh-ancestor
65202087|NCT00676156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202088|NCT00676156|Vitamin B Complex|vitamin b complex|mesh-ancestor
65202089|NCT00676156|Vitamins|vitamins|mesh-ancestor
65202090|NCT00676156|Micronutrients|micronutrients|mesh-ancestor
65202091|NCT00670150|Arsenic Trioxide|arsenic trioxide|mesh-list
65202092|NCT00670150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202093|NCT00914017|Atorvastatin|atorvastatin|mesh-list
65202094|NCT00914017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65202098|NCT00914017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65202099|NCT00914017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65202100|NCT00914017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202101|NCT00671320|Diclofenac|diclofenac|mesh-list
65202102|NCT00671320|Valdecoxib|valdecoxib|mesh-list
65202103|NCT00671320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65202104|NCT00671320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65202105|NCT00671320|Analgesics|analgesics|mesh-ancestor
65202106|NCT00671320|Sensory System Agents|sensory system agents|mesh-ancestor
65202107|NCT00671320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65202108|NCT00671320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202109|NCT00671320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65202110|NCT00671320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65202111|NCT00671320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65202112|NCT00671320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202113|NCT00671320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202114|NCT00671320|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65202115|NCT00676468|Montelukast|montelukast|mesh-list
65202116|NCT00676468|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65202117|NCT00676468|Respiratory System Agents|respiratory system agents|mesh-ancestor
65202118|NCT00676468|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64844747|NCT01677260|Metformin|metformin|mesh-list
65202119|NCT00676468|Hormone Antagonists|hormone antagonists|mesh-ancestor
65202120|NCT00676468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65202121|NCT00676468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202122|NCT00676468|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65202123|NCT00676468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65202124|NCT00676468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202125|NCT00591253|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65202126|NCT00591253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65202127|NCT00591253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65202128|NCT00591253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330620|NCT04482309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330621|NCT05190120|Ropivacaine|ropivacaine|mesh-list
65330622|NCT05190120|Anesthetics, Local|anesthetics, local|mesh-ancestor
65330623|NCT05190120|Anesthetics|anesthetics|mesh-ancestor
65330624|NCT05190120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65330625|NCT05190120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330626|NCT05190120|Sensory System Agents|sensory system agents|mesh-ancestor
65330627|NCT05190120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65330628|NCT00738374|Rituximab|rituximab|mesh-list
65330629|NCT00738374|Chlorambucil|chlorambucil|mesh-list
65330630|NCT00738374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65330631|NCT00738374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330632|NCT00738374|Immunologic Factors|immunologic factors|mesh-ancestor
65330633|NCT00738374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330634|NCT00738374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65202129|NCT00676702|Vitamin K|vitamin k|mesh-list
65202130|NCT00676702|Pancrelipase|pancrelipase|mesh-list
65202131|NCT00676702|Pancreatin|pancreatin|mesh-list
65202132|NCT00676702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65202133|NCT00676702|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65202134|NCT00676702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65202135|NCT00676702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202136|NCT00676702|Hemostatics|hemostatics|mesh-ancestor
65202137|NCT00676702|Coagulants|coagulants|mesh-ancestor
65202138|NCT00676702|Vitamins|vitamins|mesh-ancestor
65202139|NCT00676702|Micronutrients|micronutrients|mesh-ancestor
65202140|NCT00676702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202141|NCT05753371|Metformin|metformin|mesh-list
65202142|NCT05753371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65202143|NCT05753371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202144|NCT00671476|Doxorubicin|doxorubicin|mesh-list
65202145|NCT00671476|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65202146|NCT00671476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65202147|NCT00671476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202148|NCT00671476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65202149|NCT00671476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65202150|NCT00671476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202151|NCT00671476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202153|NCT00908583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65202154|NCT00908583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65202155|NCT00908583|Prednisolone|prednisolone|mesh-list
65202156|NCT00908583|Prednisolone acetate|prednisolone acetate|mesh-list
65202157|NCT00908583|Rituximab|rituximab|mesh-list
65202158|NCT00908583|Bortezomib|bortezomib|mesh-list
65202159|NCT00908583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65202160|NCT00908583|Prednisolone phosphate|prednisolone phosphate|mesh-list
65202161|NCT00908583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65202162|NCT00908583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202163|NCT00908583|Immunologic Factors|immunologic factors|mesh-ancestor
65202164|NCT00908583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202165|NCT00908583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65202169|NCT00908583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65202171|NCT00908583|Glucocorticoids|glucocorticoids|mesh-ancestor
65202172|NCT00908583|Hormones|hormones|mesh-ancestor
65202173|NCT00908583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65202174|NCT00908583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65202175|NCT00908583|Protective Agents|protective agents|mesh-ancestor
65202176|NCT00908583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65202177|NCT05519241|Paclitaxel|paclitaxel|mesh-list
65202178|NCT05519241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65202179|NCT05519241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202180|NCT05519241|Tubulin Modulators|tubulin modulators|mesh-ancestor
65330635|NCT00738374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65330636|NCT00738374|Alkylating Agents|alkylating agents|mesh-ancestor
65330637|NCT00738374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330638|NCT02581176|Apixaban|apixaban|mesh-list
65330639|NCT02581176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65330640|NCT02581176|Antithrombins|antithrombins|mesh-ancestor
65330641|NCT02581176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65330642|NCT02581176|Protease Inhibitors|protease inhibitors|mesh-ancestor
65080559|NCT00343187|Dapsone|dapsone|mesh-list
65330643|NCT02581176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330644|NCT02581176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330645|NCT02581176|Anticoagulants|anticoagulants|mesh-ancestor
65330646|NCT00697593|Antibodies|antibodies|mesh-list
65330647|NCT00697593|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65330648|NCT00697593|Immunologic Factors|immunologic factors|mesh-ancestor
65330649|NCT00697593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330650|NCT04183452|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
65330651|NCT04183452|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
64716701|NCT04495712|Diuretics|diuretics|mesh-ancestor
65202181|NCT05519241|Antimitotic Agents|antimitotic agents|mesh-ancestor
65202182|NCT05519241|Mitosis Modulators|mitosis modulators|mesh-ancestor
65202183|NCT05519241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202184|NCT00671632|Triazolam|triazolam|mesh-list
65202185|NCT00671632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65202186|NCT00671632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65202187|NCT00671632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65202188|NCT00671632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65202189|NCT00671632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202190|NCT00671632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65202191|NCT00671632|GABA Modulators|gaba modulators|mesh-ancestor
65202192|NCT00671632|GABA Agents|gaba agents|mesh-ancestor
65202193|NCT00671632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65202194|NCT00671632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202195|NCT04973605|Dexamethasone|dexamethasone|mesh-list
65202196|NCT04973605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65202197|NCT04973605|Antiemetics|antiemetics|mesh-ancestor
65202198|NCT04973605|Autonomic Agents|autonomic agents|mesh-ancestor
65202199|NCT04973605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65202200|NCT04973605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202201|NCT04973605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65202202|NCT04973605|Glucocorticoids|glucocorticoids|mesh-ancestor
65202203|NCT04973605|Hormones|hormones|mesh-ancestor
65202204|NCT04973605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65202205|NCT04973605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65202206|NCT04973605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202207|NCT04153708|Antibodies|antibodies|mesh-list
65202208|NCT04153708|Immunoglobulins|immunoglobulins|mesh-list
65202209|NCT04153708|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
65202210|NCT04153708|Immunologic Factors|immunologic factors|mesh-ancestor
65202211|NCT04153708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202212|NCT00676936|Methylprednisolone|methylprednisolone|mesh-list
65202213|NCT00676936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65202214|NCT00676936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65202215|NCT00676936|Prednisolone|prednisolone|mesh-list
65202216|NCT00676936|Prednisolone acetate|prednisolone acetate|mesh-list
65202217|NCT00676936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65202218|NCT00676936|Prednisolone phosphate|prednisolone phosphate|mesh-list
65330652|NCT04183452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65330653|NCT04183452|Hormone Antagonists|hormone antagonists|mesh-ancestor
65330654|NCT04183452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65330655|NCT04183452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330656|NCT04183452|Progestins|progestins|mesh-ancestor
65330657|NCT04183452|Hormones|hormones|mesh-ancestor
65330658|NCT04075578|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65330659|NCT04075578|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65330660|NCT04075578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64716718|NCT00377624|Protective Agents|protective agents|mesh-ancestor
65202219|NCT00676936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65202220|NCT00676936|Antiemetics|antiemetics|mesh-ancestor
65202221|NCT00676936|Autonomic Agents|autonomic agents|mesh-ancestor
65202222|NCT00676936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65202223|NCT00676936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202224|NCT00676936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65202225|NCT00676936|Glucocorticoids|glucocorticoids|mesh-ancestor
65202226|NCT00676936|Hormones|hormones|mesh-ancestor
65202227|NCT00676936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65202228|NCT00676936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65202229|NCT00676936|Protective Agents|protective agents|mesh-ancestor
65202230|NCT00676936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65202231|NCT00676936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202232|NCT02629744|Etrolizumab|etrolizumab|mesh-list
65202233|NCT02629744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65202234|NCT02629744|Immunologic Factors|immunologic factors|mesh-ancestor
65202235|NCT02629744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202236|NCT00670618|Fluorides|fluorides|mesh-list
65202237|NCT00670618|Cariostatic Agents|cariostatic agents|mesh-ancestor
65202238|NCT00670618|Protective Agents|protective agents|mesh-ancestor
65202243|NCT00908349|Oxcarbazepine|oxcarbazepine|mesh-list
65202244|NCT00908349|Anticonvulsants|anticonvulsants|mesh-ancestor
65202245|NCT00908349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65202246|NCT00908349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65202247|NCT00908349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65202248|NCT00908349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202249|NCT00908349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65202250|NCT00908349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65202251|NCT01125566|Trastuzumab|trastuzumab|mesh-list
65202252|NCT01125566|Vinorelbine|vinorelbine|mesh-list
65202253|NCT01125566|Afatinib|afatinib|mesh-list
65202254|NCT01125566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65202255|NCT01125566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202256|NCT01125566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65202257|NCT01125566|Tubulin Modulators|tubulin modulators|mesh-ancestor
65202258|NCT01125566|Antimitotic Agents|antimitotic agents|mesh-ancestor
65202259|NCT01125566|Mitosis Modulators|mitosis modulators|mesh-ancestor
65202260|NCT01125566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202261|NCT01125566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65202262|NCT01125566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202263|NCT04031872|Capecitabine|capecitabine|mesh-list
65202264|NCT04031872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65202265|NCT04031872|Antimetabolites|antimetabolites|mesh-ancestor
65202266|NCT04031872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202267|NCT04031872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844901|NCT05596617|Melatonin|melatonin|mesh-list
65202268|NCT00670696|Tetracaine|tetracaine|mesh-list
65202269|NCT00670696|Anesthetics, Local|anesthetics, local|mesh-ancestor
65202270|NCT00670696|Anesthetics|anesthetics|mesh-ancestor
65202271|NCT00670696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65202272|NCT00670696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202273|NCT00670696|Sensory System Agents|sensory system agents|mesh-ancestor
65202274|NCT00670696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65202275|NCT00677248|Ezetimibe|ezetimibe|mesh-list
65202276|NCT00677248|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65330661|NCT04075578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65330662|NCT04075578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716730|NCT04713956|Busulfan|busulfan|mesh-list
65202277|NCT00677248|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65202278|NCT00677248|Antimetabolites|antimetabolites|mesh-ancestor
65202279|NCT00677248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202280|NCT00677248|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65202281|NCT00671710|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65202282|NCT00671710|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65202283|NCT00671710|Dermatologic Agents|dermatologic agents|mesh-ancestor
65202284|NCT00671008|Insulin|insulin|mesh-list
65202285|NCT00671008|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65202286|NCT00671008|Insulin Aspart|insulin aspart|mesh-list
65202287|NCT00671008|Insulin Detemir|insulin detemir|mesh-list
65202288|NCT00671008|Biphasic Insulins|biphasic insulins|mesh-list
65202289|NCT00671008|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65202290|NCT00671008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65202291|NCT00671008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202292|NCT00911716|Cyclophosphamide|cyclophosphamide|mesh-list
65202293|NCT00911716|Bevacizumab|bevacizumab|mesh-list
65202294|NCT00911716|Docetaxel|docetaxel|mesh-list
65202295|NCT00911716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65202296|NCT00911716|Immunologic Factors|immunologic factors|mesh-ancestor
65202297|NCT00911716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202298|NCT00911716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65202299|NCT00911716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65202300|NCT00911716|Alkylating Agents|alkylating agents|mesh-ancestor
65202301|NCT00911716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202302|NCT00911716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202303|NCT00911716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65202304|NCT00911716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65202305|NCT00911716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65202306|NCT00911716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65202307|NCT00911716|Growth Substances|growth substances|mesh-ancestor
65202310|NCT00911716|Antimitotic Agents|antimitotic agents|mesh-ancestor
65202311|NCT00911716|Mitosis Modulators|mitosis modulators|mesh-ancestor
65202312|NCT00595582|Curcumin|curcumin|mesh-list
65202313|NCT00595582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65202314|NCT00595582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65202315|NCT00595582|Analgesics|analgesics|mesh-ancestor
65202316|NCT00595582|Sensory System Agents|sensory system agents|mesh-ancestor
65202317|NCT00595582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65202318|NCT00595582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202319|NCT00595582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65202320|NCT00595582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65202321|NCT00595582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202322|NCT00595582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202323|NCT00595582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202324|NCT00680446|Immunoglobulins|immunoglobulins|mesh-list
65202325|NCT00680446|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65202326|NCT00680446|Antibodies|antibodies|mesh-list
65202327|NCT00680446|Immunoglobulin G|immunoglobulin g|mesh-list
65202328|NCT00680446|Immunologic Factors|immunologic factors|mesh-ancestor
65202329|NCT00680446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202330|NCT00672022|Miglustat|miglustat|mesh-list
65202331|NCT00672022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202332|NCT00672022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202333|NCT00672022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65202334|NCT00672022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65202335|NCT00672022|Antiviral Agents|antiviral agents|mesh-ancestor
65202336|NCT00672022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65202337|NCT00672022|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65202338|NCT00672022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65202339|NCT00672022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202340|NCT00680602|Sertraline|sertraline|mesh-list
65202341|NCT00680602|Fluoxetine|fluoxetine|mesh-list
65202342|NCT00680602|Paroxetine|paroxetine|mesh-list
65202343|NCT00680602|Citalopram|citalopram|mesh-list
64844972|NCT05596097|Zanubrutinib|zanubrutinib|mesh-list
65202344|NCT00680602|Antidepressive Agents|antidepressive agents|mesh-ancestor
65202345|NCT00680602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65202346|NCT00680602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65202347|NCT00680602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65330663|NCT04075578|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65330664|NCT04075578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65330665|NCT04075578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330666|NCT04075578|Cholinergic Agents|cholinergic agents|mesh-ancestor
65330667|NCT04075578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65330668|NCT04445025|Leuprolide|leuprolide|mesh-list
65330669|NCT04445025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65330670|NCT04445025|Fertility Agents|fertility agents|mesh-ancestor
65330671|NCT04445025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65330672|NCT04445025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330673|NCT04445025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65330674|NCT04445025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330675|NCT02580474|Asunaprevir|asunaprevir|mesh-list
65330676|NCT02580474|Protease Inhibitors|protease inhibitors|mesh-ancestor
65330677|NCT02580474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330678|NCT02580474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330679|NCT04166604|Trifluridine|trifluridine|mesh-list
65202348|NCT00680602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65202349|NCT00680602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202350|NCT00680602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65202351|NCT00680602|Serotonin Agents|serotonin agents|mesh-ancestor
65202352|NCT00680602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202353|NCT00680602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65202354|NCT00680602|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65202355|NCT00680602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65202356|NCT00680602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202357|NCT00680680|Dutasteride|dutasteride|mesh-list
65202358|NCT00680680|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65202359|NCT00680680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65202360|NCT00680680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202361|NCT00680680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202362|NCT00680680|Hormone Antagonists|hormone antagonists|mesh-ancestor
65202363|NCT00680680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65202364|NCT00680680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202365|NCT00808015|Varenicline|varenicline|mesh-list
65202366|NCT00808015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65202367|NCT00808015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65202368|NCT00808015|Cholinergic Agents|cholinergic agents|mesh-ancestor
65202369|NCT00808015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65202370|NCT00808015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202371|NCT00808015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202372|NCT00680758|Paclitaxel|paclitaxel|mesh-list
65202373|NCT00680758|Everolimus|everolimus|mesh-list
65202374|NCT00680758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65202375|NCT00680758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202376|NCT00680758|Tubulin Modulators|tubulin modulators|mesh-ancestor
65202377|NCT00680758|Antimitotic Agents|antimitotic agents|mesh-ancestor
65202378|NCT00680758|Mitosis Modulators|mitosis modulators|mesh-ancestor
65202379|NCT00680758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202384|NCT00678106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65202385|NCT00678106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65202386|NCT00810199|Methotrexate|methotrexate|mesh-list
65202387|NCT00810199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65202388|NCT00810199|Abortifacient Agents|abortifacient agents|mesh-ancestor
65202389|NCT00810199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65330680|NCT04166604|Antimetabolites|antimetabolites|mesh-ancestor
65330681|NCT04166604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330682|NCT04166604|Antiviral Agents|antiviral agents|mesh-ancestor
65330683|NCT04166604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65330684|NCT04160910|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
65330685|NCT04160910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65202390|NCT00810199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202391|NCT00810199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65202392|NCT00810199|Antimetabolites|antimetabolites|mesh-ancestor
65202393|NCT00810199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202394|NCT00810199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202395|NCT00810199|Dermatologic Agents|dermatologic agents|mesh-ancestor
65202396|NCT00810199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202397|NCT00810199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65202398|NCT00810199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65202399|NCT00810199|Immunologic Factors|immunologic factors|mesh-ancestor
65202400|NCT00810199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65202401|NCT00810199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65202402|NCT00877006|Prednisone|prednisone|mesh-list
65202403|NCT00877006|Cyclophosphamide|cyclophosphamide|mesh-list
65202404|NCT00877006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65202405|NCT00877006|Rituximab|rituximab|mesh-list
65202406|NCT00877006|Doxorubicin|doxorubicin|mesh-list
65202407|NCT00877006|Vincristine|vincristine|mesh-list
65202408|NCT00877006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65202409|NCT00877006|Immunologic Factors|immunologic factors|mesh-ancestor
65202410|NCT00877006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202411|NCT00877006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65202412|NCT00877006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65202413|NCT00877006|Alkylating Agents|alkylating agents|mesh-ancestor
65202414|NCT00877006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202415|NCT00877006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845050|NCT05488847|Antiemetics|antiemetics|mesh-ancestor
65202416|NCT00877006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65202417|NCT00877006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65202418|NCT00877006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65202419|NCT00877006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65202420|NCT00877006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65202421|NCT00877006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202422|NCT00877006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65202423|NCT00877006|Glucocorticoids|glucocorticoids|mesh-ancestor
65202425|NCT00877006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65202426|NCT00877006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65202427|NCT00877006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65202428|NCT00877006|Tubulin Modulators|tubulin modulators|mesh-ancestor
65202429|NCT00877006|Antimitotic Agents|antimitotic agents|mesh-ancestor
65202430|NCT00877006|Mitosis Modulators|mitosis modulators|mesh-ancestor
65202431|NCT00678184|Atorvastatin|atorvastatin|mesh-list
65202432|NCT00678184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65202433|NCT00678184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65202434|NCT00678184|Antimetabolites|antimetabolites|mesh-ancestor
65202435|NCT00678184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202436|NCT00678184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65202437|NCT00678184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65202438|NCT00678184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202439|NCT00876928|Vitamin D|vitamin d|mesh-list
65202440|NCT00876928|Vitamins|vitamins|mesh-ancestor
65202441|NCT00876928|Micronutrients|micronutrients|mesh-ancestor
65202442|NCT00876928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202443|NCT00876928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65202444|NCT02627950|Metoclopramide|metoclopramide|mesh-list
65202445|NCT02627950|Ticagrelor|ticagrelor|mesh-list
65202446|NCT02627950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65202447|NCT02627950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65202448|NCT02627950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65202449|NCT02627950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65202450|NCT02627950|Purinergic Agents|purinergic agents|mesh-ancestor
65202457|NCT02627950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65330686|NCT04160910|Antidepressive Agents|antidepressive agents|mesh-ancestor
65330687|NCT04160910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65330688|NCT00738062|Droxidopa|droxidopa|mesh-list
65330689|NCT00738062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65330690|NCT00738062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65330691|NCT04156074|Vitamin D|vitamin d|mesh-list
65330692|NCT04156074|Ergocalciferols|ergocalciferols|mesh-list
65330693|NCT04156074|Cholecalciferol|cholecalciferol|mesh-list
65330694|NCT04156074|Vitamins|vitamins|mesh-list
65330695|NCT04156074|Micronutrients|micronutrients|mesh-ancestor
65330696|NCT04156074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330697|NCT04156074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65330698|NCT04156074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65330699|NCT04062045|Ropivacaine|ropivacaine|mesh-list
65330700|NCT04062045|Anesthetics, Local|anesthetics, local|mesh-ancestor
65330701|NCT04062045|Anesthetics|anesthetics|mesh-ancestor
65330702|NCT04062045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65330703|NCT04062045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330704|NCT04062045|Sensory System Agents|sensory system agents|mesh-ancestor
65330705|NCT04062045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65330706|NCT03733314|Quetmolimab|quetmolimab|mesh-list
65330707|NCT03733314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65330708|NCT04064073|Metformin|metformin|mesh-list
65330709|NCT04064073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65330710|NCT04064073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330711|NCT04137354|Vitamins|vitamins|mesh-list
65330712|NCT04137354|Vitamin A|vitamin a|mesh-list
65330713|NCT04137354|Iron|iron|mesh-list
65330714|NCT04137354|Retinol palmitate|retinol palmitate|mesh-list
65330715|NCT04137354|Micronutrients|micronutrients|mesh-ancestor
65330716|NCT04137354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330717|NCT04137354|Trace Elements|trace elements|mesh-ancestor
65330718|NCT04137354|Antioxidants|antioxidants|mesh-ancestor
65202458|NCT02627950|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65202459|NCT02627950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65202460|NCT02627950|Dopamine Agents|dopamine agents|mesh-ancestor
65202461|NCT00807937|Lorazepam|lorazepam|mesh-list
65202462|NCT00807937|Anticonvulsants|anticonvulsants|mesh-ancestor
65202463|NCT00807937|Antiemetics|antiemetics|mesh-ancestor
65202464|NCT00807937|Autonomic Agents|autonomic agents|mesh-ancestor
65202465|NCT00807937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65202466|NCT00807937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202467|NCT00807937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65202468|NCT00807937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65202469|NCT00807937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65202470|NCT00807937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65202471|NCT00807937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65330719|NCT04137354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330720|NCT04137354|Protective Agents|protective agents|mesh-ancestor
65330721|NCT04137354|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65330722|NCT04137354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330723|NCT04995003|Pembrolizumab|pembrolizumab|mesh-list
65330724|NCT04995003|Nivolumab|nivolumab|mesh-list
65330725|NCT04995003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65330726|NCT04995003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65330727|NCT04995003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330728|NCT04995003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330729|NCT03505320|Leucovorin|leucovorin|mesh-list
65330730|NCT03505320|Folic Acid|folic acid|mesh-list
65330731|NCT03505320|Pembrolizumab|pembrolizumab|mesh-list
65330732|NCT03505320|Nivolumab|nivolumab|mesh-list
65330733|NCT03505320|Fluorouracil|fluorouracil|mesh-list
65330734|NCT03505320|Oxaliplatin|oxaliplatin|mesh-list
65202472|NCT00807937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65202473|NCT00807937|GABA Modulators|gaba modulators|mesh-ancestor
65202474|NCT00807937|GABA Agents|gaba agents|mesh-ancestor
65202475|NCT00807937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65202476|NCT00807937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202477|NCT00681148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65202478|NCT00681148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65202479|NCT00681148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65202480|NCT00681148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202481|NCT00681148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65202482|NCT00681148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65202483|NCT00681148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202484|NCT00681148|Cholinergic Agents|cholinergic agents|mesh-ancestor
65202485|NCT00681148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65202486|NCT04935229|Nivolumab|nivolumab|mesh-list
65202487|NCT04935229|Ipilimumab|ipilimumab|mesh-list
65202488|NCT04935229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65202489|NCT04935229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202490|NCT04935229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65202491|NCT04935229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202492|NCT00681226|Ramipril|ramipril|mesh-list
65202493|NCT00681226|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65202494|NCT00681226|Protease Inhibitors|protease inhibitors|mesh-ancestor
65202495|NCT00681226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202496|NCT00681226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202497|NCT00681226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65202498|NCT00678964|Carboplatin|carboplatin|mesh-list
65202499|NCT00678964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65202500|NCT00678964|Vinorelbine|vinorelbine|mesh-list
65202501|NCT00678964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202502|NCT00678964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65202503|NCT00678964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202504|NCT00678964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202505|NCT00678964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65202506|NCT00678964|Tubulin Modulators|tubulin modulators|mesh-ancestor
65202507|NCT00678964|Antimitotic Agents|antimitotic agents|mesh-ancestor
65202508|NCT00678964|Mitosis Modulators|mitosis modulators|mesh-ancestor
65202509|NCT05753059|Bendroflumethiazide|bendroflumethiazide|mesh-list
65202510|NCT05753059|Amiloride|amiloride|mesh-list
65202511|NCT05753059|Diuretics|diuretics|mesh-ancestor
65202512|NCT05753059|Natriuretic Agents|natriuretic agents|mesh-ancestor
65202513|NCT05753059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202514|NCT05753059|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65330735|NCT03505320|Levoleucovorin|levoleucovorin|mesh-list
65330736|NCT03505320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65330737|NCT03505320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330738|NCT03505320|Antimetabolites|antimetabolites|mesh-ancestor
65330739|NCT03505320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716799|NCT03571724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65202515|NCT05753059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65202516|NCT05753059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65202517|NCT05753059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202521|NCT05753059|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65202522|NCT02627248|Cyclophosphamide|cyclophosphamide|mesh-list
65202523|NCT02627248|Docetaxel|docetaxel|mesh-list
65202524|NCT02627248|Epirubicin|epirubicin|mesh-list
65202525|NCT02627248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65202526|NCT02627248|Immunologic Factors|immunologic factors|mesh-ancestor
65202527|NCT02627248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202528|NCT02627248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65202529|NCT02627248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65202530|NCT02627248|Alkylating Agents|alkylating agents|mesh-ancestor
65202531|NCT02627248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202532|NCT02627248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202533|NCT02627248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65202534|NCT02627248|Tubulin Modulators|tubulin modulators|mesh-ancestor
65202535|NCT02627248|Antimitotic Agents|antimitotic agents|mesh-ancestor
65202536|NCT02627248|Mitosis Modulators|mitosis modulators|mesh-ancestor
65202537|NCT02627248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65202538|NCT02627248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65202539|NCT02627248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65202540|NCT02627248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202541|NCT03993535|Serotonin|serotonin|mesh-list
65202542|NCT03993535|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65202543|NCT03993535|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65202544|NCT03993535|Serotonin Agents|serotonin agents|mesh-ancestor
65202545|NCT03993535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65202546|NCT03993535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202547|NCT03993535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202548|NCT03993535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65202549|NCT03993535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65202550|NCT02626936|Insulin|insulin|mesh-list
65202551|NCT02626936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65202552|NCT02626936|Glucagon|glucagon|mesh-list
65202553|NCT02626936|Hormones|hormones|mesh-list
65202554|NCT02626936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65202555|NCT02626936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202556|NCT02626936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65202557|NCT02626936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65202558|NCT00912262|Capsaicin|capsaicin|mesh-list
65202559|NCT00912262|Antipruritics|antipruritics|mesh-ancestor
65202560|NCT00912262|Dermatologic Agents|dermatologic agents|mesh-ancestor
65202561|NCT00912262|Sensory System Agents|sensory system agents|mesh-ancestor
65202562|NCT00912262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845199|NCT05253118|Pemetrexed|pemetrexed|mesh-list
65202563|NCT00912262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202564|NCT00906945|Cytarabine|cytarabine|mesh-list
65202565|NCT00906945|Plerixafor|plerixafor|mesh-list
65202566|NCT00906945|Etoposide|etoposide|mesh-list
65202567|NCT00906945|Mitoxantrone|mitoxantrone|mesh-list
65202568|NCT00906945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65202569|NCT00906945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202570|NCT00906945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65202571|NCT00906945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65202572|NCT00906945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202573|NCT00906945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202574|NCT00906945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65202575|NCT00906945|Antimetabolites|antimetabolites|mesh-ancestor
65202576|NCT00906945|Antiviral Agents|antiviral agents|mesh-ancestor
65202577|NCT00906945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65202578|NCT00906945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65202579|NCT00906945|Immunologic Factors|immunologic factors|mesh-ancestor
65330740|NCT03505320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65330741|NCT03505320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65330742|NCT03505320|Immunologic Factors|immunologic factors|mesh-ancestor
65330743|NCT03505320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330744|NCT03505320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65330745|NCT03505320|Antidotes|antidotes|mesh-ancestor
65330746|NCT03505320|Protective Agents|protective agents|mesh-ancestor
65330747|NCT03505320|Vitamin B Complex|vitamin b complex|mesh-ancestor
65330748|NCT03505320|Vitamins|vitamins|mesh-ancestor
65330749|NCT03505320|Micronutrients|micronutrients|mesh-ancestor
65202580|NCT00906945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202581|NCT00906945|Analgesics|analgesics|mesh-ancestor
65202582|NCT00906945|Sensory System Agents|sensory system agents|mesh-ancestor
65202583|NCT00906945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65202584|NCT00906945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65202585|NCT00906945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65202586|NCT00807235|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65202587|NCT00807235|Respiratory System Agents|respiratory system agents|mesh-ancestor
65202588|NCT02627560|Tranexamic Acid|tranexamic acid|mesh-list
65202589|NCT02627560|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65202593|NCT02627560|Coagulants|coagulants|mesh-ancestor
65202594|NCT00681460|Metformin|metformin|mesh-list
65202595|NCT00681460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65202596|NCT00681460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202597|NCT00876694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65202598|NCT00876694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65202599|NCT00876694|Autonomic Agents|autonomic agents|mesh-ancestor
65202600|NCT00876694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65202601|NCT00876694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202602|NCT00876694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65202603|NCT00876694|Respiratory System Agents|respiratory system agents|mesh-ancestor
65202604|NCT00876694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65202605|NCT00876694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65202606|NCT00876694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65202607|NCT00876694|Adrenergic Agents|adrenergic agents|mesh-ancestor
65202608|NCT00876694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65202609|NCT00876694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202610|NCT05752903|Dexmedetomidine|dexmedetomidine|mesh-list
65202611|NCT05752903|Ketamine|ketamine|mesh-list
65202612|NCT05752903|Propofol|propofol|mesh-list
65202613|NCT05752903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65202614|NCT05752903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65202615|NCT05752903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202616|NCT05752903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65202617|NCT05752903|Anesthetics, General|anesthetics, general|mesh-ancestor
65202618|NCT05752903|Anesthetics|anesthetics|mesh-ancestor
65202619|NCT05752903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65202620|NCT05752903|Analgesics|analgesics|mesh-ancestor
65202621|NCT05752903|Sensory System Agents|sensory system agents|mesh-ancestor
65202622|NCT05752903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65202623|NCT05752903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65202624|NCT05752903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65202625|NCT05752903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65202626|NCT05752903|Adrenergic Agents|adrenergic agents|mesh-ancestor
65202627|NCT05752903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65202628|NCT05752903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202629|NCT05752903|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65202630|NCT05752903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65202631|NCT05752903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65202632|NCT00590317|Ondansetron|ondansetron|mesh-list
65202633|NCT00590317|Prochlorperazine|prochlorperazine|mesh-list
65202634|NCT00590317|Antiemetics|antiemetics|mesh-ancestor
65202635|NCT00590317|Autonomic Agents|autonomic agents|mesh-ancestor
65202636|NCT00590317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65202637|NCT00590317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845279|NCT05047640|Vaccines|vaccines|mesh-list
65202638|NCT00590317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65330750|NCT03505320|Hematinics|hematinics|mesh-ancestor
65330751|NCT04902729|Oxytocin|oxytocin|mesh-list
65330752|NCT04902729|Carbetocin|carbetocin|mesh-list
65330753|NCT04902729|Oxytocics|oxytocics|mesh-ancestor
65330754|NCT04902729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65330755|NCT04902729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330756|NCT03498378|Cetuximab|cetuximab|mesh-list
65330757|NCT03498378|Avelumab|avelumab|mesh-list
65330758|NCT03498378|Palbociclib|palbociclib|mesh-list
65202639|NCT00590317|Antipruritics|antipruritics|mesh-ancestor
65202640|NCT00590317|Dermatologic Agents|dermatologic agents|mesh-ancestor
65202641|NCT00590317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65202642|NCT00590317|Serotonin Agents|serotonin agents|mesh-ancestor
65202643|NCT00590317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65202644|NCT00590317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202645|NCT00590317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65202646|NCT00590317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65202647|NCT00590317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65202648|NCT00590317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65202649|NCT00590317|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65202650|NCT00590317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65202651|NCT00590317|Dopamine Agents|dopamine agents|mesh-ancestor
65202652|NCT01139762|Tadalafil|tadalafil|mesh-list
65202653|NCT01139762|Finasteride|finasteride|mesh-list
65202654|NCT01139762|Vasodilator Agents|vasodilator agents|mesh-ancestor
65202655|NCT01139762|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65202656|NCT01139762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65202657|NCT01139762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202658|NCT01139762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202659|NCT01139762|Urological Agents|urological agents|mesh-ancestor
65202660|NCT01139762|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65202664|NCT01139762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202665|NCT00805285|Budesonide|budesonide|mesh-list
65202666|NCT00805285|Hydrocortisone|hydrocortisone|mesh-list
65202667|NCT00805285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65202668|NCT00805285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65202669|NCT00805285|Autonomic Agents|autonomic agents|mesh-ancestor
65202670|NCT00805285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65202671|NCT00805285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202672|NCT00805285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65202673|NCT00805285|Respiratory System Agents|respiratory system agents|mesh-ancestor
65202674|NCT00805285|Glucocorticoids|glucocorticoids|mesh-ancestor
65202675|NCT00805285|Hormones|hormones|mesh-ancestor
65202676|NCT00805285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65202677|NCT02606773|Ascorbic Acid|ascorbic acid|mesh-list
65202678|NCT02606773|Antioxidants|antioxidants|mesh-ancestor
65202679|NCT02606773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202680|NCT02606773|Protective Agents|protective agents|mesh-ancestor
65202681|NCT02606773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202682|NCT02606773|Vitamins|vitamins|mesh-ancestor
65202683|NCT02606773|Micronutrients|micronutrients|mesh-ancestor
65202684|NCT04310774|Tegafur|tegafur|mesh-list
65202685|NCT04310774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65202686|NCT04310774|Antimetabolites|antimetabolites|mesh-ancestor
65202687|NCT04310774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202688|NCT04310774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202689|NCT05715229|Paclitaxel|paclitaxel|mesh-list
65202690|NCT05715229|Carboplatin|carboplatin|mesh-list
65202691|NCT05715229|Nivolumab|nivolumab|mesh-list
65202692|NCT05715229|Pemetrexed|pemetrexed|mesh-list
65202693|NCT05715229|Ipilimumab|ipilimumab|mesh-list
65202694|NCT05715229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65202695|NCT05715229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202696|NCT05715229|Tubulin Modulators|tubulin modulators|mesh-ancestor
65202697|NCT05715229|Antimitotic Agents|antimitotic agents|mesh-ancestor
65202698|NCT05715229|Mitosis Modulators|mitosis modulators|mesh-ancestor
65202699|NCT05715229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202700|NCT05715229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65202701|NCT05715229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65202702|NCT05715229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330759|NCT03498378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65330760|NCT03498378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330761|NCT03498378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65330762|NCT03498378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330763|NCT03498378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330764|NCT03493932|Nivolumab|nivolumab|mesh-list
64716825|NCT04343222|Bromfenac|bromfenac|mesh-list
65202703|NCT05715229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65202704|NCT05715229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65202705|NCT01139450|Tacrolimus|tacrolimus|mesh-list
65202706|NCT01139450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65202707|NCT01139450|Immunologic Factors|immunologic factors|mesh-ancestor
65202708|NCT01139450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202709|NCT01139450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65202710|NCT01139450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202711|NCT01139450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202712|NCT05110742|Cyclophosphamide|cyclophosphamide|mesh-list
65202713|NCT05110742|Fludarabine|fludarabine|mesh-list
65202714|NCT05110742|Fludarabine phosphate|fludarabine phosphate|mesh-list
65202715|NCT05110742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65202716|NCT05110742|Immunologic Factors|immunologic factors|mesh-ancestor
65202717|NCT05110742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202718|NCT05110742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65202719|NCT05110742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65202720|NCT05110742|Alkylating Agents|alkylating agents|mesh-ancestor
65202721|NCT05110742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202722|NCT05110742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202723|NCT05110742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65202724|NCT05110742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65202725|NCT05110742|Antimetabolites|antimetabolites|mesh-ancestor
65202726|NCT00805207|Estradiol|estradiol|mesh-list
65202727|NCT00805207|Estrogens|estrogens|mesh-list
65202728|NCT00805207|Testosterone|testosterone|mesh-list
65202729|NCT00805207|Progesterone|progesterone|mesh-list
65202730|NCT00805207|Glucocorticoids|glucocorticoids|mesh-list
65202731|NCT00805207|Hormones|hormones|mesh-ancestor
65202732|NCT00805207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65202738|NCT00805675|Antiviral Agents|antiviral agents|mesh-ancestor
65202739|NCT00805675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65202740|NCT00805675|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65202741|NCT00805675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65202742|NCT00805675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202743|NCT00805675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202744|NCT00805675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65202745|NCT00805675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65202746|NCT03958201|Rocuronium|rocuronium|mesh-list
65202747|NCT03958201|Neostigmine|neostigmine|mesh-list
65202748|NCT03958201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65202749|NCT03958201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65202750|NCT03958201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65202751|NCT03958201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65202752|NCT03958201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202753|NCT03958201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65202754|NCT03958201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202755|NCT03958201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202756|NCT03958201|Cholinergic Agents|cholinergic agents|mesh-ancestor
65202757|NCT03958201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65202758|NCT03958201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65202759|NCT03958201|Autonomic Agents|autonomic agents|mesh-ancestor
65202760|NCT00589303|Metoprolol|metoprolol|mesh-list
65202761|NCT00589303|Amiodarone|amiodarone|mesh-list
65202762|NCT00589303|Verapamil|verapamil|mesh-list
65202763|NCT00589303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65202764|NCT00589303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65202765|NCT00589303|Sympatholytics|sympatholytics|mesh-ancestor
65202766|NCT00589303|Autonomic Agents|autonomic agents|mesh-ancestor
65202767|NCT00589303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65202768|NCT00589303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330765|NCT03493932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65330766|NCT03493932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330767|NCT03493932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65330768|NCT03493932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330769|NCT04211259|Loratadine|loratadine|mesh-list
65330770|NCT04211259|Antipruritics|antipruritics|mesh-ancestor
65330771|NCT04211259|Dermatologic Agents|dermatologic agents|mesh-ancestor
65330772|NCT04211259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65330773|NCT04211259|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65330774|NCT04211259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65330775|NCT04211259|Histamine Antagonists|histamine antagonists|mesh-ancestor
65202769|NCT00589303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65202770|NCT00589303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65202771|NCT00589303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65202772|NCT00589303|Adrenergic Agents|adrenergic agents|mesh-ancestor
65202773|NCT00589303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65202774|NCT00589303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202775|NCT00589303|Vasodilator Agents|vasodilator agents|mesh-ancestor
65202776|NCT00589303|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65202777|NCT00589303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65202778|NCT00589303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65202779|NCT00589303|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65202780|NCT00589303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65202781|NCT00589303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202782|NCT00589303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65202783|NCT00589303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65202784|NCT00589303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65202785|NCT00589303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65202786|NCT00589303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65202787|NCT02607943|Insulin|insulin|mesh-list
65202788|NCT02607943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65202789|NCT02607943|Insulin Glargine|insulin glargine|mesh-list
65202790|NCT02607943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65202791|NCT02607943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202792|NCT02606617|Mosapride|mosapride|mesh-list
65202793|NCT02606617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65202794|NCT02606617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65202795|NCT02606617|Serotonin Agents|serotonin agents|mesh-ancestor
65202796|NCT02606617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65202797|NCT02606617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202798|NCT02606617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202799|NCT00914095|Methylphenidate|methylphenidate|mesh-list
65202800|NCT00914095|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65202801|NCT00914095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202802|NCT00914095|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65202805|NCT00914095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202806|NCT00914095|Dopamine Agents|dopamine agents|mesh-ancestor
65202807|NCT00914095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65202808|NCT03903835|Prednisone|prednisone|mesh-list
65202809|NCT03903835|Carboplatin|carboplatin|mesh-list
65202810|NCT03903835|Docetaxel|docetaxel|mesh-list
65202811|NCT03903835|Abiraterone Acetate|abiraterone acetate|mesh-list
65202812|NCT03903835|Niraparib|niraparib|mesh-list
65202813|NCT03903835|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65202814|NCT03903835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65202815|NCT03903835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202816|NCT03903835|Tubulin Modulators|tubulin modulators|mesh-ancestor
65202817|NCT03903835|Antimitotic Agents|antimitotic agents|mesh-ancestor
65202818|NCT03903835|Mitosis Modulators|mitosis modulators|mesh-ancestor
65202819|NCT03903835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202820|NCT03903835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65202821|NCT03903835|Glucocorticoids|glucocorticoids|mesh-ancestor
65330776|NCT04211259|Histamine Agents|histamine agents|mesh-ancestor
65330777|NCT04211259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64716841|NCT04342130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202822|NCT03903835|Hormones|hormones|mesh-ancestor
65202823|NCT03903835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65202824|NCT03903835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202825|NCT03903835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65202826|NCT03903835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65202827|NCT03903835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202828|NCT03903835|Hormone Antagonists|hormone antagonists|mesh-ancestor
65202829|NCT03903835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65202830|NCT03903835|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65202831|NCT05745337|Metoprolol|metoprolol|mesh-list
65202832|NCT05745337|Verapamil|verapamil|mesh-list
65202833|NCT05745337|Diltiazem|diltiazem|mesh-list
65202834|NCT05745337|Calcium Channel Blockers|calcium channel blockers|mesh-list
65202835|NCT05745337|Calcium|calcium|mesh-list
65202836|NCT05745337|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65202837|NCT05745337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65202838|NCT05745337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202839|NCT05745337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65202840|NCT05745337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65202841|NCT05745337|Sympatholytics|sympatholytics|mesh-ancestor
65202842|NCT05745337|Autonomic Agents|autonomic agents|mesh-ancestor
65202843|NCT05745337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65202844|NCT05745337|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65202845|NCT05745337|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65202846|NCT05745337|Adrenergic Agents|adrenergic agents|mesh-ancestor
65202847|NCT05745337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65202848|NCT05745337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202849|NCT05745337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65202850|NCT05745337|Vasodilator Agents|vasodilator agents|mesh-ancestor
65202851|NCT00952380|Dalteparin|dalteparin|mesh-list
65202852|NCT00952380|Tinzaparin|tinzaparin|mesh-list
65202853|NCT00952380|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65202854|NCT00952380|Anticoagulants|anticoagulants|mesh-ancestor
65202855|NCT00952380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65202856|NCT00952380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65202857|NCT00952380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202858|NCT03859921|Dydrogesterone|dydrogesterone|mesh-list
65202859|NCT03859921|Progestins|progestins|mesh-ancestor
65202860|NCT03859921|Hormones|hormones|mesh-ancestor
65202861|NCT03859921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65202862|NCT03859921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202863|NCT02856750|Gabapentin|gabapentin|mesh-list
65202864|NCT02856750|Analgesics|analgesics|mesh-ancestor
65202865|NCT02856750|Sensory System Agents|sensory system agents|mesh-ancestor
65202866|NCT02856750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65202867|NCT02856750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202868|NCT02856750|Anticonvulsants|anticonvulsants|mesh-ancestor
65202869|NCT02856750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65202870|NCT02856750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65202871|NCT02856750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65202872|NCT02856750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65202873|NCT02856750|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65202874|NCT02856750|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65202875|NCT02856750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65202877|NCT02856750|Antimanic Agents|antimanic agents|mesh-ancestor
65202878|NCT05751967|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65202879|NCT05751967|Fenofibrate|fenofibrate|mesh-list
65202880|NCT05751967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65202881|NCT05751967|Antimetabolites|antimetabolites|mesh-ancestor
65202882|NCT05751967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202883|NCT05751967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65202884|NCT05751967|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65202885|NCT05751967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65202886|NCT02857920|Bevacizumab|bevacizumab|mesh-list
65202887|NCT02857920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65202888|NCT02857920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202889|NCT02857920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65202890|NCT02857920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65330778|NCT04211259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330779|NCT04211259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330780|NCT00698685|Alemtuzumab|alemtuzumab|mesh-list
65330781|NCT00698685|Pentostatin|pentostatin|mesh-list
65330782|NCT00698685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65202891|NCT02857920|Growth Substances|growth substances|mesh-ancestor
65202892|NCT02857920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202893|NCT02857920|Growth Inhibitors|growth inhibitors|mesh-ancestor
65202895|NCT02607631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65202896|NCT02607631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202897|NCT02857842|Prednisolone|prednisolone|mesh-list
65202898|NCT02857842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65202899|NCT02857842|Glucocorticoids|glucocorticoids|mesh-ancestor
65202900|NCT02857842|Hormones|hormones|mesh-ancestor
65202901|NCT02857842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65202902|NCT02857842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202903|NCT02857842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65202904|NCT02857842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202905|NCT03641209|Acetaminophen|acetaminophen|mesh-list
65202906|NCT03641209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65202907|NCT03641209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65202908|NCT03641209|Analgesics|analgesics|mesh-ancestor
65202909|NCT03641209|Sensory System Agents|sensory system agents|mesh-ancestor
65202910|NCT03641209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65202911|NCT03641209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202912|NCT03641209|Antipyretics|antipyretics|mesh-ancestor
65202913|NCT03635437|Alprazolam|alprazolam|mesh-list
65202914|NCT03635437|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
65202915|NCT03635437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65202916|NCT03635437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65202917|NCT03635437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202918|NCT03635437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65202919|NCT03635437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65202920|NCT03635437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65202921|NCT03635437|GABA Modulators|gaba modulators|mesh-ancestor
65202922|NCT03635437|GABA Agents|gaba agents|mesh-ancestor
65202923|NCT03635437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65202924|NCT03635437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202925|NCT00803179|Hormones|hormones|mesh-list
65202926|NCT00803179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65202927|NCT00803179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202928|NCT00804193|Ciclopirox|ciclopirox|mesh-list
65202929|NCT00804193|Antifungal Agents|antifungal agents|mesh-ancestor
65202930|NCT00804193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65202931|NCT05697211|Ferric maltol|ferric maltol|mesh-list
65202932|NCT05697211|Hematinics|hematinics|mesh-ancestor
65202933|NCT00957996|Peramivir|peramivir|mesh-list
65202934|NCT00957996|Antiviral Agents|antiviral agents|mesh-ancestor
65202935|NCT00957996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65202936|NCT00957996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202937|NCT00957996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845572|NCT03600155|Nivolumab|nivolumab|mesh-list
65202938|NCT02606539|Leucovorin|leucovorin|mesh-list
65202939|NCT02606539|Folic Acid|folic acid|mesh-list
65202940|NCT02606539|Methotrexate|methotrexate|mesh-list
65202941|NCT02606539|Levoleucovorin|levoleucovorin|mesh-list
65202942|NCT02606539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65202943|NCT02606539|Abortifacient Agents|abortifacient agents|mesh-ancestor
65202944|NCT02606539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65202945|NCT02606539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202946|NCT02606539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65202947|NCT02606539|Antimetabolites|antimetabolites|mesh-ancestor
65202948|NCT02606539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202949|NCT02606539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202952|NCT02606539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65202953|NCT02606539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65202954|NCT02606539|Immunologic Factors|immunologic factors|mesh-ancestor
65202955|NCT02606539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65202956|NCT02606539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65202957|NCT02606539|Antidotes|antidotes|mesh-ancestor
65202958|NCT02606539|Protective Agents|protective agents|mesh-ancestor
65330783|NCT00698685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330784|NCT00698685|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65202959|NCT02606539|Vitamin B Complex|vitamin b complex|mesh-ancestor
65202961|NCT02606539|Micronutrients|micronutrients|mesh-ancestor
65202962|NCT02606539|Hematinics|hematinics|mesh-ancestor
65202963|NCT00589693|Imipenem|imipenem|mesh-list
65202964|NCT00589693|Doripenem|doripenem|mesh-list
65202965|NCT00589693|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
65202966|NCT00589693|Cilastatin|cilastatin|mesh-list
64508092|NCT03302208|Pregabalin|pregabalin|mesh-list
65202967|NCT00589693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65202968|NCT00589693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65202969|NCT00589693|Protease Inhibitors|protease inhibitors|mesh-ancestor
65202970|NCT00589693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202971|NCT00589693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202972|NCT02606383|Ketoconazole|ketoconazole|mesh-list
65202973|NCT02606383|Antifungal Agents|antifungal agents|mesh-ancestor
65202974|NCT02606383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65202975|NCT02606383|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65202976|NCT02606383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65202977|NCT02606383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202978|NCT02606383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202979|NCT02606383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65202980|NCT02606383|Hormone Antagonists|hormone antagonists|mesh-ancestor
65202981|NCT02606383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65202982|NCT02606383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202983|NCT02606383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65202985|NCT05734495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65202986|NCT05660473|Cytarabine|cytarabine|mesh-list
65202987|NCT05660473|Dexamethasone|dexamethasone|mesh-list
65202988|NCT05660473|Prednisone|prednisone|mesh-list
65202989|NCT05660473|Cyclophosphamide|cyclophosphamide|mesh-list
65202990|NCT05660473|Methotrexate|methotrexate|mesh-list
65202991|NCT05660473|Vincristine|vincristine|mesh-list
65202992|NCT05660473|Daunorubicin|daunorubicin|mesh-list
65202993|NCT05660473|Venetoclax|venetoclax|mesh-list
65202994|NCT05660473|Mercaptopurine|mercaptopurine|mesh-list
65202995|NCT05660473|Pegaspargase|pegaspargase|mesh-list
65202996|NCT05660473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65202997|NCT05660473|Immunologic Factors|immunologic factors|mesh-ancestor
65202998|NCT05660473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202999|NCT05660473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65203000|NCT05660473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65203001|NCT05660473|Alkylating Agents|alkylating agents|mesh-ancestor
65203002|NCT05660473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203003|NCT05660473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203004|NCT05660473|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65203005|NCT05660473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65203006|NCT05660473|Antiemetics|antiemetics|mesh-ancestor
65203007|NCT05660473|Autonomic Agents|autonomic agents|mesh-ancestor
65203008|NCT05660473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65203009|NCT05660473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65203010|NCT05660473|Glucocorticoids|glucocorticoids|mesh-ancestor
65203011|NCT05660473|Hormones|hormones|mesh-ancestor
65203012|NCT05660473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65203013|NCT05660473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65203014|NCT05660473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65203015|NCT05660473|Abortifacient Agents|abortifacient agents|mesh-ancestor
65203016|NCT05660473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65203017|NCT05660473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65203018|NCT05660473|Antimetabolites|antimetabolites|mesh-ancestor
65203019|NCT05660473|Dermatologic Agents|dermatologic agents|mesh-ancestor
65203020|NCT05660473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203021|NCT05660473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65203022|NCT05660473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65203023|NCT05660473|Antiviral Agents|antiviral agents|mesh-ancestor
65203024|NCT05660473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65203032|NCT00803101|Protein C|protein c|mesh-list
65203033|NCT00803101|Protein S|protein s|mesh-list
65203034|NCT00803101|Anticoagulants|anticoagulants|mesh-ancestor
65203035|NCT00803101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65203036|NCT00803101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65203037|NCT00803101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203038|NCT00801229|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65330785|NCT00698685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330786|NCT00698685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330787|NCT04972968|Glucocorticoids|glucocorticoids|mesh-list
65330788|NCT04972968|Hormones|hormones|mesh-ancestor
65330789|NCT04972968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65330790|NCT04972968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330791|NCT00737438|Bevacizumab|bevacizumab|mesh-list
65203039|NCT00801229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65203040|NCT00801229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508160|NCT02468232|Enalaprilat|enalaprilat|mesh-list
65203041|NCT00801229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65203042|NCT00801229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65203043|NCT00801229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65203044|NCT00801229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203045|NCT00801229|Dopamine Agents|dopamine agents|mesh-ancestor
65203046|NCT00801229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65203047|NCT01964430|Gemcitabine|gemcitabine|mesh-list
65203048|NCT01964430|Paclitaxel|paclitaxel|mesh-list
65203049|NCT01964430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65203050|NCT01964430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203051|NCT01964430|Tubulin Modulators|tubulin modulators|mesh-ancestor
65203052|NCT01964430|Antimitotic Agents|antimitotic agents|mesh-ancestor
65203053|NCT01964430|Mitosis Modulators|mitosis modulators|mesh-ancestor
65203054|NCT01964430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203055|NCT01964430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65203056|NCT01964430|Antimetabolites|antimetabolites|mesh-ancestor
65203057|NCT01964430|Antiviral Agents|antiviral agents|mesh-ancestor
65203058|NCT01964430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65203059|NCT01964430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203060|NCT01964430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65203061|NCT01964430|Immunologic Factors|immunologic factors|mesh-ancestor
65203062|NCT01964430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203063|NCT04269954|Heparin|heparin|mesh-list
65203064|NCT04269954|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65203065|NCT04269954|Tinzaparin|tinzaparin|mesh-list
65203066|NCT04269954|Dalteparin|dalteparin|mesh-list
65203067|NCT04269954|Batroxobin|batroxobin|mesh-list
65203068|NCT04269954|Anticoagulants|anticoagulants|mesh-ancestor
65203069|NCT04269954|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65203070|NCT04269954|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65203071|NCT04269954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203072|NCT04269954|Hemostatics|hemostatics|mesh-ancestor
65203073|NCT04269954|Coagulants|coagulants|mesh-ancestor
65203074|NCT00630630|Levetiracetam|levetiracetam|mesh-list
65203075|NCT00630630|Anticonvulsants|anticonvulsants|mesh-ancestor
65203076|NCT00630630|Nootropic Agents|nootropic agents|mesh-ancestor
65203077|NCT01254864|Prednisone|prednisone|mesh-list
65203078|NCT01254864|Sunitinib|sunitinib|mesh-list
65203079|NCT01254864|Dasatinib|dasatinib|mesh-list
65203080|NCT01254864|Abiraterone Acetate|abiraterone acetate|mesh-list
65203081|NCT01254864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65203082|NCT01254864|Glucocorticoids|glucocorticoids|mesh-ancestor
65203083|NCT01254864|Hormones|hormones|mesh-ancestor
65203084|NCT01254864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65203085|NCT01254864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203086|NCT01254864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65203087|NCT01254864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203088|NCT01254864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65203089|NCT01254864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65203090|NCT01254864|Growth Substances|growth substances|mesh-ancestor
65203091|NCT01254864|Growth Inhibitors|growth inhibitors|mesh-ancestor
64845722|NCT03294083|Cemiplimab|cemiplimab|mesh-list
65203092|NCT01254864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65203104|NCT02854722|Deferasirox|deferasirox|mesh-list
65203105|NCT02854722|Micronutrients|micronutrients|mesh-ancestor
65203106|NCT02854722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203107|NCT02854722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65203108|NCT02854722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65203109|NCT02854722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65330792|NCT00737438|Docetaxel|docetaxel|mesh-list
65330793|NCT00737438|Capecitabine|capecitabine|mesh-list
65330794|NCT00737438|Irinotecan|irinotecan|mesh-list
65330795|NCT00737438|Epirubicin|epirubicin|mesh-list
65080694|NCT00344006|Antiviral Agents|antiviral agents|mesh-ancestor
65330796|NCT00737438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65330798|NCT00737438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65330799|NCT00737438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65330800|NCT00737438|Growth Substances|growth substances|mesh-ancestor
64716863|NCT04337138|Gemtuzumab|gemtuzumab|mesh-list
65203110|NCT02854722|Chelating Agents|chelating agents|mesh-ancestor
65203111|NCT02854722|Sequestering Agents|sequestering agents|mesh-ancestor
65203112|NCT02854722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203113|NCT00800683|Linagliptin|linagliptin|mesh-list
65203114|NCT00800683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65203115|NCT00800683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203116|NCT00800683|Incretins|incretins|mesh-ancestor
65203117|NCT00800683|Hormones|hormones|mesh-ancestor
65203118|NCT00800683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65203119|NCT00800683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65203120|NCT00800683|Protease Inhibitors|protease inhibitors|mesh-ancestor
65203121|NCT00800683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203122|NCT00800683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203123|NCT01113710|Rotigotine|rotigotine|mesh-list
65203124|NCT01113710|Dopamine Agonists|dopamine agonists|mesh-ancestor
65203125|NCT01113710|Dopamine Agents|dopamine agents|mesh-ancestor
65203126|NCT01113710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65203127|NCT01113710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203128|NCT01113710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203129|NCT01124162|Losartan|losartan|mesh-list
65203130|NCT01124162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65203131|NCT01124162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65203132|NCT01124162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65203133|NCT01124162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65203134|NCT01124162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203135|NCT00923533|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65203136|NCT00923533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65203137|NCT00923533|Diuretics|diuretics|mesh-ancestor
65203138|NCT00923533|Natriuretic Agents|natriuretic agents|mesh-ancestor
65203139|NCT00923533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203140|NCT00923533|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65203141|NCT00923533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65203142|NCT00923533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203143|NCT00906399|Interferons|interferons|mesh-list
65203144|NCT00906399|Interferon-beta|interferon-beta|mesh-list
65203145|NCT00906399|Interferon beta-1a|interferon beta-1a|mesh-list
65203146|NCT00906399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203147|NCT00906399|Antiviral Agents|antiviral agents|mesh-ancestor
65203148|NCT00906399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65203149|NCT00906399|Immunologic Factors|immunologic factors|mesh-ancestor
65203150|NCT00906399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203151|NCT00906399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65203152|NCT00947856|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65203153|NCT00947856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65203154|NCT00947856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203155|NCT00947544|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
65203156|NCT00947544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203157|NCT00907335|Tretinoin|tretinoin|mesh-list
65203158|NCT00907335|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65203164|NCT00947154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65203165|NCT00947154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65203166|NCT00947154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65203167|NCT00947154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65203168|NCT00947154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203169|NCT00947154|Dopamine Agonists|dopamine agonists|mesh-ancestor
65203170|NCT00947154|Dopamine Agents|dopamine agents|mesh-ancestor
65203171|NCT00947154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65330801|NCT00737438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330802|NCT00737438|Growth Inhibitors|growth inhibitors|mesh-ancestor
65330803|NCT00737438|Tubulin Modulators|tubulin modulators|mesh-ancestor
65330804|NCT00737438|Antimitotic Agents|antimitotic agents|mesh-ancestor
65330805|NCT00737438|Mitosis Modulators|mitosis modulators|mesh-ancestor
65330806|NCT00737438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330807|NCT00737438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65330808|NCT00737438|Antimetabolites|antimetabolites|mesh-ancestor
65330809|NCT00737438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65330810|NCT00737438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65330811|NCT00737438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330812|NCT00737438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65330813|NCT00737438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65330814|NCT00737048|Acetaminophen|acetaminophen|mesh-list
65330815|NCT00737048|Tramadol|tramadol|mesh-list
65330816|NCT00737048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65203172|NCT00947154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203173|NCT00947154|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65203174|NCT00947154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65203175|NCT00947154|Serotonin Agents|serotonin agents|mesh-ancestor
65203176|NCT00947154|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65203177|NCT00947154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65203178|NCT00947154|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65203179|NCT00947154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65203180|NCT01862952|Anticonvulsants|anticonvulsants|mesh-list
65203182|NCT00952068|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65203183|NCT00952068|Narcotics|narcotics|mesh-ancestor
65203184|NCT00952068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65203185|NCT00952068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203186|NCT00952068|Analgesics|analgesics|mesh-ancestor
65203187|NCT00952068|Sensory System Agents|sensory system agents|mesh-ancestor
65203188|NCT00952068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65203189|NCT00951912|Genistein|genistein|mesh-list
65203190|NCT00951912|Daidzein|daidzein|mesh-list
65203191|NCT00951912|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65203192|NCT00951912|Protective Agents|protective agents|mesh-ancestor
65203193|NCT00951912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203194|NCT00951912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203195|NCT00951912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65203196|NCT00951912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203197|NCT00951912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203198|NCT00951912|Phytoestrogens|phytoestrogens|mesh-ancestor
65203199|NCT00951912|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65203200|NCT00951912|Estrogens|estrogens|mesh-ancestor
65203201|NCT00951912|Hormones|hormones|mesh-ancestor
65203202|NCT00951912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65203203|NCT02882594|Anesthetics|anesthetics|mesh-list
65203204|NCT02882594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65203205|NCT02882594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203206|NCT02856048|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65203207|NCT02856048|Luteolytic Agents|luteolytic agents|mesh-ancestor
65203208|NCT02856048|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65203209|NCT02856048|Contraceptive Agents|contraceptive agents|mesh-ancestor
65203210|NCT02856048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65203211|NCT02856048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203212|NCT02856048|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65203213|NCT02856048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65203214|NCT02856048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330817|NCT00737048|Analgesics|analgesics|mesh-ancestor
65330818|NCT00737048|Sensory System Agents|sensory system agents|mesh-ancestor
65330819|NCT00737048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65330820|NCT00737048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330821|NCT00737048|Antipyretics|antipyretics|mesh-ancestor
65330822|NCT00737048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65330823|NCT00737048|Narcotics|narcotics|mesh-ancestor
65330824|NCT00737048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65330825|NCT02593448|Anesthetics|anesthetics|mesh-list
65330826|NCT02593448|Propofol|propofol|mesh-list
65330827|NCT02593448|Sevoflurane|sevoflurane|mesh-list
65330828|NCT02593448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65203215|NCT03844815|Decitabine|decitabine|mesh-list
65203216|NCT03844815|Venetoclax|venetoclax|mesh-list
65203217|NCT03844815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65203218|NCT03844815|Antimetabolites|antimetabolites|mesh-ancestor
65203219|NCT03844815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203220|NCT03844815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203221|NCT03844815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203222|NCT01123070|Rituximab|rituximab|mesh-list
65203223|NCT01123070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65203224|NCT01123070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203225|NCT01123070|Immunologic Factors|immunologic factors|mesh-ancestor
65203226|NCT01123070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203227|NCT01123070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65203228|NCT02857686|Anesthetics|anesthetics|mesh-list
65203229|NCT02857686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65203234|NCT03198741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65203235|NCT03198741|Analgesics|analgesics|mesh-ancestor
65203236|NCT03198741|Sensory System Agents|sensory system agents|mesh-ancestor
65203237|NCT03198741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65203238|NCT03198741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845874|NCT02587312|Nicotine|nicotine|mesh-list
65203239|NCT03198741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65203240|NCT03198741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65203241|NCT03198741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65203242|NCT03198741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65203243|NCT03198741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203244|NCT03198741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65203245|NCT03198741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65203246|NCT03198741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203247|NCT03198741|Antipyretics|antipyretics|mesh-ancestor
65203248|NCT03198741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65203249|NCT03198741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65203250|NCT03198741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65203251|NCT03198741|Purinergic Agents|purinergic agents|mesh-ancestor
65203252|NCT03198741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65203253|NCT01122680|Bromides|bromides|mesh-list
65203254|NCT01122680|Tiotropium Bromide|tiotropium bromide|mesh-list
65203255|NCT01122680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65203256|NCT01122680|Autonomic Agents|autonomic agents|mesh-ancestor
65203257|NCT01122680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65203258|NCT01122680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203259|NCT01122680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65203260|NCT01122680|Respiratory System Agents|respiratory system agents|mesh-ancestor
65203261|NCT01122680|Parasympatholytics|parasympatholytics|mesh-ancestor
65203262|NCT01122680|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65203263|NCT01122680|Cholinergic Agents|cholinergic agents|mesh-ancestor
65203264|NCT01122680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65203265|NCT01122680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203266|NCT01122680|Anticonvulsants|anticonvulsants|mesh-ancestor
65203267|NCT00946998|Sertraline|sertraline|mesh-list
65203268|NCT00946998|Antidepressive Agents|antidepressive agents|mesh-ancestor
65203269|NCT00946998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65203270|NCT00946998|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65330829|NCT02593448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330830|NCT02593448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65330831|NCT02593448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65330832|NCT02593448|Anesthetics, General|anesthetics, general|mesh-ancestor
65330833|NCT02593448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65330834|NCT02593448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65203271|NCT00946998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65203272|NCT00946998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65203273|NCT00946998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203274|NCT00946998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65203275|NCT00946998|Serotonin Agents|serotonin agents|mesh-ancestor
65203276|NCT00946998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203277|NCT01138826|Amlodipine|amlodipine|mesh-list
65203278|NCT01138826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65203279|NCT01138826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65203280|NCT01138826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65203281|NCT01138826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203282|NCT01138826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65203283|NCT01138826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203284|NCT01138826|Vasodilator Agents|vasodilator agents|mesh-ancestor
65203285|NCT00906087|Timolol|timolol|mesh-list
65203286|NCT00906087|Dorzolamide|dorzolamide|mesh-list
65203287|NCT00906087|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65203288|NCT00906087|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65203289|NCT00906087|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65203290|NCT00906087|Adrenergic Agents|adrenergic agents|mesh-ancestor
65203291|NCT00906087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65203292|NCT00906087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203293|NCT00906087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203294|NCT00906087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65203295|NCT00906087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65203296|NCT00906087|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65203297|NCT00906087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203298|NCT00906087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65203300|NCT03525795|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
65203303|NCT03525795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65203304|NCT03525795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203305|NCT03525795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203306|NCT03522831|Albuterol|albuterol|mesh-list
65203307|NCT03522831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65203308|NCT03522831|Autonomic Agents|autonomic agents|mesh-ancestor
65203309|NCT03522831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65203310|NCT03522831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203311|NCT03522831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65203313|NCT03522831|Tocolytic Agents|tocolytic agents|mesh-ancestor
65203314|NCT03522831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65203315|NCT03522831|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65203316|NCT03522831|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65203317|NCT03522831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65203318|NCT03522831|Adrenergic Agents|adrenergic agents|mesh-ancestor
65203319|NCT03522831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65203320|NCT03522831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203321|NCT03504501|Lamotrigine|lamotrigine|mesh-list
65203322|NCT03504501|Lovastatin|lovastatin|mesh-list
65203323|NCT03504501|L 647318|l 647318|mesh-list
65203324|NCT03504501|Dihydromevinolin|dihydromevinolin|mesh-list
65203325|NCT03504501|Anticonvulsants|anticonvulsants|mesh-ancestor
65203326|NCT03504501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65203327|NCT03504501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65203328|NCT03504501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203329|NCT03504501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65203330|NCT03504501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203331|NCT03504501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65203332|NCT03504501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65330835|NCT02592746|Capecitabine|capecitabine|mesh-list
65330836|NCT02592746|Palbociclib|palbociclib|mesh-list
65330837|NCT02592746|Leuprolide|leuprolide|mesh-list
65330838|NCT02592746|Exemestane|exemestane|mesh-list
65330839|NCT02592746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65330840|NCT02592746|Antimetabolites|antimetabolites|mesh-ancestor
65203333|NCT03504501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65203334|NCT03504501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65203335|NCT03504501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65203336|NCT03504501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65203337|NCT03504501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65203338|NCT03504501|Antimetabolites|antimetabolites|mesh-ancestor
65203339|NCT03504501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65203340|NCT03504501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65203341|NCT03504501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203342|NCT02420574|Albendazole|albendazole|mesh-list
65203343|NCT02420574|Anthelmintics|anthelmintics|mesh-ancestor
65203344|NCT02420574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65203345|NCT02420574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65203346|NCT02420574|Anticestodal Agents|anticestodal agents|mesh-ancestor
65203347|NCT02420574|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65203348|NCT02420574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65203349|NCT02420574|Tubulin Modulators|tubulin modulators|mesh-ancestor
65203350|NCT02420574|Antimitotic Agents|antimitotic agents|mesh-ancestor
65203351|NCT02420574|Mitosis Modulators|mitosis modulators|mesh-ancestor
65203352|NCT02420574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203353|NCT02420574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203354|NCT02855502|Prednisolone|prednisolone|mesh-list
65203355|NCT02855502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65203356|NCT02855502|Glucocorticoids|glucocorticoids|mesh-ancestor
65203357|NCT02855502|Hormones|hormones|mesh-ancestor
65203358|NCT02855502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65203359|NCT02855502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203360|NCT02855502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65203361|NCT02855502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203362|NCT02853864|Dexmedetomidine|dexmedetomidine|mesh-list
65203363|NCT02853864|Propofol|propofol|mesh-list
65203364|NCT02853864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65203365|NCT02853864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65203366|NCT02853864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203367|NCT02853864|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65203368|NCT02853864|Anesthetics, General|anesthetics, general|mesh-ancestor
65203372|NCT02853864|Sensory System Agents|sensory system agents|mesh-ancestor
65203373|NCT02853864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65203374|NCT02853864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65203375|NCT02853864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65203376|NCT02853864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65203377|NCT02853864|Adrenergic Agents|adrenergic agents|mesh-ancestor
65203378|NCT02853864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65203379|NCT02853864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203380|NCT00907257|Tretinoin|tretinoin|mesh-list
65203381|NCT00907257|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65203382|NCT00907257|Dermatologic Agents|dermatologic agents|mesh-ancestor
65203383|NCT00907257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203384|NCT00907257|Keratolytic Agents|keratolytic agents|mesh-ancestor
65203385|NCT01138046|Paclitaxel|paclitaxel|mesh-list
65203386|NCT01138046|Lapatinib|lapatinib|mesh-list
65203387|NCT01138046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65203388|NCT01138046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203389|NCT01138046|Tubulin Modulators|tubulin modulators|mesh-ancestor
65203390|NCT01138046|Antimitotic Agents|antimitotic agents|mesh-ancestor
65203391|NCT01138046|Mitosis Modulators|mitosis modulators|mesh-ancestor
65203392|NCT01138046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203393|NCT01138046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65203394|NCT01138046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203395|NCT03488667|Pembrolizumab|pembrolizumab|mesh-list
65203396|NCT03488667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65203397|NCT03488667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203398|NCT02350764|Nivolumab|nivolumab|mesh-list
65203399|NCT02350764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65203400|NCT02350764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330841|NCT02592746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330842|NCT02592746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330843|NCT02592746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65330844|NCT02592746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330845|NCT02592746|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65330846|NCT02592746|Fertility Agents|fertility agents|mesh-ancestor
64687508|NCT02592629|Anesthetics|anesthetics|mesh-ancestor
65203401|NCT02350764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65203402|NCT02350764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203403|NCT00876460|Docetaxel|docetaxel|mesh-list
65203404|NCT00876460|Nintedanib|nintedanib|mesh-list
65203405|NCT00876460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203406|NCT00876460|Tubulin Modulators|tubulin modulators|mesh-ancestor
65203407|NCT00876460|Antimitotic Agents|antimitotic agents|mesh-ancestor
65203408|NCT00876460|Mitosis Modulators|mitosis modulators|mesh-ancestor
65203409|NCT00876460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203410|NCT00876460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65203411|NCT00876460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203412|NCT01137812|Metformin|metformin|mesh-list
65203413|NCT01137812|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65203414|NCT01137812|Canagliflozin|canagliflozin|mesh-list
65203415|NCT01137812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65203416|NCT01137812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203417|NCT01137812|Incretins|incretins|mesh-ancestor
65203418|NCT01137812|Hormones|hormones|mesh-ancestor
65203419|NCT01137812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65203420|NCT01137812|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65203421|NCT01137812|Protease Inhibitors|protease inhibitors|mesh-ancestor
65203422|NCT01137812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203423|NCT01137812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203424|NCT01137812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65203425|NCT00679510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65203426|NCT00679510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65203427|NCT00679510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65203428|NCT00679510|Antimetabolites|antimetabolites|mesh-ancestor
65203429|NCT00679510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203430|NCT00679510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65203431|NCT00679510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65203432|NCT00679510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203433|NCT04146220|Prednisolone|prednisolone|mesh-list
65203434|NCT04146220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65203435|NCT04146220|Glucocorticoids|glucocorticoids|mesh-ancestor
65203436|NCT04146220|Hormones|hormones|mesh-ancestor
65203437|NCT04146220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65203438|NCT04146220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203439|NCT04146220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65203440|NCT04146220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203451|NCT00679744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65203452|NCT00679744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65203453|NCT00679744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65203454|NCT00679744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203455|NCT00679744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203456|NCT00681772|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65203457|NCT00681772|Vasodilator Agents|vasodilator agents|mesh-ancestor
65203458|NCT00681772|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64846100|NCT01688362|Anesthetics|anesthetics|mesh-ancestor
65203459|NCT00681772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65203460|NCT00681772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203461|NCT00681772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203462|NCT00681772|Urological Agents|urological agents|mesh-ancestor
65203464|NCT00946920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65203465|NCT00946920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203466|NCT00679900|SR 46349B|sr 46349b|mesh-list
65203467|NCT00679900|Lormetazepam|lormetazepam|mesh-list
65203468|NCT00679900|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65203469|NCT00679900|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65330847|NCT02592746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65330848|NCT02592746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330849|NCT02592746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65330850|NCT02592746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65330851|NCT02592746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65330852|NCT02592746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65330853|NCT02592746|Hormone Antagonists|hormone antagonists|mesh-ancestor
65330854|NCT02592746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65330855|NCT03365622|Acetaminophen|acetaminophen|mesh-list
65330856|NCT03365622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65330857|NCT03365622|Analgesics|analgesics|mesh-ancestor
65330858|NCT03365622|Sensory System Agents|sensory system agents|mesh-ancestor
65330859|NCT03365622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65330860|NCT03365622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330861|NCT03365622|Antipyretics|antipyretics|mesh-ancestor
65330862|NCT00731120|Vortioxetine|vortioxetine|mesh-list
65330863|NCT00731120|Antidepressive Agents|antidepressive agents|mesh-ancestor
65203470|NCT00679900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203471|NCT00679900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65203472|NCT00679900|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65203473|NCT00679900|Serotonin Agents|serotonin agents|mesh-ancestor
65203474|NCT00679900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65203475|NCT00679900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203476|NCT00679900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65203477|NCT00679900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65203478|NCT00945906|Fibrinolysin|fibrinolysin|mesh-list
65203479|NCT00945906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65203480|NCT00945906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65203481|NCT00945906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203482|NCT00681928|Letrozole|letrozole|mesh-list
65203483|NCT00681928|Anastrozole|anastrozole|mesh-list
65203484|NCT00681928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203485|NCT00681928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65203486|NCT00681928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65203487|NCT00681928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203488|NCT00681928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203489|NCT00681928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65203490|NCT00681928|Hormone Antagonists|hormone antagonists|mesh-ancestor
65203491|NCT00681928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65203492|NCT00681928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203493|NCT00681928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65203494|NCT00594646|Tenofovir|tenofovir|mesh-list
65203495|NCT00594646|Emtricitabine|emtricitabine|mesh-list
65203496|NCT00594646|Raltegravir Potassium|raltegravir potassium|mesh-list
65203497|NCT00594646|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65203498|NCT00594646|Antiviral Agents|antiviral agents|mesh-ancestor
65203499|NCT00594646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65203500|NCT00594646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65203501|NCT00594646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65203502|NCT00594646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203503|NCT00594646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203504|NCT00594646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65203505|NCT00594646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65203507|NCT00594646|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65203508|NCT00680134|Tavaborole|tavaborole|mesh-list
65330864|NCT00731120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65330865|NCT00731120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65330866|NCT00731120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65330867|NCT00731120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65330868|NCT00731120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716919|NCT03330457|Protease Inhibitors|protease inhibitors|mesh-ancestor
65203509|NCT00680134|Antifungal Agents|antifungal agents|mesh-ancestor
65203510|NCT00680134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65203511|NCT00680212|Beta Carotene|beta carotene|mesh-list
65203512|NCT00680212|Carotenoids|carotenoids|mesh-list
65203513|NCT00680212|Antioxidants|antioxidants|mesh-ancestor
65203514|NCT00680212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203515|NCT00680212|Protective Agents|protective agents|mesh-ancestor
65203516|NCT00680212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203517|NCT00680212|Provitamins|provitamins|mesh-ancestor
65203518|NCT00680212|Vitamins|vitamins|mesh-ancestor
65203519|NCT00680212|Micronutrients|micronutrients|mesh-ancestor
65203520|NCT00682006|Chlorhexidine|chlorhexidine|mesh-list
65203521|NCT00682006|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65203522|NCT00682006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65203523|NCT00682006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65203524|NCT00682006|Disinfectants|disinfectants|mesh-ancestor
65203525|NCT00682006|Dermatologic Agents|dermatologic agents|mesh-ancestor
65203526|NCT02855346|Dapivirine|dapivirine|mesh-list
65203527|NCT02855346|Levonorgestrel|levonorgestrel|mesh-list
65203528|NCT02855346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65203529|NCT02855346|Contraceptive Agents|contraceptive agents|mesh-ancestor
65203530|NCT02855346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65203531|NCT02855346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203532|NCT02855346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65203533|NCT02855346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65203534|NCT02855346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65203535|NCT02855346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65203536|NCT02855346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65203537|NCT02855346|Antiviral Agents|antiviral agents|mesh-ancestor
65203538|NCT02855346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65203539|NCT01111604|Ramucirumab|ramucirumab|mesh-list
65203540|NCT01111604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203541|NCT00950742|Trastuzumab|trastuzumab|mesh-list
65203542|NCT00950742|Afatinib|afatinib|mesh-list
65203543|NCT00950742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65203544|NCT00950742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203545|NCT00950742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65203546|NCT00950742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203547|NCT00950742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203548|NCT05061368|Sildenafil Citrate|sildenafil citrate|mesh-list
65203549|NCT05061368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203550|NCT05061368|Vasodilator Agents|vasodilator agents|mesh-ancestor
65203551|NCT05061368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65203552|NCT05061368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65203553|NCT05061368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203554|NCT05061368|Urological Agents|urological agents|mesh-ancestor
65203555|NCT04310228|Favipiravir|favipiravir|mesh-list
65203556|NCT04310228|Antiviral Agents|antiviral agents|mesh-ancestor
65203557|NCT04310228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65203558|NCT00955110|Oxymorphone|oxymorphone|mesh-list
65203559|NCT00955110|Oxycodone|oxycodone|mesh-list
65203560|NCT00955110|Hydromorphone|hydromorphone|mesh-list
65203561|NCT00955110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65203562|NCT00955110|Narcotics|narcotics|mesh-ancestor
65203563|NCT00955110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65203564|NCT00955110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203565|NCT00955110|Analgesics|analgesics|mesh-ancestor
65203566|NCT00955110|Sensory System Agents|sensory system agents|mesh-ancestor
65203567|NCT00955110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65203568|NCT00955110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65203569|NCT05056142|Anesthetics|anesthetics|mesh-list
65203570|NCT05056142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65203571|NCT05056142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203572|NCT00950664|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65203573|NCT00950664|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65330869|NCT00731120|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65330870|NCT00731120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65330871|NCT00731120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65330872|NCT00731120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330873|NCT00731120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65330874|NCT00731120|Serotonin Agents|serotonin agents|mesh-ancestor
65330875|NCT00731120|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65330876|NCT00731120|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65330877|NCT00731120|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65330878|NCT00731120|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65330879|NCT02580006|Epoetin Alfa|epoetin alfa|mesh-list
65330880|NCT02580006|Hematinics|hematinics|mesh-ancestor
65330881|NCT00731042|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65330882|NCT00731042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65330883|NCT00731042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65330884|NCT00731042|Dermatologic Agents|dermatologic agents|mesh-ancestor
65330886|NCT02787642|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65203574|NCT00950664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65203575|NCT00950664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65203576|NCT00950664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203577|NCT00950664|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65203578|NCT00950664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65203579|NCT00950664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203580|NCT00950664|Cholinergic Agents|cholinergic agents|mesh-ancestor
65203581|NCT00950664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65203586|NCT01111526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203587|NCT02881346|Betamethasone|betamethasone|mesh-list
65203588|NCT02881346|Betamethasone Valerate|betamethasone valerate|mesh-list
65203589|NCT02881346|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65203590|NCT02881346|Betamethasone benzoate|betamethasone benzoate|mesh-list
65203591|NCT02881346|Calcipotriene|calcipotriene|mesh-list
65203592|NCT02881346|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65203593|NCT02881346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65203594|NCT02881346|Glucocorticoids|glucocorticoids|mesh-ancestor
65203595|NCT02881346|Hormones|hormones|mesh-ancestor
65203596|NCT02881346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65203597|NCT02881346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203598|NCT02881346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65203599|NCT02881346|Respiratory System Agents|respiratory system agents|mesh-ancestor
65203600|NCT02881346|Dermatologic Agents|dermatologic agents|mesh-ancestor
65203601|NCT00630708|Losartan|losartan|mesh-list
65203602|NCT00630708|Benazepril|benazepril|mesh-list
65203603|NCT00630708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65203604|NCT00630708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65203605|NCT00630708|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65203606|NCT00630708|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65203607|NCT00630708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203608|NCT00630708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65203609|NCT00630708|Protease Inhibitors|protease inhibitors|mesh-ancestor
65203610|NCT00630708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203611|NCT01111292|Inositol|inositol|mesh-list
65203612|NCT01111292|Vitamin B Complex|vitamin b complex|mesh-ancestor
65203613|NCT01111292|Vitamins|vitamins|mesh-ancestor
65203614|NCT01111292|Micronutrients|micronutrients|mesh-ancestor
65330887|NCT02787642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330888|NCT02787642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330889|NCT02787642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330890|NCT04075188|Aflibercept|aflibercept|mesh-list
65330891|NCT04075188|Verteporfin|verteporfin|mesh-list
65330892|NCT04075188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65330893|NCT04075188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65330894|NCT04075188|Growth Substances|growth substances|mesh-ancestor
65330895|NCT04075188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330896|NCT04075188|Growth Inhibitors|growth inhibitors|mesh-ancestor
65330897|NCT04075188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330898|NCT04075188|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65203615|NCT01111292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203616|NCT02853630|Metformin|metformin|mesh-list
65203617|NCT02853630|Vildagliptin|vildagliptin|mesh-list
65203618|NCT02853630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65203619|NCT02853630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203620|NCT02853630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65203621|NCT02853630|Protease Inhibitors|protease inhibitors|mesh-ancestor
65203622|NCT02853630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203623|NCT02853630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203624|NCT04309838|Treprostinil|treprostinil|mesh-list
65203625|NCT04309838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65203626|NCT05367206|Paclitaxel|paclitaxel|mesh-list
65203627|NCT05367206|Carboplatin|carboplatin|mesh-list
65203628|NCT05367206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65203629|NCT05367206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65203630|NCT05367206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203631|NCT05367206|Tubulin Modulators|tubulin modulators|mesh-ancestor
65203632|NCT05367206|Antimitotic Agents|antimitotic agents|mesh-ancestor
65203633|NCT05367206|Mitosis Modulators|mitosis modulators|mesh-ancestor
65203634|NCT05367206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203635|NCT00637286|Zolmitriptan|zolmitriptan|mesh-list
65203636|NCT00637286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65203637|NCT00637286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65203638|NCT00637286|Serotonin Agents|serotonin agents|mesh-ancestor
65203639|NCT00637286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65203640|NCT00637286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203641|NCT00637286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203642|NCT00944658|Apremilast|apremilast|mesh-list
65203643|NCT00944658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65203644|NCT00944658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65203645|NCT00944658|Analgesics|analgesics|mesh-ancestor
65203646|NCT00944658|Sensory System Agents|sensory system agents|mesh-ancestor
65203647|NCT00944658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65203648|NCT00944658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203649|NCT00944658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65203650|NCT00944658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65203651|NCT00944658|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65203652|NCT00944658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65203657|NCT01110200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65203658|NCT01110200|Autonomic Agents|autonomic agents|mesh-ancestor
65203659|NCT01110200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65203660|NCT01110200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203661|NCT01110200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65203662|NCT01110200|Respiratory System Agents|respiratory system agents|mesh-ancestor
65203663|NCT01110200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65203664|NCT01110200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65203665|NCT01110200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65203666|NCT01110200|Adrenergic Agents|adrenergic agents|mesh-ancestor
65203667|NCT01110200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65203668|NCT01110200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330899|NCT04075188|Dermatologic Agents|dermatologic agents|mesh-ancestor
65330900|NCT00726986|Etoposide|etoposide|mesh-list
65330901|NCT00726986|Sorafenib|sorafenib|mesh-list
65330902|NCT00726986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330903|NCT00726986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65330904|NCT00726986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65330905|NCT00726986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65330906|NCT00726986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330907|NCT00726986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330908|NCT00726986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65330909|NCT00696657|Liraglutide|liraglutide|mesh-list
65330910|NCT00696657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65330911|NCT00696657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330912|NCT00696657|Incretins|incretins|mesh-ancestor
65330913|NCT00696657|Hormones|hormones|mesh-ancestor
65203669|NCT01110200|Glucocorticoids|glucocorticoids|mesh-ancestor
65203670|NCT01110200|Hormones|hormones|mesh-ancestor
65203671|NCT01110200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65203672|NCT01110200|Sympathomimetics|sympathomimetics|mesh-ancestor
65203673|NCT05182112|Gemcitabine|gemcitabine|mesh-list
65203674|NCT05182112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203675|NCT05182112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65203676|NCT05182112|Antimetabolites|antimetabolites|mesh-ancestor
65203677|NCT05182112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203678|NCT05182112|Antiviral Agents|antiviral agents|mesh-ancestor
65203679|NCT05182112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65203680|NCT05182112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203681|NCT05182112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65203682|NCT05182112|Immunologic Factors|immunologic factors|mesh-ancestor
65203683|NCT05182112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203684|NCT01136954|Zonisamide|zonisamide|mesh-list
65203685|NCT01136954|Anticonvulsants|anticonvulsants|mesh-ancestor
65203686|NCT01136954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65203687|NCT01136954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65203688|NCT01136954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203689|NCT01136954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65203690|NCT01136954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203691|NCT01108094|Itraconazole|itraconazole|mesh-list
65203692|NCT01108094|Antifungal Agents|antifungal agents|mesh-ancestor
65203693|NCT01108094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65203694|NCT01108094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65203695|NCT01108094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65203696|NCT01108094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203697|NCT01108094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203698|NCT01108094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65203699|NCT01108094|Hormone Antagonists|hormone antagonists|mesh-ancestor
65203700|NCT01108094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65203701|NCT01108094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203702|NCT01108094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65203704|NCT00954174|Carboplatin|carboplatin|mesh-list
65203705|NCT00954174|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65203706|NCT00954174|Ifosfamide|ifosfamide|mesh-list
65203707|NCT00954174|Isophosphamide mustard|isophosphamide mustard|mesh-list
65203708|NCT00954174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65203709|NCT00954174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203710|NCT00954174|Tubulin Modulators|tubulin modulators|mesh-ancestor
65203711|NCT00954174|Antimitotic Agents|antimitotic agents|mesh-ancestor
65203712|NCT00954174|Mitosis Modulators|mitosis modulators|mesh-ancestor
65203713|NCT00954174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330914|NCT00696657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65330915|NCT00726752|Axitinib|axitinib|mesh-list
65330916|NCT00726752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330917|NCT00726752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65330918|NCT00726752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330919|NCT00726752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330920|NCT02594462|Contraceptive Agents|contraceptive agents|mesh-list
65330921|NCT02594462|Etonogestrel|etonogestrel|mesh-list
65330922|NCT02594462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65330923|NCT02594462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203714|NCT00954174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65203715|NCT00954174|Alkylating Agents|alkylating agents|mesh-ancestor
65203716|NCT01107626|Paclitaxel|paclitaxel|mesh-list
65203717|NCT01107626|Bevacizumab|bevacizumab|mesh-list
65203718|NCT01107626|Carboplatin|carboplatin|mesh-list
65203719|NCT01107626|Pemetrexed|pemetrexed|mesh-list
65203720|NCT01107626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65203721|NCT01107626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203724|NCT01107626|Mitosis Modulators|mitosis modulators|mesh-ancestor
65203725|NCT01107626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203726|NCT01107626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65203727|NCT01107626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65203728|NCT01107626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65203729|NCT01107626|Growth Substances|growth substances|mesh-ancestor
65203730|NCT01107626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203731|NCT01107626|Growth Inhibitors|growth inhibitors|mesh-ancestor
65203732|NCT01107626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203733|NCT01107626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65203734|NCT01107626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65203735|NCT04309058|Vitamin D|vitamin d|mesh-list
65203736|NCT04309058|Vitamins|vitamins|mesh-ancestor
65203737|NCT04309058|Micronutrients|micronutrients|mesh-ancestor
65203738|NCT04309058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203739|NCT04309058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65203740|NCT01136408|Warfarin|warfarin|mesh-list
65203741|NCT01136408|Dabigatran|dabigatran|mesh-list
65203742|NCT01136408|Anticoagulants|anticoagulants|mesh-ancestor
65203743|NCT01136408|Antithrombins|antithrombins|mesh-ancestor
65203744|NCT01136408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65203745|NCT01136408|Protease Inhibitors|protease inhibitors|mesh-ancestor
65203746|NCT01136408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203747|NCT01136408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203748|NCT01136174|Nintedanib|nintedanib|mesh-list
65203749|NCT01136174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203750|NCT01136174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65203751|NCT01136174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203752|NCT01136174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203753|NCT01135394|Pioglitazone|pioglitazone|mesh-list
65203754|NCT01135394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65203755|NCT01135394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203756|NCT00949884|Losartan|losartan|mesh-list
64846395|NCT01691053|Diuretics|diuretics|mesh-ancestor
65203757|NCT00949884|Olmesartan|olmesartan|mesh-list
65203758|NCT00949884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65203759|NCT00949884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65203760|NCT00949884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65203761|NCT00949884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65203762|NCT00949884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65203763|NCT00949884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203764|NCT00949650|Pemetrexed|pemetrexed|mesh-list
65203765|NCT00949650|Afatinib|afatinib|mesh-list
65203766|NCT00949650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203767|NCT00949650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203768|NCT00949650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330924|NCT02594462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64716977|NCT03670160|Sympatholytics|sympatholytics|mesh-ancestor
65203769|NCT00949650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65203770|NCT00949650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65203771|NCT00949650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65203773|NCT03082755|Analgesics|analgesics|mesh-ancestor
65203774|NCT03082755|Sensory System Agents|sensory system agents|mesh-ancestor
65203775|NCT03082755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65203776|NCT03082755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203777|NCT03082755|Anticonvulsants|anticonvulsants|mesh-ancestor
65203778|NCT03082755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65203779|NCT03082755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65203780|NCT03082755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65203781|NCT03082755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65203782|NCT03082755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65203783|NCT03082755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65203784|NCT03082755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65203785|NCT03082755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203786|NCT03082755|Antimanic Agents|antimanic agents|mesh-ancestor
65203787|NCT05332353|BCG Vaccine|bcg vaccine|mesh-list
65203788|NCT05332353|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65203789|NCT05332353|Immunologic Factors|immunologic factors|mesh-ancestor
65203790|NCT05332353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203791|NCT00904215|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65203792|NCT00904215|Telmisartan|telmisartan|mesh-list
65203793|NCT00904215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65203794|NCT00904215|Diuretics|diuretics|mesh-ancestor
65203795|NCT00904215|Natriuretic Agents|natriuretic agents|mesh-ancestor
65203798|NCT00904215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65203799|NCT00904215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203800|NCT00904215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65203801|NCT00904215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65203803|NCT05317689|Psilocin|psilocin|mesh-list
65203804|NCT05317689|Hallucinogens|hallucinogens|mesh-ancestor
65203805|NCT05317689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203806|NCT05317689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65203807|NCT05293665|Vaccines|vaccines|mesh-list
65203808|NCT05293665|Immunologic Factors|immunologic factors|mesh-ancestor
65203809|NCT05293665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203810|NCT00905307|Aripiprazole|aripiprazole|mesh-list
65203811|NCT00905307|Antidepressive Agents|antidepressive agents|mesh-ancestor
65203812|NCT00905307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65203813|NCT00905307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65203814|NCT00905307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65203815|NCT00905307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65203816|NCT00905307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203817|NCT00905307|Dopamine Agonists|dopamine agonists|mesh-ancestor
65203818|NCT00905307|Dopamine Agents|dopamine agents|mesh-ancestor
65203819|NCT00905307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65203820|NCT00905307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203821|NCT00905307|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65203822|NCT00905307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65203823|NCT00905307|Serotonin Agents|serotonin agents|mesh-ancestor
65203824|NCT00905307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65203825|NCT00905307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65203826|NCT00905307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65203827|NCT00905307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65203828|NCT00904839|Bevacizumab|bevacizumab|mesh-list
65203829|NCT00904839|Nintedanib|nintedanib|mesh-list
65203830|NCT00904839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64846462|NCT01691742|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65203831|NCT00904839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203832|NCT00904839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65203833|NCT00904839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65203834|NCT00904839|Growth Substances|growth substances|mesh-ancestor
65203835|NCT00904839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203836|NCT00904839|Growth Inhibitors|growth inhibitors|mesh-ancestor
65203837|NCT00904839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65203838|NCT00904839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955497|NCT00203281|Antibodies|antibodies|mesh-list
65203846|NCT00903357|Ascorbic Acid|ascorbic acid|mesh-list
65203847|NCT00903357|Montelukast|montelukast|mesh-list
65203848|NCT00903357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65330925|NCT02594462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65330926|NCT02664558|Ubenimex|ubenimex|mesh-list
65330927|NCT02664558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65330928|NCT02664558|Immunologic Factors|immunologic factors|mesh-ancestor
65330929|NCT02664558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330930|NCT02664558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64688062|NCT01852669|Furosemide|furosemide|mesh-list
65203849|NCT00903357|Respiratory System Agents|respiratory system agents|mesh-ancestor
65203850|NCT00903357|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65203851|NCT00903357|Hormone Antagonists|hormone antagonists|mesh-ancestor
65203852|NCT00903357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65203853|NCT00903357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203854|NCT00903357|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65203855|NCT00903357|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65203856|NCT00903357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203857|NCT00903357|Antioxidants|antioxidants|mesh-ancestor
65203858|NCT00903357|Protective Agents|protective agents|mesh-ancestor
65203859|NCT00903357|Vitamins|vitamins|mesh-ancestor
65203860|NCT00903357|Micronutrients|micronutrients|mesh-ancestor
65203868|NCT02754063|3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|mesh-list
65203869|NCT02754063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65203870|NCT02754063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65203871|NCT02754063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65203872|NCT02754063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203873|NCT02754063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65203874|NCT02754063|Dopamine Agonists|dopamine agonists|mesh-ancestor
65203875|NCT02754063|Dopamine Agents|dopamine agents|mesh-ancestor
65203876|NCT02754063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65203877|NCT02754063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203882|NCT04202289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65203883|NCT04202289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65203884|NCT04202289|Coccidiostats|coccidiostats|mesh-ancestor
65203885|NCT04202289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65203886|NCT02122185|Metformin|metformin|mesh-list
65203887|NCT02122185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65203888|NCT02122185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203889|NCT02087865|Donepezil|donepezil|mesh-list
65203890|NCT02087865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65203891|NCT02087865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203892|NCT02087865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203893|NCT02087865|Cholinergic Agents|cholinergic agents|mesh-ancestor
65203894|NCT02087865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65203895|NCT02087865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203896|NCT02087865|Nootropic Agents|nootropic agents|mesh-ancestor
65203897|NCT01889199|Flutamide|flutamide|mesh-list
65203898|NCT01889199|Androgen Antagonists|androgen antagonists|mesh-ancestor
65203899|NCT01889199|Hormone Antagonists|hormone antagonists|mesh-ancestor
65203900|NCT01889199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65203901|NCT01889199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203902|NCT01889199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65203903|NCT01889199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203904|NCT01730313|Pyridoxine|pyridoxine|mesh-list
65203905|NCT01730313|Vitamin B 6|vitamin b 6|mesh-list
65203906|NCT01730313|Phenytoin|phenytoin|mesh-list
65203907|NCT01730313|Valproic Acid|valproic acid|mesh-list
65203908|NCT01730313|Vitamins|vitamins|mesh-ancestor
65203909|NCT01730313|Micronutrients|micronutrients|mesh-ancestor
65203910|NCT01730313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203911|NCT01730313|Vitamin B Complex|vitamin b complex|mesh-ancestor
65203912|NCT01730313|Anticonvulsants|anticonvulsants|mesh-ancestor
65203913|NCT01730313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203914|NCT01730313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203915|NCT01730313|GABA Agents|gaba agents|mesh-ancestor
65203916|NCT01730313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65203917|NCT01730313|Antimanic Agents|antimanic agents|mesh-ancestor
65203918|NCT01730313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65203919|NCT01730313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65203920|NCT01730313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65330931|NCT02664558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65330932|NCT02664558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65330933|NCT02664558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330934|NCT02664558|Protease Inhibitors|protease inhibitors|mesh-ancestor
65330935|NCT02664558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330936|NCT02664558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330937|NCT02664558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65330938|NCT02664558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65203921|NCT01730313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65203922|NCT01730313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65203923|NCT01730313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65203924|NCT01730313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65203925|NCT01730313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65203926|NCT01104662|Vancomycin|vancomycin|mesh-list
65203927|NCT01104662|Daptomycin|daptomycin|mesh-list
65203928|NCT01104662|Penicillins|penicillins|mesh-list
65203929|NCT01104662|Cloxacillin|cloxacillin|mesh-list
65203930|NCT01104662|Oxacillin|oxacillin|mesh-list
65203931|NCT01104662|Nafcillin|nafcillin|mesh-list
65203932|NCT01104662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65203933|NCT01104662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65203934|NCT05062785|Insulin|insulin|mesh-list
65203935|NCT05062785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65203936|NCT05062785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203937|NCT01103960|Amlodipine|amlodipine|mesh-list
65203938|NCT01103960|Telmisartan|telmisartan|mesh-list
65203939|NCT01103960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65203940|NCT01103960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65203941|NCT01103960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65203942|NCT01103960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203943|NCT01103960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65203944|NCT01103960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203945|NCT01103960|Vasodilator Agents|vasodilator agents|mesh-ancestor
65203946|NCT01103960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65203947|NCT01103960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65203948|NCT04413279|Dexamethasone|dexamethasone|mesh-list
65203949|NCT04413279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65203950|NCT04413279|Antiemetics|antiemetics|mesh-ancestor
65203951|NCT04413279|Autonomic Agents|autonomic agents|mesh-ancestor
65203955|NCT04413279|Glucocorticoids|glucocorticoids|mesh-ancestor
65203956|NCT04413279|Hormones|hormones|mesh-ancestor
65203957|NCT04413279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65203958|NCT04413279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65203959|NCT04413279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203960|NCT04975256|Adagrasib|adagrasib|mesh-list
65203961|NCT04975256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203962|NCT02880800|Morphine|morphine|mesh-list
65203963|NCT02880800|Hydromorphone|hydromorphone|mesh-list
65203964|NCT02880800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65203965|NCT02880800|Narcotics|narcotics|mesh-ancestor
65203966|NCT02880800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65203967|NCT02880800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203968|NCT02880800|Analgesics|analgesics|mesh-ancestor
65203969|NCT02880800|Sensory System Agents|sensory system agents|mesh-ancestor
65203970|NCT02880800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65203971|NCT01107392|Botulinum Toxins|botulinum toxins|mesh-list
65203972|NCT01107392|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65203973|NCT01107392|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65203974|NCT01107392|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65203975|NCT01107392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65203976|NCT01107392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203977|NCT01107392|Cholinergic Agents|cholinergic agents|mesh-ancestor
65203978|NCT01107392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65203979|NCT01107392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203980|NCT01107392|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64846612|NCT01693276|Tubulin Modulators|tubulin modulators|mesh-ancestor
65203981|NCT01107392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65203982|NCT05037279|BCG Vaccine|bcg vaccine|mesh-list
65330939|NCT02664558|Antiviral Agents|antiviral agents|mesh-ancestor
65330940|NCT02566707|Lamivudine|lamivudine|mesh-list
65330941|NCT02566707|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65330942|NCT02566707|Dolutegravir|dolutegravir|mesh-list
65330943|NCT02566707|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65330944|NCT02566707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65330945|NCT02566707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080846|NCT00448110|Diclofenac|diclofenac|mesh-list
65203983|NCT05037279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65203984|NCT05037279|Immunologic Factors|immunologic factors|mesh-ancestor
65203985|NCT05037279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203986|NCT01106846|Ketamine|ketamine|mesh-list
65203987|NCT01106846|Analgesics|analgesics|mesh-ancestor
65203988|NCT01106846|Sensory System Agents|sensory system agents|mesh-ancestor
65203989|NCT01106846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65203990|NCT01106846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203991|NCT01106846|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65203992|NCT01106846|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65203993|NCT01106846|Anesthetics, General|anesthetics, general|mesh-ancestor
65203994|NCT01106846|Anesthetics|anesthetics|mesh-ancestor
65203995|NCT01106846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65203996|NCT01106846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65203997|NCT01106846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65203998|NCT01106846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65203999|NCT01106846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204001|NCT05034783|Edetic Acid|edetic acid|mesh-list
65204002|NCT05034783|Chelating Agents|chelating agents|mesh-ancestor
65204003|NCT05034783|Sequestering Agents|sequestering agents|mesh-ancestor
65204004|NCT05034783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204005|NCT05034783|Anticoagulants|anticoagulants|mesh-ancestor
65204006|NCT05034783|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65204007|NCT05034783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65204008|NCT05034783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204009|NCT05034783|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65204010|NCT05034783|Incretins|incretins|mesh-ancestor
65204011|NCT05034783|Hormones|hormones|mesh-ancestor
65204012|NCT05034783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65204013|NCT00902577|Misonidazole|misonidazole|mesh-list
65204014|NCT00902577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204015|NCT00902577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65204016|NCT00902577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65204017|NCT00902577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65204018|NCT04202367|Bupivacaine|bupivacaine|mesh-list
65204019|NCT04202367|Anesthetics, Local|anesthetics, local|mesh-ancestor
65204020|NCT04202367|Anesthetics|anesthetics|mesh-ancestor
65204021|NCT04202367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65204022|NCT04202367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204023|NCT04202367|Sensory System Agents|sensory system agents|mesh-ancestor
65204027|NCT02846493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65204028|NCT02846493|Antiemetics|antiemetics|mesh-ancestor
65204029|NCT02846493|Autonomic Agents|autonomic agents|mesh-ancestor
65204030|NCT02846493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65204031|NCT02846493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204032|NCT02846493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65204033|NCT02846493|Glucocorticoids|glucocorticoids|mesh-ancestor
65204034|NCT02846493|Hormones|hormones|mesh-ancestor
65204035|NCT02846493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65204036|NCT02846493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65204037|NCT02846493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204038|NCT02846493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65204039|NCT02846493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65204040|NCT02846493|Hormone Antagonists|hormone antagonists|mesh-ancestor
65204041|NCT02846493|Dopamine Agonists|dopamine agonists|mesh-ancestor
65204042|NCT02846493|Dopamine Agents|dopamine agents|mesh-ancestor
65204043|NCT02846493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65204044|NCT02846493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204045|NCT01106690|Metformin|metformin|mesh-list
65204046|NCT01106690|Pioglitazone|pioglitazone|mesh-list
65204047|NCT01106690|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65330946|NCT02566707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330947|NCT02566707|Antiviral Agents|antiviral agents|mesh-ancestor
65330948|NCT02566707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65330949|NCT02566707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65330950|NCT02566707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65330951|NCT02566707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65330952|NCT02566707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65330953|NCT02566707|Protease Inhibitors|protease inhibitors|mesh-ancestor
65330954|NCT02566707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65330955|NCT02566707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65330956|NCT04063683|Paclitaxel|paclitaxel|mesh-list
65330957|NCT04063683|Cisplatin|cisplatin|mesh-list
65330958|NCT04063683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65330959|NCT04063683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330960|NCT04063683|Tubulin Modulators|tubulin modulators|mesh-ancestor
65330961|NCT04063683|Antimitotic Agents|antimitotic agents|mesh-ancestor
65330962|NCT04063683|Mitosis Modulators|mitosis modulators|mesh-ancestor
65330963|NCT04063683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330964|NCT00921531|Thalidomide|thalidomide|mesh-list
65330965|NCT00921531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65330966|NCT00921531|Immunologic Factors|immunologic factors|mesh-ancestor
65330967|NCT00921531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65330968|NCT00921531|Leprostatic Agents|leprostatic agents|mesh-ancestor
65330969|NCT00921531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65330970|NCT00921531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65330971|NCT00921531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65330972|NCT00921531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65330973|NCT00921531|Growth Substances|growth substances|mesh-ancestor
65330974|NCT00921531|Growth Inhibitors|growth inhibitors|mesh-ancestor
65330975|NCT00921531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330976|NCT00730028|Clindamycin|clindamycin|mesh-list
65204048|NCT01106690|Canagliflozin|canagliflozin|mesh-list
65204049|NCT01106690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65204050|NCT01106690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204051|NCT01106690|Incretins|incretins|mesh-ancestor
65204052|NCT01106690|Hormones|hormones|mesh-ancestor
65204053|NCT01106690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65204054|NCT01106690|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65204055|NCT01106690|Protease Inhibitors|protease inhibitors|mesh-ancestor
65204056|NCT01106690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204057|NCT01106690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204058|NCT01106690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65204059|NCT03576885|Nitric Oxide|nitric oxide|mesh-list
65204060|NCT03576885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65330977|NCT00730028|Clindamycin palmitate|clindamycin palmitate|mesh-list
65330978|NCT00730028|Clindamycin phosphate|clindamycin phosphate|mesh-list
65330979|NCT00730028|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65204061|NCT03576885|Autonomic Agents|autonomic agents|mesh-ancestor
65204062|NCT03576885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65204063|NCT03576885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204064|NCT03576885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65204065|NCT03576885|Respiratory System Agents|respiratory system agents|mesh-ancestor
65204066|NCT03576885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65204067|NCT03576885|Antioxidants|antioxidants|mesh-ancestor
65204068|NCT03576885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204069|NCT03576885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65204070|NCT03576885|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65204071|NCT03576885|Vasodilator Agents|vasodilator agents|mesh-ancestor
65204072|NCT03576885|Gasotransmitters|gasotransmitters|mesh-ancestor
65204073|NCT03576885|Protective Agents|protective agents|mesh-ancestor
65204075|NCT04286529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65204076|NCT04286529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204077|NCT04286529|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65204078|NCT04286529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65204079|NCT04286529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204080|NCT04286529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65204081|NCT04286529|Vitamins|vitamins|mesh-ancestor
65204082|NCT04286529|Micronutrients|micronutrients|mesh-ancestor
65204083|NCT04286529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65204084|NCT01103180|Citalopram|citalopram|mesh-list
65204085|NCT01103180|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65204086|NCT01103180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65204087|NCT01103180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65204088|NCT01103180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204089|NCT01103180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65204090|NCT01103180|Serotonin Agents|serotonin agents|mesh-ancestor
65204091|NCT01103180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204092|NCT01103180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65204093|NCT01103180|Antidepressive Agents|antidepressive agents|mesh-ancestor
65204094|NCT01103180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65204095|NCT00625898|Cyclophosphamide|cyclophosphamide|mesh-list
65204098|NCT00625898|Docetaxel|docetaxel|mesh-list
65204099|NCT00625898|Fluorouracil|fluorouracil|mesh-list
65204100|NCT00625898|Trastuzumab|trastuzumab|mesh-list
65204101|NCT00625898|Epirubicin|epirubicin|mesh-list
65204102|NCT00625898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65204103|NCT00625898|Immunologic Factors|immunologic factors|mesh-ancestor
65204104|NCT00625898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204105|NCT00625898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65204106|NCT00625898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65204107|NCT00625898|Alkylating Agents|alkylating agents|mesh-ancestor
65204108|NCT00625898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204109|NCT00625898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204110|NCT00625898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65204111|NCT00625898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65204112|NCT00625898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65204113|NCT00625898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65204114|NCT00625898|Growth Substances|growth substances|mesh-ancestor
65204115|NCT00625898|Growth Inhibitors|growth inhibitors|mesh-ancestor
65204116|NCT00625898|Tubulin Modulators|tubulin modulators|mesh-ancestor
65204117|NCT00625898|Antimitotic Agents|antimitotic agents|mesh-ancestor
65204118|NCT00625898|Mitosis Modulators|mitosis modulators|mesh-ancestor
65204119|NCT00625898|Antimetabolites|antimetabolites|mesh-ancestor
65204120|NCT00625898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65204121|NCT00625898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65204122|NCT00625898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65204123|NCT00625898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65204124|NCT00625898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204125|NCT04527549|Hydroxychloroquine|hydroxychloroquine|mesh-list
65204126|NCT04527549|Trametinib|trametinib|mesh-list
65204127|NCT04527549|Dabrafenib|dabrafenib|mesh-list
65204128|NCT04527549|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
65204129|NCT04527549|Antimalarials|antimalarials|mesh-ancestor
65204130|NCT04527549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65204131|NCT04527549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65330980|NCT00730028|Trimethoprim|trimethoprim|mesh-list
65330981|NCT00730028|Sulfamethoxazole|sulfamethoxazole|mesh-list
65330982|NCT00730028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65330983|NCT00730028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65330984|NCT00730028|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65204132|NCT04527549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65204133|NCT04527549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204134|NCT04527549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204135|NCT04527549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65204136|NCT04527549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204137|NCT04527549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65204138|NCT04527549|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65204139|NCT04527549|Protective Agents|protective agents|mesh-ancestor
65204140|NCT04527549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204141|NCT04527549|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65204143|NCT02853552|Misoprostol|misoprostol|mesh-list
65204144|NCT02853552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65204145|NCT02853552|Abortifacient Agents|abortifacient agents|mesh-ancestor
65204146|NCT02853552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65204147|NCT02853552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204148|NCT02853552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65204149|NCT02853552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65204150|NCT02853552|Oxytocics|oxytocics|mesh-ancestor
65204151|NCT04268472|Darunavir|darunavir|mesh-list
65204152|NCT04268472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65204153|NCT04268472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65204154|NCT04268472|Protease Inhibitors|protease inhibitors|mesh-ancestor
65204155|NCT04268472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204156|NCT04268472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204157|NCT04268472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65204158|NCT04268472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65204159|NCT04268472|Antiviral Agents|antiviral agents|mesh-ancestor
65204160|NCT04268472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65204161|NCT02844621|Omeprazole|omeprazole|mesh-list
65204162|NCT02844621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65204163|NCT02844621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65204164|NCT02844621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65204165|NCT02844621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204166|NCT02844621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204167|NCT01106534|Aspirin|aspirin|mesh-list
65204168|NCT01106534|Everolimus|everolimus|mesh-list
65204169|NCT01106534|Clopidogrel|clopidogrel|mesh-list
65204170|NCT01106534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65204171|NCT01106534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65204172|NCT01106534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65204178|NCT01106534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65204179|NCT01106534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65204180|NCT01106534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65204181|NCT01106534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204182|NCT01106534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65204183|NCT01106534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65204184|NCT01106534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204185|NCT01106534|Antipyretics|antipyretics|mesh-ancestor
65204186|NCT01106534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204187|NCT01106534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65204188|NCT01106534|Immunologic Factors|immunologic factors|mesh-ancestor
65204189|NCT01106534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65204190|NCT01106534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65204191|NCT01106534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65204192|NCT01106534|Purinergic Agents|purinergic agents|mesh-ancestor
65204193|NCT01106534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65204194|NCT00941304|Oxycodone|oxycodone|mesh-list
65204195|NCT00941304|Buprenorphine|buprenorphine|mesh-list
65204196|NCT00941304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65204197|NCT00941304|Narcotics|narcotics|mesh-ancestor
65204198|NCT00941304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65204199|NCT00941304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204200|NCT00941304|Analgesics|analgesics|mesh-ancestor
65204201|NCT00941304|Sensory System Agents|sensory system agents|mesh-ancestor
65204202|NCT00941304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65204203|NCT00941304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65330985|NCT00730028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330986|NCT00730028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65330987|NCT00730028|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65330988|NCT00730028|Renal Agents|renal agents|mesh-ancestor
65330989|NCT00730028|Antimalarials|antimalarials|mesh-ancestor
65330990|NCT00730028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65330991|NCT00730028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65330992|NCT00730028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65330993|NCT00730028|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64717037|NCT00377936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204204|NCT02846025|Folic Acid|folic acid|mesh-list
65204205|NCT02846025|Vitamin B Complex|vitamin b complex|mesh-list
65204206|NCT02846025|Antioxidants|antioxidants|mesh-list
65204207|NCT02846025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204208|NCT02846025|Protective Agents|protective agents|mesh-ancestor
65204209|NCT02846025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204210|NCT02846025|Hematinics|hematinics|mesh-ancestor
65204211|NCT02846025|Vitamins|vitamins|mesh-ancestor
65204212|NCT02846025|Micronutrients|micronutrients|mesh-ancestor
65204213|NCT02880410|Temozolomide|temozolomide|mesh-list
65204214|NCT02880410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65204215|NCT02880410|Alkylating Agents|alkylating agents|mesh-ancestor
65204216|NCT02880410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204217|NCT02880410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204218|NCT02879006|Omalizumab|omalizumab|mesh-list
65204219|NCT02879006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65204220|NCT02879006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65204221|NCT02879006|Respiratory System Agents|respiratory system agents|mesh-ancestor
65204222|NCT00941070|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65204223|NCT00941070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65204224|NCT00941070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204225|NCT02857218|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65204226|NCT02857218|Hematinics|hematinics|mesh-ancestor
65204227|NCT02857218|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65204228|NCT02857218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65204229|NCT00602316|Chelating Agents|chelating agents|mesh-list
65204230|NCT00602316|Sequestering Agents|sequestering agents|mesh-ancestor
65204231|NCT00602316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204232|NCT00602394|Lithium Carbonate|lithium carbonate|mesh-list
65204233|NCT00602394|Antidepressive Agents|antidepressive agents|mesh-ancestor
65204234|NCT00602394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65204235|NCT00602394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204236|NCT00602394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204237|NCT00602394|Antimanic Agents|antimanic agents|mesh-ancestor
65204238|NCT00602394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65204239|NCT00602394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65204240|NCT00602394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204241|NCT04956302|Dexamethasone|dexamethasone|mesh-list
65204242|NCT04956302|Dexamethasone acetate|dexamethasone acetate|mesh-list
65204243|NCT04956302|Bortezomib|bortezomib|mesh-list
65204247|NCT04956302|BB 1101|bb 1101|mesh-list
65204248|NCT04956302|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65204249|NCT04956302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65204250|NCT04956302|Antiemetics|antiemetics|mesh-ancestor
65204251|NCT04956302|Autonomic Agents|autonomic agents|mesh-ancestor
65204252|NCT04956302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65204253|NCT04956302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204254|NCT04956302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65204255|NCT04956302|Glucocorticoids|glucocorticoids|mesh-ancestor
65204256|NCT04956302|Hormones|hormones|mesh-ancestor
65204257|NCT04956302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65204258|NCT04956302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65204259|NCT04956302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204260|NCT04956302|Protease Inhibitors|protease inhibitors|mesh-ancestor
65204261|NCT04956302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65330994|NCT00730028|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65330995|NCT00730028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65330996|NCT02332668|Pembrolizumab|pembrolizumab|mesh-list
65330997|NCT02332668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65330998|NCT02332668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65330999|NCT04088084|Palmidrol|palmidrol|mesh-list
65331000|NCT04088084|Analgesics|analgesics|mesh-ancestor
65331001|NCT04088084|Sensory System Agents|sensory system agents|mesh-ancestor
65331002|NCT04088084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65331003|NCT04088084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331004|NCT04088084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65204262|NCT04956302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204263|NCT04956302|Immunologic Factors|immunologic factors|mesh-ancestor
65204264|NCT04956302|Dermatologic Agents|dermatologic agents|mesh-ancestor
65204265|NCT04956302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65204266|NCT02848443|Trifluridine|trifluridine|mesh-list
65204267|NCT02848443|Bevacizumab|bevacizumab|mesh-list
65204268|NCT02848443|Nivolumab|nivolumab|mesh-list
65204269|NCT02848443|Oxaliplatin|oxaliplatin|mesh-list
65204270|NCT02848443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65204271|NCT02848443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204272|NCT02848443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65204273|NCT02848443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65204274|NCT02848443|Growth Substances|growth substances|mesh-ancestor
65204275|NCT02848443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204276|NCT02848443|Growth Inhibitors|growth inhibitors|mesh-ancestor
65204277|NCT02848443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65204278|NCT02848443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204279|NCT02848443|Antimetabolites|antimetabolites|mesh-ancestor
65204280|NCT02848443|Antiviral Agents|antiviral agents|mesh-ancestor
65204281|NCT02848443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65204282|NCT00632697|Pentoxifylline|pentoxifylline|mesh-list
65204283|NCT00632697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64846918|NCT05290857|Hemostatics|hemostatics|mesh-list
65204284|NCT00632697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204285|NCT00632697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204286|NCT00632697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65204287|NCT00632697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65204288|NCT00632697|Protective Agents|protective agents|mesh-ancestor
65204289|NCT00632697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204290|NCT00632697|Vasodilator Agents|vasodilator agents|mesh-ancestor
65204291|NCT00632697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65204292|NCT00632697|Antioxidants|antioxidants|mesh-ancestor
65204293|NCT02848209|Phenol|phenol|mesh-list
65204294|NCT02848209|Croton Oil|croton oil|mesh-list
65204295|NCT02848209|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65204296|NCT02848209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65204297|NCT02848209|Disinfectants|disinfectants|mesh-ancestor
65204298|NCT02848209|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65204299|NCT02848209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65204300|NCT02848209|Dermatologic Agents|dermatologic agents|mesh-ancestor
65204301|NCT05337969|Metformin|metformin|mesh-list
65204302|NCT05337969|Vildagliptin|vildagliptin|mesh-list
65204303|NCT05337969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65204304|NCT05337969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204305|NCT05337969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65204306|NCT05337969|Protease Inhibitors|protease inhibitors|mesh-ancestor
65204307|NCT05337969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204308|NCT05337969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204309|NCT02844153|Metformin|metformin|mesh-list
65204310|NCT02844153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65204311|NCT02844153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204312|NCT02844387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65204313|NCT02844075|Pembrolizumab|pembrolizumab|mesh-list
65331005|NCT04088084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65331006|NCT04088084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65331007|NCT04088084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65331008|NCT04088084|Antiviral Agents|antiviral agents|mesh-ancestor
65331009|NCT04088084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65331010|NCT04088084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65331011|NCT04088084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65331012|NCT04088084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65331013|NCT04088084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331014|NCT04088084|Hormones|hormones|mesh-ancestor
65331015|NCT04088084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65331016|NCT02593370|Lidocaine|lidocaine|mesh-list
65331017|NCT02593370|Epinephrine|epinephrine|mesh-list
65204314|NCT02844075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65204315|NCT02844075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204316|NCT02844309|Thalidomide|thalidomide|mesh-list
65204317|NCT02844309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65204322|NCT02844309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65204323|NCT02844309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65204324|NCT02844309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65204325|NCT02844309|Growth Substances|growth substances|mesh-ancestor
65204326|NCT02844309|Growth Inhibitors|growth inhibitors|mesh-ancestor
65204327|NCT02844309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204328|NCT02845713|Ivermectin|ivermectin|mesh-list
65204329|NCT02845713|Albendazole|albendazole|mesh-list
65204330|NCT02845713|Diethylcarbamazine|diethylcarbamazine|mesh-list
65204331|NCT02845713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65204332|NCT02845713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65204333|NCT02845713|Anthelmintics|anthelmintics|mesh-ancestor
65204334|NCT02845713|Anticestodal Agents|anticestodal agents|mesh-ancestor
65204335|NCT02845713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65204336|NCT02845713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65204337|NCT02845713|Tubulin Modulators|tubulin modulators|mesh-ancestor
65204338|NCT02845713|Antimitotic Agents|antimitotic agents|mesh-ancestor
65204339|NCT02845713|Mitosis Modulators|mitosis modulators|mesh-ancestor
65204340|NCT02845713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204341|NCT02845713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204342|NCT02845713|Filaricides|filaricides|mesh-ancestor
65204343|NCT02845713|Antinematodal Agents|antinematodal agents|mesh-ancestor
65204344|NCT02845713|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65204345|NCT02845713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204346|NCT00902265|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65204347|NCT00902265|Hemostatics|hemostatics|mesh-ancestor
65204348|NCT00902265|Coagulants|coagulants|mesh-ancestor
65204349|NCT00902265|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65204350|NCT00902265|Natriuretic Agents|natriuretic agents|mesh-ancestor
65204351|NCT00902265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204352|NCT02848287|Ropivacaine|ropivacaine|mesh-list
65204353|NCT02848287|Anesthetics, Local|anesthetics, local|mesh-ancestor
65204354|NCT02848287|Anesthetics|anesthetics|mesh-ancestor
65204355|NCT02848287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65204356|NCT02848287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204357|NCT02848287|Sensory System Agents|sensory system agents|mesh-ancestor
65204358|NCT02848287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65204359|NCT05337657|Letrozole|letrozole|mesh-list
65204360|NCT05337657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204361|NCT05337657|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65204362|NCT05337657|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65204363|NCT05337657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204364|NCT05337657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204365|NCT05337657|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65204366|NCT05337657|Hormone Antagonists|hormone antagonists|mesh-ancestor
65331018|NCT02593370|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
65080920|NCT00454545|Antimetabolites|antimetabolites|mesh-ancestor
65331019|NCT02593370|Anesthetics, Local|anesthetics, local|mesh-ancestor
65331020|NCT02593370|Anesthetics|anesthetics|mesh-ancestor
65331021|NCT02593370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65331022|NCT02593370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331023|NCT02593370|Sensory System Agents|sensory system agents|mesh-ancestor
64717072|NCT03233737|Anesthetics, Local|anesthetics, local|mesh-ancestor
65204367|NCT05337657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65204368|NCT05337657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204369|NCT05242419|Huperzine A|huperzine a|mesh-list
65204370|NCT05242419|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65204371|NCT05242419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204372|NCT05242419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204373|NCT05242419|Cholinergic Agents|cholinergic agents|mesh-ancestor
65204374|NCT05242419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65204375|NCT05242419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204376|NCT05242419|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65204377|NCT05242419|Protective Agents|protective agents|mesh-ancestor
65204378|NCT02690883|Exenatide|exenatide|mesh-list
65204379|NCT02690883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65204380|NCT02690883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204381|NCT02690883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65204382|NCT02690883|Incretins|incretins|mesh-ancestor
65204383|NCT02690883|Hormones|hormones|mesh-ancestor
65204384|NCT02690883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65204385|NCT02844933|Cannabidiol|cannabidiol|mesh-list
65204386|NCT02844933|Anticonvulsants|anticonvulsants|mesh-ancestor
65204387|NCT05104047|Lobeline|lobeline|mesh-list
65204388|NCT05104047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65204389|NCT05104047|Autonomic Agents|autonomic agents|mesh-ancestor
65204390|NCT05104047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65204395|NCT05104047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65204396|NCT05104047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204397|NCT05104047|Respiratory System Agents|respiratory system agents|mesh-ancestor
65204398|NCT04385589|Dapagliflozin|dapagliflozin|mesh-list
65204399|NCT04385589|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65204400|NCT04385589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65204401|NCT04385589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204402|NCT04385589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204403|NCT02847429|Crenolanib|crenolanib|mesh-list
65204404|NCT02847429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204405|NCT04750005|Listerine|listerine|mesh-list
65204406|NCT04750005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65204407|NCT04750005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65204408|NCT05336721|Capecitabine|capecitabine|mesh-list
65204409|NCT05336721|Chiauranib|chiauranib|mesh-list
65204410|NCT05336721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65204411|NCT05336721|Antimetabolites|antimetabolites|mesh-ancestor
65204412|NCT05336721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204413|NCT05336721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204414|NCT05336721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65204415|NCT05336721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204416|NCT04646655|Enoxaparin|enoxaparin|mesh-list
65204417|NCT04646655|Anticoagulants|anticoagulants|mesh-ancestor
65204418|NCT04646655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65204419|NCT04646655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65204420|NCT04646655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204421|NCT00653913|Ezetimibe|ezetimibe|mesh-list
65204422|NCT00653913|Pitavastatin|pitavastatin|mesh-list
65204423|NCT00653913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65204424|NCT00653913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65204425|NCT00653913|Antimetabolites|antimetabolites|mesh-ancestor
65204426|NCT00653913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204427|NCT00653913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65331024|NCT02593370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65331025|NCT02593370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65331026|NCT02593370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65331027|NCT02593370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65331028|NCT02593370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65331029|NCT02593370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204428|NCT00653913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65204429|NCT00653913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204431|NCT00652431|Niacinamide|niacinamide|mesh-list
65204432|NCT00652431|Nicotinic Acids|nicotinic acids|mesh-list
65204433|NCT00652431|Simvastatin|simvastatin|mesh-list
65204434|NCT00652431|Ezetimibe|ezetimibe|mesh-list
65204435|NCT00652431|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
65204436|NCT00652431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65204437|NCT00652431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65204438|NCT00652431|Antimetabolites|antimetabolites|mesh-ancestor
65204439|NCT00652431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204440|NCT00652431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65204441|NCT00652431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65204442|NCT00652431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204443|NCT00652431|Vasodilator Agents|vasodilator agents|mesh-ancestor
65204444|NCT00652431|Vitamin B Complex|vitamin b complex|mesh-ancestor
65204446|NCT00652431|Micronutrients|micronutrients|mesh-ancestor
65204447|NCT00652431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204448|NCT00380523|Etoricoxib|etoricoxib|mesh-list
65204449|NCT00380523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65204450|NCT00380523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65204451|NCT00380523|Analgesics|analgesics|mesh-ancestor
65204452|NCT00380523|Sensory System Agents|sensory system agents|mesh-ancestor
65204453|NCT00380523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65204454|NCT00380523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204455|NCT00380523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65204456|NCT00380523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65204457|NCT00380523|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65204458|NCT00380523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65204459|NCT00380523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204460|NCT00380523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204461|NCT00319995|Loratadine|loratadine|mesh-list
65204462|NCT00319995|Montelukast|montelukast|mesh-list
65204466|NCT00319995|Hormone Antagonists|hormone antagonists|mesh-ancestor
65204467|NCT00319995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65204468|NCT00319995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204469|NCT00319995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65204470|NCT00319995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65204471|NCT00319995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204472|NCT00319995|Antipruritics|antipruritics|mesh-ancestor
65204473|NCT00319995|Dermatologic Agents|dermatologic agents|mesh-ancestor
65204474|NCT00319995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65204475|NCT00319995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65204476|NCT00319995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65204477|NCT00319995|Histamine Antagonists|histamine antagonists|mesh-ancestor
65204478|NCT00319995|Histamine Agents|histamine agents|mesh-ancestor
65204479|NCT00319995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65204480|NCT03304821|Sargramostim|sargramostim|mesh-list
65204481|NCT03304821|Immunologic Factors|immunologic factors|mesh-ancestor
65204482|NCT03304821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204483|NCT04599075|Insulin|insulin|mesh-list
65204484|NCT04599075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65204485|NCT04599075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65204486|NCT04599075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204487|NCT02842281|Levan|levan|mesh-list
65204488|NCT02842281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204489|NCT03721341|Hormones|hormones|mesh-list
65204490|NCT03721341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65204491|NCT03721341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204492|NCT02842437|Dexmedetomidine|dexmedetomidine|mesh-list
65331030|NCT02593370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65331031|NCT02593370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65331032|NCT02593370|Adrenergic Agents|adrenergic agents|mesh-ancestor
65331033|NCT02593370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65331034|NCT02593370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65331035|NCT02593370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65331036|NCT02593370|Autonomic Agents|autonomic agents|mesh-ancestor
65331037|NCT02593370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65331038|NCT02593370|Respiratory System Agents|respiratory system agents|mesh-ancestor
65331039|NCT02593370|Mydriatics|mydriatics|mesh-ancestor
65331040|NCT02593370|Sympathomimetics|sympathomimetics|mesh-ancestor
65331041|NCT02593370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65331042|NCT02593370|Chelating Agents|chelating agents|mesh-ancestor
64717092|NCT03473665|Celecoxib|celecoxib|mesh-list
65204493|NCT02842437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65204494|NCT02842437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65204495|NCT02842437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204496|NCT02842437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65204497|NCT02842437|Analgesics|analgesics|mesh-ancestor
65204498|NCT02842437|Sensory System Agents|sensory system agents|mesh-ancestor
65204499|NCT02842437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65204500|NCT02842437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65204501|NCT02842437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65204502|NCT02842437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65204503|NCT02842437|Adrenergic Agents|adrenergic agents|mesh-ancestor
65204504|NCT02842437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65204505|NCT02842437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204506|NCT00157911|Simvastatin|simvastatin|mesh-list
65204507|NCT00157911|Ezetimibe|ezetimibe|mesh-list
65204508|NCT00157911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65204509|NCT00157911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65204510|NCT00157911|Antimetabolites|antimetabolites|mesh-ancestor
65204511|NCT00157911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204512|NCT00157911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65204513|NCT00157911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65204514|NCT00157911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204515|NCT05336175|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
65204516|NCT05336175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65204517|NCT05336175|Vasodilator Agents|vasodilator agents|mesh-ancestor
65204519|NCT02842125|Nivolumab|nivolumab|mesh-list
65204520|NCT02842125|Capecitabine|capecitabine|mesh-list
65204521|NCT02842125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65204522|NCT02842125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204523|NCT02842125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65204524|NCT02842125|Antimetabolites|antimetabolites|mesh-ancestor
65204525|NCT02842125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204526|NCT02842125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65204527|NCT03708549|Metformin|metformin|mesh-list
65204528|NCT03708549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65204529|NCT03708549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204530|NCT00156117|Olanzapine|olanzapine|mesh-list
65204531|NCT00156117|Asenapine|asenapine|mesh-list
65204532|NCT00156117|Antiemetics|antiemetics|mesh-ancestor
65204533|NCT00156117|Autonomic Agents|autonomic agents|mesh-ancestor
65204534|NCT00156117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65204538|NCT00156117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65204539|NCT00156117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65204540|NCT00156117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65204541|NCT00156117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65204542|NCT00156117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65204543|NCT00156117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65204544|NCT00156117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331043|NCT02593370|Sequestering Agents|sequestering agents|mesh-ancestor
65331044|NCT00918320|Temozolomide|temozolomide|mesh-list
65331045|NCT00918320|Topotecan|topotecan|mesh-list
65331046|NCT00918320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65331047|NCT00918320|Alkylating Agents|alkylating agents|mesh-ancestor
65331048|NCT00918320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331049|NCT00918320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331050|NCT00918320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65331051|NCT00918320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65331052|NCT00918320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331053|NCT00729560|Flutamide|flutamide|mesh-list
65331054|NCT00729560|Androgen Antagonists|androgen antagonists|mesh-ancestor
65331055|NCT00729560|Hormone Antagonists|hormone antagonists|mesh-ancestor
65331056|NCT00729560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65331057|NCT00729560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331058|NCT00729560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65204545|NCT00156117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65204546|NCT00156117|Serotonin Agents|serotonin agents|mesh-ancestor
65204547|NCT00140985|Losartan|losartan|mesh-list
65204548|NCT00140985|Amlodipine|amlodipine|mesh-list
65204549|NCT00140985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65204550|NCT00140985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65204551|NCT00140985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65204552|NCT00140985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204553|NCT00140985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65204554|NCT00140985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204555|NCT00140985|Vasodilator Agents|vasodilator agents|mesh-ancestor
65204556|NCT00140985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65204557|NCT00140985|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65204558|NCT00140985|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65204559|NCT00140907|Losartan|losartan|mesh-list
65204560|NCT00140907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65204561|NCT00140907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65204562|NCT00140907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65204563|NCT00140907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65204564|NCT00140907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204565|NCT00132717|Atorvastatin|atorvastatin|mesh-list
65204566|NCT00132717|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65204567|NCT00132717|Simvastatin|simvastatin|mesh-list
65204568|NCT00132717|Ezetimibe|ezetimibe|mesh-list
65204569|NCT00132717|Pravastatin|pravastatin|mesh-list
65204570|NCT00132717|Lovastatin|lovastatin|mesh-list
65204571|NCT00132717|L 647318|l 647318|mesh-list
65204572|NCT00132717|Dihydromevinolin|dihydromevinolin|mesh-list
65204573|NCT00132717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65204574|NCT00132717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65204575|NCT00132717|Antimetabolites|antimetabolites|mesh-ancestor
65204576|NCT00132717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204577|NCT00132717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65204578|NCT00132717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65204579|NCT00132717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204580|NCT00127179|Finasteride|finasteride|mesh-list
65204581|NCT00127179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204582|NCT00127179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204583|NCT00127179|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65204584|NCT00127179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65204585|NCT00127179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331059|NCT00729560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331060|NCT03199053|Dapagliflozin|dapagliflozin|mesh-list
65331061|NCT03199053|Saxagliptin|saxagliptin|mesh-list
65331062|NCT03199053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65331063|NCT03199053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331064|NCT03199053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65331065|NCT03199053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331066|NCT03199053|Incretins|incretins|mesh-ancestor
65331067|NCT03199053|Hormones|hormones|mesh-ancestor
65331068|NCT03199053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65331069|NCT03199053|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65331070|NCT03199053|Protease Inhibitors|protease inhibitors|mesh-ancestor
65331071|NCT03199053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204587|NCT00127179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65204588|NCT00127179|Urological Agents|urological agents|mesh-ancestor
65204589|NCT00953706|Ivacaftor|ivacaftor|mesh-list
65204590|NCT00953706|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65204591|NCT00953706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65204592|NCT00953706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204593|NCT02852382|Morphine|morphine|mesh-list
65204594|NCT02852382|Bupivacaine|bupivacaine|mesh-list
65204595|NCT02852382|Anesthetics, Local|anesthetics, local|mesh-ancestor
65204596|NCT02852382|Anesthetics|anesthetics|mesh-ancestor
65204597|NCT02852382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65204598|NCT02852382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204599|NCT02852382|Sensory System Agents|sensory system agents|mesh-ancestor
65204600|NCT02852382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65204601|NCT02852382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65204602|NCT02852382|Narcotics|narcotics|mesh-ancestor
65204603|NCT02852382|Analgesics|analgesics|mesh-ancestor
65204604|NCT00630942|Minocycline|minocycline|mesh-list
65204605|NCT00630942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65204606|NCT00630942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65204613|NCT00602550|Antiviral Agents|antiviral agents|mesh-ancestor
65204614|NCT00602550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65204615|NCT00602550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65204616|NCT00602550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65204617|NCT00602706|Melphalan|melphalan|mesh-list
65204618|NCT00602706|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
65204619|NCT00602706|Sargramostim|sargramostim|mesh-list
65204620|NCT00602706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65204621|NCT00602706|Alkylating Agents|alkylating agents|mesh-ancestor
65204622|NCT00602706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204623|NCT00602706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204624|NCT00602706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65204625|NCT00602706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65204626|NCT00602706|Immunologic Factors|immunologic factors|mesh-ancestor
65204627|NCT00602706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204628|NCT00602706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65204629|NCT00602706|Analgesics|analgesics|mesh-ancestor
65204630|NCT00602706|Sensory System Agents|sensory system agents|mesh-ancestor
65204631|NCT00602706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65204632|NCT00604344|Insulin|insulin|mesh-list
65204633|NCT00604344|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65204634|NCT00604344|Insulin Detemir|insulin detemir|mesh-list
65204635|NCT00604344|Isophane Insulin, Human|isophane insulin, human|mesh-list
65204636|NCT00604344|Insulin, Isophane|insulin, isophane|mesh-list
65204637|NCT00604344|Isophane insulin, beef|isophane insulin, beef|mesh-list
65204638|NCT00604344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65204639|NCT00604344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204640|NCT02851914|Antidepressive Agents|antidepressive agents|mesh-list
65204641|NCT02851914|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
65331072|NCT00736190|Tenofovir|tenofovir|mesh-list
65331073|NCT00736190|Antiviral Agents|antiviral agents|mesh-ancestor
65331074|NCT00736190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65331075|NCT00736190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65331076|NCT00736190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65204642|NCT02851914|Serotonin|serotonin|mesh-list
65204643|NCT02851914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65204644|NCT02851914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65204645|NCT02851914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65204646|NCT02851914|Serotonin Agents|serotonin agents|mesh-ancestor
65204647|NCT02851914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65204648|NCT02851914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204649|NCT02851914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204650|NCT02851914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65204651|NCT02851914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65204652|NCT00938964|Lidocaine|lidocaine|mesh-list
65204653|NCT00938964|Anesthetics, Local|anesthetics, local|mesh-ancestor
65204654|NCT00938964|Anesthetics|anesthetics|mesh-ancestor
65204655|NCT00938964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65204656|NCT00938964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204657|NCT00938964|Sensory System Agents|sensory system agents|mesh-ancestor
65204658|NCT00938964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65204659|NCT00938964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64847298|NCT05273242|Artesunate|artesunate|mesh-list
65204660|NCT00938964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65204661|NCT00938964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65204662|NCT00938964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65204663|NCT00938964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204664|NCT00938886|Naltrexone|naltrexone|mesh-list
65204665|NCT00938886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65204666|NCT00938886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65204667|NCT00938886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204668|NCT00938886|Sensory System Agents|sensory system agents|mesh-ancestor
65204670|NCT02852070|Dimercaprol|dimercaprol|mesh-list
65204671|NCT02852070|Chelating Agents|chelating agents|mesh-ancestor
65204672|NCT02852070|Sequestering Agents|sequestering agents|mesh-ancestor
65204673|NCT02852070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204674|NCT00602862|Bevacizumab|bevacizumab|mesh-list
65204675|NCT00602862|Sorafenib|sorafenib|mesh-list
65204678|NCT00602862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65204679|NCT00602862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65204680|NCT00602862|Growth Substances|growth substances|mesh-ancestor
65204681|NCT00602862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204682|NCT00602862|Growth Inhibitors|growth inhibitors|mesh-ancestor
65204683|NCT00602862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65204684|NCT00602862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204685|NCT00602862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204686|NCT00942708|Fluoxetine|fluoxetine|mesh-list
65204687|NCT00942708|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65204688|NCT00942708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65204689|NCT00942708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65204690|NCT00942708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204691|NCT00942708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65204692|NCT00942708|Serotonin Agents|serotonin agents|mesh-ancestor
65204693|NCT00942708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204694|NCT00942708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65204695|NCT00942708|Antidepressive Agents|antidepressive agents|mesh-ancestor
65204696|NCT00942708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65204697|NCT00942708|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65204698|NCT00942708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65204699|NCT00942708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204700|NCT00942084|Acyclovir|acyclovir|mesh-list
65204701|NCT00942084|Antiviral Agents|antiviral agents|mesh-ancestor
65204702|NCT00942084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65204703|NCT00941928|Cyclophosphamide|cyclophosphamide|mesh-list
65204704|NCT00941928|Fludarabine|fludarabine|mesh-list
65204705|NCT00941928|Fludarabine phosphate|fludarabine phosphate|mesh-list
65204706|NCT00941928|Interleukin-2|interleukin-2|mesh-list
65204707|NCT00941928|Epratuzumab|epratuzumab|mesh-list
65331077|NCT00736190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331078|NCT00736190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331079|NCT00736190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65331080|NCT00736190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65331081|NCT04686279|Tenofovir|tenofovir|mesh-list
65331082|NCT04686279|Antiviral Agents|antiviral agents|mesh-ancestor
65331083|NCT04686279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65331084|NCT04686279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65331085|NCT04686279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65331086|NCT04686279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204708|NCT00941928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65204709|NCT00941928|Immunologic Factors|immunologic factors|mesh-ancestor
65204710|NCT00941928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204711|NCT00941928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65204712|NCT00941928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65204713|NCT00941928|Alkylating Agents|alkylating agents|mesh-ancestor
65204714|NCT00941928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204715|NCT00941928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204716|NCT00941928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65204717|NCT00941928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65204718|NCT00941928|Antimetabolites|antimetabolites|mesh-ancestor
65204719|NCT00941928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65204720|NCT00941928|Analgesics|analgesics|mesh-ancestor
65204721|NCT00941928|Sensory System Agents|sensory system agents|mesh-ancestor
65204722|NCT00941928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65204723|NCT00941928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65204724|NCT02852694|Adalimumab|adalimumab|mesh-list
65204725|NCT02852694|Methotrexate|methotrexate|mesh-list
65204726|NCT02852694|Mercaptopurine|mercaptopurine|mesh-list
65204727|NCT02852694|Azathioprine|azathioprine|mesh-list
65204728|NCT02852694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65204729|NCT02852694|Abortifacient Agents|abortifacient agents|mesh-ancestor
65204730|NCT02852694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65204731|NCT02852694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204732|NCT02852694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64847364|NCT05266248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204734|NCT02852694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204735|NCT02852694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204736|NCT02852694|Dermatologic Agents|dermatologic agents|mesh-ancestor
65204737|NCT02852694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204738|NCT02852694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65204739|NCT02852694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65204740|NCT02852694|Immunologic Factors|immunologic factors|mesh-ancestor
65204741|NCT02852694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64509879|NCT03054519|Metformin|metformin|mesh-list
65204742|NCT02852694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65204743|NCT02852694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65204745|NCT00604578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65204746|NCT00604578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204747|NCT00937560|Paclitaxel|paclitaxel|mesh-list
65204748|NCT00937560|Bevacizumab|bevacizumab|mesh-list
65204749|NCT00937560|Carboplatin|carboplatin|mesh-list
65204750|NCT00937560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65204751|NCT00937560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204752|NCT00937560|Tubulin Modulators|tubulin modulators|mesh-ancestor
65204753|NCT00937560|Antimitotic Agents|antimitotic agents|mesh-ancestor
65204754|NCT00937560|Mitosis Modulators|mitosis modulators|mesh-ancestor
65204755|NCT00937560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204756|NCT00937560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65204757|NCT00937560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65204758|NCT00937560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65204759|NCT00937560|Growth Substances|growth substances|mesh-ancestor
65204760|NCT00937560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204761|NCT00937560|Growth Inhibitors|growth inhibitors|mesh-ancestor
65331087|NCT04686279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331088|NCT04686279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65331089|NCT04686279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65331090|NCT00729326|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65331091|NCT00729326|Exenatide|exenatide|mesh-list
65331092|NCT00729326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65331093|NCT00729326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331094|NCT00729326|Incretins|incretins|mesh-ancestor
65331095|NCT00729326|Hormones|hormones|mesh-ancestor
65331096|NCT00729326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65204762|NCT04268394|Metformin|metformin|mesh-list
65204763|NCT04268394|Itraconazole|itraconazole|mesh-list
65204764|NCT04268394|Rifampin|rifampin|mesh-list
65204765|NCT04268394|Sulfasalazine|sulfasalazine|mesh-list
65204766|NCT04268394|Methotrexate|methotrexate|mesh-list
65204767|NCT04268394|Digoxin|digoxin|mesh-list
65204768|NCT04268394|Midazolam|midazolam|mesh-list
65204769|NCT04268394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65204770|NCT04268394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65204771|NCT04268394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204772|NCT04268394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65204773|NCT04268394|Abortifacient Agents|abortifacient agents|mesh-ancestor
65204774|NCT04268394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65204775|NCT04268394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65204776|NCT04268394|Antimetabolites|antimetabolites|mesh-ancestor
65204777|NCT04268394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204778|NCT04268394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204779|NCT04268394|Dermatologic Agents|dermatologic agents|mesh-ancestor
65204780|NCT04268394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204781|NCT04268394|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65204782|NCT04268394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65204783|NCT04268394|Immunologic Factors|immunologic factors|mesh-ancestor
65204784|NCT04268394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65204785|NCT04268394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65204786|NCT04268394|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65204787|NCT04268394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65204788|NCT04268394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65204789|NCT04268394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65204790|NCT04268394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65204791|NCT04268394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65204792|NCT04268394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65204793|NCT04268394|Anesthetics, General|anesthetics, general|mesh-ancestor
65204794|NCT04268394|Anesthetics|anesthetics|mesh-ancestor
65204795|NCT04268394|GABA Modulators|gaba modulators|mesh-ancestor
65204796|NCT04268394|GABA Agents|gaba agents|mesh-ancestor
65204797|NCT04268394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65204798|NCT04268394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65204799|NCT04268394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65204800|NCT04268394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65204801|NCT04268394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65204802|NCT04268394|Antifungal Agents|antifungal agents|mesh-ancestor
65204803|NCT04268394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65204804|NCT04268394|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65204805|NCT04268394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65204806|NCT04268394|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65204807|NCT04268394|Hormone Antagonists|hormone antagonists|mesh-ancestor
64847442|NCT05220826|Ethanol|ethanol|mesh-list
65204808|NCT04268394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65204809|NCT04268394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65204810|NCT04268394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65204811|NCT04268394|Antitubercular Agents|antitubercular agents|mesh-ancestor
65204812|NCT04268394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65204813|NCT04268394|Leprostatic Agents|leprostatic agents|mesh-ancestor
65204814|NCT04268394|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65204815|NCT04268394|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65331097|NCT00729326|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65331098|NCT00729326|Protease Inhibitors|protease inhibitors|mesh-ancestor
65331099|NCT00729326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331100|NCT00729326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331101|NCT00729326|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65331102|NCT02565303|Ropivacaine|ropivacaine|mesh-list
65331103|NCT02565303|Anesthetics, Local|anesthetics, local|mesh-ancestor
65331104|NCT02565303|Anesthetics|anesthetics|mesh-ancestor
65331105|NCT02565303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65331106|NCT02565303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331107|NCT02565303|Sensory System Agents|sensory system agents|mesh-ancestor
65331108|NCT02565303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65331109|NCT00698451|Bevacizumab|bevacizumab|mesh-list
65331110|NCT00698451|Carboplatin|carboplatin|mesh-list
65331111|NCT00698451|Doxorubicin|doxorubicin|mesh-list
65204816|NCT04268394|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65204817|NCT04268394|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65204818|NCT04268394|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65204819|NCT04268394|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65204820|NCT04268394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65204821|NCT04268394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65204824|NCT04268394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65204826|NCT04268394|Sensory System Agents|sensory system agents|mesh-ancestor
65204827|NCT04268394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65204828|NCT04268394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65204829|NCT04268394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65204831|NCT02851212|Canagliflozin|canagliflozin|mesh-list
65204832|NCT02851212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65204833|NCT02851212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204834|NCT02851212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65204835|NCT02851212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204836|NCT04143802|Dulaglutide|dulaglutide|mesh-list
65204837|NCT04143802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65204838|NCT04143802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204839|NCT00685126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65204840|NCT00685126|Albuterol|albuterol|mesh-list
65204841|NCT00685126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65204842|NCT00685126|Autonomic Agents|autonomic agents|mesh-ancestor
65204843|NCT00685126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65204844|NCT00685126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204845|NCT00685126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65204846|NCT00685126|Respiratory System Agents|respiratory system agents|mesh-ancestor
65204847|NCT00685126|Tocolytic Agents|tocolytic agents|mesh-ancestor
65204848|NCT00685126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65204849|NCT00685126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65204850|NCT00685126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65204851|NCT00685126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65204852|NCT00685126|Adrenergic Agents|adrenergic agents|mesh-ancestor
65204853|NCT00685126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65204854|NCT00685126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204855|NCT00682630|Artesunate|artesunate|mesh-list
65204856|NCT00682630|Pyronaridine|pyronaridine|mesh-list
65204857|NCT00682630|Antimalarials|antimalarials|mesh-ancestor
65204858|NCT00682630|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65204859|NCT00682630|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65204860|NCT00682630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65204861|NCT00682630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204862|NCT00682630|Antiviral Agents|antiviral agents|mesh-ancestor
65204863|NCT00682630|Schistosomicides|schistosomicides|mesh-ancestor
65204864|NCT00682630|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65331112|NCT00698451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65331113|NCT00698451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65331114|NCT00698451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331115|NCT00698451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65331116|NCT00698451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65331117|NCT00698451|Growth Substances|growth substances|mesh-ancestor
65331118|NCT00698451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331119|NCT00698451|Growth Inhibitors|growth inhibitors|mesh-ancestor
65331120|NCT00698451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65331121|NCT00698451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65331122|NCT00698451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65331123|NCT00698451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204865|NCT00682630|Anthelmintics|anthelmintics|mesh-ancestor
65204866|NCT00875056|Vorinostat|vorinostat|mesh-list
65204867|NCT00875056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204868|NCT00875056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65204869|NCT00875056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204870|NCT00875056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204871|NCT00685594|Vitamin D|vitamin d|mesh-list
65204872|NCT00685594|Cholecalciferol|cholecalciferol|mesh-list
65204873|NCT00685594|Vitamins|vitamins|mesh-ancestor
65204874|NCT00685594|Micronutrients|micronutrients|mesh-ancestor
65204875|NCT00685594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204876|NCT00685594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65204877|NCT00685594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65204878|NCT00685672|Epinephrine|epinephrine|mesh-list
65204879|NCT00685672|Racepinephrine|racepinephrine|mesh-list
65204880|NCT00685672|Epinephryl borate|epinephryl borate|mesh-list
65204881|NCT00685672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65204882|NCT00685672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65204883|NCT00685672|Adrenergic Agents|adrenergic agents|mesh-ancestor
65204884|NCT00685672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65204885|NCT00685672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204886|NCT00685672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204887|NCT00685672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65204888|NCT00685672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65204889|NCT00685672|Autonomic Agents|autonomic agents|mesh-ancestor
65204890|NCT00685672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65204891|NCT00685672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65204892|NCT00685672|Respiratory System Agents|respiratory system agents|mesh-ancestor
65204893|NCT00685672|Mydriatics|mydriatics|mesh-ancestor
65204894|NCT00685672|Sympathomimetics|sympathomimetics|mesh-ancestor
65204895|NCT00685672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65204899|NCT00683176|Antimetabolites|antimetabolites|mesh-ancestor
65204900|NCT00683176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204901|NCT00683176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65204902|NCT00683176|Lipotropic Agents|lipotropic agents|mesh-ancestor
65204903|NCT00683176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65204904|NCT00683176|Nootropic Agents|nootropic agents|mesh-ancestor
65204905|NCT02626234|Digoxin|digoxin|mesh-list
65204906|NCT02626234|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65204907|NCT02626234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65204908|NCT02626234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65204909|NCT02626234|Antimetabolites|antimetabolites|mesh-ancestor
65204910|NCT02626234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204911|NCT02626234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65204912|NCT02626234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65204913|NCT02626234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204914|NCT02626234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65204915|NCT02626234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65204916|NCT02626234|Protective Agents|protective agents|mesh-ancestor
65204917|NCT02626234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204918|NCT00685828|Imatinib Mesylate|imatinib mesylate|mesh-list
65331124|NCT00698451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331125|NCT03980925|Carboplatin|carboplatin|mesh-list
65331126|NCT03980925|Nivolumab|nivolumab|mesh-list
65331127|NCT03980925|Etoposide|etoposide|mesh-list
65331128|NCT03980925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331129|NCT03980925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65331130|NCT03980925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65331131|NCT03980925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331132|NCT03980925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65331133|NCT03980925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65204919|NCT00685828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204920|NCT00685828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65204921|NCT00685828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204922|NCT00685828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204923|NCT00685906|Ticagrelor|ticagrelor|mesh-list
65204924|NCT00685906|Levonorgestrel|levonorgestrel|mesh-list
65204925|NCT00685906|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65204926|NCT00685906|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65204927|NCT00685906|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
65204928|NCT00685906|Estradiol|estradiol|mesh-list
65204929|NCT00685906|Estrogens|estrogens|mesh-ancestor
65204930|NCT00685906|Hormones|hormones|mesh-ancestor
65204931|NCT00685906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65204932|NCT00685906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204933|NCT00685906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65204934|NCT00685906|Contraceptive Agents|contraceptive agents|mesh-ancestor
65204935|NCT00685906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65204936|NCT00685906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65204937|NCT00685906|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65204938|NCT00685906|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65204939|NCT00685906|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65204940|NCT00685906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65204941|NCT00685906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65204942|NCT00685906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65204943|NCT00685906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65204944|NCT00685906|Purinergic Agents|purinergic agents|mesh-ancestor
65204945|NCT00685906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65204946|NCT00685906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204947|NCT00685906|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65204948|NCT00685906|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
65204949|NCT00685906|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65204950|NCT00685906|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65204951|NCT04139824|Naproxen|naproxen|mesh-list
65204952|NCT04139824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65204953|NCT04139824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65204954|NCT04139824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65204955|NCT04139824|Analgesics|analgesics|mesh-ancestor
65204956|NCT04139824|Sensory System Agents|sensory system agents|mesh-ancestor
65204957|NCT04139824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65204958|NCT04139824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204959|NCT04139824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65204960|NCT04139824|Gout Suppressants|gout suppressants|mesh-ancestor
65204961|NCT04139824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65204962|NCT04139824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204963|NCT04139824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204964|NCT00940602|Deferasirox|deferasirox|mesh-list
65204965|NCT00940602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65204966|NCT00940602|Chelating Agents|chelating agents|mesh-ancestor
65204967|NCT00940602|Sequestering Agents|sequestering agents|mesh-ancestor
65204968|NCT00940602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204969|NCT00686140|Celecoxib|celecoxib|mesh-list
65331134|NCT03980925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65331135|NCT03980925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331136|NCT00693693|Hydrocortisone|hydrocortisone|mesh-list
65331137|NCT00693693|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65331138|NCT00693693|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65331139|NCT00693693|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65331140|NCT00693693|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
65331141|NCT00693693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65331142|NCT00693693|Dermatologic Agents|dermatologic agents|mesh-ancestor
65331143|NCT03966807|Nicotine|nicotine|mesh-list
65331144|NCT03966807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65331145|NCT03966807|Autonomic Agents|autonomic agents|mesh-ancestor
65331146|NCT03966807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65331147|NCT03966807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331148|NCT03966807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65331149|NCT03966807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65331150|NCT03966807|Cholinergic Agents|cholinergic agents|mesh-ancestor
65331151|NCT03966807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65331152|NCT03966807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331153|NCT02565693|Aspirin|aspirin|mesh-list
65331154|NCT02565693|Carbaspirin calcium|carbaspirin calcium|mesh-list
65204970|NCT00686140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65204971|NCT00686140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65204972|NCT00686140|Analgesics|analgesics|mesh-ancestor
65204973|NCT00686140|Sensory System Agents|sensory system agents|mesh-ancestor
65204974|NCT00686140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65204975|NCT00686140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204976|NCT00686140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65204977|NCT00686140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65204978|NCT00686140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65204979|NCT00686140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65204980|NCT00686140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204981|NCT00686140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204982|NCT00686218|Imatinib Mesylate|imatinib mesylate|mesh-list
65204983|NCT00686218|Panobinostat|panobinostat|mesh-list
65204984|NCT00686218|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65204985|NCT00686218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204986|NCT00686218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65204987|NCT00686218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204988|NCT00686218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204989|NCT00683956|Propofol|propofol|mesh-list
65204990|NCT00683956|Anesthetics|anesthetics|mesh-ancestor
65204991|NCT00683956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65204992|NCT00683956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204993|NCT00683956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65204994|NCT00683956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65204995|NCT00683956|Anesthetics, General|anesthetics, general|mesh-ancestor
65204996|NCT02850744|Temozolomide|temozolomide|mesh-list
65204997|NCT02850744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65204998|NCT02850744|Alkylating Agents|alkylating agents|mesh-ancestor
65204999|NCT02850744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205000|NCT02850744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205001|NCT04139668|Naltrexone|naltrexone|mesh-list
65331155|NCT02565693|Dipyridamole|dipyridamole|mesh-list
65331156|NCT02565693|Apixaban|apixaban|mesh-list
65331157|NCT02565693|Clopidogrel|clopidogrel|mesh-list
65331158|NCT02565693|Calcium|calcium|mesh-list
65331159|NCT02565693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65331160|NCT02565693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331161|NCT02565693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64689568|NCT05446415|Glucagon|glucagon|mesh-list
65205002|NCT04139668|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65205003|NCT04139668|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65205004|NCT04139668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205005|NCT04139668|Sensory System Agents|sensory system agents|mesh-ancestor
65205006|NCT04139668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65205007|NCT04266756|Selexipag|selexipag|mesh-list
65205008|NCT04266756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65205009|NCT00606060|Factor VIII|factor viii|mesh-list
65205010|NCT00606060|Coagulants|coagulants|mesh-ancestor
65205011|NCT00875524|Vaccines|vaccines|mesh-list
65205012|NCT00875524|Immunologic Factors|immunologic factors|mesh-ancestor
65205013|NCT00875524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205014|NCT01094288|Docetaxel|docetaxel|mesh-list
65205015|NCT01094288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205016|NCT01094288|Tubulin Modulators|tubulin modulators|mesh-ancestor
65205017|NCT01094288|Antimitotic Agents|antimitotic agents|mesh-ancestor
65205018|NCT01094288|Mitosis Modulators|mitosis modulators|mesh-ancestor
65205019|NCT01094288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205020|NCT05380986|Apatinib|apatinib|mesh-list
65205021|NCT05380986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205022|NCT05380986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65205023|NCT05380986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205024|NCT05380986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205025|NCT00684112|Gabapentin|gabapentin|mesh-list
65205026|NCT00684112|Analgesics|analgesics|mesh-ancestor
65205027|NCT00684112|Sensory System Agents|sensory system agents|mesh-ancestor
65205028|NCT00684112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65205029|NCT00684112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205030|NCT00684112|Anticonvulsants|anticonvulsants|mesh-ancestor
65205031|NCT00684112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65205032|NCT00684112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65205033|NCT00684112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65205034|NCT00684112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65205035|NCT00684112|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65205036|NCT00684112|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65205037|NCT00684112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65205038|NCT00684112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205040|NCT00684190|Esomeprazole|esomeprazole|mesh-list
65205041|NCT00684190|Lesogaberan|lesogaberan|mesh-list
65205042|NCT00684190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65205045|NCT00684190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205046|NCT00684190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205047|NCT00684190|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65205048|NCT00684190|GABA Agonists|gaba agonists|mesh-ancestor
65205049|NCT00684190|GABA Agents|gaba agents|mesh-ancestor
65205050|NCT00684190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65205051|NCT00684190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205053|NCT00684268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65205054|NCT00684268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205055|NCT00684268|Protective Agents|protective agents|mesh-ancestor
65205056|NCT00684268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205057|NCT00604656|Insulin Aspart|insulin aspart|mesh-list
65205058|NCT00604656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65205059|NCT00604656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205060|NCT00684346|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65205061|NCT00684346|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65205062|NCT00684346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205063|NCT00874120|Phenylephrine|phenylephrine|mesh-list
65205064|NCT00874120|Oxymetazoline|oxymetazoline|mesh-list
65205065|NCT00874120|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65205066|NCT00874120|Mydriatics|mydriatics|mesh-ancestor
65331162|NCT02565693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65331163|NCT02565693|Analgesics|analgesics|mesh-ancestor
65331164|NCT02565693|Sensory System Agents|sensory system agents|mesh-ancestor
65331165|NCT02565693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65331166|NCT02565693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65331167|NCT02565693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65331168|NCT02565693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65331169|NCT02565693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65331170|NCT02565693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331171|NCT02565693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65205067|NCT00874120|Autonomic Agents|autonomic agents|mesh-ancestor
65205068|NCT00874120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65205069|NCT00874120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205070|NCT00874120|Sympathomimetics|sympathomimetics|mesh-ancestor
65205071|NCT00874120|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65205072|NCT00874120|Nasal Decongestants|nasal decongestants|mesh-ancestor
65205073|NCT00874120|Respiratory System Agents|respiratory system agents|mesh-ancestor
65205074|NCT00874120|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65205075|NCT00874120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65205076|NCT00874120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65205077|NCT00874120|Adrenergic Agents|adrenergic agents|mesh-ancestor
65205078|NCT00874120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65205079|NCT00874120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205080|NCT00874120|Protective Agents|protective agents|mesh-ancestor
65205081|NCT00939822|Simvastatin|simvastatin|mesh-list
65205082|NCT00939822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65205083|NCT00939822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65205084|NCT00939822|Antimetabolites|antimetabolites|mesh-ancestor
65205085|NCT00939822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205086|NCT00939822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65205087|NCT00939822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65205088|NCT00939822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205089|NCT00687388|Celecoxib|celecoxib|mesh-list
65205090|NCT00687388|Doxazosin|doxazosin|mesh-list
65205091|NCT00687388|Prazosin|prazosin|mesh-list
65205092|NCT00687388|Tamsulosin|tamsulosin|mesh-list
65205093|NCT00687388|Alfuzosin|alfuzosin|mesh-list
65205094|NCT00687388|Terazosin|terazosin|mesh-list
65205095|NCT00687388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
65205096|NCT00687388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65205097|NCT00687388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65205098|NCT00687388|Analgesics|analgesics|mesh-ancestor
65205099|NCT00687388|Sensory System Agents|sensory system agents|mesh-ancestor
65205100|NCT00687388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65205101|NCT00687388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205102|NCT00687388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65205103|NCT00687388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65205104|NCT00687388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65205105|NCT00687388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64847747|NCT04793867|Xenon|xenon|mesh-list
65205106|NCT00687388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205107|NCT00687388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205108|NCT00687388|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65205109|NCT00687388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65205110|NCT00687388|Adrenergic Agents|adrenergic agents|mesh-ancestor
65205111|NCT00687388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65205112|NCT00687388|Urological Agents|urological agents|mesh-ancestor
65205113|NCT00687388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65205114|NCT05382390|Cytarabine|cytarabine|mesh-list
65205116|NCT05382390|Aclarubicin|aclarubicin|mesh-list
65205117|NCT05382390|Lenograstim|lenograstim|mesh-list
65205122|NCT05382390|Antiviral Agents|antiviral agents|mesh-ancestor
65205123|NCT05382390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65205124|NCT05382390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65205125|NCT05382390|Immunologic Factors|immunologic factors|mesh-ancestor
65331172|NCT02565693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65331173|NCT02565693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331174|NCT02565693|Antipyretics|antipyretics|mesh-ancestor
65331175|NCT02565693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65331176|NCT02565693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65205126|NCT05382390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205127|NCT05382390|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65205128|NCT05382390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205129|NCT05382390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65205130|NCT05382390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65205131|NCT05382390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65205132|NCT00939510|Lenalidomide|lenalidomide|mesh-list
65205133|NCT00939510|Sargramostim|sargramostim|mesh-list
65205134|NCT00939510|Immunologic Factors|immunologic factors|mesh-ancestor
65205135|NCT00939510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205136|NCT00939510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65205137|NCT00939510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65205138|NCT00939510|Growth Substances|growth substances|mesh-ancestor
65205139|NCT00939510|Growth Inhibitors|growth inhibitors|mesh-ancestor
65205140|NCT00939510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205142|NCT00687466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65205143|NCT00687466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205144|NCT04266288|Ketamine|ketamine|mesh-list
65205145|NCT04266288|Analgesics|analgesics|mesh-ancestor
65205146|NCT04266288|Sensory System Agents|sensory system agents|mesh-ancestor
65205147|NCT04266288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65205148|NCT04266288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205149|NCT04266288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65205150|NCT04266288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65205151|NCT04266288|Anesthetics, General|anesthetics, general|mesh-ancestor
65205152|NCT04266288|Anesthetics|anesthetics|mesh-ancestor
65205153|NCT04266288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65205154|NCT04266288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65205155|NCT04266288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65205156|NCT04266288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65205157|NCT04266288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205158|NCT00687622|Trametinib|trametinib|mesh-list
65205159|NCT00687622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205160|NCT00687622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65205161|NCT00687622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205162|NCT00687622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205163|NCT00687700|Propranolol|propranolol|mesh-list
65205164|NCT00687700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65205165|NCT00687700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65205166|NCT00687700|Adrenergic Agents|adrenergic agents|mesh-ancestor
65205167|NCT00687700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65205168|NCT00687700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205169|NCT00687700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205170|NCT00687700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65205171|NCT00687700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65205172|NCT00687700|Vasodilator Agents|vasodilator agents|mesh-ancestor
65205173|NCT00935532|Insulin|insulin|mesh-list
65205174|NCT00935532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65205175|NCT00935532|Insulin Glargine|insulin glargine|mesh-list
65205176|NCT00935532|Exenatide|exenatide|mesh-list
65205177|NCT00935532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65205178|NCT00935532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205179|NCT00935532|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65205180|NCT00935532|Incretins|incretins|mesh-ancestor
65205181|NCT00935532|Hormones|hormones|mesh-ancestor
65205182|NCT00935532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65205183|NCT04138420|Bevacizumab|bevacizumab|mesh-list
65205184|NCT04138420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65205185|NCT04138420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205186|NCT04138420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65205187|NCT04138420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65205194|NCT05378646|Antiviral Agents|antiviral agents|mesh-ancestor
65205195|NCT05378646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65205196|NCT01093586|Cyclosporine|cyclosporine|mesh-list
65205197|NCT01093586|Mycophenolic Acid|mycophenolic acid|mesh-list
65331177|NCT02565693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65331178|NCT02565693|Purinergic Agents|purinergic agents|mesh-ancestor
65331179|NCT02565693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65331180|NCT02565693|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65331181|NCT02565693|Antithrombins|antithrombins|mesh-ancestor
65331182|NCT02565693|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65331183|NCT02565693|Protease Inhibitors|protease inhibitors|mesh-ancestor
65331184|NCT02565693|Anticoagulants|anticoagulants|mesh-ancestor
65331185|NCT02565693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65331186|NCT02565693|Vasodilator Agents|vasodilator agents|mesh-ancestor
65331187|NCT04061655|Iron|iron|mesh-list
65205198|NCT01093586|Methylprednisolone|methylprednisolone|mesh-list
65205199|NCT01093586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65205200|NCT01093586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65205201|NCT01093586|Prednisolone|prednisolone|mesh-list
65205202|NCT01093586|Prednisolone acetate|prednisolone acetate|mesh-list
65205203|NCT01093586|Cyclophosphamide|cyclophosphamide|mesh-list
65205204|NCT01093586|Busulfan|busulfan|mesh-list
65205205|NCT01093586|Cyclosporins|cyclosporins|mesh-list
65205206|NCT01093586|Thymoglobulin|thymoglobulin|mesh-list
65205207|NCT01093586|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65205208|NCT01093586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65205209|NCT01093586|Prednisolone phosphate|prednisolone phosphate|mesh-list
65205210|NCT01093586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65205211|NCT01093586|Immunologic Factors|immunologic factors|mesh-ancestor
65205212|NCT01093586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205213|NCT01093586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65205214|NCT01093586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65205215|NCT01093586|Alkylating Agents|alkylating agents|mesh-ancestor
65205216|NCT01093586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205217|NCT01093586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205218|NCT01093586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65205219|NCT01093586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205220|NCT01093586|Antifungal Agents|antifungal agents|mesh-ancestor
65205221|NCT01093586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65205222|NCT01093586|Dermatologic Agents|dermatologic agents|mesh-ancestor
65205223|NCT01093586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65205224|NCT01093586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65205225|NCT01093586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65205226|NCT01093586|Antitubercular Agents|antitubercular agents|mesh-ancestor
65205227|NCT01093586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65205228|NCT01093586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65205229|NCT01093586|Antiemetics|antiemetics|mesh-ancestor
65205230|NCT01093586|Autonomic Agents|autonomic agents|mesh-ancestor
65205231|NCT01093586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65205232|NCT01093586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65205233|NCT01093586|Glucocorticoids|glucocorticoids|mesh-ancestor
65205234|NCT01093586|Hormones|hormones|mesh-ancestor
65205235|NCT01093586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65205236|NCT01093586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65205237|NCT01093586|Protective Agents|protective agents|mesh-ancestor
65205238|NCT01093586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65205239|NCT04266132|Bupivacaine|bupivacaine|mesh-list
65205240|NCT04266132|Anesthetics, Local|anesthetics, local|mesh-ancestor
65205241|NCT04266132|Anesthetics|anesthetics|mesh-ancestor
65205242|NCT04266132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65205243|NCT04266132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205244|NCT04266132|Sensory System Agents|sensory system agents|mesh-ancestor
65205245|NCT04266132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65205246|NCT02625454|Acetaminophen|acetaminophen|mesh-list
65205247|NCT02625454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65205248|NCT02625454|Analgesics|analgesics|mesh-ancestor
65205249|NCT02625454|Sensory System Agents|sensory system agents|mesh-ancestor
65205250|NCT02625454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65205251|NCT02625454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205252|NCT02625454|Antipyretics|antipyretics|mesh-ancestor
65205253|NCT00606450|Thalidomide|thalidomide|mesh-list
65331188|NCT04061655|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65331189|NCT04061655|Trace Elements|trace elements|mesh-ancestor
65331190|NCT04061655|Micronutrients|micronutrients|mesh-ancestor
65331191|NCT04061655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331192|NCT04061655|Hematinics|hematinics|mesh-ancestor
65331193|NCT04061265|Lidocaine|lidocaine|mesh-list
65331194|NCT04061265|Epinephrine|epinephrine|mesh-list
65331195|NCT04061265|Carticaine|carticaine|mesh-list
65331196|NCT04061265|Anesthetics, Local|anesthetics, local|mesh-ancestor
65331197|NCT04061265|Anesthetics|anesthetics|mesh-ancestor
65331198|NCT04061265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65331199|NCT04061265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331200|NCT04061265|Sensory System Agents|sensory system agents|mesh-ancestor
65331201|NCT04061265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65205254|NCT00606450|Apremilast|apremilast|mesh-list
65205255|NCT00606450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65205256|NCT00606450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65205257|NCT00606450|Analgesics|analgesics|mesh-ancestor
65205258|NCT00606450|Sensory System Agents|sensory system agents|mesh-ancestor
65205259|NCT00606450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65205260|NCT00606450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205261|NCT00606450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65205262|NCT00606450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65205263|NCT00606450|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65205264|NCT00606450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65205265|NCT00606450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205266|NCT00606450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205268|NCT00606450|Immunologic Factors|immunologic factors|mesh-ancestor
65205269|NCT00606450|Leprostatic Agents|leprostatic agents|mesh-ancestor
65205270|NCT00606450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65205271|NCT00606450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65205272|NCT00606450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65205273|NCT00606450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65205274|NCT00606450|Growth Substances|growth substances|mesh-ancestor
65205275|NCT00606450|Growth Inhibitors|growth inhibitors|mesh-ancestor
65205276|NCT00606450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205277|NCT04138888|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65205279|NCT04138888|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65205280|NCT04138888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65205281|NCT04138888|Diuretics|diuretics|mesh-ancestor
65205282|NCT04138888|Natriuretic Agents|natriuretic agents|mesh-ancestor
65205283|NCT04138888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205284|NCT04138888|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65205285|NCT04138888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65205286|NCT04138888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205287|NCT04138888|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65205288|NCT04138888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65205289|NCT01098110|Asenapine|asenapine|mesh-list
65205290|NCT01098110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65205291|NCT01098110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65205292|NCT01098110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65205293|NCT01098110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205294|NCT01098110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65205295|NCT00688402|Lesogaberan|lesogaberan|mesh-list
65205296|NCT00688402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65205297|NCT00688402|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65205298|NCT00688402|GABA Agonists|gaba agonists|mesh-ancestor
65205299|NCT00688402|GABA Agents|gaba agents|mesh-ancestor
65205300|NCT00688402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65205301|NCT00688402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205302|NCT00688402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205303|NCT04138264|Analgesics, Opioid|analgesics, opioid|mesh-list
65331202|NCT04061265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65331203|NCT04061265|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65331204|NCT04061265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65331205|NCT04061265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65331206|NCT04061265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331207|NCT04061265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65331208|NCT04061265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65331209|NCT04061265|Adrenergic Agents|adrenergic agents|mesh-ancestor
65331210|NCT04061265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65331211|NCT04061265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65331212|NCT04061265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65205304|NCT04138264|Narcotics|narcotics|mesh-ancestor
65205305|NCT04138264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65205306|NCT04138264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205307|NCT04138264|Analgesics|analgesics|mesh-ancestor
65205308|NCT04138264|Sensory System Agents|sensory system agents|mesh-ancestor
65205309|NCT04138264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65205310|NCT00688480|Allopurinol|allopurinol|mesh-list
65205311|NCT00688480|Antimetabolites|antimetabolites|mesh-ancestor
65205312|NCT00688480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205313|NCT00688480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205314|NCT00688480|Gout Suppressants|gout suppressants|mesh-ancestor
65205315|NCT00688480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65205316|NCT00688480|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65205317|NCT00688480|Antioxidants|antioxidants|mesh-ancestor
65205318|NCT00688480|Protective Agents|protective agents|mesh-ancestor
65205319|NCT00688480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205320|NCT01092728|Dasatinib|dasatinib|mesh-list
65205321|NCT01092728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205322|NCT01092728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65205323|NCT01092728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205324|NCT01092728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205325|NCT00688558|Simvastatin|simvastatin|mesh-list
65205326|NCT00688558|Dalcetrapib|dalcetrapib|mesh-list
65205327|NCT00688558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65205328|NCT00688558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65205329|NCT00688558|Antimetabolites|antimetabolites|mesh-ancestor
65205330|NCT00688558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205331|NCT00688558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65205332|NCT00688558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65205333|NCT00688558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205334|NCT02625376|Resveratrol|resveratrol|mesh-list
65205348|NCT00688948|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65205350|NCT00688948|Adrenergic Agents|adrenergic agents|mesh-ancestor
65205351|NCT00688948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65205352|NCT00688948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205353|NCT00688948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205354|NCT00688948|Urological Agents|urological agents|mesh-ancestor
65205355|NCT04152694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
65205356|NCT04152694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65205357|NCT04152694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65205358|NCT00873730|Etanercept|etanercept|mesh-list
65205359|NCT00873730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65205360|NCT00873730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65205361|NCT00873730|Analgesics|analgesics|mesh-ancestor
65205362|NCT00873730|Sensory System Agents|sensory system agents|mesh-ancestor
65205363|NCT00873730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65205364|NCT00873730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205365|NCT00873730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65205366|NCT00873730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65205367|NCT00873730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65205368|NCT00873730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65331213|NCT04061265|Autonomic Agents|autonomic agents|mesh-ancestor
65331214|NCT04061265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65331215|NCT04061265|Respiratory System Agents|respiratory system agents|mesh-ancestor
65331216|NCT04061265|Mydriatics|mydriatics|mesh-ancestor
65331217|NCT04061265|Sympathomimetics|sympathomimetics|mesh-ancestor
65331218|NCT04061265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65331219|NCT02592980|Warfarin|warfarin|mesh-list
65331220|NCT02592980|Anticoagulants|anticoagulants|mesh-ancestor
65331221|NCT00727844|Linezolid|linezolid|mesh-list
65331222|NCT00727844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65331223|NCT00727844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65331224|NCT00727844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65331225|NCT00727844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331226|NCT00727844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331227|NCT00735878|Carboplatin|carboplatin|mesh-list
65331228|NCT00735878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331229|NCT00695955|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65331230|NCT00695955|Chlorthalidone|chlorthalidone|mesh-list
65331231|NCT00695955|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65331232|NCT00695955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65205369|NCT00873730|Immunologic Factors|immunologic factors|mesh-ancestor
65205370|NCT00689416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65205371|NCT00689416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65205372|NCT00689416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65205373|NCT00689416|Antimetabolites|antimetabolites|mesh-ancestor
65205374|NCT00689416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205375|NCT00689416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65205376|NCT00689416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65205377|NCT00689416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205378|NCT00689494|Levonorgestrel|levonorgestrel|mesh-list
65205379|NCT00689494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65205380|NCT00689494|Contraceptive Agents|contraceptive agents|mesh-ancestor
65205381|NCT00689494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65205382|NCT00689494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205383|NCT00689494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65205384|NCT00689494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65205385|NCT00689494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65205386|NCT00672568|Capsaicin|capsaicin|mesh-list
65205387|NCT00672568|Antipruritics|antipruritics|mesh-ancestor
65205388|NCT00672568|Dermatologic Agents|dermatologic agents|mesh-ancestor
65205389|NCT00672568|Sensory System Agents|sensory system agents|mesh-ancestor
65205390|NCT00672568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65205391|NCT00672568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205392|NCT00604032|Tretinoin|tretinoin|mesh-list
65205393|NCT00604032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205394|NCT00604032|Keratolytic Agents|keratolytic agents|mesh-ancestor
65205395|NCT00604032|Dermatologic Agents|dermatologic agents|mesh-ancestor
65205403|NCT00874432|Protective Agents|protective agents|mesh-ancestor
65205404|NCT00874432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205405|NCT00935220|Linagliptin|linagliptin|mesh-list
65205406|NCT00935220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65205407|NCT00935220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205408|NCT00935220|Incretins|incretins|mesh-ancestor
65205409|NCT00935220|Hormones|hormones|mesh-ancestor
65205410|NCT00935220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65205411|NCT00935220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65205412|NCT00935220|Protease Inhibitors|protease inhibitors|mesh-ancestor
65331233|NCT00695955|Diuretics|diuretics|mesh-ancestor
65331234|NCT00695955|Natriuretic Agents|natriuretic agents|mesh-ancestor
65331235|NCT00695955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331236|NCT00695955|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65331237|NCT00695955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64717263|NCT04081610|Hyaluronic Acid|hyaluronic acid|mesh-list
65205413|NCT00935220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205414|NCT00935220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205415|NCT00691912|Paclitaxel|paclitaxel|mesh-list
65205416|NCT00691912|Doxorubicin|doxorubicin|mesh-list
65205417|NCT00691912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65205418|NCT00691912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65205419|NCT00691912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205420|NCT00691912|Tubulin Modulators|tubulin modulators|mesh-ancestor
65205421|NCT00691912|Antimitotic Agents|antimitotic agents|mesh-ancestor
65205422|NCT00691912|Mitosis Modulators|mitosis modulators|mesh-ancestor
65205423|NCT00691912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205424|NCT00691912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65205425|NCT00691912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65205426|NCT00691912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65205427|NCT00691912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205428|NCT00689806|Lovastatin|lovastatin|mesh-list
65205429|NCT00689806|L 647318|l 647318|mesh-list
65205430|NCT00689806|Dihydromevinolin|dihydromevinolin|mesh-list
65205431|NCT00689806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65205432|NCT00689806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65205433|NCT00689806|Antimetabolites|antimetabolites|mesh-ancestor
65205434|NCT00689806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205435|NCT00689806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65205436|NCT00689806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65205437|NCT00689806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205438|NCT00594958|Vaccines|vaccines|mesh-list
65205439|NCT00594958|Immunologic Factors|immunologic factors|mesh-ancestor
65205440|NCT00594958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205441|NCT04204044|Folic Acid|folic acid|mesh-list
65205442|NCT04204044|Vitamin B Complex|vitamin b complex|mesh-list
65205443|NCT04204044|Inositol|inositol|mesh-list
65205444|NCT04204044|Metformin|metformin|mesh-list
65205445|NCT04204044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65205446|NCT04204044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205447|NCT04204044|Hematinics|hematinics|mesh-ancestor
65205448|NCT04204044|Vitamins|vitamins|mesh-ancestor
65205449|NCT04204044|Micronutrients|micronutrients|mesh-ancestor
65205450|NCT04267614|Etanercept|etanercept|mesh-list
65205451|NCT04267614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65205452|NCT04267614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65205453|NCT04267614|Analgesics|analgesics|mesh-ancestor
65205454|NCT04267614|Sensory System Agents|sensory system agents|mesh-ancestor
65205455|NCT04267614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65205456|NCT04267614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205457|NCT04267614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65205458|NCT04267614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65205459|NCT04267614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65205460|NCT04267614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65205461|NCT04267614|Immunologic Factors|immunologic factors|mesh-ancestor
65205462|NCT00594880|Interferons|interferons|mesh-list
65205463|NCT00594880|Interferon-alpha|interferon-alpha|mesh-list
65205464|NCT00594880|Interferon alpha-2|interferon alpha-2|mesh-list
65205465|NCT00594880|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65205468|NCT00594880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65205469|NCT00594880|Immunologic Factors|immunologic factors|mesh-ancestor
65205470|NCT00594880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205472|NCT00690118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65205473|NCT00690118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205474|NCT00694252|Lapatinib|lapatinib|mesh-list
65205475|NCT00694252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205476|NCT00694252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65205477|NCT00694252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205478|NCT00694252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205479|NCT00871858|Fulvestrant|fulvestrant|mesh-list
65205480|NCT00871858|Anastrozole|anastrozole|mesh-list
65331238|NCT00695955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331239|NCT00695955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65331240|NCT00695955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65331241|NCT00693225|Omeprazole|omeprazole|mesh-list
65331242|NCT00693225|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
65205481|NCT00871858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65205482|NCT00871858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205483|NCT00871858|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65205484|NCT00871858|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65205485|NCT00871858|Hormone Antagonists|hormone antagonists|mesh-ancestor
65205486|NCT00871858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65205487|NCT00871858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205488|NCT00871858|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65205489|NCT00871858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65205490|NCT00871858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205491|NCT00871858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205492|NCT00673270|Hydrocortisone|hydrocortisone|mesh-list
65205493|NCT00673270|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65205495|NCT00673270|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65205496|NCT00673270|Fludrocortisone|fludrocortisone|mesh-list
65205497|NCT00673270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65205498|NCT00871780|Natalizumab|natalizumab|mesh-list
65205499|NCT00871780|Immunologic Factors|immunologic factors|mesh-ancestor
65205500|NCT00871780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205501|NCT00694408|Methylprednisolone|methylprednisolone|mesh-list
65205502|NCT00694408|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65205503|NCT00694408|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65205504|NCT00694408|Prednisolone|prednisolone|mesh-list
65205505|NCT00694408|Prednisolone acetate|prednisolone acetate|mesh-list
65205506|NCT00694408|Hydrocortisone|hydrocortisone|mesh-list
65205507|NCT00694408|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65205508|NCT00694408|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65205509|NCT00694408|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65205510|NCT00694408|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65205511|NCT00694408|Prednisolone phosphate|prednisolone phosphate|mesh-list
65205512|NCT00694408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65205513|NCT00694408|Antiemetics|antiemetics|mesh-ancestor
65205514|NCT00694408|Autonomic Agents|autonomic agents|mesh-ancestor
65205515|NCT00694408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65205516|NCT00694408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205517|NCT00694408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65205518|NCT00694408|Glucocorticoids|glucocorticoids|mesh-ancestor
65205519|NCT00694408|Hormones|hormones|mesh-ancestor
65205520|NCT00694408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65205521|NCT00694408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65205522|NCT00694408|Protective Agents|protective agents|mesh-ancestor
65205523|NCT00694408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65205524|NCT00694408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205525|NCT04136782|Paclitaxel|paclitaxel|mesh-list
65205526|NCT04136782|Docetaxel|docetaxel|mesh-list
65205527|NCT04136782|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65205528|NCT04136782|Carboplatin|carboplatin|mesh-list
65205529|NCT04136782|Epirubicin|epirubicin|mesh-list
65205530|NCT04136782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65205531|NCT04136782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205532|NCT04136782|Tubulin Modulators|tubulin modulators|mesh-ancestor
65205533|NCT04136782|Antimitotic Agents|antimitotic agents|mesh-ancestor
65205534|NCT04136782|Mitosis Modulators|mitosis modulators|mesh-ancestor
65205535|NCT04136782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205536|NCT04136782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65205537|NCT04136782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65205538|NCT04136782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65205539|NCT04136782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205542|NCT04137640|Letrozole|letrozole|mesh-list
65205543|NCT04137640|Epirubicin|epirubicin|mesh-list
65205544|NCT04137640|Palbociclib|palbociclib|mesh-list
65205545|NCT04137640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65205546|NCT04137640|Immunologic Factors|immunologic factors|mesh-ancestor
65331243|NCT00693225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65331244|NCT00693225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65331245|NCT00693225|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65331246|NCT00693225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331247|NCT00693225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331248|NCT00735644|Vaccines|vaccines|mesh-list
65331249|NCT00735644|Immunologic Factors|immunologic factors|mesh-ancestor
65331250|NCT00735644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205547|NCT04137640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205548|NCT04137640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65205549|NCT04137640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65205550|NCT04137640|Alkylating Agents|alkylating agents|mesh-ancestor
65205551|NCT04137640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205552|NCT04137640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205553|NCT04137640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65205554|NCT04137640|Tubulin Modulators|tubulin modulators|mesh-ancestor
65205555|NCT04137640|Antimitotic Agents|antimitotic agents|mesh-ancestor
65205556|NCT04137640|Mitosis Modulators|mitosis modulators|mesh-ancestor
65205557|NCT04137640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65205558|NCT04137640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65205559|NCT04137640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205560|NCT04137640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65205561|NCT04137640|Hormone Antagonists|hormone antagonists|mesh-ancestor
65205562|NCT04137640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65205563|NCT04137640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65205564|NCT04137640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65205565|NCT04137640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65205566|NCT04137640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65205567|NCT02624830|Glyburide|glyburide|mesh-list
65205568|NCT02624830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65205569|NCT02624830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205571|NCT02629042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205572|NCT02629042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65205573|NCT02629042|Glucocorticoids|glucocorticoids|mesh-ancestor
65205574|NCT02629042|Hormones|hormones|mesh-ancestor
65205575|NCT02629042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65205576|NCT02629042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65205577|NCT02629042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205578|NCT00692614|Triamcinolone|triamcinolone|mesh-list
65205579|NCT00692614|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65205580|NCT00692614|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65205581|NCT00692614|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65205582|NCT00692614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65205583|NCT00692614|Glucocorticoids|glucocorticoids|mesh-ancestor
65205584|NCT00692614|Hormones|hormones|mesh-ancestor
65205585|NCT00692614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65205586|NCT00692614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205587|NCT00692614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65205588|NCT00692614|Immunologic Factors|immunologic factors|mesh-ancestor
65205589|NCT00692614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205590|NCT00692614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205591|NCT04136470|Nivolumab|nivolumab|mesh-list
65205592|NCT04136470|Ipilimumab|ipilimumab|mesh-list
65205593|NCT04136470|Atezolizumab|atezolizumab|mesh-list
65205594|NCT04136470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65205595|NCT04136470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205596|NCT04136470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65205597|NCT04136470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205598|NCT00673426|Enoxaparin|enoxaparin|mesh-list
65205599|NCT00673426|Anticoagulants|anticoagulants|mesh-ancestor
65205600|NCT00673426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65205601|NCT00673426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65205602|NCT00673426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205603|NCT00673504|Gemcitabine|gemcitabine|mesh-list
65205604|NCT00673504|Sunitinib|sunitinib|mesh-list
65331251|NCT02591888|Bupivacaine|bupivacaine|mesh-list
65331252|NCT02591888|Anesthetics, Local|anesthetics, local|mesh-ancestor
65331253|NCT02591888|Anesthetics|anesthetics|mesh-ancestor
65331254|NCT02591888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65205605|NCT00673504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65205606|NCT00673504|Antimetabolites|antimetabolites|mesh-ancestor
65205607|NCT00673504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205608|NCT00673504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205609|NCT00673504|Antiviral Agents|antiviral agents|mesh-ancestor
65205610|NCT00673504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65205611|NCT00673504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205612|NCT00673504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65205613|NCT00673504|Immunologic Factors|immunologic factors|mesh-ancestor
64323782|NCT05485766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205616|NCT00673504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65205617|NCT00673504|Growth Substances|growth substances|mesh-ancestor
65205618|NCT00673504|Growth Inhibitors|growth inhibitors|mesh-ancestor
65205619|NCT00673504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65205620|NCT00673582|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65205621|NCT00673582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65205622|NCT00673582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65205623|NCT00673582|Antimetabolites|antimetabolites|mesh-ancestor
65205624|NCT00673582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205625|NCT00673582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65205626|NCT00673582|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65205627|NCT00673582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205628|NCT00912574|Molgramostim|molgramostim|mesh-list
65205629|NCT00912574|Sargramostim|sargramostim|mesh-list
65205630|NCT00912574|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65205631|NCT00912574|Freund's Adjuvant|freund's adjuvant|mesh-list
65205632|NCT00912574|Immunologic Factors|immunologic factors|mesh-ancestor
65205633|NCT00912574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205634|NCT00912574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205635|NCT00912574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64848284|NCT03993249|Nivolumab|nivolumab|mesh-list
65205636|NCT00695032|Ifosfamide|ifosfamide|mesh-list
65205637|NCT00695032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205638|NCT00695032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65205639|NCT00695032|Alkylating Agents|alkylating agents|mesh-ancestor
65205640|NCT00695032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205641|NCT04137328|Liraglutide|liraglutide|mesh-list
65205642|NCT04137328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65205643|NCT04137328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205644|NCT04137328|Incretins|incretins|mesh-ancestor
65205645|NCT04137328|Hormones|hormones|mesh-ancestor
65205646|NCT04137328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65205647|NCT00693004|Donepezil|donepezil|mesh-list
65205648|NCT00693004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65205649|NCT00693004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205650|NCT00693004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205651|NCT00693004|Cholinergic Agents|cholinergic agents|mesh-ancestor
65205652|NCT00693004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65205653|NCT00693004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205654|NCT00693004|Nootropic Agents|nootropic agents|mesh-ancestor
65205655|NCT00695344|Mycophenolic Acid|mycophenolic acid|mesh-list
65205656|NCT00695344|Everolimus|everolimus|mesh-list
65205657|NCT00695344|Azathioprine|azathioprine|mesh-list
65205658|NCT00695344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205659|NCT00695344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65205660|NCT00695344|Immunologic Factors|immunologic factors|mesh-ancestor
65205661|NCT00695344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205662|NCT00695344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65205663|NCT00695344|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65205664|NCT00695344|Antitubercular Agents|antitubercular agents|mesh-ancestor
65205665|NCT00695344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65205666|NCT00695344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65205667|NCT00695344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205668|NCT00695344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205669|NCT00695344|Antimetabolites|antimetabolites|mesh-ancestor
65205670|NCT00695344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65205671|NCT00695344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65205672|NCT02624362|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
65331255|NCT02591888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331256|NCT02591888|Sensory System Agents|sensory system agents|mesh-ancestor
65331257|NCT02591888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65331258|NCT00724958|Infliximab|infliximab|mesh-list
65331259|NCT00724958|Dermatologic Agents|dermatologic agents|mesh-ancestor
65331260|NCT00724958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65331261|NCT00724958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65331262|NCT04088006|Hyaluronic Acid|hyaluronic acid|mesh-list
65205673|NCT02624362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65205674|NCT02624362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65205675|NCT02624362|Disinfectants|disinfectants|mesh-ancestor
65205676|NCT00607542|Baclofen|baclofen|mesh-list
65205677|NCT00607542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65205678|NCT00607542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205679|NCT00607542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65205680|NCT00607542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65205681|NCT00607542|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65205682|NCT00607542|GABA Agonists|gaba agonists|mesh-ancestor
65205683|NCT00607542|GABA Agents|gaba agents|mesh-ancestor
65205684|NCT00607542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65205685|NCT00607542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205689|NCT00936858|Immunologic Factors|immunologic factors|mesh-ancestor
65205690|NCT00936858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205691|NCT02624440|Clarithromycin|clarithromycin|mesh-list
65205692|NCT02624440|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65205693|NCT02624440|Trimethoprim|trimethoprim|mesh-list
65205694|NCT02624440|Sulfamethoxazole|sulfamethoxazole|mesh-list
65205695|NCT02624440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65205696|NCT02624440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65205697|NCT02624440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65205698|NCT02624440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205699|NCT02624440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205700|NCT02624440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65205701|NCT02624440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65205702|NCT02624440|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65205703|NCT02624440|Renal Agents|renal agents|mesh-ancestor
65205704|NCT02624440|Antimalarials|antimalarials|mesh-ancestor
65205705|NCT02624440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65205706|NCT02624440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65205707|NCT02624440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65205708|NCT02624440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65205709|NCT02624440|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64848351|NCT05802303|Estradiol|estradiol|mesh-list
65205710|NCT04136080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65205712|NCT00693862|Carbidopa|carbidopa|mesh-list
65205713|NCT00693862|Entacapone|entacapone|mesh-list
65205714|NCT00693862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65205715|NCT00693862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65205716|NCT00693862|Dopamine Agents|dopamine agents|mesh-ancestor
65205717|NCT00693862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65205718|NCT00693862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205719|NCT00693862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205720|NCT00693862|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65205721|NCT00693862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205722|NCT00693862|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65205723|NCT05377788|Lazertinib|lazertinib|mesh-list
65205724|NCT05377788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65205725|NCT05377788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205726|NCT05377788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205727|NCT00674050|Fluticasone|fluticasone|mesh-list
65205728|NCT00674050|Albuterol|albuterol|mesh-list
65205729|NCT00674050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205730|NCT00674050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65205731|NCT00674050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65205732|NCT00674050|Autonomic Agents|autonomic agents|mesh-ancestor
65205733|NCT00674050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65205734|NCT00674050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65331263|NCT04088006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65331264|NCT04088006|Immunologic Factors|immunologic factors|mesh-ancestor
65331265|NCT04088006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331266|NCT04088006|Viscosupplements|viscosupplements|mesh-ancestor
65331267|NCT04088006|Protective Agents|protective agents|mesh-ancestor
65331268|NCT00695565|Clonidine|clonidine|mesh-list
65331269|NCT00695565|Analgesics|analgesics|mesh-ancestor
64717296|NCT04039412|Renal Agents|renal agents|mesh-ancestor
65205735|NCT00674050|Respiratory System Agents|respiratory system agents|mesh-ancestor
65205736|NCT00674050|Dermatologic Agents|dermatologic agents|mesh-ancestor
65205737|NCT00674050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65205738|NCT00674050|Tocolytic Agents|tocolytic agents|mesh-ancestor
65205739|NCT00674050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65205740|NCT00674050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65205741|NCT00674050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65205742|NCT00674050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65205743|NCT00674050|Adrenergic Agents|adrenergic agents|mesh-ancestor
65205744|NCT00674050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65205745|NCT00674050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205746|NCT00872170|Sildenafil Citrate|sildenafil citrate|mesh-list
65205747|NCT00872170|Vasodilator Agents|vasodilator agents|mesh-ancestor
65205748|NCT00872170|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65205749|NCT00872170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65205750|NCT00872170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205751|NCT00872170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205752|NCT00872170|Urological Agents|urological agents|mesh-ancestor
65205753|NCT00936702|Paclitaxel|paclitaxel|mesh-list
65205754|NCT00936702|Carboplatin|carboplatin|mesh-list
65205755|NCT00936702|Everolimus|everolimus|mesh-list
65205756|NCT00936702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65205757|NCT00936702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205763|NCT00936702|Immunologic Factors|immunologic factors|mesh-ancestor
65205764|NCT00936702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205765|NCT00694174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65205766|NCT00607932|Indole-3-carbinol|indole-3-carbinol|mesh-list
65205767|NCT00607932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65205768|NCT00607932|Protective Agents|protective agents|mesh-ancestor
65205769|NCT00607932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205770|NCT00607932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205772|NCT00674596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65205773|NCT00674596|Protease Inhibitors|protease inhibitors|mesh-ancestor
65205774|NCT00674596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205775|NCT00674596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205776|NCT00674596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65205777|NCT00674674|Topotecan|topotecan|mesh-list
65205778|NCT00674674|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65205779|NCT00674674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65205780|NCT00674674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205781|NCT00674674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205782|NCT00674674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205783|NCT02628886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65205784|NCT02628886|Immunologic Factors|immunologic factors|mesh-ancestor
65205785|NCT02628886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205786|NCT04265508|Hemostatics|hemostatics|mesh-list
65205787|NCT04265508|Coagulants|coagulants|mesh-ancestor
65205788|NCT02623738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65205789|NCT02623738|Latanoprost|latanoprost|mesh-list
65205790|NCT02623738|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65205791|NCT00607074|Albendazole|albendazole|mesh-list
65205792|NCT00607074|Anthelmintics|anthelmintics|mesh-list
65205793|NCT00607074|Secnidazole|secnidazole|mesh-list
65205794|NCT00607074|Metronidazole|metronidazole|mesh-list
65205795|NCT00607074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65205796|NCT00607074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65205797|NCT00607074|Anticestodal Agents|anticestodal agents|mesh-ancestor
65205798|NCT00607074|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65205799|NCT00607074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65205800|NCT00607074|Tubulin Modulators|tubulin modulators|mesh-ancestor
65205801|NCT00607074|Antimitotic Agents|antimitotic agents|mesh-ancestor
65205802|NCT00607074|Mitosis Modulators|mitosis modulators|mesh-ancestor
65331270|NCT00695565|Sensory System Agents|sensory system agents|mesh-ancestor
65331271|NCT00695565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65331272|NCT00695565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331273|NCT00695565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65331274|NCT00695565|Sympatholytics|sympatholytics|mesh-ancestor
65331275|NCT00695565|Autonomic Agents|autonomic agents|mesh-ancestor
64690607|NCT05725135|Propofol|propofol|mesh-list
65205803|NCT00607074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205804|NCT00607074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205805|NCT00607074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65205806|NCT02623582|Cyclophosphamide|cyclophosphamide|mesh-list
65205807|NCT02623582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65205808|NCT02623582|Immunologic Factors|immunologic factors|mesh-ancestor
65205809|NCT02623582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205810|NCT02623582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65205811|NCT02623582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65205812|NCT02623582|Alkylating Agents|alkylating agents|mesh-ancestor
65205813|NCT02623582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205814|NCT02623582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205815|NCT02623582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65205816|NCT00696202|Levonorgestrel|levonorgestrel|mesh-list
64955576|NCT00203554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511138|NCT05647551|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64511139|NCT05647551|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64511140|NCT05647551|Cholinergic Agents|cholinergic agents|mesh-ancestor
65205817|NCT00696202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65205819|NCT00696202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65205820|NCT00696202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205821|NCT00696202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65205822|NCT00696202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65205823|NCT00696202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65205824|NCT00674752|Gabapentin|gabapentin|mesh-list
65205825|NCT00674752|Analgesics|analgesics|mesh-ancestor
65205832|NCT00674752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65205833|NCT00674752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65205834|NCT00674752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65205835|NCT00674752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65205836|NCT00674752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65205837|NCT00674752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205838|NCT00674752|Antimanic Agents|antimanic agents|mesh-ancestor
65205840|NCT04265274|Disulfiram|disulfiram|mesh-list
65205841|NCT04265274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205842|NCT04265274|Trace Elements|trace elements|mesh-ancestor
65205843|NCT04265274|Micronutrients|micronutrients|mesh-ancestor
65205844|NCT04265274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205845|NCT04265274|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65205846|NCT04265274|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65205847|NCT04265274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205848|NCT00607152|Allopurinol|allopurinol|mesh-list
65205849|NCT00607152|Rasburicase|rasburicase|mesh-list
65205850|NCT00607152|Antimetabolites|antimetabolites|mesh-ancestor
65205851|NCT00607152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205852|NCT00607152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205853|NCT00607152|Gout Suppressants|gout suppressants|mesh-ancestor
65205854|NCT00607152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65205855|NCT00607152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65205856|NCT00607152|Antioxidants|antioxidants|mesh-ancestor
65205857|NCT00607152|Protective Agents|protective agents|mesh-ancestor
65205858|NCT00607152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205859|NCT00696748|Methyltestosterone|methyltestosterone|mesh-list
65205860|NCT00696748|Testosterone|testosterone|mesh-list
65205861|NCT00696748|Testosterone undecanoate|testosterone undecanoate|mesh-list
65205862|NCT00696748|Testosterone enanthate|testosterone enanthate|mesh-list
65205863|NCT00696748|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65205864|NCT00696748|Androgens|androgens|mesh-ancestor
65205866|NCT00696748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65205867|NCT00696748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331276|NCT00695565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65331277|NCT00695565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65331278|NCT00695565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65331279|NCT00695565|Adrenergic Agents|adrenergic agents|mesh-ancestor
65331280|NCT00695565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65331281|NCT00695565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331282|NCT00727532|Sorafenib|sorafenib|mesh-list
64717305|NCT03831854|Lamotrigine|lamotrigine|mesh-list
65205868|NCT00696748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65205869|NCT00696748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205870|NCT00696748|Anabolic Agents|anabolic agents|mesh-ancestor
65205871|NCT02621554|Resveratrol|resveratrol|mesh-list
65205872|NCT02621554|Antioxidants|antioxidants|mesh-ancestor
65205873|NCT02621554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205874|NCT02621554|Protective Agents|protective agents|mesh-ancestor
65205875|NCT02621554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205876|NCT02621554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205877|NCT02621554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65205878|NCT02623036|Enalapril|enalapril|mesh-list
65205879|NCT02623036|Lisinopril|lisinopril|mesh-list
65205880|NCT02623036|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65205881|NCT02623036|Protease Inhibitors|protease inhibitors|mesh-ancestor
65205882|NCT02623036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205883|NCT02623036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205884|NCT02623036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65205885|NCT02623036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65205886|NCT02623036|Protective Agents|protective agents|mesh-ancestor
65205887|NCT02623036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205888|NCT00696826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65205889|NCT00696826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65205890|NCT00696826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205891|NCT00696826|Incretins|incretins|mesh-ancestor
65205892|NCT00696826|Hormones|hormones|mesh-ancestor
65205893|NCT00696826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65205894|NCT00696826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65205902|NCT01092182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65205903|NCT01092182|Etoposide|etoposide|mesh-list
65205904|NCT01092182|Etoposide phosphate|etoposide phosphate|mesh-list
65205905|NCT01092182|Vincristine|vincristine|mesh-list
65205906|NCT01092182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65205907|NCT01092182|Immunologic Factors|immunologic factors|mesh-ancestor
65205908|NCT01092182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205909|NCT01092182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65205910|NCT01092182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65205911|NCT01092182|Alkylating Agents|alkylating agents|mesh-ancestor
65205912|NCT01092182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205913|NCT01092182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205914|NCT01092182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65205915|NCT01092182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65205916|NCT01092182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65205917|NCT01092182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65205918|NCT01092182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65205919|NCT01092182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205920|NCT01092182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65205921|NCT01092182|Glucocorticoids|glucocorticoids|mesh-ancestor
65205922|NCT01092182|Hormones|hormones|mesh-ancestor
65205923|NCT01092182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65205924|NCT01092182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65205925|NCT01092182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65205926|NCT01092182|Tubulin Modulators|tubulin modulators|mesh-ancestor
65205927|NCT01092182|Antimitotic Agents|antimitotic agents|mesh-ancestor
65205928|NCT01092182|Mitosis Modulators|mitosis modulators|mesh-ancestor
65205929|NCT04135378|Ascorbic Acid|ascorbic acid|mesh-list
65205930|NCT04135378|Vitamins|vitamins|mesh-ancestor
65205931|NCT04135378|Micronutrients|micronutrients|mesh-ancestor
65205932|NCT04135378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848573|NCT05800834|Lidocaine|lidocaine|mesh-list
65331283|NCT00727532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331284|NCT00727532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65331285|NCT00727532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331286|NCT00727532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331287|NCT00721214|Azacitidine|azacitidine|mesh-list
65331288|NCT00721214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65331289|NCT00721214|Antimetabolites|antimetabolites|mesh-ancestor
65331290|NCT00721214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331291|NCT00721214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331292|NCT00721214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331293|NCT00720902|Hormones|hormones|mesh-list
65205933|NCT04135378|Antioxidants|antioxidants|mesh-ancestor
65205934|NCT04135378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205935|NCT04135378|Protective Agents|protective agents|mesh-ancestor
65205936|NCT04135690|Sorafenib|sorafenib|mesh-list
65205937|NCT04135690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205938|NCT04135690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65205939|NCT04135690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205940|NCT04135690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205941|NCT02878772|Aspirin|aspirin|mesh-list
65205942|NCT02878772|Vinpocetine|vinpocetine|mesh-list
65205943|NCT02878772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65205944|NCT02878772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65205945|NCT02878772|Analgesics|analgesics|mesh-ancestor
65205946|NCT02878772|Sensory System Agents|sensory system agents|mesh-ancestor
65205947|NCT02878772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65205948|NCT02878772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205949|NCT02878772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65205950|NCT02878772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65205951|NCT02878772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65205952|NCT02878772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65205953|NCT02878772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205954|NCT02878772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65205955|NCT02878772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65205956|NCT02878772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205957|NCT02878772|Antipyretics|antipyretics|mesh-ancestor
65205958|NCT02878772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65205959|NCT02878772|Vasodilator Agents|vasodilator agents|mesh-ancestor
65205960|NCT02878772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65205961|NCT02878772|Protective Agents|protective agents|mesh-ancestor
65205962|NCT02878772|Nootropic Agents|nootropic agents|mesh-ancestor
65205963|NCT02623114|Methylphenidate|methylphenidate|mesh-list
65205968|NCT02623114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65205970|NCT02623114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205972|NCT02623114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65205973|NCT02623114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65205974|NCT02623114|Adrenergic Agents|adrenergic agents|mesh-ancestor
65205975|NCT00932646|Olodaterol|olodaterol|mesh-list
65205976|NCT00932646|Formoterol Fumarate|formoterol fumarate|mesh-list
65205977|NCT00932646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65205978|NCT00932646|Autonomic Agents|autonomic agents|mesh-ancestor
65205979|NCT00932646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65205980|NCT00932646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205981|NCT00932646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65205982|NCT00932646|Respiratory System Agents|respiratory system agents|mesh-ancestor
65205983|NCT00932646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65205984|NCT00932646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65205985|NCT00932646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65205986|NCT00932646|Adrenergic Agents|adrenergic agents|mesh-ancestor
65205987|NCT00932646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65205988|NCT00932646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205989|NCT00871234|Etravirine|etravirine|mesh-list
65205990|NCT00871234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65331294|NCT00720902|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
65331295|NCT00720902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65331296|NCT00720902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331297|NCT02592278|Listerine|listerine|mesh-list
65205991|NCT00871234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65205992|NCT00871234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205993|NCT00871234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205994|NCT00871234|Antiviral Agents|antiviral agents|mesh-ancestor
65205995|NCT00871234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65205996|NCT04267224|Ticagrelor|ticagrelor|mesh-list
65205997|NCT04267224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65205998|NCT04267224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65205999|NCT04267224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65206000|NCT04267224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65206001|NCT04267224|Purinergic Agents|purinergic agents|mesh-ancestor
65206002|NCT04267224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65206003|NCT04267224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206004|NCT04267224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206005|NCT00675220|Insulin Aspart|insulin aspart|mesh-list
65206006|NCT00675220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64848641|NCT05797597|Antipyretics|antipyretics|mesh-ancestor
65206007|NCT00675220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206008|NCT04264260|Colchicine|colchicine|mesh-list
65206009|NCT04264260|Gout Suppressants|gout suppressants|mesh-ancestor
65206010|NCT04264260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65206011|NCT04264260|Tubulin Modulators|tubulin modulators|mesh-ancestor
65206012|NCT04264260|Antimitotic Agents|antimitotic agents|mesh-ancestor
65206013|NCT04264260|Mitosis Modulators|mitosis modulators|mesh-ancestor
65206014|NCT04264260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206015|NCT04264260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206016|NCT04267146|Nivolumab|nivolumab|mesh-list
65206017|NCT04267146|Temozolomide|temozolomide|mesh-list
65206018|NCT04267146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65206019|NCT04267146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206020|NCT04267146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65206021|NCT04267146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206022|NCT04267146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65206023|NCT04267146|Alkylating Agents|alkylating agents|mesh-ancestor
65206024|NCT02691078|Octreotide|octreotide|mesh-list
65206025|NCT02691078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65206026|NCT02691078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65206027|NCT02691078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206028|NCT02621320|Vitamin D|vitamin d|mesh-list
65206029|NCT02621320|Vitamins|vitamins|mesh-ancestor
65206030|NCT02621320|Micronutrients|micronutrients|mesh-ancestor
65206031|NCT02621320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206036|NCT01097330|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65206037|NCT01097330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65206038|NCT01097330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206039|NCT01097330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65206040|NCT01097330|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65206041|NCT01097330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65206042|NCT01097330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206043|NCT01097330|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65206044|NCT01097330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65206045|NCT01097330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65206046|NCT00934440|Bevacizumab|bevacizumab|mesh-list
65206047|NCT00934440|Azacitidine|azacitidine|mesh-list
65206048|NCT00934440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65206049|NCT00934440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206050|NCT00934440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65206051|NCT00934440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65206052|NCT00934440|Growth Substances|growth substances|mesh-ancestor
65206053|NCT00934440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206054|NCT00934440|Growth Inhibitors|growth inhibitors|mesh-ancestor
65206055|NCT00934440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65206056|NCT00934440|Antimetabolites|antimetabolites|mesh-ancestor
65331298|NCT02592278|Fluorides|fluorides|mesh-list
65331299|NCT02592278|Fluorides, Topical|fluorides, topical|mesh-list
65331300|NCT02592278|Sodium Fluoride|sodium fluoride|mesh-list
65331301|NCT02592278|Cariostatic Agents|cariostatic agents|mesh-ancestor
65331302|NCT02592278|Protective Agents|protective agents|mesh-ancestor
65331303|NCT02592278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331304|NCT02592278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65331305|NCT02592278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65331306|NCT00695019|Interferons|interferons|mesh-list
65331307|NCT00695019|Interferon-alpha|interferon-alpha|mesh-list
65331308|NCT00695019|Interferon alpha-2|interferon alpha-2|mesh-list
65331309|NCT00695019|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65331310|NCT00695019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331311|NCT00695019|Antiviral Agents|antiviral agents|mesh-ancestor
65331312|NCT00695019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65206057|NCT00934440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206058|NCT00934440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206059|NCT02622802|Acetaminophen|acetaminophen|mesh-list
65206060|NCT02622802|Azithromycin|azithromycin|mesh-list
65206061|NCT02622802|Erythromycin|erythromycin|mesh-list
65206062|NCT02622802|Erythromycin Estolate|erythromycin estolate|mesh-list
65206063|NCT02622802|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65206064|NCT02622802|Erythromycin stearate|erythromycin stearate|mesh-list
65206065|NCT02622802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65206066|NCT02622802|Analgesics|analgesics|mesh-ancestor
65206067|NCT02622802|Sensory System Agents|sensory system agents|mesh-ancestor
65206068|NCT02622802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65206069|NCT02622802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206070|NCT02622802|Antipyretics|antipyretics|mesh-ancestor
65206071|NCT02622802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65206072|NCT02622802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65206073|NCT02622802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65206074|NCT02622802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65206075|NCT02622802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206076|NCT02622802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206077|NCT05158374|Aspirin|aspirin|mesh-list
65206078|NCT05158374|Metformin|metformin|mesh-list
65206079|NCT05158374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65206080|NCT05158374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848716|NCT05756504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65206081|NCT05158374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65206082|NCT05158374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65206083|NCT05158374|Analgesics|analgesics|mesh-ancestor
65206084|NCT05158374|Sensory System Agents|sensory system agents|mesh-ancestor
65206085|NCT05158374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65206086|NCT05158374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65206087|NCT05158374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65206088|NCT05158374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65206089|NCT05158374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65206090|NCT05158374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206091|NCT05158374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65206092|NCT05158374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65206093|NCT05158374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206094|NCT05158374|Antipyretics|antipyretics|mesh-ancestor
65206095|NCT00934362|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65206096|NCT00934362|Respiratory System Agents|respiratory system agents|mesh-ancestor
65206097|NCT00675688|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65206098|NCT00675688|Bazedoxifene|bazedoxifene|mesh-list
65206099|NCT00675688|Estrogens|estrogens|mesh-list
65206100|NCT00675688|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65206101|NCT00675688|Hormones|hormones|mesh-ancestor
65206106|NCT00675688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65206107|NCT00675688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65331313|NCT00695019|Immunologic Factors|immunologic factors|mesh-ancestor
65331314|NCT00695019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331315|NCT04019600|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65081219|NCT00347204|Analgesics|analgesics|mesh-ancestor
65331316|NCT04019600|Natriuretic Agents|natriuretic agents|mesh-ancestor
65331317|NCT04019600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331318|NCT00742911|Copper|copper|mesh-list
65206108|NCT00675688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65206109|NCT02622334|Latanoprost|latanoprost|mesh-list
65206110|NCT02622334|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65206111|NCT02622334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65206112|NCT00696514|Vitamin D|vitamin d|mesh-list
65206113|NCT00696514|Ergocalciferols|ergocalciferols|mesh-list
65206114|NCT00696514|Cholecalciferol|cholecalciferol|mesh-list
65206115|NCT00696514|Vitamins|vitamins|mesh-list
65206116|NCT00696514|Folic Acid|folic acid|mesh-list
65206117|NCT00696514|Vitamin B 12|vitamin b 12|mesh-list
65206118|NCT00696514|Micronutrients|micronutrients|mesh-ancestor
65206119|NCT00696514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206120|NCT00696514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65206121|NCT00696514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65206122|NCT00696514|Hematinics|hematinics|mesh-ancestor
65206123|NCT00696514|Vitamin B Complex|vitamin b complex|mesh-ancestor
65206124|NCT04263870|Capecitabine|capecitabine|mesh-list
65206125|NCT04263870|Oxaliplatin|oxaliplatin|mesh-list
65206126|NCT04263870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65206127|NCT04263870|Antimetabolites|antimetabolites|mesh-ancestor
65206128|NCT04263870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206129|NCT04263870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206130|NCT05317182|Salicylic Acid|salicylic acid|mesh-list
65206131|NCT05317182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65206132|NCT05317182|Antifungal Agents|antifungal agents|mesh-ancestor
65206133|NCT05317182|Keratolytic Agents|keratolytic agents|mesh-ancestor
65206134|NCT05317182|Dermatologic Agents|dermatologic agents|mesh-ancestor
65206135|NCT00871000|Pentetic Acid|pentetic acid|mesh-list
65206136|NCT00871000|Antidotes|antidotes|mesh-ancestor
65206137|NCT00871000|Protective Agents|protective agents|mesh-ancestor
65206138|NCT00871000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206139|NCT00871000|Chelating Agents|chelating agents|mesh-ancestor
65206140|NCT00871000|Sequestering Agents|sequestering agents|mesh-ancestor
65206141|NCT00871000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206142|NCT00871000|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65206143|NCT01096784|Mecasermin|mecasermin|mesh-list
65206144|NCT01096784|Growth Substances|growth substances|mesh-ancestor
65206145|NCT01096784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206146|NCT00696592|Bevacizumab|bevacizumab|mesh-list
65206147|NCT00696592|Verteporfin|verteporfin|mesh-list
65206148|NCT00696592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65206149|NCT00696592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206150|NCT00696592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65206151|NCT00696592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65206152|NCT00696592|Growth Substances|growth substances|mesh-ancestor
65206153|NCT00696592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206154|NCT00696592|Growth Inhibitors|growth inhibitors|mesh-ancestor
65206155|NCT00696592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64848791|NCT05691400|Palbociclib|palbociclib|mesh-list
65206156|NCT00696592|Dermatologic Agents|dermatologic agents|mesh-ancestor
65206157|NCT02622022|Morphine|morphine|mesh-list
65206158|NCT02622022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65206159|NCT02622022|Narcotics|narcotics|mesh-ancestor
65206160|NCT02622022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65206161|NCT02622022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206162|NCT02622022|Analgesics|analgesics|mesh-ancestor
65206163|NCT02622022|Sensory System Agents|sensory system agents|mesh-ancestor
65206164|NCT02622022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65206165|NCT00934050|Inositol|inositol|mesh-list
65206166|NCT00934050|Vitamin B Complex|vitamin b complex|mesh-ancestor
65206167|NCT00934050|Vitamins|vitamins|mesh-ancestor
65206168|NCT00934050|Micronutrients|micronutrients|mesh-ancestor
65206169|NCT00934050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206170|NCT02620618|Infliximab|infliximab|mesh-list
65206171|NCT02620618|Dermatologic Agents|dermatologic agents|mesh-ancestor
65206172|NCT02620618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65331319|NCT00742911|Disulfiram|disulfiram|mesh-list
65331320|NCT00742911|Trace Elements|trace elements|mesh-ancestor
65331321|NCT00742911|Micronutrients|micronutrients|mesh-ancestor
65331322|NCT00742911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331323|NCT00742911|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65331324|NCT00742911|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65331325|NCT00742911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331326|NCT00742911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206173|NCT02620618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65206174|NCT04135456|Mannitol|mannitol|mesh-list
65206179|NCT01091168|Alkylating Agents|alkylating agents|mesh-list
65206180|NCT01091168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206181|NCT05321576|Analgesics, Opioid|analgesics, opioid|mesh-list
65206182|NCT05321576|Narcotics|narcotics|mesh-ancestor
65206183|NCT05321576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65206184|NCT05321576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206185|NCT05321576|Analgesics|analgesics|mesh-ancestor
65206186|NCT05321576|Sensory System Agents|sensory system agents|mesh-ancestor
65206187|NCT05321576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65206188|NCT00864916|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65206189|NCT00864916|Pentoxifylline|pentoxifylline|mesh-list
65206190|NCT00864916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65206191|NCT00864916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206192|NCT00864916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206193|NCT00864916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65206194|NCT00864916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65206195|NCT00864916|Protective Agents|protective agents|mesh-ancestor
65206196|NCT00864916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206197|NCT00864916|Vasodilator Agents|vasodilator agents|mesh-ancestor
65206198|NCT00864916|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65206199|NCT00864916|Antioxidants|antioxidants|mesh-ancestor
65206200|NCT00864916|Antiviral Agents|antiviral agents|mesh-ancestor
65206201|NCT00864916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65206203|NCT00864682|Propofol|propofol|mesh-list
65206204|NCT00864682|Anesthetics, Local|anesthetics, local|mesh-ancestor
65206205|NCT00864682|Anesthetics|anesthetics|mesh-ancestor
65206206|NCT00864682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65206207|NCT00864682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206208|NCT00864682|Sensory System Agents|sensory system agents|mesh-ancestor
65206209|NCT00864682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65206210|NCT00864682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65206211|NCT00864682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65206212|NCT00864682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65206213|NCT00864682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65206214|NCT00864682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206215|NCT00864682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65206216|NCT00864682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65206217|NCT00864682|Anesthetics, General|anesthetics, general|mesh-ancestor
65206218|NCT00931944|Pramipexole|pramipexole|mesh-list
65206219|NCT00931944|Antioxidants|antioxidants|mesh-ancestor
65206220|NCT00931944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206221|NCT00931944|Protective Agents|protective agents|mesh-ancestor
65206222|NCT00931944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206223|NCT00931944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65206224|NCT00931944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65206225|NCT00931944|Dopamine Agonists|dopamine agonists|mesh-ancestor
65206226|NCT00931944|Dopamine Agents|dopamine agents|mesh-ancestor
65206227|NCT00931944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65206228|NCT02614456|Interferons|interferons|mesh-list
65206229|NCT02614456|Interferon-gamma|interferon-gamma|mesh-list
65206230|NCT02614456|Nivolumab|nivolumab|mesh-list
65206231|NCT02614456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65206232|NCT02614456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206233|NCT02614456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65206234|NCT02614456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206235|NCT02614456|Antiviral Agents|antiviral agents|mesh-ancestor
65331327|NCT00694707|Risperidone|risperidone|mesh-list
65331328|NCT00694707|Cariprazine|cariprazine|mesh-list
65331329|NCT00694707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65331330|NCT00694707|Serotonin Agents|serotonin agents|mesh-ancestor
65331331|NCT00694707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65331332|NCT00694707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331333|NCT00694707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331334|NCT00694707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65331335|NCT00694707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64325582|NCT02160743|Atorvastatin|atorvastatin|mesh-list
65206236|NCT02614456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65206237|NCT04130230|Choline|choline|mesh-list
65206238|NCT04130230|Neostigmine|neostigmine|mesh-list
65206239|NCT04130230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65206240|NCT04130230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206241|NCT04130230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206242|NCT04130230|Cholinergic Agents|cholinergic agents|mesh-ancestor
65206243|NCT04130230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65206244|NCT04130230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206245|NCT04130230|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65206249|NCT04130230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65206250|NCT04130230|Antimetabolites|antimetabolites|mesh-ancestor
65206251|NCT04130230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65206252|NCT04130230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65206253|NCT04130230|Nootropic Agents|nootropic agents|mesh-ancestor
65206254|NCT05148702|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65206255|NCT05148702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65206256|NCT05148702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65206257|NCT05148702|Antitubercular Agents|antitubercular agents|mesh-ancestor
65206258|NCT02616874|Romidepsin|romidepsin|mesh-list
65206259|NCT02616874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65206260|NCT02616874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206261|NCT04133428|Valsartan|valsartan|mesh-list
65206262|NCT04133428|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65206263|NCT04133428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65206264|NCT04133428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65206265|NCT04133428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65206266|NCT04133428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206267|NCT00869050|Capecitabine|capecitabine|mesh-list
65206268|NCT00869050|Temozolomide|temozolomide|mesh-list
65206269|NCT00869050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65206270|NCT00869050|Antimetabolites|antimetabolites|mesh-ancestor
65206271|NCT00869050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206272|NCT00869050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206273|NCT00869050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65206274|NCT00869050|Alkylating Agents|alkylating agents|mesh-ancestor
65206276|NCT04133506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65206277|NCT04133506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65206278|NCT04133506|Analgesics|analgesics|mesh-ancestor
65206279|NCT04133506|Sensory System Agents|sensory system agents|mesh-ancestor
65206280|NCT04133506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65206281|NCT04133506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206282|NCT04133506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65206283|NCT04133506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65206284|NCT04133506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65206285|NCT04133506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65206286|NCT04133506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206287|NCT04133506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65206288|NCT04133506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65206289|NCT04133506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206290|NCT04133506|Antipyretics|antipyretics|mesh-ancestor
65206291|NCT04872218|Abatacept|abatacept|mesh-list
65206292|NCT04872218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65206293|NCT04872218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331336|NCT00694707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65331337|NCT00694707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65331338|NCT00694707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65331339|NCT00694707|Dopamine Agents|dopamine agents|mesh-ancestor
65331340|NCT00692913|Cholecalciferol|cholecalciferol|mesh-list
65206294|NCT04872218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206295|NCT04872218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65206296|NCT04872218|Immunologic Factors|immunologic factors|mesh-ancestor
65206297|NCT04872218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206298|NCT04872218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65206299|NCT04133194|Mesalamine|mesalamine|mesh-list
65206300|NCT04133194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65206301|NCT04133194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65206302|NCT04133194|Analgesics|analgesics|mesh-ancestor
65206303|NCT04133194|Sensory System Agents|sensory system agents|mesh-ancestor
65206304|NCT04133194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65206305|NCT04133194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206306|NCT04133194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65206307|NCT04133194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65206309|NCT00698464|Hormones|hormones|mesh-ancestor
65206310|NCT00698464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65206311|NCT00698464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206312|NCT04933682|Rifampin|rifampin|mesh-list
65206313|NCT04933682|Fluconazole|fluconazole|mesh-list
65206314|NCT04933682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65206315|NCT04933682|Antitubercular Agents|antitubercular agents|mesh-ancestor
65206316|NCT04933682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65206317|NCT04933682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65206318|NCT04933682|Leprostatic Agents|leprostatic agents|mesh-ancestor
65206322|NCT04933682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65206323|NCT04933682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65206324|NCT04933682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65206325|NCT04933682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65206326|NCT04933682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65206327|NCT04933682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65206328|NCT04933682|Antifungal Agents|antifungal agents|mesh-ancestor
65206329|NCT04933682|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65206330|NCT04933682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65206331|NCT04933682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65206332|NCT04933682|Hormone Antagonists|hormone antagonists|mesh-ancestor
65206333|NCT04933682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65206334|NCT04933682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206335|NCT04933682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65206336|NCT04933682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65206337|NCT00927186|Zoledronic Acid|zoledronic acid|mesh-list
65206339|NCT00927186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65206340|NCT00927186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206341|NCT00927186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65206342|NCT04862234|Dulaglutide|dulaglutide|mesh-list
65206343|NCT04862234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65206344|NCT04862234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206345|NCT00593554|Fludarabine|fludarabine|mesh-list
65206346|NCT00593554|Thiotepa|thiotepa|mesh-list
65206347|NCT00593554|Thymoglobulin|thymoglobulin|mesh-list
65206348|NCT00593554|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65206349|NCT00593554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206350|NCT00593554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206351|NCT00593554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65206352|NCT00593554|Immunologic Factors|immunologic factors|mesh-ancestor
65206353|NCT00593554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206354|NCT00593554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65206355|NCT00593554|Alkylating Agents|alkylating agents|mesh-ancestor
65206356|NCT00593554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65206357|NCT01101308|Oxycodone|oxycodone|mesh-list
65206358|NCT01101308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65206359|NCT01101308|Narcotics|narcotics|mesh-ancestor
65206360|NCT01101308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65206361|NCT01101308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331341|NCT00692913|Vitamin D|vitamin d|mesh-list
65331342|NCT00692913|Alendronate|alendronate|mesh-list
65331343|NCT00692913|Calcium|calcium|mesh-list
65331344|NCT00692913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65331345|NCT00692913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331346|NCT00692913|Vitamins|vitamins|mesh-ancestor
65331347|NCT00692913|Micronutrients|micronutrients|mesh-ancestor
65206362|NCT01101308|Analgesics|analgesics|mesh-ancestor
65206363|NCT01101308|Sensory System Agents|sensory system agents|mesh-ancestor
65206364|NCT01101308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65206365|NCT00626054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65206366|NCT00926796|Azithromycin|azithromycin|mesh-list
65206367|NCT00926796|Gentamicins|gentamicins|mesh-list
65206368|NCT00926796|Gemifloxacin|gemifloxacin|mesh-list
65206369|NCT00926796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65206370|NCT00926796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65206371|NCT00926796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65206372|NCT00926796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206373|NCT00926796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206374|NCT00926796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65206375|NCT00926796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65206376|NCT00926796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206377|NCT00696982|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65206378|NCT00696982|Glyburide|glyburide|mesh-list
65206379|NCT00696982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64849036|NCT05340582|Ibuprofen|ibuprofen|mesh-list
65206380|NCT00696982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206381|NCT00696982|Incretins|incretins|mesh-ancestor
65206383|NCT00696982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65206384|NCT00696982|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65206385|NCT00696982|Protease Inhibitors|protease inhibitors|mesh-ancestor
65206386|NCT00696982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206387|NCT00696982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206388|NCT01087736|Topiramate|topiramate|mesh-list
65206393|NCT04262388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65206394|NCT04262388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206395|NCT00608712|Esomeprazole|esomeprazole|mesh-list
65206396|NCT00608712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65206397|NCT00608712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65206398|NCT00608712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65206399|NCT00608712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206400|NCT00608712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206401|NCT01079936|Lenalidomide|lenalidomide|mesh-list
65206402|NCT01079936|Melphalan|melphalan|mesh-list
65206403|NCT01079936|Immunologic Factors|immunologic factors|mesh-ancestor
65206404|NCT01079936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206405|NCT01079936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65206406|NCT01079936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65206407|NCT01079936|Growth Substances|growth substances|mesh-ancestor
65206408|NCT01079936|Growth Inhibitors|growth inhibitors|mesh-ancestor
65206409|NCT01079936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206410|NCT01079936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65206411|NCT01079936|Alkylating Agents|alkylating agents|mesh-ancestor
65206412|NCT01079936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206413|NCT01079936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65206414|NCT01079936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65206415|NCT00931710|Losartan|losartan|mesh-list
65206416|NCT00931710|Amlodipine|amlodipine|mesh-list
65206417|NCT00931710|Valsartan|valsartan|mesh-list
65206418|NCT00931710|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65206419|NCT00931710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65206420|NCT00931710|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65206421|NCT00931710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65206422|NCT00931710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206423|NCT00931710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65206424|NCT00931710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206425|NCT00931710|Vasodilator Agents|vasodilator agents|mesh-ancestor
65206426|NCT00931710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65206427|NCT00931710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65331348|NCT00692913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65331349|NCT00694551|Poly I-C|poly i-c|mesh-list
65331350|NCT00694551|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65331351|NCT00694551|Vaccines|vaccines|mesh-list
65331352|NCT00694551|Poly ICLC|poly iclc|mesh-list
65206428|NCT00931710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65206429|NCT00931710|Diuretics|diuretics|mesh-ancestor
65206430|NCT00931710|Natriuretic Agents|natriuretic agents|mesh-ancestor
65206431|NCT00931710|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65206432|NCT01100528|Interferons|interferons|mesh-list
65206433|NCT01100528|Interferon-alpha|interferon-alpha|mesh-list
65206434|NCT01100528|Interferon alpha-2|interferon alpha-2|mesh-list
65206435|NCT01100528|Dacarbazine|dacarbazine|mesh-list
65206436|NCT01100528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206437|NCT01100528|Antiviral Agents|antiviral agents|mesh-ancestor
65206438|NCT01100528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65206439|NCT01100528|Immunologic Factors|immunologic factors|mesh-ancestor
65206440|NCT01100528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206441|NCT01100528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65206442|NCT01100528|Alkylating Agents|alkylating agents|mesh-ancestor
65206443|NCT01100528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206444|NCT01079234|Insulin|insulin|mesh-list
65206445|NCT01079234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65206446|NCT01079234|Insulin Glargine|insulin glargine|mesh-list
65206447|NCT01079234|Insulin Aspart|insulin aspart|mesh-list
65206448|NCT01079234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65206449|NCT01079234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206450|NCT00931632|Nitric Oxide|nitric oxide|mesh-list
65206451|NCT00931632|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65206452|NCT00931632|Autonomic Agents|autonomic agents|mesh-ancestor
65206453|NCT00931632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65206454|NCT00931632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206455|NCT00931632|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65206456|NCT00931632|Respiratory System Agents|respiratory system agents|mesh-ancestor
65206457|NCT00931632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65206458|NCT00931632|Antioxidants|antioxidants|mesh-ancestor
65206459|NCT00931632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206460|NCT00931632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65206463|NCT00931632|Gasotransmitters|gasotransmitters|mesh-ancestor
65206464|NCT00931632|Protective Agents|protective agents|mesh-ancestor
65206465|NCT00608790|Albuterol|albuterol|mesh-list
65206466|NCT00608790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65206467|NCT00608790|Autonomic Agents|autonomic agents|mesh-ancestor
65206468|NCT00608790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65206469|NCT00608790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206470|NCT00608790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65206471|NCT00608790|Respiratory System Agents|respiratory system agents|mesh-ancestor
65206472|NCT00608790|Tocolytic Agents|tocolytic agents|mesh-ancestor
65206473|NCT00608790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65206474|NCT00608790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65206475|NCT00608790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65206476|NCT00608790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65206477|NCT00608790|Adrenergic Agents|adrenergic agents|mesh-ancestor
65206478|NCT00608790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65206479|NCT00608790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206480|NCT01078922|Ofatumumab|ofatumumab|mesh-list
65206481|NCT01078922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206482|NCT00609570|Calcium|calcium|mesh-list
65206483|NCT00609570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65206484|NCT00609570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206485|NCT00863746|Sorafenib|sorafenib|mesh-list
65206486|NCT00863746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206487|NCT00863746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65206488|NCT00863746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206489|NCT00863746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206490|NCT04992156|Palbociclib|palbociclib|mesh-list
65206491|NCT04992156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206492|NCT04992156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65206493|NCT04992156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206494|NCT04992156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206496|NCT00608946|Trace Elements|trace elements|mesh-ancestor
65206497|NCT00608946|Micronutrients|micronutrients|mesh-ancestor
65331353|NCT00694551|Immunologic Factors|immunologic factors|mesh-ancestor
65331354|NCT00694551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331355|NCT00694551|Interferon Inducers|interferon inducers|mesh-ancestor
65331356|NCT00694551|Laxatives|laxatives|mesh-ancestor
65331357|NCT00694551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65331358|NCT00694551|Antiviral Agents|antiviral agents|mesh-ancestor
65331359|NCT00694551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65331360|NCT02603705|Oxycodone|oxycodone|mesh-list
65331361|NCT02603705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65331362|NCT02603705|Narcotics|narcotics|mesh-ancestor
65206498|NCT00608946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206499|NCT02615938|Hydroxychloroquine|hydroxychloroquine|mesh-list
65206500|NCT02615938|Antimalarials|antimalarials|mesh-ancestor
65206501|NCT02615938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65206502|NCT02615938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65206503|NCT02615938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65206504|NCT02615938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206505|NCT02615938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206506|NCT02615938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65206507|NCT00926328|Triclosan|triclosan|mesh-list
65206508|NCT00926328|Fluorides|fluorides|mesh-list
65206509|NCT00926328|Cariostatic Agents|cariostatic agents|mesh-ancestor
65206510|NCT00926328|Protective Agents|protective agents|mesh-ancestor
65206511|NCT00926328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206512|NCT00926328|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65206513|NCT00926328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65206514|NCT00926328|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65206515|NCT00926328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65206516|NCT00926328|Antimetabolites|antimetabolites|mesh-ancestor
65206517|NCT00926328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206518|NCT00926328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65206519|NCT04203732|Anesthetics|anesthetics|mesh-list
65206520|NCT04203732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65206521|NCT04203732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206522|NCT00863512|Gemcitabine|gemcitabine|mesh-list
65206523|NCT00863512|Docetaxel|docetaxel|mesh-list
65206524|NCT00863512|Pemetrexed|pemetrexed|mesh-list
65206525|NCT00863512|Vinorelbine|vinorelbine|mesh-list
65206526|NCT00863512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206527|NCT00863512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65206528|NCT00863512|Antimetabolites|antimetabolites|mesh-ancestor
64849173|NCT05161468|Anticoagulants|anticoagulants|mesh-ancestor
65206529|NCT00863512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206530|NCT00863512|Antiviral Agents|antiviral agents|mesh-ancestor
65206531|NCT00863512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65206532|NCT00863512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206533|NCT00863512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65206534|NCT00863512|Immunologic Factors|immunologic factors|mesh-ancestor
65206539|NCT00863512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65206540|NCT00863512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65206541|NCT00863512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65206542|NCT02619994|Levofloxacin|levofloxacin|mesh-list
65206543|NCT02619994|Ofloxacin|ofloxacin|mesh-list
65206544|NCT02619994|Linezolid|linezolid|mesh-list
65206545|NCT02619994|Pyrazinamide|pyrazinamide|mesh-list
65206546|NCT02619994|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65206547|NCT02619994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65206548|NCT02619994|Renal Agents|renal agents|mesh-ancestor
65206549|NCT02619994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65206550|NCT02619994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65206551|NCT02619994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65206552|NCT02619994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206553|NCT02619994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206554|NCT02619994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206555|NCT02619994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65206556|NCT02619994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65206557|NCT02619994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65331363|NCT02603705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65331364|NCT02603705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331365|NCT02603705|Analgesics|analgesics|mesh-ancestor
65331366|NCT02603705|Sensory System Agents|sensory system agents|mesh-ancestor
65331367|NCT02603705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65331368|NCT00776555|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65331369|NCT00776555|Dextroamphetamine|dextroamphetamine|mesh-list
65331370|NCT00776555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65331371|NCT00776555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331372|NCT00776555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65331373|NCT00776555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65331374|NCT00776555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65331375|NCT00776555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331376|NCT00776555|Dopamine Agents|dopamine agents|mesh-ancestor
65206558|NCT02619994|Antitubercular Agents|antitubercular agents|mesh-ancestor
65206559|NCT04263402|Methylprednisolone|methylprednisolone|mesh-list
65206560|NCT04263402|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65206561|NCT04263402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65206562|NCT04263402|Prednisolone|prednisolone|mesh-list
65206563|NCT04263402|Prednisolone acetate|prednisolone acetate|mesh-list
65206564|NCT04263402|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65206565|NCT04263402|Prednisolone phosphate|prednisolone phosphate|mesh-list
65206566|NCT04263402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65206567|NCT04263402|Antiemetics|antiemetics|mesh-ancestor
65206568|NCT04263402|Autonomic Agents|autonomic agents|mesh-ancestor
65206569|NCT04263402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65206570|NCT04263402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206571|NCT04263402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65206572|NCT04263402|Glucocorticoids|glucocorticoids|mesh-ancestor
65206573|NCT04263402|Hormones|hormones|mesh-ancestor
65206574|NCT04263402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65206575|NCT04263402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65206576|NCT04263402|Protective Agents|protective agents|mesh-ancestor
65206577|NCT04263402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65206578|NCT04263402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206579|NCT00868192|Bevacizumab|bevacizumab|mesh-list
65206580|NCT00868192|Pemetrexed|pemetrexed|mesh-list
65206581|NCT00868192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65206582|NCT00868192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206583|NCT00868192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65206584|NCT00868192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65206585|NCT00868192|Growth Substances|growth substances|mesh-ancestor
65206586|NCT00868192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206587|NCT00868192|Growth Inhibitors|growth inhibitors|mesh-ancestor
65206588|NCT00868192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206589|NCT00868192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206590|NCT00868192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65206591|NCT00868192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65206592|NCT02615782|Tadalafil|tadalafil|mesh-list
65206593|NCT02615782|Tamsulosin|tamsulosin|mesh-list
65206594|NCT02615782|Vasodilator Agents|vasodilator agents|mesh-ancestor
65206595|NCT02615782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65206596|NCT02615782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65206597|NCT02615782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206598|NCT02615782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206599|NCT02615782|Urological Agents|urological agents|mesh-ancestor
65206600|NCT02615782|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65331377|NCT00776555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65331378|NCT00915785|Azacitidine|azacitidine|mesh-list
65331379|NCT00915785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65331380|NCT00915785|Antimetabolites|antimetabolites|mesh-ancestor
65331381|NCT00915785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206601|NCT02615782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65206602|NCT02615782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65206603|NCT02615782|Adrenergic Agents|adrenergic agents|mesh-ancestor
64849241|NCT05003648|Dopamine Agonists|dopamine agonists|mesh-ancestor
65206604|NCT02615782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65206606|NCT00930930|Paclitaxel|paclitaxel|mesh-list
65206607|NCT00930930|Everolimus|everolimus|mesh-list
65206608|NCT00930930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65206609|NCT00930930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206610|NCT00930930|Tubulin Modulators|tubulin modulators|mesh-ancestor
65206611|NCT00930930|Antimitotic Agents|antimitotic agents|mesh-ancestor
65206612|NCT00930930|Mitosis Modulators|mitosis modulators|mesh-ancestor
65206613|NCT00930930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206614|NCT00930930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65206615|NCT00930930|Immunologic Factors|immunologic factors|mesh-ancestor
65206616|NCT00930930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206617|NCT00698776|Lenalidomide|lenalidomide|mesh-list
65206618|NCT00698776|KRN 7000|krn 7000|mesh-list
65206619|NCT00698776|Immunologic Factors|immunologic factors|mesh-ancestor
65206620|NCT00698776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206621|NCT00698776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65206622|NCT00698776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65206623|NCT00698776|Growth Substances|growth substances|mesh-ancestor
65206624|NCT00698776|Growth Inhibitors|growth inhibitors|mesh-ancestor
65206625|NCT00698776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206626|NCT00698776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65206627|NCT04122040|Roxithromycin|roxithromycin|mesh-list
65206628|NCT04122040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65206629|NCT04122040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65206630|NCT04258956|Avelumab|avelumab|mesh-list
65206631|NCT04258956|Axitinib|axitinib|mesh-list
65206632|NCT04258956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65206633|NCT04258956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206634|NCT04258956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65206635|NCT04258956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206636|NCT04258956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206637|NCT00862654|Ketoconazole|ketoconazole|mesh-list
65206638|NCT00862654|Clobetasol|clobetasol|mesh-list
65206639|NCT00862654|Antifungal Agents|antifungal agents|mesh-ancestor
65206640|NCT00862654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65206641|NCT00862654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65206642|NCT00862654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65206643|NCT00862654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206644|NCT00862654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206645|NCT00862654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65206646|NCT00862654|Hormone Antagonists|hormone antagonists|mesh-ancestor
65206647|NCT00862654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65206648|NCT00862654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206649|NCT00862654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65206650|NCT00862654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65206651|NCT00862654|Glucocorticoids|glucocorticoids|mesh-ancestor
65206652|NCT00862654|Hormones|hormones|mesh-ancestor
65206653|NCT00609180|Antioxidants|antioxidants|mesh-list
65206654|NCT00609180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206655|NCT00609180|Protective Agents|protective agents|mesh-ancestor
65206656|NCT00609180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206657|NCT05190432|Taxifolin|taxifolin|mesh-list
65206658|NCT05190432|Ergothioneine|ergothioneine|mesh-list
65206659|NCT05190432|Antioxidants|antioxidants|mesh-ancestor
65206660|NCT05190432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206661|NCT05190432|Protective Agents|protective agents|mesh-ancestor
65206662|NCT05190432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206663|NCT05190432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65206664|NCT05190432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65206665|NCT05190432|Analgesics|analgesics|mesh-ancestor
65331382|NCT00915785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331383|NCT00915785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331384|NCT00776009|Methylphenidate|methylphenidate|mesh-list
65331385|NCT00776009|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
64717396|NCT04028960|Insulin|insulin|mesh-list
65206666|NCT05190432|Sensory System Agents|sensory system agents|mesh-ancestor
65206667|NCT05190432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65206668|NCT05190432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65206669|NCT05190432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65206670|NCT00867490|Amlodipine|amlodipine|mesh-list
65206671|NCT00867490|Candesartan|candesartan|mesh-list
65206672|NCT00867490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65206673|NCT00867490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65206674|NCT00867490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65206675|NCT00867490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65206676|NCT00867490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206677|NCT00867490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64849321|NCT04931342|Maytansine|maytansine|mesh-list
65206696|NCT00867334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206697|NCT00867334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65206699|NCT00925704|Sevelamer|sevelamer|mesh-list
65206700|NCT00925704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65206701|NCT00925704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206702|NCT00925704|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65206703|NCT00925704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65206704|NCT00925704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206705|NCT00925704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65206706|NCT00925704|Vitamins|vitamins|mesh-ancestor
65206707|NCT00925704|Micronutrients|micronutrients|mesh-ancestor
65206708|NCT00925704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65206709|NCT00925704|Chelating Agents|chelating agents|mesh-ancestor
65206710|NCT00925704|Sequestering Agents|sequestering agents|mesh-ancestor
65206711|NCT00697138|Amphetamine|amphetamine|mesh-list
65206712|NCT00697138|Dextroamphetamine|dextroamphetamine|mesh-list
65206713|NCT00697138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65206714|NCT00697138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65206715|NCT00697138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65206716|NCT00697138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65206717|NCT00697138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206718|NCT00697138|Adrenergic Agents|adrenergic agents|mesh-ancestor
65206719|NCT00697138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65206720|NCT00697138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206721|NCT00697138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65206722|NCT00697138|Sympathomimetics|sympathomimetics|mesh-ancestor
65206723|NCT00697138|Autonomic Agents|autonomic agents|mesh-ancestor
65206724|NCT00697138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65206725|NCT00697138|Dopamine Agents|dopamine agents|mesh-ancestor
65206726|NCT00697138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65206727|NCT00609960|Midazolam|midazolam|mesh-list
65206728|NCT00609960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65206729|NCT00609960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65206730|NCT00609960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65206731|NCT00609960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206732|NCT00609960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65206735|NCT00609960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65206736|NCT00609960|Anesthetics, General|anesthetics, general|mesh-ancestor
65206737|NCT00609960|Anesthetics|anesthetics|mesh-ancestor
65206738|NCT00609960|GABA Modulators|gaba modulators|mesh-ancestor
65206739|NCT00609960|GABA Agents|gaba agents|mesh-ancestor
65206740|NCT00609960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65206741|NCT00609960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206742|NCT04879134|Apomorphine|apomorphine|mesh-list
65206744|NCT04879134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206745|NCT04879134|Autonomic Agents|autonomic agents|mesh-ancestor
65206746|NCT04879134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65206747|NCT04879134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65206748|NCT04879134|Dopamine Agonists|dopamine agonists|mesh-ancestor
65206749|NCT04879134|Dopamine Agents|dopamine agents|mesh-ancestor
65206750|NCT04879134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65331386|NCT00776009|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65331387|NCT00776009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331388|NCT00776009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65331389|NCT00776009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65331390|NCT00776009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65331391|NCT00776009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331392|NCT00776009|Dopamine Agents|dopamine agents|mesh-ancestor
65331393|NCT00776009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65331394|NCT00720356|Bevacizumab|bevacizumab|mesh-list
65206751|NCT04879134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849392|NCT04845035|Cytarabine|cytarabine|mesh-list
65206752|NCT04134130|Methyltestosterone|methyltestosterone|mesh-list
65206753|NCT04134130|Testosterone|testosterone|mesh-list
65206754|NCT04134130|Testosterone undecanoate|testosterone undecanoate|mesh-list
65206755|NCT04134130|Testosterone enanthate|testosterone enanthate|mesh-list
65206756|NCT04134130|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65206757|NCT04134130|Androgens|androgens|mesh-ancestor
65206758|NCT04134130|Hormones|hormones|mesh-ancestor
65206759|NCT04134130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65206760|NCT04134130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206761|NCT04134130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65206762|NCT04134130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206763|NCT04134130|Anabolic Agents|anabolic agents|mesh-ancestor
65206764|NCT04258644|Paclitaxel|paclitaxel|mesh-list
65206765|NCT04258644|Apatinib|apatinib|mesh-list
65206766|NCT04258644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65206767|NCT04258644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206768|NCT04258644|Tubulin Modulators|tubulin modulators|mesh-ancestor
65206769|NCT04258644|Antimitotic Agents|antimitotic agents|mesh-ancestor
65206770|NCT04258644|Mitosis Modulators|mitosis modulators|mesh-ancestor
65206771|NCT04258644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206772|NCT04258644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64512388|NCT04447027|Dexamethasone|dexamethasone|mesh-list
65206773|NCT04258644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206774|NCT02619448|Paclitaxel|paclitaxel|mesh-list
65206775|NCT02619448|Carboplatin|carboplatin|mesh-list
65206776|NCT02619448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65206777|NCT02619448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206778|NCT02619448|Tubulin Modulators|tubulin modulators|mesh-ancestor
65206779|NCT02619448|Antimitotic Agents|antimitotic agents|mesh-ancestor
65206780|NCT02619448|Mitosis Modulators|mitosis modulators|mesh-ancestor
65206781|NCT02619448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206782|NCT00610038|Glyburide|glyburide|mesh-list
65206783|NCT00610038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65206784|NCT00610038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206785|NCT02619526|Carvedilol|carvedilol|mesh-list
65206786|NCT02619526|Nebivolol|nebivolol|mesh-list
65206787|NCT02619526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65206788|NCT02619526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65206789|NCT02619526|Adrenergic Agents|adrenergic agents|mesh-ancestor
65206790|NCT02619526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65206791|NCT02619526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206792|NCT02619526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206793|NCT02619526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65206794|NCT02619526|Antioxidants|antioxidants|mesh-ancestor
65206795|NCT02619526|Protective Agents|protective agents|mesh-ancestor
65206796|NCT02619526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65206797|NCT02619526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65206798|NCT02619526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65206799|NCT02619526|Vasodilator Agents|vasodilator agents|mesh-ancestor
65206800|NCT02619526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65206801|NCT02619526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65206802|NCT02619526|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65206803|NCT02619526|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65331395|NCT00720356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65331396|NCT00720356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65331397|NCT00720356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331398|NCT00720356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65331399|NCT00720356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65331400|NCT00720356|Growth Substances|growth substances|mesh-ancestor
65331401|NCT00720356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331402|NCT00720356|Growth Inhibitors|growth inhibitors|mesh-ancestor
65331403|NCT00720356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65331404|NCT00720356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331405|NCT00720356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331407|NCT00745953|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65331408|NCT00745953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65331409|NCT00745953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65331410|NCT00745953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65331411|NCT00745953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331412|NCT00745953|Diuretics|diuretics|mesh-ancestor
65331413|NCT00745953|Natriuretic Agents|natriuretic agents|mesh-ancestor
65331414|NCT00745953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331415|NCT00745953|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65331416|NCT00745953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65331417|NCT00720278|Azelastine|azelastine|mesh-list
65206804|NCT02619526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65206810|NCT04119622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206811|NCT00925548|Cyclophosphamide|cyclophosphamide|mesh-list
65206812|NCT00925548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65206813|NCT00925548|Immunologic Factors|immunologic factors|mesh-ancestor
65206814|NCT00925548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206815|NCT00925548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65206816|NCT00925548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65206817|NCT00925548|Alkylating Agents|alkylating agents|mesh-ancestor
65206818|NCT00925548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206819|NCT00925548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512493|NCT04322318|Daunorubicin|daunorubicin|mesh-list
65206820|NCT00925548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65206822|NCT00866788|Diphenhydramine|diphenhydramine|mesh-list
65206823|NCT00866788|Promethazine|promethazine|mesh-list
65206824|NCT00866788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
65206825|NCT00866788|Histamine Antagonists|histamine antagonists|mesh-list
65206826|NCT00866788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64849468|NCT04762758|Cathartics|cathartics|mesh-ancestor
65206827|NCT00866788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65206828|NCT00866788|Respiratory System Agents|respiratory system agents|mesh-ancestor
65206829|NCT00866788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65206830|NCT00866788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65206831|NCT00866788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65206832|NCT00866788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206833|NCT00866788|Anesthetics, Local|anesthetics, local|mesh-ancestor
65206834|NCT00866788|Anesthetics|anesthetics|mesh-ancestor
65206835|NCT00866788|Sensory System Agents|sensory system agents|mesh-ancestor
65331418|NCT00720278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65331419|NCT00720278|Autonomic Agents|autonomic agents|mesh-ancestor
65331420|NCT00720278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65331421|NCT00720278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331422|NCT00720278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65331423|NCT00720278|Respiratory System Agents|respiratory system agents|mesh-ancestor
65331424|NCT00720278|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65206836|NCT00866788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65206837|NCT00866788|Antiemetics|antiemetics|mesh-ancestor
65206838|NCT00866788|Autonomic Agents|autonomic agents|mesh-ancestor
65206839|NCT00866788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65206840|NCT00866788|Histamine Agents|histamine agents|mesh-ancestor
65206841|NCT00866788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65206842|NCT00866788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206843|NCT00866788|Antipruritics|antipruritics|mesh-ancestor
65206844|NCT00866788|Dermatologic Agents|dermatologic agents|mesh-ancestor
65206846|NCT04132570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65206847|NCT04132570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65206848|NCT04132570|Autonomic Agents|autonomic agents|mesh-ancestor
65206849|NCT04132570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65206850|NCT04132570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206851|NCT04132570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65206852|NCT04132570|Respiratory System Agents|respiratory system agents|mesh-ancestor
65206853|NCT04132570|Glucocorticoids|glucocorticoids|mesh-ancestor
65206854|NCT04132570|Hormones|hormones|mesh-ancestor
65206855|NCT04132570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65206856|NCT00699244|Anesthetics|anesthetics|mesh-list
65206857|NCT00699244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65206858|NCT00699244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206859|NCT00699322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65206860|NCT00699322|Glimepiride|glimepiride|mesh-list
65206861|NCT00699322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65206862|NCT00699322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206863|NCT00699322|Incretins|incretins|mesh-ancestor
65206864|NCT00699322|Hormones|hormones|mesh-ancestor
65206865|NCT00699322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65206866|NCT00699322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65206867|NCT00699322|Protease Inhibitors|protease inhibitors|mesh-ancestor
65206868|NCT00699322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206869|NCT00699322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206870|NCT00699322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65206871|NCT00699322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65206872|NCT00699322|Immunologic Factors|immunologic factors|mesh-ancestor
65206873|NCT00860470|Iron|iron|mesh-list
64512570|NCT04232306|Bupivacaine|bupivacaine|mesh-list
65206877|NCT00860470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206878|NCT00860470|Hematinics|hematinics|mesh-ancestor
65206879|NCT00860470|Vitamin B Complex|vitamin b complex|mesh-ancestor
65206880|NCT00860470|Vitamins|vitamins|mesh-ancestor
65206881|NCT00923364|Cyclophosphamide|cyclophosphamide|mesh-list
65206882|NCT00923364|Fludarabine|fludarabine|mesh-list
65206883|NCT00923364|Fludarabine phosphate|fludarabine phosphate|mesh-list
65206884|NCT00923364|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65206885|NCT00923364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65206886|NCT00923364|Immunologic Factors|immunologic factors|mesh-ancestor
65206887|NCT00923364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206888|NCT00923364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65206889|NCT00923364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65206890|NCT00923364|Alkylating Agents|alkylating agents|mesh-ancestor
65206891|NCT00923364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206892|NCT00923364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206893|NCT00923364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65206894|NCT00923364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65206895|NCT00923364|Antimetabolites|antimetabolites|mesh-ancestor
65206896|NCT02613676|Bilirubin|bilirubin|mesh-list
65206897|NCT02613676|Antioxidants|antioxidants|mesh-ancestor
65206898|NCT02613676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206899|NCT02613676|Protective Agents|protective agents|mesh-ancestor
65331425|NCT00720278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331426|NCT00720278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331427|NCT00720278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65331428|NCT00720278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65331429|NCT00720278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65331430|NCT00720278|Histamine Antagonists|histamine antagonists|mesh-ancestor
65331431|NCT00720278|Histamine Agents|histamine agents|mesh-ancestor
65331432|NCT00720278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65331433|NCT00746031|Goserelin|goserelin|mesh-list
65331434|NCT00746031|Cetrorelix|cetrorelix|mesh-list
65206900|NCT02613676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206901|NCT00860158|Dasatinib|dasatinib|mesh-list
65206902|NCT00860158|Leuprolide|leuprolide|mesh-list
65206903|NCT00860158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206904|NCT00860158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65206905|NCT00860158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206906|NCT00860158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206907|NCT00860158|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65206908|NCT00860158|Fertility Agents|fertility agents|mesh-ancestor
65206909|NCT00860158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65206910|NCT00860158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206911|NCT00860158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65206912|NCT02878538|Deferiprone|deferiprone|mesh-list
65206913|NCT02878538|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65206914|NCT02878538|Chelating Agents|chelating agents|mesh-ancestor
65206915|NCT02878538|Sequestering Agents|sequestering agents|mesh-ancestor
65206916|NCT02878538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206917|NCT04134598|Tamoxifen|tamoxifen|mesh-list
65206918|NCT04134598|Letrozole|letrozole|mesh-list
65206919|NCT04134598|Anastrozole|anastrozole|mesh-list
65206920|NCT04134598|Exemestane|exemestane|mesh-list
65206921|NCT04134598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206922|NCT04134598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65206923|NCT04134598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65206924|NCT04134598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206925|NCT04134598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206926|NCT04134598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65206927|NCT04134598|Hormone Antagonists|hormone antagonists|mesh-ancestor
65206928|NCT04134598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65206929|NCT04134598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206930|NCT04134598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65206931|NCT04134598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65206932|NCT04134598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65206933|NCT04134598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65206934|NCT04134052|Midazolam|midazolam|mesh-list
65206935|NCT04134052|Ketamine|ketamine|mesh-list
65206936|NCT04134052|Analgesics|analgesics|mesh-ancestor
65206937|NCT04134052|Sensory System Agents|sensory system agents|mesh-ancestor
65206938|NCT04134052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65206939|NCT04134052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206940|NCT04134052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65206941|NCT04134052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65206942|NCT04134052|Anesthetics, General|anesthetics, general|mesh-ancestor
65206943|NCT04134052|Anesthetics|anesthetics|mesh-ancestor
65206944|NCT04134052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65206945|NCT04134052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64324111|NCT01578655|Glucocorticoids|glucocorticoids|mesh-ancestor
65206949|NCT04134052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65206950|NCT04134052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65206951|NCT04134052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65206952|NCT04134052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65206953|NCT04134052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65206954|NCT04134052|GABA Modulators|gaba modulators|mesh-ancestor
65206955|NCT04134052|GABA Agents|gaba agents|mesh-ancestor
65206956|NCT02615080|Pemirolast|pemirolast|mesh-list
65206957|NCT02615080|Histamine Antagonists|histamine antagonists|mesh-ancestor
65331435|NCT00746031|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65331436|NCT00746031|Hormones|hormones|mesh-ancestor
65331437|NCT00746031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65331438|NCT00746031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331439|NCT00746031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65331440|NCT00746031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331441|NCT00746031|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65331442|NCT00746031|Fertility Agents|fertility agents|mesh-ancestor
65331443|NCT00746031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65331444|NCT00746031|Hormone Antagonists|hormone antagonists|mesh-ancestor
65331445|NCT00720122|Insulin|insulin|mesh-list
64717447|NCT03799484|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65206958|NCT02615080|Histamine Agents|histamine agents|mesh-ancestor
65206959|NCT02615080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65206960|NCT02615080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206961|NCT02615080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206962|NCT05001750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65206963|NCT05001750|Doxycycline|doxycycline|mesh-list
65206964|NCT05001750|Nafcillin|nafcillin|mesh-list
65206965|NCT05001750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65206966|NCT05001750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65206967|NCT05001750|Antitubercular Agents|antitubercular agents|mesh-ancestor
65206968|NCT05001750|Antimalarials|antimalarials|mesh-ancestor
65206969|NCT05001750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65206970|NCT05001750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65206971|NCT00859456|Sunitinib|sunitinib|mesh-list
65206972|NCT00859456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206973|NCT00859456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65206974|NCT00859456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65206975|NCT00859456|Growth Substances|growth substances|mesh-ancestor
65206976|NCT00859456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206977|NCT00859456|Growth Inhibitors|growth inhibitors|mesh-ancestor
65206978|NCT00859456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65206979|NCT00859456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206980|NCT00859456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206981|NCT01075646|Ropivacaine|ropivacaine|mesh-list
65206982|NCT01075646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65206983|NCT01075646|Anesthetics, Local|anesthetics, local|mesh-ancestor
65206984|NCT01075646|Anesthetics|anesthetics|mesh-ancestor
65206985|NCT01075646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65206986|NCT01075646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206987|NCT01075646|Sensory System Agents|sensory system agents|mesh-ancestor
65206988|NCT01075646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65206990|NCT00799903|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
65206991|NCT00799903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206992|NCT00799903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206993|NCT01075256|Calcium, Dietary|calcium, dietary|mesh-list
65206994|NCT01075256|Calcium|calcium|mesh-list
65206995|NCT01075256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65206996|NCT01075256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206997|NCT01075256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65206998|NCT02876432|Diclofenac|diclofenac|mesh-list
65206999|NCT02876432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65207000|NCT02876432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65207001|NCT02876432|Analgesics|analgesics|mesh-ancestor
65207002|NCT02876432|Sensory System Agents|sensory system agents|mesh-ancestor
65207003|NCT02876432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65207004|NCT02876432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207005|NCT02876432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65207006|NCT02876432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65207007|NCT02876432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65207008|NCT02876432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331446|NCT00720122|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65331447|NCT00720122|Mitogens|mitogens|mesh-list
65331448|NCT00720122|Mecasermin|mecasermin|mesh-list
65331449|NCT00720122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65331450|NCT00720122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331451|NCT00720122|Mitosis Modulators|mitosis modulators|mesh-ancestor
65331452|NCT00720122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331453|NCT00720122|Growth Substances|growth substances|mesh-ancestor
65331454|NCT04085744|Mometasone Furoate|mometasone furoate|mesh-list
65331455|NCT04085744|Lidocaine|lidocaine|mesh-list
65331456|NCT04085744|Anesthetics, Local|anesthetics, local|mesh-ancestor
65207009|NCT02876432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207010|NCT02876276|Hyaluronic Acid|hyaluronic acid|mesh-list
65207011|NCT02876276|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65207012|NCT02876276|Immunologic Factors|immunologic factors|mesh-ancestor
65207013|NCT02876276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207014|NCT02876276|Viscosupplements|viscosupplements|mesh-ancestor
65207015|NCT02876276|Protective Agents|protective agents|mesh-ancestor
65207016|NCT00923130|Bevacizumab|bevacizumab|mesh-list
65207017|NCT00923130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65207020|NCT00923130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65207021|NCT00923130|Growth Substances|growth substances|mesh-ancestor
65207022|NCT00923130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207023|NCT00923130|Growth Inhibitors|growth inhibitors|mesh-ancestor
65207024|NCT04258098|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65207025|NCT04258098|Metronidazole|metronidazole|mesh-list
65207026|NCT04258098|Streptomycin|streptomycin|mesh-list
65207027|NCT04258098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65207028|NCT04258098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65207029|NCT04258098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65207030|NCT04258098|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65207031|NCT04258098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207032|NCT04258098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207033|NCT02605915|Cyclophosphamide|cyclophosphamide|mesh-list
65207034|NCT02605915|Carboplatin|carboplatin|mesh-list
65207035|NCT02605915|Docetaxel|docetaxel|mesh-list
65207036|NCT02605915|Doxorubicin|doxorubicin|mesh-list
65207037|NCT02605915|Trastuzumab|trastuzumab|mesh-list
65207038|NCT02605915|Atezolizumab|atezolizumab|mesh-list
65207039|NCT02605915|Pertuzumab|pertuzumab|mesh-list
65207040|NCT02605915|Maytansine|maytansine|mesh-list
65207041|NCT02605915|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65207042|NCT02605915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65207043|NCT02605915|Immunologic Factors|immunologic factors|mesh-ancestor
65207044|NCT02605915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207045|NCT02605915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65207046|NCT02605915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65207047|NCT02605915|Alkylating Agents|alkylating agents|mesh-ancestor
65207048|NCT02605915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207049|NCT02605915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207050|NCT02605915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65207051|NCT02605915|Tubulin Modulators|tubulin modulators|mesh-ancestor
65207052|NCT02605915|Antimitotic Agents|antimitotic agents|mesh-ancestor
64849698|NCT04002947|Rituximab|rituximab|mesh-list
65207053|NCT02605915|Mitosis Modulators|mitosis modulators|mesh-ancestor
65207054|NCT02605915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65207055|NCT02605915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65207056|NCT02605915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65207057|NCT02605915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207058|NCT02605915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65207059|NCT02605915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65207060|NCT04028323|Octreotide|octreotide|mesh-list
65207061|NCT04028323|Terlipressin|terlipressin|mesh-list
65207062|NCT04028323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65207063|NCT04028323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65207064|NCT04028323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207065|NCT04028323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65331457|NCT04085744|Anesthetics|anesthetics|mesh-ancestor
65331458|NCT04085744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65331459|NCT04085744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331460|NCT04085744|Sensory System Agents|sensory system agents|mesh-ancestor
65331461|NCT04085744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65331462|NCT04085744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65331463|NCT04085744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65331464|NCT04085744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65207066|NCT04028323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65207067|NCT02607163|Dexmedetomidine|dexmedetomidine|mesh-list
65207068|NCT02607163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65207069|NCT02607163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65207070|NCT02607163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207071|NCT02607163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65207072|NCT02607163|Analgesics|analgesics|mesh-ancestor
65207073|NCT02607163|Sensory System Agents|sensory system agents|mesh-ancestor
65207074|NCT02607163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65207075|NCT02607163|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65207076|NCT02607163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65207077|NCT02607163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65207078|NCT02607163|Adrenergic Agents|adrenergic agents|mesh-ancestor
65207079|NCT02607163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65207080|NCT02607163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207081|NCT01075100|Carboplatin|carboplatin|mesh-list
65207082|NCT01075100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207083|NCT02876354|Vitamin K|vitamin k|mesh-list
65207084|NCT02876354|Vitamin K 2|vitamin k 2|mesh-list
65207085|NCT02876354|Vitamins|vitamins|mesh-ancestor
65207086|NCT02876354|Micronutrients|micronutrients|mesh-ancestor
65207087|NCT02876354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207088|NCT02876354|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64512847|NCT03959085|Vitamins|vitamins|mesh-ancestor
65207089|NCT02876354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65207090|NCT02876354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207094|NCT00626678|Azathioprine|azathioprine|mesh-list
65207095|NCT00626678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65207096|NCT00626678|Glucocorticoids|glucocorticoids|mesh-ancestor
65207097|NCT00626678|Hormones|hormones|mesh-ancestor
65207098|NCT00626678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65207099|NCT00626678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207100|NCT00626678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65207101|NCT00626678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207102|NCT00626678|Antimetabolites|antimetabolites|mesh-ancestor
65207103|NCT00626678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207104|NCT00626678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65207105|NCT00626678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65207106|NCT00626678|Immunologic Factors|immunologic factors|mesh-ancestor
65207107|NCT00626678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65207108|NCT00803023|Sodium Oxybate|sodium oxybate|mesh-list
65207109|NCT00803023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65207110|NCT00803023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65207111|NCT00803023|Anesthetics, General|anesthetics, general|mesh-ancestor
65207112|NCT00803023|Anesthetics|anesthetics|mesh-ancestor
65207113|NCT00803023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65207114|NCT00803023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207115|NCT03076021|Dextromethorphan|dextromethorphan|mesh-list
65207116|NCT03076021|Isotretinoin|isotretinoin|mesh-list
65207117|NCT03076021|Antitussive Agents|antitussive agents|mesh-ancestor
65207118|NCT03076021|Respiratory System Agents|respiratory system agents|mesh-ancestor
65207119|NCT03076021|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65207120|NCT03076021|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65207121|NCT03076021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65207122|NCT03076021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207123|NCT03076021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207124|NCT03076021|Dermatologic Agents|dermatologic agents|mesh-ancestor
65331465|NCT04085744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65331466|NCT04085744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081375|NCT00348023|Timolol|timolol|mesh-list
65331467|NCT04085744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65331468|NCT04085744|Dermatologic Agents|dermatologic agents|mesh-ancestor
65331469|NCT04085744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65331470|NCT00743847|Varenicline|varenicline|mesh-list
65331471|NCT00743847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65207125|NCT00859222|Bevacizumab|bevacizumab|mesh-list
65207126|NCT00859222|Panobinostat|panobinostat|mesh-list
65207127|NCT00859222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65207128|NCT00859222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207129|NCT00859222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65207130|NCT00859222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65207131|NCT00859222|Growth Substances|growth substances|mesh-ancestor
65207132|NCT00859222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207133|NCT00859222|Growth Inhibitors|growth inhibitors|mesh-ancestor
65207134|NCT00859222|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65207135|NCT00859222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207136|NCT00859222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207137|NCT00858988|Rifaximin|rifaximin|mesh-list
65207138|NCT00858988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65207139|NCT00858988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65207140|NCT00858988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65207141|NCT00858832|Methylergonovine|methylergonovine|mesh-list
65207142|NCT00858832|Oxytocics|oxytocics|mesh-ancestor
65207143|NCT00858832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65207144|NCT00858832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207145|NCT01071512|Natalizumab|natalizumab|mesh-list
65207146|NCT01071512|Immunologic Factors|immunologic factors|mesh-ancestor
65207147|NCT01071512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207148|NCT00626834|Vigabatrin|vigabatrin|mesh-list
65207149|NCT00626834|Anticonvulsants|anticonvulsants|mesh-ancestor
65207150|NCT00626834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207151|NCT00626834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207152|NCT00626834|GABA Agents|gaba agents|mesh-ancestor
65207153|NCT00626834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65207154|NCT00626834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207155|NCT04255992|Calcium, Dietary|calcium, dietary|mesh-list
65207156|NCT04255992|Vitamin D|vitamin d|mesh-list
65207157|NCT04255992|Calcium|calcium|mesh-list
65207158|NCT04255992|Vitamins|vitamins|mesh-ancestor
65207159|NCT04255992|Micronutrients|micronutrients|mesh-ancestor
65207160|NCT04255992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207161|NCT04255992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65207162|NCT04255992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65207163|NCT02618824|Tryptophan|tryptophan|mesh-list
65207164|NCT02618824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65207172|NCT00610350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207173|NCT00610350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207174|NCT00610350|Protective Agents|protective agents|mesh-ancestor
65207175|NCT00610350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207177|NCT01071200|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65207178|NCT01071200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65207179|NCT01071200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207180|NCT04255836|Durvalumab|durvalumab|mesh-list
65207181|NCT04255836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65207182|NCT04255836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207183|NCT00699478|Vitamin B 12|vitamin b 12|mesh-list
65207184|NCT00699478|Vitamin B Complex|vitamin b complex|mesh-ancestor
65207185|NCT00699478|Vitamins|vitamins|mesh-ancestor
65207186|NCT00699478|Micronutrients|micronutrients|mesh-ancestor
65207187|NCT00699478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207188|NCT01070888|Budesonide|budesonide|mesh-list
65207189|NCT01070888|Formoterol Fumarate|formoterol fumarate|mesh-list
65207190|NCT01070888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65207191|NCT01070888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65207192|NCT01070888|Autonomic Agents|autonomic agents|mesh-ancestor
65331472|NCT00743847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65331473|NCT00743847|Cholinergic Agents|cholinergic agents|mesh-ancestor
65331474|NCT00743847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65331475|NCT00743847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331476|NCT00743847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331477|NCT00717860|Caspofungin|caspofungin|mesh-list
65331478|NCT00717860|Micafungin|micafungin|mesh-list
65207193|NCT01070888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65207194|NCT01070888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207195|NCT01070888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65207196|NCT01070888|Respiratory System Agents|respiratory system agents|mesh-ancestor
65207197|NCT01070888|Glucocorticoids|glucocorticoids|mesh-ancestor
65207198|NCT01070888|Hormones|hormones|mesh-ancestor
65207199|NCT01070888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65207200|NCT01070888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65207201|NCT01070888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65207202|NCT01070888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65207203|NCT01070888|Adrenergic Agents|adrenergic agents|mesh-ancestor
64849846|NCT03506061|Ivacaftor|ivacaftor|mesh-list
65207204|NCT01070888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65207205|NCT01070888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207206|NCT00857896|Fesoterodine|fesoterodine|mesh-list
65207207|NCT00857896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65207208|NCT00857896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65207209|NCT00857896|Cholinergic Agents|cholinergic agents|mesh-ancestor
65207210|NCT00857896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65207211|NCT00857896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207212|NCT00857896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207213|NCT00857896|Urological Agents|urological agents|mesh-ancestor
65207214|NCT05652673|Nivolumab|nivolumab|mesh-list
65207215|NCT05652673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65207216|NCT05652673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207217|NCT05652673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64513012|NCT03778502|Rivaroxaban|rivaroxaban|mesh-list
65207218|NCT05652673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207220|NCT00857818|Aripiprazole|aripiprazole|mesh-list
65207221|NCT00857818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65207222|NCT00857818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65207223|NCT00857818|Serotonin Agents|serotonin agents|mesh-ancestor
65207224|NCT00857818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65207225|NCT00857818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207226|NCT00857818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207227|NCT00857818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65207228|NCT00857818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65207229|NCT00857818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65207230|NCT00857818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65207234|NCT00857818|Dopamine Agonists|dopamine agonists|mesh-ancestor
65207235|NCT00857818|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65207236|NCT00857818|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65207237|NCT00857818|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65207238|NCT00857818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65207239|NCT02618668|Ketamine|ketamine|mesh-list
65207240|NCT02618668|Propofol|propofol|mesh-list
65207241|NCT02618668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65207242|NCT02618668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65207243|NCT02618668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207244|NCT02618668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65207245|NCT02618668|Anesthetics, General|anesthetics, general|mesh-ancestor
65207246|NCT02618668|Anesthetics|anesthetics|mesh-ancestor
65207247|NCT02618668|Analgesics|analgesics|mesh-ancestor
65207248|NCT02618668|Sensory System Agents|sensory system agents|mesh-ancestor
65207249|NCT02618668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65207250|NCT02618668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65207251|NCT02618668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65207252|NCT02618668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65207253|NCT02618668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65331479|NCT00717860|Antifungal Agents|antifungal agents|mesh-ancestor
65331480|NCT00717860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65331481|NCT00717860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331482|NCT00717860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331483|NCT00746499|Raltegravir Potassium|raltegravir potassium|mesh-list
65331484|NCT00746499|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65331485|NCT00746499|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65207254|NCT02618668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207255|NCT01074944|Eliglustat|eliglustat|mesh-list
65207256|NCT01074944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207257|NCT01074944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207258|NCT00802945|Etirinotecan pegol|etirinotecan pegol|mesh-list
65207259|NCT00802945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207260|NCT00802945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65207261|NCT00802945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65207262|NCT00802945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207263|NCT00802945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207264|NCT01074554|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65207265|NCT01074554|Azithromycin|azithromycin|mesh-list
65207266|NCT01074554|Levofloxacin|levofloxacin|mesh-list
65207267|NCT01074554|Rifampin|rifampin|mesh-list
65207268|NCT01074554|Ethambutol|ethambutol|mesh-list
65207269|NCT01074554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65207270|NCT01074554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65207271|NCT01074554|Antitubercular Agents|antitubercular agents|mesh-ancestor
65207272|NCT01074554|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65207273|NCT01074554|Renal Agents|renal agents|mesh-ancestor
65207274|NCT01074554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65207275|NCT01074554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65207276|NCT01074554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207277|NCT01074554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207278|NCT01074554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207279|NCT01074554|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65207280|NCT01074554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65207281|NCT01074554|Leprostatic Agents|leprostatic agents|mesh-ancestor
65207282|NCT01074554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65207283|NCT01074554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65207284|NCT01074554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65207285|NCT01074554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65207286|NCT01074554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65207287|NCT01074554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65207288|NCT01074554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65207289|NCT00857584|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65207290|NCT00857584|Sertraline|sertraline|mesh-list
65207292|NCT00857584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65207293|NCT00857584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65207294|NCT00857584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65207295|NCT00857584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65207296|NCT00857584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207297|NCT00857584|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65207298|NCT00857584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65207299|NCT00857584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65207300|NCT00857584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207301|NCT00857584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65207304|NCT00798967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65207305|NCT00798967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65207306|NCT00798967|Protective Agents|protective agents|mesh-ancestor
65207307|NCT00798967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207308|NCT04132102|Afatinib|afatinib|mesh-list
65207309|NCT04132102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207310|NCT04132102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65207311|NCT04132102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207312|NCT04132102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207313|NCT02618356|Raltitrexed|raltitrexed|mesh-list
65207314|NCT02618356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65331486|NCT00746499|Antiviral Agents|antiviral agents|mesh-ancestor
65331487|NCT00746499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65331488|NCT00746499|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65331489|NCT00746499|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65331490|NCT00746499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692724|NCT02019758|Budesonide|budesonide|mesh-list
65207315|NCT02618356|Antimetabolites|antimetabolites|mesh-ancestor
65207316|NCT02618356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207317|NCT02618356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207318|NCT02618356|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65207319|NCT02618356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207320|NCT00697996|Rituximab|rituximab|mesh-list
65207321|NCT00697996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65207322|NCT00697996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207323|NCT00697996|Immunologic Factors|immunologic factors|mesh-ancestor
65207324|NCT00697996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207325|NCT00697996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65207326|NCT04118842|Rifampin|rifampin|mesh-list
65207327|NCT04118842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65207328|NCT04118842|Antitubercular Agents|antitubercular agents|mesh-ancestor
65207329|NCT04118842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65207330|NCT04118842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65207331|NCT04118842|Leprostatic Agents|leprostatic agents|mesh-ancestor
65207332|NCT04118842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65207333|NCT04118842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207334|NCT04118842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207335|NCT04118842|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65207336|NCT04118842|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65207337|NCT04118842|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65207338|NCT04118842|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65207339|NCT04118842|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65207340|NCT04118842|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65207341|NCT00699634|Nabilone|nabilone|mesh-list
65207342|NCT00699634|Antiemetics|antiemetics|mesh-ancestor
65207343|NCT00699634|Autonomic Agents|autonomic agents|mesh-ancestor
65207344|NCT00699634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65207345|NCT00699634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207346|NCT00699634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65207347|NCT00699634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65207348|NCT00699634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65207349|NCT00699634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65207350|NCT00699634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65207351|NCT00798889|Sunitinib|sunitinib|mesh-list
65207352|NCT00798889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207353|NCT00798889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65207354|NCT00798889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65207355|NCT00798889|Growth Substances|growth substances|mesh-ancestor
65207356|NCT00798889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207357|NCT00798889|Growth Inhibitors|growth inhibitors|mesh-ancestor
65207358|NCT00798889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65207359|NCT00798889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207360|NCT00798889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207361|NCT04113889|Acetylcarnitine|acetylcarnitine|mesh-list
65207362|NCT04113889|Metformin|metformin|mesh-list
65207363|NCT04113889|Pioglitazone|pioglitazone|mesh-list
65207364|NCT04113889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65207365|NCT04113889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207366|NCT04113889|Vitamin B Complex|vitamin b complex|mesh-ancestor
65207367|NCT04113889|Vitamins|vitamins|mesh-ancestor
65207368|NCT04113889|Micronutrients|micronutrients|mesh-ancestor
65207369|NCT04113889|Nootropic Agents|nootropic agents|mesh-ancestor
65207370|NCT00796861|Sunitinib|sunitinib|mesh-list
65207371|NCT00796861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207372|NCT00796861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65207373|NCT00796861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65207374|NCT00796861|Growth Substances|growth substances|mesh-ancestor
65207375|NCT00796861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207381|NCT00914563|Antidepressive Agents|antidepressive agents|mesh-ancestor
65207382|NCT00914563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65207383|NCT00914563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331491|NCT00746499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331492|NCT02592122|Bromides|bromides|mesh-list
65331493|NCT02592122|Albuterol|albuterol|mesh-list
65331494|NCT02592122|Anticonvulsants|anticonvulsants|mesh-ancestor
65331495|NCT02592122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65331496|NCT02592122|Autonomic Agents|autonomic agents|mesh-ancestor
64717495|NCT03510481|Lumefantrine|lumefantrine|mesh-list
65207384|NCT00914563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207385|NCT00914563|Antimanic Agents|antimanic agents|mesh-ancestor
65207386|NCT00914563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65207387|NCT00914563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65207388|NCT00914563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207389|NCT00914797|Terbutaline|terbutaline|mesh-list
65207390|NCT00914797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65207391|NCT00914797|Autonomic Agents|autonomic agents|mesh-ancestor
65207392|NCT00914797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65207393|NCT00914797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207394|NCT00914797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65207395|NCT00914797|Respiratory System Agents|respiratory system agents|mesh-ancestor
65207396|NCT00914797|Sympathomimetics|sympathomimetics|mesh-ancestor
65207397|NCT00914797|Tocolytic Agents|tocolytic agents|mesh-ancestor
65207398|NCT00914797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65207399|NCT00914797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65207400|NCT00914797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65207401|NCT00914797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65207402|NCT00914797|Adrenergic Agents|adrenergic agents|mesh-ancestor
65207403|NCT00914797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65207404|NCT00914797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207406|NCT00798655|Panitumumab|panitumumab|mesh-list
65207407|NCT00798655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207408|NCT00798655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65207409|NCT00914641|Apixaban|apixaban|mesh-list
65207410|NCT00914641|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65207411|NCT00914641|Antithrombins|antithrombins|mesh-ancestor
65207412|NCT00914641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65207413|NCT00914641|Protease Inhibitors|protease inhibitors|mesh-ancestor
65207414|NCT00914641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207415|NCT00914641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207416|NCT00914641|Anticoagulants|anticoagulants|mesh-ancestor
65207417|NCT00796549|Afatinib|afatinib|mesh-list
65207418|NCT00796549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207419|NCT00796549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65207420|NCT00796549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207421|NCT00796549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207422|NCT00856492|Paclitaxel|paclitaxel|mesh-list
65207423|NCT00856492|Cyclophosphamide|cyclophosphamide|mesh-list
65207424|NCT00856492|Bevacizumab|bevacizumab|mesh-list
65207425|NCT00856492|Doxorubicin|doxorubicin|mesh-list
65207426|NCT00856492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65207427|NCT00856492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65207428|NCT00856492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65207429|NCT00856492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207430|NCT00856492|Tubulin Modulators|tubulin modulators|mesh-ancestor
65207431|NCT00856492|Antimitotic Agents|antimitotic agents|mesh-ancestor
65207432|NCT00856492|Mitosis Modulators|mitosis modulators|mesh-ancestor
65207433|NCT00856492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207434|NCT00856492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65207435|NCT00856492|Immunologic Factors|immunologic factors|mesh-ancestor
65207436|NCT00856492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207437|NCT00856492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65207438|NCT00856492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65207439|NCT00856492|Alkylating Agents|alkylating agents|mesh-ancestor
65207440|NCT00856492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65207441|NCT00856492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65207442|NCT00856492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65207443|NCT00856492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65207444|NCT00856492|Growth Substances|growth substances|mesh-ancestor
65207449|NCT00856492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207450|NCT04111159|Propofol|propofol|mesh-list
65331497|NCT02592122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65331498|NCT02592122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331499|NCT02592122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65331500|NCT02592122|Respiratory System Agents|respiratory system agents|mesh-ancestor
65331501|NCT02592122|Tocolytic Agents|tocolytic agents|mesh-ancestor
65331502|NCT02592122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65331503|NCT02592122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65331504|NCT02592122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65331505|NCT02592122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65331506|NCT02592122|Adrenergic Agents|adrenergic agents|mesh-ancestor
65331507|NCT02592122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64717509|NCT03109418|Anesthetics|anesthetics|mesh-ancestor
65207451|NCT04111159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65207452|NCT04111159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65207453|NCT04111159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207454|NCT04111159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65207455|NCT04111159|Anesthetics, General|anesthetics, general|mesh-ancestor
65207456|NCT04111159|Anesthetics|anesthetics|mesh-ancestor
65207457|NCT00697372|Sirolimus|sirolimus|mesh-list
65207458|NCT00697372|Everolimus|everolimus|mesh-list
65207459|NCT00697372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207460|NCT00697372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65207461|NCT00697372|Immunologic Factors|immunologic factors|mesh-ancestor
65207462|NCT00697372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207463|NCT00697372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65207464|NCT00697372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65207465|NCT00697372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65207466|NCT00697372|Antifungal Agents|antifungal agents|mesh-ancestor
65207467|NCT04111003|Anesthetics|anesthetics|mesh-list
65207468|NCT04111003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65207469|NCT04111003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207470|NCT05673577|Cetuximab|cetuximab|mesh-list
65207471|NCT05673577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65207472|NCT05673577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207473|NCT00856180|Cyclophosphamide|cyclophosphamide|mesh-list
65207474|NCT00856180|Bevacizumab|bevacizumab|mesh-list
65207475|NCT00856180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65207476|NCT00856180|Immunologic Factors|immunologic factors|mesh-ancestor
65207477|NCT00856180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207478|NCT00856180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65207479|NCT00856180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65207480|NCT00856180|Alkylating Agents|alkylating agents|mesh-ancestor
65207481|NCT00856180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207482|NCT00856180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207483|NCT00856180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65207484|NCT00856180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65207485|NCT00856180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65207486|NCT00856180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65207487|NCT00856180|Growth Substances|growth substances|mesh-ancestor
65207488|NCT00856180|Growth Inhibitors|growth inhibitors|mesh-ancestor
65207489|NCT02605213|Vancomycin|vancomycin|mesh-list
65207490|NCT02605213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65207491|NCT02605213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65207492|NCT00900627|Paclitaxel|paclitaxel|mesh-list
65207493|NCT00900627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65207494|NCT00900627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207495|NCT00900627|Tubulin Modulators|tubulin modulators|mesh-ancestor
65207496|NCT00900627|Antimitotic Agents|antimitotic agents|mesh-ancestor
65207497|NCT00900627|Mitosis Modulators|mitosis modulators|mesh-ancestor
65207498|NCT00900627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207499|NCT00866320|Sorafenib|sorafenib|mesh-list
65207500|NCT00866320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207501|NCT00866320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65331508|NCT02592122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331509|NCT00923637|Oxaliplatin|oxaliplatin|mesh-list
65331510|NCT00923637|Pemetrexed|pemetrexed|mesh-list
65331511|NCT00923637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331512|NCT00923637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331513|NCT00923637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331514|NCT00923637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65331515|NCT00923637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65207502|NCT00866320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207503|NCT00866320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207504|NCT04115449|Dexmedetomidine|dexmedetomidine|mesh-list
65207505|NCT04115449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65207506|NCT04115449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65207507|NCT04115449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207508|NCT04115449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65207509|NCT04115449|Analgesics|analgesics|mesh-ancestor
65207510|NCT04115449|Sensory System Agents|sensory system agents|mesh-ancestor
65207511|NCT04115449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65207512|NCT04115449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65207513|NCT04115449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65207514|NCT04115449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65207515|NCT04115449|Adrenergic Agents|adrenergic agents|mesh-ancestor
65207523|NCT04133974|Analgesics|analgesics|mesh-ancestor
65207524|NCT04133974|Sensory System Agents|sensory system agents|mesh-ancestor
65207525|NCT04133974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65207526|NCT04133974|Antitussive Agents|antitussive agents|mesh-ancestor
65207527|NCT04133974|Respiratory System Agents|respiratory system agents|mesh-ancestor
65207528|NCT03679611|Neostigmine|neostigmine|mesh-list
65207529|NCT03679611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65207530|NCT03679611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207531|NCT03679611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207532|NCT03679611|Cholinergic Agents|cholinergic agents|mesh-ancestor
65207533|NCT03679611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65207534|NCT03679611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207535|NCT03679611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65207536|NCT03679611|Autonomic Agents|autonomic agents|mesh-ancestor
65207537|NCT03679611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65207538|NCT00914953|Oxytocin|oxytocin|mesh-list
65207539|NCT00914953|Oxytocics|oxytocics|mesh-ancestor
65207540|NCT00914953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65207541|NCT00914953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207542|NCT00869518|Trimethoprim|trimethoprim|mesh-list
65207543|NCT00869518|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65207544|NCT00869518|Sulfamethoxazole|sulfamethoxazole|mesh-list
65207545|NCT00869518|Rifabutin|rifabutin|mesh-list
65207546|NCT00869518|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65207547|NCT00869518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65207548|NCT00869518|Renal Agents|renal agents|mesh-ancestor
65207549|NCT00869518|Antimalarials|antimalarials|mesh-ancestor
65207550|NCT00869518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65207551|NCT00869518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65207552|NCT00869518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65207553|NCT00869518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207554|NCT00869518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207555|NCT00869518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65207556|NCT00869518|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65207557|NCT00869518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65207558|NCT00869518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65207559|NCT00869518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65207560|NCT00869518|Antitubercular Agents|antitubercular agents|mesh-ancestor
65207561|NCT00834093|Vaccines|vaccines|mesh-list
65207562|NCT00834093|Immunologic Factors|immunologic factors|mesh-ancestor
65207563|NCT00834093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207564|NCT00869440|Midazolam|midazolam|mesh-list
65207565|NCT00869440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65331516|NCT00717314|Mycophenolic Acid|mycophenolic acid|mesh-list
65331517|NCT00717314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65331518|NCT00717314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331519|NCT00717314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65331520|NCT00717314|Antitubercular Agents|antitubercular agents|mesh-ancestor
65331521|NCT00717314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65331522|NCT00717314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65207566|NCT00869440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65207567|NCT00869440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65207568|NCT00869440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207569|NCT00869440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65207570|NCT00869440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65207571|NCT00869440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65207572|NCT00869440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65207573|NCT00869440|Anesthetics, General|anesthetics, general|mesh-ancestor
65207574|NCT00869440|Anesthetics|anesthetics|mesh-ancestor
64850229|NCT00812669|Rituximab|rituximab|mesh-list
65207575|NCT00869440|GABA Modulators|gaba modulators|mesh-ancestor
65207576|NCT00869440|GABA Agents|gaba agents|mesh-ancestor
65207577|NCT00869440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65207578|NCT00869440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207579|NCT00895947|Interferons|interferons|mesh-list
65207580|NCT00895947|Interferon-alpha|interferon-alpha|mesh-list
65207581|NCT00895947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207582|NCT00895947|Antiviral Agents|antiviral agents|mesh-ancestor
65207583|NCT00895947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65207584|NCT00895947|Immunologic Factors|immunologic factors|mesh-ancestor
65207585|NCT00895947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207586|NCT02604823|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65207588|NCT02604823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65207589|NCT02841579|Osimertinib|osimertinib|mesh-list
65207590|NCT02841579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207591|NCT02841579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65207592|NCT02841579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207593|NCT02841579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207594|NCT00588445|Gefitinib|gefitinib|mesh-list
65207595|NCT00588445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207596|NCT00588445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65207597|NCT00588445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207598|NCT00588445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207599|NCT00092781|Celecoxib|celecoxib|mesh-list
65207600|NCT00092781|Etoricoxib|etoricoxib|mesh-list
65207601|NCT00092781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65207602|NCT00092781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65207603|NCT00092781|Analgesics|analgesics|mesh-ancestor
65207604|NCT00092781|Sensory System Agents|sensory system agents|mesh-ancestor
65207605|NCT00092781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65207606|NCT00092781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207607|NCT00092781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65207608|NCT00092781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65207609|NCT00092781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65207610|NCT00092781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65207611|NCT00092781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207612|NCT00092781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207613|NCT00092703|Diclofenac|diclofenac|mesh-list
65207614|NCT00092703|Etoricoxib|etoricoxib|mesh-list
65207615|NCT00092703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65207616|NCT00092703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65207617|NCT00092703|Analgesics|analgesics|mesh-ancestor
65207618|NCT00092703|Sensory System Agents|sensory system agents|mesh-ancestor
65207619|NCT00092703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65207620|NCT00092703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207621|NCT00092703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65207622|NCT00092703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65207623|NCT00092703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65207624|NCT00092703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207625|NCT00092703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207626|NCT00092703|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65331523|NCT00717314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331524|NCT00717314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331525|NCT01090089|Dexamethasone|dexamethasone|mesh-list
65331526|NCT01090089|Dexamethasone acetate|dexamethasone acetate|mesh-list
65331527|NCT01090089|Lenalidomide|lenalidomide|mesh-list
65331528|NCT01090089|BB 1101|bb 1101|mesh-list
65331529|NCT01090089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65331530|NCT01090089|Antiemetics|antiemetics|mesh-ancestor
65331531|NCT01090089|Autonomic Agents|autonomic agents|mesh-ancestor
65331532|NCT01090089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717532|NCT02973620|Simendan|simendan|mesh-list
65207627|NCT00699946|Olanzapine|olanzapine|mesh-list
65207628|NCT00699946|Antiemetics|antiemetics|mesh-ancestor
65207629|NCT00699946|Autonomic Agents|autonomic agents|mesh-ancestor
65207630|NCT00699946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65207631|NCT00699946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207632|NCT00699946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65207633|NCT00699946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65207634|NCT00699946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65207635|NCT00699946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65207636|NCT00699946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65207637|NCT00699946|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65207638|NCT00699946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65207639|NCT00699946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65207640|NCT00699946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207641|NCT00699946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65207642|NCT00699946|Serotonin Agents|serotonin agents|mesh-ancestor
65207643|NCT00796315|Doxylamine|doxylamine|mesh-list
65207644|NCT00796315|Doxylamine succinate|doxylamine succinate|mesh-list
65207645|NCT00796315|Antiemetics|antiemetics|mesh-ancestor
65207646|NCT00796315|Autonomic Agents|autonomic agents|mesh-ancestor
65207647|NCT00796315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65207648|NCT00796315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207649|NCT00796315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65207650|NCT00796315|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65207651|NCT00796315|Histamine Antagonists|histamine antagonists|mesh-ancestor
65207652|NCT00796315|Histamine Agents|histamine agents|mesh-ancestor
65207653|NCT00796315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65207654|NCT00796315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207655|NCT00855166|Metformin|metformin|mesh-list
65207656|NCT00855166|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65207657|NCT00855166|Dapagliflozin|dapagliflozin|mesh-list
65207658|NCT00855166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65207659|NCT00855166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207660|NCT00855166|Incretins|incretins|mesh-ancestor
65207669|NCT00854620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207670|NCT00854620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65207671|NCT00854620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207672|NCT00854620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207673|NCT00793585|Allopurinol|allopurinol|mesh-list
65207674|NCT00793585|Antimetabolites|antimetabolites|mesh-ancestor
65207675|NCT00793585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207676|NCT00793585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207677|NCT00793585|Gout Suppressants|gout suppressants|mesh-ancestor
65207678|NCT00793585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65207679|NCT00793585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65207680|NCT00793585|Antioxidants|antioxidants|mesh-ancestor
65207681|NCT00793585|Protective Agents|protective agents|mesh-ancestor
65207682|NCT00793585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207683|NCT02013141|Telavancin|telavancin|mesh-list
65207684|NCT02013141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65207685|NCT02013141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65207686|NCT04107103|Nivolumab|nivolumab|mesh-list
65207687|NCT04107103|Pemetrexed|pemetrexed|mesh-list
65207688|NCT04107103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65207689|NCT04107103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207690|NCT04107103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65331533|NCT01090089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331534|NCT01090089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65331535|NCT01090089|Glucocorticoids|glucocorticoids|mesh-ancestor
65331536|NCT01090089|Hormones|hormones|mesh-ancestor
65331537|NCT01090089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65331538|NCT01090089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65331539|NCT01090089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331540|NCT01090089|Protease Inhibitors|protease inhibitors|mesh-ancestor
65331541|NCT01090089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207691|NCT04107103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207692|NCT04107103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207693|NCT04107103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65207694|NCT04107103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65207695|NCT02617810|Midazolam|midazolam|mesh-list
65207696|NCT02617810|Warfarin|warfarin|mesh-list
65207697|NCT02617810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65207698|NCT02617810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65207699|NCT02617810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65207700|NCT02617810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207701|NCT02617810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65207702|NCT02617810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65207703|NCT02617810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65207704|NCT02617810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65207705|NCT02617810|Anesthetics, General|anesthetics, general|mesh-ancestor
65207706|NCT02617810|Anesthetics|anesthetics|mesh-ancestor
65207707|NCT02617810|GABA Modulators|gaba modulators|mesh-ancestor
65207708|NCT02617810|GABA Agents|gaba agents|mesh-ancestor
65207709|NCT02617810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65207710|NCT02617810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207711|NCT02617810|Anticoagulants|anticoagulants|mesh-ancestor
65207712|NCT00898443|Anesthetics|anesthetics|mesh-list
65207713|NCT00898443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65207714|NCT00898443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207715|NCT02614612|Prednisone|prednisone|mesh-list
65207716|NCT02614612|Methylprednisolone|methylprednisolone|mesh-list
65207717|NCT02614612|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65207718|NCT02614612|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65207719|NCT02614612|Prednisolone|prednisolone|mesh-list
65207720|NCT02614612|Prednisolone acetate|prednisolone acetate|mesh-list
65207721|NCT02614612|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65207722|NCT02614612|Prednisolone phosphate|prednisolone phosphate|mesh-list
65207723|NCT02614612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65207724|NCT02614612|Glucocorticoids|glucocorticoids|mesh-ancestor
65207725|NCT02614612|Hormones|hormones|mesh-ancestor
65207726|NCT02614612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65207727|NCT02614612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207728|NCT02614612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65207733|NCT02614612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65207734|NCT02614612|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65207735|NCT02614612|Protective Agents|protective agents|mesh-ancestor
65207736|NCT00900159|Eszopiclone|eszopiclone|mesh-list
65207737|NCT00900159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65207738|NCT00900159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65207739|NCT00900159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207740|NCT01689909|Zolpidem|zolpidem|mesh-list
65207741|NCT01689909|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65207742|NCT01689909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65207743|NCT01689909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65207744|NCT01689909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207745|NCT01689909|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65207746|NCT01689909|GABA Agonists|gaba agonists|mesh-ancestor
65207747|NCT01689909|GABA Agents|gaba agents|mesh-ancestor
65207748|NCT01689909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65207749|NCT01689909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207750|NCT00854308|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65207751|NCT00854308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494089|NCT03701763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65331542|NCT01090089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331543|NCT01090089|Immunologic Factors|immunologic factors|mesh-ancestor
65331544|NCT01090089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65331545|NCT01090089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65331546|NCT01090089|Growth Substances|growth substances|mesh-ancestor
65331547|NCT01090089|Growth Inhibitors|growth inhibitors|mesh-ancestor
65331548|NCT00689793|Iron|iron|mesh-list
65331549|NCT00689793|Trace Elements|trace elements|mesh-ancestor
65331550|NCT00689793|Micronutrients|micronutrients|mesh-ancestor
65331551|NCT00689793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331552|NCT04086290|Androgens|androgens|mesh-list
65331553|NCT04086290|Hormones|hormones|mesh-ancestor
65207752|NCT00854308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65207753|NCT00854308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207754|NCT00854308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207755|NCT00592852|Fluoxetine|fluoxetine|mesh-list
65207756|NCT00592852|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65207757|NCT00592852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65207758|NCT00592852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65207759|NCT00592852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207760|NCT00592852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65207761|NCT00592852|Serotonin Agents|serotonin agents|mesh-ancestor
65207762|NCT00592852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207763|NCT00592852|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65207764|NCT00592852|Antidepressive Agents|antidepressive agents|mesh-ancestor
65207765|NCT00592852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65207766|NCT00592852|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65207767|NCT00592852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65207768|NCT00592852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207769|NCT00895245|Dexamethasone|dexamethasone|mesh-list
65207770|NCT00895245|Palonosetron|palonosetron|mesh-list
65207771|NCT00895245|Fosaprepitant|fosaprepitant|mesh-list
65207772|NCT00895245|Aprepitant|aprepitant|mesh-list
65207773|NCT00895245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65207774|NCT00895245|Antiemetics|antiemetics|mesh-ancestor
65207775|NCT00895245|Autonomic Agents|autonomic agents|mesh-ancestor
65207776|NCT00895245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65207777|NCT00895245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207778|NCT00895245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65207779|NCT00895245|Glucocorticoids|glucocorticoids|mesh-ancestor
65207780|NCT00895245|Hormones|hormones|mesh-ancestor
65207781|NCT00895245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65207782|NCT00895245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65207783|NCT00895245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207784|NCT00895245|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65207785|NCT00895245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65207786|NCT00895245|Serotonin Agents|serotonin agents|mesh-ancestor
65207787|NCT00895245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65207788|NCT00895245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207789|NCT00895245|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65207790|NCT03172377|Adalimumab|adalimumab|mesh-list
65207791|NCT03172377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65207792|NCT03172377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65207793|NCT02617654|Liraglutide|liraglutide|mesh-list
65207794|NCT02617654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65207795|NCT02617654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207796|NCT02617654|Incretins|incretins|mesh-ancestor
65207797|NCT02617654|Hormones|hormones|mesh-ancestor
65207798|NCT02617654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65207804|NCT00700024|Androgens|androgens|mesh-ancestor
65207805|NCT00700024|Hormones|hormones|mesh-ancestor
65331554|NCT04086290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65331555|NCT04086290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331556|NCT00744393|Sodium Oxybate|sodium oxybate|mesh-list
64717560|NCT03031340|Anticonvulsants|anticonvulsants|mesh-ancestor
65207806|NCT00700024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65207807|NCT00700024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207808|NCT00700024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65207809|NCT00700024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207810|NCT00700024|Anabolic Agents|anabolic agents|mesh-ancestor
65207811|NCT00697450|Insulin Detemir|insulin detemir|mesh-list
65207812|NCT00697450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65207813|NCT00697450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207814|NCT00796003|Decitabine|decitabine|mesh-list
65207815|NCT00796003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65207816|NCT00796003|Antimetabolites|antimetabolites|mesh-ancestor
65207817|NCT00796003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207818|NCT00796003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207819|NCT00796003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207820|NCT02973789|Docetaxel|docetaxel|mesh-list
65207821|NCT02973789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65207822|NCT02973789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207823|NCT02973789|Tubulin Modulators|tubulin modulators|mesh-ancestor
65207824|NCT02973789|Antimitotic Agents|antimitotic agents|mesh-ancestor
65207825|NCT02973789|Mitosis Modulators|mitosis modulators|mesh-ancestor
65207826|NCT02973789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207827|NCT04110535|Midazolam|midazolam|mesh-list
65207828|NCT04110535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65207829|NCT04110535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65207830|NCT04110535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65207831|NCT04110535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207832|NCT04110535|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65207833|NCT04110535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65207834|NCT04110535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65207835|NCT04110535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65207836|NCT04110535|Anesthetics, General|anesthetics, general|mesh-ancestor
65207837|NCT04110535|Anesthetics|anesthetics|mesh-ancestor
65207838|NCT04110535|GABA Modulators|gaba modulators|mesh-ancestor
65207839|NCT04110535|GABA Agents|gaba agents|mesh-ancestor
65207840|NCT04110535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65207841|NCT04110535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207842|NCT04025203|Ibuprofen|ibuprofen|mesh-list
65207843|NCT04025203|Ibuprofen arginine|ibuprofen arginine|mesh-list
65207844|NCT04025203|Gabapentin|gabapentin|mesh-list
65207845|NCT04025203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65207846|NCT04025203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65207847|NCT04025203|Analgesics|analgesics|mesh-ancestor
65207848|NCT04025203|Sensory System Agents|sensory system agents|mesh-ancestor
65207849|NCT04025203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65207850|NCT04025203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207851|NCT04025203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65207852|NCT04025203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65207853|NCT04025203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65207854|NCT04025203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207855|NCT04025203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207856|NCT04025203|Anticonvulsants|anticonvulsants|mesh-ancestor
65207857|NCT04025203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65207858|NCT04025203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65207859|NCT04025203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65207860|NCT04025203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65207861|NCT04025203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65207862|NCT04025203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65207863|NCT04025203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65207864|NCT04025203|Antimanic Agents|antimanic agents|mesh-ancestor
65207865|NCT02843685|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
65207866|NCT02843685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65207867|NCT00915577|Interferons|interferons|mesh-list
65207871|NCT00915577|Antiviral Agents|antiviral agents|mesh-ancestor
65207872|NCT00915577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65207873|NCT00915577|Immunologic Factors|immunologic factors|mesh-ancestor
65207874|NCT00915577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331557|NCT00744393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65331558|NCT00744393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65331559|NCT00744393|Anesthetics, General|anesthetics, general|mesh-ancestor
65331560|NCT00744393|Anesthetics|anesthetics|mesh-ancestor
64693352|NCT03124121|Golimumab|golimumab|mesh-list
65207875|NCT00915577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65207876|NCT00899847|Acetaminophen|acetaminophen|mesh-list
65207877|NCT00899847|Diphenhydramine|diphenhydramine|mesh-list
65207879|NCT00899847|Cyclosporine|cyclosporine|mesh-list
65207880|NCT00899847|Mycophenolic Acid|mycophenolic acid|mesh-list
65207881|NCT00899847|Hydrocortisone|hydrocortisone|mesh-list
65207882|NCT00899847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65207883|NCT00899847|Cyclophosphamide|cyclophosphamide|mesh-list
65207884|NCT00899847|Melphalan|melphalan|mesh-list
65207885|NCT00899847|Mechlorethamine|mechlorethamine|mesh-list
65207886|NCT00899847|Cyclosporins|cyclosporins|mesh-list
65207887|NCT00899847|Thymoglobulin|thymoglobulin|mesh-list
65207888|NCT00899847|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65207889|NCT00899847|Lenograstim|lenograstim|mesh-list
65207890|NCT00899847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65207891|NCT00899847|Immunologic Factors|immunologic factors|mesh-ancestor
65207892|NCT00899847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207893|NCT00899847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65207894|NCT00899847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65207895|NCT00899847|Alkylating Agents|alkylating agents|mesh-ancestor
65207896|NCT00899847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207897|NCT00899847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207898|NCT00899847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65207899|NCT00899847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65207900|NCT00899847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207901|NCT00899847|Antifungal Agents|antifungal agents|mesh-ancestor
65207902|NCT00899847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65207903|NCT00899847|Dermatologic Agents|dermatologic agents|mesh-ancestor
65207904|NCT00899847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65207905|NCT00899847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65207907|NCT00899847|Sensory System Agents|sensory system agents|mesh-ancestor
65207908|NCT00899847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65207909|NCT00899847|Antipyretics|antipyretics|mesh-ancestor
65207910|NCT00899847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65207911|NCT00899847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65207912|NCT00899847|Antitubercular Agents|antitubercular agents|mesh-ancestor
65207913|NCT00899847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65207914|NCT00899847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65207915|NCT00899847|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65207916|NCT00899847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65207917|NCT00899847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65207918|NCT00899847|Anesthetics, Local|anesthetics, local|mesh-ancestor
65207919|NCT00899847|Anesthetics|anesthetics|mesh-ancestor
65207920|NCT00899847|Antiemetics|antiemetics|mesh-ancestor
65207921|NCT00899847|Autonomic Agents|autonomic agents|mesh-ancestor
65207922|NCT00899847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65207923|NCT00899847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65207924|NCT00899847|Histamine Antagonists|histamine antagonists|mesh-ancestor
65207925|NCT00899847|Histamine Agents|histamine agents|mesh-ancestor
65207926|NCT00899847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65207927|NCT00899847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65207928|NCT00899847|Antipruritics|antipruritics|mesh-ancestor
65207929|NCT00899847|Glucocorticoids|glucocorticoids|mesh-ancestor
65207930|NCT00899847|Hormones|hormones|mesh-ancestor
65207931|NCT00899847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65207932|NCT00899847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65207933|NCT00899847|Protective Agents|protective agents|mesh-ancestor
65207934|NCT00899847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65207935|NCT04106791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65207936|NCT00529113|Gemcitabine|gemcitabine|mesh-list
65207937|NCT00529113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65207938|NCT00529113|Antimetabolites|antimetabolites|mesh-ancestor
65207939|NCT00529113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207940|NCT00529113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207941|NCT00529113|Antiviral Agents|antiviral agents|mesh-ancestor
65207942|NCT00529113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65207943|NCT00529113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207944|NCT00529113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65207948|NCT04106557|Analgesics|analgesics|mesh-ancestor
65331561|NCT00744393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65331562|NCT00744393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331563|NCT02563353|Teriparatide|teriparatide|mesh-list
65331564|NCT02563353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65331565|NCT02563353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331566|NCT02563353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65331567|NCT00688701|Lixisenatide|lixisenatide|mesh-list
65207949|NCT04106557|Sensory System Agents|sensory system agents|mesh-ancestor
65207950|NCT04106557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65207951|NCT04106557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207952|NCT04106557|Anticonvulsants|anticonvulsants|mesh-ancestor
65207953|NCT04106557|GABA Agonists|gaba agonists|mesh-ancestor
65207954|NCT04106557|GABA Agents|gaba agents|mesh-ancestor
65207955|NCT04106557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65207956|NCT04106557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207957|NCT04117750|Cholecalciferol|cholecalciferol|mesh-list
65207958|NCT04117750|Vitamin D|vitamin d|mesh-list
65207959|NCT04117750|Calcium Carbonate|calcium carbonate|mesh-list
65207960|NCT04117750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65207961|NCT04117750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207962|NCT04117750|Vitamins|vitamins|mesh-ancestor
65207963|NCT04117750|Micronutrients|micronutrients|mesh-ancestor
65207964|NCT04117750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65207965|NCT04117750|Antacids|antacids|mesh-ancestor
65207966|NCT04117750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207967|NCT04117750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65207968|NCT04131322|Adalimumab|adalimumab|mesh-list
65207969|NCT04131322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65207970|NCT04131322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65207971|NCT04131322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65207972|NCT02840175|Adalimumab|adalimumab|mesh-list
65207973|NCT02840175|Etanercept|etanercept|mesh-list
65207974|NCT02840175|Abatacept|abatacept|mesh-list
65207975|NCT02840175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65207976|NCT02840175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65207977|NCT02840175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65207978|NCT02840175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65207979|NCT02840175|Analgesics|analgesics|mesh-ancestor
65207980|NCT02840175|Sensory System Agents|sensory system agents|mesh-ancestor
65207981|NCT02840175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65207982|NCT02840175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207983|NCT02840175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65207984|NCT02840175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65207985|NCT02840175|Immunologic Factors|immunologic factors|mesh-ancestor
65207986|NCT02840175|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65207987|NCT02840175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207988|NCT02840175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207989|NCT02603497|Peficitinib|peficitinib|mesh-list
65207990|NCT02603497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207991|NCT02603497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207992|NCT02603497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65207993|NCT02603497|Immunologic Factors|immunologic factors|mesh-ancestor
65207994|NCT02603497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207995|NCT02840409|Bevacizumab|bevacizumab|mesh-list
65207996|NCT02840409|Vinblastine|vinblastine|mesh-list
65207997|NCT02840409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65207998|NCT02840409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207999|NCT02840409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65208000|NCT02840409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65208001|NCT02840409|Growth Substances|growth substances|mesh-ancestor
65208002|NCT02840409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208003|NCT02840409|Growth Inhibitors|growth inhibitors|mesh-ancestor
65208004|NCT02840409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65208005|NCT02840409|Tubulin Modulators|tubulin modulators|mesh-ancestor
65208006|NCT02840409|Antimitotic Agents|antimitotic agents|mesh-ancestor
65208007|NCT02840409|Mitosis Modulators|mitosis modulators|mesh-ancestor
65208008|NCT02840409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331568|NCT00688701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65331569|NCT00688701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331570|NCT00744549|Vitamin D|vitamin d|mesh-list
65331571|NCT00744549|Cholecalciferol|cholecalciferol|mesh-list
65331572|NCT00744549|Vitamins|vitamins|mesh-list
65331573|NCT00744549|Vitamin E|vitamin e|mesh-list
65331574|NCT00744549|Selenium|selenium|mesh-list
65208009|NCT02839941|Mycophenolic Acid|mycophenolic acid|mesh-list
65208010|NCT02839941|Tacrolimus|tacrolimus|mesh-list
65208011|NCT02839941|Glucocorticoids|glucocorticoids|mesh-list
65208012|NCT02839941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65208013|NCT02839941|Immunologic Factors|immunologic factors|mesh-ancestor
65208014|NCT02839941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208015|NCT02839941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65208016|NCT02839941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208017|NCT02839941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208022|NCT02839941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65208023|NCT02839941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65208024|NCT02839941|Hormones|hormones|mesh-ancestor
65208025|NCT02839941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65208026|NCT02842983|Esmolol|esmolol|mesh-list
65208027|NCT02842983|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65208028|NCT02842983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65208030|NCT02842983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65208031|NCT02842983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208032|NCT02842983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208033|NCT02842983|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65208034|NCT02839785|Ibuprofen|ibuprofen|mesh-list
65208035|NCT02839785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65208036|NCT02839785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65208037|NCT02839785|Analgesics|analgesics|mesh-ancestor
65208038|NCT02839785|Sensory System Agents|sensory system agents|mesh-ancestor
65208039|NCT02839785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65208040|NCT02839785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208041|NCT02839785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65208042|NCT02839785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65208043|NCT02839785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65208044|NCT02839785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208045|NCT02839785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208046|NCT02843061|Rituximab|rituximab|mesh-list
65208047|NCT02843061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65208048|NCT02843061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208049|NCT02843061|Immunologic Factors|immunologic factors|mesh-ancestor
65208050|NCT02843061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208051|NCT02843061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65208052|NCT02839239|Vitamin D|vitamin d|mesh-list
65208053|NCT02839239|Ergocalciferols|ergocalciferols|mesh-list
65208054|NCT02839239|Cholecalciferol|cholecalciferol|mesh-list
65208055|NCT02839239|Vitamins|vitamins|mesh-list
65208056|NCT02839239|Micronutrients|micronutrients|mesh-ancestor
65208057|NCT02839239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208058|NCT02839239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65208059|NCT02839239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65208060|NCT02837835|Ceftazidime|ceftazidime|mesh-list
65208061|NCT02837835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65208062|NCT02837835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65208063|NCT02839161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65208064|NCT02839161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65208065|NCT02839161|Immunologic Factors|immunologic factors|mesh-ancestor
65208066|NCT02839161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208067|NCT02839161|Antacids|antacids|mesh-ancestor
65208068|NCT02839161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208069|NCT02839161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65208070|NCT04249713|Brodalumab|brodalumab|mesh-list
65208071|NCT04249713|Dermatologic Agents|dermatologic agents|mesh-ancestor
65208072|NCT00610506|Dexetimide|dexetimide|mesh-list
65208073|NCT00610506|Citalopram|citalopram|mesh-list
65208074|NCT00610506|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65208075|NCT00610506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65208076|NCT00610506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65331575|NCT00744549|Lycopene|lycopene|mesh-list
65331576|NCT00744549|Micronutrients|micronutrients|mesh-ancestor
65331577|NCT00744549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331578|NCT00744549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65331579|NCT00744549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65331580|NCT00744549|Antioxidants|antioxidants|mesh-ancestor
64717580|NCT03513757|Anesthetics, Local|anesthetics, local|mesh-ancestor
65208077|NCT00610506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208078|NCT00610506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65208079|NCT00610506|Serotonin Agents|serotonin agents|mesh-ancestor
65208080|NCT00610506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208081|NCT00610506|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65208082|NCT00610506|Antidepressive Agents|antidepressive agents|mesh-ancestor
65208083|NCT00610506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65208084|NCT00610506|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65208085|NCT00610506|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65208086|NCT00610506|Parasympatholytics|parasympatholytics|mesh-ancestor
65208087|NCT00610506|Autonomic Agents|autonomic agents|mesh-ancestor
65208088|NCT00610506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65208094|NCT04260828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65208095|NCT04260828|Analgesics|analgesics|mesh-ancestor
65208096|NCT04260828|Sensory System Agents|sensory system agents|mesh-ancestor
65208097|NCT04260828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65208098|NCT04260828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208099|NCT04260828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65208100|NCT04260828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65208101|NCT04260828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65208102|NCT04260828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65208103|NCT04260828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208104|NCT04260828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65208105|NCT04260828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65208106|NCT04260828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208107|NCT04260828|Antipyretics|antipyretics|mesh-ancestor
65208108|NCT00928746|Bromides|bromides|mesh-list
65208109|NCT00928746|Ipratropium|ipratropium|mesh-list
65208110|NCT00928746|Anticonvulsants|anticonvulsants|mesh-ancestor
65208111|NCT00928746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65208112|NCT00928746|Autonomic Agents|autonomic agents|mesh-ancestor
65208113|NCT00928746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65208114|NCT00928746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208115|NCT00928746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65208116|NCT00928746|Respiratory System Agents|respiratory system agents|mesh-ancestor
65208117|NCT00928746|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65208118|NCT00928746|Cholinergic Agents|cholinergic agents|mesh-ancestor
65208119|NCT00928746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65208120|NCT00928746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208121|NCT04468815|Esomeprazole|esomeprazole|mesh-list
65208122|NCT04468815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65208123|NCT04468815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65208124|NCT04468815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65208125|NCT04468815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208126|NCT04468815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208127|NCT00610584|Cetirizine|cetirizine|mesh-list
65208128|NCT00610584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65208129|NCT00610584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65208130|NCT00610584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65208131|NCT00610584|Histamine Antagonists|histamine antagonists|mesh-ancestor
65208132|NCT00610584|Histamine Agents|histamine agents|mesh-ancestor
65208133|NCT00610584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65208134|NCT00610584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208135|NCT00610584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208136|NCT00894543|Citalopram|citalopram|mesh-list
65208137|NCT00894543|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65208138|NCT00894543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65208139|NCT00894543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65208140|NCT00894543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331581|NCT00744549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331582|NCT00744549|Protective Agents|protective agents|mesh-ancestor
65331583|NCT00744549|Trace Elements|trace elements|mesh-ancestor
65331584|NCT00744549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65331585|NCT00744549|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65331586|NCT00744549|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65331587|NCT00744549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331588|NCT00746655|Cisplatin|cisplatin|mesh-list
65331589|NCT00746655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331590|NCT04060719|Rifampin|rifampin|mesh-list
65331591|NCT04060719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65331592|NCT04060719|Antitubercular Agents|antitubercular agents|mesh-ancestor
64325798|NCT02267239|Listerine|listerine|mesh-list
65208141|NCT00894543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65208142|NCT00894543|Serotonin Agents|serotonin agents|mesh-ancestor
65208143|NCT00894543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208144|NCT00894543|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65208145|NCT00894543|Antidepressive Agents|antidepressive agents|mesh-ancestor
65208146|NCT00894543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65208147|NCT00922272|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65208148|NCT00922272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65208149|NCT00922272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208150|NCT00922272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65208151|NCT00922272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65208152|NCT00922272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65208153|NCT00922272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208154|NCT00922272|Dopamine Agents|dopamine agents|mesh-ancestor
65208155|NCT00922272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65208156|NCT00853372|Sunitinib|sunitinib|mesh-list
65208160|NCT00853372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65208161|NCT00853372|Growth Substances|growth substances|mesh-ancestor
65208162|NCT00853372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208163|NCT00853372|Growth Inhibitors|growth inhibitors|mesh-ancestor
65208164|NCT00853372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65208165|NCT00853372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208166|NCT00853372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208167|NCT02836977|Tegafur|tegafur|mesh-list
65208168|NCT02836977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65208169|NCT02836977|Antimetabolites|antimetabolites|mesh-ancestor
65208170|NCT02836977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208171|NCT02836977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208172|NCT04988256|Cyclosporine|cyclosporine|mesh-list
65208173|NCT04988256|Prednisone|prednisone|mesh-list
65208174|NCT04988256|Methylprednisolone|methylprednisolone|mesh-list
64850830|NCT05120596|Pembrolizumab|pembrolizumab|mesh-list
65208175|NCT04988256|Cyclosporins|cyclosporins|mesh-list
65208176|NCT04988256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65208177|NCT04988256|Glucocorticoids|glucocorticoids|mesh-ancestor
65208178|NCT04988256|Hormones|hormones|mesh-ancestor
65208179|NCT04988256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65208180|NCT04988256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208181|NCT04988256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65208182|NCT04988256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208183|NCT04988256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208184|NCT04988256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208185|NCT04988256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65208186|NCT04988256|Immunologic Factors|immunologic factors|mesh-ancestor
65208187|NCT04988256|Antifungal Agents|antifungal agents|mesh-ancestor
65208188|NCT04988256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65208189|NCT04988256|Dermatologic Agents|dermatologic agents|mesh-ancestor
65208190|NCT04988256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65208192|NCT04988256|Antiemetics|antiemetics|mesh-ancestor
65331593|NCT04060719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65331594|NCT04060719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65331595|NCT04060719|Leprostatic Agents|leprostatic agents|mesh-ancestor
65331596|NCT04060719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65331597|NCT04060719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331598|NCT04060719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331599|NCT04060719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65331600|NCT04060719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65208193|NCT04988256|Autonomic Agents|autonomic agents|mesh-ancestor
65208194|NCT04988256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65208195|NCT04988256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65208196|NCT04988256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65208197|NCT04988256|Protective Agents|protective agents|mesh-ancestor
65208198|NCT00848536|Travoprost|travoprost|mesh-list
65208199|NCT00848536|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65208200|NCT00848536|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65208201|NCT00848536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65208202|NCT00922116|Epoetin Alfa|epoetin alfa|mesh-list
65208203|NCT00922116|Hematinics|hematinics|mesh-ancestor
65208204|NCT04260516|Acetylcysteine|acetylcysteine|mesh-list
65208205|NCT04260516|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65208206|NCT04260516|Antiviral Agents|antiviral agents|mesh-ancestor
65208207|NCT04260516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65208208|NCT04260516|Expectorants|expectorants|mesh-ancestor
65208209|NCT04260516|Respiratory System Agents|respiratory system agents|mesh-ancestor
65208210|NCT04260516|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65208211|NCT04260516|Antioxidants|antioxidants|mesh-ancestor
65208212|NCT04260516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208213|NCT04260516|Protective Agents|protective agents|mesh-ancestor
65208214|NCT04260516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208215|NCT04260516|Antidotes|antidotes|mesh-ancestor
65208216|NCT00921024|Ceftazidime|ceftazidime|mesh-list
65208217|NCT00921024|Ceftolozane|ceftolozane|mesh-list
65208218|NCT00921024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65208219|NCT00921024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65208220|NCT00928668|Olodaterol|olodaterol|mesh-list
65208221|NCT00928668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65208222|NCT00928668|Autonomic Agents|autonomic agents|mesh-ancestor
65208223|NCT00928668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65208224|NCT00928668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208225|NCT00928668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65208226|NCT00928668|Respiratory System Agents|respiratory system agents|mesh-ancestor
65208227|NCT00700960|Insulin Detemir|insulin detemir|mesh-list
65208228|NCT00700960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65208229|NCT00700960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208230|NCT00700492|Progesterone|progesterone|mesh-list
65208231|NCT00700492|Progestins|progestins|mesh-ancestor
65208232|NCT00700492|Hormones|hormones|mesh-ancestor
65208235|NCT00700648|Insulin Aspart|insulin aspart|mesh-list
65208236|NCT00700648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65208237|NCT00700648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208238|NCT00703300|Bortezomib|bortezomib|mesh-list
65208239|NCT00703300|Decitabine|decitabine|mesh-list
65208240|NCT00703300|Azacitidine|azacitidine|mesh-list
65208241|NCT00703300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208242|NCT00703300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65208243|NCT00703300|Antimetabolites|antimetabolites|mesh-ancestor
65208244|NCT00703300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208245|NCT00703300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208246|NCT00703378|Docetaxel|docetaxel|mesh-list
65208247|NCT00703378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208248|NCT00703378|Tubulin Modulators|tubulin modulators|mesh-ancestor
65208249|NCT00703378|Antimitotic Agents|antimitotic agents|mesh-ancestor
65208250|NCT00703378|Mitosis Modulators|mitosis modulators|mesh-ancestor
65208251|NCT00703378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208252|NCT00852202|Cariprazine|cariprazine|mesh-list
65208253|NCT00852202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65208254|NCT00852202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65208255|NCT00852202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65331601|NCT04060719|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65331602|NCT04060719|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65331603|NCT04060719|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65331604|NCT04060719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65331605|NCT00741429|Insulin|insulin|mesh-list
65331606|NCT00741429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65331607|NCT00741429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331608|NCT00741507|Ethanol|ethanol|mesh-list
65331609|NCT00741507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65331610|NCT00741507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65331611|NCT00741507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65331612|NCT00741507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331613|NCT00688623|Everolimus|everolimus|mesh-list
65331614|NCT00688623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331615|NCT00688623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65331616|NCT00688623|Immunologic Factors|immunologic factors|mesh-ancestor
65331617|NCT00688623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331618|NCT02563821|Clonidine|clonidine|mesh-list
65208256|NCT00852202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208257|NCT00852202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65208258|NCT01074008|Ritonavir|ritonavir|mesh-list
65208259|NCT01074008|Ribavirin|ribavirin|mesh-list
65208260|NCT01074008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65208261|NCT01074008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65208262|NCT01074008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65208263|NCT01074008|Protease Inhibitors|protease inhibitors|mesh-ancestor
65208264|NCT01074008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208265|NCT01074008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208266|NCT01074008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65208267|NCT01074008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65208268|NCT01074008|Antiviral Agents|antiviral agents|mesh-ancestor
65208270|NCT01074008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65208271|NCT01074008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65208272|NCT01074008|Antimetabolites|antimetabolites|mesh-ancestor
65208273|NCT02613052|Propofol|propofol|mesh-list
65208274|NCT02613052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65208275|NCT02613052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65208276|NCT02613052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208277|NCT02613052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65208278|NCT02613052|Anesthetics, General|anesthetics, general|mesh-ancestor
65208279|NCT02613052|Anesthetics|anesthetics|mesh-ancestor
65208280|NCT01073930|Bisacodyl|bisacodyl|mesh-list
65208281|NCT01073930|Picosulfate sodium|picosulfate sodium|mesh-list
65208282|NCT01073930|Cathartics|cathartics|mesh-ancestor
65208283|NCT01073930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65208284|NCT01073930|Laxatives|laxatives|mesh-ancestor
65208285|NCT01073618|Voriconazole|voriconazole|mesh-list
65208286|NCT01073618|Antifungal Agents|antifungal agents|mesh-ancestor
65208287|NCT01073618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65208288|NCT01073618|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65208289|NCT01073618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65208290|NCT01073618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208291|NCT01073618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208292|NCT01073618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65208293|NCT01073618|Hormone Antagonists|hormone antagonists|mesh-ancestor
65331619|NCT02563821|Sufentanil|sufentanil|mesh-list
65331620|NCT02563821|Levobupivacaine|levobupivacaine|mesh-list
65331621|NCT02563821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65331622|NCT02563821|Narcotics|narcotics|mesh-ancestor
65331623|NCT02563821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65331624|NCT02563821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331625|NCT02563821|Analgesics|analgesics|mesh-ancestor
65331626|NCT02563821|Sensory System Agents|sensory system agents|mesh-ancestor
65331627|NCT02563821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65331628|NCT02563821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64717612|NCT03756038|Lorazepam|lorazepam|mesh-list
65208294|NCT01073618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65208295|NCT01073618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208296|NCT01073618|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65208297|NCT00789373|Pemetrexed|pemetrexed|mesh-list
65208298|NCT00789373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208299|NCT00789373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208300|NCT00789373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208301|NCT00789373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65208302|NCT00789373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65208303|NCT00851890|Interferons|interferons|mesh-list
65208304|NCT00851890|Ribavirin|ribavirin|mesh-list
65208305|NCT00851890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208306|NCT00851890|Antiviral Agents|antiviral agents|mesh-ancestor
65208313|NCT00626288|Mesalamine|mesalamine|mesh-list
65208314|NCT00626288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65208315|NCT00626288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65208316|NCT00626288|Analgesics|analgesics|mesh-ancestor
65208317|NCT00626288|Sensory System Agents|sensory system agents|mesh-ancestor
65208318|NCT00626288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65208319|NCT00626288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208320|NCT00626288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65208321|NCT00626288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65208322|NCT00792571|Epoprostenol|epoprostenol|mesh-list
65208323|NCT00792571|Beraprost|beraprost|mesh-list
65208324|NCT00792571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65208325|NCT00792571|Vasodilator Agents|vasodilator agents|mesh-ancestor
65208326|NCT00792571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65208327|NCT00794365|Varenicline|varenicline|mesh-list
65208328|NCT00794365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65208329|NCT00794365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65208330|NCT00794365|Cholinergic Agents|cholinergic agents|mesh-ancestor
65208331|NCT00794365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65208332|NCT00794365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208333|NCT00794365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208335|NCT01067144|Lorazepam|lorazepam|mesh-list
65208336|NCT01067144|Analgesics|analgesics|mesh-ancestor
65208337|NCT01067144|Sensory System Agents|sensory system agents|mesh-ancestor
65208338|NCT01067144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65208339|NCT01067144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208340|NCT01067144|Anticonvulsants|anticonvulsants|mesh-ancestor
65208341|NCT01067144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65208342|NCT01067144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65208343|NCT01067144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65208344|NCT01067144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65208345|NCT01067144|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65208346|NCT01067144|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65208347|NCT01067144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65208348|NCT01067144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208349|NCT01067144|Antimanic Agents|antimanic agents|mesh-ancestor
65208350|NCT01067144|Antiemetics|antiemetics|mesh-ancestor
65208351|NCT01067144|Autonomic Agents|autonomic agents|mesh-ancestor
65208352|NCT01067144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65208353|NCT01067144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65208354|NCT01067144|GABA Modulators|gaba modulators|mesh-ancestor
65331629|NCT02563821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65331630|NCT02563821|Anesthetics, General|anesthetics, general|mesh-ancestor
65331631|NCT02563821|Anesthetics|anesthetics|mesh-ancestor
65331632|NCT02563821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65331633|NCT02563821|Sympatholytics|sympatholytics|mesh-ancestor
65331634|NCT02563821|Autonomic Agents|autonomic agents|mesh-ancestor
65331635|NCT02563821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65331636|NCT02563821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65208355|NCT01067144|GABA Agents|gaba agents|mesh-ancestor
65208356|NCT01078298|Varenicline|varenicline|mesh-list
65208357|NCT01078298|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65208358|NCT01078298|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65208359|NCT01078298|Cholinergic Agents|cholinergic agents|mesh-ancestor
65208360|NCT01078298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65208361|NCT01078298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208362|NCT01078298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208363|NCT00788593|Pancreatin|pancreatin|mesh-list
65208364|NCT00788593|Pancrelipase|pancrelipase|mesh-list
65208365|NCT00788593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65208366|NCT04106011|Gabapentin|gabapentin|mesh-list
65208367|NCT04106011|Analgesics|analgesics|mesh-ancestor
65208368|NCT04106011|Sensory System Agents|sensory system agents|mesh-ancestor
65208369|NCT04106011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65208370|NCT04106011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208371|NCT04106011|Anticonvulsants|anticonvulsants|mesh-ancestor
65208372|NCT04106011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65208373|NCT04106011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65208374|NCT04106011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65208375|NCT04106011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65208376|NCT04106011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65208377|NCT04106011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65208402|NCT00793819|Urological Agents|urological agents|mesh-ancestor
65208403|NCT04109833|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65208404|NCT04109833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65208405|NCT02836665|Dermatologic Agents|dermatologic agents|mesh-list
65208407|NCT02836821|Apatinib|apatinib|mesh-list
65208408|NCT02836821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208409|NCT02836821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65208410|NCT02836821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208411|NCT02836821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208412|NCT02836821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65208413|NCT02836821|Antitubercular Agents|antitubercular agents|mesh-ancestor
65208414|NCT02836821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65208415|NCT02836821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65208416|NCT02836821|Leprostatic Agents|leprostatic agents|mesh-ancestor
65208417|NCT02836821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65208418|NCT02836821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65208419|NCT02836821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65208420|NCT02836821|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65208421|NCT02836821|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65208422|NCT02836821|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65208427|NCT02836743|Protective Agents|protective agents|mesh-ancestor
65208428|NCT02836743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208429|NCT02836743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65208430|NCT04255368|Choline|choline|mesh-list
65208431|NCT04255368|Lipotropic Agents|lipotropic agents|mesh-ancestor
65208432|NCT04255368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65208433|NCT04255368|Antimetabolites|antimetabolites|mesh-ancestor
65208434|NCT04255368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208435|NCT04255368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65208436|NCT04255368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65208437|NCT04255368|Nootropic Agents|nootropic agents|mesh-ancestor
65208438|NCT00610818|Mitogens|mitogens|mesh-list
65208439|NCT00610818|Mitosis Modulators|mitosis modulators|mesh-ancestor
65208440|NCT00610818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208441|NCT00787891|Rabeprazole|rabeprazole|mesh-list
65208442|NCT00787891|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65331637|NCT02563821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65331638|NCT02563821|Adrenergic Agents|adrenergic agents|mesh-ancestor
65331639|NCT02563821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65331640|NCT02563821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694028|NCT02392208|Telavancin|telavancin|mesh-list
65208443|NCT00787891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65208444|NCT00787891|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65208445|NCT00787891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208446|NCT00787891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208447|NCT00892437|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65208448|NCT00892437|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65208449|NCT00892437|Cobicistat|cobicistat|mesh-list
65208450|NCT00892437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65208451|NCT00892437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65208452|NCT00892437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208453|NCT00892437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208454|NCT00892437|Antiviral Agents|antiviral agents|mesh-ancestor
65208455|NCT00892437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65208456|NCT00892437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65208457|NCT00892437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65208458|NCT00892437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65208459|NCT00892437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65208460|NCT00892437|Protease Inhibitors|protease inhibitors|mesh-ancestor
65208461|NCT00892437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65208462|NCT00892437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65208463|NCT02838537|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
65208464|NCT02838537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65208465|NCT02838537|Serotonin Agents|serotonin agents|mesh-ancestor
65208466|NCT02838537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65208467|NCT02838537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208468|NCT02838537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208469|NCT02836509|Acetaminophen|acetaminophen|mesh-list
65208470|NCT02836509|Ibuprofen|ibuprofen|mesh-list
65208471|NCT02836509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65208472|NCT02836509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65208473|NCT02836509|Analgesics|analgesics|mesh-ancestor
65208474|NCT02836509|Sensory System Agents|sensory system agents|mesh-ancestor
65208475|NCT02836509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65208476|NCT02836509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208477|NCT02836509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65208479|NCT02836509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65208480|NCT02836509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208481|NCT02836509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208482|NCT02836509|Antipyretics|antipyretics|mesh-ancestor
65208483|NCT05306379|Simvastatin|simvastatin|mesh-list
65208484|NCT05306379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65208485|NCT05306379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65208486|NCT05306379|Antimetabolites|antimetabolites|mesh-ancestor
65208487|NCT05306379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208488|NCT05306379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65208489|NCT05306379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65208490|NCT05306379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208491|NCT05304663|Lomustine|lomustine|mesh-list
65208492|NCT05304663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64324424|NCT01499563|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65208499|NCT04248309|Progesterone|progesterone|mesh-list
65208500|NCT04248309|Progestins|progestins|mesh-ancestor
65208501|NCT04248309|Hormones|hormones|mesh-ancestor
65208502|NCT04248309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65208503|NCT04248309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208504|NCT00892281|Doxycycline|doxycycline|mesh-list
65208505|NCT00892281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65208506|NCT00892281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65208507|NCT00892281|Antimalarials|antimalarials|mesh-ancestor
65208508|NCT00892281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65208509|NCT00892281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65208510|NCT02836353|Rifaximin|rifaximin|mesh-list
65208511|NCT02836353|Somatostatin|somatostatin|mesh-list
65331641|NCT02563821|Anesthetics, Local|anesthetics, local|mesh-ancestor
65331642|NCT00717236|Certolizumab Pegol|certolizumab pegol|mesh-list
65331643|NCT00717236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65331644|NCT00717236|Immunologic Factors|immunologic factors|mesh-ancestor
65331645|NCT00717236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331646|NCT00717236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65331647|NCT04085354|Vitamins|vitamins|mesh-list
65331648|NCT04085354|Folic Acid|folic acid|mesh-list
65331649|NCT04085354|Vitamin B 12|vitamin b 12|mesh-list
65331650|NCT04085354|Hydroxocobalamin|hydroxocobalamin|mesh-list
65331651|NCT04085354|Micronutrients|micronutrients|mesh-ancestor
65331652|NCT04085354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331653|NCT04085354|Hematinics|hematinics|mesh-ancestor
65331654|NCT04085354|Vitamin B Complex|vitamin b complex|mesh-ancestor
65331655|NCT00719810|Tigecycline|tigecycline|mesh-list
65331656|NCT00719810|Fluoroquinolones|fluoroquinolones|mesh-list
65331657|NCT00719810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65331658|NCT00719810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65331659|NCT00719810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65208512|NCT02836353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65208513|NCT02836353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65208514|NCT02836353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65208515|NCT02836353|Hormones|hormones|mesh-ancestor
65208516|NCT02836353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65208517|NCT02836353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208518|NCT02836431|Dexmedetomidine|dexmedetomidine|mesh-list
65208519|NCT02836431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65208520|NCT02836431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65208521|NCT02836431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208522|NCT02836431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65208523|NCT02836431|Analgesics|analgesics|mesh-ancestor
65208524|NCT02836431|Sensory System Agents|sensory system agents|mesh-ancestor
65208525|NCT02836431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65208526|NCT02836431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65208527|NCT02836431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65208528|NCT02836431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65208529|NCT02836431|Adrenergic Agents|adrenergic agents|mesh-ancestor
65208530|NCT02836431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65208531|NCT02836431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208532|NCT05326425|Lazertinib|lazertinib|mesh-list
65208533|NCT05326425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65208534|NCT05326425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208535|NCT05326425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208536|NCT00784693|Tanezumab|tanezumab|mesh-list
65208537|NCT00784693|Analgesics|analgesics|mesh-ancestor
65208538|NCT00784693|Sensory System Agents|sensory system agents|mesh-ancestor
65208539|NCT00784693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65208540|NCT00784693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208541|NCT00915811|Fludarabine|fludarabine|mesh-list
65208542|NCT00915811|Busulfan|busulfan|mesh-list
65208543|NCT00915811|Thymoglobulin|thymoglobulin|mesh-list
65208544|NCT00915811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65208545|NCT00915811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208546|NCT00915811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208547|NCT00915811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65208548|NCT00915811|Immunologic Factors|immunologic factors|mesh-ancestor
64851207|NCT03012815|Antimanic Agents|antimanic agents|mesh-ancestor
65208549|NCT00915811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208550|NCT00915811|Alkylating Agents|alkylating agents|mesh-ancestor
65331660|NCT00719810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331661|NCT00719810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331662|NCT00719810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65331663|NCT00723710|Interferons|interferons|mesh-list
65331664|NCT00723710|Interferon-alpha|interferon-alpha|mesh-list
65331665|NCT00723710|Interferon alpha-2|interferon alpha-2|mesh-list
65331666|NCT00723710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331667|NCT00723710|Antiviral Agents|antiviral agents|mesh-ancestor
64694133|NCT04873895|Axitinib|axitinib|mesh-list
65208551|NCT00915811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65208552|NCT00915811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65208553|NCT00892047|Aripiprazole|aripiprazole|mesh-list
65208554|NCT00892047|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65208555|NCT00892047|Antidepressive Agents|antidepressive agents|mesh-ancestor
65208556|NCT00892047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65208557|NCT00892047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65208558|NCT00892047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65208559|NCT00892047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65208560|NCT00892047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208561|NCT00892047|Dopamine Agonists|dopamine agonists|mesh-ancestor
65208562|NCT00892047|Dopamine Agents|dopamine agents|mesh-ancestor
65208565|NCT00892047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65208566|NCT00892047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65208568|NCT00892047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65208569|NCT00892047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65208570|NCT00892047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65208571|NCT00892047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65208572|NCT00892047|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65208573|NCT00892047|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65208574|NCT00892047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65208575|NCT00892047|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65208576|NCT02835729|Cytarabine|cytarabine|mesh-list
65208577|NCT02835729|Idarubicin|idarubicin|mesh-list
65208578|NCT02835729|Tryptophan|tryptophan|mesh-list
65208579|NCT02835729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65208580|NCT02835729|Antimetabolites|antimetabolites|mesh-ancestor
65208581|NCT02835729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208582|NCT02835729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208583|NCT02835729|Antiviral Agents|antiviral agents|mesh-ancestor
65208584|NCT02835729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65208585|NCT02835729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65208586|NCT02835729|Immunologic Factors|immunologic factors|mesh-ancestor
65208587|NCT02835729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208588|NCT02835729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65208589|NCT02835729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65208590|NCT02835729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65208591|NCT02835729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208592|NCT02835729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65208593|NCT02835729|Antidepressive Agents|antidepressive agents|mesh-ancestor
65208594|NCT02835729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65208595|NCT02835651|Palmitic Acid|palmitic acid|mesh-list
65208596|NCT02835651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208597|NCT02835651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208598|NCT00787267|Dasatinib|dasatinib|mesh-list
65208599|NCT00787267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208600|NCT00787267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65208601|NCT00787267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208602|NCT00787267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208603|NCT02838615|Dexamethasone|dexamethasone|mesh-list
65208604|NCT02838615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65208605|NCT02838615|Antiemetics|antiemetics|mesh-ancestor
65208606|NCT02838615|Autonomic Agents|autonomic agents|mesh-ancestor
65208607|NCT02838615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65208608|NCT02838615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208609|NCT02838615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65331668|NCT00723710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65331669|NCT00723710|Immunologic Factors|immunologic factors|mesh-ancestor
65331670|NCT00723710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331671|NCT00688545|Celecoxib|celecoxib|mesh-list
65331672|NCT00688545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65331673|NCT00688545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65331674|NCT00688545|Analgesics|analgesics|mesh-ancestor
65331675|NCT00688545|Sensory System Agents|sensory system agents|mesh-ancestor
65331676|NCT00688545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717652|NCT02934932|Brexpiprazole|brexpiprazole|mesh-list
65208610|NCT02838615|Glucocorticoids|glucocorticoids|mesh-ancestor
65208611|NCT02838615|Hormones|hormones|mesh-ancestor
65208612|NCT02838615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65208613|NCT02838615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65208614|NCT02838615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208615|NCT02833701|Vitamins|vitamins|mesh-list
65208616|NCT02833701|Ascorbic Acid|ascorbic acid|mesh-list
65208617|NCT02833701|Bevacizumab|bevacizumab|mesh-list
65208618|NCT02833701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65208619|NCT02833701|Endothelial Growth Factors|endothelial growth factors|mesh-list
65208620|NCT02833701|Antibodies|antibodies|mesh-list
65208621|NCT02833701|Immunoglobulins|immunoglobulins|mesh-list
65208622|NCT02833701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65208624|NCT02833701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208625|NCT02833701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65208626|NCT02833701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65208627|NCT02833701|Growth Substances|growth substances|mesh-ancestor
65208628|NCT02833701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208629|NCT02833701|Growth Inhibitors|growth inhibitors|mesh-ancestor
65208630|NCT02833701|Micronutrients|micronutrients|mesh-ancestor
65208631|NCT02833701|Immunologic Factors|immunologic factors|mesh-ancestor
65208632|NCT02833701|Antioxidants|antioxidants|mesh-ancestor
65208633|NCT02833701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208634|NCT02833701|Protective Agents|protective agents|mesh-ancestor
65208637|NCT02838225|Doxorubicin|doxorubicin|mesh-list
65208638|NCT02838225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65208639|NCT02838225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65208640|NCT02838225|Immunologic Factors|immunologic factors|mesh-ancestor
65208641|NCT02838225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208642|NCT02838225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65208643|NCT02838225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65208644|NCT02838225|Alkylating Agents|alkylating agents|mesh-ancestor
65208645|NCT02838225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208646|NCT02838225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208647|NCT02838225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65208648|NCT02838225|Tubulin Modulators|tubulin modulators|mesh-ancestor
65208649|NCT02838225|Antimitotic Agents|antimitotic agents|mesh-ancestor
65208650|NCT02838225|Mitosis Modulators|mitosis modulators|mesh-ancestor
65208651|NCT02838225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65208652|NCT02838225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65208653|NCT02838225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65208654|NCT02838225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208655|NCT00928434|Leuprolide|leuprolide|mesh-list
65208656|NCT00928434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65208657|NCT00928434|Fertility Agents|fertility agents|mesh-ancestor
65208658|NCT00928434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65208659|NCT00928434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208660|NCT00928434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65208661|NCT00928434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208662|NCT04248621|Goserelin|goserelin|mesh-list
65208663|NCT04248621|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65208664|NCT04248621|Leuprolide|leuprolide|mesh-list
65208665|NCT04248621|Flutamide|flutamide|mesh-list
65208666|NCT04248621|Bicalutamide|bicalutamide|mesh-list
65208667|NCT04248621|Androgens|androgens|mesh-list
65208668|NCT04248621|Androgen Antagonists|androgen antagonists|mesh-list
65208669|NCT04248621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65208670|NCT04248621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331677|NCT00688545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331678|NCT00688545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65331679|NCT00688545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65331680|NCT00688545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65331681|NCT00688545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65331682|NCT00688545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331683|NCT00688545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331684|NCT04060407|Nivolumab|nivolumab|mesh-list
65208671|NCT04248621|Hormones|hormones|mesh-ancestor
65208672|NCT04248621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65208673|NCT04248621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208674|NCT04248621|Hormone Antagonists|hormone antagonists|mesh-ancestor
65208675|NCT04248621|Luteolytic Agents|luteolytic agents|mesh-ancestor
65208676|NCT04248621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65208677|NCT04248621|Contraceptive Agents|contraceptive agents|mesh-ancestor
65208678|NCT04248621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65208679|NCT04248621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65208680|NCT04248621|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65208681|NCT04248621|Fertility Agents|fertility agents|mesh-ancestor
65208682|NCT00784459|Abatacept|abatacept|mesh-list
65208683|NCT00784459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65208684|NCT00784459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208685|NCT00784459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208686|NCT00784459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65208687|NCT00784459|Immunologic Factors|immunologic factors|mesh-ancestor
65208688|NCT00784459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208689|NCT00784459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65208690|NCT04255134|Adalimumab|adalimumab|mesh-list
65208691|NCT04255134|Abatacept|abatacept|mesh-list
65208692|NCT04255134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65208693|NCT04255134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65208694|NCT04255134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65208695|NCT04255134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208696|NCT04255134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208697|NCT04255134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65208698|NCT04255134|Immunologic Factors|immunologic factors|mesh-ancestor
65208699|NCT04255134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208701|NCT02835183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65208702|NCT02835183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208703|NCT02602483|Ascorbic Acid|ascorbic acid|mesh-list
65208704|NCT02602483|Ibuprofen|ibuprofen|mesh-list
65208705|NCT02602483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65208706|NCT02602483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65208707|NCT02602483|Analgesics|analgesics|mesh-ancestor
65208708|NCT02602483|Sensory System Agents|sensory system agents|mesh-ancestor
65208709|NCT02602483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65208710|NCT02602483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208713|NCT02602483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65208714|NCT02602483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208715|NCT02602483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208716|NCT02602483|Antioxidants|antioxidants|mesh-ancestor
65208717|NCT02602483|Protective Agents|protective agents|mesh-ancestor
65208718|NCT02602483|Vitamins|vitamins|mesh-ancestor
65208719|NCT02602483|Micronutrients|micronutrients|mesh-ancestor
65208720|NCT00784147|Ibalizumab|ibalizumab|mesh-list
65208721|NCT00784147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65208722|NCT00784147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65208723|NCT00784147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65208724|NCT00784147|Antiviral Agents|antiviral agents|mesh-ancestor
65208725|NCT00784147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65208726|NCT00784147|Immunologic Factors|immunologic factors|mesh-ancestor
65208727|NCT00784147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208728|NCT04260360|Docetaxel|docetaxel|mesh-list
65208729|NCT04260360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208730|NCT04260360|Tubulin Modulators|tubulin modulators|mesh-ancestor
65208731|NCT04260360|Antimitotic Agents|antimitotic agents|mesh-ancestor
65208732|NCT04260360|Mitosis Modulators|mitosis modulators|mesh-ancestor
65331685|NCT04060407|Ipilimumab|ipilimumab|mesh-list
65331686|NCT04060407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65331687|NCT04060407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331688|NCT04060407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65331689|NCT04060407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331690|NCT00741585|Atenolol|atenolol|mesh-list
65331691|NCT00741585|Amlodipine|amlodipine|mesh-list
65208733|NCT04260360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208734|NCT04254822|Carvedilol|carvedilol|mesh-list
65208735|NCT04254822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65208736|NCT04254822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65208737|NCT04254822|Adrenergic Agents|adrenergic agents|mesh-ancestor
65208738|NCT04254822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65208739|NCT04254822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208740|NCT04254822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208741|NCT04254822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65208742|NCT04254822|Antioxidants|antioxidants|mesh-ancestor
65208743|NCT04254822|Protective Agents|protective agents|mesh-ancestor
65208744|NCT04254822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65208745|NCT04254822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65208746|NCT04254822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65208747|NCT04254822|Vasodilator Agents|vasodilator agents|mesh-ancestor
65208748|NCT04254822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65208749|NCT04254822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65208750|NCT00891813|Ergocalciferols|ergocalciferols|mesh-list
65208751|NCT00891813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65208752|NCT00891813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208753|NCT00891813|Vitamins|vitamins|mesh-ancestor
65208754|NCT00891813|Micronutrients|micronutrients|mesh-ancestor
65208755|NCT00891813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65208756|NCT04255056|Cyclophosphamide|cyclophosphamide|mesh-list
65208757|NCT04255056|Epirubicin|epirubicin|mesh-list
65208758|NCT04255056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65208759|NCT04255056|Immunologic Factors|immunologic factors|mesh-ancestor
65208760|NCT04255056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208761|NCT04255056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65208762|NCT04255056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65208763|NCT04255056|Alkylating Agents|alkylating agents|mesh-ancestor
65208764|NCT04255056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208765|NCT04255056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208766|NCT04255056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65208767|NCT04255056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65208768|NCT04255056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65208769|NCT04255056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65208770|NCT04255056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208771|NCT00783835|Methylphenidate|methylphenidate|mesh-list
65208772|NCT00783835|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65208773|NCT00783835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208775|NCT00783835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65208776|NCT00783835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65208777|NCT00783835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208778|NCT00783835|Dopamine Agents|dopamine agents|mesh-ancestor
65208779|NCT00783835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65208780|NCT04254744|Sevoflurane|sevoflurane|mesh-list
65208781|NCT04254744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65208782|NCT04254744|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65208783|NCT04254744|Anesthetics, General|anesthetics, general|mesh-ancestor
65208784|NCT04254744|Anesthetics|anesthetics|mesh-ancestor
65208792|NCT04103905|Immunologic Factors|immunologic factors|mesh-ancestor
65208793|NCT04103905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208795|NCT02831205|Chromium|chromium|mesh-list
65208796|NCT02831205|Everolimus|everolimus|mesh-list
65208797|NCT02831205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208798|NCT02831205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65208799|NCT02831205|Immunologic Factors|immunologic factors|mesh-ancestor
65208800|NCT02831205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208801|NCT02831205|Trace Elements|trace elements|mesh-ancestor
65331692|NCT00741585|Valsartan|valsartan|mesh-list
65331693|NCT00741585|Telmisartan|telmisartan|mesh-list
65331694|NCT00741585|Carvedilol|carvedilol|mesh-list
65331695|NCT00741585|Candesartan|candesartan|mesh-list
65331696|NCT00741585|Candesartan cilexetil|candesartan cilexetil|mesh-list
65331697|NCT00741585|Ramipril|ramipril|mesh-list
65331698|NCT00741585|Olmesartan|olmesartan|mesh-list
65331699|NCT00741585|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65331700|NCT00741585|Enalapril|enalapril|mesh-list
65331701|NCT00741585|Enalaprilat|enalaprilat|mesh-list
65331702|NCT00741585|Lisinopril|lisinopril|mesh-list
65331703|NCT00741585|Irbesartan|irbesartan|mesh-list
65331704|NCT00741585|Antihypertensive Agents|antihypertensive agents|mesh-list
65331705|NCT00741585|Quinapril|quinapril|mesh-list
65331706|NCT00741585|Lercanidipine|lercanidipine|mesh-list
65331707|NCT00741585|Manidipine|manidipine|mesh-list
65331708|NCT00741585|Doxazosin|doxazosin|mesh-list
64717686|NCT02892500|Betamethasone|betamethasone|mesh-list
65208802|NCT02831205|Micronutrients|micronutrients|mesh-ancestor
65208803|NCT00783289|Benralizumab|benralizumab|mesh-list
65208804|NCT00783289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65208805|NCT00783289|Respiratory System Agents|respiratory system agents|mesh-ancestor
65208806|NCT02828163|Triamcinolone|triamcinolone|mesh-list
65208807|NCT02828163|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65208808|NCT02828163|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65208809|NCT02828163|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65208810|NCT02828163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65208811|NCT02828163|Glucocorticoids|glucocorticoids|mesh-ancestor
65208812|NCT02828163|Hormones|hormones|mesh-ancestor
65208813|NCT02828163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65208814|NCT02828163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208815|NCT02828163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65208816|NCT02828163|Immunologic Factors|immunologic factors|mesh-ancestor
65208817|NCT02828163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208818|NCT02828163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208819|NCT04107805|Midazolam|midazolam|mesh-list
65208820|NCT04107805|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65208821|NCT04107805|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65208822|NCT04107805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65208823|NCT04107805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208824|NCT04107805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65208825|NCT04107805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65208826|NCT04107805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65208827|NCT04107805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65208828|NCT04107805|Anesthetics, General|anesthetics, general|mesh-ancestor
65208829|NCT04107805|Anesthetics|anesthetics|mesh-ancestor
65208830|NCT04107805|GABA Modulators|gaba modulators|mesh-ancestor
65208831|NCT04107805|GABA Agents|gaba agents|mesh-ancestor
65208832|NCT04107805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65208833|NCT04107805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208834|NCT02833155|Exemestane|exemestane|mesh-list
65208835|NCT02833155|Entinostat|entinostat|mesh-list
65208836|NCT02833155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208837|NCT02833155|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65208838|NCT02833155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65208839|NCT02833155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208840|NCT02833155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208841|NCT02833155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65208842|NCT02833155|Hormone Antagonists|hormone antagonists|mesh-ancestor
65208843|NCT02833155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65208844|NCT02833155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208845|NCT02833155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65208846|NCT04672460|Talazoparib|talazoparib|mesh-list
65208847|NCT04672460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65208848|NCT04672460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331709|NCT00741585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65331710|NCT00741585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65331711|NCT00741585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331712|NCT00741585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65331713|NCT00741585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331714|NCT00741585|Vasodilator Agents|vasodilator agents|mesh-ancestor
65331715|NCT00741585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65331716|NCT00741585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65331717|NCT00741585|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65331718|NCT00741585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65331719|NCT00741585|Adrenergic Agents|adrenergic agents|mesh-ancestor
65331720|NCT00741585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65331721|NCT00741585|Antioxidants|antioxidants|mesh-ancestor
65331722|NCT00741585|Protective Agents|protective agents|mesh-ancestor
65331723|NCT00741585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65331724|NCT00741585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65331725|NCT00741585|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65208849|NCT04672460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208850|NCT04672460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208852|NCT00847912|Antimetabolites|antimetabolites|mesh-ancestor
65208853|NCT00847912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208854|NCT00847912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65208862|NCT00850564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65208863|NCT00850564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208864|NCT00850564|Growth Substances|growth substances|mesh-ancestor
65208865|NCT00837148|Sorafenib|sorafenib|mesh-list
65208866|NCT00837148|Dacarbazine|dacarbazine|mesh-list
65208867|NCT00837148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208868|NCT00837148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65208870|NCT00837148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208871|NCT00837148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65208872|NCT00837148|Alkylating Agents|alkylating agents|mesh-ancestor
65208873|NCT00703690|Fenofibrate|fenofibrate|mesh-list
65208874|NCT00703690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65208875|NCT00703690|Antimetabolites|antimetabolites|mesh-ancestor
65208876|NCT00703690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208877|NCT00703690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65208878|NCT05297968|Oseltamivir|oseltamivir|mesh-list
65208879|NCT05297968|Antiviral Agents|antiviral agents|mesh-ancestor
65208880|NCT05297968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65208881|NCT05297968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208882|NCT05297968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208883|NCT02613130|Fluorides|fluorides|mesh-list
65208884|NCT02613130|Tin Fluorides|tin fluorides|mesh-list
65208885|NCT02613130|Cariostatic Agents|cariostatic agents|mesh-ancestor
65208886|NCT02613130|Protective Agents|protective agents|mesh-ancestor
65208887|NCT02613130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208888|NCT00849472|Paclitaxel|paclitaxel|mesh-list
65208889|NCT00849472|Cyclophosphamide|cyclophosphamide|mesh-list
65208890|NCT00849472|Doxorubicin|doxorubicin|mesh-list
65208891|NCT00849472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65208892|NCT00849472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208893|NCT00849472|Tubulin Modulators|tubulin modulators|mesh-ancestor
65331726|NCT00741585|Protease Inhibitors|protease inhibitors|mesh-ancestor
65331727|NCT00741585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331728|NCT00741585|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65331729|NCT00741585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65331730|NCT00741585|Sympatholytics|sympatholytics|mesh-ancestor
65331731|NCT00741585|Autonomic Agents|autonomic agents|mesh-ancestor
65331732|NCT00741585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65331733|NCT00741585|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65331734|NCT00746967|Sildenafil Citrate|sildenafil citrate|mesh-list
65331735|NCT00746967|Vasodilator Agents|vasodilator agents|mesh-ancestor
65331736|NCT00746967|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65331737|NCT00746967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65331738|NCT00746967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331739|NCT00746967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331740|NCT00746967|Urological Agents|urological agents|mesh-ancestor
65331741|NCT02563041|Heparin|heparin|mesh-list
65331742|NCT02563041|Calcium heparin|calcium heparin|mesh-list
65331743|NCT02563041|Anticoagulants|anticoagulants|mesh-ancestor
65331744|NCT02563041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717693|NCT02892500|Anesthetics|anesthetics|mesh-ancestor
64717694|NCT02892500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717695|NCT02892500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717696|NCT02892500|Sensory System Agents|sensory system agents|mesh-ancestor
64717697|NCT02892500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717698|NCT02892500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64717699|NCT02892500|Glucocorticoids|glucocorticoids|mesh-ancestor
65208894|NCT00849472|Antimitotic Agents|antimitotic agents|mesh-ancestor
65208895|NCT00849472|Mitosis Modulators|mitosis modulators|mesh-ancestor
65208896|NCT00849472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208897|NCT00849472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65208898|NCT00849472|Immunologic Factors|immunologic factors|mesh-ancestor
65208899|NCT00849472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208900|NCT00849472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65208901|NCT00849472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65208902|NCT00849472|Alkylating Agents|alkylating agents|mesh-ancestor
65208903|NCT00849472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65208904|NCT00849472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65208905|NCT00849472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65208906|NCT00849472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65208907|NCT00849472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208908|NCT00782509|Olodaterol|olodaterol|mesh-list
65208909|NCT00782509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65208910|NCT00782509|Autonomic Agents|autonomic agents|mesh-ancestor
65208911|NCT00782509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65208912|NCT00782509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208913|NCT00782509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65208914|NCT00782509|Respiratory System Agents|respiratory system agents|mesh-ancestor
65331745|NCT02563041|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65331746|NCT02563041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65331747|NCT00741663|Furosemide|furosemide|mesh-list
65331748|NCT00741663|Spironolactone|spironolactone|mesh-list
65331749|NCT00741663|Diuretics|diuretics|mesh-ancestor
65331750|NCT00741663|Natriuretic Agents|natriuretic agents|mesh-ancestor
65331751|NCT00741663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208915|NCT00701428|Losartan|losartan|mesh-list
65208916|NCT00701428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65208917|NCT00701428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65208918|NCT00701428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65208919|NCT00701428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65208920|NCT00701428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208921|NCT00848926|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64851595|NCT02283281|Hormones|hormones|mesh-ancestor
64324490|NCT01482403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65208923|NCT00848926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208924|NCT00706888|Vitamin B 6|vitamin b 6|mesh-list
65208925|NCT00706888|Pyridoxal|pyridoxal|mesh-list
65208926|NCT00706888|Pyridoxine|pyridoxine|mesh-list
65208927|NCT00706888|Vitamins|vitamins|mesh-ancestor
65208928|NCT00706888|Micronutrients|micronutrients|mesh-ancestor
65208929|NCT00706888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208930|NCT00706888|Vitamin B Complex|vitamin b complex|mesh-ancestor
65208931|NCT05019534|Cetuximab|cetuximab|mesh-list
65208932|NCT05019534|Vemurafenib|vemurafenib|mesh-list
65208933|NCT05019534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65208934|NCT05019534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208935|NCT05019534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65208936|NCT05019534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208937|NCT05019534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208938|NCT04254042|Perindopril|perindopril|mesh-list
65208939|NCT04254042|Zofenopril|zofenopril|mesh-list
65208940|NCT04254042|Captopril|captopril|mesh-list
65208941|NCT04254042|Calcium|calcium|mesh-list
65208942|NCT04254042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65208943|NCT04254042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208944|NCT04254042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65208945|NCT04254042|Protease Inhibitors|protease inhibitors|mesh-ancestor
65208946|NCT04254042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208947|NCT04254042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208948|NCT04254042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65208949|NCT00918138|Metformin|metformin|mesh-list
65208950|NCT00918138|Saxagliptin|saxagliptin|mesh-list
65208951|NCT00918138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65208952|NCT00918138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208953|NCT00918138|Incretins|incretins|mesh-ancestor
65208954|NCT00918138|Hormones|hormones|mesh-ancestor
65208955|NCT00918138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65208956|NCT00918138|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65208957|NCT00918138|Protease Inhibitors|protease inhibitors|mesh-ancestor
65208958|NCT00918138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208959|NCT00918138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208960|NCT04253574|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65208961|NCT04253574|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65208962|NCT04253574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208963|NCT00782275|Sirolimus|sirolimus|mesh-list
65208964|NCT00782275|Bevacizumab|bevacizumab|mesh-list
65208965|NCT00782275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65208966|NCT00782275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208967|NCT00782275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65208968|NCT00782275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65208969|NCT00782275|Growth Substances|growth substances|mesh-ancestor
65208970|NCT00782275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208971|NCT00782275|Growth Inhibitors|growth inhibitors|mesh-ancestor
65208972|NCT00782275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65208973|NCT00782275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65208974|NCT00782275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65208975|NCT00782275|Antifungal Agents|antifungal agents|mesh-ancestor
65208976|NCT00782275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65331752|NCT00741663|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65331753|NCT00741663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65331754|NCT00741663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331755|NCT00741663|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65331756|NCT00741663|Hormone Antagonists|hormone antagonists|mesh-ancestor
64717723|NCT02734940|Lidocaine|lidocaine|mesh-list
65208977|NCT00782275|Immunologic Factors|immunologic factors|mesh-ancestor
65208978|NCT00791557|Infliximab|infliximab|mesh-list
65208979|NCT00791557|Dermatologic Agents|dermatologic agents|mesh-ancestor
65208980|NCT00791557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65208981|NCT00791557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65208982|NCT00920790|Mogamulizumab|mogamulizumab|mesh-list
65208983|NCT00920790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208984|NCT05176314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65208985|NCT05176314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65208986|NCT05176314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65208987|NCT05176314|Antimetabolites|antimetabolites|mesh-ancestor
65208988|NCT05176314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208989|NCT05176314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65208990|NCT05176314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65208991|NCT05176314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65208992|NCT00920556|Bortezomib|bortezomib|mesh-list
65208993|NCT00920556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208994|NCT00781885|Beraprost|beraprost|mesh-list
65208995|NCT00781885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65208996|NCT00781885|Vasodilator Agents|vasodilator agents|mesh-ancestor
65209000|NCT04901676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209002|NCT04901676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65209003|NCT04901676|Antiviral Agents|antiviral agents|mesh-ancestor
65209004|NCT04901676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65209005|NCT04831086|Tocolytic Agents|tocolytic agents|mesh-list
65209006|NCT04831086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65209007|NCT04831086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209008|NCT02603965|Copper|copper|mesh-list
65209009|NCT02603965|Trace Elements|trace elements|mesh-ancestor
65209010|NCT02603965|Micronutrients|micronutrients|mesh-ancestor
65209011|NCT02603965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209012|NCT00918684|Citalopram|citalopram|mesh-list
65209013|NCT00918684|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65209014|NCT00918684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65209015|NCT00918684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65209016|NCT00918684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209017|NCT00918684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65209018|NCT00918684|Serotonin Agents|serotonin agents|mesh-ancestor
65209019|NCT00918684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209020|NCT00918684|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65209021|NCT00918684|Antidepressive Agents|antidepressive agents|mesh-ancestor
65209022|NCT00918684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65209023|NCT00919854|Ritonavir|ritonavir|mesh-list
65209024|NCT00919854|Darunavir|darunavir|mesh-list
65209025|NCT00919854|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65209026|NCT00919854|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65209027|NCT00919854|Protease Inhibitors|protease inhibitors|mesh-ancestor
65209028|NCT00919854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209029|NCT00919854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209030|NCT00919854|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65209031|NCT00919854|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65209032|NCT00919854|Antiviral Agents|antiviral agents|mesh-ancestor
65209033|NCT00919854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65209034|NCT00919854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65209035|NCT00919854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65209036|NCT04669782|Teriparatide|teriparatide|mesh-list
65209037|NCT04669782|Vitamin K|vitamin k|mesh-list
65209038|NCT04669782|Vitamins|vitamins|mesh-ancestor
65209039|NCT04669782|Micronutrients|micronutrients|mesh-ancestor
65209040|NCT04669782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209041|NCT04669782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65209042|NCT04669782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65331757|NCT00741663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65331758|NCT00741663|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65331759|NCT00745017|Antidepressive Agents|antidepressive agents|mesh-list
65331760|NCT00745017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65331761|NCT00741741|Rilpivirine|rilpivirine|mesh-list
65331762|NCT00741741|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65331763|NCT00741741|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65209043|NCT04669782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209044|NCT04669782|Hemostatics|hemostatics|mesh-ancestor
65209045|NCT04669782|Coagulants|coagulants|mesh-ancestor
65209046|NCT04669782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65209047|NCT04669782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65209048|NCT04871412|Vitamin D|vitamin d|mesh-list
65209049|NCT04871412|Ergocalciferols|ergocalciferols|mesh-list
65209050|NCT04871412|Cholecalciferol|cholecalciferol|mesh-list
65209051|NCT04871412|Vitamins|vitamins|mesh-list
65209052|NCT04871412|Curcumin|curcumin|mesh-list
65209053|NCT04871412|Micronutrients|micronutrients|mesh-ancestor
65209054|NCT04871412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209055|NCT04871412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65209056|NCT04871412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65209057|NCT04871412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65209058|NCT04871412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65209059|NCT04871412|Analgesics|analgesics|mesh-ancestor
65209060|NCT04871412|Sensory System Agents|sensory system agents|mesh-ancestor
65209061|NCT04871412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65209062|NCT04871412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65209063|NCT04871412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65209064|NCT04871412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209065|NCT04871412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209066|NCT04871412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209067|NCT00891735|Ranibizumab|ranibizumab|mesh-list
65209068|NCT00891735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65209069|NCT00891735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65209070|NCT00891735|Growth Substances|growth substances|mesh-ancestor
65209075|NCT04252248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65209076|NCT04252248|Antimetabolites|antimetabolites|mesh-ancestor
65209077|NCT04252248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209078|NCT04252248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209079|NCT04252248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209081|NCT04247373|Anesthetics, Local|anesthetics, local|mesh-ancestor
65209082|NCT04247373|Anesthetics|anesthetics|mesh-ancestor
65209083|NCT04247373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65209084|NCT04247373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209085|NCT04247373|Sensory System Agents|sensory system agents|mesh-ancestor
65209086|NCT04247373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65209087|NCT02832999|Liraglutide|liraglutide|mesh-list
65209088|NCT02832999|Vildagliptin|vildagliptin|mesh-list
65209089|NCT02832999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65209090|NCT02832999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209091|NCT02832999|Incretins|incretins|mesh-ancestor
65209092|NCT02832999|Hormones|hormones|mesh-ancestor
65209093|NCT02832999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65209094|NCT02832999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65209095|NCT02832999|Protease Inhibitors|protease inhibitors|mesh-ancestor
65209096|NCT02832999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209097|NCT02832999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209098|NCT04245033|Piperaquine|piperaquine|mesh-list
65209099|NCT04245033|Artenimol|artenimol|mesh-list
65209100|NCT04245033|Antimalarials|antimalarials|mesh-ancestor
65209101|NCT04245033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65209102|NCT04245033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65209103|NCT04245033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65209104|NCT00915018|Paclitaxel|paclitaxel|mesh-list
65209105|NCT00915018|Trastuzumab|trastuzumab|mesh-list
65209106|NCT00915018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65209107|NCT00915018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65331764|NCT00741741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331765|NCT00741741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331766|NCT00741741|Antiviral Agents|antiviral agents|mesh-ancestor
65331767|NCT00741741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65331768|NCT00741741|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65331769|NCT00741741|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65331770|NCT00745173|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65209108|NCT00915018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209109|NCT00915018|Tubulin Modulators|tubulin modulators|mesh-ancestor
65209110|NCT00915018|Antimitotic Agents|antimitotic agents|mesh-ancestor
65209111|NCT00915018|Mitosis Modulators|mitosis modulators|mesh-ancestor
65209112|NCT00915018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209113|NCT00915018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65209114|NCT04246905|Sulforaphane|sulforaphane|mesh-list
65209115|NCT04246905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65209116|NCT04246905|Protective Agents|protective agents|mesh-ancestor
65209117|NCT04246905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209118|NCT04246905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209119|NCT02830347|Amoxicillin|amoxicillin|mesh-list
65209120|NCT02830347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65209121|NCT02830347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65209122|NCT00916578|Capecitabine|capecitabine|mesh-list
65209123|NCT00916578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65209124|NCT00916578|Antimetabolites|antimetabolites|mesh-ancestor
65209125|NCT00916578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209126|NCT00916578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209127|NCT04675866|Paclitaxel|paclitaxel|mesh-list
65209128|NCT04675866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65209129|NCT04675866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65209130|NCT04675866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209131|NCT04675866|Tubulin Modulators|tubulin modulators|mesh-ancestor
65209132|NCT04675866|Antimitotic Agents|antimitotic agents|mesh-ancestor
65209133|NCT04675866|Mitosis Modulators|mitosis modulators|mesh-ancestor
65209134|NCT04675866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209135|NCT02829879|Listerine|listerine|mesh-list
65209136|NCT02829879|Fluorides|fluorides|mesh-list
65209137|NCT02829879|Sodium Fluoride|sodium fluoride|mesh-list
65209138|NCT02829879|Fluorophosphate|fluorophosphate|mesh-list
65209139|NCT02829879|Cariostatic Agents|cariostatic agents|mesh-ancestor
65209140|NCT02829879|Protective Agents|protective agents|mesh-ancestor
65209141|NCT02829879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209142|NCT02829879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65209152|NCT02829957|Anticoagulants|anticoagulants|mesh-ancestor
65209153|NCT05246007|Dexmedetomidine|dexmedetomidine|mesh-list
65209154|NCT05246007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65209155|NCT05246007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65209156|NCT05246007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209157|NCT05246007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65209158|NCT05246007|Analgesics|analgesics|mesh-ancestor
65209159|NCT05246007|Sensory System Agents|sensory system agents|mesh-ancestor
65209160|NCT05246007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65209161|NCT05246007|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65209162|NCT05246007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65209163|NCT05246007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65209164|NCT05246007|Adrenergic Agents|adrenergic agents|mesh-ancestor
65209165|NCT05246007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65209166|NCT05246007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209167|NCT00914940|Fludarabine|fludarabine|mesh-list
65209168|NCT00914940|Fludarabine phosphate|fludarabine phosphate|mesh-list
65209169|NCT00914940|Thiotepa|thiotepa|mesh-list
65209170|NCT00914940|Tacrolimus|tacrolimus|mesh-list
65209171|NCT00914940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209172|NCT00914940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65209173|NCT00914940|Antimetabolites|antimetabolites|mesh-ancestor
65209174|NCT00914940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209175|NCT00914940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65209176|NCT00914940|Immunologic Factors|immunologic factors|mesh-ancestor
65209177|NCT00914940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331771|NCT00745173|Estrogens|estrogens|mesh-ancestor
65331773|NCT00745173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65331774|NCT00745173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331775|NCT04060095|Anesthetics|anesthetics|mesh-list
65331776|NCT04060095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65331777|NCT04060095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331778|NCT00741897|Fexofenadine|fexofenadine|mesh-list
65331779|NCT00741897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65331780|NCT00741897|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65331781|NCT00741897|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65331782|NCT00741897|Histamine Antagonists|histamine antagonists|mesh-ancestor
65209178|NCT00914940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65209179|NCT00914940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209180|NCT00914940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65209181|NCT00914940|Alkylating Agents|alkylating agents|mesh-ancestor
65209182|NCT00914940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65209183|NCT00835978|Axitinib|axitinib|mesh-list
65209184|NCT00835978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209185|NCT00835978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65209186|NCT00835978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209187|NCT00835978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209188|NCT01077518|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65209189|NCT01077518|Ofatumumab|ofatumumab|mesh-list
65209190|NCT01077518|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65209191|NCT01077518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65209192|NCT01077518|Alkylating Agents|alkylating agents|mesh-ancestor
65209193|NCT01077518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209194|NCT01077518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209195|NCT01077518|Immunologic Factors|immunologic factors|mesh-ancestor
65209196|NCT01077518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209197|NCT04203186|Lumefantrine|lumefantrine|mesh-list
65209198|NCT04203186|Artemether|artemether|mesh-list
65209199|NCT04203186|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65209200|NCT04203186|Atovaquone|atovaquone|mesh-list
65209201|NCT04203186|Proguanil|proguanil|mesh-list
65209202|NCT04203186|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
65209203|NCT04203186|Antimalarials|antimalarials|mesh-ancestor
65209204|NCT04203186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65209205|NCT04203186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65209206|NCT04203186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65209207|NCT04203186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209208|NCT04203186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209209|NCT04203186|Antimetabolites|antimetabolites|mesh-ancestor
65209213|NCT00914316|Ranolazine|ranolazine|mesh-list
65209214|NCT00914316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65209215|NCT00914316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65209216|NCT00914316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209217|NCT00701740|Isotretinoin|isotretinoin|mesh-list
65209218|NCT00701740|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
65209219|NCT00701740|Dermatologic Agents|dermatologic agents|mesh-ancestor
65209220|NCT00701740|Sunscreening Agents|sunscreening agents|mesh-ancestor
65209221|NCT00701740|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65209222|NCT00701740|Protective Agents|protective agents|mesh-ancestor
65209223|NCT00701740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209224|NCT04938882|Lidocaine|lidocaine|mesh-list
65209225|NCT04938882|Ropivacaine|ropivacaine|mesh-list
65209226|NCT04938882|Anesthetics, Local|anesthetics, local|mesh-ancestor
65209227|NCT04938882|Anesthetics|anesthetics|mesh-ancestor
65209228|NCT04938882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65209229|NCT04938882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209230|NCT04938882|Sensory System Agents|sensory system agents|mesh-ancestor
65209231|NCT04938882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65209232|NCT04938882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65331783|NCT00741897|Histamine Agents|histamine agents|mesh-ancestor
65331784|NCT00741897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65331785|NCT00741897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331786|NCT00741897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331787|NCT00745407|Fenofibrate|fenofibrate|mesh-list
65331788|NCT00745407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65331789|NCT00745407|Antimetabolites|antimetabolites|mesh-ancestor
65331790|NCT00745407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331791|NCT00745407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65209233|NCT04938882|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65209234|NCT04938882|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65209235|NCT04938882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65209236|NCT04938882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209237|NCT00704080|Temozolomide|temozolomide|mesh-list
64851968|NCT01150045|Leucovorin|leucovorin|mesh-list
65209238|NCT00704080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65209239|NCT00704080|Alkylating Agents|alkylating agents|mesh-ancestor
65209240|NCT00704080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209241|NCT00704080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209242|NCT05253066|Docetaxel|docetaxel|mesh-list
65209243|NCT05253066|Epirubicin|epirubicin|mesh-list
65209244|NCT05253066|Exemestane|exemestane|mesh-list
65209246|NCT05253066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209247|NCT05253066|Tubulin Modulators|tubulin modulators|mesh-ancestor
65209248|NCT05253066|Antimitotic Agents|antimitotic agents|mesh-ancestor
65209249|NCT05253066|Mitosis Modulators|mitosis modulators|mesh-ancestor
65209250|NCT05253066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209251|NCT05253066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65209252|NCT05253066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65209253|NCT05253066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65209254|NCT05253066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209255|NCT05253066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65209256|NCT05253066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65209257|NCT05253066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65209258|NCT05253066|Hormone Antagonists|hormone antagonists|mesh-ancestor
65209259|NCT05253066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65209260|NCT05253066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209261|NCT05253066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65209262|NCT04303598|Tenofovir|tenofovir|mesh-list
65209263|NCT04303598|Lamivudine|lamivudine|mesh-list
65209264|NCT04303598|Efavirenz|efavirenz|mesh-list
65209265|NCT04303598|Antiviral Agents|antiviral agents|mesh-ancestor
65209266|NCT04303598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65209267|NCT04303598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65209268|NCT04303598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65209269|NCT04303598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209270|NCT04303598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209271|NCT04303598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65209272|NCT04303598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65209273|NCT04303598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65209274|NCT04303598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65209275|NCT04303598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65209276|NCT04303598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65209277|NCT04303598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65209278|NCT04303598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65209279|NCT04607460|Coal Tar|coal tar|mesh-list
65209280|NCT04607460|Keratolytic Agents|keratolytic agents|mesh-ancestor
65209290|NCT00827242|Vasodilator Agents|vasodilator agents|mesh-ancestor
65209291|NCT00827242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65209292|NCT00827242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65209293|NCT00827242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209294|NCT00827242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209295|NCT00827242|Urological Agents|urological agents|mesh-ancestor
65209296|NCT01077362|Ustekinumab|ustekinumab|mesh-list
65331792|NCT00745485|Zoledronic Acid|zoledronic acid|mesh-list
65331793|NCT00745485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65331794|NCT00745485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331795|NCT00747279|Insulin|insulin|mesh-list
64717757|NCT00378092|Serotonin Agents|serotonin agents|mesh-ancestor
65209297|NCT01077362|Dermatologic Agents|dermatologic agents|mesh-ancestor
65209298|NCT00846586|Tiotropium Bromide|tiotropium bromide|mesh-list
65209299|NCT00846586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65209300|NCT00846586|Autonomic Agents|autonomic agents|mesh-ancestor
65209301|NCT00846586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65209302|NCT00846586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209303|NCT00846586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65209304|NCT00846586|Respiratory System Agents|respiratory system agents|mesh-ancestor
65209305|NCT00846586|Parasympatholytics|parasympatholytics|mesh-ancestor
65209306|NCT00846586|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65209307|NCT00846586|Cholinergic Agents|cholinergic agents|mesh-ancestor
65209308|NCT00846586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65209309|NCT00846586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209310|NCT00785785|Imatinib Mesylate|imatinib mesylate|mesh-list
65209311|NCT00785785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209312|NCT00785785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65209313|NCT00785785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209314|NCT00785785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209315|NCT00707278|Capecitabine|capecitabine|mesh-list
65209316|NCT00707278|Oxaliplatin|oxaliplatin|mesh-list
65209317|NCT00707278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65209318|NCT00707278|Antimetabolites|antimetabolites|mesh-ancestor
65209319|NCT00707278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209321|NCT01077284|Allopurinol|allopurinol|mesh-list
65209323|NCT01077284|Antimetabolites|antimetabolites|mesh-ancestor
65209324|NCT01077284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209325|NCT01077284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209326|NCT01077284|Gout Suppressants|gout suppressants|mesh-ancestor
65209327|NCT01077284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65209328|NCT01077284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65209329|NCT01077284|Antioxidants|antioxidants|mesh-ancestor
65209330|NCT01077284|Protective Agents|protective agents|mesh-ancestor
65209331|NCT01077284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209332|NCT00704314|Simvastatin|simvastatin|mesh-list
65209333|NCT00704314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65209334|NCT00704314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65209335|NCT00704314|Antimetabolites|antimetabolites|mesh-ancestor
65209336|NCT00704314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209337|NCT00704314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65209338|NCT00704314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65209339|NCT00704314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209341|NCT00704392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209342|NCT00704392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65209343|NCT00704392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209344|NCT00704392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209345|NCT04103125|Hyaluronic Acid|hyaluronic acid|mesh-list
65209346|NCT04103125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65209347|NCT04103125|Immunologic Factors|immunologic factors|mesh-ancestor
65209348|NCT04103125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209352|NCT00826618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65209353|NCT00826618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65209354|NCT00826618|Growth Substances|growth substances|mesh-ancestor
65209355|NCT00826618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209356|NCT00826618|Growth Inhibitors|growth inhibitors|mesh-ancestor
65209357|NCT00826618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209358|NCT02876822|Vitamin D|vitamin d|mesh-list
65209359|NCT02876822|Cholecalciferol|cholecalciferol|mesh-list
65209360|NCT02876822|Vitamins|vitamins|mesh-ancestor
65209361|NCT02876822|Micronutrients|micronutrients|mesh-ancestor
65209362|NCT02876822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209363|NCT02876822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65209364|NCT02876822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65209365|NCT00826540|Bevacizumab|bevacizumab|mesh-list
65209366|NCT00826540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65209367|NCT00826540|Sorafenib|sorafenib|mesh-list
65331796|NCT00747279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65331797|NCT00747279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331798|NCT00742287|Proanthocyanidin|proanthocyanidin|mesh-list
65331799|NCT00742287|Procyanidin|procyanidin|mesh-list
65209368|NCT00826540|Antibodies|antibodies|mesh-list
65209369|NCT00826540|Immunoglobulins|immunoglobulins|mesh-list
65209370|NCT00826540|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65209371|NCT00826540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209372|NCT00826540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65209373|NCT00826540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65209374|NCT00826540|Growth Substances|growth substances|mesh-ancestor
65209375|NCT00826540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209376|NCT00826540|Growth Inhibitors|growth inhibitors|mesh-ancestor
65209377|NCT00826540|Immunologic Factors|immunologic factors|mesh-ancestor
65209378|NCT00826540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65209379|NCT00826540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209380|NCT00826540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209381|NCT04303130|Endostar protein|endostar protein|mesh-list
65209382|NCT04303130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65209383|NCT04303130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65209384|NCT04303130|Growth Substances|growth substances|mesh-ancestor
65209385|NCT04303130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209386|NCT04303130|Growth Inhibitors|growth inhibitors|mesh-ancestor
65209387|NCT04303130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209388|NCT00626600|Oxycodone|oxycodone|mesh-list
65209389|NCT00626600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65209390|NCT00626600|Narcotics|narcotics|mesh-ancestor
64955669|NCT02966652|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65209391|NCT00626600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65209392|NCT00626600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209394|NCT00626600|Sensory System Agents|sensory system agents|mesh-ancestor
65209395|NCT00626600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65209396|NCT00707512|Natalizumab|natalizumab|mesh-list
65209397|NCT00707512|Immunologic Factors|immunologic factors|mesh-ancestor
65209398|NCT00707512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209399|NCT00704548|Simvastatin|simvastatin|mesh-list
65209400|NCT00704548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65209401|NCT00704548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65209402|NCT00704548|Antimetabolites|antimetabolites|mesh-ancestor
65209403|NCT00704548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209404|NCT00704548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65209405|NCT00704548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65209406|NCT00704548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209407|NCT00592384|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65209408|NCT00592384|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65209409|NCT00592384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65209410|NCT00592384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65209411|NCT00592384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209412|NCT00592384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65209413|NCT00592384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209414|NCT00592384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65209415|NCT00592384|Antidepressive Agents|antidepressive agents|mesh-ancestor
65209416|NCT00592384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65209417|NCT00846040|Fallypride|fallypride|mesh-list
65209418|NCT00846040|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65209419|NCT00846040|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65209420|NCT00846040|Dopamine Agents|dopamine agents|mesh-ancestor
65209425|NCT02611336|Vasodilator Agents|vasodilator agents|mesh-ancestor
65209426|NCT02611336|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65209427|NCT02611336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65209428|NCT02611336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209429|NCT02611336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209430|NCT02611336|Urological Agents|urological agents|mesh-ancestor
65209431|NCT00704704|Thalidomide|thalidomide|mesh-list
65209432|NCT00704704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65209433|NCT00704704|Immunologic Factors|immunologic factors|mesh-ancestor
65209434|NCT00704704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209435|NCT00704704|Leprostatic Agents|leprostatic agents|mesh-ancestor
65209436|NCT00704704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65209437|NCT00704704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65331800|NCT00742287|Antioxidants|antioxidants|mesh-ancestor
65331801|NCT00742287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331802|NCT00742287|Protective Agents|protective agents|mesh-ancestor
65331803|NCT00742287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331804|NCT00742287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65331805|NCT00742287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65331806|NCT00742287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65331807|NCT00747669|Lidocaine|lidocaine|mesh-list
65331808|NCT00747669|Tetracaine|tetracaine|mesh-list
65331809|NCT00747669|Anesthetics, Local|anesthetics, local|mesh-ancestor
65331810|NCT00747669|Anesthetics|anesthetics|mesh-ancestor
65331811|NCT00747669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65331812|NCT00747669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331813|NCT00747669|Sensory System Agents|sensory system agents|mesh-ancestor
65331814|NCT00747669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65331815|NCT00747669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65331816|NCT00747669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65331817|NCT00747669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65331818|NCT00747669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65331819|NCT00747669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331820|NCT00690573|Adalimumab|adalimumab|mesh-list
65331821|NCT00690573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65331822|NCT00690573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65331823|NCT00719264|Interferons|interferons|mesh-list
65331824|NCT00719264|Interferon-alpha|interferon-alpha|mesh-list
65331825|NCT00719264|Interferon alpha-2|interferon alpha-2|mesh-list
65331826|NCT00719264|Bevacizumab|bevacizumab|mesh-list
65331827|NCT00719264|Everolimus|everolimus|mesh-list
65331828|NCT00719264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65331829|NCT00719264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331830|NCT00719264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65331831|NCT00719264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65331832|NCT00719264|Growth Substances|growth substances|mesh-ancestor
65331833|NCT00719264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717781|NCT03723980|Calcium|calcium|mesh-list
65209438|NCT00704704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65209439|NCT00704704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65209440|NCT00704704|Growth Substances|growth substances|mesh-ancestor
65209441|NCT00704704|Growth Inhibitors|growth inhibitors|mesh-ancestor
65209442|NCT00704704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331834|NCT00719264|Growth Inhibitors|growth inhibitors|mesh-ancestor
65331835|NCT00719264|Antiviral Agents|antiviral agents|mesh-ancestor
65331836|NCT00719264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65331837|NCT00719264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65331838|NCT00719264|Immunologic Factors|immunologic factors|mesh-ancestor
65331839|NCT00687609|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65331840|NCT00687609|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65331841|NCT00687609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65209443|NCT00707824|Nalbuphine|nalbuphine|mesh-list
65209444|NCT00707824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65209445|NCT00707824|Narcotics|narcotics|mesh-ancestor
65209446|NCT00707824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65209447|NCT00707824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209448|NCT00707824|Analgesics|analgesics|mesh-ancestor
65209449|NCT00707824|Sensory System Agents|sensory system agents|mesh-ancestor
65209450|NCT00707824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65209451|NCT00826228|Teriparatide|teriparatide|mesh-list
65209452|NCT00826228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65209453|NCT00826228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209454|NCT00826228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65209455|NCT00791479|Dulaglutide|dulaglutide|mesh-list
65209456|NCT00791479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65209457|NCT00791479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209458|NCT00890097|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65209459|NCT00890097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65209460|NCT02831751|Vaccines|vaccines|mesh-list
65209461|NCT02831751|Immunologic Factors|immunologic factors|mesh-ancestor
64852197|NCT01694134|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65209462|NCT02831751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209463|NCT00913458|Etanercept|etanercept|mesh-list
65209464|NCT00913458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65209465|NCT00913458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65209466|NCT00913458|Analgesics|analgesics|mesh-ancestor
65209467|NCT00913458|Sensory System Agents|sensory system agents|mesh-ancestor
65209468|NCT00913458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65209469|NCT00913458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209470|NCT00913458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65209471|NCT00913458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65209472|NCT00913458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65209473|NCT00913458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65209474|NCT00913458|Immunologic Factors|immunologic factors|mesh-ancestor
65209475|NCT05208333|Albendazole|albendazole|mesh-list
65209476|NCT05208333|Anthelmintics|anthelmintics|mesh-ancestor
65209477|NCT05208333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65209478|NCT05208333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65209479|NCT05208333|Anticestodal Agents|anticestodal agents|mesh-ancestor
65209480|NCT05208333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65209481|NCT05208333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65209482|NCT05208333|Tubulin Modulators|tubulin modulators|mesh-ancestor
65209483|NCT05208333|Antimitotic Agents|antimitotic agents|mesh-ancestor
65209484|NCT05208333|Mitosis Modulators|mitosis modulators|mesh-ancestor
65209485|NCT05208333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209486|NCT05208333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209487|NCT04309773|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65209488|NCT04309773|Bezafibrate|bezafibrate|mesh-list
65209489|NCT04309773|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65209490|NCT04309773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65209494|NCT04309773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65209495|NCT02829333|Anesthetics|anesthetics|mesh-list
65209496|NCT02829333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65209497|NCT02829333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209498|NCT05251662|Bevacizumab|bevacizumab|mesh-list
65209499|NCT05251662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65209500|NCT05251662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209501|NCT05251662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65209502|NCT05251662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65209503|NCT05251662|Growth Substances|growth substances|mesh-ancestor
65209504|NCT05251662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331842|NCT00687609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65331843|NCT00687609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331844|NCT00687609|Adrenergic Agents|adrenergic agents|mesh-ancestor
65331845|NCT00687609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65331846|NCT00687609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331847|NCT00751959|Poractant alfa|poractant alfa|mesh-list
65331848|NCT00751959|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
64717813|NCT01211756|Oxytocin|oxytocin|mesh-list
65209505|NCT05251662|Growth Inhibitors|growth inhibitors|mesh-ancestor
65209506|NCT02829177|Allopurinol|allopurinol|mesh-list
65209507|NCT02829177|Antimetabolites|antimetabolites|mesh-ancestor
65209508|NCT02829177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209509|NCT02829177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209510|NCT02829177|Gout Suppressants|gout suppressants|mesh-ancestor
65209511|NCT02829177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65209512|NCT02829177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65209513|NCT02829177|Antioxidants|antioxidants|mesh-ancestor
65209514|NCT02829177|Protective Agents|protective agents|mesh-ancestor
65209515|NCT02829177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209516|NCT05112081|Botulinum Toxins|botulinum toxins|mesh-list
65209517|NCT05112081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65209518|NCT05112081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65209519|NCT05112081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65209520|NCT05112081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65209521|NCT05112081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209522|NCT05112081|Cholinergic Agents|cholinergic agents|mesh-ancestor
65209523|NCT05112081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65209524|NCT05112081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209525|NCT05112081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65209526|NCT05112081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65209527|NCT04244097|Bupivacaine|bupivacaine|mesh-list
65209528|NCT04244097|Neostigmine|neostigmine|mesh-list
65209529|NCT04244097|Anesthetics, Local|anesthetics, local|mesh-ancestor
65209530|NCT04244097|Anesthetics|anesthetics|mesh-ancestor
65209531|NCT04244097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65209532|NCT04244097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209533|NCT04244097|Sensory System Agents|sensory system agents|mesh-ancestor
65209534|NCT04244097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65209535|NCT04244097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65209536|NCT04244097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209537|NCT04244097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209538|NCT04244097|Cholinergic Agents|cholinergic agents|mesh-ancestor
65209539|NCT04244097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65209540|NCT04244097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65209541|NCT04244097|Autonomic Agents|autonomic agents|mesh-ancestor
65209542|NCT04619316|Trametinib|trametinib|mesh-list
65209543|NCT04619316|Dabrafenib|dabrafenib|mesh-list
65209544|NCT04619316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209545|NCT04619316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65209546|NCT04619316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209547|NCT04619316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209548|NCT00785629|Calcium|calcium|mesh-list
65209549|NCT00785629|Sevelamer|sevelamer|mesh-list
65209550|NCT00785629|Calcium acetate|calcium acetate|mesh-list
65209551|NCT00785629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65209552|NCT00785629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209553|NCT00785629|Chelating Agents|chelating agents|mesh-ancestor
65209554|NCT00785629|Sequestering Agents|sequestering agents|mesh-ancestor
65209555|NCT00785629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209556|NCT00915733|Aspirin|aspirin|mesh-list
65209557|NCT00915733|Cilostazol|cilostazol|mesh-list
65209558|NCT00915733|Clopidogrel|clopidogrel|mesh-list
65209559|NCT00915733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65209560|NCT00915733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65209561|NCT00915733|Analgesics|analgesics|mesh-ancestor
65209562|NCT00915733|Sensory System Agents|sensory system agents|mesh-ancestor
65209564|NCT00915733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331849|NCT00751959|Respiratory System Agents|respiratory system agents|mesh-ancestor
65331851|NCT00723554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65331852|NCT00723554|Vasodilator Agents|vasodilator agents|mesh-ancestor
65331853|NCT00687219|Ribavirin|ribavirin|mesh-list
65331854|NCT00687219|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65331855|NCT00687219|Antimetabolites|antimetabolites|mesh-ancestor
65331856|NCT00687219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331857|NCT00687219|Antiviral Agents|antiviral agents|mesh-ancestor
65331858|NCT00687219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65331859|NCT04085120|Dexamethasone|dexamethasone|mesh-list
65331860|NCT04085120|Dexamethasone acetate|dexamethasone acetate|mesh-list
65331861|NCT04085120|Lidocaine|lidocaine|mesh-list
65331862|NCT04085120|Ropivacaine|ropivacaine|mesh-list
65331863|NCT04085120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65331864|NCT04085120|Antiemetics|antiemetics|mesh-ancestor
65331865|NCT04085120|Autonomic Agents|autonomic agents|mesh-ancestor
65331866|NCT04085120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717815|NCT01211756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65209565|NCT00915733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65209566|NCT00915733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65209567|NCT00915733|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65209568|NCT00915733|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65209569|NCT00915733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209570|NCT00915733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65209571|NCT00915733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65209572|NCT00915733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209573|NCT00915733|Antipyretics|antipyretics|mesh-ancestor
65209574|NCT00915733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65209575|NCT00915733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65209576|NCT00915733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65209577|NCT00915733|Purinergic Agents|purinergic agents|mesh-ancestor
65209578|NCT00915733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65209579|NCT00915733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65209580|NCT00915733|Autonomic Agents|autonomic agents|mesh-ancestor
65209581|NCT00915733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65209582|NCT00915733|Respiratory System Agents|respiratory system agents|mesh-ancestor
65209583|NCT00915733|Vasodilator Agents|vasodilator agents|mesh-ancestor
65209584|NCT00915733|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65209585|NCT00915733|Protective Agents|protective agents|mesh-ancestor
65209586|NCT00915733|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65209587|NCT00915733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65209588|NCT00913770|Buprenorphine|buprenorphine|mesh-list
65209589|NCT00913770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65209590|NCT00913770|Narcotics|narcotics|mesh-ancestor
65209591|NCT00913770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65209592|NCT00913770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209593|NCT00913770|Analgesics|analgesics|mesh-ancestor
65209594|NCT00913770|Sensory System Agents|sensory system agents|mesh-ancestor
65209595|NCT00913770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65209596|NCT00913770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65209597|NCT00912912|Sunitinib|sunitinib|mesh-list
65209598|NCT00912912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209599|NCT00912912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65209600|NCT00912912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65209601|NCT00912912|Growth Substances|growth substances|mesh-ancestor
65209602|NCT00912912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209603|NCT00912912|Growth Inhibitors|growth inhibitors|mesh-ancestor
65209604|NCT00912912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65209605|NCT00912912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331867|NCT04085120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331868|NCT04085120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65331869|NCT04085120|Glucocorticoids|glucocorticoids|mesh-ancestor
65331870|NCT04085120|Hormones|hormones|mesh-ancestor
65331871|NCT04085120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65209606|NCT00912912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209607|NCT00913692|Glycine|glycine|mesh-list
65209608|NCT00913692|Glycine Agents|glycine agents|mesh-ancestor
65209609|NCT00913692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65209610|NCT00913692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209611|NCT00913692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209613|NCT00784927|Cyclophosphamide|cyclophosphamide|mesh-list
65209614|NCT00784927|Rituximab|rituximab|mesh-list
65209615|NCT00784927|Lenalidomide|lenalidomide|mesh-list
65209616|NCT00784927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65209617|NCT00784927|Immunologic Factors|immunologic factors|mesh-ancestor
65209618|NCT00784927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209619|NCT00784927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65209620|NCT00784927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65209621|NCT00784927|Alkylating Agents|alkylating agents|mesh-ancestor
65209622|NCT00784927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209623|NCT00784927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209624|NCT00784927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65209625|NCT00784927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65209626|NCT00784927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65209627|NCT00784927|Antiemetics|antiemetics|mesh-ancestor
65209628|NCT00784927|Autonomic Agents|autonomic agents|mesh-ancestor
65209629|NCT00784927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65209630|NCT00784927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65209631|NCT00784927|Glucocorticoids|glucocorticoids|mesh-ancestor
65209632|NCT00784927|Hormones|hormones|mesh-ancestor
65209633|NCT00784927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65209634|NCT00784927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65209635|NCT00784927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65209636|NCT00784927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65209641|NCT00637884|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65209643|NCT00637884|Histamine Antagonists|histamine antagonists|mesh-ancestor
65209644|NCT00637884|Histamine Agents|histamine agents|mesh-ancestor
65209645|NCT00637884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65209646|NCT00637884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209647|NCT00637884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209648|NCT04203342|Ketoconazole|ketoconazole|mesh-list
65209649|NCT04203342|Antifungal Agents|antifungal agents|mesh-ancestor
65209650|NCT04203342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65209651|NCT04203342|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65209652|NCT04203342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65209653|NCT04203342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209654|NCT04203342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209655|NCT04203342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65209656|NCT04203342|Hormone Antagonists|hormone antagonists|mesh-ancestor
65209657|NCT04203342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65209658|NCT04203342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209659|NCT04203342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65209660|NCT05539729|Vancomycin|vancomycin|mesh-list
65209661|NCT05539729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65209662|NCT05539729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65209663|NCT04706130|Artesunate|artesunate|mesh-list
65209664|NCT04706130|Primaquine|primaquine|mesh-list
65209665|NCT04706130|Antimalarials|antimalarials|mesh-ancestor
65209666|NCT04706130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65209667|NCT04706130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65209668|NCT04706130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65209669|NCT04706130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209670|NCT04706130|Antiviral Agents|antiviral agents|mesh-ancestor
65209671|NCT04706130|Schistosomicides|schistosomicides|mesh-ancestor
65209672|NCT04706130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65209673|NCT04706130|Anthelmintics|anthelmintics|mesh-ancestor
65209674|NCT04834206|Docetaxel|docetaxel|mesh-list
65331872|NCT04085120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65331873|NCT04085120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331874|NCT04085120|Anesthetics, Local|anesthetics, local|mesh-ancestor
65331875|NCT04085120|Anesthetics|anesthetics|mesh-ancestor
65331876|NCT04085120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65331877|NCT04085120|Sensory System Agents|sensory system agents|mesh-ancestor
65331878|NCT04085120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65331879|NCT04085120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65331880|NCT04085120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65331881|NCT04085120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65331882|NCT04085120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331883|NCT00747903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65331884|NCT00747903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65331885|NCT00747903|Dermatologic Agents|dermatologic agents|mesh-ancestor
65331886|NCT02562183|Kallikreins|kallikreins|mesh-list
65331887|NCT02562183|Coagulants|coagulants|mesh-ancestor
65331888|NCT02562183|Fertility Agents, Male|fertility agents, male|mesh-ancestor
65331889|NCT02562183|Fertility Agents|fertility agents|mesh-ancestor
65331890|NCT02562183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65331891|NCT02562183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331892|NCT00723398|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65331893|NCT00723398|Pitavastatin|pitavastatin|mesh-list
65331894|NCT00723398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65331895|NCT00723398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65331896|NCT00723398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65331897|NCT00723398|Antimetabolites|antimetabolites|mesh-ancestor
65331898|NCT00723398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331899|NCT00723398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331900|NCT00723398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65331901|NCT00723398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65209675|NCT04834206|Fluorouracil|fluorouracil|mesh-list
65209676|NCT04834206|Nedaplatin|nedaplatin|mesh-list
65209677|NCT04834206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209678|NCT04834206|Tubulin Modulators|tubulin modulators|mesh-ancestor
65209679|NCT04834206|Antimitotic Agents|antimitotic agents|mesh-ancestor
65209680|NCT04834206|Mitosis Modulators|mitosis modulators|mesh-ancestor
65209681|NCT04834206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209682|NCT04834206|Antimetabolites|antimetabolites|mesh-ancestor
65209683|NCT04834206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65209684|NCT04834206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65209685|NCT04834206|Immunologic Factors|immunologic factors|mesh-ancestor
65209686|NCT04834206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852422|NCT01696409|Vitamins|vitamins|mesh-list
65209687|NCT00631722|Haloperidol|haloperidol|mesh-list
65331902|NCT00723398|Hormone Antagonists|hormone antagonists|mesh-ancestor
65331903|NCT00723398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65331904|NCT00723398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331905|NCT00723398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65331906|NCT00723398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65331907|NCT00723398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65331908|NCT00716456|Cetuximab|cetuximab|mesh-list
65209688|NCT00631722|Haloperidol decanoate|haloperidol decanoate|mesh-list
65209689|NCT00631722|Antiemetics|antiemetics|mesh-ancestor
65209690|NCT00631722|Autonomic Agents|autonomic agents|mesh-ancestor
65209691|NCT00631722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65209692|NCT00631722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209693|NCT00631722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65209694|NCT00631722|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65209695|NCT00631722|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65209696|NCT00631722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65209697|NCT00631722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65209698|NCT00631722|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65209699|NCT00631722|Dopamine Agents|dopamine agents|mesh-ancestor
65209700|NCT00631722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65209701|NCT00631722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209702|NCT00631722|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65209703|NCT00845728|Tiotropium Bromide|tiotropium bromide|mesh-list
65209704|NCT00845728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65209705|NCT00845728|Autonomic Agents|autonomic agents|mesh-ancestor
65209706|NCT00845728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64324576|NCT02264587|Mosapride|mosapride|mesh-list
65209708|NCT00845728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65209709|NCT00845728|Respiratory System Agents|respiratory system agents|mesh-ancestor
65209710|NCT00845728|Parasympatholytics|parasympatholytics|mesh-ancestor
65209711|NCT00845728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65209712|NCT00845728|Cholinergic Agents|cholinergic agents|mesh-ancestor
65209713|NCT00845728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65209714|NCT00845728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209715|NCT00779467|Fentanyl|fentanyl|mesh-list
65209716|NCT00779467|Bupivacaine|bupivacaine|mesh-list
65209717|NCT00779467|Neostigmine|neostigmine|mesh-list
65209718|NCT00779467|Anesthetics, Local|anesthetics, local|mesh-ancestor
65209719|NCT00779467|Anesthetics|anesthetics|mesh-ancestor
65209720|NCT00779467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65209721|NCT00779467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209722|NCT00779467|Sensory System Agents|sensory system agents|mesh-ancestor
65209723|NCT00779467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65209724|NCT00779467|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65209725|NCT00779467|Narcotics|narcotics|mesh-ancestor
65209726|NCT00779467|Analgesics|analgesics|mesh-ancestor
65209727|NCT00779467|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65209728|NCT00779467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65209729|NCT00779467|Anesthetics, General|anesthetics, general|mesh-ancestor
65209730|NCT00779467|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65209731|NCT00779467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209732|NCT00779467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209733|NCT00779467|Cholinergic Agents|cholinergic agents|mesh-ancestor
65209734|NCT00779467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65209735|NCT00779467|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65209736|NCT00779467|Autonomic Agents|autonomic agents|mesh-ancestor
65209737|NCT04559100|Carbon Monoxide|carbon monoxide|mesh-list
65209738|NCT04559100|Antimetabolites|antimetabolites|mesh-ancestor
65209739|NCT04559100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209740|NCT04559100|Gasotransmitters|gasotransmitters|mesh-ancestor
65209741|NCT04559100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65209742|NCT04559100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209743|NCT00778921|Amlodipine|amlodipine|mesh-list
65209744|NCT00778921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65209745|NCT00778921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65209746|NCT00778921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65209747|NCT00778921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331909|NCT00716456|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65331910|NCT00716456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65331911|NCT00716456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331912|NCT00716456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65331913|NCT00716456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331914|NCT00716456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331915|NCT00684645|Sunitinib|sunitinib|mesh-list
65331916|NCT00684645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331917|NCT00684645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65331918|NCT00684645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64717877|NCT01194908|Tamoxifen|tamoxifen|mesh-list
65209748|NCT00778921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65209749|NCT00778921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209750|NCT00778921|Vasodilator Agents|vasodilator agents|mesh-ancestor
65209751|NCT04173312|Bupivacaine|bupivacaine|mesh-list
65209752|NCT04173312|Anesthetics, Local|anesthetics, local|mesh-ancestor
65209753|NCT04173312|Anesthetics|anesthetics|mesh-ancestor
65209754|NCT04173312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65209755|NCT04173312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209756|NCT04173312|Sensory System Agents|sensory system agents|mesh-ancestor
65209757|NCT04173312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65209758|NCT00587431|Docetaxel|docetaxel|mesh-list
65209759|NCT00587431|Leuprolide|leuprolide|mesh-list
65209760|NCT00587431|Testosterone|testosterone|mesh-list
65209761|NCT00587431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209762|NCT00587431|Tubulin Modulators|tubulin modulators|mesh-ancestor
65209763|NCT00587431|Antimitotic Agents|antimitotic agents|mesh-ancestor
65209764|NCT00587431|Mitosis Modulators|mitosis modulators|mesh-ancestor
65209765|NCT00587431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209766|NCT00587431|Androgens|androgens|mesh-ancestor
65209768|NCT00587431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65209769|NCT00587431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209770|NCT00587431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65209771|NCT00587431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65209772|NCT00587431|Fertility Agents|fertility agents|mesh-ancestor
65209773|NCT00587431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65209774|NCT00776659|Exemestane|exemestane|mesh-list
65209775|NCT00776659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209776|NCT00776659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65209777|NCT00776659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65209778|NCT00776659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209779|NCT00776659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209780|NCT00776659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65209781|NCT00776659|Hormone Antagonists|hormone antagonists|mesh-ancestor
65209783|NCT00776659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209784|NCT00632268|Leucovorin|leucovorin|mesh-list
65209785|NCT00632268|Everolimus|everolimus|mesh-list
65209786|NCT00632268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209787|NCT00632268|Antidotes|antidotes|mesh-ancestor
65209788|NCT00632268|Protective Agents|protective agents|mesh-ancestor
65209789|NCT00632268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209790|NCT00632268|Vitamin B Complex|vitamin b complex|mesh-ancestor
65209791|NCT00632268|Vitamins|vitamins|mesh-ancestor
65209792|NCT00632268|Micronutrients|micronutrients|mesh-ancestor
65209793|NCT00632268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65209794|NCT00632268|Immunologic Factors|immunologic factors|mesh-ancestor
65209795|NCT04145076|Citalopram|citalopram|mesh-list
65209796|NCT04145076|Tianeptine|tianeptine|mesh-list
65209797|NCT04145076|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65209798|NCT04145076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65209799|NCT04145076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65209800|NCT04145076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209801|NCT04145076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65209802|NCT04145076|Serotonin Agents|serotonin agents|mesh-ancestor
65331919|NCT00684645|Growth Substances|growth substances|mesh-ancestor
65331920|NCT00684645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331921|NCT00684645|Growth Inhibitors|growth inhibitors|mesh-ancestor
65331922|NCT00684645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65331923|NCT00684645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331924|NCT00684645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331926|NCT00752037|Lopinavir|lopinavir|mesh-list
64695707|NCT00003213|Dexamethasone|dexamethasone|mesh-list
65209803|NCT04145076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209804|NCT04145076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65209805|NCT04145076|Antidepressive Agents|antidepressive agents|mesh-ancestor
65209806|NCT04145076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65209807|NCT04145076|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65209808|NCT00707902|Chlorhexidine|chlorhexidine|mesh-list
65209809|NCT00707902|Lidocaine|lidocaine|mesh-list
65209810|NCT00707902|Anesthetics, Local|anesthetics, local|mesh-ancestor
65209811|NCT00707902|Anesthetics|anesthetics|mesh-ancestor
65209812|NCT00707902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65209813|NCT00707902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209814|NCT00707902|Sensory System Agents|sensory system agents|mesh-ancestor
65209815|NCT00707902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65209816|NCT00707902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65209817|NCT00707902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65209818|NCT00707902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65209819|NCT00707902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65209820|NCT00707902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209821|NCT00707902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65209822|NCT00707902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65209823|NCT00707902|Disinfectants|disinfectants|mesh-ancestor
65209824|NCT00704860|Antidepressive Agents|antidepressive agents|mesh-list
65209825|NCT00704860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65209826|NCT05511337|Citric Acid|citric acid|mesh-list
65209827|NCT05511337|Sodium Citrate|sodium citrate|mesh-list
65209828|NCT05511337|Anticoagulants|anticoagulants|mesh-ancestor
65209829|NCT05511337|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65209830|NCT05511337|Chelating Agents|chelating agents|mesh-ancestor
65209831|NCT05511337|Sequestering Agents|sequestering agents|mesh-ancestor
65209832|NCT05511337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209833|NCT00833794|Tramadol|tramadol|mesh-list
65209834|NCT00833794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65209835|NCT00833794|Narcotics|narcotics|mesh-ancestor
65209836|NCT00833794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64852576|NCT01697111|Dienogest|dienogest|mesh-list
65209837|NCT00833794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209838|NCT00833794|Analgesics|analgesics|mesh-ancestor
65209839|NCT00833794|Sensory System Agents|sensory system agents|mesh-ancestor
65209840|NCT00833794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65209842|NCT00778375|Decitabine|decitabine|mesh-list
65209843|NCT00778375|Clofarabine|clofarabine|mesh-list
65209844|NCT00778375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65209845|NCT00778375|Antimetabolites|antimetabolites|mesh-ancestor
65209846|NCT00778375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209847|NCT00778375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209848|NCT00778375|Antiviral Agents|antiviral agents|mesh-ancestor
65209849|NCT00778375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65209850|NCT00778375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65209851|NCT00778375|Immunologic Factors|immunologic factors|mesh-ancestor
65209852|NCT00778375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209853|NCT00778375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209854|NCT04102267|Epinephrine|epinephrine|mesh-list
65209855|NCT04102267|Bupivacaine|bupivacaine|mesh-list
65209856|NCT04102267|Anesthetics, Local|anesthetics, local|mesh-ancestor
65209863|NCT04102267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65209864|NCT04102267|Adrenergic Agents|adrenergic agents|mesh-ancestor
65209865|NCT04102267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65209866|NCT04102267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209867|NCT04102267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65209868|NCT04102267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65331927|NCT00752037|Raltegravir Potassium|raltegravir potassium|mesh-list
65331928|NCT00752037|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65331929|NCT00752037|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65331930|NCT00752037|Protease Inhibitors|protease inhibitors|mesh-ancestor
65331931|NCT00752037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331932|NCT00752037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331933|NCT00752037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65331934|NCT00752037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65331935|NCT00752037|Antiviral Agents|antiviral agents|mesh-ancestor
65331936|NCT00752037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65331937|NCT00752037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65331938|NCT00752037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65209869|NCT04102267|Autonomic Agents|autonomic agents|mesh-ancestor
65209870|NCT04102267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65209871|NCT04102267|Respiratory System Agents|respiratory system agents|mesh-ancestor
65209872|NCT04102267|Mydriatics|mydriatics|mesh-ancestor
65209873|NCT04102267|Sympathomimetics|sympathomimetics|mesh-ancestor
65209874|NCT04102267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65209875|NCT00777829|Zolpidem|zolpidem|mesh-list
65209876|NCT00777829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65209877|NCT00777829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65209878|NCT00777829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65209879|NCT00777829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209880|NCT00777829|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65209881|NCT00777829|GABA Agonists|gaba agonists|mesh-ancestor
65209882|NCT00777829|GABA Agents|gaba agents|mesh-ancestor
65209883|NCT00777829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65209884|NCT00777829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209885|NCT00916045|Vidarabine|vidarabine|mesh-list
65209886|NCT00916045|Cyclosporine|cyclosporine|mesh-list
65209887|NCT00916045|Mycophenolic Acid|mycophenolic acid|mesh-list
65209888|NCT00916045|Cyclophosphamide|cyclophosphamide|mesh-list
65209889|NCT00916045|Melphalan|melphalan|mesh-list
65209890|NCT00916045|Busulfan|busulfan|mesh-list
65209891|NCT00916045|Thiotepa|thiotepa|mesh-list
65209892|NCT00916045|Fludarabine|fludarabine|mesh-list
65209893|NCT00916045|Fludarabine phosphate|fludarabine phosphate|mesh-list
65209894|NCT00916045|Cyclosporins|cyclosporins|mesh-list
65209895|NCT00916045|Thymoglobulin|thymoglobulin|mesh-list
65209896|NCT00916045|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65209897|NCT00916045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65209898|NCT00916045|Immunologic Factors|immunologic factors|mesh-ancestor
65209899|NCT00916045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209900|NCT00916045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65209901|NCT00916045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65209902|NCT00916045|Alkylating Agents|alkylating agents|mesh-ancestor
65209903|NCT00916045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209904|NCT00916045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209905|NCT00916045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65209906|NCT00916045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65209907|NCT00916045|Antimetabolites|antimetabolites|mesh-ancestor
65209908|NCT00916045|Antiviral Agents|antiviral agents|mesh-ancestor
65209909|NCT00916045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65209910|NCT00916045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209911|NCT00916045|Antifungal Agents|antifungal agents|mesh-ancestor
65209912|NCT00916045|Dermatologic Agents|dermatologic agents|mesh-ancestor
65209913|NCT00916045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64852651|NCT01697618|Insulin|insulin|mesh-list
65209914|NCT00916045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65209915|NCT00916045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65209916|NCT00916045|Antitubercular Agents|antitubercular agents|mesh-ancestor
65209917|NCT00916045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65209919|NCT00916123|Docetaxel|docetaxel|mesh-list
65209920|NCT00916123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209921|NCT00916123|Tubulin Modulators|tubulin modulators|mesh-ancestor
65331939|NCT00752037|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65331940|NCT00752037|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65331941|NCT00716144|R 115866|r 115866|mesh-list
65331942|NCT00716144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65331943|NCT00716144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331944|NCT00716144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331945|NCT00752115|Paclitaxel|paclitaxel|mesh-list
65331946|NCT00752115|Carboplatin|carboplatin|mesh-list
65331947|NCT00752115|Sildenafil Citrate|sildenafil citrate|mesh-list
65209922|NCT00916123|Antimitotic Agents|antimitotic agents|mesh-ancestor
65209923|NCT00916123|Mitosis Modulators|mitosis modulators|mesh-ancestor
65209924|NCT00916123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209925|NCT00916123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65209926|NCT00916123|Glucocorticoids|glucocorticoids|mesh-ancestor
65209927|NCT00916123|Hormones|hormones|mesh-ancestor
65209935|NCT00833638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65209936|NCT00833638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65209937|NCT00833638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209938|NCT00833638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209939|NCT00833638|Urological Agents|urological agents|mesh-ancestor
65209940|NCT01041404|Fluorouracil|fluorouracil|mesh-list
65209941|NCT01041404|Capecitabine|capecitabine|mesh-list
65209942|NCT01041404|Trastuzumab|trastuzumab|mesh-list
65209943|NCT01041404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209944|NCT01041404|Antimetabolites|antimetabolites|mesh-ancestor
65209945|NCT01041404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209946|NCT01041404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65209947|NCT01041404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65209948|NCT01041404|Immunologic Factors|immunologic factors|mesh-ancestor
65209949|NCT01041404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209950|NCT01041404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65209951|NCT00777049|Panobinostat|panobinostat|mesh-list
65209952|NCT00777049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209953|NCT00777049|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65209954|NCT00777049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209955|NCT00777049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209956|NCT00774787|Imiquimod|imiquimod|mesh-list
65209957|NCT00774787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65209958|NCT00774787|Immunologic Factors|immunologic factors|mesh-ancestor
65209959|NCT00774787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209960|NCT00774787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209961|NCT00774787|Interferon Inducers|interferon inducers|mesh-ancestor
65209962|NCT00888927|Mogamulizumab|mogamulizumab|mesh-list
65209963|NCT00888927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209964|NCT01040780|Gefitinib|gefitinib|mesh-list
65209965|NCT01040780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209966|NCT01040780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65209967|NCT01040780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209968|NCT01040780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209969|NCT04303988|Bevacizumab|bevacizumab|mesh-list
65209970|NCT04303988|Carboplatin|carboplatin|mesh-list
65209971|NCT04303988|Temozolomide|temozolomide|mesh-list
65209972|NCT04303988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65209973|NCT04303988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209974|NCT04303988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65209975|NCT04303988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65209976|NCT04303988|Growth Substances|growth substances|mesh-ancestor
65209977|NCT04303988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209978|NCT04303988|Growth Inhibitors|growth inhibitors|mesh-ancestor
65209979|NCT04303988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65209980|NCT04303988|Alkylating Agents|alkylating agents|mesh-ancestor
65209981|NCT04303988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209982|NCT04991493|Tramadol|tramadol|mesh-list
65209983|NCT04991493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65209984|NCT04991493|Narcotics|narcotics|mesh-ancestor
65209985|NCT04991493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65209986|NCT04991493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331948|NCT00752115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65331949|NCT00752115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65331950|NCT00752115|Tubulin Modulators|tubulin modulators|mesh-ancestor
65331951|NCT00752115|Antimitotic Agents|antimitotic agents|mesh-ancestor
65331952|NCT00752115|Mitosis Modulators|mitosis modulators|mesh-ancestor
64717908|NCT01155518|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65209987|NCT04991493|Analgesics|analgesics|mesh-ancestor
65209988|NCT04991493|Sensory System Agents|sensory system agents|mesh-ancestor
65209989|NCT04991493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65209991|NCT01059812|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65209992|NCT01059812|Insulin Aspart|insulin aspart|mesh-list
65209993|NCT01059812|Insulin, Long-Acting|insulin, long-acting|mesh-list
65209994|NCT01059812|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65209995|NCT01059812|Biphasic Insulins|biphasic insulins|mesh-list
65210001|NCT00888615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65210002|NCT00888615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210003|NCT00888615|Tubulin Modulators|tubulin modulators|mesh-ancestor
65210004|NCT00888615|Antimitotic Agents|antimitotic agents|mesh-ancestor
65210005|NCT00888615|Mitosis Modulators|mitosis modulators|mesh-ancestor
65210006|NCT00888615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210007|NCT04241601|Aldesleukin|aldesleukin|mesh-list
65210008|NCT04241601|Interleukin-2|interleukin-2|mesh-list
65210009|NCT04241601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210010|NCT04241601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65210011|NCT04241601|Analgesics|analgesics|mesh-ancestor
65210012|NCT04241601|Sensory System Agents|sensory system agents|mesh-ancestor
65210013|NCT04241601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65210014|NCT04241601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210015|NCT04241601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65210016|NCT04241601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65210017|NCT04241601|Antiviral Agents|antiviral agents|mesh-ancestor
65210018|NCT04241601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65210019|NCT00845650|Immunoglobulins|immunoglobulins|mesh-list
65210020|NCT00845650|gamma-Globulins|gamma-globulins|mesh-list
65210021|NCT00845650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65210022|NCT00845650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65210023|NCT00845650|Immunologic Factors|immunologic factors|mesh-ancestor
65210024|NCT00845650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210025|NCT00888381|Vaccines|vaccines|mesh-list
65210026|NCT00888381|Immunologic Factors|immunologic factors|mesh-ancestor
65210027|NCT00888381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210028|NCT00833560|Dexamethasone|dexamethasone|mesh-list
65210029|NCT00833560|Cyclophosphamide|cyclophosphamide|mesh-list
65210030|NCT00833560|Bortezomib|bortezomib|mesh-list
65210031|NCT00833560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65210032|NCT00833560|Immunologic Factors|immunologic factors|mesh-ancestor
65210033|NCT00833560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210034|NCT00833560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65210035|NCT00833560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65210036|NCT00833560|Alkylating Agents|alkylating agents|mesh-ancestor
65210037|NCT00833560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210038|NCT00833560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210039|NCT00833560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65210040|NCT00833560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65210041|NCT00833560|Antiemetics|antiemetics|mesh-ancestor
65210042|NCT00833560|Autonomic Agents|autonomic agents|mesh-ancestor
65210043|NCT00833560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65210044|NCT00833560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65210045|NCT00833560|Glucocorticoids|glucocorticoids|mesh-ancestor
65210046|NCT00833560|Hormones|hormones|mesh-ancestor
65210047|NCT00833560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65210048|NCT00833560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65210049|NCT04242927|Nicotinic Acids|nicotinic acids|mesh-list
65210050|NCT04242927|Niacin|niacin|mesh-list
65210051|NCT04242927|Niacinamide|niacinamide|mesh-list
65210052|NCT04242927|Vitamin B Complex|vitamin b complex|mesh-ancestor
65210053|NCT04242927|Vitamins|vitamins|mesh-ancestor
65210054|NCT04242927|Micronutrients|micronutrients|mesh-ancestor
65210055|NCT04242927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210056|NCT04242927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65210057|NCT04242927|Antimetabolites|antimetabolites|mesh-ancestor
65331953|NCT00752115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331954|NCT00752115|Vasodilator Agents|vasodilator agents|mesh-ancestor
65331955|NCT00752115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65331956|NCT00752115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65210058|NCT04242927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210059|NCT04242927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65210060|NCT04242927|Vasodilator Agents|vasodilator agents|mesh-ancestor
65210061|NCT00887679|Citalopram|citalopram|mesh-list
65210062|NCT00887679|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65210063|NCT00887679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65210064|NCT00887679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65210065|NCT00887679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210068|NCT00887679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210069|NCT00887679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65210070|NCT00887679|Antidepressive Agents|antidepressive agents|mesh-ancestor
65210071|NCT00887679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65210073|NCT04241523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210074|NCT04241523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65210075|NCT04241523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210076|NCT04241523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210078|NCT00833482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65210079|NCT00833482|Voriconazole|voriconazole|mesh-list
65210080|NCT00833482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65210081|NCT00833482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65210082|NCT00833482|Protease Inhibitors|protease inhibitors|mesh-ancestor
65210083|NCT00833482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210084|NCT00833482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210085|NCT00833482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65210086|NCT00833482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65210087|NCT00833482|Antiviral Agents|antiviral agents|mesh-ancestor
65210088|NCT00833482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65210089|NCT00833482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65210090|NCT00833482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65210091|NCT00833482|Antifungal Agents|antifungal agents|mesh-ancestor
65210092|NCT00833482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65210093|NCT00833482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65210094|NCT00833482|Hormone Antagonists|hormone antagonists|mesh-ancestor
65210095|NCT00833482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65210096|NCT00833482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210097|NCT00845182|Pioglitazone|pioglitazone|mesh-list
65210098|NCT00845182|Exenatide|exenatide|mesh-list
65210099|NCT00845182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65210100|NCT00845182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210101|NCT00845182|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65210102|NCT00845182|Incretins|incretins|mesh-ancestor
65210103|NCT00845182|Hormones|hormones|mesh-ancestor
65210104|NCT00845182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65210105|NCT00833248|Goserelin|goserelin|mesh-list
65210106|NCT00833248|Bicalutamide|bicalutamide|mesh-list
65210107|NCT00833248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65210108|NCT00833248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210109|NCT00833248|Androgen Antagonists|androgen antagonists|mesh-ancestor
65210110|NCT00833248|Hormone Antagonists|hormone antagonists|mesh-ancestor
65210111|NCT00833248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65210112|NCT00833248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210113|NCT00702130|Pravastatin|pravastatin|mesh-list
65210114|NCT00702130|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65210115|NCT00702130|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65210116|NCT00702130|Antimetabolites|antimetabolites|mesh-ancestor
65210117|NCT00702130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210118|NCT00702130|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65210119|NCT00702130|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65210120|NCT00702130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210121|NCT00823264|Charcoal|charcoal|mesh-list
65210122|NCT00823264|Antidotes|antidotes|mesh-ancestor
65210123|NCT00823264|Protective Agents|protective agents|mesh-ancestor
65210124|NCT00823264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210125|NCT04241211|Denosumab|denosumab|mesh-list
65331957|NCT00752115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65331958|NCT00752115|Urological Agents|urological agents|mesh-ancestor
65331959|NCT00918476|Contraceptive Agents|contraceptive agents|mesh-list
65331960|NCT00918476|Contraceptives, Oral|contraceptives, oral|mesh-list
65331961|NCT00918476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65331962|NCT00918476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717916|NCT03490916|Anticonvulsants|anticonvulsants|mesh-ancestor
65210126|NCT04241211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65210127|NCT04241211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210128|NCT00702442|Droperidol|droperidol|mesh-list
65210129|NCT00702442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65210130|NCT00702442|Antiemetics|antiemetics|mesh-ancestor
65210131|NCT00702442|Autonomic Agents|autonomic agents|mesh-ancestor
65210132|NCT00702442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65210133|NCT00702442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210134|NCT00702442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65210135|NCT00702442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65210136|NCT00702442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65210137|NCT00702442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64852872|NCT01699204|Antioxidants|antioxidants|mesh-ancestor
65210138|NCT00702442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65210139|NCT00702442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65210146|NCT02612272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65210147|NCT02612272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65210148|NCT02612272|Analgesics|analgesics|mesh-ancestor
65210149|NCT02612272|Sensory System Agents|sensory system agents|mesh-ancestor
65210150|NCT02612272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65210151|NCT02612272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210152|NCT02612272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65210153|NCT02612272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65210154|NCT02612272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65210155|NCT02612272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210156|NCT02612272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210157|NCT02612272|Glucocorticoids|glucocorticoids|mesh-ancestor
65210158|NCT02612272|Hormones|hormones|mesh-ancestor
65210159|NCT02612272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65210160|NCT02612272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65210161|NCT02612272|Respiratory System Agents|respiratory system agents|mesh-ancestor
65210162|NCT02611258|Tadalafil|tadalafil|mesh-list
65210163|NCT02611258|Vasodilator Agents|vasodilator agents|mesh-ancestor
65210164|NCT02611258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65210165|NCT02611258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65210166|NCT02611258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210167|NCT02611258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210168|NCT02611258|Urological Agents|urological agents|mesh-ancestor
65210169|NCT00832624|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65210170|NCT00832624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65210171|NCT00832624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210172|NCT00832624|Incretins|incretins|mesh-ancestor
65210173|NCT00832624|Hormones|hormones|mesh-ancestor
65210174|NCT00832624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65210175|NCT00832624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65210176|NCT00832624|Protease Inhibitors|protease inhibitors|mesh-ancestor
65210177|NCT00832624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210178|NCT00832624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210179|NCT00913120|Enoxaparin|enoxaparin|mesh-list
65210180|NCT00913120|Anticoagulants|anticoagulants|mesh-ancestor
65210181|NCT00913120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65210182|NCT00913120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65210183|NCT00913120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210184|NCT00822172|Cilostazol|cilostazol|mesh-list
65210185|NCT00822172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65210186|NCT00822172|Autonomic Agents|autonomic agents|mesh-ancestor
65210187|NCT00822172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65210188|NCT00822172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210189|NCT00822172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65210190|NCT00822172|Respiratory System Agents|respiratory system agents|mesh-ancestor
65331963|NCT00918476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65331964|NCT00749385|Naproxen|naproxen|mesh-list
65331965|NCT00749385|Esomeprazole|esomeprazole|mesh-list
65331966|NCT00749385|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65331967|NCT00749385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65331968|NCT00749385|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65331969|NCT00749385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210191|NCT00822172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65210192|NCT00822172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65210193|NCT00822172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210194|NCT00822172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65210195|NCT00822172|Vasodilator Agents|vasodilator agents|mesh-ancestor
65210196|NCT00822172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65210197|NCT00822172|Protective Agents|protective agents|mesh-ancestor
65210198|NCT00822172|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65210199|NCT00822172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65210200|NCT00822172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210201|NCT00832000|Mexiletine|mexiletine|mesh-list
65210202|NCT00832000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65210203|NCT00832000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65210204|NCT00832000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65210205|NCT00832000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65210206|NCT00832000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210207|NCT04202952|Sofosbuvir|sofosbuvir|mesh-list
65210208|NCT04202952|Antiviral Agents|antiviral agents|mesh-ancestor
65210209|NCT04202952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65210210|NCT04054674|Salicylic Acid|salicylic acid|mesh-list
65210214|NCT04054674|Dermatologic Agents|dermatologic agents|mesh-ancestor
65210216|NCT04166292|Anesthetics, Local|anesthetics, local|mesh-ancestor
65210217|NCT04166292|Anesthetics|anesthetics|mesh-ancestor
65210218|NCT04166292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65210219|NCT04166292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210220|NCT04166292|Sensory System Agents|sensory system agents|mesh-ancestor
65210221|NCT04166292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65210222|NCT04166292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65210223|NCT04166292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65210224|NCT04166292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65210225|NCT04166292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65210226|NCT04166292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210228|NCT04099771|Analgesics|analgesics|mesh-ancestor
65210229|NCT04099771|Sensory System Agents|sensory system agents|mesh-ancestor
65210230|NCT04099771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65210231|NCT04099771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210232|NCT04099771|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65210233|NCT04099771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65210234|NCT04099771|Anesthetics, General|anesthetics, general|mesh-ancestor
65210235|NCT04099771|Anesthetics|anesthetics|mesh-ancestor
65210236|NCT04099771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65210237|NCT04099771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65210238|NCT04099771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65210239|NCT04099771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65210240|NCT04099771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210241|NCT00768469|Paclitaxel|paclitaxel|mesh-list
65210242|NCT00768469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65210243|NCT00768469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210244|NCT00768469|Tubulin Modulators|tubulin modulators|mesh-ancestor
65210245|NCT00768469|Antimitotic Agents|antimitotic agents|mesh-ancestor
65210246|NCT00768469|Mitosis Modulators|mitosis modulators|mesh-ancestor
65210247|NCT00768469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210248|NCT02825121|Iodine|iodine|mesh-list
65210249|NCT02825121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65210250|NCT02825121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65210251|NCT02825121|Trace Elements|trace elements|mesh-ancestor
65210252|NCT02825121|Micronutrients|micronutrients|mesh-ancestor
65210253|NCT02825121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210254|NCT02825199|Caffeine|caffeine|mesh-list
65210255|NCT02825199|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65331970|NCT00749385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331971|NCT00749385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65331972|NCT00749385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65331973|NCT00749385|Analgesics|analgesics|mesh-ancestor
65331974|NCT00749385|Sensory System Agents|sensory system agents|mesh-ancestor
65331975|NCT00749385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65331976|NCT00749385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210256|NCT02825199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210257|NCT02825199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65210258|NCT02825199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210259|NCT02825199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210260|NCT02825199|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65210261|NCT02825199|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65210262|NCT02825199|Purinergic Agents|purinergic agents|mesh-ancestor
65210263|NCT02825199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65210264|NCT02824965|Pembrolizumab|pembrolizumab|mesh-list
65210265|NCT02824965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65210266|NCT02824965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210267|NCT00886743|Oprelvekin|oprelvekin|mesh-list
65210268|NCT00886743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210269|NCT02826759|Insulin|insulin|mesh-list
65210270|NCT02826759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65210271|NCT02826759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210272|NCT02823951|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65210273|NCT02823951|Dermatologic Agents|dermatologic agents|mesh-ancestor
65210274|NCT02823951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65210275|NCT02823951|Immunologic Factors|immunologic factors|mesh-ancestor
65210276|NCT02823951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210277|NCT02826837|Bevacizumab|bevacizumab|mesh-list
65210278|NCT02826837|Cetuximab|cetuximab|mesh-list
65210279|NCT02826837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65210280|NCT02826837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210281|NCT02826837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65210282|NCT02826837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65210284|NCT02826837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210286|NCT02822547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65210287|NCT02822547|Antiviral Agents|antiviral agents|mesh-ancestor
65210288|NCT02822547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65210289|NCT02823483|Sunscreening Agents|sunscreening agents|mesh-list
65210290|NCT02823483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65210291|NCT02823483|Protective Agents|protective agents|mesh-ancestor
65210292|NCT02823483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210293|NCT02823483|Dermatologic Agents|dermatologic agents|mesh-ancestor
65210294|NCT04848597|Paclitaxel|paclitaxel|mesh-list
65210295|NCT04848597|Antibodies|antibodies|mesh-list
65210296|NCT04848597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65210297|NCT04848597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65210298|NCT04848597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210299|NCT04848597|Tubulin Modulators|tubulin modulators|mesh-ancestor
65210300|NCT04848597|Antimitotic Agents|antimitotic agents|mesh-ancestor
65210301|NCT04848597|Mitosis Modulators|mitosis modulators|mesh-ancestor
65210302|NCT04848597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210303|NCT04848597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210304|NCT04848597|Immunologic Factors|immunologic factors|mesh-ancestor
65210305|NCT05037045|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65210306|NCT05037045|Incretins|incretins|mesh-ancestor
65210307|NCT05037045|Hormones|hormones|mesh-ancestor
65210308|NCT05037045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65210309|NCT05037045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210310|NCT05660811|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65210311|NCT02823405|Pembrolizumab|pembrolizumab|mesh-list
65210312|NCT02823405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65210313|NCT02823405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210314|NCT02823249|Erythritol|erythritol|mesh-list
65210315|NCT02823249|Tryptophan|tryptophan|mesh-list
65210316|NCT02823249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65210317|NCT02823249|Antidepressive Agents|antidepressive agents|mesh-ancestor
65331977|NCT00749385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65331978|NCT00749385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65331979|NCT00749385|Gout Suppressants|gout suppressants|mesh-ancestor
65331980|NCT00749385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65331981|NCT00748059|Propranolol|propranolol|mesh-list
65331982|NCT00748059|Atropine|atropine|mesh-list
65331983|NCT00748059|Clonidine|clonidine|mesh-list
65331984|NCT00748059|Nitroprusside|nitroprusside|mesh-list
65331985|NCT00748059|Methyldopa|methyldopa|mesh-list
65331986|NCT00748059|Phenylephrine|phenylephrine|mesh-list
65331987|NCT00748059|Isoproterenol|isoproterenol|mesh-list
65210318|NCT02823249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65210319|NCT02823249|Vasodilator Agents|vasodilator agents|mesh-ancestor
65210320|NCT00768079|Benralizumab|benralizumab|mesh-list
65210321|NCT00768079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65210322|NCT00768079|Respiratory System Agents|respiratory system agents|mesh-ancestor
65210323|NCT02603575|Caspofungin|caspofungin|mesh-list
65210324|NCT02603575|Sulfanilamide|sulfanilamide|mesh-list
65210325|NCT02603575|Sulfanilamides|sulfanilamides|mesh-list
65210326|NCT02603575|Methylprednisolone|methylprednisolone|mesh-list
65210327|NCT02603575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65210328|NCT02603575|Antiemetics|antiemetics|mesh-ancestor
65210329|NCT02603575|Autonomic Agents|autonomic agents|mesh-ancestor
65210330|NCT02603575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65210331|NCT02603575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210332|NCT02603575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65210333|NCT02603575|Glucocorticoids|glucocorticoids|mesh-ancestor
65210334|NCT02603575|Hormones|hormones|mesh-ancestor
65210335|NCT02603575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65210336|NCT02603575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65210337|NCT02603575|Protective Agents|protective agents|mesh-ancestor
65210338|NCT02603575|Antifungal Agents|antifungal agents|mesh-ancestor
65210339|NCT02603575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65210340|NCT02603575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210341|NCT02603575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210342|NCT02603575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65210343|NCT02601859|Lithium Carbonate|lithium carbonate|mesh-list
65210344|NCT02601859|Antidepressive Agents|antidepressive agents|mesh-ancestor
65210345|NCT02601859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65210346|NCT02601859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210347|NCT02601859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210348|NCT02601859|Antimanic Agents|antimanic agents|mesh-ancestor
65210349|NCT02601859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65210350|NCT02601859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65210351|NCT02601859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210352|NCT02822157|Gemcitabine|gemcitabine|mesh-list
65210353|NCT02822157|Paclitaxel|paclitaxel|mesh-list
65210354|NCT02822157|Carboplatin|carboplatin|mesh-list
65210355|NCT02822157|Doxorubicin|doxorubicin|mesh-list
65210356|NCT02822157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65210357|NCT02822157|Topotecan|topotecan|mesh-list
65210358|NCT02822157|Olaparib|olaparib|mesh-list
65210361|NCT02822157|Tubulin Modulators|tubulin modulators|mesh-ancestor
64853096|NCT01700478|Vasopressins|vasopressins|mesh-list
65210362|NCT02822157|Antimitotic Agents|antimitotic agents|mesh-ancestor
65210363|NCT02822157|Mitosis Modulators|mitosis modulators|mesh-ancestor
65210364|NCT02822157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210365|NCT02822157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65210366|NCT02822157|Antimetabolites|antimetabolites|mesh-ancestor
65210367|NCT02822157|Antiviral Agents|antiviral agents|mesh-ancestor
65210368|NCT02822157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65210369|NCT02822157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210370|NCT02822157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65210371|NCT02822157|Immunologic Factors|immunologic factors|mesh-ancestor
65210372|NCT02822157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210373|NCT02822157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65210374|NCT02822157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65210375|NCT02822157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65210376|NCT02822157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65210377|NCT02822157|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65331988|NCT00748059|Metoclopramide|metoclopramide|mesh-list
65331989|NCT00748059|Yohimbine|yohimbine|mesh-list
65331990|NCT00748059|Tyramine|tyramine|mesh-list
65331991|NCT00748059|Edrophonium|edrophonium|mesh-list
65331992|NCT00748059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65331993|NCT00748059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65210379|NCT02822937|Methylphenidate|methylphenidate|mesh-list
65210380|NCT02822937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65210381|NCT02822937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210382|NCT02822937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65210383|NCT02822937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65210384|NCT02822937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65210385|NCT02822937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210386|NCT02822937|Dopamine Agents|dopamine agents|mesh-ancestor
65210387|NCT02822937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65210388|NCT02822937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65210389|NCT02822937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65210390|NCT02822937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65210391|NCT02822937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65210392|NCT02822937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65210393|NCT02822937|GABA Modulators|gaba modulators|mesh-ancestor
65210394|NCT02822937|GABA Agents|gaba agents|mesh-ancestor
65210395|NCT04200885|Dexamethasone|dexamethasone|mesh-list
65210396|NCT04200885|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65210397|NCT04200885|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65210398|NCT04200885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65210399|NCT04200885|Antiemetics|antiemetics|mesh-ancestor
65210400|NCT04200885|Autonomic Agents|autonomic agents|mesh-ancestor
65210401|NCT04200885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65210402|NCT04200885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210403|NCT04200885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65210404|NCT04200885|Glucocorticoids|glucocorticoids|mesh-ancestor
65210405|NCT04200885|Hormones|hormones|mesh-ancestor
65210406|NCT04200885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65210407|NCT04200885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65210408|NCT04200885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210409|NCT04200885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65210410|NCT04200885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65210411|NCT04200885|Analgesics|analgesics|mesh-ancestor
65210412|NCT04200885|Sensory System Agents|sensory system agents|mesh-ancestor
65210413|NCT04200885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65210414|NCT05659251|Paclitaxel|paclitaxel|mesh-list
65210415|NCT05659251|Carboplatin|carboplatin|mesh-list
65210416|NCT05659251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65210417|NCT05659251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210418|NCT05659251|Tubulin Modulators|tubulin modulators|mesh-ancestor
65210419|NCT05659251|Antimitotic Agents|antimitotic agents|mesh-ancestor
65210420|NCT05659251|Mitosis Modulators|mitosis modulators|mesh-ancestor
65210421|NCT05659251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210422|NCT00766831|Hydromorphone|hydromorphone|mesh-list
65210423|NCT00766831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65210424|NCT00766831|Narcotics|narcotics|mesh-ancestor
65210425|NCT00766831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65210426|NCT00766831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210427|NCT00766831|Analgesics|analgesics|mesh-ancestor
65210428|NCT00766831|Sensory System Agents|sensory system agents|mesh-ancestor
65210429|NCT00766831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65210430|NCT02821689|Pirfenidone|pirfenidone|mesh-list
65210433|NCT02821689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65210434|NCT02821689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210435|NCT02821689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65210437|NCT02821689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65210438|NCT02821689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65210439|NCT02821689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210440|NCT02821533|Cisplatin|cisplatin|mesh-list
65210441|NCT02821533|Antineoplastic Agents|antineoplastic agents|mesh-list
65210442|NCT05659407|Rituximab|rituximab|mesh-list
65210443|NCT05659407|Belimumab|belimumab|mesh-list
65210444|NCT05659407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65210445|NCT05659407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210446|NCT05659407|Immunologic Factors|immunologic factors|mesh-ancestor
65331994|NCT00748059|Adrenergic Agents|adrenergic agents|mesh-ancestor
65331995|NCT00748059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65066810|NCT00272636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65331996|NCT00748059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65331997|NCT00748059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65331998|NCT00748059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65331999|NCT00748059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65332000|NCT00748059|Vasodilator Agents|vasodilator agents|mesh-ancestor
65332001|NCT00748059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65332002|NCT00748059|Mydriatics|mydriatics|mesh-ancestor
65332003|NCT00748059|Autonomic Agents|autonomic agents|mesh-ancestor
65332004|NCT00748059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332005|NCT00748059|Sympathomimetics|sympathomimetics|mesh-ancestor
65332006|NCT00748059|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65332007|NCT00748059|Nasal Decongestants|nasal decongestants|mesh-ancestor
65332008|NCT00748059|Respiratory System Agents|respiratory system agents|mesh-ancestor
65332009|NCT00748059|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65332010|NCT00748059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65332011|NCT00748059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64717949|NCT02417870|Aldesleukin|aldesleukin|mesh-list
65210447|NCT05659407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210448|NCT05659407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65210449|NCT05659407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65210450|NCT00766675|Acetaminophen|acetaminophen|mesh-list
65210451|NCT00766675|Tramadol|tramadol|mesh-list
65210452|NCT00766675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65210453|NCT00766675|Analgesics|analgesics|mesh-ancestor
65210454|NCT00766675|Sensory System Agents|sensory system agents|mesh-ancestor
65210455|NCT00766675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65210456|NCT00766675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210457|NCT00766675|Antipyretics|antipyretics|mesh-ancestor
65210458|NCT00766675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65210459|NCT00766675|Narcotics|narcotics|mesh-ancestor
65210460|NCT00766675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65210461|NCT02820441|Zopiclone|zopiclone|mesh-list
65210462|NCT02820441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65210463|NCT02820441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65210464|NCT02820441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210465|NCT02821377|Furosemide|furosemide|mesh-list
65210466|NCT02821377|Diuretics|diuretics|mesh-ancestor
65210467|NCT02821377|Natriuretic Agents|natriuretic agents|mesh-ancestor
65210468|NCT02821377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210469|NCT02821377|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65210470|NCT02821377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65210471|NCT02821377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210472|NCT02820987|Meropenem|meropenem|mesh-list
65210473|NCT02820987|Tazobactam|tazobactam|mesh-list
65210474|NCT02820987|Piperacillin|piperacillin|mesh-list
65210475|NCT02820987|Cefepime|cefepime|mesh-list
65210476|NCT02820987|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65210477|NCT02820987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65210478|NCT02820987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65210479|NCT02820987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65210480|NCT02820987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332012|NCT00748059|Protective Agents|protective agents|mesh-ancestor
65332013|NCT00748059|Analgesics|analgesics|mesh-ancestor
65332014|NCT00748059|Sensory System Agents|sensory system agents|mesh-ancestor
65332015|NCT00748059|Sympatholytics|sympatholytics|mesh-ancestor
65332016|NCT00748059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65332017|NCT00748059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65210481|NCT02820987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210482|NCT04052490|Salicylic Acid|salicylic acid|mesh-list
65210483|NCT04052490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65210484|NCT04052490|Antifungal Agents|antifungal agents|mesh-ancestor
65210485|NCT04052490|Keratolytic Agents|keratolytic agents|mesh-ancestor
65210486|NCT04052490|Dermatologic Agents|dermatologic agents|mesh-ancestor
65210487|NCT00773383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65210488|NCT00773383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210489|NCT00773383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65210490|NCT00773383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210491|NCT00773383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210492|NCT02818881|Methamphetamine|methamphetamine|mesh-list
65210493|NCT02818881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65210494|NCT02818881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210495|NCT02818881|Sympathomimetics|sympathomimetics|mesh-ancestor
65210496|NCT02818881|Autonomic Agents|autonomic agents|mesh-ancestor
65210497|NCT02818881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65210498|NCT02818881|Dopamine Agents|dopamine agents|mesh-ancestor
65210499|NCT02818881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65210500|NCT02818881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210501|NCT02818881|Adrenergic Agents|adrenergic agents|mesh-ancestor
65210502|NCT02818881|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65210503|NCT02818881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65210510|NCT02818725|Vinblastine|vinblastine|mesh-list
65210511|NCT02818725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853257|NCT01701479|Aldesleukin|aldesleukin|mesh-list
65210512|NCT02818725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65210513|NCT02818725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65210514|NCT02818725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65210515|NCT02818725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210516|NCT02818725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210517|NCT02818725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65210518|NCT02818725|Abortifacient Agents|abortifacient agents|mesh-ancestor
65210519|NCT02818725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65210520|NCT02818725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210521|NCT02818725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65210522|NCT02818725|Antimetabolites|antimetabolites|mesh-ancestor
65210523|NCT02818725|Dermatologic Agents|dermatologic agents|mesh-ancestor
65210524|NCT02818725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65210525|NCT02818725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65210526|NCT02818725|Immunologic Factors|immunologic factors|mesh-ancestor
65210527|NCT02818725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65210528|NCT02818725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65210529|NCT02818725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65210530|NCT02818725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65210531|NCT02818725|Tubulin Modulators|tubulin modulators|mesh-ancestor
65210532|NCT02818725|Antimitotic Agents|antimitotic agents|mesh-ancestor
65210533|NCT02818725|Mitosis Modulators|mitosis modulators|mesh-ancestor
65210535|NCT02818803|Miconazole|miconazole|mesh-list
65210536|NCT02818803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65210537|NCT02818803|Antifungal Agents|antifungal agents|mesh-ancestor
65210538|NCT02818803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65210539|NCT02818803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65210540|NCT02818803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210541|NCT02818803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210542|NCT02818803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65210543|NCT02818803|Hormone Antagonists|hormone antagonists|mesh-ancestor
65210544|NCT02818803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65210545|NCT02818803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210546|NCT02818803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65332018|NCT00748059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65332019|NCT00748059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65332020|NCT00748059|Parasympatholytics|parasympatholytics|mesh-ancestor
65210547|NCT02818803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65210548|NCT02820051|Lidocaine|lidocaine|mesh-list
65210549|NCT02820051|Midazolam|midazolam|mesh-list
65210550|NCT02820051|Nalbuphine|nalbuphine|mesh-list
65210551|NCT02820051|Propofol|propofol|mesh-list
65210552|NCT02820051|Anesthetics, Local|anesthetics, local|mesh-ancestor
65210553|NCT02820051|Anesthetics|anesthetics|mesh-ancestor
65210554|NCT02820051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65210555|NCT02820051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210556|NCT02820051|Sensory System Agents|sensory system agents|mesh-ancestor
65210557|NCT02820051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65210558|NCT02820051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65210559|NCT02820051|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65210560|NCT02820051|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65210561|NCT02820051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65210562|NCT02820051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210563|NCT02820051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65210564|NCT02820051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65210565|NCT02820051|Anesthetics, General|anesthetics, general|mesh-ancestor
65210566|NCT02820051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65210567|NCT02820051|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65210568|NCT02820051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65210569|NCT02820051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65210570|NCT02820051|GABA Modulators|gaba modulators|mesh-ancestor
65210571|NCT02820051|GABA Agents|gaba agents|mesh-ancestor
65210575|NCT02820051|Analgesics|analgesics|mesh-ancestor
65210576|NCT02817243|Simvastatin|simvastatin|mesh-list
65210577|NCT02817243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65210578|NCT02817243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65210579|NCT02817243|Antimetabolites|antimetabolites|mesh-ancestor
65210580|NCT02817243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210581|NCT02817243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65210582|NCT02817243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65210583|NCT02817243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210584|NCT00766363|Rivastigmine|rivastigmine|mesh-list
64853332|NCT01701882|Tenofovir|tenofovir|mesh-list
65210585|NCT00766363|Donepezil|donepezil|mesh-list
65210586|NCT00766363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65210587|NCT00766363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210588|NCT00766363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210589|NCT00766363|Cholinergic Agents|cholinergic agents|mesh-ancestor
65210590|NCT00766363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65210591|NCT00766363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210592|NCT00766363|Nootropic Agents|nootropic agents|mesh-ancestor
65210593|NCT00766363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65210594|NCT00766363|Protective Agents|protective agents|mesh-ancestor
65210595|NCT02636946|Bimatoprost|bimatoprost|mesh-list
65210596|NCT02636946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65210597|NCT02819661|Morphine|morphine|mesh-list
65210598|NCT02819661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65210599|NCT02819661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210600|NCT02819661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65210601|NCT02819661|Narcotics|narcotics|mesh-ancestor
65210602|NCT02819661|Analgesics|analgesics|mesh-ancestor
65210603|NCT02819661|Sensory System Agents|sensory system agents|mesh-ancestor
65210604|NCT02819661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65210605|NCT03982212|Glatiramer Acetate|glatiramer acetate|mesh-list
65210606|NCT03982212|(T,G)-A-L|(t,g)-a-l|mesh-list
65210607|NCT03982212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65210608|NCT03982212|Immunologic Factors|immunologic factors|mesh-ancestor
65210609|NCT03982212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210610|NCT03982212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65210611|NCT03982212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65210612|NCT00765817|Exenatide|exenatide|mesh-list
65210613|NCT00765817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65210614|NCT00765817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210615|NCT00765817|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65210616|NCT00765817|Incretins|incretins|mesh-ancestor
65210617|NCT00765817|Hormones|hormones|mesh-ancestor
65210618|NCT00765817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65210619|NCT02818491|Dexamethasone|dexamethasone|mesh-list
65210620|NCT02818491|Dexamethasone acetate|dexamethasone acetate|mesh-list
65332021|NCT00748059|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65332022|NCT00748059|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65332023|NCT00748059|Cholinergic Agents|cholinergic agents|mesh-ancestor
65332024|NCT00748059|Antiemetics|antiemetics|mesh-ancestor
65332025|NCT00748059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65210621|NCT02818491|Ropivacaine|ropivacaine|mesh-list
65210622|NCT02818491|BB 1101|bb 1101|mesh-list
65210623|NCT02818491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65210624|NCT02818491|Antiemetics|antiemetics|mesh-ancestor
65210625|NCT02818491|Autonomic Agents|autonomic agents|mesh-ancestor
65210626|NCT02818491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65210627|NCT02818491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210628|NCT02818491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65210629|NCT02818491|Glucocorticoids|glucocorticoids|mesh-ancestor
65210630|NCT02818491|Hormones|hormones|mesh-ancestor
65210631|NCT02818491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65210632|NCT02818491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65210633|NCT02818491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210634|NCT02818491|Protease Inhibitors|protease inhibitors|mesh-ancestor
65210635|NCT02818491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210636|NCT02818491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210637|NCT02818491|Anesthetics, Local|anesthetics, local|mesh-ancestor
65210638|NCT02818491|Anesthetics|anesthetics|mesh-ancestor
65210639|NCT02818491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65210640|NCT02818491|Sensory System Agents|sensory system agents|mesh-ancestor
65210641|NCT02816853|Moxifloxacin|moxifloxacin|mesh-list
65210642|NCT02816853|Domperidone|domperidone|mesh-list
65210643|NCT02816853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65210644|NCT02816853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65210645|NCT02816853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65210648|NCT02816853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210649|NCT02816853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210650|NCT02816853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210652|NCT02816853|Autonomic Agents|autonomic agents|mesh-ancestor
65210653|NCT02816853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65210654|NCT02816853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65210655|NCT02816853|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65210656|NCT02816853|Dopamine Agents|dopamine agents|mesh-ancestor
65210657|NCT02816853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65210658|NCT00772603|Oxcarbazepine|oxcarbazepine|mesh-list
65210659|NCT00772603|Anticonvulsants|anticonvulsants|mesh-ancestor
65210660|NCT00772603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65210661|NCT00772603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65210662|NCT00772603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65210663|NCT00772603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210664|NCT00772603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65210665|NCT00772603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65210668|NCT05658861|Sequestering Agents|sequestering agents|mesh-ancestor
65210669|NCT05658861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210670|NCT00772447|Vancomycin|vancomycin|mesh-list
65210671|NCT00772447|Daptomycin|daptomycin|mesh-list
65210672|NCT00772447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65210673|NCT00772447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65210674|NCT05656443|Ritonavir|ritonavir|mesh-list
65210675|NCT05656443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65210676|NCT05656443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65210677|NCT05656443|Protease Inhibitors|protease inhibitors|mesh-ancestor
65210678|NCT05656443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210679|NCT05656443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210680|NCT05656443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65210681|NCT05656443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65210682|NCT05656443|Antiviral Agents|antiviral agents|mesh-ancestor
65210683|NCT05656443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65210684|NCT05656443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65210685|NCT05656443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65210686|NCT04238169|Bevacizumab|bevacizumab|mesh-list
65210687|NCT04238169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65210688|NCT04238169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210689|NCT04238169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65210690|NCT04238169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65332026|NCT00748059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65332027|NCT00748059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65332028|NCT00748059|Dopamine Agents|dopamine agents|mesh-ancestor
65332029|NCT00748059|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65332030|NCT00748059|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65332031|NCT00748059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65332032|NCT00748059|Urological Agents|urological agents|mesh-ancestor
65332033|NCT00748059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65332034|NCT00748059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65332035|NCT00748059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64717979|NCT02389712|Anticonvulsants|anticonvulsants|mesh-ancestor
65210691|NCT04238169|Growth Substances|growth substances|mesh-ancestor
65210692|NCT04238169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210693|NCT04238169|Growth Inhibitors|growth inhibitors|mesh-ancestor
65210694|NCT00831844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65210695|NCT00831844|Immunologic Factors|immunologic factors|mesh-ancestor
65210696|NCT00831844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210697|NCT00764881|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65210698|NCT00764881|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
65210699|NCT00764881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65210700|NCT00764881|Contraceptive Agents|contraceptive agents|mesh-ancestor
65210701|NCT00764881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65210702|NCT00764881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210703|NCT00764881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65210704|NCT00764881|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65210705|NCT00764881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65210706|NCT00764881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65210707|NCT00764881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65210708|NCT00764881|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
65210709|NCT00764881|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65210710|NCT00764881|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65210711|NCT05385406|Acetic Acid|acetic acid|mesh-list
65210712|NCT05385406|Retinol acetate|retinol acetate|mesh-list
65210713|NCT05385406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65210714|NCT05385406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65210715|NCT05385406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65210716|NCT05385406|Immunologic Factors|immunologic factors|mesh-ancestor
65210717|NCT05385406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210721|NCT00702676|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65210722|NCT00702676|Antidepressive Agents|antidepressive agents|mesh-ancestor
65210723|NCT00702676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65210724|NCT00702676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65210725|NCT00702676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65210726|NCT00702676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65210727|NCT00702676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210728|NCT02817477|Ketamine|ketamine|mesh-list
65210729|NCT02817477|Morphine|morphine|mesh-list
65210730|NCT02817477|Analgesics|analgesics|mesh-ancestor
65210731|NCT02817477|Sensory System Agents|sensory system agents|mesh-ancestor
65210732|NCT02817477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65210733|NCT02817477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210734|NCT02817477|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65210735|NCT02817477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65210737|NCT02817477|Anesthetics|anesthetics|mesh-ancestor
65210738|NCT02817477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65210739|NCT02817477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65210740|NCT02817477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65210741|NCT02817477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65210742|NCT02817477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210743|NCT02817477|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65210744|NCT02817477|Narcotics|narcotics|mesh-ancestor
65332036|NCT00748059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65332037|NCT00748059|Antidotes|antidotes|mesh-ancestor
65332038|NCT00748059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65332039|NCT00748059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332040|NCT00576381|Dexmedetomidine|dexmedetomidine|mesh-list
65332041|NCT00576381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65332042|NCT00576381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64696963|NCT04904978|Listerine|listerine|mesh-list
65210745|NCT02819115|Vaccines|vaccines|mesh-list
65210746|NCT02819115|Immunologic Factors|immunologic factors|mesh-ancestor
65210747|NCT02819115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210748|NCT05382208|Doxycycline|doxycycline|mesh-list
65210749|NCT05382208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65210750|NCT05382208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65210751|NCT05382208|Antimalarials|antimalarials|mesh-ancestor
65210752|NCT05382208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65210753|NCT05382208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65210754|NCT04099069|Anesthetics|anesthetics|mesh-list
65210755|NCT04099069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65210756|NCT04099069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210757|NCT02816151|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65210758|NCT02816151|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65210759|NCT02816151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65210760|NCT02816151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65210761|NCT02816151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210762|NCT02816151|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65210763|NCT02816151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65210764|NCT02816151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210765|NCT02816151|Cholinergic Agents|cholinergic agents|mesh-ancestor
65210766|NCT02816151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65210767|NCT04101019|Lidocaine|lidocaine|mesh-list
65210768|NCT04101019|Anesthetics, Local|anesthetics, local|mesh-ancestor
65210769|NCT04101019|Anesthetics|anesthetics|mesh-ancestor
65210770|NCT04101019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65210771|NCT04101019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210772|NCT04101019|Sensory System Agents|sensory system agents|mesh-ancestor
65210773|NCT04101019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65210774|NCT04101019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65210775|NCT04101019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65210776|NCT04101019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65210777|NCT04101019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65210778|NCT04101019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210779|NCT02817321|Morphine|morphine|mesh-list
65210780|NCT02817321|Ropivacaine|ropivacaine|mesh-list
65210781|NCT02817321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65210782|NCT02817321|Narcotics|narcotics|mesh-ancestor
65210783|NCT02817321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65210784|NCT02817321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210785|NCT02817321|Analgesics|analgesics|mesh-ancestor
65210786|NCT02817321|Sensory System Agents|sensory system agents|mesh-ancestor
65210787|NCT02817321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65210788|NCT02817321|Anesthetics, Local|anesthetics, local|mesh-ancestor
65210789|NCT02817321|Anesthetics|anesthetics|mesh-ancestor
65210790|NCT00844480|Zoledronic Acid|zoledronic acid|mesh-list
65210792|NCT00844480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210793|NCT04605861|Liraglutide|liraglutide|mesh-list
65210794|NCT04605861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65210795|NCT04605861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210796|NCT04605861|Incretins|incretins|mesh-ancestor
65210798|NCT04605861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65210799|NCT00771901|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
65210800|NCT00771901|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
65210801|NCT00771901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210802|NCT00771901|Antiviral Agents|antiviral agents|mesh-ancestor
65210803|NCT00771901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65210804|NCT00771901|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65210805|NCT00771901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65210806|NCT00705562|Caseins|caseins|mesh-list
65332043|NCT00576381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332044|NCT00576381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65332045|NCT00576381|Analgesics|analgesics|mesh-ancestor
65332046|NCT00576381|Sensory System Agents|sensory system agents|mesh-ancestor
65332047|NCT00576381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332048|NCT00576381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65332049|NCT00576381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65210807|NCT00705562|Chelating Agents|chelating agents|mesh-ancestor
65210808|NCT00705562|Sequestering Agents|sequestering agents|mesh-ancestor
64853555|NCT01703351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65210809|NCT00705562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210811|NCT00843856|Tacrolimus|tacrolimus|mesh-list
65210812|NCT00843856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65210813|NCT00843856|Immunologic Factors|immunologic factors|mesh-ancestor
65210814|NCT00843856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210815|NCT00843856|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65210816|NCT00843856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210817|NCT00843856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210818|NCT00843856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65210819|NCT00843856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210820|NCT00843856|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65210821|NCT00843856|Antitubercular Agents|antitubercular agents|mesh-ancestor
65210822|NCT00843856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65210823|NCT00843856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65210824|NCT04480125|Azacitidine|azacitidine|mesh-list
65210825|NCT04480125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65210826|NCT04480125|Antimetabolites|antimetabolites|mesh-ancestor
65210827|NCT04480125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210828|NCT04480125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210829|NCT04480125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210830|NCT00705640|Freund's Adjuvant|freund's adjuvant|mesh-list
65210831|NCT00705640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65210832|NCT00705640|Immunologic Factors|immunologic factors|mesh-ancestor
65210833|NCT00705640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210834|NCT00705796|Methyltestosterone|methyltestosterone|mesh-list
65210835|NCT00705796|Testosterone|testosterone|mesh-list
65210836|NCT00705796|Testosterone undecanoate|testosterone undecanoate|mesh-list
65210837|NCT00705796|Testosterone enanthate|testosterone enanthate|mesh-list
65210838|NCT00705796|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65210839|NCT00705796|Androgens|androgens|mesh-ancestor
65210840|NCT00705796|Hormones|hormones|mesh-ancestor
65210841|NCT00705796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65210842|NCT00705796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210843|NCT00705796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65210844|NCT00705796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210845|NCT00705796|Anabolic Agents|anabolic agents|mesh-ancestor
65210846|NCT00843778|Certolizumab Pegol|certolizumab pegol|mesh-list
65210847|NCT00843778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65210848|NCT00843778|Immunologic Factors|immunologic factors|mesh-ancestor
65210849|NCT00843778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210850|NCT00843778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65210851|NCT04432935|Lactoferrin|lactoferrin|mesh-list
65210852|NCT04432935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65210853|NCT00591370|Temozolomide|temozolomide|mesh-list
65210854|NCT00591370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65210855|NCT00591370|Alkylating Agents|alkylating agents|mesh-ancestor
65210856|NCT00591370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210857|NCT00591370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210858|NCT00820222|Capecitabine|capecitabine|mesh-list
65210859|NCT00820222|Trastuzumab|trastuzumab|mesh-list
65210860|NCT00820222|Lapatinib|lapatinib|mesh-list
65210861|NCT00820222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65210862|NCT00820222|Antimetabolites|antimetabolites|mesh-ancestor
65210863|NCT00820222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210864|NCT00820222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210870|NCT02815449|Micronutrients|micronutrients|mesh-ancestor
65210871|NCT02815449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332050|NCT00576381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65332051|NCT00576381|Adrenergic Agents|adrenergic agents|mesh-ancestor
65332052|NCT00576381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65332053|NCT00576381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332054|NCT02562417|Dexamethasone|dexamethasone|mesh-list
65332055|NCT02562417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65332056|NCT02562417|Antiemetics|antiemetics|mesh-ancestor
65332057|NCT02562417|Autonomic Agents|autonomic agents|mesh-ancestor
65332058|NCT02562417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332059|NCT02562417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332060|NCT02562417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65332061|NCT02562417|Glucocorticoids|glucocorticoids|mesh-ancestor
65332062|NCT02562417|Hormones|hormones|mesh-ancestor
65332063|NCT02562417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65332064|NCT02562417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65332065|NCT02562417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332066|NCT00749619|Taurolidine|taurolidine|mesh-list
65332067|NCT00749619|Heparin|heparin|mesh-list
65332068|NCT00749619|Calcium heparin|calcium heparin|mesh-list
65332069|NCT00749619|Citric Acid|citric acid|mesh-list
65332070|NCT00749619|Sodium Citrate|sodium citrate|mesh-list
65494090|NCT03701763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210872|NCT01039688|Antirheumatic Agents|antirheumatic agents|mesh-list
65210873|NCT01039688|Tofacitinib|tofacitinib|mesh-list
65210874|NCT01039688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65210875|NCT01039688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210876|NCT01039688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210877|NCT02237508|Budesonide|budesonide|mesh-list
65210878|NCT02237508|Formoterol Fumarate|formoterol fumarate|mesh-list
65210879|NCT02237508|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65210880|NCT02237508|Charcoal|charcoal|mesh-list
65210881|NCT02237508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65210882|NCT02237508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65210883|NCT02237508|Autonomic Agents|autonomic agents|mesh-ancestor
65210884|NCT02237508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65210885|NCT02237508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210886|NCT02237508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65210887|NCT02237508|Respiratory System Agents|respiratory system agents|mesh-ancestor
65210890|NCT02237508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65210891|NCT02237508|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65210892|NCT02237508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65210893|NCT02237508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65210894|NCT02237508|Adrenergic Agents|adrenergic agents|mesh-ancestor
65210895|NCT02237508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65210896|NCT02237508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210897|NCT02237508|Antidotes|antidotes|mesh-ancestor
65210898|NCT02237508|Protective Agents|protective agents|mesh-ancestor
65210899|NCT04237935|Clopidogrel|clopidogrel|mesh-list
65210900|NCT04237935|Ticagrelor|ticagrelor|mesh-list
65210901|NCT04237935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65210902|NCT04237935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65210903|NCT04237935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65210904|NCT04237935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65210905|NCT04237935|Purinergic Agents|purinergic agents|mesh-ancestor
65332071|NCT00749619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65332072|NCT00749619|Anticoagulants|anticoagulants|mesh-ancestor
65332073|NCT00749619|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65332074|NCT00749619|Chelating Agents|chelating agents|mesh-ancestor
65332075|NCT00749619|Sequestering Agents|sequestering agents|mesh-ancestor
65332076|NCT00749619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332077|NCT00749619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65332078|NCT00749619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64718023|NCT00376051|Citalopram|citalopram|mesh-list
65210906|NCT04237935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65210907|NCT04237935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210908|NCT04237935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210909|NCT05579574|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
65210910|NCT05579574|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65210911|NCT05579574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65210912|NCT05579574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65210913|NCT05579574|Contraceptive Agents|contraceptive agents|mesh-ancestor
65210914|NCT05579574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65210915|NCT05579574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210916|NCT05579574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65210917|NCT05579574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65210918|NCT05579574|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
65210919|NCT05579574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65210920|NCT03954366|Rucaparib|rucaparib|mesh-list
65210921|NCT03954366|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65210922|NCT03954366|Contraceptive Agents|contraceptive agents|mesh-list
65210923|NCT03954366|Contraceptives, Oral|contraceptives, oral|mesh-list
65210924|NCT03954366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65210925|NCT03954366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65210926|NCT03954366|Antimetabolites|antimetabolites|mesh-ancestor
65210927|NCT03954366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210928|NCT03954366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65210929|NCT03954366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65210930|NCT03954366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210931|NCT03954366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65210932|NCT03954366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210933|NCT03954366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65210936|NCT02809755|Lidocaine|lidocaine|mesh-list
65210937|NCT02809755|Anesthetics, Local|anesthetics, local|mesh-ancestor
65210938|NCT02809755|Anesthetics|anesthetics|mesh-ancestor
65210939|NCT02809755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65210940|NCT02809755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210941|NCT02809755|Sensory System Agents|sensory system agents|mesh-ancestor
65210942|NCT02809755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65210943|NCT02809755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65210944|NCT02809755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65210945|NCT02809755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65210946|NCT02809755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65210947|NCT02809755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210948|NCT02812719|Salicylic Acid|salicylic acid|mesh-list
65210949|NCT02812719|Salicylates|salicylates|mesh-list
65210950|NCT02812719|Glycolic acid|glycolic acid|mesh-list
65210951|NCT02812719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65210952|NCT02812719|Antifungal Agents|antifungal agents|mesh-ancestor
65210953|NCT02812719|Keratolytic Agents|keratolytic agents|mesh-ancestor
65210954|NCT02812719|Dermatologic Agents|dermatologic agents|mesh-ancestor
65210955|NCT02812719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65210956|NCT02812719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65210957|NCT02812719|Analgesics|analgesics|mesh-ancestor
65210958|NCT02812719|Sensory System Agents|sensory system agents|mesh-ancestor
65210959|NCT02812719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65210960|NCT02812719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210962|NCT02812719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65332079|NCT00749619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65332080|NCT00749619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65332081|NCT00749619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332082|NCT00748371|Aspirin|aspirin|mesh-list
65332083|NCT00748371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65332084|NCT00748371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65210963|NCT02812719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65210964|NCT02812719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210965|NCT02812719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210966|NCT02876978|Cyclophosphamide|cyclophosphamide|mesh-list
65210967|NCT02876978|Fludarabine|fludarabine|mesh-list
65210968|NCT02876978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65210969|NCT02876978|Immunologic Factors|immunologic factors|mesh-ancestor
65210970|NCT02876978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210971|NCT02876978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65210972|NCT02876978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65210973|NCT02876978|Alkylating Agents|alkylating agents|mesh-ancestor
65210974|NCT02876978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210975|NCT02876978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210976|NCT02876978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65210977|NCT00909480|Insulin|insulin|mesh-list
65210978|NCT00909480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65210979|NCT00909480|Insulin Glargine|insulin glargine|mesh-list
65210980|NCT00909480|Insulin Detemir|insulin detemir|mesh-list
65210981|NCT00909480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65210982|NCT00909480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210983|NCT05642715|Varenicline|varenicline|mesh-list
65210984|NCT05642715|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65210985|NCT05642715|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65210986|NCT05642715|Cholinergic Agents|cholinergic agents|mesh-ancestor
65210987|NCT05642715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65210988|NCT05642715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210989|NCT05642715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65210990|NCT02874326|Octreotide|octreotide|mesh-list
65210991|NCT02874326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65210992|NCT02874326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65210993|NCT02874326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210994|NCT02812641|Bevacizumab|bevacizumab|mesh-list
65210995|NCT02812641|Cisplatin|cisplatin|mesh-list
65210996|NCT02812641|Fluorouracil|fluorouracil|mesh-list
65210997|NCT02812641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65210998|NCT02812641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210999|NCT02812641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65211000|NCT02812641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65211001|NCT02812641|Growth Substances|growth substances|mesh-ancestor
65211002|NCT02812641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211003|NCT02812641|Growth Inhibitors|growth inhibitors|mesh-ancestor
65211004|NCT02812641|Antimetabolites|antimetabolites|mesh-ancestor
65211005|NCT02812641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211006|NCT02812641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65211009|NCT01058096|Cariprazine|cariprazine|mesh-list
65211010|NCT01058096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65211011|NCT01058096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65211012|NCT01058096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65211013|NCT01058096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211014|NCT01058096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65211015|NCT00626990|Temozolomide|temozolomide|mesh-list
65211016|NCT00626990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65211017|NCT00626990|Alkylating Agents|alkylating agents|mesh-ancestor
65211018|NCT00626990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211019|NCT00626990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65211020|NCT01057862|Naltrexone|naltrexone|mesh-list
65211021|NCT01057862|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65211022|NCT01057862|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65211023|NCT01057862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211024|NCT01057862|Sensory System Agents|sensory system agents|mesh-ancestor
65211025|NCT01057862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65211026|NCT01038128|Memantine|memantine|mesh-list
65211027|NCT01038128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65332085|NCT00748371|Analgesics|analgesics|mesh-ancestor
65332086|NCT00748371|Sensory System Agents|sensory system agents|mesh-ancestor
65332087|NCT00748371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332088|NCT00748371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332089|NCT00748371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65332090|NCT00748371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65332091|NCT00748371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65332092|NCT00748371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64718035|NCT01072526|Lubricant Eye Drops|lubricant eye drops|mesh-list
65211028|NCT01038128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65211029|NCT01038128|Dopamine Agents|dopamine agents|mesh-ancestor
65211030|NCT01038128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65211031|NCT01038128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211032|NCT01038128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211033|NCT01038128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65211034|NCT01038128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65211035|NCT04303520|Cyclophosphamide|cyclophosphamide|mesh-list
65211036|NCT04303520|Fludarabine|fludarabine|mesh-list
65211037|NCT04303520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65211038|NCT04303520|Immunologic Factors|immunologic factors|mesh-ancestor
65211039|NCT04303520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211040|NCT04303520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65211041|NCT04303520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65211042|NCT04303520|Alkylating Agents|alkylating agents|mesh-ancestor
65211043|NCT04303520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211044|NCT04303520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65211045|NCT04303520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65211046|NCT02562378|Doxorubicin|doxorubicin|mesh-list
65211047|NCT02562378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65211048|NCT02562378|Trastuzumab|trastuzumab|mesh-list
65211049|NCT02562378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65211050|NCT02562378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65211051|NCT02562378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65211052|NCT02562378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65211053|NCT02562378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65211054|NCT02562378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211055|NCT02562378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65211056|NCT00842530|Vaccines|vaccines|mesh-list
65211057|NCT00842530|Immunologic Factors|immunologic factors|mesh-ancestor
65211058|NCT00842530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211059|NCT05580510|Empagliflozin|empagliflozin|mesh-list
65211060|NCT05580510|Valsartan|valsartan|mesh-list
65211061|NCT05580510|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65211062|NCT05580510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65211063|NCT05580510|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65211064|NCT05580510|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65211065|NCT05580510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211066|NCT05580510|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65211067|NCT05580510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65211068|NCT05580510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211069|NCT02811627|Memantine|memantine|mesh-list
65211070|NCT02811627|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65211071|NCT02811627|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65211072|NCT02811627|Dopamine Agents|dopamine agents|mesh-ancestor
65211073|NCT02811627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65211074|NCT02811627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211075|NCT02811627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211076|NCT02811627|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65211077|NCT02811627|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65211083|NCT00634413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65211084|NCT00634413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211085|NCT00634413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65211086|NCT00634413|Respiratory System Agents|respiratory system agents|mesh-ancestor
65332093|NCT00748371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332094|NCT00748371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65332095|NCT00748371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65332096|NCT00748371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332097|NCT00748371|Antipyretics|antipyretics|mesh-ancestor
65332098|NCT00749853|Buserelin|buserelin|mesh-list
65332099|NCT00749853|Hormones|hormones|mesh-list
65332100|NCT00749853|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65332101|NCT00749853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65332102|NCT00749853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332103|NCT00749853|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65332104|NCT00749853|Fertility Agents|fertility agents|mesh-ancestor
65332105|NCT00749853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65332106|NCT00684567|Temozolomide|temozolomide|mesh-list
65332107|NCT00684567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65332108|NCT00684567|Alkylating Agents|alkylating agents|mesh-ancestor
65332109|NCT00684567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332110|NCT00684567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332111|NCT00752427|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65332112|NCT00752427|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65332113|NCT00752427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65332114|NCT00752427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65332115|NCT00752427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332116|NCT00752427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65332117|NCT00752427|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65211087|NCT00634413|Glucocorticoids|glucocorticoids|mesh-ancestor
65211088|NCT00634413|Hormones|hormones|mesh-ancestor
65211089|NCT00634413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65211090|NCT00634413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65211091|NCT00634413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65211092|NCT00634413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211093|NCT00634413|Vasodilator Agents|vasodilator agents|mesh-ancestor
65211094|NCT00634413|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65211095|NCT00634413|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65211096|NCT00634413|Purinergic Agents|purinergic agents|mesh-ancestor
65211097|NCT00634413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65211098|NCT02815059|Prednisone|prednisone|mesh-list
65211099|NCT02815059|Dasatinib|dasatinib|mesh-list
65211100|NCT02815059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65211101|NCT02815059|Glucocorticoids|glucocorticoids|mesh-ancestor
65211102|NCT02815059|Hormones|hormones|mesh-ancestor
65211103|NCT02815059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65211104|NCT02815059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211105|NCT02815059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65211106|NCT02815059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65211107|NCT02815059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65332118|NCT00752427|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65332119|NCT00752427|Serotonin Agents|serotonin agents|mesh-ancestor
65332120|NCT00752427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65332121|NCT00752427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332122|NCT00752427|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65332123|NCT00752427|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65332124|NCT00752427|Dopamine Agents|dopamine agents|mesh-ancestor
65332125|NCT04053621|Thiamine|thiamine|mesh-list
65332126|NCT04053621|Thiamine Pyrophosphate|thiamine pyrophosphate|mesh-list
65332127|NCT04053621|Metformin|metformin|mesh-list
65332128|NCT04053621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65332129|NCT04053621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332130|NCT04053621|Vitamin B Complex|vitamin b complex|mesh-ancestor
65332131|NCT04053621|Vitamins|vitamins|mesh-ancestor
65332132|NCT04053621|Micronutrients|micronutrients|mesh-ancestor
65332133|NCT00684411|Imatinib Mesylate|imatinib mesylate|mesh-list
65332134|NCT00684411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332135|NCT00684411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65332136|NCT00684411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718055|NCT05312840|Antiviral Agents|antiviral agents|mesh-ancestor
65211108|NCT02815059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65211109|NCT02815059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211110|NCT00819910|Rosiglitazone|rosiglitazone|mesh-list
65211111|NCT00819910|Fenofibrate|fenofibrate|mesh-list
65211112|NCT00819910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65211113|NCT00819910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211114|NCT00819910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65211115|NCT00819910|Antimetabolites|antimetabolites|mesh-ancestor
65211116|NCT00819910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211117|NCT00819910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65211118|NCT02808117|Micronutrients|micronutrients|mesh-list
65211119|NCT02808117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211121|NCT04321395|Anticonvulsants|anticonvulsants|mesh-ancestor
65211122|NCT04321395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65211123|NCT04321395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211124|NCT04321395|GABA Agents|gaba agents|mesh-ancestor
65211125|NCT04321395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65211126|NCT04321395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211127|NCT02814669|Atezolizumab|atezolizumab|mesh-list
65211128|NCT02814669|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65211129|NCT02814669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65211130|NCT02808741|Olorofim|olorofim|mesh-list
65211131|NCT02808741|Antifungal Agents|antifungal agents|mesh-ancestor
65211132|NCT02808741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65211133|NCT02807727|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65211134|NCT02807727|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65211135|NCT02807727|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65211136|NCT02807727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65211137|NCT02807571|Anesthetics|anesthetics|mesh-list
65211138|NCT02807571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65211139|NCT02807571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211140|NCT02807415|Ivacaftor|ivacaftor|mesh-list
65211141|NCT02807415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65211142|NCT02807415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65211143|NCT02807415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211144|NCT02804841|Vitamin D|vitamin d|mesh-list
65211145|NCT02804841|Ergocalciferols|ergocalciferols|mesh-list
65332137|NCT00684411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332138|NCT02562651|Doxycycline|doxycycline|mesh-list
65332139|NCT02562651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65332140|NCT02562651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65332141|NCT02562651|Antimalarials|antimalarials|mesh-ancestor
65332142|NCT02562651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65332143|NCT02562651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65332144|NCT00748527|Carboplatin|carboplatin|mesh-list
65082032|NCT00352430|Antioxidants|antioxidants|mesh-ancestor
65332145|NCT00748527|Decitabine|decitabine|mesh-list
65332146|NCT00748527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332147|NCT00748527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65332148|NCT00748527|Antimetabolites|antimetabolites|mesh-ancestor
65332149|NCT00748527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332150|NCT00748527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332151|NCT00686829|Maleic acid|maleic acid|mesh-list
65332152|NCT00686829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332153|NCT00686829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332154|NCT00687297|Carboplatin|carboplatin|mesh-list
65332155|NCT00687297|Docetaxel|docetaxel|mesh-list
65332156|NCT00687297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332157|NCT00687297|Tubulin Modulators|tubulin modulators|mesh-ancestor
65332158|NCT00687297|Antimitotic Agents|antimitotic agents|mesh-ancestor
65332159|NCT00687297|Mitosis Modulators|mitosis modulators|mesh-ancestor
65332160|NCT00687297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332161|NCT00684177|Retapamulin|retapamulin|mesh-list
65332162|NCT00684177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65332163|NCT00684177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65332164|NCT00686595|Infliximab|infliximab|mesh-list
65332165|NCT00686595|Dermatologic Agents|dermatologic agents|mesh-ancestor
65211146|NCT02804841|Cholecalciferol|cholecalciferol|mesh-list
65211147|NCT02804841|Vitamins|vitamins|mesh-list
65211148|NCT02804841|Micronutrients|micronutrients|mesh-ancestor
65211149|NCT02804841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211153|NCT00634491|Anticonvulsants|anticonvulsants|mesh-ancestor
65211154|NCT00634491|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65211155|NCT00634491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65211156|NCT00634491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211157|NCT00634491|Diuretics|diuretics|mesh-ancestor
65211158|NCT00634491|Natriuretic Agents|natriuretic agents|mesh-ancestor
65211159|NCT00634491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211160|NCT02807103|Cyclophosphamide|cyclophosphamide|mesh-list
65211161|NCT02807103|Rituximab|rituximab|mesh-list
65211162|NCT02807103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65211163|NCT02807103|Immunologic Factors|immunologic factors|mesh-ancestor
65211164|NCT02807103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211165|NCT02807103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65332166|NCT00686595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65332167|NCT00686595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65332168|NCT00752661|Tramadol|tramadol|mesh-list
65332169|NCT00752661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65332170|NCT00752661|Narcotics|narcotics|mesh-ancestor
65332171|NCT00752661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65332172|NCT00752661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332173|NCT00752661|Analgesics|analgesics|mesh-ancestor
65332174|NCT00752661|Sensory System Agents|sensory system agents|mesh-ancestor
64718104|NCT01023620|Pioglitazone|pioglitazone|mesh-list
65211166|NCT02807103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65211167|NCT02807103|Alkylating Agents|alkylating agents|mesh-ancestor
65211168|NCT02807103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211169|NCT02807103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65211170|NCT02807103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65211171|NCT02807103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65211172|NCT02806791|Lenograstim|lenograstim|mesh-list
65211173|NCT02806791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65211174|NCT02806791|Immunologic Factors|immunologic factors|mesh-ancestor
65211175|NCT02806791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211176|NCT00830128|Pregabalin|pregabalin|mesh-list
65211177|NCT00830128|Analgesics|analgesics|mesh-ancestor
65211178|NCT00830128|Sensory System Agents|sensory system agents|mesh-ancestor
65211179|NCT00830128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65211180|NCT00830128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211181|NCT00830128|Anticonvulsants|anticonvulsants|mesh-ancestor
65211182|NCT00830128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65211183|NCT00830128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65211184|NCT00830128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211185|NCT00830128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65211186|NCT00830128|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65211187|NCT00830128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65211188|NCT00830128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65211189|NCT00830128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65211190|NCT05498103|Methazolamide|methazolamide|mesh-list
65211191|NCT05498103|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65211192|NCT05498103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65211193|NCT05498103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211194|NCT05498103|Diuretics|diuretics|mesh-ancestor
65211195|NCT05498103|Natriuretic Agents|natriuretic agents|mesh-ancestor
65211196|NCT05498103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211197|NCT00771667|Ustekinumab|ustekinumab|mesh-list
65211198|NCT00771667|Dermatologic Agents|dermatologic agents|mesh-ancestor
65211199|NCT05579964|Dexmedetomidine|dexmedetomidine|mesh-list
65211200|NCT05579964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65211201|NCT05579964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65211202|NCT05579964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211203|NCT05579964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65211204|NCT05579964|Analgesics|analgesics|mesh-ancestor
65211205|NCT05579964|Sensory System Agents|sensory system agents|mesh-ancestor
65211206|NCT05579964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65211207|NCT05579964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65211208|NCT05579964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65211209|NCT05579964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65211210|NCT05579964|Adrenergic Agents|adrenergic agents|mesh-ancestor
65211211|NCT05579964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65211212|NCT05579964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211213|NCT03893175|Acetaminophen|acetaminophen|mesh-list
65211214|NCT03893175|Ibuprofen|ibuprofen|mesh-list
65211215|NCT03893175|Oxycodone|oxycodone|mesh-list
65211216|NCT03893175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65211217|NCT03893175|Analgesics|analgesics|mesh-ancestor
65211218|NCT03893175|Sensory System Agents|sensory system agents|mesh-ancestor
65211219|NCT03893175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65211220|NCT03893175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211225|NCT03893175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65332175|NCT00752661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332176|NCT00576303|Epoetin Alfa|epoetin alfa|mesh-list
65332177|NCT00576303|Hematinics|hematinics|mesh-ancestor
65332178|NCT00752739|Selenium|selenium|mesh-list
65332179|NCT00752739|Antioxidants|antioxidants|mesh-ancestor
65332180|NCT00752739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332181|NCT00752739|Protective Agents|protective agents|mesh-ancestor
65332182|NCT00752739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332183|NCT00752739|Trace Elements|trace elements|mesh-ancestor
65211226|NCT03893175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65211227|NCT03893175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211228|NCT03893175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65211229|NCT03893175|Narcotics|narcotics|mesh-ancestor
65211230|NCT03893175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65211231|NCT04236453|Tenofovir|tenofovir|mesh-list
65211232|NCT04236453|Emtricitabine|emtricitabine|mesh-list
65211233|NCT04236453|Darunavir|darunavir|mesh-list
65211234|NCT04236453|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65211235|NCT04236453|Cobicistat|cobicistat|mesh-list
65211236|NCT04236453|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65211237|NCT04236453|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
65211238|NCT04236453|Antiviral Agents|antiviral agents|mesh-ancestor
65211239|NCT04236453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65211240|NCT04236453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65211241|NCT04236453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65211242|NCT04236453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65211243|NCT04236453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211244|NCT04236453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65211245|NCT04236453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65211246|NCT04236453|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65211247|NCT04236453|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65211248|NCT04236453|Protease Inhibitors|protease inhibitors|mesh-ancestor
65211249|NCT04236453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65211250|NCT04236453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65211251|NCT03865290|Ondansetron|ondansetron|mesh-list
65211252|NCT03865290|Antiemetics|antiemetics|mesh-ancestor
65211253|NCT03865290|Autonomic Agents|autonomic agents|mesh-ancestor
65211254|NCT03865290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65211255|NCT03865290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211256|NCT03865290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65211257|NCT03865290|Antipruritics|antipruritics|mesh-ancestor
65211258|NCT03865290|Dermatologic Agents|dermatologic agents|mesh-ancestor
65211259|NCT03865290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65211260|NCT03865290|Serotonin Agents|serotonin agents|mesh-ancestor
65211261|NCT03865290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65211262|NCT03865290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211263|NCT03865290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65211264|NCT03865290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65211265|NCT03865290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65211266|NCT03865290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65211267|NCT03865290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65211268|NCT05333250|Modafinil|modafinil|mesh-list
65211269|NCT05333250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65211270|NCT05333250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211271|NCT05333250|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65211272|NCT05333250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65211273|NCT05333250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65211274|NCT05333250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211275|NCT05461339|Ranibizumab|ranibizumab|mesh-list
65211276|NCT05461339|Antibodies|antibodies|mesh-list
65211277|NCT05461339|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65211278|NCT05461339|Immunologic Factors|immunologic factors|mesh-ancestor
65211279|NCT05461339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211280|NCT05461339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65211281|NCT05461339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65211282|NCT05461339|Growth Substances|growth substances|mesh-ancestor
65332184|NCT00752739|Micronutrients|micronutrients|mesh-ancestor
65332185|NCT00755781|Cyclosporine|cyclosporine|mesh-list
65332186|NCT00755781|Cyclosporins|cyclosporins|mesh-list
65332187|NCT00755781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332188|NCT00755781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332189|NCT00755781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65211283|NCT05461339|Growth Inhibitors|growth inhibitors|mesh-ancestor
65211284|NCT05461339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65211285|NCT03409848|Nivolumab|nivolumab|mesh-list
65211286|NCT03409848|Ipilimumab|ipilimumab|mesh-list
65211287|NCT03409848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65211288|NCT03409848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65211289|NCT03409848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65211290|NCT03409848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211302|NCT02804373|Oxytocics|oxytocics|mesh-ancestor
65211303|NCT02804373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65211304|NCT02804373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211305|NCT00763321|Acetaminophen|acetaminophen|mesh-list
65211306|NCT00763321|Hydrocodone|hydrocodone|mesh-list
65211307|NCT00763321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65211308|NCT00763321|Analgesics|analgesics|mesh-ancestor
65211309|NCT00763321|Sensory System Agents|sensory system agents|mesh-ancestor
65211310|NCT00763321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65211311|NCT00763321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211312|NCT00763321|Antipyretics|antipyretics|mesh-ancestor
65211313|NCT00763321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65211314|NCT00763321|Narcotics|narcotics|mesh-ancestor
65211315|NCT00763321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65211316|NCT00763321|Antitussive Agents|antitussive agents|mesh-ancestor
65211317|NCT00763321|Respiratory System Agents|respiratory system agents|mesh-ancestor
65211318|NCT02799927|Calcium|calcium|mesh-list
65211319|NCT02799927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65211320|NCT02799927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211321|NCT00770653|Metformin|metformin|mesh-list
65211322|NCT00770653|Pioglitazone|pioglitazone|mesh-list
65211323|NCT00770653|Glimepiride|glimepiride|mesh-list
65211324|NCT00770653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65211325|NCT00770653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211326|NCT00770653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65211327|NCT00770653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65211329|NCT02799615|Infliximab|infliximab|mesh-list
65211330|NCT02799615|Dermatologic Agents|dermatologic agents|mesh-ancestor
65211331|NCT02799615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65211332|NCT02799615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65211334|NCT00819052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65211335|NCT00819052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65211336|NCT00819052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65211337|NCT00819052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211338|NCT00819052|Antiviral Agents|antiviral agents|mesh-ancestor
65211339|NCT00819052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65211340|NCT00819052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65211341|NCT00819052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65211342|NCT00819052|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65211343|NCT00819052|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65211344|NCT00763009|Dipyridamole|dipyridamole|mesh-list
65211345|NCT00763009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65211346|NCT00763009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65211347|NCT00763009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211348|NCT00763009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65211349|NCT00763009|Vasodilator Agents|vasodilator agents|mesh-ancestor
65211350|NCT02799459|Anesthetics|anesthetics|mesh-list
65211351|NCT02799459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65211352|NCT02799459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211353|NCT05477589|Cyclophosphamide|cyclophosphamide|mesh-list
65211354|NCT05477589|Melphalan|melphalan|mesh-list
65211355|NCT05477589|Busulfan|busulfan|mesh-list
65211356|NCT05477589|Fludarabine|fludarabine|mesh-list
65211361|NCT05477589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65211362|NCT05477589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65211363|NCT05477589|Alkylating Agents|alkylating agents|mesh-ancestor
65332190|NCT00755781|Immunologic Factors|immunologic factors|mesh-ancestor
65332191|NCT00755781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332192|NCT00755781|Antifungal Agents|antifungal agents|mesh-ancestor
65332193|NCT00755781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65332194|NCT00755781|Dermatologic Agents|dermatologic agents|mesh-ancestor
65332195|NCT00755781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65332196|NCT00755781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65332197|NCT00755859|Prednisone|prednisone|mesh-list
65332198|NCT00755859|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65332199|NCT00755859|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64718128|NCT04327843|Antiemetics|antiemetics|mesh-ancestor
65211364|NCT05477589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211365|NCT05477589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65211366|NCT05477589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65211367|NCT05477589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65211368|NCT05477589|Antimetabolites|antimetabolites|mesh-ancestor
65211369|NCT00841672|Amlodipine|amlodipine|mesh-list
65211370|NCT00841672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65211371|NCT00841672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65211372|NCT00841672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65211373|NCT00841672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211374|NCT00841672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65211375|NCT00841672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211376|NCT00841672|Vasodilator Agents|vasodilator agents|mesh-ancestor
65211377|NCT05549115|Amoxicillin|amoxicillin|mesh-list
65211378|NCT05549115|Clarithromycin|clarithromycin|mesh-list
65211379|NCT05549115|Levofloxacin|levofloxacin|mesh-list
65211380|NCT05549115|Ofloxacin|ofloxacin|mesh-list
65211381|NCT05549115|Furazolidone|furazolidone|mesh-list
65211382|NCT05549115|Bismuth|bismuth|mesh-list
65211383|NCT05549115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65211384|NCT05549115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65211385|NCT05549115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65211386|NCT05549115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65211387|NCT05549115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211388|NCT05549115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65211389|NCT05549115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65211390|NCT05549115|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65211391|NCT05549115|Renal Agents|renal agents|mesh-ancestor
65211392|NCT05549115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65211393|NCT05549115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65211394|NCT05549115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65211395|NCT05549115|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65211396|NCT05549115|Antacids|antacids|mesh-ancestor
65211397|NCT05549115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65211398|NCT05549115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65211399|NCT05549115|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65211400|NCT05549115|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65211401|NCT05549115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65211402|NCT05549115|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65211404|NCT04236219|Gout Suppressants|gout suppressants|mesh-ancestor
65211405|NCT04236219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65211406|NCT00908232|Dexamethasone|dexamethasone|mesh-list
65211407|NCT00908232|Cyclophosphamide|cyclophosphamide|mesh-list
65211408|NCT00908232|Lenalidomide|lenalidomide|mesh-list
65211409|NCT00908232|Bortezomib|bortezomib|mesh-list
65211410|NCT00908232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65211411|NCT00908232|Immunologic Factors|immunologic factors|mesh-ancestor
65211412|NCT00908232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211413|NCT00908232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65211414|NCT00908232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65211415|NCT00908232|Alkylating Agents|alkylating agents|mesh-ancestor
65211416|NCT00908232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211417|NCT00908232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65211418|NCT00908232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65332200|NCT00755859|Methylprednisolone|methylprednisolone|mesh-list
65332201|NCT00755859|Prednisolone|prednisolone|mesh-list
65332202|NCT00755859|Prednisolone acetate|prednisolone acetate|mesh-list
65332203|NCT00755859|Azathioprine|azathioprine|mesh-list
65332204|NCT00755859|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65332205|NCT00755859|Prednisolone phosphate|prednisolone phosphate|mesh-list
65332206|NCT00755859|Antimetabolites|antimetabolites|mesh-ancestor
65332207|NCT00755859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332208|NCT00755859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65211419|NCT00908232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65211420|NCT00908232|Antiemetics|antiemetics|mesh-ancestor
65211421|NCT00908232|Autonomic Agents|autonomic agents|mesh-ancestor
65211422|NCT00908232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65211423|NCT00908232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65211424|NCT00908232|Glucocorticoids|glucocorticoids|mesh-ancestor
65211425|NCT00908232|Hormones|hormones|mesh-ancestor
65211426|NCT00908232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65211427|NCT00908232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65211428|NCT00908232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65211433|NCT00770341|Daptomycin|daptomycin|mesh-list
65211434|NCT00770341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65211435|NCT00770341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65211436|NCT05472753|Selenium|selenium|mesh-list
65211437|NCT05472753|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
65211438|NCT05472753|Curcumin|curcumin|mesh-list
65211439|NCT05472753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65211440|NCT05472753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65211441|NCT05472753|Analgesics|analgesics|mesh-ancestor
65211442|NCT05472753|Sensory System Agents|sensory system agents|mesh-ancestor
65211443|NCT05472753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65211444|NCT05472753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211445|NCT05472753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65211446|NCT05472753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65211447|NCT05472753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65211448|NCT05472753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65211449|NCT05472753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211450|NCT05472753|Antioxidants|antioxidants|mesh-ancestor
65211451|NCT05472753|Protective Agents|protective agents|mesh-ancestor
65211452|NCT05472753|Trace Elements|trace elements|mesh-ancestor
65211453|NCT05472753|Micronutrients|micronutrients|mesh-ancestor
65211454|NCT05472753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65211455|NCT05472753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65211456|NCT03396276|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65211457|NCT03396276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65211458|NCT03396276|Narcotics|narcotics|mesh-ancestor
65211459|NCT03396276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65211460|NCT03396276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211461|NCT03396276|Analgesics|analgesics|mesh-ancestor
65211462|NCT03396276|Sensory System Agents|sensory system agents|mesh-ancestor
65211463|NCT03396276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65211464|NCT03396276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65211465|NCT02799147|Fludarabine|fludarabine|mesh-list
65211466|NCT02799147|Fludarabine phosphate|fludarabine phosphate|mesh-list
65211467|NCT02799147|Busulfan|busulfan|mesh-list
65211468|NCT02799147|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65211469|NCT02799147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65211470|NCT02799147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65211471|NCT02799147|Antimetabolites|antimetabolites|mesh-ancestor
65211472|NCT02799147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211473|NCT02799147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65211474|NCT02799147|Immunologic Factors|immunologic factors|mesh-ancestor
65211475|NCT02799147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211476|NCT02799147|Alkylating Agents|alkylating agents|mesh-ancestor
65211477|NCT02799147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65211478|NCT02799147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65211479|NCT02798913|Clopidogrel|clopidogrel|mesh-list
65211480|NCT02798913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64718142|NCT02147834|Ranolazine|ranolazine|mesh-list
65211481|NCT02798913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65211482|NCT02798913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65211483|NCT02798913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65211484|NCT02798913|Purinergic Agents|purinergic agents|mesh-ancestor
65211485|NCT02798913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65211486|NCT02798913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211487|NCT02798913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211489|NCT00762463|Diclofenac|diclofenac|mesh-list
65211490|NCT00762463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65211491|NCT00762463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65211492|NCT00762463|Analgesics|analgesics|mesh-ancestor
65211493|NCT00762463|Sensory System Agents|sensory system agents|mesh-ancestor
65211494|NCT00762463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65211495|NCT00762463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211496|NCT00762463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65211497|NCT00762463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65211498|NCT00762463|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65211499|NCT00762463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65211500|NCT00762463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65211503|NCT03326310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65211504|NCT03326310|Antimetabolites|antimetabolites|mesh-ancestor
65211505|NCT03326310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211506|NCT03326310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65211507|NCT03326310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65211508|NCT05511909|Lofexidine|lofexidine|mesh-list
65211509|NCT05511909|Buspirone|buspirone|mesh-list
65211510|NCT05511909|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65211511|NCT05511909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65211512|NCT05511909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65211513|NCT05511909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211514|NCT05511909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65211515|NCT05511909|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65211516|NCT05511909|Serotonin Agents|serotonin agents|mesh-ancestor
65211517|NCT05511909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65211518|NCT05511909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211519|NCT05511909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65211520|NCT05511909|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65211521|NCT05511909|Sensory System Agents|sensory system agents|mesh-ancestor
65211522|NCT05511909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65211523|NCT05511909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65211524|NCT05511909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65211525|NCT05511909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65211526|NCT05511909|Adrenergic Agents|adrenergic agents|mesh-ancestor
65211527|NCT00906282|Carboplatin|carboplatin|mesh-list
65211528|NCT00906282|Pemetrexed|pemetrexed|mesh-list
65211529|NCT00906282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65211530|NCT00906282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65211531|NCT00906282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211532|NCT00906282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65211533|NCT00906282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65211534|NCT02798757|Dapagliflozin|dapagliflozin|mesh-list
65211535|NCT02798757|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65211536|NCT02798757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211537|NCT02798757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65211538|NCT02798757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211539|NCT02798367|Melatonin|melatonin|mesh-list
65211540|NCT02798367|Antioxidants|antioxidants|mesh-ancestor
65211541|NCT02798367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211542|NCT02798367|Protective Agents|protective agents|mesh-ancestor
65211543|NCT02798367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211544|NCT02798367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65211545|NCT00762229|Ezetimibe|ezetimibe|mesh-list
65211546|NCT00762229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65211547|NCT00762229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65211548|NCT00762229|Antimetabolites|antimetabolites|mesh-ancestor
65211549|NCT00762229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211550|NCT00762229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65211551|NCT00907374|Benazepril|benazepril|mesh-list
65211552|NCT00907374|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65211553|NCT00907374|Protease Inhibitors|protease inhibitors|mesh-ancestor
65211554|NCT00907374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332209|NCT00755859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332210|NCT00755859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65332211|NCT00755859|Immunologic Factors|immunologic factors|mesh-ancestor
65332212|NCT00755859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332213|NCT00755859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64718146|NCT00979550|Imiquimod|imiquimod|mesh-list
65211555|NCT00907374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211556|NCT00907374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65211558|NCT02805231|Vitamins|vitamins|mesh-ancestor
65211559|NCT02805231|Micronutrients|micronutrients|mesh-ancestor
65211560|NCT02805231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211561|NCT02805231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65211562|NCT03230604|Z 350|z 350|mesh-list
65211563|NCT03230604|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65211564|NCT03230604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65211565|NCT03230604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65211566|NCT03230604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211567|NCT03230604|Hormone Antagonists|hormone antagonists|mesh-ancestor
65211568|NCT03230604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65211569|NCT03230604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211570|NCT02798055|Bosentan|bosentan|mesh-list
65211571|NCT02798055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64324786|NCT05478044|Protective Agents|protective agents|mesh-ancestor
65211575|NCT05331768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65211576|NCT05331768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65211577|NCT04235439|Insulin Lispro|insulin lispro|mesh-list
65211578|NCT04235439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65211579|NCT04235439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211580|NCT02640222|Vitamin K|vitamin k|mesh-list
65211581|NCT02640222|Rivaroxaban|rivaroxaban|mesh-list
65211582|NCT02640222|Apixaban|apixaban|mesh-list
65211583|NCT02640222|Dabigatran|dabigatran|mesh-list
65211584|NCT02640222|Vitamins|vitamins|mesh-ancestor
65211585|NCT02640222|Micronutrients|micronutrients|mesh-ancestor
65211586|NCT02640222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211587|NCT02640222|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65211588|NCT02640222|Antithrombins|antithrombins|mesh-ancestor
65211589|NCT02640222|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65211590|NCT02640222|Protease Inhibitors|protease inhibitors|mesh-ancestor
65211591|NCT02640222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65211592|NCT02640222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211593|NCT02640222|Anticoagulants|anticoagulants|mesh-ancestor
65211594|NCT02640222|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65211595|NCT02640222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65211596|NCT02640222|Hemostatics|hemostatics|mesh-ancestor
65211597|NCT02640222|Coagulants|coagulants|mesh-ancestor
65211598|NCT00818662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65211599|NCT00818662|Immunoglobulins|immunoglobulins|mesh-list
65211600|NCT00818662|Antibodies|antibodies|mesh-list
65211601|NCT00818662|gamma-Globulins|gamma-globulins|mesh-list
65211602|NCT00818662|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65211603|NCT00818662|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65211604|NCT00818662|Immunoglobulin G|immunoglobulin g|mesh-list
65211605|NCT00818662|Immunologic Factors|immunologic factors|mesh-ancestor
65211606|NCT00818662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211607|NCT03983031|Rituximab|rituximab|mesh-list
65211608|NCT03983031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65211609|NCT03983031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65211610|NCT03983031|Immunologic Factors|immunologic factors|mesh-ancestor
65211611|NCT03983031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211612|NCT03983031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65211613|NCT02797977|Gemcitabine|gemcitabine|mesh-list
65211614|NCT02797977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65211615|NCT02797977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65211616|NCT02797977|Antimetabolites|antimetabolites|mesh-ancestor
65211617|NCT02797977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211618|NCT02797977|Antiviral Agents|antiviral agents|mesh-ancestor
65211619|NCT02797977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65211620|NCT02797977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65211621|NCT02797977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65211622|NCT02797977|Immunologic Factors|immunologic factors|mesh-ancestor
65211623|NCT02797977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332214|NCT00755859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65332215|NCT00755859|Glucocorticoids|glucocorticoids|mesh-ancestor
65332216|NCT00755859|Hormones|hormones|mesh-ancestor
65082108|NCT00466128|Indomethacin|indomethacin|mesh-list
65332217|NCT00755859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64718148|NCT00979550|Immunologic Factors|immunologic factors|mesh-ancestor
65211624|NCT00703066|Vaccines|vaccines|mesh-list
65211625|NCT00703066|Immunologic Factors|immunologic factors|mesh-ancestor
65211626|NCT00703066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211627|NCT00762073|Budesonide|budesonide|mesh-list
65211628|NCT00762073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65211629|NCT00762073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65211630|NCT00762073|Autonomic Agents|autonomic agents|mesh-ancestor
65211631|NCT00762073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65211632|NCT00762073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211633|NCT00762073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65211634|NCT00762073|Respiratory System Agents|respiratory system agents|mesh-ancestor
65211635|NCT00762073|Glucocorticoids|glucocorticoids|mesh-ancestor
65211637|NCT00762073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65211638|NCT03847857|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65211639|NCT03847857|Hemostatics|hemostatics|mesh-ancestor
65211640|NCT03847857|Coagulants|coagulants|mesh-ancestor
65211641|NCT02630628|Mycophenolic Acid|mycophenolic acid|mesh-list
65211642|NCT02630628|Tacrolimus|tacrolimus|mesh-list
65211643|NCT02630628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65211644|NCT02630628|Immunologic Factors|immunologic factors|mesh-ancestor
65211645|NCT02630628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211646|NCT02630628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65211647|NCT02630628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65211659|NCT00913588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211660|NCT00913588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65211661|NCT00913588|Serotonin Agents|serotonin agents|mesh-ancestor
65211662|NCT00913588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211663|NCT00913588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65211664|NCT00913588|Antidepressive Agents|antidepressive agents|mesh-ancestor
65211665|NCT00913588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65211666|NCT00913588|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65211667|NCT00913588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65211668|NCT00913588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65211669|NCT02616666|Dapagliflozin|dapagliflozin|mesh-list
65211670|NCT02616666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65211671|NCT02616666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211672|NCT02616666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65211673|NCT02616666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211674|NCT02797587|Nicotine|nicotine|mesh-list
65211675|NCT02797587|Varenicline|varenicline|mesh-list
65211676|NCT02797587|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65211677|NCT02797587|Autonomic Agents|autonomic agents|mesh-ancestor
65211678|NCT02797587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65211679|NCT02797587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211680|NCT02797587|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65211681|NCT02797587|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65211682|NCT02797587|Cholinergic Agents|cholinergic agents|mesh-ancestor
65211683|NCT02797587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65211684|NCT02797587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211685|NCT00761605|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65211686|NCT00761605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65211687|NCT00761605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65211688|NCT00761605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65211689|NCT00761605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211690|NCT00761605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65211691|NCT00761605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65211692|NCT00761605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65211693|NCT00761605|Serotonin Agents|serotonin agents|mesh-ancestor
65211694|NCT00761605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65211695|NCT00761605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211696|NCT00761605|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65211697|NCT00761605|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65332218|NCT00755859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65332219|NCT00755859|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65332220|NCT00755859|Protective Agents|protective agents|mesh-ancestor
65332221|NCT00755859|Antiemetics|antiemetics|mesh-ancestor
65332222|NCT00755859|Autonomic Agents|autonomic agents|mesh-ancestor
65332223|NCT00755859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332224|NCT00755859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65332225|NCT00686517|Interferons|interferons|mesh-list
65332226|NCT00686517|Ribavirin|ribavirin|mesh-list
65332227|NCT00686517|Interferon-alpha|interferon-alpha|mesh-list
65211698|NCT00761605|Dopamine Agents|dopamine agents|mesh-ancestor
65211699|NCT00761527|Desloratadine|desloratadine|mesh-list
65211700|NCT00761527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65211701|NCT00761527|Cholinergic Agents|cholinergic agents|mesh-ancestor
65211703|NCT00761527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211704|NCT00761527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211705|NCT00761527|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65211706|NCT00761527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65211707|NCT00761527|Histamine Antagonists|histamine antagonists|mesh-ancestor
65211708|NCT00761527|Histamine Agents|histamine agents|mesh-ancestor
65211712|NCT00770029|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65211713|NCT00770029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65211714|NCT00770029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65211715|NCT00770029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211716|NCT00770029|Cholinergic Agents|cholinergic agents|mesh-ancestor
65211717|NCT00770029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65211718|NCT00770029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211719|NCT00770029|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65211720|NCT00770029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65211722|NCT04235985|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65211723|NCT04235985|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65211724|NCT04235985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65211725|NCT04235985|Disinfectants|disinfectants|mesh-ancestor
65211726|NCT04235985|Dermatologic Agents|dermatologic agents|mesh-ancestor
65211727|NCT00769561|Salicylic Acid|salicylic acid|mesh-list
65211728|NCT00769561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65211729|NCT00769561|Antifungal Agents|antifungal agents|mesh-ancestor
65211730|NCT00769561|Keratolytic Agents|keratolytic agents|mesh-ancestor
65211731|NCT00769561|Dermatologic Agents|dermatologic agents|mesh-ancestor
65211732|NCT02797041|Bortezomib|bortezomib|mesh-list
65211733|NCT02797041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65211734|NCT02794779|Oxytocin|oxytocin|mesh-list
65211735|NCT02794779|Oxytocics|oxytocics|mesh-ancestor
65211736|NCT02794779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65211737|NCT02794779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211738|NCT00761215|Tedizolid phosphate|tedizolid phosphate|mesh-list
65211739|NCT00761215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65211740|NCT00761215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65211741|NCT05805098|Cytarabine|cytarabine|mesh-list
65211742|NCT05805098|Venetoclax|venetoclax|mesh-list
65211743|NCT05805098|Homoharringtonine|homoharringtonine|mesh-list
65211744|NCT05805098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65211745|NCT05805098|Antimetabolites|antimetabolites|mesh-ancestor
65211746|NCT05805098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211747|NCT05805098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65211748|NCT05805098|Antiviral Agents|antiviral agents|mesh-ancestor
65211749|NCT05805098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65211750|NCT05805098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65211751|NCT05805098|Immunologic Factors|immunologic factors|mesh-ancestor
65211752|NCT05805098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211753|NCT05805098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65211754|NCT05805098|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65211755|NCT05805098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65211756|NCT05805072|Cytarabine|cytarabine|mesh-list
65211757|NCT05805072|Azacitidine|azacitidine|mesh-list
65211758|NCT05805072|Decitabine|decitabine|mesh-list
65211759|NCT05805072|Homoharringtonine|homoharringtonine|mesh-list
65211760|NCT05805072|Aclacinomycins|aclacinomycins|mesh-list
65332228|NCT00686517|Interferon alpha-2|interferon alpha-2|mesh-list
65332229|NCT00686517|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65332230|NCT00686517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332231|NCT00686517|Antiviral Agents|antiviral agents|mesh-ancestor
65332232|NCT00686517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65332233|NCT00686517|Antimetabolites|antimetabolites|mesh-ancestor
64718162|NCT00379730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65211761|NCT05805072|Lenograstim|lenograstim|mesh-list
65211762|NCT05805072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65211763|NCT05805072|Antimetabolites|antimetabolites|mesh-ancestor
65211764|NCT05805072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211765|NCT05805072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65211766|NCT05805072|Antiviral Agents|antiviral agents|mesh-ancestor
65211767|NCT05805072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65211768|NCT05805072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65211769|NCT05805072|Immunologic Factors|immunologic factors|mesh-ancestor
65211770|NCT05805072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211771|NCT05805072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65211772|NCT05805072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65211773|NCT05805072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65211774|NCT05805072|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65211775|NCT05805072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65211776|NCT05804903|Fexofenadine|fexofenadine|mesh-list
65211777|NCT05804903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65211778|NCT05804903|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65211779|NCT05804903|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65211780|NCT05804903|Histamine Antagonists|histamine antagonists|mesh-ancestor
65211781|NCT05804903|Histamine Agents|histamine agents|mesh-ancestor
65211782|NCT05804903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65211783|NCT05804903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211790|NCT05804734|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65211791|NCT05804734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65211792|NCT05804734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211793|NCT05804734|Hemostatics|hemostatics|mesh-ancestor
65211794|NCT05804734|Coagulants|coagulants|mesh-ancestor
65211795|NCT05804721|Aripiprazole|aripiprazole|mesh-list
65211796|NCT05804721|Antidepressive Agents|antidepressive agents|mesh-ancestor
65211797|NCT05804721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65211798|NCT05804721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65211799|NCT05804721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65211800|NCT05804721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65211801|NCT05804721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211802|NCT05804721|Dopamine Agonists|dopamine agonists|mesh-ancestor
65211803|NCT05804721|Dopamine Agents|dopamine agents|mesh-ancestor
65211804|NCT05804721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65211805|NCT05804721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211806|NCT05804721|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65211807|NCT05804721|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65211808|NCT05804721|Serotonin Agents|serotonin agents|mesh-ancestor
65211809|NCT05804721|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65211810|NCT05804721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65211811|NCT05804721|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65211812|NCT05804721|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65211813|NCT05804708|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
65211814|NCT05804708|Hallucinogens|hallucinogens|mesh-ancestor
65211815|NCT05804708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211816|NCT05804708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65211817|NCT05804708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65211818|NCT05804708|Serotonin Agents|serotonin agents|mesh-ancestor
65211819|NCT05804708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65211820|NCT05804708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211821|NCT05804708|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65211822|NCT05804630|Lidocaine|lidocaine|mesh-list
65211823|NCT05804630|Anesthetics|anesthetics|mesh-list
65211824|NCT05804630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65211825|NCT05804630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211826|NCT05804630|Anesthetics, Local|anesthetics, local|mesh-ancestor
65211827|NCT05804630|Sensory System Agents|sensory system agents|mesh-ancestor
65332234|NCT00686517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332235|NCT00686517|Immunologic Factors|immunologic factors|mesh-ancestor
65332236|NCT00686517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332237|NCT00571701|Celecoxib|celecoxib|mesh-list
65332238|NCT00571701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65332239|NCT00571701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65332240|NCT00571701|Analgesics|analgesics|mesh-ancestor
65332241|NCT00571701|Sensory System Agents|sensory system agents|mesh-ancestor
65332242|NCT00571701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332243|NCT00571701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332244|NCT00571701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65332245|NCT00571701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65332246|NCT00571701|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65211828|NCT05804630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65211829|NCT05804630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65211830|NCT05804630|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65211831|NCT05804630|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65211832|NCT05804630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65211833|NCT05804630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211834|NCT05804591|Pregabalin|pregabalin|mesh-list
65211835|NCT05804591|Analgesics|analgesics|mesh-ancestor
65211836|NCT05804591|Sensory System Agents|sensory system agents|mesh-ancestor
65211837|NCT05804591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65211838|NCT05804591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211839|NCT05804591|Anticonvulsants|anticonvulsants|mesh-ancestor
65211840|NCT05804591|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65211841|NCT05804591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65211842|NCT05804591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211843|NCT05804591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65211844|NCT05804591|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65211845|NCT05804591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65211846|NCT05804591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65211847|NCT05804591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65211848|NCT05804370|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65211849|NCT05804370|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65211850|NCT05804370|Dermatologic Agents|dermatologic agents|mesh-ancestor
65211851|NCT05804305|Misoprostol|misoprostol|mesh-list
65211852|NCT05804305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65211853|NCT05804305|Abortifacient Agents|abortifacient agents|mesh-ancestor
65211854|NCT05804305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65211855|NCT05804305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211891|NCT05804032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65211892|NCT05804032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65211893|NCT05804032|Growth Substances|growth substances|mesh-ancestor
65211894|NCT05804032|Growth Inhibitors|growth inhibitors|mesh-ancestor
65211896|NCT05803941|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65211897|NCT05803941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211898|NCT05803863|Atropine|atropine|mesh-list
65211899|NCT05803863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65211900|NCT05803863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65211901|NCT05803863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65211902|NCT05803863|Autonomic Agents|autonomic agents|mesh-ancestor
65211903|NCT05803863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65211904|NCT05803863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211905|NCT05803863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65211906|NCT05803863|Respiratory System Agents|respiratory system agents|mesh-ancestor
65211907|NCT05803863|Mydriatics|mydriatics|mesh-ancestor
65211908|NCT05803863|Parasympatholytics|parasympatholytics|mesh-ancestor
65211909|NCT05803863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65332247|NCT00571701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65332248|NCT00571701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332249|NCT00571701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332250|NCT00686127|Lidocaine|lidocaine|mesh-list
65332251|NCT00686127|Anesthetics, Local|anesthetics, local|mesh-ancestor
65332252|NCT00686127|Anesthetics|anesthetics|mesh-ancestor
65211910|NCT05803863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65211911|NCT05803863|Cholinergic Agents|cholinergic agents|mesh-ancestor
65211912|NCT05803863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65211913|NCT05803863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211914|NCT05803811|Riboflavin|riboflavin|mesh-list
65211915|NCT05803811|Vitamin B Complex|vitamin b complex|mesh-ancestor
65211916|NCT05803811|Vitamins|vitamins|mesh-ancestor
65211917|NCT05803811|Micronutrients|micronutrients|mesh-ancestor
65211918|NCT05803811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211919|NCT05803811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65211920|NCT05803811|Dermatologic Agents|dermatologic agents|mesh-ancestor
65211921|NCT05803746|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65211922|NCT05803746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65211923|NCT05803746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211924|NCT05803642|Haloperidol|haloperidol|mesh-list
65211925|NCT05803642|Olanzapine|olanzapine|mesh-list
65211926|NCT05803642|Haloperidol decanoate|haloperidol decanoate|mesh-list
65211927|NCT05803642|Antiemetics|antiemetics|mesh-ancestor
65211928|NCT05803642|Autonomic Agents|autonomic agents|mesh-ancestor
65211929|NCT05803642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65211930|NCT05803642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211931|NCT05803642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65211933|NCT05803642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65211934|NCT05803642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65211935|NCT05803642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65211936|NCT05803642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65211937|NCT05803642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65211938|NCT05803642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65211939|NCT05803642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211940|NCT05803642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65211941|NCT05803642|Serotonin Agents|serotonin agents|mesh-ancestor
65211942|NCT05803642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65211943|NCT05803642|Dopamine Agents|dopamine agents|mesh-ancestor
65211944|NCT05803642|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65211945|NCT05803590|Chlorhexidine|chlorhexidine|mesh-list
65211946|NCT05803590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65211947|NCT05803590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65211948|NCT05803590|Disinfectants|disinfectants|mesh-ancestor
65211949|NCT05803551|Ketamine|ketamine|mesh-list
65211950|NCT05803551|Analgesics|analgesics|mesh-ancestor
65211951|NCT05803551|Sensory System Agents|sensory system agents|mesh-ancestor
65211952|NCT05803551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65211953|NCT05803551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211954|NCT05803551|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65211955|NCT05803551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65211956|NCT05803551|Anesthetics, General|anesthetics, general|mesh-ancestor
65211957|NCT05803551|Anesthetics|anesthetics|mesh-ancestor
65211958|NCT05803551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65211959|NCT05803551|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65211960|NCT05803551|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65211961|NCT05803551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65211962|NCT05803551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211963|NCT05803148|Midodrine|midodrine|mesh-list
65211964|NCT05803148|Sympathomimetics|sympathomimetics|mesh-ancestor
65211969|NCT05803148|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65211970|NCT05803148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65211971|NCT05803148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65211972|NCT05803148|Adrenergic Agents|adrenergic agents|mesh-ancestor
65211973|NCT05803148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65211974|NCT05803148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211975|NCT05803135|Tofacitinib|tofacitinib|mesh-list
65211976|NCT05803135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65211977|NCT05803135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332253|NCT00686127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65332254|NCT00686127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332255|NCT00686127|Sensory System Agents|sensory system agents|mesh-ancestor
64718189|NCT00843986|Natriuretic Agents|natriuretic agents|mesh-ancestor
65211978|NCT05803135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211979|NCT05803096|Nitrous Oxide|nitrous oxide|mesh-list
65211980|NCT05803096|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65211981|NCT05803096|Anesthetics, General|anesthetics, general|mesh-ancestor
65211982|NCT05803096|Anesthetics|anesthetics|mesh-ancestor
65211983|NCT05803096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65211984|NCT05803096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211985|NCT05803096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65211986|NCT05803096|Analgesics|analgesics|mesh-ancestor
65211987|NCT05803096|Sensory System Agents|sensory system agents|mesh-ancestor
65211988|NCT05803096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65211989|NCT05803083|Hyaluronic Acid|hyaluronic acid|mesh-list
65211990|NCT05803083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65211991|NCT05803083|Immunologic Factors|immunologic factors|mesh-ancestor
65211992|NCT05803083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211993|NCT05803083|Viscosupplements|viscosupplements|mesh-ancestor
65211994|NCT05803083|Protective Agents|protective agents|mesh-ancestor
65211995|NCT05803070|Cetirizine|cetirizine|mesh-list
65211996|NCT05803070|Betamethasone|betamethasone|mesh-list
65211997|NCT05803070|Betamethasone Valerate|betamethasone valerate|mesh-list
65211998|NCT05803070|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65211999|NCT05803070|Betamethasone benzoate|betamethasone benzoate|mesh-list
65212000|NCT05803070|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64854762|NCT01710761|Caffeine|caffeine|mesh-list
65212001|NCT05803070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65212002|NCT05803070|Glucocorticoids|glucocorticoids|mesh-ancestor
65212004|NCT05803070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65212005|NCT05803070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212006|NCT05803070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65212007|NCT05803070|Respiratory System Agents|respiratory system agents|mesh-ancestor
65212008|NCT05803070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65212009|NCT05803070|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65212010|NCT05803070|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65212011|NCT05803070|Histamine Antagonists|histamine antagonists|mesh-ancestor
65212012|NCT05803070|Histamine Agents|histamine agents|mesh-ancestor
65212013|NCT05803070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65212014|NCT05803070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212015|NCT05803031|Tea Tree Oil|tea tree oil|mesh-list
65212016|NCT05803031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65212017|NCT05803031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65212018|NCT05802992|Dexamethasone|dexamethasone|mesh-list
65212019|NCT05802992|Dexamethasone acetate|dexamethasone acetate|mesh-list
65212020|NCT05802992|Lenalidomide|lenalidomide|mesh-list
65212021|NCT05802992|Colchicine|colchicine|mesh-list
65212022|NCT05802992|BB 1101|bb 1101|mesh-list
65212023|NCT05802992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65212024|NCT05802992|Antiemetics|antiemetics|mesh-ancestor
65212025|NCT05802992|Autonomic Agents|autonomic agents|mesh-ancestor
65212026|NCT05802992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65212027|NCT05802992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212028|NCT05802992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65212029|NCT05802992|Glucocorticoids|glucocorticoids|mesh-ancestor
65212030|NCT05802992|Hormones|hormones|mesh-ancestor
65212031|NCT05802992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65212032|NCT05802992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65212033|NCT05802992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212034|NCT05802992|Protease Inhibitors|protease inhibitors|mesh-ancestor
65212035|NCT05802992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212043|NCT05802992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65212044|NCT05802992|Tubulin Modulators|tubulin modulators|mesh-ancestor
65212045|NCT05802992|Antimitotic Agents|antimitotic agents|mesh-ancestor
65212046|NCT05802992|Mitosis Modulators|mitosis modulators|mesh-ancestor
65212047|NCT05802979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-list
65212049|NCT05802888|Tetracycline|tetracycline|mesh-list
65212050|NCT05802888|Esomeprazole|esomeprazole|mesh-list
65212051|NCT05802888|Bismuth|bismuth|mesh-list
65212052|NCT05802888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65212053|NCT05802888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65212054|NCT05802888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65332256|NCT00686127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332257|NCT00686127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65332258|NCT00686127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65332259|NCT00686127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65332260|NCT00686127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65212055|NCT05802888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65212056|NCT05802888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65212057|NCT05802888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212058|NCT05802888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212059|NCT05802888|Antacids|antacids|mesh-ancestor
65212060|NCT05802888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65212061|NCT05802862|Insulin|insulin|mesh-list
65212062|NCT05802862|Insulin Aspart|insulin aspart|mesh-list
65212063|NCT05802862|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65212064|NCT05802862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65212065|NCT05802862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212066|NCT05802056|Calcium, Dietary|calcium, dietary|mesh-list
65212067|NCT05802056|Leucovorin|leucovorin|mesh-list
65212068|NCT05802056|Folic Acid|folic acid|mesh-list
65212069|NCT05802056|Aldesleukin|aldesleukin|mesh-list
65212070|NCT05802056|Fluorouracil|fluorouracil|mesh-list
65212071|NCT05802056|Oxaliplatin|oxaliplatin|mesh-list
65212072|NCT05802056|Nivolumab|nivolumab|mesh-list
65212073|NCT05802056|Interleukin-2|interleukin-2|mesh-list
65212074|NCT05802056|Calcium|calcium|mesh-list
65212075|NCT05802056|Levoleucovorin|levoleucovorin|mesh-list
65212076|NCT05802056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65212077|NCT05802056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212078|NCT05802056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65212079|NCT05802056|Antimetabolites|antimetabolites|mesh-ancestor
65212080|NCT05802056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212081|NCT05802056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65212082|NCT05802056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212083|NCT05802056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65212084|NCT05802056|Immunologic Factors|immunologic factors|mesh-ancestor
65212085|NCT05802056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65212086|NCT05802056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65212088|NCT05802056|Protective Agents|protective agents|mesh-ancestor
65212089|NCT05802056|Vitamin B Complex|vitamin b complex|mesh-ancestor
65212090|NCT05802056|Vitamins|vitamins|mesh-ancestor
65212091|NCT05802056|Micronutrients|micronutrients|mesh-ancestor
65212092|NCT05802056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65212093|NCT05802056|Analgesics|analgesics|mesh-ancestor
65212094|NCT05802056|Sensory System Agents|sensory system agents|mesh-ancestor
65212095|NCT05802056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65212096|NCT05802056|Hematinics|hematinics|mesh-ancestor
65212097|NCT05802056|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65212098|NCT05802056|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65212099|NCT05802056|Antiviral Agents|antiviral agents|mesh-ancestor
65212100|NCT05802056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65212101|NCT05801146|Botulinum Toxins|botulinum toxins|mesh-list
65212102|NCT05801146|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65212103|NCT05801146|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65212104|NCT05801146|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65212105|NCT05801146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65212106|NCT05801146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212109|NCT05801146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212111|NCT05801146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65212112|NCT05800574|Cisplatin|cisplatin|mesh-list
65212113|NCT05800574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212114|NCT05799326|Levofloxacin|levofloxacin|mesh-list
65212115|NCT05799326|Ofloxacin|ofloxacin|mesh-list
65212116|NCT05799326|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65212117|NCT05799326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65212118|NCT05799326|Renal Agents|renal agents|mesh-ancestor
65212119|NCT05799326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65212120|NCT05799326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65212121|NCT05799326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65212122|NCT05799326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212123|NCT05799326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212124|NCT05799326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332261|NCT00686127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332262|NCT00718718|Methotrexate|methotrexate|mesh-list
65332263|NCT00718718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65332264|NCT00718718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65212125|NCT05799326|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65212126|NCT05799326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65212127|NCT05776875|Bevacizumab|bevacizumab|mesh-list
65212128|NCT05776875|Atezolizumab|atezolizumab|mesh-list
65212129|NCT05776875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65212130|NCT05776875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212131|NCT05776875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65212132|NCT05776875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65212133|NCT05776875|Growth Substances|growth substances|mesh-ancestor
65212134|NCT05776875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212135|NCT05776875|Growth Inhibitors|growth inhibitors|mesh-ancestor
65212136|NCT05776290|Hyaluronic Acid|hyaluronic acid|mesh-list
65212137|NCT05776290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65212138|NCT05776290|Immunologic Factors|immunologic factors|mesh-ancestor
65212139|NCT05776290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212140|NCT05776290|Viscosupplements|viscosupplements|mesh-ancestor
65212141|NCT05776290|Protective Agents|protective agents|mesh-ancestor
65212142|NCT05772169|Mifepristone|mifepristone|mesh-list
65212143|NCT05772169|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65212144|NCT05772169|Abortifacient Agents|abortifacient agents|mesh-ancestor
65212145|NCT05772169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65212146|NCT05772169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212147|NCT05772169|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65212148|NCT05772169|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65212149|NCT05772169|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65212150|NCT05772169|Contraceptive Agents|contraceptive agents|mesh-ancestor
65212151|NCT05772169|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65212152|NCT05772169|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64854915|NCT01711567|Tenofovir|tenofovir|mesh-list
65212153|NCT05772169|Hormone Antagonists|hormone antagonists|mesh-ancestor
65212154|NCT05772169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65212155|NCT05772169|Luteolytic Agents|luteolytic agents|mesh-ancestor
65212156|NCT05772169|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65212157|NCT05772169|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65212159|NCT05768711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212160|NCT05766670|Vancomycin|vancomycin|mesh-list
65212161|NCT05766670|Gentamicins|gentamicins|mesh-list
65212162|NCT05766670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65212163|NCT05766670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65212164|NCT05766670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65212165|NCT05766670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212166|NCT05766670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212167|NCT05765227|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65212168|NCT05765227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65212169|NCT05765227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65212170|NCT05761444|Atorvastatin|atorvastatin|mesh-list
65212171|NCT05761444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65212172|NCT05761444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65212173|NCT05761444|Antimetabolites|antimetabolites|mesh-ancestor
65212174|NCT05761444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212175|NCT05761444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65212176|NCT05761444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65212177|NCT05761444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212178|NCT05758948|Formaldehyde|formaldehyde|mesh-list
65212180|NCT05758948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65212181|NCT05757791|Empagliflozin|empagliflozin|mesh-list
65212182|NCT05757791|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65212183|NCT05757791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212184|NCT05757791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65212185|NCT05757791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212186|NCT05756153|Cetuximab|cetuximab|mesh-list
65212187|NCT05756153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65212188|NCT05756153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212189|NCT05752734|Dexamethasone|dexamethasone|mesh-list
65212190|NCT05752734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65332265|NCT00718718|Abortifacient Agents|abortifacient agents|mesh-ancestor
65332266|NCT00718718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65332267|NCT00718718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332268|NCT00718718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65332269|NCT00718718|Antimetabolites|antimetabolites|mesh-ancestor
65332270|NCT00718718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332271|NCT00718718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332272|NCT00718718|Dermatologic Agents|dermatologic agents|mesh-ancestor
65212191|NCT05752734|Antiemetics|antiemetics|mesh-ancestor
65212192|NCT05752734|Autonomic Agents|autonomic agents|mesh-ancestor
65212193|NCT05752734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65212194|NCT05752734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212195|NCT05752734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65212196|NCT05752734|Glucocorticoids|glucocorticoids|mesh-ancestor
65212197|NCT05752734|Hormones|hormones|mesh-ancestor
65212198|NCT05752734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65212199|NCT05752734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65212200|NCT05752734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212201|NCT05733923|Sodium Hypochlorite|sodium hypochlorite|mesh-list
65212202|NCT05733923|Eusol|eusol|mesh-list
65212203|NCT05733923|Disinfectants|disinfectants|mesh-ancestor
65212204|NCT05733923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65212205|NCT05728775|Propofol|propofol|mesh-list
65212206|NCT05728775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65212207|NCT05728775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65212208|NCT05728775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212209|NCT05728775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65212210|NCT05728775|Anesthetics, General|anesthetics, general|mesh-ancestor
65212211|NCT05728775|Anesthetics|anesthetics|mesh-ancestor
65212212|NCT05715671|Esketamine|esketamine|mesh-list
65212213|NCT05715671|Antidepressive Agents|antidepressive agents|mesh-ancestor
65212214|NCT05715671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65212215|NCT05707208|Lidocaine|lidocaine|mesh-list
65212216|NCT05707208|Anesthetics, Local|anesthetics, local|mesh-ancestor
65212217|NCT05707208|Anesthetics|anesthetics|mesh-ancestor
65212218|NCT05707208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65212219|NCT05707208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212220|NCT05707208|Sensory System Agents|sensory system agents|mesh-ancestor
65212221|NCT05707208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65212222|NCT05707208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65212223|NCT05707208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65212224|NCT05707208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65212225|NCT05707208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65212226|NCT05707208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854987|NCT01711905|Vitamin D|vitamin d|mesh-list
65212227|NCT05705089|Warfarin|warfarin|mesh-list
65212228|NCT05705089|Rivaroxaban|rivaroxaban|mesh-list
65212229|NCT05705089|Anticoagulants|anticoagulants|mesh-ancestor
65212230|NCT05705089|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65212231|NCT05705089|Antithrombins|antithrombins|mesh-ancestor
65212232|NCT05705089|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65212233|NCT05705089|Protease Inhibitors|protease inhibitors|mesh-ancestor
65212234|NCT05705089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212235|NCT05705089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212237|NCT05701917|Calcium heparin|calcium heparin|mesh-list
65212238|NCT05701917|Rivaroxaban|rivaroxaban|mesh-list
65212239|NCT05701917|Apixaban|apixaban|mesh-list
65212240|NCT05701917|Warfarin|warfarin|mesh-list
65212241|NCT05701917|Anticoagulants|anticoagulants|mesh-ancestor
65212242|NCT05701917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65212243|NCT05701917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65212244|NCT05701917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212245|NCT05701917|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65212246|NCT05701917|Antithrombins|antithrombins|mesh-ancestor
65212247|NCT05701917|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65212248|NCT05701917|Protease Inhibitors|protease inhibitors|mesh-ancestor
65212249|NCT05701917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212250|NCT05693766|Capecitabine|capecitabine|mesh-list
65332273|NCT00718718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332274|NCT00718718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65332275|NCT00718718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65332276|NCT00718718|Immunologic Factors|immunologic factors|mesh-ancestor
65332277|NCT00718718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65332278|NCT00718718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65332279|NCT00683787|Docetaxel|docetaxel|mesh-list
65332280|NCT00683787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212251|NCT05693766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65212252|NCT05693766|Antimetabolites|antimetabolites|mesh-ancestor
65212253|NCT05693766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212254|NCT05693766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212265|NCT05683691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212266|NCT05683691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65212267|NCT05683691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65212269|NCT05672901|Estrogens|estrogens|mesh-ancestor
65212270|NCT05672901|Hormones|hormones|mesh-ancestor
65212271|NCT05672901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65212272|NCT05672901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212273|NCT05671822|Capecitabine|capecitabine|mesh-list
65212274|NCT05671822|Oxaliplatin|oxaliplatin|mesh-list
65212275|NCT05671822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65212276|NCT05671822|Antimetabolites|antimetabolites|mesh-ancestor
65212277|NCT05671822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212278|NCT05671822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212279|NCT05661578|Atezolizumab|atezolizumab|mesh-list
65212280|NCT05661578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212281|NCT05649540|Amoxicillin|amoxicillin|mesh-list
65212282|NCT05649540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65212283|NCT05649540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65212284|NCT05646693|Sertraline|sertraline|mesh-list
65212285|NCT05646693|Magnesium Oxide|magnesium oxide|mesh-list
65212286|NCT05646693|Antidepressive Agents|antidepressive agents|mesh-ancestor
65212287|NCT05646693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65212288|NCT05646693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65212289|NCT05646693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65212290|NCT05646693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65212291|NCT05646693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212292|NCT05646693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65212293|NCT05646693|Serotonin Agents|serotonin agents|mesh-ancestor
65212294|NCT05646693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212295|NCT05646693|Antacids|antacids|mesh-ancestor
65212296|NCT05646693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65212297|NCT05640102|Zanubrutinib|zanubrutinib|mesh-list
65212298|NCT05640102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212299|NCT05640102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65212300|NCT05640102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212301|NCT05640102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212302|NCT05627232|Diphenhydramine|diphenhydramine|mesh-list
65212303|NCT05627232|Promethazine|promethazine|mesh-list
65212304|NCT05627232|Cytarabine|cytarabine|mesh-list
65212305|NCT05627232|Daunorubicin|daunorubicin|mesh-list
65212307|NCT05627232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65212308|NCT05627232|Antimetabolites|antimetabolites|mesh-ancestor
65212309|NCT05627232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212311|NCT05627232|Antiviral Agents|antiviral agents|mesh-ancestor
65212312|NCT05627232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65212313|NCT05627232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65212314|NCT05627232|Immunologic Factors|immunologic factors|mesh-ancestor
65212315|NCT05627232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212316|NCT05627232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65212317|NCT05627232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65212318|NCT05627232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65212319|NCT05627232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212321|NCT05627232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65212322|NCT05627232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65212323|NCT05627232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65332281|NCT00683787|Tubulin Modulators|tubulin modulators|mesh-ancestor
65332282|NCT00683787|Antimitotic Agents|antimitotic agents|mesh-ancestor
65332283|NCT00683787|Mitosis Modulators|mitosis modulators|mesh-ancestor
65332284|NCT00683787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332285|NCT05393271|Midazolam|midazolam|mesh-list
65332286|NCT05393271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65332287|NCT05393271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65332288|NCT05393271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64718218|NCT03610633|Oxytocin|oxytocin|mesh-list
65212324|NCT05627232|Anesthetics, Local|anesthetics, local|mesh-ancestor
65212325|NCT05627232|Anesthetics|anesthetics|mesh-ancestor
65212326|NCT05627232|Sensory System Agents|sensory system agents|mesh-ancestor
65212327|NCT05627232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65212328|NCT05627232|Antiemetics|antiemetics|mesh-ancestor
65212329|NCT05627232|Autonomic Agents|autonomic agents|mesh-ancestor
65212330|NCT05627232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65212331|NCT05627232|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65212332|NCT05627232|Histamine Antagonists|histamine antagonists|mesh-ancestor
65212333|NCT05627232|Histamine Agents|histamine agents|mesh-ancestor
65212334|NCT05627232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65212335|NCT05627232|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65212336|NCT05627232|Antipruritics|antipruritics|mesh-ancestor
65212337|NCT05627232|Dermatologic Agents|dermatologic agents|mesh-ancestor
65212338|NCT05626322|Lenalidomide|lenalidomide|mesh-list
65212339|NCT05626322|Immunologic Factors|immunologic factors|mesh-ancestor
65212340|NCT05626322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212341|NCT05626322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65212342|NCT05626322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65212343|NCT05626322|Growth Substances|growth substances|mesh-ancestor
65212344|NCT05626322|Growth Inhibitors|growth inhibitors|mesh-ancestor
65212345|NCT05626322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212346|NCT05624359|Ropivacaine|ropivacaine|mesh-list
65212347|NCT05624359|Anesthetics, Local|anesthetics, local|mesh-ancestor
65212348|NCT05624359|Anesthetics|anesthetics|mesh-ancestor
65212349|NCT05624359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65212350|NCT05624359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212351|NCT05624359|Sensory System Agents|sensory system agents|mesh-ancestor
65212352|NCT05624359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65212353|NCT05616624|Gemcitabine|gemcitabine|mesh-list
65212354|NCT05616624|Docetaxel|docetaxel|mesh-list
65212355|NCT05616624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65212356|NCT05616624|Antimetabolites|antimetabolites|mesh-ancestor
65212357|NCT05616624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212358|NCT05616624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212359|NCT05616624|Antiviral Agents|antiviral agents|mesh-ancestor
65212360|NCT05616624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65212361|NCT05616624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212362|NCT05616624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65212363|NCT05616624|Immunologic Factors|immunologic factors|mesh-ancestor
65212364|NCT05616624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212365|NCT05616624|Tubulin Modulators|tubulin modulators|mesh-ancestor
65212366|NCT05616624|Antimitotic Agents|antimitotic agents|mesh-ancestor
65212367|NCT05616624|Mitosis Modulators|mitosis modulators|mesh-ancestor
65212368|NCT05601817|Tocopherols|tocopherols|mesh-list
65212369|NCT05601817|Vitamin E|vitamin e|mesh-list
65212370|NCT05601817|alpha-Tocopherol|alpha-tocopherol|mesh-list
65212371|NCT05601817|Antioxidants|antioxidants|mesh-ancestor
65212372|NCT05601817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212373|NCT05601817|Protective Agents|protective agents|mesh-ancestor
65212374|NCT05601817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212375|NCT05601817|Vitamins|vitamins|mesh-ancestor
65212376|NCT05601817|Micronutrients|micronutrients|mesh-ancestor
65212377|NCT05595642|Astegolimab|astegolimab|mesh-list
65212378|NCT05595642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65212379|NCT05595642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65212380|NCT05595642|Antiviral Agents|antiviral agents|mesh-ancestor
65212381|NCT05595642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65212382|NCT05594043|Pembrolizumab|pembrolizumab|mesh-list
65212383|NCT05594043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65332289|NCT05393271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332290|NCT05393271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65332291|NCT05393271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65332292|NCT05393271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65332293|NCT05393271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65332294|NCT05393271|Anesthetics, General|anesthetics, general|mesh-ancestor
65332295|NCT05393271|Anesthetics|anesthetics|mesh-ancestor
65332296|NCT05393271|GABA Modulators|gaba modulators|mesh-ancestor
65332297|NCT05393271|GABA Agents|gaba agents|mesh-ancestor
65212384|NCT05594043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212391|NCT05558124|Cytarabine|cytarabine|mesh-list
65212392|NCT05558124|Daunorubicin|daunorubicin|mesh-list
65212393|NCT05558124|Gemtuzumab|gemtuzumab|mesh-list
65212394|NCT05558124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65212395|NCT05558124|Antimetabolites|antimetabolites|mesh-ancestor
65212396|NCT05558124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212397|NCT05558124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212398|NCT05558124|Antiviral Agents|antiviral agents|mesh-ancestor
65212399|NCT05558124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65212400|NCT05558124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65212401|NCT05558124|Immunologic Factors|immunologic factors|mesh-ancestor
65212402|NCT05558124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212406|NCT05558124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212407|NCT05558124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65212408|NCT05555615|Pimavanserin|pimavanserin|mesh-list
65212409|NCT05555615|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65212410|NCT05555615|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65212411|NCT05555615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65212412|NCT05555615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65212413|NCT05555615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65212414|NCT05555615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212415|NCT05555615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65212416|NCT05555615|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65212417|NCT05555615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65212418|NCT05555615|Serotonin Agents|serotonin agents|mesh-ancestor
65212419|NCT05555615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65212420|NCT05555615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212421|NCT05535023|Cemiplimab|cemiplimab|mesh-list
65212422|NCT05535023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65212423|NCT05535023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212424|NCT05523895|Pimavanserin|pimavanserin|mesh-list
65212425|NCT05523895|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65212426|NCT05523895|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65212427|NCT05523895|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65212428|NCT05523895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65212429|NCT05523895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65212430|NCT05523895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212431|NCT05523895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65212432|NCT05523895|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65212433|NCT05523895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65212434|NCT05523895|Serotonin Agents|serotonin agents|mesh-ancestor
65212435|NCT05523895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65212436|NCT05523895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212437|NCT05521997|Cisplatin|cisplatin|mesh-list
65212438|NCT05521997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212439|NCT05519579|Methotrexate|methotrexate|mesh-list
65212440|NCT05519579|Blinatumomab|blinatumomab|mesh-list
65212441|NCT05519579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65212442|NCT05519579|Abortifacient Agents|abortifacient agents|mesh-ancestor
65212443|NCT05519579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65212444|NCT05519579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212445|NCT05519579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65212446|NCT05519579|Antimetabolites|antimetabolites|mesh-ancestor
65212447|NCT05519579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212448|NCT05519579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212449|NCT05519579|Dermatologic Agents|dermatologic agents|mesh-ancestor
65212450|NCT05519579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332298|NCT05393271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65332299|NCT05393271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332301|NCT02560935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332302|NCT02560935|Antisickling Agents|antisickling agents|mesh-ancestor
65332303|NCT02560935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332304|NCT02560935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332305|NCT02560935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65332306|NCT00750399|Ranibizumab|ranibizumab|mesh-list
65332307|NCT00750399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65332308|NCT00750399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65332309|NCT00750399|Growth Substances|growth substances|mesh-ancestor
65332310|NCT00750399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332311|NCT00750399|Growth Inhibitors|growth inhibitors|mesh-ancestor
65332312|NCT00750399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332313|NCT00756171|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65332314|NCT00756171|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65212451|NCT05519579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65212452|NCT05519579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65212453|NCT05519579|Immunologic Factors|immunologic factors|mesh-ancestor
65212454|NCT05519579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65212455|NCT05519579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65212456|NCT05517668|Acetylcysteine|acetylcysteine|mesh-list
65212457|NCT05517668|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65212458|NCT05517668|Fomepizole|fomepizole|mesh-list
65212460|NCT05517668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65212461|NCT05517668|Expectorants|expectorants|mesh-ancestor
65212462|NCT05517668|Respiratory System Agents|respiratory system agents|mesh-ancestor
65212463|NCT05517668|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65212464|NCT05517668|Antioxidants|antioxidants|mesh-ancestor
65212465|NCT05517668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212466|NCT05517668|Protective Agents|protective agents|mesh-ancestor
65212467|NCT05517668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212468|NCT05517668|Antidotes|antidotes|mesh-ancestor
65212469|NCT05517668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212470|NCT05515978|Metformin|metformin|mesh-list
65212471|NCT05515978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65212472|NCT05515978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212473|NCT05514444|Pembrolizumab|pembrolizumab|mesh-list
65212474|NCT05514444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65212475|NCT05514444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212478|NCT05513469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212480|NCT05501548|Olaparib|olaparib|mesh-list
65212481|NCT05501548|Vitamins|vitamins|mesh-ancestor
65212482|NCT05501548|Micronutrients|micronutrients|mesh-ancestor
65212483|NCT05501548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212484|NCT05501548|Antioxidants|antioxidants|mesh-ancestor
65212485|NCT05501548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212486|NCT05501548|Protective Agents|protective agents|mesh-ancestor
65212487|NCT05501548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65212488|NCT05501548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212489|NCT05501548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212490|NCT05494593|Rituximab|rituximab|mesh-list
65212491|NCT05494593|Methotrexate|methotrexate|mesh-list
65212492|NCT05494593|Immunoglobulins|immunoglobulins|mesh-list
65212493|NCT05494593|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65212494|NCT05494593|Antibodies|antibodies|mesh-list
65212495|NCT05494593|gamma-Globulins|gamma-globulins|mesh-list
65212496|NCT05494593|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65332315|NCT00756171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65332316|NCT00756171|Antimetabolites|antimetabolites|mesh-ancestor
65332317|NCT00756171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332318|NCT00756171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65332319|NCT00718640|Dexamethasone|dexamethasone|mesh-list
65332320|NCT00718640|Bortezomib|bortezomib|mesh-list
65332321|NCT00718640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65332322|NCT00718640|Antiemetics|antiemetics|mesh-ancestor
65332323|NCT00718640|Autonomic Agents|autonomic agents|mesh-ancestor
65332324|NCT00718640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332325|NCT00718640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332326|NCT00718640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65212497|NCT05494593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65212498|NCT05494593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212499|NCT05494593|Immunologic Factors|immunologic factors|mesh-ancestor
65212500|NCT05494593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212501|NCT05494593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65212502|NCT05494593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65212503|NCT05494593|Abortifacient Agents|abortifacient agents|mesh-ancestor
65212504|NCT05494593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65212505|NCT05494593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65212506|NCT05494593|Antimetabolites|antimetabolites|mesh-ancestor
65212507|NCT05494593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212508|NCT05494593|Dermatologic Agents|dermatologic agents|mesh-ancestor
65212509|NCT05494593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212510|NCT05494593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65212511|NCT05494593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65212512|NCT05494593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65212513|NCT05484349|Clonidine|clonidine|mesh-list
65212514|NCT05484349|Tizanidine|tizanidine|mesh-list
65212515|NCT05484349|Analgesics|analgesics|mesh-ancestor
65212516|NCT05484349|Sensory System Agents|sensory system agents|mesh-ancestor
65212517|NCT05484349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65212518|NCT05484349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212519|NCT05484349|Anticonvulsants|anticonvulsants|mesh-ancestor
65212520|NCT05484349|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65212521|NCT05484349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65212522|NCT05484349|Parasympatholytics|parasympatholytics|mesh-ancestor
65212523|NCT05484349|Autonomic Agents|autonomic agents|mesh-ancestor
65212524|NCT05484349|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65212525|NCT05484349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65212526|NCT05484349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65212527|NCT05484349|Adrenergic Agents|adrenergic agents|mesh-ancestor
65212528|NCT05484349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65212529|NCT05484349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212530|NCT05484349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65212531|NCT05484349|Sympatholytics|sympatholytics|mesh-ancestor
65212532|NCT05470244|Analgesics|analgesics|mesh-list
65212533|NCT05470244|Sensory System Agents|sensory system agents|mesh-ancestor
65212534|NCT05470244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65212535|NCT05470244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212537|NCT05459571|Cyclophosphamide|cyclophosphamide|mesh-list
65212538|NCT05459571|Fludarabine|fludarabine|mesh-list
65212539|NCT05459571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65212540|NCT05459571|Immunologic Factors|immunologic factors|mesh-ancestor
65212541|NCT05459571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212542|NCT05459571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65212543|NCT05459571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65212544|NCT05459571|Alkylating Agents|alkylating agents|mesh-ancestor
65212545|NCT05459571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212546|NCT05459571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212547|NCT05459571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65212548|NCT05459571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65332327|NCT00718640|Glucocorticoids|glucocorticoids|mesh-ancestor
65332328|NCT00718640|Hormones|hormones|mesh-ancestor
65332329|NCT00718640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65332330|NCT00718640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65332331|NCT00718640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332332|NCT00753051|Haloperidol|haloperidol|mesh-list
65332333|NCT00753051|Haloperidol decanoate|haloperidol decanoate|mesh-list
65332334|NCT00753051|Clozapine|clozapine|mesh-list
65332335|NCT00753051|Antiemetics|antiemetics|mesh-ancestor
65332336|NCT00753051|Autonomic Agents|autonomic agents|mesh-ancestor
65332337|NCT00753051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332338|NCT00753051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332339|NCT00753051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65332340|NCT00753051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65332341|NCT00753051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64718255|NCT03545893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65212549|NCT05459571|Antiemetics|antiemetics|mesh-ancestor
65212555|NCT05459571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65212556|NCT05459571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65212557|NCT05449548|Lenalidomide|lenalidomide|mesh-list
65212558|NCT05449548|Immunologic Factors|immunologic factors|mesh-ancestor
65212559|NCT05449548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212560|NCT05449548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65212561|NCT05449548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65212562|NCT05449548|Growth Substances|growth substances|mesh-ancestor
65212563|NCT05449548|Growth Inhibitors|growth inhibitors|mesh-ancestor
65212564|NCT05449548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212565|NCT05438264|Donepezil|donepezil|mesh-list
65212566|NCT05438264|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65212567|NCT05438264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212568|NCT05438264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212569|NCT05438264|Cholinergic Agents|cholinergic agents|mesh-ancestor
65212570|NCT05438264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65212571|NCT05438264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212572|NCT05438264|Nootropic Agents|nootropic agents|mesh-ancestor
65212573|NCT05399277|Rivaroxaban|rivaroxaban|mesh-list
65212574|NCT05399277|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65212575|NCT05399277|Antithrombins|antithrombins|mesh-ancestor
65212576|NCT05399277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65212577|NCT05399277|Protease Inhibitors|protease inhibitors|mesh-ancestor
65212578|NCT05399277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212579|NCT05399277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212580|NCT05399277|Anticoagulants|anticoagulants|mesh-ancestor
65212581|NCT05382325|Pembrolizumab|pembrolizumab|mesh-list
65212582|NCT05382325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65212583|NCT05382325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212584|NCT05379634|Glucocorticoids|glucocorticoids|mesh-list
65212585|NCT05379634|Hormones|hormones|mesh-ancestor
65212586|NCT05379634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65212587|NCT05379634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212588|NCT05367440|Abiraterone Acetate|abiraterone acetate|mesh-list
65212589|NCT05367440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212590|NCT05367440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65212591|NCT05367440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212592|NCT05367440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212593|NCT05367440|Hormone Antagonists|hormone antagonists|mesh-ancestor
65212594|NCT05367440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65212595|NCT05367440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332342|NCT00753051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65332343|NCT00753051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65332344|NCT00753051|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65332345|NCT00753051|Dopamine Agents|dopamine agents|mesh-ancestor
65332346|NCT00753051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65332347|NCT00753051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332348|NCT00753051|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64718277|NCT00379028|Fluticasone|fluticasone|mesh-list
65212596|NCT05367440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65212597|NCT05365035|Cytarabine|cytarabine|mesh-list
65212598|NCT05365035|Azacitidine|azacitidine|mesh-list
65212599|NCT05365035|Venetoclax|venetoclax|mesh-list
65212600|NCT05365035|Cladribine|cladribine|mesh-list
65212601|NCT05365035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65212602|NCT05365035|Antimetabolites|antimetabolites|mesh-ancestor
65212603|NCT05365035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212604|NCT05365035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212605|NCT05365035|Antiviral Agents|antiviral agents|mesh-ancestor
65212606|NCT05365035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65212607|NCT05365035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64855356|NCT01714011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65212608|NCT05365035|Immunologic Factors|immunologic factors|mesh-ancestor
65212609|NCT05365035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212610|NCT05365035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212611|NCT05359861|Bevacizumab|bevacizumab|mesh-list
65212612|NCT05359861|Atezolizumab|atezolizumab|mesh-list
65212613|NCT05359861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65212614|NCT05359861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212615|NCT05359861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65212616|NCT05359861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65212617|NCT05359861|Growth Substances|growth substances|mesh-ancestor
65212618|NCT05359861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212619|NCT05359861|Growth Inhibitors|growth inhibitors|mesh-ancestor
65212621|NCT05355857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65212622|NCT05355857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212623|NCT05350085|Midazolam|midazolam|mesh-list
65212624|NCT05350085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65212625|NCT05350085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65212626|NCT05350085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65212627|NCT05350085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212628|NCT05350085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65212629|NCT05350085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65212630|NCT05350085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65212631|NCT05350085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65212632|NCT05350085|Anesthetics, General|anesthetics, general|mesh-ancestor
65212633|NCT05350085|Anesthetics|anesthetics|mesh-ancestor
65212634|NCT05350085|GABA Modulators|gaba modulators|mesh-ancestor
65212635|NCT05350085|GABA Agents|gaba agents|mesh-ancestor
65212636|NCT05350085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65212637|NCT05350085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212638|NCT05348577|Docetaxel|docetaxel|mesh-list
65212639|NCT05348577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212640|NCT05348577|Tubulin Modulators|tubulin modulators|mesh-ancestor
65212641|NCT05348577|Antimitotic Agents|antimitotic agents|mesh-ancestor
65212642|NCT05348577|Mitosis Modulators|mitosis modulators|mesh-ancestor
65212643|NCT05348577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212644|NCT05313308|Midazolam|midazolam|mesh-list
65212645|NCT05313308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65212646|NCT05313308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65212647|NCT05313308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65212648|NCT05313308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212649|NCT05313308|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65212650|NCT05313308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65212651|NCT05313308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65212652|NCT05313308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65212653|NCT05313308|Anesthetics, General|anesthetics, general|mesh-ancestor
65212654|NCT05313308|Anesthetics|anesthetics|mesh-ancestor
65212655|NCT05313308|GABA Modulators|gaba modulators|mesh-ancestor
65332349|NCT00753051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65332350|NCT00753051|Serotonin Agents|serotonin agents|mesh-ancestor
65332351|NCT00753051|GABA Antagonists|gaba antagonists|mesh-ancestor
65332352|NCT00753051|GABA Agents|gaba agents|mesh-ancestor
65332353|NCT00753207|Epirubicin|epirubicin|mesh-list
65332354|NCT00753207|Lapatinib|lapatinib|mesh-list
65332355|NCT00753207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65212656|NCT05313308|GABA Agents|gaba agents|mesh-ancestor
65212657|NCT05313308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65212658|NCT05313308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212659|NCT05296798|Paclitaxel|paclitaxel|mesh-list
65212660|NCT05296798|Docetaxel|docetaxel|mesh-list
65212661|NCT05296798|Trastuzumab|trastuzumab|mesh-list
65212662|NCT05296798|Pertuzumab|pertuzumab|mesh-list
65212663|NCT05296798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65212664|NCT05296798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212665|NCT05296798|Tubulin Modulators|tubulin modulators|mesh-ancestor
65212666|NCT05296798|Antimitotic Agents|antimitotic agents|mesh-ancestor
65212667|NCT05296798|Mitosis Modulators|mitosis modulators|mesh-ancestor
65212668|NCT05296798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212669|NCT05296798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65212670|NCT05289349|Propofol|propofol|mesh-list
65212671|NCT05289349|Sevoflurane|sevoflurane|mesh-list
65212672|NCT05289349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65212673|NCT05289349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65212674|NCT05289349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212675|NCT05289349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65212676|NCT05289349|Anesthetics, General|anesthetics, general|mesh-ancestor
65212677|NCT05289349|Anesthetics|anesthetics|mesh-ancestor
65212678|NCT05289349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65212679|NCT05289349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65212680|NCT05273359|Benralizumab|benralizumab|mesh-list
65212681|NCT05273359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65212682|NCT05273359|Respiratory System Agents|respiratory system agents|mesh-ancestor
65212683|NCT05248321|Tranexamic Acid|tranexamic acid|mesh-list
65212684|NCT05248321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65212685|NCT05248321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65212686|NCT05248321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212688|NCT05248321|Coagulants|coagulants|mesh-ancestor
65212689|NCT05243342|Daratumumab|daratumumab|mesh-list
65212690|NCT05243342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212691|NCT05226455|Azacitidine|azacitidine|mesh-list
65212692|NCT05226455|Venetoclax|venetoclax|mesh-list
65212693|NCT05226455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65212694|NCT05226455|Antimetabolites|antimetabolites|mesh-ancestor
65212695|NCT05226455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212696|NCT05226455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212699|NCT05214287|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65212700|NCT05214287|Protective Agents|protective agents|mesh-ancestor
65212701|NCT05214287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212702|NCT05204927|Prednisone|prednisone|mesh-list
65212703|NCT05204927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65212704|NCT05204927|Glucocorticoids|glucocorticoids|mesh-ancestor
65212705|NCT05204927|Hormones|hormones|mesh-ancestor
65212706|NCT05204927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65212707|NCT05204927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212708|NCT05204927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65212709|NCT05204927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212710|NCT05170204|Durvalumab|durvalumab|mesh-list
65212711|NCT05170204|Pralsetinib|pralsetinib|mesh-list
65212712|NCT05170204|Entrectinib|entrectinib|mesh-list
65212713|NCT05170204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65212714|NCT05170204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212715|NCT05170204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65212716|NCT05170204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212717|NCT05170204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212718|NCT05169905|Vaccines|vaccines|mesh-list
65212719|NCT05169905|Immunologic Factors|immunologic factors|mesh-ancestor
65212720|NCT05169905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212721|NCT05169515|Obinutuzumab|obinutuzumab|mesh-list
65212722|NCT05169515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65332356|NCT00753207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332357|NCT00753207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65332358|NCT00753207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65212723|NCT05169515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212724|NCT05169060|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
65212725|NCT05169060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65212726|NCT05169060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65212727|NCT05169060|Analgesics|analgesics|mesh-ancestor
65212728|NCT05169060|Sensory System Agents|sensory system agents|mesh-ancestor
65212729|NCT05169060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65212730|NCT05169060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212731|NCT05169060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65212732|NCT05169060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65212733|NCT05163223|Pembrolizumab|pembrolizumab|mesh-list
65212734|NCT05163223|Capecitabine|capecitabine|mesh-list
65212735|NCT05163223|Sargramostim|sargramostim|mesh-list
65212736|NCT05163223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65212737|NCT05163223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212738|NCT05163223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65212739|NCT05163223|Antimetabolites|antimetabolites|mesh-ancestor
65212740|NCT05163223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212741|NCT05163223|Immunologic Factors|immunologic factors|mesh-ancestor
65212742|NCT05163223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212743|NCT05161533|Cisplatin|cisplatin|mesh-list
65212744|NCT05161533|Carboplatin|carboplatin|mesh-list
65212745|NCT05161533|Etoposide|etoposide|mesh-list
65212746|NCT05161533|Etoposide phosphate|etoposide phosphate|mesh-list
65212747|NCT05161533|Durvalumab|durvalumab|mesh-list
65212748|NCT05161533|Podophyllotoxin|podophyllotoxin|mesh-list
65212749|NCT05161533|Immunoglobulins|immunoglobulins|mesh-list
65212750|NCT05161533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65212751|NCT05161533|Immunoglobulin G|immunoglobulin g|mesh-list
65212752|NCT05161533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212753|NCT05161533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65212754|NCT05161533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65212755|NCT05161533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65212756|NCT05161533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212757|NCT05161533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212758|NCT05161533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65212759|NCT05161533|Immunologic Factors|immunologic factors|mesh-ancestor
65212760|NCT05161533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212761|NCT05161533|Keratolytic Agents|keratolytic agents|mesh-ancestor
65212762|NCT05161533|Dermatologic Agents|dermatologic agents|mesh-ancestor
65212763|NCT05161533|Tubulin Modulators|tubulin modulators|mesh-ancestor
65212764|NCT05161533|Antimitotic Agents|antimitotic agents|mesh-ancestor
65212765|NCT05161533|Mitosis Modulators|mitosis modulators|mesh-ancestor
65212766|NCT05155709|Azacitidine|azacitidine|mesh-list
65212767|NCT05155709|Venetoclax|venetoclax|mesh-list
65212768|NCT05155709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65212769|NCT05155709|Antimetabolites|antimetabolites|mesh-ancestor
65212770|NCT05155709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212771|NCT05155709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212774|NCT05149131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65212776|NCT05149131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65212777|NCT05149131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212778|NCT05149131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65212779|NCT05149131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212780|NCT05130268|Dronedarone|dronedarone|mesh-list
65212781|NCT05130268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65212782|NCT05115110|Risdiplam|risdiplam|mesh-list
65212783|NCT05115110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65212784|NCT05115110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65212785|NCT05115110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212786|NCT05112965|Atezolizumab|atezolizumab|mesh-list
65212787|NCT05112965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212788|NCT05101122|Dronabinol|dronabinol|mesh-list
65212789|NCT05101122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65212790|NCT05101122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65212791|NCT05101122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65212792|NCT05101122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65212793|NCT05101122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332359|NCT00753207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332360|NCT00753207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332361|NCT00753207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65332362|NCT00715910|Vaccines|vaccines|mesh-list
65332363|NCT00715910|Immunologic Factors|immunologic factors|mesh-ancestor
65332364|NCT00715910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718291|NCT00379028|Hormones|hormones|mesh-ancestor
65212794|NCT05101122|Adrenergic Agents|adrenergic agents|mesh-ancestor
65212795|NCT05101122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65212796|NCT05101122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212797|NCT05101122|Hallucinogens|hallucinogens|mesh-ancestor
65212798|NCT05101122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65212799|NCT05101122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65212800|NCT05101122|Analgesics|analgesics|mesh-ancestor
65212801|NCT05101122|Sensory System Agents|sensory system agents|mesh-ancestor
65212802|NCT05101122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65212803|NCT05101122|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65212804|NCT05101122|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65212805|NCT05101122|Hormones|hormones|mesh-ancestor
65212806|NCT05101122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65212807|NCT05092945|Niacin|niacin|mesh-list
65212808|NCT05092945|Nicotinic Acids|nicotinic acids|mesh-list
65212809|NCT05092945|Niacinamide|niacinamide|mesh-list
65212810|NCT05092945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65212811|NCT05092945|Antimetabolites|antimetabolites|mesh-ancestor
65212812|NCT05092945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212813|NCT05092945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65212814|NCT05092945|Vasodilator Agents|vasodilator agents|mesh-ancestor
65212815|NCT05092945|Vitamin B Complex|vitamin b complex|mesh-ancestor
65212816|NCT05092945|Vitamins|vitamins|mesh-ancestor
65212817|NCT05092945|Micronutrients|micronutrients|mesh-ancestor
65212818|NCT05092945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212819|NCT05087771|Naltrexone|naltrexone|mesh-list
65212820|NCT05087771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65212821|NCT05087771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65212822|NCT05087771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212823|NCT05087771|Sensory System Agents|sensory system agents|mesh-ancestor
65212824|NCT05087771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65212825|NCT05084235|Empagliflozin|empagliflozin|mesh-list
65212826|NCT05084235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65212827|NCT05084235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212828|NCT05084235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65212829|NCT05084235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212830|NCT05082142|Tranexamic Acid|tranexamic acid|mesh-list
65212831|NCT05082142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65212832|NCT05082142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65212833|NCT05082142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212834|NCT05082142|Hemostatics|hemostatics|mesh-ancestor
65212835|NCT05082142|Coagulants|coagulants|mesh-ancestor
65212836|NCT05061017|Cyclophosphamide|cyclophosphamide|mesh-list
65212838|NCT05061017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65212839|NCT05061017|Immunologic Factors|immunologic factors|mesh-ancestor
65212840|NCT05061017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212841|NCT05061017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65212842|NCT05061017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65212843|NCT05061017|Alkylating Agents|alkylating agents|mesh-ancestor
65212844|NCT05061017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212845|NCT05061017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212848|NCT05061017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65212849|NCT05056727|Valsartan|valsartan|mesh-list
65212850|NCT05056727|Lisinopril|lisinopril|mesh-list
65212851|NCT05056727|Irbesartan|irbesartan|mesh-list
65212852|NCT05056727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65212853|NCT05056727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65212854|NCT05056727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65212855|NCT05056727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212856|NCT05056727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65212857|NCT05056727|Protease Inhibitors|protease inhibitors|mesh-ancestor
65332365|NCT00715676|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
65332366|NCT00715676|Vitamins|vitamins|mesh-ancestor
65332367|NCT00715676|Micronutrients|micronutrients|mesh-ancestor
65332368|NCT00715676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332369|NCT00715676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65212858|NCT05056727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212859|NCT05056727|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65212860|NCT05056727|Protective Agents|protective agents|mesh-ancestor
65212861|NCT05056727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212862|NCT05048901|Lanreotide|lanreotide|mesh-list
65212863|NCT05048901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212864|NCT05047250|Gemcitabine|gemcitabine|mesh-list
65212865|NCT05047250|Paclitaxel|paclitaxel|mesh-list
65212866|NCT05047250|Carboplatin|carboplatin|mesh-list
65212867|NCT05047250|Pemetrexed|pemetrexed|mesh-list
65212868|NCT05047250|Atezolizumab|atezolizumab|mesh-list
65212869|NCT05047250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65212870|NCT05047250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212871|NCT05047250|Tubulin Modulators|tubulin modulators|mesh-ancestor
65212872|NCT05047250|Antimitotic Agents|antimitotic agents|mesh-ancestor
65212873|NCT05047250|Mitosis Modulators|mitosis modulators|mesh-ancestor
65212874|NCT05047250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212875|NCT05047250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65212876|NCT05047250|Antimetabolites|antimetabolites|mesh-ancestor
65212877|NCT05047250|Antiviral Agents|antiviral agents|mesh-ancestor
65212878|NCT05047250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65212879|NCT05047250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212880|NCT05047250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65212881|NCT05047250|Immunologic Factors|immunologic factors|mesh-ancestor
65212882|NCT05047250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212883|NCT05047250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65212884|NCT05047250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65212885|NCT05042973|Empagliflozin|empagliflozin|mesh-list
65212886|NCT05042973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65212887|NCT05042973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212888|NCT05042973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65212889|NCT05042973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212890|NCT05030272|Nicotine|nicotine|mesh-list
65212891|NCT05030272|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65212892|NCT05030272|Autonomic Agents|autonomic agents|mesh-ancestor
65212893|NCT05030272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65212894|NCT05030272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212895|NCT05030272|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65212896|NCT05030272|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65212897|NCT05030272|Cholinergic Agents|cholinergic agents|mesh-ancestor
65212898|NCT05030272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65212899|NCT05030272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212900|NCT05026606|Nivolumab|nivolumab|mesh-list
65212901|NCT05026606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65212902|NCT05026606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212903|NCT05026606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65212904|NCT05026606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212905|NCT05017012|Paclitaxel|paclitaxel|mesh-list
65212906|NCT05017012|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65212907|NCT05017012|Carboplatin|carboplatin|mesh-list
65212908|NCT05017012|Pembrolizumab|pembrolizumab|mesh-list
65212909|NCT05017012|Pemetrexed|pemetrexed|mesh-list
65212910|NCT05017012|Axitinib|axitinib|mesh-list
65212911|NCT05017012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65212912|NCT05017012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212913|NCT05017012|Tubulin Modulators|tubulin modulators|mesh-ancestor
65212914|NCT05017012|Antimitotic Agents|antimitotic agents|mesh-ancestor
65212915|NCT05017012|Mitosis Modulators|mitosis modulators|mesh-ancestor
65212916|NCT05017012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212917|NCT05017012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65212918|NCT05017012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212921|NCT05017012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65212923|NCT05009069|Capecitabine|capecitabine|mesh-list
65212924|NCT05009069|Atezolizumab|atezolizumab|mesh-list
65212925|NCT05009069|Antimetabolites|antimetabolites|mesh-ancestor
65212926|NCT05009069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332370|NCT00718328|Simvastatin|simvastatin|mesh-list
65332371|NCT00718328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65332372|NCT00718328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65332373|NCT00718328|Antimetabolites|antimetabolites|mesh-ancestor
65332374|NCT00718328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212927|NCT05009069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65212928|NCT05009069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212929|NCT05009069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65212930|NCT05009069|Immunologic Factors|immunologic factors|mesh-ancestor
65212931|NCT05009069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212932|NCT04994717|Blinatumomab|blinatumomab|mesh-list
65212933|NCT04994717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212934|NCT04992624|Dronabinol|dronabinol|mesh-list
65212935|NCT04992624|Cannabidiol|cannabidiol|mesh-list
65212936|NCT04992624|Anticonvulsants|anticonvulsants|mesh-ancestor
65212937|NCT04992624|Hallucinogens|hallucinogens|mesh-ancestor
65212938|NCT04992624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212939|NCT04992624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65212940|NCT04992624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65212941|NCT04992624|Analgesics|analgesics|mesh-ancestor
65212942|NCT04992624|Sensory System Agents|sensory system agents|mesh-ancestor
65212943|NCT04992624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65212944|NCT04992624|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65212945|NCT04992624|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65212946|NCT04992624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65212947|NCT04992624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212948|NCT04992624|Hormones|hormones|mesh-ancestor
65212949|NCT04992624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65212950|NCT04976257|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65212951|NCT04976257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65212952|NCT04976257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212953|NCT04959175|Mycophenolic Acid|mycophenolic acid|mesh-list
65212954|NCT04959175|Sirolimus|sirolimus|mesh-list
65212955|NCT04959175|Cyclophosphamide|cyclophosphamide|mesh-list
65212956|NCT04959175|Fludarabine|fludarabine|mesh-list
65212957|NCT04959175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65212958|NCT04959175|Immunologic Factors|immunologic factors|mesh-ancestor
65212959|NCT04959175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212960|NCT04959175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65212961|NCT04959175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65212962|NCT04959175|Alkylating Agents|alkylating agents|mesh-ancestor
65212963|NCT04959175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212964|NCT04959175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212965|NCT04959175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65212966|NCT04959175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65212967|NCT04959175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65212968|NCT04959175|Antitubercular Agents|antitubercular agents|mesh-ancestor
65212969|NCT04959175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65212970|NCT04959175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65212971|NCT04959175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212972|NCT04959175|Antifungal Agents|antifungal agents|mesh-ancestor
65212973|NCT04954365|Amisulpride|amisulpride|mesh-list
65212974|NCT04954365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65212975|NCT04954365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65212976|NCT04954365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65212977|NCT04954365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212978|NCT04954365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65212979|NCT04954365|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65212980|NCT04954365|Dopamine Agents|dopamine agents|mesh-ancestor
65212981|NCT04954365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65212982|NCT04954365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212983|NCT04954365|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64855737|NCT01715701|Iodine|iodine|mesh-list
65212984|NCT04954365|Antidepressive Agents|antidepressive agents|mesh-ancestor
65212985|NCT04952389|Budesonide|budesonide|mesh-list
65212986|NCT04952389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65212987|NCT04952389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65212988|NCT04952389|Autonomic Agents|autonomic agents|mesh-ancestor
65212989|NCT04952389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65212990|NCT04952389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332375|NCT00718328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65332376|NCT00718328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65332377|NCT00718328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332378|NCT02590874|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65332379|NCT02590874|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65212991|NCT04952389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65212995|NCT04952389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65212997|NCT04920617|Pembrolizumab|pembrolizumab|mesh-list
65212998|NCT04920617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65212999|NCT04920617|Immunologic Factors|immunologic factors|mesh-ancestor
65213000|NCT04920617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213001|NCT04920617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65213002|NCT04920617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65213003|NCT04920617|Alkylating Agents|alkylating agents|mesh-ancestor
65213004|NCT04920617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213005|NCT04920617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213006|NCT04920617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65213007|NCT04920617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213009|NCT04860804|Ketamine|ketamine|mesh-list
65213010|NCT04860804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65213011|NCT04860804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65213012|NCT04860804|Analgesics|analgesics|mesh-ancestor
65213013|NCT04860804|Sensory System Agents|sensory system agents|mesh-ancestor
65213014|NCT04860804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65213015|NCT04860804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213016|NCT04860804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65213017|NCT04860804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65213018|NCT04860804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65213019|NCT04860804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65213020|NCT04860804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213021|NCT04860804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65213022|NCT04860804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65213023|NCT04860804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213024|NCT04860804|Antipyretics|antipyretics|mesh-ancestor
65213025|NCT04860804|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65213026|NCT04860804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65213027|NCT04860804|Anesthetics, General|anesthetics, general|mesh-ancestor
65213028|NCT04860804|Anesthetics|anesthetics|mesh-ancestor
65213029|NCT04860804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65213030|NCT04860804|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65213031|NCT04860804|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65213032|NCT04860804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65213033|NCT04851964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65213034|NCT04851964|Immunologic Factors|immunologic factors|mesh-ancestor
65213035|NCT04851964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213036|NCT04817345|Plerixafor|plerixafor|mesh-list
65213037|NCT04817345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65213038|NCT04817345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65213039|NCT04817345|Antiviral Agents|antiviral agents|mesh-ancestor
65213040|NCT04817345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65213041|NCT04785820|Nivolumab|nivolumab|mesh-list
65213042|NCT04785820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213043|NCT04785820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213044|NCT04785820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65213045|NCT04785820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213046|NCT04764396|Heparin|heparin|mesh-list
65213047|NCT04764396|Calcium heparin|calcium heparin|mesh-list
65213048|NCT04764396|Anticoagulants|anticoagulants|mesh-ancestor
65213049|NCT04764396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65213050|NCT04764396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65213051|NCT04764396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213052|NCT04740918|Trastuzumab|trastuzumab|mesh-list
65213053|NCT04740918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65213054|NCT04740918|Atezolizumab|atezolizumab|mesh-list
65213055|NCT04740918|Maytansine|maytansine|mesh-list
65213056|NCT04740918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213057|NCT04740918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332380|NCT02590874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65332381|NCT02590874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65332382|NCT02590874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332383|NCT02590874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65332384|NCT02590874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213058|NCT04740918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65213059|NCT04740918|Tubulin Modulators|tubulin modulators|mesh-ancestor
64855801|NCT01716377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65213061|NCT04740918|Mitosis Modulators|mitosis modulators|mesh-ancestor
65213062|NCT04740918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213063|NCT04703920|Talazoparib|talazoparib|mesh-list
65213064|NCT04703920|Belinostat|belinostat|mesh-list
65213068|NCT04703920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213069|NCT04703920|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65213070|NCT04700072|Pembrolizumab|pembrolizumab|mesh-list
65213072|NCT04700072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213073|NCT04700072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213074|NCT04700072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65213075|NCT04700072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213076|NCT04700072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213077|NCT04684589|Tadalafil|tadalafil|mesh-list
65213078|NCT04684589|Vasodilator Agents|vasodilator agents|mesh-ancestor
65213079|NCT04684589|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65213080|NCT04684589|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65213081|NCT04684589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213082|NCT04684589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213083|NCT04684589|Urological Agents|urological agents|mesh-ancestor
65213084|NCT04683939|Gemcitabine|gemcitabine|mesh-list
65213085|NCT04683939|Paclitaxel|paclitaxel|mesh-list
65213086|NCT04683939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65213087|NCT04683939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213088|NCT04683939|Tubulin Modulators|tubulin modulators|mesh-ancestor
65213089|NCT04683939|Antimitotic Agents|antimitotic agents|mesh-ancestor
65213090|NCT04683939|Mitosis Modulators|mitosis modulators|mesh-ancestor
65213091|NCT04683939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213092|NCT04683939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65213093|NCT04683939|Antimetabolites|antimetabolites|mesh-ancestor
65213094|NCT04683939|Antiviral Agents|antiviral agents|mesh-ancestor
65213095|NCT04683939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65213096|NCT04683939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213097|NCT04683939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65213098|NCT04683939|Immunologic Factors|immunologic factors|mesh-ancestor
65213099|NCT04683939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213100|NCT04626141|Abaloparatide|abaloparatide|mesh-list
65213101|NCT04626141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65213102|NCT04626141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213103|NCT04609514|Nicotine|nicotine|mesh-list
65213104|NCT04609514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65213105|NCT04609514|Autonomic Agents|autonomic agents|mesh-ancestor
65213106|NCT04609514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65213107|NCT04609514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213108|NCT04609514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65213109|NCT04609514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65213110|NCT04609514|Cholinergic Agents|cholinergic agents|mesh-ancestor
65213111|NCT04609514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65213112|NCT04609514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213113|NCT04580121|Acetaminophen|acetaminophen|mesh-list
65213114|NCT04580121|Diphenhydramine|diphenhydramine|mesh-list
65213115|NCT04580121|Promethazine|promethazine|mesh-list
65213116|NCT04580121|Dexamethasone|dexamethasone|mesh-list
65213117|NCT04580121|Dasatinib|dasatinib|mesh-list
65213118|NCT04580121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65213119|NCT04580121|Antiemetics|antiemetics|mesh-ancestor
65213120|NCT04580121|Autonomic Agents|autonomic agents|mesh-ancestor
65213121|NCT04580121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65213122|NCT04580121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213123|NCT04580121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65213124|NCT04580121|Glucocorticoids|glucocorticoids|mesh-ancestor
65213125|NCT04580121|Hormones|hormones|mesh-ancestor
65332385|NCT02590874|Analgesics|analgesics|mesh-ancestor
65332386|NCT02590874|Sensory System Agents|sensory system agents|mesh-ancestor
65332387|NCT02590874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332388|NCT02590874|Antidepressive Agents|antidepressive agents|mesh-ancestor
65213126|NCT04580121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65213127|NCT04580121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65213128|NCT04580121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213129|NCT04580121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65213130|NCT04580121|Analgesics|analgesics|mesh-ancestor
65213131|NCT04580121|Sensory System Agents|sensory system agents|mesh-ancestor
65213132|NCT04580121|Antipyretics|antipyretics|mesh-ancestor
65213133|NCT04580121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65213134|NCT04580121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213135|NCT04580121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213137|NCT04580121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65213138|NCT04580121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65213139|NCT04580121|Anesthetics, Local|anesthetics, local|mesh-ancestor
65213141|NCT04580121|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65213142|NCT04580121|Histamine Antagonists|histamine antagonists|mesh-ancestor
65213143|NCT04580121|Histamine Agents|histamine agents|mesh-ancestor
65213144|NCT04580121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65213145|NCT04580121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65213146|NCT04580121|Antipruritics|antipruritics|mesh-ancestor
65213147|NCT04580121|Dermatologic Agents|dermatologic agents|mesh-ancestor
65213148|NCT04570956|Tamoxifen|tamoxifen|mesh-list
65213149|NCT04570956|Afimoxifene|afimoxifene|mesh-list
65213150|NCT04570956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65213151|NCT04570956|Hormone Antagonists|hormone antagonists|mesh-ancestor
65213152|NCT04570956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65213153|NCT04570956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213154|NCT04570956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65213155|NCT04570956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213156|NCT04570956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65213157|NCT04570956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65213158|NCT04570956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65213159|NCT04569461|Pembrolizumab|pembrolizumab|mesh-list
65213160|NCT04569461|Androgens|androgens|mesh-list
65213161|NCT04569461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213162|NCT04569461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213163|NCT04569461|Hormones|hormones|mesh-ancestor
65213164|NCT04569461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65213165|NCT04569461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213166|NCT04567303|Ranibizumab|ranibizumab|mesh-list
65213167|NCT04567303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65213168|NCT04567303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65213169|NCT04567303|Growth Substances|growth substances|mesh-ancestor
65213170|NCT04567303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213171|NCT04567303|Growth Inhibitors|growth inhibitors|mesh-ancestor
65213172|NCT04567303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213173|NCT04543617|Atezolizumab|atezolizumab|mesh-list
65213174|NCT04543617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65213175|NCT04543617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213176|NCT04543617|Immunologic Factors|immunologic factors|mesh-ancestor
65213177|NCT04543617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213178|NCT04542070|Rilpivirine|rilpivirine|mesh-list
65213179|NCT04542070|Cabotegravir|cabotegravir|mesh-list
65213180|NCT04542070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65213181|NCT04542070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65213182|NCT04542070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213183|NCT04542070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213184|NCT04542070|Antiviral Agents|antiviral agents|mesh-ancestor
65213185|NCT04542070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65213186|NCT04542070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65213187|NCT04542070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65213188|NCT04542070|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65213189|NCT04542070|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65213190|NCT04534205|Pembrolizumab|pembrolizumab|mesh-list
65213191|NCT04534205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213192|NCT04534205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213193|NCT04527289|Amantadine|amantadine|mesh-list
65213194|NCT04527289|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65332389|NCT02590874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65332390|NCT02590874|Dopamine Agents|dopamine agents|mesh-ancestor
65332391|NCT00715520|Levodopa|levodopa|mesh-list
65332392|NCT00715520|Carbidopa|carbidopa|mesh-list
65332393|NCT00715520|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65332394|NCT00715520|Methylphenidate|methylphenidate|mesh-list
65332395|NCT00715520|Amphetamine|amphetamine|mesh-list
65213195|NCT04527289|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65213196|NCT04527289|Antiviral Agents|antiviral agents|mesh-ancestor
65213197|NCT04527289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65213198|NCT04527289|Dopamine Agents|dopamine agents|mesh-ancestor
65213199|NCT04527289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65213200|NCT04527289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213201|NCT04527289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213202|NCT04527289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65213203|NCT04527289|Analgesics|analgesics|mesh-ancestor
65213204|NCT04527289|Sensory System Agents|sensory system agents|mesh-ancestor
65213205|NCT04527289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65213206|NCT04505735|Corticosterone|corticosterone|mesh-list
65213207|NCT04505735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65213208|NCT04460872|Methyltestosterone|methyltestosterone|mesh-list
65213209|NCT04460872|Testosterone|testosterone|mesh-list
65213210|NCT04460872|Testosterone undecanoate|testosterone undecanoate|mesh-list
65213211|NCT04460872|Testosterone enanthate|testosterone enanthate|mesh-list
65213215|NCT04460872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65213216|NCT04460872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213217|NCT04460872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65213218|NCT04460872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213219|NCT04460872|Anabolic Agents|anabolic agents|mesh-ancestor
65213220|NCT04428866|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65213222|NCT04428866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65213223|NCT04428866|Hormones|hormones|mesh-ancestor
65213224|NCT04428866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65213225|NCT04428866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213226|NCT04422795|Ethyl Chloride|ethyl chloride|mesh-list
65213227|NCT04422795|Anesthetics, Local|anesthetics, local|mesh-ancestor
65213228|NCT04422795|Anesthetics|anesthetics|mesh-ancestor
65213229|NCT04422795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65213230|NCT04422795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213231|NCT04422795|Sensory System Agents|sensory system agents|mesh-ancestor
65213232|NCT04422795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65213233|NCT04413617|Tofacitinib|tofacitinib|mesh-list
65213234|NCT04413617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65213235|NCT04413617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213236|NCT04413617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213237|NCT04408625|Sirolimus|sirolimus|mesh-list
65213238|NCT04408625|Prednisone|prednisone|mesh-list
65213239|NCT04408625|Methylprednisolone|methylprednisolone|mesh-list
65213240|NCT04408625|Rituximab|rituximab|mesh-list
65213241|NCT04408625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213242|NCT04408625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213243|NCT04408625|Immunologic Factors|immunologic factors|mesh-ancestor
65213244|NCT04408625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213245|NCT04408625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65213246|NCT04408625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65213247|NCT04408625|Glucocorticoids|glucocorticoids|mesh-ancestor
65213248|NCT04408625|Hormones|hormones|mesh-ancestor
65213249|NCT04408625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65213250|NCT04408625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65213251|NCT04408625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65213252|NCT04408625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65213253|NCT04408625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65213254|NCT04408625|Antifungal Agents|antifungal agents|mesh-ancestor
65213255|NCT04408625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65213256|NCT04408625|Antiemetics|antiemetics|mesh-ancestor
65213257|NCT04408625|Autonomic Agents|autonomic agents|mesh-ancestor
65213258|NCT04408625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65213259|NCT04408625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65213260|NCT04408625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65213261|NCT04408625|Protective Agents|protective agents|mesh-ancestor
65332396|NCT00715520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65332397|NCT00715520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332398|NCT00715520|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65332399|NCT00715520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65332400|NCT00715520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65332401|NCT00715520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332402|NCT00715520|Dopamine Agents|dopamine agents|mesh-ancestor
65213262|NCT04396860|Nivolumab|nivolumab|mesh-list
65213263|NCT04396860|Ipilimumab|ipilimumab|mesh-list
65213264|NCT04396860|Temozolomide|temozolomide|mesh-list
65213265|NCT04396860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213266|NCT04396860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213267|NCT04396860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65213268|NCT04396860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213269|NCT04396860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65213270|NCT04396860|Alkylating Agents|alkylating agents|mesh-ancestor
65213271|NCT04333576|Contraceptive Agents|contraceptive agents|mesh-list
65213272|NCT04333576|Contraceptives, Oral|contraceptives, oral|mesh-list
65213273|NCT04333576|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65213274|NCT04333576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65213275|NCT04333576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213276|NCT04333576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65213277|NCT04305054|Pembrolizumab|pembrolizumab|mesh-list
65213278|NCT04305054|Lenvatinib|lenvatinib|mesh-list
65213279|NCT04305054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213280|NCT04305054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213281|NCT04305054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65213282|NCT04305054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213283|NCT04305054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213284|NCT04305041|Pembrolizumab|pembrolizumab|mesh-list
65213285|NCT04305041|Lenvatinib|lenvatinib|mesh-list
65213290|NCT04305041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213291|NCT04303169|Pembrolizumab|pembrolizumab|mesh-list
65213292|NCT04303169|Tretinoin|tretinoin|mesh-list
65213293|NCT04303169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213294|NCT04303169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213295|NCT04303169|Keratolytic Agents|keratolytic agents|mesh-ancestor
65213296|NCT04303169|Dermatologic Agents|dermatologic agents|mesh-ancestor
65213297|NCT04294810|Atezolizumab|atezolizumab|mesh-list
65213298|NCT04294810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213299|NCT04250155|Atezolizumab|atezolizumab|mesh-list
65213300|NCT04250155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213301|NCT04241185|Gemcitabine|gemcitabine|mesh-list
65213302|NCT04241185|Pembrolizumab|pembrolizumab|mesh-list
65213303|NCT04241185|Fluorouracil|fluorouracil|mesh-list
65213304|NCT04241185|Mitomycins|mitomycins|mesh-list
65213305|NCT04241185|Mitomycin|mitomycin|mesh-list
65213306|NCT04241185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213307|NCT04241185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65213308|NCT04241185|Antimetabolites|antimetabolites|mesh-ancestor
65213309|NCT04241185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213310|NCT04241185|Antiviral Agents|antiviral agents|mesh-ancestor
65213311|NCT04241185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65213312|NCT04241185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213313|NCT04241185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65213314|NCT04241185|Immunologic Factors|immunologic factors|mesh-ancestor
65213315|NCT04241185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213316|NCT04241185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213317|NCT04241185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65213318|NCT04241185|Alkylating Agents|alkylating agents|mesh-ancestor
65213319|NCT04241185|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65213320|NCT04231760|Nitric Oxide|nitric oxide|mesh-list
65213321|NCT04231760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65213322|NCT04231760|Autonomic Agents|autonomic agents|mesh-ancestor
65213323|NCT04231760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65213324|NCT04231760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213325|NCT04231760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65332403|NCT00715520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65332404|NCT00715520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65332405|NCT00715520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65332406|NCT00715520|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65332407|NCT00715520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332408|NCT00715520|Sympathomimetics|sympathomimetics|mesh-ancestor
65332409|NCT00715520|Autonomic Agents|autonomic agents|mesh-ancestor
65332410|NCT00715520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332411|NCT00715520|Adrenergic Agents|adrenergic agents|mesh-ancestor
65332412|NCT00715520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65332413|NCT00715520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65332414|NCT00715520|Immunologic Factors|immunologic factors|mesh-ancestor
65332415|NCT00715520|Dopamine Agonists|dopamine agonists|mesh-ancestor
65332416|NCT00680901|Capecitabine|capecitabine|mesh-list
65332417|NCT00680901|Oxaliplatin|oxaliplatin|mesh-list
65332418|NCT00680901|Lapatinib|lapatinib|mesh-list
65332419|NCT00680901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65332420|NCT00680901|Antimetabolites|antimetabolites|mesh-ancestor
65332421|NCT00680901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332422|NCT00680901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332423|NCT00680901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65332424|NCT00680901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332425|NCT00756873|Etoricoxib|etoricoxib|mesh-list
65332426|NCT00756873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64718330|NCT00793520|Analgesics|analgesics|mesh-ancestor
65213326|NCT04231760|Respiratory System Agents|respiratory system agents|mesh-ancestor
65213327|NCT04231760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65213328|NCT04231760|Antioxidants|antioxidants|mesh-ancestor
65213329|NCT04231760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213330|NCT04231760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65213331|NCT04231760|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65213332|NCT04231760|Vasodilator Agents|vasodilator agents|mesh-ancestor
65213333|NCT04231760|Gasotransmitters|gasotransmitters|mesh-ancestor
65213334|NCT04231760|Protective Agents|protective agents|mesh-ancestor
65213335|NCT04218565|Golimumab|golimumab|mesh-list
65213336|NCT04218565|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65213337|NCT04218565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65213338|NCT04218565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65213339|NCT04218565|Immunologic Factors|immunologic factors|mesh-ancestor
65213340|NCT04218565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213341|NCT04193293|Pembrolizumab|pembrolizumab|mesh-list
65213342|NCT04193293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65213343|NCT04193293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213344|NCT04193293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213345|NCT04193293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213346|NCT04181359|Nitric Oxide|nitric oxide|mesh-list
65213347|NCT04181359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65213348|NCT04181359|Autonomic Agents|autonomic agents|mesh-ancestor
65213349|NCT04181359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65213350|NCT04181359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332427|NCT00756873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65332428|NCT00756873|Analgesics|analgesics|mesh-ancestor
65332429|NCT00756873|Sensory System Agents|sensory system agents|mesh-ancestor
65332430|NCT00756873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65213351|NCT04181359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65213352|NCT04181359|Respiratory System Agents|respiratory system agents|mesh-ancestor
65213353|NCT04181359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65213354|NCT04181359|Antioxidants|antioxidants|mesh-ancestor
65213355|NCT04181359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213356|NCT04181359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65213359|NCT04181359|Gasotransmitters|gasotransmitters|mesh-ancestor
64856103|NCT01718314|Lidocaine|lidocaine|mesh-list
65213360|NCT04181359|Protective Agents|protective agents|mesh-ancestor
65213362|NCT04165083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213363|NCT04165083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213364|NCT04129502|Carboplatin|carboplatin|mesh-list
65213365|NCT04129502|Pemetrexed|pemetrexed|mesh-list
65213366|NCT04129502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213367|NCT04129502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213368|NCT04129502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213369|NCT04129502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65213370|NCT04129502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65213372|NCT04114136|Rosiglitazone|rosiglitazone|mesh-list
65213373|NCT04114136|Pembrolizumab|pembrolizumab|mesh-list
65213374|NCT04114136|Nivolumab|nivolumab|mesh-list
65213375|NCT04114136|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65213376|NCT04114136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213377|NCT04114136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213378|NCT04114136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213379|NCT04114136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65213380|NCT04114136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213381|NCT04102020|Azacitidine|azacitidine|mesh-list
65213382|NCT04102020|Venetoclax|venetoclax|mesh-list
65213383|NCT04102020|Cc-486|cc-486|mesh-list
65213384|NCT04102020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65213385|NCT04102020|Antimetabolites|antimetabolites|mesh-ancestor
65213386|NCT04102020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213387|NCT04102020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213388|NCT04102020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213389|NCT04093362|Gemcitabine|gemcitabine|mesh-list
65213390|NCT04093362|Futibatinib|futibatinib|mesh-list
65213391|NCT04093362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213392|NCT04093362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65213393|NCT04093362|Antimetabolites|antimetabolites|mesh-ancestor
65213394|NCT04093362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213395|NCT04093362|Antiviral Agents|antiviral agents|mesh-ancestor
65213396|NCT04093362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65213397|NCT04093362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213398|NCT04093362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65213399|NCT04093362|Immunologic Factors|immunologic factors|mesh-ancestor
65213400|NCT04093362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213401|NCT04075747|Venetoclax|venetoclax|mesh-list
65213402|NCT04075747|Midostaurin|midostaurin|mesh-list
65213403|NCT04075747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213404|NCT04075747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65213405|NCT04075747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213406|NCT04075747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213407|NCT04060849|Ethanol|ethanol|mesh-list
65213408|NCT04060849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65213409|NCT04060849|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65213410|NCT04060849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65213411|NCT04060849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65213412|NCT04060849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213413|NCT04055116|Lidocaine|lidocaine|mesh-list
65213414|NCT04055116|Anesthetics, Local|anesthetics, local|mesh-ancestor
65213415|NCT04055116|Anesthetics|anesthetics|mesh-ancestor
65213416|NCT04055116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65213417|NCT04055116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213418|NCT04055116|Sensory System Agents|sensory system agents|mesh-ancestor
65213419|NCT04055116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65213420|NCT04055116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65332431|NCT00756873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332432|NCT00756873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65332433|NCT00756873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65332434|NCT00756873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65332435|NCT00756873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65332436|NCT00756873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718356|NCT00790478|Antioxidants|antioxidants|mesh-ancestor
65213421|NCT04055116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65213422|NCT04055116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65213423|NCT04055116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65213424|NCT04055116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213425|NCT04045028|Rituximab|rituximab|mesh-list
65213426|NCT04045028|Atezolizumab|atezolizumab|mesh-list
65213427|NCT04045028|Daratumumab|daratumumab|mesh-list
65213428|NCT04045028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213429|NCT04045028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213430|NCT04045028|Immunologic Factors|immunologic factors|mesh-ancestor
65213433|NCT04039867|Gemcitabine|gemcitabine|mesh-list
65213434|NCT04039867|Oxaliplatin|oxaliplatin|mesh-list
64856192|NCT01718626|Docetaxel|docetaxel|mesh-list
65213435|NCT04039867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65213437|NCT04039867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213438|NCT04039867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213439|NCT04039867|Antiviral Agents|antiviral agents|mesh-ancestor
65213440|NCT04039867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65213441|NCT04039867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213442|NCT04039867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65213443|NCT04039867|Immunologic Factors|immunologic factors|mesh-ancestor
65213444|NCT04039867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213445|NCT03990623|Liver Extracts|liver extracts|mesh-list
65213446|NCT03990623|Hematinics|hematinics|mesh-ancestor
65213447|NCT03927157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65213448|NCT03927157|Immunologic Factors|immunologic factors|mesh-ancestor
65213449|NCT03927157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213450|NCT03916328|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65213451|NCT03916328|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65213452|NCT03916328|Contraceptive Agents|contraceptive agents|mesh-ancestor
65213453|NCT03916328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65213454|NCT03916328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213455|NCT03916328|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65213456|NCT03916328|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65213457|NCT03916328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65213458|NCT03916328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213460|NCT03867500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65213461|NCT03867500|Antimetabolites|antimetabolites|mesh-ancestor
65213462|NCT03867500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213463|NCT03867500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65213464|NCT03867500|Vasodilator Agents|vasodilator agents|mesh-ancestor
65213465|NCT03867500|Vitamin B Complex|vitamin b complex|mesh-ancestor
65213466|NCT03867500|Vitamins|vitamins|mesh-ancestor
65213467|NCT03867500|Micronutrients|micronutrients|mesh-ancestor
65213468|NCT03867500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213469|NCT03861390|Prednisone|prednisone|mesh-list
65213470|NCT03861390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65213471|NCT03861390|Glucocorticoids|glucocorticoids|mesh-ancestor
65213472|NCT03861390|Hormones|hormones|mesh-ancestor
65213473|NCT03861390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65213474|NCT03861390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213475|NCT03861390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65213476|NCT03861390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213477|NCT03839446|Etoposide|etoposide|mesh-list
65213478|NCT03839446|Mitoxantrone|mitoxantrone|mesh-list
65213479|NCT03839446|Gemtuzumab|gemtuzumab|mesh-list
65213480|NCT03839446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65213481|NCT03839446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213482|NCT03839446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65213483|NCT03839446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65213484|NCT03839446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332437|NCT00756873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332438|NCT00790205|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65332439|NCT00790205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65332440|NCT00790205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332441|NCT00790205|Incretins|incretins|mesh-ancestor
65332442|NCT00790205|Hormones|hormones|mesh-ancestor
64718363|NCT04490239|Anticoagulants|anticoagulants|mesh-ancestor
65213485|NCT03839446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213486|NCT03839446|Analgesics|analgesics|mesh-ancestor
65213487|NCT03839446|Sensory System Agents|sensory system agents|mesh-ancestor
65213488|NCT03839446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65213489|NCT03839446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213490|NCT03839446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213491|NCT03781986|Carboplatin|carboplatin|mesh-list
65213492|NCT03781986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213493|NCT03778229|Osimertinib|osimertinib|mesh-list
65213494|NCT03778229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213495|NCT03778229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65213496|NCT03778229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213497|NCT03778229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213498|NCT03768063|Atezolizumab|atezolizumab|mesh-list
65213499|NCT03768063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213500|NCT03747939|Thalidomide|thalidomide|mesh-list
65213501|NCT03747939|Apremilast|apremilast|mesh-list
65213502|NCT03747939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65213503|NCT03747939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65213504|NCT03747939|Analgesics|analgesics|mesh-ancestor
64325093|NCT02576912|Dronabinol|dronabinol|mesh-list
65213509|NCT03747939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65213510|NCT03747939|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65213511|NCT03747939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65213512|NCT03747939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213513|NCT03747939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213514|NCT03747939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65213515|NCT03747939|Immunologic Factors|immunologic factors|mesh-ancestor
65213516|NCT03747939|Leprostatic Agents|leprostatic agents|mesh-ancestor
65213517|NCT03747939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65213518|NCT03747939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65213519|NCT03747939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65213520|NCT03747939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65213521|NCT03747939|Growth Substances|growth substances|mesh-ancestor
65213522|NCT03747939|Growth Inhibitors|growth inhibitors|mesh-ancestor
65213523|NCT03747939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213524|NCT03743402|Analgesics, Opioid|analgesics, opioid|mesh-list
65213525|NCT03743402|Narcotics|narcotics|mesh-ancestor
65213526|NCT03743402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65213527|NCT03743402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213528|NCT03743402|Analgesics|analgesics|mesh-ancestor
65213529|NCT03743402|Sensory System Agents|sensory system agents|mesh-ancestor
65213530|NCT03743402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65213531|NCT03735433|Aspirin|aspirin|mesh-list
65213532|NCT03735433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65213533|NCT03735433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65213534|NCT03735433|Analgesics|analgesics|mesh-ancestor
65213535|NCT03735433|Sensory System Agents|sensory system agents|mesh-ancestor
65213536|NCT03735433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65213537|NCT03735433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213538|NCT03735433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65213539|NCT03735433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65213540|NCT03735433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65213541|NCT03735433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65213542|NCT03735433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213543|NCT03735433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65213544|NCT03735433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65213545|NCT03735433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213546|NCT03735433|Antipyretics|antipyretics|mesh-ancestor
65213547|NCT03729401|Aspirin|aspirin|mesh-list
65213548|NCT03729401|Clopidogrel|clopidogrel|mesh-list
65213549|NCT03729401|Ticagrelor|ticagrelor|mesh-list
65332443|NCT00790205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65332444|NCT00790205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65332445|NCT00790205|Protease Inhibitors|protease inhibitors|mesh-ancestor
65332446|NCT00790205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332447|NCT00790205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332449|NCT04056039|Atorvastatin|atorvastatin|mesh-list
65332450|NCT04056039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65332451|NCT04056039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65332452|NCT04056039|Antimetabolites|antimetabolites|mesh-ancestor
65213550|NCT03729401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65213551|NCT03729401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65213552|NCT03729401|Analgesics|analgesics|mesh-ancestor
65213553|NCT03729401|Sensory System Agents|sensory system agents|mesh-ancestor
65213554|NCT03729401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65213555|NCT03729401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213556|NCT03729401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65213557|NCT03729401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65213558|NCT03729401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65213559|NCT03729401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65213560|NCT03729401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213561|NCT03729401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65213562|NCT03729401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65213563|NCT03729401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213564|NCT03729401|Antipyretics|antipyretics|mesh-ancestor
65213565|NCT03729401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65213566|NCT03729401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65213567|NCT03729401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65213568|NCT03729401|Purinergic Agents|purinergic agents|mesh-ancestor
65213569|NCT03729401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65213570|NCT03653364|Baloxavir|baloxavir|mesh-list
65213571|NCT03653364|Antiviral Agents|antiviral agents|mesh-ancestor
65213572|NCT03653364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65213573|NCT03653364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213574|NCT03653364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213577|NCT03597581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213578|NCT03597581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65213579|NCT03597581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65213580|NCT03597581|Growth Substances|growth substances|mesh-ancestor
65213581|NCT03597581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213582|NCT03597581|Growth Inhibitors|growth inhibitors|mesh-ancestor
65213583|NCT03578367|Niacinamide|niacinamide|mesh-list
65213584|NCT03578367|Imatinib Mesylate|imatinib mesylate|mesh-list
65213585|NCT03578367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213586|NCT03578367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65213587|NCT03578367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213588|NCT03578367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213589|NCT03578367|Vitamin B Complex|vitamin b complex|mesh-ancestor
65213591|NCT03578367|Micronutrients|micronutrients|mesh-ancestor
65213592|NCT03578367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213593|NCT03562416|Nintedanib|nintedanib|mesh-list
65213594|NCT03562416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213595|NCT03562416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65213596|NCT03562416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213597|NCT03562416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213598|NCT03512262|Abaloparatide|abaloparatide|mesh-list
65213599|NCT03512262|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
65213600|NCT03512262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65213601|NCT03512262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213602|NCT03512262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65213603|NCT03503058|Chloroquine|chloroquine|mesh-list
65213604|NCT03503058|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65213605|NCT03503058|Amebicides|amebicides|mesh-ancestor
65213606|NCT03503058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65213607|NCT03503058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65332453|NCT04056039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332454|NCT04056039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65332455|NCT04056039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65332456|NCT04056039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332457|NCT04056039|Gout Suppressants|gout suppressants|mesh-ancestor
65332458|NCT04056039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65332459|NCT04056039|Tubulin Modulators|tubulin modulators|mesh-ancestor
65332460|NCT04056039|Antimitotic Agents|antimitotic agents|mesh-ancestor
65332461|NCT04056039|Mitosis Modulators|mitosis modulators|mesh-ancestor
65332462|NCT04056039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332463|NCT00715208|Prednisone|prednisone|mesh-list
65332464|NCT00715208|Cyclophosphamide|cyclophosphamide|mesh-list
65213608|NCT03503058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65213609|NCT03503058|Antimalarials|antimalarials|mesh-ancestor
65213610|NCT03503058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65213611|NCT03503058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65213612|NCT03503058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65213613|NCT03503058|Analgesics|analgesics|mesh-ancestor
65213614|NCT03503058|Sensory System Agents|sensory system agents|mesh-ancestor
65213615|NCT03503058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65213616|NCT03503058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213617|NCT03503058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65213618|NCT03503058|Filaricides|filaricides|mesh-ancestor
65213619|NCT03503058|Antinematodal Agents|antinematodal agents|mesh-ancestor
65213620|NCT03503058|Anthelmintics|anthelmintics|mesh-ancestor
65213621|NCT03456063|Gemcitabine|gemcitabine|mesh-list
65213622|NCT03456063|Paclitaxel|paclitaxel|mesh-list
65213623|NCT03456063|Carboplatin|carboplatin|mesh-list
65213624|NCT03456063|Pemetrexed|pemetrexed|mesh-list
65213625|NCT03456063|Atezolizumab|atezolizumab|mesh-list
65213626|NCT03456063|Antibodies|antibodies|mesh-list
65213627|NCT03456063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65213628|NCT03456063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213629|NCT03456063|Tubulin Modulators|tubulin modulators|mesh-ancestor
65213630|NCT03456063|Antimitotic Agents|antimitotic agents|mesh-ancestor
65213631|NCT03456063|Mitosis Modulators|mitosis modulators|mesh-ancestor
65213632|NCT03456063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213633|NCT03456063|Immunologic Factors|immunologic factors|mesh-ancestor
65213634|NCT03456063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213635|NCT03456063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65213636|NCT03456063|Antimetabolites|antimetabolites|mesh-ancestor
65213637|NCT03456063|Antiviral Agents|antiviral agents|mesh-ancestor
65213638|NCT03456063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65213639|NCT03456063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213640|NCT03456063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65213641|NCT03456063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65213642|NCT03456063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65213643|NCT03396211|Nivolumab|nivolumab|mesh-list
65213644|NCT03396211|Apatinib|apatinib|mesh-list
65213645|NCT03396211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213646|NCT03396211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213647|NCT03396211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65213648|NCT03396211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213649|NCT03396211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65213653|NCT03386539|Tacrolimus|tacrolimus|mesh-list
65213654|NCT03386539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65213655|NCT03386539|Immunologic Factors|immunologic factors|mesh-ancestor
65213656|NCT03386539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213657|NCT03386539|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65213658|NCT03386539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213659|NCT03386539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213660|NCT03386539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213661|NCT03386539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65213662|NCT03386539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65332465|NCT00715208|Rituximab|rituximab|mesh-list
65332466|NCT00715208|Doxorubicin|doxorubicin|mesh-list
65332467|NCT00715208|Bortezomib|bortezomib|mesh-list
65332468|NCT00715208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65332469|NCT00715208|Immunologic Factors|immunologic factors|mesh-ancestor
65332470|NCT00715208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332471|NCT00715208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65332472|NCT00715208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65332473|NCT00715208|Alkylating Agents|alkylating agents|mesh-ancestor
65332474|NCT00715208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332475|NCT00715208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332476|NCT00715208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65332477|NCT00715208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65332478|NCT00715208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65332479|NCT00715208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65332480|NCT00715208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65332481|NCT00715208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332482|NCT00715208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65332483|NCT00715208|Glucocorticoids|glucocorticoids|mesh-ancestor
65332484|NCT00715208|Hormones|hormones|mesh-ancestor
65332485|NCT00715208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65332486|NCT00715208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65332487|NCT00919178|Vaccines|vaccines|mesh-list
65213664|NCT03386539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65213665|NCT03386539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65213666|NCT03301896|Spartalizumab|spartalizumab|mesh-list
65213667|NCT03301896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65213668|NCT03301896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213669|NCT03301896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213670|NCT03260322|Pembrolizumab|pembrolizumab|mesh-list
65213671|NCT03260322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213672|NCT03260322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213673|NCT03257761|Durvalumab|durvalumab|mesh-list
65213674|NCT03257761|Guadecitabine|guadecitabine|mesh-list
65213675|NCT03257761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213676|NCT03257761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213677|NCT03238300|Acetylcysteine|acetylcysteine|mesh-list
65213678|NCT03238300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65213679|NCT03238300|Antiviral Agents|antiviral agents|mesh-ancestor
65213680|NCT03238300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65213681|NCT03238300|Expectorants|expectorants|mesh-ancestor
65213682|NCT03238300|Respiratory System Agents|respiratory system agents|mesh-ancestor
65213683|NCT03238300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65213684|NCT03238300|Antioxidants|antioxidants|mesh-ancestor
65213685|NCT03238300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213686|NCT03238300|Protective Agents|protective agents|mesh-ancestor
65213687|NCT03238300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213688|NCT03238300|Antidotes|antidotes|mesh-ancestor
65213689|NCT03218085|Tenofovir|tenofovir|mesh-list
65213690|NCT03218085|Emtricitabine|emtricitabine|mesh-list
65213691|NCT03218085|Antiviral Agents|antiviral agents|mesh-ancestor
65213692|NCT03218085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65213693|NCT03218085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65332488|NCT00919178|Immunologic Factors|immunologic factors|mesh-ancestor
65332489|NCT00919178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332490|NCT02590250|Botulinum Toxins|botulinum toxins|mesh-list
65332491|NCT02590250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65332492|NCT02590250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65213694|NCT03218085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65213695|NCT03218085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213696|NCT03218085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213697|NCT03218085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65213698|NCT03218085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65213699|NCT03197077|Contraceptive Agents|contraceptive agents|mesh-list
65213700|NCT03197077|Desogestrel|desogestrel|mesh-list
65213701|NCT03197077|Contraceptives, Oral|contraceptives, oral|mesh-list
65213702|NCT03197077|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65213703|NCT03197077|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65213704|NCT03197077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65213705|NCT03197077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213706|NCT03197077|Hormones|hormones|mesh-ancestor
65213707|NCT03197077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65213708|NCT03197077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65213709|NCT03197077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65213710|NCT03197077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65213711|NCT03197077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65213712|NCT03197077|Progestins|progestins|mesh-ancestor
65213713|NCT03153280|Capecitabine|capecitabine|mesh-list
65213714|NCT03153280|Oxaliplatin|oxaliplatin|mesh-list
65213715|NCT03153280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65213716|NCT03153280|Antimetabolites|antimetabolites|mesh-ancestor
65213717|NCT03153280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213718|NCT03153280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213719|NCT03148418|Atezolizumab|atezolizumab|mesh-list
65213720|NCT03148418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213721|NCT03098836|Prednisone|prednisone|mesh-list
65213722|NCT03098836|Abiraterone Acetate|abiraterone acetate|mesh-list
65213723|NCT03098836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65213724|NCT03098836|Glucocorticoids|glucocorticoids|mesh-ancestor
65213727|NCT03098836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213728|NCT03098836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65213729|NCT03098836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213730|NCT03098836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65213731|NCT03098836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213732|NCT03098836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213733|NCT03098836|Hormone Antagonists|hormone antagonists|mesh-ancestor
65213734|NCT03098836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65213737|NCT03078855|Rituximab|rituximab|mesh-list
65213738|NCT03078855|Vitamins|vitamins|mesh-ancestor
65213739|NCT03078855|Micronutrients|micronutrients|mesh-ancestor
65213740|NCT03078855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213741|NCT03078855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213742|NCT03078855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213743|NCT03078855|Immunologic Factors|immunologic factors|mesh-ancestor
65213744|NCT03078855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65213745|NCT03078855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65213746|NCT03078855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65213747|NCT03047993|Azacitidine|azacitidine|mesh-list
65213748|NCT03047993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65213749|NCT03047993|Antimetabolites|antimetabolites|mesh-ancestor
65213750|NCT03047993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213751|NCT03047993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213752|NCT03047993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213753|NCT03007979|Letrozole|letrozole|mesh-list
65213754|NCT03007979|Fulvestrant|fulvestrant|mesh-list
65213755|NCT03007979|Palbociclib|palbociclib|mesh-list
65213756|NCT03007979|Goserelin|goserelin|mesh-list
65213757|NCT03007979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213758|NCT03007979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65213759|NCT03007979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65213760|NCT03007979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213761|NCT03007979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213762|NCT03007979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65332493|NCT02590250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65332494|NCT02590250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65332495|NCT02590250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332496|NCT02590250|Cholinergic Agents|cholinergic agents|mesh-ancestor
65332497|NCT02590250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65332498|NCT02590250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332499|NCT02590250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65332500|NCT02590250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332501|NCT00775463|Treprostinil|treprostinil|mesh-list
65213763|NCT03007979|Hormone Antagonists|hormone antagonists|mesh-ancestor
65213764|NCT03007979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65213765|NCT03007979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213766|NCT03007979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65213767|NCT03007979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65213768|NCT03007979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65213769|NCT02912572|Avelumab|avelumab|mesh-list
65213770|NCT02912572|Axitinib|axitinib|mesh-list
65213771|NCT02912572|Talazoparib|talazoparib|mesh-list
65213772|NCT02912572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213773|NCT02912572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213774|NCT02912572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65213775|NCT02912572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213776|NCT02912572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213777|NCT02912572|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65213778|NCT02910414|Ethanol|ethanol|mesh-list
65213779|NCT02910414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65213780|NCT02910414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65213781|NCT02910414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65213782|NCT02910414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213783|NCT02877303|Cytarabine|cytarabine|mesh-list
65213784|NCT02877303|Dexamethasone|dexamethasone|mesh-list
65213785|NCT02877303|Dexamethasone acetate|dexamethasone acetate|mesh-list
65213786|NCT02877303|Prednisone|prednisone|mesh-list
65213787|NCT02877303|Cortisone|cortisone|mesh-list
65213788|NCT02877303|Cyclophosphamide|cyclophosphamide|mesh-list
65213789|NCT02877303|Rituximab|rituximab|mesh-list
65213790|NCT02877303|Doxorubicin|doxorubicin|mesh-list
65213791|NCT02877303|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65213792|NCT02877303|Methotrexate|methotrexate|mesh-list
65213793|NCT02877303|Vincristine|vincristine|mesh-list
65213794|NCT02877303|Mercaptopurine|mercaptopurine|mesh-list
65213795|NCT02877303|Ofatumumab|ofatumumab|mesh-list
65213796|NCT02877303|Blinatumomab|blinatumomab|mesh-list
65213797|NCT02877303|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65213798|NCT02877303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65213799|NCT02877303|Muromonab-CD3|muromonab-cd3|mesh-list
65213804|NCT02877303|BB 1101|bb 1101|mesh-list
65213805|NCT02877303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65213806|NCT02877303|Immunologic Factors|immunologic factors|mesh-ancestor
65213807|NCT02877303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213808|NCT02877303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65213809|NCT02877303|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65213810|NCT02877303|Alkylating Agents|alkylating agents|mesh-ancestor
65213811|NCT02877303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213812|NCT02877303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856603|NCT01727427|PENTA|penta|mesh-list
65213813|NCT02877303|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65213814|NCT02877303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65213815|NCT02877303|Antiemetics|antiemetics|mesh-ancestor
65213816|NCT02877303|Autonomic Agents|autonomic agents|mesh-ancestor
65213817|NCT02877303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65213818|NCT02877303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65213819|NCT02877303|Glucocorticoids|glucocorticoids|mesh-ancestor
65213820|NCT02877303|Hormones|hormones|mesh-ancestor
65213821|NCT02877303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65213822|NCT02877303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65332502|NCT00775463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65332503|NCT02589782|Moxifloxacin|moxifloxacin|mesh-list
65332504|NCT02589782|Linezolid|linezolid|mesh-list
65332505|NCT02589782|Bedaquiline|bedaquiline|mesh-list
65332506|NCT02589782|Clofazimine|clofazimine|mesh-list
65332507|NCT02589782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64718426|NCT00726830|Oxycodone|oxycodone|mesh-list
65213823|NCT02877303|Protease Inhibitors|protease inhibitors|mesh-ancestor
65213824|NCT02877303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213825|NCT02877303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65213826|NCT02877303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65213827|NCT02877303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65213828|NCT02877303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65213829|NCT02877303|Abortifacient Agents|abortifacient agents|mesh-ancestor
65213830|NCT02877303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65213831|NCT02877303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65213832|NCT02877303|Antimetabolites|antimetabolites|mesh-ancestor
65213833|NCT02877303|Dermatologic Agents|dermatologic agents|mesh-ancestor
65213834|NCT02877303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65213835|NCT02877303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65213836|NCT02877303|Antiviral Agents|antiviral agents|mesh-ancestor
65213837|NCT02877303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65213838|NCT02877303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65213839|NCT02877303|Tubulin Modulators|tubulin modulators|mesh-ancestor
65213840|NCT02877303|Antimitotic Agents|antimitotic agents|mesh-ancestor
65213841|NCT02877303|Mitosis Modulators|mitosis modulators|mesh-ancestor
65213842|NCT02867813|Evolocumab|evolocumab|mesh-list
65213843|NCT02867813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65213844|NCT02867813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65213845|NCT02867813|Antimetabolites|antimetabolites|mesh-ancestor
65213846|NCT02867813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213847|NCT02867813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65213848|NCT02845596|Cyclosporine|cyclosporine|mesh-list
65213849|NCT02845596|Cyclophosphamide|cyclophosphamide|mesh-list
65213850|NCT02845596|Methotrexate|methotrexate|mesh-list
65213851|NCT02845596|Fludarabine|fludarabine|mesh-list
65213852|NCT02845596|Cyclosporins|cyclosporins|mesh-list
65213853|NCT02845596|Thymoglobulin|thymoglobulin|mesh-list
65213854|NCT02845596|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65213855|NCT02845596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65213856|NCT02845596|Immunologic Factors|immunologic factors|mesh-ancestor
65213857|NCT02845596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213858|NCT02845596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65213859|NCT02845596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65213860|NCT02845596|Alkylating Agents|alkylating agents|mesh-ancestor
65213861|NCT02845596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213862|NCT02845596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213863|NCT02845596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65213864|NCT02845596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65213865|NCT02845596|Abortifacient Agents|abortifacient agents|mesh-ancestor
65213866|NCT02845596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65213867|NCT02845596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65213868|NCT02845596|Antimetabolites|antimetabolites|mesh-ancestor
65213869|NCT02845596|Dermatologic Agents|dermatologic agents|mesh-ancestor
65213870|NCT02845596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213871|NCT02845596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65213873|NCT02845596|Antifungal Agents|antifungal agents|mesh-ancestor
65213874|NCT02845596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65213875|NCT02845596|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65213877|NCT02775695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65213878|NCT02775695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65213879|NCT02775695|Antimalarials|antimalarials|mesh-ancestor
65213880|NCT02775695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65213881|NCT02775695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65213882|NCT02737787|Nivolumab|nivolumab|mesh-list
65213883|NCT02737787|Vaccines|vaccines|mesh-list
65213884|NCT02737787|Immunologic Factors|immunologic factors|mesh-ancestor
65213885|NCT02737787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213886|NCT02737787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213887|NCT02737787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213888|NCT02737787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65332508|NCT02589782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65332509|NCT02589782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65332510|NCT02589782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65332511|NCT02589782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332512|NCT02589782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332513|NCT02589782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332514|NCT02589782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65332515|NCT02589782|Antitubercular Agents|antitubercular agents|mesh-ancestor
65332516|NCT02589782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65332517|NCT02589782|Leprostatic Agents|leprostatic agents|mesh-ancestor
65332518|NCT00918554|Methotrexate|methotrexate|mesh-list
65332519|NCT00918554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65332520|NCT00918554|Abortifacient Agents|abortifacient agents|mesh-ancestor
65332521|NCT00918554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65332522|NCT00918554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213889|NCT02737787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213891|NCT02646839|Vitamin B Complex|vitamin b complex|mesh-ancestor
65213892|NCT02646839|Vitamins|vitamins|mesh-ancestor
65213893|NCT02646839|Micronutrients|micronutrients|mesh-ancestor
65213894|NCT02646839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213896|NCT02625961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213897|NCT02625961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213898|NCT02607722|Nintedanib|nintedanib|mesh-list
65213899|NCT02607722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213900|NCT02607722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65213901|NCT02607722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213902|NCT02607722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213903|NCT02494570|Sirolimus|sirolimus|mesh-list
65213904|NCT02494570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65213905|NCT02494570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65213906|NCT02494570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65213907|NCT02494570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213908|NCT02494570|Antifungal Agents|antifungal agents|mesh-ancestor
65213909|NCT02494570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65213910|NCT02494570|Immunologic Factors|immunologic factors|mesh-ancestor
65213911|NCT02494570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213912|NCT02437071|Pembrolizumab|pembrolizumab|mesh-list
65213913|NCT02437071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213914|NCT02437071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213915|NCT02391025|Citric Acid|citric acid|mesh-list
65213916|NCT02391025|Sodium Citrate|sodium citrate|mesh-list
65213917|NCT02391025|Anticoagulants|anticoagulants|mesh-ancestor
65213918|NCT02391025|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65213919|NCT02391025|Chelating Agents|chelating agents|mesh-ancestor
65213920|NCT02391025|Sequestering Agents|sequestering agents|mesh-ancestor
65213921|NCT02391025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213922|NCT02341274|Tacrolimus|tacrolimus|mesh-list
65213923|NCT02341274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65213924|NCT02341274|Immunologic Factors|immunologic factors|mesh-ancestor
65213925|NCT02341274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213926|NCT02341274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65213927|NCT02341274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213928|NCT02341274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213929|NCT02297139|Dasatinib|dasatinib|mesh-list
65213930|NCT02297139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213931|NCT02297139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65213932|NCT02297139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213933|NCT02297139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213934|NCT02289209|Pembrolizumab|pembrolizumab|mesh-list
65332523|NCT00918554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65332525|NCT00918554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332526|NCT00918554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213935|NCT02289209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213936|NCT02289209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213937|NCT02256865|Ketoconazole|ketoconazole|mesh-list
65213938|NCT02256865|Hydrocortisone|hydrocortisone|mesh-list
65213939|NCT02256865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65213940|NCT02256865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65213941|NCT02256865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65213942|NCT02256865|Methyltestosterone|methyltestosterone|mesh-list
65213943|NCT02256865|Testosterone|testosterone|mesh-list
65213944|NCT02256865|Testosterone undecanoate|testosterone undecanoate|mesh-list
65213945|NCT02256865|Testosterone enanthate|testosterone enanthate|mesh-list
65213946|NCT02256865|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65213947|NCT02256865|Androgens|androgens|mesh-ancestor
65213948|NCT02256865|Hormones|hormones|mesh-ancestor
65213955|NCT02256865|Antifungal Agents|antifungal agents|mesh-ancestor
65213956|NCT02256865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65213957|NCT02256865|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65213958|NCT02256865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65213959|NCT02256865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213960|NCT02256865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213961|NCT02256865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65213962|NCT02256865|Hormone Antagonists|hormone antagonists|mesh-ancestor
64856712|NCT01730287|Calcium, Dietary|calcium, dietary|mesh-list
65213963|NCT02256865|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65213964|NCT02231879|Plerixafor|plerixafor|mesh-list
65213965|NCT02231879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65213966|NCT02231879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65213968|NCT02231879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65213969|NCT02141438|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65213970|NCT02141438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213971|NCT01968460|Pramipexole|pramipexole|mesh-list
65213972|NCT01968460|Rasagiline|rasagiline|mesh-list
65213973|NCT01968460|Antioxidants|antioxidants|mesh-ancestor
65213974|NCT01968460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213975|NCT01968460|Protective Agents|protective agents|mesh-ancestor
65213976|NCT01968460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213977|NCT01968460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65213978|NCT01968460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65213979|NCT01968460|Dopamine Agonists|dopamine agonists|mesh-ancestor
65213980|NCT01968460|Dopamine Agents|dopamine agents|mesh-ancestor
65213981|NCT01968460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65213982|NCT01968460|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65213983|NCT01968460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213984|NCT01968460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65213985|NCT01906853|Vaccines|vaccines|mesh-list
65213986|NCT01906853|BCG Vaccine|bcg vaccine|mesh-list
65213987|NCT01906853|Immunologic Factors|immunologic factors|mesh-ancestor
65213988|NCT01906853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213989|NCT01906853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65213990|NCT01712490|Doxorubicin|doxorubicin|mesh-list
65213991|NCT01712490|Bleomycin|bleomycin|mesh-list
65213992|NCT01712490|Dacarbazine|dacarbazine|mesh-list
65213993|NCT01712490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65213994|NCT01712490|Vinblastine|vinblastine|mesh-list
65213995|NCT01712490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65213996|NCT01712490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213997|NCT01712490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65213998|NCT01712490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65213999|NCT01712490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65214000|NCT01712490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214001|NCT01712490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65214002|NCT01712490|Alkylating Agents|alkylating agents|mesh-ancestor
65214003|NCT01712490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65214004|NCT01712490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65214005|NCT01712490|Tubulin Modulators|tubulin modulators|mesh-ancestor
65214006|NCT01712490|Antimitotic Agents|antimitotic agents|mesh-ancestor
65214007|NCT01712490|Mitosis Modulators|mitosis modulators|mesh-ancestor
65214008|NCT01527747|Saxagliptin|saxagliptin|mesh-list
65214009|NCT01527747|Incretins|incretins|mesh-ancestor
65214010|NCT01527747|Hormones|hormones|mesh-ancestor
65332527|NCT00918554|Dermatologic Agents|dermatologic agents|mesh-ancestor
65332528|NCT00918554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332529|NCT00918554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65332530|NCT00918554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65332531|NCT00918554|Immunologic Factors|immunologic factors|mesh-ancestor
65332532|NCT00918554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65332533|NCT00918554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65332534|NCT02590016|Insulin|insulin|mesh-list
65332535|NCT02590016|Insulin Aspart|insulin aspart|mesh-list
64427587|NCT02212197|Leuprolide|leuprolide|mesh-list
65214011|NCT01527747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65214012|NCT01527747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214013|NCT01527747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65214014|NCT01527747|Protease Inhibitors|protease inhibitors|mesh-ancestor
65214015|NCT01527747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65214016|NCT01527747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214019|NCT01439802|Trace Elements|trace elements|mesh-ancestor
65214020|NCT01439802|Micronutrients|micronutrients|mesh-ancestor
65214021|NCT01439802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214022|NCT01434316|Veliparib|veliparib|mesh-list
65214023|NCT01434316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65214024|NCT01434316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65214025|NCT01434316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214026|NCT01434316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214027|NCT00646230|Fenretinide|fenretinide|mesh-list
65214028|NCT00646230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214029|NCT00646230|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65214030|NCT00646230|Protective Agents|protective agents|mesh-ancestor
65214031|NCT00646230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214032|NCT00544414|Leucovorin|leucovorin|mesh-list
65214033|NCT00544414|Gemcitabine|gemcitabine|mesh-list
65214034|NCT00544414|Docetaxel|docetaxel|mesh-list
65214035|NCT00544414|Fluorouracil|fluorouracil|mesh-list
64856786|NCT01731067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65214036|NCT00544414|Calcium|calcium|mesh-list
65214037|NCT00544414|Levoleucovorin|levoleucovorin|mesh-list
65214038|NCT00544414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214039|NCT00544414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65214040|NCT00544414|Antimetabolites|antimetabolites|mesh-ancestor
65214041|NCT00544414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214042|NCT00544414|Antiviral Agents|antiviral agents|mesh-ancestor
65214043|NCT00544414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65214044|NCT00544414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65214045|NCT00544414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65214046|NCT00544414|Immunologic Factors|immunologic factors|mesh-ancestor
65214047|NCT00544414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214048|NCT00544414|Tubulin Modulators|tubulin modulators|mesh-ancestor
65214049|NCT00544414|Antimitotic Agents|antimitotic agents|mesh-ancestor
65214050|NCT00544414|Mitosis Modulators|mitosis modulators|mesh-ancestor
65214051|NCT00544414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65214053|NCT00544414|Protective Agents|protective agents|mesh-ancestor
65214054|NCT00544414|Vitamin B Complex|vitamin b complex|mesh-ancestor
65214055|NCT00544414|Vitamins|vitamins|mesh-ancestor
65214056|NCT00544414|Micronutrients|micronutrients|mesh-ancestor
65214057|NCT00816556|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65214058|NCT00816556|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65214059|NCT00816556|Estradiol|estradiol|mesh-list
65214060|NCT00816556|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65214061|NCT00816556|Estrogens|estrogens|mesh-ancestor
65214062|NCT00816556|Hormones|hormones|mesh-ancestor
65214063|NCT00816556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65214064|NCT00816556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214065|NCT00816556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65214066|NCT00816556|Contraceptive Agents|contraceptive agents|mesh-ancestor
65214067|NCT00816556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65214068|NCT00816556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65214069|NCT04100473|Insulin|insulin|mesh-list
65332536|NCT02590016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65332537|NCT02590016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332538|NCT00768053|Etanercept|etanercept|mesh-list
65332539|NCT00768053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65332540|NCT00768053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65332541|NCT00768053|Analgesics|analgesics|mesh-ancestor
65332542|NCT00768053|Sensory System Agents|sensory system agents|mesh-ancestor
65332543|NCT00768053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332544|NCT00768053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718456|NCT00685880|Glucocorticoids|glucocorticoids|mesh-ancestor
65214070|NCT04100473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65214071|NCT04100473|Insulin Lispro|insulin lispro|mesh-list
65214072|NCT04100473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65214073|NCT04100473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214074|NCT02796807|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65214075|NCT02796807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65214076|NCT02796807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214077|NCT00760747|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65214078|NCT00760747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65214079|NCT00760747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65214080|NCT00760747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65214081|NCT00760747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214082|NCT00760747|Adrenergic Agents|adrenergic agents|mesh-ancestor
65214083|NCT00760747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65214084|NCT00760747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214085|NCT00760669|Methotrexate|methotrexate|mesh-list
65214086|NCT00760669|Infliximab|infliximab|mesh-list
65214087|NCT00760669|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65214088|NCT00760669|Abortifacient Agents|abortifacient agents|mesh-ancestor
65214089|NCT00760669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65214090|NCT00760669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214091|NCT00760669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65214097|NCT00760669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65214098|NCT00760669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65214099|NCT00760669|Immunologic Factors|immunologic factors|mesh-ancestor
65214100|NCT00760669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65214101|NCT00760669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65214102|NCT00760669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65214103|NCT02796183|Bevacizumab|bevacizumab|mesh-list
65214104|NCT02796183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65214105|NCT02796183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214106|NCT02796183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65214107|NCT02796183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65214108|NCT02796183|Growth Substances|growth substances|mesh-ancestor
65214109|NCT02796183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214110|NCT02796183|Growth Inhibitors|growth inhibitors|mesh-ancestor
65214111|NCT02796105|Ganirelix|ganirelix|mesh-list
65214112|NCT02796105|Hormone Antagonists|hormone antagonists|mesh-ancestor
65214113|NCT02796105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65214114|NCT02796105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214115|NCT02795949|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65214117|NCT02795949|Ciprofloxacin|ciprofloxacin|mesh-list
65214118|NCT02795949|Meropenem|meropenem|mesh-list
65214119|NCT02795949|Tazobactam|tazobactam|mesh-list
65214120|NCT02795949|Piperacillin|piperacillin|mesh-list
65214121|NCT02795949|Clavulanic Acid|clavulanic acid|mesh-list
65214122|NCT02795949|Imipenem|imipenem|mesh-list
65214123|NCT02795949|Ceftazidime|ceftazidime|mesh-list
65214124|NCT02795949|Ampicillin|ampicillin|mesh-list
65214125|NCT02795949|Cefuroxime|cefuroxime|mesh-list
65214126|NCT02795949|Ertapenem|ertapenem|mesh-list
65214127|NCT02795949|Cefepime|cefepime|mesh-list
65214128|NCT02795949|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65214129|NCT02795949|Lactams|lactams|mesh-list
65214130|NCT02795949|Aztreonam|aztreonam|mesh-list
65214131|NCT02795949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65332545|NCT00768053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65332546|NCT00768053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65332547|NCT00768053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65332548|NCT00768053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65332549|NCT00768053|Immunologic Factors|immunologic factors|mesh-ancestor
65332550|NCT00683475|Prednisone|prednisone|mesh-list
65332551|NCT00683475|Mitoxantrone|mitoxantrone|mesh-list
65332552|NCT00683475|Ramucirumab|ramucirumab|mesh-list
65332553|NCT00683475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65332554|NCT00683475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65214132|NCT02795949|beta-Lactams|beta-lactams|mesh-list
65214133|NCT02795949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65214134|NCT02795949|Trimethoprim|trimethoprim|mesh-list
65214135|NCT02795949|Sulfamethoxazole|sulfamethoxazole|mesh-list
65214136|NCT02795949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65214137|NCT02795949|Antitubercular Agents|antitubercular agents|mesh-ancestor
65214138|NCT02795949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65214139|NCT02795949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65214140|NCT02795949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65214141|NCT02795949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214142|NCT02795949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214143|NCT02795949|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65214144|NCT02795949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65214145|NCT02795949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65214146|NCT02795949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65214147|NCT02795949|Renal Agents|renal agents|mesh-ancestor
65214148|NCT02795949|Antimalarials|antimalarials|mesh-ancestor
65214149|NCT02795949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65214150|NCT02795949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65214151|NCT02795949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65214152|NCT02795949|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65214153|NCT02795949|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65214154|NCT00769483|Gemcitabine|gemcitabine|mesh-list
65214155|NCT00769483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65214156|NCT00769483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65214157|NCT00769483|Antimetabolites|antimetabolites|mesh-ancestor
65214158|NCT00769483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214159|NCT00769483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214160|NCT00769483|Antiviral Agents|antiviral agents|mesh-ancestor
65214161|NCT00769483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65214162|NCT00769483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65214163|NCT00769483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65214164|NCT00769483|Immunologic Factors|immunologic factors|mesh-ancestor
65214169|NCT02794389|Antiviral Agents|antiviral agents|mesh-ancestor
65214170|NCT02794389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65214171|NCT02794389|Expectorants|expectorants|mesh-ancestor
65214172|NCT02794389|Respiratory System Agents|respiratory system agents|mesh-ancestor
65214173|NCT02794389|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65214174|NCT02794389|Antioxidants|antioxidants|mesh-ancestor
65214175|NCT02794389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214176|NCT02794389|Protective Agents|protective agents|mesh-ancestor
65214177|NCT02794389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214178|NCT02794389|Antidotes|antidotes|mesh-ancestor
65214179|NCT02601703|Tacrolimus|tacrolimus|mesh-list
65214180|NCT02601703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65214181|NCT02601703|Immunologic Factors|immunologic factors|mesh-ancestor
65214182|NCT02601703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214183|NCT02601703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65214184|NCT02601703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65214185|NCT02601703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214186|NCT02794077|Cyclophosphamide|cyclophosphamide|mesh-list
65214187|NCT02794077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65214188|NCT02794077|Immunologic Factors|immunologic factors|mesh-ancestor
64856935|NCT01731587|Cyclophosphamide|cyclophosphamide|mesh-list
65214189|NCT02794077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214190|NCT02794077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65214191|NCT02794077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65332555|NCT00683475|Glucocorticoids|glucocorticoids|mesh-ancestor
65332556|NCT00683475|Hormones|hormones|mesh-ancestor
65332557|NCT00683475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65214192|NCT02794077|Alkylating Agents|alkylating agents|mesh-ancestor
65214193|NCT02794077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214194|NCT02794077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214195|NCT02794077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65214196|NCT04234191|Buprenorphine|buprenorphine|mesh-list
65214197|NCT04234191|Hydromorphone|hydromorphone|mesh-list
65214198|NCT04234191|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65214199|NCT04234191|Naloxone|naloxone|mesh-list
65214200|NCT04234191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65214201|NCT04234191|Narcotics|narcotics|mesh-ancestor
65214202|NCT04234191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65214203|NCT04234191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214204|NCT04234191|Analgesics|analgesics|mesh-ancestor
65214205|NCT04234191|Sensory System Agents|sensory system agents|mesh-ancestor
65214206|NCT04234191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65214207|NCT04234191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65214208|NCT02801799|Ropivacaine|ropivacaine|mesh-list
65214209|NCT02801799|Anesthetics, Local|anesthetics, local|mesh-ancestor
65214210|NCT02801799|Anesthetics|anesthetics|mesh-ancestor
65214211|NCT02801799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65214212|NCT02801799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214213|NCT02801799|Sensory System Agents|sensory system agents|mesh-ancestor
65214214|NCT02801799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65214215|NCT02690103|Ribavirin|ribavirin|mesh-list
65214216|NCT02690103|Antimetabolites|antimetabolites|mesh-ancestor
65214217|NCT02690103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214218|NCT02690103|Antiviral Agents|antiviral agents|mesh-ancestor
65214219|NCT02690103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65214220|NCT02790099|Morphine|morphine|mesh-list
65214221|NCT02790099|Bupivacaine|bupivacaine|mesh-list
65214222|NCT02790099|Anesthetics, Local|anesthetics, local|mesh-ancestor
65214223|NCT02790099|Anesthetics|anesthetics|mesh-ancestor
65214224|NCT02790099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65214225|NCT02790099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214226|NCT02790099|Sensory System Agents|sensory system agents|mesh-ancestor
65214227|NCT02790099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65214228|NCT02790099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65214229|NCT02790099|Narcotics|narcotics|mesh-ancestor
65214230|NCT02790099|Analgesics|analgesics|mesh-ancestor
65214231|NCT02790177|Hyaluronic Acid|hyaluronic acid|mesh-list
65214232|NCT02790177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65214233|NCT02790177|Immunologic Factors|immunologic factors|mesh-ancestor
65214234|NCT02790177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214235|NCT02790177|Viscosupplements|viscosupplements|mesh-ancestor
65214236|NCT02790177|Protective Agents|protective agents|mesh-ancestor
65214240|NCT04100083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65214241|NCT04100083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214242|NCT04100083|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65214244|NCT04100083|Natriuretic Agents|natriuretic agents|mesh-ancestor
65214245|NCT02794155|Insulin|insulin|mesh-list
65214246|NCT02794155|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65214247|NCT02794155|Insulin Lispro|insulin lispro|mesh-list
65214248|NCT02794155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65214249|NCT02794155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214250|NCT02793843|Dexamethasone|dexamethasone|mesh-list
65214251|NCT02793843|Ondansetron|ondansetron|mesh-list
65214252|NCT02793843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65214253|NCT02793843|Antiemetics|antiemetics|mesh-ancestor
65214254|NCT02793843|Autonomic Agents|autonomic agents|mesh-ancestor
65214255|NCT02793843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65214256|NCT02793843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214257|NCT02793843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65214258|NCT02793843|Glucocorticoids|glucocorticoids|mesh-ancestor
65214259|NCT02793843|Hormones|hormones|mesh-ancestor
65214260|NCT02793843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65214261|NCT02793843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65214262|NCT02793843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214263|NCT02793843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65214264|NCT02793843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214265|NCT02793843|Antipruritics|antipruritics|mesh-ancestor
65332558|NCT00683475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332559|NCT00683475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65332560|NCT00683475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332561|NCT00683475|Analgesics|analgesics|mesh-ancestor
65332562|NCT00683475|Sensory System Agents|sensory system agents|mesh-ancestor
64857012|NCT01732068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214266|NCT02793843|Dermatologic Agents|dermatologic agents|mesh-ancestor
65214267|NCT02793843|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65214268|NCT02793843|Serotonin Agents|serotonin agents|mesh-ancestor
65214269|NCT02793843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65214270|NCT02793843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65214271|NCT02793843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65214272|NCT02793843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65214273|NCT02793843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65214274|NCT02793687|Emoxypine succinate|emoxypine succinate|mesh-list
65214275|NCT02793687|Antioxidants|antioxidants|mesh-ancestor
65214276|NCT02793687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214277|NCT02793687|Protective Agents|protective agents|mesh-ancestor
65214278|NCT02793687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214279|NCT02793687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65214280|NCT02793687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65214282|NCT02801487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214284|NCT02793765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214285|NCT02793765|Tubulin Modulators|tubulin modulators|mesh-ancestor
65214286|NCT02793765|Antimitotic Agents|antimitotic agents|mesh-ancestor
65214287|NCT02793765|Mitosis Modulators|mitosis modulators|mesh-ancestor
65214288|NCT02793765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214289|NCT02793219|Docetaxel|docetaxel|mesh-list
65214290|NCT02793219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214291|NCT02793219|Tubulin Modulators|tubulin modulators|mesh-ancestor
65214292|NCT02793219|Antimitotic Agents|antimitotic agents|mesh-ancestor
65214293|NCT02793219|Mitosis Modulators|mitosis modulators|mesh-ancestor
65214294|NCT02793219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214295|NCT02801409|Anesthetics|anesthetics|mesh-list
65214296|NCT02801409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65214297|NCT02801409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214298|NCT03787251|Apatinib|apatinib|mesh-list
65214299|NCT03787251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214300|NCT03787251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65214301|NCT03787251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65214302|NCT03787251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214303|NCT02789865|Metronidazole|metronidazole|mesh-list
65214304|NCT02789865|Levofloxacin|levofloxacin|mesh-list
65214305|NCT02789865|Ofloxacin|ofloxacin|mesh-list
65214306|NCT02789865|Ertapenem|ertapenem|mesh-list
65214307|NCT02789865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65214308|NCT02789865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65214309|NCT02789865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65214313|NCT02789865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65214314|NCT02789865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65214315|NCT02789865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65214316|NCT02789865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214317|NCT02789865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214318|NCT02789865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65214319|NCT02789865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65214320|NCT02792673|Hyaluronic Acid|hyaluronic acid|mesh-list
65214321|NCT02792673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65214322|NCT02792673|Immunologic Factors|immunologic factors|mesh-ancestor
65214323|NCT02792673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214324|NCT02792673|Viscosupplements|viscosupplements|mesh-ancestor
65214325|NCT02792673|Protective Agents|protective agents|mesh-ancestor
65214326|NCT00906204|Thymoglobulin|thymoglobulin|mesh-list
65214327|NCT00906204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65214328|NCT00906204|Immunologic Factors|immunologic factors|mesh-ancestor
65214329|NCT00906204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214330|NCT00906204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65214332|NCT02791737|Keratolytic Agents|keratolytic agents|mesh-ancestor
65214333|NCT02791737|Dermatologic Agents|dermatologic agents|mesh-ancestor
65214334|NCT02535936|Anesthetics|anesthetics|mesh-list
65214335|NCT02535936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65214336|NCT02535936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332563|NCT00683475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332564|NCT00683475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65332565|NCT00683475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65332566|NCT00683475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718481|NCT00423020|Epoetin Alfa|epoetin alfa|mesh-list
65214337|NCT05332470|Lamivudine|lamivudine|mesh-list
65214338|NCT05332470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65214339|NCT05332470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65214340|NCT05332470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65214341|NCT05332470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214342|NCT05332470|Antiviral Agents|antiviral agents|mesh-ancestor
65214343|NCT05332470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65214344|NCT05332470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65214345|NCT05332470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65214347|NCT02791815|Midazolam|midazolam|mesh-list
65214348|NCT02791815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65214349|NCT02791815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65214350|NCT02791815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65214351|NCT02791815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214352|NCT02791815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65214353|NCT02791815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65214354|NCT02791815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65214355|NCT02791815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65214356|NCT02791815|Anesthetics, General|anesthetics, general|mesh-ancestor
65214357|NCT02791815|Anesthetics|anesthetics|mesh-ancestor
65214358|NCT02791815|GABA Modulators|gaba modulators|mesh-ancestor
65214359|NCT02791815|GABA Agents|gaba agents|mesh-ancestor
65214360|NCT02791815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65214361|NCT02791815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214362|NCT02791815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65214363|NCT02389374|Chloroquine|chloroquine|mesh-list
65214364|NCT02389374|Lumefantrine|lumefantrine|mesh-list
65214365|NCT02389374|Artemether|artemether|mesh-list
65214366|NCT02389374|Primaquine|primaquine|mesh-list
65214367|NCT02389374|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65214368|NCT02389374|Amebicides|amebicides|mesh-ancestor
65214369|NCT02389374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65214370|NCT02389374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65214371|NCT02389374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65214372|NCT02389374|Antimalarials|antimalarials|mesh-ancestor
65214373|NCT02389374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65214374|NCT02789475|Amlodipine|amlodipine|mesh-list
65214375|NCT02789475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65214376|NCT02789475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65214377|NCT02789475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65214378|NCT02789475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65214379|NCT02789475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214380|NCT02789475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65214381|NCT02789475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214382|NCT02789475|Vasodilator Agents|vasodilator agents|mesh-ancestor
65214383|NCT02789475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65214388|NCT02789475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65214389|NCT03889743|Dexamethasone|dexamethasone|mesh-list
65214390|NCT03889743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65214391|NCT03889743|Antiemetics|antiemetics|mesh-ancestor
65214392|NCT03889743|Autonomic Agents|autonomic agents|mesh-ancestor
65214393|NCT03889743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65214394|NCT03889743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214395|NCT03889743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65214396|NCT03889743|Glucocorticoids|glucocorticoids|mesh-ancestor
65214397|NCT03889743|Hormones|hormones|mesh-ancestor
65214398|NCT03889743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65214399|NCT03889743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65214400|NCT03889743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214401|NCT04202484|Oxaliplatin|oxaliplatin|mesh-list
65214402|NCT04202484|Tegafur|tegafur|mesh-list
65214403|NCT04202484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214404|NCT04202484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65214405|NCT04202484|Antimetabolites|antimetabolites|mesh-ancestor
65214406|NCT04202484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214407|NCT03068910|Spironolactone|spironolactone|mesh-list
65214408|NCT03068910|Progesterone|progesterone|mesh-list
65332567|NCT00683475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332568|NCT00683475|Immunologic Factors|immunologic factors|mesh-ancestor
65332569|NCT02589158|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65332570|NCT02589158|Darunavir|darunavir|mesh-list
65332571|NCT02589158|Cobicistat|cobicistat|mesh-list
65332572|NCT02589158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65332573|NCT02589158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65332574|NCT02589158|Protease Inhibitors|protease inhibitors|mesh-ancestor
65214409|NCT03068910|Progestins|progestins|mesh-ancestor
65214410|NCT03068910|Hormones|hormones|mesh-ancestor
65214411|NCT03068910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65214412|NCT03068910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214413|NCT03068910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65214414|NCT03068910|Hormone Antagonists|hormone antagonists|mesh-ancestor
65214415|NCT03068910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65214416|NCT03068910|Diuretics|diuretics|mesh-ancestor
65214417|NCT03068910|Natriuretic Agents|natriuretic agents|mesh-ancestor
65214418|NCT02790957|Plerixafor|plerixafor|mesh-list
65214419|NCT02790957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65214420|NCT02790957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65214421|NCT02790957|Antiviral Agents|antiviral agents|mesh-ancestor
65214422|NCT02790957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65214423|NCT00905424|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65214424|NCT00905424|Antidepressive Agents|antidepressive agents|mesh-list
65214425|NCT00905424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65214426|NCT00905424|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65214427|NCT00905424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214428|NCT00905424|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65214429|NCT00905424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65214430|NCT00905424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65214431|NCT00905424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214433|NCT00905424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65214434|NCT02791035|Ipragliflozin|ipragliflozin|mesh-list
65214435|NCT02791035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65214436|NCT02791035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214437|NCT02791035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65214438|NCT02791035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214439|NCT03753243|Pembrolizumab|pembrolizumab|mesh-list
65214440|NCT03753243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65214441|NCT03753243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214442|NCT02339532|Carboplatin|carboplatin|mesh-list
65214443|NCT02339532|Docetaxel|docetaxel|mesh-list
65214444|NCT02339532|Trastuzumab|trastuzumab|mesh-list
65214445|NCT02339532|Pertuzumab|pertuzumab|mesh-list
65214446|NCT02339532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214447|NCT02339532|Tubulin Modulators|tubulin modulators|mesh-ancestor
65214448|NCT02339532|Antimitotic Agents|antimitotic agents|mesh-ancestor
65214449|NCT02339532|Mitosis Modulators|mitosis modulators|mesh-ancestor
65214450|NCT02339532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214451|NCT02339532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65214452|NCT00632580|Ropivacaine|ropivacaine|mesh-list
65214453|NCT00632580|Anesthetics, Local|anesthetics, local|mesh-ancestor
65214454|NCT00632580|Anesthetics|anesthetics|mesh-ancestor
65214455|NCT00632580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65214458|NCT00632580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65214460|NCT03494322|Avelumab|avelumab|mesh-list
65214461|NCT03494322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65214462|NCT03494322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214463|NCT02789397|Rituximab|rituximab|mesh-list
65214464|NCT02789397|Azathioprine|azathioprine|mesh-list
65214465|NCT02789397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65214466|NCT02789397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214467|NCT02789397|Immunologic Factors|immunologic factors|mesh-ancestor
65214468|NCT02789397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214469|NCT02789397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65214470|NCT02789397|Antimetabolites|antimetabolites|mesh-ancestor
65214471|NCT02789397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332575|NCT02589158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332576|NCT02589158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332577|NCT02589158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65332578|NCT02589158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65332579|NCT02589158|Antiviral Agents|antiviral agents|mesh-ancestor
65332580|NCT02589158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65332581|NCT02589158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65332582|NCT02589158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65332583|NCT00916253|Modafinil|modafinil|mesh-list
65332584|NCT00916253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65332585|NCT00916253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332586|NCT00916253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65332587|NCT00916253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65332588|NCT00916253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65332589|NCT00916253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332590|NCT00757029|Norepinephrine|norepinephrine|mesh-list
65332591|NCT00757029|Methylphenidate|methylphenidate|mesh-list
65332592|NCT00757029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65332593|NCT00757029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332594|NCT00757029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65082485|NCT00426179|Imatinib Mesylate|imatinib mesylate|mesh-list
65332595|NCT00757029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65332596|NCT00757029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65332597|NCT00757029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332598|NCT00757029|Dopamine Agents|dopamine agents|mesh-ancestor
65332599|NCT00757029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65332600|NCT00757029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65214472|NCT02789397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65214473|NCT02789397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65214474|NCT03485274|Vortioxetine|vortioxetine|mesh-list
65214475|NCT03485274|Antidepressive Agents|antidepressive agents|mesh-ancestor
65214476|NCT03485274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65214477|NCT03485274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65214478|NCT03485274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65214479|NCT03485274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65214480|NCT03485274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214481|NCT03485274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65214482|NCT03485274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65214483|NCT03485274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65214484|NCT03485274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214485|NCT03485274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65214486|NCT03485274|Serotonin Agents|serotonin agents|mesh-ancestor
65214487|NCT03485274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65332601|NCT00757029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65332602|NCT00757029|Adrenergic Agents|adrenergic agents|mesh-ancestor
65332603|NCT00757029|Sympathomimetics|sympathomimetics|mesh-ancestor
65332604|NCT00757029|Autonomic Agents|autonomic agents|mesh-ancestor
65332605|NCT00757029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332606|NCT00757029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65332607|NCT04101929|Irinotecan|irinotecan|mesh-list
65332608|NCT04101929|Apatinib|apatinib|mesh-list
65332609|NCT04101929|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65332610|NCT04101929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65332611|NCT04101929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332612|NCT04101929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332613|NCT04101929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332614|NCT04101929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65332615|NCT00918632|Axitinib|axitinib|mesh-list
65332616|NCT00918632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332617|NCT00918632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65332618|NCT00918632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332619|NCT00918632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332620|NCT00751257|Acetylcysteine|acetylcysteine|mesh-list
65214488|NCT03485274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65214489|NCT03485274|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65214490|NCT03485274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65214491|NCT00816166|Aspirin|aspirin|mesh-list
64857247|NCT01733979|Iron|iron|mesh-list
65214493|NCT00816166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65214494|NCT00816166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65214495|NCT00816166|Analgesics|analgesics|mesh-ancestor
65214496|NCT00816166|Sensory System Agents|sensory system agents|mesh-ancestor
65214497|NCT00816166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65214498|NCT00816166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214499|NCT00816166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65214500|NCT00816166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65214501|NCT00816166|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65214502|NCT00816166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65214503|NCT00816166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214504|NCT00816166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65214505|NCT00816166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65214506|NCT00816166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65214507|NCT00816166|Antipyretics|antipyretics|mesh-ancestor
65214508|NCT00816166|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65214509|NCT00816166|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65214510|NCT00816166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65214511|NCT00816166|Purinergic Agents|purinergic agents|mesh-ancestor
65214512|NCT00816166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65214513|NCT02788851|Guanfacine|guanfacine|mesh-list
65214514|NCT02788851|Methylphenidate|methylphenidate|mesh-list
65214515|NCT02788851|Amphetamine|amphetamine|mesh-list
65214516|NCT02788851|Adderall|adderall|mesh-list
65214517|NCT02788851|Dextroamphetamine|dextroamphetamine|mesh-list
65214518|NCT02788851|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65214519|NCT02788851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65214520|NCT02788851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214521|NCT02788851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65214522|NCT02788851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65214523|NCT02788851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65332621|NCT00751257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65332622|NCT00751257|Antiviral Agents|antiviral agents|mesh-ancestor
65332623|NCT00751257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65332624|NCT00751257|Expectorants|expectorants|mesh-ancestor
65332625|NCT00751257|Respiratory System Agents|respiratory system agents|mesh-ancestor
65332626|NCT00751257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65332627|NCT00751257|Antioxidants|antioxidants|mesh-ancestor
65332628|NCT00751257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332629|NCT00751257|Protective Agents|protective agents|mesh-ancestor
65332630|NCT00751257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332631|NCT00751257|Antidotes|antidotes|mesh-ancestor
65332632|NCT00757185|Methyltestosterone|methyltestosterone|mesh-list
65332633|NCT00757185|Testosterone|testosterone|mesh-list
65332634|NCT00757185|Testosterone undecanoate|testosterone undecanoate|mesh-list
65332635|NCT00757185|Testosterone enanthate|testosterone enanthate|mesh-list
65332636|NCT00757185|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65332637|NCT00757185|Ganirelix|ganirelix|mesh-list
65332638|NCT00757185|Androgens|androgens|mesh-ancestor
65214524|NCT02788851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214525|NCT02788851|Dopamine Agents|dopamine agents|mesh-ancestor
65214526|NCT02788851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65214535|NCT02788851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65214536|NCT03477396|Estrogens|estrogens|mesh-list
65214537|NCT03477396|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65214538|NCT03477396|Hormones|hormones|mesh-ancestor
65214539|NCT03477396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65214540|NCT03477396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214541|NCT03477396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65214542|NCT03477396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65214543|NCT03477396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214544|NCT03477396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65214545|NCT03477396|Hormone Antagonists|hormone antagonists|mesh-ancestor
65214546|NCT02786823|Folic Acid|folic acid|mesh-list
65214547|NCT02786823|Vitamin B 12|vitamin b 12|mesh-list
65214548|NCT02786823|Metformin|metformin|mesh-list
65214549|NCT02786823|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65214550|NCT02786823|Vitamins|vitamins|mesh-ancestor
65214551|NCT02786823|Micronutrients|micronutrients|mesh-ancestor
65214552|NCT02786823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214553|NCT02786823|Hematinics|hematinics|mesh-ancestor
65214554|NCT02786823|Vitamin B Complex|vitamin b complex|mesh-ancestor
65214555|NCT05332314|Ibuprofen|ibuprofen|mesh-list
65214556|NCT05332314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65214557|NCT05332314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65214558|NCT05332314|Analgesics|analgesics|mesh-ancestor
65214559|NCT05332314|Sensory System Agents|sensory system agents|mesh-ancestor
65214560|NCT05332314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65214561|NCT05332314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214562|NCT05332314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65214563|NCT05332314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65214564|NCT05332314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65214565|NCT05332314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857315|NCT01734408|Antacids|antacids|mesh-ancestor
65214566|NCT05332314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214567|NCT00815308|Paclitaxel|paclitaxel|mesh-list
65214568|NCT00815308|Cetuximab|cetuximab|mesh-list
65214569|NCT00815308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65214570|NCT00815308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214571|NCT00815308|Tubulin Modulators|tubulin modulators|mesh-ancestor
65214572|NCT00815308|Antimitotic Agents|antimitotic agents|mesh-ancestor
65214573|NCT00815308|Mitosis Modulators|mitosis modulators|mesh-ancestor
65332639|NCT00757185|Hormones|hormones|mesh-ancestor
65332640|NCT00757185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65332641|NCT00757185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332642|NCT00757185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65332643|NCT00757185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332644|NCT00757185|Anabolic Agents|anabolic agents|mesh-ancestor
65332645|NCT00757185|Hormone Antagonists|hormone antagonists|mesh-ancestor
65332646|NCT00751491|Clopidogrel|clopidogrel|mesh-list
65332647|NCT00751491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65332648|NCT00751491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65332649|NCT00751491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65214574|NCT00815308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214575|NCT00815308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65214576|NCT01039376|Ofatumumab|ofatumumab|mesh-list
65214577|NCT01039376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214578|NCT02610712|Ketamine|ketamine|mesh-list
65214579|NCT02610712|Analgesics|analgesics|mesh-ancestor
65214580|NCT02610712|Sensory System Agents|sensory system agents|mesh-ancestor
65214581|NCT02610712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65214582|NCT02610712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214583|NCT02610712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65214584|NCT02610712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65214585|NCT02610712|Anesthetics, General|anesthetics, general|mesh-ancestor
65214586|NCT02610712|Anesthetics|anesthetics|mesh-ancestor
65214587|NCT02610712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65214588|NCT02610712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65214589|NCT02610712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65214590|NCT02610712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65214591|NCT02610712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214592|NCT00905034|Dexamethasone|dexamethasone|mesh-list
65214593|NCT00905034|Rituximab|rituximab|mesh-list
65214598|NCT00905034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65214599|NCT00905034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214601|NCT00905034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214602|NCT00905034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65214603|NCT00905034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65214604|NCT00905034|Antiemetics|antiemetics|mesh-ancestor
65214605|NCT00905034|Autonomic Agents|autonomic agents|mesh-ancestor
65214606|NCT00905034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65214607|NCT00905034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65214608|NCT00905034|Glucocorticoids|glucocorticoids|mesh-ancestor
65214609|NCT00905034|Hormones|hormones|mesh-ancestor
65214610|NCT00905034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65214611|NCT00905034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65214612|NCT00905034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65214613|NCT00905034|Abortifacient Agents|abortifacient agents|mesh-ancestor
65214614|NCT00905034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65214615|NCT00905034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65214616|NCT00905034|Antimetabolites|antimetabolites|mesh-ancestor
65214617|NCT00905034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214618|NCT00905034|Dermatologic Agents|dermatologic agents|mesh-ancestor
65214619|NCT00905034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65214620|NCT00905034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65214621|NCT00905034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65214622|NCT00905034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65214623|NCT00905034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65214624|NCT00905034|Tubulin Modulators|tubulin modulators|mesh-ancestor
65214625|NCT00905034|Antimitotic Agents|antimitotic agents|mesh-ancestor
65214626|NCT00905034|Mitosis Modulators|mitosis modulators|mesh-ancestor
65214627|NCT02611804|Diclofenac|diclofenac|mesh-list
65214628|NCT02611804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65332650|NCT00751491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65332651|NCT00751491|Purinergic Agents|purinergic agents|mesh-ancestor
65332652|NCT00751491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65332653|NCT00751491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332654|NCT00751491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332655|NCT02561169|Oseltamivir|oseltamivir|mesh-list
65332656|NCT02561169|Calcium Carbonate|calcium carbonate|mesh-list
65332657|NCT02561169|Antacids|antacids|mesh-ancestor
65332658|NCT02561169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214629|NCT02611804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65214630|NCT02611804|Analgesics|analgesics|mesh-ancestor
65214631|NCT02611804|Sensory System Agents|sensory system agents|mesh-ancestor
65214632|NCT02611804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65214633|NCT02611804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214634|NCT02611804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65214635|NCT02611804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65214636|NCT02611804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65214637|NCT02611804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857388|NCT01735019|Analgesics|analgesics|mesh-ancestor
65214638|NCT02611804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214639|NCT00706186|Sodium Oxybate|sodium oxybate|mesh-list
65214640|NCT00706186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65214641|NCT00706186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65214642|NCT00706186|Anesthetics, General|anesthetics, general|mesh-ancestor
65214643|NCT00706186|Anesthetics|anesthetics|mesh-ancestor
65214644|NCT00706186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65214645|NCT00706186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214647|NCT02611492|Dexamethasone|dexamethasone|mesh-list
65214648|NCT02611492|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65214649|NCT02611492|Methotrexate|methotrexate|mesh-list
65214650|NCT02611492|Vincristine|vincristine|mesh-list
65214651|NCT02611492|Mercaptopurine|mercaptopurine|mesh-list
65214652|NCT02611492|Lenograstim|lenograstim|mesh-list
65214653|NCT02611492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65214654|NCT02611492|Antiemetics|antiemetics|mesh-ancestor
65214655|NCT02611492|Autonomic Agents|autonomic agents|mesh-ancestor
65214656|NCT02611492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65214657|NCT02611492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214658|NCT02611492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65214659|NCT02611492|Glucocorticoids|glucocorticoids|mesh-ancestor
65214660|NCT02611492|Hormones|hormones|mesh-ancestor
65214661|NCT02611492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65214662|NCT02611492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65214663|NCT02611492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214664|NCT02611492|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65214665|NCT02611492|Abortifacient Agents|abortifacient agents|mesh-ancestor
65214669|NCT02611492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214671|NCT02611492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65214672|NCT02611492|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65214673|NCT02611492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65214674|NCT02611492|Immunologic Factors|immunologic factors|mesh-ancestor
65214675|NCT02611492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65214676|NCT02611492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65214677|NCT02611492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65214678|NCT02611492|Tubulin Modulators|tubulin modulators|mesh-ancestor
65214679|NCT02611492|Antimitotic Agents|antimitotic agents|mesh-ancestor
65214680|NCT02611492|Mitosis Modulators|mitosis modulators|mesh-ancestor
65214681|NCT02611492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65214682|NCT02611492|Antiviral Agents|antiviral agents|mesh-ancestor
65214683|NCT02611492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65214684|NCT00706576|Mitogens|mitogens|mesh-list
65214685|NCT00706576|Enkephalins|enkephalins|mesh-list
65214686|NCT00706576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214687|NCT00706576|Mitosis Modulators|mitosis modulators|mesh-ancestor
65214688|NCT00706576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332659|NCT02561169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65332660|NCT02561169|Antiviral Agents|antiviral agents|mesh-ancestor
65332661|NCT02561169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65332662|NCT02561169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332663|NCT00753597|Rituximab|rituximab|mesh-list
65332664|NCT00753597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65332665|NCT00753597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332666|NCT00753597|Immunologic Factors|immunologic factors|mesh-ancestor
65332667|NCT00753597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332668|NCT00753597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65332669|NCT00757419|Lesogaberan|lesogaberan|mesh-list
65332670|NCT00757419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65332671|NCT00757419|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65332672|NCT00757419|GABA Agonists|gaba agonists|mesh-ancestor
65332673|NCT00757419|GABA Agents|gaba agents|mesh-ancestor
65214689|NCT00706576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65214690|NCT00828568|Imiquimod|imiquimod|mesh-list
65214691|NCT00828568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65214692|NCT00828568|Immunologic Factors|immunologic factors|mesh-ancestor
65214693|NCT00828568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214694|NCT00828568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214695|NCT00828568|Interferon Inducers|interferon inducers|mesh-ancestor
65214696|NCT01038752|Suramin|suramin|mesh-list
65214697|NCT01038752|Carboplatin|carboplatin|mesh-list
65214698|NCT01038752|Docetaxel|docetaxel|mesh-list
65214699|NCT01038752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214700|NCT01038752|Tubulin Modulators|tubulin modulators|mesh-ancestor
65214701|NCT01038752|Antimitotic Agents|antimitotic agents|mesh-ancestor
65214702|NCT01038752|Mitosis Modulators|mitosis modulators|mesh-ancestor
65214703|NCT01038752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214704|NCT01038752|Antinematodal Agents|antinematodal agents|mesh-ancestor
65214705|NCT01038752|Anthelmintics|anthelmintics|mesh-ancestor
65214706|NCT01038752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65214707|NCT01038752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65214708|NCT01038752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65214709|NCT01038752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65214710|NCT04233021|Osimertinib|osimertinib|mesh-list
65214711|NCT04233021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214712|NCT04233021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65214713|NCT04233021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65214714|NCT04233021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214715|NCT00903630|Doxorubicin|doxorubicin|mesh-list
65214716|NCT00903630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65214717|NCT00903630|Lenalidomide|lenalidomide|mesh-list
65214718|NCT00903630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65214719|NCT00903630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214720|NCT00903630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65214721|NCT00903630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65214722|NCT00903630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65214723|NCT00903630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214724|NCT00903630|Immunologic Factors|immunologic factors|mesh-ancestor
65214725|NCT00903630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214727|NCT00903630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65214728|NCT00903630|Growth Substances|growth substances|mesh-ancestor
65214729|NCT00903630|Growth Inhibitors|growth inhibitors|mesh-ancestor
65214730|NCT04302584|Vasopressins|vasopressins|mesh-list
65214731|NCT04302584|Arginine Vasopressin|arginine vasopressin|mesh-list
65214732|NCT04302584|Norepinephrine|norepinephrine|mesh-list
65214733|NCT04302584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65214734|NCT04302584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65214735|NCT04302584|Adrenergic Agents|adrenergic agents|mesh-ancestor
65214736|NCT04302584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65214737|NCT04302584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332674|NCT00757419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65332675|NCT00757419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332676|NCT00757419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332677|NCT00757731|Milnacipran|milnacipran|mesh-list
65332678|NCT00757731|Levomilnacipran|levomilnacipran|mesh-list
65332679|NCT00757731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65332680|NCT00757731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65332681|NCT00757731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64718596|NCT00624650|Dobutamine|dobutamine|mesh-list
65214738|NCT04302584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214748|NCT00703144|Piperacillin|piperacillin|mesh-list
65214749|NCT00703144|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65214750|NCT00703144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65214751|NCT00703144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65214752|NCT00703144|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65214753|NCT00703144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65214754|NCT00703144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214755|NCT01054820|Diclofenac|diclofenac|mesh-list
65214756|NCT01054820|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
65214757|NCT01054820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65214758|NCT01054820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65214759|NCT01054820|Analgesics|analgesics|mesh-ancestor
65214760|NCT01054820|Sensory System Agents|sensory system agents|mesh-ancestor
65214761|NCT01054820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65214762|NCT01054820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214763|NCT01054820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65214764|NCT01054820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65214765|NCT01054820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65214766|NCT01054820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65214767|NCT01054820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214768|NCT03105843|Methacholine Chloride|methacholine chloride|mesh-list
65214769|NCT03105843|Miotics|miotics|mesh-ancestor
65214770|NCT03105843|Autonomic Agents|autonomic agents|mesh-ancestor
65214771|NCT03105843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65214772|NCT03105843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214773|NCT03105843|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65214774|NCT03105843|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
65214775|NCT03105843|Respiratory System Agents|respiratory system agents|mesh-ancestor
65214776|NCT03105843|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65214777|NCT03105843|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65214778|NCT03105843|Cholinergic Agents|cholinergic agents|mesh-ancestor
65214779|NCT03105843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65214780|NCT03105843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214781|NCT02874248|Drospirenone|drospirenone|mesh-list
65214782|NCT02874248|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65214783|NCT02874248|Hormone Antagonists|hormone antagonists|mesh-ancestor
65214784|NCT02874248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65214785|NCT02874248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214786|NCT02874248|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65214787|NCT02874248|Diuretics|diuretics|mesh-ancestor
65214788|NCT02874248|Natriuretic Agents|natriuretic agents|mesh-ancestor
65214789|NCT02787603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65214790|NCT02787603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65214791|NCT02004834|Levobupivacaine|levobupivacaine|mesh-list
65214792|NCT02004834|Anesthetics, Local|anesthetics, local|mesh-ancestor
65214793|NCT02004834|Anesthetics|anesthetics|mesh-ancestor
65214794|NCT02004834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65214795|NCT02004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214796|NCT02004834|Sensory System Agents|sensory system agents|mesh-ancestor
65214797|NCT02004834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65214798|NCT02788305|Misoprostol|misoprostol|mesh-list
65214799|NCT02788305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65332682|NCT00757731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332683|NCT00757731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65332684|NCT00757731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332685|NCT00757731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65332686|NCT00757731|Analgesics|analgesics|mesh-ancestor
65332687|NCT00757731|Sensory System Agents|sensory system agents|mesh-ancestor
65332688|NCT00757731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64703268|NCT02525653|Paclitaxel|paclitaxel|mesh-list
65214800|NCT02788305|Abortifacient Agents|abortifacient agents|mesh-ancestor
65214801|NCT02788305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65214802|NCT02788305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214803|NCT02788305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65214804|NCT02788305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65214807|NCT05758012|Carbetocin|carbetocin|mesh-list
65214808|NCT05758012|Oxytocics|oxytocics|mesh-ancestor
65214809|NCT05758012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65214810|NCT05758012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214811|NCT02786667|Rotigotine|rotigotine|mesh-list
65214812|NCT02786667|Dopamine Agonists|dopamine agonists|mesh-ancestor
65214813|NCT02786667|Dopamine Agents|dopamine agents|mesh-ancestor
65214814|NCT02786667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65214815|NCT02786667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214816|NCT02786667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214817|NCT00913276|Propofol|propofol|mesh-list
65214818|NCT00913276|Sevoflurane|sevoflurane|mesh-list
65214819|NCT00913276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65214820|NCT00913276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65214821|NCT00913276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214822|NCT00913276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65214823|NCT00913276|Anesthetics, General|anesthetics, general|mesh-ancestor
65214824|NCT00913276|Anesthetics|anesthetics|mesh-ancestor
65214825|NCT00913276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65214826|NCT00913276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65214827|NCT04302116|Prednisolone|prednisolone|mesh-list
65214828|NCT04302116|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65214829|NCT04302116|Methylprednisolone|methylprednisolone|mesh-list
65214830|NCT04302116|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65214831|NCT04302116|Prednisolone acetate|prednisolone acetate|mesh-list
65214832|NCT04302116|Vigabatrin|vigabatrin|mesh-list
65214833|NCT04302116|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65214834|NCT04302116|Prednisolone phosphate|prednisolone phosphate|mesh-list
65214835|NCT04302116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65214836|NCT04302116|Glucocorticoids|glucocorticoids|mesh-ancestor
65214837|NCT04302116|Hormones|hormones|mesh-ancestor
65214838|NCT04302116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65214839|NCT04302116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214840|NCT04302116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65214841|NCT04302116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214842|NCT04302116|Antiemetics|antiemetics|mesh-ancestor
65214843|NCT04302116|Autonomic Agents|autonomic agents|mesh-ancestor
65214844|NCT04302116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65214845|NCT04302116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65214846|NCT04302116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65214847|NCT04302116|Protective Agents|protective agents|mesh-ancestor
65214848|NCT04302116|Anticonvulsants|anticonvulsants|mesh-ancestor
65214849|NCT04302116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65214850|NCT04302116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214851|NCT04302116|GABA Agents|gaba agents|mesh-ancestor
65214852|NCT04302116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65214853|NCT05756998|Copper|copper|mesh-list
65214854|NCT05756998|Trace Elements|trace elements|mesh-ancestor
65214855|NCT05756998|Micronutrients|micronutrients|mesh-ancestor
65214856|NCT05756998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214857|NCT02890212|Selenium|selenium|mesh-list
65214858|NCT02890212|Antioxidants|antioxidants|mesh-ancestor
65214859|NCT02890212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214860|NCT02890212|Protective Agents|protective agents|mesh-ancestor
65214861|NCT02890212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332689|NCT00757731|Antidepressive Agents|antidepressive agents|mesh-ancestor
65332690|NCT00757731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65332691|NCT00753909|Paclitaxel|paclitaxel|mesh-list
65332692|NCT00753909|Bevacizumab|bevacizumab|mesh-list
65332693|NCT00753909|Carboplatin|carboplatin|mesh-list
65332694|NCT00753909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65214862|NCT02890212|Trace Elements|trace elements|mesh-ancestor
65214863|NCT02890212|Micronutrients|micronutrients|mesh-ancestor
65214864|NCT05387577|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65214865|NCT05387577|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65214866|NCT05387577|Estradiol|estradiol|mesh-list
65214867|NCT05387577|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65214868|NCT05387577|Estrogens|estrogens|mesh-ancestor
65214869|NCT05387577|Hormones|hormones|mesh-ancestor
65214870|NCT05387577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65214871|NCT05387577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214872|NCT05387577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65214873|NCT05387577|Contraceptive Agents|contraceptive agents|mesh-ancestor
65214874|NCT05387577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65214875|NCT05387577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65214876|NCT03044613|Paclitaxel|paclitaxel|mesh-list
65214877|NCT03044613|Carboplatin|carboplatin|mesh-list
65214878|NCT03044613|Nivolumab|nivolumab|mesh-list
65214879|NCT03044613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65214880|NCT03044613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214881|NCT03044613|Tubulin Modulators|tubulin modulators|mesh-ancestor
65214885|NCT03044613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65214886|NCT03044613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65214887|NCT01372254|Nicotine|nicotine|mesh-list
65214888|NCT01372254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65214889|NCT01372254|Autonomic Agents|autonomic agents|mesh-ancestor
65214890|NCT01372254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65214891|NCT01372254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214892|NCT01372254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65214893|NCT01372254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65214894|NCT01372254|Cholinergic Agents|cholinergic agents|mesh-ancestor
65214895|NCT01372254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65214896|NCT01372254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214897|NCT02785653|Sevoflurane|sevoflurane|mesh-list
65214898|NCT02785653|Rocuronium|rocuronium|mesh-list
65214899|NCT02785653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65214900|NCT02785653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65214901|NCT02785653|Anesthetics, General|anesthetics, general|mesh-ancestor
65214902|NCT02785653|Anesthetics|anesthetics|mesh-ancestor
65214903|NCT02785653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65214904|NCT02785653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214905|NCT02785653|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65214906|NCT02785653|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65214907|NCT02785653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65214908|NCT02785653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65214909|NCT02787447|Gefitinib|gefitinib|mesh-list
65214910|NCT02787447|Thymalfasin|thymalfasin|mesh-list
65214911|NCT02787447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214912|NCT02787447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65214913|NCT02787447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65214914|NCT02787447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214915|NCT02787447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65214916|NCT02787447|Immunologic Factors|immunologic factors|mesh-ancestor
65214917|NCT02787447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214918|NCT00904722|Rituximab|rituximab|mesh-list
65214919|NCT00904722|Pidilizumab|pidilizumab|mesh-list
65214920|NCT00904722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65214921|NCT00904722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214922|NCT00904722|Immunologic Factors|immunologic factors|mesh-ancestor
65214923|NCT00904722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214924|NCT00904722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65214925|NCT02909361|Fulvestrant|fulvestrant|mesh-list
65214926|NCT02909361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65214927|NCT02909361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214928|NCT02909361|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65214929|NCT02909361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65332695|NCT00753909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332696|NCT00753909|Tubulin Modulators|tubulin modulators|mesh-ancestor
65332697|NCT00753909|Antimitotic Agents|antimitotic agents|mesh-ancestor
65332698|NCT00753909|Mitosis Modulators|mitosis modulators|mesh-ancestor
64718616|NCT00624650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65214930|NCT02909361|Hormone Antagonists|hormone antagonists|mesh-ancestor
65214931|NCT02909361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65214932|NCT02909361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214933|NCT04301024|Nitrous Oxide|nitrous oxide|mesh-list
65214934|NCT04301024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65214935|NCT04301024|Anesthetics, General|anesthetics, general|mesh-ancestor
65214936|NCT04301024|Anesthetics|anesthetics|mesh-ancestor
65214937|NCT04301024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65214938|NCT04301024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214939|NCT04301024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65214940|NCT04301024|Analgesics|analgesics|mesh-ancestor
65214941|NCT04301024|Sensory System Agents|sensory system agents|mesh-ancestor
65214942|NCT04301024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65214943|NCT01340430|Trastuzumab|trastuzumab|mesh-list
65214944|NCT01340430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65214945|NCT01340430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214946|NCT01029782|Cefazolin|cefazolin|mesh-list
65214947|NCT01029782|Cephalexin|cephalexin|mesh-list
65214948|NCT01029782|Probenecid|probenecid|mesh-list
65214949|NCT01029782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65214950|NCT01029782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65214951|NCT01029782|Uricosuric Agents|uricosuric agents|mesh-ancestor
65214952|NCT01029782|Gout Suppressants|gout suppressants|mesh-ancestor
65214953|NCT01029782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65214957|NCT02901717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65214958|NCT02901717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65214959|NCT02901717|Antitubercular Agents|antitubercular agents|mesh-ancestor
65214960|NCT02849730|Fentanyl|fentanyl|mesh-list
65214961|NCT02849730|Analgesics|analgesics|mesh-list
65214962|NCT02849730|Ropivacaine|ropivacaine|mesh-list
65214963|NCT02849730|Anesthetics, Local|anesthetics, local|mesh-ancestor
65214964|NCT02849730|Anesthetics|anesthetics|mesh-ancestor
65214965|NCT02849730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65214966|NCT02849730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214967|NCT02849730|Sensory System Agents|sensory system agents|mesh-ancestor
65214968|NCT02849730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65214969|NCT02849730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65214970|NCT02849730|Narcotics|narcotics|mesh-ancestor
65214971|NCT02849730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65214972|NCT02849730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65214973|NCT02849730|Anesthetics, General|anesthetics, general|mesh-ancestor
65214974|NCT03936192|Meloxicam|meloxicam|mesh-list
65214975|NCT03936192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65214976|NCT03936192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65214977|NCT03936192|Analgesics|analgesics|mesh-ancestor
65214978|NCT03936192|Sensory System Agents|sensory system agents|mesh-ancestor
65214979|NCT03936192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65214980|NCT03936192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214981|NCT03936192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65214982|NCT03936192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65214983|NCT03936192|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65214984|NCT03936192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65214985|NCT03936192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65214986|NCT03936192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214987|NCT00930228|Flutamide|flutamide|mesh-list
65214988|NCT00930228|Androgen Antagonists|androgen antagonists|mesh-ancestor
65214989|NCT00930228|Hormone Antagonists|hormone antagonists|mesh-ancestor
65214990|NCT00930228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65214991|NCT00930228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214992|NCT00930228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65214993|NCT00930228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214994|NCT05043870|Infliximab|infliximab|mesh-list
65214995|NCT05043870|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65214996|NCT05043870|Dermatologic Agents|dermatologic agents|mesh-ancestor
65214997|NCT05043870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65214998|NCT05043870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65332699|NCT00753909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332700|NCT00753909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65332701|NCT00753909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65332702|NCT00753909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65332703|NCT00753909|Growth Substances|growth substances|mesh-ancestor
65214999|NCT05043870|Immunologic Factors|immunologic factors|mesh-ancestor
65215000|NCT05043870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215001|NCT01029704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65215002|NCT01029704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215003|NCT01029704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65215004|NCT01029704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215005|NCT02786979|Aspirin|aspirin|mesh-list
65215006|NCT02786979|Beraprost|beraprost|mesh-list
65215007|NCT02786979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65215008|NCT02786979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65215009|NCT02786979|Analgesics|analgesics|mesh-ancestor
65215010|NCT02786979|Sensory System Agents|sensory system agents|mesh-ancestor
65215011|NCT02786979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65215012|NCT02786979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215013|NCT02786979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65215014|NCT02786979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65215015|NCT02786979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65215016|NCT02786979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65215017|NCT02786979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215018|NCT02786979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65215019|NCT02786979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65215020|NCT02786979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215021|NCT02786979|Antipyretics|antipyretics|mesh-ancestor
65215022|NCT02786979|Vasodilator Agents|vasodilator agents|mesh-ancestor
65215023|NCT02689869|Obinutuzumab|obinutuzumab|mesh-list
65215024|NCT02689869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65215025|NCT02689869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215026|NCT02785809|Contraceptive Agents|contraceptive agents|mesh-list
65215027|NCT02785809|Contraceptives, Oral|contraceptives, oral|mesh-list
65215032|NCT00221988|Anticonvulsants|anticonvulsants|mesh-ancestor
65215033|NCT00221988|Nootropic Agents|nootropic agents|mesh-ancestor
65215034|NCT02341911|Gemcitabine|gemcitabine|mesh-list
65215035|NCT02341911|Carboplatin|carboplatin|mesh-list
65215036|NCT02341911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215037|NCT02341911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65215038|NCT02341911|Antimetabolites|antimetabolites|mesh-ancestor
65215039|NCT02341911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215040|NCT02341911|Antiviral Agents|antiviral agents|mesh-ancestor
65215041|NCT02341911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65215042|NCT02341911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215043|NCT02341911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65215044|NCT02341911|Immunologic Factors|immunologic factors|mesh-ancestor
65215045|NCT02341911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215046|NCT02847000|Decitabine|decitabine|mesh-list
65215047|NCT02847000|Tetrahydrouridine|tetrahydrouridine|mesh-list
65215048|NCT02847000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65215049|NCT02847000|Antimetabolites|antimetabolites|mesh-ancestor
65215050|NCT02847000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215051|NCT02847000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215052|NCT02847000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215053|NCT02784327|Ropivacaine|ropivacaine|mesh-list
65215054|NCT02784327|Anesthetics, Local|anesthetics, local|mesh-ancestor
65215055|NCT02784327|Anesthetics|anesthetics|mesh-ancestor
65215056|NCT02784327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65215057|NCT02784327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215058|NCT02784327|Sensory System Agents|sensory system agents|mesh-ancestor
65215059|NCT02784327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65215060|NCT02845050|Cisplatin|cisplatin|mesh-list
65215061|NCT02845050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215062|NCT02690922|Dexamethasone|dexamethasone|mesh-list
65215063|NCT02690922|Prednisone|prednisone|mesh-list
65215064|NCT02690922|Methotrexate|methotrexate|mesh-list
65215065|NCT02690922|Dasatinib|dasatinib|mesh-list
65215066|NCT02690922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65215067|NCT02690922|Antiemetics|antiemetics|mesh-ancestor
65332704|NCT00753909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332705|NCT00753909|Growth Inhibitors|growth inhibitors|mesh-ancestor
65332706|NCT02560155|Chlorhexidine|chlorhexidine|mesh-list
65215068|NCT02690922|Autonomic Agents|autonomic agents|mesh-ancestor
65215069|NCT02690922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65215070|NCT02690922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215071|NCT02690922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65215072|NCT02690922|Glucocorticoids|glucocorticoids|mesh-ancestor
65215073|NCT02690922|Hormones|hormones|mesh-ancestor
65215074|NCT02690922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65215075|NCT02690922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65215076|NCT02690922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215077|NCT02690922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65215078|NCT02690922|Abortifacient Agents|abortifacient agents|mesh-ancestor
65215079|NCT02690922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65215080|NCT02690922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65215081|NCT02690922|Antimetabolites|antimetabolites|mesh-ancestor
65215082|NCT02690922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215083|NCT02690922|Dermatologic Agents|dermatologic agents|mesh-ancestor
65215084|NCT02690922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215085|NCT02690922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65215086|NCT02690922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65215087|NCT02690922|Immunologic Factors|immunologic factors|mesh-ancestor
65215088|NCT02690922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65215089|NCT02690922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65215090|NCT02690922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65215091|NCT02848950|Metformin|metformin|mesh-list
65215092|NCT02848950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65215093|NCT02848950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215094|NCT04202406|Acetaminophen|acetaminophen|mesh-list
65215095|NCT04202406|Codeine|codeine|mesh-list
65215096|NCT04202406|Caffeine|caffeine|mesh-list
65215097|NCT04202406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65215098|NCT04202406|Analgesics|analgesics|mesh-ancestor
65215099|NCT04202406|Sensory System Agents|sensory system agents|mesh-ancestor
65215100|NCT04202406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65215101|NCT04202406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215102|NCT04202406|Antipyretics|antipyretics|mesh-ancestor
65215104|NCT04202406|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65215105|NCT04202406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215106|NCT04202406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215107|NCT04202406|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65215108|NCT04202406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65215109|NCT04202406|Purinergic Agents|purinergic agents|mesh-ancestor
65215110|NCT04202406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65215111|NCT04202406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65215112|NCT04202406|Narcotics|narcotics|mesh-ancestor
65215113|NCT04202406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65215114|NCT04202406|Antitussive Agents|antitussive agents|mesh-ancestor
65215115|NCT04202406|Respiratory System Agents|respiratory system agents|mesh-ancestor
65215116|NCT02846766|Lenvatinib|lenvatinib|mesh-list
65215117|NCT02846766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215118|NCT02846766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65215119|NCT02846766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215120|NCT02846766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215121|NCT00839956|Bortezomib|bortezomib|mesh-list
65215122|NCT00839956|Vorinostat|vorinostat|mesh-list
65215123|NCT00839956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215124|NCT00839956|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65215125|NCT00839956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215126|NCT00839956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215127|NCT00839800|Terbutaline|terbutaline|mesh-list
65215128|NCT00839800|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65215129|NCT00839800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65215130|NCT00839800|Respiratory System Agents|respiratory system agents|mesh-ancestor
65215131|NCT00839800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65215132|NCT00839800|Autonomic Agents|autonomic agents|mesh-ancestor
65215133|NCT00839800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65215134|NCT00839800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215135|NCT00839800|Sympathomimetics|sympathomimetics|mesh-ancestor
65215136|NCT00839800|Tocolytic Agents|tocolytic agents|mesh-ancestor
65215137|NCT00839800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65332707|NCT02560155|Mupirocin|mupirocin|mesh-list
65332708|NCT02560155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65332709|NCT02560155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65332710|NCT02560155|Disinfectants|disinfectants|mesh-ancestor
65332711|NCT02560155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65332712|NCT02560155|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65215138|NCT00839800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65215139|NCT00839800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65215140|NCT00839800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65215141|NCT00839800|Adrenergic Agents|adrenergic agents|mesh-ancestor
65215142|NCT00839800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65215143|NCT00839800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215144|NCT00867321|Bevacizumab|bevacizumab|mesh-list
65215145|NCT00867321|Sorafenib|sorafenib|mesh-list
65215146|NCT00867321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65215147|NCT00867321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215148|NCT00867321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65215149|NCT00867321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65215150|NCT00867321|Growth Substances|growth substances|mesh-ancestor
65215151|NCT00867321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215152|NCT00867321|Growth Inhibitors|growth inhibitors|mesh-ancestor
65215153|NCT00867321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65215154|NCT00867321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215155|NCT00867321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215156|NCT00913666|Interferons|interferons|mesh-list
65215157|NCT00913666|Interferon-beta|interferon-beta|mesh-list
65215158|NCT00913666|Interferon beta-1a|interferon beta-1a|mesh-list
65215159|NCT00913666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215160|NCT00913666|Antiviral Agents|antiviral agents|mesh-ancestor
65215161|NCT00913666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65215162|NCT00913666|Immunologic Factors|immunologic factors|mesh-ancestor
65215163|NCT00913666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215164|NCT00913666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65215165|NCT05756764|Liraglutide|liraglutide|mesh-list
65215166|NCT05756764|Topiramate|topiramate|mesh-list
65215167|NCT05756764|Phentermine|phentermine|mesh-list
65215168|NCT05756764|Glucagon|glucagon|mesh-list
65215169|NCT05756764|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65215170|NCT05756764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65215171|NCT05756764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215172|NCT05756764|Incretins|incretins|mesh-ancestor
65215173|NCT05756764|Hormones|hormones|mesh-ancestor
65215174|NCT05756764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65215175|NCT05756764|Anticonvulsants|anticonvulsants|mesh-ancestor
65215176|NCT05756764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65215180|NCT05756764|Sympathomimetics|sympathomimetics|mesh-ancestor
65215181|NCT05756764|Autonomic Agents|autonomic agents|mesh-ancestor
65215182|NCT05756764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65215183|NCT05756764|Adrenergic Agents|adrenergic agents|mesh-ancestor
65215184|NCT05756764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65215185|NCT05756764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215186|NCT05190471|Decitabine|decitabine|mesh-list
65215187|NCT05190471|Oblimersen|oblimersen|mesh-list
65215188|NCT05190471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65215189|NCT05190471|Antimetabolites|antimetabolites|mesh-ancestor
65215190|NCT05190471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215191|NCT05190471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215192|NCT05190471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215193|NCT05308095|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65215194|NCT05308095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215195|NCT02601157|Aspirin|aspirin|mesh-list
65215196|NCT02601157|Clopidogrel|clopidogrel|mesh-list
65215197|NCT02601157|Ticagrelor|ticagrelor|mesh-list
65215198|NCT02601157|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65215199|NCT02601157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65215200|NCT02601157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65215201|NCT02601157|Analgesics|analgesics|mesh-ancestor
65215202|NCT02601157|Sensory System Agents|sensory system agents|mesh-ancestor
65215203|NCT02601157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65215204|NCT02601157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215205|NCT02601157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65332713|NCT02560155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332714|NCT02560155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332715|NCT02559921|Vaccines|vaccines|mesh-list
65332716|NCT02559921|Immunologic Factors|immunologic factors|mesh-ancestor
65332717|NCT02559921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332718|NCT00754143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65332719|NCT00754143|Immunologic Factors|immunologic factors|mesh-ancestor
65215206|NCT02601157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65215207|NCT02601157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65215208|NCT02601157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65215209|NCT02601157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215210|NCT02601157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65215211|NCT02601157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65215212|NCT02601157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215213|NCT02601157|Antipyretics|antipyretics|mesh-ancestor
65215214|NCT02601157|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65215215|NCT02601157|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65215216|NCT02601157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65215217|NCT02601157|Purinergic Agents|purinergic agents|mesh-ancestor
65215218|NCT02601157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65215219|NCT02784717|Rivaroxaban|rivaroxaban|mesh-list
65215220|NCT02784717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65215221|NCT02784717|Antithrombins|antithrombins|mesh-ancestor
65215222|NCT02784717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65215223|NCT02784717|Protease Inhibitors|protease inhibitors|mesh-ancestor
65215224|NCT02784717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215225|NCT02784717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215226|NCT02784717|Anticoagulants|anticoagulants|mesh-ancestor
65215227|NCT00902304|Amlodipine|amlodipine|mesh-list
65215228|NCT00902304|Valsartan|valsartan|mesh-list
65215229|NCT00902304|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65215230|NCT00902304|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
65215231|NCT00902304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65215232|NCT00902304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65215233|NCT00902304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65215234|NCT00902304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215235|NCT00902304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65215236|NCT00902304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215237|NCT00902304|Vasodilator Agents|vasodilator agents|mesh-ancestor
65215238|NCT00902304|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65215239|NCT00902304|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65215240|NCT00902304|Diuretics|diuretics|mesh-ancestor
65215241|NCT00902304|Natriuretic Agents|natriuretic agents|mesh-ancestor
65215242|NCT00902304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65215243|NCT02784795|Gemcitabine|gemcitabine|mesh-list
65215244|NCT02784795|Carboplatin|carboplatin|mesh-list
64857965|NCT01738867|Naltrexone|naltrexone|mesh-list
65215245|NCT02784795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215246|NCT02784795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65215247|NCT02784795|Antimetabolites|antimetabolites|mesh-ancestor
65215249|NCT02784795|Antiviral Agents|antiviral agents|mesh-ancestor
65215250|NCT02784795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65215251|NCT02784795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215252|NCT02784795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65215253|NCT02784795|Immunologic Factors|immunologic factors|mesh-ancestor
65215254|NCT02784795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215255|NCT05282277|Raclopride|raclopride|mesh-list
65215256|NCT05282277|Estradiol|estradiol|mesh-list
65215257|NCT05282277|Progesterone|progesterone|mesh-list
65215258|NCT05282277|Estrogens|estrogens|mesh-ancestor
65215259|NCT05282277|Hormones|hormones|mesh-ancestor
65215260|NCT05282277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65215261|NCT05282277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215262|NCT05282277|Progestins|progestins|mesh-ancestor
65215263|NCT05282277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65215264|NCT05282277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65215265|NCT05282277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65215266|NCT05282277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65215267|NCT05282277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65332720|NCT00754143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332721|NCT05266040|Valacyclovir|valacyclovir|mesh-list
65332722|NCT05266040|Antiviral Agents|antiviral agents|mesh-ancestor
65332723|NCT05266040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65332724|NCT00773747|Bortezomib|bortezomib|mesh-list
65332725|NCT00773747|Vorinostat|vorinostat|mesh-list
65332726|NCT00773747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332727|NCT00773747|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64718641|NCT00377143|Warfarin|warfarin|mesh-list
65215268|NCT05282277|Dopamine Agents|dopamine agents|mesh-ancestor
65215269|NCT05282277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65215270|NCT05282277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215271|NCT00759109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65215272|NCT00759109|Antiviral Agents|antiviral agents|mesh-ancestor
65215273|NCT00759109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65215274|NCT02848794|Irinotecan|irinotecan|mesh-list
65215275|NCT02848794|Apatinib|apatinib|mesh-list
65215276|NCT02848794|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65215277|NCT02848794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65215278|NCT02848794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215279|NCT02848794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215280|NCT02848794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215281|NCT02848794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65215282|NCT04096027|Cabergoline|cabergoline|mesh-list
65215283|NCT04096027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65215284|NCT04096027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65215285|NCT04096027|Dopamine Agonists|dopamine agonists|mesh-ancestor
65215286|NCT04096027|Dopamine Agents|dopamine agents|mesh-ancestor
65215287|NCT04096027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65215288|NCT04096027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215289|NCT04096027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215290|NCT04216134|Edetic Acid|edetic acid|mesh-list
65215291|NCT04216134|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65215292|NCT04216134|Chelating Agents|chelating agents|mesh-ancestor
65215293|NCT04216134|Sequestering Agents|sequestering agents|mesh-ancestor
65215294|NCT04216134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215295|NCT04216134|Anticoagulants|anticoagulants|mesh-ancestor
65215296|NCT04216134|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65215297|NCT04216134|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65215298|NCT00638079|Megestrol|megestrol|mesh-list
65215299|NCT00638079|Megestrol Acetate|megestrol acetate|mesh-list
65215300|NCT00638079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65215301|NCT00638079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65215302|NCT00638079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65215303|NCT00638079|Contraceptive Agents|contraceptive agents|mesh-ancestor
65215304|NCT00638079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65215305|NCT00638079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215306|NCT00638079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65215307|NCT00638079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65215308|NCT00638079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65215309|NCT00638079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215310|NCT00638079|Appetite Stimulants|appetite stimulants|mesh-ancestor
65215311|NCT00638079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65215312|NCT00759031|Listerine|listerine|mesh-list
65215313|NCT00759031|Triclosan|triclosan|mesh-list
65215314|NCT00759031|Fluorides|fluorides|mesh-list
65215315|NCT00759031|Sodium Fluoride|sodium fluoride|mesh-list
65215316|NCT00759031|Fluorophosphate|fluorophosphate|mesh-list
65215317|NCT00759031|Cariostatic Agents|cariostatic agents|mesh-ancestor
65215318|NCT00759031|Protective Agents|protective agents|mesh-ancestor
65215319|NCT00759031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215320|NCT00759031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65215321|NCT00759031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65215322|NCT00759031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65215325|NCT00759031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215327|NCT04197219|Pembrolizumab|pembrolizumab|mesh-list
65215329|NCT04197219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65215330|NCT04197219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332728|NCT00773747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332729|NCT00773747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332730|NCT00784277|Oxycodone|oxycodone|mesh-list
65332731|NCT00784277|Tapentadol|tapentadol|mesh-list
65332732|NCT00784277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65332733|NCT00784277|Narcotics|narcotics|mesh-ancestor
64703859|NCT03119012|Aspirin|aspirin|mesh-list
65215331|NCT04197219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65215332|NCT04197219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215333|NCT04197219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215334|NCT04834908|Immune Sera|immune sera|mesh-list
65215335|NCT04834908|Immunologic Factors|immunologic factors|mesh-ancestor
65215336|NCT04834908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215337|NCT02512497|Fludarabine|fludarabine|mesh-list
65215338|NCT02512497|Fludarabine phosphate|fludarabine phosphate|mesh-list
65215339|NCT02512497|Busulfan|busulfan|mesh-list
65215340|NCT02512497|Romidepsin|romidepsin|mesh-list
65215341|NCT02512497|Thymoglobulin|thymoglobulin|mesh-list
65215342|NCT02512497|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65215343|NCT02512497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215344|NCT02512497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65215345|NCT02512497|Antimetabolites|antimetabolites|mesh-ancestor
65215346|NCT02512497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215347|NCT02512497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65215348|NCT02512497|Immunologic Factors|immunologic factors|mesh-ancestor
65215349|NCT02512497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215350|NCT02512497|Alkylating Agents|alkylating agents|mesh-ancestor
65215351|NCT02512497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65215352|NCT02512497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65215353|NCT02512497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65215354|NCT00916669|Etoposide|etoposide|mesh-list
65215355|NCT00916669|Enoxaparin|enoxaparin|mesh-list
65215356|NCT00916669|Enoxaparin sodium|enoxaparin sodium|mesh-list
65215357|NCT00916669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215358|NCT00916669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65215359|NCT00916669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65215360|NCT00916669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65215361|NCT00916669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215362|NCT00916669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215363|NCT00916669|Anticoagulants|anticoagulants|mesh-ancestor
65215364|NCT00916669|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65215365|NCT00916669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65215366|NCT02784015|Cyclophosphamide|cyclophosphamide|mesh-list
65215367|NCT02784015|Melphalan|melphalan|mesh-list
65215368|NCT02784015|Ifosfamide|ifosfamide|mesh-list
65215369|NCT02784015|Thiotepa|thiotepa|mesh-list
65215370|NCT02784015|Carboplatin|carboplatin|mesh-list
65215371|NCT02784015|Doxorubicin|doxorubicin|mesh-list
65215372|NCT02784015|Etoposide|etoposide|mesh-list
65215373|NCT02784015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65215374|NCT02784015|Immunologic Factors|immunologic factors|mesh-ancestor
65215375|NCT02784015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215376|NCT02784015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65215377|NCT02784015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65215378|NCT02784015|Alkylating Agents|alkylating agents|mesh-ancestor
65215379|NCT02784015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215380|NCT02784015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215381|NCT02784015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65215382|NCT02784015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65215383|NCT02784015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65215384|NCT02784015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65215385|NCT02784015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215386|NCT02784015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65215387|NCT02601235|Pyrilamine|pyrilamine|mesh-list
65215388|NCT02601235|Phenylephrine|phenylephrine|mesh-list
65215389|NCT02601235|Oxymetazoline|oxymetazoline|mesh-list
65215390|NCT02601235|Naphazoline|naphazoline|mesh-list
65215391|NCT02601235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215392|NCT02601235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65215393|NCT02601235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65215394|NCT02601235|Adrenergic Agents|adrenergic agents|mesh-ancestor
65215395|NCT02601235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65332734|NCT00784277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65332735|NCT00784277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332736|NCT00784277|Analgesics|analgesics|mesh-ancestor
65332737|NCT00784277|Sensory System Agents|sensory system agents|mesh-ancestor
65332738|NCT00784277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65215396|NCT02601235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215397|NCT02601235|Sympathomimetics|sympathomimetics|mesh-ancestor
65215401|NCT02601235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65215402|NCT02601235|Respiratory System Agents|respiratory system agents|mesh-ancestor
65215403|NCT02601235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65215404|NCT02601235|Mydriatics|mydriatics|mesh-ancestor
65215405|NCT02601235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65215406|NCT02601235|Protective Agents|protective agents|mesh-ancestor
65215407|NCT02601235|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65215408|NCT02601235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65215409|NCT02601235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65215410|NCT02601235|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65215411|NCT02601235|Histamine Antagonists|histamine antagonists|mesh-ancestor
65215413|NCT02601235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65215414|NCT02783937|Lenograstim|lenograstim|mesh-list
65215415|NCT02783937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65215416|NCT02783937|Immunologic Factors|immunologic factors|mesh-ancestor
65215417|NCT02783937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215418|NCT02846142|Levonorgestrel|levonorgestrel|mesh-list
65215419|NCT02846142|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65215421|NCT02846142|Estrogens|estrogens|mesh-ancestor
65215422|NCT02846142|Hormones|hormones|mesh-ancestor
65215423|NCT02846142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65215424|NCT02846142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215425|NCT02846142|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65215426|NCT02846142|Contraceptive Agents|contraceptive agents|mesh-ancestor
65215427|NCT02846142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65215428|NCT02846142|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65215429|NCT02846142|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65215430|NCT02846142|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65215431|NCT02846142|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65215432|NCT00757783|Ritonavir|ritonavir|mesh-list
65215433|NCT00757783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65215434|NCT00757783|Darunavir|darunavir|mesh-list
65215435|NCT00757783|Tenofovir|tenofovir|mesh-list
65215436|NCT00757783|Emtricitabine|emtricitabine|mesh-list
65215437|NCT00757783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65215438|NCT00757783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65215439|NCT00757783|Protease Inhibitors|protease inhibitors|mesh-ancestor
65215440|NCT00757783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215441|NCT00757783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215442|NCT00757783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65215443|NCT00757783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65215444|NCT00757783|Antiviral Agents|antiviral agents|mesh-ancestor
65215445|NCT00757783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65215446|NCT00757783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65215447|NCT00757783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65215448|NCT00757783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65215449|NCT00757783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65215450|NCT05242926|Docetaxel|docetaxel|mesh-list
65215451|NCT05242926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215452|NCT05242926|Tubulin Modulators|tubulin modulators|mesh-ancestor
65215453|NCT05242926|Antimitotic Agents|antimitotic agents|mesh-ancestor
65215454|NCT05242926|Mitosis Modulators|mitosis modulators|mesh-ancestor
65215455|NCT05242926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215456|NCT02782221|Hormones|hormones|mesh-list
65215457|NCT02782221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65215458|NCT02782221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215459|NCT04231617|Glyburide|glyburide|mesh-list
65215460|NCT04231617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65215461|NCT04231617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215462|NCT00757705|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65215463|NCT00757705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65215464|NCT00757705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65332739|NCT00784277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65332740|NCT00784277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65332741|NCT00784277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65332742|NCT00784277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332743|NCT00784277|Adrenergic Agents|adrenergic agents|mesh-ancestor
65332744|NCT00784277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65332745|NCT05113784|Meplazumab|meplazumab|mesh-list
65332747|NCT05113784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65332748|NCT02588534|Etanercept|etanercept|mesh-list
64718661|NCT03642457|Sensory System Agents|sensory system agents|mesh-ancestor
65215465|NCT00757705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65215466|NCT00757705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215467|NCT00757705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65215468|NCT00757705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65215469|NCT00757705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65215470|NCT00757705|Serotonin Agents|serotonin agents|mesh-ancestor
65215478|NCT02845908|Oxaliplatin|oxaliplatin|mesh-list
65215479|NCT02845908|Antimetabolites|antimetabolites|mesh-ancestor
65215480|NCT02845908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215481|NCT02845908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65215482|NCT02845908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215483|NCT02845908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65215484|NCT02845908|Immunologic Factors|immunologic factors|mesh-ancestor
65215485|NCT02845908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215486|NCT02845908|Antidotes|antidotes|mesh-ancestor
65215487|NCT02845908|Protective Agents|protective agents|mesh-ancestor
65215488|NCT02845908|Vitamin B Complex|vitamin b complex|mesh-ancestor
65215489|NCT02845908|Vitamins|vitamins|mesh-ancestor
65215490|NCT02845908|Micronutrients|micronutrients|mesh-ancestor
65215491|NCT02784483|Atezolizumab|atezolizumab|mesh-list
65215492|NCT02784483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215493|NCT02784561|Cytarabine|cytarabine|mesh-list
65215494|NCT02784561|Fludarabine|fludarabine|mesh-list
65215495|NCT02784561|Fludarabine phosphate|fludarabine phosphate|mesh-list
65215496|NCT02784561|Busulfan|busulfan|mesh-list
65215497|NCT02784561|Thymoglobulin|thymoglobulin|mesh-list
65215498|NCT02784561|Lenograstim|lenograstim|mesh-list
65215499|NCT02784561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215500|NCT02784561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65215501|NCT02784561|Antimetabolites|antimetabolites|mesh-ancestor
65215502|NCT02784561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215503|NCT02784561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65215504|NCT02784561|Immunologic Factors|immunologic factors|mesh-ancestor
65215505|NCT02784561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215506|NCT02784561|Antiviral Agents|antiviral agents|mesh-ancestor
65215507|NCT02784561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65215508|NCT02784561|Alkylating Agents|alkylating agents|mesh-ancestor
65215509|NCT02784561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65215510|NCT02784561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65215511|NCT02784561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65215512|NCT00757627|Etoricoxib|etoricoxib|mesh-list
65215513|NCT00757627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65215514|NCT00757627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65215515|NCT00757627|Analgesics|analgesics|mesh-ancestor
65215516|NCT00757627|Sensory System Agents|sensory system agents|mesh-ancestor
65215517|NCT00757627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65215518|NCT00757627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215519|NCT00757627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65215520|NCT00757627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65215521|NCT00757627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65215522|NCT00757627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65215523|NCT00757627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215524|NCT00757627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215525|NCT02600455|Abatacept|abatacept|mesh-list
65215526|NCT02600455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65332749|NCT02588534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65332750|NCT02588534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65215527|NCT02600455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215528|NCT02600455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215529|NCT02600455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65215530|NCT02600455|Immunologic Factors|immunologic factors|mesh-ancestor
65215531|NCT02600455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215532|NCT02600455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65215533|NCT01023308|Dexamethasone|dexamethasone|mesh-list
65215534|NCT01023308|Bortezomib|bortezomib|mesh-list
65215535|NCT01023308|Panobinostat|panobinostat|mesh-list
65215536|NCT01023308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65215537|NCT01023308|Antiemetics|antiemetics|mesh-ancestor
65215538|NCT01023308|Autonomic Agents|autonomic agents|mesh-ancestor
65215539|NCT01023308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65215540|NCT01023308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215541|NCT01023308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65215551|NCT02781909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65215552|NCT02781909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65215554|NCT02781909|Sensory System Agents|sensory system agents|mesh-ancestor
65215555|NCT02781909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65215556|NCT02781909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215557|NCT02781909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65215558|NCT02781909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65215559|NCT02781909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65215560|NCT02781909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215561|NCT02781909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215562|NCT01022996|Everolimus|everolimus|mesh-list
65215563|NCT01022996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215564|NCT01022996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65215565|NCT01022996|Immunologic Factors|immunologic factors|mesh-ancestor
65215566|NCT01022996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215567|NCT02781597|Tranexamic Acid|tranexamic acid|mesh-list
65215568|NCT02781597|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65215569|NCT02781597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65215570|NCT02781597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215571|NCT02781597|Hemostatics|hemostatics|mesh-ancestor
65215572|NCT02781597|Coagulants|coagulants|mesh-ancestor
65215573|NCT00757237|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65215574|NCT00757237|Tobramycin|tobramycin|mesh-list
65215575|NCT00757237|Aztreonam|aztreonam|mesh-list
65215576|NCT00757237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65215577|NCT00757237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65215578|NCT00757237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65215579|NCT00757237|Antitubercular Agents|antitubercular agents|mesh-ancestor
65215580|NCT01029392|Vitamin D|vitamin d|mesh-list
65215581|NCT01029392|Cholecalciferol|cholecalciferol|mesh-list
65215582|NCT01029392|Vitamins|vitamins|mesh-ancestor
65215583|NCT01029392|Micronutrients|micronutrients|mesh-ancestor
65215584|NCT01029392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215585|NCT01029392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65215586|NCT01029392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65215587|NCT02781753|Interferons|interferons|mesh-list
65215588|NCT02781753|Interferon-alpha|interferon-alpha|mesh-list
65215589|NCT02781753|Interferon alpha-2|interferon alpha-2|mesh-list
65215590|NCT02781753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215591|NCT02781753|Antiviral Agents|antiviral agents|mesh-ancestor
65215592|NCT02781753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65215593|NCT02781753|Immunologic Factors|immunologic factors|mesh-ancestor
65215594|NCT02781753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215595|NCT00903006|Dasatinib|dasatinib|mesh-list
65215596|NCT00903006|Fulvestrant|fulvestrant|mesh-list
65215597|NCT00903006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215598|NCT00903006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65215599|NCT00903006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215600|NCT00903006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215601|NCT00903006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65215602|NCT00903006|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65215603|NCT00903006|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65215604|NCT00903006|Hormone Antagonists|hormone antagonists|mesh-ancestor
65215609|NCT02845986|Oxaliplatin|oxaliplatin|mesh-list
65215610|NCT02845986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215611|NCT00839332|Gemcitabine|gemcitabine|mesh-list
65215612|NCT00839332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65332751|NCT02588534|Analgesics|analgesics|mesh-ancestor
65332752|NCT02588534|Sensory System Agents|sensory system agents|mesh-ancestor
65332753|NCT02588534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332754|NCT02588534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332755|NCT02588534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65332756|NCT02588534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65332757|NCT02588534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65215613|NCT00839332|Antimetabolites|antimetabolites|mesh-ancestor
65215614|NCT00839332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215615|NCT00839332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215616|NCT00839332|Antiviral Agents|antiviral agents|mesh-ancestor
65215617|NCT00839332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65215618|NCT00839332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215619|NCT00839332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65215620|NCT00839332|Immunologic Factors|immunologic factors|mesh-ancestor
65215621|NCT00839332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215622|NCT04095169|Complement System Proteins|complement system proteins|mesh-list
65215623|NCT04095169|Complement C3|complement c3|mesh-list
65215624|NCT04095169|Complement C3d|complement c3d|mesh-list
65215625|NCT04095169|Immunologic Factors|immunologic factors|mesh-ancestor
65215626|NCT04095169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215627|NCT05241912|Dobutamine|dobutamine|mesh-list
65215628|NCT05241912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65215629|NCT05241912|Sympathomimetics|sympathomimetics|mesh-ancestor
65215630|NCT05241912|Autonomic Agents|autonomic agents|mesh-ancestor
65215631|NCT05241912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65215632|NCT05241912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215633|NCT05241912|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65215634|NCT05241912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65215635|NCT05241912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65215636|NCT05241912|Adrenergic Agents|adrenergic agents|mesh-ancestor
65215637|NCT05241912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65215638|NCT05241912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215639|NCT05241912|Protective Agents|protective agents|mesh-ancestor
65215640|NCT05217654|Dapagliflozin|dapagliflozin|mesh-list
65215641|NCT05217654|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65215642|NCT05217654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215643|NCT05217654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65215644|NCT05217654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215645|NCT04229355|Sorafenib|sorafenib|mesh-list
65215646|NCT04229355|Lenvatinib|lenvatinib|mesh-list
65215647|NCT04229355|Chlorotrianisene|chlorotrianisene|mesh-list
65215648|NCT04229355|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65215649|NCT04229355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215650|NCT04229355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65215651|NCT04229355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215652|NCT04229355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215653|NCT04229355|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65215654|NCT04229355|Estrogens|estrogens|mesh-ancestor
65215655|NCT04229355|Hormones|hormones|mesh-ancestor
65215656|NCT04229355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65215657|NCT04229355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215658|NCT04229355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65215659|NCT02848170|Olmesartan|olmesartan|mesh-list
65215660|NCT02848170|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65215661|NCT02848170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65215662|NCT02848170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65215663|NCT02848170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65215664|NCT02848170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215665|NCT04420884|Pembrolizumab|pembrolizumab|mesh-list
65215666|NCT04420884|Fluorouracil|fluorouracil|mesh-list
65215667|NCT04420884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65215668|NCT04420884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215669|NCT04420884|Antimetabolites|antimetabolites|mesh-ancestor
65215670|NCT04420884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215671|NCT04420884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65215672|NCT04420884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65332758|NCT02588534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65332759|NCT02588534|Immunologic Factors|immunologic factors|mesh-ancestor
65332760|NCT05109728|Temozolomide|temozolomide|mesh-list
65332761|NCT05109728|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
65332762|NCT05109728|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65332763|NCT05109728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65332764|NCT05109728|Alkylating Agents|alkylating agents|mesh-ancestor
65215673|NCT04420884|Immunologic Factors|immunologic factors|mesh-ancestor
65215676|NCT05341401|Budesonide|budesonide|mesh-list
65215677|NCT05341401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65215678|NCT05341401|Glucocorticoids|glucocorticoids|mesh-ancestor
65215679|NCT05341401|Hormones|hormones|mesh-ancestor
65215680|NCT05341401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65215681|NCT05341401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215682|NCT05341401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65215683|NCT05341401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215684|NCT05341401|Autonomic Agents|autonomic agents|mesh-ancestor
65215685|NCT05341401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65215686|NCT05341401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65215687|NCT05341401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65215688|NCT05341401|Respiratory System Agents|respiratory system agents|mesh-ancestor
65215689|NCT05340153|Lumefantrine|lumefantrine|mesh-list
65215690|NCT05340153|Artemether|artemether|mesh-list
65215691|NCT05340153|Piperaquine|piperaquine|mesh-list
65215692|NCT05340153|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65215693|NCT05340153|Artenimol|artenimol|mesh-list
65215694|NCT05340153|Antimalarials|antimalarials|mesh-ancestor
65215695|NCT05340153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65215696|NCT05340153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65215697|NCT05340153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65215698|NCT05078502|Vitamin D|vitamin d|mesh-list
65215699|NCT05078502|Cholecalciferol|cholecalciferol|mesh-list
65215700|NCT05078502|Vitamins|vitamins|mesh-ancestor
65215701|NCT05078502|Micronutrients|micronutrients|mesh-ancestor
64858410|NCT01742247|Hormones|hormones|mesh-ancestor
65215702|NCT05078502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215703|NCT05078502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65215704|NCT05078502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65215705|NCT02844894|Dexmedetomidine|dexmedetomidine|mesh-list
65215706|NCT02844894|Esmolol|esmolol|mesh-list
65215707|NCT02844894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65215708|NCT02844894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65215709|NCT02844894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215710|NCT02844894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65215711|NCT02844894|Analgesics|analgesics|mesh-ancestor
65215712|NCT02844894|Sensory System Agents|sensory system agents|mesh-ancestor
65215713|NCT02844894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65215714|NCT02844894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65215715|NCT02844894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65215716|NCT02844894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65215717|NCT02844894|Adrenergic Agents|adrenergic agents|mesh-ancestor
65215718|NCT02844894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65215719|NCT02844894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215720|NCT02844894|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65215721|NCT02844894|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65215722|NCT02844894|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65215723|NCT04778904|Nivolumab|nivolumab|mesh-list
65215724|NCT04778904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65215725|NCT04778904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215726|NCT04778904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65215727|NCT04778904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215728|NCT02339922|Rituximab|rituximab|mesh-list
65215729|NCT02339922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65215730|NCT02339922|Ixazomib|ixazomib|mesh-list
65215731|NCT02339922|Antibodies|antibodies|mesh-list
65215732|NCT02339922|Immunoglobulins|immunoglobulins|mesh-list
65215733|NCT02339922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65215734|NCT02339922|Glycine|glycine|mesh-list
65215735|NCT02339922|Immunologic Factors|immunologic factors|mesh-ancestor
65332765|NCT05109728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332766|NCT05109728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332767|NCT05109728|Chelating Agents|chelating agents|mesh-ancestor
65332768|NCT05109728|Sequestering Agents|sequestering agents|mesh-ancestor
65332769|NCT05109728|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65332770|NCT05099276|Tranexamic Acid|tranexamic acid|mesh-list
64718684|NCT00378716|Vitamins|vitamins|mesh-ancestor
65215736|NCT02339922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215737|NCT02339922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215738|NCT02339922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65215739|NCT02339922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215740|NCT02339922|Protease Inhibitors|protease inhibitors|mesh-ancestor
65215741|NCT02339922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215742|NCT02339922|Glycine Agents|glycine agents|mesh-ancestor
65215743|NCT02339922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65215744|NCT00634725|Gemcitabine|gemcitabine|mesh-list
65215745|NCT00634725|Capecitabine|capecitabine|mesh-list
65215746|NCT00634725|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65215747|NCT00634725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65215754|NCT00634725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65215755|NCT00634725|Immunologic Factors|immunologic factors|mesh-ancestor
65215756|NCT00634725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215757|NCT00634725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65215758|NCT05325489|Budesonide|budesonide|mesh-list
65215759|NCT05325489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65215760|NCT05325489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65215761|NCT05325489|Autonomic Agents|autonomic agents|mesh-ancestor
65215762|NCT05325489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65215763|NCT05325489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215764|NCT05325489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65215765|NCT05325489|Respiratory System Agents|respiratory system agents|mesh-ancestor
65215766|NCT05325489|Glucocorticoids|glucocorticoids|mesh-ancestor
65215767|NCT05325489|Hormones|hormones|mesh-ancestor
65215768|NCT05325489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65215769|NCT00902538|Amlodipine|amlodipine|mesh-list
65215770|NCT00902538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65215771|NCT00902538|Olmesartan|olmesartan|mesh-list
65215772|NCT00902538|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65215773|NCT00902538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65215774|NCT00902538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65215775|NCT00902538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65215776|NCT00902538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215777|NCT00902538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65215778|NCT00902538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215779|NCT00902538|Vasodilator Agents|vasodilator agents|mesh-ancestor
65215781|NCT00902538|Natriuretic Agents|natriuretic agents|mesh-ancestor
65215782|NCT00902538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65215783|NCT00902538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65215784|NCT00902538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65215786|NCT02780505|Vitamins|vitamins|mesh-ancestor
65215787|NCT02780505|Micronutrients|micronutrients|mesh-ancestor
65215788|NCT02780505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215789|NCT02780505|Antioxidants|antioxidants|mesh-ancestor
65215790|NCT02780505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215791|NCT02780505|Protective Agents|protective agents|mesh-ancestor
65215792|NCT02690844|Clonazepam|clonazepam|mesh-list
65215793|NCT02690844|Anticonvulsants|anticonvulsants|mesh-ancestor
65215794|NCT02690844|GABA Modulators|gaba modulators|mesh-ancestor
65215795|NCT02690844|GABA Agents|gaba agents|mesh-ancestor
65215796|NCT02690844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65215797|NCT02690844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215798|NCT02690844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215799|NCT04201860|Hemostatics|hemostatics|mesh-list
65215800|NCT04201860|Coagulants|coagulants|mesh-ancestor
65215801|NCT02847702|Naproxen|naproxen|mesh-list
65215802|NCT02847702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65215803|NCT02847702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65215804|NCT02847702|Analgesics|analgesics|mesh-ancestor
65215805|NCT02847702|Sensory System Agents|sensory system agents|mesh-ancestor
65332771|NCT05099276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65332772|NCT05099276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65332773|NCT05099276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332774|NCT05099276|Hemostatics|hemostatics|mesh-ancestor
65332775|NCT05099276|Coagulants|coagulants|mesh-ancestor
65332776|NCT00682929|Dronabinol|dronabinol|mesh-list
65332777|NCT00682929|Hallucinogens|hallucinogens|mesh-ancestor
65332778|NCT00682929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215806|NCT02847702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65215807|NCT02847702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215808|NCT02847702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65215809|NCT02847702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65215810|NCT02847702|Gout Suppressants|gout suppressants|mesh-ancestor
65215811|NCT02847702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65215812|NCT02847702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215813|NCT02847702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215814|NCT02779413|Insulin|insulin|mesh-list
65215815|NCT02779413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65215816|NCT02779413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215817|NCT04887402|Clomiphene|clomiphene|mesh-list
65215818|NCT04887402|Enclomiphene|enclomiphene|mesh-list
65215821|NCT04887402|Hormone Antagonists|hormone antagonists|mesh-ancestor
65215822|NCT04887402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65215823|NCT04887402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215824|NCT04887402|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65215825|NCT04887402|Fertility Agents|fertility agents|mesh-ancestor
65215826|NCT04887402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65215827|NCT04887402|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65215828|NCT04887402|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65215830|NCT04793568|Interferon-gamma|interferon-gamma|mesh-list
65215831|NCT04793568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215832|NCT04793568|Antiviral Agents|antiviral agents|mesh-ancestor
65215833|NCT04793568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65215834|NCT01979211|Cetuximab|cetuximab|mesh-list
65215835|NCT01979211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65215836|NCT01979211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215837|NCT05339217|Aldesleukin|aldesleukin|mesh-list
65215838|NCT05339217|Interleukin-2|interleukin-2|mesh-list
65215839|NCT05339217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215840|NCT05339217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65215841|NCT05339217|Analgesics|analgesics|mesh-ancestor
65215842|NCT05339217|Sensory System Agents|sensory system agents|mesh-ancestor
65215843|NCT05339217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65215844|NCT05339217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215845|NCT05339217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65215846|NCT05339217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65215847|NCT05339217|Antiviral Agents|antiviral agents|mesh-ancestor
65215848|NCT05339217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65215849|NCT04793490|Acetaminophen|acetaminophen|mesh-list
65215850|NCT04793490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65215851|NCT04793490|Analgesics|analgesics|mesh-ancestor
65215852|NCT04793490|Sensory System Agents|sensory system agents|mesh-ancestor
65215853|NCT04793490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65215854|NCT04793490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215855|NCT04793490|Antipyretics|antipyretics|mesh-ancestor
65215856|NCT00779532|Moxifloxacin|moxifloxacin|mesh-list
65215857|NCT00779532|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65215858|NCT00779532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65215859|NCT00779532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65215860|NCT00779532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65215861|NCT00779532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65215862|NCT00779532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215863|NCT00779532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215864|NCT00779532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215865|NCT00779532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65215866|NCT00779532|Contraceptive Agents|contraceptive agents|mesh-ancestor
65215867|NCT00779532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65332779|NCT00682929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65332780|NCT00682929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65332781|NCT00682929|Analgesics|analgesics|mesh-ancestor
65332782|NCT00682929|Sensory System Agents|sensory system agents|mesh-ancestor
65332783|NCT00682929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332784|NCT00682929|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65215868|NCT00779532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215869|NCT00779532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65215870|NCT00779532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65215871|NCT00779532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65215872|NCT05319093|Ozanimod|ozanimod|mesh-list
65215873|NCT05319093|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65215874|NCT05319093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215875|NCT05319093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65215876|NCT05319093|Immunologic Factors|immunologic factors|mesh-ancestor
65215877|NCT05319093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215878|NCT00752557|Calcium, Dietary|calcium, dietary|mesh-list
65215879|NCT00752557|Vitamin D|vitamin d|mesh-list
65215880|NCT00752557|Ergocalciferols|ergocalciferols|mesh-list
65215881|NCT00752557|Cholecalciferol|cholecalciferol|mesh-list
65215882|NCT00752557|Diphosphonates|diphosphonates|mesh-list
65215883|NCT00752557|Vitamins|vitamins|mesh-list
65215884|NCT00752557|Calcium|calcium|mesh-list
65215885|NCT00752557|Micronutrients|micronutrients|mesh-ancestor
65215886|NCT00752557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215887|NCT00752557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65215888|NCT00752557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65215889|NCT04570176|Epinephrine|epinephrine|mesh-list
65215890|NCT04570176|Racepinephrine|racepinephrine|mesh-list
65215891|NCT04570176|Epinephryl borate|epinephryl borate|mesh-list
65215892|NCT04570176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65215896|NCT04570176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215897|NCT04570176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215898|NCT04570176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65215899|NCT04570176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65215900|NCT04570176|Autonomic Agents|autonomic agents|mesh-ancestor
65215901|NCT04570176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65215902|NCT04570176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65215903|NCT04570176|Respiratory System Agents|respiratory system agents|mesh-ancestor
65215904|NCT04570176|Mydriatics|mydriatics|mesh-ancestor
65215905|NCT04570176|Sympathomimetics|sympathomimetics|mesh-ancestor
65215906|NCT04570176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65215907|NCT00751218|Cetirizine|cetirizine|mesh-list
65215908|NCT00751218|Desloratadine|desloratadine|mesh-list
65215909|NCT00751218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65215910|NCT00751218|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65215911|NCT00751218|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65215912|NCT00751218|Histamine Antagonists|histamine antagonists|mesh-ancestor
65215913|NCT00751218|Histamine Agents|histamine agents|mesh-ancestor
65215914|NCT00751218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65215915|NCT00751218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215916|NCT00751218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215917|NCT00751218|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65215918|NCT00751218|Cholinergic Agents|cholinergic agents|mesh-ancestor
65215919|NCT02779569|Decitabine|decitabine|mesh-list
65215920|NCT02779569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65215921|NCT02779569|Antimetabolites|antimetabolites|mesh-ancestor
65215922|NCT02779569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215923|NCT02779569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215924|NCT02779569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215925|NCT04095013|Fentanyl|fentanyl|mesh-list
65215926|NCT04095013|Dexmedetomidine|dexmedetomidine|mesh-list
65215927|NCT04095013|Bupivacaine|bupivacaine|mesh-list
65215928|NCT04095013|Anesthetics, Local|anesthetics, local|mesh-ancestor
65215929|NCT04095013|Anesthetics|anesthetics|mesh-ancestor
65215930|NCT04095013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65215931|NCT04095013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215932|NCT04095013|Sensory System Agents|sensory system agents|mesh-ancestor
65215933|NCT04095013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65215934|NCT04095013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65332785|NCT00682929|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65332786|NCT00682929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65332787|NCT00682929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332788|NCT00682929|Hormones|hormones|mesh-ancestor
65215935|NCT04095013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65215936|NCT04095013|Analgesics|analgesics|mesh-ancestor
65215937|NCT04095013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65215938|NCT04095013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65215939|NCT04095013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65215940|NCT04095013|Adrenergic Agents|adrenergic agents|mesh-ancestor
65215941|NCT04095013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65215942|NCT04095013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215943|NCT04095013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65215944|NCT04095013|Narcotics|narcotics|mesh-ancestor
65215945|NCT04095013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65215946|NCT04095013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65215947|NCT04095013|Anesthetics, General|anesthetics, general|mesh-ancestor
65215948|NCT02779881|Caseins|caseins|mesh-list
65215949|NCT02779881|Chelating Agents|chelating agents|mesh-ancestor
65215950|NCT02779881|Sequestering Agents|sequestering agents|mesh-ancestor
65215951|NCT02779881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215952|NCT00651378|Atorvastatin|atorvastatin|mesh-list
65215953|NCT00651378|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65215954|NCT00651378|Ezetimibe|ezetimibe|mesh-list
65215955|NCT00651378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65215956|NCT00651378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65215957|NCT00651378|Antimetabolites|antimetabolites|mesh-ancestor
65215958|NCT00651378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215959|NCT00651378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65215960|NCT00651378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65215961|NCT00651378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215962|NCT00747643|Varenicline|varenicline|mesh-list
65215963|NCT00747643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65215964|NCT00747643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65215965|NCT00747643|Cholinergic Agents|cholinergic agents|mesh-ancestor
65215972|NCT00627692|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65215973|NCT00627692|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65215974|NCT00627692|Serotonin Agents|serotonin agents|mesh-ancestor
65215975|NCT00627692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65215976|NCT00627692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215977|NCT00627692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215978|NCT00634881|Alemtuzumab|alemtuzumab|mesh-list
65215979|NCT00634881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65215980|NCT00634881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215981|NCT04301882|Interferons|interferons|mesh-list
65215982|NCT04301882|Ribavirin|ribavirin|mesh-list
65215983|NCT04301882|Antiviral Agents|antiviral agents|mesh-list
65215984|NCT04301882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215985|NCT04301882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65215986|NCT04301882|Antimetabolites|antimetabolites|mesh-ancestor
65215987|NCT04301882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215988|NCT03896880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65215989|NCT03896880|Clotrimazole|clotrimazole|mesh-list
65215990|NCT03896880|Miconazole|miconazole|mesh-list
65215991|NCT03896880|Antifungal Agents|antifungal agents|mesh-list
65215992|NCT03896880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65215993|NCT03896880|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65215994|NCT03896880|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65215995|NCT03896880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65215996|NCT03896880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215997|NCT03896880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215998|NCT03896880|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65215999|NCT03896880|Hormone Antagonists|hormone antagonists|mesh-ancestor
65216000|NCT03896880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64858718|NCT01743365|Afatinib|afatinib|mesh-list
65216001|NCT03896880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216002|NCT03896880|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65216003|NCT03896880|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65216005|NCT04300322|Progestins|progestins|mesh-ancestor
65216006|NCT04300322|Hormones|hormones|mesh-ancestor
65332789|NCT00682929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65332790|NCT00758199|Moxifloxacin|moxifloxacin|mesh-list
65332791|NCT00758199|Prednisolone|prednisolone|mesh-list
65332792|NCT00758199|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65332793|NCT00758199|Methylprednisolone|methylprednisolone|mesh-list
64718709|NCT04585490|Paclitaxel|paclitaxel|mesh-list
65216007|NCT04300322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65216008|NCT04300322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216009|NCT01022762|Repaglinide|repaglinide|mesh-list
65216010|NCT01022762|Gliclazide|gliclazide|mesh-list
65216011|NCT01022762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65216012|NCT01022762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216013|NCT05338671|Anesthetics|anesthetics|mesh-list
65216014|NCT05338671|Anesthetics, Local|anesthetics, local|mesh-list
65216015|NCT05338671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65216016|NCT05338671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216017|NCT05338671|Sensory System Agents|sensory system agents|mesh-ancestor
65216018|NCT05338671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65216019|NCT00311844|Desloratadine|desloratadine|mesh-list
65216020|NCT00311844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65216021|NCT00311844|Cholinergic Agents|cholinergic agents|mesh-ancestor
65216022|NCT00311844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65216023|NCT00311844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216024|NCT00311844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216025|NCT00311844|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65216026|NCT00311844|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65216027|NCT00311844|Histamine Antagonists|histamine antagonists|mesh-ancestor
65216028|NCT00311844|Histamine Agents|histamine agents|mesh-ancestor
65216029|NCT02599675|Vitamin D|vitamin d|mesh-list
65216030|NCT02599675|Cholecalciferol|cholecalciferol|mesh-list
65216031|NCT02599675|Vitamins|vitamins|mesh-ancestor
65216032|NCT02599675|Micronutrients|micronutrients|mesh-ancestor
65216033|NCT02599675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216039|NCT02778789|Infliximab|infliximab|mesh-list
65216040|NCT02778789|Certolizumab Pegol|certolizumab pegol|mesh-list
65216041|NCT02778789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65216042|NCT02778789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65216043|NCT02778789|Dermatologic Agents|dermatologic agents|mesh-ancestor
65216044|NCT02778789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65216045|NCT02778789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65216046|NCT02778789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65216047|NCT02778789|Analgesics|analgesics|mesh-ancestor
65216048|NCT02778789|Sensory System Agents|sensory system agents|mesh-ancestor
65216049|NCT02778789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65216050|NCT02778789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216051|NCT02778789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65216052|NCT02778789|Immunologic Factors|immunologic factors|mesh-ancestor
65216053|NCT02778789|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65216054|NCT00212784|Olanzapine|olanzapine|mesh-list
65216055|NCT00212784|Asenapine|asenapine|mesh-list
65216056|NCT00212784|Antiemetics|antiemetics|mesh-ancestor
65216057|NCT00212784|Autonomic Agents|autonomic agents|mesh-ancestor
65216058|NCT00212784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65216059|NCT00212784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216060|NCT00212784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65216061|NCT00212784|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65216062|NCT00212784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65216063|NCT00212784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65216064|NCT00212784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65216065|NCT00212784|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65216066|NCT00212784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65216067|NCT00212784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65216068|NCT00212784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216069|NCT00212784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65216070|NCT00212784|Serotonin Agents|serotonin agents|mesh-ancestor
65216071|NCT00751933|Vaccines|vaccines|mesh-list
65216072|NCT00751933|Immunologic Factors|immunologic factors|mesh-ancestor
65216073|NCT00751933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216074|NCT04092751|Ibrexafungerp|ibrexafungerp|mesh-list
64858791|NCT01743885|Sympathomimetics|sympathomimetics|mesh-ancestor
65332794|NCT00758199|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65332795|NCT00758199|Prednisolone acetate|prednisolone acetate|mesh-list
65332796|NCT00758199|Bromfenac|bromfenac|mesh-list
65332797|NCT00758199|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65216075|NCT04092751|Antifungal Agents|antifungal agents|mesh-ancestor
65216076|NCT04092751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65216077|NCT02778945|Rocuronium|rocuronium|mesh-list
65216078|NCT02778945|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65216079|NCT02778945|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65216080|NCT02778945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65216081|NCT02778945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65216082|NCT02778945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216084|NCT02721342|Irbesartan|irbesartan|mesh-list
65216085|NCT02721342|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65216086|NCT02721342|Protease Inhibitors|protease inhibitors|mesh-ancestor
65216087|NCT02721342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216088|NCT02721342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216089|NCT02721342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65216090|NCT02721342|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65216091|NCT02721342|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65216092|NCT02779101|Pembrolizumab|pembrolizumab|mesh-list
65216093|NCT02779101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65216094|NCT02779101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216095|NCT02779959|Prochlorperazine|prochlorperazine|mesh-list
65216096|NCT02779959|Antiemetics|antiemetics|mesh-ancestor
65216097|NCT02779959|Autonomic Agents|autonomic agents|mesh-ancestor
65216098|NCT02779959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65216099|NCT02779959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216100|NCT02779959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65216101|NCT02779959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65216102|NCT02779959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65216103|NCT02779959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65216104|NCT02779959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65216109|NCT05335278|Nintedanib|nintedanib|mesh-list
65216110|NCT05335278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216111|NCT05335278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65216112|NCT05335278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216113|NCT05335278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216114|NCT00092898|Ezetimibe|ezetimibe|mesh-list
65216115|NCT00092898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65216116|NCT00092898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65216117|NCT00092898|Antimetabolites|antimetabolites|mesh-ancestor
65216118|NCT00092898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216119|NCT00092898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65216120|NCT04094467|Leuprolide|leuprolide|mesh-list
65216121|NCT04094467|Cetrorelix|cetrorelix|mesh-list
65216122|NCT04094467|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65216123|NCT04094467|Fertility Agents|fertility agents|mesh-ancestor
65216124|NCT04094467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65216125|NCT04094467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216126|NCT04094467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65216127|NCT04094467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216128|NCT04094467|Hormone Antagonists|hormone antagonists|mesh-ancestor
65216129|NCT04094467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65216130|NCT04987281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65216131|NCT00092820|Ezetimibe|ezetimibe|mesh-list
65216132|NCT00092820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65216133|NCT00092820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65216134|NCT00092820|Antimetabolites|antimetabolites|mesh-ancestor
65216135|NCT00092820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216136|NCT00092820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65216137|NCT04228263|Aspirin|aspirin|mesh-list
65216138|NCT04228263|Folic Acid|folic acid|mesh-list
65216139|NCT04228263|Hydroxychloroquine|hydroxychloroquine|mesh-list
65216140|NCT04228263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65216141|NCT04228263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65216142|NCT04228263|Analgesics|analgesics|mesh-ancestor
65216143|NCT04228263|Sensory System Agents|sensory system agents|mesh-ancestor
65216144|NCT04228263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65216145|NCT04228263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332798|NCT00758199|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65332799|NCT00758199|Prednisolone phosphate|prednisolone phosphate|mesh-list
65332800|NCT00758199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65332801|NCT00758199|Glucocorticoids|glucocorticoids|mesh-ancestor
65332802|NCT00758199|Hormones|hormones|mesh-ancestor
65332803|NCT00758199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65332804|NCT00758199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332805|NCT00758199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65332806|NCT00758199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704672|NCT03678428|Leucovorin|leucovorin|mesh-list
65216146|NCT04228263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65216147|NCT04228263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65216148|NCT04228263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65216149|NCT04228263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64858860|NCT01744236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65216150|NCT04228263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216151|NCT04228263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65216152|NCT04228263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65216153|NCT04228263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216154|NCT04228263|Antipyretics|antipyretics|mesh-ancestor
65216155|NCT04228263|Antimalarials|antimalarials|mesh-ancestor
65216156|NCT04228263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65216157|NCT04228263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65216158|NCT04228263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65216159|NCT04228263|Hematinics|hematinics|mesh-ancestor
65216160|NCT04228263|Vitamin B Complex|vitamin b complex|mesh-ancestor
65216161|NCT04228263|Vitamins|vitamins|mesh-ancestor
65216162|NCT04228263|Micronutrients|micronutrients|mesh-ancestor
65216163|NCT00092742|Diclofenac|diclofenac|mesh-list
65216164|NCT00092742|Etoricoxib|etoricoxib|mesh-list
65216165|NCT00092742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65216166|NCT00092742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65216167|NCT00092742|Analgesics|analgesics|mesh-ancestor
65216168|NCT00092742|Sensory System Agents|sensory system agents|mesh-ancestor
65216169|NCT00092742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65216170|NCT00092742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216171|NCT00092742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65216172|NCT00092742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65216173|NCT00092742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65216174|NCT00092742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216175|NCT00092742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216177|NCT02844270|Sirolimus|sirolimus|mesh-list
65216178|NCT02844270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65216179|NCT02844270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65216180|NCT02844270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65216181|NCT02844270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216182|NCT02844270|Antifungal Agents|antifungal agents|mesh-ancestor
65216183|NCT02844270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65216184|NCT02844270|Immunologic Factors|immunologic factors|mesh-ancestor
65216185|NCT02844270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216186|NCT00634959|Maraviroc|maraviroc|mesh-list
65216187|NCT00634959|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65216188|NCT00634959|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65216189|NCT00634959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216190|NCT00634959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65216191|NCT00634959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65216192|NCT00634959|Antiviral Agents|antiviral agents|mesh-ancestor
65216193|NCT00634959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65216194|NCT00634959|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65216195|NCT02598427|Trastuzumab|trastuzumab|mesh-list
65216196|NCT02598427|Pertuzumab|pertuzumab|mesh-list
65216197|NCT02598427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65216198|NCT02598427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216199|NCT05128071|Progesterone|progesterone|mesh-list
65216200|NCT05128071|Progestins|progestins|mesh-ancestor
65216201|NCT05128071|Hormones|hormones|mesh-ancestor
65332807|NCT00758199|Antiemetics|antiemetics|mesh-ancestor
65332808|NCT00758199|Autonomic Agents|autonomic agents|mesh-ancestor
65332809|NCT00758199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332810|NCT00758199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65216202|NCT05128071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65216203|NCT05128071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216204|NCT04092595|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65216205|NCT04092595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65216206|NCT04092595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65216207|NCT04092595|Antimetabolites|antimetabolites|mesh-ancestor
65216208|NCT04092595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216209|NCT04092595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65216210|NCT04092595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65216211|NCT04092595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216212|NCT04092205|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
65216213|NCT04092205|Chelating Agents|chelating agents|mesh-ancestor
65216214|NCT04092205|Sequestering Agents|sequestering agents|mesh-ancestor
65216215|NCT04092205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216216|NCT05117853|Parathyroid Hormone|parathyroid hormone|mesh-list
65216217|NCT05117853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65216218|NCT05117853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216219|NCT01028222|Dacarbazine|dacarbazine|mesh-list
65216220|NCT01028222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65216221|NCT01028222|Alkylating Agents|alkylating agents|mesh-ancestor
65216222|NCT01028222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858935|NCT01744587|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65216223|NCT01028222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216224|NCT00586495|Sorafenib|sorafenib|mesh-list
65216225|NCT00586495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216226|NCT00586495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65216227|NCT00586495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216228|NCT00586495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216230|NCT02776137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216231|NCT02776137|Tubulin Modulators|tubulin modulators|mesh-ancestor
65216232|NCT02776137|Antimitotic Agents|antimitotic agents|mesh-ancestor
65216233|NCT02776137|Mitosis Modulators|mitosis modulators|mesh-ancestor
65216234|NCT02776137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216235|NCT01027754|Varenicline|varenicline|mesh-list
65216236|NCT01027754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65216237|NCT01027754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65216238|NCT01027754|Cholinergic Agents|cholinergic agents|mesh-ancestor
65216239|NCT01027754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65216240|NCT01027754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216241|NCT01027754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216242|NCT02773017|Dexmedetomidine|dexmedetomidine|mesh-list
65216243|NCT02773017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65216244|NCT02773017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65216245|NCT02773017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216246|NCT02773017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65216247|NCT02773017|Analgesics|analgesics|mesh-ancestor
65216251|NCT02773017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65216252|NCT02773017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65216253|NCT02773017|Adrenergic Agents|adrenergic agents|mesh-ancestor
65216254|NCT02773017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65216255|NCT02773017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216256|NCT02776059|Prednisolone|prednisolone|mesh-list
65216257|NCT02776059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65216258|NCT02776059|Glucocorticoids|glucocorticoids|mesh-ancestor
65216259|NCT02776059|Hormones|hormones|mesh-ancestor
65216260|NCT02776059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65216261|NCT02776059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216262|NCT02776059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65216263|NCT02776059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216264|NCT00774930|Lanreotide|lanreotide|mesh-list
65216265|NCT00774930|Somatostatin|somatostatin|mesh-list
65216266|NCT00774930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216267|NCT00774930|Hormones|hormones|mesh-ancestor
65216268|NCT00774930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65332811|NCT00758199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65332812|NCT00758199|Protective Agents|protective agents|mesh-ancestor
65332813|NCT00758199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65332814|NCT00758199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65332815|NCT00758199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64718727|NCT04714099|Cyclosporine|cyclosporine|mesh-list
65216269|NCT00774930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216270|NCT02841774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65216271|NCT02841774|Pravastatin|pravastatin|mesh-list
65216272|NCT02841774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65216273|NCT02841774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65216274|NCT02841774|Antimetabolites|antimetabolites|mesh-ancestor
65216275|NCT02841774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216276|NCT02841774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65216277|NCT02841774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65216278|NCT02841774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216279|NCT02772237|Riboflavin|riboflavin|mesh-list
65216280|NCT02772237|Vitamins|vitamins|mesh-ancestor
65216281|NCT02772237|Micronutrients|micronutrients|mesh-ancestor
65216282|NCT02772237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216283|NCT02772237|Vitamin B Complex|vitamin b complex|mesh-ancestor
65216284|NCT02772237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65216285|NCT02772237|Dermatologic Agents|dermatologic agents|mesh-ancestor
65216286|NCT02841306|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65216287|NCT02841306|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65216288|NCT02841306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65216289|NCT01316250|Imatinib Mesylate|imatinib mesylate|mesh-list
65216290|NCT01316250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216291|NCT01316250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65216292|NCT01316250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216293|NCT01316250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216294|NCT02771925|Gabapentin|gabapentin|mesh-list
65216295|NCT02771925|Analgesics|analgesics|mesh-ancestor
65216296|NCT02771925|Sensory System Agents|sensory system agents|mesh-ancestor
65216297|NCT02771925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65216298|NCT02771925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216299|NCT02771925|Anticonvulsants|anticonvulsants|mesh-ancestor
65216300|NCT02771925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65216301|NCT02771925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65216302|NCT02771925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65216303|NCT02771925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65216304|NCT02771925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65216305|NCT02771925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65216306|NCT02771925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65216307|NCT02771925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216308|NCT02771925|Antimanic Agents|antimanic agents|mesh-ancestor
65216310|NCT03205956|Carbidopa|carbidopa|mesh-list
65216311|NCT03205956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65216312|NCT03205956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65216313|NCT03205956|Dopamine Agents|dopamine agents|mesh-ancestor
65216314|NCT03205956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65216315|NCT03205956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216316|NCT03205956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216317|NCT03205956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65216318|NCT03205956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216319|NCT02840994|Pembrolizumab|pembrolizumab|mesh-list
65216323|NCT02840994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65216324|NCT02840994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216325|NCT02771457|Infliximab|infliximab|mesh-list
65216326|NCT02771457|Dermatologic Agents|dermatologic agents|mesh-ancestor
65216327|NCT02771457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65216328|NCT02771457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65216329|NCT02771379|Idebenone|idebenone|mesh-list
65216330|NCT02771379|Antioxidants|antioxidants|mesh-ancestor
65216331|NCT02771379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216332|NCT02771379|Protective Agents|protective agents|mesh-ancestor
65216333|NCT02771379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216334|NCT01026870|Mometasone Furoate|mometasone furoate|mesh-list
65216335|NCT01026870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65332816|NCT00758199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65332817|NCT00758199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718732|NCT04714099|Immunologic Factors|immunologic factors|mesh-ancestor
65216336|NCT01026870|Dermatologic Agents|dermatologic agents|mesh-ancestor
65216337|NCT01026870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65216338|NCT02844114|Gemcitabine|gemcitabine|mesh-list
65216339|NCT02844114|Cisplatin|cisplatin|mesh-list
65216340|NCT02844114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216341|NCT02844114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65216342|NCT02844114|Antimetabolites|antimetabolites|mesh-ancestor
65216343|NCT02844114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216344|NCT02844114|Antiviral Agents|antiviral agents|mesh-ancestor
65216345|NCT02844114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65216346|NCT02844114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216347|NCT02844114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65216348|NCT02844114|Immunologic Factors|immunologic factors|mesh-ancestor
65216349|NCT02844114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216350|NCT02696733|Cephalosporins|cephalosporins|mesh-list
65216351|NCT02696733|Lidocaine|lidocaine|mesh-list
65216352|NCT02696733|Anesthetics, Local|anesthetics, local|mesh-ancestor
65216353|NCT02696733|Anesthetics|anesthetics|mesh-ancestor
65216354|NCT02696733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65216355|NCT02696733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216356|NCT02696733|Sensory System Agents|sensory system agents|mesh-ancestor
65216357|NCT02696733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65216358|NCT02696733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65216359|NCT02696733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65216360|NCT02696733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65216361|NCT02696733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65216362|NCT02696733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216363|NCT02696733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65216364|NCT02696733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65216365|NCT05335122|Bimatoprost|bimatoprost|mesh-list
65216366|NCT05335122|Travoprost|travoprost|mesh-list
65216367|NCT05335122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65216368|NCT00897390|Metformin|metformin|mesh-list
65216369|NCT00897390|Saxagliptin|saxagliptin|mesh-list
65216370|NCT00897390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65216371|NCT00897390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216372|NCT00897390|Incretins|incretins|mesh-ancestor
65216373|NCT00897390|Hormones|hormones|mesh-ancestor
65216374|NCT00897390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65216375|NCT00897390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65216376|NCT00897390|Protease Inhibitors|protease inhibitors|mesh-ancestor
65216377|NCT00897390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216378|NCT00897390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216379|NCT01034462|Milnacipran|milnacipran|mesh-list
65216380|NCT01034462|Levomilnacipran|levomilnacipran|mesh-list
65216381|NCT01034462|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65216382|NCT01034462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65216383|NCT01034462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65216384|NCT01034462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216385|NCT01034462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65216386|NCT01034462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216387|NCT01034462|Antidepressive Agents|antidepressive agents|mesh-ancestor
65216388|NCT01034462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65216389|NCT01034462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65216390|NCT01034462|Analgesics|analgesics|mesh-ancestor
65216391|NCT01034462|Sensory System Agents|sensory system agents|mesh-ancestor
65216393|NCT01033448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65216394|NCT01033448|Antiviral Agents|antiviral agents|mesh-ancestor
65216395|NCT01033448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65216396|NCT02873234|Antidepressive Agents|antidepressive agents|mesh-list
65216397|NCT02873234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65216398|NCT02774811|Bimatoprost|bimatoprost|mesh-list
65216399|NCT02774811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65216400|NCT00817050|Fluticasone|fluticasone|mesh-list
65216401|NCT00817050|Mometasone Furoate|mometasone furoate|mesh-list
65216402|NCT00817050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65216403|NCT00817050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65216404|NCT00817050|Autonomic Agents|autonomic agents|mesh-ancestor
65216405|NCT00817050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332818|NCT00758199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082710|NCT00468351|Hormones|hormones|mesh-ancestor
65332819|NCT00758199|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65332820|NCT00758199|Contraceptive Agents|contraceptive agents|mesh-ancestor
65216406|NCT00817050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216407|NCT00817050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65216408|NCT00817050|Respiratory System Agents|respiratory system agents|mesh-ancestor
65216409|NCT00817050|Dermatologic Agents|dermatologic agents|mesh-ancestor
65216410|NCT00817050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65216411|NCT04224831|Mitogens|mitogens|mesh-list
65216412|NCT04224831|Mitosis Modulators|mitosis modulators|mesh-ancestor
65216413|NCT04224831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216414|NCT00816972|Loratadine|loratadine|mesh-list
65216415|NCT00816972|Mandelic Acids|mandelic acids|mesh-list
65216416|NCT00816972|Oxybutynin|oxybutynin|mesh-list
65216417|NCT00816972|Desloratadine|desloratadine|mesh-list
65216418|NCT00816972|Parasympatholytics|parasympatholytics|mesh-ancestor
65216419|NCT00816972|Autonomic Agents|autonomic agents|mesh-ancestor
65216420|NCT00816972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65216421|NCT00816972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216422|NCT00816972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65216423|NCT00816972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65216424|NCT00816972|Cholinergic Agents|cholinergic agents|mesh-ancestor
65216425|NCT00816972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65216426|NCT00816972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216427|NCT00816972|Urological Agents|urological agents|mesh-ancestor
65216428|NCT00816972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65216429|NCT00816972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65216430|NCT00816972|Renal Agents|renal agents|mesh-ancestor
65216431|NCT00816972|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65216432|NCT00816972|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65216433|NCT00816972|Histamine Antagonists|histamine antagonists|mesh-ancestor
65216434|NCT00816972|Histamine Agents|histamine agents|mesh-ancestor
65216435|NCT00816972|Antipruritics|antipruritics|mesh-ancestor
65216436|NCT00816972|Dermatologic Agents|dermatologic agents|mesh-ancestor
65216437|NCT00816972|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65216438|NCT02774499|Methadone|methadone|mesh-list
65216439|NCT02774499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65216440|NCT02774499|Narcotics|narcotics|mesh-ancestor
65216441|NCT02774499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65216442|NCT02774499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216443|NCT02774499|Analgesics|analgesics|mesh-ancestor
65216444|NCT02774499|Sensory System Agents|sensory system agents|mesh-ancestor
65216445|NCT02774499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65216446|NCT02774499|Antitussive Agents|antitussive agents|mesh-ancestor
65216447|NCT02774499|Respiratory System Agents|respiratory system agents|mesh-ancestor
65216448|NCT02770443|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65216449|NCT02770443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65216450|NCT02770443|Adrenergic Agents|adrenergic agents|mesh-ancestor
65216451|NCT02770443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65216452|NCT02770443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216453|NCT02770443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216454|NCT02774187|Leucovorin|leucovorin|mesh-list
65216455|NCT02774187|Fluorouracil|fluorouracil|mesh-list
65216456|NCT02774187|Oxaliplatin|oxaliplatin|mesh-list
65216457|NCT02774187|Sorafenib|sorafenib|mesh-list
65216458|NCT02774187|Antimetabolites|antimetabolites|mesh-ancestor
65216459|NCT02774187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216460|NCT02774187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65216461|NCT02774187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216462|NCT02774187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65216463|NCT02774187|Immunologic Factors|immunologic factors|mesh-ancestor
65216464|NCT02774187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216465|NCT02774187|Antidotes|antidotes|mesh-ancestor
65216466|NCT02774187|Protective Agents|protective agents|mesh-ancestor
65216467|NCT02774187|Vitamin B Complex|vitamin b complex|mesh-ancestor
65216470|NCT02774187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65216471|NCT02774187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216472|NCT02773797|Dexmedetomidine|dexmedetomidine|mesh-list
65216473|NCT02773797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65216474|NCT02773797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65216475|NCT02773797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332821|NCT00758199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65332822|NCT00758199|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65332823|NCT00758199|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65332824|NCT00758199|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64718739|NCT04566770|Vaccines|vaccines|mesh-list
65216476|NCT02773797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65216477|NCT02773797|Analgesics|analgesics|mesh-ancestor
65216478|NCT02773797|Sensory System Agents|sensory system agents|mesh-ancestor
65216479|NCT02773797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65216480|NCT02773797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65216481|NCT02773797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65216482|NCT02773797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65216483|NCT02773797|Adrenergic Agents|adrenergic agents|mesh-ancestor
65216484|NCT02773797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65216485|NCT02773797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216486|NCT02773875|Pancrelipase|pancrelipase|mesh-list
65216487|NCT02773875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65216489|NCT02768961|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
65216490|NCT02768961|Ledipasvir|ledipasvir|mesh-list
65216491|NCT02768961|Antiviral Agents|antiviral agents|mesh-ancestor
65216492|NCT02768961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65216493|NCT02773641|Botulinum Toxins|botulinum toxins|mesh-list
65216494|NCT02773641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65216495|NCT02773641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65216496|NCT02773641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65216497|NCT02773641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65216498|NCT02773641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216499|NCT02773641|Cholinergic Agents|cholinergic agents|mesh-ancestor
65216500|NCT02773641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65216501|NCT02773641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216502|NCT02773641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65216503|NCT02773641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65216504|NCT02768805|Vaccines|vaccines|mesh-list
65216505|NCT02768805|Immunologic Factors|immunologic factors|mesh-ancestor
65216506|NCT02768805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216507|NCT02773251|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65216508|NCT02773251|Hyaluronic Acid|hyaluronic acid|mesh-list
65216509|NCT02773251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65216510|NCT02773251|Immunologic Factors|immunologic factors|mesh-ancestor
65216511|NCT02773251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216512|NCT02773251|Viscosupplements|viscosupplements|mesh-ancestor
65216513|NCT02773251|Protective Agents|protective agents|mesh-ancestor
65216514|NCT02773251|Laxatives|laxatives|mesh-ancestor
65216515|NCT02773251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65216516|NCT02768649|Risperidone|risperidone|mesh-list
65216517|NCT02768649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65216518|NCT02768649|Serotonin Agents|serotonin agents|mesh-ancestor
65216519|NCT02768649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65216520|NCT02768649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216521|NCT02768649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216522|NCT02768649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65216523|NCT02768649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65216524|NCT02768649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65216525|NCT02768649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65216526|NCT02768649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65216527|NCT02768649|Dopamine Agents|dopamine agents|mesh-ancestor
65216528|NCT02773407|Azithromycin|azithromycin|mesh-list
65216529|NCT02773407|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65216530|NCT02773407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65216531|NCT02773407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65216532|NCT02773407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65216533|NCT02773407|Renal Agents|renal agents|mesh-ancestor
65216534|NCT02773407|Antimalarials|antimalarials|mesh-ancestor
65216535|NCT02773407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65216536|NCT02773407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65216537|NCT00715611|Carboplatin|carboplatin|mesh-list
65216538|NCT00715611|Pemetrexed|pemetrexed|mesh-list
65216539|NCT00715611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216540|NCT00715611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216541|NCT00715611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216544|NCT04224675|Atenolol|atenolol|mesh-list
65332825|NCT00758199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65332826|NCT00758199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65332827|NCT00758199|Analgesics|analgesics|mesh-ancestor
65332828|NCT00758199|Sensory System Agents|sensory system agents|mesh-ancestor
65332829|NCT00758199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65332830|NCT05683808|Apixaban|apixaban|mesh-list
65332831|NCT05683808|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65332832|NCT05683808|Antithrombins|antithrombins|mesh-ancestor
65332833|NCT05683808|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65332834|NCT05683808|Protease Inhibitors|protease inhibitors|mesh-ancestor
65332835|NCT05683808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332836|NCT05683808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332837|NCT05683808|Anticoagulants|anticoagulants|mesh-ancestor
65332838|NCT00680745|Metformin|metformin|mesh-list
65332839|NCT00680745|Pioglitazone|pioglitazone|mesh-list
65332840|NCT00680745|Dapagliflozin|dapagliflozin|mesh-list
65216545|NCT04224675|Captopril|captopril|mesh-list
65216546|NCT04224675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65216547|NCT04224675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65216548|NCT04224675|Sympatholytics|sympatholytics|mesh-ancestor
65216549|NCT04224675|Autonomic Agents|autonomic agents|mesh-ancestor
65216550|NCT04224675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65216551|NCT04224675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216552|NCT04224675|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65216553|NCT04224675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65216554|NCT04224675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65216555|NCT04224675|Adrenergic Agents|adrenergic agents|mesh-ancestor
65216556|NCT04224675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65216557|NCT04224675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216558|NCT04224675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65216559|NCT04224675|Protease Inhibitors|protease inhibitors|mesh-ancestor
65216560|NCT04224675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216561|NCT02768493|Ropivacaine|ropivacaine|mesh-list
65216562|NCT02768493|Anesthetics, Local|anesthetics, local|mesh-ancestor
65216563|NCT02768493|Anesthetics|anesthetics|mesh-ancestor
65216564|NCT02768493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65216565|NCT02768493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216566|NCT02768493|Sensory System Agents|sensory system agents|mesh-ancestor
65216567|NCT02768493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65216568|NCT02768415|Apatinib|apatinib|mesh-list
65216569|NCT02768415|Vinorelbine|vinorelbine|mesh-list
65216570|NCT02768415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216571|NCT02768415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65216572|NCT02768415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216573|NCT02768415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216574|NCT02768415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65216575|NCT02768415|Tubulin Modulators|tubulin modulators|mesh-ancestor
65216576|NCT02768415|Antimitotic Agents|antimitotic agents|mesh-ancestor
65216577|NCT02768415|Mitosis Modulators|mitosis modulators|mesh-ancestor
65216578|NCT02773095|Lactitol|lactitol|mesh-list
65216579|NCT02773095|Cathartics|cathartics|mesh-ancestor
65216580|NCT02773095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65216581|NCT02768337|Afatinib|afatinib|mesh-list
65216582|NCT02768337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216583|NCT02768337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65216584|NCT02768337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216585|NCT02768337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216586|NCT02768571|Cerebrolysin|cerebrolysin|mesh-list
65216587|NCT02768571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65216588|NCT02768571|Protective Agents|protective agents|mesh-ancestor
65216589|NCT02768571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332841|NCT00680745|Glimepiride|glimepiride|mesh-list
65332842|NCT00680745|Rosiglitazone|rosiglitazone|mesh-list
65332843|NCT00680745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65332844|NCT00680745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216590|NCT02768571|Nootropic Agents|nootropic agents|mesh-ancestor
65216591|NCT02767713|Dexamethasone|dexamethasone|mesh-list
65216592|NCT02767713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65216593|NCT02767713|Antiemetics|antiemetics|mesh-ancestor
65216594|NCT02767713|Autonomic Agents|autonomic agents|mesh-ancestor
65216595|NCT02767713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65216596|NCT02767713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216597|NCT02767713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65216598|NCT02767713|Glucocorticoids|glucocorticoids|mesh-ancestor
65216599|NCT02767713|Hormones|hormones|mesh-ancestor
65216600|NCT02767713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65216601|NCT02767713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65216602|NCT02767713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216603|NCT02767245|Thiamine|thiamine|mesh-list
65216605|NCT02767245|Micronutrients|micronutrients|mesh-ancestor
65216606|NCT02767245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216607|NCT02767245|Vitamin B Complex|vitamin b complex|mesh-ancestor
65216608|NCT02767401|Aspirin|aspirin|mesh-list
65216609|NCT02767401|Metoprolol|metoprolol|mesh-list
65216610|NCT02767401|Clopidogrel|clopidogrel|mesh-list
65216611|NCT02767401|Ticagrelor|ticagrelor|mesh-list
65216612|NCT02767401|Atorvastatin|atorvastatin|mesh-list
65216613|NCT02767401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65216614|NCT02767401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65216615|NCT02767401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65216616|NCT02767401|Analgesics|analgesics|mesh-ancestor
65216617|NCT02767401|Sensory System Agents|sensory system agents|mesh-ancestor
65216619|NCT02767401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216620|NCT02767401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65216621|NCT02767401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65216622|NCT02767401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65216623|NCT02767401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65216624|NCT02767401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216625|NCT02767401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65216626|NCT02767401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65216627|NCT02767401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216629|NCT02767401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65216630|NCT02767401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65216631|NCT02767401|Antimetabolites|antimetabolites|mesh-ancestor
65216632|NCT02767401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65216633|NCT02767401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65216634|NCT02767401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65216635|NCT02767401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65216636|NCT02767401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65216637|NCT02767401|Purinergic Agents|purinergic agents|mesh-ancestor
65216638|NCT02767401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65216639|NCT02767401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65216640|NCT02767401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65216641|NCT02767401|Sympatholytics|sympatholytics|mesh-ancestor
65216642|NCT02767401|Autonomic Agents|autonomic agents|mesh-ancestor
65216643|NCT02767401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65216644|NCT02767401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65216645|NCT02767401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65216646|NCT02767401|Adrenergic Agents|adrenergic agents|mesh-ancestor
65216647|NCT02767479|Esomeprazole|esomeprazole|mesh-list
65216648|NCT02767479|Rabeprazole|rabeprazole|mesh-list
65216649|NCT02767479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65216650|NCT02767479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65216651|NCT02767479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65216652|NCT02767479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216653|NCT02767479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216654|NCT02767635|Triamcinolone|triamcinolone|mesh-list
65216655|NCT02767635|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65216656|NCT02767635|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65216657|NCT02767635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65216658|NCT02767635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65216659|NCT02767635|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65216660|NCT02767635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65216661|NCT02767635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332845|NCT00680745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65332846|NCT00680745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332847|NCT00680745|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65216662|NCT02767635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216663|NCT02767635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65216664|NCT02767635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65216665|NCT02767635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216666|NCT02767635|Cholinergic Agents|cholinergic agents|mesh-ancestor
65216667|NCT02767635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65216668|NCT02767635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65216669|NCT02767635|Glucocorticoids|glucocorticoids|mesh-ancestor
65216670|NCT02767635|Hormones|hormones|mesh-ancestor
65216671|NCT02767635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65216672|NCT02767635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65216673|NCT02767635|Immunologic Factors|immunologic factors|mesh-ancestor
65216674|NCT02767635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216675|NCT04224441|Temozolomide|temozolomide|mesh-list
65216676|NCT04224441|Chlorpromazine|chlorpromazine|mesh-list
65216677|NCT04224441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65216678|NCT04224441|Alkylating Agents|alkylating agents|mesh-ancestor
65216679|NCT04224441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216680|NCT04224441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216681|NCT04224441|Antiemetics|antiemetics|mesh-ancestor
65216682|NCT04224441|Autonomic Agents|autonomic agents|mesh-ancestor
65216683|NCT04224441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65216684|NCT04224441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216685|NCT04224441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65216686|NCT04224441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65216687|NCT04224441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65216688|NCT04224441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65216689|NCT04224441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65216692|NCT04224441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65216694|NCT02767089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65216695|NCT02767089|Glucocorticoids|glucocorticoids|mesh-ancestor
65216696|NCT02767089|Hormones|hormones|mesh-ancestor
65216697|NCT02767089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65216698|NCT02767089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216699|NCT02767089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65216700|NCT02767089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216701|NCT02766855|Cysteamine|cysteamine|mesh-list
65216702|NCT02766855|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
65216703|NCT02766855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216704|NCT02762643|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65216705|NCT02762643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65216706|NCT02762643|Hormone Antagonists|hormone antagonists|mesh-ancestor
65216707|NCT02762643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65216708|NCT02762643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216709|NCT02762643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65216710|NCT02762643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65216711|NCT02762643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65216712|NCT04224051|Metformin|metformin|mesh-list
65216713|NCT04224051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65216714|NCT04224051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216715|NCT02762253|Riboflavin|riboflavin|mesh-list
65216716|NCT02762253|Vitamin B Complex|vitamin b complex|mesh-ancestor
65216717|NCT02762253|Vitamins|vitamins|mesh-ancestor
65216718|NCT02762253|Micronutrients|micronutrients|mesh-ancestor
65216719|NCT02762253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216720|NCT02762253|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65216721|NCT02762253|Dermatologic Agents|dermatologic agents|mesh-ancestor
65216722|NCT00746941|Mefloquine|mefloquine|mesh-list
65216723|NCT00746941|Antimalarials|antimalarials|mesh-ancestor
65216724|NCT00746941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65216725|NCT00746941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65216726|NCT00746941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65216727|NCT04532463|Fluconazole|fluconazole|mesh-list
65216728|NCT04532463|Amphotericin B|amphotericin b|mesh-list
65216729|NCT04532463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65216730|NCT04532463|Flucytosine|flucytosine|mesh-list
65216731|NCT04532463|Antifungal Agents|antifungal agents|mesh-ancestor
65332848|NCT00680745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65332849|NCT00680745|Immunologic Factors|immunologic factors|mesh-ancestor
65332850|NCT05434377|Vitamin D|vitamin d|mesh-list
65332851|NCT05434377|Ergocalciferols|ergocalciferols|mesh-list
65332852|NCT05434377|Vitamins|vitamins|mesh-ancestor
65332853|NCT05434377|Micronutrients|micronutrients|mesh-ancestor
65332854|NCT05434377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332855|NCT05434377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65332856|NCT05434377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65332857|NCT05428293|Acetaminophen|acetaminophen|mesh-list
65216732|NCT04532463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65216733|NCT04532463|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65216734|NCT04532463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65216735|NCT04532463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216736|NCT04532463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216737|NCT04532463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65216738|NCT04532463|Hormone Antagonists|hormone antagonists|mesh-ancestor
65216739|NCT04532463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65216740|NCT04532463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216741|NCT04532463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65216742|NCT04532463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65216743|NCT04532463|Amebicides|amebicides|mesh-ancestor
65216744|NCT04532463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65216745|NCT04532463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65216746|NCT04532463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65216747|NCT04532463|Antimetabolites|antimetabolites|mesh-ancestor
65216748|NCT04091971|Ketamine|ketamine|mesh-list
65216749|NCT04091971|Analgesics|analgesics|mesh-ancestor
65216750|NCT04091971|Sensory System Agents|sensory system agents|mesh-ancestor
65216751|NCT04091971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65216752|NCT04091971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216753|NCT04091971|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65216754|NCT04091971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65216755|NCT04091971|Anesthetics, General|anesthetics, general|mesh-ancestor
65216757|NCT04091971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65216758|NCT04091971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65216759|NCT04091971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65216760|NCT04091971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65216761|NCT04091971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216762|NCT04091815|Anesthetics|anesthetics|mesh-list
65216764|NCT04091815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216767|NCT00746785|Autonomic Agents|autonomic agents|mesh-ancestor
65216768|NCT00746785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65216769|NCT00746785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216770|NCT00746785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65216771|NCT00746785|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65216772|NCT00746785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65216773|NCT00746785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65216774|NCT00746785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65216775|NCT00746785|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65216776|NCT00746785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65216777|NCT00746785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65216778|NCT00746785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216779|NCT00746785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65216780|NCT00746785|Serotonin Agents|serotonin agents|mesh-ancestor
65216781|NCT04090021|Amoxicillin|amoxicillin|mesh-list
65216782|NCT04090021|Metronidazole|metronidazole|mesh-list
65216783|NCT04090021|Clarithromycin|clarithromycin|mesh-list
65216784|NCT04090021|Levofloxacin|levofloxacin|mesh-list
65216785|NCT04090021|Ofloxacin|ofloxacin|mesh-list
65216786|NCT04090021|Rifabutin|rifabutin|mesh-list
65216787|NCT04090021|Esomeprazole|esomeprazole|mesh-list
65216788|NCT04090021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65216789|NCT04090021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65216790|NCT04090021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65332858|NCT05428293|Ibuprofen|ibuprofen|mesh-list
65332859|NCT05428293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65332860|NCT05428293|Analgesics|analgesics|mesh-ancestor
65332861|NCT05428293|Sensory System Agents|sensory system agents|mesh-ancestor
65332862|NCT05428293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332863|NCT05428293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332864|NCT05428293|Antipyretics|antipyretics|mesh-ancestor
65216791|NCT04090021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65216792|NCT04090021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65216793|NCT04090021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65216794|NCT04090021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65216795|NCT04090021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216796|NCT04090021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216797|NCT04090021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65216798|NCT04090021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65216799|NCT04090021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65216800|NCT04090021|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65216801|NCT04090021|Renal Agents|renal agents|mesh-ancestor
65216802|NCT04090021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65216803|NCT04090021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65216804|NCT04090021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216805|NCT04090021|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65216806|NCT04090021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65216807|NCT04090021|Antitubercular Agents|antitubercular agents|mesh-ancestor
65216808|NCT04223973|Insulin|insulin|mesh-list
65216809|NCT04223973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65216810|NCT04223973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216811|NCT00750919|Mirtazapine|mirtazapine|mesh-list
65216812|NCT00750919|Antidepressive Agents|antidepressive agents|mesh-ancestor
65216813|NCT00750919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65216814|NCT00750919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65216815|NCT00750919|Histamine Antagonists|histamine antagonists|mesh-ancestor
65216816|NCT00750919|Histamine Agents|histamine agents|mesh-ancestor
65216817|NCT00750919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65216818|NCT00750919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216819|NCT00750919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216820|NCT00750919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65216821|NCT00750919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65216822|NCT00750919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65216823|NCT00750919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65216824|NCT00750919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64859536|NCT01748344|Cetirizine|cetirizine|mesh-list
65216825|NCT00750919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65216826|NCT00750919|Adrenergic Agents|adrenergic agents|mesh-ancestor
65216827|NCT00750919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65216828|NCT00750919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65216829|NCT00750919|Serotonin Agents|serotonin agents|mesh-ancestor
65216830|NCT00750919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65216831|NCT02761161|Mianserin|mianserin|mesh-list
65216832|NCT02761161|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65216833|NCT02761161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65216834|NCT02761161|Adrenergic Agents|adrenergic agents|mesh-ancestor
65216835|NCT02761161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65216840|NCT02761161|Histamine Agents|histamine agents|mesh-ancestor
65216841|NCT02761161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65216842|NCT02761161|Serotonin Agents|serotonin agents|mesh-ancestor
65216843|NCT02761161|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65216844|NCT02761161|Antidepressive Agents|antidepressive agents|mesh-ancestor
65216845|NCT02761161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65216846|NCT02761395|Deferasirox|deferasirox|mesh-list
65216847|NCT02761395|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65216848|NCT02761395|Chelating Agents|chelating agents|mesh-ancestor
65216849|NCT02761395|Sequestering Agents|sequestering agents|mesh-ancestor
65216850|NCT02761395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216851|NCT02761317|Bisacodyl|bisacodyl|mesh-list
65216852|NCT02761317|Cathartics|cathartics|mesh-ancestor
65216853|NCT02761317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65216854|NCT02761317|Laxatives|laxatives|mesh-ancestor
65216855|NCT00746551|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65332865|NCT05428293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65216856|NCT00746551|Hematinics|hematinics|mesh-ancestor
65216857|NCT02696577|Aspirin|aspirin|mesh-list
65216858|NCT02696577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65216859|NCT02696577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65216860|NCT02696577|Analgesics|analgesics|mesh-ancestor
65216861|NCT02696577|Sensory System Agents|sensory system agents|mesh-ancestor
65216862|NCT02696577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65216863|NCT02696577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216864|NCT02696577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65216865|NCT02696577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65216866|NCT02696577|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65216867|NCT02696577|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65216868|NCT02696577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216869|NCT02696577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65216870|NCT02696577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65216871|NCT02696577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216872|NCT02696577|Antipyretics|antipyretics|mesh-ancestor
65216873|NCT00750061|Lithium Carbonate|lithium carbonate|mesh-list
65216874|NCT00750061|Antidepressive Agents|antidepressive agents|mesh-ancestor
65216875|NCT00750061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65216876|NCT00750061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216877|NCT00750061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216878|NCT00750061|Antimanic Agents|antimanic agents|mesh-ancestor
65216879|NCT00750061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65216880|NCT00750061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65216881|NCT00750061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216882|NCT04223739|Amiodarone|amiodarone|mesh-list
65216883|NCT04223739|Landiolol|landiolol|mesh-list
65216884|NCT04223739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65216885|NCT04223739|Vasodilator Agents|vasodilator agents|mesh-ancestor
65216886|NCT04223739|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65216887|NCT04223739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65216888|NCT04223739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216889|NCT04223739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65216890|NCT04223739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65216891|NCT04223739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65216892|NCT04223739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216893|NCT04223739|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65216894|NCT04223739|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65216895|NCT04223739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65216896|NCT04223739|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65216897|NCT04223739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65216898|NCT04223739|Adrenergic Agents|adrenergic agents|mesh-ancestor
65216899|NCT04223739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65216900|NCT04223739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216902|NCT02765373|Anastrozole|anastrozole|mesh-list
65216903|NCT02765373|Exemestane|exemestane|mesh-list
65216904|NCT02765373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216905|NCT02765373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65216906|NCT02765373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65216911|NCT02765373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65216912|NCT02765373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216913|NCT02765373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65216915|NCT02760615|Midazolam|midazolam|mesh-list
65216916|NCT02760615|Dextromethorphan|dextromethorphan|mesh-list
65216917|NCT02760615|Caffeine|caffeine|mesh-list
65216918|NCT02760615|Omeprazole|omeprazole|mesh-list
65216919|NCT02760615|Vedolizumab|vedolizumab|mesh-list
65216920|NCT02760615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65216921|NCT02760615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65216922|NCT02760615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65216923|NCT02760615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216924|NCT02760615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65216925|NCT02760615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65216926|NCT02760615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65216927|NCT02760615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65216928|NCT02760615|Anesthetics, General|anesthetics, general|mesh-ancestor
65216929|NCT02760615|Anesthetics|anesthetics|mesh-ancestor
65216930|NCT02760615|GABA Modulators|gaba modulators|mesh-ancestor
65216931|NCT02760615|GABA Agents|gaba agents|mesh-ancestor
65216932|NCT02760615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65332866|NCT05428293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65332867|NCT05428293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65332868|NCT05428293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65332869|NCT05428293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332870|NCT05428293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332871|NCT05427825|Anesthetics|anesthetics|mesh-list
65332872|NCT05427825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65332873|NCT05427825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332874|NCT00680121|Benphothiamine|benphothiamine|mesh-list
65332875|NCT00680121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65332876|NCT00680121|Immunologic Factors|immunologic factors|mesh-ancestor
65332877|NCT00680121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216933|NCT02760615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216934|NCT02760615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65216935|NCT02760615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65216936|NCT02760615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65216937|NCT02760615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65216938|NCT02760615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65216939|NCT02760615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65216940|NCT02760615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216941|NCT02760615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65216942|NCT02760615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65216943|NCT02760615|Purinergic Agents|purinergic agents|mesh-ancestor
65216944|NCT02760615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65216945|NCT02760615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65216946|NCT02760615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65216947|NCT02760615|Antitussive Agents|antitussive agents|mesh-ancestor
65216948|NCT02760615|Respiratory System Agents|respiratory system agents|mesh-ancestor
65216949|NCT02760615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65216950|NCT02760615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65216951|NCT02760459|Dexamethasone|dexamethasone|mesh-list
65216952|NCT02760459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65216953|NCT02760459|Antiemetics|antiemetics|mesh-ancestor
65216954|NCT02760459|Autonomic Agents|autonomic agents|mesh-ancestor
65216955|NCT02760459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65216956|NCT02760459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216957|NCT02760459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65216958|NCT02760459|Glucocorticoids|glucocorticoids|mesh-ancestor
65216959|NCT02760459|Hormones|hormones|mesh-ancestor
65216960|NCT02760459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65216961|NCT02760459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65216962|NCT02760459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216963|NCT02765217|Amoxicillin|amoxicillin|mesh-list
65216964|NCT02765217|Clavulanic Acids|clavulanic acids|mesh-list
65216965|NCT02765217|Clavulanic Acid|clavulanic acid|mesh-list
65216966|NCT02765217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65216967|NCT02765217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65216968|NCT02765217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65216969|NCT02765217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216970|NCT02765217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216971|NCT02765217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65216972|NCT02760381|Acetic Acid|acetic acid|mesh-list
65216973|NCT02760381|Retinol acetate|retinol acetate|mesh-list
65216974|NCT02760381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65216975|NCT02760381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65216976|NCT02760381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65216979|NCT02760381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65216980|NCT02760381|Protective Agents|protective agents|mesh-ancestor
65216981|NCT02760381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216982|NCT02760225|Pembrolizumab|pembrolizumab|mesh-list
65216983|NCT02760225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65332878|NCT00680121|Chelating Agents|chelating agents|mesh-ancestor
65332879|NCT00680121|Sequestering Agents|sequestering agents|mesh-ancestor
65332880|NCT00680121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332881|NCT00754689|Metformin|metformin|mesh-list
65332882|NCT00754689|Rimonabant|rimonabant|mesh-list
65332883|NCT00754689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65332884|NCT00754689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332885|NCT00754689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65216984|NCT02760225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216985|NCT00744757|Decitabine|decitabine|mesh-list
65216986|NCT00744757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65216987|NCT00744757|Antimetabolites|antimetabolites|mesh-ancestor
65216988|NCT00744757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216989|NCT00744757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216990|NCT00744757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216991|NCT00917527|Atorvastatin|atorvastatin|mesh-list
65216992|NCT00917527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65216993|NCT00917527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65216994|NCT00917527|Antimetabolites|antimetabolites|mesh-ancestor
65216995|NCT00917527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216996|NCT00917527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65216997|NCT00917527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65216998|NCT00917527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216999|NCT00745849|Esomeprazole|esomeprazole|mesh-list
65217000|NCT00745849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65217001|NCT00745849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65217002|NCT00745849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65217003|NCT00745849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217004|NCT00745849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217005|NCT02759991|Vaccines|vaccines|mesh-list
65217006|NCT02759991|Immunologic Factors|immunologic factors|mesh-ancestor
65217007|NCT02759991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217008|NCT04112277|Morphine|morphine|mesh-list
65217009|NCT04112277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65217010|NCT04112277|Narcotics|narcotics|mesh-ancestor
65217011|NCT04112277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65217012|NCT04112277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217013|NCT04112277|Analgesics|analgesics|mesh-ancestor
65217014|NCT04112277|Sensory System Agents|sensory system agents|mesh-ancestor
65217015|NCT04112277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65217016|NCT00749203|Midazolam|midazolam|mesh-list
65217017|NCT00749203|Ketamine|ketamine|mesh-list
65217018|NCT00749203|Analgesics|analgesics|mesh-ancestor
65217019|NCT00749203|Sensory System Agents|sensory system agents|mesh-ancestor
65217020|NCT00749203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65217021|NCT00749203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217022|NCT00749203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65217023|NCT00749203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65217024|NCT00749203|Anesthetics, General|anesthetics, general|mesh-ancestor
65217025|NCT00749203|Anesthetics|anesthetics|mesh-ancestor
65217026|NCT00749203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65217027|NCT00749203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65217028|NCT00749203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65217029|NCT00749203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65217030|NCT00749203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217031|NCT00749203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65217032|NCT00749203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65217033|NCT00749203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65217034|NCT00749203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65217035|NCT00749203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65217036|NCT00749203|GABA Modulators|gaba modulators|mesh-ancestor
65217037|NCT00749203|GABA Agents|gaba agents|mesh-ancestor
65217038|NCT02764515|Methotrexate|methotrexate|mesh-list
65217039|NCT02764515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65217040|NCT02764515|Abortifacient Agents|abortifacient agents|mesh-ancestor
65217041|NCT02764515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65217042|NCT02764515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217043|NCT02764515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65332886|NCT00754689|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65332887|NCT00754689|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65332888|NCT00754689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65332889|NCT00754689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217044|NCT02764515|Antimetabolites|antimetabolites|mesh-ancestor
65217045|NCT02764515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217046|NCT02764515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217047|NCT02764515|Dermatologic Agents|dermatologic agents|mesh-ancestor
65217048|NCT02764515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217049|NCT02764515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65217058|NCT02764749|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65217059|NCT02764749|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65217060|NCT02764359|Vancomycin|vancomycin|mesh-list
65217061|NCT02764359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65217062|NCT02764359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65217063|NCT02764125|Levodopa|levodopa|mesh-list
65217064|NCT02764125|Carbidopa|carbidopa|mesh-list
65217065|NCT02764125|Entacapone|entacapone|mesh-list
65217066|NCT02764125|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65217067|NCT02764125|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65217068|NCT02764125|Dopamine Agents|dopamine agents|mesh-ancestor
65217069|NCT02764125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65217070|NCT02764125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217071|NCT02764125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217072|NCT02764125|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65217073|NCT02764125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217074|NCT02764125|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65217075|NCT02764281|Dexamethasone|dexamethasone|mesh-list
65217076|NCT02764281|Methotrexate|methotrexate|mesh-list
65217077|NCT02764281|Etoposide|etoposide|mesh-list
65217078|NCT02764281|Pegaspargase|pegaspargase|mesh-list
65217079|NCT02764281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65217080|NCT02764281|Antiemetics|antiemetics|mesh-ancestor
65217081|NCT02764281|Autonomic Agents|autonomic agents|mesh-ancestor
65217082|NCT02764281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65217083|NCT02764281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217084|NCT02764281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65217085|NCT02764281|Glucocorticoids|glucocorticoids|mesh-ancestor
65217086|NCT02764281|Hormones|hormones|mesh-ancestor
65217087|NCT02764281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65217088|NCT02764281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65217089|NCT02764281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217090|NCT02764281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217091|NCT02764281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217092|NCT02764281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65217093|NCT02764281|Abortifacient Agents|abortifacient agents|mesh-ancestor
65217094|NCT02764281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65217095|NCT02764281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65217096|NCT02764281|Antimetabolites|antimetabolites|mesh-ancestor
65217097|NCT02764281|Dermatologic Agents|dermatologic agents|mesh-ancestor
65217098|NCT02764281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65217099|NCT02764281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65217100|NCT02764281|Immunologic Factors|immunologic factors|mesh-ancestor
65217101|NCT02764281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65217102|NCT02764281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65217103|NCT02764281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65217104|NCT02764281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65217105|NCT02764281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65217106|NCT02763969|Interferons|interferons|mesh-list
65217107|NCT02763969|Interferon-alpha|interferon-alpha|mesh-list
65217108|NCT02763969|Interferon alpha-2|interferon alpha-2|mesh-list
65217109|NCT02763969|Ustekinumab|ustekinumab|mesh-list
65217110|NCT02763969|Famotidine|famotidine|mesh-list
65217111|NCT02763969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217112|NCT02763969|Antiviral Agents|antiviral agents|mesh-ancestor
65217113|NCT02763969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65217114|NCT02763969|Immunologic Factors|immunologic factors|mesh-ancestor
65217115|NCT02763969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217116|NCT02763969|Dermatologic Agents|dermatologic agents|mesh-ancestor
65217117|NCT02763969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65217118|NCT02763969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65332890|NCT00754689|Hormones|hormones|mesh-ancestor
65332891|NCT00754689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65332892|NCT00767819|Everolimus|everolimus|mesh-list
65082785|NCT00427271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65332893|NCT00767819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332894|NCT00767819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65332895|NCT00767819|Immunologic Factors|immunologic factors|mesh-ancestor
65332896|NCT00767819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332898|NCT00758277|Anticonvulsants|anticonvulsants|mesh-ancestor
65332899|NCT00758277|Nootropic Agents|nootropic agents|mesh-ancestor
65332900|NCT00584870|Naproxen|naproxen|mesh-list
65332901|NCT00584870|Tanezumab|tanezumab|mesh-list
65332902|NCT00584870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65332903|NCT00584870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65332904|NCT00584870|Analgesics|analgesics|mesh-ancestor
65332905|NCT00584870|Sensory System Agents|sensory system agents|mesh-ancestor
65332906|NCT00584870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332907|NCT00584870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332908|NCT00584870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65332909|NCT00584870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65332910|NCT00584870|Gout Suppressants|gout suppressants|mesh-ancestor
65332911|NCT00584870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65332912|NCT00584870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65332913|NCT00584870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332914|NCT00679341|Docetaxel|docetaxel|mesh-list
65332915|NCT00679341|Trastuzumab|trastuzumab|mesh-list
65332916|NCT00679341|Maytansine|maytansine|mesh-list
65332917|NCT00679341|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65332918|NCT00679341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332919|NCT00679341|Tubulin Modulators|tubulin modulators|mesh-ancestor
65217127|NCT02758587|Pembrolizumab|pembrolizumab|mesh-list
65217128|NCT02758587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65217129|NCT02758587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217130|NCT02758509|Interferons|interferons|mesh-list
65217131|NCT02758509|Ritonavir|ritonavir|mesh-list
65217132|NCT02758509|Ribavirin|ribavirin|mesh-list
65217133|NCT02758509|Interferon-alpha|interferon-alpha|mesh-list
65217134|NCT02758509|Interferon alpha-2|interferon alpha-2|mesh-list
65217135|NCT02758509|Sofosbuvir|sofosbuvir|mesh-list
65217136|NCT02758509|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65217137|NCT02758509|Ledipasvir|ledipasvir|mesh-list
65217138|NCT02758509|Simeprevir|simeprevir|mesh-list
65217139|NCT02758509|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
65217140|NCT02758509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217141|NCT02758509|Antiviral Agents|antiviral agents|mesh-ancestor
65217142|NCT02758509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65217143|NCT02758509|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65217144|NCT02758509|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65332920|NCT00679341|Antimitotic Agents|antimitotic agents|mesh-ancestor
65332921|NCT00679341|Mitosis Modulators|mitosis modulators|mesh-ancestor
65332922|NCT00679341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332923|NCT00679341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65332924|NCT00679341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65217145|NCT02758509|Protease Inhibitors|protease inhibitors|mesh-ancestor
65217146|NCT02758509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217147|NCT02758509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217148|NCT02758509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65217149|NCT02758509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65217150|NCT02758509|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65217151|NCT02758509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65217152|NCT02758509|Antimetabolites|antimetabolites|mesh-ancestor
65217153|NCT02758509|Immunologic Factors|immunologic factors|mesh-ancestor
65217154|NCT02758509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217155|NCT02762955|Adalimumab|adalimumab|mesh-list
65217156|NCT02762955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65217157|NCT02762955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65217158|NCT04191681|Valsartan|valsartan|mesh-list
65217159|NCT04191681|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65217160|NCT04191681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65217161|NCT04191681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65217162|NCT04191681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65217163|NCT04191681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217164|NCT02757651|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65217165|NCT02757651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65217166|NCT02757651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65217167|NCT02752503|Nalmefene|nalmefene|mesh-list
65217168|NCT02752503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65217169|NCT02752503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217170|NCT02752503|Sensory System Agents|sensory system agents|mesh-ancestor
65217171|NCT02752503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65217172|NCT04479579|Apixaban|apixaban|mesh-list
65217173|NCT04479579|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65217174|NCT04479579|Antithrombins|antithrombins|mesh-ancestor
65217175|NCT04479579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65217176|NCT04479579|Protease Inhibitors|protease inhibitors|mesh-ancestor
65217177|NCT04479579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217178|NCT04479579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217179|NCT04479579|Anticoagulants|anticoagulants|mesh-ancestor
65217180|NCT02757495|Dexmedetomidine|dexmedetomidine|mesh-list
65217181|NCT02757495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65217182|NCT02757495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65217183|NCT02757495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217184|NCT02757495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65217185|NCT02757495|Analgesics|analgesics|mesh-ancestor
65217188|NCT02757495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65217189|NCT02757495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65217190|NCT02757495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65217191|NCT02757495|Adrenergic Agents|adrenergic agents|mesh-ancestor
65217192|NCT02757495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65217193|NCT02757495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217194|NCT02757261|Salicylic Acid|salicylic acid|mesh-list
65217195|NCT02757261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65217196|NCT02757261|Antifungal Agents|antifungal agents|mesh-ancestor
65217197|NCT02757261|Keratolytic Agents|keratolytic agents|mesh-ancestor
65217198|NCT02757261|Dermatologic Agents|dermatologic agents|mesh-ancestor
65217199|NCT02752113|Metformin|metformin|mesh-list
65217200|NCT02752113|Empagliflozin|empagliflozin|mesh-list
65217201|NCT02752113|Linagliptin|linagliptin|mesh-list
65217202|NCT02752113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65217203|NCT02752113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217204|NCT02752113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65217205|NCT02752113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217206|NCT02752113|Incretins|incretins|mesh-ancestor
65217208|NCT02752113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65332925|NCT00680043|Epoetin Alfa|epoetin alfa|mesh-list
65332926|NCT00680043|Hematinics|hematinics|mesh-ancestor
65332927|NCT05436093|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65332928|NCT05436093|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65332929|NCT05436093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718832|NCT01570634|Antidiarrheals|antidiarrheals|mesh-list
65217209|NCT02752113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65217210|NCT02752113|Protease Inhibitors|protease inhibitors|mesh-ancestor
65217211|NCT02752113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217212|NCT02756715|Propofol|propofol|mesh-list
65217213|NCT02756715|Desflurane|desflurane|mesh-list
65217214|NCT02756715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65217215|NCT02756715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65217216|NCT02756715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217217|NCT02756715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65217218|NCT02756715|Anesthetics, General|anesthetics, general|mesh-ancestor
65217219|NCT02756715|Anesthetics|anesthetics|mesh-ancestor
65217220|NCT02756715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65217221|NCT04221321|Atorvastatin|atorvastatin|mesh-list
65217222|NCT04221321|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65217223|NCT04221321|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65217224|NCT04221321|Antimetabolites|antimetabolites|mesh-ancestor
65217225|NCT04221321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217226|NCT04221321|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65217227|NCT04221321|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65217228|NCT04221321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217229|NCT04220931|Botulinum Toxins|botulinum toxins|mesh-list
65217230|NCT04220931|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65217231|NCT04220931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65217232|NCT04220931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217233|NCT04220931|Cholinergic Agents|cholinergic agents|mesh-ancestor
65217234|NCT04220931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65217235|NCT04220931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217236|NCT02755857|Itraconazole|itraconazole|mesh-list
65217237|NCT02755857|Antifungal Agents|antifungal agents|mesh-ancestor
65217238|NCT02755857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65217239|NCT02755857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65217240|NCT02755857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65217241|NCT02755857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217242|NCT02755857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217243|NCT02755857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65217244|NCT02755857|Hormone Antagonists|hormone antagonists|mesh-ancestor
65217245|NCT02755857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65217246|NCT02755857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217247|NCT02755857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65217248|NCT02755545|Salicylic Acid|salicylic acid|mesh-list
65217249|NCT02755545|Adapalene|adapalene|mesh-list
65217250|NCT02755545|Salicylates|salicylates|mesh-list
65217251|NCT02755545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65217252|NCT02755545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65217253|NCT02755545|Analgesics|analgesics|mesh-ancestor
65217254|NCT02755545|Sensory System Agents|sensory system agents|mesh-ancestor
65217255|NCT02755545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65217256|NCT02755545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217257|NCT02755545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65217260|NCT02755545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65217261|NCT02755545|Antifungal Agents|antifungal agents|mesh-ancestor
65217262|NCT02755545|Keratolytic Agents|keratolytic agents|mesh-ancestor
65217263|NCT02755545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65217264|NCT02755545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217265|NCT02755545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217267|NCT02695797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65217268|NCT02695797|Glucocorticoids|glucocorticoids|mesh-ancestor
65217269|NCT02695797|Hormones|hormones|mesh-ancestor
65217270|NCT02695797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65217271|NCT02695797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217272|NCT02695797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65332930|NCT05058092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65332931|NCT00682539|Triamcinolone|triamcinolone|mesh-list
65332932|NCT00682539|Bevacizumab|bevacizumab|mesh-list
65332933|NCT00682539|Ranibizumab|ranibizumab|mesh-list
65332934|NCT00682539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65332935|NCT00682539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217273|NCT02695797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217274|NCT02755311|Cisplatin|cisplatin|mesh-list
65217275|NCT02755311|Carboplatin|carboplatin|mesh-list
65217276|NCT02755311|Fluorouracil|fluorouracil|mesh-list
65217277|NCT02755311|Epirubicin|epirubicin|mesh-list
65217278|NCT02755311|Ethiodized Oil|ethiodized oil|mesh-list
65217279|NCT02755311|Pirarubicin|pirarubicin|mesh-list
65217280|NCT02755311|Doxorubicin|doxorubicin|mesh-list
65217281|NCT02755311|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
65217282|NCT02755311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217283|NCT02755311|Antimetabolites|antimetabolites|mesh-ancestor
65217284|NCT02755311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217285|NCT02755311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65217286|NCT02755311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65217287|NCT02755311|Immunologic Factors|immunologic factors|mesh-ancestor
65217288|NCT02755311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217289|NCT02755311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65217290|NCT02755311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65217291|NCT02755311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65217292|NCT02755311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217293|NCT02755311|Hemostatics|hemostatics|mesh-ancestor
65217294|NCT02755311|Coagulants|coagulants|mesh-ancestor
65217296|NCT04554771|Carboplatin|carboplatin|mesh-list
65217297|NCT04554771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65217298|NCT04554771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217299|NCT04554771|Tubulin Modulators|tubulin modulators|mesh-ancestor
65217300|NCT04554771|Antimitotic Agents|antimitotic agents|mesh-ancestor
65217301|NCT04554771|Mitosis Modulators|mitosis modulators|mesh-ancestor
65217302|NCT04554771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217303|NCT02754765|Moxifloxacin|moxifloxacin|mesh-list
65217304|NCT02754765|Levofloxacin|levofloxacin|mesh-list
65217305|NCT02754765|Ofloxacin|ofloxacin|mesh-list
65217306|NCT02754765|Linezolid|linezolid|mesh-list
65217307|NCT02754765|Pyrazinamide|pyrazinamide|mesh-list
65217308|NCT02754765|Bedaquiline|bedaquiline|mesh-list
65217309|NCT02754765|Clofazimine|clofazimine|mesh-list
65217310|NCT02754765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65217311|NCT02754765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65217312|NCT02754765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65217313|NCT02754765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65217314|NCT02754765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217315|NCT02754765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217316|NCT02754765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217317|NCT02754765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65217318|NCT02754765|Renal Agents|renal agents|mesh-ancestor
65217319|NCT02754765|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65217320|NCT02754765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65217321|NCT02754765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65217322|NCT02754765|Antitubercular Agents|antitubercular agents|mesh-ancestor
65217323|NCT02754765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65217324|NCT02754765|Leprostatic Agents|leprostatic agents|mesh-ancestor
65217325|NCT04358289|Anti-Infective Agents|anti-infective agents|mesh-list
65217326|NCT04358289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65217327|NCT04090801|Ethanol|ethanol|mesh-list
65217328|NCT04090801|Minoxidil|minoxidil|mesh-list
65217329|NCT04090801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65217330|NCT04090801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65217331|NCT04090801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65217332|NCT04090801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217333|NCT04090801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65217338|NCT04089631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217339|NCT04089631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217340|NCT00917059|Citalopram|citalopram|mesh-list
65217341|NCT00917059|Bupropion|bupropion|mesh-list
65217342|NCT00917059|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65217343|NCT00917059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65332936|NCT00682539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65332937|NCT00682539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65332938|NCT00682539|Growth Substances|growth substances|mesh-ancestor
65332939|NCT00682539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332940|NCT00682539|Growth Inhibitors|growth inhibitors|mesh-ancestor
65332941|NCT00682539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65217344|NCT00917059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65217345|NCT00917059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217346|NCT00917059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65217347|NCT00917059|Serotonin Agents|serotonin agents|mesh-ancestor
65217348|NCT00917059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217349|NCT00917059|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65217350|NCT00917059|Antidepressive Agents|antidepressive agents|mesh-ancestor
65217351|NCT00917059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65217352|NCT00917059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65217353|NCT00917059|Dopamine Agents|dopamine agents|mesh-ancestor
65217354|NCT00917059|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65217355|NCT00917059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65217356|NCT00917059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217357|NCT02754687|Nandrolone Decanoate|nandrolone decanoate|mesh-list
65217358|NCT02754687|Nandrolone|nandrolone|mesh-list
65217359|NCT02754687|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
65217360|NCT02754687|Androgens|androgens|mesh-ancestor
65217361|NCT02754687|Hormones|hormones|mesh-ancestor
65217362|NCT02754687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65217363|NCT02754687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217364|NCT02754687|Anabolic Agents|anabolic agents|mesh-ancestor
65217365|NCT02754687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65217366|NCT02754297|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65217367|NCT02754297|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65217368|NCT02754297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217369|NCT05429775|Budesonide|budesonide|mesh-list
65217370|NCT05429775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65217371|NCT05429775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65217372|NCT05429775|Autonomic Agents|autonomic agents|mesh-ancestor
65217373|NCT05429775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65217374|NCT05429775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217375|NCT05429775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65217376|NCT05429775|Respiratory System Agents|respiratory system agents|mesh-ancestor
65217377|NCT05429775|Glucocorticoids|glucocorticoids|mesh-ancestor
65217378|NCT05429775|Hormones|hormones|mesh-ancestor
65217379|NCT05429775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65217380|NCT04220073|Antibodies|antibodies|mesh-list
65217381|NCT04220073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65217382|NCT04220073|Immunologic Factors|immunologic factors|mesh-ancestor
65217383|NCT04220073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217384|NCT05429151|Acyclovir|acyclovir|mesh-list
65217385|NCT05429151|Antiviral Agents|antiviral agents|mesh-ancestor
65217386|NCT05429151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65217387|NCT04219995|Methylprednisolone|methylprednisolone|mesh-list
65217388|NCT04219995|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65217389|NCT04219995|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65217390|NCT04219995|Prednisolone|prednisolone|mesh-list
65217391|NCT04219995|Prednisolone acetate|prednisolone acetate|mesh-list
65217392|NCT04219995|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65217393|NCT04219995|Prednisolone phosphate|prednisolone phosphate|mesh-list
65217394|NCT04219995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65217395|NCT04219995|Antiemetics|antiemetics|mesh-ancestor
65217396|NCT04219995|Autonomic Agents|autonomic agents|mesh-ancestor
65217397|NCT04219995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65217398|NCT04219995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217399|NCT04219995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65217400|NCT04219995|Glucocorticoids|glucocorticoids|mesh-ancestor
65217401|NCT04219995|Hormones|hormones|mesh-ancestor
65217402|NCT04219995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65217403|NCT04219995|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65217404|NCT04219995|Protective Agents|protective agents|mesh-ancestor
65217408|NCT04544475|Estradiol|estradiol|mesh-list
65217409|NCT04544475|Hormones|hormones|mesh-ancestor
65332942|NCT00682539|Glucocorticoids|glucocorticoids|mesh-ancestor
65332943|NCT00682539|Hormones|hormones|mesh-ancestor
65332944|NCT00682539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65332945|NCT00682461|Nicotine|nicotine|mesh-list
65332946|NCT00682461|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65332947|NCT00682461|Autonomic Agents|autonomic agents|mesh-ancestor
65332948|NCT00682461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332949|NCT00682461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332950|NCT00682461|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64705964|NCT02207088|Ritonavir|ritonavir|mesh-list
65217410|NCT04544475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65217411|NCT04544475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217412|NCT04200417|Mitomycins|mitomycins|mesh-list
65217413|NCT04200417|Mitomycin|mitomycin|mesh-list
65217414|NCT04200417|Ethiodized Oil|ethiodized oil|mesh-list
65217415|NCT04200417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65217416|NCT04200417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217417|NCT04200417|Alkylating Agents|alkylating agents|mesh-ancestor
65217418|NCT04200417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217419|NCT04200417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65217420|NCT04200417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217421|NCT02753205|Dexmedetomidine|dexmedetomidine|mesh-list
65217422|NCT02753205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65217423|NCT02753205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65217424|NCT02753205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217425|NCT02753205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65217426|NCT02753205|Analgesics|analgesics|mesh-ancestor
65217427|NCT02753205|Sensory System Agents|sensory system agents|mesh-ancestor
65217428|NCT02753205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65217429|NCT02753205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65217430|NCT02753205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65217431|NCT02753205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65217432|NCT02753205|Adrenergic Agents|adrenergic agents|mesh-ancestor
65217433|NCT02753205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65217434|NCT02753205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217435|NCT02752971|Diclofenac|diclofenac|mesh-list
65217436|NCT02752971|Bupivacaine|bupivacaine|mesh-list
65217437|NCT02752971|Anesthetics, Local|anesthetics, local|mesh-ancestor
65217438|NCT02752971|Anesthetics|anesthetics|mesh-ancestor
65217439|NCT02752971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65217440|NCT02752971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217441|NCT02752971|Sensory System Agents|sensory system agents|mesh-ancestor
65217442|NCT02752971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65217443|NCT02752971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65217444|NCT02752971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65217445|NCT02752971|Analgesics|analgesics|mesh-ancestor
65217446|NCT02752971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65217447|NCT02752971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65217448|NCT02752971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65217449|NCT02752971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217450|NCT02752971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217451|NCT04188873|Varenicline|varenicline|mesh-list
65217452|NCT04188873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65217453|NCT04188873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217454|NCT04188873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217455|NCT04188873|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65217456|NCT04188873|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65217457|NCT04188873|Cholinergic Agents|cholinergic agents|mesh-ancestor
65217458|NCT05289687|Daratumumab|daratumumab|mesh-list
65217459|NCT05289687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65217460|NCT05289687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217461|NCT05289687|Immunologic Factors|immunologic factors|mesh-ancestor
65217462|NCT05289687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217463|NCT02695641|Bevacizumab|bevacizumab|mesh-list
65332951|NCT00682461|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65332952|NCT00682461|Cholinergic Agents|cholinergic agents|mesh-ancestor
65332953|NCT00682461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64326992|NCT04265534|Pembrolizumab|pembrolizumab|mesh-list
65217464|NCT02695641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65217465|NCT02695641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217466|NCT02695641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65217467|NCT02695641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65217468|NCT02695641|Growth Substances|growth substances|mesh-ancestor
65217469|NCT02695641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217470|NCT02695641|Growth Inhibitors|growth inhibitors|mesh-ancestor
65217471|NCT02750475|Sunscreening Agents|sunscreening agents|mesh-list
65217472|NCT02750475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65217473|NCT02750475|Protective Agents|protective agents|mesh-ancestor
65217474|NCT02750475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217475|NCT02750475|Dermatologic Agents|dermatologic agents|mesh-ancestor
65217476|NCT04217265|Letrozole|letrozole|mesh-list
65217481|NCT04217265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217482|NCT04217265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217483|NCT04217265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65217484|NCT04217265|Hormone Antagonists|hormone antagonists|mesh-ancestor
65217485|NCT04217265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65217486|NCT04217265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217487|NCT04217265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65217488|NCT04217265|Abortifacient Agents|abortifacient agents|mesh-ancestor
65217489|NCT04217265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65217490|NCT04217265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65217491|NCT04217265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65217492|NCT04217265|Oxytocics|oxytocics|mesh-ancestor
65217494|NCT00635973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217495|NCT00635973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65217496|NCT00635973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217497|NCT00635973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217498|NCT02750163|Acetaminophen|acetaminophen|mesh-list
65217499|NCT02750163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65217500|NCT02750163|Analgesics|analgesics|mesh-ancestor
65217501|NCT02750163|Sensory System Agents|sensory system agents|mesh-ancestor
65217502|NCT02750163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65217503|NCT02750163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217504|NCT02750163|Antipyretics|antipyretics|mesh-ancestor
65217505|NCT04217421|Allopurinol|allopurinol|mesh-list
65217506|NCT04217421|Mannitol|mannitol|mesh-list
65217508|NCT04217421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217509|NCT04217421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217510|NCT04217421|Gout Suppressants|gout suppressants|mesh-ancestor
65217511|NCT04217421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65217512|NCT04217421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65217513|NCT04217421|Antioxidants|antioxidants|mesh-ancestor
65217514|NCT04217421|Protective Agents|protective agents|mesh-ancestor
65217515|NCT04217421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217516|NCT04217421|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65217517|NCT04217421|Diuretics|diuretics|mesh-ancestor
65217518|NCT04217421|Natriuretic Agents|natriuretic agents|mesh-ancestor
65217519|NCT04036929|Bazedoxifene|bazedoxifene|mesh-list
65217520|NCT04036929|Estrogens|estrogens|mesh-list
65217521|NCT04036929|Hormones|hormones|mesh-ancestor
65217522|NCT04036929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65217523|NCT04036929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217524|NCT04036929|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65217525|NCT04036929|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65217526|NCT04036929|Hormone Antagonists|hormone antagonists|mesh-ancestor
65217527|NCT04036929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65217528|NCT04281147|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65217529|NCT04281147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217530|NCT04218981|Antipsychotic Agents|antipsychotic agents|mesh-list
65217531|NCT04218981|Paroxetine|paroxetine|mesh-list
65217532|NCT04218981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65217533|NCT04218981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65217534|NCT04218981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65217535|NCT04218981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217536|NCT04218981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65332954|NCT00682461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332955|NCT00921765|Ketamine|ketamine|mesh-list
65332956|NCT00921765|Naloxone|naloxone|mesh-list
65332957|NCT00921765|Analgesics|analgesics|mesh-ancestor
65332958|NCT00921765|Sensory System Agents|sensory system agents|mesh-ancestor
65332959|NCT00921765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65332960|NCT00921765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332961|NCT00921765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65332962|NCT00921765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65332963|NCT00921765|Anesthetics, General|anesthetics, general|mesh-ancestor
65332964|NCT00921765|Anesthetics|anesthetics|mesh-ancestor
65332965|NCT00921765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65217537|NCT04218981|Serotonin Agents|serotonin agents|mesh-ancestor
65217538|NCT04218981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217539|NCT04218981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65217540|NCT04218981|Antidepressive Agents|antidepressive agents|mesh-ancestor
65217541|NCT04218981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65217542|NCT04218981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65217543|NCT04218981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65217544|NCT04218981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217545|NCT04218981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65217546|NCT04218981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65217547|NCT04218513|Edaravone|edaravone|mesh-list
65217550|NCT04218513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217551|NCT04218513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65217552|NCT04218513|Protective Agents|protective agents|mesh-ancestor
65217553|NCT04218513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217554|NCT04218435|Valsartan|valsartan|mesh-list
65217555|NCT04218435|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65217556|NCT04218435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65217557|NCT04218435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65217558|NCT04218435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65217559|NCT04218435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217560|NCT04138875|Rituximab|rituximab|mesh-list
65217561|NCT04138875|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65217562|NCT04138875|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65217563|NCT04138875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65217564|NCT04138875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217565|NCT04138875|Immunologic Factors|immunologic factors|mesh-ancestor
65217566|NCT04138875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217567|NCT04138875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65217568|NCT04138875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65217569|NCT04138875|Alkylating Agents|alkylating agents|mesh-ancestor
65217570|NCT04138875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217571|NCT02748135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65217572|NCT02748135|Immunologic Factors|immunologic factors|mesh-ancestor
65217573|NCT02748135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217574|NCT02695563|Lactoferrin|lactoferrin|mesh-list
64860287|NCT01753037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65217575|NCT02695563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65217576|NCT02747823|Bevacizumab|bevacizumab|mesh-list
65217577|NCT02747823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65217578|NCT02747823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217579|NCT02747823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65217580|NCT02747823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65217581|NCT02747823|Growth Substances|growth substances|mesh-ancestor
65217582|NCT02747823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217583|NCT02747823|Growth Inhibitors|growth inhibitors|mesh-ancestor
65217584|NCT02747511|Haloperidol|haloperidol|mesh-list
65217585|NCT02747511|Haloperidol decanoate|haloperidol decanoate|mesh-list
65217586|NCT02747511|Antiemetics|antiemetics|mesh-ancestor
65332966|NCT00921765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65082859|NCT00427466|Pemetrexed|pemetrexed|mesh-list
65332967|NCT00921765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65332968|NCT00921765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65332969|NCT00921765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217587|NCT02747511|Autonomic Agents|autonomic agents|mesh-ancestor
65217588|NCT02747511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65217589|NCT02747511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217590|NCT02747511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65217591|NCT02747511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65217592|NCT02747511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65217593|NCT02747511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65217594|NCT02747511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65217595|NCT02747511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65217596|NCT02747511|Dopamine Agents|dopamine agents|mesh-ancestor
65217597|NCT02747511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65217598|NCT02747511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217599|NCT02747511|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65217600|NCT04217733|Ethosuximide|ethosuximide|mesh-list
65217601|NCT04217733|Mebeverine|mebeverine|mesh-list
65217602|NCT04217733|Alverine|alverine|mesh-list
65217603|NCT04217733|Anticonvulsants|anticonvulsants|mesh-ancestor
65217604|NCT04217733|Parasympatholytics|parasympatholytics|mesh-ancestor
65217605|NCT04217733|Autonomic Agents|autonomic agents|mesh-ancestor
65217606|NCT04217733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65217607|NCT04217733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217608|NCT03154359|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65217609|NCT03154359|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65217610|NCT03154359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65217611|NCT03154359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65217612|NCT03154359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217613|NCT03154359|Adrenergic Agents|adrenergic agents|mesh-ancestor
65217614|NCT03154359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65217615|NCT03154359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217616|NCT00636285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65217617|NCT00636285|Immunologic Factors|immunologic factors|mesh-ancestor
65217618|NCT00636285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217625|NCT02746185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65217626|NCT02746185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65217627|NCT02746185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217628|NCT02746185|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65217629|NCT02746185|Antithrombins|antithrombins|mesh-ancestor
65217630|NCT02746185|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65217631|NCT02746185|Protease Inhibitors|protease inhibitors|mesh-ancestor
65217632|NCT02746185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217633|NCT02742051|Cyclophosphamide|cyclophosphamide|mesh-list
65217634|NCT02742051|Fluorouracil|fluorouracil|mesh-list
65217635|NCT02742051|Everolimus|everolimus|mesh-list
65217636|NCT02742051|Letrozole|letrozole|mesh-list
65217637|NCT02742051|Epirubicin|epirubicin|mesh-list
65217638|NCT02742051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65217639|NCT02742051|Immunologic Factors|immunologic factors|mesh-ancestor
65217640|NCT02742051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217641|NCT02742051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65217642|NCT02742051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65217643|NCT02742051|Alkylating Agents|alkylating agents|mesh-ancestor
65217644|NCT02742051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217645|NCT02742051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217646|NCT02742051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65217647|NCT02742051|Antimetabolites|antimetabolites|mesh-ancestor
65217648|NCT02742051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65217649|NCT02742051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65217650|NCT02742051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65217651|NCT02742051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217652|NCT02742051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65217653|NCT02742051|Hormone Antagonists|hormone antagonists|mesh-ancestor
64401040|NCT02034331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217654|NCT02742051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65332970|NCT00921765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65332971|NCT05435781|Hydrocortisone|hydrocortisone|mesh-list
65332972|NCT05435781|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65332973|NCT05435781|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65332974|NCT05435781|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65217655|NCT02742051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65217656|NCT02742051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65217657|NCT02742051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65217658|NCT03879135|Factor VIII|factor viii|mesh-list
65217659|NCT03879135|Coagulants|coagulants|mesh-ancestor
65217660|NCT02741817|Aspirin|aspirin|mesh-list
65217661|NCT02741817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65217662|NCT02741817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65217663|NCT02741817|Analgesics|analgesics|mesh-ancestor
65217664|NCT02741817|Sensory System Agents|sensory system agents|mesh-ancestor
65217665|NCT02741817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65217666|NCT02741817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217667|NCT02741817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65217668|NCT02741817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65217669|NCT02741817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65217670|NCT02741817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65217671|NCT02741817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217672|NCT02741817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65217673|NCT02741817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65217674|NCT02741817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217675|NCT02741817|Antipyretics|antipyretics|mesh-ancestor
65217676|NCT02745873|Ascorbic Acid|ascorbic acid|mesh-list
65217677|NCT02745873|Vitamins|vitamins|mesh-ancestor
65217678|NCT02745873|Micronutrients|micronutrients|mesh-ancestor
65217679|NCT02745873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217680|NCT02745873|Antioxidants|antioxidants|mesh-ancestor
65217681|NCT02745873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217682|NCT02745873|Protective Agents|protective agents|mesh-ancestor
65217683|NCT02745639|Capecitabine|capecitabine|mesh-list
65217684|NCT02745639|Oxaliplatin|oxaliplatin|mesh-list
65217685|NCT02745639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65217686|NCT02745639|Antimetabolites|antimetabolites|mesh-ancestor
65217687|NCT02745639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217688|NCT02745639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217689|NCT02745717|Cyclosporine|cyclosporine|mesh-list
65217692|NCT02745717|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65217693|NCT02745717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217694|NCT02745717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217695|NCT02745717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65217696|NCT02745717|Immunologic Factors|immunologic factors|mesh-ancestor
65217697|NCT02745717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217698|NCT02745717|Antifungal Agents|antifungal agents|mesh-ancestor
65217699|NCT02745717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65217700|NCT02745717|Dermatologic Agents|dermatologic agents|mesh-ancestor
65217701|NCT02745717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65217702|NCT02745717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65217703|NCT02745561|Oxaliplatin|oxaliplatin|mesh-list
65217704|NCT02745561|Endostatins|endostatins|mesh-list
65217705|NCT02745561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217706|NCT02745561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65217707|NCT02745561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65217708|NCT02745561|Growth Substances|growth substances|mesh-ancestor
65217709|NCT02745561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217710|NCT02745561|Growth Inhibitors|growth inhibitors|mesh-ancestor
65217711|NCT02741427|Carbamide Peroxide|carbamide peroxide|mesh-list
65217712|NCT02741427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65217713|NCT02741427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65217714|NCT02745093|Misoprostol|misoprostol|mesh-list
65217715|NCT02745093|Mifepristone|mifepristone|mesh-list
65217716|NCT02745093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65217717|NCT02745093|Abortifacient Agents|abortifacient agents|mesh-ancestor
65217718|NCT02745093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65217719|NCT02745093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217720|NCT02745093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65217721|NCT02745093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65217722|NCT02745093|Oxytocics|oxytocics|mesh-ancestor
65332975|NCT05435781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65332976|NCT00755157|Bevacizumab|bevacizumab|mesh-list
65332977|NCT00755157|Docetaxel|docetaxel|mesh-list
65332978|NCT00755157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65332979|NCT00755157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332980|NCT00755157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65217723|NCT02745093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65217724|NCT02745093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65217725|NCT02745093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65217726|NCT02745093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65217727|NCT02745093|Contraceptive Agents|contraceptive agents|mesh-ancestor
65217728|NCT02745093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65217729|NCT02745093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65217731|NCT02745093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65217732|NCT02745093|Luteolytic Agents|luteolytic agents|mesh-ancestor
65217733|NCT02745093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65217734|NCT02745093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65217735|NCT00839254|Vaccines|vaccines|mesh-list
65217736|NCT00839254|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65217737|NCT00839254|Immunologic Factors|immunologic factors|mesh-ancestor
65217738|NCT00839254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217739|NCT02741115|Udenafil|udenafil|mesh-list
65217740|NCT02741115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65217741|NCT02741115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65217742|NCT02741115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217743|NCT02741115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217744|NCT02740803|Listerine|listerine|mesh-list
65217745|NCT02740803|Fluorides|fluorides|mesh-list
65217746|NCT02740803|Sodium Fluoride|sodium fluoride|mesh-list
65217747|NCT02740803|Tin Fluorides|tin fluorides|mesh-list
65217748|NCT02740803|Fluorophosphate|fluorophosphate|mesh-list
65217749|NCT02740803|Cariostatic Agents|cariostatic agents|mesh-ancestor
65217750|NCT02740803|Protective Agents|protective agents|mesh-ancestor
65217751|NCT02740803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217752|NCT02740803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65217753|NCT02740803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65217754|NCT02740647|Amoxicillin|amoxicillin|mesh-list
65217755|NCT02740647|Clavulanic Acid|clavulanic acid|mesh-list
65217756|NCT02740647|Clavulanic Acids|clavulanic acids|mesh-list
65217757|NCT02740647|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65217758|NCT02740647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65217759|NCT02740647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65217760|NCT02740647|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65217761|NCT02740647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217762|NCT02740647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217763|NCT03737253|Menotropins|menotropins|mesh-list
65217764|NCT03737253|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65217768|NCT03737253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65217769|NCT03737253|Fertility Agents|fertility agents|mesh-ancestor
65217770|NCT03737253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65217771|NCT00812968|Lenalidomide|lenalidomide|mesh-list
65217772|NCT00812968|Immunologic Factors|immunologic factors|mesh-ancestor
65217773|NCT00812968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217774|NCT00812968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65217775|NCT00812968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65217776|NCT00812968|Growth Substances|growth substances|mesh-ancestor
65217777|NCT00812968|Growth Inhibitors|growth inhibitors|mesh-ancestor
65217778|NCT00812968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217779|NCT02744703|Capecitabine|capecitabine|mesh-list
65217780|NCT02744703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65217781|NCT02744703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65217782|NCT02744703|Antimetabolites|antimetabolites|mesh-ancestor
65217783|NCT02744703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217784|NCT02744703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217785|NCT02744937|Aspirin|aspirin|mesh-list
65217786|NCT02744937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65217787|NCT02744937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65217788|NCT02744937|Analgesics|analgesics|mesh-ancestor
65217789|NCT02744937|Sensory System Agents|sensory system agents|mesh-ancestor
65332981|NCT00755157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65332982|NCT00755157|Growth Substances|growth substances|mesh-ancestor
65332983|NCT00755157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65332984|NCT00755157|Growth Inhibitors|growth inhibitors|mesh-ancestor
65332985|NCT00755157|Tubulin Modulators|tubulin modulators|mesh-ancestor
65332986|NCT00755157|Antimitotic Agents|antimitotic agents|mesh-ancestor
65332987|NCT00755157|Mitosis Modulators|mitosis modulators|mesh-ancestor
64718885|NCT01055756|Adrenergic Agents|adrenergic agents|mesh-ancestor
65217790|NCT02744937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65217791|NCT02744937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217792|NCT02744937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65217793|NCT02744937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65217794|NCT02744937|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65217795|NCT02744937|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65217796|NCT02744937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217797|NCT02744937|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65217798|NCT02744937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65217799|NCT02744937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217800|NCT02744937|Antipyretics|antipyretics|mesh-ancestor
65217801|NCT05394337|Atezolizumab|atezolizumab|mesh-list
65217802|NCT05394337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217803|NCT02744625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65217804|NCT02744625|Propofol|propofol|mesh-list
65217805|NCT02744625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65217806|NCT02744625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65217807|NCT02744625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217808|NCT02744625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65217809|NCT02744625|Anesthetics, General|anesthetics, general|mesh-ancestor
65217810|NCT02744625|Anesthetics|anesthetics|mesh-ancestor
65217811|NCT02610556|Cisplatin|cisplatin|mesh-list
65217812|NCT02610556|Docetaxel|docetaxel|mesh-list
65217813|NCT02610556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217814|NCT02610556|Tubulin Modulators|tubulin modulators|mesh-ancestor
65217815|NCT02610556|Antimitotic Agents|antimitotic agents|mesh-ancestor
65217816|NCT02610556|Mitosis Modulators|mitosis modulators|mesh-ancestor
65217817|NCT02610556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217818|NCT02740101|Oxytocin|oxytocin|mesh-list
65217819|NCT02740101|Oxytocics|oxytocics|mesh-ancestor
65217820|NCT02740101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65217821|NCT02740101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217822|NCT02612116|Ticagrelor|ticagrelor|mesh-list
65217823|NCT02612116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65217824|NCT02612116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65217825|NCT02612116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65217826|NCT02612116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65217827|NCT02612116|Purinergic Agents|purinergic agents|mesh-ancestor
65217828|NCT02612116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65217829|NCT02612116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217830|NCT02612116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217831|NCT00813748|Omalizumab|omalizumab|mesh-list
65217832|NCT00813748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65217833|NCT00813748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65217834|NCT00813748|Respiratory System Agents|respiratory system agents|mesh-ancestor
65217835|NCT02739711|polysaccharide-K|polysaccharide-k|mesh-list
65217836|NCT02739711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65217840|NCT02739711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217841|NCT02739711|Antiviral Agents|antiviral agents|mesh-ancestor
65217842|NCT02739711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65217843|NCT02739711|Interferon Inducers|interferon inducers|mesh-ancestor
65217844|NCT02739711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65217845|NCT02739711|Protective Agents|protective agents|mesh-ancestor
65217847|NCT00813592|Hormones|hormones|mesh-ancestor
65217848|NCT00813592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65217849|NCT00813592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217850|NCT02739633|Gemcitabine|gemcitabine|mesh-list
65217851|NCT02739633|Paclitaxel|paclitaxel|mesh-list
65217852|NCT02739633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65217853|NCT02739633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332988|NCT00755157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332989|NCT00919880|Paclitaxel|paclitaxel|mesh-list
65332990|NCT00919880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65332991|NCT00919880|Carboplatin|carboplatin|mesh-list
65332992|NCT00919880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65332993|NCT00919880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65332994|NCT00919880|Tubulin Modulators|tubulin modulators|mesh-ancestor
65332995|NCT00919880|Antimitotic Agents|antimitotic agents|mesh-ancestor
65217854|NCT02739633|Tubulin Modulators|tubulin modulators|mesh-ancestor
65217855|NCT02739633|Antimitotic Agents|antimitotic agents|mesh-ancestor
65217856|NCT02739633|Mitosis Modulators|mitosis modulators|mesh-ancestor
65217857|NCT02739633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217858|NCT02739633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65217859|NCT02739633|Antimetabolites|antimetabolites|mesh-ancestor
65217860|NCT02739633|Antiviral Agents|antiviral agents|mesh-ancestor
65217861|NCT02739633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65217862|NCT02739633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217863|NCT02739633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65217864|NCT02739633|Immunologic Factors|immunologic factors|mesh-ancestor
65217865|NCT02739633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217866|NCT02739477|Favipiravir|favipiravir|mesh-list
65217867|NCT02739477|Antiviral Agents|antiviral agents|mesh-ancestor
65217868|NCT02739477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65217869|NCT02739399|Phenylephrine|phenylephrine|mesh-list
65217870|NCT02739399|Oxymetazoline|oxymetazoline|mesh-list
65217871|NCT02739399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65217872|NCT02739399|Mydriatics|mydriatics|mesh-ancestor
65217873|NCT02739399|Autonomic Agents|autonomic agents|mesh-ancestor
65217874|NCT02739399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65217875|NCT02739399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217876|NCT02739399|Sympathomimetics|sympathomimetics|mesh-ancestor
65217877|NCT02739399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65217878|NCT02739399|Nasal Decongestants|nasal decongestants|mesh-ancestor
65217879|NCT02739399|Respiratory System Agents|respiratory system agents|mesh-ancestor
65217880|NCT02739399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65217881|NCT02739399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65217882|NCT02739399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65217883|NCT02739399|Adrenergic Agents|adrenergic agents|mesh-ancestor
65217884|NCT02739399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65217885|NCT02739399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217886|NCT02739399|Protective Agents|protective agents|mesh-ancestor
65217887|NCT02743065|Doxorubicin|doxorubicin|mesh-list
65217888|NCT02743065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65217889|NCT02743065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217890|NCT02743065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65217891|NCT02743065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65217892|NCT02743065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217893|NCT02743065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217894|NCT02742909|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65217895|NCT02742909|Natriuretic Agents|natriuretic agents|mesh-ancestor
65217896|NCT02742909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217897|NCT02742675|Leuprolide|leuprolide|mesh-list
65217898|NCT02742675|Goserelin|goserelin|mesh-list
65217899|NCT02742675|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65217900|NCT02742675|Flutamide|flutamide|mesh-list
65217901|NCT02742675|Bicalutamide|bicalutamide|mesh-list
65217902|NCT02742675|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65217903|NCT02742675|Fertility Agents|fertility agents|mesh-ancestor
65217904|NCT02742675|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65217905|NCT02742675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217906|NCT02742675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65217907|NCT02742675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217908|NCT02742675|Androgen Antagonists|androgen antagonists|mesh-ancestor
65217909|NCT02742675|Hormone Antagonists|hormone antagonists|mesh-ancestor
65217911|NCT02742675|Luteolytic Agents|luteolytic agents|mesh-ancestor
65217912|NCT02742675|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65217913|NCT02742675|Contraceptive Agents|contraceptive agents|mesh-ancestor
65217914|NCT02742675|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65332996|NCT00919880|Mitosis Modulators|mitosis modulators|mesh-ancestor
65332997|NCT00919880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65332998|NCT00755313|Cyclophosphamide|cyclophosphamide|mesh-list
65332999|NCT00755313|Carboplatin|carboplatin|mesh-list
65333000|NCT00755313|Docetaxel|docetaxel|mesh-list
65217915|NCT00812812|Paroxetine|paroxetine|mesh-list
65217916|NCT00812812|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65217917|NCT00812812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65217918|NCT00812812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65217919|NCT00812812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217920|NCT00812812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65217921|NCT00812812|Serotonin Agents|serotonin agents|mesh-ancestor
65217922|NCT00812812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217923|NCT00812812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65217924|NCT00812812|Antidepressive Agents|antidepressive agents|mesh-ancestor
65217925|NCT00812812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65217926|NCT00812812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65217927|NCT00812812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65217928|NCT00812812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217929|NCT02742285|Lumefantrine|lumefantrine|mesh-list
65217930|NCT02742285|Artemether|artemether|mesh-list
65217931|NCT02742285|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65217932|NCT02742285|Antimalarials|antimalarials|mesh-ancestor
65217933|NCT02742285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65217934|NCT02742285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65217935|NCT02742285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65217937|NCT03673527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65217938|NCT03673527|Immunologic Factors|immunologic factors|mesh-ancestor
65217939|NCT03673527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217940|NCT03673527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65217941|NCT03673527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217942|NCT03673527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217943|NCT02738931|Lamivudine|lamivudine|mesh-list
65217944|NCT02738931|Dolutegravir|dolutegravir|mesh-list
65217945|NCT02738931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65217946|NCT02738931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65217947|NCT02738931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217948|NCT02738931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217949|NCT02738931|Antiviral Agents|antiviral agents|mesh-ancestor
65217950|NCT02738931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65217951|NCT02738931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64860667|NCT01755728|Analgesics|analgesics|mesh-ancestor
65217952|NCT02738931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65217953|NCT02738931|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65217954|NCT02738931|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65217955|NCT05208892|Dexmedetomidine|dexmedetomidine|mesh-list
65217956|NCT05208892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65217957|NCT05208892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65217958|NCT05208892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217959|NCT05208892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65217960|NCT05208892|Analgesics|analgesics|mesh-ancestor
65217961|NCT05208892|Sensory System Agents|sensory system agents|mesh-ancestor
65217962|NCT05208892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65217963|NCT05208892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65217964|NCT05208892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65217965|NCT05208892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65217966|NCT05208892|Adrenergic Agents|adrenergic agents|mesh-ancestor
65217967|NCT05208892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65217968|NCT05208892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217969|NCT02609386|Zinc|zinc|mesh-list
65217970|NCT02609386|Indomethacin|indomethacin|mesh-list
65217971|NCT02609386|Cyclophosphamide|cyclophosphamide|mesh-list
65217972|NCT02609386|Omeprazole|omeprazole|mesh-list
65217973|NCT02609386|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65217974|NCT02609386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65217975|NCT02609386|Immunologic Factors|immunologic factors|mesh-ancestor
65217976|NCT02609386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217977|NCT02609386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65217978|NCT02609386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65217979|NCT02609386|Alkylating Agents|alkylating agents|mesh-ancestor
65333001|NCT00755313|Doxorubicin|doxorubicin|mesh-list
65333002|NCT00755313|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65333003|NCT00755313|Trastuzumab|trastuzumab|mesh-list
64718905|NCT04333225|Hydroxychloroquine|hydroxychloroquine|mesh-list
65217980|NCT02609386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217981|NCT02609386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217986|NCT02609386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65217987|NCT02609386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65217988|NCT02609386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65217989|NCT02609386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65217990|NCT02609386|Analgesics|analgesics|mesh-ancestor
65217991|NCT02609386|Sensory System Agents|sensory system agents|mesh-ancestor
65217992|NCT02609386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65217993|NCT02609386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65217994|NCT02609386|Gout Suppressants|gout suppressants|mesh-ancestor
65217995|NCT02609386|Tocolytic Agents|tocolytic agents|mesh-ancestor
65217996|NCT02609386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65217997|NCT02609386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65217998|NCT02738619|Vitamin D|vitamin d|mesh-list
65217999|NCT02738619|Ergocalciferols|ergocalciferols|mesh-list
65218000|NCT02738619|Cholecalciferol|cholecalciferol|mesh-list
65218001|NCT02738619|Vitamins|vitamins|mesh-list
65218002|NCT02738619|Micronutrients|micronutrients|mesh-ancestor
65218003|NCT02738619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218004|NCT02738619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65218005|NCT02738619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65218006|NCT04016116|Pembrolizumab|pembrolizumab|mesh-list
65218007|NCT04016116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65218008|NCT04016116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218009|NCT02736591|Hormones|hormones|mesh-list
65218010|NCT02736591|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
65218011|NCT02736591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65218012|NCT02736591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218013|NCT05757466|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65218014|NCT05757466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65218015|NCT05757466|Alkylating Agents|alkylating agents|mesh-ancestor
65218016|NCT05757466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218017|NCT05757466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218018|NCT02736513|Osimertinib|osimertinib|mesh-list
65218019|NCT02736513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218020|NCT02736513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65218021|NCT02736513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218022|NCT02736513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218023|NCT02736435|Leuprolide|leuprolide|mesh-list
65218024|NCT02736435|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65218025|NCT02736435|Fertility Agents|fertility agents|mesh-ancestor
65218026|NCT02736435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65218027|NCT02736435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218028|NCT02736435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65218029|NCT02736435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218030|NCT02736279|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65218031|NCT02736279|Dermatologic Agents|dermatologic agents|mesh-ancestor
65218032|NCT02736279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65218033|NCT02736279|Immunologic Factors|immunologic factors|mesh-ancestor
65218034|NCT02736279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218035|NCT00748189|Ofatumumab|ofatumumab|mesh-list
65218036|NCT00748189|Chlorambucil|chlorambucil|mesh-list
65218037|NCT00748189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218038|NCT00748189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65218039|NCT00748189|Alkylating Agents|alkylating agents|mesh-ancestor
65218040|NCT00748189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218041|NCT02609230|TIC10 compound|tic10 compound|mesh-list
65218042|NCT02609230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218043|NCT00913822|Desipramine|desipramine|mesh-list
65218044|NCT00913822|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65218045|NCT00913822|Antidepressive Agents|antidepressive agents|mesh-ancestor
65218046|NCT00913822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65218047|NCT00913822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218048|NCT00913822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218049|NCT00913822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65218050|NCT00913822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65333004|NCT00755313|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65333005|NCT00755313|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65333006|NCT00755313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65333007|NCT00755313|Immunologic Factors|immunologic factors|mesh-ancestor
65218051|NCT00913822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65218052|NCT00913822|Adrenergic Agents|adrenergic agents|mesh-ancestor
65218055|NCT02736123|Nivolumab|nivolumab|mesh-list
65218056|NCT02736123|Ipilimumab|ipilimumab|mesh-list
65218057|NCT02736123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65218058|NCT02736123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218059|NCT02736123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65218060|NCT02736123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218061|NCT00744055|Prazosin|prazosin|mesh-list
65218062|NCT00744055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65218063|NCT00744055|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65218064|NCT00744055|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65218065|NCT00744055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65218066|NCT00744055|Adrenergic Agents|adrenergic agents|mesh-ancestor
65218067|NCT00744055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65218068|NCT00744055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218069|NCT00744055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218070|NCT02738073|Tranexamic Acid|tranexamic acid|mesh-list
65218071|NCT02738073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65218072|NCT02738073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65218073|NCT02738073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218074|NCT02738073|Hemostatics|hemostatics|mesh-ancestor
65218075|NCT02738073|Coagulants|coagulants|mesh-ancestor
65218076|NCT03967483|Indomethacin|indomethacin|mesh-list
65218077|NCT03967483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65218078|NCT03967483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65218079|NCT03967483|Analgesics|analgesics|mesh-ancestor
65218080|NCT03967483|Sensory System Agents|sensory system agents|mesh-ancestor
65218081|NCT03967483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65218082|NCT03967483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218083|NCT03967483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65218084|NCT03967483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65218085|NCT03967483|Gout Suppressants|gout suppressants|mesh-ancestor
65218086|NCT03967483|Tocolytic Agents|tocolytic agents|mesh-ancestor
65218087|NCT03967483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65218088|NCT03967483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65218089|NCT03967483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218090|NCT03967483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218091|NCT00740779|Silodosin|silodosin|mesh-list
65218092|NCT00740779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65218093|NCT00740779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65218094|NCT00740779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65218095|NCT00740779|Adrenergic Agents|adrenergic agents|mesh-ancestor
65218096|NCT00740779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65218097|NCT00740779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218098|NCT00740779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218099|NCT00740779|Urological Agents|urological agents|mesh-ancestor
65218100|NCT00735475|Vaccines|vaccines|mesh-list
65218101|NCT00735475|Immunologic Factors|immunologic factors|mesh-ancestor
65218102|NCT00735475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218103|NCT01026818|Tadalafil|tadalafil|mesh-list
65218104|NCT01026818|Vasodilator Agents|vasodilator agents|mesh-ancestor
65218105|NCT01026818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65218106|NCT01026818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65218107|NCT01026818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218108|NCT01026818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218109|NCT01026818|Urological Agents|urological agents|mesh-ancestor
65218110|NCT02593747|Loratadine|loratadine|mesh-list
65218111|NCT02593747|Antipruritics|antipruritics|mesh-ancestor
65218112|NCT02593747|Dermatologic Agents|dermatologic agents|mesh-ancestor
65218113|NCT02593747|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65218114|NCT02593747|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65218115|NCT02593747|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65218116|NCT02593747|Histamine Antagonists|histamine antagonists|mesh-ancestor
65218117|NCT02593747|Histamine Agents|histamine agents|mesh-ancestor
65218118|NCT02593747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65333008|NCT00755313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333009|NCT00755313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65333010|NCT00755313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65333011|NCT00755313|Alkylating Agents|alkylating agents|mesh-ancestor
64706737|NCT04708106|Menthol|menthol|mesh-list
65218119|NCT02593747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218120|NCT02593747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218121|NCT00743509|Sirolimus|sirolimus|mesh-list
65218122|NCT00743509|Cyclophosphamide|cyclophosphamide|mesh-list
65218123|NCT00743509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65218124|NCT00743509|Immunologic Factors|immunologic factors|mesh-ancestor
65218127|NCT00743509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65218128|NCT00743509|Alkylating Agents|alkylating agents|mesh-ancestor
65218129|NCT00743509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218130|NCT00743509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218131|NCT00743509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65218132|NCT00743509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65218133|NCT00743509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65218134|NCT00743509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65218135|NCT00743509|Antifungal Agents|antifungal agents|mesh-ancestor
65218136|NCT00734929|Dexamethasone|dexamethasone|mesh-list
65218137|NCT00734929|Dexamethasone acetate|dexamethasone acetate|mesh-list
65218138|NCT00734929|Ondansetron|ondansetron|mesh-list
65218139|NCT00734929|Aprepitant|aprepitant|mesh-list
65218140|NCT00734929|BB 1101|bb 1101|mesh-list
65218141|NCT00734929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65218142|NCT00734929|Antiemetics|antiemetics|mesh-ancestor
65218143|NCT00734929|Autonomic Agents|autonomic agents|mesh-ancestor
65218144|NCT00734929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65218145|NCT00734929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218146|NCT00734929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65218147|NCT00734929|Glucocorticoids|glucocorticoids|mesh-ancestor
65218148|NCT00734929|Hormones|hormones|mesh-ancestor
65218149|NCT00734929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65218150|NCT00734929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65218151|NCT00734929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218152|NCT00734929|Protease Inhibitors|protease inhibitors|mesh-ancestor
65218153|NCT00734929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218154|NCT00734929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218155|NCT00734929|Antipruritics|antipruritics|mesh-ancestor
65218156|NCT00734929|Dermatologic Agents|dermatologic agents|mesh-ancestor
65218157|NCT00734929|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65218158|NCT00734929|Serotonin Agents|serotonin agents|mesh-ancestor
65218159|NCT00734929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65218160|NCT00734929|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65218161|NCT00734929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65218162|NCT00734929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65218163|NCT00734929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65218164|NCT00734929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65218165|NCT00734929|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65218167|NCT00734851|Sunitinib|sunitinib|mesh-list
65218168|NCT00734851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218169|NCT00734851|Tubulin Modulators|tubulin modulators|mesh-ancestor
65218170|NCT00734851|Antimitotic Agents|antimitotic agents|mesh-ancestor
65218171|NCT00734851|Mitosis Modulators|mitosis modulators|mesh-ancestor
65218172|NCT00734851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218173|NCT00734851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65218174|NCT00734851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65218175|NCT00734851|Growth Substances|growth substances|mesh-ancestor
65218176|NCT00734851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218177|NCT00734851|Growth Inhibitors|growth inhibitors|mesh-ancestor
65218178|NCT00734851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65218179|NCT00734851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218180|NCT00734617|Nicotine|nicotine|mesh-list
65218181|NCT00734617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65218182|NCT00734617|Autonomic Agents|autonomic agents|mesh-ancestor
65218183|NCT00734617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65218184|NCT00734617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218185|NCT00734617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65218186|NCT00734617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65218187|NCT00734617|Cholinergic Agents|cholinergic agents|mesh-ancestor
65333012|NCT00755313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333013|NCT00755313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333014|NCT00755313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65333015|NCT00755313|Tubulin Modulators|tubulin modulators|mesh-ancestor
65333016|NCT00755313|Antimitotic Agents|antimitotic agents|mesh-ancestor
65333017|NCT00755313|Mitosis Modulators|mitosis modulators|mesh-ancestor
65333018|NCT00755313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65333019|NCT00755313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65218188|NCT00734617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65218189|NCT00734617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218190|NCT00743431|Doxorubicin|doxorubicin|mesh-list
65218191|NCT00743431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65218192|NCT00743431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218193|NCT00743431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65218194|NCT00743431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65218195|NCT00743431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218196|NCT00743431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218197|NCT03593655|Tenofovir|tenofovir|mesh-list
65218198|NCT03593655|Emtricitabine|emtricitabine|mesh-list
65218199|NCT03593655|Dapivirine|dapivirine|mesh-list
65218201|NCT03593655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65218202|NCT03593655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65218203|NCT03593655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65218204|NCT03593655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218205|NCT03593655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218206|NCT03593655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65218207|NCT03593655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65218208|NCT05380453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65218209|NCT05380453|Immunologic Factors|immunologic factors|mesh-ancestor
65218210|NCT05380453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218211|NCT02737605|Moxifloxacin|moxifloxacin|mesh-list
65218212|NCT02737605|Esketamine|esketamine|mesh-list
65218213|NCT02737605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65218214|NCT02737605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65218215|NCT02737605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65218216|NCT02737605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65218217|NCT02737605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218218|NCT02737605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218219|NCT02737605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218220|NCT02737605|Antidepressive Agents|antidepressive agents|mesh-ancestor
65218221|NCT02737605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65218222|NCT02737371|Antifungal Agents|antifungal agents|mesh-list
65218223|NCT02737371|Clotrimazole|clotrimazole|mesh-list
65218224|NCT02737371|Miconazole|miconazole|mesh-list
65218225|NCT02737371|Olorofim|olorofim|mesh-list
65218226|NCT02737371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65218227|NCT02737371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65218228|NCT02737371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65218229|NCT02737371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65218230|NCT02737371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218231|NCT02737371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218232|NCT02737371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65218233|NCT02737371|Hormone Antagonists|hormone antagonists|mesh-ancestor
65218234|NCT02737371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65218235|NCT02737371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218236|NCT02737371|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65218237|NCT02737371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65218239|NCT02737527|Anesthetics, Local|anesthetics, local|mesh-ancestor
65218240|NCT02737527|Anesthetics|anesthetics|mesh-ancestor
65218241|NCT02737527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65218242|NCT02737527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218243|NCT02737527|Sensory System Agents|sensory system agents|mesh-ancestor
65218244|NCT02737527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65218245|NCT00734539|Fluconazole|fluconazole|mesh-list
65218246|NCT00734539|Antifungal Agents|antifungal agents|mesh-ancestor
65333020|NCT00755313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65333021|NCT00755313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333022|NCT00755313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65333023|NCT00755313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65333024|NCT00755313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65333025|NCT00755313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65333026|NCT00755313|Hormone Antagonists|hormone antagonists|mesh-ancestor
65218247|NCT00734539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65218248|NCT00734539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65218249|NCT00734539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65218250|NCT00734539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218251|NCT00734539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218252|NCT00734539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65218253|NCT00734539|Hormone Antagonists|hormone antagonists|mesh-ancestor
65218254|NCT00734539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65218255|NCT00734539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218256|NCT00734539|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65218257|NCT00734539|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65218258|NCT02737059|Codeine|codeine|mesh-list
65218259|NCT02737059|Naloxegol|naloxegol|mesh-list
65218260|NCT02737059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65218261|NCT02737059|Narcotics|narcotics|mesh-ancestor
65218262|NCT02737059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65218263|NCT02737059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218264|NCT02737059|Analgesics|analgesics|mesh-ancestor
65218265|NCT02737059|Sensory System Agents|sensory system agents|mesh-ancestor
65218266|NCT02737059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65218267|NCT02737059|Antitussive Agents|antitussive agents|mesh-ancestor
65218268|NCT02737059|Respiratory System Agents|respiratory system agents|mesh-ancestor
65218269|NCT02737059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65218270|NCT02731911|Dexamethasone|dexamethasone|mesh-list
65218271|NCT02731911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65218272|NCT02731911|Antiemetics|antiemetics|mesh-ancestor
65218274|NCT02731911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65218275|NCT02731911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218276|NCT02731911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65218277|NCT02731911|Glucocorticoids|glucocorticoids|mesh-ancestor
65218279|NCT02731911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65218280|NCT02731911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65218281|NCT02731911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218282|NCT00734149|Prednisone|prednisone|mesh-list
65218283|NCT00734149|Bortezomib|bortezomib|mesh-list
65218284|NCT00734149|Melphalan|melphalan|mesh-list
65218285|NCT00734149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65218286|NCT00734149|Glucocorticoids|glucocorticoids|mesh-ancestor
65218287|NCT00734149|Hormones|hormones|mesh-ancestor
65218288|NCT00734149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65218289|NCT00734149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218290|NCT00734149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65218291|NCT00734149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218292|NCT00734149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65218293|NCT00734149|Alkylating Agents|alkylating agents|mesh-ancestor
65218294|NCT00734149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218295|NCT00734149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65218296|NCT00734149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65218297|NCT00734149|Immunologic Factors|immunologic factors|mesh-ancestor
65218298|NCT04089163|Flucytosine|flucytosine|mesh-list
65218299|NCT04089163|Antifungal Agents|antifungal agents|mesh-ancestor
65218301|NCT04089163|Antimetabolites|antimetabolites|mesh-ancestor
65218302|NCT04089163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218303|NCT00743197|Aspirin|aspirin|mesh-list
65218304|NCT00743197|Lisinopril|lisinopril|mesh-list
65218305|NCT00743197|Simvastatin|simvastatin|mesh-list
65218306|NCT00743197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65218307|NCT00743197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65218308|NCT00743197|Analgesics|analgesics|mesh-ancestor
65218309|NCT00743197|Sensory System Agents|sensory system agents|mesh-ancestor
65333027|NCT00755313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65333028|NCT04082858|Midazolam|midazolam|mesh-list
65333029|NCT04082858|Ketamine|ketamine|mesh-list
65333030|NCT04082858|Analgesics|analgesics|mesh-ancestor
65333031|NCT04082858|Sensory System Agents|sensory system agents|mesh-ancestor
65333032|NCT04082858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333033|NCT04082858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333034|NCT04082858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65333035|NCT04082858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65218310|NCT00743197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65218311|NCT00743197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218312|NCT00743197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65218313|NCT00743197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65218314|NCT00743197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65218315|NCT00743197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65218316|NCT00743197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218317|NCT00743197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65218318|NCT00743197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65218319|NCT00743197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218320|NCT00743197|Antipyretics|antipyretics|mesh-ancestor
65218321|NCT00743197|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65218322|NCT00743197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65218323|NCT00743197|Antimetabolites|antimetabolites|mesh-ancestor
65218324|NCT00743197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65218325|NCT00743197|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65218326|NCT00743197|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65218327|NCT00743197|Protease Inhibitors|protease inhibitors|mesh-ancestor
65218328|NCT00743197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65218329|NCT00743197|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65218330|NCT00743197|Protective Agents|protective agents|mesh-ancestor
65218332|NCT02731287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218333|NCT02731287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65218334|NCT02731287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65218335|NCT02731287|Adrenergic Agents|adrenergic agents|mesh-ancestor
65218336|NCT02731287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65218337|NCT02731287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218338|NCT02731287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65218339|NCT02731287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65218340|NCT02735343|Ketamine|ketamine|mesh-list
65218341|NCT02735343|Prochlorperazine|prochlorperazine|mesh-list
65218342|NCT02735343|Analgesics|analgesics|mesh-ancestor
65218343|NCT02735343|Sensory System Agents|sensory system agents|mesh-ancestor
65218344|NCT02735343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65218345|NCT02735343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218346|NCT02735343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65218347|NCT02735343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65218352|NCT02735343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65218353|NCT02735343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65218354|NCT02735343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218355|NCT02735343|Antiemetics|antiemetics|mesh-ancestor
65218356|NCT02735343|Autonomic Agents|autonomic agents|mesh-ancestor
65218357|NCT02735343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65218358|NCT02735343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65218359|NCT02735343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65218360|NCT02735343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65218361|NCT02735343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65218362|NCT02735343|Dopamine Agents|dopamine agents|mesh-ancestor
65218363|NCT02730975|Abiraterone Acetate|abiraterone acetate|mesh-list
65218364|NCT02730975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218365|NCT02730975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65218366|NCT02730975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218367|NCT02730975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218368|NCT02730975|Hormone Antagonists|hormone antagonists|mesh-ancestor
65218369|NCT02730975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65333036|NCT04082858|Anesthetics, General|anesthetics, general|mesh-ancestor
65333037|NCT04082858|Anesthetics|anesthetics|mesh-ancestor
65333038|NCT04082858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65333039|NCT04082858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65333040|NCT04082858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65333041|NCT04082858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65082944|NCT00460473|Analgesics|analgesics|mesh-ancestor
65333042|NCT04082858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218370|NCT02730975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218371|NCT02730975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65218372|NCT00734071|Vortioxetine|vortioxetine|mesh-list
65218373|NCT00734071|Antidepressive Agents|antidepressive agents|mesh-ancestor
65218375|NCT00734071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65218376|NCT00734071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65218377|NCT00734071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65218378|NCT00734071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218379|NCT00734071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65218380|NCT00734071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65218381|NCT00734071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65218382|NCT00734071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218383|NCT00734071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65218384|NCT00734071|Serotonin Agents|serotonin agents|mesh-ancestor
65218385|NCT00734071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65218386|NCT00734071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65218387|NCT00734071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65218388|NCT00734071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65218389|NCT03255915|Tenofovir|tenofovir|mesh-list
65218390|NCT03255915|Emtricitabine|emtricitabine|mesh-list
65218391|NCT03255915|Antiviral Agents|antiviral agents|mesh-ancestor
65218392|NCT03255915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65218393|NCT03255915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65218394|NCT03255915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65218395|NCT03255915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218396|NCT03255915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218397|NCT03255915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65218398|NCT03255915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65218399|NCT04188951|Pembrolizumab|pembrolizumab|mesh-list
65218400|NCT04188951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65218401|NCT04188951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218402|NCT00739297|Montelukast|montelukast|mesh-list
65218403|NCT00739297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65218404|NCT00739297|Respiratory System Agents|respiratory system agents|mesh-ancestor
65218405|NCT00739297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65218406|NCT00739297|Hormone Antagonists|hormone antagonists|mesh-ancestor
65218407|NCT00739297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65218408|NCT00739297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218409|NCT00739297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65218410|NCT00739297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65218411|NCT00739297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218412|NCT05430243|Empagliflozin|empagliflozin|mesh-list
65218413|NCT05430243|Diuretics|diuretics|mesh-list
65218414|NCT05430243|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65218415|NCT05430243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218421|NCT02730117|Dobutamine|dobutamine|mesh-list
65218422|NCT02730117|Dopamine|dopamine|mesh-list
65218423|NCT02730117|Milrinone|milrinone|mesh-list
65218424|NCT02730117|Norepinephrine|norepinephrine|mesh-list
65218425|NCT02730117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65218426|NCT02730117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65218427|NCT02730117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65218428|NCT02730117|Adrenergic Agents|adrenergic agents|mesh-ancestor
65218429|NCT02730117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65218430|NCT02730117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333043|NCT04082858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65333044|NCT04082858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65333045|NCT04082858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65333046|NCT04082858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65333047|NCT04082858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65333048|NCT04082858|GABA Modulators|gaba modulators|mesh-ancestor
65333050|NCT00679029|Gemcitabine|gemcitabine|mesh-list
65218431|NCT02730117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218432|NCT02730117|Sympathomimetics|sympathomimetics|mesh-ancestor
65218433|NCT02730117|Autonomic Agents|autonomic agents|mesh-ancestor
65218434|NCT02730117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65218435|NCT02730117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65218436|NCT02730117|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65218437|NCT02730117|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65218438|NCT02730117|Protective Agents|protective agents|mesh-ancestor
65218439|NCT02730117|Dopamine Agents|dopamine agents|mesh-ancestor
65218440|NCT02730117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65218441|NCT02730117|Vasodilator Agents|vasodilator agents|mesh-ancestor
65218442|NCT02730117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65218443|NCT02730117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65218444|NCT02730117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218445|NCT02730117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65218446|NCT02595463|Lidocaine|lidocaine|mesh-list
65218447|NCT02595463|Anesthetics, Local|anesthetics, local|mesh-ancestor
65218448|NCT02595463|Anesthetics|anesthetics|mesh-ancestor
65218449|NCT02595463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65218450|NCT02595463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218451|NCT02595463|Sensory System Agents|sensory system agents|mesh-ancestor
65218452|NCT02595463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65218453|NCT02595463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65218454|NCT02595463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65218455|NCT02595463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65218456|NCT02595463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65218457|NCT02595463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218458|NCT02597257|Lidocaine|lidocaine|mesh-list
65218459|NCT02597257|Anesthetics, Local|anesthetics, local|mesh-ancestor
65218460|NCT02597257|Anesthetics|anesthetics|mesh-ancestor
65218461|NCT02597257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65218462|NCT02597257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218463|NCT02597257|Sensory System Agents|sensory system agents|mesh-ancestor
65218464|NCT02597257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65218465|NCT02597257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65218466|NCT02597257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65218467|NCT02597257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65218468|NCT02597257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64861190|NCT01758380|Gliclazide|gliclazide|mesh-list
65218469|NCT02597257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218470|NCT02593669|Dexamethasone|dexamethasone|mesh-list
65218471|NCT02593669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65218472|NCT02593669|Antiemetics|antiemetics|mesh-ancestor
65218473|NCT02593669|Autonomic Agents|autonomic agents|mesh-ancestor
65218474|NCT02593669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65218475|NCT02593669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218476|NCT02593669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65218477|NCT02593669|Glucocorticoids|glucocorticoids|mesh-ancestor
65218479|NCT02593669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65218480|NCT02593669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65218481|NCT02593669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218482|NCT02729961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65218483|NCT02729961|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65218484|NCT02729961|Ceritinib|ceritinib|mesh-list
65218485|NCT02729961|Antibodies|antibodies|mesh-list
65218487|NCT02729961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65218488|NCT02729961|Immunoconjugates|immunoconjugates|mesh-list
65218489|NCT02729961|Immunologic Factors|immunologic factors|mesh-ancestor
65218490|NCT02729961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218491|NCT02729961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218492|NCT02729961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65333051|NCT00679029|Cyclophosphamide|cyclophosphamide|mesh-list
65333052|NCT00679029|Bevacizumab|bevacizumab|mesh-list
65333053|NCT00679029|Doxorubicin|doxorubicin|mesh-list
65333054|NCT00679029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65333055|NCT00679029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65218493|NCT02729961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218494|NCT02729961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218495|NCT02735031|Exenatide|exenatide|mesh-list
65218496|NCT02735031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65218497|NCT02735031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218498|NCT02735031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65218499|NCT02735031|Incretins|incretins|mesh-ancestor
65218500|NCT02735031|Hormones|hormones|mesh-ancestor
65218501|NCT02735031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65218502|NCT02595541|Milrinone|milrinone|mesh-list
65218503|NCT02595541|Sildenafil Citrate|sildenafil citrate|mesh-list
65218504|NCT02595541|Vasodilator Agents|vasodilator agents|mesh-ancestor
65218505|NCT02595541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65218506|NCT02595541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65218507|NCT02595541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218508|NCT02595541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218509|NCT02595541|Urological Agents|urological agents|mesh-ancestor
65218510|NCT02595541|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65218511|NCT02595541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65218512|NCT02595541|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65218513|NCT02595541|Protective Agents|protective agents|mesh-ancestor
65218514|NCT02595541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218515|NCT00739063|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65218516|NCT00739063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218517|NCT00739063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65218518|NCT00739063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218519|NCT00739063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218521|NCT01026194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65218522|NCT01026194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218523|NCT02734875|Anticoagulants|anticoagulants|mesh-list
65218524|NCT04088461|Metformin|metformin|mesh-list
65218525|NCT04088461|Linagliptin|linagliptin|mesh-list
65218526|NCT04088461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65218527|NCT04088461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218528|NCT04088461|Incretins|incretins|mesh-ancestor
65218529|NCT04088461|Hormones|hormones|mesh-ancestor
65218530|NCT04088461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65218531|NCT04088461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65218532|NCT04088461|Protease Inhibitors|protease inhibitors|mesh-ancestor
65218533|NCT04088461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218534|NCT04088461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218535|NCT00636519|Antitoxins|antitoxins|mesh-list
65218536|NCT00636519|Botulinum Antitoxin|botulinum antitoxin|mesh-list
65218537|NCT00636519|Immunologic Factors|immunologic factors|mesh-ancestor
65218538|NCT00636519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218539|NCT02729805|Ketamine|ketamine|mesh-list
65218540|NCT02729805|Analgesics|analgesics|mesh-ancestor
65218541|NCT02729805|Sensory System Agents|sensory system agents|mesh-ancestor
65218542|NCT02729805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65218543|NCT02729805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218544|NCT02729805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65218545|NCT02729805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65218546|NCT02729805|Anesthetics, General|anesthetics, general|mesh-ancestor
65218547|NCT02729805|Anesthetics|anesthetics|mesh-ancestor
65218548|NCT02729805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65218549|NCT02729805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65218550|NCT02729805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65218551|NCT02729805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65218552|NCT02729805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218553|NCT05377333|Dulaglutide|dulaglutide|mesh-list
65218554|NCT05377333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65218555|NCT05377333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218556|NCT00811954|Ritonavir|ritonavir|mesh-list
65218557|NCT00811954|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65218558|NCT00811954|Darunavir|darunavir|mesh-list
65218559|NCT00811954|Tenofovir|tenofovir|mesh-list
65333056|NCT00679029|Antibodies|antibodies|mesh-list
65333057|NCT00679029|Immunoglobulins|immunoglobulins|mesh-list
65333058|NCT00679029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65333059|NCT00679029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333060|NCT00679029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333061|NCT00679029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65333062|NCT00679029|Immunologic Factors|immunologic factors|mesh-ancestor
65218560|NCT00811954|Emtricitabine|emtricitabine|mesh-list
65218561|NCT00811954|Raltegravir Potassium|raltegravir potassium|mesh-list
65218565|NCT00811954|Protease Inhibitors|protease inhibitors|mesh-ancestor
65218566|NCT00811954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218567|NCT00811954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218568|NCT00811954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65218569|NCT00811954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65218570|NCT00811954|Antiviral Agents|antiviral agents|mesh-ancestor
65218571|NCT00811954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65218572|NCT00811954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65218573|NCT00811954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65218574|NCT00811954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65218575|NCT00811954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65218576|NCT00811954|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65218577|NCT00811954|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65218578|NCT00917839|Lamotrigine|lamotrigine|mesh-list
65218579|NCT00917839|Anticonvulsants|anticonvulsants|mesh-ancestor
65218580|NCT00917839|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65218581|NCT00917839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65218582|NCT00917839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218583|NCT00917839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65218584|NCT00917839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218585|NCT00917839|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65218586|NCT00917839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65218587|NCT00917839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65218588|NCT00917839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65218589|NCT00917839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65218590|NCT01032200|Modafinil|modafinil|mesh-list
65218591|NCT01032200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65218592|NCT01032200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218593|NCT01032200|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65218594|NCT01032200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65218595|NCT01032200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65218596|NCT01032200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218597|NCT03345771|Anti-Infective Agents|anti-infective agents|mesh-list
65218598|NCT03345771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65218599|NCT00586105|Sorafenib|sorafenib|mesh-list
65218600|NCT00586105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218601|NCT00586105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65218602|NCT00586105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218603|NCT00586105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218604|NCT05510427|Bevacizumab|bevacizumab|mesh-list
65218605|NCT05510427|Atezolizumab|atezolizumab|mesh-list
65218606|NCT05510427|Infigratinib|infigratinib|mesh-list
65218607|NCT05510427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65218608|NCT05510427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218609|NCT05510427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65218610|NCT05510427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65218611|NCT05510427|Growth Substances|growth substances|mesh-ancestor
65218612|NCT05510427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218613|NCT05510427|Growth Inhibitors|growth inhibitors|mesh-ancestor
65218614|NCT05757310|Vidarabine|vidarabine|mesh-list
65218615|NCT05757310|Cyclophosphamide|cyclophosphamide|mesh-list
65218616|NCT05757310|Pentostatin|pentostatin|mesh-list
64861341|NCT01759589|Narcotics|narcotics|mesh-ancestor
65218617|NCT05757310|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65218618|NCT05757310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65218619|NCT05757310|Immunologic Factors|immunologic factors|mesh-ancestor
65218620|NCT05757310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218621|NCT05757310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65333063|NCT00679029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333064|NCT00679029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65333065|NCT00679029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65333066|NCT00679029|Alkylating Agents|alkylating agents|mesh-ancestor
65218622|NCT05757310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65218623|NCT05757310|Alkylating Agents|alkylating agents|mesh-ancestor
65218624|NCT05757310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218625|NCT05757310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218626|NCT05757310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65218627|NCT05757310|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65218628|NCT05757310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218629|NCT05757310|Antimetabolites|antimetabolites|mesh-ancestor
65218639|NCT00743119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65218640|NCT00743119|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65218641|NCT00743119|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65218642|NCT00743119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65218643|NCT00743119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218644|NCT00743119|Hormones|hormones|mesh-ancestor
65218645|NCT00743119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65218646|NCT02610010|Cisplatin|cisplatin|mesh-list
65218647|NCT02610010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218648|NCT02610088|Dapagliflozin|dapagliflozin|mesh-list
65218649|NCT02610088|Gliclazide|gliclazide|mesh-list
65218650|NCT02610088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65218651|NCT02610088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218652|NCT02610088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65218653|NCT02610088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218654|NCT02734407|Aflibercept|aflibercept|mesh-list
65218655|NCT02734407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65218656|NCT02734407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65218657|NCT02734407|Growth Substances|growth substances|mesh-ancestor
65218658|NCT02734407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218659|NCT02734407|Growth Inhibitors|growth inhibitors|mesh-ancestor
65218660|NCT02734407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218661|NCT02734173|Ritonavir|ritonavir|mesh-list
65218662|NCT02734173|Ribavirin|ribavirin|mesh-list
65218663|NCT02734173|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65218664|NCT02734173|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65218665|NCT02734173|Protease Inhibitors|protease inhibitors|mesh-ancestor
65218666|NCT02734173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218667|NCT02734173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218669|NCT02734173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65218670|NCT02734173|Antiviral Agents|antiviral agents|mesh-ancestor
65218671|NCT02734173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65218672|NCT02734173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65218673|NCT02734173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65218674|NCT02734173|Antimetabolites|antimetabolites|mesh-ancestor
65218675|NCT05297422|Ketamine|ketamine|mesh-list
65218676|NCT05297422|Ropivacaine|ropivacaine|mesh-list
65218677|NCT05297422|Analgesics|analgesics|mesh-ancestor
65218678|NCT05297422|Sensory System Agents|sensory system agents|mesh-ancestor
65218679|NCT05297422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65218680|NCT05297422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218681|NCT05297422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65218682|NCT05297422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65218683|NCT05297422|Anesthetics, General|anesthetics, general|mesh-ancestor
65218684|NCT05297422|Anesthetics|anesthetics|mesh-ancestor
65218685|NCT05297422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65218686|NCT05297422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65218687|NCT05297422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65218688|NCT05297422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65218689|NCT05297422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218690|NCT05297422|Anesthetics, Local|anesthetics, local|mesh-ancestor
65218691|NCT00813124|Fludarabine|fludarabine|mesh-list
65218692|NCT00813124|Fludarabine phosphate|fludarabine phosphate|mesh-list
65218694|NCT00813124|Busulfan|busulfan|mesh-list
65218695|NCT00813124|Thymoglobulin|thymoglobulin|mesh-list
65218696|NCT00813124|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65218697|NCT00813124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218698|NCT00813124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65333067|NCT00679029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65333068|NCT00679029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65333069|NCT00679029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65333070|NCT00679029|Growth Substances|growth substances|mesh-ancestor
65333071|NCT00679029|Growth Inhibitors|growth inhibitors|mesh-ancestor
65333072|NCT00679029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65333073|NCT00679029|Antimetabolites|antimetabolites|mesh-ancestor
65333074|NCT00679029|Antiviral Agents|antiviral agents|mesh-ancestor
65218704|NCT00813124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218705|NCT00813124|Alkylating Agents|alkylating agents|mesh-ancestor
65218706|NCT00813124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65218707|NCT00813124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65218708|NCT00733291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65218709|NCT05117866|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65218710|NCT05117866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65218711|NCT03133221|Idelalisib|idelalisib|mesh-list
65218712|NCT03133221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218713|NCT03133221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218714|NCT03133221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218715|NCT02728869|Vaccines|vaccines|mesh-list
65218716|NCT02728869|Immunologic Factors|immunologic factors|mesh-ancestor
65218717|NCT02728869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218718|NCT02594761|Trastuzumab|trastuzumab|mesh-list
65218719|NCT02594761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65218720|NCT02594761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218721|NCT02728947|Rotigotine|rotigotine|mesh-list
65218722|NCT02728947|Dopamine Agonists|dopamine agonists|mesh-ancestor
65218723|NCT02728947|Dopamine Agents|dopamine agents|mesh-ancestor
65218724|NCT02728947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65218725|NCT02728947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218726|NCT02728947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218727|NCT02729103|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65218728|NCT02729103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218729|NCT02733705|Fentanyl|fentanyl|mesh-list
65218730|NCT02733705|Propofol|propofol|mesh-list
65218731|NCT02733705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65218732|NCT02733705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65218733|NCT02733705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218734|NCT02733705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65218735|NCT02733705|Anesthetics, General|anesthetics, general|mesh-ancestor
65218736|NCT02733705|Anesthetics|anesthetics|mesh-ancestor
65218737|NCT02733705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65218738|NCT02733705|Narcotics|narcotics|mesh-ancestor
65218739|NCT02733705|Analgesics|analgesics|mesh-ancestor
65218740|NCT02733705|Sensory System Agents|sensory system agents|mesh-ancestor
65218741|NCT02733705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65218742|NCT02733705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65218743|NCT02596555|Dabigatran|dabigatran|mesh-list
65218744|NCT02596555|Antithrombins|antithrombins|mesh-ancestor
65218745|NCT02596555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65218747|NCT02596555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218748|NCT02596555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218749|NCT02596555|Anticoagulants|anticoagulants|mesh-ancestor
65218750|NCT02733471|Lidocaine|lidocaine|mesh-list
65218751|NCT02733471|Anesthetics, Local|anesthetics, local|mesh-ancestor
65218752|NCT02733471|Anesthetics|anesthetics|mesh-ancestor
65218753|NCT02733471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65218754|NCT02733471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218755|NCT02733471|Sensory System Agents|sensory system agents|mesh-ancestor
65218756|NCT02733471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65218757|NCT02733471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65218758|NCT02733471|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65218759|NCT02733471|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65218760|NCT02733471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65218761|NCT02733471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218762|NCT02733237|Oxytocin|oxytocin|mesh-list
65218763|NCT02733237|Oxytocics|oxytocics|mesh-ancestor
65218764|NCT02733237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65333075|NCT00679029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65333076|NCT00679029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333077|NCT00679029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65333078|NCT00679029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65333079|NCT00679029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65218765|NCT02733237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218766|NCT04206813|Vaccines|vaccines|mesh-list
65218767|NCT04206813|Immunologic Factors|immunologic factors|mesh-ancestor
65218768|NCT04206813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218769|NCT02728323|Levobupivacaine|levobupivacaine|mesh-list
65218775|NCT02728323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65218777|NCT00811720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65218778|NCT00811720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218779|NCT00811720|Sensory System Agents|sensory system agents|mesh-ancestor
65218780|NCT00811720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65218781|NCT04202679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
65218782|NCT04202679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218783|NCT04202679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218784|NCT00811642|Posaconazole|posaconazole|mesh-list
65218785|NCT00811642|Antifungal Agents|antifungal agents|mesh-ancestor
65218786|NCT00811642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65218787|NCT00811642|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65218788|NCT00811642|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65218789|NCT00811642|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65218790|NCT00811642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65218791|NCT00811642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65218792|NCT00811642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218793|NCT00811642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218794|NCT00811642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65218795|NCT00811642|Hormone Antagonists|hormone antagonists|mesh-ancestor
65218796|NCT00811642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65218797|NCT00811642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218798|NCT02609152|Esmolol|esmolol|mesh-list
65218799|NCT02609152|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65218800|NCT02609152|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65218801|NCT02609152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65218802|NCT02609152|Adrenergic Agents|adrenergic agents|mesh-ancestor
65218803|NCT02609152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65218804|NCT02609152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218805|NCT02609152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218806|NCT02733393|Lidocaine|lidocaine|mesh-list
65218807|NCT02733393|Anesthetics, Local|anesthetics, local|mesh-ancestor
65218808|NCT02733393|Anesthetics|anesthetics|mesh-ancestor
65218809|NCT02733393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65218810|NCT02733393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218811|NCT02733393|Sensory System Agents|sensory system agents|mesh-ancestor
65218812|NCT02733393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65218813|NCT02733393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65218814|NCT02733393|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65218815|NCT02733393|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65218816|NCT02733393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65218817|NCT02733393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218819|NCT00809926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65218820|NCT00809926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65218821|NCT00809926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65218822|NCT00809926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218823|NCT02728245|Dienogest|dienogest|mesh-list
65218824|NCT02728245|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65218825|NCT02728245|Contraceptive Agents|contraceptive agents|mesh-ancestor
65218826|NCT02728245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65218827|NCT02728245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218828|NCT02728245|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65218829|NCT02728245|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65218830|NCT02728245|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65218831|NCT02728245|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65218832|NCT02728245|Hormone Antagonists|hormone antagonists|mesh-ancestor
65333080|NCT00919022|Cyproterone Acetate|cyproterone acetate|mesh-list
65333081|NCT00919022|Cyproterone|cyproterone|mesh-list
65333082|NCT00919022|Androgen Antagonists|androgen antagonists|mesh-ancestor
65333083|NCT00919022|Hormone Antagonists|hormone antagonists|mesh-ancestor
65333084|NCT00919022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65218833|NCT02728245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65218834|NCT02728245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65218835|NCT02728245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218839|NCT02690415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65218840|NCT02690415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65218841|NCT02690415|Antitubercular Agents|antitubercular agents|mesh-ancestor
65218842|NCT05753722|Pembrolizumab|pembrolizumab|mesh-list
65218843|NCT05753722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65218844|NCT05753722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218845|NCT02727621|Dexmedetomidine|dexmedetomidine|mesh-list
65218846|NCT02727621|Propofol|propofol|mesh-list
65218847|NCT02727621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65218848|NCT02727621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65218849|NCT02727621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218850|NCT02727621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65218851|NCT02727621|Anesthetics, General|anesthetics, general|mesh-ancestor
65218852|NCT02727621|Anesthetics|anesthetics|mesh-ancestor
65218853|NCT02727621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65218854|NCT02727621|Analgesics|analgesics|mesh-ancestor
65218855|NCT02727621|Sensory System Agents|sensory system agents|mesh-ancestor
65218856|NCT02727621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65218857|NCT02727621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65218858|NCT02727621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65218859|NCT02727621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65218860|NCT02727621|Adrenergic Agents|adrenergic agents|mesh-ancestor
65218861|NCT02727621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65218862|NCT02727621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218863|NCT02608606|Tacrolimus|tacrolimus|mesh-list
65218864|NCT02608606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65218865|NCT02608606|Immunologic Factors|immunologic factors|mesh-ancestor
65218866|NCT02608606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218867|NCT02608606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65218868|NCT02608606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218869|NCT02608606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218870|NCT02608918|BMS-955176|bms-955176|mesh-list
65218871|NCT02608918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65218872|NCT02608918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65218873|NCT02608918|Antiviral Agents|antiviral agents|mesh-ancestor
65218874|NCT02608918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65218875|NCT05755204|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65218876|NCT05755204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65218877|NCT05755204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65218878|NCT05755204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218879|NCT05755204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218880|NCT05755204|Antiviral Agents|antiviral agents|mesh-ancestor
65218881|NCT05755204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65218882|NCT05755204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65218883|NCT05755204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65218884|NCT02727309|Apatinib|apatinib|mesh-list
65218885|NCT02727309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218886|NCT02727309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65218887|NCT02727309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218888|NCT02727309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218889|NCT05755750|Genipin|genipin|mesh-list
65218890|NCT05755750|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65218891|NCT05755750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65218892|NCT02732067|Anesthetics|anesthetics|mesh-list
65218893|NCT02732067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65218894|NCT02732067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218895|NCT02609932|Interferons|interferons|mesh-list
65218896|NCT02609932|Interferon-gamma|interferon-gamma|mesh-list
65218897|NCT02609932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218898|NCT02609932|Antiviral Agents|antiviral agents|mesh-ancestor
65333085|NCT00919022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333086|NCT00919022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333087|NCT00919022|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65333088|NCT00919022|Contraceptive Agents|contraceptive agents|mesh-ancestor
65218899|NCT02609932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65218900|NCT02726919|Clobazam|clobazam|mesh-list
65218901|NCT02726919|Anticonvulsants|anticonvulsants|mesh-ancestor
65218902|NCT02726919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65218903|NCT02726919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65218904|NCT02726919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65218905|NCT02726919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218906|NCT02726919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65218907|NCT02726919|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65218913|NCT00590902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218914|NCT00590902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65218915|NCT00590902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218916|NCT00590902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218918|NCT05753566|Hormones|hormones|mesh-ancestor
65218919|NCT05753566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65218920|NCT05753566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218921|NCT05154747|Rilpivirine|rilpivirine|mesh-list
65218922|NCT05154747|Cabotegravir|cabotegravir|mesh-list
65218923|NCT05154747|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
65218924|NCT05154747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65218925|NCT05154747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65218926|NCT05154747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218927|NCT05154747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218928|NCT05154747|Antiviral Agents|antiviral agents|mesh-ancestor
65218929|NCT05154747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65218930|NCT05154747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65218931|NCT05154747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65218932|NCT05154747|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65218933|NCT05154747|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65218934|NCT00590824|Interleukin-2|interleukin-2|mesh-list
65218935|NCT00590824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218936|NCT00590824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65218937|NCT00590824|Analgesics|analgesics|mesh-ancestor
65218938|NCT00590824|Sensory System Agents|sensory system agents|mesh-ancestor
65218939|NCT00590824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65218940|NCT00590824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218941|NCT02720991|Misoprostol|misoprostol|mesh-list
65218942|NCT02720991|Mifepristone|mifepristone|mesh-list
65218943|NCT02720991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65218944|NCT02720991|Abortifacient Agents|abortifacient agents|mesh-ancestor
65218945|NCT02720991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65218946|NCT02720991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218947|NCT02720991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65218948|NCT02720991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65218949|NCT02720991|Oxytocics|oxytocics|mesh-ancestor
65218950|NCT02720991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65218951|NCT02720991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65218952|NCT02720991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65218953|NCT02720991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65218954|NCT02720991|Contraceptive Agents|contraceptive agents|mesh-ancestor
65218955|NCT02720991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65218956|NCT02720991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65218957|NCT02720991|Hormone Antagonists|hormone antagonists|mesh-ancestor
65218958|NCT02720991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65218959|NCT02720991|Luteolytic Agents|luteolytic agents|mesh-ancestor
65218960|NCT02720991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65218961|NCT02720991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65218962|NCT02720601|Capecitabine|capecitabine|mesh-list
65218963|NCT02720601|Irinotecan|irinotecan|mesh-list
65218964|NCT02720601|Camptothecin|camptothecin|mesh-list
65218965|NCT02720601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65218966|NCT02720601|Antimetabolites|antimetabolites|mesh-ancestor
65218967|NCT02720601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218968|NCT02720601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218969|NCT02720601|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65333089|NCT00919022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65333090|NCT05004350|Fluorouracil|fluorouracil|mesh-list
65333091|NCT05004350|Irinotecan|irinotecan|mesh-list
65333092|NCT05004350|Cetuximab|cetuximab|mesh-list
65333093|NCT05004350|Antimetabolites|antimetabolites|mesh-ancestor
65333094|NCT05004350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333095|NCT05004350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65218970|NCT02720601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65218971|NCT02720601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218972|NCT02720601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65218973|NCT00590590|Diphenhydramine|diphenhydramine|mesh-list
65218974|NCT00590590|Promethazine|promethazine|mesh-list
65218975|NCT00590590|Lidocaine|lidocaine|mesh-list
65218976|NCT00590590|Anesthetics, Local|anesthetics, local|mesh-ancestor
65218977|NCT00590590|Anesthetics|anesthetics|mesh-ancestor
65218987|NCT00590590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65218988|NCT00590590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65218990|NCT00590590|Autonomic Agents|autonomic agents|mesh-ancestor
65218991|NCT00590590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65218992|NCT00590590|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65218993|NCT00590590|Histamine Antagonists|histamine antagonists|mesh-ancestor
65218994|NCT00590590|Histamine Agents|histamine agents|mesh-ancestor
65218995|NCT00590590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65218996|NCT00590590|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65218997|NCT00590590|Antipruritics|antipruritics|mesh-ancestor
65218998|NCT00590590|Dermatologic Agents|dermatologic agents|mesh-ancestor
65218999|NCT02720367|Gemcitabine|gemcitabine|mesh-list
65219000|NCT02720367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65219001|NCT02720367|Antimetabolites|antimetabolites|mesh-ancestor
65219002|NCT02720367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219003|NCT02720367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219004|NCT02720367|Antiviral Agents|antiviral agents|mesh-ancestor
65219005|NCT02720367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65219006|NCT02720367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219007|NCT02720367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65219008|NCT02720367|Immunologic Factors|immunologic factors|mesh-ancestor
65219009|NCT02720367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219010|NCT02693769|Fluticasone|fluticasone|mesh-list
65219011|NCT02693769|Xhance|xhance|mesh-list
65219012|NCT02693769|Glycopyrrolate|glycopyrrolate|mesh-list
65219013|NCT02693769|Bromides|bromides|mesh-list
65219014|NCT02693769|Formoterol Fumarate|formoterol fumarate|mesh-list
65219015|NCT02693769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65219016|NCT02693769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65219017|NCT02693769|Autonomic Agents|autonomic agents|mesh-ancestor
65219018|NCT02693769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65219019|NCT02693769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219020|NCT02693769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65219021|NCT02693769|Respiratory System Agents|respiratory system agents|mesh-ancestor
65219022|NCT02693769|Dermatologic Agents|dermatologic agents|mesh-ancestor
65219023|NCT02693769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65219024|NCT02693769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65219025|NCT02693769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65219026|NCT02693769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65219027|NCT02693769|Adrenergic Agents|adrenergic agents|mesh-ancestor
65219028|NCT02693769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65219029|NCT02693769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219030|NCT02693769|Anticonvulsants|anticonvulsants|mesh-ancestor
65219031|NCT02693769|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65219032|NCT02693769|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65219033|NCT02693769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65219034|NCT02693769|Cholinergic Agents|cholinergic agents|mesh-ancestor
65219035|NCT05335941|Pemetrexed|pemetrexed|mesh-list
65219036|NCT05335941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219037|NCT05335941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219038|NCT05335941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219039|NCT05335941|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65219040|NCT05335941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65219041|NCT02725359|Tizanidine|tizanidine|mesh-list
65219044|NCT02725359|Anesthetics|anesthetics|mesh-ancestor
65219045|NCT02725359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65333096|NCT05004350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333097|NCT05004350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65333098|NCT05004350|Immunologic Factors|immunologic factors|mesh-ancestor
65333099|NCT05004350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707713|NCT00369044|Prednisone|prednisone|mesh-list
65219046|NCT02725359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219047|NCT02725359|Sensory System Agents|sensory system agents|mesh-ancestor
65219048|NCT02725359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65219049|NCT02725359|Analgesics|analgesics|mesh-ancestor
65219050|NCT02725359|Anticonvulsants|anticonvulsants|mesh-ancestor
65219051|NCT02725359|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65219052|NCT02725359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65219053|NCT02725359|Parasympatholytics|parasympatholytics|mesh-ancestor
65219054|NCT02725359|Autonomic Agents|autonomic agents|mesh-ancestor
65219055|NCT02725359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65219056|NCT02725359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65219057|NCT02725359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65219058|NCT02725359|Adrenergic Agents|adrenergic agents|mesh-ancestor
65219059|NCT02725359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65219060|NCT02725359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219061|NCT00731731|Temozolomide|temozolomide|mesh-list
65219063|NCT00731731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65219064|NCT00731731|Alkylating Agents|alkylating agents|mesh-ancestor
65219065|NCT00731731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219066|NCT00731731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219067|NCT00731731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65219068|NCT00731731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219069|NCT05755048|Trastuzumab|trastuzumab|mesh-list
65219070|NCT05755048|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65219071|NCT05755048|Maytansine|maytansine|mesh-list
65219072|NCT05755048|Antibodies|antibodies|mesh-list
65219073|NCT05755048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65219074|NCT05755048|Immunologic Factors|immunologic factors|mesh-ancestor
65219075|NCT05755048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219076|NCT05755048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65219077|NCT05755048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219078|NCT05755048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65219079|NCT05755048|Tubulin Modulators|tubulin modulators|mesh-ancestor
65219080|NCT05755048|Antimitotic Agents|antimitotic agents|mesh-ancestor
65219081|NCT05755048|Mitosis Modulators|mitosis modulators|mesh-ancestor
65219082|NCT05755048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219083|NCT02719431|Warfarin|warfarin|mesh-list
65219084|NCT02719431|Anticoagulants|anticoagulants|mesh-ancestor
65219085|NCT00806494|Fesoterodine|fesoterodine|mesh-list
65219086|NCT00806494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65219087|NCT00806494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65219088|NCT00806494|Cholinergic Agents|cholinergic agents|mesh-ancestor
65219089|NCT00806494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65219090|NCT00806494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219091|NCT00806494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219092|NCT00806494|Urological Agents|urological agents|mesh-ancestor
65219093|NCT00806416|Vitamin D|vitamin d|mesh-list
65219094|NCT00806416|Cholecalciferol|cholecalciferol|mesh-list
65219095|NCT00806416|Alendronate|alendronate|mesh-list
65219096|NCT00806416|Vitamins|vitamins|mesh-ancestor
65219097|NCT00806416|Micronutrients|micronutrients|mesh-ancestor
65219098|NCT00806416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219099|NCT00806416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65219100|NCT00806416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65219101|NCT00811252|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65219102|NCT00811252|Vortioxetine|vortioxetine|mesh-list
65219103|NCT00811252|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65219104|NCT00811252|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65219105|NCT00811252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65219106|NCT00811252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219107|NCT00811252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65219108|NCT00811252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219109|NCT00811252|Analgesics|analgesics|mesh-ancestor
65219110|NCT00811252|Sensory System Agents|sensory system agents|mesh-ancestor
65219111|NCT00811252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333100|NCT05004350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65333101|NCT05004350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65333102|NCT05004350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333103|NCT05004350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65333104|NCT05122221|Cyclophosphamide|cyclophosphamide|mesh-list
65219112|NCT00811252|Antidepressive Agents|antidepressive agents|mesh-ancestor
65219113|NCT00811252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64325756|NCT04914741|Prednisolone|prednisolone|mesh-list
65219128|NCT02608996|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65219129|NCT02608996|Natriuretic Agents|natriuretic agents|mesh-ancestor
65219130|NCT02608996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219131|NCT00736957|Acetaminophen|acetaminophen|mesh-list
65219133|NCT00736957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65219134|NCT00736957|Analgesics|analgesics|mesh-ancestor
65219135|NCT00736957|Sensory System Agents|sensory system agents|mesh-ancestor
65219136|NCT00736957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65219137|NCT00736957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219138|NCT00736957|Antipyretics|antipyretics|mesh-ancestor
65219139|NCT00736957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65219140|NCT00736957|Narcotics|narcotics|mesh-ancestor
65219141|NCT00736957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65219142|NCT05024344|Dexamethasone|dexamethasone|mesh-list
65219143|NCT05024344|Ropivacaine|ropivacaine|mesh-list
65219144|NCT05024344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65219145|NCT05024344|Antiemetics|antiemetics|mesh-ancestor
65219146|NCT05024344|Autonomic Agents|autonomic agents|mesh-ancestor
65219147|NCT05024344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65219148|NCT05024344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219149|NCT05024344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65219150|NCT05024344|Glucocorticoids|glucocorticoids|mesh-ancestor
65219151|NCT05024344|Hormones|hormones|mesh-ancestor
65219152|NCT05024344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65219153|NCT05024344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65219154|NCT05024344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219155|NCT05024344|Anesthetics, Local|anesthetics, local|mesh-ancestor
65219156|NCT05024344|Anesthetics|anesthetics|mesh-ancestor
65219157|NCT05024344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65219158|NCT05024344|Sensory System Agents|sensory system agents|mesh-ancestor
65219159|NCT05294523|Rocuronium|rocuronium|mesh-list
65219160|NCT05294523|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65219161|NCT05294523|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65219162|NCT05294523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65219163|NCT05294523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65219164|NCT05294523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219165|NCT00736879|Dapagliflozin|dapagliflozin|mesh-list
65219166|NCT00736879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65219167|NCT00736879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219168|NCT00736879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65219169|NCT00736879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219170|NCT02718261|Pantoprazole|pantoprazole|mesh-list
65219171|NCT02718261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65219172|NCT02718261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65219173|NCT02718261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65219174|NCT02718261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219175|NCT02718261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219176|NCT00806260|Ethanol|ethanol|mesh-list
65219177|NCT00806260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65219178|NCT00806260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65219179|NCT00806260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65219180|NCT00806260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219181|NCT02718183|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65219182|NCT02718183|Carbamide Peroxide|carbamide peroxide|mesh-list
65219183|NCT02718183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65219184|NCT02718183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65219185|NCT00811174|gamma-Globulins|gamma-globulins|mesh-list
65219186|NCT00811174|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65219187|NCT00811174|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65219188|NCT00811174|Immunologic Factors|immunologic factors|mesh-ancestor
65219189|NCT00811174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219194|NCT02723487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333105|NCT05122221|Fludarabine|fludarabine|mesh-list
65333106|NCT05122221|Interleukin-2|interleukin-2|mesh-list
65333107|NCT05122221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65333108|NCT05122221|Immunologic Factors|immunologic factors|mesh-ancestor
65333109|NCT05122221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333110|NCT05122221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65333111|NCT05122221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65333112|NCT05122221|Alkylating Agents|alkylating agents|mesh-ancestor
65219196|NCT02723487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65219197|NCT02717871|Moxifloxacin|moxifloxacin|mesh-list
65219198|NCT02717871|Ciprofloxacin|ciprofloxacin|mesh-list
65219199|NCT02717871|Levofloxacin|levofloxacin|mesh-list
65219200|NCT02717871|Ofloxacin|ofloxacin|mesh-list
65219201|NCT02717871|Gentamicins|gentamicins|mesh-list
65219202|NCT02717871|Cefazolin|cefazolin|mesh-list
65219203|NCT02717871|Tobramycin|tobramycin|mesh-list
65219204|NCT02717871|Gatifloxacin|gatifloxacin|mesh-list
65219205|NCT02717871|Fluoroquinolones|fluoroquinolones|mesh-list
65219206|NCT02717871|Besifloxacin|besifloxacin|mesh-list
65219207|NCT02717871|Prednisolone|prednisolone|mesh-list
65219208|NCT02717871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65219209|NCT02717871|Methylprednisolone|methylprednisolone|mesh-list
65219210|NCT02717871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65219211|NCT02717871|Prednisolone acetate|prednisolone acetate|mesh-list
65219212|NCT02717871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65219213|NCT02717871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65219214|NCT02717871|Prednisolone phosphate|prednisolone phosphate|mesh-list
65219215|NCT02717871|Cyclopentolate|cyclopentolate|mesh-list
65219216|NCT02717871|Mydriatics|mydriatics|mesh-list
65219217|NCT02717871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65219218|NCT02717871|Glucocorticoids|glucocorticoids|mesh-ancestor
65219219|NCT02717871|Hormones|hormones|mesh-ancestor
65219220|NCT02717871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65219221|NCT02717871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219222|NCT02717871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65219223|NCT02717871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219224|NCT02717871|Antiemetics|antiemetics|mesh-ancestor
65219225|NCT02717871|Autonomic Agents|autonomic agents|mesh-ancestor
65219226|NCT02717871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65219227|NCT02717871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65219228|NCT02717871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65219229|NCT02717871|Protective Agents|protective agents|mesh-ancestor
65219230|NCT02717871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65219231|NCT02717871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65219232|NCT02717871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65219233|NCT02717871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65219234|NCT02717871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219235|NCT02717871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219236|NCT02717871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65219237|NCT02717871|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65219238|NCT02717871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65219239|NCT02717871|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65219240|NCT02717871|Renal Agents|renal agents|mesh-ancestor
65219241|NCT02717871|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65219242|NCT02717871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65219243|NCT02717871|Parasympatholytics|parasympatholytics|mesh-ancestor
65219244|NCT02717871|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65219245|NCT02717871|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65219246|NCT02717871|Cholinergic Agents|cholinergic agents|mesh-ancestor
65219247|NCT02717871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65219248|NCT02723253|Raltitrexed|raltitrexed|mesh-list
65219249|NCT02723253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219250|NCT02723253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65219251|NCT02723253|Antimetabolites|antimetabolites|mesh-ancestor
65219252|NCT02723253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219253|NCT02723253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65219254|NCT02723253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219255|NCT00730405|Albaconazole|albaconazole|mesh-list
65219256|NCT00730405|Antifungal Agents|antifungal agents|mesh-ancestor
65219257|NCT00730405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65333113|NCT05122221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333114|NCT05122221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333115|NCT05122221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65333116|NCT05122221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65333117|NCT05122221|Analgesics|analgesics|mesh-ancestor
65333118|NCT05122221|Sensory System Agents|sensory system agents|mesh-ancestor
65333119|NCT05122221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333120|NCT03802305|Anesthetics|anesthetics|mesh-list
65333121|NCT03802305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65333122|NCT03802305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333123|NCT02587052|Tacrolimus|tacrolimus|mesh-list
65333124|NCT02587052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65333125|NCT02587052|Immunologic Factors|immunologic factors|mesh-ancestor
65333126|NCT02587052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333127|NCT02587052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65333128|NCT02587052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333129|NCT02587052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333130|NCT02587130|Ketamine|ketamine|mesh-list
65333131|NCT02587130|Analgesics|analgesics|mesh-ancestor
65333132|NCT02587130|Sensory System Agents|sensory system agents|mesh-ancestor
65333133|NCT02587130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333134|NCT02587130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333135|NCT02587130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65333136|NCT02587130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65333137|NCT02587130|Anesthetics, General|anesthetics, general|mesh-ancestor
65333138|NCT02587130|Anesthetics|anesthetics|mesh-ancestor
65333139|NCT02587130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65219258|NCT04088851|Metformin|metformin|mesh-list
65219259|NCT04088851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65219260|NCT04088851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219261|NCT02594449|Benzalkonium Compounds|benzalkonium compounds|mesh-list
65219262|NCT02594449|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65219263|NCT02594449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65219264|NCT02722083|Chlorpheniramine|chlorpheniramine|mesh-list
65219270|NCT02722083|Histamine Agents|histamine agents|mesh-ancestor
65219271|NCT02722083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65219272|NCT02722083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219273|NCT02722083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65219274|NCT05201079|Fidaxomicin|fidaxomicin|mesh-list
65219275|NCT05201079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65219276|NCT05201079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65219277|NCT00736645|Selenium|selenium|mesh-list
65219278|NCT00736645|Finasteride|finasteride|mesh-list
65219279|NCT00736645|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65219280|NCT00736645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65219281|NCT00736645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219282|NCT00736645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333140|NCT02587130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65333141|NCT02587130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65333142|NCT02587130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65333143|NCT02587130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333144|NCT02559141|Dobutamine|dobutamine|mesh-list
65333145|NCT02559141|Norepinephrine|norepinephrine|mesh-list
65333146|NCT02559141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65333147|NCT02559141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65333148|NCT02559141|Adrenergic Agents|adrenergic agents|mesh-ancestor
65333149|NCT02559141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65333150|NCT02559141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333151|NCT02559141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333152|NCT02559141|Sympathomimetics|sympathomimetics|mesh-ancestor
65333153|NCT02559141|Autonomic Agents|autonomic agents|mesh-ancestor
65333154|NCT02559141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333155|NCT02559141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65333156|NCT02559141|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65333157|NCT02559141|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65333158|NCT02559141|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65333159|NCT02559141|Protective Agents|protective agents|mesh-ancestor
65333160|NCT02561013|Monensin|monensin|mesh-list
65333161|NCT02561013|Antifungal Agents|antifungal agents|mesh-ancestor
65333162|NCT02561013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65333163|NCT02561013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65333164|NCT02561013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65333165|NCT02561013|Coccidiostats|coccidiostats|mesh-ancestor
64719054|NCT00448682|Leucovorin|leucovorin|mesh-list
65219283|NCT00736645|Hormone Antagonists|hormone antagonists|mesh-ancestor
65219284|NCT00736645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65219285|NCT00736645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219286|NCT00736645|Urological Agents|urological agents|mesh-ancestor
65219287|NCT00736645|Antioxidants|antioxidants|mesh-ancestor
65219288|NCT00736645|Protective Agents|protective agents|mesh-ancestor
65219289|NCT00736645|Trace Elements|trace elements|mesh-ancestor
65219290|NCT00736645|Micronutrients|micronutrients|mesh-ancestor
65219291|NCT02326311|Imatinib Mesylate|imatinib mesylate|mesh-list
65219292|NCT02326311|Dasatinib|dasatinib|mesh-list
65219293|NCT02326311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219294|NCT02326311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65219295|NCT02326311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219296|NCT02326311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219297|NCT00736489|Formoterol Fumarate|formoterol fumarate|mesh-list
65219298|NCT00736489|AZD-3199|azd-3199|mesh-list
65219299|NCT00736489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65219300|NCT00736489|Autonomic Agents|autonomic agents|mesh-ancestor
65219301|NCT00736489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65219302|NCT00736489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219303|NCT00736489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65333166|NCT02561013|Proton Ionophores|proton ionophores|mesh-ancestor
65333167|NCT02561013|Uncoupling Agents|uncoupling agents|mesh-ancestor
65333168|NCT02561013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333169|NCT02561013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333170|NCT02561013|Ionophores|ionophores|mesh-ancestor
65333171|NCT02561013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65333172|NCT02561013|Sodium Ionophores|sodium ionophores|mesh-ancestor
65333173|NCT04779242|Moxifloxacin|moxifloxacin|mesh-list
65333174|NCT04779242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65333175|NCT04779242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65333176|NCT04779242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65333177|NCT04779242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65333178|NCT04779242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333179|NCT04779242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333180|NCT04779242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333181|NCT00678795|Nabiximols|nabiximols|mesh-list
65333182|NCT00678795|Analgesics|analgesics|mesh-ancestor
65333183|NCT00678795|Sensory System Agents|sensory system agents|mesh-ancestor
65333184|NCT00678795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333185|NCT00678795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333186|NCT04774406|Olaparib|olaparib|mesh-list
65333187|NCT04774406|Niraparib|niraparib|mesh-list
65333188|NCT04774406|Talazoparib|talazoparib|mesh-list
65333189|NCT04774406|Veliparib|veliparib|mesh-list
65333190|NCT04774406|Rucaparib|rucaparib|mesh-list
65333191|NCT04774406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65333192|NCT04774406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333193|NCT04774406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333194|NCT04774406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333195|NCT03417687|Xenon|xenon|mesh-list
65219304|NCT00736489|Respiratory System Agents|respiratory system agents|mesh-ancestor
65219305|NCT00736489|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65219306|NCT00736489|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65219307|NCT00736489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65219308|NCT00736489|Adrenergic Agents|adrenergic agents|mesh-ancestor
65219309|NCT00736489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65219310|NCT00736489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219311|NCT02716233|Pegaspargase|pegaspargase|mesh-list
65219312|NCT02716233|Asparaginase|asparaginase|mesh-list
65219313|NCT02716233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219314|NCT01999569|Letrozole|letrozole|mesh-list
65219315|NCT01999569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219316|NCT01999569|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65219317|NCT01999569|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65219318|NCT01999569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219319|NCT01999569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719095|NCT00368654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65333196|NCT03417687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65333197|NCT03417687|Anesthetics, General|anesthetics, general|mesh-ancestor
65333198|NCT03417687|Anesthetics|anesthetics|mesh-ancestor
65333199|NCT03417687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65333200|NCT03417687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333201|NCT04767698|Belimumab|belimumab|mesh-list
65333202|NCT04767698|Ocrelizumab|ocrelizumab|mesh-list
65333203|NCT04767698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65333204|NCT04767698|Immunologic Factors|immunologic factors|mesh-ancestor
65333205|NCT04767698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219320|NCT01999569|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65219321|NCT01999569|Hormone Antagonists|hormone antagonists|mesh-ancestor
65219322|NCT01999569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65219323|NCT01999569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219324|NCT04087915|Evolocumab|evolocumab|mesh-list
65219325|NCT04087915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65219326|NCT04087915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65219327|NCT04087915|Antimetabolites|antimetabolites|mesh-ancestor
65219328|NCT04087915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219329|NCT04087915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65219330|NCT02715687|Amiodarone|amiodarone|mesh-list
65219331|NCT02715687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65219332|NCT02715687|Vasodilator Agents|vasodilator agents|mesh-ancestor
65219333|NCT02715687|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65219334|NCT02715687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65219335|NCT02715687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219338|NCT02715687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65219339|NCT02715687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219340|NCT02715687|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65219341|NCT02715687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65219342|NCT02715687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65219343|NCT04068831|Avelumab|avelumab|mesh-list
65219344|NCT04068831|Talazoparib|talazoparib|mesh-list
65219345|NCT04068831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65219346|NCT04068831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219347|NCT04068831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65219348|NCT04068831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219349|NCT04068831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219350|NCT02715531|Leucovorin|leucovorin|mesh-list
65219351|NCT02715531|Gemcitabine|gemcitabine|mesh-list
65219352|NCT02715531|Paclitaxel|paclitaxel|mesh-list
65219353|NCT02715531|Bevacizumab|bevacizumab|mesh-list
65219354|NCT02715531|Capecitabine|capecitabine|mesh-list
65219355|NCT02715531|Oxaliplatin|oxaliplatin|mesh-list
65219356|NCT02715531|Atezolizumab|atezolizumab|mesh-list
65219357|NCT02715531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65219358|NCT02715531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219359|NCT02715531|Tubulin Modulators|tubulin modulators|mesh-ancestor
65219360|NCT02715531|Antimitotic Agents|antimitotic agents|mesh-ancestor
65219361|NCT02715531|Mitosis Modulators|mitosis modulators|mesh-ancestor
65219362|NCT02715531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219363|NCT02715531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65219364|NCT02715531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65219365|NCT02715531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65219366|NCT02715531|Growth Substances|growth substances|mesh-ancestor
65219367|NCT02715531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219368|NCT02715531|Growth Inhibitors|growth inhibitors|mesh-ancestor
65219369|NCT02715531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65219370|NCT02715531|Antimetabolites|antimetabolites|mesh-ancestor
65219371|NCT02715531|Antiviral Agents|antiviral agents|mesh-ancestor
65219372|NCT02715531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65219373|NCT02715531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333206|NCT04049253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65333207|NCT03205137|Amlodipine|amlodipine|mesh-list
65333208|NCT03205137|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65333209|NCT03205137|Telmisartan|telmisartan|mesh-list
65333210|NCT03205137|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
65333211|NCT03205137|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
65219374|NCT02715531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65219375|NCT02715531|Immunologic Factors|immunologic factors|mesh-ancestor
65219376|NCT02715531|Antidotes|antidotes|mesh-ancestor
65219377|NCT02715531|Protective Agents|protective agents|mesh-ancestor
65219378|NCT02715531|Vitamin B Complex|vitamin b complex|mesh-ancestor
65219379|NCT02715531|Vitamins|vitamins|mesh-ancestor
65219380|NCT02715531|Micronutrients|micronutrients|mesh-ancestor
65219381|NCT00811018|Sitaxsentan|sitaxsentan|mesh-list
65219382|NCT00811018|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65219383|NCT00811018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219384|NCT04037085|Ketamine|ketamine|mesh-list
65219385|NCT04037085|Analgesics|analgesics|mesh-ancestor
65219386|NCT04037085|Sensory System Agents|sensory system agents|mesh-ancestor
65219387|NCT04037085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65219388|NCT04037085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219389|NCT04037085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65219390|NCT04037085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65219391|NCT04037085|Anesthetics, General|anesthetics, general|mesh-ancestor
65219392|NCT04037085|Anesthetics|anesthetics|mesh-ancestor
65219393|NCT04037085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65219394|NCT04037085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65219395|NCT04037085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65219396|NCT04037085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65219397|NCT04037085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219398|NCT00914056|Lactulose|lactulose|mesh-list
65219399|NCT00914056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65219400|NCT00730171|Linaclotide|linaclotide|mesh-list
65219401|NCT00730171|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65219402|NCT00730171|Enzyme Activators|enzyme activators|mesh-ancestor
65219403|NCT00730171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219404|NCT00730171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65219405|NCT04787835|Anesthetics|anesthetics|mesh-list
65219406|NCT04787835|Anesthetics, Local|anesthetics, local|mesh-list
65219407|NCT04787835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65219408|NCT04787835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219412|NCT00730015|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65219413|NCT00730015|Enzyme Activators|enzyme activators|mesh-ancestor
65219414|NCT00730015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219415|NCT00730015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65219416|NCT00806026|Pregabalin|pregabalin|mesh-list
65219417|NCT00806026|Pramipexole|pramipexole|mesh-list
65219418|NCT00806026|Analgesics|analgesics|mesh-ancestor
65219419|NCT00806026|Sensory System Agents|sensory system agents|mesh-ancestor
65219420|NCT00806026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65219421|NCT00806026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219422|NCT00806026|Anticonvulsants|anticonvulsants|mesh-ancestor
65219423|NCT00806026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65219424|NCT00806026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65219425|NCT00806026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219426|NCT00806026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65219427|NCT00806026|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65219428|NCT00806026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65219429|NCT00806026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65219430|NCT00806026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65219431|NCT00806026|Antioxidants|antioxidants|mesh-ancestor
65219432|NCT00806026|Protective Agents|protective agents|mesh-ancestor
65219433|NCT00806026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65219434|NCT00806026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65219435|NCT00806026|Dopamine Agonists|dopamine agonists|mesh-ancestor
65219436|NCT00806026|Dopamine Agents|dopamine agents|mesh-ancestor
65219437|NCT00806026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65219438|NCT04227093|Acetazolamide|acetazolamide|mesh-list
65219439|NCT04227093|Anticonvulsants|anticonvulsants|mesh-ancestor
65333212|NCT03205137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65333213|NCT03205137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65333214|NCT03205137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65333215|NCT03205137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333216|NCT03205137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65333217|NCT03205137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333218|NCT03205137|Vasodilator Agents|vasodilator agents|mesh-ancestor
65333219|NCT03205137|Diuretics|diuretics|mesh-ancestor
65333220|NCT03205137|Natriuretic Agents|natriuretic agents|mesh-ancestor
65333221|NCT03205137|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65333222|NCT03205137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65333223|NCT03205137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65333224|NCT04745234|Mogamulizumab|mogamulizumab|mesh-list
64719110|NCT00000776|Fluconazole|fluconazole|mesh-list
65219440|NCT04227093|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65219441|NCT04227093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219442|NCT04227093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219443|NCT04227093|Diuretics|diuretics|mesh-ancestor
65219444|NCT04227093|Natriuretic Agents|natriuretic agents|mesh-ancestor
65219445|NCT04227093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219446|NCT00805792|Donepezil|donepezil|mesh-list
65219447|NCT00805792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65219448|NCT00805792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219449|NCT00805792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219450|NCT00805792|Cholinergic Agents|cholinergic agents|mesh-ancestor
65219451|NCT00805792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65219452|NCT00805792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219453|NCT00805792|Nootropic Agents|nootropic agents|mesh-ancestor
65219454|NCT04783935|Cladribine|cladribine|mesh-list
65219455|NCT04783935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219456|NCT04783935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65219457|NCT04783935|Immunologic Factors|immunologic factors|mesh-ancestor
65219458|NCT04783935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219459|NCT04777929|Progesterone|progesterone|mesh-list
65219460|NCT04777929|Estrogens|estrogens|mesh-list
65219461|NCT04777929|Progestins|progestins|mesh-ancestor
65219462|NCT04777929|Hormones|hormones|mesh-ancestor
65219463|NCT04777929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65219464|NCT04777929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219465|NCT00590044|Insulin|insulin|mesh-list
65219466|NCT00590044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65219467|NCT00590044|Insulin Glargine|insulin glargine|mesh-list
65219468|NCT00590044|Insulin, Isophane|insulin, isophane|mesh-list
65219469|NCT00590044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65219470|NCT00590044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219471|NCT02714361|Vitamin D|vitamin d|mesh-list
65219472|NCT02714361|Cholecalciferol|cholecalciferol|mesh-list
65219473|NCT02714361|Vitamins|vitamins|mesh-ancestor
65219474|NCT02714361|Micronutrients|micronutrients|mesh-ancestor
65219475|NCT02714361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219476|NCT02714361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65219477|NCT02714361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65219478|NCT00248703|Docetaxel|docetaxel|mesh-list
65219479|NCT00248703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219480|NCT00248703|Tubulin Modulators|tubulin modulators|mesh-ancestor
65219481|NCT00248703|Antimitotic Agents|antimitotic agents|mesh-ancestor
65219482|NCT00248703|Mitosis Modulators|mitosis modulators|mesh-ancestor
65219484|NCT02713893|Econazole|econazole|mesh-list
65219485|NCT02713893|Benzydamine|benzydamine|mesh-list
65219486|NCT02713893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65219487|NCT02713893|Antifungal Agents|antifungal agents|mesh-ancestor
65333225|NCT04745234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333226|NCT00678561|Tofacitinib|tofacitinib|mesh-list
65333227|NCT00678561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65333228|NCT00678561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333229|NCT00678561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333230|NCT04732286|Bevacizumab|bevacizumab|mesh-list
65333231|NCT04732286|Atezolizumab|atezolizumab|mesh-list
65333232|NCT04732286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65333233|NCT04732286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333234|NCT04732286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65333235|NCT04732286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65333236|NCT04732286|Growth Substances|growth substances|mesh-ancestor
65219488|NCT02713893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65219489|NCT02713893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65219490|NCT02713893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65219491|NCT02713893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219492|NCT02713893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219493|NCT02713893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65219494|NCT02713893|Hormone Antagonists|hormone antagonists|mesh-ancestor
65219495|NCT02713893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65219496|NCT02713893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219497|NCT00729937|Clindamycin|clindamycin|mesh-list
65219498|NCT00729937|Clindamycin palmitate|clindamycin palmitate|mesh-list
65219499|NCT00729937|Clindamycin phosphate|clindamycin phosphate|mesh-list
65219500|NCT00729937|Cephalexin|cephalexin|mesh-list
65219501|NCT00729937|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65219502|NCT00729937|Trimethoprim|trimethoprim|mesh-list
65219503|NCT00729937|Sulfamethoxazole|sulfamethoxazole|mesh-list
65219504|NCT00729937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65219505|NCT00729937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65219506|NCT00729937|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65219507|NCT00729937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219508|NCT00729937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219509|NCT00729937|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65219510|NCT00729937|Renal Agents|renal agents|mesh-ancestor
65219511|NCT00729937|Antimalarials|antimalarials|mesh-ancestor
65219512|NCT00729937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65219513|NCT00729937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65219514|NCT00729937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65219515|NCT00729937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65219516|NCT00729937|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64862267|NCT01763658|Hormones|hormones|mesh-ancestor
65219517|NCT00729937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65219519|NCT00729859|Anastrozole|anastrozole|mesh-list
65219520|NCT00729859|Testosterone|testosterone|mesh-list
65219521|NCT00729859|Testosterone undecanoate|testosterone undecanoate|mesh-list
65219522|NCT00729859|Testosterone enanthate|testosterone enanthate|mesh-list
65219523|NCT00729859|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65219524|NCT00729859|Acyline|acyline|mesh-list
65219525|NCT00729859|Androgens|androgens|mesh-ancestor
65219526|NCT00729859|Hormones|hormones|mesh-ancestor
65219527|NCT00729859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65219528|NCT00729859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219529|NCT00729859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65219530|NCT00729859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219531|NCT00729859|Anabolic Agents|anabolic agents|mesh-ancestor
65219532|NCT00729859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65219533|NCT00729859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65219534|NCT00729859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219535|NCT00729859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219536|NCT00729859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65219537|NCT00729859|Hormone Antagonists|hormone antagonists|mesh-ancestor
65333237|NCT04732286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333238|NCT04732286|Growth Inhibitors|growth inhibitors|mesh-ancestor
65333239|NCT04949828|Pancrelipase|pancrelipase|mesh-list
65333240|NCT04949828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65333241|NCT04939142|Dexamethasone|dexamethasone|mesh-list
65333242|NCT04939142|Dexamethasone acetate|dexamethasone acetate|mesh-list
65333243|NCT04939142|Bortezomib|bortezomib|mesh-list
65333244|NCT04939142|BB 1101|bb 1101|mesh-list
65333245|NCT04939142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65333246|NCT04939142|Antiemetics|antiemetics|mesh-ancestor
64719141|NCT04283773|Antibodies|antibodies|mesh-list
65219538|NCT00810394|Sorafenib|sorafenib|mesh-list
65219539|NCT00810394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219540|NCT00810394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65219541|NCT00810394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219542|NCT00810394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219543|NCT00736333|Doxorubicin|doxorubicin|mesh-list
65219544|NCT00736333|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65219545|NCT00736333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65219546|NCT00736333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219547|NCT00736333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65219548|NCT00736333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65219549|NCT00736333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219550|NCT00736333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219551|NCT00736255|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65219552|NCT00736255|Dextroamphetamine|dextroamphetamine|mesh-list
65219553|NCT00736255|Nicotine|nicotine|mesh-list
65219554|NCT00736255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65219555|NCT00736255|Autonomic Agents|autonomic agents|mesh-ancestor
65219557|NCT00736255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219558|NCT00736255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65219559|NCT00736255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65219560|NCT00736255|Cholinergic Agents|cholinergic agents|mesh-ancestor
65219561|NCT00736255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65219562|NCT00736255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219563|NCT00736255|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65219564|NCT00736255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65219565|NCT00736255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65219566|NCT00736255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65219568|NCT00742183|Silver Sulfadiazine|silver sulfadiazine|mesh-list
65219569|NCT00742183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65219570|NCT00742183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65219572|NCT00808444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65219573|NCT00808444|Immunologic Factors|immunologic factors|mesh-ancestor
65219574|NCT00808444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219575|NCT00914134|Levodopa|levodopa|mesh-list
65219576|NCT00914134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65219577|NCT00914134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65219578|NCT00914134|Dopamine Agents|dopamine agents|mesh-ancestor
65219579|NCT00914134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65219580|NCT00914134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219581|NCT00914134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219582|NCT05754736|Bevacizumab|bevacizumab|mesh-list
65219583|NCT05754736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65219584|NCT05754736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219585|NCT05754736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65219586|NCT05754736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65219587|NCT05754736|Growth Substances|growth substances|mesh-ancestor
65219588|NCT05754736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219589|NCT05754736|Growth Inhibitors|growth inhibitors|mesh-ancestor
65219590|NCT00742027|Panobinostat|panobinostat|mesh-list
65219591|NCT00742027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219592|NCT00742027|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65219593|NCT00742027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219594|NCT00742027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333247|NCT04939142|Autonomic Agents|autonomic agents|mesh-ancestor
65333248|NCT04939142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333249|NCT04939142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333250|NCT04939142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65333251|NCT04939142|Glucocorticoids|glucocorticoids|mesh-ancestor
65333252|NCT04939142|Hormones|hormones|mesh-ancestor
65333253|NCT04939142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65333254|NCT04939142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65333255|NCT04939142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333256|NCT04939142|Protease Inhibitors|protease inhibitors|mesh-ancestor
65333257|NCT04939142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333258|NCT04939142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219595|NCT02609698|Aspirin|aspirin|mesh-list
65219596|NCT02609698|Clopidogrel|clopidogrel|mesh-list
65219597|NCT02609698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65219598|NCT02609698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65219599|NCT02609698|Analgesics|analgesics|mesh-ancestor
65219600|NCT02609698|Sensory System Agents|sensory system agents|mesh-ancestor
65219601|NCT02609698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65219602|NCT02609698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219603|NCT02609698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65219604|NCT02609698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65219605|NCT02609698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65219606|NCT02609698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65219607|NCT02609698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219608|NCT02609698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65219609|NCT02609698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65219610|NCT02609698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219611|NCT02609698|Antipyretics|antipyretics|mesh-ancestor
65219612|NCT02609698|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65219613|NCT02609698|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65219614|NCT02609698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65219615|NCT02609698|Purinergic Agents|purinergic agents|mesh-ancestor
65219616|NCT02609698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65219617|NCT05750134|Pancrelipase|pancrelipase|mesh-list
65219618|NCT05750134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65219619|NCT05749822|Fenofibrate|fenofibrate|mesh-list
65219620|NCT05749822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65219621|NCT05749822|Antimetabolites|antimetabolites|mesh-ancestor
65219622|NCT05749822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219623|NCT05749822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65219624|NCT02713191|Fentanyl|fentanyl|mesh-list
65219625|NCT02713191|Midazolam|midazolam|mesh-list
65219626|NCT02713191|Dexmedetomidine|dexmedetomidine|mesh-list
65219627|NCT02713191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65219628|NCT02713191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65219632|NCT02713191|Sensory System Agents|sensory system agents|mesh-ancestor
65219633|NCT02713191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65219634|NCT02713191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65219635|NCT02713191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65219637|NCT02713191|Adrenergic Agents|adrenergic agents|mesh-ancestor
65219638|NCT02713191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65219639|NCT02713191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219641|NCT02713191|Narcotics|narcotics|mesh-ancestor
65219642|NCT02713191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65219643|NCT02713191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65219644|NCT02713191|Anesthetics, General|anesthetics, general|mesh-ancestor
65219645|NCT02713191|Anesthetics|anesthetics|mesh-ancestor
65219646|NCT02713191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65219647|NCT02713191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65219648|NCT02713191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65219649|NCT02713191|GABA Modulators|gaba modulators|mesh-ancestor
65333259|NCT05683340|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
65333260|NCT05683340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65333261|NCT05683340|Antimetabolites|antimetabolites|mesh-ancestor
65333262|NCT05683340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333263|NCT05683340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65333264|NCT05683340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333265|NCT05683340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65333266|NCT05683340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333267|NCT04081376|Hydromorphone|hydromorphone|mesh-list
65333268|NCT04081376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65083158|NCT00430079|Etanidazole|etanidazole|mesh-list
65333270|NCT04081376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65333271|NCT04081376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333272|NCT04081376|Analgesics|analgesics|mesh-ancestor
65333273|NCT04081376|Sensory System Agents|sensory system agents|mesh-ancestor
65333274|NCT04081376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333275|NCT02584400|Imidazole|imidazole|mesh-list
65333276|NCT02584400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333277|NCT02584400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219650|NCT02713191|GABA Agents|gaba agents|mesh-ancestor
65219651|NCT00611169|Tirofiban|tirofiban|mesh-list
65219652|NCT00611169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65219653|NCT00611169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65219654|NCT00611169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219655|NCT00611169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65219656|NCT05754502|Trastuzumab|trastuzumab|mesh-list
65219657|NCT05754502|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65219658|NCT05754502|Maytansine|maytansine|mesh-list
65219659|NCT05754502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65219660|NCT05754502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219661|NCT05754502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65219662|NCT05754502|Tubulin Modulators|tubulin modulators|mesh-ancestor
65219663|NCT05754502|Antimitotic Agents|antimitotic agents|mesh-ancestor
65219664|NCT05754502|Mitosis Modulators|mitosis modulators|mesh-ancestor
65219665|NCT05754502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219666|NCT02712957|Naproxen|naproxen|mesh-list
65219667|NCT02712957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65219668|NCT02712957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65219669|NCT02712957|Analgesics|analgesics|mesh-ancestor
65219670|NCT02712957|Sensory System Agents|sensory system agents|mesh-ancestor
65219671|NCT02712957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65219672|NCT02712957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219673|NCT02712957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65219674|NCT02712957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65219675|NCT02712957|Gout Suppressants|gout suppressants|mesh-ancestor
65219676|NCT02712957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65219677|NCT02712957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219678|NCT02712957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219679|NCT04226625|Propofol|propofol|mesh-list
65219680|NCT04226625|Desflurane|desflurane|mesh-list
65219681|NCT04226625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65219682|NCT04226625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65219683|NCT04226625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219684|NCT04226625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65333278|NCT04585022|Cimetidine|cimetidine|mesh-list
65333279|NCT04585022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65333280|NCT04585022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65333281|NCT04585022|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65333282|NCT04585022|Histamine Antagonists|histamine antagonists|mesh-ancestor
65333283|NCT04585022|Histamine Agents|histamine agents|mesh-ancestor
65333284|NCT04585022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65333285|NCT04585022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333286|NCT04585022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719177|NCT00000800|Analgesics|analgesics|mesh-ancestor
65219685|NCT04226625|Anesthetics, General|anesthetics, general|mesh-ancestor
65219686|NCT04226625|Anesthetics|anesthetics|mesh-ancestor
65219687|NCT04226625|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65219688|NCT02777619|Dexmedetomidine|dexmedetomidine|mesh-list
65219689|NCT02777619|Propofol|propofol|mesh-list
65219690|NCT02777619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65219691|NCT02777619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65219692|NCT02777619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219693|NCT02777619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65219694|NCT02777619|Anesthetics, General|anesthetics, general|mesh-ancestor
65219695|NCT02777619|Anesthetics|anesthetics|mesh-ancestor
65219696|NCT02777619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65219697|NCT02777619|Analgesics|analgesics|mesh-ancestor
65219698|NCT02777619|Sensory System Agents|sensory system agents|mesh-ancestor
65219699|NCT02777619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65219700|NCT02777619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65219701|NCT02777619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65219708|NCT05754424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219709|NCT00636831|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65219710|NCT00636831|Cefazolin|cefazolin|mesh-list
65219711|NCT00636831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65219712|NCT04193631|Cannabidiol|cannabidiol|mesh-list
65219713|NCT04193631|Anticonvulsants|anticonvulsants|mesh-ancestor
65219714|NCT04856631|Cetuximab|cetuximab|mesh-list
65219715|NCT04856631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65219716|NCT04856631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219717|NCT00808210|Methylprednisolone|methylprednisolone|mesh-list
65219718|NCT00808210|Methotrexate|methotrexate|mesh-list
65219719|NCT00808210|Infliximab|infliximab|mesh-list
65219720|NCT00808210|Ocrelizumab|ocrelizumab|mesh-list
65219721|NCT00808210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65219722|NCT00808210|Abortifacient Agents|abortifacient agents|mesh-ancestor
65219723|NCT00808210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65219724|NCT00808210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219725|NCT00808210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65219726|NCT00808210|Antimetabolites|antimetabolites|mesh-ancestor
65219727|NCT00808210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219728|NCT00808210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219729|NCT00808210|Dermatologic Agents|dermatologic agents|mesh-ancestor
65219730|NCT00808210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219731|NCT00808210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65219732|NCT00808210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65219733|NCT00808210|Immunologic Factors|immunologic factors|mesh-ancestor
65219734|NCT00808210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65219735|NCT00808210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65219736|NCT00808210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65219737|NCT00808210|Antiemetics|antiemetics|mesh-ancestor
65219738|NCT00808210|Autonomic Agents|autonomic agents|mesh-ancestor
65219739|NCT00808210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65219740|NCT00808210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65219741|NCT00808210|Glucocorticoids|glucocorticoids|mesh-ancestor
65219742|NCT00808210|Hormones|hormones|mesh-ancestor
65219743|NCT00808210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65219744|NCT00808210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65219745|NCT00808210|Protective Agents|protective agents|mesh-ancestor
65219746|NCT02777229|Tenofovir|tenofovir|mesh-list
65219747|NCT02777229|Lamivudine|lamivudine|mesh-list
65333287|NCT04585022|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65333288|NCT04585022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65333289|NCT04585022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333290|NCT02586194|Peficitinib|peficitinib|mesh-list
65333291|NCT02586194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333292|NCT02586194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333293|NCT02586194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65333294|NCT02586194|Immunologic Factors|immunologic factors|mesh-ancestor
65333295|NCT02586194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333296|NCT00761241|Gemcitabine|gemcitabine|mesh-list
65333297|NCT00761241|Interferons|interferons|mesh-list
65333298|NCT00761241|Interferon-alpha|interferon-alpha|mesh-list
65333299|NCT00761241|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65333300|NCT00761241|Docetaxel|docetaxel|mesh-list
65333301|NCT00761241|Oxaliplatin|oxaliplatin|mesh-list
65333302|NCT00761241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65333303|NCT00761241|Antimetabolites|antimetabolites|mesh-ancestor
65219748|NCT02777229|Efavirenz|efavirenz|mesh-list
65219749|NCT02777229|Dolutegravir|dolutegravir|mesh-list
65219750|NCT02777229|Antiviral Agents|antiviral agents|mesh-ancestor
65219751|NCT02777229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65219752|NCT02777229|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65219753|NCT02777229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65219754|NCT02777229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219755|NCT02777229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219756|NCT02777229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65219757|NCT02777229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65219758|NCT02777229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65219759|NCT02777229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65219760|NCT02777229|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65219761|NCT02777229|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65219762|NCT02777229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65219763|NCT02777229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65219764|NCT02777229|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65219765|NCT02777229|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65219766|NCT02712177|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65219767|NCT02712177|Immunologic Factors|immunologic factors|mesh-ancestor
65219768|NCT02712177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219769|NCT00635037|Bupivacaine|bupivacaine|mesh-list
65219770|NCT00635037|Anesthetics, Local|anesthetics, local|mesh-ancestor
65219771|NCT00635037|Anesthetics|anesthetics|mesh-ancestor
65219775|NCT00635037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65219776|NCT02777151|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
65219777|NCT02777151|Atoltivimab|atoltivimab|mesh-list
65219778|NCT02777151|Antiviral Agents|antiviral agents|mesh-ancestor
65219779|NCT02777151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65219780|NCT02777073|Dapagliflozin|dapagliflozin|mesh-list
65219781|NCT02777073|Liraglutide|liraglutide|mesh-list
65219782|NCT02777073|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65219783|NCT02777073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219784|NCT02777073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65219785|NCT02777073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219786|NCT02777073|Incretins|incretins|mesh-ancestor
65219787|NCT02777073|Hormones|hormones|mesh-ancestor
65219788|NCT02777073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65219789|NCT02711865|Antibodies|antibodies|mesh-list
65219790|NCT02711865|Immunologic Factors|immunologic factors|mesh-ancestor
65333304|NCT00761241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333305|NCT00761241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333306|NCT00761241|Antiviral Agents|antiviral agents|mesh-ancestor
65333307|NCT00761241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65333308|NCT00761241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333309|NCT00761241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65333310|NCT00761241|Immunologic Factors|immunologic factors|mesh-ancestor
65333311|NCT00761241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333312|NCT00761241|Tubulin Modulators|tubulin modulators|mesh-ancestor
65219791|NCT02711865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219792|NCT02711943|Levofloxacin|levofloxacin|mesh-list
65219793|NCT02711943|Ofloxacin|ofloxacin|mesh-list
65219794|NCT02711943|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65219795|NCT02711943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65219796|NCT02711943|Renal Agents|renal agents|mesh-ancestor
65219797|NCT02711943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65219798|NCT02711943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65219799|NCT02711943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65219800|NCT02711943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219801|NCT02711943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219802|NCT02711943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219803|NCT02711943|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65219804|NCT02711943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65219805|NCT02776761|Vaccines|vaccines|mesh-list
65219806|NCT02776761|Immunologic Factors|immunologic factors|mesh-ancestor
65219807|NCT02776761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219808|NCT04848753|Paclitaxel|paclitaxel|mesh-list
65219809|NCT04848753|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65219810|NCT04848753|Cisplatin|cisplatin|mesh-list
65219811|NCT04848753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65219812|NCT04848753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219813|NCT04848753|Tubulin Modulators|tubulin modulators|mesh-ancestor
65219814|NCT04848753|Antimitotic Agents|antimitotic agents|mesh-ancestor
65219815|NCT04848753|Mitosis Modulators|mitosis modulators|mesh-ancestor
65219816|NCT04848753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219817|NCT00736099|Pioglitazone|pioglitazone|mesh-list
65219818|NCT00736099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65219819|NCT00736099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219820|NCT04616547|Edetic Acid|edetic acid|mesh-list
65219821|NCT04616547|Pentetic Acid|pentetic acid|mesh-list
65219822|NCT04616547|Antidotes|antidotes|mesh-ancestor
65219823|NCT04616547|Protective Agents|protective agents|mesh-ancestor
65219824|NCT04616547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219825|NCT04616547|Chelating Agents|chelating agents|mesh-ancestor
65219826|NCT04616547|Sequestering Agents|sequestering agents|mesh-ancestor
65219827|NCT04616547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219828|NCT04616547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65219829|NCT04616547|Anticoagulants|anticoagulants|mesh-ancestor
65219830|NCT04616547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65219831|NCT02711241|Dipyrone|dipyrone|mesh-list
65219832|NCT02711241|Papaverine|papaverine|mesh-list
65219833|NCT02711241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65219834|NCT02711241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65219835|NCT02711241|Analgesics|analgesics|mesh-ancestor
65219836|NCT02711241|Sensory System Agents|sensory system agents|mesh-ancestor
65219837|NCT02711241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65219838|NCT02711241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219839|NCT02711241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65219840|NCT02711241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65219841|NCT02711241|Antipyretics|antipyretics|mesh-ancestor
65219842|NCT02711241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65219843|NCT02711241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219848|NCT02711007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219849|NCT02711007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65219851|NCT02711007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219852|NCT02710539|Amlodipine|amlodipine|mesh-list
65333313|NCT00761241|Antimitotic Agents|antimitotic agents|mesh-ancestor
65333314|NCT00761241|Mitosis Modulators|mitosis modulators|mesh-ancestor
65333315|NCT02981979|Prednisone|prednisone|mesh-list
65333316|NCT02981979|Leflunomide|leflunomide|mesh-list
65333317|NCT02981979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65333318|NCT02981979|Glucocorticoids|glucocorticoids|mesh-ancestor
65333319|NCT02981979|Hormones|hormones|mesh-ancestor
65333320|NCT02981979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64719213|NCT00218036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65219853|NCT02710539|Perindopril|perindopril|mesh-list
65219854|NCT02710539|Indapamide|indapamide|mesh-list
65219855|NCT02710539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65219856|NCT02710539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65219857|NCT02710539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65219858|NCT02710539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219859|NCT02710539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65219860|NCT02710539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219861|NCT02710539|Vasodilator Agents|vasodilator agents|mesh-ancestor
65219862|NCT02710539|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65219863|NCT02710539|Protease Inhibitors|protease inhibitors|mesh-ancestor
65219864|NCT02710539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219865|NCT02710539|Diuretics|diuretics|mesh-ancestor
65219866|NCT02710539|Natriuretic Agents|natriuretic agents|mesh-ancestor
65219867|NCT02710539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65219868|NCT00735709|Vortioxetine|vortioxetine|mesh-list
65219869|NCT00735709|Antidepressive Agents|antidepressive agents|mesh-ancestor
65219870|NCT00735709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65219871|NCT00735709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65219872|NCT00735709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65219873|NCT00735709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65219874|NCT00735709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219875|NCT00735709|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65219876|NCT00735709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65219877|NCT00735709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65219878|NCT00735709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219879|NCT00735709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65219880|NCT00735709|Serotonin Agents|serotonin agents|mesh-ancestor
65219881|NCT00735709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65219882|NCT00735709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65219883|NCT00735709|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65219884|NCT00735709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65219886|NCT02776527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219887|NCT02776527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65219888|NCT02776527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219889|NCT02776527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219890|NCT04843761|Remdesivir|remdesivir|mesh-list
65219891|NCT04843761|Phentolamine|phentolamine|mesh-list
65219892|NCT04843761|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
65219893|NCT04843761|Antimetabolites|antimetabolites|mesh-ancestor
65219894|NCT04843761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219895|NCT04843761|Antiviral Agents|antiviral agents|mesh-ancestor
65219896|NCT04843761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65219897|NCT04843761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65219898|NCT04843761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65219899|NCT04843761|Adrenergic Agents|adrenergic agents|mesh-ancestor
65219900|NCT04843761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65219901|NCT04843761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219902|NCT04843761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65219903|NCT04843761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65219904|NCT04843761|Vasodilator Agents|vasodilator agents|mesh-ancestor
65219905|NCT04843761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65219906|NCT04843761|Protective Agents|protective agents|mesh-ancestor
65219907|NCT00729157|Deoxyglucose|deoxyglucose|mesh-list
65219908|NCT00729157|Aflibercept|aflibercept|mesh-list
65219909|NCT00729157|Endothelial Growth Factors|endothelial growth factors|mesh-list
65219910|NCT00729157|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65333321|NCT02981979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333322|NCT02981979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65333323|NCT02981979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333324|NCT02981979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333325|NCT02981979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333326|NCT02981979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65333327|NCT02981979|Immunologic Factors|immunologic factors|mesh-ancestor
65333328|NCT04049409|Trastuzumab|trastuzumab|mesh-list
65333329|NCT04049409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65333330|NCT04049409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333331|NCT00920660|Prednisolone|prednisolone|mesh-list
65333332|NCT00920660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65333333|NCT00920660|Glucocorticoids|glucocorticoids|mesh-ancestor
65333334|NCT00920660|Hormones|hormones|mesh-ancestor
65333335|NCT00920660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65333336|NCT00920660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719217|NCT00218036|Antidepressive Agents|antidepressive agents|mesh-ancestor
65219911|NCT00729157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65219912|NCT00729157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65219913|NCT00729157|Growth Substances|growth substances|mesh-ancestor
65219920|NCT00729157|Antiviral Agents|antiviral agents|mesh-ancestor
65219921|NCT00729157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65219923|NCT02710305|Scopolamine|scopolamine|mesh-list
65219924|NCT02710305|Bromides|bromides|mesh-list
65219925|NCT02710305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65219926|NCT02710305|Anesthetics, Local|anesthetics, local|mesh-ancestor
65219927|NCT02710305|Anesthetics|anesthetics|mesh-ancestor
65219928|NCT02710305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65219929|NCT02710305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219930|NCT02710305|Sensory System Agents|sensory system agents|mesh-ancestor
65219931|NCT02710305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65219932|NCT02710305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65219933|NCT02710305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65219934|NCT02710305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65219935|NCT02710305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65219936|NCT02710305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219937|NCT02710305|Anticonvulsants|anticonvulsants|mesh-ancestor
65219938|NCT02710305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65219940|NCT02710305|Autonomic Agents|autonomic agents|mesh-ancestor
65219941|NCT02710305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65219942|NCT02710305|Mydriatics|mydriatics|mesh-ancestor
65219943|NCT02710305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65219944|NCT02710305|Cholinergic Agents|cholinergic agents|mesh-ancestor
65219945|NCT02710305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65219946|NCT02710305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65219947|NCT02710305|Parasympatholytics|parasympatholytics|mesh-ancestor
65219948|NCT02708511|Copper|copper|mesh-list
65219949|NCT02708511|Trace Elements|trace elements|mesh-ancestor
65219950|NCT02708511|Micronutrients|micronutrients|mesh-ancestor
65219951|NCT02708511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219952|NCT02596243|Vaccines|vaccines|mesh-list
65219953|NCT02596243|Immunologic Factors|immunologic factors|mesh-ancestor
65219954|NCT02596243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219955|NCT02717091|Gemcitabine|gemcitabine|mesh-list
65219956|NCT02717091|Paclitaxel|paclitaxel|mesh-list
65219957|NCT02717091|Folfirinox|folfirinox|mesh-list
65219958|NCT02717091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65219959|NCT02717091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333337|NCT00920660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65333338|NCT00920660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333339|NCT02583464|Tenofovir|tenofovir|mesh-list
65333340|NCT02583464|Emtricitabine|emtricitabine|mesh-list
65333341|NCT02583464|Antiviral Agents|antiviral agents|mesh-ancestor
65333342|NCT02583464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65333343|NCT02583464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65333344|NCT02583464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65333346|NCT02583464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333347|NCT02583464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65333348|NCT02583464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65333349|NCT00675597|Bevacizumab|bevacizumab|mesh-list
65333350|NCT00675597|Docetaxel|docetaxel|mesh-list
65333351|NCT00675597|Vinorelbine|vinorelbine|mesh-list
65219960|NCT02717091|Tubulin Modulators|tubulin modulators|mesh-ancestor
65219961|NCT02717091|Antimitotic Agents|antimitotic agents|mesh-ancestor
65219962|NCT02717091|Mitosis Modulators|mitosis modulators|mesh-ancestor
65219963|NCT02717091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219964|NCT02717091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65219965|NCT02717091|Antimetabolites|antimetabolites|mesh-ancestor
65219966|NCT02717091|Antiviral Agents|antiviral agents|mesh-ancestor
65219967|NCT02717091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65219968|NCT02717091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219969|NCT02717091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65219970|NCT02717091|Immunologic Factors|immunologic factors|mesh-ancestor
65219971|NCT02717091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219972|NCT03911973|Talazoparib|talazoparib|mesh-list
65219973|NCT03911973|Gedatolisib|gedatolisib|mesh-list
65219974|NCT03911973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65219975|NCT03911973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219976|NCT03911973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219977|NCT03911973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219978|NCT03911973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65219979|NCT00726895|Quinine|quinine|mesh-list
65219980|NCT00726895|Antimalarials|antimalarials|mesh-ancestor
65219981|NCT00726895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65219982|NCT00726895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65219983|NCT00726895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65219984|NCT00726895|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65219991|NCT02593201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65219992|NCT02593201|Cefazolin|cefazolin|mesh-list
65219993|NCT02593201|Ceftazidime|ceftazidime|mesh-list
65219994|NCT02593201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65219995|NCT02593201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65219996|NCT02593201|Antitubercular Agents|antitubercular agents|mesh-ancestor
65219997|NCT02707809|Dexmedetomidine|dexmedetomidine|mesh-list
65219998|NCT02707809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65219999|NCT02707809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65220000|NCT02707809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220001|NCT02707809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65220002|NCT02707809|Analgesics|analgesics|mesh-ancestor
65220003|NCT02707809|Sensory System Agents|sensory system agents|mesh-ancestor
65220004|NCT02707809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65220005|NCT02707809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65220006|NCT02707809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65220007|NCT02707809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65220008|NCT02707809|Adrenergic Agents|adrenergic agents|mesh-ancestor
65220009|NCT02707809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65220010|NCT02707809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220011|NCT00585325|Lidocaine|lidocaine|mesh-list
65220012|NCT00585325|Anesthetics, Local|anesthetics, local|mesh-ancestor
65220013|NCT00585325|Anesthetics|anesthetics|mesh-ancestor
65333352|NCT00675597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65333353|NCT00675597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333354|NCT00675597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65333355|NCT00675597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65333356|NCT00675597|Growth Substances|growth substances|mesh-ancestor
65333357|NCT00675597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333358|NCT00675597|Growth Inhibitors|growth inhibitors|mesh-ancestor
65333359|NCT00675597|Tubulin Modulators|tubulin modulators|mesh-ancestor
65333360|NCT00675597|Antimitotic Agents|antimitotic agents|mesh-ancestor
65333361|NCT00675597|Mitosis Modulators|mitosis modulators|mesh-ancestor
65333362|NCT00675597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333363|NCT00675597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65333364|NCT02677545|Aspirin|aspirin|mesh-list
65333365|NCT02677545|Clopidogrel|clopidogrel|mesh-list
65220014|NCT00585325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65220015|NCT00585325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220016|NCT00585325|Sensory System Agents|sensory system agents|mesh-ancestor
65220017|NCT00585325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65220018|NCT00585325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65220019|NCT00585325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65220020|NCT00585325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65220021|NCT00585325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65220022|NCT00585325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220024|NCT02716857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65220025|NCT02716857|Narcotics|narcotics|mesh-ancestor
65220026|NCT02716857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65220027|NCT02716857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220028|NCT02716857|Analgesics|analgesics|mesh-ancestor
65220029|NCT02716857|Sensory System Agents|sensory system agents|mesh-ancestor
65220030|NCT02716857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65220031|NCT04170309|Ceftobiprole|ceftobiprole|mesh-list
65220032|NCT04170309|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
65220033|NCT04170309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65220034|NCT04170309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65220035|NCT03944577|Evolocumab|evolocumab|mesh-list
65220036|NCT03944577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65220037|NCT03944577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65220038|NCT03944577|Antimetabolites|antimetabolites|mesh-ancestor
65220039|NCT03944577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220040|NCT03944577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65220041|NCT00917761|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65220042|NCT00917761|Interferon-alpha|interferon-alpha|mesh-list
65220043|NCT00917761|Entecavir|entecavir|mesh-list
65220044|NCT00917761|Antiviral Agents|antiviral agents|mesh-ancestor
65220045|NCT00917761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65220046|NCT00917761|Immunologic Factors|immunologic factors|mesh-ancestor
65220047|NCT00917761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220048|NCT02709603|Scopolamine|scopolamine|mesh-list
65220049|NCT02709603|Bromides|bromides|mesh-list
65220050|NCT02709603|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65220051|NCT02709603|Anticonvulsants|anticonvulsants|mesh-ancestor
65220052|NCT02709603|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65220053|NCT02709603|Antiemetics|antiemetics|mesh-ancestor
65220054|NCT02709603|Autonomic Agents|autonomic agents|mesh-ancestor
65220055|NCT02709603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65220066|NCT00611793|Vatalanib|vatalanib|mesh-list
65220067|NCT00611793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65220068|NCT00611793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65220069|NCT00611793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65220070|NCT00611793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65333366|NCT02677545|Ticagrelor|ticagrelor|mesh-list
65333367|NCT02677545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65333368|NCT02677545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65333369|NCT02677545|Analgesics|analgesics|mesh-ancestor
65333370|NCT02677545|Sensory System Agents|sensory system agents|mesh-ancestor
65333371|NCT02677545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333372|NCT02677545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333373|NCT02677545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65333374|NCT02677545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65333375|NCT02677545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65333376|NCT02677545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65333377|NCT02677545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719263|NCT00000818|Antiviral Agents|antiviral agents|mesh-ancestor
65220071|NCT00611793|Growth Substances|growth substances|mesh-ancestor
65220072|NCT00611793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220073|NCT00611793|Growth Inhibitors|growth inhibitors|mesh-ancestor
65220074|NCT00611793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65220075|NCT00611793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220076|NCT00611793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220077|NCT00611871|Propranolol|propranolol|mesh-list
65220078|NCT00611871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65220079|NCT00611871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65220080|NCT00611871|Adrenergic Agents|adrenergic agents|mesh-ancestor
65220081|NCT00611871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65220082|NCT00611871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220083|NCT00611871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220084|NCT00611871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65220085|NCT00611871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65220086|NCT00611871|Vasodilator Agents|vasodilator agents|mesh-ancestor
65220087|NCT02709525|Hyaluronic Acid|hyaluronic acid|mesh-list
65220088|NCT02709525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65220089|NCT02709525|Immunologic Factors|immunologic factors|mesh-ancestor
65220090|NCT02709525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220091|NCT02709525|Viscosupplements|viscosupplements|mesh-ancestor
65220092|NCT02709525|Protective Agents|protective agents|mesh-ancestor
65220093|NCT05087589|Tofacitinib|tofacitinib|mesh-list
65220094|NCT05087589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65220095|NCT05087589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220096|NCT05087589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220097|NCT05375929|Abrocitinib|abrocitinib|mesh-list
65220098|NCT05375929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65220099|NCT05375929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220100|NCT05375929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220101|NCT00612651|Temozolomide|temozolomide|mesh-list
65220102|NCT00612651|Lonafarnib|lonafarnib|mesh-list
65220103|NCT00612651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65220104|NCT00612651|Alkylating Agents|alkylating agents|mesh-ancestor
65220105|NCT00612651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220106|NCT00612651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65220107|NCT00612651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220108|NCT00918307|Varenicline|varenicline|mesh-list
65220109|NCT00918307|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65220110|NCT00918307|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65220111|NCT00918307|Cholinergic Agents|cholinergic agents|mesh-ancestor
65220112|NCT00918307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65220113|NCT00918307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220114|NCT00918307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220115|NCT00741013|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
65220116|NCT00741013|Protein C|protein c|mesh-list
65220117|NCT00741013|Lovastatin|lovastatin|mesh-list
65220118|NCT00741013|L 647318|l 647318|mesh-list
65333378|NCT02677545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65333379|NCT02677545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65333380|NCT02677545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333381|NCT02677545|Antipyretics|antipyretics|mesh-ancestor
65333382|NCT02677545|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65333383|NCT02677545|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65220119|NCT00741013|Dihydromevinolin|dihydromevinolin|mesh-list
65220120|NCT00741013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65220126|NCT00741013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220127|NCT00741013|Anticoagulants|anticoagulants|mesh-ancestor
65220128|NCT00741013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65220129|NCT00741013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65220130|NCT00741013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65220131|NCT04087759|Bedaquiline|bedaquiline|mesh-list
65220132|NCT04087759|Diarylquinolines|diarylquinolines|mesh-list
65220133|NCT04087759|Antitubercular Agents|antitubercular agents|mesh-ancestor
65220134|NCT04087759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65220135|NCT04087759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65220136|NCT00740857|Ibuprofen|ibuprofen|mesh-list
65220137|NCT00740857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65220138|NCT00740857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65220139|NCT00740857|Analgesics|analgesics|mesh-ancestor
65220140|NCT00740857|Sensory System Agents|sensory system agents|mesh-ancestor
65220141|NCT00740857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65220142|NCT00740857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220143|NCT00740857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65220144|NCT00740857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65220145|NCT00740857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65220146|NCT00740857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220147|NCT00740857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220148|NCT00808132|Bazedoxifene|bazedoxifene|mesh-list
65220149|NCT00808132|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65220150|NCT00808132|Medroxyprogesterone|medroxyprogesterone|mesh-list
65220151|NCT00808132|Estrogens|estrogens|mesh-list
65220152|NCT00808132|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65220153|NCT00808132|Hormones|hormones|mesh-ancestor
65220154|NCT00808132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65220155|NCT00808132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220156|NCT00808132|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65220157|NCT00808132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65220158|NCT00808132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65220159|NCT00808132|Contraceptive Agents|contraceptive agents|mesh-ancestor
65220160|NCT00808132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65220161|NCT00808132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65220162|NCT00808132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65220163|NCT00808132|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65220164|NCT00808132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65220165|NCT00808132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65220166|NCT00808132|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65220167|NCT00808132|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65220168|NCT00808132|Hormone Antagonists|hormone antagonists|mesh-ancestor
65220169|NCT00808132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65220170|NCT00727441|Cyclophosphamide|cyclophosphamide|mesh-list
65220171|NCT00727441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65220172|NCT00727441|Immunologic Factors|immunologic factors|mesh-ancestor
65220173|NCT00727441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220174|NCT00727441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65220175|NCT00727441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65220176|NCT00727441|Alkylating Agents|alkylating agents|mesh-ancestor
65220177|NCT00727441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220178|NCT00727441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65220179|NCT00727441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65220180|NCT00914368|Clopidogrel|clopidogrel|mesh-list
65220181|NCT00914368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65220182|NCT00914368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65220183|NCT00914368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65220184|NCT00914368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65333384|NCT02677545|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65333385|NCT02677545|Purinergic Agents|purinergic agents|mesh-ancestor
65333386|NCT02677545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65333387|NCT04079426|Dimercaprol|dimercaprol|mesh-list
65333388|NCT04079426|Chelating Agents|chelating agents|mesh-ancestor
65333389|NCT04079426|Sequestering Agents|sequestering agents|mesh-ancestor
65333390|NCT04079426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333391|NCT04557020|Gemcitabine|gemcitabine|mesh-list
65333392|NCT04557020|Cisplatin|cisplatin|mesh-list
65333393|NCT04557020|Antibodies|antibodies|mesh-list
65220185|NCT00914368|Purinergic Agents|purinergic agents|mesh-ancestor
65220186|NCT00914368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65220187|NCT00914368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220190|NCT02607982|Oxaliplatin|oxaliplatin|mesh-list
65220191|NCT02607982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64862924|NCT01768039|Vitamin D|vitamin d|mesh-list
65220192|NCT02607982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65220193|NCT02607982|Tubulin Modulators|tubulin modulators|mesh-ancestor
65220194|NCT02607982|Antimitotic Agents|antimitotic agents|mesh-ancestor
65220195|NCT02607982|Mitosis Modulators|mitosis modulators|mesh-ancestor
65220196|NCT02607982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220197|NCT02692989|Anesthetics|anesthetics|mesh-list
65220198|NCT02692989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65220199|NCT02692989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220200|NCT04126473|Ivacaftor|ivacaftor|mesh-list
65220201|NCT04126473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65220202|NCT04126473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65220203|NCT04126473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220204|NCT03643276|Cytarabine|cytarabine|mesh-list
65220205|NCT03643276|Dexamethasone|dexamethasone|mesh-list
65220206|NCT03643276|Prednisone|prednisone|mesh-list
65220207|NCT03643276|Prednisolone|prednisolone|mesh-list
65220208|NCT03643276|Cyclophosphamide|cyclophosphamide|mesh-list
65220209|NCT03643276|Ifosfamide|ifosfamide|mesh-list
65220210|NCT03643276|Doxorubicin|doxorubicin|mesh-list
65220211|NCT03643276|Methotrexate|methotrexate|mesh-list
65220212|NCT03643276|Fludarabine|fludarabine|mesh-list
65220213|NCT03643276|Fludarabine phosphate|fludarabine phosphate|mesh-list
65220214|NCT03643276|Etoposide|etoposide|mesh-list
65220215|NCT03643276|Vincristine|vincristine|mesh-list
65220216|NCT03643276|Bortezomib|bortezomib|mesh-list
65220217|NCT03643276|Daunorubicin|daunorubicin|mesh-list
65220218|NCT03643276|Mercaptopurine|mercaptopurine|mesh-list
65220219|NCT03643276|Pegaspargase|pegaspargase|mesh-list
65220220|NCT03643276|Blinatumomab|blinatumomab|mesh-list
65220221|NCT03643276|Vindesine|vindesine|mesh-list
65220222|NCT03643276|Asparaginase|asparaginase|mesh-list
65220223|NCT03643276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65220224|NCT03643276|Immunologic Factors|immunologic factors|mesh-ancestor
65220225|NCT03643276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220226|NCT03643276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65220227|NCT03643276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65220228|NCT03643276|Alkylating Agents|alkylating agents|mesh-ancestor
65220229|NCT03643276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220230|NCT03643276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65220231|NCT03643276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65220232|NCT03643276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65220233|NCT03643276|Antiemetics|antiemetics|mesh-ancestor
65220234|NCT03643276|Autonomic Agents|autonomic agents|mesh-ancestor
65220235|NCT03643276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65220236|NCT03643276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65220237|NCT03643276|Glucocorticoids|glucocorticoids|mesh-ancestor
65220238|NCT03643276|Hormones|hormones|mesh-ancestor
65220239|NCT03643276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65220240|NCT03643276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65220241|NCT03643276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65220242|NCT03643276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65220243|NCT03643276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65220244|NCT03643276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333394|NCT04557020|Immunologic Factors|immunologic factors|mesh-ancestor
65333395|NCT04557020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333396|NCT04557020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65333397|NCT04557020|Antimetabolites|antimetabolites|mesh-ancestor
65333398|NCT04557020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333399|NCT04557020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333400|NCT04557020|Antiviral Agents|antiviral agents|mesh-ancestor
65333401|NCT04557020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65333402|NCT04557020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333403|NCT04557020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65333404|NCT00675441|Lenalidomide|lenalidomide|mesh-list
65333405|NCT00675441|Immunologic Factors|immunologic factors|mesh-ancestor
65220245|NCT03643276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65220246|NCT03643276|Abortifacient Agents|abortifacient agents|mesh-ancestor
65220247|NCT03643276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65220248|NCT03643276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65220249|NCT03643276|Antimetabolites|antimetabolites|mesh-ancestor
65220250|NCT03643276|Dermatologic Agents|dermatologic agents|mesh-ancestor
65220251|NCT03643276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65220252|NCT03643276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65220253|NCT03643276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65220254|NCT03643276|Antiviral Agents|antiviral agents|mesh-ancestor
65220255|NCT03643276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65220256|NCT03643276|Tubulin Modulators|tubulin modulators|mesh-ancestor
65220257|NCT03643276|Antimitotic Agents|antimitotic agents|mesh-ancestor
65220258|NCT03643276|Mitosis Modulators|mitosis modulators|mesh-ancestor
65220259|NCT04882293|Atorvastatin|atorvastatin|mesh-list
65220260|NCT04882293|Fenofibrate|fenofibrate|mesh-list
65220261|NCT04882293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65220262|NCT04882293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65220263|NCT04882293|Antimetabolites|antimetabolites|mesh-ancestor
65220272|NCT04085575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65220273|NCT04085575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220274|NCT04085575|Hemostatics|hemostatics|mesh-ancestor
65220275|NCT04085575|Coagulants|coagulants|mesh-ancestor
65220276|NCT00585169|Memantine|memantine|mesh-list
65220277|NCT00585169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65220278|NCT00585169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65220279|NCT00585169|Dopamine Agents|dopamine agents|mesh-ancestor
65220280|NCT00585169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65220281|NCT00585169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220282|NCT00585169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220283|NCT00585169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65220284|NCT00585169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65220285|NCT00807742|Nicotine|nicotine|mesh-list
65220286|NCT00807742|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65220287|NCT00807742|Autonomic Agents|autonomic agents|mesh-ancestor
65220288|NCT00807742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65220289|NCT00807742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220290|NCT00807742|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65220291|NCT00807742|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65220292|NCT00807742|Cholinergic Agents|cholinergic agents|mesh-ancestor
65220293|NCT00807742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65220294|NCT00807742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220295|NCT04741815|Carbon Fiber|carbon fiber|mesh-list
65220296|NCT04741815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65220297|NCT04741815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65220298|NCT05738434|Apatinib|apatinib|mesh-list
65220299|NCT05738434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65220300|NCT05738434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65220301|NCT05738434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220302|NCT05738434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220303|NCT00803452|Azithromycin|azithromycin|mesh-list
65333406|NCT00675441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333407|NCT00675441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65333408|NCT00675441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65333409|NCT00675441|Growth Substances|growth substances|mesh-ancestor
65333410|NCT00675441|Growth Inhibitors|growth inhibitors|mesh-ancestor
65220304|NCT00803452|Doxycycline|doxycycline|mesh-list
65220305|NCT00803452|Minocycline|minocycline|mesh-list
65220306|NCT00803452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65220307|NCT00803452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65220308|NCT00803452|Antimalarials|antimalarials|mesh-ancestor
65220309|NCT00803452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65220310|NCT00803452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65220311|NCT04546113|Ropivacaine|ropivacaine|mesh-list
65220312|NCT04546113|Anesthetics, Local|anesthetics, local|mesh-ancestor
65220313|NCT04546113|Anesthetics|anesthetics|mesh-ancestor
65220314|NCT04546113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65220315|NCT04546113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220316|NCT04546113|Sensory System Agents|sensory system agents|mesh-ancestor
65220317|NCT04546113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65220318|NCT05737342|Red yeast rice|red yeast rice|mesh-list
65220319|NCT05737342|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65220320|NCT05737342|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65220321|NCT05737342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65220322|NCT05737342|Antimetabolites|antimetabolites|mesh-ancestor
65220323|NCT05737342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220324|NCT05737342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220325|NCT05737342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65220326|NCT00914212|Sibutramine|sibutramine|mesh-list
65220327|NCT00914212|Antidepressive Agents|antidepressive agents|mesh-ancestor
65220328|NCT00914212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65220329|NCT00914212|Appetite Depressants|appetite depressants|mesh-ancestor
65220330|NCT00914212|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65220331|NCT05705050|Aminophylline|aminophylline|mesh-list
65220332|NCT05705050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65220335|NCT05705050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220336|NCT05705050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65220337|NCT05705050|Respiratory System Agents|respiratory system agents|mesh-ancestor
65220339|NCT05705050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65220340|NCT05705050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220341|NCT05705050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220342|NCT05705050|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65220343|NCT05705050|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65220344|NCT05705050|Purinergic Agents|purinergic agents|mesh-ancestor
65220345|NCT05705050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65220346|NCT05705050|Protective Agents|protective agents|mesh-ancestor
65220348|NCT04188483|Antioxidants|antioxidants|mesh-ancestor
65220349|NCT04188483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220350|NCT04188483|Protective Agents|protective agents|mesh-ancestor
65220351|NCT04188483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220352|NCT04188483|Trace Elements|trace elements|mesh-ancestor
65220353|NCT04188483|Micronutrients|micronutrients|mesh-ancestor
65220354|NCT02693145|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65220355|NCT02693145|Antiviral Agents|antiviral agents|mesh-ancestor
65220356|NCT02693145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65220357|NCT00717067|Ritonavir|ritonavir|mesh-list
65220358|NCT00717067|Saquinavir|saquinavir|mesh-list
65220359|NCT00717067|Maraviroc|maraviroc|mesh-list
65220360|NCT00717067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65220361|NCT00717067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65220362|NCT00717067|Protease Inhibitors|protease inhibitors|mesh-ancestor
65220363|NCT00717067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220364|NCT00717067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220365|NCT00717067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65220366|NCT00717067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65220367|NCT00717067|Antiviral Agents|antiviral agents|mesh-ancestor
65220368|NCT00717067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65220369|NCT00717067|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65220370|NCT00717067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65220371|NCT00717067|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65220372|NCT00717067|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65333411|NCT00675441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333412|NCT02559297|Sevoflurane|sevoflurane|mesh-list
65333413|NCT02559297|Desflurane|desflurane|mesh-list
65333414|NCT02559297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65333415|NCT02559297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65333416|NCT02559297|Anesthetics, General|anesthetics, general|mesh-ancestor
65333417|NCT02559297|Anesthetics|anesthetics|mesh-ancestor
65333418|NCT02559297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65333419|NCT02559297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333420|NCT02558517|Prednisone|prednisone|mesh-list
65333421|NCT02558517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65220373|NCT00717067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65220374|NCT05731960|Dexamethasone|dexamethasone|mesh-list
65220375|NCT05731960|Metoclopramide|metoclopramide|mesh-list
65220376|NCT05731960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65220377|NCT05731960|Antiemetics|antiemetics|mesh-ancestor
65220378|NCT05731960|Autonomic Agents|autonomic agents|mesh-ancestor
65220379|NCT05731960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65220380|NCT05731960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220381|NCT05731960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65220382|NCT05731960|Glucocorticoids|glucocorticoids|mesh-ancestor
65220383|NCT05731960|Hormones|hormones|mesh-ancestor
65220384|NCT05731960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65220385|NCT05731960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65220386|NCT05731960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65220387|NCT05731960|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65220388|NCT05731960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65220389|NCT05731960|Dopamine Agents|dopamine agents|mesh-ancestor
65220390|NCT05731960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65220391|NCT05731960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220392|NCT04393311|Urinastatin|urinastatin|mesh-list
65220393|NCT04393311|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65220394|NCT04393311|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65220395|NCT04393311|Protease Inhibitors|protease inhibitors|mesh-ancestor
65220396|NCT04393311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220397|NCT04393311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220399|NCT02607436|Sarpogrelate|sarpogrelate|mesh-list
65220400|NCT02607436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65220401|NCT02607436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65220402|NCT02607436|Analgesics|analgesics|mesh-ancestor
65220403|NCT02607436|Sensory System Agents|sensory system agents|mesh-ancestor
65220404|NCT02607436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65220405|NCT02607436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220406|NCT02607436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65220415|NCT02607436|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65220416|NCT02607436|Serotonin Agents|serotonin agents|mesh-ancestor
65220417|NCT02607436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65220418|NCT02607592|Pemetrexed|pemetrexed|mesh-list
65220419|NCT02607592|Nedaplatin|nedaplatin|mesh-list
65220420|NCT02607592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65220421|NCT02607592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220422|NCT02607592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220423|NCT02607592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65220424|NCT02607592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65220425|NCT04356339|Interferons|interferons|mesh-list
65220426|NCT04356339|Interferon-beta|interferon-beta|mesh-list
65220427|NCT04356339|Interferon beta-1b|interferon beta-1b|mesh-list
65220428|NCT04356339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65220429|NCT04356339|Antiviral Agents|antiviral agents|mesh-ancestor
65220430|NCT04356339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65220431|NCT04356339|Immunologic Factors|immunologic factors|mesh-ancestor
65220432|NCT04356339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220433|NCT04356339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65220434|NCT03511846|Capsaicin|capsaicin|mesh-list
65220435|NCT03511846|Antipruritics|antipruritics|mesh-ancestor
65220436|NCT03511846|Dermatologic Agents|dermatologic agents|mesh-ancestor
65333422|NCT02558517|Glucocorticoids|glucocorticoids|mesh-ancestor
65333423|NCT02558517|Hormones|hormones|mesh-ancestor
65333424|NCT02558517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65333425|NCT02558517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220437|NCT03511846|Sensory System Agents|sensory system agents|mesh-ancestor
65220438|NCT03511846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65220439|NCT03511846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220440|NCT04331145|Ticagrelor|ticagrelor|mesh-list
65220441|NCT04331145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65220442|NCT04331145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65220443|NCT04331145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65220444|NCT04331145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65220445|NCT04331145|Purinergic Agents|purinergic agents|mesh-ancestor
65220446|NCT04331145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65220447|NCT04331145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220448|NCT04331145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220449|NCT03460522|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65220450|NCT03460522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65220451|NCT03460522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65220452|NCT03460522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65220453|NCT02605720|Piperaquine|piperaquine|mesh-list
65220454|NCT02605720|Artenimol|artenimol|mesh-list
65220455|NCT02605720|Antimalarials|antimalarials|mesh-ancestor
65220456|NCT02605720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65220457|NCT02605720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65220458|NCT02605720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65220459|NCT04188561|Hyaluronic Acid|hyaluronic acid|mesh-list
65220460|NCT04188561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65220461|NCT04188561|Immunologic Factors|immunologic factors|mesh-ancestor
65220462|NCT04188561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220463|NCT04188561|Viscosupplements|viscosupplements|mesh-ancestor
65220464|NCT04188561|Protective Agents|protective agents|mesh-ancestor
65220465|NCT00588952|Ketamine|ketamine|mesh-list
65220466|NCT00588952|Analgesics|analgesics|mesh-ancestor
65220467|NCT00588952|Sensory System Agents|sensory system agents|mesh-ancestor
65220468|NCT00588952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65220469|NCT00588952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220470|NCT00588952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65220471|NCT00588952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65220472|NCT00588952|Anesthetics, General|anesthetics, general|mesh-ancestor
65220473|NCT00588952|Anesthetics|anesthetics|mesh-ancestor
65220474|NCT00588952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65220476|NCT00588952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65220477|NCT00588952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65220478|NCT00588952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220479|NCT04885257|Methylphenidate|methylphenidate|mesh-list
65220480|NCT04885257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65220481|NCT04885257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220482|NCT04885257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65220483|NCT04885257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65220484|NCT04885257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65220485|NCT04885257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220486|NCT04885257|Dopamine Agents|dopamine agents|mesh-ancestor
65220487|NCT04885257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65220488|NCT05073003|Vaccines|vaccines|mesh-list
65220489|NCT05073003|Immunologic Factors|immunologic factors|mesh-ancestor
65220490|NCT05073003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220491|NCT03484923|Spartalizumab|spartalizumab|mesh-list
65220492|NCT03484923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65220493|NCT03484923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220494|NCT03484923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65220495|NCT00802360|Menotropins|menotropins|mesh-list
65220496|NCT00802360|Progesterone|progesterone|mesh-list
65220497|NCT00802360|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65220498|NCT00802360|Ganirelix|ganirelix|mesh-list
65220499|NCT00802360|Progestins|progestins|mesh-ancestor
65220500|NCT00802360|Hormones|hormones|mesh-ancestor
65220501|NCT00802360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65220502|NCT00802360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333426|NCT02558517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65333427|NCT02558517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333428|NCT00674973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65333429|NCT00674973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333430|NCT00674973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65333431|NCT00674973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333432|NCT00674973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220503|NCT00802360|Hormone Antagonists|hormone antagonists|mesh-ancestor
65220504|NCT00802360|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65220505|NCT00802360|Fertility Agents|fertility agents|mesh-ancestor
65220506|NCT00802360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65220507|NCT04908423|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65220508|NCT04908423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65220509|NCT04908423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65220510|NCT04908423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220511|NCT04908423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65220512|NCT04908423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65220513|NCT04908423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220514|NCT04908423|Cholinergic Agents|cholinergic agents|mesh-ancestor
65220515|NCT04908423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65220516|NCT04811625|Aspirin|aspirin|mesh-list
65220517|NCT04811625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65220518|NCT04811625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65220519|NCT04811625|Analgesics|analgesics|mesh-ancestor
65220520|NCT04811625|Sensory System Agents|sensory system agents|mesh-ancestor
65220521|NCT04811625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65220522|NCT04811625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220523|NCT04811625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65220524|NCT04811625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65220525|NCT04811625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65220526|NCT04811625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65220527|NCT04811625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220528|NCT04811625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65220529|NCT04811625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65220530|NCT04811625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220531|NCT04811625|Antipyretics|antipyretics|mesh-ancestor
65220532|NCT02764593|Nivolumab|nivolumab|mesh-list
65220533|NCT02764593|Cetuximab|cetuximab|mesh-list
65220534|NCT02764593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65220535|NCT02764593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65220536|NCT02764593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65220537|NCT02764593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220539|NCT04028596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65220540|NCT04028596|Analgesics|analgesics|mesh-ancestor
65220541|NCT04028596|Sensory System Agents|sensory system agents|mesh-ancestor
65220542|NCT04028596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65220543|NCT04028596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220544|NCT04028596|Antipyretics|antipyretics|mesh-ancestor
65220545|NCT04594551|Vaccines|vaccines|mesh-list
65220546|NCT04594551|Immunoglobulins|immunoglobulins|mesh-list
65220547|NCT04594551|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65220551|NCT02692599|Vaccines|vaccines|mesh-list
65220552|NCT02692599|Immunologic Factors|immunologic factors|mesh-ancestor
65220553|NCT02692599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220554|NCT01026038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65220555|NCT01026038|Immunologic Factors|immunologic factors|mesh-ancestor
65220556|NCT01026038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220557|NCT02606266|Valganciclovir|valganciclovir|mesh-list
65220558|NCT02606266|Antiviral Agents|antiviral agents|mesh-ancestor
65220559|NCT02606266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65220560|NCT04115020|Naltrexone|naltrexone|mesh-list
65220561|NCT04115020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65220562|NCT04115020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65220563|NCT04115020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220564|NCT04115020|Sensory System Agents|sensory system agents|mesh-ancestor
65220565|NCT04115020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333433|NCT00673179|Leucovorin|leucovorin|mesh-list
65333434|NCT00673179|Gemcitabine|gemcitabine|mesh-list
65333435|NCT00673179|Doxorubicin|doxorubicin|mesh-list
65333436|NCT00673179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65333437|NCT00673179|Methotrexate|methotrexate|mesh-list
65333438|NCT00673179|Ifosfamide|ifosfamide|mesh-list
65333439|NCT00673179|Dexrazoxane|dexrazoxane|mesh-list
65333440|NCT00673179|Razoxane|razoxane|mesh-list
65333441|NCT00673179|Sargramostim|sargramostim|mesh-list
65333442|NCT00673179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333443|NCT00673179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65333444|NCT00673179|Antimetabolites|antimetabolites|mesh-ancestor
65220566|NCT02801266|Contraceptive Agents|contraceptive agents|mesh-list
65220567|NCT02801266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65220568|NCT02801266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220569|NCT03292666|Warfarin|warfarin|mesh-list
65220570|NCT03292666|Rivaroxaban|rivaroxaban|mesh-list
65220571|NCT03292666|Dabigatran|dabigatran|mesh-list
65220572|NCT03292666|Apixaban|apixaban|mesh-list
65220573|NCT03292666|Anticoagulants|anticoagulants|mesh-list
65220574|NCT03292666|Edoxaban|edoxaban|mesh-list
65220575|NCT03292666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65220576|NCT03292666|Antithrombins|antithrombins|mesh-ancestor
65220577|NCT03292666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65220578|NCT03292666|Protease Inhibitors|protease inhibitors|mesh-ancestor
65220579|NCT03292666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220580|NCT03292666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220581|NCT02707653|Misoprostol|misoprostol|mesh-list
65220582|NCT02707653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65220583|NCT02707653|Abortifacient Agents|abortifacient agents|mesh-ancestor
65220584|NCT02707653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65220585|NCT02707653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220586|NCT02707653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65220587|NCT02707653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65220588|NCT02707653|Oxytocics|oxytocics|mesh-ancestor
65220589|NCT03901131|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65220590|NCT03901131|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65220591|NCT03901131|Norethindrone|norethindrone|mesh-list
65220592|NCT03901131|Norethindrone Acetate|norethindrone acetate|mesh-list
65220593|NCT03901131|Norethindrone enanthate|norethindrone enanthate|mesh-list
65220594|NCT03901131|Estradiol|estradiol|mesh-list
65220595|NCT03901131|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65220596|NCT03901131|Estrogens|estrogens|mesh-ancestor
65220597|NCT03901131|Hormones|hormones|mesh-ancestor
65220598|NCT03901131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65220599|NCT03901131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220600|NCT03901131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65220601|NCT03901131|Contraceptive Agents|contraceptive agents|mesh-ancestor
65220602|NCT03901131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65220603|NCT03901131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65220604|NCT03901131|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65220605|NCT03901131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65220606|NCT03901131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65220607|NCT02607202|Gemcitabine|gemcitabine|mesh-list
65220608|NCT02607202|Paclitaxel|paclitaxel|mesh-list
65220609|NCT02607202|Carboplatin|carboplatin|mesh-list
65220610|NCT02607202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65220611|NCT02607202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65220612|NCT02607202|Tubulin Modulators|tubulin modulators|mesh-ancestor
65220613|NCT02607202|Antimitotic Agents|antimitotic agents|mesh-ancestor
65220614|NCT02607202|Mitosis Modulators|mitosis modulators|mesh-ancestor
65220615|NCT02607202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220616|NCT02607202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65220617|NCT02607202|Antimetabolites|antimetabolites|mesh-ancestor
65220618|NCT02607202|Antiviral Agents|antiviral agents|mesh-ancestor
65220619|NCT02607202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65220620|NCT02607202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220621|NCT02607202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65220622|NCT02607202|Immunologic Factors|immunologic factors|mesh-ancestor
65333445|NCT00673179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333446|NCT00673179|Antiviral Agents|antiviral agents|mesh-ancestor
65333447|NCT00673179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65333448|NCT00673179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333449|NCT00673179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65333450|NCT00673179|Immunologic Factors|immunologic factors|mesh-ancestor
65333451|NCT00673179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220631|NCT03896685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220632|NCT03896685|Antitubercular Agents|antitubercular agents|mesh-ancestor
65220633|NCT03896685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65220634|NCT03896685|Leprostatic Agents|leprostatic agents|mesh-ancestor
65220635|NCT02731612|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65220636|NCT02731612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65220637|NCT02731612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65220638|NCT02731612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65220639|NCT02731612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220640|NCT02731612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65220641|NCT02731612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65220642|NCT02731612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65220643|NCT02731612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65220644|NCT02731612|Adrenergic Agents|adrenergic agents|mesh-ancestor
65220645|NCT02731612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65220646|NCT02731612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220647|NCT02731612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65220648|NCT02731612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65220649|NCT02731612|Serotonin Agents|serotonin agents|mesh-ancestor
65220650|NCT02731612|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65220651|NCT02731612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65220652|NCT02731612|Dopamine Agents|dopamine agents|mesh-ancestor
65220653|NCT04371393|Remestemcel-l|remestemcel-l|mesh-list
65220654|NCT04371393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65220655|NCT04371393|Antiviral Agents|antiviral agents|mesh-ancestor
65220656|NCT04371393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65220657|NCT00923182|Alemtuzumab|alemtuzumab|mesh-list
65220658|NCT00923182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65220659|NCT00923182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65220660|NCT03868839|Telmisartan|telmisartan|mesh-list
65220661|NCT03868839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65220662|NCT03868839|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65220663|NCT03868839|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65220664|NCT03868839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220665|NCT00589420|Docetaxel|docetaxel|mesh-list
65220666|NCT00589420|Sorafenib|sorafenib|mesh-list
65220667|NCT00589420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65220668|NCT00589420|Tubulin Modulators|tubulin modulators|mesh-ancestor
65220669|NCT00589420|Antimitotic Agents|antimitotic agents|mesh-ancestor
65220670|NCT00589420|Mitosis Modulators|mitosis modulators|mesh-ancestor
65220671|NCT00589420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220672|NCT00589420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65220673|NCT00589420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220674|NCT03815019|Megestrol|megestrol|mesh-list
65220675|NCT03815019|Megestrol Acetate|megestrol acetate|mesh-list
65220676|NCT03815019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65220677|NCT03815019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65220678|NCT03815019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65220679|NCT03815019|Contraceptive Agents|contraceptive agents|mesh-ancestor
65220680|NCT03815019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65220681|NCT03815019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220682|NCT03815019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65220683|NCT03815019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65220684|NCT03815019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65220685|NCT03815019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65220686|NCT03815019|Appetite Stimulants|appetite stimulants|mesh-ancestor
65220687|NCT03815019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65220689|NCT04114630|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65333452|NCT00673179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65333453|NCT00673179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65333454|NCT00673179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65333455|NCT00673179|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65333456|NCT00673179|Abortifacient Agents|abortifacient agents|mesh-ancestor
65333457|NCT00673179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65333458|NCT00673179|Dermatologic Agents|dermatologic agents|mesh-ancestor
64709632|NCT04762381|Hormones|hormones|mesh-ancestor
65220700|NCT00914524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65220701|NCT00914524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65220702|NCT00914524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220704|NCT03787095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65220705|NCT03787095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65220706|NCT04103385|Risedronic Acid|risedronic acid|mesh-list
65220707|NCT04103385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65220708|NCT04103385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65220709|NCT04103385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220710|NCT04103385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65220711|NCT04103385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220712|NCT04103385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65220713|NCT00796978|Trastuzumab|trastuzumab|mesh-list
65220714|NCT00796978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65220715|NCT00796978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65220716|NCT03779295|Clindamycin|clindamycin|mesh-list
65220717|NCT03779295|Clindamycin palmitate|clindamycin palmitate|mesh-list
65220718|NCT03779295|Clindamycin phosphate|clindamycin phosphate|mesh-list
65220719|NCT03779295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65220720|NCT03779295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65220721|NCT03779295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65220722|NCT03779295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220723|NCT03779295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220724|NCT00613665|Vaccines|vaccines|mesh-list
65220725|NCT00613665|Immunologic Factors|immunologic factors|mesh-ancestor
65220726|NCT00613665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220727|NCT00923572|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65220728|NCT00923572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65220729|NCT00923572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220730|NCT03746769|Gastrins|gastrins|mesh-list
65220731|NCT03746769|Hormones|hormones|mesh-ancestor
65220732|NCT03746769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65220733|NCT03746769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220734|NCT00796822|Pentoxifylline|pentoxifylline|mesh-list
65220735|NCT00796822|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65220736|NCT00796822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220737|NCT00796822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220738|NCT00796822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65220739|NCT00796822|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65220740|NCT00796822|Protective Agents|protective agents|mesh-ancestor
65220741|NCT00796822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220742|NCT00796822|Vasodilator Agents|vasodilator agents|mesh-ancestor
65220743|NCT00796822|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65220744|NCT00796822|Antioxidants|antioxidants|mesh-ancestor
65220745|NCT04007991|Ecopipam|ecopipam|mesh-list
65220746|NCT04007991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65220747|NCT04007991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65220748|NCT04007991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65220749|NCT04007991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220750|NCT04007991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65220751|NCT04007991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65220758|NCT03822507|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65220759|NCT03822507|Hormone Antagonists|hormone antagonists|mesh-ancestor
65220760|NCT03822507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65220761|NCT04301726|Tetrabenazine|tetrabenazine|mesh-list
65220762|NCT04301726|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65333459|NCT00673179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65333460|NCT00673179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65333461|NCT00673179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65333462|NCT00673179|Antidotes|antidotes|mesh-ancestor
65333463|NCT00673179|Protective Agents|protective agents|mesh-ancestor
65333464|NCT00673179|Vitamin B Complex|vitamin b complex|mesh-ancestor
65333465|NCT00673179|Vitamins|vitamins|mesh-ancestor
65333466|NCT00673179|Micronutrients|micronutrients|mesh-ancestor
65333467|NCT00673179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65333468|NCT00673179|Alkylating Agents|alkylating agents|mesh-ancestor
65333469|NCT00673179|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65220763|NCT04301726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65220764|NCT04301726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65220765|NCT04301726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220766|NCT04301726|Adrenergic Agents|adrenergic agents|mesh-ancestor
65220767|NCT04301726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65220768|NCT04301726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220769|NCT00614679|Tigecycline|tigecycline|mesh-list
65220771|NCT00614679|Anticoagulants|anticoagulants|mesh-ancestor
65220772|NCT00614679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65220773|NCT00614679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65220774|NCT00614679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220775|NCT00614679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65220776|NCT00614679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65220777|NCT00614679|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65220778|NCT00614679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220779|NCT03760965|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65220780|NCT03760965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65220781|NCT03760965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220782|NCT03760965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65220783|NCT03760965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220784|NCT03703869|Insulin Glargine|insulin glargine|mesh-list
65220785|NCT03703869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65220786|NCT03703869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220787|NCT01024946|Everolimus|everolimus|mesh-list
65220788|NCT01024946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65220789|NCT01024946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64863523|NCT01770470|Hemostatics|hemostatics|mesh-ancestor
65220790|NCT01024946|Immunologic Factors|immunologic factors|mesh-ancestor
65220791|NCT01024946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220792|NCT00724867|Belimumab|belimumab|mesh-list
65220793|NCT00724867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65220794|NCT00724867|Immunologic Factors|immunologic factors|mesh-ancestor
65220795|NCT00724867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220796|NCT00627536|Mitogens|mitogens|mesh-list
65220797|NCT00627536|Mitosis Modulators|mitosis modulators|mesh-ancestor
65220798|NCT00627536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220799|NCT00724711|Tenofovir|tenofovir|mesh-list
65220800|NCT00724711|Lamivudine|lamivudine|mesh-list
65220801|NCT00724711|Emtricitabine|emtricitabine|mesh-list
65220802|NCT00724711|Abacavir|abacavir|mesh-list
65220803|NCT00724711|Antiviral Agents|antiviral agents|mesh-ancestor
65220804|NCT00724711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65220805|NCT00724711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65220806|NCT00724711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65220807|NCT00724711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220808|NCT00724711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220809|NCT00724711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65220810|NCT00724711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65220811|NCT00721279|Pramipexole|pramipexole|mesh-list
65220812|NCT00721279|Antioxidants|antioxidants|mesh-ancestor
65220813|NCT00721279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220814|NCT00721279|Protective Agents|protective agents|mesh-ancestor
65333470|NCT00673179|Antimitotic Agents|antimitotic agents|mesh-ancestor
65333471|NCT00673179|Mitosis Modulators|mitosis modulators|mesh-ancestor
65333472|NCT00758433|Capsaicin|capsaicin|mesh-list
65333473|NCT00758433|Antipruritics|antipruritics|mesh-ancestor
65333474|NCT00758433|Dermatologic Agents|dermatologic agents|mesh-ancestor
65333475|NCT00758433|Sensory System Agents|sensory system agents|mesh-ancestor
65333476|NCT00758433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333477|NCT00758433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333478|NCT00584012|Docetaxel|docetaxel|mesh-list
65333479|NCT00584012|Lovastatin|lovastatin|mesh-list
65333480|NCT00584012|L 647318|l 647318|mesh-list
65333481|NCT00584012|Dihydromevinolin|dihydromevinolin|mesh-list
65333482|NCT00584012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333483|NCT00584012|Tubulin Modulators|tubulin modulators|mesh-ancestor
65333484|NCT00584012|Antimitotic Agents|antimitotic agents|mesh-ancestor
65333485|NCT00584012|Mitosis Modulators|mitosis modulators|mesh-ancestor
65333486|NCT00584012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333487|NCT00584012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65333488|NCT00584012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65333489|NCT00584012|Antimetabolites|antimetabolites|mesh-ancestor
65333490|NCT00584012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65333491|NCT00584012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65220815|NCT00721279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220816|NCT00721279|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65220819|NCT00721279|Dopamine Agents|dopamine agents|mesh-ancestor
65220820|NCT00721279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65220821|NCT01030952|Acarbose|acarbose|mesh-list
65220822|NCT01030952|Nateglinide|nateglinide|mesh-list
65220823|NCT01030952|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65220824|NCT01030952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220825|NCT01030952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220826|NCT01030952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65220827|NCT01030952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220828|NCT03611751|Apremilast|apremilast|mesh-list
65220829|NCT03611751|BMS-986165|bms-986165|mesh-list
65220830|NCT03611751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65220831|NCT03611751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65220832|NCT03611751|Analgesics|analgesics|mesh-ancestor
65220833|NCT03611751|Sensory System Agents|sensory system agents|mesh-ancestor
65220834|NCT03611751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65220835|NCT03611751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220836|NCT03611751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65220837|NCT03611751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65220838|NCT03611751|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65220839|NCT03611751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65220840|NCT03611751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220841|NCT03611751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220842|NCT03611751|Dermatologic Agents|dermatologic agents|mesh-ancestor
65220843|NCT03611751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65220844|NCT00613743|Morphine|morphine|mesh-list
65220845|NCT00613743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65220846|NCT00613743|Narcotics|narcotics|mesh-ancestor
65220847|NCT00613743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65220848|NCT00613743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333492|NCT00584012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333493|NCT05435846|Trametinib|trametinib|mesh-list
65333494|NCT05435846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333495|NCT05435846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65333496|NCT05435846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333497|NCT05435846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333498|NCT00920270|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65333499|NCT00920270|Colistin|colistin|mesh-list
65333500|NCT00920270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65333501|NCT04078724|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
65333502|NCT04078724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65333503|NCT04078724|Antidepressive Agents|antidepressive agents|mesh-ancestor
64719375|NCT03714919|Dextromethorphan|dextromethorphan|mesh-list
65220849|NCT00613743|Analgesics|analgesics|mesh-ancestor
65220850|NCT00613743|Sensory System Agents|sensory system agents|mesh-ancestor
65220851|NCT00613743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65220852|NCT00614757|Acetylcysteine|acetylcysteine|mesh-list
65220853|NCT00614757|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65220854|NCT00614757|Antiviral Agents|antiviral agents|mesh-ancestor
65220855|NCT00614757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65220856|NCT00614757|Expectorants|expectorants|mesh-ancestor
65220857|NCT00614757|Respiratory System Agents|respiratory system agents|mesh-ancestor
65220858|NCT00614757|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65220859|NCT00614757|Antioxidants|antioxidants|mesh-ancestor
65220860|NCT00614757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220861|NCT00614757|Protective Agents|protective agents|mesh-ancestor
65220862|NCT00614757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220863|NCT00614757|Antidotes|antidotes|mesh-ancestor
65220864|NCT02692365|Manganese|manganese|mesh-list
65220865|NCT02692365|Trace Elements|trace elements|mesh-ancestor
65220866|NCT02692365|Micronutrients|micronutrients|mesh-ancestor
65220867|NCT02692365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220869|NCT03492099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65220870|NCT03492099|Narcotics|narcotics|mesh-ancestor
65220871|NCT03492099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65220872|NCT03492099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220873|NCT03492099|Analgesics|analgesics|mesh-ancestor
65220874|NCT03492099|Sensory System Agents|sensory system agents|mesh-ancestor
65220875|NCT03492099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65220876|NCT03492099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65220877|NCT03481959|Methylphenidate|methylphenidate|mesh-list
65220878|NCT03481959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65220879|NCT03481959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220880|NCT03481959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65220881|NCT03481959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65220882|NCT03481959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65220883|NCT03481959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220884|NCT03481959|Dopamine Agents|dopamine agents|mesh-ancestor
65220885|NCT03481959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65220886|NCT03245229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65220887|NCT03245229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65220888|NCT03245229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65220889|NCT03245229|Antimetabolites|antimetabolites|mesh-ancestor
65220890|NCT03245229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220896|NCT03462069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65220897|NCT03462069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220899|NCT03462069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220900|NCT03414723|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65220901|NCT03414723|Ramipril|ramipril|mesh-list
65220902|NCT03414723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65333504|NCT04078724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65333505|NCT02585882|Fluorides|fluorides|mesh-list
65333506|NCT02585882|Cariostatic Agents|cariostatic agents|mesh-ancestor
65333507|NCT02585882|Protective Agents|protective agents|mesh-ancestor
65333508|NCT02585882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333509|NCT02585648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65333510|NCT02585648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65333511|NCT04431518|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
65333512|NCT04431518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65220903|NCT03414723|Protease Inhibitors|protease inhibitors|mesh-ancestor
65220904|NCT03414723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220905|NCT03414723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220906|NCT03414723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65220907|NCT03414723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65220908|NCT03414723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65220909|NCT03414723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220910|NCT03387657|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65220911|NCT03387657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65220912|NCT03387657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65220914|NCT03387657|Natriuretic Agents|natriuretic agents|mesh-ancestor
65220915|NCT03387657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220916|NCT03387657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65220917|NCT03387657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65220918|NCT03387657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220919|NCT03387657|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65220920|NCT03387657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65220921|NCT00720499|Bromides|bromides|mesh-list
65220922|NCT00720499|Tiotropium Bromide|tiotropium bromide|mesh-list
65220923|NCT00720499|Olodaterol|olodaterol|mesh-list
65220924|NCT00720499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65220925|NCT00720499|Autonomic Agents|autonomic agents|mesh-ancestor
65220926|NCT00720499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65220927|NCT00720499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220928|NCT00720499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65220929|NCT00720499|Respiratory System Agents|respiratory system agents|mesh-ancestor
65220930|NCT00720499|Parasympatholytics|parasympatholytics|mesh-ancestor
65220931|NCT00720499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65220932|NCT00720499|Cholinergic Agents|cholinergic agents|mesh-ancestor
65220933|NCT00720499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64863682|NCT01771874|Bupropion|bupropion|mesh-list
65220934|NCT00720499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220935|NCT00720499|Anticonvulsants|anticonvulsants|mesh-ancestor
65220936|NCT00724243|Infliximab|infliximab|mesh-list
65220937|NCT00724243|Dermatologic Agents|dermatologic agents|mesh-ancestor
65220938|NCT00724243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65220939|NCT00724243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65220940|NCT02590705|Lidocaine|lidocaine|mesh-list
65220941|NCT02590705|Anesthetics, Local|anesthetics, local|mesh-ancestor
65220942|NCT02590705|Anesthetics|anesthetics|mesh-ancestor
65220943|NCT02590705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65220944|NCT02590705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220945|NCT02590705|Sensory System Agents|sensory system agents|mesh-ancestor
65220946|NCT02590705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65220947|NCT02590705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65220948|NCT02590705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65220949|NCT02590705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65220950|NCT02590705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65220951|NCT02590705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220956|NCT00720343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220957|NCT00720343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65220958|NCT00720343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65220959|NCT00720343|Nootropic Agents|nootropic agents|mesh-ancestor
65220960|NCT00720109|Calcium, Dietary|calcium, dietary|mesh-list
65220961|NCT00720109|Leucovorin|leucovorin|mesh-list
65333513|NCT04431518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65333514|NCT04431518|Antiviral Agents|antiviral agents|mesh-ancestor
65333515|NCT04431518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65333516|NCT02584010|Silicon|silicon|mesh-list
65333517|NCT02584010|Trace Elements|trace elements|mesh-ancestor
65333518|NCT02584010|Micronutrients|micronutrients|mesh-ancestor
65333519|NCT02584010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333520|NCT02585804|Dapagliflozin|dapagliflozin|mesh-list
65333521|NCT02585804|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65333522|NCT02585804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333523|NCT02585804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65333524|NCT02585804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333525|NCT02582996|Acetaminophen|acetaminophen|mesh-list
65333526|NCT02582996|Dihydroergotamine|dihydroergotamine|mesh-list
65333527|NCT02582996|Metoclopramide|metoclopramide|mesh-list
65220962|NCT00720109|Folic Acid|folic acid|mesh-list
65220963|NCT00720109|Cytarabine|cytarabine|mesh-list
65220964|NCT00720109|Dexamethasone|dexamethasone|mesh-list
65220965|NCT00720109|Dexamethasone acetate|dexamethasone acetate|mesh-list
65220966|NCT00720109|Prednisone|prednisone|mesh-list
65220967|NCT00720109|Methylprednisolone|methylprednisolone|mesh-list
65220968|NCT00720109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65220969|NCT00720109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65220970|NCT00720109|Prednisolone|prednisolone|mesh-list
65220971|NCT00720109|Prednisolone acetate|prednisolone acetate|mesh-list
65220972|NCT00720109|Hydrocortisone|hydrocortisone|mesh-list
65220973|NCT00720109|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65220974|NCT00720109|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65220975|NCT00720109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65220976|NCT00720109|Cortisone|cortisone|mesh-list
65220977|NCT00720109|Cyclophosphamide|cyclophosphamide|mesh-list
65220978|NCT00720109|Ifosfamide|ifosfamide|mesh-list
65220979|NCT00720109|Isophosphamide mustard|isophosphamide mustard|mesh-list
65220981|NCT00720109|Etoposide|etoposide|mesh-list
65220982|NCT00720109|Vincristine|vincristine|mesh-list
65220983|NCT00720109|Etoposide phosphate|etoposide phosphate|mesh-list
65220984|NCT00720109|Daunorubicin|daunorubicin|mesh-list
65220985|NCT00720109|Asparaginase|asparaginase|mesh-list
65220986|NCT00720109|Dasatinib|dasatinib|mesh-list
65220987|NCT00720109|Mercaptopurine|mercaptopurine|mesh-list
65220988|NCT00720109|Podophyllotoxin|podophyllotoxin|mesh-list
65220989|NCT00720109|Pegaspargase|pegaspargase|mesh-list
65220990|NCT00720109|Lenograstim|lenograstim|mesh-list
65220991|NCT00720109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65220992|NCT00720109|Prednisolone phosphate|prednisolone phosphate|mesh-list
65220993|NCT00720109|BB 1101|bb 1101|mesh-list
65220994|NCT00720109|Calcium|calcium|mesh-list
65220995|NCT00720109|Levoleucovorin|levoleucovorin|mesh-list
65220996|NCT00720109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65220997|NCT00720109|Immunologic Factors|immunologic factors|mesh-ancestor
65220998|NCT00720109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220999|NCT00720109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65221000|NCT00720109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65221001|NCT00720109|Alkylating Agents|alkylating agents|mesh-ancestor
65221002|NCT00720109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221003|NCT00720109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221004|NCT00720109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65221005|NCT00720109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65221006|NCT00720109|Antiemetics|antiemetics|mesh-ancestor
65221007|NCT00720109|Autonomic Agents|autonomic agents|mesh-ancestor
65221008|NCT00720109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65221009|NCT00720109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65221010|NCT00720109|Glucocorticoids|glucocorticoids|mesh-ancestor
65221011|NCT00720109|Hormones|hormones|mesh-ancestor
65221012|NCT00720109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65333528|NCT02582996|Caffeine|caffeine|mesh-list
65333529|NCT02582996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65333530|NCT02582996|Analgesics|analgesics|mesh-ancestor
65333531|NCT02582996|Sensory System Agents|sensory system agents|mesh-ancestor
65333532|NCT02582996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333533|NCT02582996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333534|NCT02582996|Antipyretics|antipyretics|mesh-ancestor
65333535|NCT02582996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65333536|NCT02582996|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65221013|NCT00720109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65221014|NCT00720109|Protease Inhibitors|protease inhibitors|mesh-ancestor
65221015|NCT00720109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221016|NCT00720109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65221017|NCT00720109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65221018|NCT00720109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65221019|NCT00720109|Abortifacient Agents|abortifacient agents|mesh-ancestor
65221020|NCT00720109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65221021|NCT00720109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65221022|NCT00720109|Antimetabolites|antimetabolites|mesh-ancestor
65221023|NCT00720109|Dermatologic Agents|dermatologic agents|mesh-ancestor
65221024|NCT00720109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65221025|NCT00720109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65221026|NCT00720109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65221027|NCT00720109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65221028|NCT00720109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65221051|NCT02590627|Piperaquine|piperaquine|mesh-list
65221052|NCT02590627|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65221053|NCT02590627|Artenimol|artenimol|mesh-list
65221054|NCT02590627|Antimalarials|antimalarials|mesh-ancestor
65221055|NCT02590627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65221056|NCT02590627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65221058|NCT01015118|Paclitaxel|paclitaxel|mesh-list
65221059|NCT01015118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65221060|NCT01015118|Carboplatin|carboplatin|mesh-list
65221061|NCT01015118|Nintedanib|nintedanib|mesh-list
65221062|NCT01015118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65221063|NCT01015118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221064|NCT01015118|Tubulin Modulators|tubulin modulators|mesh-ancestor
65221065|NCT01015118|Antimitotic Agents|antimitotic agents|mesh-ancestor
65221066|NCT01015118|Mitosis Modulators|mitosis modulators|mesh-ancestor
65221067|NCT01015118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221068|NCT01015118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65221069|NCT01015118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221070|NCT02415153|Pomalidomide|pomalidomide|mesh-list
65221071|NCT02415153|Immunologic Factors|immunologic factors|mesh-ancestor
65221072|NCT02415153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221073|NCT02415153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65221074|NCT02415153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65221075|NCT02415153|Growth Substances|growth substances|mesh-ancestor
65221076|NCT02415153|Growth Inhibitors|growth inhibitors|mesh-ancestor
65221077|NCT02415153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221078|NCT04111822|Tranexamic Acid|tranexamic acid|mesh-list
65221079|NCT04111822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65221080|NCT04111822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65221081|NCT04111822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221082|NCT04111822|Hemostatics|hemostatics|mesh-ancestor
65221083|NCT04111822|Coagulants|coagulants|mesh-ancestor
65221084|NCT00628160|Terlipressin|terlipressin|mesh-list
65221085|NCT00628160|Dopamine|dopamine|mesh-list
65221086|NCT00628160|Norepinephrine|norepinephrine|mesh-list
65221087|NCT00628160|Adrenergic Agents|adrenergic agents|mesh-list
65221088|NCT00628160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65221093|NCT00628160|Sympathomimetics|sympathomimetics|mesh-ancestor
65221094|NCT00628160|Autonomic Agents|autonomic agents|mesh-ancestor
65221095|NCT00628160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65221096|NCT00628160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65221097|NCT00628160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65333537|NCT02582996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333538|NCT02582996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333539|NCT02582996|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65333540|NCT02582996|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65333541|NCT02582996|Purinergic Agents|purinergic agents|mesh-ancestor
65333542|NCT02582996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65221098|NCT00628160|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65221099|NCT00628160|Dopamine Agents|dopamine agents|mesh-ancestor
65221100|NCT00628160|Protective Agents|protective agents|mesh-ancestor
65221101|NCT02274285|Vaccines|vaccines|mesh-list
65221102|NCT02274285|Immunologic Factors|immunologic factors|mesh-ancestor
65221103|NCT02274285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221104|NCT02283112|Anti-Infective Agents|anti-infective agents|mesh-list
65221105|NCT02283112|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65221106|NCT02283112|Antiviral Agents|antiviral agents|mesh-list
65221107|NCT02283112|Contraceptive Agents|contraceptive agents|mesh-list
65221108|NCT02283112|Contraceptives, Oral|contraceptives, oral|mesh-list
65221109|NCT02283112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65221110|NCT02283112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221111|NCT02283112|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65221112|NCT00614835|Gemcitabine|gemcitabine|mesh-list
65221113|NCT00614835|Docetaxel|docetaxel|mesh-list
65221114|NCT00614835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65221115|NCT00614835|Antimetabolites|antimetabolites|mesh-ancestor
65221116|NCT00614835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221117|NCT00614835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221118|NCT00614835|Antiviral Agents|antiviral agents|mesh-ancestor
65221119|NCT00614835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65221120|NCT00614835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221121|NCT00614835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65221122|NCT00614835|Immunologic Factors|immunologic factors|mesh-ancestor
65221123|NCT00614835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221124|NCT00614835|Tubulin Modulators|tubulin modulators|mesh-ancestor
65221125|NCT00614835|Antimitotic Agents|antimitotic agents|mesh-ancestor
65221126|NCT00614835|Mitosis Modulators|mitosis modulators|mesh-ancestor
65221127|NCT00715429|Vitamin D|vitamin d|mesh-list
65221128|NCT00715429|Ergocalciferols|ergocalciferols|mesh-list
65221129|NCT00715429|Vitamins|vitamins|mesh-ancestor
65221130|NCT00715429|Micronutrients|micronutrients|mesh-ancestor
65221131|NCT00715429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221132|NCT00715429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65221133|NCT00715429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65221135|NCT02606032|Doxycycline|doxycycline|mesh-list
65221136|NCT02606032|Terbinafine|terbinafine|mesh-list
65221137|NCT02606032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65221138|NCT02606032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65221139|NCT02606032|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65221140|NCT02606032|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65221141|NCT02606032|Antimalarials|antimalarials|mesh-ancestor
65221142|NCT02606032|Antifungal Agents|antifungal agents|mesh-ancestor
65221143|NCT02606032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221144|NCT02606032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221145|NCT02145507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65221146|NCT01743651|Baclofen|baclofen|mesh-list
65221147|NCT01743651|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65221148|NCT01743651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221149|NCT01743651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65221150|NCT01743651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65221151|NCT01743651|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65221152|NCT01743651|GABA Agonists|gaba agonists|mesh-ancestor
65221153|NCT01743651|GABA Agents|gaba agents|mesh-ancestor
65221154|NCT01743651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65221155|NCT01743651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221156|NCT00715117|Naltrexone|naltrexone|mesh-list
65221157|NCT00715117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65221158|NCT00715117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65221159|NCT00715117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221160|NCT00715117|Sensory System Agents|sensory system agents|mesh-ancestor
65221161|NCT00715117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333543|NCT02582996|Antiemetics|antiemetics|mesh-ancestor
65333544|NCT02582996|Autonomic Agents|autonomic agents|mesh-ancestor
65333545|NCT02582996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65333546|NCT02582996|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65333547|NCT02582996|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65333548|NCT02582996|Dopamine Agents|dopamine agents|mesh-ancestor
65333549|NCT02582996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65333550|NCT02582996|Dopamine Agonists|dopamine agonists|mesh-ancestor
65221166|NCT01093521|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65221167|NCT01093521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221168|NCT01093521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221170|NCT01030718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221171|NCT01030718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65221172|NCT01030718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221173|NCT01030718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221174|NCT00722761|Drospirenone|drospirenone|mesh-list
65221175|NCT00722761|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65221176|NCT00722761|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65221177|NCT00722761|Estradiol|estradiol|mesh-list
65221178|NCT00722761|Estrogens|estrogens|mesh-ancestor
65221179|NCT00722761|Hormones|hormones|mesh-ancestor
65221180|NCT00722761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65221181|NCT00722761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221182|NCT00722761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65221183|NCT00722761|Contraceptive Agents|contraceptive agents|mesh-ancestor
65221184|NCT00722761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65221185|NCT00722761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65221186|NCT00722761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65221187|NCT00722761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65221188|NCT00722761|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65221189|NCT00722761|Hormone Antagonists|hormone antagonists|mesh-ancestor
65221190|NCT00722761|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65221191|NCT00722761|Diuretics|diuretics|mesh-ancestor
65221192|NCT00722761|Natriuretic Agents|natriuretic agents|mesh-ancestor
65221193|NCT00628238|Rituximab|rituximab|mesh-list
65221194|NCT00628238|Lenalidomide|lenalidomide|mesh-list
65221195|NCT00628238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65221196|NCT00628238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221197|NCT00628238|Immunologic Factors|immunologic factors|mesh-ancestor
65221198|NCT00628238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221199|NCT00628238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65221200|NCT00628238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65221201|NCT00628238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65221202|NCT00628238|Growth Substances|growth substances|mesh-ancestor
65221203|NCT00628238|Growth Inhibitors|growth inhibitors|mesh-ancestor
65221204|NCT05132179|Sodium Hypochlorite|sodium hypochlorite|mesh-list
65221205|NCT05132179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65221206|NCT05132179|Disinfectants|disinfectants|mesh-ancestor
65221207|NCT05132179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65221208|NCT01019486|Regadenoson|regadenoson|mesh-list
65221209|NCT01019486|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
65221210|NCT01019486|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65221211|NCT01019486|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65221212|NCT01019486|Purinergic Agonists|purinergic agonists|mesh-ancestor
65221213|NCT01019486|Purinergic Agents|purinergic agents|mesh-ancestor
65221214|NCT01019486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65221215|NCT01019486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221216|NCT01019486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221217|NCT01019486|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65221218|NCT02803203|Bevacizumab|bevacizumab|mesh-list
65221219|NCT02803203|Osimertinib|osimertinib|mesh-list
65221220|NCT02803203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65221221|NCT02803203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221222|NCT02803203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65221223|NCT02803203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65221224|NCT02803203|Growth Substances|growth substances|mesh-ancestor
65221225|NCT02803203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333551|NCT04078880|Ascorbic Acid|ascorbic acid|mesh-list
65333552|NCT04078880|Antioxidants|antioxidants|mesh-ancestor
65333553|NCT04078880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333554|NCT04078880|Protective Agents|protective agents|mesh-ancestor
65333555|NCT04078880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333556|NCT04078880|Vitamins|vitamins|mesh-ancestor
65333557|NCT04078880|Micronutrients|micronutrients|mesh-ancestor
65333558|NCT02585570|Phenylephrine|phenylephrine|mesh-list
65221226|NCT02803203|Growth Inhibitors|growth inhibitors|mesh-ancestor
65221227|NCT02803203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65221228|NCT02803203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221229|NCT02803203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221230|NCT00714493|Infliximab|infliximab|mesh-list
65221231|NCT00714493|Dermatologic Agents|dermatologic agents|mesh-ancestor
65221232|NCT00714493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65221238|NCT01013870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221239|NCT01013870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65221240|NCT01013870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65221241|NCT01013870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221242|NCT05020184|Cimetidine|cimetidine|mesh-list
65221243|NCT05020184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65221244|NCT05020184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65221245|NCT05020184|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65221246|NCT05020184|Histamine Antagonists|histamine antagonists|mesh-ancestor
65221247|NCT05020184|Histamine Agents|histamine agents|mesh-ancestor
65221248|NCT05020184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65221249|NCT05020184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221250|NCT05020184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221251|NCT05020184|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65221252|NCT05020184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65221253|NCT05020184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221254|NCT00628316|Caffeine|caffeine|mesh-list
65221255|NCT00628316|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65221256|NCT00628316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221257|NCT00628316|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65221258|NCT00628316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221259|NCT00628316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221260|NCT00628316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65221261|NCT00628316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65221262|NCT00628316|Purinergic Agents|purinergic agents|mesh-ancestor
65221263|NCT00628316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65221264|NCT01018862|Azelastine|azelastine|mesh-list
65221265|NCT01018862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65221266|NCT01018862|Autonomic Agents|autonomic agents|mesh-ancestor
65221267|NCT01018862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65221268|NCT01018862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221269|NCT01018862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65221270|NCT01018862|Respiratory System Agents|respiratory system agents|mesh-ancestor
65221271|NCT01018862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65221272|NCT01018862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221273|NCT01018862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221274|NCT01018862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65221275|NCT01018862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65221276|NCT01018862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65221277|NCT01018862|Histamine Antagonists|histamine antagonists|mesh-ancestor
65221278|NCT01018862|Histamine Agents|histamine agents|mesh-ancestor
65221279|NCT01018862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65221280|NCT01018394|Nicotine|nicotine|mesh-list
65221281|NCT01018394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65221282|NCT01018394|Autonomic Agents|autonomic agents|mesh-ancestor
65221283|NCT01018394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65221284|NCT01018394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221285|NCT01018394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65221286|NCT01018394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65221287|NCT01018394|Cholinergic Agents|cholinergic agents|mesh-ancestor
65221288|NCT01018394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65333559|NCT02585570|Oxymetazoline|oxymetazoline|mesh-list
65333560|NCT02585570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65333561|NCT02585570|Mydriatics|mydriatics|mesh-ancestor
65333562|NCT02585570|Autonomic Agents|autonomic agents|mesh-ancestor
65333563|NCT02585570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333564|NCT02585570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333565|NCT02585570|Sympathomimetics|sympathomimetics|mesh-ancestor
65333566|NCT02585570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64719439|NCT04204057|Tenalisib|tenalisib|mesh-list
65221289|NCT01018394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221291|NCT04301336|Folic Acid|folic acid|mesh-list
65221292|NCT04301336|Vitamin B Complex|vitamin b complex|mesh-list
65221293|NCT04301336|Hydroxyurea|hydroxyurea|mesh-list
65221294|NCT04301336|Morphine|morphine|mesh-list
65221295|NCT04301336|Zinc Sulfate|zinc sulfate|mesh-list
65221296|NCT04301336|Simvastatin|simvastatin|mesh-list
65221297|NCT04301336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65221298|NCT04301336|Narcotics|narcotics|mesh-ancestor
65221299|NCT04301336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65221300|NCT04301336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221301|NCT04301336|Analgesics|analgesics|mesh-ancestor
65221302|NCT04301336|Sensory System Agents|sensory system agents|mesh-ancestor
65221303|NCT04301336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65221309|NCT04301336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65221310|NCT04301336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221311|NCT04301336|Trace Elements|trace elements|mesh-ancestor
65221312|NCT04301336|Micronutrients|micronutrients|mesh-ancestor
65221313|NCT04301336|Hematinics|hematinics|mesh-ancestor
65221314|NCT04301336|Vitamins|vitamins|mesh-ancestor
65221315|NCT04301336|Astringents|astringents|mesh-ancestor
65221316|NCT04301336|Dermatologic Agents|dermatologic agents|mesh-ancestor
65221317|NCT04301336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221318|NCT04301336|Antisickling Agents|antisickling agents|mesh-ancestor
65221319|NCT04301336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65221320|NCT00627848|Rivastigmine|rivastigmine|mesh-list
65221321|NCT00627848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65221323|NCT00627848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221324|NCT00627848|Cholinergic Agents|cholinergic agents|mesh-ancestor
65221325|NCT00627848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65221326|NCT00627848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221327|NCT00627848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65221328|NCT00627848|Protective Agents|protective agents|mesh-ancestor
65221329|NCT04299854|Dinoprostone|dinoprostone|mesh-list
65221330|NCT04299854|Oxytocics|oxytocics|mesh-ancestor
65221331|NCT04299854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65221332|NCT04299854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221333|NCT01017146|Tazarotene|tazarotene|mesh-list
65221334|NCT01017146|Dermatologic Agents|dermatologic agents|mesh-ancestor
65221335|NCT01017146|Keratolytic Agents|keratolytic agents|mesh-ancestor
65221336|NCT02872064|Verteporfin|verteporfin|mesh-list
65221337|NCT02872064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65221338|NCT02872064|Dermatologic Agents|dermatologic agents|mesh-ancestor
65221339|NCT04205240|Mycophenolic Acid|mycophenolic acid|mesh-list
65221340|NCT04205240|Cyclophosphamide|cyclophosphamide|mesh-list
65221341|NCT04205240|Melphalan|melphalan|mesh-list
65221342|NCT04205240|Mechlorethamine|mechlorethamine|mesh-list
65221343|NCT04205240|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65221344|NCT04205240|Fludarabine|fludarabine|mesh-list
65221345|NCT04205240|Daratumumab|daratumumab|mesh-list
65221346|NCT04205240|Tacrolimus|tacrolimus|mesh-list
65221347|NCT04205240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65221348|NCT04205240|Immunologic Factors|immunologic factors|mesh-ancestor
65221349|NCT04205240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221350|NCT04205240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65221351|NCT04205240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65221352|NCT04205240|Alkylating Agents|alkylating agents|mesh-ancestor
65221353|NCT04205240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221354|NCT04205240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221355|NCT04205240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65221356|NCT04205240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65221357|NCT04205240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333567|NCT02585570|Nasal Decongestants|nasal decongestants|mesh-ancestor
65333568|NCT02585570|Respiratory System Agents|respiratory system agents|mesh-ancestor
65333569|NCT02585570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65333570|NCT02585570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65333571|NCT02585570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65333572|NCT02585570|Adrenergic Agents|adrenergic agents|mesh-ancestor
65333573|NCT02585570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65333574|NCT02585570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333575|NCT02585570|Protective Agents|protective agents|mesh-ancestor
65221358|NCT04205240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65221359|NCT04205240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65221360|NCT04205240|Antitubercular Agents|antitubercular agents|mesh-ancestor
65221361|NCT04205240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65221362|NCT04205240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65221363|NCT01010750|Amphetamine|amphetamine|mesh-list
65221364|NCT01010750|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65221365|NCT01010750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65221366|NCT01010750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221367|NCT01010750|Sympathomimetics|sympathomimetics|mesh-ancestor
65221368|NCT01010750|Autonomic Agents|autonomic agents|mesh-ancestor
65221369|NCT01010750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65221370|NCT01010750|Dopamine Agents|dopamine agents|mesh-ancestor
65221371|NCT01010750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65221372|NCT01010750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221373|NCT01010750|Adrenergic Agents|adrenergic agents|mesh-ancestor
65221374|NCT01010750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65221375|NCT01010750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65221383|NCT01012622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65221384|NCT01012622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221385|NCT01012622|Dopamine Agents|dopamine agents|mesh-ancestor
65221386|NCT01012622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65221388|NCT00722371|Pioglitazone|pioglitazone|mesh-list
65221389|NCT00722371|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65221390|NCT00722371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65221391|NCT00722371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221392|NCT00722371|Incretins|incretins|mesh-ancestor
65221393|NCT00722371|Hormones|hormones|mesh-ancestor
65221394|NCT00722371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64864118|NCT01775579|Metformin|metformin|mesh-list
65221395|NCT00722371|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65221396|NCT00722371|Protease Inhibitors|protease inhibitors|mesh-ancestor
65221397|NCT00722371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221398|NCT00722371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221399|NCT02871986|Estrogens|estrogens|mesh-list
65221400|NCT02871986|Hormones|hormones|mesh-ancestor
65221401|NCT02871986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65221402|NCT02871986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221403|NCT00722137|Prednisone|prednisone|mesh-list
65221404|NCT00722137|Cyclophosphamide|cyclophosphamide|mesh-list
65221405|NCT00722137|Rituximab|rituximab|mesh-list
65221406|NCT00722137|Doxorubicin|doxorubicin|mesh-list
65221407|NCT00722137|Vincristine|vincristine|mesh-list
65221408|NCT00722137|Bortezomib|bortezomib|mesh-list
65221409|NCT00722137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65221410|NCT00722137|Immunologic Factors|immunologic factors|mesh-ancestor
65221411|NCT00722137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221412|NCT00722137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65221413|NCT00722137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65221414|NCT00722137|Alkylating Agents|alkylating agents|mesh-ancestor
65221415|NCT00722137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221416|NCT00722137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221417|NCT00722137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65221418|NCT00722137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65221419|NCT00722137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65333576|NCT02583854|Hemostatics|hemostatics|mesh-list
65333577|NCT02583854|Coagulants|coagulants|mesh-ancestor
65333578|NCT00764907|Leucovorin|leucovorin|mesh-list
65333579|NCT00764907|Cytarabine|cytarabine|mesh-list
65333580|NCT00764907|Dexamethasone|dexamethasone|mesh-list
65333581|NCT00764907|Prednisone|prednisone|mesh-list
65221420|NCT00722137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65221421|NCT00722137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65221422|NCT00722137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221423|NCT00722137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65221424|NCT00722137|Glucocorticoids|glucocorticoids|mesh-ancestor
65221425|NCT00722137|Hormones|hormones|mesh-ancestor
65221426|NCT00722137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65221427|NCT00722137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65221428|NCT00722137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65221429|NCT00722137|Tubulin Modulators|tubulin modulators|mesh-ancestor
65221430|NCT00722137|Antimitotic Agents|antimitotic agents|mesh-ancestor
65221431|NCT00722137|Mitosis Modulators|mitosis modulators|mesh-ancestor
65221432|NCT02281084|Azacitidine|azacitidine|mesh-list
65221434|NCT02281084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65221435|NCT02281084|Antimetabolites|antimetabolites|mesh-ancestor
65221436|NCT02281084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221437|NCT02281084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221438|NCT02281084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221439|NCT02281084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65221440|NCT04114396|Antibodies|antibodies|mesh-list
65221444|NCT00796666|Sitaxsentan|sitaxsentan|mesh-list
65221445|NCT00796666|Vasodilator Agents|vasodilator agents|mesh-ancestor
65221446|NCT00796666|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65221447|NCT00796666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65221448|NCT00796666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221449|NCT00796666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221450|NCT00796666|Urological Agents|urological agents|mesh-ancestor
65221451|NCT00796666|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65221452|NCT00799708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65221453|NCT00799708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65221454|NCT00799708|Estradiol|estradiol|mesh-list
65221455|NCT00799708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65221456|NCT00799708|Estrogens|estrogens|mesh-ancestor
65221457|NCT00799708|Hormones|hormones|mesh-ancestor
65221458|NCT00799708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65221459|NCT00799708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221460|NCT00799708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65221461|NCT00799708|Contraceptive Agents|contraceptive agents|mesh-ancestor
65221462|NCT00799708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65221463|NCT00799708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65221464|NCT00796510|Sildenafil Citrate|sildenafil citrate|mesh-list
65221465|NCT00796510|Sitaxsentan|sitaxsentan|mesh-list
65221466|NCT00796510|Vasodilator Agents|vasodilator agents|mesh-ancestor
65221467|NCT00796510|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65221468|NCT00796510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65221469|NCT00796510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221470|NCT00796510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221471|NCT00796510|Urological Agents|urological agents|mesh-ancestor
65221472|NCT00796510|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65221473|NCT04111432|Vaccines|vaccines|mesh-list
65221474|NCT04111432|Immunologic Factors|immunologic factors|mesh-ancestor
65221475|NCT04111432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221476|NCT00915070|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
65221477|NCT00915070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65221478|NCT00915070|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65221479|NCT00915070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221480|NCT00588640|Methadone|methadone|mesh-list
65221481|NCT00588640|D-methadone|d-methadone|mesh-list
65221482|NCT00588640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65221483|NCT00588640|Narcotics|narcotics|mesh-ancestor
65221484|NCT00588640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65221485|NCT00588640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221486|NCT00588640|Analgesics|analgesics|mesh-ancestor
65221487|NCT00588640|Sensory System Agents|sensory system agents|mesh-ancestor
65221488|NCT00588640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333582|NCT00764907|Cyclophosphamide|cyclophosphamide|mesh-list
65333583|NCT00764907|Ifosfamide|ifosfamide|mesh-list
65333584|NCT00764907|Doxorubicin|doxorubicin|mesh-list
65333585|NCT00764907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65333586|NCT00764907|Methotrexate|methotrexate|mesh-list
65333587|NCT00764907|Etoposide|etoposide|mesh-list
65333588|NCT00764907|Vincristine|vincristine|mesh-list
65333589|NCT00764907|Daunorubicin|daunorubicin|mesh-list
64719457|NCT00000896|Lamivudine|lamivudine|mesh-list
65221489|NCT00588640|Antitussive Agents|antitussive agents|mesh-ancestor
65221490|NCT00588640|Respiratory System Agents|respiratory system agents|mesh-ancestor
65221491|NCT00588640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65221492|NCT01016912|Ribavirin|ribavirin|mesh-list
65221493|NCT01016912|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65221494|NCT01016912|Antimetabolites|antimetabolites|mesh-ancestor
65221495|NCT01016912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221496|NCT01016912|Antiviral Agents|antiviral agents|mesh-ancestor
65221497|NCT01016912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65221498|NCT02604940|Dexmedetomidine|dexmedetomidine|mesh-list
65221499|NCT02604940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65221500|NCT02604940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65221501|NCT02604940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221502|NCT02604940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65221503|NCT02604940|Analgesics|analgesics|mesh-ancestor
65221504|NCT02604940|Sensory System Agents|sensory system agents|mesh-ancestor
65221505|NCT02604940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65221506|NCT02604940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65221508|NCT02604940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65221509|NCT02604940|Adrenergic Agents|adrenergic agents|mesh-ancestor
65221510|NCT02604940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65221511|NCT02604940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221512|NCT02605798|Sofosbuvir|sofosbuvir|mesh-list
65221513|NCT02605798|Antiviral Agents|antiviral agents|mesh-ancestor
65221520|NCT04113772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221521|NCT04113928|Mechlorethamine|mechlorethamine|mesh-list
65221522|NCT04113928|Alkylating Agents|alkylating agents|mesh-ancestor
65221523|NCT04113928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221524|NCT04113928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65221525|NCT04113928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221526|NCT04115800|Sirolimus|sirolimus|mesh-list
65221527|NCT04115800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65221528|NCT04115800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65221529|NCT04115800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65221530|NCT04115800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221531|NCT04115800|Antifungal Agents|antifungal agents|mesh-ancestor
65221532|NCT04115800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65221533|NCT04115800|Immunologic Factors|immunologic factors|mesh-ancestor
65221534|NCT04115800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221535|NCT04115410|Gemcitabine|gemcitabine|mesh-list
65221536|NCT04115410|Cisplatin|cisplatin|mesh-list
65221537|NCT04115410|Carboplatin|carboplatin|mesh-list
65221538|NCT04115410|Docetaxel|docetaxel|mesh-list
65221539|NCT04115410|Pemetrexed|pemetrexed|mesh-list
65221540|NCT04115410|Vinorelbine|vinorelbine|mesh-list
65221541|NCT04115410|Gefitinib|gefitinib|mesh-list
65221542|NCT04115410|Mitomycins|mitomycins|mesh-list
65221543|NCT04115410|Mitomycin|mitomycin|mesh-list
65221544|NCT04115410|Osimertinib|osimertinib|mesh-list
65221545|NCT04115410|Vinblastine|vinblastine|mesh-list
65221546|NCT04115410|Afatinib|afatinib|mesh-list
65221547|NCT04115410|Crizotinib|crizotinib|mesh-list
65221548|NCT04115410|Ceritinib|ceritinib|mesh-list
65221549|NCT04115410|Antineoplastic Agents|antineoplastic agents|mesh-list
65221550|NCT04115410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65221551|NCT04115410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65221552|NCT04115410|Antimetabolites|antimetabolites|mesh-ancestor
65221553|NCT04115410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221554|NCT04115410|Antiviral Agents|antiviral agents|mesh-ancestor
65221555|NCT04115410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65221556|NCT04115410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221557|NCT04115410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65221558|NCT04115410|Immunologic Factors|immunologic factors|mesh-ancestor
65221559|NCT04115410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333590|NCT00764907|Asparaginase|asparaginase|mesh-list
65333591|NCT00764907|Mercaptopurine|mercaptopurine|mesh-list
65333592|NCT00764907|Thioguanine|thioguanine|mesh-list
65333593|NCT00764907|Vindesine|vindesine|mesh-list
65333594|NCT00764907|Levoleucovorin|levoleucovorin|mesh-list
65333595|NCT00764907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65333596|NCT00764907|Immunologic Factors|immunologic factors|mesh-ancestor
65333597|NCT00764907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333598|NCT00764907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64719467|NCT00000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221560|NCT04115410|Tubulin Modulators|tubulin modulators|mesh-ancestor
65221561|NCT04115410|Antimitotic Agents|antimitotic agents|mesh-ancestor
65221562|NCT04115410|Mitosis Modulators|mitosis modulators|mesh-ancestor
65221563|NCT04115410|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65221564|NCT04115410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65221565|NCT04115410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65221566|NCT04115410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65221567|NCT04115410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65221568|NCT04115410|Alkylating Agents|alkylating agents|mesh-ancestor
65221569|NCT02604628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65221570|NCT02604628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65221571|NCT02604784|Cisplatin|cisplatin|mesh-list
65221572|NCT02604784|Doxorubicin|doxorubicin|mesh-list
65221573|NCT02604784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65221574|NCT02604784|Oxaliplatin|oxaliplatin|mesh-list
65221575|NCT02604784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221576|NCT02604784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65221577|NCT02604784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65221578|NCT02604784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65221579|NCT02604784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221580|NCT02604784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221581|NCT04110808|Phentolamine|phentolamine|mesh-list
65221582|NCT04110808|Antihypertensive Agents|antihypertensive agents|mesh-list
65221583|NCT04110808|Nitroglycerin|nitroglycerin|mesh-list
65221584|NCT04110808|Anesthetics|anesthetics|mesh-list
64956037|NCT00411190|Antipyretics|antipyretics|mesh-ancestor
65221585|NCT04110808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65221586|NCT04110808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221588|NCT04110808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65221589|NCT04110808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65221590|NCT04110808|Adrenergic Agents|adrenergic agents|mesh-ancestor
65221591|NCT04110808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65221592|NCT04110808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221594|NCT00714259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221595|NCT00796120|Doxorubicin|doxorubicin|mesh-list
65221596|NCT00796120|Ifosfamide|ifosfamide|mesh-list
65221597|NCT00796120|Trabectedin|trabectedin|mesh-list
65221598|NCT00796120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65221599|NCT00796120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221600|NCT00796120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65221601|NCT00796120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65221602|NCT00796120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221603|NCT00796120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221604|NCT00796120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65221605|NCT00796120|Alkylating Agents|alkylating agents|mesh-ancestor
65221606|NCT00795886|Sirolimus|sirolimus|mesh-list
65221607|NCT00795886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65221608|NCT00795886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65221609|NCT00795886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65221610|NCT00795886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221611|NCT00795886|Antifungal Agents|antifungal agents|mesh-ancestor
65221612|NCT00795886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65221613|NCT00795886|Immunologic Factors|immunologic factors|mesh-ancestor
65221614|NCT00795886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221615|NCT04110418|Terlipressin|terlipressin|mesh-list
65221616|NCT04110418|Methylene Blue|methylene blue|mesh-list
65221617|NCT04110418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221618|NCT04110418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333599|NCT00764907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65333600|NCT00764907|Alkylating Agents|alkylating agents|mesh-ancestor
65333601|NCT00764907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333602|NCT00764907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333603|NCT00764907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65333604|NCT00764907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65333605|NCT00764907|Antiemetics|antiemetics|mesh-ancestor
65333606|NCT00764907|Autonomic Agents|autonomic agents|mesh-ancestor
65333607|NCT00764907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333608|NCT00764907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64719473|NCT00000896|Antimetabolites|antimetabolites|mesh-ancestor
64719474|NCT00000896|Immunologic Factors|immunologic factors|mesh-ancestor
64719475|NCT00000896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221619|NCT04110418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65221620|NCT04110418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65221621|NCT04110028|Niacinamide|niacinamide|mesh-list
65221622|NCT04110028|Niacin|niacin|mesh-list
65221623|NCT04110028|Nicotinic Acids|nicotinic acids|mesh-list
65221624|NCT04110028|Vitamin B Complex|vitamin b complex|mesh-ancestor
64864350|NCT01777919|Copper|copper|mesh-list
65221626|NCT04110028|Micronutrients|micronutrients|mesh-ancestor
65221627|NCT04110028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221628|NCT04110028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65221629|NCT04110028|Antimetabolites|antimetabolites|mesh-ancestor
65221630|NCT04110028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221631|NCT04110028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65221632|NCT04110028|Vasodilator Agents|vasodilator agents|mesh-ancestor
65221633|NCT02589457|Tenofovir|tenofovir|mesh-list
65221634|NCT02589457|Antiviral Agents|antiviral agents|mesh-ancestor
65221635|NCT02589457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65221636|NCT02589457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65221637|NCT02589457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65221638|NCT02589457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221639|NCT02589457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221640|NCT02589457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65221641|NCT02589457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65221642|NCT00718861|Zoledronic Acid|zoledronic acid|mesh-list
65221643|NCT00718861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65221644|NCT00718861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221645|NCT05310643|Nivolumab|nivolumab|mesh-list
65221646|NCT05310643|Ipilimumab|ipilimumab|mesh-list
65221647|NCT05310643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65221648|NCT05310643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221649|NCT05310643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65221650|NCT05310643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221651|NCT05269459|Cannabidiol|cannabidiol|mesh-list
65221652|NCT05269459|Anticonvulsants|anticonvulsants|mesh-ancestor
65221653|NCT05257213|Heparin|heparin|mesh-list
65221654|NCT05257213|Anticoagulants|anticoagulants|mesh-ancestor
65221655|NCT05257213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65221656|NCT05257213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65221657|NCT05257213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221658|NCT00918853|Pancrelipase|pancrelipase|mesh-list
65221659|NCT00918853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65221660|NCT01016600|Lenalidomide|lenalidomide|mesh-list
65221661|NCT01016600|Azacitidine|azacitidine|mesh-list
65221662|NCT01016600|Immunologic Factors|immunologic factors|mesh-ancestor
65221663|NCT01016600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221668|NCT01016600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221669|NCT01016600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65221670|NCT01016600|Antimetabolites|antimetabolites|mesh-ancestor
65221671|NCT01016600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333609|NCT00764907|Glucocorticoids|glucocorticoids|mesh-ancestor
65333610|NCT00764907|Hormones|hormones|mesh-ancestor
65333611|NCT00764907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65333612|NCT00764907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65333613|NCT00764907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65333614|NCT00764907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65333615|NCT00764907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65333616|NCT00764907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333617|NCT00764907|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65333618|NCT00764907|Abortifacient Agents|abortifacient agents|mesh-ancestor
65333619|NCT00764907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65333620|NCT00764907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65333621|NCT00764907|Antimetabolites|antimetabolites|mesh-ancestor
65333622|NCT00764907|Dermatologic Agents|dermatologic agents|mesh-ancestor
65333623|NCT00764907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64719485|NCT00000896|Growth Substances|growth substances|mesh-ancestor
65221672|NCT01016600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221673|NCT05175235|Pembrolizumab|pembrolizumab|mesh-list
65221675|NCT05175235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65221676|NCT05175235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221677|NCT05175235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65221678|NCT05175235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221679|NCT05236777|Natalizumab|natalizumab|mesh-list
65221680|NCT05236777|Immunologic Factors|immunologic factors|mesh-ancestor
65221681|NCT05236777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221682|NCT04298684|Metformin|metformin|mesh-list
65221683|NCT04298684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65221684|NCT04298684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65221685|NCT04298684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221686|NCT04298684|Incretins|incretins|mesh-ancestor
65221687|NCT04298684|Hormones|hormones|mesh-ancestor
65221688|NCT04298684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65221689|NCT04298684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65221690|NCT04298684|Protease Inhibitors|protease inhibitors|mesh-ancestor
65221691|NCT04298684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221692|NCT04298684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221693|NCT04298372|Lenalidomide|lenalidomide|mesh-list
65221694|NCT04298372|Immunologic Factors|immunologic factors|mesh-ancestor
65221695|NCT04298372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221696|NCT04298372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65221697|NCT04298372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65221698|NCT04298372|Growth Substances|growth substances|mesh-ancestor
65221699|NCT04298372|Growth Inhibitors|growth inhibitors|mesh-ancestor
65221700|NCT04298372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221701|NCT01010204|Varenicline|varenicline|mesh-list
65221702|NCT01010204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65221703|NCT01010204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65221704|NCT01010204|Cholinergic Agents|cholinergic agents|mesh-ancestor
65221705|NCT01010204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65221706|NCT01010204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221707|NCT01010204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221708|NCT00718549|Cyclophosphamide|cyclophosphamide|mesh-list
65221709|NCT00718549|Rituximab|rituximab|mesh-list
65221710|NCT00718549|Cladribine|cladribine|mesh-list
65221711|NCT00718549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65221712|NCT00718549|Immunologic Factors|immunologic factors|mesh-ancestor
65221713|NCT00718549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221714|NCT00718549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65333624|NCT00764907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65333625|NCT00764907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65333626|NCT00764907|Antiviral Agents|antiviral agents|mesh-ancestor
65333627|NCT00764907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65333628|NCT00764907|Antidotes|antidotes|mesh-ancestor
65221715|NCT00718549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65221716|NCT00718549|Alkylating Agents|alkylating agents|mesh-ancestor
65221717|NCT00718549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221718|NCT00718549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221719|NCT00718549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65221720|NCT00718549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65221721|NCT00793624|Formoterol Fumarate|formoterol fumarate|mesh-list
65221722|NCT00793624|Olodaterol|olodaterol|mesh-list
65221723|NCT00793624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65221724|NCT00793624|Autonomic Agents|autonomic agents|mesh-ancestor
65221725|NCT00793624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65221726|NCT00793624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221727|NCT00793624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65221728|NCT00793624|Respiratory System Agents|respiratory system agents|mesh-ancestor
65221729|NCT00793624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65221730|NCT00793624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65221731|NCT00793624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65221732|NCT00793624|Adrenergic Agents|adrenergic agents|mesh-ancestor
65221733|NCT00793624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65221740|NCT00919243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65221742|NCT00919243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65221743|NCT00919243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221744|NCT00919243|Antimetabolites|antimetabolites|mesh-ancestor
65221745|NCT00919243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221746|NCT00919243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221747|NCT00919243|Gout Suppressants|gout suppressants|mesh-ancestor
65221748|NCT00919243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65221749|NCT00919243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65221750|NCT00919243|Antioxidants|antioxidants|mesh-ancestor
65221751|NCT00919243|Protective Agents|protective agents|mesh-ancestor
65221752|NCT00794950|Sunitinib|sunitinib|mesh-list
65221753|NCT00794950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221754|NCT00794950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65221755|NCT00794950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65221756|NCT00794950|Growth Substances|growth substances|mesh-ancestor
65221757|NCT00794950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221758|NCT00794950|Growth Inhibitors|growth inhibitors|mesh-ancestor
65221759|NCT00794950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65221760|NCT00794950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221761|NCT00794950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221762|NCT02591173|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
65221763|NCT02591173|Angiotensin II|angiotensin ii|mesh-list
65221764|NCT02591173|Angiotensinogen|angiotensinogen|mesh-list
65221765|NCT02591173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65221766|NCT02591173|Vasodilator Agents|vasodilator agents|mesh-ancestor
65221767|NCT02591173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65221768|NCT02591173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65221769|NCT02591173|Protease Inhibitors|protease inhibitors|mesh-ancestor
65221770|NCT02591173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221771|NCT02591173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221772|NCT00793546|Exemestane|exemestane|mesh-list
65221773|NCT00793546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221774|NCT00793546|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65221775|NCT00793546|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65221776|NCT00793546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221777|NCT00793546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221778|NCT00793546|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65221779|NCT00793546|Hormone Antagonists|hormone antagonists|mesh-ancestor
65221780|NCT00793546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65221781|NCT00793546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221782|NCT02604238|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65221783|NCT02604238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65221784|NCT02604238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65333629|NCT00764907|Protective Agents|protective agents|mesh-ancestor
65333630|NCT00764907|Vitamin B Complex|vitamin b complex|mesh-ancestor
65333631|NCT00764907|Vitamins|vitamins|mesh-ancestor
65333632|NCT00764907|Micronutrients|micronutrients|mesh-ancestor
65333633|NCT00764907|Tubulin Modulators|tubulin modulators|mesh-ancestor
65333634|NCT00764907|Antimitotic Agents|antimitotic agents|mesh-ancestor
65333635|NCT00764907|Mitosis Modulators|mitosis modulators|mesh-ancestor
65333636|NCT02583698|Carvedilol|carvedilol|mesh-list
65333637|NCT02583698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65333638|NCT02583698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65333639|NCT02583698|Adrenergic Agents|adrenergic agents|mesh-ancestor
64719505|NCT00000902|Antiviral Agents|antiviral agents|mesh-ancestor
65221785|NCT02604238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221786|NCT00798694|Travoprost|travoprost|mesh-list
65221787|NCT00798694|Latanoprost|latanoprost|mesh-list
65221788|NCT00798694|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65221789|NCT00798694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65221790|NCT00798694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65221791|NCT00718315|Erythromycin|erythromycin|mesh-list
65221792|NCT00718315|Erythromycin Estolate|erythromycin estolate|mesh-list
65221793|NCT00718315|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65221794|NCT00718315|Erythromycin stearate|erythromycin stearate|mesh-list
65221795|NCT00718315|Fusidic Acid|fusidic acid|mesh-list
65221796|NCT00718315|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65221797|NCT00718315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221798|NCT00718315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65221799|NCT00718315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221800|NCT00718315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221801|NCT00718315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65221804|NCT00718315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65221805|NCT00798304|Vaccines|vaccines|mesh-list
65221806|NCT00798304|Immunologic Factors|immunologic factors|mesh-ancestor
65221807|NCT00798304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221808|NCT04109872|Lenalidomide|lenalidomide|mesh-list
65221809|NCT04109872|Immunologic Factors|immunologic factors|mesh-ancestor
65221810|NCT04109872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221811|NCT04109872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65221812|NCT04109872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65221813|NCT04109872|Growth Substances|growth substances|mesh-ancestor
65221814|NCT04109872|Growth Inhibitors|growth inhibitors|mesh-ancestor
65221815|NCT04109872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221816|NCT00793780|Naltrexone|naltrexone|mesh-list
65221817|NCT00793780|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65221818|NCT00793780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65221819|NCT00793780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221820|NCT00793780|Sensory System Agents|sensory system agents|mesh-ancestor
65221821|NCT00793780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65221822|NCT05650996|Calpastatin|calpastatin|mesh-list
65221823|NCT05650996|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65221824|NCT05650996|Protease Inhibitors|protease inhibitors|mesh-ancestor
65221825|NCT05650996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221826|NCT05650996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221827|NCT04107220|Valsartan|valsartan|mesh-list
65221828|NCT04107220|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65221829|NCT04107220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65221830|NCT04107220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65221831|NCT04107220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65221832|NCT04107220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221833|NCT02591017|Ketamine|ketamine|mesh-list
65221834|NCT02591017|Morphine|morphine|mesh-list
65221835|NCT02591017|Chitosan|chitosan|mesh-list
65221836|NCT02591017|Analgesics|analgesics|mesh-ancestor
65221837|NCT02591017|Sensory System Agents|sensory system agents|mesh-ancestor
65221838|NCT02591017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65221839|NCT02591017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333640|NCT02583698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65333641|NCT02583698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333642|NCT02583698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333643|NCT02583698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65333644|NCT02583698|Antioxidants|antioxidants|mesh-ancestor
65333645|NCT02583698|Protective Agents|protective agents|mesh-ancestor
65333646|NCT02583698|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64719515|NCT04331600|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64719516|NCT04331600|Amebicides|amebicides|mesh-ancestor
64719517|NCT04331600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64711016|NCT05774236|Dinoprostone|dinoprostone|mesh-list
65221840|NCT02591017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65221841|NCT02591017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65221842|NCT02591017|Anesthetics, General|anesthetics, general|mesh-ancestor
65221843|NCT02591017|Anesthetics|anesthetics|mesh-ancestor
65221844|NCT02591017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65221845|NCT02591017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65221846|NCT02591017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65221847|NCT02591017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65221848|NCT02591017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221849|NCT02591017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65221850|NCT02591017|Narcotics|narcotics|mesh-ancestor
65221851|NCT02591017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65221852|NCT02591017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65221853|NCT02591017|Antimetabolites|antimetabolites|mesh-ancestor
65221854|NCT02591017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65221855|NCT02591017|Chelating Agents|chelating agents|mesh-ancestor
65221856|NCT02591017|Sequestering Agents|sequestering agents|mesh-ancestor
65221857|NCT02591017|Hemostatics|hemostatics|mesh-ancestor
65221858|NCT02591017|Coagulants|coagulants|mesh-ancestor
65221860|NCT02591095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221861|NCT02588755|Chlorotrianisene|chlorotrianisene|mesh-list
65221862|NCT02588755|Tegafur|tegafur|mesh-list
65221863|NCT02588755|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65221864|NCT02588755|Estrogens|estrogens|mesh-ancestor
65221865|NCT02588755|Hormones|hormones|mesh-ancestor
65221866|NCT02588755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65221867|NCT02588755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221868|NCT02588755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65221869|NCT02588755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221870|NCT02588755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65221871|NCT02588755|Antimetabolites|antimetabolites|mesh-ancestor
65221872|NCT02588755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221873|NCT00919321|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65221874|NCT00919321|Immunologic Factors|immunologic factors|mesh-ancestor
65221875|NCT00919321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221880|NCT02643303|Tremelimumab|tremelimumab|mesh-list
65221881|NCT02643303|Poly ICLC|poly iclc|mesh-list
65221882|NCT02643303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65221883|NCT02643303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956042|NCT00411229|Capecitabine|capecitabine|mesh-list
65221884|NCT02643303|Interferon Inducers|interferon inducers|mesh-ancestor
65221885|NCT02643303|Immunologic Factors|immunologic factors|mesh-ancestor
65221886|NCT02643303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221887|NCT01939275|Copper|copper|mesh-list
65221888|NCT01939275|Trastuzumab|trastuzumab|mesh-list
65221889|NCT01939275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65221890|NCT01939275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221891|NCT01939275|Trace Elements|trace elements|mesh-ancestor
65221892|NCT01939275|Micronutrients|micronutrients|mesh-ancestor
65221893|NCT01939275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221894|NCT00615147|Fibrin fragment D|fibrin fragment d|mesh-list
65221895|NCT00615147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65221896|NCT00615147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65221897|NCT00615147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333647|NCT02583698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65333648|NCT02583698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65333649|NCT02583698|Vasodilator Agents|vasodilator agents|mesh-ancestor
65333650|NCT02583698|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65333651|NCT02583698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65333652|NCT00762099|Pregabalin|pregabalin|mesh-list
64719524|NCT04331600|Analgesics|analgesics|mesh-ancestor
65221898|NCT00615147|Hemostatics|hemostatics|mesh-ancestor
65221899|NCT00615147|Coagulants|coagulants|mesh-ancestor
65221900|NCT01029717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65221901|NCT01029717|Minocycline|minocycline|mesh-list
65221902|NCT01029717|Rifampin|rifampin|mesh-list
65221903|NCT01029717|Heparin|heparin|mesh-list
65221904|NCT01029717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65221905|NCT01029717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65221906|NCT01029717|Antitubercular Agents|antitubercular agents|mesh-ancestor
65221907|NCT01029717|Anticoagulants|anticoagulants|mesh-ancestor
65221908|NCT01029717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65221909|NCT01029717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65221910|NCT01029717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221911|NCT01029717|Leprostatic Agents|leprostatic agents|mesh-ancestor
65221912|NCT01029717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65221913|NCT01029717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221914|NCT01029717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65221915|NCT01029717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65221916|NCT01029717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65221917|NCT01029717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65221918|NCT01029717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65221919|NCT01029717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65221920|NCT00790036|Everolimus|everolimus|mesh-list
65221921|NCT00790036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221922|NCT00790036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65221923|NCT00790036|Immunologic Factors|immunologic factors|mesh-ancestor
64864650|NCT01779908|Vitamin D|vitamin d|mesh-list
65221924|NCT00790036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221926|NCT05563168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65221927|NCT05563168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65221928|NCT05563168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65221929|NCT05563168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221930|NCT05563168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65221931|NCT05563168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221932|NCT05563168|Vasodilator Agents|vasodilator agents|mesh-ancestor
65221933|NCT00789958|Gemcitabine|gemcitabine|mesh-list
65221934|NCT00789958|Capecitabine|capecitabine|mesh-list
65221935|NCT00789958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65221936|NCT00789958|Antimetabolites|antimetabolites|mesh-ancestor
65221937|NCT00789958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221938|NCT00789958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65221939|NCT00789958|Antiviral Agents|antiviral agents|mesh-ancestor
65221940|NCT00789958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65221941|NCT00789958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221942|NCT00789958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65221943|NCT00789958|Immunologic Factors|immunologic factors|mesh-ancestor
65221944|NCT00789958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221945|NCT00789880|Vitamin D|vitamin d|mesh-list
65221946|NCT00789880|Ergocalciferols|ergocalciferols|mesh-list
65221947|NCT00789880|Cholecalciferol|cholecalciferol|mesh-list
65221948|NCT00789880|Vitamins|vitamins|mesh-list
65221954|NCT00915616|Antioxidants|antioxidants|mesh-ancestor
65221955|NCT00915616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221956|NCT00915616|Protective Agents|protective agents|mesh-ancestor
65221957|NCT00915616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221958|NCT00915616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65221959|NCT00914836|Betamethasone|betamethasone|mesh-list
65221960|NCT00914836|Betamethasone Valerate|betamethasone valerate|mesh-list
65221961|NCT00914836|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65221962|NCT00914836|Betamethasone benzoate|betamethasone benzoate|mesh-list
65333654|NCT00762099|Sensory System Agents|sensory system agents|mesh-ancestor
65333655|NCT00762099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333656|NCT00762099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333657|NCT00762099|Anticonvulsants|anticonvulsants|mesh-ancestor
65333658|NCT00762099|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65333659|NCT00762099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65333660|NCT00762099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333661|NCT00762099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65221963|NCT00914836|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
65221964|NCT00914836|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65221965|NCT00914836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65221966|NCT00914836|Glucocorticoids|glucocorticoids|mesh-ancestor
65221968|NCT00914836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65221969|NCT00914836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221970|NCT00914836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65221971|NCT00914836|Respiratory System Agents|respiratory system agents|mesh-ancestor
65221972|NCT04106752|Caffeine|caffeine|mesh-list
65221973|NCT04106752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65221974|NCT04106752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221975|NCT04106752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65221976|NCT04106752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221977|NCT04106752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221978|NCT04106752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65221979|NCT04106752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65221980|NCT04106752|Purinergic Agents|purinergic agents|mesh-ancestor
65221981|NCT04106752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65221982|NCT00792298|Suvorexant|suvorexant|mesh-list
65221983|NCT00792298|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65221984|NCT00792298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65221985|NCT00792298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65221986|NCT00792298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221987|NCT00792298|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65221988|NCT00792298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65221989|NCT00792298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221990|NCT04108468|Golimumab|golimumab|mesh-list
65221991|NCT04108468|Methotrexate|methotrexate|mesh-list
65221992|NCT04108468|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65221993|NCT04108468|Abortifacient Agents|abortifacient agents|mesh-ancestor
65221994|NCT04108468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65221995|NCT04108468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221996|NCT04108468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65221997|NCT04108468|Antimetabolites|antimetabolites|mesh-ancestor
65221998|NCT04108468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221999|NCT04108468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65222000|NCT04108468|Dermatologic Agents|dermatologic agents|mesh-ancestor
65222001|NCT04108468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222002|NCT04108468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65222003|NCT04108468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65222004|NCT04108468|Immunologic Factors|immunologic factors|mesh-ancestor
65222005|NCT04108468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65222006|NCT04108468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65222007|NCT04108468|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65222008|NCT04108468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65222009|NCT04106362|Cisplatin|cisplatin|mesh-list
65222010|NCT04106362|Cetuximab|cetuximab|mesh-list
65222011|NCT04106362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65222012|NCT04106362|Antibodies|antibodies|mesh-list
65222013|NCT04106362|Immunoglobulins|immunoglobulins|mesh-list
65222014|NCT04106362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65222015|NCT04106362|Immunologic Factors|immunologic factors|mesh-ancestor
65222021|NCT00718081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65222022|NCT00718081|Narcotics|narcotics|mesh-ancestor
65333662|NCT00762099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65333663|NCT00762099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65333664|NCT00762099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65333665|NCT00762099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65333666|NCT00762255|Bevacizumab|bevacizumab|mesh-list
65333667|NCT00762255|Irinotecan|irinotecan|mesh-list
65333668|NCT00762255|Vorinostat|vorinostat|mesh-list
65333669|NCT00762255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65222023|NCT00718081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65222024|NCT00718081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222025|NCT00718081|Analgesics|analgesics|mesh-ancestor
65222026|NCT00718081|Sensory System Agents|sensory system agents|mesh-ancestor
65222027|NCT00718081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65222028|NCT00718081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65222029|NCT00718081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65222030|NCT00718081|Anesthetics, General|anesthetics, general|mesh-ancestor
65222031|NCT00718081|Anesthetics|anesthetics|mesh-ancestor
65222032|NCT00788710|Etoricoxib|etoricoxib|mesh-list
65222033|NCT00788710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65222034|NCT00788710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65222035|NCT00788710|Analgesics|analgesics|mesh-ancestor
65222036|NCT00788710|Sensory System Agents|sensory system agents|mesh-ancestor
65222037|NCT00788710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65222038|NCT00788710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222039|NCT00788710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65222040|NCT00788710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65222041|NCT00788710|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65222042|NCT00788710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65222043|NCT00788710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222044|NCT00788710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222045|NCT04084093|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65222046|NCT04084093|Respiratory System Agents|respiratory system agents|mesh-ancestor
65222047|NCT04083625|Carbetocin|carbetocin|mesh-list
65222048|NCT04083625|Oxytocics|oxytocics|mesh-ancestor
65222049|NCT04083625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65222050|NCT04083625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222051|NCT00787930|Valproic Acid|valproic acid|mesh-list
65222052|NCT00787930|Anticonvulsants|anticonvulsants|mesh-ancestor
65222053|NCT00787930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222054|NCT00787930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222055|NCT00787930|GABA Agents|gaba agents|mesh-ancestor
65222056|NCT00787930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65222057|NCT00787930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222058|NCT00787930|Antimanic Agents|antimanic agents|mesh-ancestor
65222059|NCT00787930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65222060|NCT00787930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65222061|NCT00787930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65222062|NCT04106050|Lidocaine|lidocaine|mesh-list
65222063|NCT04106050|Anesthetics, Local|anesthetics, local|mesh-ancestor
65222064|NCT04106050|Anesthetics|anesthetics|mesh-ancestor
65222065|NCT04106050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65222066|NCT04106050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222067|NCT04106050|Sensory System Agents|sensory system agents|mesh-ancestor
65222068|NCT04106050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65222069|NCT04106050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65222070|NCT04106050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64864801|NCT01780753|Primaquine|primaquine|mesh-list
65222071|NCT04106050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65222072|NCT04106050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65222073|NCT04106050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222075|NCT00588094|Carboplatin|carboplatin|mesh-list
65222076|NCT00588094|Etoposide|etoposide|mesh-list
65222077|NCT00588094|Ifosfamide|ifosfamide|mesh-list
65222078|NCT00588094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65222079|NCT00588094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65222080|NCT00588094|Immunologic Factors|immunologic factors|mesh-ancestor
65222081|NCT00588094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222082|NCT00588094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65333670|NCT00762255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333671|NCT00762255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65333672|NCT00762255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65333673|NCT00762255|Growth Substances|growth substances|mesh-ancestor
65333674|NCT00762255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333675|NCT00762255|Growth Inhibitors|growth inhibitors|mesh-ancestor
65222083|NCT00588094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65222084|NCT00588094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65222085|NCT00588094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65222086|NCT00588094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222092|NCT05194735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65222093|NCT05194735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65222094|NCT05194735|Antiviral Agents|antiviral agents|mesh-ancestor
65222095|NCT05194735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65222096|NCT05590624|Phentermine|phentermine|mesh-list
65222097|NCT05590624|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65222098|NCT05590624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222099|NCT05590624|Appetite Depressants|appetite depressants|mesh-ancestor
65222100|NCT05590624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65222101|NCT05590624|Sympathomimetics|sympathomimetics|mesh-ancestor
65222102|NCT05590624|Autonomic Agents|autonomic agents|mesh-ancestor
65222103|NCT05590624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65222104|NCT05590624|Adrenergic Agents|adrenergic agents|mesh-ancestor
65222105|NCT05590624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65222106|NCT05590624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222107|NCT02605252|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65222108|NCT02605252|Antiviral Agents|antiviral agents|mesh-ancestor
65222109|NCT02605252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65222110|NCT00482157|Vitamin D|vitamin d|mesh-list
65222111|NCT00482157|Calcitriol|calcitriol|mesh-list
65222112|NCT00482157|Vitamins|vitamins|mesh-ancestor
65222113|NCT00482157|Micronutrients|micronutrients|mesh-ancestor
65222114|NCT00482157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222115|NCT00482157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65222116|NCT00482157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65222117|NCT00482157|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65222118|NCT00482157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65222119|NCT00482157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222120|NCT00482157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65222121|NCT02706015|Dipyrone|dipyrone|mesh-list
65222122|NCT02706015|Dihydroergotamine|dihydroergotamine|mesh-list
65222123|NCT02706015|Caffeine|caffeine|mesh-list
65222124|NCT02706015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65222125|NCT02706015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222126|NCT02706015|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65222127|NCT02706015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222128|NCT02706015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222129|NCT02706015|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65222130|NCT02706015|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65222131|NCT02706015|Purinergic Agents|purinergic agents|mesh-ancestor
65222132|NCT02706015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65222133|NCT02706015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65222134|NCT02706015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65222135|NCT02706015|Analgesics|analgesics|mesh-ancestor
65222136|NCT02706015|Sensory System Agents|sensory system agents|mesh-ancestor
65222137|NCT02706015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65222138|NCT02706015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65222139|NCT02706015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65222140|NCT02706015|Antipyretics|antipyretics|mesh-ancestor
65222141|NCT02706015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65222142|NCT02706015|Dopamine Agonists|dopamine agonists|mesh-ancestor
65222143|NCT02706015|Dopamine Agents|dopamine agents|mesh-ancestor
65222144|NCT02707575|Ranibizumab|ranibizumab|mesh-list
65222145|NCT02707575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65222146|NCT02707575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65222147|NCT02707575|Growth Substances|growth substances|mesh-ancestor
65222148|NCT02707575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222149|NCT02707575|Growth Inhibitors|growth inhibitors|mesh-ancestor
65222150|NCT02707575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333676|NCT00762255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65333677|NCT00762255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65333678|NCT00762255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333679|NCT00762255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333680|NCT00762255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65333681|NCT02585180|Silver Sulfadiazine|silver sulfadiazine|mesh-list
65333682|NCT02585180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65333683|NCT02585180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65222151|NCT00919399|Tamoxifen|tamoxifen|mesh-list
65222152|NCT00919399|Exemestane|exemestane|mesh-list
65222153|NCT00919399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65222154|NCT00919399|Hormone Antagonists|hormone antagonists|mesh-ancestor
65222155|NCT00919399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65222156|NCT00919399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222161|NCT00919399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65222162|NCT00919399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65222163|NCT00919399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65222164|NCT00919399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222165|NCT00919399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222166|NCT00784654|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65222167|NCT00784654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65222168|NCT00784654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222169|NCT00784654|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65222170|NCT00784654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65222171|NCT00784654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65222172|NCT00784654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222173|NCT00784654|Dopamine Agents|dopamine agents|mesh-ancestor
65222174|NCT00784654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65222175|NCT02588287|Tenofovir|tenofovir|mesh-list
65222176|NCT02588287|Antiviral Agents|antiviral agents|mesh-ancestor
65222177|NCT02588287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65222178|NCT02588287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65222179|NCT02588287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65222180|NCT02588287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222181|NCT02588287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222182|NCT02588287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65222183|NCT02588287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65222184|NCT02707263|Heparin|heparin|mesh-list
65222185|NCT02707263|Calcium heparin|calcium heparin|mesh-list
65222186|NCT02707263|Anticoagulants|anticoagulants|mesh-ancestor
65222187|NCT02707263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65222188|NCT02707263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65222189|NCT02707263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222190|NCT02705547|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65222191|NCT02705547|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65222192|NCT02705547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65222193|NCT02705547|Antimetabolites|antimetabolites|mesh-ancestor
65222194|NCT02705547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222195|NCT02705547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65222196|NCT02705547|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65222197|NCT02705547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222198|NCT00615303|Simethicone|simethicone|mesh-list
65222199|NCT00615303|Antifoaming Agents|antifoaming agents|mesh-ancestor
65222200|NCT00615303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222201|NCT00615303|Emollients|emollients|mesh-ancestor
65222202|NCT00615303|Dermatologic Agents|dermatologic agents|mesh-ancestor
65222203|NCT00787150|Warfarin|warfarin|mesh-list
65222204|NCT00787150|Apixaban|apixaban|mesh-list
65222205|NCT00787150|Anticoagulants|anticoagulants|mesh-ancestor
65222206|NCT00787150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65222207|NCT00787150|Antithrombins|antithrombins|mesh-ancestor
65222208|NCT00787150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65222209|NCT00787150|Protease Inhibitors|protease inhibitors|mesh-ancestor
65222210|NCT00787150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333684|NCT02557971|Botulinum Toxins|botulinum toxins|mesh-list
65333685|NCT02557971|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65333686|NCT02557971|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65333687|NCT02557971|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65333688|NCT02557971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64719560|NCT00000914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65222211|NCT00787150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222212|NCT03606837|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65222213|NCT03606837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65222214|NCT03606837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222215|NCT02705313|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65222216|NCT02705313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65222217|NCT02705313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222218|NCT00786838|Trabectedin|trabectedin|mesh-list
65222219|NCT00786838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65222220|NCT00786838|Alkylating Agents|alkylating agents|mesh-ancestor
65222221|NCT00786838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222222|NCT00786838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65222223|NCT05683171|Rituximab|rituximab|mesh-list
65222224|NCT05683171|Lenalidomide|lenalidomide|mesh-list
65222232|NCT05683171|Growth Substances|growth substances|mesh-ancestor
65222233|NCT05683171|Growth Inhibitors|growth inhibitors|mesh-ancestor
65222235|NCT02604004|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65222236|NCT02604004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65222237|NCT02604004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222238|NCT02604004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222239|NCT02604004|Antiviral Agents|antiviral agents|mesh-ancestor
65222240|NCT02604004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65222241|NCT02604004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65222242|NCT02604004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65222243|NCT05095207|Bicalutamide|bicalutamide|mesh-list
65222244|NCT05095207|Androgen Antagonists|androgen antagonists|mesh-ancestor
65222245|NCT05095207|Hormone Antagonists|hormone antagonists|mesh-ancestor
65222246|NCT05095207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65222247|NCT05095207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222248|NCT05095207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65222249|NCT03354039|Tamoxifen|tamoxifen|mesh-list
65222250|NCT03354039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65222251|NCT03354039|Hormone Antagonists|hormone antagonists|mesh-ancestor
65222252|NCT03354039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65222253|NCT03354039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222254|NCT03354039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65222255|NCT03354039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65222256|NCT03354039|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65222257|NCT03354039|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65222258|NCT03354039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65222259|NCT04105426|Antioxidants|antioxidants|mesh-list
65222260|NCT04105426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222261|NCT04105426|Protective Agents|protective agents|mesh-ancestor
65222262|NCT04105426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222264|NCT02704923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65222265|NCT02704923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65222266|NCT02704923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65222267|NCT02704923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65222268|NCT02704923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65222269|NCT02704923|Autonomic Agents|autonomic agents|mesh-ancestor
65222270|NCT02704923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65222271|NCT02704923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222272|NCT02704923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65222273|NCT02704923|Respiratory System Agents|respiratory system agents|mesh-ancestor
65222274|NCT02704923|Mydriatics|mydriatics|mesh-ancestor
65222275|NCT02704923|Parasympatholytics|parasympatholytics|mesh-ancestor
65222276|NCT02704923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65222277|NCT02704923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65222278|NCT02704923|Cholinergic Agents|cholinergic agents|mesh-ancestor
65222279|NCT02704923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65333689|NCT02557971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333690|NCT02557971|Cholinergic Agents|cholinergic agents|mesh-ancestor
65333691|NCT02557971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64719566|NCT00000920|Saquinavir|saquinavir|mesh-list
65222280|NCT02704923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222281|NCT04815967|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
65222282|NCT04815967|Botulinum Toxins|botulinum toxins|mesh-list
65222283|NCT04815967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65222284|NCT04815967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65222285|NCT04815967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65222286|NCT04815967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65222287|NCT04815967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222288|NCT04815967|Cholinergic Agents|cholinergic agents|mesh-ancestor
65222289|NCT04815967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65222294|NCT02704767|Apatinib|apatinib|mesh-list
65222295|NCT02704767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65222296|NCT02704767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65222297|NCT02704767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65222298|NCT02704767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222299|NCT02704767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222300|NCT02587273|Fentanyl|fentanyl|mesh-list
65222301|NCT02587273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65222302|NCT02587273|Narcotics|narcotics|mesh-ancestor
65222303|NCT02587273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65222304|NCT02587273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222305|NCT02587273|Analgesics|analgesics|mesh-ancestor
65222306|NCT02587273|Sensory System Agents|sensory system agents|mesh-ancestor
65222307|NCT02587273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65222308|NCT02587273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65222309|NCT02587273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65222310|NCT02587273|Anesthetics, General|anesthetics, general|mesh-ancestor
65222311|NCT02587273|Anesthetics|anesthetics|mesh-ancestor
65222312|NCT02587741|Metformin|metformin|mesh-list
65222313|NCT02587741|Acarbose|acarbose|mesh-list
65222314|NCT02587741|Gliclazide|gliclazide|mesh-list
65222315|NCT02587741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65222316|NCT02587741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65222317|NCT02587741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222318|NCT02587741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65222319|NCT02587741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222320|NCT02587741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222321|NCT02703363|Minocycline|minocycline|mesh-list
65222322|NCT02703363|Celecoxib|celecoxib|mesh-list
65222323|NCT02703363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65222324|NCT02703363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65222325|NCT02703363|Analgesics|analgesics|mesh-ancestor
65222326|NCT02703363|Sensory System Agents|sensory system agents|mesh-ancestor
65222327|NCT02703363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65222328|NCT02703363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222330|NCT02703363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65222331|NCT02703363|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65222332|NCT02703363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65222333|NCT02703363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222334|NCT02703363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222335|NCT02703363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65222336|NCT02703363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65222337|NCT05018221|Vitamins|vitamins|mesh-list
65222338|NCT05018221|Vitamin K|vitamin k|mesh-list
65222339|NCT05018221|Vitamin K 1|vitamin k 1|mesh-list
65222340|NCT05018221|Sodium thiosulfate|sodium thiosulfate|mesh-list
65222341|NCT05018221|Magnesium citrate|magnesium citrate|mesh-list
65222342|NCT05018221|Citric Acid|citric acid|mesh-list
65222343|NCT05018221|Sodium Citrate|sodium citrate|mesh-list
65222344|NCT05018221|Micronutrients|micronutrients|mesh-ancestor
65222345|NCT05018221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222346|NCT05018221|Anticoagulants|anticoagulants|mesh-ancestor
65222347|NCT05018221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65222348|NCT05018221|Chelating Agents|chelating agents|mesh-ancestor
65222349|NCT05018221|Sequestering Agents|sequestering agents|mesh-ancestor
65222350|NCT05018221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222351|NCT05018221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65333692|NCT02557971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333693|NCT02557971|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65333694|NCT02557971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333695|NCT05332730|Golimumab|golimumab|mesh-list
65333696|NCT05332730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65333697|NCT05332730|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65333698|NCT05332730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65333699|NCT05332730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65333700|NCT05332730|Immunologic Factors|immunologic factors|mesh-ancestor
65333701|NCT05332730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333702|NCT02581826|Silodosin|silodosin|mesh-list
65333703|NCT02581826|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65333704|NCT02581826|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65333705|NCT02581826|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64719583|NCT00000938|Doxycycline|doxycycline|mesh-list
65222352|NCT05018221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65222353|NCT05018221|Hemostatics|hemostatics|mesh-ancestor
65222354|NCT05018221|Coagulants|coagulants|mesh-ancestor
65222355|NCT05018221|Antidotes|antidotes|mesh-ancestor
65222356|NCT05018221|Protective Agents|protective agents|mesh-ancestor
65222357|NCT05018221|Antioxidants|antioxidants|mesh-ancestor
65222358|NCT05018221|Antitubercular Agents|antitubercular agents|mesh-ancestor
65222359|NCT05018221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65222360|NCT05018221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65222361|NCT05018221|Cathartics|cathartics|mesh-ancestor
65222362|NCT05018221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65222363|NCT00615381|Insulin|insulin|mesh-list
65222367|NCT00785980|Ciprofloxacin|ciprofloxacin|mesh-list
65222368|NCT00785980|Quinine|quinine|mesh-list
65222369|NCT00785980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65222370|NCT00785980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65222371|NCT00785980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65222372|NCT00785980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65222373|NCT00785980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222374|NCT00785980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222375|NCT00785980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65222376|NCT00785980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65222377|NCT00785980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65222378|NCT00785980|Antimalarials|antimalarials|mesh-ancestor
65222379|NCT00785980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65222380|NCT00785980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65222381|NCT00785980|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65222382|NCT00785980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222383|NCT00785980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65222384|NCT00785980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65222385|NCT00785980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65222386|NCT00785980|Analgesics|analgesics|mesh-ancestor
65222387|NCT00785980|Sensory System Agents|sensory system agents|mesh-ancestor
65222388|NCT04805073|Promethazine|promethazine|mesh-list
65222389|NCT04805073|Diphenhydramine|diphenhydramine|mesh-list
65222390|NCT04805073|Antipruritics|antipruritics|mesh-ancestor
65222391|NCT04805073|Dermatologic Agents|dermatologic agents|mesh-ancestor
65222392|NCT04805073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65222393|NCT04805073|Histamine Antagonists|histamine antagonists|mesh-ancestor
65222394|NCT04805073|Histamine Agents|histamine agents|mesh-ancestor
65222395|NCT04805073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65222396|NCT04805073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222397|NCT04805073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222398|NCT04805073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65222399|NCT04805073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65222400|NCT04805073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65333706|NCT02581826|Adrenergic Agents|adrenergic agents|mesh-ancestor
65333707|NCT02581826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65333708|NCT02581826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333709|NCT02581826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333710|NCT02581826|Urological Agents|urological agents|mesh-ancestor
65333711|NCT04340882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65333712|NCT04340882|Pembrolizumab|pembrolizumab|mesh-list
65333713|NCT04340882|Docetaxel|docetaxel|mesh-list
65333714|NCT04340882|Ramucirumab|ramucirumab|mesh-list
65333715|NCT04340882|Antibodies|antibodies|mesh-list
65333716|NCT04340882|Immunoglobulins|immunoglobulins|mesh-list
65333717|NCT04340882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65222401|NCT04805073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65222402|NCT04805073|Anesthetics, Local|anesthetics, local|mesh-ancestor
65222403|NCT04805073|Anesthetics|anesthetics|mesh-ancestor
65222404|NCT04805073|Sensory System Agents|sensory system agents|mesh-ancestor
65222405|NCT04805073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65222406|NCT04805073|Antiemetics|antiemetics|mesh-ancestor
65222407|NCT04805073|Autonomic Agents|autonomic agents|mesh-ancestor
65222408|NCT04805073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65222409|NCT00915694|Nelfinavir|nelfinavir|mesh-list
65222410|NCT00915694|Temozolomide|temozolomide|mesh-list
65222411|NCT00915694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65222412|NCT00915694|Alkylating Agents|alkylating agents|mesh-ancestor
65222413|NCT00915694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222414|NCT00915694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65222415|NCT00915694|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65222416|NCT00915694|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65222417|NCT00915694|Protease Inhibitors|protease inhibitors|mesh-ancestor
65222418|NCT00915694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222419|NCT00915694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65222420|NCT00915694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65222421|NCT00915694|Antiviral Agents|antiviral agents|mesh-ancestor
65222422|NCT00915694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65222423|NCT04799431|Poly I-C|poly i-c|mesh-list
65222424|NCT04799431|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65222425|NCT04799431|Poly ICLC|poly iclc|mesh-list
65222426|NCT04799431|Interferon Inducers|interferon inducers|mesh-ancestor
65222427|NCT04799431|Immunologic Factors|immunologic factors|mesh-ancestor
65222428|NCT04799431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222429|NCT04799431|Laxatives|laxatives|mesh-ancestor
65222430|NCT04799431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65222431|NCT04799431|Antiviral Agents|antiviral agents|mesh-ancestor
65222432|NCT04799431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65222433|NCT02703051|Lenograstim|lenograstim|mesh-list
65222434|NCT02703051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65222435|NCT02703051|Immunologic Factors|immunologic factors|mesh-ancestor
65222436|NCT02703051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222437|NCT00785512|Nebivolol|nebivolol|mesh-list
65222443|NCT00785512|Adrenergic Agents|adrenergic agents|mesh-ancestor
65222444|NCT00785512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65222445|NCT00785512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222446|NCT00785512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222448|NCT02702817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65222449|NCT02702817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65222450|NCT02702817|Analgesics|analgesics|mesh-ancestor
65222451|NCT02702817|Sensory System Agents|sensory system agents|mesh-ancestor
65222452|NCT02702817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65222453|NCT02702817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222454|NCT02702817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65222455|NCT02702817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65222456|NCT02702817|Gout Suppressants|gout suppressants|mesh-ancestor
65222457|NCT02702817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65222458|NCT02702817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222459|NCT02702817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333718|NCT04340882|Lexatumumab|lexatumumab|mesh-list
65333719|NCT04340882|Immunologic Factors|immunologic factors|mesh-ancestor
65333720|NCT04340882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333721|NCT04340882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333722|NCT04340882|Tubulin Modulators|tubulin modulators|mesh-ancestor
65222460|NCT02702739|Ribavirin|ribavirin|mesh-list
65222461|NCT02702739|Sofosbuvir|sofosbuvir|mesh-list
65222462|NCT02702739|Simeprevir|simeprevir|mesh-list
65222463|NCT02702739|Antimetabolites|antimetabolites|mesh-ancestor
65222464|NCT02702739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222465|NCT02702739|Antiviral Agents|antiviral agents|mesh-ancestor
65222466|NCT02702739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65222467|NCT02702739|Protease Inhibitors|protease inhibitors|mesh-ancestor
65222468|NCT02702739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222469|NCT02602444|Ticagrelor|ticagrelor|mesh-list
65222470|NCT02602444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65222471|NCT02602444|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65222472|NCT02602444|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65222473|NCT02602444|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65222474|NCT02602444|Purinergic Agents|purinergic agents|mesh-ancestor
65222475|NCT02602444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65222476|NCT02602444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222477|NCT02602444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222478|NCT02702661|Anesthetics|anesthetics|mesh-list
65222479|NCT02702661|Levobupivacaine|levobupivacaine|mesh-list
65222480|NCT02702661|Anesthetics, Local|anesthetics, local|mesh-list
65222481|NCT02702661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65222482|NCT02702661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222483|NCT02702661|Sensory System Agents|sensory system agents|mesh-ancestor
65222484|NCT02702661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65222486|NCT05065021|Bevacizumab|bevacizumab|mesh-list
65222487|NCT05065021|Niraparib|niraparib|mesh-list
65222488|NCT05065021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65222489|NCT05065021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65222490|NCT05065021|Tubulin Modulators|tubulin modulators|mesh-ancestor
65222491|NCT05065021|Antimitotic Agents|antimitotic agents|mesh-ancestor
65222492|NCT05065021|Mitosis Modulators|mitosis modulators|mesh-ancestor
65222493|NCT05065021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222494|NCT05065021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65222495|NCT05065021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65222496|NCT05065021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65222497|NCT05065021|Growth Substances|growth substances|mesh-ancestor
65222498|NCT05065021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222499|NCT05065021|Growth Inhibitors|growth inhibitors|mesh-ancestor
65222500|NCT05065021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65222501|NCT05065021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222502|NCT02702349|Penicillins|penicillins|mesh-list
65222503|NCT02702349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65222504|NCT02702349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65222505|NCT04104334|Remifentanil|remifentanil|mesh-list
65222506|NCT04104334|Desflurane|desflurane|mesh-list
65222507|NCT04104334|Anesthetics|anesthetics|mesh-ancestor
65222511|NCT04104334|Narcotics|narcotics|mesh-ancestor
65222512|NCT04104334|Analgesics|analgesics|mesh-ancestor
65222513|NCT04104334|Sensory System Agents|sensory system agents|mesh-ancestor
65222514|NCT04104334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65222515|NCT04104334|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65222516|NCT04104334|Anesthetics, General|anesthetics, general|mesh-ancestor
65222517|NCT04215393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65222518|NCT04215393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65222519|NCT02602600|Liraglutide|liraglutide|mesh-list
65222520|NCT02602600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64865257|NCT01784380|Metformin|metformin|mesh-list
65222522|NCT02602600|Incretins|incretins|mesh-ancestor
65222523|NCT02602600|Hormones|hormones|mesh-ancestor
65222524|NCT02602600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65222525|NCT00615615|Levetiracetam|levetiracetam|mesh-list
65222526|NCT00615615|Anticonvulsants|anticonvulsants|mesh-ancestor
65222527|NCT00615615|Nootropic Agents|nootropic agents|mesh-ancestor
65222528|NCT00784810|Acetaminophen|acetaminophen|mesh-list
65222529|NCT00784810|Oxycodone|oxycodone|mesh-list
65222530|NCT00784810|Codeine|codeine|mesh-list
65222531|NCT00784810|Naloxone|naloxone|mesh-list
65222532|NCT00784810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65333723|NCT04340882|Antimitotic Agents|antimitotic agents|mesh-ancestor
65333724|NCT04340882|Mitosis Modulators|mitosis modulators|mesh-ancestor
65333725|NCT04340882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333726|NCT00765921|Ranibizumab|ranibizumab|mesh-list
65333727|NCT00765921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65333728|NCT00765921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65333729|NCT00765921|Growth Substances|growth substances|mesh-ancestor
65333730|NCT00765921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333731|NCT00765921|Growth Inhibitors|growth inhibitors|mesh-ancestor
65333732|NCT00765921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333733|NCT02583308|Silver Sulfadiazine|silver sulfadiazine|mesh-list
65222533|NCT00784810|Analgesics|analgesics|mesh-ancestor
65222534|NCT00784810|Sensory System Agents|sensory system agents|mesh-ancestor
65222535|NCT00784810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65222536|NCT00784810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222537|NCT00784810|Antipyretics|antipyretics|mesh-ancestor
65222538|NCT00784810|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65222539|NCT00784810|Narcotics|narcotics|mesh-ancestor
65222540|NCT00784810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65222541|NCT00784810|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65222542|NCT00784810|Antitussive Agents|antitussive agents|mesh-ancestor
65222543|NCT00784810|Respiratory System Agents|respiratory system agents|mesh-ancestor
65222544|NCT02603770|Lovastatin|lovastatin|mesh-list
65222545|NCT02603770|L 647318|l 647318|mesh-list
65222546|NCT02603770|Dihydromevinolin|dihydromevinolin|mesh-list
65222547|NCT02603770|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65222548|NCT02603770|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65222549|NCT02603770|Antimetabolites|antimetabolites|mesh-ancestor
65222550|NCT02603770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222551|NCT02603770|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65222552|NCT02603770|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65222553|NCT02603770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222554|NCT04081909|Fentanyl|fentanyl|mesh-list
65222555|NCT04081909|Dexmedetomidine|dexmedetomidine|mesh-list
65222556|NCT04081909|Ketamine|ketamine|mesh-list
65222557|NCT04081909|Remifentanil|remifentanil|mesh-list
65222558|NCT04081909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65222559|NCT04081909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65222560|NCT04081909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222561|NCT04081909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65222562|NCT04081909|Analgesics|analgesics|mesh-ancestor
65222563|NCT04081909|Sensory System Agents|sensory system agents|mesh-ancestor
65222564|NCT04081909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65222565|NCT04081909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65222566|NCT04081909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65222567|NCT04081909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65222568|NCT04081909|Adrenergic Agents|adrenergic agents|mesh-ancestor
65222569|NCT04081909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65222570|NCT04081909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222571|NCT04081909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65222572|NCT04081909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65222573|NCT04081909|Anesthetics, General|anesthetics, general|mesh-ancestor
65222574|NCT04081909|Anesthetics|anesthetics|mesh-ancestor
65222575|NCT04081909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65222576|NCT04081909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65222577|NCT04081909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65222578|NCT04081909|Narcotics|narcotics|mesh-ancestor
65222579|NCT04081909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65222580|NCT03272217|Bevacizumab|bevacizumab|mesh-list
65222581|NCT03272217|Atezolizumab|atezolizumab|mesh-list
65222582|NCT03272217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65222590|NCT03262701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65222591|NCT03262701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65222592|NCT00915382|Cisplatin|cisplatin|mesh-list
65222593|NCT00915382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333734|NCT02583308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65333735|NCT02583308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65333736|NCT00672477|Methylnaltrexone|methylnaltrexone|mesh-list
65333737|NCT00672477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65333738|NCT00672477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333739|NCT00672477|Sensory System Agents|sensory system agents|mesh-ancestor
65333740|NCT00672477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333741|NCT00766155|Capecitabine|capecitabine|mesh-list
65333742|NCT00766155|Oxaliplatin|oxaliplatin|mesh-list
65333743|NCT00766155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65333744|NCT00766155|Antimetabolites|antimetabolites|mesh-ancestor
65333745|NCT00766155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333746|NCT00766155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333747|NCT02585258|Prednisolone|prednisolone|mesh-list
64719613|NCT00000200|Narcotics|narcotics|mesh-ancestor
64719614|NCT00000200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64719615|NCT00000200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719616|NCT00000200|Analgesics|analgesics|mesh-ancestor
64719617|NCT00000200|Sensory System Agents|sensory system agents|mesh-ancestor
64719618|NCT00000200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719619|NCT00000200|Antitussive Agents|antitussive agents|mesh-ancestor
65222594|NCT05344443|Lemborexant|lemborexant|mesh-list
65222595|NCT05344443|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64865330|NCT01784978|Growth Inhibitors|growth inhibitors|mesh-ancestor
65222596|NCT05344443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65222597|NCT05344443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222598|NCT05344443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65222599|NCT05344443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65222600|NCT05344443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65222601|NCT05344443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222603|NCT00919555|Tretinoin|tretinoin|mesh-list
65222604|NCT00919555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65222605|NCT00919555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222606|NCT00919555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65222607|NCT00919555|Keratolytic Agents|keratolytic agents|mesh-ancestor
65222608|NCT00919555|Dermatologic Agents|dermatologic agents|mesh-ancestor
65222609|NCT02979093|Oxytocin|oxytocin|mesh-list
65222610|NCT02979093|Oxytocics|oxytocics|mesh-ancestor
65222611|NCT02979093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65222612|NCT02979093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222616|NCT02588131|Durvalumab|durvalumab|mesh-list
65222617|NCT02588131|Tremelimumab|tremelimumab|mesh-list
65222618|NCT02588131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65222619|NCT02588131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65222620|NCT04766983|Dimercaprol|dimercaprol|mesh-list
65222621|NCT04766983|Chelating Agents|chelating agents|mesh-ancestor
65222622|NCT04766983|Sequestering Agents|sequestering agents|mesh-ancestor
65222623|NCT04766983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222624|NCT04766437|Ticagrelor|ticagrelor|mesh-list
65222625|NCT04766437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65222626|NCT04766437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65222627|NCT04766437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65222628|NCT04766437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65333748|NCT02585258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65333749|NCT02585258|Glucocorticoids|glucocorticoids|mesh-ancestor
65333750|NCT02585258|Hormones|hormones|mesh-ancestor
65333751|NCT02585258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65333752|NCT02585258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333753|NCT02585258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65222629|NCT04766437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65222630|NCT04766437|Purinergic Agents|purinergic agents|mesh-ancestor
65222631|NCT04766437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65222632|NCT04766437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222633|NCT04766437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222635|NCT00776230|Immunologic Factors|immunologic factors|mesh-ancestor
65222636|NCT00776230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222637|NCT05561959|Nitroglycerin|nitroglycerin|mesh-list
65222638|NCT05561959|Vasodilator Agents|vasodilator agents|mesh-ancestor
65222639|NCT02586259|Budesonide|budesonide|mesh-list
65222640|NCT02586259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65222641|NCT02586259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65222642|NCT02586259|Autonomic Agents|autonomic agents|mesh-ancestor
65222643|NCT02586259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65222644|NCT02586259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222645|NCT02586259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65222646|NCT02586259|Respiratory System Agents|respiratory system agents|mesh-ancestor
65222647|NCT02586259|Glucocorticoids|glucocorticoids|mesh-ancestor
65222648|NCT02586259|Hormones|hormones|mesh-ancestor
65222649|NCT02586259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65222650|NCT00775606|Ritonavir|ritonavir|mesh-list
65222651|NCT00775606|Lopinavir|lopinavir|mesh-list
65222652|NCT00775606|Efavirenz|efavirenz|mesh-list
65222653|NCT00775606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65222654|NCT00775606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65222655|NCT00775606|Protease Inhibitors|protease inhibitors|mesh-ancestor
65222658|NCT00775606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65222659|NCT00775606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65222660|NCT00775606|Antiviral Agents|antiviral agents|mesh-ancestor
65222661|NCT00775606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65222662|NCT00775606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65222663|NCT00775606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65222664|NCT00775606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65222665|NCT00775606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65222666|NCT00775606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65222667|NCT00775606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65222668|NCT00775606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65222669|NCT00775606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64865409|NCT01785446|Analgesics|analgesics|mesh-ancestor
65222670|NCT00775606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65222671|NCT04761601|Gemcitabine|gemcitabine|mesh-list
65222672|NCT04761601|Paclitaxel|paclitaxel|mesh-list
65222673|NCT04761601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65222674|NCT04761601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65222675|NCT04761601|Tubulin Modulators|tubulin modulators|mesh-ancestor
65222676|NCT04761601|Antimitotic Agents|antimitotic agents|mesh-ancestor
65222677|NCT04761601|Mitosis Modulators|mitosis modulators|mesh-ancestor
65222678|NCT04761601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222679|NCT04761601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65222680|NCT04761601|Antimetabolites|antimetabolites|mesh-ancestor
65222681|NCT04761601|Antiviral Agents|antiviral agents|mesh-ancestor
65222682|NCT04761601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65222683|NCT04761601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222684|NCT04761601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65222685|NCT04761601|Immunologic Factors|immunologic factors|mesh-ancestor
65222686|NCT04761601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222687|NCT02960763|Aripiprazole|aripiprazole|mesh-list
65222688|NCT02960763|Lithium Carbonate|lithium carbonate|mesh-list
65222689|NCT02960763|Bupropion|bupropion|mesh-list
65222690|NCT02960763|Nortriptyline|nortriptyline|mesh-list
65222691|NCT02960763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65222692|NCT02960763|Antidepressive Agents|antidepressive agents|mesh-ancestor
65333754|NCT02585258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333755|NCT00762567|Phenylephrine|phenylephrine|mesh-list
65333756|NCT00762567|Oxymetazoline|oxymetazoline|mesh-list
65333757|NCT00762567|Nasal Decongestants|nasal decongestants|mesh-list
65333758|NCT00762567|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65333759|NCT00762567|Mydriatics|mydriatics|mesh-ancestor
65333760|NCT00762567|Autonomic Agents|autonomic agents|mesh-ancestor
65333761|NCT00762567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333762|NCT00762567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333763|NCT00762567|Sympathomimetics|sympathomimetics|mesh-ancestor
65333764|NCT00762567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65333765|NCT00762567|Respiratory System Agents|respiratory system agents|mesh-ancestor
65333766|NCT00762567|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65333767|NCT00762567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65333768|NCT00762567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65333769|NCT00762567|Adrenergic Agents|adrenergic agents|mesh-ancestor
65333770|NCT00762567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65333771|NCT00762567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333772|NCT00762567|Protective Agents|protective agents|mesh-ancestor
65333773|NCT04338620|Paclitaxel|paclitaxel|mesh-list
65333774|NCT04338620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65333775|NCT04338620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65333776|NCT04338620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333777|NCT04338620|Tubulin Modulators|tubulin modulators|mesh-ancestor
65333778|NCT04338620|Antimitotic Agents|antimitotic agents|mesh-ancestor
65333779|NCT04338620|Mitosis Modulators|mitosis modulators|mesh-ancestor
65333780|NCT04338620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333781|NCT00923234|Lenalidomide|lenalidomide|mesh-list
65333782|NCT00923234|Azacitidine|azacitidine|mesh-list
65333783|NCT00923234|Immunologic Factors|immunologic factors|mesh-ancestor
65333784|NCT00923234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333785|NCT00923234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65333786|NCT00923234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65333787|NCT00923234|Growth Substances|growth substances|mesh-ancestor
65333788|NCT00923234|Growth Inhibitors|growth inhibitors|mesh-ancestor
65333789|NCT00923234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65222693|NCT02960763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65222694|NCT02960763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64719642|NCT00000944|Lamivudine|lamivudine|mesh-list
64719643|NCT00000944|Zidovudine|zidovudine|mesh-list
64719644|NCT00000944|Indinavir|indinavir|mesh-list
64719645|NCT00000944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64719646|NCT00000944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64719647|NCT00000944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719648|NCT00000944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719649|NCT00000944|Antiviral Agents|antiviral agents|mesh-ancestor
64327728|NCT00485563|Folic Acid|folic acid|mesh-list
64327729|NCT00485563|Vitamin B Complex|vitamin b complex|mesh-list
64327730|NCT00485563|Interferons|interferons|mesh-list
64327731|NCT00485563|Interferon-alpha|interferon-alpha|mesh-list
64327732|NCT00485563|Interleukin-2|interleukin-2|mesh-list
64327733|NCT00485563|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
64327734|NCT00485563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327735|NCT00485563|Antiviral Agents|antiviral agents|mesh-ancestor
64327736|NCT00485563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65333790|NCT00923234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65333791|NCT00923234|Antimetabolites|antimetabolites|mesh-ancestor
65333792|NCT00923234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333793|NCT00923234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333794|NCT04323956|Prednisone|prednisone|mesh-list
65333795|NCT04323956|Cortisone|cortisone|mesh-list
64719650|NCT00000944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719651|NCT00000944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65333827|NCT04323956|Tubulin Modulators|tubulin modulators|mesh-ancestor
65333828|NCT04323956|Antimitotic Agents|antimitotic agents|mesh-ancestor
65333829|NCT04323956|Mitosis Modulators|mitosis modulators|mesh-ancestor
65333830|NCT00674661|Riboflavin|riboflavin|mesh-list
65333831|NCT00674661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65333832|NCT00674661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65333833|NCT00674661|Vitamin B Complex|vitamin b complex|mesh-ancestor
65333834|NCT00674661|Vitamins|vitamins|mesh-ancestor
65333835|NCT00674661|Micronutrients|micronutrients|mesh-ancestor
65333836|NCT00674661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333837|NCT00674661|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65333838|NCT00674661|Dermatologic Agents|dermatologic agents|mesh-ancestor
65333839|NCT00766545|Cilostazol|cilostazol|mesh-list
65333840|NCT00766545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65333841|NCT00766545|Autonomic Agents|autonomic agents|mesh-ancestor
65333842|NCT00766545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333843|NCT00766545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333844|NCT00766545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65333845|NCT00766545|Respiratory System Agents|respiratory system agents|mesh-ancestor
65222695|NCT02960763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65222696|NCT02960763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65222697|NCT02960763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222698|NCT02960763|Dopamine Agents|dopamine agents|mesh-ancestor
65222699|NCT02960763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65222700|NCT02960763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222701|NCT02960763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65222702|NCT02960763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65222703|NCT02960763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222704|NCT02960763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65222705|NCT02960763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65222706|NCT02960763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65222707|NCT02960763|Dopamine Agonists|dopamine agonists|mesh-ancestor
65222708|NCT02960763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65222709|NCT02960763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65222710|NCT02960763|Serotonin Agents|serotonin agents|mesh-ancestor
65222711|NCT02960763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65222712|NCT02960763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65222713|NCT02960763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65222714|NCT02960763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65222715|NCT02960763|Antimanic Agents|antimanic agents|mesh-ancestor
65222716|NCT02960763|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65222717|NCT02960763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65222718|NCT02960763|Adrenergic Agents|adrenergic agents|mesh-ancestor
65222719|NCT00775528|Pancrelipase|pancrelipase|mesh-list
65222720|NCT00775528|Pancreatin|pancreatin|mesh-list
65222721|NCT00775528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65222722|NCT04977271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65222723|NCT04977271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65222724|NCT04977271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65222727|NCT04977271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65222728|NCT04977271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222729|NCT04977271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64719663|NCT00000950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64719664|NCT00000950|Antitubercular Agents|antitubercular agents|mesh-ancestor
64719665|NCT00000950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64719666|NCT00000950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719667|NCT00000950|Leprostatic Agents|leprostatic agents|mesh-ancestor
65333846|NCT00766545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65333847|NCT00766545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65333848|NCT00766545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333849|NCT00766545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65333850|NCT00766545|Vasodilator Agents|vasodilator agents|mesh-ancestor
65333851|NCT00766545|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65333852|NCT00766545|Protective Agents|protective agents|mesh-ancestor
65333853|NCT00766545|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65333854|NCT00766545|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65333855|NCT00766545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333856|NCT02558205|Liver Extracts|liver extracts|mesh-list
65333857|NCT02558205|Hematinics|hematinics|mesh-ancestor
65333858|NCT02557737|Botulinum Toxins|botulinum toxins|mesh-list
65333859|NCT02557737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65333860|NCT02557737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65333861|NCT02557737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65333862|NCT02557737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65333863|NCT02557737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333864|NCT02557737|Cholinergic Agents|cholinergic agents|mesh-ancestor
65222730|NCT04977271|Antidepressive Agents|antidepressive agents|mesh-ancestor
65222731|NCT04977271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65222732|NCT02701179|Lidocaine|lidocaine|mesh-list
65222733|NCT02701179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65222734|NCT02701179|Anesthetics, Local|anesthetics, local|mesh-ancestor
65222735|NCT02701179|Anesthetics|anesthetics|mesh-ancestor
65222736|NCT02701179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65222737|NCT02701179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222738|NCT02701179|Sensory System Agents|sensory system agents|mesh-ancestor
65222739|NCT02701179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65222740|NCT02701179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65222741|NCT02701179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64865481|NCT01785836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65222742|NCT02701179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65222743|NCT02701179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65222744|NCT02701179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222746|NCT02586961|Betamethasone Valerate|betamethasone valerate|mesh-list
65222747|NCT02586961|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65222748|NCT02586961|Betamethasone benzoate|betamethasone benzoate|mesh-list
65222749|NCT02586961|Epinephrine|epinephrine|mesh-list
65222750|NCT02586961|Racepinephrine|racepinephrine|mesh-list
65222751|NCT02586961|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65222752|NCT02586961|Epinephryl borate|epinephryl borate|mesh-list
65222753|NCT02586961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65222754|NCT02586961|Glucocorticoids|glucocorticoids|mesh-ancestor
65222755|NCT02586961|Hormones|hormones|mesh-ancestor
64719671|NCT00000950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64719672|NCT00000950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64719673|NCT00000950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64719674|NCT00000950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64719675|NCT00000950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64719676|NCT00000950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64327748|NCT02170805|Dabigatran|dabigatran|mesh-list
65333865|NCT02557737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65333866|NCT02557737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333867|NCT02557737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65333868|NCT02557737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333869|NCT00766857|Insulin|insulin|mesh-list
65333870|NCT00766857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65333871|NCT00766857|Insulin Glargine|insulin glargine|mesh-list
65333872|NCT00766857|Exenatide|exenatide|mesh-list
65333873|NCT00766857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65333874|NCT00766857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333875|NCT00766857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65333876|NCT00766857|Incretins|incretins|mesh-ancestor
65333877|NCT00766857|Hormones|hormones|mesh-ancestor
65333878|NCT00766857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65333879|NCT02558283|Lidocaine|lidocaine|mesh-list
65333880|NCT02558283|Anesthetics, Local|anesthetics, local|mesh-ancestor
65333881|NCT02558283|Anesthetics|anesthetics|mesh-ancestor
65333882|NCT02558283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65333883|NCT02558283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333884|NCT02558283|Sensory System Agents|sensory system agents|mesh-ancestor
65333885|NCT02558283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333886|NCT02558283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65333887|NCT02558283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65222756|NCT02586961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65222757|NCT02586961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222758|NCT02586961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65222759|NCT02586961|Respiratory System Agents|respiratory system agents|mesh-ancestor
65222760|NCT02586961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65222761|NCT02586961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65222762|NCT02586961|Adrenergic Agents|adrenergic agents|mesh-ancestor
65222763|NCT02586961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65222764|NCT02586961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222765|NCT02586961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65222766|NCT02586961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65222767|NCT02586961|Autonomic Agents|autonomic agents|mesh-ancestor
64719678|NCT00000950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64719679|NCT00000950|Antimetabolites|antimetabolites|mesh-ancestor
64719680|NCT00000950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64719681|NCT00000950|Vitamin B Complex|vitamin b complex|mesh-ancestor
64719682|NCT00000950|Vitamins|vitamins|mesh-ancestor
64719683|NCT00000950|Micronutrients|micronutrients|mesh-ancestor
64719684|NCT00000950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719685|NCT00000218|Carbamazepine|carbamazepine|mesh-list
64719686|NCT00000218|Anticonvulsants|anticonvulsants|mesh-ancestor
64719687|NCT00000218|Antimanic Agents|antimanic agents|mesh-ancestor
64327755|NCT02170805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64327756|NCT02170805|Protease Inhibitors|protease inhibitors|mesh-ancestor
65333888|NCT02558283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65333889|NCT02558283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65333890|NCT02558283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333891|NCT00767091|Rivastigmine|rivastigmine|mesh-list
65333892|NCT00767091|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
65333893|NCT00767091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333894|NCT00767091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333895|NCT00767091|Cholinergic Agents|cholinergic agents|mesh-ancestor
65333896|NCT00767091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65333897|NCT00767091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333898|NCT00767091|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65333899|NCT00767091|Protective Agents|protective agents|mesh-ancestor
65333900|NCT00767169|Ibandronic Acid|ibandronic acid|mesh-list
65333901|NCT00767169|Pamidronate|pamidronate|mesh-list
65333902|NCT00767169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65333903|NCT00767169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333904|NCT05256381|Pembrolizumab|pembrolizumab|mesh-list
65333905|NCT05256381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65333906|NCT05256381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333907|NCT00767481|Travoprost|travoprost|mesh-list
65333908|NCT00767481|Brinzolamide|brinzolamide|mesh-list
65333909|NCT00767481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65333910|NCT00767481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65333911|NCT00767481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719688|NCT00000218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64719689|NCT00000218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64719690|NCT00000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719691|NCT00000218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64719692|NCT00000218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64719693|NCT00000218|Analgesics|analgesics|mesh-ancestor
64719694|NCT00000218|Sensory System Agents|sensory system agents|mesh-ancestor
64719695|NCT00000218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719696|NCT00000218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64719697|NCT00000218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64327760|NCT00606697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64327761|NCT00606697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64327762|NCT00606697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327764|NCT00606697|Antiemetics|antiemetics|mesh-ancestor
65333914|NCT04305236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65333915|NCT04305236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65333916|NCT04305236|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65333917|NCT04305236|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65333918|NCT04305236|Hormone Antagonists|hormone antagonists|mesh-ancestor
65333919|NCT04305236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65333920|NCT04305236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333921|NCT00671931|Dexmedetomidine|dexmedetomidine|mesh-list
65333950|NCT00767559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65333951|NCT00767715|Haloperidol|haloperidol|mesh-list
64719698|NCT00000218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719699|NCT00000218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64719700|NCT00000218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64719701|NCT00000224|Buprenorphine|buprenorphine|mesh-list
64719702|NCT00000224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64719703|NCT00000224|Narcotics|narcotics|mesh-ancestor
64719704|NCT00000224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64719705|NCT00000224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333952|NCT00767715|Olanzapine|olanzapine|mesh-list
65333953|NCT00767715|Haloperidol decanoate|haloperidol decanoate|mesh-list
65333954|NCT00767715|Antiemetics|antiemetics|mesh-ancestor
65333955|NCT00767715|Autonomic Agents|autonomic agents|mesh-ancestor
65333956|NCT00767715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65333957|NCT00767715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65333958|NCT00767715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65333959|NCT00767715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65333960|NCT00767715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65333961|NCT00767715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65333962|NCT00767715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64719716|NCT04332991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719717|NCT04332991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64719718|NCT00000230|Buprenorphine|buprenorphine|mesh-list
64719719|NCT00000230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64719720|NCT00000230|Narcotics|narcotics|mesh-ancestor
64719721|NCT00000230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64719722|NCT00000230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719723|NCT00000230|Analgesics|analgesics|mesh-ancestor
64327773|NCT02404077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64327775|NCT02404077|Autonomic Agents|autonomic agents|mesh-ancestor
64327776|NCT02404077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64327777|NCT02404077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65333995|NCT00763347|Protease Inhibitors|protease inhibitors|mesh-ancestor
65333996|NCT00763347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65333997|NCT00763347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65333998|NCT00767871|Citalopram|citalopram|mesh-list
65333999|NCT00767871|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65334000|NCT00767871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65334001|NCT00767871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65334002|NCT00767871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334003|NCT00767871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65334004|NCT00767871|Serotonin Agents|serotonin agents|mesh-ancestor
64719724|NCT00000230|Sensory System Agents|sensory system agents|mesh-ancestor
64719725|NCT00000230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719726|NCT00000230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64719727|NCT00000236|Buprenorphine|buprenorphine|mesh-list
64719728|NCT00000236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64719729|NCT00000236|Naloxone|naloxone|mesh-list
64719730|NCT00000236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64719731|NCT00000236|Narcotics|narcotics|mesh-ancestor
64719732|NCT00000236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64327778|NCT02404077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64327779|NCT02404077|Adrenergic Agents|adrenergic agents|mesh-ancestor
64327780|NCT02404077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64327781|NCT02404077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327782|NCT02174939|Cilostazol|cilostazol|mesh-list
64327783|NCT02174939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64712834|NCT03827070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64712835|NCT03827070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712836|NCT03827070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334032|NCT00768183|Morphine|morphine|mesh-list
65334033|NCT00768183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65334034|NCT00768183|Narcotics|narcotics|mesh-ancestor
65334035|NCT00768183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65334062|NCT02558751|Vaccines|vaccines|mesh-list
64719733|NCT00000236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719734|NCT00000236|Analgesics|analgesics|mesh-ancestor
64719735|NCT00000236|Sensory System Agents|sensory system agents|mesh-ancestor
64719736|NCT00000236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719737|NCT00000236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65334066|NCT00768573|Sildenafil Citrate|sildenafil citrate|mesh-list
65334067|NCT00768573|Vasodilator Agents|vasodilator agents|mesh-ancestor
65334068|NCT00768573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65334069|NCT00768573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65334070|NCT00768573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334071|NCT00768573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334072|NCT00768573|Urological Agents|urological agents|mesh-ancestor
65334073|NCT02558361|Apremilast|apremilast|mesh-list
65334074|NCT02558361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65334075|NCT02558361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65334076|NCT02558361|Analgesics|analgesics|mesh-ancestor
65334077|NCT02558361|Sensory System Agents|sensory system agents|mesh-ancestor
65334078|NCT02558361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65334079|NCT02558361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334080|NCT02558361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65334081|NCT02558361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65334082|NCT02558361|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65334083|NCT02558361|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65334084|NCT02558361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334085|NCT02558361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334086|NCT02558595|Niacinamide|niacinamide|mesh-list
65334087|NCT02558595|Niacin|niacin|mesh-list
65334088|NCT02558595|Nicotinic Acids|nicotinic acids|mesh-list
65334089|NCT02558595|Vitamins|vitamins|mesh-ancestor
65334090|NCT02558595|Micronutrients|micronutrients|mesh-ancestor
65334091|NCT02558595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334092|NCT02558595|Vitamin B Complex|vitamin b complex|mesh-ancestor
65334093|NCT02558595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65222768|NCT02586961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65222769|NCT02586961|Mydriatics|mydriatics|mesh-ancestor
65222770|NCT02586961|Sympathomimetics|sympathomimetics|mesh-ancestor
65222771|NCT02586961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65222772|NCT02700711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65222773|NCT02700711|Methylphenidate|methylphenidate|mesh-list
65222774|NCT02700711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65222775|NCT02700711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222776|NCT02700711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65334094|NCT02558595|Antimetabolites|antimetabolites|mesh-ancestor
65334095|NCT02558595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334096|NCT02558595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65334097|NCT02558595|Vasodilator Agents|vasodilator agents|mesh-ancestor
65334098|NCT00760695|Dronabinol|dronabinol|mesh-list
65334099|NCT00760695|Hallucinogens|hallucinogens|mesh-ancestor
65083976|NCT00464217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334100|NCT00760695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334101|NCT00760695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65334102|NCT00760695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65334104|NCT00760695|Sensory System Agents|sensory system agents|mesh-ancestor
65334105|NCT00760695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65334106|NCT00760695|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65334107|NCT00760695|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65334108|NCT00760695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65334109|NCT00760695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334110|NCT00760695|Hormones|hormones|mesh-ancestor
65334111|NCT00760695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65334112|NCT02582372|Fentanyl|fentanyl|mesh-list
65334113|NCT02582372|Dexmedetomidine|dexmedetomidine|mesh-list
64719745|NCT00000242|Anticonvulsants|anticonvulsants|mesh-ancestor
64719746|NCT00000242|Antimanic Agents|antimanic agents|mesh-ancestor
65334114|NCT02582372|Bupivacaine|bupivacaine|mesh-list
65334115|NCT02582372|Anesthetics, Local|anesthetics, local|mesh-ancestor
65334116|NCT02582372|Anesthetics|anesthetics|mesh-ancestor
64719769|NCT00000992|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64719770|NCT00000992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64719771|NCT00000992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719772|NCT00000992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334141|NCT00768729|Antifungal Agents|antifungal agents|mesh-ancestor
65334142|NCT00768729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65334143|NCT00768729|Immunologic Factors|immunologic factors|mesh-ancestor
65334144|NCT00768729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334145|NCT00768729|Antimetabolites|antimetabolites|mesh-ancestor
65334146|NCT00768729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334147|NCT00768729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65334148|NCT00768729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65334149|NCT00768963|Ranibizumab|ranibizumab|mesh-list
65334150|NCT00768963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65334151|NCT00768963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65334152|NCT00768963|Growth Substances|growth substances|mesh-ancestor
65334153|NCT00768963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334154|NCT00768963|Growth Inhibitors|growth inhibitors|mesh-ancestor
65334155|NCT00768963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334156|NCT00769041|Moxifloxacin|moxifloxacin|mesh-list
65334157|NCT00769041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65334158|NCT00769041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65334159|NCT00769041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65334160|NCT00769041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65334161|NCT00769041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334162|NCT00769041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334163|NCT00769041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334164|NCT00770445|Insulin|insulin|mesh-list
65334165|NCT00770445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65334166|NCT00770445|Metformin|metformin|mesh-list
65334167|NCT00770445|Pioglitazone|pioglitazone|mesh-list
65334168|NCT00770445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65334169|NCT00770445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334170|NCT04077398|Ropivacaine|ropivacaine|mesh-list
65334171|NCT04077398|Anesthetics, Local|anesthetics, local|mesh-ancestor
65334172|NCT04077398|Anesthetics|anesthetics|mesh-ancestor
64719791|NCT00000260|Anesthetics, General|anesthetics, general|mesh-ancestor
64719792|NCT00000260|Anesthetics|anesthetics|mesh-ancestor
64719793|NCT00000260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64719794|NCT00000260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719795|NCT00000260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64719796|NCT00000260|Analgesics|analgesics|mesh-ancestor
64719797|NCT00000260|Sensory System Agents|sensory system agents|mesh-ancestor
65334175|NCT04077398|Sensory System Agents|sensory system agents|mesh-ancestor
65334176|NCT04077398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65334177|NCT04239716|Anesthetics|anesthetics|mesh-list
65334178|NCT04239716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65334179|NCT04239716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334180|NCT04048707|Octreotide|octreotide|mesh-list
65334181|NCT04048707|Midodrine|midodrine|mesh-list
65334182|NCT04048707|Angiotensin II|angiotensin ii|mesh-list
65334183|NCT04048707|Giapreza|giapreza|mesh-list
65334184|NCT04048707|Angiotensinogen|angiotensinogen|mesh-list
65334185|NCT04048707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65334186|NCT04048707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65334187|NCT04048707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334188|NCT04048707|Sympathomimetics|sympathomimetics|mesh-ancestor
65334189|NCT04048707|Autonomic Agents|autonomic agents|mesh-ancestor
65334190|NCT04048707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65334191|NCT04048707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334192|NCT04048707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65334193|NCT04048707|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65334194|NCT04048707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65334195|NCT04048707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65334196|NCT04048707|Adrenergic Agents|adrenergic agents|mesh-ancestor
65334197|NCT04048707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65334198|NCT04048707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334199|NCT04048707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65334200|NCT04048707|Protease Inhibitors|protease inhibitors|mesh-ancestor
65334201|NCT04048707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334202|NCT00763893|Losartan|losartan|mesh-list
65222777|NCT02700711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65222778|NCT02700711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65222779|NCT02700711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222780|NCT02700711|Dopamine Agents|dopamine agents|mesh-ancestor
65222781|NCT02700711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64719804|NCT00000266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719805|NCT00000266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64719806|NCT00000266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64719807|NCT00000266|Dopamine Agents|dopamine agents|mesh-ancestor
64719808|NCT00000266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64719809|NCT00000266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719810|NCT00001016|Leucovorin|leucovorin|mesh-list
64719811|NCT00001016|Trimetrexate|trimetrexate|mesh-list
64719812|NCT00001016|Calcium|calcium|mesh-list
64719813|NCT00001016|Levoleucovorin|levoleucovorin|mesh-list
64327809|NCT02404233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64327810|NCT02404233|Antiviral Agents|antiviral agents|mesh-ancestor
65334203|NCT00763893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65334204|NCT00763893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65334205|NCT00763893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65334206|NCT00763893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65334207|NCT00763893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334208|NCT00770835|Metformin|metformin|mesh-list
65334209|NCT00770835|Pioglitazone|pioglitazone|mesh-list
65334210|NCT00770835|Glyburide|glyburide|mesh-list
65334211|NCT00770835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65334212|NCT00770835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334213|NCT00769587|Thalidomide|thalidomide|mesh-list
65334214|NCT00769587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65334215|NCT00769587|Immunologic Factors|immunologic factors|mesh-ancestor
65334216|NCT00769587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334217|NCT00769587|Leprostatic Agents|leprostatic agents|mesh-ancestor
65334218|NCT00769587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65334219|NCT00769587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65334220|NCT00769587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65334221|NCT00769587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65334222|NCT00769587|Growth Substances|growth substances|mesh-ancestor
65334223|NCT00769587|Growth Inhibitors|growth inhibitors|mesh-ancestor
65334224|NCT00769587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64719814|NCT00001016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64719815|NCT00001016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719816|NCT00001016|Antidotes|antidotes|mesh-ancestor
64719817|NCT00001016|Protective Agents|protective agents|mesh-ancestor
64719818|NCT00001016|Vitamin B Complex|vitamin b complex|mesh-ancestor
65334233|NCT00570921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334234|NCT00570921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65334235|NCT00570921|Immunologic Factors|immunologic factors|mesh-ancestor
65334236|NCT00570921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334237|NCT00570921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64719819|NCT00001016|Vitamins|vitamins|mesh-ancestor
64719820|NCT00001016|Micronutrients|micronutrients|mesh-ancestor
64719821|NCT00001016|Antifungal Agents|antifungal agents|mesh-ancestor
64719822|NCT00001016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719823|NCT00001016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64327817|NCT00603577|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64327818|NCT00603577|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64327819|NCT00603577|Serotonin Agents|serotonin agents|mesh-ancestor
65334250|NCT04048317|Doxorubicin|doxorubicin|mesh-list
65334270|NCT00771147|Sorafenib|sorafenib|mesh-list
65334271|NCT00771147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334272|NCT00771147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65334273|NCT00771147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719824|NCT00001016|Antimetabolites|antimetabolites|mesh-ancestor
64719825|NCT00001016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719826|NCT00001016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64719827|NCT00001016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64719828|NCT00001016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719829|NCT03811951|Insulin|insulin|mesh-list
64719830|NCT03811951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64719831|NCT03811951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327826|NCT02178293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64327827|NCT02178293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64327828|NCT02178293|Analgesics|analgesics|mesh-ancestor
64327829|NCT02178293|Sensory System Agents|sensory system agents|mesh-ancestor
64383141|NCT04588311|Hematinics|hematinics|mesh-ancestor
64719832|NCT04332289|Deuterium Oxide|deuterium oxide|mesh-list
64719833|NCT04332289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64719834|NCT04332289|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64719835|NCT04332289|Protective Agents|protective agents|mesh-ancestor
64719836|NCT04332289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719837|NCT00001022|Zidovudine|zidovudine|mesh-list
64719838|NCT00001022|Didanosine|didanosine|mesh-list
64719839|NCT00001022|Zalcitabine|zalcitabine|mesh-list
64719840|NCT00001022|Antimetabolites|antimetabolites|mesh-ancestor
64719841|NCT00001022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327834|NCT02178293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64327835|NCT02178293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334308|NCT00775125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65334309|NCT02557503|Fluorouracil|fluorouracil|mesh-list
65334310|NCT02557503|Oxaliplatin|oxaliplatin|mesh-list
65334311|NCT02557503|Antimetabolites|antimetabolites|mesh-ancestor
65334312|NCT02557503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334313|NCT02557503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65334314|NCT02557503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334315|NCT02557503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65334316|NCT02557503|Immunologic Factors|immunologic factors|mesh-ancestor
65334317|NCT02557503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334318|NCT00764439|Nicotine|nicotine|mesh-list
65334319|NCT00764439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65334320|NCT00764439|Autonomic Agents|autonomic agents|mesh-ancestor
65334321|NCT00764439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65334322|NCT00764439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334323|NCT00764439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65334324|NCT00764439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65334325|NCT00764439|Cholinergic Agents|cholinergic agents|mesh-ancestor
65084196|NCT00464919|Sorafenib|sorafenib|mesh-list
65334326|NCT00764439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65334328|NCT04130516|Pembrolizumab|pembrolizumab|mesh-list
65334337|NCT00771303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719842|NCT00001022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64719843|NCT00001022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64719844|NCT00001022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719845|NCT00001022|Antiviral Agents|antiviral agents|mesh-ancestor
64719846|NCT00001022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719847|NCT00001022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64719848|NCT00001022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64719849|NCT05218148|Oxaliplatin|oxaliplatin|mesh-list
65334338|NCT00771303|Hemostatics|hemostatics|mesh-ancestor
65334339|NCT00771303|Coagulants|coagulants|mesh-ancestor
65334340|NCT05674526|Cetuximab|cetuximab|mesh-list
65334341|NCT05674526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65334342|NCT05674526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334343|NCT00771381|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
65334344|NCT00771381|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65334345|NCT00771381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334346|NCT04125836|Octreotide|octreotide|mesh-list
65334347|NCT04125836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65334348|NCT04125836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65334349|NCT04125836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334350|NCT00771459|Ropivacaine|ropivacaine|mesh-list
65334351|NCT00771459|Anesthetics, Local|anesthetics, local|mesh-ancestor
65334352|NCT00771459|Anesthetics|anesthetics|mesh-ancestor
65334353|NCT00771459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65334354|NCT00771459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334355|NCT00771459|Sensory System Agents|sensory system agents|mesh-ancestor
65334356|NCT00771459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65334357|NCT00764595|Imatinib Mesylate|imatinib mesylate|mesh-list
65334358|NCT00764595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334359|NCT00764595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65334360|NCT00764595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334361|NCT00764595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334362|NCT00775359|Fenofibrate|fenofibrate|mesh-list
65334363|NCT00775359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65334367|NCT05338502|Omeprazole|omeprazole|mesh-list
64719854|NCT00001934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64719855|NCT00001934|Immunologic Factors|immunologic factors|mesh-ancestor
64719856|NCT00001934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334368|NCT05338502|Ranitidine|ranitidine|mesh-list
65334369|NCT05338502|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65334370|NCT05338502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65334371|NCT05338502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65334372|NCT05338502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65334373|NCT05338502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334374|NCT05338502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334375|NCT05338502|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65334376|NCT05338502|Histamine Antagonists|histamine antagonists|mesh-ancestor
65334377|NCT05338502|Histamine Agents|histamine agents|mesh-ancestor
65334378|NCT05338502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65334379|NCT05338502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334380|NCT02557269|Mometasone Furoate|mometasone furoate|mesh-list
65334381|NCT02557269|Azelastine|azelastine|mesh-list
65334382|NCT02557269|Prednisolone|prednisolone|mesh-list
65334383|NCT02557269|Xylometazoline|xylometazoline|mesh-list
65334384|NCT02557269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65334385|NCT02557269|Glucocorticoids|glucocorticoids|mesh-ancestor
65334386|NCT02557269|Hormones|hormones|mesh-ancestor
65334387|NCT02557269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65334388|NCT02557269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334389|NCT02557269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65334390|NCT02557269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334391|NCT02557269|Autonomic Agents|autonomic agents|mesh-ancestor
65334392|NCT02557269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65334393|NCT02557269|Dermatologic Agents|dermatologic agents|mesh-ancestor
65334394|NCT02557269|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65334395|NCT02557269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65334396|NCT02557269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65334397|NCT02557269|Respiratory System Agents|respiratory system agents|mesh-ancestor
64719871|NCT00001028|Leprostatic Agents|leprostatic agents|mesh-ancestor
64719872|NCT00001028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64719873|NCT00001028|Antifungal Agents|antifungal agents|mesh-ancestor
64719874|NCT00001028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64719875|NCT00001940|Voriconazole|voriconazole|mesh-list
64719876|NCT00001940|Antifungal Agents|antifungal agents|mesh-ancestor
64719877|NCT00001940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719878|NCT00001940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65334405|NCT02557269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65334406|NCT02557269|Nasal Decongestants|nasal decongestants|mesh-ancestor
65334407|NCT02557269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65334408|NCT02556411|Levonorgestrel|levonorgestrel|mesh-list
65334409|NCT02556411|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65334410|NCT02556411|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65334411|NCT02556411|Contraceptive Agents|contraceptive agents|mesh-ancestor
65334412|NCT02556411|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65334413|NCT02556411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334414|NCT02556411|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65334415|NCT02556411|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65334416|NCT02556411|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65334417|NCT02556411|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65334418|NCT02556411|Estrogens|estrogens|mesh-ancestor
65334419|NCT02556411|Hormones|hormones|mesh-ancestor
65334420|NCT02556411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65334421|NCT04085276|Paclitaxel|paclitaxel|mesh-list
65334422|NCT04085276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65334423|NCT04085276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65334424|NCT04085276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334425|NCT04085276|Tubulin Modulators|tubulin modulators|mesh-ancestor
65334426|NCT04085276|Antimitotic Agents|antimitotic agents|mesh-ancestor
65334427|NCT04085276|Mitosis Modulators|mitosis modulators|mesh-ancestor
65334428|NCT04085276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248454|NCT02548117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65248455|NCT02548117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248456|NCT02548117|Urological Agents|urological agents|mesh-ancestor
65248457|NCT02841800|Phenobarbital|phenobarbital|mesh-list
65248458|NCT02841800|Anticonvulsants|anticonvulsants|mesh-ancestor
65248459|NCT02841800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65248460|NCT02841800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65248461|NCT02841800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248462|NCT02841800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64719879|NCT00001940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64719880|NCT00001940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719881|NCT00001940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334429|NCT00775827|Fenofibrate|fenofibrate|mesh-list
65334430|NCT00775827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65334431|NCT00775827|Antimetabolites|antimetabolites|mesh-ancestor
65334432|NCT00775827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334433|NCT00775827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65334434|NCT00775905|Amlodipine|amlodipine|mesh-list
65334435|NCT00775905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65334436|NCT00775905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65334437|NCT00775905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65334438|NCT00775905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334439|NCT00775905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65334440|NCT00775905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334441|NCT00775905|Vasodilator Agents|vasodilator agents|mesh-ancestor
65334442|NCT00772161|Methylphenidate|methylphenidate|mesh-list
65334443|NCT00772161|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65334444|NCT00772161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334445|NCT00772161|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65334446|NCT00772161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65334447|NCT00772161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65334448|NCT00772161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334449|NCT00772161|Dopamine Agents|dopamine agents|mesh-ancestor
65334450|NCT00772161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65334451|NCT00776139|Cetirizine|cetirizine|mesh-list
65334452|NCT00776139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65334453|NCT00776139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65334454|NCT00776139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65334455|NCT00776139|Histamine Antagonists|histamine antagonists|mesh-ancestor
65248463|NCT02841800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65248464|NCT02841800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65248465|NCT02841800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248496|NCT00621751|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65248497|NCT00621751|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65248498|NCT02690792|Vitamin E|vitamin e|mesh-list
65248499|NCT02690792|Vitamins|vitamins|mesh-ancestor
65248500|NCT02690792|Micronutrients|micronutrients|mesh-ancestor
65248501|NCT02690792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248502|NCT02690792|Antioxidants|antioxidants|mesh-ancestor
64327893|NCT02175017|Nivolumab|nivolumab|mesh-list
65334456|NCT00776139|Histamine Agents|histamine agents|mesh-ancestor
65334457|NCT00776139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65334458|NCT00776139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334459|NCT00776139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334460|NCT05153408|Carboplatin|carboplatin|mesh-list
65334461|NCT05153408|Pemetrexed|pemetrexed|mesh-list
65334462|NCT05153408|Osimertinib|osimertinib|mesh-list
65334463|NCT05153408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334464|NCT05153408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334465|NCT05153408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334466|NCT05153408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65334467|NCT05153408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65334468|NCT05153408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65334469|NCT00779493|Curcumin|curcumin|mesh-list
65334470|NCT00779493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334471|NCT00779493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65334472|NCT00779493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65334473|NCT00779493|Analgesics|analgesics|mesh-ancestor
65334474|NCT00779493|Sensory System Agents|sensory system agents|mesh-ancestor
65334475|NCT00779493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65334476|NCT00779493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65334477|NCT00779493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65334478|NCT00779493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334479|NCT00779493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334480|NCT00779493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334481|NCT02580344|Ibuprofen|ibuprofen|mesh-list
65334482|NCT02580344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65248503|NCT02690792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248504|NCT02690792|Protective Agents|protective agents|mesh-ancestor
65248505|NCT00831649|Natalizumab|natalizumab|mesh-list
65248506|NCT00831649|Immunologic Factors|immunologic factors|mesh-ancestor
65248507|NCT00831649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248508|NCT02841332|Misonidazole|misonidazole|mesh-list
65248534|NCT00156104|Autonomic Agents|autonomic agents|mesh-ancestor
65248535|NCT00156104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65248536|NCT00156104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248537|NCT00156104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65248538|NCT00156104|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65248539|NCT00156104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65248540|NCT00156104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65248541|NCT00156104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65248542|NCT00156104|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65248543|NCT00156104|Dopamine Agents|dopamine agents|mesh-ancestor
65248544|NCT00156104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64719903|NCT03818815|Clavulanic Acids|clavulanic acids|mesh-list
64719904|NCT03818815|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64719905|NCT03818815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64719906|NCT03818815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719907|NCT03818815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64719908|NCT03818815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719909|NCT03818815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327903|NCT02178449|Antiemetics|antiemetics|mesh-ancestor
64327904|NCT02178449|Autonomic Agents|autonomic agents|mesh-ancestor
64327905|NCT02178449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64327906|NCT02178449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327907|NCT02178449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64327908|NCT02178449|Glucocorticoids|glucocorticoids|mesh-ancestor
64327909|NCT02178449|Hormones|hormones|mesh-ancestor
64713091|NCT03211416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64713092|NCT03211416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334483|NCT02580344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65334484|NCT02580344|Analgesics|analgesics|mesh-ancestor
65334485|NCT02580344|Sensory System Agents|sensory system agents|mesh-ancestor
65334486|NCT02580344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65334487|NCT02580344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334493|NCT00779649|Bisacodyl|bisacodyl|mesh-list
64719910|NCT00001958|Hydroxyurea|hydroxyurea|mesh-list
64719911|NCT00001958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64719912|NCT00001958|Antisickling Agents|antisickling agents|mesh-ancestor
64719913|NCT00001958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719914|NCT00001958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719915|NCT00001958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64719916|NCT00001964|Cyclosporine|cyclosporine|mesh-list
64719917|NCT00001964|Cyclosporins|cyclosporins|mesh-list
64719918|NCT00001964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719919|NCT00001964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334516|NCT00667875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65334517|NCT00667875|Antidepressive Agents|antidepressive agents|mesh-ancestor
65334518|NCT00667875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65334519|NCT00667875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65334520|NCT00667875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65334521|NCT00667875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65334522|NCT00667875|Dopamine Agonists|dopamine agonists|mesh-ancestor
65334523|NCT00667875|Dopamine Agents|dopamine agents|mesh-ancestor
65334524|NCT00667875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65334525|NCT00667875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334526|NCT00667875|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65334527|NCT00667875|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65334528|NCT00667875|Serotonin Agents|serotonin agents|mesh-ancestor
64719929|NCT03801265|Anesthetics, Local|anesthetics, local|mesh-ancestor
64719930|NCT03801265|Anesthetics|anesthetics|mesh-ancestor
64719931|NCT03801265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64719932|NCT03801265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334549|NCT00779805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65334550|NCT00779805|Autonomic Agents|autonomic agents|mesh-ancestor
65334551|NCT00779805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65334552|NCT00779805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334553|NCT00779805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65334554|NCT00779805|Respiratory System Agents|respiratory system agents|mesh-ancestor
65334555|NCT00779805|Nasal Decongestants|nasal decongestants|mesh-ancestor
65334556|NCT00779805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65334557|NCT00779805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65334558|NCT00779805|Sympathomimetics|sympathomimetics|mesh-ancestor
65334559|NCT00779805|Adrenergic Agents|adrenergic agents|mesh-ancestor
65334560|NCT00779805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65334561|NCT00779805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334562|NCT00772395|Risedronic Acid|risedronic acid|mesh-list
65334563|NCT00772395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65334564|NCT00772395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65334565|NCT00772395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334566|NCT00772395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65334567|NCT00772395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334568|NCT00772395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65334569|NCT00667251|Paclitaxel|paclitaxel|mesh-list
65334570|NCT00667251|Docetaxel|docetaxel|mesh-list
65334571|NCT00667251|Trastuzumab|trastuzumab|mesh-list
65334572|NCT00667251|Lapatinib|lapatinib|mesh-list
65334573|NCT00667251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65334574|NCT00667251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334575|NCT00667251|Tubulin Modulators|tubulin modulators|mesh-ancestor
65334576|NCT00667251|Antimitotic Agents|antimitotic agents|mesh-ancestor
65334577|NCT00667251|Mitosis Modulators|mitosis modulators|mesh-ancestor
64719936|NCT00000290|Anesthetics, Local|anesthetics, local|mesh-ancestor
64719948|NCT00000290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64719949|NCT00000302|Buprenorphine|buprenorphine|mesh-list
64719950|NCT00000302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64719951|NCT00000302|Narcotics|narcotics|mesh-ancestor
64719952|NCT00000302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65334578|NCT00667251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334579|NCT00667251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65334580|NCT00667251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65334581|NCT00667251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334582|NCT04063124|Dasatinib|dasatinib|mesh-list
65334583|NCT04063124|Quercetin|quercetin|mesh-list
65334584|NCT04063124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334585|NCT04063124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65334586|NCT04063124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334587|NCT04063124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334588|NCT04063124|Antioxidants|antioxidants|mesh-ancestor
65334589|NCT04063124|Protective Agents|protective agents|mesh-ancestor
65334590|NCT04063124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334591|NCT04060862|Fulvestrant|fulvestrant|mesh-list
65334592|NCT04060862|Palbociclib|palbociclib|mesh-list
65334593|NCT04060862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65334594|NCT04060862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334595|NCT04060862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65334596|NCT04060862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65334597|NCT04060862|Hormone Antagonists|hormone antagonists|mesh-ancestor
65334598|NCT04060862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65334599|NCT04060862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334600|NCT04060862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65334601|NCT04060862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248545|NCT00156104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248546|NCT00156104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65248547|NCT00254462|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65248548|NCT00254462|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65248549|NCT00254462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65248550|NCT00254462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65248551|NCT00254462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248552|NCT00254462|Adrenergic Agents|adrenergic agents|mesh-ancestor
65248553|NCT00254462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65248554|NCT00254462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248555|NCT00891930|Irinotecan|irinotecan|mesh-list
65248556|NCT00891930|Panitumumab|panitumumab|mesh-list
65248557|NCT00891930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65248558|NCT00891930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64719958|NCT00001052|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64719959|NCT00001052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64719960|NCT00001052|Immunologic Factors|immunologic factors|mesh-ancestor
64719961|NCT00001052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719962|NCT00001052|Antacids|antacids|mesh-ancestor
64719963|NCT00001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719964|NCT00001052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65334602|NCT04060862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334603|NCT00772473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
65334604|NCT00772473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65334605|NCT00772473|Serotonin Agents|serotonin agents|mesh-ancestor
65334606|NCT00772473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65334607|NCT00772473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334608|NCT00772473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334609|NCT00776607|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65334610|NCT00776607|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65334611|NCT00776607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334612|NCT00780039|Carboplatin|carboplatin|mesh-list
65334613|NCT00780039|Doxorubicin|doxorubicin|mesh-list
65334614|NCT00780039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65334615|NCT00780039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334616|NCT00780039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65334617|NCT00780039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65334618|NCT00780039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65334619|NCT00780039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334620|NCT00780039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334621|NCT00776763|Bevacizumab|bevacizumab|mesh-list
65334622|NCT00776763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65334623|NCT00776763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334624|NCT00776763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65248559|NCT00891930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923870|NCT00027391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65248586|NCT01615874|Glucocorticoids|glucocorticoids|mesh-ancestor
65248587|NCT01615874|Hormones|hormones|mesh-ancestor
65248588|NCT01615874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65248589|NCT01615874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248590|NCT01615874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65248591|NCT01615874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65248592|NCT01615874|Autonomic Agents|autonomic agents|mesh-ancestor
64719968|NCT00001058|Ethambutol|ethambutol|mesh-list
64719969|NCT00001058|Rifabutin|rifabutin|mesh-list
64719970|NCT00001058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64719971|NCT00001058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64719972|NCT00001058|Protease Inhibitors|protease inhibitors|mesh-ancestor
64719973|NCT00001058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719974|NCT00001058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719975|NCT00001058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64719976|NCT00001058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64719977|NCT00001058|Antiviral Agents|antiviral agents|mesh-ancestor
64719978|NCT00001058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64327939|NCT00829023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65334625|NCT00776763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65334626|NCT00776763|Growth Substances|growth substances|mesh-ancestor
65334627|NCT00776763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334628|NCT00776763|Growth Inhibitors|growth inhibitors|mesh-ancestor
65334629|NCT00772551|Raltegravir Potassium|raltegravir potassium|mesh-list
65334630|NCT00772551|Ezetimibe|ezetimibe|mesh-list
65334631|NCT00772551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65334632|NCT00772551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65334633|NCT00772551|Antimetabolites|antimetabolites|mesh-ancestor
65334634|NCT00772551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334636|NCT00772551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64719979|NCT00001058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64719980|NCT00001058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64719981|NCT00001058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64719982|NCT00001058|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64719983|NCT00001058|Antitubercular Agents|antitubercular agents|mesh-ancestor
65334664|NCT00667719|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65334665|NCT00667719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65334666|NCT00667719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65334667|NCT00667719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65334668|NCT00667719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334669|NCT00667719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65334670|NCT00667719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334671|NCT00667719|Vasodilator Agents|vasodilator agents|mesh-ancestor
65334672|NCT00667719|Diuretics|diuretics|mesh-ancestor
65334673|NCT00667719|Natriuretic Agents|natriuretic agents|mesh-ancestor
65334674|NCT00667719|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65334675|NCT04032704|Pembrolizumab|pembrolizumab|mesh-list
65334676|NCT04032704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65334677|NCT04032704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334678|NCT00669669|Plerixafor|plerixafor|mesh-list
65334679|NCT00669669|Temozolomide|temozolomide|mesh-list
65334680|NCT00669669|Carmustine|carmustine|mesh-list
65334681|NCT00669669|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
65334682|NCT00669669|Lenograstim|lenograstim|mesh-list
65334683|NCT00669669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65334684|NCT00669669|Immunologic Factors|immunologic factors|mesh-ancestor
65334685|NCT00669669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334686|NCT00669669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65334687|NCT00669669|Alkylating Agents|alkylating agents|mesh-ancestor
65334688|NCT00669669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334689|NCT00669669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334690|NCT00669669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65334691|NCT00669669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65334692|NCT00669669|Antiviral Agents|antiviral agents|mesh-ancestor
64719993|NCT00000308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64719994|NCT00000308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719995|NCT00000308|Adrenergic Agents|adrenergic agents|mesh-ancestor
64719996|NCT00000308|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64719997|NCT00000308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64719998|NCT00000308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64719999|NCT00000308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64720000|NCT00001994|Atovaquone|atovaquone|mesh-list
64327964|NCT03170739|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64327965|NCT03170739|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64713203|NCT03007147|Isophosphamide mustard|isophosphamide mustard|mesh-list
64713204|NCT03007147|Doxorubicin|doxorubicin|mesh-list
64713205|NCT03007147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64713206|NCT03007147|Methotrexate|methotrexate|mesh-list
64713207|NCT03007147|Etoposide|etoposide|mesh-list
64713208|NCT03007147|Vincristine|vincristine|mesh-list
64713209|NCT03007147|Etoposide phosphate|etoposide phosphate|mesh-list
64713210|NCT03007147|Imatinib Mesylate|imatinib mesylate|mesh-list
64713211|NCT03007147|Daunorubicin|daunorubicin|mesh-list
65334699|NCT02579564|Endostar protein|endostar protein|mesh-list
65334700|NCT02579564|Endostatins|endostatins|mesh-list
65334701|NCT02579564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65334702|NCT02579564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64720001|NCT00001994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720002|NCT00001994|Antimalarials|antimalarials|mesh-ancestor
64720003|NCT00001994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64720004|NCT00001994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64720005|NCT00001994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720006|NCT00001994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720007|NCT00000320|Buprenorphine|buprenorphine|mesh-list
64720008|NCT00000320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64720009|NCT00000320|Narcotics|narcotics|mesh-ancestor
64720010|NCT00000320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64327966|NCT03170739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64327967|NCT03170739|Adrenergic Agents|adrenergic agents|mesh-ancestor
64327968|NCT03170739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64327969|NCT03170739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327970|NCT03170739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64327971|NCT03170739|Sympathomimetics|sympathomimetics|mesh-ancestor
64327972|NCT03170739|Autonomic Agents|autonomic agents|mesh-ancestor
65334731|NCT00467779|Anesthetics, General|anesthetics, general|mesh-ancestor
65334732|NCT00467779|Anesthetics|anesthetics|mesh-ancestor
65334733|NCT00467779|GABA Modulators|gaba modulators|mesh-ancestor
65334734|NCT00467779|GABA Agents|gaba agents|mesh-ancestor
65334735|NCT00467779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65334736|NCT00467779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334737|NCT00467779|Antitussive Agents|antitussive agents|mesh-ancestor
65334766|NCT01029223|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65334767|NCT01029223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65334768|NCT01029223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65334769|NCT01029223|Adrenergic Agents|adrenergic agents|mesh-ancestor
65334770|NCT01029223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65334771|NCT01029223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084641|NCT00437450|Epoetin Alfa|epoetin alfa|mesh-list
65334773|NCT02556723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65334774|NCT02556723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65334775|NCT02556723|Growth Substances|growth substances|mesh-ancestor
65334776|NCT02556723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334777|NCT02556723|Growth Inhibitors|growth inhibitors|mesh-ancestor
65334778|NCT02556723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334779|NCT00777543|Ferulic acid|ferulic acid|mesh-list
65334780|NCT00777543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65334781|NCT00777543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65334782|NCT00777543|Analgesics|analgesics|mesh-ancestor
65334783|NCT00777543|Sensory System Agents|sensory system agents|mesh-ancestor
65334784|NCT00777543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65334785|NCT00777543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334786|NCT00777543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65334787|NCT00777543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65334788|NCT00777543|Anticoagulants|anticoagulants|mesh-ancestor
65334789|NCT00777543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65334790|NCT00777543|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65334791|NCT00777543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65334792|NCT00777543|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65334793|NCT00777543|Antioxidants|antioxidants|mesh-ancestor
65334794|NCT00777543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334795|NCT00777543|Protective Agents|protective agents|mesh-ancestor
65334796|NCT03410654|Tacrolimus|tacrolimus|mesh-list
65334808|NCT04006262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327991|NCT00459745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64720029|NCT03978403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720030|NCT03978403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720031|NCT00002000|Valacyclovir|valacyclovir|mesh-list
64720032|NCT00002000|Acyclovir|acyclovir|mesh-list
65334809|NCT01032499|Oxytetracycline|oxytetracycline|mesh-list
65334810|NCT01032499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65334811|NCT01032499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65334812|NCT01022047|Budesonide|budesonide|mesh-list
65334813|NCT01022047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65334814|NCT01022047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65334815|NCT01022047|Autonomic Agents|autonomic agents|mesh-ancestor
65334816|NCT01022047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65334817|NCT01022047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334818|NCT01022047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65334819|NCT01022047|Respiratory System Agents|respiratory system agents|mesh-ancestor
65334820|NCT01022047|Glucocorticoids|glucocorticoids|mesh-ancestor
65334821|NCT01022047|Hormones|hormones|mesh-ancestor
65334822|NCT01022047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65334823|NCT01022125|Simeprevir|simeprevir|mesh-list
65334824|NCT01022125|Antiviral Agents|antiviral agents|mesh-ancestor
65334825|NCT01022125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65334826|NCT01022125|Protease Inhibitors|protease inhibitors|mesh-ancestor
65334827|NCT01022125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334828|NCT01022125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248593|NCT01615874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65248594|NCT01615874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65248595|NCT01615874|Respiratory System Agents|respiratory system agents|mesh-ancestor
65248596|NCT01615874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65248597|NCT01615874|Hormone Antagonists|hormone antagonists|mesh-ancestor
65248598|NCT01615874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65248599|NCT01615874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65248600|NCT01615874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248601|NCT01615874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65248602|NCT00891462|Bromides|bromides|mesh-list
65248603|NCT00891462|Anticonvulsants|anticonvulsants|mesh-ancestor
65248604|NCT04248348|Heparin|heparin|mesh-list
65248605|NCT04248348|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65248632|NCT00140972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65248634|NCT00140972|Sensory System Agents|sensory system agents|mesh-ancestor
65248635|NCT00140972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65248636|NCT00140972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248637|NCT00140972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65248638|NCT00140972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65248639|NCT00140972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65248640|NCT00140972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720040|NCT03979807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64720041|NCT03979807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720042|NCT03979807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64720043|NCT03979807|Respiratory System Agents|respiratory system agents|mesh-ancestor
64720044|NCT03979807|Parasympatholytics|parasympatholytics|mesh-ancestor
64720045|NCT03979807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64720046|NCT03979807|Cholinergic Agents|cholinergic agents|mesh-ancestor
64720047|NCT03979807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64720048|NCT03979807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720049|NCT03979807|Anticonvulsants|anticonvulsants|mesh-ancestor
64720050|NCT00001082|Adefovir|adefovir|mesh-list
64720051|NCT00001082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64327996|NCT02178761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327997|NCT02178761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64327998|NCT02178761|Immunologic Factors|immunologic factors|mesh-ancestor
64327999|NCT02178761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713270|NCT03007147|Antimitotic Agents|antimitotic agents|mesh-ancestor
64713274|NCT03007147|Hematinics|hematinics|mesh-ancestor
65334829|NCT03385928|Tranexamic Acid|tranexamic acid|mesh-list
65334830|NCT03385928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65334831|NCT03385928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65334833|NCT03385928|Hemostatics|hemostatics|mesh-ancestor
65334864|NCT00441103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334865|NCT00441103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334866|NCT00441103|Antiviral Agents|antiviral agents|mesh-ancestor
65334867|NCT00441103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65334868|NCT01029613|Adalimumab|adalimumab|mesh-list
65334869|NCT01029613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65334870|NCT01029613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65334871|NCT03540212|Sofosbuvir|sofosbuvir|mesh-list
65334872|NCT03540212|Antiviral Agents|antiviral agents|mesh-ancestor
65334873|NCT03540212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65334874|NCT03268057|Avelumab|avelumab|mesh-list
65334875|NCT03268057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65334876|NCT03268057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334877|NCT03339128|Eluxadoline|eluxadoline|mesh-list
65334878|NCT03339128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65334879|NCT01033903|Misoprostol|misoprostol|mesh-list
65334880|NCT01033903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65334881|NCT01033903|Abortifacient Agents|abortifacient agents|mesh-ancestor
65334882|NCT01033903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65334883|NCT01033903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334884|NCT01033903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65334885|NCT01033903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65334886|NCT01033903|Oxytocics|oxytocics|mesh-ancestor
65334887|NCT03281954|Atezolizumab|atezolizumab|mesh-list
65334888|NCT03281954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334889|NCT03526250|Palbociclib|palbociclib|mesh-list
65334890|NCT03526250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334891|NCT03526250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65334892|NCT03526250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334893|NCT03526250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334911|NCT00433537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65334912|NCT00433537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65334913|NCT00433537|Antiemetics|antiemetics|mesh-ancestor
65334914|NCT00433537|Autonomic Agents|autonomic agents|mesh-ancestor
65334915|NCT00433537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65334916|NCT00433537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65334917|NCT00433537|Glucocorticoids|glucocorticoids|mesh-ancestor
65334918|NCT00433537|Hormones|hormones|mesh-ancestor
65334919|NCT00433537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65334920|NCT00433537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65084789|NCT00438113|Diuretics|diuretics|mesh-ancestor
65334921|NCT00433537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65334922|NCT00433537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65334923|NCT00433537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65334924|NCT00433537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334925|NCT00433537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65334926|NCT00433537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65334927|NCT00433537|Tubulin Modulators|tubulin modulators|mesh-ancestor
65334928|NCT00433537|Antimitotic Agents|antimitotic agents|mesh-ancestor
65334929|NCT00433537|Mitosis Modulators|mitosis modulators|mesh-ancestor
65334930|NCT00570765|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
65334931|NCT00570765|Cathartics|cathartics|mesh-ancestor
65334932|NCT00570765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65334933|NCT00777699|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65334934|NCT00777699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65334935|NCT00777699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65334936|NCT00777699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334937|NCT00777699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334938|NCT05118477|Caffeine|caffeine|mesh-list
65334939|NCT05118477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65334940|NCT05118477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334941|NCT05118477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65334942|NCT05118477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334943|NCT05118477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334944|NCT05118477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65334945|NCT05118477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64720096|NCT03799783|Analgesics|analgesics|mesh-ancestor
64720097|NCT03799783|Sensory System Agents|sensory system agents|mesh-ancestor
64720098|NCT03799783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64720099|NCT03799783|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64720100|NCT03799783|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64720101|NCT03799783|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64720102|NCT03799783|Adrenergic Agents|adrenergic agents|mesh-ancestor
65334946|NCT05118477|Purinergic Agents|purinergic agents|mesh-ancestor
65334947|NCT05118477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65334948|NCT00667095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65334949|NCT00667095|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
65334950|NCT00667095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65334951|NCT00667095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65334952|NCT00667095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334953|NCT00667095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65334954|NCT00667095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65334955|NCT00667095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334956|NCT00667095|Cholinergic Agents|cholinergic agents|mesh-ancestor
65334957|NCT00667095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65334958|NCT00667095|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65334959|NCT00667095|Protective Agents|protective agents|mesh-ancestor
65334960|NCT00667095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65334961|NCT00667095|Antioxidants|antioxidants|mesh-ancestor
65334962|NCT00777933|Cyclosporine|cyclosporine|mesh-list
65334963|NCT00777933|Tacrolimus|tacrolimus|mesh-list
65334964|NCT00777933|Cyclosporins|cyclosporins|mesh-list
65334965|NCT00777933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65334966|NCT00777933|Immunologic Factors|immunologic factors|mesh-ancestor
65334967|NCT00777933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334968|NCT00777933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65334969|NCT00777933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65334970|NCT00777933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334971|NCT00777933|Antifungal Agents|antifungal agents|mesh-ancestor
65334972|NCT00777933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65334973|NCT00777933|Dermatologic Agents|dermatologic agents|mesh-ancestor
64720108|NCT00001088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64720109|NCT00001088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720110|NCT00001088|Sensory System Agents|sensory system agents|mesh-ancestor
65334978|NCT00778011|Metoclopramide|metoclopramide|mesh-list
65334979|NCT00778011|Antiemetics|antiemetics|mesh-ancestor
65334980|NCT00778011|Autonomic Agents|autonomic agents|mesh-ancestor
65334981|NCT00778011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65334982|NCT00778011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65334983|NCT00778011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65334984|NCT00778011|Antipruritics|antipruritics|mesh-ancestor
65334985|NCT00778011|Dermatologic Agents|dermatologic agents|mesh-ancestor
65334986|NCT00778011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65334987|NCT00778011|Serotonin Agents|serotonin agents|mesh-ancestor
65334988|NCT00778011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65334989|NCT00778011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65334990|NCT00778011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65334991|NCT00778011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65334992|NCT00778011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65334993|NCT00778011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65334994|NCT00778011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65334995|NCT00778011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65334996|NCT00778011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65334997|NCT00778011|Dopamine Agents|dopamine agents|mesh-ancestor
65334998|NCT00778089|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
65334999|NCT00778089|Vasodilator Agents|vasodilator agents|mesh-ancestor
65335000|NCT00778089|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65335001|NCT00778089|Protective Agents|protective agents|mesh-ancestor
65335002|NCT00778089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335003|NCT00433381|Bevacizumab|bevacizumab|mesh-list
65335004|NCT00433381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65335005|NCT00433381|Irinotecan|irinotecan|mesh-list
65335006|NCT00433381|Temozolomide|temozolomide|mesh-list
65335007|NCT00433381|Camptothecin|camptothecin|mesh-list
65335008|NCT00433381|Endothelial Growth Factors|endothelial growth factors|mesh-list
64720125|NCT00001094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64720126|NCT00001094|Antimetabolites|antimetabolites|mesh-ancestor
64720127|NCT00001094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64720128|NCT00001094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64720129|NCT00001094|Protease Inhibitors|protease inhibitors|mesh-ancestor
64720130|NCT00001094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64720131|NCT00001094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64720132|NCT00001100|Ganciclovir|ganciclovir|mesh-list
64720133|NCT00001100|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64720134|NCT00001100|Antiviral Agents|antiviral agents|mesh-ancestor
64328074|NCT04575779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64328075|NCT02741713|Lidocaine|lidocaine|mesh-list
64328076|NCT02741713|Clonidine|clonidine|mesh-list
64328077|NCT02741713|Epinephrine|epinephrine|mesh-list
65335017|NCT00433381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335018|NCT00433381|Growth Inhibitors|growth inhibitors|mesh-ancestor
65335019|NCT00433381|Immunologic Factors|immunologic factors|mesh-ancestor
65335020|NCT00433381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65335021|NCT00433381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65335022|NCT00433381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335023|NCT00433381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335024|NCT00433381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65335025|NCT00433381|Alkylating Agents|alkylating agents|mesh-ancestor
65335026|NCT00433381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65335027|NCT00667017|Immunotoxins|immunotoxins|mesh-list
65335028|NCT00667017|Immunologic Factors|immunologic factors|mesh-ancestor
65335029|NCT00667017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335030|NCT00781131|Pregabalin|pregabalin|mesh-list
65335031|NCT00781131|Analgesics|analgesics|mesh-ancestor
65335032|NCT00781131|Sensory System Agents|sensory system agents|mesh-ancestor
64720135|NCT00001100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720136|NCT00001100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720137|NCT00001100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720138|NCT00001100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720139|NCT00000332|Nimodipine|nimodipine|mesh-list
64720140|NCT00000332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64720141|NCT00000332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64720142|NCT00000332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64720143|NCT00000332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720145|NCT00000332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335047|NCT00778401|Gabapentin|gabapentin|mesh-list
65335048|NCT00778401|Analgesics|analgesics|mesh-ancestor
65335049|NCT00778401|Sensory System Agents|sensory system agents|mesh-ancestor
65335050|NCT00778401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65335051|NCT00778401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335052|NCT00778401|Anticonvulsants|anticonvulsants|mesh-ancestor
65335053|NCT00778401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65335054|NCT00778401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65335055|NCT00778401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65335056|NCT00778401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65335057|NCT00778401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65335058|NCT00778401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65335059|NCT00778401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65335060|NCT00778401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335061|NCT00778401|Antimanic Agents|antimanic agents|mesh-ancestor
65335062|NCT00666705|Raltegravir Potassium|raltegravir potassium|mesh-list
64720147|NCT00000338|Lisuride|lisuride|mesh-list
64720148|NCT00000338|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64720149|NCT00000338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64720150|NCT00000338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64720151|NCT00000338|Serotonin Agents|serotonin agents|mesh-ancestor
64720152|NCT00000338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64720153|NCT00000338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720154|NCT00000338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720155|NCT00000338|Dopamine Agonists|dopamine agonists|mesh-ancestor
64720156|NCT00000338|Dopamine Agents|dopamine agents|mesh-ancestor
64328095|NCT02741713|Adrenergic Agents|adrenergic agents|mesh-ancestor
64328096|NCT02741713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64328097|NCT02741713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64328098|NCT02741713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64713302|NCT02998528|Antiviral Agents|antiviral agents|mesh-ancestor
64713303|NCT02998528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64713304|NCT02998528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64713322|NCT02989597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64713323|NCT02989597|Glucocorticoids|glucocorticoids|mesh-ancestor
64713325|NCT02989597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64720157|NCT04085341|Sunitinib|sunitinib|mesh-list
64720158|NCT04085341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64720159|NCT04085341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64720160|NCT04085341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64720161|NCT04085341|Growth Substances|growth substances|mesh-ancestor
64720162|NCT04085341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720163|NCT04085341|Growth Inhibitors|growth inhibitors|mesh-ancestor
64720164|NCT04085341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64720165|NCT04085341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328099|NCT02741713|Autonomic Agents|autonomic agents|mesh-ancestor
64328100|NCT02741713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64328101|NCT02741713|Respiratory System Agents|respiratory system agents|mesh-ancestor
64328102|NCT02741713|Mydriatics|mydriatics|mesh-ancestor
64328103|NCT02741713|Sympathomimetics|sympathomimetics|mesh-ancestor
64328104|NCT02741713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64713326|NCT02989597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64713327|NCT02989597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713328|NCT02989597|Analgesics|analgesics|mesh-ancestor
64713329|NCT02989597|Sensory System Agents|sensory system agents|mesh-ancestor
65335118|NCT00774189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65335119|NCT00774189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335123|NCT00774423|Riluzole|riluzole|mesh-list
65335150|NCT00784485|Respiratory System Agents|respiratory system agents|mesh-ancestor
65335151|NCT00781755|Varenicline|varenicline|mesh-list
65335152|NCT00781755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65335153|NCT00781755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65335154|NCT00781755|Cholinergic Agents|cholinergic agents|mesh-ancestor
65335155|NCT00781755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65335156|NCT00781755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335157|NCT00781755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335158|NCT00774735|Dolutegravir|dolutegravir|mesh-list
65335159|NCT00774735|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65335160|NCT00774735|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65335161|NCT00774735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335162|NCT00774735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335163|NCT00774735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65335164|NCT00774735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65335165|NCT00774735|Antiviral Agents|antiviral agents|mesh-ancestor
65335166|NCT00774735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335167|NCT00666237|Mitomycins|mitomycins|mesh-list
65335168|NCT00666237|Mitomycin|mitomycin|mesh-list
65335169|NCT00666237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65335170|NCT00666237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335171|NCT00666237|Alkylating Agents|alkylating agents|mesh-ancestor
65335172|NCT00666237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335173|NCT00666237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65335174|NCT00666237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335175|NCT00774813|Citalopram|citalopram|mesh-list
65335176|NCT00774813|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65335177|NCT00774813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65335178|NCT00774813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65335179|NCT00774813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335180|NCT00774813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65335181|NCT00774813|Serotonin Agents|serotonin agents|mesh-ancestor
65335182|NCT00774813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335190|NCT00784797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328140|NCT00602329|Antidotes|antidotes|mesh-ancestor
64720200|NCT00000344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64720201|NCT00000344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64720202|NCT04103515|Cimetidine|cimetidine|mesh-list
64720203|NCT04103515|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64720204|NCT04103515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64720205|NCT04103515|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64720206|NCT04103515|Histamine Antagonists|histamine antagonists|mesh-ancestor
64720207|NCT04103515|Histamine Agents|histamine agents|mesh-ancestor
64720208|NCT04103515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64328141|NCT00602329|Protective Agents|protective agents|mesh-ancestor
64328142|NCT00602329|Vitamin B Complex|vitamin b complex|mesh-ancestor
64328143|NCT00602329|Vitamins|vitamins|mesh-ancestor
64328144|NCT00602329|Micronutrients|micronutrients|mesh-ancestor
64328145|NCT02182505|Fenoterol|fenoterol|mesh-list
64328146|NCT02182505|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
64328147|NCT02182505|Ipratropium|ipratropium|mesh-list
64328148|NCT02182505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64713332|NCT02989597|Anesthetics, General|anesthetics, general|mesh-ancestor
65335191|NCT00784797|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65335225|NCT00662025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65335226|NCT00662025|Growth Substances|growth substances|mesh-ancestor
65335227|NCT00662025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335228|NCT00662025|Growth Inhibitors|growth inhibitors|mesh-ancestor
65335229|NCT00662025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65335230|NCT00662025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335231|NCT00789945|Insulin|insulin|mesh-list
65335232|NCT00789945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65335233|NCT00789945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65335234|NCT00789945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335235|NCT00790101|Risedronic Acid|risedronic acid|mesh-list
65335236|NCT00790101|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65335237|NCT00790101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65335238|NCT00790101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65335239|NCT00790101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335240|NCT00790101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65335241|NCT00790101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335242|NCT00790101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65335243|NCT00790101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65335244|NCT00790101|Hormone Antagonists|hormone antagonists|mesh-ancestor
65335245|NCT00790101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65335246|NCT00790101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65335247|NCT00790101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65335248|NCT00782301|Maraviroc|maraviroc|mesh-list
65335249|NCT00782301|Etravirine|etravirine|mesh-list
65335250|NCT00782301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65335251|NCT00782301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65335253|NCT00782301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65335269|NCT00785421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65335270|NCT00785421|Antimetabolites|antimetabolites|mesh-ancestor
65335271|NCT00785421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335272|NCT00785421|Antiviral Agents|antiviral agents|mesh-ancestor
65335273|NCT00785421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335274|NCT00785421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335275|NCT00785421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65335276|NCT00785421|Immunologic Factors|immunologic factors|mesh-ancestor
65335277|NCT00785421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335278|NCT00785421|Antidotes|antidotes|mesh-ancestor
65335279|NCT00785421|Protective Agents|protective agents|mesh-ancestor
65335280|NCT00785421|Vitamin B Complex|vitamin b complex|mesh-ancestor
65335281|NCT00785421|Vitamins|vitamins|mesh-ancestor
65335282|NCT00785421|Micronutrients|micronutrients|mesh-ancestor
65335283|NCT00785421|Hematinics|hematinics|mesh-ancestor
65335284|NCT00785421|Anticoagulants|anticoagulants|mesh-ancestor
65335285|NCT00785421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65335286|NCT00785421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65335287|NCT00790179|Ropivacaine|ropivacaine|mesh-list
65335288|NCT00790179|Anesthetics, Local|anesthetics, local|mesh-ancestor
65335289|NCT00790179|Anesthetics|anesthetics|mesh-ancestor
65335290|NCT00790179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65335291|NCT00790179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335292|NCT00790179|Sensory System Agents|sensory system agents|mesh-ancestor
65335293|NCT00790179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65335294|NCT00790413|Rituximab|rituximab|mesh-list
65335295|NCT00790413|Fludarabine|fludarabine|mesh-list
65335296|NCT00790413|Thiotepa|thiotepa|mesh-list
65335297|NCT00790413|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65335298|NCT00790413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65335299|NCT00790413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335300|NCT00790413|Immunologic Factors|immunologic factors|mesh-ancestor
65335301|NCT00790413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335302|NCT00790413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65335303|NCT00790413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335304|NCT00790413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65335305|NCT00790413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64720263|NCT00000374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64720264|NCT00000374|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64720265|NCT00000374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64720266|NCT00000374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64720267|NCT00002042|Epoetin Alfa|epoetin alfa|mesh-list
64720270|NCT03789175|Niacin|niacin|mesh-list
65335307|NCT00790413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65335308|NCT00790413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335309|NCT00790413|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65335310|NCT00785811|N-Methylaspartate|n-methylaspartate|mesh-list
65335311|NCT00785811|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
65335312|NCT00785811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65335313|NCT00785811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65335314|NCT00785811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335315|NCT00785811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335316|NCT00440947|Ritonavir|ritonavir|mesh-list
65335317|NCT00440947|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65335318|NCT00440947|Lamivudine|lamivudine|mesh-list
65335319|NCT00440947|Abacavir|abacavir|mesh-list
65335320|NCT00440947|Dideoxynucleosides|dideoxynucleosides|mesh-list
65335321|NCT00440947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65335322|NCT00440947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65335323|NCT00440947|Protease Inhibitors|protease inhibitors|mesh-ancestor
65335324|NCT00440947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335325|NCT00440947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335326|NCT00440947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65335327|NCT00440947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65335328|NCT00440947|Antiviral Agents|antiviral agents|mesh-ancestor
65335329|NCT00440947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335330|NCT00440947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65335331|NCT00440947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65335332|NCT00440947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65335333|NCT00440947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720279|NCT03789175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64720280|NCT03789175|Vasodilator Agents|vasodilator agents|mesh-ancestor
64720281|NCT00002048|Zidovudine|zidovudine|mesh-list
64720282|NCT00002048|Antimetabolites|antimetabolites|mesh-ancestor
64720283|NCT00002048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720284|NCT00002048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64720285|NCT00002048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720286|NCT00002048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328215|NCT02182661|Oxitropium|oxitropium|mesh-list
64328216|NCT02182661|Parasympatholytics|parasympatholytics|mesh-ancestor
64328217|NCT02182661|Autonomic Agents|autonomic agents|mesh-ancestor
64328218|NCT02182661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64328219|NCT02182661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328220|NCT02663271|Bevacizumab|bevacizumab|mesh-list
64328221|NCT02663271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64328222|NCT02663271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713337|NCT02989597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64713338|NCT02989597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335343|NCT01029769|Amisulpride|amisulpride|mesh-list
65335344|NCT01029769|Antiemetics|antiemetics|mesh-ancestor
65335378|NCT03929666|Leucovorin|leucovorin|mesh-list
65335379|NCT03929666|Gemcitabine|gemcitabine|mesh-list
65335380|NCT03929666|Bevacizumab|bevacizumab|mesh-list
65335381|NCT03929666|Fluorouracil|fluorouracil|mesh-list
65335382|NCT03929666|Capecitabine|capecitabine|mesh-list
65335383|NCT03929666|Oxaliplatin|oxaliplatin|mesh-list
65335384|NCT03929666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65335385|NCT03929666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335386|NCT03929666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65335387|NCT03929666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65335388|NCT03929666|Growth Substances|growth substances|mesh-ancestor
65335389|NCT03929666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335390|NCT03929666|Growth Inhibitors|growth inhibitors|mesh-ancestor
65335391|NCT03929666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65335392|NCT03929666|Antimetabolites|antimetabolites|mesh-ancestor
65335393|NCT03929666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335394|NCT03929666|Antiviral Agents|antiviral agents|mesh-ancestor
65335395|NCT03929666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335396|NCT03929666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335397|NCT03929666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65335398|NCT03929666|Immunologic Factors|immunologic factors|mesh-ancestor
65335399|NCT03929666|Antidotes|antidotes|mesh-ancestor
65335400|NCT03929666|Protective Agents|protective agents|mesh-ancestor
65335401|NCT03929666|Vitamin B Complex|vitamin b complex|mesh-ancestor
65335402|NCT03929666|Vitamins|vitamins|mesh-ancestor
65335403|NCT03929666|Micronutrients|micronutrients|mesh-ancestor
65335404|NCT00664521|Rituximab|rituximab|mesh-list
65335405|NCT00664521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65335406|NCT00664521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335407|NCT00664521|Immunologic Factors|immunologic factors|mesh-ancestor
65335408|NCT00664521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335409|NCT00664521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65335410|NCT02581046|Dexamethasone|dexamethasone|mesh-list
65335411|NCT02581046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65335412|NCT02581046|Antiemetics|antiemetics|mesh-ancestor
64720316|NCT00000440|Naltrexone|naltrexone|mesh-list
65248641|NCT00140972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248642|NCT00140972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65248643|NCT02830932|Vaccines|vaccines|mesh-list
65248644|NCT02830932|Immunologic Factors|immunologic factors|mesh-ancestor
65248645|NCT02830932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248646|NCT00895310|Ketoconazole|ketoconazole|mesh-list
65248647|NCT00895310|Hydrocortisone|hydrocortisone|mesh-list
65335413|NCT02581046|Autonomic Agents|autonomic agents|mesh-ancestor
65335414|NCT02581046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65335415|NCT02581046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335416|NCT02581046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65335417|NCT02581046|Glucocorticoids|glucocorticoids|mesh-ancestor
65335418|NCT02581046|Hormones|hormones|mesh-ancestor
65335419|NCT02581046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65335420|NCT02581046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65335421|NCT02581046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335422|NCT00664209|Amoxicillin|amoxicillin|mesh-list
65335423|NCT00664209|Omeprazole|omeprazole|mesh-list
65335424|NCT00664209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65335425|NCT00664209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335426|NCT00664209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65335427|NCT00664209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65335428|NCT00664209|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65335429|NCT00664209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335430|NCT00664209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335431|NCT03192332|Plasminogen|plasminogen|mesh-list
65335432|NCT03192332|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65335433|NCT03192332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65335434|NCT03192332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65335435|NCT03192332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335436|NCT02555943|Ritonavir|ritonavir|mesh-list
65335437|NCT02555943|Tenofovir|tenofovir|mesh-list
65335438|NCT02555943|Sofosbuvir|sofosbuvir|mesh-list
65335439|NCT02555943|Entecavir|entecavir|mesh-list
65335440|NCT02555943|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
65335441|NCT02555943|Ledipasvir|ledipasvir|mesh-list
65335442|NCT02555943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65335443|NCT02555943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65335444|NCT02555943|Protease Inhibitors|protease inhibitors|mesh-ancestor
65335445|NCT02555943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335446|NCT02555943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335447|NCT02555943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65248648|NCT00895310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65248649|NCT00895310|Antifungal Agents|antifungal agents|mesh-ancestor
65248650|NCT00895310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65248651|NCT00895310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65248652|NCT00895310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64720354|NCT04131517|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64720355|NCT04131517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64720356|NCT04131517|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
64720357|NCT04131517|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64720358|NCT04131517|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64720359|NCT00001256|Prednisone|prednisone|mesh-list
64720360|NCT00001256|Methotrexate|methotrexate|mesh-list
64720361|NCT00001256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64720362|NCT00001256|Glucocorticoids|glucocorticoids|mesh-ancestor
65085308|NCT00440219|Hormones|hormones|mesh-ancestor
65335448|NCT02555943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65335449|NCT02555943|Antiviral Agents|antiviral agents|mesh-ancestor
65335450|NCT02555943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720363|NCT00001256|Hormones|hormones|mesh-ancestor
64720364|NCT00001256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64328288|NCT02176187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328289|NCT02176187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65335456|NCT00782847|Cyproterone|cyproterone|mesh-list
65335485|NCT03139370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335486|NCT03139370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65335487|NCT01029847|Adalimumab|adalimumab|mesh-list
65335488|NCT01029847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65335489|NCT01029847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65335490|NCT02452268|Spartalizumab|spartalizumab|mesh-list
65335491|NCT02452268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65335492|NCT02452268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335493|NCT02452268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335494|NCT02524249|Caffeine|caffeine|mesh-list
65335495|NCT02524249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65335496|NCT02524249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335497|NCT02524249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65335498|NCT02524249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335499|NCT02524249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335500|NCT02524249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65335501|NCT02524249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65335502|NCT02524249|Purinergic Agents|purinergic agents|mesh-ancestor
65335503|NCT02524249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65335504|NCT01033981|Sunitinib|sunitinib|mesh-list
65335505|NCT01033981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335506|NCT01033981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65335507|NCT01033981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65335508|NCT01033981|Growth Substances|growth substances|mesh-ancestor
65335509|NCT01033981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335510|NCT01033981|Growth Inhibitors|growth inhibitors|mesh-ancestor
65335511|NCT01033981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65248653|NCT00895310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248654|NCT00895310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248678|NCT00092768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65248679|NCT00092768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248680|NCT00092768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65248682|NCT00092768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65248683|NCT00092768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65248684|NCT00092768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248685|NCT00092768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248686|NCT02831712|Ferrous fumarate|ferrous fumarate|mesh-list
65248687|NCT02831712|Trace Elements|trace elements|mesh-ancestor
65248688|NCT02831712|Micronutrients|micronutrients|mesh-ancestor
65248689|NCT02831712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248690|NCT05104554|Folic Acid|folic acid|mesh-list
65248691|NCT05104554|Micronutrients|micronutrients|mesh-list
65248692|NCT05104554|Trace Elements|trace elements|mesh-list
65248693|NCT05104554|Hematinics|hematinics|mesh-ancestor
65248694|NCT05104554|Vitamin B Complex|vitamin b complex|mesh-ancestor
65248695|NCT05104554|Vitamins|vitamins|mesh-ancestor
64720378|NCT00001256|Immunologic Factors|immunologic factors|mesh-ancestor
64720379|NCT00001256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64720380|NCT00001256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720381|NCT00000452|Naltrexone|naltrexone|mesh-list
64720382|NCT00000452|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64459674|NCT01672450|Ipilimumab|ipilimumab|mesh-list
64720383|NCT00000452|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64720384|NCT00000452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720385|NCT00000452|Sensory System Agents|sensory system agents|mesh-ancestor
64328307|NCT02176733|Cyclosporine|cyclosporine|mesh-list
64328308|NCT02176733|Cyclosporins|cyclosporins|mesh-list
64328309|NCT02176733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335512|NCT01033981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335513|NCT01033981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335514|NCT02430194|Interferons|interferons|mesh-list
65335515|NCT02430194|Ritonavir|ritonavir|mesh-list
65335516|NCT02430194|Interferon-alpha|interferon-alpha|mesh-list
65335517|NCT02430194|Interferon alpha-2|interferon alpha-2|mesh-list
65335518|NCT02430194|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65335519|NCT02430194|Lonafarnib|lonafarnib|mesh-list
65335520|NCT02430194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335521|NCT02430194|Antiviral Agents|antiviral agents|mesh-ancestor
65335522|NCT02430194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335523|NCT02430194|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65335524|NCT02430194|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65335525|NCT02430194|Protease Inhibitors|protease inhibitors|mesh-ancestor
65335526|NCT02430194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085386|NCT00440843|Olanzapine|olanzapine|mesh-list
65335527|NCT02430194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335529|NCT02430194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65335530|NCT02430194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65335531|NCT02430194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65335532|NCT02430194|Immunologic Factors|immunologic factors|mesh-ancestor
65335533|NCT02430194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335534|NCT00582608|N-(2-aminoethyl)-5-isoquinolinesulfonamide|n-(2-aminoethyl)-5-isoquinolinesulfonamide|mesh-list
65335535|NCT00582608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64720386|NCT00000452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64720388|NCT00000458|Antidepressive Agents|antidepressive agents|mesh-ancestor
64720389|NCT00000458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64720390|NCT00000458|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64720391|NCT00000458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64720392|NCT00000458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64720393|NCT00000458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335539|NCT02400242|Pomalidomide|pomalidomide|mesh-list
65335540|NCT02400242|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65335541|NCT02400242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65335542|NCT02400242|Antiemetics|antiemetics|mesh-ancestor
65335543|NCT02400242|Autonomic Agents|autonomic agents|mesh-ancestor
65335544|NCT02400242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65335545|NCT02400242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335546|NCT02400242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65335547|NCT02400242|Glucocorticoids|glucocorticoids|mesh-ancestor
65335548|NCT02400242|Hormones|hormones|mesh-ancestor
65335549|NCT02400242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65335550|NCT02400242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65335551|NCT02400242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335552|NCT02400242|Immunologic Factors|immunologic factors|mesh-ancestor
65335553|NCT02400242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65335554|NCT02400242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65335555|NCT02400242|Growth Substances|growth substances|mesh-ancestor
65335556|NCT02400242|Growth Inhibitors|growth inhibitors|mesh-ancestor
65335557|NCT02400242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335558|NCT02400242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335559|NCT03087656|Levofloxacin|levofloxacin|mesh-list
65335560|NCT03087656|Ofloxacin|ofloxacin|mesh-list
65335561|NCT03087656|Ceftriaxone|ceftriaxone|mesh-list
65335562|NCT03087656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65335563|NCT03087656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335564|NCT03087656|Renal Agents|renal agents|mesh-ancestor
65335565|NCT03087656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65335566|NCT03087656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64720397|NCT03782233|Bromides|bromides|mesh-list
65248696|NCT05104554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248697|NCT02843984|Lactoferrin|lactoferrin|mesh-list
64720399|NCT03782233|Rocuronium|rocuronium|mesh-list
64720400|NCT03782233|Anticonvulsants|anticonvulsants|mesh-ancestor
64720401|NCT03782233|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64720402|NCT03782233|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64720403|NCT03782233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64720404|NCT03782233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64720406|NCT00002090|Azithromycin|azithromycin|mesh-list
65335567|NCT03087656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65335568|NCT03087656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335569|NCT03087656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335570|NCT03087656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335571|NCT03087656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65335572|NCT03087656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65335573|NCT03068624|Aldesleukin|aldesleukin|mesh-list
65335574|NCT03068624|Cyclophosphamide|cyclophosphamide|mesh-list
65335575|NCT03068624|Ipilimumab|ipilimumab|mesh-list
65335576|NCT03068624|Interleukin-2|interleukin-2|mesh-list
65335577|NCT03068624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65335578|NCT03068624|Immunologic Factors|immunologic factors|mesh-ancestor
65335579|NCT03068624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335580|NCT03068624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65335581|NCT03068624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65335582|NCT03068624|Alkylating Agents|alkylating agents|mesh-ancestor
65335583|NCT03068624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335584|NCT03068624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335585|NCT03068624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65335586|NCT03068624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65335587|NCT03068624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65335588|NCT03068624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65335589|NCT03068624|Analgesics|analgesics|mesh-ancestor
65335590|NCT03068624|Sensory System Agents|sensory system agents|mesh-ancestor
65335591|NCT03068624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65335592|NCT03068624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65335593|NCT03068624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65248698|NCT02843984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65248699|NCT02840708|Sargramostim|sargramostim|mesh-list
65248700|NCT02840708|Immunologic Factors|immunologic factors|mesh-ancestor
65248701|NCT02840708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248702|NCT00817076|Desloratadine|desloratadine|mesh-list
65248703|NCT00817076|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65335594|NCT03068624|Antiviral Agents|antiviral agents|mesh-ancestor
65335595|NCT03068624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335596|NCT03025256|Nivolumab|nivolumab|mesh-list
65335597|NCT03025256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65335598|NCT03025256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335599|NCT03025256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65335600|NCT03025256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335601|NCT03005366|Flecainide|flecainide|mesh-list
65335602|NCT03005366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65335603|NCT03005366|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65335604|NCT03005366|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65335605|NCT03005366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65335606|NCT03005366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335607|NCT04076228|Pembrolizumab|pembrolizumab|mesh-list
65335608|NCT04076228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65335609|NCT04076228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335610|NCT02580734|Melatonin|melatonin|mesh-list
65335611|NCT02580734|Antioxidants|antioxidants|mesh-ancestor
65335612|NCT02580734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335613|NCT02580734|Protective Agents|protective agents|mesh-ancestor
65335614|NCT02580734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335615|NCT02580734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65335616|NCT00427999|Pioglitazone|pioglitazone|mesh-list
65335617|NCT00427999|Dexamethasone|dexamethasone|mesh-list
65335618|NCT00427999|Dexamethasone acetate|dexamethasone acetate|mesh-list
65335619|NCT00427999|Etoricoxib|etoricoxib|mesh-list
65335620|NCT00427999|Imatinib Mesylate|imatinib mesylate|mesh-list
65335621|NCT00427999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65335622|NCT00427999|Antiemetics|antiemetics|mesh-ancestor
65335623|NCT00427999|Autonomic Agents|autonomic agents|mesh-ancestor
65335624|NCT00427999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65335625|NCT00427999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335635|NCT00427999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335636|NCT00427999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65335637|NCT00427999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65335638|NCT00427999|Analgesics|analgesics|mesh-ancestor
65335639|NCT00427999|Sensory System Agents|sensory system agents|mesh-ancestor
65335640|NCT00427999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65335641|NCT00427999|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65335642|NCT00427999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65335643|NCT04825652|177Lu-PSMA-617|177lu-psma-617|mesh-list
65335644|NCT04825652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65335645|NCT04825652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335646|NCT00661713|Vaccines|vaccines|mesh-list
65335647|NCT00661713|Immunologic Factors|immunologic factors|mesh-ancestor
65335648|NCT00661713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335649|NCT02578472|Zolpidem|zolpidem|mesh-list
65335650|NCT02578472|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65335651|NCT02578472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65335652|NCT02578472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65335653|NCT02578472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335654|NCT02578472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65335655|NCT02578472|GABA Agonists|gaba agonists|mesh-ancestor
65335656|NCT02578472|GABA Agents|gaba agents|mesh-ancestor
65335657|NCT02578472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65335658|NCT02578472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335659|NCT03840902|Paclitaxel|paclitaxel|mesh-list
65335660|NCT03840902|Etoposide|etoposide|mesh-list
65335661|NCT03840902|Carboplatin|carboplatin|mesh-list
65335662|NCT03840902|Pemetrexed|pemetrexed|mesh-list
65335663|NCT03840902|Durvalumab|durvalumab|mesh-list
65335664|NCT03840902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65335665|NCT03840902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335666|NCT03840902|Tubulin Modulators|tubulin modulators|mesh-ancestor
65335667|NCT03840902|Antimitotic Agents|antimitotic agents|mesh-ancestor
65335676|NCT03835975|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65335677|NCT03835975|Immunologic Factors|immunologic factors|mesh-ancestor
65335678|NCT03835975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335679|NCT04038086|Insulin|insulin|mesh-list
65335680|NCT04038086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65335681|NCT04038086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335682|NCT04072640|Voriconazole|voriconazole|mesh-list
65335683|NCT04072640|Amphotericin B|amphotericin b|mesh-list
65335684|NCT04072640|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65335685|NCT04072640|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
65335686|NCT04072640|Deoxycholic Acid|deoxycholic acid|mesh-list
65335687|NCT04072640|Antifungal Agents|antifungal agents|mesh-ancestor
65335688|NCT04072640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335689|NCT04072640|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65335690|NCT04072640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65335691|NCT04072640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335692|NCT04072640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335693|NCT04072640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65335694|NCT04072640|Hormone Antagonists|hormone antagonists|mesh-ancestor
65335695|NCT04072640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65335696|NCT04072640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335697|NCT04072640|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65335698|NCT04072640|Amebicides|amebicides|mesh-ancestor
65335699|NCT04072640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65335700|NCT04072640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65335701|NCT04072640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65335702|NCT04072640|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65335703|NCT04072640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65335704|NCT01566487|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65335705|NCT01566487|Antidepressive Agents|antidepressive agents|mesh-ancestor
65335706|NCT01566487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65335707|NCT01566487|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64720493|NCT00000512|Vitamin B Complex|vitamin b complex|mesh-ancestor
64720494|NCT00000512|Vitamins|vitamins|mesh-ancestor
64720495|NCT00000512|Micronutrients|micronutrients|mesh-ancestor
64720496|NCT00000512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720497|NCT00000512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64720498|NCT00000512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64720499|NCT00000512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720500|NCT00000512|Sequestering Agents|sequestering agents|mesh-ancestor
64720501|NCT00380822|Miglitol|miglitol|mesh-list
64720502|NCT00380822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720503|NCT00380822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328415|NCT02183051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64328416|NCT02183051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328417|NCT02183051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335716|NCT02576288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65335717|NCT02576288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65335718|NCT02576288|Protease Inhibitors|protease inhibitors|mesh-ancestor
65335719|NCT02576288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335720|NCT02576288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335721|NCT00427921|Adalimumab|adalimumab|mesh-list
65335722|NCT00427921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65335723|NCT00427921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65335724|NCT00432991|Ephedrine|ephedrine|mesh-list
65335725|NCT00432991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65335726|NCT00432991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335727|NCT00432991|Sympathomimetics|sympathomimetics|mesh-ancestor
65335728|NCT00432991|Autonomic Agents|autonomic agents|mesh-ancestor
65335734|NCT00580970|Lovastatin|lovastatin|mesh-list
65335747|NCT01030081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64720504|NCT00380822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65335748|NCT01030081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65335749|NCT01030081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335750|NCT01030081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65335751|NCT01030081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335752|NCT01030081|Vasodilator Agents|vasodilator agents|mesh-ancestor
65335753|NCT01030081|Tocolytic Agents|tocolytic agents|mesh-ancestor
65335754|NCT01030081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65335755|NCT00903110|Mecasermin|mecasermin|mesh-list
65335756|NCT00903110|Growth Substances|growth substances|mesh-ancestor
65335757|NCT00903110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335758|NCT00426751|Abciximab|abciximab|mesh-list
65335759|NCT00426751|Eptifibatide|eptifibatide|mesh-list
65335760|NCT00426751|Anticoagulants|anticoagulants|mesh-ancestor
65335761|NCT00426751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65335762|NCT02576366|Rifampin|rifampin|mesh-list
65335763|NCT02576366|Voriconazole|voriconazole|mesh-list
65335764|NCT02576366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65335765|NCT02576366|Antitubercular Agents|antitubercular agents|mesh-ancestor
65335766|NCT02576366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65335767|NCT02576366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335768|NCT02576366|Leprostatic Agents|leprostatic agents|mesh-ancestor
65335769|NCT02576366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65335770|NCT02576366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335771|NCT02576366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335772|NCT02576366|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65335773|NCT02576366|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65335774|NCT02576366|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65335775|NCT02576366|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64720519|NCT00000542|Vasodilator Agents|vasodilator agents|mesh-ancestor
64720520|NCT00000542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64720521|NCT00000542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64720522|NCT00000542|Antimetabolites|antimetabolites|mesh-ancestor
64720523|NCT00000542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64720524|NCT00000542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64720525|NCT00000542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720526|NCT00000542|Protease Inhibitors|protease inhibitors|mesh-ancestor
64328437|NCT02183129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64328438|NCT02183129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64328439|NCT02183129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328440|NCT02183129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328441|NCT02183129|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64328442|NCT02279953|Vortioxetine|vortioxetine|mesh-list
64328443|NCT02279953|Antidepressive Agents|antidepressive agents|mesh-ancestor
64328444|NCT02279953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64713629|NCT02101788|Doxorubicin|doxorubicin|mesh-list
65335789|NCT04046679|Bleomycin|bleomycin|mesh-list
65335823|NCT00791271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335824|NCT00791271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335825|NCT00791349|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65335826|NCT00791349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65335827|NCT00791349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65335828|NCT00791349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65335829|NCT00791349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335830|NCT00791349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64720527|NCT00000542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64720528|NCT00000542|Protective Agents|protective agents|mesh-ancestor
64720529|NCT00000542|Diuretics|diuretics|mesh-ancestor
65335831|NCT00791349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65335832|NCT00791349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65335834|NCT00791349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65335835|NCT00791349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335836|NCT00791349|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65335837|NCT00791349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65335838|NCT00791349|Dopamine Agents|dopamine agents|mesh-ancestor
65335839|NCT00440401|Thrombin|thrombin|mesh-list
65335840|NCT00440401|Hemostatics|hemostatics|mesh-list
65335841|NCT00440401|Coagulants|coagulants|mesh-ancestor
65335842|NCT00791427|Ranibizumab|ranibizumab|mesh-list
65335843|NCT00791427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65335844|NCT00791427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65335845|NCT00791427|Growth Substances|growth substances|mesh-ancestor
65335846|NCT00791427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335847|NCT00791427|Growth Inhibitors|growth inhibitors|mesh-ancestor
65335848|NCT00791427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335849|NCT00786513|Anti-Infective Agents|anti-infective agents|mesh-list
64720551|NCT00002120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64720552|NCT00002120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720553|NCT00002120|Renal Agents|renal agents|mesh-ancestor
64720554|NCT00002120|Antimalarials|antimalarials|mesh-ancestor
64720555|NCT00002120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64720556|NCT00002120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64720557|NCT00002120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64720558|NCT00002120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328451|NCT02279953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64328452|NCT02279953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328453|NCT02279953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64328455|NCT02279953|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64328456|NCT02279953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64328457|NCT02279953|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64328458|NCT02279953|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65335865|NCT00791505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65335866|NCT00791505|Renal Agents|renal agents|mesh-ancestor
65335867|NCT00791505|Antimalarials|antimalarials|mesh-ancestor
65335868|NCT00791505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65335869|NCT00791505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65335870|NCT00791505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64720559|NCT00002120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720560|NCT00002120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64720561|NCT00002120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64720562|NCT00002120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64720563|NCT00002120|Leprostatic Agents|leprostatic agents|mesh-ancestor
64720564|NCT00002120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64720565|NCT00002120|Antifungal Agents|antifungal agents|mesh-ancestor
64720567|NCT00002120|Antimetabolites|antimetabolites|mesh-ancestor
65335901|NCT00783081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335902|NCT00783081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65335903|NCT00783081|Vasodilator Agents|vasodilator agents|mesh-ancestor
65335904|NCT00783081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65335905|NCT00783081|Protective Agents|protective agents|mesh-ancestor
65335906|NCT00783081|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65335907|NCT00783081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65335908|NCT00783081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335910|NCT00426127|Doxorubicin|doxorubicin|mesh-list
65335911|NCT00426127|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65335912|NCT00426127|Enoxaparin|enoxaparin|mesh-list
65335913|NCT00426127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335914|NCT00426127|Tubulin Modulators|tubulin modulators|mesh-ancestor
65335915|NCT00426127|Antimitotic Agents|antimitotic agents|mesh-ancestor
65335916|NCT00426127|Mitosis Modulators|mitosis modulators|mesh-ancestor
65335917|NCT00426127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335918|NCT00426127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65335919|NCT00426127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65335920|NCT00426127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65335921|NCT00426127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335922|NCT00426127|Anticoagulants|anticoagulants|mesh-ancestor
65335923|NCT00426127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65335924|NCT00426127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65335925|NCT02554851|Mitogens|mitogens|mesh-list
65335926|NCT02554851|Mitosis Modulators|mitosis modulators|mesh-ancestor
65335927|NCT02554851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335933|NCT00425503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335934|NCT00786669|Cefixime|cefixime|mesh-list
65335935|NCT00786669|Cefpodoxime|cefpodoxime|mesh-list
65335936|NCT00786669|Bevacizumab|bevacizumab|mesh-list
65335937|NCT00786669|Irinotecan|irinotecan|mesh-list
65335938|NCT00786669|Vincristine|vincristine|mesh-list
65335939|NCT00786669|Temozolomide|temozolomide|mesh-list
65335940|NCT00786669|Camptothecin|camptothecin|mesh-list
65335941|NCT00786669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65335942|NCT00786669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65335943|NCT00786669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65335944|NCT00786669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65335945|NCT00786669|Growth Substances|growth substances|mesh-ancestor
65335946|NCT00786669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335947|NCT00786669|Growth Inhibitors|growth inhibitors|mesh-ancestor
65335948|NCT00786669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65335949|NCT00786669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65335950|NCT00786669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65335951|NCT00786669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65335952|NCT00786669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65335953|NCT00786669|Tubulin Modulators|tubulin modulators|mesh-ancestor
65335954|NCT00786669|Antimitotic Agents|antimitotic agents|mesh-ancestor
65335955|NCT00786669|Mitosis Modulators|mitosis modulators|mesh-ancestor
65335956|NCT00786669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65335957|NCT00786669|Alkylating Agents|alkylating agents|mesh-ancestor
65335958|NCT00786669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65335959|NCT00786669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65335960|NCT00791739|Pregabalin|pregabalin|mesh-list
65335961|NCT00791739|Trazodone|trazodone|mesh-list
65335962|NCT00791739|Analgesics|analgesics|mesh-ancestor
65335963|NCT00791739|Sensory System Agents|sensory system agents|mesh-ancestor
65335964|NCT00791739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65335965|NCT00791739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65335966|NCT00791739|Anticonvulsants|anticonvulsants|mesh-ancestor
65335967|NCT00791739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65335968|NCT00791739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65335971|NCT00791739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65335972|NCT00791739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65335973|NCT00791739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65335974|NCT00791739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65335975|NCT00791739|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65335976|NCT00791739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65335977|NCT00791739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65335978|NCT00791739|Serotonin Agents|serotonin agents|mesh-ancestor
65335980|NCT00791739|Antidepressive Agents|antidepressive agents|mesh-ancestor
64720652|NCT00000590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720653|NCT00000614|Warfarin|warfarin|mesh-list
64720654|NCT00000614|Anticoagulants|anticoagulants|mesh-ancestor
64720655|NCT02973464|Valganciclovir|valganciclovir|mesh-list
64720656|NCT02973464|Ganciclovir|ganciclovir|mesh-list
64720657|NCT02973464|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64720658|NCT02973464|Antiviral Agents|antiviral agents|mesh-ancestor
64720659|NCT02973464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720660|NCT02973464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720661|NCT02973464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720662|NCT02973464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336038|NCT00792363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65336039|NCT00792363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336040|NCT00792363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336041|NCT00792363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336042|NCT00792363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65336043|NCT00425113|Metronidazole|metronidazole|mesh-list
65336044|NCT00425113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65336045|NCT00425113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65336046|NCT00425113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65336047|NCT00425113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65336049|NCT04895280|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65336050|NCT04895280|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65336051|NCT04895280|Ketorolac|ketorolac|mesh-list
65336052|NCT04895280|Bupivacaine|bupivacaine|mesh-list
65336053|NCT04895280|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65336054|NCT04895280|Anesthetics, Local|anesthetics, local|mesh-ancestor
65336055|NCT04895280|Anesthetics|anesthetics|mesh-ancestor
65336075|NCT03994783|Immunoglobulins|immunoglobulins|mesh-list
65336076|NCT03994783|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65336077|NCT03994783|gamma-Globulins|gamma-globulins|mesh-list
65336078|NCT03994783|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65336079|NCT03994783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65336080|NCT03994783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336081|NCT03994783|Immunologic Factors|immunologic factors|mesh-ancestor
65336082|NCT03994783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336083|NCT03994783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65336084|NCT03994783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65336085|NCT03994783|Antiemetics|antiemetics|mesh-ancestor
65336086|NCT03994783|Autonomic Agents|autonomic agents|mesh-ancestor
65336087|NCT03994783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65336088|NCT03994783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65336089|NCT03994783|Glucocorticoids|glucocorticoids|mesh-ancestor
65336090|NCT03994783|Hormones|hormones|mesh-ancestor
65336091|NCT03994783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65336092|NCT03994783|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65336093|NCT03994783|Protective Agents|protective agents|mesh-ancestor
65336094|NCT00440011|Bimatoprost|bimatoprost|mesh-list
65336095|NCT00440011|Travoprost|travoprost|mesh-list
65336096|NCT00440011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65336097|NCT00440011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65336098|NCT00440011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65336099|NCT03105102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65336100|NCT03105102|Immunologic Factors|immunologic factors|mesh-ancestor
65336101|NCT03105102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336102|NCT01937468|Interleukin-2|interleukin-2|mesh-list
65336103|NCT01937468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336104|NCT01937468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65336105|NCT01937468|Analgesics|analgesics|mesh-ancestor
65336106|NCT01937468|Sensory System Agents|sensory system agents|mesh-ancestor
65336107|NCT01937468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64720685|NCT04713254|Bupropion|bupropion|mesh-list
64720686|NCT04713254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64720687|NCT04713254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64720688|NCT04713254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64720689|NCT04713254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720690|NCT04713254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64720691|NCT04713254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64720692|NCT04713254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64720693|NCT04713254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64720694|NCT04713254|Anesthetics, General|anesthetics, general|mesh-ancestor
64720695|NCT04713254|Anesthetics|anesthetics|mesh-ancestor
65336118|NCT04072328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65336119|NCT04072328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336120|NCT04072328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65336121|NCT04072328|Anesthetics, General|anesthetics, general|mesh-ancestor
65336122|NCT04072328|Anesthetics|anesthetics|mesh-ancestor
65336123|NCT04072328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65336124|NCT04072328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65336125|NCT04072328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65336126|NCT04072328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65336127|NCT04072328|GABA Modulators|gaba modulators|mesh-ancestor
65336128|NCT04072328|GABA Agents|gaba agents|mesh-ancestor
65336129|NCT04072328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65336130|NCT04072328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336131|NCT00495716|Acyclovir|acyclovir|mesh-list
65336132|NCT00495716|Antiviral Agents|antiviral agents|mesh-ancestor
65336133|NCT00495716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65336134|NCT00784017|Asparaginase|asparaginase|mesh-list
64720701|NCT04713254|Antidepressive Agents|antidepressive agents|mesh-ancestor
64720702|NCT04713254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64720703|NCT04713254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64720704|NCT04713254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64720705|NCT04713254|Dopamine Agents|dopamine agents|mesh-ancestor
64720706|NCT04713254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64720707|NCT04713254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64720708|NCT04713254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328590|NCT02177357|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64328591|NCT02177357|Dopamine Agonists|dopamine agonists|mesh-ancestor
64328592|NCT02177357|Dopamine Agents|dopamine agents|mesh-ancestor
64328593|NCT02177357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64328594|NCT02386449|Mannitol|mannitol|mesh-list
64328595|NCT02386449|Bisacodyl|bisacodyl|mesh-list
64328596|NCT02386449|Picosulfate sodium|picosulfate sodium|mesh-list
64328597|NCT02386449|Magnesium Oxide|magnesium oxide|mesh-list
64328598|NCT02386449|Citric Acid|citric acid|mesh-list
64713667|NCT02016924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336154|NCT04074122|Analgesics|analgesics|mesh-ancestor
65336163|NCT02578550|Tenofovir|tenofovir|mesh-list
64720709|NCT04713254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64720710|NCT04713254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64720711|NCT04713254|Sympatholytics|sympatholytics|mesh-ancestor
65336190|NCT00788463|Respiratory System Agents|respiratory system agents|mesh-ancestor
65336191|NCT00579254|Amlodipine|amlodipine|mesh-list
65336192|NCT00579254|Atorvastatin|atorvastatin|mesh-list
65336193|NCT00579254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65336194|NCT00579254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65336195|NCT00579254|Antimetabolites|antimetabolites|mesh-ancestor
65336196|NCT00579254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336197|NCT00579254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65336198|NCT00579254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65336199|NCT00579254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336200|NCT00579254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65336201|NCT00579254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65336202|NCT00579254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65336203|NCT00579254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65336204|NCT00579254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336205|NCT00579254|Vasodilator Agents|vasodilator agents|mesh-ancestor
65336206|NCT00793221|Sirolimus|sirolimus|mesh-list
65336207|NCT00793221|Everolimus|everolimus|mesh-list
65336208|NCT00793221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336209|NCT00793221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65336210|NCT00793221|Immunologic Factors|immunologic factors|mesh-ancestor
65336211|NCT00793221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336212|NCT00793221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65336213|NCT00793221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65336214|NCT00793221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65336215|NCT00793221|Antifungal Agents|antifungal agents|mesh-ancestor
65336216|NCT04941144|Vaccines|vaccines|mesh-list
65336217|NCT04941144|Immunologic Factors|immunologic factors|mesh-ancestor
65336228|NCT00661089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65336229|NCT00661089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65336230|NCT01773278|Antioxidants|antioxidants|mesh-list
65336231|NCT01773278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336232|NCT01773278|Protective Agents|protective agents|mesh-ancestor
65336233|NCT01773278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336234|NCT00788931|Paclitaxel|paclitaxel|mesh-list
65336235|NCT00788931|Trastuzumab|trastuzumab|mesh-list
65336236|NCT00788931|Panobinostat|panobinostat|mesh-list
65336237|NCT00788931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65336238|NCT00788931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336239|NCT00788931|Tubulin Modulators|tubulin modulators|mesh-ancestor
65336240|NCT00788931|Antimitotic Agents|antimitotic agents|mesh-ancestor
65336241|NCT00788931|Mitosis Modulators|mitosis modulators|mesh-ancestor
65336242|NCT00788931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336243|NCT00788931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65336244|NCT00788931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65336245|NCT00788931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336246|NCT02577848|Liraglutide|liraglutide|mesh-list
65336247|NCT02577848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65336248|NCT02577848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336249|NCT02577848|Incretins|incretins|mesh-ancestor
65336250|NCT02577848|Hormones|hormones|mesh-ancestor
65336251|NCT02577848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65336252|NCT00582426|Octreotide|octreotide|mesh-list
65336253|NCT00582426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65336254|NCT00582426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65336276|NCT04070690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65336277|NCT00710138|Vitamins|vitamins|mesh-list
65336278|NCT00710138|Vitamin B 12|vitamin b 12|mesh-list
65336279|NCT00710138|Hydroxocobalamin|hydroxocobalamin|mesh-list
65336280|NCT00710138|Vitamin B Complex|vitamin b complex|mesh-list
65336281|NCT00710138|Micronutrients|micronutrients|mesh-ancestor
65336282|NCT00710138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336283|NCT00710138|Hematinics|hematinics|mesh-ancestor
65336284|NCT00580034|Alemtuzumab|alemtuzumab|mesh-list
65336285|NCT00580034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65336286|NCT00580034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336287|NCT00710216|Lamivudine|lamivudine|mesh-list
65336288|NCT00710216|Telbivudine|telbivudine|mesh-list
65336289|NCT00710216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65336290|NCT00710216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65336291|NCT00710216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336292|NCT00710216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336293|NCT00710216|Antiviral Agents|antiviral agents|mesh-ancestor
65336294|NCT00710216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65336295|NCT00710216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65336296|NCT00710216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65336297|NCT00773513|Epoetin Alfa|epoetin alfa|mesh-list
65336298|NCT00773513|Darbepoetin alfa|darbepoetin alfa|mesh-list
65336299|NCT00773513|Hematinics|hematinics|mesh-ancestor
65336300|NCT00710528|Idelalisib|idelalisib|mesh-list
65336301|NCT00710528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336302|NCT00710528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336303|NCT00710528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336325|NCT00711308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65336326|NCT02601911|Acetaminophen|acetaminophen|mesh-list
65336327|NCT02601911|Ketorolac|ketorolac|mesh-list
65336328|NCT02601911|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65336329|NCT02601911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65336396|NCT00129896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336397|NCT00129896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65336398|NCT02574338|Alprostadil|alprostadil|mesh-list
65336399|NCT02574338|Misoprostol|misoprostol|mesh-list
65336400|NCT02574338|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65336401|NCT02574338|Abortifacient Agents|abortifacient agents|mesh-ancestor
65336402|NCT02574338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65336403|NCT02574338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336404|NCT02574338|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65336405|NCT02574338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65336406|NCT02574338|Oxytocics|oxytocics|mesh-ancestor
65336407|NCT02574338|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65336408|NCT02574338|Vasodilator Agents|vasodilator agents|mesh-ancestor
65336409|NCT02574338|Urological Agents|urological agents|mesh-ancestor
65336410|NCT03070392|Pembrolizumab|pembrolizumab|mesh-list
65336411|NCT03070392|Ipilimumab|ipilimumab|mesh-list
65336412|NCT03070392|Dacarbazine|dacarbazine|mesh-list
65336413|NCT03070392|Imidazole|imidazole|mesh-list
65336414|NCT03070392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65336415|NCT03070392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336416|NCT03070392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65336417|NCT03070392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336418|NCT03070392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65336419|NCT03070392|Alkylating Agents|alkylating agents|mesh-ancestor
65336420|NCT03070392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336421|NCT00711698|Analgesics, Opioid|analgesics, opioid|mesh-list
65336422|NCT00711698|Narcotics|narcotics|mesh-ancestor
65336423|NCT00711698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65336424|NCT00711698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336425|NCT00711698|Analgesics|analgesics|mesh-ancestor
65336426|NCT00711698|Sensory System Agents|sensory system agents|mesh-ancestor
65336440|NCT00795171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65336441|NCT00795171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336442|NCT00711854|Rifampin|rifampin|mesh-list
65336443|NCT00711854|Linezolid|linezolid|mesh-list
65336444|NCT00711854|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65336445|NCT00711854|Trimethoprim|trimethoprim|mesh-list
65336446|NCT00711854|Sulfamethoxazole|sulfamethoxazole|mesh-list
65336447|NCT00711854|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65336448|NCT00711854|Antitubercular Agents|antitubercular agents|mesh-ancestor
65336449|NCT00711854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65336450|NCT00711854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65336451|NCT00711854|Leprostatic Agents|leprostatic agents|mesh-ancestor
65336452|NCT00711854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65336453|NCT00711854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336454|NCT00711854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336455|NCT00711854|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65336456|NCT00711854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65336457|NCT00711854|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65336458|NCT00711854|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65336459|NCT00711854|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65336460|NCT00711854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65336461|NCT00711854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65336462|NCT00711854|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65336463|NCT00711854|Renal Agents|renal agents|mesh-ancestor
65336464|NCT00711854|Antimalarials|antimalarials|mesh-ancestor
65336465|NCT00711854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65336466|NCT00711854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65336467|NCT00711854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65336468|NCT00711854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65336469|NCT00711854|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65336470|NCT00711854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65336471|NCT04072068|Edoxaban|edoxaban|mesh-list
65336472|NCT04072068|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65336473|NCT04072068|Antithrombins|antithrombins|mesh-ancestor
64720893|NCT00002192|Ethambutol|ethambutol|mesh-list
65248704|NCT00817076|Cholinergic Agents|cholinergic agents|mesh-ancestor
65248705|NCT00817076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64924028|NCT00027703|Antibodies|antibodies|mesh-list
64720927|NCT00000728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720928|NCT00000728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64720929|NCT00000728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720930|NCT00000728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720931|NCT00000728|Antiviral Agents|antiviral agents|mesh-ancestor
64720932|NCT00000728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720933|NCT00000728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64720934|NCT00000728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64720935|NCT00000728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64720936|NCT00001520|Neostigmine|neostigmine|mesh-list
64328803|NCT00547651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65336474|NCT04072068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65336475|NCT04072068|Protease Inhibitors|protease inhibitors|mesh-ancestor
65336476|NCT04072068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336477|NCT04072068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336478|NCT04072068|Anticoagulants|anticoagulants|mesh-ancestor
65336479|NCT00795483|Zoledronic Acid|zoledronic acid|mesh-list
65336480|NCT00795483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65336481|NCT00795483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336482|NCT00712400|Latanoprost|latanoprost|mesh-list
65336483|NCT00712400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65336484|NCT00712400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65336485|NCT00712478|Insulin|insulin|mesh-list
65336486|NCT00712478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65336487|NCT00712478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336488|NCT03015792|Dexamethasone|dexamethasone|mesh-list
65336489|NCT03015792|Dexamethasone acetate|dexamethasone acetate|mesh-list
65336490|NCT03015792|Lenalidomide|lenalidomide|mesh-list
65336491|NCT03015792|Ichthammol|ichthammol|mesh-list
65336492|NCT03015792|BB 1101|bb 1101|mesh-list
65336493|NCT03015792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65336494|NCT03015792|Antiemetics|antiemetics|mesh-ancestor
65336495|NCT03015792|Autonomic Agents|autonomic agents|mesh-ancestor
65336499|NCT03015792|Glucocorticoids|glucocorticoids|mesh-ancestor
64720937|NCT00001520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65336506|NCT03015792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336507|NCT03015792|Immunologic Factors|immunologic factors|mesh-ancestor
65336508|NCT03015792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65336509|NCT03015792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65336510|NCT03015792|Growth Substances|growth substances|mesh-ancestor
65336511|NCT03015792|Growth Inhibitors|growth inhibitors|mesh-ancestor
65336512|NCT03015792|Dermatologic Agents|dermatologic agents|mesh-ancestor
65336513|NCT00789165|Quinidine|quinidine|mesh-list
65336514|NCT00789165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65336515|NCT00789165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65336516|NCT00789165|Adrenergic Agents|adrenergic agents|mesh-ancestor
65336517|NCT00789165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65336518|NCT00789165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336519|NCT00789165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336520|NCT00789165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65336521|NCT00789165|Antimalarials|antimalarials|mesh-ancestor
65336522|NCT00789165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65336523|NCT00789165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65336524|NCT00789165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65336525|NCT00789165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336526|NCT00789165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65336527|NCT00789165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65336528|NCT00789165|Cholinergic Agents|cholinergic agents|mesh-ancestor
65336529|NCT00789165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65336530|NCT00789165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65336531|NCT00789165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65336532|NCT00789165|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65336533|NCT00789165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65336534|NCT00712556|Fluorides|fluorides|mesh-list
65248736|NCT02840240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65248737|NCT02840240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65248738|NCT02840240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65248739|NCT02840240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65248740|NCT02840240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248741|NCT02840240|Antimanic Agents|antimanic agents|mesh-ancestor
65248742|NCT00888654|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
65248743|NCT00888654|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65248744|NCT00888654|Protective Agents|protective agents|mesh-ancestor
65248745|NCT00888654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248746|NCT00888654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65248747|NCT03238430|Morphine|morphine|mesh-list
64720960|NCT00002294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720961|NCT00002294|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64720962|NCT00002294|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64720963|NCT03758365|Triamcinolone|triamcinolone|mesh-list
64720964|NCT03758365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65336535|NCT00712556|Cariostatic Agents|cariostatic agents|mesh-ancestor
65336536|NCT00712556|Protective Agents|protective agents|mesh-ancestor
65336537|NCT00712556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336538|NCT00772967|Naproxen|naproxen|mesh-list
65336539|NCT00772967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65336540|NCT00772967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65336541|NCT00772967|Analgesics|analgesics|mesh-ancestor
65336542|NCT00772967|Sensory System Agents|sensory system agents|mesh-ancestor
65336543|NCT00772967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65336544|NCT00772967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336545|NCT00772967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65336546|NCT00772967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65336547|NCT00772967|Gout Suppressants|gout suppressants|mesh-ancestor
65336548|NCT00772967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65336549|NCT00772967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336550|NCT00772967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336551|NCT00793377|Tamoxifen|tamoxifen|mesh-list
65336552|NCT00793377|Cyclophosphamide|cyclophosphamide|mesh-list
65336553|NCT00793377|Docetaxel|docetaxel|mesh-list
65336554|NCT00793377|Doxorubicin|doxorubicin|mesh-list
65336555|NCT00793377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65336556|NCT00793377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65248748|NCT03238430|Ropivacaine|ropivacaine|mesh-list
65248749|NCT03238430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65248777|NCT03223220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64999048|NCT04702048|Aflibercept|aflibercept|mesh-list
65248779|NCT03223220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65248780|NCT03223220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248781|NCT03223220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65248782|NCT03223220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65248783|NCT03223220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65248784|NCT03223220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65248785|NCT03223220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65248786|NCT03223220|GABA Modulators|gaba modulators|mesh-ancestor
65248787|NCT03223220|GABA Agents|gaba agents|mesh-ancestor
65248788|NCT02827890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65248789|NCT02827890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65248790|NCT02827890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248791|NCT02827890|Incretins|incretins|mesh-ancestor
65248792|NCT02827890|Hormones|hormones|mesh-ancestor
65248793|NCT02827890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65248794|NCT02827890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65248795|NCT02827890|Protease Inhibitors|protease inhibitors|mesh-ancestor
64720968|NCT03758365|Betamethasone Valerate|betamethasone valerate|mesh-list
64720969|NCT03758365|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65336557|NCT00793377|Immunologic Factors|immunologic factors|mesh-ancestor
65336558|NCT00793377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336559|NCT00793377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65336560|NCT00793377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65336561|NCT00793377|Alkylating Agents|alkylating agents|mesh-ancestor
65336562|NCT00793377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336563|NCT00793377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336564|NCT00793377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65336565|NCT00793377|Tubulin Modulators|tubulin modulators|mesh-ancestor
65336566|NCT00793377|Antimitotic Agents|antimitotic agents|mesh-ancestor
65336567|NCT00793377|Mitosis Modulators|mitosis modulators|mesh-ancestor
65336568|NCT00793377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65336569|NCT00793377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65336570|NCT00793377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65336571|NCT00793377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336572|NCT00793377|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65336573|NCT00793377|Hormone Antagonists|hormone antagonists|mesh-ancestor
65336574|NCT00793377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65336575|NCT00793377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65336576|NCT00793377|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65336577|NCT00793377|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65336578|NCT00793377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65336579|NCT00662259|Alprazolam|alprazolam|mesh-list
65336580|NCT00662259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65336581|NCT00662259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65336582|NCT00662259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336583|NCT00662259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65336584|NCT00662259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65336585|NCT00662259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65336586|NCT00662259|GABA Modulators|gaba modulators|mesh-ancestor
65336587|NCT00662259|GABA Agents|gaba agents|mesh-ancestor
65336588|NCT00662259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64720970|NCT03758365|Betamethasone benzoate|betamethasone benzoate|mesh-list
65248796|NCT02827890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248829|NCT02827578|Solifenacin Succinate|solifenacin succinate|mesh-list
64720984|NCT03758365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720985|NCT03758365|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64720986|NCT03758365|Respiratory System Agents|respiratory system agents|mesh-ancestor
64720987|NCT03758365|Dermatologic Agents|dermatologic agents|mesh-ancestor
64720988|NCT00002300|Megestrol|megestrol|mesh-list
64720989|NCT00002300|Megestrol Acetate|megestrol acetate|mesh-list
64720990|NCT00002300|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64720991|NCT00002300|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65336589|NCT00662259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336590|NCT00712790|Sorafenib|sorafenib|mesh-list
65336591|NCT00712790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336592|NCT00712790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65336593|NCT00712790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336594|NCT00712790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336595|NCT00660699|Gemcitabine|gemcitabine|mesh-list
65336596|NCT00660699|Docetaxel|docetaxel|mesh-list
65336597|NCT00660699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65336598|NCT00660699|Antimetabolites|antimetabolites|mesh-ancestor
65336599|NCT00660699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336600|NCT00660699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336601|NCT00660699|Antiviral Agents|antiviral agents|mesh-ancestor
65336602|NCT00660699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65336603|NCT00660699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336604|NCT00660699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65336605|NCT00660699|Immunologic Factors|immunologic factors|mesh-ancestor
65336606|NCT00660699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336607|NCT00660699|Tubulin Modulators|tubulin modulators|mesh-ancestor
65336608|NCT00660699|Antimitotic Agents|antimitotic agents|mesh-ancestor
65336609|NCT00660699|Mitosis Modulators|mitosis modulators|mesh-ancestor
65336610|NCT02577068|Propacetamol|propacetamol|mesh-list
65336611|NCT02577068|Nefopam|nefopam|mesh-list
65336612|NCT02577068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64720997|NCT00002300|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64720998|NCT00002300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64720999|NCT00002300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721000|NCT00002300|Appetite Stimulants|appetite stimulants|mesh-ancestor
65336624|NCT00582114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336625|NCT00582114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336626|NCT00582114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65336627|NCT00582114|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65336628|NCT00582114|Protective Agents|protective agents|mesh-ancestor
65336629|NCT00582114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336630|NCT00582114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65336631|NCT00582114|Sympatholytics|sympatholytics|mesh-ancestor
65336632|NCT00582114|Autonomic Agents|autonomic agents|mesh-ancestor
65336633|NCT00582114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65336634|NCT00582114|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65336635|NCT00582114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65336636|NCT00582114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65336637|NCT00582114|Adrenergic Agents|adrenergic agents|mesh-ancestor
65336638|NCT00582114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65336639|NCT00582036|Insulin|insulin|mesh-list
65336640|NCT00582036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65336641|NCT00582036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65336642|NCT00582036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336643|NCT00581360|Doxorubicin|doxorubicin|mesh-list
65248830|NCT02827578|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65248831|NCT02827578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65248832|NCT02827578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65248833|NCT02827578|Adrenergic Agents|adrenergic agents|mesh-ancestor
65248834|NCT02827578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65248835|NCT02827578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924161|NCT00012051|Immunologic Factors|immunologic factors|mesh-ancestor
65248863|NCT00887484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65248864|NCT00887484|Analgesics|analgesics|mesh-ancestor
65248865|NCT00887484|Sensory System Agents|sensory system agents|mesh-ancestor
65248866|NCT00887484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65248867|NCT00887484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248868|NCT00887484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65248869|NCT00887484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65248870|NCT00794378|Cetirizine|cetirizine|mesh-list
65248871|NCT00794378|Desloratadine|desloratadine|mesh-list
65248872|NCT00794378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65248873|NCT00794378|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65248874|NCT00794378|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65248875|NCT00794378|Histamine Antagonists|histamine antagonists|mesh-ancestor
65248876|NCT00794378|Histamine Agents|histamine agents|mesh-ancestor
65248877|NCT00794378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65248878|NCT00794378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248879|NCT00794378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248880|NCT00794378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65336644|NCT00581360|Bortezomib|bortezomib|mesh-list
65336645|NCT00581360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65336646|NCT00581360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336647|NCT00581360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65336648|NCT00581360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65086510|NCT00455585|Stavudine|stavudine|mesh-list
65336649|NCT00581360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336651|NCT01650792|Aspirin|aspirin|mesh-list
64721072|NCT00002318|Mitosis Modulators|mitosis modulators|mesh-ancestor
64721073|NCT00002228|Enfuvirtide|enfuvirtide|mesh-list
64721074|NCT00002228|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64721075|NCT00002228|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64721076|NCT00002228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721077|NCT00002228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64721078|NCT00002228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64721079|NCT00002228|Antiviral Agents|antiviral agents|mesh-ancestor
64721080|NCT00002228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721081|NCT04714177|Edaravone|edaravone|mesh-list
64328950|NCT02282683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64328951|NCT00375193|Amrubicin|amrubicin|mesh-list
64328952|NCT00375193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64328953|NCT00151411|Metformin|metformin|mesh-list
64328954|NCT00151411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65336710|NCT00713726|Fentanyl|fentanyl|mesh-list
65336711|NCT00713726|Tramadol|tramadol|mesh-list
65336712|NCT00713726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65336713|NCT00713726|Narcotics|narcotics|mesh-ancestor
65336714|NCT00713726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65336715|NCT00713726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336716|NCT00713726|Analgesics|analgesics|mesh-ancestor
65336717|NCT00713726|Sensory System Agents|sensory system agents|mesh-ancestor
65336718|NCT00713726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65336719|NCT00713726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65336720|NCT00713726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65336721|NCT00713726|Anesthetics, General|anesthetics, general|mesh-ancestor
65336722|NCT00713726|Anesthetics|anesthetics|mesh-ancestor
65336723|NCT00800553|Donepezil|donepezil|mesh-list
65336724|NCT00800553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65336725|NCT00800553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336726|NCT00800553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336727|NCT00800553|Cholinergic Agents|cholinergic agents|mesh-ancestor
64721082|NCT04714177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64721083|NCT04714177|Antioxidants|antioxidants|mesh-ancestor
64721084|NCT04714177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721085|NCT04714177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64721086|NCT04714177|Protective Agents|protective agents|mesh-ancestor
64721087|NCT04714177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721088|NCT00001628|Angiotensin II|angiotensin ii|mesh-list
64721089|NCT00001628|Giapreza|giapreza|mesh-list
64721090|NCT00001628|Angiotensinogen|angiotensinogen|mesh-list
65336740|NCT00796029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65336741|NCT00796029|Serotonin Agents|serotonin agents|mesh-ancestor
65336742|NCT00796029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65336743|NCT00796029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336744|NCT00796029|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65336745|NCT00796029|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65336746|NCT00796029|Dopamine Agents|dopamine agents|mesh-ancestor
65336747|NCT00793845|Cyclophosphamide|cyclophosphamide|mesh-list
65336748|NCT00793845|Melphalan|melphalan|mesh-list
65336749|NCT00793845|Thiotepa|thiotepa|mesh-list
65336750|NCT00793845|Carboplatin|carboplatin|mesh-list
65336751|NCT00793845|Etoposide|etoposide|mesh-list
65336752|NCT00793845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65336753|NCT00793845|Immunologic Factors|immunologic factors|mesh-ancestor
65336754|NCT00793845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336755|NCT00793845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65336756|NCT00793845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64721096|NCT00001628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721097|NCT00001628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64721098|NCT00002234|Lamivudine|lamivudine|mesh-list
64721099|NCT00002234|Efavirenz|efavirenz|mesh-list
64721100|NCT00002234|Didanosine|didanosine|mesh-list
64721101|NCT00002234|Adefovir|adefovir|mesh-list
65336781|NCT00793923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65336782|NCT00793923|Glucocorticoids|glucocorticoids|mesh-ancestor
65336783|NCT00793923|Hormones|hormones|mesh-ancestor
65336784|NCT00793923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65336785|NCT00793923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65336786|NCT00793923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336787|NCT00793923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65336788|NCT00793923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65336789|NCT00793923|Growth Substances|growth substances|mesh-ancestor
65336790|NCT00793923|Growth Inhibitors|growth inhibitors|mesh-ancestor
65336791|NCT01247324|Interferons|interferons|mesh-list
65336792|NCT01247324|Interferon-beta|interferon-beta|mesh-list
65336793|NCT01247324|Interferon beta-1a|interferon beta-1a|mesh-list
65336794|NCT01247324|Ocrelizumab|ocrelizumab|mesh-list
65336795|NCT01247324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336796|NCT01247324|Antiviral Agents|antiviral agents|mesh-ancestor
65336797|NCT01247324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65336798|NCT01247324|Immunologic Factors|immunologic factors|mesh-ancestor
65336799|NCT01247324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336800|NCT01247324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65336801|NCT00772577|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65336802|NCT00772577|Ramipril|ramipril|mesh-list
65336803|NCT00772577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65336804|NCT00772577|Diuretics|diuretics|mesh-ancestor
65336805|NCT00772577|Natriuretic Agents|natriuretic agents|mesh-ancestor
65336806|NCT00772577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336807|NCT00772577|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65336808|NCT00772577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64721102|NCT00002234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64721103|NCT00002234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65248881|NCT00794378|Cholinergic Agents|cholinergic agents|mesh-ancestor
65248882|NCT00789152|Levocetirizine|levocetirizine|mesh-list
65248883|NCT00789152|Desloratadine|desloratadine|mesh-list
65248884|NCT00789152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65336809|NCT00772577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336810|NCT00772577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65336811|NCT00772577|Protease Inhibitors|protease inhibitors|mesh-ancestor
65336812|NCT00772577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336813|NCT02345850|Cyclophosphamide|cyclophosphamide|mesh-list
65336814|NCT02345850|Methotrexate|methotrexate|mesh-list
65336815|NCT02345850|Tacrolimus|tacrolimus|mesh-list
65336816|NCT02345850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65336817|NCT02345850|Immunologic Factors|immunologic factors|mesh-ancestor
65336818|NCT02345850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336819|NCT02345850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65336820|NCT02345850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65336821|NCT02345850|Alkylating Agents|alkylating agents|mesh-ancestor
65336822|NCT02345850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336823|NCT02345850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336824|NCT02345850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65336825|NCT02345850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65336826|NCT02345850|Abortifacient Agents|abortifacient agents|mesh-ancestor
65336827|NCT02345850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65336828|NCT02345850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65336829|NCT02345850|Antimetabolites|antimetabolites|mesh-ancestor
65336830|NCT02345850|Dermatologic Agents|dermatologic agents|mesh-ancestor
65336831|NCT02345850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336832|NCT02345850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65336833|NCT02345850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65336834|NCT02345850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65336835|NCT00800787|Immunoglobulins|immunoglobulins|mesh-list
65336855|NCT02576600|Sensory System Agents|sensory system agents|mesh-ancestor
65336856|NCT02576600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65336857|NCT02863770|Pancrelipase|pancrelipase|mesh-list
65336858|NCT02863770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65336859|NCT00796185|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65336860|NCT00796185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65336861|NCT00796185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65336862|NCT00796185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65336863|NCT00796185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336864|NCT00796185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65336865|NCT00796185|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65336866|NCT00796185|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65336867|NCT00796185|Serotonin Agents|serotonin agents|mesh-ancestor
65336868|NCT00796185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448423|NCT02229383|Exenatide|exenatide|mesh-list
65248918|NCT02829060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248919|NCT02829060|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65248920|NCT02829060|Renal Agents|renal agents|mesh-ancestor
65248921|NCT00838669|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65248922|NCT00838669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65248923|NCT00838669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65248924|NCT00838669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65248958|NCT02826252|Vasodilator Agents|vasodilator agents|mesh-ancestor
65248959|NCT02839928|Ketamine|ketamine|mesh-list
65248960|NCT02839928|Analgesics|analgesics|mesh-list
65248961|NCT02839928|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65248962|NCT02839928|Sensory System Agents|sensory system agents|mesh-ancestor
65248963|NCT02839928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64924290|NCT00000482|Niacin|niacin|mesh-list
65248996|NCT05018520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65248997|NCT05018520|Tubulin Modulators|tubulin modulators|mesh-ancestor
65248998|NCT05018520|Antimitotic Agents|antimitotic agents|mesh-ancestor
65248999|NCT05018520|Mitosis Modulators|mitosis modulators|mesh-ancestor
65249000|NCT05018520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64999275|NCT03275857|Cisplatin|cisplatin|mesh-list
65249001|NCT05018520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65249002|NCT05018520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65249004|NCT04321746|Ketamine|ketamine|mesh-list
65249037|NCT04243434|Cyclophosphamide|cyclophosphamide|mesh-list
65249038|NCT04243434|Doxorubicin|doxorubicin|mesh-list
65249039|NCT04243434|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65249040|NCT04243434|Vincristine|vincristine|mesh-list
65249041|NCT04243434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65249042|NCT04243434|Immunologic Factors|immunologic factors|mesh-ancestor
65249043|NCT04243434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249044|NCT04243434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65249045|NCT04243434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65249072|NCT02837978|Tacrolimus|tacrolimus|mesh-list
65249073|NCT02837978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64999346|NCT00138099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65249074|NCT02837978|Abortifacient Agents|abortifacient agents|mesh-ancestor
65249075|NCT02837978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65249076|NCT02837978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249077|NCT02837978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65249078|NCT02837978|Antimetabolites|antimetabolites|mesh-ancestor
65249079|NCT02837978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249080|NCT02837978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249081|NCT02837978|Dermatologic Agents|dermatologic agents|mesh-ancestor
65249082|NCT02837978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249083|NCT02837978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65249084|NCT02837978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65336869|NCT00796185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336870|NCT00796185|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65336871|NCT00796185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65336872|NCT00796185|Dopamine Agents|dopamine agents|mesh-ancestor
65336873|NCT00660309|Irbesartan|irbesartan|mesh-list
65336874|NCT00660309|Captopril|captopril|mesh-list
65336875|NCT00660309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65336876|NCT00660309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65336877|NCT00660309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65336878|NCT00660309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336879|NCT00660309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65336880|NCT00660309|Protease Inhibitors|protease inhibitors|mesh-ancestor
65336881|NCT00660309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336882|NCT04046133|Pembrolizumab|pembrolizumab|mesh-list
65336883|NCT04046133|Capecitabine|capecitabine|mesh-list
65336884|NCT04046133|Mitomycins|mitomycins|mesh-list
65336885|NCT04046133|Mitomycin|mitomycin|mesh-list
65249085|NCT02837978|Immunologic Factors|immunologic factors|mesh-ancestor
65249086|NCT02837978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65249087|NCT02837978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65249088|NCT02837978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65249089|NCT00839059|Lenalidomide|lenalidomide|mesh-list
65249090|NCT00839059|Immunologic Factors|immunologic factors|mesh-ancestor
65249091|NCT00839059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249092|NCT00839059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65249121|NCT00845221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249122|NCT00845221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65249123|NCT00845221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249124|NCT00845221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249125|NCT02546401|Insulin Aspart|insulin aspart|mesh-list
65249126|NCT02546401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65249127|NCT02546401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249128|NCT02826876|Ropivacaine|ropivacaine|mesh-list
65249129|NCT02826876|Anesthetics, Local|anesthetics, local|mesh-ancestor
65249130|NCT02826876|Anesthetics|anesthetics|mesh-ancestor
65249131|NCT02826876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65249132|NCT02826876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249133|NCT02826876|Sensory System Agents|sensory system agents|mesh-ancestor
65249134|NCT02826876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65249135|NCT04244448|Emtricitabine|emtricitabine|mesh-list
65249136|NCT04244448|Antiviral Agents|antiviral agents|mesh-ancestor
64924466|NCT00028717|Hormones|hormones|mesh-ancestor
65249163|NCT02547025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65249164|NCT02547025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65249165|NCT02547025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249166|NCT02547025|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65249167|NCT02547025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65249168|NCT02547025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65249169|NCT02547025|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65249171|NCT00839293|Fenofibric acid|fenofibric acid|mesh-list
65249172|NCT00839293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65249173|NCT00839293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65249174|NCT00839293|Antimetabolites|antimetabolites|mesh-ancestor
65249175|NCT00839293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249176|NCT00839293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65249177|NCT05660382|Miconazole|miconazole|mesh-list
65249178|NCT05660382|Clotrimazole|clotrimazole|mesh-list
65249179|NCT05660382|Mineral Oil|mineral oil|mesh-list
65249180|NCT05660382|Antifungal Agents|antifungal agents|mesh-ancestor
64721150|NCT03740659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64721151|NCT03740659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721152|NCT03740659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64721153|NCT03740659|Glucocorticoids|glucocorticoids|mesh-ancestor
64721154|NCT03740659|Hormones|hormones|mesh-ancestor
64721155|NCT03740659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64721156|NCT03740659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64721157|NCT03740659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721158|NCT03740659|Protease Inhibitors|protease inhibitors|mesh-ancestor
64721159|NCT03740659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329023|NCT02256683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64329024|NCT02256683|Protease Inhibitors|protease inhibitors|mesh-ancestor
64329025|NCT02256683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336886|NCT04046133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65336887|NCT04046133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336888|NCT04046133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65336889|NCT04046133|Antimetabolites|antimetabolites|mesh-ancestor
65336890|NCT04046133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336891|NCT04046133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65336892|NCT04046133|Alkylating Agents|alkylating agents|mesh-ancestor
65336893|NCT04046133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65336894|NCT04046133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336895|NCT02573714|Ketamine|ketamine|mesh-list
65336896|NCT02573714|Analgesics|analgesics|mesh-ancestor
65336897|NCT02573714|Sensory System Agents|sensory system agents|mesh-ancestor
64721160|NCT03740659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721161|NCT03740659|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64721162|NCT03740659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721163|NCT03740659|Renal Agents|renal agents|mesh-ancestor
64721164|NCT03740659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64721165|NCT03740659|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64721166|NCT03740659|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64721167|NCT03740659|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65336919|NCT00800943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336920|NCT02575664|Buprenorphine|buprenorphine|mesh-list
65336921|NCT02575664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65336922|NCT02575664|Narcotics|narcotics|mesh-ancestor
65336923|NCT02575664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65336924|NCT02575664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336925|NCT02575664|Analgesics|analgesics|mesh-ancestor
65336926|NCT02575664|Sensory System Agents|sensory system agents|mesh-ancestor
65336927|NCT02575664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65336928|NCT02575664|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65336929|NCT00796497|Ondansetron|ondansetron|mesh-list
65336930|NCT00796497|Antiemetics|antiemetics|mesh-ancestor
65336931|NCT00796497|Autonomic Agents|autonomic agents|mesh-ancestor
65336932|NCT00796497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65336933|NCT00796497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336934|NCT00796497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65336935|NCT00796497|Antipruritics|antipruritics|mesh-ancestor
65336936|NCT00796497|Dermatologic Agents|dermatologic agents|mesh-ancestor
65336937|NCT00796497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65336938|NCT00796497|Serotonin Agents|serotonin agents|mesh-ancestor
65336939|NCT00796497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65336940|NCT00796497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336941|NCT00796497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65336942|NCT00796497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65249181|NCT05660382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65249182|NCT05660382|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65249183|NCT05660382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65249184|NCT05660382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924509|NCT00012324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249209|NCT00839371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65249210|NCT00839371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249212|NCT02826408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65249213|NCT02826408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65249214|NCT02826408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64721170|NCT00002336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64721171|NCT00002336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721172|NCT00002336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64721173|NCT00002336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721174|NCT00002336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721175|NCT00002336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64721176|NCT00002336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64329038|NCT00411385|Immunologic Factors|immunologic factors|mesh-ancestor
64329039|NCT00411385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329040|NCT02385513|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64329042|NCT02385513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329043|NCT02185547|Sertraline|sertraline|mesh-list
65336943|NCT00796497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65336944|NCT00796497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65336945|NCT00796497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65336946|NCT04330820|Venetoclax|venetoclax|mesh-list
65336947|NCT04330820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336948|NCT00801177|Necitumumab|necitumumab|mesh-list
65336949|NCT00801177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65336950|NCT00801177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65336951|NCT00801177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65336952|NCT00801177|Immunologic Factors|immunologic factors|mesh-ancestor
65336953|NCT00801177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336954|NCT00581100|Etanercept|etanercept|mesh-list
65336955|NCT00581100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65336956|NCT00581100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65336957|NCT00581100|Analgesics|analgesics|mesh-ancestor
65336958|NCT00581100|Sensory System Agents|sensory system agents|mesh-ancestor
65336959|NCT00581100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65336960|NCT00581100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336961|NCT00581100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65336962|NCT00581100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65336963|NCT00581100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65336964|NCT00581100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65336970|NCT00579098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336971|NCT00579098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65336972|NCT00579098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65336973|NCT00579098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336974|NCT00772109|Vaccines|vaccines|mesh-list
65336975|NCT00772109|Immunologic Factors|immunologic factors|mesh-ancestor
65336976|NCT00772109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336977|NCT00801255|Lactams|lactams|mesh-list
65336978|NCT00801255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65336979|NCT00801255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65336980|NCT00794625|Valproic Acid|valproic acid|mesh-list
65336981|NCT00794625|Risperidone|risperidone|mesh-list
65336982|NCT00794625|Dextroamphetamine|dextroamphetamine|mesh-list
65336983|NCT00794625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65336984|NCT00794625|Serotonin Agents|serotonin agents|mesh-ancestor
65336985|NCT00794625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65336986|NCT00794625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65336987|NCT00794625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65336988|NCT00794625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65336989|NCT00794625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65336990|NCT00794625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65336991|NCT00794625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65336992|NCT00794625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65336993|NCT00794625|Dopamine Agents|dopamine agents|mesh-ancestor
65336994|NCT00794625|Anticonvulsants|anticonvulsants|mesh-ancestor
65336995|NCT00794625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65336996|NCT00794625|GABA Agents|gaba agents|mesh-ancestor
65336997|NCT00794625|Antimanic Agents|antimanic agents|mesh-ancestor
65336998|NCT00794625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65336999|NCT00794625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64721177|NCT00001646|Voriconazole|voriconazole|mesh-list
65249215|NCT02826408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249216|NCT02826408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249217|NCT00573937|Morphine|morphine|mesh-list
65249218|NCT00573937|Methadone|methadone|mesh-list
65249219|NCT00573937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65249220|NCT00573937|Narcotics|narcotics|mesh-ancestor
65249221|NCT00573937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65249222|NCT00573937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249223|NCT00573937|Analgesics|analgesics|mesh-ancestor
65249224|NCT00573937|Sensory System Agents|sensory system agents|mesh-ancestor
65249226|NCT00573937|Antitussive Agents|antitussive agents|mesh-ancestor
65249227|NCT00573937|Respiratory System Agents|respiratory system agents|mesh-ancestor
65249228|NCT00845533|Piperaquine|piperaquine|mesh-list
65249229|NCT00845533|Artenimol|artenimol|mesh-list
64721191|NCT00001646|Amebicides|amebicides|mesh-ancestor
64721192|NCT00001646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64721193|NCT00001646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64721194|NCT00001646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64721195|NCT00001658|Amoxicillin|amoxicillin|mesh-list
64721196|NCT00001658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64721197|NCT00001658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721198|NCT00002252|Octreotide|octreotide|mesh-list
65337000|NCT00794625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65337001|NCT00794625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65337002|NCT02577432|Fentanyl|fentanyl|mesh-list
65337003|NCT02577432|Bupivacaine|bupivacaine|mesh-list
65337004|NCT02577432|Anesthetics, Local|anesthetics, local|mesh-ancestor
65337005|NCT02577432|Anesthetics|anesthetics|mesh-ancestor
65337006|NCT02577432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65337007|NCT02577432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337008|NCT02577432|Sensory System Agents|sensory system agents|mesh-ancestor
65337009|NCT02577432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65337010|NCT02577432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65337011|NCT02577432|Narcotics|narcotics|mesh-ancestor
65337012|NCT02577432|Analgesics|analgesics|mesh-ancestor
65337013|NCT02577432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65337014|NCT02577432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65337015|NCT02577432|Anesthetics, General|anesthetics, general|mesh-ancestor
65337016|NCT00794703|Itraconazole|itraconazole|mesh-list
65337017|NCT00794703|Micafungin|micafungin|mesh-list
65337018|NCT00794703|Antifungal Agents|antifungal agents|mesh-ancestor
65337019|NCT00794703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65337020|NCT00794703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65337021|NCT00794703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65337022|NCT00794703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337023|NCT00794703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337024|NCT00794703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65086881|NCT00458315|Gemcitabine|gemcitabine|mesh-list
64721199|NCT00002252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64721202|NCT00002348|Mitoguazone|mitoguazone|mesh-list
65249230|NCT00845533|Antimalarials|antimalarials|mesh-ancestor
65249231|NCT00845533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65249232|NCT00845533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65249233|NCT00845533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65249234|NCT00839449|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
65337025|NCT00794703|Hormone Antagonists|hormone antagonists|mesh-ancestor
65337026|NCT00794703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65337027|NCT00794703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337028|NCT00794703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65337030|NCT00772031|Propranolol|propranolol|mesh-list
65337031|NCT00772031|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65337032|NCT00772031|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65337033|NCT00772031|Adrenergic Agents|adrenergic agents|mesh-ancestor
65337034|NCT00772031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65337035|NCT00772031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337036|NCT00772031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337037|NCT00772031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65337038|NCT00772031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65337039|NCT00772031|Vasodilator Agents|vasodilator agents|mesh-ancestor
65337040|NCT00772031|Anticonvulsants|anticonvulsants|mesh-ancestor
65337041|NCT00772031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65337042|NCT00801411|Cyclophosphamide|cyclophosphamide|mesh-list
65337043|NCT00801411|Docetaxel|docetaxel|mesh-list
65337044|NCT00801411|Doxorubicin|doxorubicin|mesh-list
65337045|NCT00801411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65337046|NCT00801411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65337047|NCT00801411|Immunologic Factors|immunologic factors|mesh-ancestor
65337048|NCT00801411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337049|NCT00801411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65337050|NCT00801411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65337051|NCT00801411|Alkylating Agents|alkylating agents|mesh-ancestor
65337073|NCT04940013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65337074|NCT04940013|Oxytocics|oxytocics|mesh-ancestor
65337075|NCT00771953|Docetaxel|docetaxel|mesh-list
65337076|NCT00771953|Pemetrexed|pemetrexed|mesh-list
65337077|NCT00771953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337078|NCT00771953|Tubulin Modulators|tubulin modulators|mesh-ancestor
65337079|NCT00771953|Antimitotic Agents|antimitotic agents|mesh-ancestor
65337080|NCT00771953|Mitosis Modulators|mitosis modulators|mesh-ancestor
65337081|NCT00771953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337082|NCT00771953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337083|NCT00771953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65337084|NCT00771953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65337085|NCT00714584|Naltrexone|naltrexone|mesh-list
65337086|NCT00714584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65337087|NCT00714584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65337088|NCT00714584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337089|NCT00714584|Sensory System Agents|sensory system agents|mesh-ancestor
65337090|NCT00714584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65337091|NCT00621244|Panobinostat|panobinostat|mesh-list
65337092|NCT00621244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337093|NCT00621244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65337094|NCT00621244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337095|NCT00621244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337096|NCT00916409|Temozolomide|temozolomide|mesh-list
65337097|NCT00916409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65337098|NCT00916409|Alkylating Agents|alkylating agents|mesh-ancestor
65337099|NCT00916409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337100|NCT00916409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337101|NCT00714740|Acetazolamide|acetazolamide|mesh-list
65337102|NCT00714740|Anticonvulsants|anticonvulsants|mesh-ancestor
65337103|NCT00714740|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65337116|NCT02575508|Fluorouracil|fluorouracil|mesh-list
65337117|NCT02575508|Oxaliplatin|oxaliplatin|mesh-list
65337118|NCT02575508|Irinotecan|irinotecan|mesh-list
65337119|NCT02575508|Camptothecin|camptothecin|mesh-list
65337120|NCT02575508|Infigratinib|infigratinib|mesh-list
65337121|NCT02575508|Antimetabolites|antimetabolites|mesh-ancestor
65337122|NCT02575508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337123|NCT02575508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65337124|NCT02575508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337125|NCT02575508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65337126|NCT02575508|Immunologic Factors|immunologic factors|mesh-ancestor
65337127|NCT02575508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337128|NCT02575508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65337129|NCT02575508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65337130|NCT02575508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337131|NCT02575508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65337132|NCT00795015|Insulin|insulin|mesh-list
65337133|NCT00795015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65337134|NCT00795015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65337135|NCT00795015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337136|NCT00796887|Niacin|niacin|mesh-list
65337137|NCT00796887|Niacinamide|niacinamide|mesh-list
65337138|NCT00796887|Nicotinic Acids|nicotinic acids|mesh-list
65337139|NCT00796887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65337140|NCT00796887|Antimetabolites|antimetabolites|mesh-ancestor
65337141|NCT00796887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337142|NCT00796887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65337143|NCT00796887|Vasodilator Agents|vasodilator agents|mesh-ancestor
65337144|NCT00796887|Vitamin B Complex|vitamin b complex|mesh-ancestor
65337145|NCT00796887|Vitamins|vitamins|mesh-ancestor
65337146|NCT00796887|Micronutrients|micronutrients|mesh-ancestor
65337147|NCT00796887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337148|NCT00578942|Alemtuzumab|alemtuzumab|mesh-list
65337149|NCT00578942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65337150|NCT00578942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337151|NCT00843934|Epirubicin|epirubicin|mesh-list
65337152|NCT00843934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721270|NCT00002276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64721271|NCT00002276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64721272|NCT00002276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64721273|NCT00002276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721274|NCT00002276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721275|NCT00002276|Antimetabolites|antimetabolites|mesh-ancestor
64721276|NCT00002276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64721277|NCT00002276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64721278|NCT00002276|Antiviral Agents|antiviral agents|mesh-ancestor
64721279|NCT00002276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721280|NCT00002276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64721281|NCT00002276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64329128|NCT02190149|Factor VIII|factor viii|mesh-list
64329129|NCT02190149|Coagulants|coagulants|mesh-ancestor
64329130|NCT00366145|Remestemcel-l|remestemcel-l|mesh-list
64329131|NCT00366145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64329132|NCT00366145|Antiviral Agents|antiviral agents|mesh-ancestor
64495003|NCT05431920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65337157|NCT00843934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337158|NCT00805701|Dutasteride|dutasteride|mesh-list
65337159|NCT00805701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64721282|NCT00378547|Acetaminophen|acetaminophen|mesh-list
64721283|NCT00378547|Dexamethasone|dexamethasone|mesh-list
64721284|NCT00378547|Dexamethasone acetate|dexamethasone acetate|mesh-list
64721285|NCT00378547|Pregabalin|pregabalin|mesh-list
64721286|NCT00378547|BB 1101|bb 1101|mesh-list
64721287|NCT00378547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64721288|NCT00378547|Antiemetics|antiemetics|mesh-ancestor
64721289|NCT00378547|Autonomic Agents|autonomic agents|mesh-ancestor
64721290|NCT00378547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64721291|NCT00378547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329133|NCT00366145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64329134|NCT02185859|Lidocaine|lidocaine|mesh-list
64495010|NCT03467022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495011|NCT03467022|Protective Agents|protective agents|mesh-ancestor
65337191|NCT00801879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337192|NCT00801879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337193|NCT00718484|Doxorubicin|doxorubicin|mesh-list
65337194|NCT00718484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65337195|NCT00718484|Isophosphamide mustard|isophosphamide mustard|mesh-list
65337196|NCT00718484|Ifosfamide|ifosfamide|mesh-list
65337197|NCT00718484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65337198|NCT00718484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337199|NCT00718484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65337200|NCT00718484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65337201|NCT00718484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337202|NCT00718484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337204|NCT00718484|Alkylating Agents|alkylating agents|mesh-ancestor
64721292|NCT00378547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64721293|NCT00378547|Glucocorticoids|glucocorticoids|mesh-ancestor
64721294|NCT00378547|Hormones|hormones|mesh-ancestor
64721295|NCT00378547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64721296|NCT00378547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64721297|NCT00378547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721298|NCT00378547|Protease Inhibitors|protease inhibitors|mesh-ancestor
64721299|NCT00378547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721300|NCT00378547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721301|NCT00378547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65337227|NCT00801957|Dermatologic Agents|dermatologic agents|mesh-ancestor
65337228|NCT00836134|Bupivacaine|bupivacaine|mesh-list
65337229|NCT00836134|Anesthetics, Local|anesthetics, local|mesh-list
65337230|NCT00836134|Anesthetics|anesthetics|mesh-list
65337231|NCT00836134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65337232|NCT00836134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337233|NCT00836134|Sensory System Agents|sensory system agents|mesh-ancestor
65337234|NCT00836134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65337235|NCT00782795|Pioglitazone|pioglitazone|mesh-list
65337236|NCT00782795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65337237|NCT00782795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337238|NCT02573558|Dexmedetomidine|dexmedetomidine|mesh-list
65337239|NCT02573558|Propofol|propofol|mesh-list
65337240|NCT02573558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65337241|NCT02573558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65337242|NCT02573558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337243|NCT02573558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65337244|NCT02573558|Anesthetics, General|anesthetics, general|mesh-ancestor
65337245|NCT02573558|Anesthetics|anesthetics|mesh-ancestor
65337246|NCT02573558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65337247|NCT02573558|Analgesics|analgesics|mesh-ancestor
64721303|NCT00378547|Sensory System Agents|sensory system agents|mesh-ancestor
64721304|NCT00378547|Antipyretics|antipyretics|mesh-ancestor
64721305|NCT00378547|Anticonvulsants|anticonvulsants|mesh-ancestor
64721306|NCT00378547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64721307|NCT00378547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64721308|NCT00378547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64721309|NCT00378547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64721310|NCT00378547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64721311|NCT00378547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64721312|NCT00378547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64721313|NCT00002282|Fluconazole|fluconazole|mesh-list
64329146|NCT02185859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329147|NCT02185859|Analgesics|analgesics|mesh-ancestor
64329148|NCT02185859|Anticonvulsants|anticonvulsants|mesh-ancestor
64329149|NCT02185859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64329150|NCT02185859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64329151|NCT02185859|Tocolytic Agents|tocolytic agents|mesh-ancestor
65337261|NCT00656799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65337262|NCT00656799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65337263|NCT00656799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337264|NCT00764699|Mecasermin|mecasermin|mesh-list
65337265|NCT00764699|Growth Substances|growth substances|mesh-ancestor
65337266|NCT00764699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337269|NCT00844012|Estradiol|estradiol|mesh-list
65337294|NCT00836212|Lopinavir|lopinavir|mesh-list
65337295|NCT00836212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65337296|NCT00836212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65337297|NCT00836212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337298|NCT00836212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337299|NCT00836212|Antiviral Agents|antiviral agents|mesh-ancestor
65337300|NCT00836212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65337301|NCT00836212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65337302|NCT00836212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65337303|NCT00836212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65337304|NCT00836212|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65337305|NCT00836212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65337306|NCT00836212|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65337307|NCT00836212|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65337308|NCT00836212|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65337309|NCT00836212|Protease Inhibitors|protease inhibitors|mesh-ancestor
65337310|NCT00836212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65337311|NCT00836212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65337312|NCT00836212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65337313|NCT00782717|Prednisolone|prednisolone|mesh-list
65337314|NCT00782717|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65337315|NCT00782717|Methylprednisolone|methylprednisolone|mesh-list
65337316|NCT00782717|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65337317|NCT00782717|Prednisolone acetate|prednisolone acetate|mesh-list
65337318|NCT00782717|Nepafenac|nepafenac|mesh-list
65337319|NCT00782717|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65337320|NCT00782717|Prednisolone phosphate|prednisolone phosphate|mesh-list
65337321|NCT00782717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65337322|NCT00782717|Glucocorticoids|glucocorticoids|mesh-ancestor
65337323|NCT00782717|Hormones|hormones|mesh-ancestor
65337324|NCT00782717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64721338|NCT00002288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64721339|NCT00002288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721340|NCT00002288|Antiviral Agents|antiviral agents|mesh-ancestor
64721341|NCT00002288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721342|NCT00002288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64721343|NCT00002288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64721344|NCT00002366|Ritonavir|ritonavir|mesh-list
64721345|NCT00002366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64721346|NCT00002366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64721347|NCT00002366|Protease Inhibitors|protease inhibitors|mesh-ancestor
64329179|NCT02181335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64329180|NCT02181335|Autonomic Agents|autonomic agents|mesh-ancestor
64329181|NCT02181335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64329182|NCT02181335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329183|NCT02181335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64329184|NCT02181335|Respiratory System Agents|respiratory system agents|mesh-ancestor
64495040|NCT05339334|Protease Inhibitors|protease inhibitors|mesh-ancestor
64495041|NCT05339334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337334|NCT00782717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65337335|NCT00782717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64721348|NCT00002366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721349|NCT00002366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721350|NCT00002366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64721351|NCT00002366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64721352|NCT00002366|Antiviral Agents|antiviral agents|mesh-ancestor
64721353|NCT00002366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721354|NCT00002366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64721355|NCT00002366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64721356|NCT00378313|Gemcitabine|gemcitabine|mesh-list
64721357|NCT00378313|Paclitaxel|paclitaxel|mesh-list
64721358|NCT00378313|Epirubicin|epirubicin|mesh-list
64329185|NCT02181335|Glucocorticoids|glucocorticoids|mesh-ancestor
65337369|NCT00620776|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65337370|NCT00620776|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65337371|NCT00620776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65337372|NCT00620776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65337373|NCT00620776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337374|NCT00620776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65337375|NCT00620776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337376|NCT00620776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65337377|NCT00620776|Antidepressive Agents|antidepressive agents|mesh-ancestor
65337378|NCT00620776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65337379|NCT05479097|Antihypertensive Agents|antihypertensive agents|mesh-list
65337380|NCT00656019|Vitamin D|vitamin d|mesh-list
65337381|NCT00656019|Calcipotriene|calcipotriene|mesh-list
65337382|NCT00656019|Vitamins|vitamins|mesh-ancestor
65337405|NCT00836368|Antioxidants|antioxidants|mesh-ancestor
64721359|NCT00378313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64721360|NCT00378313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721361|NCT00378313|Tubulin Modulators|tubulin modulators|mesh-ancestor
64721362|NCT00378313|Antimitotic Agents|antimitotic agents|mesh-ancestor
64721363|NCT00378313|Mitosis Modulators|mitosis modulators|mesh-ancestor
64721364|NCT00378313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721365|NCT00378313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64721366|NCT00378313|Antimetabolites|antimetabolites|mesh-ancestor
64721367|NCT00378313|Antiviral Agents|antiviral agents|mesh-ancestor
64721368|NCT00378313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721369|NCT00378313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337406|NCT00836368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337407|NCT00836368|Protective Agents|protective agents|mesh-ancestor
65337408|NCT00718796|Coenzyme Q10|coenzyme q10|mesh-list
65337409|NCT00718796|Ubiquinone|ubiquinone|mesh-list
65337410|NCT00718796|Atorvastatin|atorvastatin|mesh-list
65337411|NCT00718796|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65337412|NCT00718796|Simvastatin|simvastatin|mesh-list
65337413|NCT00718796|Pravastatin|pravastatin|mesh-list
65337414|NCT00718796|Lovastatin|lovastatin|mesh-list
65337415|NCT00718796|L 647318|l 647318|mesh-list
65337416|NCT00718796|Dihydromevinolin|dihydromevinolin|mesh-list
65337417|NCT00718796|Anticholesteremic Agents|anticholesteremic agents|mesh-list
65337418|NCT00718796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65337419|NCT00718796|Antimetabolites|antimetabolites|mesh-ancestor
64721371|NCT00378313|Immunologic Factors|immunologic factors|mesh-ancestor
64721372|NCT00378313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721373|NCT00378313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64721374|NCT00378313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64721375|NCT00378313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64721376|NCT00002372|Nelfinavir|nelfinavir|mesh-list
64721377|NCT00002372|Indinavir|indinavir|mesh-list
64721378|NCT00002372|Saquinavir|saquinavir|mesh-list
64721379|NCT00002372|Amprenavir|amprenavir|mesh-list
64721380|NCT00002372|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64721381|NCT00002372|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64721382|NCT00002372|Protease Inhibitors|protease inhibitors|mesh-ancestor
65337444|NCT00764465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65337445|NCT00764465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65337446|NCT00764465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65337447|NCT00764465|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65337448|NCT00764465|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65337449|NCT00764465|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65337450|NCT00655863|Pioglitazone|pioglitazone|mesh-list
65337451|NCT00655863|Alogliptin|alogliptin|mesh-list
65337452|NCT00655863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65337453|NCT00655863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337454|NCT00655863|Incretins|incretins|mesh-ancestor
65337455|NCT00655863|Hormones|hormones|mesh-ancestor
65337456|NCT00655863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65337457|NCT00655863|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65337458|NCT00655863|Protease Inhibitors|protease inhibitors|mesh-ancestor
65337459|NCT00655863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337461|NCT04263922|Valsartan|valsartan|mesh-list
65337476|NCT00781937|Incretins|incretins|mesh-ancestor
65337477|NCT00781937|Hormones|hormones|mesh-ancestor
65337478|NCT00781937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65337479|NCT00802581|Anesthetics|anesthetics|mesh-list
65337480|NCT00802581|Anesthetics, Local|anesthetics, local|mesh-list
65337481|NCT00802581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65337482|NCT00802581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337483|NCT00802581|Sensory System Agents|sensory system agents|mesh-ancestor
65337484|NCT00802581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65337485|NCT00719108|Insulin|insulin|mesh-list
65337486|NCT00719108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65337487|NCT00719108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65337488|NCT00719108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337489|NCT00842140|Metformin|metformin|mesh-list
65337490|NCT00842140|Spironolactone|spironolactone|mesh-list
65337491|NCT00842140|Contraceptive Agents|contraceptive agents|mesh-list
65337492|NCT00842140|Contraceptives, Oral|contraceptives, oral|mesh-list
65337493|NCT00842140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65337494|NCT00842140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337495|NCT00842140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65337496|NCT00842140|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65337497|NCT00842140|Hormone Antagonists|hormone antagonists|mesh-ancestor
65337498|NCT00842140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65337499|NCT00842140|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65337500|NCT00842140|Diuretics|diuretics|mesh-ancestor
65337501|NCT00842140|Natriuretic Agents|natriuretic agents|mesh-ancestor
65337502|NCT00842140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65337503|NCT00806169|Triamcinolone|triamcinolone|mesh-list
65337504|NCT00806169|Bevacizumab|bevacizumab|mesh-list
65337505|NCT00806169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65337506|NCT00806169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337507|NCT00806169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65337508|NCT00806169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65337509|NCT00806169|Growth Substances|growth substances|mesh-ancestor
65337510|NCT00806169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337511|NCT00806169|Growth Inhibitors|growth inhibitors|mesh-ancestor
65337512|NCT00806169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64721409|NCT00002378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721410|NCT00002378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64721411|NCT00002378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64721412|NCT00002378|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64721414|NCT00002378|Antimetabolites|antimetabolites|mesh-ancestor
65337513|NCT00806169|Glucocorticoids|glucocorticoids|mesh-ancestor
65337514|NCT00806169|Hormones|hormones|mesh-ancestor
65337515|NCT00806169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65337516|NCT00844324|Candesartan|candesartan|mesh-list
65337517|NCT00844324|Candesartan cilexetil|candesartan cilexetil|mesh-list
65337518|NCT00844324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65337519|NCT00844324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65337520|NCT00844324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65337521|NCT00844324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337522|NCT00802815|Etanercept|etanercept|mesh-list
65337523|NCT00802815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65337524|NCT00802815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65337525|NCT00802815|Analgesics|analgesics|mesh-ancestor
65337526|NCT00802815|Sensory System Agents|sensory system agents|mesh-ancestor
65337527|NCT00802815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65337528|NCT00802815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337529|NCT00802815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65337530|NCT00802815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65337531|NCT00802815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65337532|NCT00802815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65337533|NCT00802815|Immunologic Factors|immunologic factors|mesh-ancestor
65337534|NCT04100759|Sildenafil Citrate|sildenafil citrate|mesh-list
65337535|NCT04100759|Vasodilator Agents|vasodilator agents|mesh-ancestor
65337536|NCT04100759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65337537|NCT04100759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65337538|NCT04100759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337539|NCT04100759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337547|NCT00844402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65337548|NCT00844402|Antimetabolites|antimetabolites|mesh-ancestor
65337549|NCT00844402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066811|NCT00272636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337550|NCT00844402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65337551|NCT00844402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65337552|NCT00844402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337553|NCT00806247|Tapentadol|tapentadol|mesh-list
65337554|NCT00806247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65337555|NCT00806247|Narcotics|narcotics|mesh-ancestor
65337556|NCT00806247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64721426|NCT02589145|Immunologic Factors|immunologic factors|mesh-ancestor
64721427|NCT02589145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721428|NCT02589145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64721429|NCT02589145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64721430|NCT02589145|Antiemetics|antiemetics|mesh-ancestor
64721431|NCT02589145|Autonomic Agents|autonomic agents|mesh-ancestor
64721432|NCT02589145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65337557|NCT00806247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337558|NCT00806247|Analgesics|analgesics|mesh-ancestor
65337559|NCT00806247|Sensory System Agents|sensory system agents|mesh-ancestor
65337560|NCT00806247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65337561|NCT00806247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64721442|NCT02589145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721443|NCT02589145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721444|NCT02589145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64721445|NCT02589145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64721446|NCT02589145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64721447|NCT02589145|Growth Substances|growth substances|mesh-ancestor
64721448|NCT02589145|Growth Inhibitors|growth inhibitors|mesh-ancestor
64721449|NCT02589145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64329265|NCT02190695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64329266|NCT02190695|Antimetabolites|antimetabolites|mesh-ancestor
64329267|NCT02190695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495058|NCT03461328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65337588|NCT00659373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337589|NCT00659373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65337590|NCT00659373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337591|NCT00659373|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65337592|NCT00659373|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65337593|NCT00659373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65337594|NCT00659373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65337595|NCT00659373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65337596|NCT00659373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337597|NCT00659373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721450|NCT02589145|Alkylating Agents|alkylating agents|mesh-ancestor
65337624|NCT02547844|Emtricitabine|emtricitabine|mesh-list
65337625|NCT02547844|Antiviral Agents|antiviral agents|mesh-ancestor
65337626|NCT02547844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65337627|NCT02547844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65337628|NCT02547844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65337629|NCT02547844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337630|NCT02547844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337631|NCT02547844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65337632|NCT02547844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65337633|NCT02547844|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65337634|NCT02547844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65337635|NCT02547844|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65337636|NCT02547844|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65337637|NCT02547844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65337638|NCT02547844|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65337639|NCT00439777|Enoxaparin|enoxaparin|mesh-list
65337640|NCT00439777|Rivaroxaban|rivaroxaban|mesh-list
65337641|NCT00439777|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65337642|NCT00439777|Antithrombins|antithrombins|mesh-ancestor
65337643|NCT00439777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65337644|NCT00439777|Protease Inhibitors|protease inhibitors|mesh-ancestor
65337645|NCT00439777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337646|NCT00439777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337647|NCT00439777|Anticoagulants|anticoagulants|mesh-ancestor
65337648|NCT00439777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65337649|NCT00439777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65337650|NCT00842686|Bevacizumab|bevacizumab|mesh-list
65249235|NCT00839449|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65249265|NCT02548195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249266|NCT00573859|Methylphenidate|methylphenidate|mesh-list
65249267|NCT00573859|Amphetamine|amphetamine|mesh-list
65249268|NCT00573859|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65249269|NCT00573859|Dextroamphetamine|dextroamphetamine|mesh-list
65249270|NCT00573859|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65249271|NCT00573859|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65249272|NCT00573859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249273|NCT00573859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65249274|NCT00573859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65249275|NCT00573859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65249276|NCT00573859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249277|NCT00573859|Dopamine Agents|dopamine agents|mesh-ancestor
65249278|NCT00573859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65249279|NCT00573859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65337651|NCT00842686|Capecitabine|capecitabine|mesh-list
65337652|NCT00842686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65337653|NCT00842686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337654|NCT00842686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65337655|NCT00842686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65337656|NCT00842686|Growth Substances|growth substances|mesh-ancestor
65337657|NCT00842686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337658|NCT00842686|Growth Inhibitors|growth inhibitors|mesh-ancestor
65337659|NCT00842686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65337660|NCT00842686|Antimetabolites|antimetabolites|mesh-ancestor
65337661|NCT00842686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337662|NCT04045821|Plerixafor|plerixafor|mesh-list
65337663|NCT04045821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65337664|NCT04045821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65337665|NCT04045821|Antiviral Agents|antiviral agents|mesh-ancestor
65337666|NCT04045821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65337667|NCT00803439|Clobetasol|clobetasol|mesh-list
65337668|NCT00803439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65337669|NCT00803439|Glucocorticoids|glucocorticoids|mesh-ancestor
65337670|NCT00803439|Hormones|hormones|mesh-ancestor
65337671|NCT00803439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65337672|NCT00803439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337673|NCT00806481|Sevelamer|sevelamer|mesh-list
65337674|NCT00806481|Chelating Agents|chelating agents|mesh-ancestor
65337675|NCT00806481|Sequestering Agents|sequestering agents|mesh-ancestor
65337676|NCT00806481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337677|NCT00709436|Ketamine|ketamine|mesh-list
65337678|NCT00709436|Analgesics|analgesics|mesh-ancestor
65337679|NCT00709436|Sensory System Agents|sensory system agents|mesh-ancestor
65337680|NCT00709436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65337681|NCT00709436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337682|NCT00709436|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65337691|NCT00844792|Vitamin D|vitamin d|mesh-list
64721496|NCT00002402|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64721497|NCT00002402|Immunologic Factors|immunologic factors|mesh-ancestor
64721498|NCT00002402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721499|NCT00002402|Antacids|antacids|mesh-ancestor
64721500|NCT00002402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721501|NCT00002402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64721502|NCT00002420|Stavudine|stavudine|mesh-list
64721503|NCT00002420|Didanosine|didanosine|mesh-list
64721504|NCT00002420|Delavirdine|delavirdine|mesh-list
64721505|NCT00002420|Emivirine|emivirine|mesh-list
64721506|NCT00002420|Hydroxyurea|hydroxyurea|mesh-list
64329313|NCT00511459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329314|NCT00511459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64329315|NCT00511459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65337693|NCT00844792|Vitamins|vitamins|mesh-list
65337694|NCT00844792|Vitamin E|vitamin e|mesh-list
65337695|NCT00844792|Selenium|selenium|mesh-list
65337696|NCT00844792|Lycopene|lycopene|mesh-list
65337697|NCT00844792|Micronutrients|micronutrients|mesh-ancestor
65337698|NCT00844792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337699|NCT00844792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65337700|NCT00844792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65337701|NCT00844792|Antioxidants|antioxidants|mesh-ancestor
65337702|NCT00844792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337703|NCT00844792|Protective Agents|protective agents|mesh-ancestor
65337704|NCT00844792|Trace Elements|trace elements|mesh-ancestor
65337705|NCT00844792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65337706|NCT00844792|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65337707|NCT00844792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65337708|NCT00844792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337709|NCT00719420|Amoxicillin|amoxicillin|mesh-list
65337710|NCT00719420|Metronidazole|metronidazole|mesh-list
65337711|NCT00719420|Clarithromycin|clarithromycin|mesh-list
65337712|NCT00719420|Omeprazole|omeprazole|mesh-list
64721507|NCT00002420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721508|NCT00002420|Antisickling Agents|antisickling agents|mesh-ancestor
64721509|NCT00002420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337722|NCT00719420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65337723|NCT00719420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65337724|NCT00719420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65337725|NCT00803829|Sulfalene|sulfalene|mesh-list
65337726|NCT00803829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65337727|NCT00803829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65337728|NCT00803829|Renal Agents|renal agents|mesh-ancestor
65337729|NCT00803829|Antimalarials|antimalarials|mesh-ancestor
65337730|NCT00803829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65337731|NCT00803829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65337732|NCT00716612|Ubiquinone|ubiquinone|mesh-list
65337733|NCT00716612|Coenzyme Q10|coenzyme q10|mesh-list
65337734|NCT00716612|Micronutrients|micronutrients|mesh-ancestor
65337735|NCT00716612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337736|NCT00716612|Vitamins|vitamins|mesh-ancestor
65337737|NCT00842920|Simvastatin|simvastatin|mesh-list
65337738|NCT00842920|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65337739|NCT00842920|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65337740|NCT00842920|Antimetabolites|antimetabolites|mesh-ancestor
65337741|NCT00842920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337742|NCT00842920|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65337743|NCT00842920|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65337744|NCT00842920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249312|NCT00839683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249313|NCT00839683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65249314|NCT00839683|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65249315|NCT00839683|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65249317|NCT00839761|Trace Elements|trace elements|mesh-ancestor
65249318|NCT00839761|Micronutrients|micronutrients|mesh-ancestor
65249319|NCT00839761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249320|NCT02825394|Ecarin|ecarin|mesh-list
65249321|NCT02825394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65249352|NCT05660694|Antioxidants|antioxidants|mesh-ancestor
65249353|NCT05660694|Protective Agents|protective agents|mesh-ancestor
65249354|NCT05660694|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65249355|NCT05660694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65249356|NCT05660694|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65249357|NCT05660694|Vasodilator Agents|vasodilator agents|mesh-ancestor
65249358|NCT05660694|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65249359|NCT05113368|Fulvestrant|fulvestrant|mesh-list
65249360|NCT05113368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65249361|NCT05113368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249362|NCT05113368|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65249363|NCT05113368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65249364|NCT05113368|Hormone Antagonists|hormone antagonists|mesh-ancestor
64304107|NCT03067688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65249392|NCT00840385|Fludarabine phosphate|fludarabine phosphate|mesh-list
65337745|NCT00842998|Trastuzumab|trastuzumab|mesh-list
65337746|NCT00842998|Lapatinib|lapatinib|mesh-list
65337747|NCT00842998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65337748|NCT00842998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337749|NCT00842998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65337750|NCT00842998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337751|NCT00842998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337752|NCT00716846|Atorvastatin|atorvastatin|mesh-list
65337753|NCT00716846|Simvastatin|simvastatin|mesh-list
65337754|NCT00716846|Pitavastatin|pitavastatin|mesh-list
65337755|NCT00716846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65337756|NCT00716846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65337757|NCT00716846|Antimetabolites|antimetabolites|mesh-ancestor
65337758|NCT00716846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337759|NCT00716846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65337760|NCT00716846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65337761|NCT00716846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65337762|NCT00620854|Calcitonin|calcitonin|mesh-list
65337763|NCT00620854|Salmon calcitonin|salmon calcitonin|mesh-list
65337764|NCT00620854|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
65337765|NCT00620854|Katacalcin|katacalcin|mesh-list
65337766|NCT00620854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65337767|NCT00620854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337768|NCT00620854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65337769|NCT00620854|Vasodilator Agents|vasodilator agents|mesh-ancestor
65337770|NCT00716924|Clopidogrel|clopidogrel|mesh-list
65337771|NCT00716924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65337772|NCT00716924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65087633|NCT00497328|Antidotes|antidotes|mesh-ancestor
65337773|NCT00716924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65337774|NCT00716924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65337775|NCT00716924|Purinergic Agents|purinergic agents|mesh-ancestor
65337776|NCT00716924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65337777|NCT00716924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337778|NCT00716924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337779|NCT00430027|Capecitabine|capecitabine|mesh-list
65249393|NCT00840385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337780|NCT00430027|Oxaliplatin|oxaliplatin|mesh-list
65337781|NCT00430027|Cetuximab|cetuximab|mesh-list
65337782|NCT00430027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65337783|NCT00430027|Antimetabolites|antimetabolites|mesh-ancestor
65337784|NCT00430027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337785|NCT00430027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337786|NCT00430027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65337787|NCT00792948|Calcium, Dietary|calcium, dietary|mesh-list
65337788|NCT00792948|Leucovorin|leucovorin|mesh-list
65337789|NCT00792948|Folic Acid|folic acid|mesh-list
65337790|NCT00792948|Cytarabine|cytarabine|mesh-list
65337791|NCT00792948|Sirolimus|sirolimus|mesh-list
65337792|NCT00792948|Dexamethasone|dexamethasone|mesh-list
65337848|NCT00792948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65337849|NCT00792948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65337850|NCT00792948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65337851|NCT00792948|Antiviral Agents|antiviral agents|mesh-ancestor
65337852|NCT00792948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65337853|NCT00792948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65337854|NCT00792948|Antidotes|antidotes|mesh-ancestor
65337855|NCT00792948|Protective Agents|protective agents|mesh-ancestor
65337856|NCT00792948|Vitamin B Complex|vitamin b complex|mesh-ancestor
65337857|NCT00792948|Vitamins|vitamins|mesh-ancestor
65337858|NCT00792948|Micronutrients|micronutrients|mesh-ancestor
65337859|NCT00792948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65337860|NCT00792948|Tubulin Modulators|tubulin modulators|mesh-ancestor
65337861|NCT00792948|Antimitotic Agents|antimitotic agents|mesh-ancestor
65337862|NCT00792948|Mitosis Modulators|mitosis modulators|mesh-ancestor
65337863|NCT00792948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65337864|NCT00792948|Antifungal Agents|antifungal agents|mesh-ancestor
65337865|NCT00792948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65337866|NCT00792948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65337867|NCT00792948|Hematinics|hematinics|mesh-ancestor
65337868|NCT00792948|Keratolytic Agents|keratolytic agents|mesh-ancestor
65337869|NCT04766229|Gabapentin|gabapentin|mesh-list
65337870|NCT04766229|Citalopram|citalopram|mesh-list
65337871|NCT04766229|Analgesics|analgesics|mesh-ancestor
65337872|NCT04766229|Sensory System Agents|sensory system agents|mesh-ancestor
65337873|NCT04766229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65337874|NCT04766229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337875|NCT04766229|Anticonvulsants|anticonvulsants|mesh-ancestor
65337876|NCT04766229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65337877|NCT04766229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65337878|NCT04766229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65337879|NCT04766229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65337880|NCT04766229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65337881|NCT04766229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64721613|NCT05701436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64721614|NCT05701436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721615|NCT05701436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721616|NCT05701436|Antimetabolites|antimetabolites|mesh-ancestor
64721617|NCT05701436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64721618|NCT05701436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64721619|NCT05701436|Immunologic Factors|immunologic factors|mesh-ancestor
64721620|NCT05701436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721621|NCT05701436|Antidotes|antidotes|mesh-ancestor
64721622|NCT05701436|Protective Agents|protective agents|mesh-ancestor
64329421|NCT02384343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329422|NCT02384343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64329423|NCT02384343|Analgesics|analgesics|mesh-ancestor
64329424|NCT02384343|Sensory System Agents|sensory system agents|mesh-ancestor
64329425|NCT02384343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65337890|NCT04766229|Antidepressive Agents|antidepressive agents|mesh-ancestor
65337891|NCT04068506|Gabapentin|gabapentin|mesh-list
65337892|NCT04068506|Analgesics|analgesics|mesh-ancestor
65337893|NCT04068506|Sensory System Agents|sensory system agents|mesh-ancestor
65337894|NCT04068506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65337895|NCT04068506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337896|NCT04068506|Anticonvulsants|anticonvulsants|mesh-ancestor
65337897|NCT04068506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64721623|NCT05701436|Vitamin B Complex|vitamin b complex|mesh-ancestor
64721624|NCT05701436|Vitamins|vitamins|mesh-ancestor
64721625|NCT05701436|Micronutrients|micronutrients|mesh-ancestor
65337925|NCT00429793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337926|NCT00806871|Methylprednisolone|methylprednisolone|mesh-list
65337927|NCT00806871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65337928|NCT00806871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65337930|NCT00806871|Prednisolone acetate|prednisolone acetate|mesh-list
65337931|NCT00806871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65337932|NCT00806871|Prednisolone phosphate|prednisolone phosphate|mesh-list
65337933|NCT00806871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65337934|NCT00806871|Antiemetics|antiemetics|mesh-ancestor
65337935|NCT00806871|Autonomic Agents|autonomic agents|mesh-ancestor
65337936|NCT00806871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65337937|NCT00806871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337938|NCT00806871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65337939|NCT00806871|Glucocorticoids|glucocorticoids|mesh-ancestor
65337940|NCT00806871|Hormones|hormones|mesh-ancestor
65337941|NCT00806871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65337942|NCT00806871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65337943|NCT00806871|Protective Agents|protective agents|mesh-ancestor
65337944|NCT00806871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65337945|NCT00806871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337946|NCT00798213|Gemtuzumab|gemtuzumab|mesh-list
65337947|NCT00798213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65337948|NCT00798213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337949|NCT04069208|Cytarabine|cytarabine|mesh-list
65337950|NCT04069208|Idarubicin|idarubicin|mesh-list
65337951|NCT04069208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65337964|NCT00845104|Bevacizumab|bevacizumab|mesh-list
64721646|NCT00002438|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64721647|NCT00002438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64721648|NCT00002438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721649|NCT00002438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721650|NCT00002438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64721651|NCT00002438|Hormone Antagonists|hormone antagonists|mesh-ancestor
65337970|NCT00845104|Immunoglobulins|immunoglobulins|mesh-list
65337971|NCT00845104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65337972|NCT00845104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65337973|NCT00845104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65337974|NCT00845104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65337975|NCT00845104|Growth Substances|growth substances|mesh-ancestor
65337976|NCT00845104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337977|NCT00845104|Growth Inhibitors|growth inhibitors|mesh-ancestor
65337978|NCT00845104|Immunologic Factors|immunologic factors|mesh-ancestor
65337979|NCT00845104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65337980|NCT00845104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65337981|NCT00845104|Antimetabolites|antimetabolites|mesh-ancestor
65337982|NCT00845104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337983|NCT00845104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65337984|NCT00763451|Metformin|metformin|mesh-list
65337985|NCT00763451|Lixisenatide|lixisenatide|mesh-list
65337986|NCT00763451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65337987|NCT00763451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337988|NCT00762762|Triclosan|triclosan|mesh-list
65337989|NCT00762762|Fluorides|fluorides|mesh-list
65337990|NCT00762762|Cariostatic Agents|cariostatic agents|mesh-ancestor
65337991|NCT00762762|Protective Agents|protective agents|mesh-ancestor
65337992|NCT00762762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337993|NCT00762762|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65337994|NCT00762762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65337995|NCT00762762|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65337996|NCT00762762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65337997|NCT00762762|Antimetabolites|antimetabolites|mesh-ancestor
65249394|NCT00840385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65249395|NCT00840385|Antimetabolites|antimetabolites|mesh-ancestor
65249396|NCT00840385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249397|NCT00840385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65249398|NCT00840385|Immunologic Factors|immunologic factors|mesh-ancestor
65249399|NCT00840385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65337998|NCT00762762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65337999|NCT00762762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65338000|NCT00424489|Methylprednisolone|methylprednisolone|mesh-list
65338001|NCT00424489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65338002|NCT00424489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65338003|NCT00424489|Prednisolone|prednisolone|mesh-list
65338004|NCT00424489|Prednisolone acetate|prednisolone acetate|mesh-list
65338005|NCT00424489|Cyclophosphamide|cyclophosphamide|mesh-list
65338006|NCT00424489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65338007|NCT00424489|Prednisolone phosphate|prednisolone phosphate|mesh-list
65338008|NCT00424489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65338009|NCT00424489|Immunologic Factors|immunologic factors|mesh-ancestor
65338010|NCT00424489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338011|NCT00424489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65338012|NCT00424489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65338013|NCT00424489|Alkylating Agents|alkylating agents|mesh-ancestor
65338014|NCT00424489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338015|NCT00424489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338016|NCT00424489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65338017|NCT00424489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65338018|NCT00424489|Antiemetics|antiemetics|mesh-ancestor
65338019|NCT00424489|Autonomic Agents|autonomic agents|mesh-ancestor
65338020|NCT00424489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65338021|NCT00424489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65338022|NCT00424489|Glucocorticoids|glucocorticoids|mesh-ancestor
65338023|NCT00424489|Hormones|hormones|mesh-ancestor
65338024|NCT00424489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65338025|NCT00424489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65338026|NCT00424489|Protective Agents|protective agents|mesh-ancestor
65338027|NCT00424489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65338028|NCT00578864|Cyclophosphamide|cyclophosphamide|mesh-list
65338029|NCT00578864|Doxorubicin|doxorubicin|mesh-list
64721691|NCT00002450|Antiviral Agents|antiviral agents|mesh-ancestor
64721692|NCT00002450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721693|NCT00002450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64721694|NCT00002450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64721695|NCT00002450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721696|NCT00002450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721697|NCT00002450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64721698|NCT00002450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64721699|NCT03277183|Epoetin Alfa|epoetin alfa|mesh-list
64721700|NCT03277183|Hematinics|hematinics|mesh-ancestor
64329475|NCT02187107|Protease Inhibitors|protease inhibitors|mesh-ancestor
65338039|NCT00578864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338040|NCT00578864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65338041|NCT00578864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65338042|NCT00578864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65338043|NCT00578864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65338044|NCT00578864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338045|NCT00578864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65338046|NCT01034683|Leucovorin|leucovorin|mesh-list
65338047|NCT01034683|Antidotes|antidotes|mesh-ancestor
65338048|NCT01034683|Protective Agents|protective agents|mesh-ancestor
65338049|NCT01034683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338050|NCT01034683|Vitamin B Complex|vitamin b complex|mesh-ancestor
65338051|NCT01034683|Vitamins|vitamins|mesh-ancestor
65338052|NCT01034683|Micronutrients|micronutrients|mesh-ancestor
65338053|NCT00717470|Mycophenolic Acid|mycophenolic acid|mesh-list
65338054|NCT00717470|Prednisone|prednisone|mesh-list
65338055|NCT00717470|Methylprednisolone|methylprednisolone|mesh-list
65338056|NCT00717470|Tacrolimus|tacrolimus|mesh-list
65338057|NCT00717470|Basiliximab|basiliximab|mesh-list
65338058|NCT00717470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65338059|NCT00717470|Glucocorticoids|glucocorticoids|mesh-ancestor
65338060|NCT00717470|Hormones|hormones|mesh-ancestor
65338061|NCT00717470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64721701|NCT00002456|Cyclosporine|cyclosporine|mesh-list
64721702|NCT00002456|Methotrexate|methotrexate|mesh-list
64721703|NCT00002456|Cyclosporins|cyclosporins|mesh-list
64721704|NCT00002456|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64721705|NCT00002456|Abortifacient Agents|abortifacient agents|mesh-ancestor
64721706|NCT00002456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64721707|NCT00002456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721708|NCT00002456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64721709|NCT00002456|Antimetabolites|antimetabolites|mesh-ancestor
65338071|NCT00717470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65338072|NCT00717470|Antitubercular Agents|antitubercular agents|mesh-ancestor
65338073|NCT00717470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65338074|NCT00717470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65338075|NCT00717470|Antiemetics|antiemetics|mesh-ancestor
65338076|NCT00717470|Autonomic Agents|autonomic agents|mesh-ancestor
65338077|NCT00717470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65338078|NCT00717470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65338079|NCT00717470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65338080|NCT00717470|Protective Agents|protective agents|mesh-ancestor
65338081|NCT00631566|Mupirocin|mupirocin|mesh-list
65338082|NCT00631566|Triclosan|triclosan|mesh-list
65338083|NCT00631566|Hexachlorophene|hexachlorophene|mesh-list
65338084|NCT00631566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65338085|NCT00631566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65338086|NCT00631566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65338111|NCT01410942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65338112|NCT01410942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338113|NCT01410942|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65338114|NCT01410942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65338115|NCT01410942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65338116|NCT01410942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338117|NCT01410942|Dopamine Agents|dopamine agents|mesh-ancestor
65338118|NCT01410942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65338119|NCT04833426|Testosterone|testosterone|mesh-list
65338120|NCT04833426|Androgens|androgens|mesh-ancestor
65338121|NCT04833426|Hormones|hormones|mesh-ancestor
65338122|NCT04833426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65338123|NCT04833426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338124|NCT02576964|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65338125|NCT02576964|Capecitabine|capecitabine|mesh-list
65338126|NCT02576964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65338127|NCT02576964|Antimetabolites|antimetabolites|mesh-ancestor
65338128|NCT02576964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338129|NCT02576964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338130|NCT02576964|Antiviral Agents|antiviral agents|mesh-ancestor
65338131|NCT02576964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65338132|NCT00763139|Pioglitazone|pioglitazone|mesh-list
65338133|NCT00763139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65338134|NCT00763139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338135|NCT01366092|Interleukin-2|interleukin-2|mesh-list
65338136|NCT01366092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338137|NCT01366092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65338138|NCT01366092|Analgesics|analgesics|mesh-ancestor
65338139|NCT01366092|Sensory System Agents|sensory system agents|mesh-ancestor
65338140|NCT01366092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65338141|NCT01366092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338142|NCT00781859|Plasminogen|plasminogen|mesh-list
65338143|NCT00781859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65338144|NCT00781859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64721713|NCT00002456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249400|NCT00840385|Antiviral Agents|antiviral agents|mesh-ancestor
65249401|NCT00840385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65249402|NCT02824458|Apatinib|apatinib|mesh-list
65249403|NCT02824458|Gefitinib|gefitinib|mesh-list
64721731|NCT00002474|Cyclophosphamide|cyclophosphamide|mesh-list
64721732|NCT00002474|Carboplatin|carboplatin|mesh-list
65338145|NCT00781859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338146|NCT01344252|Lidocaine|lidocaine|mesh-list
65338147|NCT01344252|Anesthetics, Local|anesthetics, local|mesh-ancestor
65338148|NCT01344252|Anesthetics|anesthetics|mesh-ancestor
65338149|NCT01344252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65338150|NCT01344252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338151|NCT01344252|Sensory System Agents|sensory system agents|mesh-ancestor
65338152|NCT01344252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65338153|NCT01344252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65338154|NCT01344252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65338155|NCT01344252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65338156|NCT01344252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65338157|NCT01344252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338158|NCT04101383|Insulin|insulin|mesh-list
65338159|NCT04101383|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65338160|NCT04101383|Insulin Glargine|insulin glargine|mesh-list
65338161|NCT04101383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65338162|NCT04101383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338163|NCT02576808|Loratadine|loratadine|mesh-list
65249404|NCT02824458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249405|NCT02824458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65249406|NCT02824458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249407|NCT02824458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249408|NCT00840931|Lenalidomide|lenalidomide|mesh-list
65249409|NCT00840931|Immunologic Factors|immunologic factors|mesh-ancestor
65249410|NCT00840931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249447|NCT00834457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249448|NCT00834457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65249449|NCT00834457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65249450|NCT00834457|Antiviral Agents|antiviral agents|mesh-ancestor
65249476|NCT02824926|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65249477|NCT02824926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65249478|NCT02824926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249479|NCT02824926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249480|NCT02824926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65249481|NCT02824926|Hormone Antagonists|hormone antagonists|mesh-ancestor
65249482|NCT02824926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65249483|NCT02824926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249484|NCT02824926|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65249485|NCT00705471|Infliximab|infliximab|mesh-list
65249486|NCT00705471|Dermatologic Agents|dermatologic agents|mesh-ancestor
65249487|NCT00705471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65249488|NCT00705471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65249489|NCT00705549|Gemcitabine|gemcitabine|mesh-list
65249490|NCT00705549|Cisplatin|cisplatin|mesh-list
65249491|NCT00705549|Docetaxel|docetaxel|mesh-list
65249492|NCT00705549|Vinorelbine|vinorelbine|mesh-list
65249493|NCT00705549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249494|NCT00705549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65249495|NCT00705549|Antimetabolites|antimetabolites|mesh-ancestor
64721739|NCT00002474|Alkylating Agents|alkylating agents|mesh-ancestor
64721740|NCT00002474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721741|NCT00002474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721742|NCT00002474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64721743|NCT00002474|Analgesics|analgesics|mesh-ancestor
64721744|NCT00002474|Sensory System Agents|sensory system agents|mesh-ancestor
64721745|NCT00002474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64721746|NCT00002474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64721747|NCT00002474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64329521|NCT02187497|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64329524|NCT04195750|Everolimus|everolimus|mesh-list
65338164|NCT02576808|Antipruritics|antipruritics|mesh-ancestor
65338165|NCT02576808|Dermatologic Agents|dermatologic agents|mesh-ancestor
65338166|NCT02576808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65338167|NCT02576808|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65338168|NCT02576808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65338169|NCT02576808|Histamine Antagonists|histamine antagonists|mesh-ancestor
65338170|NCT02576808|Histamine Agents|histamine agents|mesh-ancestor
65338171|NCT02576808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65338172|NCT02576808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338173|NCT02576808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338174|NCT00580788|Parathyroid Hormone|parathyroid hormone|mesh-list
65338175|NCT00580788|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
65338176|NCT00580788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338177|NCT00580788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65338178|NCT04073160|Durvalumab|durvalumab|mesh-list
65338179|NCT04073160|Tremelimumab|tremelimumab|mesh-list
65338180|NCT04073160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65338181|NCT04073160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338182|NCT00417079|Prednisone|prednisone|mesh-list
65338183|NCT00417079|Mitoxantrone|mitoxantrone|mesh-list
65338184|NCT00417079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65338185|NCT00417079|Glucocorticoids|glucocorticoids|mesh-ancestor
65338186|NCT00417079|Hormones|hormones|mesh-ancestor
65338187|NCT00417079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65338190|NCT00417079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338191|NCT00417079|Analgesics|analgesics|mesh-ancestor
65338192|NCT00417079|Sensory System Agents|sensory system agents|mesh-ancestor
65338193|NCT00417079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65338194|NCT00417079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65338195|NCT00417079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65338196|NCT00417079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338197|NCT00417079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338198|NCT02578914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65338199|NCT02578914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65338200|NCT00429169|Bupropion|bupropion|mesh-list
65338201|NCT00429169|Paroxetine|paroxetine|mesh-list
65338202|NCT00429169|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65338203|NCT00429169|Antidepressive Agents|antidepressive agents|mesh-ancestor
65338204|NCT00429169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65338205|NCT00429169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65338206|NCT00429169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65338207|NCT00429169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65338208|NCT00429169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338209|NCT00429169|Dopamine Agents|dopamine agents|mesh-ancestor
65338210|NCT00429169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65338211|NCT00429169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338212|NCT00429169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65338213|NCT00429169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65338214|NCT00429169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338215|NCT00429169|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65338216|NCT00429169|Serotonin Agents|serotonin agents|mesh-ancestor
65338217|NCT01037491|Aspirin|aspirin|mesh-list
65338218|NCT01037491|Rabeprazole|rabeprazole|mesh-list
65338219|NCT01037491|Clopidogrel|clopidogrel|mesh-list
65338221|NCT01037491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65338231|NCT01037491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65338232|NCT01037491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65338233|NCT01037491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338235|NCT01037491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65338236|NCT01037491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65338237|NCT01037491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65338238|NCT01037491|Purinergic Agents|purinergic agents|mesh-ancestor
65338239|NCT01037491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65338240|NCT01037491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65338241|NCT01037491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65338242|NCT01037491|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65338243|NCT01033279|Warfarin|warfarin|mesh-list
65338244|NCT01033279|Anticoagulants|anticoagulants|mesh-ancestor
65338245|NCT01188096|Poly ICLC|poly iclc|mesh-list
65338246|NCT01188096|Interferon Inducers|interferon inducers|mesh-ancestor
65338247|NCT01188096|Immunologic Factors|immunologic factors|mesh-ancestor
65338248|NCT01188096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338249|NCT04745832|Prednisone|prednisone|mesh-list
65338250|NCT04745832|Cyclophosphamide|cyclophosphamide|mesh-list
65338251|NCT04745832|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65338252|NCT04745832|Rituximab|rituximab|mesh-list
65338253|NCT04745832|Vincristine|vincristine|mesh-list
65338254|NCT04745832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65338255|NCT04745832|Immunologic Factors|immunologic factors|mesh-ancestor
65338256|NCT04745832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338257|NCT04745832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65338258|NCT04745832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65338259|NCT04745832|Alkylating Agents|alkylating agents|mesh-ancestor
65338260|NCT04745832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338261|NCT04745832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338262|NCT04745832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65338263|NCT04745832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65338264|NCT04745832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65338265|NCT04745832|Glucocorticoids|glucocorticoids|mesh-ancestor
65338266|NCT04745832|Hormones|hormones|mesh-ancestor
65338267|NCT04745832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65338268|NCT04745832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64721790|NCT02373865|Protease Inhibitors|protease inhibitors|mesh-ancestor
64721791|NCT02373865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721792|NCT02373865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721793|NCT02373865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64721794|NCT02373865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64721795|NCT02373865|Immunologic Factors|immunologic factors|mesh-ancestor
64721796|NCT00002498|Cyclophosphamide|cyclophosphamide|mesh-list
64721797|NCT00002498|Fluorouracil|fluorouracil|mesh-list
64721798|NCT00002498|Methotrexate|methotrexate|mesh-list
65338269|NCT04745832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65338270|NCT04745832|Tubulin Modulators|tubulin modulators|mesh-ancestor
65338271|NCT04745832|Antimitotic Agents|antimitotic agents|mesh-ancestor
65338272|NCT04745832|Mitosis Modulators|mitosis modulators|mesh-ancestor
65338273|NCT04619004|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
65338274|NCT04619004|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65338275|NCT04619004|Immunologic Factors|immunologic factors|mesh-ancestor
65338276|NCT04619004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338277|NCT04619004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65338278|NCT04619004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338279|NCT02576340|Octylonium|octylonium|mesh-list
65338280|NCT02576340|Bromides|bromides|mesh-list
65338281|NCT02576340|Anticonvulsants|anticonvulsants|mesh-ancestor
64721806|NCT00002498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721807|NCT00002498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721808|NCT00002498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64721809|NCT00002498|Antimetabolites|antimetabolites|mesh-ancestor
64721810|NCT00002498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64721811|NCT00002498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64721812|NCT00002498|Abortifacient Agents|abortifacient agents|mesh-ancestor
64721813|NCT00002498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64721814|NCT00002498|Dermatologic Agents|dermatologic agents|mesh-ancestor
64721815|NCT00002498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329575|NCT02296840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65338314|NCT00128856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338315|NCT00128856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65338316|NCT00128856|Antimetabolites|antimetabolites|mesh-ancestor
65338317|NCT00128856|Antiviral Agents|antiviral agents|mesh-ancestor
65338318|NCT00128856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65338319|NCT00128856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338320|NCT00128856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65338321|NCT00128856|Immunologic Factors|immunologic factors|mesh-ancestor
65338322|NCT00128856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338323|NCT00128856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65338324|NCT00128856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65338325|NCT00128856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65338326|NCT00128778|Doxorubicin|doxorubicin|mesh-list
65338327|NCT00128778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65338328|NCT00128778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65338329|NCT00128778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338330|NCT00128778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65338331|NCT00128778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65338332|NCT00128778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338333|NCT00128778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338334|NCT00709488|Talaporfin|talaporfin|mesh-list
64721816|NCT00002498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64721817|NCT00002498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64721818|NCT00002498|Analgesics|analgesics|mesh-ancestor
64721819|NCT00002498|Sensory System Agents|sensory system agents|mesh-ancestor
64721820|NCT00002498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64721821|NCT00002498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64721822|NCT00002498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64721823|NCT00002504|Interferons|interferons|mesh-list
64721824|NCT00002504|Interferon-alpha|interferon-alpha|mesh-list
64721825|NCT00002504|Aldesleukin|aldesleukin|mesh-list
64721826|NCT00002504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329581|NCT02191319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329582|NCT02191319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495321|NCT01105702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495322|NCT01105702|Growth Inhibitors|growth inhibitors|mesh-ancestor
64495323|NCT01105702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64495324|NCT01105702|Alkylating Agents|alkylating agents|mesh-ancestor
64495325|NCT01105702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495326|NCT01105702|Antidepressive Agents|antidepressive agents|mesh-ancestor
65338344|NCT00714246|Mitosis Modulators|mitosis modulators|mesh-ancestor
65338346|NCT00416455|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65338378|NCT00415597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338379|NCT00415597|Analgesics|analgesics|mesh-ancestor
65338380|NCT00415597|Sensory System Agents|sensory system agents|mesh-ancestor
65338381|NCT00415597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65338382|NCT00415597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65338383|NCT00415597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65338384|NCT04454658|Navitoclax|navitoclax|mesh-list
65338385|NCT04454658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338386|NCT00714480|Thymoglobulin|thymoglobulin|mesh-list
65338387|NCT00714480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65338388|NCT00714480|Immunologic Factors|immunologic factors|mesh-ancestor
65338389|NCT00714480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338390|NCT00714480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65338391|NCT00714558|Fentanyl|fentanyl|mesh-list
65338392|NCT00714558|Naltrexone|naltrexone|mesh-list
65338393|NCT00714558|Naloxone|naloxone|mesh-list
65338394|NCT00714558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65338395|NCT00714558|Narcotics|narcotics|mesh-ancestor
65338396|NCT00714558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65338397|NCT00714558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338398|NCT00714558|Analgesics|analgesics|mesh-ancestor
65338399|NCT00714558|Sensory System Agents|sensory system agents|mesh-ancestor
65338400|NCT00714558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65338401|NCT00714558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65338402|NCT00714558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65338403|NCT00714558|Anesthetics, General|anesthetics, general|mesh-ancestor
65338404|NCT00714558|Anesthetics|anesthetics|mesh-ancestor
65338405|NCT00714558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65338406|NCT00714558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65338407|NCT02575638|Camptothecin|camptothecin|mesh-list
65338408|NCT02575638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65338409|NCT02575638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338424|NCT02573610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338425|NCT02573610|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65338426|NCT02573610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65338427|NCT02574468|Dexamethasone|dexamethasone|mesh-list
65338428|NCT02574468|Dexamethasone acetate|dexamethasone acetate|mesh-list
65338429|NCT02574468|BB 1101|bb 1101|mesh-list
65338430|NCT02574468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65338431|NCT02574468|Antiemetics|antiemetics|mesh-ancestor
65338432|NCT02574468|Autonomic Agents|autonomic agents|mesh-ancestor
65338433|NCT02574468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65338434|NCT02574468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338435|NCT02574468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65338436|NCT02574468|Glucocorticoids|glucocorticoids|mesh-ancestor
65338437|NCT02574468|Hormones|hormones|mesh-ancestor
65338438|NCT02574468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65338439|NCT02574468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65338440|NCT02574468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338441|NCT02574468|Protease Inhibitors|protease inhibitors|mesh-ancestor
65338442|NCT02574468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338443|NCT02574468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338444|NCT00710268|Bevacizumab|bevacizumab|mesh-list
65338445|NCT00710268|Olaparib|olaparib|mesh-list
65338446|NCT00710268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65338447|NCT00710268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338448|NCT00710268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65338449|NCT00710268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65338450|NCT00710268|Growth Substances|growth substances|mesh-ancestor
65338451|NCT00710268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338452|NCT00710268|Growth Inhibitors|growth inhibitors|mesh-ancestor
65338454|NCT00710268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721876|NCT00002516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64721877|NCT00002516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64721878|NCT00002516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721879|NCT00002516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64721880|NCT00002516|Tubulin Modulators|tubulin modulators|mesh-ancestor
64721881|NCT00002516|Antimitotic Agents|antimitotic agents|mesh-ancestor
64721882|NCT00002516|Mitosis Modulators|mitosis modulators|mesh-ancestor
64721883|NCT00002516|Trace Elements|trace elements|mesh-ancestor
64721884|NCT00002516|Micronutrients|micronutrients|mesh-ancestor
64721885|NCT00002516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64721886|NCT00002516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721887|NCT00002516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64329630|NCT00071461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64329631|NCT00071461|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64329632|NCT00071461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329633|NCT00069745|Prednisone|prednisone|mesh-list
64329634|NCT00069745|Satraplatin|satraplatin|mesh-list
64495327|NCT01105702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64495328|NCT01105702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338467|NCT02575248|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65338470|NCT02575248|Contraceptive Agents|contraceptive agents|mesh-ancestor
65338501|NCT00851344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65338502|NCT00851344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65338503|NCT00851344|Histamine Antagonists|histamine antagonists|mesh-ancestor
65338504|NCT00851344|Histamine Agents|histamine agents|mesh-ancestor
65338505|NCT00851344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65338506|NCT00851344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338507|NCT00851344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338508|NCT04523922|Oxytocin|oxytocin|mesh-list
65338509|NCT04523922|Oxytocics|oxytocics|mesh-ancestor
65338510|NCT04523922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65338511|NCT04523922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338512|NCT00711204|Donepezil|donepezil|mesh-list
65338513|NCT00711204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65338514|NCT00711204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338515|NCT00711204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338516|NCT00711204|Cholinergic Agents|cholinergic agents|mesh-ancestor
65338517|NCT00711204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65338518|NCT00711204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338519|NCT00711204|Nootropic Agents|nootropic agents|mesh-ancestor
65338520|NCT05810792|Interleukin-2|interleukin-2|mesh-list
65338521|NCT05810792|Histamine|histamine|mesh-list
65338522|NCT05810792|Histamine phosphate|histamine phosphate|mesh-list
65338523|NCT05810792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338524|NCT05810792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65338525|NCT05810792|Analgesics|analgesics|mesh-ancestor
65338526|NCT05810792|Sensory System Agents|sensory system agents|mesh-ancestor
65338527|NCT05810792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64721907|NCT00002528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64721908|NCT00002528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721909|NCT00002528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64721910|NCT00002528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721911|NCT00002528|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64721912|NCT00002528|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65338549|NCT05810558|Glycine Agents|glycine agents|mesh-ancestor
65338550|NCT05810558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65338551|NCT05810558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338552|NCT05810558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338553|NCT05810480|Immunoglobulins|immunoglobulins|mesh-list
65338554|NCT05810480|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65338555|NCT05810480|Antibodies|antibodies|mesh-list
65338556|NCT05810480|Immunoglobulin G|immunoglobulin g|mesh-list
65338557|NCT05810480|Autoantibodies|autoantibodies|mesh-list
65338558|NCT05810480|Immunologic Factors|immunologic factors|mesh-ancestor
65338559|NCT05810480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338560|NCT05810389|Fluorides|fluorides|mesh-list
65338561|NCT05810389|Cariostatic Agents|cariostatic agents|mesh-ancestor
65338562|NCT05810389|Protective Agents|protective agents|mesh-ancestor
65338563|NCT05810389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338564|NCT05810311|Darbepoetin alfa|darbepoetin alfa|mesh-list
65338565|NCT05810311|Hematinics|hematinics|mesh-ancestor
65338566|NCT05809986|Ofatumumab|ofatumumab|mesh-list
65338567|NCT05809986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338568|NCT05809895|Gemcitabine|gemcitabine|mesh-list
65338569|NCT05809895|Paclitaxel|paclitaxel|mesh-list
65338570|NCT05809895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65338571|NCT05809895|Carboplatin|carboplatin|mesh-list
65338572|NCT05809895|Pembrolizumab|pembrolizumab|mesh-list
65338573|NCT05809895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65338574|NCT05809895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338575|NCT05809895|Tubulin Modulators|tubulin modulators|mesh-ancestor
65338576|NCT05809895|Antimitotic Agents|antimitotic agents|mesh-ancestor
65338577|NCT05809895|Mitosis Modulators|mitosis modulators|mesh-ancestor
65249496|NCT00705549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249497|NCT00705549|Antiviral Agents|antiviral agents|mesh-ancestor
65249498|NCT00705549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65249499|NCT00705549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249500|NCT00705549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65249501|NCT00705549|Immunologic Factors|immunologic factors|mesh-ancestor
65338578|NCT05809895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338579|NCT05809895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65338580|NCT05809895|Antimetabolites|antimetabolites|mesh-ancestor
65338581|NCT05809895|Antiviral Agents|antiviral agents|mesh-ancestor
65338582|NCT05809895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65338583|NCT05809895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338584|NCT05809895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65338585|NCT05809895|Immunologic Factors|immunologic factors|mesh-ancestor
65338586|NCT05809895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338587|NCT05809895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65338588|NCT05809869|Durvalumab|durvalumab|mesh-list
65338589|NCT05809869|Tremelimumab|tremelimumab|mesh-list
65338590|NCT05809869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65338591|NCT05809869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338592|NCT05809843|Pancrelipase|pancrelipase|mesh-list
65338593|NCT05809843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65338594|NCT05809830|Doxorubicin|doxorubicin|mesh-list
65338595|NCT05809830|LB100|lb100|mesh-list
65338596|NCT05809830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65338597|NCT05809830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338598|NCT05809830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65338599|NCT05809830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65338600|NCT05809830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338601|NCT05809830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338602|NCT05809804|Esketamine|esketamine|mesh-list
65338603|NCT05809804|Antidepressive Agents|antidepressive agents|mesh-ancestor
65338604|NCT05809804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65338605|NCT05809700|Hyaluronic Acid|hyaluronic acid|mesh-list
65338606|NCT05809700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65338607|NCT05809700|Immunologic Factors|immunologic factors|mesh-ancestor
65338608|NCT05809700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338609|NCT05809700|Viscosupplements|viscosupplements|mesh-ancestor
65338610|NCT05809700|Protective Agents|protective agents|mesh-ancestor
64721940|NCT00002534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64721941|NCT00002534|Alkylating Agents|alkylating agents|mesh-ancestor
64721942|NCT00002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721943|NCT00002534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721944|NCT00002534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64721945|NCT00002534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64721946|NCT00002534|Antimetabolites|antimetabolites|mesh-ancestor
64721947|NCT00002534|Antiviral Agents|antiviral agents|mesh-ancestor
64721948|NCT00002534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721949|NCT00002534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65338622|NCT05809609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65338623|NCT05809609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65338624|NCT05809609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338625|NCT05809518|Dexmedetomidine|dexmedetomidine|mesh-list
65338626|NCT05809518|Propofol|propofol|mesh-list
65338627|NCT05809518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65338628|NCT05809518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65338629|NCT05809518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338630|NCT05809518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65338631|NCT05809518|Anesthetics, General|anesthetics, general|mesh-ancestor
65338632|NCT05809518|Anesthetics|anesthetics|mesh-ancestor
65338633|NCT05809518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65338634|NCT05809518|Analgesics|analgesics|mesh-ancestor
65338635|NCT05809518|Sensory System Agents|sensory system agents|mesh-ancestor
65338636|NCT05809518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64329692|NCT02192723|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64495436|NCT01106950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64495437|NCT01106950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64495438|NCT01106950|Alkylating Agents|alkylating agents|mesh-ancestor
64495439|NCT01106950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495440|NCT01106950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495441|NCT01106950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64495442|NCT01106950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65338660|NCT05809336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65338661|NCT05809336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338662|NCT05809336|Immunologic Factors|immunologic factors|mesh-ancestor
65338663|NCT05809336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338664|NCT05809336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338665|NCT05809297|Ciclopirox|ciclopirox|mesh-list
65338666|NCT05809297|Chitosan|chitosan|mesh-list
65338667|NCT05809297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65338668|NCT05809297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65338669|NCT05809297|Antimetabolites|antimetabolites|mesh-ancestor
64495443|NCT01106950|Analgesics|analgesics|mesh-ancestor
64495446|NCT03463044|Nangibotide|nangibotide|mesh-list
65249535|NCT00831129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249536|NCT00637962|polysaccharide-K|polysaccharide-k|mesh-list
65249537|NCT00637962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65249538|NCT00637962|Immunologic Factors|immunologic factors|mesh-ancestor
65249539|NCT00637962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249540|NCT00637962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65249541|NCT00637962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924877|NCT00030238|Calcium|calcium|mesh-list
65249576|NCT00633672|Esomeprazole|esomeprazole|mesh-list
65249577|NCT00633672|Ranitidine|ranitidine|mesh-list
65249578|NCT00633672|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65249579|NCT00633672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65249580|NCT00633672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65249581|NCT00633672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65249582|NCT00633672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304108|NCT03067688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249613|NCT00834847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249615|NCT00841477|Immunologic Factors|immunologic factors|mesh-ancestor
65249616|NCT00841477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249617|NCT00834925|Diltiazem|diltiazem|mesh-list
65249618|NCT00834925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65249619|NCT00834925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65249620|NCT00834925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65249621|NCT00834925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249622|NCT00834925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65249623|NCT00834925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249624|NCT00834925|Vasodilator Agents|vasodilator agents|mesh-ancestor
65249625|NCT00841633|Norepinephrine|norepinephrine|mesh-list
65249652|NCT00841789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249653|NCT00841789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65249655|NCT00841789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65249656|NCT00841789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65249657|NCT00841789|Immunologic Factors|immunologic factors|mesh-ancestor
65249658|NCT00841945|Prednisone|prednisone|mesh-list
65249659|NCT00841945|Rituximab|rituximab|mesh-list
65249660|NCT00841945|Doxorubicin|doxorubicin|mesh-list
65338670|NCT05809297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338671|NCT05809297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65338672|NCT05809297|Chelating Agents|chelating agents|mesh-ancestor
65338673|NCT05809297|Sequestering Agents|sequestering agents|mesh-ancestor
65338674|NCT05809297|Hemostatics|hemostatics|mesh-ancestor
65338675|NCT05809297|Coagulants|coagulants|mesh-ancestor
65338676|NCT05809297|Antifungal Agents|antifungal agents|mesh-ancestor
65338677|NCT05809297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65338678|NCT05809271|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65338679|NCT05809271|Hallucinogens|hallucinogens|mesh-ancestor
65338680|NCT05809271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338681|NCT05809271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65338682|NCT05809271|Serotonin Agents|serotonin agents|mesh-ancestor
65338683|NCT05809271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65338684|NCT05809271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338685|NCT05809271|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65088534|NCT00593164|Anesthetics|anesthetics|mesh-ancestor
65338686|NCT05809271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65338687|NCT05809271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65338688|NCT05809271|Adrenergic Agents|adrenergic agents|mesh-ancestor
65338690|NCT05809024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338691|NCT05809024|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65338692|NCT05809024|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65338693|NCT05809024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338694|NCT05809024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338695|NCT05809024|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65338696|NCT05809024|Hormone Antagonists|hormone antagonists|mesh-ancestor
65338697|NCT05809024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65338698|NCT05809024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338699|NCT05809011|Dexamethasone|dexamethasone|mesh-list
65338700|NCT05809011|Prednisone|prednisone|mesh-list
65338701|NCT05809011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65338702|NCT05809011|Antiemetics|antiemetics|mesh-ancestor
65338703|NCT05809011|Autonomic Agents|autonomic agents|mesh-ancestor
65338708|NCT05809011|Hormones|hormones|mesh-ancestor
64721978|NCT00378625|Antiviral Agents|antiviral agents|mesh-ancestor
64721979|NCT00378625|Schistosomicides|schistosomicides|mesh-ancestor
64721980|NCT00378625|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64721981|NCT00378625|Anthelmintics|anthelmintics|mesh-ancestor
64721982|NCT04005391|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64721983|NCT04005391|Contraceptive Agents|contraceptive agents|mesh-list
64721984|NCT04005391|Levonorgestrel|levonorgestrel|mesh-list
64721985|NCT04005391|Medroxyprogesterone|medroxyprogesterone|mesh-list
64721986|NCT04005391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64721987|NCT04005391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721988|NCT04005391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64721989|NCT04005391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64329719|NCT00317395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65338709|NCT05809011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65338710|NCT05809011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65338711|NCT05809011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338712|NCT05808985|Butyric Acid|butyric acid|mesh-list
65338713|NCT05808985|Histamine Antagonists|histamine antagonists|mesh-ancestor
65338714|NCT05808985|Histamine Agents|histamine agents|mesh-ancestor
65338715|NCT05808985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65338716|NCT05808985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338717|NCT05808985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338718|NCT05808972|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65338719|NCT05808946|Thioctic Acid|thioctic acid|mesh-list
65338720|NCT05808946|Antioxidants|antioxidants|mesh-ancestor
65338721|NCT05808946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338722|NCT05808946|Protective Agents|protective agents|mesh-ancestor
65338725|NCT05808946|Vitamins|vitamins|mesh-ancestor
65338740|NCT05806346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338741|NCT05806346|Hemostatics|hemostatics|mesh-ancestor
65338742|NCT05806346|Coagulants|coagulants|mesh-ancestor
65338743|NCT05792540|Dapagliflozin|dapagliflozin|mesh-list
65338744|NCT05792540|Fluoxetine|fluoxetine|mesh-list
65338745|NCT05792540|Atorvastatin|atorvastatin|mesh-list
65338746|NCT05792540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65338747|NCT05792540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65338748|NCT05792540|Antimetabolites|antimetabolites|mesh-ancestor
65338749|NCT05792540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338750|NCT05792540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65338751|NCT05792540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65338752|NCT05792540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338753|NCT05792540|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65338754|NCT05792540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65338755|NCT05792540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338756|NCT05792540|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65338757|NCT05792540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64721991|NCT04005391|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65249661|NCT00841945|Vincristine|vincristine|mesh-list
65249662|NCT00841945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65249663|NCT00841945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249664|NCT00841945|Immunologic Factors|immunologic factors|mesh-ancestor
65249665|NCT00841945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249666|NCT00841945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65249667|NCT00841945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65249668|NCT00841945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65249669|NCT00841945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65249670|NCT00841945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249671|NCT00841945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249672|NCT00841945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64924999|NCT00030862|Irinotecan|irinotecan|mesh-list
65249702|NCT00849355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65249703|NCT00849355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249704|NCT00849355|Immunologic Factors|immunologic factors|mesh-ancestor
65249705|NCT00849355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249706|NCT00849355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65249707|NCT00835393|Pantoprazole|pantoprazole|mesh-list
65249708|NCT00835393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65249709|NCT00835393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65249710|NCT00835393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65249711|NCT00835393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249712|NCT00835393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249713|NCT00706173|Hydrocortisone|hydrocortisone|mesh-list
65249714|NCT00706173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65249715|NCT02822742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65249742|NCT00966875|Dermatologic Agents|dermatologic agents|mesh-ancestor
65249743|NCT00849745|Alemtuzumab|alemtuzumab|mesh-list
65249744|NCT00849745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65249745|NCT00849745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249746|NCT00835627|Sertraline|sertraline|mesh-list
65249747|NCT00835627|Antidepressive Agents|antidepressive agents|mesh-ancestor
65249748|NCT00835627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65249749|NCT00835627|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64722000|NCT00002552|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64722001|NCT00002552|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64722002|NCT00002552|Cyclophosphamide|cyclophosphamide|mesh-list
64722003|NCT00002552|Carmustine|carmustine|mesh-list
64722004|NCT00002552|Methotrexate|methotrexate|mesh-list
64722005|NCT00002552|Etoposide|etoposide|mesh-list
64722006|NCT00002552|Sargramostim|sargramostim|mesh-list
64722007|NCT00002552|Levoleucovorin|levoleucovorin|mesh-list
64722008|NCT00002552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64722009|NCT00002552|Immunologic Factors|immunologic factors|mesh-ancestor
64329735|NCT02380755|Enclomiphene|enclomiphene|mesh-list
64329736|NCT02380755|Zuclomiphene|zuclomiphene|mesh-list
64329737|NCT02380755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64329738|NCT02380755|Hormone Antagonists|hormone antagonists|mesh-ancestor
64329739|NCT02380755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64329740|NCT02380755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495573|NCT02460588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64495574|NCT02460588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64495575|NCT02460588|Alkylating Agents|alkylating agents|mesh-ancestor
65338758|NCT05792540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65338759|NCT05792540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65338760|NCT05792540|Serotonin Agents|serotonin agents|mesh-ancestor
65338761|NCT05792540|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65338762|NCT05792540|Antidepressive Agents|antidepressive agents|mesh-ancestor
65338763|NCT05792540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65338767|NCT05781711|Levodopa|levodopa|mesh-list
64722010|NCT00002552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722011|NCT00002552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64722012|NCT00002552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64722013|NCT00002552|Alkylating Agents|alkylating agents|mesh-ancestor
64722014|NCT00002552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722015|NCT00002552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338790|NCT05737576|Insulin, Long-Acting|insulin, long-acting|mesh-list
65338791|NCT05737576|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65338792|NCT05737576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65338793|NCT05737576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338794|NCT05736874|Fluticasone|fluticasone|mesh-list
65338795|NCT05736874|Xhance|xhance|mesh-list
65338796|NCT05736874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65338797|NCT05736874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65338798|NCT05736874|Autonomic Agents|autonomic agents|mesh-ancestor
65338799|NCT05736874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65338800|NCT05736874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338801|NCT05736874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65338802|NCT05736874|Respiratory System Agents|respiratory system agents|mesh-ancestor
65338803|NCT05736874|Dermatologic Agents|dermatologic agents|mesh-ancestor
65338804|NCT05736874|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65338805|NCT05720988|Azacitidine|azacitidine|mesh-list
65338806|NCT05720988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65338807|NCT05720988|Antimetabolites|antimetabolites|mesh-ancestor
65338808|NCT05720988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338809|NCT05720988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338810|NCT05720988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338811|NCT05716763|Tramadol|tramadol|mesh-list
65338812|NCT05716763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65338813|NCT05716763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65338814|NCT05716763|Narcotics|narcotics|mesh-ancestor
65338815|NCT05716763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65338816|NCT05716763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338817|NCT05716763|Analgesics|analgesics|mesh-ancestor
65338818|NCT05716763|Sensory System Agents|sensory system agents|mesh-ancestor
64722022|NCT00002552|Dermatologic Agents|dermatologic agents|mesh-ancestor
64722023|NCT00002552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64722024|NCT00002552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64722025|NCT00002552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64722026|NCT00002552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64722027|NCT00002552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64722028|NCT00002552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64722029|NCT00002552|Antiviral Agents|antiviral agents|mesh-ancestor
64722030|NCT00002552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64329753|NCT02188277|Cholinergic Agents|cholinergic agents|mesh-ancestor
64329756|NCT02188277|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65338823|NCT05716009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65338824|NCT05716009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338825|NCT05706753|Drospirenone|drospirenone|mesh-list
65338826|NCT05706753|Midazolam|midazolam|mesh-list
65338827|NCT05706753|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65338828|NCT05706753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65338829|NCT05706753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65338830|NCT05706753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65338831|NCT05706753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338832|NCT05706753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65338833|NCT05706753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65338834|NCT05706753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65088695|NCT00468533|Aripiprazole|aripiprazole|mesh-list
65338835|NCT05706753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65338836|NCT05706753|Anesthetics, General|anesthetics, general|mesh-ancestor
65338837|NCT05706753|Anesthetics|anesthetics|mesh-ancestor
65338838|NCT05706753|GABA Modulators|gaba modulators|mesh-ancestor
65338839|NCT05706753|GABA Agents|gaba agents|mesh-ancestor
65338840|NCT05706753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65338841|NCT05706753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338842|NCT05706753|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65338843|NCT05706753|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65338844|NCT05706753|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65338845|NCT05706753|Contraceptive Agents|contraceptive agents|mesh-ancestor
65338846|NCT05706753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65338848|NCT05706753|Estrogens|estrogens|mesh-ancestor
64722031|NCT00002552|Antidotes|antidotes|mesh-ancestor
64722032|NCT00002552|Protective Agents|protective agents|mesh-ancestor
64722033|NCT00002552|Vitamin B Complex|vitamin b complex|mesh-ancestor
64722034|NCT00002552|Vitamins|vitamins|mesh-ancestor
64722035|NCT00002552|Micronutrients|micronutrients|mesh-ancestor
64722036|NCT00002552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64722037|NCT05750966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64722038|NCT05750966|Ciprofloxacin|ciprofloxacin|mesh-list
64722039|NCT05750966|Gentamicins|gentamicins|mesh-list
64722040|NCT05750966|Ceftriaxone|ceftriaxone|mesh-list
64329762|NCT02380521|Incretins|incretins|mesh-ancestor
64329763|NCT02380521|Hormones|hormones|mesh-ancestor
64329764|NCT02380521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64329765|NCT00315757|Bortezomib|bortezomib|mesh-list
64329766|NCT00315757|Mapatumumab|mapatumumab|mesh-list
64329767|NCT00315757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65338850|NCT05706753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65338851|NCT05706753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65338852|NCT05706753|Hormone Antagonists|hormone antagonists|mesh-ancestor
65338853|NCT05706753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65338854|NCT05706753|Diuretics|diuretics|mesh-ancestor
65338855|NCT05706753|Natriuretic Agents|natriuretic agents|mesh-ancestor
65338856|NCT05696938|Niacinamide|niacinamide|mesh-list
65338857|NCT05696938|Niacin|niacin|mesh-list
65338858|NCT05696938|Nicotinic Acids|nicotinic acids|mesh-list
65338859|NCT05696938|Vitamin B Complex|vitamin b complex|mesh-ancestor
65338860|NCT05696938|Vitamins|vitamins|mesh-ancestor
65338861|NCT05696938|Micronutrients|micronutrients|mesh-ancestor
65338862|NCT05696938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338863|NCT05696938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65338864|NCT05696938|Antimetabolites|antimetabolites|mesh-ancestor
65338882|NCT05695508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338883|NCT05695508|Immunologic Factors|immunologic factors|mesh-ancestor
65338884|NCT05695508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65338885|NCT05695508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65338886|NCT05695508|Growth Substances|growth substances|mesh-ancestor
65338887|NCT05695508|Growth Inhibitors|growth inhibitors|mesh-ancestor
65338888|NCT05694533|Midazolam|midazolam|mesh-list
65338889|NCT05694533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65338890|NCT05694533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65338891|NCT05694533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65338892|NCT05694533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338893|NCT05694533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65338894|NCT05694533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65338895|NCT05694533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65338896|NCT05694533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65338897|NCT05694533|Anesthetics, General|anesthetics, general|mesh-ancestor
65338898|NCT05694533|Anesthetics|anesthetics|mesh-ancestor
65338899|NCT05694533|GABA Modulators|gaba modulators|mesh-ancestor
65338900|NCT05694533|GABA Agents|gaba agents|mesh-ancestor
65338901|NCT05694533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65338902|NCT05694533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338903|NCT05681715|Rozanolixizumab|rozanolixizumab|mesh-list
65338904|NCT05681715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65338905|NCT05681715|Immunologic Factors|immunologic factors|mesh-ancestor
65338906|NCT05681715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338907|NCT05679908|Oxytocin|oxytocin|mesh-list
65338908|NCT05679908|Oxytocics|oxytocics|mesh-ancestor
65338909|NCT05679908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65338910|NCT05679908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338911|NCT05671562|Lycopene|lycopene|mesh-list
65338912|NCT05671562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65338913|NCT05671562|Antioxidants|antioxidants|mesh-ancestor
65338914|NCT05671562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338915|NCT05671562|Protective Agents|protective agents|mesh-ancestor
65338916|NCT05671562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338917|NCT05671562|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65249750|NCT00835627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65249751|NCT00835627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64722058|NCT00377923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722059|NCT00002570|Leucovorin|leucovorin|mesh-list
64722060|NCT00002570|Fluorouracil|fluorouracil|mesh-list
64722061|NCT00002570|Calcium|calcium|mesh-list
64722062|NCT00002570|Levoleucovorin|levoleucovorin|mesh-list
64722063|NCT00002570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64722064|NCT00002570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722065|NCT00002570|Antimetabolites|antimetabolites|mesh-ancestor
64722066|NCT00002570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338918|NCT05671562|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65338919|NCT05671562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338920|NCT05669820|Antisecretory factor|antisecretory factor|mesh-list
65338921|NCT05669820|Antidiarrheals|antidiarrheals|mesh-ancestor
65338922|NCT05669820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65338923|NCT05663866|Dexamethasone|dexamethasone|mesh-list
65338924|NCT05663866|Methotrexate|methotrexate|mesh-list
65338925|NCT05663866|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
65338926|NCT05663866|Montelukast|montelukast|mesh-list
65338927|NCT05663866|Lazertinib|lazertinib|mesh-list
65338928|NCT05663866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65338929|NCT05663866|Antiemetics|antiemetics|mesh-ancestor
65338930|NCT05663866|Autonomic Agents|autonomic agents|mesh-ancestor
65338931|NCT05663866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65338932|NCT05663866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338933|NCT05663866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65338934|NCT05663866|Glucocorticoids|glucocorticoids|mesh-ancestor
65338935|NCT05663866|Hormones|hormones|mesh-ancestor
65338936|NCT05663866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65338937|NCT05663866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65338938|NCT05663866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338939|NCT05663866|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65338940|NCT05663866|Abortifacient Agents|abortifacient agents|mesh-ancestor
65338941|NCT05663866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64722070|NCT00002570|Immunologic Factors|immunologic factors|mesh-ancestor
64722071|NCT00002570|Antidotes|antidotes|mesh-ancestor
64722072|NCT00002570|Protective Agents|protective agents|mesh-ancestor
64722073|NCT00002570|Vitamin B Complex|vitamin b complex|mesh-ancestor
64722074|NCT00002570|Vitamins|vitamins|mesh-ancestor
64722075|NCT00002570|Micronutrients|micronutrients|mesh-ancestor
64722076|NCT00002576|Prednisolone|prednisolone|mesh-list
64722077|NCT00002576|Cyclophosphamide|cyclophosphamide|mesh-list
64722078|NCT00002576|Doxorubicin|doxorubicin|mesh-list
64722079|NCT00002576|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64722080|NCT00002576|Vincristine|vincristine|mesh-list
65338951|NCT05663866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65338952|NCT05663866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65338953|NCT05663866|Respiratory System Agents|respiratory system agents|mesh-ancestor
65338954|NCT05663866|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65338955|NCT05663866|Hormone Antagonists|hormone antagonists|mesh-ancestor
65338956|NCT05663866|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65338957|NCT05663866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65338958|NCT05663866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65338959|NCT05663866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65338960|NCT05653427|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
65338961|NCT05653427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65338962|NCT05653427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338963|NCT05648435|Lithium Carbonate|lithium carbonate|mesh-list
65338964|NCT05648435|Antidepressive Agents|antidepressive agents|mesh-ancestor
65338965|NCT05648435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65338966|NCT05648435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65338967|NCT05648435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338968|NCT05648435|Antimanic Agents|antimanic agents|mesh-ancestor
65338969|NCT05648435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65338970|NCT05648435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65338971|NCT05648435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722083|NCT00002576|Immunologic Factors|immunologic factors|mesh-ancestor
64722084|NCT00002576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722085|NCT00002576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64722086|NCT00002576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64722087|NCT00002576|Alkylating Agents|alkylating agents|mesh-ancestor
64722088|NCT00002576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722089|NCT00002576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329812|NCT02188511|Nicotine|nicotine|mesh-list
65338982|NCT05642767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65338983|NCT05642767|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65338984|NCT05640180|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65338985|NCT05640180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338986|NCT05640180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65338987|NCT05640180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65338988|NCT05634707|Temozolomide|temozolomide|mesh-list
65338989|NCT05634707|Fluoxetine|fluoxetine|mesh-list
65338990|NCT05634707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65338991|NCT05634707|Alkylating Agents|alkylating agents|mesh-ancestor
65338992|NCT05634707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65338993|NCT05634707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65338994|NCT05634707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65338995|NCT05634707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65338996|NCT05634707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65338997|NCT05634707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65338998|NCT05634707|Serotonin Agents|serotonin agents|mesh-ancestor
65338999|NCT05634707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339000|NCT05634707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65339001|NCT05634707|Antidepressive Agents|antidepressive agents|mesh-ancestor
65339002|NCT05634707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65249752|NCT00835627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249753|NCT00835627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65249754|NCT00835627|Serotonin Agents|serotonin agents|mesh-ancestor
65249755|NCT00835627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249756|NCT00842491|Cisplatin|cisplatin|mesh-list
65249757|NCT00842491|Capecitabine|capecitabine|mesh-list
65249758|NCT00842491|Endostar protein|endostar protein|mesh-list
65249759|NCT00842491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249760|NCT00842491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65249761|NCT00842491|Antimetabolites|antimetabolites|mesh-ancestor
65249762|NCT00842491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249763|NCT00842491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65339003|NCT05634707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65339004|NCT05634707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65339005|NCT05634707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339006|NCT05633667|Paclitaxel|paclitaxel|mesh-list
65339007|NCT05633667|Docetaxel|docetaxel|mesh-list
65339008|NCT05633667|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65339009|NCT05633667|Carboplatin|carboplatin|mesh-list
65339010|NCT05633667|Pemetrexed|pemetrexed|mesh-list
65339011|NCT05633667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65339012|NCT05633667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339013|NCT05633667|Tubulin Modulators|tubulin modulators|mesh-ancestor
65339014|NCT05633667|Antimitotic Agents|antimitotic agents|mesh-ancestor
65339015|NCT05633667|Mitosis Modulators|mitosis modulators|mesh-ancestor
65339016|NCT05633667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339017|NCT05633667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339018|NCT05633667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65339019|NCT05633667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65339020|NCT05624138|Leucovorin|leucovorin|mesh-list
65339021|NCT05624138|Ketotifen|ketotifen|mesh-list
65339022|NCT05624138|Fluorouracil|fluorouracil|mesh-list
65339023|NCT05624138|Oxaliplatin|oxaliplatin|mesh-list
65339024|NCT05624138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339025|NCT05624138|Antimetabolites|antimetabolites|mesh-ancestor
65339026|NCT05624138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339027|NCT05624138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65339028|NCT05624138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339029|NCT05624138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65339030|NCT05624138|Immunologic Factors|immunologic factors|mesh-ancestor
65339031|NCT05624138|Antidotes|antidotes|mesh-ancestor
65339032|NCT05624138|Protective Agents|protective agents|mesh-ancestor
65339033|NCT05624138|Vitamin B Complex|vitamin b complex|mesh-ancestor
65339034|NCT05624138|Vitamins|vitamins|mesh-ancestor
65339035|NCT05624138|Micronutrients|micronutrients|mesh-ancestor
65339036|NCT05624138|Antipruritics|antipruritics|mesh-ancestor
65339037|NCT05624138|Dermatologic Agents|dermatologic agents|mesh-ancestor
65339038|NCT05624138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65339039|NCT05624138|Histamine Antagonists|histamine antagonists|mesh-ancestor
65249764|NCT00842491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65249795|NCT00835939|Lidocaine|lidocaine|mesh-list
65249796|NCT00835939|Anesthetics, Local|anesthetics, local|mesh-ancestor
65249797|NCT00835939|Anesthetics|anesthetics|mesh-ancestor
65339040|NCT05624138|Histamine Agents|histamine agents|mesh-ancestor
65339041|NCT05624138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65339042|NCT05624138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65339043|NCT05610800|Exenatide|exenatide|mesh-list
65339044|NCT05610800|Nicotine|nicotine|mesh-list
65339045|NCT05610800|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65339046|NCT05610800|Autonomic Agents|autonomic agents|mesh-ancestor
65339047|NCT05610800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65339048|NCT05610800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339049|NCT05610800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65339050|NCT05610800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65339051|NCT05610800|Cholinergic Agents|cholinergic agents|mesh-ancestor
65339052|NCT05610800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65339053|NCT05610800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339054|NCT05610800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65339055|NCT05610800|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65339056|NCT05610800|Incretins|incretins|mesh-ancestor
65339057|NCT05610800|Hormones|hormones|mesh-ancestor
65339058|NCT05610800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65339059|NCT05609370|Bevacizumab|bevacizumab|mesh-list
65339060|NCT05609370|Capecitabine|capecitabine|mesh-list
65339061|NCT05609370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65339062|NCT05609370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339063|NCT05609370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65339064|NCT05609370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65339065|NCT05609370|Growth Substances|growth substances|mesh-ancestor
65339066|NCT05609370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339067|NCT05609370|Growth Inhibitors|growth inhibitors|mesh-ancestor
65339068|NCT05609370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65339069|NCT05609370|Antimetabolites|antimetabolites|mesh-ancestor
65339070|NCT05609370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339071|NCT05605080|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
65339072|NCT05605080|Hemostatics|hemostatics|mesh-ancestor
65339073|NCT05605080|Coagulants|coagulants|mesh-ancestor
65339082|NCT05579626|Ezetimibe|ezetimibe|mesh-list
65339083|NCT05579626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65339084|NCT05579626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65339085|NCT05579626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65339086|NCT05579626|Antimetabolites|antimetabolites|mesh-ancestor
65339087|NCT05579626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339088|NCT05579626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65339089|NCT05579626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339090|NCT05572515|Dexamethasone|dexamethasone|mesh-list
65339091|NCT05572515|Bortezomib|bortezomib|mesh-list
65339092|NCT05572515|Pomalidomide|pomalidomide|mesh-list
65339093|NCT05572515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65339094|NCT05572515|Antiemetics|antiemetics|mesh-ancestor
65339095|NCT05572515|Autonomic Agents|autonomic agents|mesh-ancestor
65339096|NCT05572515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65339097|NCT05572515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339098|NCT05572515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65339099|NCT05572515|Glucocorticoids|glucocorticoids|mesh-ancestor
65339100|NCT05572515|Hormones|hormones|mesh-ancestor
65339101|NCT05572515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65339102|NCT05572515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65339103|NCT05572515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339104|NCT05572515|Immunologic Factors|immunologic factors|mesh-ancestor
65339105|NCT05572515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65339106|NCT05572515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65339107|NCT05572515|Growth Substances|growth substances|mesh-ancestor
65339108|NCT05572515|Growth Inhibitors|growth inhibitors|mesh-ancestor
65339109|NCT05569954|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65339129|NCT05564039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65339130|NCT05564039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339131|NCT05564039|Incretins|incretins|mesh-ancestor
65339132|NCT05564039|Hormones|hormones|mesh-ancestor
65339133|NCT05564039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65339134|NCT05558098|Dapagliflozin|dapagliflozin|mesh-list
65339135|NCT05558098|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65339136|NCT05558098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339137|NCT05558098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65339138|NCT05558098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339139|NCT05556200|Apatinib|apatinib|mesh-list
65339140|NCT05556200|Antibodies|antibodies|mesh-list
65339141|NCT05556200|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65339142|NCT05556200|Immunologic Factors|immunologic factors|mesh-ancestor
65339143|NCT05556200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339144|NCT05556200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339145|NCT05556200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65339146|NCT05556200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339147|NCT05556200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339149|NCT05554133|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65339150|NCT05554133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65339151|NCT05553691|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
65339152|NCT05553691|Hallucinogens|hallucinogens|mesh-ancestor
65339153|NCT05553691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339154|NCT05553691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65339155|NCT05553691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65339156|NCT05553691|Serotonin Agents|serotonin agents|mesh-ancestor
65339157|NCT05553691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65339158|NCT05553691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339159|NCT05553691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65339160|NCT05553132|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65339161|NCT05553132|Hemostatics|hemostatics|mesh-ancestor
65339170|NCT05551936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65339171|NCT05551936|Alkylating Agents|alkylating agents|mesh-ancestor
65339172|NCT05551936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339173|NCT05536154|Cytarabine|cytarabine|mesh-list
65339174|NCT05536154|Etoposide|etoposide|mesh-list
65339175|NCT05536154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65339176|NCT05536154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339177|NCT05536154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65339178|NCT05536154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65339179|NCT05536154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339180|NCT05536154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339181|NCT05536154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65339182|NCT05536154|Antimetabolites|antimetabolites|mesh-ancestor
65339183|NCT05536154|Antiviral Agents|antiviral agents|mesh-ancestor
65339184|NCT05536154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65339185|NCT05536154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65339186|NCT05536154|Immunologic Factors|immunologic factors|mesh-ancestor
65339187|NCT05536154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339188|NCT05532215|Misoprostol|misoprostol|mesh-list
65339189|NCT05532215|Oxytocin|oxytocin|mesh-list
65339190|NCT05532215|Oxytocics|oxytocics|mesh-ancestor
65339191|NCT05532215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65339192|NCT05532215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339193|NCT05532215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65339194|NCT05532215|Abortifacient Agents|abortifacient agents|mesh-ancestor
65339195|NCT05532215|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65339196|NCT05532215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65339197|NCT05528510|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65339198|NCT05528510|Immunologic Factors|immunologic factors|mesh-ancestor
65339199|NCT05528510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339200|NCT05521087|Cytarabine|cytarabine|mesh-list
65339201|NCT05521087|Dexamethasone|dexamethasone|mesh-list
64722222|NCT00002618|Cobalt|cobalt|mesh-list
65339213|NCT05521087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65339214|NCT05521087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65089060|NCT01605994|Antacids|antacids|mesh-list
65339215|NCT05521087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339216|NCT05521087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65339217|NCT05521087|Antimetabolites|antimetabolites|mesh-ancestor
65339218|NCT05521087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339219|NCT05521087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65339220|NCT05521087|Immunologic Factors|immunologic factors|mesh-ancestor
65339221|NCT05521087|Antiviral Agents|antiviral agents|mesh-ancestor
65339222|NCT05521087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65339223|NCT05521087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65339224|NCT05521087|Tubulin Modulators|tubulin modulators|mesh-ancestor
65339225|NCT05521087|Antimitotic Agents|antimitotic agents|mesh-ancestor
65339226|NCT05521087|Mitosis Modulators|mitosis modulators|mesh-ancestor
65339227|NCT05516654|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65339228|NCT05516654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65339229|NCT05510089|Cytarabine|cytarabine|mesh-list
65339230|NCT05510089|Etoposide|etoposide|mesh-list
65339231|NCT05510089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65339232|NCT05510089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339233|NCT05510089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65339234|NCT05510089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65339235|NCT05510089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339236|NCT05510089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339237|NCT05510089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65339238|NCT05510089|Antimetabolites|antimetabolites|mesh-ancestor
65339260|NCT05498428|Dalteparin|dalteparin|mesh-list
65339261|NCT05498428|Anticoagulants|anticoagulants|mesh-list
65339262|NCT05498428|Lazertinib|lazertinib|mesh-list
65339263|NCT05498428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339264|NCT05498428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339265|NCT05498428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339266|NCT05498428|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65339267|NCT05498428|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65339268|NCT05498428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65339269|NCT05498428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65339270|NCT05498428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65339271|NCT05498428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65339272|NCT05488314|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
65339273|NCT05488314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65339274|NCT05488314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339275|NCT05485012|Analgesics, Opioid|analgesics, opioid|mesh-list
65339276|NCT05485012|Narcotics|narcotics|mesh-ancestor
65339277|NCT05485012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65339278|NCT05485012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339279|NCT05485012|Analgesics|analgesics|mesh-ancestor
65339280|NCT05485012|Sensory System Agents|sensory system agents|mesh-ancestor
65339281|NCT05485012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65339282|NCT05477485|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65339283|NCT05477485|Antiviral Agents|antiviral agents|mesh-ancestor
65339284|NCT05477485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65339285|NCT05473520|Doxycycline|doxycycline|mesh-list
65339286|NCT05473520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65339287|NCT05473520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65339288|NCT05473520|Antimalarials|antimalarials|mesh-ancestor
65339289|NCT05473520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65339290|NCT05473520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65339291|NCT05471947|Glycolic acid|glycolic acid|mesh-list
65339292|NCT05471947|Keratolytic Agents|keratolytic agents|mesh-ancestor
65339293|NCT05471947|Dermatologic Agents|dermatologic agents|mesh-ancestor
65339303|NCT05467891|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65339304|NCT05467891|Hormone Antagonists|hormone antagonists|mesh-ancestor
65339305|NCT05467891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65339306|NCT05467891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339307|NCT05467891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65339308|NCT05467891|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65339309|NCT05463601|Tamoxifen|tamoxifen|mesh-list
65339310|NCT05463601|Letrozole|letrozole|mesh-list
65339311|NCT05463601|Fulvestrant|fulvestrant|mesh-list
65339312|NCT05463601|Exemestane|exemestane|mesh-list
65339313|NCT05463601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339314|NCT05463601|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65339315|NCT05463601|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65339316|NCT05463601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339317|NCT05463601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339318|NCT05463601|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65339319|NCT05463601|Hormone Antagonists|hormone antagonists|mesh-ancestor
65339320|NCT05463601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65339321|NCT05463601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339322|NCT05463601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65339323|NCT05463601|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65339324|NCT05463601|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65339325|NCT05463601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65339326|NCT05463601|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65339327|NCT05455684|Aticaprant|aticaprant|mesh-list
65339328|NCT05455684|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65339329|NCT05455684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339330|NCT05455684|Sensory System Agents|sensory system agents|mesh-ancestor
65339331|NCT05455684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65339332|NCT05444530|Ipilimumab|ipilimumab|mesh-list
65339333|NCT05444530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65339334|NCT05444530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339335|NCT05444530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65339336|NCT05444530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339337|NCT05441280|Pimavanserin|pimavanserin|mesh-list
65339338|NCT05441280|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64330058|NCT00004171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722330|NCT05750030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722331|NCT05750030|Growth Inhibitors|growth inhibitors|mesh-ancestor
64722332|NCT04331054|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64722333|NCT04331054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64722334|NCT04331054|Respiratory System Agents|respiratory system agents|mesh-ancestor
64722335|NCT00002654|Cobalt|cobalt|mesh-list
64722336|NCT00002654|Trace Elements|trace elements|mesh-ancestor
64722337|NCT00002654|Micronutrients|micronutrients|mesh-ancestor
64722338|NCT00002654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722339|NCT01426555|Zoledronic Acid|zoledronic acid|mesh-list
65339339|NCT05441280|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65339340|NCT05441280|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65339341|NCT05441280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65339342|NCT05441280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65339343|NCT05441280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339344|NCT05441280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65339345|NCT05441280|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65339346|NCT05441280|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65339347|NCT05441280|Serotonin Agents|serotonin agents|mesh-ancestor
65339348|NCT05441280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65339349|NCT05441280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339350|NCT05438082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65339351|NCT05438082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65339352|NCT05427162|Epoprostenol|epoprostenol|mesh-list
65339353|NCT05427162|Tezosentan|tezosentan|mesh-list
65339354|NCT05427162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65339355|NCT05427162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65339356|NCT05427162|Vasodilator Agents|vasodilator agents|mesh-ancestor
65339357|NCT05408091|Antibodies|antibodies|mesh-list
65339358|NCT05408091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65339359|NCT05408091|Immunologic Factors|immunologic factors|mesh-ancestor
65339361|NCT05396014|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64722340|NCT01426555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64722341|NCT01426555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722342|NCT01434745|Simvastatin|simvastatin|mesh-list
64722343|NCT01434745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64722344|NCT01434745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64722345|NCT01434745|Antimetabolites|antimetabolites|mesh-ancestor
64722346|NCT01434745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722347|NCT01434745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64722348|NCT01434745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64722349|NCT01434745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64722350|NCT01401049|Lidocaine|lidocaine|mesh-list
64722351|NCT01401049|Propofol|propofol|mesh-list
64330067|NCT00004165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64330068|NCT00004165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64330069|NCT00004093|Gemcitabine|gemcitabine|mesh-list
64330070|NCT00004093|Paclitaxel|paclitaxel|mesh-list
65339367|NCT05396014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339368|NCT05396014|Analgesics|analgesics|mesh-ancestor
65339369|NCT05396014|Sensory System Agents|sensory system agents|mesh-ancestor
65339370|NCT05396014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65339371|NCT05396014|Antidepressive Agents|antidepressive agents|mesh-ancestor
65339372|NCT05396014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65339373|NCT05396014|Dopamine Agents|dopamine agents|mesh-ancestor
65339374|NCT05395195|Epoetin Alfa|epoetin alfa|mesh-list
65339402|NCT05379595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65339403|NCT05379595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339404|NCT05379595|Antidotes|antidotes|mesh-ancestor
65339405|NCT05379595|Protective Agents|protective agents|mesh-ancestor
65339406|NCT05379595|Vitamin B Complex|vitamin b complex|mesh-ancestor
65339407|NCT05379595|Vitamins|vitamins|mesh-ancestor
65339408|NCT05379595|Micronutrients|micronutrients|mesh-ancestor
65339409|NCT05379595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65339410|NCT05372887|Cyclobenzaprine|cyclobenzaprine|mesh-list
65339411|NCT05372887|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65339412|NCT05372887|Antidepressive Agents|antidepressive agents|mesh-ancestor
65339413|NCT05372887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65339414|NCT05372887|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65339415|NCT05372887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339416|NCT05372887|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65339417|NCT05372887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65339418|NCT05372887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65339419|NCT05372887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65339420|NCT05366764|Albuterol|albuterol|mesh-list
65339421|NCT05366764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65339422|NCT05366764|Autonomic Agents|autonomic agents|mesh-ancestor
65339423|NCT05366764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65339424|NCT05366764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339425|NCT05366764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65339426|NCT05366764|Respiratory System Agents|respiratory system agents|mesh-ancestor
65339427|NCT05366764|Tocolytic Agents|tocolytic agents|mesh-ancestor
65339428|NCT05366764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65339429|NCT05366764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65339430|NCT05366764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65339431|NCT05366764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65339432|NCT05366764|Adrenergic Agents|adrenergic agents|mesh-ancestor
65339445|NCT05359835|Edetic Acid|edetic acid|mesh-list
65339446|NCT05359835|Calcium|calcium|mesh-list
65339447|NCT05359835|Pentetic Acid|pentetic acid|mesh-list
65339448|NCT05359835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65339449|NCT05359835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339450|NCT05359835|Antidotes|antidotes|mesh-ancestor
65339451|NCT05359835|Protective Agents|protective agents|mesh-ancestor
65339452|NCT05359835|Chelating Agents|chelating agents|mesh-ancestor
65339453|NCT05359835|Sequestering Agents|sequestering agents|mesh-ancestor
65339454|NCT05359835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339455|NCT05359835|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65339456|NCT05359835|Anticoagulants|anticoagulants|mesh-ancestor
65339457|NCT05359835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65339458|NCT05357898|Pembrolizumab|pembrolizumab|mesh-list
65339459|NCT05357898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65339460|NCT05357898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339461|NCT05355051|Pembrolizumab|pembrolizumab|mesh-list
65339462|NCT05355051|Azacitidine|azacitidine|mesh-list
65249798|NCT00835939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65249799|NCT00835939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249800|NCT00835939|Sensory System Agents|sensory system agents|mesh-ancestor
65249801|NCT00835939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65249802|NCT00835939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65249803|NCT00835939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65249804|NCT00835939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65249805|NCT00835939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65249806|NCT00835939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249840|NCT00961571|Growth Inhibitors|growth inhibitors|mesh-ancestor
65249841|NCT00961571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65249842|NCT00961571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249843|NCT02820948|Vitamins|vitamins|mesh-list
65249844|NCT02820948|Vitamin E|vitamin e|mesh-list
65249845|NCT02820948|Tocopherols|tocopherols|mesh-list
65249846|NCT02820948|Tocotrienols|tocotrienols|mesh-list
65249847|NCT02820948|alpha-Tocopherol|alpha-tocopherol|mesh-list
65249848|NCT02820948|Micronutrients|micronutrients|mesh-ancestor
65249849|NCT02820948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925198|NCT00031837|Dalteparin|dalteparin|mesh-list
65249878|NCT02860949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65249879|NCT02860949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65249880|NCT02860949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65249881|NCT02860949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65249883|NCT02860949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65249884|NCT02860949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249885|NCT03248063|Cefazolin|cefazolin|mesh-list
65249886|NCT03248063|Cloxacillin|cloxacillin|mesh-list
65249887|NCT03248063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65249888|NCT03248063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65249889|NCT00964223|Clindamycin|clindamycin|mesh-list
65249890|NCT00964223|Clindamycin palmitate|clindamycin palmitate|mesh-list
65249891|NCT00964223|Clindamycin phosphate|clindamycin phosphate|mesh-list
65249892|NCT00964223|Adapalene|adapalene|mesh-list
65249893|NCT00964223|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
65249894|NCT00964223|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65249895|NCT00964223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65249896|NCT00964223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65249897|NCT00964223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65249898|NCT00964223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249927|NCT04238988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65339463|NCT05355051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65339464|NCT05355051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339465|NCT05355051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65339466|NCT05355051|Antimetabolites|antimetabolites|mesh-ancestor
65339467|NCT05355051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339468|NCT05355051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339469|NCT05338775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65339470|NCT05338775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339471|NCT05338775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339472|NCT05335148|Colchicine|colchicine|mesh-list
65339473|NCT05335148|Gout Suppressants|gout suppressants|mesh-ancestor
65339474|NCT05335148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65339475|NCT05335148|Tubulin Modulators|tubulin modulators|mesh-ancestor
65339476|NCT05335148|Antimitotic Agents|antimitotic agents|mesh-ancestor
65339477|NCT05335148|Mitosis Modulators|mitosis modulators|mesh-ancestor
65339478|NCT05335148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339479|NCT05335148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339480|NCT05328297|JNJ-55308942|jnj-55308942|mesh-list
65339481|NCT05328297|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
65339482|NCT05328297|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65339483|NCT05328297|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65339484|NCT05328297|Purinergic Agents|purinergic agents|mesh-ancestor
65339485|NCT05328297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65339486|NCT05328297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339487|NCT05328297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339488|NCT05314933|Deoxyglucose|deoxyglucose|mesh-list
65339489|NCT05314933|Antimetabolites|antimetabolites|mesh-ancestor
65339490|NCT05314933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339491|NCT05314933|Antiviral Agents|antiviral agents|mesh-ancestor
65339493|NCT05303090|Lenvatinib|lenvatinib|mesh-list
64722398|NCT00002678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64722399|NCT00002678|Glucocorticoids|glucocorticoids|mesh-ancestor
64722400|NCT00002678|Hormones|hormones|mesh-ancestor
64722401|NCT00002678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64722402|NCT00002678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64722403|NCT00002678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722404|NCT00002678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64722405|NCT00002678|Alkylating Agents|alkylating agents|mesh-ancestor
64722406|NCT00002678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722407|NCT00002678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64330121|NCT05715385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64330122|NCT05715385|Analgesics|analgesics|mesh-ancestor
64330123|NCT05715385|Sensory System Agents|sensory system agents|mesh-ancestor
64330124|NCT05715385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330125|NCT05715385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330126|NCT05715385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65339505|NCT05275023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64722408|NCT00002678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64722409|NCT00002678|Immunologic Factors|immunologic factors|mesh-ancestor
64722410|NCT01397695|Bevacizumab|bevacizumab|mesh-list
64722411|NCT01397695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64722412|NCT01397695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722413|NCT01397695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64722414|NCT01397695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64722415|NCT01397695|Growth Substances|growth substances|mesh-ancestor
64722416|NCT01397695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722417|NCT01397695|Growth Inhibitors|growth inhibitors|mesh-ancestor
65339542|NCT05242484|Golimumab|golimumab|mesh-list
65339543|NCT05242484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65339544|NCT05242484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65339545|NCT05242484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65339546|NCT05242484|Immunologic Factors|immunologic factors|mesh-ancestor
65339547|NCT05242484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339548|NCT05242471|Golimumab|golimumab|mesh-list
65339549|NCT05242471|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65339550|NCT05242471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65339551|NCT05242471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65339552|NCT05242471|Immunologic Factors|immunologic factors|mesh-ancestor
65339553|NCT05242471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339554|NCT05242458|Ustekinumab|ustekinumab|mesh-list
65339555|NCT05242458|Dermatologic Agents|dermatologic agents|mesh-ancestor
65339556|NCT05225363|Cyclophosphamide|cyclophosphamide|mesh-list
65339557|NCT05225363|Fludarabine|fludarabine|mesh-list
65339580|NCT05213208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339581|NCT05213208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65339582|NCT05213208|Anesthetics, General|anesthetics, general|mesh-ancestor
65339583|NCT05213208|Anesthetics|anesthetics|mesh-ancestor
65339584|NCT05207709|Paclitaxel|paclitaxel|mesh-list
65339585|NCT05207709|Letrozole|letrozole|mesh-list
65339586|NCT05207709|Fulvestrant|fulvestrant|mesh-list
65339587|NCT05207709|Palbociclib|palbociclib|mesh-list
65339588|NCT05207709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65339589|NCT05207709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339590|NCT05207709|Tubulin Modulators|tubulin modulators|mesh-ancestor
65339591|NCT05207709|Antimitotic Agents|antimitotic agents|mesh-ancestor
65339592|NCT05207709|Mitosis Modulators|mitosis modulators|mesh-ancestor
65339593|NCT05207709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339594|NCT05207709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65339595|NCT05207709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65339596|NCT05207709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339597|NCT05207709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65339598|NCT05207709|Hormone Antagonists|hormone antagonists|mesh-ancestor
65339599|NCT05207709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65339600|NCT05207709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339601|NCT05207709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65339602|NCT05207709|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65339603|NCT05207709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65339604|NCT05197049|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65339605|NCT05197049|Immunologic Factors|immunologic factors|mesh-ancestor
65339606|NCT05197049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339608|NCT05171075|Tinzaparin|tinzaparin|mesh-list
65339609|NCT05171075|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65339610|NCT05171075|Anticoagulants|anticoagulants|mesh-ancestor
65339611|NCT05171075|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64722444|NCT00002696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64722445|NCT00002696|Fluorouracil|fluorouracil|mesh-list
64722446|NCT00002696|Methotrexate|methotrexate|mesh-list
64722447|NCT00002696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64722448|NCT00002696|Immunologic Factors|immunologic factors|mesh-ancestor
64722449|NCT00002696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722450|NCT00002696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65339624|NCT05170399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339625|NCT05167825|Macitentan|macitentan|mesh-list
65339626|NCT05167825|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65339627|NCT05167825|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65339628|NCT05167825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339629|NCT05167825|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65339630|NCT05138822|Nitrofurantoin|nitrofurantoin|mesh-list
65339631|NCT05138822|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65339632|NCT05138822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65339633|NCT05138822|Renal Agents|renal agents|mesh-ancestor
65339634|NCT05138822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65339635|NCT05117034|Morphine|morphine|mesh-list
65339636|NCT05117034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65339637|NCT05117034|Narcotics|narcotics|mesh-ancestor
65339638|NCT05117034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65339639|NCT05117034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339640|NCT05117034|Analgesics|analgesics|mesh-ancestor
65339641|NCT05117034|Sensory System Agents|sensory system agents|mesh-ancestor
65339642|NCT05117034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65339643|NCT05115838|Islatravir|islatravir|mesh-list
65339644|NCT05115838|Antiviral Agents|antiviral agents|mesh-ancestor
65339645|NCT05115838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65339646|NCT05115838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339647|NCT05115838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339648|NCT05115838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65339649|NCT05115838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65339650|NCT05115838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65339651|NCT05112939|Cabotegravir|cabotegravir|mesh-list
65339652|NCT05112939|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65339653|NCT05112939|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64722462|NCT00002696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65339655|NCT05112939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339656|NCT05112939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65339657|NCT05112939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65339658|NCT05112939|Antiviral Agents|antiviral agents|mesh-ancestor
65339659|NCT05112939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65339660|NCT05098210|Poly I-C|poly i-c|mesh-list
65339661|NCT05098210|Nivolumab|nivolumab|mesh-list
65339662|NCT05098210|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65339663|NCT05098210|Poly ICLC|poly iclc|mesh-list
65339664|NCT05098210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65339665|NCT05098210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339666|NCT05098210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65339667|NCT05098210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339669|NCT05098210|Immunologic Factors|immunologic factors|mesh-ancestor
65339670|NCT05098210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339671|NCT05098210|Laxatives|laxatives|mesh-ancestor
65339672|NCT05098210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65339673|NCT05098210|Antiviral Agents|antiviral agents|mesh-ancestor
65339674|NCT05098210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65339675|NCT05093920|Doxorubicin|doxorubicin|mesh-list
65339676|NCT05093920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65339677|NCT05093920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65339678|NCT05093920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339679|NCT05093920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65339680|NCT05093920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65339681|NCT05093920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339682|NCT05093920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249928|NCT04284215|Paclitaxel|paclitaxel|mesh-list
65249929|NCT04284215|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65249930|NCT04284215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65249931|NCT04284215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249932|NCT04284215|Tubulin Modulators|tubulin modulators|mesh-ancestor
65249933|NCT04284215|Antimitotic Agents|antimitotic agents|mesh-ancestor
65249934|NCT04284215|Mitosis Modulators|mitosis modulators|mesh-ancestor
65249935|NCT04284215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249936|NCT02816970|Vildagliptin|vildagliptin|mesh-list
65249937|NCT02816970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65249938|NCT02816970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249939|NCT02816970|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65249940|NCT02816970|Protease Inhibitors|protease inhibitors|mesh-ancestor
65249941|NCT02816970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249942|NCT02816970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249943|NCT03372941|Dalbavancin|dalbavancin|mesh-list
65249944|NCT03372941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64722476|NCT01315873|Bortezomib|bortezomib|mesh-list
64722477|NCT01315873|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64722478|NCT01315873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722479|NCT01315873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64722480|NCT01315873|Alkylating Agents|alkylating agents|mesh-ancestor
64722481|NCT01315873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722482|NCT01895959|Hyaluronic Acid|hyaluronic acid|mesh-list
64722483|NCT01895959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65339683|NCT05092269|Ustekinumab|ustekinumab|mesh-list
65339684|NCT05092269|Dermatologic Agents|dermatologic agents|mesh-ancestor
65339685|NCT05083169|Dexamethasone|dexamethasone|mesh-list
65339686|NCT05083169|Bortezomib|bortezomib|mesh-list
65339687|NCT05083169|Daratumumab|daratumumab|mesh-list
65339688|NCT05083169|Pomalidomide|pomalidomide|mesh-list
65339689|NCT05083169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65339690|NCT05083169|Antiemetics|antiemetics|mesh-ancestor
65339691|NCT05083169|Autonomic Agents|autonomic agents|mesh-ancestor
65339692|NCT05083169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65339693|NCT05083169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339694|NCT05083169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65339695|NCT05083169|Glucocorticoids|glucocorticoids|mesh-ancestor
65339696|NCT05083169|Hormones|hormones|mesh-ancestor
65339697|NCT05083169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65339698|NCT05083169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65339699|NCT05083169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339700|NCT05083169|Immunologic Factors|immunologic factors|mesh-ancestor
65339701|NCT05083169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65339702|NCT05083169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65339703|NCT05083169|Growth Substances|growth substances|mesh-ancestor
65339704|NCT05083169|Growth Inhibitors|growth inhibitors|mesh-ancestor
65339705|NCT05080946|Aspirin|aspirin|mesh-list
65339706|NCT05080946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65339707|NCT05080946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65339708|NCT05080946|Analgesics|analgesics|mesh-ancestor
65339709|NCT05080946|Sensory System Agents|sensory system agents|mesh-ancestor
64722484|NCT01895959|Immunologic Factors|immunologic factors|mesh-ancestor
65249945|NCT03372941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65249977|NCT00634062|Anticonvulsants|anticonvulsants|mesh-ancestor
65249978|NCT00634062|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65249979|NCT00634062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64722488|NCT01303003|Dexamethasone|dexamethasone|mesh-list
64722489|NCT01303003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64461782|NCT04602494|Varenicline|varenicline|mesh-list
64722490|NCT01303003|Antiemetics|antiemetics|mesh-ancestor
64722491|NCT01303003|Autonomic Agents|autonomic agents|mesh-ancestor
64722492|NCT01303003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64722493|NCT01303003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722494|NCT01303003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64722495|NCT01303003|Glucocorticoids|glucocorticoids|mesh-ancestor
64330177|NCT00232141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330178|NCT00232141|Anticonvulsants|anticonvulsants|mesh-ancestor
64330179|NCT00232141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64330180|NCT00232141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64330181|NCT00232141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330182|NCT00232141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64330183|NCT00232141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64330184|NCT00232141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64495857|NCT01212874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339710|NCT05080946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64722496|NCT01303003|Hormones|hormones|mesh-ancestor
64722497|NCT01303003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64722498|NCT01303003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64722499|NCT01303003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722500|NCT00002714|Prednisone|prednisone|mesh-list
64722501|NCT00002714|Doxorubicin|doxorubicin|mesh-list
64722502|NCT00002714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64722503|NCT00002714|Bleomycin|bleomycin|mesh-list
64722504|NCT00002714|Etoposide|etoposide|mesh-list
64722505|NCT00002714|Vincristine|vincristine|mesh-list
64330185|NCT00232141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64330186|NCT00232141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64330187|NCT02378415|Ketamine|ketamine|mesh-list
64330188|NCT02378415|Analgesics|analgesics|mesh-ancestor
65339744|NCT05052879|Urological Agents|urological agents|mesh-ancestor
65339745|NCT05049707|Magnesium Sulfate|magnesium sulfate|mesh-list
65339746|NCT05049707|Analgesics|analgesics|mesh-ancestor
65339747|NCT05049707|Sensory System Agents|sensory system agents|mesh-ancestor
65339748|NCT05049707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65339749|NCT05049707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339750|NCT05049707|Anesthetics|anesthetics|mesh-ancestor
65339751|NCT05049707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65339752|NCT05049707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65339753|NCT05049707|Anticonvulsants|anticonvulsants|mesh-ancestor
65339754|NCT05049707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65339755|NCT05049707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65339756|NCT05049707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339757|NCT05049707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65339758|NCT05049707|Tocolytic Agents|tocolytic agents|mesh-ancestor
65339759|NCT05049707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65339760|NCT05043805|Dextromethorphan|dextromethorphan|mesh-list
65339761|NCT05043805|Antitussive Agents|antitussive agents|mesh-ancestor
65339762|NCT05043805|Respiratory System Agents|respiratory system agents|mesh-ancestor
65339763|NCT05043805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65339764|NCT05043805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65339769|NCT05042687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65339770|NCT05042687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339771|NCT05039619|Acetaminophen|acetaminophen|mesh-list
65339772|NCT05039619|Diphenhydramine|diphenhydramine|mesh-list
65339773|NCT05039619|Promethazine|promethazine|mesh-list
65339774|NCT05039619|Mycophenolic Acid|mycophenolic acid|mesh-list
65339775|NCT05039619|Prednisone|prednisone|mesh-list
65339776|NCT05039619|Methylprednisolone|methylprednisolone|mesh-list
65339777|NCT05039619|Obinutuzumab|obinutuzumab|mesh-list
65339778|NCT05039619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65339779|NCT05039619|Glucocorticoids|glucocorticoids|mesh-ancestor
65339780|NCT05039619|Hormones|hormones|mesh-ancestor
65339781|NCT05039619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65339782|NCT05039619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339783|NCT05039619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65339784|NCT05039619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339785|NCT05039619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65339786|NCT05039619|Analgesics|analgesics|mesh-ancestor
65339787|NCT05039619|Sensory System Agents|sensory system agents|mesh-ancestor
65339788|NCT05039619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65339789|NCT05039619|Antipyretics|antipyretics|mesh-ancestor
65339790|NCT05039619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65339791|NCT05039619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65339792|NCT05039619|Antitubercular Agents|antitubercular agents|mesh-ancestor
65339793|NCT05039619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65339794|NCT05039619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65339797|NCT05039619|Antiemetics|antiemetics|mesh-ancestor
65339819|NCT05036109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339820|NCT05036109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65339821|NCT05036109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65339822|NCT05036109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65339823|NCT05036109|Analgesics|analgesics|mesh-ancestor
65339824|NCT05036109|Sensory System Agents|sensory system agents|mesh-ancestor
64722626|NCT00002744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64722627|NCT00002744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64722628|NCT00002744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64722629|NCT00002744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64722630|NCT00002744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64722631|NCT00002744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64722632|NCT00002744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64722633|NCT00002744|Abortifacient Agents|abortifacient agents|mesh-ancestor
64722634|NCT00002744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64330309|NCT02288923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330310|NCT02288923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330311|NCT02288923|Antipyretics|antipyretics|mesh-ancestor
64330312|NCT02288923|Autonomic Agents|autonomic agents|mesh-ancestor
64330313|NCT02288923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64722635|NCT00002744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64722636|NCT00002744|Antimetabolites|antimetabolites|mesh-ancestor
64722637|NCT00002744|Dermatologic Agents|dermatologic agents|mesh-ancestor
64722638|NCT00002744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64722639|NCT00002744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64722640|NCT00002744|Antiviral Agents|antiviral agents|mesh-ancestor
65339923|NCT04904536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65339924|NCT04904536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339925|NCT04899479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65339926|NCT04899479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339927|NCT04899479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65339928|NCT04899479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339929|NCT04886531|Trastuzumab|trastuzumab|mesh-list
65339930|NCT04886531|Letrozole|letrozole|mesh-list
65339931|NCT04886531|Anastrozole|anastrozole|mesh-list
65339932|NCT04886531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65339933|NCT04886531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339934|NCT04886531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65339935|NCT04886531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65339936|NCT04886531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339937|NCT04886531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339938|NCT04886531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65339939|NCT04886531|Hormone Antagonists|hormone antagonists|mesh-ancestor
65339940|NCT04886531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65339941|NCT04886531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65339942|NCT04886531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65339943|NCT04884360|Olaparib|olaparib|mesh-list
65339944|NCT04884360|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65339945|NCT04884360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339946|NCT04884360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249980|NCT00634062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249981|NCT00634062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65249982|NCT00634062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249983|NCT00634062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65249984|NCT00634062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65249985|NCT00634062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65249986|NCT00634062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65250009|NCT02818140|Sensory System Agents|sensory system agents|mesh-ancestor
65250010|NCT02818140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64722645|NCT00002744|Mitosis Modulators|mitosis modulators|mesh-ancestor
64722646|NCT00002744|Trace Elements|trace elements|mesh-ancestor
64722647|NCT00002744|Micronutrients|micronutrients|mesh-ancestor
64722648|NCT01788475|Dexamethasone|dexamethasone|mesh-list
64722649|NCT01788475|Dexamethasone acetate|dexamethasone acetate|mesh-list
64722650|NCT01788475|BB 1101|bb 1101|mesh-list
64722651|NCT01788475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64722652|NCT01788475|Antiemetics|antiemetics|mesh-ancestor
64722653|NCT01788475|Autonomic Agents|autonomic agents|mesh-ancestor
64722654|NCT01788475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330324|NCT02195375|Sympathomimetics|sympathomimetics|mesh-ancestor
64330325|NCT03531931|Apatinib|apatinib|mesh-list
64330326|NCT03531931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330327|NCT03531931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64330328|NCT03531931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330329|NCT03531931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339947|NCT04884360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339948|NCT04852367|Doxorubicin|doxorubicin|mesh-list
65339949|NCT04852367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65339950|NCT04852367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65339951|NCT04852367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65339952|NCT04852367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65339953|NCT04852367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65339954|NCT04852367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65339955|NCT04849364|Capecitabine|capecitabine|mesh-list
64722655|NCT01788475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722656|NCT01788475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64722657|NCT01788475|Glucocorticoids|glucocorticoids|mesh-ancestor
64722658|NCT01788475|Hormones|hormones|mesh-ancestor
65339980|NCT04824417|Hormone Antagonists|hormone antagonists|mesh-ancestor
64722659|NCT01788475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64722660|NCT01788475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64722661|NCT01788475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722662|NCT01788475|Protease Inhibitors|protease inhibitors|mesh-ancestor
64722663|NCT01788475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330334|NCT03601455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64330335|NCT03601455|Immunoglobulin G|immunoglobulin g|mesh-list
64330336|NCT03601455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64330337|NCT03601455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330338|NCT03601455|Immunologic Factors|immunologic factors|mesh-ancestor
64330339|NCT03601455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330340|NCT03601455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64330341|NCT03601455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722664|NCT01788475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722665|NCT00381914|Vitamin D|vitamin d|mesh-list
64722666|NCT00381914|Ergocalciferols|ergocalciferols|mesh-list
64722667|NCT00381914|Cholecalciferol|cholecalciferol|mesh-list
64722668|NCT00381914|Vitamins|vitamins|mesh-list
64722669|NCT00381914|Micronutrients|micronutrients|mesh-ancestor
64722670|NCT00381914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722671|NCT00381914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64722672|NCT00381914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64722673|NCT00423007|Bromfenac|bromfenac|mesh-list
64330342|NCT03531697|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64330343|NCT03531697|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64330344|NCT02369133|Acetaminophen|acetaminophen|mesh-list
64330345|NCT02369133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64330346|NCT02369133|Analgesics|analgesics|mesh-ancestor
64495908|NCT00493896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64495909|NCT00493896|Antithrombins|antithrombins|mesh-ancestor
64495910|NCT00493896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65340017|NCT04690608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65340018|NCT04690608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65340019|NCT04690608|Glucocorticoids|glucocorticoids|mesh-ancestor
65340020|NCT04690608|Hormones|hormones|mesh-ancestor
65340023|NCT04690608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65340054|NCT04629248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340055|NCT04629248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340056|NCT04629248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65340057|NCT04629248|Analgesics|analgesics|mesh-ancestor
65340058|NCT04629248|Sensory System Agents|sensory system agents|mesh-ancestor
65340059|NCT04629248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65340060|NCT04629248|Antipyretics|antipyretics|mesh-ancestor
65340061|NCT04629248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65340062|NCT04629248|Antiemetics|antiemetics|mesh-ancestor
65340063|NCT04629248|Autonomic Agents|autonomic agents|mesh-ancestor
65340064|NCT04629248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65340065|NCT04629248|Glucocorticoids|glucocorticoids|mesh-ancestor
65340066|NCT04629248|Hormones|hormones|mesh-ancestor
65340067|NCT04629248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65340068|NCT04629248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65340069|NCT04629248|Protective Agents|protective agents|mesh-ancestor
65340070|NCT04629248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340071|NCT04629248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65340072|NCT04629248|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65340073|NCT04629248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65340074|NCT04629248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65340075|NCT04629248|Anesthetics, Local|anesthetics, local|mesh-ancestor
65340076|NCT04629248|Anesthetics|anesthetics|mesh-ancestor
65340077|NCT04629248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65340078|NCT04629248|Histamine Antagonists|histamine antagonists|mesh-ancestor
65340079|NCT04629248|Histamine Agents|histamine agents|mesh-ancestor
65340080|NCT04629248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65340081|NCT04629248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65340082|NCT04629248|Antipruritics|antipruritics|mesh-ancestor
65340083|NCT04629248|Dermatologic Agents|dermatologic agents|mesh-ancestor
65340084|NCT04623775|Paclitaxel|paclitaxel|mesh-list
65340085|NCT04623775|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65340086|NCT04623775|Carboplatin|carboplatin|mesh-list
65340087|NCT04623775|Nivolumab|nivolumab|mesh-list
65340088|NCT04623775|Pemetrexed|pemetrexed|mesh-list
65340089|NCT04623775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65340090|NCT04623775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250011|NCT04238208|Lidocaine|lidocaine|mesh-list
65250012|NCT04238208|Capsaicin|capsaicin|mesh-list
65250013|NCT04238208|Anesthetics, Local|anesthetics, local|mesh-ancestor
65340091|NCT04623775|Tubulin Modulators|tubulin modulators|mesh-ancestor
65340092|NCT04623775|Antimitotic Agents|antimitotic agents|mesh-ancestor
65340093|NCT04623775|Mitosis Modulators|mitosis modulators|mesh-ancestor
65340094|NCT04623775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340095|NCT04623775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65340096|NCT04623775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65340097|NCT04623775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340098|NCT04623775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65340099|NCT04623775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65340100|NCT04612751|Carboplatin|carboplatin|mesh-list
65340101|NCT04612751|Durvalumab|durvalumab|mesh-list
65340102|NCT04612751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340103|NCT04612751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65340104|NCT04586348|Iodine|iodine|mesh-list
65340105|NCT04586348|Cadexomer iodine|cadexomer iodine|mesh-list
65340106|NCT04586348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65340107|NCT04586348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65340108|NCT04586348|Trace Elements|trace elements|mesh-ancestor
65340109|NCT04586348|Micronutrients|micronutrients|mesh-ancestor
65340110|NCT04586348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340111|NCT04577001|Letrozole|letrozole|mesh-list
65340112|NCT04577001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340113|NCT04577001|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65340114|NCT04577001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65340115|NCT04577001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340116|NCT04577001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340118|NCT04577001|Hormone Antagonists|hormone antagonists|mesh-ancestor
65340119|NCT04577001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65340120|NCT04577001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340121|NCT04576078|Nefopam|nefopam|mesh-list
65340122|NCT04576078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65340123|NCT04576078|Analgesics|analgesics|mesh-ancestor
65340124|NCT04576078|Sensory System Agents|sensory system agents|mesh-ancestor
65250014|NCT04238208|Anesthetics|anesthetics|mesh-ancestor
65250015|NCT04238208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65250016|NCT04238208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250017|NCT04238208|Sensory System Agents|sensory system agents|mesh-ancestor
65250018|NCT04238208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250019|NCT04238208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65250020|NCT04238208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65340125|NCT04576078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65340126|NCT04576078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340127|NCT04561557|Cyclophosphamide|cyclophosphamide|mesh-list
65340128|NCT04561557|Fludarabine|fludarabine|mesh-list
65340129|NCT04561557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65340130|NCT04561557|Immunologic Factors|immunologic factors|mesh-ancestor
65340131|NCT04561557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340132|NCT04561557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65340133|NCT04561557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65340134|NCT04561557|Alkylating Agents|alkylating agents|mesh-ancestor
65340135|NCT04561557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340136|NCT04561557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340137|NCT04561557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65340138|NCT04561375|Fentanyl|fentanyl|mesh-list
65340139|NCT04561375|Sufentanil|sufentanil|mesh-list
65340140|NCT04561375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65340141|NCT04561375|Narcotics|narcotics|mesh-ancestor
65340142|NCT04561375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65340143|NCT04561375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340144|NCT04561375|Analgesics|analgesics|mesh-ancestor
65340145|NCT04561375|Sensory System Agents|sensory system agents|mesh-ancestor
65340146|NCT04561375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65340147|NCT04561375|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65340148|NCT04561375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65340149|NCT04561375|Anesthetics, General|anesthetics, general|mesh-ancestor
65340150|NCT04561375|Anesthetics|anesthetics|mesh-ancestor
65340151|NCT04560127|Apatinib|apatinib|mesh-list
65340152|NCT04560127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340153|NCT04560127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65340174|NCT04553536|Sensory System Agents|sensory system agents|mesh-ancestor
65340175|NCT04553536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65340176|NCT04553536|Anticonvulsants|anticonvulsants|mesh-ancestor
65340177|NCT04553536|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65340178|NCT04553536|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65340179|NCT04553536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65340180|NCT04553536|Antidepressive Agents|antidepressive agents|mesh-ancestor
65340181|NCT04553536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65340182|NCT04553536|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65340183|NCT04553536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65340184|NCT04553536|Cholinergic Agents|cholinergic agents|mesh-ancestor
65340185|NCT04553536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65340186|NCT04553536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340187|NCT04553536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65340188|NCT04550260|Cisplatin|cisplatin|mesh-list
65340189|NCT04550260|Fluorouracil|fluorouracil|mesh-list
65340190|NCT04550260|Capecitabine|capecitabine|mesh-list
65340191|NCT04550260|Durvalumab|durvalumab|mesh-list
65340192|NCT04550260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340193|NCT04550260|Antimetabolites|antimetabolites|mesh-ancestor
65340194|NCT04550260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340195|NCT04550260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65340197|NCT04550260|Immunologic Factors|immunologic factors|mesh-ancestor
65340198|NCT04550260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340199|NCT04550260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65340200|NCT04540211|Paclitaxel|paclitaxel|mesh-list
65340201|NCT04540211|Atezolizumab|atezolizumab|mesh-list
65340202|NCT04540211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65340203|NCT04540211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65340204|NCT04540211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340205|NCT04540211|Tubulin Modulators|tubulin modulators|mesh-ancestor
65340206|NCT04540211|Antimitotic Agents|antimitotic agents|mesh-ancestor
65340207|NCT04540211|Mitosis Modulators|mitosis modulators|mesh-ancestor
65340208|NCT04540211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340209|NCT04540211|Immunologic Factors|immunologic factors|mesh-ancestor
65340210|NCT04540211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250021|NCT04238208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65340211|NCT04536532|Entecavir|entecavir|mesh-list
65340212|NCT04536532|Antiviral Agents|antiviral agents|mesh-ancestor
65340213|NCT04536532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65340214|NCT04535882|polysaccharide-K|polysaccharide-k|mesh-list
65340215|NCT04535882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65340216|NCT04535882|Immunologic Factors|immunologic factors|mesh-ancestor
65340217|NCT04535882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340218|NCT04535882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65340219|NCT04535882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340220|NCT04535882|Antiviral Agents|antiviral agents|mesh-ancestor
65340221|NCT04535882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65340222|NCT04535882|Interferon Inducers|interferon inducers|mesh-ancestor
65340223|NCT04535882|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65340224|NCT04535882|Protective Agents|protective agents|mesh-ancestor
65340225|NCT04513145|Ropivacaine|ropivacaine|mesh-list
65340226|NCT04513145|Anesthetics, Local|anesthetics, local|mesh-ancestor
65340227|NCT04513145|Anesthetics|anesthetics|mesh-ancestor
65340228|NCT04513145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65340229|NCT04513145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340230|NCT04513145|Sensory System Agents|sensory system agents|mesh-ancestor
65340231|NCT04513145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65340232|NCT04509115|Analgesics, Opioid|analgesics, opioid|mesh-list
65340233|NCT04509115|Narcotics|narcotics|mesh-ancestor
65340234|NCT04509115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65340235|NCT04509115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340236|NCT04509115|Analgesics|analgesics|mesh-ancestor
65340237|NCT04509115|Sensory System Agents|sensory system agents|mesh-ancestor
65340238|NCT04509115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65340239|NCT04508634|Metformin|metformin|mesh-list
65340240|NCT04508634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65340241|NCT04508634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340242|NCT04485130|Disulfiram|disulfiram|mesh-list
65340243|NCT04485130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64722789|NCT01756573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722790|NCT01756573|Sensory System Agents|sensory system agents|mesh-ancestor
64722791|NCT01756573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64722792|NCT01126801|Estradiol|estradiol|mesh-list
64722793|NCT01126801|Estrogens|estrogens|mesh-ancestor
64722794|NCT01126801|Hormones|hormones|mesh-ancestor
64722795|NCT01126801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64722796|NCT01126801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330457|NCT00135343|Ritonavir|ritonavir|mesh-list
64330458|NCT00135343|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64330459|NCT00135343|Efavirenz|efavirenz|mesh-list
64330460|NCT00135343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64330461|NCT00135343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64330462|NCT00135343|Protease Inhibitors|protease inhibitors|mesh-ancestor
64330463|NCT00135343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64495934|NCT03449940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64495935|NCT03449940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64495936|NCT03449940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64495937|NCT03449940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65340254|NCT04484818|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65340255|NCT04484818|Fertility Agents|fertility agents|mesh-ancestor
65340267|NCT04480502|Ipilimumab|ipilimumab|mesh-list
65340288|NCT04447092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340289|NCT04447092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65340290|NCT04447092|Immunologic Factors|immunologic factors|mesh-ancestor
65340291|NCT04447092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340292|NCT04447092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65340293|NCT04447092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65340294|NCT04447092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65340295|NCT04447092|Antidotes|antidotes|mesh-ancestor
65340296|NCT04447092|Protective Agents|protective agents|mesh-ancestor
65340297|NCT04447092|Vitamin B Complex|vitamin b complex|mesh-ancestor
65340298|NCT04447092|Vitamins|vitamins|mesh-ancestor
65340299|NCT04447092|Micronutrients|micronutrients|mesh-ancestor
65340300|NCT04433780|Tenofovir|tenofovir|mesh-list
65340301|NCT04433780|Lamivudine|lamivudine|mesh-list
65340302|NCT04433780|Antiviral Agents|antiviral agents|mesh-ancestor
65340303|NCT04433780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65340304|NCT04433780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65340305|NCT04433780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65340306|NCT04433780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340307|NCT04433780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340308|NCT04433780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65340309|NCT04433780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65340310|NCT04398524|Cemiplimab|cemiplimab|mesh-list
65340311|NCT04398524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65340312|NCT04398524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340313|NCT04371224|Leucovorin|leucovorin|mesh-list
65340314|NCT04371224|Fluorouracil|fluorouracil|mesh-list
65340315|NCT04371224|Capecitabine|capecitabine|mesh-list
65340316|NCT04371224|Irinotecan|irinotecan|mesh-list
65340317|NCT04371224|Antimetabolites|antimetabolites|mesh-ancestor
65250022|NCT04238208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65250023|NCT04238208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250024|NCT04238208|Antipruritics|antipruritics|mesh-ancestor
65250025|NCT04238208|Dermatologic Agents|dermatologic agents|mesh-ancestor
65250026|NCT02816112|Ciprofloxacin|ciprofloxacin|mesh-list
65250027|NCT02816112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65250028|NCT02816112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65250029|NCT02816112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65250030|NCT02816112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65250031|NCT02816112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65250032|NCT02816112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250033|NCT02816112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250034|NCT02816112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65250035|NCT02816112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65250036|NCT02815722|Simvastatin|simvastatin|mesh-list
65250037|NCT02815722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65250038|NCT02815722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64722815|NCT00002768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722816|NCT00002768|Dermatologic Agents|dermatologic agents|mesh-ancestor
64722817|NCT00002768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64722818|NCT00002768|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64722819|NCT00002768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64722820|NCT00002768|Immunologic Factors|immunologic factors|mesh-ancestor
64722821|NCT00002768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64722822|NCT00002768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64330480|NCT02201225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330481|NCT02365155|Vitamin D|vitamin d|mesh-list
64330482|NCT02365155|Vitamins|vitamins|mesh-ancestor
64330483|NCT02365155|Micronutrients|micronutrients|mesh-ancestor
64330484|NCT02365155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330485|NCT02365155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64330486|NCT05724745|Albuterol|albuterol|mesh-list
65340318|NCT04371224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340319|NCT04371224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65340320|NCT04371224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340321|NCT04371224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65340322|NCT04371224|Immunologic Factors|immunologic factors|mesh-ancestor
65340323|NCT04371224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340324|NCT04371224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65340325|NCT04371224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65340326|NCT04371224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340327|NCT04371224|Antidotes|antidotes|mesh-ancestor
65340328|NCT04371224|Protective Agents|protective agents|mesh-ancestor
65340329|NCT04371224|Vitamin B Complex|vitamin b complex|mesh-ancestor
65340330|NCT04371224|Vitamins|vitamins|mesh-ancestor
65340331|NCT04371224|Micronutrients|micronutrients|mesh-ancestor
65340332|NCT04306900|Gemcitabine|gemcitabine|mesh-list
65340333|NCT04306900|Paclitaxel|paclitaxel|mesh-list
64722823|NCT00002768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64722824|NCT00002768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64722825|NCT00002768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64722826|NCT00002768|Antiviral Agents|antiviral agents|mesh-ancestor
64722827|NCT00002768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64722828|NCT00002768|Alkylating Agents|alkylating agents|mesh-ancestor
64722829|NCT00002768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64722830|NCT00002768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64722831|NCT05599243|Dutasteride|dutasteride|mesh-list
65340348|NCT04306900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65340349|NCT04306900|Immunologic Factors|immunologic factors|mesh-ancestor
65340350|NCT04306900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340351|NCT04306900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65340352|NCT04288687|Niraparib|niraparib|mesh-list
65340353|NCT04288687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65340354|NCT04288687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340355|NCT04288687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340356|NCT04288687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340357|NCT04231708|Hydrocortisone|hydrocortisone|mesh-list
65340358|NCT04231708|Yohimbine|yohimbine|mesh-list
65340359|NCT04231708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65340360|NCT04231708|Mydriatics|mydriatics|mesh-ancestor
65340361|NCT04231708|Autonomic Agents|autonomic agents|mesh-ancestor
65340362|NCT04231708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65340363|NCT04231708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340364|NCT04231708|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65340365|NCT04231708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65340366|NCT04231708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65340367|NCT04231708|Adrenergic Agents|adrenergic agents|mesh-ancestor
65340368|NCT04231708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65340369|NCT04231708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340370|NCT04231708|Urological Agents|urological agents|mesh-ancestor
65340371|NCT04221477|Acetaminophen|acetaminophen|mesh-list
65340372|NCT04221477|Diphenhydramine|diphenhydramine|mesh-list
65340373|NCT04221477|Promethazine|promethazine|mesh-list
64330487|NCT05724745|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65250046|NCT02817750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65340374|NCT04221477|Prednisone|prednisone|mesh-list
64722833|NCT05599243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64722834|NCT05599243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64722835|NCT05599243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722836|NCT05599243|Hormone Antagonists|hormone antagonists|mesh-ancestor
64722838|NCT05599243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340375|NCT04221477|Methylprednisolone|methylprednisolone|mesh-list
65340376|NCT04221477|Obinutuzumab|obinutuzumab|mesh-list
65340377|NCT04221477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65340378|NCT04221477|Glucocorticoids|glucocorticoids|mesh-ancestor
65340379|NCT04221477|Hormones|hormones|mesh-ancestor
65340380|NCT04221477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65340381|NCT04221477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340382|NCT04221477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65340383|NCT04221477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340384|NCT04221477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65340385|NCT04221477|Analgesics|analgesics|mesh-ancestor
65340386|NCT04221477|Sensory System Agents|sensory system agents|mesh-ancestor
65340387|NCT04221477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65340388|NCT04221477|Antipyretics|antipyretics|mesh-ancestor
65340389|NCT04221477|Antiemetics|antiemetics|mesh-ancestor
65340390|NCT04221477|Autonomic Agents|autonomic agents|mesh-ancestor
65340391|NCT04221477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65340392|NCT04221477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65340393|NCT04221477|Protective Agents|protective agents|mesh-ancestor
65340394|NCT04221477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65340395|NCT04221477|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65340396|NCT04221477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65340397|NCT04221477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65340398|NCT04221477|Anesthetics, Local|anesthetics, local|mesh-ancestor
65250047|NCT02817750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65250048|NCT02817750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250049|NCT02817750|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65250050|NCT02817750|GABA Agonists|gaba agonists|mesh-ancestor
65250051|NCT02817750|GABA Agents|gaba agents|mesh-ancestor
65250052|NCT02817750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65250053|NCT02817750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250054|NCT02815410|Levetiracetam|levetiracetam|mesh-list
65250055|NCT02815410|Anticonvulsants|anticonvulsants|mesh-ancestor
65250056|NCT02815410|Nootropic Agents|nootropic agents|mesh-ancestor
65250057|NCT02814630|Omalizumab|omalizumab|mesh-list
65250058|NCT02814630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65250059|NCT02814630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65250060|NCT02814630|Respiratory System Agents|respiratory system agents|mesh-ancestor
65250061|NCT00619957|Risedronic Acid|risedronic acid|mesh-list
65340399|NCT04221477|Anesthetics|anesthetics|mesh-ancestor
65340400|NCT04221477|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65340401|NCT04221477|Histamine Antagonists|histamine antagonists|mesh-ancestor
65340402|NCT04221477|Histamine Agents|histamine agents|mesh-ancestor
65340403|NCT04221477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65340404|NCT04221477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340405|NCT04221477|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65340406|NCT04221477|Antipruritics|antipruritics|mesh-ancestor
65340407|NCT04221477|Dermatologic Agents|dermatologic agents|mesh-ancestor
65340408|NCT04218786|Colchicine|colchicine|mesh-list
65340409|NCT04218786|Gout Suppressants|gout suppressants|mesh-ancestor
65340410|NCT04218786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65340411|NCT04218786|Tubulin Modulators|tubulin modulators|mesh-ancestor
65340412|NCT04218786|Antimitotic Agents|antimitotic agents|mesh-ancestor
65340413|NCT04218786|Mitosis Modulators|mitosis modulators|mesh-ancestor
65340414|NCT04218786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340415|NCT04218786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340416|NCT04216524|Cytarabine|cytarabine|mesh-list
65340417|NCT04216524|Dexamethasone|dexamethasone|mesh-list
65340418|NCT04216524|Dexamethasone acetate|dexamethasone acetate|mesh-list
65340419|NCT04216524|Prednisone|prednisone|mesh-list
65340420|NCT04216524|Methylprednisolone|methylprednisolone|mesh-list
65340421|NCT04216524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65340422|NCT04216524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65340423|NCT04216524|Prednisolone|prednisolone|mesh-list
65340424|NCT04216524|Prednisolone acetate|prednisolone acetate|mesh-list
65250062|NCT00619957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65250063|NCT00619957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65250064|NCT00619957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250065|NCT00619957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65250066|NCT00619957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250067|NCT00619957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65250068|NCT04519476|Methylprednisolone|methylprednisolone|mesh-list
65250069|NCT04519476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65250070|NCT04519476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65250071|NCT04519476|Prednisolone|prednisolone|mesh-list
65250072|NCT04519476|Prednisolone acetate|prednisolone acetate|mesh-list
65250073|NCT04519476|Lenalidomide|lenalidomide|mesh-list
65250074|NCT04519476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65250075|NCT04519476|Prednisolone phosphate|prednisolone phosphate|mesh-list
65250076|NCT04519476|Immunologic Factors|immunologic factors|mesh-ancestor
65250077|NCT04519476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250078|NCT04519476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65250079|NCT04519476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65250080|NCT04519476|Growth Substances|growth substances|mesh-ancestor
65250081|NCT04519476|Growth Inhibitors|growth inhibitors|mesh-ancestor
65250082|NCT04519476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250083|NCT04519476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65250084|NCT04519476|Antiemetics|antiemetics|mesh-ancestor
65250085|NCT04519476|Autonomic Agents|autonomic agents|mesh-ancestor
65250086|NCT04519476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64722857|NCT00002780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64722858|NCT00002780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64722859|NCT00002780|Alkylating Agents|alkylating agents|mesh-ancestor
64722860|NCT00002780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722861|NCT00002780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722862|NCT00002780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64722863|NCT00002780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64722864|NCT00002780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64722865|NCT00002780|Antiviral Agents|antiviral agents|mesh-ancestor
64330512|NCT02198417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64330513|NCT02198417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330514|NCT02201459|Interferons|interferons|mesh-list
64330515|NCT02201459|Interferon-alpha|interferon-alpha|mesh-list
64330516|NCT02201459|Interferon alpha-2|interferon alpha-2|mesh-list
64330517|NCT02201459|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64330518|NCT02201459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330519|NCT02201459|Antiviral Agents|antiviral agents|mesh-ancestor
64330520|NCT02201459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65340425|NCT04216524|Cortisone|cortisone|mesh-list
65340426|NCT04216524|Cyclophosphamide|cyclophosphamide|mesh-list
65340427|NCT04216524|Rituximab|rituximab|mesh-list
65340464|NCT04216524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65340465|NCT04216524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65340466|NCT04216524|Abortifacient Agents|abortifacient agents|mesh-ancestor
65340467|NCT04216524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65340468|NCT04216524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65340469|NCT04216524|Antimetabolites|antimetabolites|mesh-ancestor
65340470|NCT04216524|Dermatologic Agents|dermatologic agents|mesh-ancestor
65340471|NCT04216524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65340472|NCT04216524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65340473|NCT04216524|Antiviral Agents|antiviral agents|mesh-ancestor
65340474|NCT04216524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65340475|NCT04216524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65340476|NCT04216524|Tubulin Modulators|tubulin modulators|mesh-ancestor
65340477|NCT04216524|Antimitotic Agents|antimitotic agents|mesh-ancestor
65340478|NCT04216524|Mitosis Modulators|mitosis modulators|mesh-ancestor
65340479|NCT04216524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65340480|NCT04216524|Protective Agents|protective agents|mesh-ancestor
65340481|NCT04202692|Magnesium trisilicate|magnesium trisilicate|mesh-list
65340482|NCT04202692|Hyaluronic Acid|hyaluronic acid|mesh-list
65340483|NCT04202692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65340484|NCT04202692|Immunologic Factors|immunologic factors|mesh-ancestor
65340485|NCT04202692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340486|NCT04202692|Viscosupplements|viscosupplements|mesh-ancestor
65340487|NCT04202692|Protective Agents|protective agents|mesh-ancestor
65340488|NCT04202692|Antacids|antacids|mesh-ancestor
65340489|NCT04202692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340490|NCT04202692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65340491|NCT04191499|Fulvestrant|fulvestrant|mesh-list
65340492|NCT04191499|Palbociclib|palbociclib|mesh-list
65340493|NCT04191499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65340503|NCT04177758|Vitamin D|vitamin d|mesh-list
64722882|NCT01122511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722883|NCT01122511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64722884|NCT01122511|Glucocorticoids|glucocorticoids|mesh-ancestor
64722886|NCT01122511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64722887|NCT01122511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64722888|NCT01122511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722889|NCT01122511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65340507|NCT04177758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65340508|NCT04170543|Dapagliflozin|dapagliflozin|mesh-list
65340509|NCT04170543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65340510|NCT04170543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340511|NCT04170543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65340512|NCT04170543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340513|NCT04168112|Dexamethasone|dexamethasone|mesh-list
65340514|NCT04168112|Prednisolone|prednisolone|mesh-list
65340515|NCT04168112|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65340516|NCT04168112|Methylprednisolone|methylprednisolone|mesh-list
65340517|NCT04168112|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65340518|NCT04168112|Prednisolone acetate|prednisolone acetate|mesh-list
65340519|NCT04168112|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65340520|NCT04168112|Prednisolone phosphate|prednisolone phosphate|mesh-list
65340521|NCT04168112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65340522|NCT04168112|Antiemetics|antiemetics|mesh-ancestor
65340523|NCT04168112|Autonomic Agents|autonomic agents|mesh-ancestor
65340524|NCT04168112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65340525|NCT04168112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340526|NCT04168112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65340527|NCT04168112|Glucocorticoids|glucocorticoids|mesh-ancestor
65340528|NCT04168112|Hormones|hormones|mesh-ancestor
65340529|NCT04168112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65340530|NCT04168112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65340531|NCT04168112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340532|NCT04168112|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65250087|NCT04519476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65250088|NCT04519476|Glucocorticoids|glucocorticoids|mesh-ancestor
65250089|NCT04519476|Hormones|hormones|mesh-ancestor
65250090|NCT04519476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65250091|NCT04519476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65250092|NCT04519476|Protective Agents|protective agents|mesh-ancestor
64722895|NCT05535218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722896|NCT05531708|Cyclophosphamide|cyclophosphamide|mesh-list
64722897|NCT05531708|Fludarabine|fludarabine|mesh-list
64722898|NCT05531708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64722899|NCT05531708|Immunologic Factors|immunologic factors|mesh-ancestor
64722900|NCT05531708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722901|NCT05531708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64722902|NCT05531708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64330543|NCT02201849|Immunologic Factors|immunologic factors|mesh-ancestor
64330544|NCT02201849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330545|NCT02375217|Glycopyrrolate|glycopyrrolate|mesh-list
64330546|NCT02375217|Neostigmine|neostigmine|mesh-list
64330547|NCT02375217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64330548|NCT02375217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330549|NCT02375217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340533|NCT04168112|Protective Agents|protective agents|mesh-ancestor
65340534|NCT04150458|Choline|choline|mesh-list
65340535|NCT04150458|Lipotropic Agents|lipotropic agents|mesh-ancestor
65340536|NCT04150458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65340537|NCT04150458|Antimetabolites|antimetabolites|mesh-ancestor
65340538|NCT04150458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340539|NCT04150458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65340540|NCT04150458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65340541|NCT04150458|Nootropic Agents|nootropic agents|mesh-ancestor
65340542|NCT04147208|Ritonavir|ritonavir|mesh-list
65340543|NCT04147208|Entecavir|entecavir|mesh-list
65340544|NCT04147208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65340545|NCT04147208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65340556|NCT04140487|Venetoclax|venetoclax|mesh-list
64722903|NCT05531708|Alkylating Agents|alkylating agents|mesh-ancestor
64722904|NCT05531708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722905|NCT05531708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722906|NCT05531708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64722907|NCT01663285|Gemcitabine|gemcitabine|mesh-list
64722908|NCT01663285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722909|NCT01663285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64722910|NCT01663285|Antimetabolites|antimetabolites|mesh-ancestor
64722911|NCT01663285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330551|NCT02375217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64330552|NCT02375217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330553|NCT02375217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65340565|NCT04136756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340566|NCT04136756|Immunologic Factors|immunologic factors|mesh-ancestor
65340567|NCT04136756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340568|NCT04136756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65340569|NCT04067726|Vitamin D|vitamin d|mesh-list
65340570|NCT04067726|Cholecalciferol|cholecalciferol|mesh-list
65340571|NCT04067726|Denosumab|denosumab|mesh-list
65340572|NCT04067726|Calcium|calcium|mesh-list
65340573|NCT04067726|Vitamins|vitamins|mesh-ancestor
65340574|NCT04067726|Micronutrients|micronutrients|mesh-ancestor
65340575|NCT04067726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340576|NCT04067726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65340577|NCT04067726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65340578|NCT04045665|Anticoagulants|anticoagulants|mesh-list
65340579|NCT04008706|Acalabrutinib|acalabrutinib|mesh-list
65340580|NCT04008706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340582|NCT04003103|Antiviral Agents|antiviral agents|mesh-ancestor
65340583|NCT04003103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65340584|NCT04003103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64722912|NCT01663285|Antiviral Agents|antiviral agents|mesh-ancestor
64722913|NCT01663285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64722914|NCT01663285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64722915|NCT01663285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65340597|NCT03996850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65340598|NCT03996850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340599|NCT03978611|Ipilimumab|ipilimumab|mesh-list
65340600|NCT03978611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65340601|NCT03978611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340602|NCT03978611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65340603|NCT03978611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340604|NCT03945448|Fluconazole|fluconazole|mesh-list
65340605|NCT03945448|Amphotericin B|amphotericin b|mesh-list
65340606|NCT03945448|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65340607|NCT03945448|Antifungal Agents|antifungal agents|mesh-ancestor
65340608|NCT03945448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65340609|NCT03945448|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65340610|NCT03945448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65340611|NCT03945448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340612|NCT03945448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340613|NCT03945448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65340614|NCT03945448|Hormone Antagonists|hormone antagonists|mesh-ancestor
65340615|NCT03945448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65340616|NCT03945448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340617|NCT03945448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65340618|NCT03945448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65340619|NCT03945448|Amebicides|amebicides|mesh-ancestor
65340620|NCT03945448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65340621|NCT03945448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65340622|NCT03945448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65340623|NCT03942328|Vaccines|vaccines|mesh-list
65340633|NCT03917420|Tenofovir|tenofovir|mesh-list
65340634|NCT03917420|Emtricitabine|emtricitabine|mesh-list
65340635|NCT03917420|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65340636|NCT03917420|Antiviral Agents|antiviral agents|mesh-ancestor
65340637|NCT03917420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65340638|NCT03917420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65340639|NCT03917420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65340640|NCT03917420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340641|NCT03917420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340642|NCT03917420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65340643|NCT03917420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65340644|NCT03913195|Ibalizumab|ibalizumab|mesh-list
65340645|NCT03913195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65340646|NCT03913195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65340647|NCT03913195|Antiviral Agents|antiviral agents|mesh-ancestor
65340648|NCT03913195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65340649|NCT03913104|Mifepristone|mifepristone|mesh-list
65340650|NCT03913104|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65340651|NCT03913104|Abortifacient Agents|abortifacient agents|mesh-ancestor
65250093|NCT04519476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65250094|NCT00961415|Bevacizumab|bevacizumab|mesh-list
65250095|NCT00961415|Pemetrexed|pemetrexed|mesh-list
65250096|NCT00961415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65250097|NCT00961415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250098|NCT00961415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65250099|NCT00961415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65250100|NCT00961415|Growth Substances|growth substances|mesh-ancestor
65250101|NCT00961415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250102|NCT00961415|Growth Inhibitors|growth inhibitors|mesh-ancestor
65250103|NCT00961415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65250104|NCT00961415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250105|NCT00961415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65250131|NCT00836485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65250132|NCT00836485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65250133|NCT00836485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65250134|NCT00836485|Analgesics|analgesics|mesh-ancestor
65250135|NCT00836485|Sensory System Agents|sensory system agents|mesh-ancestor
65250136|NCT00836485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250137|NCT00836485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250138|NCT00836485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65250139|NCT00836485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65250140|NCT00836485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65250141|NCT00836485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65250142|NCT00836485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65250143|NCT00836485|Histamine Antagonists|histamine antagonists|mesh-ancestor
65250144|NCT00836485|Histamine Agents|histamine agents|mesh-ancestor
65250145|NCT00836485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65250146|NCT00836485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250147|NCT00836485|Antipruritics|antipruritics|mesh-ancestor
65250148|NCT00836485|Dermatologic Agents|dermatologic agents|mesh-ancestor
65250149|NCT00963599|Loratadine|loratadine|mesh-list
65250150|NCT00963599|Montelukast|montelukast|mesh-list
65250151|NCT00963599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65250152|NCT00963599|Respiratory System Agents|respiratory system agents|mesh-ancestor
65250153|NCT00963599|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64722942|NCT00002792|Cyclophosphamide|cyclophosphamide|mesh-list
64722943|NCT00002792|Busulfan|busulfan|mesh-list
64722944|NCT00002792|Methotrexate|methotrexate|mesh-list
64722945|NCT00002792|Tacrolimus|tacrolimus|mesh-list
64722946|NCT00002792|Cyclosporins|cyclosporins|mesh-list
64722947|NCT00002792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64722948|NCT00002792|Immunologic Factors|immunologic factors|mesh-ancestor
64722949|NCT00002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722950|NCT00002792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64722951|NCT00002792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64330583|NCT02741245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330584|NCT02202239|Fentanyl|fentanyl|mesh-list
64330585|NCT02202239|Midazolam|midazolam|mesh-list
64330586|NCT02202239|Remifentanil|remifentanil|mesh-list
64330587|NCT02202239|Propofol|propofol|mesh-list
64330588|NCT02202239|Etomidate|etomidate|mesh-list
64330589|NCT02202239|Sevoflurane|sevoflurane|mesh-list
65340652|NCT03913104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65340653|NCT03913104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340654|NCT03913104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65340655|NCT03913104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65340656|NCT03913104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65340657|NCT03913104|Contraceptive Agents|contraceptive agents|mesh-ancestor
65340658|NCT03913104|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64722952|NCT00002792|Alkylating Agents|alkylating agents|mesh-ancestor
64722953|NCT00002792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722954|NCT00002792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722955|NCT00002792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64722956|NCT00002792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64722957|NCT00002792|Abortifacient Agents|abortifacient agents|mesh-ancestor
64722958|NCT00002792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64722959|NCT00002792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65340686|NCT03879629|Adrenergic Agents|adrenergic agents|mesh-ancestor
65340687|NCT03879629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65340688|NCT03879629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340689|NCT03879629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340690|NCT03879629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65340691|NCT03879629|Antioxidants|antioxidants|mesh-ancestor
65340692|NCT03879629|Protective Agents|protective agents|mesh-ancestor
65340693|NCT03879629|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65340694|NCT03879629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65340695|NCT03879629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65340696|NCT03879629|Vasodilator Agents|vasodilator agents|mesh-ancestor
65340697|NCT03879629|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65340698|NCT03879629|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65340699|NCT03878589|Oxytocin|oxytocin|mesh-list
65340700|NCT03878589|Oxytocics|oxytocics|mesh-ancestor
65340701|NCT03878589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65340702|NCT03878589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340703|NCT03825536|Methamphetamine|methamphetamine|mesh-list
65340704|NCT03825536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65340705|NCT03825536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340706|NCT03825536|Sympathomimetics|sympathomimetics|mesh-ancestor
65340707|NCT03825536|Autonomic Agents|autonomic agents|mesh-ancestor
65340708|NCT03825536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65340709|NCT03825536|Dopamine Agents|dopamine agents|mesh-ancestor
65340710|NCT03825536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65340712|NCT03825536|Adrenergic Agents|adrenergic agents|mesh-ancestor
65340715|NCT03825536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65340716|NCT03825536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65340717|NCT03720119|Lidocaine|lidocaine|mesh-list
65340718|NCT03720119|Anesthetics, Local|anesthetics, local|mesh-ancestor
65340719|NCT03720119|Anesthetics|anesthetics|mesh-ancestor
65340720|NCT03720119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65340721|NCT03720119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340722|NCT03720119|Sensory System Agents|sensory system agents|mesh-ancestor
65340723|NCT03720119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65340724|NCT03720119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65090557|NCT00477854|Chromium|chromium|mesh-list
65340725|NCT03720119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65340726|NCT03720119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65340727|NCT03720119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65340728|NCT03720119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340730|NCT03713528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65340731|NCT03713528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65340732|NCT03705845|Tocotrienols|tocotrienols|mesh-list
65340733|NCT03705845|Vitamin E|vitamin e|mesh-list
65340734|NCT03705845|Tocopherols|tocopherols|mesh-list
65340735|NCT03705845|Antioxidants|antioxidants|mesh-ancestor
65340736|NCT03705845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340737|NCT03705845|Protective Agents|protective agents|mesh-ancestor
65340738|NCT03705845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340739|NCT03705845|Vitamins|vitamins|mesh-ancestor
65340740|NCT03705845|Micronutrients|micronutrients|mesh-ancestor
65340741|NCT03669718|Cemiplimab|cemiplimab|mesh-list
65340742|NCT03669718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65340743|NCT03669718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340744|NCT03644966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65250154|NCT00963599|Hormone Antagonists|hormone antagonists|mesh-ancestor
65250155|NCT00963599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65250156|NCT00963599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250180|NCT04205136|Diuretics|diuretics|mesh-ancestor
65250181|NCT04205136|Natriuretic Agents|natriuretic agents|mesh-ancestor
65250182|NCT02815332|Minocycline|minocycline|mesh-list
65250183|NCT02815332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65250184|NCT02815332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65250185|NCT02811354|Osimertinib|osimertinib|mesh-list
65250186|NCT02811354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250187|NCT02811354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65250188|NCT02811354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65250189|NCT02811354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250190|NCT02810808|Ranibizumab|ranibizumab|mesh-list
65340745|NCT03644966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65340746|NCT03642990|Niacinamide|niacinamide|mesh-list
65340747|NCT03642990|Niacin|niacin|mesh-list
65340748|NCT03642990|Nicotinic Acids|nicotinic acids|mesh-list
65340749|NCT03642990|Vitamin B Complex|vitamin b complex|mesh-ancestor
65340750|NCT03642990|Vitamins|vitamins|mesh-ancestor
65340751|NCT03642990|Micronutrients|micronutrients|mesh-ancestor
65340752|NCT03642990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340753|NCT03642990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65340754|NCT03642990|Antimetabolites|antimetabolites|mesh-ancestor
65340755|NCT03642990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340756|NCT03642990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65340757|NCT03642990|Vasodilator Agents|vasodilator agents|mesh-ancestor
65340758|NCT03582475|Cisplatin|cisplatin|mesh-list
65340759|NCT03582475|Carboplatin|carboplatin|mesh-list
65340760|NCT03582475|Docetaxel|docetaxel|mesh-list
65340761|NCT03582475|Pembrolizumab|pembrolizumab|mesh-list
65340762|NCT03582475|Etoposide|etoposide|mesh-list
65340763|NCT03582475|Etoposide phosphate|etoposide phosphate|mesh-list
65340764|NCT03582475|Podophyllotoxin|podophyllotoxin|mesh-list
65340765|NCT03582475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340766|NCT03582475|Tubulin Modulators|tubulin modulators|mesh-ancestor
65340767|NCT03582475|Antimitotic Agents|antimitotic agents|mesh-ancestor
65340768|NCT03582475|Mitosis Modulators|mitosis modulators|mesh-ancestor
65340769|NCT03582475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340770|NCT03582475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65340771|NCT03582475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65340772|NCT03582475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65340773|NCT03582475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65340774|NCT03582475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340775|NCT03582475|Keratolytic Agents|keratolytic agents|mesh-ancestor
65340776|NCT03582475|Dermatologic Agents|dermatologic agents|mesh-ancestor
65340777|NCT03579784|Paclitaxel|paclitaxel|mesh-list
65340778|NCT03579784|Durvalumab|durvalumab|mesh-list
65340779|NCT03579784|Olaparib|olaparib|mesh-list
64723003|NCT05594407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64723004|NCT05594407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723005|NCT05594407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64723006|NCT05594407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64723007|NCT05594407|Analgesics|analgesics|mesh-ancestor
64723008|NCT05594407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64723009|NCT05594407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64723010|NCT05594407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64723011|NCT05594407|Adrenergic Agents|adrenergic agents|mesh-ancestor
64330635|NCT03529201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64330636|NCT03529201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330637|NCT03529201|Analgesics|analgesics|mesh-ancestor
64330638|NCT03529201|Sensory System Agents|sensory system agents|mesh-ancestor
65340789|NCT03564678|Folic Acid|folic acid|mesh-list
65340790|NCT03564678|Vitamin B Complex|vitamin b complex|mesh-list
65340791|NCT03564678|Vitamins|vitamins|mesh-ancestor
65340792|NCT03564678|Micronutrients|micronutrients|mesh-ancestor
65340793|NCT03564678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340794|NCT03564678|Hematinics|hematinics|mesh-ancestor
65340795|NCT03554473|Temozolomide|temozolomide|mesh-list
65340796|NCT03554473|Topotecan|topotecan|mesh-list
65340797|NCT03554473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65340798|NCT03554473|Alkylating Agents|alkylating agents|mesh-ancestor
65340799|NCT03554473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340800|NCT03554473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340801|NCT03554473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65340802|NCT03554473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65340803|NCT03554473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340804|NCT03553563|Esomeprazole|esomeprazole|mesh-list
65340805|NCT03553563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65340806|NCT03553563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64723012|NCT05594407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65340821|NCT03530397|Mitosis Modulators|mitosis modulators|mesh-ancestor
65340822|NCT03530397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340823|NCT03530397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65340824|NCT03530397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340825|NCT03530397|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65340826|NCT03530397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65340827|NCT03515304|Evolocumab|evolocumab|mesh-list
65340828|NCT03515304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65340829|NCT03515304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65340830|NCT03515304|Antimetabolites|antimetabolites|mesh-ancestor
65340831|NCT03515304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340832|NCT03515304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65340833|NCT03479554|Antihypertensive Agents|antihypertensive agents|mesh-list
65340834|NCT03477292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65340835|NCT03477292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65340836|NCT03465540|Dexamethasone|dexamethasone|mesh-list
65340837|NCT03465540|Azacitidine|azacitidine|mesh-list
65340838|NCT03465540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65340839|NCT03465540|Antiemetics|antiemetics|mesh-ancestor
65340840|NCT03465540|Autonomic Agents|autonomic agents|mesh-ancestor
65340841|NCT03465540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65340842|NCT03465540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250191|NCT02810808|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65250192|NCT02810808|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65250193|NCT02810808|Growth Substances|growth substances|mesh-ancestor
65250194|NCT02810808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250195|NCT02810808|Growth Inhibitors|growth inhibitors|mesh-ancestor
65250196|NCT02810808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250198|NCT00619801|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65250199|NCT00619801|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65250200|NCT00619801|Histamine Antagonists|histamine antagonists|mesh-ancestor
65250201|NCT00619801|Histamine Agents|histamine agents|mesh-ancestor
65250202|NCT00619801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65250203|NCT00619801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250204|NCT00619801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250205|NCT02545777|Diclofenac|diclofenac|mesh-list
65250229|NCT00962741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65250230|NCT00962741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65250231|NCT00962741|Immunologic Factors|immunologic factors|mesh-ancestor
65250233|NCT00851929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65250234|NCT02813382|Bupivacaine|bupivacaine|mesh-list
65250235|NCT02813382|Prilocaine|prilocaine|mesh-list
65250236|NCT02813382|Chloroprocaine|chloroprocaine|mesh-list
65250237|NCT02813382|Procaine|procaine|mesh-list
65250238|NCT02813382|Anesthetics, Local|anesthetics, local|mesh-ancestor
65250239|NCT02813382|Anesthetics|anesthetics|mesh-ancestor
65250240|NCT02813382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65250241|NCT02813382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250242|NCT02813382|Sensory System Agents|sensory system agents|mesh-ancestor
65250243|NCT02813382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250244|NCT00619645|Cyclosporine|cyclosporine|mesh-list
64723023|NCT00379717|Tubulin Modulators|tubulin modulators|mesh-ancestor
64723024|NCT00379717|Antimitotic Agents|antimitotic agents|mesh-ancestor
64462312|NCT01808534|Ifosfamide|ifosfamide|mesh-list
64723025|NCT00379717|Mitosis Modulators|mitosis modulators|mesh-ancestor
64723026|NCT00379717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723028|NCT04706377|Vitamins|vitamins|mesh-ancestor
64723029|NCT04706377|Micronutrients|micronutrients|mesh-ancestor
64723030|NCT04706377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723031|NCT04706377|Vitamin B Complex|vitamin b complex|mesh-ancestor
64723032|NCT01583647|Niacin|niacin|mesh-list
64723033|NCT01583647|Niacinamide|niacinamide|mesh-list
65340843|NCT03465540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65340844|NCT03465540|Glucocorticoids|glucocorticoids|mesh-ancestor
65340845|NCT03465540|Hormones|hormones|mesh-ancestor
65340846|NCT03465540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65340847|NCT03465540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65340848|NCT03465540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340849|NCT03465540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65340850|NCT03465540|Antimetabolites|antimetabolites|mesh-ancestor
65340851|NCT03465540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340852|NCT03465540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340853|NCT03374085|Dexamethasone|dexamethasone|mesh-list
65340854|NCT03374085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65340855|NCT03374085|Antiemetics|antiemetics|mesh-ancestor
65340856|NCT03374085|Autonomic Agents|autonomic agents|mesh-ancestor
65340857|NCT03374085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65340860|NCT03374085|Glucocorticoids|glucocorticoids|mesh-ancestor
64723037|NCT01583647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723038|NCT01583647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64723041|NCT01583647|Vitamins|vitamins|mesh-ancestor
65340879|NCT03152903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65340880|NCT03152903|Immunologic Factors|immunologic factors|mesh-ancestor
65340881|NCT03152903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340883|NCT03152890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65340884|NCT03152890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340885|NCT03125811|Ethanol|ethanol|mesh-list
65340886|NCT03125811|Ondansetron|ondansetron|mesh-list
65340887|NCT03125811|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65340888|NCT03125811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65340889|NCT03125811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65340890|NCT03125811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340891|NCT03125811|Antiemetics|antiemetics|mesh-ancestor
65340892|NCT03125811|Autonomic Agents|autonomic agents|mesh-ancestor
65340893|NCT03125811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65340894|NCT03125811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65340895|NCT03125811|Antipruritics|antipruritics|mesh-ancestor
65340896|NCT03125811|Dermatologic Agents|dermatologic agents|mesh-ancestor
65340897|NCT03125811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65340898|NCT03125811|Serotonin Agents|serotonin agents|mesh-ancestor
65340899|NCT03125811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65340900|NCT03125811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340901|NCT03125811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65340902|NCT03125811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65340903|NCT03125811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65340904|NCT03125811|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65340905|NCT03123029|Venetoclax|venetoclax|mesh-list
65340906|NCT03123029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340907|NCT03117933|Paclitaxel|paclitaxel|mesh-list
65340908|NCT03117933|Olaparib|olaparib|mesh-list
65340909|NCT03117933|Cediranib|cediranib|mesh-list
65340910|NCT03117933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65340911|NCT03117933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340912|NCT03117933|Tubulin Modulators|tubulin modulators|mesh-ancestor
65250245|NCT00619645|Mycophenolic Acid|mycophenolic acid|mesh-list
65250246|NCT00619645|Fludarabine|fludarabine|mesh-list
65250247|NCT00619645|Fludarabine phosphate|fludarabine phosphate|mesh-list
65250248|NCT00619645|Busulfan|busulfan|mesh-list
65250249|NCT00619645|Cyclosporins|cyclosporins|mesh-list
64723052|NCT04403516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64723053|NCT04403516|Antiemetics|antiemetics|mesh-ancestor
64723054|NCT04403516|Autonomic Agents|autonomic agents|mesh-ancestor
65340913|NCT03117933|Antimitotic Agents|antimitotic agents|mesh-ancestor
65340914|NCT03117933|Mitosis Modulators|mitosis modulators|mesh-ancestor
65340915|NCT03117933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340916|NCT03117933|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65340917|NCT03117933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340918|NCT03117933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65340919|NCT03077243|Cisplatin|cisplatin|mesh-list
65340920|NCT03077243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340921|NCT03048877|Apatinib|apatinib|mesh-list
65340922|NCT03048877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340923|NCT03048877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65340924|NCT03048877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340925|NCT03048877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340926|NCT02951351|Proxymetacaine|proxymetacaine|mesh-list
65340927|NCT02951351|Anesthetics, Local|anesthetics, local|mesh-ancestor
65340928|NCT02951351|Anesthetics|anesthetics|mesh-ancestor
65340929|NCT02951351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65340930|NCT02951351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340931|NCT02951351|Sensory System Agents|sensory system agents|mesh-ancestor
65340932|NCT02951351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65340933|NCT02940925|Cisplatin|cisplatin|mesh-list
65340934|NCT02940925|Fluorouracil|fluorouracil|mesh-list
65340935|NCT02940925|Capecitabine|capecitabine|mesh-list
65340936|NCT02940925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340937|NCT02940925|Antimetabolites|antimetabolites|mesh-ancestor
65340938|NCT02940925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340939|NCT02940925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65340940|NCT02940925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64723068|NCT01555489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723069|NCT01555489|Antioxidants|antioxidants|mesh-ancestor
65340953|NCT02891278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340954|NCT02891278|Antiviral Agents|antiviral agents|mesh-ancestor
65340955|NCT02891278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65340956|NCT02891278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65340957|NCT02891278|Immunologic Factors|immunologic factors|mesh-ancestor
65340958|NCT02891278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340959|NCT02891278|Antidepressive Agents|antidepressive agents|mesh-ancestor
65340960|NCT02891278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65340961|NCT02891278|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65340962|NCT02891278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65340963|NCT02891278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65340964|NCT02891278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65340965|NCT02891278|Serotonin Agents|serotonin agents|mesh-ancestor
65340966|NCT02807181|Gemcitabine|gemcitabine|mesh-list
65340967|NCT02807181|Cisplatin|cisplatin|mesh-list
65340968|NCT02807181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340969|NCT02807181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65340970|NCT02807181|Antimetabolites|antimetabolites|mesh-ancestor
65340971|NCT02807181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340972|NCT02807181|Antiviral Agents|antiviral agents|mesh-ancestor
65340973|NCT02807181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65340974|NCT02807181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340975|NCT02807181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65340976|NCT02807181|Immunologic Factors|immunologic factors|mesh-ancestor
65340977|NCT02807181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340978|NCT02752035|Azacitidine|azacitidine|mesh-list
65340979|NCT02752035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65340980|NCT02752035|Antimetabolites|antimetabolites|mesh-ancestor
65340981|NCT02752035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340982|NCT02752035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65340983|NCT02752035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340984|NCT02632409|Nivolumab|nivolumab|mesh-list
65340985|NCT02632409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65340986|NCT02632409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250250|NCT00619645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250251|NCT00619645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64723083|NCT01035073|Sensory System Agents|sensory system agents|mesh-ancestor
64723084|NCT01035073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64723085|NCT01035073|Antidepressive Agents|antidepressive agents|mesh-ancestor
64723086|NCT01035073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64723087|NCT01035073|Dopamine Agents|dopamine agents|mesh-ancestor
64723088|NCT04331743|Mitoxantrone|mitoxantrone|mesh-list
64723089|NCT04331743|Analgesics|analgesics|mesh-ancestor
64723090|NCT04331743|Sensory System Agents|sensory system agents|mesh-ancestor
64723091|NCT04331743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64723092|NCT04331743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723093|NCT04331743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723094|NCT04331743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64330709|NCT02202473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340987|NCT02632409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65340988|NCT02632409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340989|NCT02454543|Androgens|androgens|mesh-list
65340990|NCT02454543|Hormones|hormones|mesh-ancestor
65340991|NCT02454543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65340992|NCT02454543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65340993|NCT02384512|Rasagiline|rasagiline|mesh-list
65340994|NCT02384512|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65340995|NCT02384512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65340996|NCT02384512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65340997|NCT02384512|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65340998|NCT02384512|Protective Agents|protective agents|mesh-ancestor
65340999|NCT02384512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341000|NCT02366494|Docetaxel|docetaxel|mesh-list
65341001|NCT02366494|Leuprolide|leuprolide|mesh-list
65341002|NCT02366494|Goserelin|goserelin|mesh-list
65341018|NCT02366494|Luteolytic Agents|luteolytic agents|mesh-ancestor
65341019|NCT02366494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65341020|NCT02366494|Contraceptive Agents|contraceptive agents|mesh-ancestor
65341021|NCT02366494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65341022|NCT02311933|Tamoxifen|tamoxifen|mesh-list
64723095|NCT04331743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64723096|NCT04331743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64723097|NCT04331743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723098|NCT05296759|Gabapentin|gabapentin|mesh-list
64723099|NCT05296759|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64723100|NCT05296759|Botulinum Toxins|botulinum toxins|mesh-list
65341023|NCT02311933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65341024|NCT02311933|Hormone Antagonists|hormone antagonists|mesh-ancestor
65341025|NCT02311933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65341026|NCT02311933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341027|NCT02311933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65341028|NCT02311933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090862|NCT00479609|Hormones|hormones|mesh-ancestor
65341029|NCT02311933|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65341030|NCT02311933|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65341031|NCT02311933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65341032|NCT02157610|Nicotine|nicotine|mesh-list
65341033|NCT02157610|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65341034|NCT02157610|Autonomic Agents|autonomic agents|mesh-ancestor
65341035|NCT02157610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65341036|NCT02157610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341037|NCT02157610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65341038|NCT02157610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64723110|NCT05296759|Sensory System Agents|sensory system agents|mesh-ancestor
64723111|NCT05296759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64723112|NCT05296759|Anticonvulsants|anticonvulsants|mesh-ancestor
64723113|NCT05296759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64723114|NCT05296759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65341056|NCT02138617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65341057|NCT02138617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65341058|NCT02138617|Immunologic Factors|immunologic factors|mesh-ancestor
65341059|NCT02138617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65341060|NCT02138617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65341061|NCT02138617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341062|NCT02138617|Antidotes|antidotes|mesh-ancestor
65341063|NCT02138617|Protective Agents|protective agents|mesh-ancestor
65341064|NCT02138617|Vitamin B Complex|vitamin b complex|mesh-ancestor
65341065|NCT02138617|Vitamins|vitamins|mesh-ancestor
65341066|NCT02138617|Micronutrients|micronutrients|mesh-ancestor
65341067|NCT02115282|Exemestane|exemestane|mesh-list
65341068|NCT02115282|Goserelin|goserelin|mesh-list
65341069|NCT02115282|Entinostat|entinostat|mesh-list
65341070|NCT02115282|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65341071|NCT02115282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341072|NCT02115282|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65341073|NCT02115282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65341074|NCT02115282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341075|NCT02115282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341076|NCT02115282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65341077|NCT02115282|Hormone Antagonists|hormone antagonists|mesh-ancestor
65341078|NCT02115282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65341079|NCT02115282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341080|NCT02115282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65341081|NCT02078869|Progesterone|progesterone|mesh-list
65341082|NCT02078869|Progestins|progestins|mesh-ancestor
65341083|NCT02078869|Hormones|hormones|mesh-ancestor
65341084|NCT02078869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65341092|NCT02031419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65341093|NCT02031419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341094|NCT02031419|Immunologic Factors|immunologic factors|mesh-ancestor
65341095|NCT02031419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341096|NCT02031419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65341097|NCT02031419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65341098|NCT02031419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341099|NCT02031419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341100|NCT01946815|Atorvastatin|atorvastatin|mesh-list
65341101|NCT01946815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65341102|NCT01946815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65341103|NCT01946815|Antimetabolites|antimetabolites|mesh-ancestor
65341104|NCT01946815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341105|NCT01946815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65341106|NCT01946815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65341107|NCT01946815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341108|NCT01937156|Granisetron|granisetron|mesh-list
65341109|NCT01937156|Antiemetics|antiemetics|mesh-ancestor
65341110|NCT01937156|Autonomic Agents|autonomic agents|mesh-ancestor
65341111|NCT01937156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65341112|NCT01937156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341113|NCT01937156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65341114|NCT01937156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65341115|NCT01937156|Serotonin Agents|serotonin agents|mesh-ancestor
65341116|NCT01937156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65341117|NCT01937156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341119|NCT01805804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65341120|NCT01805804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65341121|NCT01805804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65341122|NCT01805804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341123|NCT01718873|Leucovorin|leucovorin|mesh-list
65341124|NCT01718873|Folic Acid|folic acid|mesh-list
65250252|NCT00619645|Antimetabolites|antimetabolites|mesh-ancestor
65250253|NCT00619645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250254|NCT00619645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65250255|NCT00619645|Immunologic Factors|immunologic factors|mesh-ancestor
64925580|NCT00033319|Analgesics|analgesics|mesh-ancestor
65250283|NCT00852163|Busulfan|busulfan|mesh-list
65250284|NCT00852163|Clofarabine|clofarabine|mesh-list
65250285|NCT00852163|Alkylating Agents|alkylating agents|mesh-ancestor
65341125|NCT01718873|Bevacizumab|bevacizumab|mesh-list
65341126|NCT01718873|Fluorouracil|fluorouracil|mesh-list
65341127|NCT01718873|Capecitabine|capecitabine|mesh-list
65341128|NCT01718873|Oxaliplatin|oxaliplatin|mesh-list
65341129|NCT01718873|Levoleucovorin|levoleucovorin|mesh-list
65341130|NCT01718873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65341131|NCT01718873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341132|NCT01718873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65341133|NCT01718873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65341134|NCT01718873|Growth Substances|growth substances|mesh-ancestor
65341135|NCT01718873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723162|NCT05203172|Cetuximab|cetuximab|mesh-list
65250286|NCT00852163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250287|NCT00852163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65250288|NCT00852163|Immunologic Factors|immunologic factors|mesh-ancestor
65250289|NCT00852163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250290|NCT00852163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65250291|NCT00852163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250292|NCT00852163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65250293|NCT00852163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65250294|NCT00852163|Antimetabolites|antimetabolites|mesh-ancestor
65250295|NCT00855517|Latanoprost|latanoprost|mesh-list
65250296|NCT00855517|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65250297|NCT00855517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65250298|NCT02544919|SMOFlipid|smoflipid|mesh-list
65250299|NCT02544919|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65250300|NCT02544919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64925628|NCT00000635|Trifluridine|trifluridine|mesh-list
65250330|NCT05578482|Dicloxacillin|dicloxacillin|mesh-list
65250331|NCT05578482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65250332|NCT05578482|Dermatologic Agents|dermatologic agents|mesh-ancestor
65250333|NCT05578482|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65250334|NCT05578482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65250335|NCT05578482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65250337|NCT02809404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250338|NCT02809404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65250339|NCT02809404|Immunologic Factors|immunologic factors|mesh-ancestor
65250340|NCT02809404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250341|NCT00619099|Decitabine|decitabine|mesh-list
65250342|NCT00619099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65000618|NCT00143130|Pregabalin|pregabalin|mesh-list
65250343|NCT00619099|Antimetabolites|antimetabolites|mesh-ancestor
65250344|NCT00619099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250345|NCT00619099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250346|NCT00619099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65250355|NCT02812992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65250356|NCT02812992|Antimetabolites|antimetabolites|mesh-ancestor
65250357|NCT02812992|Antiviral Agents|antiviral agents|mesh-ancestor
65250358|NCT02812992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65250359|NCT02812992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65250360|NCT02812992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65250361|NCT02812992|Immunologic Factors|immunologic factors|mesh-ancestor
65250362|NCT02812992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250363|NCT00856063|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65250364|NCT00856063|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65250365|NCT00856063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65250366|NCT00856063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65250367|NCT00856063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250368|NCT00856063|Adrenergic Agents|adrenergic agents|mesh-ancestor
65250369|NCT00856063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65250370|NCT00856063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250371|NCT02812602|Lidocaine|lidocaine|mesh-list
65250372|NCT02812602|Anesthetics, Local|anesthetics, local|mesh-ancestor
65250373|NCT02812602|Anesthetics|anesthetics|mesh-ancestor
65341136|NCT01718873|Growth Inhibitors|growth inhibitors|mesh-ancestor
65341137|NCT01718873|Antimetabolites|antimetabolites|mesh-ancestor
65341138|NCT01718873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341139|NCT01718873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65341140|NCT01718873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65341141|NCT01718873|Immunologic Factors|immunologic factors|mesh-ancestor
65341142|NCT01718873|Antidotes|antidotes|mesh-ancestor
65341143|NCT01718873|Protective Agents|protective agents|mesh-ancestor
65341144|NCT01718873|Vitamin B Complex|vitamin b complex|mesh-ancestor
65341145|NCT01718873|Vitamins|vitamins|mesh-ancestor
65341146|NCT01718873|Micronutrients|micronutrients|mesh-ancestor
65341147|NCT01718873|Hematinics|hematinics|mesh-ancestor
65341148|NCT01612351|Paclitaxel|paclitaxel|mesh-list
65341149|NCT01612351|Cisplatin|cisplatin|mesh-list
65341150|NCT01612351|Carboplatin|carboplatin|mesh-list
65341151|NCT01612351|Lapatinib|lapatinib|mesh-list
65341152|NCT01612351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65341153|NCT01612351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341154|NCT01612351|Tubulin Modulators|tubulin modulators|mesh-ancestor
65341155|NCT01612351|Antimitotic Agents|antimitotic agents|mesh-ancestor
65341156|NCT01612351|Mitosis Modulators|mitosis modulators|mesh-ancestor
65341157|NCT01612351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250374|NCT02812602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65250375|NCT02812602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250376|NCT02812602|Sensory System Agents|sensory system agents|mesh-ancestor
65250377|NCT02812602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250378|NCT02812602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65250379|NCT02812602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65250380|NCT02812602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65250381|NCT02812602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65250382|NCT02812602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250383|NCT00837187|Dexmedetomidine|dexmedetomidine|mesh-list
65250384|NCT00837187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65250385|NCT00837187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65250386|NCT00837187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250387|NCT00837187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65250388|NCT00837187|Analgesics|analgesics|mesh-ancestor
65250389|NCT00837187|Sensory System Agents|sensory system agents|mesh-ancestor
65250390|NCT00837187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250391|NCT00837187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65250392|NCT00837187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65250393|NCT00837187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65250394|NCT00837187|Adrenergic Agents|adrenergic agents|mesh-ancestor
65250395|NCT00837187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65250396|NCT00837187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250397|NCT00962585|Equol|equol|mesh-list
65250398|NCT00962585|Phytoestrogens|phytoestrogens|mesh-ancestor
65250399|NCT00962585|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65250400|NCT00962585|Estrogens|estrogens|mesh-ancestor
65250401|NCT00962585|Hormones|hormones|mesh-ancestor
65250402|NCT00962585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65250403|NCT00962585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250404|NCT00621985|Dexamethasone|dexamethasone|mesh-list
65250405|NCT00621985|Hydrocortisone|hydrocortisone|mesh-list
65341158|NCT01612351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65341159|NCT01612351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341160|NCT01424566|Nabiximols|nabiximols|mesh-list
65341161|NCT01424566|Analgesics|analgesics|mesh-ancestor
65341162|NCT01424566|Sensory System Agents|sensory system agents|mesh-ancestor
65341163|NCT01424566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65341164|NCT01424566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341165|NCT01367561|Naloxone|naloxone|mesh-list
65341166|NCT01367561|Methylnaltrexone|methylnaltrexone|mesh-list
65341167|NCT01367561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65341168|NCT01367561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250406|NCT00621985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65250407|NCT00621985|Antiemetics|antiemetics|mesh-ancestor
65250408|NCT00621985|Autonomic Agents|autonomic agents|mesh-ancestor
65250409|NCT00621985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250410|NCT00621985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250411|NCT00621985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65250412|NCT00621985|Glucocorticoids|glucocorticoids|mesh-ancestor
65250444|NCT03312257|Cholinergic Agents|cholinergic agents|mesh-ancestor
65250445|NCT03312257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65250446|NCT03312257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250447|NCT00856687|Montelukast|montelukast|mesh-list
65250448|NCT00856687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65250449|NCT00856687|Respiratory System Agents|respiratory system agents|mesh-ancestor
65250450|NCT00856687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65250451|NCT00856687|Hormone Antagonists|hormone antagonists|mesh-ancestor
65250452|NCT00856687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65250453|NCT00856687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925792|NCT00034138|Oregovomab|oregovomab|mesh-list
65250481|NCT04285073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250482|NCT04285073|Tubulin Modulators|tubulin modulators|mesh-ancestor
65250483|NCT04285073|Antimitotic Agents|antimitotic agents|mesh-ancestor
65250484|NCT04285073|Mitosis Modulators|mitosis modulators|mesh-ancestor
65250485|NCT04285073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250486|NCT00861445|Lacosamide|lacosamide|mesh-list
65250487|NCT00861445|Anticonvulsants|anticonvulsants|mesh-ancestor
65250488|NCT00861445|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65250489|NCT00861445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65250490|NCT00861445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65250491|NCT00861445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250492|NCT04284059|Vitamin D|vitamin d|mesh-list
65250493|NCT04284059|Vitamins|vitamins|mesh-list
65250494|NCT04284059|Micronutrients|micronutrients|mesh-ancestor
65250495|NCT04284059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250496|NCT04284059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65250497|NCT00852709|Cyclophosphamide|cyclophosphamide|mesh-list
65250498|NCT00852709|Clofarabine|clofarabine|mesh-list
65250499|NCT00852709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65250534|NCT00861523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65250535|NCT02811978|Dexamethasone|dexamethasone|mesh-list
65250536|NCT02811978|Bortezomib|bortezomib|mesh-list
65250537|NCT02811978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65250538|NCT02811978|Antiemetics|antiemetics|mesh-ancestor
65250539|NCT02811978|Autonomic Agents|autonomic agents|mesh-ancestor
65250540|NCT02811978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250541|NCT02811978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250564|NCT00852787|Protective Agents|protective agents|mesh-ancestor
65250565|NCT00852787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250566|NCT02545465|Riociguat|riociguat|mesh-list
65250567|NCT02545465|Enzyme Activators|enzyme activators|mesh-ancestor
65250568|NCT02545465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250569|NCT00961259|Fenofibric acid|fenofibric acid|mesh-list
65250570|NCT00961259|Fenofibrate|fenofibrate|mesh-list
65250571|NCT00961259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65250572|NCT00961259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65250573|NCT00961259|Antimetabolites|antimetabolites|mesh-ancestor
65341169|NCT01367561|Sensory System Agents|sensory system agents|mesh-ancestor
65341170|NCT01367561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65341171|NCT01361607|Nabiximols|nabiximols|mesh-list
65341172|NCT01361607|Analgesics|analgesics|mesh-ancestor
65341173|NCT01361607|Sensory System Agents|sensory system agents|mesh-ancestor
65341174|NCT01361607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250574|NCT00961259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250575|NCT00961259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65250576|NCT04283747|Immunoglobulins|immunoglobulins|mesh-list
65250577|NCT04283747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65250578|NCT04283747|Antibodies|antibodies|mesh-list
65250579|NCT04283747|Immunologic Factors|immunologic factors|mesh-ancestor
65250580|NCT04283747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250581|NCT04111926|Dexmedetomidine|dexmedetomidine|mesh-list
65250582|NCT04111926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65250583|NCT04111926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65250584|NCT04111926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250585|NCT04111926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65250586|NCT04111926|Analgesics|analgesics|mesh-ancestor
65250587|NCT04111926|Sensory System Agents|sensory system agents|mesh-ancestor
65250588|NCT04111926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250589|NCT04111926|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65250590|NCT04111926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65250591|NCT04111926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65250592|NCT04111926|Adrenergic Agents|adrenergic agents|mesh-ancestor
65250623|NCT00857077|Antimalarials|antimalarials|mesh-ancestor
65250624|NCT00857077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65250625|NCT00857077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65250626|NCT00857077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65250627|NCT00857077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65250628|NCT00857077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65250629|NCT00857077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250630|NCT00857077|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65250631|NCT00857077|Renal Agents|renal agents|mesh-ancestor
65250632|NCT00857155|Clopidogrel|clopidogrel|mesh-list
65250633|NCT00857155|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65250634|NCT00857155|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65250635|NCT00857155|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65250636|NCT00857155|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65250659|NCT00853177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65250660|NCT00853177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65250661|NCT00853177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250662|NCT00924079|Nalbuphine|nalbuphine|mesh-list
65250663|NCT00924079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65250664|NCT00924079|Narcotics|narcotics|mesh-ancestor
65250665|NCT00924079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65250666|NCT00924079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250667|NCT00924079|Analgesics|analgesics|mesh-ancestor
65250668|NCT00924079|Sensory System Agents|sensory system agents|mesh-ancestor
65250669|NCT00924079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250670|NCT00817479|Dexamethasone|dexamethasone|mesh-list
65250671|NCT00817479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65250672|NCT00817479|Antiemetics|antiemetics|mesh-ancestor
65250673|NCT00817479|Autonomic Agents|autonomic agents|mesh-ancestor
65250674|NCT00817479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250675|NCT00817479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250676|NCT00817479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65250677|NCT00817479|Glucocorticoids|glucocorticoids|mesh-ancestor
65250678|NCT00817479|Hormones|hormones|mesh-ancestor
65250679|NCT00817479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65250680|NCT00817479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65250681|NCT00817479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250682|NCT00853411|Prednisone|prednisone|mesh-list
65250683|NCT00853411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65250684|NCT00853411|Glucocorticoids|glucocorticoids|mesh-ancestor
65250685|NCT00853411|Hormones|hormones|mesh-ancestor
65250686|NCT00853411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65250687|NCT00853411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341175|NCT01361607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341176|NCT01337089|Nabiximols|nabiximols|mesh-list
65341177|NCT01337089|Analgesics|analgesics|mesh-ancestor
65341178|NCT01337089|Sensory System Agents|sensory system agents|mesh-ancestor
65341179|NCT01337089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65341180|NCT01337089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250708|NCT02807298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65250709|NCT02807298|Respiratory System Agents|respiratory system agents|mesh-ancestor
65250710|NCT02807298|Mydriatics|mydriatics|mesh-ancestor
65250711|NCT02807298|Sympathomimetics|sympathomimetics|mesh-ancestor
65250712|NCT02807298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65250713|NCT02807298|Anesthetics, Local|anesthetics, local|mesh-ancestor
65250714|NCT02807298|Anesthetics|anesthetics|mesh-ancestor
65250715|NCT02807298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65250716|NCT02807298|Sensory System Agents|sensory system agents|mesh-ancestor
65250717|NCT02807298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65250718|NCT02807298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65250719|NCT02807298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65250720|NCT02807298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65250721|NCT04041427|Albendazole|albendazole|mesh-list
65250722|NCT04041427|Anthelmintics|anthelmintics|mesh-ancestor
65250723|NCT04041427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65250724|NCT04041427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65250725|NCT04041427|Anticestodal Agents|anticestodal agents|mesh-ancestor
65250726|NCT04041427|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65250727|NCT04041427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65250728|NCT04041427|Tubulin Modulators|tubulin modulators|mesh-ancestor
65250729|NCT04041427|Antimitotic Agents|antimitotic agents|mesh-ancestor
65250730|NCT04041427|Mitosis Modulators|mitosis modulators|mesh-ancestor
65250731|NCT04041427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250732|NCT04041427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250733|NCT00961961|Lithium Carbonate|lithium carbonate|mesh-list
65250735|NCT00961961|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65250736|NCT00961961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65250737|NCT00961961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65250738|NCT00961961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250739|NCT00961961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65250740|NCT00961961|Serotonin Agents|serotonin agents|mesh-ancestor
65250741|NCT00961961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250742|NCT00961961|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64926070|NCT00034840|Valsartan|valsartan|mesh-list
65250779|NCT03296033|Enoxaparin sodium|enoxaparin sodium|mesh-list
65250780|NCT03296033|Anticoagulants|anticoagulants|mesh-ancestor
65250781|NCT03296033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65250782|NCT03296033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65250783|NCT03296033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250784|NCT05758389|Paclitaxel|paclitaxel|mesh-list
65250785|NCT05758389|Cisplatin|cisplatin|mesh-list
65250809|NCT04171843|Immunologic Factors|immunologic factors|mesh-ancestor
65250810|NCT04171843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250811|NCT04171843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65250812|NCT04171843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65250813|NCT04171843|Alkylating Agents|alkylating agents|mesh-ancestor
65250814|NCT04171843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250815|NCT04171843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250816|NCT04171843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65250817|NCT00815919|Prednisone|prednisone|mesh-list
65250818|NCT00815919|Bortezomib|bortezomib|mesh-list
65250819|NCT00815919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65250820|NCT00815919|Glucocorticoids|glucocorticoids|mesh-ancestor
65250821|NCT00815919|Hormones|hormones|mesh-ancestor
65250822|NCT00815919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65250823|NCT00815919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250824|NCT00815919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65250825|NCT00815919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250826|NCT02545153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65250827|NCT02545153|Aprotinin|aprotinin|mesh-list
65250828|NCT02545153|Hemostatics|hemostatics|mesh-ancestor
65250829|NCT02545153|Coagulants|coagulants|mesh-ancestor
65090996|NCT01313728|Dapsone|dapsone|mesh-list
65341181|NCT01297400|Sulfadiazine|sulfadiazine|mesh-list
65341183|NCT01297400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65341184|NCT01297400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65341185|NCT01297400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65341186|NCT01297400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65341187|NCT01297400|Coccidiostats|coccidiostats|mesh-ancestor
65341188|NCT01297400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65341189|NCT01276587|Vitamin D|vitamin d|mesh-list
65341190|NCT01276587|Ergocalciferols|ergocalciferols|mesh-list
65341191|NCT01276587|Cholecalciferol|cholecalciferol|mesh-list
65341192|NCT01276587|Vitamins|vitamins|mesh-list
65341193|NCT01276587|Micronutrients|micronutrients|mesh-ancestor
65341194|NCT01276587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723213|NCT00382538|Abortifacient Agents|abortifacient agents|mesh-ancestor
65250830|NCT02545153|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65250831|NCT02545153|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65250832|NCT02545153|Protease Inhibitors|protease inhibitors|mesh-ancestor
65250833|NCT02545153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65250834|NCT02545153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250835|NCT00913653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65250836|NCT00913653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65250837|NCT00913653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250838|NCT00854035|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65250839|NCT00854035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64926171|NCT00000716|Zidovudine|zidovudine|mesh-list
65250862|NCT00957905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250863|NCT00957905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65250864|NCT00957905|Immunologic Factors|immunologic factors|mesh-ancestor
65250865|NCT00957905|Antidotes|antidotes|mesh-ancestor
65250866|NCT00957905|Protective Agents|protective agents|mesh-ancestor
65250867|NCT00957905|Vitamin B Complex|vitamin b complex|mesh-ancestor
65250868|NCT00957905|Vitamins|vitamins|mesh-ancestor
65250869|NCT00957905|Micronutrients|micronutrients|mesh-ancestor
65250870|NCT00957905|Hematinics|hematinics|mesh-ancestor
65250871|NCT00957905|Growth Inhibitors|growth inhibitors|mesh-ancestor
65001166|NCT00113100|Ethanol|ethanol|mesh-list
65250872|NCT00957905|Growth Substances|growth substances|mesh-ancestor
65250873|NCT00957905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65250874|NCT00957905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65250875|NCT02804646|Carboplatin|carboplatin|mesh-list
65250877|NCT02804646|Endostatins|endostatins|mesh-list
65250878|NCT02804646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250879|NCT02804646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65250880|NCT02804646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250881|NCT02804646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65250882|NCT02804646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65250883|NCT02804646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65250884|NCT02804646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65250885|NCT02804646|Growth Substances|growth substances|mesh-ancestor
65250886|NCT02804646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250887|NCT02804646|Growth Inhibitors|growth inhibitors|mesh-ancestor
65250888|NCT02858297|Triamcinolone|triamcinolone|mesh-list
65250889|NCT02858297|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65250890|NCT02858297|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65250891|NCT02858297|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65250892|NCT02858297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65250893|NCT02858297|Glucocorticoids|glucocorticoids|mesh-ancestor
65250894|NCT02858297|Hormones|hormones|mesh-ancestor
65250925|NCT00960323|Tubulin Modulators|tubulin modulators|mesh-ancestor
65250926|NCT00960323|Antimitotic Agents|antimitotic agents|mesh-ancestor
65250927|NCT00960323|Mitosis Modulators|mitosis modulators|mesh-ancestor
65250928|NCT00960323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250929|NCT00617929|Rituximab|rituximab|mesh-list
65250930|NCT00617929|Clofarabine|clofarabine|mesh-list
65341195|NCT01276587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65341196|NCT01276587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65250931|NCT00617929|Thymoglobulin|thymoglobulin|mesh-list
65250932|NCT00617929|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65250933|NCT00617929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65250934|NCT00617929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250935|NCT00617929|Immunologic Factors|immunologic factors|mesh-ancestor
65250936|NCT00617929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250937|NCT00617929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65250938|NCT00617929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65250939|NCT00617929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65250940|NCT00617929|Antimetabolites|antimetabolites|mesh-ancestor
65250969|NCT02806752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65250970|NCT02806752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65250971|NCT02806752|Growth Substances|growth substances|mesh-ancestor
65250972|NCT02806752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250973|NCT02806752|Growth Inhibitors|growth inhibitors|mesh-ancestor
65250974|NCT02806752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250975|NCT02806752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65250976|NCT02806752|Glucocorticoids|glucocorticoids|mesh-ancestor
65250978|NCT02806752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65250979|NCT02806752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65250980|NCT02806752|Immunologic Factors|immunologic factors|mesh-ancestor
65250981|NCT02806752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65250982|NCT02806752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250983|NCT00854425|Asparaginase|asparaginase|mesh-list
65250984|NCT00854425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65251010|NCT02544529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65251011|NCT02544529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251012|NCT02544529|Miotics|miotics|mesh-ancestor
65251013|NCT02544529|Autonomic Agents|autonomic agents|mesh-ancestor
65251014|NCT02544529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65251015|NCT02544529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65251016|NCT02806596|Sevoflurane|sevoflurane|mesh-list
65251017|NCT02806596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65251018|NCT02806596|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65251019|NCT02806596|Anesthetics, General|anesthetics, general|mesh-ancestor
65251020|NCT02806596|Anesthetics|anesthetics|mesh-ancestor
65251021|NCT02806596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65251022|NCT02806596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251023|NCT04282031|Letrozole|letrozole|mesh-list
65251024|NCT04282031|Fulvestrant|fulvestrant|mesh-list
65251025|NCT04282031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65251027|NCT04282031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65251028|NCT04282031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251029|NCT04282031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251030|NCT04282031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65251031|NCT04282031|Hormone Antagonists|hormone antagonists|mesh-ancestor
65251032|NCT04282031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64926365|NCT00000752|Pseudoephedrine|pseudoephedrine|mesh-list
65251064|NCT00858715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65251065|NCT00858715|Purinergic Agents|purinergic agents|mesh-ancestor
65251066|NCT00858715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65251067|NCT02806284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65251068|NCT02806284|Immunologic Factors|immunologic factors|mesh-ancestor
65251069|NCT02806284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251070|NCT00960869|Aspirin|aspirin|mesh-list
65251071|NCT00960869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65251072|NCT00960869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65251087|NCT02799888|Maraviroc|maraviroc|mesh-list
65251088|NCT02799888|Methotrexate|methotrexate|mesh-list
65251089|NCT02799888|Tacrolimus|tacrolimus|mesh-list
65251090|NCT02799888|Cyclosporins|cyclosporins|mesh-list
65251091|NCT02799888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65251092|NCT02799888|Abortifacient Agents|abortifacient agents|mesh-ancestor
65251093|NCT02799888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65251094|NCT02799888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251095|NCT02799888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65251096|NCT02799888|Antimetabolites|antimetabolites|mesh-ancestor
65001361|NCT00457054|Antimanic Agents|antimanic agents|mesh-ancestor
65251097|NCT02799888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251098|NCT02799888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341197|NCT01274338|Interferons|interferons|mesh-list
65341198|NCT01274338|Interferon-alpha|interferon-alpha|mesh-list
65341199|NCT01274338|Interferon alpha-2|interferon alpha-2|mesh-list
65341200|NCT01274338|Ipilimumab|ipilimumab|mesh-list
65341201|NCT01274338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341202|NCT01274338|Antiviral Agents|antiviral agents|mesh-ancestor
65341203|NCT01274338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65341204|NCT01274338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65341205|NCT01274338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65341206|NCT01274338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341207|NCT01274338|Immunologic Factors|immunologic factors|mesh-ancestor
65251100|NCT02799888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251101|NCT02799888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65251102|NCT02799888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65251103|NCT02799888|Immunologic Factors|immunologic factors|mesh-ancestor
65251104|NCT02799888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65251105|NCT02799888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65251106|NCT02799888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65251107|NCT02799888|Antifungal Agents|antifungal agents|mesh-ancestor
65251108|NCT02799888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65251109|NCT02799888|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65251110|NCT02799888|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65251111|NCT02799888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65251112|NCT02799888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65251113|NCT02799888|Antiviral Agents|antiviral agents|mesh-ancestor
65251114|NCT02799888|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65251115|NCT00859105|Imiquimod|imiquimod|mesh-list
65251116|NCT00859105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65251117|NCT00859105|Immunologic Factors|immunologic factors|mesh-ancestor
65251118|NCT00859105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251119|NCT00859105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65251120|NCT00859105|Interferon Inducers|interferon inducers|mesh-ancestor
65251121|NCT00859183|Sirolimus|sirolimus|mesh-list
65251122|NCT00859183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65251123|NCT00859183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65251124|NCT00859183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65251125|NCT00859183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65251126|NCT00859183|Antifungal Agents|antifungal agents|mesh-ancestor
65251127|NCT00859183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65251128|NCT00859183|Immunologic Factors|immunologic factors|mesh-ancestor
65251129|NCT00859183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251130|NCT02803944|Azithromycin|azithromycin|mesh-list
65251131|NCT02803944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65251132|NCT02803944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65251133|NCT02545231|Pitavastatin|pitavastatin|mesh-list
64926457|NCT00035581|Poly I-C|poly i-c|mesh-list
65251163|NCT02803788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65251164|NCT02803788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65251165|NCT02803788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65251167|NCT02610153|Vitamins|vitamins|mesh-ancestor
65251168|NCT02610153|Micronutrients|micronutrients|mesh-ancestor
65251169|NCT02610153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251170|NCT02610153|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65251171|NCT02610153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65001432|NCT00110903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65251172|NCT02610153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251174|NCT02610153|Coagulants|coagulants|mesh-ancestor
65251175|NCT00862693|Calcitriol|calcitriol|mesh-list
65251176|NCT00862693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65251177|NCT00862693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251178|NCT00862693|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65251207|NCT02799498|Sensory System Agents|sensory system agents|mesh-ancestor
65251208|NCT02799498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65251209|NCT02799498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251210|NCT02799498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65341208|NCT01274338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341209|NCT01217580|Ropivacaine|ropivacaine|mesh-list
65341210|NCT01217580|Anesthetics, Local|anesthetics, local|mesh-ancestor
65341211|NCT01217580|Anesthetics|anesthetics|mesh-ancestor
65341212|NCT01217580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65251211|NCT02799498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65251212|NCT02799498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65251213|NCT02799498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65251214|NCT02799498|Immunologic Factors|immunologic factors|mesh-ancestor
65251215|NCT00617851|Vaccines|vaccines|mesh-list
65251216|NCT00617851|Immunologic Factors|immunologic factors|mesh-ancestor
65251217|NCT00617851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251218|NCT02806440|Naltrexone|naltrexone|mesh-list
65251219|NCT02806440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65251220|NCT02806440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65251221|NCT02806440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251222|NCT02806440|Sensory System Agents|sensory system agents|mesh-ancestor
65251223|NCT02806440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65251224|NCT00913809|Desipramine|desipramine|mesh-list
65251254|NCT00855049|Antipyretics|antipyretics|mesh-ancestor
65251255|NCT02799030|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65251256|NCT02799030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65251257|NCT02799030|Dermatologic Agents|dermatologic agents|mesh-ancestor
65251258|NCT00812955|Simvastatin|simvastatin|mesh-list
65251259|NCT00812955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65251260|NCT00812955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65251261|NCT00812955|Antimetabolites|antimetabolites|mesh-ancestor
65251262|NCT00812955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251263|NCT00812955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65251264|NCT00812955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65251265|NCT00812955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251266|NCT04235478|Triamcinolone|triamcinolone|mesh-list
65251267|NCT04235478|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65251303|NCT00859885|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65251304|NCT00859885|Purinergic Agents|purinergic agents|mesh-ancestor
65251305|NCT00859885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65251306|NCT02798874|Clopidogrel|clopidogrel|mesh-list
65251307|NCT02798874|Ticagrelor|ticagrelor|mesh-list
65251340|NCT02806128|Fertility Agents|fertility agents|mesh-ancestor
65251341|NCT02806128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65251342|NCT02806128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251343|NCT00860119|Alprazolam|alprazolam|mesh-list
65251344|NCT00860119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65251345|NCT00860119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65251346|NCT00860119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251347|NCT00860119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65251348|NCT00860119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65251349|NCT00860119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64926705|NCT00036439|Infliximab|infliximab|mesh-list
65251382|NCT05550636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65251383|NCT05550636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65251384|NCT05550636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251385|NCT05550636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65251386|NCT05550636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65251387|NCT05550636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65251388|NCT05550636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65251389|NCT05550636|Anesthetics, General|anesthetics, general|mesh-ancestor
65251390|NCT05550636|Anesthetics|anesthetics|mesh-ancestor
65251391|NCT05550636|GABA Modulators|gaba modulators|mesh-ancestor
65251419|NCT00860275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65251420|NCT02798250|Insulin|insulin|mesh-list
65251421|NCT02798250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65251422|NCT02798250|Glucagon|glucagon|mesh-list
65251423|NCT02798250|Hormones|hormones|mesh-list
65251424|NCT02798250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65251425|NCT02798250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251426|NCT02798250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65251427|NCT02798250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65251428|NCT00865111|Bupropion|bupropion|mesh-list
65251429|NCT00865111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65251430|NCT00865111|Antidepressive Agents|antidepressive agents|mesh-ancestor
65251431|NCT00865111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65251432|NCT00865111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65341213|NCT01217580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341214|NCT01217580|Sensory System Agents|sensory system agents|mesh-ancestor
65341215|NCT01217580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65341216|NCT01174121|Aldesleukin|aldesleukin|mesh-list
64330849|NCT03240861|Aldesleukin|aldesleukin|mesh-list
65251464|NCT00865423|Sensory System Agents|sensory system agents|mesh-ancestor
65251465|NCT00865423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65251466|NCT00865423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251467|NCT00865423|Anticonvulsants|anticonvulsants|mesh-ancestor
65251468|NCT00865423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65251469|NCT00865423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65251470|NCT00865423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65251471|NCT00865423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65251472|NCT00865423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65251500|NCT02802540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65251501|NCT00865501|Spironolactone|spironolactone|mesh-list
65251502|NCT00865501|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65251503|NCT00865501|Hormone Antagonists|hormone antagonists|mesh-ancestor
65251504|NCT00865501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65251505|NCT00865501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251506|NCT00865501|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65251507|NCT00865501|Diuretics|diuretics|mesh-ancestor
65251508|NCT00865501|Natriuretic Agents|natriuretic agents|mesh-ancestor
65251509|NCT02797704|Aflibercept|aflibercept|mesh-list
65251510|NCT02797704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65251511|NCT02797704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65251512|NCT02797704|Growth Substances|growth substances|mesh-ancestor
65251513|NCT02797704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251514|NCT02797704|Growth Inhibitors|growth inhibitors|mesh-ancestor
65251515|NCT02797704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65251516|NCT04281095|Botulinum Toxins|botulinum toxins|mesh-list
65251517|NCT04281095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65251518|NCT04281095|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65251519|NCT04281095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64926860|NCT00037141|Ethanol|ethanol|mesh-list
65251551|NCT02802072|Sensory System Agents|sensory system agents|mesh-ancestor
65251552|NCT02802072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65251553|NCT02802072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251554|NCT02802072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65251555|NCT02802072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65251556|NCT02802072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65251557|NCT02802072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65251558|NCT02802072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251559|NCT02802072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65251560|NCT02802072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65251561|NCT02802072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251562|NCT02802072|Antipyretics|antipyretics|mesh-ancestor
65251625|NCT03074513|Immunoglobulin G|immunoglobulin g|mesh-list
65251626|NCT03074513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65251627|NCT03074513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65251628|NCT03074513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65251629|NCT03074513|Growth Substances|growth substances|mesh-ancestor
65251630|NCT03074513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251631|NCT03074513|Growth Inhibitors|growth inhibitors|mesh-ancestor
65251632|NCT03074513|Immunologic Factors|immunologic factors|mesh-ancestor
65251633|NCT02801838|Morphine|morphine|mesh-list
65251634|NCT02801838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65251635|NCT02801838|Narcotics|narcotics|mesh-ancestor
65251636|NCT02801838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65251637|NCT02801838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251638|NCT02801838|Analgesics|analgesics|mesh-ancestor
65251639|NCT02801838|Sensory System Agents|sensory system agents|mesh-ancestor
65251640|NCT02801838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65251641|NCT04276025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65251642|NCT04276025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65251643|NCT04276025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251644|NCT02797860|Rocuronium|rocuronium|mesh-list
65251645|NCT02797860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65251678|NCT00865891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65341217|NCT01174121|Cyclophosphamide|cyclophosphamide|mesh-list
65341218|NCT01174121|Pembrolizumab|pembrolizumab|mesh-list
65341219|NCT01174121|Fludarabine|fludarabine|mesh-list
65341220|NCT01174121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65341221|NCT01174121|Immunologic Factors|immunologic factors|mesh-ancestor
65341222|NCT01174121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341223|NCT01174121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65341224|NCT01174121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65341225|NCT01174121|Alkylating Agents|alkylating agents|mesh-ancestor
65341226|NCT01174121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341227|NCT01174121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341228|NCT01174121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65341229|NCT01174121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65341230|NCT01174121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64723241|NCT00954187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65251679|NCT00865891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65251680|NCT00865891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251681|NCT00865891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65251682|NCT00865891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251684|NCT00865891|Tocolytic Agents|tocolytic agents|mesh-ancestor
65251685|NCT00865891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65251686|NCT02797236|Vaccines|vaccines|mesh-list
65251687|NCT02797236|Immunologic Factors|immunologic factors|mesh-ancestor
64927035|NCT00038233|Thalidomide|thalidomide|mesh-list
65251716|NCT02805426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251717|NCT02805426|Hemostatics|hemostatics|mesh-ancestor
65251718|NCT02805426|Coagulants|coagulants|mesh-ancestor
65251719|NCT02805426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65251720|NCT02805426|Abortifacient Agents|abortifacient agents|mesh-ancestor
65251721|NCT02805426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65251722|NCT02805426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251723|NCT02805426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65251724|NCT02805426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65251725|NCT02805426|Oxytocics|oxytocics|mesh-ancestor
65251726|NCT02801292|Ketamine|ketamine|mesh-list
65251727|NCT02801292|Analgesics|analgesics|mesh-ancestor
65251728|NCT02801292|Sensory System Agents|sensory system agents|mesh-ancestor
65251729|NCT02801292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65251730|NCT02801292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251731|NCT02801292|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65251732|NCT02801292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65251733|NCT02801292|Anesthetics, General|anesthetics, general|mesh-ancestor
65251761|NCT03853044|Alkylating Agents|alkylating agents|mesh-ancestor
65251762|NCT03853044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251763|NCT03853044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65251764|NCT03853044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65251765|NCT03853044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65251766|NCT03853044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65251767|NCT03853044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65251768|NCT03853044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251769|NCT03853044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65251770|NCT03853044|Glucocorticoids|glucocorticoids|mesh-ancestor
65251771|NCT03853044|Hormones|hormones|mesh-ancestor
65251772|NCT03853044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65251773|NCT03853044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65251774|NCT03853044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65251775|NCT03853044|Tubulin Modulators|tubulin modulators|mesh-ancestor
65251776|NCT03853044|Antimitotic Agents|antimitotic agents|mesh-ancestor
65341231|NCT01174121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65341232|NCT01174121|Antiviral Agents|antiviral agents|mesh-ancestor
65341233|NCT01174121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65341234|NCT00802646|Epinephrine|epinephrine|mesh-list
65341235|NCT00802646|Fentanyl|fentanyl|mesh-list
65341236|NCT00802646|Bupivacaine|bupivacaine|mesh-list
65341237|NCT00802646|Anesthetics, Local|anesthetics, local|mesh-ancestor
65341238|NCT00802646|Anesthetics|anesthetics|mesh-ancestor
65341239|NCT00802646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65341240|NCT00802646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341241|NCT00802646|Sensory System Agents|sensory system agents|mesh-ancestor
65341242|NCT00802646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65341243|NCT00802646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65341244|NCT00802646|Narcotics|narcotics|mesh-ancestor
65341245|NCT00802646|Analgesics|analgesics|mesh-ancestor
65341246|NCT00802646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65341247|NCT00802646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65341248|NCT00802646|Anesthetics, General|anesthetics, general|mesh-ancestor
65341249|NCT00802646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65341250|NCT00802646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65341251|NCT00802646|Adrenergic Agents|adrenergic agents|mesh-ancestor
65341252|NCT00802646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65091076|NCT04516317|Analgesics|analgesics|mesh-ancestor
65341253|NCT00802646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341254|NCT00802646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65341255|NCT00802646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65341256|NCT00802646|Autonomic Agents|autonomic agents|mesh-ancestor
65341257|NCT00802646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65251777|NCT03853044|Mitosis Modulators|mitosis modulators|mesh-ancestor
65251778|NCT00870337|Everolimus|everolimus|mesh-list
65251779|NCT00870337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65251780|NCT00870337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64927122|NCT00000959|Pyridoxine|pyridoxine|mesh-list
65251814|NCT00812565|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65251815|NCT00812565|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65251816|NCT00812565|Immunologic Factors|immunologic factors|mesh-ancestor
65251817|NCT00812565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251818|NCT00866515|Ketoconazole|ketoconazole|mesh-list
65251819|NCT00866515|Antifungal Agents|antifungal agents|mesh-ancestor
65251820|NCT00866515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927174|NCT00396721|Antimetabolites|antimetabolites|mesh-ancestor
65251850|NCT00864019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65251851|NCT00864019|Serotonin Agents|serotonin agents|mesh-ancestor
65251852|NCT00864019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251853|NCT00812487|Insulin|insulin|mesh-list
65251854|NCT00812487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65251855|NCT00812487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65251856|NCT00812487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251857|NCT04235868|Mitogens|mitogens|mesh-list
65251858|NCT04235868|Mitosis Modulators|mitosis modulators|mesh-ancestor
65341258|NCT00802646|Respiratory System Agents|respiratory system agents|mesh-ancestor
65341259|NCT00802646|Mydriatics|mydriatics|mesh-ancestor
65341260|NCT00802646|Sympathomimetics|sympathomimetics|mesh-ancestor
65341261|NCT00802646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65341262|NCT00473707|Oxytocin|oxytocin|mesh-list
65341263|NCT00473707|Oxytocics|oxytocics|mesh-ancestor
65341264|NCT00473707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65341265|NCT00473707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341266|NCT00452023|Interferons|interferons|mesh-list
65341267|NCT00452023|Interferon-alpha|interferon-alpha|mesh-list
65341268|NCT00452023|Interferon alpha-2|interferon alpha-2|mesh-list
65341269|NCT00452023|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65341270|NCT00452023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341271|NCT00452023|Antiviral Agents|antiviral agents|mesh-ancestor
65341272|NCT00452023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65341273|NCT00452023|Immunologic Factors|immunologic factors|mesh-ancestor
65341274|NCT00452023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341275|NCT00310180|Tamoxifen|tamoxifen|mesh-list
65341276|NCT00310180|Letrozole|letrozole|mesh-list
65341277|NCT00310180|Anastrozole|anastrozole|mesh-list
65251859|NCT04235868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251860|NCT02800902|Atorvastatin|atorvastatin|mesh-list
65251888|NCT00812331|Protease Inhibitors|protease inhibitors|mesh-ancestor
65251889|NCT00812331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251890|NCT00812331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251891|NCT04233996|Meropenem|meropenem|mesh-list
65251892|NCT04233996|Tazobactam|tazobactam|mesh-list
65251893|NCT04233996|Piperacillin|piperacillin|mesh-list
65251894|NCT04233996|Cefepime|cefepime|mesh-list
65251895|NCT04233996|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65251896|NCT04233996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65251897|NCT04233996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65251898|NCT04233996|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65251899|NCT04233996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251900|NCT04233996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251901|NCT00812253|Insulin|insulin|mesh-list
65251902|NCT00812253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65251903|NCT00812253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65251904|NCT00812253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251905|NCT00870571|Amlodipine|amlodipine|mesh-list
65251906|NCT00870571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65251907|NCT00870571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65251931|NCT00866593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251932|NCT00866593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65251933|NCT00866593|Serotonin Agents|serotonin agents|mesh-ancestor
65251934|NCT00866593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251935|NCT00866593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65251936|NCT00866593|Antidepressive Agents|antidepressive agents|mesh-ancestor
65251937|NCT00866593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65251938|NCT00866593|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65251939|NCT00866593|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65251940|NCT00866593|Parasympatholytics|parasympatholytics|mesh-ancestor
65251941|NCT00866593|Autonomic Agents|autonomic agents|mesh-ancestor
65251942|NCT00866593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65251943|NCT00866593|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65251944|NCT00866593|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65251945|NCT00866593|Cholinergic Agents|cholinergic agents|mesh-ancestor
65251946|NCT02796378|Ubiquinone|ubiquinone|mesh-list
65251947|NCT02796378|Coenzyme Q10|coenzyme q10|mesh-list
65251948|NCT02796378|Simvastatin|simvastatin|mesh-list
65341278|NCT00310180|Exemestane|exemestane|mesh-list
65341279|NCT00310180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341280|NCT00310180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341281|NCT00310180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65341282|NCT00310180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65341283|NCT00310180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251949|NCT02796378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65251950|NCT02796378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65251951|NCT02796378|Antimetabolites|antimetabolites|mesh-ancestor
65251952|NCT02796378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251953|NCT02796378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65251954|NCT02796378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65251982|NCT00870883|Respiratory System Agents|respiratory system agents|mesh-ancestor
65251983|NCT00870883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65251984|NCT00870883|Antioxidants|antioxidants|mesh-ancestor
65251985|NCT00870883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251986|NCT00870883|Protective Agents|protective agents|mesh-ancestor
65251987|NCT00870883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251988|NCT00870883|Antidotes|antidotes|mesh-ancestor
65251989|NCT00870883|Siderophores|siderophores|mesh-ancestor
65251990|NCT00870883|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65251991|NCT00870883|Chelating Agents|chelating agents|mesh-ancestor
65251992|NCT00870883|Sequestering Agents|sequestering agents|mesh-ancestor
65251993|NCT00870961|Cholecalciferol|cholecalciferol|mesh-list
65251994|NCT00870961|Vitamin D|vitamin d|mesh-list
65251995|NCT00870961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65251996|NCT00870961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251997|NCT00870961|Vitamins|vitamins|mesh-ancestor
65251998|NCT00870961|Micronutrients|micronutrients|mesh-ancestor
65251999|NCT00870961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65252000|NCT00811941|Nalmefene|nalmefene|mesh-list
65252001|NCT00811941|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65252002|NCT00811941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252003|NCT00811941|Sensory System Agents|sensory system agents|mesh-ancestor
65252004|NCT00811941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65252005|NCT00864565|Fentanyl|fentanyl|mesh-list
65252039|NCT00871039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65252040|NCT00871039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252041|NCT00867061|ON 01910|on 01910|mesh-list
65252042|NCT00867061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252043|NCT00867061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65252044|NCT00867061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65252045|NCT00867061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252046|NCT00864799|Misoprostol|misoprostol|mesh-list
65252047|NCT00864799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64927393|NCT01786434|Fentanyl|fentanyl|mesh-list
65252070|NCT04234776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65252071|NCT04234776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65252072|NCT04234776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65252073|NCT04234776|Serotonin Agents|serotonin agents|mesh-ancestor
65252074|NCT04234776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65252075|NCT04234776|Antidepressive Agents|antidepressive agents|mesh-ancestor
65252076|NCT04234776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65252077|NCT04234776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65252078|NCT04234776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65252079|NCT04234776|Dopamine Agonists|dopamine agonists|mesh-ancestor
65252080|NCT04234776|Dopamine Agents|dopamine agents|mesh-ancestor
65252081|NCT04234776|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65252082|NCT04234776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65252083|NCT04234776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65252084|NCT04234776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65252085|NCT04234776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65252086|NCT04234776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65252087|NCT05756049|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65252088|NCT05756049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65252090|NCT00871273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65252091|NCT00871273|Antimetabolites|antimetabolites|mesh-ancestor
65341284|NCT00310180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65341285|NCT00310180|Hormone Antagonists|hormone antagonists|mesh-ancestor
65341286|NCT00310180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65341287|NCT00310180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341288|NCT00310180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65341289|NCT00310180|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65341290|NCT00310180|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65341291|NCT00310180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65341292|NCT00233675|Tiagabine|tiagabine|mesh-list
65341293|NCT00233675|Anticonvulsants|anticonvulsants|mesh-ancestor
65341294|NCT00233675|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
65341295|NCT00233675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65341296|NCT00233675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65252092|NCT00871273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252093|NCT00871273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252094|NCT00867295|Cefazolin|cefazolin|mesh-list
65252095|NCT00867295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65252096|NCT00867295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65252097|NCT02794506|Propolis|propolis|mesh-list
65252098|NCT02794506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65252099|NCT04040491|Gemcitabine|gemcitabine|mesh-list
65252100|NCT04040491|Lenalidomide|lenalidomide|mesh-list
65252101|NCT04040491|Antibodies|antibodies|mesh-list
65252130|NCT00811473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65252131|NCT00811473|Antidepressive Agents|antidepressive agents|mesh-ancestor
65252132|NCT00811473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65252133|NCT00811473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65252134|NCT00811473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65252135|NCT00811473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65252136|NCT00811473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252137|NCT00871507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65252138|NCT00871507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65252139|NCT00871507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002409|NCT00352378|Tubulin Modulators|tubulin modulators|mesh-ancestor
65252141|NCT00871507|Hormones|hormones|mesh-ancestor
65252142|NCT00871507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65252143|NCT00871507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65252144|NCT00871507|Protease Inhibitors|protease inhibitors|mesh-ancestor
65252145|NCT00871507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65252146|NCT00871507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252147|NCT00865033|Metformin|metformin|mesh-list
65252183|NCT00876421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65252184|NCT00876421|Cholinergic Agents|cholinergic agents|mesh-ancestor
65252185|NCT00876421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65252186|NCT00876421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252187|NCT00876421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927538|NCT03668431|Trametinib|trametinib|mesh-list
65252217|NCT00872365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252219|NCT03637062|Progestins|progestins|mesh-ancestor
65252220|NCT03637062|Hormones|hormones|mesh-ancestor
65252221|NCT03637062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65252222|NCT03637062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252223|NCT02793648|Vitamins|vitamins|mesh-list
65252224|NCT02793648|Ascorbic Acid|ascorbic acid|mesh-list
65252225|NCT02793648|Vitamin E|vitamin e|mesh-list
65252226|NCT02793648|Tocopherols|tocopherols|mesh-list
65252227|NCT02793648|alpha-Tocopherol|alpha-tocopherol|mesh-list
65252228|NCT02793648|Micronutrients|micronutrients|mesh-ancestor
65252229|NCT02793648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252230|NCT02793648|Antioxidants|antioxidants|mesh-ancestor
64304110|NCT03067688|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65341297|NCT00233675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341298|NCT00233675|GABA Agents|gaba agents|mesh-ancestor
65341299|NCT00233675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65341300|NCT00233675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341301|NCT00202774|Fluorouracil|fluorouracil|mesh-list
65341302|NCT00202774|Capecitabine|capecitabine|mesh-list
65341303|NCT00202774|Oxaliplatin|oxaliplatin|mesh-list
65341304|NCT00202774|Antimetabolites|antimetabolites|mesh-ancestor
65341305|NCT00202774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341306|NCT00202774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65341307|NCT00202774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723323|NCT00379015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65252261|NCT03847506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65252262|NCT03847506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65252263|NCT03847506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65252264|NCT03847506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65252265|NCT00617305|Ambrisentan|ambrisentan|mesh-list
65252266|NCT00617305|Sildenafil Citrate|sildenafil citrate|mesh-list
65252267|NCT00617305|Tadalafil|tadalafil|mesh-list
65252268|NCT00617305|Vasodilator Agents|vasodilator agents|mesh-ancestor
65252269|NCT00617305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65252270|NCT00617305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65252271|NCT00617305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65252272|NCT00617305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927639|NCT00016107|Docetaxel|docetaxel|mesh-list
65252301|NCT00811395|Immunologic Factors|immunologic factors|mesh-ancestor
65252302|NCT00811395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252303|NCT00811395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65252304|NCT00811395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65252305|NCT00811395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65252306|NCT00811395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65252307|NCT00811395|Analgesics|analgesics|mesh-ancestor
65252308|NCT00811395|Sensory System Agents|sensory system agents|mesh-ancestor
65252309|NCT00811395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65252310|NCT00811395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65252311|NCT02792946|Ambroxol|ambroxol|mesh-list
65252312|NCT02792946|Expectorants|expectorants|mesh-ancestor
65252313|NCT02792946|Respiratory System Agents|respiratory system agents|mesh-ancestor
65252314|NCT00876577|Moxifloxacin|moxifloxacin|mesh-list
65252315|NCT00876577|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65252316|NCT00876577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65252317|NCT00876577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65252318|NCT00876577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65252319|NCT00876577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65252320|NCT00876577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304111|NCT03067688|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65252348|NCT02609997|Dexamethasone|dexamethasone|mesh-list
65252349|NCT02609997|Proxymetacaine|proxymetacaine|mesh-list
65252350|NCT02609997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65252351|NCT02609997|Antiemetics|antiemetics|mesh-ancestor
65252352|NCT02609997|Autonomic Agents|autonomic agents|mesh-ancestor
65252353|NCT02609997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65252354|NCT02609997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252355|NCT02609997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65252356|NCT02609997|Glucocorticoids|glucocorticoids|mesh-ancestor
65252357|NCT02609997|Hormones|hormones|mesh-ancestor
65252358|NCT02609997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65252359|NCT02609997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65252360|NCT02609997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252361|NCT02609997|Anesthetics, Local|anesthetics, local|mesh-ancestor
65252362|NCT02609997|Anesthetics|anesthetics|mesh-ancestor
65252387|NCT05755659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65341308|NCT00202774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65341309|NCT00202774|Immunologic Factors|immunologic factors|mesh-ancestor
65341310|NCT00202774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341311|NCT00114530|Cyclophosphamide|cyclophosphamide|mesh-list
65341312|NCT00114530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65341313|NCT00114530|Immunologic Factors|immunologic factors|mesh-ancestor
65341314|NCT00114530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341315|NCT00114530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65341316|NCT00114530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65341317|NCT00114530|Alkylating Agents|alkylating agents|mesh-ancestor
65341318|NCT00114530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341319|NCT00114530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341320|NCT00114530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65341321|NCT00107744|Caseins|caseins|mesh-list
65252388|NCT05755659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252390|NCT00913887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65252391|NCT00913887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65252392|NCT00913887|Analgesics|analgesics|mesh-ancestor
65252393|NCT00913887|Sensory System Agents|sensory system agents|mesh-ancestor
65252394|NCT00913887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65252395|NCT00913887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252396|NCT00913887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65252397|NCT00913887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65252398|NCT00913887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65252399|NCT00913887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65252400|NCT00913887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252401|NCT05401110|Osimertinib|osimertinib|mesh-list
65252402|NCT05401110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252403|NCT05401110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65252404|NCT05401110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65252405|NCT05401110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252406|NCT02792400|Empagliflozin|empagliflozin|mesh-list
65252407|NCT02792400|Linagliptin|linagliptin|mesh-list
65252408|NCT02792400|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65252409|NCT02792400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252410|NCT02792400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65252411|NCT02792400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252436|NCT05017155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65252437|NCT05017155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252438|NCT05017155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65252439|NCT05017155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252440|NCT05017155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65252441|NCT05017155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65252442|NCT05017155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65252443|NCT05017155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65252444|NCT05017155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65252445|NCT05017155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65252446|NCT05017155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65252448|NCT05162131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65252449|NCT05162131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65252450|NCT05162131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65252451|NCT05162131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65252452|NCT05162131|Purinergic Agents|purinergic agents|mesh-ancestor
65252453|NCT05162131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65252454|NCT05162131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252455|NCT05162131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341322|NCT00107744|Chelating Agents|chelating agents|mesh-ancestor
65341323|NCT00107744|Sequestering Agents|sequestering agents|mesh-ancestor
65341324|NCT00107744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341325|NCT00845338|Darifenacin|darifenacin|mesh-list
65341326|NCT00845338|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65341327|NCT00845338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65341328|NCT00845338|Cholinergic Agents|cholinergic agents|mesh-ancestor
65341329|NCT00845338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65341330|NCT00845338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341331|NCT00845338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341332|NCT00845338|Urological Agents|urological agents|mesh-ancestor
65341333|NCT00923962|Adenosine|adenosine|mesh-list
65341334|NCT00923962|Glucagon|glucagon|mesh-list
65341335|NCT00923962|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65341336|NCT00923962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65341337|NCT00923962|Hormones|hormones|mesh-ancestor
64723348|NCT04713410|Hormones|hormones|mesh-ancestor
65252456|NCT00868153|Levonorgestrel|levonorgestrel|mesh-list
65252457|NCT00868153|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65252458|NCT00868153|Contraceptive Agents|contraceptive agents|mesh-ancestor
65252459|NCT00868153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65252460|NCT00868153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252462|NCT00868153|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65252463|NCT00868153|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65252464|NCT00876889|Riluzole|riluzole|mesh-list
65252465|NCT00876889|Anticonvulsants|anticonvulsants|mesh-ancestor
65252466|NCT00876889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65252467|NCT00876889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65252468|NCT00876889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65252469|NCT00876889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252470|NCT00876889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252471|NCT00876889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65252472|NCT00876889|Protective Agents|protective agents|mesh-ancestor
65252473|NCT00868465|Lumefantrine|lumefantrine|mesh-list
65252474|NCT00868465|Artemether|artemether|mesh-list
65252475|NCT00868465|Piperaquine|piperaquine|mesh-list
65252476|NCT00868465|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65252477|NCT00868465|Artenimol|artenimol|mesh-list
65252478|NCT00868465|Antimalarials|antimalarials|mesh-ancestor
65252479|NCT00868465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65252480|NCT00868465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65252481|NCT00868465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65252482|NCT02689986|Rituximab|rituximab|mesh-list
65252483|NCT02689986|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65252484|NCT02689986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65252485|NCT02689986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252486|NCT02689986|Immunologic Factors|immunologic factors|mesh-ancestor
65252487|NCT02689986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252488|NCT02689986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65252489|NCT02689986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65252490|NCT02689986|Alkylating Agents|alkylating agents|mesh-ancestor
65252491|NCT02689986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252492|NCT00876967|Pyrithione zinc|pyrithione zinc|mesh-list
65252493|NCT00876967|Keratolytic Agents|keratolytic agents|mesh-ancestor
65252494|NCT00876967|Dermatologic Agents|dermatologic agents|mesh-ancestor
65252495|NCT00955409|Saponin QA-21V1|saponin qa-21v1|mesh-list
65252496|NCT00955409|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65252497|NCT00955409|Immunologic Factors|immunologic factors|mesh-ancestor
65252498|NCT00955409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341338|NCT00923962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65341339|NCT00923962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341340|NCT00923962|Incretins|incretins|mesh-ancestor
65341341|NCT00923962|Analgesics|analgesics|mesh-ancestor
65341342|NCT00923962|Sensory System Agents|sensory system agents|mesh-ancestor
65341343|NCT00923962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65341344|NCT00923962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65341345|NCT00923962|Vasodilator Agents|vasodilator agents|mesh-ancestor
65341346|NCT00923962|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65341347|NCT00923962|Purinergic Agonists|purinergic agonists|mesh-ancestor
65341348|NCT00923962|Purinergic Agents|purinergic agents|mesh-ancestor
65341349|NCT00923962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65341350|NCT00923962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341351|NCT02575092|Folic Acid|folic acid|mesh-list
65341352|NCT02575092|Enalapril|enalapril|mesh-list
65252499|NCT05390892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65252500|NCT05390892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252501|NCT05390892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65252502|NCT05390892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252503|NCT00877123|Vitamin D|vitamin d|mesh-list
65252504|NCT00877123|Vitamins|vitamins|mesh-ancestor
65252505|NCT00877123|Micronutrients|micronutrients|mesh-ancestor
65252506|NCT00877123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252507|NCT00877123|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65252508|NCT00873223|Liraglutide|liraglutide|mesh-list
65252509|NCT00873223|Insulin Detemir|insulin detemir|mesh-list
65252510|NCT00873223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65252511|NCT00873223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252512|NCT00873223|Incretins|incretins|mesh-ancestor
65252513|NCT00873223|Hormones|hormones|mesh-ancestor
65252514|NCT00873223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65252515|NCT00873379|Melatonin|melatonin|mesh-list
65252516|NCT00873379|Antioxidants|antioxidants|mesh-ancestor
65252517|NCT00873379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252518|NCT00873379|Protective Agents|protective agents|mesh-ancestor
65252519|NCT00873379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252520|NCT00873379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65252521|NCT00868855|Bradykinin|bradykinin|mesh-list
65252522|NCT00868855|Kininogens|kininogens|mesh-list
65252523|NCT00868855|Vasodilator Agents|vasodilator agents|mesh-ancestor
65252524|NCT00868855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65252525|NCT00868855|Protease Inhibitors|protease inhibitors|mesh-ancestor
65252526|NCT00868855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65252527|NCT00868855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252528|NCT00615901|Cyclophosphamide|cyclophosphamide|mesh-list
65252529|NCT00615901|Fluorouracil|fluorouracil|mesh-list
65252530|NCT00615901|Methotrexate|methotrexate|mesh-list
65252531|NCT00615901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65252532|NCT00615901|Immunologic Factors|immunologic factors|mesh-ancestor
65252533|NCT00615901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252534|NCT00615901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65252535|NCT00615901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65252569|NCT00616603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65252570|NCT00616603|Sensory System Agents|sensory system agents|mesh-ancestor
65252571|NCT00873535|Varenicline|varenicline|mesh-list
65252572|NCT00873535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65252573|NCT00873535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65252574|NCT00873535|Cholinergic Agents|cholinergic agents|mesh-ancestor
65252575|NCT00873535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64304112|NCT03067688|Antimetabolites|antimetabolites|mesh-ancestor
65341353|NCT02575092|Enalaprilat|enalaprilat|mesh-list
65341354|NCT02575092|Maleic acid|maleic acid|mesh-list
65341355|NCT02575092|Hematinics|hematinics|mesh-ancestor
65341356|NCT02575092|Vitamin B Complex|vitamin b complex|mesh-ancestor
65341357|NCT02575092|Vitamins|vitamins|mesh-ancestor
65341358|NCT02575092|Micronutrients|micronutrients|mesh-ancestor
65341359|NCT02575092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341365|NCT04097470|Decitabine|decitabine|mesh-list
65341422|NCT04227184|Urological Agents|urological agents|mesh-ancestor
65341424|NCT02545972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65341425|NCT02545972|Immunologic Factors|immunologic factors|mesh-ancestor
65341426|NCT02545972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341427|NCT02545972|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65341428|NCT02545972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341429|NCT02545972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341430|NCT00852046|Dexmedetomidine|dexmedetomidine|mesh-list
65341431|NCT00852046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65341432|NCT00852046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65341433|NCT00852046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341434|NCT00852046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65341435|NCT00852046|Analgesics|analgesics|mesh-ancestor
65341436|NCT00852046|Sensory System Agents|sensory system agents|mesh-ancestor
65341437|NCT00852046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65341438|NCT00852046|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65341439|NCT00852046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65341440|NCT00852046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65341441|NCT00852046|Adrenergic Agents|adrenergic agents|mesh-ancestor
65252604|NCT02790450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65252605|NCT02790450|Renal Agents|renal agents|mesh-ancestor
65252606|NCT02790528|Atorvastatin|atorvastatin|mesh-list
65252607|NCT02790528|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65252608|NCT02790528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65252609|NCT02790528|Antimetabolites|antimetabolites|mesh-ancestor
65252610|NCT02790528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252611|NCT02790528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65252612|NCT02790528|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65252613|NCT02790528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65252614|NCT00953615|Thalidomide|thalidomide|mesh-list
65252615|NCT00953615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65252616|NCT00953615|Immunologic Factors|immunologic factors|mesh-ancestor
65252617|NCT00953615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252618|NCT00953615|Leprostatic Agents|leprostatic agents|mesh-ancestor
65252619|NCT00953615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65252620|NCT00953615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65252621|NCT00953615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65252622|NCT00953615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65252623|NCT00953615|Growth Substances|growth substances|mesh-ancestor
65252624|NCT00953615|Growth Inhibitors|growth inhibitors|mesh-ancestor
65252657|NCT02787018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252658|NCT02787018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65252659|NCT02787018|Glucocorticoids|glucocorticoids|mesh-ancestor
65252660|NCT02787018|Hormones|hormones|mesh-ancestor
65252661|NCT02787018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65252662|NCT02787018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65252663|NCT02787018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252664|NCT02787018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65252665|NCT02787018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65252702|NCT03412266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65252703|NCT03412266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65252704|NCT03412266|Alkylating Agents|alkylating agents|mesh-ancestor
65252705|NCT03412266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341442|NCT00852046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65341443|NCT00852046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341444|NCT02573064|Vancomycin|vancomycin|mesh-list
65341445|NCT02573064|Colistin|colistin|mesh-list
65252706|NCT03412266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252707|NCT03412266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65252708|NCT03412266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65252738|NCT00877591|Antitubercular Agents|antitubercular agents|mesh-ancestor
65252739|NCT00877591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65002998|NCT00446173|Busulfan|busulfan|mesh-list
65252740|NCT00877591|Leprostatic Agents|leprostatic agents|mesh-ancestor
65252741|NCT00877591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65252742|NCT00877591|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65252743|NCT00877591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65252744|NCT00877591|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65252745|NCT00877591|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65252746|NCT00877591|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65252747|NCT00877591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65252748|NCT04200222|Vanadium|vanadium|mesh-list
65252749|NCT04200222|Trace Elements|trace elements|mesh-ancestor
65252750|NCT04200222|Micronutrients|micronutrients|mesh-ancestor
65252751|NCT04200222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252752|NCT00874003|Mirtazapine|mirtazapine|mesh-list
65252753|NCT00874003|Antidepressive Agents|antidepressive agents|mesh-ancestor
65252754|NCT00874003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65252755|NCT00874003|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65252787|NCT02785146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252788|NCT02785146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65252790|NCT02785146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252791|NCT02785146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65252792|NCT02785146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252793|NCT02785146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65252794|NCT02785146|Immunologic Factors|immunologic factors|mesh-ancestor
65252795|NCT02785146|Antidotes|antidotes|mesh-ancestor
65252826|NCT05753787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65252827|NCT05753787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65252828|NCT00874315|Cyclosporine|cyclosporine|mesh-list
65252829|NCT00874315|Mycophenolic Acid|mycophenolic acid|mesh-list
65252830|NCT00874315|Fludarabine|fludarabine|mesh-list
65252831|NCT00874315|Fludarabine phosphate|fludarabine phosphate|mesh-list
65252832|NCT00874315|Busulfan|busulfan|mesh-list
65252833|NCT00874315|Tacrolimus|tacrolimus|mesh-list
65252834|NCT00874315|Cyclosporins|cyclosporins|mesh-list
65252835|NCT00874315|Thymoglobulin|thymoglobulin|mesh-list
65252836|NCT00874315|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65252837|NCT00874315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252838|NCT00874315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65252839|NCT00874315|Antimetabolites|antimetabolites|mesh-ancestor
65252871|NCT04199364|Respiratory System Agents|respiratory system agents|mesh-ancestor
65252872|NCT00870025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65252873|NCT00870025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65252874|NCT00870025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252875|NCT00877981|Parathyroid Hormone|parathyroid hormone|mesh-list
65252876|NCT00877981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65252877|NCT00877981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252878|NCT02786550|Botulinum Toxins|botulinum toxins|mesh-list
65252879|NCT02786550|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65252880|NCT02786550|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65252881|NCT02786550|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64928233|NCT04731961|Cholinergic Agents|cholinergic agents|mesh-ancestor
65252910|NCT00874861|Interferon Inducers|interferon inducers|mesh-ancestor
65252911|NCT00874861|Immunologic Factors|immunologic factors|mesh-ancestor
65252912|NCT00874861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252913|NCT04038853|Vitamin D|vitamin d|mesh-list
65252914|NCT04038853|Cholecalciferol|cholecalciferol|mesh-list
65252915|NCT04038853|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
65252916|NCT04038853|Calcitriol|calcitriol|mesh-list
65252917|NCT04038853|Vitamins|vitamins|mesh-ancestor
65252918|NCT04038853|Micronutrients|micronutrients|mesh-ancestor
65252919|NCT04038853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252920|NCT04038853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65252921|NCT04038853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65252922|NCT04038853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65341446|NCT02573064|Tigecycline|tigecycline|mesh-list
65341447|NCT02573064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65341448|NCT02573064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65341449|NCT02573064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65341450|NCT02573064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341451|NCT02573064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252923|NCT04038853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65252924|NCT04038853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252925|NCT04038853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65252926|NCT02066220|Cyclophosphamide|cyclophosphamide|mesh-list
65252927|NCT02066220|Lomustine|lomustine|mesh-list
65252928|NCT02066220|Cisplatin|cisplatin|mesh-list
65252955|NCT00573391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65252956|NCT00573391|Glucocorticoids|glucocorticoids|mesh-ancestor
65252957|NCT00573391|Hormones|hormones|mesh-ancestor
65252958|NCT00573391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65252959|NCT00573391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65252960|NCT00573391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252961|NCT00573391|Protease Inhibitors|protease inhibitors|mesh-ancestor
65252962|NCT00573391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65252963|NCT00573391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252964|NCT00573391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65252965|NCT00573391|Alkylating Agents|alkylating agents|mesh-ancestor
65252966|NCT00573391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65252967|NCT00573391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65252968|NCT00573391|Immunologic Factors|immunologic factors|mesh-ancestor
65252969|NCT00573391|Leprostatic Agents|leprostatic agents|mesh-ancestor
65252970|NCT00573391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65252971|NCT00573391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65252972|NCT00573391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65252973|NCT00573391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65252974|NCT00573391|Growth Substances|growth substances|mesh-ancestor
65252975|NCT00573391|Growth Inhibitors|growth inhibitors|mesh-ancestor
65252976|NCT00590967|Cisplatin|cisplatin|mesh-list
65252977|NCT00590967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252978|NCT02783976|Sofosbuvir|sofosbuvir|mesh-list
65252979|NCT02783976|Antiviral Agents|antiviral agents|mesh-ancestor
65253005|NCT05753397|Anesthetics, Local|anesthetics, local|mesh-ancestor
65253006|NCT05753397|Anesthetics|anesthetics|mesh-ancestor
65253007|NCT05753397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65253008|NCT05753397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253009|NCT05753397|Sensory System Agents|sensory system agents|mesh-ancestor
65253010|NCT05753397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65253011|NCT00875173|Selenium|selenium|mesh-list
65253012|NCT00875173|Antioxidants|antioxidants|mesh-list
65253013|NCT00875173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253014|NCT00875173|Protective Agents|protective agents|mesh-ancestor
65253015|NCT00875173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253016|NCT00875173|Trace Elements|trace elements|mesh-ancestor
65253017|NCT00875173|Micronutrients|micronutrients|mesh-ancestor
65253018|NCT05243550|Mitomycins|mitomycins|mesh-list
65253019|NCT05243550|Mitomycin|mitomycin|mesh-list
65253020|NCT05243550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65253021|NCT05243550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253022|NCT05243550|Alkylating Agents|alkylating agents|mesh-ancestor
65253023|NCT05243550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253024|NCT05243550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65253025|NCT05243550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253026|NCT04029831|Ketamine|ketamine|mesh-list
65253027|NCT04029831|Propofol|propofol|mesh-list
65253028|NCT04029831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65253029|NCT04029831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65253030|NCT04029831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253031|NCT04029831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65253060|NCT02932956|Cyclophosphamide|cyclophosphamide|mesh-list
65253061|NCT02932956|Fludarabine|fludarabine|mesh-list
65253062|NCT02932956|Fludarabine phosphate|fludarabine phosphate|mesh-list
65253063|NCT02932956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65253064|NCT02932956|Immunologic Factors|immunologic factors|mesh-ancestor
65341452|NCT00845884|Bevacizumab|bevacizumab|mesh-list
65341453|NCT00845884|Cisplatin|cisplatin|mesh-list
65341454|NCT00845884|Docetaxel|docetaxel|mesh-list
65341455|NCT00845884|Capecitabine|capecitabine|mesh-list
65341456|NCT00845884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65341457|NCT00845884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341458|NCT00845884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65341459|NCT00845884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65341460|NCT00845884|Growth Substances|growth substances|mesh-ancestor
65341461|NCT00845884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341462|NCT00845884|Growth Inhibitors|growth inhibitors|mesh-ancestor
65341463|NCT00845884|Tubulin Modulators|tubulin modulators|mesh-ancestor
65341464|NCT00845884|Antimitotic Agents|antimitotic agents|mesh-ancestor
65341465|NCT00845884|Mitosis Modulators|mitosis modulators|mesh-ancestor
65341466|NCT00845884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341467|NCT00845884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65341468|NCT00845884|Antimetabolites|antimetabolites|mesh-ancestor
65341469|NCT00923806|Aldesleukin|aldesleukin|mesh-list
65341470|NCT00923806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341471|NCT00923806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65341472|NCT00923806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65341473|NCT00923806|Antiviral Agents|antiviral agents|mesh-ancestor
65341474|NCT00923806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65341475|NCT00848068|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65253065|NCT02932956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253066|NCT02932956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65253067|NCT02932956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65253068|NCT02932956|Alkylating Agents|alkylating agents|mesh-ancestor
65253069|NCT02932956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253070|NCT02932956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253071|NCT02932956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65253072|NCT02932956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65253073|NCT02932956|Antimetabolites|antimetabolites|mesh-ancestor
65253074|NCT01716312|Omalizumab|omalizumab|mesh-list
65253075|NCT01716312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65253076|NCT01716312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64928424|NCT00040768|Bortezomib|bortezomib|mesh-list
65253107|NCT02783586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65253109|NCT00590577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65253110|NCT00590577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65253111|NCT00590577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65253112|NCT00590577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253113|NCT00590577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65253114|NCT00590577|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65253115|NCT00590577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65253116|NCT00590577|Serotonin Agents|serotonin agents|mesh-ancestor
65253117|NCT00590577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65003381|NCT00449020|Docetaxel|docetaxel|mesh-list
65253118|NCT00590577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253119|NCT00590577|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65253120|NCT00590577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65253153|NCT04230330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65341476|NCT00848068|Lubricant Eye Drops|lubricant eye drops|mesh-list
65341477|NCT00848068|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65341478|NCT00718536|Raltegravir Potassium|raltegravir potassium|mesh-list
65341479|NCT00718536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65341480|NCT00718536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65341481|NCT00718536|Antiviral Agents|antiviral agents|mesh-ancestor
65253154|NCT04230330|Antiemetics|antiemetics|mesh-ancestor
65253155|NCT04230330|Autonomic Agents|autonomic agents|mesh-ancestor
65253156|NCT04230330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65253157|NCT04230330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253158|NCT04230330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65253159|NCT04230330|Glucocorticoids|glucocorticoids|mesh-ancestor
65253160|NCT04230330|Hormones|hormones|mesh-ancestor
65253161|NCT04230330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65253162|NCT04230330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65253163|NCT04230330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253164|NCT04230330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65253165|NCT04230330|Antimetabolites|antimetabolites|mesh-ancestor
64928515|NCT00041314|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65253190|NCT05752929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65253191|NCT05752929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253192|NCT00880477|Edetic Acid|edetic acid|mesh-list
65253193|NCT00880477|Vaccines|vaccines|mesh-list
65253194|NCT00880477|Pentetic Acid|pentetic acid|mesh-list
65253195|NCT00880477|Immunologic Factors|immunologic factors|mesh-ancestor
65253196|NCT00880477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253197|NCT00880477|Antidotes|antidotes|mesh-ancestor
65253198|NCT00880477|Protective Agents|protective agents|mesh-ancestor
65253199|NCT00880477|Chelating Agents|chelating agents|mesh-ancestor
65253200|NCT00880477|Sequestering Agents|sequestering agents|mesh-ancestor
65253201|NCT00880477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253202|NCT00880477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65253203|NCT00880477|Anticoagulants|anticoagulants|mesh-ancestor
65253204|NCT00880477|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65253205|NCT05293938|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
65253206|NCT05293938|Cathartics|cathartics|mesh-ancestor
65253207|NCT05293938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65253208|NCT00882739|Clopidogrel|clopidogrel|mesh-list
65253209|NCT00882739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65253210|NCT00882739|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65253211|NCT00882739|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65253212|NCT00882739|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65253213|NCT00882739|Purinergic Agents|purinergic agents|mesh-ancestor
65253214|NCT00882739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65253215|NCT00882739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253216|NCT00882739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253248|NCT02512926|Immunologic Factors|immunologic factors|mesh-ancestor
65253249|NCT02512926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253250|NCT02512926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65253251|NCT02512926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65253252|NCT02512926|Alkylating Agents|alkylating agents|mesh-ancestor
65253253|NCT02512926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253254|NCT02512926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253255|NCT02512926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65253256|NCT02512926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65253257|NCT02512926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65253258|NCT02512926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65253259|NCT02512926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253260|NCT02786082|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65253261|NCT02786082|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65253262|NCT02786082|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64928611|NCT00041899|Contraceptive Agents|contraceptive agents|mesh-ancestor
65253295|NCT00805935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65253296|NCT00805935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253297|NCT00878917|Dorzolamide|dorzolamide|mesh-list
65253298|NCT00878917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65253299|NCT00878917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65253300|NCT00878917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65253301|NCT00878917|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65341482|NCT00718536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65341483|NCT00718536|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65341484|NCT00718536|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65341485|NCT00718536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341486|NCT00718536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341487|NCT00712062|Pemetrexed|pemetrexed|mesh-list
65341488|NCT00712062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341489|NCT00712062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341490|NCT00712062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341491|NCT00712062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65341492|NCT00712062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65341493|NCT00712140|Trastuzumab|trastuzumab|mesh-list
65341494|NCT00712140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65341495|NCT00712140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341496|NCT02545738|Liraglutide|liraglutide|mesh-list
65341497|NCT02545738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65341498|NCT02545738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341499|NCT02545738|Incretins|incretins|mesh-ancestor
65341500|NCT02545738|Hormones|hormones|mesh-ancestor
65341501|NCT02545738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65341502|NCT00848302|Nitric Oxide|nitric oxide|mesh-list
65341503|NCT00848302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65341504|NCT00848302|Autonomic Agents|autonomic agents|mesh-ancestor
65341505|NCT00848302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65341506|NCT00848302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341507|NCT00848302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65341508|NCT00848302|Respiratory System Agents|respiratory system agents|mesh-ancestor
65253302|NCT00878917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253303|NCT00878917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253304|NCT00638118|Fexofenadine|fexofenadine|mesh-list
65253305|NCT00638118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65253306|NCT00638118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65253333|NCT05188170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65253334|NCT05188170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65253335|NCT05188170|Antinematodal Agents|antinematodal agents|mesh-ancestor
65253336|NCT05180994|Infliximab|infliximab|mesh-list
65253337|NCT05180994|Dermatologic Agents|dermatologic agents|mesh-ancestor
65253338|NCT05180994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65253339|NCT05180994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65253340|NCT02782338|Diclofenac|diclofenac|mesh-list
65253341|NCT02782338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65253342|NCT02782338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65253343|NCT02782338|Analgesics|analgesics|mesh-ancestor
65253344|NCT02782338|Sensory System Agents|sensory system agents|mesh-ancestor
65253345|NCT02782338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65253346|NCT02782338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341509|NCT00848302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65341510|NCT00848302|Antioxidants|antioxidants|mesh-ancestor
65341511|NCT00848302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341512|NCT00848302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65341513|NCT00848302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65341514|NCT00848302|Vasodilator Agents|vasodilator agents|mesh-ancestor
65341515|NCT00848302|Gasotransmitters|gasotransmitters|mesh-ancestor
65341516|NCT00848302|Protective Agents|protective agents|mesh-ancestor
65341517|NCT02572596|Cyclophosphamide|cyclophosphamide|mesh-list
65341518|NCT02572596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65341519|NCT02572596|Immunologic Factors|immunologic factors|mesh-ancestor
65341520|NCT02572596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341521|NCT02572596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65341522|NCT02572596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65341523|NCT02572596|Alkylating Agents|alkylating agents|mesh-ancestor
64331160|NCT05790239|Amphetamine|amphetamine|mesh-list
65253347|NCT02782338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65253348|NCT02782338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65253349|NCT02782338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65253373|NCT03577704|Immunoglobulins|immunoglobulins|mesh-list
65253374|NCT03577704|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65253375|NCT03577704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65253376|NCT03577704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253377|NCT03577704|Tubulin Modulators|tubulin modulators|mesh-ancestor
65253378|NCT03577704|Antimitotic Agents|antimitotic agents|mesh-ancestor
65253379|NCT03577704|Mitosis Modulators|mitosis modulators|mesh-ancestor
65253380|NCT03577704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253381|NCT03577704|Immunologic Factors|immunologic factors|mesh-ancestor
65253382|NCT03577704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253383|NCT03577704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65253384|NCT03577704|Antimetabolites|antimetabolites|mesh-ancestor
65253385|NCT03577704|Antiviral Agents|antiviral agents|mesh-ancestor
65253386|NCT03577704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65253387|NCT03577704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253388|NCT03577704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65253389|NCT05176626|Phentermine|phentermine|mesh-list
65253390|NCT05176626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65253391|NCT05176626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253392|NCT05176626|Appetite Depressants|appetite depressants|mesh-ancestor
65253393|NCT05176626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65253394|NCT05176626|Sympathomimetics|sympathomimetics|mesh-ancestor
65253395|NCT05176626|Autonomic Agents|autonomic agents|mesh-ancestor
65253396|NCT05176626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65253397|NCT05176626|Adrenergic Agents|adrenergic agents|mesh-ancestor
65253398|NCT05176626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65253399|NCT05176626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253400|NCT05030766|Nicotine|nicotine|mesh-list
65253401|NCT05030766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65253402|NCT05030766|Autonomic Agents|autonomic agents|mesh-ancestor
65253427|NCT02782182|Irinotecan|irinotecan|mesh-list
65253428|NCT02782182|Folfirinox|folfirinox|mesh-list
65253429|NCT02782182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253430|NCT02782182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65253431|NCT02782182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65253432|NCT02782182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253433|NCT02782182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253434|NCT02782182|Antidotes|antidotes|mesh-ancestor
65253435|NCT02782182|Protective Agents|protective agents|mesh-ancestor
65253436|NCT02782182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341524|NCT02572596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341525|NCT02572596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341526|NCT02572596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65341527|NCT00712374|Pyrimethamine|pyrimethamine|mesh-list
65341528|NCT00712374|Sulfadoxine|sulfadoxine|mesh-list
65341529|NCT00712374|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65253437|NCT02782182|Vitamin B Complex|vitamin b complex|mesh-ancestor
65253438|NCT02782182|Vitamins|vitamins|mesh-ancestor
65253439|NCT02782182|Micronutrients|micronutrients|mesh-ancestor
65253440|NCT02780778|Docetaxel|docetaxel|mesh-list
65253441|NCT02780778|Apatinib|apatinib|mesh-list
65253442|NCT02780778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253443|NCT02780778|Tubulin Modulators|tubulin modulators|mesh-ancestor
65253444|NCT02780778|Antimitotic Agents|antimitotic agents|mesh-ancestor
65253445|NCT02780778|Mitosis Modulators|mitosis modulators|mesh-ancestor
65253446|NCT02780778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253447|NCT02780778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65253448|NCT02780778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253449|NCT00881101|Paclitaxel|paclitaxel|mesh-list
65253450|NCT00881101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65253451|NCT00881101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253452|NCT00881101|Tubulin Modulators|tubulin modulators|mesh-ancestor
65253453|NCT00881101|Antimitotic Agents|antimitotic agents|mesh-ancestor
65253479|NCT03955861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65253480|NCT03955861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65253481|NCT03955861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65253482|NCT03955861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65253483|NCT03955861|Analgesics|analgesics|mesh-ancestor
65253484|NCT03955861|Sensory System Agents|sensory system agents|mesh-ancestor
65253485|NCT03955861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65253486|NCT03955861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253487|NCT03955861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65253488|NCT03955861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65253489|NCT03955861|Immunologic Factors|immunologic factors|mesh-ancestor
65253490|NCT03955861|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65253491|NCT00881179|Clarithromycin|clarithromycin|mesh-list
65253492|NCT00881179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65253493|NCT00881179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65253494|NCT00881179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65253495|NCT00881179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253496|NCT00881179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253497|NCT00881179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65253498|NCT00881179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65253499|NCT02781246|Dexmedetomidine|dexmedetomidine|mesh-list
65253500|NCT02781246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65253501|NCT02781246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65253502|NCT02781246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253535|NCT00958841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65253536|NCT00958841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253538|NCT02937116|Cisplatin|cisplatin|mesh-list
65253539|NCT02937116|Capecitabine|capecitabine|mesh-list
65253540|NCT02937116|Oxaliplatin|oxaliplatin|mesh-list
65253541|NCT02937116|Irinotecan|irinotecan|mesh-list
65253542|NCT02937116|Etoposide|etoposide|mesh-list
65253543|NCT02937116|Pemetrexed|pemetrexed|mesh-list
65253544|NCT02937116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253545|NCT02937116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65253546|NCT02937116|Antimetabolites|antimetabolites|mesh-ancestor
65253562|NCT03927105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253563|NCT03927105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65253564|NCT03927105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253566|NCT00613327|Parasympatholytics|parasympatholytics|mesh-ancestor
65253567|NCT00613327|Autonomic Agents|autonomic agents|mesh-ancestor
65253568|NCT00613327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65253569|NCT00613327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253570|NCT00613327|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65253571|NCT00613327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65253572|NCT00613327|Cholinergic Agents|cholinergic agents|mesh-ancestor
65341530|NCT00712374|Amodiaquine|amodiaquine|mesh-list
65341531|NCT00712374|Antimalarials|antimalarials|mesh-ancestor
65341532|NCT00712374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65341533|NCT00712374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65341534|NCT00712374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65341535|NCT00712374|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65341536|NCT00712374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341537|NCT00712374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341538|NCT00712374|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65341539|NCT00712374|Renal Agents|renal agents|mesh-ancestor
65341540|NCT02573220|Leucovorin|leucovorin|mesh-list
65341541|NCT02573220|Fluorouracil|fluorouracil|mesh-list
65341542|NCT02573220|Irinotecan|irinotecan|mesh-list
65341543|NCT02573220|Cetuximab|cetuximab|mesh-list
65341544|NCT02573220|Camptothecin|camptothecin|mesh-list
65341545|NCT02573220|Calcium|calcium|mesh-list
65341546|NCT02573220|Levoleucovorin|levoleucovorin|mesh-list
65341547|NCT02573220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65253573|NCT00613327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65253574|NCT00613327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253575|NCT00613327|Urological Agents|urological agents|mesh-ancestor
65253576|NCT04273997|Metronidazole|metronidazole|mesh-list
65253577|NCT04273997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65253578|NCT04273997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65253579|NCT04273997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65253580|NCT04273997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65253581|NCT05339802|Linezolid|linezolid|mesh-list
65253582|NCT05339802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65253583|NCT05339802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65253584|NCT05339802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65253585|NCT05339802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253586|NCT05339802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253587|NCT04649203|Riboflavin|riboflavin|mesh-list
65253588|NCT04649203|Niacinamide|niacinamide|mesh-list
65253589|NCT04649203|Niacin|niacin|mesh-list
65253590|NCT04649203|Nicotinic Acids|nicotinic acids|mesh-list
65253591|NCT04649203|Vitamin B Complex|vitamin b complex|mesh-ancestor
65253592|NCT04649203|Vitamins|vitamins|mesh-ancestor
65253593|NCT04649203|Micronutrients|micronutrients|mesh-ancestor
65253594|NCT04649203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253595|NCT04649203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65253596|NCT04649203|Dermatologic Agents|dermatologic agents|mesh-ancestor
65253597|NCT04649203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65253598|NCT04649203|Antimetabolites|antimetabolites|mesh-ancestor
65253599|NCT04649203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253600|NCT04649203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65253601|NCT04649203|Vasodilator Agents|vasodilator agents|mesh-ancestor
65253602|NCT00881725|Metformin|metformin|mesh-list
65253603|NCT00881725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65253604|NCT00881725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253605|NCT05086224|Lidocaine|lidocaine|mesh-list
65253640|NCT05339646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253641|NCT05339646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253642|NCT05339646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65253643|NCT05339646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65253644|NCT05339646|Antiviral Agents|antiviral agents|mesh-ancestor
65253671|NCT00954707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65253672|NCT00954707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65253673|NCT00954707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253674|NCT00954707|Antipyretics|antipyretics|mesh-ancestor
65253675|NCT00954707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65341548|NCT02573220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341549|NCT02573220|Antimetabolites|antimetabolites|mesh-ancestor
65341550|NCT02573220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341551|NCT02573220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65341552|NCT02573220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341553|NCT02573220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65253676|NCT00954707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65253677|NCT00954707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65253678|NCT00954707|Purinergic Agents|purinergic agents|mesh-ancestor
65253679|NCT00954707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65253680|NCT00630851|Donepezil|donepezil|mesh-list
65253681|NCT00630851|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65253682|NCT00630851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253683|NCT00630851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253684|NCT00630851|Cholinergic Agents|cholinergic agents|mesh-ancestor
65253685|NCT00630851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65253686|NCT00630851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253687|NCT00630851|Nootropic Agents|nootropic agents|mesh-ancestor
65253688|NCT00613171|Imatinib Mesylate|imatinib mesylate|mesh-list
65253689|NCT00613171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253708|NCT05156892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253709|NCT05156892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253710|NCT05156892|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65253711|NCT05156892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65253712|NCT03894345|Prazosin|prazosin|mesh-list
65253713|NCT03894345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65253714|NCT03894345|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65253715|NCT03894345|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65253716|NCT03894345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65253717|NCT03894345|Adrenergic Agents|adrenergic agents|mesh-ancestor
65253718|NCT03894345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65253719|NCT03894345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253720|NCT03894345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253721|NCT02859077|Gemcitabine|gemcitabine|mesh-list
65253723|NCT02859077|Pemetrexed|pemetrexed|mesh-list
65253724|NCT02859077|Gefitinib|gefitinib|mesh-list
65253725|NCT02859077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253726|NCT02859077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65253727|NCT02859077|Antimetabolites|antimetabolites|mesh-ancestor
65253728|NCT02859077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253729|NCT02859077|Antiviral Agents|antiviral agents|mesh-ancestor
65253730|NCT02859077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65253731|NCT02859077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253732|NCT02859077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65253733|NCT02859077|Immunologic Factors|immunologic factors|mesh-ancestor
65253734|NCT02859077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253735|NCT02859077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65253736|NCT02859077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65253737|NCT02859077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65253738|NCT00879307|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65253739|NCT00879307|Antidepressive Agents|antidepressive agents|mesh-ancestor
65253740|NCT00879307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65253741|NCT00879307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65253742|NCT00879307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64929075|NCT00043966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65253760|NCT03851835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65253761|NCT03851835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65253762|NCT00879385|Decitabine|decitabine|mesh-list
65253763|NCT00879385|Panitumumab|panitumumab|mesh-list
65253764|NCT00879385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65253765|NCT00879385|Antimetabolites|antimetabolites|mesh-ancestor
65253766|NCT00879385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253767|NCT00879385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253768|NCT00879385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253769|NCT00879385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65253770|NCT00914121|Moxifloxacin|moxifloxacin|mesh-list
65253771|NCT00914121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65341554|NCT02573220|Immunologic Factors|immunologic factors|mesh-ancestor
65341555|NCT02573220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65341556|NCT02573220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65341557|NCT02573220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341558|NCT02573220|Antidotes|antidotes|mesh-ancestor
65341559|NCT02573220|Protective Agents|protective agents|mesh-ancestor
65341560|NCT02573220|Vitamin B Complex|vitamin b complex|mesh-ancestor
65341561|NCT02573220|Vitamins|vitamins|mesh-ancestor
65341562|NCT02573220|Micronutrients|micronutrients|mesh-ancestor
65341563|NCT02573220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65341564|NCT02573220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65341565|NCT00712452|Cyclophosphamide|cyclophosphamide|mesh-list
65341566|NCT00712452|Vinblastine|vinblastine|mesh-list
65341567|NCT00712452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65341568|NCT00712452|Immunologic Factors|immunologic factors|mesh-ancestor
65341569|NCT00712452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341570|NCT00712452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65341571|NCT00712452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65341572|NCT00712452|Alkylating Agents|alkylating agents|mesh-ancestor
65341573|NCT00712452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341574|NCT00712452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341575|NCT00712452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65253772|NCT00914121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65253773|NCT00914121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65253774|NCT00914121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65253775|NCT00914121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253776|NCT00914121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253777|NCT00914121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253778|NCT00953225|Vitamin D|vitamin d|mesh-list
65253779|NCT00953225|Cholecalciferol|cholecalciferol|mesh-list
65253780|NCT00953225|Vitamins|vitamins|mesh-ancestor
65253781|NCT00953225|Micronutrients|micronutrients|mesh-ancestor
65253782|NCT00953225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253783|NCT00953225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65253784|NCT00953225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65253785|NCT03819231|Oxytocin|oxytocin|mesh-list
65253786|NCT03819231|Oxytocics|oxytocics|mesh-ancestor
65253787|NCT03819231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65253788|NCT03819231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253789|NCT00613015|Guanfacine|guanfacine|mesh-list
65253790|NCT00613015|Modafinil|modafinil|mesh-list
65253791|NCT00613015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65253792|NCT00613015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253793|NCT00613015|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65253794|NCT00613015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65253795|NCT00613015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65253796|NCT00613015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253797|NCT00613015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65253798|NCT00613015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64929135|NCT00044551|Taxane|taxane|mesh-list
65253826|NCT02838992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253828|NCT02838992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65341576|NCT00712452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65341577|NCT00712452|Tubulin Modulators|tubulin modulators|mesh-ancestor
65341578|NCT00712452|Antimitotic Agents|antimitotic agents|mesh-ancestor
65341579|NCT00712452|Mitosis Modulators|mitosis modulators|mesh-ancestor
65341580|NCT00618982|Sorafenib|sorafenib|mesh-list
65341581|NCT00618982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341582|NCT00618982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65341583|NCT00618982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341584|NCT00618982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341585|NCT02544880|Tadalafil|tadalafil|mesh-list
65341586|NCT02544880|Vaccines|vaccines|mesh-list
65341587|NCT02544880|Immunologic Factors|immunologic factors|mesh-ancestor
65341588|NCT02544880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341589|NCT02544880|Vasodilator Agents|vasodilator agents|mesh-ancestor
65341590|NCT02544880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65341591|NCT02544880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65253829|NCT02838992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253830|NCT02838992|Antifungal Agents|antifungal agents|mesh-ancestor
65253831|NCT02838992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65253832|NCT02838992|Dermatologic Agents|dermatologic agents|mesh-ancestor
65253833|NCT02838992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65253834|NCT00879541|Factor VIII|factor viii|mesh-list
65253835|NCT00879541|Coagulants|coagulants|mesh-ancestor
65253836|NCT00884299|Antioxidants|antioxidants|mesh-list
65253837|NCT00884299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253838|NCT00884299|Protective Agents|protective agents|mesh-ancestor
65253839|NCT00884299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253840|NCT02843126|Trastuzumab|trastuzumab|mesh-list
65253841|NCT02843126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65253842|NCT02843126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253843|NCT04201652|Anesthetics|anesthetics|mesh-list
65253844|NCT04201652|Anesthetics, Local|anesthetics, local|mesh-list
65253845|NCT04201652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65253846|NCT04201652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253847|NCT04201652|Sensory System Agents|sensory system agents|mesh-ancestor
65253848|NCT04201652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65253878|NCT00803595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65253879|NCT00803595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253880|NCT00803595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253881|NCT02843204|Pembrolizumab|pembrolizumab|mesh-list
65253882|NCT02843204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65253883|NCT02843204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253884|NCT02606565|Chlorhexidine|chlorhexidine|mesh-list
65253885|NCT02606565|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65253886|NCT02606565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65253887|NCT02606565|Disinfectants|disinfectants|mesh-ancestor
65253888|NCT04227990|Cyclophosphamide|cyclophosphamide|mesh-list
65253890|NCT04227990|Doxorubicin|doxorubicin|mesh-list
65253891|NCT04227990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65253892|NCT04227990|Immunologic Factors|immunologic factors|mesh-ancestor
64929237|NCT00044785|Leucovorin|leucovorin|mesh-list
65253917|NCT02606409|Sensory System Agents|sensory system agents|mesh-ancestor
65253918|NCT02606409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65253919|NCT02606409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65253920|NCT02606409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65253921|NCT02606409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65253922|NCT02606409|Adrenergic Agents|adrenergic agents|mesh-ancestor
65253923|NCT02606409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65253924|NCT02606409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723621|NCT00402883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723622|NCT00402883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64723623|NCT00402883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64723624|NCT00402883|Hematinics|hematinics|mesh-ancestor
65341592|NCT02544880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341593|NCT02544880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341594|NCT02544880|Urological Agents|urological agents|mesh-ancestor
65341595|NCT00856570|Warfarin|warfarin|mesh-list
65341596|NCT00856570|Mirabegron|mirabegron|mesh-list
65341597|NCT00856570|Anticoagulants|anticoagulants|mesh-ancestor
65341598|NCT00856570|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65341599|NCT00856570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65341600|NCT00856570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65341601|NCT00856570|Adrenergic Agents|adrenergic agents|mesh-ancestor
65341602|NCT00856570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65341603|NCT00856570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341604|NCT00856570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341605|NCT00856570|Urological Agents|urological agents|mesh-ancestor
65341606|NCT04068870|Contraceptive Agents|contraceptive agents|mesh-list
65341607|NCT04068870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65341608|NCT04068870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341609|NCT00856804|Ribavirin|ribavirin|mesh-list
65341610|NCT00856804|Thalidomide|thalidomide|mesh-list
65341611|NCT00856804|Antimetabolites|antimetabolites|mesh-ancestor
65341612|NCT00856804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341613|NCT00856804|Antiviral Agents|antiviral agents|mesh-ancestor
65341614|NCT00856804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65341615|NCT00856804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65341616|NCT00856804|Immunologic Factors|immunologic factors|mesh-ancestor
65341617|NCT00856804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253925|NCT00611767|Thiopental|thiopental|mesh-list
65253926|NCT00611767|Anticonvulsants|anticonvulsants|mesh-ancestor
65253927|NCT00611767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65253928|NCT00611767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65253929|NCT00611767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253930|NCT00611767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65253931|NCT00611767|Anesthetics, General|anesthetics, general|mesh-ancestor
65253932|NCT00611767|Anesthetics|anesthetics|mesh-ancestor
65253933|NCT00611767|GABA Modulators|gaba modulators|mesh-ancestor
65253934|NCT00611767|GABA Agents|gaba agents|mesh-ancestor
65253935|NCT00611767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65253936|NCT00611767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253937|NCT04967508|Ustekinumab|ustekinumab|mesh-list
65253938|NCT04967508|Dermatologic Agents|dermatologic agents|mesh-ancestor
64723648|NCT05286320|Pembrolizumab|pembrolizumab|mesh-list
65341618|NCT00856804|Leprostatic Agents|leprostatic agents|mesh-ancestor
65341619|NCT00856804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65341620|NCT00856804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65341621|NCT00856804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65341622|NCT00856804|Growth Substances|growth substances|mesh-ancestor
65341623|NCT00856804|Growth Inhibitors|growth inhibitors|mesh-ancestor
65341624|NCT00856804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341625|NCT00856882|Caseins|caseins|mesh-list
65341626|NCT00856882|Chelating Agents|chelating agents|mesh-ancestor
65341627|NCT00856882|Sequestering Agents|sequestering agents|mesh-ancestor
65341628|NCT00856882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341629|NCT00712686|Olanzapine|olanzapine|mesh-list
65341630|NCT00712686|Aripiprazole|aripiprazole|mesh-list
65253939|NCT00803361|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65253940|NCT00803361|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65253941|NCT00803361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64929281|NCT00044902|Epratuzumab|epratuzumab|mesh-list
65253972|NCT04038307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65253973|NCT04038307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253975|NCT04985604|Niacinamide|niacinamide|mesh-list
65253976|NCT04985604|Vitamin B Complex|vitamin b complex|mesh-ancestor
65253977|NCT04985604|Vitamins|vitamins|mesh-ancestor
65253978|NCT04985604|Micronutrients|micronutrients|mesh-ancestor
65253979|NCT04985604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253980|NCT00884533|Moxifloxacin|moxifloxacin|mesh-list
65253981|NCT00884533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65253982|NCT00884533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65253983|NCT00884533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65253984|NCT00884533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65253985|NCT00884533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254013|NCT02778360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254014|NCT02778360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65254015|NCT02778360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65254016|NCT02778360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65254017|NCT02778360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254018|NCT02778360|Dopamine Agents|dopamine agents|mesh-ancestor
65004273|NCT00464347|Growth Inhibitors|growth inhibitors|mesh-ancestor
65254019|NCT02778360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65254020|NCT00953147|Ciclesonide|ciclesonide|mesh-list
65254021|NCT00953147|Glucocorticoids|glucocorticoids|mesh-ancestor
65254022|NCT00953147|Hormones|hormones|mesh-ancestor
65254023|NCT00953147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65254024|NCT00953147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254025|NCT00953147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65254026|NCT05333744|Prednisone|prednisone|mesh-list
65254027|NCT05333744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65254028|NCT05333744|Glucocorticoids|glucocorticoids|mesh-ancestor
65254029|NCT05333744|Hormones|hormones|mesh-ancestor
64929377|NCT00045604|Imatinib Mesylate|imatinib mesylate|mesh-list
65254060|NCT02858843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254061|NCT02779530|Diclofenac|diclofenac|mesh-list
65254062|NCT02779530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65254063|NCT02779530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65254064|NCT02779530|Analgesics|analgesics|mesh-ancestor
65254065|NCT02779530|Sensory System Agents|sensory system agents|mesh-ancestor
65254066|NCT02779530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254067|NCT02779530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254068|NCT02779530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65254069|NCT02779530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65254070|NCT02779530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65254071|NCT02779530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091444|NCT01309828|Diuretics|diuretics|mesh-ancestor
65341631|NCT00712686|Antiemetics|antiemetics|mesh-ancestor
65341632|NCT00712686|Autonomic Agents|autonomic agents|mesh-ancestor
65341633|NCT00712686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65341634|NCT00712686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341635|NCT00712686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65341637|NCT00712686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65254072|NCT02779530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254103|NCT02857361|Anesthetics|anesthetics|mesh-ancestor
65254104|NCT02857361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65254105|NCT02857361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65254106|NCT02857361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65254107|NCT02857361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65254108|NCT02857361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254109|NCT05050500|Dapagliflozin|dapagliflozin|mesh-list
65254110|NCT05050500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65254111|NCT05050500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254112|NCT05050500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65254113|NCT05050500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254114|NCT02232737|Nicotine|nicotine|mesh-list
65254115|NCT02232737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65254116|NCT02232737|Autonomic Agents|autonomic agents|mesh-ancestor
65254142|NCT00630929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65254143|NCT00630929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65254144|NCT00630929|Analgesics|analgesics|mesh-ancestor
65254145|NCT00630929|Sensory System Agents|sensory system agents|mesh-ancestor
65254146|NCT00630929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254147|NCT00630929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254148|NCT00630929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65254149|NCT00630929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65254150|NCT00630929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65254151|NCT00630929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254152|NCT00630929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254153|NCT00630929|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65254154|NCT04204928|Pralsetinib|pralsetinib|mesh-list
65254155|NCT04204928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254156|NCT02834546|Sorafenib|sorafenib|mesh-list
65254157|NCT02834546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254158|NCT02834546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65254159|NCT02834546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254160|NCT02834546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254161|NCT00948857|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65254162|NCT00948857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65254163|NCT00948857|Immunologic Factors|immunologic factors|mesh-ancestor
65254164|NCT00948857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254165|NCT04227912|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65254192|NCT02854787|Adrenergic Agents|adrenergic agents|mesh-ancestor
65254193|NCT02854787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65254194|NCT02854787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254195|NCT02854787|Protective Agents|protective agents|mesh-ancestor
65254196|NCT02778828|Linezolid|linezolid|mesh-list
65254197|NCT02778828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65254198|NCT02778828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65254199|NCT02778828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65254200|NCT02778828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254201|NCT02778828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254202|NCT05206110|Ketorolac|ketorolac|mesh-list
65254203|NCT05206110|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65254204|NCT05206110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65254205|NCT05206110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65254206|NCT05206110|Analgesics|analgesics|mesh-ancestor
65254207|NCT05206110|Sensory System Agents|sensory system agents|mesh-ancestor
65254208|NCT05206110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254209|NCT05206110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254210|NCT05206110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65254211|NCT05206110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65341638|NCT00712686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65341639|NCT00712686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65341640|NCT00712686|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65341641|NCT00712686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65341642|NCT00712686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65341643|NCT00712686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341644|NCT00712686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65341645|NCT00712686|Serotonin Agents|serotonin agents|mesh-ancestor
64723668|NCT00728845|Growth Substances|growth substances|mesh-ancestor
65254212|NCT05206110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65254213|NCT05206110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254214|NCT05206110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254239|NCT02836184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65254241|NCT02836184|Vitamin B Complex|vitamin b complex|mesh-ancestor
65004501|NCT00473980|Gout Suppressants|gout suppressants|mesh-ancestor
65254245|NCT02836184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65254246|NCT04824144|Dexmedetomidine|dexmedetomidine|mesh-list
65254247|NCT04824144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65254248|NCT04824144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65254249|NCT04824144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254250|NCT04824144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65254251|NCT04824144|Analgesics|analgesics|mesh-ancestor
65254252|NCT04824144|Sensory System Agents|sensory system agents|mesh-ancestor
65254253|NCT04824144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254254|NCT04824144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65254255|NCT04824144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65254256|NCT04824144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65254257|NCT04824144|Adrenergic Agents|adrenergic agents|mesh-ancestor
65254258|NCT04824144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65254259|NCT04824144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254260|NCT02775474|Fentanyl|fentanyl|mesh-list
65254261|NCT02775474|Methadone|methadone|mesh-list
65254262|NCT02775474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65254263|NCT02775474|Narcotics|narcotics|mesh-ancestor
65254264|NCT02775474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65254265|NCT02775474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254266|NCT02775474|Analgesics|analgesics|mesh-ancestor
65254297|NCT02836028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65254298|NCT02836028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254302|NCT01778946|Nicotine|nicotine|mesh-list
65254303|NCT01778946|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65254304|NCT01778946|Autonomic Agents|autonomic agents|mesh-ancestor
65254305|NCT01778946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254306|NCT01778946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254307|NCT01778946|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65254308|NCT01778946|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65254309|NCT01778946|Cholinergic Agents|cholinergic agents|mesh-ancestor
65254310|NCT01778946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65254311|NCT01778946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254312|NCT04227210|Vaccines|vaccines|mesh-list
65254343|NCT04247984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65254344|NCT04247984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65254345|NCT04247984|Growth Substances|growth substances|mesh-ancestor
65254346|NCT04247984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254347|NCT04247984|Growth Inhibitors|growth inhibitors|mesh-ancestor
65254348|NCT04247984|Antimetabolites|antimetabolites|mesh-ancestor
65254349|NCT04247984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254350|NCT04247984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65254351|NCT04247984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65254352|NCT04247984|Immunologic Factors|immunologic factors|mesh-ancestor
65254353|NCT04247984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65254354|NCT04247984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65254355|NCT04247984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254356|NCT00948389|Dasatinib|dasatinib|mesh-list
65341646|NCT00712686|Antidepressive Agents|antidepressive agents|mesh-ancestor
65341647|NCT00712686|Dopamine Agonists|dopamine agonists|mesh-ancestor
65341648|NCT00712686|Dopamine Agents|dopamine agents|mesh-ancestor
65341649|NCT00712686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65341650|NCT00712686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65254357|NCT00948389|Lomustine|lomustine|mesh-list
65254358|NCT00948389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254359|NCT00948389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65254360|NCT00948389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929652|NCT04258410|Quercetin|quercetin|mesh-list
65254396|NCT04910178|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65254430|NCT01880567|Antibodies|antibodies|mesh-list
65254431|NCT01880567|Immunoglobulins|immunoglobulins|mesh-list
65254432|NCT01880567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65254433|NCT01880567|Immunologic Factors|immunologic factors|mesh-ancestor
65254434|NCT01880567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254435|NCT01880567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254436|NCT01880567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65254437|NCT02776722|Tagatose|tagatose|mesh-list
65254438|NCT02776722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65254439|NCT02776722|Chelating Agents|chelating agents|mesh-ancestor
65254440|NCT02776722|Sequestering Agents|sequestering agents|mesh-ancestor
65254466|NCT02772744|Antimetabolites|antimetabolites|mesh-ancestor
65254467|NCT02772744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004727|NCT00475696|Dopamine Agents|dopamine agents|mesh-ancestor
65254468|NCT02772744|Antiviral Agents|antiviral agents|mesh-ancestor
65254469|NCT02772744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65254471|NCT02774382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65254472|NCT02774382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65254473|NCT02774460|Amlodipine|amlodipine|mesh-list
65254474|NCT02774460|Candesartan|candesartan|mesh-list
65254475|NCT02774460|Candesartan cilexetil|candesartan cilexetil|mesh-list
65254476|NCT02774460|Lisinopril|lisinopril|mesh-list
65254477|NCT02774460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65254478|NCT02774460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65254479|NCT02774460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65254480|NCT02774460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254481|NCT02774460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65254482|NCT02774460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254483|NCT02774460|Vasodilator Agents|vasodilator agents|mesh-ancestor
65254484|NCT02774460|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65254485|NCT02774460|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65254486|NCT02774460|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65254487|NCT02774460|Protease Inhibitors|protease inhibitors|mesh-ancestor
65254488|NCT02774460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929774|NCT04733781|Mydriatics|mydriatics|mesh-ancestor
65254511|NCT02767752|Gemcitabine|gemcitabine|mesh-list
65254512|NCT02767752|Capecitabine|capecitabine|mesh-list
65254513|NCT02767752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65254514|NCT02767752|Antimetabolites|antimetabolites|mesh-ancestor
65254515|NCT02767752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254516|NCT02767752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254517|NCT02767752|Antiviral Agents|antiviral agents|mesh-ancestor
65254518|NCT02767752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65254519|NCT02767752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254520|NCT02767752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65254521|NCT02767752|Immunologic Factors|immunologic factors|mesh-ancestor
65254522|NCT02767752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254523|NCT00885625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65254524|NCT00885625|Immunologic Factors|immunologic factors|mesh-ancestor
65254525|NCT00885625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254526|NCT02835404|Nedaplatin|nedaplatin|mesh-list
65254527|NCT02835404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254528|NCT00885781|SMOFlipid|smoflipid|mesh-list
65254529|NCT00885781|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65254530|NCT00885781|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65254531|NCT00885781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65254532|NCT02767674|Gemcitabine|gemcitabine|mesh-list
65254533|NCT02767674|Prednisone|prednisone|mesh-list
65254534|NCT02767674|Cyclophosphamide|cyclophosphamide|mesh-list
65254535|NCT02767674|Rituximab|rituximab|mesh-list
65254536|NCT02767674|Oxaliplatin|oxaliplatin|mesh-list
65254537|NCT02767674|Epirubicin|epirubicin|mesh-list
65341651|NCT00712686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65341652|NCT00712686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65341653|NCT00712686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65341654|NCT00712686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65341655|NCT04041856|Povidone-Iodine|povidone-iodine|mesh-list
65341656|NCT04041856|Povidone|povidone|mesh-list
65341657|NCT04041856|Plasma Substitutes|plasma substitutes|mesh-ancestor
65341658|NCT04041856|Blood Substitutes|blood substitutes|mesh-ancestor
65341659|NCT04041856|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65341660|NCT04041856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65341661|NCT00856960|Losartan|losartan|mesh-list
65341662|NCT00856960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65254538|NCT02767674|Vindesine|vindesine|mesh-list
65254539|NCT02767674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65254540|NCT02767674|Immunologic Factors|immunologic factors|mesh-ancestor
65254541|NCT02767674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254542|NCT02767674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65254563|NCT02767674|Tubulin Modulators|tubulin modulators|mesh-ancestor
65254564|NCT02767674|Antimitotic Agents|antimitotic agents|mesh-ancestor
65254565|NCT02767674|Mitosis Modulators|mitosis modulators|mesh-ancestor
65254566|NCT02833688|Dexmedetomidine|dexmedetomidine|mesh-list
65254567|NCT02833688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65254568|NCT02833688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65254569|NCT02833688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254570|NCT02833688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65254571|NCT02833688|Analgesics|analgesics|mesh-ancestor
65254572|NCT02833688|Sensory System Agents|sensory system agents|mesh-ancestor
65254573|NCT02833688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254574|NCT02833688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65254575|NCT02833688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65254576|NCT02833688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65254577|NCT02833688|Adrenergic Agents|adrenergic agents|mesh-ancestor
65254578|NCT02833688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65254579|NCT02833688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254580|NCT00947531|Cerebrolysin|cerebrolysin|mesh-list
65254581|NCT00947531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65254582|NCT00947531|Protective Agents|protective agents|mesh-ancestor
65254583|NCT00947531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254584|NCT00947531|Nootropic Agents|nootropic agents|mesh-ancestor
65254585|NCT00612313|Fluoxetine|fluoxetine|mesh-list
65254586|NCT00612313|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65254587|NCT00612313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65254588|NCT00612313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65254589|NCT00612313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254590|NCT00612313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65254591|NCT00612313|Serotonin Agents|serotonin agents|mesh-ancestor
65254592|NCT00612313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254593|NCT00612313|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65254629|NCT02856503|Vitamins|vitamins|mesh-ancestor
65254630|NCT02856503|Micronutrients|micronutrients|mesh-ancestor
65254631|NCT02856503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254632|NCT02856503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65254633|NCT02856503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65254667|NCT04783194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254668|NCT04783194|Anesthetics, Local|anesthetics, local|mesh-ancestor
65254669|NCT04783194|Anesthetics|anesthetics|mesh-ancestor
65254670|NCT04783194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65254671|NCT04783194|Sensory System Agents|sensory system agents|mesh-ancestor
65254672|NCT02854241|Liver Extracts|liver extracts|mesh-list
65254673|NCT02854241|Hematinics|hematinics|mesh-ancestor
65254674|NCT02835170|Immunoglobulins|immunoglobulins|mesh-list
65254675|NCT02835170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65254677|NCT02835170|Immunologic Factors|immunologic factors|mesh-ancestor
65004957|NCT03277066|Diclofenac|diclofenac|mesh-list
65341663|NCT00856960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65341664|NCT00856960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65341665|NCT00856960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65341666|NCT00856960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341667|NCT00712764|Adenosine|adenosine|mesh-list
65341668|NCT00712764|Analgesics|analgesics|mesh-ancestor
65341669|NCT00712764|Sensory System Agents|sensory system agents|mesh-ancestor
65341670|NCT00712764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65341671|NCT00712764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341672|NCT00712764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65341673|NCT00712764|Vasodilator Agents|vasodilator agents|mesh-ancestor
65341674|NCT00712764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65341675|NCT00712764|Purinergic Agonists|purinergic agonists|mesh-ancestor
65341676|NCT00712764|Purinergic Agents|purinergic agents|mesh-ancestor
65341677|NCT00712764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65341678|NCT00712764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341679|NCT00848458|Azelaic acid|azelaic acid|mesh-list
65254693|NCT00946985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65254694|NCT00611923|Flutamide|flutamide|mesh-list
65254695|NCT00611923|Androgen Antagonists|androgen antagonists|mesh-ancestor
65254696|NCT00611923|Hormone Antagonists|hormone antagonists|mesh-ancestor
65254697|NCT00611923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65254698|NCT00611923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254699|NCT00611923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65254700|NCT00611923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254701|NCT04246502|Capecitabine|capecitabine|mesh-list
65254702|NCT04246502|Trastuzumab|trastuzumab|mesh-list
65254703|NCT04246502|Pertuzumab|pertuzumab|mesh-list
65254704|NCT04246502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65254705|NCT04246502|Antimetabolites|antimetabolites|mesh-ancestor
65254706|NCT04246502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254707|NCT04246502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254708|NCT04246502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65254709|NCT02767362|Atorvastatin|atorvastatin|mesh-list
65254710|NCT02767362|Ezetimibe|ezetimibe|mesh-list
65254711|NCT02767362|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65254712|NCT02767362|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65254713|NCT02767362|Antimetabolites|antimetabolites|mesh-ancestor
65254714|NCT02767362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254715|NCT02767362|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65254716|NCT02767362|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65254717|NCT02767362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254718|NCT00609973|Ciprofloxacin|ciprofloxacin|mesh-list
65254719|NCT00609973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65254720|NCT00609973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65254721|NCT00609973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65254722|NCT00609973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65254723|NCT00609973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254724|NCT00609973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254725|NCT00609973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254726|NCT00609973|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65254727|NCT00609973|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65254728|NCT02541643|Elotuzumab|elotuzumab|mesh-list
65254729|NCT02541643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254730|NCT02696694|Progesterone|progesterone|mesh-list
65341680|NCT00848458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341681|NCT00848458|Dermatologic Agents|dermatologic agents|mesh-ancestor
65341682|NCT00578786|Ambrisentan|ambrisentan|mesh-list
65341683|NCT00578786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65341684|NCT00424255|Lapatinib|lapatinib|mesh-list
65341685|NCT00424255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341686|NCT00424255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65341687|NCT00424255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341688|NCT00424255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341689|NCT02574156|Insulin|insulin|mesh-list
65341690|NCT02574156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65341691|NCT02574156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341692|NCT00848692|Rituximab|rituximab|mesh-list
65341693|NCT00848692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65341694|NCT00848692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341695|NCT00848692|Immunologic Factors|immunologic factors|mesh-ancestor
65341696|NCT00848692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341697|NCT00848692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65341698|NCT00848770|Norepinephrine|norepinephrine|mesh-list
65341699|NCT00848770|Esmolol|esmolol|mesh-list
65341700|NCT00848770|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65341701|NCT00848770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65341702|NCT00848770|Adrenergic Agents|adrenergic agents|mesh-ancestor
65341703|NCT00848770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65254731|NCT02696694|Progestins|progestins|mesh-ancestor
65254732|NCT02696694|Hormones|hormones|mesh-ancestor
65254733|NCT02696694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65254734|NCT02696694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254735|NCT04038073|Antibodies|antibodies|mesh-list
65254756|NCT00633386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65254757|NCT00633386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65254758|NCT00633386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254759|NCT00633386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254760|NCT02771418|Anesthetics|anesthetics|mesh-list
65254761|NCT02771418|Propofol|propofol|mesh-list
65254762|NCT02771418|Sevoflurane|sevoflurane|mesh-list
65254763|NCT02771418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65254764|NCT02771418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254765|NCT02771418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65254766|NCT02771418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65254767|NCT02771418|Anesthetics, General|anesthetics, general|mesh-ancestor
65254768|NCT02771418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65254769|NCT02771418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65254770|NCT00888901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65254771|NCT00888901|Methylprednisolone|methylprednisolone|mesh-list
65254772|NCT00888901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65254773|NCT00888901|Prednisolone|prednisolone|mesh-list
65254774|NCT00888901|Prednisolone acetate|prednisolone acetate|mesh-list
65254775|NCT00888901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65254776|NCT00888901|Prednisolone phosphate|prednisolone phosphate|mesh-list
65254777|NCT00888901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65254778|NCT00888901|Antiemetics|antiemetics|mesh-ancestor
65254779|NCT00888901|Autonomic Agents|autonomic agents|mesh-ancestor
65341704|NCT00848770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341705|NCT00848770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341706|NCT00848770|Sympathomimetics|sympathomimetics|mesh-ancestor
65341707|NCT00848770|Autonomic Agents|autonomic agents|mesh-ancestor
65341708|NCT00848770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254780|NCT00888901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254781|NCT00888901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254782|NCT00888901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65254783|NCT00888901|Glucocorticoids|glucocorticoids|mesh-ancestor
65254784|NCT00888901|Hormones|hormones|mesh-ancestor
65254785|NCT00888901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65254786|NCT00888901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65254787|NCT00888901|Protective Agents|protective agents|mesh-ancestor
65254788|NCT00888901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65254789|NCT00888901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254790|NCT00803049|Teriflunomide|teriflunomide|mesh-list
65254791|NCT00803049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65254821|NCT00890084|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
65254823|NCT00890084|Diuretics|diuretics|mesh-ancestor
65254824|NCT00890084|Natriuretic Agents|natriuretic agents|mesh-ancestor
65254825|NCT00890084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254826|NCT00890084|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65254827|NCT00890084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65254828|NCT00890084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254829|NCT00890084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65254830|NCT00890084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65254831|NCT00884845|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65254832|NCT00884845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254833|NCT00884845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65254834|NCT00884845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254835|NCT00884845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254836|NCT02773602|Dexamethasone|dexamethasone|mesh-list
65254837|NCT02773602|Clonidine|clonidine|mesh-list
65254869|NCT02770950|Tocolytic Agents|tocolytic agents|mesh-ancestor
65254870|NCT02770950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65254871|NCT02770950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65254872|NCT02770950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254873|NCT02770950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254874|NCT00889057|Sorafenib|sorafenib|mesh-list
65254875|NCT00889057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254876|NCT00889057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65254877|NCT00889057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254878|NCT00889057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254879|NCT05684289|Sildenafil Citrate|sildenafil citrate|mesh-list
65254909|NCT00889135|Droxidopa|droxidopa|mesh-list
65254910|NCT00889135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65254911|NCT00889135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65254912|NCT00889213|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65254913|NCT00889213|Hemostatics|hemostatics|mesh-ancestor
65254914|NCT00889213|Coagulants|coagulants|mesh-ancestor
65254915|NCT00382200|Decitabine|decitabine|mesh-list
65254916|NCT00382200|Tretinoin|tretinoin|mesh-list
65254917|NCT00382200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65254918|NCT00382200|Antimetabolites|antimetabolites|mesh-ancestor
65254919|NCT00382200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254920|NCT00382200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254921|NCT00382200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254922|NCT00382200|Keratolytic Agents|keratolytic agents|mesh-ancestor
65254923|NCT00382200|Dermatologic Agents|dermatologic agents|mesh-ancestor
65254924|NCT02696928|Lumefantrine|lumefantrine|mesh-list
65254955|NCT02766192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65254956|NCT02766192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65254957|NCT02766192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65254958|NCT02766192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254960|NCT05278897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65254961|NCT05278897|Immunologic Factors|immunologic factors|mesh-ancestor
65254962|NCT05278897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254963|NCT05278897|Viscosupplements|viscosupplements|mesh-ancestor
65341709|NCT00848770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65341710|NCT00848770|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65341711|NCT00848770|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65341712|NCT00848770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65341713|NCT00717704|Dasatinib|dasatinib|mesh-list
65341714|NCT00717704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254964|NCT05278897|Protective Agents|protective agents|mesh-ancestor
65254965|NCT00889525|Cabergoline|cabergoline|mesh-list
65254966|NCT00889525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65254967|NCT00889525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65254968|NCT00889525|Dopamine Agonists|dopamine agonists|mesh-ancestor
65254969|NCT00889525|Dopamine Agents|dopamine agents|mesh-ancestor
65254998|NCT02766348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65254999|NCT02766348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255000|NCT02766348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65255001|NCT02766348|Immunologic Factors|immunologic factors|mesh-ancestor
65255002|NCT02766348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255003|NCT00608569|Ritonavir|ritonavir|mesh-list
65255004|NCT00608569|Lopinavir|lopinavir|mesh-list
65255005|NCT00608569|Tenofovir|tenofovir|mesh-list
65255006|NCT00608569|Zidovudine|zidovudine|mesh-list
65255007|NCT00608569|Emtricitabine|emtricitabine|mesh-list
65255008|NCT00608569|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65255009|NCT00608569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65255010|NCT00608569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65255011|NCT00608569|Protease Inhibitors|protease inhibitors|mesh-ancestor
65255012|NCT00608569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255013|NCT00608569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255014|NCT00608569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65255046|NCT00889837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255048|NCT00889837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65255049|NCT00889837|Dopamine Agents|dopamine agents|mesh-ancestor
65255050|NCT00889837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65255051|NCT00889837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255052|NCT02770404|Nafithromycin|nafithromycin|mesh-list
65255053|NCT02770404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65255054|NCT02770404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65255055|NCT02770404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65255056|NCT02770404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255057|NCT02770404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255088|NCT00892801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65255089|NCT00892801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65255090|NCT00892801|Immunologic Factors|immunologic factors|mesh-ancestor
65255091|NCT00892801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255093|NCT04222842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65255094|NCT04222842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255095|NCT04222842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255096|NCT00633542|Interferons|interferons|mesh-list
65255129|NCT00610675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65255130|NCT00610675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65255131|NCT00610675|Serotonin Agents|serotonin agents|mesh-ancestor
65255132|NCT00610675|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65255133|NCT02828228|Vitamin D|vitamin d|mesh-list
65255134|NCT02828228|Cholecalciferol|cholecalciferol|mesh-list
65255135|NCT02828228|Vitamins|vitamins|mesh-ancestor
65255136|NCT02828228|Micronutrients|micronutrients|mesh-ancestor
65255137|NCT02828228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255138|NCT02828228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64930414|NCT05573958|Aspirin|aspirin|mesh-list
65255157|NCT00887029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255159|NCT00887029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65255160|NCT00887029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65255161|NCT00887029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65255162|NCT00635310|Liver Extracts|liver extracts|mesh-list
65255163|NCT00635310|Hematinics|hematinics|mesh-ancestor
65255164|NCT02762448|Asunaprevir|asunaprevir|mesh-list
65255165|NCT02762448|Protease Inhibitors|protease inhibitors|mesh-ancestor
65255166|NCT02762448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255167|NCT02762448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255168|NCT00573157|Mycophenolic Acid|mycophenolic acid|mesh-list
65341715|NCT00717704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65341716|NCT00717704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341717|NCT00717704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341718|NCT00620074|Voriconazole|voriconazole|mesh-list
65341719|NCT00620074|Anidulafungin|anidulafungin|mesh-list
65341720|NCT00620074|Antifungal Agents|antifungal agents|mesh-ancestor
65341721|NCT00620074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65341722|NCT00620074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65341723|NCT00620074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65341724|NCT00620074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341725|NCT00620074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331355|NCT05553392|Petrolatum|petrolatum|mesh-list
65255169|NCT00573157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65255170|NCT00573157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65255171|NCT00573157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65255172|NCT00573157|Antitubercular Agents|antitubercular agents|mesh-ancestor
65255173|NCT00573157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65255174|NCT00573157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65255175|NCT00573157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255176|NCT00573157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255177|NCT00890383|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65255178|NCT00890383|Plasma Substitutes|plasma substitutes|mesh-ancestor
65255179|NCT00890383|Blood Substitutes|blood substitutes|mesh-ancestor
65255180|NCT00887107|Sorafenib|sorafenib|mesh-list
65255181|NCT00887107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65255182|NCT00887107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65255183|NCT00887107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255184|NCT00887107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255185|NCT00802737|Ofatumumab|ofatumumab|mesh-list
65255186|NCT00802737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65255187|NCT02769390|Clonidine|clonidine|mesh-list
65255188|NCT02769390|Diazepam|diazepam|mesh-list
65255189|NCT02769390|Analgesics|analgesics|mesh-ancestor
65255190|NCT02769390|Sensory System Agents|sensory system agents|mesh-ancestor
65255191|NCT02769390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65255192|NCT02769390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255193|NCT02769390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65255194|NCT02769390|Sympatholytics|sympatholytics|mesh-ancestor
65255195|NCT02769390|Autonomic Agents|autonomic agents|mesh-ancestor
65255223|NCT00890539|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65255224|NCT00890539|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
65255225|NCT00890539|Respiratory System Agents|respiratory system agents|mesh-ancestor
65255226|NCT00890539|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65255227|NCT00890539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65255228|NCT00890539|Cholinergic Agents|cholinergic agents|mesh-ancestor
65255229|NCT00890539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65255230|NCT00890539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255232|NCT00887263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65255233|NCT00887263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65255234|NCT00887263|Autonomic Agents|autonomic agents|mesh-ancestor
65255235|NCT00887263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65255236|NCT00887263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255237|NCT00887263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65255238|NCT00887263|Respiratory System Agents|respiratory system agents|mesh-ancestor
65255239|NCT00887263|Glucocorticoids|glucocorticoids|mesh-ancestor
65255240|NCT00887263|Hormones|hormones|mesh-ancestor
65255241|NCT00887263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65255242|NCT00415233|Hormones|hormones|mesh-list
65255243|NCT00415233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64930516|NCT00052351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65255265|NCT02765022|beta-Endorphin|beta-endorphin|mesh-list
65255266|NCT02765022|Hormones|hormones|mesh-ancestor
65341726|NCT00620074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65341727|NCT00620074|Hormone Antagonists|hormone antagonists|mesh-ancestor
65341728|NCT00620074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65341729|NCT00620074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341730|NCT00620074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65341731|NCT02571296|Progesterone|progesterone|mesh-list
65341732|NCT02571296|Progestins|progestins|mesh-ancestor
65341733|NCT02571296|Hormones|hormones|mesh-ancestor
65341734|NCT02571296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65341735|NCT02571296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341736|NCT00857038|Doxycycline|doxycycline|mesh-list
65341737|NCT00857038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65341738|NCT00857038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65255267|NCT02765022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65255268|NCT02765022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255269|NCT02765022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65255270|NCT02765022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255271|NCT04224636|Bevacizumab|bevacizumab|mesh-list
65255272|NCT04224636|Atezolizumab|atezolizumab|mesh-list
65255273|NCT04224636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65255274|NCT04224636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65255275|NCT04224636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65255276|NCT04224636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65255277|NCT04224636|Growth Substances|growth substances|mesh-ancestor
65255278|NCT04224636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255279|NCT04224636|Growth Inhibitors|growth inhibitors|mesh-ancestor
65255280|NCT00607789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65255281|NCT00607789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65255282|NCT00607789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65255283|NCT00607789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65255284|NCT00607789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255285|NCT00607789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65255286|NCT00607789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255287|NCT00607789|Analgesics|analgesics|mesh-ancestor
65255288|NCT00607789|Sensory System Agents|sensory system agents|mesh-ancestor
65255289|NCT00607789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65255290|NCT00607789|Antidepressive Agents|antidepressive agents|mesh-ancestor
65255291|NCT00607789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65255292|NCT00607789|Dopamine Agents|dopamine agents|mesh-ancestor
65255293|NCT02761512|Lansoprazole|lansoprazole|mesh-list
65255294|NCT02761512|Dexlansoprazole|dexlansoprazole|mesh-list
64930563|NCT00052585|Leucovorin|leucovorin|mesh-list
65255327|NCT00887822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65255329|NCT00887822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255330|NCT04222920|Adalimumab|adalimumab|mesh-list
65255331|NCT04222920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65255332|NCT04222920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65255333|NCT04115163|Gemcitabine|gemcitabine|mesh-list
65255334|NCT04115163|Paclitaxel|paclitaxel|mesh-list
65255335|NCT04115163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64930623|NCT00053092|Rituximab|rituximab|mesh-list
65255352|NCT02542111|Bortezomib|bortezomib|mesh-list
65255353|NCT02542111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65255354|NCT02542111|Antiemetics|antiemetics|mesh-ancestor
65255355|NCT02542111|Autonomic Agents|autonomic agents|mesh-ancestor
65255356|NCT02542111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65255357|NCT02542111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255358|NCT02542111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65255359|NCT02542111|Glucocorticoids|glucocorticoids|mesh-ancestor
65255360|NCT02542111|Hormones|hormones|mesh-ancestor
65341739|NCT00857038|Antimalarials|antimalarials|mesh-ancestor
65341740|NCT00857038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65341741|NCT00857038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65341742|NCT00857116|Albendazole|albendazole|mesh-list
65341743|NCT00857116|Anthelmintics|anthelmintics|mesh-ancestor
65341744|NCT00857116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65341745|NCT00857116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65341746|NCT00857116|Anticestodal Agents|anticestodal agents|mesh-ancestor
65341747|NCT00857116|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65341748|NCT00857116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65255361|NCT02542111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65255362|NCT02542111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65255363|NCT02542111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65255364|NCT02542111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65255365|NCT02542111|Antimetabolites|antimetabolites|mesh-ancestor
65255366|NCT02542111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255367|NCT02542111|Antiviral Agents|antiviral agents|mesh-ancestor
65255368|NCT02542111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65255369|NCT02542111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255370|NCT02542111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65255371|NCT02542111|Immunologic Factors|immunologic factors|mesh-ancestor
65255372|NCT02768688|Dexmedetomidine|dexmedetomidine|mesh-list
65255373|NCT02768688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65255374|NCT02768688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65255375|NCT02768688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255376|NCT02768688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65255377|NCT02768688|Analgesics|analgesics|mesh-ancestor
65255378|NCT02768688|Sensory System Agents|sensory system agents|mesh-ancestor
65255379|NCT02768688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65255380|NCT02768688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65255381|NCT02768688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65255382|NCT02768688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65255383|NCT02768688|Adrenergic Agents|adrenergic agents|mesh-ancestor
65255384|NCT02768688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65255385|NCT02768688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255386|NCT05662527|Pembrolizumab|pembrolizumab|mesh-list
65255387|NCT05662527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65255388|NCT05662527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65255389|NCT00891163|Lidocaine|lidocaine|mesh-list
65255390|NCT00891163|Tetracaine|tetracaine|mesh-list
65255391|NCT00891163|Anesthetics, Local|anesthetics, local|mesh-ancestor
65255392|NCT00891163|Anesthetics|anesthetics|mesh-ancestor
65255393|NCT00891163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65255394|NCT00891163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255419|NCT00951665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65255420|NCT00951665|Tubulin Modulators|tubulin modulators|mesh-ancestor
65255421|NCT00951665|Antimitotic Agents|antimitotic agents|mesh-ancestor
65255422|NCT00951665|Mitosis Modulators|mitosis modulators|mesh-ancestor
65255423|NCT00951665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255424|NCT00951665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65255425|NCT02769078|Warfarin|warfarin|mesh-list
65255426|NCT02769078|Rivaroxaban|rivaroxaban|mesh-list
65255427|NCT02769078|Dabigatran|dabigatran|mesh-list
65255428|NCT02769078|Apixaban|apixaban|mesh-list
65255429|NCT02769078|Anticoagulants|anticoagulants|mesh-ancestor
65255430|NCT02769078|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65255431|NCT02769078|Antithrombins|antithrombins|mesh-ancestor
65255432|NCT02769078|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65255433|NCT02769078|Protease Inhibitors|protease inhibitors|mesh-ancestor
65255434|NCT02769078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255435|NCT02769078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255436|NCT04036201|Bupivacaine|bupivacaine|mesh-list
65255437|NCT04036201|Hyaluronic Acid|hyaluronic acid|mesh-list
65255438|NCT04036201|Anesthetics, Local|anesthetics, local|mesh-ancestor
65255439|NCT04036201|Anesthetics|anesthetics|mesh-ancestor
65255440|NCT04036201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65341749|NCT00857116|Tubulin Modulators|tubulin modulators|mesh-ancestor
65341750|NCT00857116|Antimitotic Agents|antimitotic agents|mesh-ancestor
65341751|NCT00857116|Mitosis Modulators|mitosis modulators|mesh-ancestor
64499096|NCT01390246|Bupropion|bupropion|mesh-list
65255441|NCT04036201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255442|NCT04036201|Sensory System Agents|sensory system agents|mesh-ancestor
65255443|NCT04036201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65255444|NCT04036201|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64930716|NCT00053638|Lamivudine|lamivudine|mesh-list
65255474|NCT02764710|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65255475|NCT02764710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65255476|NCT02764710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65255477|NCT02764710|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65255478|NCT02764710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255479|NCT02764710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255480|NCT00923169|Mitogens|mitogens|mesh-list
65255481|NCT00923169|Mitosis Modulators|mitosis modulators|mesh-ancestor
65255482|NCT00923169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255483|NCT02541019|Ondansetron|ondansetron|mesh-list
65255484|NCT02541019|Palonosetron|palonosetron|mesh-list
65255485|NCT02541019|Antiemetics|antiemetics|mesh-ancestor
65255486|NCT02541019|Autonomic Agents|autonomic agents|mesh-ancestor
65255487|NCT02541019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65255488|NCT02541019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255515|NCT05658003|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65005778|NCT00120419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65255516|NCT05658003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255517|NCT01786265|Prednisone|prednisone|mesh-list
65255518|NCT01786265|Cortisone|cortisone|mesh-list
65255520|NCT01786265|Goserelin|goserelin|mesh-list
65255521|NCT01786265|Flutamide|flutamide|mesh-list
65255522|NCT01786265|Abiraterone Acetate|abiraterone acetate|mesh-list
65255523|NCT01786265|Bicalutamide|bicalutamide|mesh-list
65255524|NCT01786265|Nilutamide|nilutamide|mesh-list
65255525|NCT01786265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65255526|NCT01786265|Glucocorticoids|glucocorticoids|mesh-ancestor
65255527|NCT01786265|Hormones|hormones|mesh-ancestor
65255528|NCT01786265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65255529|NCT01786265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255530|NCT01786265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65255531|NCT01786265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65255532|NCT01786265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65255533|NCT01786265|Fertility Agents|fertility agents|mesh-ancestor
65255534|NCT01786265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65255535|NCT01786265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65255536|NCT01786265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304113|NCT03067688|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65255566|NCT02696460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65255567|NCT02696460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255568|NCT02696460|Sensory System Agents|sensory system agents|mesh-ancestor
65255569|NCT02696460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65255570|NCT02696460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65255571|NCT02696460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65255572|NCT02696460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65255573|NCT02696460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65255574|NCT02696460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255575|NCT02696460|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65255577|NCT00888043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65255578|NCT00888043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65255579|NCT00888043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65255580|NCT00888043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65255581|NCT00888043|Growth Substances|growth substances|mesh-ancestor
65255612|NCT00799617|Methyltestosterone|methyltestosterone|mesh-list
65255613|NCT00799617|Testosterone|testosterone|mesh-list
65255614|NCT00799617|Testosterone undecanoate|testosterone undecanoate|mesh-list
65255615|NCT00799617|Testosterone enanthate|testosterone enanthate|mesh-list
65255616|NCT00799617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65255617|NCT00799617|Androgens|androgens|mesh-ancestor
65255619|NCT00799617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65255620|NCT00799617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255621|NCT00799617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65341752|NCT00857116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341753|NCT00857116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341754|NCT00717782|Botulinum Toxins|botulinum toxins|mesh-list
65341755|NCT00717782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65341756|NCT00717782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65341757|NCT00717782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255622|NCT00799617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65255655|NCT04114149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255657|NCT04114149|Sensory System Agents|sensory system agents|mesh-ancestor
65255658|NCT04114149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65255659|NCT00891397|Pregabalin|pregabalin|mesh-list
65255660|NCT00891397|Analgesics|analgesics|mesh-ancestor
65255661|NCT00891397|Sensory System Agents|sensory system agents|mesh-ancestor
65255662|NCT00891397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65255663|NCT00891397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255664|NCT00891397|Anticonvulsants|anticonvulsants|mesh-ancestor
65255696|NCT04504734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65255697|NCT04504734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255698|NCT04504734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65255699|NCT04504734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65255700|NCT04504734|Antioxidants|antioxidants|mesh-ancestor
65255701|NCT04504734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255702|NCT04504734|Protective Agents|protective agents|mesh-ancestor
65255703|NCT00798759|Travoprost|travoprost|mesh-list
65255704|NCT00798759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65255705|NCT00798759|Latanoprost|latanoprost|mesh-list
65255706|NCT00798759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65255707|NCT00798759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65255708|NCT00891475|Interferons|interferons|mesh-list
65255709|NCT00891475|Interferon-alpha|interferon-alpha|mesh-list
65255742|NCT04113915|Dexamethasone|dexamethasone|mesh-list
65255743|NCT04113915|Cyclosporins|cyclosporins|mesh-list
65255744|NCT04113915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65255745|NCT04113915|Immunologic Factors|immunologic factors|mesh-ancestor
65255746|NCT04113915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255748|NCT04113915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65255749|NCT04113915|Antiemetics|antiemetics|mesh-ancestor
65255750|NCT04113915|Autonomic Agents|autonomic agents|mesh-ancestor
65255751|NCT04113915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65255752|NCT04113915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65255753|NCT04113915|Glucocorticoids|glucocorticoids|mesh-ancestor
65255784|NCT04688658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65255785|NCT04688658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65255786|NCT04688658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65255787|NCT04688658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255788|NCT04688658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65255789|NCT04688658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255791|NCT04113993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65255792|NCT04113993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65255793|NCT04113993|Hormone Antagonists|hormone antagonists|mesh-ancestor
65255794|NCT04113993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64931079|NCT00055549|Anticonvulsants|anticonvulsants|mesh-ancestor
65255826|NCT00798603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65255827|NCT00798603|Growth Substances|growth substances|mesh-ancestor
65255828|NCT00798603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255829|NCT00798603|Growth Inhibitors|growth inhibitors|mesh-ancestor
65255830|NCT00798603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255831|NCT00798603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255832|NCT00798603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65255833|NCT00798603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65255834|NCT04036981|Botulinum Toxins|botulinum toxins|mesh-list
65255835|NCT04036981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65255836|NCT04036981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65255837|NCT04036981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65255838|NCT04036981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65255871|NCT02760420|Amoxicillin|amoxicillin|mesh-list
65341758|NCT00717782|Cholinergic Agents|cholinergic agents|mesh-ancestor
65341759|NCT00717782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65341760|NCT00717782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341761|NCT04011410|Hydroxychloroquine|hydroxychloroquine|mesh-list
65341762|NCT04011410|Antimalarials|antimalarials|mesh-ancestor
65341763|NCT04011410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65341764|NCT04011410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65341765|NCT04011410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65341766|NCT04011410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255872|NCT02760420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65255873|NCT02760420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65255874|NCT04612530|Nivolumab|nivolumab|mesh-list
65255875|NCT04612530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65255876|NCT04612530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65255877|NCT04612530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65255878|NCT04612530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255879|NCT00945815|Cytarabine|cytarabine|mesh-list
65255880|NCT00945815|Clofarabine|clofarabine|mesh-list
65255898|NCT00798369|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65255899|NCT00798369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65255900|NCT00798369|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65255901|NCT00798369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65255902|NCT00798369|Glucocorticoids|glucocorticoids|mesh-ancestor
65255904|NCT00798369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65255905|NCT00798369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255906|NCT00798369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65255907|NCT00798369|Immunologic Factors|immunologic factors|mesh-ancestor
65255908|NCT00798369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255909|NCT00798369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255910|NCT00608959|Chlorhexidine|chlorhexidine|mesh-list
65255911|NCT00608959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65255912|NCT00608959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65255913|NCT00608959|Disinfectants|disinfectants|mesh-ancestor
65255914|NCT02760342|Metformin|metformin|mesh-list
65255915|NCT02760342|Peficitinib|peficitinib|mesh-list
65255916|NCT02760342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65255917|NCT02760342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255918|NCT02760342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255919|NCT02760342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255920|NCT02760342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65255921|NCT02760342|Immunologic Factors|immunologic factors|mesh-ancestor
65255922|NCT04221282|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
65255923|NCT04221282|Anticonvulsants|anticonvulsants|mesh-ancestor
65255924|NCT04221282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65255925|NCT04221282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65255926|NCT04221282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65255927|NCT04221282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255928|NCT00894283|Enoxaparin|enoxaparin|mesh-list
65255929|NCT00894283|PENTA|penta|mesh-list
65255930|NCT00894283|Fondaparinux|fondaparinux|mesh-list
65255931|NCT00894283|Anticoagulants|anticoagulants|mesh-ancestor
65255932|NCT00894283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65255933|NCT00894283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65255934|NCT00894283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255935|NCT00894283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65255936|NCT00894283|Antithrombins|antithrombins|mesh-ancestor
65255957|NCT04035889|Melatonin|melatonin|mesh-list
65255958|NCT04035889|Antioxidants|antioxidants|mesh-ancestor
65255959|NCT04035889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255960|NCT04035889|Protective Agents|protective agents|mesh-ancestor
65255961|NCT04035889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255962|NCT04035889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65255963|NCT00895687|Bortezomib|bortezomib|mesh-list
65255964|NCT00895687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65255965|NCT00895687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65255966|NCT00895687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65255967|NCT00895687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341767|NCT04011410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341768|NCT04011410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65341769|NCT00717938|Carboplatin|carboplatin|mesh-list
65341770|NCT00717938|Etoposide|etoposide|mesh-list
65341771|NCT00717938|Etoposide phosphate|etoposide phosphate|mesh-list
65341772|NCT00717938|Cisplatin|cisplatin|mesh-list
65341773|NCT00717938|Enoxaparin|enoxaparin|mesh-list
65341774|NCT00717938|Enoxaparin sodium|enoxaparin sodium|mesh-list
65341775|NCT00717938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341776|NCT00717938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65341777|NCT00717938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65341778|NCT00717938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65341779|NCT00717938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341780|NCT00717938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255968|NCT00895687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255970|NCT00798135|Antifungal Agents|antifungal agents|mesh-ancestor
65255971|NCT00798135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65255972|NCT00798135|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65255973|NCT00798135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65255974|NCT00798135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255975|NCT00798135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255976|NCT00798135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65255977|NCT00798135|Hormone Antagonists|hormone antagonists|mesh-ancestor
65255978|NCT00798135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65255979|NCT00798135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255980|NCT00798135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65255981|NCT02762838|Folic Acid|folic acid|mesh-list
65255982|NCT02762838|Methotrexate|methotrexate|mesh-list
65255983|NCT02762838|Infliximab|infliximab|mesh-list
65255984|NCT02762838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65255985|NCT02762838|Abortifacient Agents|abortifacient agents|mesh-ancestor
65255986|NCT02762838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65255987|NCT02762838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255988|NCT02762838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65255989|NCT02762838|Antimetabolites|antimetabolites|mesh-ancestor
64931260|NCT00056797|Interleukin-2|interleukin-2|mesh-list
65256014|NCT02753166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65256015|NCT02753166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256016|NCT02753088|Glatiramer Acetate|glatiramer acetate|mesh-list
65256017|NCT02753088|Mannitol|mannitol|mesh-list
65256018|NCT02753088|(T,G)-A-L|(t,g)-a-l|mesh-list
65256019|NCT02753088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65256020|NCT02753088|Diuretics|diuretics|mesh-ancestor
65256021|NCT02753088|Natriuretic Agents|natriuretic agents|mesh-ancestor
65256022|NCT02753088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256023|NCT02753088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65256024|NCT02753088|Immunologic Factors|immunologic factors|mesh-ancestor
65256025|NCT02753088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65256026|NCT02753088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65256027|NCT02757534|Domperidone|domperidone|mesh-list
65256028|NCT02757534|Antiemetics|antiemetics|mesh-ancestor
65256029|NCT02757534|Autonomic Agents|autonomic agents|mesh-ancestor
65256030|NCT02757534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65256031|NCT02757534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256032|NCT02757534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65256033|NCT02757534|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65256034|NCT02757534|Dopamine Agents|dopamine agents|mesh-ancestor
65256062|NCT02760030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256063|NCT02760030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65256064|NCT02760030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65256065|NCT02760030|Hormone Antagonists|hormone antagonists|mesh-ancestor
65341781|NCT00717938|Anticoagulants|anticoagulants|mesh-ancestor
65341782|NCT00717938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65341783|NCT00717938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65341784|NCT00857428|Oxymorphone|oxymorphone|mesh-list
65341785|NCT00857428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65341786|NCT00857428|Narcotics|narcotics|mesh-ancestor
65341787|NCT00857428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65341788|NCT00857428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341789|NCT00857428|Analgesics|analgesics|mesh-ancestor
65341790|NCT00857428|Sensory System Agents|sensory system agents|mesh-ancestor
65341791|NCT00857428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65341792|NCT00857428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65341793|NCT04018768|Acetaminophen|acetaminophen|mesh-list
65341794|NCT04018768|Ibuprofen|ibuprofen|mesh-list
65341795|NCT04018768|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65341796|NCT04018768|Oxycodone|oxycodone|mesh-list
65341797|NCT04018768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65256066|NCT02760030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65256067|NCT02760030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256068|NCT02760030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65256069|NCT02760030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256070|NCT02760030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256071|NCT02760030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65256072|NCT02757144|Esomeprazole|esomeprazole|mesh-list
65256073|NCT02757144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65256074|NCT02757144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65256075|NCT02757144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65256076|NCT02757144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256077|NCT02757144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256078|NCT04568616|Letrozole|letrozole|mesh-list
65256107|NCT05608395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256108|NCT04221906|Betamethasone|betamethasone|mesh-list
65256109|NCT04221906|Calcipotriene|calcipotriene|mesh-list
65256110|NCT04221906|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65256111|NCT04221906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65256112|NCT04221906|Glucocorticoids|glucocorticoids|mesh-ancestor
65006368|NCT00119145|Amodiaquine|amodiaquine|mesh-list
65256113|NCT04221906|Hormones|hormones|mesh-ancestor
65256114|NCT04221906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65256115|NCT04221906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256116|NCT04221906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65256117|NCT04221906|Respiratory System Agents|respiratory system agents|mesh-ancestor
65256118|NCT04221906|Dermatologic Agents|dermatologic agents|mesh-ancestor
65256119|NCT00945191|Paclitaxel|paclitaxel|mesh-list
65256120|NCT00945191|Carboplatin|carboplatin|mesh-list
65256121|NCT00945191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65256122|NCT00945191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931418|NCT00058084|Prednisone|prednisone|mesh-list
65256158|NCT00892489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65256159|NCT00892489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65256160|NCT00892489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64931449|NCT00058201|Leucovorin|leucovorin|mesh-list
65256193|NCT02752308|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65256194|NCT02752308|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65256195|NCT02752308|Autonomic Agents|autonomic agents|mesh-ancestor
65256196|NCT02752308|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65256197|NCT02752308|Respiratory System Agents|respiratory system agents|mesh-ancestor
65256198|NCT02752308|Mydriatics|mydriatics|mesh-ancestor
65256199|NCT02752308|Sympathomimetics|sympathomimetics|mesh-ancestor
65341798|NCT04018768|Analgesics|analgesics|mesh-ancestor
65341799|NCT04018768|Sensory System Agents|sensory system agents|mesh-ancestor
65341800|NCT04018768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65341801|NCT04018768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341802|NCT04018768|Antipyretics|antipyretics|mesh-ancestor
65341803|NCT04018768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65341804|NCT04018768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65341805|NCT04018768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65341806|NCT04018768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65341807|NCT04018768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341808|NCT04018768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341809|NCT04018768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65341810|NCT04018768|Narcotics|narcotics|mesh-ancestor
64723824|NCT00000223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65256200|NCT02752308|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65256201|NCT02752308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65256202|NCT02752308|Parasympatholytics|parasympatholytics|mesh-ancestor
64931490|NCT00058318|Immunologic Factors|immunologic factors|mesh-ancestor
65256226|NCT00894751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256228|NCT00896077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65256229|NCT00896077|Immunologic Factors|immunologic factors|mesh-ancestor
65256230|NCT00896077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256231|NCT00896077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65256232|NCT00896077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65256233|NCT00896077|Analgesics|analgesics|mesh-ancestor
65256234|NCT00896077|Sensory System Agents|sensory system agents|mesh-ancestor
65256235|NCT00896077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65256236|NCT00896077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65256237|NCT00896077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65256238|NCT00896077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65256239|NCT00792909|Vaccines|vaccines|mesh-list
65256240|NCT00792909|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65256241|NCT00792909|Immunologic Factors|immunologic factors|mesh-ancestor
65256242|NCT00792909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256243|NCT00896155|Tamoxifen|tamoxifen|mesh-list
65256244|NCT00896155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65256245|NCT00896155|Hormone Antagonists|hormone antagonists|mesh-ancestor
65256246|NCT00896155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65256247|NCT00896155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256248|NCT00896155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65256249|NCT00896155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256250|NCT00896155|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65256251|NCT00896155|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65256252|NCT00896155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65256286|NCT02751918|Tubulin Modulators|tubulin modulators|mesh-ancestor
65256287|NCT02751918|Antimitotic Agents|antimitotic agents|mesh-ancestor
65256288|NCT02751918|Mitosis Modulators|mitosis modulators|mesh-ancestor
65256289|NCT00901069|Cyclophosphamide|cyclophosphamide|mesh-list
65256290|NCT00901069|Rituximab|rituximab|mesh-list
65256291|NCT00901069|Vincristine|vincristine|mesh-list
65256292|NCT00901069|Azacitidine|azacitidine|mesh-list
65256293|NCT00901069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65256294|NCT00901069|Immunologic Factors|immunologic factors|mesh-ancestor
65256295|NCT00901069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256296|NCT00901069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65256297|NCT00901069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64931583|NCT00059722|Gefitinib|gefitinib|mesh-list
65256327|NCT00894829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65256328|NCT00894829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341811|NCT04018768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65341812|NCT03518060|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
65341813|NCT03518060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65341814|NCT03518060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65341815|NCT03518060|Antiviral Agents|antiviral agents|mesh-ancestor
65341816|NCT03518060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65341817|NCT00848848|Vaccines|vaccines|mesh-list
65341818|NCT00848848|Immunologic Factors|immunologic factors|mesh-ancestor
65341819|NCT00848848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341820|NCT02573922|Oxycodone|oxycodone|mesh-list
65341821|NCT02573922|Naloxone|naloxone|mesh-list
65341822|NCT02573922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65341823|NCT02573922|Narcotics|narcotics|mesh-ancestor
65341824|NCT02573922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65341825|NCT02573922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341826|NCT02573922|Analgesics|analgesics|mesh-ancestor
65341827|NCT02573922|Sensory System Agents|sensory system agents|mesh-ancestor
65341828|NCT02573922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65341829|NCT02573922|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65341830|NCT00852436|Pregabalin|pregabalin|mesh-list
65341831|NCT00852436|Analgesics|analgesics|mesh-ancestor
65341832|NCT00852436|Sensory System Agents|sensory system agents|mesh-ancestor
65341833|NCT00852436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65341834|NCT00852436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341835|NCT00852436|Anticonvulsants|anticonvulsants|mesh-ancestor
65341836|NCT00852436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65341837|NCT00852436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65341838|NCT00852436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256329|NCT04108845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65256330|NCT04108845|Immunologic Factors|immunologic factors|mesh-ancestor
65256331|NCT04108845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256332|NCT00606229|Aripiprazole|aripiprazole|mesh-list
65256333|NCT00606229|Antidepressive Agents|antidepressive agents|mesh-ancestor
65256334|NCT00606229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65256335|NCT00606229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65256336|NCT00606229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65256337|NCT00606229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65256338|NCT00606229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256339|NCT00606229|Dopamine Agonists|dopamine agonists|mesh-ancestor
65256340|NCT00606229|Dopamine Agents|dopamine agents|mesh-ancestor
65256341|NCT00606229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65256377|NCT00901147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256378|NCT00901147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256379|NCT04268537|Antibodies|antibodies|mesh-list
65256380|NCT04268537|Antibodies, Blocking|antibodies, blocking|mesh-list
65256381|NCT04268537|Immunologic Factors|immunologic factors|mesh-ancestor
65256382|NCT04268537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341839|NCT00852436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65341840|NCT00852436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65341841|NCT00852436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65341842|NCT00852436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65341843|NCT00852436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65341844|NCT00720512|Leucovorin|leucovorin|mesh-list
65341845|NCT00720512|Bevacizumab|bevacizumab|mesh-list
65341846|NCT00720512|Fluorouracil|fluorouracil|mesh-list
65341847|NCT00720512|Oxaliplatin|oxaliplatin|mesh-list
65341848|NCT00720512|Irinotecan|irinotecan|mesh-list
65341849|NCT00720512|Calcium|calcium|mesh-list
65341850|NCT00720512|Levoleucovorin|levoleucovorin|mesh-list
65341851|NCT00720512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65341852|NCT00720512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341853|NCT00720512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65341854|NCT00720512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65341855|NCT00720512|Growth Substances|growth substances|mesh-ancestor
65256383|NCT02756130|Carboplatin|carboplatin|mesh-list
65256384|NCT02756130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256418|NCT00631085|Vitamin E|vitamin e|mesh-list
65256419|NCT00631085|Tocotrienols|tocotrienols|mesh-list
65256420|NCT00631085|alpha-Tocopherol|alpha-tocopherol|mesh-list
65256421|NCT00631085|gamma-Tocopherol|gamma-tocopherol|mesh-list
65256422|NCT00631085|Antioxidants|antioxidants|mesh-ancestor
65256423|NCT00631085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256457|NCT02751528|Vaccines|vaccines|mesh-list
65256458|NCT02751528|Immunologic Factors|immunologic factors|mesh-ancestor
65256459|NCT02751528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256460|NCT00901537|Azacitidine|azacitidine|mesh-list
65256461|NCT00901537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256462|NCT00901537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65256463|NCT00901537|Antimetabolites|antimetabolites|mesh-ancestor
65256464|NCT00901537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256497|NCT00901615|Growth Substances|growth substances|mesh-ancestor
65256498|NCT00901615|Growth Inhibitors|growth inhibitors|mesh-ancestor
65256499|NCT00901615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256500|NCT00949325|Sirolimus|sirolimus|mesh-list
65256501|NCT00949325|Doxorubicin|doxorubicin|mesh-list
65256502|NCT00949325|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65256503|NCT00949325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65256504|NCT00949325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256505|NCT00949325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65256506|NCT00949325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65256507|NCT00949325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256538|NCT02758782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65256539|NCT02758782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65256540|NCT02758782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256541|NCT02758782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256542|NCT02758782|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65256543|NCT02758782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65256544|NCT02758782|Immunologic Factors|immunologic factors|mesh-ancestor
65256545|NCT04221672|Terlipressin|terlipressin|mesh-list
65256546|NCT04221672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65256547|NCT04221672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65256548|NCT00895297|Dasatinib|dasatinib|mesh-list
65256549|NCT00895297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256550|NCT00895297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64931843|NCT00061087|Bupropion|bupropion|mesh-list
65256583|NCT02540785|Glucocorticoids|glucocorticoids|mesh-ancestor
65256584|NCT02540785|Hormones|hormones|mesh-ancestor
65256585|NCT02540785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65341856|NCT00720512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341857|NCT00720512|Growth Inhibitors|growth inhibitors|mesh-ancestor
65091664|NCT01240941|Exemestane|exemestane|mesh-list
65341858|NCT00720512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65341859|NCT00720512|Antimetabolites|antimetabolites|mesh-ancestor
65256586|NCT02540785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65256587|NCT02540785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256588|NCT02540785|Protease Inhibitors|protease inhibitors|mesh-ancestor
65256589|NCT02540785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256590|NCT02540785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256591|NCT02540785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65256592|NCT02540785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65256593|NCT02540785|Renal Agents|renal agents|mesh-ancestor
65256594|NCT02540785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64931876|NCT00061360|Cyclosporine|cyclosporine|mesh-list
65256616|NCT04243278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65256617|NCT04243278|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65256618|NCT04243278|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65256619|NCT04243278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256620|NCT04243278|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65256621|NCT04243278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65256622|NCT04243278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256623|NCT04243278|Antipyretics|antipyretics|mesh-ancestor
65256624|NCT00915369|Paclitaxel|paclitaxel|mesh-list
65256625|NCT00915369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65256626|NCT00915369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256627|NCT00915369|Tubulin Modulators|tubulin modulators|mesh-ancestor
65256628|NCT00915369|Antimitotic Agents|antimitotic agents|mesh-ancestor
65256629|NCT00915369|Mitosis Modulators|mitosis modulators|mesh-ancestor
65256630|NCT00915369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256631|NCT00901849|Sirolimus|sirolimus|mesh-list
65256632|NCT00901849|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65256633|NCT00901849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65256634|NCT00901849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65256635|NCT00901849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65256636|NCT00901849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256637|NCT00901849|Antifungal Agents|antifungal agents|mesh-ancestor
65256638|NCT00901849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65256639|NCT00901849|Immunologic Factors|immunologic factors|mesh-ancestor
65006873|NCT00122486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256640|NCT00901849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256641|NCT00901849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65256642|NCT00901849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256643|NCT00901849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256644|NCT04243122|Aspirin|aspirin|mesh-list
65256645|NCT04243122|Apixaban|apixaban|mesh-list
65256646|NCT04243122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65256675|NCT04268927|Hormone Antagonists|hormone antagonists|mesh-ancestor
65256676|NCT04268927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65256677|NCT04268927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256678|NCT04268927|Hormones|hormones|mesh-ancestor
65256679|NCT05429580|Tranexamic Acid|tranexamic acid|mesh-list
65256680|NCT05429580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65256681|NCT05429580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65256682|NCT05429580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256683|NCT05429580|Hemostatics|hemostatics|mesh-ancestor
65256684|NCT05429580|Coagulants|coagulants|mesh-ancestor
65256685|NCT00790647|Bortezomib|bortezomib|mesh-list
65256686|NCT00790647|Melphalan|melphalan|mesh-list
65256687|NCT00790647|Immunologic Factors|immunologic factors|mesh-ancestor
65256688|NCT00790647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256689|NCT00790647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256716|NCT02754882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65256717|NCT02754882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65256718|NCT02754882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65256719|NCT02754882|Growth Substances|growth substances|mesh-ancestor
65256720|NCT02754882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256721|NCT02754882|Growth Inhibitors|growth inhibitors|mesh-ancestor
65256722|NCT00790569|Nicotine|nicotine|mesh-list
65256723|NCT00790569|Varenicline|varenicline|mesh-list
65341860|NCT00720512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341861|NCT00720512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65341862|NCT00720512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65341863|NCT00720512|Immunologic Factors|immunologic factors|mesh-ancestor
65341864|NCT00720512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65341865|NCT00720512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65341866|NCT00720512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341867|NCT00720512|Antidotes|antidotes|mesh-ancestor
65341868|NCT00720512|Protective Agents|protective agents|mesh-ancestor
65256724|NCT00790569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65256725|NCT00790569|Autonomic Agents|autonomic agents|mesh-ancestor
65256726|NCT00790569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65256727|NCT00790569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256728|NCT00790569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65256729|NCT00790569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65256730|NCT00790569|Cholinergic Agents|cholinergic agents|mesh-ancestor
65256731|NCT00790569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65256732|NCT00790569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256733|NCT00939029|Nicotine|nicotine|mesh-list
65256734|NCT00939029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65256735|NCT00939029|Autonomic Agents|autonomic agents|mesh-ancestor
65256736|NCT00939029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65256737|NCT00939029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256762|NCT02754960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256763|NCT02754960|Leprostatic Agents|leprostatic agents|mesh-ancestor
65256764|NCT02754960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65256765|NCT02754960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65256766|NCT02754960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65256767|NCT02754960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65256768|NCT02754960|Growth Substances|growth substances|mesh-ancestor
65256769|NCT02754960|Growth Inhibitors|growth inhibitors|mesh-ancestor
65256770|NCT02754960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256772|NCT00587847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65256773|NCT00587847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256774|NCT02540239|Simethicone|simethicone|mesh-list
65256775|NCT02540239|Antifoaming Agents|antifoaming agents|mesh-ancestor
65256776|NCT02540239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256777|NCT02540239|Emollients|emollients|mesh-ancestor
65256778|NCT02540239|Dermatologic Agents|dermatologic agents|mesh-ancestor
65256779|NCT02540395|Mycophenolic Acid|mycophenolic acid|mesh-list
65256780|NCT02540395|Prednisolone|prednisolone|mesh-list
65256781|NCT02540395|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65256782|NCT02540395|Methylprednisolone|methylprednisolone|mesh-list
65256783|NCT02540395|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65256784|NCT02540395|Prednisolone acetate|prednisolone acetate|mesh-list
65256785|NCT02540395|Tacrolimus|tacrolimus|mesh-list
65256786|NCT02540395|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65256787|NCT02540395|Prednisolone phosphate|prednisolone phosphate|mesh-list
65256788|NCT02540395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65256821|NCT04547166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256822|NCT04547166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65256823|NCT04547166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65256824|NCT04547166|Growth Substances|growth substances|mesh-ancestor
65256825|NCT04547166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256826|NCT04547166|Growth Inhibitors|growth inhibitors|mesh-ancestor
65256827|NCT00602693|Sirolimus|sirolimus|mesh-list
65256828|NCT00602693|Cyclophosphamide|cyclophosphamide|mesh-list
65256829|NCT00602693|Fludarabine|fludarabine|mesh-list
65256830|NCT00602693|Fludarabine phosphate|fludarabine phosphate|mesh-list
65007123|NCT00493402|Hormones|hormones|mesh-ancestor
65256864|NCT00902395|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65256865|NCT00902395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65256866|NCT00902395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256867|NCT00902395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65256868|NCT00902395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65256869|NCT00902395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65341869|NCT00720512|Vitamin B Complex|vitamin b complex|mesh-ancestor
65341870|NCT00720512|Vitamins|vitamins|mesh-ancestor
65341871|NCT00720512|Micronutrients|micronutrients|mesh-ancestor
65341872|NCT04069286|Amoxicillin|amoxicillin|mesh-list
65341873|NCT04069286|Omeprazole|omeprazole|mesh-list
65341874|NCT04069286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65341875|NCT04069286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65341876|NCT04069286|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65256870|NCT00902395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65256871|NCT00902395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65256902|NCT04104789|Anesthetics, Local|anesthetics, local|mesh-ancestor
65256903|NCT04104789|Anesthetics|anesthetics|mesh-ancestor
65256904|NCT04104789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65256905|NCT04104789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256906|NCT04104789|Sensory System Agents|sensory system agents|mesh-ancestor
65256907|NCT04104789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65256908|NCT04104789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65256909|NCT04104789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65256910|NCT04104789|Adrenergic Agents|adrenergic agents|mesh-ancestor
65256911|NCT04104789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65256912|NCT04104789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256913|NCT04104789|Sympathomimetics|sympathomimetics|mesh-ancestor
65256914|NCT04104789|Autonomic Agents|autonomic agents|mesh-ancestor
65256915|NCT04104789|Nasal Decongestants|nasal decongestants|mesh-ancestor
65256916|NCT04104789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65256917|NCT04104789|Respiratory System Agents|respiratory system agents|mesh-ancestor
65256944|NCT00906061|Antiviral Agents|antiviral agents|mesh-ancestor
65256945|NCT00906061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65256946|NCT00906061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256947|NCT00906061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65256948|NCT00906061|Immunologic Factors|immunologic factors|mesh-ancestor
65256949|NCT00906061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256950|NCT00906061|Tubulin Modulators|tubulin modulators|mesh-ancestor
65256951|NCT00906061|Antimitotic Agents|antimitotic agents|mesh-ancestor
65256952|NCT00906061|Mitosis Modulators|mitosis modulators|mesh-ancestor
65256954|NCT02602509|Pyrazinamide|pyrazinamide|mesh-list
65256955|NCT02602509|Celecoxib|celecoxib|mesh-list
65256956|NCT02602509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65256957|NCT02602509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65256958|NCT02602509|Analgesics|analgesics|mesh-ancestor
65256959|NCT02602509|Sensory System Agents|sensory system agents|mesh-ancestor
65256960|NCT02602509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65256961|NCT02602509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256962|NCT02602509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65256963|NCT02602509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65256964|NCT02602509|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64932243|NCT00063583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65256992|NCT04495452|Analgesics|analgesics|mesh-ancestor
65256993|NCT04495452|Sensory System Agents|sensory system agents|mesh-ancestor
65256994|NCT04495452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65256995|NCT04495452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65256996|NCT04495452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65256997|NCT04495452|Anesthetics, General|anesthetics, general|mesh-ancestor
65256998|NCT04495452|Anesthetics|anesthetics|mesh-ancestor
65256999|NCT00897871|Cyclophosphamide|cyclophosphamide|mesh-list
65257000|NCT00897871|Carboplatin|carboplatin|mesh-list
65257001|NCT00897871|Etoposide|etoposide|mesh-list
65257002|NCT00897871|Etoposide phosphate|etoposide phosphate|mesh-list
65257003|NCT00897871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65257004|NCT00897871|Immunologic Factors|immunologic factors|mesh-ancestor
65257005|NCT00897871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257006|NCT00897871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65257007|NCT00897871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65257008|NCT00897871|Alkylating Agents|alkylating agents|mesh-ancestor
65257009|NCT00897871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257040|NCT00906139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65257041|NCT00906139|Anesthetics, General|anesthetics, general|mesh-ancestor
65257042|NCT00906139|Anesthetics|anesthetics|mesh-ancestor
65257043|NCT00906139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65257044|NCT00906139|Narcotics|narcotics|mesh-ancestor
65257045|NCT00906139|Analgesics|analgesics|mesh-ancestor
65341877|NCT04069286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65341878|NCT04069286|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65341879|NCT04069286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341880|NCT04069286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341881|NCT00713622|Zonisamide|zonisamide|mesh-list
65341882|NCT00713622|Valproic Acid|valproic acid|mesh-list
64945667|NCT05329766|Leucovorin|leucovorin|mesh-list
65257046|NCT00906139|Sensory System Agents|sensory system agents|mesh-ancestor
65257047|NCT00906139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65257048|NCT00906139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65257049|NCT00906139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65257050|NCT00906139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65257051|NCT00906139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65257052|NCT00906139|GABA Modulators|gaba modulators|mesh-ancestor
65257086|NCT02754258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257087|NCT02754258|Dopamine Agents|dopamine agents|mesh-ancestor
65257088|NCT02754258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65257089|NCT04267991|Tacrolimus|tacrolimus|mesh-list
65257090|NCT04267991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64932378|NCT00064636|Bortezomib|bortezomib|mesh-list
65257118|NCT00602849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65257119|NCT00602849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65257120|NCT00602849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65257121|NCT00602849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257122|NCT00602849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65257123|NCT00602849|Serotonin Agents|serotonin agents|mesh-ancestor
65257124|NCT00602849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257125|NCT00906451|Simvastatin|simvastatin|mesh-list
65257126|NCT00906451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65257127|NCT00906451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65257128|NCT00906451|Antimetabolites|antimetabolites|mesh-ancestor
65257129|NCT00906451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257130|NCT00906451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65257131|NCT00906451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65257132|NCT00906451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257133|NCT00898417|Paclitaxel|paclitaxel|mesh-list
65257134|NCT00898417|Bevacizumab|bevacizumab|mesh-list
65257135|NCT00898417|Carboplatin|carboplatin|mesh-list
65257165|NCT04268303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65257167|NCT04268303|Sensory System Agents|sensory system agents|mesh-ancestor
65257168|NCT04268303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65257169|NCT04268303|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65257170|NCT04268303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65257171|NCT04268303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65257172|NCT04268303|Adrenergic Agents|adrenergic agents|mesh-ancestor
65257173|NCT04268303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65257174|NCT04268303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257175|NCT02755350|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65257176|NCT02755350|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65257177|NCT02755350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65257178|NCT02755350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932464|NCT04488081|Histamine Agents|histamine agents|mesh-ancestor
65257214|NCT02602197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65257245|NCT04220892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65257247|NCT02696148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65257248|NCT02696148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257249|NCT02696148|Incretins|incretins|mesh-ancestor
65257250|NCT02696148|Hormones|hormones|mesh-ancestor
65257251|NCT02696148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65257252|NCT00887198|Prednisone|prednisone|mesh-list
65257253|NCT00887198|Abiraterone Acetate|abiraterone acetate|mesh-list
65257254|NCT00887198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65257255|NCT00887198|Glucocorticoids|glucocorticoids|mesh-ancestor
65257256|NCT00887198|Hormones|hormones|mesh-ancestor
64932543|NCT00066196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257282|NCT02826746|Analgesics|analgesics|mesh-ancestor
65257283|NCT02826746|Sensory System Agents|sensory system agents|mesh-ancestor
65257284|NCT02826746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65341883|NCT00713622|Anticonvulsants|anticonvulsants|mesh-ancestor
65341884|NCT00713622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341885|NCT00713622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341886|NCT00713622|GABA Agents|gaba agents|mesh-ancestor
65341887|NCT00713622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65341888|NCT00713622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341889|NCT00713622|Antimanic Agents|antimanic agents|mesh-ancestor
65341890|NCT00713622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65341891|NCT00713622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65341892|NCT00713622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65341893|NCT00713622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65341894|NCT00713622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65341895|NCT00713622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65257285|NCT02826746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257286|NCT02826746|Anesthetics|anesthetics|mesh-ancestor
65257287|NCT02826746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65257288|NCT02826746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65257289|NCT02826746|Anticonvulsants|anticonvulsants|mesh-ancestor
65257290|NCT02826746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65257291|NCT02826746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65257292|NCT02826746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257293|NCT02826746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65257294|NCT02826746|Tocolytic Agents|tocolytic agents|mesh-ancestor
65257295|NCT02826746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65257296|NCT02750904|Nicotine|nicotine|mesh-list
65257297|NCT02750904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65257298|NCT02750904|Autonomic Agents|autonomic agents|mesh-ancestor
65257299|NCT02750904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65257300|NCT02750904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257301|NCT02750904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65257302|NCT02750904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65257339|NCT04244708|Temozolomide|temozolomide|mesh-list
65257340|NCT04244708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65257372|NCT00906685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257373|NCT00906685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65257374|NCT00906685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65257375|NCT00906685|Growth Substances|growth substances|mesh-ancestor
65257376|NCT00906685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257377|NCT00906685|Growth Inhibitors|growth inhibitors|mesh-ancestor
65257378|NCT05660720|Moxifloxacin|moxifloxacin|mesh-list
65257379|NCT05660720|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65257380|NCT05660720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65257381|NCT05660720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65257404|NCT02695212|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65257405|NCT02695212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257406|NCT02695212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257407|NCT05381207|Fluticasone|fluticasone|mesh-list
65257408|NCT05381207|Xhance|xhance|mesh-list
65257409|NCT05381207|Montelukast|montelukast|mesh-list
65257410|NCT05381207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65257411|NCT05381207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65257412|NCT05381207|Autonomic Agents|autonomic agents|mesh-ancestor
65257413|NCT05381207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65257414|NCT05381207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257415|NCT05381207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65257416|NCT05381207|Respiratory System Agents|respiratory system agents|mesh-ancestor
65257417|NCT05381207|Dermatologic Agents|dermatologic agents|mesh-ancestor
65257418|NCT05381207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65257419|NCT05381207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65257420|NCT05381207|Hormone Antagonists|hormone antagonists|mesh-ancestor
65341896|NCT00718172|Ribavirin|ribavirin|mesh-list
65341897|NCT00718172|Antimetabolites|antimetabolites|mesh-ancestor
65341898|NCT00718172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341899|NCT00718172|Antiviral Agents|antiviral agents|mesh-ancestor
65341900|NCT00718172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65341901|NCT00720018|Sumatriptan|sumatriptan|mesh-list
65341902|NCT00720018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65341903|NCT00720018|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65341904|NCT00720018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65341905|NCT00720018|Serotonin Agents|serotonin agents|mesh-ancestor
65341906|NCT00720018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65341907|NCT00720018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341908|NCT00720018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341909|NCT03992456|Trifluridine|trifluridine|mesh-list
65341910|NCT03992456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65341911|NCT03992456|Panitumumab|panitumumab|mesh-list
65257421|NCT05381207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65257422|NCT05381207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65257423|NCT05381207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65257424|NCT05381207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257425|NCT02750670|Gemcitabine|gemcitabine|mesh-list
65257426|NCT02750670|Dexamethasone|dexamethasone|mesh-list
65257427|NCT02750670|Obinutuzumab|obinutuzumab|mesh-list
65257428|NCT02750670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65257429|NCT02750670|Antiemetics|antiemetics|mesh-ancestor
65257430|NCT02750670|Autonomic Agents|autonomic agents|mesh-ancestor
65257431|NCT02750670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65257457|NCT00605891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65257458|NCT00605891|Adrenergic Agents|adrenergic agents|mesh-ancestor
65257459|NCT00605891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65257460|NCT00605891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257461|NCT05122208|Famotidine|famotidine|mesh-list
65257462|NCT05122208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65257463|NCT05122208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65257464|NCT05122208|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65257465|NCT05122208|Histamine Antagonists|histamine antagonists|mesh-ancestor
65257466|NCT05122208|Histamine Agents|histamine agents|mesh-ancestor
65257467|NCT05122208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65257468|NCT05122208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257469|NCT05122208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257470|NCT00781911|Octreotide|octreotide|mesh-list
65257471|NCT00781911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65257472|NCT00781911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65257473|NCT00781911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257474|NCT00605917|Sertraline|sertraline|mesh-list
65257475|NCT00605917|Antidepressive Agents|antidepressive agents|mesh-ancestor
65257476|NCT00605917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65257477|NCT00605917|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65257478|NCT00605917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65257497|NCT00781599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65257498|NCT00781599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257499|NCT00781599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257500|NCT00904111|Lidocaine|lidocaine|mesh-list
65257501|NCT00904111|Anesthetics, Local|anesthetics, local|mesh-ancestor
65257502|NCT00904111|Anesthetics|anesthetics|mesh-ancestor
65257503|NCT00904111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65257504|NCT00904111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341912|NCT03992456|Antibodies|antibodies|mesh-list
65341913|NCT03992456|Immunoglobulins|immunoglobulins|mesh-list
65341914|NCT03992456|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65341915|NCT03992456|Immunologic Factors|immunologic factors|mesh-ancestor
65341916|NCT03992456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341917|NCT03992456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341918|NCT03992456|Antimetabolites|antimetabolites|mesh-ancestor
65257505|NCT00904111|Sensory System Agents|sensory system agents|mesh-ancestor
65257506|NCT00904111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65257507|NCT00904111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65257508|NCT00904111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65257509|NCT00904111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65257510|NCT00904111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65257511|NCT00904111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257512|NCT03240211|Pembrolizumab|pembrolizumab|mesh-list
65257513|NCT03240211|Decitabine|decitabine|mesh-list
65257514|NCT03240211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65257515|NCT03240211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257516|NCT03240211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65257517|NCT03240211|Antimetabolites|antimetabolites|mesh-ancestor
65257518|NCT03240211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257519|NCT03240211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257520|NCT04278144|Nivolumab|nivolumab|mesh-list
65257521|NCT04278144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65257522|NCT04278144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257523|NCT04278144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65257524|NCT04278144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257525|NCT00899197|Tamoxifen|tamoxifen|mesh-list
65257526|NCT00899197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65257527|NCT00899197|Hormone Antagonists|hormone antagonists|mesh-ancestor
65257528|NCT00899197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65257529|NCT00899197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257530|NCT00899197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65257531|NCT00899197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932817|NCT00068068|Dermatologic Agents|dermatologic agents|mesh-ancestor
65257559|NCT04241744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65257560|NCT04241744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65257562|NCT02824094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257563|NCT02824094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65257564|NCT02824094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257565|NCT02824094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257566|NCT00899587|Enalapril|enalapril|mesh-list
65257567|NCT00899587|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65257568|NCT00899587|Protease Inhibitors|protease inhibitors|mesh-ancestor
65257569|NCT00899587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257570|NCT00899587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257571|NCT00899587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65257572|NCT04268069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65257573|NCT04268069|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65257574|NCT02824406|Acetazolamide|acetazolamide|mesh-list
65257575|NCT02824406|Anticonvulsants|anticonvulsants|mesh-ancestor
64932882|NCT00069355|Propranolol|propranolol|mesh-list
65257599|NCT04951388|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65257600|NCT04951388|Protease Inhibitors|protease inhibitors|mesh-ancestor
65257601|NCT04951388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257602|NCT04951388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066798|NCT00272597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257603|NCT04242914|Midazolam|midazolam|mesh-list
65257604|NCT04242914|Ketamine|ketamine|mesh-list
65257605|NCT04242914|Analgesics|analgesics|mesh-ancestor
65257606|NCT04242914|Sensory System Agents|sensory system agents|mesh-ancestor
65257607|NCT04242914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65257608|NCT04242914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257609|NCT04242914|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65257610|NCT04242914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65257611|NCT04242914|Anesthetics, General|anesthetics, general|mesh-ancestor
65257612|NCT04242914|Anesthetics|anesthetics|mesh-ancestor
65341919|NCT03992456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341920|NCT03992456|Antiviral Agents|antiviral agents|mesh-ancestor
65341921|NCT03992456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65341922|NCT00618826|Gemcitabine|gemcitabine|mesh-list
65341923|NCT00618826|Paclitaxel|paclitaxel|mesh-list
65341924|NCT00618826|Bevacizumab|bevacizumab|mesh-list
65341925|NCT00618826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65257613|NCT04242914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65257614|NCT04242914|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65257615|NCT04242914|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65257616|NCT04242914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65257617|NCT04242914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257618|NCT04242914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65257619|NCT04242914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65257620|NCT04242914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65257621|NCT04242914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65257622|NCT04242914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65257623|NCT04242914|GABA Modulators|gaba modulators|mesh-ancestor
65257624|NCT04242914|GABA Agents|gaba agents|mesh-ancestor
65257625|NCT00780273|Cimetidine|cimetidine|mesh-list
65257654|NCT00899821|Interleukin-12|interleukin-12|mesh-list
65257655|NCT00899821|Sargramostim|sargramostim|mesh-list
65257656|NCT00899821|Immunologic Factors|immunologic factors|mesh-ancestor
65257657|NCT00899821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257658|NCT00899821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257659|NCT00899821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65257660|NCT00899821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65257661|NCT00899821|Antiviral Agents|antiviral agents|mesh-ancestor
65257662|NCT00899821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65257663|NCT00899821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65257664|NCT00899821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65257665|NCT00899821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65257666|NCT00899821|Growth Substances|growth substances|mesh-ancestor
65257667|NCT00899821|Growth Inhibitors|growth inhibitors|mesh-ancestor
65257668|NCT00005112|Hormones|hormones|mesh-list
65257669|NCT00005112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65257695|NCT00904657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257696|NCT00904735|Imatinib Mesylate|imatinib mesylate|mesh-list
65257697|NCT00904735|Hydroxyurea|hydroxyurea|mesh-list
65257698|NCT00904735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257699|NCT00904735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65257700|NCT00904735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257701|NCT00904735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257702|NCT00904735|Antisickling Agents|antisickling agents|mesh-ancestor
65257703|NCT00904735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65257704|NCT02823626|Spironolactone|spironolactone|mesh-list
65257705|NCT02823626|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65257706|NCT02823626|Hormone Antagonists|hormone antagonists|mesh-ancestor
65257707|NCT02823626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65257708|NCT02823626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257709|NCT02823626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65257710|NCT02823626|Diuretics|diuretics|mesh-ancestor
65257711|NCT02823626|Natriuretic Agents|natriuretic agents|mesh-ancestor
65257712|NCT00779259|Quinine|quinine|mesh-list
65257713|NCT00779259|Theophylline|theophylline|mesh-list
65257714|NCT00779259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65257715|NCT00779259|Autonomic Agents|autonomic agents|mesh-ancestor
65257716|NCT00779259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64933016|NCT00070252|Docetaxel|docetaxel|mesh-list
65257744|NCT02745990|Hematinics|hematinics|mesh-ancestor
65257745|NCT04417062|Olaparib|olaparib|mesh-list
65257746|NCT04417062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65257747|NCT04417062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257748|NCT04417062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257749|NCT04417062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257750|NCT00915915|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65257751|NCT00915915|Gestodene|gestodene|mesh-list
65257752|NCT00915915|Femovan|femovan|mesh-list
65257753|NCT00915915|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65341926|NCT00618826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341927|NCT00618826|Tubulin Modulators|tubulin modulators|mesh-ancestor
65341928|NCT00618826|Antimitotic Agents|antimitotic agents|mesh-ancestor
65341929|NCT00618826|Mitosis Modulators|mitosis modulators|mesh-ancestor
65341930|NCT00618826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341931|NCT00618826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65341932|NCT00618826|Antimetabolites|antimetabolites|mesh-ancestor
65341933|NCT00618826|Antiviral Agents|antiviral agents|mesh-ancestor
65341934|NCT00618826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65341935|NCT00618826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341936|NCT00618826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65341937|NCT00618826|Immunologic Factors|immunologic factors|mesh-ancestor
65341938|NCT00618826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341939|NCT00618826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65341940|NCT00618826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65341941|NCT00618826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65341942|NCT00618826|Growth Substances|growth substances|mesh-ancestor
65341943|NCT00618826|Growth Inhibitors|growth inhibitors|mesh-ancestor
65341944|NCT00720174|Doxorubicin|doxorubicin|mesh-list
65341945|NCT00720174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65341946|NCT00720174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65341947|NCT00720174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65341948|NCT00720174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341949|NCT00720174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65341950|NCT00720174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65341951|NCT00720174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341952|NCT00720174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341953|NCT00720174|Immunologic Factors|immunologic factors|mesh-ancestor
65341954|NCT00720174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257754|NCT00915915|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65257755|NCT00915915|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65257756|NCT00915915|Contraceptive Agents|contraceptive agents|mesh-ancestor
65257757|NCT00915915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65257758|NCT00915915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257759|NCT00915915|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65257761|NCT00915915|Hormones|hormones|mesh-ancestor
65257762|NCT00915915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65257763|NCT00915915|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65257764|NCT00915915|Progestins|progestins|mesh-ancestor
65257765|NCT00915915|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65257788|NCT00900445|Daunorubicin|daunorubicin|mesh-list
65257789|NCT00900445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65257790|NCT00900445|Prednisolone phosphate|prednisolone phosphate|mesh-list
65257791|NCT00900445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65341955|NCT00722930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65341956|NCT00722930|Immunologic Factors|immunologic factors|mesh-ancestor
65341957|NCT00722930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341958|NCT03834740|Everolimus|everolimus|mesh-list
65341959|NCT03834740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341960|NCT03834740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65341961|NCT03834740|Immunologic Factors|immunologic factors|mesh-ancestor
65341962|NCT03834740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341963|NCT00849082|Goserelin|goserelin|mesh-list
65341964|NCT00849082|Cyproterone Acetate|cyproterone acetate|mesh-list
65341965|NCT00849082|Cyproterone|cyproterone|mesh-list
65341966|NCT00849082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65341967|NCT00849082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65341968|NCT00849082|Androgen Antagonists|androgen antagonists|mesh-ancestor
65341969|NCT00849082|Hormone Antagonists|hormone antagonists|mesh-ancestor
64723971|NCT04295486|Antipyretics|antipyretics|mesh-ancestor
65257792|NCT00900445|Glucocorticoids|glucocorticoids|mesh-ancestor
65257793|NCT00900445|Hormones|hormones|mesh-ancestor
65257794|NCT00900445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65257795|NCT00900445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257796|NCT00900445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65257797|NCT00900445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257798|NCT00900445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65257799|NCT00900445|Tubulin Modulators|tubulin modulators|mesh-ancestor
65257800|NCT00900445|Antimitotic Agents|antimitotic agents|mesh-ancestor
65257801|NCT00900445|Mitosis Modulators|mitosis modulators|mesh-ancestor
65257802|NCT00900445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257803|NCT00900445|Antiemetics|antiemetics|mesh-ancestor
65257804|NCT00900445|Autonomic Agents|autonomic agents|mesh-ancestor
65257805|NCT00900445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65257806|NCT00900445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65257807|NCT00900445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65257808|NCT00900445|Protective Agents|protective agents|mesh-ancestor
65257809|NCT00900445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65257810|NCT00900445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65257811|NCT00900445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65257812|NCT00900445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257813|NCT03994419|Anesthetics|anesthetics|mesh-list
65257814|NCT03994419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65257815|NCT03994419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257816|NCT00936065|Etanercept|etanercept|mesh-list
65257817|NCT00936065|Acitretin|acitretin|mesh-list
65257818|NCT00936065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65257819|NCT00936065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65257820|NCT00936065|Analgesics|analgesics|mesh-ancestor
65257840|NCT04241276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65257841|NCT04241276|Antimetabolites|antimetabolites|mesh-ancestor
65257842|NCT04241276|Antiviral Agents|antiviral agents|mesh-ancestor
65257843|NCT04241276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65257844|NCT04241276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257845|NCT04241276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65257846|NCT04241276|Immunologic Factors|immunologic factors|mesh-ancestor
65257847|NCT04241276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257848|NCT04241276|Keratolytic Agents|keratolytic agents|mesh-ancestor
65257849|NCT04241276|Dermatologic Agents|dermatologic agents|mesh-ancestor
65257850|NCT00905047|Leucovorin|leucovorin|mesh-list
65257851|NCT00905047|Folic Acid|folic acid|mesh-list
65257852|NCT00905047|Tegafur|tegafur|mesh-list
65257853|NCT00905047|Levoleucovorin|levoleucovorin|mesh-list
65257854|NCT00905047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65257855|NCT00905047|Antimetabolites|antimetabolites|mesh-ancestor
65341970|NCT00849082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65341971|NCT00849082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65341972|NCT00849082|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65341973|NCT00849082|Contraceptive Agents|contraceptive agents|mesh-ancestor
65341974|NCT00849082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65341975|NCT03472040|Berotralstat|berotralstat|mesh-list
65341976|NCT03472040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341977|NCT03472040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341978|NCT00849160|Darunavir|darunavir|mesh-list
65341979|NCT00849160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65341980|NCT00849160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65341981|NCT00849160|Protease Inhibitors|protease inhibitors|mesh-ancestor
65341982|NCT00849160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341983|NCT00849160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341984|NCT00849160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65341985|NCT00849160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65341986|NCT00849160|Antiviral Agents|antiviral agents|mesh-ancestor
65341987|NCT00849160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65341988|NCT00720590|Ritonavir|ritonavir|mesh-list
65341989|NCT00720590|Lopinavir|lopinavir|mesh-list
65341990|NCT00720590|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65341991|NCT00720590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65341992|NCT00720590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65341993|NCT00720590|Protease Inhibitors|protease inhibitors|mesh-ancestor
65341994|NCT00720590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65341995|NCT00720590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65341996|NCT00720590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65341997|NCT00720590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65341998|NCT00720590|Antiviral Agents|antiviral agents|mesh-ancestor
65341999|NCT00720590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65342000|NCT00720590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65342001|NCT00720590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65342002|NCT00718406|Metoprolol|metoprolol|mesh-list
65257856|NCT00905047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257857|NCT00905047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257858|NCT00905047|Antidotes|antidotes|mesh-ancestor
65257859|NCT00905047|Protective Agents|protective agents|mesh-ancestor
65257860|NCT00905047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257861|NCT00905047|Vitamin B Complex|vitamin b complex|mesh-ancestor
65257862|NCT00905047|Vitamins|vitamins|mesh-ancestor
65257863|NCT00905047|Micronutrients|micronutrients|mesh-ancestor
65342003|NCT00718406|Morphine|morphine|mesh-list
65342004|NCT00718406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65342005|NCT00718406|Narcotics|narcotics|mesh-ancestor
65342006|NCT00718406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65342007|NCT00718406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342008|NCT00718406|Analgesics|analgesics|mesh-ancestor
65342009|NCT00718406|Sensory System Agents|sensory system agents|mesh-ancestor
64331594|NCT05221840|Durvalumab|durvalumab|mesh-list
65342010|NCT00718406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65342011|NCT00718406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65342012|NCT00718406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65342013|NCT00718406|Sympatholytics|sympatholytics|mesh-ancestor
65342014|NCT00718406|Autonomic Agents|autonomic agents|mesh-ancestor
65342015|NCT00718406|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65342016|NCT00718406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65342017|NCT00718406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65342018|NCT00718406|Adrenergic Agents|adrenergic agents|mesh-ancestor
65342019|NCT00718406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65342020|NCT00718406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342021|NCT00849238|Mycophenolic Acid|mycophenolic acid|mesh-list
65342022|NCT00849238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65342023|NCT00849238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342024|NCT00849238|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65342025|NCT00849238|Antitubercular Agents|antitubercular agents|mesh-ancestor
65342026|NCT00849238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65342027|NCT00849238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65342028|NCT00849238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724012|NCT00000301|Amantadine|amantadine|mesh-list
65257864|NCT00905047|Hematinics|hematinics|mesh-ancestor
65257865|NCT04102449|Apremilast|apremilast|mesh-list
65257866|NCT04102449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65257867|NCT04102449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65257868|NCT04102449|Analgesics|analgesics|mesh-ancestor
65257869|NCT04102449|Sensory System Agents|sensory system agents|mesh-ancestor
65257870|NCT04102449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65257871|NCT04102449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257872|NCT04102449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65257873|NCT04102449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65257874|NCT04102449|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65257875|NCT04102449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65257876|NCT04102449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257877|NCT04102449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257878|NCT02823236|Triamcinolone|triamcinolone|mesh-list
65257879|NCT02823236|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65257900|NCT00633698|Nicotinic Acids|nicotinic acids|mesh-list
65257901|NCT00633698|Niacinamide|niacinamide|mesh-list
65257902|NCT00633698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65257903|NCT00633698|Antimetabolites|antimetabolites|mesh-ancestor
65342029|NCT00849238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342030|NCT00720408|Mycophenolic Acid|mycophenolic acid|mesh-list
65342031|NCT00720408|Tacrolimus|tacrolimus|mesh-list
65342032|NCT00720408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65342033|NCT00720408|Immunologic Factors|immunologic factors|mesh-ancestor
65342034|NCT00720408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342035|NCT00720408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65342036|NCT00720408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257904|NCT00633698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257905|NCT00633698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65257906|NCT00633698|Vasodilator Agents|vasodilator agents|mesh-ancestor
65257907|NCT00633698|Vitamin B Complex|vitamin b complex|mesh-ancestor
65257909|NCT00633698|Micronutrients|micronutrients|mesh-ancestor
65257910|NCT00633698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257911|NCT02825342|Citalopram|citalopram|mesh-list
65257912|NCT02825342|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65257913|NCT02825342|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65257914|NCT02825342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65257915|NCT02825342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65257916|NCT02825342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257917|NCT02825342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65257918|NCT02825342|Serotonin Agents|serotonin agents|mesh-ancestor
65257919|NCT02825342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257920|NCT02825342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65257921|NCT02825342|Antidepressive Agents|antidepressive agents|mesh-ancestor
65257922|NCT02825342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65257923|NCT02825342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257924|NCT02749890|Insulin Glargine|insulin glargine|mesh-list
65257925|NCT02749890|Lixisenatide|lixisenatide|mesh-list
65257926|NCT02749890|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65257927|NCT02749890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257928|NCT04242758|Dapagliflozin|dapagliflozin|mesh-list
65257929|NCT04242758|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65257930|NCT04242758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65257931|NCT04242758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257932|NCT04242758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65257933|NCT04242758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933232|NCT00072007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257969|NCT02825186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65257970|NCT02825186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65257971|NCT02825186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258007|NCT02851433|Anesthetics, General|anesthetics, general|mesh-ancestor
65258008|NCT02851433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65258009|NCT02851433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65258040|NCT02822144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258041|NCT02822144|Sensory System Agents|sensory system agents|mesh-ancestor
65258042|NCT02822144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65258043|NCT02822144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65258044|NCT02822144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65258045|NCT02822144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65258046|NCT02822144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65258047|NCT02822144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258048|NCT02822144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65258049|NCT02822144|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65258050|NCT02822144|Anesthetics, General|anesthetics, general|mesh-ancestor
65258051|NCT02822144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65258052|NCT02822144|Narcotics|narcotics|mesh-ancestor
65258053|NCT02822144|Analgesics|analgesics|mesh-ancestor
65258054|NCT02822144|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
65258055|NCT02822144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65258056|NCT02822144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65258057|NCT04217148|Dexamethasone|dexamethasone|mesh-list
65258087|NCT04216836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65258088|NCT00937157|Glatiramer Acetate|glatiramer acetate|mesh-list
65342037|NCT00720408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342038|NCT00720408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65342039|NCT00720408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342040|NCT00720408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65342041|NCT00720408|Antitubercular Agents|antitubercular agents|mesh-ancestor
65342042|NCT00720408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65342043|NCT00720408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65342044|NCT00849316|Insulin Aspart|insulin aspart|mesh-list
65342045|NCT00849316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65342046|NCT00849316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342047|NCT00852670|Ponesimod|ponesimod|mesh-list
65342048|NCT00852670|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65342049|NCT00852670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342050|NCT00852670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65342051|NCT00852670|Immunologic Factors|immunologic factors|mesh-ancestor
65342052|NCT00852670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342053|NCT00717210|Temozolomide|temozolomide|mesh-list
65342054|NCT00717210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65342055|NCT00717210|Alkylating Agents|alkylating agents|mesh-ancestor
65342056|NCT00717210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258090|NCT00937157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65258091|NCT00937157|Immunologic Factors|immunologic factors|mesh-ancestor
65258092|NCT00937157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258093|NCT00937157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65258094|NCT00937157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65258095|NCT04034173|Leucovorin|leucovorin|mesh-list
65258096|NCT04034173|Folic Acid|folic acid|mesh-list
65258097|NCT04034173|Irinotecan|irinotecan|mesh-list
65258098|NCT04034173|Panitumumab|panitumumab|mesh-list
65258099|NCT04034173|Levoleucovorin|levoleucovorin|mesh-list
65258100|NCT04034173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65258101|NCT04034173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65258102|NCT04034173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65258103|NCT04034173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933403|NCT00072553|Analgesics|analgesics|mesh-ancestor
65258129|NCT02539849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65258130|NCT02749578|Atorvastatin|atorvastatin|mesh-list
65258131|NCT02749578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65258132|NCT02749578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65258133|NCT02749578|Antimetabolites|antimetabolites|mesh-ancestor
65258134|NCT02749578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258135|NCT02749578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65258136|NCT02749578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65258137|NCT02749578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65258138|NCT05378867|Bevacizumab|bevacizumab|mesh-list
65258139|NCT05378867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65258140|NCT05378867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258141|NCT05378867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65258142|NCT05378867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65258143|NCT05378867|Growth Substances|growth substances|mesh-ancestor
65258144|NCT05378867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258145|NCT05378867|Growth Inhibitors|growth inhibitors|mesh-ancestor
65342057|NCT00717210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342058|NCT00723086|Docetaxel|docetaxel|mesh-list
65342059|NCT00723086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342060|NCT00723086|Tubulin Modulators|tubulin modulators|mesh-ancestor
65342061|NCT00723086|Antimitotic Agents|antimitotic agents|mesh-ancestor
65342062|NCT00723086|Mitosis Modulators|mitosis modulators|mesh-ancestor
65342063|NCT00723086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342064|NCT04018378|Varenicline|varenicline|mesh-list
65342065|NCT04018378|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65342066|NCT04018378|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65342067|NCT04018378|Cholinergic Agents|cholinergic agents|mesh-ancestor
65342068|NCT04018378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65342069|NCT04018378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342070|NCT04018378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342071|NCT00849550|Bevacizumab|bevacizumab|mesh-list
65258146|NCT02749656|Desoximetasone|desoximetasone|mesh-list
65258147|NCT02749656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65258148|NCT02749656|Glucocorticoids|glucocorticoids|mesh-ancestor
65258149|NCT02749656|Hormones|hormones|mesh-ancestor
65258150|NCT02749656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65258151|NCT02749656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258152|NCT00603317|Amoxicillin|amoxicillin|mesh-list
65258183|NCT05378711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258184|NCT05378711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65258185|NCT05378711|Serotonin Agents|serotonin agents|mesh-ancestor
65258186|NCT05378711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258187|NCT05378711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65258188|NCT05378711|Antidepressive Agents|antidepressive agents|mesh-ancestor
65258189|NCT05378711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65258190|NCT05378711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65258191|NCT05378711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65258192|NCT05378711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65258193|NCT00777153|Cediranib|cediranib|mesh-list
65258194|NCT00777153|Lomustine|lomustine|mesh-list
65258195|NCT00777153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258223|NCT04266509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65258224|NCT02824874|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65258225|NCT02824874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65258226|NCT02824874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258227|NCT02824874|Incretins|incretins|mesh-ancestor
65258228|NCT02824874|Hormones|hormones|mesh-ancestor
65258229|NCT02824874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65258230|NCT02824874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65258231|NCT02824874|Protease Inhibitors|protease inhibitors|mesh-ancestor
65258232|NCT02824874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65258233|NCT02824874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258234|NCT04204265|Hyaluronic Acid|hyaluronic acid|mesh-list
65258235|NCT04204265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65258236|NCT04204265|Immunologic Factors|immunologic factors|mesh-ancestor
65258237|NCT04204265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258238|NCT04204265|Viscosupplements|viscosupplements|mesh-ancestor
65258239|NCT04204265|Protective Agents|protective agents|mesh-ancestor
64933548|NCT00073411|Citalopram|citalopram|mesh-list
65258264|NCT04267913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258266|NCT04267913|Antimitotic Agents|antimitotic agents|mesh-ancestor
65258267|NCT04267913|Mitosis Modulators|mitosis modulators|mesh-ancestor
65258268|NCT04216758|Gemcitabine|gemcitabine|mesh-list
65258269|NCT04216758|Paclitaxel|paclitaxel|mesh-list
65258270|NCT04216758|Tegafur|tegafur|mesh-list
65258271|NCT04216758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65342072|NCT00849550|Capecitabine|capecitabine|mesh-list
65342073|NCT00849550|Oxaliplatin|oxaliplatin|mesh-list
65342074|NCT00849550|Everolimus|everolimus|mesh-list
65342075|NCT00849550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65342076|NCT00849550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342077|NCT00849550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65342078|NCT00849550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65342079|NCT00849550|Growth Substances|growth substances|mesh-ancestor
65342080|NCT00849550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342081|NCT00849550|Growth Inhibitors|growth inhibitors|mesh-ancestor
65342082|NCT00849550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65342083|NCT00849550|Antimetabolites|antimetabolites|mesh-ancestor
65342084|NCT00849550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342085|NCT00849550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65342086|NCT00849550|Immunologic Factors|immunologic factors|mesh-ancestor
65342087|NCT03816488|Metformin|metformin|mesh-list
65258272|NCT04216758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258273|NCT04216758|Tubulin Modulators|tubulin modulators|mesh-ancestor
65258274|NCT04216758|Antimitotic Agents|antimitotic agents|mesh-ancestor
65258275|NCT04216758|Mitosis Modulators|mitosis modulators|mesh-ancestor
65258276|NCT04216758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258277|NCT04216758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65258278|NCT04216758|Antimetabolites|antimetabolites|mesh-ancestor
65258279|NCT04216758|Antiviral Agents|antiviral agents|mesh-ancestor
65258280|NCT04216758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65258281|NCT04216758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65258282|NCT04216758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65258283|NCT04216758|Immunologic Factors|immunologic factors|mesh-ancestor
65258284|NCT04216758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258286|NCT00606437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258287|NCT02538211|Vaccines|vaccines|mesh-list
65258288|NCT02538211|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65258289|NCT02538211|Immunologic Factors|immunologic factors|mesh-ancestor
65258290|NCT02538211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258291|NCT02821676|Anesthetics|anesthetics|mesh-list
65258292|NCT02821676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65258293|NCT02821676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258318|NCT00908089|Protective Agents|protective agents|mesh-ancestor
65258319|NCT00908089|Dermatologic Agents|dermatologic agents|mesh-ancestor
65258320|NCT00908089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65258321|NCT00908089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65258322|NCT00908089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65258323|NCT00908089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65258324|NCT00908089|Analgesics|analgesics|mesh-ancestor
65258325|NCT00908089|Sensory System Agents|sensory system agents|mesh-ancestor
65258326|NCT00908089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65258327|NCT00908089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65258328|NCT00908089|Antimalarials|antimalarials|mesh-ancestor
65258329|NCT00908089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65258330|NCT00908089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65258331|NCT00908089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65258332|NCT00908089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258333|NCT04758416|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65258334|NCT04758416|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65258335|NCT04758416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258336|NCT05378555|Ketamine|ketamine|mesh-list
65258337|NCT05378555|Analgesics|analgesics|mesh-ancestor
65258338|NCT05378555|Sensory System Agents|sensory system agents|mesh-ancestor
65258339|NCT05378555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65342089|NCT03816488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65342090|NCT03816488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342091|NCT03816488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65342092|NCT03816488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65342093|NCT03816488|Analgesics|analgesics|mesh-ancestor
65342094|NCT03816488|Sensory System Agents|sensory system agents|mesh-ancestor
65342095|NCT03816488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65342096|NCT03816488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65342097|NCT03816488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65342098|NCT00858676|Acarbose|acarbose|mesh-list
65342099|NCT00858676|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65342100|NCT00858676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342101|NCT00858676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342102|NCT00858676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65258340|NCT05378555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258341|NCT05378555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65258342|NCT05378555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65258343|NCT05378555|Anesthetics, General|anesthetics, general|mesh-ancestor
65258344|NCT05378555|Anesthetics|anesthetics|mesh-ancestor
65258345|NCT05378555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65258346|NCT05378555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65258381|NCT00606515|Mitosis Modulators|mitosis modulators|mesh-ancestor
65258382|NCT00606515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258384|NCT00908323|Immunologic Factors|immunologic factors|mesh-ancestor
65258385|NCT00908323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258386|NCT02749032|Metformin|metformin|mesh-list
65258387|NCT02749032|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65258413|NCT00908713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65258414|NCT00908713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65258415|NCT00908713|Protective Agents|protective agents|mesh-ancestor
65258416|NCT00908713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65258417|NCT00908713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258418|NCT00908869|Interferons|interferons|mesh-list
65258419|NCT00908869|Interferon-alpha|interferon-alpha|mesh-list
65258420|NCT00908869|Interferon alpha-2|interferon alpha-2|mesh-list
65258421|NCT00908869|Cyclophosphamide|cyclophosphamide|mesh-list
65258422|NCT00908869|Vinorelbine|vinorelbine|mesh-list
65258423|NCT00908869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65258424|NCT00908869|Immunologic Factors|immunologic factors|mesh-ancestor
65258425|NCT00908869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258426|NCT00908869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65258427|NCT00908869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65258428|NCT00908869|Alkylating Agents|alkylating agents|mesh-ancestor
65258429|NCT00908869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258430|NCT00908869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258431|NCT00908869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65258432|NCT00908869|Antiviral Agents|antiviral agents|mesh-ancestor
65258433|NCT00908869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65258434|NCT00908869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65008669|NCT01249690|Bortezomib|bortezomib|mesh-list
65258435|NCT00908869|Tubulin Modulators|tubulin modulators|mesh-ancestor
65258436|NCT00908869|Antimitotic Agents|antimitotic agents|mesh-ancestor
65258455|NCT04240496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65258456|NCT04240496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65258457|NCT04240496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65258458|NCT04240496|GABA Antagonists|gaba antagonists|mesh-ancestor
65258459|NCT04240496|GABA Agents|gaba agents|mesh-ancestor
65258460|NCT03450018|Gemcitabine|gemcitabine|mesh-list
65258461|NCT03450018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65258462|NCT03450018|Antimetabolites|antimetabolites|mesh-ancestor
65342103|NCT00858676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342104|NCT00858754|Methylnaltrexone|methylnaltrexone|mesh-list
65342105|NCT00858754|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65342106|NCT00858754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342107|NCT00858754|Sensory System Agents|sensory system agents|mesh-ancestor
65258463|NCT03450018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258464|NCT03450018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258465|NCT03450018|Antiviral Agents|antiviral agents|mesh-ancestor
65258466|NCT03450018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65258467|NCT03450018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65258468|NCT03450018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65258469|NCT03450018|Immunologic Factors|immunologic factors|mesh-ancestor
65258470|NCT03450018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258471|NCT00909337|Bosentan|bosentan|mesh-list
65258472|NCT00909337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65258473|NCT00909337|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65258474|NCT00909337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258475|NCT00909571|Tacrolimus|tacrolimus|mesh-list
65258476|NCT00909571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65258477|NCT00909571|Immunologic Factors|immunologic factors|mesh-ancestor
65258478|NCT00909571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258479|NCT00909571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65258480|NCT00909571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65258481|NCT00909571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258482|NCT04015375|Dapsone|dapsone|mesh-list
65258483|NCT04015375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65258484|NCT04015375|Antimalarials|antimalarials|mesh-ancestor
65258485|NCT04015375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65258486|NCT04015375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65258487|NCT04015375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65258488|NCT04015375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65258489|NCT04015375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258490|NCT04015375|Leprostatic Agents|leprostatic agents|mesh-ancestor
65258491|NCT04015375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65258492|NCT04239794|Propofol|propofol|mesh-list
65258493|NCT04239794|Sevoflurane|sevoflurane|mesh-list
65258494|NCT04239794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64933781|NCT00075517|Gemcitabine|gemcitabine|mesh-list
65258513|NCT00931645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65258514|NCT00931645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65258515|NCT00931645|Alkylating Agents|alkylating agents|mesh-ancestor
65258516|NCT00931645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258517|NCT00931645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258518|NCT00931645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65258519|NCT00931645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65258521|NCT00931645|Autonomic Agents|autonomic agents|mesh-ancestor
65258522|NCT00931645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65258523|NCT00931645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65258524|NCT00931645|Glucocorticoids|glucocorticoids|mesh-ancestor
65258525|NCT00931645|Hormones|hormones|mesh-ancestor
65258526|NCT00931645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65258527|NCT00931645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65258528|NCT00931645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65258529|NCT00931645|Antimetabolites|antimetabolites|mesh-ancestor
65258530|NCT00931645|Antiviral Agents|antiviral agents|mesh-ancestor
65258531|NCT00931645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65258532|NCT05658692|Anti-Infective Agents|anti-infective agents|mesh-list
65258533|NCT05658692|Dexamethasone|dexamethasone|mesh-list
65258534|NCT05658692|Hydrocortisone|hydrocortisone|mesh-list
65258535|NCT05658692|Simendan|simendan|mesh-list
65258536|NCT05658692|Dopamine|dopamine|mesh-list
65258537|NCT05658692|Isoproterenol|isoproterenol|mesh-list
65258538|NCT05658692|Olprinone|olprinone|mesh-list
65258539|NCT05658692|Epinephrine|epinephrine|mesh-list
65258540|NCT05658692|Norepinephrine|norepinephrine|mesh-list
65258541|NCT05658692|Metaraminol|metaraminol|mesh-list
65258542|NCT05658692|Midazolam|midazolam|mesh-list
65258543|NCT05658692|Dexmedetomidine|dexmedetomidine|mesh-list
65258544|NCT05658692|Bromides|bromides|mesh-list
65258545|NCT05658692|Propofol|propofol|mesh-list
65258546|NCT05658692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65258547|NCT05658692|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65258548|NCT05658692|Simvastatin|simvastatin|mesh-list
65342108|NCT00858754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65342109|NCT00723164|Fentanyl|fentanyl|mesh-list
65342110|NCT00723164|Midazolam|midazolam|mesh-list
65342111|NCT00723164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65258549|NCT05658692|Glucocorticoids|glucocorticoids|mesh-list
65258550|NCT05658692|Succinylcholine|succinylcholine|mesh-list
65258551|NCT05658692|Vecuronium Bromide|vecuronium bromide|mesh-list
65258552|NCT05658692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65258553|NCT05658692|Antiemetics|antiemetics|mesh-ancestor
65258554|NCT05658692|Autonomic Agents|autonomic agents|mesh-ancestor
64933841|NCT00075634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65258579|NCT05658692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65258581|NCT05658692|GABA Agents|gaba agents|mesh-ancestor
65258582|NCT05658692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65258583|NCT05658692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65258584|NCT05658692|Antimetabolites|antimetabolites|mesh-ancestor
65258585|NCT05658692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65258586|NCT05658692|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65258587|NCT05658692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65258588|NCT05658692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65258589|NCT05658692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65258590|NCT05658692|Respiratory System Agents|respiratory system agents|mesh-ancestor
65258591|NCT05658692|Mydriatics|mydriatics|mesh-ancestor
65258592|NCT05658692|Sympathomimetics|sympathomimetics|mesh-ancestor
65258593|NCT05658692|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65258594|NCT05658692|Anticonvulsants|anticonvulsants|mesh-ancestor
65258595|NCT05658692|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65258596|NCT05658692|Vasodilator Agents|vasodilator agents|mesh-ancestor
65258597|NCT05658692|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65258598|NCT05658692|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65258599|NCT05658692|Protective Agents|protective agents|mesh-ancestor
65258600|NCT05658692|Dopamine Agents|dopamine agents|mesh-ancestor
65258601|NCT05658692|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
65258602|NCT05658692|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64933912|NCT03958383|Nivolumab|nivolumab|mesh-list
65258633|NCT00927511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65258634|NCT00927511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258635|NCT04637594|Pembrolizumab|pembrolizumab|mesh-list
65258637|NCT04637594|Durvalumab|durvalumab|mesh-list
65258638|NCT04637594|Avelumab|avelumab|mesh-list
65258639|NCT04637594|Atezolizumab|atezolizumab|mesh-list
65258640|NCT04637594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65258641|NCT04637594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258642|NCT04637594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65258643|NCT04637594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258644|NCT03211338|Progesterone|progesterone|mesh-list
65258645|NCT03211338|Mitogens|mitogens|mesh-list
65258663|NCT02744196|Abortifacient Agents|abortifacient agents|mesh-ancestor
65008909|NCT02736422|Xenon|xenon|mesh-list
65258664|NCT02744196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65258665|NCT02744196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65258666|NCT02744196|Antimetabolites|antimetabolites|mesh-ancestor
65258667|NCT02744196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258668|NCT02744196|Dermatologic Agents|dermatologic agents|mesh-ancestor
65258669|NCT02744196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65258670|NCT02744196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65258671|NCT02744196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65258672|NCT02744196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65258673|NCT02139852|Capsaicin|capsaicin|mesh-list
65258674|NCT02139852|Antipruritics|antipruritics|mesh-ancestor
65258675|NCT02139852|Dermatologic Agents|dermatologic agents|mesh-ancestor
65258676|NCT02139852|Sensory System Agents|sensory system agents|mesh-ancestor
65258677|NCT02139852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65258678|NCT02139852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258679|NCT05379647|Cyclophosphamide|cyclophosphamide|mesh-list
65258680|NCT05379647|Rituximab|rituximab|mesh-list
65258681|NCT05379647|Fludarabine|fludarabine|mesh-list
65258682|NCT05379647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65258683|NCT05379647|Immunologic Factors|immunologic factors|mesh-ancestor
65258684|NCT05379647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258685|NCT05379647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65258686|NCT05379647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65258687|NCT05379647|Alkylating Agents|alkylating agents|mesh-ancestor
65258688|NCT05379647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342112|NCT00723164|Narcotics|narcotics|mesh-ancestor
65342113|NCT00723164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65342114|NCT00723164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342115|NCT00723164|Analgesics|analgesics|mesh-ancestor
65342116|NCT00723164|Sensory System Agents|sensory system agents|mesh-ancestor
65342117|NCT00723164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65342118|NCT00723164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65342119|NCT00723164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65342120|NCT00723164|Anesthetics, General|anesthetics, general|mesh-ancestor
65342121|NCT00723164|Anesthetics|anesthetics|mesh-ancestor
65342122|NCT00723164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65342123|NCT00723164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65342124|NCT00723164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65342125|NCT00723164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65342126|NCT00723164|GABA Modulators|gaba modulators|mesh-ancestor
65342127|NCT00723164|GABA Agents|gaba agents|mesh-ancestor
65342128|NCT00723164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65342129|NCT00723164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342130|NCT00723242|Ribavirin|ribavirin|mesh-list
65342131|NCT00723242|Antimetabolites|antimetabolites|mesh-ancestor
65342132|NCT00723242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342133|NCT00723242|Antiviral Agents|antiviral agents|mesh-ancestor
65342134|NCT00723242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65342135|NCT02545426|Dialysis Solutions|dialysis solutions|mesh-list
65342136|NCT02545426|Calcium|calcium|mesh-list
64331684|NCT04969133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258689|NCT05379647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258690|NCT05379647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65258691|NCT05379647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65258692|NCT02748330|Aspirin|aspirin|mesh-list
65258693|NCT02748330|Clopidogrel|clopidogrel|mesh-list
65258694|NCT02748330|Ticagrelor|ticagrelor|mesh-list
65258695|NCT02748330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65258696|NCT02748330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65258697|NCT02748330|Analgesics|analgesics|mesh-ancestor
65258698|NCT02748330|Sensory System Agents|sensory system agents|mesh-ancestor
65258699|NCT02748330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65258700|NCT02748330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258728|NCT02818556|Immunologic Factors|immunologic factors|mesh-ancestor
65258729|NCT02818556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258730|NCT02818556|Viscosupplements|viscosupplements|mesh-ancestor
65258731|NCT02818556|Protective Agents|protective agents|mesh-ancestor
65258732|NCT04171128|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65258733|NCT04171128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65258734|NCT04238936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65258735|NCT04238936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65258737|NCT04627142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65258738|NCT04627142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65258739|NCT04627142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65258740|NCT04627142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342137|NCT02545426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65342138|NCT02545426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342139|NCT02545426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65342140|NCT00720824|Anesthetics|anesthetics|mesh-list
65342141|NCT00720824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65342142|NCT00720824|Anesthetics, Local|anesthetics, local|mesh-list
65342143|NCT00720824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65342144|NCT00720824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342145|NCT00720824|Sensory System Agents|sensory system agents|mesh-ancestor
65342146|NCT00720824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65342147|NCT05373134|Pentoxifylline|pentoxifylline|mesh-list
65258741|NCT04627142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258742|NCT00936221|Dacarbazine|dacarbazine|mesh-list
65258743|NCT00936221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65258744|NCT00936221|Alkylating Agents|alkylating agents|mesh-ancestor
65258745|NCT00936221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258778|NCT02747940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65258780|NCT02747940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65258781|NCT02747940|Histamine Antagonists|histamine antagonists|mesh-ancestor
65258782|NCT02747940|Histamine Agents|histamine agents|mesh-ancestor
65258783|NCT02747940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65258784|NCT02747940|Vasodilator Agents|vasodilator agents|mesh-ancestor
65258785|NCT04238702|Empagliflozin|empagliflozin|mesh-list
65258786|NCT04238702|Losartan|losartan|mesh-list
65258787|NCT04238702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64934095|NCT04551482|Oxytocin|oxytocin|mesh-list
65258823|NCT02743572|Hematinics|hematinics|mesh-ancestor
65258859|NCT02743260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65258860|NCT02743260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65258861|NCT02743260|Protease Inhibitors|protease inhibitors|mesh-ancestor
65258862|NCT02743260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934174|NCT00078247|Antiviral Agents|antiviral agents|mesh-ancestor
65258898|NCT00934661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258899|NCT00934661|Analgesics|analgesics|mesh-ancestor
65258900|NCT00934661|Sensory System Agents|sensory system agents|mesh-ancestor
64934223|NCT01350128|Bromides|bromides|mesh-list
65258933|NCT02743104|Anesthetics|anesthetics|mesh-ancestor
65258934|NCT02743104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65258935|NCT02743104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258936|NCT02743104|Sensory System Agents|sensory system agents|mesh-ancestor
65258937|NCT02743104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65258938|NCT02743104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65258939|NCT02743104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65258940|NCT02743104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65258941|NCT02743104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65258942|NCT02743104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258943|NCT02743104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65258944|NCT02743104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65258945|NCT02743104|Anesthetics, General|anesthetics, general|mesh-ancestor
65258946|NCT02743104|Analgesics|analgesics|mesh-ancestor
65258976|NCT00775203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65258977|NCT00775203|Serotonin Agents|serotonin agents|mesh-ancestor
65258978|NCT00775203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65258979|NCT00775203|Antidepressive Agents|antidepressive agents|mesh-ancestor
65258980|NCT02816684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65258981|NCT02816684|Antiviral Agents|antiviral agents|mesh-ancestor
65258982|NCT02816684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65258984|NCT00607217|Immunologic Factors|immunologic factors|mesh-ancestor
65258985|NCT00607217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258986|NCT02747316|Iron|iron|mesh-list
65258987|NCT02747316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65258988|NCT02747316|Trace Elements|trace elements|mesh-ancestor
65258989|NCT02747316|Micronutrients|micronutrients|mesh-ancestor
65342148|NCT05373134|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65342149|NCT05373134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342150|NCT05373134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342151|NCT05373134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65342152|NCT05373134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65342153|NCT05373134|Protective Agents|protective agents|mesh-ancestor
64724129|NCT00000781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65258990|NCT02747316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258991|NCT05648708|Bupivacaine|bupivacaine|mesh-list
65258992|NCT05648708|Prilocaine|prilocaine|mesh-list
65259005|NCT00636246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65259006|NCT00636246|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65259007|NCT00636246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65259008|NCT00636246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65259009|NCT00636246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259010|NCT00636246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65259011|NCT00636246|Serotonin Agents|serotonin agents|mesh-ancestor
65259012|NCT00636246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259013|NCT00636246|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65259014|NCT00636246|Adrenergic Agents|adrenergic agents|mesh-ancestor
65259015|NCT02819570|Ampicillin|ampicillin|mesh-list
65259016|NCT02819570|Cefuroxime|cefuroxime|mesh-list
65259017|NCT02819570|Cefuroxime axetil|cefuroxime axetil|mesh-list
65259018|NCT02819570|Roxithromycin|roxithromycin|mesh-list
65259019|NCT02819570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65259020|NCT02819570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65259021|NCT04239170|Gemcitabine|gemcitabine|mesh-list
65259022|NCT04239170|Oxaliplatin|oxaliplatin|mesh-list
65259023|NCT04239170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65259024|NCT04239170|Antimetabolites|antimetabolites|mesh-ancestor
65259025|NCT04239170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259026|NCT04239170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259027|NCT04239170|Antiviral Agents|antiviral agents|mesh-ancestor
65259028|NCT04239170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65259029|NCT04239170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259030|NCT04239170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65259031|NCT04239170|Immunologic Factors|immunologic factors|mesh-ancestor
65259032|NCT04239170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259033|NCT04480190|Gemcitabine|gemcitabine|mesh-list
65259034|NCT04480190|Fluorouracil|fluorouracil|mesh-list
65259035|NCT04480190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259036|NCT04480190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65259037|NCT04480190|Antimetabolites|antimetabolites|mesh-ancestor
65259038|NCT04480190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259039|NCT04480190|Antiviral Agents|antiviral agents|mesh-ancestor
65009281|NCT00131261|Dexamethasone|dexamethasone|mesh-list
65259040|NCT04480190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65259041|NCT04480190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259042|NCT04480190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65259043|NCT04480190|Immunologic Factors|immunologic factors|mesh-ancestor
65259044|NCT04480190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259045|NCT02741856|Paclitaxel|paclitaxel|mesh-list
65259046|NCT02741856|Carboplatin|carboplatin|mesh-list
65259047|NCT02741856|Capecitabine|capecitabine|mesh-list
65259048|NCT02741856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65259049|NCT02741856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259050|NCT02741856|Tubulin Modulators|tubulin modulators|mesh-ancestor
65259051|NCT02741856|Antimitotic Agents|antimitotic agents|mesh-ancestor
65259052|NCT02741856|Mitosis Modulators|mitosis modulators|mesh-ancestor
65259053|NCT02741856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259054|NCT02741856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65259055|NCT02741856|Antimetabolites|antimetabolites|mesh-ancestor
65259056|NCT02741232|Lidocaine|lidocaine|mesh-list
65259084|NCT04237922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65259085|NCT04237922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65259086|NCT04237922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65259087|NCT04237922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65259088|NCT04237922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65342154|NCT05373134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342155|NCT05373134|Vasodilator Agents|vasodilator agents|mesh-ancestor
65342156|NCT05373134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65342157|NCT05373134|Antioxidants|antioxidants|mesh-ancestor
65342158|NCT00723320|Atorvastatin|atorvastatin|mesh-list
65342159|NCT00723320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65342160|NCT00723320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65342161|NCT00723320|Antimetabolites|antimetabolites|mesh-ancestor
65342162|NCT00723320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342163|NCT00723320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65342164|NCT00723320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65342165|NCT00723320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342166|NCT00578448|Abatacept|abatacept|mesh-list
65342167|NCT00578448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65342168|NCT00578448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342169|NCT00578448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342170|NCT00578448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65342171|NCT00578448|Immunologic Factors|immunologic factors|mesh-ancestor
65259089|NCT04237922|Purinergic Agents|purinergic agents|mesh-ancestor
65259090|NCT04237922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65259091|NCT04237922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259092|NCT04237922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259094|NCT04239014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65259095|NCT04239014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259096|NCT04239014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259097|NCT04239014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259098|NCT00568321|Tanezumab|tanezumab|mesh-list
65259099|NCT00568321|Analgesics|analgesics|mesh-ancestor
65259100|NCT00568321|Sensory System Agents|sensory system agents|mesh-ancestor
65259101|NCT00568321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65259102|NCT00568321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259128|NCT04661930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65259129|NCT04661930|Antimetabolites|antimetabolites|mesh-ancestor
65259130|NCT04661930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259131|NCT04661930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65259132|NCT02815046|Botulinum Toxins|botulinum toxins|mesh-list
65259133|NCT02815046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65259134|NCT02815046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65259135|NCT02815046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65259136|NCT02815046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65259137|NCT02815046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259138|NCT02815046|Cholinergic Agents|cholinergic agents|mesh-ancestor
65259139|NCT02815046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65259140|NCT02815046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259141|NCT02815046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65259142|NCT02815046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65259144|NCT02601963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65259145|NCT02601963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65259146|NCT00927979|Ropivacaine|ropivacaine|mesh-list
65259147|NCT00927979|Anesthetics, Local|anesthetics, local|mesh-ancestor
65259148|NCT00927979|Anesthetics|anesthetics|mesh-ancestor
65259149|NCT00927979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65259150|NCT00927979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259151|NCT00927979|Sensory System Agents|sensory system agents|mesh-ancestor
65342172|NCT00578448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342173|NCT00578448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65342174|NCT00720564|Temozolomide|temozolomide|mesh-list
65342175|NCT00720564|Arsenic Trioxide|arsenic trioxide|mesh-list
65342176|NCT00720564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65342177|NCT00720564|Alkylating Agents|alkylating agents|mesh-ancestor
65342178|NCT00720564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342179|NCT00720564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342180|NCT00714090|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65342181|NCT00714090|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65342182|NCT00714090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65259152|NCT00927979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65259185|NCT02731950|Anesthetics|anesthetics|mesh-ancestor
65259186|NCT02731950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65259187|NCT02731950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259188|NCT02731950|Sensory System Agents|sensory system agents|mesh-ancestor
65259189|NCT02731950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65259190|NCT02731950|Analgesics|analgesics|mesh-ancestor
65259191|NCT02731950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65259192|NCT02731950|Anticonvulsants|anticonvulsants|mesh-ancestor
65259193|NCT02731950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65259194|NCT02731950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65259214|NCT00928213|Progesterone|progesterone|mesh-list
65259215|NCT00928213|Hormones|hormones|mesh-ancestor
65259216|NCT00928213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65259217|NCT00928213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259218|NCT00928213|Anticoagulants|anticoagulants|mesh-ancestor
65259219|NCT00928213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65259220|NCT00928213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65259221|NCT00928213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259222|NCT00928213|Progestins|progestins|mesh-ancestor
65259223|NCT00928291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65259224|NCT00928291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65259225|NCT02736240|Vaccines|vaccines|mesh-list
65259226|NCT02736240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65259227|NCT02736240|Immunologic Factors|immunologic factors|mesh-ancestor
65259228|NCT02736240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259229|NCT02741154|Letrozole|letrozole|mesh-list
65259230|NCT02741154|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65259231|NCT02741154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259232|NCT02741154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65259233|NCT02741154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65259234|NCT02741154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259235|NCT02741154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259236|NCT02741154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65259237|NCT02741154|Hormone Antagonists|hormone antagonists|mesh-ancestor
65259238|NCT02741154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65259239|NCT02741154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259240|NCT02741154|Luteolytic Agents|luteolytic agents|mesh-ancestor
65259241|NCT02741154|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65259242|NCT02741154|Contraceptive Agents|contraceptive agents|mesh-ancestor
65259243|NCT02741154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65259244|NCT02741154|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65259245|NCT02741154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65259246|NCT04287816|Antithrombin III|antithrombin iii|mesh-list
65259247|NCT04287816|Antithrombins|antithrombins|mesh-list
65259248|NCT04287816|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65259280|NCT02814110|Immunologic Factors|immunologic factors|mesh-ancestor
65259281|NCT02814110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259282|NCT00928525|Imatinib Mesylate|imatinib mesylate|mesh-list
65259283|NCT00928525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342183|NCT00714090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65342184|NCT00714090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342185|NCT00714090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65342186|NCT00714090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342187|NCT00714090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65259284|NCT00928525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65259285|NCT00928525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259286|NCT00928525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259287|NCT04264481|Lidocaine|lidocaine|mesh-list
65259288|NCT04264481|Anesthetics, Local|anesthetics, local|mesh-ancestor
65259289|NCT04264481|Anesthetics|anesthetics|mesh-ancestor
65259290|NCT04264481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65259304|NCT05303909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259306|NCT04306692|Clomiphene|clomiphene|mesh-list
65259307|NCT04306692|Enclomiphene|enclomiphene|mesh-list
65259308|NCT04306692|Zuclomiphene|zuclomiphene|mesh-list
65259309|NCT04306692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65259310|NCT04306692|Hormone Antagonists|hormone antagonists|mesh-ancestor
65259311|NCT04306692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65259312|NCT04306692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259313|NCT04306692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65259314|NCT04306692|Fertility Agents|fertility agents|mesh-ancestor
65259315|NCT04306692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65259316|NCT04306692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65259317|NCT04306692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65259318|NCT04306692|Vitamin B Complex|vitamin b complex|mesh-ancestor
65259319|NCT04306692|Vitamins|vitamins|mesh-ancestor
65259320|NCT04306692|Micronutrients|micronutrients|mesh-ancestor
65259321|NCT00772941|Varenicline|varenicline|mesh-list
65259322|NCT00772941|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65259323|NCT00772941|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65259324|NCT00772941|Cholinergic Agents|cholinergic agents|mesh-ancestor
65259325|NCT00772941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65259326|NCT00772941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259327|NCT00772941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259328|NCT02735694|Cycloserine|cycloserine|mesh-list
65259329|NCT02735694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65259330|NCT02735694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65259331|NCT02735694|Renal Agents|renal agents|mesh-ancestor
65259332|NCT02735694|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65259333|NCT02735694|Antitubercular Agents|antitubercular agents|mesh-ancestor
65259334|NCT02735694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65259335|NCT02735694|Antimetabolites|antimetabolites|mesh-ancestor
65259336|NCT02735694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259337|NCT05345717|Abatacept|abatacept|mesh-list
65009579|NCT00132548|Renal Agents|renal agents|mesh-ancestor
65259338|NCT05345717|Proteasome Inhibitors|proteasome inhibitors|mesh-list
65259339|NCT05345717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65259340|NCT05345717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259341|NCT05345717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259342|NCT05345717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65259343|NCT05345717|Immunologic Factors|immunologic factors|mesh-ancestor
65259344|NCT05345717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259345|NCT05345717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65259346|NCT05345717|Protease Inhibitors|protease inhibitors|mesh-ancestor
65259347|NCT05345717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259348|NCT04717375|Pembrolizumab|pembrolizumab|mesh-list
65259349|NCT04717375|Cetuximab|cetuximab|mesh-list
65259382|NCT02730936|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65259383|NCT00925093|Vancomycin|vancomycin|mesh-list
65259384|NCT00925093|Linezolid|linezolid|mesh-list
65259385|NCT00925093|Teicoplanin|teicoplanin|mesh-list
65259386|NCT00925093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65259387|NCT00925093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65259388|NCT00925093|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65259389|NCT00925093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934698|NCT00080782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65259411|NCT00607685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259412|NCT00607685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65342188|NCT00714090|Antidepressive Agents|antidepressive agents|mesh-ancestor
65342189|NCT00714090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65342190|NCT04067024|Anesthetics|anesthetics|mesh-list
65342191|NCT04067024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65342192|NCT04067024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342193|NCT00618748|Olanzapine|olanzapine|mesh-list
65342194|NCT00618748|Antiemetics|antiemetics|mesh-ancestor
65259413|NCT00607685|Immunologic Factors|immunologic factors|mesh-ancestor
65259414|NCT00607685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259415|NCT00607685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65259416|NCT00607685|Viscosupplements|viscosupplements|mesh-ancestor
65259417|NCT00607685|Protective Agents|protective agents|mesh-ancestor
65259418|NCT05450718|Buprenorphine|buprenorphine|mesh-list
65259419|NCT05450718|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65259420|NCT05450718|Naloxone|naloxone|mesh-list
65259421|NCT05450718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65259422|NCT05450718|Narcotics|narcotics|mesh-ancestor
65259423|NCT05450718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65259424|NCT05450718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259425|NCT05450718|Analgesics|analgesics|mesh-ancestor
65259426|NCT05450718|Sensory System Agents|sensory system agents|mesh-ancestor
65259427|NCT05450718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65259428|NCT05450718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65259429|NCT04265027|Opicapone|opicapone|mesh-list
65259430|NCT04265027|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65259431|NCT04265027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259432|NCT04265027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259433|NCT04265027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65259434|NCT04265027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65259435|NCT00607763|Micafungin|micafungin|mesh-list
65259436|NCT00607763|Antifungal Agents|antifungal agents|mesh-ancestor
65259437|NCT00607763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65259438|NCT00928915|Thrombin|thrombin|mesh-list
65259439|NCT00928915|Hemostatics|hemostatics|mesh-ancestor
65259440|NCT00928915|Coagulants|coagulants|mesh-ancestor
65259441|NCT02814500|Amlodipine|amlodipine|mesh-list
65259442|NCT02814500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65259443|NCT02814500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65259444|NCT02814500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65259475|NCT00925327|Riboflavin|riboflavin|mesh-list
65259476|NCT00925327|Vitamin B Complex|vitamin b complex|mesh-ancestor
65259477|NCT00925327|Vitamins|vitamins|mesh-ancestor
65259478|NCT00925327|Micronutrients|micronutrients|mesh-ancestor
65259479|NCT00925327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259480|NCT00925327|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65259481|NCT00925327|Dermatologic Agents|dermatologic agents|mesh-ancestor
65259482|NCT04237376|Tenofovir|tenofovir|mesh-list
65259483|NCT04237376|Antiviral Agents|antiviral agents|mesh-ancestor
65259484|NCT04237376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65259485|NCT04237376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65259509|NCT02739672|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65259510|NCT02739672|Telmisartan|telmisartan|mesh-list
65259511|NCT02739672|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
65259512|NCT02739672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65259513|NCT02739672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65259514|NCT02739672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65259515|NCT02739672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259516|NCT02739672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65259517|NCT02739672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259518|NCT02739672|Vasodilator Agents|vasodilator agents|mesh-ancestor
65259519|NCT02739672|Diuretics|diuretics|mesh-ancestor
65259520|NCT02739672|Natriuretic Agents|natriuretic agents|mesh-ancestor
65259521|NCT02739672|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65259522|NCT02739672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65259523|NCT02739672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65259524|NCT00932971|Tenofovir|tenofovir|mesh-list
65259525|NCT00932971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65259526|NCT00932971|Interferon-alpha|interferon-alpha|mesh-list
65259527|NCT00932971|Interferon alpha-2|interferon alpha-2|mesh-list
65259528|NCT00932971|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65259529|NCT00932971|Antiviral Agents|antiviral agents|mesh-ancestor
65342195|NCT00618748|Autonomic Agents|autonomic agents|mesh-ancestor
65342196|NCT00618748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65342197|NCT00618748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259530|NCT00932971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65259531|NCT00932971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64934843|NCT00081835|Immunoglobulins|immunoglobulins|mesh-list
65259565|NCT05788393|Anesthetics|anesthetics|mesh-ancestor
65259566|NCT05788393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65259567|NCT05788393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259568|NCT05788393|Sensory System Agents|sensory system agents|mesh-ancestor
65259569|NCT05788393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65259570|NCT05788393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64934879|NCT00082537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65259590|NCT05788159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65259592|NCT05788159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65259593|NCT05788159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259594|NCT05788094|Chloroquine|chloroquine|mesh-list
65259595|NCT05788094|Piperaquine|piperaquine|mesh-list
65259596|NCT05788094|Artenimol|artenimol|mesh-list
65259597|NCT05788094|Tafenoquine|tafenoquine|mesh-list
65259598|NCT05788094|Amebicides|amebicides|mesh-ancestor
65259599|NCT05788094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65259600|NCT05788094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65259601|NCT05788094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65259602|NCT05788094|Antimalarials|antimalarials|mesh-ancestor
65259603|NCT05788094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65259604|NCT05788016|Analgesics, Opioid|analgesics, opioid|mesh-list
65259605|NCT05788016|Narcotics|narcotics|mesh-ancestor
65259606|NCT05788016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65259607|NCT05788016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259608|NCT05788016|Analgesics|analgesics|mesh-ancestor
65259609|NCT05788016|Sensory System Agents|sensory system agents|mesh-ancestor
65259610|NCT05788016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65259611|NCT05787925|Vitamin E|vitamin e|mesh-list
65259612|NCT05787925|Vitamins|vitamins|mesh-ancestor
65259613|NCT05787925|Micronutrients|micronutrients|mesh-ancestor
65259614|NCT05787925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259615|NCT05787925|Antioxidants|antioxidants|mesh-ancestor
65259616|NCT05787925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259617|NCT05787925|Protective Agents|protective agents|mesh-ancestor
65259618|NCT05787912|Hyaluronic Acid|hyaluronic acid|mesh-list
65259619|NCT05787912|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65259620|NCT05787912|Immunologic Factors|immunologic factors|mesh-ancestor
65259621|NCT05787912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259622|NCT05787912|Viscosupplements|viscosupplements|mesh-ancestor
65259623|NCT05787912|Protective Agents|protective agents|mesh-ancestor
65259624|NCT05787808|Vitamin D|vitamin d|mesh-list
65259625|NCT05787808|Vitamins|vitamins|mesh-ancestor
65259655|NCT05787535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259656|NCT05787535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65259657|NCT05787535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65259658|NCT05787535|Alkylating Agents|alkylating agents|mesh-ancestor
65259659|NCT05787535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259660|NCT05787535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259661|NCT05787535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65259663|NCT05787509|Progestins|progestins|mesh-ancestor
65259664|NCT05787509|Hormones|hormones|mesh-ancestor
65259665|NCT05787509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65259666|NCT05787509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259667|NCT05787002|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65259668|NCT05787002|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65259669|NCT05787002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65259670|NCT05787002|Antimetabolites|antimetabolites|mesh-ancestor
65259671|NCT05787002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259672|NCT05787002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65259698|NCT05786885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259699|NCT05786885|Antioxidants|antioxidants|mesh-ancestor
65259700|NCT05786885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259701|NCT05786885|Protective Agents|protective agents|mesh-ancestor
65259702|NCT05786859|Rifaximin|rifaximin|mesh-list
65259703|NCT05786859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65259704|NCT05786859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65259705|NCT05786859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65342198|NCT00618748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65342199|NCT00618748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65342200|NCT00618748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65342201|NCT00618748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65342202|NCT00618748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65342203|NCT00618748|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65342204|NCT00618748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65342205|NCT00618748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65342206|NCT00618748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342207|NCT00618748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65342208|NCT00618748|Serotonin Agents|serotonin agents|mesh-ancestor
65342209|NCT04067102|Paclitaxel|paclitaxel|mesh-list
65342210|NCT04067102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64724188|NCT00000811|Azithromycin|azithromycin|mesh-list
65259706|NCT05786820|Pycnogenols|pycnogenols|mesh-list
65259707|NCT05786820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65259708|NCT05786820|Immunologic Factors|immunologic factors|mesh-ancestor
65259709|NCT05786820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259710|NCT05786820|Antioxidants|antioxidants|mesh-ancestor
65259711|NCT05786820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259712|NCT05786820|Protective Agents|protective agents|mesh-ancestor
65009947|NCT00133757|Dopamine Agents|dopamine agents|mesh-ancestor
65259713|NCT05786820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65259714|NCT05786768|Rituximab|rituximab|mesh-list
65259715|NCT05786768|Obinutuzumab|obinutuzumab|mesh-list
65259716|NCT05786768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65259717|NCT05786768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259718|NCT05786768|Immunologic Factors|immunologic factors|mesh-ancestor
65259719|NCT05786768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259720|NCT05786768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65259721|NCT05785897|Sirolimus|sirolimus|mesh-list
65259722|NCT05785897|Ticagrelor|ticagrelor|mesh-list
64935024|NCT00083785|Talaporfin|talaporfin|mesh-list
65259755|NCT05770297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65259756|NCT05765084|Pemetrexed|pemetrexed|mesh-list
65259757|NCT05765084|Atezolizumab|atezolizumab|mesh-list
65259758|NCT05765084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259759|NCT05765084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259760|NCT05765084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259761|NCT05765084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65259762|NCT05765084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65259783|NCT05763121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65259785|NCT05760378|Capecitabine|capecitabine|mesh-list
65259786|NCT05760378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259787|NCT05760378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65259788|NCT05760378|Antimetabolites|antimetabolites|mesh-ancestor
65259789|NCT05760378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259790|NCT05748600|Pramipexole|pramipexole|mesh-list
65259791|NCT05748600|Antioxidants|antioxidants|mesh-ancestor
65259792|NCT05748600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259793|NCT05748600|Protective Agents|protective agents|mesh-ancestor
65259794|NCT05748600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259795|NCT05748600|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65259796|NCT05748600|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65259797|NCT05748600|Dopamine Agonists|dopamine agonists|mesh-ancestor
65259798|NCT05748600|Dopamine Agents|dopamine agents|mesh-ancestor
65259799|NCT05748600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65259800|NCT05739136|Norethindrone|norethindrone|mesh-list
65259801|NCT05739136|Norethindrone Acetate|norethindrone acetate|mesh-list
65259803|NCT05739136|Relugolix|relugolix|mesh-list
65259804|NCT05739136|Estrogens|estrogens|mesh-ancestor
65259805|NCT05739136|Hormones|hormones|mesh-ancestor
65342211|NCT04067102|Cyclophosphamide|cyclophosphamide|mesh-list
65342212|NCT04067102|Carboplatin|carboplatin|mesh-list
65342213|NCT04067102|Epirubicin|epirubicin|mesh-list
65342214|NCT04067102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65342215|NCT04067102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342216|NCT04067102|Tubulin Modulators|tubulin modulators|mesh-ancestor
65342217|NCT04067102|Antimitotic Agents|antimitotic agents|mesh-ancestor
65259806|NCT05739136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65259807|NCT05739136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259808|NCT05739136|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65259809|NCT05739136|Contraceptive Agents|contraceptive agents|mesh-ancestor
65259810|NCT05739136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65259811|NCT05739136|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65259812|NCT05739136|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65259813|NCT05739136|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65259814|NCT05739136|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65259815|NCT05739136|Androgen Antagonists|androgen antagonists|mesh-ancestor
65259816|NCT05739136|Hormone Antagonists|hormone antagonists|mesh-ancestor
65259817|NCT05739123|Relugolix|relugolix|mesh-list
65259818|NCT05739123|Androgen Antagonists|androgen antagonists|mesh-ancestor
65259841|NCT05716295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259843|NCT05715216|Nivolumab|nivolumab|mesh-list
65259844|NCT05715216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65259845|NCT05715216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259846|NCT05715216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65259847|NCT05715216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259848|NCT05708625|Doxycycline|doxycycline|mesh-list
65259849|NCT05708625|Voriconazole|voriconazole|mesh-list
65259850|NCT05708625|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
65259851|NCT05708625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65259852|NCT05708625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65259853|NCT05708625|Antimalarials|antimalarials|mesh-ancestor
65259854|NCT05708625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65259855|NCT05708625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65259856|NCT05708625|Antifungal Agents|antifungal agents|mesh-ancestor
65259857|NCT05708625|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65259858|NCT05708625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65259859|NCT05708625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259860|NCT05708625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259861|NCT05708625|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65259862|NCT05708625|Hormone Antagonists|hormone antagonists|mesh-ancestor
65259863|NCT05708625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65259864|NCT05708625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935170|NCT00135928|Immunologic Factors|immunologic factors|mesh-ancestor
65259887|NCT05702827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259888|NCT05702827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259889|NCT05685628|Charcoal|charcoal|mesh-list
65259890|NCT05685628|Antidotes|antidotes|mesh-ancestor
65259891|NCT05685628|Protective Agents|protective agents|mesh-ancestor
65259892|NCT05685628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259893|NCT05673889|Dabigatran|dabigatran|mesh-list
65259894|NCT05673889|Antithrombins|antithrombins|mesh-ancestor
65259895|NCT05673889|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65259896|NCT05673889|Protease Inhibitors|protease inhibitors|mesh-ancestor
65259897|NCT05673889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259898|NCT05673889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259899|NCT05673889|Anticoagulants|anticoagulants|mesh-ancestor
65259900|NCT05658510|Dexmedetomidine|dexmedetomidine|mesh-list
65259901|NCT05658510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65259902|NCT05658510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65259903|NCT05658510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259904|NCT05658510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65259905|NCT05658510|Analgesics|analgesics|mesh-ancestor
65259906|NCT05658510|Sensory System Agents|sensory system agents|mesh-ancestor
65259907|NCT05658510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65259908|NCT05658510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65259909|NCT05658510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65342218|NCT04067102|Mitosis Modulators|mitosis modulators|mesh-ancestor
65342219|NCT04067102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342220|NCT04067102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65342221|NCT04067102|Immunologic Factors|immunologic factors|mesh-ancestor
65259910|NCT05658510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65259911|NCT05658510|Adrenergic Agents|adrenergic agents|mesh-ancestor
65259912|NCT05658510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65259913|NCT05658510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259914|NCT05654298|Sumatriptan|sumatriptan|mesh-list
65259915|NCT05654298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64935220|NCT00136396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259957|NCT05618613|Onapristone|onapristone|mesh-list
65259958|NCT05618613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259959|NCT05618613|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65259960|NCT05618613|Fertility Agents|fertility agents|mesh-ancestor
65259961|NCT05618613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65259962|NCT05618613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259963|NCT05618613|Hormone Antagonists|hormone antagonists|mesh-ancestor
65259964|NCT05618613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65259965|NCT05617963|Durvalumab|durvalumab|mesh-list
65259966|NCT05617963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65260003|NCT05535309|Sulbactam|sulbactam|mesh-list
65260004|NCT05535309|Cefoperazone|cefoperazone|mesh-list
65260005|NCT05535309|Sulperazone|sulperazone|mesh-list
65260006|NCT05535309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65260007|NCT05535309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65260008|NCT05535309|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65066799|NCT00272597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260009|NCT05535309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260010|NCT05535309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260011|NCT05535309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65260013|NCT05506046|Nicotine|nicotine|mesh-list
65260014|NCT05506046|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65260015|NCT05506046|Autonomic Agents|autonomic agents|mesh-ancestor
65260016|NCT05506046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65260017|NCT05506046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260018|NCT05506046|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65260019|NCT05506046|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65260020|NCT05506046|Cholinergic Agents|cholinergic agents|mesh-ancestor
65260021|NCT05506046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65260022|NCT05506046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260042|NCT05503875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65260043|NCT05503875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65260044|NCT05490381|Ethiodized Oil|ethiodized oil|mesh-list
65260045|NCT05490381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260046|NCT05487950|Rivaroxaban|rivaroxaban|mesh-list
65260047|NCT05487950|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65260048|NCT05487950|Antithrombins|antithrombins|mesh-ancestor
65260049|NCT05487950|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65260050|NCT05487950|Protease Inhibitors|protease inhibitors|mesh-ancestor
65260051|NCT05487950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260052|NCT05487950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260053|NCT05487950|Anticoagulants|anticoagulants|mesh-ancestor
65260054|NCT05487040|Ritonavir|ritonavir|mesh-list
65260055|NCT05487040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65260056|NCT05487040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65260057|NCT05487040|Protease Inhibitors|protease inhibitors|mesh-ancestor
65260058|NCT05487040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260059|NCT05487040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260060|NCT05487040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65260061|NCT05487040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65260062|NCT05487040|Antiviral Agents|antiviral agents|mesh-ancestor
65260063|NCT05487040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65260064|NCT05487040|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65260065|NCT05487040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65260066|NCT05477823|Androgens|androgens|mesh-list
65260067|NCT05477823|Hormones|hormones|mesh-ancestor
65260068|NCT05477823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65260069|NCT05477823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260070|NCT05467761|Psilocybin|psilocybin|mesh-list
65342222|NCT04067102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342223|NCT04067102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65342224|NCT04067102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65342225|NCT04067102|Alkylating Agents|alkylating agents|mesh-ancestor
65342226|NCT04067102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65342227|NCT04067102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65342228|NCT04067102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65342229|NCT04067102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65342230|NCT04067102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342231|NCT05659290|Bevacizumab|bevacizumab|mesh-list
65342232|NCT05659290|Capecitabine|capecitabine|mesh-list
65260071|NCT05467761|Hallucinogens|hallucinogens|mesh-ancestor
65260072|NCT05467761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260073|NCT05467761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65260074|NCT05455320|Dexamethasone|dexamethasone|mesh-list
65260075|NCT05455320|Daratumumab|daratumumab|mesh-list
65260076|NCT05455320|Pomalidomide|pomalidomide|mesh-list
65260077|NCT05455320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65260078|NCT05455320|Antiemetics|antiemetics|mesh-ancestor
65260079|NCT05455320|Autonomic Agents|autonomic agents|mesh-ancestor
65260113|NCT05428826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260114|NCT05428826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65260115|NCT05428826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260116|NCT05427513|Tranexamic Acid|tranexamic acid|mesh-list
65260117|NCT05427513|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65260118|NCT05427513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64935416|NCT00137566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65260156|NCT05408845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260157|NCT05408845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65260179|NCT05386095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65260180|NCT05386095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260181|NCT05386095|Sensory System Agents|sensory system agents|mesh-ancestor
65260182|NCT05386095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65260183|NCT05360264|Decitabine|decitabine|mesh-list
65260184|NCT05360264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65260185|NCT05360264|Antimetabolites|antimetabolites|mesh-ancestor
65260186|NCT05360264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260187|NCT05360264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260188|NCT05360264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260189|NCT05357482|Sirolimus|sirolimus|mesh-list
65260190|NCT05357482|Plerixafor|plerixafor|mesh-list
65260191|NCT05357482|Alemtuzumab|alemtuzumab|mesh-list
65260192|NCT05357482|Hydroxyurea|hydroxyurea|mesh-list
65260193|NCT05357482|Immunologic Factors|immunologic factors|mesh-ancestor
65260194|NCT05357482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260195|NCT05357482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65260196|NCT05357482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65260197|NCT05357482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65260198|NCT05357482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260199|NCT05357482|Antifungal Agents|antifungal agents|mesh-ancestor
65260200|NCT05357482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65260201|NCT05357482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65260202|NCT05357482|Antisickling Agents|antisickling agents|mesh-ancestor
65260203|NCT05357482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260204|NCT05357482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260205|NCT05357482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65260206|NCT05357482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65260207|NCT05357482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65260208|NCT05357482|Antiviral Agents|antiviral agents|mesh-ancestor
65260209|NCT05327686|Pembrolizumab|pembrolizumab|mesh-list
65260210|NCT05327686|Nivolumab|nivolumab|mesh-list
65260211|NCT05327686|Ipilimumab|ipilimumab|mesh-list
65260212|NCT05327686|Avelumab|avelumab|mesh-list
65260229|NCT05323812|Protective Agents|protective agents|mesh-ancestor
65260230|NCT05323812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342233|NCT05659290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65342234|NCT05659290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342235|NCT05659290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65342236|NCT05659290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65342237|NCT05659290|Growth Substances|growth substances|mesh-ancestor
65342238|NCT05659290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342239|NCT05659290|Growth Inhibitors|growth inhibitors|mesh-ancestor
65342240|NCT05659290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65342241|NCT05659290|Antimetabolites|antimetabolites|mesh-ancestor
65342242|NCT05659290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342243|NCT00717678|Mycophenolic Acid|mycophenolic acid|mesh-list
65342244|NCT00717678|Tacrolimus|tacrolimus|mesh-list
65342245|NCT00717678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65342246|NCT00717678|Immunologic Factors|immunologic factors|mesh-ancestor
65342247|NCT00717678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342248|NCT00717678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64724228|NCT00000823|Zidovudine|zidovudine|mesh-list
65260231|NCT05321524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
65260233|NCT05321524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65260234|NCT05306873|Mycophenolic Acid|mycophenolic acid|mesh-list
65260235|NCT05306873|Cyclosporine|cyclosporine|mesh-list
65260236|NCT05306873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65260237|NCT05306873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260238|NCT05306873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65260239|NCT05306873|Antitubercular Agents|antitubercular agents|mesh-ancestor
65260240|NCT05306873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65260241|NCT05306873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65260242|NCT05306873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260243|NCT05306873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260244|NCT05306873|Antifungal Agents|antifungal agents|mesh-ancestor
65260245|NCT05306873|Dermatologic Agents|dermatologic agents|mesh-ancestor
65260246|NCT05306873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65260247|NCT05306873|Immunologic Factors|immunologic factors|mesh-ancestor
65260248|NCT05306873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260249|NCT05306873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65260250|NCT05306873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65260251|NCT05286060|Pembrolizumab|pembrolizumab|mesh-list
65260252|NCT05286060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65260253|NCT05286060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260254|NCT05280496|Metformin|metformin|mesh-list
65260255|NCT05280496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65260256|NCT05280496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260257|NCT05280457|Nivolumab|nivolumab|mesh-list
65260258|NCT05280457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65260259|NCT05280457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260260|NCT05280457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65260261|NCT05280457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260262|NCT05279937|Lidocaine|lidocaine|mesh-list
65260263|NCT05279937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65260264|NCT05279937|Anesthetics, Local|anesthetics, local|mesh-ancestor
65260265|NCT05279937|Anesthetics|anesthetics|mesh-ancestor
65260266|NCT05279937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65260267|NCT05279937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260268|NCT05279937|Sensory System Agents|sensory system agents|mesh-ancestor
65260269|NCT05279937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65260270|NCT05279937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65260301|NCT05247268|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65342249|NCT00717678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342250|NCT00717678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342251|NCT00717678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65260303|NCT05247268|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65260304|NCT05247268|Contraceptive Agents|contraceptive agents|mesh-ancestor
65260305|NCT05247268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65260306|NCT05247268|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65260307|NCT05247268|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65260308|NCT05247268|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65260309|NCT05247268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65010552|NCT00152958|Pramipexole|pramipexole|mesh-list
65260319|NCT05211804|Growth Inhibitors|growth inhibitors|mesh-ancestor
65260342|NCT05095376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65260344|NCT05095376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260345|NCT05095376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260355|NCT05084586|Epirubicin|epirubicin|mesh-list
65260356|NCT05084586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65260357|NCT05084586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65260358|NCT05084586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260359|NCT05084586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65260360|NCT05084586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65260361|NCT05084586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260362|NCT05084586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260363|NCT05077085|Vancomycin|vancomycin|mesh-list
65260364|NCT05077085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65260365|NCT05077085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65260366|NCT05059626|Bazedoxifene|bazedoxifene|mesh-list
65260367|NCT05059626|Simvastatin|simvastatin|mesh-list
65260368|NCT05059626|Estrogens|estrogens|mesh-list
65260369|NCT05059626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65260370|NCT05059626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65260371|NCT05059626|Antimetabolites|antimetabolites|mesh-ancestor
65260372|NCT05059626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260373|NCT05059626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65260374|NCT05059626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65260375|NCT05059626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260376|NCT05059626|Hormones|hormones|mesh-ancestor
65260377|NCT05059626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65260378|NCT05059626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260379|NCT05059626|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64935648|NCT00139165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65260402|NCT05050084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65260403|NCT05050084|Fertility Agents|fertility agents|mesh-ancestor
65260404|NCT05050084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65260405|NCT05050084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65260406|NCT05050084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260407|NCT05050084|Androgen Antagonists|androgen antagonists|mesh-ancestor
65260408|NCT05050084|Hormone Antagonists|hormone antagonists|mesh-ancestor
65260409|NCT05050084|Luteolytic Agents|luteolytic agents|mesh-ancestor
65260410|NCT05050084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65260411|NCT05050084|Contraceptive Agents|contraceptive agents|mesh-ancestor
65260412|NCT05050084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65260413|NCT05050084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65260414|NCT05050084|Antidepressive Agents|antidepressive agents|mesh-ancestor
65260415|NCT05050084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65260416|NCT05035407|Aldesleukin|aldesleukin|mesh-list
65260417|NCT05035407|Cyclophosphamide|cyclophosphamide|mesh-list
65260418|NCT05035407|Fludarabine|fludarabine|mesh-list
65260419|NCT05035407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65260420|NCT05035407|Immunologic Factors|immunologic factors|mesh-ancestor
65260421|NCT05035407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260422|NCT05035407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65260423|NCT05035407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65260424|NCT05035407|Alkylating Agents|alkylating agents|mesh-ancestor
65260425|NCT05035407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260426|NCT05035407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260427|NCT05035407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65260428|NCT05035407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65260429|NCT05035407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65260430|NCT05035407|Antiviral Agents|antiviral agents|mesh-ancestor
65342252|NCT00717678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342253|NCT00717678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65342254|NCT00717678|Antitubercular Agents|antitubercular agents|mesh-ancestor
65342255|NCT00717678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65342256|NCT00717678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724239|NCT00000379|Fluoxetine|fluoxetine|mesh-list
65260431|NCT05035407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65260432|NCT05009992|TIC10 compound|tic10 compound|mesh-list
65260433|NCT05009992|Dopamine|dopamine|mesh-list
65260434|NCT05009992|GDC-0084|gdc-0084|mesh-list
65260435|NCT05009992|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65260457|NCT04973930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65260459|NCT04973930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65260460|NCT04973930|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65260461|NCT04972942|Daratumumab|daratumumab|mesh-list
65260462|NCT04972942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260463|NCT04930744|Metformin|metformin|mesh-list
65260464|NCT04930744|Rifampin|rifampin|mesh-list
65260465|NCT04930744|Isoniazid|isoniazid|mesh-list
65260466|NCT04930744|Pyrazinamide|pyrazinamide|mesh-list
65260467|NCT04930744|Ethambutol|ethambutol|mesh-list
65260468|NCT04930744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65260469|NCT04930744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260470|NCT04930744|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65260471|NCT04930744|Antitubercular Agents|antitubercular agents|mesh-ancestor
65260472|NCT04930744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65260473|NCT04930744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65260474|NCT04930744|Leprostatic Agents|leprostatic agents|mesh-ancestor
65260475|NCT04930744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65260476|NCT04930744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260477|NCT04930744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260478|NCT04930744|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65260479|NCT04930744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65260480|NCT04930744|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65260481|NCT04930744|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65260482|NCT04930744|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65260483|NCT04930744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65260484|NCT04930744|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65260485|NCT04930744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64935758|NCT03837977|Leucovorin|leucovorin|mesh-list
65260508|NCT04877093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260510|NCT04866017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65260511|NCT04866017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260512|NCT04850911|Ketamine|ketamine|mesh-list
65260513|NCT04850911|Analgesics|analgesics|mesh-ancestor
65260514|NCT04850911|Sensory System Agents|sensory system agents|mesh-ancestor
65260515|NCT04850911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65260516|NCT04850911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260517|NCT04850911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65260518|NCT04850911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65260519|NCT04850911|Anesthetics, General|anesthetics, general|mesh-ancestor
65260520|NCT04850911|Anesthetics|anesthetics|mesh-ancestor
65260521|NCT04850911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65260522|NCT04850911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65260523|NCT04850911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65260524|NCT04850911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65260525|NCT04850911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260526|NCT04836533|Antidepressive Agents|antidepressive agents|mesh-list
65260527|NCT04836533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65260528|NCT04828694|Naltrexone|naltrexone|mesh-list
65260529|NCT04828694|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65260530|NCT04828694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65260531|NCT04828694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260532|NCT04828694|Sensory System Agents|sensory system agents|mesh-ancestor
65260533|NCT04828694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65260534|NCT04827056|Ethanol|ethanol|mesh-list
65260535|NCT04827056|Dexmedetomidine|dexmedetomidine|mesh-list
65260542|NCT04827056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65260570|NCT04804644|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65342257|NCT05145296|Daratumumab|daratumumab|mesh-list
65342258|NCT05145296|Abatacept|abatacept|mesh-list
65342259|NCT05145296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342260|NCT05145296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65342261|NCT05145296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342262|NCT05145296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65342263|NCT05145296|Immunologic Factors|immunologic factors|mesh-ancestor
65342264|NCT05145296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342265|NCT05145296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65342266|NCT00859534|Afamelanotide|afamelanotide|mesh-list
65342267|NCT00859534|Dermatologic Agents|dermatologic agents|mesh-ancestor
65342268|NCT04230304|Daratumumab|daratumumab|mesh-list
65342269|NCT04230304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342270|NCT05036408|Coal Tar|coal tar|mesh-list
65342271|NCT05036408|Keratolytic Agents|keratolytic agents|mesh-ancestor
65342272|NCT05036408|Dermatologic Agents|dermatologic agents|mesh-ancestor
65342273|NCT02571842|Prednisolone|prednisolone|mesh-list
65342274|NCT02571842|Rituximab|rituximab|mesh-list
65342275|NCT02571842|Enalapril|enalapril|mesh-list
65342276|NCT02571842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65342277|NCT02571842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342278|NCT02571842|Immunologic Factors|immunologic factors|mesh-ancestor
65260579|NCT04746924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65260580|NCT04746924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260581|NCT04674813|Cyclophosphamide|cyclophosphamide|mesh-list
65260582|NCT04674813|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65260583|NCT04674813|Fludarabine|fludarabine|mesh-list
65260584|NCT04674813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65260585|NCT04674813|Immunologic Factors|immunologic factors|mesh-ancestor
65260586|NCT04674813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260587|NCT04674813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65260588|NCT04674813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65260589|NCT04674813|Alkylating Agents|alkylating agents|mesh-ancestor
65260590|NCT04674813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260591|NCT04674813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260592|NCT04674813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65260621|NCT04598477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65260622|NCT04598477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260623|NCT04598477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65260624|NCT04598477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260625|NCT04594408|Epinephrine|epinephrine|mesh-list
65260626|NCT04594408|Racepinephrine|racepinephrine|mesh-list
65260627|NCT04594408|Tranexamic Acid|tranexamic acid|mesh-list
65260628|NCT04594408|Epinephryl borate|epinephryl borate|mesh-list
65260629|NCT04594408|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65260630|NCT04594408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65260631|NCT04594408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260632|NCT04594408|Hemostatics|hemostatics|mesh-ancestor
65260633|NCT04594408|Coagulants|coagulants|mesh-ancestor
65260634|NCT04594408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65260635|NCT04594408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65260636|NCT04594408|Adrenergic Agents|adrenergic agents|mesh-ancestor
65260637|NCT04594408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65260638|NCT04594408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260639|NCT04594408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65342279|NCT02571842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342280|NCT02571842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65342281|NCT02571842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65342282|NCT02571842|Glucocorticoids|glucocorticoids|mesh-ancestor
65342283|NCT02571842|Hormones|hormones|mesh-ancestor
64724262|NCT00002894|Paclitaxel|paclitaxel|mesh-list
65260655|NCT04588246|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65260656|NCT04588246|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65260658|NCT04557215|Rifaximin|rifaximin|mesh-list
65260659|NCT04557215|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65260660|NCT04557215|Antiviral Agents|antiviral agents|mesh-ancestor
65260661|NCT04557215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65260662|NCT04557215|Expectorants|expectorants|mesh-ancestor
65260663|NCT04557215|Respiratory System Agents|respiratory system agents|mesh-ancestor
65260664|NCT04557215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65260665|NCT04557215|Antioxidants|antioxidants|mesh-ancestor
65260666|NCT04557215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260667|NCT04557215|Protective Agents|protective agents|mesh-ancestor
65260668|NCT04557215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260669|NCT04557215|Antidotes|antidotes|mesh-ancestor
65260670|NCT04557215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65260671|NCT04557215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65260672|NCT04513717|Leuprolide|leuprolide|mesh-list
65260673|NCT04513717|Goserelin|goserelin|mesh-list
65260674|NCT04513717|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65260675|NCT04513717|Flutamide|flutamide|mesh-list
65260676|NCT04513717|Bicalutamide|bicalutamide|mesh-list
65260677|NCT04513717|Tryptophan|tryptophan|mesh-list
65260678|NCT04513717|Buserelin|buserelin|mesh-list
65260679|NCT04513717|Hormones|hormones|mesh-list
65260680|NCT04513717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65260681|NCT04513717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260682|NCT04513717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65260683|NCT04513717|Fertility Agents|fertility agents|mesh-ancestor
65260684|NCT04513717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65260685|NCT04513717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65260686|NCT04513717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260687|NCT04513717|Androgen Antagonists|androgen antagonists|mesh-ancestor
65260688|NCT04513717|Hormone Antagonists|hormone antagonists|mesh-ancestor
65260689|NCT04513717|Luteolytic Agents|luteolytic agents|mesh-ancestor
65260690|NCT04513717|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65260691|NCT04513717|Contraceptive Agents|contraceptive agents|mesh-ancestor
65260692|NCT04513717|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65260693|NCT04513717|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65260694|NCT04513717|Antidepressive Agents|antidepressive agents|mesh-ancestor
65260695|NCT04513717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65260696|NCT04498117|Paclitaxel|paclitaxel|mesh-list
65260697|NCT04498117|Carboplatin|carboplatin|mesh-list
65260698|NCT04498117|Oregovomab|oregovomab|mesh-list
65260699|NCT04498117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65260700|NCT04498117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260701|NCT04498117|Tubulin Modulators|tubulin modulators|mesh-ancestor
65260736|NCT04423627|Adrenergic Agents|adrenergic agents|mesh-ancestor
65260737|NCT04423627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65260738|NCT04410653|Afatinib|afatinib|mesh-list
65260739|NCT04410653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260740|NCT04410653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65260795|NCT04305158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65260820|NCT04292470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260821|NCT04292470|Adrenergic Agents|adrenergic agents|mesh-ancestor
65260822|NCT04292470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65260823|NCT04208334|Curcumin|curcumin|mesh-list
65260824|NCT04208334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65260825|NCT04208334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65260826|NCT04208334|Analgesics|analgesics|mesh-ancestor
65260827|NCT04208334|Sensory System Agents|sensory system agents|mesh-ancestor
65260828|NCT04208334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65260829|NCT04208334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260830|NCT04208334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65260831|NCT04208334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65260832|NCT04208334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260833|NCT04208334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342284|NCT02571842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65342285|NCT02571842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65342286|NCT02571842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65342287|NCT02571842|Protease Inhibitors|protease inhibitors|mesh-ancestor
65342288|NCT02571842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342289|NCT02571842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342290|NCT02571842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65260834|NCT04208334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260835|NCT04158141|Cisplatin|cisplatin|mesh-list
65260837|NCT04158141|Pemetrexed|pemetrexed|mesh-list
65260838|NCT04158141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260839|NCT04158141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260840|NCT04158141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260841|NCT04158141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65260842|NCT04158141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65260843|NCT04134260|Hormones|hormones|mesh-list
65260844|NCT04134260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65260845|NCT04134260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260846|NCT04080284|Niraparib|niraparib|mesh-list
65260867|NCT04060017|Calcium|calcium|mesh-list
65260868|NCT04060017|Levoleucovorin|levoleucovorin|mesh-list
65260869|NCT04060017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65260870|NCT04060017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260871|NCT04060017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65260872|NCT04060017|Antidotes|antidotes|mesh-ancestor
65260873|NCT04060017|Protective Agents|protective agents|mesh-ancestor
65260874|NCT04060017|Vitamin B Complex|vitamin b complex|mesh-ancestor
65260875|NCT04060017|Vitamins|vitamins|mesh-ancestor
65260876|NCT04060017|Micronutrients|micronutrients|mesh-ancestor
65260877|NCT04052334|Cyclophosphamide|cyclophosphamide|mesh-list
65260878|NCT04052334|Fludarabine|fludarabine|mesh-list
65260879|NCT04052334|Interleukin-2|interleukin-2|mesh-list
65260880|NCT04052334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65260881|NCT04052334|Immunologic Factors|immunologic factors|mesh-ancestor
65260882|NCT04052334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260883|NCT04052334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65260884|NCT04052334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65260885|NCT04052334|Alkylating Agents|alkylating agents|mesh-ancestor
65260886|NCT04052334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260887|NCT04052334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260888|NCT04052334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65260889|NCT04052334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65260890|NCT04052334|Analgesics|analgesics|mesh-ancestor
65260891|NCT04052334|Sensory System Agents|sensory system agents|mesh-ancestor
65260892|NCT04052334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65260893|NCT04046549|Abatacept|abatacept|mesh-list
65260894|NCT04046549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65260895|NCT04046549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260896|NCT04046549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260897|NCT04046549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65260898|NCT04046549|Immunologic Factors|immunologic factors|mesh-ancestor
65260899|NCT04046549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260900|NCT04046549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65260901|NCT04042935|Thioctic Acid|thioctic acid|mesh-list
65260927|NCT03988933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65260928|NCT03988933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260929|NCT03988933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260930|NCT03988933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65260931|NCT03988933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65260932|NCT03988933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65260933|NCT03988933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65260934|NCT03988933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65260935|NCT03988933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65260936|NCT03958565|Zoledronic Acid|zoledronic acid|mesh-list
65342291|NCT00721448|Ticagrelor|ticagrelor|mesh-list
65342292|NCT00721448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65342293|NCT00721448|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65342294|NCT00721448|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65342295|NCT00721448|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65342296|NCT00721448|Purinergic Agents|purinergic agents|mesh-ancestor
65342297|NCT00721448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64724274|NCT03282344|Nivolumab|nivolumab|mesh-list
65260937|NCT03958565|Denosumab|denosumab|mesh-list
65260938|NCT03958565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65260939|NCT03958565|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65260940|NCT03958565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260941|NCT03947385|Crizotinib|crizotinib|mesh-list
65260942|NCT03947385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260943|NCT03947385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65260944|NCT03947385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260945|NCT03947385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260946|NCT03910452|Sirolimus|sirolimus|mesh-list
65260947|NCT03910452|Cyclophosphamide|cyclophosphamide|mesh-list
65260948|NCT03910452|Busulfan|busulfan|mesh-list
65260949|NCT03910452|Alemtuzumab|alemtuzumab|mesh-list
65260970|NCT03801876|Docetaxel|docetaxel|mesh-list
65260971|NCT03801876|Carboplatin|carboplatin|mesh-list
65260972|NCT03801876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65260973|NCT03801876|Fluorouracil|fluorouracil|mesh-list
65260974|NCT03801876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65260975|NCT03801876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260976|NCT03801876|Tubulin Modulators|tubulin modulators|mesh-ancestor
65260977|NCT03801876|Antimitotic Agents|antimitotic agents|mesh-ancestor
65260978|NCT03801876|Mitosis Modulators|mitosis modulators|mesh-ancestor
65260979|NCT03801876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260980|NCT03801876|Antimetabolites|antimetabolites|mesh-ancestor
65260981|NCT03801876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65260982|NCT03801876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65260983|NCT03801876|Immunologic Factors|immunologic factors|mesh-ancestor
65260984|NCT03801876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260998|NCT03752398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65261000|NCT03752398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65261001|NCT03752398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261002|NCT03734692|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
65261003|NCT03734692|Pembrolizumab|pembrolizumab|mesh-list
65261004|NCT03734692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261005|NCT03734692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65261006|NCT03734692|Antiviral Agents|antiviral agents|mesh-ancestor
65261007|NCT03734692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65261008|NCT03700476|Gemcitabine|gemcitabine|mesh-list
65261009|NCT03700476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261010|NCT03700476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65261011|NCT03700476|Antimetabolites|antimetabolites|mesh-ancestor
65261012|NCT03700476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261013|NCT03700476|Antiviral Agents|antiviral agents|mesh-ancestor
65261014|NCT03700476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65261015|NCT03700476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936239|NCT00142870|Bupropion|bupropion|mesh-list
65261031|NCT03678883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261032|NCT03678883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65261033|NCT03678883|Antimetabolites|antimetabolites|mesh-ancestor
65261034|NCT03678883|Antiviral Agents|antiviral agents|mesh-ancestor
65261035|NCT03678883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65261036|NCT03678883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261037|NCT03678883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65261038|NCT03678883|Immunologic Factors|immunologic factors|mesh-ancestor
65261039|NCT03678883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261040|NCT03678883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65261041|NCT03678883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65261042|NCT03678883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65261043|NCT03678883|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65342298|NCT00721448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342299|NCT00721448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342300|NCT00853216|Oxycodone|oxycodone|mesh-list
65342301|NCT00853216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65342302|NCT00853216|Narcotics|narcotics|mesh-ancestor
65342303|NCT00853216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65342304|NCT00853216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342305|NCT00853216|Analgesics|analgesics|mesh-ancestor
65342306|NCT00853216|Sensory System Agents|sensory system agents|mesh-ancestor
65342307|NCT00853216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65342308|NCT04961528|Terlipressin|terlipressin|mesh-list
65342309|NCT04961528|Tranexamic Acid|tranexamic acid|mesh-list
65342310|NCT04961528|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65342311|NCT04961528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65342312|NCT04961528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342313|NCT04961528|Hemostatics|hemostatics|mesh-ancestor
65342314|NCT04961528|Coagulants|coagulants|mesh-ancestor
65342315|NCT04961528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65342316|NCT04961528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65261044|NCT03678883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65261045|NCT03678883|Alkylating Agents|alkylating agents|mesh-ancestor
65261046|NCT03644667|Mycophenolic Acid|mycophenolic acid|mesh-list
65261048|NCT03644667|Methylprednisolone|methylprednisolone|mesh-list
65261049|NCT03644667|Tacrolimus|tacrolimus|mesh-list
65261050|NCT03644667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
65261051|NCT03644667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65261052|NCT03644667|Glucocorticoids|glucocorticoids|mesh-ancestor
65261053|NCT03644667|Hormones|hormones|mesh-ancestor
65261054|NCT03644667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65261055|NCT03644667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261056|NCT03644667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65261057|NCT03644667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261058|NCT03644667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65261059|NCT03644667|Immunologic Factors|immunologic factors|mesh-ancestor
65261060|NCT03644667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261061|NCT03644667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261062|NCT03644667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65261063|NCT03644667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65261064|NCT03644667|Antitubercular Agents|antitubercular agents|mesh-ancestor
65261065|NCT03644667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65261066|NCT03644667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65261067|NCT03644667|Antiemetics|antiemetics|mesh-ancestor
65261068|NCT03644667|Autonomic Agents|autonomic agents|mesh-ancestor
65261069|NCT03644667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65261070|NCT03644667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65261071|NCT03644667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65261072|NCT03644667|Protective Agents|protective agents|mesh-ancestor
65261073|NCT03638141|Durvalumab|durvalumab|mesh-list
65261074|NCT03638141|Ipilimumab|ipilimumab|mesh-list
65261075|NCT03638141|Tremelimumab|tremelimumab|mesh-list
65261076|NCT03638141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65261077|NCT03638141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64936299|NCT00143065|Rituximab|rituximab|mesh-list
65261094|NCT03330106|Tubulin Modulators|tubulin modulators|mesh-ancestor
65261095|NCT03330106|Antimitotic Agents|antimitotic agents|mesh-ancestor
65261096|NCT03330106|Mitosis Modulators|mitosis modulators|mesh-ancestor
65261097|NCT03330106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342317|NCT00721032|Amiodarone|amiodarone|mesh-list
65342318|NCT00721032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65342319|NCT00721032|Vasodilator Agents|vasodilator agents|mesh-ancestor
65342320|NCT00721032|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65342321|NCT00721032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65342322|NCT00721032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261098|NCT03330106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261100|NCT03239145|Trebananib|trebananib|mesh-list
65261101|NCT03239145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65261102|NCT03239145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261103|NCT03239145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65261104|NCT03239145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65261105|NCT03239145|Growth Substances|growth substances|mesh-ancestor
65261106|NCT03239145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261107|NCT03239145|Growth Inhibitors|growth inhibitors|mesh-ancestor
65261108|NCT03164564|Tenofovir|tenofovir|mesh-list
65261109|NCT03164564|Emtricitabine|emtricitabine|mesh-list
65261110|NCT03164564|Cabotegravir|cabotegravir|mesh-list
65261111|NCT03164564|Antiviral Agents|antiviral agents|mesh-ancestor
65261112|NCT03164564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65261113|NCT03164564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65261114|NCT03164564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65261115|NCT03164564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261116|NCT03164564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261117|NCT03164564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65261118|NCT03164564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65261119|NCT03164564|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65261120|NCT03164564|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65261121|NCT03153410|Cyclophosphamide|cyclophosphamide|mesh-list
65261122|NCT03153410|Pembrolizumab|pembrolizumab|mesh-list
65261123|NCT03153410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65261124|NCT03153410|Immunologic Factors|immunologic factors|mesh-ancestor
65261125|NCT03153410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261126|NCT03153410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65261127|NCT03153410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65261128|NCT03153410|Alkylating Agents|alkylating agents|mesh-ancestor
65261129|NCT03153410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261130|NCT03153410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261131|NCT03153410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65261132|NCT03153410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65261133|NCT03113422|Venetoclax|venetoclax|mesh-list
65261134|NCT03113422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261135|NCT03070886|Docetaxel|docetaxel|mesh-list
65261136|NCT03070886|Leuprolide|leuprolide|mesh-list
65261176|NCT02987257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65261178|NCT02987257|Analgesics|analgesics|mesh-ancestor
65261179|NCT02987257|Sensory System Agents|sensory system agents|mesh-ancestor
65261180|NCT02987257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65261181|NCT02987257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65261182|NCT02987257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65261190|NCT02913274|Paclitaxel|paclitaxel|mesh-list
65261191|NCT02913274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65261192|NCT02913274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261193|NCT02913274|Tubulin Modulators|tubulin modulators|mesh-ancestor
65261212|NCT02772003|Interleukin-12|interleukin-12|mesh-list
65261213|NCT02772003|Vaccines|vaccines|mesh-list
65261214|NCT02772003|Immunologic Factors|immunologic factors|mesh-ancestor
65261215|NCT02772003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261216|NCT02772003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65261217|NCT02772003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65261218|NCT02772003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65261219|NCT02772003|Growth Substances|growth substances|mesh-ancestor
65261220|NCT02772003|Growth Inhibitors|growth inhibitors|mesh-ancestor
65261221|NCT02772003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261222|NCT02684162|Guadecitabine|guadecitabine|mesh-list
65261223|NCT02684162|Azacitidine|azacitidine|mesh-list
65261224|NCT02684162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261225|NCT02684162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65261226|NCT02684162|Antimetabolites|antimetabolites|mesh-ancestor
65261227|NCT02684162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342323|NCT00721032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65342324|NCT00721032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65342325|NCT00721032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65342326|NCT00721032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261228|NCT02684162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261229|NCT02619682|Lenalidomide|lenalidomide|mesh-list
65261230|NCT02619682|Ixazomib|ixazomib|mesh-list
65261231|NCT02619682|Glycine|glycine|mesh-list
65261232|NCT02619682|Immunologic Factors|immunologic factors|mesh-ancestor
65261233|NCT02619682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261234|NCT02619682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65261235|NCT02619682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65261236|NCT02619682|Growth Substances|growth substances|mesh-ancestor
65261237|NCT02619682|Growth Inhibitors|growth inhibitors|mesh-ancestor
65261238|NCT02619682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261239|NCT02619682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261240|NCT02619682|Protease Inhibitors|protease inhibitors|mesh-ancestor
65261241|NCT02619682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261242|NCT02619682|Glycine Agents|glycine agents|mesh-ancestor
65261243|NCT02619682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65261244|NCT02617589|Nivolumab|nivolumab|mesh-list
65261245|NCT02617589|Temozolomide|temozolomide|mesh-list
65261246|NCT02617589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64936454|NCT00144118|Sevoflurane|sevoflurane|mesh-list
65261280|NCT02506959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261281|NCT02506959|Antiviral Agents|antiviral agents|mesh-ancestor
65261282|NCT02506959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65261283|NCT02506959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261284|NCT02506959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65261285|NCT02506959|Immunologic Factors|immunologic factors|mesh-ancestor
65261286|NCT02506959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261287|NCT02506959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65261288|NCT02506959|Alkylating Agents|alkylating agents|mesh-ancestor
65261318|NCT02345265|Maleic acid|maleic acid|mesh-list
65261319|NCT02345265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261320|NCT02345265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261321|NCT02345265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261322|NCT02345265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65261323|NCT02340169|Desoximetasone|desoximetasone|mesh-list
65261324|NCT02340169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65261325|NCT02340169|Glucocorticoids|glucocorticoids|mesh-ancestor
65261326|NCT02340169|Hormones|hormones|mesh-ancestor
65261327|NCT02340169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65261328|NCT02340169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261329|NCT02337829|Acalabrutinib|acalabrutinib|mesh-list
65261330|NCT02337829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261331|NCT02317874|Paclitaxel|paclitaxel|mesh-list
65261332|NCT02317874|Carboplatin|carboplatin|mesh-list
65261333|NCT02317874|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65261334|NCT02317874|Talazoparib|talazoparib|mesh-list
65261335|NCT02317874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65261336|NCT02317874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261357|NCT02160015|Immunoglobulins|immunoglobulins|mesh-list
65261358|NCT02160015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65261359|NCT02160015|Immunologic Factors|immunologic factors|mesh-ancestor
65261360|NCT02160015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261361|NCT02160015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261362|NCT02160015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65261363|NCT02160015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65066801|NCT00272597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65261364|NCT02160015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65261366|NCT02160015|Growth Inhibitors|growth inhibitors|mesh-ancestor
65261367|NCT02135042|Gemcitabine|gemcitabine|mesh-list
65261368|NCT02135042|Paclitaxel|paclitaxel|mesh-list
65261369|NCT02135042|Cisplatin|cisplatin|mesh-list
65261370|NCT02135042|Fluorouracil|fluorouracil|mesh-list
65261371|NCT02135042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65261372|NCT02135042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65261373|NCT02135042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261374|NCT02135042|Tubulin Modulators|tubulin modulators|mesh-ancestor
65261375|NCT02135042|Antimitotic Agents|antimitotic agents|mesh-ancestor
65261376|NCT02135042|Mitosis Modulators|mitosis modulators|mesh-ancestor
65261377|NCT02135042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342327|NCT00721032|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65342328|NCT00721032|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65342329|NCT00721032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65342330|NCT00723866|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65342331|NCT00723866|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65342332|NCT00723866|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65342333|NCT00723866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65342334|NCT00723866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342335|NCT00723866|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65342336|NCT00723866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65342337|NCT00723866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261378|NCT02135042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65261379|NCT02135042|Antimetabolites|antimetabolites|mesh-ancestor
65261380|NCT02135042|Antiviral Agents|antiviral agents|mesh-ancestor
65261381|NCT02135042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65261382|NCT02135042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261383|NCT02135042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65261384|NCT02135042|Immunologic Factors|immunologic factors|mesh-ancestor
65261385|NCT02135042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261386|NCT01899326|Desipramine|desipramine|mesh-list
65261387|NCT01899326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261388|NCT01899326|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65261389|NCT01899326|Antidepressive Agents|antidepressive agents|mesh-ancestor
65261390|NCT01899326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65261418|NCT01856192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65261419|NCT01856192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65261420|NCT01856192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65261421|NCT01856192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65261422|NCT01856192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261423|NCT01856192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65261424|NCT01856192|Glucocorticoids|glucocorticoids|mesh-ancestor
65261425|NCT01856192|Hormones|hormones|mesh-ancestor
65261426|NCT01856192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65261427|NCT01856192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65261428|NCT01856192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65261429|NCT01856192|Tubulin Modulators|tubulin modulators|mesh-ancestor
65261430|NCT01856192|Antimitotic Agents|antimitotic agents|mesh-ancestor
65261431|NCT01856192|Mitosis Modulators|mitosis modulators|mesh-ancestor
65261432|NCT01856192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65261433|NCT01856192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65261434|NCT01856192|Growth Substances|growth substances|mesh-ancestor
65261435|NCT01856192|Growth Inhibitors|growth inhibitors|mesh-ancestor
65261436|NCT01849146|Temozolomide|temozolomide|mesh-list
65261437|NCT01849146|Adavosertib|adavosertib|mesh-list
65261438|NCT01849146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64936641|NCT03128021|Analgesics|analgesics|mesh-ancestor
65261473|NCT01515137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65261474|NCT01515137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65261475|NCT01515137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65261476|NCT01393509|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
64936695|NCT01807494|Cimetidine|cimetidine|mesh-list
65261498|NCT01126190|Mitosis Modulators|mitosis modulators|mesh-ancestor
65261499|NCT01126190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261500|NCT01126190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65261501|NCT01126190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65261502|NCT01126190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65261503|NCT01126190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261504|NCT00866554|Tamoxifen|tamoxifen|mesh-list
65261505|NCT00866554|Bicalutamide|bicalutamide|mesh-list
65261506|NCT00866554|Dutasteride|dutasteride|mesh-list
65342338|NCT00723866|Cholinergic Agents|cholinergic agents|mesh-ancestor
65342339|NCT00723866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65342340|NCT00853294|Chlorpheniramine|chlorpheniramine|mesh-list
65342341|NCT00853294|Hydrocodone|hydrocodone|mesh-list
65342342|NCT00853294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342343|NCT00853294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65342344|NCT00853294|Narcotics|narcotics|mesh-ancestor
65261507|NCT00866554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65261508|NCT00866554|Hormone Antagonists|hormone antagonists|mesh-ancestor
65261509|NCT00866554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65261510|NCT00866554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261511|NCT00866554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65261512|NCT00866554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261513|NCT00866554|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65261514|NCT00866554|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65261515|NCT00866554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65261516|NCT00866554|Androgen Antagonists|androgen antagonists|mesh-ancestor
65261517|NCT00866554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65261518|NCT00866554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65261519|NCT00866554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261520|NCT00866554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261521|NCT00472654|Vitamin D|vitamin d|mesh-list
65261522|NCT00472654|Vitamins|vitamins|mesh-ancestor
65261523|NCT00472654|Micronutrients|micronutrients|mesh-ancestor
65261524|NCT00472654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261525|NCT00472654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65261526|NCT00323037|Carvedilol|carvedilol|mesh-list
65261527|NCT00323037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65261528|NCT00323037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65261529|NCT00323037|Adrenergic Agents|adrenergic agents|mesh-ancestor
65261530|NCT00323037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64936727|NCT03096782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65261556|NCT02808104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65261557|NCT02808104|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65261558|NCT02808104|Dopamine Agents|dopamine agents|mesh-ancestor
65261559|NCT05165771|Tofacitinib|tofacitinib|mesh-list
65261560|NCT05165771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65261561|NCT05165771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261562|NCT05165771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261563|NCT02730624|Tazobactam|tazobactam|mesh-list
65261564|NCT02730624|Piperacillin|piperacillin|mesh-list
65261565|NCT02730624|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65261566|NCT02730624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65261567|NCT02730624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65261568|NCT02730624|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65261569|NCT02730624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261570|NCT02730624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261571|NCT02807870|Methylphenidate|methylphenidate|mesh-list
65261572|NCT02807870|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65261573|NCT02807870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261574|NCT02807870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65261575|NCT02807870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65261608|NCT00925951|Acetaminophen|acetaminophen|mesh-list
65261609|NCT00925951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65261610|NCT00925951|Analgesics|analgesics|mesh-ancestor
65261611|NCT00925951|Sensory System Agents|sensory system agents|mesh-ancestor
65261612|NCT00925951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65261613|NCT00925951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936847|NCT03087071|Trametinib|trametinib|mesh-list
65261650|NCT02813018|Anesthetics|anesthetics|mesh-ancestor
65261651|NCT02813018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65261652|NCT02813018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261653|NCT02813018|Sensory System Agents|sensory system agents|mesh-ancestor
65261679|NCT04174196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65261680|NCT04174196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65261682|NCT04174196|Growth Inhibitors|growth inhibitors|mesh-ancestor
65261683|NCT04174196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342345|NCT00853294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65342346|NCT00853294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342347|NCT00853294|Analgesics|analgesics|mesh-ancestor
65342348|NCT00853294|Sensory System Agents|sensory system agents|mesh-ancestor
64724328|NCT04226456|Antioxidants|antioxidants|mesh-ancestor
65261684|NCT04173962|Midazolam|midazolam|mesh-list
65261685|NCT04173962|Ketamine|ketamine|mesh-list
65261686|NCT04173962|Analgesics|analgesics|mesh-ancestor
65261687|NCT04173962|Sensory System Agents|sensory system agents|mesh-ancestor
65261688|NCT04173962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65261689|NCT04173962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261690|NCT04173962|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65261691|NCT04173962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65261692|NCT04173962|Anesthetics, General|anesthetics, general|mesh-ancestor
65261693|NCT04173962|Anesthetics|anesthetics|mesh-ancestor
65261694|NCT04173962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65261695|NCT04173962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65261696|NCT04173962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65261697|NCT04173962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65261698|NCT04173962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261699|NCT04173962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65261700|NCT04173962|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65261701|NCT04173962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65261702|NCT04173962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65261703|NCT04173962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65261704|NCT04173962|GABA Modulators|gaba modulators|mesh-ancestor
65261732|NCT04262999|Antimanic Agents|antimanic agents|mesh-ancestor
65261733|NCT04262999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65261734|NCT04262999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65261735|NCT04262999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65261736|NCT05582174|Esomeprazole|esomeprazole|mesh-list
65011958|NCT00162318|Cetuximab|cetuximab|mesh-list
65261737|NCT05582174|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65261738|NCT05582174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65261739|NCT05582174|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65261740|NCT05582174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261741|NCT05582174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261742|NCT00926107|Sirolimus|sirolimus|mesh-list
65261743|NCT00926107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65261744|NCT00926107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65261745|NCT00926107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65261746|NCT00926107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261747|NCT00926107|Antifungal Agents|antifungal agents|mesh-ancestor
65261748|NCT00926107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65261749|NCT00926107|Immunologic Factors|immunologic factors|mesh-ancestor
64936959|NCT05227456|Contraceptive Agents|contraceptive agents|mesh-ancestor
65261767|NCT00933439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261769|NCT00933439|Sensory System Agents|sensory system agents|mesh-ancestor
65261770|NCT00933439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65261771|NCT00933439|Antidepressive Agents|antidepressive agents|mesh-ancestor
65261772|NCT00933439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65261773|NCT00933439|Dopamine Agents|dopamine agents|mesh-ancestor
65261774|NCT00608075|Lithium Carbonate|lithium carbonate|mesh-list
65261775|NCT00608075|Antidepressive Agents|antidepressive agents|mesh-ancestor
65261776|NCT00608075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65261777|NCT00608075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261778|NCT00608075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261779|NCT00608075|Antimanic Agents|antimanic agents|mesh-ancestor
65261780|NCT00608075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65261781|NCT00608075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65261782|NCT00608075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261783|NCT02809742|Ropivacaine|ropivacaine|mesh-list
65261784|NCT02809742|Anesthetics, Local|anesthetics, local|mesh-ancestor
65261785|NCT02809742|Anesthetics|anesthetics|mesh-ancestor
65261786|NCT02809742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65261787|NCT02809742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261788|NCT02809742|Sensory System Agents|sensory system agents|mesh-ancestor
65261789|NCT02809742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65261790|NCT00929851|Formoterol Fumarate|formoterol fumarate|mesh-list
65261791|NCT00929851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65261792|NCT00929851|Autonomic Agents|autonomic agents|mesh-ancestor
65342349|NCT00853294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65342350|NCT00853294|Antitussive Agents|antitussive agents|mesh-ancestor
65342351|NCT00853294|Respiratory System Agents|respiratory system agents|mesh-ancestor
65342352|NCT00853294|Antipruritics|antipruritics|mesh-ancestor
65342353|NCT00853294|Dermatologic Agents|dermatologic agents|mesh-ancestor
65342354|NCT00853294|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65342355|NCT00853294|Histamine Antagonists|histamine antagonists|mesh-ancestor
65342356|NCT00853294|Histamine Agents|histamine agents|mesh-ancestor
65342357|NCT00853294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65342358|NCT00853294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65342359|NCT03246230|BCG Vaccine|bcg vaccine|mesh-list
65342360|NCT03246230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65342361|NCT03246230|Immunologic Factors|immunologic factors|mesh-ancestor
65342362|NCT03246230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342363|NCT00717834|Formaldehyde|formaldehyde|mesh-list
65342364|NCT00717834|Disinfectants|disinfectants|mesh-ancestor
65342365|NCT00717834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65342366|NCT00658359|Cyclosporine|cyclosporine|mesh-list
65342367|NCT00658359|Cyclosporins|cyclosporins|mesh-list
65342368|NCT00658359|Tofacitinib|tofacitinib|mesh-list
65342369|NCT00658359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261793|NCT00929851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65261794|NCT00929851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261795|NCT00929851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65261796|NCT00929851|Respiratory System Agents|respiratory system agents|mesh-ancestor
65261797|NCT00929851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65261798|NCT00929851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65261799|NCT00929851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65261800|NCT00929851|Adrenergic Agents|adrenergic agents|mesh-ancestor
65261801|NCT00929851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64937006|NCT05175430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65261825|NCT00933517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65261826|NCT00933517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261828|NCT00926341|Telmisartan|telmisartan|mesh-list
65261829|NCT00926341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65261830|NCT00926341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261831|NCT00926341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65261832|NCT00926341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65261833|NCT00926341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65261834|NCT00926341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261835|NCT00926419|Vaccines|vaccines|mesh-list
65261836|NCT00926419|Immunologic Factors|immunologic factors|mesh-ancestor
65261837|NCT00926419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261838|NCT00608231|Dexmedetomidine|dexmedetomidine|mesh-list
65261839|NCT00608231|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65261840|NCT00608231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65261841|NCT00608231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261842|NCT00608231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65261843|NCT00608231|Analgesics|analgesics|mesh-ancestor
65261844|NCT00608231|Sensory System Agents|sensory system agents|mesh-ancestor
65261845|NCT00608231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65261846|NCT00608231|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65261847|NCT00608231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65261848|NCT00608231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65261849|NCT00608231|Adrenergic Agents|adrenergic agents|mesh-ancestor
64724350|NCT04195568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65342370|NCT00658359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342371|NCT00658359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65342372|NCT00658359|Immunologic Factors|immunologic factors|mesh-ancestor
65342373|NCT00658359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342374|NCT00658359|Antifungal Agents|antifungal agents|mesh-ancestor
65342375|NCT00658359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65342376|NCT00658359|Dermatologic Agents|dermatologic agents|mesh-ancestor
65342377|NCT00658359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65342378|NCT00658359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65342379|NCT00658359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65342380|NCT00853450|Clopidogrel|clopidogrel|mesh-list
65342381|NCT00853450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65342382|NCT00853450|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65342383|NCT00853450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65092184|NCT01242566|Temozolomide|temozolomide|mesh-list
65342384|NCT00853450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65261873|NCT02739204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65261874|NCT02739204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261875|NCT02739204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65261876|NCT02739204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65261877|NCT02739204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65261878|NCT02739204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65261879|NCT02739204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261880|NCT02739204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261881|NCT00927485|Curcumin|curcumin|mesh-list
65012109|NCT00141596|Amiloride|amiloride|mesh-list
65261882|NCT00927485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65261883|NCT00927485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65261884|NCT00927485|Analgesics|analgesics|mesh-ancestor
65261885|NCT00927485|Sensory System Agents|sensory system agents|mesh-ancestor
65261886|NCT00927485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65261887|NCT00927485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261888|NCT00927485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65261889|NCT00927485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65261890|NCT00927485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261891|NCT00927485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261892|NCT00927485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261893|NCT00926653|Citalopram|citalopram|mesh-list
65261894|NCT00926653|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65261895|NCT00926653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65261896|NCT00926653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64937113|NCT04861051|Anesthetics|anesthetics|mesh-ancestor
65261928|NCT04260269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65261929|NCT02738970|Trastuzumab|trastuzumab|mesh-list
65261930|NCT02738970|Pertuzumab|pertuzumab|mesh-list
65261931|NCT02738970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65261932|NCT02738970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261933|NCT00926731|Cytarabine|cytarabine|mesh-list
65261934|NCT00926731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65261935|NCT00926731|Antimetabolites|antimetabolites|mesh-ancestor
65261936|NCT00926731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261937|NCT00926731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261967|NCT04262765|Atorvastatin|atorvastatin|mesh-list
65261968|NCT04262765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65261969|NCT04262765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65342385|NCT00853450|Purinergic Agents|purinergic agents|mesh-ancestor
65342386|NCT00853450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65342387|NCT00853450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342388|NCT00853450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342389|NCT04066790|Paclitaxel|paclitaxel|mesh-list
65342390|NCT04066790|Trastuzumab|trastuzumab|mesh-list
65342391|NCT04066790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65342392|NCT04066790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342393|NCT04066790|Tubulin Modulators|tubulin modulators|mesh-ancestor
65342394|NCT04066790|Antimitotic Agents|antimitotic agents|mesh-ancestor
65342395|NCT04066790|Mitosis Modulators|mitosis modulators|mesh-ancestor
65342396|NCT04066790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342397|NCT04066790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65342398|NCT00721526|Disulfiram|disulfiram|mesh-list
65342399|NCT00721526|Lorazepam|lorazepam|mesh-list
65342400|NCT00721526|Anticonvulsants|anticonvulsants|mesh-ancestor
65342401|NCT00721526|Antiemetics|antiemetics|mesh-ancestor
65342402|NCT00721526|Autonomic Agents|autonomic agents|mesh-ancestor
65342403|NCT00721526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65342404|NCT00721526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342405|NCT00721526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65342406|NCT00721526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65342407|NCT00721526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65342408|NCT00721526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65342409|NCT00721526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65342410|NCT00721526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64724370|NCT00002912|Analgesics|analgesics|mesh-ancestor
65261970|NCT04262765|Antimetabolites|antimetabolites|mesh-ancestor
65261971|NCT04262765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261972|NCT04262765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65261973|NCT04262765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65261974|NCT04262765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261975|NCT04262765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65261976|NCT04262765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65261977|NCT04262765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65261978|NCT04262765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65261979|NCT04262765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261980|NCT04262765|Vasodilator Agents|vasodilator agents|mesh-ancestor
64937195|NCT00405301|Rifampin|rifampin|mesh-list
65262003|NCT02805608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262004|NCT02729064|Insulin|insulin|mesh-list
65262005|NCT02729064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65262006|NCT02729064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65262007|NCT02729064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262008|NCT00609401|Sorafenib|sorafenib|mesh-list
65262009|NCT00609401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262010|NCT00609401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65342411|NCT00721526|GABA Modulators|gaba modulators|mesh-ancestor
65342412|NCT00721526|GABA Agents|gaba agents|mesh-ancestor
65342413|NCT00721526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65342414|NCT00721526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342415|NCT00721526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65342416|NCT00721526|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65342417|NCT00721526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342418|NCT00721604|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65342419|NCT00721604|Plasma Substitutes|plasma substitutes|mesh-ancestor
65342420|NCT00721604|Blood Substitutes|blood substitutes|mesh-ancestor
65342421|NCT02571192|Volixibat|volixibat|mesh-list
65342422|NCT02571192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65342423|NCT00724022|Mycophenolic Acid|mycophenolic acid|mesh-list
65342424|NCT00724022|Prednisolone|prednisolone|mesh-list
65342425|NCT00724022|Tacrolimus|tacrolimus|mesh-list
65342426|NCT00724022|Thymoglobulin|thymoglobulin|mesh-list
65342427|NCT00724022|Basiliximab|basiliximab|mesh-list
65342428|NCT00724022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65342429|NCT00724022|Immunologic Factors|immunologic factors|mesh-ancestor
65262011|NCT00609401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262012|NCT00609401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262013|NCT02805842|Tacrolimus|tacrolimus|mesh-list
65262014|NCT02805842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65262015|NCT02805842|Immunologic Factors|immunologic factors|mesh-ancestor
65262016|NCT02805842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262017|NCT02805842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65262018|NCT02805842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262019|NCT02805842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262020|NCT00926965|Olanzapine|olanzapine|mesh-list
65262021|NCT00926965|Antipsychotic Agents|antipsychotic agents|mesh-list
65262022|NCT00926965|Amisulpride|amisulpride|mesh-list
65262023|NCT00926965|Antiemetics|antiemetics|mesh-ancestor
65262024|NCT00926965|Autonomic Agents|autonomic agents|mesh-ancestor
65262025|NCT00926965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262026|NCT00926965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262027|NCT00926965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65262028|NCT00926965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65262029|NCT00926965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65262030|NCT00926965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65262031|NCT00926965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64937246|NCT02593175|Paclitaxel|paclitaxel|mesh-list
65262066|NCT02733510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65262067|NCT02733510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65262068|NCT02733510|Protective Agents|protective agents|mesh-ancestor
65262069|NCT02733510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65262070|NCT02733510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262071|NCT03663504|Metronidazole|metronidazole|mesh-list
65262093|NCT00933985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262094|NCT00933985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262095|NCT00933985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65262096|NCT00933985|Tubulin Modulators|tubulin modulators|mesh-ancestor
65262097|NCT00933985|Antimitotic Agents|antimitotic agents|mesh-ancestor
65262098|NCT00933985|Mitosis Modulators|mitosis modulators|mesh-ancestor
65262099|NCT00933985|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65262100|NCT00933985|Protective Agents|protective agents|mesh-ancestor
65262101|NCT00933985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262102|NCT02812394|Levodopa|levodopa|mesh-list
65262103|NCT02812394|Carbidopa|carbidopa|mesh-list
65342430|NCT00724022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342431|NCT00724022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65342432|NCT00724022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342433|NCT00724022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342434|NCT00724022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65342435|NCT00724022|Glucocorticoids|glucocorticoids|mesh-ancestor
65342436|NCT00724022|Hormones|hormones|mesh-ancestor
65342437|NCT00724022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65342438|NCT00724022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65342439|NCT00724022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64724409|NCT00000865|Antiviral Agents|antiviral agents|mesh-ancestor
65262104|NCT02812394|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65262105|NCT02812394|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65262106|NCT02812394|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65262107|NCT02812394|Dopamine Agents|dopamine agents|mesh-ancestor
65262108|NCT02812394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65262109|NCT02812394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262110|NCT02812394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262111|NCT02812394|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65262112|NCT02812394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262113|NCT02812394|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65262114|NCT02812394|Immunologic Factors|immunologic factors|mesh-ancestor
65262115|NCT02812394|Dopamine Agonists|dopamine agonists|mesh-ancestor
65262116|NCT00930475|Carboplatin|carboplatin|mesh-list
65262117|NCT00930475|Everolimus|everolimus|mesh-list
65262118|NCT00930475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262119|NCT00930475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65262120|NCT00930475|Immunologic Factors|immunologic factors|mesh-ancestor
65262121|NCT00930475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262122|NCT02728518|Amikacin|amikacin|mesh-list
65262123|NCT02728518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65262124|NCT02728518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65262125|NCT00634400|Candesartan|candesartan|mesh-list
65262126|NCT00634400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65262146|NCT00936793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65262147|NCT00936793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65262148|NCT00936793|Glucocorticoids|glucocorticoids|mesh-ancestor
65262149|NCT00936793|Hormones|hormones|mesh-ancestor
65262150|NCT00936793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65262151|NCT00936793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262152|NCT00936793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65262153|NCT00936793|Respiratory System Agents|respiratory system agents|mesh-ancestor
65262154|NCT02805452|Solifenacin Succinate|solifenacin succinate|mesh-list
65262155|NCT02805452|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65262156|NCT02805452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65262157|NCT02805452|Cholinergic Agents|cholinergic agents|mesh-ancestor
65262158|NCT02805452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65262159|NCT02805452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262160|NCT02805452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262161|NCT02805452|Urological Agents|urological agents|mesh-ancestor
65262162|NCT00937027|Aminopterin|aminopterin|mesh-list
65262163|NCT00937027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65262164|NCT00937027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262165|NCT00937027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262166|NCT02738502|Ritonavir|ritonavir|mesh-list
65262167|NCT02738502|Darunavir|darunavir|mesh-list
65262168|NCT02738502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65262169|NCT02738502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65262170|NCT02738502|Protease Inhibitors|protease inhibitors|mesh-ancestor
65262171|NCT02738502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262172|NCT02738502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262173|NCT02738502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65342440|NCT00724022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65342441|NCT00724022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65342442|NCT00724022|Antitubercular Agents|antitubercular agents|mesh-ancestor
65342443|NCT00724022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65342444|NCT00724022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65342445|NCT00721344|Moxifloxacin|moxifloxacin|mesh-list
65342446|NCT00721344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65342447|NCT00721344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65342448|NCT00721344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65342449|NCT00721344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65342450|NCT00721344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342451|NCT00721344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342452|NCT00721344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342453|NCT00717990|Bevacizumab|bevacizumab|mesh-list
65342454|NCT00717990|Capecitabine|capecitabine|mesh-list
65342455|NCT00717990|Irinotecan|irinotecan|mesh-list
65342456|NCT00717990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65342457|NCT00717990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342458|NCT00717990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65342459|NCT00717990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65342460|NCT00717990|Growth Substances|growth substances|mesh-ancestor
65342461|NCT00717990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342462|NCT00717990|Growth Inhibitors|growth inhibitors|mesh-ancestor
64724421|NCT00000469|Sensory System Agents|sensory system agents|mesh-ancestor
65262174|NCT02738502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65262175|NCT02738502|Antiviral Agents|antiviral agents|mesh-ancestor
65262176|NCT02738502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65262177|NCT02738502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65262178|NCT02738502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65262179|NCT04261907|Ritonavir|ritonavir|mesh-list
65262180|NCT04261907|Lopinavir|lopinavir|mesh-list
64937393|NCT00391157|Bortezomib|bortezomib|mesh-list
65262200|NCT00930709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262201|NCT00930709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65262202|NCT00930709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262203|NCT02738346|Carboplatin|carboplatin|mesh-list
65262204|NCT02738346|Etoposide|etoposide|mesh-list
65262205|NCT02738346|Topotecan|topotecan|mesh-list
65262206|NCT02738346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262207|NCT02738346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65262208|NCT02738346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65262209|NCT02738346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65262210|NCT02738346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262211|NCT02738346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262212|NCT02738346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65262213|NCT00932165|Exemestane|exemestane|mesh-list
65262214|NCT00932165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262215|NCT00932165|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65262216|NCT00932165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65262217|NCT00932165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262218|NCT00932165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342463|NCT00717990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65342464|NCT00717990|Antimetabolites|antimetabolites|mesh-ancestor
65342465|NCT00717990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342466|NCT00717990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65342467|NCT00717990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65342468|NCT00717990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342469|NCT02572986|Permethrin|permethrin|mesh-list
65342470|NCT02572986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342471|NCT02572986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342472|NCT00853684|Capecitabine|capecitabine|mesh-list
65342473|NCT00853684|Endostar protein|endostar protein|mesh-list
65342474|NCT00853684|Endostatins|endostatins|mesh-list
65262219|NCT00932165|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65262220|NCT00932165|Hormone Antagonists|hormone antagonists|mesh-ancestor
65262221|NCT00932165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65262222|NCT00932165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262223|NCT00937183|Vaccines|vaccines|mesh-list
65262224|NCT00937183|Immunologic Factors|immunologic factors|mesh-ancestor
65262225|NCT00937183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262226|NCT00937261|Risperidone|risperidone|mesh-list
65262227|NCT00937261|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65262228|NCT00937261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65262229|NCT00937261|Serotonin Agents|serotonin agents|mesh-ancestor
65262230|NCT00937261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65262231|NCT00937261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262232|NCT00937261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262233|NCT00937261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65262249|NCT00609557|Sensory System Agents|sensory system agents|mesh-ancestor
65262250|NCT00609557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262251|NCT00609557|Antidepressive Agents|antidepressive agents|mesh-ancestor
65262252|NCT00609557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65224052|NCT04214145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224053|NCT04214145|Protective Agents|protective agents|mesh-ancestor
65224055|NCT04214145|Coagulants|coagulants|mesh-ancestor
65224056|NCT04214145|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65224057|NCT04214145|Natriuretic Agents|natriuretic agents|mesh-ancestor
65224058|NCT04212429|Moxifloxacin|moxifloxacin|mesh-list
65224059|NCT04212429|Levofloxacin|levofloxacin|mesh-list
65224060|NCT04212429|Ofloxacin|ofloxacin|mesh-list
65224061|NCT04212429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65224062|NCT04212429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65224063|NCT04212429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65224064|NCT04212429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65224065|NCT04212429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65224066|NCT04212429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65224067|NCT04212429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224068|NCT04212429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224069|NCT04212429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224070|NCT04212429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65224071|NCT04212429|Renal Agents|renal agents|mesh-ancestor
65224072|NCT04212429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65224073|NCT04212429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65224074|NCT01068665|Insulin|insulin|mesh-list
65224075|NCT01068665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65224076|NCT01068665|Insulin Glargine|insulin glargine|mesh-list
65224077|NCT01068665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65224078|NCT01068665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224079|NCT00618501|Leucovorin|leucovorin|mesh-list
65224080|NCT00618501|Cytarabine|cytarabine|mesh-list
65224081|NCT00618501|Prednisolone|prednisolone|mesh-list
65224082|NCT00618501|Hydrocortisone|hydrocortisone|mesh-list
65224083|NCT00618501|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65224084|NCT00618501|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65224085|NCT00618501|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65342475|NCT00853684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65342476|NCT00853684|Antimetabolites|antimetabolites|mesh-ancestor
65342477|NCT00853684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342478|NCT00853684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342479|NCT00853684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65342480|NCT00853684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65342481|NCT00853684|Growth Substances|growth substances|mesh-ancestor
65342482|NCT00853684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342483|NCT00853684|Growth Inhibitors|growth inhibitors|mesh-ancestor
65342484|NCT00723060|Citalopram|citalopram|mesh-list
65342485|NCT00723060|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65342486|NCT00723060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65342487|NCT00723060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65342488|NCT00723060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342489|NCT00723060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65342490|NCT00723060|Serotonin Agents|serotonin agents|mesh-ancestor
65342491|NCT00723060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224086|NCT00618501|Methotrexate|methotrexate|mesh-list
65224087|NCT00618501|Etoposide|etoposide|mesh-list
65224088|NCT00618501|Vincristine|vincristine|mesh-list
65224089|NCT00618501|Imatinib Mesylate|imatinib mesylate|mesh-list
65224090|NCT00618501|Daunorubicin|daunorubicin|mesh-list
65224091|NCT00618501|Levoleucovorin|levoleucovorin|mesh-list
65224111|NCT00618501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65224113|NCT00618501|Protective Agents|protective agents|mesh-ancestor
65224114|NCT00618501|Vitamin B Complex|vitamin b complex|mesh-ancestor
65224115|NCT00618501|Vitamins|vitamins|mesh-ancestor
65224116|NCT00618501|Micronutrients|micronutrients|mesh-ancestor
65224117|NCT00618501|Tubulin Modulators|tubulin modulators|mesh-ancestor
65224118|NCT00618501|Antimitotic Agents|antimitotic agents|mesh-ancestor
65224119|NCT00618501|Mitosis Modulators|mitosis modulators|mesh-ancestor
65224120|NCT00618501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65224121|NCT00618501|Glucocorticoids|glucocorticoids|mesh-ancestor
65224122|NCT00618501|Hormones|hormones|mesh-ancestor
65224123|NCT00618501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65224124|NCT00618501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65224125|NCT00618501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65224126|NCT00618501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65224127|NCT00772954|Vaccines|vaccines|mesh-list
65224128|NCT00772954|Immunologic Factors|immunologic factors|mesh-ancestor
65224129|NCT00772954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224130|NCT05322681|Pregabalin|pregabalin|mesh-list
65224131|NCT05322681|Analgesics|analgesics|mesh-ancestor
65224132|NCT05322681|Sensory System Agents|sensory system agents|mesh-ancestor
65224133|NCT05322681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65224134|NCT05322681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224135|NCT05322681|Anticonvulsants|anticonvulsants|mesh-ancestor
65224136|NCT05322681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65224137|NCT05322681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65224138|NCT05322681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224139|NCT05322681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65224140|NCT05322681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65224141|NCT05322681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65224142|NCT05322681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65224143|NCT05322681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65224144|NCT05322603|Diclofenac|diclofenac|mesh-list
65224145|NCT05322603|Morphine|morphine|mesh-list
65342492|NCT00723060|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65342493|NCT00723060|Antidepressive Agents|antidepressive agents|mesh-ancestor
65342494|NCT00723060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65342495|NCT02571140|Teriparatide|teriparatide|mesh-list
65342565|NCT01005914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65342566|NCT01005914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65342567|NCT01005914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65342568|NCT01005914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342569|NCT01005914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65342570|NCT01005914|Abortifacient Agents|abortifacient agents|mesh-ancestor
65342571|NCT01005914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65342572|NCT01005914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65342573|NCT01005914|Antimetabolites|antimetabolites|mesh-ancestor
65342574|NCT01005914|Dermatologic Agents|dermatologic agents|mesh-ancestor
65342575|NCT01005914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65342576|NCT01005914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65342577|NCT01005914|Antiviral Agents|antiviral agents|mesh-ancestor
65342578|NCT01005914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65342579|NCT01005914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65342580|NCT01005914|Tubulin Modulators|tubulin modulators|mesh-ancestor
64332113|NCT03816332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65224178|NCT00781768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65224179|NCT00781768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65224180|NCT00781768|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65224181|NCT01005680|Gemcitabine|gemcitabine|mesh-list
65224182|NCT01005680|Pemetrexed|pemetrexed|mesh-list
65224183|NCT01005680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224184|NCT01005680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65224185|NCT01005680|Antimetabolites|antimetabolites|mesh-ancestor
65224186|NCT01005680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224187|NCT01005680|Antiviral Agents|antiviral agents|mesh-ancestor
65224188|NCT01005680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65224209|NCT00618657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224210|NCT00618657|Tubulin Modulators|tubulin modulators|mesh-ancestor
65224211|NCT00618657|Antimitotic Agents|antimitotic agents|mesh-ancestor
65224212|NCT00618657|Mitosis Modulators|mitosis modulators|mesh-ancestor
65224213|NCT00618657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224214|NCT00618657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65224215|NCT00618657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65224216|NCT00618657|Growth Substances|growth substances|mesh-ancestor
65224217|NCT00618657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224218|NCT00618657|Growth Inhibitors|growth inhibitors|mesh-ancestor
65224219|NCT00618657|Immunologic Factors|immunologic factors|mesh-ancestor
65224220|NCT04188249|Golimumab|golimumab|mesh-list
65224221|NCT04188249|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65224222|NCT04188249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65224223|NCT04188249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65224224|NCT04188249|Immunologic Factors|immunologic factors|mesh-ancestor
65224225|NCT04188249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224226|NCT01005602|Digoxin|digoxin|mesh-list
65224227|NCT01005602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65224228|NCT01005602|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65224229|NCT01005602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224230|NCT01005602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224231|NCT01005602|Protective Agents|protective agents|mesh-ancestor
65224232|NCT01005602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224233|NCT05490940|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65224234|NCT05490940|Hemostatics|hemostatics|mesh-ancestor
65224235|NCT05490940|Coagulants|coagulants|mesh-ancestor
65224236|NCT04304261|Metformin|metformin|mesh-list
65224237|NCT04304261|Dapagliflozin|dapagliflozin|mesh-list
65342581|NCT01005914|Antimitotic Agents|antimitotic agents|mesh-ancestor
65342582|NCT01005914|Mitosis Modulators|mitosis modulators|mesh-ancestor
65342583|NCT01005914|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65342584|NCT01005914|Protective Agents|protective agents|mesh-ancestor
65342585|NCT01005914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65342586|NCT00854230|Naltrexone|naltrexone|mesh-list
65342587|NCT00854230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65342588|NCT00854230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65342589|NCT00854230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342590|NCT00854230|Sensory System Agents|sensory system agents|mesh-ancestor
65342591|NCT00854230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65342592|NCT00861016|Metoprolol|metoprolol|mesh-list
65342593|NCT00861016|Felodipine|felodipine|mesh-list
65342594|NCT00861016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65342595|NCT00861016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65342596|NCT00861016|Sympatholytics|sympatholytics|mesh-ancestor
65342597|NCT00861016|Autonomic Agents|autonomic agents|mesh-ancestor
65342598|NCT00861016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65342599|NCT00861016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342600|NCT00861016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65342601|NCT00861016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65342602|NCT00861016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65342603|NCT00861016|Adrenergic Agents|adrenergic agents|mesh-ancestor
65342604|NCT00861016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65342605|NCT00861016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342606|NCT00861016|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65342607|NCT00861016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65224238|NCT04304261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65224239|NCT04304261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224240|NCT04304261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65224241|NCT04304261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224242|NCT04103398|Sorafenib|sorafenib|mesh-list
65224243|NCT04103398|Chlorotrianisene|chlorotrianisene|mesh-list
64937654|NCT01466361|Autonomic Agents|autonomic agents|mesh-ancestor
65224277|NCT04101136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65224278|NCT04101136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65224279|NCT04101136|Antimetabolites|antimetabolites|mesh-ancestor
65224280|NCT04101136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224282|NCT04101136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65224283|NCT04101136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224305|NCT01064297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65224306|NCT01064297|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65224307|NCT01064297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224309|NCT01064297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65224310|NCT01064297|Antimanic Agents|antimanic agents|mesh-ancestor
65224311|NCT00781456|Contraceptive Agents|contraceptive agents|mesh-list
65224312|NCT00781456|Levonorgestrel|levonorgestrel|mesh-list
65342608|NCT00861016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65342609|NCT00861016|Vasodilator Agents|vasodilator agents|mesh-ancestor
65342610|NCT00721916|Leucovorin|leucovorin|mesh-list
65342611|NCT00721916|Oxaliplatin|oxaliplatin|mesh-list
65342612|NCT00721916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342613|NCT00721916|Antidotes|antidotes|mesh-ancestor
65342614|NCT00721916|Protective Agents|protective agents|mesh-ancestor
65342615|NCT00721916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342616|NCT00721916|Vitamin B Complex|vitamin b complex|mesh-ancestor
65342617|NCT00721916|Vitamins|vitamins|mesh-ancestor
65342618|NCT00721916|Micronutrients|micronutrients|mesh-ancestor
65342619|NCT00861250|Dexamethasone|dexamethasone|mesh-list
65342620|NCT00861250|Bortezomib|bortezomib|mesh-list
65342621|NCT00861250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65342622|NCT00861250|Antiemetics|antiemetics|mesh-ancestor
65342623|NCT00861250|Autonomic Agents|autonomic agents|mesh-ancestor
65342624|NCT00861250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65342625|NCT00861250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342626|NCT00861250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65342627|NCT00861250|Glucocorticoids|glucocorticoids|mesh-ancestor
65342628|NCT00861250|Hormones|hormones|mesh-ancestor
65342629|NCT00861250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65342630|NCT00861250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65342631|NCT00861250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342632|NCT00722150|Artesunate|artesunate|mesh-list
65342633|NCT00722150|Antimalarials|antimalarials|mesh-ancestor
65342634|NCT00722150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65342635|NCT00722150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64724583|NCT00000649|Zidovudine|zidovudine|mesh-list
65224313|NCT00781456|Contraceptives, Oral|contraceptives, oral|mesh-list
65224314|NCT00781456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65224315|NCT00781456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224316|NCT00781456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65224317|NCT00781456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65224318|NCT00781456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65224319|NCT04716881|Naltrexone|naltrexone|mesh-list
65224320|NCT04716881|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65224321|NCT04716881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65224322|NCT04716881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224323|NCT04716881|Sensory System Agents|sensory system agents|mesh-ancestor
65224324|NCT04716881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65224325|NCT00582907|Rilonacept|rilonacept|mesh-list
65224326|NCT00582907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65224327|NCT01062113|Celecoxib|celecoxib|mesh-list
65224328|NCT01062113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65224329|NCT01062113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65224330|NCT01062113|Analgesics|analgesics|mesh-ancestor
65224331|NCT01062113|Sensory System Agents|sensory system agents|mesh-ancestor
65224332|NCT01062113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65342636|NCT00722150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65342637|NCT00722150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342638|NCT00722150|Antiviral Agents|antiviral agents|mesh-ancestor
65342639|NCT00722150|Schistosomicides|schistosomicides|mesh-ancestor
65342640|NCT00722150|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65342641|NCT00722150|Anthelmintics|anthelmintics|mesh-ancestor
65342642|NCT00861094|Leucovorin|leucovorin|mesh-list
65342643|NCT00861094|Folic Acid|folic acid|mesh-list
65342644|NCT00861094|Fluorouracil|fluorouracil|mesh-list
65342645|NCT00861094|Oxaliplatin|oxaliplatin|mesh-list
65342646|NCT00861094|Levoleucovorin|levoleucovorin|mesh-list
65342647|NCT00861094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342648|NCT00861094|Antimetabolites|antimetabolites|mesh-ancestor
65342649|NCT00861094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342650|NCT00861094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65342651|NCT00861094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65342652|NCT00861094|Immunologic Factors|immunologic factors|mesh-ancestor
65342653|NCT00861094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342654|NCT00861094|Antidotes|antidotes|mesh-ancestor
65342655|NCT00861094|Protective Agents|protective agents|mesh-ancestor
65342656|NCT00861094|Vitamin B Complex|vitamin b complex|mesh-ancestor
65224333|NCT01062113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224334|NCT01062113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65224335|NCT01062113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65224336|NCT01062113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64937763|NCT01465893|Vitamin D|vitamin d|mesh-list
65224364|NCT00767806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65224365|NCT00767806|Dopamine Agents|dopamine agents|mesh-ancestor
65224366|NCT00780910|Ribavirin|ribavirin|mesh-list
65224367|NCT00780910|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65224368|NCT00780910|Antimetabolites|antimetabolites|mesh-ancestor
65224369|NCT00780910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224370|NCT00780910|Antiviral Agents|antiviral agents|mesh-ancestor
65224371|NCT00780910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65224372|NCT02582203|Vancomycin|vancomycin|mesh-list
65224373|NCT02582203|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
65224374|NCT02582203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65224375|NCT02582203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65224376|NCT05035927|Psilocybin|psilocybin|mesh-list
65224377|NCT05035927|Hallucinogens|hallucinogens|mesh-ancestor
65224378|NCT05035927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224379|NCT05035927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65224380|NCT00771472|Vorinostat|vorinostat|mesh-list
65224381|NCT00771472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224382|NCT00771472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65224383|NCT00771472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937801|NCT00009815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224414|NCT04348045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224415|NCT03337009|Naloxone|naloxone|mesh-list
65224416|NCT03337009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65224417|NCT03337009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224418|NCT03337009|Sensory System Agents|sensory system agents|mesh-ancestor
65224419|NCT03337009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65224420|NCT03328273|Acalabrutinib|acalabrutinib|mesh-list
65224421|NCT03328273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224422|NCT04963153|Immunoconjugates|immunoconjugates|mesh-list
65224423|NCT04963153|Immunologic Factors|immunologic factors|mesh-ancestor
65224424|NCT04963153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342657|NCT00861094|Vitamins|vitamins|mesh-ancestor
65342658|NCT00861094|Micronutrients|micronutrients|mesh-ancestor
65342659|NCT00861094|Hematinics|hematinics|mesh-ancestor
65342660|NCT00807261|Gemcitabine|gemcitabine|mesh-list
65342661|NCT00807261|Docetaxel|docetaxel|mesh-list
65342662|NCT00807261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65342663|NCT00807261|Antimetabolites|antimetabolites|mesh-ancestor
64724615|NCT00000655|Sulfamethoxazole|sulfamethoxazole|mesh-list
65224425|NCT03277729|Cyclophosphamide|cyclophosphamide|mesh-list
64937847|NCT00009893|Vitamins|vitamins|mesh-ancestor
65224447|NCT04099732|Dabigatran|dabigatran|mesh-list
65224448|NCT04099732|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65224449|NCT04099732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65224450|NCT04099732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65224451|NCT04099732|Antimetabolites|antimetabolites|mesh-ancestor
65224452|NCT04099732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224453|NCT04099732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65224454|NCT04099732|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65224455|NCT04099732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224456|NCT04099732|Antithrombins|antithrombins|mesh-ancestor
65224457|NCT04099732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65224458|NCT04099732|Protease Inhibitors|protease inhibitors|mesh-ancestor
65224459|NCT04099732|Anticoagulants|anticoagulants|mesh-ancestor
65224460|NCT03183115|Lugol's solution|lugol's solution|mesh-list
65224461|NCT03183115|Hemostatics|hemostatics|mesh-ancestor
65224462|NCT03183115|Coagulants|coagulants|mesh-ancestor
65224463|NCT02743897|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65224464|NCT02743897|Antiviral Agents|antiviral agents|mesh-ancestor
65224465|NCT02743897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65224466|NCT02743819|Pembrolizumab|pembrolizumab|mesh-list
65224467|NCT02743819|Ipilimumab|ipilimumab|mesh-list
65224468|NCT02743819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65224469|NCT02743819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224470|NCT02743819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65224471|NCT02743819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224472|NCT04074421|Rifaximin|rifaximin|mesh-list
65224473|NCT04074421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65224474|NCT04074421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65224475|NCT04074421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65224476|NCT02579707|Ivosidenib|ivosidenib|mesh-list
65224477|NCT02579707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224478|NCT02579707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224479|NCT02579707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224480|NCT02713009|Vitamin D|vitamin d|mesh-list
65224481|NCT02713009|Ergocalciferols|ergocalciferols|mesh-list
65224483|NCT02713009|Vitamins|vitamins|mesh-list
65224484|NCT02713009|Micronutrients|micronutrients|mesh-ancestor
65224546|NCT00628706|Sensory System Agents|sensory system agents|mesh-ancestor
65224547|NCT00628706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65224548|NCT00628706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65224549|NCT00628706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65224550|NCT00628706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65224551|NCT00628706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224553|NCT00628706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65224554|NCT01001234|Rizatriptan|rizatriptan|mesh-list
64867280|NCT01809444|Doxycycline|doxycycline|mesh-list
65224555|NCT01001234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65224556|NCT01001234|Serotonin Agents|serotonin agents|mesh-ancestor
65224557|NCT01001234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65224558|NCT01001234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224559|NCT01001234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224560|NCT04462328|Durvalumab|durvalumab|mesh-list
65224561|NCT04462328|Acalabrutinib|acalabrutinib|mesh-list
65224562|NCT04462328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65224594|NCT01004432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65224595|NCT01004432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224596|NCT01004432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65224597|NCT01004432|Antimetabolites|antimetabolites|mesh-ancestor
65224598|NCT01004432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224599|NCT01004432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342664|NCT00807261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342665|NCT00807261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342666|NCT00807261|Antiviral Agents|antiviral agents|mesh-ancestor
65342667|NCT00807261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65342668|NCT00807261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342669|NCT00807261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65342670|NCT00807261|Immunologic Factors|immunologic factors|mesh-ancestor
65342671|NCT00807261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342672|NCT00807261|Tubulin Modulators|tubulin modulators|mesh-ancestor
65342673|NCT00807261|Antimitotic Agents|antimitotic agents|mesh-ancestor
65342674|NCT00807261|Mitosis Modulators|mitosis modulators|mesh-ancestor
65342675|NCT04019106|Budesonide|budesonide|mesh-list
65342676|NCT04019106|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65342677|NCT04019106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65342678|NCT04019106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65342679|NCT04019106|Autonomic Agents|autonomic agents|mesh-ancestor
65342680|NCT04019106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65342681|NCT04019106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342682|NCT04019106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65342683|NCT04019106|Respiratory System Agents|respiratory system agents|mesh-ancestor
65342684|NCT04019106|Glucocorticoids|glucocorticoids|mesh-ancestor
65342685|NCT04019106|Hormones|hormones|mesh-ancestor
65342686|NCT04019106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65342687|NCT02571608|Metformin|metformin|mesh-list
65342688|NCT02571608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64724629|NCT00002948|Topotecan|topotecan|mesh-list
65224600|NCT01004432|Dermatologic Agents|dermatologic agents|mesh-ancestor
65224601|NCT01004432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224602|NCT01004432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65224603|NCT01004432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65224604|NCT01004432|Immunologic Factors|immunologic factors|mesh-ancestor
65224626|NCT02539537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65224627|NCT02539537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65224628|NCT02539537|Antidotes|antidotes|mesh-ancestor
65224629|NCT02539537|Protective Agents|protective agents|mesh-ancestor
65224630|NCT02539537|Vitamin B Complex|vitamin b complex|mesh-ancestor
65224631|NCT02539537|Vitamins|vitamins|mesh-ancestor
65224632|NCT02539537|Micronutrients|micronutrients|mesh-ancestor
65224633|NCT02539537|Hematinics|hematinics|mesh-ancestor
65224634|NCT02576275|Rituximab|rituximab|mesh-list
65224635|NCT02576275|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65224636|NCT02576275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65224637|NCT02576275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224638|NCT02576275|Immunologic Factors|immunologic factors|mesh-ancestor
65224639|NCT02576275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224640|NCT02576275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65224641|NCT02576275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65224642|NCT02576275|Alkylating Agents|alkylating agents|mesh-ancestor
65224643|NCT02576275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224644|NCT01000610|Methylprednisolone|methylprednisolone|mesh-list
65342689|NCT02571608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342690|NCT00865072|Metformin|metformin|mesh-list
65342691|NCT00865072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65342692|NCT00865072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342694|NCT00804297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65342695|NCT00804297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65342696|NCT00804297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342697|NCT00861328|Oxaliplatin|oxaliplatin|mesh-list
65342698|NCT00861328|Irinotecan|irinotecan|mesh-list
65342699|NCT00861328|Camptothecin|camptothecin|mesh-list
65342700|NCT00861328|ON 01910|on 01910|mesh-list
65342701|NCT00861328|Glycine|glycine|mesh-list
65342702|NCT00861328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342703|NCT00861328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65224645|NCT01000610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65224646|NCT01000610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65224647|NCT01000610|Prednisolone|prednisolone|mesh-list
65224648|NCT01000610|Prednisolone acetate|prednisolone acetate|mesh-list
65224649|NCT01000610|Rituximab|rituximab|mesh-list
65224650|NCT01000610|Methotrexate|methotrexate|mesh-list
65224651|NCT01000610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65224652|NCT01000610|Prednisolone phosphate|prednisolone phosphate|mesh-list
65224653|NCT01000610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65224654|NCT01000610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224655|NCT01000610|Immunologic Factors|immunologic factors|mesh-ancestor
65224656|NCT01000610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224657|NCT01000610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65224658|NCT01000610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65224659|NCT01000610|Abortifacient Agents|abortifacient agents|mesh-ancestor
65224660|NCT01000610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64938068|NCT00011297|Gabapentin|gabapentin|mesh-list
65224680|NCT02523469|Nivolumab|nivolumab|mesh-list
65224681|NCT02523469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65224682|NCT02523469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224683|NCT02523469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65224684|NCT02523469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224685|NCT00586924|Immunotoxin HA22|immunotoxin ha22|mesh-list
65224686|NCT00586924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224687|NCT04211961|Scopolamine|scopolamine|mesh-list
65224688|NCT04211961|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65224689|NCT04211961|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65224690|NCT04211961|Antiemetics|antiemetics|mesh-ancestor
65224691|NCT04211961|Autonomic Agents|autonomic agents|mesh-ancestor
65224692|NCT04211961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65224693|NCT04211961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224694|NCT04211961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65224695|NCT04211961|Mydriatics|mydriatics|mesh-ancestor
65224696|NCT04211961|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65224697|NCT04211961|Cholinergic Agents|cholinergic agents|mesh-ancestor
65224698|NCT04211961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65224699|NCT04211961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224700|NCT04211961|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65224701|NCT04211961|Parasympatholytics|parasympatholytics|mesh-ancestor
65224702|NCT01000376|Ketoconazole|ketoconazole|mesh-list
65224703|NCT01000376|Antifungal Agents|antifungal agents|mesh-ancestor
65224704|NCT01000376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65224705|NCT01000376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64867433|NCT01810601|Hormones|hormones|mesh-ancestor
65224706|NCT01000376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65224708|NCT01000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224709|NCT01000376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65224710|NCT01000376|Hormone Antagonists|hormone antagonists|mesh-ancestor
65224711|NCT01000376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65342704|NCT00861328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65342705|NCT00861328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342706|NCT00861328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342707|NCT00861328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65342708|NCT00861328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65342709|NCT00861328|Glycine Agents|glycine agents|mesh-ancestor
65342710|NCT00861328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65342711|NCT00861328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342712|NCT00861406|Interferons|interferons|mesh-list
65342713|NCT00861406|Interferon-alpha|interferon-alpha|mesh-list
65342714|NCT00861406|Interferon alpha-2|interferon alpha-2|mesh-list
65342715|NCT00861406|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65342716|NCT00861406|Vaccines|vaccines|mesh-list
65342717|NCT00861406|Immunologic Factors|immunologic factors|mesh-ancestor
65342718|NCT00861406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342719|NCT00861406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342720|NCT00861406|Antiviral Agents|antiviral agents|mesh-ancestor
65342721|NCT00861406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65342722|NCT04261790|Ocrelizumab|ocrelizumab|mesh-list
65342723|NCT04261790|Immunologic Factors|immunologic factors|mesh-ancestor
65342724|NCT04261790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342725|NCT00865384|Mirtazapine|mirtazapine|mesh-list
65342726|NCT00865384|Antidepressive Agents|antidepressive agents|mesh-ancestor
65342727|NCT00865384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65342728|NCT00865384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65342729|NCT00865384|Histamine Antagonists|histamine antagonists|mesh-ancestor
65342730|NCT00865384|Histamine Agents|histamine agents|mesh-ancestor
65342731|NCT00865384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65342732|NCT00865384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342733|NCT00865384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342734|NCT00865384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65342735|NCT00865384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65342736|NCT00865384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65342737|NCT00865384|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65224712|NCT01000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224713|NCT01000376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65224732|NCT00619203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65224733|NCT00619203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224734|NCT00619203|Antipyretics|antipyretics|mesh-ancestor
65342738|NCT00865384|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65342739|NCT00865384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65342740|NCT00865384|Adrenergic Agents|adrenergic agents|mesh-ancestor
65342741|NCT00865384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65342742|NCT00865384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65342743|NCT00865384|Serotonin Agents|serotonin agents|mesh-ancestor
65342744|NCT00865384|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65342745|NCT00578292|Cyclophosphamide|cyclophosphamide|mesh-list
65342746|NCT00578292|Busulfan|busulfan|mesh-list
65342747|NCT00578292|Fludarabine|fludarabine|mesh-list
65342748|NCT00578292|Alemtuzumab|alemtuzumab|mesh-list
65342749|NCT00578292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65342750|NCT00578292|Immunologic Factors|immunologic factors|mesh-ancestor
65342751|NCT00578292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342752|NCT00578292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65342753|NCT00578292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65342754|NCT00578292|Alkylating Agents|alkylating agents|mesh-ancestor
65342755|NCT00578292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342756|NCT00578292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342757|NCT00578292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65224735|NCT00619203|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65224736|NCT00619203|Protective Agents|protective agents|mesh-ancestor
65224737|NCT04072471|Lesinurad|lesinurad|mesh-list
65224738|NCT04072471|Gout Suppressants|gout suppressants|mesh-ancestor
65224739|NCT04072471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65224740|NCT04072471|Uricosuric Agents|uricosuric agents|mesh-ancestor
65224741|NCT04072471|Renal Agents|renal agents|mesh-ancestor
65224742|NCT01000064|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65224743|NCT01000064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65224744|NCT01000064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224745|NCT01000064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65224746|NCT01000064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65224747|NCT01000064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65224748|NCT01000064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224749|NCT01000064|Dopamine Agents|dopamine agents|mesh-ancestor
65224750|NCT01000064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65224751|NCT01812603|Nabiximols|nabiximols|mesh-list
65224752|NCT01812603|Analgesics|analgesics|mesh-ancestor
65224753|NCT01812603|Sensory System Agents|sensory system agents|mesh-ancestor
65224754|NCT01812603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65224755|NCT01812603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224756|NCT04211805|Tenofovir|tenofovir|mesh-list
65224757|NCT04211805|Vaccines|vaccines|mesh-list
65224758|NCT04211805|Immunologic Factors|immunologic factors|mesh-ancestor
65224759|NCT04211805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224760|NCT04211805|Antiviral Agents|antiviral agents|mesh-ancestor
65224761|NCT04211805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65224762|NCT04211805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65224763|NCT04211805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65224764|NCT04211805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224765|NCT04211805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224766|NCT04211805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65224767|NCT04211805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65224768|NCT02874287|Hydroxychloroquine|hydroxychloroquine|mesh-list
65224769|NCT02874287|Antimalarials|antimalarials|mesh-ancestor
65342758|NCT00578292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65342759|NCT00724724|Aspirin|aspirin|mesh-list
65342760|NCT00724724|3-n-butylphthalide|3-n-butylphthalide|mesh-list
65342761|NCT00724724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65342762|NCT00724724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65342763|NCT00724724|Analgesics|analgesics|mesh-ancestor
65342764|NCT00724724|Sensory System Agents|sensory system agents|mesh-ancestor
65342765|NCT00724724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65342766|NCT00724724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342767|NCT00724724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65342768|NCT00724724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65342769|NCT00724724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65342770|NCT00724724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64724714|NCT00000673|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65224770|NCT02874287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65224771|NCT02874287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65224804|NCT00628550|Epinephrine|epinephrine|mesh-list
65224805|NCT00628550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65224807|NCT00628550|Adrenergic Agents|adrenergic agents|mesh-ancestor
65224808|NCT00628550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65224809|NCT00628550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224810|NCT00628550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224811|NCT00628550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65224812|NCT00628550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65224813|NCT00628550|Autonomic Agents|autonomic agents|mesh-ancestor
64938230|NCT00012116|Alkylating Agents|alkylating agents|mesh-ancestor
65224844|NCT02576119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65224845|NCT02576119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65224846|NCT02576119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65224847|NCT02576119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65224848|NCT02576119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224849|NCT02576119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224850|NCT02576119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224851|NCT02576119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65224852|NCT02576119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65224853|NCT02576119|Antiviral Agents|antiviral agents|mesh-ancestor
65224854|NCT02871518|Cisplatin|cisplatin|mesh-list
65224855|NCT02871518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867587|NCT01811667|Sirolimus|sirolimus|mesh-list
65224857|NCT04304144|Cyclophosphamide|cyclophosphamide|mesh-list
65224858|NCT04304144|Bortezomib|bortezomib|mesh-list
65224859|NCT04304144|Daratumumab|daratumumab|mesh-list
65224860|NCT04304144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65224882|NCT04676867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224884|NCT00770224|Prednisone|prednisone|mesh-list
65224885|NCT00770224|Cyclophosphamide|cyclophosphamide|mesh-list
65224886|NCT00770224|Rituximab|rituximab|mesh-list
65224887|NCT00770224|Doxorubicin|doxorubicin|mesh-list
65224888|NCT00770224|Vincristine|vincristine|mesh-list
65224889|NCT00770224|Tositumomab I-131|tositumomab i-131|mesh-list
65224890|NCT00770224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65224891|NCT00770224|Immunologic Factors|immunologic factors|mesh-ancestor
65224892|NCT00770224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224893|NCT00770224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65224894|NCT00770224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65224895|NCT00770224|Alkylating Agents|alkylating agents|mesh-ancestor
65224896|NCT00770224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224897|NCT00770224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224898|NCT00770224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65224899|NCT00770224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65224900|NCT00770224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65224901|NCT00770224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65342771|NCT00724724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342772|NCT00724724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65342773|NCT00724724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65342774|NCT00724724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342775|NCT00724724|Antipyretics|antipyretics|mesh-ancestor
65342776|NCT00724724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65224902|NCT00770224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65224903|NCT00770224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224904|NCT00770224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65224905|NCT00770224|Glucocorticoids|glucocorticoids|mesh-ancestor
65224906|NCT00770224|Hormones|hormones|mesh-ancestor
65224907|NCT00770224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65224908|NCT00770224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65224909|NCT00770224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65224910|NCT00770224|Tubulin Modulators|tubulin modulators|mesh-ancestor
65224911|NCT00770224|Antimitotic Agents|antimitotic agents|mesh-ancestor
65224912|NCT00770224|Mitosis Modulators|mitosis modulators|mesh-ancestor
64938366|NCT00012584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65224971|NCT02575885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65224972|NCT02575885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224973|NCT02575885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65224974|NCT02575885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65224975|NCT02575885|Cholinergic Agents|cholinergic agents|mesh-ancestor
65224976|NCT02575885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65224977|NCT02575885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224978|NCT02575729|Betamethasone|betamethasone|mesh-list
65224979|NCT02575729|Glucocorticoids|glucocorticoids|mesh-list
65224980|NCT02575729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65224981|NCT02575729|Hormones|hormones|mesh-ancestor
65224982|NCT02575729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65224983|NCT02575729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224984|NCT02575729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65224985|NCT02575729|Respiratory System Agents|respiratory system agents|mesh-ancestor
65224986|NCT01835041|Leucovorin|leucovorin|mesh-list
65224987|NCT01835041|Thioctic Acid|thioctic acid|mesh-list
65224988|NCT01835041|Fluorouracil|fluorouracil|mesh-list
65224989|NCT01835041|Oxaliplatin|oxaliplatin|mesh-list
65224990|NCT01835041|Irinotecan|irinotecan|mesh-list
65224991|NCT01835041|Calcium|calcium|mesh-list
65224992|NCT01835041|Levoleucovorin|levoleucovorin|mesh-list
65224993|NCT01835041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65224994|NCT01835041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224995|NCT01835041|Antimetabolites|antimetabolites|mesh-ancestor
65224996|NCT01835041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224997|NCT01835041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65224998|NCT01835041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224999|NCT01835041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65225000|NCT01835041|Immunologic Factors|immunologic factors|mesh-ancestor
65225001|NCT01835041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65225002|NCT01835041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65225023|NCT04209933|Potassium Citrate|potassium citrate|mesh-list
65225024|NCT04209933|Bismuth|bismuth|mesh-list
65225025|NCT04209933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225026|NCT04209933|Antacids|antacids|mesh-ancestor
65225027|NCT04209933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65225028|NCT04209933|Diuretics|diuretics|mesh-ancestor
65225029|NCT04209933|Natriuretic Agents|natriuretic agents|mesh-ancestor
65225030|NCT04209933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225031|NCT04209933|Expectorants|expectorants|mesh-ancestor
65225032|NCT04209933|Respiratory System Agents|respiratory system agents|mesh-ancestor
65225033|NCT00619905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65225034|NCT00619905|Immunologic Factors|immunologic factors|mesh-ancestor
65225035|NCT00619905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225037|NCT04209699|Famotidine|famotidine|mesh-list
65225038|NCT04209699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65225039|NCT04209699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65225040|NCT04209699|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65225041|NCT04209699|Histamine Antagonists|histamine antagonists|mesh-ancestor
65225042|NCT04209699|Histamine Agents|histamine agents|mesh-ancestor
65342777|NCT00724724|Protective Agents|protective agents|mesh-ancestor
65342779|NCT00865462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65342780|NCT00865462|Antidepressive Agents|antidepressive agents|mesh-ancestor
65342781|NCT00865462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65342782|NCT00865462|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65342783|NCT00865462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65342784|NCT00865462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65342785|NCT00865462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342786|NCT00865462|Dopamine Agents|dopamine agents|mesh-ancestor
65342787|NCT00865462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64724737|NCT00000691|Foscarnet|foscarnet|mesh-list
65225043|NCT04209699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65225044|NCT04209699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225045|NCT04209699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225046|NCT04209699|Dermatologic Agents|dermatologic agents|mesh-ancestor
65225047|NCT04209699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65225048|NCT04209699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225049|NCT00620295|Gemcitabine|gemcitabine|mesh-list
65225050|NCT00620295|Bortezomib|bortezomib|mesh-list
65225051|NCT00620295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65225052|NCT00620295|Antimetabolites|antimetabolites|mesh-ancestor
65225053|NCT00620295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225054|NCT00620295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225055|NCT00620295|Antiviral Agents|antiviral agents|mesh-ancestor
65225056|NCT00620295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65225057|NCT00620295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225058|NCT00620295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65225059|NCT00620295|Immunologic Factors|immunologic factors|mesh-ancestor
65225060|NCT00620295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225061|NCT00581893|Phenytoin|phenytoin|mesh-list
65225074|NCT04664023|Vaccines|vaccines|mesh-list
65225075|NCT04664023|Immunologic Factors|immunologic factors|mesh-ancestor
65225076|NCT04664023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225077|NCT02334865|Lenalidomide|lenalidomide|mesh-list
65225078|NCT02334865|Sargramostim|sargramostim|mesh-list
65225079|NCT02334865|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65225080|NCT02334865|Freund's Adjuvant|freund's adjuvant|mesh-list
65225081|NCT02334865|Immunologic Factors|immunologic factors|mesh-ancestor
65225082|NCT02334865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225083|NCT02334865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64867815|NCT01813162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65225084|NCT02334865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65225085|NCT02334865|Growth Substances|growth substances|mesh-ancestor
65225086|NCT02334865|Growth Inhibitors|growth inhibitors|mesh-ancestor
65225087|NCT02334865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225088|NCT02334865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65225090|NCT04073719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65225091|NCT04073719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65225092|NCT00379431|Methylprednisolone|methylprednisolone|mesh-list
65225093|NCT00379431|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65225094|NCT00379431|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65225095|NCT00379431|Prednisolone|prednisolone|mesh-list
65225096|NCT00379431|Prednisolone acetate|prednisolone acetate|mesh-list
65225097|NCT00379431|Rituximab|rituximab|mesh-list
65225098|NCT00379431|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65225099|NCT00379431|Prednisolone phosphate|prednisolone phosphate|mesh-list
65225100|NCT00379431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65225101|NCT00379431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225102|NCT00379431|Immunologic Factors|immunologic factors|mesh-ancestor
65225103|NCT00379431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225104|NCT00379431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65225105|NCT00379431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65225106|NCT00379431|Antiemetics|antiemetics|mesh-ancestor
65225107|NCT00379431|Autonomic Agents|autonomic agents|mesh-ancestor
65342788|NCT00865462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342789|NCT00865462|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65342790|NCT00865462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65342791|NCT00865462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342792|NCT04042558|Bevacizumab|bevacizumab|mesh-list
65342793|NCT04042558|Carboplatin|carboplatin|mesh-list
65342794|NCT04042558|Pemetrexed|pemetrexed|mesh-list
65342795|NCT04042558|Atezolizumab|atezolizumab|mesh-list
65342796|NCT04042558|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65342797|NCT04042558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65342798|NCT04042558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342799|NCT04042558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65342800|NCT04042558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65342801|NCT04042558|Growth Substances|growth substances|mesh-ancestor
65342802|NCT04042558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342803|NCT04042558|Growth Inhibitors|growth inhibitors|mesh-ancestor
65342804|NCT04042558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342805|NCT04042558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342806|NCT04042558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65342807|NCT04042558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65342808|NCT04042558|Immunologic Factors|immunologic factors|mesh-ancestor
65342809|NCT04130204|Colchicine|colchicine|mesh-list
65342810|NCT04130204|Gout Suppressants|gout suppressants|mesh-ancestor
65342811|NCT04130204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65342812|NCT04130204|Tubulin Modulators|tubulin modulators|mesh-ancestor
64724745|NCT00002984|Paclitaxel|paclitaxel|mesh-list
65225108|NCT00379431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65225109|NCT00379431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65225110|NCT00379431|Glucocorticoids|glucocorticoids|mesh-ancestor
65225111|NCT00379431|Hormones|hormones|mesh-ancestor
65225112|NCT00379431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65225113|NCT00379431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65225114|NCT00379431|Protective Agents|protective agents|mesh-ancestor
65225115|NCT00379431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65225116|NCT04855617|Ocrelizumab|ocrelizumab|mesh-list
65225117|NCT04855617|Immunologic Factors|immunologic factors|mesh-ancestor
65225118|NCT04855617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225119|NCT04954989|Epoetin Alfa|epoetin alfa|mesh-list
65225120|NCT04954989|Hematinics|hematinics|mesh-ancestor
65225121|NCT03890289|Obinutuzumab|obinutuzumab|mesh-list
65225122|NCT03890289|Idelalisib|idelalisib|mesh-list
65225123|NCT03890289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65225124|NCT03890289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225154|NCT00915850|Antimitotic Agents|antimitotic agents|mesh-ancestor
65225155|NCT00915850|Mitosis Modulators|mitosis modulators|mesh-ancestor
65225156|NCT00915850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225158|NCT04208763|Colistin|colistin|mesh-list
65225159|NCT04208763|Tigecycline|tigecycline|mesh-list
65225160|NCT04208763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65225161|NCT04208763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65342813|NCT04130204|Antimitotic Agents|antimitotic agents|mesh-ancestor
65342814|NCT04130204|Mitosis Modulators|mitosis modulators|mesh-ancestor
65342815|NCT04130204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342816|NCT04130204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342817|NCT00723918|Methadone|methadone|mesh-list
65342818|NCT00723918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65342819|NCT00723918|Narcotics|narcotics|mesh-ancestor
65342820|NCT00723918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65342821|NCT00723918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342822|NCT00723918|Analgesics|analgesics|mesh-ancestor
65225162|NCT04208763|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65225163|NCT04208763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225164|NCT04208763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225165|NCT00620919|Secretin|secretin|mesh-list
65225166|NCT00620919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65225167|NCT00620919|Hormones|hormones|mesh-ancestor
65225168|NCT00620919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65225169|NCT00620919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225192|NCT00620997|Sensory System Agents|sensory system agents|mesh-ancestor
65225193|NCT00620997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65225194|NCT00622011|Risperidone|risperidone|mesh-list
65225195|NCT00622011|Zotepine|zotepine|mesh-list
65225196|NCT00622011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65225197|NCT00622011|Serotonin Agents|serotonin agents|mesh-ancestor
65225198|NCT00622011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65225199|NCT00622011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225200|NCT00622011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225201|NCT00622011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65225202|NCT00622011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65225203|NCT00622011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65225204|NCT00622011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65225205|NCT00622011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65225206|NCT00622011|Dopamine Agents|dopamine agents|mesh-ancestor
65225207|NCT03936309|Lidocaine|lidocaine|mesh-list
65225208|NCT03936309|Anesthetics, Local|anesthetics, local|mesh-ancestor
65225209|NCT03936309|Anesthetics|anesthetics|mesh-ancestor
65225210|NCT03936309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65225211|NCT03936309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225212|NCT03936309|Sensory System Agents|sensory system agents|mesh-ancestor
65225213|NCT03936309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65225214|NCT03936309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65225215|NCT03936309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65225216|NCT03936309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65225217|NCT03936309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65225218|NCT03936309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225219|NCT03838263|Cisplatin|cisplatin|mesh-list
65225220|NCT03838263|Nivolumab|nivolumab|mesh-list
65225221|NCT03838263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225222|NCT03838263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65225223|NCT03838263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64938615|NCT00013871|Immunologic Factors|immunologic factors|mesh-ancestor
65225241|NCT03771651|Aspirin|aspirin|mesh-list
65225242|NCT03771651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65225243|NCT03771651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65225244|NCT03771651|Analgesics|analgesics|mesh-ancestor
65225245|NCT03771651|Sensory System Agents|sensory system agents|mesh-ancestor
65225246|NCT03771651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65225247|NCT03771651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225248|NCT03771651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65225249|NCT03771651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65225250|NCT03771651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65225251|NCT03771651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65225252|NCT03771651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225253|NCT03771651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65342823|NCT00723918|Sensory System Agents|sensory system agents|mesh-ancestor
65342824|NCT00723918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65342825|NCT00723918|Antitussive Agents|antitussive agents|mesh-ancestor
65342826|NCT00723918|Respiratory System Agents|respiratory system agents|mesh-ancestor
65342827|NCT00865540|Prednisolone|prednisolone|mesh-list
65342828|NCT00865540|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65342829|NCT00865540|Methylprednisolone|methylprednisolone|mesh-list
65342830|NCT00865540|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65342831|NCT00865540|Prednisolone acetate|prednisolone acetate|mesh-list
65342832|NCT00865540|Ketorolac|ketorolac|mesh-list
65342833|NCT00865540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65342834|NCT00865540|Nepafenac|nepafenac|mesh-list
65342835|NCT00865540|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65342836|NCT00865540|Prednisolone phosphate|prednisolone phosphate|mesh-list
65225254|NCT03771651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65225255|NCT03771651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225256|NCT03771651|Antipyretics|antipyretics|mesh-ancestor
65225257|NCT00622245|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65225258|NCT00622245|Antidepressive Agents|antidepressive agents|mesh-ancestor
65225259|NCT00622245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65225260|NCT00622245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65225261|NCT00622245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65225262|NCT00622245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65225263|NCT00622245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225264|NCT01056341|Propranolol|propranolol|mesh-list
65225265|NCT01056341|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65225266|NCT01056341|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65225267|NCT01056341|Adrenergic Agents|adrenergic agents|mesh-ancestor
65225268|NCT01056341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65225269|NCT01056341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225270|NCT01056341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225271|NCT01056341|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65225272|NCT01056341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65225273|NCT01056341|Vasodilator Agents|vasodilator agents|mesh-ancestor
65225274|NCT00999518|Tanezumab|tanezumab|mesh-list
64938674|NCT00276588|Paclitaxel|paclitaxel|mesh-list
65225293|NCT02873273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65225294|NCT02873273|Antiemetics|antiemetics|mesh-ancestor
65225295|NCT02873273|Autonomic Agents|autonomic agents|mesh-ancestor
65225296|NCT02873273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65225297|NCT02873273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225298|NCT02873273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65225299|NCT02873273|Glucocorticoids|glucocorticoids|mesh-ancestor
65225300|NCT02873273|Hormones|hormones|mesh-ancestor
65225301|NCT02873273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65225302|NCT02873273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65225303|NCT02873273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225304|NCT04208841|Sulfamethazine|sulfamethazine|mesh-list
65225305|NCT04208841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65225306|NCT01056263|Axitinib|axitinib|mesh-list
65225307|NCT01056263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225308|NCT01056263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65225309|NCT01056263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225310|NCT01056263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225311|NCT00637143|Cyclosporine|cyclosporine|mesh-list
65225312|NCT00637143|Tacrolimus|tacrolimus|mesh-list
65225313|NCT00637143|Cyclosporins|cyclosporins|mesh-list
65225314|NCT00637143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65225315|NCT00637143|Immunologic Factors|immunologic factors|mesh-ancestor
65225316|NCT00637143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225317|NCT00637143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65225318|NCT00637143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225319|NCT00637143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342837|NCT00865540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65342838|NCT00865540|Glucocorticoids|glucocorticoids|mesh-ancestor
65342839|NCT00865540|Hormones|hormones|mesh-ancestor
65342840|NCT00865540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65342841|NCT00865540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342842|NCT00865540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65342844|NCT00865540|Antiemetics|antiemetics|mesh-ancestor
65342845|NCT00865540|Autonomic Agents|autonomic agents|mesh-ancestor
65342846|NCT00865540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65342847|NCT00865540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65342848|NCT00865540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65342849|NCT00865540|Protective Agents|protective agents|mesh-ancestor
65342850|NCT00865540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65342851|NCT00865540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65225320|NCT00637143|Antifungal Agents|antifungal agents|mesh-ancestor
65225321|NCT00637143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65225322|NCT00637143|Dermatologic Agents|dermatologic agents|mesh-ancestor
65225323|NCT00637143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65225324|NCT01056107|Glucagon|glucagon|mesh-list
65225325|NCT01056107|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65225326|NCT01056107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65225327|NCT01056107|Hormones|hormones|mesh-ancestor
65225328|NCT01056107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65225329|NCT01056107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225330|NCT01056107|Incretins|incretins|mesh-ancestor
65225331|NCT03548805|Mitomycins|mitomycins|mesh-list
65225354|NCT04138641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65225355|NCT04138641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225356|NCT04138641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225358|NCT01003184|Insulin Detemir|insulin detemir|mesh-list
65225359|NCT01003184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65225360|NCT01003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225361|NCT01003184|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65225362|NCT01003184|Incretins|incretins|mesh-ancestor
65225363|NCT01003184|Hormones|hormones|mesh-ancestor
65225364|NCT01003184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65225365|NCT04314219|Cyclophosphamide|cyclophosphamide|mesh-list
65225366|NCT04314219|Methotrexate|methotrexate|mesh-list
65225367|NCT04314219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65225368|NCT04314219|Immunologic Factors|immunologic factors|mesh-ancestor
65225369|NCT04314219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225370|NCT04314219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65225371|NCT04314219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65225372|NCT04314219|Alkylating Agents|alkylating agents|mesh-ancestor
65225373|NCT04314219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225374|NCT04314219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225375|NCT04314219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65225376|NCT04314219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65225377|NCT04314219|Abortifacient Agents|abortifacient agents|mesh-ancestor
65225378|NCT04314219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65225379|NCT04314219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65225380|NCT04314219|Antimetabolites|antimetabolites|mesh-ancestor
65225400|NCT01008410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65225401|NCT01008410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65225402|NCT01008410|Autonomic Agents|autonomic agents|mesh-ancestor
65225403|NCT01008410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65225404|NCT01008410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225405|NCT01008410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65225406|NCT01008410|Respiratory System Agents|respiratory system agents|mesh-ancestor
65342852|NCT00865540|Analgesics|analgesics|mesh-ancestor
65342853|NCT00865540|Sensory System Agents|sensory system agents|mesh-ancestor
65342854|NCT00865540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65342855|NCT00865540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65342856|NCT00865540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342857|NCT00865540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342858|NCT00865618|Eplerenone|eplerenone|mesh-list
65342859|NCT00865618|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65342860|NCT00865618|Hormone Antagonists|hormone antagonists|mesh-ancestor
65342861|NCT00865618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65342862|NCT00865618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342863|NCT00865618|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65342864|NCT00865618|Diuretics|diuretics|mesh-ancestor
65342865|NCT00865618|Natriuretic Agents|natriuretic agents|mesh-ancestor
65342866|NCT00865618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65342867|NCT00655629|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65225407|NCT01008410|Glucocorticoids|glucocorticoids|mesh-ancestor
65225408|NCT01008410|Hormones|hormones|mesh-ancestor
65225409|NCT01008410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65225416|NCT02347917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225417|NCT02347917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225418|NCT02347917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225419|NCT02347917|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65225420|NCT02347917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65225421|NCT01972035|Valacyclovir|valacyclovir|mesh-list
65225422|NCT01972035|Valganciclovir|valganciclovir|mesh-list
65225423|NCT01972035|Antiviral Agents|antiviral agents|mesh-ancestor
65225424|NCT01972035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65225425|NCT00622479|Sorafenib|sorafenib|mesh-list
65225426|NCT00622479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225427|NCT00622479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65225428|NCT00622479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225429|NCT00622479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225436|NCT01207011|Docetaxel|docetaxel|mesh-list
65225437|NCT01207011|Amrubicin|amrubicin|mesh-list
65225438|NCT01207011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225439|NCT01207011|Tubulin Modulators|tubulin modulators|mesh-ancestor
65225440|NCT01207011|Antimitotic Agents|antimitotic agents|mesh-ancestor
65225441|NCT01207011|Mitosis Modulators|mitosis modulators|mesh-ancestor
65225442|NCT01207011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225443|NCT05264883|Azacitidine|azacitidine|mesh-list
65225444|NCT05264883|Decitabine|decitabine|mesh-list
65225445|NCT05264883|Venetoclax|venetoclax|mesh-list
65225446|NCT05264883|Aclarubicin|aclarubicin|mesh-list
65225447|NCT05264883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65225448|NCT05264883|Antimetabolites|antimetabolites|mesh-ancestor
65225449|NCT05264883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225450|NCT05264883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225451|NCT05264883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225468|NCT00612261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65225469|NCT00612261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65225470|NCT00612261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65225471|NCT00612261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65225472|NCT00612261|Glucocorticoids|glucocorticoids|mesh-ancestor
65225473|NCT00612261|Hormones|hormones|mesh-ancestor
65225474|NCT00612261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65225475|NCT00612261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225476|NCT00612261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65342868|NCT00655629|Vasodilator Agents|vasodilator agents|mesh-ancestor
65225477|NCT00612261|Immunologic Factors|immunologic factors|mesh-ancestor
65225478|NCT00612261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225479|NCT00612261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225480|NCT00636909|Cyclosporine|cyclosporine|mesh-list
65225481|NCT00636909|Cyclophosphamide|cyclophosphamide|mesh-list
65225482|NCT00636909|Methotrexate|methotrexate|mesh-list
65225483|NCT00636909|Fludarabine|fludarabine|mesh-list
65225484|NCT00636909|Cyclosporins|cyclosporins|mesh-list
65225485|NCT00636909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65225486|NCT00636909|Immunologic Factors|immunologic factors|mesh-ancestor
65225487|NCT00636909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225488|NCT00636909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65225489|NCT00636909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65225490|NCT00636909|Alkylating Agents|alkylating agents|mesh-ancestor
65225491|NCT00636909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225492|NCT00636909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225493|NCT00636909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65225494|NCT00636909|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65225495|NCT00636909|Abortifacient Agents|abortifacient agents|mesh-ancestor
65225496|NCT00636909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65225497|NCT00636909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65225498|NCT00636909|Antimetabolites|antimetabolites|mesh-ancestor
65225499|NCT00636909|Dermatologic Agents|dermatologic agents|mesh-ancestor
65225500|NCT00636909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225501|NCT00636909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65225502|NCT00636909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65225503|NCT00636909|Antifungal Agents|antifungal agents|mesh-ancestor
65225504|NCT00636909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65225505|NCT00636909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65225506|NCT02697669|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65225507|NCT02697669|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65225508|NCT02697669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225509|NCT02697201|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65225527|NCT02697045|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65225528|NCT02697045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65225529|NCT02697045|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65225530|NCT02697045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65225531|NCT01007942|Trastuzumab|trastuzumab|mesh-list
65225532|NCT01007942|Everolimus|everolimus|mesh-list
65225533|NCT01007942|Vinorelbine|vinorelbine|mesh-list
65225534|NCT01007942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65225535|NCT01007942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225536|NCT01007942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65225537|NCT01007942|Immunologic Factors|immunologic factors|mesh-ancestor
65225538|NCT01007942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225539|NCT01007942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65225540|NCT01007942|Tubulin Modulators|tubulin modulators|mesh-ancestor
65225541|NCT01007942|Antimitotic Agents|antimitotic agents|mesh-ancestor
65225542|NCT01007942|Mitosis Modulators|mitosis modulators|mesh-ancestor
65225543|NCT01007942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225544|NCT05661669|Ketamine|ketamine|mesh-list
65225545|NCT05661669|Analgesics|analgesics|mesh-ancestor
65225546|NCT05661669|Sensory System Agents|sensory system agents|mesh-ancestor
65225547|NCT05661669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65225548|NCT05661669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225549|NCT05661669|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65225550|NCT05661669|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65225551|NCT05661669|Anesthetics, General|anesthetics, general|mesh-ancestor
65225552|NCT05661669|Anesthetics|anesthetics|mesh-ancestor
65225553|NCT05661669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65225554|NCT05661669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65225555|NCT05661669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65225556|NCT05661669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65225557|NCT05661669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225558|NCT01023035|Ribavirin|ribavirin|mesh-list
65225559|NCT01023035|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65225560|NCT01023035|Epoetin Alfa|epoetin alfa|mesh-list
65225561|NCT01023035|Antimetabolites|antimetabolites|mesh-ancestor
65225562|NCT01023035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225563|NCT01023035|Antiviral Agents|antiviral agents|mesh-ancestor
65225564|NCT01023035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65225565|NCT01023035|Hematinics|hematinics|mesh-ancestor
65225585|NCT00627731|Protective Agents|protective agents|mesh-ancestor
65342869|NCT00655629|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65342870|NCT00655629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65342871|NCT00655629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342872|NCT00655629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342873|NCT00655629|Urological Agents|urological agents|mesh-ancestor
65342874|NCT00865696|Mirtazapine|mirtazapine|mesh-list
65342875|NCT00865696|Antidepressive Agents|antidepressive agents|mesh-ancestor
65342876|NCT00865696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65342877|NCT00865696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65342878|NCT00865696|Histamine Antagonists|histamine antagonists|mesh-ancestor
65342879|NCT00865696|Histamine Agents|histamine agents|mesh-ancestor
65342880|NCT00865696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65342881|NCT00865696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342882|NCT00865696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342883|NCT00865696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65342884|NCT00865696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65342885|NCT00865696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65342886|NCT00865696|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65342887|NCT00865696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65342888|NCT00865696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65342889|NCT00865696|Adrenergic Agents|adrenergic agents|mesh-ancestor
65342890|NCT00865696|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65342891|NCT00865696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65342892|NCT00865696|Serotonin Agents|serotonin agents|mesh-ancestor
65342893|NCT00865696|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65342894|NCT00724802|Triacetin|triacetin|mesh-list
65342895|NCT00724802|Antifungal Agents|antifungal agents|mesh-ancestor
65342896|NCT00724802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65342897|NCT02545114|Tolvaptan|tolvaptan|mesh-list
65225586|NCT00627731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65225587|NCT00627731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225588|NCT01028027|Loteprednol Etabonate|loteprednol etabonate|mesh-list
65225590|NCT01028027|Dexamethasone|dexamethasone|mesh-list
65225591|NCT01028027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65225592|NCT01028027|Antiemetics|antiemetics|mesh-ancestor
65225593|NCT01028027|Autonomic Agents|autonomic agents|mesh-ancestor
65225594|NCT01028027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65225595|NCT01028027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225596|NCT01028027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65225597|NCT01028027|Glucocorticoids|glucocorticoids|mesh-ancestor
65225598|NCT01028027|Hormones|hormones|mesh-ancestor
65225599|NCT01028027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65225600|NCT01028027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65225601|NCT01028027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342898|NCT02545114|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65342899|NCT02545114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342900|NCT02545114|Natriuretic Agents|natriuretic agents|mesh-ancestor
65342901|NCT02545114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342902|NCT00724880|Clopidogrel|clopidogrel|mesh-list
65342903|NCT00724880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65342904|NCT00724880|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65342905|NCT00724880|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65225602|NCT01028027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65225603|NCT01028027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65225604|NCT01028027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65225605|NCT01007552|Gemcitabine|gemcitabine|mesh-list
65225606|NCT01007552|Bevacizumab|bevacizumab|mesh-list
65225607|NCT01007552|Capecitabine|capecitabine|mesh-list
65225608|NCT01007552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65225609|NCT01007552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225610|NCT01007552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65225611|NCT01007552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65225613|NCT01007552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225614|NCT01007552|Growth Inhibitors|growth inhibitors|mesh-ancestor
65225615|NCT01007552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65225616|NCT01007552|Antimetabolites|antimetabolites|mesh-ancestor
65225617|NCT01007552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225618|NCT01007552|Antiviral Agents|antiviral agents|mesh-ancestor
65225619|NCT01007552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65225620|NCT01007552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225621|NCT01007552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65225622|NCT01007552|Immunologic Factors|immunologic factors|mesh-ancestor
65225623|NCT02870036|Leucovorin|leucovorin|mesh-list
65225653|NCT04296422|Contraceptive Agents|contraceptive agents|mesh-list
65225654|NCT04296422|Contraceptives, Oral|contraceptives, oral|mesh-list
65225655|NCT04296422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65225656|NCT04296422|Analgesics|analgesics|mesh-ancestor
65225657|NCT04296422|Sensory System Agents|sensory system agents|mesh-ancestor
65225658|NCT04296422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65225659|NCT04296422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225660|NCT04296422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65225661|NCT04296422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65225662|NCT04296422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65225663|NCT04296422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225664|NCT04296422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225665|NCT04296422|Gout Suppressants|gout suppressants|mesh-ancestor
65225666|NCT04296422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65225667|NCT04296422|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65225668|NCT00998738|Calcium, Dietary|calcium, dietary|mesh-list
65225669|NCT00998738|Magnesium Sulfate|magnesium sulfate|mesh-list
65225670|NCT00998738|Calcium|calcium|mesh-list
65225671|NCT00998738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64939068|NCT00275184|Metoclopramide|metoclopramide|mesh-list
65225702|NCT04296578|Sodium Selenite|sodium selenite|mesh-list
65225703|NCT04296578|Prednisone|prednisone|mesh-list
65225704|NCT04296578|Abiraterone Acetate|abiraterone acetate|mesh-list
65225705|NCT04296578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65225706|NCT04296578|Glucocorticoids|glucocorticoids|mesh-ancestor
65225707|NCT04296578|Hormones|hormones|mesh-ancestor
65225708|NCT04296578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65225709|NCT04296578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225710|NCT04296578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65225711|NCT04296578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225712|NCT04296578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65225713|NCT04296578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939110|NCT00275106|Methotrexate|methotrexate|mesh-list
65225733|NCT01038323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65225734|NCT01038323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342906|NCT00724880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65342907|NCT00724880|Purinergic Agents|purinergic agents|mesh-ancestor
65342908|NCT00724880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65342909|NCT00724880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342910|NCT00724880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342911|NCT00724074|Bupivacaine|bupivacaine|mesh-list
65342912|NCT00724074|Anesthetics, Local|anesthetics, local|mesh-ancestor
65342913|NCT00724074|Anesthetics|anesthetics|mesh-ancestor
65342914|NCT00724074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65342915|NCT00724074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342916|NCT00724074|Sensory System Agents|sensory system agents|mesh-ancestor
65342917|NCT00724074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65342918|NCT00854776|Lansoprazole|lansoprazole|mesh-list
65342919|NCT00854776|Dexlansoprazole|dexlansoprazole|mesh-list
65342920|NCT00854776|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65342921|NCT00854776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65342922|NCT00854776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65342923|NCT00854776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65342924|NCT00854776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342925|NCT00854776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342926|NCT00854776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65342927|NCT00854776|Immunologic Factors|immunologic factors|mesh-ancestor
65342928|NCT00854776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342929|NCT00854776|Antacids|antacids|mesh-ancestor
65225735|NCT01038323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65225736|NCT01038323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225737|NCT01038323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65225738|NCT01038323|Analgesics|analgesics|mesh-ancestor
65225739|NCT01038323|Sensory System Agents|sensory system agents|mesh-ancestor
65225740|NCT01038323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65225741|NCT01038323|Antidepressive Agents|antidepressive agents|mesh-ancestor
65225742|NCT01038323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65225743|NCT01027871|Insulin Glargine|insulin glargine|mesh-list
65225744|NCT01027871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65225745|NCT01027871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225746|NCT04301375|Paclitaxel|paclitaxel|mesh-list
65225747|NCT04301375|Trastuzumab|trastuzumab|mesh-list
65225748|NCT04301375|Pertuzumab|pertuzumab|mesh-list
65225749|NCT04301375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65225750|NCT04301375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225751|NCT04301375|Tubulin Modulators|tubulin modulators|mesh-ancestor
65225752|NCT04301375|Antimitotic Agents|antimitotic agents|mesh-ancestor
65225753|NCT04301375|Mitosis Modulators|mitosis modulators|mesh-ancestor
65225754|NCT04301375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225755|NCT04301375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65225756|NCT01021553|Diketopiperazines|diketopiperazines|mesh-list
65225757|NCT01021553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65225758|NCT01021553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64868493|NCT01817023|Cisplatin|cisplatin|mesh-list
65225759|NCT01026389|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
65342930|NCT00798525|Lepirudin|lepirudin|mesh-list
65342931|NCT00798525|Argatroban|argatroban|mesh-list
65342932|NCT00798525|Antithrombins|antithrombins|mesh-ancestor
65342933|NCT00798525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65342934|NCT00798525|Protease Inhibitors|protease inhibitors|mesh-ancestor
65342935|NCT00798525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342936|NCT00798525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342937|NCT00798525|Anticoagulants|anticoagulants|mesh-ancestor
65342938|NCT00798525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65342939|NCT00798525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65342940|NCT00798525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65342941|NCT00861640|Omeprazole|omeprazole|mesh-list
65342942|NCT00861640|Rabeprazole|rabeprazole|mesh-list
65342943|NCT00861640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65342944|NCT00861640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65342945|NCT00861640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65342946|NCT00861640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342947|NCT00861640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342948|NCT00724230|Ribavirin|ribavirin|mesh-list
65342949|NCT00724230|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65342950|NCT00724230|Interferon-alpha|interferon-alpha|mesh-list
65342951|NCT00724230|Antimetabolites|antimetabolites|mesh-ancestor
65342952|NCT00724230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342953|NCT00724230|Antiviral Agents|antiviral agents|mesh-ancestor
65342954|NCT00724230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65342955|NCT00724230|Immunologic Factors|immunologic factors|mesh-ancestor
65342956|NCT00724230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342957|NCT05373108|Macitentan|macitentan|mesh-list
65342958|NCT05373108|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64724875|NCT00000727|Zidovudine|zidovudine|mesh-list
65225760|NCT01026389|Chelating Agents|chelating agents|mesh-ancestor
65225761|NCT01026389|Sequestering Agents|sequestering agents|mesh-ancestor
65225762|NCT01026389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225763|NCT01025843|Candesartan|candesartan|mesh-list
65225764|NCT01025843|Candesartan cilexetil|candesartan cilexetil|mesh-list
65225765|NCT01025843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64939155|NCT00275106|Tubulin Modulators|tubulin modulators|mesh-ancestor
65225795|NCT04299971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65225796|NCT04299971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65225797|NCT04299971|Immunologic Factors|immunologic factors|mesh-ancestor
65225798|NCT04299971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65225799|NCT04299971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65225800|NCT04299971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65225801|NCT01020305|Sirolimus|sirolimus|mesh-list
65225802|NCT01020305|Bicalutamide|bicalutamide|mesh-list
65225803|NCT01020305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65225804|NCT01020305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65342959|NCT05373108|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65342960|NCT05373108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342961|NCT05373108|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65342962|NCT00725036|Insulin|insulin|mesh-list
65342963|NCT00725036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65342964|NCT00725036|Insulin Aspart|insulin aspart|mesh-list
65342965|NCT00725036|Isophane Insulin, Human|isophane insulin, human|mesh-list
65342966|NCT00725036|Insulin, Isophane|insulin, isophane|mesh-list
65342967|NCT00725036|Isophane insulin, beef|isophane insulin, beef|mesh-list
65342968|NCT00725036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65342969|NCT00725036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342970|NCT00724386|Paclitaxel|paclitaxel|mesh-list
65342971|NCT00724386|Vinorelbine|vinorelbine|mesh-list
65342972|NCT00724386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65342973|NCT00724386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65342974|NCT00724386|Tubulin Modulators|tubulin modulators|mesh-ancestor
65342975|NCT00724386|Antimitotic Agents|antimitotic agents|mesh-ancestor
65342976|NCT00724386|Mitosis Modulators|mitosis modulators|mesh-ancestor
65342977|NCT00724386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342978|NCT00865852|Metformin|metformin|mesh-list
65342979|NCT00865852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65342980|NCT00865852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342981|NCT00725114|Tetrodotoxin|tetrodotoxin|mesh-list
65342982|NCT00725114|Anesthetics, Local|anesthetics, local|mesh-ancestor
65342983|NCT00725114|Anesthetics|anesthetics|mesh-ancestor
65342984|NCT00725114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65342985|NCT00725114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342986|NCT00725114|Sensory System Agents|sensory system agents|mesh-ancestor
65342987|NCT00725114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64724904|NCT00001039|Ethambutol|ethambutol|mesh-list
65225805|NCT01020305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65225806|NCT01020305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225807|NCT01020305|Antifungal Agents|antifungal agents|mesh-ancestor
64939209|NCT01678586|Anesthetics, Local|anesthetics, local|mesh-ancestor
65225834|NCT00627575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65225835|NCT00627575|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65225836|NCT00627575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65225837|NCT00627809|Streptokinase|streptokinase|mesh-list
65225838|NCT00627809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65225839|NCT00627809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65225840|NCT00627809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225841|NCT01024751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65225842|NCT02872649|Warfarin|warfarin|mesh-list
65225843|NCT02872649|Dabigatran|dabigatran|mesh-list
65225844|NCT02872649|Phenprocoumon|phenprocoumon|mesh-list
65342988|NCT00725114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65342989|NCT00725114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65342990|NCT00725114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342991|NCT00724542|Voglibose|voglibose|mesh-list
65342992|NCT00724542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65342993|NCT00724542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65342994|NCT00724542|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65342995|NCT00724542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65342996|NCT00724542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65342997|NCT00724620|Ribavirin|ribavirin|mesh-list
65342998|NCT00724620|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65342999|NCT00724620|Antimetabolites|antimetabolites|mesh-ancestor
65343000|NCT00724620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343001|NCT00724620|Antiviral Agents|antiviral agents|mesh-ancestor
65343002|NCT00724620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65343003|NCT00866008|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65343004|NCT00866008|Ganirelix|ganirelix|mesh-list
65343005|NCT00866008|Luteolytic Agents|luteolytic agents|mesh-ancestor
65343006|NCT00866008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65343007|NCT00866008|Contraceptive Agents|contraceptive agents|mesh-ancestor
65343008|NCT00866008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64724931|NCT00002299|Interferons|interferons|mesh-list
65225845|NCT02872649|Anticoagulants|anticoagulants|mesh-ancestor
65225846|NCT02872649|Antithrombins|antithrombins|mesh-ancestor
65225847|NCT02872649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65225848|NCT02872649|Protease Inhibitors|protease inhibitors|mesh-ancestor
65225849|NCT02872649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225850|NCT02872649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225851|NCT01019369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65225852|NCT01019369|Medroxyprogesterone|medroxyprogesterone|mesh-list
65225853|NCT01019369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64939256|NCT00130455|Citalopram|citalopram|mesh-list
65225871|NCT01018511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225872|NCT01018511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225873|NCT01018511|Urological Agents|urological agents|mesh-ancestor
65225874|NCT01018511|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65225875|NCT01018511|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65225876|NCT01018511|Cholinergic Agents|cholinergic agents|mesh-ancestor
65225878|NCT00996476|Antiviral Agents|antiviral agents|mesh-ancestor
65225879|NCT00996476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65225880|NCT00996476|Protease Inhibitors|protease inhibitors|mesh-ancestor
65225881|NCT00996476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225882|NCT00996476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225883|NCT02269267|Imatinib Mesylate|imatinib mesylate|mesh-list
65225884|NCT02269267|Dasatinib|dasatinib|mesh-list
65225885|NCT02269267|Tin Fluorides|tin fluorides|mesh-list
65225886|NCT02269267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225887|NCT02269267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65225888|NCT02269267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225889|NCT02269267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225890|NCT02269267|Cariostatic Agents|cariostatic agents|mesh-ancestor
65225891|NCT02269267|Protective Agents|protective agents|mesh-ancestor
65343009|NCT00866008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343010|NCT00866008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65343011|NCT00866008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65343012|NCT00866008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343013|NCT00866008|Hormone Antagonists|hormone antagonists|mesh-ancestor
65343014|NCT00866008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65343015|NCT02571426|Propofol|propofol|mesh-list
65343016|NCT02571426|Sevoflurane|sevoflurane|mesh-list
65343017|NCT02571426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65343018|NCT02571426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65343019|NCT02571426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343020|NCT02571426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65343021|NCT02571426|Anesthetics, General|anesthetics, general|mesh-ancestor
65343022|NCT02571426|Anesthetics|anesthetics|mesh-ancestor
65343023|NCT02571426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65343024|NCT02571426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65343025|NCT03491540|Gentamicins|gentamicins|mesh-list
65343026|NCT03491540|Ornidazole|ornidazole|mesh-list
65343027|NCT03491540|Sennosides|sennosides|mesh-list
65343028|NCT03491540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65343029|NCT03491540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65343063|NCT04067856|Growth Substances|growth substances|mesh-ancestor
65343064|NCT04067856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343065|NCT04067856|Growth Inhibitors|growth inhibitors|mesh-ancestor
65343066|NCT04067856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65343067|NCT04067856|Antiemetics|antiemetics|mesh-ancestor
65343068|NCT04067856|Autonomic Agents|autonomic agents|mesh-ancestor
65343069|NCT04067856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65343070|NCT04067856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65343071|NCT04067856|Glucocorticoids|glucocorticoids|mesh-ancestor
65343072|NCT04067856|Hormones|hormones|mesh-ancestor
65343073|NCT04067856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65343074|NCT04067856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65343075|NCT04042714|Trifluridine|trifluridine|mesh-list
65343076|NCT04042714|Antimetabolites|antimetabolites|mesh-ancestor
65343077|NCT04042714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343078|NCT04042714|Antiviral Agents|antiviral agents|mesh-ancestor
65343079|NCT04042714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65343080|NCT03401918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65343081|NCT03401918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65343082|NCT03613116|Vitamin D|vitamin d|mesh-list
65343083|NCT03613116|Cholecalciferol|cholecalciferol|mesh-list
65343084|NCT03613116|Vitamins|vitamins|mesh-ancestor
65343085|NCT03613116|Micronutrients|micronutrients|mesh-ancestor
65343086|NCT03613116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343087|NCT03613116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65343088|NCT03613116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65343089|NCT00725348|R 115866|r 115866|mesh-list
65343090|NCT00725348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65343091|NCT00725348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343092|NCT00725348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343093|NCT00577772|Rifaximin|rifaximin|mesh-list
65343094|NCT00577772|Lactulose|lactulose|mesh-list
65343095|NCT00577772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64332532|NCT02539966|Sirolimus|sirolimus|mesh-list
65225892|NCT02269267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225893|NCT02575495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65225894|NCT02575495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65225895|NCT02575495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65225896|NCT02575495|Antitubercular Agents|antitubercular agents|mesh-ancestor
65225897|NCT01017731|Diphenhydramine|diphenhydramine|mesh-list
65225898|NCT01017731|Promethazine|promethazine|mesh-list
65225899|NCT01017731|Moxifloxacin|moxifloxacin|mesh-list
65343096|NCT00577772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65343097|NCT00577772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65343098|NCT00578136|Bupivacaine|bupivacaine|mesh-list
65343099|NCT00578136|Anesthetics, Local|anesthetics, local|mesh-ancestor
65343100|NCT00578136|Anesthetics|anesthetics|mesh-ancestor
65343101|NCT00578136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65343102|NCT00578136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343103|NCT00578136|Sensory System Agents|sensory system agents|mesh-ancestor
65343104|NCT00578136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65343105|NCT00861952|Mineral Oil|mineral oil|mesh-list
65343106|NCT00861952|Emollients|emollients|mesh-ancestor
65343107|NCT00861952|Dermatologic Agents|dermatologic agents|mesh-ancestor
65343108|NCT00655551|Lacosamide|lacosamide|mesh-list
65343109|NCT00655551|Anticonvulsants|anticonvulsants|mesh-ancestor
65343110|NCT00655551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65343111|NCT00655551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65343112|NCT00655551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65343113|NCT00655551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343114|NCT00855088|Ritonavir|ritonavir|mesh-list
65343115|NCT00855088|Darunavir|darunavir|mesh-list
65343116|NCT00855088|Etravirine|etravirine|mesh-list
65343117|NCT00855088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65343118|NCT00855088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65343119|NCT00855088|Protease Inhibitors|protease inhibitors|mesh-ancestor
65343120|NCT00855088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343121|NCT00855088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343122|NCT00855088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65343123|NCT00855088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65343124|NCT00855088|Antiviral Agents|antiviral agents|mesh-ancestor
65225900|NCT01017731|Ramucirumab|ramucirumab|mesh-list
65225901|NCT01017731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65225902|NCT01017731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65225903|NCT01017731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65225904|NCT01017731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65225905|NCT01017731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225906|NCT01017731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225907|NCT01017731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225908|NCT01017731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225909|NCT01017731|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65225937|NCT00779584|Antimetabolites|antimetabolites|mesh-ancestor
65225938|NCT00779584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225939|NCT00779584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225940|NCT00779584|Antiviral Agents|antiviral agents|mesh-ancestor
65225941|NCT00779584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65225942|NCT00779584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225943|NCT00779584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65225944|NCT00779584|Immunologic Factors|immunologic factors|mesh-ancestor
65343125|NCT00855088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65343126|NCT00855088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65343127|NCT00855088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65343128|NCT00855088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65343129|NCT00855088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65343130|NCT03479268|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65343131|NCT03479268|Pevonedistat|pevonedistat|mesh-list
65343132|NCT03479268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343133|NCT02553603|Hormones|hormones|mesh-list
65343134|NCT02553603|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
65343135|NCT02553603|Tesamorelin|tesamorelin|mesh-list
65343136|NCT02553603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65343137|NCT02553603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343138|NCT02553603|Growth Substances|growth substances|mesh-ancestor
65343139|NCT00804531|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65343140|NCT00804531|Methylprednisolone|methylprednisolone|mesh-list
65092923|NCT00486174|Methylene Blue|methylene blue|mesh-list
65343141|NCT00804531|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65343142|NCT00804531|Prednisolone|prednisolone|mesh-list
65343143|NCT00804531|Prednisolone acetate|prednisolone acetate|mesh-list
65343144|NCT00804531|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65343145|NCT00804531|Prednisolone phosphate|prednisolone phosphate|mesh-list
65343146|NCT00804531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65225945|NCT00779584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225946|NCT00779506|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65225947|NCT00779506|Antidepressive Agents|antidepressive agents|mesh-ancestor
65225948|NCT00779506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65225949|NCT00779506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65225950|NCT00779506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65225951|NCT00779506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65225952|NCT00779506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225953|NCT01385059|Axitinib|axitinib|mesh-list
65225954|NCT01385059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225955|NCT01385059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65225956|NCT01385059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225957|NCT01385059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225959|NCT00769132|Niacinamide|niacinamide|mesh-list
64868710|NCT01818869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65225980|NCT00991952|Alvocidib|alvocidib|mesh-list
65225981|NCT00991952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65225982|NCT00991952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65225983|NCT00991952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225984|NCT00991952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225985|NCT00991952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225986|NCT00991952|Growth Inhibitors|growth inhibitors|mesh-ancestor
65225987|NCT00991952|Growth Substances|growth substances|mesh-ancestor
65225988|NCT00991952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225989|NCT00991952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65225991|NCT00779038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65225992|NCT00779038|Narcotics|narcotics|mesh-ancestor
65343147|NCT00804531|Antiemetics|antiemetics|mesh-ancestor
65343148|NCT00804531|Autonomic Agents|autonomic agents|mesh-ancestor
65343149|NCT00804531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65343150|NCT00804531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343151|NCT00804531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65343152|NCT00804531|Glucocorticoids|glucocorticoids|mesh-ancestor
65343153|NCT00804531|Hormones|hormones|mesh-ancestor
65343154|NCT00804531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65343155|NCT00804531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65343156|NCT00804531|Protective Agents|protective agents|mesh-ancestor
65343157|NCT00804531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65343158|NCT00804531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343159|NCT00866866|Acetylcysteine|acetylcysteine|mesh-list
65343160|NCT00866866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65343161|NCT00866866|Antiviral Agents|antiviral agents|mesh-ancestor
65225993|NCT00779038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65225994|NCT00779038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225995|NCT00779038|Analgesics|analgesics|mesh-ancestor
65225996|NCT00779038|Sensory System Agents|sensory system agents|mesh-ancestor
65225997|NCT00779038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65225998|NCT00779038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65225999|NCT00779038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65226000|NCT00779038|Anesthetics, General|anesthetics, general|mesh-ancestor
65226001|NCT00779038|Anesthetics|anesthetics|mesh-ancestor
65226002|NCT04292990|Fentanyl|fentanyl|mesh-list
65226003|NCT04292990|Morphine|morphine|mesh-list
65226004|NCT04292990|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65226005|NCT04292990|Narcotics|narcotics|mesh-ancestor
65226006|NCT04292990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65226007|NCT04292990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226008|NCT04292990|Analgesics|analgesics|mesh-ancestor
65226009|NCT04292990|Sensory System Agents|sensory system agents|mesh-ancestor
65226010|NCT04292990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65226011|NCT04292990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65226012|NCT04292990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65226013|NCT04292990|Anesthetics, General|anesthetics, general|mesh-ancestor
65226014|NCT04292990|Anesthetics|anesthetics|mesh-ancestor
65226015|NCT02868632|Durvalumab|durvalumab|mesh-list
65226016|NCT02868632|Tremelimumab|tremelimumab|mesh-list
65226017|NCT02868632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65226035|NCT00994448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65226037|NCT00994448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226038|NCT00994448|Dopamine Agents|dopamine agents|mesh-ancestor
65226039|NCT00994448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65226040|NCT00994448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226041|NCT00994448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65226042|NCT00994448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65226043|NCT00994448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226044|NCT04292444|Oxytocin|oxytocin|mesh-list
65226045|NCT04292444|Oxytocics|oxytocics|mesh-ancestor
65226046|NCT04292444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65226047|NCT04292444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226048|NCT01017575|Ribavirin|ribavirin|mesh-list
65226049|NCT01017575|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65226050|NCT01017575|Antimetabolites|antimetabolites|mesh-ancestor
65226051|NCT01017575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226052|NCT01017575|Antiviral Agents|antiviral agents|mesh-ancestor
65226053|NCT01017575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65226054|NCT01017263|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65226055|NCT01017263|Dextroamphetamine|dextroamphetamine|mesh-list
65226056|NCT01017263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65343162|NCT00866866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65343163|NCT00866866|Expectorants|expectorants|mesh-ancestor
65343164|NCT00866866|Respiratory System Agents|respiratory system agents|mesh-ancestor
65343165|NCT00866866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65343166|NCT00866866|Antioxidants|antioxidants|mesh-ancestor
65343167|NCT00866866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343168|NCT00866866|Protective Agents|protective agents|mesh-ancestor
65343169|NCT00866866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343170|NCT00866866|Antidotes|antidotes|mesh-ancestor
65343171|NCT00312728|Bevacizumab|bevacizumab|mesh-list
65343172|NCT00312728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65343173|NCT00312728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343174|NCT00312728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65343175|NCT00312728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65343176|NCT00312728|Growth Substances|growth substances|mesh-ancestor
65343177|NCT00312728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343178|NCT00312728|Growth Inhibitors|growth inhibitors|mesh-ancestor
65226057|NCT01017263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226058|NCT01017263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65226059|NCT01017263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65226060|NCT01017263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65226061|NCT01017263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226062|NCT01017263|Dopamine Agents|dopamine agents|mesh-ancestor
65226063|NCT01017263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65226064|NCT01253161|Pasireotide|pasireotide|mesh-list
65226065|NCT01253161|Hormones|hormones|mesh-ancestor
65226066|NCT01253161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65226067|NCT01253161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226068|NCT00709423|Moxaverine|moxaverine|mesh-list
65226069|NCT00709423|Parasympatholytics|parasympatholytics|mesh-ancestor
65226070|NCT00709423|Autonomic Agents|autonomic agents|mesh-ancestor
65226071|NCT00709423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64939462|NCT00129753|Alemtuzumab|alemtuzumab|mesh-list
65226091|NCT00627887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65226092|NCT00627887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65226093|NCT00627887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65226095|NCT00627887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65226096|NCT02576665|Flucytosine|flucytosine|mesh-list
65226097|NCT02576665|Antifungal Agents|antifungal agents|mesh-ancestor
65226098|NCT02576665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65226099|NCT02576665|Antimetabolites|antimetabolites|mesh-ancestor
65226100|NCT02576665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226101|NCT00627965|Sildenafil Citrate|sildenafil citrate|mesh-list
65226102|NCT00627965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226103|NCT00627965|Vasodilator Agents|vasodilator agents|mesh-ancestor
65226104|NCT00627965|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65226105|NCT00627965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65226106|NCT00627965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226107|NCT00627965|Urological Agents|urological agents|mesh-ancestor
65226108|NCT02576353|Fentanyl|fentanyl|mesh-list
65226109|NCT02576353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65226110|NCT02576353|Narcotics|narcotics|mesh-ancestor
65226111|NCT02576353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65226112|NCT02576353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226113|NCT02576353|Analgesics|analgesics|mesh-ancestor
65226114|NCT02576353|Sensory System Agents|sensory system agents|mesh-ancestor
65343179|NCT00804921|Bevacizumab|bevacizumab|mesh-list
65343180|NCT00804921|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65343181|NCT00804921|Acetazolamide|acetazolamide|mesh-list
65343182|NCT00804921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65343183|NCT00804921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343184|NCT00804921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65343185|NCT00804921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65343186|NCT00804921|Growth Substances|growth substances|mesh-ancestor
65343187|NCT00804921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343188|NCT00804921|Growth Inhibitors|growth inhibitors|mesh-ancestor
65343189|NCT00804921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65343190|NCT00804921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65343191|NCT00804921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65343192|NCT00804921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65343193|NCT00804921|Adrenergic Agents|adrenergic agents|mesh-ancestor
65226115|NCT02576353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65226116|NCT02576353|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65226117|NCT02576353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65226118|NCT02576353|Anesthetics, General|anesthetics, general|mesh-ancestor
65226119|NCT02576353|Anesthetics|anesthetics|mesh-ancestor
65226120|NCT01016015|Sirolimus|sirolimus|mesh-list
65226121|NCT01016015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65226122|NCT01016015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65226123|NCT01016015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64939530|NCT00957086|Nimotuzumab|nimotuzumab|mesh-list
65226157|NCT00709969|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65226158|NCT00709969|Antimalarials|antimalarials|mesh-ancestor
65226159|NCT00709969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65226160|NCT00709969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65226161|NCT00709969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65226162|NCT00710125|Doxorubicin|doxorubicin|mesh-list
65226163|NCT00710125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65226164|NCT00710125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226165|NCT00710125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65226166|NCT00710125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65226187|NCT00710359|Vitamin B Complex|vitamin b complex|mesh-list
65226188|NCT00710359|Micronutrients|micronutrients|mesh-ancestor
65226189|NCT00710359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226190|NCT00710359|Hematinics|hematinics|mesh-ancestor
65226191|NCT02578849|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65226192|NCT02578849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65226193|NCT02578849|Immunologic Factors|immunologic factors|mesh-ancestor
65226194|NCT02578849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226195|NCT02578849|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65226196|NCT02578849|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65226197|NCT02578849|Dopamine Agonists|dopamine agonists|mesh-ancestor
65226198|NCT02578849|Dopamine Agents|dopamine agents|mesh-ancestor
65226199|NCT02578849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65226200|NCT02578849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226201|NCT00710437|Dexmedetomidine|dexmedetomidine|mesh-list
65226202|NCT00710437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65226203|NCT00710437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65226204|NCT00710437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226205|NCT00710437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65226206|NCT00710437|Analgesics|analgesics|mesh-ancestor
65226207|NCT00710437|Sensory System Agents|sensory system agents|mesh-ancestor
65226208|NCT00710437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65226209|NCT00710437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65226210|NCT00710437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65226211|NCT00710437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65343194|NCT00804921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65343195|NCT00804921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343196|NCT00804921|Anticonvulsants|anticonvulsants|mesh-ancestor
65343197|NCT00804921|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65343198|NCT00804921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343199|NCT00804921|Diuretics|diuretics|mesh-ancestor
65343200|NCT00804921|Natriuretic Agents|natriuretic agents|mesh-ancestor
65343201|NCT00866944|Leucovorin|leucovorin|mesh-list
65343202|NCT00866944|Fluorouracil|fluorouracil|mesh-list
65343203|NCT00866944|Oxaliplatin|oxaliplatin|mesh-list
65343204|NCT00866944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65343205|NCT00866944|Antimetabolites|antimetabolites|mesh-ancestor
65343206|NCT00866944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343207|NCT00866944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65343208|NCT00866944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343209|NCT00866944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65343210|NCT00866944|Immunologic Factors|immunologic factors|mesh-ancestor
65343211|NCT00866944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343212|NCT00866944|Antidotes|antidotes|mesh-ancestor
65343213|NCT00866944|Protective Agents|protective agents|mesh-ancestor
65343214|NCT00866944|Vitamin B Complex|vitamin b complex|mesh-ancestor
65226212|NCT00710437|Adrenergic Agents|adrenergic agents|mesh-ancestor
65226213|NCT00710437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65226214|NCT00710437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226215|NCT02574715|Levonorgestrel|levonorgestrel|mesh-list
65226216|NCT02574715|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65226217|NCT02574715|Contraceptive Agents|contraceptive agents|mesh-ancestor
65226218|NCT02574715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65226219|NCT02574715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226220|NCT02574715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65226234|NCT00710827|Hormones|hormones|mesh-ancestor
65226235|NCT00710827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65226236|NCT00710827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226237|NCT01034657|Panobinostat|panobinostat|mesh-list
65226238|NCT01034657|Epoetin Alfa|epoetin alfa|mesh-list
65226239|NCT01034657|Hematinics|hematinics|mesh-ancestor
65226240|NCT01034657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226241|NCT01034657|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65226242|NCT01034657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226243|NCT01034657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226244|NCT01014767|Leucovorin|leucovorin|mesh-list
65226245|NCT01014767|Dactinomycin|dactinomycin|mesh-list
65226246|NCT01014767|Cyclophosphamide|cyclophosphamide|mesh-list
65226247|NCT01014767|Temozolomide|temozolomide|mesh-list
65226248|NCT01014767|Cisplatin|cisplatin|mesh-list
65226249|NCT01014767|Carboplatin|carboplatin|mesh-list
65226250|NCT01014767|Doxorubicin|doxorubicin|mesh-list
65226251|NCT01014767|Methotrexate|methotrexate|mesh-list
65226252|NCT01014767|Irinotecan|irinotecan|mesh-list
65226253|NCT01014767|Etoposide|etoposide|mesh-list
65226254|NCT01014767|Vincristine|vincristine|mesh-list
65226255|NCT01014767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65226256|NCT01014767|Immunologic Factors|immunologic factors|mesh-ancestor
65226257|NCT01014767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226258|NCT01014767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65226259|NCT01014767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65343215|NCT00866944|Vitamins|vitamins|mesh-ancestor
65343216|NCT00866944|Micronutrients|micronutrients|mesh-ancestor
64332651|NCT02203526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343217|NCT00577824|Exenatide|exenatide|mesh-list
65343219|NCT00577824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343220|NCT00577824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65343221|NCT00577824|Incretins|incretins|mesh-ancestor
65343222|NCT00577824|Hormones|hormones|mesh-ancestor
65343223|NCT00577824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65343224|NCT02632448|Gemcitabine|gemcitabine|mesh-list
65343225|NCT02632448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65343226|NCT02632448|Antimetabolites|antimetabolites|mesh-ancestor
65343227|NCT02632448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343228|NCT02632448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343229|NCT02632448|Antiviral Agents|antiviral agents|mesh-ancestor
65343230|NCT02632448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65343231|NCT02632448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343232|NCT02632448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65343233|NCT02632448|Immunologic Factors|immunologic factors|mesh-ancestor
65343234|NCT02632448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343235|NCT04046289|Calcium, Dietary|calcium, dietary|mesh-list
65343236|NCT04046289|Calcium Carbonate|calcium carbonate|mesh-list
65343237|NCT04046289|Calcium|calcium|mesh-list
65343238|NCT04046289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65226260|NCT01014767|Alkylating Agents|alkylating agents|mesh-ancestor
65226261|NCT01014767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226262|NCT01014767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226263|NCT01014767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65226264|NCT01014767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65226265|NCT01014767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65226266|NCT01014767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65226267|NCT01014767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226268|NCT01014767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65226269|NCT01014767|Abortifacient Agents|abortifacient agents|mesh-ancestor
65226270|NCT01014767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65226271|NCT01014767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65226272|NCT01014767|Antimetabolites|antimetabolites|mesh-ancestor
65226273|NCT01014767|Dermatologic Agents|dermatologic agents|mesh-ancestor
65226274|NCT01014767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65226275|NCT01014767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65226276|NCT01014767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65226277|NCT01014767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65226278|NCT01014767|Antidotes|antidotes|mesh-ancestor
65226279|NCT01014767|Protective Agents|protective agents|mesh-ancestor
65226280|NCT01014767|Vitamin B Complex|vitamin b complex|mesh-ancestor
65226281|NCT01014767|Vitamins|vitamins|mesh-ancestor
65226282|NCT01014767|Micronutrients|micronutrients|mesh-ancestor
65226283|NCT01014767|Tubulin Modulators|tubulin modulators|mesh-ancestor
65226284|NCT01014767|Antimitotic Agents|antimitotic agents|mesh-ancestor
65226285|NCT01014767|Mitosis Modulators|mitosis modulators|mesh-ancestor
65226320|NCT02013427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65226321|NCT02013427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65343239|NCT04046289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343240|NCT04046289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65343241|NCT04046289|Antacids|antacids|mesh-ancestor
65343242|NCT04046289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343243|NCT04046289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65343244|NCT00807807|Folic Acid|folic acid|mesh-list
65343245|NCT00807807|Vitamin B Complex|vitamin b complex|mesh-list
65343246|NCT00807807|Hematinics|hematinics|mesh-ancestor
65343247|NCT00807807|Vitamins|vitamins|mesh-ancestor
65343248|NCT00807807|Micronutrients|micronutrients|mesh-ancestor
65343249|NCT00807807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343250|NCT03011814|Lenalidomide|lenalidomide|mesh-list
65343251|NCT03011814|Durvalumab|durvalumab|mesh-list
65343252|NCT03011814|Immunoglobulins|immunoglobulins|mesh-list
65343253|NCT03011814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65343254|NCT03011814|Immunoglobulin G|immunoglobulin g|mesh-list
65343255|NCT03011814|Immunologic Factors|immunologic factors|mesh-ancestor
65343256|NCT03011814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343257|NCT03011814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65343258|NCT03011814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65343259|NCT03011814|Growth Substances|growth substances|mesh-ancestor
65343260|NCT03011814|Growth Inhibitors|growth inhibitors|mesh-ancestor
65343261|NCT03011814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343262|NCT03011814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65343263|NCT00870298|Trimethoprim|trimethoprim|mesh-list
65343264|NCT00870298|Sulfamethoxazole|sulfamethoxazole|mesh-list
65343265|NCT00870298|Warfarin|warfarin|mesh-list
65343266|NCT00870298|Anticoagulants|anticoagulants|mesh-ancestor
65343267|NCT00870298|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65343268|NCT00870298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65343269|NCT00870298|Renal Agents|renal agents|mesh-ancestor
65343270|NCT00870298|Antimalarials|antimalarials|mesh-ancestor
65343271|NCT00870298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65343272|NCT00870298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65343273|NCT00870298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65343274|NCT00870298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343275|NCT00870298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343276|NCT00870298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65226322|NCT02013427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343277|NCT00870298|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65343278|NCT00870298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65343279|NCT00805155|Mometasone Furoate|mometasone furoate|mesh-list
65343280|NCT00805155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65343281|NCT00805155|Dermatologic Agents|dermatologic agents|mesh-ancestor
64725167|NCT00001963|Antioxidants|antioxidants|mesh-ancestor
65226323|NCT02013427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226324|NCT02013427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65226325|NCT02013427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65226326|NCT02013427|Analgesics|analgesics|mesh-ancestor
65226327|NCT02013427|Sensory System Agents|sensory system agents|mesh-ancestor
64939732|NCT00128934|Estradiol|estradiol|mesh-list
65226355|NCT00714961|Purinergic Agents|purinergic agents|mesh-ancestor
65226356|NCT00714961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65226357|NCT00714961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226358|NCT00714961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226359|NCT02574403|Eculizumab|eculizumab|mesh-list
65226360|NCT02574403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65226361|NCT02574403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65226362|NCT02574403|Immunologic Factors|immunologic factors|mesh-ancestor
65226363|NCT02574403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226364|NCT01013753|Formoterol Fumarate|formoterol fumarate|mesh-list
65226365|NCT01013753|Olodaterol|olodaterol|mesh-list
65226366|NCT01013753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65226367|NCT01013753|Autonomic Agents|autonomic agents|mesh-ancestor
65226368|NCT01013753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65226369|NCT01013753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226370|NCT01013753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65226371|NCT01013753|Respiratory System Agents|respiratory system agents|mesh-ancestor
65226372|NCT01013753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65226373|NCT01013753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64939778|NCT00128739|Budesonide|budesonide|mesh-list
65226410|NCT02871869|Rituximab|rituximab|mesh-list
65226411|NCT02871869|Epirubicin|epirubicin|mesh-list
65226412|NCT02871869|Vindesine|vindesine|mesh-list
65226413|NCT02871869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65226414|NCT02871869|Immunologic Factors|immunologic factors|mesh-ancestor
65226415|NCT02871869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226433|NCT02871869|Tubulin Modulators|tubulin modulators|mesh-ancestor
65226434|NCT02871869|Antimitotic Agents|antimitotic agents|mesh-ancestor
65226435|NCT02871869|Mitosis Modulators|mitosis modulators|mesh-ancestor
65226436|NCT02871869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65226437|NCT01013597|Panobinostat|panobinostat|mesh-list
65226438|NCT01013597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226439|NCT01013597|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65226440|NCT01013597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226441|NCT01013597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226442|NCT00715273|Niacin|niacin|mesh-list
65226443|NCT00715273|Niacinamide|niacinamide|mesh-list
65226444|NCT00715273|Nicotinic Acids|nicotinic acids|mesh-list
65226445|NCT00715273|Atorvastatin|atorvastatin|mesh-list
65226446|NCT00715273|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65226447|NCT00715273|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65226448|NCT00715273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65226449|NCT00715273|Antimetabolites|antimetabolites|mesh-ancestor
65226450|NCT00715273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226451|NCT00715273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65226452|NCT00715273|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65226453|NCT00715273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226454|NCT00715273|Vasodilator Agents|vasodilator agents|mesh-ancestor
65226455|NCT00715273|Vitamin B Complex|vitamin b complex|mesh-ancestor
65226456|NCT00715273|Vitamins|vitamins|mesh-ancestor
65226457|NCT00715273|Micronutrients|micronutrients|mesh-ancestor
65226458|NCT00715273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226459|NCT01013285|Bevacizumab|bevacizumab|mesh-list
65226460|NCT01013285|Temozolomide|temozolomide|mesh-list
65226461|NCT01013285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65226462|NCT01013285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226463|NCT01013285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65226464|NCT01013285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65343282|NCT00805155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65343283|NCT00807963|Zoledronic Acid|zoledronic acid|mesh-list
65343284|NCT00807963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65343285|NCT00807963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343286|NCT00730418|Doxazosin|doxazosin|mesh-list
65343287|NCT00730418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65343288|NCT00730418|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65343289|NCT00730418|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65343290|NCT00730418|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65343291|NCT00730418|Adrenergic Agents|adrenergic agents|mesh-ancestor
65343292|NCT00730418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65343293|NCT00730418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343294|NCT00730418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343295|NCT00805233|Bromfenac|bromfenac|mesh-list
65343296|NCT00805233|Ranibizumab|ranibizumab|mesh-list
65343297|NCT00805233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65343298|NCT00805233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65343299|NCT00805233|Growth Substances|growth substances|mesh-ancestor
65343300|NCT00805233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226465|NCT01013285|Growth Substances|growth substances|mesh-ancestor
65226466|NCT01013285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226467|NCT01013285|Growth Inhibitors|growth inhibitors|mesh-ancestor
65226468|NCT01013285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65226469|NCT01013285|Alkylating Agents|alkylating agents|mesh-ancestor
65226483|NCT04245085|Atezolizumab|atezolizumab|mesh-list
65226484|NCT04245085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65226485|NCT04245085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226486|NCT04245085|Tubulin Modulators|tubulin modulators|mesh-ancestor
65226487|NCT04245085|Antimitotic Agents|antimitotic agents|mesh-ancestor
65226488|NCT04245085|Mitosis Modulators|mitosis modulators|mesh-ancestor
65226489|NCT04245085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226490|NCT04245085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65226491|NCT04245085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65226492|NCT04245085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65226493|NCT04245085|Growth Substances|growth substances|mesh-ancestor
65226494|NCT04245085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226495|NCT04245085|Growth Inhibitors|growth inhibitors|mesh-ancestor
65226496|NCT04245085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226497|NCT04245085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65226498|NCT04245085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65226499|NCT00711841|Dexamethasone|dexamethasone|mesh-list
65226500|NCT00711841|Dexamethasone acetate|dexamethasone acetate|mesh-list
65226501|NCT00711841|BB 1101|bb 1101|mesh-list
65226502|NCT00711841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65226503|NCT00711841|Antiemetics|antiemetics|mesh-ancestor
65226504|NCT00711841|Autonomic Agents|autonomic agents|mesh-ancestor
65226505|NCT00711841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65226506|NCT00711841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226507|NCT00711841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65226508|NCT00711841|Glucocorticoids|glucocorticoids|mesh-ancestor
65226509|NCT00711841|Hormones|hormones|mesh-ancestor
65226510|NCT00711841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65226511|NCT00711841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65226512|NCT00711841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343301|NCT00805233|Growth Inhibitors|growth inhibitors|mesh-ancestor
65343302|NCT00805233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343303|NCT00805233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65343304|NCT00805233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65226513|NCT00711841|Protease Inhibitors|protease inhibitors|mesh-ancestor
65226514|NCT00711841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226515|NCT00711841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226517|NCT00711919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65226518|NCT00711919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65226519|NCT00711919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65226520|NCT00711919|Antimetabolites|antimetabolites|mesh-ancestor
65226521|NCT00711919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226522|NCT00711919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226523|NCT00711919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65226524|NCT00715663|Insulin Aspart|insulin aspart|mesh-list
65226525|NCT00715663|Biphasic Insulins|biphasic insulins|mesh-list
65226526|NCT00715663|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65226527|NCT00715663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65226528|NCT00715663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226529|NCT00712465|Digoxin|digoxin|mesh-list
65226530|NCT00712465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65226531|NCT00712465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65226532|NCT00712465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226533|NCT00712465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226567|NCT00603447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65226568|NCT00603447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65226569|NCT00603447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226570|NCT00603447|Immunologic Factors|immunologic factors|mesh-ancestor
65226571|NCT00603447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65226572|NCT00603447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65226573|NCT00603447|Growth Substances|growth substances|mesh-ancestor
65226574|NCT00603447|Growth Inhibitors|growth inhibitors|mesh-ancestor
65226575|NCT00718705|Josamycin|josamycin|mesh-list
65226596|NCT00639015|Protective Agents|protective agents|mesh-ancestor
65226598|NCT00712855|Mapatumumab|mapatumumab|mesh-list
65226599|NCT00712855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226600|NCT00712855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65226601|NCT00712855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226602|NCT00712855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226603|NCT02537925|Celecoxib|celecoxib|mesh-list
65226604|NCT02537925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
65226605|NCT02537925|Nedaplatin|nedaplatin|mesh-list
65226606|NCT02537925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65226607|NCT02537925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65226608|NCT02537925|Analgesics|analgesics|mesh-ancestor
65226609|NCT02537925|Sensory System Agents|sensory system agents|mesh-ancestor
65226610|NCT02537925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65226611|NCT02537925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226612|NCT02537925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65226613|NCT02537925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65226614|NCT02537925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65226615|NCT02537925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226616|NCT02537925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226617|NCT02537925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226618|NCT00713011|Nifedipine|nifedipine|mesh-list
65226619|NCT00713011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65226620|NCT00713011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65226621|NCT00713011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226622|NCT00713011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65226623|NCT00713011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226624|NCT00713011|Vasodilator Agents|vasodilator agents|mesh-ancestor
65226625|NCT00713011|Tocolytic Agents|tocolytic agents|mesh-ancestor
65226626|NCT00713011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65226627|NCT04185675|Anesthetics|anesthetics|mesh-list
65226628|NCT04185675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65226629|NCT04185675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226654|NCT00988208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343305|NCT00805233|Analgesics|analgesics|mesh-ancestor
65343306|NCT00805233|Sensory System Agents|sensory system agents|mesh-ancestor
65343307|NCT00805233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65343308|NCT00805233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65343309|NCT00805233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65343310|NCT02569502|Enfuvirtide|enfuvirtide|mesh-list
65226655|NCT00988208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65226656|NCT00988208|Glucocorticoids|glucocorticoids|mesh-ancestor
65226657|NCT00988208|Hormones|hormones|mesh-ancestor
65226658|NCT00988208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65226659|NCT00988208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226660|NCT00988208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65226661|NCT00988208|Immunologic Factors|immunologic factors|mesh-ancestor
65226662|NCT00988208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65226663|NCT00988208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65226664|NCT00988208|Growth Substances|growth substances|mesh-ancestor
65226665|NCT00988208|Growth Inhibitors|growth inhibitors|mesh-ancestor
65226666|NCT00639249|SA 4503|sa 4503|mesh-list
65226667|NCT00639249|Nootropic Agents|nootropic agents|mesh-ancestor
65226668|NCT04185831|Everolimus|everolimus|mesh-list
65226669|NCT04185831|Atezolizumab|atezolizumab|mesh-list
65226670|NCT04185831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226671|NCT04185831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65226672|NCT04185831|Immunologic Factors|immunologic factors|mesh-ancestor
65226673|NCT04185831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226674|NCT02686983|Betamethasone|betamethasone|mesh-list
65226675|NCT02686983|Anesthetics|anesthetics|mesh-list
65226676|NCT02686983|Anesthetics, Local|anesthetics, local|mesh-list
65226677|NCT02686983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65226678|NCT02686983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226679|NCT02686983|Sensory System Agents|sensory system agents|mesh-ancestor
65226680|NCT02686983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65226681|NCT02686983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65226682|NCT02686983|Glucocorticoids|glucocorticoids|mesh-ancestor
65226683|NCT02686983|Hormones|hormones|mesh-ancestor
65226693|NCT02686905|Micronutrients|micronutrients|mesh-ancestor
65226694|NCT02686905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226695|NCT02686905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65226696|NCT02686905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65226697|NCT02686905|Hematinics|hematinics|mesh-ancestor
65226698|NCT02686905|Vitamin B Complex|vitamin b complex|mesh-ancestor
65226699|NCT00990704|Maxacalcitol|maxacalcitol|mesh-list
65226700|NCT00990704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226701|NCT00990704|Dermatologic Agents|dermatologic agents|mesh-ancestor
65226702|NCT00990704|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65226703|NCT00990704|Protective Agents|protective agents|mesh-ancestor
65226704|NCT00990704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226705|NCT00639327|Irinotecan|irinotecan|mesh-list
65226706|NCT00639327|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65226707|NCT00639327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65226708|NCT00639327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226709|NCT00639327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226710|NCT00639327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226711|NCT02686749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
65226712|NCT04089553|Durvalumab|durvalumab|mesh-list
65226713|NCT04089553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65226714|NCT04089553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226715|NCT02867852|Abiraterone Acetate|abiraterone acetate|mesh-list
65226716|NCT02867852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226717|NCT02867852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65226718|NCT02867852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226719|NCT02867852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226720|NCT02867852|Hormone Antagonists|hormone antagonists|mesh-ancestor
65226721|NCT02867852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65226722|NCT02867852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226723|NCT02867852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65226724|NCT02686827|Vitamin D|vitamin d|mesh-list
65226725|NCT02686827|Ergocalciferols|ergocalciferols|mesh-list
65226726|NCT02686827|Vitamins|vitamins|mesh-ancestor
65226727|NCT02686827|Micronutrients|micronutrients|mesh-ancestor
65343311|NCT02569502|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65343312|NCT02569502|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65343313|NCT02569502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343314|NCT02569502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65343315|NCT02569502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65343316|NCT02569502|Antiviral Agents|antiviral agents|mesh-ancestor
65343317|NCT02569502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65226728|NCT02686827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226729|NCT02686827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65226730|NCT02686827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65226731|NCT00713167|Grape Seed Extract|grape seed extract|mesh-list
65226732|NCT00713167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65226733|NCT00713167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226734|NCT00713167|Antioxidants|antioxidants|mesh-ancestor
65226735|NCT00713167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226736|NCT00713167|Protective Agents|protective agents|mesh-ancestor
65226737|NCT00713167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226738|NCT00716521|Zolpidem|zolpidem|mesh-list
65226739|NCT00716521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65226740|NCT00716521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65226741|NCT00716521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65226742|NCT00716521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226743|NCT00716521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65226744|NCT00716521|GABA Agonists|gaba agonists|mesh-ancestor
65226745|NCT00716521|GABA Agents|gaba agents|mesh-ancestor
65226746|NCT00716521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65226747|NCT00716521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226748|NCT00993668|Certolizumab Pegol|certolizumab pegol|mesh-list
65226749|NCT00993668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65226771|NCT00778102|Protective Agents|protective agents|mesh-ancestor
65226772|NCT00778102|Vitamin B Complex|vitamin b complex|mesh-ancestor
65226774|NCT00778102|Micronutrients|micronutrients|mesh-ancestor
65226775|NCT00778102|Antimetabolites|antimetabolites|mesh-ancestor
65226776|NCT00778102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65226777|NCT00778102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65226778|NCT00778102|Immunologic Factors|immunologic factors|mesh-ancestor
65226779|NCT00713557|Tirofiban|tirofiban|mesh-list
65226780|NCT00713557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65226781|NCT00713557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65226782|NCT00713557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226783|NCT00713557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65226784|NCT00719095|Naltrexone|naltrexone|mesh-list
65226785|NCT00719095|Buprenorphine|buprenorphine|mesh-list
65226786|NCT00719095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65226787|NCT00719095|Narcotics|narcotics|mesh-ancestor
65226788|NCT00719095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65226789|NCT00719095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226790|NCT00719095|Analgesics|analgesics|mesh-ancestor
65226791|NCT00719095|Sensory System Agents|sensory system agents|mesh-ancestor
65226792|NCT00719095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65226793|NCT00719095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65226794|NCT00719095|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65226795|NCT00916630|Pemetrexed|pemetrexed|mesh-list
65226796|NCT00916630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226797|NCT00916630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226798|NCT00916630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226799|NCT00916630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65226800|NCT00916630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65226801|NCT02572375|Phenylpropanolamine|phenylpropanolamine|mesh-list
65226802|NCT02572375|Codeine|codeine|mesh-list
65226803|NCT02572375|Guaifenesin|guaifenesin|mesh-list
65226804|NCT02572375|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
65226805|NCT02572375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65226819|NCT02572375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226820|NCT02572375|Appetite Depressants|appetite depressants|mesh-ancestor
65226821|NCT02572375|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65226822|NCT02572375|Sympathomimetics|sympathomimetics|mesh-ancestor
65343318|NCT03906136|Adalimumab|adalimumab|mesh-list
65343319|NCT03906136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65343320|NCT03906136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65343321|NCT00725400|Cetuximab|cetuximab|mesh-list
65343322|NCT00725400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65343323|NCT00725400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343324|NCT00798915|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
65343325|NCT00798915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65343326|NCT00798915|Incretins|incretins|mesh-ancestor
65343327|NCT00798915|Hormones|hormones|mesh-ancestor
65343328|NCT00798915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65343329|NCT00798915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226823|NCT02572375|Autonomic Agents|autonomic agents|mesh-ancestor
65226824|NCT02572375|Nasal Decongestants|nasal decongestants|mesh-ancestor
65226825|NCT02572375|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65226827|NCT00716911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65226828|NCT00716911|Antiviral Agents|antiviral agents|mesh-ancestor
65226829|NCT00716911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65226830|NCT00716911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65226831|NCT00716911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226832|NCT00716911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226833|NCT00612495|Fluorouracil|fluorouracil|mesh-list
65226834|NCT00612495|Oxaliplatin|oxaliplatin|mesh-list
65226835|NCT00612495|Antimetabolites|antimetabolites|mesh-ancestor
65226836|NCT00612495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226837|NCT00612495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65226838|NCT00612495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226839|NCT00612495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65226840|NCT00612495|Immunologic Factors|immunologic factors|mesh-ancestor
65226841|NCT00612495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226842|NCT00719173|Cyclophosphamide|cyclophosphamide|mesh-list
65226843|NCT00719173|Aprepitant|aprepitant|mesh-list
65226844|NCT00719173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65226845|NCT00719173|Immunologic Factors|immunologic factors|mesh-ancestor
65226846|NCT00719173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226847|NCT00719173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65226848|NCT00719173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65226849|NCT00719173|Alkylating Agents|alkylating agents|mesh-ancestor
65226850|NCT00719173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226851|NCT00719173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226852|NCT00719173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65226853|NCT00719173|Antiemetics|antiemetics|mesh-ancestor
65226854|NCT00719173|Autonomic Agents|autonomic agents|mesh-ancestor
65226855|NCT00719173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65226856|NCT00719173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65226857|NCT00719173|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65226858|NCT00719173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65226859|NCT00756886|Atorvastatin|atorvastatin|mesh-list
65226860|NCT00756886|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65226861|NCT00756886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65226862|NCT00756886|Antimetabolites|antimetabolites|mesh-ancestor
65226863|NCT00756886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226864|NCT00756886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65226865|NCT00756886|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65226866|NCT00756886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226894|NCT00984620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226895|NCT00717145|Risedronic Acid|risedronic acid|mesh-list
65226896|NCT00717145|Etidronic Acid|etidronic acid|mesh-list
65226897|NCT00717145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65226898|NCT00717145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65226899|NCT00717145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343330|NCT00798993|Cholecalciferol|cholecalciferol|mesh-list
65343331|NCT00798993|Vitamin D|vitamin d|mesh-list
65343332|NCT00798993|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65226900|NCT00717145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65226901|NCT00717145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226902|NCT00717145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65226904|NCT00639483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65226905|NCT00639483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65226906|NCT00639483|Analgesics|analgesics|mesh-ancestor
65226907|NCT00639483|Sensory System Agents|sensory system agents|mesh-ancestor
65226908|NCT00639483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65226909|NCT00639483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226944|NCT00713947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65226945|NCT00713947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65226946|NCT00713947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65226947|NCT00990314|Epoprostenol|epoprostenol|mesh-list
65226948|NCT00990314|Beraprost|beraprost|mesh-list
65226949|NCT00990314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65226976|NCT00717379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226977|NCT00717379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65226978|NCT00717379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226979|NCT00717379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65226981|NCT00717379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65226982|NCT00717379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226983|NCT00717379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226984|NCT00717379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65226985|NCT00717379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65226986|NCT00717379|Antitubercular Agents|antitubercular agents|mesh-ancestor
65226987|NCT00717379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65226988|NCT00717379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65226989|NCT00717379|Antiemetics|antiemetics|mesh-ancestor
65226990|NCT00717379|Autonomic Agents|autonomic agents|mesh-ancestor
65226991|NCT00717379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65226992|NCT00717379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65226993|NCT00717379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65226994|NCT00717379|Protective Agents|protective agents|mesh-ancestor
65226995|NCT02867306|Methotrexate|methotrexate|mesh-list
65226996|NCT02867306|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65226997|NCT02867306|Abortifacient Agents|abortifacient agents|mesh-ancestor
65226998|NCT02867306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64940391|NCT00020709|Docetaxel|docetaxel|mesh-list
65227005|NCT02867306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227006|NCT02867306|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65227007|NCT02867306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65227008|NCT02867306|Immunologic Factors|immunologic factors|mesh-ancestor
65227009|NCT02867306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65227010|NCT02867306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65227012|NCT00777556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65227013|NCT00777556|Contraceptive Agents|contraceptive agents|mesh-ancestor
65227014|NCT00777556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65227015|NCT00777556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227016|NCT00777556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65227017|NCT00777556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65227018|NCT00777556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65227019|NCT02685657|Cyclophosphamide|cyclophosphamide|mesh-list
65227020|NCT02685657|Docetaxel|docetaxel|mesh-list
65227021|NCT02685657|Doxorubicin|doxorubicin|mesh-list
65227022|NCT02685657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65227023|NCT02685657|Immunologic Factors|immunologic factors|mesh-ancestor
65227024|NCT02685657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227025|NCT02685657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65227026|NCT02685657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65227027|NCT02685657|Alkylating Agents|alkylating agents|mesh-ancestor
65227028|NCT02685657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227029|NCT02685657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227030|NCT02685657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65227031|NCT02685657|Tubulin Modulators|tubulin modulators|mesh-ancestor
65227032|NCT02685657|Antimitotic Agents|antimitotic agents|mesh-ancestor
65227033|NCT02685657|Mitosis Modulators|mitosis modulators|mesh-ancestor
65227034|NCT02685657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65227035|NCT02685657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65227036|NCT02685657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65343333|NCT00798993|Calcifediol|calcifediol|mesh-list
65343334|NCT00798993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65343335|NCT00798993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343336|NCT00798993|Vitamins|vitamins|mesh-ancestor
65343337|NCT00798993|Micronutrients|micronutrients|mesh-ancestor
65343338|NCT00798993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65343339|NCT00862108|Methylphenidate|methylphenidate|mesh-list
65343340|NCT00862108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65343341|NCT00862108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725217|NCT00001999|Ganciclovir|ganciclovir|mesh-list
65227037|NCT02685657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227038|NCT04290884|Tranexamic Acid|tranexamic acid|mesh-list
65227039|NCT04290884|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65227040|NCT04290884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65227041|NCT04290884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227042|NCT04290884|Hemostatics|hemostatics|mesh-ancestor
65227043|NCT04290884|Coagulants|coagulants|mesh-ancestor
65227044|NCT00719407|Epoetin Alfa|epoetin alfa|mesh-list
65227045|NCT00719407|Hematinics|hematinics|mesh-ancestor
65227046|NCT00714025|Everolimus|everolimus|mesh-list
65227047|NCT00714025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227048|NCT00714025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65227049|NCT00714025|Immunologic Factors|immunologic factors|mesh-ancestor
65227050|NCT00714025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227051|NCT02685345|Firuglipel|firuglipel|mesh-list
65227052|NCT02685345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65227053|NCT02685345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227054|NCT02869100|Listerine|listerine|mesh-list
65227055|NCT02869100|Fluorides|fluorides|mesh-list
65227056|NCT02869100|Sodium Fluoride|sodium fluoride|mesh-list
65227057|NCT02869100|Cariostatic Agents|cariostatic agents|mesh-ancestor
65227058|NCT02869100|Protective Agents|protective agents|mesh-ancestor
65227059|NCT02869100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227060|NCT02869100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65227061|NCT02869100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65227062|NCT04096768|Dexmedetomidine|dexmedetomidine|mesh-list
65227063|NCT04096768|Ketamine|ketamine|mesh-list
65227064|NCT04096768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65227065|NCT04096768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64940439|NCT00020943|Prednisone|prednisone|mesh-list
65227089|NCT00714103|Vasodilator Agents|vasodilator agents|mesh-ancestor
65227090|NCT00714103|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65227091|NCT00714103|Purinergic Agonists|purinergic agonists|mesh-ancestor
65227092|NCT00714103|Purinergic Agents|purinergic agents|mesh-ancestor
65227093|NCT00714103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65227094|NCT00714103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227095|NCT00993044|Bevacizumab|bevacizumab|mesh-list
65227096|NCT00993044|Irinotecan|irinotecan|mesh-list
65227097|NCT00993044|Vincristine|vincristine|mesh-list
65227098|NCT00993044|Temozolomide|temozolomide|mesh-list
65227099|NCT00993044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65227100|NCT00993044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227101|NCT00993044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65227102|NCT00993044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65227103|NCT00993044|Growth Substances|growth substances|mesh-ancestor
65227104|NCT00993044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227105|NCT00993044|Growth Inhibitors|growth inhibitors|mesh-ancestor
65227106|NCT00993044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65227107|NCT00993044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65227108|NCT00993044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227109|NCT00993044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227110|NCT00993044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65227111|NCT00993044|Tubulin Modulators|tubulin modulators|mesh-ancestor
65227112|NCT00993044|Antimitotic Agents|antimitotic agents|mesh-ancestor
65227113|NCT00993044|Mitosis Modulators|mitosis modulators|mesh-ancestor
65227114|NCT00993044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65227115|NCT00993044|Alkylating Agents|alkylating agents|mesh-ancestor
65343342|NCT00862108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64725224|NCT00001999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227116|NCT00714181|Hydroxychloroquine|hydroxychloroquine|mesh-list
65227117|NCT00714181|Temozolomide|temozolomide|mesh-list
65227141|NCT02600806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65227142|NCT00639873|Doxycycline|doxycycline|mesh-list
65227143|NCT00639873|Artesunate|artesunate|mesh-list
65227144|NCT00639873|Quinine|quinine|mesh-list
65227145|NCT00639873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65227146|NCT00639873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65227147|NCT00639873|Antimalarials|antimalarials|mesh-ancestor
65227148|NCT00639873|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65227149|NCT00639873|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65227150|NCT00639873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227151|NCT00639873|Antiviral Agents|antiviral agents|mesh-ancestor
65227152|NCT00639873|Schistosomicides|schistosomicides|mesh-ancestor
65227153|NCT00639873|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65227154|NCT00639873|Anthelmintics|anthelmintics|mesh-ancestor
65227155|NCT00639873|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65227156|NCT00639873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227157|NCT00639873|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65227158|NCT00639873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65227159|NCT00639873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65227160|NCT00639873|Analgesics|analgesics|mesh-ancestor
65227161|NCT00639873|Sensory System Agents|sensory system agents|mesh-ancestor
65227162|NCT04291118|Budesonide|budesonide|mesh-list
65227163|NCT04291118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65227164|NCT04291118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65227165|NCT04291118|Autonomic Agents|autonomic agents|mesh-ancestor
65227166|NCT04291118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65227167|NCT04291118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227168|NCT04291118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65227169|NCT04291118|Respiratory System Agents|respiratory system agents|mesh-ancestor
65227170|NCT04291118|Glucocorticoids|glucocorticoids|mesh-ancestor
65227200|NCT03565783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65227201|NCT03565783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227202|NCT00719797|Leucovorin|leucovorin|mesh-list
65227203|NCT00719797|Bevacizumab|bevacizumab|mesh-list
65227204|NCT00719797|Fluorouracil|fluorouracil|mesh-list
65227205|NCT00719797|Oxaliplatin|oxaliplatin|mesh-list
65227206|NCT00719797|Irinotecan|irinotecan|mesh-list
65227207|NCT00719797|Calcium|calcium|mesh-list
65227208|NCT00719797|Levoleucovorin|levoleucovorin|mesh-list
65227209|NCT00719797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65227210|NCT00719797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227211|NCT00719797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65227212|NCT00719797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65227213|NCT00719797|Growth Substances|growth substances|mesh-ancestor
65227214|NCT00719797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227215|NCT00719797|Growth Inhibitors|growth inhibitors|mesh-ancestor
65227216|NCT00719797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65227217|NCT00719797|Antimetabolites|antimetabolites|mesh-ancestor
65227218|NCT00719797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227219|NCT00719797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65227220|NCT00719797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64940608|NCT00021489|Mycophenolic Acid|mycophenolic acid|mesh-list
65227253|NCT00640029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65227255|NCT00640029|Analgesics|analgesics|mesh-ancestor
65227256|NCT00640029|Sensory System Agents|sensory system agents|mesh-ancestor
65227257|NCT00640029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65227258|NCT00640029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227259|NCT00640029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65227260|NCT00640029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65227261|NCT00640029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65227262|NCT00640029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65227263|NCT00640029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227264|NCT00640029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227265|NCT02684799|Cenicriviroc|cenicriviroc|mesh-list
65227266|NCT02684799|Omeprazole|omeprazole|mesh-list
65227300|NCT00752986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227301|NCT00752986|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65227302|NCT00752986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65227303|NCT00752986|Hormone Antagonists|hormone antagonists|mesh-ancestor
65227304|NCT00752986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65343343|NCT00862108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65343344|NCT00862108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65227305|NCT00752986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227306|NCT02684487|Vitamin D|vitamin d|mesh-list
65227307|NCT02684487|Cholecalciferol|cholecalciferol|mesh-list
65227340|NCT04290572|Dermatologic Agents|dermatologic agents|mesh-ancestor
65227341|NCT04069429|Heparin|heparin|mesh-list
65227342|NCT04069429|Anticoagulants|anticoagulants|mesh-ancestor
65227343|NCT04069429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64870054|NCT01827878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65227344|NCT04069429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65227368|NCT00629252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65227369|NCT00629252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65227370|NCT00629252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65227371|NCT00629252|Dopamine Agents|dopamine agents|mesh-ancestor
65227372|NCT04096144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
65227373|NCT04096144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65227374|NCT04096144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65227375|NCT04096144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227376|NCT04095754|Dexmedetomidine|dexmedetomidine|mesh-list
65227377|NCT04095754|Anesthetics|anesthetics|mesh-list
65227378|NCT04095754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65227379|NCT04095754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227380|NCT04095754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65227381|NCT04095754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65227382|NCT04095754|Analgesics|analgesics|mesh-ancestor
65227383|NCT04095754|Sensory System Agents|sensory system agents|mesh-ancestor
65227384|NCT04095754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65227385|NCT04095754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65227386|NCT04095754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65227387|NCT04095754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64940786|NCT00022581|Thalidomide|thalidomide|mesh-list
65227411|NCT00718471|Enoxaparin|enoxaparin|mesh-list
65227412|NCT00718471|Calcium heparin|calcium heparin|mesh-list
65227413|NCT00718471|Anticoagulants|anticoagulants|mesh-ancestor
65227414|NCT00718471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65227415|NCT00718471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65227416|NCT00718471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227417|NCT00723307|Metformin|metformin|mesh-list
65227418|NCT00723307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65227419|NCT00723307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227420|NCT00723385|Vitamin D|vitamin d|mesh-list
65227421|NCT00723385|Cholecalciferol|cholecalciferol|mesh-list
65227422|NCT00723385|Vitamins|vitamins|mesh-ancestor
65227423|NCT00723385|Micronutrients|micronutrients|mesh-ancestor
65227424|NCT00723385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227425|NCT00723385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65227426|NCT00723385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65227427|NCT00754936|Citalopram|citalopram|mesh-list
65227428|NCT00754936|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65227429|NCT00754936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65227430|NCT00754936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65227431|NCT00754936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227432|NCT00754936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65227433|NCT00754936|Serotonin Agents|serotonin agents|mesh-ancestor
65227434|NCT00754936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227435|NCT00754936|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65227436|NCT00754936|Antidepressive Agents|antidepressive agents|mesh-ancestor
65227437|NCT00754936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65227438|NCT02684019|Magnesium Sulfate|magnesium sulfate|mesh-list
65227439|NCT02684019|Dexmedetomidine|dexmedetomidine|mesh-list
65227462|NCT00720421|Anticonvulsants|anticonvulsants|mesh-ancestor
65227463|NCT00720421|Antiemetics|antiemetics|mesh-ancestor
65227464|NCT00720421|Autonomic Agents|autonomic agents|mesh-ancestor
65227465|NCT00720421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65227466|NCT00720421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227467|NCT00720421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65227468|NCT00720421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65227469|NCT00720421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65227470|NCT00720421|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65227471|NCT00720421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65227472|NCT00720421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65227473|NCT00720421|GABA Modulators|gaba modulators|mesh-ancestor
65227474|NCT00720421|GABA Agents|gaba agents|mesh-ancestor
65343345|NCT00862108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343346|NCT00862108|Dopamine Agents|dopamine agents|mesh-ancestor
65343347|NCT00862108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65343348|NCT00862264|Beclomethasone|beclomethasone|mesh-list
65343349|NCT00862264|Norflurane|norflurane|mesh-list
65343350|NCT00862264|Formoterol Fumarate|formoterol fumarate|mesh-list
64725228|NCT00002383|Saquinavir|saquinavir|mesh-list
65227475|NCT00720421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65227476|NCT00720421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227477|NCT02689713|Voriconazole|voriconazole|mesh-list
65227478|NCT02689713|Antifungal Agents|antifungal agents|mesh-ancestor
65227479|NCT02689713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65227480|NCT02689713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65227481|NCT02689713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65227482|NCT02689713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227483|NCT02689713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227484|NCT02689713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65227485|NCT02689713|Hormone Antagonists|hormone antagonists|mesh-ancestor
65227486|NCT02689713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65227487|NCT02689713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227488|NCT02689713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65227489|NCT02601508|Rocuronium|rocuronium|mesh-list
65227490|NCT02601508|Atracurium|atracurium|mesh-list
65227491|NCT02601508|Cisatracurium|cisatracurium|mesh-list
64940873|NCT00022737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65227526|NCT02570581|Cholinergic Agents|cholinergic agents|mesh-ancestor
65227527|NCT02570581|Nootropic Agents|nootropic agents|mesh-ancestor
65227528|NCT02570581|Diuretics|diuretics|mesh-ancestor
65227529|NCT02570581|Natriuretic Agents|natriuretic agents|mesh-ancestor
65227530|NCT02570581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65227531|NCT02570581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65227532|NCT02570581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64940928|NCT00394992|Bevacizumab|bevacizumab|mesh-list
65227560|NCT00640263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65227561|NCT00640263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65227562|NCT00640263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65227564|NCT02683863|Dermatologic Agents|dermatologic agents|mesh-ancestor
65227565|NCT02683863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65227566|NCT02683863|Immunologic Factors|immunologic factors|mesh-ancestor
64870291|NCT01830153|Everolimus|everolimus|mesh-list
65227567|NCT02683863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227568|NCT04019288|Durvalumab|durvalumab|mesh-list
65227569|NCT04019288|Immunoglobulins|immunoglobulins|mesh-list
65227570|NCT04019288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65227571|NCT04019288|Immunoglobulin G|immunoglobulin g|mesh-list
65227572|NCT04019288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65227573|NCT04019288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227574|NCT04019288|Immunologic Factors|immunologic factors|mesh-ancestor
65227575|NCT04019288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227577|NCT02865668|Canagliflozin|canagliflozin|mesh-list
65227578|NCT02865668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65227579|NCT02865668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227580|NCT02865668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65227602|NCT02867930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65227603|NCT02867930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65227605|NCT02570893|Carboplatin|carboplatin|mesh-list
65227606|NCT02570893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65227607|NCT02570893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227608|NCT02570893|Tubulin Modulators|tubulin modulators|mesh-ancestor
65227609|NCT02570893|Antimitotic Agents|antimitotic agents|mesh-ancestor
65227610|NCT02570893|Mitosis Modulators|mitosis modulators|mesh-ancestor
65227611|NCT02570893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227612|NCT02538081|Risperidone|risperidone|mesh-list
65227613|NCT02538081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65227614|NCT02538081|Serotonin Agents|serotonin agents|mesh-ancestor
65227615|NCT02538081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65227616|NCT02538081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343351|NCT00862264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65343352|NCT00862264|Autonomic Agents|autonomic agents|mesh-ancestor
65343353|NCT00862264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65343354|NCT00862264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343355|NCT00862264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64332768|NCT01371630|Cytarabine|cytarabine|mesh-list
65227617|NCT02538081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227618|NCT02538081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65227619|NCT02538081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65227620|NCT02538081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65227621|NCT02538081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65227622|NCT02538081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65227623|NCT02538081|Dopamine Agents|dopamine agents|mesh-ancestor
65227624|NCT02570971|Mannitol|mannitol|mesh-list
65227625|NCT02570971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65227626|NCT02570971|Diuretics|diuretics|mesh-ancestor
65227627|NCT02570971|Natriuretic Agents|natriuretic agents|mesh-ancestor
65227628|NCT02570971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227629|NCT02866214|Febuxostat|febuxostat|mesh-list
65227630|NCT02866214|Gout Suppressants|gout suppressants|mesh-ancestor
65227631|NCT02866214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65227632|NCT02866448|Aspirin|aspirin|mesh-list
64941018|NCT00023400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65227656|NCT00720577|Antimetabolites|antimetabolites|mesh-ancestor
65227657|NCT00720577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227658|NCT00720577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65227659|NCT00720577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65227660|NCT00720577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227661|NCT00720577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65227662|NCT00720577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227663|NCT00720577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65227664|NCT00720577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65227665|NCT00720577|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65227666|NCT00720577|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65227668|NCT05373277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65227669|NCT05373277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65227670|NCT05373277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65227671|NCT05373277|Antimetabolites|antimetabolites|mesh-ancestor
65227672|NCT05373277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227673|NCT05373277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65227674|NCT05373277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65227675|NCT05373277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227676|NCT05373277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65227677|NCT05373277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65227678|NCT05373277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65227679|NCT05373277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65227680|NCT05373277|Purinergic Agents|purinergic agents|mesh-ancestor
65227681|NCT05373277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65227713|NCT00577993|Prednisolone acetate|prednisolone acetate|mesh-list
65227714|NCT00577993|Cyclophosphamide|cyclophosphamide|mesh-list
65227715|NCT00577993|Rituximab|rituximab|mesh-list
65227716|NCT00577993|Doxorubicin|doxorubicin|mesh-list
65227717|NCT00577993|Fludarabine|fludarabine|mesh-list
65227718|NCT00577993|Etoposide|etoposide|mesh-list
65227719|NCT00577993|Vincristine|vincristine|mesh-list
65227720|NCT00577993|Mitoxantrone|mitoxantrone|mesh-list
65227721|NCT00577993|Bleomycin|bleomycin|mesh-list
65227722|NCT00577993|Procarbazine|procarbazine|mesh-list
65227724|NCT00577993|Prednisolone phosphate|prednisolone phosphate|mesh-list
65227725|NCT00577993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65227726|NCT00577993|Immunologic Factors|immunologic factors|mesh-ancestor
65227727|NCT00577993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227728|NCT00577993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65227729|NCT00577993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65227730|NCT00577993|Alkylating Agents|alkylating agents|mesh-ancestor
65227731|NCT00577993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227732|NCT00577993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227762|NCT00975806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65227763|NCT00975806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65227764|NCT00975806|Growth Substances|growth substances|mesh-ancestor
65343356|NCT00862264|Respiratory System Agents|respiratory system agents|mesh-ancestor
65343357|NCT00862264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65343358|NCT00862264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65343359|NCT00862264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65343360|NCT00862264|Adrenergic Agents|adrenergic agents|mesh-ancestor
65343361|NCT00862264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65227765|NCT00975806|Growth Inhibitors|growth inhibitors|mesh-ancestor
65227766|NCT00975806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227767|NCT00975806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65227768|NCT00975806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227769|NCT00975806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227770|NCT00721201|Mifepristone|mifepristone|mesh-list
65227771|NCT00721201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65227772|NCT00721201|Abortifacient Agents|abortifacient agents|mesh-ancestor
65227773|NCT00721201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65227774|NCT00721201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227775|NCT00721201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65227776|NCT00721201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65227777|NCT00721201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65227778|NCT00721201|Contraceptive Agents|contraceptive agents|mesh-ancestor
65227779|NCT00721201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65227802|NCT02866370|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65227803|NCT02866370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65227804|NCT00978068|Ritonavir|ritonavir|mesh-list
65227805|NCT00978068|Lopinavir|lopinavir|mesh-list
65227806|NCT00978068|Nevirapine|nevirapine|mesh-list
65227807|NCT00978068|Efavirenz|efavirenz|mesh-list
65227808|NCT00978068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
65227809|NCT00978068|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65227810|NCT00978068|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65227811|NCT00978068|Protease Inhibitors|protease inhibitors|mesh-ancestor
65227812|NCT00978068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227813|NCT00978068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227814|NCT00978068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65227815|NCT00978068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65227816|NCT00978068|Antiviral Agents|antiviral agents|mesh-ancestor
65227817|NCT00978068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65227818|NCT00978068|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65227819|NCT00978068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65227820|NCT00978068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65227821|NCT00978068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65227822|NCT00978068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65227823|NCT00978068|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65227824|NCT00978068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65227825|NCT00978068|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65227826|NCT00629642|Solifenacin Succinate|solifenacin succinate|mesh-list
65227827|NCT00629642|Oxybutynin|oxybutynin|mesh-list
65227828|NCT00629642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65227829|NCT00629642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65227830|NCT00629642|Cholinergic Agents|cholinergic agents|mesh-ancestor
65227831|NCT00629642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65227848|NCT02865356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65227849|NCT02865356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65227850|NCT04287842|Sevoflurane|sevoflurane|mesh-list
65227851|NCT04287842|Desflurane|desflurane|mesh-list
65227852|NCT04287842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65227853|NCT04287842|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65227854|NCT04287842|Anesthetics, General|anesthetics, general|mesh-ancestor
65227855|NCT04287842|Anesthetics|anesthetics|mesh-ancestor
65227856|NCT04287842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65227857|NCT04287842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227858|NCT00721747|Cyclophosphamide|cyclophosphamide|mesh-list
65227859|NCT00721747|Docetaxel|docetaxel|mesh-list
65227860|NCT00721747|Doxorubicin|doxorubicin|mesh-list
65227861|NCT00721747|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65227862|NCT00721747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65227863|NCT00721747|Immunologic Factors|immunologic factors|mesh-ancestor
65227864|NCT00721747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227865|NCT00721747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65343362|NCT00862264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343363|NCT00862264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65343364|NCT00862264|Glucocorticoids|glucocorticoids|mesh-ancestor
65343365|NCT00862264|Hormones|hormones|mesh-ancestor
65343366|NCT00862264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65227866|NCT00721747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65227867|NCT00721747|Alkylating Agents|alkylating agents|mesh-ancestor
65227868|NCT00721747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227869|NCT00721747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227870|NCT00721747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64870579|NCT01840423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227871|NCT00721747|Tubulin Modulators|tubulin modulators|mesh-ancestor
65227872|NCT00721747|Antimitotic Agents|antimitotic agents|mesh-ancestor
65227873|NCT00721747|Mitosis Modulators|mitosis modulators|mesh-ancestor
65227874|NCT00721747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65227875|NCT00721747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65227876|NCT00721747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65227877|NCT00721747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227879|NCT00603525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227880|NCT02570191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65227881|NCT02570191|Antiviral Agents|antiviral agents|mesh-ancestor
65227882|NCT02570191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65227883|NCT03715933|Carboplatin|carboplatin|mesh-list
65227884|NCT03715933|Fluorouracil|fluorouracil|mesh-list
65227885|NCT03715933|Irinotecan|irinotecan|mesh-list
65227886|NCT03715933|Pemetrexed|pemetrexed|mesh-list
65227887|NCT03715933|Temozolomide|temozolomide|mesh-list
65227888|NCT03715933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227889|NCT03715933|Antimetabolites|antimetabolites|mesh-ancestor
65227890|NCT03715933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941272|NCT05055830|Narcotics|narcotics|mesh-ancestor
65227911|NCT04541407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227912|NCT04541407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65227913|NCT04541407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227915|NCT00640575|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65227916|NCT00640575|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65227917|NCT00640575|Lidocaine|lidocaine|mesh-list
65227918|NCT00640575|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65227919|NCT00640575|Anesthetics, Local|anesthetics, local|mesh-ancestor
65227920|NCT00640575|Anesthetics|anesthetics|mesh-ancestor
65227921|NCT00640575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65227922|NCT00640575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227923|NCT00640575|Sensory System Agents|sensory system agents|mesh-ancestor
65227924|NCT00640575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65227925|NCT00640575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65227926|NCT00640575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65227927|NCT00640575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65227928|NCT00640575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65227929|NCT00640575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227930|NCT00640575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65227931|NCT00640575|Glucocorticoids|glucocorticoids|mesh-ancestor
65227932|NCT00640575|Hormones|hormones|mesh-ancestor
65227933|NCT00640575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65227934|NCT00640575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65227935|NCT00640575|Immunologic Factors|immunologic factors|mesh-ancestor
65227936|NCT00640575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227937|NCT04067791|Melatonin|melatonin|mesh-list
65227938|NCT04067791|Antioxidants|antioxidants|mesh-ancestor
65227939|NCT04067791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227940|NCT04067791|Protective Agents|protective agents|mesh-ancestor
65227941|NCT04067791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227942|NCT04067791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65227969|NCT02387229|Anticoagulants|anticoagulants|mesh-ancestor
65227971|NCT04183881|Dermatologic Agents|dermatologic agents|mesh-ancestor
65227972|NCT04093648|Cyclophosphamide|cyclophosphamide|mesh-list
65227973|NCT04093648|Fludarabine|fludarabine|mesh-list
65227974|NCT04093648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65227975|NCT04093648|Immunologic Factors|immunologic factors|mesh-ancestor
65227976|NCT04093648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343367|NCT00862264|Anesthetics|anesthetics|mesh-ancestor
65093155|NCT05642689|Iron|iron|mesh-list
65343368|NCT00862264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65343369|NCT00730574|Vitamins|vitamins|mesh-list
65343370|NCT00730574|Folic Acid|folic acid|mesh-list
65227977|NCT04093648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65227978|NCT04093648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65227979|NCT04093648|Alkylating Agents|alkylating agents|mesh-ancestor
65227980|NCT04093648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227981|NCT04093648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227982|NCT04093648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65227983|NCT04184115|Scopolamine|scopolamine|mesh-list
65227984|NCT04184115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65227985|NCT04184115|Antiemetics|antiemetics|mesh-ancestor
65227986|NCT04184115|Autonomic Agents|autonomic agents|mesh-ancestor
65227987|NCT04184115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65227988|NCT04184115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227989|NCT04184115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65227990|NCT04184115|Mydriatics|mydriatics|mesh-ancestor
65227991|NCT04184115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65228018|NCT00640809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65228019|NCT00640809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228020|NCT00640809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228021|NCT00640809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65228022|NCT00640809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65228023|NCT00640809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65228024|NCT00640809|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65228026|NCT00754624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65228027|NCT00754624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228029|NCT05630209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65228030|NCT05630209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228031|NCT05630209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65228032|NCT05630209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65228033|NCT05630209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228034|NCT05630209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228035|NCT00722293|Doxorubicin|doxorubicin|mesh-list
65228036|NCT00722293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65228037|NCT00722293|Epirubicin|epirubicin|mesh-list
65228038|NCT00722293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65228058|NCT03583957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65228059|NCT03583957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228060|NCT03583957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65228061|NCT03583957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228062|NCT03583957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228063|NCT03583957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65228064|NCT03583957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65228065|NCT03583957|Purinergic Agents|purinergic agents|mesh-ancestor
65228066|NCT03583957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65228067|NCT02176863|Immunoglobulins|immunoglobulins|mesh-list
65228068|NCT02176863|gamma-Globulins|gamma-globulins|mesh-list
65228069|NCT02176863|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65228070|NCT02176863|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65228071|NCT02176863|Immunologic Factors|immunologic factors|mesh-ancestor
65228072|NCT02176863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228073|NCT02571283|Epinephrine|epinephrine|mesh-list
65228074|NCT02571283|Bupivacaine|bupivacaine|mesh-list
65228075|NCT02571283|Anesthetics, Local|anesthetics, local|mesh-ancestor
65228076|NCT02571283|Anesthetics|anesthetics|mesh-ancestor
65228077|NCT02571283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65228078|NCT02571283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228079|NCT02571283|Sensory System Agents|sensory system agents|mesh-ancestor
65228080|NCT02571283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65228081|NCT02571283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228082|NCT02571283|Autonomic Agents|autonomic agents|mesh-ancestor
65228083|NCT02571283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65228084|NCT02571283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65228085|NCT02571283|Adrenergic Agents|adrenergic agents|mesh-ancestor
65228086|NCT02571283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65228087|NCT02571283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65228088|NCT02571283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65343371|NCT00730574|Vitamin B 12|vitamin b 12|mesh-list
65343372|NCT00730574|Hydroxocobalamin|hydroxocobalamin|mesh-list
65343373|NCT00730574|Vitamin B Complex|vitamin b complex|mesh-list
65343374|NCT00730574|Micronutrients|micronutrients|mesh-ancestor
65343375|NCT00730574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228089|NCT02571283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65228090|NCT02571283|Respiratory System Agents|respiratory system agents|mesh-ancestor
65228091|NCT02571283|Mydriatics|mydriatics|mesh-ancestor
65228092|NCT02571283|Sympathomimetics|sympathomimetics|mesh-ancestor
65228093|NCT02571283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65228094|NCT02682693|Denosumab|denosumab|mesh-list
65228132|NCT02571517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228133|NCT02571517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65228134|NCT02571517|Hormones|hormones|mesh-ancestor
65228135|NCT02571517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65228162|NCT04144465|Norepinephrine|norepinephrine|mesh-list
65228163|NCT04144465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65228164|NCT04144465|Mydriatics|mydriatics|mesh-ancestor
65228165|NCT04144465|Autonomic Agents|autonomic agents|mesh-ancestor
65228166|NCT04144465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65228167|NCT04144465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228168|NCT04144465|Sympathomimetics|sympathomimetics|mesh-ancestor
65228169|NCT04144465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64870876|NCT01842373|Benzocaine|benzocaine|mesh-list
65228170|NCT04144465|Nasal Decongestants|nasal decongestants|mesh-ancestor
65228171|NCT04144465|Respiratory System Agents|respiratory system agents|mesh-ancestor
65228172|NCT04144465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65228173|NCT04144465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65228174|NCT04144465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65228175|NCT04144465|Adrenergic Agents|adrenergic agents|mesh-ancestor
65228176|NCT04144465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65228177|NCT04144465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228178|NCT04144465|Protective Agents|protective agents|mesh-ancestor
65228179|NCT00754390|Calcium, Dietary|calcium, dietary|mesh-list
65228181|NCT00754390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65228182|NCT00754390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228183|NCT00754390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65228215|NCT02865824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65228216|NCT02865824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65228217|NCT02865824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65228218|NCT02865824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228219|NCT02865824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65228220|NCT02865824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65228221|NCT02865824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228222|NCT02865824|Antipyretics|antipyretics|mesh-ancestor
65228223|NCT02570035|Mirabegron|mirabegron|mesh-list
65228224|NCT02570035|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65228225|NCT02570035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65228226|NCT02570035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65228248|NCT00726973|Growth Inhibitors|growth inhibitors|mesh-ancestor
65228249|NCT00726973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228250|NCT02571361|Acetaminophen|acetaminophen|mesh-list
65228251|NCT02571361|Ibuprofen|ibuprofen|mesh-list
65228252|NCT02571361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65228253|NCT02571361|Analgesics|analgesics|mesh-ancestor
65228254|NCT02571361|Sensory System Agents|sensory system agents|mesh-ancestor
65228255|NCT02571361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65228256|NCT02571361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228257|NCT02571361|Antipyretics|antipyretics|mesh-ancestor
65228258|NCT02571361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65228259|NCT02571361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65228260|NCT02571361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65228261|NCT02571361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65228262|NCT02571361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228263|NCT02571361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228264|NCT04290104|Ampicillin|ampicillin|mesh-list
65228265|NCT04290104|Sulbactam|sulbactam|mesh-list
65228266|NCT04290104|Sultamicillin|sultamicillin|mesh-list
65228267|NCT04290104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65228268|NCT04290104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65228269|NCT04290104|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65228270|NCT04290104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343376|NCT00730574|Hematinics|hematinics|mesh-ancestor
65343377|NCT00870532|Sorafenib|sorafenib|mesh-list
65343378|NCT00870532|Vinorelbine|vinorelbine|mesh-list
65343379|NCT00870532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343380|NCT00870532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65343381|NCT00870532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343382|NCT00870532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343383|NCT00870532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65343384|NCT00870532|Tubulin Modulators|tubulin modulators|mesh-ancestor
65343385|NCT00870532|Antimitotic Agents|antimitotic agents|mesh-ancestor
65343386|NCT00870532|Mitosis Modulators|mitosis modulators|mesh-ancestor
65343387|NCT00725478|Piribedil|piribedil|mesh-list
65228271|NCT04290104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228272|NCT02571205|Testosterone|testosterone|mesh-list
65228273|NCT02571205|Androgens|androgens|mesh-ancestor
65228274|NCT02571205|Hormones|hormones|mesh-ancestor
65228275|NCT02571205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65228276|NCT02571205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228277|NCT04290026|Metoclopramide|metoclopramide|mesh-list
65228278|NCT04290026|Granisetron|granisetron|mesh-list
65228279|NCT04290026|Antiemetics|antiemetics|mesh-ancestor
65228280|NCT04290026|Autonomic Agents|autonomic agents|mesh-ancestor
65228281|NCT04290026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65228282|NCT04290026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228297|NCT00640887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65228298|NCT00640887|Protease Inhibitors|protease inhibitors|mesh-ancestor
65228299|NCT00640887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228300|NCT00640887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228301|NCT00640887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65228302|NCT00640887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65228303|NCT00640887|Antiviral Agents|antiviral agents|mesh-ancestor
65228304|NCT00640887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65228305|NCT00640887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65228306|NCT00640887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65228307|NCT00640887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65228308|NCT00640887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65228309|NCT00640887|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65228310|NCT00640887|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65228311|NCT00640887|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65228312|NCT00640887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65228313|NCT00640887|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65228314|NCT00640887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65228315|NCT00640887|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65228316|NCT00640887|Antitubercular Agents|antitubercular agents|mesh-ancestor
65228317|NCT05615623|Doxorubicin|doxorubicin|mesh-list
65228318|NCT05615623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65228319|NCT05615623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228320|NCT05615623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65228321|NCT05615623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65228322|NCT05615623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228323|NCT05615623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228324|NCT00730093|Vitamin B 12|vitamin b 12|mesh-list
65228325|NCT00730093|Hydroxocobalamin|hydroxocobalamin|mesh-list
65228327|NCT00730093|Micronutrients|micronutrients|mesh-ancestor
65228328|NCT00730093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228329|NCT00730093|Vitamin B Complex|vitamin b complex|mesh-ancestor
65228330|NCT00730093|Hematinics|hematinics|mesh-ancestor
65228331|NCT00727129|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65228332|NCT00727129|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65228333|NCT00727129|Estradiol|estradiol|mesh-list
65228334|NCT00727129|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65228335|NCT00727129|Estrogens|estrogens|mesh-ancestor
65228336|NCT00727129|Hormones|hormones|mesh-ancestor
65343388|NCT00725478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65343389|NCT00725478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65343390|NCT00725478|Dopamine Agonists|dopamine agonists|mesh-ancestor
65343391|NCT00725478|Dopamine Agents|dopamine agents|mesh-ancestor
65343392|NCT00725478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65228337|NCT00727129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65228338|NCT00727129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228339|NCT00727129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65228340|NCT00727129|Contraceptive Agents|contraceptive agents|mesh-ancestor
65228341|NCT00727129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65228342|NCT00727129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65228343|NCT04183725|Oseltamivir|oseltamivir|mesh-list
65228344|NCT04183725|Antiviral Agents|antiviral agents|mesh-ancestor
65228370|NCT01632657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228371|NCT00727207|Everolimus|everolimus|mesh-list
65228372|NCT00727207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228373|NCT00727207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65228374|NCT00727207|Immunologic Factors|immunologic factors|mesh-ancestor
65228375|NCT00727207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228376|NCT02682459|Lisinopril|lisinopril|mesh-list
65228377|NCT02682459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65228378|NCT02682459|Protease Inhibitors|protease inhibitors|mesh-ancestor
65228379|NCT02682459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228380|NCT02682459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228381|NCT02682459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65228382|NCT02682459|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65228383|NCT02682459|Protective Agents|protective agents|mesh-ancestor
65228384|NCT02682459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228385|NCT02620579|Propranolol|propranolol|mesh-list
65228386|NCT02620579|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65228387|NCT02620579|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65228388|NCT02620579|Adrenergic Agents|adrenergic agents|mesh-ancestor
65228389|NCT02620579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64941784|NCT00027885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228416|NCT03900793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65228417|NCT03900793|Growth Substances|growth substances|mesh-ancestor
65228418|NCT03900793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228419|NCT03900793|Growth Inhibitors|growth inhibitors|mesh-ancestor
65228420|NCT03900793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65228421|NCT03900793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228422|NCT03900793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228423|NCT03900793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65228424|NCT03900793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65228425|NCT03900793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65228426|NCT03900793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65228427|NCT00365157|Halichondrin B|halichondrin b|mesh-list
65228428|NCT00365157|Tubulin Modulators|tubulin modulators|mesh-ancestor
65228429|NCT00365157|Antimitotic Agents|antimitotic agents|mesh-ancestor
65228430|NCT00365157|Mitosis Modulators|mitosis modulators|mesh-ancestor
65228431|NCT00365157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228432|NCT00365157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228433|NCT04066231|Erythromycin|erythromycin|mesh-list
65228434|NCT04066231|Erythromycin Estolate|erythromycin estolate|mesh-list
65228435|NCT04066231|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65228436|NCT04066231|Erythromycin stearate|erythromycin stearate|mesh-list
65228437|NCT04066231|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
65228438|NCT04066231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65228471|NCT00727831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65228472|NCT00727831|Abortifacient Agents|abortifacient agents|mesh-ancestor
65228473|NCT00727831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65228474|NCT00727831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65228475|NCT00727831|Antimetabolites|antimetabolites|mesh-ancestor
65228476|NCT00727831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228477|NCT00727831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228478|NCT00727831|Dermatologic Agents|dermatologic agents|mesh-ancestor
65228479|NCT00727831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228480|NCT00727831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65228481|NCT00727831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65228482|NCT00727831|Immunologic Factors|immunologic factors|mesh-ancestor
65343393|NCT00725478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343394|NCT00725478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228516|NCT02681913|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65228517|NCT02681913|Purinergic Agonists|purinergic agonists|mesh-ancestor
65228518|NCT02681913|Purinergic Agents|purinergic agents|mesh-ancestor
65228519|NCT02681913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65228520|NCT02681913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228521|NCT02681679|Bromfenac|bromfenac|mesh-list
65228522|NCT02681679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65228523|NCT02681679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65228524|NCT02681679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65228525|NCT02681679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65228526|NCT02681679|Analgesics|analgesics|mesh-ancestor
65228553|NCT00734383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228554|NCT00734383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65228555|NCT00734383|Anesthetics, General|anesthetics, general|mesh-ancestor
65228556|NCT00734383|Anesthetics|anesthetics|mesh-ancestor
65228557|NCT00586612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65228558|NCT00586612|Immunologic Factors|immunologic factors|mesh-ancestor
65228559|NCT00586612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228560|NCT02680977|Levodopa|levodopa|mesh-list
65228561|NCT02680977|Benserazide|benserazide|mesh-list
65228562|NCT02680977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65228563|NCT02680977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65228564|NCT02680977|Dopamine Agents|dopamine agents|mesh-ancestor
65228565|NCT02680977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65228566|NCT02680977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228567|NCT02680977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228568|NCT02680977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228569|NCT00734695|Vitamins|vitamins|mesh-list
65228570|NCT00734695|Ascorbic Acid|ascorbic acid|mesh-list
65228571|NCT00734695|Micronutrients|micronutrients|mesh-ancestor
65228572|NCT00734695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228573|NCT00734695|Antioxidants|antioxidants|mesh-ancestor
65228574|NCT00734695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228575|NCT00734695|Protective Agents|protective agents|mesh-ancestor
65228576|NCT00586690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65228577|NCT00586690|Antibodies|antibodies|mesh-list
65228600|NCT00909987|Oxaliplatin|oxaliplatin|mesh-list
65228601|NCT00909987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65228602|NCT00909987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228603|NCT00909987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65228604|NCT00909987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65228605|NCT00909987|Growth Substances|growth substances|mesh-ancestor
65228606|NCT00909987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228607|NCT00909987|Growth Inhibitors|growth inhibitors|mesh-ancestor
65228608|NCT00909987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65228609|NCT00909987|Antimetabolites|antimetabolites|mesh-ancestor
65228610|NCT00909987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228611|NCT00729001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65228612|NCT00729001|Immunologic Factors|immunologic factors|mesh-ancestor
65228613|NCT00729001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228614|NCT00760474|Pregabalin|pregabalin|mesh-list
65228615|NCT00760474|Analgesics|analgesics|mesh-ancestor
65228616|NCT00760474|Sensory System Agents|sensory system agents|mesh-ancestor
65228617|NCT00760474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65228618|NCT00760474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228619|NCT00760474|Anticonvulsants|anticonvulsants|mesh-ancestor
65228620|NCT00760474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65228621|NCT00760474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65228622|NCT00760474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228623|NCT00760474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65228624|NCT00760474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65228625|NCT00760474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65228626|NCT00760474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65228627|NCT00760474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65228628|NCT02680119|Esomeprazole|esomeprazole|mesh-list
65228629|NCT02680119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64942018|NCT03959540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228648|NCT00734773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65228650|NCT00734773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343395|NCT01951274|Serlopitant|serlopitant|mesh-list
65343396|NCT01951274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65343397|NCT01951274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65343398|NCT01951274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343399|NCT01951274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343400|NCT03355794|Everolimus|everolimus|mesh-list
65343401|NCT03355794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343402|NCT03355794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65343403|NCT03355794|Immunologic Factors|immunologic factors|mesh-ancestor
65343404|NCT03355794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343405|NCT01487174|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65343406|NCT01487174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343407|NCT01487174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65343408|NCT01487174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228651|NCT00734773|Dermatologic Agents|dermatologic agents|mesh-ancestor
65228652|NCT00734773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228653|NCT00734773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65228654|NCT00734773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65228655|NCT00734773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65228656|NCT00734773|Antiviral Agents|antiviral agents|mesh-ancestor
65228657|NCT00734773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65228658|NCT00734773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65228659|NCT00734773|Tubulin Modulators|tubulin modulators|mesh-ancestor
65228660|NCT00734773|Antimitotic Agents|antimitotic agents|mesh-ancestor
65228661|NCT00734773|Mitosis Modulators|mitosis modulators|mesh-ancestor
65228662|NCT00734773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65228663|NCT04289090|Propofol|propofol|mesh-list
65228664|NCT04289090|Sevoflurane|sevoflurane|mesh-list
65228665|NCT04289090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65228666|NCT04289090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65228667|NCT04289090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228668|NCT04289090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65228669|NCT04289090|Anesthetics, General|anesthetics, general|mesh-ancestor
65228670|NCT04289090|Anesthetics|anesthetics|mesh-ancestor
65228671|NCT04289090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65228672|NCT04289090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65228673|NCT00975416|Oxytocin|oxytocin|mesh-list
65228674|NCT00975416|Oxytocics|oxytocics|mesh-ancestor
65228675|NCT00975416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65228676|NCT00975416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228677|NCT02679963|Olaparib|olaparib|mesh-list
65228678|NCT02679963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65228679|NCT02679963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228680|NCT02679963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228681|NCT02679963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228682|NCT00760084|Decitabine|decitabine|mesh-list
65228683|NCT00760084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65228684|NCT00760084|Antimetabolites|antimetabolites|mesh-ancestor
65228685|NCT00760084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228686|NCT00760084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228687|NCT00760084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228719|NCT00641979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228720|NCT00641979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65228721|NCT00641979|Respiratory System Agents|respiratory system agents|mesh-ancestor
65228722|NCT00641979|Glucocorticoids|glucocorticoids|mesh-ancestor
65228724|NCT00641979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65228725|NCT02679339|Lidocaine|lidocaine|mesh-list
65228726|NCT02679339|Anesthetics, Local|anesthetics, local|mesh-ancestor
65228727|NCT02679339|Anesthetics|anesthetics|mesh-ancestor
65228728|NCT02679339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65343409|NCT01487174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343410|NCT00725634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65343411|NCT00725634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65343412|NCT00725634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228729|NCT02679339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228730|NCT02679339|Sensory System Agents|sensory system agents|mesh-ancestor
65228731|NCT02679339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65228732|NCT02679339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65228733|NCT02679339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65228734|NCT02679339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65228766|NCT02678949|Adrenergic Agents|adrenergic agents|mesh-ancestor
65228767|NCT02678949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65228768|NCT02678949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228769|NCT00642135|Phenylephrine|phenylephrine|mesh-list
65228770|NCT00642135|Oxymetazoline|oxymetazoline|mesh-list
65228771|NCT00642135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65228772|NCT00642135|Tropicamide|tropicamide|mesh-list
65228773|NCT00642135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65228774|NCT00642135|Mydriatics|mydriatics|mesh-ancestor
65228775|NCT00642135|Autonomic Agents|autonomic agents|mesh-ancestor
65228776|NCT00642135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65228777|NCT00642135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228795|NCT00642291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65228796|NCT00642291|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65228797|NCT00642291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65228798|NCT00642291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228799|NCT00642291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228800|NCT00642291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65228801|NCT00642291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65228802|NCT02600260|Enoxaparin|enoxaparin|mesh-list
65228803|NCT02600260|Enoxaparin sodium|enoxaparin sodium|mesh-list
65228804|NCT02600260|Anticoagulants|anticoagulants|mesh-ancestor
65228805|NCT02600260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65228806|NCT02600260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65228807|NCT02600260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228808|NCT02537379|Ribavirin|ribavirin|mesh-list
65228809|NCT02537379|Antimetabolites|antimetabolites|mesh-ancestor
65228810|NCT02537379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228811|NCT02537379|Antiviral Agents|antiviral agents|mesh-ancestor
65228812|NCT02537379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65228813|NCT05442034|Mitogens|mitogens|mesh-list
65228814|NCT05442034|Mitosis Modulators|mitosis modulators|mesh-ancestor
65228815|NCT05442034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228816|NCT04179747|Sildenafil Citrate|sildenafil citrate|mesh-list
65228817|NCT04179747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228818|NCT04179747|Vasodilator Agents|vasodilator agents|mesh-ancestor
65228819|NCT04179747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65228820|NCT04179747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65228821|NCT04179747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228822|NCT04179747|Urological Agents|urological agents|mesh-ancestor
65228823|NCT04204772|Charcoal|charcoal|mesh-list
65228824|NCT04204772|Antidotes|antidotes|mesh-ancestor
65228825|NCT04204772|Protective Agents|protective agents|mesh-ancestor
65228826|NCT04204772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228827|NCT02675205|Aspirin|aspirin|mesh-list
65228828|NCT02675205|Clopidogrel|clopidogrel|mesh-list
65228829|NCT02675205|Ticagrelor|ticagrelor|mesh-list
65228830|NCT02675205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65228831|NCT02675205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65228832|NCT02675205|Analgesics|analgesics|mesh-ancestor
65228833|NCT02675205|Sensory System Agents|sensory system agents|mesh-ancestor
65228834|NCT02675205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65228835|NCT02675205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228853|NCT00753454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228854|NCT00753454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65228855|NCT00643539|Azithromycin|azithromycin|mesh-list
65228856|NCT00643539|Amoxicillin|amoxicillin|mesh-list
65228857|NCT00643539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65228858|NCT00643539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65228859|NCT00759148|Moxifloxacin|moxifloxacin|mesh-list
65228860|NCT00759148|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65343413|NCT00725634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65343414|NCT00725634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343415|NCT00725634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343416|NCT00725634|Immunologic Factors|immunologic factors|mesh-ancestor
65343417|NCT00725634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343418|NCT00617344|Vaccines|vaccines|mesh-list
65228861|NCT00759148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65228862|NCT00759148|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65228863|NCT00759148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65228864|NCT00759148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65228865|NCT00759148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65228866|NCT00759148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65228867|NCT00759148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228868|NCT00759148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228869|NCT00759148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228870|NCT00759148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65228871|NCT00759148|Contraceptive Agents|contraceptive agents|mesh-ancestor
65228872|NCT00759148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65228873|NCT00759148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228874|NCT00759148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65228875|NCT00759148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65228876|NCT00759148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65228877|NCT00910065|Aspirin|aspirin|mesh-list
65228878|NCT00910065|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
65228879|NCT00910065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65228880|NCT00910065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65228881|NCT00910065|Analgesics|analgesics|mesh-ancestor
65228882|NCT00910065|Sensory System Agents|sensory system agents|mesh-ancestor
65228883|NCT00910065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65228884|NCT00910065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228885|NCT00910065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65228886|NCT00910065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65228887|NCT00910065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65228888|NCT00910065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65228889|NCT00910065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228890|NCT00910065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64942277|NCT00030459|Mitomycins|mitomycins|mesh-list
65228921|NCT02675049|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65228922|NCT02675049|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65228923|NCT02675049|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65228924|NCT02675049|Adrenergic Agents|adrenergic agents|mesh-ancestor
65228925|NCT02675049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65228926|NCT02675049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228928|NCT02674737|Dexmedetomidine|dexmedetomidine|mesh-list
65228929|NCT02674737|Tramadol|tramadol|mesh-list
65228930|NCT02674737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65228931|NCT02674737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65228932|NCT02674737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228933|NCT02674737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65228968|NCT02674581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228970|NCT04065919|Bupivacaine|bupivacaine|mesh-list
65228971|NCT04065919|Anesthetics, Local|anesthetics, local|mesh-ancestor
65228972|NCT04065919|Anesthetics|anesthetics|mesh-ancestor
65228994|NCT04179045|Sirolimus|sirolimus|mesh-list
65228995|NCT04179045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65228996|NCT04179045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64871712|NCT01847677|Paclitaxel|paclitaxel|mesh-list
65228997|NCT04179045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65228998|NCT04179045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229000|NCT04179045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65229001|NCT04179045|Immunologic Factors|immunologic factors|mesh-ancestor
65229002|NCT04179045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229003|NCT00970268|Bromides|bromides|mesh-list
65229004|NCT00970268|Anticonvulsants|anticonvulsants|mesh-ancestor
65229005|NCT02674113|Bupivacaine|bupivacaine|mesh-list
65229006|NCT02674113|Anesthetics|anesthetics|mesh-list
65229007|NCT02674113|Anesthetics, Local|anesthetics, local|mesh-ancestor
65229008|NCT02674113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65343419|NCT00617344|Immunologic Factors|immunologic factors|mesh-ancestor
65343420|NCT00617344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343421|NCT00862342|Bevacizumab|bevacizumab|mesh-list
65343422|NCT00862342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65343423|NCT00862342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343424|NCT00862342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65343425|NCT00862342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65343426|NCT00862342|Growth Substances|growth substances|mesh-ancestor
65343427|NCT00862342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343428|NCT00862342|Growth Inhibitors|growth inhibitors|mesh-ancestor
65343429|NCT00732212|Hemostatics|hemostatics|mesh-list
65343430|NCT00732212|Coagulants|coagulants|mesh-ancestor
65229009|NCT02674113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229010|NCT02674113|Sensory System Agents|sensory system agents|mesh-ancestor
65229011|NCT02674113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229012|NCT03698552|Epratuzumab|epratuzumab|mesh-list
65229013|NCT03698552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65229014|NCT03698552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229015|NCT00644085|Aspirin|aspirin|mesh-list
65229016|NCT00644085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65229017|NCT00644085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65229018|NCT00644085|Analgesics|analgesics|mesh-ancestor
65229019|NCT00644085|Sensory System Agents|sensory system agents|mesh-ancestor
65229020|NCT00644085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229021|NCT00644085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229022|NCT00644085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65229023|NCT00644085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65229024|NCT00644085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65229025|NCT00644085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65229026|NCT00644085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229056|NCT02674191|Benzocaine|benzocaine|mesh-list
65229057|NCT02674191|Povidone|povidone|mesh-list
65229058|NCT02674191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65229059|NCT02674191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65229060|NCT02674191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65229061|NCT02674191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229062|NCT02674191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229063|NCT02674191|Plasma Substitutes|plasma substitutes|mesh-ancestor
65229064|NCT02674191|Blood Substitutes|blood substitutes|mesh-ancestor
65229065|NCT02674191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65229066|NCT02674191|Anesthetics, Local|anesthetics, local|mesh-ancestor
65229067|NCT02674191|Anesthetics|anesthetics|mesh-ancestor
65229068|NCT02674191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65229069|NCT02674191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229070|NCT02674191|Sensory System Agents|sensory system agents|mesh-ancestor
65229071|NCT02674191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229072|NCT00736021|Citalopram|citalopram|mesh-list
65229073|NCT00736021|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65229074|NCT00736021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65229075|NCT00736021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65229096|NCT02673879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65229097|NCT02673879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229098|NCT00738595|Nicotine|nicotine|mesh-list
65229099|NCT00738595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65229100|NCT00738595|Autonomic Agents|autonomic agents|mesh-ancestor
65229101|NCT00738595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229102|NCT00738595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229103|NCT00738595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65229104|NCT00738595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65229105|NCT00738595|Cholinergic Agents|cholinergic agents|mesh-ancestor
65229106|NCT00738595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65229107|NCT00738595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343431|NCT02544724|Interleukin-12|interleukin-12|mesh-list
65343432|NCT02544724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65343433|NCT02544724|Immunologic Factors|immunologic factors|mesh-ancestor
65343434|NCT02544724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343435|NCT02544724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64725316|NCT00002047|Antiviral Agents|antiviral agents|mesh-ancestor
65229109|NCT05273775|Vitamin K 1|vitamin k 1|mesh-list
65229110|NCT05273775|Digoxin|digoxin|mesh-list
65229111|NCT05273775|Midazolam|midazolam|mesh-list
65229112|NCT05273775|Omeprazole|omeprazole|mesh-list
65229113|NCT05273775|Warfarin|warfarin|mesh-list
65229114|NCT05273775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65229115|NCT05273775|Vitamins|vitamins|mesh-ancestor
65229116|NCT05273775|Micronutrients|micronutrients|mesh-ancestor
65229117|NCT05273775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229118|NCT05273775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65229119|NCT05273775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65229120|NCT05273775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65229121|NCT05273775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65229122|NCT05273775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65229123|NCT05273775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65229124|NCT05273775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65229125|NCT05273775|Anesthetics, General|anesthetics, general|mesh-ancestor
65229126|NCT05273775|Anesthetics|anesthetics|mesh-ancestor
65229127|NCT05273775|GABA Modulators|gaba modulators|mesh-ancestor
65229128|NCT05273775|GABA Agents|gaba agents|mesh-ancestor
65229129|NCT05273775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65229130|NCT05273775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229131|NCT05273775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65229132|NCT05273775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65229154|NCT02671851|Anesthetics|anesthetics|mesh-ancestor
65229155|NCT02671851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65229156|NCT02671851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229157|NCT02671851|Sensory System Agents|sensory system agents|mesh-ancestor
65229158|NCT02671851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229159|NCT02671851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65229160|NCT02671851|Narcotics|narcotics|mesh-ancestor
65229161|NCT02671851|Analgesics|analgesics|mesh-ancestor
65229162|NCT02671851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65229163|NCT02671851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65229164|NCT02671851|Anesthetics, General|anesthetics, general|mesh-ancestor
65229165|NCT02671851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65229166|NCT02671851|Antipyretics|antipyretics|mesh-ancestor
65229167|NCT02671851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65229168|NCT02671851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65229169|NCT02671851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65229170|NCT02135419|Fluorouracil|fluorouracil|mesh-list
65229171|NCT02135419|Imiquimod|imiquimod|mesh-list
65229172|NCT02135419|Antimetabolites|antimetabolites|mesh-ancestor
65229173|NCT02135419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229174|NCT02135419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65229175|NCT02135419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229176|NCT02135419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65229177|NCT02135419|Immunologic Factors|immunologic factors|mesh-ancestor
65229178|NCT02135419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229179|NCT02135419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65229180|NCT02135419|Interferon Inducers|interferon inducers|mesh-ancestor
65229181|NCT04177095|Sirolimus|sirolimus|mesh-list
65229182|NCT04177095|Prednisone|prednisone|mesh-list
65229183|NCT04177095|Everolimus|everolimus|mesh-list
65229184|NCT04177095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65229185|NCT04177095|Glucocorticoids|glucocorticoids|mesh-ancestor
65229186|NCT04177095|Hormones|hormones|mesh-ancestor
65229187|NCT04177095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65229188|NCT04177095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229189|NCT04177095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65229190|NCT04177095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942562|NCT04711668|Analgesics|analgesics|mesh-ancestor
65229200|NCT02671695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65229201|NCT02671695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229202|NCT02671695|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65229203|NCT02671695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343436|NCT02544724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65343437|NCT02544724|Growth Substances|growth substances|mesh-ancestor
65343438|NCT02544724|Growth Inhibitors|growth inhibitors|mesh-ancestor
65343439|NCT02544724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343440|NCT00862420|Ticlopidine|ticlopidine|mesh-list
64948692|NCT03387787|Insulin|insulin|mesh-list
65229204|NCT02671695|Vasodilator Agents|vasodilator agents|mesh-ancestor
65229205|NCT00644631|Sildenafil Citrate|sildenafil citrate|mesh-list
65229206|NCT00644631|Vasodilator Agents|vasodilator agents|mesh-ancestor
65229207|NCT00644631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65229208|NCT00644631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65229209|NCT00644631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229210|NCT00644631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229211|NCT00644631|Urological Agents|urological agents|mesh-ancestor
65229212|NCT02671383|Lopinavir|lopinavir|mesh-list
65229213|NCT02671383|Darunavir|darunavir|mesh-list
65229214|NCT02671383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65229215|NCT02671383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65229216|NCT02671383|Protease Inhibitors|protease inhibitors|mesh-ancestor
65229217|NCT02671383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229218|NCT02671383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229219|NCT02671383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65229220|NCT02671383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65229221|NCT02671383|Antiviral Agents|antiviral agents|mesh-ancestor
65229222|NCT02671383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65229223|NCT02671383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65229224|NCT02671383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64871944|NCT01849094|Milrinone|milrinone|mesh-list
65229226|NCT00738751|Panobinostat|panobinostat|mesh-list
65229227|NCT00738751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65229228|NCT00738751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229229|NCT00738751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65229230|NCT00738751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229231|NCT00738751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229232|NCT05243823|Estradiol|estradiol|mesh-list
65229233|NCT05243823|Estrogens|estrogens|mesh-ancestor
65229234|NCT05243823|Hormones|hormones|mesh-ancestor
65229235|NCT05243823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65229236|NCT05243823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229237|NCT00736801|Fluticasone|fluticasone|mesh-list
65229238|NCT00736801|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65229239|NCT00736801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65229240|NCT00736801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65229241|NCT00736801|Autonomic Agents|autonomic agents|mesh-ancestor
65229242|NCT00736801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229243|NCT00736801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229244|NCT00736801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65229245|NCT00736801|Respiratory System Agents|respiratory system agents|mesh-ancestor
65229246|NCT00736801|Dermatologic Agents|dermatologic agents|mesh-ancestor
65229247|NCT00736801|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65229248|NCT00736801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65229249|NCT00736801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65229250|NCT00736801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65229251|NCT00736801|Adrenergic Agents|adrenergic agents|mesh-ancestor
65229252|NCT00736801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65229253|NCT00736801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229254|NCT00738829|Rituximab|rituximab|mesh-list
65229256|NCT00738829|Fludarabine phosphate|fludarabine phosphate|mesh-list
65229257|NCT00738829|Lenalidomide|lenalidomide|mesh-list
65229275|NCT02671227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229276|NCT02671227|Sensory System Agents|sensory system agents|mesh-ancestor
65229277|NCT02671227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229278|NCT00644709|Atorvastatin|atorvastatin|mesh-list
65229279|NCT00644709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65229280|NCT00644709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65229281|NCT00644709|Antimetabolites|antimetabolites|mesh-ancestor
65229282|NCT00644709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229283|NCT00644709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65229284|NCT00644709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65343441|NCT00862420|Clopidogrel|clopidogrel|mesh-list
65343442|NCT00862420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65343443|NCT00862420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65343444|NCT00862420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65343446|NCT00862420|Purinergic Agents|purinergic agents|mesh-ancestor
65229285|NCT00644709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229286|NCT00738985|Simvastatin|simvastatin|mesh-list
65229287|NCT00738985|Ezetimibe|ezetimibe|mesh-list
65229288|NCT00738985|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
65229289|NCT00738985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65229290|NCT00738985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65229291|NCT00738985|Antimetabolites|antimetabolites|mesh-ancestor
65229292|NCT00738985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229293|NCT00738985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65229294|NCT00738985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65229295|NCT00738985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229296|NCT05216211|Bupivacaine|bupivacaine|mesh-list
65229297|NCT05216211|Anesthetics, Local|anesthetics, local|mesh-ancestor
65229298|NCT05216211|Anesthetics|anesthetics|mesh-ancestor
65229299|NCT05216211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65229300|NCT05216211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229301|NCT05216211|Sensory System Agents|sensory system agents|mesh-ancestor
65229302|NCT05216211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229303|NCT00732121|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65229304|NCT00732121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65229305|NCT00732121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229306|NCT00732121|Incretins|incretins|mesh-ancestor
65229308|NCT00732121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65229309|NCT00732121|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65229310|NCT00732121|Protease Inhibitors|protease inhibitors|mesh-ancestor
65229311|NCT00732121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229312|NCT00732121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229313|NCT02537223|Cisplatin|cisplatin|mesh-list
65229331|NCT02668497|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65229332|NCT02668497|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65229333|NCT02668497|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65229334|NCT02668497|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65229335|NCT02668497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65229336|NCT02668497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229337|NCT02668497|Cholinergic Agents|cholinergic agents|mesh-ancestor
65229338|NCT02668497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65229339|NCT02668497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229340|NCT02668497|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65229341|NCT02668497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229342|NCT00737113|Hormones|hormones|mesh-list
65229343|NCT00737113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65229344|NCT00737113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229345|NCT00737191|Olanzapine|olanzapine|mesh-list
65229346|NCT00737191|Antiemetics|antiemetics|mesh-ancestor
65229347|NCT00737191|Autonomic Agents|autonomic agents|mesh-ancestor
65229348|NCT00737191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229349|NCT00737191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229350|NCT00737191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65229351|NCT00737191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65229352|NCT00737191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65229353|NCT00737191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65229354|NCT00737191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65229355|NCT00737191|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65229356|NCT00737191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65229357|NCT00737191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65229358|NCT00737191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229359|NCT00737191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65229360|NCT00737191|Serotonin Agents|serotonin agents|mesh-ancestor
65229361|NCT04175067|Antioxidants|antioxidants|mesh-list
65229362|NCT04175067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229363|NCT04175067|Protective Agents|protective agents|mesh-ancestor
65229364|NCT04175067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343447|NCT00862420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65343448|NCT00862420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343449|NCT00862420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343450|NCT00862420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65343451|NCT00862420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64725330|NCT00002059|Antiviral Agents|antiviral agents|mesh-ancestor
65229365|NCT00758602|Mycophenolic Acid|mycophenolic acid|mesh-list
65229366|NCT00758602|Tacrolimus|tacrolimus|mesh-list
65229367|NCT00758602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65229368|NCT00758602|Immunologic Factors|immunologic factors|mesh-ancestor
65229377|NCT00758602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65229378|NCT00758602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65229380|NCT00713323|Analgesics|analgesics|mesh-ancestor
65229381|NCT00713323|Sensory System Agents|sensory system agents|mesh-ancestor
65229382|NCT00713323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229383|NCT00713323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229384|NCT02667561|Methyltestosterone|methyltestosterone|mesh-list
65229385|NCT02667561|Testosterone|testosterone|mesh-list
65229386|NCT02667561|Testosterone undecanoate|testosterone undecanoate|mesh-list
65229387|NCT02667561|Testosterone enanthate|testosterone enanthate|mesh-list
65229388|NCT02667561|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65229389|NCT02667561|Androgens|androgens|mesh-ancestor
65229390|NCT02667561|Hormones|hormones|mesh-ancestor
65229391|NCT02667561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65229392|NCT02667561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229393|NCT02667561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65229394|NCT02667561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229395|NCT02667561|Anabolic Agents|anabolic agents|mesh-ancestor
65229396|NCT00732511|Metoprolol|metoprolol|mesh-list
65229397|NCT00732511|Carvedilol|carvedilol|mesh-list
65229398|NCT00732511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65229399|NCT00732511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65229400|NCT00732511|Sympatholytics|sympatholytics|mesh-ancestor
65229401|NCT00732511|Autonomic Agents|autonomic agents|mesh-ancestor
65229402|NCT00732511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229403|NCT00732511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229404|NCT00732511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65229405|NCT00732511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65229406|NCT00732511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65229407|NCT00732511|Adrenergic Agents|adrenergic agents|mesh-ancestor
65229408|NCT00732511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65229409|NCT00732511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229410|NCT00732511|Antioxidants|antioxidants|mesh-ancestor
65229411|NCT00732511|Protective Agents|protective agents|mesh-ancestor
65229412|NCT00732511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65229413|NCT00732511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65229414|NCT00732511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65229415|NCT00732511|Vasodilator Agents|vasodilator agents|mesh-ancestor
65229416|NCT00732511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65229417|NCT00732511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65229418|NCT00739531|Nitric Oxide|nitric oxide|mesh-list
65229419|NCT00739531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65229420|NCT00739531|Autonomic Agents|autonomic agents|mesh-ancestor
65229421|NCT00739531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229422|NCT00739531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229423|NCT00739531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65229424|NCT00739531|Respiratory System Agents|respiratory system agents|mesh-ancestor
65229425|NCT00739531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65229426|NCT00739531|Antioxidants|antioxidants|mesh-ancestor
65229427|NCT00739531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229428|NCT00739531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65229429|NCT00739531|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65229430|NCT00739531|Vasodilator Agents|vasodilator agents|mesh-ancestor
65229431|NCT00739531|Gasotransmitters|gasotransmitters|mesh-ancestor
65229432|NCT00739531|Protective Agents|protective agents|mesh-ancestor
65229433|NCT00739609|Tryptophan|tryptophan|mesh-list
65229455|NCT00711529|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65229456|NCT00711529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65343452|NCT00862420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65343453|NCT00862420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65343454|NCT00862420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343455|NCT00321698|Docetaxel|docetaxel|mesh-list
65343456|NCT00321698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343457|NCT00321698|Tubulin Modulators|tubulin modulators|mesh-ancestor
65343458|NCT00321698|Antimitotic Agents|antimitotic agents|mesh-ancestor
65229457|NCT00711529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229458|NCT00711529|Antimanic Agents|antimanic agents|mesh-ancestor
65229459|NCT00732589|Lidocaine|lidocaine|mesh-list
65229460|NCT00732589|Anesthetics, Local|anesthetics, local|mesh-ancestor
65229461|NCT00732589|Anesthetics|anesthetics|mesh-ancestor
65229462|NCT00732589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65229463|NCT00732589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229464|NCT00732589|Sensory System Agents|sensory system agents|mesh-ancestor
65229465|NCT00732589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229466|NCT00732589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65229467|NCT00732589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65229468|NCT00732589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65229469|NCT00732589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65229470|NCT00732589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229471|NCT00645879|Citric Acid|citric acid|mesh-list
65229472|NCT00645879|Sodium Citrate|sodium citrate|mesh-list
65229473|NCT00645879|Anticoagulants|anticoagulants|mesh-ancestor
65229474|NCT00645879|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65229475|NCT00645879|Chelating Agents|chelating agents|mesh-ancestor
65229476|NCT00645879|Sequestering Agents|sequestering agents|mesh-ancestor
65229477|NCT00645879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229478|NCT00737659|Mycophenolic Acid|mycophenolic acid|mesh-list
65229479|NCT00737659|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65229480|NCT00737659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229481|NCT00737659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65229482|NCT00737659|Antitubercular Agents|antitubercular agents|mesh-ancestor
65229483|NCT00737659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65229484|NCT00737659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65229485|NCT00737659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229496|NCT02666703|Autonomic Agents|autonomic agents|mesh-ancestor
65229497|NCT02666703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229498|NCT02666703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229499|NCT02666703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65229500|NCT02666703|Glucocorticoids|glucocorticoids|mesh-ancestor
65229502|NCT02666703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65229503|NCT02666703|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65229504|NCT02666703|Protective Agents|protective agents|mesh-ancestor
65229505|NCT02666703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65229506|NCT02666703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229507|NCT05560009|Levodopa|levodopa|mesh-list
65229508|NCT05560009|Fluorides|fluorides|mesh-list
65229509|NCT05560009|Cariostatic Agents|cariostatic agents|mesh-ancestor
65229510|NCT05560009|Protective Agents|protective agents|mesh-ancestor
65229511|NCT05560009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229512|NCT05560009|Dopamine Agents|dopamine agents|mesh-ancestor
65229513|NCT05560009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65229514|NCT05560009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229515|NCT05560009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65229516|NCT05560009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65229517|NCT04174131|Lidocaine|lidocaine|mesh-list
65229518|NCT04174131|Hyaluronic Acid|hyaluronic acid|mesh-list
65229519|NCT04174131|Anesthetics, Local|anesthetics, local|mesh-ancestor
65229520|NCT04174131|Anesthetics|anesthetics|mesh-ancestor
65229521|NCT04174131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65229522|NCT04174131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229523|NCT04174131|Sensory System Agents|sensory system agents|mesh-ancestor
65229524|NCT04174131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229525|NCT04174131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65229526|NCT04174131|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65229527|NCT04174131|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65343459|NCT00321698|Mitosis Modulators|mitosis modulators|mesh-ancestor
65343460|NCT00321698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343461|NCT02569970|Fluoxetine|fluoxetine|mesh-list
65343462|NCT02569970|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64725344|NCT00002395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229528|NCT04174131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65229529|NCT04174131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229530|NCT04174131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65229531|NCT04174131|Immunologic Factors|immunologic factors|mesh-ancestor
65229532|NCT04174131|Viscosupplements|viscosupplements|mesh-ancestor
65229533|NCT04174131|Protective Agents|protective agents|mesh-ancestor
65229534|NCT00646035|Ergocalciferols|ergocalciferols|mesh-list
65229535|NCT00646035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65229536|NCT00646035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229537|NCT00646035|Vitamins|vitamins|mesh-ancestor
65229538|NCT00646035|Micronutrients|micronutrients|mesh-ancestor
65229539|NCT00646035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65229540|NCT00646191|Adalimumab|adalimumab|mesh-list
65229541|NCT00646191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65229542|NCT00646191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65229543|NCT02666157|Rivaroxaban|rivaroxaban|mesh-list
65229544|NCT02666157|Apixaban|apixaban|mesh-list
65229545|NCT02666157|Dabigatran|dabigatran|mesh-list
65229546|NCT02666157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65229547|NCT02666157|Antithrombins|antithrombins|mesh-ancestor
65229548|NCT02666157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65229549|NCT02666157|Protease Inhibitors|protease inhibitors|mesh-ancestor
65229550|NCT02666157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942921|NCT00032292|Visilizumab|visilizumab|mesh-list
65229563|NCT02666001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65229564|NCT02666001|Antitussive Agents|antitussive agents|mesh-ancestor
65229565|NCT02666001|Respiratory System Agents|respiratory system agents|mesh-ancestor
65229566|NCT02666001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65229567|NCT02666001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65229568|NCT02666001|Antiviral Agents|antiviral agents|mesh-ancestor
65229569|NCT02666001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65229570|NCT02666001|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65229571|NCT02666001|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65229572|NCT02666001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229573|NCT02665845|Mesalamine|mesalamine|mesh-list
65229574|NCT02665845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65229575|NCT02665845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65229576|NCT02665845|Analgesics|analgesics|mesh-ancestor
65229577|NCT02665845|Sensory System Agents|sensory system agents|mesh-ancestor
65229578|NCT02665845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229579|NCT02665845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229580|NCT02665845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65229581|NCT02665845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65229582|NCT00646425|Basiliximab|basiliximab|mesh-list
65229583|NCT00646425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65229584|NCT00646425|Immunologic Factors|immunologic factors|mesh-ancestor
65229585|NCT00646425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229586|NCT04837209|Niraparib|niraparib|mesh-list
65229587|NCT04837209|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65229588|NCT04837209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229589|NCT04837209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229590|NCT04837209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229591|NCT02665533|Dexamethasone|dexamethasone|mesh-list
65229592|NCT02665533|Dexamethasone acetate|dexamethasone acetate|mesh-list
65229593|NCT02665533|Diclofenac|diclofenac|mesh-list
65229594|NCT02665533|Codeine|codeine|mesh-list
65229595|NCT02665533|BB 1101|bb 1101|mesh-list
64872318|NCT01851941|Vitamins|vitamins|mesh-ancestor
65229596|NCT02665533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65229597|NCT02665533|Antiemetics|antiemetics|mesh-ancestor
65229598|NCT02665533|Autonomic Agents|autonomic agents|mesh-ancestor
65229599|NCT02665533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229600|NCT02665533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229601|NCT02665533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65229602|NCT02665533|Glucocorticoids|glucocorticoids|mesh-ancestor
65229603|NCT02665533|Hormones|hormones|mesh-ancestor
65229604|NCT02665533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65343463|NCT02569970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65343464|NCT02569970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65343465|NCT02569970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343466|NCT02569970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65343467|NCT02569970|Serotonin Agents|serotonin agents|mesh-ancestor
65229605|NCT02665533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65229606|NCT02665533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229607|NCT02665533|Protease Inhibitors|protease inhibitors|mesh-ancestor
65229608|NCT02665533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229609|NCT02665533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229610|NCT02665533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65229611|NCT02665533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65229612|NCT02665533|Analgesics|analgesics|mesh-ancestor
65229613|NCT02665533|Sensory System Agents|sensory system agents|mesh-ancestor
65229614|NCT02665533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65229615|NCT02665533|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65229626|NCT00646503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229629|NCT04173039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229630|NCT00646659|Carboplatin|carboplatin|mesh-list
65229631|NCT00646659|Docetaxel|docetaxel|mesh-list
65229632|NCT00646659|Fluorouracil|fluorouracil|mesh-list
65229633|NCT00646659|Cetuximab|cetuximab|mesh-list
65229634|NCT00646659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229635|NCT00646659|Tubulin Modulators|tubulin modulators|mesh-ancestor
65229636|NCT00646659|Antimitotic Agents|antimitotic agents|mesh-ancestor
65229637|NCT00646659|Mitosis Modulators|mitosis modulators|mesh-ancestor
65229638|NCT00646659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229639|NCT00646659|Antimetabolites|antimetabolites|mesh-ancestor
65229640|NCT00646659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65229641|NCT00646659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65229642|NCT00646659|Immunologic Factors|immunologic factors|mesh-ancestor
65229643|NCT00646659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229644|NCT00646659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65229645|NCT00648531|Balsalazide|balsalazide|mesh-list
65229646|NCT00648531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65229647|NCT00648531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65229648|NCT00648531|Analgesics|analgesics|mesh-ancestor
65229649|NCT00648531|Sensory System Agents|sensory system agents|mesh-ancestor
65229650|NCT00648531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229651|NCT00648531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229652|NCT00648531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65229653|NCT00648531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65229654|NCT00648531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65229655|NCT00648765|Anagrelide|anagrelide|mesh-list
65229656|NCT00648765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65229657|NCT00648765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65229658|NCT00648765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229659|NCT00648765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65229660|NCT00648843|Oxybutynin|oxybutynin|mesh-list
65229661|NCT00648843|Parasympatholytics|parasympatholytics|mesh-ancestor
65229662|NCT00648843|Autonomic Agents|autonomic agents|mesh-ancestor
65229663|NCT00648843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229664|NCT00648843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229665|NCT00648843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65229666|NCT00648843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65229667|NCT00648843|Cholinergic Agents|cholinergic agents|mesh-ancestor
65229668|NCT00648843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65229669|NCT00648843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229670|NCT00648843|Urological Agents|urological agents|mesh-ancestor
65229671|NCT02662959|Irinotecan|irinotecan|mesh-list
65229672|NCT02662959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65229673|NCT02662959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65229674|NCT02662959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229675|NCT02662959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229676|NCT02662959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229677|NCT02662647|Cytarabine|cytarabine|mesh-list
65229678|NCT02662647|Decitabine|decitabine|mesh-list
65229679|NCT02662647|Aclacinomycins|aclacinomycins|mesh-list
65343468|NCT02569970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343469|NCT02569970|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65343470|NCT02569970|Antidepressive Agents|antidepressive agents|mesh-ancestor
65343471|NCT02569970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65343472|NCT02569970|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65343473|NCT02569970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65343474|NCT02569970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343475|NCT00725790|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65343476|NCT00725790|Vasodilator Agents|vasodilator agents|mesh-ancestor
65343477|NCT00725790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65343478|NCT00725790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65343479|NCT00725790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343480|NCT00725790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343481|NCT00725790|Urological Agents|urological agents|mesh-ancestor
65343482|NCT00731276|Irinotecan|irinotecan|mesh-list
65343483|NCT00731276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65343484|NCT00731276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65343485|NCT00731276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343486|NCT00731276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343487|NCT00731276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343488|NCT00725946|Iodine|iodine|mesh-list
65229680|NCT02662647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65229681|NCT02662647|Antimetabolites|antimetabolites|mesh-ancestor
65229710|NCT00648921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229711|NCT00648921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65229712|NCT00648921|Serotonin Agents|serotonin agents|mesh-ancestor
65229713|NCT02662491|Calcium, Dietary|calcium, dietary|mesh-list
65229715|NCT02662491|Ergocalciferols|ergocalciferols|mesh-list
65229716|NCT02662491|Cholecalciferol|cholecalciferol|mesh-list
65229717|NCT02662491|Vitamins|vitamins|mesh-list
65229718|NCT02662491|Calcium|calcium|mesh-list
65229719|NCT02662491|Micronutrients|micronutrients|mesh-ancestor
65229720|NCT02662491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229721|NCT02662491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65229722|NCT02662491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65229723|NCT00648999|Ritonavir|ritonavir|mesh-list
65229724|NCT00648999|Lopinavir|lopinavir|mesh-list
65229725|NCT00648999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65229726|NCT00648999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65229736|NCT02661711|Aflibercept|aflibercept|mesh-list
65229737|NCT02661711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65229738|NCT02661711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65229739|NCT02661711|Growth Substances|growth substances|mesh-ancestor
65229740|NCT02661711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229741|NCT02661711|Growth Inhibitors|growth inhibitors|mesh-ancestor
65229742|NCT02661711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229743|NCT02661789|Goserelin|goserelin|mesh-list
65229744|NCT02661789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65229745|NCT02661789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229746|NCT02661477|Interferons|interferons|mesh-list
65229747|NCT02661477|Interferon-alpha|interferon-alpha|mesh-list
65229748|NCT02661477|Interferon alpha-2|interferon alpha-2|mesh-list
65229749|NCT02661477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343489|NCT00725946|Cadexomer iodine|cadexomer iodine|mesh-list
65343490|NCT00725946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65343491|NCT00725946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65343492|NCT00725946|Trace Elements|trace elements|mesh-ancestor
65343493|NCT00725946|Micronutrients|micronutrients|mesh-ancestor
65343494|NCT00725946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343495|NCT02569346|Triumeq|triumeq|mesh-list
65343496|NCT02569346|Lamivudine|lamivudine|mesh-list
65229750|NCT02661477|Antiviral Agents|antiviral agents|mesh-ancestor
65229751|NCT02661477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65229752|NCT02661477|Immunologic Factors|immunologic factors|mesh-ancestor
65229753|NCT02661477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229754|NCT00649077|Meloxicam|meloxicam|mesh-list
65229755|NCT00649077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65229756|NCT00649077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65229757|NCT00649077|Analgesics|analgesics|mesh-ancestor
65229758|NCT00649077|Sensory System Agents|sensory system agents|mesh-ancestor
65229759|NCT00649077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229760|NCT00649077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229761|NCT00649077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65229762|NCT00649077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65229763|NCT00649077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65229764|NCT00649077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65229765|NCT00649077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229766|NCT00649077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229767|NCT02656251|Ethanol|ethanol|mesh-list
65229768|NCT02656251|Chlorhexidine|chlorhexidine|mesh-list
65229769|NCT02656251|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65229770|NCT02656251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65229771|NCT02656251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65229772|NCT02656251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65229773|NCT02656251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229774|NCT02656251|Disinfectants|disinfectants|mesh-ancestor
65229775|NCT02656251|Dermatologic Agents|dermatologic agents|mesh-ancestor
65229776|NCT02656095|Heparin|heparin|mesh-list
65229778|NCT02656095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65229779|NCT02656095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65229780|NCT02656095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229781|NCT00649935|Azithromycin|azithromycin|mesh-list
65229782|NCT00649935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65229783|NCT00649935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65229784|NCT02655705|Cyclosporine|cyclosporine|mesh-list
65229785|NCT02655705|Methotrexate|methotrexate|mesh-list
65229786|NCT02655705|Cyclosporins|cyclosporins|mesh-list
65229787|NCT02655705|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65229788|NCT02655705|Abortifacient Agents|abortifacient agents|mesh-ancestor
65229789|NCT02655705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65229790|NCT02655705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229791|NCT02655705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65229792|NCT02655705|Antimetabolites|antimetabolites|mesh-ancestor
64943159|NCT00033813|Oxatomide|oxatomide|mesh-list
65229805|NCT02655471|Zidovudine|zidovudine|mesh-list
65229806|NCT02655471|Raltegravir Potassium|raltegravir potassium|mesh-list
65229807|NCT02655471|Antimetabolites|antimetabolites|mesh-ancestor
65229808|NCT02655471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229809|NCT02655471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65229810|NCT02655471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65229811|NCT02655471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229812|NCT02655471|Antiviral Agents|antiviral agents|mesh-ancestor
65229813|NCT02655471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65229814|NCT02655471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65229815|NCT02655471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65229816|NCT02655471|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65229817|NCT02655471|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65229818|NCT00650013|Midodrine|midodrine|mesh-list
65229819|NCT00650013|Sympathomimetics|sympathomimetics|mesh-ancestor
65229820|NCT00650013|Autonomic Agents|autonomic agents|mesh-ancestor
65229821|NCT00650013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229822|NCT00650013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343497|NCT02569346|Abacavir|abacavir|mesh-list
65343498|NCT02569346|Dolutegravir|dolutegravir|mesh-list
65343499|NCT02569346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65343500|NCT02569346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64725387|NCT00002419|Efavirenz|efavirenz|mesh-list
65229823|NCT00650013|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65229824|NCT00650013|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65229825|NCT00650013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65229826|NCT00650013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65229827|NCT00650013|Adrenergic Agents|adrenergic agents|mesh-ancestor
65229828|NCT00650013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65229829|NCT00650013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229830|NCT00712933|Belimumab|belimumab|mesh-list
65229831|NCT00712933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65229832|NCT00712933|Immunologic Factors|immunologic factors|mesh-ancestor
65229833|NCT00712933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229834|NCT02654847|Norepinephrine|norepinephrine|mesh-list
65229835|NCT02654847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65229836|NCT02654847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65229837|NCT02654847|Adrenergic Agents|adrenergic agents|mesh-ancestor
65229838|NCT02654847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65229839|NCT02654847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229840|NCT02654847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229841|NCT02654847|Sympathomimetics|sympathomimetics|mesh-ancestor
65229842|NCT02654847|Autonomic Agents|autonomic agents|mesh-ancestor
65229843|NCT02654847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229844|NCT02654847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65229845|NCT02536209|Oxycodone|oxycodone|mesh-list
65229846|NCT02536209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65229847|NCT02536209|Narcotics|narcotics|mesh-ancestor
65229848|NCT02536209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65229849|NCT02536209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229850|NCT02536209|Analgesics|analgesics|mesh-ancestor
65229851|NCT02536209|Sensory System Agents|sensory system agents|mesh-ancestor
65229852|NCT02536209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229854|NCT00732745|Oxaliplatin|oxaliplatin|mesh-list
65229855|NCT00732745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943226|NCT00034086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65229869|NCT04341129|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
65229872|NCT04341129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229873|NCT00712543|Lactulose|lactulose|mesh-list
65229874|NCT00712543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65229875|NCT00650169|Clopidogrel|clopidogrel|mesh-list
65229876|NCT00650169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65229877|NCT00650169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65229878|NCT00650169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65229879|NCT00650169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65229880|NCT00650169|Purinergic Agents|purinergic agents|mesh-ancestor
65229881|NCT00650169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65229882|NCT00650169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229883|NCT00650169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229884|NCT04064125|Minocycline|minocycline|mesh-list
65229885|NCT04064125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65229886|NCT04064125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65229887|NCT00740389|Etravirine|etravirine|mesh-list
65229888|NCT00740389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65229889|NCT00740389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65229890|NCT00740389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229891|NCT00740389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229892|NCT00740389|Antiviral Agents|antiviral agents|mesh-ancestor
65229893|NCT00740389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65229894|NCT00740467|Cyclosporine|cyclosporine|mesh-list
65229895|NCT00740467|Mycophenolic Acid|mycophenolic acid|mesh-list
65229896|NCT00740467|Cyclophosphamide|cyclophosphamide|mesh-list
65229897|NCT00740467|Busulfan|busulfan|mesh-list
65229898|NCT00740467|Fludarabine|fludarabine|mesh-list
65229899|NCT00740467|Fludarabine phosphate|fludarabine phosphate|mesh-list
65229900|NCT00740467|Cyclosporins|cyclosporins|mesh-list
65229901|NCT00740467|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65229902|NCT00740467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65229903|NCT00740467|Immunologic Factors|immunologic factors|mesh-ancestor
65229904|NCT00740467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343501|NCT02569346|Antiviral Agents|antiviral agents|mesh-ancestor
65343502|NCT02569346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65343503|NCT02569346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65343504|NCT02569346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65343505|NCT02569346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725389|NCT00002419|Adefovir|adefovir|mesh-list
65229905|NCT00740467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65229906|NCT00740467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65229907|NCT00740467|Alkylating Agents|alkylating agents|mesh-ancestor
65229908|NCT00740467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229909|NCT00740467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229910|NCT00740467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65229911|NCT00740467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65229912|NCT00740467|Antimetabolites|antimetabolites|mesh-ancestor
65229913|NCT00740467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229914|NCT00740467|Antifungal Agents|antifungal agents|mesh-ancestor
65229915|NCT00740467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65229928|NCT02653833|Vasodilator Agents|vasodilator agents|mesh-ancestor
65229929|NCT02653833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65229930|NCT02653833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65229931|NCT02653833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229932|NCT02653833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229933|NCT02653833|Urological Agents|urological agents|mesh-ancestor
65229934|NCT00733057|Minocycline|minocycline|mesh-list
65229935|NCT00733057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65229936|NCT00733057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65229937|NCT00737971|Triamcinolone|triamcinolone|mesh-list
65229938|NCT00737971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65229939|NCT00737971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65229940|NCT00737971|Bevacizumab|bevacizumab|mesh-list
65229941|NCT00737971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65229942|NCT00737971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65229943|NCT00737971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229944|NCT00737971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65229945|NCT00737971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65229946|NCT00737971|Growth Substances|growth substances|mesh-ancestor
65229947|NCT00737971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229948|NCT00737971|Growth Inhibitors|growth inhibitors|mesh-ancestor
65229949|NCT00737971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65229950|NCT00737971|Glucocorticoids|glucocorticoids|mesh-ancestor
65229951|NCT00737971|Hormones|hormones|mesh-ancestor
65229952|NCT00737971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65229953|NCT00737971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65229954|NCT00737971|Immunologic Factors|immunologic factors|mesh-ancestor
65229955|NCT00737971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229956|NCT00737971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229957|NCT00650247|Sumatriptan|sumatriptan|mesh-list
65229958|NCT00650247|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65229959|NCT00650247|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65229960|NCT00650247|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65229961|NCT00650247|Serotonin Agents|serotonin agents|mesh-ancestor
65229962|NCT00650247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65229963|NCT00650247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229964|NCT00650247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229965|NCT02568709|Oxytocin|oxytocin|mesh-list
65229966|NCT02568709|Oxytocics|oxytocics|mesh-ancestor
65229967|NCT02568709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65229968|NCT02568709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229969|NCT04316169|Hydroxychloroquine|hydroxychloroquine|mesh-list
65229970|NCT04316169|Letrozole|letrozole|mesh-list
65229971|NCT04316169|Fulvestrant|fulvestrant|mesh-list
65229972|NCT04316169|Anastrozole|anastrozole|mesh-list
65229973|NCT04316169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229974|NCT04316169|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65229975|NCT04316169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65229976|NCT04316169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229977|NCT04316169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229978|NCT04316169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65229986|NCT04316169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65343506|NCT02569346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343507|NCT02569346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65343508|NCT02569346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65343509|NCT00726804|Adalimumab|adalimumab|mesh-list
65343510|NCT00726804|Etanercept|etanercept|mesh-list
65343511|NCT00726804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65343512|NCT00726804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65343513|NCT00726804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65343514|NCT00726804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65343515|NCT00726804|Analgesics|analgesics|mesh-ancestor
65343516|NCT00726804|Sensory System Agents|sensory system agents|mesh-ancestor
65093310|NCT00491582|Hormones|hormones|mesh-list
65343517|NCT00726804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65343518|NCT00726804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343519|NCT00726804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65343520|NCT00726804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65343521|NCT00726804|Immunologic Factors|immunologic factors|mesh-ancestor
65343522|NCT00726960|Buprenorphine|buprenorphine|mesh-list
65343523|NCT00726960|Aprepitant|aprepitant|mesh-list
65343524|NCT00726960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65229987|NCT04316169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65229988|NCT04316169|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65229990|NCT02653209|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65229991|NCT02653209|Canagliflozin|canagliflozin|mesh-list
65229992|NCT02653209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65229993|NCT02653209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229994|NCT02653209|Incretins|incretins|mesh-ancestor
65229995|NCT02653209|Hormones|hormones|mesh-ancestor
65229996|NCT02653209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65229997|NCT02653209|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65229998|NCT02653209|Protease Inhibitors|protease inhibitors|mesh-ancestor
65229999|NCT02653209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230000|NCT02653209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230001|NCT02653209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65230003|NCT00733525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65230004|NCT00733525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65230005|NCT00733525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65230006|NCT00733525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230007|NCT00733525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65230008|NCT00733525|Serotonin Agents|serotonin agents|mesh-ancestor
65230009|NCT00733525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230010|NCT00733525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65230011|NCT00733525|Antidepressive Agents|antidepressive agents|mesh-ancestor
65230012|NCT00733525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65230013|NCT00733525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65230014|NCT00733525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65230015|NCT00733525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230016|NCT02653131|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65230017|NCT02653131|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65230018|NCT02653131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65230019|NCT02653131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230020|NCT02653131|Incretins|incretins|mesh-ancestor
65230021|NCT02653131|Hormones|hormones|mesh-ancestor
65230022|NCT02653131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65343525|NCT00726960|Narcotics|narcotics|mesh-ancestor
65343526|NCT00726960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65343527|NCT00726960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343528|NCT00726960|Analgesics|analgesics|mesh-ancestor
65343529|NCT00726960|Sensory System Agents|sensory system agents|mesh-ancestor
65343530|NCT00726960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64725414|NCT00381511|Tinzaparin|tinzaparin|mesh-list
65230023|NCT02653131|Protease Inhibitors|protease inhibitors|mesh-ancestor
65230024|NCT02653131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230025|NCT02653131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230026|NCT02652585|Naltrexone|naltrexone|mesh-list
65230027|NCT02652585|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65230028|NCT02652585|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65230029|NCT02652585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230030|NCT02652585|Sensory System Agents|sensory system agents|mesh-ancestor
65230031|NCT02652585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65230032|NCT00741169|Rifampin|rifampin|mesh-list
65230033|NCT00741169|Simeprevir|simeprevir|mesh-list
65230034|NCT00741169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65230035|NCT00741169|Antitubercular Agents|antitubercular agents|mesh-ancestor
65230036|NCT00741169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65230037|NCT00741169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65230038|NCT00741169|Leprostatic Agents|leprostatic agents|mesh-ancestor
65230039|NCT00741169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65230040|NCT00741169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230041|NCT00741169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230042|NCT00741169|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65230043|NCT00741169|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65230055|NCT00741325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65230056|NCT00741325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65230057|NCT00741325|Antiviral Agents|antiviral agents|mesh-ancestor
65230058|NCT00741325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65230059|NCT02652741|Enalapril|enalapril|mesh-list
65230060|NCT02652741|Enalaprilat|enalaprilat|mesh-list
65230061|NCT02652741|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65230062|NCT02652741|Protease Inhibitors|protease inhibitors|mesh-ancestor
65230063|NCT02652741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230064|NCT02652741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230065|NCT02652741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65230066|NCT02652507|Dexmedetomidine|dexmedetomidine|mesh-list
65230067|NCT02652507|Ketamine|ketamine|mesh-list
65230068|NCT02652507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65230069|NCT02652507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65230070|NCT02652507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230071|NCT02652507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65230072|NCT02652507|Analgesics|analgesics|mesh-ancestor
65230073|NCT02652507|Sensory System Agents|sensory system agents|mesh-ancestor
65230074|NCT02652507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65230075|NCT02652507|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65230076|NCT02652507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65230077|NCT02652507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65230078|NCT02652507|Adrenergic Agents|adrenergic agents|mesh-ancestor
65230079|NCT02652507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65230080|NCT02652507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230081|NCT02652507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65230082|NCT02652507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65230083|NCT02652507|Anesthetics, General|anesthetics, general|mesh-ancestor
65230084|NCT02652507|Anesthetics|anesthetics|mesh-ancestor
65230085|NCT02652507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65230086|NCT02652507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65230088|NCT05742295|Vitamins|vitamins|mesh-ancestor
65230089|NCT05742295|Micronutrients|micronutrients|mesh-ancestor
65230090|NCT05742295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230091|NCT05742295|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65230092|NCT05742295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65230093|NCT05742295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230094|NCT05742295|Hemostatics|hemostatics|mesh-ancestor
65230095|NCT05742295|Coagulants|coagulants|mesh-ancestor
65343531|NCT00726960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65343532|NCT00726960|Antiemetics|antiemetics|mesh-ancestor
65343533|NCT00726960|Autonomic Agents|autonomic agents|mesh-ancestor
65343534|NCT00726960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65343535|NCT00726960|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65343536|NCT00726960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65343537|NCT00726960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343538|NCT00727038|Ranibizumab|ranibizumab|mesh-list
65343539|NCT00727038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65343540|NCT00727038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65343541|NCT00727038|Growth Substances|growth substances|mesh-ancestor
65343542|NCT00727038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230096|NCT02652273|Abatacept|abatacept|mesh-list
65230097|NCT02652273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65230098|NCT02652273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230099|NCT02652273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230100|NCT02652273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65230101|NCT02652273|Immunologic Factors|immunologic factors|mesh-ancestor
65230102|NCT02652273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230103|NCT02652273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65230104|NCT00650325|Sertraline|sertraline|mesh-list
65230105|NCT00650325|Antidepressive Agents|antidepressive agents|mesh-ancestor
65230106|NCT00650325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65230107|NCT00650325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65230108|NCT00650325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65230122|NCT00650403|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65230123|NCT00650403|Antidepressive Agents|antidepressive agents|mesh-ancestor
65230124|NCT00650403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65230125|NCT00650403|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65230126|NCT00650403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65230127|NCT00650403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230128|NCT02568319|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65230129|NCT02568319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65230130|NCT02568319|Autonomic Agents|autonomic agents|mesh-ancestor
65230131|NCT02568319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65230132|NCT02568319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230133|NCT02568319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65230134|NCT02568319|Respiratory System Agents|respiratory system agents|mesh-ancestor
65230135|NCT02568319|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65230136|NCT02568319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65230137|NCT02568319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65230138|NCT02568319|Adrenergic Agents|adrenergic agents|mesh-ancestor
65230139|NCT02568319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65230140|NCT02568319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230141|NCT00920803|Resveratrol|resveratrol|mesh-list
65230142|NCT00920803|Antioxidants|antioxidants|mesh-ancestor
65230143|NCT00920803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230144|NCT00920803|Protective Agents|protective agents|mesh-ancestor
65230145|NCT00920803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230146|NCT00920803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230147|NCT00920803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65230148|NCT03912363|Insulin|insulin|mesh-list
65230149|NCT03912363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65230150|NCT03912363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230151|NCT05740969|Fluorouracil|fluorouracil|mesh-list
65230152|NCT05740969|Imiquimod|imiquimod|mesh-list
65230153|NCT05740969|Melatonin|melatonin|mesh-list
65230154|NCT05740969|Antimetabolites|antimetabolites|mesh-ancestor
65230155|NCT05740969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230156|NCT05740969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65230157|NCT05740969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230158|NCT05740969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65343543|NCT00727038|Growth Inhibitors|growth inhibitors|mesh-ancestor
65343544|NCT00727038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343545|NCT00726258|Ketamine|ketamine|mesh-list
65343546|NCT00726258|Analgesics|analgesics|mesh-ancestor
65343547|NCT00726258|Sensory System Agents|sensory system agents|mesh-ancestor
65343548|NCT00726258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65343549|NCT00726258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230159|NCT05740969|Immunologic Factors|immunologic factors|mesh-ancestor
65230160|NCT05740969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230161|NCT05740969|Antioxidants|antioxidants|mesh-ancestor
65230162|NCT05740969|Protective Agents|protective agents|mesh-ancestor
65230163|NCT05740969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65230164|NCT05740969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65230165|NCT05740969|Interferon Inducers|interferon inducers|mesh-ancestor
65230166|NCT02568241|Interferons|interferons|mesh-list
65230167|NCT02568241|Interferon-alpha|interferon-alpha|mesh-list
65230180|NCT05551897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230181|NCT05551897|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65230182|NCT05551897|Hormone Antagonists|hormone antagonists|mesh-ancestor
65230183|NCT05551897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65230184|NCT05551897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230185|NCT05551897|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65230186|NCT02647671|Calcium Carbonate|calcium carbonate|mesh-list
65230187|NCT02647671|Calcium|calcium|mesh-list
65230188|NCT02647671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65230189|NCT02647671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230190|NCT02647671|Antacids|antacids|mesh-ancestor
65230191|NCT02647671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230192|NCT02647671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65230193|NCT04578613|Rituximab|rituximab|mesh-list
65230194|NCT04578613|Chlorambucil|chlorambucil|mesh-list
65230195|NCT04578613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65230196|NCT04578613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230197|NCT04578613|Immunologic Factors|immunologic factors|mesh-ancestor
65230198|NCT04578613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230199|NCT04578613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65230200|NCT04578613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65230201|NCT04578613|Alkylating Agents|alkylating agents|mesh-ancestor
65230202|NCT04578613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230203|NCT02647515|Ranibizumab|ranibizumab|mesh-list
65230204|NCT02647515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65230205|NCT02647515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65230206|NCT02647515|Growth Substances|growth substances|mesh-ancestor
65230207|NCT02647515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230208|NCT02647515|Growth Inhibitors|growth inhibitors|mesh-ancestor
65230209|NCT02647515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230210|NCT03818763|Factor VIII|factor viii|mesh-list
65230211|NCT03818763|Coagulants|coagulants|mesh-ancestor
65230212|NCT02647047|Acetaminophen|acetaminophen|mesh-list
65230213|NCT02647047|Ketorolac|ketorolac|mesh-list
65230214|NCT02647047|Sufentanil|sufentanil|mesh-list
65230215|NCT02647047|Ropivacaine|ropivacaine|mesh-list
65230216|NCT02647047|Anesthetics, Local|anesthetics, local|mesh-ancestor
65230217|NCT02647047|Anesthetics|anesthetics|mesh-ancestor
65230218|NCT02647047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65230219|NCT02647047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230220|NCT02647047|Sensory System Agents|sensory system agents|mesh-ancestor
65230221|NCT02647047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65230222|NCT02647047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65230223|NCT02647047|Analgesics|analgesics|mesh-ancestor
65230224|NCT02647047|Antipyretics|antipyretics|mesh-ancestor
65230225|NCT02647047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65230226|NCT02647047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65230227|NCT02647047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65230228|NCT02647047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65230229|NCT02647047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943589|NCT01805726|Analgesics|analgesics|mesh-ancestor
65230250|NCT00651651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65230251|NCT00651651|Adrenergic Agents|adrenergic agents|mesh-ancestor
65343550|NCT00726258|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65343551|NCT00726258|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65343552|NCT00726258|Anesthetics, General|anesthetics, general|mesh-ancestor
65343553|NCT00726258|Anesthetics|anesthetics|mesh-ancestor
64725438|NCT00002077|Fluconazole|fluconazole|mesh-list
65230252|NCT00651651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65230253|NCT00651651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230254|NCT00709111|Maraviroc|maraviroc|mesh-list
65230255|NCT00709111|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65230256|NCT00709111|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65230257|NCT00709111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230258|NCT00709111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65230259|NCT00709111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65230260|NCT00709111|Antiviral Agents|antiviral agents|mesh-ancestor
65230261|NCT00709111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65230262|NCT00709111|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65230263|NCT00651729|Botulinum Toxins|botulinum toxins|mesh-list
65230264|NCT00651729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65230265|NCT00651729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65230266|NCT00651729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64872998|NCT01856517|Clonidine|clonidine|mesh-list
65230267|NCT00651729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65230268|NCT00651729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230269|NCT00651729|Cholinergic Agents|cholinergic agents|mesh-ancestor
65230270|NCT00651729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65230271|NCT00651729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230272|NCT00651729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65230273|NCT00651729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65230274|NCT02646735|Fulvestrant|fulvestrant|mesh-list
65230275|NCT02646735|Exemestane|exemestane|mesh-list
65230276|NCT02646735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65230277|NCT02646735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230278|NCT02646735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65230279|NCT02646735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65230280|NCT02646735|Hormone Antagonists|hormone antagonists|mesh-ancestor
65230281|NCT02646735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65230293|NCT05741905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65230294|NCT05741905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65230295|NCT05741905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230296|NCT05741905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230297|NCT05741905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230298|NCT05741905|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65230299|NCT05741905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65230300|NCT02646501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
65230302|NCT02646657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65230303|NCT00652041|Thalidomide|thalidomide|mesh-list
65230304|NCT00652041|Bortezomib|bortezomib|mesh-list
65230305|NCT00652041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230306|NCT00652041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65230307|NCT00652041|Immunologic Factors|immunologic factors|mesh-ancestor
65230308|NCT00652041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230309|NCT00652041|Leprostatic Agents|leprostatic agents|mesh-ancestor
65230310|NCT00652041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65230311|NCT00652041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65230312|NCT00652041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65230313|NCT00652041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65230314|NCT00652041|Growth Substances|growth substances|mesh-ancestor
65230315|NCT00652041|Growth Inhibitors|growth inhibitors|mesh-ancestor
65230316|NCT02646111|Ribavirin|ribavirin|mesh-list
65230317|NCT02646111|Antimetabolites|antimetabolites|mesh-ancestor
65230318|NCT02646111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230319|NCT02646111|Antiviral Agents|antiviral agents|mesh-ancestor
65230320|NCT02646111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65230321|NCT00652119|Paclitaxel|paclitaxel|mesh-list
65230322|NCT00652119|Bevacizumab|bevacizumab|mesh-list
65230323|NCT00652119|Carboplatin|carboplatin|mesh-list
65230324|NCT00652119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65230325|NCT00652119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230326|NCT00652119|Tubulin Modulators|tubulin modulators|mesh-ancestor
65230327|NCT00652119|Antimitotic Agents|antimitotic agents|mesh-ancestor
65343554|NCT00726258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65343555|NCT00726258|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65343556|NCT00726258|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65343557|NCT00726258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65343558|NCT00726258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343559|NCT02950766|Ipilimumab|ipilimumab|mesh-list
64949887|NCT00021359|Hormones|hormones|mesh-ancestor
65230328|NCT00652119|Mitosis Modulators|mitosis modulators|mesh-ancestor
65230329|NCT00652119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230330|NCT00652119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65230331|NCT00652119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65230332|NCT00652119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65230333|NCT00652119|Growth Substances|growth substances|mesh-ancestor
65230334|NCT00652119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230335|NCT00652119|Growth Inhibitors|growth inhibitors|mesh-ancestor
65230336|NCT05740657|Fentanyl|fentanyl|mesh-list
65230337|NCT05740657|Sufentanil|sufentanil|mesh-list
65230338|NCT05740657|Morphine|morphine|mesh-list
65230339|NCT05740657|Remifentanil|remifentanil|mesh-list
65230340|NCT05740657|Oxycodone|oxycodone|mesh-list
65230341|NCT05740657|Hydromorphone|hydromorphone|mesh-list
65230342|NCT05740657|Alfentanil|alfentanil|mesh-list
64873105|NCT01857011|Iron|iron|mesh-list
65230359|NCT02646267|Protease Inhibitors|protease inhibitors|mesh-ancestor
65230360|NCT02646267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230361|NCT02646267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230362|NCT02646189|Interferons|interferons|mesh-list
65230363|NCT02646189|Interferon-alpha|interferon-alpha|mesh-list
65230364|NCT02646189|Interferon alpha-2|interferon alpha-2|mesh-list
65230365|NCT02646189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65230366|NCT02646189|REP 2139|rep 2139|mesh-list
65230367|NCT02646189|Thymalfasin|thymalfasin|mesh-list
65230368|NCT02646189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230369|NCT02646189|Antiviral Agents|antiviral agents|mesh-ancestor
65230370|NCT02646189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65230371|NCT02646189|Immunologic Factors|immunologic factors|mesh-ancestor
65230372|NCT02646189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230373|NCT02646189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65230386|NCT02645565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65230387|NCT02645565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65230388|NCT02645565|Prednisolone|prednisolone|mesh-list
65230389|NCT02645565|Prednisolone acetate|prednisolone acetate|mesh-list
65230390|NCT02645565|Cyclophosphamide|cyclophosphamide|mesh-list
65230391|NCT02645565|Azathioprine|azathioprine|mesh-list
65230392|NCT02645565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65230393|NCT02645565|Prednisolone phosphate|prednisolone phosphate|mesh-list
65230394|NCT02645565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65230395|NCT02645565|Immunologic Factors|immunologic factors|mesh-ancestor
65230396|NCT02645565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230397|NCT02645565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65230398|NCT02645565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65230399|NCT02645565|Alkylating Agents|alkylating agents|mesh-ancestor
65230400|NCT02645565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230401|NCT02645565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230402|NCT02645565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65230403|NCT02645565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65230404|NCT02645565|Antiemetics|antiemetics|mesh-ancestor
65230405|NCT02645565|Autonomic Agents|autonomic agents|mesh-ancestor
65230406|NCT02645565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65230407|NCT02645565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65230408|NCT02645565|Glucocorticoids|glucocorticoids|mesh-ancestor
65230409|NCT02645565|Hormones|hormones|mesh-ancestor
65230410|NCT02645565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65230411|NCT02645565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65230412|NCT02645565|Protective Agents|protective agents|mesh-ancestor
65230413|NCT02645565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65230414|NCT02645565|Antimetabolites|antimetabolites|mesh-ancestor
65230415|NCT02645565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65230416|NCT05460871|Pregabalin|pregabalin|mesh-list
65230417|NCT05460871|Analgesics|analgesics|mesh-ancestor
65343560|NCT02950766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65343561|NCT02950766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343562|NCT02950766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65343563|NCT02950766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343564|NCT02569814|Amlodipine|amlodipine|mesh-list
64464727|NCT01893658|Omalizumab|omalizumab|mesh-list
65230418|NCT05460871|Sensory System Agents|sensory system agents|mesh-ancestor
65230429|NCT05460871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65230430|NCT00699907|Flutamide|flutamide|mesh-list
65230431|NCT00699907|Androgen Antagonists|androgen antagonists|mesh-ancestor
65230432|NCT00699907|Hormone Antagonists|hormone antagonists|mesh-ancestor
65230433|NCT00699907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65230434|NCT00699907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230435|NCT00699907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65230436|NCT00699907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230437|NCT00599313|Sunitinib|sunitinib|mesh-list
65230438|NCT00599313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230439|NCT00599313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65230440|NCT00599313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65230441|NCT00599313|Growth Substances|growth substances|mesh-ancestor
65230442|NCT00599313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230443|NCT00599313|Growth Inhibitors|growth inhibitors|mesh-ancestor
65230444|NCT00599313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65230445|NCT00599313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230446|NCT00599313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230448|NCT03159897|Bleomycin|bleomycin|mesh-list
65230449|NCT03159897|Dacarbazine|dacarbazine|mesh-list
65230450|NCT03159897|Vinblastine|vinblastine|mesh-list
65230451|NCT03159897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65230452|NCT03159897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230453|NCT03159897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65230454|NCT03159897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65230455|NCT03159897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230456|NCT03159897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230457|NCT03159897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65230458|NCT03159897|Alkylating Agents|alkylating agents|mesh-ancestor
65230459|NCT03159897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65230460|NCT03159897|Tubulin Modulators|tubulin modulators|mesh-ancestor
65230461|NCT03159897|Antimitotic Agents|antimitotic agents|mesh-ancestor
65230462|NCT03159897|Mitosis Modulators|mitosis modulators|mesh-ancestor
65230463|NCT00708175|Pioglitazone|pioglitazone|mesh-list
65230464|NCT00708175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65230465|NCT00708175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230466|NCT05740345|Metformin|metformin|mesh-list
65230467|NCT05740345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65230468|NCT05740345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230469|NCT02641431|Ajmaline|ajmaline|mesh-list
65230470|NCT02641431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65230471|NCT02641431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65230472|NCT02641431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65230473|NCT02641431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65230474|NCT02641431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230475|NCT02567149|Cidofovir|cidofovir|mesh-list
65230476|NCT02567149|Antiviral Agents|antiviral agents|mesh-ancestor
65230477|NCT02567149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65230478|NCT02567149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230479|NCT02567149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230480|NCT00707239|Imipenem|imipenem|mesh-list
65230481|NCT00707239|Tigecycline|tigecycline|mesh-list
65230482|NCT00707239|Cilastatin|cilastatin|mesh-list
65230488|NCT00707239|Protease Inhibitors|protease inhibitors|mesh-ancestor
65230490|NCT00968708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65230491|NCT00968708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230492|NCT00968708|Incretins|incretins|mesh-ancestor
65230493|NCT00968708|Hormones|hormones|mesh-ancestor
64873223|NCT01857596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230494|NCT00968708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65230495|NCT00968708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65230496|NCT00968708|Protease Inhibitors|protease inhibitors|mesh-ancestor
65343565|NCT02569814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65343566|NCT02569814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65343567|NCT02569814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65343568|NCT02569814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65343569|NCT02569814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343570|NCT02569814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65343571|NCT02569814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343572|NCT02569814|Vasodilator Agents|vasodilator agents|mesh-ancestor
65230497|NCT00968708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230498|NCT00968708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230499|NCT05417269|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65230500|NCT05417269|Dermatologic Agents|dermatologic agents|mesh-ancestor
65230501|NCT05417269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65230502|NCT05417269|Immunologic Factors|immunologic factors|mesh-ancestor
65230503|NCT05417269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230504|NCT05079841|Oxytocin|oxytocin|mesh-list
65230505|NCT05079841|Oxytocics|oxytocics|mesh-ancestor
65230506|NCT05079841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65230507|NCT05079841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230508|NCT04062565|Treprostinil|treprostinil|mesh-list
65230509|NCT04062565|Riociguat|riociguat|mesh-list
65230510|NCT04062565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65230511|NCT04062565|Enzyme Activators|enzyme activators|mesh-ancestor
65230512|NCT04062565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230513|NCT00967694|Nitrous Oxide|nitrous oxide|mesh-list
65230514|NCT00967694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65230515|NCT00967694|Anesthetics, General|anesthetics, general|mesh-ancestor
65230516|NCT00967694|Anesthetics|anesthetics|mesh-ancestor
65230517|NCT00967694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65230518|NCT00967694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230519|NCT00967694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65230520|NCT00967694|Analgesics|analgesics|mesh-ancestor
65230521|NCT00967694|Sensory System Agents|sensory system agents|mesh-ancestor
65230522|NCT00967694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65230524|NCT04288700|Propranolol|propranolol|mesh-list
65230525|NCT04288700|Captopril|captopril|mesh-list
65230526|NCT04288700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65230527|NCT04288700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65230528|NCT04288700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230529|NCT04288700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230530|NCT04288700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65230531|NCT04288700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65230532|NCT04288700|Adrenergic Agents|adrenergic agents|mesh-ancestor
65230533|NCT04288700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65230534|NCT04288700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230535|NCT04288700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65230536|NCT04288700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65230537|NCT04288700|Vasodilator Agents|vasodilator agents|mesh-ancestor
65230538|NCT04288700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65230539|NCT04288700|Protease Inhibitors|protease inhibitors|mesh-ancestor
65230540|NCT02863406|Dimercaprol|dimercaprol|mesh-list
65230541|NCT02863406|Chelating Agents|chelating agents|mesh-ancestor
65230542|NCT02863406|Sequestering Agents|sequestering agents|mesh-ancestor
65230543|NCT02863406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230544|NCT03664232|JNJ-42165279|jnj-42165279|mesh-list
65230545|NCT03664232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230546|NCT03664232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230547|NCT00629720|Alfuzosin|alfuzosin|mesh-list
65230561|NCT00967616|Antimetabolites|antimetabolites|mesh-ancestor
65230562|NCT00967616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230563|NCT00967616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65230564|NCT00967616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230565|NCT00967616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65230566|NCT00967616|Immunologic Factors|immunologic factors|mesh-ancestor
65230567|NCT00967616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343573|NCT02569814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65343574|NCT02569814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65343575|NCT02569814|Antimetabolites|antimetabolites|mesh-ancestor
65343576|NCT02569814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65343577|NCT02569814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65343578|NCT02569814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230568|NCT00967616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65230569|NCT00967616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65230570|NCT00967616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230571|NCT00967616|Antidotes|antidotes|mesh-ancestor
65230572|NCT00967616|Protective Agents|protective agents|mesh-ancestor
65230573|NCT00967616|Vitamin B Complex|vitamin b complex|mesh-ancestor
65230574|NCT00967616|Vitamins|vitamins|mesh-ancestor
65230575|NCT00967616|Micronutrients|micronutrients|mesh-ancestor
65230576|NCT04288232|Aflibercept|aflibercept|mesh-list
65230577|NCT04288232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65230578|NCT04288232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65230579|NCT04288232|Growth Substances|growth substances|mesh-ancestor
65230580|NCT04288232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230581|NCT04288232|Growth Inhibitors|growth inhibitors|mesh-ancestor
65230582|NCT04288232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230583|NCT02864264|Interferons|interferons|mesh-list
65230584|NCT02864264|Interferon-gamma|interferon-gamma|mesh-list
65230585|NCT02864264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230586|NCT02864264|Antiviral Agents|antiviral agents|mesh-ancestor
65230587|NCT02864264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65230588|NCT03107793|Ustekinumab|ustekinumab|mesh-list
65230589|NCT03107793|Dermatologic Agents|dermatologic agents|mesh-ancestor
65230590|NCT02640417|Vitamin B Complex|vitamin b complex|mesh-list
65230591|NCT02640417|Vitamins|vitamins|mesh-ancestor
65230592|NCT02640417|Micronutrients|micronutrients|mesh-ancestor
65230593|NCT02640417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230594|NCT02640495|Artesunate|artesunate|mesh-list
65230595|NCT02640495|Antimalarials|antimalarials|mesh-ancestor
65230596|NCT02640495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65230597|NCT02640495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65230598|NCT02640495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65230599|NCT02640495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230600|NCT02640495|Antiviral Agents|antiviral agents|mesh-ancestor
65230601|NCT02640495|Schistosomicides|schistosomicides|mesh-ancestor
65230602|NCT02640495|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65230603|NCT02640495|Anthelmintics|anthelmintics|mesh-ancestor
65230604|NCT00653757|Leuprolide|leuprolide|mesh-list
65230605|NCT00653757|Goserelin|goserelin|mesh-list
65230606|NCT00653757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65230607|NCT00653757|Fertility Agents|fertility agents|mesh-ancestor
65230608|NCT00653757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65230609|NCT00653757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230610|NCT00653757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65230611|NCT00653757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230612|NCT00654225|Atorvastatin|atorvastatin|mesh-list
65230613|NCT00654225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64943996|NCT01464671|Bivalirudin|bivalirudin|mesh-list
64943997|NCT01464671|Anticoagulants|anticoagulants|mesh-ancestor
65230618|NCT00654225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65230619|NCT00654225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65230620|NCT00654225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230621|NCT00974090|Glimepiride|glimepiride|mesh-list
65230622|NCT00974090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65230623|NCT00974090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65230624|NCT00974090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230625|NCT00974090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65230626|NCT00974090|Immunologic Factors|immunologic factors|mesh-ancestor
65230627|NCT00654303|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65230628|NCT00654303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65230629|NCT00654303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65230630|NCT00654303|Antimetabolites|antimetabolites|mesh-ancestor
65230631|NCT00654303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230632|NCT00654303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65230633|NCT00654303|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65230634|NCT00654303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230635|NCT02639091|Pemetrexed|pemetrexed|mesh-list
65343579|NCT00726570|Heparin|heparin|mesh-list
65343580|NCT00726570|Calcium heparin|calcium heparin|mesh-list
65343581|NCT00726570|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65343582|NCT00726570|Tinzaparin|tinzaparin|mesh-list
65343583|NCT00726570|Dalteparin|dalteparin|mesh-list
65343584|NCT00726570|Anticoagulants|anticoagulants|mesh-list
65343585|NCT00726570|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64950192|NCT00022178|Antimetabolites|antimetabolites|mesh-ancestor
65230636|NCT02639091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230637|NCT02639091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230638|NCT02639091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230639|NCT02639091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65230640|NCT02639091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65230641|NCT03909152|Anastrozole|anastrozole|mesh-list
65230642|NCT03909152|Onapristone|onapristone|mesh-list
65230643|NCT03909152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65230644|NCT03909152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230645|NCT03909152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65230646|NCT03909152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65230647|NCT03909152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230648|NCT03909152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230649|NCT03909152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65230650|NCT03909152|Hormone Antagonists|hormone antagonists|mesh-ancestor
65230651|NCT03909152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65230652|NCT03909152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230653|NCT03909152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65230654|NCT03909152|Fertility Agents|fertility agents|mesh-ancestor
65230655|NCT03909152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65230656|NCT00654459|Policosanol|policosanol|mesh-list
65230657|NCT00654459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65230658|NCT00654459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65230659|NCT00654459|Antimetabolites|antimetabolites|mesh-ancestor
65230660|NCT00654459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230661|NCT00654459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65230662|NCT00654459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65230663|NCT00654537|Atorvastatin|atorvastatin|mesh-list
65230664|NCT00654537|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65230665|NCT00654537|Simvastatin|simvastatin|mesh-list
65230666|NCT00654537|Pravastatin|pravastatin|mesh-list
65230667|NCT00654537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65230668|NCT00654537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65230669|NCT00654537|Antimetabolites|antimetabolites|mesh-ancestor
65230670|NCT00654537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230671|NCT00654537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64401042|NCT03067883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65230672|NCT00654537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65230673|NCT00654537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230674|NCT03887702|Tenofovir|tenofovir|mesh-list
65230675|NCT03887702|Entecavir|entecavir|mesh-list
65230676|NCT03887702|Antiviral Agents|antiviral agents|mesh-ancestor
64943998|NCT01464671|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65230697|NCT02638545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65230698|NCT02638545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65230699|NCT02638545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230700|NCT02638545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65230701|NCT02638545|Analgesics|analgesics|mesh-ancestor
65230702|NCT02638545|Sensory System Agents|sensory system agents|mesh-ancestor
65230703|NCT02638545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65230704|NCT02638545|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65230705|NCT02638545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65230706|NCT02638545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65230707|NCT02638545|Adrenergic Agents|adrenergic agents|mesh-ancestor
65230708|NCT02638545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65230709|NCT02638545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230710|NCT02638233|Sofosbuvir|sofosbuvir|mesh-list
65230711|NCT02638233|Ledipasvir|ledipasvir|mesh-list
65230712|NCT02638233|Antiviral Agents|antiviral agents|mesh-ancestor
65230713|NCT02638233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65230714|NCT04285268|Rituximab|rituximab|mesh-list
65343586|NCT00726570|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65343587|NCT00726570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343588|NCT00726726|Vitamin K|vitamin k|mesh-list
65343589|NCT00726726|Midazolam|midazolam|mesh-list
65343590|NCT00726726|Dextromethorphan|dextromethorphan|mesh-list
65343591|NCT00726726|Caffeine|caffeine|mesh-list
65343592|NCT00726726|Omeprazole|omeprazole|mesh-list
65343593|NCT00726726|Warfarin|warfarin|mesh-list
65343594|NCT00726726|Vitamins|vitamins|mesh-ancestor
65343595|NCT00726726|Micronutrients|micronutrients|mesh-ancestor
64725473|NCT02335424|Pembrolizumab|pembrolizumab|mesh-list
65230715|NCT04285268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65230716|NCT04285268|Bortezomib|bortezomib|mesh-list
65230717|NCT04285268|Venetoclax|venetoclax|mesh-list
65230718|NCT04285268|Antibodies|antibodies|mesh-list
65230719|NCT04285268|Immunoglobulins|immunoglobulins|mesh-list
65230720|NCT04285268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65230721|NCT04285268|Immunologic Factors|immunologic factors|mesh-ancestor
65230722|NCT04285268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230723|NCT04285268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230724|NCT04285268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65230725|NCT00699751|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65230726|NCT00699751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230727|NCT01842399|Resveratrol|resveratrol|mesh-list
65230728|NCT01842399|Antioxidants|antioxidants|mesh-ancestor
65230729|NCT01842399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230730|NCT01842399|Protective Agents|protective agents|mesh-ancestor
65230731|NCT01842399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944067|NCT00038259|Aldesleukin|aldesleukin|mesh-list
65230752|NCT02635893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65230753|NCT02635893|Renal Agents|renal agents|mesh-ancestor
65230754|NCT02635893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65230755|NCT02635893|Antitubercular Agents|antitubercular agents|mesh-ancestor
65230756|NCT02635893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65230757|NCT02635893|Antimetabolites|antimetabolites|mesh-ancestor
65230758|NCT02635893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230760|NCT05729503|Anesthetics, Local|anesthetics, local|mesh-ancestor
65230761|NCT05729503|Anesthetics|anesthetics|mesh-ancestor
65230762|NCT05729503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65230763|NCT05729503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230764|NCT05729503|Sensory System Agents|sensory system agents|mesh-ancestor
65230765|NCT05729503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65230766|NCT05729503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65230767|NCT05729503|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65230768|NCT05729503|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65230769|NCT05729503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65230770|NCT05729503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230771|NCT02567773|Itraconazole|itraconazole|mesh-list
65230772|NCT02567773|GSK2881078|gsk2881078|mesh-list
65230773|NCT02567773|Antifungal Agents|antifungal agents|mesh-ancestor
65230774|NCT02567773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65230775|NCT02567773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65230776|NCT02567773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65230777|NCT02567773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230778|NCT02567773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230779|NCT02567773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65230780|NCT02567773|Hormone Antagonists|hormone antagonists|mesh-ancestor
65230781|NCT02567773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65230782|NCT02567773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230792|NCT00967226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65230793|NCT00967226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230794|NCT00967226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65230796|NCT00967226|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65230797|NCT00967226|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65230798|NCT00967226|Adrenergic Agents|adrenergic agents|mesh-ancestor
65343596|NCT00726726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343597|NCT00726726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65343598|NCT00726726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65343599|NCT00726726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65343600|NCT00726726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65230799|NCT00967226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65230800|NCT00967226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230801|NCT00967226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65230802|NCT00967226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65230803|NCT00967226|Vasodilator Agents|vasodilator agents|mesh-ancestor
65230804|NCT00706381|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65230805|NCT00706381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65230806|NCT00706381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65230807|NCT00964886|Benztropine|benztropine|mesh-list
65230808|NCT00964886|Desipramine|desipramine|mesh-list
65230809|NCT00964886|Clomipramine|clomipramine|mesh-list
65230810|NCT00964886|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65230811|NCT00964886|Antidepressive Agents|antidepressive agents|mesh-ancestor
65230812|NCT00964886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65230813|NCT00964886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230814|NCT00964886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230815|NCT00964886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65230816|NCT00964886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65230817|NCT00964886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65230818|NCT00964886|Adrenergic Agents|adrenergic agents|mesh-ancestor
65230819|NCT00964886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65230820|NCT00964886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230821|NCT00964886|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65230822|NCT00964886|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65230823|NCT00964886|Parasympatholytics|parasympatholytics|mesh-ancestor
65230824|NCT00964886|Autonomic Agents|autonomic agents|mesh-ancestor
65230825|NCT00964886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65230826|NCT00964886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65230827|NCT00964886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65230828|NCT00964886|Cholinergic Agents|cholinergic agents|mesh-ancestor
65230829|NCT00964886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65230830|NCT00964886|Dopamine Agents|dopamine agents|mesh-ancestor
65230831|NCT00964886|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65230832|NCT00964886|Serotonin Agents|serotonin agents|mesh-ancestor
65230833|NCT02861222|Doxorubicin|doxorubicin|mesh-list
65230834|NCT02861222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65230835|NCT02861222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230836|NCT02861222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65230837|NCT02861222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65230838|NCT02861222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230839|NCT02861222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230840|NCT04062019|Aldesleukin|aldesleukin|mesh-list
65230841|NCT04062019|Interleukin-2|interleukin-2|mesh-list
65230842|NCT04062019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230843|NCT04062019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65230844|NCT04062019|Analgesics|analgesics|mesh-ancestor
65230845|NCT04062019|Sensory System Agents|sensory system agents|mesh-ancestor
65230846|NCT04062019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64944169|NCT00846950|GABA Agents|gaba agents|mesh-ancestor
65230865|NCT05332561|Trastuzumab|trastuzumab|mesh-list
65230866|NCT05332561|Pertuzumab|pertuzumab|mesh-list
65230867|NCT05332561|Atezolizumab|atezolizumab|mesh-list
65230868|NCT05332561|Olaparib|olaparib|mesh-list
65230869|NCT05332561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65230870|NCT05332561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230871|NCT05332561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65230872|NCT05332561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230873|NCT05332561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230874|NCT03630224|Plasma-lyte 148|plasma-lyte 148|mesh-list
65230875|NCT03630224|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65230876|NCT03630224|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65230877|NCT00705757|Bimatoprost|bimatoprost|mesh-list
65230878|NCT00705757|Travoprost|travoprost|mesh-list
65230879|NCT00705757|Latanoprost|latanoprost|mesh-list
65230880|NCT00705757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65230881|NCT00705757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65343601|NCT00726726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65343602|NCT00726726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65343603|NCT00726726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65343604|NCT00726726|Anesthetics, General|anesthetics, general|mesh-ancestor
65343605|NCT00726726|Anesthetics|anesthetics|mesh-ancestor
65343606|NCT00726726|GABA Modulators|gaba modulators|mesh-ancestor
65343607|NCT00726726|GABA Agents|gaba agents|mesh-ancestor
65343608|NCT00726726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65230882|NCT00705757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65230883|NCT04284644|Propofol|propofol|mesh-list
65230884|NCT04284644|Sevoflurane|sevoflurane|mesh-list
65230885|NCT04284644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65230886|NCT04284644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65230887|NCT04284644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230888|NCT04284644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65230889|NCT04284644|Anesthetics, General|anesthetics, general|mesh-ancestor
65230890|NCT04284644|Anesthetics|anesthetics|mesh-ancestor
65230891|NCT04284644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65230892|NCT04284644|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65230893|NCT05330143|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65230894|NCT05330143|Antiviral Agents|antiviral agents|mesh-ancestor
65230895|NCT05330143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65230896|NCT04284722|Metformin|metformin|mesh-list
65230897|NCT04284722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65230898|NCT04284722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230899|NCT04283240|Sildenafil Citrate|sildenafil citrate|mesh-list
65230900|NCT04283240|Vasodilator Agents|vasodilator agents|mesh-ancestor
65230901|NCT04283240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65230902|NCT04283240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65230903|NCT04283240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230904|NCT04283240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230917|NCT02862782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65230918|NCT02862782|Contraceptive Agents|contraceptive agents|mesh-ancestor
65230919|NCT02862782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65230920|NCT02862782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230921|NCT02862782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65230922|NCT02862782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65230923|NCT02862782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230924|NCT04283162|Calcium, Dietary|calcium, dietary|mesh-list
65230925|NCT04283162|Calcium Dobesilate|calcium dobesilate|mesh-list
65230927|NCT04283162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65230928|NCT04283162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230929|NCT04283162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65230930|NCT04283162|Hemostatics|hemostatics|mesh-ancestor
65230931|NCT04283162|Coagulants|coagulants|mesh-ancestor
65230932|NCT00758524|Eplerenone|eplerenone|mesh-list
65230933|NCT00758524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65230934|NCT00758524|Hormone Antagonists|hormone antagonists|mesh-ancestor
65230935|NCT00758524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65230936|NCT00758524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230937|NCT00758524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65230938|NCT00758524|Diuretics|diuretics|mesh-ancestor
65230939|NCT00758524|Natriuretic Agents|natriuretic agents|mesh-ancestor
65230940|NCT00758524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65230941|NCT02601196|Ulipristal acetate|ulipristal acetate|mesh-list
65230942|NCT02601196|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65230943|NCT02601196|Contraceptive Agents|contraceptive agents|mesh-ancestor
65230944|NCT02601196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65230945|NCT02601196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230946|NCT02601196|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65230947|NCT00757588|Insulin|insulin|mesh-list
65230948|NCT00757588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65230949|NCT00757588|Saxagliptin|saxagliptin|mesh-list
65230950|NCT00757588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65230951|NCT00757588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230952|NCT00757588|Incretins|incretins|mesh-ancestor
65230953|NCT00757588|Hormones|hormones|mesh-ancestor
65230954|NCT00757588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65343609|NCT00726726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343610|NCT00726726|Anticoagulants|anticoagulants|mesh-ancestor
65343611|NCT00726726|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65343612|NCT00726726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65343613|NCT00726726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343614|NCT00726726|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65343615|NCT00726726|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65343616|NCT00726726|Purinergic Agents|purinergic agents|mesh-ancestor
65343617|NCT00726726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65343618|NCT00726726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65343619|NCT00726726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65343620|NCT00726726|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65343621|NCT00726726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65343622|NCT00726726|Hemostatics|hemostatics|mesh-ancestor
65343623|NCT00726726|Coagulants|coagulants|mesh-ancestor
65343624|NCT00726726|Antitussive Agents|antitussive agents|mesh-ancestor
65230955|NCT00757588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65230956|NCT00757588|Protease Inhibitors|protease inhibitors|mesh-ancestor
65230957|NCT00757588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230958|NCT00757588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230959|NCT00917254|Enoxaparin|enoxaparin|mesh-list
65230960|NCT00917254|Anticoagulants|anticoagulants|mesh-ancestor
65230961|NCT00917254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65230962|NCT00917254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65230963|NCT00917254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230964|NCT02599792|Ivacaftor|ivacaftor|mesh-list
65230965|NCT02599792|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65230966|NCT02599792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65230967|NCT02599792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230968|NCT00705679|Tenofovir|tenofovir|mesh-list
65230969|NCT00705679|Emtricitabine|emtricitabine|mesh-list
65230983|NCT05695573|Cystatins|cystatins|mesh-list
65230984|NCT05695573|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65230985|NCT05695573|Protease Inhibitors|protease inhibitors|mesh-ancestor
65230986|NCT05695573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230987|NCT05695573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230988|NCT00916942|Lidocaine|lidocaine|mesh-list
65230989|NCT00916942|Prilocaine|prilocaine|mesh-list
65230990|NCT00916942|Capsaicin|capsaicin|mesh-list
65230991|NCT00916942|Anesthetics, Local|anesthetics, local|mesh-ancestor
65230992|NCT00916942|Anesthetics|anesthetics|mesh-ancestor
65230993|NCT00916942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65230994|NCT00916942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230995|NCT00916942|Sensory System Agents|sensory system agents|mesh-ancestor
65230996|NCT00916942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65230997|NCT00916942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65230998|NCT00916942|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65230999|NCT00916942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65231000|NCT00916942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65231001|NCT00916942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231002|NCT00916942|Antipruritics|antipruritics|mesh-ancestor
65231003|NCT00916942|Dermatologic Agents|dermatologic agents|mesh-ancestor
65231004|NCT00751114|Metformin|metformin|mesh-list
65231005|NCT00751114|Insulin Glargine|insulin glargine|mesh-list
65231006|NCT00751114|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65231007|NCT00751114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65231008|NCT00751114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231009|NCT00751114|Incretins|incretins|mesh-ancestor
65231010|NCT00751114|Hormones|hormones|mesh-ancestor
65343625|NCT00726726|Respiratory System Agents|respiratory system agents|mesh-ancestor
65343626|NCT00726726|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65343627|NCT00726726|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65343628|NCT02914938|Rituximab|rituximab|mesh-list
65343629|NCT02914938|Zanubrutinib|zanubrutinib|mesh-list
65343630|NCT02914938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64725512|NCT04329650|Siltuximab|siltuximab|mesh-list
65231011|NCT00751114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65231012|NCT00751114|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65231013|NCT00751114|Protease Inhibitors|protease inhibitors|mesh-ancestor
65231014|NCT00751114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231015|NCT00751114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231016|NCT00960440|Tofacitinib|tofacitinib|mesh-list
65231017|NCT00960440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65231018|NCT00960440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231019|NCT00960440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231020|NCT04092478|Anesthetics|anesthetics|mesh-list
65231021|NCT04092478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65231023|NCT02598466|Abatacept|abatacept|mesh-list
65231024|NCT02598466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65231025|NCT02598466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231026|NCT02598466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231027|NCT02598466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65231028|NCT02598466|Immunologic Factors|immunologic factors|mesh-ancestor
65231029|NCT02598466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231061|NCT00961298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231063|NCT00961298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231064|NCT00961298|Analgesics|analgesics|mesh-ancestor
65231065|NCT00961298|Sensory System Agents|sensory system agents|mesh-ancestor
65231066|NCT00961298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65231067|NCT00961298|Antidepressive Agents|antidepressive agents|mesh-ancestor
65231068|NCT00961298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64944419|NCT00276809|Hormones|hormones|mesh-ancestor
65231081|NCT00744328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231082|NCT00744328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65231083|NCT00744328|Serotonin Agents|serotonin agents|mesh-ancestor
65231084|NCT04019782|Hylan|hylan|mesh-list
65231085|NCT04019782|Viscosupplements|viscosupplements|mesh-ancestor
65231086|NCT04019782|Protective Agents|protective agents|mesh-ancestor
65231087|NCT04019782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231088|NCT02599480|Mirabegron|mirabegron|mesh-list
65231089|NCT02599480|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65231090|NCT02599480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65231091|NCT02599480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65231092|NCT02599480|Adrenergic Agents|adrenergic agents|mesh-ancestor
65231093|NCT02599480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65231094|NCT02599480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231095|NCT02599480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231096|NCT02599480|Urological Agents|urological agents|mesh-ancestor
65231097|NCT03245840|Budesonide|budesonide|mesh-list
65231098|NCT03245840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65231099|NCT03245840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65231100|NCT03245840|Autonomic Agents|autonomic agents|mesh-ancestor
65231101|NCT03245840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65231102|NCT03245840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231103|NCT03245840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65231104|NCT03245840|Respiratory System Agents|respiratory system agents|mesh-ancestor
65231105|NCT03245840|Glucocorticoids|glucocorticoids|mesh-ancestor
65231106|NCT03245840|Hormones|hormones|mesh-ancestor
65231107|NCT03245840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65231108|NCT04091698|Coenzyme Q10|coenzyme q10|mesh-list
65231109|NCT04091698|Ubiquinone|ubiquinone|mesh-list
65231110|NCT04091698|Vitamins|vitamins|mesh-ancestor
65231111|NCT04091698|Micronutrients|micronutrients|mesh-ancestor
65231112|NCT04091698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231113|NCT04281290|Bleomycin|bleomycin|mesh-list
65231114|NCT04281290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65343631|NCT02914938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343632|NCT02914938|Immunologic Factors|immunologic factors|mesh-ancestor
65343633|NCT02914938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343634|NCT02914938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65343635|NCT02914938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65343636|NCT02914938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343637|NCT02914938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343638|NCT00654381|Inositol|inositol|mesh-list
65231115|NCT04281290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231116|NCT04091932|Pembrolizumab|pembrolizumab|mesh-list
65231117|NCT04091932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65231118|NCT04091932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65231119|NCT04091932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231120|NCT04091932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231121|NCT00959894|Tenofovir|tenofovir|mesh-list
65231122|NCT00959894|Emtricitabine|emtricitabine|mesh-list
65231123|NCT00959894|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65231124|NCT00959894|Etravirine|etravirine|mesh-list
65231125|NCT00959894|Antiviral Agents|antiviral agents|mesh-ancestor
65231126|NCT00959894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65231127|NCT00959894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65231128|NCT00959894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65231129|NCT00959894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231130|NCT00959894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231131|NCT00959894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65231146|NCT02599168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65231147|NCT02599168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65231148|NCT02599168|Adrenergic Agents|adrenergic agents|mesh-ancestor
65231149|NCT02599168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65231150|NCT02599168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231151|NCT00746590|Tretazicar|tretazicar|mesh-list
65231152|NCT00746590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231153|NCT01032629|Canagliflozin|canagliflozin|mesh-list
65231154|NCT01032629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65231155|NCT01032629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231156|NCT01032629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65231157|NCT01032629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231158|NCT04205201|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65231159|NCT04205201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65231160|NCT04205201|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65231161|NCT04205201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65231162|NCT04205201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65231163|NCT04205201|Adrenergic Agents|adrenergic agents|mesh-ancestor
65231164|NCT04205201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65231165|NCT04205201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231166|NCT04205201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231167|NCT00749944|Varenicline|varenicline|mesh-list
65231168|NCT00749944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65231169|NCT00749944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65231170|NCT00749944|Cholinergic Agents|cholinergic agents|mesh-ancestor
65231171|NCT00749944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65231172|NCT00749944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231173|NCT00749944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231174|NCT02597140|Lidocaine|lidocaine|mesh-list
65231175|NCT02597140|Propofol|propofol|mesh-list
65231176|NCT02597140|Anesthetics, Local|anesthetics, local|mesh-ancestor
65231177|NCT02597140|Anesthetics|anesthetics|mesh-ancestor
65231178|NCT02597140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65231179|NCT02597140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231180|NCT02597140|Sensory System Agents|sensory system agents|mesh-ancestor
65231181|NCT02597140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65231182|NCT02597140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65231183|NCT02597140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65231184|NCT02597140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65343639|NCT00654381|Linagliptin|linagliptin|mesh-list
65343640|NCT00654381|Voglibose|voglibose|mesh-list
65343641|NCT00654381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65343642|NCT00654381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343643|NCT00654381|Incretins|incretins|mesh-ancestor
65343644|NCT00654381|Hormones|hormones|mesh-ancestor
65343645|NCT00654381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65343646|NCT00654381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65231185|NCT02597140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65231186|NCT02597140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231187|NCT02597140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65231188|NCT02597140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65231189|NCT02597140|Anesthetics, General|anesthetics, general|mesh-ancestor
65231190|NCT02598310|Paclitaxel|paclitaxel|mesh-list
65231191|NCT02598310|Trastuzumab|trastuzumab|mesh-list
65231206|NCT04091074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65231207|NCT04091074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231208|NCT04091074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231209|NCT00749398|Infliximab|infliximab|mesh-list
65231210|NCT00749398|Dermatologic Agents|dermatologic agents|mesh-ancestor
65231211|NCT00749398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65231212|NCT00749398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65231213|NCT01012973|Aflibercept|aflibercept|mesh-list
65231214|NCT01012973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65231215|NCT01012973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65231216|NCT01012973|Growth Substances|growth substances|mesh-ancestor
65231217|NCT01012973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231218|NCT01012973|Growth Inhibitors|growth inhibitors|mesh-ancestor
65231219|NCT01012973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231220|NCT03974464|Arginine Vasopressin|arginine vasopressin|mesh-list
65231221|NCT03974464|Hemostatics|hemostatics|mesh-ancestor
65231222|NCT03974464|Coagulants|coagulants|mesh-ancestor
65231223|NCT03974464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65231224|NCT03974464|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65231225|NCT03974464|Natriuretic Agents|natriuretic agents|mesh-ancestor
65231226|NCT03974464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231227|NCT00742924|Zoledronic Acid|zoledronic acid|mesh-list
65231228|NCT00742924|Leucovorin|leucovorin|mesh-list
65231229|NCT00742924|Cisplatin|cisplatin|mesh-list
65231230|NCT00742924|Doxorubicin|doxorubicin|mesh-list
65231231|NCT00742924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65231232|NCT00742924|Methotrexate|methotrexate|mesh-list
65231233|NCT00742924|Etoposide|etoposide|mesh-list
65231234|NCT00742924|Ifosfamide|ifosfamide|mesh-list
65231235|NCT00742924|Isophosphamide mustard|isophosphamide mustard|mesh-list
65231236|NCT00742924|Dexrazoxane|dexrazoxane|mesh-list
65231237|NCT00742924|Razoxane|razoxane|mesh-list
65231238|NCT00742924|Imidazole|imidazole|mesh-list
65231239|NCT00742924|Lenograstim|lenograstim|mesh-list
65231240|NCT00742924|Levoleucovorin|levoleucovorin|mesh-list
65231241|NCT00742924|Mesna|mesna|mesh-list
65231242|NCT00742924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231243|NCT00742924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65231244|NCT00742924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65231245|NCT00742924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65231246|NCT00742924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231247|NCT00742924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231248|NCT00742924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231249|NCT00742924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65231250|NCT00742924|Abortifacient Agents|abortifacient agents|mesh-ancestor
65231251|NCT00742924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65231252|NCT00742924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65231253|NCT00742924|Antimetabolites|antimetabolites|mesh-ancestor
65231254|NCT00742924|Dermatologic Agents|dermatologic agents|mesh-ancestor
65231255|NCT00742924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65231264|NCT00742924|Vitamins|vitamins|mesh-ancestor
65231265|NCT00742924|Micronutrients|micronutrients|mesh-ancestor
65231266|NCT00742924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65231267|NCT00742924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65231268|NCT00742924|Alkylating Agents|alkylating agents|mesh-ancestor
65231269|NCT00742924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65343647|NCT00654381|Protease Inhibitors|protease inhibitors|mesh-ancestor
65343648|NCT00654381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343649|NCT00654381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343650|NCT00654381|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65343651|NCT00654381|Vitamin B Complex|vitamin b complex|mesh-ancestor
65343652|NCT00654381|Vitamins|vitamins|mesh-ancestor
65343653|NCT00654381|Micronutrients|micronutrients|mesh-ancestor
65231270|NCT00742924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65231271|NCT00742924|Antimitotic Agents|antimitotic agents|mesh-ancestor
65231272|NCT00742924|Mitosis Modulators|mitosis modulators|mesh-ancestor
65231277|NCT02596984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231278|NCT00698815|Pemetrexed|pemetrexed|mesh-list
65231279|NCT00698815|Sunitinib|sunitinib|mesh-list
65231280|NCT00698815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231281|NCT00698815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231282|NCT00698815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231283|NCT00698815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65231284|NCT00698815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65231285|NCT00698815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65231286|NCT00698815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65231287|NCT00698815|Growth Substances|growth substances|mesh-ancestor
65231288|NCT00698815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231289|NCT00698815|Growth Inhibitors|growth inhibitors|mesh-ancestor
65231290|NCT00698815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65231291|NCT02599090|Temozolomide|temozolomide|mesh-list
65231292|NCT02599090|Sorafenib|sorafenib|mesh-list
65231293|NCT02599090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65231294|NCT02599090|Alkylating Agents|alkylating agents|mesh-ancestor
65231295|NCT02599090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231296|NCT02599090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231297|NCT02599090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65231298|NCT02599090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231299|NCT00745498|Bevacizumab|bevacizumab|mesh-list
65231300|NCT00745498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65231301|NCT00745498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231302|NCT00745498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65231303|NCT00745498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65231304|NCT00745498|Growth Substances|growth substances|mesh-ancestor
65231305|NCT00745498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231306|NCT00745498|Growth Inhibitors|growth inhibitors|mesh-ancestor
65231310|NCT02596828|Sirolimus|sirolimus|mesh-list
65231311|NCT02596828|Irinotecan|irinotecan|mesh-list
65231312|NCT02596828|Temozolomide|temozolomide|mesh-list
65231313|NCT02596828|Dasatinib|dasatinib|mesh-list
65231314|NCT02596828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65231315|NCT02596828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65231316|NCT02596828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231317|NCT02596828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231318|NCT02596828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231319|NCT02596828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65231320|NCT02596828|Alkylating Agents|alkylating agents|mesh-ancestor
65231321|NCT02596828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65231322|NCT02596828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65231323|NCT02596828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65231324|NCT02596828|Antifungal Agents|antifungal agents|mesh-ancestor
65231325|NCT02596828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65231326|NCT02596828|Immunologic Factors|immunologic factors|mesh-ancestor
65231327|NCT02596828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231328|NCT02596828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65231329|NCT03896815|INCB054329|incb054329|mesh-list
65231341|NCT05256901|Cholinergic Agents|cholinergic agents|mesh-ancestor
65231342|NCT05256901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65231343|NCT05256901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231344|NCT05256901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65231345|NCT05256901|Autonomic Agents|autonomic agents|mesh-ancestor
65231346|NCT05256901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65231347|NCT05256901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65231348|NCT05256901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65343654|NCT04018482|Povidone-Iodine|povidone-iodine|mesh-list
65343655|NCT04018482|Povidone|povidone|mesh-list
65343656|NCT04018482|Plasma Substitutes|plasma substitutes|mesh-ancestor
65343657|NCT04018482|Blood Substitutes|blood substitutes|mesh-ancestor
65343658|NCT04018482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65343659|NCT04018482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65343660|NCT00805311|Aspirin|aspirin|mesh-list
65343661|NCT00805311|Losartan|losartan|mesh-list
65343662|NCT00805311|Amlodipine|amlodipine|mesh-list
65343663|NCT00805311|Atorvastatin|atorvastatin|mesh-list
65343664|NCT00805311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65343665|NCT00805311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65093448|NCT00506298|Bezafibrate|bezafibrate|mesh-list
65343666|NCT00805311|Analgesics|analgesics|mesh-ancestor
65343667|NCT00805311|Sensory System Agents|sensory system agents|mesh-ancestor
65343668|NCT00805311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65343669|NCT00805311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343670|NCT00805311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65343671|NCT00805311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65343672|NCT00805311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65343673|NCT00805311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65343674|NCT00805311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343675|NCT00805311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65343676|NCT00805311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65343677|NCT00805311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343678|NCT00805311|Antipyretics|antipyretics|mesh-ancestor
65343679|NCT00805311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65343680|NCT00805311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65343681|NCT00805311|Antimetabolites|antimetabolites|mesh-ancestor
65231349|NCT05256901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65231350|NCT04827979|Daratumumab|daratumumab|mesh-list
65231351|NCT04827979|Abatacept|abatacept|mesh-list
65231352|NCT04827979|Immunoglobulins|immunoglobulins|mesh-list
65231353|NCT04827979|Immunoglobulin G|immunoglobulin g|mesh-list
65231354|NCT04827979|Immunologic Factors|immunologic factors|mesh-ancestor
65231355|NCT04827979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231356|NCT04827979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231357|NCT04827979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65231358|NCT04827979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231359|NCT04827979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65231360|NCT04827979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65231361|NCT02597998|BI 409306|bi 409306|mesh-list
65231362|NCT02597998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65231363|NCT02597998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231364|NCT02597998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231365|NCT02595658|Insulin, Short-Acting|insulin, short-acting|mesh-list
65231366|NCT02595658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65231367|NCT02595658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343682|NCT00805311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65343683|NCT00805311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65343684|NCT00805311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65343685|NCT00805311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65343686|NCT00805311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65343687|NCT00805311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65343688|NCT00805311|Vasodilator Agents|vasodilator agents|mesh-ancestor
65343689|NCT00805311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65343690|NCT00805311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64725556|NCT00002125|Foscarnet|foscarnet|mesh-list
65231368|NCT00576901|Bevacizumab|bevacizumab|mesh-list
65231369|NCT00576901|Docetaxel|docetaxel|mesh-list
65231370|NCT00576901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65231371|NCT00576901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231372|NCT00576901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65231373|NCT00576901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65231374|NCT00576901|Growth Substances|growth substances|mesh-ancestor
65231375|NCT00576901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231376|NCT00576901|Growth Inhibitors|growth inhibitors|mesh-ancestor
65231377|NCT00576901|Tubulin Modulators|tubulin modulators|mesh-ancestor
65231378|NCT00576901|Antimitotic Agents|antimitotic agents|mesh-ancestor
65231379|NCT00576901|Mitosis Modulators|mitosis modulators|mesh-ancestor
65231380|NCT00576901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231381|NCT00699283|Brivaracetam|brivaracetam|mesh-list
65231382|NCT00699283|Anticonvulsants|anticonvulsants|mesh-ancestor
65231383|NCT01023815|Cyclosporine|cyclosporine|mesh-list
65231384|NCT01023815|Everolimus|everolimus|mesh-list
65231385|NCT01023815|Cyclosporins|cyclosporins|mesh-list
65231386|NCT01023815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231387|NCT01023815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231388|NCT01023815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65231389|NCT01023815|Immunologic Factors|immunologic factors|mesh-ancestor
65231390|NCT01023815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231391|NCT01023815|Antifungal Agents|antifungal agents|mesh-ancestor
65231392|NCT01023815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65231393|NCT01023815|Dermatologic Agents|dermatologic agents|mesh-ancestor
65231394|NCT01023815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65231405|NCT01023659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65231407|NCT01023659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65231408|NCT01023659|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65231409|NCT01023659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65231410|NCT01023659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65231411|NCT01023659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231412|NCT01023659|Dopamine Agents|dopamine agents|mesh-ancestor
65231413|NCT01023659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65231414|NCT01023659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231415|NCT01023659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65231416|NCT01023659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65231417|NCT01023659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231418|NCT01023659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65231419|NCT01023659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65231420|NCT01023659|Cholinergic Agents|cholinergic agents|mesh-ancestor
65231421|NCT00740116|Tranexamic Acid|tranexamic acid|mesh-list
65231422|NCT00740116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65231423|NCT00740116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65231424|NCT00740116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231426|NCT00740116|Coagulants|coagulants|mesh-ancestor
65231427|NCT02567461|Aspirin|aspirin|mesh-list
65231428|NCT02567461|Edoxaban|edoxaban|mesh-list
65231429|NCT02567461|Clopidogrel|clopidogrel|mesh-list
65231430|NCT02567461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65231431|NCT02567461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65231432|NCT02567461|Analgesics|analgesics|mesh-ancestor
65343691|NCT00805311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65343692|NCT00732290|Fluoxetine|fluoxetine|mesh-list
65343693|NCT00732290|Clopidogrel|clopidogrel|mesh-list
65343694|NCT00732290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65343695|NCT00732290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65343696|NCT00732290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65343697|NCT00732290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65343698|NCT00732290|Purinergic Agents|purinergic agents|mesh-ancestor
65343699|NCT00732290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65343700|NCT00732290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343701|NCT00732290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343702|NCT00732290|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65343703|NCT00732290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65343704|NCT00732290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65231433|NCT02567461|Sensory System Agents|sensory system agents|mesh-ancestor
65231434|NCT02567461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65231435|NCT02567461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231436|NCT02567461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65231437|NCT02567461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65231438|NCT02567461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65231439|NCT02567461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65231440|NCT02567461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231441|NCT02567461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65231442|NCT02567461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65231443|NCT02567461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231444|NCT02567461|Antipyretics|antipyretics|mesh-ancestor
65231445|NCT02567461|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65231446|NCT02567461|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65231447|NCT02567461|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65231448|NCT02567461|Purinergic Agents|purinergic agents|mesh-ancestor
65231449|NCT02567461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65231450|NCT02567461|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65231451|NCT02567461|Antithrombins|antithrombins|mesh-ancestor
65231452|NCT02567461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65231453|NCT02567461|Protease Inhibitors|protease inhibitors|mesh-ancestor
65231454|NCT02567461|Anticoagulants|anticoagulants|mesh-ancestor
65231455|NCT00698581|Brivaracetam|brivaracetam|mesh-list
65231456|NCT00698581|Anticonvulsants|anticonvulsants|mesh-ancestor
65231457|NCT02595346|Hydroxychloroquine|hydroxychloroquine|mesh-list
65231458|NCT02595346|Antimalarials|antimalarials|mesh-ancestor
65231459|NCT02595346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65231460|NCT02595346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65231470|NCT01023581|Hormones|hormones|mesh-ancestor
65231471|NCT01023581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65231472|NCT01023581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65231474|NCT01023581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231475|NCT01023581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231476|NCT05571787|Rabeprazole|rabeprazole|mesh-list
65231477|NCT05571787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65231478|NCT05571787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65231479|NCT05571787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65231480|NCT05571787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231481|NCT05571787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231482|NCT04063189|Clarithromycin|clarithromycin|mesh-list
65231483|NCT04063189|Dexamethasone|dexamethasone|mesh-list
65231484|NCT04063189|Lenalidomide|lenalidomide|mesh-list
65231485|NCT04063189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65231486|NCT04063189|Antiemetics|antiemetics|mesh-ancestor
65343705|NCT00732290|Serotonin Agents|serotonin agents|mesh-ancestor
65343706|NCT00732290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65343707|NCT00732290|Antidepressive Agents|antidepressive agents|mesh-ancestor
65343708|NCT00732290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65343709|NCT00732290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65343710|NCT00732290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65343711|NCT00732290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343712|NCT02570334|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65231487|NCT04063189|Autonomic Agents|autonomic agents|mesh-ancestor
65231488|NCT04063189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65231489|NCT04063189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231490|NCT04063189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65231491|NCT04063189|Glucocorticoids|glucocorticoids|mesh-ancestor
65231492|NCT04063189|Hormones|hormones|mesh-ancestor
65231493|NCT04063189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65231494|NCT04063189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65231495|NCT04063189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231496|NCT04063189|Immunologic Factors|immunologic factors|mesh-ancestor
65231497|NCT04063189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65231498|NCT04063189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65231499|NCT04063189|Growth Substances|growth substances|mesh-ancestor
65231501|NCT04063189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65231502|NCT04063189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65231503|NCT04063189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65231504|NCT04063189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231505|NCT04063189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231506|NCT04063189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65231507|NCT04063189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65231508|NCT02567929|Propofol|propofol|mesh-list
65231509|NCT02567929|Sevoflurane|sevoflurane|mesh-list
65231510|NCT02567929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65231511|NCT02567929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65231512|NCT02567929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231513|NCT02567929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65231514|NCT02567929|Anesthetics, General|anesthetics, general|mesh-ancestor
65231515|NCT02567929|Anesthetics|anesthetics|mesh-ancestor
65231516|NCT02567929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65231517|NCT02567929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65231518|NCT05188417|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65231519|NCT05188417|Tirofiban|tirofiban|mesh-list
65231520|NCT05188417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65231521|NCT05188417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65231522|NCT05188417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231523|NCT05188417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65231524|NCT00962780|Vaccines|vaccines|mesh-list
65231525|NCT00962780|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65231526|NCT00962780|Immunologic Factors|immunologic factors|mesh-ancestor
65231541|NCT00961220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231542|NCT00734656|Ethanol|ethanol|mesh-list
65231543|NCT00734656|Dutasteride|dutasteride|mesh-list
65231544|NCT00734656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65231545|NCT00734656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65231546|NCT00734656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65231547|NCT00734656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231548|NCT00734656|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65231549|NCT00734656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65231550|NCT00734656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231551|NCT00734656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231552|NCT00734656|Hormone Antagonists|hormone antagonists|mesh-ancestor
65231553|NCT00734656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65231554|NCT04644289|Durvalumab|durvalumab|mesh-list
65231555|NCT04644289|Olaparib|olaparib|mesh-list
65231556|NCT04644289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65231557|NCT04644289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343713|NCT02570334|Antiviral Agents|antiviral agents|mesh-ancestor
65343714|NCT02570334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65343715|NCT00732446|Moxifloxacin|moxifloxacin|mesh-list
65343716|NCT00732446|Dexamethasone|dexamethasone|mesh-list
65343717|NCT00732446|Dexamethasone acetate|dexamethasone acetate|mesh-list
65343718|NCT00732446|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65343719|NCT00732446|BB 1101|bb 1101|mesh-list
65343720|NCT00732446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64950974|NCT00052728|Tamoxifen|tamoxifen|mesh-list
65231558|NCT04644289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65231559|NCT04644289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231560|NCT04644289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231561|NCT02565979|Resveratrol|resveratrol|mesh-list
65231562|NCT02565979|Antioxidants|antioxidants|mesh-ancestor
65231563|NCT02565979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231564|NCT02565979|Protective Agents|protective agents|mesh-ancestor
65231565|NCT02565979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231566|NCT02565979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231567|NCT02565979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65231568|NCT04062175|Azithromycin|azithromycin|mesh-list
65231569|NCT04062175|Cephalosporins|cephalosporins|mesh-list
65231570|NCT04062175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65231571|NCT04062175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65231572|NCT02859584|Hydrocortisone|hydrocortisone|mesh-list
65231573|NCT02859584|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65231575|NCT02859584|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65231576|NCT02859584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65231577|NCT04391569|Ganaxolone|ganaxolone|mesh-list
65231578|NCT04391569|Neurosteroids|neurosteroids|mesh-ancestor
65231579|NCT04391569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65231580|NCT04391569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231581|NCT04391569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231582|NCT04391569|GABA Modulators|gaba modulators|mesh-ancestor
65231583|NCT04391569|GABA Agents|gaba agents|mesh-ancestor
65231584|NCT05324917|Rituximab|rituximab|mesh-list
65231585|NCT05324917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65231586|NCT05324917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231587|NCT05324917|Immunologic Factors|immunologic factors|mesh-ancestor
65231613|NCT04354129|Immunologic Factors|immunologic factors|mesh-ancestor
65231614|NCT04354129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231615|NCT02871713|Morphine|morphine|mesh-list
65231616|NCT02871713|Ropivacaine|ropivacaine|mesh-list
65231617|NCT02871713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65231618|NCT02871713|Narcotics|narcotics|mesh-ancestor
65231619|NCT02871713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65231620|NCT02871713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231622|NCT02871713|Sensory System Agents|sensory system agents|mesh-ancestor
65231623|NCT02871713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65231624|NCT02871713|Anesthetics, Local|anesthetics, local|mesh-ancestor
65231625|NCT02871713|Anesthetics|anesthetics|mesh-ancestor
65231626|NCT04342975|Niacinamide|niacinamide|mesh-list
65231627|NCT04342975|Niacin|niacin|mesh-list
65231628|NCT04342975|Nicotinic Acids|nicotinic acids|mesh-list
65231629|NCT04342975|Vitamin B Complex|vitamin b complex|mesh-ancestor
65231630|NCT04342975|Vitamins|vitamins|mesh-ancestor
65231631|NCT04342975|Micronutrients|micronutrients|mesh-ancestor
65231632|NCT04342975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231633|NCT04342975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65231634|NCT04342975|Antimetabolites|antimetabolites|mesh-ancestor
65231635|NCT04342975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231636|NCT04342975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65231637|NCT04342975|Vasodilator Agents|vasodilator agents|mesh-ancestor
65231638|NCT00734578|Guanfacine|guanfacine|mesh-list
65231660|NCT04557085|Anticonvulsants|anticonvulsants|mesh-ancestor
65231661|NCT02593708|Paclitaxel|paclitaxel|mesh-list
65231662|NCT02593708|Trastuzumab|trastuzumab|mesh-list
65231663|NCT02593708|Pertuzumab|pertuzumab|mesh-list
65231664|NCT02593708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65231665|NCT02593708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231666|NCT02593708|Tubulin Modulators|tubulin modulators|mesh-ancestor
65343721|NCT00732446|Antiemetics|antiemetics|mesh-ancestor
65343722|NCT00732446|Autonomic Agents|autonomic agents|mesh-ancestor
65343723|NCT00732446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65343724|NCT00732446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343725|NCT00732446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65343726|NCT00732446|Glucocorticoids|glucocorticoids|mesh-ancestor
65343727|NCT00732446|Hormones|hormones|mesh-ancestor
65343728|NCT00732446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65343729|NCT00732446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65343730|NCT00732446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343731|NCT00732446|Protease Inhibitors|protease inhibitors|mesh-ancestor
65343732|NCT00732446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343733|NCT00732446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343734|NCT00732446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65343735|NCT00732446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65231667|NCT02593708|Antimitotic Agents|antimitotic agents|mesh-ancestor
65231668|NCT02593708|Mitosis Modulators|mitosis modulators|mesh-ancestor
65231669|NCT02593708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231670|NCT02593708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65231671|NCT00959192|Saponin QA-21V1|saponin qa-21v1|mesh-list
65231672|NCT00959192|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65231673|NCT00959192|Immunologic Factors|immunologic factors|mesh-ancestor
65231674|NCT00959192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231675|NCT00696787|Pregabalin|pregabalin|mesh-list
65231676|NCT00696787|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65231677|NCT00696787|Analgesics|analgesics|mesh-ancestor
65231678|NCT00696787|Sensory System Agents|sensory system agents|mesh-ancestor
65231679|NCT00696787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65231680|NCT00696787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231681|NCT00696787|Anticonvulsants|anticonvulsants|mesh-ancestor
65231682|NCT00696787|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65231683|NCT00696787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65231684|NCT00696787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231685|NCT00696787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65231686|NCT00696787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65231687|NCT00696787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65231688|NCT00696787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64945006|NCT00129038|Aspirin|aspirin|mesh-list
65231695|NCT01012037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65231696|NCT01012037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231698|NCT01012037|Hormones|hormones|mesh-ancestor
65231699|NCT01012037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65231700|NCT01012037|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65231701|NCT01012037|Protease Inhibitors|protease inhibitors|mesh-ancestor
65231702|NCT01012037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231703|NCT01012037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231704|NCT00630110|Docetaxel|docetaxel|mesh-list
65231705|NCT00630110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231706|NCT00630110|Tubulin Modulators|tubulin modulators|mesh-ancestor
65231707|NCT00630110|Antimitotic Agents|antimitotic agents|mesh-ancestor
65231708|NCT00630110|Mitosis Modulators|mitosis modulators|mesh-ancestor
65231709|NCT00630110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231710|NCT00734032|Darapladib|darapladib|mesh-list
65231711|NCT00734032|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
65231712|NCT00734032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231713|NCT00734032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231714|NCT04284098|Dexmedetomidine|dexmedetomidine|mesh-list
65343736|NCT00732446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65343737|NCT00732446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65343738|NCT00732446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65343739|NCT00732446|Contraceptive Agents|contraceptive agents|mesh-ancestor
65343740|NCT00732446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65343741|NCT00732446|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65343742|NCT00732446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65231715|NCT04284098|Bupivacaine|bupivacaine|mesh-list
65231716|NCT04284098|Anesthetics, Local|anesthetics, local|mesh-ancestor
65231717|NCT04284098|Anesthetics|anesthetics|mesh-ancestor
65231718|NCT04284098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65231719|NCT04284098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231720|NCT04284098|Sensory System Agents|sensory system agents|mesh-ancestor
65231721|NCT04284098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65231722|NCT04284098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65231723|NCT04284098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65231724|NCT04284098|Analgesics|analgesics|mesh-ancestor
65231725|NCT04284098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65231726|NCT04284098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65231727|NCT04284098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65231728|NCT04284098|Adrenergic Agents|adrenergic agents|mesh-ancestor
65231729|NCT04284098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65231730|NCT04284098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231731|NCT01010633|Loteprednol Etabonate|loteprednol etabonate|mesh-list
65231732|NCT01010633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65231733|NCT00733954|Clobetasol|clobetasol|mesh-list
65231734|NCT00733954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65231735|NCT00733954|Glucocorticoids|glucocorticoids|mesh-ancestor
65231736|NCT00733954|Hormones|hormones|mesh-ancestor
65231737|NCT00733954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65231738|NCT00733954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231739|NCT02595268|Pitavastatin|pitavastatin|mesh-list
65231740|NCT02595268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65231741|NCT02595268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65231742|NCT02595268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65231743|NCT02595268|Antimetabolites|antimetabolites|mesh-ancestor
65231744|NCT02595268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231745|NCT02595268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231746|NCT02595268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65231747|NCT00921505|Acetaminophen|acetaminophen|mesh-list
65231748|NCT00921505|Ibuprofen|ibuprofen|mesh-list
65231749|NCT00921505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65231750|NCT00921505|Analgesics|analgesics|mesh-ancestor
65231751|NCT00921505|Sensory System Agents|sensory system agents|mesh-ancestor
65231752|NCT00921505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65231753|NCT00921505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231754|NCT00921505|Antipyretics|antipyretics|mesh-ancestor
65231778|NCT02595190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65231779|NCT02595190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231781|NCT02595190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65231782|NCT02595190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65231783|NCT02595190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65231784|NCT02595190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65231785|NCT02595190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65231786|NCT02595190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65231787|NCT02595190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65231788|NCT02595190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231789|NCT02595190|Antimanic Agents|antimanic agents|mesh-ancestor
65231790|NCT02595190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65231791|NCT02595190|Narcotics|narcotics|mesh-ancestor
65231792|NCT04061473|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65231793|NCT04061473|Empagliflozin|empagliflozin|mesh-list
65231794|NCT04061473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65231795|NCT04061473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231797|NCT04061473|Hormones|hormones|mesh-ancestor
65231798|NCT04061473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65343743|NCT00732446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65343744|NCT00732524|Glipizide|glipizide|mesh-list
65343745|NCT00732524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65343746|NCT00732524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343747|NCT00657267|Temozolomide|temozolomide|mesh-list
65343748|NCT00657267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65343749|NCT00657267|Alkylating Agents|alkylating agents|mesh-ancestor
65343750|NCT00657267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343751|NCT00657267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343752|NCT00733850|Gemcitabine|gemcitabine|mesh-list
64725619|NCT00003026|Flutamide|flutamide|mesh-list
65231799|NCT04061473|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65231800|NCT04061473|Protease Inhibitors|protease inhibitors|mesh-ancestor
65231801|NCT04061473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231802|NCT04061473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945127|NCT00038532|Saquinavir|saquinavir|mesh-list
65231827|NCT00733408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65231828|NCT00733408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231829|NCT04296383|Azithromycin|azithromycin|mesh-list
65231830|NCT04296383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65231831|NCT04296383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65231832|NCT00576823|Alfuzosin|alfuzosin|mesh-list
65231833|NCT00576823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65231834|NCT00576823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65231835|NCT00576823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65231836|NCT00576823|Adrenergic Agents|adrenergic agents|mesh-ancestor
65231837|NCT00576823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65231838|NCT00576823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231839|NCT00576823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231840|NCT00576823|Urological Agents|urological agents|mesh-ancestor
65231841|NCT00732940|Belimumab|belimumab|mesh-list
65231842|NCT00732940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65231843|NCT00732940|Immunologic Factors|immunologic factors|mesh-ancestor
65231844|NCT00732940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231846|NCT00962390|Phytoestrogens|phytoestrogens|mesh-ancestor
65231847|NCT00962390|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65231848|NCT00962390|Estrogens|estrogens|mesh-ancestor
65231849|NCT00962390|Hormones|hormones|mesh-ancestor
65231850|NCT00962390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65231851|NCT00962390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231852|NCT00742807|Alfentanil|alfentanil|mesh-list
65231853|NCT00742807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65231854|NCT00742807|Narcotics|narcotics|mesh-ancestor
65231867|NCT03221257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65231868|NCT03221257|Antitubercular Agents|antitubercular agents|mesh-ancestor
65231869|NCT03221257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65231870|NCT03221257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65231871|NCT03221257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231872|NCT03221257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231874|NCT03221257|Sensory System Agents|sensory system agents|mesh-ancestor
65231875|NCT03221257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65231876|NCT03221257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231877|NCT03221257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65231878|NCT03221257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65231879|NCT03221257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65231880|NCT03221257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65231881|NCT00960986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65231882|NCT00960986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65231883|NCT00960986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65231884|NCT00960986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65231885|NCT00960986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231886|NCT00960986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65343753|NCT00733850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65343754|NCT00733850|Antimetabolites|antimetabolites|mesh-ancestor
65343755|NCT00733850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343756|NCT00733850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343757|NCT00733850|Antiviral Agents|antiviral agents|mesh-ancestor
65343758|NCT00733850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65343759|NCT00733850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343760|NCT00733850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65343761|NCT00733850|Immunologic Factors|immunologic factors|mesh-ancestor
64725631|NCT00002143|Acitretin|acitretin|mesh-list
65231887|NCT00960986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231888|NCT00960986|Analgesics|analgesics|mesh-ancestor
65231889|NCT00960986|Sensory System Agents|sensory system agents|mesh-ancestor
65231890|NCT00960986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65231891|NCT00960986|Antidepressive Agents|antidepressive agents|mesh-ancestor
65231892|NCT00960986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65231893|NCT00960986|Dopamine Agents|dopamine agents|mesh-ancestor
65231894|NCT00732238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65231895|NCT00732238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65231896|NCT00958880|Yohimbine|yohimbine|mesh-list
65231897|NCT00958880|Mydriatics|mydriatics|mesh-ancestor
65231898|NCT00958880|Autonomic Agents|autonomic agents|mesh-ancestor
65231899|NCT00958880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65231900|NCT00958880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231901|NCT00958880|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65231902|NCT00958880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65231903|NCT00958880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65231904|NCT00958880|Adrenergic Agents|adrenergic agents|mesh-ancestor
65231905|NCT00958880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65231906|NCT00958880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231907|NCT00958880|Urological Agents|urological agents|mesh-ancestor
65231908|NCT02595034|Clindamycin|clindamycin|mesh-list
65231909|NCT02595034|Clindamycin palmitate|clindamycin palmitate|mesh-list
65231910|NCT02595034|Clindamycin phosphate|clindamycin phosphate|mesh-list
65231911|NCT02595034|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65231912|NCT02595034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65231913|NCT02595034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65231914|NCT02595034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65231915|NCT02595034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231916|NCT02595034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231925|NCT00738400|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65231926|NCT00738400|Vasodilator Agents|vasodilator agents|mesh-ancestor
65231927|NCT00738400|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65231928|NCT00738400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65231929|NCT00738400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231930|NCT00738400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231931|NCT00738400|Urological Agents|urological agents|mesh-ancestor
65231932|NCT00958568|Olanzapine|olanzapine|mesh-list
65231933|NCT00958568|Fluoxetine|fluoxetine|mesh-list
65231934|NCT00958568|Antiemetics|antiemetics|mesh-ancestor
65231935|NCT00958568|Autonomic Agents|autonomic agents|mesh-ancestor
65231936|NCT00958568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65231937|NCT00958568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231938|NCT00958568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65231939|NCT00958568|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65231940|NCT00958568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65231941|NCT00958568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65231942|NCT00958568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64963826|NCT00157261|Tenecteplase|tenecteplase|mesh-list
65231943|NCT00958568|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65231944|NCT00958568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65231945|NCT00958568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65231946|NCT00958568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231947|NCT00958568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65231948|NCT00958568|Serotonin Agents|serotonin agents|mesh-ancestor
65343762|NCT00733850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343763|NCT00727766|Clofarabine|clofarabine|mesh-list
65343764|NCT00727766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65343765|NCT00727766|Antimetabolites|antimetabolites|mesh-ancestor
65343766|NCT00727766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725638|NCT00002149|Ephedrine|ephedrine|mesh-list
65231949|NCT00958568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65231950|NCT00958568|Antidepressive Agents|antidepressive agents|mesh-ancestor
65231951|NCT00958568|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65231952|NCT00958568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65231953|NCT00958568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231954|NCT00630500|Memantine|memantine|mesh-list
65231955|NCT00630500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65231956|NCT00630500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65231957|NCT00630500|Dopamine Agents|dopamine agents|mesh-ancestor
65231958|NCT00630500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65231959|NCT00630500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231960|NCT00630500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231961|NCT00630500|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65231962|NCT00630500|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65231963|NCT02858804|Cytarabine|cytarabine|mesh-list
65231964|NCT02858804|Thalidomide|thalidomide|mesh-list
65231965|NCT02858804|Dexamethasone|dexamethasone|mesh-list
65231966|NCT02858804|Prednisone|prednisone|mesh-list
65231967|NCT02858804|Cyclophosphamide|cyclophosphamide|mesh-list
65231968|NCT02858804|Rituximab|rituximab|mesh-list
65231969|NCT02858804|Doxorubicin|doxorubicin|mesh-list
65231970|NCT02858804|Etoposide|etoposide|mesh-list
65231971|NCT02858804|Vincristine|vincristine|mesh-list
65231972|NCT02858804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65231973|NCT02858804|Immunologic Factors|immunologic factors|mesh-ancestor
65231974|NCT02858804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231975|NCT02858804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65231976|NCT02858804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65231977|NCT02858804|Alkylating Agents|alkylating agents|mesh-ancestor
65231978|NCT02858804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231979|NCT02858804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231980|NCT02858804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65231981|NCT02858804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65231982|NCT02858804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65231991|NCT02858804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65231992|NCT02858804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65231993|NCT02858804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65231994|NCT02858804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231995|NCT02858804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65231996|NCT02858804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65231997|NCT02858804|Antimetabolites|antimetabolites|mesh-ancestor
65231998|NCT02858804|Antiviral Agents|antiviral agents|mesh-ancestor
65231999|NCT02858804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65232000|NCT02858804|Tubulin Modulators|tubulin modulators|mesh-ancestor
65232001|NCT02858804|Antimitotic Agents|antimitotic agents|mesh-ancestor
65232002|NCT02858804|Mitosis Modulators|mitosis modulators|mesh-ancestor
65232003|NCT02858804|Leprostatic Agents|leprostatic agents|mesh-ancestor
65232004|NCT02858804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65232005|NCT02858804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65232006|NCT02858804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65232007|NCT02858804|Growth Substances|growth substances|mesh-ancestor
65232008|NCT02858804|Growth Inhibitors|growth inhibitors|mesh-ancestor
65232009|NCT00958256|Cyclophosphamide|cyclophosphamide|mesh-list
65232010|NCT00958256|Rituximab|rituximab|mesh-list
65232011|NCT00958256|Bortezomib|bortezomib|mesh-list
65232012|NCT00958256|Lenograstim|lenograstim|mesh-list
65232013|NCT00958256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65232014|NCT00958256|Immunologic Factors|immunologic factors|mesh-ancestor
65232015|NCT00958256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232016|NCT00958256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65232017|NCT00958256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65232018|NCT00958256|Alkylating Agents|alkylating agents|mesh-ancestor
65232019|NCT00958256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232020|NCT00958256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343767|NCT00727766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343768|NCT00799071|Posaconazole|posaconazole|mesh-list
65343769|NCT00799071|Antifungal Agents|antifungal agents|mesh-ancestor
65343770|NCT00799071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65343771|NCT00799071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65343772|NCT00799071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65343773|NCT00799071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65343774|NCT00799071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65343775|NCT00799071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65343776|NCT00799071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343777|NCT00799071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232021|NCT00958256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65232022|NCT00958256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65232023|NCT00958256|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65232025|NCT01006265|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65232026|NCT01006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232027|NCT01006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65232028|NCT01006265|Immunologic Factors|immunologic factors|mesh-ancestor
65232029|NCT01006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232030|NCT02861690|Paclitaxel|paclitaxel|mesh-list
65232031|NCT02861690|Nedaplatin|nedaplatin|mesh-list
65232032|NCT02861690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65232033|NCT02861690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232034|NCT02861690|Tubulin Modulators|tubulin modulators|mesh-ancestor
65232035|NCT02861690|Antimitotic Agents|antimitotic agents|mesh-ancestor
65232036|NCT02861690|Mitosis Modulators|mitosis modulators|mesh-ancestor
65232037|NCT02861690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232038|NCT05141552|Dapagliflozin|dapagliflozin|mesh-list
65232039|NCT05141552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65232040|NCT05141552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232041|NCT05141552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65232042|NCT05141552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232043|NCT02564107|Ibandronic Acid|ibandronic acid|mesh-list
65232044|NCT02564107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65232045|NCT02564107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232046|NCT00628667|Esomeprazole|esomeprazole|mesh-list
65232047|NCT00628667|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65232048|NCT00628667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65232049|NCT00628667|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65232065|NCT04295993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65232066|NCT04295993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232067|NCT04295993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232068|NCT04295993|Sympathomimetics|sympathomimetics|mesh-ancestor
65232069|NCT04295993|Autonomic Agents|autonomic agents|mesh-ancestor
65232070|NCT04295993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65232071|NCT04295993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65232072|NCT04295993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232075|NCT00743587|Tramadol|tramadol|mesh-list
65232076|NCT00743587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65232077|NCT00743587|Narcotics|narcotics|mesh-ancestor
65232078|NCT00743587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65232079|NCT00743587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232080|NCT00743587|Analgesics|analgesics|mesh-ancestor
65232081|NCT00743587|Sensory System Agents|sensory system agents|mesh-ancestor
65232082|NCT00743587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65232083|NCT00743587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65232084|NCT00743587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65232085|NCT00743587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65232086|NCT00743587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65232087|NCT00743587|Gout Suppressants|gout suppressants|mesh-ancestor
65232088|NCT00743587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65232089|NCT00743587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343778|NCT00799071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65343779|NCT00799071|Hormone Antagonists|hormone antagonists|mesh-ancestor
65343780|NCT00799071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65343781|NCT00799071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343782|NCT00732836|Paclitaxel|paclitaxel|mesh-list
65343783|NCT00732836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65343784|NCT00732836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65343785|NCT00732836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343786|NCT00732836|Tubulin Modulators|tubulin modulators|mesh-ancestor
65343787|NCT00732836|Antimitotic Agents|antimitotic agents|mesh-ancestor
65343788|NCT00732836|Mitosis Modulators|mitosis modulators|mesh-ancestor
65343789|NCT00732836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343790|NCT00799149|Etoricoxib|etoricoxib|mesh-list
65343791|NCT00799149|Gabapentin|gabapentin|mesh-list
65343792|NCT00799149|Analgesics|analgesics|mesh-ancestor
65343793|NCT00799149|Sensory System Agents|sensory system agents|mesh-ancestor
65343794|NCT00799149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65343795|NCT00799149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343796|NCT00799149|Anticonvulsants|anticonvulsants|mesh-ancestor
65343797|NCT00799149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65343798|NCT00799149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64725659|NCT02973295|Silymarin|silymarin|mesh-list
65232090|NCT00743587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232091|NCT00957944|Rotigotine|rotigotine|mesh-list
65232092|NCT00957944|Dopamine Agonists|dopamine agonists|mesh-ancestor
65232093|NCT00957944|Dopamine Agents|dopamine agents|mesh-ancestor
65232094|NCT00957944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65232095|NCT00957944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232096|NCT00957944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232098|NCT02871323|Immunoglobulins|immunoglobulins|mesh-list
65232099|NCT02871323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65232100|NCT02871323|Immunoglobulin G|immunoglobulin g|mesh-list
65232101|NCT02871323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65232102|NCT02871323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232103|NCT02871323|Immunologic Factors|immunologic factors|mesh-ancestor
65232104|NCT02871323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232105|NCT04296149|Octreotide|octreotide|mesh-list
65232106|NCT04296149|Edotreotide|edotreotide|mesh-list
65232107|NCT04296149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65232108|NCT04296149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65232109|NCT04296149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232110|NCT04296149|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65232111|NCT04296149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232124|NCT02701088|Alkylating Agents|alkylating agents|mesh-ancestor
65232125|NCT02701088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232126|NCT02701088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65232127|NCT02701088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232128|NCT04279106|Chlorhexidine|chlorhexidine|mesh-list
65232129|NCT04279106|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65232131|NCT04279106|Fluorides|fluorides|mesh-list
65232132|NCT04279106|Sodium Fluoride|sodium fluoride|mesh-list
65232133|NCT04279106|Cariostatic Agents|cariostatic agents|mesh-ancestor
65232134|NCT04279106|Protective Agents|protective agents|mesh-ancestor
65343799|NCT00799149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65343800|NCT00799149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65343801|NCT00799149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65343802|NCT00799149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65343803|NCT00799149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64725675|NCT00003032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65232135|NCT04279106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232136|NCT04279106|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65232137|NCT04279106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65232138|NCT04279106|Disinfectants|disinfectants|mesh-ancestor
65232139|NCT04279106|Dermatologic Agents|dermatologic agents|mesh-ancestor
65232140|NCT00743743|Resveratrol|resveratrol|mesh-list
65232141|NCT00743743|Antioxidants|antioxidants|mesh-ancestor
64874883|NCT01868750|Calcitriol|calcitriol|mesh-list
65232142|NCT00743743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232143|NCT00743743|Protective Agents|protective agents|mesh-ancestor
65232144|NCT00743743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232145|NCT00743743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232146|NCT00743743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65232147|NCT03881917|Cystatins|cystatins|mesh-list
65232148|NCT03881917|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65232149|NCT03881917|Protease Inhibitors|protease inhibitors|mesh-ancestor
65232150|NCT03881917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232151|NCT03881917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232152|NCT01005719|Omeprazole|omeprazole|mesh-list
65232153|NCT01005719|Lansoprazole|lansoprazole|mesh-list
65232154|NCT01005719|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
65232155|NCT01005719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65232156|NCT01005719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65232157|NCT01005719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65232158|NCT01005719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232159|NCT01005719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232160|NCT02840227|Anesthetics|anesthetics|mesh-list
65232161|NCT02840227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65232162|NCT02840227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232163|NCT02856854|Cocaine|cocaine|mesh-list
65232164|NCT02856854|Oxazepam|oxazepam|mesh-list
65232165|NCT02856854|Metyrapone|metyrapone|mesh-list
65232166|NCT02856854|Anesthetics, Local|anesthetics, local|mesh-ancestor
65232167|NCT02856854|Anesthetics|anesthetics|mesh-ancestor
65232168|NCT02856854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65232169|NCT02856854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232170|NCT02856854|Sensory System Agents|sensory system agents|mesh-ancestor
65232171|NCT02856854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65232172|NCT02856854|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65232173|NCT02856854|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64484432|NCT01709084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65232185|NCT02856854|GABA Modulators|gaba modulators|mesh-ancestor
65232186|NCT02856854|GABA Agents|gaba agents|mesh-ancestor
65232187|NCT02857166|Antibodies|antibodies|mesh-list
65232188|NCT02857166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65232189|NCT02857166|Immunologic Factors|immunologic factors|mesh-ancestor
65232190|NCT02857166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232191|NCT02856932|Methamphetamine|methamphetamine|mesh-list
65232192|NCT02856932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65232193|NCT02856932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232194|NCT02856932|Sympathomimetics|sympathomimetics|mesh-ancestor
65232195|NCT02856932|Autonomic Agents|autonomic agents|mesh-ancestor
65232196|NCT02856932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65232197|NCT02856932|Dopamine Agents|dopamine agents|mesh-ancestor
65232198|NCT02856932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65232199|NCT02856932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232200|NCT02856932|Adrenergic Agents|adrenergic agents|mesh-ancestor
65232201|NCT02856932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65232202|NCT02856932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65232203|NCT02856932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65232204|NCT02856932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65232205|NCT02563951|Granisetron|granisetron|mesh-list
65232206|NCT02563951|Antiemetics|antiemetics|mesh-ancestor
65343804|NCT00799149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343805|NCT00799149|Antimanic Agents|antimanic agents|mesh-ancestor
65343806|NCT00799149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65343807|NCT00799149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65343808|NCT00799149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65343809|NCT00799149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65232207|NCT02563951|Autonomic Agents|autonomic agents|mesh-ancestor
65232208|NCT02563951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65232209|NCT02563951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232210|NCT02563951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65232211|NCT02563951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65232212|NCT02563951|Serotonin Agents|serotonin agents|mesh-ancestor
65232213|NCT02563951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65232214|NCT02563951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232215|NCT00953576|Ketoconazole|ketoconazole|mesh-list
65232216|NCT00953576|Hydrocortisone|hydrocortisone|mesh-list
65232217|NCT00953576|Lapatinib|lapatinib|mesh-list
65232218|NCT00953576|Dutasteride|dutasteride|mesh-list
65232219|NCT00953576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65232220|NCT00953576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232221|NCT00953576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65232222|NCT00953576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232223|NCT00953576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232224|NCT00953576|Antifungal Agents|antifungal agents|mesh-ancestor
65232225|NCT00953576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65232226|NCT00953576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65232227|NCT00953576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65232228|NCT00953576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65232229|NCT00953576|Hormone Antagonists|hormone antagonists|mesh-ancestor
65232230|NCT00953576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65232231|NCT00953576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232232|NCT00953576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65232233|NCT00953576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65232234|NCT02100956|Oxytocin|oxytocin|mesh-list
65232235|NCT02100956|Oxytocics|oxytocics|mesh-ancestor
64453644|NCT01438060|Dopamine Agonists|dopamine agonists|mesh-ancestor
65232251|NCT01005329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65232252|NCT01005329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65232253|NCT01005329|Endothelial Growth Factors|endothelial growth factors|mesh-list
65232254|NCT01005329|Antibodies|antibodies|mesh-list
65232255|NCT01005329|Immunoglobulins|immunoglobulins|mesh-list
65232256|NCT01005329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65232257|NCT01005329|Immunoglobulin G|immunoglobulin g|mesh-list
65232258|NCT01005329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65232259|NCT01005329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232260|NCT01005329|Tubulin Modulators|tubulin modulators|mesh-ancestor
65232261|NCT01005329|Antimitotic Agents|antimitotic agents|mesh-ancestor
65232262|NCT01005329|Mitosis Modulators|mitosis modulators|mesh-ancestor
65232263|NCT01005329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232264|NCT01005329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65232265|NCT01005329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65232266|NCT01005329|Growth Substances|growth substances|mesh-ancestor
65232267|NCT01005329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232268|NCT01005329|Growth Inhibitors|growth inhibitors|mesh-ancestor
65232269|NCT01005329|Immunologic Factors|immunologic factors|mesh-ancestor
65232270|NCT00921349|Nadolol|nadolol|mesh-list
65232271|NCT00921349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65232272|NCT00921349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65232273|NCT00921349|Adrenergic Agents|adrenergic agents|mesh-ancestor
65232274|NCT00921349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65232275|NCT00921349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232276|NCT00921349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232277|NCT00921349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65232278|NCT00921349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65232279|NCT00921349|Sympatholytics|sympatholytics|mesh-ancestor
65232280|NCT00921349|Autonomic Agents|autonomic agents|mesh-ancestor
65232281|NCT00921349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65343810|NCT00799149|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65343811|NCT00799149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65343812|NCT00799149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343813|NCT00732914|Sorafenib|sorafenib|mesh-list
65343814|NCT00732914|Sunitinib|sunitinib|mesh-list
65232282|NCT01005251|Lesogaberan|lesogaberan|mesh-list
65232283|NCT01005251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65232284|NCT01005251|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65232285|NCT01005251|GABA Agonists|gaba agonists|mesh-ancestor
65232286|NCT01005251|GABA Agents|gaba agents|mesh-ancestor
65232287|NCT01005251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65232288|NCT01005251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232289|NCT01005251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232290|NCT03048578|Liraglutide|liraglutide|mesh-list
65232291|NCT03048578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65232292|NCT03048578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232293|NCT03048578|Incretins|incretins|mesh-ancestor
64875028|NCT01869751|Laxatives|laxatives|mesh-ancestor
65232294|NCT03048578|Hormones|hormones|mesh-ancestor
65232295|NCT03048578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65232296|NCT02856776|Vitamin D|vitamin d|mesh-list
65232327|NCT02857712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65232328|NCT02857712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232329|NCT02857712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232330|NCT00696241|Olmesartan|olmesartan|mesh-list
65232331|NCT00696241|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65232332|NCT00696241|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65232333|NCT00696241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65232334|NCT00696241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65232335|NCT00696241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65232336|NCT00696241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232337|NCT02007044|Rituximab|rituximab|mesh-list
65232338|NCT02007044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65232339|NCT02007044|Antibodies|antibodies|mesh-list
65232340|NCT02007044|Immunoglobulins|immunoglobulins|mesh-list
65232341|NCT02007044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65232342|NCT02007044|Immunologic Factors|immunologic factors|mesh-ancestor
65232343|NCT02007044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232348|NCT00630968|Nootropic Agents|nootropic agents|mesh-ancestor
65232349|NCT02513563|Paclitaxel|paclitaxel|mesh-list
65232350|NCT02513563|Carboplatin|carboplatin|mesh-list
65232351|NCT02513563|Adavosertib|adavosertib|mesh-list
65232352|NCT02513563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65232353|NCT02513563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232354|NCT02513563|Tubulin Modulators|tubulin modulators|mesh-ancestor
65232355|NCT02513563|Antimitotic Agents|antimitotic agents|mesh-ancestor
65232356|NCT02513563|Mitosis Modulators|mitosis modulators|mesh-ancestor
65232357|NCT02513563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232358|NCT02513563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232359|NCT00952484|Immunoglobulin G|immunoglobulin g|mesh-list
65232360|NCT00952484|Immunologic Factors|immunologic factors|mesh-ancestor
65232361|NCT00952484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232362|NCT00689611|Bupropion|bupropion|mesh-list
65232363|NCT00689611|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65232364|NCT00689611|Antidepressive Agents|antidepressive agents|mesh-ancestor
65232365|NCT00689611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65232366|NCT00689611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65232367|NCT00689611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65232368|NCT00689611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65232369|NCT00689611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232371|NCT00689611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65232372|NCT00689611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232373|NCT00689611|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65232374|NCT00689611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65232375|NCT00689611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232376|NCT02563795|Fentanyl|fentanyl|mesh-list
65232377|NCT02563795|Bupivacaine|bupivacaine|mesh-list
65232378|NCT02563795|Anesthetics, Local|anesthetics, local|mesh-ancestor
65232379|NCT02563795|Anesthetics|anesthetics|mesh-ancestor
65232380|NCT02563795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65232381|NCT02563795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343815|NCT00732914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343816|NCT00732914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65343818|NCT00732914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343819|NCT00732914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65343820|NCT00732914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65343821|NCT00732914|Growth Substances|growth substances|mesh-ancestor
65232382|NCT02563795|Sensory System Agents|sensory system agents|mesh-ancestor
65232383|NCT02563795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65232384|NCT02563795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65232385|NCT02563795|Narcotics|narcotics|mesh-ancestor
65232386|NCT02563795|Analgesics|analgesics|mesh-ancestor
65232387|NCT02563795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65232388|NCT02563795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65232389|NCT02563795|Anesthetics, General|anesthetics, general|mesh-ancestor
65232390|NCT04281680|Octreotide|octreotide|mesh-list
65232391|NCT04281680|Pasireotide|pasireotide|mesh-list
65232392|NCT04281680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65232393|NCT04281680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65232394|NCT04281680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232395|NCT04281680|Hormones|hormones|mesh-ancestor
65232396|NCT04281680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65232398|NCT00744445|Epoetin Alfa|epoetin alfa|mesh-list
65232399|NCT00744445|Hematinics|hematinics|mesh-ancestor
65232400|NCT02854748|Empagliflozin|empagliflozin|mesh-list
65232401|NCT02854748|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65232402|NCT02854748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232403|NCT02854748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65232404|NCT02854748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232405|NCT00744679|Natalizumab|natalizumab|mesh-list
65232406|NCT00744679|Immunologic Factors|immunologic factors|mesh-ancestor
65232407|NCT00744679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232408|NCT04060459|Paclitaxel|paclitaxel|mesh-list
65232409|NCT04060459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65232410|NCT04060459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232411|NCT04060459|Tubulin Modulators|tubulin modulators|mesh-ancestor
65232412|NCT04060459|Antimitotic Agents|antimitotic agents|mesh-ancestor
65232413|NCT04060459|Mitosis Modulators|mitosis modulators|mesh-ancestor
65232414|NCT04060459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232415|NCT01007435|Methotrexate|methotrexate|mesh-list
65232416|NCT01007435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65232417|NCT01007435|Abortifacient Agents|abortifacient agents|mesh-ancestor
65232430|NCT01007435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65232431|NCT00948896|Pyrimethamine|pyrimethamine|mesh-list
65232432|NCT00948896|Piperaquine|piperaquine|mesh-list
65232433|NCT00948896|Sulfadoxine|sulfadoxine|mesh-list
65232434|NCT00948896|Trimethoprim|trimethoprim|mesh-list
65232435|NCT00948896|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65232436|NCT00948896|Artenimol|artenimol|mesh-list
65232437|NCT00948896|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65232438|NCT00948896|Sulfamethoxazole|sulfamethoxazole|mesh-list
65232439|NCT00948896|Antimalarials|antimalarials|mesh-ancestor
65232440|NCT00948896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65232441|NCT00948896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65232442|NCT00948896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65232443|NCT00948896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65232444|NCT00948896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232445|NCT00948896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232446|NCT00948896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65232447|NCT00948896|Renal Agents|renal agents|mesh-ancestor
65232448|NCT00948896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65232449|NCT00948896|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65232450|NCT00948896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65232451|NCT00948896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65232452|NCT01004159|Irinotecan|irinotecan|mesh-list
65232453|NCT01004159|Cetuximab|cetuximab|mesh-list
65232454|NCT01004159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65232455|NCT01004159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65232456|NCT01004159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343822|NCT00732914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343823|NCT00732914|Growth Inhibitors|growth inhibitors|mesh-ancestor
65343824|NCT00808275|Calcium, Dietary|calcium, dietary|mesh-list
65343825|NCT00808275|Calcium|calcium|mesh-list
65343826|NCT00808275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65343827|NCT00808275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343828|NCT00808275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65232457|NCT01004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232458|NCT01004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232459|NCT01004159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65232460|NCT00948818|Linaclotide|linaclotide|mesh-list
65232461|NCT00948818|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65232462|NCT00948818|Enzyme Activators|enzyme activators|mesh-ancestor
65232463|NCT00948818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232464|NCT00948818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65232465|NCT02854592|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65232466|NCT02854592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65232467|NCT02854592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64964362|NCT00160849|Lopinavir|lopinavir|mesh-list
65232468|NCT02854592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232470|NCT00948506|Antiviral Agents|antiviral agents|mesh-ancestor
65232471|NCT00948506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65232472|NCT00948506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232473|NCT00948506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232474|NCT00689221|Temozolomide|temozolomide|mesh-list
65232475|NCT00689221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65232476|NCT00689221|Alkylating Agents|alkylating agents|mesh-ancestor
65232477|NCT00689221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232478|NCT00689221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232490|NCT04060771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65232491|NCT04060771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232492|NCT04060771|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65232493|NCT04060771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65232494|NCT04060771|Serotonin Agents|serotonin agents|mesh-ancestor
65232495|NCT04060771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65232496|NCT04060771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232498|NCT00744913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65232499|NCT00744913|Autonomic Agents|autonomic agents|mesh-ancestor
65232500|NCT00744913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65232501|NCT00744913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232502|NCT00744913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65232503|NCT00744913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65232504|NCT00744913|Cholinergic Agents|cholinergic agents|mesh-ancestor
65232505|NCT00744913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65232506|NCT00744913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232507|NCT01875445|Inositol|inositol|mesh-list
65232508|NCT01875445|Vitamin B Complex|vitamin b complex|mesh-ancestor
65232509|NCT01875445|Vitamins|vitamins|mesh-ancestor
65232510|NCT01875445|Micronutrients|micronutrients|mesh-ancestor
65232511|NCT01875445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232512|NCT00745069|Tapentadol|tapentadol|mesh-list
65232513|NCT00745069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65232514|NCT00745069|Narcotics|narcotics|mesh-ancestor
65232515|NCT00745069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65232516|NCT00745069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232517|NCT00745069|Analgesics|analgesics|mesh-ancestor
65232518|NCT00745069|Sensory System Agents|sensory system agents|mesh-ancestor
65232519|NCT00745069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65232520|NCT00745069|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65232521|NCT00745069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65232522|NCT00745069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65232523|NCT00745069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232524|NCT00745069|Adrenergic Agents|adrenergic agents|mesh-ancestor
65232525|NCT00745069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65232526|NCT00745147|Laxatives|laxatives|mesh-list
65232527|NCT00745147|Lactulose|lactulose|mesh-list
65343829|NCT00809289|Moxifloxacin|moxifloxacin|mesh-list
65343830|NCT00809289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65343831|NCT00809289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65343832|NCT00809289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65343833|NCT00809289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65232528|NCT00745147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65232529|NCT00688909|Letrozole|letrozole|mesh-list
65232530|NCT00688909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232531|NCT00688909|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65232532|NCT00688909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65232533|NCT00688909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232534|NCT00688909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232535|NCT00688909|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65232536|NCT00688909|Hormone Antagonists|hormone antagonists|mesh-ancestor
65232537|NCT00688909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65232538|NCT00688909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232539|NCT00948428|Imiquimod|imiquimod|mesh-list
65232540|NCT00948428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65232541|NCT00948428|Immunologic Factors|immunologic factors|mesh-ancestor
64453955|NCT01998919|Antimetabolites|antimetabolites|mesh-ancestor
65232553|NCT00948194|Antioxidants|antioxidants|mesh-ancestor
65232554|NCT00948194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232555|NCT00948194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65232556|NCT00948194|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65232557|NCT00948194|Vasodilator Agents|vasodilator agents|mesh-ancestor
65232558|NCT00948194|Gasotransmitters|gasotransmitters|mesh-ancestor
65232559|NCT00948194|Protective Agents|protective agents|mesh-ancestor
65232560|NCT00691483|Varenicline|varenicline|mesh-list
65232561|NCT00691483|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65232562|NCT00691483|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65232563|NCT00691483|Cholinergic Agents|cholinergic agents|mesh-ancestor
65232564|NCT00691483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65232565|NCT00691483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232566|NCT00691483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232567|NCT00691093|Fesoterodine|fesoterodine|mesh-list
65232568|NCT00691093|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65232569|NCT00691093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65232570|NCT00691093|Cholinergic Agents|cholinergic agents|mesh-ancestor
65232571|NCT00691093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65232572|NCT00691093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232573|NCT00691093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232574|NCT00691093|Urological Agents|urological agents|mesh-ancestor
65232575|NCT03646825|Antioxidants|antioxidants|mesh-list
65232576|NCT03646825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232577|NCT03646825|Protective Agents|protective agents|mesh-ancestor
65232578|NCT03646825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232579|NCT00745225|Pioglitazone|pioglitazone|mesh-list
65232580|NCT00745225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65232581|NCT00745225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232582|NCT02856542|Betamethasone|betamethasone|mesh-list
65232583|NCT02856542|Betamethasone Valerate|betamethasone valerate|mesh-list
65232584|NCT02856542|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65232585|NCT02856542|Betamethasone benzoate|betamethasone benzoate|mesh-list
65232586|NCT02856542|Calcipotriene|calcipotriene|mesh-list
65232587|NCT02856542|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65232588|NCT02856542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65232589|NCT02856542|Glucocorticoids|glucocorticoids|mesh-ancestor
65232590|NCT02856542|Hormones|hormones|mesh-ancestor
65232591|NCT02856542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65232592|NCT02856542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232593|NCT02856542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65232594|NCT02856542|Respiratory System Agents|respiratory system agents|mesh-ancestor
65232595|NCT02856542|Dermatologic Agents|dermatologic agents|mesh-ancestor
65232596|NCT00688753|Everolimus|everolimus|mesh-list
65232597|NCT00688753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232598|NCT00688753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65232599|NCT00688753|Immunologic Factors|immunologic factors|mesh-ancestor
65232600|NCT00688753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232601|NCT04204382|Levofloxacin|levofloxacin|mesh-list
65232602|NCT04204382|Ofloxacin|ofloxacin|mesh-list
65343834|NCT00809289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343835|NCT00809289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343836|NCT00809289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232603|NCT04204382|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65232604|NCT04204382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65232605|NCT04204382|Renal Agents|renal agents|mesh-ancestor
65232606|NCT04204382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64454015|NCT01970540|Doxorubicin|doxorubicin|mesh-list
65232614|NCT02856230|Paclitaxel|paclitaxel|mesh-list
65232615|NCT02856230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65232616|NCT02856230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232617|NCT02856230|Tubulin Modulators|tubulin modulators|mesh-ancestor
65232618|NCT02856230|Antimitotic Agents|antimitotic agents|mesh-ancestor
65232619|NCT02856230|Mitosis Modulators|mitosis modulators|mesh-ancestor
65232620|NCT02856230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232621|NCT00631124|Drospirenone|drospirenone|mesh-list
65232622|NCT00631124|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65232623|NCT00631124|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65232625|NCT00631124|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65232626|NCT00631124|Estrogens|estrogens|mesh-ancestor
65232627|NCT00631124|Hormones|hormones|mesh-ancestor
65232628|NCT00631124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65232629|NCT00631124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232630|NCT00631124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65232631|NCT00631124|Contraceptive Agents|contraceptive agents|mesh-ancestor
65232632|NCT00631124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65232633|NCT00631124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65232634|NCT00631124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65232635|NCT00631124|Hormone Antagonists|hormone antagonists|mesh-ancestor
65232636|NCT00631124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65232637|NCT00631124|Diuretics|diuretics|mesh-ancestor
65232638|NCT00631124|Natriuretic Agents|natriuretic agents|mesh-ancestor
65232639|NCT02855684|Insulin|insulin|mesh-list
65232640|NCT02855684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65232641|NCT02855684|Insulin Glargine|insulin glargine|mesh-list
65232642|NCT02855684|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65232643|NCT02855684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232644|NCT01667744|Citalopram|citalopram|mesh-list
65232645|NCT01667744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65232646|NCT01667744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65232647|NCT01667744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65232648|NCT01667744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232649|NCT01667744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65232650|NCT01667744|Serotonin Agents|serotonin agents|mesh-ancestor
65232651|NCT01667744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232652|NCT01667744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65232653|NCT01667744|Antidepressive Agents|antidepressive agents|mesh-ancestor
65232654|NCT01667744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65232655|NCT04274270|Endostar protein|endostar protein|mesh-list
65232656|NCT04274270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65232657|NCT04274270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65232658|NCT04274270|Growth Substances|growth substances|mesh-ancestor
65232659|NCT04274270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232660|NCT04274270|Growth Inhibitors|growth inhibitors|mesh-ancestor
65232661|NCT04274270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232662|NCT02855294|Drospirenone|drospirenone|mesh-list
65232663|NCT02855294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65232664|NCT02855294|Hormone Antagonists|hormone antagonists|mesh-ancestor
65232665|NCT02855294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65232666|NCT02855294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232667|NCT02855294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65232669|NCT02855294|Natriuretic Agents|natriuretic agents|mesh-ancestor
65232670|NCT00950690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65232671|NCT00950690|Latanoprost|latanoprost|mesh-list
65232672|NCT00950690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65232673|NCT02855138|Isotretinoin|isotretinoin|mesh-list
65232709|NCT02563405|Nifedipine|nifedipine|mesh-list
65232710|NCT02563405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65232711|NCT02563405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65232712|NCT02563405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343837|NCT00728000|Gemcitabine|gemcitabine|mesh-list
65343838|NCT00728000|Oxaliplatin|oxaliplatin|mesh-list
65343839|NCT00728000|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65343840|NCT00728000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65343841|NCT00728000|Antimetabolites|antimetabolites|mesh-ancestor
65343842|NCT00728000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343843|NCT00728000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343844|NCT00728000|Antiviral Agents|antiviral agents|mesh-ancestor
65343845|NCT00728000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65343846|NCT00728000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343847|NCT00728000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65343848|NCT00728000|Immunologic Factors|immunologic factors|mesh-ancestor
65343849|NCT00728000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343850|NCT00728000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65343851|NCT04065230|Tenofovir|tenofovir|mesh-list
65343852|NCT04065230|Antiviral Agents|antiviral agents|mesh-ancestor
65232713|NCT02563405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64454150|NCT04624178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232727|NCT00513019|Lamotrigine|lamotrigine|mesh-list
65232728|NCT00513019|Anticonvulsants|anticonvulsants|mesh-list
65232729|NCT00513019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65232730|NCT00513019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65232731|NCT00513019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232732|NCT00513019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65232733|NCT00513019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232734|NCT00513019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65232735|NCT00513019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65232736|NCT00513019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65232737|NCT00513019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65232738|NCT00513019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65232739|NCT00053677|Naltrexone|naltrexone|mesh-list
65232740|NCT00053677|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65232741|NCT00053677|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65232742|NCT00053677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232743|NCT00053677|Sensory System Agents|sensory system agents|mesh-ancestor
65232744|NCT00053677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65232746|NCT00954512|Folic Acid|folic acid|mesh-list
65232747|NCT00954512|Gemcitabine|gemcitabine|mesh-list
65232748|NCT00954512|Carboplatin|carboplatin|mesh-list
65232749|NCT00954512|Trastuzumab|trastuzumab|mesh-list
65232750|NCT00954512|Irinotecan|irinotecan|mesh-list
65232751|NCT00954512|Cetuximab|cetuximab|mesh-list
65232752|NCT00954512|Everolimus|everolimus|mesh-list
65232753|NCT00954512|Epirubicin|epirubicin|mesh-list
65232754|NCT00954512|Levoleucovorin|levoleucovorin|mesh-list
65232755|NCT00954512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232756|NCT00954512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232757|NCT00954512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65232758|NCT00954512|Antimetabolites|antimetabolites|mesh-ancestor
65232759|NCT00954512|Antiviral Agents|antiviral agents|mesh-ancestor
65232760|NCT00954512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65232761|NCT00954512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232762|NCT00954512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65232763|NCT00954512|Immunologic Factors|immunologic factors|mesh-ancestor
65232764|NCT00954512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232765|NCT00954512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65232766|NCT00954512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65232767|NCT00954512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65232768|NCT00954512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65232769|NCT00954512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65343853|NCT04065230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65343854|NCT04065230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65343855|NCT04065230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65343856|NCT04065230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232771|NCT00954512|Protective Agents|protective agents|mesh-ancestor
65232772|NCT00954512|Vitamin B Complex|vitamin b complex|mesh-ancestor
65232773|NCT00954512|Vitamins|vitamins|mesh-ancestor
65232774|NCT00954512|Micronutrients|micronutrients|mesh-ancestor
65232775|NCT00954512|Hematinics|hematinics|mesh-ancestor
65232776|NCT00691015|Cytarabine|cytarabine|mesh-list
65232777|NCT00691015|Cyclophosphamide|cyclophosphamide|mesh-list
65232791|NCT00691015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65232793|NCT00691015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232794|NCT00691015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232795|NCT00691015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65232796|NCT00691015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65232797|NCT00691015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65232798|NCT00691015|Antimetabolites|antimetabolites|mesh-ancestor
65232799|NCT00691015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65232800|NCT00691015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65232801|NCT00691015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65232802|NCT00691015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232803|NCT00691015|Antiviral Agents|antiviral agents|mesh-ancestor
65232804|NCT00691015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65232805|NCT00950300|Cyclophosphamide|cyclophosphamide|mesh-list
65232806|NCT00950300|Docetaxel|docetaxel|mesh-list
65232807|NCT00950300|Fluorouracil|fluorouracil|mesh-list
65232808|NCT00950300|Trastuzumab|trastuzumab|mesh-list
65232809|NCT00950300|Epirubicin|epirubicin|mesh-list
65232810|NCT00950300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65232811|NCT00950300|Immunologic Factors|immunologic factors|mesh-ancestor
65232812|NCT00950300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232813|NCT00950300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65232814|NCT00950300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65232815|NCT00950300|Alkylating Agents|alkylating agents|mesh-ancestor
65232816|NCT00950300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232817|NCT00950300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232818|NCT00950300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65232819|NCT00950300|Tubulin Modulators|tubulin modulators|mesh-ancestor
65232820|NCT00950300|Antimitotic Agents|antimitotic agents|mesh-ancestor
65232821|NCT00950300|Mitosis Modulators|mitosis modulators|mesh-ancestor
65232822|NCT00950300|Antimetabolites|antimetabolites|mesh-ancestor
65232823|NCT00950300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65232824|NCT00950300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65232825|NCT00950300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65232826|NCT00950300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65232827|NCT00950300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65232828|NCT00950300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232829|NCT00949988|Rituximab|rituximab|mesh-list
65232830|NCT00949988|Dasatinib|dasatinib|mesh-list
65232831|NCT00949988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65232832|NCT00949988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232833|NCT00949988|Immunologic Factors|immunologic factors|mesh-ancestor
65232834|NCT00949988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232835|NCT00949988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65232836|NCT00949988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65232837|NCT00949988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232838|NCT00949988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232839|NCT00731692|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65232840|NCT00731692|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65232866|NCT00730912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65232867|NCT00730912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232868|NCT00730912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232869|NCT00730756|Fluticasone|fluticasone|mesh-list
65232870|NCT00730756|Xhance|xhance|mesh-list
65232871|NCT00730756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65232872|NCT00730756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65232873|NCT00730756|Autonomic Agents|autonomic agents|mesh-ancestor
65232874|NCT00730756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65232875|NCT00730756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232876|NCT00730756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65343857|NCT04065230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343858|NCT04065230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65343859|NCT04065230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65343860|NCT04213794|Sodium thiosulfate|sodium thiosulfate|mesh-list
65343861|NCT04213794|Cisplatin|cisplatin|mesh-list
65343862|NCT04213794|Doxorubicin|doxorubicin|mesh-list
65343863|NCT04213794|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65232877|NCT00730756|Respiratory System Agents|respiratory system agents|mesh-ancestor
65232878|NCT00730756|Dermatologic Agents|dermatologic agents|mesh-ancestor
65232879|NCT00730756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65232880|NCT00730132|Ezetimibe|ezetimibe|mesh-list
65232881|NCT00730132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65232882|NCT00730132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65232883|NCT00730132|Antimetabolites|antimetabolites|mesh-ancestor
65232884|NCT00730132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232885|NCT00730132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65232886|NCT00737464|Epoetin Alfa|epoetin alfa|mesh-list
65232887|NCT00737464|Hematinics|hematinics|mesh-ancestor
65232888|NCT00729586|Tamoxifen|tamoxifen|mesh-list
65232889|NCT00729586|Sirolimus|sirolimus|mesh-list
65232890|NCT00729586|Megestrol|megestrol|mesh-list
65232899|NCT00729586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232900|NCT00729586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65232901|NCT00729586|Hormone Antagonists|hormone antagonists|mesh-ancestor
65232902|NCT00729586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65232903|NCT00729586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65232904|NCT00729586|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65232905|NCT00729586|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65232906|NCT00729586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65232907|NCT00729586|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65232908|NCT00729586|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65232909|NCT00729586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65232910|NCT00729586|Contraceptive Agents|contraceptive agents|mesh-ancestor
65232911|NCT00729586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65232912|NCT00729586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65232913|NCT00729586|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65232914|NCT00729586|Appetite Stimulants|appetite stimulants|mesh-ancestor
65232915|NCT00729586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65232916|NCT00949910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65232917|NCT00949910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232918|NCT00949910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65232920|NCT00949910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232921|NCT02594800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65232922|NCT02594800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65232923|NCT02594800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65232924|NCT02594800|Antimetabolites|antimetabolites|mesh-ancestor
65232925|NCT02594800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232926|NCT02594800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65232927|NCT02594800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65232928|NCT02594800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232929|NCT02593162|Ribavirin|ribavirin|mesh-list
65232930|NCT02593162|Antimetabolites|antimetabolites|mesh-ancestor
65232931|NCT02593162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232932|NCT02593162|Antiviral Agents|antiviral agents|mesh-ancestor
65232933|NCT02593162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65232934|NCT00686959|Paclitaxel|paclitaxel|mesh-list
65232935|NCT00686959|Etoposide|etoposide|mesh-list
65232936|NCT00686959|Vinorelbine|vinorelbine|mesh-list
65232937|NCT00686959|Carboplatin|carboplatin|mesh-list
65232938|NCT00686959|Pemetrexed|pemetrexed|mesh-list
65232939|NCT00686959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65232940|NCT00686959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232941|NCT00686959|Tubulin Modulators|tubulin modulators|mesh-ancestor
65232942|NCT00686959|Antimitotic Agents|antimitotic agents|mesh-ancestor
65232943|NCT00686959|Mitosis Modulators|mitosis modulators|mesh-ancestor
65232944|NCT00686959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232945|NCT00686959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65232946|NCT00686959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65232947|NCT00686959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343864|NCT04213794|Daunorubicin|daunorubicin|mesh-list
65343865|NCT04213794|Antidotes|antidotes|mesh-list
65343866|NCT04213794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343867|NCT04213794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65343868|NCT04213794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65343869|NCT04213794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65343870|NCT04213794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343871|NCT04213794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343872|NCT04213794|Protective Agents|protective agents|mesh-ancestor
65343873|NCT04213794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343874|NCT04213794|Antioxidants|antioxidants|mesh-ancestor
65343875|NCT04213794|Antitubercular Agents|antitubercular agents|mesh-ancestor
65343876|NCT04213794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65343877|NCT04213794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65343878|NCT04213794|Chelating Agents|chelating agents|mesh-ancestor
65343879|NCT04213794|Sequestering Agents|sequestering agents|mesh-ancestor
65343880|NCT00728078|Thalidomide|thalidomide|mesh-list
65343881|NCT00728078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65343882|NCT00728078|Immunologic Factors|immunologic factors|mesh-ancestor
65343883|NCT00728078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343884|NCT00728078|Leprostatic Agents|leprostatic agents|mesh-ancestor
65343885|NCT00728078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65343886|NCT00728078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65343887|NCT00728078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65343888|NCT00728078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65343889|NCT00728078|Growth Substances|growth substances|mesh-ancestor
65343890|NCT00728078|Growth Inhibitors|growth inhibitors|mesh-ancestor
65343891|NCT00728078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343893|NCT04066088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65343894|NCT04066088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65343895|NCT04066088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65343896|NCT04066088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65343897|NCT04066088|Adrenergic Agents|adrenergic agents|mesh-ancestor
65343898|NCT04066088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65343899|NCT04066088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343904|NCT00730392|Etanercept|etanercept|mesh-list
65343905|NCT00730392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65343906|NCT00730392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65343907|NCT00730392|Analgesics|analgesics|mesh-ancestor
65343908|NCT00730392|Sensory System Agents|sensory system agents|mesh-ancestor
65343909|NCT00730392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65343910|NCT00730392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343911|NCT00730392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65232948|NCT00686959|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65232949|NCT00686959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65232950|NCT04088110|Trastuzumab|trastuzumab|mesh-list
65232951|NCT04088110|Letrozole|letrozole|mesh-list
65232952|NCT04088110|Anastrozole|anastrozole|mesh-list
65232953|NCT04088110|Exemestane|exemestane|mesh-list
65232954|NCT04088110|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65232955|NCT04088110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65232956|NCT04088110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232957|NCT04088110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65232983|NCT00602342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232984|NCT00602342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232985|NCT00602498|Clarithromycin|clarithromycin|mesh-list
65232986|NCT00602498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65232987|NCT00602498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65232988|NCT00602498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65232989|NCT00602498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232990|NCT00602498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232991|NCT00602498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64964872|NCT00163462|Ciclesonide|ciclesonide|mesh-list
65232992|NCT00602498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65232993|NCT00749359|Paroxetine|paroxetine|mesh-list
65232994|NCT00749359|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65232995|NCT00749359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65232996|NCT00749359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65232997|NCT00749359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232998|NCT00749359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65232999|NCT00749359|Serotonin Agents|serotonin agents|mesh-ancestor
65233000|NCT00749359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233001|NCT00749359|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65233002|NCT00749359|Antidepressive Agents|antidepressive agents|mesh-ancestor
64454425|NCT01951417|Adapalene|adapalene|mesh-list
65233014|NCT02562313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233015|NCT00736996|Pioglitazone|pioglitazone|mesh-list
65233016|NCT00736996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65233017|NCT00736996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233019|NCT00741949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65233020|NCT00741949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65233021|NCT00741949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233022|NCT00741949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65233023|NCT00741949|Anesthetics, General|anesthetics, general|mesh-ancestor
65233024|NCT00741949|Anesthetics|anesthetics|mesh-ancestor
65233025|NCT01410344|Vidarabine|vidarabine|mesh-list
65233026|NCT01410344|Cyclophosphamide|cyclophosphamide|mesh-list
65233027|NCT01410344|Melphalan|melphalan|mesh-list
65233028|NCT01410344|Busulfan|busulfan|mesh-list
65233029|NCT01410344|Fludarabine|fludarabine|mesh-list
65233030|NCT01410344|Fludarabine phosphate|fludarabine phosphate|mesh-list
65233031|NCT01410344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65233032|NCT01410344|Immunologic Factors|immunologic factors|mesh-ancestor
65233033|NCT01410344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233034|NCT01410344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65233035|NCT01410344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65233036|NCT01410344|Alkylating Agents|alkylating agents|mesh-ancestor
65233037|NCT01410344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233038|NCT01410344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233039|NCT01410344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65233040|NCT01410344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65343912|NCT00730392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65343913|NCT00730392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65343914|NCT00730392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65343915|NCT00730392|Immunologic Factors|immunologic factors|mesh-ancestor
65343916|NCT01528046|Metformin|metformin|mesh-list
65343917|NCT01528046|Irinotecan|irinotecan|mesh-list
65343918|NCT01528046|Camptothecin|camptothecin|mesh-list
65233041|NCT01410344|Antimetabolites|antimetabolites|mesh-ancestor
65233042|NCT01410344|Antiviral Agents|antiviral agents|mesh-ancestor
65233043|NCT01410344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65233044|NCT02594410|Lercanidipine|lercanidipine|mesh-list
65233045|NCT02594410|Clopidogrel|clopidogrel|mesh-list
64875784|NCT01873027|Sirolimus|sirolimus|mesh-list
65233046|NCT02594410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65233047|NCT02594410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65233048|NCT02594410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65233049|NCT02594410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65233050|NCT02594410|Purinergic Agents|purinergic agents|mesh-ancestor
65233051|NCT02594410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65233052|NCT02594410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233053|NCT02594410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233054|NCT02594410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65233055|NCT02594410|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65233056|NCT02594410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65233057|NCT02594410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65233058|NCT00954122|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65233059|NCT00954122|Antidepressive Agents|antidepressive agents|mesh-ancestor
65233060|NCT00954122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65233061|NCT00954122|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65233062|NCT00954122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65233063|NCT00954122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65233064|NCT00954122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233065|NCT00586066|Memantine|memantine|mesh-list
65233078|NCT00630890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233080|NCT00728494|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65233081|NCT00728494|Interferon-alpha|interferon-alpha|mesh-list
65233082|NCT00728494|Antimetabolites|antimetabolites|mesh-ancestor
65233083|NCT00728494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233084|NCT00728494|Antiviral Agents|antiviral agents|mesh-ancestor
65233085|NCT00728494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65233086|NCT00728494|Immunologic Factors|immunologic factors|mesh-ancestor
65233087|NCT00728494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233088|NCT02854904|Dexmedetomidine|dexmedetomidine|mesh-list
65233089|NCT02854904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65233090|NCT02854904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65233091|NCT02854904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233092|NCT02854904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65233093|NCT02854904|Analgesics|analgesics|mesh-ancestor
65233094|NCT02854904|Sensory System Agents|sensory system agents|mesh-ancestor
65233095|NCT02854904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65233096|NCT02854904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65233097|NCT02854904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65233098|NCT02854904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65233099|NCT02854904|Adrenergic Agents|adrenergic agents|mesh-ancestor
65233100|NCT02854904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65233101|NCT02854904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233102|NCT00728416|Mometasone Furoate|mometasone furoate|mesh-list
65233103|NCT00728416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65233104|NCT00728416|Dermatologic Agents|dermatologic agents|mesh-ancestor
65233105|NCT00728416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65233106|NCT00941330|Cyclophosphamide|cyclophosphamide|mesh-list
65233107|NCT00941330|Docetaxel|docetaxel|mesh-list
65233108|NCT00941330|Exemestane|exemestane|mesh-list
65233109|NCT00941330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65233110|NCT00941330|Immunologic Factors|immunologic factors|mesh-ancestor
65233111|NCT00941330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233112|NCT00941330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65233113|NCT00941330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65233136|NCT00736450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233137|NCT00736450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65343919|NCT01528046|Vincristine|vincristine|mesh-list
65343920|NCT01528046|Temozolomide|temozolomide|mesh-list
65343921|NCT01528046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65343922|NCT01528046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343923|NCT01528046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65343924|NCT01528046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65343925|NCT01528046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343926|NCT01528046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343927|NCT01528046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343928|NCT01528046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65233138|NCT00736450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65233139|NCT00736450|Alkylating Agents|alkylating agents|mesh-ancestor
65233140|NCT00736450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233142|NCT00736450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65233143|NCT00736450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65233144|NCT00736450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65233145|NCT00736450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65233146|NCT00736450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65233147|NCT00736450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233148|NCT00736450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65233149|NCT00736450|Glucocorticoids|glucocorticoids|mesh-ancestor
65233150|NCT00736450|Hormones|hormones|mesh-ancestor
65233151|NCT00736450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65233152|NCT00736450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65233153|NCT00736450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65233154|NCT00736450|Tubulin Modulators|tubulin modulators|mesh-ancestor
65233155|NCT00736450|Antimitotic Agents|antimitotic agents|mesh-ancestor
65233156|NCT00736450|Mitosis Modulators|mitosis modulators|mesh-ancestor
65233157|NCT00686881|Interferons|interferons|mesh-list
65233158|NCT00686881|Interferon-alpha|interferon-alpha|mesh-list
65233159|NCT00686881|Interferon alpha-2|interferon alpha-2|mesh-list
65233160|NCT00686881|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65233161|NCT00686881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233162|NCT00686881|Antiviral Agents|antiviral agents|mesh-ancestor
65233163|NCT00686881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65233164|NCT00686881|Immunologic Factors|immunologic factors|mesh-ancestor
65233165|NCT00686881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233166|NCT02857244|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65233167|NCT02857244|Modafinil|modafinil|mesh-list
65233168|NCT02857244|Donepezil|donepezil|mesh-list
64454578|NCT01951105|Analgesics|analgesics|mesh-ancestor
65233192|NCT04273256|Micronutrients|micronutrients|mesh-ancestor
65233193|NCT04273256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233194|NCT00921661|Aflibercept|aflibercept|mesh-list
65233195|NCT00921661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65233196|NCT00921661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65233197|NCT00921661|Growth Substances|growth substances|mesh-ancestor
65233198|NCT00921661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233199|NCT00921661|Growth Inhibitors|growth inhibitors|mesh-ancestor
65233200|NCT00921661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233201|NCT05096468|Pregabalin|pregabalin|mesh-list
65233202|NCT05096468|Ketamine|ketamine|mesh-list
65233203|NCT05096468|Esketamine|esketamine|mesh-list
65233204|NCT05096468|Analgesics|analgesics|mesh-ancestor
65233205|NCT05096468|Sensory System Agents|sensory system agents|mesh-ancestor
65233206|NCT05096468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65233207|NCT05096468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233208|NCT05096468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65233209|NCT05096468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65233210|NCT05096468|Anesthetics, General|anesthetics, general|mesh-ancestor
65233211|NCT05096468|Anesthetics|anesthetics|mesh-ancestor
65233212|NCT05096468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65233213|NCT05096468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65233214|NCT05096468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65233215|NCT05096468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65343929|NCT01528046|Tubulin Modulators|tubulin modulators|mesh-ancestor
65343930|NCT01528046|Antimitotic Agents|antimitotic agents|mesh-ancestor
65343931|NCT01528046|Mitosis Modulators|mitosis modulators|mesh-ancestor
65343932|NCT01528046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65343933|NCT01528046|Alkylating Agents|alkylating agents|mesh-ancestor
65343934|NCT00652899|Aldesleukin|aldesleukin|mesh-list
65343935|NCT00652899|Cyclophosphamide|cyclophosphamide|mesh-list
65343936|NCT00652899|Fludarabine|fludarabine|mesh-list
65233216|NCT05096468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233217|NCT05096468|Anticonvulsants|anticonvulsants|mesh-ancestor
65233218|NCT05096468|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65233247|NCT00735904|Antiviral Agents|antiviral agents|mesh-ancestor
65233248|NCT00735904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65233249|NCT00735904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233250|NCT00735904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65233251|NCT00735904|Immunologic Factors|immunologic factors|mesh-ancestor
65233252|NCT00735904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233253|NCT00735904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65233254|NCT02561923|Rivaroxaban|rivaroxaban|mesh-list
65233255|NCT02561923|Tranexamic Acid|tranexamic acid|mesh-list
65233256|NCT02561923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65233257|NCT02561923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65233258|NCT02561923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233259|NCT02561923|Hemostatics|hemostatics|mesh-ancestor
65233260|NCT02561923|Coagulants|coagulants|mesh-ancestor
65233261|NCT02561923|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65233262|NCT02561923|Antithrombins|antithrombins|mesh-ancestor
64454687|NCT01993823|Miconazole|miconazole|mesh-list
65233283|NCT00918190|Protease Inhibitors|protease inhibitors|mesh-ancestor
65233284|NCT00918190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233285|NCT00918190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233286|NCT00918190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65233287|NCT00918190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65233288|NCT00918190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65233289|NCT00918190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65233290|NCT00918190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65233291|NCT00918190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65233292|NCT00918190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65233293|NCT00918190|Anesthetics, General|anesthetics, general|mesh-ancestor
65233294|NCT00918190|Anesthetics|anesthetics|mesh-ancestor
65233295|NCT00918190|GABA Modulators|gaba modulators|mesh-ancestor
65233296|NCT00918190|GABA Agents|gaba agents|mesh-ancestor
65233297|NCT00918190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65233298|NCT00918190|Antipruritics|antipruritics|mesh-ancestor
65233299|NCT00918190|Dermatologic Agents|dermatologic agents|mesh-ancestor
65233300|NCT00918190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65233301|NCT00918190|Serotonin Agents|serotonin agents|mesh-ancestor
65233302|NCT00918190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65233304|NCT02563327|Vitamin B 6|vitamin b 6|mesh-list
65233305|NCT02563327|Moxifloxacin|moxifloxacin|mesh-list
65233306|NCT02563327|Rifampin|rifampin|mesh-list
65233307|NCT02563327|Isoniazid|isoniazid|mesh-list
65233308|NCT02563327|Pyrazinamide|pyrazinamide|mesh-list
65233309|NCT02563327|Ethambutol|ethambutol|mesh-list
65233310|NCT02563327|Rifapentine|rifapentine|mesh-list
65233311|NCT02563327|Vitamins|vitamins|mesh-ancestor
65233312|NCT02563327|Micronutrients|micronutrients|mesh-ancestor
65233313|NCT02563327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233314|NCT02563327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65233315|NCT02563327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65233316|NCT02563327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65233317|NCT02563327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65233318|NCT02563327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233319|NCT02563327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233320|NCT02563327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233321|NCT02563327|Vitamin B Complex|vitamin b complex|mesh-ancestor
65233322|NCT02563327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65233335|NCT02563327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65233336|NCT00918034|Talaporfin|talaporfin|mesh-list
65233337|NCT00918034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233338|NCT00918034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65233339|NCT00918034|Dermatologic Agents|dermatologic agents|mesh-ancestor
65343937|NCT00652899|Fludarabine phosphate|fludarabine phosphate|mesh-list
65343938|NCT00652899|Interleukin-2|interleukin-2|mesh-list
65343939|NCT00652899|Allopurinol|allopurinol|mesh-list
65343940|NCT00652899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65233340|NCT02593942|Remifentanil|remifentanil|mesh-list
65233341|NCT02593942|Propofol|propofol|mesh-list
65233342|NCT02593942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65233343|NCT02593942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65233344|NCT02593942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233345|NCT02593942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65233346|NCT02593942|Anesthetics, General|anesthetics, general|mesh-ancestor
65233347|NCT02593942|Anesthetics|anesthetics|mesh-ancestor
65233348|NCT02593942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65233350|NCT02593942|Analgesics|analgesics|mesh-ancestor
65233351|NCT02593942|Sensory System Agents|sensory system agents|mesh-ancestor
65233352|NCT02593942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65233353|NCT00742339|Octreotide|octreotide|mesh-list
65233354|NCT00742339|Terlipressin|terlipressin|mesh-list
65233355|NCT00742339|Midodrine|midodrine|mesh-list
65233356|NCT00742339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65233357|NCT00742339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65233358|NCT00742339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233359|NCT00742339|Sympathomimetics|sympathomimetics|mesh-ancestor
65233360|NCT00742339|Autonomic Agents|autonomic agents|mesh-ancestor
65233361|NCT00742339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65233362|NCT00742339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233363|NCT00742339|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65233364|NCT00742339|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65233365|NCT00742339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65233366|NCT00742339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65233367|NCT00742339|Adrenergic Agents|adrenergic agents|mesh-ancestor
65233368|NCT00742339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65233369|NCT00742339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233371|NCT02592772|Menthol|menthol|mesh-list
65233372|NCT02592772|Nicotine|nicotine|mesh-list
65233373|NCT02592772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65233374|NCT02592772|Autonomic Agents|autonomic agents|mesh-ancestor
65233375|NCT02592772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65233376|NCT02592772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233377|NCT02592772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65233378|NCT02592772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65233379|NCT02592772|Cholinergic Agents|cholinergic agents|mesh-ancestor
65233380|NCT02592772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65233381|NCT02592772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233382|NCT02592772|Antipruritics|antipruritics|mesh-ancestor
65233383|NCT02592772|Dermatologic Agents|dermatologic agents|mesh-ancestor
65233384|NCT00631202|Epoetin Alfa|epoetin alfa|mesh-list
65233385|NCT00631202|Hematinics|hematinics|mesh-ancestor
65233386|NCT00721630|Capecitabine|capecitabine|mesh-list
65233387|NCT00721630|Lapatinib|lapatinib|mesh-list
65233401|NCT04055623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233402|NCT04055623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65233403|NCT04055623|Analgesics|analgesics|mesh-ancestor
65233404|NCT04055623|Sensory System Agents|sensory system agents|mesh-ancestor
65233405|NCT04055623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65233406|NCT04055623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233407|NCT04055623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65233408|NCT04055623|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65233409|NCT04055623|Antiviral Agents|antiviral agents|mesh-ancestor
65233410|NCT04055623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65233411|NCT02561845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65233412|NCT02561845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65233413|NCT02561845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65233414|NCT02561845|Antimetabolites|antimetabolites|mesh-ancestor
65233415|NCT02561845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233416|NCT02561845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65233417|NCT02561845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65233418|NCT02561845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233419|NCT00727246|Choline|choline|mesh-list
65233420|NCT00727246|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
65233421|NCT00727246|Lipotropic Agents|lipotropic agents|mesh-ancestor
65233422|NCT00727246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65233423|NCT00727246|Antimetabolites|antimetabolites|mesh-ancestor
65233424|NCT00727246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343941|NCT00652899|Immunologic Factors|immunologic factors|mesh-ancestor
65343942|NCT00652899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343943|NCT00652899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65343944|NCT00652899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65343945|NCT00652899|Alkylating Agents|alkylating agents|mesh-ancestor
65343946|NCT00652899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343947|NCT00652899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343948|NCT00652899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65233425|NCT00727246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65233426|NCT00727246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65233427|NCT00727246|Nootropic Agents|nootropic agents|mesh-ancestor
65233428|NCT05381558|Triamcinolone|triamcinolone|mesh-list
65233429|NCT05381558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65233430|NCT05381558|Glucocorticoids|glucocorticoids|mesh-ancestor
65233431|NCT05381558|Hormones|hormones|mesh-ancestor
65233432|NCT05381558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65233433|NCT05381558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233434|NCT04055233|Biguanides|biguanides|mesh-list
65233435|NCT04055233|Polihexanide|polihexanide|mesh-list
65233436|NCT04055233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65233437|NCT04055233|Disinfectants|disinfectants|mesh-ancestor
65233438|NCT04055233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65233439|NCT04055233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233440|NCT05411497|Cyclophosphamide|cyclophosphamide|mesh-list
65233441|NCT05411497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65233442|NCT05411497|Immunologic Factors|immunologic factors|mesh-ancestor
65233443|NCT05411497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233444|NCT05411497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65233445|NCT05411497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65233447|NCT05411497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233448|NCT05411497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233449|NCT05411497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65233462|NCT04269278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65233463|NCT04269278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65233464|NCT04269278|Adrenergic Agents|adrenergic agents|mesh-ancestor
65233465|NCT04269278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65233466|NCT04269278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233467|NCT02853578|Budesonide|budesonide|mesh-list
65233468|NCT02853578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65233469|NCT02853578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65233470|NCT02853578|Autonomic Agents|autonomic agents|mesh-ancestor
65233471|NCT02853578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65233472|NCT02853578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233473|NCT02853578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65233474|NCT02853578|Respiratory System Agents|respiratory system agents|mesh-ancestor
65233475|NCT02853578|Glucocorticoids|glucocorticoids|mesh-ancestor
65233476|NCT02853578|Hormones|hormones|mesh-ancestor
65233477|NCT02853578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65233478|NCT02592694|Tenecteplase|tenecteplase|mesh-list
65233479|NCT02592694|Tirofiban|tirofiban|mesh-list
65233480|NCT02592694|Bivalirudin|bivalirudin|mesh-list
65233481|NCT02592694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65233482|NCT02592694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65233483|NCT02592694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233484|NCT02592694|Antithrombins|antithrombins|mesh-ancestor
65233485|NCT02592694|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65233486|NCT02592694|Protease Inhibitors|protease inhibitors|mesh-ancestor
65233487|NCT02592694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233488|NCT02592694|Anticoagulants|anticoagulants|mesh-ancestor
65233489|NCT02592694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65233490|NCT02591836|Atorvastatin|atorvastatin|mesh-list
65233491|NCT02591836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65233492|NCT02591836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65233493|NCT02591836|Antimetabolites|antimetabolites|mesh-ancestor
65233494|NCT02591836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233495|NCT02591836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65343949|NCT00652899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65343950|NCT00652899|Antimetabolites|antimetabolites|mesh-ancestor
65343951|NCT00652899|Antiviral Agents|antiviral agents|mesh-ancestor
65343952|NCT00652899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65343953|NCT00652899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65233496|NCT02591836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65233497|NCT02591836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233498|NCT02851472|Nitric Oxide|nitric oxide|mesh-list
65233499|NCT02851472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65233500|NCT02851472|Autonomic Agents|autonomic agents|mesh-ancestor
65233501|NCT02851472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65233502|NCT02851472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233503|NCT02851472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65233504|NCT02851472|Respiratory System Agents|respiratory system agents|mesh-ancestor
65233505|NCT02851472|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65233506|NCT02851472|Antioxidants|antioxidants|mesh-ancestor
65233507|NCT02851472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233508|NCT02851472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65233509|NCT02851472|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65233510|NCT02851472|Vasodilator Agents|vasodilator agents|mesh-ancestor
65233511|NCT02851472|Gasotransmitters|gasotransmitters|mesh-ancestor
65233527|NCT00687973|Autonomic Agents|autonomic agents|mesh-ancestor
65233528|NCT00687973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65233529|NCT00687973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65233530|NCT00687973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65233531|NCT00687973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65233532|NCT00687973|Adrenergic Agents|adrenergic agents|mesh-ancestor
65233533|NCT00687973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65233534|NCT00747097|Gemcitabine|gemcitabine|mesh-list
65233535|NCT00747097|Cetuximab|cetuximab|mesh-list
65233536|NCT00747097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65233537|NCT00747097|Antimetabolites|antimetabolites|mesh-ancestor
65233538|NCT00747097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233539|NCT00747097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233540|NCT00747097|Antiviral Agents|antiviral agents|mesh-ancestor
65233541|NCT00747097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65233542|NCT00747097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233543|NCT00747097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65233544|NCT00747097|Immunologic Factors|immunologic factors|mesh-ancestor
65233545|NCT00747097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233546|NCT00747097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65233547|NCT00747331|Fenoldopam|fenoldopam|mesh-list
65233548|NCT00747331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65233549|NCT00747331|Vasodilator Agents|vasodilator agents|mesh-ancestor
65233550|NCT00747331|Dopamine Agonists|dopamine agonists|mesh-ancestor
65233551|NCT00747331|Dopamine Agents|dopamine agents|mesh-ancestor
65233552|NCT00747331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65233553|NCT00747331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233554|NCT00747331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233555|NCT00747409|Insulin|insulin|mesh-list
65233556|NCT00747409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65233557|NCT00747409|Insulin Aspart|insulin aspart|mesh-list
65233558|NCT00747409|Insulin Detemir|insulin detemir|mesh-list
65233559|NCT00747409|Insulin, Long-Acting|insulin, long-acting|mesh-list
65233560|NCT00747409|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65233561|NCT00747409|Insulin, Isophane|insulin, isophane|mesh-list
65233562|NCT00747409|Isophane Insulin, Human|isophane insulin, human|mesh-list
65233563|NCT00747409|Isophane insulin, beef|isophane insulin, beef|mesh-list
65233564|NCT00747409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65233565|NCT00747409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233566|NCT00752011|Carboplatin|carboplatin|mesh-list
65233567|NCT00752011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233568|NCT00721396|Vaccines|vaccines|mesh-list
65233569|NCT00721396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65233570|NCT00721396|Immunologic Factors|immunologic factors|mesh-ancestor
65233571|NCT00721396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233572|NCT00943826|Bevacizumab|bevacizumab|mesh-list
64454970|NCT04060030|Leucovorin|leucovorin|mesh-list
65233593|NCT04268888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65233594|NCT04268888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343954|NCT00652899|Analgesics|analgesics|mesh-ancestor
65343955|NCT00652899|Sensory System Agents|sensory system agents|mesh-ancestor
65343956|NCT00652899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65343957|NCT00652899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65343958|NCT00652899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65343959|NCT00652899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343960|NCT00652899|Gout Suppressants|gout suppressants|mesh-ancestor
65343961|NCT00652899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65343962|NCT00652899|Antioxidants|antioxidants|mesh-ancestor
65343963|NCT00652899|Protective Agents|protective agents|mesh-ancestor
65343964|NCT04066452|Immunoglobulins|immunoglobulins|mesh-list
65343965|NCT04066452|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65343966|NCT04066452|Antibodies|antibodies|mesh-list
65343967|NCT04066452|Immunologic Factors|immunologic factors|mesh-ancestor
65343968|NCT04066452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343969|NCT00728520|Azacitidine|azacitidine|mesh-list
65343970|NCT00728520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65343971|NCT00728520|Antimetabolites|antimetabolites|mesh-ancestor
65343972|NCT00728520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952549|NCT00030719|Melphalan|melphalan|mesh-list
65233595|NCT04268888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65233596|NCT00603356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65233597|NCT00603356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233598|NCT00603356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65233599|NCT00603356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233600|NCT00603356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233601|NCT02851394|Tramadol|tramadol|mesh-list
65233602|NCT02851394|Levobupivacaine|levobupivacaine|mesh-list
65233603|NCT02851394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65233604|NCT02851394|Narcotics|narcotics|mesh-ancestor
65233605|NCT02851394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65233606|NCT02851394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233607|NCT02851394|Analgesics|analgesics|mesh-ancestor
65233608|NCT02851394|Sensory System Agents|sensory system agents|mesh-ancestor
65233609|NCT02851394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65233610|NCT02851394|Anesthetics, Local|anesthetics, local|mesh-ancestor
65233611|NCT02851394|Anesthetics|anesthetics|mesh-ancestor
65233612|NCT00603434|Methylphenidate|methylphenidate|mesh-list
65233613|NCT00603434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65233614|NCT00603434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233615|NCT00603434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65233616|NCT00603434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65233617|NCT00603434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65233618|NCT00603434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233619|NCT00603434|Dopamine Agents|dopamine agents|mesh-ancestor
65233620|NCT00603434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65233621|NCT01004003|Sorafenib|sorafenib|mesh-list
65233622|NCT01004003|Nintedanib|nintedanib|mesh-list
65233623|NCT01004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233635|NCT00943670|Antimitotic Agents|antimitotic agents|mesh-ancestor
65233636|NCT00943670|Mitosis Modulators|mitosis modulators|mesh-ancestor
65233637|NCT00943670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233639|NCT02851004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65233640|NCT02851004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233641|NCT00938366|Cladribine|cladribine|mesh-list
65233642|NCT00938366|Pantoprazole|pantoprazole|mesh-list
65343973|NCT00728520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343974|NCT00728520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343975|NCT04065308|Daratumumab|daratumumab|mesh-list
65343976|NCT04065308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65343977|NCT00733538|Zoledronic Acid|zoledronic acid|mesh-list
65343978|NCT00733538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65343979|NCT00733538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343980|NCT00728156|Clopidogrel|clopidogrel|mesh-list
65233643|NCT00938366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65233644|NCT00938366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65233645|NCT00938366|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65233646|NCT00938366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233647|NCT00938366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233648|NCT00938366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233649|NCT00938366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65233650|NCT00938366|Immunologic Factors|immunologic factors|mesh-ancestor
65233651|NCT00938366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233652|NCT00943592|Melphalan|melphalan|mesh-list
65233653|NCT00943592|Alemtuzumab|alemtuzumab|mesh-list
65233654|NCT00943592|Clofarabine|clofarabine|mesh-list
65233655|NCT00943592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65233656|NCT00943592|Alkylating Agents|alkylating agents|mesh-ancestor
65233657|NCT00943592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233658|NCT00943592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233659|NCT00943592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65233660|NCT00943592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65233661|NCT00943592|Immunologic Factors|immunologic factors|mesh-ancestor
65233662|NCT00943592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233663|NCT00943592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65233664|NCT00943592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65233665|NCT00943592|Antimetabolites|antimetabolites|mesh-ancestor
65233667|NCT00943124|Niacinamide|niacinamide|mesh-list
65233668|NCT00943124|Nicotinic Acids|nicotinic acids|mesh-list
65233669|NCT00943124|Simvastatin|simvastatin|mesh-list
65233670|NCT00943124|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65233671|NCT00943124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65233672|NCT00943124|Antimetabolites|antimetabolites|mesh-ancestor
65233673|NCT00943124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233674|NCT00943124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65233675|NCT00943124|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65233676|NCT00943124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233677|NCT00943124|Vasodilator Agents|vasodilator agents|mesh-ancestor
65233678|NCT00943124|Vitamin B Complex|vitamin b complex|mesh-ancestor
65233679|NCT00943124|Vitamins|vitamins|mesh-ancestor
65233680|NCT00943124|Micronutrients|micronutrients|mesh-ancestor
65233681|NCT00943124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233682|NCT00492050|Valacyclovir|valacyclovir|mesh-list
65233683|NCT00492050|Rituximab|rituximab|mesh-list
65233684|NCT00492050|Bortezomib|bortezomib|mesh-list
65233685|NCT00492050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65233686|NCT00492050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233687|NCT00492050|Immunologic Factors|immunologic factors|mesh-ancestor
65233688|NCT00492050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233700|NCT00940316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233702|NCT00940316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65233703|NCT00940316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65233704|NCT02850848|Entecavir|entecavir|mesh-list
65233705|NCT02850848|Antiviral Agents|antiviral agents|mesh-ancestor
65233706|NCT02850848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65233707|NCT05381168|Calcium, Dietary|calcium, dietary|mesh-list
65233708|NCT05381168|Calcium Carbonate|calcium carbonate|mesh-list
65233709|NCT05381168|Calcium|calcium|mesh-list
65233710|NCT05381168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65233711|NCT05381168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233712|NCT05381168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65233713|NCT05381168|Antacids|antacids|mesh-ancestor
65233714|NCT05381168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233715|NCT05381168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65343981|NCT00728156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65343982|NCT00728156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65343983|NCT00728156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65343984|NCT00728156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65343985|NCT00728156|Purinergic Agents|purinergic agents|mesh-ancestor
65343986|NCT00728156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65343987|NCT00728156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343988|NCT00728156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65343989|NCT02569554|Rabeprazole|rabeprazole|mesh-list
65233716|NCT00726388|Diclofenac|diclofenac|mesh-list
65233717|NCT00726388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65233718|NCT00726388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65233719|NCT00726388|Analgesics|analgesics|mesh-ancestor
65233720|NCT00726388|Sensory System Agents|sensory system agents|mesh-ancestor
65233721|NCT00726388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65233722|NCT00726388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233723|NCT00726388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65233724|NCT00726388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65233725|NCT00726388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65233726|NCT00726388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233727|NCT00726388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233728|NCT00572455|Latanoprost|latanoprost|mesh-list
65233729|NCT00572455|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65233730|NCT00572455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65233731|NCT00752323|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65233732|NCT00752323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65233733|NCT00752323|Dermatologic Agents|dermatologic agents|mesh-ancestor
65233734|NCT00686335|Prednisone|prednisone|mesh-list
65233735|NCT00686335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65233736|NCT00686335|Glucocorticoids|glucocorticoids|mesh-ancestor
65233737|NCT00686335|Hormones|hormones|mesh-ancestor
65233738|NCT00686335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65233739|NCT00686335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233740|NCT00686335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65233741|NCT00686335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233742|NCT00685945|Isosorbide|isosorbide|mesh-list
65233743|NCT00685945|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65233744|NCT00685945|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65233746|NCT00685945|Bradykinin|bradykinin|mesh-list
65233747|NCT00685945|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
65233748|NCT00685945|Kininogens|kininogens|mesh-list
65233749|NCT00685945|Vasodilator Agents|vasodilator agents|mesh-ancestor
65233750|NCT00685945|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65233751|NCT00685945|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65233752|NCT00685945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233753|NCT00685945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233754|NCT00685945|Urological Agents|urological agents|mesh-ancestor
65233768|NCT00750217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65233769|NCT00750217|Narcotics|narcotics|mesh-ancestor
65233770|NCT00750217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65233771|NCT00750217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233772|NCT00750217|Analgesics|analgesics|mesh-ancestor
65233773|NCT00750217|Sensory System Agents|sensory system agents|mesh-ancestor
65233774|NCT00750217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65233775|NCT00750217|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65233776|NCT00687739|Leuprolide|leuprolide|mesh-list
65233777|NCT00687739|Estradiol|estradiol|mesh-list
65233778|NCT00687739|Estrogens|estrogens|mesh-ancestor
65233779|NCT00687739|Hormones|hormones|mesh-ancestor
65233780|NCT00687739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65233781|NCT00687739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233782|NCT00687739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65233783|NCT00687739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65233784|NCT00687739|Fertility Agents|fertility agents|mesh-ancestor
65233785|NCT00687739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65343990|NCT02569554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65343991|NCT02569554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65343992|NCT02569554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65343993|NCT02569554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65343994|NCT02569554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65343995|NCT00734318|Fluticasone|fluticasone|mesh-list
65343996|NCT00734318|Xhance|xhance|mesh-list
65343997|NCT00734318|Formoterol Fumarate|formoterol fumarate|mesh-list
65343998|NCT00734318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65343999|NCT00734318|Autonomic Agents|autonomic agents|mesh-ancestor
65344000|NCT00734318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65344001|NCT00734318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233786|NCT00687739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233787|NCT00752401|Vitamin D|vitamin d|mesh-list
65233788|NCT00752401|Cholecalciferol|cholecalciferol|mesh-list
65233789|NCT00752401|Vitamins|vitamins|mesh-ancestor
65233790|NCT00752401|Micronutrients|micronutrients|mesh-ancestor
65233791|NCT00752401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233792|NCT00752401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65233793|NCT00752401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65233794|NCT00750451|Heparin|heparin|mesh-list
65233795|NCT00750451|Enoxaparin|enoxaparin|mesh-list
65233796|NCT00750451|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65233797|NCT00750451|Tinzaparin|tinzaparin|mesh-list
65233798|NCT00750451|Dalteparin|dalteparin|mesh-list
65233799|NCT00750451|Enoxaparin sodium|enoxaparin sodium|mesh-list
65233800|NCT00750451|Anticoagulants|anticoagulants|mesh-ancestor
65233801|NCT00750451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65233802|NCT00750451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65233803|NCT00750451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233804|NCT00747721|Dexmedetomidine|dexmedetomidine|mesh-list
65233805|NCT00747721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65233806|NCT00747721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65233807|NCT00747721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233808|NCT00747721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65233809|NCT00747721|Analgesics|analgesics|mesh-ancestor
65233810|NCT00747721|Sensory System Agents|sensory system agents|mesh-ancestor
65233811|NCT00747721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65233812|NCT00747721|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65233813|NCT00747721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65233814|NCT00747721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65233815|NCT00747721|Adrenergic Agents|adrenergic agents|mesh-ancestor
65233816|NCT00747721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65233817|NCT00747721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233818|NCT01006889|Exenatide|exenatide|mesh-list
65233831|NCT02561767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65233832|NCT02561767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233833|NCT02561767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233834|NCT02561767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65233835|NCT02561767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233836|NCT02561767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65233837|NCT02561767|Antitubercular Agents|antitubercular agents|mesh-ancestor
65233838|NCT02561767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65233839|NCT02561767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65233841|NCT00747799|Sorafenib|sorafenib|mesh-list
65233842|NCT00747799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233843|NCT00747799|Antimetabolites|antimetabolites|mesh-ancestor
65233844|NCT00747799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233845|NCT00747799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65233846|NCT00747799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65233847|NCT00747799|Immunologic Factors|immunologic factors|mesh-ancestor
65233848|NCT00747799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233849|NCT00747799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65344002|NCT00734318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65344003|NCT00734318|Respiratory System Agents|respiratory system agents|mesh-ancestor
65344004|NCT00734318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65344005|NCT00734318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65233850|NCT00747799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233851|NCT04294823|Esomeprazole|esomeprazole|mesh-list
65233852|NCT04294823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65233853|NCT04294823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65233854|NCT04294823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65233855|NCT04294823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233856|NCT04294823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233857|NCT04294511|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65233858|NCT04294511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233859|NCT04294511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233860|NCT01001429|Dexmedetomidine|dexmedetomidine|mesh-list
65233861|NCT01001429|Propofol|propofol|mesh-list
65233862|NCT01001429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65233863|NCT01001429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65233864|NCT01001429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233865|NCT01001429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65233866|NCT01001429|Anesthetics, General|anesthetics, general|mesh-ancestor
65233867|NCT01001429|Anesthetics|anesthetics|mesh-ancestor
65233868|NCT01001429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65233869|NCT01001429|Analgesics|analgesics|mesh-ancestor
65233870|NCT01001429|Sensory System Agents|sensory system agents|mesh-ancestor
65233871|NCT01001429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65233872|NCT01001429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65233873|NCT01001429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65233874|NCT01001429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65233875|NCT01001429|Adrenergic Agents|adrenergic agents|mesh-ancestor
65233876|NCT01001429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65233877|NCT01001429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233878|NCT01000961|Cysteamine|cysteamine|mesh-list
65233879|NCT01000961|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
65233880|NCT01000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233881|NCT01000805|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65233882|NCT01000805|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65233896|NCT00684307|Vitamins|vitamins|mesh-ancestor
65233897|NCT00684307|Micronutrients|micronutrients|mesh-ancestor
65233898|NCT00684307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233899|NCT00684307|Anticoagulants|anticoagulants|mesh-ancestor
65233900|NCT00684307|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65233901|NCT00684307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65233902|NCT00684307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233903|NCT00684307|Hemostatics|hemostatics|mesh-ancestor
65233904|NCT00684307|Coagulants|coagulants|mesh-ancestor
65233905|NCT00683917|Leuprolide|leuprolide|mesh-list
65233906|NCT00683917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65233907|NCT00683917|Fertility Agents|fertility agents|mesh-ancestor
65233908|NCT00683917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65233909|NCT00683917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233910|NCT00683917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65233911|NCT00683917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233912|NCT00750529|Donepezil|donepezil|mesh-list
65233913|NCT00750529|Galantamine|galantamine|mesh-list
65233914|NCT00750529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65233915|NCT00750529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233916|NCT00750529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233917|NCT00750529|Cholinergic Agents|cholinergic agents|mesh-ancestor
65233918|NCT00750529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65233919|NCT00750529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233920|NCT00750529|Nootropic Agents|nootropic agents|mesh-ancestor
65233921|NCT00750529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65233922|NCT00750529|Autonomic Agents|autonomic agents|mesh-ancestor
65233923|NCT00750529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65233924|NCT00747877|Cyclophosphamide|cyclophosphamide|mesh-list
65233925|NCT00747877|Melphalan|melphalan|mesh-list
65233926|NCT00747877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65233927|NCT00747877|Immunologic Factors|immunologic factors|mesh-ancestor
65233928|NCT00747877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344006|NCT00734318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65344007|NCT00734318|Adrenergic Agents|adrenergic agents|mesh-ancestor
65344008|NCT00734318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65344009|NCT00734318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344010|NCT00734318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65233929|NCT00747877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65233930|NCT00747877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65233931|NCT00747877|Alkylating Agents|alkylating agents|mesh-ancestor
65233932|NCT00747877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233933|NCT00747877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233934|NCT00747877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65233935|NCT00750763|Picosulfate sodium|picosulfate sodium|mesh-list
65233936|NCT00750763|Cathartics|cathartics|mesh-ancestor
65233937|NCT00750763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65233938|NCT00752479|Cyclosporine|cyclosporine|mesh-list
65233939|NCT00752479|Mycophenolic Acid|mycophenolic acid|mesh-list
65233940|NCT00752479|Methylprednisolone|methylprednisolone|mesh-list
65233941|NCT00752479|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65233942|NCT00752479|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65233943|NCT00752479|Prednisolone|prednisolone|mesh-list
65233944|NCT00752479|Prednisolone acetate|prednisolone acetate|mesh-list
65233945|NCT00752479|Cyclosporins|cyclosporins|mesh-list
65233946|NCT00752479|Basiliximab|basiliximab|mesh-list
65233947|NCT00752479|Thymoglobulin|thymoglobulin|mesh-list
65233948|NCT00752479|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65233949|NCT00752479|Prednisolone phosphate|prednisolone phosphate|mesh-list
65233973|NCT00752479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65233974|NCT00752479|Protective Agents|protective agents|mesh-ancestor
65233975|NCT00752479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65233976|NCT00752635|Moxifloxacin|moxifloxacin|mesh-list
65233977|NCT00752635|Cyproterone Acetate|cyproterone acetate|mesh-list
65233978|NCT00752635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65233979|NCT00752635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65233980|NCT00752635|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65233981|NCT00752635|Norgestimate|norgestimate|mesh-list
65233982|NCT00752635|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65233984|NCT00752635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65233985|NCT00752635|Cyproterone|cyproterone|mesh-list
65233986|NCT00752635|Estrogens|estrogens|mesh-ancestor
65233987|NCT00752635|Hormones|hormones|mesh-ancestor
65233988|NCT00752635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65233989|NCT00752635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233990|NCT00752635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65233991|NCT00752635|Contraceptive Agents|contraceptive agents|mesh-ancestor
65233992|NCT00752635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65233993|NCT00752635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65233994|NCT00752635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65233995|NCT00752635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65233996|NCT00752635|Androgen Antagonists|androgen antagonists|mesh-ancestor
65233997|NCT00752635|Hormone Antagonists|hormone antagonists|mesh-ancestor
64455395|NCT01900730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65234022|NCT00752869|Hormone Antagonists|hormone antagonists|mesh-ancestor
65234023|NCT00752869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65234024|NCT00752869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234025|NCT00751153|Raltegravir Potassium|raltegravir potassium|mesh-list
65234026|NCT00751153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65234027|NCT00751153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65234029|NCT00751153|Antiviral Agents|antiviral agents|mesh-ancestor
65234030|NCT00751153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65234031|NCT00751153|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65234032|NCT00751153|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65234033|NCT00751153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234034|NCT00751153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234035|NCT00751153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65234036|NCT00751153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65234037|NCT00751153|Protease Inhibitors|protease inhibitors|mesh-ancestor
65234038|NCT00748423|Nitric Oxide|nitric oxide|mesh-list
65234039|NCT00748423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65234040|NCT00748423|Autonomic Agents|autonomic agents|mesh-ancestor
65234041|NCT00748423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65344011|NCT00734318|Dermatologic Agents|dermatologic agents|mesh-ancestor
65344012|NCT00734318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65344013|NCT00733616|Docetaxel|docetaxel|mesh-list
65344014|NCT00733616|Capecitabine|capecitabine|mesh-list
65344015|NCT00733616|Oxaliplatin|oxaliplatin|mesh-list
65344016|NCT00733616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234042|NCT00748423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234043|NCT00748423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65234044|NCT00748423|Respiratory System Agents|respiratory system agents|mesh-ancestor
65234046|NCT00748423|Antioxidants|antioxidants|mesh-ancestor
64455443|NCT01411774|Renal Agents|renal agents|mesh-ancestor
65234059|NCT00687271|Antimetabolites|antimetabolites|mesh-ancestor
65234060|NCT00687271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234061|NCT00687271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65234062|NCT00687271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65234063|NCT00687271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234064|NCT02562625|Pembrolizumab|pembrolizumab|mesh-list
65234065|NCT02562625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65234066|NCT02562625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234067|NCT00752947|Moxifloxacin|moxifloxacin|mesh-list
65234068|NCT00752947|Metronidazole|metronidazole|mesh-list
65234069|NCT00752947|Levofloxacin|levofloxacin|mesh-list
65234070|NCT00752947|Ofloxacin|ofloxacin|mesh-list
65234071|NCT00752947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65234072|NCT00752947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65234073|NCT00752947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65234074|NCT00752947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65234075|NCT00752947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234076|NCT00752947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234077|NCT00752947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234078|NCT00752947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65234079|NCT00752947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65234080|NCT00752947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65234081|NCT00752947|Renal Agents|renal agents|mesh-ancestor
65234082|NCT00752947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65234083|NCT00752947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65234084|NCT04614545|Phentermine|phentermine|mesh-list
65234085|NCT04614545|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65234086|NCT04614545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234087|NCT04614545|Appetite Depressants|appetite depressants|mesh-ancestor
65234088|NCT04614545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65234089|NCT04614545|Sympathomimetics|sympathomimetics|mesh-ancestor
65234090|NCT04614545|Autonomic Agents|autonomic agents|mesh-ancestor
65234091|NCT04614545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65234092|NCT04614545|Adrenergic Agents|adrenergic agents|mesh-ancestor
65234093|NCT04614545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65234094|NCT04614545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234095|NCT01031381|Bevacizumab|bevacizumab|mesh-list
65234096|NCT01031381|Everolimus|everolimus|mesh-list
65234097|NCT01031381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65234098|NCT01031381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234099|NCT01031381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65234100|NCT01031381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65234101|NCT01031381|Growth Substances|growth substances|mesh-ancestor
65234102|NCT01031381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234103|NCT01031381|Growth Inhibitors|growth inhibitors|mesh-ancestor
65234104|NCT01031381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65234105|NCT01031381|Immunologic Factors|immunologic factors|mesh-ancestor
65234106|NCT00685399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65234107|NCT00685399|Immunologic Factors|immunologic factors|mesh-ancestor
64455491|NCT01976845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65234120|NCT00753103|Prednisolone|prednisolone|mesh-list
65234121|NCT00753103|Cyclophosphamide|cyclophosphamide|mesh-list
65234122|NCT00753103|Azathioprine|azathioprine|mesh-list
65234123|NCT00753103|Infliximab|infliximab|mesh-list
65234124|NCT00753103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65234125|NCT00753103|Immunologic Factors|immunologic factors|mesh-ancestor
65234126|NCT00753103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234127|NCT00753103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65234128|NCT00753103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65234129|NCT00753103|Alkylating Agents|alkylating agents|mesh-ancestor
65344017|NCT00733616|Tubulin Modulators|tubulin modulators|mesh-ancestor
65344018|NCT00733616|Antimitotic Agents|antimitotic agents|mesh-ancestor
65344019|NCT00733616|Mitosis Modulators|mitosis modulators|mesh-ancestor
65344020|NCT00733616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344021|NCT00733616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65344022|NCT00733616|Antimetabolites|antimetabolites|mesh-ancestor
65344023|NCT00728832|Morphine|morphine|mesh-list
65344024|NCT00728832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65344025|NCT00728832|Narcotics|narcotics|mesh-ancestor
65344026|NCT00728832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65344027|NCT00728832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344028|NCT00728832|Analgesics|analgesics|mesh-ancestor
65344029|NCT00728832|Sensory System Agents|sensory system agents|mesh-ancestor
65344030|NCT00728832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65344031|NCT03924804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65344032|NCT00728312|Aripiprazole|aripiprazole|mesh-list
65344033|NCT00728312|Antidepressive Agents|antidepressive agents|mesh-ancestor
65344034|NCT00728312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65344035|NCT00728312|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65344036|NCT00728312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65344037|NCT00728312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65344038|NCT00728312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344039|NCT00728312|Dopamine Agonists|dopamine agonists|mesh-ancestor
65344040|NCT00728312|Dopamine Agents|dopamine agents|mesh-ancestor
65344041|NCT00728312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65234130|NCT00753103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234131|NCT00753103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234132|NCT00753103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65234133|NCT00753103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65234134|NCT00753103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65234135|NCT00753103|Antitubercular Agents|antitubercular agents|mesh-ancestor
65234136|NCT00753103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65234137|NCT00753103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65234138|NCT00753103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234139|NCT00753103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65234140|NCT00753103|Antiemetics|antiemetics|mesh-ancestor
65234141|NCT00753103|Autonomic Agents|autonomic agents|mesh-ancestor
65234142|NCT00753103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65234143|NCT00753103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65234144|NCT00753103|Glucocorticoids|glucocorticoids|mesh-ancestor
65234145|NCT00753103|Hormones|hormones|mesh-ancestor
65234146|NCT00753103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65234147|NCT00753103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65234148|NCT00753103|Protective Agents|protective agents|mesh-ancestor
65234149|NCT00753103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65234150|NCT00753103|Dermatologic Agents|dermatologic agents|mesh-ancestor
65234151|NCT00753103|Antimetabolites|antimetabolites|mesh-ancestor
65234152|NCT00753103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65234153|NCT00748891|Cediranib|cediranib|mesh-list
65234154|NCT00748891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344042|NCT00728312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344043|NCT00728312|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65344044|NCT00728312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65344045|NCT00728312|Serotonin Agents|serotonin agents|mesh-ancestor
65344046|NCT00728312|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65344047|NCT00728312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65344048|NCT00728312|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65344049|NCT00728312|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65344050|NCT00728546|Isoniazid|isoniazid|mesh-list
65344051|NCT00728546|Antitubercular Agents|antitubercular agents|mesh-ancestor
65344052|NCT00728546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65344053|NCT00728546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65344054|NCT00728546|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65344055|NCT00728546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65344056|NCT00728546|Antimetabolites|antimetabolites|mesh-ancestor
64725909|NCT00003080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234155|NCT00748891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65234156|NCT00748891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234157|NCT00748891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234158|NCT00685165|Primidone|primidone|mesh-list
65234159|NCT00685165|Anticonvulsants|anticonvulsants|mesh-ancestor
65234160|NCT00685165|GABA Modulators|gaba modulators|mesh-ancestor
65234161|NCT00685165|GABA Agents|gaba agents|mesh-ancestor
65234162|NCT00685165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65234163|NCT00685165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234164|NCT00685165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234165|NCT00749047|Pioglitazone|pioglitazone|mesh-list
65234166|NCT00749047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65234167|NCT00749047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234168|NCT05393713|Antibodies|antibodies|mesh-list
65234169|NCT05393713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65234170|NCT05393713|Immunologic Factors|immunologic factors|mesh-ancestor
64455560|NCT01940887|Bevacizumab|bevacizumab|mesh-list
65234204|NCT00755989|Analgesics|analgesics|mesh-ancestor
65234205|NCT00755989|Sensory System Agents|sensory system agents|mesh-ancestor
65234206|NCT00755989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65234207|NCT00756067|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65234208|NCT00756067|Immunologic Factors|immunologic factors|mesh-ancestor
65234209|NCT00756067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234210|NCT05388877|Dabrafenib|dabrafenib|mesh-list
65234211|NCT05388877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455616|NCT01408888|Protease Inhibitors|protease inhibitors|mesh-ancestor
65234244|NCT00720382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65234245|NCT00720382|Dermatologic Agents|dermatologic agents|mesh-ancestor
65234246|NCT00720382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65234247|NCT00720382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65234248|NCT00720382|Autonomic Agents|autonomic agents|mesh-ancestor
65234249|NCT00720382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65234250|NCT00720382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234251|NCT00720382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65234252|NCT00720382|Respiratory System Agents|respiratory system agents|mesh-ancestor
65234253|NCT00720382|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65234263|NCT00754039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65234264|NCT00754039|Antimetabolites|antimetabolites|mesh-ancestor
65234265|NCT00754039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234266|NCT00754039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65234267|NCT00754039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65234268|NCT02560909|Vaccines|vaccines|mesh-list
65234269|NCT02560909|Immunologic Factors|immunologic factors|mesh-ancestor
65344057|NCT00728546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344058|NCT00728546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65344059|NCT00617890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65344060|NCT00617890|Immunologic Factors|immunologic factors|mesh-ancestor
65344061|NCT00617890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344062|NCT00728780|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65344063|NCT00728780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65344064|NCT00728780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65344065|NCT00728780|Antimetabolites|antimetabolites|mesh-ancestor
65344066|NCT00728780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344067|NCT00728780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65344068|NCT00728780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65344069|NCT00728780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344070|NCT04066296|Bupivacaine|bupivacaine|mesh-list
65234270|NCT02560909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234272|NCT02592226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65234273|NCT02592226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234274|NCT02970448|Temozolomide|temozolomide|mesh-list
65234275|NCT02970448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65234276|NCT02970448|Alkylating Agents|alkylating agents|mesh-ancestor
65234277|NCT02970448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234278|NCT02970448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234279|NCT00756301|Lidocaine|lidocaine|mesh-list
65234280|NCT00756301|Anesthetics, Local|anesthetics, local|mesh-ancestor
65234281|NCT00756301|Anesthetics|anesthetics|mesh-ancestor
65234282|NCT00756301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65234283|NCT00756301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234284|NCT00756301|Sensory System Agents|sensory system agents|mesh-ancestor
65234285|NCT00756301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65234286|NCT00756301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65234287|NCT00756301|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65234288|NCT00756301|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65234289|NCT00756301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65234290|NCT00756301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234291|NCT00756691|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
65234292|NCT00756691|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65234293|NCT00756691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234294|NCT00720226|Losartan|losartan|mesh-list
65234295|NCT00720226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65234296|NCT00720226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65234297|NCT00720226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65234298|NCT00720226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65234299|NCT00720226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234300|NCT00725920|Topiramate|topiramate|mesh-list
65234301|NCT00725920|Anticonvulsants|anticonvulsants|mesh-ancestor
65234302|NCT00725920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65234303|NCT00725920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234304|NCT00725842|Ribavirin|ribavirin|mesh-list
65234305|NCT00725842|Interferon alpha-2|interferon alpha-2|mesh-list
65234306|NCT00725842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65234307|NCT00725842|Antimetabolites|antimetabolites|mesh-ancestor
65234308|NCT00725842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234309|NCT00725842|Antiviral Agents|antiviral agents|mesh-ancestor
65234310|NCT00725842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65234311|NCT00725842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234312|NCT04051723|Dexamethasone|dexamethasone|mesh-list
65234313|NCT04051723|Ropivacaine|ropivacaine|mesh-list
65344071|NCT04066296|Anesthetics, Local|anesthetics, local|mesh-list
65344072|NCT04066296|Anesthetics|anesthetics|mesh-list
65344073|NCT04066296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65344074|NCT04066296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344075|NCT04066296|Sensory System Agents|sensory system agents|mesh-ancestor
64725942|NCT00003086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65234314|NCT04051723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65234315|NCT04051723|Antiemetics|antiemetics|mesh-ancestor
65234316|NCT04051723|Autonomic Agents|autonomic agents|mesh-ancestor
65234317|NCT04051723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65234318|NCT04051723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234332|NCT00918424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65234333|NCT00918424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65234334|NCT00918424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234335|NCT00918424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65234336|NCT00918424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65234338|NCT00756847|Carboplatin|carboplatin|mesh-list
65234339|NCT00756847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65234340|NCT00756847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234341|NCT00756847|Tubulin Modulators|tubulin modulators|mesh-ancestor
65234342|NCT00756847|Antimitotic Agents|antimitotic agents|mesh-ancestor
65234343|NCT00756847|Mitosis Modulators|mitosis modulators|mesh-ancestor
65234344|NCT00756847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234346|NCT04051567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65234347|NCT04051567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65234348|NCT04051567|Analgesics|analgesics|mesh-ancestor
65234349|NCT04051567|Sensory System Agents|sensory system agents|mesh-ancestor
65234350|NCT04051567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65234351|NCT04051567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234352|NCT04051567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65234353|NCT04051567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65234354|NCT04051567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65234355|NCT04051567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65234356|NCT04051567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234357|NCT04051567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65234358|NCT04051567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65234359|NCT04051567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234360|NCT04051567|Antipyretics|antipyretics|mesh-ancestor
65234361|NCT00757081|Deoxycholic Acid|deoxycholic acid|mesh-list
65234362|NCT00757081|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65234363|NCT00757081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65234364|NCT00757315|Triamcinolone|triamcinolone|mesh-list
65234365|NCT00757315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65234366|NCT00757315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65234367|NCT00757315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65234368|NCT00757315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65234369|NCT00757315|Glucocorticoids|glucocorticoids|mesh-ancestor
65234370|NCT00757315|Hormones|hormones|mesh-ancestor
65234371|NCT00757315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65234372|NCT00757315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234373|NCT00757315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65234374|NCT00757315|Immunologic Factors|immunologic factors|mesh-ancestor
65234375|NCT00757315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234376|NCT00757315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234377|NCT00757393|Calcium, Dietary|calcium, dietary|mesh-list
65234378|NCT00757393|Vitamin D|vitamin d|mesh-list
65234379|NCT00757393|Ergocalciferols|ergocalciferols|mesh-list
65234404|NCT00754351|Immunologic Factors|immunologic factors|mesh-ancestor
65234405|NCT00754351|Tubulin Modulators|tubulin modulators|mesh-ancestor
65234406|NCT00754351|Antimitotic Agents|antimitotic agents|mesh-ancestor
65234407|NCT00754351|Mitosis Modulators|mitosis modulators|mesh-ancestor
65234410|NCT00754429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65234411|NCT00754429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65234412|NCT00754429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65234413|NCT00754429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234414|NCT00754429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65234415|NCT00754429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344076|NCT04066296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65344077|NCT02341014|Lenalidomide|lenalidomide|mesh-list
65344078|NCT02341014|Romidepsin|romidepsin|mesh-list
65344079|NCT02341014|Immunologic Factors|immunologic factors|mesh-ancestor
65344080|NCT02341014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344081|NCT02341014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65344082|NCT02341014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65344083|NCT02341014|Growth Substances|growth substances|mesh-ancestor
65344084|NCT02341014|Growth Inhibitors|growth inhibitors|mesh-ancestor
65344085|NCT02341014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234416|NCT00754429|Vasodilator Agents|vasodilator agents|mesh-ancestor
65234417|NCT00754429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65234418|NCT00754429|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65234419|NCT00754429|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65234420|NCT00754507|Atorvastatin|atorvastatin|mesh-list
65234421|NCT00754507|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65234422|NCT00754507|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65234423|NCT00754507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65234424|NCT00754507|Antimetabolites|antimetabolites|mesh-ancestor
65234425|NCT00754507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234426|NCT00754507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65234427|NCT00754507|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65234428|NCT00754507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234429|NCT00725608|Buprenorphine|buprenorphine|mesh-list
64455834|NCT01597557|Tocolytic Agents|tocolytic agents|mesh-ancestor
65234455|NCT00585052|Antimitotic Agents|antimitotic agents|mesh-ancestor
65234456|NCT00585052|Mitosis Modulators|mitosis modulators|mesh-ancestor
65234457|NCT00585052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234458|NCT00585052|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65234459|NCT00585052|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65234460|NCT00585052|Antimetabolites|antimetabolites|mesh-ancestor
65234461|NCT00585052|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65234462|NCT00585052|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65234463|NCT00585052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234464|NCT00724282|Eszopiclone|eszopiclone|mesh-list
65234465|NCT00724282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65234466|NCT00724282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65234467|NCT00724282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234468|NCT04086238|Decitabine|decitabine|mesh-list
65234469|NCT04086238|Tetrahydrouridine|tetrahydrouridine|mesh-list
65234470|NCT04086238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65234471|NCT04086238|Antimetabolites|antimetabolites|mesh-ancestor
65234472|NCT04086238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234473|NCT04086238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234474|NCT04086238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234475|NCT00724126|Rifaximin|rifaximin|mesh-list
64877217|NCT01884506|Micronutrients|micronutrients|mesh-ancestor
65234476|NCT00724126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65234477|NCT00724126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65234478|NCT00724126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65234479|NCT00723892|Ribavirin|ribavirin|mesh-list
65234480|NCT00723892|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65234481|NCT00723892|Interferon-alpha|interferon-alpha|mesh-list
65234482|NCT00723892|Antimetabolites|antimetabolites|mesh-ancestor
65234483|NCT00723892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234511|NCT02591914|Growth Inhibitors|growth inhibitors|mesh-ancestor
65234512|NCT00723190|Clonidine|clonidine|mesh-list
65234513|NCT00723190|Analgesics|analgesics|mesh-ancestor
65234514|NCT00723190|Sensory System Agents|sensory system agents|mesh-ancestor
65234515|NCT00723190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65234516|NCT00723190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234517|NCT00723190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65234518|NCT00723190|Sympatholytics|sympatholytics|mesh-ancestor
65234519|NCT00723190|Autonomic Agents|autonomic agents|mesh-ancestor
65234520|NCT00723190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65234521|NCT00723190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65344086|NCT02341014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65344087|NCT00868426|Budesonide|budesonide|mesh-list
65344088|NCT00868426|Formoterol Fumarate|formoterol fumarate|mesh-list
65344089|NCT00868426|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65344090|NCT00868426|Charcoal|charcoal|mesh-list
65344091|NCT00868426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65344092|NCT00868426|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65344093|NCT00868426|Autonomic Agents|autonomic agents|mesh-ancestor
65344094|NCT00868426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65344095|NCT00868426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344096|NCT00868426|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65344097|NCT00868426|Respiratory System Agents|respiratory system agents|mesh-ancestor
65344098|NCT00868426|Glucocorticoids|glucocorticoids|mesh-ancestor
65344099|NCT00868426|Hormones|hormones|mesh-ancestor
64725955|NCT00003086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65234522|NCT00723190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65234523|NCT00723190|Adrenergic Agents|adrenergic agents|mesh-ancestor
65234524|NCT00723190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65234525|NCT00723190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234526|NCT00722800|Drospirenone|drospirenone|mesh-list
65234527|NCT00722800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65234528|NCT00722800|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65234529|NCT00722800|Estradiol|estradiol|mesh-list
65234530|NCT00722800|Estrogens|estrogens|mesh-ancestor
65234531|NCT00722800|Hormones|hormones|mesh-ancestor
65234550|NCT00741598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65234551|NCT00741598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234552|NCT00741598|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65234553|NCT00741598|Autonomic Agents|autonomic agents|mesh-ancestor
65234554|NCT00741598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65234555|NCT00741598|Nootropic Agents|nootropic agents|mesh-ancestor
65234556|NCT03947632|Chrysarobin|chrysarobin|mesh-list
65234557|NCT03947632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65234558|NCT03947632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65234559|NCT03947632|Analgesics|analgesics|mesh-ancestor
65234560|NCT03947632|Sensory System Agents|sensory system agents|mesh-ancestor
65234561|NCT03947632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65234562|NCT03947632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234563|NCT03947632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65234564|NCT03947632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65234565|NCT04085770|Alfacalcidol|alfacalcidol|mesh-list
65234566|NCT04085770|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65234567|NCT04085770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65234568|NCT04085770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234569|NCT04085770|Vitamins|vitamins|mesh-ancestor
65234570|NCT04085770|Micronutrients|micronutrients|mesh-ancestor
65234571|NCT00741286|Aspirin|aspirin|mesh-list
65234572|NCT00741286|Cilostazol|cilostazol|mesh-list
65234573|NCT00741286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65234574|NCT00741286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65234575|NCT00741286|Analgesics|analgesics|mesh-ancestor
65234576|NCT00741286|Sensory System Agents|sensory system agents|mesh-ancestor
65234577|NCT00741286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65234578|NCT00741286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234579|NCT00741286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65234580|NCT00741286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65234581|NCT00741286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65234582|NCT00741286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65234583|NCT00741286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234584|NCT00741286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65234585|NCT00741286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65344100|NCT00868426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65344101|NCT00868426|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65344102|NCT00868426|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65344103|NCT00868426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65344104|NCT00868426|Adrenergic Agents|adrenergic agents|mesh-ancestor
65344105|NCT00868426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65344106|NCT00868426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344107|NCT00868426|Antidotes|antidotes|mesh-ancestor
65234590|NCT00741286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65234591|NCT00741286|Respiratory System Agents|respiratory system agents|mesh-ancestor
65234592|NCT00741286|Vasodilator Agents|vasodilator agents|mesh-ancestor
65234593|NCT00741286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65234594|NCT00741286|Protective Agents|protective agents|mesh-ancestor
65234595|NCT00741286|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65234596|NCT00741286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65234597|NCT05040334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65234598|NCT05040334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65234599|NCT00716092|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65234601|NCT00716092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65234602|NCT00716092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234603|NCT00716092|Incretins|incretins|mesh-ancestor
65234604|NCT00716092|Hormones|hormones|mesh-ancestor
65234605|NCT00716092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65234606|NCT00716092|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65234607|NCT00716092|Protease Inhibitors|protease inhibitors|mesh-ancestor
65234608|NCT00716092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234609|NCT00716092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234610|NCT02589496|Pembrolizumab|pembrolizumab|mesh-list
65234611|NCT02589496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65234612|NCT02589496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234613|NCT02590510|Methotrexate|methotrexate|mesh-list
65234614|NCT02590510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65234615|NCT02590510|Abortifacient Agents|abortifacient agents|mesh-ancestor
65234616|NCT02590510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65234617|NCT02590510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234618|NCT02590510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65234619|NCT02590510|Antimetabolites|antimetabolites|mesh-ancestor
65234620|NCT02590510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234621|NCT02590510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234622|NCT02590510|Dermatologic Agents|dermatologic agents|mesh-ancestor
65234623|NCT02590510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234624|NCT02590510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65234625|NCT02590510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65234626|NCT02590510|Immunologic Factors|immunologic factors|mesh-ancestor
64877368|NCT01885481|BB 1101|bb 1101|mesh-list
65234627|NCT02590510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65234628|NCT02590510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65234629|NCT00919204|Axitinib|axitinib|mesh-list
65234630|NCT00919204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234631|NCT00919204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65234632|NCT00919204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234633|NCT00919204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234634|NCT00715624|Metformin|metformin|mesh-list
65234635|NCT00715624|Lixisenatide|lixisenatide|mesh-list
65234636|NCT00715624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65234637|NCT00715624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234638|NCT00919282|Leucovorin|leucovorin|mesh-list
65234639|NCT00919282|Folic Acid|folic acid|mesh-list
65234640|NCT00919282|Gemcitabine|gemcitabine|mesh-list
65234641|NCT00919282|Levoleucovorin|levoleucovorin|mesh-list
65234642|NCT00919282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65234643|NCT00919282|Antimetabolites|antimetabolites|mesh-ancestor
65234644|NCT00919282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234645|NCT00919282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234646|NCT00919282|Antiviral Agents|antiviral agents|mesh-ancestor
65344108|NCT00868426|Protective Agents|protective agents|mesh-ancestor
65344109|NCT03853746|Ocrelizumab|ocrelizumab|mesh-list
65344110|NCT03853746|Immunologic Factors|immunologic factors|mesh-ancestor
65344111|NCT03853746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344112|NCT00868738|Vitamin D|vitamin d|mesh-list
65344113|NCT00868738|Vitamins|vitamins|mesh-ancestor
65344114|NCT00868738|Micronutrients|micronutrients|mesh-ancestor
65344115|NCT00868738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234647|NCT00919282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65234648|NCT00919282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234649|NCT00919282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65234650|NCT00919282|Immunologic Factors|immunologic factors|mesh-ancestor
65234651|NCT00919282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234652|NCT00919282|Antidotes|antidotes|mesh-ancestor
65234653|NCT00919282|Protective Agents|protective agents|mesh-ancestor
65234654|NCT00919282|Vitamin B Complex|vitamin b complex|mesh-ancestor
65234655|NCT00919282|Vitamins|vitamins|mesh-ancestor
65234656|NCT00919282|Micronutrients|micronutrients|mesh-ancestor
65234657|NCT00919282|Hematinics|hematinics|mesh-ancestor
65234673|NCT05414305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65234674|NCT05414305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65234675|NCT05414305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234676|NCT05414305|Anticoagulants|anticoagulants|mesh-ancestor
65234677|NCT05414305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65234678|NCT05414305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65234680|NCT00757549|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65234681|NCT00757549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234682|NCT00757549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65234683|NCT00757549|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65234684|NCT00757549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234685|NCT00576199|Bevacizumab|bevacizumab|mesh-list
65234686|NCT00576199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65234687|NCT00576199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234688|NCT00576199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65234689|NCT00576199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65234690|NCT00576199|Growth Substances|growth substances|mesh-ancestor
65234691|NCT00576199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234692|NCT00576199|Growth Inhibitors|growth inhibitors|mesh-ancestor
65234693|NCT00754819|Colchicine|colchicine|mesh-list
65234694|NCT00754819|Gout Suppressants|gout suppressants|mesh-ancestor
65234695|NCT00754819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65234696|NCT00754819|Tubulin Modulators|tubulin modulators|mesh-ancestor
65234697|NCT00754819|Antimitotic Agents|antimitotic agents|mesh-ancestor
65234698|NCT00754819|Mitosis Modulators|mitosis modulators|mesh-ancestor
65234699|NCT00754819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234700|NCT00754819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234701|NCT05684692|Siltuximab|siltuximab|mesh-list
65234702|NCT05684692|Erenumab|erenumab|mesh-list
65234703|NCT05684692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65234704|NCT05684692|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65234705|NCT05684692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234706|NCT05684692|Analgesics|analgesics|mesh-ancestor
65234707|NCT05684692|Sensory System Agents|sensory system agents|mesh-ancestor
65234708|NCT05684692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65234709|NCT05684692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234710|NCT05684692|Immunologic Factors|immunologic factors|mesh-ancestor
65234711|NCT05684692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234712|NCT02589652|Interferons|interferons|mesh-list
65234713|NCT02589652|Interferon-alpha|interferon-alpha|mesh-list
65234714|NCT02589652|Interferon alpha-2|interferon alpha-2|mesh-list
65234715|NCT02589652|Entecavir|entecavir|mesh-list
64456105|NCT01427608|Olanzapine|olanzapine|mesh-list
65234750|NCT04051099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65234751|NCT04051099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234752|NCT04051099|Sensory System Agents|sensory system agents|mesh-ancestor
65234753|NCT04051099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65234754|NCT04051099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65234755|NCT04051099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65222782|NCT02700711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65344116|NCT00868738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65344117|NCT00868816|Oxaliplatin|oxaliplatin|mesh-list
65344118|NCT00868816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344119|NCT02569866|Cephalexin|cephalexin|mesh-list
65344120|NCT02569866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65344121|NCT02569866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65344122|NCT00868894|Latanoprost|latanoprost|mesh-list
65344123|NCT00868894|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65344124|NCT00868894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65344125|NCT00730938|Cefuroxime|cefuroxime|mesh-list
65344126|NCT00730938|Cefuroxime axetil|cefuroxime axetil|mesh-list
65344127|NCT00730938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65344128|NCT00730938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65344129|NCT00712010|Caseins|caseins|mesh-list
65344130|NCT00712010|Chelating Agents|chelating agents|mesh-ancestor
65344131|NCT00712010|Sequestering Agents|sequestering agents|mesh-ancestor
65344132|NCT00712010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344133|NCT00731016|Zoledronic Acid|zoledronic acid|mesh-list
65234780|NCT04084912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65234781|NCT04084912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65234782|NCT04084912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234783|NCT04084912|Protease Inhibitors|protease inhibitors|mesh-ancestor
65234784|NCT04084912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234785|NCT04084912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234786|NCT00755053|Clotrimazole|clotrimazole|mesh-list
65234787|NCT00755053|Miconazole|miconazole|mesh-list
65234788|NCT00755053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65234789|NCT00755053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65234790|NCT00755053|Antifungal Agents|antifungal agents|mesh-ancestor
65234791|NCT00755053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65234792|NCT00755053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65234793|NCT00755053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234794|NCT00755053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234795|NCT00755053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65234796|NCT00755053|Hormone Antagonists|hormone antagonists|mesh-ancestor
65234797|NCT00755053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65234798|NCT00755053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234799|NCT00755053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65234800|NCT00755053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65234801|NCT00755209|Tranexamic Acid|tranexamic acid|mesh-list
65234802|NCT00755209|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65234803|NCT00755209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65234804|NCT00755209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456212|NCT01426438|Niacin|niacin|mesh-list
65234836|NCT05340205|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65234837|NCT05340205|Abortifacient Agents|abortifacient agents|mesh-ancestor
65234838|NCT05340205|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65234839|NCT05340205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65234840|NCT00713830|Metformin|metformin|mesh-list
65234841|NCT00713830|Lixisenatide|lixisenatide|mesh-list
65234842|NCT00713830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65234843|NCT00713830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234844|NCT05291221|Lidocaine|lidocaine|mesh-list
65234845|NCT05291221|Dexmedetomidine|dexmedetomidine|mesh-list
65234846|NCT05291221|Anesthetics, Local|anesthetics, local|mesh-ancestor
65234847|NCT05291221|Anesthetics|anesthetics|mesh-ancestor
65234848|NCT05291221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65222783|NCT02700711|Analgesics|analgesics|mesh-ancestor
65344134|NCT00731016|Pravastatin|pravastatin|mesh-list
65344135|NCT00731016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65344136|NCT00731016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344137|NCT00731016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65344138|NCT00731016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65344139|NCT00731016|Antimetabolites|antimetabolites|mesh-ancestor
65234849|NCT05291221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234850|NCT05291221|Sensory System Agents|sensory system agents|mesh-ancestor
65234888|NCT00680407|Protective Agents|protective agents|mesh-ancestor
65234889|NCT00680407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234890|NCT02560519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65234891|NCT04007809|Glucagon|glucagon|mesh-list
65234892|NCT04007809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65234893|NCT04007809|Hormones|hormones|mesh-ancestor
65234912|NCT05202730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65234914|NCT00677365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65234915|NCT00677365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65234916|NCT00677365|Renal Agents|renal agents|mesh-ancestor
65234917|NCT00677365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65234918|NCT00677365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65234919|NCT00677365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65234920|NCT00677365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234921|NCT00677365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234922|NCT00677365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234923|NCT00677365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65234924|NCT00677365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65234925|NCT05039944|Irinotecan|irinotecan|mesh-list
64877669|NCT01887405|Racepinephrine|racepinephrine|mesh-list
65234926|NCT05039944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65234927|NCT05039944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65234928|NCT05039944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234929|NCT05039944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234930|NCT05039944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234931|NCT05038462|Lactoferrin|lactoferrin|mesh-list
65234932|NCT05038462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65234933|NCT03719131|Rituximab|rituximab|mesh-list
65234934|NCT03719131|Nivolumab|nivolumab|mesh-list
65234935|NCT03719131|Ipilimumab|ipilimumab|mesh-list
65234936|NCT03719131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65234937|NCT03719131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234938|NCT03719131|Immunologic Factors|immunologic factors|mesh-ancestor
65234939|NCT03719131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234940|NCT03719131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65234941|NCT03719131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65234942|NCT03719131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234944|NCT05190094|Palbociclib|palbociclib|mesh-list
65234945|NCT05190094|Anastrozole|anastrozole|mesh-list
65234946|NCT05190094|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65234947|NCT05190094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234948|NCT05190094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65234949|NCT05190094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234950|NCT05190094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234951|NCT05190094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65234952|NCT05190094|Hormone Antagonists|hormone antagonists|mesh-ancestor
65234953|NCT05190094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65234954|NCT05190094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234966|NCT05020912|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65234967|NCT05020912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65234968|NCT05020912|Dermatologic Agents|dermatologic agents|mesh-ancestor
65234970|NCT00676663|Entinostat|entinostat|mesh-list
65234971|NCT00676663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234972|NCT00676663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65234973|NCT00676663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65234974|NCT00676663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234975|NCT00676663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234976|NCT00676663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65234977|NCT00676663|Hormone Antagonists|hormone antagonists|mesh-ancestor
65234978|NCT00676663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65344140|NCT00731016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344141|NCT00731016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65344142|NCT00731016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65344143|NCT00731016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344144|NCT00799539|Prednisone|prednisone|mesh-list
65344145|NCT00799539|Bortezomib|bortezomib|mesh-list
65344146|NCT00799539|Melphalan|melphalan|mesh-list
64953523|NCT00034151|Paclitaxel|paclitaxel|mesh-list
65234979|NCT00676663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234980|NCT00676663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65234981|NCT02560207|Cefotaxime|cefotaxime|mesh-list
65234982|NCT02560207|Cefoxitin|cefoxitin|mesh-list
65234983|NCT02560207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65234984|NCT02560207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65234985|NCT04949191|Pembrolizumab|pembrolizumab|mesh-list
65234986|NCT04949191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65234987|NCT04949191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234988|NCT00678691|Modafinil|modafinil|mesh-list
65234989|NCT00678691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65234990|NCT00678691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234991|NCT00678691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65234992|NCT00678691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65234993|NCT00678691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65234994|NCT00678691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234995|NCT05003752|Goserelin|goserelin|mesh-list
65234996|NCT05003752|Androgens|androgens|mesh-list
65234997|NCT05003752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65234998|NCT05003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234999|NCT05003752|Hormones|hormones|mesh-ancestor
65235000|NCT05003752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65235001|NCT05003752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235002|NCT04997980|Amiodarone|amiodarone|mesh-list
65235003|NCT04997980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65235004|NCT04997980|Vasodilator Agents|vasodilator agents|mesh-ancestor
65235005|NCT04997980|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65235006|NCT04997980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65235007|NCT04997980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235008|NCT04997980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65235009|NCT04997980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65235010|NCT04997980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65235011|NCT04997980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235012|NCT04997980|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65235013|NCT04997980|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65235014|NCT04997980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65235033|NCT00679939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235035|NCT04082260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65235036|NCT04082260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235037|NCT02587390|Simvastatin|simvastatin|mesh-list
65235038|NCT02587390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65235039|NCT02587390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65235040|NCT02587390|Antimetabolites|antimetabolites|mesh-ancestor
65235041|NCT02587390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235042|NCT02587390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65235043|NCT02587390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65235044|NCT02587390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235045|NCT00760981|Imatinib Mesylate|imatinib mesylate|mesh-list
65235046|NCT00760981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235047|NCT00760981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65235048|NCT00760981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235049|NCT00760981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235050|NCT02588716|Terlipressin|terlipressin|mesh-list
65235051|NCT02588716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65235052|NCT02588716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65235053|NCT00673933|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65235054|NCT00673933|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65344147|NCT00799539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65344148|NCT00799539|Glucocorticoids|glucocorticoids|mesh-ancestor
65344149|NCT00799539|Hormones|hormones|mesh-ancestor
65344150|NCT00799539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65344151|NCT00799539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344152|NCT00799539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65344153|NCT00799539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344154|NCT00799539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65344155|NCT00799539|Alkylating Agents|alkylating agents|mesh-ancestor
65344156|NCT00799539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344157|NCT00799539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65344158|NCT00799539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65344159|NCT00799539|Immunologic Factors|immunologic factors|mesh-ancestor
65344160|NCT00731172|Glatiramer Acetate|glatiramer acetate|mesh-list
65344161|NCT00731172|(T,G)-A-L|(t,g)-a-l|mesh-list
65344162|NCT00731172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65235055|NCT00673933|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65235056|NCT00673933|Dermatologic Agents|dermatologic agents|mesh-ancestor
65235057|NCT00761449|Lenalidomide|lenalidomide|mesh-list
65235058|NCT00761449|Immunologic Factors|immunologic factors|mesh-ancestor
65235059|NCT00761449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235060|NCT00761449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65235061|NCT00761449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65235062|NCT00761449|Growth Substances|growth substances|mesh-ancestor
65235063|NCT00761449|Growth Inhibitors|growth inhibitors|mesh-ancestor
65235064|NCT00761449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235065|NCT04968106|Doxorubicin|doxorubicin|mesh-list
65235066|NCT04968106|Ifosfamide|ifosfamide|mesh-list
65235067|NCT04968106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65235068|NCT04968106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235069|NCT04968106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65235070|NCT04968106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65235071|NCT04968106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235072|NCT04968106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235108|NCT05068726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235110|NCT04807816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65235111|NCT04807816|Antimetabolites|antimetabolites|mesh-ancestor
65235112|NCT04807816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456513|NCT05365984|Carbon Monoxide|carbon monoxide|mesh-list
65235137|NCT02558959|Capecitabine|capecitabine|mesh-list
65235138|NCT02558959|Irinotecan|irinotecan|mesh-list
65235139|NCT02558959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65235140|NCT02558959|Antimetabolites|antimetabolites|mesh-ancestor
65235141|NCT02558959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235142|NCT02558959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235143|NCT02558959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65235144|NCT02558959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65235145|NCT02558959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235146|NCT04049539|Cytarabine|cytarabine|mesh-list
65235147|NCT04049539|Daunorubicin|daunorubicin|mesh-list
65235148|NCT04049539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65235149|NCT04049539|Antimetabolites|antimetabolites|mesh-ancestor
65235150|NCT04049539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235151|NCT04049539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235153|NCT04049539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65235154|NCT04049539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65235155|NCT04049539|Immunologic Factors|immunologic factors|mesh-ancestor
65344163|NCT00731172|Immunologic Factors|immunologic factors|mesh-ancestor
65344164|NCT00731172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344165|NCT00731172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65344166|NCT00731172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65344167|NCT00738842|Ticagrelor|ticagrelor|mesh-list
65344168|NCT00738842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65344169|NCT00738842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65344170|NCT00738842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65344171|NCT00738842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65344172|NCT00738842|Purinergic Agents|purinergic agents|mesh-ancestor
65344173|NCT00738842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65344174|NCT00738842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344175|NCT00738842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344176|NCT00809913|Ciprofloxacin|ciprofloxacin|mesh-list
65344177|NCT00809913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65344178|NCT00809913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65344179|NCT00809913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65344180|NCT00809913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65344181|NCT00809913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726028|NCT00002521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65235156|NCT04049539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235157|NCT04049539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65235158|NCT04049539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65235159|NCT04049539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65235160|NCT04049539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235161|NCT05681650|Paclitaxel|paclitaxel|mesh-list
65235162|NCT05681650|Cyclophosphamide|cyclophosphamide|mesh-list
65235163|NCT05681650|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65235164|NCT05681650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65235165|NCT05681650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456552|NCT01399372|Rituximab|rituximab|mesh-list
65235189|NCT02476279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65235190|NCT02476279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235191|NCT02476279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235192|NCT04082962|Dexamethasone|dexamethasone|mesh-list
65235193|NCT04082962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65235194|NCT04082962|Antiemetics|antiemetics|mesh-ancestor
65235195|NCT04082962|Autonomic Agents|autonomic agents|mesh-ancestor
65235196|NCT04082962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65235197|NCT04082962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235198|NCT04082962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65235199|NCT04082962|Glucocorticoids|glucocorticoids|mesh-ancestor
65235201|NCT04082962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65235202|NCT04082962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65235203|NCT04082962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235204|NCT02471833|Telmisartan|telmisartan|mesh-list
65235205|NCT02471833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65235206|NCT02471833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65235207|NCT02471833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65235208|NCT02471833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235209|NCT04895410|Dexamethasone|dexamethasone|mesh-list
65235210|NCT04895410|Daratumumab|daratumumab|mesh-list
65235211|NCT04895410|Pomalidomide|pomalidomide|mesh-list
65344182|NCT00809913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344183|NCT00809913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344184|NCT00809913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65344185|NCT00809913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65344186|NCT00729222|Rolofylline|rolofylline|mesh-list
65344187|NCT00729222|Diuretics|diuretics|mesh-ancestor
65344188|NCT00729222|Natriuretic Agents|natriuretic agents|mesh-ancestor
65344189|NCT00729222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344190|NCT00729300|Disulfiram|disulfiram|mesh-list
65344191|NCT00729300|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65344192|NCT00729300|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65344193|NCT00729300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344194|NCT00729300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344195|NCT00808743|Celecoxib|celecoxib|mesh-list
65344196|NCT00808743|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65344197|NCT00808743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65344198|NCT00808743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65344199|NCT00808743|Analgesics|analgesics|mesh-ancestor
65344200|NCT00808743|Sensory System Agents|sensory system agents|mesh-ancestor
65344201|NCT00808743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65344202|NCT00808743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344203|NCT00808743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65344204|NCT00808743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65344205|NCT00808743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65344206|NCT00808743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65344207|NCT00808743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344208|NCT00808743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344209|NCT00808743|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65344226|NCT00869596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65344227|NCT00869596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65344228|NCT00869596|Adrenergic Agents|adrenergic agents|mesh-ancestor
65344229|NCT00869596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65344230|NCT00869596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344231|NCT03743376|UB-421|ub-421|mesh-list
65344232|NCT03743376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65344233|NCT03743376|Antiviral Agents|antiviral agents|mesh-ancestor
64333621|NCT03523741|Clozapine|clozapine|mesh-list
65235212|NCT04895410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65235213|NCT04895410|Antiemetics|antiemetics|mesh-ancestor
65235214|NCT04895410|Autonomic Agents|autonomic agents|mesh-ancestor
65235215|NCT04895410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65235216|NCT04895410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235252|NCT02312245|Antimitotic Agents|antimitotic agents|mesh-ancestor
65235253|NCT02312245|Mitosis Modulators|mitosis modulators|mesh-ancestor
65235254|NCT02312245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235255|NCT02312245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65235256|NCT02312245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65235257|NCT02312245|Growth Substances|growth substances|mesh-ancestor
65235258|NCT02312245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235259|NCT02312245|Growth Inhibitors|growth inhibitors|mesh-ancestor
65235289|NCT04767061|Labetalol|labetalol|mesh-list
65235290|NCT04767061|Pindolol|pindolol|mesh-list
65235291|NCT04767061|Betaxolol|betaxolol|mesh-list
65235292|NCT04767061|Penbutolol|penbutolol|mesh-list
65235293|NCT04767061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65235294|NCT04767061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65235295|NCT04767061|Adrenergic Agents|adrenergic agents|mesh-ancestor
65235296|NCT04767061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65235297|NCT04767061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235298|NCT04767061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235299|NCT04767061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65235300|NCT04767061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65235301|NCT04767061|Vasodilator Agents|vasodilator agents|mesh-ancestor
65235302|NCT04767061|Sympatholytics|sympatholytics|mesh-ancestor
65235303|NCT04767061|Autonomic Agents|autonomic agents|mesh-ancestor
65235304|NCT04767061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65235305|NCT04767061|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65235306|NCT04767061|Antioxidants|antioxidants|mesh-ancestor
65235307|NCT04767061|Protective Agents|protective agents|mesh-ancestor
65235308|NCT04767061|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64456697|NCT01777191|Ixekizumab|ixekizumab|mesh-list
65235337|NCT00759421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65235338|NCT00759421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65235339|NCT00759421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235340|NCT00759421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65235341|NCT00759421|Serotonin Agents|serotonin agents|mesh-ancestor
65235342|NCT04869358|Ofatumumab|ofatumumab|mesh-list
65235343|NCT04869358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235344|NCT00762775|Vitamin D|vitamin d|mesh-list
65235345|NCT00762775|Calcium|calcium|mesh-list
65235346|NCT00762775|Vitamins|vitamins|mesh-ancestor
65235347|NCT00762775|Micronutrients|micronutrients|mesh-ancestor
65235348|NCT00762775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235349|NCT00762775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65235350|NCT00762775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65235351|NCT00763165|Triclosan|triclosan|mesh-list
65235352|NCT00763165|Fluorides|fluorides|mesh-list
65235353|NCT00763165|Cariostatic Agents|cariostatic agents|mesh-ancestor
65235354|NCT00763165|Protective Agents|protective agents|mesh-ancestor
65235355|NCT00763165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235356|NCT00763165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65235388|NCT00678379|Anesthetics|anesthetics|mesh-ancestor
65235389|NCT00678379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65235390|NCT00678379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235391|NCT00678379|Sensory System Agents|sensory system agents|mesh-ancestor
65235392|NCT00678379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65344234|NCT03743376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65344235|NCT00734864|Anticonvulsants|anticonvulsants|mesh-list
65344236|NCT03728478|Etanercept|etanercept|mesh-list
65344237|NCT03728478|Methotrexate|methotrexate|mesh-list
65344238|NCT03728478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65235393|NCT00678379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65235394|NCT00678379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65235395|NCT00678379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65235396|NCT00678379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65235397|NCT00678379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235425|NCT00763633|Micronutrients|micronutrients|mesh-ancestor
65235426|NCT00763633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235428|NCT00763789|Anesthetics|anesthetics|mesh-list
65235429|NCT00763789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65235430|NCT00763789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235431|NCT00763789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65235432|NCT00763789|Narcotics|narcotics|mesh-ancestor
65235433|NCT00763789|Analgesics|analgesics|mesh-ancestor
65235434|NCT00763789|Sensory System Agents|sensory system agents|mesh-ancestor
65235435|NCT00763789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65235436|NCT04115956|Dexamethasone|dexamethasone|mesh-list
65235437|NCT04115956|Melphalan|melphalan|mesh-list
65235438|NCT04115956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65235439|NCT04115956|Antiemetics|antiemetics|mesh-ancestor
65235440|NCT04115956|Autonomic Agents|autonomic agents|mesh-ancestor
65235441|NCT04115956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65235442|NCT04115956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235443|NCT04115956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65235444|NCT04115956|Glucocorticoids|glucocorticoids|mesh-ancestor
65235445|NCT04115956|Hormones|hormones|mesh-ancestor
65235446|NCT04115956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65235447|NCT04115956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65235448|NCT04115956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235449|NCT04115956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65235481|NCT02558569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235482|NCT02558569|Sensory System Agents|sensory system agents|mesh-ancestor
65235483|NCT02558569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65235485|NCT00939692|Anticonvulsants|anticonvulsants|mesh-ancestor
65235486|NCT00939692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65235487|NCT00939692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235488|NCT00920608|Methotrexate|methotrexate|mesh-list
65235489|NCT00920608|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65235490|NCT00920608|Abortifacient Agents|abortifacient agents|mesh-ancestor
65235491|NCT00920608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65235492|NCT00920608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235493|NCT00920608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65235494|NCT00920608|Antimetabolites|antimetabolites|mesh-ancestor
65235510|NCT04674514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235511|NCT04674514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65235512|NCT04674514|Glucocorticoids|glucocorticoids|mesh-ancestor
65235514|NCT04674514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65235515|NCT04674514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65235516|NCT04674514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235517|NCT04674514|Immunologic Factors|immunologic factors|mesh-ancestor
65235518|NCT04674514|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65235519|NCT04674514|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65235520|NCT04674514|Growth Substances|growth substances|mesh-ancestor
65235521|NCT04674514|Growth Inhibitors|growth inhibitors|mesh-ancestor
65235522|NCT04081012|Acetylcysteine|acetylcysteine|mesh-list
65235523|NCT04081012|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65235524|NCT04081012|Antiviral Agents|antiviral agents|mesh-ancestor
65235525|NCT04081012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65235526|NCT04081012|Expectorants|expectorants|mesh-ancestor
65235527|NCT04081012|Respiratory System Agents|respiratory system agents|mesh-ancestor
65235528|NCT04081012|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65235529|NCT04081012|Antioxidants|antioxidants|mesh-ancestor
65235530|NCT04081012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235531|NCT04081012|Protective Agents|protective agents|mesh-ancestor
65235532|NCT04081012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235533|NCT04081012|Antidotes|antidotes|mesh-ancestor
65344239|NCT03728478|Abortifacient Agents|abortifacient agents|mesh-ancestor
65344240|NCT03728478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65344241|NCT03728478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726106|NCT00002527|Aspirin|aspirin|mesh-list
65235534|NCT04551040|Terazosin|terazosin|mesh-list
65235535|NCT04551040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65235536|NCT04551040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65235537|NCT04551040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65235538|NCT04551040|Adrenergic Agents|adrenergic agents|mesh-ancestor
65235539|NCT04551040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65235540|NCT04551040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235541|NCT04551040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235542|NCT04551040|Urological Agents|urological agents|mesh-ancestor
65235543|NCT00942968|Dalteparin|dalteparin|mesh-list
65235544|NCT00942968|Tinzaparin|tinzaparin|mesh-list
65235545|NCT00942968|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65235547|NCT00942968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65235548|NCT00942968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65235549|NCT00942968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235550|NCT00942734|Everolimus|everolimus|mesh-list
65235551|NCT00942734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65235552|NCT00942734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235553|NCT00942734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65235554|NCT00942734|Immunologic Factors|immunologic factors|mesh-ancestor
65235555|NCT00942734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235582|NCT00942422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235583|NCT00942422|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65235584|NCT00942422|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65235585|NCT00942422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235586|NCT00942422|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65235587|NCT05380934|Methotrexate|methotrexate|mesh-list
65235588|NCT05380934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65235589|NCT05380934|Abortifacient Agents|abortifacient agents|mesh-ancestor
65235590|NCT05380934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65235591|NCT05380934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235592|NCT05380934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65235593|NCT05380934|Antimetabolites|antimetabolites|mesh-ancestor
65235594|NCT05380934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235595|NCT05380934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235596|NCT05380934|Dermatologic Agents|dermatologic agents|mesh-ancestor
65235597|NCT05380934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235598|NCT05380934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65235599|NCT05380934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65235600|NCT05380934|Immunologic Factors|immunologic factors|mesh-ancestor
64457009|NCT01743027|Histamine Agents|histamine agents|mesh-ancestor
65235622|NCT00677833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65235623|NCT00677833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65235624|NCT00677833|Amebicides|amebicides|mesh-ancestor
65235625|NCT00677833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65235626|NCT00677833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65235627|NCT00677833|Antimalarials|antimalarials|mesh-ancestor
65235628|NCT00677833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65235629|NCT05086874|3-n-butylphthalide|3-n-butylphthalide|mesh-list
65235630|NCT05086874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65235631|NCT05086874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65235632|NCT05086874|Protective Agents|protective agents|mesh-ancestor
65235633|NCT05086874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235634|NCT02585674|Insulin Glargine|insulin glargine|mesh-list
65235635|NCT02585674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65235636|NCT02585674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235637|NCT00942266|Calcium, Dietary|calcium, dietary|mesh-list
65235638|NCT00942266|Leucovorin|leucovorin|mesh-list
65235639|NCT00942266|Fluorouracil|fluorouracil|mesh-list
65235640|NCT00942266|Vorinostat|vorinostat|mesh-list
65235641|NCT00942266|Calcium|calcium|mesh-list
65235642|NCT00942266|Levoleucovorin|levoleucovorin|mesh-list
65235643|NCT00942266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65235644|NCT00942266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235645|NCT00942266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65235646|NCT00942266|Antimetabolites|antimetabolites|mesh-ancestor
65235647|NCT00942266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235648|NCT00942266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65344242|NCT03728478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65344243|NCT03728478|Antimetabolites|antimetabolites|mesh-ancestor
65344244|NCT03728478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344245|NCT03728478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953884|NCT00062556|Niacin|niacin|mesh-list
65235649|NCT00942266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235650|NCT00942266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65235651|NCT00942266|Immunologic Factors|immunologic factors|mesh-ancestor
65235652|NCT00942266|Antidotes|antidotes|mesh-ancestor
65235653|NCT00942266|Protective Agents|protective agents|mesh-ancestor
65235654|NCT00942266|Vitamin B Complex|vitamin b complex|mesh-ancestor
65235655|NCT00942266|Vitamins|vitamins|mesh-ancestor
65235656|NCT00942266|Micronutrients|micronutrients|mesh-ancestor
65235657|NCT00942266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65235658|NCT00942266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235659|NCT05382182|Androgens|androgens|mesh-list
65235688|NCT04079374|Sensory System Agents|sensory system agents|mesh-ancestor
65235689|NCT04079374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65235690|NCT04079374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235691|NCT04079374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65235692|NCT04079374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65235693|NCT04079374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65235694|NCT04079374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65235695|NCT04079374|Immunologic Factors|immunologic factors|mesh-ancestor
65235696|NCT00673231|Dapagliflozin|dapagliflozin|mesh-list
65235697|NCT00673231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65235698|NCT00673231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235699|NCT00673231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65235700|NCT00673231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235701|NCT02583958|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65235702|NCT02583958|Laxatives|laxatives|mesh-ancestor
65235703|NCT02583958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65235705|NCT00604058|Immunologic Factors|immunologic factors|mesh-ancestor
65235736|NCT00672841|Antifungal Agents|antifungal agents|mesh-list
65235737|NCT00672841|Clotrimazole|clotrimazole|mesh-list
65235738|NCT00672841|Miconazole|miconazole|mesh-list
65235739|NCT00672841|Anidulafungin|anidulafungin|mesh-list
65235740|NCT00672841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65235741|NCT00672841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65235742|NCT00672841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65235743|NCT00672841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65235744|NCT00672841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235745|NCT00672841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235746|NCT00672841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65235747|NCT00672841|Hormone Antagonists|hormone antagonists|mesh-ancestor
64457133|NCT01726335|Risperidone|risperidone|mesh-list
65235771|NCT04080622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235774|NCT04079140|Dinoprostone|dinoprostone|mesh-list
65235775|NCT04079140|Oxytocics|oxytocics|mesh-ancestor
65235776|NCT04079140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65235777|NCT04079140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235778|NCT04707196|Fulvestrant|fulvestrant|mesh-list
65235779|NCT04707196|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65235780|NCT04707196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65235781|NCT04707196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235782|NCT04707196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65235783|NCT04707196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65235784|NCT04707196|Hormone Antagonists|hormone antagonists|mesh-ancestor
65235785|NCT04707196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65235786|NCT04707196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235787|NCT04707196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65235788|NCT04707196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235789|NCT04707196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235790|NCT00673465|Metformin|metformin|mesh-list
65235791|NCT00673465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65235792|NCT00673465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235793|NCT00764413|Methylprednisolone|methylprednisolone|mesh-list
65235794|NCT00764413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65235795|NCT00764413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65235796|NCT00764413|Prednisolone|prednisolone|mesh-list
65344246|NCT03728478|Dermatologic Agents|dermatologic agents|mesh-ancestor
65344247|NCT03728478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344248|NCT03728478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65344249|NCT03728478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65344250|NCT03728478|Immunologic Factors|immunologic factors|mesh-ancestor
65344251|NCT03728478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64953929|NCT00062595|Vitamins|vitamins|mesh-ancestor
65235797|NCT00764413|Prednisolone acetate|prednisolone acetate|mesh-list
65235798|NCT00764413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65235799|NCT00764413|Prednisolone phosphate|prednisolone phosphate|mesh-list
65235833|NCT00583102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65235834|NCT00583102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235835|NCT02585440|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
65235836|NCT02585440|Antiviral Agents|antiviral agents|mesh-ancestor
65235837|NCT02585440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65235838|NCT02585440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65235839|NCT02585440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65235840|NCT00605930|Niacinamide|niacinamide|mesh-list
65235841|NCT00605930|Niacin|niacin|mesh-list
65235842|NCT00605930|Nicotinic Acids|nicotinic acids|mesh-list
65235863|NCT00602186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235865|NCT04204304|Dermatologic Agents|dermatologic agents|mesh-ancestor
65235866|NCT05380778|Anesthetics|anesthetics|mesh-list
65235867|NCT05380778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65235868|NCT05380778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235869|NCT02852720|Anesthetics|anesthetics|mesh-list
65235870|NCT02852720|Levobupivacaine|levobupivacaine|mesh-list
65235871|NCT02852720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65235872|NCT02852720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235873|NCT02852720|Anesthetics, Local|anesthetics, local|mesh-ancestor
65235874|NCT02852720|Sensory System Agents|sensory system agents|mesh-ancestor
65235875|NCT02852720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65235876|NCT00941720|Cyclophosphamide|cyclophosphamide|mesh-list
65235877|NCT00941720|Busulfan|busulfan|mesh-list
65235878|NCT00941720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65235879|NCT00941720|Immunologic Factors|immunologic factors|mesh-ancestor
65235880|NCT00941720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235881|NCT00941720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65235882|NCT00941720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65235883|NCT00941720|Alkylating Agents|alkylating agents|mesh-ancestor
65235884|NCT00941720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235885|NCT00941720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235886|NCT00941720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65235887|NCT02583568|Bevacizumab|bevacizumab|mesh-list
65235888|NCT02583568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65235889|NCT02583568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235890|NCT02583568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65235891|NCT02583568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65235892|NCT02583568|Growth Substances|growth substances|mesh-ancestor
65235893|NCT02583568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235894|NCT02583568|Growth Inhibitors|growth inhibitors|mesh-ancestor
64457279|NCT01722045|Aflibercept|aflibercept|mesh-list
65235930|NCT04080310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65235932|NCT04078048|Vitamins|vitamins|mesh-list
65235933|NCT04078048|Vitamin E|vitamin e|mesh-list
65235962|NCT02558023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235963|NCT02558023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65235964|NCT02558023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235965|NCT02558023|Vasodilator Agents|vasodilator agents|mesh-ancestor
65235966|NCT02558023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65235967|NCT02558023|Serotonin Agents|serotonin agents|mesh-ancestor
65235968|NCT02558023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65235969|NCT02558023|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65235970|NCT02558023|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65235971|NCT02558023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65235972|NCT02558023|Adrenergic Agents|adrenergic agents|mesh-ancestor
65235973|NCT00607568|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65235974|NCT00607568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65344252|NCT03728478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65344253|NCT03728478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65344254|NCT03728478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65344255|NCT03728478|Analgesics|analgesics|mesh-ancestor
65235975|NCT00607568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65235976|NCT00607568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65235977|NCT00607568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236000|NCT02584738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65236001|NCT02584738|Antiemetics|antiemetics|mesh-ancestor
65236002|NCT02584738|Autonomic Agents|autonomic agents|mesh-ancestor
65236003|NCT02584738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236004|NCT02584738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236005|NCT02584738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65236006|NCT02584738|Glucocorticoids|glucocorticoids|mesh-ancestor
65236007|NCT02584738|Hormones|hormones|mesh-ancestor
65236008|NCT02584738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65236009|NCT02584738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65236010|NCT02584738|Protective Agents|protective agents|mesh-ancestor
65236011|NCT02584738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65236012|NCT02584738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236013|NCT02584738|Anticonvulsants|anticonvulsants|mesh-ancestor
65236014|NCT02584738|Analgesics|analgesics|mesh-ancestor
65236015|NCT02584738|Sensory System Agents|sensory system agents|mesh-ancestor
65236016|NCT02584738|Anesthetics|anesthetics|mesh-ancestor
65236017|NCT02584738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65236018|NCT02584738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65236019|NCT02584738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65236020|NCT02584738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65236021|NCT02584738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236022|NCT02584738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65236023|NCT02584738|Tocolytic Agents|tocolytic agents|mesh-ancestor
65236024|NCT02584738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65236025|NCT02584738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65236026|NCT02584738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65236027|NCT02584738|Respiratory System Agents|respiratory system agents|mesh-ancestor
65236028|NCT02584738|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65236029|NCT02584738|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65236030|NCT02584738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65236031|NCT02584738|Adrenergic Agents|adrenergic agents|mesh-ancestor
65236032|NCT02584738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65236033|NCT02584738|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65236034|NCT02584738|Cholinergic Agents|cholinergic agents|mesh-ancestor
65236056|NCT04416568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65236058|NCT04416568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64878796|NCT01902108|Clonidine|clonidine|mesh-list
65236059|NCT04416568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236060|NCT05269381|Cyclophosphamide|cyclophosphamide|mesh-list
65236061|NCT05269381|Pembrolizumab|pembrolizumab|mesh-list
65236062|NCT05269381|Sargramostim|sargramostim|mesh-list
65236063|NCT05269381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65236064|NCT05269381|Immunologic Factors|immunologic factors|mesh-ancestor
65236065|NCT05269381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236066|NCT05269381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65236067|NCT05269381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65236068|NCT05269381|Alkylating Agents|alkylating agents|mesh-ancestor
65236069|NCT05269381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236070|NCT05269381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236071|NCT05269381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65236072|NCT05269381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65236073|NCT02583022|Pimecrolimus|pimecrolimus|mesh-list
65236074|NCT02583022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65236075|NCT02583022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65236076|NCT02583022|Analgesics|analgesics|mesh-ancestor
65236077|NCT02583022|Sensory System Agents|sensory system agents|mesh-ancestor
65236078|NCT02583022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236079|NCT02583022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236080|NCT02583022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65236081|NCT02583022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65344256|NCT03728478|Sensory System Agents|sensory system agents|mesh-ancestor
65344257|NCT03728478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65344258|NCT03728478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65344259|NCT03728478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65236082|NCT02583022|Dermatologic Agents|dermatologic agents|mesh-ancestor
65236083|NCT02583022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65236084|NCT02583022|Immunologic Factors|immunologic factors|mesh-ancestor
65236085|NCT02583022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65236086|NCT02583022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457458|NCT01719003|Metformin|metformin|mesh-list
65236116|NCT00936884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236117|NCT00936884|Sensory System Agents|sensory system agents|mesh-ancestor
65236118|NCT00936884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236119|NCT04077892|Budesonide|budesonide|mesh-list
65236120|NCT04077892|Montelukast|montelukast|mesh-list
65236121|NCT04077892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65236122|NCT04077892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65236123|NCT04077892|Autonomic Agents|autonomic agents|mesh-ancestor
65236124|NCT04077892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236125|NCT04077892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236126|NCT04077892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65236127|NCT04077892|Respiratory System Agents|respiratory system agents|mesh-ancestor
65236128|NCT04077892|Glucocorticoids|glucocorticoids|mesh-ancestor
65236129|NCT04077892|Hormones|hormones|mesh-ancestor
65236130|NCT04077892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65236151|NCT00770263|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65236152|NCT00770263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236153|NCT00770263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65236154|NCT00770263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236155|NCT00770263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236156|NCT00770263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65236157|NCT00770263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65236158|NCT00770263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65236159|NCT00770263|Antifungal Agents|antifungal agents|mesh-ancestor
65236160|NCT00770263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65236161|NCT00770263|Immunologic Factors|immunologic factors|mesh-ancestor
65236162|NCT00770263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236164|NCT02691026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65236165|NCT02691026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236166|NCT05400148|Bupivacaine|bupivacaine|mesh-list
65236167|NCT05400148|Anesthetics, Local|anesthetics, local|mesh-ancestor
65236168|NCT05400148|Anesthetics|anesthetics|mesh-ancestor
65236169|NCT05400148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65236170|NCT05400148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236171|NCT05400148|Sensory System Agents|sensory system agents|mesh-ancestor
65236172|NCT05400148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236173|NCT00765427|Retinol acetate|retinol acetate|mesh-list
65236174|NCT00765427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65236175|NCT00765427|Immunologic Factors|immunologic factors|mesh-ancestor
65236176|NCT00765427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236177|NCT00765427|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65236178|NCT00765427|Protective Agents|protective agents|mesh-ancestor
65236179|NCT00765427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236180|NCT02584582|Liraglutide|liraglutide|mesh-list
65236181|NCT02584582|Exenatide|exenatide|mesh-list
65236182|NCT02584582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65236183|NCT02584582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236184|NCT02584582|Incretins|incretins|mesh-ancestor
65236216|NCT00770497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65236217|NCT02581696|Irsogladine|irsogladine|mesh-list
65236218|NCT02581696|Lafutidine|lafutidine|mesh-list
65236219|NCT02581696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236220|NCT02581696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65236221|NCT02581696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65236222|NCT02581696|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65236223|NCT02581696|Histamine Antagonists|histamine antagonists|mesh-ancestor
65236224|NCT02581696|Histamine Agents|histamine agents|mesh-ancestor
65236225|NCT02581696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65236226|NCT02581696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236227|NCT02581696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236247|NCT00770575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65236248|NCT00770575|Antimetabolites|antimetabolites|mesh-ancestor
65344260|NCT00653523|Simvastatin|simvastatin|mesh-list
65344261|NCT00653523|Ezetimibe|ezetimibe|mesh-list
65344262|NCT00653523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65344263|NCT00653523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65344264|NCT00653523|Antimetabolites|antimetabolites|mesh-ancestor
65344265|NCT00653523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236249|NCT00770575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236250|NCT00770575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65236251|NCT00770575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65236252|NCT00770575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236253|NCT00770575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65236254|NCT00770575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236256|NCT00770731|Bortezomib|bortezomib|mesh-list
65236257|NCT00770731|Topotecan|topotecan|mesh-list
65236258|NCT00770731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236259|NCT00770731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65236260|NCT00770731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65236261|NCT00770731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236262|NCT00770731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236263|NCT00770731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65236264|NCT00770731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65236265|NCT00770731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65236266|NCT00770731|Antifungal Agents|antifungal agents|mesh-ancestor
65236267|NCT00770731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65236268|NCT00770731|Immunologic Factors|immunologic factors|mesh-ancestor
65236269|NCT00770731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236270|NCT00775255|Clarithromycin|clarithromycin|mesh-list
65236271|NCT00775255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65236272|NCT00775255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65236273|NCT00775255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65236274|NCT00775255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236275|NCT00775255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236276|NCT00775255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65236277|NCT00775255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65236278|NCT00606866|Sorafenib|sorafenib|mesh-list
65236279|NCT00606866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236280|NCT00606866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65236281|NCT00606866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236282|NCT00606866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236300|NCT04265456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65236301|NCT04265456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65236302|NCT04265456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65236304|NCT04379518|Interferon-alpha|interferon-alpha|mesh-list
65236305|NCT04379518|Interferon alpha-2|interferon alpha-2|mesh-list
65236306|NCT04379518|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
65236307|NCT04379518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236308|NCT04379518|Antiviral Agents|antiviral agents|mesh-ancestor
65236309|NCT04379518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65236310|NCT04379518|Immunologic Factors|immunologic factors|mesh-ancestor
65236311|NCT04379518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236313|NCT04378426|Nitrous Oxide|nitrous oxide|mesh-list
65236314|NCT04378426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65236315|NCT04378426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65236316|NCT04378426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65236317|NCT04378426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236318|NCT04378426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65236319|NCT04378426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65236320|NCT04378426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65236321|NCT04378426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65236322|NCT04378426|Anesthetics, General|anesthetics, general|mesh-ancestor
65236323|NCT04378426|Anesthetics|anesthetics|mesh-ancestor
65236324|NCT04378426|GABA Modulators|gaba modulators|mesh-ancestor
65236325|NCT04378426|GABA Agents|gaba agents|mesh-ancestor
65236326|NCT04378426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65236327|NCT04378426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236328|NCT04378426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65236329|NCT04378426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65236330|NCT04378426|Analgesics|analgesics|mesh-ancestor
65236331|NCT04378426|Sensory System Agents|sensory system agents|mesh-ancestor
65344266|NCT00653523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65344267|NCT00653523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65344268|NCT00653523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344269|NCT00869752|Etoposide|etoposide|mesh-list
65344270|NCT00869752|Antibodies|antibodies|mesh-list
65344271|NCT00869752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65236332|NCT04378426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236333|NCT02581462|Trastuzumab|trastuzumab|mesh-list
65236334|NCT02581462|Pertuzumab|pertuzumab|mesh-list
65236335|NCT02581462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65236336|NCT02581462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236337|NCT00668863|Leucovorin|leucovorin|mesh-list
65236338|NCT00668863|Fluorouracil|fluorouracil|mesh-list
65236339|NCT00668863|Irinotecan|irinotecan|mesh-list
65236340|NCT00668863|Sunitinib|sunitinib|mesh-list
65236341|NCT00668863|Levoleucovorin|levoleucovorin|mesh-list
65236342|NCT00668863|Antimetabolites|antimetabolites|mesh-ancestor
65236366|NCT04077736|Analgesics|analgesics|mesh-ancestor
65236367|NCT04077736|Sensory System Agents|sensory system agents|mesh-ancestor
65236368|NCT04077736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236369|NCT04077736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236370|NCT04077736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65236371|NCT04077736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65236372|NCT04077736|Antiviral Agents|antiviral agents|mesh-ancestor
65236373|NCT04077736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65236374|NCT05379530|Anesthetics|anesthetics|mesh-list
65236375|NCT05379530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65236376|NCT05379530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236377|NCT00766441|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65236378|NCT00766441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65236379|NCT00766441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236380|NCT00766441|Incretins|incretins|mesh-ancestor
65236381|NCT00766441|Hormones|hormones|mesh-ancestor
65236382|NCT00766441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65236383|NCT00766441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65236384|NCT00766441|Protease Inhibitors|protease inhibitors|mesh-ancestor
65236385|NCT00766441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236386|NCT00766441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236387|NCT05265806|Oxytocin|oxytocin|mesh-list
65236388|NCT05265806|Oxytocics|oxytocics|mesh-ancestor
65236389|NCT05265806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65236390|NCT05265806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236391|NCT00771043|Natalizumab|natalizumab|mesh-list
65236392|NCT00771043|Immunologic Factors|immunologic factors|mesh-ancestor
64457766|NCT04006522|Atezolizumab|atezolizumab|mesh-list
65236426|NCT00771199|Sensory System Agents|sensory system agents|mesh-ancestor
65236427|NCT00771199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236428|NCT00771199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65236429|NCT00771199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65236430|NCT00771199|Anesthetics, General|anesthetics, general|mesh-ancestor
65236431|NCT00771199|Anesthetics|anesthetics|mesh-ancestor
65236432|NCT04264130|Artesunate|artesunate|mesh-list
65236433|NCT04264130|Lumefantrine|lumefantrine|mesh-list
65236434|NCT04264130|Artemether|artemether|mesh-list
65236459|NCT02557867|Adrenergic Agents|adrenergic agents|mesh-ancestor
65236460|NCT02557867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65236461|NCT02557867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236462|NCT00605774|Epinephrine|epinephrine|mesh-list
65236463|NCT00605774|Racepinephrine|racepinephrine|mesh-list
65236464|NCT00605774|Epinephryl borate|epinephryl borate|mesh-list
65236465|NCT00605774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65236466|NCT00605774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65236467|NCT00605774|Adrenergic Agents|adrenergic agents|mesh-ancestor
65236468|NCT00605774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65236469|NCT00605774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236470|NCT00605774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236471|NCT00605774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65236472|NCT00605774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65236473|NCT00605774|Autonomic Agents|autonomic agents|mesh-ancestor
65236474|NCT00605774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236475|NCT00605774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65236476|NCT00605774|Respiratory System Agents|respiratory system agents|mesh-ancestor
65344272|NCT00869752|Immunologic Factors|immunologic factors|mesh-ancestor
65344273|NCT00869752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344274|NCT00869752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344275|NCT00869752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65344276|NCT00869752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65344277|NCT00869752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65344278|NCT00869752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344279|NCT00869752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344280|NCT00808977|Mesalamine|mesalamine|mesh-list
65344281|NCT00808977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65344282|NCT00808977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65344283|NCT00808977|Analgesics|analgesics|mesh-ancestor
65344284|NCT00808977|Sensory System Agents|sensory system agents|mesh-ancestor
65344285|NCT00808977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65344286|NCT00808977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344287|NCT00808977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65344288|NCT00808977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65344289|NCT00735020|Vaccines|vaccines|mesh-list
65344290|NCT00735020|Immunologic Factors|immunologic factors|mesh-ancestor
65344291|NCT00735020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344292|NCT04065906|Methylphenidate|methylphenidate|mesh-list
65344293|NCT04065906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65344294|NCT04065906|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65344295|NCT04065906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344296|NCT04065906|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65344297|NCT04065906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65344298|NCT04065906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65344299|NCT04065906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344300|NCT04065906|Dopamine Agents|dopamine agents|mesh-ancestor
65344301|NCT04065906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64726140|NCT00002539|Doxorubicin|doxorubicin|mesh-list
65236477|NCT00605774|Mydriatics|mydriatics|mesh-ancestor
65236478|NCT00605774|Sympathomimetics|sympathomimetics|mesh-ancestor
65236479|NCT00605774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65236480|NCT04264286|Esmolol|esmolol|mesh-list
65236481|NCT04264286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65236482|NCT04264286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65236483|NCT04264286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65236484|NCT04264286|Adrenergic Agents|adrenergic agents|mesh-ancestor
65236485|NCT04264286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64457857|NCT03978442|Dopamine Agents|dopamine agents|mesh-ancestor
65344302|NCT04065906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65344303|NCT04065906|Adrenergic Agents|adrenergic agents|mesh-ancestor
65344304|NCT00739388|Azacitidine|azacitidine|mesh-list
65344305|NCT00739388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65344306|NCT00739388|Antimetabolites|antimetabolites|mesh-ancestor
65344307|NCT00739388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344308|NCT00739388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954298|NCT04730622|Mitogens|mitogens|mesh-list
65236506|NCT04077580|Methenamine mandelate|methenamine mandelate|mesh-list
65236507|NCT04077580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65236508|NCT04077580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65236509|NCT04077580|Renal Agents|renal agents|mesh-ancestor
65236510|NCT04077580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65236511|NCT04240054|Dexamethasone|dexamethasone|mesh-list
65236512|NCT04240054|Cyclophosphamide|cyclophosphamide|mesh-list
65236514|NCT04240054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65236515|NCT04240054|Immunologic Factors|immunologic factors|mesh-ancestor
65236516|NCT04240054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236517|NCT04240054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65236518|NCT04240054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65236519|NCT04240054|Alkylating Agents|alkylating agents|mesh-ancestor
65236520|NCT04240054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236521|NCT04240054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236522|NCT04240054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65236523|NCT04240054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65236524|NCT04240054|Antiemetics|antiemetics|mesh-ancestor
65236525|NCT04240054|Autonomic Agents|autonomic agents|mesh-ancestor
65236526|NCT04240054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236527|NCT04240054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65236528|NCT04240054|Glucocorticoids|glucocorticoids|mesh-ancestor
65236529|NCT04240054|Hormones|hormones|mesh-ancestor
65236530|NCT04240054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65236531|NCT04240054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65236532|NCT00668707|Melatonin|melatonin|mesh-list
65236533|NCT00668707|Antioxidants|antioxidants|mesh-ancestor
65236534|NCT00668707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236535|NCT00668707|Protective Agents|protective agents|mesh-ancestor
65236536|NCT00668707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236537|NCT00668707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64457912|NCT03598192|Sufentanil|sufentanil|mesh-list
65236561|NCT00668395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65236562|NCT00668395|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65236563|NCT00668395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65236564|NCT00668395|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65236565|NCT00668395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65236566|NCT00668395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65236567|NCT00668395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65236568|NCT04047628|Alemtuzumab|alemtuzumab|mesh-list
65236569|NCT04047628|Ofatumumab|ofatumumab|mesh-list
65236570|NCT04047628|Cladribine|cladribine|mesh-list
65236571|NCT04047628|Ocrelizumab|ocrelizumab|mesh-list
65236572|NCT04047628|Natalizumab|natalizumab|mesh-list
65236573|NCT04047628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65236574|NCT04047628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236575|NCT04047628|Immunologic Factors|immunologic factors|mesh-ancestor
65236576|NCT04047628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236577|NCT04047628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65236578|NCT00668317|Omeprazole|omeprazole|mesh-list
65236579|NCT00668317|Ranitidine|ranitidine|mesh-list
65236580|NCT00668317|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65236581|NCT00668317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65236582|NCT00668317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65236583|NCT00668317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65236584|NCT00668317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236585|NCT00668317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879319|NCT01905150|Antimetabolites|antimetabolites|mesh-ancestor
65236586|NCT00668317|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65344309|NCT00739388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344310|NCT00862888|Sildenafil Citrate|sildenafil citrate|mesh-list
65344311|NCT00862888|Vasodilator Agents|vasodilator agents|mesh-ancestor
65344312|NCT00862888|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65344313|NCT00862888|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65344314|NCT00862888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726181|NCT00002239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65236587|NCT00668317|Histamine Antagonists|histamine antagonists|mesh-ancestor
65236588|NCT00668317|Histamine Agents|histamine agents|mesh-ancestor
65236589|NCT00668317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65236620|NCT00776113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65236621|NCT00776113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65236622|NCT00776113|Adrenergic Agents|adrenergic agents|mesh-ancestor
65236623|NCT00776113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65236624|NCT00776113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236625|NCT00776113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236626|NCT00776113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65236627|NCT00776113|Antioxidants|antioxidants|mesh-ancestor
65236628|NCT00776113|Protective Agents|protective agents|mesh-ancestor
65236629|NCT00776113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65236630|NCT00776113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65236631|NCT00776113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65236632|NCT00776113|Vasodilator Agents|vasodilator agents|mesh-ancestor
65236633|NCT00776113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64458021|NCT01824290|Tadalafil|tadalafil|mesh-list
65236651|NCT00672139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236652|NCT02557789|Lefamulin|lefamulin|mesh-list
65236653|NCT02557789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65236654|NCT02557789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65236655|NCT00771823|Maraviroc|maraviroc|mesh-list
65236656|NCT00771823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65236657|NCT00771823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65236658|NCT00771823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236659|NCT00771823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65236660|NCT00771823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65236661|NCT00771823|Antiviral Agents|antiviral agents|mesh-ancestor
65236662|NCT00771823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65236663|NCT00771823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65236664|NCT03766126|Cyclophosphamide|cyclophosphamide|mesh-list
65236665|NCT03766126|Fludarabine|fludarabine|mesh-list
65236666|NCT03766126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65236667|NCT03766126|Immunologic Factors|immunologic factors|mesh-ancestor
65236668|NCT03766126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236669|NCT03766126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65236670|NCT03766126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65236671|NCT03766126|Alkylating Agents|alkylating agents|mesh-ancestor
65236672|NCT03766126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236673|NCT03766126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236674|NCT03766126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65236675|NCT04219540|Buprenorphine|buprenorphine|mesh-list
65236676|NCT04219540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65236677|NCT04219540|Narcotics|narcotics|mesh-ancestor
65236678|NCT04219540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65236679|NCT04219540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236680|NCT04219540|Analgesics|analgesics|mesh-ancestor
65236681|NCT04219540|Sensory System Agents|sensory system agents|mesh-ancestor
65236682|NCT04219540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236683|NCT04219540|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65236684|NCT03955042|Pemetrexed|pemetrexed|mesh-list
65236685|NCT03955042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236686|NCT03955042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236687|NCT03955042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236688|NCT03955042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65236689|NCT03955042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65236690|NCT03742102|Paclitaxel|paclitaxel|mesh-list
65236725|NCT00771979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236726|NCT00767689|Vitamin B 6|vitamin b 6|mesh-list
65236728|NCT00767689|Pyridoxine|pyridoxine|mesh-list
65344315|NCT00862888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344316|NCT00862888|Urological Agents|urological agents|mesh-ancestor
65344317|NCT00729170|Calcium|calcium|mesh-list
65344318|NCT00729170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65344319|NCT00729170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344320|NCT00862966|Heparin|heparin|mesh-list
65236729|NCT00767689|Vitamins|vitamins|mesh-ancestor
65236730|NCT00767689|Micronutrients|micronutrients|mesh-ancestor
65236746|NCT00776347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236748|NCT00776347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65236749|NCT00776347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236751|NCT00776425|Epoetin Alfa|epoetin alfa|mesh-list
65236752|NCT00776425|Hematinics|hematinics|mesh-ancestor
65236753|NCT03913702|Methylprednisolone|methylprednisolone|mesh-list
65236754|NCT03913702|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65236755|NCT03913702|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65236756|NCT03913702|Prednisolone|prednisolone|mesh-list
65236757|NCT03913702|Prednisolone acetate|prednisolone acetate|mesh-list
65236758|NCT03913702|Ketorolac|ketorolac|mesh-list
65236759|NCT03913702|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65236760|NCT03913702|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65236761|NCT03913702|Prednisolone phosphate|prednisolone phosphate|mesh-list
65236762|NCT03913702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65236763|NCT03913702|Antiemetics|antiemetics|mesh-ancestor
65236764|NCT03913702|Autonomic Agents|autonomic agents|mesh-ancestor
65236765|NCT03913702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236766|NCT03913702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236767|NCT03913702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65236768|NCT03913702|Glucocorticoids|glucocorticoids|mesh-ancestor
65236769|NCT03913702|Hormones|hormones|mesh-ancestor
65236770|NCT03913702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65236771|NCT03913702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65236772|NCT03913702|Protective Agents|protective agents|mesh-ancestor
65236773|NCT03913702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65236774|NCT03913702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236775|NCT03913702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65236776|NCT03913702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65236777|NCT03913702|Analgesics|analgesics|mesh-ancestor
65236778|NCT03913702|Sensory System Agents|sensory system agents|mesh-ancestor
65236779|NCT03913702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65236780|NCT03913702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65236781|NCT03913702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236782|NCT03913702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236783|NCT03909412|Dexamethasone|dexamethasone|mesh-list
65236784|NCT03909412|Cyclophosphamide|cyclophosphamide|mesh-list
65236785|NCT03909412|Lenograstim|lenograstim|mesh-list
65236786|NCT03909412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65236787|NCT03909412|Immunologic Factors|immunologic factors|mesh-ancestor
65236788|NCT03909412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236789|NCT03909412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65236817|NCT04075006|Ketamine|ketamine|mesh-list
65236818|NCT04075006|Analgesics|analgesics|mesh-ancestor
65236819|NCT04075006|Sensory System Agents|sensory system agents|mesh-ancestor
65236820|NCT04075006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236821|NCT04075006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236822|NCT04075006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65236823|NCT04075006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65236824|NCT04075006|Anesthetics, General|anesthetics, general|mesh-ancestor
65236825|NCT04075006|Anesthetics|anesthetics|mesh-ancestor
65236826|NCT04075006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65236827|NCT04075006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65236828|NCT04075006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65236829|NCT04075006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65236830|NCT04075006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236831|NCT04188106|Hydroxyzine|hydroxyzine|mesh-list
65236832|NCT04188106|Varenicline|varenicline|mesh-list
65236858|NCT00669955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236859|NCT00669955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236860|NCT00669955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65344321|NCT00862966|Anticoagulants|anticoagulants|mesh-ancestor
65344322|NCT00862966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344323|NCT00862966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65344324|NCT00862966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65236861|NCT00669955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65236862|NCT00669955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65236864|NCT00772291|Pregabalin|pregabalin|mesh-list
65236865|NCT00772291|Analgesics|analgesics|mesh-ancestor
65236866|NCT00772291|Sensory System Agents|sensory system agents|mesh-ancestor
65236867|NCT00772291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236868|NCT00772291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236869|NCT00772291|Anticonvulsants|anticonvulsants|mesh-ancestor
65236870|NCT00772291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65236871|NCT00772291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65236872|NCT00772291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236873|NCT00772291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65236874|NCT00772291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65236875|NCT00772291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65236876|NCT00772291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65236877|NCT00772291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65236878|NCT05673928|Trastuzumab|trastuzumab|mesh-list
65236879|NCT05673928|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65236880|NCT05673928|Maytansine|maytansine|mesh-list
65236881|NCT05673928|Tucatinib|tucatinib|mesh-list
65236882|NCT05673928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65236883|NCT05673928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458264|NCT04194034|Flucytosine|flucytosine|mesh-list
65236905|NCT00768157|Antiviral Agents|antiviral agents|mesh-list
65236906|NCT00768157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65236907|NCT00768157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65236908|NCT00768157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236909|NCT00768157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236910|NCT00768157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65236911|NCT00768157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65236912|NCT00768157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65236913|NCT00671749|Clindamycin|clindamycin|mesh-list
65236914|NCT00671749|Clindamycin palmitate|clindamycin palmitate|mesh-list
65236915|NCT00671749|Clindamycin phosphate|clindamycin phosphate|mesh-list
65236916|NCT00671749|Adapalene|adapalene|mesh-list
65236917|NCT00671749|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65236918|NCT00671749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65236919|NCT00671749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65236920|NCT00671749|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65236921|NCT00671749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236922|NCT00671749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236923|NCT00671749|Dermatologic Agents|dermatologic agents|mesh-ancestor
65236924|NCT00671749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65236925|NCT00671749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65236926|NCT00671749|Analgesics|analgesics|mesh-ancestor
65236927|NCT00671749|Sensory System Agents|sensory system agents|mesh-ancestor
65236928|NCT00671749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236929|NCT00671749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236930|NCT00671749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65236931|NCT00671749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65236932|NCT04149106|Pyrimethamine|pyrimethamine|mesh-list
65236933|NCT04149106|Sulfadoxine|sulfadoxine|mesh-list
65236934|NCT04149106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65236935|NCT04149106|Amodiaquine|amodiaquine|mesh-list
65236936|NCT04149106|Artenimol|artenimol|mesh-list
65236937|NCT04149106|Antimalarials|antimalarials|mesh-ancestor
65236967|NCT00669877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236969|NCT00669877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65236970|NCT00669877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65236971|NCT00669877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65236972|NCT00669877|Antiemetics|antiemetics|mesh-ancestor
65236973|NCT00669877|Autonomic Agents|autonomic agents|mesh-ancestor
65236974|NCT00669877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236975|NCT00669877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65236976|NCT00669877|Glucocorticoids|glucocorticoids|mesh-ancestor
65236977|NCT00669877|Hormones|hormones|mesh-ancestor
65222784|NCT02700711|Sensory System Agents|sensory system agents|mesh-ancestor
65344325|NCT02569320|Dexamethasone|dexamethasone|mesh-list
65344326|NCT02569320|Dexamethasone acetate|dexamethasone acetate|mesh-list
65344327|NCT02569320|Pomalidomide|pomalidomide|mesh-list
65344328|NCT02569320|Ichthammol|ichthammol|mesh-list
65344329|NCT02569320|BB 1101|bb 1101|mesh-list
65344330|NCT02569320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65236978|NCT00669877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65236979|NCT00669877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65236980|NCT00669877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65236981|NCT00669877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65236982|NCT00669877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65236983|NCT00669877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458371|NCT04020328|Prednisone|prednisone|mesh-list
65237003|NCT00772681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237004|NCT00772759|AZD-3199|azd-3199|mesh-list
65237005|NCT00772759|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65237006|NCT00772759|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65237007|NCT00772759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65237008|NCT00772759|Adrenergic Agents|adrenergic agents|mesh-ancestor
65237009|NCT00772759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65237010|NCT00772759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237011|NCT00772759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237012|NCT03866668|Esomeprazole|esomeprazole|mesh-list
65237013|NCT03866668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65237014|NCT03866668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65237015|NCT03866668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65237016|NCT03866668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237017|NCT03866668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237018|NCT00772837|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65237019|NCT00772837|Amoxicillin|amoxicillin|mesh-list
65237020|NCT00772837|Clarithromycin|clarithromycin|mesh-list
65237021|NCT00772837|Omeprazole|omeprazole|mesh-list
65237022|NCT00772837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65237023|NCT00772837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65237024|NCT00772837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65237025|NCT00772837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65237026|NCT00772837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237027|NCT00772837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237028|NCT00772837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65237029|NCT00772837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65237030|NCT00772837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65237031|NCT00773149|Alemtuzumab|alemtuzumab|mesh-list
65237032|NCT00773149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65237033|NCT00773149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237034|NCT00768859|Paclitaxel|paclitaxel|mesh-list
65237035|NCT00768859|Carboplatin|carboplatin|mesh-list
65237036|NCT00768859|Trastuzumab|trastuzumab|mesh-list
65237037|NCT00768859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65237038|NCT00768859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237039|NCT00768859|Tubulin Modulators|tubulin modulators|mesh-ancestor
65237072|NCT00671437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65237073|NCT00671437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237074|NCT00777517|Atorvastatin|atorvastatin|mesh-list
65237075|NCT00777517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65237076|NCT00777517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65237077|NCT00777517|Antimetabolites|antimetabolites|mesh-ancestor
65237078|NCT00777517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237079|NCT00777517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65237080|NCT00777517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65237081|NCT00777517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237097|NCT00769171|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65237098|NCT00769171|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65237099|NCT00769171|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65237100|NCT00769171|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65237101|NCT00769171|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65237102|NCT00777595|Moxifloxacin|moxifloxacin|mesh-list
65237103|NCT00777595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65237104|NCT00777595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65237105|NCT00777595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65237106|NCT00777595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65344331|NCT02569320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65344332|NCT02569320|Antiemetics|antiemetics|mesh-ancestor
65237107|NCT00777595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237108|NCT00777595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237109|NCT00777595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237110|NCT00769405|Leucovorin|leucovorin|mesh-list
65237111|NCT00769405|Fluorouracil|fluorouracil|mesh-list
65237112|NCT00769405|Oxaliplatin|oxaliplatin|mesh-list
65237113|NCT00769405|Calcium|calcium|mesh-list
65237114|NCT00769405|Levoleucovorin|levoleucovorin|mesh-list
65237115|NCT00769405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65237116|NCT00769405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237117|NCT00769405|Antimetabolites|antimetabolites|mesh-ancestor
65237118|NCT00769405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237119|NCT00769405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65237120|NCT00769405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237121|NCT00769405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65237122|NCT00769405|Immunologic Factors|immunologic factors|mesh-ancestor
65237123|NCT00769405|Antidotes|antidotes|mesh-ancestor
65237124|NCT00769405|Protective Agents|protective agents|mesh-ancestor
65237125|NCT00769405|Vitamin B Complex|vitamin b complex|mesh-ancestor
65237126|NCT00769405|Vitamins|vitamins|mesh-ancestor
65237127|NCT00769405|Micronutrients|micronutrients|mesh-ancestor
65237128|NCT02829502|Exenatide|exenatide|mesh-list
65237129|NCT02829502|Glucagon|glucagon|mesh-list
65237130|NCT02829502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65237131|NCT02829502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65237132|NCT02829502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237133|NCT02829502|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65237134|NCT02829502|Incretins|incretins|mesh-ancestor
65237135|NCT02829502|Hormones|hormones|mesh-ancestor
65237136|NCT02829502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65237137|NCT02829502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65237138|NCT02635191|Amoxicillin|amoxicillin|mesh-list
65237139|NCT02635191|Metronidazole|metronidazole|mesh-list
65237140|NCT02635191|Clarithromycin|clarithromycin|mesh-list
65237141|NCT02635191|Esomeprazole|esomeprazole|mesh-list
65237142|NCT02635191|Omeprazole|omeprazole|mesh-list
65237143|NCT02635191|Rabeprazole|rabeprazole|mesh-list
65237170|NCT00777673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237172|NCT00777673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65237173|NCT00777673|Alkylating Agents|alkylating agents|mesh-ancestor
65237174|NCT00777673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65237175|NCT00777673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65237176|NCT00777673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65237177|NCT00777673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65237178|NCT00777673|Growth Substances|growth substances|mesh-ancestor
65237179|NCT00777673|Growth Inhibitors|growth inhibitors|mesh-ancestor
65237180|NCT00777673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65237181|NCT00777673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65237182|NCT00777673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65237183|NCT00777673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237184|NCT02579902|Vitamin D|vitamin d|mesh-list
65237185|NCT02579902|Cholecalciferol|cholecalciferol|mesh-list
65237186|NCT02579902|Vitamins|vitamins|mesh-ancestor
65237187|NCT02579902|Micronutrients|micronutrients|mesh-ancestor
65237188|NCT02579902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237189|NCT02579902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65237190|NCT02579902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65237192|NCT02557087|Scopolamine|scopolamine|mesh-list
65237214|NCT02579590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65237216|NCT02579590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65237217|NCT02579590|Contraceptive Agents|contraceptive agents|mesh-ancestor
65237218|NCT02579590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65237219|NCT02579590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237220|NCT02579590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65237221|NCT02579590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65237222|NCT02579590|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65237223|NCT02579590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65237224|NCT02579590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237225|NCT02579590|Progestins|progestins|mesh-ancestor
65237226|NCT02579590|Hormones|hormones|mesh-ancestor
65237227|NCT02579590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65237228|NCT02634723|Factor VIII|factor viii|mesh-list
65237229|NCT02634723|Coagulants|coagulants|mesh-ancestor
65237230|NCT02634489|Tamsulosin|tamsulosin|mesh-list
65344333|NCT02569320|Autonomic Agents|autonomic agents|mesh-ancestor
65344334|NCT02569320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65344335|NCT02569320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237231|NCT02634489|Solifenacin Succinate|solifenacin succinate|mesh-list
65237232|NCT02634489|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65237233|NCT02634489|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65237234|NCT02634489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65237235|NCT02634489|Adrenergic Agents|adrenergic agents|mesh-ancestor
65237236|NCT02634489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65237237|NCT02634489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237238|NCT02634489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237239|NCT02634489|Urological Agents|urological agents|mesh-ancestor
65237240|NCT02634489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65237241|NCT02634489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65237242|NCT02634489|Cholinergic Agents|cholinergic agents|mesh-ancestor
65237243|NCT00582712|Lithium Carbonate|lithium carbonate|mesh-list
65237244|NCT00582712|Antidepressive Agents|antidepressive agents|mesh-ancestor
65237245|NCT00582712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64444431|NCT01586338|Hylan|hylan|mesh-list
65237264|NCT00582790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65237265|NCT00582790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237266|NCT00582790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65237267|NCT00774007|Mesalamine|mesalamine|mesh-list
65237268|NCT00774007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65237269|NCT00774007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65237270|NCT00774007|Analgesics|analgesics|mesh-ancestor
65237271|NCT00774007|Sensory System Agents|sensory system agents|mesh-ancestor
65237272|NCT00774007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65237273|NCT00774007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237274|NCT00774007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65237275|NCT00774007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65237276|NCT00769873|Heparin|heparin|mesh-list
65237277|NCT00769873|Enoxaparin|enoxaparin|mesh-list
65237278|NCT00769873|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65237279|NCT00769873|Tinzaparin|tinzaparin|mesh-list
65237280|NCT00769873|Dalteparin|dalteparin|mesh-list
65237281|NCT00769873|Anticoagulants|anticoagulants|mesh-ancestor
65237282|NCT00769873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65237283|NCT00769873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65237284|NCT00769873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237285|NCT00777985|Bosentan|bosentan|mesh-list
65237286|NCT00777985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65237287|NCT00777985|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65237288|NCT00777985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237289|NCT00770107|Thiamine|thiamine|mesh-list
65237290|NCT00770107|Vitamin B Complex|vitamin b complex|mesh-ancestor
65237291|NCT00770107|Vitamins|vitamins|mesh-ancestor
65237292|NCT00770107|Micronutrients|micronutrients|mesh-ancestor
65237293|NCT00770107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237294|NCT00774241|Bevacizumab|bevacizumab|mesh-list
65237295|NCT00774241|Docetaxel|docetaxel|mesh-list
65237296|NCT00774241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65237297|NCT00774241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237298|NCT00774241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65237299|NCT00774241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65237300|NCT00774241|Growth Substances|growth substances|mesh-ancestor
65237301|NCT00774241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237302|NCT00774241|Growth Inhibitors|growth inhibitors|mesh-ancestor
65237303|NCT00774241|Tubulin Modulators|tubulin modulators|mesh-ancestor
65237340|NCT02634021|Midazolam|midazolam|mesh-list
65237341|NCT02634021|Dexmedetomidine|dexmedetomidine|mesh-list
65237359|NCT02634021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65237360|NCT02634021|Anesthetics, General|anesthetics, general|mesh-ancestor
65237361|NCT02634021|Anesthetics|anesthetics|mesh-ancestor
65237362|NCT02634021|GABA Modulators|gaba modulators|mesh-ancestor
65237363|NCT02634021|GABA Agents|gaba agents|mesh-ancestor
65237364|NCT04161729|Magnesium Sulfate|magnesium sulfate|mesh-list
65237365|NCT04161729|Analgesics|analgesics|mesh-ancestor
65237366|NCT04161729|Sensory System Agents|sensory system agents|mesh-ancestor
65237367|NCT04161729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65237368|NCT04161729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237369|NCT04161729|Anesthetics|anesthetics|mesh-ancestor
65237370|NCT04161729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65237371|NCT04161729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65344336|NCT02569320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65344337|NCT02569320|Glucocorticoids|glucocorticoids|mesh-ancestor
65344338|NCT02569320|Hormones|hormones|mesh-ancestor
65344339|NCT02569320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65237372|NCT04161729|Anticonvulsants|anticonvulsants|mesh-ancestor
65237373|NCT04161729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65237374|NCT04161729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65237375|NCT04161729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237376|NCT04161729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65237377|NCT04161729|Tocolytic Agents|tocolytic agents|mesh-ancestor
65237378|NCT04161729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65237379|NCT04161339|Hydroxychloroquine|hydroxychloroquine|mesh-list
65237380|NCT04161339|Antimalarials|antimalarials|mesh-ancestor
65237381|NCT04161339|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65237382|NCT04161339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65237383|NCT04161339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65237384|NCT04161339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237385|NCT04161339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237386|NCT04161339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65237388|NCT00934856|Trastuzumab|trastuzumab|mesh-list
65237389|NCT00934856|Pertuzumab|pertuzumab|mesh-list
65237390|NCT00934856|Maytansine|maytansine|mesh-list
65237391|NCT00934856|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65237392|NCT00934856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237393|NCT00934856|Tubulin Modulators|tubulin modulators|mesh-ancestor
65237394|NCT00934856|Antimitotic Agents|antimitotic agents|mesh-ancestor
65237395|NCT00934856|Mitosis Modulators|mitosis modulators|mesh-ancestor
65237396|NCT00934856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237397|NCT00934856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64458766|NCT04405960|Vitamins|vitamins|mesh-ancestor
65237420|NCT00774475|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65237421|NCT00774475|Purinergic Agents|purinergic agents|mesh-ancestor
65237422|NCT00774475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65237423|NCT00774475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237424|NCT00774475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237426|NCT00669331|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65237428|NCT00669331|Natriuretic Agents|natriuretic agents|mesh-ancestor
65237429|NCT00669331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237430|NCT00778297|Vaccines|vaccines|mesh-list
65237431|NCT00778297|Immunologic Factors|immunologic factors|mesh-ancestor
65237432|NCT00778297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237433|NCT00779233|Zidovudine|zidovudine|mesh-list
65237434|NCT00779233|Antimetabolites|antimetabolites|mesh-ancestor
65237435|NCT00779233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237436|NCT00779233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65237437|NCT00779233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65237438|NCT00779233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237439|NCT00779233|Antiviral Agents|antiviral agents|mesh-ancestor
65237440|NCT00779233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65237441|NCT00779233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65237442|NCT00779233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65237443|NCT00607178|Vaccines|vaccines|mesh-list
65237444|NCT00607178|Immunologic Factors|immunologic factors|mesh-ancestor
65237445|NCT00607178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237446|NCT02556463|Durvalumab|durvalumab|mesh-list
65237447|NCT02556463|MEDI9197|medi9197|mesh-list
65237448|NCT02556463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65237449|NCT02556463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237450|NCT02556463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65237451|NCT02556463|Immunologic Factors|immunologic factors|mesh-ancestor
65237468|NCT00778609|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65237469|NCT00778609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65237470|NCT00778609|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
65237471|NCT00778609|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65237472|NCT00778609|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65237473|NCT05153174|Sulforaphane|sulforaphane|mesh-list
65237474|NCT05153174|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65237475|NCT05153174|Protective Agents|protective agents|mesh-ancestor
65237476|NCT05153174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237477|NCT05153174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237478|NCT00778765|Gabapentin|gabapentin|mesh-list
65344340|NCT02569320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65344341|NCT02569320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344342|NCT02569320|Protease Inhibitors|protease inhibitors|mesh-ancestor
65344343|NCT02569320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726209|NCT00003128|Paclitaxel|paclitaxel|mesh-list
65237479|NCT00778765|Analgesics|analgesics|mesh-ancestor
65237480|NCT00778765|Sensory System Agents|sensory system agents|mesh-ancestor
65237481|NCT00778765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65237482|NCT00778765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237483|NCT00778765|Anticonvulsants|anticonvulsants|mesh-ancestor
65237484|NCT00778765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65237485|NCT00778765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65237486|NCT00778765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65237487|NCT00778765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65237488|NCT00778765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65237489|NCT00778765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65237490|NCT00778765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65237491|NCT00778765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237492|NCT00778765|Antimanic Agents|antimanic agents|mesh-ancestor
65237493|NCT00779935|Infliximab|infliximab|mesh-list
65237494|NCT00779935|Dermatologic Agents|dermatologic agents|mesh-ancestor
65237495|NCT00779935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65237496|NCT00779935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65237497|NCT00780013|Metformin|metformin|mesh-list
65237498|NCT00780013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65237499|NCT00780013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237500|NCT00667225|Cantharidin|cantharidin|mesh-list
65237501|NCT00667225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969334|NCT00193531|Paclitaxel|paclitaxel|mesh-list
65237502|NCT00667225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237504|NCT00780169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237505|NCT00780169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65237506|NCT00780169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458874|NCT04143880|Progesterone|progesterone|mesh-list
65237528|NCT02556229|Aflibercept|aflibercept|mesh-list
65237529|NCT02556229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65237530|NCT02556229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65237531|NCT02556229|Growth Substances|growth substances|mesh-ancestor
65237532|NCT02556229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237533|NCT02556229|Growth Inhibitors|growth inhibitors|mesh-ancestor
65237534|NCT02556229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237535|NCT00929864|Adalimumab|adalimumab|mesh-list
65237536|NCT00929864|Abatacept|abatacept|mesh-list
65237537|NCT00929864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65237538|NCT00929864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65237539|NCT00929864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65237540|NCT00929864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237541|NCT00929864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237542|NCT00929864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65237543|NCT00929864|Immunologic Factors|immunologic factors|mesh-ancestor
65237544|NCT00929864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237545|NCT00597753|Epoetin Alfa|epoetin alfa|mesh-list
65237546|NCT00597753|Hematinics|hematinics|mesh-ancestor
65237547|NCT04262804|Gemcitabine|gemcitabine|mesh-list
65237548|NCT04262804|Capecitabine|capecitabine|mesh-list
65237549|NCT04262804|Trastuzumab|trastuzumab|mesh-list
65237550|NCT04262804|Vinorelbine|vinorelbine|mesh-list
65237551|NCT04262804|Margetuximab|margetuximab|mesh-list
65237552|NCT04262804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65237553|NCT04262804|Antimetabolites|antimetabolites|mesh-ancestor
65237554|NCT04262804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237555|NCT04262804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237556|NCT04262804|Antiviral Agents|antiviral agents|mesh-ancestor
65237557|NCT04262804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65237558|NCT04262804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237559|NCT04262804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65237560|NCT04262804|Immunologic Factors|immunologic factors|mesh-ancestor
64458934|NCT01822496|Paclitaxel|paclitaxel|mesh-list
65237588|NCT02633709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237589|NCT02633709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237590|NCT02633709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65237591|NCT02633709|Hormone Antagonists|hormone antagonists|mesh-ancestor
65344344|NCT02569320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344345|NCT02569320|Immunologic Factors|immunologic factors|mesh-ancestor
65344346|NCT02569320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65237592|NCT02633709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65237593|NCT02633709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237594|NCT02633709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65237595|NCT02633709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65237596|NCT02633709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65237597|NCT04264988|Tin Fluorides|tin fluorides|mesh-list
65237598|NCT04264988|Cariostatic Agents|cariostatic agents|mesh-ancestor
65237599|NCT04264988|Protective Agents|protective agents|mesh-ancestor
65237600|NCT04264988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237601|NCT00657033|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65237602|NCT00657033|Vasodilator Agents|vasodilator agents|mesh-ancestor
65237603|NCT00657033|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65237604|NCT00657033|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65237605|NCT00657033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237636|NCT00879879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237638|NCT00661999|Ferric gluconate|ferric gluconate|mesh-list
64880381|NCT01912053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65237639|NCT00661999|Hematinics|hematinics|mesh-ancestor
65237640|NCT00661167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65237641|NCT00661167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237642|NCT04156815|Isotretinoin|isotretinoin|mesh-list
65237643|NCT04156815|Dermatologic Agents|dermatologic agents|mesh-ancestor
65237644|NCT04156425|Golimumab|golimumab|mesh-list
65237645|NCT04156425|Dexetimide|dexetimide|mesh-list
65237646|NCT04156425|Citalopram|citalopram|mesh-list
65237647|NCT04156425|Calcium|calcium|mesh-list
65237667|NCT04156425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65237669|NCT04156425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65237670|NCT04156425|Immunologic Factors|immunologic factors|mesh-ancestor
65237671|NCT02555059|Ciprofloxacin|ciprofloxacin|mesh-list
65237672|NCT02555059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65237673|NCT02555059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65237674|NCT02555059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65237675|NCT02555059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65237676|NCT02555059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237677|NCT02555059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237678|NCT02555059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237679|NCT02555059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65237680|NCT02555059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65237681|NCT00790075|Risperidone|risperidone|mesh-list
65237682|NCT00790075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65237683|NCT00790075|Serotonin Agents|serotonin agents|mesh-ancestor
65237684|NCT00790075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65237685|NCT00790075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237686|NCT00790075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237687|NCT00790075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65237688|NCT00790075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65237689|NCT00790075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65237690|NCT00790075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65237691|NCT00790075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65237692|NCT00790075|Dopamine Agents|dopamine agents|mesh-ancestor
65237693|NCT00785083|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65237694|NCT00785083|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65237695|NCT00785083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237696|NCT00785083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65237697|NCT00785083|Immunologic Factors|immunologic factors|mesh-ancestor
64459072|NCT03589690|Micronutrients|micronutrients|mesh-ancestor
65237735|NCT00790387|Calcium heparin|calcium heparin|mesh-list
65237736|NCT00790387|Tirofiban|tirofiban|mesh-list
65237737|NCT00790387|Anticoagulants|anticoagulants|mesh-ancestor
65237738|NCT00790387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65237739|NCT00790387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65237747|NCT04156035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237748|NCT04156035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65237750|NCT04156035|Anesthetics, General|anesthetics, general|mesh-ancestor
65237751|NCT04156035|Anesthetics|anesthetics|mesh-ancestor
65237752|NCT04156035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65237753|NCT04156035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65344347|NCT02569320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65344348|NCT02569320|Growth Substances|growth substances|mesh-ancestor
65344349|NCT02569320|Growth Inhibitors|growth inhibitors|mesh-ancestor
65344350|NCT02569320|Dermatologic Agents|dermatologic agents|mesh-ancestor
65344351|NCT00739466|Alendronate|alendronate|mesh-list
65344352|NCT00739466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65344353|NCT00739466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344354|NCT00869908|Insulin|insulin|mesh-list
65344355|NCT00869908|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65344356|NCT00869908|Insulin Aspart|insulin aspart|mesh-list
65344357|NCT00869908|Insulin, Long-Acting|insulin, long-acting|mesh-list
65344358|NCT00869908|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65344359|NCT00869908|Insulin Detemir|insulin detemir|mesh-list
65237754|NCT04156035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65237755|NCT04156035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65237756|NCT04156035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237757|NCT04156035|Anticonvulsants|anticonvulsants|mesh-ancestor
65237758|NCT04156035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65237759|NCT04156035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65237760|NCT04156035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65237761|NCT04156035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65237762|NCT04156035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65237763|NCT04156035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65237764|NCT04156035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65237765|NCT00662337|Diphenhydramine|diphenhydramine|mesh-list
65237766|NCT00662337|Promethazine|promethazine|mesh-list
65237767|NCT00662337|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65237768|NCT00662337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65237769|NCT00662337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65237770|NCT00662337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237771|NCT00662337|Anesthetics, Local|anesthetics, local|mesh-ancestor
65237772|NCT00662337|Anesthetics|anesthetics|mesh-ancestor
65237773|NCT00662337|Sensory System Agents|sensory system agents|mesh-ancestor
65237774|NCT00662337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65237775|NCT00662337|Antiemetics|antiemetics|mesh-ancestor
65237776|NCT00662337|Autonomic Agents|autonomic agents|mesh-ancestor
65237777|NCT00662337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65237778|NCT00662337|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65237779|NCT00662337|Histamine Antagonists|histamine antagonists|mesh-ancestor
65237780|NCT00662337|Histamine Agents|histamine agents|mesh-ancestor
65237781|NCT00662337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65237782|NCT00662337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237783|NCT00662337|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65237784|NCT00662337|Antipruritics|antipruritics|mesh-ancestor
65237785|NCT00662337|Dermatologic Agents|dermatologic agents|mesh-ancestor
65237786|NCT00665353|Pioglitazone|pioglitazone|mesh-list
65237787|NCT00665353|Ribavirin|ribavirin|mesh-list
65237788|NCT00665353|Antimetabolites|antimetabolites|mesh-ancestor
65237789|NCT00665353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237790|NCT00665353|Antiviral Agents|antiviral agents|mesh-ancestor
65237791|NCT00665353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65237792|NCT00665353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65237793|NCT00665353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237794|NCT00785395|Oxytocin|oxytocin|mesh-list
65237795|NCT00785395|Oxytocics|oxytocics|mesh-ancestor
65237796|NCT00785395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65237797|NCT00785395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237798|NCT00662571|Acamprosate|acamprosate|mesh-list
65237799|NCT00662571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65237800|NCT00780793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
65237801|NCT00780793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65237802|NCT02555761|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65237803|NCT02555761|Alcaftadine|alcaftadine|mesh-list
65344360|NCT00869908|Biphasic Insulins|biphasic insulins|mesh-list
65344361|NCT00869908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65344362|NCT00869908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344363|NCT00739622|Rilpivirine|rilpivirine|mesh-list
65344364|NCT00739622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65344365|NCT00739622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65344366|NCT00739622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344367|NCT00739622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344368|NCT00739622|Antiviral Agents|antiviral agents|mesh-ancestor
65344369|NCT00739622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65344370|NCT00739622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65344371|NCT00739622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65344372|NCT00731562|Varenicline|varenicline|mesh-list
65344373|NCT00731562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65344374|NCT00731562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65344375|NCT00731562|Cholinergic Agents|cholinergic agents|mesh-ancestor
65344376|NCT00731562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65344377|NCT00731562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344378|NCT00731562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344379|NCT00870142|Amlodipine|amlodipine|mesh-list
65344380|NCT00870142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65344381|NCT00870142|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65344382|NCT00870142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65344383|NCT00870142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344384|NCT00870142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65344385|NCT00870142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237804|NCT02555761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65237805|NCT02555761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65237806|NCT02555761|Histamine Antagonists|histamine antagonists|mesh-ancestor
65237807|NCT02555761|Histamine Agents|histamine agents|mesh-ancestor
65237826|NCT00662805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237827|NCT00662805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65237828|NCT00662805|Respiratory System Agents|respiratory system agents|mesh-ancestor
65237829|NCT00662805|Dermatologic Agents|dermatologic agents|mesh-ancestor
65237830|NCT00662805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65237831|NCT00662805|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65237832|NCT00662805|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65237833|NCT00662805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65237834|NCT00662805|Adrenergic Agents|adrenergic agents|mesh-ancestor
65237835|NCT00662805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65237836|NCT00662805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237837|NCT00662883|Mometasone Furoate|mometasone furoate|mesh-list
65237838|NCT00662883|Ketamine|ketamine|mesh-list
65237839|NCT00662883|Analgesics|analgesics|mesh-ancestor
65237840|NCT00662883|Sensory System Agents|sensory system agents|mesh-ancestor
65237841|NCT00662883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65344386|NCT00870142|Vasodilator Agents|vasodilator agents|mesh-ancestor
65344387|NCT00870220|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65344388|NCT00870220|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65344389|NCT00870220|Estradiol|estradiol|mesh-list
65344390|NCT00870220|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65344391|NCT00870220|Estrogens|estrogens|mesh-ancestor
65344392|NCT00870220|Hormones|hormones|mesh-ancestor
64726257|NCT00002798|Cyclophosphamide|cyclophosphamide|mesh-list
65237842|NCT00662883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237843|NCT00662883|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65237844|NCT00662883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65237845|NCT00662883|Anesthetics, General|anesthetics, general|mesh-ancestor
65237846|NCT00662883|Anesthetics|anesthetics|mesh-ancestor
65237847|NCT00662883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65237848|NCT00662883|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65237849|NCT00662883|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65237850|NCT00662883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65237851|NCT00662883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237852|NCT00662883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65237853|NCT00662883|Dermatologic Agents|dermatologic agents|mesh-ancestor
65237854|NCT00662883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65237855|NCT00785473|Cholecalciferol|cholecalciferol|mesh-list
65237856|NCT00785473|Vitamin D|vitamin d|mesh-list
65237857|NCT00785473|Calcium Carbonate|calcium carbonate|mesh-list
65237858|NCT00785473|Calcium|calcium|mesh-list
65237859|NCT00785473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65237860|NCT00785473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237861|NCT00785473|Vitamins|vitamins|mesh-ancestor
65237862|NCT00785473|Micronutrients|micronutrients|mesh-ancestor
65237863|NCT00785473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65237864|NCT00785473|Antacids|antacids|mesh-ancestor
65237865|NCT00785473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237901|NCT00663195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65237902|NCT00663195|Hormone Antagonists|hormone antagonists|mesh-ancestor
65237903|NCT00663195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65237935|NCT00785863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237936|NCT00785863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65237937|NCT00664105|Carboplatin|carboplatin|mesh-list
65237938|NCT00664105|Docetaxel|docetaxel|mesh-list
65237939|NCT00664105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237940|NCT00664105|Tubulin Modulators|tubulin modulators|mesh-ancestor
65237941|NCT00664105|Antimitotic Agents|antimitotic agents|mesh-ancestor
65237942|NCT00664105|Mitosis Modulators|mitosis modulators|mesh-ancestor
65237943|NCT00664105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237944|NCT00785941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65237945|NCT00785941|Immunologic Factors|immunologic factors|mesh-ancestor
65237946|NCT00785941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237947|NCT02555605|Dexmedetomidine|dexmedetomidine|mesh-list
65237971|NCT00791167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237972|NCT00791167|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65237973|NCT00791167|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65237974|NCT00791167|Dopamine Agents|dopamine agents|mesh-ancestor
65237976|NCT00663741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237977|NCT00663741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65237978|NCT00663741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237979|NCT00663741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237980|NCT00663897|Lansoprazole|lansoprazole|mesh-list
65237981|NCT00663897|Dexlansoprazole|dexlansoprazole|mesh-list
65237982|NCT00663897|Mosapride|mosapride|mesh-list
65237983|NCT00663897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65237984|NCT00663897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65237985|NCT00663897|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65237986|NCT00663897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237987|NCT00663897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237988|NCT00663897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65237989|NCT00663897|Serotonin Agents|serotonin agents|mesh-ancestor
65237990|NCT00663897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65344393|NCT00870220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65344394|NCT00870220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237991|NCT00663897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237992|NCT00664053|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65237993|NCT00664053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65237994|NCT00664053|Immunologic Factors|immunologic factors|mesh-ancestor
65237995|NCT00664053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237996|NCT04031859|Aspirin|aspirin|mesh-list
65238017|NCT00664287|Vasodilator Agents|vasodilator agents|mesh-ancestor
65238018|NCT00664287|Vitamin B Complex|vitamin b complex|mesh-ancestor
65238020|NCT00664287|Micronutrients|micronutrients|mesh-ancestor
65238021|NCT00664287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238022|NCT00664599|Rituximab|rituximab|mesh-list
65238023|NCT00664599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65238024|NCT00664599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238025|NCT00664599|Immunologic Factors|immunologic factors|mesh-ancestor
65238026|NCT00664599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238027|NCT00664599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65238028|NCT02631135|Dexmedetomidine|dexmedetomidine|mesh-list
65238029|NCT02631135|Remifentanil|remifentanil|mesh-list
65238030|NCT02631135|Propofol|propofol|mesh-list
65238031|NCT02631135|Rocuronium|rocuronium|mesh-list
65238032|NCT02631135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65238033|NCT02631135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65238034|NCT02631135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238035|NCT02631135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65238036|NCT02631135|Anesthetics, General|anesthetics, general|mesh-ancestor
65238037|NCT02631135|Anesthetics|anesthetics|mesh-ancestor
65238038|NCT02631135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65238039|NCT02631135|Analgesics|analgesics|mesh-ancestor
65238040|NCT02631135|Sensory System Agents|sensory system agents|mesh-ancestor
65238041|NCT02631135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65238042|NCT02631135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65238043|NCT02631135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65238044|NCT02631135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65238045|NCT02631135|Adrenergic Agents|adrenergic agents|mesh-ancestor
65238046|NCT02631135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65238047|NCT02631135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238048|NCT02631135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65238049|NCT02631135|Narcotics|narcotics|mesh-ancestor
65238081|NCT00596817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65238082|NCT00596817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65238083|NCT00596817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65238084|NCT00596817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65238085|NCT01000649|Vasopressins|vasopressins|mesh-list
65238086|NCT01000649|Hemostatics|hemostatics|mesh-ancestor
65238087|NCT01000649|Coagulants|coagulants|mesh-ancestor
65238088|NCT01000649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65238089|NCT01000649|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65238090|NCT01000649|Natriuretic Agents|natriuretic agents|mesh-ancestor
65238113|NCT00671151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65238114|NCT00671151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238115|NCT00671151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238116|NCT00671151|Vasodilator Agents|vasodilator agents|mesh-ancestor
65238117|NCT00671151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65238118|NCT00671151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65238119|NCT00671151|Purinergic Agents|purinergic agents|mesh-ancestor
65238120|NCT00671151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65238121|NCT00666757|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65238122|NCT00666757|Sertraline|sertraline|mesh-list
65238123|NCT00666757|Fluoxetine|fluoxetine|mesh-list
65238124|NCT00666757|Paroxetine|paroxetine|mesh-list
65238125|NCT00666757|Citalopram|citalopram|mesh-list
65238126|NCT00666757|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65238127|NCT00666757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65238128|NCT00666757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65238129|NCT00666757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238130|NCT00666757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65238131|NCT00666757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238132|NCT00666757|Analgesics|analgesics|mesh-ancestor
65238133|NCT00666757|Sensory System Agents|sensory system agents|mesh-ancestor
65238134|NCT00666757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65344395|NCT00870220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65344396|NCT00870220|Contraceptive Agents|contraceptive agents|mesh-ancestor
65238135|NCT00666757|Antidepressive Agents|antidepressive agents|mesh-ancestor
65238136|NCT00666757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65238137|NCT00666757|Dopamine Agents|dopamine agents|mesh-ancestor
65238138|NCT00666757|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65238139|NCT00666757|Serotonin Agents|serotonin agents|mesh-ancestor
65238140|NCT00666757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65238171|NCT00671541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65238172|NCT00671541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65238173|NCT00671541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65238174|NCT00671541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238175|NCT00671541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238176|NCT00671541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65238177|NCT00671697|Decitabine|decitabine|mesh-list
65238178|NCT00671697|Arsenic Trioxide|arsenic trioxide|mesh-list
65238179|NCT00671697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65238180|NCT00671697|Antimetabolites|antimetabolites|mesh-ancestor
65238181|NCT00671697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238182|NCT00671697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238183|NCT00671697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238184|NCT00666679|Mometasone Furoate|mometasone furoate|mesh-list
65238206|NCT00791401|Serotonin Agents|serotonin agents|mesh-ancestor
65238207|NCT00791401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65238208|NCT00791401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238209|NCT00791401|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65238210|NCT00791401|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65238211|NCT00791401|Dopamine Agents|dopamine agents|mesh-ancestor
65238212|NCT00786253|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65238213|NCT00786253|Vasodilator Agents|vasodilator agents|mesh-ancestor
65238214|NCT00786253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65238215|NCT00786253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65238216|NCT00786253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238217|NCT00786253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238218|NCT00786253|Urological Agents|urological agents|mesh-ancestor
65238219|NCT00595413|Adalimumab|adalimumab|mesh-list
65238220|NCT00595413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65238221|NCT00595413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65238222|NCT00781261|Zoledronic Acid|zoledronic acid|mesh-list
65238223|NCT00781261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65238224|NCT00781261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238225|NCT00786331|Carboplatin|carboplatin|mesh-list
65238226|NCT00786331|Pemetrexed|pemetrexed|mesh-list
65238227|NCT00786331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238228|NCT00786331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238229|NCT00786331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238230|NCT00786331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65238231|NCT00786331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65238232|NCT00791713|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65238233|NCT00791713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65238234|NCT00791713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65238259|NCT00595335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65238261|NCT00595335|Autonomic Agents|autonomic agents|mesh-ancestor
65238262|NCT00595335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65238263|NCT00595335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65238264|NCT00595335|Glucocorticoids|glucocorticoids|mesh-ancestor
65238265|NCT00595335|Hormones|hormones|mesh-ancestor
65238266|NCT00595335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65238267|NCT00595335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65238268|NCT00595335|Protective Agents|protective agents|mesh-ancestor
65238269|NCT00595335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65238270|NCT00781417|Vitamin D|vitamin d|mesh-list
65238271|NCT00781417|Ergocalciferols|ergocalciferols|mesh-list
65238272|NCT00781417|Cholecalciferol|cholecalciferol|mesh-list
65238273|NCT00781417|Vitamins|vitamins|mesh-list
65238274|NCT00781417|Micronutrients|micronutrients|mesh-ancestor
65238275|NCT00781417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238276|NCT00781417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65238277|NCT00781417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65238278|NCT00672165|Antibodies|antibodies|mesh-list
65238279|NCT00672165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65238280|NCT00672165|Immunologic Factors|immunologic factors|mesh-ancestor
65238281|NCT00672165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344397|NCT00870220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65344398|NCT00870220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65344399|NCT00729768|Cyclosporine|cyclosporine|mesh-list
65238282|NCT04293809|Bupivacaine|bupivacaine|mesh-list
65238283|NCT04293809|Anesthetics, Local|anesthetics, local|mesh-ancestor
65238284|NCT04293809|Anesthetics|anesthetics|mesh-ancestor
65238285|NCT04293809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65238286|NCT04293809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238298|NCT00672399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238299|NCT00672399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65238300|NCT00672399|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65238301|NCT00672399|Incretins|incretins|mesh-ancestor
65238302|NCT00672399|Hormones|hormones|mesh-ancestor
65238303|NCT00672399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65238304|NCT00661531|Anastrozole|anastrozole|mesh-list
65238305|NCT00661531|Estradiol|estradiol|mesh-list
65238306|NCT00661531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65238307|NCT00661531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238308|NCT00661531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65238309|NCT00661531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65238310|NCT00661531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238311|NCT00661531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238312|NCT00661531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65238313|NCT00661531|Hormone Antagonists|hormone antagonists|mesh-ancestor
65238314|NCT00661531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65238315|NCT00661531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238316|NCT00661531|Estrogens|estrogens|mesh-ancestor
65238317|NCT00661531|Hormones|hormones|mesh-ancestor
65238318|NCT00998309|Azithromycin|azithromycin|mesh-list
65238319|NCT00998309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65238320|NCT00998309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65238321|NCT02629575|Sirolimus|sirolimus|mesh-list
65238322|NCT02629575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65238323|NCT02629575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65238324|NCT02629575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65238325|NCT02629575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238326|NCT02629575|Antifungal Agents|antifungal agents|mesh-ancestor
65238327|NCT02629575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65238328|NCT02629575|Immunologic Factors|immunologic factors|mesh-ancestor
65238329|NCT02629575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238330|NCT00781573|Clopidogrel|clopidogrel|mesh-list
65238331|NCT00781573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65238332|NCT00781573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65238333|NCT00781573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65238334|NCT00781573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65238335|NCT00781573|Purinergic Agents|purinergic agents|mesh-ancestor
65238336|NCT00781573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65238337|NCT00781573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238338|NCT00781573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238339|NCT04152681|Apatinib|apatinib|mesh-list
65238340|NCT04152681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238341|NCT04152681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65238342|NCT04152681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238343|NCT04152681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238344|NCT00999713|Calfactant|calfactant|mesh-list
65238345|NCT00999713|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
65238346|NCT00999713|Respiratory System Agents|respiratory system agents|mesh-ancestor
65238347|NCT00672867|Adefovir|adefovir|mesh-list
65238348|NCT00672867|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65238349|NCT00672867|Clevudine|clevudine|mesh-list
65238350|NCT00672867|Antiviral Agents|antiviral agents|mesh-ancestor
65238371|NCT04152759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238372|NCT00792025|Sunitinib|sunitinib|mesh-list
65238373|NCT00792025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238374|NCT00792025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65238375|NCT00792025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65238376|NCT00792025|Growth Substances|growth substances|mesh-ancestor
65238377|NCT00792025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238378|NCT00792025|Growth Inhibitors|growth inhibitors|mesh-ancestor
65238379|NCT00792025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65238380|NCT00792025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238381|NCT00792025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238382|NCT02870231|Liraglutide|liraglutide|mesh-list
65344400|NCT00729768|Mycophenolic Acid|mycophenolic acid|mesh-list
65344401|NCT00729768|Cyclosporins|cyclosporins|mesh-list
65344402|NCT00729768|Basiliximab|basiliximab|mesh-list
65344403|NCT00729768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344404|NCT00729768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344405|NCT00729768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65344406|NCT00729768|Immunologic Factors|immunologic factors|mesh-ancestor
65344407|NCT00729768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344408|NCT00729768|Antifungal Agents|antifungal agents|mesh-ancestor
65344409|NCT00729768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65344410|NCT00729768|Dermatologic Agents|dermatologic agents|mesh-ancestor
65344411|NCT00729768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65344412|NCT00729768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65344413|NCT00729768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64726274|NCT00002798|Alkylating Agents|alkylating agents|mesh-ancestor
65238383|NCT02870231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65238384|NCT02870231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238385|NCT02870231|Incretins|incretins|mesh-ancestor
65238386|NCT02870231|Hormones|hormones|mesh-ancestor
65238387|NCT02870231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65238388|NCT00782041|Leucovorin|leucovorin|mesh-list
65238389|NCT00782041|Folic Acid|folic acid|mesh-list
65238390|NCT00782041|Fluorouracil|fluorouracil|mesh-list
65238391|NCT00782041|Oxaliplatin|oxaliplatin|mesh-list
65238392|NCT00782041|Levoleucovorin|levoleucovorin|mesh-list
65238393|NCT00782041|Antimetabolites|antimetabolites|mesh-ancestor
65238394|NCT00782041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238395|NCT00782041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65238396|NCT00782041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238397|NCT00782041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65238398|NCT00782041|Immunologic Factors|immunologic factors|mesh-ancestor
65238399|NCT00782041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238401|NCT00782041|Protective Agents|protective agents|mesh-ancestor
65238402|NCT00782041|Vitamin B Complex|vitamin b complex|mesh-ancestor
65238403|NCT00782041|Vitamins|vitamins|mesh-ancestor
65238404|NCT00782041|Micronutrients|micronutrients|mesh-ancestor
65238414|NCT00792181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65238415|NCT00792181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238416|NCT00792181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65238417|NCT00792181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65238418|NCT00792181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65238419|NCT00792181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65238420|NCT00792181|Anesthetics, General|anesthetics, general|mesh-ancestor
65238422|NCT00792181|GABA Modulators|gaba modulators|mesh-ancestor
65238423|NCT00792181|GABA Agents|gaba agents|mesh-ancestor
65238424|NCT00792181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65238425|NCT00792181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238426|NCT00792337|Simvastatin|simvastatin|mesh-list
65238427|NCT00792337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65238428|NCT00792337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65238429|NCT00792337|Antimetabolites|antimetabolites|mesh-ancestor
65238430|NCT00792337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238431|NCT00792337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65238432|NCT00792337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65238433|NCT00792337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238434|NCT00787111|Fluoxetine|fluoxetine|mesh-list
65238435|NCT00787111|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65238436|NCT00787111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65238437|NCT00787111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65238438|NCT00787111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344414|NCT00729768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344415|NCT00729768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65344416|NCT00729768|Antitubercular Agents|antitubercular agents|mesh-ancestor
65344417|NCT00729768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64726288|NCT00002798|Abortifacient Agents|abortifacient agents|mesh-ancestor
65238439|NCT00787111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65238440|NCT00787111|Serotonin Agents|serotonin agents|mesh-ancestor
65238441|NCT00787111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238442|NCT00787111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65238443|NCT00787111|Antidepressive Agents|antidepressive agents|mesh-ancestor
65238444|NCT00787111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65238445|NCT00787111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65238446|NCT00787111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65238447|NCT00787111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238448|NCT00782197|Hyaluronic Acid|hyaluronic acid|mesh-list
65238449|NCT00782197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65238450|NCT00782197|Immunologic Factors|immunologic factors|mesh-ancestor
65238451|NCT00782197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238452|NCT00782197|Viscosupplements|viscosupplements|mesh-ancestor
65238453|NCT00782197|Protective Agents|protective agents|mesh-ancestor
65238454|NCT04152291|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
65238455|NCT04152291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65238456|NCT04152291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65238458|NCT00996593|Tositumomab I-131|tositumomab i-131|mesh-list
65238459|NCT00996593|Antibodies|antibodies|mesh-list
64881206|NCT01917279|Antimetabolites|antimetabolites|mesh-ancestor
65238460|NCT00996593|Immunoglobulins|immunoglobulins|mesh-list
65238461|NCT00996593|Immunologic Factors|immunologic factors|mesh-ancestor
65238462|NCT00996593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238463|NCT00996593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65238464|NCT00996593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65238465|NCT00996593|Trace Elements|trace elements|mesh-ancestor
65238466|NCT00996593|Micronutrients|micronutrients|mesh-ancestor
65238467|NCT00996593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238468|NCT00570661|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
65238469|NCT00570661|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65238502|NCT04264676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65238503|NCT04264676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65238504|NCT04047355|Propranolol|propranolol|mesh-list
65238505|NCT04047355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65238506|NCT04047355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65238507|NCT04047355|Adrenergic Agents|adrenergic agents|mesh-ancestor
65238508|NCT04047355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65238509|NCT04047355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238510|NCT04047355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238511|NCT04047355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65238546|NCT00927758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65238547|NCT00927758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65238548|NCT00927758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65238549|NCT00927758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65238550|NCT00927758|Adrenergic Agents|adrenergic agents|mesh-ancestor
65238569|NCT00783601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238570|NCT00783601|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65238571|NCT00783601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65238572|NCT00783601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238574|NCT00787813|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65238575|NCT00787813|Antiviral Agents|antiviral agents|mesh-ancestor
65238576|NCT00787813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65238577|NCT00787813|Expectorants|expectorants|mesh-ancestor
65238578|NCT00787813|Respiratory System Agents|respiratory system agents|mesh-ancestor
65238579|NCT00787813|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65238580|NCT00787813|Antioxidants|antioxidants|mesh-ancestor
65238581|NCT00787813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238582|NCT00787813|Protective Agents|protective agents|mesh-ancestor
65238583|NCT00787813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238584|NCT00787813|Antidotes|antidotes|mesh-ancestor
65238585|NCT04261634|Mitogens|mitogens|mesh-list
65238586|NCT04261634|Mitosis Modulators|mitosis modulators|mesh-ancestor
65238587|NCT04261634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238588|NCT00787969|Sirolimus|sirolimus|mesh-list
65344419|NCT00871156|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65344420|NCT00871156|Tafenoquine|tafenoquine|mesh-list
65344421|NCT00871156|Amebicides|amebicides|mesh-ancestor
65344422|NCT00871156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65344423|NCT00871156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65344424|NCT00871156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65344425|NCT00871156|Antimalarials|antimalarials|mesh-ancestor
65344426|NCT00871156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64503575|NCT04974580|Nicotine|nicotine|mesh-list
65238589|NCT00787969|Rituximab|rituximab|mesh-list
65238590|NCT00787969|Cladribine|cladribine|mesh-list
65238591|NCT00787969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65238592|NCT00787969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238593|NCT00787969|Immunologic Factors|immunologic factors|mesh-ancestor
65238594|NCT00787969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238595|NCT00787969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65238596|NCT00787969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65238597|NCT00787969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65238598|NCT00787969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65238599|NCT00787969|Antifungal Agents|antifungal agents|mesh-ancestor
65238600|NCT00787969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65238601|NCT00609596|Dutasteride|dutasteride|mesh-list
65238602|NCT00609596|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65238603|NCT00609596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65238604|NCT00609596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238605|NCT00609596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238606|NCT00609596|Hormone Antagonists|hormone antagonists|mesh-ancestor
65238634|NCT02535273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65238635|NCT02535273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65238636|NCT02535273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65238637|NCT02535273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65238638|NCT02535273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65238639|NCT02535273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238640|NCT02535273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65238641|NCT02535273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65238642|NCT02535273|Analgesics|analgesics|mesh-ancestor
65238643|NCT02535273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65238644|NCT02535273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65238645|NCT02535273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65238646|NCT02535273|Adrenergic Agents|adrenergic agents|mesh-ancestor
65238647|NCT02535273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65238648|NCT00788047|Dextromethorphan|dextromethorphan|mesh-list
65238649|NCT00788047|Antitussive Agents|antitussive agents|mesh-ancestor
65238650|NCT00788047|Respiratory System Agents|respiratory system agents|mesh-ancestor
65238651|NCT00788047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65238652|NCT00788047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65238672|NCT04259684|Antioxidants|antioxidants|mesh-ancestor
65238673|NCT04259684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238674|NCT04259684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65238675|NCT04259684|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65238676|NCT04259684|Vasodilator Agents|vasodilator agents|mesh-ancestor
65238677|NCT04259684|Gasotransmitters|gasotransmitters|mesh-ancestor
65238678|NCT04259684|Protective Agents|protective agents|mesh-ancestor
65238679|NCT00788515|Lormetazepam|lormetazepam|mesh-list
65238680|NCT00788515|Volinanserin|volinanserin|mesh-list
65238681|NCT00788515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65238682|NCT00788515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65238683|NCT00788515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238684|NCT00788515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65238685|NCT00788515|Serotonin Agents|serotonin agents|mesh-ancestor
65238686|NCT00788515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65238687|NCT00788515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238688|NCT04259606|Magnesium Oxide|magnesium oxide|mesh-list
65238689|NCT04259606|Antacids|antacids|mesh-ancestor
65238690|NCT04259606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970517|NCT00061256|Vitamin D|vitamin d|mesh-list
65238691|NCT04259606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65344427|NCT00871156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65344428|NCT00871156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65344429|NCT00871156|Analgesics|analgesics|mesh-ancestor
65344430|NCT00871156|Sensory System Agents|sensory system agents|mesh-ancestor
65344431|NCT00871156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65344432|NCT00871156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344433|NCT00871156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65344434|NCT00871156|Filaricides|filaricides|mesh-ancestor
65344435|NCT00871156|Antinematodal Agents|antinematodal agents|mesh-ancestor
65344436|NCT00871156|Anthelmintics|anthelmintics|mesh-ancestor
65344437|NCT00734448|Inositol|inositol|mesh-list
65344438|NCT00734448|Vitamin B Complex|vitamin b complex|mesh-ancestor
65344439|NCT00734448|Vitamins|vitamins|mesh-ancestor
65344440|NCT00734448|Micronutrients|micronutrients|mesh-ancestor
65344441|NCT00734448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344442|NCT00876226|Citalopram|citalopram|mesh-list
65344443|NCT00876226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65344444|NCT00876226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65344445|NCT00876226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65238692|NCT00788749|Fluticasone|fluticasone|mesh-list
65238694|NCT00788749|Prednisolone|prednisolone|mesh-list
65238695|NCT00788749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65238696|NCT00788749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65238697|NCT00788749|Autonomic Agents|autonomic agents|mesh-ancestor
65238698|NCT00788749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65238699|NCT00788749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238700|NCT00788749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65238701|NCT00788749|Respiratory System Agents|respiratory system agents|mesh-ancestor
65238702|NCT00788749|Dermatologic Agents|dermatologic agents|mesh-ancestor
65238703|NCT00788749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65238704|NCT00788749|Glucocorticoids|glucocorticoids|mesh-ancestor
65238705|NCT00788749|Hormones|hormones|mesh-ancestor
64460074|NCT01675804|Dopamine Agents|dopamine agents|mesh-ancestor
65238729|NCT00878553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238731|NCT05220020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238732|NCT05220020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65238733|NCT05220020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238734|NCT05220020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238735|NCT00789061|Lansoprazole|lansoprazole|mesh-list
65238736|NCT00789061|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65238737|NCT00789061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65238738|NCT00789061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65238739|NCT00789061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238740|NCT00789061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238741|NCT00996437|Ranibizumab|ranibizumab|mesh-list
65238742|NCT00996437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65238743|NCT00996437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65238744|NCT00996437|Growth Substances|growth substances|mesh-ancestor
65238745|NCT00996437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238746|NCT00996437|Growth Inhibitors|growth inhibitors|mesh-ancestor
65238747|NCT00996437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238748|NCT02628951|Paclitaxel|paclitaxel|mesh-list
65238749|NCT02628951|Ramucirumab|ramucirumab|mesh-list
65238750|NCT02628951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65238751|NCT02628951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238752|NCT02628951|Tubulin Modulators|tubulin modulators|mesh-ancestor
65238753|NCT02628951|Antimitotic Agents|antimitotic agents|mesh-ancestor
65344446|NCT00876226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344447|NCT00876226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65344448|NCT00876226|Serotonin Agents|serotonin agents|mesh-ancestor
65238754|NCT02628951|Mitosis Modulators|mitosis modulators|mesh-ancestor
65238755|NCT02628951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238776|NCT00929708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65238777|NCT00929708|Adrenergic Agents|adrenergic agents|mesh-ancestor
65238778|NCT00929708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65238779|NCT00929708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238780|NCT00996281|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65238781|NCT00996281|Olmesartan|olmesartan|mesh-list
65238782|NCT00996281|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65238783|NCT00996281|Chlorthalidone|chlorthalidone|mesh-list
65238784|NCT00996281|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65238785|NCT00996281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65238786|NCT00996281|Diuretics|diuretics|mesh-ancestor
65238787|NCT00996281|Natriuretic Agents|natriuretic agents|mesh-ancestor
65238788|NCT00996281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238789|NCT00996281|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65238790|NCT00996281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65238791|NCT00996281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238792|NCT00996281|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65238793|NCT00996281|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65238794|NCT04046653|Sulforaphane|sulforaphane|mesh-list
65238795|NCT04046653|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65238796|NCT04046653|Protective Agents|protective agents|mesh-ancestor
65238797|NCT04046653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238798|NCT04046653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238799|NCT04293887|Interferons|interferons|mesh-list
65238800|NCT04293887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238801|NCT04293887|Antiviral Agents|antiviral agents|mesh-ancestor
65238802|NCT04293887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65238803|NCT00675207|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65238804|NCT00675207|Dorzolamide|dorzolamide|mesh-list
65238805|NCT00675207|Brinzolamide|brinzolamide|mesh-list
65238806|NCT00675207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65238807|NCT00675207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65238808|NCT00675207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65238839|NCT00675285|Hormone Antagonists|hormone antagonists|mesh-ancestor
65238840|NCT00675285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65238841|NCT00675285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238842|NCT00675285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65238843|NCT00675285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65238844|NCT00675285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238845|NCT00996203|Antirheumatic Agents|antirheumatic agents|mesh-list
65238846|NCT00789763|Gemcitabine|gemcitabine|mesh-list
65238848|NCT00789763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65238849|NCT00789763|Antimetabolites|antimetabolites|mesh-ancestor
65238850|NCT00789763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238851|NCT00789763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238852|NCT00789763|Antiviral Agents|antiviral agents|mesh-ancestor
65238853|NCT00789763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65238881|NCT00795457|Immunologic Factors|immunologic factors|mesh-ancestor
65238882|NCT00795457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238883|NCT00795457|Interferon Inducers|interferon inducers|mesh-ancestor
65238884|NCT00795457|Laxatives|laxatives|mesh-ancestor
65238885|NCT00795457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65238886|NCT00795457|Antiviral Agents|antiviral agents|mesh-ancestor
65238887|NCT00795457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65238888|NCT00793195|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65238889|NCT00793195|SMOFlipid|smoflipid|mesh-list
65238890|NCT00793195|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65238891|NCT00793195|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65238892|NCT00793195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65238893|NCT00793273|Insulin Detemir|insulin detemir|mesh-list
65238894|NCT00793273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65238895|NCT00793273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238896|NCT04979780|Heparin|heparin|mesh-list
65238897|NCT04979780|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65238898|NCT04979780|Tinzaparin|tinzaparin|mesh-list
65238899|NCT04979780|Dalteparin|dalteparin|mesh-list
65344449|NCT00876226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344450|NCT00876226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65344451|NCT00876226|Antidepressive Agents|antidepressive agents|mesh-ancestor
65344452|NCT00876226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65344453|NCT00734526|Temozolomide|temozolomide|mesh-list
65238900|NCT04979780|Rivaroxaban|rivaroxaban|mesh-list
65238901|NCT04979780|Anticoagulants|anticoagulants|mesh-list
64460276|NCT03825796|Antiviral Agents|antiviral agents|mesh-ancestor
65238928|NCT00795613|Mitosis Modulators|mitosis modulators|mesh-ancestor
65238929|NCT00800761|Deferiprone|deferiprone|mesh-list
65238930|NCT00800761|Deferoxamine|deferoxamine|mesh-list
65238931|NCT00800761|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65238932|NCT00800761|Chelating Agents|chelating agents|mesh-ancestor
65238933|NCT00800761|Sequestering Agents|sequestering agents|mesh-ancestor
65238934|NCT00800761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238935|NCT00800761|Siderophores|siderophores|mesh-ancestor
65238936|NCT00676221|Mycophenolic Acid|mycophenolic acid|mesh-list
65238937|NCT00676221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65238938|NCT00676221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238939|NCT00676221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65238940|NCT00676221|Antitubercular Agents|antitubercular agents|mesh-ancestor
65238941|NCT00676221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65238942|NCT00676221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65238943|NCT00676221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238944|NCT00676221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238945|NCT00800917|Sirolimus|sirolimus|mesh-list
65238946|NCT00800917|Bevacizumab|bevacizumab|mesh-list
65238947|NCT00800917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65238948|NCT00800917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238949|NCT00800917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65238950|NCT00800917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65238951|NCT00800917|Growth Substances|growth substances|mesh-ancestor
65238970|NCT05003102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65238972|NCT05003102|Adrenergic Agents|adrenergic agents|mesh-ancestor
65238973|NCT05003102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65238974|NCT05003102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238975|NCT05003102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65238976|NCT05003102|Narcotics|narcotics|mesh-ancestor
65238977|NCT05003102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65238978|NCT05003102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65238979|NCT05003102|Anesthetics, General|anesthetics, general|mesh-ancestor
65238980|NCT05003102|Anesthetics|anesthetics|mesh-ancestor
65238981|NCT00676377|Neostigmine|neostigmine|mesh-list
65238982|NCT00676377|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64881757|NCT01923935|Melphalan|melphalan|mesh-list
65238983|NCT00676377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238984|NCT00676377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238985|NCT00676377|Cholinergic Agents|cholinergic agents|mesh-ancestor
65238986|NCT00676377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65238987|NCT00676377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238988|NCT00676377|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65238989|NCT00676377|Autonomic Agents|autonomic agents|mesh-ancestor
65238990|NCT00676377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65238991|NCT00676533|Ciprofloxacin|ciprofloxacin|mesh-list
65238992|NCT00676533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65238993|NCT00676533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65238994|NCT00676533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65238995|NCT00676533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65238996|NCT00676533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238997|NCT00676533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238998|NCT00676533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238999|NCT00676533|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65239000|NCT00676533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65239002|NCT00676845|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65239003|NCT00676845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65239004|NCT00676845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65239005|NCT00676845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64460375|NCT03806530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65239038|NCT04151823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65344454|NCT00734526|Sorafenib|sorafenib|mesh-list
65344455|NCT00734526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65344456|NCT00734526|Alkylating Agents|alkylating agents|mesh-ancestor
64726321|NCT00003134|Irinotecan|irinotecan|mesh-list
65239040|NCT05199038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65239041|NCT05199038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65239042|NCT05199038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239043|NCT00660907|Metformin|metformin|mesh-list
65239044|NCT00660907|Dapagliflozin|dapagliflozin|mesh-list
65239045|NCT00660907|Glipizide|glipizide|mesh-list
65239046|NCT00660907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65239047|NCT00660907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239083|NCT04031703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239084|NCT04031703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65239085|NCT04031703|Immunologic Factors|immunologic factors|mesh-ancestor
65239086|NCT04031703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239106|NCT00795847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239107|NCT00795847|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65239108|NCT00795847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65239110|NCT00877773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65239111|NCT00877773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65239112|NCT00877773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65239113|NCT00877773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239114|NCT00877773|Antifungal Agents|antifungal agents|mesh-ancestor
65239115|NCT00877773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65239116|NCT00877773|Immunologic Factors|immunologic factors|mesh-ancestor
65239117|NCT00877773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239118|NCT00659815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65239119|NCT00994643|Aldesleukin|aldesleukin|mesh-list
65239120|NCT00994643|Rituximab|rituximab|mesh-list
65239121|NCT00994643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65239122|NCT00994643|Interleukin-2|interleukin-2|mesh-list
65239123|NCT00994643|Antibodies|antibodies|mesh-list
65239124|NCT00994643|Immunoglobulins|immunoglobulins|mesh-list
65239125|NCT00994643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65239126|NCT00994643|Immunologic Factors|immunologic factors|mesh-ancestor
65239127|NCT00994643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239128|NCT00994643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239129|NCT00994643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65239130|NCT00994643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65239131|NCT00994643|Analgesics|analgesics|mesh-ancestor
65239132|NCT00994643|Sensory System Agents|sensory system agents|mesh-ancestor
65239133|NCT00994643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65239134|NCT00994643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65239135|NCT00994643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65239136|NCT00994643|Antiviral Agents|antiviral agents|mesh-ancestor
65239137|NCT00994643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65239138|NCT00912171|Budesonide|budesonide|mesh-list
65239139|NCT00912171|Montelukast|montelukast|mesh-list
65239140|NCT00912171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65239141|NCT00912171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65239142|NCT00912171|Autonomic Agents|autonomic agents|mesh-ancestor
65239169|NCT00660829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239170|NCT00660829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65239171|NCT00660829|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65239172|NCT00660829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65239173|NCT00660829|Histamine Antagonists|histamine antagonists|mesh-ancestor
65239174|NCT00660829|Histamine Agents|histamine agents|mesh-ancestor
65239175|NCT00660829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65239176|NCT00677469|Cholestyramine Resin|cholestyramine resin|mesh-list
65239177|NCT00677469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65239178|NCT00677469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65239179|NCT00677469|Antimetabolites|antimetabolites|mesh-ancestor
65239180|NCT00677469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239181|NCT00677469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65239182|NCT00629135|Moxifloxacin|moxifloxacin|mesh-list
65239183|NCT00629135|Metronidazole|metronidazole|mesh-list
65239184|NCT00629135|Tazobactam|tazobactam|mesh-list
65239185|NCT00629135|Piperacillin|piperacillin|mesh-list
65239186|NCT00629135|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65239187|NCT00629135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65239188|NCT00629135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65239189|NCT00629135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65239217|NCT00793429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65344457|NCT00734526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344458|NCT00734526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344459|NCT00734526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65344460|NCT00734526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239218|NCT00793429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239219|NCT00793429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239220|NCT00801151|Vinorelbine|vinorelbine|mesh-list
65239221|NCT00801151|Vorinostat|vorinostat|mesh-list
65239222|NCT00801151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65239223|NCT00801151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239224|NCT00801151|Tubulin Modulators|tubulin modulators|mesh-ancestor
65239225|NCT00801151|Antimitotic Agents|antimitotic agents|mesh-ancestor
65239226|NCT00801151|Mitosis Modulators|mitosis modulators|mesh-ancestor
65239227|NCT00801151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239228|NCT00801151|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65239229|NCT00801151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239230|NCT00796081|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65239231|NCT00796081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65239232|NCT00796081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65239233|NCT00796081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65239234|NCT00796081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239235|NCT00796081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64460609|NCT03694834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239255|NCT00877383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239257|NCT00796159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65239258|NCT00796159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65239259|NCT00796159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65239260|NCT00796159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65239261|NCT00796159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239262|NCT00993473|Insulin|insulin|mesh-list
65239263|NCT00993473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65239264|NCT00993473|Insulin Glargine|insulin glargine|mesh-list
65239265|NCT00993473|Insulin Lispro|insulin lispro|mesh-list
65239266|NCT00993473|Protamines|protamines|mesh-list
65239267|NCT00993473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65239268|NCT00993473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239269|NCT00993473|Heparin Antagonists|heparin antagonists|mesh-ancestor
65239270|NCT00993473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239271|NCT00993473|Coagulants|coagulants|mesh-ancestor
65239272|NCT00660595|Risperidone|risperidone|mesh-list
65239273|NCT00660595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65239274|NCT00660595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65239275|NCT00660595|Serotonin Agents|serotonin agents|mesh-ancestor
65239276|NCT00660595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65239277|NCT00660595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239278|NCT00660595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239279|NCT00660595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65239280|NCT00660595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64882091|NCT01931332|Heroin|heroin|mesh-list
65239281|NCT00660595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65239282|NCT00660595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65239283|NCT00660595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65239284|NCT00660595|Dopamine Agents|dopamine agents|mesh-ancestor
65239285|NCT00660595|Antidepressive Agents|antidepressive agents|mesh-ancestor
65239286|NCT00929240|Bevacizumab|bevacizumab|mesh-list
65239287|NCT00929240|Capecitabine|capecitabine|mesh-list
65239288|NCT00929240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65239289|NCT00929240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239317|NCT00793663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65239319|NCT00793663|Dermatologic Agents|dermatologic agents|mesh-ancestor
65239320|NCT00793663|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65239321|NCT00793663|Serotonin Agents|serotonin agents|mesh-ancestor
65239322|NCT00793663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65239323|NCT00793663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239324|NCT00793663|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65239325|NCT00793663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65239326|NCT00793663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65239327|NCT00793663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65239328|NCT04932980|Aflibercept|aflibercept|mesh-list
65239329|NCT04932980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65344461|NCT00729404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65344462|NCT00729404|Gestodene|gestodene|mesh-list
65344463|NCT00729404|Femovan|femovan|mesh-list
65344464|NCT00729404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65344465|NCT00729404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65344466|NCT00729404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65344467|NCT00729404|Contraceptive Agents|contraceptive agents|mesh-ancestor
65344468|NCT00729404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65239330|NCT04932980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65239331|NCT04932980|Growth Substances|growth substances|mesh-ancestor
65239332|NCT04932980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239333|NCT04932980|Growth Inhibitors|growth inhibitors|mesh-ancestor
65239334|NCT04932980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239335|NCT02554045|Tadalafil|tadalafil|mesh-list
65239336|NCT02554045|Vasodilator Agents|vasodilator agents|mesh-ancestor
65239371|NCT05330078|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65239372|NCT05330078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65239395|NCT00678327|Dacarbazine|dacarbazine|mesh-list
65239396|NCT00678327|Doxorubicin|doxorubicin|mesh-list
65239397|NCT00678327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65239398|NCT00678327|Etoposide|etoposide|mesh-list
65239399|NCT00678327|Vincristine|vincristine|mesh-list
65239400|NCT00678327|Bleomycin|bleomycin|mesh-list
65239401|NCT00678327|Vinblastine|vinblastine|mesh-list
65239402|NCT00678327|Procarbazine|procarbazine|mesh-list
65239403|NCT00678327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65239404|NCT00678327|Immunologic Factors|immunologic factors|mesh-ancestor
65239405|NCT00678327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239406|NCT00678327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65239407|NCT00678327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65239408|NCT00678327|Alkylating Agents|alkylating agents|mesh-ancestor
65239409|NCT00678327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239410|NCT00678327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239411|NCT00678327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65239412|NCT00678327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65239413|NCT00678327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65239414|NCT00678327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65239415|NCT00678327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239416|NCT00678327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65239417|NCT00678327|Tubulin Modulators|tubulin modulators|mesh-ancestor
65239418|NCT00678327|Antimitotic Agents|antimitotic agents|mesh-ancestor
65239419|NCT00678327|Mitosis Modulators|mitosis modulators|mesh-ancestor
65239420|NCT00678327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65239421|NCT00678327|Glucocorticoids|glucocorticoids|mesh-ancestor
65239422|NCT00678327|Hormones|hormones|mesh-ancestor
65239423|NCT00678327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65239424|NCT00678327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65239425|NCT00987389|Glucocorticoids|glucocorticoids|mesh-list
65239426|NCT00987389|Hormones|hormones|mesh-ancestor
64460790|NCT03570814|Azithromycin|azithromycin|mesh-list
65239454|NCT00678483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239456|NCT00678483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65239457|NCT00678483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239458|NCT00610454|Levetiracetam|levetiracetam|mesh-list
65239459|NCT00610454|Anticonvulsants|anticonvulsants|mesh-ancestor
65239460|NCT00610454|Nootropic Agents|nootropic agents|mesh-ancestor
65239461|NCT04151355|Atorvastatin|atorvastatin|mesh-list
65239462|NCT04151355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65239463|NCT04151355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65239464|NCT04151355|Antimetabolites|antimetabolites|mesh-ancestor
65239465|NCT04151355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239466|NCT04151355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65239467|NCT04151355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65239468|NCT04151355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239469|NCT00609284|Carboplatin|carboplatin|mesh-list
65239500|NCT04257812|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
65239501|NCT04257812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65239502|NCT04257812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65344469|NCT00729404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344470|NCT00729404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65344471|NCT00729404|Estrogens|estrogens|mesh-ancestor
65344472|NCT00729404|Hormones|hormones|mesh-ancestor
65344473|NCT00729404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65344474|NCT00729404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65344475|NCT00729404|Progestins|progestins|mesh-ancestor
65344476|NCT00729404|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65344477|NCT00731952|Bortezomib|bortezomib|mesh-list
65344478|NCT00731952|Vorinostat|vorinostat|mesh-list
65344479|NCT00731952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344480|NCT00731952|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65344481|NCT00731952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344482|NCT00731952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344483|NCT04065932|BMS-986165|bms-986165|mesh-list
65344484|NCT04065932|Famotidine|famotidine|mesh-list
65344485|NCT04065932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65344486|NCT04065932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65344487|NCT04065932|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65344488|NCT04065932|Histamine Antagonists|histamine antagonists|mesh-ancestor
65344489|NCT04065932|Histamine Agents|histamine agents|mesh-ancestor
65344490|NCT04065932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65239503|NCT04257812|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65239504|NCT04257812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239505|NCT04257812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239506|NCT04257812|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65239508|NCT02868749|Hyaluronic Acid|hyaluronic acid|mesh-list
65239509|NCT02868749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65239510|NCT02868749|Immunologic Factors|immunologic factors|mesh-ancestor
65239511|NCT02868749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239513|NCT02868749|Protective Agents|protective agents|mesh-ancestor
65239534|NCT00796471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65239536|NCT00796471|Dopamine Agents|dopamine agents|mesh-ancestor
65239537|NCT00991289|Interferons|interferons|mesh-list
65239538|NCT00991289|Ribavirin|ribavirin|mesh-list
65239539|NCT00991289|Interferon-alpha|interferon-alpha|mesh-list
65239540|NCT00991289|Interferon alpha-2|interferon alpha-2|mesh-list
65239541|NCT00991289|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65239542|NCT00991289|Nitazoxanide|nitazoxanide|mesh-list
65239543|NCT00991289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239544|NCT00991289|Antiviral Agents|antiviral agents|mesh-ancestor
65239545|NCT00991289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65239546|NCT00991289|Antimetabolites|antimetabolites|mesh-ancestor
65239547|NCT00991289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239548|NCT00991289|Immunologic Factors|immunologic factors|mesh-ancestor
65239549|NCT00991289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239550|NCT00991289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65239551|NCT04046029|Heparin|heparin|mesh-list
65239552|NCT04046029|Bivalirudin|bivalirudin|mesh-list
65239553|NCT04046029|Anticoagulants|anticoagulants|mesh-ancestor
65239554|NCT04046029|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65239555|NCT04046029|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65239556|NCT04046029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239557|NCT04046029|Antithrombins|antithrombins|mesh-ancestor
65344491|NCT04065932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344492|NCT04065932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344493|NCT04065932|Dermatologic Agents|dermatologic agents|mesh-ancestor
65344494|NCT04065932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65344495|NCT04065932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344496|NCT00740090|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65344497|NCT00740090|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65344498|NCT00740090|Immunologic Factors|immunologic factors|mesh-ancestor
65344499|NCT00740090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344500|NCT00740090|Antacids|antacids|mesh-ancestor
65344501|NCT00740090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344502|NCT00740090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65344503|NCT00738660|Telmisartan|telmisartan|mesh-list
65344504|NCT00738660|Ramipril|ramipril|mesh-list
65344505|NCT00738660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65344506|NCT00738660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65344507|NCT00738660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65344508|NCT00738660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344509|NCT00738660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65344510|NCT00738660|Protease Inhibitors|protease inhibitors|mesh-ancestor
65344511|NCT00738660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344512|NCT00740168|Bevacizumab|bevacizumab|mesh-list
65344513|NCT00740168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64726366|NCT00003140|Letrozole|letrozole|mesh-list
65239558|NCT04046029|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65239559|NCT04046029|Protease Inhibitors|protease inhibitors|mesh-ancestor
65239560|NCT04046029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239561|NCT00679653|Sibutramine|sibutramine|mesh-list
65239562|NCT00679653|Metoprolol|metoprolol|mesh-list
65239563|NCT00679653|Verapamil|verapamil|mesh-list
65239564|NCT00679653|Felodipine|felodipine|mesh-list
65239565|NCT00679653|Ramipril|ramipril|mesh-list
65239566|NCT00679653|Trandolapril|trandolapril|mesh-list
65239567|NCT00679653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65239580|NCT00679653|Protease Inhibitors|protease inhibitors|mesh-ancestor
65239581|NCT00679653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239582|NCT00679653|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65239583|NCT00679653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65239584|NCT00679653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65239585|NCT00679653|Vasodilator Agents|vasodilator agents|mesh-ancestor
65239587|NCT00679653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65239588|NCT00679653|Appetite Depressants|appetite depressants|mesh-ancestor
65239589|NCT00679653|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65239590|NCT00793897|Paclitaxel|paclitaxel|mesh-list
65239591|NCT00793897|Carboplatin|carboplatin|mesh-list
65239592|NCT00793897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65239593|NCT00793897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239594|NCT00793897|Tubulin Modulators|tubulin modulators|mesh-ancestor
65239595|NCT00793897|Antimitotic Agents|antimitotic agents|mesh-ancestor
65239596|NCT00793897|Mitosis Modulators|mitosis modulators|mesh-ancestor
65239597|NCT00793897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344514|NCT00740168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344515|NCT00740168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65344516|NCT00740168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65344517|NCT00740168|Growth Substances|growth substances|mesh-ancestor
65344518|NCT00740168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344519|NCT00740168|Growth Inhibitors|growth inhibitors|mesh-ancestor
65239598|NCT00793975|Ramucirumab|ramucirumab|mesh-list
65239599|NCT00793975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239600|NCT00679965|Tavaborole|tavaborole|mesh-list
65239601|NCT00679965|Antifungal Agents|antifungal agents|mesh-ancestor
65239602|NCT00679965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65239603|NCT00930644|Teduglutide|teduglutide|mesh-list
65239604|NCT00930644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65239605|NCT00930644|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65239606|NCT00930644|Protective Agents|protective agents|mesh-ancestor
65239607|NCT00930644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239608|NCT02627469|Listerine|listerine|mesh-list
65239609|NCT02627469|Fluorides|fluorides|mesh-list
65239610|NCT02627469|Sodium Fluoride|sodium fluoride|mesh-list
65239611|NCT02627469|Cariostatic Agents|cariostatic agents|mesh-ancestor
65239612|NCT02627469|Protective Agents|protective agents|mesh-ancestor
65239613|NCT02627469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239614|NCT02627469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65239615|NCT02627469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65239616|NCT00680277|Carotenoids|carotenoids|mesh-list
65239617|NCT00680277|Antioxidants|antioxidants|mesh-ancestor
65239618|NCT00680277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239619|NCT00680277|Protective Agents|protective agents|mesh-ancestor
65239620|NCT00680277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239621|NCT00680355|Carotenoids|carotenoids|mesh-list
65239622|NCT00680355|Antioxidants|antioxidants|mesh-ancestor
65239623|NCT00680355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239624|NCT00680355|Protective Agents|protective agents|mesh-ancestor
65239625|NCT00680355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239626|NCT00801697|Vaccines|vaccines|mesh-list
65239627|NCT00801697|Immunologic Factors|immunologic factors|mesh-ancestor
64460996|NCT01678612|Copper|copper|mesh-list
65239654|NCT00990821|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65239655|NCT00801853|Interleukin-4|interleukin-4|mesh-list
65239656|NCT00801853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65239657|NCT00801853|Immunologic Factors|immunologic factors|mesh-ancestor
64882411|NCT01933516|Rituximab|rituximab|mesh-list
65239658|NCT00801853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239659|NCT00801853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239660|NCT00801853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65239661|NCT00990665|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64971482|NCT00225589|Calcium|calcium|mesh-list
65239662|NCT00990665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65239663|NCT00990665|Contraceptive Agents|contraceptive agents|mesh-ancestor
65239664|NCT00990665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65239665|NCT00990665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239666|NCT00990665|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65239667|NCT00990665|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65239668|NCT00990665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65239669|NCT00658567|Pimavanserin|pimavanserin|mesh-list
65239670|NCT00658567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65239671|NCT00658567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65239672|NCT00658567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65239673|NCT00658567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65239674|NCT00658567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65239675|NCT00658567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239676|NCT00658567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65239706|NCT00794209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65239707|NCT00794209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239709|NCT00794209|Sensory System Agents|sensory system agents|mesh-ancestor
65239710|NCT00794209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65239711|NCT00794209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65239712|NCT00794209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65239713|NCT00794209|Anesthetics, General|anesthetics, general|mesh-ancestor
65239714|NCT00794209|Anesthetics|anesthetics|mesh-ancestor
65239715|NCT00985985|Nicotine|nicotine|mesh-list
65344520|NCT05225974|Liraglutide|liraglutide|mesh-list
65344521|NCT05225974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65344522|NCT05225974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239716|NCT00985985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65239717|NCT00985985|Autonomic Agents|autonomic agents|mesh-ancestor
65239718|NCT00985985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65239719|NCT00985985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239720|NCT00985985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65239721|NCT00985985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65239754|NCT00685425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239755|NCT04290455|Castor Oil|castor oil|mesh-list
65239756|NCT04290455|Cathartics|cathartics|mesh-ancestor
65239757|NCT04290455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65239758|NCT00685503|Ranibizumab|ranibizumab|mesh-list
65239759|NCT00685503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65239760|NCT00685503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65239761|NCT00685503|Growth Substances|growth substances|mesh-ancestor
65239762|NCT00685503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239763|NCT00685503|Growth Inhibitors|growth inhibitors|mesh-ancestor
65239784|NCT02868437|Immunologic Factors|immunologic factors|mesh-ancestor
65239785|NCT02868437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239786|NCT02868437|Viscosupplements|viscosupplements|mesh-ancestor
65239787|NCT02868437|Protective Agents|protective agents|mesh-ancestor
65239788|NCT00802087|Acetaminophen|acetaminophen|mesh-list
65239789|NCT00802087|Hydrocodone|hydrocodone|mesh-list
65239790|NCT00802087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65239791|NCT00802087|Analgesics|analgesics|mesh-ancestor
65239792|NCT00802087|Sensory System Agents|sensory system agents|mesh-ancestor
65239793|NCT00802087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65239794|NCT00802087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239795|NCT00802087|Antipyretics|antipyretics|mesh-ancestor
65239796|NCT00802087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65239797|NCT00802087|Narcotics|narcotics|mesh-ancestor
65239798|NCT00802087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65239799|NCT00802087|Antitussive Agents|antitussive agents|mesh-ancestor
65239800|NCT00802087|Respiratory System Agents|respiratory system agents|mesh-ancestor
65239801|NCT00923936|Bevacizumab|bevacizumab|mesh-list
65239802|NCT00923936|Doxorubicin|doxorubicin|mesh-list
65239803|NCT00923936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65239804|NCT00923936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65239805|NCT00923936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239806|NCT00923936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65239807|NCT00923936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65239808|NCT00923936|Growth Substances|growth substances|mesh-ancestor
65239809|NCT00923936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239810|NCT00923936|Growth Inhibitors|growth inhibitors|mesh-ancestor
65239811|NCT00923936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65239812|NCT00923936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65239813|NCT00923936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65239814|NCT00923936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239815|NCT00923936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239816|NCT00797017|Fentanyl|fentanyl|mesh-list
65239817|NCT00797017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65239818|NCT00797017|Narcotics|narcotics|mesh-ancestor
65239819|NCT00797017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65239845|NCT00924950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65239846|NCT00924950|Glucocorticoids|glucocorticoids|mesh-ancestor
65239847|NCT00924950|Hormones|hormones|mesh-ancestor
65239848|NCT00924950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65239849|NCT00924950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239850|NCT00924950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65239851|NCT00924950|Respiratory System Agents|respiratory system agents|mesh-ancestor
65239852|NCT00924950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65239853|NCT00924950|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65239854|NCT00924950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65239855|NCT00924950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239856|NCT00924950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65239857|NCT00924950|Vitamins|vitamins|mesh-ancestor
65239858|NCT00924950|Micronutrients|micronutrients|mesh-ancestor
65239859|NCT00924950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65239860|NCT02866955|Tamoxifen|tamoxifen|mesh-list
65239861|NCT02866955|Estramustine|estramustine|mesh-list
65239862|NCT02866955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65344523|NCT05225974|Incretins|incretins|mesh-ancestor
65344524|NCT05225974|Hormones|hormones|mesh-ancestor
65344525|NCT05225974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65344526|NCT01139970|Temozolomide|temozolomide|mesh-list
65344527|NCT01139970|Veliparib|veliparib|mesh-list
65344528|NCT01139970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65239863|NCT02866955|Hormone Antagonists|hormone antagonists|mesh-ancestor
65239864|NCT02866955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65239865|NCT02866955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461245|NCT01556997|Perindopril|perindopril|mesh-list
65239873|NCT02866955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239875|NCT04842643|Immunologic Factors|immunologic factors|mesh-ancestor
65239876|NCT04842643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239877|NCT02626065|Nivolumab|nivolumab|mesh-list
65239878|NCT02626065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65239879|NCT02626065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239880|NCT02626065|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65239881|NCT02626065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239882|NCT00794755|Vitamin K|vitamin k|mesh-list
65239883|NCT00794755|Vitamin K 1|vitamin k 1|mesh-list
65239884|NCT00794755|Vitamins|vitamins|mesh-ancestor
65239885|NCT00794755|Micronutrients|micronutrients|mesh-ancestor
65239886|NCT00794755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239887|NCT00794755|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65239888|NCT00794755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65239889|NCT00794755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239890|NCT00794755|Hemostatics|hemostatics|mesh-ancestor
65239891|NCT00794755|Coagulants|coagulants|mesh-ancestor
65239892|NCT00685971|Cholecalciferol|cholecalciferol|mesh-list
65239893|NCT00685971|Vitamin D|vitamin d|mesh-list
65239894|NCT00685971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65239895|NCT00685971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239896|NCT00685971|Vitamins|vitamins|mesh-ancestor
65239897|NCT00685971|Micronutrients|micronutrients|mesh-ancestor
65239898|NCT00685971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65239899|NCT00802243|Leflunomide|leflunomide|mesh-list
65239900|NCT00802243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239901|NCT00802243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239902|NCT00802243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65239903|NCT00802243|Immunologic Factors|immunologic factors|mesh-ancestor
65239904|NCT00802243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239905|NCT00988637|Calcitriol|calcitriol|mesh-list
65239906|NCT00988637|Clobetasol|clobetasol|mesh-list
65239907|NCT00988637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65239908|NCT00988637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239909|NCT00988637|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65239910|NCT00988637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65239911|NCT00988637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239912|NCT00988637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65239913|NCT00988637|Vitamins|vitamins|mesh-ancestor
65239914|NCT00988637|Micronutrients|micronutrients|mesh-ancestor
65239915|NCT00988637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65239916|NCT00988637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65239917|NCT00988637|Glucocorticoids|glucocorticoids|mesh-ancestor
65239918|NCT00988637|Hormones|hormones|mesh-ancestor
65239919|NCT00988637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65239920|NCT00802321|Dutasteride|dutasteride|mesh-list
65239921|NCT00802321|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65239922|NCT00802321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65239923|NCT00802321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239924|NCT00802321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239925|NCT00802321|Hormone Antagonists|hormone antagonists|mesh-ancestor
65239926|NCT00802321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65239927|NCT00802321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239928|NCT00686361|Choline|choline|mesh-list
65239929|NCT00686361|Lipotropic Agents|lipotropic agents|mesh-ancestor
65239930|NCT00686361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65239993|NCT00687843|Tegafur|tegafur|mesh-list
65344529|NCT01139970|Alkylating Agents|alkylating agents|mesh-ancestor
65344530|NCT01139970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344531|NCT01139970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344532|NCT01139970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65239994|NCT00687843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65239995|NCT00687843|Antimetabolites|antimetabolites|mesh-ancestor
65239996|NCT00687843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239997|NCT00687843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239998|NCT00687843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65239999|NCT00687843|Immunologic Factors|immunologic factors|mesh-ancestor
65240000|NCT00687843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240001|NCT00687843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65240002|NCT00687843|Antiviral Agents|antiviral agents|mesh-ancestor
65240003|NCT00687843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65240004|NCT00687843|Interferon Inducers|interferon inducers|mesh-ancestor
65240005|NCT00687843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65240006|NCT00687843|Protective Agents|protective agents|mesh-ancestor
65240007|NCT04257656|Remdesivir|remdesivir|mesh-list
65240008|NCT04257656|Antimetabolites|antimetabolites|mesh-ancestor
65240009|NCT04257656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240010|NCT04257656|Antiviral Agents|antiviral agents|mesh-ancestor
65240011|NCT04257656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65240012|NCT05329844|Vildagliptin|vildagliptin|mesh-list
65240013|NCT05329844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65240014|NCT05329844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240015|NCT05329844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65240016|NCT05329844|Protease Inhibitors|protease inhibitors|mesh-ancestor
65240017|NCT05329844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240018|NCT05329844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240019|NCT00687999|Interferons|interferons|mesh-list
65240039|NCT00923156|Protease Inhibitors|protease inhibitors|mesh-ancestor
65240040|NCT00923156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240041|NCT00923156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240042|NCT00923156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65240043|NCT00688857|Diazoxide|diazoxide|mesh-list
65240044|NCT00688857|Choline|choline|mesh-list
65240045|NCT00688857|Lipotropic Agents|lipotropic agents|mesh-ancestor
65240046|NCT00688857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65240047|NCT00688857|Antimetabolites|antimetabolites|mesh-ancestor
65240048|NCT00688857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240049|NCT00688857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65240050|NCT00688857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65240051|NCT00688857|Nootropic Agents|nootropic agents|mesh-ancestor
65240052|NCT00688857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65240053|NCT00688857|Vasodilator Agents|vasodilator agents|mesh-ancestor
65240054|NCT04256798|Chlorhexidine|chlorhexidine|mesh-list
65240055|NCT04256798|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65240056|NCT04256798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65240057|NCT04256798|Disinfectants|disinfectants|mesh-ancestor
65240058|NCT00689169|Cytarabine|cytarabine|mesh-list
65240059|NCT00689169|Rituximab|rituximab|mesh-list
65240060|NCT00689169|Etoposide|etoposide|mesh-list
65240061|NCT00689169|Melphalan|melphalan|mesh-list
65240062|NCT00689169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65240063|NCT00689169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240064|NCT00689169|Immunologic Factors|immunologic factors|mesh-ancestor
65240065|NCT00689169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240066|NCT00689169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65240067|NCT00689169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65240068|NCT00689169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65240069|NCT00689169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65240070|NCT00689169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240071|NCT00689169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240072|NCT00689169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65240073|NCT00689169|Alkylating Agents|alkylating agents|mesh-ancestor
65240074|NCT00689169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65240075|NCT00689169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64461460|NCT03082300|Naquotinib|naquotinib|mesh-list
65240095|NCT02625519|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65240096|NCT02625519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65344533|NCT01139970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344534|NCT00729638|Lenalidomide|lenalidomide|mesh-list
65344535|NCT00729638|Everolimus|everolimus|mesh-list
65344536|NCT00729638|Immunologic Factors|immunologic factors|mesh-ancestor
65240097|NCT02625519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240098|NCT00912483|Heparin|heparin|mesh-list
65240099|NCT00912483|Calcium heparin|calcium heparin|mesh-list
65240100|NCT00912483|Anticoagulants|anticoagulants|mesh-ancestor
65240101|NCT00912483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65240102|NCT00912483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65240103|NCT00912483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240104|NCT04257032|Dabigatran|dabigatran|mesh-list
65240105|NCT04257032|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65240106|NCT04257032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65240107|NCT04257032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65240108|NCT04257032|Antimetabolites|antimetabolites|mesh-ancestor
65240109|NCT04257032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240110|NCT04257032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65240111|NCT04257032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65240112|NCT04257032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240113|NCT04257032|Antithrombins|antithrombins|mesh-ancestor
65240114|NCT04257032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65240115|NCT04257032|Protease Inhibitors|protease inhibitors|mesh-ancestor
65240116|NCT04257032|Anticoagulants|anticoagulants|mesh-ancestor
65240117|NCT00924560|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65240118|NCT00924560|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65240119|NCT00924560|Levonorgestrel|levonorgestrel|mesh-list
65240120|NCT00924560|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65240121|NCT00924560|Contraceptive Agents|contraceptive agents|mesh-list
65240122|NCT00924560|Contraceptives, Oral|contraceptives, oral|mesh-list
65240123|NCT00924560|Estradiol|estradiol|mesh-list
65240124|NCT00924560|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65240125|NCT00924560|Estrogens|estrogens|mesh-ancestor
65240126|NCT00924560|Hormones|hormones|mesh-ancestor
65240127|NCT00924560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65240128|NCT00924560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240129|NCT00924560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65240130|NCT00924560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64461515|NCT03080740|Metronidazole|metronidazole|mesh-list
65240151|NCT00689559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65240153|NCT00689637|Anticoagulants|anticoagulants|mesh-ancestor
65240154|NCT00689715|Ethanol|ethanol|mesh-list
65240155|NCT00689715|Paclitaxel|paclitaxel|mesh-list
65240156|NCT00689715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65240157|NCT00689715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65240158|NCT00689715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240159|NCT00689715|Tubulin Modulators|tubulin modulators|mesh-ancestor
65240160|NCT00689715|Antimitotic Agents|antimitotic agents|mesh-ancestor
65240161|NCT00689715|Mitosis Modulators|mitosis modulators|mesh-ancestor
65240162|NCT00689715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240163|NCT00689715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65240164|NCT00689715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65240165|NCT00689715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65240166|NCT00689715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240167|NCT00689949|Folic Acid|folic acid|mesh-list
65240168|NCT00689949|Hematinics|hematinics|mesh-ancestor
65240169|NCT00689949|Vitamin B Complex|vitamin b complex|mesh-ancestor
65240170|NCT00689949|Vitamins|vitamins|mesh-ancestor
65240171|NCT00689949|Micronutrients|micronutrients|mesh-ancestor
65240172|NCT00689949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240173|NCT04256642|Morphine|morphine|mesh-list
65240174|NCT04256642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65240175|NCT04256642|Narcotics|narcotics|mesh-ancestor
65240176|NCT04256642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65240177|NCT04256642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240178|NCT04256642|Analgesics|analgesics|mesh-ancestor
65240179|NCT04256642|Sensory System Agents|sensory system agents|mesh-ancestor
65240180|NCT04256642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882937|NCT01936233|Analgesics|analgesics|mesh-ancestor
65240181|NCT00611000|Folic Acid|folic acid|mesh-list
65240182|NCT00611000|Hematinics|hematinics|mesh-ancestor
65240183|NCT00611000|Vitamin B Complex|vitamin b complex|mesh-ancestor
65240212|NCT00694317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65240213|NCT00694317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240215|NCT04136613|Trace Elements|trace elements|mesh-ancestor
65344537|NCT00729638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344538|NCT00729638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65344539|NCT00729638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65344540|NCT00729638|Growth Substances|growth substances|mesh-ancestor
65344541|NCT00729638|Growth Inhibitors|growth inhibitors|mesh-ancestor
65344542|NCT00729638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240216|NCT04136613|Micronutrients|micronutrients|mesh-ancestor
65240217|NCT04136613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240218|NCT00978731|Dasatinib|dasatinib|mesh-list
65240219|NCT00978731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240220|NCT00978731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65240221|NCT00978731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240222|NCT00978731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240223|NCT04136535|Carboplatin|carboplatin|mesh-list
65240224|NCT04136535|Pemetrexed|pemetrexed|mesh-list
65240225|NCT04136535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240226|NCT04136535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240227|NCT04136535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240228|NCT04136535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65240229|NCT04136535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65240230|NCT00694629|Rifampin|rifampin|mesh-list
65240231|NCT00694629|Rifapentine|rifapentine|mesh-list
65240260|NCT02866409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65240261|NCT02866409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65240262|NCT02866409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65240302|NCT05833815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240303|NCT05833815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65240304|NCT05833815|Immunologic Factors|immunologic factors|mesh-ancestor
65240305|NCT05833815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240306|NCT05833802|Antineoplastic Agents|antineoplastic agents|mesh-list
65240322|NCT05833763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65240323|NCT05833763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240324|NCT05833529|Cocaine|cocaine|mesh-list
65240325|NCT05833529|Anesthetics, Local|anesthetics, local|mesh-ancestor
65240350|NCT05833399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65240351|NCT05833399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240352|NCT05833399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240353|NCT05833399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65240354|NCT05833399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65240355|NCT05833399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65240356|NCT05833399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65240357|NCT05833399|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65240358|NCT05833399|Dopamine Agents|dopamine agents|mesh-ancestor
65240359|NCT05833399|Antiemetics|antiemetics|mesh-ancestor
65240360|NCT05833399|Autonomic Agents|autonomic agents|mesh-ancestor
65240361|NCT05833399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65240362|NCT05833399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65240363|NCT05833399|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65240364|NCT05833399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65240365|NCT05833399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65240366|NCT05833399|Antidepressive Agents|antidepressive agents|mesh-ancestor
65240367|NCT05833399|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65240368|NCT05833399|Histamine Antagonists|histamine antagonists|mesh-ancestor
65240369|NCT05833399|Histamine Agents|histamine agents|mesh-ancestor
65240370|NCT05833399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65240371|NCT05833399|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65240372|NCT05833399|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65240373|NCT05833399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65240374|NCT05833399|Adrenergic Agents|adrenergic agents|mesh-ancestor
65240375|NCT05833399|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64461748|NCT01931059|Risperidone|risperidone|mesh-list
65240377|NCT05833399|Anticonvulsants|anticonvulsants|mesh-ancestor
65240378|NCT05833399|Antimanic Agents|antimanic agents|mesh-ancestor
65240379|NCT05833399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65240380|NCT05833399|Analgesics|analgesics|mesh-ancestor
65240381|NCT05833399|Sensory System Agents|sensory system agents|mesh-ancestor
65240382|NCT05833399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65240383|NCT05833399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65344543|NCT00729638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65344544|NCT00734682|Irinotecan|irinotecan|mesh-list
65344545|NCT00734682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65344546|NCT00734682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65344547|NCT00734682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726409|NCT00002551|Vitamins|vitamins|mesh-ancestor
65240384|NCT05833399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65240385|NCT05833399|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65240386|NCT05833399|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65240387|NCT05833217|Insulin|insulin|mesh-list
65240388|NCT05833217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65240389|NCT05833217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240390|NCT05833139|Itraconazole|itraconazole|mesh-list
65240391|NCT05833139|Antifungal Agents|antifungal agents|mesh-ancestor
65240392|NCT05833139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65240393|NCT05833139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65240394|NCT05833139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65240395|NCT05833139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240396|NCT05833139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240397|NCT05833139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65240398|NCT05833139|Hormone Antagonists|hormone antagonists|mesh-ancestor
65240399|NCT05833139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65240400|NCT05833139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240401|NCT05833139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65240403|NCT05833126|Atezolizumab|atezolizumab|mesh-list
64883171|NCT01937767|Fentanyl|fentanyl|mesh-list
65240404|NCT05833126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65240405|NCT05833126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240406|NCT05833126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65240407|NCT05833126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65240408|NCT05833126|Growth Substances|growth substances|mesh-ancestor
65240409|NCT05833126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240410|NCT05833126|Growth Inhibitors|growth inhibitors|mesh-ancestor
65240411|NCT05832996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65240412|NCT05832996|Lubricant Eye Drops|lubricant eye drops|mesh-list
65240413|NCT05832996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65240414|NCT05832892|Gemcitabine|gemcitabine|mesh-list
65240415|NCT05832892|Paclitaxel|paclitaxel|mesh-list
65240416|NCT05832892|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65240417|NCT05832892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65240450|NCT05832697|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65240451|NCT05832697|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65240452|NCT05832697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65240453|NCT05832619|Serotonin|serotonin|mesh-list
65240454|NCT05832619|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65240455|NCT05832619|Serotonin Agents|serotonin agents|mesh-ancestor
65240456|NCT05832619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65240457|NCT05832619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240458|NCT05832619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240459|NCT05832580|Etidronic Acid|etidronic acid|mesh-list
65240460|NCT05832580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65240485|NCT05832398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240486|NCT05832398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65240487|NCT05832398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240488|NCT05832398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65240490|NCT05832398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240491|NCT05832398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65240492|NCT05832398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65240493|NCT05832398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240494|NCT05832398|Antidotes|antidotes|mesh-ancestor
65240495|NCT05832398|Protective Agents|protective agents|mesh-ancestor
65240496|NCT05832398|Vitamin B Complex|vitamin b complex|mesh-ancestor
65240497|NCT05832398|Vitamins|vitamins|mesh-ancestor
65240498|NCT05832398|Micronutrients|micronutrients|mesh-ancestor
65240499|NCT05832333|Vaccines|vaccines|mesh-list
65240500|NCT05832333|Immunologic Factors|immunologic factors|mesh-ancestor
65240501|NCT05832333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240502|NCT05832320|Etoposide|etoposide|mesh-list
65240503|NCT05832320|Daunorubicin|daunorubicin|mesh-list
65240504|NCT05832320|Tretinoin|tretinoin|mesh-list
65344548|NCT00734682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344549|NCT00734682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344550|NCT00732108|Topiramate|topiramate|mesh-list
65344551|NCT00732108|Lactulose|lactulose|mesh-list
65344552|NCT00732108|Anticonvulsants|anticonvulsants|mesh-ancestor
65344553|NCT00732108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65240505|NCT05832320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65240506|NCT05832320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240507|NCT05832320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65240508|NCT05832320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65240509|NCT05832320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240510|NCT05832320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240574|NCT05827055|Mitosis Modulators|mitosis modulators|mesh-ancestor
65240575|NCT05827055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240576|NCT05827055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65240577|NCT05827055|Antimetabolites|antimetabolites|mesh-ancestor
65240578|NCT05827055|Antiviral Agents|antiviral agents|mesh-ancestor
65240579|NCT05827055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65240580|NCT05827055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240581|NCT05827055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65240582|NCT05827055|Immunologic Factors|immunologic factors|mesh-ancestor
65240583|NCT05827055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240584|NCT05827055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65240585|NCT05827055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65240586|NCT05826275|Pembrolizumab|pembrolizumab|mesh-list
65240587|NCT05826275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65240588|NCT05826275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240589|NCT05822830|Tirzepatide|tirzepatide|mesh-list
65240590|NCT05822830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65240591|NCT05822830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240592|NCT05822830|Incretins|incretins|mesh-ancestor
65240593|NCT05822830|Hormones|hormones|mesh-ancestor
65240594|NCT05822830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65240595|NCT05818423|Benzocaine|benzocaine|mesh-list
65240596|NCT05818423|Anesthetics, Local|anesthetics, local|mesh-ancestor
65240597|NCT05818423|Anesthetics|anesthetics|mesh-ancestor
65240598|NCT05818423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65240599|NCT05818423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240600|NCT05818423|Sensory System Agents|sensory system agents|mesh-ancestor
65240629|NCT05807399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65240630|NCT05807399|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64883391|NCT01939093|Histamine Agents|histamine agents|mesh-ancestor
65240631|NCT05807399|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65240632|NCT05807399|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65240633|NCT05807399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65240634|NCT05807399|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65240635|NCT05807399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65240636|NCT05807399|Antimetabolites|antimetabolites|mesh-ancestor
65240637|NCT05807399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65240638|NCT05806021|Triamcinolone|triamcinolone|mesh-list
65240639|NCT05806021|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65240640|NCT05806021|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65240641|NCT05806021|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65240642|NCT05806021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65240643|NCT05806021|Glucocorticoids|glucocorticoids|mesh-ancestor
65240644|NCT05806021|Hormones|hormones|mesh-ancestor
65240645|NCT05806021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65240646|NCT05806021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240647|NCT05806021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65240648|NCT05806021|Immunologic Factors|immunologic factors|mesh-ancestor
65240649|NCT05806021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240650|NCT05806021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240651|NCT05805826|Vaccines|vaccines|mesh-list
65240652|NCT05805826|Immunologic Factors|immunologic factors|mesh-ancestor
65240653|NCT05805826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240654|NCT05805501|Pembrolizumab|pembrolizumab|mesh-list
65240655|NCT05805501|Axitinib|axitinib|mesh-list
65240656|NCT05805501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65240657|NCT05805501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344554|NCT00732108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344555|NCT00732108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65344556|NCT00876616|Mycophenolic Acid|mycophenolic acid|mesh-list
65344557|NCT00876616|Cyclophosphamide|cyclophosphamide|mesh-list
65344558|NCT00876616|Tacrolimus|tacrolimus|mesh-list
65240658|NCT05805501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65240659|NCT05805501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240660|NCT05805501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240661|NCT05798390|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
65240730|NCT05737069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65240731|NCT05737069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240732|NCT05737069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65240733|NCT05737069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65240734|NCT05737069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65240735|NCT05737069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240736|NCT05737069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240737|NCT05722015|Paclitaxel|paclitaxel|mesh-list
65240738|NCT05722015|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65240739|NCT05722015|Carboplatin|carboplatin|mesh-list
65240740|NCT05722015|Pembrolizumab|pembrolizumab|mesh-list
65240741|NCT05722015|Pemetrexed|pemetrexed|mesh-list
65240742|NCT05722015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65240743|NCT05722015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240744|NCT05722015|Tubulin Modulators|tubulin modulators|mesh-ancestor
65240745|NCT05722015|Antimitotic Agents|antimitotic agents|mesh-ancestor
64462076|NCT04591210|Giapreza|giapreza|mesh-list
65240802|NCT05704049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240803|NCT05704049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240805|NCT05673187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240850|NCT05646303|Hallucinogens|hallucinogens|mesh-ancestor
65240851|NCT05646303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240852|NCT05646303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65240853|NCT05646082|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65240854|NCT05646082|Antiviral Agents|antiviral agents|mesh-ancestor
65240855|NCT05646082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65240856|NCT05643794|Rozanolixizumab|rozanolixizumab|mesh-list
65240857|NCT05643794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65240859|NCT05643794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240864|NCT05641363|Ketorolac|ketorolac|mesh-list
65240865|NCT05641363|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65240866|NCT05641363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65240867|NCT05641363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65240868|NCT05641363|Analgesics|analgesics|mesh-ancestor
65240869|NCT05641363|Sensory System Agents|sensory system agents|mesh-ancestor
65240870|NCT05641363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65240871|NCT05641363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240872|NCT05641363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65240900|NCT05629702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240901|NCT05627245|Belinostat|belinostat|mesh-list
65240902|NCT05627245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240903|NCT05627245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65240904|NCT05627245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240905|NCT05627245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240906|NCT05622201|Rituximab|rituximab|mesh-list
65240907|NCT05622201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65240908|NCT05622201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240909|NCT05622201|Immunologic Factors|immunologic factors|mesh-ancestor
65240910|NCT05622201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240911|NCT05622201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65240912|NCT05612490|Furosemide|furosemide|mesh-list
65240913|NCT05612490|Diuretics|diuretics|mesh-ancestor
65240914|NCT05612490|Natriuretic Agents|natriuretic agents|mesh-ancestor
65240921|NCT05605964|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65240922|NCT05605964|Fertility Agents|fertility agents|mesh-ancestor
65240923|NCT05605964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65240924|NCT05605964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240965|NCT05594602|Quinidine|quinidine|mesh-list
65240966|NCT05594602|Carbamazepine|carbamazepine|mesh-list
65240967|NCT05594602|Antifungal Agents|antifungal agents|mesh-ancestor
65240968|NCT05594602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65240969|NCT05594602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65344559|NCT00876616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65344560|NCT00876616|Immunologic Factors|immunologic factors|mesh-ancestor
65344561|NCT00876616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344562|NCT00876616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65344563|NCT00876616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65344564|NCT00876616|Alkylating Agents|alkylating agents|mesh-ancestor
65344565|NCT00876616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344566|NCT00876616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344567|NCT00876616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65344568|NCT00876616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65240970|NCT05594602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65240997|NCT05594602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65240998|NCT05594602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65240999|NCT05594602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65241000|NCT05594602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65241001|NCT05594602|Cholinergic Agents|cholinergic agents|mesh-ancestor
65241002|NCT05594602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65241003|NCT05594602|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65241005|NCT05590260|Trace Elements|trace elements|mesh-ancestor
65241006|NCT05590260|Micronutrients|micronutrients|mesh-ancestor
65241007|NCT05590260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241008|NCT05589844|Vaccines|vaccines|mesh-list
65241009|NCT05589844|Immunologic Factors|immunologic factors|mesh-ancestor
65241010|NCT05589844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241043|NCT05576077|Pembrolizumab|pembrolizumab|mesh-list
65241044|NCT05576077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65241045|NCT05576077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241046|NCT05503797|Cobicistat|cobicistat|mesh-list
65241047|NCT05503797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64462283|NCT01908829|Cholinergic Agents|cholinergic agents|mesh-ancestor
65241119|NCT05467176|Hormone Antagonists|hormone antagonists|mesh-ancestor
65241120|NCT05467176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65241121|NCT05467176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241123|NCT05439616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65241124|NCT05439616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65241125|NCT05439616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65241126|NCT05439616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241127|NCT05439616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65241128|NCT05436418|Sirolimus|sirolimus|mesh-list
65241129|NCT05436418|Cyclophosphamide|cyclophosphamide|mesh-list
65241130|NCT05436418|Melphalan|melphalan|mesh-list
65241131|NCT05436418|Fludarabine|fludarabine|mesh-list
65241132|NCT05436418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65241133|NCT05436418|Immunologic Factors|immunologic factors|mesh-ancestor
65241134|NCT05436418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241135|NCT05436418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65241136|NCT05436418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65241137|NCT05436418|Alkylating Agents|alkylating agents|mesh-ancestor
64401043|NCT03067883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65241180|NCT05400603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64462331|NCT03621904|Hormones|hormones|mesh-ancestor
65241250|NCT05371093|Vincristine|vincristine|mesh-list
65241251|NCT05371093|Lenalidomide|lenalidomide|mesh-list
65241252|NCT05371093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65241253|NCT05371093|Immunologic Factors|immunologic factors|mesh-ancestor
65241254|NCT05371093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241255|NCT05371093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65241256|NCT05371093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65241257|NCT05371093|Alkylating Agents|alkylating agents|mesh-ancestor
64462375|NCT03568708|Estrogens|estrogens|mesh-list
65241277|NCT05371093|Growth Substances|growth substances|mesh-ancestor
65241278|NCT05371093|Growth Inhibitors|growth inhibitors|mesh-ancestor
65241280|NCT05371054|Venetoclax|venetoclax|mesh-list
65241281|NCT05371054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65241282|NCT05371054|Glucocorticoids|glucocorticoids|mesh-ancestor
65241283|NCT05371054|Hormones|hormones|mesh-ancestor
65344569|NCT00876616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344570|NCT00876616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65344571|NCT00876616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65344572|NCT00876616|Antitubercular Agents|antitubercular agents|mesh-ancestor
65344573|NCT00876616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65344574|NCT00876616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65344575|NCT05575440|Fluorides|fluorides|mesh-list
65344576|NCT05575440|Cariostatic Agents|cariostatic agents|mesh-ancestor
65344577|NCT05575440|Protective Agents|protective agents|mesh-ancestor
65344578|NCT05575440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344579|NCT02099058|Nivolumab|nivolumab|mesh-list
65344580|NCT02099058|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65241284|NCT05371054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65241285|NCT05371054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241286|NCT05371054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65241287|NCT05371054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241288|NCT05364944|Octreotide|octreotide|mesh-list
65241289|NCT05364944|Lanreotide|lanreotide|mesh-list
65241290|NCT05364944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65241291|NCT05364944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65241306|NCT05319730|Irinotecan|irinotecan|mesh-list
65241307|NCT05319730|Lenvatinib|lenvatinib|mesh-list
65241308|NCT05319730|Immunoglobulins|immunoglobulins|mesh-list
65241309|NCT05319730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65241310|NCT05319730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241311|NCT05319730|Tubulin Modulators|tubulin modulators|mesh-ancestor
65241312|NCT05319730|Antimitotic Agents|antimitotic agents|mesh-ancestor
65241313|NCT05319730|Mitosis Modulators|mitosis modulators|mesh-ancestor
65241314|NCT05319730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241315|NCT05319730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65241316|NCT05319730|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65241317|NCT05319730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65241318|NCT05319730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241319|NCT05319730|Immunologic Factors|immunologic factors|mesh-ancestor
65241320|NCT05319730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241321|NCT05319730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65241323|NCT05318105|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
65241324|NCT05318105|Natriuretic Agents|natriuretic agents|mesh-ancestor
65241325|NCT05318105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241332|NCT05295784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241334|NCT05295784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241335|NCT05295784|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65241336|NCT05295784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65241337|NCT05295784|Purinergic Agents|purinergic agents|mesh-ancestor
65241338|NCT05295784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65241344|NCT05246293|Tofacitinib|tofacitinib|mesh-list
65241345|NCT05246293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65241346|NCT05246293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241347|NCT05246293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241348|NCT05243147|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
65241349|NCT05243147|Hemostatics|hemostatics|mesh-ancestor
65241350|NCT05243147|Coagulants|coagulants|mesh-ancestor
65241351|NCT05236673|Empagliflozin|empagliflozin|mesh-list
65241352|NCT05236673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65241353|NCT05236673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241354|NCT05236673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65241355|NCT05236673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241356|NCT05212610|Vaccines|vaccines|mesh-list
65241357|NCT05212610|Immunologic Factors|immunologic factors|mesh-ancestor
65241358|NCT05212610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241359|NCT05207280|Terlipressin|terlipressin|mesh-list
65241360|NCT05207280|Norepinephrine|norepinephrine|mesh-list
65241361|NCT05207280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65344581|NCT02099058|Osimertinib|osimertinib|mesh-list
65344582|NCT02099058|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65344583|NCT02099058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65344584|NCT02099058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344585|NCT02099058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65344586|NCT02099058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726447|NCT00002263|Antiviral Agents|antiviral agents|mesh-ancestor
65241362|NCT05207280|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65241363|NCT05207280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65241364|NCT05207280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65241365|NCT05207280|Adrenergic Agents|adrenergic agents|mesh-ancestor
65241366|NCT05207280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65241367|NCT05207280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241368|NCT05207280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241369|NCT05207280|Sympathomimetics|sympathomimetics|mesh-ancestor
65241370|NCT05207280|Autonomic Agents|autonomic agents|mesh-ancestor
65241371|NCT05207280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65241372|NCT05184712|Carboplatin|carboplatin|mesh-list
65241373|NCT05184712|Pemetrexed|pemetrexed|mesh-list
65241374|NCT05184712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241375|NCT05184712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241376|NCT05184712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241377|NCT05184712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65241378|NCT05184712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65241379|NCT05180240|Cannabidiol|cannabidiol|mesh-list
65241380|NCT05180240|Anticonvulsants|anticonvulsants|mesh-ancestor
65241381|NCT05174832|Paclitaxel|paclitaxel|mesh-list
65241382|NCT05174832|Pembrolizumab|pembrolizumab|mesh-list
65241383|NCT05174832|Olaparib|olaparib|mesh-list
65241384|NCT05174832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65241385|NCT05174832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241386|NCT05174832|Tubulin Modulators|tubulin modulators|mesh-ancestor
65241387|NCT05174832|Antimitotic Agents|antimitotic agents|mesh-ancestor
65241388|NCT05174832|Mitosis Modulators|mitosis modulators|mesh-ancestor
65241389|NCT05174832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241390|NCT05174832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65241391|NCT05174832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65241392|NCT05174832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241393|NCT05171647|Gemcitabine|gemcitabine|mesh-list
65241394|NCT05171647|Rituximab|rituximab|mesh-list
65241395|NCT05171647|Oxaliplatin|oxaliplatin|mesh-list
65241396|NCT05171647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64462470|NCT04398316|Lidocaine|lidocaine|mesh-list
65241425|NCT05157672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65241426|NCT05157672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65241427|NCT05157672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241428|NCT05157672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65241429|NCT05157672|Hormone Antagonists|hormone antagonists|mesh-ancestor
65241430|NCT05157672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65241431|NCT05155293|Aflibercept|aflibercept|mesh-list
65241432|NCT05155293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65241433|NCT05155293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65241434|NCT05155293|Growth Substances|growth substances|mesh-ancestor
65241435|NCT05155293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241436|NCT05155293|Growth Inhibitors|growth inhibitors|mesh-ancestor
65241437|NCT05155293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241438|NCT05149378|Azacitidine|azacitidine|mesh-list
65241439|NCT05149378|Venetoclax|venetoclax|mesh-list
65241440|NCT05149378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65241441|NCT05149378|Antimetabolites|antimetabolites|mesh-ancestor
65241442|NCT05149378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241468|NCT05108935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65241469|NCT05108935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65241470|NCT05108935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241471|NCT05108935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241472|NCT05108935|Antiviral Agents|antiviral agents|mesh-ancestor
65241473|NCT05108935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65344587|NCT02099058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65344588|NCT02099058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344589|NCT02099058|Immunologic Factors|immunologic factors|mesh-ancestor
65344590|NCT02099058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344591|NCT00729794|Methylprednisolone|methylprednisolone|mesh-list
65344592|NCT00729794|Hydrocortisone|hydrocortisone|mesh-list
65241474|NCT05108935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65241475|NCT05108935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65241476|NCT05078866|Vaccines|vaccines|mesh-list
65241477|NCT05078866|Immunologic Factors|immunologic factors|mesh-ancestor
65241478|NCT05078866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241479|NCT05067283|Leucovorin|leucovorin|mesh-list
65241480|NCT05067283|Carboplatin|carboplatin|mesh-list
65241481|NCT05067283|Pembrolizumab|pembrolizumab|mesh-list
65241482|NCT05067283|Fluorouracil|fluorouracil|mesh-list
65241483|NCT05067283|Oxaliplatin|oxaliplatin|mesh-list
65241484|NCT05067283|Pemetrexed|pemetrexed|mesh-list
65241485|NCT05067283|Cetuximab|cetuximab|mesh-list
65241486|NCT05067283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241487|NCT05067283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65241488|NCT05067283|Antimetabolites|antimetabolites|mesh-ancestor
65241489|NCT05067283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241534|NCT04980222|Doxorubicin|doxorubicin|mesh-list
64884292|NCT01944618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65241535|NCT04980222|Vincristine|vincristine|mesh-list
65241536|NCT04980222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65241537|NCT04980222|Immunologic Factors|immunologic factors|mesh-ancestor
65241538|NCT04980222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241539|NCT04980222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65241540|NCT04980222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65241541|NCT04980222|Alkylating Agents|alkylating agents|mesh-ancestor
65241542|NCT04980222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241543|NCT04980222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241544|NCT04980222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65241545|NCT04980222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65241546|NCT04980222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65241547|NCT04980222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65241548|NCT04980222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65241549|NCT04980222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241579|NCT04924036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241588|NCT04908956|Osimertinib|osimertinib|mesh-list
65241589|NCT04908956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241590|NCT04908956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65241601|NCT04902885|Etoposide|etoposide|mesh-list
65241602|NCT04902885|Topotecan|topotecan|mesh-list
65241603|NCT04902885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241604|NCT04902885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65241605|NCT04902885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65241606|NCT04902885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65241607|NCT04902885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241608|NCT04902885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884367|NCT01945450|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65241609|NCT04902885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65241610|NCT04900220|Methylprednisolone|methylprednisolone|mesh-list
65241611|NCT04900220|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65241612|NCT04900220|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65241613|NCT04900220|Prednisolone|prednisolone|mesh-list
65241614|NCT04900220|Prednisolone acetate|prednisolone acetate|mesh-list
65241615|NCT04900220|Betamethasone|betamethasone|mesh-list
65241616|NCT04900220|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65241617|NCT04900220|Prednisolone phosphate|prednisolone phosphate|mesh-list
65241618|NCT04900220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65241619|NCT04900220|Antiemetics|antiemetics|mesh-ancestor
65241620|NCT04900220|Autonomic Agents|autonomic agents|mesh-ancestor
65241621|NCT04900220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65241622|NCT04900220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241623|NCT04900220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65241624|NCT04900220|Glucocorticoids|glucocorticoids|mesh-ancestor
64462670|NCT01930045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65241655|NCT04868058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65241656|NCT04868058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344593|NCT00729794|Vasopressins|vasopressins|mesh-list
65344594|NCT00729794|Arginine Vasopressin|arginine vasopressin|mesh-list
65344595|NCT00729794|Epinephrine|epinephrine|mesh-list
65344596|NCT00729794|Racepinephrine|racepinephrine|mesh-list
65344597|NCT00729794|Epinephryl borate|epinephryl borate|mesh-list
65344598|NCT00729794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65241657|NCT04868058|Sensory System Agents|sensory system agents|mesh-ancestor
65241658|NCT04868058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65241659|NCT04858334|Olaparib|olaparib|mesh-list
65241660|NCT04858334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65241661|NCT04858334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241662|NCT04858334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241663|NCT04858334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241664|NCT04847063|Sodium thiosulfate|sodium thiosulfate|mesh-list
65241665|NCT04847063|Doxorubicin|doxorubicin|mesh-list
65241666|NCT04847063|Fluorouracil|fluorouracil|mesh-list
65241667|NCT04847063|Oxaliplatin|oxaliplatin|mesh-list
65241668|NCT04847063|Mitomycins|mitomycins|mesh-list
65241669|NCT04847063|Mitomycin|mitomycin|mesh-list
65241670|NCT04847063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241671|NCT04847063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65241672|NCT04847063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65241673|NCT04847063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65241674|NCT04847063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241675|NCT04847063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241676|NCT04847063|Antimetabolites|antimetabolites|mesh-ancestor
65241677|NCT04847063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65241678|NCT04847063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65241679|NCT04847063|Immunologic Factors|immunologic factors|mesh-ancestor
65241680|NCT04847063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241681|NCT04847063|Alkylating Agents|alkylating agents|mesh-ancestor
65241682|NCT04847063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64884448|NCT05410782|Vitamins|vitamins|mesh-list
65241683|NCT04847063|Antidotes|antidotes|mesh-ancestor
65241684|NCT04847063|Protective Agents|protective agents|mesh-ancestor
65241686|NCT04847063|Antitubercular Agents|antitubercular agents|mesh-ancestor
65241687|NCT04847063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65241688|NCT04847063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65241689|NCT04847063|Chelating Agents|chelating agents|mesh-ancestor
65241690|NCT04847063|Sequestering Agents|sequestering agents|mesh-ancestor
65241691|NCT04837196|Pembrolizumab|pembrolizumab|mesh-list
65241722|NCT04799275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65241723|NCT04799275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65241724|NCT04799275|Alkylating Agents|alkylating agents|mesh-ancestor
65241725|NCT04799275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241726|NCT04799275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241727|NCT04799275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65241728|NCT04799275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65241729|NCT04799275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65241730|NCT04799275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65241731|NCT04799275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241732|NCT04799275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65241733|NCT04799275|Glucocorticoids|glucocorticoids|mesh-ancestor
65241734|NCT04799275|Hormones|hormones|mesh-ancestor
65241735|NCT04799275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65241736|NCT04799275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65241737|NCT04799275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65241738|NCT04799275|Tubulin Modulators|tubulin modulators|mesh-ancestor
65241739|NCT04799275|Antimitotic Agents|antimitotic agents|mesh-ancestor
65241768|NCT04628988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241769|NCT04628988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241770|NCT04626518|Pembrolizumab|pembrolizumab|mesh-list
65241771|NCT04626518|Lenvatinib|lenvatinib|mesh-list
65241772|NCT04626518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65241773|NCT04626518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241774|NCT04626518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65241775|NCT04626518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241776|NCT04626518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241777|NCT04614363|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65241778|NCT04614363|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65344599|NCT00729794|Antiemetics|antiemetics|mesh-ancestor
65344600|NCT00729794|Autonomic Agents|autonomic agents|mesh-ancestor
65344601|NCT00729794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65241779|NCT04614363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241780|NCT04576117|Vinblastine|vinblastine|mesh-list
65241781|NCT04576117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65241782|NCT04576117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241783|NCT04576117|Tubulin Modulators|tubulin modulators|mesh-ancestor
65241784|NCT04576117|Antimitotic Agents|antimitotic agents|mesh-ancestor
65241785|NCT04576117|Mitosis Modulators|mitosis modulators|mesh-ancestor
65241786|NCT04576117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241787|NCT04567615|Nivolumab|nivolumab|mesh-list
65241788|NCT04567615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65241789|NCT04567615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241790|NCT04567615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65241791|NCT04567615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241792|NCT04563520|Coagulants|coagulants|mesh-list
65241793|NCT04563520|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
65241801|NCT04530565|Cytarabine|cytarabine|mesh-list
65241802|NCT04530565|Dexamethasone|dexamethasone|mesh-list
65241803|NCT04530565|Dexamethasone acetate|dexamethasone acetate|mesh-list
65241804|NCT04530565|Prednisone|prednisone|mesh-list
65241805|NCT04530565|Cortisone|cortisone|mesh-list
65241806|NCT04530565|Cyclophosphamide|cyclophosphamide|mesh-list
65241807|NCT04530565|Doxorubicin|doxorubicin|mesh-list
65241808|NCT04530565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65241835|NCT04530565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64884587|NCT04812028|Tocolytic Agents|tocolytic agents|mesh-ancestor
65241837|NCT04530565|Hormones|hormones|mesh-ancestor
65241838|NCT04530565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65241839|NCT04530565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65241840|NCT04530565|Protease Inhibitors|protease inhibitors|mesh-ancestor
65241841|NCT04530565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241842|NCT04530565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65241843|NCT04530565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65241844|NCT04530565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65241845|NCT04530565|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65241846|NCT04530565|Abortifacient Agents|abortifacient agents|mesh-ancestor
65241847|NCT04530565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65241848|NCT04530565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65241849|NCT04530565|Antimetabolites|antimetabolites|mesh-ancestor
65241850|NCT04530565|Dermatologic Agents|dermatologic agents|mesh-ancestor
65241851|NCT04530565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65241852|NCT04530565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65241853|NCT04530565|Antiviral Agents|antiviral agents|mesh-ancestor
65241854|NCT04530565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65241855|NCT04530565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65241856|NCT04530565|Tubulin Modulators|tubulin modulators|mesh-ancestor
65241857|NCT04530565|Antimitotic Agents|antimitotic agents|mesh-ancestor
65241858|NCT04530565|Mitosis Modulators|mitosis modulators|mesh-ancestor
65241859|NCT04530565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65241860|NCT04530565|Protective Agents|protective agents|mesh-ancestor
65241894|NCT04503668|Antiemetics|antiemetics|mesh-ancestor
65241895|NCT04503668|Autonomic Agents|autonomic agents|mesh-ancestor
65241896|NCT04503668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65241897|NCT04503668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241898|NCT04503668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65241899|NCT04503668|Glucocorticoids|glucocorticoids|mesh-ancestor
65241901|NCT04503668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65241902|NCT04503668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65241919|NCT04503668|Dopamine Agents|dopamine agents|mesh-ancestor
65241920|NCT04481113|Niraparib|niraparib|mesh-list
65241921|NCT04481113|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65241922|NCT04481113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241923|NCT04481113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241924|NCT04481113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241925|NCT04472611|Colchicine|colchicine|mesh-list
65241926|NCT04472611|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65241927|NCT04472611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65241928|NCT04472611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65241929|NCT04472611|Antimetabolites|antimetabolites|mesh-ancestor
65241930|NCT04472611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344602|NCT00729794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344603|NCT00729794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65344604|NCT00729794|Glucocorticoids|glucocorticoids|mesh-ancestor
65241931|NCT04472611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65241932|NCT04472611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65241933|NCT04472611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241934|NCT04472611|Gout Suppressants|gout suppressants|mesh-ancestor
65241935|NCT04472611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65241936|NCT04472611|Tubulin Modulators|tubulin modulators|mesh-ancestor
65241937|NCT04472611|Antimitotic Agents|antimitotic agents|mesh-ancestor
65241938|NCT04472611|Mitosis Modulators|mitosis modulators|mesh-ancestor
65241939|NCT04472611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241940|NCT04472598|Navitoclax|navitoclax|mesh-list
65241941|NCT04472598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241942|NCT04460885|Insulin|insulin|mesh-list
65241943|NCT04460885|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65241944|NCT04460885|Insulin Glargine|insulin glargine|mesh-list
65241945|NCT04460885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65241946|NCT04460885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241947|NCT04458259|Axitinib|axitinib|mesh-list
65241948|NCT04458259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241949|NCT04458259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65241950|NCT04458259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241951|NCT04458259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241952|NCT04444921|Paclitaxel|paclitaxel|mesh-list
65241953|NCT04444921|Carboplatin|carboplatin|mesh-list
65241954|NCT04444921|Nivolumab|nivolumab|mesh-list
65241955|NCT04444921|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65241956|NCT04444921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65241957|NCT04444921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241958|NCT04444921|Tubulin Modulators|tubulin modulators|mesh-ancestor
65241959|NCT04444921|Antimitotic Agents|antimitotic agents|mesh-ancestor
65241960|NCT04444921|Mitosis Modulators|mitosis modulators|mesh-ancestor
64462968|NCT01968031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242012|NCT04368559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65242013|NCT04368559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65242014|NCT04367233|Anesthetics|anesthetics|mesh-list
65242015|NCT04367233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65242016|NCT04367233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242017|NCT04341350|Analgesics|analgesics|mesh-list
65242018|NCT04341350|Propofol|propofol|mesh-list
65242019|NCT04341350|Isoflurane|isoflurane|mesh-list
65242020|NCT04341350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65242021|NCT04341350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65242022|NCT04341350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242023|NCT04341350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65242024|NCT04341350|Anesthetics, General|anesthetics, general|mesh-ancestor
65242025|NCT04341350|Anesthetics|anesthetics|mesh-ancestor
65242026|NCT04341350|Sensory System Agents|sensory system agents|mesh-ancestor
65242027|NCT04341350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65242028|NCT04341350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65242034|NCT04310007|Gemcitabine|gemcitabine|mesh-list
65242035|NCT04310007|Paclitaxel|paclitaxel|mesh-list
65242036|NCT04310007|Docetaxel|docetaxel|mesh-list
65242037|NCT04310007|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65242038|NCT04310007|Nivolumab|nivolumab|mesh-list
65242039|NCT04310007|Ramucirumab|ramucirumab|mesh-list
65242063|NCT04270409|Antiemetics|antiemetics|mesh-ancestor
65242064|NCT04270409|Autonomic Agents|autonomic agents|mesh-ancestor
65242123|NCT04210115|Leucovorin|leucovorin|mesh-list
65242124|NCT04210115|Pembrolizumab|pembrolizumab|mesh-list
65242125|NCT04210115|Oxaliplatin|oxaliplatin|mesh-list
65242126|NCT04210115|Calcium|calcium|mesh-list
65242127|NCT04210115|Levoleucovorin|levoleucovorin|mesh-list
65242128|NCT04210115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242129|NCT04210115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65242130|NCT04210115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65242131|NCT04210115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242132|NCT04210115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65242133|NCT04210115|Antidotes|antidotes|mesh-ancestor
65242134|NCT04210115|Protective Agents|protective agents|mesh-ancestor
65242135|NCT04210115|Vitamin B Complex|vitamin b complex|mesh-ancestor
65242136|NCT04210115|Vitamins|vitamins|mesh-ancestor
65242137|NCT04210115|Micronutrients|micronutrients|mesh-ancestor
65242138|NCT04193215|Vaccines|vaccines|mesh-list
65242139|NCT04193215|Immunologic Factors|immunologic factors|mesh-ancestor
65242140|NCT04193215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344605|NCT00729794|Hormones|hormones|mesh-ancestor
65344606|NCT00729794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65242141|NCT04182204|Gemcitabine|gemcitabine|mesh-list
65242213|NCT04078295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242214|NCT04078295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65242215|NCT04078295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242216|NCT04068597|Dexamethasone|dexamethasone|mesh-list
65242217|NCT04068597|Azacitidine|azacitidine|mesh-list
65242218|NCT04068597|Venetoclax|venetoclax|mesh-list
65242219|NCT04068597|Pomalidomide|pomalidomide|mesh-list
65242220|NCT04068597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65242221|NCT04068597|Antiemetics|antiemetics|mesh-ancestor
65242222|NCT04068597|Autonomic Agents|autonomic agents|mesh-ancestor
65242223|NCT04068597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65242224|NCT04068597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242225|NCT04068597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65242226|NCT04068597|Glucocorticoids|glucocorticoids|mesh-ancestor
65242227|NCT04068597|Hormones|hormones|mesh-ancestor
64513635|NCT01457469|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65242253|NCT04004611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65242254|NCT03974828|Anesthetics|anesthetics|mesh-list
65242255|NCT03974828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65242256|NCT03974828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242257|NCT03972306|Ocrelizumab|ocrelizumab|mesh-list
65242258|NCT03972306|Immunologic Factors|immunologic factors|mesh-ancestor
65242259|NCT03972306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242260|NCT03970447|Temozolomide|temozolomide|mesh-list
65242261|NCT03970447|Lomustine|lomustine|mesh-list
65242262|NCT03970447|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
65242263|NCT03970447|GDC-0084|gdc-0084|mesh-list
65242264|NCT03970447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65242265|NCT03970447|Alkylating Agents|alkylating agents|mesh-ancestor
65242266|NCT03970447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401044|NCT03067883|Protease Inhibitors|protease inhibitors|mesh-ancestor
65242267|NCT03970447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242268|NCT03970447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65242269|NCT03968653|Carboplatin|carboplatin|mesh-list
65242270|NCT03968653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242271|NCT03953677|Dexmedetomidine|dexmedetomidine|mesh-list
65242272|NCT03953677|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65242273|NCT03953677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65242274|NCT03953677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65242275|NCT03953677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242276|NCT03953677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65242277|NCT03953677|Analgesics|analgesics|mesh-ancestor
65242278|NCT03953677|Sensory System Agents|sensory system agents|mesh-ancestor
65242279|NCT03953677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64463166|NCT00636610|Growth Inhibitors|growth inhibitors|mesh-ancestor
65242302|NCT03948035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65242303|NCT03948035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65242304|NCT03948035|Growth Substances|growth substances|mesh-ancestor
65242305|NCT03948035|Growth Inhibitors|growth inhibitors|mesh-ancestor
65242307|NCT03937713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65242308|NCT03937713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65242309|NCT03937713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242310|NCT03934216|BMS-986165|bms-986165|mesh-list
65242311|NCT03934216|Dermatologic Agents|dermatologic agents|mesh-ancestor
65242312|NCT03934216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65242313|NCT03934216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65242314|NCT03934216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242315|NCT03925480|Azithromycin|azithromycin|mesh-list
65242316|NCT03925480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65242317|NCT03925480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65242318|NCT03924869|Pembrolizumab|pembrolizumab|mesh-list
65242319|NCT03924869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65242320|NCT03924869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242321|NCT03915769|Ozanimod|ozanimod|mesh-list
65242322|NCT03915769|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65242323|NCT03915769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242324|NCT03915769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65242325|NCT03915769|Immunologic Factors|immunologic factors|mesh-ancestor
65242326|NCT03915769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242327|NCT03878069|Elapegademase|elapegademase|mesh-list
65242328|NCT03878069|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65344607|NCT00729794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65344608|NCT00729794|Protective Agents|protective agents|mesh-ancestor
65344609|NCT00729794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65344610|NCT00729794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65344611|NCT00729794|Adrenergic Agents|adrenergic agents|mesh-ancestor
65344612|NCT00729794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65344613|NCT00729794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344614|NCT00729794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65344615|NCT00729794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65344616|NCT00729794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65344617|NCT00729794|Respiratory System Agents|respiratory system agents|mesh-ancestor
65344618|NCT00729794|Mydriatics|mydriatics|mesh-ancestor
65344619|NCT00729794|Sympathomimetics|sympathomimetics|mesh-ancestor
65344620|NCT00729794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65344621|NCT00729794|Hemostatics|hemostatics|mesh-ancestor
65344622|NCT00729794|Coagulants|coagulants|mesh-ancestor
65242329|NCT03878069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65242330|NCT03878069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242331|NCT03876873|Anesthetics|anesthetics|mesh-list
64463217|NCT00634504|Antidotes|antidotes|mesh-ancestor
65242360|NCT03860844|Autonomic Agents|autonomic agents|mesh-ancestor
65242361|NCT03860844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65242362|NCT03860844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65242363|NCT03860844|Glucocorticoids|glucocorticoids|mesh-ancestor
65242365|NCT03860844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65242366|NCT03860844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65242367|NCT03860844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65242368|NCT03860844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65242369|NCT03860844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65242370|NCT03860844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65242371|NCT03860844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65242372|NCT03860844|Abortifacient Agents|abortifacient agents|mesh-ancestor
65242373|NCT03860844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65242374|NCT03860844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65242375|NCT03860844|Antimetabolites|antimetabolites|mesh-ancestor
65242376|NCT03860844|Dermatologic Agents|dermatologic agents|mesh-ancestor
65242377|NCT03860844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65242378|NCT03860844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65242379|NCT03860844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65242380|NCT03860844|Antiviral Agents|antiviral agents|mesh-ancestor
65242381|NCT03860844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64463269|NCT01924000|Minoxidil|minoxidil|mesh-list
65242409|NCT03842696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65242410|NCT03842696|Alkylating Agents|alkylating agents|mesh-ancestor
65242411|NCT03842696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242412|NCT03842696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242413|NCT03842696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65242414|NCT03842696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65242415|NCT03842696|Abortifacient Agents|abortifacient agents|mesh-ancestor
65242416|NCT03842696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65242417|NCT03842696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65242418|NCT03842696|Antimetabolites|antimetabolites|mesh-ancestor
65242419|NCT03842696|Dermatologic Agents|dermatologic agents|mesh-ancestor
65242420|NCT03842696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65242421|NCT03842696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65242422|NCT03842696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65242423|NCT03842696|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65242424|NCT03842696|Antifungal Agents|antifungal agents|mesh-ancestor
65344623|NCT00729794|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65344624|NCT00729794|Natriuretic Agents|natriuretic agents|mesh-ancestor
65344625|NCT00871546|Bortezomib|bortezomib|mesh-list
65344626|NCT00871546|Alemtuzumab|alemtuzumab|mesh-list
65344627|NCT00871546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344628|NCT00871546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65344629|NCT03778294|Temozolomide|temozolomide|mesh-list
65344630|NCT03778294|Levodopa|levodopa|mesh-list
65344631|NCT03778294|Fluorides|fluorides|mesh-list
65344632|NCT03778294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65344633|NCT03778294|Alkylating Agents|alkylating agents|mesh-ancestor
65344634|NCT03778294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344635|NCT03778294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344636|NCT03778294|Cariostatic Agents|cariostatic agents|mesh-ancestor
65344637|NCT03778294|Protective Agents|protective agents|mesh-ancestor
65344638|NCT03778294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344639|NCT03778294|Dopamine Agents|dopamine agents|mesh-ancestor
65344640|NCT03778294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65344641|NCT03778294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65344642|NCT03778294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65344643|NCT00732186|Ipilimumab|ipilimumab|mesh-list
65344644|NCT00732186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65344645|NCT00732186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344646|NCT00732186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65344647|NCT00732186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344649|NCT04039828|Zinc Sulfate|zinc sulfate|mesh-list
65344650|NCT04039828|Trace Elements|trace elements|mesh-ancestor
65344651|NCT04039828|Micronutrients|micronutrients|mesh-ancestor
65344652|NCT04039828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344653|NCT04039828|Astringents|astringents|mesh-ancestor
65344654|NCT04039828|Dermatologic Agents|dermatologic agents|mesh-ancestor
65344655|NCT00876772|Olanzapine|olanzapine|mesh-list
65242425|NCT03842696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65242426|NCT03842696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65242427|NCT03842696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65242428|NCT03842696|Antitubercular Agents|antitubercular agents|mesh-ancestor
65242429|NCT03842696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65242430|NCT03842696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65242462|NCT03811002|Etoposide|etoposide|mesh-list
65242463|NCT03811002|Etoposide phosphate|etoposide phosphate|mesh-list
65242464|NCT03811002|Atezolizumab|atezolizumab|mesh-list
65242465|NCT03811002|Podophyllotoxin|podophyllotoxin|mesh-list
65242466|NCT03811002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65242467|NCT03811002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242468|NCT03811002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65344656|NCT00876772|Antiemetics|antiemetics|mesh-ancestor
65344657|NCT00876772|Autonomic Agents|autonomic agents|mesh-ancestor
65344658|NCT00876772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65344659|NCT00876772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344660|NCT00876772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65344661|NCT00876772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64505405|NCT01722292|Etoposide|etoposide|mesh-list
65242469|NCT03811002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65242470|NCT03811002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65242471|NCT03811002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65242472|NCT03811002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242473|NCT03811002|Immunologic Factors|immunologic factors|mesh-ancestor
65242474|NCT03811002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242475|NCT03811002|Keratolytic Agents|keratolytic agents|mesh-ancestor
65242476|NCT03811002|Dermatologic Agents|dermatologic agents|mesh-ancestor
65242477|NCT03811002|Tubulin Modulators|tubulin modulators|mesh-ancestor
65242478|NCT03811002|Antimitotic Agents|antimitotic agents|mesh-ancestor
65242513|NCT03762850|Dapagliflozin|dapagliflozin|mesh-list
65242514|NCT03762850|Irbesartan|irbesartan|mesh-list
65242515|NCT03762850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65242516|NCT03762850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242517|NCT03762850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65242518|NCT03762850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885337|NCT03993327|Iodine|iodine|mesh-list
65242519|NCT03762850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65242520|NCT03762850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65242521|NCT03762850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65242522|NCT03759288|Adalimumab|adalimumab|mesh-list
65242523|NCT03759288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65242524|NCT03759288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65242533|NCT03711032|Pembrolizumab|pembrolizumab|mesh-list
65242534|NCT03711032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65242535|NCT03711032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242536|NCT03601078|Lenalidomide|lenalidomide|mesh-list
65242537|NCT03601078|Immunologic Factors|immunologic factors|mesh-ancestor
65242538|NCT03601078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242539|NCT03601078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65242540|NCT03601078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65242541|NCT03601078|Growth Substances|growth substances|mesh-ancestor
65242542|NCT03601078|Growth Inhibitors|growth inhibitors|mesh-ancestor
65242577|NCT03479502|Methylprednisolone|methylprednisolone|mesh-list
65242578|NCT03479502|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65242579|NCT03479502|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65242580|NCT03479502|Prednisolone|prednisolone|mesh-list
65242581|NCT03479502|Prednisolone acetate|prednisolone acetate|mesh-list
65242582|NCT03479502|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65242583|NCT03479502|Prednisolone phosphate|prednisolone phosphate|mesh-list
65242584|NCT03479502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65242585|NCT03479502|Glucocorticoids|glucocorticoids|mesh-ancestor
65242586|NCT03479502|Hormones|hormones|mesh-ancestor
65242608|NCT03478865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242609|NCT03478865|Protective Agents|protective agents|mesh-ancestor
65242610|NCT03478865|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65242611|NCT03478865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242612|NCT03474107|Paclitaxel|paclitaxel|mesh-list
65242613|NCT03474107|Docetaxel|docetaxel|mesh-list
65242614|NCT03474107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65242615|NCT03474107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242616|NCT03474107|Tubulin Modulators|tubulin modulators|mesh-ancestor
65242617|NCT03474107|Antimitotic Agents|antimitotic agents|mesh-ancestor
65242618|NCT03474107|Mitosis Modulators|mitosis modulators|mesh-ancestor
65242619|NCT03474107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242620|NCT03467958|Ozanimod|ozanimod|mesh-list
65242621|NCT03467958|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65242622|NCT03467958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242623|NCT03467958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65242624|NCT03467958|Immunologic Factors|immunologic factors|mesh-ancestor
65242625|NCT03467958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242626|NCT03440385|Ozanimod|ozanimod|mesh-list
65344662|NCT00876772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65344663|NCT00876772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65344664|NCT00876772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64726520|NCT00002269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65242627|NCT03440385|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65242628|NCT03440385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242629|NCT03440385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65242630|NCT03440385|Immunologic Factors|immunologic factors|mesh-ancestor
65242631|NCT03440385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242632|NCT03407144|Prednisone|prednisone|mesh-list
65242633|NCT03407144|Prednisolone|prednisolone|mesh-list
65242634|NCT03407144|Cyclophosphamide|cyclophosphamide|mesh-list
65242635|NCT03407144|Dacarbazine|dacarbazine|mesh-list
65242636|NCT03407144|Doxorubicin|doxorubicin|mesh-list
65242637|NCT03407144|Pembrolizumab|pembrolizumab|mesh-list
65242638|NCT03407144|Etoposide|etoposide|mesh-list
65242639|NCT03407144|Etoposide phosphate|etoposide phosphate|mesh-list
65242662|NCT03407144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65242663|NCT03407144|Tubulin Modulators|tubulin modulators|mesh-ancestor
65242664|NCT03407144|Antimitotic Agents|antimitotic agents|mesh-ancestor
65242665|NCT03407144|Mitosis Modulators|mitosis modulators|mesh-ancestor
65242666|NCT03294460|Ethanol|ethanol|mesh-list
65242667|NCT03294460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65242668|NCT03294460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65242669|NCT03294460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65242670|NCT03294460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242671|NCT03240016|Pembrolizumab|pembrolizumab|mesh-list
65242672|NCT03240016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65242673|NCT03240016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65242674|NCT03240016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242675|NCT03223610|Prednisone|prednisone|mesh-list
65242676|NCT03223610|Lenalidomide|lenalidomide|mesh-list
65242677|NCT03223610|Venetoclax|venetoclax|mesh-list
65242678|NCT03223610|Obinutuzumab|obinutuzumab|mesh-list
65242679|NCT03223610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65242680|NCT03223610|Glucocorticoids|glucocorticoids|mesh-ancestor
65242681|NCT03223610|Hormones|hormones|mesh-ancestor
65242682|NCT03223610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65242683|NCT03223610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242684|NCT03223610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65242685|NCT03223610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242686|NCT03223610|Immunologic Factors|immunologic factors|mesh-ancestor
65242687|NCT03223610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65242688|NCT03223610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65242689|NCT03223610|Growth Substances|growth substances|mesh-ancestor
65242690|NCT03223610|Growth Inhibitors|growth inhibitors|mesh-ancestor
65242691|NCT03223610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65242726|NCT03126916|Micronutrients|micronutrients|mesh-ancestor
65242727|NCT03126916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65242728|NCT03126916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65242729|NCT03126916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65242730|NCT03126916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65242731|NCT03126916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65242732|NCT03126916|Tubulin Modulators|tubulin modulators|mesh-ancestor
65242733|NCT03126916|Antimitotic Agents|antimitotic agents|mesh-ancestor
65242734|NCT03126916|Mitosis Modulators|mitosis modulators|mesh-ancestor
65242735|NCT03126916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65242736|NCT03126916|Keratolytic Agents|keratolytic agents|mesh-ancestor
65242737|NCT03126916|Dermatologic Agents|dermatologic agents|mesh-ancestor
65242738|NCT03126916|Protective Agents|protective agents|mesh-ancestor
65242739|NCT03126916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65242740|NCT03126916|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65242766|NCT03092518|Sequestering Agents|sequestering agents|mesh-ancestor
65242767|NCT03067051|Verteporfin|verteporfin|mesh-list
65242768|NCT03067051|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65242769|NCT03067051|Dermatologic Agents|dermatologic agents|mesh-ancestor
65242770|NCT03013998|Cytarabine|cytarabine|mesh-list
65242771|NCT03013998|Azacitidine|azacitidine|mesh-list
65242772|NCT03013998|Decitabine|decitabine|mesh-list
65242773|NCT03013998|Daunorubicin|daunorubicin|mesh-list
65242774|NCT03013998|Venetoclax|venetoclax|mesh-list
65242775|NCT03013998|AZD5991|azd5991|mesh-list
65242776|NCT03013998|Pevonedistat|pevonedistat|mesh-list
65242777|NCT03013998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65242778|NCT03013998|Antimetabolites|antimetabolites|mesh-ancestor
65344665|NCT00876772|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65344666|NCT00876772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65344667|NCT00876772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65344668|NCT00876772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344669|NCT00876772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65242779|NCT03013998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242780|NCT03013998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242781|NCT03013998|Antiviral Agents|antiviral agents|mesh-ancestor
65242782|NCT03013998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65242783|NCT03013998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65242784|NCT03013998|Immunologic Factors|immunologic factors|mesh-ancestor
65242785|NCT03013998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242786|NCT03013998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65242787|NCT03013998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65242788|NCT03013998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65242789|NCT03013998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65242790|NCT03006068|Upadacitinib|upadacitinib|mesh-list
65242791|NCT03006068|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65242792|NCT03006068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65242793|NCT03006068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65242849|NCT02911142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65242850|NCT02911142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65242851|NCT02911142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65242852|NCT02911142|Tubulin Modulators|tubulin modulators|mesh-ancestor
65242853|NCT02911142|Antimitotic Agents|antimitotic agents|mesh-ancestor
65242854|NCT02911142|Mitosis Modulators|mitosis modulators|mesh-ancestor
65242855|NCT02911142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65242856|NCT02911142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65242857|NCT02911142|Growth Substances|growth substances|mesh-ancestor
65242858|NCT02911142|Growth Inhibitors|growth inhibitors|mesh-ancestor
65242859|NCT02901067|Aspirin|aspirin|mesh-list
65242860|NCT02901067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65242861|NCT02901067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65242862|NCT02901067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65242863|NCT02901067|Analgesics|analgesics|mesh-ancestor
65242864|NCT02901067|Sensory System Agents|sensory system agents|mesh-ancestor
65242865|NCT02901067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65242866|NCT02901067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242867|NCT02901067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65242892|NCT02858310|Aldesleukin|aldesleukin|mesh-list
65242893|NCT02858310|Cyclophosphamide|cyclophosphamide|mesh-list
65242894|NCT02858310|Fludarabine|fludarabine|mesh-list
65242895|NCT02858310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65242896|NCT02858310|Immunologic Factors|immunologic factors|mesh-ancestor
65242897|NCT02858310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242898|NCT02858310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65242899|NCT02858310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65242900|NCT02858310|Alkylating Agents|alkylating agents|mesh-ancestor
65242901|NCT02858310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242902|NCT02858310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242903|NCT02858310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65242904|NCT02858310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65242905|NCT02858310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65242906|NCT02858310|Antiviral Agents|antiviral agents|mesh-ancestor
65242907|NCT02858310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65242909|NCT02784210|Methylprednisolone|methylprednisolone|mesh-list
65242910|NCT02784210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65242911|NCT02784210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65242912|NCT02784210|Prednisolone|prednisolone|mesh-list
65242913|NCT02784210|Prednisolone acetate|prednisolone acetate|mesh-list
65242914|NCT02784210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65242915|NCT02784210|Prednisolone phosphate|prednisolone phosphate|mesh-list
65242916|NCT02784210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65242951|NCT02616640|Autonomic Agents|autonomic agents|mesh-ancestor
65242952|NCT02616640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65242953|NCT02616640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242954|NCT02616640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65242955|NCT02616640|Glucocorticoids|glucocorticoids|mesh-ancestor
65344670|NCT00876772|Serotonin Agents|serotonin agents|mesh-ancestor
65344671|NCT00729950|Ipilimumab|ipilimumab|mesh-list
65344672|NCT00729950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65344673|NCT00729950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344674|NCT00729950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65344675|NCT00729950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344676|NCT00616018|Acetaminophen|acetaminophen|mesh-list
65344677|NCT00616018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65344678|NCT00616018|Analgesics|analgesics|mesh-ancestor
65344679|NCT00616018|Sensory System Agents|sensory system agents|mesh-ancestor
65344680|NCT00616018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65344681|NCT00616018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344682|NCT00616018|Antipyretics|antipyretics|mesh-ancestor
65344683|NCT00740948|Rituximab|rituximab|mesh-list
65344684|NCT00740948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65344685|NCT00740948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344686|NCT00740948|Immunologic Factors|immunologic factors|mesh-ancestor
65344687|NCT00740948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344688|NCT00740948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65344689|NCT04735068|Hydroxychloroquine|hydroxychloroquine|mesh-list
65344690|NCT04735068|Antimalarials|antimalarials|mesh-ancestor
65344691|NCT04735068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65344692|NCT04735068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65344693|NCT04735068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726529|NCT00003152|Cyclophosphamide|cyclophosphamide|mesh-list
64463800|NCT05601700|Hormone Antagonists|hormone antagonists|mesh-ancestor
65242980|NCT02581527|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65242981|NCT02581527|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65242982|NCT02581527|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65242983|NCT02581527|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65242984|NCT02581527|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65242985|NCT02581527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65242986|NCT02581527|Antimetabolites|antimetabolites|mesh-ancestor
65242987|NCT02581527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65242988|NCT02558010|Morphine|morphine|mesh-list
65242989|NCT02558010|Methadone|methadone|mesh-list
65242990|NCT02558010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65242991|NCT02558010|Narcotics|narcotics|mesh-ancestor
65242992|NCT02558010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65242993|NCT02558010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242994|NCT02558010|Analgesics|analgesics|mesh-ancestor
65242995|NCT02558010|Sensory System Agents|sensory system agents|mesh-ancestor
65242996|NCT02558010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65242997|NCT02558010|Antitussive Agents|antitussive agents|mesh-ancestor
65242998|NCT02558010|Respiratory System Agents|respiratory system agents|mesh-ancestor
65242999|NCT02496663|Osimertinib|osimertinib|mesh-list
65243000|NCT02496663|Necitumumab|necitumumab|mesh-list
65243001|NCT02496663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65243002|NCT02496663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243003|NCT02496663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243004|NCT02496663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65344694|NCT04735068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344695|NCT04735068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344696|NCT04735068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65243005|NCT02496663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243006|NCT02496663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65243025|NCT02393794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243026|NCT02393794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65243027|NCT02393794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65243028|NCT02393794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243083|NCT02020707|Paclitaxel|paclitaxel|mesh-list
65243084|NCT02020707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65243085|NCT02020707|Bevacizumab|bevacizumab|mesh-list
65243086|NCT02020707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65243087|NCT02020707|Endothelial Growth Factors|endothelial growth factors|mesh-list
65243088|NCT02020707|Antibodies|antibodies|mesh-list
65243089|NCT02020707|Immunoglobulins|immunoglobulins|mesh-list
65243090|NCT02020707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65243091|NCT02020707|Immunoglobulin G|immunoglobulin g|mesh-list
65243092|NCT02020707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65243093|NCT02020707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243094|NCT02020707|Tubulin Modulators|tubulin modulators|mesh-ancestor
65243095|NCT02020707|Antimitotic Agents|antimitotic agents|mesh-ancestor
65243096|NCT02020707|Mitosis Modulators|mitosis modulators|mesh-ancestor
65243097|NCT02020707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243098|NCT02020707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65243099|NCT02020707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65243100|NCT02020707|Growth Substances|growth substances|mesh-ancestor
65243101|NCT02020707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243102|NCT02020707|Growth Inhibitors|growth inhibitors|mesh-ancestor
65243103|NCT02020707|Immunologic Factors|immunologic factors|mesh-ancestor
65243104|NCT02007512|Exemestane|exemestane|mesh-list
65243105|NCT02007512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243106|NCT02007512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65243107|NCT02007512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65243108|NCT02007512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243109|NCT02007512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243110|NCT02007512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65243111|NCT02007512|Hormone Antagonists|hormone antagonists|mesh-ancestor
65243112|NCT02007512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65243113|NCT02007512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243115|NCT01971489|Cisplatin|cisplatin|mesh-list
65243116|NCT01971489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243117|NCT01971489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64449634|NCT02109133|Rocuronium|rocuronium|mesh-list
65243149|NCT01838174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243150|NCT01838174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65243151|NCT01838174|Glucocorticoids|glucocorticoids|mesh-ancestor
65243152|NCT01838174|Hormones|hormones|mesh-ancestor
65243153|NCT01838174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65243154|NCT01838174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65243155|NCT01838174|Protective Agents|protective agents|mesh-ancestor
65243156|NCT01838174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65243157|NCT01838174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243158|NCT01743131|Abatacept|abatacept|mesh-list
65243159|NCT01743131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65243180|NCT01391962|Growth Substances|growth substances|mesh-ancestor
65243181|NCT01391962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243182|NCT01391962|Growth Inhibitors|growth inhibitors|mesh-ancestor
65243183|NCT01391962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65243184|NCT01391962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243185|NCT01391962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243186|NCT01319565|Aldesleukin|aldesleukin|mesh-list
65243187|NCT01319565|Cyclophosphamide|cyclophosphamide|mesh-list
65243188|NCT01319565|Fludarabine|fludarabine|mesh-list
65243189|NCT01319565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65243190|NCT01319565|Immunologic Factors|immunologic factors|mesh-ancestor
65243191|NCT01319565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243192|NCT01319565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65243193|NCT01319565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65243194|NCT01319565|Alkylating Agents|alkylating agents|mesh-ancestor
65344697|NCT00876850|Linezolid|linezolid|mesh-list
65344698|NCT00876850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65344699|NCT00876850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65344700|NCT00876850|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65344701|NCT00876850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505761|NCT03331302|Xenon|xenon|mesh-list
65243195|NCT01319565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243196|NCT01319565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243197|NCT01319565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65243198|NCT01319565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65243199|NCT01319565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65243200|NCT01319565|Antiviral Agents|antiviral agents|mesh-ancestor
65243201|NCT01319565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65243202|NCT01294020|Tacrolimus|tacrolimus|mesh-list
65243203|NCT01294020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65243204|NCT01294020|Immunologic Factors|immunologic factors|mesh-ancestor
65243205|NCT01294020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243206|NCT01294020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65243207|NCT01294020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243208|NCT01294020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243209|NCT01147016|Paclitaxel|paclitaxel|mesh-list
65243210|NCT01147016|Cyclophosphamide|cyclophosphamide|mesh-list
65243211|NCT01147016|Doxorubicin|doxorubicin|mesh-list
65243212|NCT01147016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65243213|NCT01147016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65243214|NCT01147016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463993|NCT03036904|Venetoclax|venetoclax|mesh-list
65243236|NCT00923013|Cladribine|cladribine|mesh-list
65243237|NCT00923013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65243238|NCT00923013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243239|NCT00923013|Immunologic Factors|immunologic factors|mesh-ancestor
65243240|NCT00923013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243241|NCT00923013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65243242|NCT00923013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65243243|NCT00862433|Vitamins|vitamins|mesh-list
65243244|NCT00862433|Vitamin E|vitamin e|mesh-list
65243245|NCT00862433|Tocopherols|tocopherols|mesh-list
65243246|NCT00862433|Tocotrienols|tocotrienols|mesh-list
65243247|NCT00862433|alpha-Tocopherol|alpha-tocopherol|mesh-list
65243248|NCT00862433|Micronutrients|micronutrients|mesh-ancestor
65243249|NCT00862433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243250|NCT00862433|Antioxidants|antioxidants|mesh-ancestor
65243251|NCT00862433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243252|NCT00862433|Protective Agents|protective agents|mesh-ancestor
65243253|NCT00720785|Bortezomib|bortezomib|mesh-list
65243254|NCT00720785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243255|NCT00539591|Interferons|interferons|mesh-list
65243256|NCT00539591|Interferon-alpha|interferon-alpha|mesh-list
65243257|NCT00539591|Interferon alpha-2|interferon alpha-2|mesh-list
65243258|NCT00539591|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65243259|NCT00539591|Temozolomide|temozolomide|mesh-list
65243260|NCT00539591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243261|NCT00539591|Antiviral Agents|antiviral agents|mesh-ancestor
65243262|NCT00539591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65243263|NCT00539591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65243264|NCT00539591|Alkylating Agents|alkylating agents|mesh-ancestor
65243265|NCT00539591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243266|NCT00539591|Immunologic Factors|immunologic factors|mesh-ancestor
65243267|NCT00539591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243269|NCT00359684|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
65243270|NCT00359684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464064|NCT03827200|Ambrisentan|ambrisentan|mesh-list
65243304|NCT00200200|Bevacizumab|bevacizumab|mesh-list
65243305|NCT00200200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65243306|NCT00200200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243307|NCT00200200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65243308|NCT00200200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65243309|NCT00200200|Growth Substances|growth substances|mesh-ancestor
65243310|NCT00200200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243311|NCT00200200|Growth Inhibitors|growth inhibitors|mesh-ancestor
65243313|NCT00106587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65243314|NCT00106587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344702|NCT00876850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344703|NCT00734916|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65344704|NCT00734916|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65344705|NCT00734916|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65344706|NCT00734916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65344707|NCT05157412|Doxycycline|doxycycline|mesh-list
65344708|NCT05157412|Prednisolone|prednisolone|mesh-list
65243350|NCT00092222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65243351|NCT00092222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65243352|NCT00092222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65243353|NCT00092222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243354|NCT00092222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65243355|NCT00092222|Glucocorticoids|glucocorticoids|mesh-ancestor
65243356|NCT00092222|Hormones|hormones|mesh-ancestor
65243357|NCT00092222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65243387|NCT00061568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65243388|NCT00044304|Imatinib Mesylate|imatinib mesylate|mesh-list
65243389|NCT00044304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243390|NCT00044304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65243391|NCT00044304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243392|NCT00044304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243393|NCT00018057|Fluoxetine|fluoxetine|mesh-list
65243394|NCT00018057|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65243395|NCT00018057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65243396|NCT00018057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65243397|NCT00018057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243398|NCT00018057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65243399|NCT00018057|Serotonin Agents|serotonin agents|mesh-ancestor
65243400|NCT00018057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243401|NCT00018057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64464189|NCT03824314|Midazolam|midazolam|mesh-list
65243430|NCT00001379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243431|NCT00001379|Antiviral Agents|antiviral agents|mesh-ancestor
65243432|NCT00001379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65243433|NCT00001379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65243434|NCT00001379|Immunologic Factors|immunologic factors|mesh-ancestor
65243435|NCT00001379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243436|NCT00001379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64887074|NCT01951053|Serotonin Agents|serotonin agents|mesh-ancestor
64887369|NCT01953172|Vitamins|vitamins|mesh-ancestor
64887816|NCT01955421|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64887891|NCT01955759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64888559|NCT01961388|Metformin|metformin|mesh-list
64888631|NCT01961843|Glucocorticoids|glucocorticoids|mesh-ancestor
64888705|NCT01962454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64888721|NCT01963182|Irinotecan|irinotecan|mesh-list
64889021|NCT01964404|Analgesics|analgesics|mesh-ancestor
64891042|NCT01978483|Denosumab|denosumab|mesh-list
64891420|NCT01981746|Anesthetics|anesthetics|mesh-ancestor
64892106|NCT01986283|Narcotics|narcotics|mesh-ancestor
64892329|NCT01987739|Zolpidem|zolpidem|mesh-list
64892559|NCT01989884|IDN 5109|idn 5109|mesh-list
64894671|NCT02003768|Anesthetics|anesthetics|mesh-ancestor
64894753|NCT02004509|Anticoagulants|anticoagulants|mesh-list
64907171|NCT00000553|Vitamins|vitamins|mesh-ancestor
64907325|NCT00000643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64908388|NCT00001693|Analgesics|analgesics|mesh-ancestor
64908461|NCT05641636|Hormones|hormones|mesh-list
64908535|NCT00000258|Nitrous Oxide|nitrous oxide|mesh-list
64908832|NCT05312008|Oxytocin|oxytocin|mesh-list
64923695|NCT00026143|Interferons|interferons|mesh-list
64924151|NCT00012051|Cytarabine|cytarabine|mesh-list
64924679|NCT00029497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64925279|NCT00032149|Prednisolone|prednisolone|mesh-list
64925584|NCT00033319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64925745|NCT02971423|Imipenem|imipenem|mesh-list
64925963|NCT00034528|Busulfan|busulfan|mesh-list
64926039|NCT00000686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935228|NCT00136552|Rituximab|rituximab|mesh-list
64936513|NCT00404716|Cilostazol|cilostazol|mesh-list
64936797|NCT01807377|Midazolam|midazolam|mesh-list
64938673|NCT00276588|Gemcitabine|gemcitabine|mesh-list
64938823|NCT00014729|Isotretinoin|isotretinoin|mesh-list
65344709|NCT05157412|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65344710|NCT05157412|Methylprednisolone|methylprednisolone|mesh-list
65344711|NCT05157412|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65344712|NCT05157412|Prednisolone acetate|prednisolone acetate|mesh-list
65344713|NCT05157412|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65344714|NCT05157412|Prednisolone phosphate|prednisolone phosphate|mesh-list
65344715|NCT05157412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65344716|NCT05157412|Glucocorticoids|glucocorticoids|mesh-ancestor
65344717|NCT05157412|Hormones|hormones|mesh-ancestor
65344718|NCT05157412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65344719|NCT05157412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344720|NCT05157412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65094504|NCT05146089|Bosentan|bosentan|mesh-list
65344721|NCT05157412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344723|NCT05157412|Autonomic Agents|autonomic agents|mesh-ancestor
65344724|NCT05157412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65344725|NCT05157412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65344726|NCT05157412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65344727|NCT05157412|Protective Agents|protective agents|mesh-ancestor
65344728|NCT05157412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65344729|NCT05157412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65344730|NCT05157412|Antimalarials|antimalarials|mesh-ancestor
65344731|NCT05157412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65344732|NCT05157412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65344733|NCT00732420|Topotecan|topotecan|mesh-list
65344734|NCT00732420|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65344735|NCT00732420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65344736|NCT00732420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726567|NCT05751421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938975|NCT00275535|Sirolimus|sirolimus|mesh-list
64939506|NCT00016601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64939583|NCT00129363|Antioxidants|antioxidants|mesh-ancestor
64939655|NCT00017147|Carmustine|carmustine|mesh-list
64940177|NCT00019383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64940326|NCT05576675|Sufentanil|sufentanil|mesh-list
64940405|NCT00020748|Irinotecan|irinotecan|mesh-list
64993778|NCT00125151|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64993779|NCT00125151|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64993780|NCT00125151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64993781|NCT00125151|Immunologic Factors|immunologic factors|mesh-ancestor
64993782|NCT00125151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993784|NCT00087815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64993785|NCT00087815|Antiemetics|antiemetics|mesh-ancestor
64993786|NCT00087815|Autonomic Agents|autonomic agents|mesh-ancestor
64993787|NCT00087815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64993788|NCT00087815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993789|NCT00087815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64993790|NCT00087815|Glucocorticoids|glucocorticoids|mesh-ancestor
65344737|NCT00732420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344738|NCT00732420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344739|NCT00735228|Pancrelipase|pancrelipase|mesh-list
65344740|NCT00735228|Pancreatin|pancreatin|mesh-list
65344741|NCT00735228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65344742|NCT00739128|Vaccines|vaccines|mesh-list
65344743|NCT00739128|Immunologic Factors|immunologic factors|mesh-ancestor
65344744|NCT00739128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344745|NCT00863668|Tenofovir|tenofovir|mesh-list
65344746|NCT00863668|Emtricitabine|emtricitabine|mesh-list
65344747|NCT00863668|Efavirenz|efavirenz|mesh-list
65344748|NCT00863668|Raltegravir Potassium|raltegravir potassium|mesh-list
65344749|NCT00863668|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65344750|NCT00863668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
64993791|NCT00087815|Hormones|hormones|mesh-ancestor
64993792|NCT00087815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64993793|NCT00087815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64993820|NCT00126906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64993822|NCT00088049|Olanzapine|olanzapine|mesh-list
64993823|NCT00088049|Aripiprazole|aripiprazole|mesh-list
64993824|NCT00088049|Antiemetics|antiemetics|mesh-ancestor
64993825|NCT00088049|Autonomic Agents|autonomic agents|mesh-ancestor
64993826|NCT00088049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64993827|NCT00088049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993828|NCT00088049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64993829|NCT00088049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64993830|NCT00088049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64993831|NCT00088049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64993832|NCT00088049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64993833|NCT00088049|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64993834|NCT00088049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64993835|NCT00088049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64993836|NCT00088049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993837|NCT00088049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64993838|NCT00088049|Serotonin Agents|serotonin agents|mesh-ancestor
64993839|NCT00088049|Antidepressive Agents|antidepressive agents|mesh-ancestor
64993840|NCT00088049|Dopamine Agonists|dopamine agonists|mesh-ancestor
64993841|NCT00088049|Dopamine Agents|dopamine agents|mesh-ancestor
64993842|NCT00088049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64993862|NCT00125307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993864|NCT00127023|Immunologic Factors|immunologic factors|mesh-ancestor
64993865|NCT00127023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993866|NCT00332761|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
64993867|NCT00332761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64993868|NCT00332761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64993869|NCT00332761|Antimetabolites|antimetabolites|mesh-ancestor
64993870|NCT00332761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993871|NCT00332761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64993872|NCT00332761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64993873|NCT00332761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64993874|NCT00332761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64993875|NCT00332761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64993876|NCT00332761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993877|NCT00332761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64993878|NCT00332761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993879|NCT00332995|Dapivirine|dapivirine|mesh-list
64993880|NCT00332995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64993881|NCT00332995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64993882|NCT00332995|Antiviral Agents|antiviral agents|mesh-ancestor
65344751|NCT00863668|Integrase Inhibitors|integrase inhibitors|mesh-list
65344752|NCT00863668|Antiviral Agents|antiviral agents|mesh-ancestor
64726610|NCT00002287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993883|NCT00332995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64993884|NCT00333034|Etanercept|etanercept|mesh-list
64993885|NCT00333034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64993886|NCT00333034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64993887|NCT00333034|Analgesics|analgesics|mesh-ancestor
64993888|NCT00333034|Sensory System Agents|sensory system agents|mesh-ancestor
64993889|NCT00333034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64993890|NCT00333034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993891|NCT00333034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64993892|NCT00333034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64993893|NCT00333034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64993894|NCT00333034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64993895|NCT00333034|Immunologic Factors|immunologic factors|mesh-ancestor
64993896|NCT00088478|Olanzapine|olanzapine|mesh-list
64993923|NCT00333112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993925|NCT00333112|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64993926|NCT00333112|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64993927|NCT00333112|Cholinergic Agents|cholinergic agents|mesh-ancestor
64993928|NCT00333151|Metformin|metformin|mesh-list
64993929|NCT00333151|Liraglutide|liraglutide|mesh-list
64993930|NCT00333151|Rosiglitazone|rosiglitazone|mesh-list
64993931|NCT00333151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64993932|NCT00333151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993933|NCT00333151|Incretins|incretins|mesh-ancestor
64993934|NCT00333151|Hormones|hormones|mesh-ancestor
64993935|NCT00333151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64993936|NCT00125385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64993937|NCT00125385|Immunologic Factors|immunologic factors|mesh-ancestor
64993938|NCT00125385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993939|NCT00088556|Paclitaxel|paclitaxel|mesh-list
64993940|NCT00088556|Carboplatin|carboplatin|mesh-list
64993941|NCT00088556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64993942|NCT00088556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993943|NCT00088556|Tubulin Modulators|tubulin modulators|mesh-ancestor
64993970|NCT00125424|GABA Agents|gaba agents|mesh-ancestor
64993971|NCT00125424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64993972|NCT00125424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993973|NCT00333346|Tramadol|tramadol|mesh-list
64993974|NCT00333346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64993975|NCT00333346|Narcotics|narcotics|mesh-ancestor
64993976|NCT00333346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64993977|NCT00333346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993978|NCT00333346|Analgesics|analgesics|mesh-ancestor
64993979|NCT00333346|Sensory System Agents|sensory system agents|mesh-ancestor
64993980|NCT00333346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64993981|NCT00333385|Ceftazidime|ceftazidime|mesh-list
64993982|NCT00333385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64993983|NCT00333385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64993984|NCT00127257|Diazepam|diazepam|mesh-list
64993985|NCT00127257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64993986|NCT00127257|Anticonvulsants|anticonvulsants|mesh-ancestor
64993987|NCT00127257|Antiemetics|antiemetics|mesh-ancestor
64993988|NCT00127257|Autonomic Agents|autonomic agents|mesh-ancestor
64993989|NCT00127257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64993990|NCT00127257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993991|NCT00127257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64993992|NCT00127257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64464565|NCT01892644|Chelating Agents|chelating agents|mesh-ancestor
64994019|NCT00088946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994020|NCT00421018|Montelukast|montelukast|mesh-list
64994021|NCT00421018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64994022|NCT00421018|Respiratory System Agents|respiratory system agents|mesh-ancestor
64994023|NCT00421018|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64994024|NCT00421018|Hormone Antagonists|hormone antagonists|mesh-ancestor
64994025|NCT00421018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64994026|NCT00421018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994027|NCT00421018|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64994028|NCT00421018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64994029|NCT00421018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994030|NCT00421096|Gemcitabine|gemcitabine|mesh-list
65344753|NCT00863668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65344754|NCT00863668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65344755|NCT00863668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344756|NCT00863668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344757|NCT00863668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65344758|NCT00863668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65344759|NCT00863668|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65344760|NCT00863668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65344761|NCT00863668|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65344762|NCT00863668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65344763|NCT00863668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65344764|NCT00863668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65344765|NCT00863668|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65344766|NCT00872248|Anesthetics|anesthetics|mesh-list
65344767|NCT00872248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65344768|NCT00872248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344769|NCT00732576|Vitamin K 2|vitamin k 2|mesh-list
65344770|NCT00732576|Vitamin K|vitamin k|mesh-list
65344771|NCT00732576|Vitamin MK 7|vitamin mk 7|mesh-list
64994031|NCT00421096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994032|NCT00421096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64994033|NCT00421096|Antimetabolites|antimetabolites|mesh-ancestor
64994034|NCT00421096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994035|NCT00421096|Antiviral Agents|antiviral agents|mesh-ancestor
64994036|NCT00421096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64994037|NCT00421096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994038|NCT00421096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64994067|NCT00334126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64994068|NCT00334126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64994069|NCT00334126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64994070|NCT00334126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994071|NCT00334126|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64994072|NCT00334126|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64994074|NCT00334126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64994075|NCT00334126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994076|NCT00334126|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64994077|NCT00334126|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64994078|NCT00334126|Dopamine Agents|dopamine agents|mesh-ancestor
64994079|NCT00089219|Sargramostim|sargramostim|mesh-list
64994080|NCT00089219|Freund's Adjuvant|freund's adjuvant|mesh-list
64994081|NCT00089219|Immunologic Factors|immunologic factors|mesh-ancestor
64994082|NCT00089219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464670|NCT02762266|Ethiodized Oil|ethiodized oil|mesh-list
64994108|NCT00334360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64994109|NCT00334360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64994110|NCT00334360|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64994111|NCT00334360|Serotonin Agents|serotonin agents|mesh-ancestor
64994112|NCT00334399|Miglitol|miglitol|mesh-list
64994113|NCT00334399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994114|NCT00334399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994115|NCT00334399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64994116|NCT00334399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994117|NCT00334399|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65344772|NCT00732576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65344773|NCT00732576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65344774|NCT00732576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344775|NCT00732576|Hemostatics|hemostatics|mesh-ancestor
65344776|NCT00732576|Coagulants|coagulants|mesh-ancestor
65344777|NCT00732576|Vitamins|vitamins|mesh-ancestor
65344778|NCT00732576|Micronutrients|micronutrients|mesh-ancestor
65344779|NCT00732576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344780|NCT00863902|Cetirizine|cetirizine|mesh-list
65344781|NCT00863902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64726637|NCT00384020|Citalopram|citalopram|mesh-list
64994118|NCT00334438|Rituximab|rituximab|mesh-list
64994119|NCT00334438|Bortezomib|bortezomib|mesh-list
64994120|NCT00334438|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64994121|NCT00334438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64994122|NCT00334438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994123|NCT00334438|Immunologic Factors|immunologic factors|mesh-ancestor
64994124|NCT00334438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994125|NCT00334438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64994126|NCT00334477|Tadalafil|tadalafil|mesh-list
64994127|NCT00334477|Vasodilator Agents|vasodilator agents|mesh-ancestor
64994128|NCT00334477|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64994129|NCT00334477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64994130|NCT00334477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994131|NCT00334477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994160|NCT00127569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994161|NCT00127569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64994162|NCT00334594|Pemetrexed|pemetrexed|mesh-list
64994163|NCT00334594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994164|NCT00334594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994165|NCT00334594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994166|NCT00334594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64994167|NCT00334594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64994168|NCT00334672|Cyclosporine|cyclosporine|mesh-list
64994169|NCT00334672|Mycophenolic Acid|mycophenolic acid|mesh-list
64994170|NCT00334672|Dexamethasone|dexamethasone|mesh-list
64994171|NCT00334672|Hydrocortisone|hydrocortisone|mesh-list
64994172|NCT00334672|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64994173|NCT00334672|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64994174|NCT00334672|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64994175|NCT00334672|Cyclophosphamide|cyclophosphamide|mesh-list
64994176|NCT00334672|Busulfan|busulfan|mesh-list
64994177|NCT00334672|Methotrexate|methotrexate|mesh-list
64994178|NCT00334672|Etoposide|etoposide|mesh-list
64994179|NCT00334672|Cyclosporins|cyclosporins|mesh-list
64994180|NCT00334672|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64994214|NCT00334672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64994215|NCT00334672|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64994216|NCT00334672|Antitubercular Agents|antitubercular agents|mesh-ancestor
64994217|NCT00334672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64994218|NCT00089453|Dexamethasone|dexamethasone|mesh-list
64464818|NCT02707588|Cetuximab|cetuximab|mesh-list
64994251|NCT00127686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64994252|NCT00127686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64994253|NCT00127686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64994254|NCT00127686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994255|NCT00127686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994256|NCT00334789|Vitamin A|vitamin a|mesh-list
64994257|NCT00334789|Tretinoin|tretinoin|mesh-list
64994258|NCT00334789|Belinostat|belinostat|mesh-list
64994259|NCT00334789|Isotretinoin|isotretinoin|mesh-list
64994260|NCT00334789|Vitamins|vitamins|mesh-ancestor
64994261|NCT00334789|Micronutrients|micronutrients|mesh-ancestor
64994262|NCT00334789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994299|NCT04715152|Dexamethasone acetate|dexamethasone acetate|mesh-list
64994300|NCT04715152|Levobupivacaine|levobupivacaine|mesh-list
64994301|NCT04715152|BB 1101|bb 1101|mesh-list
64994302|NCT04715152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64994303|NCT04715152|Antiemetics|antiemetics|mesh-ancestor
65344782|NCT00863902|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65344783|NCT00863902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65344784|NCT00863902|Histamine Antagonists|histamine antagonists|mesh-ancestor
65344785|NCT00863902|Histamine Agents|histamine agents|mesh-ancestor
65344786|NCT00863902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64726641|NCT00384020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64994304|NCT04715152|Autonomic Agents|autonomic agents|mesh-ancestor
64994330|NCT00089570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64994331|NCT00089570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64994332|NCT00342862|Alefacept|alefacept|mesh-list
64994333|NCT00342862|Dermatologic Agents|dermatologic agents|mesh-ancestor
64994334|NCT00342862|Immunologic Factors|immunologic factors|mesh-ancestor
64994335|NCT00342862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994336|NCT00089687|Vanoxerine|vanoxerine|mesh-list
64994337|NCT00089687|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64994338|NCT00089687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64994339|NCT00089687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64994340|NCT00089687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994341|NCT00089687|Dopamine Agents|dopamine agents|mesh-ancestor
64994342|NCT00089687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64994343|NCT00089687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994344|NCT00127764|Dexamethasone|dexamethasone|mesh-list
64994345|NCT00127764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64994346|NCT00127764|Antiemetics|antiemetics|mesh-ancestor
64994347|NCT00127764|Autonomic Agents|autonomic agents|mesh-ancestor
64994348|NCT00127764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64994349|NCT00127764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994350|NCT00127764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64994351|NCT00127764|Glucocorticoids|glucocorticoids|mesh-ancestor
64994352|NCT00127764|Hormones|hormones|mesh-ancestor
64994373|NCT00343096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64994374|NCT00343096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64994375|NCT00343096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64994376|NCT00343096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64994377|NCT00343096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64994378|NCT00343096|GABA Modulators|gaba modulators|mesh-ancestor
64994380|NCT00343096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64994381|NCT00343096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994383|NCT00335179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64994384|NCT00335179|Immunologic Factors|immunologic factors|mesh-ancestor
64994385|NCT00335179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994386|NCT00335179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994387|NCT00335179|Interferon Inducers|interferon inducers|mesh-ancestor
64994388|NCT00089765|Ranibizumab|ranibizumab|mesh-list
64994389|NCT00089765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64994390|NCT00089765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64994391|NCT00089765|Growth Substances|growth substances|mesh-ancestor
64994392|NCT00089765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994393|NCT00089765|Growth Inhibitors|growth inhibitors|mesh-ancestor
64994394|NCT00089765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994395|NCT00343135|Amoxicillin|amoxicillin|mesh-list
64994396|NCT00343135|Clavulanic Acid|clavulanic acid|mesh-list
64994397|NCT00343135|Clavulanic Acids|clavulanic acids|mesh-list
64994398|NCT00343135|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64994399|NCT00343135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64994400|NCT00343135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64994401|NCT00343135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64994402|NCT00343135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994403|NCT00343135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994405|NCT00343174|Anticoagulants|anticoagulants|mesh-ancestor
64994406|NCT00343174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64464977|NCT03012880|Dexamethasone|dexamethasone|mesh-list
64994440|NCT00343369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64994441|NCT00343369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64994442|NCT00343369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64994443|NCT00343369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64994444|NCT00343369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994445|NCT00343369|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64994446|NCT00343369|Abortifacient Agents|abortifacient agents|mesh-ancestor
65344787|NCT00863902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344788|NCT00863902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344789|NCT00732810|Capecitabine|capecitabine|mesh-list
65344790|NCT00732810|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65344791|NCT00732810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65344792|NCT00732810|Antimetabolites|antimetabolites|mesh-ancestor
65344793|NCT00732810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344794|NCT00732810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994447|NCT00343369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64994448|NCT00343369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64994449|NCT00343369|Antimetabolites|antimetabolites|mesh-ancestor
64994450|NCT00343369|Dermatologic Agents|dermatologic agents|mesh-ancestor
64465029|NCT03007732|Ascorbic Acid|ascorbic acid|mesh-list
64994469|NCT00343408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994471|NCT00343408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64994472|NCT00343408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994473|NCT00343408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64994474|NCT00343408|Immunologic Factors|immunologic factors|mesh-ancestor
64994475|NCT00343408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994476|NCT00343408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64994477|NCT00343408|Antidotes|antidotes|mesh-ancestor
64994478|NCT00343408|Protective Agents|protective agents|mesh-ancestor
64994479|NCT00343408|Vitamin B Complex|vitamin b complex|mesh-ancestor
64994480|NCT00343408|Vitamins|vitamins|mesh-ancestor
64994481|NCT00343408|Micronutrients|micronutrients|mesh-ancestor
64994482|NCT00343408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64994483|NCT02958111|Capecitabine|capecitabine|mesh-list
64994484|NCT02958111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64994485|NCT02958111|Antimetabolites|antimetabolites|mesh-ancestor
64994486|NCT02958111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994487|NCT02958111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994488|NCT00343447|Cyclophosphamide|cyclophosphamide|mesh-list
64994489|NCT00343447|Rituximab|rituximab|mesh-list
64994490|NCT00343447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64994491|NCT00343447|Immunologic Factors|immunologic factors|mesh-ancestor
64994492|NCT00343447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994493|NCT00343447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64994494|NCT00343447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64994495|NCT00343447|Alkylating Agents|alkylating agents|mesh-ancestor
64994496|NCT00343447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994497|NCT00343447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994498|NCT00343447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64994499|NCT00343447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64994500|NCT00343486|Solabegron|solabegron|mesh-list
64994501|NCT00343486|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64994502|NCT00343486|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64994503|NCT00343486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64994504|NCT00343486|Adrenergic Agents|adrenergic agents|mesh-ancestor
64994505|NCT00343486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64994506|NCT00343486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994507|NCT00343486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994538|NCT00343798|Cyclosporins|cyclosporins|mesh-list
64994539|NCT00343798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64994540|NCT00343798|Immunologic Factors|immunologic factors|mesh-ancestor
64994541|NCT00343798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994542|NCT00343798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64994543|NCT00343798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64994544|NCT00343798|Alkylating Agents|alkylating agents|mesh-ancestor
64994545|NCT00343798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994546|NCT00343798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994547|NCT00343798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64994548|NCT00343798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64994549|NCT00343798|Antimetabolites|antimetabolites|mesh-ancestor
64994550|NCT00343798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344795|NCT00732810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65344796|NCT00732810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344797|NCT00732888|Calcium Carbonate|calcium carbonate|mesh-list
65344798|NCT00732888|Calcium|calcium|mesh-list
65344799|NCT00732888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65344800|NCT00732888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344801|NCT00732888|Antacids|antacids|mesh-ancestor
64994551|NCT00343798|Antifungal Agents|antifungal agents|mesh-ancestor
64465129|NCT01884571|Tacrolimus|tacrolimus|mesh-list
64994585|NCT00402636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994586|NCT00402636|Antifungal Agents|antifungal agents|mesh-ancestor
64994587|NCT00402636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64994588|NCT00402636|Immunologic Factors|immunologic factors|mesh-ancestor
64994589|NCT00402636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994590|NCT00344149|Rituximab|rituximab|mesh-list
64994591|NCT00344149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64465175|NCT04121416|Sufentanil|sufentanil|mesh-list
64994619|NCT00344383|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64994620|NCT00344383|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64994621|NCT00344422|Dexamethasone|dexamethasone|mesh-list
64994622|NCT00344422|Dexamethasone acetate|dexamethasone acetate|mesh-list
64994623|NCT00344422|Doxorubicin|doxorubicin|mesh-list
64994624|NCT00344422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64994625|NCT00344422|Vincristine|vincristine|mesh-list
64994626|NCT00344422|BB 1101|bb 1101|mesh-list
64994627|NCT00344422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64994628|NCT00344422|Antiemetics|antiemetics|mesh-ancestor
64994629|NCT00344422|Autonomic Agents|autonomic agents|mesh-ancestor
64994630|NCT00344422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64994631|NCT00344422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994632|NCT00344422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64994633|NCT00344422|Glucocorticoids|glucocorticoids|mesh-ancestor
64994634|NCT00344422|Hormones|hormones|mesh-ancestor
64994635|NCT00344422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64994636|NCT00344422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64994637|NCT00344422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994638|NCT00344422|Protease Inhibitors|protease inhibitors|mesh-ancestor
64994639|NCT00344422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994662|NCT00402792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994663|NCT00402792|Antipyretics|antipyretics|mesh-ancestor
64994664|NCT00402792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64994665|NCT00402792|Narcotics|narcotics|mesh-ancestor
64994666|NCT00402792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64994667|NCT00402792|Antitussive Agents|antitussive agents|mesh-ancestor
64994668|NCT00402792|Respiratory System Agents|respiratory system agents|mesh-ancestor
64994669|NCT00402792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64994670|NCT00402792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64994671|NCT00402792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64994672|NCT00127959|Tenofovir|tenofovir|mesh-list
64994673|NCT00127959|Zidovudine|zidovudine|mesh-list
64994674|NCT00127959|Emtricitabine|emtricitabine|mesh-list
64994675|NCT00127959|Efavirenz|efavirenz|mesh-list
64994676|NCT00127959|Antiviral Agents|antiviral agents|mesh-ancestor
64994677|NCT00127959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64994678|NCT00127959|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64994679|NCT00127959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64994680|NCT00127959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994681|NCT00127959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994682|NCT00127959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64994683|NCT00127959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64994684|NCT00127959|Antimetabolites|antimetabolites|mesh-ancestor
64994685|NCT00127959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64994686|NCT00127959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64994687|NCT00127959|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64994688|NCT00127959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64994689|NCT00127959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64994690|NCT00127959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64994691|NCT00344539|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64994728|NCT00127998|Amebicides|amebicides|mesh-ancestor
64994729|NCT00127998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65344802|NCT00732888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344803|NCT00732888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65344804|NCT00732966|Losartan|losartan|mesh-list
65344805|NCT00732966|Valsartan|valsartan|mesh-list
65344806|NCT00732966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64726662|NCT00002557|Levoleucovorin|levoleucovorin|mesh-list
64994730|NCT00127998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64994731|NCT00127998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994732|NCT00127998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994752|NCT00344695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64994753|NCT00344695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994754|NCT00344695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64994755|NCT00344695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64994756|NCT00344695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994757|NCT00128037|Mitomycins|mitomycins|mesh-list
64994758|NCT00128037|Mitomycin|mitomycin|mesh-list
64994759|NCT00128037|Vindesine|vindesine|mesh-list
64994760|NCT00128037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994761|NCT00128037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64994762|NCT00128037|Alkylating Agents|alkylating agents|mesh-ancestor
64994763|NCT00128037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994764|NCT00128037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64994765|NCT00128037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994766|NCT00128037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64994767|NCT00128037|Tubulin Modulators|tubulin modulators|mesh-ancestor
64994768|NCT00128037|Antimitotic Agents|antimitotic agents|mesh-ancestor
64994769|NCT00128037|Mitosis Modulators|mitosis modulators|mesh-ancestor
64994770|NCT00344734|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
64994771|NCT00344734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994772|NCT00344734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994773|NCT00344812|Buprenorphine|buprenorphine|mesh-list
64994774|NCT00344812|Methadone|methadone|mesh-list
64994775|NCT00344812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64994776|NCT00344812|Narcotics|narcotics|mesh-ancestor
64994777|NCT00344812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64994778|NCT00344812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994779|NCT00344812|Analgesics|analgesics|mesh-ancestor
64994780|NCT00344812|Sensory System Agents|sensory system agents|mesh-ancestor
64994805|NCT00090155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994807|NCT00090155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64994808|NCT00090155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64994809|NCT00090155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64994810|NCT00090155|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64994811|NCT00090155|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64994812|NCT00335413|Spironolactone|spironolactone|mesh-list
64994813|NCT00335413|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64994814|NCT00335413|Hormone Antagonists|hormone antagonists|mesh-ancestor
64994815|NCT00335413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64994816|NCT00335413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994817|NCT00335413|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64994818|NCT00335413|Diuretics|diuretics|mesh-ancestor
64994819|NCT00335413|Natriuretic Agents|natriuretic agents|mesh-ancestor
64994820|NCT00090194|Immunoglobulins|immunoglobulins|mesh-list
64994821|NCT00090194|Antibodies|antibodies|mesh-list
64994822|NCT00090194|gamma-Globulins|gamma-globulins|mesh-list
64994823|NCT00090194|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64994824|NCT00090194|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64994825|NCT00090194|Immunologic Factors|immunologic factors|mesh-ancestor
64994826|NCT00090194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994827|NCT00345163|Bevacizumab|bevacizumab|mesh-list
64994829|NCT00345163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64994830|NCT00345163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994831|NCT00345163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64994832|NCT00345163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64994833|NCT00345163|Growth Substances|growth substances|mesh-ancestor
64994856|NCT00335647|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64994857|NCT00335647|Dopamine Agents|dopamine agents|mesh-ancestor
64994858|NCT00335647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65222785|NCT02700711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65344807|NCT00732966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65344808|NCT00732966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65344809|NCT00732966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344810|NCT00732966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65344811|NCT02568618|Analgesics|analgesics|mesh-list
65344812|NCT02568618|Sensory System Agents|sensory system agents|mesh-ancestor
65344813|NCT02568618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65344814|NCT02568618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344815|NCT00735852|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65344816|NCT00735852|Luteolytic Agents|luteolytic agents|mesh-ancestor
64994859|NCT00335647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994860|NCT00128154|Chromium|chromium|mesh-list
64994861|NCT00128154|Picolinic acid|picolinic acid|mesh-list
64994862|NCT00128154|Trace Elements|trace elements|mesh-ancestor
64994863|NCT00128154|Micronutrients|micronutrients|mesh-ancestor
64994864|NCT00128154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994865|NCT00128154|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64994866|NCT00128154|Chelating Agents|chelating agents|mesh-ancestor
64994867|NCT00128154|Sequestering Agents|sequestering agents|mesh-ancestor
64994868|NCT00128154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994869|NCT00335686|Lopinavir|lopinavir|mesh-list
64994870|NCT00335686|Nevirapine|nevirapine|mesh-list
64994871|NCT00335686|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64994872|NCT00335686|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64994873|NCT00335686|Protease Inhibitors|protease inhibitors|mesh-ancestor
64994874|NCT00335686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994875|NCT00335686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994876|NCT00335686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64994877|NCT00335686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64994878|NCT00335686|Antiviral Agents|antiviral agents|mesh-ancestor
64994879|NCT00335686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64994880|NCT00335686|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64994881|NCT00335686|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64994882|NCT00335686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64994883|NCT00335686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64994884|NCT00335686|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64994920|NCT02959762|Vitamin K 2|vitamin k 2|mesh-list
64994921|NCT02959762|Vitamin MK 7|vitamin mk 7|mesh-list
64994922|NCT02959762|Micronutrients|micronutrients|mesh-ancestor
64994923|NCT02959762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994924|NCT02959762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64994925|NCT02959762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64465508|NCT01450774|Adrenergic Agents|adrenergic agents|mesh-ancestor
64994947|NCT00346099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64994949|NCT00125736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64994950|NCT00125736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64994951|NCT00125736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64994952|NCT00125736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994953|NCT00125736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994954|NCT00090428|Caseins|caseins|mesh-list
64994955|NCT00090428|Chelating Agents|chelating agents|mesh-ancestor
64994956|NCT00090428|Sequestering Agents|sequestering agents|mesh-ancestor
64994957|NCT00090428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994958|NCT00346255|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
64994959|NCT00346255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64994960|NCT00346255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994961|NCT00346255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64994962|NCT00346294|Etanercept|etanercept|mesh-list
64994963|NCT00346294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64994964|NCT00346294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64994965|NCT00346294|Analgesics|analgesics|mesh-ancestor
64994966|NCT00346294|Sensory System Agents|sensory system agents|mesh-ancestor
64994967|NCT00346294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65344817|NCT00735852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65344818|NCT00735852|Contraceptive Agents|contraceptive agents|mesh-ancestor
65344819|NCT00735852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64726678|NCT00002557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64994968|NCT00346294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994969|NCT00346294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64994970|NCT00346294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64994971|NCT00346294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64994972|NCT00346294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64994973|NCT00346294|Immunologic Factors|immunologic factors|mesh-ancestor
64994974|NCT00346489|Fluorouracil|fluorouracil|mesh-list
64994975|NCT00346489|Mitomycins|mitomycins|mesh-list
64994976|NCT00346489|Mitomycin|mitomycin|mesh-list
64994977|NCT00346489|Antimetabolites|antimetabolites|mesh-ancestor
64994978|NCT00346489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994995|NCT00125814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994996|NCT00346567|Tenofovir|tenofovir|mesh-list
64994997|NCT00346567|Lamivudine|lamivudine|mesh-list
64994998|NCT00346567|Zidovudine|zidovudine|mesh-list
64994999|NCT00346567|Emtricitabine|emtricitabine|mesh-list
64995000|NCT00346567|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64995001|NCT00346567|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64995002|NCT00346567|Antiviral Agents|antiviral agents|mesh-ancestor
64995003|NCT00346567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64995004|NCT00346567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64995005|NCT00346567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64995006|NCT00346567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995007|NCT00346567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995008|NCT00346567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64995009|NCT00346567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64995010|NCT00346567|Antimetabolites|antimetabolites|mesh-ancestor
64995011|NCT00090623|Ranibizumab|ranibizumab|mesh-list
64995012|NCT00090623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64995013|NCT00090623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64995014|NCT00090623|Growth Substances|growth substances|mesh-ancestor
64995015|NCT00090623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995016|NCT00090623|Growth Inhibitors|growth inhibitors|mesh-ancestor
64995017|NCT00090623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995018|NCT02957994|Tenofovir|tenofovir|mesh-list
64995019|NCT02957994|Antiviral Agents|antiviral agents|mesh-ancestor
64995020|NCT02957994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64995021|NCT02957994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64995022|NCT02957994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64995023|NCT02957994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995024|NCT02957994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995025|NCT02957994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64995026|NCT02957994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64995027|NCT00346645|Bortezomib|bortezomib|mesh-list
64995028|NCT00346645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995029|NCT00346684|Rituximab|rituximab|mesh-list
64995030|NCT00346684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64995031|NCT00346684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995032|NCT00346684|Immunologic Factors|immunologic factors|mesh-ancestor
64995033|NCT00346684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995034|NCT00346684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64995035|NCT04728932|Simendan|simendan|mesh-list
64995036|NCT04728932|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64995037|NCT04728932|Vasodilator Agents|vasodilator agents|mesh-ancestor
64465600|NCT01452568|Antipyretics|antipyretics|mesh-ancestor
64995063|NCT00346801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995064|NCT00346801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995065|NCT00346801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64995066|NCT00346801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64995067|NCT00346801|Analgesics|analgesics|mesh-ancestor
64995068|NCT00346801|Sensory System Agents|sensory system agents|mesh-ancestor
64995069|NCT00346801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64995070|NCT00346801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995071|NCT00346801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64995072|NCT00346801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64995073|NCT00346801|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64995074|NCT00346801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65344820|NCT00735852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344821|NCT00735852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65344822|NCT00735852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65344823|NCT00735852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344824|NCT00424021|Ambrisentan|ambrisentan|mesh-list
65344825|NCT00424021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65344826|NCT00735930|Lenalidomide|lenalidomide|mesh-list
65344827|NCT00735930|Alvocidib|alvocidib|mesh-list
65344828|NCT00735930|Immunologic Factors|immunologic factors|mesh-ancestor
64726682|NCT00002557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64726683|NCT00002557|Antidotes|antidotes|mesh-ancestor
64726684|NCT00002557|Protective Agents|protective agents|mesh-ancestor
64726685|NCT00002557|Vitamin B Complex|vitamin b complex|mesh-ancestor
64726686|NCT00002557|Vitamins|vitamins|mesh-ancestor
64726687|NCT00002557|Micronutrients|micronutrients|mesh-ancestor
64726688|NCT00003158|Paclitaxel|paclitaxel|mesh-list
64726689|NCT00003158|Etoposide|etoposide|mesh-list
64726690|NCT00003158|Carboplatin|carboplatin|mesh-list
64995075|NCT00346840|Misoprostol|misoprostol|mesh-list
64995076|NCT00346840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64995077|NCT00346840|Abortifacient Agents|abortifacient agents|mesh-ancestor
64995078|NCT00346840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64995079|NCT00346840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995080|NCT00346840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64995081|NCT00346840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64995082|NCT00346840|Oxytocics|oxytocics|mesh-ancestor
64995084|NCT00346879|Fondaparinux|fondaparinux|mesh-list
64995108|NCT00346918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64995109|NCT00346918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64995110|NCT00346918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995111|NCT00346918|Antifungal Agents|antifungal agents|mesh-ancestor
64995112|NCT00346918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64995113|NCT00346918|Immunologic Factors|immunologic factors|mesh-ancestor
64995114|NCT00346918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995115|NCT00346957|Hydrocortisone|hydrocortisone|mesh-list
64995116|NCT00346957|Anecortave|anecortave|mesh-list
64995117|NCT00346957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64995118|NCT00346957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64995119|NCT00346957|Growth Substances|growth substances|mesh-ancestor
64995120|NCT00346957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995121|NCT00346957|Growth Inhibitors|growth inhibitors|mesh-ancestor
64995122|NCT00346957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995123|NCT00346957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64995124|NCT00346996|Insulin|insulin|mesh-list
64995125|NCT00346996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64995126|NCT00346996|Insulin Detemir|insulin detemir|mesh-list
64995127|NCT00346996|Isophane Insulin, Human|isophane insulin, human|mesh-list
64995128|NCT00346996|Insulin, Isophane|insulin, isophane|mesh-list
64995129|NCT00346996|Isophane insulin, beef|isophane insulin, beef|mesh-list
64995130|NCT00346996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64995131|NCT00346996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995132|NCT00402480|Hydroxyurea|hydroxyurea|mesh-list
64995133|NCT00402480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995134|NCT00402480|Antisickling Agents|antisickling agents|mesh-ancestor
64995135|NCT00402480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995136|NCT00402480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995158|NCT00347113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995159|NCT00347113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995160|NCT00347152|Valproic Acid|valproic acid|mesh-list
64995161|NCT00347152|Anticonvulsants|anticonvulsants|mesh-ancestor
64995162|NCT00347152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344829|NCT00735930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344830|NCT00735930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65344831|NCT00735930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65344832|NCT00735930|Growth Substances|growth substances|mesh-ancestor
64995163|NCT00347152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995164|NCT00347152|GABA Agents|gaba agents|mesh-ancestor
64995165|NCT00347152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64995166|NCT00347152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995167|NCT00347152|Antimanic Agents|antimanic agents|mesh-ancestor
64995168|NCT00347152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64995169|NCT00347152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64995170|NCT00347152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64995171|NCT00090896|Ipilimumab|ipilimumab|mesh-list
64995172|NCT00090896|Antibodies|antibodies|mesh-list
64995173|NCT00090896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64995174|NCT00090896|Immunologic Factors|immunologic factors|mesh-ancestor
64995175|NCT00090896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995176|NCT00090896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64995177|NCT00090896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995178|NCT00090896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64995179|NCT00090896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995180|NCT00402558|Aldesleukin|aldesleukin|mesh-list
64995181|NCT00402558|Methotrexate|methotrexate|mesh-list
64995182|NCT00402558|Fludarabine phosphate|fludarabine phosphate|mesh-list
64995183|NCT00402558|Fludarabine|fludarabine|mesh-list
64995184|NCT00402558|Busulfan|busulfan|mesh-list
64995185|NCT00402558|Interleukin-2|interleukin-2|mesh-list
64995186|NCT00402558|Tacrolimus|tacrolimus|mesh-list
64995187|NCT00402558|Thymoglobulin|thymoglobulin|mesh-list
64995188|NCT00402558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64995189|NCT00402558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64995190|NCT00402558|Abortifacient Agents|abortifacient agents|mesh-ancestor
64465758|NCT05021926|Anesthetics|anesthetics|mesh-ancestor
64995215|NCT00402558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64995216|NCT00347386|Zinc Sulfate|zinc sulfate|mesh-list
64995217|NCT00347386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995218|NCT00347386|Astringents|astringents|mesh-ancestor
64995219|NCT00347386|Dermatologic Agents|dermatologic agents|mesh-ancestor
64995220|NCT00347425|Olanzapine|olanzapine|mesh-list
64995221|NCT00347425|Risperidone|risperidone|mesh-list
64995222|NCT00347425|Aripiprazole|aripiprazole|mesh-list
64995223|NCT00347425|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64995224|NCT00347425|Ziprasidone|ziprasidone|mesh-list
64995225|NCT00347425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64995226|NCT00347425|Serotonin Agents|serotonin agents|mesh-ancestor
64995227|NCT00347425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64995228|NCT00347425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995229|NCT00347425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995230|NCT00347425|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64995231|NCT00347425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64995232|NCT00347425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64995233|NCT00347425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64995234|NCT00347425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64995235|NCT00347425|Dopamine Agents|dopamine agents|mesh-ancestor
64995236|NCT00347425|Antiemetics|antiemetics|mesh-ancestor
64995237|NCT00347425|Autonomic Agents|autonomic agents|mesh-ancestor
64995238|NCT00347425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64995239|NCT00347425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64995240|NCT00347425|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64995241|NCT00347425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64995268|NCT00347503|Bromfenac|bromfenac|mesh-list
64995269|NCT00347503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64995270|NCT00347503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64995271|NCT00347503|Analgesics|analgesics|mesh-ancestor
64995272|NCT00347503|Sensory System Agents|sensory system agents|mesh-ancestor
64995273|NCT00347503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64995274|NCT00347503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995275|NCT00347503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64995276|NCT00347503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64995277|NCT00347503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64995278|NCT00347503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995279|NCT00347503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995280|NCT00347542|Vitamin D|vitamin d|mesh-list
65344833|NCT00735930|Growth Inhibitors|growth inhibitors|mesh-ancestor
65344834|NCT00735930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344835|NCT00735930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65344836|NCT00735930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344837|NCT00735930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995281|NCT00347542|Vitamins|vitamins|mesh-ancestor
64995282|NCT00347542|Micronutrients|micronutrients|mesh-ancestor
64995283|NCT00347542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995284|NCT00347542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64995285|NCT00091052|Sargramostim|sargramostim|mesh-list
64995286|NCT00091052|Immunologic Factors|immunologic factors|mesh-ancestor
64995287|NCT00091052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995288|NCT00347581|Methamphetamine|methamphetamine|mesh-list
64995302|NCT00421252|Clopidogrel|clopidogrel|mesh-list
64995303|NCT00421252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64995304|NCT00421252|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64995305|NCT00421252|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64995306|NCT00421252|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64995307|NCT00421252|Purinergic Agents|purinergic agents|mesh-ancestor
64995308|NCT00421252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64995309|NCT00421252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995310|NCT00421252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995311|NCT00126204|Doxycycline|doxycycline|mesh-list
64995312|NCT00126204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64995313|NCT00126204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64995314|NCT00126204|Antimalarials|antimalarials|mesh-ancestor
64995315|NCT00126204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64995316|NCT00126204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64995317|NCT04705402|Mannitol|mannitol|mesh-list
64995318|NCT04705402|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64995319|NCT04705402|Diuretics|diuretics|mesh-ancestor
64995320|NCT04705402|Natriuretic Agents|natriuretic agents|mesh-ancestor
64995321|NCT04705402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995322|NCT00091130|Vaccines|vaccines|mesh-list
64995323|NCT00091130|Immunologic Factors|immunologic factors|mesh-ancestor
64995324|NCT00091130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995325|NCT00126243|Rituximab|rituximab|mesh-list
64995326|NCT00126243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64995327|NCT00126243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995328|NCT00126243|Immunologic Factors|immunologic factors|mesh-ancestor
64995329|NCT00126243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995330|NCT00126243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64995331|NCT00426439|Chloroquine|chloroquine|mesh-list
64995332|NCT00426439|Lumefantrine|lumefantrine|mesh-list
64995333|NCT00426439|Artemether|artemether|mesh-list
64995334|NCT00426439|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64995335|NCT00426439|Amebicides|amebicides|mesh-ancestor
64995336|NCT00426439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64995337|NCT00426439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64995338|NCT00426439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64995339|NCT00426439|Antimalarials|antimalarials|mesh-ancestor
64995340|NCT00426439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64995341|NCT00426478|Amlodipine|amlodipine|mesh-list
64995342|NCT00426478|Valsartan|valsartan|mesh-list
64995343|NCT00426478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64995344|NCT00426478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64995345|NCT00426478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64995346|NCT00426478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64995347|NCT00426478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995348|NCT00426478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64995349|NCT00426478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995377|NCT00126282|Antimetabolites|antimetabolites|mesh-ancestor
64995378|NCT00126282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995379|NCT04705129|Zanubrutinib|zanubrutinib|mesh-list
64995380|NCT04705129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995381|NCT04705129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64995382|NCT04705129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995383|NCT04705129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995384|NCT00126321|Cladribine|cladribine|mesh-list
64995385|NCT00126321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995386|NCT00126321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65344838|NCT00617734|Cetuximab|cetuximab|mesh-list
65344839|NCT00617734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65344840|NCT00617734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65344841|NCT00617734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995387|NCT00126321|Immunologic Factors|immunologic factors|mesh-ancestor
64995388|NCT00126321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995389|NCT00426595|Omeprazole|omeprazole|mesh-list
64995390|NCT00426595|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64995391|NCT00426595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64995392|NCT00426595|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64995393|NCT00426595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995394|NCT00426595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995395|NCT00426673|Brivaracetam|brivaracetam|mesh-list
64465997|NCT02538484|Letrozole|letrozole|mesh-list
64995414|NCT00126360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64995415|NCT00126360|Hormone Antagonists|hormone antagonists|mesh-ancestor
64995416|NCT00126360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64995417|NCT00126360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995418|NCT01058863|Albuterol|albuterol|mesh-list
64995419|NCT01058863|Procaterol|procaterol|mesh-list
64995420|NCT01058863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64995421|NCT01058863|Autonomic Agents|autonomic agents|mesh-ancestor
64995422|NCT01058863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64995423|NCT01058863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995424|NCT01058863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64995425|NCT01058863|Respiratory System Agents|respiratory system agents|mesh-ancestor
64995426|NCT01058863|Tocolytic Agents|tocolytic agents|mesh-ancestor
64995427|NCT01058863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64995428|NCT01058863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64995429|NCT01058863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64995430|NCT01058863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64995431|NCT01058863|Adrenergic Agents|adrenergic agents|mesh-ancestor
64995432|NCT01058863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64995433|NCT01058863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995434|NCT01058863|Sympathomimetics|sympathomimetics|mesh-ancestor
64995435|NCT00091286|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64995436|NCT00091286|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64995438|NCT00091286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995439|NCT00126399|Doxycycline|doxycycline|mesh-list
64995440|NCT00126399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64995441|NCT00126399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64995442|NCT00126399|Antimalarials|antimalarials|mesh-ancestor
64995443|NCT00126399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64995444|NCT00126399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64995445|NCT01058395|Minocycline|minocycline|mesh-list
64995446|NCT01058395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64995447|NCT01058395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64995448|NCT00091325|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
64995449|NCT00091325|Antioxidants|antioxidants|mesh-ancestor
64995450|NCT00091325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995451|NCT00091325|Protective Agents|protective agents|mesh-ancestor
64466037|NCT02523976|Cytarabine|cytarabine|mesh-list
64995479|NCT01058005|Glatiramer Acetate|glatiramer acetate|mesh-list
64995481|NCT01058005|(T,G)-A-L|(t,g)-a-l|mesh-list
64995482|NCT01058005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995483|NCT01058005|Antiviral Agents|antiviral agents|mesh-ancestor
64995484|NCT01058005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64995485|NCT01058005|Immunologic Factors|immunologic factors|mesh-ancestor
64995486|NCT01058005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995487|NCT01058005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64995488|NCT01058005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64995489|NCT01058005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64995490|NCT00091559|Vorinostat|vorinostat|mesh-list
64995491|NCT00091559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995492|NCT00091559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64995493|NCT00091559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995494|NCT00091559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995495|NCT00426829|Bevacizumab|bevacizumab|mesh-list
64995496|NCT00426829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64995497|NCT00426829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995498|NCT00426829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64995504|NCT00426946|Antidepressive Agents|antidepressive agents|mesh-ancestor
65344842|NCT00617734|Immunologic Factors|immunologic factors|mesh-ancestor
65344843|NCT00617734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344844|NCT00577460|Pramipexole|pramipexole|mesh-list
65344845|NCT00577460|Antioxidants|antioxidants|mesh-ancestor
64726706|NCT05751187|Pemetrexed|pemetrexed|mesh-list
64995505|NCT00426946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64995506|NCT00426946|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64995507|NCT00426946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64995508|NCT00426946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64995509|NCT00426946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995510|NCT00426946|Adrenergic Agents|adrenergic agents|mesh-ancestor
64995511|NCT00426946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64995512|NCT00426946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995514|NCT00091598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64995516|NCT00426985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64995517|NCT00426985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64995518|NCT00426985|Analgesics|analgesics|mesh-ancestor
64995519|NCT00426985|Sensory System Agents|sensory system agents|mesh-ancestor
64995520|NCT00426985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64995521|NCT00426985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995522|NCT00426985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64995523|NCT00426985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64995524|NCT00426985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64995525|NCT00426985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995526|NCT00426985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995527|NCT00427102|Cisplatin|cisplatin|mesh-list
64995528|NCT00427102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995529|NCT00427414|Daunorubicin|daunorubicin|mesh-list
64995530|NCT00427414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995531|NCT00427414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64995532|NCT00427414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995533|NCT00427414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64995534|NCT00427414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64995535|NCT00427414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995536|NCT03929718|Spironolactone|spironolactone|mesh-list
64995537|NCT03929718|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64995538|NCT03929718|Hormone Antagonists|hormone antagonists|mesh-ancestor
64995539|NCT03929718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64995540|NCT03929718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995541|NCT03929718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64995542|NCT03929718|Diuretics|diuretics|mesh-ancestor
64995543|NCT03929718|Natriuretic Agents|natriuretic agents|mesh-ancestor
64995544|NCT01056523|Cytarabine|cytarabine|mesh-list
64995545|NCT01056523|Ribavirin|ribavirin|mesh-list
64995546|NCT01056523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64995547|NCT01056523|Antimetabolites|antimetabolites|mesh-ancestor
64995548|NCT01056523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995549|NCT01056523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995550|NCT01056523|Antiviral Agents|antiviral agents|mesh-ancestor
64995551|NCT01056523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64995552|NCT01056523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64995553|NCT01056523|Immunologic Factors|immunologic factors|mesh-ancestor
64995554|NCT01056523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995555|NCT00091715|Bosentan|bosentan|mesh-list
64995556|NCT00091715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64995557|NCT00091715|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64995558|NCT00091715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995559|NCT00427492|Magnesium Oxide|magnesium oxide|mesh-list
64995560|NCT00427492|Antacids|antacids|mesh-ancestor
64995561|NCT00427492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995562|NCT00427492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64995563|NCT00427570|Fluorouracil|fluorouracil|mesh-list
64995564|NCT00427570|Vincristine|vincristine|mesh-list
64995565|NCT00427570|Semustine|semustine|mesh-list
64995566|NCT00427570|BCG Vaccine|bcg vaccine|mesh-list
64995567|NCT00427570|Antimetabolites|antimetabolites|mesh-ancestor
64995568|NCT00427570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466139|NCT02493322|Diuretics|diuretics|mesh-ancestor
64995602|NCT04704622|Analgesics|analgesics|mesh-ancestor
64995603|NCT04704622|Sensory System Agents|sensory system agents|mesh-ancestor
65344846|NCT00577460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344847|NCT00577460|Protective Agents|protective agents|mesh-ancestor
65344848|NCT00577460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344849|NCT00577460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65344850|NCT00577460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65344851|NCT00577460|Dopamine Agonists|dopamine agonists|mesh-ancestor
65344852|NCT00577460|Dopamine Agents|dopamine agents|mesh-ancestor
65344853|NCT00577460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64995604|NCT04704622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64995605|NCT04704622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64995606|NCT04704622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64995607|NCT04704622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64995608|NCT04704622|Adrenergic Agents|adrenergic agents|mesh-ancestor
64995609|NCT04704622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64995634|NCT00092183|Autonomic Agents|autonomic agents|mesh-ancestor
64995635|NCT00092183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64995636|NCT00092183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995637|NCT00092183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64995638|NCT00092183|Antipruritics|antipruritics|mesh-ancestor
64995639|NCT00092183|Dermatologic Agents|dermatologic agents|mesh-ancestor
64995640|NCT00092183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64995641|NCT00092183|Serotonin Agents|serotonin agents|mesh-ancestor
64995642|NCT00092183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64995643|NCT00092183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995644|NCT00092183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64995645|NCT00092183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64995646|NCT00092183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64995647|NCT00092183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64995648|NCT00092183|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64995649|NCT00092183|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64995650|NCT00428272|Interferons|interferons|mesh-list
64995651|NCT00428272|Interferon-gamma|interferon-gamma|mesh-list
64995652|NCT00428272|Lexatumumab|lexatumumab|mesh-list
64995653|NCT00428272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64995654|NCT00428272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995655|NCT00428272|Antiviral Agents|antiviral agents|mesh-ancestor
64995656|NCT00428272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64995657|NCT00428272|Immunologic Factors|immunologic factors|mesh-ancestor
64995658|NCT00428272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995659|NCT01580254|Latanoprost|latanoprost|mesh-list
64995660|NCT01580254|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64942678|NCT00031707|Megestrol|megestrol|mesh-list
64995672|NCT00428311|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64995673|NCT00428311|Contraceptive Agents|contraceptive agents|mesh-ancestor
64995674|NCT00428311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64995675|NCT00428311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64995676|NCT00428311|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64995677|NCT00428311|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64995678|NCT00428311|Androgen Antagonists|androgen antagonists|mesh-ancestor
64995679|NCT00428311|Hormone Antagonists|hormone antagonists|mesh-ancestor
64995680|NCT00428311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995681|NCT00428311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64995682|NCT00092300|Valdecoxib|valdecoxib|mesh-list
64995683|NCT00092300|Rofecoxib|rofecoxib|mesh-list
64995684|NCT00092300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64995685|NCT00092300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64995686|NCT00092300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995687|NCT00092300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995688|NCT00092300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64995689|NCT00092300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64995690|NCT00092300|Analgesics|analgesics|mesh-ancestor
64995691|NCT00092300|Sensory System Agents|sensory system agents|mesh-ancestor
64995692|NCT00092300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64995693|NCT00092300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995694|NCT00092300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64995695|NCT00092300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64995696|NCT00428350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65344854|NCT00863980|Telmisartan|telmisartan|mesh-list
65344855|NCT00863980|Candesartan|candesartan|mesh-list
65344856|NCT00863980|Candesartan cilexetil|candesartan cilexetil|mesh-list
65344857|NCT00863980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65344858|NCT00863980|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65344859|NCT00863980|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64726717|NCT05751187|Antiemetics|antiemetics|mesh-ancestor
64995697|NCT00428350|Antidepressive Agents|antidepressive agents|mesh-ancestor
64995698|NCT00428350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64995699|NCT00428350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64995700|NCT00428350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64995701|NCT00428350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64995702|NCT00428350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995703|NCT00428428|Isoproterenol|isoproterenol|mesh-list
64995704|NCT00428428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64995705|NCT00428428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64995706|NCT00428428|Adrenergic Agents|adrenergic agents|mesh-ancestor
64995707|NCT00428428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64995708|NCT00428428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995709|NCT00428428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995710|NCT00428428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64995711|NCT00428428|Autonomic Agents|autonomic agents|mesh-ancestor
64995712|NCT00428428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64995713|NCT00428428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64995714|NCT00428428|Respiratory System Agents|respiratory system agents|mesh-ancestor
64995715|NCT00428428|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64995716|NCT00428428|Sympathomimetics|sympathomimetics|mesh-ancestor
64995717|NCT00428428|Protective Agents|protective agents|mesh-ancestor
64995718|NCT00092339|Valdecoxib|valdecoxib|mesh-list
64995719|NCT00092339|Rofecoxib|rofecoxib|mesh-list
64995720|NCT00092339|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64995721|NCT00092339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64995722|NCT00092339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995723|NCT00092339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995724|NCT00092339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64466308|NCT02344186|Hormones|hormones|mesh-ancestor
64942753|NCT00031863|Analgesics|analgesics|mesh-ancestor
64995734|NCT00428545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64995735|NCT00428545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995736|NCT00428545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64995737|NCT00428545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64995738|NCT00428545|Growth Substances|growth substances|mesh-ancestor
64995739|NCT00428545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995740|NCT00428545|Growth Inhibitors|growth inhibitors|mesh-ancestor
64995741|NCT00092378|Diclofenac|diclofenac|mesh-list
64995742|NCT00092378|Rofecoxib|rofecoxib|mesh-list
64995743|NCT00092378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64995744|NCT00092378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64995745|NCT00092378|Analgesics|analgesics|mesh-ancestor
64995746|NCT00092378|Sensory System Agents|sensory system agents|mesh-ancestor
64995747|NCT00092378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64995748|NCT00092378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995749|NCT00092378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64995750|NCT00092378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64995751|NCT00092378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64995752|NCT00092378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995753|NCT00092378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995754|NCT00092378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64995755|NCT00092846|Lovastatin|lovastatin|mesh-list
64995756|NCT00092846|L 647318|l 647318|mesh-list
64995757|NCT00092846|Dihydromevinolin|dihydromevinolin|mesh-list
64995758|NCT00092846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64995759|NCT00092846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64995760|NCT00092846|Antimetabolites|antimetabolites|mesh-ancestor
64995761|NCT00092846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995762|NCT00092846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64995763|NCT00092846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64995764|NCT00092846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344860|NCT00863980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344861|NCT00415519|Edaravone|edaravone|mesh-list
65344862|NCT00415519|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65344863|NCT00415519|Antioxidants|antioxidants|mesh-ancestor
65344864|NCT00415519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344865|NCT00415519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65344866|NCT00415519|Protective Agents|protective agents|mesh-ancestor
65344867|NCT00415519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344868|NCT05741294|Tirbanibulin|tirbanibulin|mesh-list
65344869|NCT05741294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094648|NCT05145270|Serotonin Agents|serotonin agents|mesh-ancestor
65344870|NCT05741294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995765|NCT00092924|Mapatumumab|mapatumumab|mesh-list
64995766|NCT00092924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995767|NCT03705507|Dexamethasone|dexamethasone|mesh-list
64995768|NCT03705507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64995769|NCT03705507|Antiemetics|antiemetics|mesh-ancestor
64995770|NCT03705507|Autonomic Agents|autonomic agents|mesh-ancestor
64995771|NCT03705507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64995772|NCT03705507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995773|NCT03705507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64995774|NCT03705507|Glucocorticoids|glucocorticoids|mesh-ancestor
64995775|NCT03705507|Hormones|hormones|mesh-ancestor
64995776|NCT03705507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64995777|NCT03705507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64995778|NCT03705507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995779|NCT00093002|Fulvestrant|fulvestrant|mesh-list
64995780|NCT00093002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64995781|NCT00093002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995782|NCT00093002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64995783|NCT00093002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64995784|NCT00093002|Hormone Antagonists|hormone antagonists|mesh-ancestor
64995785|NCT00093002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64995786|NCT00093002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995787|NCT00093119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64995788|NCT00093119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995789|NCT00093158|Anticoagulants|anticoagulants|mesh-list
64995790|NCT00093158|Bivalirudin|bivalirudin|mesh-list
64995797|NCT03501498|Antidiarrheals|antidiarrheals|mesh-list
64995798|NCT03501498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64995799|NCT05561049|Thalidomide|thalidomide|mesh-list
64995800|NCT05561049|Dexamethasone|dexamethasone|mesh-list
64995801|NCT05561049|Bortezomib|bortezomib|mesh-list
64995802|NCT05561049|Daratumumab|daratumumab|mesh-list
64995803|NCT05561049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64995804|NCT05561049|Antiemetics|antiemetics|mesh-ancestor
64995806|NCT05561049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64995807|NCT05561049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995808|NCT05561049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64995809|NCT05561049|Glucocorticoids|glucocorticoids|mesh-ancestor
64995810|NCT05561049|Hormones|hormones|mesh-ancestor
64995811|NCT05561049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64995812|NCT05561049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64995813|NCT05561049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995814|NCT05561049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64995815|NCT05561049|Immunologic Factors|immunologic factors|mesh-ancestor
64995816|NCT05561049|Leprostatic Agents|leprostatic agents|mesh-ancestor
64995817|NCT05561049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64995818|NCT05561049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64995819|NCT05561049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64995820|NCT05561049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64995821|NCT05561049|Growth Substances|growth substances|mesh-ancestor
64995822|NCT05561049|Growth Inhibitors|growth inhibitors|mesh-ancestor
65344871|NCT02568176|Midazolam|midazolam|mesh-list
65344872|NCT02568176|Bupropion|bupropion|mesh-list
65344873|NCT02568176|Esketamine|esketamine|mesh-list
65344874|NCT02568176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65344875|NCT02568176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65344876|NCT02568176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64995823|NCT00424034|Ambrisentan|ambrisentan|mesh-list
64995824|NCT00424034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64995825|NCT05561010|Bupivacaine|bupivacaine|mesh-list
64995826|NCT05561010|Anesthetics, Local|anesthetics, local|mesh-ancestor
64995827|NCT05561010|Anesthetics|anesthetics|mesh-ancestor
64995828|NCT05561010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64995829|NCT05561010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995830|NCT05561010|Sensory System Agents|sensory system agents|mesh-ancestor
64995831|NCT05561010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64995832|NCT03448107|Fluorides|fluorides|mesh-list
64995833|NCT03448107|Fluorides, Topical|fluorides, topical|mesh-list
64995834|NCT03448107|Cariostatic Agents|cariostatic agents|mesh-ancestor
64995835|NCT03448107|Protective Agents|protective agents|mesh-ancestor
64995836|NCT03448107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995837|NCT00093314|Ofatumumab|ofatumumab|mesh-list
64995838|NCT00093314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995839|NCT00093353|Cefixime|cefixime|mesh-list
64995840|NCT00093353|Irinotecan|irinotecan|mesh-list
64995841|NCT00093353|Temozolomide|temozolomide|mesh-list
64995842|NCT00093353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64995843|NCT00093353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64995844|NCT00093353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995845|NCT00093353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995846|NCT00093353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995847|NCT00093353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64995848|NCT00093353|Alkylating Agents|alkylating agents|mesh-ancestor
64995849|NCT00093353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64995850|NCT00093353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64995851|NCT00093509|Doxorubicin|doxorubicin|mesh-list
64995852|NCT00093509|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64995853|NCT00093509|Ifosfamide|ifosfamide|mesh-list
64995854|NCT00093509|Isophosphamide mustard|isophosphamide mustard|mesh-list
64995855|NCT00093509|Mesna|mesna|mesh-list
64995856|NCT00093509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64995857|NCT00093509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995858|NCT00093509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64995859|NCT00093509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64995860|NCT00093509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995861|NCT00093509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995862|NCT00093509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64995863|NCT00093509|Alkylating Agents|alkylating agents|mesh-ancestor
64995875|NCT05549895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64995876|NCT05549895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995877|NCT05549895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64995878|NCT05549895|Glucocorticoids|glucocorticoids|mesh-ancestor
64995879|NCT05549895|Hormones|hormones|mesh-ancestor
64995880|NCT05549895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64977104|NCT00105144|Micafungin|micafungin|mesh-list
64995881|NCT05549895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64995882|NCT05549895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995883|NCT05549895|Anesthetics, Local|anesthetics, local|mesh-ancestor
64995885|NCT05549895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64995886|NCT05549895|Sensory System Agents|sensory system agents|mesh-ancestor
64942895|NCT03151343|Empagliflozin|empagliflozin|mesh-list
64995887|NCT00093587|Cyclosporine|cyclosporine|mesh-list
64995888|NCT00093587|Cyclophosphamide|cyclophosphamide|mesh-list
64995889|NCT00093587|Busulfan|busulfan|mesh-list
64995890|NCT00093587|Cyclosporins|cyclosporins|mesh-list
64995892|NCT00093587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64995893|NCT00093587|Immunologic Factors|immunologic factors|mesh-ancestor
64995894|NCT00093587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995895|NCT00093587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64995896|NCT00093587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64995897|NCT00093587|Alkylating Agents|alkylating agents|mesh-ancestor
64995898|NCT00093587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995899|NCT00093587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344877|NCT02568176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344878|NCT02568176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65344879|NCT02568176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65344880|NCT02568176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65344881|NCT02568176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65344882|NCT02568176|Anesthetics, General|anesthetics, general|mesh-ancestor
65344883|NCT02568176|Anesthetics|anesthetics|mesh-ancestor
65344884|NCT02568176|GABA Modulators|gaba modulators|mesh-ancestor
64995900|NCT00093587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64995901|NCT00093587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995902|NCT00093587|Antifungal Agents|antifungal agents|mesh-ancestor
64995903|NCT00093587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64995904|NCT00093587|Dermatologic Agents|dermatologic agents|mesh-ancestor
64995905|NCT00093587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64995906|NCT00093626|Sorafenib|sorafenib|mesh-list
64995907|NCT00093626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995908|NCT00093626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64995909|NCT00093626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995910|NCT00093626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995911|NCT05543109|Fentanyl|fentanyl|mesh-list
64995912|NCT05543109|Narcotics|narcotics|mesh-list
64995913|NCT05543109|Propofol|propofol|mesh-list
64995914|NCT05543109|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
64995915|NCT05543109|Ropivacaine|ropivacaine|mesh-list
64995916|NCT05543109|Anesthetics|anesthetics|mesh-list
64995917|NCT05543109|Sevoflurane|sevoflurane|mesh-list
64995918|NCT05543109|Anesthetics, Local|anesthetics, local|mesh-list
64995919|NCT05543109|Rocuronium|rocuronium|mesh-list
64995920|NCT05543109|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64995921|NCT05543109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64995922|NCT05543109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995923|NCT05543109|Anesthetics, General|anesthetics, general|mesh-ancestor
64995924|NCT05543109|Sensory System Agents|sensory system agents|mesh-ancestor
64995925|NCT05543109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64995926|NCT05543109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64995927|NCT05543109|Analgesics|analgesics|mesh-ancestor
64995928|NCT05543109|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64995929|NCT05543109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64995930|NCT05543109|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64995931|NCT05543109|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64995942|NCT00093704|Ganciclovir|ganciclovir|mesh-list
64995943|NCT00093704|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64995944|NCT00093704|Bortezomib|bortezomib|mesh-list
64995945|NCT00093704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995946|NCT00093704|Antiviral Agents|antiviral agents|mesh-ancestor
64995947|NCT00093704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64995948|NCT00093704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64995949|NCT00093704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995950|NCT00093704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995951|NCT01055314|Dactinomycin|dactinomycin|mesh-list
64995952|NCT01055314|Cyclophosphamide|cyclophosphamide|mesh-list
64995953|NCT01055314|Temozolomide|temozolomide|mesh-list
64995954|NCT01055314|Ifosfamide|ifosfamide|mesh-list
64995955|NCT01055314|Isophosphamide mustard|isophosphamide mustard|mesh-list
64995956|NCT01055314|Doxorubicin|doxorubicin|mesh-list
64995957|NCT01055314|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64995958|NCT01055314|Irinotecan|irinotecan|mesh-list
64995959|NCT01055314|Etoposide|etoposide|mesh-list
64995960|NCT01055314|Vincristine|vincristine|mesh-list
64995961|NCT01055314|Etoposide phosphate|etoposide phosphate|mesh-list
64995962|NCT01055314|Podophyllotoxin|podophyllotoxin|mesh-list
64995963|NCT01055314|Camptothecin|camptothecin|mesh-list
64995964|NCT01055314|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64995965|NCT01055314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64995966|NCT01055314|Immunologic Factors|immunologic factors|mesh-ancestor
64995967|NCT01055314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995968|NCT01055314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64995969|NCT01055314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64995970|NCT01055314|Alkylating Agents|alkylating agents|mesh-ancestor
64995971|NCT01055314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995972|NCT01055314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995973|NCT01055314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65344885|NCT02568176|GABA Agents|gaba agents|mesh-ancestor
65344886|NCT02568176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65344887|NCT02568176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344888|NCT02568176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65344889|NCT02568176|Antidepressive Agents|antidepressive agents|mesh-ancestor
65344890|NCT02568176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65344891|NCT02568176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65344892|NCT02568176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64995974|NCT01055314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64995975|NCT01055314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64995976|NCT01055314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64995977|NCT01055314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995978|NCT01055314|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64995979|NCT01055314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64995980|NCT01055314|Tubulin Modulators|tubulin modulators|mesh-ancestor
64995981|NCT01055314|Antimitotic Agents|antimitotic agents|mesh-ancestor
64995982|NCT01055314|Mitosis Modulators|mitosis modulators|mesh-ancestor
64995983|NCT01055314|Keratolytic Agents|keratolytic agents|mesh-ancestor
64995984|NCT01055314|Dermatologic Agents|dermatologic agents|mesh-ancestor
64995985|NCT01055314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64995986|NCT01055314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64995987|NCT01055314|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64995988|NCT01055314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64995990|NCT00093743|Mycophenolic Acid|mycophenolic acid|mesh-list
64995991|NCT00093743|Fludarabine|fludarabine|mesh-list
64995992|NCT00093743|Fludarabine phosphate|fludarabine phosphate|mesh-list
64995993|NCT00093743|Cyclosporins|cyclosporins|mesh-list
64995994|NCT00093743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995995|NCT00093743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64995996|NCT00093743|Antimetabolites|antimetabolites|mesh-ancestor
64995997|NCT00093743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466559|NCT02209636|Ascorbic Acid|ascorbic acid|mesh-list
64996022|NCT00093860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64996023|NCT00093860|Vasodilator Agents|vasodilator agents|mesh-ancestor
64996024|NCT00402909|Nateglinide|nateglinide|mesh-list
64996025|NCT00402909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64996026|NCT00402909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996027|NCT02823366|Fenofibrate|fenofibrate|mesh-list
64996028|NCT02823366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64996029|NCT02823366|Antimetabolites|antimetabolites|mesh-ancestor
64996030|NCT02823366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996031|NCT02823366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64996032|NCT00093977|Darbepoetin alfa|darbepoetin alfa|mesh-list
64996033|NCT00093977|Hematinics|hematinics|mesh-ancestor
64996034|NCT00094289|Disulfiram|disulfiram|mesh-list
64996035|NCT00094289|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64996036|NCT00094289|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
64996037|NCT00094289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996038|NCT00094289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996039|NCT00094367|Lamivudine|lamivudine|mesh-list
64996040|NCT00094367|Abacavir|abacavir|mesh-list
64996041|NCT00094367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64996042|NCT00094367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64996043|NCT00094367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996044|NCT00094367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996045|NCT00094367|Antiviral Agents|antiviral agents|mesh-ancestor
64996046|NCT00094367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996047|NCT00094367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64466643|NCT01865110|Hormones|hormones|mesh-ancestor
64996064|NCT00094523|Fosamprenavir|fosamprenavir|mesh-list
64996065|NCT00094523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64996066|NCT00094523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64996067|NCT00094523|Protease Inhibitors|protease inhibitors|mesh-ancestor
64996068|NCT00094523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996069|NCT00094523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996070|NCT00094523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65344893|NCT02568176|Dopamine Agents|dopamine agents|mesh-ancestor
65344894|NCT02568176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65344895|NCT02568176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65344896|NCT02568176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344897|NCT00741182|Teriparatide|teriparatide|mesh-list
65344898|NCT00741182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65344899|NCT00741182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996071|NCT00094523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64996072|NCT00094523|Antiviral Agents|antiviral agents|mesh-ancestor
64996073|NCT00094523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996074|NCT00428701|Esomeprazole|esomeprazole|mesh-list
64996075|NCT00428701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64996076|NCT00428701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64996077|NCT00428701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64996078|NCT00428701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996079|NCT00428701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996080|NCT00428818|Doxycycline|doxycycline|mesh-list
64996081|NCT00428818|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64996082|NCT00428818|Trimethoprim|trimethoprim|mesh-list
64996083|NCT00428818|Sulfamethoxazole|sulfamethoxazole|mesh-list
64996084|NCT00428818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64996085|NCT00428818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996086|NCT00428818|Antimalarials|antimalarials|mesh-ancestor
64996087|NCT00428818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64996088|NCT00428818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64996089|NCT00428818|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64996090|NCT00428818|Renal Agents|renal agents|mesh-ancestor
64996091|NCT00428818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64996092|NCT00428818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996093|NCT00428818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996094|NCT00428818|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64996095|NCT00428818|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64996096|NCT00428818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64996097|NCT00094640|Olanzapine|olanzapine|mesh-list
64996098|NCT00094640|Antiemetics|antiemetics|mesh-ancestor
64996099|NCT00094640|Autonomic Agents|autonomic agents|mesh-ancestor
64996100|NCT00094640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64996101|NCT00094640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996102|NCT00094640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64996103|NCT00094640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64996104|NCT00094640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64996105|NCT00094640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64996116|NCT02415309|Protective Agents|protective agents|mesh-ancestor
64996117|NCT02415309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996118|NCT02415309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64996120|NCT05393817|Caffeine citrate|caffeine citrate|mesh-list
64996121|NCT05393817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996122|NCT05393817|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64996123|NCT05393817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996124|NCT05393817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64996125|NCT05393817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996126|NCT05393817|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64996127|NCT05393817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64996128|NCT05393817|Purinergic Agents|purinergic agents|mesh-ancestor
64996129|NCT05393817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64996130|NCT00403338|Sirolimus|sirolimus|mesh-list
64996131|NCT00403338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64996132|NCT00403338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996133|NCT00403338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64996134|NCT00403338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996135|NCT00403338|Antifungal Agents|antifungal agents|mesh-ancestor
64996136|NCT00403338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64996137|NCT00403338|Immunologic Factors|immunologic factors|mesh-ancestor
64996138|NCT00403338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996139|NCT00095069|Gaboxadol|gaboxadol|mesh-list
64996140|NCT00095069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65344900|NCT00741182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65344901|NCT00423943|Modafinil|modafinil|mesh-list
65344902|NCT00423943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65344903|NCT00423943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344904|NCT00423943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65344905|NCT00423943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64996141|NCT00095069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996142|NCT00095069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996143|NCT00095069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64996144|NCT00095069|Analgesics|analgesics|mesh-ancestor
64996145|NCT00095069|Sensory System Agents|sensory system agents|mesh-ancestor
64996146|NCT00095069|Anticonvulsants|anticonvulsants|mesh-ancestor
64996147|NCT00095069|GABA Agonists|gaba agonists|mesh-ancestor
64996148|NCT00095069|GABA Agents|gaba agents|mesh-ancestor
64996149|NCT00403533|Atorvastatin|atorvastatin|mesh-list
64996150|NCT00403533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64996151|NCT00403533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64996152|NCT00403533|Antimetabolites|antimetabolites|mesh-ancestor
64996153|NCT00403533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996154|NCT00403533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64996155|NCT00403533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64996156|NCT00403533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996157|NCT00095186|Lactoferrin|lactoferrin|mesh-list
64996158|NCT00095186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996159|NCT00095225|Bevacizumab|bevacizumab|mesh-list
64996160|NCT00095225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64996161|NCT00095225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64996162|NCT00095225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996163|NCT00095225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64996164|NCT00095225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64996165|NCT00095225|Growth Substances|growth substances|mesh-ancestor
64996166|NCT00095225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996167|NCT00095225|Growth Inhibitors|growth inhibitors|mesh-ancestor
64996168|NCT00095225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64466738|NCT02144584|Memantine|memantine|mesh-list
64996199|NCT00095459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996200|NCT00095459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64996201|NCT00095459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64996202|NCT00095459|Growth Substances|growth substances|mesh-ancestor
64996203|NCT00095459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996204|NCT00095459|Growth Inhibitors|growth inhibitors|mesh-ancestor
64996205|NCT00095459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64996206|NCT00095459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996207|NCT00095459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996209|NCT00429208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64996210|NCT00429208|Autonomic Agents|autonomic agents|mesh-ancestor
64466791|NCT01407562|Paclitaxel|paclitaxel|mesh-list
64996219|NCT00429247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64996220|NCT00429247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996221|NCT00095654|Rosiglitazone|rosiglitazone|mesh-list
64996222|NCT00095654|Ramipril|ramipril|mesh-list
64996223|NCT00095654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64996224|NCT00095654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996225|NCT00095654|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64996226|NCT00095654|Protease Inhibitors|protease inhibitors|mesh-ancestor
64996227|NCT00095654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996228|NCT00095654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996229|NCT00095654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64996230|NCT00095693|Sorafenib|sorafenib|mesh-list
64996231|NCT00095693|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64996232|NCT00095693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996233|NCT00095693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64996234|NCT00095693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996235|NCT00095693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996236|NCT00095693|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64996237|NCT01054573|Interferons|interferons|mesh-list
64996238|NCT01054573|Ribavirin|ribavirin|mesh-list
64996239|NCT01054573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274264|NCT02686476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274265|NCT02686476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65274266|NCT02686476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274267|NCT02702414|Pembrolizumab|pembrolizumab|mesh-list
65274268|NCT02702414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65274269|NCT02702414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274270|NCT04972175|Insulin Lispro|insulin lispro|mesh-list
65274271|NCT04972175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65274272|NCT04972175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955468|NCT00202969|Cisplatin|cisplatin|mesh-list
64996240|NCT01054573|Antiviral Agents|antiviral agents|mesh-ancestor
64996241|NCT01054573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996242|NCT01054573|Antimetabolites|antimetabolites|mesh-ancestor
64996243|NCT01054573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996244|NCT00095771|Arsenic Trioxide|arsenic trioxide|mesh-list
64996245|NCT00095771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996246|NCT00429442|Simvastatin|simvastatin|mesh-list
64996247|NCT00429442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64996248|NCT00429442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64996249|NCT00429442|Antimetabolites|antimetabolites|mesh-ancestor
64996250|NCT00429442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996251|NCT00429442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64996252|NCT00429442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64996253|NCT00429442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996254|NCT00429520|Hyaluronic Acid|hyaluronic acid|mesh-list
64996255|NCT00429520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64996256|NCT00429520|Immunologic Factors|immunologic factors|mesh-ancestor
64996257|NCT00429520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996258|NCT00429520|Viscosupplements|viscosupplements|mesh-ancestor
64996259|NCT00429520|Protective Agents|protective agents|mesh-ancestor
64996261|NCT00429559|Topotecan|topotecan|mesh-list
64996262|NCT00429559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64996263|NCT00429559|Antimetabolites|antimetabolites|mesh-ancestor
64996264|NCT00429559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996265|NCT00429559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996266|NCT00429559|Antiviral Agents|antiviral agents|mesh-ancestor
64996267|NCT00429559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996268|NCT00429559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996269|NCT00429559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64996270|NCT00429559|Immunologic Factors|immunologic factors|mesh-ancestor
64996271|NCT00429559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996272|NCT00429559|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64996273|NCT00429559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64996274|NCT00095810|Aripiprazole|aripiprazole|mesh-list
64996275|NCT00095810|Antidepressive Agents|antidepressive agents|mesh-ancestor
64996276|NCT00095810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64996277|NCT00095810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64466833|NCT01787500|Antibodies|antibodies|mesh-list
64996306|NCT00095888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996307|NCT00095888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996308|NCT00095888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64996309|NCT00095888|Immunologic Factors|immunologic factors|mesh-ancestor
64996310|NCT00095888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996312|NCT00429676|Haloperidol decanoate|haloperidol decanoate|mesh-list
64996313|NCT00429676|Antiemetics|antiemetics|mesh-ancestor
64996314|NCT00429676|Autonomic Agents|autonomic agents|mesh-ancestor
64996315|NCT00429676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64996316|NCT00429676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996317|NCT00429676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64996318|NCT00429676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64996319|NCT00429676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64996320|NCT00429676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64996335|NCT00095927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996336|NCT00095927|Tubulin Modulators|tubulin modulators|mesh-ancestor
64996337|NCT00095927|Antimitotic Agents|antimitotic agents|mesh-ancestor
65274273|NCT00616382|Indomethacin|indomethacin|mesh-list
65274274|NCT00616382|Pentoxifylline|pentoxifylline|mesh-list
65274275|NCT00616382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65274276|NCT00616382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274277|NCT00616382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274278|NCT00616382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65274279|NCT00616382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65274280|NCT00616382|Protective Agents|protective agents|mesh-ancestor
65274281|NCT00616382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274282|NCT00616382|Vasodilator Agents|vasodilator agents|mesh-ancestor
65274283|NCT00616382|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65274284|NCT00616382|Antioxidants|antioxidants|mesh-ancestor
65274285|NCT00616382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65274286|NCT00616382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65274287|NCT00616382|Analgesics|analgesics|mesh-ancestor
65274288|NCT00616382|Sensory System Agents|sensory system agents|mesh-ancestor
65274289|NCT00616382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65274290|NCT00616382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65274291|NCT00616382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65274292|NCT00616382|Gout Suppressants|gout suppressants|mesh-ancestor
65274293|NCT00616382|Tocolytic Agents|tocolytic agents|mesh-ancestor
65274294|NCT00616382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65274295|NCT00616382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65274296|NCT01864746|Palbociclib|palbociclib|mesh-list
64726781|NCT00002846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726782|NCT05720767|Itraconazole|itraconazole|mesh-list
64726783|NCT05720767|Rifampin|rifampin|mesh-list
64996338|NCT00095927|Mitosis Modulators|mitosis modulators|mesh-ancestor
64996339|NCT00095927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996340|NCT00095927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64996341|NCT00095927|Protective Agents|protective agents|mesh-ancestor
64996342|NCT00095927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996344|NCT00429754|Antiemetics|antiemetics|mesh-ancestor
64996345|NCT00429754|Autonomic Agents|autonomic agents|mesh-ancestor
64996346|NCT00429754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64996347|NCT00429754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996348|NCT00429754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64996349|NCT00429754|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64996350|NCT00429754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64996351|NCT00429754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996352|NCT05232084|Fentanyl|fentanyl|mesh-list
64996353|NCT05232084|Bupivacaine|bupivacaine|mesh-list
64996354|NCT05232084|Anesthetics, Local|anesthetics, local|mesh-ancestor
64996355|NCT05232084|Anesthetics|anesthetics|mesh-ancestor
64996356|NCT05232084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64996357|NCT05232084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996358|NCT05232084|Sensory System Agents|sensory system agents|mesh-ancestor
64996359|NCT05232084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65274297|NCT01864746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274298|NCT01864746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65274299|NCT01864746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274300|NCT01864746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274301|NCT04967573|Rivaroxaban|rivaroxaban|mesh-list
65274302|NCT04967573|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65274303|NCT04967573|Antithrombins|antithrombins|mesh-ancestor
64507816|NCT00550420|Rosiglitazone|rosiglitazone|mesh-list
64996360|NCT05232084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64996361|NCT05232084|Narcotics|narcotics|mesh-ancestor
64996362|NCT05232084|Analgesics|analgesics|mesh-ancestor
64996363|NCT05232084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64996364|NCT05232084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64996365|NCT05232084|Anesthetics, General|anesthetics, general|mesh-ancestor
64996366|NCT00429832|Promethazine|promethazine|mesh-list
64996367|NCT00429832|Diphenhydramine|diphenhydramine|mesh-list
64996368|NCT00429832|Ondansetron|ondansetron|mesh-list
64996369|NCT00429832|Antiemetics|antiemetics|mesh-ancestor
64996370|NCT00429832|Autonomic Agents|autonomic agents|mesh-ancestor
64996371|NCT00429832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64996372|NCT00429832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996373|NCT00429832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64996374|NCT00429832|Antipruritics|antipruritics|mesh-ancestor
64996375|NCT00429832|Dermatologic Agents|dermatologic agents|mesh-ancestor
64996376|NCT00429832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64996377|NCT00429832|Serotonin Agents|serotonin agents|mesh-ancestor
64996378|NCT00429832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64996379|NCT00429832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996380|NCT00429832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64996381|NCT00429832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64996382|NCT00429832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64996383|NCT00429832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64996407|NCT00429871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996409|NCT00095966|Sorafenib|sorafenib|mesh-list
64996410|NCT00095966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64996411|NCT00095966|Antimetabolites|antimetabolites|mesh-ancestor
64996412|NCT00095966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996413|NCT00095966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996414|NCT00095966|Antiviral Agents|antiviral agents|mesh-ancestor
64996415|NCT00095966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996416|NCT00095966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996417|NCT00095966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64996418|NCT00095966|Immunologic Factors|immunologic factors|mesh-ancestor
64996419|NCT00095966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996420|NCT00095966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64996422|NCT01803594|Niacin|niacin|mesh-list
64996423|NCT01803594|Niacinamide|niacinamide|mesh-list
64996424|NCT01803594|Vitamin B Complex|vitamin b complex|mesh-ancestor
64996425|NCT01803594|Vitamins|vitamins|mesh-ancestor
64996426|NCT01803594|Micronutrients|micronutrients|mesh-ancestor
64996427|NCT01803594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996428|NCT01803594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64996429|NCT01803594|Antimetabolites|antimetabolites|mesh-ancestor
64996430|NCT01803594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996431|NCT01803594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64996432|NCT01803594|Vasodilator Agents|vasodilator agents|mesh-ancestor
64996433|NCT00430066|Imatinib Mesylate|imatinib mesylate|mesh-list
64996434|NCT00430066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996435|NCT00430066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64996436|NCT00430066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996437|NCT00430066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996438|NCT00096005|Bortezomib|bortezomib|mesh-list
64996467|NCT00096083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64996468|NCT00096083|Alkylating Agents|alkylating agents|mesh-ancestor
64996469|NCT00096083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996470|NCT00096083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996471|NCT00096083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64996472|NCT00096083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64996473|NCT00096083|Immunologic Factors|immunologic factors|mesh-ancestor
65274304|NCT04967573|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65274305|NCT04967573|Protease Inhibitors|protease inhibitors|mesh-ancestor
65274306|NCT04967573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274307|NCT04967573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274308|NCT04967573|Anticoagulants|anticoagulants|mesh-ancestor
64996474|NCT00096083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996475|NCT01726452|Leucovorin|leucovorin|mesh-list
64996476|NCT01726452|Paclitaxel|paclitaxel|mesh-list
64996477|NCT01726452|Docetaxel|docetaxel|mesh-list
64996478|NCT01726452|Carboplatin|carboplatin|mesh-list
64996479|NCT01726452|Fluorouracil|fluorouracil|mesh-list
64996480|NCT01726452|Capecitabine|capecitabine|mesh-list
64996481|NCT01726452|Oxaliplatin|oxaliplatin|mesh-list
64996482|NCT01726452|Epirubicin|epirubicin|mesh-list
64996483|NCT01726452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64996484|NCT01726452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996514|NCT00096317|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64996516|NCT00096395|Sorafenib|sorafenib|mesh-list
64996517|NCT00096395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64996518|NCT00096395|Antimetabolites|antimetabolites|mesh-ancestor
64996519|NCT00096395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996520|NCT00096395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996521|NCT00096395|Antiviral Agents|antiviral agents|mesh-ancestor
64996522|NCT00096395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996523|NCT00096395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996524|NCT00096395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64996525|NCT00096395|Immunologic Factors|immunologic factors|mesh-ancestor
64996526|NCT00096395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996527|NCT00096395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64996528|NCT00096434|Sorafenib|sorafenib|mesh-list
64996529|NCT00096434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996552|NCT00096551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64996553|NCT00096551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64996554|NCT00130572|Pimecrolimus|pimecrolimus|mesh-list
64996555|NCT00130572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64996556|NCT00130572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64996557|NCT00130572|Analgesics|analgesics|mesh-ancestor
64996558|NCT00130572|Sensory System Agents|sensory system agents|mesh-ancestor
64996559|NCT00130572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64996560|NCT00130572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996561|NCT00130572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64996562|NCT00130572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64996563|NCT00130572|Dermatologic Agents|dermatologic agents|mesh-ancestor
64996564|NCT00130572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64996565|NCT00130572|Immunologic Factors|immunologic factors|mesh-ancestor
64996566|NCT00130572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64996567|NCT00130572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943569|NCT04732377|Anesthetics|anesthetics|mesh-ancestor
64996568|NCT00130572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996569|NCT00096629|Vaccines|vaccines|mesh-list
64996570|NCT00096629|Immunologic Factors|immunologic factors|mesh-ancestor
64996571|NCT00096629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996572|NCT00430651|Carboplatin|carboplatin|mesh-list
64996573|NCT00430651|Docetaxel|docetaxel|mesh-list
64996574|NCT00430651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996575|NCT00430651|Tubulin Modulators|tubulin modulators|mesh-ancestor
64996576|NCT00430651|Antimitotic Agents|antimitotic agents|mesh-ancestor
64996577|NCT00430651|Mitosis Modulators|mitosis modulators|mesh-ancestor
64996578|NCT00430651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996579|NCT00430807|Hydroxychloroquine|hydroxychloroquine|mesh-list
64996580|NCT00430807|Antimalarials|antimalarials|mesh-ancestor
64467201|NCT03800524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64467202|NCT03800524|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64467203|NCT03800524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64467204|NCT04634578|Bevacizumab|bevacizumab|mesh-list
64996588|NCT00096668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64996589|NCT00096668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996590|NCT00096668|Tubulin Modulators|tubulin modulators|mesh-ancestor
64996591|NCT00096668|Antimitotic Agents|antimitotic agents|mesh-ancestor
64996592|NCT00096668|Mitosis Modulators|mitosis modulators|mesh-ancestor
64996593|NCT00096668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996594|NCT00430846|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65274309|NCT04212650|Losartan|losartan|mesh-list
65274310|NCT04212650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65274311|NCT04212650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65274312|NCT04212650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65274313|NCT04212650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65274314|NCT04212650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996595|NCT00430846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64996596|NCT00430846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996597|NCT00430885|Immunoglobulins|immunoglobulins|mesh-list
64996598|NCT00430885|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64996599|NCT00430885|gamma-Globulins|gamma-globulins|mesh-list
64996600|NCT00430885|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64996601|NCT00430885|Immunologic Factors|immunologic factors|mesh-ancestor
64996602|NCT00430885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996604|NCT00430924|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64996605|NCT00430924|Hormone Antagonists|hormone antagonists|mesh-ancestor
64996606|NCT00430924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64996607|NCT00430924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996608|NCT00430924|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64996609|NCT00430924|Diuretics|diuretics|mesh-ancestor
64996610|NCT00430924|Natriuretic Agents|natriuretic agents|mesh-ancestor
64996611|NCT00430924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64996612|NCT00096707|Deoxyglucose|deoxyglucose|mesh-list
64996613|NCT00096707|Antimetabolites|antimetabolites|mesh-ancestor
64996614|NCT00096707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996615|NCT00096707|Antiviral Agents|antiviral agents|mesh-ancestor
64996616|NCT00096707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996617|NCT00430963|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64996618|NCT00430963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64996619|NCT00430963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64996620|NCT00430963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996621|NCT00430963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64996622|NCT00430963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64996623|NCT00430963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996624|NCT00430963|Cholinergic Agents|cholinergic agents|mesh-ancestor
64996625|NCT00430963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64996626|NCT05102409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64996627|NCT05102409|Lifitegrast|lifitegrast|mesh-list
64996628|NCT05102409|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64996629|NCT01053247|Tacrolimus|tacrolimus|mesh-list
64996630|NCT01053247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64996631|NCT01053247|Immunologic Factors|immunologic factors|mesh-ancestor
64996632|NCT01053247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996633|NCT01053247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64996634|NCT01053247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996635|NCT01053247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996636|NCT00096863|Haloperidol|haloperidol|mesh-list
64467205|NCT04634578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64996642|NCT00096863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996643|NCT00096863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64996644|NCT00096863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64996645|NCT00096863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64996646|NCT00096863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64996647|NCT00096863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64996648|NCT00096863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64996649|NCT00096863|Dopamine Agents|dopamine agents|mesh-ancestor
64996650|NCT00096863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64996651|NCT00096863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996652|NCT00096863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64996653|NCT00096863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64996654|NCT00096863|Serotonin Agents|serotonin agents|mesh-ancestor
64996655|NCT01052779|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64996656|NCT01052779|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64996657|NCT01052779|Hematinics|hematinics|mesh-ancestor
64996658|NCT01052779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64996659|NCT01052779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65274315|NCT02574728|Sirolimus|sirolimus|mesh-list
65274316|NCT02574728|Celecoxib|celecoxib|mesh-list
65274317|NCT02574728|Cyclophosphamide|cyclophosphamide|mesh-list
65274318|NCT02574728|Etoposide|etoposide|mesh-list
65274319|NCT02574728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65274320|NCT02574728|Immunologic Factors|immunologic factors|mesh-ancestor
65274321|NCT02574728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274322|NCT02574728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65024332|NCT01715974|Molgramostim|molgramostim|mesh-list
65274323|NCT02574728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65274324|NCT02574728|Alkylating Agents|alkylating agents|mesh-ancestor
65274325|NCT02574728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274326|NCT02574728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996660|NCT00130767|Finasteride|finasteride|mesh-list
64996661|NCT00130767|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64996662|NCT00130767|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64996663|NCT00130767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996664|NCT00130767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996665|NCT00130767|Hormone Antagonists|hormone antagonists|mesh-ancestor
64996666|NCT00130767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64996667|NCT00130767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996668|NCT00130767|Urological Agents|urological agents|mesh-ancestor
64996669|NCT00431080|Paclitaxel|paclitaxel|mesh-list
64996670|NCT00431080|Docetaxel|docetaxel|mesh-list
64996671|NCT00431080|Cyclophosphamide|cyclophosphamide|mesh-list
64996672|NCT00431080|Epirubicin|epirubicin|mesh-list
64996673|NCT00431080|Fluorouracil|fluorouracil|mesh-list
64996674|NCT00431080|Lenograstim|lenograstim|mesh-list
64996675|NCT00431080|Mitogens|mitogens|mesh-list
64996676|NCT00431080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64996677|NCT00431080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996678|NCT00431080|Tubulin Modulators|tubulin modulators|mesh-ancestor
64996679|NCT00431080|Antimitotic Agents|antimitotic agents|mesh-ancestor
64996680|NCT00431080|Mitosis Modulators|mitosis modulators|mesh-ancestor
64996681|NCT00431080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996682|NCT00431080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64996683|NCT00431080|Immunologic Factors|immunologic factors|mesh-ancestor
64996684|NCT00431080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996685|NCT00431080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64996686|NCT00431080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64996687|NCT00431080|Alkylating Agents|alkylating agents|mesh-ancestor
64996688|NCT00431080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64996689|NCT00431080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64996690|NCT00431080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64996691|NCT00431080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64996692|NCT00431080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996693|NCT00431080|Antimetabolites|antimetabolites|mesh-ancestor
64996694|NCT00431080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64996695|NCT00431080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64996696|NCT00431119|Mycophenolic Acid|mycophenolic acid|mesh-list
64996697|NCT00431119|Azathioprine|azathioprine|mesh-list
64996698|NCT00431119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64996699|NCT00431119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996700|NCT00431119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64996701|NCT00431119|Antitubercular Agents|antitubercular agents|mesh-ancestor
64996702|NCT00431119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64996703|NCT00431119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996704|NCT00431119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996705|NCT00431119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996706|NCT00431119|Antimetabolites|antimetabolites|mesh-ancestor
64467248|NCT01506609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996733|NCT00431197|Androgens|androgens|mesh-ancestor
64996734|NCT00431197|Hormones|hormones|mesh-ancestor
64996735|NCT00431236|Dexamethasone|dexamethasone|mesh-list
65274327|NCT02574728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65274328|NCT02574728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65274329|NCT02574728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65274330|NCT02574728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65274331|NCT02574728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996736|NCT00431236|Ondansetron|ondansetron|mesh-list
64996737|NCT00431236|Casopitant|casopitant|mesh-list
64996738|NCT00431236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64996739|NCT00431236|Antiemetics|antiemetics|mesh-ancestor
64996740|NCT00431236|Autonomic Agents|autonomic agents|mesh-ancestor
64996741|NCT00431236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64996742|NCT00431236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996743|NCT00431236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64996744|NCT00431236|Glucocorticoids|glucocorticoids|mesh-ancestor
64996745|NCT00431236|Hormones|hormones|mesh-ancestor
64996746|NCT00431236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64996747|NCT00431236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64996748|NCT00431236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996749|NCT00431236|Antipruritics|antipruritics|mesh-ancestor
64996750|NCT00431236|Dermatologic Agents|dermatologic agents|mesh-ancestor
64996751|NCT00431236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64996752|NCT00431236|Serotonin Agents|serotonin agents|mesh-ancestor
64996753|NCT00431236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64996754|NCT00431236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996778|NCT00130845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996779|NCT00431392|Atropine|atropine|mesh-list
64996780|NCT00431392|Propranolol|propranolol|mesh-list
64996781|NCT00431392|Phenylephrine|phenylephrine|mesh-list
64996782|NCT00431392|Oxymetazoline|oxymetazoline|mesh-list
64996783|NCT00431392|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
64996784|NCT00431392|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64996785|NCT00431392|Mydriatics|mydriatics|mesh-ancestor
64996786|NCT00431392|Autonomic Agents|autonomic agents|mesh-ancestor
64996787|NCT00431392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64996788|NCT00431392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943786|NCT00036582|GABA Agents|gaba agents|mesh-ancestor
64996789|NCT00431392|Sympathomimetics|sympathomimetics|mesh-ancestor
64996790|NCT00431392|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64996791|NCT00431392|Nasal Decongestants|nasal decongestants|mesh-ancestor
64996792|NCT00431392|Respiratory System Agents|respiratory system agents|mesh-ancestor
64996793|NCT00431392|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64996794|NCT00431392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64996795|NCT00431392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64996796|NCT00431392|Adrenergic Agents|adrenergic agents|mesh-ancestor
64996797|NCT00431392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64996798|NCT00431392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996799|NCT00431392|Protective Agents|protective agents|mesh-ancestor
64996800|NCT00431392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64996801|NCT00431392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64996802|NCT00431392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64996803|NCT00431392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64996804|NCT00431392|Parasympatholytics|parasympatholytics|mesh-ancestor
64996805|NCT00431392|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64996826|NCT01052662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64996827|NCT01052662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996828|NCT01052662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996829|NCT01052662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64996830|NCT01052662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64996831|NCT00097214|Carboplatin|carboplatin|mesh-list
64996832|NCT00097214|Cetuximab|cetuximab|mesh-list
64996833|NCT00097214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996834|NCT00097214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64996835|NCT05049057|Erenumab|erenumab|mesh-list
64996836|NCT05049057|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64996837|NCT05049057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996838|NCT05049057|Analgesics|analgesics|mesh-ancestor
64996839|NCT05049057|Sensory System Agents|sensory system agents|mesh-ancestor
64996840|NCT05049057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64996841|NCT05049057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996842|NCT00431665|Heparin|heparin|mesh-list
65274332|NCT02574728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65274333|NCT02574728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65274334|NCT02574728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65274335|NCT02574728|Antifungal Agents|antifungal agents|mesh-ancestor
64996843|NCT00431665|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64996844|NCT00431665|Somatostatin|somatostatin|mesh-list
64996845|NCT00431665|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
64996846|NCT00431665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996847|NCT00431665|Anticoagulants|anticoagulants|mesh-ancestor
64996848|NCT00431665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64996849|NCT00431665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64996850|NCT00431665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996851|NCT00431665|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64996852|NCT00431665|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64996853|NCT00431665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64996854|NCT00431665|Hormones|hormones|mesh-ancestor
64996855|NCT00431665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64996856|NCT00431665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996857|NCT05001828|Azacitidine|azacitidine|mesh-list
64996858|NCT05001828|Venetoclax|venetoclax|mesh-list
64996859|NCT05001828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64996883|NCT00432016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64996884|NCT00432016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64996885|NCT01052077|Antidepressive Agents|antidepressive agents|mesh-list
64996886|NCT01052077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64996887|NCT00131040|Aprotinin|aprotinin|mesh-list
64996888|NCT00131040|Hemostatics|hemostatics|mesh-ancestor
64996889|NCT00131040|Coagulants|coagulants|mesh-ancestor
64996890|NCT00131040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64996891|NCT00131040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64996892|NCT00131040|Protease Inhibitors|protease inhibitors|mesh-ancestor
64996893|NCT00131040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996894|NCT00131040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996895|NCT00400478|Rituximab|rituximab|mesh-list
64996896|NCT00400478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64996897|NCT00400478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996898|NCT00400478|Immunologic Factors|immunologic factors|mesh-ancestor
64996899|NCT00400478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996900|NCT00400478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64996901|NCT01052038|Dexamethasone|dexamethasone|mesh-list
64996902|NCT01052038|Dexamethasone acetate|dexamethasone acetate|mesh-list
64996903|NCT01052038|BB 1101|bb 1101|mesh-list
64996904|NCT01052038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64996905|NCT01052038|Antiemetics|antiemetics|mesh-ancestor
64996906|NCT01052038|Autonomic Agents|autonomic agents|mesh-ancestor
64996907|NCT01052038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64996908|NCT01052038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996909|NCT01052038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64996910|NCT01052038|Glucocorticoids|glucocorticoids|mesh-ancestor
64996911|NCT01052038|Hormones|hormones|mesh-ancestor
64996936|NCT04711044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996937|NCT04711044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996938|NCT01051960|Ambrisentan|ambrisentan|mesh-list
64996939|NCT01051960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64943936|NCT01464983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64996940|NCT00432367|Artesunate|artesunate|mesh-list
64996941|NCT00432367|Pyrimethamine|pyrimethamine|mesh-list
64996942|NCT00432367|Sulfadoxine|sulfadoxine|mesh-list
64996943|NCT00432367|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64996944|NCT00432367|Amodiaquine|amodiaquine|mesh-list
64996945|NCT00432367|Antimalarials|antimalarials|mesh-ancestor
64996946|NCT00432367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64996947|NCT00432367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64996948|NCT00432367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996949|NCT00432367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996950|NCT00432367|Antiviral Agents|antiviral agents|mesh-ancestor
64996951|NCT00432367|Schistosomicides|schistosomicides|mesh-ancestor
64996952|NCT00432367|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64996953|NCT00432367|Anthelmintics|anthelmintics|mesh-ancestor
64996954|NCT00432367|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64996955|NCT00432367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996956|NCT00432367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996957|NCT00432367|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65274336|NCT02574728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65274337|NCT02574728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65274338|NCT02574728|Analgesics|analgesics|mesh-ancestor
65274339|NCT02574728|Sensory System Agents|sensory system agents|mesh-ancestor
65274340|NCT02574728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65274341|NCT02574728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65274342|NCT02574728|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64726843|NCT00003176|Alkylating Agents|alkylating agents|mesh-ancestor
64726844|NCT00003176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726845|NCT00003176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726846|NCT00002858|Cyclophosphamide|cyclophosphamide|mesh-list
64726847|NCT00002858|Doxorubicin|doxorubicin|mesh-list
64726848|NCT00002858|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64726849|NCT00002858|Etoposide|etoposide|mesh-list
64726850|NCT00002858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64508420|NCT05447520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508422|NCT05438550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64996958|NCT00432367|Renal Agents|renal agents|mesh-ancestor
64996959|NCT00097760|Natalizumab|natalizumab|mesh-list
64996960|NCT00097760|Immunologic Factors|immunologic factors|mesh-ancestor
64996988|NCT00097799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996990|NCT00097799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64996991|NCT00097799|Antiviral Agents|antiviral agents|mesh-ancestor
64996992|NCT00097799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996993|NCT00097799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64996994|NCT00097799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64996995|NCT01051921|Interferons|interferons|mesh-list
64996996|NCT01051921|Ribavirin|ribavirin|mesh-list
64996997|NCT01051921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996998|NCT01051921|Antiviral Agents|antiviral agents|mesh-ancestor
64996999|NCT01051921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997000|NCT01051921|Antimetabolites|antimetabolites|mesh-ancestor
64997001|NCT01051921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997002|NCT02273479|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
64997003|NCT02273479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64997004|NCT02273518|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
64997005|NCT02273518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64997006|NCT00432757|Ketotifen|ketotifen|mesh-list
64997007|NCT00432757|Antipruritics|antipruritics|mesh-ancestor
64997008|NCT00432757|Dermatologic Agents|dermatologic agents|mesh-ancestor
64997021|NCT00432796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64997022|NCT00432796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997024|NCT00097877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64997025|NCT00097877|Insulin Glargine|insulin glargine|mesh-list
64997026|NCT00097877|Insulin Aspart|insulin aspart|mesh-list
64997027|NCT00097877|Biphasic Insulins|biphasic insulins|mesh-list
64997028|NCT00097877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64997029|NCT00097877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997031|NCT00097916|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64997032|NCT00097916|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64997033|NCT00097916|Dopamine Agents|dopamine agents|mesh-ancestor
64997034|NCT00097916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64997035|NCT00097916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997036|NCT00097916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997037|NCT00097916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64997038|NCT00097916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65274343|NCT02574728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65274344|NCT00617474|Epoetin Alfa|epoetin alfa|mesh-list
65274345|NCT00617474|Hematinics|hematinics|mesh-ancestor
65274346|NCT00619034|Diclofenac|diclofenac|mesh-list
64997039|NCT00433069|Pioglitazone|pioglitazone|mesh-list
64997040|NCT00433069|Interferons|interferons|mesh-list
64997041|NCT00433069|Ribavirin|ribavirin|mesh-list
64997042|NCT00433069|Interferon-alpha|interferon-alpha|mesh-list
64997043|NCT00433069|Interferon alpha-2|interferon alpha-2|mesh-list
64997044|NCT00433069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997045|NCT00433069|Antiviral Agents|antiviral agents|mesh-ancestor
64997046|NCT00433069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997047|NCT00433069|Antimetabolites|antimetabolites|mesh-ancestor
64997048|NCT00433069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997049|NCT00433069|Immunologic Factors|immunologic factors|mesh-ancestor
64997050|NCT00433069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997051|NCT00433069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64997052|NCT01580371|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
64997053|NCT01580371|CKD-581|ckd-581|mesh-list
64997054|NCT01580371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997055|NCT01580371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997056|NCT00403026|Bevacizumab|bevacizumab|mesh-list
64997057|NCT00403026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64997058|NCT00403026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997059|NCT00403026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64997060|NCT00403026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64997061|NCT00403026|Growth Substances|growth substances|mesh-ancestor
64997062|NCT00403026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997063|NCT00403026|Growth Inhibitors|growth inhibitors|mesh-ancestor
64997064|NCT00131274|Imatinib Mesylate|imatinib mesylate|mesh-list
64997065|NCT00131274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997066|NCT00131274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64997067|NCT00131274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997068|NCT00131274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997069|NCT00098033|Clofarabine|clofarabine|mesh-list
64997070|NCT00098033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64997071|NCT00098033|Antimetabolites|antimetabolites|mesh-ancestor
64997072|NCT00098033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997084|NCT00403065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64997085|NCT00403065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997086|NCT00098111|Azathioprine|azathioprine|mesh-list
64997087|NCT00098111|Antimetabolites|antimetabolites|mesh-ancestor
64997088|NCT00098111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997089|NCT00098111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64997091|NCT00098111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64997092|NCT00098111|Immunologic Factors|immunologic factors|mesh-ancestor
64997093|NCT00098111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997094|NCT00098111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64997095|NCT04702906|Trimetazidine|trimetazidine|mesh-list
64997096|NCT04702906|Vasodilator Agents|vasodilator agents|mesh-ancestor
64997097|NCT00131313|Cyclophosphamide|cyclophosphamide|mesh-list
64997098|NCT00131313|Rituximab|rituximab|mesh-list
64997099|NCT00131313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64997100|NCT00131313|Immunologic Factors|immunologic factors|mesh-ancestor
64997101|NCT00131313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997102|NCT00131313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64997103|NCT00131313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64997104|NCT00131313|Alkylating Agents|alkylating agents|mesh-ancestor
64997105|NCT00131313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997106|NCT00131313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997107|NCT00131313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64997108|NCT00131313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64997109|NCT00433186|Mycophenolic Acid|mycophenolic acid|mesh-list
64997110|NCT00433186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64997111|NCT00433186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997112|NCT00433186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64997113|NCT00433186|Antitubercular Agents|antitubercular agents|mesh-ancestor
64997114|NCT00433186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64997115|NCT00433186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997116|NCT00433186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997117|NCT00433186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997118|NCT00433225|Gatifloxacin|gatifloxacin|mesh-list
65274347|NCT00619034|Dorzolamide|dorzolamide|mesh-list
65274348|NCT00619034|Latanoprost|latanoprost|mesh-list
65274349|NCT00619034|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65274350|NCT00619034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65274351|NCT00619034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65274352|NCT00619034|Analgesics|analgesics|mesh-ancestor
65274353|NCT00619034|Sensory System Agents|sensory system agents|mesh-ancestor
64726855|NCT00002858|Alkylating Agents|alkylating agents|mesh-ancestor
64997119|NCT00433225|Prednisolone|prednisolone|mesh-list
64997120|NCT00433225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64997121|NCT00433225|Methylprednisolone|methylprednisolone|mesh-list
64997122|NCT00433225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64997123|NCT00433225|Prednisolone acetate|prednisolone acetate|mesh-list
64997124|NCT00433225|Ketorolac|ketorolac|mesh-list
64997125|NCT00433225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64997126|NCT00433225|Prednisolone phosphate|prednisolone phosphate|mesh-list
64997127|NCT00433225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64997128|NCT00433225|Glucocorticoids|glucocorticoids|mesh-ancestor
64997129|NCT00433225|Hormones|hormones|mesh-ancestor
64997130|NCT00433225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64997131|NCT00433225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997132|NCT00433225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64997133|NCT00433225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997134|NCT00433225|Antiemetics|antiemetics|mesh-ancestor
64997135|NCT00433225|Autonomic Agents|autonomic agents|mesh-ancestor
64997136|NCT00433225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64997137|NCT00433225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64997154|NCT00433342|Floxacillin|floxacillin|mesh-list
64997155|NCT00433342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64997156|NCT00433342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997157|NCT00131391|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
64997158|NCT00131391|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64997159|NCT00131391|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64997160|NCT00131391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64997161|NCT00131391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997162|NCT00131391|Hormones|hormones|mesh-ancestor
64997163|NCT00131391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64997164|NCT00131391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997165|NCT00433459|Prednisone|prednisone|mesh-list
64997166|NCT00433459|Prednisolone|prednisolone|mesh-list
64997167|NCT00433459|Cyclophosphamide|cyclophosphamide|mesh-list
64997168|NCT00433459|Dacarbazine|dacarbazine|mesh-list
64997169|NCT00433459|Vincristine|vincristine|mesh-list
64997170|NCT00433459|Procarbazine|procarbazine|mesh-list
64997171|NCT00433459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64997172|NCT00433459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64997173|NCT00433459|Immunologic Factors|immunologic factors|mesh-ancestor
64997174|NCT00433459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997175|NCT00433459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64997176|NCT00433459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64997177|NCT00433459|Alkylating Agents|alkylating agents|mesh-ancestor
64997178|NCT00433459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997179|NCT00433459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997180|NCT00433459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64997181|NCT00433459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64997182|NCT00433459|Glucocorticoids|glucocorticoids|mesh-ancestor
64997184|NCT00433459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64997185|NCT00433459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64997186|NCT00433459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64997187|NCT00433459|Tubulin Modulators|tubulin modulators|mesh-ancestor
64997188|NCT00433459|Antimitotic Agents|antimitotic agents|mesh-ancestor
64997189|NCT00433459|Mitosis Modulators|mitosis modulators|mesh-ancestor
64997190|NCT00433459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64997191|NCT00433498|Carboplatin|carboplatin|mesh-list
64997192|NCT00433498|Etoposide|etoposide|mesh-list
64997193|NCT00433498|Etoposide phosphate|etoposide phosphate|mesh-list
64997194|NCT00433498|Pravastatin|pravastatin|mesh-list
65274354|NCT00619034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65274355|NCT00619034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274356|NCT00619034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64467760|NCT04771390|Selitrectinib|selitrectinib|mesh-list
64997216|NCT00098384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64997217|NCT00098384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997218|NCT00098384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64997219|NCT00433732|Naproxen|naproxen|mesh-list
64997220|NCT00433732|Sumatriptan|sumatriptan|mesh-list
64997221|NCT00433732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64997222|NCT00433732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64997223|NCT00433732|Analgesics|analgesics|mesh-ancestor
64997224|NCT00433732|Sensory System Agents|sensory system agents|mesh-ancestor
64997225|NCT00433732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64997226|NCT00433732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997227|NCT00433732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64997228|NCT00433732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64997229|NCT00433732|Gout Suppressants|gout suppressants|mesh-ancestor
64997230|NCT00433732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64997231|NCT00433732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997232|NCT00433732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997233|NCT00433732|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64997234|NCT00433732|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64997235|NCT00433732|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64997236|NCT00433732|Serotonin Agents|serotonin agents|mesh-ancestor
64997237|NCT00433732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64997238|NCT00098423|Cytarabine|cytarabine|mesh-list
64997239|NCT00098423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64997240|NCT00098423|Antimetabolites|antimetabolites|mesh-ancestor
64944235|NCT00846677|Vitamins|vitamins|mesh-list
64997241|NCT00098423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997242|NCT00098423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997243|NCT00098423|Antiviral Agents|antiviral agents|mesh-ancestor
64997244|NCT00098423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997245|NCT00098423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64997246|NCT00098423|Immunologic Factors|immunologic factors|mesh-ancestor
64997266|NCT00433927|Levoleucovorin|levoleucovorin|mesh-list
64997267|NCT00433927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64997268|NCT00433927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997269|NCT00433927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64997270|NCT00433927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64997271|NCT00433927|Growth Substances|growth substances|mesh-ancestor
64997272|NCT00433927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997273|NCT00433927|Growth Inhibitors|growth inhibitors|mesh-ancestor
64997274|NCT00433927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64997275|NCT00433927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64997276|NCT00433927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997277|NCT00433927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997278|NCT00433927|Antidotes|antidotes|mesh-ancestor
64997279|NCT00433927|Protective Agents|protective agents|mesh-ancestor
64997280|NCT00433927|Vitamin B Complex|vitamin b complex|mesh-ancestor
64997281|NCT00433927|Vitamins|vitamins|mesh-ancestor
64997282|NCT00433927|Micronutrients|micronutrients|mesh-ancestor
64997283|NCT00433927|Hematinics|hematinics|mesh-ancestor
64997284|NCT00131430|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
64997285|NCT00131430|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64997286|NCT00131430|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64997287|NCT00131430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64997288|NCT00131430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997289|NCT00131430|Hormones|hormones|mesh-ancestor
64997290|NCT00131430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64997291|NCT00131430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997292|NCT00098462|Sirolimus|sirolimus|mesh-list
64997293|NCT00098462|Gefitinib|gefitinib|mesh-list
64997294|NCT00098462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64997295|NCT00098462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997296|NCT00098462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64997297|NCT00098462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997298|NCT00098462|Antifungal Agents|antifungal agents|mesh-ancestor
64997299|NCT00098462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65274357|NCT00619034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65274358|NCT00619034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64726864|NCT00002864|Tamoxifen|tamoxifen|mesh-list
64997300|NCT00098462|Immunologic Factors|immunologic factors|mesh-ancestor
64997301|NCT00098462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997302|NCT00098462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64997335|NCT00434044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64997336|NCT00434044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997337|NCT00434044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64997338|NCT00434044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64997339|NCT00434044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64997340|NCT00434044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64997341|NCT00434044|Immunologic Factors|immunologic factors|mesh-ancestor
64997342|NCT00434083|Naproxen|naproxen|mesh-list
64997343|NCT00434083|Sumatriptan|sumatriptan|mesh-list
64997344|NCT00434083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64997345|NCT00434083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64997346|NCT00434083|Analgesics|analgesics|mesh-ancestor
64997347|NCT00434083|Sensory System Agents|sensory system agents|mesh-ancestor
64997383|NCT00098618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997384|NCT00098618|Antiviral Agents|antiviral agents|mesh-ancestor
64978607|NCT00074438|Rituximab|rituximab|mesh-list
64997385|NCT00098618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997408|NCT00098891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997409|NCT00098969|Resveratrol|resveratrol|mesh-list
64997410|NCT00098969|Antioxidants|antioxidants|mesh-ancestor
64997411|NCT00098969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997412|NCT00098969|Protective Agents|protective agents|mesh-ancestor
64997413|NCT00098969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997414|NCT00098969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997415|NCT00098969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64997416|NCT00099008|Genistein|genistein|mesh-list
64997417|NCT00099008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64997418|NCT00099008|Protective Agents|protective agents|mesh-ancestor
64997419|NCT00099008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997420|NCT00099008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997421|NCT00099008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64997422|NCT00099008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997423|NCT00099008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997424|NCT00099008|Phytoestrogens|phytoestrogens|mesh-ancestor
64997425|NCT00099008|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64997426|NCT00099008|Estrogens|estrogens|mesh-ancestor
64997427|NCT00099008|Hormones|hormones|mesh-ancestor
64997428|NCT00099008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64997429|NCT00434239|Lenalidomide|lenalidomide|mesh-list
64997430|NCT00434239|Immunologic Factors|immunologic factors|mesh-ancestor
64997431|NCT00434239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997432|NCT00434239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64997433|NCT00434239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64997434|NCT00434239|Growth Substances|growth substances|mesh-ancestor
64997435|NCT00434239|Growth Inhibitors|growth inhibitors|mesh-ancestor
64997436|NCT00434239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997444|NCT01057147|Protective Agents|protective agents|mesh-ancestor
64997445|NCT01057147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997446|NCT01057147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997448|NCT00099125|Temozolomide|temozolomide|mesh-list
64997449|NCT00099125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64997450|NCT00099125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64997451|NCT00099125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997452|NCT00099125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997453|NCT00099125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997454|NCT00099125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64997455|NCT00099125|Alkylating Agents|alkylating agents|mesh-ancestor
64997456|NCT00131703|Chloroquine|chloroquine|mesh-list
64997457|NCT00131703|Pyrimethamine|pyrimethamine|mesh-list
64997458|NCT00131703|Sulfadoxine|sulfadoxine|mesh-list
64997459|NCT00131703|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64997460|NCT00131703|Amodiaquine|amodiaquine|mesh-list
64997461|NCT00131703|Amebicides|amebicides|mesh-ancestor
64944463|NCT00276575|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64997462|NCT00131703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64997463|NCT00131703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64997464|NCT00131703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65274359|NCT00619034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274360|NCT00619034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274361|NCT00619034|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65274362|NCT00619034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64955493|NCT00203281|Mycophenolic Acid|mycophenolic acid|mesh-list
64997465|NCT00131703|Antimalarials|antimalarials|mesh-ancestor
64997466|NCT00131703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64997467|NCT00131703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64997468|NCT00131703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997469|NCT00131703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997470|NCT00131703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64997471|NCT00131703|Renal Agents|renal agents|mesh-ancestor
64997472|NCT01051414|Asunaprevir|asunaprevir|mesh-list
64997473|NCT01051414|Protease Inhibitors|protease inhibitors|mesh-ancestor
64997474|NCT01051414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997475|NCT01051414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997476|NCT00434317|Zoledronic Acid|zoledronic acid|mesh-list
64997477|NCT00434317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64997478|NCT00434317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997479|NCT00099164|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
64997480|NCT00099164|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
64997481|NCT00099164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64997482|NCT00099164|Hormone Antagonists|hormone antagonists|mesh-ancestor
64997483|NCT00099164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64997484|NCT00099164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997485|NCT00099164|Progestins|progestins|mesh-ancestor
64997487|NCT00131742|Lamivudine|lamivudine|mesh-list
64997488|NCT00131742|Telbivudine|telbivudine|mesh-list
64997489|NCT00131742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64997490|NCT00131742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64997491|NCT00131742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997492|NCT00131742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997493|NCT00131742|Antiviral Agents|antiviral agents|mesh-ancestor
64997494|NCT00131742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997495|NCT00131742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64997496|NCT00131742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64997497|NCT04621149|Lactoferrin|lactoferrin|mesh-list
64997498|NCT04621149|Chlorine dioxide|chlorine dioxide|mesh-list
64997499|NCT04621149|Famotidine|famotidine|mesh-list
64997500|NCT04621149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64997501|NCT04621149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64997502|NCT04621149|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64997503|NCT04621149|Histamine Antagonists|histamine antagonists|mesh-ancestor
64997504|NCT04621149|Histamine Agents|histamine agents|mesh-ancestor
64997505|NCT04621149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64997528|NCT00099320|Incretins|incretins|mesh-ancestor
64997529|NCT00099320|Hormones|hormones|mesh-ancestor
64997530|NCT00099320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64997531|NCT00403650|Iloprost|iloprost|mesh-list
64997532|NCT00403650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64997533|NCT00403650|Vasodilator Agents|vasodilator agents|mesh-ancestor
64978750|NCT00271492|Atrasentan|atrasentan|mesh-list
64997535|NCT00403728|Cyclosporins|cyclosporins|mesh-list
64944538|NCT00276068|Antidepressive Agents|antidepressive agents|mesh-ancestor
64997536|NCT00403728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997537|NCT00403728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997538|NCT00403728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64997539|NCT00403728|Immunologic Factors|immunologic factors|mesh-ancestor
64997540|NCT00403728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997541|NCT00403728|Antifungal Agents|antifungal agents|mesh-ancestor
64997542|NCT00403728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997543|NCT00403728|Dermatologic Agents|dermatologic agents|mesh-ancestor
64997544|NCT00403728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64997545|NCT00403728|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64997546|NCT00403806|Dexamethasone|dexamethasone|mesh-list
64997547|NCT00403806|Dexamethasone acetate|dexamethasone acetate|mesh-list
64997548|NCT00403806|BB 1101|bb 1101|mesh-list
64997549|NCT00403806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64997550|NCT00403806|Antiemetics|antiemetics|mesh-ancestor
64997551|NCT00403806|Autonomic Agents|autonomic agents|mesh-ancestor
64997552|NCT00403806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65274363|NCT00619034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65274364|NCT01614912|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65274365|NCT01614912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65274366|NCT01614912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64726871|NCT00002864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997553|NCT00403806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997554|NCT00403806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64997555|NCT00403806|Glucocorticoids|glucocorticoids|mesh-ancestor
64997556|NCT00403806|Hormones|hormones|mesh-ancestor
64304114|NCT03067688|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64997582|NCT00099554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64997583|NCT00099554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64997584|NCT00099554|Immunologic Factors|immunologic factors|mesh-ancestor
64997585|NCT00132054|Irinotecan|irinotecan|mesh-list
64997586|NCT00132054|Amrubicin|amrubicin|mesh-list
64997587|NCT00132054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64997588|NCT00132054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64997589|NCT00132054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997590|NCT00132054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997591|NCT00132054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997592|NCT00099710|Curcumin|curcumin|mesh-list
64997593|NCT00099710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64997594|NCT00099710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64997595|NCT00099710|Analgesics|analgesics|mesh-ancestor
64997596|NCT00099710|Sensory System Agents|sensory system agents|mesh-ancestor
64997597|NCT00099710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64997598|NCT00099710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997599|NCT00099710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64997600|NCT00099710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64997601|NCT00099710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997602|NCT00099710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997603|NCT00099710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997626|NCT00099866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997627|NCT00099866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64997628|NCT00099866|Protease Inhibitors|protease inhibitors|mesh-ancestor
64997629|NCT00099866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997630|NCT00099866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997631|NCT00099905|Vildagliptin|vildagliptin|mesh-list
64997632|NCT00099905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64997633|NCT00099905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997634|NCT00099905|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64997635|NCT00099905|Protease Inhibitors|protease inhibitors|mesh-ancestor
64997636|NCT00099905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997637|NCT00099905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997638|NCT00132210|Interferons|interferons|mesh-list
64997639|NCT00132210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997640|NCT00132210|Antiviral Agents|antiviral agents|mesh-ancestor
64997641|NCT00132210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997642|NCT00099944|Glimepiride|glimepiride|mesh-list
64997643|NCT00099944|Vildagliptin|vildagliptin|mesh-list
64997644|NCT00099944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64997645|NCT00099944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64997646|NCT00099944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997647|NCT00099944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64997648|NCT00099944|Immunologic Factors|immunologic factors|mesh-ancestor
64997649|NCT00099944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64997650|NCT00099944|Protease Inhibitors|protease inhibitors|mesh-ancestor
64997651|NCT00099944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997652|NCT00099944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956478|NCT00208702|Sertraline|sertraline|mesh-list
64997656|NCT04352166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64997658|NCT04352166|Analgesics|analgesics|mesh-ancestor
64997659|NCT04352166|Sensory System Agents|sensory system agents|mesh-ancestor
64997660|NCT04352166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64997661|NCT04352166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64997662|NCT04333914|Avdoralimab|avdoralimab|mesh-list
64997663|NCT04333914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64997664|NCT04333914|Antiviral Agents|antiviral agents|mesh-ancestor
64997665|NCT04333914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997666|NCT00100100|Modafinil|modafinil|mesh-list
65274367|NCT01614912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65274368|NCT01614912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274369|NCT01614912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65274370|NCT01614912|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65274371|NCT01614912|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65274372|NCT01614912|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65274373|NCT01614912|Adrenergic Agents|adrenergic agents|mesh-ancestor
64997667|NCT00100100|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64997668|NCT00100100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997669|NCT00100100|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64997670|NCT00100100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64997671|NCT00100100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64997672|NCT00100100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997673|NCT00100139|Paclitaxel|paclitaxel|mesh-list
64997674|NCT00100139|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64997675|NCT00100139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64997676|NCT00100139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997677|NCT00100139|Tubulin Modulators|tubulin modulators|mesh-ancestor
64997678|NCT00100139|Antimitotic Agents|antimitotic agents|mesh-ancestor
64997679|NCT00100139|Mitosis Modulators|mitosis modulators|mesh-ancestor
64997680|NCT00100139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997681|NCT00100412|Phenylephrine|phenylephrine|mesh-list
64997682|NCT00100412|Dobutamine|dobutamine|mesh-list
64997683|NCT00100412|Oxymetazoline|oxymetazoline|mesh-list
64997684|NCT00100412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64997685|NCT00100412|Mydriatics|mydriatics|mesh-ancestor
64997686|NCT00100412|Autonomic Agents|autonomic agents|mesh-ancestor
64997687|NCT00100412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64944682|NCT00275444|Tipranavir|tipranavir|mesh-list
64997688|NCT00100412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997689|NCT00100412|Sympathomimetics|sympathomimetics|mesh-ancestor
64997690|NCT00100412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64997691|NCT00100412|Nasal Decongestants|nasal decongestants|mesh-ancestor
64997692|NCT00100412|Respiratory System Agents|respiratory system agents|mesh-ancestor
64997693|NCT00100412|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64997694|NCT00100412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64997695|NCT00100412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64997696|NCT00100412|Adrenergic Agents|adrenergic agents|mesh-ancestor
64997697|NCT00100412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64997698|NCT00100412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997699|NCT00100412|Protective Agents|protective agents|mesh-ancestor
64997700|NCT00100412|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64997701|NCT00100412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64997702|NCT04244058|Amantadine|amantadine|mesh-list
64997703|NCT04244058|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64997704|NCT04244058|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64997705|NCT04244058|Antiviral Agents|antiviral agents|mesh-ancestor
64997706|NCT04244058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997707|NCT04244058|Dopamine Agents|dopamine agents|mesh-ancestor
64997708|NCT04244058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64997709|NCT04244058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997710|NCT04244058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997711|NCT04244058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64997712|NCT04244058|Analgesics|analgesics|mesh-ancestor
64997713|NCT04244058|Sensory System Agents|sensory system agents|mesh-ancestor
64997714|NCT04244058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64997715|NCT00132444|UC-781|uc-781|mesh-list
64997716|NCT00132444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64997717|NCT00132444|Antiviral Agents|antiviral agents|mesh-ancestor
64997718|NCT00132444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997719|NCT00100568|Lamivudine|lamivudine|mesh-list
64997720|NCT00100568|Zidovudine|zidovudine|mesh-list
64997721|NCT00100568|Efavirenz|efavirenz|mesh-list
64997722|NCT00100568|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64997723|NCT00100568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64997724|NCT00100568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64997756|NCT04728581|Mirtazapine|mirtazapine|mesh-list
65274374|NCT01614912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65274375|NCT01614912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274376|NCT01614912|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64997758|NCT04728581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64997759|NCT04728581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64997760|NCT04728581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64997761|NCT04728581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64997762|NCT04728581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997763|NCT04728581|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64997764|NCT04728581|Histamine Antagonists|histamine antagonists|mesh-ancestor
64997765|NCT04728581|Histamine Agents|histamine agents|mesh-ancestor
64997766|NCT04728581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64997767|NCT04728581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997789|NCT04728659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64997790|NCT04728659|Hormone Antagonists|hormone antagonists|mesh-ancestor
64997792|NCT00132600|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64997793|NCT00132600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997794|NCT00132600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64997795|NCT00132639|Docetaxel|docetaxel|mesh-list
64997796|NCT00132639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997797|NCT00132639|Tubulin Modulators|tubulin modulators|mesh-ancestor
64997798|NCT00132639|Antimitotic Agents|antimitotic agents|mesh-ancestor
64997799|NCT00132639|Mitosis Modulators|mitosis modulators|mesh-ancestor
64997800|NCT00132639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997801|NCT04728386|Sodium Hypochlorite|sodium hypochlorite|mesh-list
64997802|NCT04728386|Eusol|eusol|mesh-list
64997803|NCT04728386|Curcumin|curcumin|mesh-list
64997804|NCT04728386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64997805|NCT04728386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64997806|NCT04728386|Analgesics|analgesics|mesh-ancestor
64997807|NCT04728386|Sensory System Agents|sensory system agents|mesh-ancestor
64997808|NCT04728386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64997809|NCT04728386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997810|NCT04728386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64997811|NCT04728386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64997812|NCT04728386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997813|NCT04728386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997814|NCT04728386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997815|NCT04728386|Disinfectants|disinfectants|mesh-ancestor
64997816|NCT04728386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997817|NCT00100646|Ritonavir|ritonavir|mesh-list
64997818|NCT00100646|Lopinavir|lopinavir|mesh-list
64997819|NCT00100646|Lamivudine|lamivudine|mesh-list
64997820|NCT00100646|Stavudine|stavudine|mesh-list
64997821|NCT00100646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64997825|NCT00100646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997826|NCT00100646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64997827|NCT00100646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64997828|NCT00100646|Antiviral Agents|antiviral agents|mesh-ancestor
64997829|NCT00100646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997830|NCT00100646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64979048|NCT00108186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64997831|NCT00100646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64997832|NCT00100646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64997833|NCT00100646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64997834|NCT00100646|Antimetabolites|antimetabolites|mesh-ancestor
64997835|NCT00100685|Volociximab|volociximab|mesh-list
64997836|NCT00100685|Antibodies|antibodies|mesh-list
64997837|NCT00100685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64944841|NCT03062826|Aspirin|aspirin|mesh-list
64997838|NCT00100685|Immunologic Factors|immunologic factors|mesh-ancestor
64997839|NCT00100685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997840|NCT00100685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64997841|NCT00100685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64997842|NCT00100685|Growth Substances|growth substances|mesh-ancestor
64997843|NCT00100685|Growth Inhibitors|growth inhibitors|mesh-ancestor
64997844|NCT00100685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997845|NCT00132756|Estramustine|estramustine|mesh-list
64997846|NCT00132756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64997847|NCT00132756|Alkylating Agents|alkylating agents|mesh-ancestor
64997848|NCT00132756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274377|NCT01614912|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65274378|NCT01614912|Serotonin Agents|serotonin agents|mesh-ancestor
65274379|NCT01614912|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65274380|NCT01614912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65274381|NCT01614912|Dopamine Agents|dopamine agents|mesh-ancestor
64997849|NCT00132756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997850|NCT00132756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64997851|NCT00100880|Lenalidomide|lenalidomide|mesh-list
64997852|NCT00100880|Immunologic Factors|immunologic factors|mesh-ancestor
64997853|NCT00100880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997854|NCT00100880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64997855|NCT00100880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64997856|NCT00100880|Growth Substances|growth substances|mesh-ancestor
64997857|NCT00100880|Growth Inhibitors|growth inhibitors|mesh-ancestor
64997858|NCT00100880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997859|NCT00100958|Indole-3-carbinol|indole-3-carbinol|mesh-list
64997860|NCT00100958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64997861|NCT00100958|Protective Agents|protective agents|mesh-ancestor
64997862|NCT00100958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997863|NCT00100958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997864|NCT00101075|Capecitabine|capecitabine|mesh-list
64997865|NCT00101075|Oxaliplatin|oxaliplatin|mesh-list
64997866|NCT00101075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64997867|NCT00101075|Antimetabolites|antimetabolites|mesh-ancestor
64997868|NCT00101075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997869|NCT00101075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997870|NCT00132912|Vorapaxar|vorapaxar|mesh-list
64997871|NCT00132912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64997872|NCT00403182|Letrozole|letrozole|mesh-list
64997873|NCT00403182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997874|NCT00403182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64997875|NCT00403182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64997876|NCT00403182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997877|NCT00403182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997878|NCT00403182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64997879|NCT00403182|Hormone Antagonists|hormone antagonists|mesh-ancestor
64997880|NCT00403182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64997881|NCT00403182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997882|NCT00101114|Interferons|interferons|mesh-list
64997883|NCT00101114|Interferon-alpha|interferon-alpha|mesh-list
64997884|NCT00101114|Interferon alpha-2|interferon alpha-2|mesh-list
64997885|NCT00101114|Sorafenib|sorafenib|mesh-list
64997886|NCT00101114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997887|NCT00101114|Antiviral Agents|antiviral agents|mesh-ancestor
64997888|NCT00101114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997889|NCT00101114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64997890|NCT00101114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997891|NCT00101114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997910|NCT00132951|Azithromycin|azithromycin|mesh-list
64997911|NCT00132951|Telithromycin|telithromycin|mesh-list
64997912|NCT00132951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64997913|NCT00132951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997914|NCT00400790|Propofol|propofol|mesh-list
64997915|NCT00400790|Desflurane|desflurane|mesh-list
64997917|NCT00400790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64997918|NCT00400790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997919|NCT00400790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64997920|NCT00400790|Anesthetics, General|anesthetics, general|mesh-ancestor
64997921|NCT00400790|Anesthetics|anesthetics|mesh-ancestor
64997922|NCT00400790|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64997923|NCT00133029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64997924|NCT00133029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997925|NCT00135408|Budesonide|budesonide|mesh-list
64997926|NCT00135408|Ipilimumab|ipilimumab|mesh-list
64997927|NCT00135408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64997928|NCT00135408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997929|NCT00135408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64997930|NCT00135408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997931|NCT00135408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64997932|NCT00135408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64997933|NCT00135408|Autonomic Agents|autonomic agents|mesh-ancestor
65274382|NCT00638742|Latanoprost|latanoprost|mesh-list
65274383|NCT00638742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65274384|NCT00638742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65274385|NCT03512418|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65274386|NCT03512418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65274387|NCT03512418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65274388|NCT03512418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726895|NCT00002581|Tamoxifen|tamoxifen|mesh-list
64997934|NCT00135408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64997935|NCT00135408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997936|NCT00135408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64997937|NCT00135408|Respiratory System Agents|respiratory system agents|mesh-ancestor
64997938|NCT00135408|Glucocorticoids|glucocorticoids|mesh-ancestor
64997939|NCT00135408|Hormones|hormones|mesh-ancestor
64997940|NCT00135408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64997941|NCT00101231|Alvocidib|alvocidib|mesh-list
64997942|NCT00101231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997943|NCT00101231|Growth Inhibitors|growth inhibitors|mesh-ancestor
64997944|NCT00101231|Growth Substances|growth substances|mesh-ancestor
64997945|NCT00101231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997946|NCT00101231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64997947|NCT00101231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997948|NCT00101231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997949|NCT00101270|Oxaliplatin|oxaliplatin|mesh-list
64997950|NCT00101270|Irinotecan|irinotecan|mesh-list
64997951|NCT00101270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956748|NCT00209833|Antiviral Agents|antiviral agents|mesh-ancestor
64998050|NCT00135681|Hormones|hormones|mesh-ancestor
64998051|NCT00135681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64998052|NCT00135681|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
64998053|NCT00135681|Immunologic Factors|immunologic factors|mesh-ancestor
64998054|NCT00135681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64998055|NCT00135720|Etanercept|etanercept|mesh-list
64998056|NCT00135720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64998057|NCT00135720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64998058|NCT00135720|Analgesics|analgesics|mesh-ancestor
64998059|NCT00135720|Sensory System Agents|sensory system agents|mesh-ancestor
64998060|NCT00135720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64998061|NCT00135720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998062|NCT00135720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64998063|NCT00135720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64998064|NCT00135720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64998065|NCT00135720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64998066|NCT00135720|Immunologic Factors|immunologic factors|mesh-ancestor
64998067|NCT00101894|Panitumumab|panitumumab|mesh-list
64998068|NCT00101894|Motesanib diphosphate|motesanib diphosphate|mesh-list
64998124|NCT00102206|Lamivudine|lamivudine|mesh-list
64998125|NCT00102206|Zidovudine|zidovudine|mesh-list
64998126|NCT00102206|Emtricitabine|emtricitabine|mesh-list
64998127|NCT00102206|Abacavir|abacavir|mesh-list
64998128|NCT00102206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64998129|NCT00102206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64998130|NCT00102206|Protease Inhibitors|protease inhibitors|mesh-ancestor
64998131|NCT00102206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998132|NCT00102206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998133|NCT00102206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64998134|NCT00102206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64945135|NCT00038532|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64998135|NCT00102206|Antiviral Agents|antiviral agents|mesh-ancestor
64998136|NCT00102206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64998137|NCT00102206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64998138|NCT00102206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64998139|NCT00102206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64998140|NCT00102206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64998141|NCT00102206|Antimetabolites|antimetabolites|mesh-ancestor
64998142|NCT00102284|Levodopa|levodopa|mesh-list
64998143|NCT00102284|Modafinil|modafinil|mesh-list
64998144|NCT00102284|Rivastigmine|rivastigmine|mesh-list
65274389|NCT03512418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274390|NCT03512418|Antiviral Agents|antiviral agents|mesh-ancestor
65274391|NCT03512418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64998145|NCT00102284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64998146|NCT00102284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64998147|NCT00102284|Dopamine Agents|dopamine agents|mesh-ancestor
64998148|NCT00102284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64998149|NCT00102284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998150|NCT00102284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998151|NCT00102284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64998152|NCT00102284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64998153|NCT00102284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64956937|NCT00041327|Interferon-alpha|interferon-alpha|mesh-list
64998180|NCT00102479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64998181|NCT00102479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64998182|NCT00102479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998183|NCT00102479|Dopamine Agonists|dopamine agonists|mesh-ancestor
64998184|NCT00102479|Dopamine Agents|dopamine agents|mesh-ancestor
64998185|NCT00102479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64998186|NCT00102479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998187|NCT00102479|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64998188|NCT00102479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64998189|NCT00102479|Serotonin Agents|serotonin agents|mesh-ancestor
64998190|NCT00102479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64998191|NCT00102479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64998192|NCT00102479|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64998193|NCT00102479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64998194|NCT00135954|Prednisolone|prednisolone|mesh-list
64998195|NCT00135954|Cyclophosphamide|cyclophosphamide|mesh-list
64998196|NCT00135954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64998197|NCT00135954|Immunologic Factors|immunologic factors|mesh-ancestor
64998198|NCT00135954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956994|NCT00210691|Risperidone|risperidone|mesh-list
64998220|NCT00102635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64998221|NCT00102635|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64998222|NCT00102635|Protective Agents|protective agents|mesh-ancestor
64998223|NCT00102635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998224|NCT00102635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998225|NCT00102635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998226|NCT00133419|Vitamins|vitamins|mesh-list
64998227|NCT00133419|Vitamin A|vitamin a|mesh-list
64998229|NCT00133419|Trace Elements|trace elements|mesh-list
64998230|NCT00133419|Micronutrients|micronutrients|mesh-list
64998231|NCT00133419|Retinol palmitate|retinol palmitate|mesh-list
64998232|NCT00133419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998233|NCT00133419|Antioxidants|antioxidants|mesh-ancestor
64998234|NCT00133419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998235|NCT00133419|Protective Agents|protective agents|mesh-ancestor
64998236|NCT00133419|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64998237|NCT00133419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64998238|NCT00102674|Cangrelor|cangrelor|mesh-list
64998239|NCT00102674|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64998240|NCT00102674|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64998241|NCT00102674|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64998242|NCT00102674|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64998243|NCT00102674|Purinergic Agents|purinergic agents|mesh-ancestor
64998244|NCT00102674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64998245|NCT00102674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998246|NCT00102674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998247|NCT00135993|Rotigotine|rotigotine|mesh-list
64998248|NCT00135993|Dopamine Agonists|dopamine agonists|mesh-ancestor
64998249|NCT00135993|Dopamine Agents|dopamine agents|mesh-ancestor
64998250|NCT00135993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64998251|NCT00135993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998252|NCT00135993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998253|NCT00102713|Valproic Acid|valproic acid|mesh-list
64998284|NCT00102752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64998285|NCT00102752|Immunologic Factors|immunologic factors|mesh-ancestor
64998286|NCT00102752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998287|NCT00102830|Trebananib|trebananib|mesh-list
65274392|NCT03512418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65274393|NCT03512418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65274394|NCT02686242|Anesthetics|anesthetics|mesh-list
65024405|NCT04686058|Narcotics|narcotics|mesh-ancestor
65274395|NCT02686242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65274396|NCT02686242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274397|NCT05661786|Antiviral Agents|antiviral agents|mesh-list
65274398|NCT05661786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65274399|NCT00639522|Paclitaxel|paclitaxel|mesh-list
65274400|NCT00639522|Capecitabine|capecitabine|mesh-list
64998288|NCT00102830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64998289|NCT00102830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64998290|NCT00102830|Growth Substances|growth substances|mesh-ancestor
64998291|NCT00102830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998292|NCT00102830|Growth Inhibitors|growth inhibitors|mesh-ancestor
64998293|NCT00102830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64998294|NCT00136110|Valproic Acid|valproic acid|mesh-list
64998295|NCT00136110|Anticonvulsants|anticonvulsants|mesh-ancestor
64998296|NCT00136110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998297|NCT00136110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957096|NCT00211471|Anecortave|anecortave|mesh-list
64998317|NCT00102869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998318|NCT00102908|Zoledronic Acid|zoledronic acid|mesh-list
64998319|NCT00102908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64998320|NCT00102908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998321|NCT00401024|Imatinib Mesylate|imatinib mesylate|mesh-list
64998322|NCT00401024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64998323|NCT00401024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64998324|NCT00401024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998325|NCT00401024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998327|NCT00136266|Vitamins|vitamins|mesh-list
64998328|NCT00136266|Vitamin A|vitamin a|mesh-list
64998329|NCT00136266|Ferrous fumarate|ferrous fumarate|mesh-list
64998330|NCT00136266|Micronutrients|micronutrients|mesh-ancestor
64998331|NCT00136266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998332|NCT00136266|Trace Elements|trace elements|mesh-ancestor
64998333|NCT00136266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64998334|NCT00102947|Daptomycin|daptomycin|mesh-list
64998335|NCT00102947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64998336|NCT00102947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64998337|NCT00136344|Levofloxacin|levofloxacin|mesh-list
64998338|NCT00136344|Ofloxacin|ofloxacin|mesh-list
64998339|NCT00136344|Cefuroxime|cefuroxime|mesh-list
64998340|NCT00136344|Cefuroxime axetil|cefuroxime axetil|mesh-list
64998341|NCT00136344|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64998342|NCT00136344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64998343|NCT00136344|Renal Agents|renal agents|mesh-ancestor
64998344|NCT00136344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64998345|NCT00136344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64998346|NCT00136344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64998347|NCT00136344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998348|NCT00136344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998349|NCT00136344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64998350|NCT00136344|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64998351|NCT00136344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64998352|NCT00102986|Ritonavir|ritonavir|mesh-list
64998353|NCT00102986|Lopinavir|lopinavir|mesh-list
64998354|NCT00102986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64998355|NCT00102986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64998356|NCT00102986|Protease Inhibitors|protease inhibitors|mesh-ancestor
64998362|NCT00102986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64998363|NCT00102986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64998364|NCT00102986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64998365|NCT00136383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64998366|NCT00136383|Paroxetine|paroxetine|mesh-list
64998367|NCT00136383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64998368|NCT00136383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65274401|NCT00639522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65274402|NCT00639522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274403|NCT00639522|Tubulin Modulators|tubulin modulators|mesh-ancestor
65274404|NCT00639522|Antimitotic Agents|antimitotic agents|mesh-ancestor
65274405|NCT00639522|Mitosis Modulators|mitosis modulators|mesh-ancestor
64998369|NCT00136383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64998370|NCT00136383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998371|NCT00136383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64998372|NCT00136383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998373|NCT00136383|Analgesics|analgesics|mesh-ancestor
64998374|NCT00136383|Sensory System Agents|sensory system agents|mesh-ancestor
64998375|NCT00136383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64998376|NCT00136383|Antidepressive Agents|antidepressive agents|mesh-ancestor
64998377|NCT00136383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64998378|NCT00136383|Dopamine Agents|dopamine agents|mesh-ancestor
64998379|NCT00136383|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64998380|NCT00136383|Serotonin Agents|serotonin agents|mesh-ancestor
64998381|NCT00136383|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64998382|NCT00136383|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64998383|NCT00136383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64998384|NCT00136383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998385|NCT00103103|Leucovorin|leucovorin|mesh-list
64998386|NCT00103103|Fluorouracil|fluorouracil|mesh-list
64998387|NCT00103103|Bortezomib|bortezomib|mesh-list
64998388|NCT00103103|Calcium|calcium|mesh-list
64998389|NCT00103103|Levoleucovorin|levoleucovorin|mesh-list
64998390|NCT00103103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64998391|NCT00103103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998392|NCT00103103|Antimetabolites|antimetabolites|mesh-ancestor
64998393|NCT00103103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998394|NCT00103103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64998395|NCT00103103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64998396|NCT00103103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64998397|NCT00103103|Immunologic Factors|immunologic factors|mesh-ancestor
64998398|NCT00103103|Antidotes|antidotes|mesh-ancestor
64998399|NCT00103103|Protective Agents|protective agents|mesh-ancestor
64998400|NCT00103103|Vitamin B Complex|vitamin b complex|mesh-ancestor
64998401|NCT00103103|Vitamins|vitamins|mesh-ancestor
64998402|NCT00103103|Micronutrients|micronutrients|mesh-ancestor
64998403|NCT00133692|Atenolol|atenolol|mesh-list
64998404|NCT00133692|Verapamil|verapamil|mesh-list
64998405|NCT00133692|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64998406|NCT00133692|Trandolapril|trandolapril|mesh-list
64998407|NCT00133692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64998408|NCT00133692|Diuretics|diuretics|mesh-ancestor
64998409|NCT00133692|Natriuretic Agents|natriuretic agents|mesh-ancestor
64998410|NCT00133692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998411|NCT00133692|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64998412|NCT00133692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64998413|NCT00133692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998414|NCT00133692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64998415|NCT00133692|Sympatholytics|sympatholytics|mesh-ancestor
64998416|NCT00133692|Autonomic Agents|autonomic agents|mesh-ancestor
64998417|NCT00133692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64998418|NCT00133692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64998419|NCT00133692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64998420|NCT00133692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64998421|NCT00133692|Adrenergic Agents|adrenergic agents|mesh-ancestor
64998422|NCT00133692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64998423|NCT00133692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64998424|NCT00133692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64998425|NCT00133692|Vasodilator Agents|vasodilator agents|mesh-ancestor
64484384|NCT01729819|Hemostatics|hemostatics|mesh-ancestor
64998440|NCT00133731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998442|NCT00103298|Fluorouracil|fluorouracil|mesh-list
64998443|NCT00103298|Oxaliplatin|oxaliplatin|mesh-list
64998444|NCT00103298|Melphalan|melphalan|mesh-list
64998445|NCT00103298|Calcium|calcium|mesh-list
64998446|NCT00103298|Levoleucovorin|levoleucovorin|mesh-list
64998447|NCT00103298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64998448|NCT00103298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274406|NCT00639522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274407|NCT00639522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65274408|NCT00639522|Antimetabolites|antimetabolites|mesh-ancestor
65274409|NCT00411138|Paclitaxel|paclitaxel|mesh-list
64998449|NCT00103298|Antimetabolites|antimetabolites|mesh-ancestor
64998450|NCT00103298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998451|NCT00103298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64998452|NCT00103298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64998453|NCT00103298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64998454|NCT00103298|Immunologic Factors|immunologic factors|mesh-ancestor
64998455|NCT00103298|Antidotes|antidotes|mesh-ancestor
64998456|NCT00103298|Protective Agents|protective agents|mesh-ancestor
64998457|NCT00103298|Vitamin B Complex|vitamin b complex|mesh-ancestor
64998458|NCT00103298|Vitamins|vitamins|mesh-ancestor
64998459|NCT00103298|Micronutrients|micronutrients|mesh-ancestor
64998460|NCT00103298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64998461|NCT00103298|Alkylating Agents|alkylating agents|mesh-ancestor
64998462|NCT00103298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64998463|NCT00136461|Tretinoin|tretinoin|mesh-list
64998464|NCT00136461|Bryostatin 1|bryostatin 1|mesh-list
64998465|NCT00136461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64998466|NCT00136461|Keratolytic Agents|keratolytic agents|mesh-ancestor
64998467|NCT00136461|Dermatologic Agents|dermatologic agents|mesh-ancestor
64998468|NCT00136461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64998469|NCT00136461|Immunologic Factors|immunologic factors|mesh-ancestor
64998470|NCT00136461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998471|NCT00133770|Pantoprazole|pantoprazole|mesh-list
64998472|NCT00133770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64998473|NCT00133770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64998474|NCT00133770|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64998475|NCT00133770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998476|NCT00133770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998477|NCT00133848|Retapamulin|retapamulin|mesh-list
64998478|NCT00133848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64998479|NCT00133848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64998480|NCT00133887|Sirolimus|sirolimus|mesh-list
64998481|NCT00133887|Cyclosporine|cyclosporine|mesh-list
64998482|NCT00133887|Tacrolimus|tacrolimus|mesh-list
64998483|NCT00133887|Cyclosporins|cyclosporins|mesh-list
64998484|NCT00133887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64998485|NCT00133887|Immunologic Factors|immunologic factors|mesh-ancestor
64998486|NCT00133887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998487|NCT00133887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64998488|NCT00133887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998489|NCT00133887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957259|NCT00213538|Antimetabolites|antimetabolites|mesh-ancestor
64998511|NCT00136539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64998512|NCT00136539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64998513|NCT00136539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998514|NCT00136539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64998516|NCT00103571|Aripiprazole|aripiprazole|mesh-list
64998517|NCT00103571|Antiemetics|antiemetics|mesh-ancestor
64998518|NCT00103571|Autonomic Agents|autonomic agents|mesh-ancestor
64998519|NCT00103571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64998520|NCT00103571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998521|NCT00103571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64998522|NCT00103571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64998523|NCT00103571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64998524|NCT00103571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64998525|NCT00103571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64998526|NCT00103571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64998527|NCT00103571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64998528|NCT00103571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64998529|NCT00103571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998530|NCT00103571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64998531|NCT00103571|Serotonin Agents|serotonin agents|mesh-ancestor
64998532|NCT00103571|Antidepressive Agents|antidepressive agents|mesh-ancestor
64998533|NCT00103571|Dopamine Agonists|dopamine agonists|mesh-ancestor
64998534|NCT00103571|Dopamine Agents|dopamine agents|mesh-ancestor
64998535|NCT00103571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64998536|NCT00103571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64998537|NCT00103571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65274410|NCT00411138|Carboplatin|carboplatin|mesh-list
65274411|NCT00411138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65274412|NCT00411138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274413|NCT00411138|Tubulin Modulators|tubulin modulators|mesh-ancestor
65274414|NCT00411138|Antimitotic Agents|antimitotic agents|mesh-ancestor
65274415|NCT00411138|Mitosis Modulators|mitosis modulators|mesh-ancestor
65274416|NCT00411138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274417|NCT02686086|Albuterol|albuterol|mesh-list
64998538|NCT00103571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64998539|NCT00103571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64998540|NCT00103571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64998541|NCT00136578|Carboplatin|carboplatin|mesh-list
64998542|NCT00136578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64998569|NCT00103727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64998570|NCT00103727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64998571|NCT00103727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64998572|NCT00103727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64998573|NCT00103727|Dopamine Agents|dopamine agents|mesh-ancestor
64998574|NCT00103766|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64998575|NCT00103766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64998576|NCT00103766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64998577|NCT00103766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998578|NCT00103805|Levodopa|levodopa|mesh-list
64998579|NCT00103805|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64998580|NCT00103805|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64998581|NCT00103805|Dopamine Agents|dopamine agents|mesh-ancestor
64998582|NCT00103805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64998583|NCT00103805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998584|NCT00103805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998585|NCT00404040|Lactulose|lactulose|mesh-list
64998586|NCT00404040|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64998587|NCT00404040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64998588|NCT00404040|Laxatives|laxatives|mesh-ancestor
64998589|NCT00103922|Cilomilast|cilomilast|mesh-list
64957366|NCT00214630|Atorvastatin|atorvastatin|mesh-list
64998607|NCT00136656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64998608|NCT00136656|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64998609|NCT00136656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64998610|NCT00136656|Antitubercular Agents|antitubercular agents|mesh-ancestor
64998611|NCT00134199|Sibutramine|sibutramine|mesh-list
64998612|NCT00134199|Antidepressive Agents|antidepressive agents|mesh-ancestor
64998613|NCT00134199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64998614|NCT00134199|Appetite Depressants|appetite depressants|mesh-ancestor
64998615|NCT00134199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64998616|NCT04729088|Isosorbide|isosorbide|mesh-list
64998617|NCT04729088|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64998618|NCT04729088|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64998619|NCT04729088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64998620|NCT04729088|Diuretics|diuretics|mesh-ancestor
64998621|NCT04729088|Natriuretic Agents|natriuretic agents|mesh-ancestor
64998622|NCT04729088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998623|NCT04729088|Vasodilator Agents|vasodilator agents|mesh-ancestor
64998624|NCT04729088|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64998625|NCT04729088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998626|NCT00136734|Methylphenidate|methylphenidate|mesh-list
64998627|NCT00136734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64998628|NCT00136734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998629|NCT00136734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64998630|NCT00136734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64998631|NCT00136734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64998632|NCT00136734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998633|NCT00136734|Dopamine Agents|dopamine agents|mesh-ancestor
64998634|NCT00136734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64998635|NCT00136773|Amlodipine|amlodipine|mesh-list
64998636|NCT00136773|Benazepril|benazepril|mesh-list
64998637|NCT00136773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64998638|NCT00136773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64998639|NCT00136773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65274418|NCT02686086|Ipratropium|ipratropium|mesh-list
65274419|NCT02686086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65274420|NCT02686086|Autonomic Agents|autonomic agents|mesh-ancestor
65274421|NCT02686086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64998640|NCT00136773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998641|NCT00136773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64998642|NCT00136773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998665|NCT00104273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998667|NCT00136929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64998668|NCT00136929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998669|NCT00134355|Vatalanib|vatalanib|mesh-list
64998670|NCT00134355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64998671|NCT00134355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998672|NCT00134355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998673|NCT00104429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64998674|NCT00104429|Aplaviroc|aplaviroc|mesh-list
64998675|NCT00104429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64998676|NCT00104429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64998677|NCT00104429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998678|NCT00104429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998679|NCT00104429|Antiviral Agents|antiviral agents|mesh-ancestor
64998680|NCT00104429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64998681|NCT00104429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64998682|NCT00104429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64998683|NCT00104429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64998684|NCT00104429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64998685|NCT00136968|Voriconazole|voriconazole|mesh-list
64998686|NCT00136968|Antifungal Agents|antifungal agents|mesh-ancestor
64998687|NCT00136968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64998688|NCT00136968|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64998689|NCT00136968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64998690|NCT00136968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957465|NCT00215176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64998723|NCT00137085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64998724|NCT00137085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64998725|NCT00137085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998727|NCT00104546|Vitamins|vitamins|mesh-ancestor
64998728|NCT00104546|Micronutrients|micronutrients|mesh-ancestor
64998729|NCT00104546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998730|NCT00104546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64998731|NCT00104546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64998748|NCT00134394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64998749|NCT00134394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64998750|NCT00134394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64998752|NCT00104624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64998753|NCT00104624|Tubulin Modulators|tubulin modulators|mesh-ancestor
64998754|NCT00104624|Antimitotic Agents|antimitotic agents|mesh-ancestor
64998755|NCT00104624|Mitosis Modulators|mitosis modulators|mesh-ancestor
64998756|NCT00104624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998757|NCT00104663|Quinacrine|quinacrine|mesh-list
64998758|NCT00104663|Anticestodal Agents|anticestodal agents|mesh-ancestor
64998759|NCT00104663|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64998760|NCT00104663|Anthelmintics|anthelmintics|mesh-ancestor
64998761|NCT00104663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64998762|NCT00104663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64998763|NCT00104663|Antimalarials|antimalarials|mesh-ancestor
64998764|NCT00104663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64998765|NCT00104663|Antinematodal Agents|antinematodal agents|mesh-ancestor
64998766|NCT00104663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64998767|NCT00104663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998768|NCT00104663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998769|NCT00104741|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64998770|NCT00104741|Flutamide|flutamide|mesh-list
64998771|NCT00104741|Luteolytic Agents|luteolytic agents|mesh-ancestor
64998772|NCT00104741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64998773|NCT00104741|Contraceptive Agents|contraceptive agents|mesh-ancestor
64998774|NCT00104741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64998775|NCT00104741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998776|NCT00104741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65274422|NCT02686086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274423|NCT02686086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65274424|NCT02686086|Respiratory System Agents|respiratory system agents|mesh-ancestor
65274425|NCT02686086|Tocolytic Agents|tocolytic agents|mesh-ancestor
65274426|NCT02686086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65274427|NCT02686086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65274428|NCT02686086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65274429|NCT02686086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64998777|NCT00104741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64998778|NCT00104741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64998779|NCT00104741|Androgen Antagonists|androgen antagonists|mesh-ancestor
64998780|NCT00104741|Hormone Antagonists|hormone antagonists|mesh-ancestor
64998781|NCT00104741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64998782|NCT00134511|Atorvastatin|atorvastatin|mesh-list
64998783|NCT00134511|Torcetrapib|torcetrapib|mesh-list
64998784|NCT00134511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64998785|NCT00134511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64998786|NCT00134511|Antimetabolites|antimetabolites|mesh-ancestor
64998787|NCT00134511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957558|NCT00216034|Antiviral Agents|antiviral agents|mesh-ancestor
64998821|NCT00137202|Serotonin Agents|serotonin agents|mesh-ancestor
64998822|NCT00137202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64998823|NCT00137202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998824|NCT00137202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64998825|NCT00137202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64998826|NCT00137202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64998827|NCT00137202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64998828|NCT00137202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64998829|NCT00137202|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64998859|NCT00137358|Protective Agents|protective agents|mesh-ancestor
64998860|NCT00137358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998861|NCT00134667|Verteporfin|verteporfin|mesh-list
64998862|NCT00134667|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64998863|NCT00134667|Dermatologic Agents|dermatologic agents|mesh-ancestor
64998864|NCT00134706|Carboplatin|carboplatin|mesh-list
64998865|NCT00134706|Docetaxel|docetaxel|mesh-list
64998866|NCT00134706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64998867|NCT00134706|Tubulin Modulators|tubulin modulators|mesh-ancestor
64998868|NCT00134706|Antimitotic Agents|antimitotic agents|mesh-ancestor
64998869|NCT00134706|Mitosis Modulators|mitosis modulators|mesh-ancestor
64998870|NCT00134706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998871|NCT00137397|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64998872|NCT00137397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64998873|NCT00137397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64998874|NCT00137397|Cholinergic Agents|cholinergic agents|mesh-ancestor
64998875|NCT00137397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64998876|NCT00137397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998877|NCT00137397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998901|NCT00105209|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64998902|NCT00105209|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64998903|NCT00105209|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64998904|NCT00105209|Purinergic Agents|purinergic agents|mesh-ancestor
64998905|NCT00105209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64998906|NCT00105287|Fentanyl|fentanyl|mesh-list
64998907|NCT00105287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64998908|NCT00105287|Narcotics|narcotics|mesh-ancestor
64998909|NCT00105287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64998910|NCT00105287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998911|NCT00105287|Analgesics|analgesics|mesh-ancestor
64998912|NCT00105287|Sensory System Agents|sensory system agents|mesh-ancestor
64998913|NCT00105287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64998914|NCT00105287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64998915|NCT00105287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64998916|NCT00105287|Anesthetics, General|anesthetics, general|mesh-ancestor
64998917|NCT00105287|Anesthetics|anesthetics|mesh-ancestor
64998918|NCT00137514|Chloroquine|chloroquine|mesh-list
65274430|NCT02686086|Adrenergic Agents|adrenergic agents|mesh-ancestor
65274431|NCT02686086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65274432|NCT02686086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998919|NCT00137514|Amodiaquine|amodiaquine|mesh-list
64998920|NCT00137514|Amebicides|amebicides|mesh-ancestor
64998921|NCT00137514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64998922|NCT00137514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64998923|NCT00137514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64998924|NCT00137514|Antimalarials|antimalarials|mesh-ancestor
64998925|NCT00137514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64998926|NCT00105326|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64998927|NCT00105326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64998928|NCT00105326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64998929|NCT00105326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64998930|NCT00105326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957702|NCT00216775|Interferon-alpha|interferon-alpha|mesh-list
64998962|NCT00105404|Immunologic Factors|immunologic factors|mesh-ancestor
64998963|NCT00105404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998964|NCT00105404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998965|NCT00134979|Formoterol Fumarate|formoterol fumarate|mesh-list
64998966|NCT00134979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64998967|NCT00134979|Autonomic Agents|autonomic agents|mesh-ancestor
64998968|NCT00134979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64998969|NCT00134979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998970|NCT00134979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64998971|NCT00134979|Respiratory System Agents|respiratory system agents|mesh-ancestor
64957755|NCT00412204|Respiratory System Agents|respiratory system agents|mesh-ancestor
64998990|NCT00135018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998991|NCT00137709|Lamotrigine|lamotrigine|mesh-list
64998992|NCT00137709|Valproic Acid|valproic acid|mesh-list
64998993|NCT00137709|Anticonvulsants|anticonvulsants|mesh-ancestor
64998994|NCT00137709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64998995|NCT00137709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64998996|NCT00137709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998997|NCT00137709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64998998|NCT00137709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998999|NCT00137709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64999000|NCT00137709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64999001|NCT00137709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64999002|NCT00137709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64999003|NCT00137709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64999004|NCT00137709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999005|NCT00137709|GABA Agents|gaba agents|mesh-ancestor
64999006|NCT00137709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64999007|NCT00137709|Antimanic Agents|antimanic agents|mesh-ancestor
64999008|NCT01054144|Dexamethasone|dexamethasone|mesh-list
64999009|NCT01054144|Prednisone|prednisone|mesh-list
64999010|NCT01054144|Lenalidomide|lenalidomide|mesh-list
64999011|NCT01054144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64999012|NCT01054144|Antiemetics|antiemetics|mesh-ancestor
64999013|NCT01054144|Autonomic Agents|autonomic agents|mesh-ancestor
64999014|NCT01054144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64999015|NCT01054144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999016|NCT01054144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64999017|NCT01054144|Glucocorticoids|glucocorticoids|mesh-ancestor
64999018|NCT01054144|Hormones|hormones|mesh-ancestor
64999019|NCT01054144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64999020|NCT01054144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64999021|NCT01054144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999022|NCT01054144|Immunologic Factors|immunologic factors|mesh-ancestor
64999023|NCT01054144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64999024|NCT01054144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64999025|NCT01054144|Growth Substances|growth substances|mesh-ancestor
64999026|NCT01054144|Growth Inhibitors|growth inhibitors|mesh-ancestor
64999027|NCT03277495|Nicotine|nicotine|mesh-list
64999053|NCT04702048|Growth Inhibitors|growth inhibitors|mesh-ancestor
64999054|NCT04702048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999055|NCT00434629|Tositumomab I-131|tositumomab i-131|mesh-list
64999056|NCT00434629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999057|NCT00135057|Insulin|insulin|mesh-list
64999058|NCT00135057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64999059|NCT00135057|Insulin Glargine|insulin glargine|mesh-list
64999060|NCT00135057|Insulin glulisine|insulin glulisine|mesh-list
65274433|NCT02686086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65274434|NCT02686086|Cholinergic Agents|cholinergic agents|mesh-ancestor
65274435|NCT03460158|Hyaluronic Acid|hyaluronic acid|mesh-list
65274436|NCT03460158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65274437|NCT03460158|Immunologic Factors|immunologic factors|mesh-ancestor
65274438|NCT03460158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274439|NCT03460158|Viscosupplements|viscosupplements|mesh-ancestor
65274440|NCT03460158|Protective Agents|protective agents|mesh-ancestor
65274441|NCT02697630|Pembrolizumab|pembrolizumab|mesh-list
65274442|NCT02697630|Entinostat|entinostat|mesh-list
65274443|NCT02697630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65274444|NCT02697630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274445|NCT02697630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65274446|NCT02697630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274447|NCT02697630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999061|NCT00135057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64999062|NCT00135057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999063|NCT00434668|Cisplatin|cisplatin|mesh-list
64999064|NCT00434668|Docetaxel|docetaxel|mesh-list
64999065|NCT00434668|Vinorelbine|vinorelbine|mesh-list
64999066|NCT00434668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999067|NCT00434668|Tubulin Modulators|tubulin modulators|mesh-ancestor
64999068|NCT00434668|Antimitotic Agents|antimitotic agents|mesh-ancestor
64999069|NCT00434668|Mitosis Modulators|mitosis modulators|mesh-ancestor
64999070|NCT00434668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999071|NCT00434668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64999072|NCT00434746|Fezakinumab|fezakinumab|mesh-list
64999073|NCT00434746|Dermatologic Agents|dermatologic agents|mesh-ancestor
64999074|NCT00137826|Bevacizumab|bevacizumab|mesh-list
64999075|NCT00137826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64999076|NCT00137826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64999077|NCT00137826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957856|NCT00217828|Citalopram|citalopram|mesh-list
64999103|NCT00434863|Botulinum Toxins|botulinum toxins|mesh-list
64999104|NCT00434863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64999105|NCT00434863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64999106|NCT00434863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64999107|NCT00434863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64999108|NCT00434863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999109|NCT00434863|Cholinergic Agents|cholinergic agents|mesh-ancestor
64999110|NCT00434863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64999111|NCT00434863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999112|NCT00434863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64999113|NCT00434863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64999114|NCT00434941|Capecitabine|capecitabine|mesh-list
64999115|NCT00434941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64999116|NCT00434941|Antimetabolites|antimetabolites|mesh-ancestor
64999117|NCT00434941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999118|NCT00434941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999119|NCT00135096|Insulin|insulin|mesh-list
64999120|NCT00135096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64999121|NCT00135096|Insulin Glargine|insulin glargine|mesh-list
64999122|NCT00135096|Insulin glulisine|insulin glulisine|mesh-list
64999123|NCT00135096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64999124|NCT00135096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999125|NCT00435058|Timolol|timolol|mesh-list
64999159|NCT00135135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64999160|NCT00135135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64999161|NCT00135135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64999162|NCT00135135|Alkylating Agents|alkylating agents|mesh-ancestor
65274448|NCT02685852|Exenatide|exenatide|mesh-list
65274449|NCT02685852|Acarbose|acarbose|mesh-list
65274450|NCT02685852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65274451|NCT02685852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274452|NCT02685852|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65274453|NCT02685852|Incretins|incretins|mesh-ancestor
65274454|NCT02685852|Hormones|hormones|mesh-ancestor
65274455|NCT02685852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65274456|NCT02685852|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65274457|NCT02685852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344906|NCT00423943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64999163|NCT00135135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64999164|NCT00135135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64999165|NCT00135135|Immunologic Factors|immunologic factors|mesh-ancestor
64999166|NCT00135135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999167|NCT00135135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64999168|NCT00135135|Keratolytic Agents|keratolytic agents|mesh-ancestor
64999169|NCT00135135|Dermatologic Agents|dermatologic agents|mesh-ancestor
64999199|NCT00435448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64999200|NCT00435448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64999201|NCT00435448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64999202|NCT00435760|Bromides|bromides|mesh-list
64999203|NCT00435760|Tiotropium Bromide|tiotropium bromide|mesh-list
64999204|NCT00435760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64999205|NCT00435760|Autonomic Agents|autonomic agents|mesh-ancestor
64999206|NCT00435760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64999207|NCT00435760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999208|NCT00435760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64999209|NCT00435760|Respiratory System Agents|respiratory system agents|mesh-ancestor
64999210|NCT00435760|Parasympatholytics|parasympatholytics|mesh-ancestor
64999211|NCT00435760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64999212|NCT00435760|Cholinergic Agents|cholinergic agents|mesh-ancestor
64999213|NCT00435760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64999214|NCT00435760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999215|NCT00435760|Anticonvulsants|anticonvulsants|mesh-ancestor
64999242|NCT00142467|Antiviral Agents|antiviral agents|mesh-ancestor
64999243|NCT00142467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64999244|NCT00142467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999245|NCT00142467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64999246|NCT00142467|Immunologic Factors|immunologic factors|mesh-ancestor
64999248|NCT00435955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64999249|NCT00435955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999250|NCT00435955|Immunologic Factors|immunologic factors|mesh-ancestor
64999251|NCT00435955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999252|NCT00435955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64999253|NCT00436033|Milnacipran|milnacipran|mesh-list
64999254|NCT00436033|Levomilnacipran|levomilnacipran|mesh-list
64999255|NCT00436033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64999256|NCT00436033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64999257|NCT00436033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64999258|NCT00436033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999259|NCT00436033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64980453|NCT00285805|Natriuretic Agents|natriuretic agents|mesh-ancestor
64999260|NCT00436033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999261|NCT00436033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64999262|NCT00436033|Analgesics|analgesics|mesh-ancestor
64999263|NCT00436033|Sensory System Agents|sensory system agents|mesh-ancestor
64999264|NCT00436033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64999289|NCT04702360|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64999290|NCT04702360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64999291|NCT04702360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999292|NCT04702204|Denosumab|denosumab|mesh-list
64999293|NCT04702204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65274458|NCT02685852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274459|NCT02697162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
65274460|NCT02697162|Octenidine|octenidine|mesh-list
65274461|NCT02697162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65274462|NCT02685930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65274463|NCT02685930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65274464|NCT02685930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726962|NCT00002593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64726963|NCT00002593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726964|NCT00002593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64726965|NCT00002593|Immunologic Factors|immunologic factors|mesh-ancestor
64726966|NCT00002593|Antidotes|antidotes|mesh-ancestor
64726967|NCT00002593|Protective Agents|protective agents|mesh-ancestor
64726968|NCT00002593|Vitamin B Complex|vitamin b complex|mesh-ancestor
64726969|NCT00002593|Vitamins|vitamins|mesh-ancestor
64509988|NCT02630121|Mydriatics|mydriatics|mesh-ancestor
64999294|NCT04702204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999295|NCT00138060|Fluorouracil|fluorouracil|mesh-list
64999296|NCT00138060|Irinotecan|irinotecan|mesh-list
64999297|NCT00138060|Antimetabolites|antimetabolites|mesh-ancestor
64999298|NCT00138060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999299|NCT00138060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64999300|NCT00138060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999301|NCT00138060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64999302|NCT00138060|Immunologic Factors|immunologic factors|mesh-ancestor
64999303|NCT00138060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999304|NCT00138060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64999305|NCT00138060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64999306|NCT00138060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999307|NCT04702009|Antibodies|antibodies|mesh-list
64999308|NCT04702009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64999309|NCT04702009|Immunologic Factors|immunologic factors|mesh-ancestor
64999310|NCT04702009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999311|NCT00142545|Apomorphine|apomorphine|mesh-list
64999312|NCT00142545|Emetics|emetics|mesh-ancestor
64999313|NCT00142545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999314|NCT00142545|Autonomic Agents|autonomic agents|mesh-ancestor
64999315|NCT00142545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64999316|NCT00142545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64999317|NCT00142545|Dopamine Agonists|dopamine agonists|mesh-ancestor
64999318|NCT00142545|Dopamine Agents|dopamine agents|mesh-ancestor
64999319|NCT00142545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64999347|NCT00138099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64999348|NCT00138099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999349|NCT00106379|Tenofovir|tenofovir|mesh-list
64999350|NCT00106379|Emtricitabine|emtricitabine|mesh-list
64999351|NCT00106379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64999352|NCT00106379|Antiviral Agents|antiviral agents|mesh-ancestor
64999353|NCT00106379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64999354|NCT00106379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64999355|NCT00106379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64999356|NCT00106379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999357|NCT00106379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999358|NCT00106379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64999359|NCT00106379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64999360|NCT00436423|Gemcitabine|gemcitabine|mesh-list
64999361|NCT00436423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64999362|NCT00436423|Antimetabolites|antimetabolites|mesh-ancestor
64999363|NCT00436423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274465|NCT02685930|Antitubercular Agents|antitubercular agents|mesh-ancestor
65274466|NCT00622674|Cetuximab|cetuximab|mesh-list
65274467|NCT00622674|Bortezomib|bortezomib|mesh-list
65274468|NCT00622674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65274469|NCT00622674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274470|NCT02687724|Golimumab|golimumab|mesh-list
64999364|NCT00436423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999365|NCT00436423|Antiviral Agents|antiviral agents|mesh-ancestor
64999366|NCT00436423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64999367|NCT00436423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999368|NCT00436423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64999369|NCT00436423|Immunologic Factors|immunologic factors|mesh-ancestor
64999391|NCT00437086|Bortezomib|bortezomib|mesh-list
64999392|NCT00437086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999393|NCT00437164|Insulin|insulin|mesh-list
64999394|NCT00437164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64999395|NCT00437164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64999396|NCT00437164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999397|NCT00437320|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
64999398|NCT00437320|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64999399|NCT00437320|Dermatologic Agents|dermatologic agents|mesh-ancestor
64999400|NCT00106496|Tacrolimus|tacrolimus|mesh-list
64999401|NCT00106496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64999402|NCT00106496|Immunologic Factors|immunologic factors|mesh-ancestor
64999403|NCT00106496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999404|NCT00106496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64999405|NCT00106496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999406|NCT00106496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999407|NCT00437359|Toremifene|toremifene|mesh-list
64999408|NCT00437359|Anastrozole|anastrozole|mesh-list
64999409|NCT00437359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999410|NCT00437359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64999411|NCT00437359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999412|NCT00437359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64999413|NCT00437359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64999414|NCT00437359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999415|NCT00437359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64999416|NCT00437359|Hormone Antagonists|hormone antagonists|mesh-ancestor
64999417|NCT00437359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64999418|NCT00437359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454525|NCT01935128|Everolimus|everolimus|mesh-list
64999419|NCT00437359|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64999420|NCT00437359|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64999421|NCT00437359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64999422|NCT00437476|Ribavirin|ribavirin|mesh-list
64999449|NCT00437671|gamma-Globulins|gamma-globulins|mesh-list
64999450|NCT00437671|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64999451|NCT00437671|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64999452|NCT00437671|Immunologic Factors|immunologic factors|mesh-ancestor
64999453|NCT00437671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999454|NCT00106613|Romidepsin|romidepsin|mesh-list
64999455|NCT00106613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64999456|NCT00106613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999457|NCT00401180|Docetaxel|docetaxel|mesh-list
64999458|NCT00401180|Temozolomide|temozolomide|mesh-list
64999459|NCT00401180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999460|NCT00401180|Tubulin Modulators|tubulin modulators|mesh-ancestor
64999461|NCT00401180|Antimitotic Agents|antimitotic agents|mesh-ancestor
64999462|NCT00401180|Mitosis Modulators|mitosis modulators|mesh-ancestor
64999463|NCT00401180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999464|NCT00401180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64999465|NCT00401180|Alkylating Agents|alkylating agents|mesh-ancestor
64999466|NCT03278665|Pembrolizumab|pembrolizumab|mesh-list
64999467|NCT03278665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64999468|NCT03278665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999469|NCT00401219|Estrogens|estrogens|mesh-list
64999470|NCT00401219|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64999494|NCT00438178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999496|NCT00438217|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64999497|NCT00438217|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64999498|NCT00438217|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65274471|NCT02687724|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65274472|NCT02687724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65274473|NCT02687724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65274474|NCT02687724|Immunologic Factors|immunologic factors|mesh-ancestor
65274475|NCT02687724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274476|NCT02687958|Everolimus|everolimus|mesh-list
65274477|NCT02687958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274478|NCT02687958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64999499|NCT00438217|Fertility Agents|fertility agents|mesh-ancestor
64999500|NCT00438217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64999501|NCT00438217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999502|NCT00438217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64999503|NCT00438217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999504|NCT00438217|Hormones|hormones|mesh-ancestor
64999505|NCT00438217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64999506|NCT00438217|Luteolytic Agents|luteolytic agents|mesh-ancestor
64999507|NCT00438217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64999508|NCT00438217|Contraceptive Agents|contraceptive agents|mesh-ancestor
64999509|NCT00438217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64999510|NCT00106691|Toremifene|toremifene|mesh-list
64999511|NCT00106691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64999512|NCT00106691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999513|NCT00106691|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64999514|NCT00106691|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64999515|NCT00106691|Hormone Antagonists|hormone antagonists|mesh-ancestor
64999516|NCT00106691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64999517|NCT00106691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999518|NCT00106691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64999550|NCT00438568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64999551|NCT00438568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999552|NCT00438607|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
64999553|NCT00438607|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
64999554|NCT00438607|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64999555|NCT00438607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64999556|NCT00438607|Purinergic Agents|purinergic agents|mesh-ancestor
64999557|NCT00438607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64999558|NCT00438607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999559|NCT00438607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999560|NCT00106847|Infliximab|infliximab|mesh-list
64999561|NCT00106847|Dermatologic Agents|dermatologic agents|mesh-ancestor
64999562|NCT00106847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64999573|NCT00438841|Thalidomide|thalidomide|mesh-list
64999574|NCT00438841|Dexamethasone|dexamethasone|mesh-list
64999575|NCT00438841|Cyclophosphamide|cyclophosphamide|mesh-list
64999577|NCT00438841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64999578|NCT00438841|Immunologic Factors|immunologic factors|mesh-ancestor
64999579|NCT00438841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999580|NCT00438841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64999581|NCT00438841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64999582|NCT00438841|Alkylating Agents|alkylating agents|mesh-ancestor
64999583|NCT00438841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999584|NCT00438841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999585|NCT00438841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64999586|NCT00438841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64999587|NCT00438841|Antiemetics|antiemetics|mesh-ancestor
64999588|NCT00438841|Autonomic Agents|autonomic agents|mesh-ancestor
64999589|NCT00438841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64999590|NCT00438841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64999591|NCT00438841|Glucocorticoids|glucocorticoids|mesh-ancestor
64999592|NCT00438841|Hormones|hormones|mesh-ancestor
64999593|NCT00438841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64999594|NCT00438841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64999595|NCT00438841|Leprostatic Agents|leprostatic agents|mesh-ancestor
65274479|NCT02687958|Immunologic Factors|immunologic factors|mesh-ancestor
65274480|NCT02687958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274481|NCT02685774|Metformin|metformin|mesh-list
65274482|NCT02685774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65274483|NCT02685774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274484|NCT00638976|Eptifibatide|eptifibatide|mesh-list
65274485|NCT00638976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65274486|NCT05661708|Chitosan|chitosan|mesh-list
65274487|NCT05661708|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65274488|NCT05661708|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65274489|NCT05661708|Antimetabolites|antimetabolites|mesh-ancestor
65274490|NCT05661708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510213|NCT03859869|Pancreatin|pancreatin|mesh-list
64999596|NCT00438841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64999597|NCT00438841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64999598|NCT00438841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64999599|NCT00438841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64999600|NCT00438841|Growth Substances|growth substances|mesh-ancestor
64999601|NCT00438841|Growth Inhibitors|growth inhibitors|mesh-ancestor
64999602|NCT00438958|Lenograstim|lenograstim|mesh-list
64999603|NCT00438958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64999604|NCT00438958|Immunologic Factors|immunologic factors|mesh-ancestor
64999605|NCT00438958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999606|NCT00107003|Lapatinib|lapatinib|mesh-list
64999607|NCT00107003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999608|NCT00107003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64999609|NCT00107003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999610|NCT00107003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999611|NCT00107081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64999612|NCT00107081|Amoxicillin|amoxicillin|mesh-list
64999613|NCT00107081|Ciprofloxacin|ciprofloxacin|mesh-list
64999614|NCT00107081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64999615|NCT00107081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64999616|NCT00107081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64999617|NCT00107081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999618|NCT00107081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999619|NCT00107081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999620|NCT00107081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64999621|NCT00107081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64999622|NCT00439192|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64999623|NCT00439192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64999624|NCT00439192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64999625|NCT00439192|Cholinergic Agents|cholinergic agents|mesh-ancestor
64999626|NCT00439192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64999627|NCT00439192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999628|NCT00439192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999629|NCT00439192|Urological Agents|urological agents|mesh-ancestor
64999630|NCT00439426|Capecitabine|capecitabine|mesh-list
64999654|NCT00439504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999656|NCT00439543|Iloprost|iloprost|mesh-list
64999657|NCT00439543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64999658|NCT00439543|Vasodilator Agents|vasodilator agents|mesh-ancestor
64999659|NCT00107237|Everolimus|everolimus|mesh-list
64999660|NCT00107237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999661|NCT00107237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64999662|NCT00107237|Immunologic Factors|immunologic factors|mesh-ancestor
64999663|NCT00107237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999664|NCT00439699|Memantine|memantine|mesh-list
64999665|NCT00439699|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64999666|NCT00439699|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64999667|NCT00439699|Dopamine Agents|dopamine agents|mesh-ancestor
64999668|NCT00439699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65222786|NCT02700711|Antidepressive Agents|antidepressive agents|mesh-ancestor
65274491|NCT05661708|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65274492|NCT05661708|Chelating Agents|chelating agents|mesh-ancestor
65274493|NCT05661708|Sequestering Agents|sequestering agents|mesh-ancestor
65274494|NCT05661708|Hemostatics|hemostatics|mesh-ancestor
65274495|NCT05661708|Coagulants|coagulants|mesh-ancestor
65274496|NCT00639756|Allopurinol|allopurinol|mesh-list
65274497|NCT00639756|Antimetabolites|antimetabolites|mesh-ancestor
65274498|NCT00639756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274499|NCT00639756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999669|NCT00439699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999670|NCT00439699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999671|NCT00439699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64999672|NCT00439699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64999673|NCT00439855|Heparin|heparin|mesh-list
64999674|NCT00439855|Enoxaparin|enoxaparin|mesh-list
64999675|NCT00439855|Calcium heparin|calcium heparin|mesh-list
64999676|NCT00439855|Anticoagulants|anticoagulants|mesh-ancestor
64999677|NCT00439855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64999678|NCT00439855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64958452|NCT00123175|Progestins|progestins|mesh-list
64999699|NCT00107354|Analgesics|analgesics|mesh-ancestor
64999700|NCT00107354|Sensory System Agents|sensory system agents|mesh-ancestor
64999701|NCT00107354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64999702|NCT00138177|Leucovorin|leucovorin|mesh-list
64999703|NCT00138177|Fluorouracil|fluorouracil|mesh-list
64999704|NCT00138177|Oxaliplatin|oxaliplatin|mesh-list
64999705|NCT00138177|Vorinostat|vorinostat|mesh-list
64999706|NCT00138177|Calcium|calcium|mesh-list
64999707|NCT00138177|Levoleucovorin|levoleucovorin|mesh-list
64999708|NCT00138177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64999709|NCT00138177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999710|NCT00138177|Antimetabolites|antimetabolites|mesh-ancestor
64999711|NCT00138177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999712|NCT00138177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64999713|NCT00138177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999714|NCT00138177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64999715|NCT00138177|Immunologic Factors|immunologic factors|mesh-ancestor
64999716|NCT00138177|Antidotes|antidotes|mesh-ancestor
64999717|NCT00138177|Protective Agents|protective agents|mesh-ancestor
64454818|NCT01929980|Bortezomib|bortezomib|mesh-list
64999719|NCT00138177|Vitamins|vitamins|mesh-ancestor
64999720|NCT00138177|Micronutrients|micronutrients|mesh-ancestor
64999721|NCT00138177|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64999722|NCT00138177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999723|NCT03279601|Capecitabine|capecitabine|mesh-list
64999724|NCT03279601|Temozolomide|temozolomide|mesh-list
64999725|NCT03279601|Dacarbazine|dacarbazine|mesh-list
64999726|NCT03279601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64999727|NCT03279601|Antimetabolites|antimetabolites|mesh-ancestor
64999728|NCT03279601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999729|NCT03279601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999730|NCT03279601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64999731|NCT03279601|Alkylating Agents|alkylating agents|mesh-ancestor
64999732|NCT00107393|Capecitabine|capecitabine|mesh-list
64999733|NCT00107393|Trastuzumab|trastuzumab|mesh-list
64999734|NCT00107393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64999735|NCT00107393|Antimetabolites|antimetabolites|mesh-ancestor
64999762|NCT00105586|Antidepressive Agents|antidepressive agents|mesh-ancestor
64999763|NCT00105586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64999764|NCT00107432|Sorafenib|sorafenib|mesh-list
64999765|NCT00107432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999766|NCT00107432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64999767|NCT00107432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999768|NCT00107432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999769|NCT00439972|Moxifloxacin|moxifloxacin|mesh-list
64999770|NCT00439972|Ortho Evra|ortho evra|mesh-list
64999771|NCT00439972|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64999772|NCT00439972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64999773|NCT00439972|Contraceptive Agents|contraceptive agents|mesh-ancestor
64999774|NCT00439972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65274500|NCT00639756|Gout Suppressants|gout suppressants|mesh-ancestor
65274501|NCT00639756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65274502|NCT00639756|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65274503|NCT00639756|Antioxidants|antioxidants|mesh-ancestor
65274504|NCT00639756|Protective Agents|protective agents|mesh-ancestor
65274505|NCT00639756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274506|NCT00622752|Nicotine|nicotine|mesh-list
65274507|NCT00622752|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65274508|NCT00622752|Autonomic Agents|autonomic agents|mesh-ancestor
65274509|NCT00622752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65274510|NCT00622752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274511|NCT00622752|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65274512|NCT00622752|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65274513|NCT00622752|Cholinergic Agents|cholinergic agents|mesh-ancestor
65274514|NCT00622752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64999775|NCT00439972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999776|NCT00439972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64999777|NCT00439972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64999778|NCT00439972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64999779|NCT00439972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64999780|NCT00439972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999801|NCT00440167|Capecitabine|capecitabine|mesh-list
64999802|NCT00440167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64999803|NCT00440167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64999804|NCT00440167|Antimetabolites|antimetabolites|mesh-ancestor
64999805|NCT00440167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999806|NCT00440167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999807|NCT00440167|Antiviral Agents|antiviral agents|mesh-ancestor
64999808|NCT00440167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64999809|NCT00440167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999810|NCT00440167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64999811|NCT00440167|Immunologic Factors|immunologic factors|mesh-ancestor
64999812|NCT00440167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999813|NCT00440167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64999814|NCT00107471|Topotecan|topotecan|mesh-list
64999815|NCT00107471|Lenograstim|lenograstim|mesh-list
64999816|NCT00107471|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64999817|NCT00107471|Immunologic Factors|immunologic factors|mesh-ancestor
64999818|NCT00107471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999819|NCT00107471|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64999820|NCT00107471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64999821|NCT00107471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999822|NCT00107471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999823|NCT00107471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999824|NCT00404157|Rituximab|rituximab|mesh-list
64999825|NCT00404157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64999826|NCT00404157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999827|NCT00404157|Immunologic Factors|immunologic factors|mesh-ancestor
64999828|NCT00404157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999829|NCT00404157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64999830|NCT02957266|Gemcitabine|gemcitabine|mesh-list
64999831|NCT02957266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999832|NCT02957266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64999833|NCT02957266|Antimetabolites|antimetabolites|mesh-ancestor
64999834|NCT02957266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999835|NCT02957266|Antiviral Agents|antiviral agents|mesh-ancestor
64999836|NCT02957266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64999864|NCT00440245|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64999865|NCT00440245|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64999866|NCT00440245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64999867|NCT00440245|Adrenergic Agents|adrenergic agents|mesh-ancestor
65274515|NCT00622752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274516|NCT03451578|alpha-MSH|alpha-msh|mesh-list
65274517|NCT03451578|Hormones|hormones|mesh-ancestor
65274518|NCT03451578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65274519|NCT03451578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274520|NCT02686008|Olaparib|olaparib|mesh-list
64999868|NCT00440245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64999869|NCT00440245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999871|NCT00440284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64999872|NCT00440284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999874|NCT00142779|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64999875|NCT00142779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64999876|NCT00142779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64999877|NCT00142779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999878|NCT00142779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64999879|NCT00142779|Serotonin Agents|serotonin agents|mesh-ancestor
64999880|NCT00142779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999881|NCT00142779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64999882|NCT00142779|Antidepressive Agents|antidepressive agents|mesh-ancestor
64999883|NCT00142779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64999884|NCT00142779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64999885|NCT00142779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64999911|NCT00142896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64999912|NCT00142896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64999913|NCT00440479|Bortezomib|bortezomib|mesh-list
64999914|NCT00440479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999915|NCT00440635|Bortezomib|bortezomib|mesh-list
64999916|NCT00440635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999917|NCT00440674|Paclitaxel|paclitaxel|mesh-list
64999918|NCT00440674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64999919|NCT00440674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999920|NCT00440674|Tubulin Modulators|tubulin modulators|mesh-ancestor
64999921|NCT00440674|Antimitotic Agents|antimitotic agents|mesh-ancestor
64999922|NCT00440674|Mitosis Modulators|mitosis modulators|mesh-ancestor
64999923|NCT00440674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999924|NCT00440713|Aripiprazole|aripiprazole|mesh-list
64999925|NCT00440713|Antidepressive Agents|antidepressive agents|mesh-ancestor
64999926|NCT00440713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64999927|NCT00440713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64999928|NCT00440713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64999929|NCT00440713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64999930|NCT00440713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999931|NCT00440713|Dopamine Agonists|dopamine agonists|mesh-ancestor
64999932|NCT00440713|Dopamine Agents|dopamine agents|mesh-ancestor
64999933|NCT00440713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64999934|NCT00440713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999935|NCT00440713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64999936|NCT00440713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64999963|NCT00441298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64999964|NCT00441298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999965|NCT00441298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999966|NCT00441298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64999967|NCT00441298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64999968|NCT00441415|Adapalene|adapalene|mesh-list
64999969|NCT00441415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64999970|NCT00441415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64999971|NCT00441415|Analgesics|analgesics|mesh-ancestor
64999972|NCT00441415|Sensory System Agents|sensory system agents|mesh-ancestor
64999973|NCT00441415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64999974|NCT00441415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999975|NCT00441415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64999976|NCT00441415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64999977|NCT00441415|Dermatologic Agents|dermatologic agents|mesh-ancestor
64999978|NCT02964728|Botulinum Toxins|botulinum toxins|mesh-list
64999979|NCT02964728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64999980|NCT02964728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65274521|NCT02686008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65274522|NCT02686008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274523|NCT02686008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274524|NCT02686008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274525|NCT02685618|Iloprost|iloprost|mesh-list
65274526|NCT02685618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64999981|NCT02964728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64999982|NCT02964728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64999983|NCT02964728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999984|NCT02964728|Cholinergic Agents|cholinergic agents|mesh-ancestor
64999985|NCT02964728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64999986|NCT02964728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999987|NCT02964728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65000014|NCT00107822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65000015|NCT00107822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000016|NCT00107822|Sensory System Agents|sensory system agents|mesh-ancestor
65000017|NCT00107822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65000018|NCT00107822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65000019|NCT00107822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65000020|NCT00107822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65000021|NCT00107822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65000022|NCT00107822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000024|NCT03279328|Emollients|emollients|mesh-ancestor
65000025|NCT03279328|Dermatologic Agents|dermatologic agents|mesh-ancestor
65000026|NCT00142974|Tegaserod|tegaserod|mesh-list
65000027|NCT00142974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65000028|NCT00142974|Serotonin Agents|serotonin agents|mesh-ancestor
65000029|NCT00142974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000030|NCT00142974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000031|NCT00142974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000032|NCT00441844|Simvastatin|simvastatin|mesh-list
65000054|NCT00108017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65000055|NCT00108017|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65000057|NCT00441922|Vinorelbine|vinorelbine|mesh-list
65000058|NCT00441922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65000059|NCT00441922|Tubulin Modulators|tubulin modulators|mesh-ancestor
65000060|NCT00441922|Antimitotic Agents|antimitotic agents|mesh-ancestor
65000061|NCT00441922|Mitosis Modulators|mitosis modulators|mesh-ancestor
65000062|NCT00441922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000063|NCT00441922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65000064|NCT00441961|Methotrexate|methotrexate|mesh-list
65000065|NCT00441961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65000066|NCT00441961|Abortifacient Agents|abortifacient agents|mesh-ancestor
65000067|NCT00441961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65000068|NCT00441961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000069|NCT00441961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65000070|NCT00441961|Antimetabolites|antimetabolites|mesh-ancestor
65000071|NCT00441961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000072|NCT00441961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65000073|NCT00441961|Dermatologic Agents|dermatologic agents|mesh-ancestor
65000074|NCT00441961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000075|NCT00441961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65000076|NCT00441961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65000077|NCT00441961|Immunologic Factors|immunologic factors|mesh-ancestor
65000078|NCT00441961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65000079|NCT00441961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65000080|NCT00138411|Ciprofloxacin|ciprofloxacin|mesh-list
65000081|NCT00138411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65000082|NCT00138411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65000083|NCT00138411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65000084|NCT00138411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65000085|NCT00138411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000113|NCT03278938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65000114|NCT03278938|Antidepressive Agents|antidepressive agents|mesh-ancestor
65000115|NCT03278938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65274527|NCT02685618|Vasodilator Agents|vasodilator agents|mesh-ancestor
65274528|NCT00602472|Linagliptin|linagliptin|mesh-list
65274529|NCT00602472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65274530|NCT00602472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000116|NCT03278938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65000117|NCT03278938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65000118|NCT03278938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65000119|NCT03278938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000120|NCT03278938|Dopamine Agents|dopamine agents|mesh-ancestor
65000121|NCT03278938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000122|NCT03278938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000123|NCT03278938|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65000124|NCT03278938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65000125|NCT03278938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000126|NCT03278938|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65000127|NCT03278938|Serotonin Agents|serotonin agents|mesh-ancestor
65000128|NCT03278860|Oxytocin|oxytocin|mesh-list
65000129|NCT03278860|Oxytocics|oxytocics|mesh-ancestor
65000130|NCT03278860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64958888|NCT00125827|Clofarabine|clofarabine|mesh-list
65000153|NCT00442585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65000154|NCT00442585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65000155|NCT00442585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65000156|NCT00442585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000157|NCT00442585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000158|NCT00442741|Epothilone B|epothilone b|mesh-list
65000159|NCT00442741|Epothilones|epothilones|mesh-list
65000160|NCT00442741|Omeprazole|omeprazole|mesh-list
65000161|NCT00442741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65000162|NCT00442741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65000163|NCT00442741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65000164|NCT00442741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000165|NCT00442741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000166|NCT00442741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65000167|NCT00442741|Tubulin Modulators|tubulin modulators|mesh-ancestor
65000168|NCT00442741|Antimitotic Agents|antimitotic agents|mesh-ancestor
65000169|NCT00442741|Mitosis Modulators|mitosis modulators|mesh-ancestor
65000170|NCT00442780|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
65000171|NCT00442780|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
65000172|NCT00442780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65000173|NCT00442780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65000174|NCT00442780|Purinergic Agents|purinergic agents|mesh-ancestor
65000175|NCT00442780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000176|NCT00442780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000177|NCT00442780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000178|NCT00404586|Fluticasone|fluticasone|mesh-list
65000217|NCT00443170|Anesthetics|anesthetics|mesh-ancestor
64958986|NCT00402493|Ibuprofen|ibuprofen|mesh-list
65000236|NCT00443170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65000237|NCT00443170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65000238|NCT00443170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65000239|NCT00443170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65000240|NCT00404625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65000241|NCT00404625|Anti-Infective Agents|anti-infective agents|mesh-list
65000243|NCT00138567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65000244|NCT00138567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000245|NCT00138567|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65000246|NCT00138567|Protease Inhibitors|protease inhibitors|mesh-ancestor
65000247|NCT00138567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000248|NCT00138567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000249|NCT00108368|Olanzapine|olanzapine|mesh-list
65000250|NCT00108368|Risperidone|risperidone|mesh-list
65000251|NCT00108368|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65000252|NCT00108368|Serotonin Agents|serotonin agents|mesh-ancestor
65000253|NCT00108368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000254|NCT00108368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000255|NCT00108368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000256|NCT00108368|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65000257|NCT00108368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65222787|NCT02700711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65274531|NCT00602472|Incretins|incretins|mesh-ancestor
65274532|NCT00602472|Hormones|hormones|mesh-ancestor
65274533|NCT00602472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65274534|NCT00602472|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65274535|NCT00602472|Protease Inhibitors|protease inhibitors|mesh-ancestor
65274536|NCT00602472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727036|NCT00002599|Interferons|interferons|mesh-list
65000258|NCT00108368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65000259|NCT00108368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65000260|NCT00108368|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65000261|NCT00108368|Dopamine Agents|dopamine agents|mesh-ancestor
65000262|NCT00108368|Antiemetics|antiemetics|mesh-ancestor
65000263|NCT00108368|Autonomic Agents|autonomic agents|mesh-ancestor
65000264|NCT00108368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65000265|NCT00108368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65000266|NCT00108368|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65000267|NCT00108368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65000268|NCT00108368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65000269|NCT00108446|Lidocaine|lidocaine|mesh-list
65000270|NCT00108446|Fentanyl|fentanyl|mesh-list
65000271|NCT00108446|Dextromethorphan|dextromethorphan|mesh-list
65000272|NCT00108446|Naloxone|naloxone|mesh-list
65000273|NCT00108446|Anesthetics, Local|anesthetics, local|mesh-ancestor
65000307|NCT00443482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000308|NCT00443482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65000309|NCT00443482|Respiratory System Agents|respiratory system agents|mesh-ancestor
65000310|NCT00443482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65000311|NCT00443482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65000349|NCT03278431|Antinematodal Agents|antinematodal agents|mesh-ancestor
65000350|NCT03278431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000364|NCT04726332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65000365|NCT04726332|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65000367|NCT04726332|Hormone Antagonists|hormone antagonists|mesh-ancestor
65000368|NCT00108563|Citalopram|citalopram|mesh-list
65000369|NCT00108563|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65000370|NCT00108563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65000371|NCT00108563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65000372|NCT00108563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000373|NCT00108563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000374|NCT00108563|Serotonin Agents|serotonin agents|mesh-ancestor
65000375|NCT00108563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000376|NCT00108563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65000377|NCT00108563|Antidepressive Agents|antidepressive agents|mesh-ancestor
65000378|NCT00108563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65000379|NCT00443716|Estrogens|estrogens|mesh-list
65000380|NCT00443716|Hormones|hormones|mesh-ancestor
65000381|NCT00443716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65000382|NCT00443716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000383|NCT00443794|Aspirin|aspirin|mesh-list
65000384|NCT00443794|Atenolol|atenolol|mesh-list
65000385|NCT00443794|Ramipril|ramipril|mesh-list
65000386|NCT00443794|Simvastatin|simvastatin|mesh-list
65000387|NCT00443794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
65000388|NCT00443794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65000389|NCT00443794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65000390|NCT00443794|Analgesics|analgesics|mesh-ancestor
65000391|NCT00443794|Sensory System Agents|sensory system agents|mesh-ancestor
65000392|NCT00443794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65000393|NCT00443794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000394|NCT00443794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65000395|NCT00443794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65000396|NCT00443794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65000397|NCT00443794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65000398|NCT00443794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000399|NCT00443794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65000400|NCT00443794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65000401|NCT00443794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000402|NCT00443794|Antipyretics|antipyretics|mesh-ancestor
65274537|NCT00602472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274538|NCT03384654|Cytarabine|cytarabine|mesh-list
65274539|NCT03384654|Prednisone|prednisone|mesh-list
65274540|NCT03384654|Cyclophosphamide|cyclophosphamide|mesh-list
65274541|NCT03384654|Doxorubicin|doxorubicin|mesh-list
65274542|NCT03384654|Methotrexate|methotrexate|mesh-list
65274543|NCT03384654|Vincristine|vincristine|mesh-list
65274544|NCT03384654|Asparaginase|asparaginase|mesh-list
65274545|NCT03384654|Mercaptopurine|mercaptopurine|mesh-list
65274546|NCT03384654|Daratumumab|daratumumab|mesh-list
65274547|NCT03384654|Pegaspargase|pegaspargase|mesh-list
65274548|NCT03384654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727045|NCT00002599|Vincristine|vincristine|mesh-list
65000403|NCT00443794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65000404|NCT00443794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65000405|NCT00443794|Antimetabolites|antimetabolites|mesh-ancestor
65000406|NCT00443794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65000407|NCT00443794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65000408|NCT00443794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65000409|NCT00443794|Protease Inhibitors|protease inhibitors|mesh-ancestor
65000429|NCT00108602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000431|NCT03278314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65000432|NCT03278314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65000433|NCT03278314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000434|NCT00443950|Etanercept|etanercept|mesh-list
65000435|NCT00443950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65000436|NCT00443950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65000437|NCT00443950|Analgesics|analgesics|mesh-ancestor
65000438|NCT00443950|Sensory System Agents|sensory system agents|mesh-ancestor
65000439|NCT00443950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65000440|NCT00443950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000441|NCT00443950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65000442|NCT00443950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65000443|NCT00443950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65000444|NCT00443950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65000445|NCT00443950|Immunologic Factors|immunologic factors|mesh-ancestor
65000446|NCT00444184|Timolol|timolol|mesh-list
65000447|NCT00444184|Travoprost|travoprost|mesh-list
65000448|NCT00444184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65000449|NCT00444184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65000450|NCT00444184|Adrenergic Agents|adrenergic agents|mesh-ancestor
65000451|NCT00444184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000452|NCT00444184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000453|NCT00444184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000454|NCT00444184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65000455|NCT00444184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65000457|NCT00444223|Cariostatic Agents|cariostatic agents|mesh-ancestor
65000458|NCT00444223|Protective Agents|protective agents|mesh-ancestor
65000459|NCT00444223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000460|NCT00138801|Doxycycline|doxycycline|mesh-list
65000461|NCT00138801|Ceftriaxone|ceftriaxone|mesh-list
65000462|NCT00138801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65000463|NCT00138801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65000464|NCT00138801|Antimalarials|antimalarials|mesh-ancestor
65000465|NCT00138801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64959223|NCT00043784|Enoxaparin|enoxaparin|mesh-list
65000494|NCT04698772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65000495|NCT04698772|Narcotics|narcotics|mesh-ancestor
65000496|NCT00451594|Dexamethasone|dexamethasone|mesh-list
65000497|NCT00451594|Prednisolone|prednisolone|mesh-list
65000498|NCT00451594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65000499|NCT00451594|Antiemetics|antiemetics|mesh-ancestor
65000500|NCT00451594|Autonomic Agents|autonomic agents|mesh-ancestor
65000501|NCT00451594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65000502|NCT00451594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000503|NCT00451594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65000504|NCT00451594|Glucocorticoids|glucocorticoids|mesh-ancestor
65274549|NCT03384654|Immunologic Factors|immunologic factors|mesh-ancestor
65274550|NCT03384654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274551|NCT03384654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65274552|NCT03384654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65274553|NCT03384654|Alkylating Agents|alkylating agents|mesh-ancestor
65274554|NCT03384654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274555|NCT03384654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274556|NCT03384654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65274557|NCT03384654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65274558|NCT03384654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65274559|NCT03384654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65274560|NCT03384654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274561|NCT03384654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65274562|NCT03384654|Glucocorticoids|glucocorticoids|mesh-ancestor
65274563|NCT03384654|Hormones|hormones|mesh-ancestor
65274564|NCT03384654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65274565|NCT03384654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65000505|NCT00451594|Hormones|hormones|mesh-ancestor
65000506|NCT00451594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65000507|NCT00451594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65000508|NCT00451594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65000509|NCT00139035|Cyclosporine|cyclosporine|mesh-list
65000510|NCT00139035|Cyclosporins|cyclosporins|mesh-list
65000511|NCT00139035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000512|NCT00139035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000513|NCT00139035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64959281|NCT00043862|Topotecan|topotecan|mesh-list
65000525|NCT00451672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65000526|NCT00451672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000527|NCT00451672|Dopamine Agonists|dopamine agonists|mesh-ancestor
65000528|NCT00451672|Dopamine Agents|dopamine agents|mesh-ancestor
65000529|NCT00451672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000530|NCT00451672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000531|NCT00108875|BIRC5 protein, human|birc5 protein, human|mesh-list
65000532|NCT00108875|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65000533|NCT00108875|Protease Inhibitors|protease inhibitors|mesh-ancestor
65000534|NCT00108875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000535|NCT00108875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000536|NCT00451711|Amphotericin B|amphotericin b|mesh-list
65000537|NCT00451711|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65000538|NCT00451711|Amebicides|amebicides|mesh-ancestor
65000539|NCT00451711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65000540|NCT00451711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65000541|NCT00451711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65000542|NCT00451711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65000543|NCT00451711|Antifungal Agents|antifungal agents|mesh-ancestor
65000544|NCT00139074|Valproic Acid|valproic acid|mesh-list
65000545|NCT00139074|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65000546|NCT00139074|Antidepressive Agents|antidepressive agents|mesh-ancestor
65000547|NCT00139074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65000548|NCT00139074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65000549|NCT00139074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65000550|NCT00139074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65000551|NCT00139074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000552|NCT00139074|Anticonvulsants|anticonvulsants|mesh-ancestor
65274566|NCT03384654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65274567|NCT03384654|Abortifacient Agents|abortifacient agents|mesh-ancestor
65274568|NCT03384654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65274569|NCT03384654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65274570|NCT03384654|Antimetabolites|antimetabolites|mesh-ancestor
65274571|NCT03384654|Dermatologic Agents|dermatologic agents|mesh-ancestor
65274572|NCT03384654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64727077|NCT00002599|Trace Elements|trace elements|mesh-ancestor
65000553|NCT00139074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000554|NCT00139074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000555|NCT00139074|GABA Agents|gaba agents|mesh-ancestor
65000556|NCT00139074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000557|NCT00139074|Antimanic Agents|antimanic agents|mesh-ancestor
65000558|NCT00451750|Hydrocortisone|hydrocortisone|mesh-list
65000559|NCT00451750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65000560|NCT00451828|Simvastatin|simvastatin|mesh-list
65000561|NCT00451828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65000562|NCT00451828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65000563|NCT00451828|Antimetabolites|antimetabolites|mesh-ancestor
65000564|NCT00451828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000565|NCT00451828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65000566|NCT00451828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65000567|NCT00451828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000568|NCT00451867|Mycophenolic Acid|mycophenolic acid|mesh-list
65000569|NCT00451867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65000570|NCT00451867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65000571|NCT00451867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65000572|NCT00451867|Antitubercular Agents|antitubercular agents|mesh-ancestor
65000573|NCT00451867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65000574|NCT00451867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65000575|NCT00451867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000576|NCT00451867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000577|NCT00143091|Sertraline|sertraline|mesh-list
65000602|NCT00452062|Hormones|hormones|mesh-ancestor
65000603|NCT00452062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65000604|NCT00452062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65000605|NCT00452062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65000606|NCT00108992|Diclofenac|diclofenac|mesh-list
65000607|NCT00108992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65000608|NCT00108992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65000609|NCT00108992|Analgesics|analgesics|mesh-ancestor
65000610|NCT00108992|Sensory System Agents|sensory system agents|mesh-ancestor
65000611|NCT00108992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65000612|NCT00108992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000613|NCT00108992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64455723|NCT01987505|Rituximab|rituximab|mesh-list
65000614|NCT00108992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65000615|NCT00108992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65000616|NCT00108992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000617|NCT00108992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000619|NCT00143130|Analgesics|analgesics|mesh-ancestor
65000620|NCT00143130|Sensory System Agents|sensory system agents|mesh-ancestor
65000621|NCT00143130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65000622|NCT00143130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000623|NCT00143130|Anticonvulsants|anticonvulsants|mesh-ancestor
65000624|NCT00143130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65000625|NCT00143130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65000626|NCT00143130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000656|NCT00143169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65000657|NCT00143169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65000658|NCT00109109|Vorinostat|vorinostat|mesh-list
65000659|NCT00109109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65000660|NCT00109109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65000661|NCT00109109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000662|NCT00109109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274573|NCT03384654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65274574|NCT03384654|Antiviral Agents|antiviral agents|mesh-ancestor
65274575|NCT03384654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65274576|NCT03384654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65274577|NCT03384654|Tubulin Modulators|tubulin modulators|mesh-ancestor
65274578|NCT03384654|Antimitotic Agents|antimitotic agents|mesh-ancestor
65274579|NCT03384654|Mitosis Modulators|mitosis modulators|mesh-ancestor
65274580|NCT02685462|Digoxin|digoxin|mesh-list
65274581|NCT02685462|Caffeine|caffeine|mesh-list
65274582|NCT02685462|Atorvastatin|atorvastatin|mesh-list
65274583|NCT02685462|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65000663|NCT03275116|Bromides|bromides|mesh-list
65000664|NCT03275116|Formoterol Fumarate|formoterol fumarate|mesh-list
65000665|NCT03275116|Tiotropium Bromide|tiotropium bromide|mesh-list
65000666|NCT03275116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65000667|NCT03275116|Autonomic Agents|autonomic agents|mesh-ancestor
65000668|NCT03275116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64959432|NCT00044135|Clevudine|clevudine|mesh-list
65000694|NCT00452569|Dexamethasone|dexamethasone|mesh-list
65000695|NCT00452569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65000696|NCT00452569|Antiemetics|antiemetics|mesh-ancestor
65000697|NCT00452569|Autonomic Agents|autonomic agents|mesh-ancestor
65000698|NCT00452569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65000699|NCT00452569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000700|NCT00452569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65000701|NCT00452569|Glucocorticoids|glucocorticoids|mesh-ancestor
65000702|NCT00452569|Hormones|hormones|mesh-ancestor
65000703|NCT00452569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65000704|NCT00452569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65000705|NCT00452569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65000706|NCT00452569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65000707|NCT00452569|Immunologic Factors|immunologic factors|mesh-ancestor
65000708|NCT00452569|Leprostatic Agents|leprostatic agents|mesh-ancestor
65000709|NCT00452569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65000710|NCT00452569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65000711|NCT00452569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64959473|NCT00078234|Rituximab|rituximab|mesh-list
65000733|NCT00452608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000734|NCT00109226|Bevacizumab|bevacizumab|mesh-list
65000735|NCT00109226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65000736|NCT00109226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65000737|NCT00109226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65000738|NCT00109226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65000739|NCT00109226|Growth Substances|growth substances|mesh-ancestor
65000740|NCT00109226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000741|NCT00109226|Growth Inhibitors|growth inhibitors|mesh-ancestor
65000742|NCT00143325|Varenicline|varenicline|mesh-list
65000743|NCT00143325|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65000744|NCT00143325|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65000745|NCT00143325|Cholinergic Agents|cholinergic agents|mesh-ancestor
65000746|NCT00143325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000747|NCT00143325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000748|NCT00143325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000749|NCT00452725|Hormones|hormones|mesh-list
65000750|NCT00452725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65000751|NCT00452725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000752|NCT00109265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65000753|NCT00109265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65000754|NCT00109265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65000755|NCT00109265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000756|NCT00109265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000757|NCT00143364|Varenicline|varenicline|mesh-list
65000758|NCT00143364|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65000759|NCT00143364|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65000760|NCT00143364|Cholinergic Agents|cholinergic agents|mesh-ancestor
65000761|NCT00143364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65274584|NCT02685462|Simvastatin|simvastatin|mesh-list
65274585|NCT02685462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65274586|NCT02685462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65274587|NCT02685462|Antimetabolites|antimetabolites|mesh-ancestor
65274588|NCT02685462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274589|NCT02685462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65274590|NCT02685462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65274591|NCT02685462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000762|NCT00143364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000763|NCT00143364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000792|NCT00109382|Aspirin|aspirin|mesh-list
65000793|NCT00109382|Clopidogrel|clopidogrel|mesh-list
65000794|NCT00109382|Simvastatin|simvastatin|mesh-list
65000795|NCT00109382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65000796|NCT00109382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65000797|NCT00109382|Analgesics|analgesics|mesh-ancestor
65000798|NCT00109382|Sensory System Agents|sensory system agents|mesh-ancestor
65000799|NCT00109382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65000800|NCT00109382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000801|NCT00109382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65000802|NCT00109382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65000803|NCT00109382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65000804|NCT00109382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64959575|NCT00078546|Immunologic Factors|immunologic factors|mesh-ancestor
64959577|NCT00044642|Lorazepam|lorazepam|mesh-list
65000834|NCT00453115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65000835|NCT00453115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000836|NCT00453115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65000837|NCT00453115|Immunologic Factors|immunologic factors|mesh-ancestor
65000838|NCT00453115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000839|NCT00143481|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65000840|NCT00143481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65000841|NCT00143481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65000842|NCT00143481|Cholinergic Agents|cholinergic agents|mesh-ancestor
65000843|NCT00143481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000844|NCT00143481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000845|NCT00143481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000846|NCT00143481|Urological Agents|urological agents|mesh-ancestor
64959617|NCT04938466|Hormones|hormones|mesh-list
65000871|NCT00453778|Autonomic Agents|autonomic agents|mesh-ancestor
65000872|NCT00453778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65000873|NCT00453778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000874|NCT00453778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65000875|NCT00453778|Respiratory System Agents|respiratory system agents|mesh-ancestor
65000876|NCT00453778|Dermatologic Agents|dermatologic agents|mesh-ancestor
65000877|NCT00453778|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65000878|NCT00109616|Chlorhexidine|chlorhexidine|mesh-list
65000879|NCT00109616|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65000880|NCT00109616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65000881|NCT00109616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65000882|NCT00109616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65000883|NCT00109616|Disinfectants|disinfectants|mesh-ancestor
65000884|NCT00109616|Dermatologic Agents|dermatologic agents|mesh-ancestor
65000885|NCT00453856|Pyrimethamine|pyrimethamine|mesh-list
65000886|NCT00453856|Sulfadoxine|sulfadoxine|mesh-list
65000887|NCT00453856|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65000888|NCT00453856|Antimalarials|antimalarials|mesh-ancestor
65000889|NCT00453856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65000890|NCT00453856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65000891|NCT00453856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65000892|NCT00453856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65000893|NCT00453856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000894|NCT00453856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000895|NCT00453856|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65000896|NCT00453856|Renal Agents|renal agents|mesh-ancestor
65000897|NCT00454168|Sargramostim|sargramostim|mesh-list
64959660|NCT00044759|Tazobactam|tazobactam|mesh-list
65274592|NCT02685462|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65274593|NCT02685462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274594|NCT02685462|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65274595|NCT02685462|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65274596|NCT02685462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65274597|NCT02685462|Purinergic Agents|purinergic agents|mesh-ancestor
65274598|NCT02685462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000930|NCT00454480|Melphalan|melphalan|mesh-list
65000931|NCT00454480|Busulfan|busulfan|mesh-list
65000932|NCT00454480|Daunorubicin|daunorubicin|mesh-list
65000933|NCT00454480|Alemtuzumab|alemtuzumab|mesh-list
65000934|NCT00454480|Clofarabine|clofarabine|mesh-list
65000935|NCT00454480|Arsenic Trioxide|arsenic trioxide|mesh-list
65000936|NCT00454480|Gemtuzumab|gemtuzumab|mesh-list
65000937|NCT00454480|Tipifarnib|tipifarnib|mesh-list
65000938|NCT00454480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65000939|NCT00454480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65000940|NCT00454480|Antimetabolites|antimetabolites|mesh-ancestor
65000941|NCT00454480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000973|NCT00110006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65000974|NCT00110006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65000975|NCT00110006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000976|NCT00110006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65000977|NCT00110006|Glucocorticoids|glucocorticoids|mesh-ancestor
65000979|NCT00110006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65000980|NCT00110006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65000981|NCT00110006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64456092|NCT01970527|Ipilimumab|ipilimumab|mesh-list
65000982|NCT00110006|Tubulin Modulators|tubulin modulators|mesh-ancestor
64959748|NCT00079014|Doxorubicin|doxorubicin|mesh-list
65001013|NCT00143715|Vitamin K|vitamin k|mesh-list
65001014|NCT00143715|Vitamin K 1|vitamin k 1|mesh-list
65001015|NCT00143715|Vitamins|vitamins|mesh-ancestor
65001016|NCT00143715|Micronutrients|micronutrients|mesh-ancestor
65001017|NCT00143715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001018|NCT00143715|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65001019|NCT00143715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65001020|NCT00143715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001021|NCT00143715|Hemostatics|hemostatics|mesh-ancestor
65001022|NCT00143715|Coagulants|coagulants|mesh-ancestor
65001023|NCT00454831|Chitosan|chitosan|mesh-list
65001024|NCT00454831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65001025|NCT00454831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65001026|NCT00454831|Antimetabolites|antimetabolites|mesh-ancestor
65001027|NCT00454831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959787|NCT04263298|Capecitabine|capecitabine|mesh-list
65001045|NCT00112983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65001046|NCT00112983|Immunologic Factors|immunologic factors|mesh-ancestor
65001047|NCT00112983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001049|NCT00110162|Androgen Antagonists|androgen antagonists|mesh-list
65001050|NCT00110162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65001051|NCT00110162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001052|NCT00110162|Hormone Antagonists|hormone antagonists|mesh-ancestor
65001053|NCT02273713|Paclitaxel|paclitaxel|mesh-list
65001054|NCT02273713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65001055|NCT02273713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001056|NCT02273713|Tubulin Modulators|tubulin modulators|mesh-ancestor
65001057|NCT02273713|Antimitotic Agents|antimitotic agents|mesh-ancestor
65001058|NCT02273713|Mitosis Modulators|mitosis modulators|mesh-ancestor
65001059|NCT02273713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001060|NCT00110201|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65001061|NCT00110201|Natriuretic Agents|natriuretic agents|mesh-ancestor
65001062|NCT00110201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001063|NCT02273791|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65001064|NCT02273791|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65001065|NCT02273791|Clomiphene|clomiphene|mesh-list
65001066|NCT02273791|Enclomiphene|enclomiphene|mesh-list
65001067|NCT02273791|Zuclomiphene|zuclomiphene|mesh-list
65001068|NCT02273791|Estradiol|estradiol|mesh-list
65274599|NCT02685462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65274600|NCT02685462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65274601|NCT02685462|Protective Agents|protective agents|mesh-ancestor
65274602|NCT02685306|Paclitaxel|paclitaxel|mesh-list
65274603|NCT02685306|Taxane|taxane|mesh-list
65274604|NCT02685306|Bavituximab|bavituximab|mesh-list
65274605|NCT02685306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65001069|NCT02273791|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65001070|NCT02273791|Estrogens|estrogens|mesh-ancestor
65001071|NCT02273791|Hormones|hormones|mesh-ancestor
65001072|NCT02273791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65001073|NCT02273791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001074|NCT02273791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65001075|NCT02273791|Contraceptive Agents|contraceptive agents|mesh-ancestor
65001076|NCT02273791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65001077|NCT02273791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65001078|NCT02273791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65001079|NCT02273791|Hormone Antagonists|hormone antagonists|mesh-ancestor
65001080|NCT02273791|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65001081|NCT02273791|Fertility Agents|fertility agents|mesh-ancestor
65001082|NCT02273791|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65001083|NCT02273791|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65001084|NCT00110240|Vildagliptin|vildagliptin|mesh-list
65001085|NCT00110240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65001086|NCT00110240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959831|NCT00079092|Growth Substances|growth substances|mesh-ancestor
65001105|NCT00455416|Antimetabolites|antimetabolites|mesh-ancestor
65001106|NCT00455416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65001107|NCT00455416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65001108|NCT00455416|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65001109|NCT00143871|Rituximab|rituximab|mesh-list
65001110|NCT00143871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65001111|NCT00143871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001112|NCT00143871|Immunologic Factors|immunologic factors|mesh-ancestor
65001113|NCT00143871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001114|NCT00143871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65001115|NCT00455572|Vinorelbine|vinorelbine|mesh-list
65001116|NCT00455572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001117|NCT00455572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65001118|NCT00455572|Tubulin Modulators|tubulin modulators|mesh-ancestor
65001119|NCT00455572|Antimitotic Agents|antimitotic agents|mesh-ancestor
65001120|NCT00455572|Mitosis Modulators|mitosis modulators|mesh-ancestor
65001121|NCT00455572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001122|NCT00401492|Gemcitabine|gemcitabine|mesh-list
65001123|NCT00401492|Vinorelbine|vinorelbine|mesh-list
65001124|NCT00401492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001125|NCT00401492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65001126|NCT00401492|Antimetabolites|antimetabolites|mesh-ancestor
65001127|NCT00401492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001128|NCT00401492|Antiviral Agents|antiviral agents|mesh-ancestor
65001129|NCT00401492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65001130|NCT00401492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001131|NCT00401492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65001132|NCT00401492|Immunologic Factors|immunologic factors|mesh-ancestor
65001133|NCT00401492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001134|NCT00401492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65001135|NCT00401492|Tubulin Modulators|tubulin modulators|mesh-ancestor
65001136|NCT00401492|Antimitotic Agents|antimitotic agents|mesh-ancestor
65001137|NCT00401492|Mitosis Modulators|mitosis modulators|mesh-ancestor
65001138|NCT00455806|Amoxicillin|amoxicillin|mesh-list
65001139|NCT00455806|Moxifloxacin|moxifloxacin|mesh-list
65001140|NCT00455806|Esomeprazole|esomeprazole|mesh-list
65001141|NCT00455806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65001142|NCT00455806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65001143|NCT00455806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65001144|NCT00455806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65001145|NCT00455806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001178|NCT00113100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65001179|NCT00113100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65001180|NCT00113100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65274606|NCT02685306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274607|NCT02685306|Tubulin Modulators|tubulin modulators|mesh-ancestor
65274608|NCT02685306|Antimitotic Agents|antimitotic agents|mesh-ancestor
65274609|NCT02685306|Mitosis Modulators|mitosis modulators|mesh-ancestor
65274610|NCT02685306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274611|NCT02685306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65274612|NCT02680938|Oxytocin|oxytocin|mesh-list
65001181|NCT00113100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65001182|NCT00143949|Losartan|losartan|mesh-list
65001183|NCT00143949|Enalapril|enalapril|mesh-list
65001184|NCT00143949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65001185|NCT00143949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65001186|NCT00143949|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65001187|NCT00143949|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64959945|NCT03948568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65001202|NCT00456235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65001203|NCT00456235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001204|NCT00456235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65001205|NCT00456235|Antitubercular Agents|antitubercular agents|mesh-ancestor
65001206|NCT00456235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65001207|NCT00456235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65001208|NCT00456235|Antifungal Agents|antifungal agents|mesh-ancestor
65001209|NCT00456235|Dermatologic Agents|dermatologic agents|mesh-ancestor
65001210|NCT00456235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65001211|NCT00456313|Fluticasone|fluticasone|mesh-list
65001212|NCT00456313|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65001213|NCT00456313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65001215|NCT00456313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65001216|NCT00456313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001217|NCT00456313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65001218|NCT00456313|Respiratory System Agents|respiratory system agents|mesh-ancestor
65001219|NCT00456313|Glucocorticoids|glucocorticoids|mesh-ancestor
65001221|NCT00456313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65001222|NCT00456313|Sympathomimetics|sympathomimetics|mesh-ancestor
65001223|NCT00456313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65001224|NCT00456313|Dermatologic Agents|dermatologic agents|mesh-ancestor
65001225|NCT00456313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65001226|NCT00110630|Nicotine|nicotine|mesh-list
65001227|NCT00110630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65001228|NCT00110630|Autonomic Agents|autonomic agents|mesh-ancestor
65001229|NCT00110630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65001230|NCT00110630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001231|NCT00110630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65001232|NCT00110630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65001233|NCT00110630|Cholinergic Agents|cholinergic agents|mesh-ancestor
65001234|NCT00110630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65001235|NCT00110630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001236|NCT00456430|Citalopram|citalopram|mesh-list
65001237|NCT00456430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65001238|NCT00456430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65001239|NCT00456430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65001240|NCT00456430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001241|NCT00456430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65001242|NCT00456430|Serotonin Agents|serotonin agents|mesh-ancestor
65001243|NCT00456430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001244|NCT00456430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65001245|NCT00456430|Antidepressive Agents|antidepressive agents|mesh-ancestor
65001246|NCT00456430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65001247|NCT00456586|Istradefylline|istradefylline|mesh-list
65001248|NCT00456586|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
65001270|NCT00110708|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65001272|NCT00110708|Immunologic Factors|immunologic factors|mesh-ancestor
65001273|NCT00110708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001274|NCT00456820|Bupropion|bupropion|mesh-list
65001275|NCT00456820|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65001276|NCT00456820|Antidepressive Agents|antidepressive agents|mesh-ancestor
65274613|NCT02680938|Oxytocics|oxytocics|mesh-ancestor
65274614|NCT02680938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65274615|NCT02680938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274616|NCT05663892|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64727118|NCT00003446|Vitamins|vitamins|mesh-ancestor
65001277|NCT00456820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65001278|NCT00456820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65001279|NCT00456820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65001280|NCT00456820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65001281|NCT00456820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001282|NCT00456820|Dopamine Agents|dopamine agents|mesh-ancestor
65001283|NCT00456820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65001284|NCT00456820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001285|NCT00456820|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65001286|NCT00456820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65001287|NCT00456820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001288|NCT00456898|Codeine|codeine|mesh-list
65001289|NCT00456898|Paroxetine|paroxetine|mesh-list
65001290|NCT00456898|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65001291|NCT00456898|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65001292|NCT00456898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65001293|NCT00456898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65001294|NCT00456898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001295|NCT00456898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65001296|NCT00456898|Serotonin Agents|serotonin agents|mesh-ancestor
65001297|NCT00456898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960047|NCT00045539|Methotrexate|methotrexate|mesh-list
65001330|NCT00456937|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65001331|NCT00456937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65001332|NCT00456937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65001333|NCT00456937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001334|NCT00456937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65001335|NCT00456937|Serotonin Agents|serotonin agents|mesh-ancestor
65001336|NCT00456937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001366|NCT00457093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65001367|NCT00457093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001368|NCT00457405|Dipyridamole|dipyridamole|mesh-list
65001369|NCT00457405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65001370|NCT00457405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001371|NCT00457405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001372|NCT00457405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65001373|NCT00457405|Vasodilator Agents|vasodilator agents|mesh-ancestor
65001375|NCT00457483|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65001376|NCT00457483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65001377|NCT00457483|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65001378|NCT00457483|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65001379|NCT00457483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001407|NCT00457678|Dermatologic Agents|dermatologic agents|mesh-ancestor
65001409|NCT00457717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65001410|NCT00457717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65001411|NCT00457717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65001412|NCT00457717|Autonomic Agents|autonomic agents|mesh-ancestor
65001413|NCT00457717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65001414|NCT00457717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001415|NCT00457717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65001416|NCT00457717|Respiratory System Agents|respiratory system agents|mesh-ancestor
65001417|NCT00457717|Mydriatics|mydriatics|mesh-ancestor
65001418|NCT00457717|Parasympatholytics|parasympatholytics|mesh-ancestor
65001419|NCT00457717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65001420|NCT00457717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65001421|NCT00457717|Cholinergic Agents|cholinergic agents|mesh-ancestor
65001422|NCT00457717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65001423|NCT00457717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001424|NCT00110903|Etanercept|etanercept|mesh-list
65001425|NCT00110903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65001426|NCT00110903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65001427|NCT00110903|Analgesics|analgesics|mesh-ancestor
65274617|NCT05663892|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65274618|NCT05663892|Estradiol|estradiol|mesh-list
65274619|NCT05663892|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65274620|NCT05663892|Estrogens|estrogens|mesh-ancestor
65274621|NCT05663892|Hormones|hormones|mesh-ancestor
65274622|NCT05663892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65024627|NCT00536653|Hormones|hormones|mesh-ancestor
64727123|NCT00003446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001459|NCT00144183|Nevirapine|nevirapine|mesh-list
65001460|NCT00144183|Antimetabolites|antimetabolites|mesh-ancestor
65001461|NCT00144183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001462|NCT00144183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65001463|NCT00144183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65001464|NCT00144183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001465|NCT00144183|Antiviral Agents|antiviral agents|mesh-ancestor
65001466|NCT00144183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65001467|NCT00144183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65001468|NCT00144183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65001469|NCT00144183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65001470|NCT00144183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65001471|NCT00465751|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
64456613|NCT01778049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65001505|NCT00111020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65001506|NCT00111020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001507|NCT00111020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001508|NCT00466063|Deferasirox|deferasirox|mesh-list
65001509|NCT00466063|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65001510|NCT00466063|Chelating Agents|chelating agents|mesh-ancestor
65001511|NCT00466063|Sequestering Agents|sequestering agents|mesh-ancestor
65001512|NCT00466063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960279|NCT00079638|Antimetabolites|antimetabolites|mesh-ancestor
65001533|NCT00466180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65001534|NCT00466219|Interferons|interferons|mesh-list
65001535|NCT00466219|Ribavirin|ribavirin|mesh-list
65001536|NCT00466219|Interferon-alpha|interferon-alpha|mesh-list
65001537|NCT00466219|Interferon alpha-2|interferon alpha-2|mesh-list
65001538|NCT00466219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65001539|NCT00466219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001540|NCT00466219|Antiviral Agents|antiviral agents|mesh-ancestor
65001541|NCT00466219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65001542|NCT00466219|Antimetabolites|antimetabolites|mesh-ancestor
65001543|NCT00466219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001544|NCT00466219|Immunologic Factors|immunologic factors|mesh-ancestor
65001545|NCT00466219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001546|NCT00144261|Nevirapine|nevirapine|mesh-list
65001547|NCT00144261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65001548|NCT00144261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65001549|NCT00144261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001550|NCT00144261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001551|NCT00144261|Antiviral Agents|antiviral agents|mesh-ancestor
65001552|NCT00144261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65001553|NCT00144261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65001554|NCT00144261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65001555|NCT00144261|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65001556|NCT00144261|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65001557|NCT00466258|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65001558|NCT00466258|Antiviral Agents|antiviral agents|mesh-ancestor
65001559|NCT00466258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65001560|NCT00144378|Irinotecan|irinotecan|mesh-list
65001561|NCT00144378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65001562|NCT00144378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65001563|NCT00144378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001564|NCT00144378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001565|NCT00144378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001566|NCT00111098|Darbepoetin alfa|darbepoetin alfa|mesh-list
65001567|NCT00111098|Hematinics|hematinics|mesh-ancestor
65001588|NCT00347815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65001589|NCT00113802|Epratuzumab|epratuzumab|mesh-list
65001590|NCT00113802|Antibodies|antibodies|mesh-list
65274623|NCT05663892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274624|NCT05663892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65274625|NCT05663892|Contraceptive Agents|contraceptive agents|mesh-ancestor
65274626|NCT05663892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65274627|NCT05663892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65274628|NCT02685228|Gemcitabine|gemcitabine|mesh-list
65274629|NCT02685228|Decitabine|decitabine|mesh-list
65274630|NCT02685228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65274631|NCT02685228|Antimetabolites|antimetabolites|mesh-ancestor
64727129|NCT00003938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65001591|NCT00113802|Immunologic Factors|immunologic factors|mesh-ancestor
65001592|NCT00113802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001593|NCT00113802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65001594|NCT00113802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001595|NCT00111137|Darbepoetin alfa|darbepoetin alfa|mesh-list
65001596|NCT00111137|Hematinics|hematinics|mesh-ancestor
65001597|NCT00347854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65001598|NCT00347854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65001599|NCT00347854|Lubricant Eye Drops|lubricant eye drops|mesh-list
65001600|NCT00347854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65001601|NCT00347854|Laxatives|laxatives|mesh-ancestor
65001602|NCT00347854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65001603|NCT00347971|Rituximab|rituximab|mesh-list
65001604|NCT00347971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65001605|NCT00347971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001606|NCT00347971|Immunologic Factors|immunologic factors|mesh-ancestor
65001607|NCT00347971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001608|NCT00347971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65001609|NCT00113958|Cinacalcet|cinacalcet|mesh-list
65001610|NCT00113958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65001611|NCT00113958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001612|NCT00113958|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65001613|NCT00113958|Hormone Antagonists|hormone antagonists|mesh-ancestor
65001614|NCT00113958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65001615|NCT00348010|Tramadol|tramadol|mesh-list
65001616|NCT00348010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65001617|NCT00348010|Narcotics|narcotics|mesh-ancestor
65001618|NCT00348010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65001619|NCT00348010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001620|NCT00348010|Analgesics|analgesics|mesh-ancestor
65001621|NCT00348010|Sensory System Agents|sensory system agents|mesh-ancestor
65001622|NCT00348010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65001655|NCT00111215|Coagulants|coagulants|mesh-ancestor
65001656|NCT00111215|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65001657|NCT00111215|Natriuretic Agents|natriuretic agents|mesh-ancestor
65001658|NCT00111215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001660|NCT00348166|Mydriatics|mydriatics|mesh-ancestor
65001661|NCT00348166|Autonomic Agents|autonomic agents|mesh-ancestor
65001662|NCT00348166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65001663|NCT00348166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001664|NCT00348166|Parasympatholytics|parasympatholytics|mesh-ancestor
65001665|NCT00348166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65001666|NCT00348166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65001688|NCT00348244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65001689|NCT00348244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65001690|NCT00348244|Protective Agents|protective agents|mesh-ancestor
65001691|NCT00348244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65001692|NCT00348244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65001693|NCT00348244|Analgesics|analgesics|mesh-ancestor
65001694|NCT00348244|Sensory System Agents|sensory system agents|mesh-ancestor
65001695|NCT00348244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65001696|NCT00348244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65001697|NCT00348244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001698|NCT00348244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001699|NCT00348322|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65274632|NCT02685228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274633|NCT02685228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274634|NCT02685228|Antiviral Agents|antiviral agents|mesh-ancestor
65274635|NCT02685228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65274636|NCT02685228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274637|NCT02685228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65001700|NCT00348322|Lubricant Eye Drops|lubricant eye drops|mesh-list
65001701|NCT00348322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65001702|NCT00348361|Fluticasone|fluticasone|mesh-list
65001703|NCT00348361|Xhance|xhance|mesh-list
65001704|NCT00348361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65001705|NCT00348361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65001706|NCT00348361|Autonomic Agents|autonomic agents|mesh-ancestor
65001707|NCT00348361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65001708|NCT00348361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001709|NCT00348361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65001710|NCT00348361|Respiratory System Agents|respiratory system agents|mesh-ancestor
65001711|NCT00348361|Dermatologic Agents|dermatologic agents|mesh-ancestor
65001712|NCT00348361|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65001713|NCT00348400|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65001714|NCT00348400|Dorzolamide|dorzolamide|mesh-list
65001715|NCT00348400|Latanoprost|latanoprost|mesh-list
65001716|NCT00348400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65001717|NCT00348400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65001718|NCT00348400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65001719|NCT00348400|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65001720|NCT00348400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64960470|NCT00131326|Hylan|hylan|mesh-list
65001736|NCT00348439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65001737|NCT00348439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65001738|NCT00348439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001739|NCT00348517|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65001740|NCT00348517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65001741|NCT00348517|Lubricant Eye Drops|lubricant eye drops|mesh-list
65001742|NCT00348517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65001743|NCT00348517|Laxatives|laxatives|mesh-ancestor
65001744|NCT00348517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65001745|NCT00348634|Tegaserod|tegaserod|mesh-list
65001746|NCT00348634|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65001747|NCT00348634|Serotonin Agents|serotonin agents|mesh-ancestor
65001748|NCT00348634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65001749|NCT00348634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001750|NCT00348634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001751|NCT00348712|Insulin|insulin|mesh-list
65001752|NCT00348712|Metformin|metformin|mesh-list
65001753|NCT00348712|Rosiglitazone|rosiglitazone|mesh-list
65001754|NCT00348712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65001755|NCT00348712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65001756|NCT00348712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001757|NCT02964689|Pemetrexed|pemetrexed|mesh-list
65001758|NCT02964689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001759|NCT02964689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001760|NCT02964689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001761|NCT02964689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65001762|NCT02964689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65001763|NCT04715113|Sildenafil Citrate|sildenafil citrate|mesh-list
65001764|NCT04715113|Vasodilator Agents|vasodilator agents|mesh-ancestor
65001765|NCT04715113|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65001766|NCT04715113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65001767|NCT04715113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001768|NCT04715113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001769|NCT04715113|Urological Agents|urological agents|mesh-ancestor
65001770|NCT00348985|Bortezomib|bortezomib|mesh-list
65001771|NCT00348985|Belinostat|belinostat|mesh-list
65001772|NCT00348985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001773|NCT00348985|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65001774|NCT00348985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001775|NCT00348985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001776|NCT00349024|Povidone|povidone|mesh-list
65001777|NCT00349024|Hyaluronic Acid|hyaluronic acid|mesh-list
65274638|NCT02685228|Immunologic Factors|immunologic factors|mesh-ancestor
65274639|NCT02685228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274640|NCT00616460|Bivalirudin|bivalirudin|mesh-list
65274641|NCT00616460|Antithrombins|antithrombins|mesh-ancestor
65274642|NCT00616460|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65274643|NCT00616460|Protease Inhibitors|protease inhibitors|mesh-ancestor
65274644|NCT00616460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001778|NCT00349024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65001779|NCT00349024|Immunologic Factors|immunologic factors|mesh-ancestor
65001780|NCT00349024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001781|NCT00349024|Viscosupplements|viscosupplements|mesh-ancestor
65001813|NCT00421447|Anastrozole|anastrozole|mesh-list
65001814|NCT00421447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65001815|NCT00421447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001816|NCT00421447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65001817|NCT00421447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65001818|NCT00421447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001819|NCT00421447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001820|NCT00421447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65001821|NCT00421447|Hormone Antagonists|hormone antagonists|mesh-ancestor
65001822|NCT00421447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65001823|NCT00421447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001824|NCT04729140|Doxycycline|doxycycline|mesh-list
65001826|NCT04729140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65001844|NCT00349219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65001845|NCT00111449|Etanercept|etanercept|mesh-list
65001846|NCT00111449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65001847|NCT00111449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65001848|NCT00111449|Analgesics|analgesics|mesh-ancestor
65001849|NCT00111449|Sensory System Agents|sensory system agents|mesh-ancestor
65001850|NCT00111449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65001851|NCT00111449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001852|NCT00111449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65001853|NCT00111449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65001854|NCT00111449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65001855|NCT00111449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65001856|NCT00111449|Immunologic Factors|immunologic factors|mesh-ancestor
65001857|NCT00349258|Leuprolide|leuprolide|mesh-list
65001858|NCT00349258|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65001859|NCT00349258|Fertility Agents|fertility agents|mesh-ancestor
65001860|NCT00349258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65001861|NCT00349258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001862|NCT00349258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65001863|NCT00349258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001864|NCT00349375|Simvastatin|simvastatin|mesh-list
65001865|NCT00349375|Fenofibrate|fenofibrate|mesh-list
65001866|NCT00349375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65001867|NCT00349375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65001868|NCT00349375|Antimetabolites|antimetabolites|mesh-ancestor
65001869|NCT00349375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001870|NCT00349375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65001871|NCT00349375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65001872|NCT00349375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001873|NCT00349453|Deferiprone|deferiprone|mesh-list
65001874|NCT00349453|Deferoxamine|deferoxamine|mesh-list
65001875|NCT00349453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65001876|NCT00349453|Chelating Agents|chelating agents|mesh-ancestor
65001877|NCT00349453|Sequestering Agents|sequestering agents|mesh-ancestor
65001878|NCT00349453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001879|NCT00349453|Siderophores|siderophores|mesh-ancestor
65001880|NCT00349492|Cisplatin|cisplatin|mesh-list
65001881|NCT00349492|Irinotecan|irinotecan|mesh-list
64456999|NCT01743027|Analgesics|analgesics|mesh-ancestor
65001882|NCT00349492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001883|NCT00349492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65001884|NCT00349492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64960628|NCT00080340|Gefitinib|gefitinib|mesh-list
65001902|NCT00404703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65001903|NCT00404703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65274645|NCT00616460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274646|NCT00616460|Anticoagulants|anticoagulants|mesh-ancestor
65274647|NCT00616538|Fluticasone|fluticasone|mesh-list
65274648|NCT00616538|Xhance|xhance|mesh-list
65274649|NCT00616538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65274650|NCT00616538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65001904|NCT00404703|Growth Substances|growth substances|mesh-ancestor
65001905|NCT00404703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001906|NCT00404703|Growth Inhibitors|growth inhibitors|mesh-ancestor
65001907|NCT00349726|Inositol|inositol|mesh-list
65001908|NCT00349726|Vitamin B Complex|vitamin b complex|mesh-ancestor
65001909|NCT00349726|Vitamins|vitamins|mesh-ancestor
65001910|NCT00349726|Micronutrients|micronutrients|mesh-ancestor
65001911|NCT00349726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001912|NCT00111644|Ceftriaxone|ceftriaxone|mesh-list
65001913|NCT00111644|Lactams|lactams|mesh-list
65001914|NCT00111644|beta-Lactams|beta-lactams|mesh-list
65001915|NCT00111644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65001916|NCT00111644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65001917|NCT00350038|Irbesartan|irbesartan|mesh-list
65001918|NCT00350038|Ciprofibrate|ciprofibrate|mesh-list
65001919|NCT00350038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65001920|NCT00350038|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65001921|NCT00350038|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65001922|NCT00350038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001923|NCT00350038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65001924|NCT00350038|Antimetabolites|antimetabolites|mesh-ancestor
65001925|NCT00350038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65001926|NCT00350077|Vitamins|vitamins|mesh-list
65001927|NCT00350077|Ascorbic Acid|ascorbic acid|mesh-list
65001928|NCT00350077|Micronutrients|micronutrients|mesh-ancestor
65001929|NCT00350077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001930|NCT00350077|Antioxidants|antioxidants|mesh-ancestor
65001931|NCT00350077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001932|NCT00350077|Protective Agents|protective agents|mesh-ancestor
65001933|NCT00114153|Carboplatin|carboplatin|mesh-list
65001934|NCT00114153|Capecitabine|capecitabine|mesh-list
65001935|NCT00114153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001936|NCT00114153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65001937|NCT00114153|Antimetabolites|antimetabolites|mesh-ancestor
65001938|NCT00114153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001939|NCT00350116|Vitamin B 12|vitamin b 12|mesh-list
65001940|NCT00350116|Hydroxocobalamin|hydroxocobalamin|mesh-list
65001941|NCT00350116|Vitamins|vitamins|mesh-ancestor
65001942|NCT00350116|Micronutrients|micronutrients|mesh-ancestor
65001943|NCT00350116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960684|NCT00046748|Omalizumab|omalizumab|mesh-list
65001965|NCT00404781|Sensory System Agents|sensory system agents|mesh-ancestor
65001966|NCT00404781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65001967|NCT00404781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001968|NCT00404781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65001969|NCT00404781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65001970|NCT00404781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65001971|NCT00404781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65001972|NCT00404781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001973|NCT00404781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65001974|NCT00404781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65001975|NCT00404781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001977|NCT00404781|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65001978|NCT00404781|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65001979|NCT00404781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65001980|NCT00404781|Purinergic Agents|purinergic agents|mesh-ancestor
65001981|NCT00404781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65001982|NCT00404781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65001983|NCT00404781|Autonomic Agents|autonomic agents|mesh-ancestor
65001984|NCT00404781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65001985|NCT00404781|Respiratory System Agents|respiratory system agents|mesh-ancestor
65001986|NCT00404781|Vasodilator Agents|vasodilator agents|mesh-ancestor
65001987|NCT00404781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65001988|NCT00404781|Protective Agents|protective agents|mesh-ancestor
65001989|NCT00404781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65274651|NCT00616538|Autonomic Agents|autonomic agents|mesh-ancestor
65274652|NCT00616538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65274653|NCT00616538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274654|NCT00616538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65274655|NCT00616538|Respiratory System Agents|respiratory system agents|mesh-ancestor
65274656|NCT00616538|Dermatologic Agents|dermatologic agents|mesh-ancestor
65274657|NCT00616538|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65274658|NCT02680548|Methylprednisolone|methylprednisolone|mesh-list
65274659|NCT02680548|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65274660|NCT02680548|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65274661|NCT02680548|Prednisolone|prednisolone|mesh-list
65274662|NCT02680548|Prednisolone acetate|prednisolone acetate|mesh-list
65274663|NCT02680548|Bupivacaine|bupivacaine|mesh-list
65274664|NCT02680548|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65001990|NCT00404781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65001991|NCT00350311|Nicotine|nicotine|mesh-list
65001992|NCT00350311|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65001993|NCT00350311|Autonomic Agents|autonomic agents|mesh-ancestor
65001994|NCT00350311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65001995|NCT00350311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001996|NCT00350311|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65001997|NCT00350311|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64960750|NCT00133237|Sirolimus|sirolimus|mesh-list
65002017|NCT00114192|Growth Inhibitors|growth inhibitors|mesh-ancestor
65002018|NCT00350467|Olanzapine|olanzapine|mesh-list
65002019|NCT00350467|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65002020|NCT00350467|Antiemetics|antiemetics|mesh-ancestor
65002021|NCT00350467|Autonomic Agents|autonomic agents|mesh-ancestor
65002022|NCT00350467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65002023|NCT00350467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002024|NCT00350467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65002025|NCT00350467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65002026|NCT00350467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65002027|NCT00350467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65002028|NCT00350467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65002029|NCT00350467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65002031|NCT00350467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65002032|NCT00350467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457145|NCT04563273|Vaccines|vaccines|mesh-list
65002033|NCT00350467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65002034|NCT00350467|Serotonin Agents|serotonin agents|mesh-ancestor
65002035|NCT00350467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65002036|NCT00350467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65002037|NCT00350467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65002038|NCT00350467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65002039|NCT00350467|Dopamine Agents|dopamine agents|mesh-ancestor
65002040|NCT00350662|Deferiprone|deferiprone|mesh-list
65002041|NCT00350662|Deferoxamine|deferoxamine|mesh-list
65002042|NCT00350662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65002043|NCT00350662|Chelating Agents|chelating agents|mesh-ancestor
65002044|NCT00350662|Sequestering Agents|sequestering agents|mesh-ancestor
65002045|NCT00350662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002046|NCT00350662|Siderophores|siderophores|mesh-ancestor
65002047|NCT00350818|Azacitidine|azacitidine|mesh-list
65002048|NCT00350818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65002049|NCT00350818|Antimetabolites|antimetabolites|mesh-ancestor
65002050|NCT00350818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002051|NCT00350818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002052|NCT00350818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002053|NCT00350857|Carbamazepine|carbamazepine|mesh-list
65002068|NCT00350857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65002070|NCT00111956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65274665|NCT02680548|Prednisolone phosphate|prednisolone phosphate|mesh-list
65274666|NCT02680548|Anesthetics, Local|anesthetics, local|mesh-ancestor
65274667|NCT02680548|Anesthetics|anesthetics|mesh-ancestor
65274668|NCT02680548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65274669|NCT02680548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274670|NCT02680548|Sensory System Agents|sensory system agents|mesh-ancestor
65274671|NCT02680548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65274672|NCT02680548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64727163|NCT00002611|Tubulin Modulators|tubulin modulators|mesh-ancestor
65002071|NCT00111956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65002072|NCT00111956|Analgesics|analgesics|mesh-ancestor
65002073|NCT00111956|Sensory System Agents|sensory system agents|mesh-ancestor
65002074|NCT00111956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65002075|NCT00111956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002076|NCT00111956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65002077|NCT00111956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65002078|NCT00111956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65002079|NCT00111956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65002080|NCT00111956|Immunologic Factors|immunologic factors|mesh-ancestor
65002081|NCT00114270|Zoledronic Acid|zoledronic acid|mesh-list
65002082|NCT00114270|Letrozole|letrozole|mesh-list
65002083|NCT00114270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002084|NCT00114270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65002085|NCT00114270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65002086|NCT00114270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002087|NCT00114270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002088|NCT00114270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65002089|NCT00114270|Hormone Antagonists|hormone antagonists|mesh-ancestor
65002090|NCT00114270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65002091|NCT00114270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002092|NCT00114270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65002093|NCT00111995|Darbepoetin alfa|darbepoetin alfa|mesh-list
65002094|NCT00111995|Hematinics|hematinics|mesh-ancestor
65002095|NCT00351052|Pimecrolimus|pimecrolimus|mesh-list
65002096|NCT00351052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65002097|NCT00351052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65002098|NCT00351052|Analgesics|analgesics|mesh-ancestor
65002099|NCT00351052|Sensory System Agents|sensory system agents|mesh-ancestor
65002100|NCT00351052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65002101|NCT00351052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002103|NCT00351052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65002104|NCT00351052|Dermatologic Agents|dermatologic agents|mesh-ancestor
65002105|NCT00351052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65002106|NCT00351052|Immunologic Factors|immunologic factors|mesh-ancestor
64457211|NCT01722669|Protective Agents|protective agents|mesh-ancestor
65002107|NCT00351052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65002108|NCT00351052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002109|NCT00351052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002110|NCT00401609|Gemcitabine|gemcitabine|mesh-list
65002111|NCT00401609|Carboplatin|carboplatin|mesh-list
65002113|NCT00401609|Vinorelbine|vinorelbine|mesh-list
65002136|NCT00351091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65002137|NCT00351130|Amlodipine|amlodipine|mesh-list
65002138|NCT00351130|Valsartan|valsartan|mesh-list
65002139|NCT00351130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65002140|NCT00351130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65002141|NCT00351130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65002142|NCT00351130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002143|NCT00351130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65002144|NCT00351130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002145|NCT00351130|Vasodilator Agents|vasodilator agents|mesh-ancestor
65002146|NCT00351130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65002147|NCT00351130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65002148|NCT00351169|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65002149|NCT00351169|Citalopram|citalopram|mesh-list
65274673|NCT02680548|Antiemetics|antiemetics|mesh-ancestor
65274674|NCT02680548|Autonomic Agents|autonomic agents|mesh-ancestor
65274675|NCT02680548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65274676|NCT02680548|Glucocorticoids|glucocorticoids|mesh-ancestor
65274677|NCT02680548|Hormones|hormones|mesh-ancestor
65274678|NCT02680548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65274679|NCT02680548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65274680|NCT02680548|Protective Agents|protective agents|mesh-ancestor
65274681|NCT02680548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65274682|NCT02680548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274683|NCT05663736|Glimepiride|glimepiride|mesh-list
65274684|NCT05663736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65274685|NCT05663736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65274686|NCT05663736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274687|NCT05663736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65274688|NCT05663736|Immunologic Factors|immunologic factors|mesh-ancestor
65274689|NCT02685150|Omeprazole|omeprazole|mesh-list
65002150|NCT00351169|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65002151|NCT00351169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65002152|NCT00351169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65002153|NCT00351169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002154|NCT00351169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65002155|NCT00351169|Serotonin Agents|serotonin agents|mesh-ancestor
65002156|NCT00351169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002157|NCT00351169|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65002158|NCT00351169|Antidepressive Agents|antidepressive agents|mesh-ancestor
65002159|NCT00351169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65002160|NCT00351169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65002161|NCT00351169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65002178|NCT00112034|Methotrexate|methotrexate|mesh-list
65002179|NCT00112034|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65002180|NCT00112034|Prednisolone phosphate|prednisolone phosphate|mesh-list
65002181|NCT00112034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65002182|NCT00112034|Abortifacient Agents|abortifacient agents|mesh-ancestor
65002183|NCT00112034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65002184|NCT00112034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002185|NCT00112034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65002186|NCT00112034|Antimetabolites|antimetabolites|mesh-ancestor
65002187|NCT00112034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002188|NCT00112034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002189|NCT00112034|Dermatologic Agents|dermatologic agents|mesh-ancestor
65002190|NCT00112034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002191|NCT00112034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65002192|NCT00112034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65002193|NCT00112034|Immunologic Factors|immunologic factors|mesh-ancestor
65002194|NCT00112034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65002195|NCT00112034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65002196|NCT00112034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65002197|NCT00112034|Antiemetics|antiemetics|mesh-ancestor
65002198|NCT00112034|Autonomic Agents|autonomic agents|mesh-ancestor
65002199|NCT00112034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65002200|NCT00112034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65002201|NCT00112034|Glucocorticoids|glucocorticoids|mesh-ancestor
65002202|NCT00112034|Hormones|hormones|mesh-ancestor
65002203|NCT00112034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65002204|NCT00112034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65002205|NCT00112034|Protective Agents|protective agents|mesh-ancestor
65222788|NCT04215159|Gemcitabine|gemcitabine|mesh-list
65274690|NCT02685150|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65274691|NCT02685150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65274692|NCT02685150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64512725|NCT04022239|Tacrolimus|tacrolimus|mesh-list
65002206|NCT00112034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65002207|NCT00114387|Tocopherols|tocopherols|mesh-list
65002208|NCT00114387|Vitamin E|vitamin e|mesh-list
65002209|NCT00114387|Tocotrienols|tocotrienols|mesh-list
65002210|NCT00114387|alpha-Tocopherol|alpha-tocopherol|mesh-list
65002211|NCT00114387|Antioxidants|antioxidants|mesh-ancestor
65002212|NCT00114387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002213|NCT00114387|Protective Agents|protective agents|mesh-ancestor
65002214|NCT00114387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002215|NCT00114387|Vitamins|vitamins|mesh-ancestor
65002216|NCT00114387|Micronutrients|micronutrients|mesh-ancestor
65002217|NCT00351364|Montelukast|montelukast|mesh-list
65002218|NCT00351364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65002219|NCT00351364|Respiratory System Agents|respiratory system agents|mesh-ancestor
65002220|NCT00351364|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65002221|NCT00351364|Hormone Antagonists|hormone antagonists|mesh-ancestor
65002222|NCT00351364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65002252|NCT00351715|Sensory System Agents|sensory system agents|mesh-ancestor
65002253|NCT00351715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65002254|NCT00351715|Antitussive Agents|antitussive agents|mesh-ancestor
65002255|NCT00351715|Respiratory System Agents|respiratory system agents|mesh-ancestor
65002256|NCT00351832|Vildagliptin|vildagliptin|mesh-list
65002257|NCT00351832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65002258|NCT00351832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002259|NCT00351832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65002260|NCT00351832|Protease Inhibitors|protease inhibitors|mesh-ancestor
65002261|NCT00351832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002262|NCT00351832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002263|NCT00351871|Ribavirin|ribavirin|mesh-list
65002264|NCT00351871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65002265|NCT00351871|Antimetabolites|antimetabolites|mesh-ancestor
65002266|NCT00351871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002267|NCT00351871|Antiviral Agents|antiviral agents|mesh-ancestor
65002268|NCT00351871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65002269|NCT00351910|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65002300|NCT00351910|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65002301|NCT00351910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65002302|NCT00351910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65002303|NCT00351910|Adrenergic Agents|adrenergic agents|mesh-ancestor
65002304|NCT00112346|Gemcitabine|gemcitabine|mesh-list
65002305|NCT00112346|Cetuximab|cetuximab|mesh-list
65002306|NCT00112346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65002307|NCT00112346|Antimetabolites|antimetabolites|mesh-ancestor
65002308|NCT00112346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002309|NCT00112346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002310|NCT00112346|Antiviral Agents|antiviral agents|mesh-ancestor
65002311|NCT00112346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65002312|NCT00112346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002313|NCT00112346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65002334|NCT00112619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002335|NCT00112619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002336|NCT00112619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002337|NCT00352261|Esomeprazole|esomeprazole|mesh-list
65002338|NCT00352261|Lansoprazole|lansoprazole|mesh-list
65002339|NCT00352261|Dexlansoprazole|dexlansoprazole|mesh-list
65002340|NCT00352261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65002341|NCT00352261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65002342|NCT00352261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65002343|NCT00352261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002344|NCT00352261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002346|NCT00352300|Carboplatin|carboplatin|mesh-list
65002347|NCT00352300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65002348|NCT00352300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002349|NCT00352300|Tubulin Modulators|tubulin modulators|mesh-ancestor
65002350|NCT00352300|Antimitotic Agents|antimitotic agents|mesh-ancestor
65002351|NCT00352300|Mitosis Modulators|mitosis modulators|mesh-ancestor
65002352|NCT00352300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002353|NCT00112658|Leucovorin|leucovorin|mesh-list
65274693|NCT02685150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274694|NCT02685150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274695|NCT02682186|Ropivacaine|ropivacaine|mesh-list
65274696|NCT02682186|Anesthetics, Local|anesthetics, local|mesh-ancestor
65274697|NCT02682186|Anesthetics|anesthetics|mesh-ancestor
65274698|NCT02682186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65024703|NCT04685512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65274699|NCT02682186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274700|NCT02682186|Sensory System Agents|sensory system agents|mesh-ancestor
65274701|NCT02682186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65274702|NCT01832402|Fentanyl|fentanyl|mesh-list
65274703|NCT01832402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65274704|NCT01832402|Narcotics|narcotics|mesh-ancestor
65274705|NCT01832402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65274706|NCT01832402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274707|NCT01832402|Analgesics|analgesics|mesh-ancestor
65002354|NCT00112658|Gemcitabine|gemcitabine|mesh-list
65002355|NCT00112658|Fluorouracil|fluorouracil|mesh-list
65002356|NCT00112658|Oxaliplatin|oxaliplatin|mesh-list
65002357|NCT00112658|Irinotecan|irinotecan|mesh-list
65002358|NCT00112658|Calcium|calcium|mesh-list
65002359|NCT00112658|Levoleucovorin|levoleucovorin|mesh-list
65002360|NCT00112658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65002361|NCT00112658|Antimetabolites|antimetabolites|mesh-ancestor
65002362|NCT00112658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002363|NCT00112658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002364|NCT00112658|Antiviral Agents|antiviral agents|mesh-ancestor
65002365|NCT00112658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65002366|NCT00112658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002367|NCT00112658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65002368|NCT00112658|Immunologic Factors|immunologic factors|mesh-ancestor
65002369|NCT00112658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002370|NCT00112658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65002371|NCT00112658|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65002387|NCT00352339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65002388|NCT00352339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002389|NCT00352339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65002390|NCT00352339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65002392|NCT00352339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65002393|NCT00352339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65002394|NCT00352339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65002395|NCT00352339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65002396|NCT00352378|Cyclophosphamide|cyclophosphamide|mesh-list
65002397|NCT00352378|Docetaxel|docetaxel|mesh-list
65002398|NCT00352378|Doxorubicin|doxorubicin|mesh-list
65002400|NCT00352378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65002401|NCT00352378|Immunologic Factors|immunologic factors|mesh-ancestor
65002402|NCT00352378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002403|NCT00352378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65002404|NCT00352378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65002405|NCT00352378|Alkylating Agents|alkylating agents|mesh-ancestor
65002406|NCT00352378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002407|NCT00352378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002408|NCT00352378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65002410|NCT00352378|Antimitotic Agents|antimitotic agents|mesh-ancestor
65002411|NCT00352378|Mitosis Modulators|mitosis modulators|mesh-ancestor
65002412|NCT00352378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65002413|NCT00352378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65002414|NCT00352378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65274708|NCT01832402|Sensory System Agents|sensory system agents|mesh-ancestor
65274709|NCT01832402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65274710|NCT01832402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65274711|NCT01832402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65274712|NCT01832402|Anesthetics, General|anesthetics, general|mesh-ancestor
65002415|NCT00352378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002416|NCT00352378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65002417|NCT00352378|Antimetabolites|antimetabolites|mesh-ancestor
65002418|NCT00352495|Carboplatin|carboplatin|mesh-list
65002419|NCT00352495|Vinblastine|vinblastine|mesh-list
65002420|NCT00352495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002421|NCT00352495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65002422|NCT00352495|Tubulin Modulators|tubulin modulators|mesh-ancestor
65002423|NCT00352495|Antimitotic Agents|antimitotic agents|mesh-ancestor
65002424|NCT00352495|Mitosis Modulators|mitosis modulators|mesh-ancestor
65002425|NCT00352495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002426|NCT00112697|Docetaxel|docetaxel|mesh-list
65002427|NCT00112697|Fluorouracil|fluorouracil|mesh-list
65002428|NCT00112697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002429|NCT00112697|Tubulin Modulators|tubulin modulators|mesh-ancestor
65002430|NCT00112697|Antimitotic Agents|antimitotic agents|mesh-ancestor
65002431|NCT00112697|Mitosis Modulators|mitosis modulators|mesh-ancestor
65002432|NCT00112697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002433|NCT00112697|Antimetabolites|antimetabolites|mesh-ancestor
65002434|NCT00112697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65002461|NCT00352651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65002462|NCT00352651|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65002463|NCT00352651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65002464|NCT00352651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65002465|NCT00352651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65002466|NCT00112775|Imatinib Mesylate|imatinib mesylate|mesh-list
65002468|NCT00112775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002469|NCT00112775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65002470|NCT00112775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002471|NCT00112775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002472|NCT00352768|Fluvoxamine|fluvoxamine|mesh-list
64983668|NCT00120822|Folic Acid|folic acid|mesh-list
65002473|NCT00352768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002474|NCT00352768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002475|NCT00352768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65002476|NCT00352768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65002477|NCT00352768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65002478|NCT00352768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002479|NCT00352768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65002501|NCT00112853|Tipifarnib|tipifarnib|mesh-list
65002502|NCT00112853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65002503|NCT00112853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002504|NCT00112853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65002505|NCT00112853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65002506|NCT00112853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002507|NCT00112853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002508|NCT00353002|Lidocaine|lidocaine|mesh-list
65002509|NCT00353002|Tetracaine|tetracaine|mesh-list
65002510|NCT00353002|Anesthetics, Local|anesthetics, local|mesh-ancestor
65002511|NCT00353002|Anesthetics|anesthetics|mesh-ancestor
65002512|NCT00353002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65002513|NCT00353002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002514|NCT00353002|Sensory System Agents|sensory system agents|mesh-ancestor
65002515|NCT00353002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65002516|NCT00353002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65002517|NCT00353002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65002518|NCT00353002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65002519|NCT00353002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65002520|NCT00353002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002521|NCT00353041|Lidocaine|lidocaine|mesh-list
65002522|NCT00353041|Anesthetics, Local|anesthetics, local|mesh-ancestor
65002523|NCT00353041|Anesthetics|anesthetics|mesh-ancestor
65002524|NCT00353041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65002525|NCT00353041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274713|NCT01832402|Anesthetics|anesthetics|mesh-ancestor
65274714|NCT00619268|Interferons|interferons|mesh-list
65274715|NCT00619268|Interferon-alpha|interferon-alpha|mesh-list
65274716|NCT00619268|Interferon alpha-2|interferon alpha-2|mesh-list
65274717|NCT00619268|Sirolimus|sirolimus|mesh-list
65274718|NCT00619268|Bevacizumab|bevacizumab|mesh-list
65274719|NCT00619268|Sunitinib|sunitinib|mesh-list
64727206|NCT00003464|Temozolomide|temozolomide|mesh-list
65002526|NCT00353041|Sensory System Agents|sensory system agents|mesh-ancestor
65002527|NCT00353041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65002553|NCT00112931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65002554|NCT00112931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002555|NCT00112931|Immunologic Factors|immunologic factors|mesh-ancestor
65002556|NCT00112931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002557|NCT00112931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65002558|NCT00353665|Riluzole|riluzole|mesh-list
65002559|NCT00353665|Memantine|memantine|mesh-list
65002560|NCT00353665|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65002561|NCT00353665|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65002562|NCT00353665|Dopamine Agents|dopamine agents|mesh-ancestor
65002563|NCT00353665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65002564|NCT00353665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002565|NCT00353665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002566|NCT00353665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65002567|NCT00353665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65002568|NCT00353665|Anticonvulsants|anticonvulsants|mesh-ancestor
65002569|NCT00353665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65002570|NCT00353665|Protective Agents|protective agents|mesh-ancestor
65002571|NCT05594784|Prednisone|prednisone|mesh-list
65002572|NCT05594784|Vincristine|vincristine|mesh-list
65002573|NCT05594784|Venetoclax|venetoclax|mesh-list
65002587|NCT00113048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65002589|NCT00353743|Metronidazole|metronidazole|mesh-list
65002590|NCT00353743|Doxycycline|doxycycline|mesh-list
65002591|NCT00353743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65002592|NCT00353743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65002593|NCT00353743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65002594|NCT00353743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65002595|NCT00353743|Antimalarials|antimalarials|mesh-ancestor
65002596|NCT00113165|Lamotrigine|lamotrigine|mesh-list
65002597|NCT00113165|Anticonvulsants|anticonvulsants|mesh-ancestor
65002598|NCT00113165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65002599|NCT00113165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65002600|NCT00113165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002601|NCT00113165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65002602|NCT00113165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002603|NCT00113165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65002604|NCT00113165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65002605|NCT00113165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65002606|NCT00113165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65002607|NCT00113165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65002608|NCT00354094|Reboxetine|reboxetine|mesh-list
65002609|NCT00354094|Antidepressive Agents|antidepressive agents|mesh-ancestor
65002610|NCT00354094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65002611|NCT00354094|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65002612|NCT00354094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65002613|NCT00354094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65002614|NCT00354094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002615|NCT00354094|Adrenergic Agents|adrenergic agents|mesh-ancestor
65002616|NCT00354094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65002617|NCT00354094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002618|NCT00114816|Docetaxel|docetaxel|mesh-list
65002619|NCT00114816|Capecitabine|capecitabine|mesh-list
65002620|NCT00114816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002621|NCT00114816|Tubulin Modulators|tubulin modulators|mesh-ancestor
65002622|NCT00114816|Antimitotic Agents|antimitotic agents|mesh-ancestor
64457733|NCT03989362|Ipilimumab|ipilimumab|mesh-list
65002623|NCT00114816|Mitosis Modulators|mitosis modulators|mesh-ancestor
65002624|NCT00114816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002625|NCT00114816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65002626|NCT00114816|Antimetabolites|antimetabolites|mesh-ancestor
65274720|NCT00619268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65274721|NCT00619268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274722|NCT00619268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65274723|NCT00619268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65274724|NCT00619268|Growth Substances|growth substances|mesh-ancestor
65274725|NCT00619268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274726|NCT00619268|Growth Inhibitors|growth inhibitors|mesh-ancestor
65002627|NCT00354367|Certolizumab Pegol|certolizumab pegol|mesh-list
65002628|NCT00354367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65002629|NCT00354367|Immunologic Factors|immunologic factors|mesh-ancestor
65002630|NCT00354367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002631|NCT00354367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65002632|NCT00354406|Abciximab|abciximab|mesh-list
65002664|NCT00113282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65002665|NCT00113282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002667|NCT00425932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65002668|NCT00425932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002669|NCT00425932|Immunologic Factors|immunologic factors|mesh-ancestor
65002670|NCT00425932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002671|NCT00425932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65002672|NCT00426010|Caffeine|caffeine|mesh-list
65002673|NCT00426010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65002674|NCT00426010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002675|NCT00426010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65002696|NCT00113594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64457803|NCT03024580|Fulvestrant|fulvestrant|mesh-list
65002697|NCT00113594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002698|NCT00113594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65002699|NCT00113594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65002700|NCT00113594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65002701|NCT00113594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65002702|NCT00113594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65002703|NCT00113594|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65002704|NCT00113594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65002705|NCT00113594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65002706|NCT00113594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002707|NCT00113594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65002708|NCT00113594|Serotonin Agents|serotonin agents|mesh-ancestor
65002709|NCT00426049|Everolimus|everolimus|mesh-list
65002710|NCT00426049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002711|NCT00426049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65002712|NCT00426049|Immunologic Factors|immunologic factors|mesh-ancestor
65002713|NCT00426049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002714|NCT05594433|Lenograstim|lenograstim|mesh-list
65002715|NCT05594433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65002716|NCT05594433|Immunologic Factors|immunologic factors|mesh-ancestor
65002717|NCT05594433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002718|NCT00115089|Beclomethasone|beclomethasone|mesh-list
65002719|NCT00115089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65002720|NCT00115089|Glucocorticoids|glucocorticoids|mesh-ancestor
65002721|NCT00115089|Hormones|hormones|mesh-ancestor
65002722|NCT00115089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65002723|NCT00115089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002724|NCT00115089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65002725|NCT00115089|Respiratory System Agents|respiratory system agents|mesh-ancestor
65002726|NCT00115128|Lenograstim|lenograstim|mesh-list
64961468|NCT00145990|Miotics|miotics|mesh-ancestor
65002752|NCT00444340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65002753|NCT00444340|Analgesics|analgesics|mesh-ancestor
65002754|NCT00444340|Sensory System Agents|sensory system agents|mesh-ancestor
65002755|NCT00444340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65002756|NCT00444340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002757|NCT00444340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65002758|NCT00444340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65002759|NCT00444340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65002760|NCT00444340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65002761|NCT00444340|Immunologic Factors|immunologic factors|mesh-ancestor
65274727|NCT00619268|Antiviral Agents|antiviral agents|mesh-ancestor
65274728|NCT00619268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65274729|NCT00619268|Immunologic Factors|immunologic factors|mesh-ancestor
65274730|NCT00619268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65274731|NCT00619268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274732|NCT00619268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274733|NCT00619268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65274734|NCT00619268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65274735|NCT00619268|Antifungal Agents|antifungal agents|mesh-ancestor
65274736|NCT00619268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65274737|NCT00619346|Pafuramidine|pafuramidine|mesh-list
65274738|NCT00619346|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65002762|NCT00444379|Ritonavir|ritonavir|mesh-list
65002763|NCT00444379|Lopinavir|lopinavir|mesh-list
65002764|NCT00444379|Tenofovir|tenofovir|mesh-list
65002765|NCT00444379|Emtricitabine|emtricitabine|mesh-list
65002766|NCT00444379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65002767|NCT00444379|Efavirenz|efavirenz|mesh-list
65002768|NCT00444379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65002769|NCT00444379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65002770|NCT00444379|Protease Inhibitors|protease inhibitors|mesh-ancestor
65002771|NCT00444379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002772|NCT00444379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002773|NCT00444379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64457884|NCT03593668|Metformin|metformin|mesh-list
65002774|NCT00444379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65002775|NCT00444379|Antiviral Agents|antiviral agents|mesh-ancestor
65002776|NCT00444379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65002793|NCT00444574|Methylphenidate|methylphenidate|mesh-list
65002794|NCT00444574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65002795|NCT00444574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002796|NCT00444574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65002797|NCT00444574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65002798|NCT00444574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65002799|NCT00444574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002800|NCT00444574|Dopamine Agents|dopamine agents|mesh-ancestor
65002801|NCT00444574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65002802|NCT00444613|Vitamin B 12|vitamin b 12|mesh-list
65002803|NCT00444613|Vitamin B Complex|vitamin b complex|mesh-ancestor
65002804|NCT00444613|Vitamins|vitamins|mesh-ancestor
65002805|NCT00444613|Micronutrients|micronutrients|mesh-ancestor
65002806|NCT00444613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002807|NCT00444652|Enoxaparin|enoxaparin|mesh-list
65002808|NCT00444652|Anticoagulants|anticoagulants|mesh-ancestor
65002809|NCT00444652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65002810|NCT00444652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65002811|NCT00444652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002812|NCT04699903|Antibodies|antibodies|mesh-list
65002813|NCT04699903|Immunoglobulin G|immunoglobulin g|mesh-list
65002814|NCT04699903|Immunologic Factors|immunologic factors|mesh-ancestor
65002815|NCT04699903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002816|NCT00444808|Calcitonin|calcitonin|mesh-list
65002817|NCT00444808|Salmon calcitonin|salmon calcitonin|mesh-list
65002818|NCT00444808|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
65002819|NCT00444808|Katacalcin|katacalcin|mesh-list
65002820|NCT00444808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65002821|NCT00444808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002822|NCT00444808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65002823|NCT00444808|Vasodilator Agents|vasodilator agents|mesh-ancestor
65002824|NCT00113828|Cyclosporine|cyclosporine|mesh-list
65002825|NCT00113828|Cyclosporins|cyclosporins|mesh-list
65002826|NCT00113828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002827|NCT00113828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002828|NCT00113828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65274739|NCT00619346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65274740|NCT00619346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65274741|NCT00619346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65274742|NCT03063944|Azacitidine|azacitidine|mesh-list
65274743|NCT03063944|Decitabine|decitabine|mesh-list
65274744|NCT03063944|Venetoclax|venetoclax|mesh-list
65274745|NCT03063944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65274746|NCT03063944|Antimetabolites|antimetabolites|mesh-ancestor
65274747|NCT03063944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274748|NCT03063944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274749|NCT03063944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274750|NCT04182828|Lidocaine|lidocaine|mesh-list
64727225|NCT00003956|Antimetabolites|antimetabolites|mesh-ancestor
65002829|NCT00113828|Immunologic Factors|immunologic factors|mesh-ancestor
65002830|NCT00113828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002831|NCT00113828|Antifungal Agents|antifungal agents|mesh-ancestor
65002832|NCT00113828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65002858|NCT00115362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65002859|NCT00115362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65002860|NCT00115362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002861|NCT00115362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65002862|NCT00115362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002863|NCT00115362|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65002864|NCT00115362|Antidepressive Agents|antidepressive agents|mesh-ancestor
65002865|NCT00115362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65002866|NCT00445042|Sorafenib|sorafenib|mesh-list
65002867|NCT00445042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002868|NCT00445042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65002869|NCT00445042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002870|NCT00445042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002871|NCT00445081|Cyclosporine|cyclosporine|mesh-list
65002872|NCT00445081|Prednisolone|prednisolone|mesh-list
65002873|NCT00445081|Cyclosporins|cyclosporins|mesh-list
65002874|NCT00445081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65002875|NCT00445081|Glucocorticoids|glucocorticoids|mesh-ancestor
65002876|NCT00445081|Hormones|hormones|mesh-ancestor
65002877|NCT00445081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65002878|NCT00445081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002879|NCT00445081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65002880|NCT00445081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961624|NCT00042978|Etoposide|etoposide|mesh-list
65002912|NCT00113984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65002914|NCT00113984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002915|NCT00113984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65002916|NCT00113984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65002917|NCT00113984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65002918|NCT00113984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65002919|NCT00445510|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
65002941|NCT00445900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65002942|NCT00445900|Immunologic Factors|immunologic factors|mesh-ancestor
65002943|NCT00445900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002944|NCT00445900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65002945|NCT00445900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65002946|NCT00445900|Alkylating Agents|alkylating agents|mesh-ancestor
65002947|NCT00445900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002948|NCT00445900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002949|NCT00445900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65002950|NCT00445900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65002951|NCT00445900|Glucocorticoids|glucocorticoids|mesh-ancestor
65002952|NCT00445900|Hormones|hormones|mesh-ancestor
65222789|NCT04215159|Trastuzumab|trastuzumab|mesh-list
65274751|NCT04182828|Anesthetics, Local|anesthetics, local|mesh-ancestor
65274752|NCT04182828|Anesthetics|anesthetics|mesh-ancestor
65274753|NCT04182828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65274754|NCT04182828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274755|NCT04182828|Sensory System Agents|sensory system agents|mesh-ancestor
65274756|NCT04182828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65274757|NCT04182828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65274758|NCT04182828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65274759|NCT04182828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65274760|NCT04182828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65274761|NCT04182828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274762|NCT00619424|Pemetrexed|pemetrexed|mesh-list
65274763|NCT00619424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65274764|NCT00619424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002953|NCT00445900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65002954|NCT00445900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65002955|NCT00445900|Leprostatic Agents|leprostatic agents|mesh-ancestor
65002956|NCT00445900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65002957|NCT00445900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65002958|NCT00445900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65002959|NCT00445900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65002960|NCT00445900|Growth Substances|growth substances|mesh-ancestor
65002961|NCT00445900|Growth Inhibitors|growth inhibitors|mesh-ancestor
65002962|NCT00115479|Insulin|insulin|mesh-list
65002963|NCT00115479|Benzocaine|benzocaine|mesh-list
65002964|NCT00115479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65002965|NCT00115479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002966|NCT00115479|Anesthetics, Local|anesthetics, local|mesh-ancestor
65002967|NCT00115479|Anesthetics|anesthetics|mesh-ancestor
65002968|NCT00115479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65002969|NCT00115479|Sensory System Agents|sensory system agents|mesh-ancestor
65002970|NCT00115479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65002971|NCT00446017|Milrinone|milrinone|mesh-list
65002972|NCT00446017|Epinephrine|epinephrine|mesh-list
65002973|NCT00446017|Racepinephrine|racepinephrine|mesh-list
65002974|NCT00446017|Epinephryl borate|epinephryl borate|mesh-list
65003003|NCT00446173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65003004|NCT00446173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65003005|NCT00446173|Alkylating Agents|alkylating agents|mesh-ancestor
65003006|NCT00446173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003007|NCT00446173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003008|NCT00446173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65003009|NCT00446212|Propofol|propofol|mesh-list
65003010|NCT00446212|Desflurane|desflurane|mesh-list
65003011|NCT00446212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65003012|NCT00446212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65003013|NCT00446212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003014|NCT00446212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65003015|NCT00446212|Anesthetics, General|anesthetics, general|mesh-ancestor
65003016|NCT00446212|Anesthetics|anesthetics|mesh-ancestor
65003017|NCT00446212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65003018|NCT00446329|Cinacalcet|cinacalcet|mesh-list
65003019|NCT00446329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65003020|NCT00446329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003021|NCT00446329|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65003022|NCT00446329|Hormone Antagonists|hormone antagonists|mesh-ancestor
65003023|NCT00446329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65003024|NCT00446368|Everolimus|everolimus|mesh-list
65003044|NCT00446524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274765|NCT00619424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274766|NCT00619424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274767|NCT00619424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65274768|NCT00619424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65003045|NCT00446524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65003046|NCT00446524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003047|NCT00446524|Vasodilator Agents|vasodilator agents|mesh-ancestor
65003048|NCT00446524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65003049|NCT00446524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65003050|NCT00446602|Epoetin Alfa|epoetin alfa|mesh-list
65003051|NCT00446602|Hematinics|hematinics|mesh-ancestor
65003052|NCT05589753|Acetazolamide|acetazolamide|mesh-list
65003053|NCT05589753|Anticonvulsants|anticonvulsants|mesh-ancestor
65003054|NCT05589753|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65003055|NCT05589753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003056|NCT05589753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003057|NCT05589753|Diuretics|diuretics|mesh-ancestor
65003058|NCT05589753|Natriuretic Agents|natriuretic agents|mesh-ancestor
64984264|NCT00088998|Bevacizumab|bevacizumab|mesh-list
65003059|NCT05589753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003060|NCT00114179|Gemcitabine|gemcitabine|mesh-list
65003061|NCT00114179|Bevacizumab|bevacizumab|mesh-list
65003062|NCT00114179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65003063|NCT00114179|Capecitabine|capecitabine|mesh-list
65003065|NCT00114179|Immunoglobulins|immunoglobulins|mesh-list
65003066|NCT00114179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65003067|NCT00114179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003068|NCT00114179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65003069|NCT00114179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65003070|NCT00114179|Growth Substances|growth substances|mesh-ancestor
65003071|NCT00114179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003073|NCT00114179|Immunologic Factors|immunologic factors|mesh-ancestor
65003074|NCT00114179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65003075|NCT00114179|Antimetabolites|antimetabolites|mesh-ancestor
65003076|NCT00114179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003077|NCT00114179|Antiviral Agents|antiviral agents|mesh-ancestor
65003078|NCT00114179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65003079|NCT00114179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003080|NCT00114179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65003082|NCT00446680|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65003109|NCT00446836|Antimitotic Agents|antimitotic agents|mesh-ancestor
65003110|NCT00446836|Mitosis Modulators|mitosis modulators|mesh-ancestor
65003111|NCT00446836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003112|NCT00114374|Citalopram|citalopram|mesh-list
65003113|NCT00114374|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65003114|NCT00114374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65003115|NCT00114374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65003116|NCT00114374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003117|NCT00114374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65003118|NCT00114374|Serotonin Agents|serotonin agents|mesh-ancestor
65003119|NCT00114374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003120|NCT00114374|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65003121|NCT00114374|Antidepressive Agents|antidepressive agents|mesh-ancestor
65003122|NCT00114374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65003123|NCT00446953|Betamethasone|betamethasone|mesh-list
65003124|NCT00446953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65003125|NCT00446953|Glucocorticoids|glucocorticoids|mesh-ancestor
65003126|NCT00446953|Hormones|hormones|mesh-ancestor
65003127|NCT00446953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65003128|NCT00446953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003129|NCT00446953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65003152|NCT00447070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65003153|NCT00447070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65003154|NCT00447070|Protease Inhibitors|protease inhibitors|mesh-ancestor
65003155|NCT00447070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003156|NCT00447070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003158|NCT00447070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65003159|NCT00447070|Antiviral Agents|antiviral agents|mesh-ancestor
65274769|NCT00619424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65274770|NCT00641004|Esomeprazole|esomeprazole|mesh-list
65274771|NCT00641004|Rebamipide|rebamipide|mesh-list
65274772|NCT00641004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65274773|NCT00641004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65274774|NCT00641004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65274775|NCT00641004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003160|NCT00447070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65003161|NCT00115635|Gemcitabine|gemcitabine|mesh-list
65003162|NCT00115635|Docetaxel|docetaxel|mesh-list
65003163|NCT00115635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65003164|NCT00115635|Antimetabolites|antimetabolites|mesh-ancestor
65003165|NCT00115635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003166|NCT00115635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003167|NCT00115635|Antiviral Agents|antiviral agents|mesh-ancestor
65003168|NCT00115635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65003169|NCT00115635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003170|NCT00115635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65003171|NCT00115635|Immunologic Factors|immunologic factors|mesh-ancestor
65003172|NCT00115635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003173|NCT00115635|Tubulin Modulators|tubulin modulators|mesh-ancestor
65003174|NCT00115635|Antimitotic Agents|antimitotic agents|mesh-ancestor
65003175|NCT00115635|Mitosis Modulators|mitosis modulators|mesh-ancestor
65003176|NCT00447304|Moxifloxacin|moxifloxacin|mesh-list
65003177|NCT00447304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65003178|NCT00447304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65003179|NCT00447304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65003180|NCT00447304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65003181|NCT00447304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003182|NCT00447304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003183|NCT00447304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003184|NCT00447577|Loteprednol Etabonate|loteprednol etabonate|mesh-list
65003214|NCT00114491|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65003215|NCT00114491|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65003216|NCT00114491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65003217|NCT00114491|Antimetabolites|antimetabolites|mesh-ancestor
65003218|NCT00114491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003219|NCT00114491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65003220|NCT00114491|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65003221|NCT00114491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003222|NCT00114569|Lorazepam|lorazepam|mesh-list
65003223|NCT00114569|Anticonvulsants|anticonvulsants|mesh-ancestor
65003224|NCT00114569|Antiemetics|antiemetics|mesh-ancestor
65003225|NCT00114569|Autonomic Agents|autonomic agents|mesh-ancestor
65003226|NCT00114569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65003227|NCT00114569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003228|NCT00114569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65003229|NCT00114569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65003230|NCT00114569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65003267|NCT00401856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003268|NCT00401856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65003269|NCT00401856|Diuretics|diuretics|mesh-ancestor
65003270|NCT00401856|Natriuretic Agents|natriuretic agents|mesh-ancestor
65003271|NCT00401856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65003272|NCT00448240|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65003289|NCT00114686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65003290|NCT00114686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003291|NCT00114686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003292|NCT00114686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003293|NCT00114686|Antimanic Agents|antimanic agents|mesh-ancestor
64458414|NCT04029610|Anesthetics|anesthetics|mesh-ancestor
65003294|NCT00114686|Anticonvulsants|anticonvulsants|mesh-ancestor
65003295|NCT00114686|GABA Agents|gaba agents|mesh-ancestor
65003296|NCT00114686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65003297|NCT05553678|Midazolam|midazolam|mesh-list
65003298|NCT05553678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65003299|NCT05553678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65003300|NCT05553678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65003301|NCT05553678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274776|NCT00641004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274777|NCT00641004|Antioxidants|antioxidants|mesh-ancestor
65274778|NCT00641004|Protective Agents|protective agents|mesh-ancestor
65274779|NCT00641004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274780|NCT02680080|Moxifloxacin|moxifloxacin|mesh-list
65274781|NCT02680080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65274782|NCT02680080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65003302|NCT05553678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65003303|NCT05553678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65003304|NCT05553678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65003305|NCT05553678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65003306|NCT05553678|Anesthetics, General|anesthetics, general|mesh-ancestor
65003307|NCT05553678|Anesthetics|anesthetics|mesh-ancestor
65003308|NCT05553678|GABA Modulators|gaba modulators|mesh-ancestor
65003309|NCT05553678|GABA Agents|gaba agents|mesh-ancestor
65003310|NCT05553678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65003311|NCT05553678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003312|NCT00448552|Capecitabine|capecitabine|mesh-list
65003313|NCT00448552|Oxaliplatin|oxaliplatin|mesh-list
65003314|NCT00448552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65003315|NCT00448552|Antimetabolites|antimetabolites|mesh-ancestor
65003316|NCT00448552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003317|NCT00448552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003318|NCT03276520|Ethanol|ethanol|mesh-list
65003319|NCT03276520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65003320|NCT03276520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65003321|NCT03276520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65003322|NCT03276520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003323|NCT00114764|Lenograstim|lenograstim|mesh-list
65003324|NCT00114764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65003325|NCT00114764|Immunologic Factors|immunologic factors|mesh-ancestor
65003326|NCT00114764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003327|NCT00448786|Niacinamide|niacinamide|mesh-list
65003328|NCT00448786|Motesanib diphosphate|motesanib diphosphate|mesh-list
65003329|NCT00448786|Imetelstat|imetelstat|mesh-list
65003330|NCT00448786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65003331|NCT00448786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003332|NCT00448786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003355|NCT00402012|Pioglitazone|pioglitazone|mesh-list
65003356|NCT00402012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65003357|NCT00402012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003358|NCT00448981|Hand Sanitizers|hand sanitizers|mesh-list
65003359|NCT00448981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65003360|NCT00448981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65003361|NCT00448981|Disinfectants|disinfectants|mesh-ancestor
65003362|NCT03276325|Dexamethasone|dexamethasone|mesh-list
65003363|NCT03276325|Nalbuphine|nalbuphine|mesh-list
64984582|NCT04711161|Paclitaxel|paclitaxel|mesh-list
65003364|NCT03276325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65003365|NCT03276325|Antiemetics|antiemetics|mesh-ancestor
65003366|NCT03276325|Autonomic Agents|autonomic agents|mesh-ancestor
65003367|NCT03276325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65003368|NCT03276325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003369|NCT03276325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65003370|NCT03276325|Glucocorticoids|glucocorticoids|mesh-ancestor
65003372|NCT03276325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65003373|NCT03276325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65003374|NCT03276325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003375|NCT03276325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65003376|NCT03276325|Narcotics|narcotics|mesh-ancestor
65003377|NCT03276325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65003378|NCT03276325|Analgesics|analgesics|mesh-ancestor
65003379|NCT03276325|Sensory System Agents|sensory system agents|mesh-ancestor
65003380|NCT00449020|Carboplatin|carboplatin|mesh-list
65003382|NCT00449020|Irinotecan|irinotecan|mesh-list
65003383|NCT00449020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003384|NCT00449020|Tubulin Modulators|tubulin modulators|mesh-ancestor
65003385|NCT00449020|Antimitotic Agents|antimitotic agents|mesh-ancestor
65003386|NCT00449020|Mitosis Modulators|mitosis modulators|mesh-ancestor
65003387|NCT00449020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274783|NCT02680080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65274784|NCT02680080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65274785|NCT02680080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274786|NCT02680080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274787|NCT02680080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274788|NCT01009788|Temozolomide|temozolomide|mesh-list
65003388|NCT00449020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65003389|NCT00449020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65003390|NCT00449020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003413|NCT00449137|Antimetabolites|antimetabolites|mesh-ancestor
65003414|NCT00449137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003415|NCT00449137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65003416|NCT00449137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003417|NCT00449137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65003418|NCT00449137|Immunologic Factors|immunologic factors|mesh-ancestor
65003419|NCT00449137|Antidotes|antidotes|mesh-ancestor
65003420|NCT00449137|Protective Agents|protective agents|mesh-ancestor
65003421|NCT00449137|Vitamin B Complex|vitamin b complex|mesh-ancestor
65003422|NCT00449137|Vitamins|vitamins|mesh-ancestor
65003423|NCT00449137|Micronutrients|micronutrients|mesh-ancestor
65003424|NCT00449254|Oleoyl-estrone|oleoyl-estrone|mesh-list
65003425|NCT00449254|Estrone|estrone|mesh-list
65003426|NCT00449254|Estrogens|estrogens|mesh-ancestor
65003427|NCT00449254|Hormones|hormones|mesh-ancestor
65003428|NCT00449254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65003429|NCT00449254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003430|NCT00449254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65003431|NCT00449410|Atorvastatin|atorvastatin|mesh-list
65003432|NCT00449410|Ezetimibe|ezetimibe|mesh-list
65003433|NCT00449410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65003434|NCT00449410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65003435|NCT00449410|Antimetabolites|antimetabolites|mesh-ancestor
65003436|NCT00449410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003437|NCT00449410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65003438|NCT00449410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65003439|NCT00449410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003440|NCT00449449|Lidocaine|lidocaine|mesh-list
65003441|NCT00449449|Anesthetics, Local|anesthetics, local|mesh-ancestor
65003442|NCT00449449|Anesthetics|anesthetics|mesh-ancestor
65003443|NCT00449449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65003444|NCT00449449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962181|NCT00048854|Sertraline|sertraline|mesh-list
65003478|NCT00115154|Interferon Inducers|interferon inducers|mesh-ancestor
65003480|NCT00449527|Formoterol Fumarate|formoterol fumarate|mesh-list
65003481|NCT00449527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65003482|NCT00449527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65003483|NCT00449527|Autonomic Agents|autonomic agents|mesh-ancestor
65003484|NCT00449527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962222|NCT00149578|Antidotes|antidotes|mesh-ancestor
65003508|NCT00449722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65003509|NCT00449722|Analgesics|analgesics|mesh-ancestor
65003510|NCT00449722|Sensory System Agents|sensory system agents|mesh-ancestor
65003511|NCT00449722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65003512|NCT00449722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003513|NCT00449722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65003514|NCT00449722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65003515|NCT00449800|Ceftriaxone|ceftriaxone|mesh-list
65003516|NCT00449800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65003517|NCT00449800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65003518|NCT00449839|Insulin|insulin|mesh-list
65003519|NCT00449839|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65003520|NCT00449839|Insulin Aspart|insulin aspart|mesh-list
65003521|NCT00449839|Insulin, Long-Acting|insulin, long-acting|mesh-list
65003522|NCT00449839|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65003523|NCT00449839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65003524|NCT00449839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003525|NCT00450229|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
65003526|NCT00450229|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65003527|NCT00450229|Protective Agents|protective agents|mesh-ancestor
65003528|NCT00450229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003529|NCT00450229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274789|NCT01009788|Veliparib|veliparib|mesh-list
65274790|NCT01009788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65274791|NCT01009788|Alkylating Agents|alkylating agents|mesh-ancestor
65274792|NCT01009788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274793|NCT01009788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003530|NCT04699279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65003531|NCT04699279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65003532|NCT04699279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65003533|NCT04699279|Antimetabolites|antimetabolites|mesh-ancestor
65003565|NCT05536362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65003566|NCT05536362|Anesthetics, General|anesthetics, general|mesh-ancestor
65003567|NCT05536362|Anesthetics|anesthetics|mesh-ancestor
65003568|NCT05536362|Analgesics|analgesics|mesh-ancestor
65003569|NCT05536362|Sensory System Agents|sensory system agents|mesh-ancestor
65003570|NCT05536362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65003571|NCT05536362|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65003572|NCT05536362|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65003573|NCT05536362|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65003574|NCT05536362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65003575|NCT05536362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003592|NCT00450853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003594|NCT00450892|Trastuzumab|trastuzumab|mesh-list
65003595|NCT00450892|Lapatinib|lapatinib|mesh-list
65003596|NCT00450892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003597|NCT00450892|Tubulin Modulators|tubulin modulators|mesh-ancestor
65003598|NCT00450892|Antimitotic Agents|antimitotic agents|mesh-ancestor
65003599|NCT00450892|Mitosis Modulators|mitosis modulators|mesh-ancestor
64458790|NCT03944434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65003600|NCT00450892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003601|NCT00450892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65003602|NCT00450892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65003603|NCT00450892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003604|NCT00115310|Capsaicin|capsaicin|mesh-list
65003605|NCT00115310|Antipruritics|antipruritics|mesh-ancestor
65003606|NCT00115310|Dermatologic Agents|dermatologic agents|mesh-ancestor
65003607|NCT00115310|Sensory System Agents|sensory system agents|mesh-ancestor
65003608|NCT00115310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65003609|NCT00115310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003610|NCT00115908|Ribavirin|ribavirin|mesh-list
65003611|NCT00115908|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65003612|NCT00115908|Antimetabolites|antimetabolites|mesh-ancestor
65003613|NCT00115908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003614|NCT00115908|Antiviral Agents|antiviral agents|mesh-ancestor
65003615|NCT00115908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65003616|NCT00458185|Etanercept|etanercept|mesh-list
65003617|NCT00458185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65003618|NCT00458185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65003619|NCT00458185|Analgesics|analgesics|mesh-ancestor
65003620|NCT00458185|Sensory System Agents|sensory system agents|mesh-ancestor
65003621|NCT00458185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65003622|NCT00458185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003623|NCT00458185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65003624|NCT00458185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65003625|NCT00458185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65003626|NCT00458185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65003627|NCT00458185|Immunologic Factors|immunologic factors|mesh-ancestor
65003628|NCT00458263|Hormones|hormones|mesh-list
65003629|NCT00458263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65003630|NCT00458263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003631|NCT00458419|Naloxone|naloxone|mesh-list
65003632|NCT00458419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65003633|NCT00458419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003634|NCT00458419|Sensory System Agents|sensory system agents|mesh-ancestor
64962361|NCT00082251|Niacin|niacin|mesh-list
65003655|NCT00458614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65003656|NCT00458614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003657|NCT00458614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003658|NCT00458731|Bevacizumab|bevacizumab|mesh-list
65003659|NCT00458731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65274794|NCT01009788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65274795|NCT01009788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274796|NCT04183608|Adalimumab|adalimumab|mesh-list
65274797|NCT04183608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65274798|NCT04183608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65003661|NCT00458731|Antibodies|antibodies|mesh-list
65003662|NCT00458731|Immunoglobulins|immunoglobulins|mesh-list
65003663|NCT00458731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65003664|NCT00458731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003665|NCT00458731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65003666|NCT00458731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65003667|NCT00458731|Growth Substances|growth substances|mesh-ancestor
65003668|NCT00458731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003669|NCT00458731|Growth Inhibitors|growth inhibitors|mesh-ancestor
65003670|NCT00458731|Immunologic Factors|immunologic factors|mesh-ancestor
65003671|NCT00458731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003672|NCT00458731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003673|NCT00458731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65003674|NCT03274024|Mitomycins|mitomycins|mesh-list
65003675|NCT03274024|Mitomycin|mitomycin|mesh-list
65003676|NCT03274024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65003677|NCT03274024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003678|NCT03274024|Alkylating Agents|alkylating agents|mesh-ancestor
65003679|NCT03274024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003680|NCT03274024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65003681|NCT03274024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003682|NCT00115947|Terlipressin|terlipressin|mesh-list
65003683|NCT00115947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65003684|NCT00115947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65003685|NCT00458809|Oxaliplatin|oxaliplatin|mesh-list
65003686|NCT00458809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003687|NCT00115544|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
65003688|NCT00115544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003689|NCT00115544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003721|NCT04728321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003722|NCT04728321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65003723|NCT04728321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003724|NCT04728321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003725|NCT00459901|Capecitabine|capecitabine|mesh-list
65003726|NCT00459901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65003727|NCT00459901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65003728|NCT00459901|Antimetabolites|antimetabolites|mesh-ancestor
65003729|NCT00459901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003730|NCT00459901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962473|NCT00082446|Vaccines|vaccines|mesh-list
65003760|NCT00401921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65003761|NCT00401921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65003762|NCT00460174|Gemcitabine|gemcitabine|mesh-list
65003763|NCT00460174|Bevacizumab|bevacizumab|mesh-list
65003764|NCT00460174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65003765|NCT00460174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003766|NCT00460174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65003767|NCT00460174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65003768|NCT00460174|Growth Substances|growth substances|mesh-ancestor
65003769|NCT00460174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003770|NCT00460174|Growth Inhibitors|growth inhibitors|mesh-ancestor
65003771|NCT00460174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65003772|NCT00460174|Antimetabolites|antimetabolites|mesh-ancestor
65003773|NCT00460174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003774|NCT00460174|Antiviral Agents|antiviral agents|mesh-ancestor
65003775|NCT00460174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64962510|NCT00150865|Ropivacaine|ropivacaine|mesh-list
65003805|NCT00460369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65003806|NCT00460369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65003807|NCT00460369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003808|NCT00460369|Antiviral Agents|antiviral agents|mesh-ancestor
65003809|NCT00460369|Schistosomicides|schistosomicides|mesh-ancestor
65003810|NCT00460369|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65003811|NCT00460369|Anthelmintics|anthelmintics|mesh-ancestor
65003812|NCT00460369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65003813|NCT00460369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274799|NCT00641082|Adefovir|adefovir|mesh-list
65274800|NCT00641082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65274801|NCT00641082|Clevudine|clevudine|mesh-list
65274802|NCT00641082|Antiviral Agents|antiviral agents|mesh-ancestor
65274803|NCT00641082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65274804|NCT00641082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65274805|NCT00641082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65003814|NCT00460369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003815|NCT00460369|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65003816|NCT00460369|Renal Agents|renal agents|mesh-ancestor
65003818|NCT00460447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65003819|NCT00460447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003820|NCT00460642|Cetrorelix|cetrorelix|mesh-list
65003821|NCT00460642|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65003822|NCT00460642|Fertility Agents|fertility agents|mesh-ancestor
64962552|NCT00151060|Paclitaxel|paclitaxel|mesh-list
65003846|NCT00460876|Topotecan|topotecan|mesh-list
65003847|NCT00460876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65003848|NCT00460876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65003849|NCT00460876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003850|NCT00460876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003851|NCT00460876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003852|NCT00460915|Amlodipine|amlodipine|mesh-list
65003853|NCT00460915|Lacidipine|lacidipine|mesh-list
65003854|NCT00460915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65003855|NCT00460915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65003856|NCT00460915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65003857|NCT00460915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003858|NCT00460915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65003859|NCT00460915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003860|NCT00460915|Vasodilator Agents|vasodilator agents|mesh-ancestor
65003861|NCT00460954|Levodopa|levodopa|mesh-list
65003862|NCT00460954|Carbidopa|carbidopa|mesh-list
65003863|NCT00460954|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65003864|NCT00460954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65003865|NCT00460954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65003866|NCT00460954|Dopamine Agents|dopamine agents|mesh-ancestor
65003867|NCT00460954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65003868|NCT00460954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003869|NCT00460954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003870|NCT00460954|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65003871|NCT00460954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003872|NCT00460954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65003884|NCT00461266|Antiviral Agents|antiviral agents|mesh-ancestor
65003885|NCT00461266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65003886|NCT00461266|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65003887|NCT00461266|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65003888|NCT00461266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985087|NCT00296608|Leucovorin|leucovorin|mesh-list
65003889|NCT00461266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65003890|NCT00461344|Docetaxel|docetaxel|mesh-list
65003891|NCT00461344|Doxorubicin|doxorubicin|mesh-list
65003892|NCT00461344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003893|NCT00461344|Tubulin Modulators|tubulin modulators|mesh-ancestor
65003894|NCT00461344|Antimitotic Agents|antimitotic agents|mesh-ancestor
65003895|NCT00461344|Mitosis Modulators|mitosis modulators|mesh-ancestor
65003896|NCT00461344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003897|NCT00461344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65003898|NCT00461344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65003899|NCT00461344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65003900|NCT00461344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003901|NCT03273634|Lansoprazole|lansoprazole|mesh-list
65003902|NCT03273634|Dexlansoprazole|dexlansoprazole|mesh-list
65003903|NCT03273634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65003904|NCT03273634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65003905|NCT03273634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65003906|NCT03273634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003907|NCT03273634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003909|NCT03273595|Cyclophosphamide|cyclophosphamide|mesh-list
65274806|NCT00641082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274807|NCT00641082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274808|NCT00641160|Vinorelbine|vinorelbine|mesh-list
65274809|NCT00641160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65003910|NCT03273595|Trastuzumab|trastuzumab|mesh-list
65003911|NCT03273595|Epirubicin|epirubicin|mesh-list
65003912|NCT03273595|Lapatinib|lapatinib|mesh-list
65003913|NCT03273595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65003914|NCT03273595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003915|NCT03273595|Tubulin Modulators|tubulin modulators|mesh-ancestor
65003916|NCT03273595|Antimitotic Agents|antimitotic agents|mesh-ancestor
65003917|NCT03273595|Mitosis Modulators|mitosis modulators|mesh-ancestor
65003918|NCT03273595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003919|NCT03273595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65003920|NCT03273595|Immunologic Factors|immunologic factors|mesh-ancestor
65003921|NCT03273595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003922|NCT03273595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65003923|NCT03273595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65003924|NCT03273595|Alkylating Agents|alkylating agents|mesh-ancestor
65003925|NCT03273595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65003926|NCT03273595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65003927|NCT03273595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65003928|NCT03273595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65003929|NCT03273595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65003930|NCT03273595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003931|NCT03273595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65003932|NCT03273556|Lidocaine|lidocaine|mesh-list
65003933|NCT03273556|Anesthetics, Local|anesthetics, local|mesh-ancestor
65003934|NCT03273556|Anesthetics|anesthetics|mesh-ancestor
65003935|NCT03273556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65003936|NCT03273556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003937|NCT03273556|Sensory System Agents|sensory system agents|mesh-ancestor
65003938|NCT03273556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65003962|NCT04697992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003963|NCT04697992|Hemostatics|hemostatics|mesh-ancestor
65003965|NCT04697992|Antioxidants|antioxidants|mesh-ancestor
65003966|NCT04697992|Protective Agents|protective agents|mesh-ancestor
65003967|NCT05483634|Estrogens|estrogens|mesh-list
65003968|NCT05483634|Hormones|hormones|mesh-ancestor
65003969|NCT05483634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65003970|NCT05483634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003971|NCT00461578|Artesunate|artesunate|mesh-list
65003972|NCT00461578|Dapsone|dapsone|mesh-list
65003973|NCT00461578|Chlorproguanil|chlorproguanil|mesh-list
65003974|NCT00461578|Antimalarials|antimalarials|mesh-ancestor
65003975|NCT00461578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65003976|NCT00461578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65003977|NCT00461578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65003978|NCT00461578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003979|NCT00461578|Antiviral Agents|antiviral agents|mesh-ancestor
65003980|NCT00461578|Schistosomicides|schistosomicides|mesh-ancestor
65003981|NCT00461578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65003982|NCT00461578|Anthelmintics|anthelmintics|mesh-ancestor
65003983|NCT00461578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65003984|NCT00461578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003985|NCT00461578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003986|NCT00461578|Leprostatic Agents|leprostatic agents|mesh-ancestor
65003987|NCT00461578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65003988|NCT00461617|Mitiglinide|mitiglinide|mesh-list
65003989|NCT00461617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65003990|NCT00461617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003991|NCT00116064|Lorazepam|lorazepam|mesh-list
65004009|NCT04728035|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65004010|NCT04728035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65004012|NCT04728035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004013|NCT04728035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65004014|NCT00461890|Naltrexone|naltrexone|mesh-list
65004015|NCT00461890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65004016|NCT00461890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65004017|NCT00461890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004018|NCT00461890|Sensory System Agents|sensory system agents|mesh-ancestor
65274810|NCT00641160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274811|NCT00641160|Tubulin Modulators|tubulin modulators|mesh-ancestor
65274812|NCT00641160|Antimitotic Agents|antimitotic agents|mesh-ancestor
65274813|NCT00641160|Mitosis Modulators|mitosis modulators|mesh-ancestor
64727294|NCT05664061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65004019|NCT00461890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65004020|NCT04727723|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65004021|NCT04727723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65004022|NCT04727723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004023|NCT00461968|Simvastatin|simvastatin|mesh-list
65004024|NCT00461968|Ezetimibe|ezetimibe|mesh-list
65004025|NCT00461968|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65004026|NCT00461968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65004027|NCT00461968|Antimetabolites|antimetabolites|mesh-ancestor
65004028|NCT00461968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004029|NCT00461968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65004030|NCT00461968|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65004031|NCT00461968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004032|NCT00116103|Tacrolimus|tacrolimus|mesh-list
65004033|NCT00116103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65004034|NCT00116103|Immunologic Factors|immunologic factors|mesh-ancestor
65004035|NCT00116103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004036|NCT00116103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65004037|NCT00116103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004038|NCT00116103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004039|NCT02956252|Anesthetics|anesthetics|mesh-list
64985233|NCT00297739|Risperidone|risperidone|mesh-list
65004040|NCT02956252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65004041|NCT02956252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004043|NCT00462358|Lenograstim|lenograstim|mesh-list
65004044|NCT00462358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65004045|NCT00462358|Immunologic Factors|immunologic factors|mesh-ancestor
65004046|NCT00462358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004047|NCT00462358|Antimitotic Agents|antimitotic agents|mesh-ancestor
65004048|NCT00462358|Mitosis Modulators|mitosis modulators|mesh-ancestor
64962761|NCT00151528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65004072|NCT00462475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65004074|NCT00462553|Gemcitabine|gemcitabine|mesh-list
65004075|NCT00462553|Sunitinib|sunitinib|mesh-list
65004076|NCT00462553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65004077|NCT00462553|Antimetabolites|antimetabolites|mesh-ancestor
65004078|NCT00462553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004079|NCT00462553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65004080|NCT00462553|Antiviral Agents|antiviral agents|mesh-ancestor
65004081|NCT00462553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65004082|NCT00462553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004083|NCT00462553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65004084|NCT00462553|Immunologic Factors|immunologic factors|mesh-ancestor
65004085|NCT00462553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004086|NCT00462553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65004087|NCT00462553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65004088|NCT00462553|Growth Substances|growth substances|mesh-ancestor
65004089|NCT00462553|Growth Inhibitors|growth inhibitors|mesh-ancestor
65004090|NCT00462553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65004091|NCT00462592|Budesonide|budesonide|mesh-list
65004092|NCT00462592|Montelukast|montelukast|mesh-list
65004093|NCT00462592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65004094|NCT00462592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65004095|NCT00462592|Autonomic Agents|autonomic agents|mesh-ancestor
65004096|NCT00462592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962822|NCT04725253|Niacin|niacin|mesh-list
65004114|NCT00462631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65004115|NCT00462631|Tubulin Modulators|tubulin modulators|mesh-ancestor
65004116|NCT00462631|Antimitotic Agents|antimitotic agents|mesh-ancestor
65004117|NCT00462631|Mitosis Modulators|mitosis modulators|mesh-ancestor
65004118|NCT00462631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004119|NCT00462787|Dexamethasone|dexamethasone|mesh-list
65004120|NCT00462787|Topotecan|topotecan|mesh-list
65004121|NCT00462787|Vinorelbine|vinorelbine|mesh-list
65004122|NCT00462787|Thiotepa|thiotepa|mesh-list
65004123|NCT00462787|Clofarabine|clofarabine|mesh-list
65004124|NCT00462787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65274814|NCT00641160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274815|NCT02679924|Hyaluronic Acid|hyaluronic acid|mesh-list
65274816|NCT02679924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65274817|NCT02679924|Immunologic Factors|immunologic factors|mesh-ancestor
65004125|NCT00462787|Antiemetics|antiemetics|mesh-ancestor
65004126|NCT00462787|Autonomic Agents|autonomic agents|mesh-ancestor
65004127|NCT00462787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65004128|NCT00462787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004129|NCT00462787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65004131|NCT00462787|Hormones|hormones|mesh-ancestor
65004132|NCT00462787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65004133|NCT00462787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65004134|NCT00462787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65004135|NCT00462787|Immunologic Factors|immunologic factors|mesh-ancestor
65004136|NCT00462787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65004137|NCT00462787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65004138|NCT00462787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004139|NCT00462787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004140|NCT00462787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65004141|NCT00462787|Tubulin Modulators|tubulin modulators|mesh-ancestor
65004142|NCT00462787|Antimitotic Agents|antimitotic agents|mesh-ancestor
65004143|NCT00462787|Mitosis Modulators|mitosis modulators|mesh-ancestor
65004144|NCT00462787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65004145|NCT00462787|Alkylating Agents|alkylating agents|mesh-ancestor
65004146|NCT00462787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65004147|NCT00462787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65004148|NCT00462787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65004149|NCT00462787|Antimetabolites|antimetabolites|mesh-ancestor
65004150|NCT00463021|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
65004151|NCT00463021|Vitamins|vitamins|mesh-ancestor
65004152|NCT00463021|Micronutrients|micronutrients|mesh-ancestor
65004174|NCT00116324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65004175|NCT00116324|Respiratory System Agents|respiratory system agents|mesh-ancestor
65004176|NCT00116324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65004178|NCT00116324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65004179|NCT00116324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004180|NCT00116324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65004181|NCT00116324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65004182|NCT00116324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004183|NCT00116402|Fluticasone|fluticasone|mesh-list
65004184|NCT00116402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65004185|NCT00116402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65004186|NCT00116402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65004187|NCT00116402|Autonomic Agents|autonomic agents|mesh-ancestor
65004188|NCT00116402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65004189|NCT00116402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004190|NCT00116402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65004191|NCT00116402|Respiratory System Agents|respiratory system agents|mesh-ancestor
65004192|NCT00116402|Dermatologic Agents|dermatologic agents|mesh-ancestor
65004193|NCT00116402|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65004194|NCT00116402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65004195|NCT00116402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65004196|NCT00116402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65004197|NCT00116402|Adrenergic Agents|adrenergic agents|mesh-ancestor
65004198|NCT00116402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65004199|NCT00116402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004200|NCT00463723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65004201|NCT00463723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65004203|NCT00463762|Cefoperazone|cefoperazone|mesh-list
65004228|NCT00463879|Autonomic Agents|autonomic agents|mesh-ancestor
65004229|NCT00463879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65004230|NCT00463879|Nootropic Agents|nootropic agents|mesh-ancestor
65004231|NCT00463918|Varenicline|varenicline|mesh-list
65004232|NCT00463918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65004233|NCT00463918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65004234|NCT00463918|Cholinergic Agents|cholinergic agents|mesh-ancestor
65004235|NCT00463918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65004236|NCT00463918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274818|NCT02679924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274819|NCT02679924|Viscosupplements|viscosupplements|mesh-ancestor
65274820|NCT02679924|Protective Agents|protective agents|mesh-ancestor
65274821|NCT00618176|Lamivudine|lamivudine|mesh-list
65004237|NCT00463918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004238|NCT00463957|Sildenafil Citrate|sildenafil citrate|mesh-list
65004239|NCT00463957|Tadalafil|tadalafil|mesh-list
65004240|NCT00463957|Vasodilator Agents|vasodilator agents|mesh-ancestor
65004241|NCT00463957|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65004242|NCT00463957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65004243|NCT00463957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004244|NCT00463957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004245|NCT00463957|Urological Agents|urological agents|mesh-ancestor
65004246|NCT00464035|Calcium|calcium|mesh-list
65004247|NCT00464035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65004248|NCT00464035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004249|NCT00116454|Ethiodized Oil|ethiodized oil|mesh-list
65004250|NCT00116454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65004251|NCT00464191|Citalopram|citalopram|mesh-list
65004252|NCT00464191|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65004253|NCT00464191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65004275|NCT00464347|Glucocorticoids|glucocorticoids|mesh-ancestor
65004277|NCT00464347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65004278|NCT00464347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65004279|NCT00464347|Immunologic Factors|immunologic factors|mesh-ancestor
65004280|NCT00464347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004281|NCT00464347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004282|NCT00116493|Folic Acid|folic acid|mesh-list
65004283|NCT00116493|Mebendazole|mebendazole|mesh-list
65004284|NCT00116493|Piperazine|piperazine|mesh-list
65004285|NCT00116493|Piperazine citrate|piperazine citrate|mesh-list
65004286|NCT00116493|DMP 777|dmp 777|mesh-list
65004287|NCT00116493|Hematinics|hematinics|mesh-ancestor
65004288|NCT00116493|Vitamin B Complex|vitamin b complex|mesh-ancestor
65004289|NCT00116493|Vitamins|vitamins|mesh-ancestor
65004290|NCT00116493|Micronutrients|micronutrients|mesh-ancestor
65004291|NCT00116493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004292|NCT00116493|Antinematodal Agents|antinematodal agents|mesh-ancestor
65004293|NCT00116493|Anthelmintics|anthelmintics|mesh-ancestor
65004294|NCT00116493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65004295|NCT00116493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65004296|NCT00116493|Tubulin Modulators|tubulin modulators|mesh-ancestor
65004297|NCT00116493|Antimitotic Agents|antimitotic agents|mesh-ancestor
65004298|NCT00116493|Mitosis Modulators|mitosis modulators|mesh-ancestor
65004299|NCT00116493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004300|NCT00116493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65004301|NCT00116493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004302|NCT00464503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65004303|NCT00464503|Pravastatin|pravastatin|mesh-list
65004304|NCT00464503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65004305|NCT00464503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65004306|NCT00464503|Antimetabolites|antimetabolites|mesh-ancestor
65004307|NCT00464503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004308|NCT00464503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65004321|NCT00116532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65004323|NCT00464854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65004324|NCT00464854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004325|NCT00464893|Catumaxomab|catumaxomab|mesh-list
65004326|NCT00464893|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65004327|NCT00464893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65004328|NCT00464893|Immunologic Factors|immunologic factors|mesh-ancestor
65004329|NCT00464893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004330|NCT00464932|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
65004331|NCT00464932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65004332|NCT00464932|Vasodilator Agents|vasodilator agents|mesh-ancestor
65004333|NCT00464932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65004334|NCT00464932|Protective Agents|protective agents|mesh-ancestor
65004335|NCT00464932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004336|NCT00464971|Estradiol|estradiol|mesh-list
65004337|NCT00464971|Estrogens|estrogens|mesh-ancestor
65004338|NCT00464971|Hormones|hormones|mesh-ancestor
65004339|NCT00464971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65004340|NCT00464971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274822|NCT00618176|Zidovudine|zidovudine|mesh-list
65274823|NCT00618176|Nevirapine|nevirapine|mesh-list
65274824|NCT00618176|Stavudine|stavudine|mesh-list
65274825|NCT00618176|Didanosine|didanosine|mesh-list
65274826|NCT00618176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65274827|NCT00618176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65274828|NCT00618176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274829|NCT00618176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274830|NCT00618176|Antiviral Agents|antiviral agents|mesh-ancestor
65004341|NCT00116870|Lovastatin|lovastatin|mesh-list
65004342|NCT00116870|L 647318|l 647318|mesh-list
65004343|NCT00116870|Dihydromevinolin|dihydromevinolin|mesh-list
65004344|NCT00116870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65004345|NCT00116870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65004346|NCT00116870|Antimetabolites|antimetabolites|mesh-ancestor
65004347|NCT00116870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004348|NCT00116870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65004349|NCT00116870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65004350|NCT00116870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004351|NCT00465205|Valacyclovir|valacyclovir|mesh-list
65004352|NCT00465205|Antiviral Agents|antiviral agents|mesh-ancestor
65004353|NCT00465205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65004354|NCT00465244|Levetiracetam|levetiracetam|mesh-list
65004355|NCT00465244|Lorazepam|lorazepam|mesh-list
65004356|NCT00465244|Anticonvulsants|anticonvulsants|mesh-ancestor
65004357|NCT00465244|Nootropic Agents|nootropic agents|mesh-ancestor
65004358|NCT00465244|Antiemetics|antiemetics|mesh-ancestor
65004359|NCT00465244|Autonomic Agents|autonomic agents|mesh-ancestor
65004360|NCT00465244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65004361|NCT00465244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004362|NCT00465244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65004363|NCT00465244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65004364|NCT00465244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65004365|NCT00465244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65004366|NCT00465244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65004367|NCT00465244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65004368|NCT00465244|GABA Modulators|gaba modulators|mesh-ancestor
65004369|NCT00465244|GABA Agents|gaba agents|mesh-ancestor
65004370|NCT00465244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65004385|NCT03272425|Gout Suppressants|gout suppressants|mesh-ancestor
65004386|NCT03272425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65004387|NCT03272425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65004388|NCT03272425|Antioxidants|antioxidants|mesh-ancestor
65004389|NCT03272425|Protective Agents|protective agents|mesh-ancestor
65004390|NCT03272425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004391|NCT03272425|Uricosuric Agents|uricosuric agents|mesh-ancestor
65004392|NCT03272425|Renal Agents|renal agents|mesh-ancestor
65004393|NCT00116948|Cimetidine|cimetidine|mesh-list
65004394|NCT00116948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65004395|NCT00116948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65004396|NCT00116948|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65004397|NCT00116948|Histamine Antagonists|histamine antagonists|mesh-ancestor
65004398|NCT00116948|Histamine Agents|histamine agents|mesh-ancestor
65004399|NCT00116948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65004400|NCT00116948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004401|NCT00116948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004402|NCT00116948|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65004403|NCT00116948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65004404|NCT00116948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004405|NCT03272503|Pimozide|pimozide|mesh-list
65004406|NCT03272503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65004407|NCT03272503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65004408|NCT03272503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65004409|NCT03272503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004410|NCT03272503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65004411|NCT03272503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65004412|NCT03272503|Dopamine Agents|dopamine agents|mesh-ancestor
65004413|NCT03272503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65004414|NCT03272503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274831|NCT00618176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65274832|NCT00618176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65274833|NCT00618176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65274834|NCT00618176|Antimetabolites|antimetabolites|mesh-ancestor
64727313|NCT00003248|Fludarabine|fludarabine|mesh-list
65004415|NCT03272503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65004416|NCT00465439|Lidocaine|lidocaine|mesh-list
65004417|NCT00465439|Epinephrine|epinephrine|mesh-list
65004418|NCT00465439|Racepinephrine|racepinephrine|mesh-list
65004419|NCT00465439|Epinephryl borate|epinephryl borate|mesh-list
65004420|NCT00465439|Anesthetics, Local|anesthetics, local|mesh-ancestor
65004421|NCT00465439|Anesthetics|anesthetics|mesh-ancestor
65004422|NCT00465439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65004423|NCT00465439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004424|NCT00465439|Sensory System Agents|sensory system agents|mesh-ancestor
65004425|NCT00465439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65004426|NCT00465439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65004427|NCT00465439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65004428|NCT00465439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65004429|NCT00465439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64963135|NCT00043758|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65004447|NCT00116727|Sensory System Agents|sensory system agents|mesh-ancestor
65004448|NCT00116727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65004449|NCT00116727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004450|NCT00116727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65004451|NCT00116727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65004452|NCT00116727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65004453|NCT00116727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65004454|NCT00116727|Immunologic Factors|immunologic factors|mesh-ancestor
65004455|NCT00473551|Sirolimus|sirolimus|mesh-list
65004456|NCT00473551|Cyclophosphamide|cyclophosphamide|mesh-list
65004457|NCT00473551|Rituximab|rituximab|mesh-list
65004458|NCT00473551|Fludarabine|fludarabine|mesh-list
65004459|NCT00473551|Fludarabine phosphate|fludarabine phosphate|mesh-list
65004460|NCT00473551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65004461|NCT00473551|Immunologic Factors|immunologic factors|mesh-ancestor
65004462|NCT00473551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004463|NCT00473551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65004464|NCT00473551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65004465|NCT00473551|Alkylating Agents|alkylating agents|mesh-ancestor
65004466|NCT00473551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004467|NCT00473551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65004468|NCT00473551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65004469|NCT00473551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65004470|NCT00473551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65004471|NCT00473551|Antimetabolites|antimetabolites|mesh-ancestor
65004472|NCT00473551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65004473|NCT00473551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65004474|NCT00473551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65004475|NCT00473551|Antifungal Agents|antifungal agents|mesh-ancestor
65004476|NCT00117026|Benphothiamine|benphothiamine|mesh-list
65004477|NCT00117026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65004478|NCT00117026|Immunologic Factors|immunologic factors|mesh-ancestor
65004479|NCT00117026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004480|NCT00117026|Chelating Agents|chelating agents|mesh-ancestor
65004481|NCT00117026|Sequestering Agents|sequestering agents|mesh-ancestor
65004482|NCT00117026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004483|NCT00473980|Celecoxib|celecoxib|mesh-list
65004484|NCT00473980|Indomethacin|indomethacin|mesh-list
65004485|NCT00473980|Esomeprazole|esomeprazole|mesh-list
65004486|NCT00473980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65004487|NCT00473980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65004488|NCT00473980|Analgesics|analgesics|mesh-ancestor
65004516|NCT00474136|Sensory System Agents|sensory system agents|mesh-ancestor
65004517|NCT00474136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65004518|NCT00474136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004519|NCT00474136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65004520|NCT00474136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65004521|NCT00474136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65004522|NCT00474136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004523|NCT00474136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274835|NCT00618176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65274836|NCT00618176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65274837|NCT04211558|Ozanimod|ozanimod|mesh-list
65274838|NCT04211558|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65274839|NCT04211558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274840|NCT04211558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65274841|NCT04211558|Immunologic Factors|immunologic factors|mesh-ancestor
65274842|NCT04211558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004524|NCT00117104|Darbepoetin alfa|darbepoetin alfa|mesh-list
65004525|NCT00117104|Hematinics|hematinics|mesh-ancestor
65004526|NCT03270709|Vitamin D|vitamin d|mesh-list
65004527|NCT03270709|Cholecalciferol|cholecalciferol|mesh-list
65004528|NCT03270709|Vitamins|vitamins|mesh-ancestor
65004529|NCT03270709|Micronutrients|micronutrients|mesh-ancestor
65004530|NCT03270709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004531|NCT03270709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65004532|NCT03270709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65004533|NCT03270553|Metformin|metformin|mesh-list
65004534|NCT03270553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65004535|NCT03270553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004536|NCT00117182|Budesonide|budesonide|mesh-list
65004537|NCT00117182|Mannitol|mannitol|mesh-list
65004538|NCT00117182|Bromides|bromides|mesh-list
65004571|NCT00116961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65004572|NCT00116961|Antiemetics|antiemetics|mesh-ancestor
65004573|NCT00116961|Autonomic Agents|autonomic agents|mesh-ancestor
65004574|NCT00116961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65004575|NCT00116961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004576|NCT00116961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65004577|NCT00116961|Glucocorticoids|glucocorticoids|mesh-ancestor
65004578|NCT00116961|Hormones|hormones|mesh-ancestor
65004579|NCT00116961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65004580|NCT00116961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65004581|NCT00116961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65004582|NCT00474721|Acetaminophen|acetaminophen|mesh-list
65004583|NCT00474721|Ibuprofen|ibuprofen|mesh-list
65004584|NCT00474721|Codeine|codeine|mesh-list
65004585|NCT00474721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65004612|NCT00117260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65004613|NCT00117260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65004614|NCT00117260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65004615|NCT00117260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65004616|NCT00117260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65004617|NCT00117260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65004618|NCT00474838|Metformin|metformin|mesh-list
65004619|NCT00474838|Glimepiride|glimepiride|mesh-list
65004620|NCT00474838|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65004621|NCT00474838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004622|NCT00474838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65004623|NCT00474838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65004624|NCT00474838|Immunologic Factors|immunologic factors|mesh-ancestor
65004625|NCT00474916|KRN 5500|krn 5500|mesh-list
65004626|NCT00474916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65004627|NCT00474916|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65004628|NCT00474916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004629|NCT00474916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004630|NCT00475072|Ribavirin|ribavirin|mesh-list
65004631|NCT00475072|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65004632|NCT00475072|Antimetabolites|antimetabolites|mesh-ancestor
64963345|NCT00154024|Irbesartan|irbesartan|mesh-list
65004659|NCT00475189|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
65004660|NCT00475189|Norinyl|norinyl|mesh-list
65004661|NCT00475189|Mestranol|mestranol|mesh-list
65004662|NCT00475189|Norethindrone|norethindrone|mesh-list
65004663|NCT00475189|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65004664|NCT00475189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65004665|NCT00475189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65004666|NCT00475189|Contraceptive Agents|contraceptive agents|mesh-ancestor
65274843|NCT05048498|Azacitidine|azacitidine|mesh-list
65274844|NCT05048498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65274845|NCT05048498|Antimetabolites|antimetabolites|mesh-ancestor
65274846|NCT05048498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274847|NCT05048498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274848|NCT05048498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274849|NCT00901901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65024853|NCT00534391|Polymyxin B|polymyxin b|mesh-list
65004667|NCT00475189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65004668|NCT00475189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004669|NCT00475189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65004670|NCT00475189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65004671|NCT00475189|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
65004672|NCT00475189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65004673|NCT00475189|Estrogens|estrogens|mesh-ancestor
65004674|NCT00475189|Hormones|hormones|mesh-ancestor
65004675|NCT00475189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65004676|NCT00117377|Pimecrolimus|pimecrolimus|mesh-list
65004677|NCT00117377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64963400|NCT00154258|Clozapine|clozapine|mesh-list
65004698|NCT00475462|Sympatholytics|sympatholytics|mesh-ancestor
65004699|NCT00475462|Autonomic Agents|autonomic agents|mesh-ancestor
65004700|NCT00475462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65004701|NCT00475462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004702|NCT00475462|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65004703|NCT00475462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65004704|NCT00475462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65004705|NCT00475462|Adrenergic Agents|adrenergic agents|mesh-ancestor
65004706|NCT00475462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65004707|NCT00475462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004708|NCT00475618|Fluorides|fluorides|mesh-list
65004709|NCT00475618|Fluorides, Topical|fluorides, topical|mesh-list
65004710|NCT00475618|Cariostatic Agents|cariostatic agents|mesh-ancestor
65004711|NCT00475618|Protective Agents|protective agents|mesh-ancestor
65004712|NCT00475618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004713|NCT00117039|Darbepoetin alfa|darbepoetin alfa|mesh-list
65004714|NCT00117039|Hematinics|hematinics|mesh-ancestor
65004715|NCT00475696|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65004716|NCT00475696|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65004717|NCT00475696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65004718|NCT00475696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65004719|NCT00475696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004720|NCT00475696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65004721|NCT00475696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004722|NCT00475696|Analgesics|analgesics|mesh-ancestor
65004723|NCT00475696|Sensory System Agents|sensory system agents|mesh-ancestor
65004724|NCT00475696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65004725|NCT00475696|Antidepressive Agents|antidepressive agents|mesh-ancestor
65004726|NCT00475696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64459839|NCT02738866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004728|NCT00117455|Lenograstim|lenograstim|mesh-list
65004729|NCT00117455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65004730|NCT00117455|Immunologic Factors|immunologic factors|mesh-ancestor
65004731|NCT00117455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004732|NCT03270007|Vinorelbine|vinorelbine|mesh-list
65004756|NCT00475813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004758|NCT00117078|Hematinics|hematinics|mesh-ancestor
65004759|NCT00402038|Methylnaltrexone|methylnaltrexone|mesh-list
65004760|NCT00402038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65004761|NCT00402038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004762|NCT00402038|Sensory System Agents|sensory system agents|mesh-ancestor
65004763|NCT00402038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65004764|NCT00475930|Chlorhexidine|chlorhexidine|mesh-list
65004765|NCT00475930|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65004766|NCT00475930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65222790|NCT04215159|Irinotecan|irinotecan|mesh-list
65274850|NCT00901901|Sorafenib|sorafenib|mesh-list
65274851|NCT00901901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274852|NCT00901901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65274853|NCT00901901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274854|NCT00901901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274855|NCT00618254|Granisetron|granisetron|mesh-list
65274856|NCT00618254|Antiemetics|antiemetics|mesh-ancestor
65274857|NCT00618254|Autonomic Agents|autonomic agents|mesh-ancestor
65004767|NCT00475930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65004768|NCT00475930|Disinfectants|disinfectants|mesh-ancestor
65004769|NCT00475930|Dermatologic Agents|dermatologic agents|mesh-ancestor
65004770|NCT00475969|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65004771|NCT00475969|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65004772|NCT00475969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65004773|NCT00475969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65004774|NCT00475969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004775|NCT00475969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65004776|NCT00475969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004777|NCT00475969|Analgesics|analgesics|mesh-ancestor
65004778|NCT00475969|Sensory System Agents|sensory system agents|mesh-ancestor
65004779|NCT00475969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65004780|NCT00475969|Antidepressive Agents|antidepressive agents|mesh-ancestor
65004781|NCT00475969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64963494|NCT00406432|Paroxetine|paroxetine|mesh-list
65004790|NCT00402077|Phentermine|phentermine|mesh-list
65004791|NCT00402077|Sibutramine|sibutramine|mesh-list
65004792|NCT00402077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65004793|NCT00402077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004794|NCT00402077|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65004795|NCT00402077|Appetite Depressants|appetite depressants|mesh-ancestor
65004796|NCT00402077|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65004797|NCT00402077|Sympathomimetics|sympathomimetics|mesh-ancestor
65004798|NCT00402077|Autonomic Agents|autonomic agents|mesh-ancestor
65004799|NCT00402077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65004800|NCT00402077|Adrenergic Agents|adrenergic agents|mesh-ancestor
65004801|NCT00402077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65004802|NCT00402077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004803|NCT00402077|Antidepressive Agents|antidepressive agents|mesh-ancestor
65004804|NCT00402077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65004806|NCT00476359|Saquinavir|saquinavir|mesh-list
65004807|NCT00476359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65004808|NCT00476359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65004809|NCT00476359|Protease Inhibitors|protease inhibitors|mesh-ancestor
65004810|NCT00476359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004811|NCT00476359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004812|NCT00476359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65004813|NCT00476359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65004814|NCT00476359|Antiviral Agents|antiviral agents|mesh-ancestor
65004815|NCT00476359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65004816|NCT00476359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65004817|NCT00476359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65004818|NCT00117117|Darbepoetin alfa|darbepoetin alfa|mesh-list
65004819|NCT00117117|Hematinics|hematinics|mesh-ancestor
65004820|NCT00476437|Insulin|insulin|mesh-list
65004821|NCT00476437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65004822|NCT00476437|Insulin Aspart|insulin aspart|mesh-list
65004823|NCT00476437|Biphasic Insulins|biphasic insulins|mesh-list
65004824|NCT00476437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65004825|NCT00476437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004826|NCT00117494|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65004827|NCT00117494|Pravastatin|pravastatin|mesh-list
65004828|NCT00117494|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65004829|NCT00117494|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65004830|NCT00117494|Antimetabolites|antimetabolites|mesh-ancestor
65004831|NCT00117494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004832|NCT00117494|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65004833|NCT00117494|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65004834|NCT00117494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274858|NCT00618254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65274859|NCT00618254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274860|NCT00618254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65274861|NCT00618254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65004835|NCT03279952|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
65004836|NCT03279952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004837|NCT00117533|Ribavirin|ribavirin|mesh-list
65004838|NCT00117533|Interferon alpha-2|interferon alpha-2|mesh-list
65004839|NCT00117533|Antimetabolites|antimetabolites|mesh-ancestor
65004840|NCT00117533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004841|NCT00117533|Antiviral Agents|antiviral agents|mesh-ancestor
65004842|NCT00117533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65004843|NCT00117533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65004844|NCT00117234|Darbepoetin alfa|darbepoetin alfa|mesh-list
65004845|NCT00117234|Hematinics|hematinics|mesh-ancestor
65004846|NCT00117611|Omalizumab|omalizumab|mesh-list
65004847|NCT00117611|Antibodies|antibodies|mesh-list
65004848|NCT00117611|Immunologic Factors|immunologic factors|mesh-ancestor
65004849|NCT00117611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004850|NCT00117611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65004851|NCT00117611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64963537|NCT00083460|Thalidomide|thalidomide|mesh-list
64459988|NCT01674946|Cathartics|cathartics|mesh-ancestor
65004877|NCT03277261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65004878|NCT03277261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65004879|NCT03277261|Immunologic Factors|immunologic factors|mesh-ancestor
65004881|NCT02273947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65004882|NCT02273947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65004883|NCT02273947|Antiviral Agents|antiviral agents|mesh-ancestor
65004884|NCT02273947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65004885|NCT05367336|Fentanyl|fentanyl|mesh-list
65004886|NCT05367336|Morphine|morphine|mesh-list
65004887|NCT05367336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65004888|NCT05367336|Narcotics|narcotics|mesh-ancestor
65004889|NCT05367336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65004890|NCT05367336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004891|NCT05367336|Analgesics|analgesics|mesh-ancestor
65004892|NCT05367336|Sensory System Agents|sensory system agents|mesh-ancestor
65004893|NCT05367336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65004894|NCT05367336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65004895|NCT05367336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65004896|NCT05367336|Anesthetics, General|anesthetics, general|mesh-ancestor
65004897|NCT05367336|Anesthetics|anesthetics|mesh-ancestor
65004898|NCT00476515|Rituximab|rituximab|mesh-list
65004899|NCT00476515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65004900|NCT00476515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65004925|NCT00117273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65004926|NCT00117273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004927|NCT00117273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65004929|NCT00117273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65004930|NCT00117273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65004931|NCT00117273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65004932|NCT00117273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65004933|NCT00117273|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65004934|NCT00476710|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65004935|NCT00476710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65004936|NCT00476710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65004937|NCT00476710|Antimetabolites|antimetabolites|mesh-ancestor
65004938|NCT00476710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004939|NCT00476710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65004940|NCT00117728|Nevirapine|nevirapine|mesh-list
65004941|NCT00117728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65004942|NCT00117728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65004943|NCT00117728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004944|NCT00117728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004945|NCT00117728|Antiviral Agents|antiviral agents|mesh-ancestor
65004946|NCT00117728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65004947|NCT00117728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65004948|NCT00117728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65004949|NCT00117728|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64460067|NCT01675804|Methylphenidate|methylphenidate|mesh-list
64963654|NCT00051155|Timolol|timolol|mesh-list
65274862|NCT00618254|Serotonin Agents|serotonin agents|mesh-ancestor
65274863|NCT00618254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64727346|NCT00003992|Tubulin Modulators|tubulin modulators|mesh-ancestor
65004977|NCT00118196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004978|NCT00118235|Bevacizumab|bevacizumab|mesh-list
65004979|NCT00118235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65004981|NCT00118235|Antibodies|antibodies|mesh-list
65004982|NCT00118235|Immunoglobulins|immunoglobulins|mesh-list
65004983|NCT00118235|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65004984|NCT00118235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65004985|NCT00118235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65004986|NCT00118235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65004987|NCT00118235|Growth Substances|growth substances|mesh-ancestor
65004988|NCT00118235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004989|NCT00118235|Growth Inhibitors|growth inhibitors|mesh-ancestor
65004990|NCT00118235|Immunologic Factors|immunologic factors|mesh-ancestor
65004991|NCT00118235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65004992|NCT00118235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65004993|NCT00118235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004994|NCT00118235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004995|NCT00118313|Imiquimod|imiquimod|mesh-list
65004996|NCT00118313|Sargramostim|sargramostim|mesh-list
65004997|NCT00118313|Freund's Adjuvant|freund's adjuvant|mesh-list
65004998|NCT00118313|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
65005023|NCT00118508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65005025|NCT00118508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65005027|NCT00476983|Saquinavir|saquinavir|mesh-list
65005028|NCT00476983|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65005029|NCT00476983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65005030|NCT00476983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65005031|NCT00476983|Protease Inhibitors|protease inhibitors|mesh-ancestor
65005032|NCT00476983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005033|NCT00476983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005034|NCT00476983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65005035|NCT00476983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65005036|NCT00476983|Antiviral Agents|antiviral agents|mesh-ancestor
65005037|NCT00476983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65005038|NCT00476983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65005039|NCT00476983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65005040|NCT00476983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65005041|NCT00476983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65005042|NCT00477061|Morphine|morphine|mesh-list
65005043|NCT00477061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65005044|NCT00477061|Narcotics|narcotics|mesh-ancestor
65005045|NCT00477061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65005046|NCT00477061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005068|NCT00477763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65005069|NCT00477763|Immunologic Factors|immunologic factors|mesh-ancestor
65005070|NCT00477763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005071|NCT00477763|Antifungal Agents|antifungal agents|mesh-ancestor
65005072|NCT00477763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65005073|NCT00477763|Dermatologic Agents|dermatologic agents|mesh-ancestor
65005074|NCT00477763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65005075|NCT00477763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65005076|NCT00477802|Botulinum Toxins|botulinum toxins|mesh-list
65005077|NCT00477802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65005078|NCT00477802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65005079|NCT00477802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65005080|NCT00477802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65005081|NCT00477802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005082|NCT00477802|Cholinergic Agents|cholinergic agents|mesh-ancestor
65005083|NCT00477802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65005084|NCT00477802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005085|NCT00477802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65005086|NCT00477802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65005087|NCT00477880|Cetuximab|cetuximab|mesh-list
65005088|NCT00477880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65005089|NCT00477880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005090|NCT00118820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65005091|NCT00118820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65005092|NCT00477997|Hormones|hormones|mesh-list
65222791|NCT04215159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65274864|NCT00618254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274865|NCT04184466|Insulin|insulin|mesh-list
65274866|NCT04184466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65274867|NCT04184466|Insulin Aspart|insulin aspart|mesh-list
65274868|NCT04184466|Insulin, Long-Acting|insulin, long-acting|mesh-list
65274869|NCT04184466|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65005093|NCT00477997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65005094|NCT00477997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005096|NCT00478075|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
65005097|NCT00478075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005098|NCT00478075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65005099|NCT00478075|Analgesics|analgesics|mesh-ancestor
65005100|NCT00478075|Sensory System Agents|sensory system agents|mesh-ancestor
65005132|NCT00117468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65005133|NCT00117468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005134|NCT03271879|Empagliflozin|empagliflozin|mesh-list
65005135|NCT03271879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65005136|NCT03271879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005137|NCT03271879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65005138|NCT03271879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005139|NCT00478543|Furosemide|furosemide|mesh-list
64963854|NCT00406861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65005159|NCT00478699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65005161|NCT00478699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005162|NCT00478699|Antiviral Agents|antiviral agents|mesh-ancestor
65005163|NCT00478699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65005164|NCT00478699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005165|NCT00478699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65005166|NCT00478699|Immunologic Factors|immunologic factors|mesh-ancestor
65005167|NCT00478699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005168|NCT00478699|Tubulin Modulators|tubulin modulators|mesh-ancestor
65005169|NCT00478699|Antimitotic Agents|antimitotic agents|mesh-ancestor
65005170|NCT00478699|Mitosis Modulators|mitosis modulators|mesh-ancestor
65005171|NCT00118976|Lisinopril|lisinopril|mesh-list
65005172|NCT00118976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65005173|NCT00118976|Protease Inhibitors|protease inhibitors|mesh-ancestor
65005174|NCT00118976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460301|NCT03824938|Antipyretics|antipyretics|mesh-ancestor
65005175|NCT00118976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005176|NCT00118976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65005177|NCT00118976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65005178|NCT00118976|Protective Agents|protective agents|mesh-ancestor
65005179|NCT00118976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005180|NCT05288361|Acetylcholine|acetylcholine|mesh-list
65005181|NCT05288361|Vasodilator Agents|vasodilator agents|mesh-ancestor
65005182|NCT05288361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65005183|NCT05288361|Cholinergic Agents|cholinergic agents|mesh-ancestor
65005184|NCT05288361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65005185|NCT05288361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005186|NCT05288361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005187|NCT00478816|Vaccines|vaccines|mesh-list
65005188|NCT00478816|Immunologic Factors|immunologic factors|mesh-ancestor
65005189|NCT00478816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005190|NCT00478855|Piperacillin|piperacillin|mesh-list
65005191|NCT00478855|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65005192|NCT00478855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65005193|NCT00478855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65005194|NCT00478855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65005221|NCT00119132|Sulfadoxine|sulfadoxine|mesh-list
65005222|NCT00119132|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65005223|NCT00119132|Amodiaquine|amodiaquine|mesh-list
65005224|NCT00119132|Antimalarials|antimalarials|mesh-ancestor
65005225|NCT00119132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65005226|NCT00119132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65005227|NCT00119132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65005228|NCT00119132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005229|NCT00119132|Antiviral Agents|antiviral agents|mesh-ancestor
65274870|NCT04184466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65274871|NCT04184466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274872|NCT03620201|Atezolizumab|atezolizumab|mesh-list
65274873|NCT03620201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274874|NCT04201769|Dexamethasone|dexamethasone|mesh-list
65274875|NCT04201769|Palonosetron|palonosetron|mesh-list
65274876|NCT04201769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65274877|NCT04201769|Antiemetics|antiemetics|mesh-ancestor
65274878|NCT04201769|Autonomic Agents|autonomic agents|mesh-ancestor
65274879|NCT04201769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65005230|NCT00119132|Schistosomicides|schistosomicides|mesh-ancestor
65005231|NCT00119132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65005232|NCT00119132|Anthelmintics|anthelmintics|mesh-ancestor
65005233|NCT00119132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65005234|NCT00119132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005235|NCT00119132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005236|NCT00119132|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65005237|NCT00119132|Renal Agents|renal agents|mesh-ancestor
65005238|NCT00479323|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65005239|NCT00479323|Immunologic Factors|immunologic factors|mesh-ancestor
65005240|NCT00479323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005241|NCT00479362|Aspirin|aspirin|mesh-list
65005242|NCT00479362|Warfarin|warfarin|mesh-list
65005243|NCT00479362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65005244|NCT00479362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65005245|NCT00479362|Analgesics|analgesics|mesh-ancestor
65005267|NCT00479479|Hydroxocobalamin|hydroxocobalamin|mesh-list
65005269|NCT00479479|Micronutrients|micronutrients|mesh-ancestor
65005270|NCT00479479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005271|NCT00479479|Vitamin B Complex|vitamin b complex|mesh-ancestor
65005272|NCT00479479|Hematinics|hematinics|mesh-ancestor
65005273|NCT00119210|Bupropion|bupropion|mesh-list
65005274|NCT00119210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65005275|NCT00119210|Antidepressive Agents|antidepressive agents|mesh-ancestor
65005276|NCT00119210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65005277|NCT00119210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65005278|NCT00119210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65005279|NCT00119210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65005280|NCT00119210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005281|NCT00119210|Dopamine Agents|dopamine agents|mesh-ancestor
65005282|NCT00119210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65005283|NCT00119210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005284|NCT00119210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65005285|NCT00119210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65005286|NCT00119210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005287|NCT00117663|Hormones|hormones|mesh-list
65005288|NCT00117663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65005289|NCT00117663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005290|NCT00479752|Oxaliplatin|oxaliplatin|mesh-list
65005291|NCT00479752|Cetuximab|cetuximab|mesh-list
65005292|NCT00479752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005293|NCT00479752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65005294|NCT00119249|Sorafenib|sorafenib|mesh-list
65005295|NCT00119249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005296|NCT00119249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65005297|NCT00119249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964002|NCT00158470|Didanosine|didanosine|mesh-list
65005327|NCT00480142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65005328|NCT00480142|Narcotics|narcotics|mesh-ancestor
65005329|NCT00480142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65005330|NCT00480142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005331|NCT00480142|Analgesics|analgesics|mesh-ancestor
65005332|NCT00480142|Sensory System Agents|sensory system agents|mesh-ancestor
65005333|NCT00480142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65005334|NCT00119483|Methyltestosterone|methyltestosterone|mesh-list
65005335|NCT00119483|Testosterone|testosterone|mesh-list
65005336|NCT00119483|Testosterone undecanoate|testosterone undecanoate|mesh-list
65274880|NCT04201769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274881|NCT04201769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65274882|NCT04201769|Glucocorticoids|glucocorticoids|mesh-ancestor
65274883|NCT04201769|Hormones|hormones|mesh-ancestor
65274884|NCT04201769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65274885|NCT04201769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65274886|NCT04201769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274887|NCT04201769|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65274888|NCT04201769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64727370|NCT00003518|Paclitaxel|paclitaxel|mesh-list
65005337|NCT00119483|Testosterone enanthate|testosterone enanthate|mesh-list
65005338|NCT00119483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65005339|NCT00119483|Androgens|androgens|mesh-ancestor
65005340|NCT00119483|Hormones|hormones|mesh-ancestor
65005341|NCT00119483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65005342|NCT00119483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005343|NCT00119483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65005344|NCT00119483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964056|NCT00158821|Stavudine|stavudine|mesh-list
65005375|NCT00480298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005376|NCT00480376|Gentamicins|gentamicins|mesh-list
65005377|NCT00480376|Ofloxacin|ofloxacin|mesh-list
65005378|NCT00480376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65005379|NCT00480376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65005380|NCT00480376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65005381|NCT00480376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005382|NCT00480376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005383|NCT00480376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65005384|NCT00480376|Renal Agents|renal agents|mesh-ancestor
65005385|NCT00480376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65005386|NCT00480376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65005387|NCT00480376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005388|NCT00480376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65005389|NCT00480376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65005420|NCT00480610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005422|NCT00480649|Xhance|xhance|mesh-list
65005423|NCT00480649|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65005424|NCT00480649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65005425|NCT00480649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65005426|NCT00480649|Autonomic Agents|autonomic agents|mesh-ancestor
65005427|NCT00480649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65005428|NCT00480649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005429|NCT00480649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65005430|NCT00480649|Respiratory System Agents|respiratory system agents|mesh-ancestor
65005431|NCT00480649|Dermatologic Agents|dermatologic agents|mesh-ancestor
65005432|NCT00480649|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65005433|NCT00480649|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65005434|NCT00480649|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65005460|NCT00480883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005461|NCT00480883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005462|NCT00480883|Gout Suppressants|gout suppressants|mesh-ancestor
65005463|NCT00480883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65005464|NCT00480883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65005465|NCT00480883|Antioxidants|antioxidants|mesh-ancestor
65005466|NCT00480883|Protective Agents|protective agents|mesh-ancestor
65005467|NCT00480883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005468|NCT00480883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65005469|NCT00480883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65005470|NCT00480883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65005471|NCT05236998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65005472|NCT05236998|Dapagliflozin|dapagliflozin|mesh-list
65005473|NCT05236998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64460617|NCT03586414|Ubiquinone|ubiquinone|mesh-list
65005474|NCT05236998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274889|NCT04201769|Serotonin Agents|serotonin agents|mesh-ancestor
65274890|NCT04201769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65274891|NCT04201769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274892|NCT05336825|Lidocaine|lidocaine|mesh-list
65274893|NCT05336825|Anesthetics, Local|anesthetics, local|mesh-ancestor
65274894|NCT05336825|Anesthetics|anesthetics|mesh-ancestor
65274895|NCT05336825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65274896|NCT05336825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005475|NCT05236998|Incretins|incretins|mesh-ancestor
65005476|NCT05236998|Hormones|hormones|mesh-ancestor
65005477|NCT05236998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65005478|NCT05236998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65005479|NCT05236998|Protease Inhibitors|protease inhibitors|mesh-ancestor
65005480|NCT05236998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005481|NCT05236998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005482|NCT05236998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65005483|NCT01240096|Mirtazapine|mirtazapine|mesh-list
65005506|NCT00119756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65005507|NCT00119756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005508|NCT00119756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65005509|NCT00119756|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65005510|NCT00119756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65005511|NCT00119756|Serotonin Agents|serotonin agents|mesh-ancestor
65005512|NCT00119756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65005513|NCT00119756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005514|NCT00119756|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65005515|NCT00119756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65005516|NCT00119756|Dopamine Agents|dopamine agents|mesh-ancestor
65005517|NCT01240174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65005518|NCT01240174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65005519|NCT01240252|Insulin|insulin|mesh-list
65005520|NCT01240252|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65005521|NCT01240252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65005522|NCT01240252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005523|NCT05233605|Dexmedetomidine|dexmedetomidine|mesh-list
65005524|NCT05233605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65005525|NCT05233605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65005526|NCT05233605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005527|NCT05233605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65005528|NCT05233605|Analgesics|analgesics|mesh-ancestor
65005529|NCT05233605|Sensory System Agents|sensory system agents|mesh-ancestor
65005530|NCT05233605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65005531|NCT05233605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65005532|NCT05233605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65005533|NCT05233605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65005557|NCT00481312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65005558|NCT00481312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005559|NCT00481312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65005560|NCT00481312|Analgesics|analgesics|mesh-ancestor
65005561|NCT00481312|Sensory System Agents|sensory system agents|mesh-ancestor
65005562|NCT00481312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65005563|NCT00481312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65005564|NCT00481312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65005565|NCT00481312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65005566|NCT00481312|Adrenergic Agents|adrenergic agents|mesh-ancestor
65005567|NCT00481312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65005568|NCT00481312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005569|NCT00481312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65005570|NCT00481312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65005571|NCT00481312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65005572|NCT00481312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65005573|NCT00481312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65005574|NCT00481312|Anesthetics, General|anesthetics, general|mesh-ancestor
65005575|NCT00481312|Anesthetics|anesthetics|mesh-ancestor
65274897|NCT05336825|Sensory System Agents|sensory system agents|mesh-ancestor
65274898|NCT05336825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65274899|NCT05336825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65274900|NCT05336825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65274901|NCT05336825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65274902|NCT05336825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65274903|NCT05336825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274904|NCT04748783|Listerine|listerine|mesh-list
65274905|NCT04748783|Chlorhexidine|chlorhexidine|mesh-list
64727385|NCT00002647|Verteporfin|verteporfin|mesh-list
65005576|NCT00481312|GABA Modulators|gaba modulators|mesh-ancestor
65005577|NCT00481312|GABA Agents|gaba agents|mesh-ancestor
65005578|NCT00481429|Rosiglitazone|rosiglitazone|mesh-list
65005579|NCT00481429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65005580|NCT00481429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005581|NCT00119990|Dialysis Solutions|dialysis solutions|mesh-list
65005583|NCT00119990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65005584|NCT00481624|Epoetin Alfa|epoetin alfa|mesh-list
65005585|NCT00481624|Ferric gluconate|ferric gluconate|mesh-list
65005586|NCT00481624|Hematinics|hematinics|mesh-ancestor
65005611|NCT00481819|Methylprednisolone|methylprednisolone|mesh-list
65005612|NCT00481819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65005613|NCT00481819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65005614|NCT00481819|Prednisolone|prednisolone|mesh-list
65005615|NCT00481819|Prednisolone acetate|prednisolone acetate|mesh-list
65005616|NCT00481819|Tacrolimus|tacrolimus|mesh-list
65005617|NCT00481819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65005618|NCT00481819|Prednisolone phosphate|prednisolone phosphate|mesh-list
65005619|NCT00481819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65005621|NCT00481819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005622|NCT00481819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65005623|NCT00481819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005624|NCT00481819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005625|NCT00481819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65005626|NCT00481819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005627|NCT00481819|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65005628|NCT00481819|Antitubercular Agents|antitubercular agents|mesh-ancestor
65005629|NCT00481819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65005630|NCT00481819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65005631|NCT00481819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65005632|NCT00481819|Antiemetics|antiemetics|mesh-ancestor
65005633|NCT00481819|Autonomic Agents|autonomic agents|mesh-ancestor
65005634|NCT00481819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65005635|NCT00481819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65005636|NCT00481819|Glucocorticoids|glucocorticoids|mesh-ancestor
65005637|NCT00481819|Hormones|hormones|mesh-ancestor
65005638|NCT00481819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65005639|NCT00481819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64964344|NCT00160498|Lercanidipine|lercanidipine|mesh-list
65005662|NCT00482209|Oxytocics|oxytocics|mesh-ancestor
65005663|NCT00482209|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65005664|NCT00482209|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65005665|NCT00482209|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65005666|NCT00482209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65005667|NCT00482209|Contraceptive Agents|contraceptive agents|mesh-ancestor
65005668|NCT00482209|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65005669|NCT00482209|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65005670|NCT00482209|Hormone Antagonists|hormone antagonists|mesh-ancestor
65005671|NCT00482209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65005672|NCT00482209|Luteolytic Agents|luteolytic agents|mesh-ancestor
65005673|NCT00482209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65005674|NCT00482209|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65005675|NCT00117936|Mitogens|mitogens|mesh-list
65005676|NCT00117936|Mitosis Modulators|mitosis modulators|mesh-ancestor
65005677|NCT00117936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274906|NCT04748783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65274907|NCT04748783|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65274908|NCT04748783|Sodium Fluoride|sodium fluoride|mesh-list
65274909|NCT04748783|Cariostatic Agents|cariostatic agents|mesh-ancestor
65274910|NCT04748783|Protective Agents|protective agents|mesh-ancestor
65274911|NCT04748783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274912|NCT04748783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65274913|NCT04748783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65274914|NCT04748783|Disinfectants|disinfectants|mesh-ancestor
65274915|NCT04748783|Dermatologic Agents|dermatologic agents|mesh-ancestor
65274916|NCT02777580|Tenecteplase|tenecteplase|mesh-list
65274917|NCT02777580|Clopidogrel|clopidogrel|mesh-list
65274918|NCT02777580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65274919|NCT02777580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65274920|NCT02777580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65274921|NCT02777580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65005678|NCT00482248|Omalizumab|omalizumab|mesh-list
65005679|NCT00482248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65005680|NCT00482248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65005681|NCT00482248|Respiratory System Agents|respiratory system agents|mesh-ancestor
65005682|NCT00120185|Interleukin-2|interleukin-2|mesh-list
65005683|NCT00120185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005684|NCT00120185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65005685|NCT00120185|Analgesics|analgesics|mesh-ancestor
65005686|NCT00120185|Sensory System Agents|sensory system agents|mesh-ancestor
65005687|NCT00120185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65005688|NCT00120185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005689|NCT01240642|Vadimezan|vadimezan|mesh-list
65005690|NCT01240642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005719|NCT00120302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65005720|NCT00120302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005721|NCT00120302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005722|NCT00482716|Iron|iron|mesh-list
65005723|NCT00482716|Dextrans|dextrans|mesh-list
65005724|NCT00482716|Epoetin Alfa|epoetin alfa|mesh-list
65005725|NCT00482716|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65005726|NCT00482716|Iron-Dextran Complex|iron-dextran complex|mesh-list
65005727|NCT00482716|Trace Elements|trace elements|mesh-ancestor
65005728|NCT00482716|Micronutrients|micronutrients|mesh-ancestor
65005729|NCT00482716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005730|NCT00482716|Hematinics|hematinics|mesh-ancestor
65005731|NCT00482716|Anticoagulants|anticoagulants|mesh-ancestor
65005732|NCT00482716|Plasma Substitutes|plasma substitutes|mesh-ancestor
65005733|NCT00482716|Blood Substitutes|blood substitutes|mesh-ancestor
65005734|NCT00482755|Sunitinib|sunitinib|mesh-list
65005735|NCT00482755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005736|NCT00482755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65005737|NCT00482755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65005755|NCT00483028|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65005757|NCT00483028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005758|NCT00483028|Cholinergic Agents|cholinergic agents|mesh-ancestor
65005759|NCT00483028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65005760|NCT00483028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005761|NCT00483028|Nootropic Agents|nootropic agents|mesh-ancestor
65005762|NCT00118014|Sertraline|sertraline|mesh-list
65005763|NCT00118014|Antidepressive Agents|antidepressive agents|mesh-ancestor
65005764|NCT00118014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65005765|NCT00118014|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65005766|NCT00118014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65005767|NCT00118014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65222792|NCT04215159|Antimetabolites|antimetabolites|mesh-ancestor
65274922|NCT02777580|Purinergic Agents|purinergic agents|mesh-ancestor
65274923|NCT02777580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65274924|NCT02777580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274925|NCT02777580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274926|NCT02777580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65274927|NCT02777580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65005768|NCT00118014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005769|NCT00118014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65005770|NCT00118014|Serotonin Agents|serotonin agents|mesh-ancestor
65005771|NCT00118014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005772|NCT00120419|Mycophenolic Acid|mycophenolic acid|mesh-list
65005773|NCT00120419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65005774|NCT00120419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005775|NCT00120419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65005776|NCT00120419|Antitubercular Agents|antitubercular agents|mesh-ancestor
65005777|NCT00120419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65005779|NCT00120419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005780|NCT00120419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005781|NCT05176470|Cyclophosphamide|cyclophosphamide|mesh-list
65005783|NCT05176470|Fludarabine|fludarabine|mesh-list
65005784|NCT05176470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65005785|NCT05176470|Immunologic Factors|immunologic factors|mesh-ancestor
65005786|NCT05176470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005787|NCT05176470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65005788|NCT05176470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65005789|NCT05176470|Alkylating Agents|alkylating agents|mesh-ancestor
65005790|NCT05176470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005791|NCT05176470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005792|NCT05176470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65005793|NCT05176470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65005794|NCT01241032|Udenafil|udenafil|mesh-list
65005795|NCT01241032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65005828|NCT00120497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005829|NCT00483145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65005830|NCT00483145|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65005831|NCT00483145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65005832|NCT00483145|Dermatologic Agents|dermatologic agents|mesh-ancestor
65005834|NCT00483301|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65005848|NCT00483730|Actovegin|actovegin|mesh-list
65005849|NCT00483730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64461041|NCT02401750|Narcotics|narcotics|mesh-ancestor
65005850|NCT00483730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005851|NCT00483730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65005852|NCT00483730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65005853|NCT00483730|Antioxidants|antioxidants|mesh-ancestor
65005854|NCT00483730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005855|NCT00483730|Protective Agents|protective agents|mesh-ancestor
65005856|NCT00483730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65005857|NCT00118326|Lenograstim|lenograstim|mesh-list
65005858|NCT00118326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65005859|NCT00118326|Immunologic Factors|immunologic factors|mesh-ancestor
65005860|NCT00118326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005861|NCT00483769|Insulin Glargine|insulin glargine|mesh-list
65005862|NCT00483769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65005863|NCT00483769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005865|NCT00405171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65005866|NCT00405171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65005867|NCT00405171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005868|NCT00405171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005869|NCT00405171|Antiviral Agents|antiviral agents|mesh-ancestor
65005870|NCT00405171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65005871|NCT00405171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65005872|NCT00405171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65005873|NCT00405171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65005874|NCT00405171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65005875|NCT00483886|Prucalopride|prucalopride|mesh-list
65005876|NCT00483886|Laxatives|laxatives|mesh-ancestor
65274928|NCT04628663|Dexmedetomidine|dexmedetomidine|mesh-list
65274929|NCT04628663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65274930|NCT04628663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65274931|NCT04628663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274932|NCT04628663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65274933|NCT04628663|Analgesics|analgesics|mesh-ancestor
65274934|NCT04628663|Sensory System Agents|sensory system agents|mesh-ancestor
65274935|NCT04628663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65274936|NCT04628663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65274937|NCT04628663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65274938|NCT04628663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65274939|NCT04628663|Adrenergic Agents|adrenergic agents|mesh-ancestor
65274940|NCT04628663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65274941|NCT04628663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274942|NCT05663268|Infliximab|infliximab|mesh-list
65274943|NCT05663268|Dermatologic Agents|dermatologic agents|mesh-ancestor
65274944|NCT05663268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65274945|NCT05663268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65274946|NCT02822027|gamma-Globulins|gamma-globulins|mesh-list
64727414|NCT00003254|Antimetabolites|antimetabolites|mesh-ancestor
65005877|NCT00483886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65005878|NCT00483886|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65005879|NCT00483886|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65005880|NCT00483886|Serotonin Agents|serotonin agents|mesh-ancestor
65005881|NCT00483886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65005882|NCT00483886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005883|NCT00483886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005884|NCT00483964|Olanzapine|olanzapine|mesh-list
65005885|NCT00483964|Antiemetics|antiemetics|mesh-ancestor
65005886|NCT00483964|Autonomic Agents|autonomic agents|mesh-ancestor
65005887|NCT00483964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65005888|NCT00483964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005889|NCT00483964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65005890|NCT00483964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65005891|NCT00483964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65005892|NCT00483964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65005893|NCT00483964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64964589|NCT04731116|Cannabidiol|cannabidiol|mesh-list
65005909|NCT00484003|Dermatologic Agents|dermatologic agents|mesh-ancestor
65005910|NCT00484003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65005911|NCT00484003|Immunologic Factors|immunologic factors|mesh-ancestor
65005912|NCT00484003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65005913|NCT00484003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987131|NCT00329914|Hormones|hormones|mesh-ancestor
65005914|NCT00484003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005915|NCT01241110|Ofloxacin|ofloxacin|mesh-list
65005916|NCT01241110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65005917|NCT01241110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65005918|NCT01241110|Renal Agents|renal agents|mesh-ancestor
65005919|NCT01241110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65005920|NCT01241110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65005921|NCT01241110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65005922|NCT01241110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005923|NCT01241110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274947|NCT02822027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65274948|NCT02822027|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65274949|NCT02822027|Immunologic Factors|immunologic factors|mesh-ancestor
65274950|NCT02822027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274951|NCT00642096|Metoprolol|metoprolol|mesh-list
65274952|NCT00642096|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65274953|NCT00642096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65005924|NCT01241110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005925|NCT01241110|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65005926|NCT01241110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65005927|NCT00120653|Metoclopramide|metoclopramide|mesh-list
65005928|NCT00120653|Antiemetics|antiemetics|mesh-ancestor
65005929|NCT00120653|Autonomic Agents|autonomic agents|mesh-ancestor
65005930|NCT00120653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65005931|NCT00120653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005932|NCT00120653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65005933|NCT00120653|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65005934|NCT00120653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65005935|NCT00120653|Dopamine Agents|dopamine agents|mesh-ancestor
65005936|NCT00120653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65005937|NCT00120653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005938|NCT00484120|Diclofenac|diclofenac|mesh-list
65005939|NCT00484120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65005940|NCT00484120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65005941|NCT00484120|Analgesics|analgesics|mesh-ancestor
65005942|NCT00484120|Sensory System Agents|sensory system agents|mesh-ancestor
65005943|NCT00484120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65005944|NCT00484120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005945|NCT00484120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65005946|NCT00484120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65005947|NCT00484120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65005948|NCT00484120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005949|NCT00484120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005968|NCT00484432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65005969|NCT00484432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65005970|NCT00484432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005971|NCT00484432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005972|NCT00484510|Ascorbic Acid|ascorbic acid|mesh-list
65005974|NCT00484510|Micronutrients|micronutrients|mesh-ancestor
65005975|NCT00484510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005976|NCT00484510|Antioxidants|antioxidants|mesh-ancestor
65005977|NCT00484510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005978|NCT00484510|Protective Agents|protective agents|mesh-ancestor
65005979|NCT00120731|Acetazolamide|acetazolamide|mesh-list
65005980|NCT00120731|Potassium Citrate|potassium citrate|mesh-list
65005981|NCT00120731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005982|NCT00120731|Anticonvulsants|anticonvulsants|mesh-ancestor
65005983|NCT00120731|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65005984|NCT00120731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005985|NCT00120731|Diuretics|diuretics|mesh-ancestor
65005986|NCT00120731|Natriuretic Agents|natriuretic agents|mesh-ancestor
65005987|NCT00120731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005988|NCT00120731|Expectorants|expectorants|mesh-ancestor
65005989|NCT00120731|Respiratory System Agents|respiratory system agents|mesh-ancestor
65005990|NCT00120770|Anti-Infective Agents|anti-infective agents|mesh-list
65005991|NCT00484744|Acetaminophen|acetaminophen|mesh-list
65005992|NCT00484744|Ibuprofen|ibuprofen|mesh-list
65005993|NCT00484744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65005994|NCT00484744|Analgesics|analgesics|mesh-ancestor
65005995|NCT00484744|Sensory System Agents|sensory system agents|mesh-ancestor
65005996|NCT00484744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65005997|NCT00484744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005998|NCT00484744|Antipyretics|antipyretics|mesh-ancestor
65005999|NCT00484744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65006000|NCT00484744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65006001|NCT00484744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65006002|NCT00484744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65006003|NCT00484744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274954|NCT00642096|Diuretics|diuretics|mesh-ancestor
65274955|NCT00642096|Natriuretic Agents|natriuretic agents|mesh-ancestor
65274956|NCT00642096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334892|NCT03541655|Analgesics|analgesics|mesh-ancestor
65006004|NCT00484744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006005|NCT00484822|Heparin|heparin|mesh-list
65006006|NCT00484822|Calcium heparin|calcium heparin|mesh-list
65006007|NCT00484822|Anticoagulants|anticoagulants|mesh-ancestor
65006008|NCT00484822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65006033|NCT00484900|Antimalarials|antimalarials|mesh-ancestor
65006034|NCT00484900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65006035|NCT00484900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65006036|NCT00484900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006037|NCT05062356|Ketorolac|ketorolac|mesh-list
65006038|NCT05062356|Epinephrine|epinephrine|mesh-list
65006039|NCT05062356|Bupivacaine|bupivacaine|mesh-list
65006040|NCT05062356|Prilocaine|prilocaine|mesh-list
65006041|NCT05062356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65006042|NCT05062356|Anesthetics, Local|anesthetics, local|mesh-ancestor
65006043|NCT05062356|Anesthetics|anesthetics|mesh-ancestor
65006044|NCT05062356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65006045|NCT05062356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006046|NCT05062356|Sensory System Agents|sensory system agents|mesh-ancestor
65006047|NCT05062356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65006048|NCT05062356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65006049|NCT05062356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65006050|NCT05062356|Adrenergic Agents|adrenergic agents|mesh-ancestor
65006051|NCT05062356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65006052|NCT05062356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006053|NCT05062356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65006054|NCT05062356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65006055|NCT05062356|Autonomic Agents|autonomic agents|mesh-ancestor
65006056|NCT05062356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65006057|NCT05062356|Respiratory System Agents|respiratory system agents|mesh-ancestor
65006058|NCT05062356|Mydriatics|mydriatics|mesh-ancestor
65006059|NCT05062356|Sympathomimetics|sympathomimetics|mesh-ancestor
65006094|NCT00118638|Hematinics|hematinics|mesh-ancestor
65006095|NCT00485368|Perindopril|perindopril|mesh-list
65006096|NCT00485368|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65006097|NCT00485368|Protease Inhibitors|protease inhibitors|mesh-ancestor
65006098|NCT00485368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964810|NCT00163111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006110|NCT01241500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65006111|NCT01241500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65006112|NCT01241500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006113|NCT01241500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006114|NCT05058612|Midodrine|midodrine|mesh-list
65006115|NCT05058612|Sympathomimetics|sympathomimetics|mesh-ancestor
65006116|NCT05058612|Autonomic Agents|autonomic agents|mesh-ancestor
65006117|NCT05058612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65006118|NCT05058612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006119|NCT05058612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65006120|NCT05058612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65006121|NCT05058612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65006122|NCT05058612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65006123|NCT05058612|Adrenergic Agents|adrenergic agents|mesh-ancestor
65006124|NCT05058612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65006125|NCT05058612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006126|NCT02274181|Enclomiphene|enclomiphene|mesh-list
65006127|NCT02274181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65006128|NCT02274181|Hormone Antagonists|hormone antagonists|mesh-ancestor
65006129|NCT02274181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65006130|NCT02274181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006131|NCT02274181|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65006132|NCT02274181|Fertility Agents|fertility agents|mesh-ancestor
65006133|NCT02274181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65006134|NCT02274181|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65006135|NCT02274181|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65006136|NCT05058417|Empagliflozin|empagliflozin|mesh-list
64987346|NCT00317746|Citalopram|citalopram|mesh-list
65006137|NCT05058417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65006138|NCT05058417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274957|NCT00642096|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65274958|NCT00642096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65274959|NCT00642096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274960|NCT00642096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65274961|NCT00642096|Sympatholytics|sympatholytics|mesh-ancestor
65006139|NCT05058417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65006140|NCT05058417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006141|NCT02274337|Abivertinib|abivertinib|mesh-list
65006142|NCT02274337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65006143|NCT02274337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006144|NCT02274337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006145|NCT00121043|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65006146|NCT00121043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65006147|NCT00485680|Olanzapine|olanzapine|mesh-list
65006148|NCT00485680|Lithium Carbonate|lithium carbonate|mesh-list
65006149|NCT00485680|Antiemetics|antiemetics|mesh-ancestor
65006150|NCT00485680|Autonomic Agents|autonomic agents|mesh-ancestor
65006151|NCT00485680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65006152|NCT00485680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006153|NCT00485680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65006154|NCT00485680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65006155|NCT00485680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65006156|NCT00485680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65006157|NCT00485680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65006177|NCT00118794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006178|NCT00118794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006179|NCT00118794|Leprostatic Agents|leprostatic agents|mesh-ancestor
65006180|NCT00118794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65006181|NCT01241773|Efavirenz|efavirenz|mesh-list
65006182|NCT01241773|Raltegravir Potassium|raltegravir potassium|mesh-list
65006183|NCT01241773|Simeprevir|simeprevir|mesh-list
65006184|NCT01241773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65006185|NCT01241773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65006186|NCT01241773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006187|NCT01241773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006188|NCT01241773|Antiviral Agents|antiviral agents|mesh-ancestor
65006189|NCT01241773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006190|NCT01241773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65006191|NCT01241773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65006192|NCT01241773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65006193|NCT01241773|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65006194|NCT01241773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65006195|NCT01241773|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65006196|NCT01241773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65006197|NCT01241773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65006198|NCT01241773|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65006199|NCT01241773|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65006200|NCT01241773|Protease Inhibitors|protease inhibitors|mesh-ancestor
65006201|NCT00121277|Capecitabine|capecitabine|mesh-list
65006202|NCT00121277|Vorinostat|vorinostat|mesh-list
65006203|NCT00121277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65006204|NCT00121277|Antimetabolites|antimetabolites|mesh-ancestor
65006205|NCT00121277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006206|NCT00121277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65006207|NCT00121277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65006208|NCT00121277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006209|NCT00485797|Methylphenidate|methylphenidate|mesh-list
65006210|NCT00485797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65006211|NCT00485797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006212|NCT00485797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65006236|NCT00121316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65006237|NCT00121316|Immunologic Factors|immunologic factors|mesh-ancestor
65006238|NCT00121316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65006239|NCT00121316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006240|NCT00121316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006241|NCT00118950|Metformin|metformin|mesh-list
65006242|NCT00118950|Repaglinide|repaglinide|mesh-list
65006243|NCT00118950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65274962|NCT00642096|Autonomic Agents|autonomic agents|mesh-ancestor
65274963|NCT00642096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65274964|NCT00642096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65274965|NCT00642096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65274966|NCT00642096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65274967|NCT00642096|Adrenergic Agents|adrenergic agents|mesh-ancestor
65274968|NCT00642096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65274969|NCT05336513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65006244|NCT00118950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006245|NCT00486187|Metformin|metformin|mesh-list
65006246|NCT00486187|Rosiglitazone|rosiglitazone|mesh-list
65006247|NCT00486187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65006248|NCT00486187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006249|NCT00121394|Chlorhexidine|chlorhexidine|mesh-list
65006250|NCT00121394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65006251|NCT00121394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006252|NCT00121394|Disinfectants|disinfectants|mesh-ancestor
65006253|NCT00486343|Zileuton|zileuton|mesh-list
65006254|NCT00486343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65006255|NCT00486343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65006256|NCT00486343|Analgesics|analgesics|mesh-ancestor
65006257|NCT00486343|Sensory System Agents|sensory system agents|mesh-ancestor
65006258|NCT00486343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65006259|NCT00486343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006279|NCT00486421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65006280|NCT00486460|Gemcitabine|gemcitabine|mesh-list
65006281|NCT00486460|Curcumin|curcumin|mesh-list
65006282|NCT00486460|Celecoxib|celecoxib|mesh-list
65006283|NCT00486460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65006284|NCT00486460|Antimetabolites|antimetabolites|mesh-ancestor
65006285|NCT00486460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006286|NCT00486460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65006287|NCT00486460|Antiviral Agents|antiviral agents|mesh-ancestor
65006288|NCT00486460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006289|NCT00486460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006290|NCT00486460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65006291|NCT00486460|Immunologic Factors|immunologic factors|mesh-ancestor
65006292|NCT00486460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006293|NCT00486460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65006294|NCT00486460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65006295|NCT00486460|Analgesics|analgesics|mesh-ancestor
65006296|NCT00486460|Sensory System Agents|sensory system agents|mesh-ancestor
65006297|NCT00486460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65006298|NCT00486460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65006299|NCT00486460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65006300|NCT00486460|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65006301|NCT00486460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65006302|NCT00121511|Fluorouracil|fluorouracil|mesh-list
65006303|NCT00121511|Antimetabolites|antimetabolites|mesh-ancestor
65006304|NCT00121511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006305|NCT00121511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65006306|NCT00121511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65006307|NCT00121511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65006308|NCT00121511|Immunologic Factors|immunologic factors|mesh-ancestor
65006309|NCT00121511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006311|NCT00486694|Chloroquine|chloroquine|mesh-list
65006312|NCT00486694|Pyrimethamine|pyrimethamine|mesh-list
65006313|NCT00486694|Sulfadoxine|sulfadoxine|mesh-list
65006314|NCT00486694|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64965017|NCT00053612|Vitamin A|vitamin a|mesh-list
65006349|NCT01242046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006350|NCT01242046|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65006351|NCT01242046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006352|NCT01242046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006353|NCT01242046|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64965072|NCT00053768|Prednisone|prednisone|mesh-list
65006380|NCT00119184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65274970|NCT02679456|Fluconazole|fluconazole|mesh-list
65274971|NCT02679456|Ibrexafungerp|ibrexafungerp|mesh-list
65274972|NCT02679456|Antifungal Agents|antifungal agents|mesh-ancestor
65006381|NCT00119184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006383|NCT00487123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65006384|NCT00487123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65006385|NCT00487123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65006386|NCT00487123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65006387|NCT00487123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006388|NCT00487123|Diuretics|diuretics|mesh-ancestor
65006389|NCT00487123|Natriuretic Agents|natriuretic agents|mesh-ancestor
65006390|NCT00487123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006391|NCT00487123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65006392|NCT00487123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65006393|NCT04985916|Botulinum Toxins|botulinum toxins|mesh-list
65006394|NCT04985916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65006395|NCT04985916|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65006396|NCT04985916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65006397|NCT04985916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65006398|NCT04985916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006399|NCT04985916|Cholinergic Agents|cholinergic agents|mesh-ancestor
65006400|NCT04985916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65006401|NCT04985916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006402|NCT04985916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65006403|NCT04985916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65006404|NCT00487591|Simvastatin|simvastatin|mesh-list
65006405|NCT00487591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65006437|NCT00488176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006439|NCT00488176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65006440|NCT00488176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65006441|NCT00488176|Histamine Antagonists|histamine antagonists|mesh-ancestor
65006442|NCT00488176|Histamine Agents|histamine agents|mesh-ancestor
65006443|NCT00488176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65006445|NCT00488215|Laxatives|laxatives|mesh-ancestor
65006446|NCT00488215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65006447|NCT00488215|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65006479|NCT00488605|Prednisone|prednisone|mesh-list
65006480|NCT00488605|Methotrexate|methotrexate|mesh-list
65006481|NCT00488605|Vinblastine|vinblastine|mesh-list
65006482|NCT00488605|Levoleucovorin|levoleucovorin|mesh-list
65006483|NCT00488605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65006484|NCT00488605|Glucocorticoids|glucocorticoids|mesh-ancestor
65006485|NCT00488605|Hormones|hormones|mesh-ancestor
65006486|NCT00488605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65006487|NCT00488605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006488|NCT00488605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64461662|NCT05688202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461664|NCT05688202|Analgesics|analgesics|mesh-ancestor
64461665|NCT05688202|Antipyretics|antipyretics|mesh-ancestor
64461666|NCT05688202|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64461667|NCT05688124|Esomeprazole|esomeprazole|mesh-list
64461668|NCT05688124|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65006494|NCT00488605|Antimetabolites|antimetabolites|mesh-ancestor
65006495|NCT00488605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006496|NCT00488605|Dermatologic Agents|dermatologic agents|mesh-ancestor
65006497|NCT00488605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006498|NCT00488605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65006499|NCT00488605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65006500|NCT00488605|Immunologic Factors|immunologic factors|mesh-ancestor
65006501|NCT00488605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65006502|NCT00488605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65006503|NCT00488605|Antidotes|antidotes|mesh-ancestor
65006504|NCT00488605|Protective Agents|protective agents|mesh-ancestor
65006505|NCT00488605|Vitamin B Complex|vitamin b complex|mesh-ancestor
65006506|NCT00488605|Vitamins|vitamins|mesh-ancestor
65006507|NCT00488605|Micronutrients|micronutrients|mesh-ancestor
65006508|NCT00488605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65006509|NCT00488605|Tubulin Modulators|tubulin modulators|mesh-ancestor
65006510|NCT00488605|Antimitotic Agents|antimitotic agents|mesh-ancestor
65006511|NCT00488605|Mitosis Modulators|mitosis modulators|mesh-ancestor
65006512|NCT00488722|Goserelin|goserelin|mesh-list
65006513|NCT00488722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65006514|NCT00488722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274973|NCT02679456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65274974|NCT02679456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65274975|NCT02679456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65274976|NCT02679456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274977|NCT02679456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274978|NCT02679456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65274979|NCT02679456|Hormone Antagonists|hormone antagonists|mesh-ancestor
64727454|NCT00003260|Vitamin B Complex|vitamin b complex|mesh-ancestor
65006515|NCT00488761|Tigecycline|tigecycline|mesh-list
65006516|NCT00488761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65006517|NCT00488761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006518|NCT00488761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65006519|NCT00488761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006520|NCT00488761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006521|NCT00121784|Mycophenolic Acid|mycophenolic acid|mesh-list
65006522|NCT00121784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65006523|NCT00121784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65006543|NCT00488800|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65006544|NCT00488800|Immunologic Factors|immunologic factors|mesh-ancestor
65006545|NCT00488800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006546|NCT00145275|Zoledronic Acid|zoledronic acid|mesh-list
65006547|NCT00145275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65006548|NCT00145275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006549|NCT00488995|Tremelimumab|tremelimumab|mesh-list
65006550|NCT00488995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65006551|NCT04911816|Hydroxychloroquine|hydroxychloroquine|mesh-list
65006552|NCT04911816|Antimalarials|antimalarials|mesh-ancestor
65006553|NCT04911816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65006554|NCT04911816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65006555|NCT04911816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006556|NCT04911816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006557|NCT04911816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006558|NCT04911816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65006559|NCT00489073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65006560|NCT00489073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65006561|NCT00489073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65006562|NCT00489073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65006563|NCT00489073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006564|NCT00489073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65006565|NCT00489073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006566|NCT00489073|Analgesics|analgesics|mesh-ancestor
65006567|NCT00489073|Sensory System Agents|sensory system agents|mesh-ancestor
65006568|NCT00489073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65006569|NCT00489073|Antidepressive Agents|antidepressive agents|mesh-ancestor
65006570|NCT00489073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65006571|NCT00489073|Dopamine Agents|dopamine agents|mesh-ancestor
65006572|NCT00489151|Lamivudine|lamivudine|mesh-list
65006573|NCT00489151|Adefovir|adefovir|mesh-list
65006574|NCT00489151|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65006575|NCT00489151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65006576|NCT00489151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65006609|NCT00489229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006610|NCT00489229|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65006611|NCT00489229|Protease Inhibitors|protease inhibitors|mesh-ancestor
65006612|NCT00489229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006613|NCT00489229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006614|NCT00489229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65006615|NCT00489385|Ribavirin|ribavirin|mesh-list
65006616|NCT00489385|Antimetabolites|antimetabolites|mesh-ancestor
65006617|NCT00489385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006618|NCT00489385|Antiviral Agents|antiviral agents|mesh-ancestor
65006619|NCT00489385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006620|NCT01242631|Everolimus|everolimus|mesh-list
65006621|NCT01242631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274980|NCT02679456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65274981|NCT02679456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65274982|NCT02679456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65274983|NCT02679456|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65274984|NCT00640458|Sildenafil Citrate|sildenafil citrate|mesh-list
65274985|NCT00640458|Vasodilator Agents|vasodilator agents|mesh-ancestor
65274986|NCT00640458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65274987|NCT00640458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64727465|NCT00002665|Etoposide|etoposide|mesh-list
65006622|NCT01242631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64965362|NCT00045396|Tipifarnib|tipifarnib|mesh-list
65006651|NCT00489658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006653|NCT00122018|Fenoldopam|fenoldopam|mesh-list
65006654|NCT00122018|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65006655|NCT00122018|Antiviral Agents|antiviral agents|mesh-ancestor
65006656|NCT00122018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006657|NCT00122018|Expectorants|expectorants|mesh-ancestor
65006658|NCT00122018|Respiratory System Agents|respiratory system agents|mesh-ancestor
65006659|NCT00122018|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65006660|NCT00122018|Antioxidants|antioxidants|mesh-ancestor
65006661|NCT00122018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006662|NCT00122018|Protective Agents|protective agents|mesh-ancestor
65006663|NCT00122018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006664|NCT00122018|Antidotes|antidotes|mesh-ancestor
65006665|NCT00122018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65006666|NCT00122018|Vasodilator Agents|vasodilator agents|mesh-ancestor
65006667|NCT00122018|Dopamine Agonists|dopamine agonists|mesh-ancestor
65006668|NCT00122018|Dopamine Agents|dopamine agents|mesh-ancestor
65006669|NCT00122018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65006670|NCT00489775|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65006694|NCT00489892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006695|NCT00489892|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65006696|NCT00489892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65006697|NCT00489892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65006698|NCT00489892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006699|NCT00490087|Levonorgestrel|levonorgestrel|mesh-list
65006700|NCT00490087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65006701|NCT00490087|Contraceptive Agents|contraceptive agents|mesh-ancestor
65006702|NCT00490087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65006703|NCT00490087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006704|NCT00490087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65006705|NCT00490087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65006706|NCT00490087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65006707|NCT01243060|Zolpidem|zolpidem|mesh-list
65006708|NCT01243060|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65006709|NCT01243060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65006710|NCT01243060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65006711|NCT01243060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006712|NCT01243060|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65006713|NCT01243060|GABA Agonists|gaba agonists|mesh-ancestor
65006714|NCT01243060|GABA Agents|gaba agents|mesh-ancestor
65006715|NCT01243060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65006716|NCT01243060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006717|NCT00490204|Cetirizine|cetirizine|mesh-list
65006718|NCT00490204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65006746|NCT00490243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006747|NCT00490243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65006748|NCT00490243|Respiratory System Agents|respiratory system agents|mesh-ancestor
65006749|NCT00490243|Glucocorticoids|glucocorticoids|mesh-ancestor
65006750|NCT00490243|Hormones|hormones|mesh-ancestor
65006751|NCT00490243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65006752|NCT00490243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65006753|NCT00490243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65274988|NCT00640458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65274989|NCT00640458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274990|NCT00640458|Urological Agents|urological agents|mesh-ancestor
65274991|NCT00909948|Fludarabine|fludarabine|mesh-list
65274992|NCT00909948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274993|NCT02681562|Olaparib|olaparib|mesh-list
65274994|NCT02681562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65274995|NCT02681562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727482|NCT00002665|Antiemetics|antiemetics|mesh-ancestor
65006754|NCT00490243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65006755|NCT00490243|Adrenergic Agents|adrenergic agents|mesh-ancestor
65006756|NCT00490243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65006757|NCT00490243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006758|NCT00490243|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65006759|NCT00490243|Hormone Antagonists|hormone antagonists|mesh-ancestor
65006760|NCT00490243|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65006761|NCT00490243|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65006762|NCT00490360|Gemcitabine|gemcitabine|mesh-list
65006763|NCT00490360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65006792|NCT04844385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006793|NCT04844385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65006795|NCT00490633|Ethanol|ethanol|mesh-list
65006796|NCT00490633|Hand Sanitizers|hand sanitizers|mesh-list
65006797|NCT00490633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65006798|NCT00490633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006799|NCT00490633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65006800|NCT00490633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006801|NCT00490633|Disinfectants|disinfectants|mesh-ancestor
65006802|NCT00490711|Gemcitabine|gemcitabine|mesh-list
65006803|NCT00490711|Paclitaxel|paclitaxel|mesh-list
65006804|NCT00490711|Carboplatin|carboplatin|mesh-list
65006805|NCT00490711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65006806|NCT00490711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65006807|NCT00490711|Tubulin Modulators|tubulin modulators|mesh-ancestor
65006808|NCT00490711|Antimitotic Agents|antimitotic agents|mesh-ancestor
65006809|NCT00490711|Mitosis Modulators|mitosis modulators|mesh-ancestor
65006810|NCT00490711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965541|NCT00054587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65006839|NCT04829604|Immunologic Factors|immunologic factors|mesh-ancestor
65006840|NCT04829604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006841|NCT00490867|Thioctic Acid|thioctic acid|mesh-list
65006842|NCT00490867|Antioxidants|antioxidants|mesh-ancestor
65006843|NCT00490867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006844|NCT00490867|Protective Agents|protective agents|mesh-ancestor
65006845|NCT00490867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006846|NCT00490867|Vitamin B Complex|vitamin b complex|mesh-ancestor
65006847|NCT00490867|Vitamins|vitamins|mesh-ancestor
65006848|NCT00490867|Micronutrients|micronutrients|mesh-ancestor
65006849|NCT00122330|Eculizumab|eculizumab|mesh-list
65006850|NCT00122330|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65006851|NCT00122330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65006852|NCT00122330|Immunologic Factors|immunologic factors|mesh-ancestor
65006853|NCT00122330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006854|NCT00490906|Interferons|interferons|mesh-list
65006855|NCT00490906|Interferon-beta|interferon-beta|mesh-list
65006856|NCT00490906|Interferon beta-1a|interferon beta-1a|mesh-list
65006857|NCT00490906|Glatiramer Acetate|glatiramer acetate|mesh-list
65006858|NCT00490906|(T,G)-A-L|(t,g)-a-l|mesh-list
65006877|NCT00491413|Epoetin Alfa|epoetin alfa|mesh-list
65006878|NCT00491413|Hematinics|hematinics|mesh-ancestor
65006879|NCT00145665|Telbivudine|telbivudine|mesh-list
65006880|NCT00145665|Antiviral Agents|antiviral agents|mesh-ancestor
65006881|NCT00145665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006882|NCT00145665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65006883|NCT00145665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006884|NCT00145665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006886|NCT00491725|Repaglinide|repaglinide|mesh-list
65006887|NCT00491725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65274996|NCT02681562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65274997|NCT02681562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65274999|NCT00633035|Famotidine|famotidine|mesh-list
65006888|NCT00491725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006889|NCT00491803|Sildenafil Citrate|sildenafil citrate|mesh-list
65006890|NCT00491803|Vasodilator Agents|vasodilator agents|mesh-ancestor
65006891|NCT00491803|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65006892|NCT00491803|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65006893|NCT00491803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006894|NCT00491803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006895|NCT00491803|Urological Agents|urological agents|mesh-ancestor
65006896|NCT00122603|Saquinavir|saquinavir|mesh-list
65006897|NCT00122603|Fosamprenavir|fosamprenavir|mesh-list
65006898|NCT00122603|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65006899|NCT00122603|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65006900|NCT00122603|Protease Inhibitors|protease inhibitors|mesh-ancestor
65006901|NCT00122603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006902|NCT00122603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006903|NCT00122603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65006904|NCT00122603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65006905|NCT00122603|Antiviral Agents|antiviral agents|mesh-ancestor
65006906|NCT00122603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006907|NCT00122603|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65006908|NCT00122603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65006909|NCT00491920|Vitamin D|vitamin d|mesh-list
65006910|NCT00491920|Cholecalciferol|cholecalciferol|mesh-list
65006911|NCT00491920|Vitamins|vitamins|mesh-ancestor
65006912|NCT00491920|Micronutrients|micronutrients|mesh-ancestor
65006913|NCT00491920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006914|NCT00491920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65006915|NCT00491920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65006916|NCT00491998|Entacapone|entacapone|mesh-list
65006945|NCT00492388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006947|NCT01243528|Vitamins|vitamins|mesh-ancestor
65006948|NCT01243528|Micronutrients|micronutrients|mesh-ancestor
65006949|NCT01243528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006950|NCT01243528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65006951|NCT00492427|Epoetin Alfa|epoetin alfa|mesh-list
65006952|NCT00492427|Hematinics|hematinics|mesh-ancestor
65006953|NCT00492466|Interferons|interferons|mesh-list
65006954|NCT00492466|Interferon-beta|interferon-beta|mesh-list
65006955|NCT00492466|Interferon beta-1a|interferon beta-1a|mesh-list
65006956|NCT00492466|Methylprednisolone|methylprednisolone|mesh-list
65006957|NCT00492466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65006958|NCT00492466|Antiviral Agents|antiviral agents|mesh-ancestor
65006959|NCT00492466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006960|NCT00492466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65006961|NCT00492466|Antiemetics|antiemetics|mesh-ancestor
65006962|NCT00492466|Autonomic Agents|autonomic agents|mesh-ancestor
64965694|NCT00168493|Serotonin|serotonin|mesh-list
65006986|NCT00492505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65006987|NCT00492661|Tacrolimus|tacrolimus|mesh-list
65006988|NCT00492661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65006989|NCT00492661|Immunologic Factors|immunologic factors|mesh-ancestor
65006990|NCT00492661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006991|NCT00492661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65006992|NCT00492661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006993|NCT00492661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006994|NCT00492700|Rosiglitazone|rosiglitazone|mesh-list
65006995|NCT00492700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65006996|NCT00492700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006997|NCT00402350|Fentanyl|fentanyl|mesh-list
65006998|NCT00402350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65006999|NCT00402350|Narcotics|narcotics|mesh-ancestor
65007000|NCT00402350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65007001|NCT00402350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007002|NCT00402350|Analgesics|analgesics|mesh-ancestor
65007003|NCT00402350|Sensory System Agents|sensory system agents|mesh-ancestor
65007004|NCT00402350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65007005|NCT00402350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65007006|NCT00402350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65007007|NCT00402350|Anesthetics, General|anesthetics, general|mesh-ancestor
65007008|NCT00402350|Anesthetics|anesthetics|mesh-ancestor
65007009|NCT00122720|Darbepoetin alfa|darbepoetin alfa|mesh-list
65275000|NCT00633035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65275001|NCT00633035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65275002|NCT00633035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65275003|NCT00633035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275004|NCT00633035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007010|NCT00122720|Hematinics|hematinics|mesh-ancestor
65007011|NCT00492934|Menotropins|menotropins|mesh-list
64965733|NCT00168649|Vitamins|vitamins|mesh-ancestor
65007040|NCT00493129|Interleukin-2|interleukin-2|mesh-list
65007041|NCT00493129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007042|NCT00493129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65007043|NCT00493129|Analgesics|analgesics|mesh-ancestor
65007044|NCT00493129|Sensory System Agents|sensory system agents|mesh-ancestor
65007045|NCT00493129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65007046|NCT00493129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007047|NCT00126542|Bevacizumab|bevacizumab|mesh-list
65007048|NCT00126542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65007049|NCT00126542|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65007050|NCT00126542|Antibodies|antibodies|mesh-list
65007051|NCT00126542|Immunoglobulins|immunoglobulins|mesh-list
65007052|NCT00126542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65007053|NCT00126542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007054|NCT00126542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65007055|NCT00126542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65007056|NCT00126542|Growth Substances|growth substances|mesh-ancestor
65007057|NCT00126542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007058|NCT00126542|Growth Inhibitors|growth inhibitors|mesh-ancestor
65007059|NCT00126542|Immunologic Factors|immunologic factors|mesh-ancestor
65007082|NCT00126620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65007084|NCT00126620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007085|NCT00126620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65007086|NCT00126620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007087|NCT00126620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007089|NCT00493363|Mefloquine|mefloquine|mesh-list
65007090|NCT00493363|Antimalarials|antimalarials|mesh-ancestor
65007091|NCT00493363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65007092|NCT00493363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65007093|NCT00493363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65007094|NCT00493363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007095|NCT00493363|Antiviral Agents|antiviral agents|mesh-ancestor
65007096|NCT00493363|Schistosomicides|schistosomicides|mesh-ancestor
65007097|NCT00493363|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65007098|NCT00493363|Anthelmintics|anthelmintics|mesh-ancestor
65007099|NCT00126698|Ciprofloxacin|ciprofloxacin|mesh-list
65007100|NCT00126698|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65007101|NCT00126698|Trimethoprim|trimethoprim|mesh-list
65007102|NCT00126698|Sulfamethoxazole|sulfamethoxazole|mesh-list
65007103|NCT00126698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65007104|NCT00126698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65007105|NCT00126698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65007106|NCT00126698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65007107|NCT00126698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007108|NCT00126698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007109|NCT00126698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007110|NCT00126698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65007132|NCT00145938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007133|NCT00145938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007134|NCT00145938|Urological Agents|urological agents|mesh-ancestor
65007136|NCT00493480|Carvedilol|carvedilol|mesh-list
65007137|NCT00493480|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65007138|NCT00493480|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65007139|NCT00493480|Adrenergic Agents|adrenergic agents|mesh-ancestor
65007140|NCT00493480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65007141|NCT00493480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007142|NCT00493480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007143|NCT00493480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65007144|NCT00493480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65007145|NCT00493480|Vasodilator Agents|vasodilator agents|mesh-ancestor
65007146|NCT00493480|Antioxidants|antioxidants|mesh-ancestor
65007147|NCT00493480|Protective Agents|protective agents|mesh-ancestor
65007148|NCT00493480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65275005|NCT00633035|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65275006|NCT00633035|Histamine Antagonists|histamine antagonists|mesh-ancestor
65275007|NCT00633035|Histamine Agents|histamine agents|mesh-ancestor
65275008|NCT00633035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65275009|NCT00633035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275010|NCT02511132|Gemcitabine|gemcitabine|mesh-list
65275011|NCT02511132|Docetaxel|docetaxel|mesh-list
65275012|NCT02511132|Irinotecan|irinotecan|mesh-list
65007149|NCT00493480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65007150|NCT00493480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65007151|NCT00493480|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65007152|NCT00493480|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65007153|NCT01243996|Ibuprofen|ibuprofen|mesh-list
65007154|NCT01243996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65007155|NCT01243996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65007156|NCT01243996|Analgesics|analgesics|mesh-ancestor
65007157|NCT01243996|Sensory System Agents|sensory system agents|mesh-ancestor
65007158|NCT01243996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65007159|NCT01243996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007160|NCT01243996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65007161|NCT01243996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65007162|NCT01243996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65007163|NCT01243996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007191|NCT00493987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65007192|NCT00493987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007194|NCT00493987|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65007195|NCT00493987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65007196|NCT00493987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007197|NCT00493987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007198|NCT00493987|Hormone Antagonists|hormone antagonists|mesh-ancestor
65007199|NCT00494104|Vitamin D|vitamin d|mesh-list
65007200|NCT00494104|Vitamins|vitamins|mesh-ancestor
65007201|NCT00494104|Micronutrients|micronutrients|mesh-ancestor
65007202|NCT00494104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007203|NCT00494104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65007204|NCT00405366|Sorafenib|sorafenib|mesh-list
65007205|NCT00405366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007206|NCT00405366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65007207|NCT00405366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007208|NCT00405366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007209|NCT00494338|Docetaxel|docetaxel|mesh-list
65007210|NCT00494338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007211|NCT00494338|Tubulin Modulators|tubulin modulators|mesh-ancestor
65007235|NCT00146016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007236|NCT00146016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007238|NCT00146016|Analgesics|analgesics|mesh-ancestor
65007239|NCT00146016|Sensory System Agents|sensory system agents|mesh-ancestor
65007240|NCT00146016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65007241|NCT00126971|Dapsone|dapsone|mesh-list
65007242|NCT00126971|Chlorproguanil|chlorproguanil|mesh-list
65007243|NCT00126971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64462401|NCT04305106|Antiemetics|antiemetics|mesh-ancestor
65007244|NCT00126971|Antimalarials|antimalarials|mesh-ancestor
65007245|NCT00126971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65007246|NCT00126971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65007247|NCT00126971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65007248|NCT00126971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007249|NCT00126971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007250|NCT00126971|Leprostatic Agents|leprostatic agents|mesh-ancestor
65007251|NCT00126971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65007252|NCT01244230|Fexofenadine|fexofenadine|mesh-list
65007253|NCT01244230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65007254|NCT01244230|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65007255|NCT01244230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65007256|NCT01244230|Histamine Antagonists|histamine antagonists|mesh-ancestor
65007257|NCT01244230|Histamine Agents|histamine agents|mesh-ancestor
65007258|NCT01244230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65007259|NCT01244230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275013|NCT02511132|Temozolomide|temozolomide|mesh-list
65275014|NCT02511132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65275015|NCT02511132|Antimetabolites|antimetabolites|mesh-ancestor
65275016|NCT02511132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275017|NCT02511132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007290|NCT00127049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007291|NCT00127049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65007292|NCT00127049|Antimetabolites|antimetabolites|mesh-ancestor
65007293|NCT00127049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007294|NCT00127049|Antiviral Agents|antiviral agents|mesh-ancestor
65007295|NCT00127049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65007296|NCT00127049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007297|NCT00127049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65007298|NCT00127049|Immunologic Factors|immunologic factors|mesh-ancestor
65007299|NCT00127049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007300|NCT00127049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65007318|NCT02957877|Anticoagulants|anticoagulants|mesh-ancestor
65007319|NCT02957877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65007320|NCT02957877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65007321|NCT02957877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007322|NCT01244581|Amoxicillin|amoxicillin|mesh-list
65007323|NCT01244581|Clavulanic Acid|clavulanic acid|mesh-list
65007324|NCT01244581|Clavulanic Acids|clavulanic acids|mesh-list
65007325|NCT01244581|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65007326|NCT01244581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65007327|NCT01244581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65007328|NCT01244581|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65007329|NCT01244581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007330|NCT01244581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007331|NCT01244659|Tacrolimus|tacrolimus|mesh-list
65007332|NCT01244659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65007333|NCT01244659|Immunologic Factors|immunologic factors|mesh-ancestor
65007334|NCT01244659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007335|NCT01244659|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65007336|NCT01244659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007337|NCT01244659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007338|NCT01244698|Clindamycin|clindamycin|mesh-list
65007339|NCT01244698|Clindamycin palmitate|clindamycin palmitate|mesh-list
65007340|NCT01244698|Clindamycin phosphate|clindamycin phosphate|mesh-list
65007341|NCT01244698|Cefazolin|cefazolin|mesh-list
65007342|NCT01244698|Cefadroxil|cefadroxil|mesh-list
65007343|NCT01244698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65007344|NCT01244698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65007345|NCT01244698|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65007346|NCT01244698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007347|NCT01244698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007348|NCT00495118|Risperidone|risperidone|mesh-list
65007349|NCT00495118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65007350|NCT00495118|Serotonin Agents|serotonin agents|mesh-ancestor
65007351|NCT00495118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65007352|NCT00495118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007353|NCT00495118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007354|NCT00495118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65007355|NCT00495118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65007356|NCT00495118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65007357|NCT00495118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65007358|NCT00495118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65007359|NCT00495118|Dopamine Agents|dopamine agents|mesh-ancestor
65007383|NCT00495547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65007384|NCT00495547|Antimetabolites|antimetabolites|mesh-ancestor
65007385|NCT00495547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007386|NCT00495547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007387|NCT00495547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007388|NCT00495547|Hematinics|hematinics|mesh-ancestor
65007390|NCT00495781|Trace Elements|trace elements|mesh-ancestor
65007391|NCT00495781|Micronutrients|micronutrients|mesh-ancestor
65007392|NCT00495781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007393|NCT00405405|Bevacizumab|bevacizumab|mesh-list
65007394|NCT00405405|Cisplatin|cisplatin|mesh-list
65007395|NCT00405405|Docetaxel|docetaxel|mesh-list
65275018|NCT02511132|Antiviral Agents|antiviral agents|mesh-ancestor
65275019|NCT02511132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65275020|NCT02511132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275021|NCT02511132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65275022|NCT02511132|Immunologic Factors|immunologic factors|mesh-ancestor
65275023|NCT02511132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727503|NCT00002665|Antiviral Agents|antiviral agents|mesh-ancestor
65007396|NCT00405405|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65007397|NCT00405405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65007398|NCT00405405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007399|NCT00405405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65007400|NCT00405405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65007401|NCT00405405|Growth Substances|growth substances|mesh-ancestor
65007402|NCT00405405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007403|NCT00405405|Growth Inhibitors|growth inhibitors|mesh-ancestor
65007404|NCT00405405|Tubulin Modulators|tubulin modulators|mesh-ancestor
65007405|NCT00405405|Antimitotic Agents|antimitotic agents|mesh-ancestor
65007406|NCT00405405|Mitosis Modulators|mitosis modulators|mesh-ancestor
65007407|NCT00405405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007408|NCT00405405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65007409|NCT00405405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007410|NCT00495898|Sirolimus|sirolimus|mesh-list
65007411|NCT00495898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65007412|NCT00495898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65007438|NCT00496444|Azacitidine|azacitidine|mesh-list
65007439|NCT00496444|Valproic Acid|valproic acid|mesh-list
65007440|NCT00496444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65007441|NCT00496444|Antimetabolites|antimetabolites|mesh-ancestor
65007442|NCT00496444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007443|NCT00496444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007444|NCT00496444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007445|NCT00496444|Anticonvulsants|anticonvulsants|mesh-ancestor
65007446|NCT00496444|GABA Agents|gaba agents|mesh-ancestor
65007447|NCT00496444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65007448|NCT00496444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007449|NCT00496444|Antimanic Agents|antimanic agents|mesh-ancestor
65007450|NCT00496444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65007451|NCT00496444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65007452|NCT00496444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65007453|NCT00496561|Immunologic Factors|immunologic factors|mesh-list
65007454|NCT00496561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007455|NCT00146250|Nitrous Oxide|nitrous oxide|mesh-list
65007456|NCT00146250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65007457|NCT00146250|Anesthetics, General|anesthetics, general|mesh-ancestor
65007458|NCT00146250|Anesthetics|anesthetics|mesh-ancestor
64966177|NCT00171496|Dermatologic Agents|dermatologic agents|mesh-ancestor
65007491|NCT04665765|Etoposide phosphate|etoposide phosphate|mesh-list
65007493|NCT04665765|Isophosphamide mustard|isophosphamide mustard|mesh-list
65007494|NCT04665765|Podophyllotoxin|podophyllotoxin|mesh-list
65007495|NCT04665765|Antibodies|antibodies|mesh-list
65007496|NCT04665765|Immunoglobulins|immunoglobulins|mesh-list
65007497|NCT04665765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65007498|NCT04665765|Immunoconjugates|immunoconjugates|mesh-list
65007499|NCT04665765|Immunologic Factors|immunologic factors|mesh-ancestor
65007500|NCT04665765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007501|NCT04665765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007502|NCT04665765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65007503|NCT04665765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65007504|NCT04665765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65007525|NCT00497107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007526|NCT00497107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65007528|NCT00497107|Protective Agents|protective agents|mesh-ancestor
65007529|NCT00497107|Vitamin B Complex|vitamin b complex|mesh-ancestor
65007530|NCT00497107|Vitamins|vitamins|mesh-ancestor
65007531|NCT00497107|Micronutrients|micronutrients|mesh-ancestor
65007532|NCT00146289|Telmisartan|telmisartan|mesh-list
65007533|NCT00146289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65007534|NCT00146289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65007535|NCT00146289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65275024|NCT02511132|Tubulin Modulators|tubulin modulators|mesh-ancestor
65275025|NCT02511132|Antimitotic Agents|antimitotic agents|mesh-ancestor
65275026|NCT02511132|Mitosis Modulators|mitosis modulators|mesh-ancestor
65275027|NCT02511132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65275028|NCT02511132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65275029|NCT02511132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65007536|NCT00146289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007537|NCT01244932|Bupivacaine|bupivacaine|mesh-list
65007538|NCT01244932|Anesthetics, Local|anesthetics, local|mesh-ancestor
65007540|NCT01244932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65007541|NCT01244932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007542|NCT01244932|Sensory System Agents|sensory system agents|mesh-ancestor
65007543|NCT01244932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65007544|NCT01244971|Acarbose|acarbose|mesh-list
65007545|NCT01244971|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65007546|NCT01244971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007547|NCT01244971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007548|NCT01244971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65007549|NCT01244971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007550|NCT04599894|Pregabalin|pregabalin|mesh-list
65007551|NCT04599894|Analgesics|analgesics|mesh-ancestor
65007552|NCT04599894|Sensory System Agents|sensory system agents|mesh-ancestor
65007553|NCT04599894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65007554|NCT04599894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007555|NCT04599894|Anticonvulsants|anticonvulsants|mesh-ancestor
65007556|NCT04599894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65007557|NCT04599894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65007558|NCT04599894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007559|NCT04599894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64966273|NCT00171847|Trastuzumab|trastuzumab|mesh-list
65007577|NCT00497341|Cefuroxime|cefuroxime|mesh-list
65007578|NCT00497341|Cefuroxime axetil|cefuroxime axetil|mesh-list
65007579|NCT00497341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65007580|NCT00497341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65007581|NCT00127829|Gefitinib|gefitinib|mesh-list
65007582|NCT00127829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007583|NCT00127829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65007584|NCT00127829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007585|NCT00127829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007586|NCT00497458|Testosterone|testosterone|mesh-list
65007587|NCT00497458|Androgens|androgens|mesh-ancestor
65007588|NCT00497458|Hormones|hormones|mesh-ancestor
65007589|NCT00497458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65007590|NCT00497458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007591|NCT00497497|Bevacizumab|bevacizumab|mesh-list
65007592|NCT00497497|Cetuximab|cetuximab|mesh-list
65007593|NCT00497497|Irinotecan|irinotecan|mesh-list
65007594|NCT00497497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65007595|NCT00497497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007596|NCT00497497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65007597|NCT00497497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65007598|NCT00497497|Growth Substances|growth substances|mesh-ancestor
65007599|NCT00497497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007600|NCT00497497|Growth Inhibitors|growth inhibitors|mesh-ancestor
65007601|NCT00497497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65007602|NCT00497497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65007603|NCT00497497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007604|NCT00497497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007605|NCT00127868|Selenium|selenium|mesh-list
65007606|NCT00127868|Ketoconazole|ketoconazole|mesh-list
65007607|NCT00127868|Ciclopirox|ciclopirox|mesh-list
65007608|NCT00127868|Griseofulvin|griseofulvin|mesh-list
65007609|NCT00127868|Selenium disulfide|selenium disulfide|mesh-list
65007610|NCT00127868|Antifungal Agents|antifungal agents|mesh-ancestor
65007611|NCT00127868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64988818|NCT00330772|Antipyretics|antipyretics|mesh-ancestor
65007612|NCT00127868|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65007613|NCT00127868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65007614|NCT00127868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275030|NCT02511132|Alkylating Agents|alkylating agents|mesh-ancestor
65275031|NCT02678520|Goserelin|goserelin|mesh-list
65275032|NCT02678520|Bicalutamide|bicalutamide|mesh-list
65275033|NCT02678520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65275034|NCT02678520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007615|NCT00127868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007616|NCT00127868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65007634|NCT00497614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65007635|NCT00497614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65007636|NCT00127907|Vasopressins|vasopressins|mesh-list
65007637|NCT00127907|Arginine Vasopressin|arginine vasopressin|mesh-list
65007638|NCT00127907|Epinephrine|epinephrine|mesh-list
65007639|NCT00127907|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65007640|NCT00127907|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65007641|NCT00127907|Adrenergic Agents|adrenergic agents|mesh-ancestor
65007642|NCT00127907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65007643|NCT00127907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007644|NCT00127907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007645|NCT00127907|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65007646|NCT00127907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65007647|NCT00127907|Autonomic Agents|autonomic agents|mesh-ancestor
65007648|NCT00127907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65007649|NCT00127907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65007650|NCT00127907|Respiratory System Agents|respiratory system agents|mesh-ancestor
65007651|NCT00127907|Mydriatics|mydriatics|mesh-ancestor
65007652|NCT00127907|Sympathomimetics|sympathomimetics|mesh-ancestor
65007653|NCT00127907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65007654|NCT00127907|Hemostatics|hemostatics|mesh-ancestor
65007655|NCT00127907|Coagulants|coagulants|mesh-ancestor
65007656|NCT00127907|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65007657|NCT00127907|Natriuretic Agents|natriuretic agents|mesh-ancestor
65007658|NCT00497809|Lenograstim|lenograstim|mesh-list
65007659|NCT00497809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65007660|NCT00497809|Immunologic Factors|immunologic factors|mesh-ancestor
65007661|NCT00497809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007662|NCT00146484|Insulin|insulin|mesh-list
65007663|NCT00146484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65007664|NCT00146484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007665|NCT00402584|Sibutramine|sibutramine|mesh-list
65007666|NCT00402584|Antidepressive Agents|antidepressive agents|mesh-ancestor
65007667|NCT00402584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65007668|NCT00402584|Appetite Depressants|appetite depressants|mesh-ancestor
65007669|NCT00402584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65007670|NCT00498004|Risperidone|risperidone|mesh-list
65007671|NCT00498004|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65007672|NCT00498004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65007673|NCT00498004|Serotonin Agents|serotonin agents|mesh-ancestor
65007674|NCT00498004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65007675|NCT00498004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007676|NCT00498004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007697|NCT00146523|Luteolytic Agents|luteolytic agents|mesh-ancestor
65007698|NCT00146523|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65007699|NCT00146523|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65007700|NCT00402623|Quercetin|quercetin|mesh-list
65007701|NCT00402623|Antioxidants|antioxidants|mesh-ancestor
65007702|NCT00402623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007703|NCT00402623|Protective Agents|protective agents|mesh-ancestor
65007704|NCT00402623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007705|NCT04520490|Exenatide|exenatide|mesh-list
65007706|NCT04520490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65007707|NCT04520490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007708|NCT04520490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65007709|NCT04520490|Incretins|incretins|mesh-ancestor
65007710|NCT04520490|Hormones|hormones|mesh-ancestor
65007711|NCT04520490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65007712|NCT00402662|Everolimus|everolimus|mesh-list
65007713|NCT00402662|Imatinib Mesylate|imatinib mesylate|mesh-list
65007714|NCT00402662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007715|NCT00402662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65007716|NCT00402662|Immunologic Factors|immunologic factors|mesh-ancestor
65007717|NCT00402662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275035|NCT02678520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65275036|NCT02678520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275037|NCT02678520|Androgen Antagonists|androgen antagonists|mesh-ancestor
65007718|NCT00402662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65007719|NCT00402662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007720|NCT00402662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007721|NCT00498316|Mycophenolic Acid|mycophenolic acid|mesh-list
65007722|NCT00498316|Cyclophosphamide|cyclophosphamide|mesh-list
65007723|NCT00498316|Melphalan|melphalan|mesh-list
65007724|NCT00498316|Busulfan|busulfan|mesh-list
65007725|NCT00498316|Rituximab|rituximab|mesh-list
65007726|NCT00498316|Fludarabine|fludarabine|mesh-list
65007727|NCT00498316|Fludarabine phosphate|fludarabine phosphate|mesh-list
65007728|NCT00498316|Clofarabine|clofarabine|mesh-list
65007729|NCT00498316|Tacrolimus|tacrolimus|mesh-list
65007730|NCT00498316|Thymoglobulin|thymoglobulin|mesh-list
64966434|NCT04631484|Riboflavin|riboflavin|mesh-list
65007758|NCT00146562|Antimitotic Agents|antimitotic agents|mesh-ancestor
65007759|NCT00146562|Mitosis Modulators|mitosis modulators|mesh-ancestor
65007760|NCT00146562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007761|NCT00146562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65007762|NCT00146562|Immunologic Factors|immunologic factors|mesh-ancestor
65007763|NCT00146562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007764|NCT00146562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65007765|NCT00146562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65007766|NCT00146562|Alkylating Agents|alkylating agents|mesh-ancestor
65007767|NCT00146562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65007768|NCT00146562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65007769|NCT00146562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65007770|NCT00146562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65007771|NCT00146562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007772|NCT00146562|Hematinics|hematinics|mesh-ancestor
65007773|NCT01245166|Metformin|metformin|mesh-list
65007774|NCT01245166|Acarbose|acarbose|mesh-list
65007775|NCT01245166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65007776|NCT01245166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007777|NCT01245166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65007792|NCT00498589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007793|NCT00498589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65007794|NCT00498589|Antimetabolites|antimetabolites|mesh-ancestor
65007795|NCT00498589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007796|NCT00498589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007797|NCT00498589|Dermatologic Agents|dermatologic agents|mesh-ancestor
65007798|NCT00498589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007799|NCT00498589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65007800|NCT00498589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65007801|NCT00498589|Immunologic Factors|immunologic factors|mesh-ancestor
65007802|NCT00498589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65007803|NCT00498589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65007804|NCT00498784|Levonorgestrel|levonorgestrel|mesh-list
65007805|NCT00498784|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65007806|NCT00498784|Contraceptive Agents|contraceptive agents|mesh-ancestor
65007807|NCT00498784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65007808|NCT00498784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007809|NCT00498784|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65007810|NCT00498784|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65007811|NCT00498784|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65007812|NCT00498901|Letrozole|letrozole|mesh-list
65007813|NCT00498901|Leuprolide|leuprolide|mesh-list
65007814|NCT00498901|Goserelin|goserelin|mesh-list
65007815|NCT00498901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007816|NCT00498901|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65007817|NCT00498901|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65007818|NCT00498901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007819|NCT00498901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007820|NCT00498901|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65007821|NCT00498901|Hormone Antagonists|hormone antagonists|mesh-ancestor
65007822|NCT00498901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65007823|NCT00498901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007824|NCT00498901|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65007825|NCT00498901|Fertility Agents|fertility agents|mesh-ancestor
65007826|NCT00498901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65007827|NCT00498901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65275038|NCT02678520|Hormone Antagonists|hormone antagonists|mesh-ancestor
65007828|NCT00498979|Interferons|interferons|mesh-list
65007829|NCT00498979|Interferon-alpha|interferon-alpha|mesh-list
65007830|NCT00498979|Interferon alpha-2|interferon alpha-2|mesh-list
65007831|NCT00498979|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
65007832|NCT00498979|Dacarbazine|dacarbazine|mesh-list
65007833|NCT00498979|Vinblastine|vinblastine|mesh-list
65007834|NCT00498979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007835|NCT00498979|Antiviral Agents|antiviral agents|mesh-ancestor
65007836|NCT00498979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65007862|NCT01245244|Analgesics|analgesics|mesh-ancestor
65007863|NCT01245244|Sensory System Agents|sensory system agents|mesh-ancestor
65007864|NCT01245244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65007865|NCT00405717|Atorvastatin|atorvastatin|mesh-list
65007866|NCT00405717|Pravastatin|pravastatin|mesh-list
65007867|NCT00405717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65007868|NCT00405717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65007869|NCT00405717|Antimetabolites|antimetabolites|mesh-ancestor
65007870|NCT00405717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007871|NCT00405717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65007872|NCT00405717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65007873|NCT00405717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007874|NCT00499018|Cytarabine|cytarabine|mesh-list
65007875|NCT00499018|Prednisone|prednisone|mesh-list
65007876|NCT00499018|Rituximab|rituximab|mesh-list
65007877|NCT00499018|Mitoxantrone|mitoxantrone|mesh-list
65007878|NCT00499018|Cyclophosphamide|cyclophosphamide|mesh-list
65007879|NCT00499018|Vincristine|vincristine|mesh-list
65007880|NCT00499018|Doxorubicin|doxorubicin|mesh-list
65007881|NCT00499018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65007882|NCT00499018|Lenograstim|lenograstim|mesh-list
65007883|NCT00499018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65007884|NCT00499018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007885|NCT00499018|Immunologic Factors|immunologic factors|mesh-ancestor
65007905|NCT00499018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65007906|NCT00499018|Alkylating Agents|alkylating agents|mesh-ancestor
65007907|NCT00499018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65007908|NCT00499018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65007909|NCT00499018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65007910|NCT00499018|Tubulin Modulators|tubulin modulators|mesh-ancestor
65007911|NCT00499018|Antimitotic Agents|antimitotic agents|mesh-ancestor
65007912|NCT00499018|Mitosis Modulators|mitosis modulators|mesh-ancestor
65007913|NCT00499018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65007915|NCT00127985|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65007916|NCT00127985|Methylprednisolone|methylprednisolone|mesh-list
65007917|NCT00127985|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65007918|NCT00127985|Prednisolone acetate|prednisolone acetate|mesh-list
65007919|NCT00127985|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65007920|NCT00127985|Prednisolone phosphate|prednisolone phosphate|mesh-list
65007921|NCT00127985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64463075|NCT01518153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65007922|NCT00127985|Glucocorticoids|glucocorticoids|mesh-ancestor
65007923|NCT00127985|Hormones|hormones|mesh-ancestor
65007924|NCT00127985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65007925|NCT00127985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007926|NCT00127985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65007927|NCT00127985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007928|NCT00127985|Antiemetics|antiemetics|mesh-ancestor
65007929|NCT00127985|Autonomic Agents|autonomic agents|mesh-ancestor
65007930|NCT00127985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65007931|NCT00127985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65007932|NCT00127985|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65007933|NCT00127985|Protective Agents|protective agents|mesh-ancestor
65007934|NCT00424164|Tamoxifen|tamoxifen|mesh-list
65007935|NCT00424164|Lapatinib|lapatinib|mesh-list
65007936|NCT00424164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007937|NCT00424164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65007938|NCT00424164|Hormone Antagonists|hormone antagonists|mesh-ancestor
65007970|NCT00424203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007971|NCT00424203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65007972|NCT00424203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65007973|NCT00424203|Alkylating Agents|alkylating agents|mesh-ancestor
65007974|NCT00424203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007975|NCT00424203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007976|NCT00424203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65007977|NCT00424203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65275039|NCT00642252|Fluorides|fluorides|mesh-list
65275040|NCT00642252|Cariostatic Agents|cariostatic agents|mesh-ancestor
65275041|NCT00642252|Protective Agents|protective agents|mesh-ancestor
65275042|NCT00642252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275043|NCT00642330|Ibuprofen|ibuprofen|mesh-list
65275044|NCT00642330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65275045|NCT00642330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65275046|NCT00642330|Analgesics|analgesics|mesh-ancestor
65275047|NCT00642330|Sensory System Agents|sensory system agents|mesh-ancestor
65275048|NCT00642330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65007978|NCT00424203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65007979|NCT00424203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65008013|NCT00499720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65008014|NCT00499720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65008015|NCT05562518|Estrogens|estrogens|mesh-list
65008016|NCT05562518|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65008017|NCT05562518|Hormones|hormones|mesh-ancestor
65008018|NCT05562518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65008019|NCT05562518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008037|NCT00146718|Antimalarials|antimalarials|mesh-ancestor
65008038|NCT00146718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65008039|NCT00146718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65008040|NCT00146718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65008041|NCT00146718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65008042|NCT00146718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008043|NCT00146718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008044|NCT00146718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65008046|NCT00499993|Lanreotide|lanreotide|mesh-list
65008047|NCT00499993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008048|NCT00500188|Imatinib Mesylate|imatinib mesylate|mesh-list
65008049|NCT00500188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008050|NCT00500188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65008051|NCT00500188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008052|NCT00500188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008053|NCT04710914|Midazolam|midazolam|mesh-list
65008054|NCT04710914|Isoflurane|isoflurane|mesh-list
65008055|NCT04710914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65008056|NCT04710914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65008057|NCT04710914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65008058|NCT04710914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008059|NCT04710914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65008060|NCT04710914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65008061|NCT04710914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65008062|NCT04710914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65008063|NCT04710914|Anesthetics, General|anesthetics, general|mesh-ancestor
65008064|NCT04710914|Anesthetics|anesthetics|mesh-ancestor
65008065|NCT04710914|GABA Modulators|gaba modulators|mesh-ancestor
65008066|NCT04710914|GABA Agents|gaba agents|mesh-ancestor
65008067|NCT04710914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65008068|NCT04710914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008069|NCT04710914|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65008070|NCT00500344|Ranibizumab|ranibizumab|mesh-list
65008071|NCT00500344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65008072|NCT00500344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65008073|NCT00500344|Growth Substances|growth substances|mesh-ancestor
65008074|NCT00500344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008075|NCT00500344|Growth Inhibitors|growth inhibitors|mesh-ancestor
65008076|NCT00500344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008077|NCT00146835|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65008078|NCT00146835|Immunologic Factors|immunologic factors|mesh-ancestor
65008079|NCT00146835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008110|NCT01245946|Doxycycline|doxycycline|mesh-list
65008111|NCT01245946|Adapalene|adapalene|mesh-list
65008112|NCT01245946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65008113|NCT01245946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65008114|NCT01245946|Antimalarials|antimalarials|mesh-ancestor
65275049|NCT00642330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275050|NCT00642330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65275051|NCT00642330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65275052|NCT00642330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65275053|NCT00642330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727531|NCT00003266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008115|NCT01245946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65008116|NCT01245946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65008117|NCT01245946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65008118|NCT01245946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65008119|NCT01245946|Analgesics|analgesics|mesh-ancestor
65008120|NCT01245946|Sensory System Agents|sensory system agents|mesh-ancestor
65008121|NCT01245946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65008122|NCT01245946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008123|NCT01245946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65008124|NCT01245946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65008125|NCT01245946|Dermatologic Agents|dermatologic agents|mesh-ancestor
65008151|NCT01246180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008153|NCT01246180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65008154|NCT01246180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65008155|NCT01246180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008156|NCT01246180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008157|NCT01246180|Diuretics|diuretics|mesh-ancestor
65008158|NCT01246180|Natriuretic Agents|natriuretic agents|mesh-ancestor
65008159|NCT01246180|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65008160|NCT01246180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65008161|NCT01246180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65008162|NCT01246180|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65008163|NCT01246180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65008164|NCT05561972|Hyaluronic Acid|hyaluronic acid|mesh-list
65008165|NCT05561972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65008166|NCT05561972|Immunologic Factors|immunologic factors|mesh-ancestor
65008167|NCT05561972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008168|NCT05561972|Viscosupplements|viscosupplements|mesh-ancestor
65008169|NCT05561972|Protective Agents|protective agents|mesh-ancestor
65008170|NCT02274610|Docetaxel|docetaxel|mesh-list
65008171|NCT02274610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008172|NCT02274610|Tubulin Modulators|tubulin modulators|mesh-ancestor
64966889|NCT00176293|Hormones|hormones|mesh-ancestor
65008185|NCT00501397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65008186|NCT00501397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008187|NCT00501397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65008188|NCT00501514|Hormones|hormones|mesh-list
65008189|NCT00501514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65008190|NCT00501514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008191|NCT00147186|Hylan|hylan|mesh-list
65008192|NCT00147186|Viscosupplements|viscosupplements|mesh-ancestor
65008193|NCT00147186|Protective Agents|protective agents|mesh-ancestor
65008194|NCT00147186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008195|NCT00501748|Rituximab|rituximab|mesh-list
65008196|NCT00501748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65008197|NCT00501748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008198|NCT00501748|Immunologic Factors|immunologic factors|mesh-ancestor
65008199|NCT00501748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008200|NCT00501748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65008201|NCT00501787|Metformin|metformin|mesh-list
65008202|NCT00501787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65008203|NCT00501787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008204|NCT00147264|Telmisartan|telmisartan|mesh-list
65008205|NCT00147264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65008206|NCT00147264|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65008207|NCT00147264|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65008208|NCT00147264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008209|NCT00501904|Metformin|metformin|mesh-list
65008210|NCT00501904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65008211|NCT00501904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008212|NCT00501982|Poractant alfa|poractant alfa|mesh-list
65008213|NCT00501982|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
65275054|NCT00642330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275055|NCT02681796|Bupivacaine|bupivacaine|mesh-list
65275056|NCT02681796|Anesthetics, Local|anesthetics, local|mesh-ancestor
65275057|NCT02681796|Anesthetics|anesthetics|mesh-ancestor
65275058|NCT02681796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65275059|NCT02681796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008214|NCT00501982|Respiratory System Agents|respiratory system agents|mesh-ancestor
65008215|NCT00147303|Sarpogrelate|sarpogrelate|mesh-list
65008216|NCT00147303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65008217|NCT00147303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65008218|NCT00147303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008219|NCT00147303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65008220|NCT00147303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65008221|NCT00147303|Serotonin Agents|serotonin agents|mesh-ancestor
65008222|NCT00147303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65008223|NCT00147303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008224|NCT00502060|Cediranib|cediranib|mesh-list
65008225|NCT00502060|Gefitinib|gefitinib|mesh-list
65008226|NCT00502060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008227|NCT00502060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65008228|NCT00502060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008229|NCT00502060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008230|NCT00502099|Interferons|interferons|mesh-list
65008231|NCT00502099|Ribavirin|ribavirin|mesh-list
65008232|NCT00502099|Interferon-alpha|interferon-alpha|mesh-list
65008233|NCT00502099|Interferon alpha-2|interferon alpha-2|mesh-list
65008255|NCT00502411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65008256|NCT00502411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65008257|NCT00502411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008258|NCT00502411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65008259|NCT00502411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65008260|NCT00502411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008261|NCT00502411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008262|NCT00502528|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
65008263|NCT00502528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65008264|NCT00502528|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65008265|NCT00502528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008266|NCT00147381|Alemtuzumab|alemtuzumab|mesh-list
65008267|NCT00147381|Tacrolimus|tacrolimus|mesh-list
65008268|NCT00147381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65008269|NCT00147381|Immunologic Factors|immunologic factors|mesh-ancestor
65008270|NCT00147381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008271|NCT00147381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65008272|NCT00147381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008273|NCT00147381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008274|NCT00147381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65008275|NCT00147381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008276|NCT00502567|Leucovorin|leucovorin|mesh-list
65008277|NCT00502567|Docetaxel|docetaxel|mesh-list
65008278|NCT00502567|Fluorouracil|fluorouracil|mesh-list
65008279|NCT00502567|Oxaliplatin|oxaliplatin|mesh-list
65008280|NCT00502567|Irinotecan|irinotecan|mesh-list
65008281|NCT00502567|Pemetrexed|pemetrexed|mesh-list
65008282|NCT00502567|Cetuximab|cetuximab|mesh-list
65008283|NCT00502567|Cediranib|cediranib|mesh-list
65008284|NCT00502567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008285|NCT00502567|Tubulin Modulators|tubulin modulators|mesh-ancestor
65008286|NCT00502567|Antimitotic Agents|antimitotic agents|mesh-ancestor
65008287|NCT00502567|Mitosis Modulators|mitosis modulators|mesh-ancestor
64966989|NCT00398489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65008319|NCT00502684|Vasodilator Agents|vasodilator agents|mesh-ancestor
65008320|NCT00502684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65008321|NCT00502684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65008322|NCT00502684|Analgesics|analgesics|mesh-ancestor
65008323|NCT00502684|Sensory System Agents|sensory system agents|mesh-ancestor
65008324|NCT00502684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65008325|NCT00502684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65008326|NCT00502684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65008327|NCT00502684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65008328|NCT00502684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65275060|NCT02681796|Sensory System Agents|sensory system agents|mesh-ancestor
65275061|NCT02681796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65275062|NCT02842931|Prednisone|prednisone|mesh-list
65275063|NCT02842931|Cyclophosphamide|cyclophosphamide|mesh-list
65275064|NCT02842931|Doxorubicin|doxorubicin|mesh-list
65275065|NCT02842931|Etoposide|etoposide|mesh-list
65008329|NCT00502684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008364|NCT00503386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65008365|NCT00503386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008366|NCT00503386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65008367|NCT00503386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65008368|NCT00503386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65008369|NCT00503386|Serotonin Agents|serotonin agents|mesh-ancestor
64463522|NCT04629547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65008370|NCT00503386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65008371|NCT00503386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008395|NCT00503542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008397|NCT00503542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65008398|NCT00503542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65008399|NCT00503542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65008400|NCT00503542|Hormone Antagonists|hormone antagonists|mesh-ancestor
65008401|NCT00503542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65008402|NCT00503542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008403|NCT00503542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65008404|NCT00503542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65008405|NCT00147615|Eplerenone|eplerenone|mesh-list
65008406|NCT00147615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65008407|NCT00147615|Hormone Antagonists|hormone antagonists|mesh-ancestor
65008408|NCT00147615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65008409|NCT00147615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008410|NCT00147615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65008411|NCT00147615|Diuretics|diuretics|mesh-ancestor
65008412|NCT00147615|Natriuretic Agents|natriuretic agents|mesh-ancestor
65008413|NCT00147615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65008414|NCT05561036|Doxorubicin|doxorubicin|mesh-list
65008415|NCT05561036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65008416|NCT05561036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008417|NCT05561036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65008418|NCT05561036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65008419|NCT05561036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008420|NCT05561036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008421|NCT01246804|Raltegravir Potassium|raltegravir potassium|mesh-list
65008433|NCT00147654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65008436|NCT00147654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65008437|NCT00147654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008438|NCT00147654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008439|NCT00147654|Urological Agents|urological agents|mesh-ancestor
65008440|NCT00147654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65008441|NCT00147654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65008442|NCT00147654|Cholinergic Agents|cholinergic agents|mesh-ancestor
65008443|NCT01246921|Fluticasone|fluticasone|mesh-list
65008444|NCT01246921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65008445|NCT01246921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65008446|NCT01246921|Autonomic Agents|autonomic agents|mesh-ancestor
65008447|NCT01246921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65008448|NCT01246921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008449|NCT01246921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65008450|NCT01246921|Respiratory System Agents|respiratory system agents|mesh-ancestor
65008451|NCT01246921|Dermatologic Agents|dermatologic agents|mesh-ancestor
65008452|NCT01246921|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65008453|NCT04696939|Carboplatin|carboplatin|mesh-list
65008454|NCT04696939|Etoposide|etoposide|mesh-list
65008455|NCT04696939|Atezolizumab|atezolizumab|mesh-list
65008456|NCT04696939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008457|NCT04696939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65008458|NCT04696939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65008459|NCT04696939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65275066|NCT02842931|Vincristine|vincristine|mesh-list
65275067|NCT02842931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65275068|NCT02842931|Immunologic Factors|immunologic factors|mesh-ancestor
65275069|NCT02842931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727545|NCT00004010|Prednisone|prednisone|mesh-list
65008460|NCT04696939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008461|NCT04696939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008462|NCT05560919|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
65008463|NCT05560919|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
65008464|NCT05560919|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65008465|NCT05560919|Protective Agents|protective agents|mesh-ancestor
65008466|NCT05560919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008467|NCT05560919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65008468|NCT05560919|Antioxidants|antioxidants|mesh-ancestor
65008469|NCT05560919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008470|NCT05560919|Vitamins|vitamins|mesh-ancestor
65008471|NCT05560919|Micronutrients|micronutrients|mesh-ancestor
65008472|NCT05560919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65008473|NCT00503620|Botulinum Toxins|botulinum toxins|mesh-list
65008474|NCT00503620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65008475|NCT00503620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65008476|NCT00503620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65008477|NCT00503620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65008478|NCT00503620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008479|NCT00503620|Cholinergic Agents|cholinergic agents|mesh-ancestor
65008480|NCT00503620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65008481|NCT00503620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008482|NCT00503620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65008483|NCT00503620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65008484|NCT00503659|Methacholine Chloride|methacholine chloride|mesh-list
65008485|NCT00503659|Miotics|miotics|mesh-ancestor
65008503|NCT04063163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008504|NCT04063163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008505|NCT00503815|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65008507|NCT00503815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65008509|NCT01247077|Antioxidants|antioxidants|mesh-ancestor
65008510|NCT01247077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008511|NCT01247077|Protective Agents|protective agents|mesh-ancestor
65008512|NCT01247077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008513|NCT01247077|Trace Elements|trace elements|mesh-ancestor
65008514|NCT01247077|Micronutrients|micronutrients|mesh-ancestor
65008515|NCT03990467|Tazobactam|tazobactam|mesh-list
65008516|NCT03990467|Piperacillin|piperacillin|mesh-list
65008517|NCT03990467|Amikacin|amikacin|mesh-list
65008518|NCT03990467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65008519|NCT03990467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65008520|NCT03990467|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64463671|NCT01890265|Pirfenidone|pirfenidone|mesh-list
65008521|NCT03990467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008522|NCT03990467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008523|NCT01247311|Vitamin D|vitamin d|mesh-list
65008524|NCT01247311|Ergocalciferols|ergocalciferols|mesh-list
65008525|NCT01247311|Cholecalciferol|cholecalciferol|mesh-list
65008526|NCT01247311|Vitamins|vitamins|mesh-list
65008527|NCT01247311|Micronutrients|micronutrients|mesh-ancestor
65008528|NCT01247311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008529|NCT01247311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65008530|NCT01247311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65008531|NCT00147771|Imiquimod|imiquimod|mesh-list
65008532|NCT00147771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65008533|NCT00147771|Immunologic Factors|immunologic factors|mesh-ancestor
65008534|NCT00147771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008535|NCT00147771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008536|NCT00147771|Interferon Inducers|interferon inducers|mesh-ancestor
65008537|NCT00503932|Capecitabine|capecitabine|mesh-list
65008538|NCT00503932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65008539|NCT00503932|Antimetabolites|antimetabolites|mesh-ancestor
65008540|NCT00503932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008541|NCT00503932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008542|NCT03981146|Nivolumab|nivolumab|mesh-list
64967237|NCT00179257|Serotonin Agents|serotonin agents|mesh-ancestor
65008560|NCT04331730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275070|NCT02842931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65275071|NCT02842931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65275072|NCT02842931|Alkylating Agents|alkylating agents|mesh-ancestor
65275073|NCT02842931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008561|NCT01248091|Nitroprusside|nitroprusside|mesh-list
65008562|NCT01248091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65008563|NCT01248091|Vasodilator Agents|vasodilator agents|mesh-ancestor
65008564|NCT01248091|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65008565|NCT01248091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008566|NCT00503971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65008567|NCT00503971|Vorinostat|vorinostat|mesh-list
65008568|NCT00503971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008569|NCT00503971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65008570|NCT00503971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008571|NCT00503971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008572|NCT00503971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65008573|NCT01248325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65008574|NCT02274961|Pantoprazole|pantoprazole|mesh-list
65008575|NCT02274961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65008576|NCT02274961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65008577|NCT02274961|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65008578|NCT02274961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008579|NCT02274961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008580|NCT02275039|Gemcitabine|gemcitabine|mesh-list
65008581|NCT02275039|Vaccines|vaccines|mesh-list
65008583|NCT02275039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008584|NCT02275039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65008585|NCT02275039|Antimetabolites|antimetabolites|mesh-ancestor
65008586|NCT02275039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008587|NCT02275039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008588|NCT02275039|Antiviral Agents|antiviral agents|mesh-ancestor
65008589|NCT02275039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65008590|NCT02275039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008591|NCT02275039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65008592|NCT04263051|Nivolumab|nivolumab|mesh-list
65008593|NCT04263051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65008594|NCT04263051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463752|NCT03088540|Antimetabolites|antimetabolites|mesh-ancestor
65008595|NCT04263051|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65008596|NCT04263051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008597|NCT01248403|Paclitaxel|paclitaxel|mesh-list
65008598|NCT01248403|Everolimus|everolimus|mesh-list
65008612|NCT01248442|Vitamins|vitamins|mesh-ancestor
65008613|NCT01248442|Micronutrients|micronutrients|mesh-ancestor
65008614|NCT01248442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65008615|NCT01248481|Acarbose|acarbose|mesh-list
65008616|NCT01248481|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65008617|NCT01248481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008618|NCT01248481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008619|NCT01248481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65008620|NCT01248481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008621|NCT01249339|Lobeline|lobeline|mesh-list
65008622|NCT01249339|Nicotine|nicotine|mesh-list
65008623|NCT01249339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65008624|NCT01249339|Autonomic Agents|autonomic agents|mesh-ancestor
65008625|NCT01249339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65008626|NCT01249339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008627|NCT01249339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65008628|NCT01249339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65008629|NCT01249339|Cholinergic Agents|cholinergic agents|mesh-ancestor
65008630|NCT01249339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65008631|NCT01249339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008632|NCT01249339|Respiratory System Agents|respiratory system agents|mesh-ancestor
65008633|NCT03809429|Cetrorelix|cetrorelix|mesh-list
65008634|NCT03809429|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65008635|NCT03809429|Hormones|hormones|mesh-ancestor
65008636|NCT03809429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65008637|NCT03809429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008638|NCT03809429|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65008639|NCT03809429|Fertility Agents|fertility agents|mesh-ancestor
65275074|NCT02842931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275075|NCT02842931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65275076|NCT02842931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65275077|NCT02842931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65275078|NCT02842931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65275079|NCT02842931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275080|NCT02842931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65275081|NCT02842931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65008640|NCT03809429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65008641|NCT03809429|Hormone Antagonists|hormone antagonists|mesh-ancestor
65008642|NCT00504127|Naproxen|naproxen|mesh-list
65008643|NCT00504127|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
65008644|NCT00504127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65008645|NCT00504127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65008646|NCT00504127|Analgesics|analgesics|mesh-ancestor
65008647|NCT00504127|Sensory System Agents|sensory system agents|mesh-ancestor
65008648|NCT00504127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65008649|NCT00504127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008650|NCT00504127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65008651|NCT00504127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65008652|NCT00504127|Gout Suppressants|gout suppressants|mesh-ancestor
65008653|NCT00504127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65008654|NCT00504127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008655|NCT00504127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008656|NCT00504127|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65008657|NCT04088292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65008658|NCT04088292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65008672|NCT01249690|BB 1101|bb 1101|mesh-list
65008673|NCT01249690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65008674|NCT01249690|Antiemetics|antiemetics|mesh-ancestor
65008675|NCT01249690|Autonomic Agents|autonomic agents|mesh-ancestor
65008676|NCT01249690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65008677|NCT01249690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008678|NCT01249690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65008679|NCT01249690|Glucocorticoids|glucocorticoids|mesh-ancestor
65008680|NCT01249690|Hormones|hormones|mesh-ancestor
65008681|NCT01249690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65008682|NCT01249690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65008683|NCT01249690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008684|NCT01249690|Protease Inhibitors|protease inhibitors|mesh-ancestor
65008685|NCT01249690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008686|NCT01249690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008687|NCT01249690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65008688|NCT01249690|Immunologic Factors|immunologic factors|mesh-ancestor
65008689|NCT01249690|Leprostatic Agents|leprostatic agents|mesh-ancestor
65008690|NCT01249690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65008691|NCT01249690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65008692|NCT01249690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65008693|NCT01249690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65008694|NCT01249690|Growth Substances|growth substances|mesh-ancestor
65008695|NCT01249690|Growth Inhibitors|growth inhibitors|mesh-ancestor
65008696|NCT01249690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65008697|NCT01249690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65008698|NCT01249690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65008699|NCT03712826|Ustekinumab|ustekinumab|mesh-list
65008700|NCT03712826|Dermatologic Agents|dermatologic agents|mesh-ancestor
65008701|NCT01249846|Chlorhexidine|chlorhexidine|mesh-list
65008702|NCT01249846|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65008703|NCT01249846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65008704|NCT01249846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65008705|NCT01249846|Disinfectants|disinfectants|mesh-ancestor
65008706|NCT01249846|Dermatologic Agents|dermatologic agents|mesh-ancestor
65008707|NCT00504244|Mycophenolic Acid|mycophenolic acid|mesh-list
65008708|NCT00504244|Azathioprine|azathioprine|mesh-list
65008709|NCT00504244|Antimetabolites|antimetabolites|mesh-ancestor
65008710|NCT00504244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275082|NCT02842931|Glucocorticoids|glucocorticoids|mesh-ancestor
65275083|NCT02842931|Hormones|hormones|mesh-ancestor
65275084|NCT02842931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65275085|NCT02842931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65008711|NCT00504244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65008712|NCT00504244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008713|NCT00504244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65008714|NCT00504244|Immunologic Factors|immunologic factors|mesh-ancestor
65008715|NCT00504244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008716|NCT00504244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65008717|NCT00504244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65008718|NCT00504244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65008719|NCT00504244|Antitubercular Agents|antitubercular agents|mesh-ancestor
65008720|NCT00504244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65008721|NCT00504244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65008741|NCT00504283|Analgesics|analgesics|mesh-ancestor
65008742|NCT00504283|Sensory System Agents|sensory system agents|mesh-ancestor
65008743|NCT00504283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65008744|NCT00504283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65008745|NCT00504283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65008746|NCT00504283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65008748|NCT00504283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65008749|NCT00504283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008750|NCT00504283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008751|NCT00504400|Ranibizumab|ranibizumab|mesh-list
65008752|NCT00504400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65008753|NCT00504400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65008754|NCT00504400|Growth Substances|growth substances|mesh-ancestor
65008755|NCT00504400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008756|NCT00504400|Growth Inhibitors|growth inhibitors|mesh-ancestor
65008757|NCT00504400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008758|NCT00504439|Simvastatin|simvastatin|mesh-list
65008759|NCT00504439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65008760|NCT00504439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65008761|NCT00504439|Antimetabolites|antimetabolites|mesh-ancestor
65008762|NCT00504439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008763|NCT00504439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65008764|NCT00504439|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65008765|NCT00504439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008766|NCT04054830|Diclofenac|diclofenac|mesh-list
65008767|NCT04054830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65008768|NCT04054830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65008769|NCT04054830|Analgesics|analgesics|mesh-ancestor
65008770|NCT04054830|Sensory System Agents|sensory system agents|mesh-ancestor
65008771|NCT04054830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65008772|NCT04054830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008773|NCT04054830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65008774|NCT04054830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65008775|NCT04054830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65008776|NCT04054830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008777|NCT04054830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008778|NCT03622775|Daratumumab|daratumumab|mesh-list
65008796|NCT01249417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65008797|NCT01249417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65008798|NCT01249417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008799|NCT01249417|Cholinergic Agents|cholinergic agents|mesh-ancestor
65008800|NCT01249417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65008801|NCT01249417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008802|NCT01249417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65008803|NCT01249417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65008805|NCT00403325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65008806|NCT00403325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65008807|NCT00403325|Growth Substances|growth substances|mesh-ancestor
65008808|NCT00403325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008809|NCT00403325|Growth Inhibitors|growth inhibitors|mesh-ancestor
65008810|NCT00403325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008811|NCT04725747|Midazolam|midazolam|mesh-list
65008812|NCT04725747|Ketamine|ketamine|mesh-list
65008813|NCT04725747|Analgesics|analgesics|mesh-ancestor
65275086|NCT02842931|Tubulin Modulators|tubulin modulators|mesh-ancestor
65275087|NCT02842931|Antimitotic Agents|antimitotic agents|mesh-ancestor
65275088|NCT02842931|Mitosis Modulators|mitosis modulators|mesh-ancestor
65275089|NCT04183296|Propofol|propofol|mesh-list
65008814|NCT04725747|Sensory System Agents|sensory system agents|mesh-ancestor
65008815|NCT04725747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65008816|NCT04725747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463975|NCT05608564|Amoxicillin|amoxicillin|mesh-list
65008817|NCT04725747|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65008818|NCT04725747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65008819|NCT04725747|Anesthetics, General|anesthetics, general|mesh-ancestor
65008820|NCT04725747|Anesthetics|anesthetics|mesh-ancestor
65008821|NCT04725747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65008822|NCT04725747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65008823|NCT04725747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65008824|NCT04725747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65008825|NCT04725747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008826|NCT04725747|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65008827|NCT04725747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65008828|NCT04725747|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65008829|NCT04725747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65008830|NCT04725747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65008831|NCT04725747|GABA Modulators|gaba modulators|mesh-ancestor
65008832|NCT04725747|GABA Agents|gaba agents|mesh-ancestor
65008833|NCT03546686|Nivolumab|nivolumab|mesh-list
65008834|NCT03546686|Ipilimumab|ipilimumab|mesh-list
65008835|NCT03546686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65008836|NCT03546686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008837|NCT03546686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65008847|NCT04725942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008848|NCT04725942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008849|NCT04725942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65008850|NCT04725942|Hormone Antagonists|hormone antagonists|mesh-ancestor
65008851|NCT04725942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65008852|NCT04725942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008853|NCT01249261|Risedronic Acid|risedronic acid|mesh-list
65008854|NCT01249261|Etidronic Acid|etidronic acid|mesh-list
65008855|NCT01249261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65008856|NCT01249261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65008857|NCT01249261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008858|NCT01249261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65008859|NCT01249261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008860|NCT01249261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65008861|NCT03890952|Bevacizumab|bevacizumab|mesh-list
65008862|NCT03890952|Nivolumab|nivolumab|mesh-list
65008863|NCT03890952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
65008864|NCT03890952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65008865|NCT03890952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008866|NCT03890952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65008867|NCT03890952|Growth Substances|growth substances|mesh-ancestor
65008868|NCT03890952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008869|NCT03890952|Growth Inhibitors|growth inhibitors|mesh-ancestor
65008870|NCT03890952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65008871|NCT03890952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008872|NCT03868722|Venetoclax|venetoclax|mesh-list
65008873|NCT03868722|Acalabrutinib|acalabrutinib|mesh-list
65008874|NCT03868722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008875|NCT03761511|Niacinamide|niacinamide|mesh-list
65008877|NCT03761511|Nicotinic Acids|nicotinic acids|mesh-list
65008878|NCT03761511|Vitamin B Complex|vitamin b complex|mesh-ancestor
65008879|NCT03761511|Vitamins|vitamins|mesh-ancestor
65008880|NCT03761511|Micronutrients|micronutrients|mesh-ancestor
65008881|NCT03761511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008882|NCT03761511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65008883|NCT03761511|Antimetabolites|antimetabolites|mesh-ancestor
65008884|NCT03761511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008885|NCT03761511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65008886|NCT03761511|Vasodilator Agents|vasodilator agents|mesh-ancestor
65008887|NCT02952092|Darbepoetin alfa|darbepoetin alfa|mesh-list
65008888|NCT02952092|Hematinics|hematinics|mesh-ancestor
65008889|NCT00139152|Omalizumab|omalizumab|mesh-list
65008890|NCT00139152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65275090|NCT04183296|Sevoflurane|sevoflurane|mesh-list
65275091|NCT04183296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65275092|NCT04183296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65275093|NCT04183296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275094|NCT04183296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65008891|NCT00139152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65008892|NCT00139152|Respiratory System Agents|respiratory system agents|mesh-ancestor
65008893|NCT02824523|Aspirin|aspirin|mesh-list
65008894|NCT02824523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65008895|NCT02824523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65008896|NCT02824523|Analgesics|analgesics|mesh-ancestor
65008897|NCT02824523|Sensory System Agents|sensory system agents|mesh-ancestor
65008898|NCT02824523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65008899|NCT02824523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008900|NCT02824523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65008901|NCT02824523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65008902|NCT02824523|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65008920|NCT03721497|Androgens|androgens|mesh-ancestor
65008921|NCT03721497|Hormones|hormones|mesh-ancestor
65008922|NCT03721497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65008923|NCT03721497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008924|NCT03721497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65008925|NCT03721497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008926|NCT03721497|Anabolic Agents|anabolic agents|mesh-ancestor
65008927|NCT03682029|Ascorbic Acid|ascorbic acid|mesh-list
65008928|NCT03682029|Vitamins|vitamins|mesh-ancestor
65008929|NCT03682029|Micronutrients|micronutrients|mesh-ancestor
65008930|NCT03682029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008931|NCT03682029|Antioxidants|antioxidants|mesh-ancestor
65008932|NCT03682029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008933|NCT03682029|Protective Agents|protective agents|mesh-ancestor
65008934|NCT00139230|Leucovorin|leucovorin|mesh-list
65008935|NCT00139230|Ciprofloxacin|ciprofloxacin|mesh-list
65008936|NCT00139230|Fluorouracil|fluorouracil|mesh-list
65008937|NCT00139230|Docetaxel|docetaxel|mesh-list
65008938|NCT00139230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008939|NCT00139230|Antimetabolites|antimetabolites|mesh-ancestor
65008940|NCT00139230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008941|NCT00139230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65008942|NCT00139230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65008943|NCT00139230|Immunologic Factors|immunologic factors|mesh-ancestor
65008944|NCT00139230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008945|NCT00139230|Antidotes|antidotes|mesh-ancestor
65008946|NCT00139230|Protective Agents|protective agents|mesh-ancestor
65008947|NCT00139230|Vitamin B Complex|vitamin b complex|mesh-ancestor
65008948|NCT00139230|Vitamins|vitamins|mesh-ancestor
65008949|NCT00139230|Micronutrients|micronutrients|mesh-ancestor
65008950|NCT00139230|Tubulin Modulators|tubulin modulators|mesh-ancestor
65008951|NCT00139230|Antimitotic Agents|antimitotic agents|mesh-ancestor
65008952|NCT00139230|Mitosis Modulators|mitosis modulators|mesh-ancestor
65008953|NCT00139230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65008954|NCT00139230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65008955|NCT00139230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65008956|NCT00139230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65008957|NCT00139230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008958|NCT00139230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65008959|NCT00139230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65008960|NCT03648996|Allopurinol|allopurinol|mesh-list
65008961|NCT03648996|Antimetabolites|antimetabolites|mesh-ancestor
65008962|NCT03648996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008963|NCT03648996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008998|NCT00403364|Amoxicillin|amoxicillin|mesh-list
65008999|NCT00403364|Clarithromycin|clarithromycin|mesh-list
65009000|NCT00403364|Tinidazole|tinidazole|mesh-list
65009001|NCT00403364|Pantoprazole|pantoprazole|mesh-list
65009002|NCT00403364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65009003|NCT00403364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65009004|NCT00403364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65009005|NCT00403364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967704|NCT00183742|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65009019|NCT00403442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275095|NCT04183296|Anesthetics, General|anesthetics, general|mesh-ancestor
65275096|NCT04183296|Anesthetics|anesthetics|mesh-ancestor
65275097|NCT04183296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65275098|NCT04183296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65275099|NCT00642408|Micronutrients|micronutrients|mesh-list
65275100|NCT00642408|Trace Elements|trace elements|mesh-list
65275101|NCT00642408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275102|NCT02678598|Micafungin|micafungin|mesh-list
65275103|NCT02678598|Antifungal Agents|antifungal agents|mesh-ancestor
65275104|NCT02678598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65275105|NCT02359019|Pembrolizumab|pembrolizumab|mesh-list
65275106|NCT02359019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65009020|NCT00403442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65009021|NCT00403442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65009022|NCT00403442|Growth Substances|growth substances|mesh-ancestor
65009023|NCT00403442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009024|NCT00403442|Growth Inhibitors|growth inhibitors|mesh-ancestor
65009025|NCT00403442|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65009026|NCT00403442|Dermatologic Agents|dermatologic agents|mesh-ancestor
65009027|NCT00139386|Candesartan|candesartan|mesh-list
65009028|NCT00139386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65009029|NCT00139386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65009030|NCT00139386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65009031|NCT00139386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009032|NCT00402974|Vitamin K 2|vitamin k 2|mesh-list
65009033|NCT00402974|Vitamin K|vitamin k|mesh-list
65009034|NCT00402974|Vitamin MK 7|vitamin mk 7|mesh-list
65009035|NCT00402974|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65009036|NCT00402974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65009037|NCT00402974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009038|NCT00402974|Hemostatics|hemostatics|mesh-ancestor
65009039|NCT00402974|Coagulants|coagulants|mesh-ancestor
65009040|NCT00402974|Vitamins|vitamins|mesh-ancestor
65009041|NCT00402974|Micronutrients|micronutrients|mesh-ancestor
65009042|NCT00402974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009043|NCT01731236|Aspirin|aspirin|mesh-list
65009044|NCT01731236|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65009045|NCT01731236|Vancomycin|vancomycin|mesh-list
65009046|NCT01731236|Ciprofloxacin|ciprofloxacin|mesh-list
65009047|NCT01731236|Neomycin|neomycin|mesh-list
65009048|NCT01731236|Choline|choline|mesh-list
65009049|NCT01731236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65009050|NCT01731236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65009051|NCT01731236|Analgesics|analgesics|mesh-ancestor
65009052|NCT01731236|Sensory System Agents|sensory system agents|mesh-ancestor
65009053|NCT01731236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65009054|NCT01731236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009055|NCT01731236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65009056|NCT01731236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65009057|NCT01731236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65009058|NCT01731236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65009059|NCT01731236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009060|NCT01731236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65009061|NCT01731236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65009062|NCT01731236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009063|NCT01731236|Antipyretics|antipyretics|mesh-ancestor
65009064|NCT01731236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65009065|NCT01731236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65009066|NCT01731236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65009067|NCT01731236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009078|NCT03510078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65009079|NCT03510078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009080|NCT00139581|Pimecrolimus|pimecrolimus|mesh-list
65009081|NCT00139581|Tacrolimus|tacrolimus|mesh-list
65009082|NCT00139581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65009083|NCT00139581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65275107|NCT02359019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275108|NCT02678364|Vitamin D|vitamin d|mesh-list
65275109|NCT02678364|Cholecalciferol|cholecalciferol|mesh-list
65275110|NCT02678364|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65275111|NCT02678364|Calcifediol|calcifediol|mesh-list
65275112|NCT02678364|Vitamins|vitamins|mesh-ancestor
65275113|NCT02678364|Micronutrients|micronutrients|mesh-ancestor
64727592|NCT00381901|Trastuzumab|trastuzumab|mesh-list
65009084|NCT00139581|Analgesics|analgesics|mesh-ancestor
65009085|NCT00139581|Sensory System Agents|sensory system agents|mesh-ancestor
65009086|NCT00139581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65009087|NCT00139581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009088|NCT00139581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65009089|NCT00139581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65009090|NCT00139581|Dermatologic Agents|dermatologic agents|mesh-ancestor
65009091|NCT00139581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65009092|NCT00139581|Immunologic Factors|immunologic factors|mesh-ancestor
65009093|NCT00139581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65009094|NCT00139581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009095|NCT00139581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009096|NCT03500913|Hormones|hormones|mesh-list
65009097|NCT03500913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65009098|NCT03500913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009099|NCT00139620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65009100|NCT00139620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009101|NCT00139620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65009102|NCT00139620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009103|NCT00139620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009104|NCT00130481|Atorvastatin|atorvastatin|mesh-list
65009105|NCT00130481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65009106|NCT00130481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65009107|NCT00130481|Antimetabolites|antimetabolites|mesh-ancestor
65009108|NCT00130481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009109|NCT00130481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65009110|NCT00130481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65009111|NCT00130481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009112|NCT00139698|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65009113|NCT00139698|Olmesartan|olmesartan|mesh-list
65009114|NCT00139698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65009115|NCT00139698|Diuretics|diuretics|mesh-ancestor
65009116|NCT00139698|Natriuretic Agents|natriuretic agents|mesh-ancestor
65009117|NCT00139698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009118|NCT00139698|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65009119|NCT00139698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65009120|NCT00139698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009121|NCT00139698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65009122|NCT00139698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65009123|NCT00130676|Mifepristone|mifepristone|mesh-list
65009124|NCT00130676|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65009125|NCT00130676|Abortifacient Agents|abortifacient agents|mesh-ancestor
65009126|NCT00130676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65009127|NCT00130676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009128|NCT00130676|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65009129|NCT00130676|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65009130|NCT00130676|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65009149|NCT00404274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009151|NCT00130754|Immunologic Factors|immunologic factors|mesh-ancestor
65009152|NCT00130754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009153|NCT00130754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65009154|NCT00130871|Simendan|simendan|mesh-list
65009155|NCT00130871|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65009156|NCT00130871|Vasodilator Agents|vasodilator agents|mesh-ancestor
65009157|NCT00130871|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65009158|NCT00130871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65009159|NCT00130871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009160|NCT00130871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275114|NCT02678364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275115|NCT02678364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65275116|NCT02678364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65275117|NCT02678208|Tranexamic Acid|tranexamic acid|mesh-list
65275118|NCT02678208|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65275119|NCT02678208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64727595|NCT00003278|Dexamethasone|dexamethasone|mesh-list
65009161|NCT00130871|Protective Agents|protective agents|mesh-ancestor
65009162|NCT00130871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009163|NCT00130910|Albendazole|albendazole|mesh-list
65009164|NCT00130910|Anthelmintics|anthelmintics|mesh-ancestor
65009165|NCT00130910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65009166|NCT00130910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65009167|NCT00130910|Anticestodal Agents|anticestodal agents|mesh-ancestor
65009168|NCT00130910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65009169|NCT00130910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65009170|NCT00130910|Tubulin Modulators|tubulin modulators|mesh-ancestor
65009171|NCT00130910|Antimitotic Agents|antimitotic agents|mesh-ancestor
65009172|NCT00130910|Mitosis Modulators|mitosis modulators|mesh-ancestor
65009173|NCT00130910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009174|NCT00130910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009175|NCT03226821|Tesamorelin|tesamorelin|mesh-list
65009176|NCT03226821|Growth Substances|growth substances|mesh-ancestor
65009177|NCT03226821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009178|NCT00139815|Enoxaparin|enoxaparin|mesh-list
65009179|NCT00139815|PENTA|penta|mesh-list
65009180|NCT00139815|Fondaparinux|fondaparinux|mesh-list
65009182|NCT00139815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65009183|NCT00139815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65009184|NCT00139815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009185|NCT00139815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65009186|NCT00139815|Antithrombins|antithrombins|mesh-ancestor
64967875|NCT00184795|Estrogens|estrogens|mesh-ancestor
65009214|NCT00131027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65009215|NCT00131027|Glucocorticoids|glucocorticoids|mesh-ancestor
65009217|NCT00131027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65009218|NCT00131027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65009219|NCT00131027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65009220|NCT00131027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65009221|NCT00131027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65009222|NCT00131027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009223|NCT00131027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65009224|NCT00131027|Abortifacient Agents|abortifacient agents|mesh-ancestor
65009225|NCT00131027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65009226|NCT00131027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65009227|NCT00131027|Antimetabolites|antimetabolites|mesh-ancestor
65009228|NCT00131027|Dermatologic Agents|dermatologic agents|mesh-ancestor
65009229|NCT00131027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65009230|NCT00131027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65009231|NCT00131027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65009232|NCT00131027|Antiviral Agents|antiviral agents|mesh-ancestor
65009233|NCT00131027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65009234|NCT00131027|Tubulin Modulators|tubulin modulators|mesh-ancestor
65009235|NCT00131027|Antimitotic Agents|antimitotic agents|mesh-ancestor
65009254|NCT00139893|Autonomic Agents|autonomic agents|mesh-ancestor
65009255|NCT00139893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65009256|NCT00139893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009257|NCT00139893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65009258|NCT00139893|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65009259|NCT00139893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65009260|NCT00139893|Dopamine Agents|dopamine agents|mesh-ancestor
65009261|NCT00139893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65009262|NCT00139893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009263|NCT00131183|Testosterone undecanoate|testosterone undecanoate|mesh-list
65009264|NCT00131183|Androgens|androgens|mesh-ancestor
65009265|NCT00131183|Hormones|hormones|mesh-ancestor
65009266|NCT00131183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65275120|NCT02678208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275121|NCT02678208|Hemostatics|hemostatics|mesh-ancestor
65275122|NCT02678208|Coagulants|coagulants|mesh-ancestor
65275123|NCT05551182|Nicergoline|nicergoline|mesh-list
65275124|NCT05551182|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65275125|NCT05551182|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65275126|NCT05551182|Adrenergic Agents|adrenergic agents|mesh-ancestor
65275127|NCT05551182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65275128|NCT05551182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275129|NCT05551182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275130|NCT05551182|Vasodilator Agents|vasodilator agents|mesh-ancestor
65275131|NCT05551182|Nootropic Agents|nootropic agents|mesh-ancestor
65275132|NCT02677584|Caffeine|caffeine|mesh-list
65275133|NCT02677584|Caffeine citrate|caffeine citrate|mesh-list
65275134|NCT02677584|Citric Acid|citric acid|mesh-list
65275135|NCT02677584|Sodium Citrate|sodium citrate|mesh-list
65275136|NCT02677584|Anticoagulants|anticoagulants|mesh-ancestor
65275137|NCT02677584|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65275138|NCT02677584|Chelating Agents|chelating agents|mesh-ancestor
65275139|NCT02677584|Sequestering Agents|sequestering agents|mesh-ancestor
64727600|NCT00003278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009267|NCT00131183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009268|NCT00139932|Formoterol Fumarate|formoterol fumarate|mesh-list
65009269|NCT00139932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65009270|NCT00139932|Autonomic Agents|autonomic agents|mesh-ancestor
65009271|NCT00139932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65009272|NCT00139932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009273|NCT00139932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65009274|NCT00139932|Respiratory System Agents|respiratory system agents|mesh-ancestor
65009275|NCT00139932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65009276|NCT00139932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65009277|NCT00139932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65009278|NCT00139932|Adrenergic Agents|adrenergic agents|mesh-ancestor
65009279|NCT00139932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65009280|NCT00139932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009282|NCT00131261|Belinostat|belinostat|mesh-list
65009283|NCT00131261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65009284|NCT00131261|Antiemetics|antiemetics|mesh-ancestor
65009285|NCT00131261|Autonomic Agents|autonomic agents|mesh-ancestor
65009286|NCT00131261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65009287|NCT00131261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009288|NCT00131261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65009289|NCT00131261|Glucocorticoids|glucocorticoids|mesh-ancestor
65009290|NCT00131261|Hormones|hormones|mesh-ancestor
65009291|NCT00131261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65009292|NCT00131261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65009293|NCT00131261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009317|NCT00139971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009318|NCT00139971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65009319|NCT00139971|Immunologic Factors|immunologic factors|mesh-ancestor
65009320|NCT00139971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009321|NCT00140010|Epoetin Alfa|epoetin alfa|mesh-list
65009322|NCT00140010|Hematinics|hematinics|mesh-ancestor
65009323|NCT00131495|Testosterone|testosterone|mesh-list
65009324|NCT00131495|Androgens|androgens|mesh-ancestor
65009325|NCT00131495|Hormones|hormones|mesh-ancestor
65275140|NCT02677584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275141|NCT02677584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65275142|NCT02677584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275143|NCT02677584|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64727621|NCT00003554|Glucocorticoids|glucocorticoids|mesh-ancestor
65009326|NCT00131495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65009327|NCT00131495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009328|NCT04726631|Insulin|insulin|mesh-list
65009329|NCT04726631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65009330|NCT04726631|Insulin, Short-Acting|insulin, short-acting|mesh-list
65009331|NCT04726631|Protamines|protamines|mesh-list
65009332|NCT04726631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65009333|NCT04726631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009334|NCT04726631|Heparin Antagonists|heparin antagonists|mesh-ancestor
65009335|NCT04726631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009336|NCT04726631|Coagulants|coagulants|mesh-ancestor
65009337|NCT02957760|Hydroxyurea|hydroxyurea|mesh-list
65009338|NCT02957760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009339|NCT02957760|Antisickling Agents|antisickling agents|mesh-ancestor
65009340|NCT02957760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009341|NCT02957760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009342|NCT02957760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65009343|NCT03117309|Nivolumab|nivolumab|mesh-list
65009344|NCT03117309|Ipilimumab|ipilimumab|mesh-list
65009345|NCT03117309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65009372|NCT01248949|Carboplatin|carboplatin|mesh-list
65009373|NCT01248949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65009374|NCT01248949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009375|NCT01248949|Tubulin Modulators|tubulin modulators|mesh-ancestor
65009376|NCT01248949|Antimitotic Agents|antimitotic agents|mesh-ancestor
65009377|NCT01248949|Mitosis Modulators|mitosis modulators|mesh-ancestor
65009378|NCT01248949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009379|NCT01248949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65009380|NCT01248949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65009381|NCT01248949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65009382|NCT01248949|Growth Substances|growth substances|mesh-ancestor
65009383|NCT01248949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009384|NCT01248949|Growth Inhibitors|growth inhibitors|mesh-ancestor
65009385|NCT00403637|Maleic acid|maleic acid|mesh-list
65009386|NCT00403637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009387|NCT00403637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009388|NCT04696666|Hyaluronic Acid|hyaluronic acid|mesh-list
65009389|NCT04696666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65009390|NCT04696666|Immunologic Factors|immunologic factors|mesh-ancestor
65009391|NCT04696666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009392|NCT04696666|Viscosupplements|viscosupplements|mesh-ancestor
65009393|NCT04696666|Protective Agents|protective agents|mesh-ancestor
65009394|NCT01248793|Golimumab|golimumab|mesh-list
65009395|NCT01248793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65009396|NCT01248793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65009397|NCT01248793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65009420|NCT00140361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65009421|NCT00140361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65009422|NCT00140361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65009423|NCT00140361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009424|NCT00140361|Antiviral Agents|antiviral agents|mesh-ancestor
65009425|NCT00140361|Schistosomicides|schistosomicides|mesh-ancestor
65009426|NCT00140361|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65009427|NCT00140361|Anthelmintics|anthelmintics|mesh-ancestor
65009428|NCT00140361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65009429|NCT00140361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009430|NCT00140361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009431|NCT00140361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65009432|NCT00140361|Renal Agents|renal agents|mesh-ancestor
65009433|NCT00131846|Diuretics|diuretics|mesh-list
65009434|NCT00131846|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
65009435|NCT00131846|Natriuretic Agents|natriuretic agents|mesh-ancestor
65009436|NCT00131846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275144|NCT02677584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275145|NCT02677584|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65275146|NCT02677584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65275147|NCT02677584|Purinergic Agents|purinergic agents|mesh-ancestor
65275148|NCT02677584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65275149|NCT05662956|Azacitidine|azacitidine|mesh-list
65009437|NCT00131846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65009438|NCT00131846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009439|NCT00131963|Paclitaxel|paclitaxel|mesh-list
65009440|NCT00131963|Cyclophosphamide|cyclophosphamide|mesh-list
65009441|NCT00131963|Doxorubicin|doxorubicin|mesh-list
65009442|NCT00131963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65009443|NCT00131963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009444|NCT00131963|Tubulin Modulators|tubulin modulators|mesh-ancestor
65009445|NCT00131963|Antimitotic Agents|antimitotic agents|mesh-ancestor
65009446|NCT00131963|Mitosis Modulators|mitosis modulators|mesh-ancestor
65009447|NCT00131963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009448|NCT00131963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65009449|NCT00131963|Immunologic Factors|immunologic factors|mesh-ancestor
65009450|NCT00131963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009459|NCT00132119|Nalmefene|nalmefene|mesh-list
65009460|NCT00132119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65009461|NCT00132119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009462|NCT00132119|Sensory System Agents|sensory system agents|mesh-ancestor
65009463|NCT00132119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65009464|NCT00132158|Irinotecan|irinotecan|mesh-list
65009465|NCT00132158|Gefitinib|gefitinib|mesh-list
65009466|NCT00132158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65009467|NCT00132158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65009468|NCT00132158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009469|NCT00132158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009470|NCT00132158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009471|NCT00132158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65009472|NCT00140478|Mifepristone|mifepristone|mesh-list
65009473|NCT00140478|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65009474|NCT00140478|Abortifacient Agents|abortifacient agents|mesh-ancestor
65009475|NCT00140478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65009476|NCT00140478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009477|NCT00140478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65009478|NCT00140478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65009479|NCT00140478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65009480|NCT00140478|Contraceptive Agents|contraceptive agents|mesh-ancestor
65009481|NCT00140478|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65009482|NCT00140478|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65009483|NCT00140478|Hormone Antagonists|hormone antagonists|mesh-ancestor
65009484|NCT00140478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65009485|NCT00140478|Luteolytic Agents|luteolytic agents|mesh-ancestor
65009486|NCT00140478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65009487|NCT00140478|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65009488|NCT00140517|Chloroquine|chloroquine|mesh-list
65009489|NCT00140517|Pyrimethamine|pyrimethamine|mesh-list
65009490|NCT00140517|Sulfadoxine|sulfadoxine|mesh-list
65009491|NCT00140517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65009492|NCT00140517|Amebicides|amebicides|mesh-ancestor
65009493|NCT00140517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65009494|NCT00140517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65009495|NCT00140517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65009496|NCT00140517|Antimalarials|antimalarials|mesh-ancestor
65009497|NCT00140517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64464667|NCT02769520|Pembrolizumab|pembrolizumab|mesh-list
65009498|NCT00140517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65009500|NCT00140517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009501|NCT00140517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65009502|NCT00140517|Renal Agents|renal agents|mesh-ancestor
65009503|NCT00132236|Nicotine|nicotine|mesh-list
65009504|NCT00132236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65009505|NCT00132236|Autonomic Agents|autonomic agents|mesh-ancestor
65009506|NCT00132236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65009507|NCT00132236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025162|NCT03429946|Spironolactone|spironolactone|mesh-list
65275150|NCT05662956|Venetoclax|venetoclax|mesh-list
65275151|NCT05662956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65275152|NCT05662956|Antimetabolites|antimetabolites|mesh-ancestor
65275153|NCT05662956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275154|NCT05662956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009508|NCT00132236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65009509|NCT00132236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65009510|NCT00132236|Cholinergic Agents|cholinergic agents|mesh-ancestor
65009511|NCT00132236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65009512|NCT00132236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009513|NCT00132275|Amoxicillin|amoxicillin|mesh-list
65009514|NCT00132275|Clavulanic Acid|clavulanic acid|mesh-list
65009515|NCT00132275|Clavulanic Acids|clavulanic acids|mesh-list
65009516|NCT00132275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64968185|NCT00186823|Immunologic Factors|immunologic factors|mesh-ancestor
65009545|NCT04696783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009546|NCT04696783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009547|NCT00132431|Cinacalcet|cinacalcet|mesh-list
65009548|NCT00132431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65009549|NCT00132431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009550|NCT00132431|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65009551|NCT00132431|Hormone Antagonists|hormone antagonists|mesh-ancestor
65009552|NCT00132431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65009553|NCT00140712|Ropinirole|ropinirole|mesh-list
65009554|NCT00140712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65009555|NCT00140712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65009556|NCT00140712|Dopamine Agonists|dopamine agonists|mesh-ancestor
65009557|NCT00140712|Dopamine Agents|dopamine agents|mesh-ancestor
65009558|NCT00140712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65009559|NCT00140712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009560|NCT00140712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009561|NCT00132548|Artesunate|artesunate|mesh-list
65009585|NCT00140751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009586|NCT00140751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009587|NCT00140751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65009588|NCT00140751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65009589|NCT00140751|Antiviral Agents|antiviral agents|mesh-ancestor
65009590|NCT00140751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65009591|NCT00140751|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65009592|NCT00140751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65009593|NCT00132587|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
65009594|NCT00132587|Vasodilator Agents|vasodilator agents|mesh-ancestor
65009595|NCT00132587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65009596|NCT00132587|Protective Agents|protective agents|mesh-ancestor
65009597|NCT00132587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009598|NCT00140790|Valsartan|valsartan|mesh-list
65009599|NCT00140790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65009600|NCT00140790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65009601|NCT00140790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65009602|NCT00140790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009603|NCT01245673|Lenalidomide|lenalidomide|mesh-list
65009604|NCT01245673|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65009605|NCT01245673|Poly ICLC|poly iclc|mesh-list
65009606|NCT01245673|Immunologic Factors|immunologic factors|mesh-ancestor
65009607|NCT01245673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009608|NCT01245673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65009609|NCT01245673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65009610|NCT01245673|Growth Substances|growth substances|mesh-ancestor
65009611|NCT01245673|Growth Inhibitors|growth inhibitors|mesh-ancestor
65009612|NCT01245673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009613|NCT01245673|Interferon Inducers|interferon inducers|mesh-ancestor
65009614|NCT02261415|Tranexamic Acid|tranexamic acid|mesh-list
65009615|NCT02261415|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65009616|NCT02261415|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65009626|NCT00132743|Respiratory System Agents|respiratory system agents|mesh-ancestor
65009627|NCT00132743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65009628|NCT00132743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65275155|NCT05662956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275156|NCT02838173|Ropivacaine|ropivacaine|mesh-list
65275157|NCT02838173|Anesthetics, Local|anesthetics, local|mesh-ancestor
65275158|NCT02838173|Anesthetics|anesthetics|mesh-ancestor
65275159|NCT02838173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65275160|NCT02838173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275161|NCT02838173|Sensory System Agents|sensory system agents|mesh-ancestor
65275162|NCT02838173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65275163|NCT00641472|Budesonide|budesonide|mesh-list
65275164|NCT00641472|Montelukast|montelukast|mesh-list
65275165|NCT00641472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65275166|NCT00641472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65275167|NCT00641472|Autonomic Agents|autonomic agents|mesh-ancestor
64727635|NCT00003284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009629|NCT00132743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009630|NCT00132743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65009631|NCT00132743|Vasodilator Agents|vasodilator agents|mesh-ancestor
65009632|NCT00132743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65009633|NCT00132743|Protective Agents|protective agents|mesh-ancestor
65009634|NCT00132743|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65009635|NCT00132743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65009636|NCT00132743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009638|NCT00132821|Nicotine|nicotine|mesh-list
65009639|NCT00132821|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65009640|NCT00132821|Autonomic Agents|autonomic agents|mesh-ancestor
65009641|NCT00132821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65009642|NCT00132821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009643|NCT00132821|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65009644|NCT00132821|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65009645|NCT00132821|Cholinergic Agents|cholinergic agents|mesh-ancestor
65009646|NCT00132821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64464813|NCT01886287|Octreotide|octreotide|mesh-list
65009647|NCT00132821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009648|NCT00132821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65009649|NCT00132821|Antidepressive Agents|antidepressive agents|mesh-ancestor
65009650|NCT00132821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65009651|NCT00132821|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65009652|NCT00132821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65009653|NCT00132821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65009654|NCT00132821|Dopamine Agents|dopamine agents|mesh-ancestor
65009655|NCT00132821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65009656|NCT00132821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65009657|NCT00132821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009658|NCT00132860|Azithromycin|azithromycin|mesh-list
65009659|NCT00132860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65009660|NCT00132860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65009661|NCT01244815|Asenapine|asenapine|mesh-list
65009662|NCT01244815|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65009663|NCT01244815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65009664|NCT01244815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65009665|NCT01244815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009666|NCT01244815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65009667|NCT00132899|Methotrexate|methotrexate|mesh-list
65009668|NCT00132899|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65009669|NCT00132899|Abortifacient Agents|abortifacient agents|mesh-ancestor
65009670|NCT00132899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65009671|NCT00132899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009672|NCT00132899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65009673|NCT00132899|Antimetabolites|antimetabolites|mesh-ancestor
65009674|NCT00132899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009675|NCT00132899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275168|NCT00641472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65275169|NCT00641472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275170|NCT00641472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65275171|NCT00641472|Respiratory System Agents|respiratory system agents|mesh-ancestor
65275172|NCT00641472|Glucocorticoids|glucocorticoids|mesh-ancestor
65275173|NCT00641472|Hormones|hormones|mesh-ancestor
65275174|NCT00641472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65009676|NCT00132899|Dermatologic Agents|dermatologic agents|mesh-ancestor
65009677|NCT00132899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009678|NCT00132899|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65009679|NCT00132899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65009680|NCT00132899|Immunologic Factors|immunologic factors|mesh-ancestor
64968353|NCT00187564|Vitamins|vitamins|mesh-ancestor
65009695|NCT00140868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65009696|NCT00140868|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65009697|NCT00132938|Telithromycin|telithromycin|mesh-list
65009698|NCT00132938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65009699|NCT00132938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65009700|NCT02955706|Acetylcarnitine|acetylcarnitine|mesh-list
65009701|NCT02955706|Vitamin B Complex|vitamin b complex|mesh-ancestor
65009703|NCT02955706|Micronutrients|micronutrients|mesh-ancestor
65009704|NCT02955706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009705|NCT02955706|Nootropic Agents|nootropic agents|mesh-ancestor
65009706|NCT01244425|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65009707|NCT01244425|Hemostatics|hemostatics|mesh-ancestor
65009708|NCT01244425|Coagulants|coagulants|mesh-ancestor
65009709|NCT00141063|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
65009710|NCT00141063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65009711|NCT00141063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009712|NCT00141063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65009713|NCT00141063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65009714|NCT00141063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65009715|NCT00141063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009716|NCT00141063|Dopamine Agents|dopamine agents|mesh-ancestor
65009717|NCT00141063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65009718|NCT01154439|Cytarabine|cytarabine|mesh-list
65009719|NCT01154439|Etoposide|etoposide|mesh-list
65009720|NCT01154439|Mitoxantrone|mitoxantrone|mesh-list
65009722|NCT01154439|Etoposide phosphate|etoposide phosphate|mesh-list
65009723|NCT01154439|Everolimus|everolimus|mesh-list
65009724|NCT01154439|Ifosfamide|ifosfamide|mesh-list
65009725|NCT01154439|Carboplatin|carboplatin|mesh-list
65009726|NCT01154439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65009727|NCT01154439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009728|NCT01154439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65009729|NCT01154439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65009730|NCT01154439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009731|NCT01154439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009732|NCT01154439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65009733|NCT01154439|Antimetabolites|antimetabolites|mesh-ancestor
65009734|NCT01154439|Antiviral Agents|antiviral agents|mesh-ancestor
65009735|NCT01154439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65009736|NCT01154439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65009737|NCT01154439|Immunologic Factors|immunologic factors|mesh-ancestor
65009738|NCT01154439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009739|NCT01154439|Analgesics|analgesics|mesh-ancestor
65009740|NCT01154439|Sensory System Agents|sensory system agents|mesh-ancestor
65009741|NCT01154439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65009776|NCT00133250|Abciximab|abciximab|mesh-list
65009777|NCT00133250|Anticoagulants|anticoagulants|mesh-ancestor
65009778|NCT00133250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65009779|NCT00133250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65009780|NCT00133250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968480|NCT00188383|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65009811|NCT00141258|Sensory System Agents|sensory system agents|mesh-ancestor
65009812|NCT00141258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65009813|NCT00141258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009814|NCT00141258|Anticonvulsants|anticonvulsants|mesh-ancestor
65275175|NCT00641472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65275176|NCT00641472|Hormone Antagonists|hormone antagonists|mesh-ancestor
65275177|NCT00641472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65275178|NCT00641472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65275179|NCT00641472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275180|NCT00896051|Ritonavir|ritonavir|mesh-list
65275181|NCT00896051|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65275182|NCT00896051|Tenofovir|tenofovir|mesh-list
65275183|NCT00896051|Etravirine|etravirine|mesh-list
65009815|NCT00141258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65009816|NCT00141258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65009817|NCT00141258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009818|NCT00141258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65009819|NCT00141258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65009820|NCT00141258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65009821|NCT00141258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65009822|NCT00141258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65009823|NCT00403910|Canrenone|canrenone|mesh-list
65009824|NCT00403910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65009825|NCT00403910|Hormone Antagonists|hormone antagonists|mesh-ancestor
64968520|NCT00409357|Alfuzosin|alfuzosin|mesh-list
65009855|NCT00133445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009857|NCT00141375|Analgesics|analgesics|mesh-ancestor
65009858|NCT00141375|Sensory System Agents|sensory system agents|mesh-ancestor
65009859|NCT00141375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65009860|NCT00141375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009861|NCT00141375|Anticonvulsants|anticonvulsants|mesh-ancestor
65009862|NCT00141375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65009863|NCT00141375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65009864|NCT00141375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009865|NCT00141375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65009866|NCT00141375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65009867|NCT00141375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65009868|NCT00141375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65009869|NCT00141375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65009896|NCT00144807|Cyclophosphamide|cyclophosphamide|mesh-list
65009897|NCT00144807|Rituximab|rituximab|mesh-list
65009898|NCT00144807|Doxorubicin|doxorubicin|mesh-list
65009899|NCT00144807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65009900|NCT00144807|Immunologic Factors|immunologic factors|mesh-ancestor
65009901|NCT00144807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009902|NCT00144807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65009903|NCT00144807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65009904|NCT00144807|Alkylating Agents|alkylating agents|mesh-ancestor
65009905|NCT00144807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009906|NCT00144807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009907|NCT00144807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65009908|NCT00144807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65009909|NCT00144807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65009910|NCT00144807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65009911|NCT00144807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65009912|NCT00144807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009913|NCT00133640|Cholecalciferol|cholecalciferol|mesh-list
65009914|NCT00133640|Vitamin D|vitamin d|mesh-list
65009915|NCT00133640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65009916|NCT00133640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009917|NCT00133640|Vitamins|vitamins|mesh-ancestor
65009918|NCT00133640|Micronutrients|micronutrients|mesh-ancestor
65009919|NCT00133640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64968617|NCT00399945|Tobramycin|tobramycin|mesh-list
65009944|NCT00133757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65009945|NCT00133757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65009946|NCT00133757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009948|NCT00133757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65275184|NCT00896051|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
65275185|NCT00896051|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65275186|NCT00896051|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65275187|NCT00896051|Protease Inhibitors|protease inhibitors|mesh-ancestor
65009949|NCT00133757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009950|NCT00133757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65009951|NCT00133757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65009952|NCT00133757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009953|NCT00144846|Albuterol|albuterol|mesh-list
65009954|NCT00144846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65009955|NCT00144846|Autonomic Agents|autonomic agents|mesh-ancestor
65009956|NCT00144846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65009957|NCT00144846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009958|NCT00144846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65009959|NCT00144846|Respiratory System Agents|respiratory system agents|mesh-ancestor
65009960|NCT00144846|Tocolytic Agents|tocolytic agents|mesh-ancestor
65009961|NCT00144846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65009962|NCT00144846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65009963|NCT00144846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65009964|NCT00144846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65009965|NCT00144846|Adrenergic Agents|adrenergic agents|mesh-ancestor
65009966|NCT00144846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65009967|NCT00144846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009998|NCT00134030|Doxorubicin|doxorubicin|mesh-list
65009999|NCT00134030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65010000|NCT00134030|Methotrexate|methotrexate|mesh-list
65010001|NCT00134030|Etoposide|etoposide|mesh-list
65010002|NCT00134030|Etoposide phosphate|etoposide phosphate|mesh-list
65010003|NCT00134030|Ifosfamide|ifosfamide|mesh-list
65010004|NCT00134030|Isophosphamide mustard|isophosphamide mustard|mesh-list
65010005|NCT00134030|Podophyllotoxin|podophyllotoxin|mesh-list
65010006|NCT00134030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010007|NCT00134030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65010008|NCT00134030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65010009|NCT00134030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65010010|NCT00134030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010011|NCT00134030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010012|NCT00134030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65010013|NCT00134030|Abortifacient Agents|abortifacient agents|mesh-ancestor
65010014|NCT00134030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65010031|NCT00134030|Antimitotic Agents|antimitotic agents|mesh-ancestor
65010032|NCT00134030|Mitosis Modulators|mitosis modulators|mesh-ancestor
65010033|NCT00141492|Testosterone|testosterone|mesh-list
65010034|NCT00141492|Androgens|androgens|mesh-ancestor
65010035|NCT00141492|Hormones|hormones|mesh-ancestor
65010036|NCT00141492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65010037|NCT00141492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010038|NCT00141531|Apaziquone|apaziquone|mesh-list
65010039|NCT00141531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010040|NCT00134069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65010041|NCT00134069|Cetuximab|cetuximab|mesh-list
65010042|NCT00134069|Irinotecan|irinotecan|mesh-list
65010043|NCT00134069|Sorafenib|sorafenib|mesh-list
65010044|NCT00134069|Antibodies|antibodies|mesh-list
65010045|NCT00134069|Immunoglobulins|immunoglobulins|mesh-list
65010046|NCT00134069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65010047|NCT00134069|Immunologic Factors|immunologic factors|mesh-ancestor
65010048|NCT00134069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010049|NCT00134069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010050|NCT00134069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65010051|NCT00134069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65010052|NCT00134069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010053|NCT00134069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010054|NCT00134069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65010055|NCT00141570|Methyltestosterone|methyltestosterone|mesh-list
65010056|NCT00141570|Estrogens|estrogens|mesh-list
65010057|NCT00141570|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
65010058|NCT00141570|Testosterone|testosterone|mesh-list
65010059|NCT00141570|Testosterone undecanoate|testosterone undecanoate|mesh-list
65010060|NCT00141570|Testosterone enanthate|testosterone enanthate|mesh-list
65010061|NCT00141570|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65010062|NCT00141570|Hormones|hormones|mesh-ancestor
65275188|NCT00896051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275189|NCT00896051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275190|NCT00896051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65275191|NCT00896051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65275192|NCT00896051|Antiviral Agents|antiviral agents|mesh-ancestor
65275193|NCT00896051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65275194|NCT00896051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65275195|NCT00896051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64727668|NCT00004046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010063|NCT00141570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65010064|NCT00141570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010065|NCT00141570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65010066|NCT00141570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010067|NCT00141570|Anabolic Agents|anabolic agents|mesh-ancestor
65010068|NCT00141570|Androgens|androgens|mesh-ancestor
65010069|NCT00134147|Insulin|insulin|mesh-list
65010070|NCT00134147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65010071|NCT00134147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010072|NCT00403988|Oxaliplatin|oxaliplatin|mesh-list
65010073|NCT00403988|Vinorelbine|vinorelbine|mesh-list
65010096|NCT00141648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65010097|NCT00141648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65010098|NCT00141648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65010099|NCT00141648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65010100|NCT00141648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010101|NCT00141648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65010102|NCT00141648|Tubulin Modulators|tubulin modulators|mesh-ancestor
65010103|NCT00141648|Antimitotic Agents|antimitotic agents|mesh-ancestor
65010104|NCT00141648|Mitosis Modulators|mitosis modulators|mesh-ancestor
65010105|NCT00141648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65010106|NCT00141648|Glucocorticoids|glucocorticoids|mesh-ancestor
65010107|NCT00141648|Hormones|hormones|mesh-ancestor
65010108|NCT00141648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65010109|NCT00141648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65010110|NCT00134420|Clonidine|clonidine|mesh-list
65010111|NCT00134420|Mitogens|mitogens|mesh-list
65010112|NCT00134420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010113|NCT00134420|Mitosis Modulators|mitosis modulators|mesh-ancestor
65010114|NCT00134420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010115|NCT00134420|Analgesics|analgesics|mesh-ancestor
65010116|NCT00134420|Sensory System Agents|sensory system agents|mesh-ancestor
65010117|NCT00134420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65010118|NCT00134420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65010119|NCT00134420|Sympatholytics|sympatholytics|mesh-ancestor
65010120|NCT00134420|Autonomic Agents|autonomic agents|mesh-ancestor
65010121|NCT00134420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65010122|NCT00134420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65010123|NCT00134420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65010124|NCT00134420|Adrenergic Agents|adrenergic agents|mesh-ancestor
65010125|NCT00134420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65010144|NCT00141843|Factor VIII|factor viii|mesh-list
65010145|NCT00141843|Coagulants|coagulants|mesh-ancestor
65010146|NCT00141882|Memantine|memantine|mesh-list
65010147|NCT00141882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65010148|NCT00141882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65010149|NCT00141882|Dopamine Agents|dopamine agents|mesh-ancestor
65010150|NCT00141882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65010151|NCT00141882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010152|NCT00141882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010153|NCT00141882|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65010154|NCT00141882|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65010155|NCT00152295|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65010156|NCT00152295|Estrogens|estrogens|mesh-ancestor
65010157|NCT00152295|Hormones|hormones|mesh-ancestor
65010158|NCT00152295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65275196|NCT00896051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65275197|NCT04250051|Vidarabine|vidarabine|mesh-list
65275198|NCT04250051|Cytarabine|cytarabine|mesh-list
65275199|NCT04250051|Fludarabine|fludarabine|mesh-list
65275200|NCT04250051|Fludarabine phosphate|fludarabine phosphate|mesh-list
65275201|NCT04250051|Ivosidenib|ivosidenib|mesh-list
65275202|NCT04250051|Lenograstim|lenograstim|mesh-list
65275203|NCT04250051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275204|NCT04250051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65275205|NCT04250051|Antimetabolites|antimetabolites|mesh-ancestor
65010159|NCT00152295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010160|NCT00152373|Levetiracetam|levetiracetam|mesh-list
65010161|NCT00152373|Anticonvulsants|anticonvulsants|mesh-ancestor
65010162|NCT00152373|Nootropic Agents|nootropic agents|mesh-ancestor
65010163|NCT00134654|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65010164|NCT00134654|Estrogens|estrogens|mesh-ancestor
65010165|NCT00134654|Hormones|hormones|mesh-ancestor
65010166|NCT00134654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65010167|NCT00134654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010168|NCT00141960|Famotidine|famotidine|mesh-list
65010169|NCT00141960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65010170|NCT00141960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65010171|NCT00141960|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65010173|NCT00141960|Histamine Agents|histamine agents|mesh-ancestor
65010174|NCT00141960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65010175|NCT00141960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010176|NCT00141960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010177|NCT00134693|Prednisolone|prednisolone|mesh-list
65010178|NCT00134693|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65010179|NCT00134693|Methylprednisolone|methylprednisolone|mesh-list
65010180|NCT00134693|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65010181|NCT00134693|Prednisolone acetate|prednisolone acetate|mesh-list
65010182|NCT00134693|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65010183|NCT00134693|Prednisolone phosphate|prednisolone phosphate|mesh-list
65010198|NCT00152412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65010199|NCT00152412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65010200|NCT00152412|Histamine Antagonists|histamine antagonists|mesh-ancestor
65010201|NCT00152412|Histamine Agents|histamine agents|mesh-ancestor
65010202|NCT00152412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65010203|NCT00152412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010204|NCT00152412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010205|NCT00142038|Docetaxel|docetaxel|mesh-list
65010206|NCT00142038|Capecitabine|capecitabine|mesh-list
65010207|NCT00142038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010208|NCT00142038|Tubulin Modulators|tubulin modulators|mesh-ancestor
65010209|NCT00142038|Antimitotic Agents|antimitotic agents|mesh-ancestor
65010210|NCT00142038|Mitosis Modulators|mitosis modulators|mesh-ancestor
65010211|NCT00142038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010212|NCT00142038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65010213|NCT00142038|Antimetabolites|antimetabolites|mesh-ancestor
65010214|NCT00134810|Botulinum Toxins|botulinum toxins|mesh-list
65010215|NCT00134810|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65010216|NCT00134810|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65010217|NCT00134810|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65010218|NCT00134810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65010219|NCT00134810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010220|NCT00134810|Cholinergic Agents|cholinergic agents|mesh-ancestor
65010221|NCT00134810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65010222|NCT00134810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010223|NCT00134810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65010224|NCT00134810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65010225|NCT02964455|Docetaxel|docetaxel|mesh-list
65010226|NCT02964455|Nedaplatin|nedaplatin|mesh-list
65010227|NCT02964455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010228|NCT02964455|Tubulin Modulators|tubulin modulators|mesh-ancestor
65010229|NCT02964455|Antimitotic Agents|antimitotic agents|mesh-ancestor
65010230|NCT02964455|Mitosis Modulators|mitosis modulators|mesh-ancestor
65275206|NCT04250051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275207|NCT04250051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65275208|NCT04250051|Immunologic Factors|immunologic factors|mesh-ancestor
65275209|NCT04250051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275210|NCT04250051|Antiviral Agents|antiviral agents|mesh-ancestor
65275211|NCT04250051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65275212|NCT04250051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65275213|NCT04250051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275214|NCT02673606|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65275215|NCT02673606|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65275216|NCT02673606|Estradiol|estradiol|mesh-list
65275217|NCT02673606|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65275218|NCT02673606|Estrogens|estrogens|mesh-ancestor
65275219|NCT02673606|Hormones|hormones|mesh-ancestor
65275220|NCT02673606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65275221|NCT02673606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727683|NCT00382213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65010231|NCT02964455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010232|NCT00142155|Rituximab|rituximab|mesh-list
65010233|NCT00142155|Antibodies|antibodies|mesh-list
65010234|NCT00142155|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65010235|NCT00142155|Immunologic Factors|immunologic factors|mesh-ancestor
65010236|NCT00142155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010237|NCT00142155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65010238|NCT00142155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010239|NCT00142155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65010241|NCT00152490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65010242|NCT00152490|Immunologic Factors|immunologic factors|mesh-ancestor
65010243|NCT00152490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010244|NCT00152490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65010245|NCT00134888|Buprenorphine|buprenorphine|mesh-list
65010264|NCT00134966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010265|NCT00134966|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65010266|NCT00134966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010267|NCT00134966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65010268|NCT00135005|Imatinib Mesylate|imatinib mesylate|mesh-list
65010269|NCT00135005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010270|NCT00135005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65010271|NCT00135005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010272|NCT00135005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010273|NCT00142233|N-Methylaspartate|n-methylaspartate|mesh-list
65010274|NCT00142233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
65010275|NCT00142233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65010276|NCT00142233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65010277|NCT00142233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010278|NCT00142233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010279|NCT00135083|Insulin glulisine|insulin glulisine|mesh-list
65010280|NCT00135083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65010281|NCT00135083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010282|NCT04725357|Meloxicam|meloxicam|mesh-list
65010283|NCT04725357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65010284|NCT04725357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65010285|NCT04725357|Analgesics|analgesics|mesh-ancestor
65010286|NCT04725357|Sensory System Agents|sensory system agents|mesh-ancestor
65010287|NCT04725357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65010288|NCT04725357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275222|NCT02673606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65275223|NCT02673606|Contraceptive Agents|contraceptive agents|mesh-ancestor
65275224|NCT02673606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65275225|NCT02673606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65275226|NCT02675400|Methylphenidate|methylphenidate|mesh-list
65275227|NCT02675400|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65275228|NCT02675400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65275229|NCT02675400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275230|NCT02675400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65275231|NCT02675400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65275232|NCT02675400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65275233|NCT02675400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275234|NCT02675400|Dopamine Agents|dopamine agents|mesh-ancestor
65275235|NCT02675400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65275236|NCT05501886|Fulvestrant|fulvestrant|mesh-list
65275237|NCT05501886|Palbociclib|palbociclib|mesh-list
65275238|NCT05501886|Gedatolisib|gedatolisib|mesh-list
65275239|NCT05501886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65275240|NCT05501886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275241|NCT05501886|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65275242|NCT05501886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65275243|NCT05501886|Hormone Antagonists|hormone antagonists|mesh-ancestor
65275244|NCT05501886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65275245|NCT05501886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275246|NCT05501886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65275247|NCT05501886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727707|NCT00002689|Dexamethasone|dexamethasone|mesh-list
65010289|NCT04725357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65010290|NCT04725357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65010291|NCT04725357|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65010292|NCT04725357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65010293|NCT04725357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010294|NCT04725357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010295|NCT00135122|Prednisolone|prednisolone|mesh-list
65010296|NCT00135122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65010297|NCT00135122|Methylprednisolone|methylprednisolone|mesh-list
65010298|NCT00135122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65010299|NCT00135122|Prednisolone acetate|prednisolone acetate|mesh-list
65010300|NCT00135122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65010317|NCT00142350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465492|NCT01450462|Vitamins|vitamins|mesh-ancestor
65010319|NCT00142350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010320|NCT00142350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65010321|NCT00142350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65275248|NCT05501886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275249|NCT00894647|Imiquimod|imiquimod|mesh-list
65275250|NCT00894647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65275251|NCT00894647|Immunologic Factors|immunologic factors|mesh-ancestor
65275252|NCT00894647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275253|NCT00894647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275254|NCT00894647|Interferon Inducers|interferon inducers|mesh-ancestor
65275255|NCT02839421|Moxifloxacin|moxifloxacin|mesh-list
65275256|NCT02839421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65275257|NCT02839421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65010322|NCT00142350|Immunologic Factors|immunologic factors|mesh-ancestor
65010323|NCT00142350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010324|NCT00142350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65010325|NCT00142350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65010326|NCT00142350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010327|NCT00135317|Darbepoetin alfa|darbepoetin alfa|mesh-list
65010328|NCT00135317|Hematinics|hematinics|mesh-ancestor
65010329|NCT00152646|Clopidogrel|clopidogrel|mesh-list
65010330|NCT00152646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65010331|NCT00152646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65010332|NCT00152646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65010333|NCT00152646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65010334|NCT00152646|Purinergic Agents|purinergic agents|mesh-ancestor
65010335|NCT00152646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65010336|NCT00152646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010337|NCT00152646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010338|NCT00135434|Ritonavir|ritonavir|mesh-list
65010339|NCT00135434|Lopinavir|lopinavir|mesh-list
65010340|NCT00135434|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65010341|NCT00135434|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65010342|NCT00135434|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65010343|NCT00135434|Protease Inhibitors|protease inhibitors|mesh-ancestor
65010344|NCT00135434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010345|NCT00135434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010346|NCT00135434|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65010347|NCT00135434|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65010348|NCT00135434|Antiviral Agents|antiviral agents|mesh-ancestor
65010349|NCT00135434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65010350|NCT00135434|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65010351|NCT00135434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65010352|NCT00135473|Insulin|insulin|mesh-list
65010353|NCT00135473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65010354|NCT00135473|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65010355|NCT00135473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65010356|NCT00135473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010357|NCT00135473|Plasma Substitutes|plasma substitutes|mesh-ancestor
65010358|NCT00135473|Blood Substitutes|blood substitutes|mesh-ancestor
65010359|NCT00142428|Cetuximab|cetuximab|mesh-list
64969021|NCT00191464|Insulin|insulin|mesh-list
65010384|NCT00152724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65010385|NCT00152724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65010387|NCT00152724|Sensory System Agents|sensory system agents|mesh-ancestor
65010388|NCT00152724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65010389|NCT00152724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010390|NCT00152724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65010391|NCT00152724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65010392|NCT00152724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65010393|NCT00152724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65010394|NCT00152724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010395|NCT00152724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65010396|NCT00152724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65010397|NCT00152724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010399|NCT00152724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65010400|NCT00152724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65275258|NCT02839421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65275259|NCT02839421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65275260|NCT02839421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275261|NCT02839421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275262|NCT02839421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275263|NCT02841839|Fluorides|fluorides|mesh-list
65275264|NCT02841839|Tin Fluorides|tin fluorides|mesh-list
65275265|NCT02841839|Cariostatic Agents|cariostatic agents|mesh-ancestor
65275266|NCT02841839|Protective Agents|protective agents|mesh-ancestor
65010401|NCT00152724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65010402|NCT00152724|Purinergic Agents|purinergic agents|mesh-ancestor
65010403|NCT00152724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65010404|NCT00152724|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65010405|NCT00152724|Antipruritics|antipruritics|mesh-ancestor
65010406|NCT00152724|Dermatologic Agents|dermatologic agents|mesh-ancestor
65010407|NCT00152724|Gout Suppressants|gout suppressants|mesh-ancestor
65010408|NCT00152724|Tocolytic Agents|tocolytic agents|mesh-ancestor
65010409|NCT00152724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65010410|NCT00152724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65010411|NCT00152724|Vasodilator Agents|vasodilator agents|mesh-ancestor
65010431|NCT00135746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65010432|NCT00135746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010433|NCT00135785|Bupropion|bupropion|mesh-list
65010434|NCT00135785|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65010435|NCT00135785|Antidepressive Agents|antidepressive agents|mesh-ancestor
65010436|NCT00135785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65010437|NCT00135785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65010438|NCT00135785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65010439|NCT00135785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65010440|NCT00135785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010441|NCT00135785|Dopamine Agents|dopamine agents|mesh-ancestor
65010442|NCT00135785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65010443|NCT00135785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010444|NCT00135785|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65010445|NCT00135785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65010446|NCT00135785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010447|NCT00159081|Haloperidol|haloperidol|mesh-list
65010448|NCT00159081|Risperidone|risperidone|mesh-list
65010449|NCT00159081|Haloperidol decanoate|haloperidol decanoate|mesh-list
65010450|NCT00159081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65010451|NCT00159081|Serotonin Agents|serotonin agents|mesh-ancestor
65010452|NCT00159081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65010453|NCT00159081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010454|NCT00159081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010455|NCT00159081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65010456|NCT00159081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65010457|NCT00159081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65010458|NCT00159081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65010459|NCT00159081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65010460|NCT00159081|Dopamine Agents|dopamine agents|mesh-ancestor
65010461|NCT00159081|Antiemetics|antiemetics|mesh-ancestor
65010462|NCT00159081|Autonomic Agents|autonomic agents|mesh-ancestor
65010463|NCT00159081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65010464|NCT00159081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65010465|NCT00159081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65010467|NCT00152841|Vitamins|vitamins|mesh-ancestor
64451498|NCT02141633|Xhance|xhance|mesh-list
64969128|NCT00191932|Analgesics|analgesics|mesh-ancestor
65010489|NCT00159159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65010490|NCT00135824|Povidone|povidone|mesh-list
65010491|NCT00135824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65010492|NCT00135824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65010493|NCT00135824|Plasma Substitutes|plasma substitutes|mesh-ancestor
65010494|NCT00135824|Blood Substitutes|blood substitutes|mesh-ancestor
65010495|NCT00135863|Tinzaparin|tinzaparin|mesh-list
65010496|NCT00135863|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65010497|NCT00135863|Dalteparin|dalteparin|mesh-list
65010498|NCT00135863|Anticoagulants|anticoagulants|mesh-ancestor
65275267|NCT02841839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275268|NCT04179942|Nitric Oxide|nitric oxide|mesh-list
65275269|NCT04179942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65275270|NCT04179942|Autonomic Agents|autonomic agents|mesh-ancestor
65275271|NCT04179942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65275272|NCT04179942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275273|NCT04179942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65275274|NCT04179942|Respiratory System Agents|respiratory system agents|mesh-ancestor
65275275|NCT04179942|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65275276|NCT04179942|Antioxidants|antioxidants|mesh-ancestor
65275277|NCT04179942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275278|NCT04179942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65275279|NCT04179942|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65275280|NCT04179942|Vasodilator Agents|vasodilator agents|mesh-ancestor
65275281|NCT04179942|Gasotransmitters|gasotransmitters|mesh-ancestor
65275282|NCT04179942|Protective Agents|protective agents|mesh-ancestor
65275283|NCT05498766|Oxaliplatin|oxaliplatin|mesh-list
65010499|NCT00135863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65010500|NCT00135863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65010501|NCT00135863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010502|NCT00135902|Progesterone|progesterone|mesh-list
65010503|NCT00135902|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
65010504|NCT00135902|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
65010505|NCT00135902|Progestins|progestins|mesh-ancestor
65010506|NCT00135902|Hormones|hormones|mesh-ancestor
65010507|NCT00135902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65010508|NCT00135902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010509|NCT00135902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65010510|NCT00135902|Hormone Antagonists|hormone antagonists|mesh-ancestor
65010511|NCT00135941|Insulin|insulin|mesh-list
65010512|NCT00135941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65010513|NCT00135941|Insulin Glargine|insulin glargine|mesh-list
65010514|NCT00135941|Insulin glulisine|insulin glulisine|mesh-list
65010515|NCT00135941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65010516|NCT00135941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010517|NCT00152919|Meloxicam|meloxicam|mesh-list
65010518|NCT00152919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65010519|NCT00152919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65010520|NCT00152919|Analgesics|analgesics|mesh-ancestor
65010521|NCT00152919|Sensory System Agents|sensory system agents|mesh-ancestor
64969176|NCT00192088|Oxaliplatin|oxaliplatin|mesh-list
65010547|NCT00136058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010548|NCT00136058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65010549|NCT00136058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65010550|NCT00136058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010551|NCT00136058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65010554|NCT00152958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010555|NCT00152958|Protective Agents|protective agents|mesh-ancestor
65010556|NCT00152958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010557|NCT00152958|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65010558|NCT00152958|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65010559|NCT00152958|Dopamine Agonists|dopamine agonists|mesh-ancestor
65010560|NCT00152958|Dopamine Agents|dopamine agents|mesh-ancestor
65010561|NCT00152958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65010562|NCT00136175|Gemcitabine|gemcitabine|mesh-list
65010563|NCT00136175|Paclitaxel|paclitaxel|mesh-list
65010564|NCT00136175|Carboplatin|carboplatin|mesh-list
65275284|NCT05498766|Tegafur|tegafur|mesh-list
65275285|NCT05498766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275286|NCT05498766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65275287|NCT05498766|Antimetabolites|antimetabolites|mesh-ancestor
65275288|NCT05498766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275289|NCT04250831|Chromium|chromium|mesh-list
65275290|NCT04250831|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
65275291|NCT04250831|Trace Elements|trace elements|mesh-ancestor
65275292|NCT04250831|Micronutrients|micronutrients|mesh-ancestor
65275293|NCT04250831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275294|NCT04250831|Cathartics|cathartics|mesh-ancestor
65275295|NCT04250831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65275296|NCT00643500|Levetiracetam|levetiracetam|mesh-list
65275297|NCT00643500|Anticonvulsants|anticonvulsants|mesh-ancestor
65010565|NCT00136175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65010566|NCT00136175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010567|NCT00136175|Tubulin Modulators|tubulin modulators|mesh-ancestor
65010568|NCT00136175|Antimitotic Agents|antimitotic agents|mesh-ancestor
65010569|NCT00136175|Mitosis Modulators|mitosis modulators|mesh-ancestor
65010570|NCT00136175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010571|NCT00136175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65010572|NCT00136175|Antimetabolites|antimetabolites|mesh-ancestor
65010605|NCT00153075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65010606|NCT00153075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65010607|NCT00153075|Adrenergic Agents|adrenergic agents|mesh-ancestor
65010608|NCT00153075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65010609|NCT00153075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010610|NCT00153075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65010611|NCT00153075|Cholinergic Agents|cholinergic agents|mesh-ancestor
65010612|NCT00159471|Gemcitabine|gemcitabine|mesh-list
65010613|NCT00159471|Capecitabine|capecitabine|mesh-list
65010615|NCT00159471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65010616|NCT00159471|Antimetabolites|antimetabolites|mesh-ancestor
64969277|NCT00193024|Epirubicin|epirubicin|mesh-list
65010646|NCT00159510|Gasotransmitters|gasotransmitters|mesh-ancestor
65010647|NCT00159510|Protective Agents|protective agents|mesh-ancestor
65010648|NCT00159510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010649|NCT00136409|Imatinib Mesylate|imatinib mesylate|mesh-list
65010650|NCT00136409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010651|NCT00136409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65010652|NCT00136409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010653|NCT00136409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010654|NCT00153114|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65010655|NCT00153114|Laxatives|laxatives|mesh-ancestor
65010656|NCT00153114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65010657|NCT00136448|Cytarabine|cytarabine|mesh-list
65010658|NCT00136448|Interleukin-2|interleukin-2|mesh-list
65010659|NCT00136448|Daunorubicin|daunorubicin|mesh-list
65010660|NCT00136448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65010661|NCT00136448|Antimetabolites|antimetabolites|mesh-ancestor
65010662|NCT00136448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010681|NCT00136487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65010682|NCT00136487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65010683|NCT00136487|Analgesics|analgesics|mesh-ancestor
65010684|NCT00136487|Sensory System Agents|sensory system agents|mesh-ancestor
65010685|NCT00136487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65010686|NCT00136487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010687|NCT00136487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65010688|NCT00136487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64991897|NCT04092283|Immunoglobulins|immunoglobulins|mesh-list
65010689|NCT00136487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65010690|NCT00136487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65010691|NCT00136487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275298|NCT00643500|Nootropic Agents|nootropic agents|mesh-ancestor
65275299|NCT02837081|Anti-Infective Agents|anti-infective agents|mesh-list
65275300|NCT02837081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65275301|NCT00633269|Olaparib|olaparib|mesh-list
65275302|NCT00633269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65275303|NCT00633269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275304|NCT00633269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275305|NCT00633269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275306|NCT04181346|Pregabalin|pregabalin|mesh-list
65275307|NCT04181346|Analgesics|analgesics|mesh-ancestor
65275308|NCT04181346|Sensory System Agents|sensory system agents|mesh-ancestor
65275309|NCT04181346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65275310|NCT04181346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275311|NCT04181346|Anticonvulsants|anticonvulsants|mesh-ancestor
65275312|NCT04181346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65275313|NCT04181346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65275314|NCT04181346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275315|NCT04181346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65275316|NCT04181346|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65275317|NCT04181346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65275318|NCT04181346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65275319|NCT04181346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65275320|NCT00642798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65275321|NCT00642798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65275322|NCT00642798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275323|NCT00642798|Incretins|incretins|mesh-ancestor
65275324|NCT00642798|Hormones|hormones|mesh-ancestor
65275325|NCT00642798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65275326|NCT00642798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65275327|NCT00642798|Protease Inhibitors|protease inhibitors|mesh-ancestor
65275328|NCT00642798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275340|NCT00643734|Renal Agents|renal agents|mesh-ancestor
65275341|NCT00643734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65275342|NCT00643734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65275343|NCT00643734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275344|NCT00643734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275345|NCT00643734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275346|NCT00643734|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65275347|NCT00643734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65275348|NCT02674308|Vedolizumab|vedolizumab|mesh-list
65275349|NCT02674308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65275350|NCT04179006|Antidepressive Agents|antidepressive agents|mesh-list
65275351|NCT04179006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65275352|NCT02672592|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65275353|NCT02672592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65275354|NCT04178850|Folic Acid|folic acid|mesh-list
65275355|NCT04178850|Vitamin B Complex|vitamin b complex|mesh-list
65275356|NCT04178850|Infliximab|infliximab|mesh-list
65275357|NCT04178850|Dermatologic Agents|dermatologic agents|mesh-ancestor
65275358|NCT04178850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65275359|NCT04178850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65275360|NCT04178850|Hematinics|hematinics|mesh-ancestor
65275361|NCT04178850|Vitamins|vitamins|mesh-ancestor
65275362|NCT04178850|Micronutrients|micronutrients|mesh-ancestor
65275363|NCT04178850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275364|NCT02676336|Iodine|iodine|mesh-list
65275365|NCT02676336|Cadexomer iodine|cadexomer iodine|mesh-list
65275366|NCT02676336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65275367|NCT02676336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65275368|NCT02676336|Trace Elements|trace elements|mesh-ancestor
65010692|NCT00136487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010693|NCT00153192|Dronabinol|dronabinol|mesh-list
65010694|NCT00153192|Hallucinogens|hallucinogens|mesh-ancestor
65010695|NCT00153192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010696|NCT00153192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65010697|NCT00153192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65010698|NCT00153192|Analgesics|analgesics|mesh-ancestor
65010699|NCT00153192|Sensory System Agents|sensory system agents|mesh-ancestor
65010700|NCT00153192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65010701|NCT00153192|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65010702|NCT00153192|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65010703|NCT00153192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65010704|NCT00153192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010705|NCT00153192|Hormones|hormones|mesh-ancestor
65010706|NCT00153192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65010707|NCT00136526|Docetaxel|docetaxel|mesh-list
65010708|NCT00136526|Fosfestrol|fosfestrol|mesh-list
65010709|NCT00136526|Diethylstilbestrol|diethylstilbestrol|mesh-list
65010710|NCT00136526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275369|NCT02676336|Micronutrients|micronutrients|mesh-ancestor
65275370|NCT02676336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275371|NCT02672358|Trametinib|trametinib|mesh-list
65275372|NCT02672358|Dabrafenib|dabrafenib|mesh-list
65275373|NCT02672358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275374|NCT02672358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65275375|NCT02672358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275376|NCT02672358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025419|NCT00158834|Xhance|xhance|mesh-list
65275378|NCT02675868|Vasopressins|vasopressins|mesh-list
65275379|NCT02675868|Arginine Vasopressin|arginine vasopressin|mesh-list
65275380|NCT02675868|Oxymetazoline|oxymetazoline|mesh-list
65275381|NCT02675868|Norepinephrine|norepinephrine|mesh-list
65275382|NCT02675868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65010711|NCT00136526|Tubulin Modulators|tubulin modulators|mesh-ancestor
65010712|NCT00136526|Antimitotic Agents|antimitotic agents|mesh-ancestor
65010713|NCT00136526|Mitosis Modulators|mitosis modulators|mesh-ancestor
65010714|NCT00136526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010715|NCT00136526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65010716|NCT00136526|Estrogens|estrogens|mesh-ancestor
65010717|NCT00136526|Hormones|hormones|mesh-ancestor
65010718|NCT00136526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65010741|NCT00136565|Glucocorticoids|glucocorticoids|mesh-ancestor
65010743|NCT00136565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65010744|NCT00136565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65010745|NCT00136565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65010746|NCT00136565|Tubulin Modulators|tubulin modulators|mesh-ancestor
65010747|NCT00136565|Antimitotic Agents|antimitotic agents|mesh-ancestor
65010748|NCT00136565|Mitosis Modulators|mitosis modulators|mesh-ancestor
65010749|NCT00159627|Rolofylline|rolofylline|mesh-list
65010750|NCT00159627|Diuretics|diuretics|mesh-ancestor
65010751|NCT00159627|Natriuretic Agents|natriuretic agents|mesh-ancestor
65010752|NCT00159627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010753|NCT00159666|Pregabalin|pregabalin|mesh-list
65010754|NCT00159666|Analgesics|analgesics|mesh-ancestor
65010755|NCT00159666|Sensory System Agents|sensory system agents|mesh-ancestor
65010756|NCT00159666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65010757|NCT00159666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010758|NCT00159666|Anticonvulsants|anticonvulsants|mesh-ancestor
65010759|NCT00159666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65010760|NCT00159666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65010761|NCT00159666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010762|NCT00159666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65010763|NCT00159666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65010764|NCT00159666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65010765|NCT00159666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65010766|NCT00159666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65010767|NCT00153270|Valproic Acid|valproic acid|mesh-list
65010768|NCT00153270|Anticonvulsants|anticonvulsants|mesh-ancestor
65010769|NCT00153270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010770|NCT00153270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010771|NCT00153270|GABA Agents|gaba agents|mesh-ancestor
65010799|NCT00136994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65010800|NCT00136994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65010801|NCT00136994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65010802|NCT00136994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65010803|NCT00136994|Dopamine Agents|dopamine agents|mesh-ancestor
65010804|NCT00137033|Celecoxib|celecoxib|mesh-list
65010805|NCT00137033|Naproxen|naproxen|mesh-list
65010806|NCT00137033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65010807|NCT00137033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65010808|NCT00137033|Analgesics|analgesics|mesh-ancestor
65010809|NCT00137033|Sensory System Agents|sensory system agents|mesh-ancestor
65275383|NCT02675868|Mydriatics|mydriatics|mesh-ancestor
65275384|NCT02675868|Autonomic Agents|autonomic agents|mesh-ancestor
65275385|NCT02675868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65010810|NCT00137033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65010811|NCT00137033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010812|NCT00137033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65010813|NCT00137033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65010814|NCT00137033|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65010815|NCT00137033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65010816|NCT00137033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969476|NCT00194272|Abortifacient Agents|abortifacient agents|mesh-ancestor
65010844|NCT00137345|Antifungal Agents|antifungal agents|mesh-ancestor
65010845|NCT00137345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65010846|NCT00137345|Immunologic Factors|immunologic factors|mesh-ancestor
65010847|NCT00137345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010849|NCT00137462|Torcetrapib|torcetrapib|mesh-list
65010850|NCT00137462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65010851|NCT00137462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65010852|NCT00137462|Antimetabolites|antimetabolites|mesh-ancestor
65010853|NCT00137462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010854|NCT00137462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65010855|NCT00137462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65010856|NCT00137462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010857|NCT00153543|Vaccines|vaccines|mesh-list
65010858|NCT00153543|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65010859|NCT00153543|Immunologic Factors|immunologic factors|mesh-ancestor
65010860|NCT00153543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010861|NCT00137501|Nifedipine|nifedipine|mesh-list
65010862|NCT00137501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64969525|NCT00194740|Docetaxel|docetaxel|mesh-list
65010884|NCT00153660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010885|NCT00153660|Gout Suppressants|gout suppressants|mesh-ancestor
65010886|NCT00137657|Trimethoprim|trimethoprim|mesh-list
65010887|NCT00137657|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65010888|NCT00137657|Sulfamethoxazole|sulfamethoxazole|mesh-list
65010889|NCT00137657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65010890|NCT00137657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65010891|NCT00137657|Renal Agents|renal agents|mesh-ancestor
65010892|NCT00137657|Antimalarials|antimalarials|mesh-ancestor
65010893|NCT00137657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65010894|NCT00137657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65010895|NCT00137657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65010896|NCT00137657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010897|NCT00137657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010898|NCT00137657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65010899|NCT00137657|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65010900|NCT00137657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65010901|NCT00137657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65010902|NCT00153699|Topiramate|topiramate|mesh-list
65010903|NCT00153699|Anticonvulsants|anticonvulsants|mesh-ancestor
65010904|NCT00153699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65010905|NCT00153699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010906|NCT00160290|Lactulose|lactulose|mesh-list
65010907|NCT00160290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65010908|NCT00137735|Gabapentin|gabapentin|mesh-list
65010909|NCT00137735|Analgesics|analgesics|mesh-ancestor
65010910|NCT00137735|Sensory System Agents|sensory system agents|mesh-ancestor
65010911|NCT00137735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65010912|NCT00137735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010913|NCT00137735|Anticonvulsants|anticonvulsants|mesh-ancestor
65010914|NCT00137735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65010915|NCT00137735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65010936|NCT00160329|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65010937|NCT00160329|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65010938|NCT00160329|Protease Inhibitors|protease inhibitors|mesh-ancestor
65010939|NCT00160329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010940|NCT00160329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010941|NCT00160329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65010942|NCT00160329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65010943|NCT00160329|Antiviral Agents|antiviral agents|mesh-ancestor
65010944|NCT00160329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65010945|NCT00137813|Bevacizumab|bevacizumab|mesh-list
65010946|NCT00137813|Docetaxel|docetaxel|mesh-list
65275386|NCT02675868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275387|NCT02675868|Sympathomimetics|sympathomimetics|mesh-ancestor
65275388|NCT02675868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65275389|NCT02675868|Nasal Decongestants|nasal decongestants|mesh-ancestor
65275390|NCT02675868|Respiratory System Agents|respiratory system agents|mesh-ancestor
65275391|NCT02675868|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65275392|NCT02675868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65275393|NCT02675868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65275394|NCT02675868|Adrenergic Agents|adrenergic agents|mesh-ancestor
65275395|NCT02675868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65275396|NCT02675868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010947|NCT00137813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65010948|NCT00137813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010949|NCT00137813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65010950|NCT00137813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65010951|NCT00137813|Growth Substances|growth substances|mesh-ancestor
65010952|NCT00137813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010953|NCT00137813|Growth Inhibitors|growth inhibitors|mesh-ancestor
65010954|NCT00137813|Tubulin Modulators|tubulin modulators|mesh-ancestor
65010955|NCT00137813|Antimitotic Agents|antimitotic agents|mesh-ancestor
65010956|NCT00137813|Mitosis Modulators|mitosis modulators|mesh-ancestor
65010957|NCT00137813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010958|NCT00137852|Celecoxib|celecoxib|mesh-list
65010959|NCT00137852|Irinotecan|irinotecan|mesh-list
65010960|NCT00137852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010961|NCT00137852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65010962|NCT00137852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65010963|NCT00137852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010964|NCT00137852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010965|NCT00137852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65010966|NCT00137852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65010967|NCT00137852|Analgesics|analgesics|mesh-ancestor
65010990|NCT00138164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010992|NCT00153972|Cabergoline|cabergoline|mesh-list
65010993|NCT00153972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65010994|NCT00153972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65010995|NCT00153972|Dopamine Agents|dopamine agents|mesh-ancestor
65010996|NCT00153972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65010997|NCT00153972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010998|NCT00153972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010999|NCT00153972|Dopamine Agonists|dopamine agonists|mesh-ancestor
65011000|NCT00160485|Glyburide|glyburide|mesh-list
65011001|NCT00160485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65011002|NCT00160485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011003|NCT00404183|Acetaminophen|acetaminophen|mesh-list
65011004|NCT00404183|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65011005|NCT00404183|Hydrocodone|hydrocodone|mesh-list
65011006|NCT00404183|Oxycodone|oxycodone|mesh-list
65011007|NCT00404183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65011008|NCT00404183|Analgesics|analgesics|mesh-ancestor
65011009|NCT00404183|Sensory System Agents|sensory system agents|mesh-ancestor
65011010|NCT00404183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65011011|NCT00404183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011012|NCT00404183|Antipyretics|antipyretics|mesh-ancestor
65011013|NCT00404183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65011014|NCT00404183|Narcotics|narcotics|mesh-ancestor
65011015|NCT00404183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65011016|NCT00404183|Antitussive Agents|antitussive agents|mesh-ancestor
65011017|NCT00404183|Respiratory System Agents|respiratory system agents|mesh-ancestor
65011018|NCT00404183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65011019|NCT00404183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65011020|NCT00404183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65011042|NCT00160602|Certolizumab Pegol|certolizumab pegol|mesh-list
65275397|NCT02675868|Protective Agents|protective agents|mesh-ancestor
65275398|NCT02675868|Hemostatics|hemostatics|mesh-ancestor
65275399|NCT02675868|Coagulants|coagulants|mesh-ancestor
65275400|NCT02675868|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65275401|NCT02675868|Natriuretic Agents|natriuretic agents|mesh-ancestor
65275402|NCT05279742|Valsartan|valsartan|mesh-list
65275403|NCT05279742|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65011043|NCT00160602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65011044|NCT00160602|Immunologic Factors|immunologic factors|mesh-ancestor
65011045|NCT00160602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011046|NCT00160602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65011048|NCT00138242|Docetaxel|docetaxel|mesh-list
65011049|NCT00138242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011050|NCT00138242|Tubulin Modulators|tubulin modulators|mesh-ancestor
65011051|NCT00138242|Antimitotic Agents|antimitotic agents|mesh-ancestor
65011052|NCT00138242|Mitosis Modulators|mitosis modulators|mesh-ancestor
65011053|NCT00138242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011054|NCT00154050|Candesartan|candesartan|mesh-list
65011055|NCT00154050|Quinapril|quinapril|mesh-list
65011056|NCT00154050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65011057|NCT00154050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65011058|NCT00154050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65011059|NCT00154050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011060|NCT00154050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65011061|NCT00154050|Protease Inhibitors|protease inhibitors|mesh-ancestor
65011062|NCT00154050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011063|NCT00154089|Masoprocol|masoprocol|mesh-list
65011064|NCT00154089|Antioxidants|antioxidants|mesh-ancestor
65011065|NCT00154089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011066|NCT00154089|Protective Agents|protective agents|mesh-ancestor
65011067|NCT00154089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011068|NCT00154089|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65011069|NCT00154089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011070|NCT00154089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65011071|NCT00154089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65011072|NCT00154089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65011073|NCT00154089|Analgesics|analgesics|mesh-ancestor
65011074|NCT00154089|Sensory System Agents|sensory system agents|mesh-ancestor
65011105|NCT00154206|Mycophenolic Acid|mycophenolic acid|mesh-list
65011106|NCT00154206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65011107|NCT00154206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011108|NCT00154206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65011109|NCT00154206|Antitubercular Agents|antitubercular agents|mesh-ancestor
65011110|NCT00154206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65011111|NCT00154206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65011112|NCT00154206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011113|NCT00154206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011114|NCT00138554|Pioglitazone|pioglitazone|mesh-list
65011115|NCT00138554|Vildagliptin|vildagliptin|mesh-list
65011116|NCT00138554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65011117|NCT00138554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011118|NCT00138554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65011137|NCT00154245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011139|NCT00138632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65011140|NCT00138632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011141|NCT00138632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011142|NCT00160875|Irinotecan|irinotecan|mesh-list
65011143|NCT00160875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011144|NCT00160875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65011145|NCT00160875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65011146|NCT00160875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011147|NCT00160875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011149|NCT00138710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011150|NCT00138710|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65011151|NCT00138710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65011152|NCT00138710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275404|NCT05279742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65275405|NCT05279742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65275406|NCT05279742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65275407|NCT05279742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275408|NCT02673840|Ketotifen|ketotifen|mesh-list
65275409|NCT02673840|Antipruritics|antipruritics|mesh-ancestor
65275410|NCT02673840|Dermatologic Agents|dermatologic agents|mesh-ancestor
65275411|NCT02673840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65275412|NCT02673840|Histamine Antagonists|histamine antagonists|mesh-ancestor
65275413|NCT02673840|Histamine Agents|histamine agents|mesh-ancestor
65275414|NCT02673840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65275415|NCT02673840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275416|NCT02673840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275417|NCT02673840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65275418|NCT00644124|Aflibercept|aflibercept|mesh-list
65275419|NCT00644124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65275420|NCT00644124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65275421|NCT00644124|Growth Substances|growth substances|mesh-ancestor
65275422|NCT00644124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011153|NCT00138710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011154|NCT00138710|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65011155|NCT00138710|Hormone Antagonists|hormone antagonists|mesh-ancestor
65011156|NCT00138710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65011157|NCT00138710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011158|NCT00154323|Oxcarbazepine|oxcarbazepine|mesh-list
65011159|NCT00154323|Anticonvulsants|anticonvulsants|mesh-ancestor
65011160|NCT00154323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65011161|NCT00154323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65011162|NCT00154323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65011163|NCT00154323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011164|NCT00154323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65011165|NCT00154323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65011166|NCT00138866|Risedronic Acid|risedronic acid|mesh-list
65011167|NCT00138866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65011168|NCT00138866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65011169|NCT00138866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011170|NCT00138866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65011207|NCT00161070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65011208|NCT00161070|Analgesics|analgesics|mesh-ancestor
65011209|NCT00161070|Sensory System Agents|sensory system agents|mesh-ancestor
65011210|NCT00161070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65011211|NCT00161070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011213|NCT00161070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65011214|NCT00161070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65011215|NCT00161070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65011216|NCT00161070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011217|NCT00161070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65011218|NCT00161070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65011219|NCT00161070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011220|NCT00161070|Antipyretics|antipyretics|mesh-ancestor
65011221|NCT00161070|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65275423|NCT00644124|Growth Inhibitors|growth inhibitors|mesh-ancestor
65275424|NCT00644124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275425|NCT02670954|Flurbiprofen|flurbiprofen|mesh-list
65275426|NCT02670954|Dexmedetomidine|dexmedetomidine|mesh-list
65275427|NCT02670954|Tramadol|tramadol|mesh-list
65275428|NCT02670954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65275429|NCT02670954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65275430|NCT02670954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727907|NCT00002719|Cytarabine|cytarabine|mesh-list
65011222|NCT00161070|Vasodilator Agents|vasodilator agents|mesh-ancestor
65011223|NCT00138983|Vitamin D|vitamin d|mesh-list
65011224|NCT00138983|Alendronate|alendronate|mesh-list
65011225|NCT00138983|Alfacalcidol|alfacalcidol|mesh-list
65011226|NCT00138983|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65011227|NCT00138983|Vitamins|vitamins|mesh-ancestor
65011228|NCT00138983|Micronutrients|micronutrients|mesh-ancestor
65011229|NCT00138983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011230|NCT00138983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65011231|NCT01243177|Lacosamide|lacosamide|mesh-list
65011232|NCT01243177|Carbamazepine|carbamazepine|mesh-list
65011233|NCT01243177|Anticonvulsants|anticonvulsants|mesh-ancestor
65011234|NCT01243177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65011235|NCT01243177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65011236|NCT01243177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65011237|NCT01243177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011238|NCT01243177|Antimanic Agents|antimanic agents|mesh-ancestor
65011239|NCT01243177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65011240|NCT01243177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65011241|NCT01243177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011242|NCT01243177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65011243|NCT01243177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65011244|NCT01243177|Analgesics|analgesics|mesh-ancestor
65011245|NCT01243177|Sensory System Agents|sensory system agents|mesh-ancestor
65011246|NCT01243177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65011247|NCT01243177|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65011248|NCT01243177|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65011249|NCT00154440|Amoxicillin|amoxicillin|mesh-list
65011250|NCT00154440|Metronidazole|metronidazole|mesh-list
65011251|NCT00154440|Clarithromycin|clarithromycin|mesh-list
65011252|NCT00154440|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65011253|NCT00154440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65011254|NCT00154440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65011255|NCT00154440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65011256|NCT00154440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65011257|NCT00154440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65011258|NCT00154440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011259|NCT00154440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011260|NCT00154440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65011261|NCT00154440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65011262|NCT00139061|Atorvastatin|atorvastatin|mesh-list
65011263|NCT00139061|Torcetrapib|torcetrapib|mesh-list
65011264|NCT00139061|Fenofibrate|fenofibrate|mesh-list
65011265|NCT00139061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65011266|NCT00139061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65011267|NCT00139061|Antimetabolites|antimetabolites|mesh-ancestor
65011268|NCT00139061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011269|NCT00139061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65011270|NCT00139061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65011271|NCT00139061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011272|NCT00139100|Anti-Infective Agents|anti-infective agents|mesh-list
65011273|NCT00139100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65011274|NCT04705584|Cyclosporine|cyclosporine|mesh-list
65011275|NCT04705584|Prednisolone|prednisolone|mesh-list
65011277|NCT04705584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011278|NCT04705584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011279|NCT04705584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65011280|NCT04705584|Immunologic Factors|immunologic factors|mesh-ancestor
65011281|NCT04705584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275431|NCT02670954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65275432|NCT02670954|Analgesics|analgesics|mesh-ancestor
65275433|NCT02670954|Sensory System Agents|sensory system agents|mesh-ancestor
65275434|NCT02670954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65275435|NCT02670954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65275436|NCT02670954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65275437|NCT02670954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65275438|NCT02670954|Adrenergic Agents|adrenergic agents|mesh-ancestor
65275439|NCT02670954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65275440|NCT02670954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275441|NCT02670954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65275442|NCT02670954|Narcotics|narcotics|mesh-ancestor
65275443|NCT02670954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65275444|NCT02670954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65275445|NCT02670954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65275446|NCT02670954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65275447|NCT02670954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275448|NCT00644904|Vitamin D|vitamin d|mesh-list
65275449|NCT00644904|Ergocalciferols|ergocalciferols|mesh-list
65275450|NCT00644904|Cholecalciferol|cholecalciferol|mesh-list
65011282|NCT04705584|Antifungal Agents|antifungal agents|mesh-ancestor
65011283|NCT04705584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65011284|NCT04705584|Dermatologic Agents|dermatologic agents|mesh-ancestor
65011285|NCT04705584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65011286|NCT04705584|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65011287|NCT04705584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65011289|NCT04705584|Hormones|hormones|mesh-ancestor
65011290|NCT04705584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65011291|NCT04705584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65011292|NCT04705584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011293|NCT00139217|Nitric Oxide|nitric oxide|mesh-list
65011294|NCT00139217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65011295|NCT00139217|Autonomic Agents|autonomic agents|mesh-ancestor
65011296|NCT00139217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65011297|NCT00139217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011298|NCT00139217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65011299|NCT00139217|Respiratory System Agents|respiratory system agents|mesh-ancestor
65011300|NCT00139217|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65011301|NCT00139217|Antioxidants|antioxidants|mesh-ancestor
65011302|NCT00139217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011303|NCT00139217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65011304|NCT00139217|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65011305|NCT00139217|Vasodilator Agents|vasodilator agents|mesh-ancestor
65011306|NCT00139217|Gasotransmitters|gasotransmitters|mesh-ancestor
65011307|NCT00139217|Protective Agents|protective agents|mesh-ancestor
65011308|NCT00161226|Levonorgestrel|levonorgestrel|mesh-list
65011309|NCT00161226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65011310|NCT00161226|Contraceptive Agents|contraceptive agents|mesh-ancestor
65011311|NCT00161226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65011312|NCT00161226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011313|NCT00161226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65011314|NCT00161226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65011315|NCT00161226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65011316|NCT00139256|Betamethasone|betamethasone|mesh-list
65275451|NCT00644904|Vitamins|vitamins|mesh-list
65275452|NCT00644904|Micronutrients|micronutrients|mesh-ancestor
65275453|NCT00644904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275454|NCT00644904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65275455|NCT00644904|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65275456|NCT02670564|Busulfan|busulfan|mesh-list
65275457|NCT02670564|Alkylating Agents|alkylating agents|mesh-ancestor
65275458|NCT02670564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275459|NCT02670564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65275460|NCT02670564|Immunologic Factors|immunologic factors|mesh-ancestor
64727932|NCT00003326|Paclitaxel|paclitaxel|mesh-list
65011317|NCT00139256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65011318|NCT00139256|Glucocorticoids|glucocorticoids|mesh-ancestor
65011319|NCT00139256|Hormones|hormones|mesh-ancestor
65011320|NCT00139256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65011321|NCT00139256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011322|NCT00139256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65011323|NCT00139256|Respiratory System Agents|respiratory system agents|mesh-ancestor
65011324|NCT00161304|Methyltestosterone|methyltestosterone|mesh-list
65011325|NCT00161304|Testosterone|testosterone|mesh-list
65011326|NCT00161304|Testosterone undecanoate|testosterone undecanoate|mesh-list
65011327|NCT00161304|Testosterone enanthate|testosterone enanthate|mesh-list
65011328|NCT00161304|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65011329|NCT00161304|Androgens|androgens|mesh-ancestor
65011330|NCT00161304|Hormones|hormones|mesh-ancestor
65011331|NCT00161304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65011332|NCT00161304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011333|NCT00161304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65011334|NCT00161304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011335|NCT00161304|Anabolic Agents|anabolic agents|mesh-ancestor
65011336|NCT01242748|Goserelin|goserelin|mesh-list
65011337|NCT01242748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65011338|NCT01242748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011339|NCT00139373|Donepezil|donepezil|mesh-list
65011340|NCT00139373|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65011341|NCT00139373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011342|NCT00139373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011343|NCT00139373|Cholinergic Agents|cholinergic agents|mesh-ancestor
65011344|NCT00139373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65011345|NCT00139373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011346|NCT00139373|Nootropic Agents|nootropic agents|mesh-ancestor
65011347|NCT00161421|Leuprolide|leuprolide|mesh-list
65011348|NCT00161421|Testosterone|testosterone|mesh-list
65011349|NCT00161421|Dutasteride|dutasteride|mesh-list
65011386|NCT00406302|Cetuximab|cetuximab|mesh-list
65011387|NCT00406302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970055|NCT00048360|Bupropion|bupropion|mesh-list
65011415|NCT00139724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65011416|NCT00139724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011417|NCT00139724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011418|NCT00139724|Urological Agents|urological agents|mesh-ancestor
65011419|NCT00161577|Ketorolac|ketorolac|mesh-list
65011420|NCT00161577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65011421|NCT00161577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65011422|NCT00161577|Analgesics|analgesics|mesh-ancestor
65011423|NCT00161577|Sensory System Agents|sensory system agents|mesh-ancestor
65011424|NCT00161577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65011425|NCT00161577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011426|NCT00161577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65011427|NCT00161577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65011428|NCT00161577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65011429|NCT00161577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011430|NCT00161577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011431|NCT00404261|Fluticasone|fluticasone|mesh-list
65011458|NCT00406380|Growth Substances|growth substances|mesh-ancestor
65275461|NCT02670564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275462|NCT02670564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65275463|NCT02670564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275464|NCT02670564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65275465|NCT02672202|Pregabalin|pregabalin|mesh-list
65275466|NCT02672202|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65275467|NCT02672202|Analgesics|analgesics|mesh-ancestor
65275468|NCT02672202|Sensory System Agents|sensory system agents|mesh-ancestor
65275469|NCT02672202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65011459|NCT00406380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011460|NCT00406380|Growth Inhibitors|growth inhibitors|mesh-ancestor
65011461|NCT00406497|Difluprednate|difluprednate|mesh-list
65011462|NCT00406497|Glucocorticoids|glucocorticoids|mesh-ancestor
65011463|NCT00406497|Hormones|hormones|mesh-ancestor
65011464|NCT00406497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65011465|NCT00406497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011466|NCT00161655|Etanercept|etanercept|mesh-list
65011467|NCT00161655|Methotrexate|methotrexate|mesh-list
65011468|NCT00161655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65011469|NCT00161655|Abortifacient Agents|abortifacient agents|mesh-ancestor
65011470|NCT00161655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65011471|NCT00161655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011472|NCT00161655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65011473|NCT00161655|Antimetabolites|antimetabolites|mesh-ancestor
65011474|NCT00161655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011475|NCT00161655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011476|NCT00161655|Dermatologic Agents|dermatologic agents|mesh-ancestor
65011477|NCT00161655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011478|NCT00161655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65011479|NCT00161655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65011498|NCT00139880|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65011499|NCT00139880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65011500|NCT00139880|Immunologic Factors|immunologic factors|mesh-ancestor
65011501|NCT00139880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011502|NCT00139880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65011503|NCT00139880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65011504|NCT00139880|Dopamine Agonists|dopamine agonists|mesh-ancestor
65011505|NCT00139880|Dopamine Agents|dopamine agents|mesh-ancestor
65011506|NCT00139880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65011507|NCT00139880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011508|NCT04724187|Misoprostol|misoprostol|mesh-list
65011509|NCT04724187|Oxytocin|oxytocin|mesh-list
65011510|NCT04724187|Oxytocics|oxytocics|mesh-ancestor
65011511|NCT04724187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64466712|NCT01810588|Rituximab|rituximab|mesh-list
65011512|NCT04724187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011513|NCT04724187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65011514|NCT04724187|Abortifacient Agents|abortifacient agents|mesh-ancestor
65011515|NCT04724187|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65011516|NCT04724187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65011517|NCT04727021|Rivaroxaban|rivaroxaban|mesh-list
65011518|NCT04727021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65011519|NCT04727021|Antithrombins|antithrombins|mesh-ancestor
65011520|NCT04727021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65011521|NCT04727021|Protease Inhibitors|protease inhibitors|mesh-ancestor
65011522|NCT04727021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011523|NCT04727021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011524|NCT04727021|Anticoagulants|anticoagulants|mesh-ancestor
65011525|NCT04724226|Apatinib|apatinib|mesh-list
65011526|NCT04724226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011527|NCT04724226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65011528|NCT04724226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011529|NCT04724226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011530|NCT04724343|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65011531|NCT04724343|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65011532|NCT04724343|Cetrorelix|cetrorelix|mesh-list
65011533|NCT04724343|Menotropins|menotropins|mesh-list
65275470|NCT02672202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275471|NCT02672202|Anticonvulsants|anticonvulsants|mesh-ancestor
65275472|NCT02672202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65275473|NCT02672202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65275474|NCT02672202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275475|NCT02672202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65275476|NCT02672202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65275477|NCT02672202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65275478|NCT02672202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65275479|NCT02672202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65275480|NCT02672202|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65275481|NCT02672202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65275482|NCT02672202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65275483|NCT02672202|Antidepressive Agents|antidepressive agents|mesh-ancestor
65275484|NCT02672202|Dopamine Agents|dopamine agents|mesh-ancestor
65275485|NCT02671578|Nitrous Oxide|nitrous oxide|mesh-list
65275486|NCT02671578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65275487|NCT02671578|Anesthetics, General|anesthetics, general|mesh-ancestor
65275488|NCT02671578|Anesthetics|anesthetics|mesh-ancestor
65275489|NCT02671578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65275490|NCT02671578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275491|NCT02671578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65275492|NCT02671578|Analgesics|analgesics|mesh-ancestor
65275493|NCT02671578|Sensory System Agents|sensory system agents|mesh-ancestor
65275494|NCT02671578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65275495|NCT00644982|Sertraline|sertraline|mesh-list
65275496|NCT00644982|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65275497|NCT00644982|Antidepressive Agents|antidepressive agents|mesh-ancestor
65275498|NCT00644982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65275499|NCT00644982|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65275500|NCT00644982|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65275501|NCT00644982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65275502|NCT00644982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275504|NCT00644982|Serotonin Agents|serotonin agents|mesh-ancestor
65275506|NCT00644982|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65275507|NCT00644982|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65275508|NCT02670642|Esomeprazole|esomeprazole|mesh-list
65275509|NCT02670642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65275510|NCT02670642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65275511|NCT02670642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65275512|NCT02670642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275513|NCT02670642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275514|NCT04175496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65275515|NCT02670018|Metformin|metformin|mesh-list
65275516|NCT02670018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65275517|NCT02670018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275518|NCT02670096|Acetazolamide|acetazolamide|mesh-list
65275519|NCT02670096|Anticonvulsants|anticonvulsants|mesh-ancestor
65275520|NCT02670096|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65275521|NCT02670096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275522|NCT02670096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275523|NCT02670096|Diuretics|diuretics|mesh-ancestor
65275524|NCT02670096|Natriuretic Agents|natriuretic agents|mesh-ancestor
65025544|NCT00183612|Olanzapine|olanzapine|mesh-list
65275525|NCT02670096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275527|NCT00645060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65275528|NCT00645060|Immunologic Factors|immunologic factors|mesh-ancestor
65275529|NCT00645060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275530|NCT04176978|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65275531|NCT04176978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65275532|NCT04176978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65275533|NCT04176978|Antimetabolites|antimetabolites|mesh-ancestor
65275534|NCT04176978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275535|NCT04176978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65275536|NCT04176978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65275537|NCT04176978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275538|NCT00644670|Atorvastatin|atorvastatin|mesh-list
65275544|NCT00644670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65275545|NCT00644670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275546|NCT02669706|Pentamidine|pentamidine|mesh-list
65275547|NCT02669706|Antifungal Agents|antifungal agents|mesh-ancestor
65275548|NCT02669706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65275549|NCT02669706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65275550|NCT02669706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65275551|NCT02669706|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65275552|NCT00645138|Anesthetics|anesthetics|mesh-list
65275553|NCT00645138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65275554|NCT00645138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275555|NCT00895895|Donepezil|donepezil|mesh-list
65275556|NCT00895895|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65275557|NCT00895895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275558|NCT00895895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275559|NCT00895895|Cholinergic Agents|cholinergic agents|mesh-ancestor
65275560|NCT00895895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65275561|NCT00895895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275562|NCT00895895|Nootropic Agents|nootropic agents|mesh-ancestor
65275563|NCT00644748|Gabapentin|gabapentin|mesh-list
65275564|NCT00644748|Analgesics|analgesics|mesh-ancestor
65275565|NCT00644748|Sensory System Agents|sensory system agents|mesh-ancestor
65275566|NCT00644748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65275567|NCT00644748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275568|NCT00644748|Anticonvulsants|anticonvulsants|mesh-ancestor
65275569|NCT00644748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64728039|NCT00003620|Alvocidib|alvocidib|mesh-list
65011534|NCT04724343|Luteolytic Agents|luteolytic agents|mesh-ancestor
65011535|NCT04724343|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65011568|NCT00140114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65011569|NCT00140114|Oxytocics|oxytocics|mesh-ancestor
65011570|NCT00140153|Testosterone|testosterone|mesh-list
65011571|NCT00140153|Androgens|androgens|mesh-ancestor
65011572|NCT00140153|Hormones|hormones|mesh-ancestor
65011573|NCT00140153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65011574|NCT00140153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011575|NCT00140309|Moxifloxacin|moxifloxacin|mesh-list
65011576|NCT00140309|Rifampin|rifampin|mesh-list
65011598|NCT00140309|Antimetabolites|antimetabolites|mesh-ancestor
65011599|NCT00140309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65011601|NCT00161811|Immunologic Factors|immunologic factors|mesh-ancestor
65011602|NCT00161811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011603|NCT01240135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65011604|NCT01240759|Metformin|metformin|mesh-list
65011605|NCT01240759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65011606|NCT01240759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011607|NCT01241734|Lenalidomide|lenalidomide|mesh-list
65011608|NCT01241734|Immunologic Factors|immunologic factors|mesh-ancestor
65011609|NCT01241734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011610|NCT01241734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65275570|NCT00644748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65275571|NCT00644748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65275572|NCT00644748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65275573|NCT00644748|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65275574|NCT00644748|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65275575|NCT00644748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64728055|NCT00003626|Tubulin Modulators|tubulin modulators|mesh-ancestor
65011611|NCT01241734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65011612|NCT01241734|Growth Substances|growth substances|mesh-ancestor
65011613|NCT01241734|Growth Inhibitors|growth inhibitors|mesh-ancestor
65011614|NCT01241734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011615|NCT00504634|Bortezomib|bortezomib|mesh-list
65011616|NCT00504634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011617|NCT00140465|Clopidogrel|clopidogrel|mesh-list
65011618|NCT00140465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65011619|NCT00140465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65011620|NCT00140465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65011621|NCT00140465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65011622|NCT00140465|Purinergic Agents|purinergic agents|mesh-ancestor
65011623|NCT00140465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65011624|NCT00140465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011625|NCT00140465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011626|NCT00504673|Insulin|insulin|mesh-list
65011627|NCT00504673|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65011651|NCT00140543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65011652|NCT00140543|Antitubercular Agents|antitubercular agents|mesh-ancestor
65011653|NCT00140543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65011654|NCT00140543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65011655|NCT00140543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011656|NCT00140543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011657|NCT00140543|Antifungal Agents|antifungal agents|mesh-ancestor
65011658|NCT00140543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65011659|NCT00140543|Immunologic Factors|immunologic factors|mesh-ancestor
65011660|NCT00140543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011661|NCT00154791|Gemcitabine|gemcitabine|mesh-list
65011662|NCT00154791|Oxaliplatin|oxaliplatin|mesh-list
65011663|NCT00154791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65011664|NCT00154791|Antimetabolites|antimetabolites|mesh-ancestor
65011665|NCT00154791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011666|NCT00154791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011667|NCT00154791|Antiviral Agents|antiviral agents|mesh-ancestor
65011668|NCT00154791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65011669|NCT00154791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011670|NCT00154791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65011671|NCT00154791|Immunologic Factors|immunologic factors|mesh-ancestor
65011672|NCT00154791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011673|NCT00140582|Rituximab|rituximab|mesh-list
65011674|NCT00140582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65011675|NCT00140582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011676|NCT00140582|Immunologic Factors|immunologic factors|mesh-ancestor
65011677|NCT00140582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011678|NCT00140582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65011679|NCT00154869|Ribavirin|ribavirin|mesh-list
65011680|NCT00154869|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65011681|NCT00154869|Antimetabolites|antimetabolites|mesh-ancestor
65011715|NCT00162201|Immunologic Factors|immunologic factors|mesh-ancestor
65011716|NCT00162201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011717|NCT00162201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65011718|NCT01248247|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65011719|NCT01248247|Sorafenib|sorafenib|mesh-list
65011720|NCT01248247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011721|NCT01248247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65011745|NCT00155064|Protease Inhibitors|protease inhibitors|mesh-ancestor
65011746|NCT00155064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011747|NCT02483260|Ribavirin|ribavirin|mesh-list
65011748|NCT02483260|Antimetabolites|antimetabolites|mesh-ancestor
65011749|NCT02483260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011750|NCT02483260|Antiviral Agents|antiviral agents|mesh-ancestor
65275576|NCT00644748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275577|NCT00644748|Antimanic Agents|antimanic agents|mesh-ancestor
65275578|NCT00910416|Remifentanil|remifentanil|mesh-list
65275579|NCT00910416|Propofol|propofol|mesh-list
65275580|NCT00910416|Sevoflurane|sevoflurane|mesh-list
65275581|NCT00910416|Atracurium|atracurium|mesh-list
65011751|NCT02483260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65011752|NCT00140933|Diclofenac|diclofenac|mesh-list
65011753|NCT00140933|Rofecoxib|rofecoxib|mesh-list
65011754|NCT00140933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65011755|NCT00140933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65011756|NCT00140933|Analgesics|analgesics|mesh-ancestor
65011757|NCT00140933|Sensory System Agents|sensory system agents|mesh-ancestor
65011758|NCT00140933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65011759|NCT00140933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011760|NCT00140933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65011761|NCT00140933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65011762|NCT00140933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65011763|NCT00140933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011764|NCT00140933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011765|NCT00140933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65011766|NCT04515628|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65011767|NCT04515628|Branebrutinib|branebrutinib|mesh-list
65011768|NCT04515628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65011769|NCT04515628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65011770|NCT04515628|Antimetabolites|antimetabolites|mesh-ancestor
64970405|NCT00084981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011784|NCT04510051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65011786|NCT04510051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011787|NCT04510051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011788|NCT04510051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65011789|NCT00141011|Ancrod|ancrod|mesh-list
65011790|NCT00141011|Anticoagulants|anticoagulants|mesh-ancestor
65011791|NCT00141011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65011792|NCT00141011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65011793|NCT00141011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011794|NCT00504946|Cholecalciferol|cholecalciferol|mesh-list
65011795|NCT00504946|Vitamin D|vitamin d|mesh-list
65011796|NCT00504946|Prednisone|prednisone|mesh-list
65011797|NCT00504946|Budesonide|budesonide|mesh-list
65011798|NCT00504946|Montelukast|montelukast|mesh-list
65011799|NCT00504946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65011800|NCT00504946|Glucocorticoids|glucocorticoids|mesh-ancestor
65011801|NCT00504946|Hormones|hormones|mesh-ancestor
65011802|NCT00504946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65011803|NCT00504946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011804|NCT00504946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65011805|NCT00504946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011806|NCT00504946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65011807|NCT00504946|Respiratory System Agents|respiratory system agents|mesh-ancestor
65011808|NCT00504946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65011809|NCT00504946|Hormone Antagonists|hormone antagonists|mesh-ancestor
65011810|NCT00504946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65011811|NCT00504946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65011812|NCT00504946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011814|NCT00504946|Autonomic Agents|autonomic agents|mesh-ancestor
65011815|NCT00504946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65011816|NCT00504946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65011817|NCT00504946|Vitamins|vitamins|mesh-ancestor
65011818|NCT00504946|Micronutrients|micronutrients|mesh-ancestor
65011819|NCT00504946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65011820|NCT00141050|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
65011821|NCT00141050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65011822|NCT00141050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011823|NCT00141050|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65011824|NCT00141050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65011825|NCT00141050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65011826|NCT00141050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011827|NCT00141050|Dopamine Agents|dopamine agents|mesh-ancestor
65275582|NCT00910416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65275583|NCT00910416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65275584|NCT00910416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275585|NCT00910416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65275586|NCT00910416|Anesthetics, General|anesthetics, general|mesh-ancestor
65275587|NCT00910416|Anesthetics|anesthetics|mesh-ancestor
65275588|NCT00910416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65275589|NCT00910416|Narcotics|narcotics|mesh-ancestor
65275590|NCT00910416|Analgesics|analgesics|mesh-ancestor
65275591|NCT00910416|Sensory System Agents|sensory system agents|mesh-ancestor
65011828|NCT00141050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65011829|NCT04511416|Metformin|metformin|mesh-list
65011830|NCT04511416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65011883|NCT00141362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64467157|NCT00425230|Sensory System Agents|sensory system agents|mesh-ancestor
65011884|NCT00141362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011885|NCT00141362|Anticonvulsants|anticonvulsants|mesh-ancestor
65011886|NCT00141362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65011887|NCT00141362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65011888|NCT00141362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011889|NCT00141362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65011890|NCT00141362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65011891|NCT00141362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65011892|NCT00141362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65011893|NCT00141362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65011894|NCT00155259|Docetaxel|docetaxel|mesh-list
65011895|NCT00155259|Capecitabine|capecitabine|mesh-list
65011896|NCT00155259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011897|NCT00155259|Tubulin Modulators|tubulin modulators|mesh-ancestor
65011898|NCT00155259|Antimitotic Agents|antimitotic agents|mesh-ancestor
65011899|NCT00155259|Mitosis Modulators|mitosis modulators|mesh-ancestor
65011900|NCT00155259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011901|NCT00155259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65011902|NCT00155259|Antimetabolites|antimetabolites|mesh-ancestor
65011903|NCT04518124|Propranolol|propranolol|mesh-list
65011904|NCT04518124|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65011905|NCT04518124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65011906|NCT04518124|Adrenergic Agents|adrenergic agents|mesh-ancestor
65011907|NCT04518124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65011908|NCT04518124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011909|NCT04518124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011910|NCT04518124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65011911|NCT04518124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65011912|NCT04518124|Vasodilator Agents|vasodilator agents|mesh-ancestor
65011913|NCT00141401|Pregabalin|pregabalin|mesh-list
65011914|NCT00141401|Analgesics|analgesics|mesh-ancestor
65011915|NCT00141401|Sensory System Agents|sensory system agents|mesh-ancestor
65011916|NCT00141401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65011917|NCT00141401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011940|NCT00404378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65011941|NCT00404378|Hormone Antagonists|hormone antagonists|mesh-ancestor
65011942|NCT00404378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65011943|NCT00404378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011944|NCT00404378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65011945|NCT00404378|Antiemetics|antiemetics|mesh-ancestor
65011946|NCT00404378|Autonomic Agents|autonomic agents|mesh-ancestor
65011947|NCT00404378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65011948|NCT00404378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65011949|NCT00404378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65011950|NCT00404378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65011951|NCT04511728|Propofol|propofol|mesh-list
65011952|NCT04511728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65011953|NCT04511728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65011954|NCT04511728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275592|NCT00910416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65275593|NCT00910416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65275594|NCT00910416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65275595|NCT00910416|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65275596|NCT00910416|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65275597|NCT00910416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65275598|NCT00910416|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65275599|NCT00910416|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65275601|NCT00910416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65275602|NCT00910416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275603|NCT02669238|Etonogestrel|etonogestrel|mesh-list
65275604|NCT02669238|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65275605|NCT02669238|Contraceptive Agents|contraceptive agents|mesh-ancestor
65275606|NCT02669238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65275607|NCT02669238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011955|NCT04511728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65011956|NCT04511728|Anesthetics, General|anesthetics, general|mesh-ancestor
65011957|NCT04511728|Anesthetics|anesthetics|mesh-ancestor
65011959|NCT00162318|Gefitinib|gefitinib|mesh-list
65011960|NCT00162318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65011961|NCT00162318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011962|NCT00162318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65011963|NCT00162318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011964|NCT00162318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011965|NCT00404417|Botulinum Toxins|botulinum toxins|mesh-list
65011966|NCT00404417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65011967|NCT00404417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65011968|NCT00404417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65011993|NCT00404534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65011994|NCT00404534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65011995|NCT00404534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011996|NCT00404534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011997|NCT00404534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65011998|NCT00404534|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65011999|NCT00404534|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65012000|NCT00505258|Ceftobiprole|ceftobiprole|mesh-list
65012001|NCT00505258|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
65012002|NCT00505258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65012003|NCT00505258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65012004|NCT00162396|Albuterol|albuterol|mesh-list
65012005|NCT00162396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65012006|NCT00162396|Autonomic Agents|autonomic agents|mesh-ancestor
65012007|NCT00162396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65012008|NCT00162396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012009|NCT00162396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65012010|NCT00162396|Respiratory System Agents|respiratory system agents|mesh-ancestor
65012011|NCT00162396|Tocolytic Agents|tocolytic agents|mesh-ancestor
65012012|NCT00162396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65012013|NCT00162396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65012014|NCT00162396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65012015|NCT00162396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65012016|NCT00162396|Adrenergic Agents|adrenergic agents|mesh-ancestor
64970660|NCT00221494|Pindolol|pindolol|mesh-list
65012037|NCT00155376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65012039|NCT00155376|Hormones|hormones|mesh-ancestor
65012040|NCT00155376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65012041|NCT00141557|Methyltestosterone|methyltestosterone|mesh-list
65275608|NCT02669238|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65275609|NCT02669004|Morphine|morphine|mesh-list
65275610|NCT02669004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65275611|NCT02669004|Narcotics|narcotics|mesh-ancestor
65275612|NCT02669004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65275613|NCT02669004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275614|NCT02669004|Analgesics|analgesics|mesh-ancestor
65275615|NCT02669004|Sensory System Agents|sensory system agents|mesh-ancestor
65275616|NCT02669004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65275617|NCT00895661|Rituximab|rituximab|mesh-list
65275618|NCT00895661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65275619|NCT00895661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275620|NCT00895661|Immunologic Factors|immunologic factors|mesh-ancestor
65275621|NCT00895661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275622|NCT00895661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65275623|NCT00645294|Adefovir|adefovir|mesh-list
65275624|NCT00645294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65012042|NCT00141557|Estrogens|estrogens|mesh-list
65012043|NCT00141557|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
65012044|NCT00141557|Estrone|estrone|mesh-list
65012045|NCT00141557|Testosterone|testosterone|mesh-list
65012046|NCT00141557|Testosterone undecanoate|testosterone undecanoate|mesh-list
65012047|NCT00141557|Testosterone enanthate|testosterone enanthate|mesh-list
65012048|NCT00141557|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65012049|NCT00141557|Hormones|hormones|mesh-ancestor
65012050|NCT00141557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65012051|NCT00141557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012052|NCT00141557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65012053|NCT00141557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65012054|NCT00141557|Anabolic Agents|anabolic agents|mesh-ancestor
65012055|NCT00141557|Androgens|androgens|mesh-ancestor
65012056|NCT00162474|Phenytoin|phenytoin|mesh-list
65012057|NCT00162474|Warfarin|warfarin|mesh-list
65012058|NCT00162474|Anticoagulants|anticoagulants|mesh-ancestor
65012059|NCT00162474|Anticonvulsants|anticonvulsants|mesh-ancestor
65012060|NCT00162474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65012061|NCT00162474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65012062|NCT00162474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65012063|NCT00162474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012064|NCT00162474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65012065|NCT00162474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65012066|NCT04518553|Antiviral Agents|antiviral agents|mesh-list
65012067|NCT04518553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65012068|NCT00505336|Eplerenone|eplerenone|mesh-list
65012069|NCT00505336|Atorvastatin|atorvastatin|mesh-list
65012070|NCT00505336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65012071|NCT00505336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65012072|NCT00505336|Antimetabolites|antimetabolites|mesh-ancestor
65012073|NCT00505336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012074|NCT00505336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65012130|NCT02275663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012132|NCT02275663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65012133|NCT02275663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012134|NCT02275702|Dexamethasone|dexamethasone|mesh-list
65012135|NCT02275702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65012136|NCT02275702|Antiemetics|antiemetics|mesh-ancestor
65012137|NCT02275702|Autonomic Agents|autonomic agents|mesh-ancestor
65012138|NCT02275702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65012139|NCT02275702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012140|NCT02275702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65275625|NCT00645294|Antiviral Agents|antiviral agents|mesh-ancestor
65275626|NCT00645294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65275627|NCT00645294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65275628|NCT00645294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65275629|NCT00645294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275630|NCT00645294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275631|NCT02837003|Aspirin|aspirin|mesh-list
64728108|NCT00004112|Glucocorticoids|glucocorticoids|mesh-ancestor
65012141|NCT02275702|Glucocorticoids|glucocorticoids|mesh-ancestor
65012142|NCT02275702|Hormones|hormones|mesh-ancestor
65012143|NCT02275702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65012144|NCT02275702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65012145|NCT02275702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65012146|NCT04518163|Tranexamic Acid|tranexamic acid|mesh-list
65012147|NCT04518163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65012148|NCT04518163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65012149|NCT04518163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012172|NCT04517188|Trace Elements|trace elements|mesh-ancestor
65012173|NCT04517188|Micronutrients|micronutrients|mesh-ancestor
65012174|NCT04517188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012175|NCT04517188|Plasma Substitutes|plasma substitutes|mesh-ancestor
65012176|NCT04517188|Blood Substitutes|blood substitutes|mesh-ancestor
65012177|NCT00162552|Pentoxifylline|pentoxifylline|mesh-list
65012178|NCT00162552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65012179|NCT00162552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012180|NCT00162552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012181|NCT00162552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65012182|NCT00162552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65012184|NCT00162552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012185|NCT00162552|Vasodilator Agents|vasodilator agents|mesh-ancestor
65012186|NCT00162552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65012187|NCT00162552|Antioxidants|antioxidants|mesh-ancestor
65012188|NCT04516681|Ascorbic Acid|ascorbic acid|mesh-list
65012189|NCT04516681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012190|NCT04516681|Vitamins|vitamins|mesh-ancestor
65012191|NCT04516681|Micronutrients|micronutrients|mesh-ancestor
65012192|NCT04516681|Antioxidants|antioxidants|mesh-ancestor
65012193|NCT04516681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012194|NCT04516681|Protective Agents|protective agents|mesh-ancestor
65012195|NCT00141791|Etanercept|etanercept|mesh-list
65012196|NCT00141791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65012197|NCT00141791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65012198|NCT00141791|Analgesics|analgesics|mesh-ancestor
65012199|NCT00141791|Sensory System Agents|sensory system agents|mesh-ancestor
65012200|NCT00141791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65012201|NCT00141791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012202|NCT00141791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65012203|NCT00141791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65012204|NCT00141791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65012205|NCT00141791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64970863|NCT00222820|Citalopram|citalopram|mesh-list
65012230|NCT00141830|Abortifacient Agents|abortifacient agents|mesh-ancestor
65012231|NCT00141830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65012232|NCT00141830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012233|NCT00141830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65012234|NCT00141830|Antimetabolites|antimetabolites|mesh-ancestor
65012235|NCT00141830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012236|NCT00141830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65012237|NCT00141830|Dermatologic Agents|dermatologic agents|mesh-ancestor
65012238|NCT00141830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012239|NCT00141830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65012240|NCT00141830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65012241|NCT00141830|Immunologic Factors|immunologic factors|mesh-ancestor
65012242|NCT00141830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65012243|NCT00141830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65012244|NCT04516174|Dexmedetomidine|dexmedetomidine|mesh-list
65012245|NCT04516174|Ropivacaine|ropivacaine|mesh-list
65275632|NCT02837003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65275633|NCT02837003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65275634|NCT02837003|Analgesics|analgesics|mesh-ancestor
65275635|NCT02837003|Sensory System Agents|sensory system agents|mesh-ancestor
65275636|NCT02837003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65275637|NCT02837003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275638|NCT02837003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65275639|NCT02837003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65275640|NCT02837003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65012246|NCT04516174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65012247|NCT04516174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65012248|NCT04516174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012249|NCT04516174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65012250|NCT04516174|Analgesics|analgesics|mesh-ancestor
65012251|NCT04516174|Sensory System Agents|sensory system agents|mesh-ancestor
65012252|NCT04516174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65012253|NCT04516174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65012254|NCT04516174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64970893|NCT00223015|Tacrolimus|tacrolimus|mesh-list
65012272|NCT00505531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65012273|NCT00505531|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65012274|NCT00505531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65012275|NCT00505531|Anesthetics, Local|anesthetics, local|mesh-ancestor
65012277|NCT00505531|Antiemetics|antiemetics|mesh-ancestor
65012278|NCT00505531|Autonomic Agents|autonomic agents|mesh-ancestor
65012279|NCT00505531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65012280|NCT00505531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65012281|NCT00505531|Histamine Antagonists|histamine antagonists|mesh-ancestor
65012282|NCT00505531|Histamine Agents|histamine agents|mesh-ancestor
65012283|NCT00505531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65012284|NCT00505531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012285|NCT00505531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65012286|NCT00141908|Castor Oil|castor oil|mesh-list
65012287|NCT00141908|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
65012288|NCT00141908|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
65012289|NCT00141908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65012290|NCT00141908|Hormone Antagonists|hormone antagonists|mesh-ancestor
65012291|NCT00141908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65012292|NCT00141908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012293|NCT00141908|Progestins|progestins|mesh-ancestor
65012294|NCT00141908|Hormones|hormones|mesh-ancestor
65012295|NCT00141908|Cathartics|cathartics|mesh-ancestor
65012296|NCT00141908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65012297|NCT00162669|Bevacizumab|bevacizumab|mesh-list
65012298|NCT00162669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65012299|NCT00162669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65012300|NCT00162669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65012301|NCT00162669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65012302|NCT00162669|Growth Substances|growth substances|mesh-ancestor
65012303|NCT00162669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012304|NCT00162669|Growth Inhibitors|growth inhibitors|mesh-ancestor
65012305|NCT00141947|Bexarotene|bexarotene|mesh-list
65012306|NCT00141947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65012307|NCT04514770|Misoprostol|misoprostol|mesh-list
65012308|NCT04514770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65012309|NCT04514770|Abortifacient Agents|abortifacient agents|mesh-ancestor
65012310|NCT04514770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65012311|NCT04514770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012312|NCT04514770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65012313|NCT04514770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65012341|NCT04514419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65012342|NCT04514419|Tubulin Modulators|tubulin modulators|mesh-ancestor
65012343|NCT04514419|Antimitotic Agents|antimitotic agents|mesh-ancestor
65012344|NCT04514419|Mitosis Modulators|mitosis modulators|mesh-ancestor
65012345|NCT04514419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275641|NCT02837003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65275642|NCT02837003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275643|NCT02837003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65275644|NCT02837003|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65275645|NCT02837003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012346|NCT04514419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65012348|NCT00142025|Anticonvulsants|anticonvulsants|mesh-ancestor
65012349|NCT00142025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65012350|NCT00142025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65012351|NCT00142025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65012352|NCT00142025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012353|NCT00142025|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65012354|NCT00142025|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65012355|NCT02275897|Methamphetamine|methamphetamine|mesh-list
65012356|NCT02275897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65012357|NCT02275897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012358|NCT02275897|Sympathomimetics|sympathomimetics|mesh-ancestor
65012359|NCT02275897|Autonomic Agents|autonomic agents|mesh-ancestor
65012360|NCT02275897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65012387|NCT00505804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65012388|NCT00505804|Analgesics|analgesics|mesh-ancestor
65012389|NCT00505804|Sensory System Agents|sensory system agents|mesh-ancestor
65012390|NCT00505804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65012391|NCT00505804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65012392|NCT00505804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65012393|NCT00505804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65012394|NCT00505804|Adrenergic Agents|adrenergic agents|mesh-ancestor
65012395|NCT00505804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65012396|NCT00505804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012397|NCT00505804|Antiemetics|antiemetics|mesh-ancestor
65012398|NCT00505804|Autonomic Agents|autonomic agents|mesh-ancestor
65012399|NCT00505804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65012401|NCT00505804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65012402|NCT00505804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65012403|NCT00505804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65012404|NCT00505804|Dopamine Agents|dopamine agents|mesh-ancestor
65012405|NCT00505804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65012406|NCT00505843|Levodopa|levodopa|mesh-list
65012407|NCT00505843|Carbidopa|carbidopa|mesh-list
65012408|NCT00505843|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65012409|NCT00505843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65012424|NCT00142337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65012425|NCT00142337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012426|NCT00142337|Antiviral Agents|antiviral agents|mesh-ancestor
65012427|NCT00142337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65012428|NCT00142337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65012429|NCT00142337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65012430|NCT00162864|Montelukast|montelukast|mesh-list
65012431|NCT00162864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65012432|NCT00162864|Respiratory System Agents|respiratory system agents|mesh-ancestor
65012433|NCT00162864|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65012434|NCT00162864|Hormone Antagonists|hormone antagonists|mesh-ancestor
65012435|NCT00162864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65012436|NCT00162864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012437|NCT00162864|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65012438|NCT00162864|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65012439|NCT00162864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012441|NCT04512313|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65012442|NCT04512313|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65012443|NCT04512313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65012444|NCT04512313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65012445|NCT04512313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012446|NCT00142493|Midazolam|midazolam|mesh-list
65012447|NCT00142493|Dexmedetomidine|dexmedetomidine|mesh-list
65012448|NCT00142493|Thiopental|thiopental|mesh-list
65012449|NCT00142493|Propofol|propofol|mesh-list
65012450|NCT00142493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65275646|NCT02837003|Antipyretics|antipyretics|mesh-ancestor
65275647|NCT02668926|Amphetamine|amphetamine|mesh-list
65275648|NCT02668926|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65275649|NCT02668926|Dextroamphetamine|dextroamphetamine|mesh-list
65275650|NCT02668926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65275651|NCT02668926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275652|NCT02668926|Sympathomimetics|sympathomimetics|mesh-ancestor
65275653|NCT02668926|Autonomic Agents|autonomic agents|mesh-ancestor
65275654|NCT02668926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65275655|NCT02668926|Dopamine Agents|dopamine agents|mesh-ancestor
65275656|NCT02668926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65275657|NCT02668926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275658|NCT02668926|Adrenergic Agents|adrenergic agents|mesh-ancestor
65275659|NCT02668926|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65275660|NCT02668926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65275661|NCT02668926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65275662|NCT02668926|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65275663|NCT02668536|Sunscreening Agents|sunscreening agents|mesh-list
65275664|NCT02668536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65275665|NCT02668536|Protective Agents|protective agents|mesh-ancestor
65275666|NCT02668536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275667|NCT02668536|Dermatologic Agents|dermatologic agents|mesh-ancestor
65275668|NCT00645372|Risperidone|risperidone|mesh-list
65275669|NCT00645372|Ziprasidone|ziprasidone|mesh-list
65275670|NCT00645372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65275671|NCT00645372|Serotonin Agents|serotonin agents|mesh-ancestor
65275672|NCT00645372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65025689|NCT00540085|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65275673|NCT00645372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275674|NCT00645372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275675|NCT00645372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65275676|NCT00645372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64728129|NCT05586373|Dipyrone|dipyrone|mesh-list
65012451|NCT00142493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65012452|NCT00142493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012453|NCT00142493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65012454|NCT00142493|Anesthetics, General|anesthetics, general|mesh-ancestor
65012455|NCT00142493|Anesthetics|anesthetics|mesh-ancestor
65012456|NCT00142493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65012457|NCT00142493|Analgesics|analgesics|mesh-ancestor
65012458|NCT00142493|Sensory System Agents|sensory system agents|mesh-ancestor
65275677|NCT00645372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65275678|NCT00645372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65275679|NCT00645372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65275680|NCT00645372|Dopamine Agents|dopamine agents|mesh-ancestor
65275681|NCT00645918|Clopidogrel|clopidogrel|mesh-list
65275682|NCT00645918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65275683|NCT00645918|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65275684|NCT00645918|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65275685|NCT00645918|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65275686|NCT00645918|Purinergic Agents|purinergic agents|mesh-ancestor
65275687|NCT00645918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65275688|NCT00645918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012459|NCT00142493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64468073|NCT00074308|Immunoglobulins|immunoglobulins|mesh-list
65012460|NCT00142493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65012461|NCT00142493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65012462|NCT00142493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65012463|NCT00142493|Adrenergic Agents|adrenergic agents|mesh-ancestor
65012464|NCT00142493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64468609|NCT01524783|Everolimus|everolimus|mesh-list
64468746|NCT00107536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012465|NCT00142493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012484|NCT04511611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012485|NCT04511611|Anticoagulants|anticoagulants|mesh-ancestor
65012486|NCT04511299|SMOFlipid|smoflipid|mesh-list
65012487|NCT04511299|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65012488|NCT04511299|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65012489|NCT04511299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65012490|NCT00142571|Gemcitabine|gemcitabine|mesh-list
65012491|NCT00142571|Docetaxel|docetaxel|mesh-list
65012492|NCT00142571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65012493|NCT00142571|Antimetabolites|antimetabolites|mesh-ancestor
65012494|NCT00142571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012495|NCT00142571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65012496|NCT00142571|Antiviral Agents|antiviral agents|mesh-ancestor
65012497|NCT00142571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65012498|NCT00142571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012499|NCT00142571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65012500|NCT00142571|Immunologic Factors|immunologic factors|mesh-ancestor
65012501|NCT00142571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012502|NCT00142571|Tubulin Modulators|tubulin modulators|mesh-ancestor
65012503|NCT00142571|Antimitotic Agents|antimitotic agents|mesh-ancestor
65012504|NCT00142571|Mitosis Modulators|mitosis modulators|mesh-ancestor
65012505|NCT00142610|Vitamins|vitamins|mesh-list
65012506|NCT00142610|Vitamin E|vitamin e|mesh-list
65012507|NCT00142610|Micronutrients|micronutrients|mesh-ancestor
65012508|NCT00142610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012509|NCT00142610|Antioxidants|antioxidants|mesh-ancestor
65012528|NCT02275975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65012529|NCT02275975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012530|NCT02275975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65012531|NCT02275975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65012532|NCT02276092|Anti-Infective Agents|anti-infective agents|mesh-list
65012533|NCT02276092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65012534|NCT00142727|Analgesics, Opioid|analgesics, opioid|mesh-list
65012535|NCT00142727|Methadone|methadone|mesh-list
65012536|NCT00142727|Narcotic Antagonists|narcotic antagonists|mesh-list
65012537|NCT00142727|Narcotics|narcotics|mesh-ancestor
65012538|NCT00142727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65012539|NCT00142727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012540|NCT00142727|Analgesics|analgesics|mesh-ancestor
65012541|NCT00142727|Sensory System Agents|sensory system agents|mesh-ancestor
65275689|NCT00645918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275690|NCT00646854|Cyclophosphamide|cyclophosphamide|mesh-list
65275691|NCT00646854|Alemtuzumab|alemtuzumab|mesh-list
65275692|NCT00646854|Doxorubicin|doxorubicin|mesh-list
65275693|NCT00646854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65275694|NCT00646854|Vincristine|vincristine|mesh-list
65012542|NCT00142727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65012543|NCT00142727|Antitussive Agents|antitussive agents|mesh-ancestor
65012544|NCT00142727|Respiratory System Agents|respiratory system agents|mesh-ancestor
65012545|NCT04510402|Povidone-Iodine|povidone-iodine|mesh-list
65012546|NCT04510402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65012547|NCT04510402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65012548|NCT00506194|Gliclazide|gliclazide|mesh-list
65012549|NCT00506194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65012550|NCT00506194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012551|NCT00404573|Cariprazine|cariprazine|mesh-list
65012552|NCT00404573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65012553|NCT00404573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65012554|NCT00404573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65012555|NCT00404573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012556|NCT00404573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64957057|NCT00211120|Epoetin Alfa|epoetin alfa|mesh-list
64957646|NCT00216502|Cholinergic Agents|cholinergic agents|mesh-ancestor
64957724|NCT00216931|Iloprost|iloprost|mesh-list
64957871|NCT00041990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958094|NCT00219895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64958395|NCT00077532|Immunologic Factors|immunologic factors|mesh-ancestor
64958612|NCT00124111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965776|NCT00054938|Aspirin|aspirin|mesh-list
64965999|NCT00170209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64966445|NCT04631484|Antimetabolites|antimetabolites|mesh-ancestor
64966898|NCT00056693|Sunitinib|sunitinib|mesh-list
64966966|NCT00398489|Cyclophosphamide|cyclophosphamide|mesh-list
64967062|NCT00177853|Celecoxib|celecoxib|mesh-list
64967183|NCT00179023|Sympathomimetics|sympathomimetics|mesh-ancestor
64967299|NCT00179764|Busulfan|busulfan|mesh-list
64967551|NCT00408538|Anti-Infective Agents|anti-infective agents|mesh-list
64967780|NCT00408772|Bevacizumab|bevacizumab|mesh-list
64968000|NCT00185185|Adrenergic Agents|adrenergic agents|mesh-ancestor
64968601|NCT03428373|Protease Inhibitors|protease inhibitors|mesh-ancestor
64968964|NCT00191035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64508829|NCT03037437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64970142|NCT00084708|Vitamins|vitamins|mesh-ancestor
64970658|NCT00221416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64970828|NCT00222547|Vitamin A|vitamin a|mesh-list
64971106|NCT00061958|Arsenic Trioxide|arsenic trioxide|mesh-list
64971624|NCT00400374|Celecoxib|celecoxib|mesh-list
64972114|NCT00229138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972115|NCT00229138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972116|NCT00063323|Bupropion|bupropion|mesh-list
64972117|NCT00063323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64972118|NCT00063323|Antidepressive Agents|antidepressive agents|mesh-ancestor
64972119|NCT00063323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64972120|NCT00063323|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64972121|NCT00063323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64972130|NCT00229216|Tinidazole|tinidazole|mesh-list
64972302|NCT00230035|Antimetabolites|antimetabolites|mesh-ancestor
64972303|NCT00230035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972304|NCT00230035|Dermatologic Agents|dermatologic agents|mesh-ancestor
64972305|NCT00230035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972306|NCT00230035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64972307|NCT00230035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64972308|NCT00230035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64972309|NCT00230035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64972310|NCT00230035|Antitubercular Agents|antitubercular agents|mesh-ancestor
64972311|NCT00230035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64972312|NCT00230035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64972313|NCT00230035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64975990|NCT00252889|Topotecan|topotecan|mesh-list
64976512|NCT00256321|Celecoxib|celecoxib|mesh-list
64976876|NCT00258271|Antimetabolites|antimetabolites|mesh-ancestor
64977177|NCT00424086|Vaccines|vaccines|mesh-list
64977253|NCT00261547|Rituximab|rituximab|mesh-list
64977414|NCT00262210|Glucocorticoids|glucocorticoids|mesh-ancestor
64977558|NCT00101673|Vildagliptin|vildagliptin|mesh-list
64977635|NCT04709029|BB 1101|bb 1101|mesh-list
65275695|NCT00646854|Lenograstim|lenograstim|mesh-list
65275696|NCT00646854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65275697|NCT00646854|Immunologic Factors|immunologic factors|mesh-ancestor
65275698|NCT00646854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275699|NCT00646854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65275700|NCT00646854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65275701|NCT00646854|Alkylating Agents|alkylating agents|mesh-ancestor
64728179|NCT00002749|Carboplatin|carboplatin|mesh-list
64977929|NCT00102258|Hormones|hormones|mesh-list
64978157|NCT00073736|Cytarabine|cytarabine|mesh-list
64979497|NCT00279565|Ribavirin|ribavirin|mesh-list
64980526|NCT00286273|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64980974|NCT00289042|Anticoagulants|anticoagulants|mesh-ancestor
64981123|NCT00290680|Celecoxib|celecoxib|mesh-list
64981504|NCT00119301|Antimetabolites|antimetabolites|mesh-ancestor
64982267|NCT00301483|HBOC 201|hboc 201|mesh-list
64982546|NCT00306358|Hydroxocobalamin|hydroxocobalamin|mesh-list
64982996|NCT00399698|Risperidone|risperidone|mesh-list
64983292|NCT00082316|Sensory System Agents|sensory system agents|mesh-ancestor
64983371|NCT00087867|Bortezomib|bortezomib|mesh-list
64983449|NCT00082784|Bortezomib|bortezomib|mesh-list
64983515|NCT00307255|Gemcitabine|gemcitabine|mesh-list
64983595|NCT00307645|Mycophenolic Acid|mycophenolic acid|mesh-list
64983820|NCT00309088|Immunologic Factors|immunologic factors|mesh-ancestor
64984040|NCT00418873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64984712|NCT00294385|Antiviral Agents|antiviral agents|mesh-ancestor
64984862|NCT00295282|Antibodies|antibodies|mesh-list
64985158|NCT00297388|Serotonin Agents|serotonin agents|mesh-ancestor
64985459|NCT00323206|Growth Substances|growth substances|mesh-ancestor
64985919|NCT00313690|Docetaxel|docetaxel|mesh-list
64986826|NCT00316927|Antipyretics|antipyretics|mesh-ancestor
64987635|NCT02959879|Folfirinox|folfirinox|mesh-list
64987788|NCT00319072|Hormones|hormones|mesh-list
64987930|NCT00419536|Panobinostat|panobinostat|mesh-list
64988076|NCT00093873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988225|NCT05458765|Tenofovir|tenofovir|mesh-list
64988298|NCT05458180|Etoposide|etoposide|mesh-list
64988521|NCT00124644|Cytarabine|cytarabine|mesh-list
64988601|NCT00094614|Atropine|atropine|mesh-list
64988741|NCT05126836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988896|NCT00331123|Hormones|hormones|mesh-ancestor
64988965|NCT00087620|Capecitabine|capecitabine|mesh-list
64989262|NCT05830916|Antibodies|antibodies|mesh-list
64989936|NCT05600894|Venetoclax|venetoclax|mesh-list
64990090|NCT05552976|Antiemetics|antiemetics|mesh-ancestor
64990688|NCT05019716|Cisplatin|cisplatin|mesh-list
64991519|NCT04340843|Decitabine|decitabine|mesh-list
64467848|NCT00060346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467849|NCT00060346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467850|NCT00060346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64467851|NCT00060346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64467852|NCT00060346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64467853|NCT00060346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64467854|NCT00060346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64467855|NCT00060346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467856|NCT00060346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64467857|NCT00060346|Glucocorticoids|glucocorticoids|mesh-ancestor
64467858|NCT00060346|Hormones|hormones|mesh-ancestor
64467859|NCT00060346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64467860|NCT00060346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64467861|NCT00060346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64467862|NCT00060346|Tubulin Modulators|tubulin modulators|mesh-ancestor
64467863|NCT00060346|Antimitotic Agents|antimitotic agents|mesh-ancestor
64467864|NCT00060346|Mitosis Modulators|mitosis modulators|mesh-ancestor
64467865|NCT03026907|Azathioprine|azathioprine|mesh-list
64467866|NCT03026907|Alitretinoin|alitretinoin|mesh-list
64467867|NCT03026907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467868|NCT03026907|Dermatologic Agents|dermatologic agents|mesh-ancestor
64467869|NCT03026907|Antimetabolites|antimetabolites|mesh-ancestor
64467870|NCT03026907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467871|NCT03026907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64467872|NCT03026907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64467873|NCT03026907|Immunologic Factors|immunologic factors|mesh-ancestor
64467874|NCT03026907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467902|NCT00063232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65275702|NCT00646854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275703|NCT00646854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275704|NCT00646854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65275705|NCT00646854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65275706|NCT00646854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65275707|NCT00646854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64467903|NCT00063232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467904|NCT00063622|Vitamin E|vitamin e|mesh-list
64467905|NCT00063622|Pioglitazone|pioglitazone|mesh-list
64467906|NCT00063622|Vitamins|vitamins|mesh-ancestor
64467907|NCT00063622|Micronutrients|micronutrients|mesh-ancestor
64467908|NCT00063622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467909|NCT00063622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64467910|NCT00063622|Antioxidants|antioxidants|mesh-ancestor
64467911|NCT00063622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467912|NCT00063622|Protective Agents|protective agents|mesh-ancestor
64467913|NCT05605756|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64467914|NCT05605756|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64467915|NCT05605756|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64467916|NCT05605756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64467917|NCT05605756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467918|NCT05605756|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64467919|NCT05605756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64467920|NCT05605756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467921|NCT05605756|Cholinergic Agents|cholinergic agents|mesh-ancestor
64467922|NCT05605756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64467923|NCT00153166|Pioglitazone|pioglitazone|mesh-list
64467924|NCT00153166|Atorvastatin|atorvastatin|mesh-list
64467925|NCT00153166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64467926|NCT00153166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64467942|NCT00156910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467943|NCT00156910|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64467944|NCT00156910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64467945|NCT01475721|Fluticasone|fluticasone|mesh-list
64467946|NCT01475721|Xhance|xhance|mesh-list
64467947|NCT01475721|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64467948|NCT01475721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64467949|NCT01475721|Autonomic Agents|autonomic agents|mesh-ancestor
64467950|NCT01475721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64467951|NCT01475721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467952|NCT01475721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64467953|NCT01475721|Respiratory System Agents|respiratory system agents|mesh-ancestor
64467954|NCT01475721|Glucocorticoids|glucocorticoids|mesh-ancestor
64467955|NCT01475721|Hormones|hormones|mesh-ancestor
64467956|NCT01475721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64467957|NCT01475721|Sympathomimetics|sympathomimetics|mesh-ancestor
64467958|NCT01475721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64467959|NCT01475721|Dermatologic Agents|dermatologic agents|mesh-ancestor
64467960|NCT01475721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64467962|NCT00065806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64467963|NCT00065806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64467965|NCT00065806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467966|NCT00065806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64467967|NCT00065806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64467968|NCT00065806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467969|NCT05152888|Evolocumab|evolocumab|mesh-list
64467970|NCT05152888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64467971|NCT05152888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64467972|NCT05152888|Antimetabolites|antimetabolites|mesh-ancestor
64467973|NCT05152888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467974|NCT05152888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64467975|NCT00068770|Celecoxib|celecoxib|mesh-list
64467976|NCT00068770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64467977|NCT00068770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64467978|NCT00068770|Analgesics|analgesics|mesh-ancestor
64467979|NCT00068770|Sensory System Agents|sensory system agents|mesh-ancestor
64467980|NCT00068770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65275708|NCT00646854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65275709|NCT00646854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65275710|NCT00646854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275711|NCT00646854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65275712|NCT00646854|Tubulin Modulators|tubulin modulators|mesh-ancestor
65275713|NCT00646854|Antimitotic Agents|antimitotic agents|mesh-ancestor
65275714|NCT00646854|Mitosis Modulators|mitosis modulators|mesh-ancestor
64467981|NCT00068770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467982|NCT00068770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64467983|NCT00068770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64467984|NCT00068770|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64467985|NCT00068770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64468010|NCT01500213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468011|NCT01500213|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64468012|NCT00069160|Docetaxel|docetaxel|mesh-list
64468013|NCT00069160|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
64468014|NCT00069160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468015|NCT00069160|Tubulin Modulators|tubulin modulators|mesh-ancestor
64468016|NCT00069160|Antimitotic Agents|antimitotic agents|mesh-ancestor
64468017|NCT00069160|Mitosis Modulators|mitosis modulators|mesh-ancestor
64468018|NCT00069160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468019|NCT00069160|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64468020|NCT00071890|Aldesleukin|aldesleukin|mesh-list
64468021|NCT00071890|Interleukin-2|interleukin-2|mesh-list
64468022|NCT00071890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468023|NCT00071890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64468024|NCT00071890|Analgesics|analgesics|mesh-ancestor
64468025|NCT00071890|Sensory System Agents|sensory system agents|mesh-ancestor
64468026|NCT00071890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64468027|NCT00071890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468028|NCT00071890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64468029|NCT00071890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64468030|NCT00071890|Antiviral Agents|antiviral agents|mesh-ancestor
64468031|NCT00071890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64468032|NCT01475253|Lidocaine|lidocaine|mesh-list
64468034|NCT01475253|Anesthetics|anesthetics|mesh-ancestor
64468035|NCT01475253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64971530|NCT00095706|Bevacizumab|bevacizumab|mesh-list
64468058|NCT00072514|Glucocorticoids|glucocorticoids|mesh-ancestor
64468059|NCT00072514|Hormones|hormones|mesh-ancestor
64468060|NCT00072514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64468061|NCT00072514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64468062|NCT00072514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64468063|NCT00072514|Antimetabolites|antimetabolites|mesh-ancestor
64468064|NCT00072514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468065|NCT00072514|Antiviral Agents|antiviral agents|mesh-ancestor
64468066|NCT00072514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64468067|NCT00072514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468068|NCT00072514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64468069|NCT00074308|Bevacizumab|bevacizumab|mesh-list
64468070|NCT00074308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64468071|NCT00074308|Imatinib Mesylate|imatinib mesylate|mesh-list
64713978|NCT02839772|Glycerol|glycerol|mesh-list
64468072|NCT00074308|Antibodies|antibodies|mesh-list
64468074|NCT00074308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64468075|NCT00074308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468076|NCT00074308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64468077|NCT00074308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64468078|NCT00074308|Growth Substances|growth substances|mesh-ancestor
64468079|NCT00074308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468080|NCT00074308|Growth Inhibitors|growth inhibitors|mesh-ancestor
64468081|NCT00074308|Immunologic Factors|immunologic factors|mesh-ancestor
64468082|NCT00074308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64468083|NCT00074308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468084|NCT00074308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468085|NCT00166036|Atorvastatin|atorvastatin|mesh-list
64468086|NCT00166036|Pravastatin|pravastatin|mesh-list
64971579|NCT00226096|Glycerol|glycerol|mesh-list
64468106|NCT01474551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275716|NCT04173858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65275717|NCT04173858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275718|NCT04173858|Sensory System Agents|sensory system agents|mesh-ancestor
65275719|NCT04173858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65275720|NCT00646932|Ergocalciferols|ergocalciferols|mesh-list
65275721|NCT00646932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65275722|NCT00646932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275723|NCT00646932|Vitamins|vitamins|mesh-ancestor
65275724|NCT00646932|Micronutrients|micronutrients|mesh-ancestor
65275725|NCT00646932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65275726|NCT00646152|Poly ICLC|poly iclc|mesh-list
65275727|NCT00646152|Interferon Inducers|interferon inducers|mesh-ancestor
65275728|NCT00646152|Immunologic Factors|immunologic factors|mesh-ancestor
65275729|NCT00646152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275730|NCT00647166|Azathioprine|azathioprine|mesh-list
65275731|NCT00647166|Antimetabolites|antimetabolites|mesh-ancestor
65275732|NCT00647166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275733|NCT00647166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65275734|NCT00647166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275735|NCT00647166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65275736|NCT00647166|Immunologic Factors|immunologic factors|mesh-ancestor
64468107|NCT01474551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64468108|NCT01474551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468109|NCT01474551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468110|NCT01499667|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64468111|NCT01499667|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64468112|NCT01499667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468113|NCT01499667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64468114|NCT01499667|Immunologic Factors|immunologic factors|mesh-ancestor
64468115|NCT01499667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468116|NCT00168298|Dexamethasone|dexamethasone|mesh-list
64468117|NCT00168298|Dexamethasone acetate|dexamethasone acetate|mesh-list
64468119|NCT00168298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64468120|NCT00168298|Antiemetics|antiemetics|mesh-ancestor
64468121|NCT00168298|Autonomic Agents|autonomic agents|mesh-ancestor
64468122|NCT00168298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64468123|NCT00168298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468124|NCT00168298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64468125|NCT00168298|Glucocorticoids|glucocorticoids|mesh-ancestor
64468126|NCT00168298|Hormones|hormones|mesh-ancestor
64468127|NCT00168298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64468128|NCT00168298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64468129|NCT00168298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468130|NCT00168298|Protease Inhibitors|protease inhibitors|mesh-ancestor
64468131|NCT00168298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468132|NCT00168298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468133|NCT00078286|Sertraline|sertraline|mesh-list
64468134|NCT00078286|Antidepressive Agents|antidepressive agents|mesh-ancestor
64468135|NCT00078286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64468136|NCT00078286|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64468137|NCT00078286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64468138|NCT00078286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65275737|NCT00647166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275738|NCT00647166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65275739|NCT00647244|Tenofovir|tenofovir|mesh-list
65275740|NCT00647244|Abacavir|abacavir|mesh-list
65275741|NCT00647244|Antiviral Agents|antiviral agents|mesh-ancestor
65275742|NCT00647244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65275743|NCT00647244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65275744|NCT00647244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65275745|NCT00647244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275746|NCT00647244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275747|NCT00647244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65275748|NCT00647244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65275749|NCT00895583|Sirolimus|sirolimus|mesh-list
65275750|NCT00895583|Tacrolimus|tacrolimus|mesh-list
65275751|NCT00895583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65275752|NCT00895583|Immunologic Factors|immunologic factors|mesh-ancestor
65275753|NCT00895583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275754|NCT00895583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65275755|NCT00895583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275756|NCT00895583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275757|NCT00895583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65275758|NCT00895583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65275759|NCT00895583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65275760|NCT00895583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275761|NCT00895583|Antifungal Agents|antifungal agents|mesh-ancestor
65275762|NCT00647322|Anticonvulsants|anticonvulsants|mesh-list
65275763|NCT04174872|Midazolam|midazolam|mesh-list
65275764|NCT04174872|Dexmedetomidine|dexmedetomidine|mesh-list
65275765|NCT04174872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65275766|NCT04174872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65275767|NCT04174872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275768|NCT04174872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65275769|NCT04174872|Analgesics|analgesics|mesh-ancestor
65275770|NCT04174872|Sensory System Agents|sensory system agents|mesh-ancestor
65275771|NCT04174872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65275772|NCT04174872|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64728223|NCT00003650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65275773|NCT04174872|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65275774|NCT04174872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65275775|NCT04174872|Adrenergic Agents|adrenergic agents|mesh-ancestor
65275776|NCT04174872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65275777|NCT04174872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275778|NCT04174872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65275779|NCT04174872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65275780|NCT04174872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65275781|NCT04174872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65275782|NCT04174872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65275783|NCT04174872|Anesthetics, General|anesthetics, general|mesh-ancestor
65275784|NCT04174872|Anesthetics|anesthetics|mesh-ancestor
65275785|NCT04174872|GABA Modulators|gaba modulators|mesh-ancestor
65275786|NCT04174872|GABA Agents|gaba agents|mesh-ancestor
65275787|NCT02841137|Progesterone|progesterone|mesh-list
65275788|NCT02841137|Progestins|progestins|mesh-ancestor
65275789|NCT02841137|Hormones|hormones|mesh-ancestor
65275790|NCT02841137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65275791|NCT02841137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275792|NCT00645606|Rituximab|rituximab|mesh-list
65275793|NCT00645606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65275794|NCT00645606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275795|NCT00645606|Immunologic Factors|immunologic factors|mesh-ancestor
65275796|NCT00645606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275797|NCT00645606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64468139|NCT00078286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468162|NCT00078754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64468163|NCT00081328|Metformin|metformin|mesh-list
64468164|NCT00081328|Rosiglitazone|rosiglitazone|mesh-list
64468165|NCT00081328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64468166|NCT00081328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468167|NCT01499355|Mycophenolic Acid|mycophenolic acid|mesh-list
64468168|NCT01499355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64468169|NCT01499355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468170|NCT01499355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64468171|NCT01499355|Antitubercular Agents|antitubercular agents|mesh-ancestor
64468172|NCT01499355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64468173|NCT01499355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64468174|NCT01499355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468175|NCT01499355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468176|NCT00083122|Cisplatin|cisplatin|mesh-list
64468177|NCT00083122|Alvocidib|alvocidib|mesh-list
64468178|NCT00083122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468179|NCT00083122|Growth Inhibitors|growth inhibitors|mesh-ancestor
64468180|NCT00083122|Growth Substances|growth substances|mesh-ancestor
64468181|NCT00083122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513651|NCT01457547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64468182|NCT00083122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64468183|NCT00083122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468184|NCT00083122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275798|NCT02836847|Trastuzumab|trastuzumab|mesh-list
65275799|NCT02836847|Cetuximab|cetuximab|mesh-list
65275800|NCT02836847|Everolimus|everolimus|mesh-list
65275801|NCT02836847|Sorafenib|sorafenib|mesh-list
65275802|NCT02836847|Lapatinib|lapatinib|mesh-list
65275803|NCT02836847|Gefitinib|gefitinib|mesh-list
65275804|NCT02836847|Crizotinib|crizotinib|mesh-list
65275805|NCT02836847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65275806|NCT02836847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275807|NCT02836847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65275808|NCT02836847|Immunologic Factors|immunologic factors|mesh-ancestor
65275809|NCT02836847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275810|NCT02836847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65275811|NCT02836847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275812|NCT02836847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275813|NCT02666040|Anesthetics|anesthetics|mesh-list
65275814|NCT02666040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65275815|NCT02666040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275816|NCT00894413|Tadalafil|tadalafil|mesh-list
65275817|NCT00894413|Vasodilator Agents|vasodilator agents|mesh-ancestor
65275818|NCT00894413|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65275819|NCT00894413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65275820|NCT00894413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275821|NCT00894413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275822|NCT00894413|Urological Agents|urological agents|mesh-ancestor
65275823|NCT04250519|Sodium Hypochlorite|sodium hypochlorite|mesh-list
65275824|NCT04250519|Eusol|eusol|mesh-list
65275825|NCT04250519|Disinfectants|disinfectants|mesh-ancestor
65275826|NCT04250519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65275827|NCT04172220|Midazolam|midazolam|mesh-list
65275828|NCT04172220|Anesthetics|anesthetics|mesh-list
65275829|NCT04172220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65275830|NCT04172220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275831|NCT04172220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65275832|NCT04172220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64468186|NCT01474239|Fotemustine|fotemustine|mesh-list
64468187|NCT01474239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64468188|NCT01474239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468189|NCT01474239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64468190|NCT01474239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64468210|NCT01473381|Autonomic Agents|autonomic agents|mesh-ancestor
64468211|NCT01473381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65275833|NCT04172220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65275834|NCT04172220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65275835|NCT04172220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65275836|NCT04172220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65275837|NCT04172220|Anesthetics, General|anesthetics, general|mesh-ancestor
65275838|NCT04172220|GABA Modulators|gaba modulators|mesh-ancestor
65275839|NCT04172220|GABA Agents|gaba agents|mesh-ancestor
65275840|NCT04172220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65275841|NCT04172220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275842|NCT02665806|Fluticasone|fluticasone|mesh-list
65275843|NCT02665806|Ciclesonide|ciclesonide|mesh-list
65275844|NCT02665806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65275845|NCT02665806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65275846|NCT02665806|Autonomic Agents|autonomic agents|mesh-ancestor
64468212|NCT01473381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64468213|NCT01473381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64468214|NCT01473381|Cholinergic Agents|cholinergic agents|mesh-ancestor
64468215|NCT01473381|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64468216|NCT01473381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64468217|NCT00168454|Botulinum Toxins|botulinum toxins|mesh-list
64468218|NCT00168454|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64468219|NCT00168454|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64468220|NCT00168454|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64468221|NCT00168454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64468222|NCT00168454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468223|NCT00168454|Cholinergic Agents|cholinergic agents|mesh-ancestor
64468224|NCT00168454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64468225|NCT00168454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468227|NCT00168454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64468228|NCT01499277|Vancomycin|vancomycin|mesh-list
64468229|NCT01499277|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64468230|NCT01499277|Aztreonam|aztreonam|mesh-list
64468231|NCT01499277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64468232|NCT01499277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64468233|NCT00176800|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
64468234|NCT00176800|Chelating Agents|chelating agents|mesh-ancestor
64468235|NCT00176800|Sequestering Agents|sequestering agents|mesh-ancestor
64468236|NCT00176800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468237|NCT00176800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468238|NCT00176800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64468239|NCT00176800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64468240|NCT00176800|Growth Substances|growth substances|mesh-ancestor
64468241|NCT00176800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468242|NCT00176800|Growth Inhibitors|growth inhibitors|mesh-ancestor
64468243|NCT00176800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468244|NCT00176878|Fludarabine|fludarabine|mesh-list
64468245|NCT00176878|Fludarabine phosphate|fludarabine phosphate|mesh-list
64468246|NCT00176878|Busulfan|busulfan|mesh-list
64468273|NCT02119468|Ixazomib|ixazomib|mesh-list
64468274|NCT02119468|Glycine|glycine|mesh-list
64468275|NCT02119468|Proteasome Inhibitors|proteasome inhibitors|mesh-list
64468276|NCT02119468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64468277|NCT02119468|Antiemetics|antiemetics|mesh-ancestor
64468278|NCT02119468|Autonomic Agents|autonomic agents|mesh-ancestor
64468279|NCT02119468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64468280|NCT02119468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468281|NCT02119468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64468282|NCT02119468|Glucocorticoids|glucocorticoids|mesh-ancestor
64468283|NCT02119468|Hormones|hormones|mesh-ancestor
64468284|NCT02119468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64468285|NCT02119468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64468286|NCT02119468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275847|NCT02665806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65275848|NCT02665806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275849|NCT02665806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65275850|NCT02665806|Respiratory System Agents|respiratory system agents|mesh-ancestor
65275851|NCT02665806|Dermatologic Agents|dermatologic agents|mesh-ancestor
65275852|NCT02665806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64468287|NCT02119468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468288|NCT02119468|Immunologic Factors|immunologic factors|mesh-ancestor
64468289|NCT02119468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64468290|NCT02119468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64468291|NCT02119468|Growth Substances|growth substances|mesh-ancestor
64468292|NCT02119468|Growth Inhibitors|growth inhibitors|mesh-ancestor
64468293|NCT02119468|Protease Inhibitors|protease inhibitors|mesh-ancestor
64468294|NCT02119468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468295|NCT02119468|Glycine Agents|glycine agents|mesh-ancestor
64468319|NCT01498185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468320|NCT01498185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64468321|NCT01498185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468322|NCT01527357|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64468323|NCT01527357|Fibrin Foam|fibrin foam|mesh-list
64468324|NCT01527357|Hemostatics|hemostatics|mesh-ancestor
64468325|NCT01527357|Coagulants|coagulants|mesh-ancestor
64468326|NCT00181714|Methylphenidate|methylphenidate|mesh-list
64468327|NCT00181714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64468328|NCT00181714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468329|NCT00181714|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64468330|NCT00181714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64468331|NCT00181714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64468332|NCT00181714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468333|NCT00181714|Dopamine Agents|dopamine agents|mesh-ancestor
64468334|NCT00181714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64468336|NCT01472835|Midazolam|midazolam|mesh-list
64468337|NCT01472835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64468338|NCT01472835|Narcotics|narcotics|mesh-ancestor
64468339|NCT01472835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64468340|NCT01472835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468341|NCT01472835|Analgesics|analgesics|mesh-ancestor
64468342|NCT01472835|Sensory System Agents|sensory system agents|mesh-ancestor
64468343|NCT01472835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64468344|NCT01472835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64468345|NCT01472835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64468346|NCT01472835|Anesthetics, General|anesthetics, general|mesh-ancestor
64468363|NCT00185692|Prednisolone acetate|prednisolone acetate|mesh-list
64468364|NCT00185692|Hydrocortisone|hydrocortisone|mesh-list
64468365|NCT00185692|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64468366|NCT00185692|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64468367|NCT00185692|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64454127|NCT02017535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64468368|NCT00185692|Cyclosporins|cyclosporins|mesh-list
64468369|NCT00185692|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64468370|NCT00185692|Lenograstim|lenograstim|mesh-list
64468371|NCT00185692|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64468372|NCT00185692|Prednisolone phosphate|prednisolone phosphate|mesh-list
64468373|NCT00185692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468374|NCT00185692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468375|NCT00185692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64471236|NCT04662944|Aflibercept|aflibercept|mesh-list
64468376|NCT00185692|Immunologic Factors|immunologic factors|mesh-ancestor
64468377|NCT00185692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468378|NCT00185692|Antifungal Agents|antifungal agents|mesh-ancestor
64468379|NCT00185692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64468380|NCT00185692|Dermatologic Agents|dermatologic agents|mesh-ancestor
64468381|NCT00185692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64468382|NCT00185692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64468383|NCT00185692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64468384|NCT00185692|Analgesics|analgesics|mesh-ancestor
64468385|NCT00185692|Sensory System Agents|sensory system agents|mesh-ancestor
64468386|NCT00185692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64468387|NCT00185692|Antipyretics|antipyretics|mesh-ancestor
65275853|NCT02665806|Glucocorticoids|glucocorticoids|mesh-ancestor
65275854|NCT02665806|Hormones|hormones|mesh-ancestor
65275855|NCT02665806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65275856|NCT00646386|Adalimumab|adalimumab|mesh-list
65275857|NCT00646386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65275858|NCT00646386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65275859|NCT00647634|Alprazolam|alprazolam|mesh-list
65275860|NCT00647634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65275861|NCT00647634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65275862|NCT00647634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275863|NCT00647634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65275864|NCT00647634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65275865|NCT00647634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65275866|NCT00647634|GABA Modulators|gaba modulators|mesh-ancestor
65275867|NCT00647634|GABA Agents|gaba agents|mesh-ancestor
65275868|NCT00647634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65275869|NCT00647634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275870|NCT04172064|Dobutamine|dobutamine|mesh-list
65275871|NCT04172064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65275872|NCT04172064|Sympathomimetics|sympathomimetics|mesh-ancestor
65275873|NCT04172064|Autonomic Agents|autonomic agents|mesh-ancestor
65275874|NCT04172064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65275875|NCT04172064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275876|NCT04172064|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65275877|NCT04172064|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65275878|NCT04172064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65275879|NCT04172064|Adrenergic Agents|adrenergic agents|mesh-ancestor
65275880|NCT04172064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65275881|NCT04172064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275882|NCT04172064|Protective Agents|protective agents|mesh-ancestor
65275883|NCT00647712|Valproic Acid|valproic acid|mesh-list
65275884|NCT00647712|Anticonvulsants|anticonvulsants|mesh-ancestor
65275887|NCT00647712|GABA Agents|gaba agents|mesh-ancestor
65275896|NCT04173390|Sensory System Agents|sensory system agents|mesh-ancestor
65275897|NCT04173390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65275898|NCT04173390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275899|NCT04173390|Anticonvulsants|anticonvulsants|mesh-ancestor
65275900|NCT04173390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65275901|NCT04173390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65275902|NCT04173390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728381|NCT00004160|Antiviral Agents|antiviral agents|mesh-ancestor
64468388|NCT00185692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64468389|NCT00185692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468390|NCT00185692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64468391|NCT00185692|Antitubercular Agents|antitubercular agents|mesh-ancestor
64468392|NCT00185692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64468393|NCT00185692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64468394|NCT00185692|Antiemetics|antiemetics|mesh-ancestor
64468395|NCT00185692|Autonomic Agents|autonomic agents|mesh-ancestor
64468396|NCT00185692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64468397|NCT00185692|Glucocorticoids|glucocorticoids|mesh-ancestor
64468399|NCT00185692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64468400|NCT00185692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64468401|NCT00185692|Protective Agents|protective agents|mesh-ancestor
64468402|NCT00185692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64468403|NCT00185692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64468404|NCT01526733|Insulin|insulin|mesh-list
64468405|NCT01526733|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64513652|NCT01457859|Triclosan|triclosan|mesh-list
64468406|NCT01526733|Insulin Aspart|insulin aspart|mesh-list
64468407|NCT01526733|Insulin Lispro|insulin lispro|mesh-list
64468432|NCT00096460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64468433|NCT00096460|Antimetabolites|antimetabolites|mesh-ancestor
64468434|NCT00096460|Dermatologic Agents|dermatologic agents|mesh-ancestor
64468435|NCT00096460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468436|NCT00096460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64468437|NCT00096460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64468438|NCT00096460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64468439|NCT00096460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64713979|NCT02839772|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64468440|NCT00096460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64468441|NCT00096460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64468442|NCT00006178|Sirolimus|sirolimus|mesh-list
64468443|NCT00006178|Thymoglobulin|thymoglobulin|mesh-list
64454205|NCT05119166|Antimetabolites|antimetabolites|mesh-ancestor
64468444|NCT00006178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64468445|NCT00006178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64468446|NCT00006178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64468447|NCT00006178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468448|NCT00006178|Antifungal Agents|antifungal agents|mesh-ancestor
64468449|NCT00006178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64468450|NCT00006178|Immunologic Factors|immunologic factors|mesh-ancestor
64468451|NCT00006178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468452|NCT00097708|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
64468453|NCT00097708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64468454|NCT00097708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64468455|NCT00097708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468456|NCT00097708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64468457|NCT00098956|Topotecan|topotecan|mesh-list
64468458|NCT00098956|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
64468459|NCT00098956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64468474|NCT02197156|Narcotics|narcotics|mesh-ancestor
64468475|NCT02197156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64468476|NCT02197156|Antitussive Agents|antitussive agents|mesh-ancestor
64468477|NCT02197156|Respiratory System Agents|respiratory system agents|mesh-ancestor
64468479|NCT00187720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64468480|NCT00187720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468481|NCT00006244|Interferons|interferons|mesh-list
64468482|NCT00006244|Interferon-alpha|interferon-alpha|mesh-list
64468483|NCT00006244|Aldesleukin|aldesleukin|mesh-list
64468484|NCT00006244|Interferon alpha-2|interferon alpha-2|mesh-list
65275903|NCT04173390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65275904|NCT04173390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65275905|NCT04173390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65275906|NCT04173390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65275907|NCT04173390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65275908|NCT04895202|Siponimod|siponimod|mesh-list
65275909|NCT04895202|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65275910|NCT04895202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728393|NCT00003674|Dalteparin|dalteparin|mesh-list
64468485|NCT00006244|Melphalan|melphalan|mesh-list
64468486|NCT00006244|Interleukin-2|interleukin-2|mesh-list
64468487|NCT00006244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468488|NCT00006244|Antiviral Agents|antiviral agents|mesh-ancestor
64468489|NCT00006244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64468490|NCT00006244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64468491|NCT00006244|Alkylating Agents|alkylating agents|mesh-ancestor
64468492|NCT00006244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468493|NCT00006244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64468494|NCT00006244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64468495|NCT00006244|Immunologic Factors|immunologic factors|mesh-ancestor
64468496|NCT00006244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468497|NCT00006244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64468498|NCT00006244|Analgesics|analgesics|mesh-ancestor
64468499|NCT00006244|Sensory System Agents|sensory system agents|mesh-ancestor
64468500|NCT00006244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64468501|NCT00006244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64468502|NCT00006244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64468503|NCT01525875|Magnesium Oxide|magnesium oxide|mesh-list
64468504|NCT01525875|Antacids|antacids|mesh-ancestor
64468505|NCT01525875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468506|NCT01525875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64468507|NCT01525641|Pramipexole|pramipexole|mesh-list
64468508|NCT01525641|Antioxidants|antioxidants|mesh-ancestor
64468509|NCT01525641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468510|NCT01525641|Protective Agents|protective agents|mesh-ancestor
64468511|NCT01525641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468512|NCT01525641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64468513|NCT01525641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64468514|NCT01525641|Dopamine Agonists|dopamine agonists|mesh-ancestor
64468515|NCT01525641|Dopamine Agents|dopamine agents|mesh-ancestor
64468516|NCT01525641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64468517|NCT00006400|Hydroxyurea|hydroxyurea|mesh-list
64468518|NCT00006400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713980|NCT02839772|Protective Agents|protective agents|mesh-ancestor
64468519|NCT00006400|Antisickling Agents|antisickling agents|mesh-ancestor
64468520|NCT00006400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468545|NCT00189436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468547|NCT01471353|Sorafenib|sorafenib|mesh-list
64468548|NCT01471353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64468549|NCT01471353|Antimetabolites|antimetabolites|mesh-ancestor
64468550|NCT01471353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468551|NCT01471353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468552|NCT01471353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64468553|NCT01471353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468554|NCT01525407|Atorvastatin|atorvastatin|mesh-list
64468555|NCT01525407|Calcium|calcium|mesh-list
64468556|NCT01525407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64468557|NCT01525407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468558|NCT01525407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64468559|NCT01525407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64468560|NCT01525407|Antimetabolites|antimetabolites|mesh-ancestor
64468561|NCT01525407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468562|NCT01525407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64468563|NCT01525407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65275911|NCT04895202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65275912|NCT04895202|Immunologic Factors|immunologic factors|mesh-ancestor
65275913|NCT04895202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275914|NCT02665650|Pembrolizumab|pembrolizumab|mesh-list
65275915|NCT02665650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65275916|NCT02665650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275917|NCT00647868|Testosterone|testosterone|mesh-list
65275918|NCT00647868|Androgens|androgens|mesh-ancestor
65275919|NCT00647868|Hormones|hormones|mesh-ancestor
65275920|NCT00647868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65275921|NCT00647868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275922|NCT00647946|Tenofovir|tenofovir|mesh-list
65275923|NCT00647946|Abacavir|abacavir|mesh-list
65275924|NCT00647946|Antiviral Agents|antiviral agents|mesh-ancestor
65275925|NCT00647946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65275926|NCT00647946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65275927|NCT00647946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65275928|NCT00647946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65275929|NCT00647946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275930|NCT00647946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65275931|NCT00647946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65275932|NCT00648024|Anagrelide|anagrelide|mesh-list
65275933|NCT00648024|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65275934|NCT00648024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65275935|NCT00648024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275936|NCT00648024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65275937|NCT02665416|Bevacizumab|bevacizumab|mesh-list
65275938|NCT02665416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65275939|NCT02665416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275940|NCT02665416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65275941|NCT02665416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65275942|NCT02665416|Growth Substances|growth substances|mesh-ancestor
65275953|NCT00646620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65275954|NCT00646620|Autonomic Agents|autonomic agents|mesh-ancestor
65275955|NCT00646620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65275956|NCT00646620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275957|NCT00646620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65275958|NCT00646620|Respiratory System Agents|respiratory system agents|mesh-ancestor
65275959|NCT00646620|Dermatologic Agents|dermatologic agents|mesh-ancestor
64468564|NCT01525407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468565|NCT01471197|Pemetrexed|pemetrexed|mesh-list
64468566|NCT01471197|Ipilimumab|ipilimumab|mesh-list
64468567|NCT01471197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468568|NCT01471197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468569|NCT01471197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468598|NCT00011986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468599|NCT00011986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64468600|NCT00011986|Immunologic Factors|immunologic factors|mesh-ancestor
64468601|NCT00011986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468602|NCT00011986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64468603|NCT00011986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64468604|NCT00011986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64468605|NCT00011986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64468606|NCT01898416|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64468607|NCT01898416|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64468608|NCT01898416|Dermatologic Agents|dermatologic agents|mesh-ancestor
64468610|NCT01524783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468611|NCT01524783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64468612|NCT01524783|Immunologic Factors|immunologic factors|mesh-ancestor
64468613|NCT01524783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468614|NCT01494987|Glimepiride|glimepiride|mesh-list
64468615|NCT01494987|Ranolazine|ranolazine|mesh-list
64468616|NCT01494987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64468617|NCT01494987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64468646|NCT01524627|Varenicline|varenicline|mesh-list
64468647|NCT01524627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64468648|NCT01524627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64468649|NCT01524627|Cholinergic Agents|cholinergic agents|mesh-ancestor
64468650|NCT01524627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64468651|NCT01524627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468652|NCT01524627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468653|NCT01469637|Sulfamethoxazole|sulfamethoxazole|mesh-list
64468655|NCT01469637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64468656|NCT01469637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64468657|NCT01469637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64468658|NCT01469637|Analgesics|analgesics|mesh-ancestor
64468659|NCT01469637|Sensory System Agents|sensory system agents|mesh-ancestor
64468660|NCT01469637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64468661|NCT01469637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468662|NCT01469637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64468663|NCT01469637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64468685|NCT00193258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64468686|NCT00193258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468687|NCT00193258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64468688|NCT00193258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64468689|NCT00193258|Growth Substances|growth substances|mesh-ancestor
64468690|NCT00193258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468691|NCT00193258|Growth Inhibitors|growth inhibitors|mesh-ancestor
64468692|NCT00193258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64468693|NCT00193258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468694|NCT00193258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468695|NCT00029536|Progesterone|progesterone|mesh-list
64468696|NCT00029536|Progestins|progestins|mesh-ancestor
64468697|NCT00029536|Hormones|hormones|mesh-ancestor
64468698|NCT00029536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64468699|NCT00029536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468700|NCT00193492|Bevacizumab|bevacizumab|mesh-list
64468701|NCT00193492|Rituximab|rituximab|mesh-list
64468702|NCT00193492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64468703|NCT00193492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65275960|NCT00646620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65275961|NCT00646620|Glucocorticoids|glucocorticoids|mesh-ancestor
65275962|NCT00646620|Hormones|hormones|mesh-ancestor
65275963|NCT00646620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65275964|NCT00646620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65275965|NCT00646620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65275966|NCT00646620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65275967|NCT00646620|Adrenergic Agents|adrenergic agents|mesh-ancestor
64728448|NCT00003680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64728449|NCT00003680|Hormone Antagonists|hormone antagonists|mesh-ancestor
64468704|NCT00193492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64468705|NCT00193492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64468706|NCT00193492|Growth Substances|growth substances|mesh-ancestor
64468707|NCT00193492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468708|NCT00193492|Growth Inhibitors|growth inhibitors|mesh-ancestor
64468709|NCT00193492|Immunologic Factors|immunologic factors|mesh-ancestor
64468710|NCT00193492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64468711|NCT00194116|Valproic Acid|valproic acid|mesh-list
64468712|NCT00194116|Anticonvulsants|anticonvulsants|mesh-ancestor
64468713|NCT00194116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468714|NCT00194116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468715|NCT00194116|GABA Agents|gaba agents|mesh-ancestor
64468716|NCT00194116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64468717|NCT00194116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468749|NCT00108550|Analgesics|analgesics|mesh-ancestor
64468750|NCT00108550|Sensory System Agents|sensory system agents|mesh-ancestor
64468751|NCT00108550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64468752|NCT00108550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468753|NCT00108550|Anticonvulsants|anticonvulsants|mesh-ancestor
64468754|NCT00108550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64468755|NCT00108550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64468756|NCT00108550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64468757|NCT00108550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64468758|NCT00108550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64468759|NCT00108550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64468760|NCT00108550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64468761|NCT00108550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468762|NCT00108550|Antimanic Agents|antimanic agents|mesh-ancestor
64468763|NCT02093962|Pemetrexed|pemetrexed|mesh-list
64468764|NCT02093962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468765|NCT02093962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972221|NCT02967341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468804|NCT00201838|Etanercept|etanercept|mesh-list
64468805|NCT00201838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64468806|NCT00201838|Antimetabolites|antimetabolites|mesh-ancestor
64471243|NCT04655222|Interferons|interferons|mesh-list
64468807|NCT00201838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468808|NCT00201838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468810|NCT00201838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64468811|NCT00201838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468812|NCT00201838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64468813|NCT00201838|Immunologic Factors|immunologic factors|mesh-ancestor
64468814|NCT00201838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468815|NCT00201838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64468816|NCT00201838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64468817|NCT00201838|Analgesics|analgesics|mesh-ancestor
64468818|NCT00201838|Sensory System Agents|sensory system agents|mesh-ancestor
64468819|NCT00201838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64468820|NCT00201838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64468821|NCT00201838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64468822|NCT00201838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64468823|NCT00040846|Cyclosporine|cyclosporine|mesh-list
64468824|NCT00040846|Mycophenolic Acid|mycophenolic acid|mesh-list
64468825|NCT00040846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64468826|NCT00040846|Alemtuzumab|alemtuzumab|mesh-list
65275968|NCT00646620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65275969|NCT00646620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275970|NCT00646620|Tocolytic Agents|tocolytic agents|mesh-ancestor
65275971|NCT00646620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65275972|NCT00646620|Sympathomimetics|sympathomimetics|mesh-ancestor
65275973|NCT00648180|Doxycycline|doxycycline|mesh-list
65275974|NCT00648180|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65275975|NCT00648180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65275976|NCT00648180|Antimalarials|antimalarials|mesh-ancestor
65275977|NCT00648180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65275978|NCT00648180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65275979|NCT02664168|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64728455|NCT00002785|Leucovorin|leucovorin|mesh-list
64468827|NCT00040846|Fludarabine|fludarabine|mesh-list
64468828|NCT00040846|Fludarabine phosphate|fludarabine phosphate|mesh-list
64468829|NCT00040846|Antibodies|antibodies|mesh-list
64468830|NCT00040846|Immunoglobulins|immunoglobulins|mesh-list
64468831|NCT00040846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64468832|NCT00040846|Cyclosporins|cyclosporins|mesh-list
64468833|NCT00040846|Immunologic Factors|immunologic factors|mesh-ancestor
64468834|NCT00040846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468835|NCT00040846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468836|NCT00040846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64468837|NCT00040846|Antimetabolites|antimetabolites|mesh-ancestor
64468838|NCT00040846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468839|NCT00040846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64468840|NCT00040846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468841|NCT00040846|Antifungal Agents|antifungal agents|mesh-ancestor
64468842|NCT00040846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64468843|NCT00040846|Dermatologic Agents|dermatologic agents|mesh-ancestor
64468844|NCT00040846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64468845|NCT00040846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64468846|NCT00040846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64468847|NCT00040846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64468848|NCT00040846|Antitubercular Agents|antitubercular agents|mesh-ancestor
64468849|NCT00040846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64468850|NCT00041938|Aspirin|aspirin|mesh-list
64972323|NCT00063401|Paclitaxel|paclitaxel|mesh-list
64468874|NCT00044044|Haloperidol|haloperidol|mesh-list
64468875|NCT00044044|Haloperidol decanoate|haloperidol decanoate|mesh-list
64468876|NCT00044044|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64468877|NCT00044044|Antiemetics|antiemetics|mesh-ancestor
64468878|NCT00044044|Autonomic Agents|autonomic agents|mesh-ancestor
64468879|NCT00044044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64468880|NCT00044044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468881|NCT00044044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64468882|NCT00044044|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64468883|NCT00044044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64468884|NCT00044044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64468885|NCT00044044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64468886|NCT00044044|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64468887|NCT00044044|Dopamine Agents|dopamine agents|mesh-ancestor
64468888|NCT00044044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64468889|NCT00044044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468890|NCT00044044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64468891|NCT00044044|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64468892|NCT00044044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64468893|NCT00044044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64468894|NCT00044044|Adrenergic Agents|adrenergic agents|mesh-ancestor
64468895|NCT00044044|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64468896|NCT00044044|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64468897|NCT00044044|Serotonin Agents|serotonin agents|mesh-ancestor
64468898|NCT00044044|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64468899|NCT00112918|Leucovorin|leucovorin|mesh-list
65275980|NCT02664168|Laxatives|laxatives|mesh-ancestor
65275981|NCT02664168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65275982|NCT00648492|Metformin|metformin|mesh-list
65275983|NCT00648492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65275984|NCT00648492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275985|NCT00648570|Dexetimide|dexetimide|mesh-list
65275986|NCT00648570|Citalopram|citalopram|mesh-list
64468900|NCT00112918|Bevacizumab|bevacizumab|mesh-list
64468901|NCT00112918|Fluorouracil|fluorouracil|mesh-list
64468902|NCT00112918|Capecitabine|capecitabine|mesh-list
64468930|NCT00046228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64468931|NCT00046228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468932|NCT00205504|Moxifloxacin|moxifloxacin|mesh-list
64468933|NCT00205504|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64468934|NCT00205504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64468935|NCT00205504|Contraceptive Agents|contraceptive agents|mesh-ancestor
64468936|NCT00205504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64468937|NCT00205504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468938|NCT00205504|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64468939|NCT00205504|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64468940|NCT00205504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64468941|NCT00205504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64468942|NCT00205504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64468943|NCT00205504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64468944|NCT00205504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64468945|NCT00205504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468946|NCT00205504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468947|NCT00205504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468948|NCT00113230|Bevacizumab|bevacizumab|mesh-list
64468949|NCT00113230|Capecitabine|capecitabine|mesh-list
64468950|NCT00113230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64468975|NCT00049036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468976|NCT00049036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64468977|NCT00049036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64468978|NCT00049036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64468979|NCT00049036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64468980|NCT00049036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64468981|NCT00049036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468982|NCT00049036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64468983|NCT00049036|Glucocorticoids|glucocorticoids|mesh-ancestor
64468985|NCT00049036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64468986|NCT00049036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64468987|NCT00049036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64468988|NCT00049036|Tubulin Modulators|tubulin modulators|mesh-ancestor
64468989|NCT00049036|Antimitotic Agents|antimitotic agents|mesh-ancestor
64468990|NCT00049036|Mitosis Modulators|mitosis modulators|mesh-ancestor
64468991|NCT00049504|Mycophenolic Acid|mycophenolic acid|mesh-list
64468992|NCT00049504|Cyclophosphamide|cyclophosphamide|mesh-list
64468993|NCT00049504|Fludarabine|fludarabine|mesh-list
64468994|NCT00049504|Fludarabine phosphate|fludarabine phosphate|mesh-list
64468995|NCT00049504|Tacrolimus|tacrolimus|mesh-list
64468996|NCT00049504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64468997|NCT00049504|Immunologic Factors|immunologic factors|mesh-ancestor
64468998|NCT00049504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468999|NCT00049504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64469000|NCT00049504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64469001|NCT00049504|Alkylating Agents|alkylating agents|mesh-ancestor
64469002|NCT00049504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469033|NCT00217438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469035|NCT00217438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64469036|NCT00217438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64469037|NCT00217438|Immunologic Factors|immunologic factors|mesh-ancestor
64469038|NCT00217438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469039|NCT00217438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64469040|NCT00217438|Protective Agents|protective agents|mesh-ancestor
64469041|NCT04480450|Rituximab|rituximab|mesh-list
64469042|NCT04480450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64469062|NCT05820594|Immunologic Factors|immunologic factors|mesh-ancestor
65275987|NCT00648570|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65275988|NCT00648570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65275989|NCT00648570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65275990|NCT00648570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65275991|NCT00648570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65275992|NCT00648570|Serotonin Agents|serotonin agents|mesh-ancestor
65275993|NCT00648570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65275994|NCT00648570|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65275995|NCT00648570|Antidepressive Agents|antidepressive agents|mesh-ancestor
65275996|NCT00648570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65275997|NCT00648570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65275998|NCT00648570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65275999|NCT00648570|Parasympatholytics|parasympatholytics|mesh-ancestor
65276000|NCT00648570|Autonomic Agents|autonomic agents|mesh-ancestor
65276001|NCT00648570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276002|NCT00648570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65276003|NCT00648570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65276004|NCT00648570|Cholinergic Agents|cholinergic agents|mesh-ancestor
65276005|NCT00648258|Naproxen|naproxen|mesh-list
65276006|NCT00648258|Valdecoxib|valdecoxib|mesh-list
65276007|NCT00648258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65276008|NCT00648258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65276009|NCT00648258|Analgesics|analgesics|mesh-ancestor
65276010|NCT00648258|Sensory System Agents|sensory system agents|mesh-ancestor
65276011|NCT00648258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276012|NCT00648258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276013|NCT00648258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65276014|NCT00648258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65276015|NCT00648258|Gout Suppressants|gout suppressants|mesh-ancestor
65276016|NCT00648258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65276017|NCT00648258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276018|NCT00648258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469063|NCT05820594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469064|NCT05820503|Anesthetics|anesthetics|mesh-list
64469065|NCT05820503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64469066|NCT05820503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469067|NCT05820347|Rocuronium|rocuronium|mesh-list
64469068|NCT05820347|Succinylcholine|succinylcholine|mesh-list
64469069|NCT05820347|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64469070|NCT05820347|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65276019|NCT00648258|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65276020|NCT00648336|Mercaptopurine|mercaptopurine|mesh-list
65276021|NCT00648336|Antimetabolites|antimetabolites|mesh-ancestor
65276022|NCT00648336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276023|NCT00648336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65276024|NCT00648336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276025|NCT00648336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65276026|NCT00648336|Immunologic Factors|immunologic factors|mesh-ancestor
65276027|NCT00648336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276028|NCT00648336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65276029|NCT00648336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276030|NCT04650984|Doxorubicin|doxorubicin|mesh-list
65276031|NCT04650984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65276032|NCT04650984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276033|NCT04650984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65276034|NCT04650984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65276035|NCT04650984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276036|NCT04650984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276037|NCT00648414|Fentanyl|fentanyl|mesh-list
65276038|NCT00648414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65276039|NCT00648414|Narcotics|narcotics|mesh-ancestor
65276040|NCT00648414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65276041|NCT00648414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276042|NCT00648414|Analgesics|analgesics|mesh-ancestor
65276043|NCT00648414|Sensory System Agents|sensory system agents|mesh-ancestor
65276069|NCT02663700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65276070|NCT02663700|Anthelmintics|anthelmintics|mesh-ancestor
65276071|NCT00648726|Azithromycin|azithromycin|mesh-list
65276072|NCT00648726|Erythromycin|erythromycin|mesh-list
65276073|NCT00648726|Erythromycin Estolate|erythromycin estolate|mesh-list
64469071|NCT05820347|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64469072|NCT05820347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64469073|NCT05820347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469074|NCT05820347|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
64469075|NCT05820256|Caseins|caseins|mesh-list
64469076|NCT05820256|Chelating Agents|chelating agents|mesh-ancestor
64469077|NCT05820256|Sequestering Agents|sequestering agents|mesh-ancestor
64469078|NCT05820256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469079|NCT05820048|Lansoprazole|lansoprazole|mesh-list
64469080|NCT05820048|Dexlansoprazole|dexlansoprazole|mesh-list
64469081|NCT05820048|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64469082|NCT05820048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64469083|NCT05820048|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64469084|NCT05820048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469085|NCT05820048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469086|NCT05819983|Ivermectin|ivermectin|mesh-list
64469087|NCT05819983|Permethrin|permethrin|mesh-list
64469088|NCT05819983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64469089|NCT05819983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64469090|NCT05819983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469091|NCT05819983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469092|NCT05819970|Allyl sulfide|allyl sulfide|mesh-list
64469093|NCT05819970|Antioxidants|antioxidants|mesh-ancestor
64469094|NCT05819970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469095|NCT05819970|Protective Agents|protective agents|mesh-ancestor
64469096|NCT05819970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972524|NCT00231556|Anticonvulsants|anticonvulsants|mesh-ancestor
64469114|NCT05819892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469116|NCT05819710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64469117|NCT05819710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64469118|NCT05819710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469120|NCT05819632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64469121|NCT05819632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64469123|NCT05819632|Sensory System Agents|sensory system agents|mesh-ancestor
64469124|NCT05819632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64469125|NCT05819632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469126|NCT05819632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64469127|NCT05819632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64469128|NCT05819632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469129|NCT05819632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469130|NCT05819632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469131|NCT05819619|Ibuprofen|ibuprofen|mesh-list
64469132|NCT05819619|Ondansetron|ondansetron|mesh-list
64469133|NCT05819619|Misoprostol|misoprostol|mesh-list
64469134|NCT05819619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64469135|NCT05819619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64469136|NCT05819619|Analgesics|analgesics|mesh-ancestor
64469137|NCT05819619|Sensory System Agents|sensory system agents|mesh-ancestor
64469138|NCT05819619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64469139|NCT05819619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469140|NCT05819619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64469141|NCT05819619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64469142|NCT05819619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64469143|NCT05819619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469144|NCT05819619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469145|NCT05819619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64469146|NCT05819619|Abortifacient Agents|abortifacient agents|mesh-ancestor
64469147|NCT05819619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64469148|NCT05819619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64469149|NCT05819619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64469150|NCT05819619|Oxytocics|oxytocics|mesh-ancestor
64469151|NCT05819619|Antiemetics|antiemetics|mesh-ancestor
64469152|NCT05819619|Autonomic Agents|autonomic agents|mesh-ancestor
64469153|NCT05819619|Antipruritics|antipruritics|mesh-ancestor
64469154|NCT05819619|Dermatologic Agents|dermatologic agents|mesh-ancestor
65276074|NCT00648726|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65276075|NCT00648726|Erythromycin stearate|erythromycin stearate|mesh-list
65276076|NCT00648726|Cefuroxime|cefuroxime|mesh-list
65276077|NCT00648726|Cefuroxime axetil|cefuroxime axetil|mesh-list
65276078|NCT00648726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65276079|NCT00648726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65276080|NCT00648726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65276081|NCT00648726|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65276082|NCT00648726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276083|NCT00648726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276084|NCT04171674|Ceftobiprole|ceftobiprole|mesh-list
65276085|NCT04171674|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
64469155|NCT05819619|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64469156|NCT05819619|Serotonin Agents|serotonin agents|mesh-ancestor
64469157|NCT05819619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64469158|NCT05819619|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64469159|NCT05819619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64469160|NCT05819619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64469161|NCT05819619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64469162|NCT05819619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64469163|NCT05819541|Albuterol|albuterol|mesh-list
64469164|NCT05819541|Montelukast|montelukast|mesh-list
64469165|NCT05819541|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64469166|NCT05819541|Respiratory System Agents|respiratory system agents|mesh-ancestor
64469167|NCT05819541|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64469168|NCT05819541|Hormone Antagonists|hormone antagonists|mesh-ancestor
64469196|NCT05818995|Calcium Channel Blockers|calcium channel blockers|mesh-list
64469197|NCT05818995|Angiotensin II|angiotensin ii|mesh-list
64469198|NCT05818995|Giapreza|giapreza|mesh-list
64469199|NCT05818995|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64469200|NCT05818995|Angiotensinogen|angiotensinogen|mesh-list
64469201|NCT05818995|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64469202|NCT05818995|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64469203|NCT05818995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64469204|NCT05818995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469205|NCT05818995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469206|NCT05818995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64469207|NCT05818995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64469208|NCT05818995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64469209|NCT05818995|Protease Inhibitors|protease inhibitors|mesh-ancestor
64469210|NCT05818995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64469224|NCT05818852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64469225|NCT05818852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469226|NCT05818852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469227|NCT05818852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469228|NCT05818852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64469229|NCT05818852|Contraceptive Agents|contraceptive agents|mesh-ancestor
64469230|NCT05818852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64469231|NCT05818852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469232|NCT05818852|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64469233|NCT05818852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64469234|NCT05818852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64469236|NCT05818826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64469237|NCT05818826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64469239|NCT05818735|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64469240|NCT05818735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64469241|NCT05818735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64469242|NCT05818735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469243|NCT05818735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64469244|NCT05818735|Serotonin Agents|serotonin agents|mesh-ancestor
64469245|NCT05818735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276086|NCT04171674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65276087|NCT04171674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65276088|NCT00648804|Ondansetron|ondansetron|mesh-list
65276089|NCT00648804|Antiemetics|antiemetics|mesh-ancestor
65276090|NCT00648804|Autonomic Agents|autonomic agents|mesh-ancestor
65276091|NCT00648804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276092|NCT00648804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276093|NCT00648804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65276094|NCT00648804|Antipruritics|antipruritics|mesh-ancestor
65276095|NCT00648804|Dermatologic Agents|dermatologic agents|mesh-ancestor
65276096|NCT00648804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65276097|NCT00648804|Serotonin Agents|serotonin agents|mesh-ancestor
65276098|NCT00648804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65276099|NCT00648804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276100|NCT00648804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65276101|NCT00648804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65276102|NCT00648804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65276103|NCT00648804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65276104|NCT00648804|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65276105|NCT02664012|Menthol|menthol|mesh-list
65276106|NCT02664012|Nicotine|nicotine|mesh-list
65276107|NCT02664012|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65276108|NCT02664012|Autonomic Agents|autonomic agents|mesh-ancestor
65276109|NCT02664012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276110|NCT02664012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276111|NCT02664012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65276112|NCT02664012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65276113|NCT02664012|Cholinergic Agents|cholinergic agents|mesh-ancestor
65276114|NCT02664012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65276116|NCT02664012|Antipruritics|antipruritics|mesh-ancestor
65276131|NCT04170504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65276132|NCT04170504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65276133|NCT04170504|Immunologic Factors|immunologic factors|mesh-ancestor
65276134|NCT04170504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65276135|NCT04170504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65276137|NCT04170270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65276138|NCT04170270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65276139|NCT04170270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65276140|NCT04170270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276141|NCT04170270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469246|NCT05818735|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64469247|NCT05818735|Antidepressive Agents|antidepressive agents|mesh-ancestor
64469248|NCT05818735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64469249|NCT05818670|Tadalafil|tadalafil|mesh-list
64469250|NCT05818670|Tamsulosin|tamsulosin|mesh-list
64469251|NCT05818670|Vasodilator Agents|vasodilator agents|mesh-ancestor
64469252|NCT05818670|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64469253|NCT05818670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64469254|NCT05818670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469255|NCT05818670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469256|NCT05818670|Urological Agents|urological agents|mesh-ancestor
64469257|NCT05818670|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64469258|NCT05818670|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64469259|NCT05818670|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64469260|NCT05818670|Adrenergic Agents|adrenergic agents|mesh-ancestor
64469261|NCT05818670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64469262|NCT05818670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469263|NCT05818618|Clobetasol|clobetasol|mesh-list
64469264|NCT05818618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64469265|NCT05818618|Glucocorticoids|glucocorticoids|mesh-ancestor
64469266|NCT05818618|Hormones|hormones|mesh-ancestor
64469267|NCT05818618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64469268|NCT05818618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469269|NCT05816512|Chlorhexidine|chlorhexidine|mesh-list
64469291|NCT05816343|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64469292|NCT05816343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64469293|NCT05816252|Carboplatin|carboplatin|mesh-list
64469294|NCT05816252|Pembrolizumab|pembrolizumab|mesh-list
64469295|NCT05816252|Osimertinib|osimertinib|mesh-list
64469296|NCT05816252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469297|NCT05816252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64469298|NCT05816252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64469299|NCT05816252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469300|NCT05816252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469301|NCT05816226|Hydrocortisone|hydrocortisone|mesh-list
64469302|NCT05816226|Diclofenac|diclofenac|mesh-list
64469303|NCT05816226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64469304|NCT05816226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64469305|NCT05816226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64469306|NCT05816226|Analgesics|analgesics|mesh-ancestor
64513654|NCT01457859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64469307|NCT05816226|Sensory System Agents|sensory system agents|mesh-ancestor
64469308|NCT05816226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64469309|NCT05816226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469310|NCT05816226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64469311|NCT05816226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64469312|NCT05816226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469313|NCT05816226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469314|NCT05816070|Ofloxacin|ofloxacin|mesh-list
64469315|NCT05816070|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64469316|NCT05816070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64469317|NCT05816070|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64469318|NCT05816070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64469319|NCT05816070|Renal Agents|renal agents|mesh-ancestor
65276142|NCT00633347|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65276143|NCT00633347|Cetrorelix|cetrorelix|mesh-list
65276144|NCT00633347|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65276145|NCT00633347|Hormones|hormones|mesh-ancestor
65276146|NCT00633347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65276147|NCT00633347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469320|NCT05816070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64469321|NCT05816070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64469322|NCT05816070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64469351|NCT05815758|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64469352|NCT05815758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64469353|NCT05815758|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64469354|NCT05815758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64469355|NCT05815758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64469356|NCT05815758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64469357|NCT05815758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64469358|NCT05815758|Adrenergic Agents|adrenergic agents|mesh-ancestor
64469359|NCT05815758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64469360|NCT05815758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469361|NCT05815758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469362|NCT05815758|Antipruritics|antipruritics|mesh-ancestor
64469363|NCT05815758|Dermatologic Agents|dermatologic agents|mesh-ancestor
64469364|NCT05815758|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64469365|NCT05815758|Histamine Antagonists|histamine antagonists|mesh-ancestor
64469366|NCT05815758|Histamine Agents|histamine agents|mesh-ancestor
64469367|NCT05815758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64469368|NCT05815719|Hormones|hormones|mesh-list
64469369|NCT05815719|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64972748|NCT00232765|Immunologic Factors|immunologic factors|mesh-ancestor
64469385|NCT05815680|Anticoagulants|anticoagulants|mesh-ancestor
64469386|NCT05815680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64469387|NCT05815680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64469388|NCT05815680|Protective Agents|protective agents|mesh-ancestor
64469390|NCT05815654|Sensory System Agents|sensory system agents|mesh-ancestor
64469391|NCT05815654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64469392|NCT05815654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469393|NCT05815602|Mebeverine|mebeverine|mesh-list
64469394|NCT05815602|Ebastine|ebastine|mesh-list
64469395|NCT05815602|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64469396|NCT05815602|Histamine Antagonists|histamine antagonists|mesh-ancestor
64469397|NCT05815602|Histamine Agents|histamine agents|mesh-ancestor
64469398|NCT05815602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64469399|NCT05815602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469400|NCT05815602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469401|NCT05815602|Anticonvulsants|anticonvulsants|mesh-ancestor
64469402|NCT05815602|Parasympatholytics|parasympatholytics|mesh-ancestor
64469403|NCT05815602|Autonomic Agents|autonomic agents|mesh-ancestor
64469404|NCT05815602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64469405|NCT05815303|Capecitabine|capecitabine|mesh-list
64469406|NCT05815303|Oxaliplatin|oxaliplatin|mesh-list
64469407|NCT05815303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64469408|NCT05815303|Antimetabolites|antimetabolites|mesh-ancestor
64469409|NCT05815303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469410|NCT05815303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469411|NCT05815264|Vaccines|vaccines|mesh-list
64469412|NCT05815264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64469414|NCT05815264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469416|NCT05815199|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64469417|NCT05815199|Autonomic Agents|autonomic agents|mesh-ancestor
64469418|NCT05815199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64469419|NCT05815199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469420|NCT05815199|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64469421|NCT05815199|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64469422|NCT05815199|Cholinergic Agents|cholinergic agents|mesh-ancestor
64469423|NCT05815199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64469424|NCT05815199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469425|NCT05815160|Carboplatin|carboplatin|mesh-list
64469426|NCT05815160|Etoposide|etoposide|mesh-list
64469427|NCT05815160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276148|NCT00633347|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65276149|NCT00633347|Fertility Agents|fertility agents|mesh-ancestor
65276150|NCT00633347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65276151|NCT00633347|Hormone Antagonists|hormone antagonists|mesh-ancestor
65276152|NCT00633347|Luteolytic Agents|luteolytic agents|mesh-ancestor
65276153|NCT00633347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65276154|NCT00633347|Contraceptive Agents|contraceptive agents|mesh-ancestor
65276155|NCT00633347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65276156|NCT00633347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64469428|NCT05815160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64469429|NCT05815160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64469430|NCT05815160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64469457|NCT05814744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469458|NCT05814744|Sensory System Agents|sensory system agents|mesh-ancestor
64469459|NCT05814744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64469460|NCT05814744|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64469461|NCT05814744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64469462|NCT05814744|Analgesics|analgesics|mesh-ancestor
64469463|NCT05814744|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64469464|NCT05814744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64469465|NCT05814744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64469466|NCT05814744|Adrenergic Agents|adrenergic agents|mesh-ancestor
64469467|NCT05814744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64469468|NCT05814744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469469|NCT05814731|Cytarabine|cytarabine|mesh-list
64469470|NCT05814731|Cyclophosphamide|cyclophosphamide|mesh-list
64469471|NCT05814731|Busulfan|busulfan|mesh-list
64469472|NCT05814731|Semustine|semustine|mesh-list
64469473|NCT05814731|Mitoxantrone|mitoxantrone|mesh-list
64469474|NCT05814731|Thymoglobulin|thymoglobulin|mesh-list
64469475|NCT05814731|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64469476|NCT05814731|Immunoglobulins|immunoglobulins|mesh-list
64469477|NCT05814731|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64469478|NCT05814731|Antibodies|antibodies|mesh-list
64469479|NCT05814731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64469509|NCT05814718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469510|NCT05814718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64469511|NCT05814718|Antimetabolites|antimetabolites|mesh-ancestor
64469512|NCT05814718|Antiviral Agents|antiviral agents|mesh-ancestor
64469513|NCT05814718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64469514|NCT05814718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64469515|NCT05814718|Immunologic Factors|immunologic factors|mesh-ancestor
64469516|NCT05814718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469517|NCT05814718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64469518|NCT05814718|Alkylating Agents|alkylating agents|mesh-ancestor
64469519|NCT05814718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64469520|NCT05814718|Analgesics|analgesics|mesh-ancestor
64469521|NCT05814718|Sensory System Agents|sensory system agents|mesh-ancestor
64469522|NCT05814718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64469523|NCT05814666|Pembrolizumab|pembrolizumab|mesh-list
64469524|NCT05814666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64469525|NCT05814666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469526|NCT05814640|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64469527|NCT05814640|Olanzapine|olanzapine|mesh-list
64469553|NCT05814640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64469554|NCT05814640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64469555|NCT05814640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64469556|NCT05814640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64469557|NCT05814640|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64469558|NCT05814640|Analgesics|analgesics|mesh-ancestor
64469559|NCT05814640|Sensory System Agents|sensory system agents|mesh-ancestor
64469560|NCT05814640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64469561|NCT05814640|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64469562|NCT05814640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64469571|NCT05814627|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65276157|NCT00633347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276158|NCT02838719|Dexamethasone|dexamethasone|mesh-list
65276159|NCT02838719|Dexamethasone acetate|dexamethasone acetate|mesh-list
65276160|NCT02838719|BB 1101|bb 1101|mesh-list
65276161|NCT02838719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65276162|NCT02838719|Antiemetics|antiemetics|mesh-ancestor
65276163|NCT02838719|Autonomic Agents|autonomic agents|mesh-ancestor
65276164|NCT02838719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276165|NCT02838719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276166|NCT02838719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65276167|NCT02838719|Glucocorticoids|glucocorticoids|mesh-ancestor
65276168|NCT02838719|Hormones|hormones|mesh-ancestor
65276169|NCT02838719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65276170|NCT02838719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65276171|NCT02838719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276172|NCT02838719|Protease Inhibitors|protease inhibitors|mesh-ancestor
65276173|NCT02838719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276174|NCT02838719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276175|NCT02659488|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65276176|NCT02659488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65276177|NCT02659488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276178|NCT02659488|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65276179|NCT02659488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65276180|NCT02659488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65276181|NCT02659488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276182|NCT02659488|Dopamine Agents|dopamine agents|mesh-ancestor
65276183|NCT02659488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65276184|NCT00649194|Rabeprazole|rabeprazole|mesh-list
65276185|NCT00649194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65276186|NCT00649194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65276187|NCT00649194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65276188|NCT00649194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276189|NCT00649194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276190|NCT02659254|Sirolimus|sirolimus|mesh-list
64728644|NCT00004202|Tubulin Modulators|tubulin modulators|mesh-ancestor
64469572|NCT05814627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64469573|NCT05814627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276191|NCT02659254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65276192|NCT02659254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65276193|NCT02659254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65276194|NCT02659254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276195|NCT02659254|Antifungal Agents|antifungal agents|mesh-ancestor
65276196|NCT02659254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65276197|NCT02659254|Immunologic Factors|immunologic factors|mesh-ancestor
65276198|NCT02659254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276199|NCT02658864|Lafutidine|lafutidine|mesh-list
65276200|NCT02658864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64728680|NCT00004862|Oblimersen|oblimersen|mesh-list
64469574|NCT05814627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469575|NCT05814601|Norepinephrine|norepinephrine|mesh-list
64469576|NCT05814601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64469577|NCT05814601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64469578|NCT05814601|Adrenergic Agents|adrenergic agents|mesh-ancestor
64469579|NCT05814601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64469580|NCT05814601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469581|NCT05814601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469582|NCT05814601|Sympathomimetics|sympathomimetics|mesh-ancestor
64972951|NCT00233584|Hormones|hormones|mesh-ancestor
64469615|NCT05807139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64471323|NCT04592744|Angiotensin II|angiotensin ii|mesh-list
64469616|NCT05807139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469617|NCT05807139|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64469618|NCT05807139|Diuretics|diuretics|mesh-ancestor
64469619|NCT05807139|Natriuretic Agents|natriuretic agents|mesh-ancestor
64469620|NCT05805605|Mycophenolic Acid|mycophenolic acid|mesh-list
64469621|NCT05805605|Sirolimus|sirolimus|mesh-list
64469622|NCT05805605|Cyclophosphamide|cyclophosphamide|mesh-list
64469623|NCT05805605|Fludarabine|fludarabine|mesh-list
64469624|NCT05805605|Allopurinol|allopurinol|mesh-list
64469625|NCT05805605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64469626|NCT05805605|Immunologic Factors|immunologic factors|mesh-ancestor
64469627|NCT05805605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469628|NCT05805605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64469629|NCT05805605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64469630|NCT05805605|Alkylating Agents|alkylating agents|mesh-ancestor
64469631|NCT05805605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469632|NCT05805605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469633|NCT05805605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64469634|NCT05805605|Antimetabolites|antimetabolites|mesh-ancestor
64469635|NCT05805605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64469636|NCT05805605|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64972993|NCT00233818|Sirolimus|sirolimus|mesh-list
64469656|NCT05795257|Dimercaprol|dimercaprol|mesh-list
64469657|NCT05795257|Chelating Agents|chelating agents|mesh-ancestor
64469658|NCT05795257|Sequestering Agents|sequestering agents|mesh-ancestor
64469659|NCT05795257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469660|NCT05788328|Dabigatran|dabigatran|mesh-list
64469661|NCT05788328|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64469662|NCT05788328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64469663|NCT05788328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64469664|NCT05788328|Antimetabolites|antimetabolites|mesh-ancestor
64469665|NCT05788328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469666|NCT05788328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64469667|NCT05788328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64469668|NCT05788328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469669|NCT05788328|Antithrombins|antithrombins|mesh-ancestor
64469670|NCT05788328|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64469671|NCT05788328|Protease Inhibitors|protease inhibitors|mesh-ancestor
64469672|NCT05788328|Anticoagulants|anticoagulants|mesh-ancestor
64469673|NCT05786378|Anesthetics|anesthetics|mesh-list
64469674|NCT05786378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64469675|NCT05786378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276201|NCT02658864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65276202|NCT02658864|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65276203|NCT02658864|Histamine Antagonists|histamine antagonists|mesh-ancestor
65276204|NCT02658864|Histamine Agents|histamine agents|mesh-ancestor
65276205|NCT02658864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65276206|NCT02658864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276207|NCT02658864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469676|NCT05779241|Risperidone|risperidone|mesh-list
64469677|NCT05779241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64469678|NCT05779241|Serotonin Agents|serotonin agents|mesh-ancestor
64469679|NCT05779241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64469680|NCT05779241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469681|NCT05779241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469682|NCT05779241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64469683|NCT05779241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64469684|NCT05779241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64469685|NCT05779241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64469686|NCT05779241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64469687|NCT05779241|Dopamine Agents|dopamine agents|mesh-ancestor
64469688|NCT05768360|Metformin|metformin|mesh-list
64469689|NCT05768360|Digoxin|digoxin|mesh-list
64469690|NCT05768360|Furosemide|furosemide|mesh-list
64469691|NCT05768360|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64469692|NCT05768360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64469693|NCT05768360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469694|NCT05768360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64469695|NCT05768360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64469724|NCT05757557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64469725|NCT05757557|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64469726|NCT05757557|Vasodilator Agents|vasodilator agents|mesh-ancestor
64469727|NCT05757557|Gasotransmitters|gasotransmitters|mesh-ancestor
64469728|NCT05757557|Protective Agents|protective agents|mesh-ancestor
64469730|NCT05754710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64469731|NCT05754710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469732|NCT05754710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469733|NCT05751317|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64469734|NCT05751317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64469735|NCT05735431|Fluticasone|fluticasone|mesh-list
64469736|NCT05735431|Formoterol Fumarate|formoterol fumarate|mesh-list
64469737|NCT05735431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64469738|NCT05735431|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64469739|NCT05735431|Autonomic Agents|autonomic agents|mesh-ancestor
64469740|NCT05735431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64469771|NCT05716984|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64469772|NCT05716984|Natriuretic Agents|natriuretic agents|mesh-ancestor
64469773|NCT05716984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469774|NCT05713630|Tranexamic Acid|tranexamic acid|mesh-list
64469775|NCT05713630|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64469776|NCT05713630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64469777|NCT05713630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469778|NCT05713630|Hemostatics|hemostatics|mesh-ancestor
64469779|NCT05713630|Coagulants|coagulants|mesh-ancestor
64469780|NCT05700344|Avelumab|avelumab|mesh-list
64469781|NCT05700344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64469782|NCT05700344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469783|NCT05690984|Dexamethasone|dexamethasone|mesh-list
64469784|NCT05690984|Lenalidomide|lenalidomide|mesh-list
64469798|NCT05690984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64469799|NCT05690984|Growth Substances|growth substances|mesh-ancestor
64469800|NCT05690984|Growth Inhibitors|growth inhibitors|mesh-ancestor
64469802|NCT05688904|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64469803|NCT05688904|Antidepressive Agents|antidepressive agents|mesh-ancestor
64469804|NCT05688904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64469805|NCT05688904|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64469806|NCT05688904|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64469807|NCT05688904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64469808|NCT05688904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469809|NCT05688904|Adrenergic Agents|adrenergic agents|mesh-ancestor
65276208|NCT02835833|Bevacizumab|bevacizumab|mesh-list
65276209|NCT02835833|Nintedanib|nintedanib|mesh-list
65276210|NCT02835833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65276211|NCT02835833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276212|NCT02835833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65276213|NCT02835833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65276214|NCT02835833|Growth Substances|growth substances|mesh-ancestor
65276215|NCT02835833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728702|NCT00003704|Capecitabine|capecitabine|mesh-list
64469810|NCT05688904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64469811|NCT05688904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469813|NCT05687357|Oxaliplatin|oxaliplatin|mesh-list
64469814|NCT05687357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64469815|NCT05687357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469816|NCT05687357|Tubulin Modulators|tubulin modulators|mesh-ancestor
64469817|NCT05687357|Antimitotic Agents|antimitotic agents|mesh-ancestor
64469818|NCT05687357|Mitosis Modulators|mitosis modulators|mesh-ancestor
64469819|NCT05687357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469820|NCT05683574|Etoricoxib|etoricoxib|mesh-list
64469821|NCT05683574|Amitriptyline|amitriptyline|mesh-list
64469822|NCT05683574|Cyclobenzaprine|cyclobenzaprine|mesh-list
64469823|NCT05683574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64469824|NCT05683574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64469825|NCT05683574|Analgesics|analgesics|mesh-ancestor
64469826|NCT05683574|Sensory System Agents|sensory system agents|mesh-ancestor
64469827|NCT05683574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64469828|NCT05683574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469829|NCT05683574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64469830|NCT05683574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64469831|NCT05683574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64469832|NCT05683574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64469836|NCT05683574|Antidepressive Agents|antidepressive agents|mesh-ancestor
64469837|NCT05683574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64469838|NCT05683574|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64469839|NCT05683574|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64469840|NCT05683574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64469841|NCT05683574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64469842|NCT05683574|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64469843|NCT05683574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64469844|NCT05683574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64469845|NCT05683574|Adrenergic Agents|adrenergic agents|mesh-ancestor
64469862|NCT05677295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64469863|NCT05677295|Dopamine Agents|dopamine agents|mesh-ancestor
64713981|NCT02839772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455622|NCT01918033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64469864|NCT05677295|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64469865|NCT05677295|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64469866|NCT05677295|Adrenergic Agents|adrenergic agents|mesh-ancestor
64469867|NCT05675943|Antibodies|antibodies|mesh-list
64469868|NCT05675943|Immunologic Factors|immunologic factors|mesh-ancestor
64469869|NCT05675943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469870|NCT05664386|Propofol|propofol|mesh-list
64469871|NCT05664386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64469872|NCT05664386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64469873|NCT05664386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469875|NCT05664386|Anesthetics, General|anesthetics, general|mesh-ancestor
64469876|NCT05664386|Anesthetics|anesthetics|mesh-ancestor
64469877|NCT05660538|Pregabalin|pregabalin|mesh-list
64469878|NCT05660538|Analgesics|analgesics|mesh-ancestor
64469879|NCT05660538|Sensory System Agents|sensory system agents|mesh-ancestor
64469880|NCT05660538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64469881|NCT05660538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469882|NCT05660538|Anticonvulsants|anticonvulsants|mesh-ancestor
64469883|NCT05660538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64469884|NCT05660538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64469885|NCT05660538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276216|NCT02835833|Growth Inhibitors|growth inhibitors|mesh-ancestor
65276217|NCT02835833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65276218|NCT02835833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276219|NCT02835833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276220|NCT04171284|Docetaxel|docetaxel|mesh-list
64728704|NCT00003704|Antimetabolites|antimetabolites|mesh-ancestor
64469886|NCT05660538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64469887|NCT05660538|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64469888|NCT05660538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64469889|NCT05660538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64469890|NCT05660538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64469891|NCT05654506|Daratumumab|daratumumab|mesh-list
64469892|NCT05654506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469893|NCT05644600|Nintedanib|nintedanib|mesh-list
64469894|NCT05644600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469895|NCT05644600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64469896|NCT05644600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469897|NCT05644600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469902|NCT05632133|Lacosamide|lacosamide|mesh-list
64469903|NCT05632133|Anticonvulsants|anticonvulsants|mesh-ancestor
64469904|NCT05632133|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64469905|NCT05632133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64512144|NCT04747314|Analgesics|analgesics|mesh-ancestor
64469942|NCT05618002|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64713982|NCT03041636|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
64469943|NCT05618002|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64469944|NCT05618002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64469945|NCT05618002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64469971|NCT05605899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64469972|NCT05605899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469973|NCT05605899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64469974|NCT05605899|Glucocorticoids|glucocorticoids|mesh-ancestor
64469975|NCT05605899|Hormones|hormones|mesh-ancestor
64469976|NCT05605899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64469977|NCT05605899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64469978|NCT05605899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64469979|NCT05605899|Tubulin Modulators|tubulin modulators|mesh-ancestor
64469980|NCT05605899|Antimitotic Agents|antimitotic agents|mesh-ancestor
64469981|NCT05605899|Mitosis Modulators|mitosis modulators|mesh-ancestor
64469982|NCT05605470|Vaccines|vaccines|mesh-list
64469986|NCT05604222|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64469987|NCT05604222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64469988|NCT05604222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64469989|NCT05604222|Adrenergic Agents|adrenergic agents|mesh-ancestor
64469990|NCT05604222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64469991|NCT05604222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469992|NCT05604222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469993|NCT05604222|Urological Agents|urological agents|mesh-ancestor
64469995|NCT05603910|Lenvatinib|lenvatinib|mesh-list
64470001|NCT05592223|Isoniazid|isoniazid|mesh-list
64470002|NCT05592223|BCG Vaccine|bcg vaccine|mesh-list
64470003|NCT05592223|Antitubercular Agents|antitubercular agents|mesh-ancestor
64470004|NCT05592223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64470005|NCT05592223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64470006|NCT05592223|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64470007|NCT05592223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64470070|NCT05565222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470072|NCT05563766|Antifungal Agents|antifungal agents|mesh-ancestor
64470150|NCT05536349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470151|NCT05536349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470152|NCT05536349|Gout Suppressants|gout suppressants|mesh-ancestor
64470153|NCT05536349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64470154|NCT05536349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64470155|NCT05536349|Antioxidants|antioxidants|mesh-ancestor
64470156|NCT05536349|Protective Agents|protective agents|mesh-ancestor
64470157|NCT05536349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470158|NCT05536349|Antiviral Agents|antiviral agents|mesh-ancestor
64470159|NCT05536349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64470160|NCT05526989|Niraparib|niraparib|mesh-list
65276221|NCT04171284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276222|NCT04171284|Tubulin Modulators|tubulin modulators|mesh-ancestor
65276223|NCT04171284|Antimitotic Agents|antimitotic agents|mesh-ancestor
65276224|NCT04171284|Mitosis Modulators|mitosis modulators|mesh-ancestor
65276225|NCT04171284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276226|NCT02838329|Ropivacaine|ropivacaine|mesh-list
64470161|NCT05526989|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64470162|NCT05526989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470163|NCT05526989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470164|NCT05526989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470165|NCT05506943|Paclitaxel|paclitaxel|mesh-list
64470166|NCT05506943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64470167|NCT05506943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470168|NCT05506943|Tubulin Modulators|tubulin modulators|mesh-ancestor
64470169|NCT05506943|Antimitotic Agents|antimitotic agents|mesh-ancestor
64470170|NCT05506943|Mitosis Modulators|mitosis modulators|mesh-ancestor
64470171|NCT05506943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470173|NCT05497778|Paclitaxel|paclitaxel|mesh-list
64470175|NCT05497778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64470176|NCT05497778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470177|NCT05497778|Tubulin Modulators|tubulin modulators|mesh-ancestor
64470187|NCT05497778|Immunologic Factors|immunologic factors|mesh-ancestor
64470188|NCT05497778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470189|NCT05493501|Gemcitabine|gemcitabine|mesh-list
64470190|NCT05493501|Paclitaxel|paclitaxel|mesh-list
64470191|NCT05493501|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64470192|NCT05493501|Carboplatin|carboplatin|mesh-list
64470193|NCT05493501|Pemetrexed|pemetrexed|mesh-list
64470194|NCT05493501|Osimertinib|osimertinib|mesh-list
64470195|NCT05493501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64470196|NCT05493501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470197|NCT05493501|Tubulin Modulators|tubulin modulators|mesh-ancestor
64470198|NCT05493501|Antimitotic Agents|antimitotic agents|mesh-ancestor
64470199|NCT05493501|Mitosis Modulators|mitosis modulators|mesh-ancestor
64470200|NCT05493501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470201|NCT05493501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64470202|NCT05493501|Antimetabolites|antimetabolites|mesh-ancestor
64470203|NCT05493501|Antiviral Agents|antiviral agents|mesh-ancestor
64470204|NCT05493501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64470205|NCT05493501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470206|NCT05493501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64470207|NCT05493501|Immunologic Factors|immunologic factors|mesh-ancestor
64470208|NCT05493501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470209|NCT05493501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64470210|NCT05493501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64470211|NCT05493501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64470212|NCT05487586|Ceftazidime|ceftazidime|mesh-list
64470213|NCT05487586|Avibactam|avibactam|mesh-list
64470214|NCT05487586|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
64470215|NCT05487586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64470216|NCT05487586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64470217|NCT05487586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64470218|NCT05487586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470219|NCT05487586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470220|NCT05483491|Aldesleukin|aldesleukin|mesh-list
64470221|NCT05483491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470222|NCT05483491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64470223|NCT05483491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64470224|NCT05483491|Antiviral Agents|antiviral agents|mesh-ancestor
64470225|NCT05483491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64470226|NCT05482789|Exenatide|exenatide|mesh-list
64470227|NCT05482789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64470228|NCT05482789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470229|NCT05482789|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64470230|NCT05482789|Incretins|incretins|mesh-ancestor
64470231|NCT05482789|Hormones|hormones|mesh-ancestor
64470232|NCT05482789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64470233|NCT05474950|Minocycline|minocycline|mesh-list
64470234|NCT05474950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64470235|NCT05474950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65276227|NCT02838329|Anesthetics, Local|anesthetics, local|mesh-ancestor
65276228|NCT02838329|Anesthetics|anesthetics|mesh-ancestor
65276229|NCT02838329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65276230|NCT02838329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276231|NCT02838329|Sensory System Agents|sensory system agents|mesh-ancestor
65276232|NCT02838329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276233|NCT02662530|Botulinum Toxins|botulinum toxins|mesh-list
65276234|NCT02662530|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65276235|NCT02662530|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65276236|NCT02662530|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65276237|NCT02662530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64728717|NCT00003710|Irinotecan|irinotecan|mesh-list
64470236|NCT05461404|Emollients|emollients|mesh-list
64470237|NCT05461404|Dermatologic Agents|dermatologic agents|mesh-ancestor
64470238|NCT05453903|Cytarabine|cytarabine|mesh-list
64470239|NCT05453903|Azacitidine|azacitidine|mesh-list
64470240|NCT05453903|Daunorubicin|daunorubicin|mesh-list
64470241|NCT05453903|Venetoclax|venetoclax|mesh-list
64470242|NCT05453903|Idarubicin|idarubicin|mesh-list
64470243|NCT05453903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64470244|NCT05453903|Antimetabolites|antimetabolites|mesh-ancestor
64973459|NCT00236821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64470280|NCT05428488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470281|NCT05428488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64470282|NCT05428488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64470293|NCT05421741|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64470294|NCT05421741|Vancomycin|vancomycin|mesh-list
64470295|NCT05421741|Gentamicins|gentamicins|mesh-list
64470296|NCT05421741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64470297|NCT05421741|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64470298|NCT05421741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470299|NCT05421741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470300|NCT05415215|Trastuzumab|trastuzumab|mesh-list
64470301|NCT05415215|Pertuzumab|pertuzumab|mesh-list
64470302|NCT05415215|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64470303|NCT05415215|Maytansine|maytansine|mesh-list
64470304|NCT05415215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64470305|NCT05415215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470306|NCT05415215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64470308|NCT05415215|Antimitotic Agents|antimitotic agents|mesh-ancestor
64470309|NCT05415215|Mitosis Modulators|mitosis modulators|mesh-ancestor
64470310|NCT05415215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470340|NCT05389722|Rifampin|rifampin|mesh-list
64470341|NCT05389722|Digoxin|digoxin|mesh-list
64470342|NCT05389722|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64470343|NCT05389722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64470344|NCT05389722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64470346|NCT05389722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470347|NCT05389722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64470348|NCT05389722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64470349|NCT05389722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470350|NCT05389722|Antifungal Agents|antifungal agents|mesh-ancestor
64470351|NCT05389722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64470352|NCT05389722|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64470353|NCT05389722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64973560|NCT00065273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64470384|NCT05382286|Antimitotic Agents|antimitotic agents|mesh-ancestor
64470385|NCT05382286|Mitosis Modulators|mitosis modulators|mesh-ancestor
64470386|NCT05382286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470387|NCT05382286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64470388|NCT05382286|Antimetabolites|antimetabolites|mesh-ancestor
64470389|NCT05382286|Antiviral Agents|antiviral agents|mesh-ancestor
64470390|NCT05382286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64470391|NCT05382286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470392|NCT05382286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65276238|NCT02662530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276239|NCT02662530|Cholinergic Agents|cholinergic agents|mesh-ancestor
65276240|NCT02662530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65276241|NCT02662530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276242|NCT02662530|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65276243|NCT02662530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276244|NCT02835521|Triamcinolone|triamcinolone|mesh-list
65276245|NCT02835521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64728725|NCT00003710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64728728|NCT00004232|Cyclosporine|cyclosporine|mesh-list
64470393|NCT05382286|Immunologic Factors|immunologic factors|mesh-ancestor
64470394|NCT05382286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470395|NCT05382286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64470396|NCT05378464|Trastuzumab|trastuzumab|mesh-list
64470397|NCT05378464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64973613|NCT04710160|Calcium|calcium|mesh-list
64470423|NCT05344469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470424|NCT05344469|Antiviral Agents|antiviral agents|mesh-ancestor
64470425|NCT05344469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64470426|NCT05344469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64470427|NCT05344469|Immunologic Factors|immunologic factors|mesh-ancestor
64470428|NCT05344469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470429|NCT05344469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64470430|NCT05344469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64470432|NCT05304520|Immunologic Factors|immunologic factors|mesh-ancestor
64470433|NCT05304520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470435|NCT05300152|Immunoglobulins|immunoglobulins|mesh-list
64470436|NCT05300152|Immunologic Factors|immunologic factors|mesh-ancestor
64470437|NCT05300152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470449|NCT05295173|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64470450|NCT05295173|Plasminogen|plasminogen|mesh-list
64470451|NCT05295173|Reteplase|reteplase|mesh-list
64470452|NCT05295173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64470453|NCT05295173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64470454|NCT05295173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470455|NCT05294263|Varenicline|varenicline|mesh-list
64470456|NCT05294263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64470457|NCT05294263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64470458|NCT05294263|Cholinergic Agents|cholinergic agents|mesh-ancestor
64470459|NCT05294263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64470460|NCT05294263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470461|NCT05294263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470462|NCT05265728|Natalizumab|natalizumab|mesh-list
64512607|NCT04184622|Hormones|hormones|mesh-ancestor
64470477|NCT05256290|Alkylating Agents|alkylating agents|mesh-ancestor
64470478|NCT05256290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470479|NCT05256290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470481|NCT05253651|Bevacizumab|bevacizumab|mesh-list
64470482|NCT05253651|Trastuzumab|trastuzumab|mesh-list
64470483|NCT05253651|Cetuximab|cetuximab|mesh-list
64470484|NCT05253651|Fluorouracil|fluorouracil|mesh-list
64470485|NCT05253651|Oxaliplatin|oxaliplatin|mesh-list
64470486|NCT05253651|Tucatinib|tucatinib|mesh-list
64470487|NCT05253651|Levoleucovorin|levoleucovorin|mesh-list
64470488|NCT05253651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64470489|NCT05253651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470490|NCT05253651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64470491|NCT05253651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64470492|NCT05253651|Growth Substances|growth substances|mesh-ancestor
64470493|NCT05253651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470494|NCT05253651|Growth Inhibitors|growth inhibitors|mesh-ancestor
64470495|NCT05253651|Antimetabolites|antimetabolites|mesh-ancestor
64470496|NCT05253651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470497|NCT05253651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64470498|NCT05253651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65276246|NCT02835521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65276247|NCT02835521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65276248|NCT02835521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65276249|NCT02835521|Glucocorticoids|glucocorticoids|mesh-ancestor
65276250|NCT02835521|Hormones|hormones|mesh-ancestor
65276251|NCT02835521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65276252|NCT02835521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276253|NCT02835521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65276254|NCT02835521|Immunologic Factors|immunologic factors|mesh-ancestor
64470499|NCT05253651|Immunologic Factors|immunologic factors|mesh-ancestor
64470500|NCT05253651|Antidotes|antidotes|mesh-ancestor
64470501|NCT05253651|Protective Agents|protective agents|mesh-ancestor
64470502|NCT05253651|Vitamin B Complex|vitamin b complex|mesh-ancestor
64470503|NCT05253651|Vitamins|vitamins|mesh-ancestor
64470504|NCT05253651|Micronutrients|micronutrients|mesh-ancestor
64470505|NCT05253651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64470506|NCT05253651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470507|NCT05250791|Lidocaine|lidocaine|mesh-list
64470508|NCT05250791|Anesthetics, Local|anesthetics, local|mesh-ancestor
64470509|NCT05250791|Anesthetics|anesthetics|mesh-ancestor
64470510|NCT05250791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64470511|NCT05250791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470512|NCT05250791|Sensory System Agents|sensory system agents|mesh-ancestor
64470513|NCT05250791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64470514|NCT05250791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64470515|NCT05250791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64470516|NCT05250791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64470517|NCT05250791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64470518|NCT05250791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470519|NCT05246111|Topotecan|topotecan|mesh-list
64470520|NCT05246111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64470521|NCT05246111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64470522|NCT05246111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470544|NCT05241288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64470545|NCT05241288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64470546|NCT05241288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64470547|NCT05241288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64470548|NCT05241288|Adrenergic Agents|adrenergic agents|mesh-ancestor
64470549|NCT05241288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64470550|NCT05241288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470551|NCT05220748|Pembrolizumab|pembrolizumab|mesh-list
64470575|NCT05180357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64470576|NCT05180357|Respiratory System Agents|respiratory system agents|mesh-ancestor
64470577|NCT05169684|Docetaxel|docetaxel|mesh-list
64470578|NCT05169684|Nivolumab|nivolumab|mesh-list
64470579|NCT05169684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470580|NCT05169684|Tubulin Modulators|tubulin modulators|mesh-ancestor
64470581|NCT05169684|Antimitotic Agents|antimitotic agents|mesh-ancestor
64470582|NCT05169684|Mitosis Modulators|mitosis modulators|mesh-ancestor
64470586|NCT05144542|Nicotine|nicotine|mesh-list
64470587|NCT05144542|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64470594|NCT05144542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64470595|NCT05144542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470596|NCT05141708|Talazoparib|talazoparib|mesh-list
64470597|NCT05141708|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64470598|NCT05141708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470599|NCT05141708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470600|NCT05141708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470601|NCT05137119|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64470602|NCT05137119|Vancomycin|vancomycin|mesh-list
64470603|NCT05137119|Clindamycin|clindamycin|mesh-list
64470604|NCT05137119|Cefazolin|cefazolin|mesh-list
64470605|NCT05137119|Daptomycin|daptomycin|mesh-list
64470606|NCT05137119|Penicillins|penicillins|mesh-list
64470607|NCT05137119|Penicillin G|penicillin g|mesh-list
64470608|NCT05137119|Lincomycin|lincomycin|mesh-list
64470609|NCT05137119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64470633|NCT05132582|Pertuzumab|pertuzumab|mesh-list
65276255|NCT02835521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276256|NCT02835521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276257|NCT00649272|Oxybutynin|oxybutynin|mesh-list
65276258|NCT00649272|Parasympatholytics|parasympatholytics|mesh-ancestor
65276259|NCT00649272|Autonomic Agents|autonomic agents|mesh-ancestor
65276260|NCT00649272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64728743|NCT00004232|Antifungal Agents|antifungal agents|mesh-ancestor
64470634|NCT05132582|Tucatinib|tucatinib|mesh-list
64470635|NCT05132582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64470636|NCT05132582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470637|NCT05132582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64470638|NCT05132582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470639|NCT05132582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470641|NCT05117489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64470649|NCT05090033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470650|NCT05087992|Bevacizumab|bevacizumab|mesh-list
64470651|NCT05087992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64470652|NCT05087992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470653|NCT05087992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64470654|NCT05087992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64470655|NCT05087992|Growth Substances|growth substances|mesh-ancestor
64470656|NCT05087992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470657|NCT05087992|Growth Inhibitors|growth inhibitors|mesh-ancestor
64470658|NCT05086250|Ketamine|ketamine|mesh-list
64470659|NCT05086250|Analgesics|analgesics|mesh-ancestor
64470660|NCT05086250|Sensory System Agents|sensory system agents|mesh-ancestor
64470661|NCT05086250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64470662|NCT05086250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470663|NCT05086250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64470665|NCT05086250|Anesthetics, General|anesthetics, general|mesh-ancestor
64470666|NCT05086250|Anesthetics|anesthetics|mesh-ancestor
64470667|NCT05086250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64470668|NCT05086250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64470669|NCT05086250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64470700|NCT05081102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64470701|NCT05081102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64470702|NCT05081102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470703|NCT05081102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470704|NCT05081102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64470705|NCT05081102|Narcotics|narcotics|mesh-ancestor
64470706|NCT05081102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64470707|NCT05078944|Donepezil|donepezil|mesh-list
64470708|NCT05078944|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64470709|NCT05078944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470710|NCT05078944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470711|NCT05078944|Cholinergic Agents|cholinergic agents|mesh-ancestor
64470712|NCT05078944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64470737|NCT05063097|Gasotransmitters|gasotransmitters|mesh-ancestor
64470738|NCT05063097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64470751|NCT05048797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64470752|NCT05048797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64470753|NCT05047718|Vaccines|vaccines|mesh-list
64470754|NCT05047718|Immunologic Factors|immunologic factors|mesh-ancestor
64470755|NCT05047718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470756|NCT05036005|Pertuzumab|pertuzumab|mesh-list
64470757|NCT05036005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64470758|NCT05036005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470759|NCT05033769|Paclitaxel|paclitaxel|mesh-list
64470760|NCT05033769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64470761|NCT05033769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64470762|NCT05033769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470763|NCT05033769|Tubulin Modulators|tubulin modulators|mesh-ancestor
64470764|NCT05033769|Antimitotic Agents|antimitotic agents|mesh-ancestor
64470765|NCT05033769|Mitosis Modulators|mitosis modulators|mesh-ancestor
64470766|NCT05033769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470778|NCT05019846|Bicalutamide|bicalutamide|mesh-list
64470779|NCT05019846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64470780|NCT05019846|Androgen Antagonists|androgen antagonists|mesh-ancestor
65276261|NCT00649272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276262|NCT00649272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65276263|NCT00649272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65276264|NCT00649272|Cholinergic Agents|cholinergic agents|mesh-ancestor
65276265|NCT00649272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65276266|NCT00649272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276267|NCT00649272|Urological Agents|urological agents|mesh-ancestor
64470781|NCT05019846|Hormone Antagonists|hormone antagonists|mesh-ancestor
64470782|NCT05019846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64470783|NCT05019846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470784|NCT05019846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713983|NCT03041636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64471341|NCT04592744|Hemostatics|hemostatics|mesh-ancestor
64470816|NCT04994509|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64470817|NCT04994509|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64470818|NCT04994509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64470819|NCT04994509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64470820|NCT04994509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470821|NCT04994509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470822|NCT04994509|Antiviral Agents|antiviral agents|mesh-ancestor
64470823|NCT04994509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64470835|NCT04972292|Dipyrone|dipyrone|mesh-list
64470836|NCT04972292|Codeine|codeine|mesh-list
64470837|NCT04972292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64470838|NCT04972292|Narcotics|narcotics|mesh-ancestor
64470839|NCT04972292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64470840|NCT04972292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470841|NCT04972292|Analgesics|analgesics|mesh-ancestor
64470842|NCT04972292|Sensory System Agents|sensory system agents|mesh-ancestor
64470843|NCT04972292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64470844|NCT04972292|Antitussive Agents|antitussive agents|mesh-ancestor
64470845|NCT04972292|Respiratory System Agents|respiratory system agents|mesh-ancestor
64470846|NCT04972292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64470847|NCT04972292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64470848|NCT04972292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64470849|NCT04972292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64470850|NCT04972292|Antipyretics|antipyretics|mesh-ancestor
64470852|NCT04960618|Pembrolizumab|pembrolizumab|mesh-list
64470853|NCT04960618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64470854|NCT04960618|Antimetabolites|antimetabolites|mesh-ancestor
64470855|NCT04960618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470856|NCT04960618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470857|NCT04960618|Antiviral Agents|antiviral agents|mesh-ancestor
64470858|NCT04960618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64470859|NCT04960618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470860|NCT04960618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64470861|NCT04960618|Immunologic Factors|immunologic factors|mesh-ancestor
64470862|NCT04960618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470863|NCT04960618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64470864|NCT04955743|Pembrolizumab|pembrolizumab|mesh-list
64470865|NCT04955743|Lenvatinib|lenvatinib|mesh-list
64470866|NCT04955743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64470867|NCT04955743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470868|NCT04955743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64470869|NCT04955743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470870|NCT04955743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470871|NCT04952324|Folic Acid|folic acid|mesh-list
64470872|NCT04952324|Vitamin B 12|vitamin b 12|mesh-list
64470873|NCT04952324|Hydroxocobalamin|hydroxocobalamin|mesh-list
64470874|NCT04952324|Vitamins|vitamins|mesh-ancestor
64470875|NCT04952324|Micronutrients|micronutrients|mesh-ancestor
64470876|NCT04952324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470877|NCT04952324|Hematinics|hematinics|mesh-ancestor
64470878|NCT04952324|Vitamin B Complex|vitamin b complex|mesh-ancestor
64470879|NCT04951726|Neostigmine|neostigmine|mesh-list
64470880|NCT04951726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65276268|NCT02666898|Cyclophosphamide|cyclophosphamide|mesh-list
65276269|NCT02666898|Fludarabine|fludarabine|mesh-list
65276270|NCT02666898|Obinutuzumab|obinutuzumab|mesh-list
65276271|NCT02666898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65276272|NCT02666898|Immunologic Factors|immunologic factors|mesh-ancestor
65276273|NCT02666898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276274|NCT02666898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65276275|NCT02666898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65276276|NCT02666898|Alkylating Agents|alkylating agents|mesh-ancestor
65276277|NCT02666898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470881|NCT04951726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470882|NCT04951726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470883|NCT04951726|Cholinergic Agents|cholinergic agents|mesh-ancestor
64470884|NCT04951726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64470885|NCT04951726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470886|NCT04951726|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64470887|NCT04951726|Autonomic Agents|autonomic agents|mesh-ancestor
64470888|NCT04951726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64470889|NCT04950764|Seladelpar|seladelpar|mesh-list
64470890|NCT04950764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64470891|NCT04950764|Antimetabolites|antimetabolites|mesh-ancestor
64713984|NCT03041636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470926|NCT04933266|Anesthetics|anesthetics|mesh-ancestor
64470927|NCT04933266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64470928|NCT04933266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470929|NCT04933266|Sensory System Agents|sensory system agents|mesh-ancestor
64470930|NCT04933266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64470931|NCT04930562|Belumosudil|belumosudil|mesh-list
64470932|NCT04930562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64470933|NCT04930562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470934|NCT04930562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470935|NCT04930094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64470936|NCT04930094|Immunologic Factors|immunologic factors|mesh-ancestor
64470937|NCT04930094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470938|NCT04926571|Dexamethasone|dexamethasone|mesh-list
64470939|NCT04926571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64470940|NCT04926571|Antiemetics|antiemetics|mesh-ancestor
64470941|NCT04926571|Autonomic Agents|autonomic agents|mesh-ancestor
64470942|NCT04926571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64470943|NCT04926571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470944|NCT04926571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64470945|NCT04926571|Glucocorticoids|glucocorticoids|mesh-ancestor
64470946|NCT04926571|Hormones|hormones|mesh-ancestor
64470947|NCT04926571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64470948|NCT04926571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64470949|NCT04926571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470950|NCT04919382|Temozolomide|temozolomide|mesh-list
64470951|NCT04919382|Atezolizumab|atezolizumab|mesh-list
64470952|NCT04919382|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64470953|NCT04919382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64470954|NCT04919382|Alkylating Agents|alkylating agents|mesh-ancestor
64470955|NCT04919382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470956|NCT04919382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470999|NCT04873362|Mitosis Modulators|mitosis modulators|mesh-ancestor
64471005|NCT04854499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471006|NCT04854499|Tubulin Modulators|tubulin modulators|mesh-ancestor
64471007|NCT04854499|Antimitotic Agents|antimitotic agents|mesh-ancestor
64471008|NCT04854499|Mitosis Modulators|mitosis modulators|mesh-ancestor
64471009|NCT04854499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471010|NCT04854499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64471038|NCT04833855|Omalizumab|omalizumab|mesh-list
64471039|NCT04833855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64471040|NCT04833855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64471041|NCT04833855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65276278|NCT02666898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276279|NCT02666898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65276280|NCT02666898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65276281|NCT00633425|Glimepiride|glimepiride|mesh-list
65276282|NCT00633425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65276283|NCT00633425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65276284|NCT00633425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276285|NCT00633425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65276286|NCT00633425|Immunologic Factors|immunologic factors|mesh-ancestor
65276287|NCT00648960|Clarithromycin|clarithromycin|mesh-list
65276288|NCT00648960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65276289|NCT00648960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65276290|NCT00648960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65276291|NCT00648960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276292|NCT00648960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728769|NCT05231629|Hormones|hormones|mesh-ancestor
64471042|NCT04833855|Respiratory System Agents|respiratory system agents|mesh-ancestor
64471043|NCT04833855|Immunologic Factors|immunologic factors|mesh-ancestor
64471044|NCT04833855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471045|NCT04810078|Nivolumab|nivolumab|mesh-list
64471046|NCT04810078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64471047|NCT04810078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471048|NCT04810078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64471049|NCT04810078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471050|NCT04808843|Dienogest|dienogest|mesh-list
64471051|NCT04808843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64471052|NCT04808843|Contraceptive Agents|contraceptive agents|mesh-ancestor
64471053|NCT04808843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64471054|NCT04808843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471055|NCT04808843|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64471056|NCT04808843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64471057|NCT04808843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64471058|NCT04808843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64471059|NCT04808843|Hormone Antagonists|hormone antagonists|mesh-ancestor
64471060|NCT04808843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64471061|NCT04808843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64471062|NCT04808843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471064|NCT04798339|Hematinics|hematinics|mesh-ancestor
64471065|NCT04792385|Drospirenone|drospirenone|mesh-list
64471066|NCT04792385|Contraceptive Agents|contraceptive agents|mesh-list
64471067|NCT04792385|Contraceptives, Oral|contraceptives, oral|mesh-list
64471068|NCT04792385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64471216|NCT04669197|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64471217|NCT04669197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64471218|NCT04669197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471219|NCT04669197|Tubulin Modulators|tubulin modulators|mesh-ancestor
64471220|NCT04669197|Antimitotic Agents|antimitotic agents|mesh-ancestor
64471221|NCT04669197|Mitosis Modulators|mitosis modulators|mesh-ancestor
64471222|NCT04669197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471223|NCT04669197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64471224|NCT04669197|Antimetabolites|antimetabolites|mesh-ancestor
64471225|NCT04669197|Antiviral Agents|antiviral agents|mesh-ancestor
64471226|NCT04669197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64471227|NCT04669197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64471228|NCT04669197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64471229|NCT04669197|Immunologic Factors|immunologic factors|mesh-ancestor
64513137|NCT03448042|Trastuzumab|trastuzumab|mesh-list
64471312|NCT04615013|Vitamin B Complex|vitamin b complex|mesh-ancestor
65276293|NCT00648960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65276294|NCT00648960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65276295|NCT04437329|Cisplatin|cisplatin|mesh-list
65276296|NCT04437329|Docetaxel|docetaxel|mesh-list
64471313|NCT04615013|Vitamins|vitamins|mesh-ancestor
64471314|NCT04615013|Micronutrients|micronutrients|mesh-ancestor
64471315|NCT04612725|Benralizumab|benralizumab|mesh-list
64471316|NCT04612725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64471317|NCT04612725|Respiratory System Agents|respiratory system agents|mesh-ancestor
64471318|NCT04604067|Acalabrutinib|acalabrutinib|mesh-list
64471319|NCT04604067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471320|NCT04592744|Vasopressins|vasopressins|mesh-list
64471321|NCT04592744|Epinephrine|epinephrine|mesh-list
64471322|NCT04592744|Norepinephrine|norepinephrine|mesh-list
64471324|NCT04592744|Giapreza|giapreza|mesh-list
64471325|NCT04592744|Angiotensinogen|angiotensinogen|mesh-list
64471326|NCT04592744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64471327|NCT04592744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64473315|NCT00123604|Sympatholytics|sympatholytics|mesh-ancestor
64974230|NCT02965404|Vaccines|vaccines|mesh-list
64473329|NCT00123604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64473330|NCT00123604|Vasodilator Agents|vasodilator agents|mesh-ancestor
64473331|NCT00123604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64473332|NCT00123604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64473334|NCT00221338|Analgesics|analgesics|mesh-ancestor
64473335|NCT00221338|Sensory System Agents|sensory system agents|mesh-ancestor
64473336|NCT00221338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64473337|NCT00221338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473338|NCT00221338|Anticonvulsants|anticonvulsants|mesh-ancestor
64473339|NCT00221338|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64473340|NCT00221338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64473341|NCT00221338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64473342|NCT00221338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64473343|NCT00221338|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64473344|NCT00221338|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64473345|NCT00221338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64473346|NCT00221338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473347|NCT00221338|Antimanic Agents|antimanic agents|mesh-ancestor
64473348|NCT00223678|Sirolimus|sirolimus|mesh-list
64473349|NCT00223678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64473350|NCT00223678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64473351|NCT00223678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64473352|NCT00223678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473353|NCT00223678|Antifungal Agents|antifungal agents|mesh-ancestor
64473354|NCT00223678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64473355|NCT00223678|Immunologic Factors|immunologic factors|mesh-ancestor
64473356|NCT00223678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473357|NCT00053482|Vaccines|vaccines|mesh-list
64473358|NCT00053482|Immunologic Factors|immunologic factors|mesh-ancestor
64473359|NCT00053482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473360|NCT00130780|Bevacizumab|bevacizumab|mesh-list
64473361|NCT00130780|Docetaxel|docetaxel|mesh-list
64473362|NCT00130780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64473363|NCT00130780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473364|NCT00130780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64473365|NCT00130780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64473366|NCT00130780|Growth Substances|growth substances|mesh-ancestor
64513287|NCT02786264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64473385|NCT00225784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64473387|NCT02092168|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64473388|NCT02092168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473389|NCT02092168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473390|NCT02092168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64473391|NCT02092168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64473393|NCT00133978|Antioxidants|antioxidants|mesh-list
64473394|NCT00133978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458922|NCT04143412|Diuretics|diuretics|mesh-ancestor
64473395|NCT00133978|Protective Agents|protective agents|mesh-ancestor
64473396|NCT00133978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473397|NCT00133978|Trace Elements|trace elements|mesh-ancestor
64473398|NCT00133978|Micronutrients|micronutrients|mesh-ancestor
64473399|NCT01897324|Hormones|hormones|mesh-list
65276297|NCT04437329|Fluorouracil|fluorouracil|mesh-list
65276298|NCT04437329|Nedaplatin|nedaplatin|mesh-list
65276299|NCT04437329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276300|NCT04437329|Tubulin Modulators|tubulin modulators|mesh-ancestor
65276301|NCT04437329|Antimitotic Agents|antimitotic agents|mesh-ancestor
65276302|NCT04437329|Mitosis Modulators|mitosis modulators|mesh-ancestor
65276303|NCT04437329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276304|NCT04437329|Antimetabolites|antimetabolites|mesh-ancestor
64473400|NCT01897324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64473401|NCT01897324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473402|NCT00254410|Cyclophosphamide|cyclophosphamide|mesh-list
64473403|NCT00254410|Rituximab|rituximab|mesh-list
64473404|NCT00254410|Fludarabine|fludarabine|mesh-list
64473405|NCT00254410|Mitoxantrone|mitoxantrone|mesh-list
64473406|NCT00254410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64473407|NCT00254410|Immunologic Factors|immunologic factors|mesh-ancestor
64473408|NCT00254410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473409|NCT00254410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64473410|NCT00254410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64473411|NCT00254410|Alkylating Agents|alkylating agents|mesh-ancestor
64473412|NCT00254410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473413|NCT00254410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473414|NCT00254410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64473415|NCT00254410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64473416|NCT00254410|Analgesics|analgesics|mesh-ancestor
64473417|NCT00254410|Sensory System Agents|sensory system agents|mesh-ancestor
64473418|NCT00254410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64473419|NCT00254410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64473420|NCT00254410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64473421|NCT00254410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473440|NCT01899118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64473442|NCT00231868|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64473443|NCT00231868|Carboplatin|carboplatin|mesh-list
64473444|NCT00231868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64473445|NCT00231868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473446|NCT00231868|Tubulin Modulators|tubulin modulators|mesh-ancestor
64473447|NCT00231868|Antimitotic Agents|antimitotic agents|mesh-ancestor
64473448|NCT00231868|Mitosis Modulators|mitosis modulators|mesh-ancestor
64473449|NCT00231868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473450|NCT00257686|Pravastatin|pravastatin|mesh-list
64473451|NCT00257686|Pitavastatin|pitavastatin|mesh-list
64473452|NCT00257686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64473453|NCT00257686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64473454|NCT00257686|Antimetabolites|antimetabolites|mesh-ancestor
64473455|NCT00257686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473456|NCT00257686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64473457|NCT00257686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64473458|NCT00257686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473460|NCT01469013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64473461|NCT01469013|Abortifacient Agents|abortifacient agents|mesh-ancestor
64473462|NCT01469013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64473463|NCT01469013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473464|NCT01469013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64473465|NCT01469013|Antimetabolites|antimetabolites|mesh-ancestor
64473466|NCT01469013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713986|NCT03043105|Thalidomide|thalidomide|mesh-list
64473467|NCT01469013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473468|NCT01469013|Dermatologic Agents|dermatologic agents|mesh-ancestor
64473469|NCT01469013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473470|NCT01469013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64473471|NCT01469013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64473472|NCT01469013|Immunologic Factors|immunologic factors|mesh-ancestor
64473473|NCT01469013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64473474|NCT01469013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64473475|NCT01493427|Travoprost|travoprost|mesh-list
64473476|NCT01493427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64473477|NCT01523457|Folfirinox|folfirinox|mesh-list
65276305|NCT04437329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65276306|NCT04437329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65276307|NCT04437329|Immunologic Factors|immunologic factors|mesh-ancestor
65276308|NCT04437329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276309|NCT02834507|Levodopa|levodopa|mesh-list
64473491|NCT01609556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473493|NCT01766336|Vitamin B Complex|vitamin b complex|mesh-ancestor
64473494|NCT01766336|Vitamins|vitamins|mesh-ancestor
64473495|NCT01766336|Micronutrients|micronutrients|mesh-ancestor
64473496|NCT01766336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473497|NCT01797302|Vitamin D|vitamin d|mesh-list
64473498|NCT01797302|Cholecalciferol|cholecalciferol|mesh-list
64473499|NCT01797302|Vitamins|vitamins|mesh-ancestor
64473500|NCT01797302|Micronutrients|micronutrients|mesh-ancestor
64473501|NCT01797302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473502|NCT01797302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64473503|NCT01797302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64473504|NCT01804946|Oseltamivir|oseltamivir|mesh-list
64473505|NCT01804946|Antiviral Agents|antiviral agents|mesh-ancestor
64473506|NCT01804946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64473507|NCT01804946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473508|NCT01804946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473509|NCT01795898|Fentanyl|fentanyl|mesh-list
64473510|NCT01795898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64473511|NCT01795898|Narcotics|narcotics|mesh-ancestor
64473512|NCT01795898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64473513|NCT01795898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473514|NCT01795898|Analgesics|analgesics|mesh-ancestor
64473515|NCT01795898|Sensory System Agents|sensory system agents|mesh-ancestor
64473516|NCT01795898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64473517|NCT01795898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64473518|NCT01795898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64473519|NCT01795898|Anesthetics, General|anesthetics, general|mesh-ancestor
64473520|NCT01795898|Anesthetics|anesthetics|mesh-ancestor
64473521|NCT01736696|Tofacitinib|tofacitinib|mesh-list
64473522|NCT01736696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64473523|NCT01736696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473524|NCT01736696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473526|NCT01609478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64473527|NCT01609478|Dermatologic Agents|dermatologic agents|mesh-ancestor
64473528|NCT01609478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64473529|NCT01764464|Gabapentin|gabapentin|mesh-list
64473530|NCT01764464|Analgesics|analgesics|mesh-ancestor
64473531|NCT01764464|Sensory System Agents|sensory system agents|mesh-ancestor
64473532|NCT01764464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64473533|NCT01764464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473534|NCT01764464|Anticonvulsants|anticonvulsants|mesh-ancestor
64473535|NCT01764464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64473536|NCT01764464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64473537|NCT01764464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64473538|NCT01764464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64473539|NCT01764464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64974375|NCT00098982|Antidotes|antidotes|mesh-ancestor
64473562|NCT01606748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64473563|NCT01606748|Immunologic Factors|immunologic factors|mesh-ancestor
64473564|NCT01606748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473565|NCT01606748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64473566|NCT01597622|Belimumab|belimumab|mesh-list
64473567|NCT01597622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64473568|NCT01597622|Immunologic Factors|immunologic factors|mesh-ancestor
64473569|NCT01597622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473570|NCT01761266|Sorafenib|sorafenib|mesh-list
64473571|NCT01761266|Lenvatinib|lenvatinib|mesh-list
64473572|NCT01761266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473573|NCT01761266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64473574|NCT01761266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473575|NCT01761266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473576|NCT01759862|Aminophylline|aminophylline|mesh-list
64473577|NCT01759862|Theophylline|theophylline|mesh-list
64473578|NCT01759862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64473579|NCT01759862|Autonomic Agents|autonomic agents|mesh-ancestor
64473580|NCT01759862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276310|NCT02834507|Carbidopa|carbidopa|mesh-list
65276311|NCT02834507|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65276312|NCT02834507|Entacapone|entacapone|mesh-list
65276313|NCT02834507|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65276314|NCT02834507|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64473581|NCT01759862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473582|NCT01759862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64473583|NCT01759862|Respiratory System Agents|respiratory system agents|mesh-ancestor
64473584|NCT01759862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64473585|NCT01759862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473586|NCT01759862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473587|NCT01759862|Vasodilator Agents|vasodilator agents|mesh-ancestor
64473588|NCT01759862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64473589|NCT01759862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64473590|NCT01759862|Purinergic Agents|purinergic agents|mesh-ancestor
64473591|NCT01759862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64473592|NCT01759862|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64473593|NCT01759862|Protective Agents|protective agents|mesh-ancestor
64473594|NCT01790828|Factor VIII|factor viii|mesh-list
64473619|NCT01790594|Glucocorticoids|glucocorticoids|mesh-ancestor
64473620|NCT01790594|Hormones|hormones|mesh-ancestor
64473621|NCT01790594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64473622|NCT01790594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64473623|NCT01790594|Protective Agents|protective agents|mesh-ancestor
64473624|NCT01790594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64473625|NCT01790594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64473627|NCT01790516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473628|NCT01790516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64473629|NCT01790438|Insulin|insulin|mesh-list
64473630|NCT01790438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64473631|NCT01790438|Isophane Insulin, Human|isophane insulin, human|mesh-list
64471349|NCT04587427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471350|NCT04585711|Etanercept|etanercept|mesh-list
64473632|NCT01790438|Insulin, Isophane|insulin, isophane|mesh-list
64473633|NCT01790438|Isophane insulin, beef|isophane insulin, beef|mesh-list
64473634|NCT01790438|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64473635|NCT01790438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473636|NCT01790126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64473637|NCT01790126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64473638|NCT01790126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473639|NCT01790126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64473640|NCT01790126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473641|NCT01790126|Luteolytic Agents|luteolytic agents|mesh-ancestor
64473642|NCT01790126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64473643|NCT01790126|Contraceptive Agents|contraceptive agents|mesh-ancestor
64473644|NCT01790126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64473666|NCT01789970|Sensory System Agents|sensory system agents|mesh-ancestor
64473667|NCT01789970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64473668|NCT01789970|Antitussive Agents|antitussive agents|mesh-ancestor
64473669|NCT01789970|Respiratory System Agents|respiratory system agents|mesh-ancestor
64473670|NCT01788566|Gemcitabine|gemcitabine|mesh-list
64473671|NCT01788566|Necitumumab|necitumumab|mesh-list
64473672|NCT01788566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473673|NCT01788566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64473674|NCT01788566|Antimetabolites|antimetabolites|mesh-ancestor
64473675|NCT01788566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473676|NCT01788566|Antiviral Agents|antiviral agents|mesh-ancestor
64473677|NCT01788566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64473679|NCT01788566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64473680|NCT01788566|Immunologic Factors|immunologic factors|mesh-ancestor
64473681|NCT01788566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473682|NCT01788566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64473683|NCT01733732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64473684|NCT01733732|Lubricant Eye Drops|lubricant eye drops|mesh-list
64473685|NCT01733732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64473686|NCT01732796|Ribavirin|ribavirin|mesh-list
64473687|NCT01732796|Antimetabolites|antimetabolites|mesh-ancestor
64473688|NCT01732796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473689|NCT01732796|Antiviral Agents|antiviral agents|mesh-ancestor
64473690|NCT01732796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64473691|NCT01732640|Paclitaxel|paclitaxel|mesh-list
65276315|NCT02834507|Dopamine Agents|dopamine agents|mesh-ancestor
65276316|NCT02834507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65276317|NCT02834507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276318|NCT02834507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276319|NCT02834507|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65276320|NCT02834507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276321|NCT02834507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65276322|NCT02834507|Immunologic Factors|immunologic factors|mesh-ancestor
65276323|NCT02834507|Dopamine Agonists|dopamine agonists|mesh-ancestor
65276324|NCT02834507|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65276325|NCT02831543|Mosapride|mosapride|mesh-list
65276326|NCT02831543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276327|NCT02831543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65276328|NCT02831543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65276329|NCT02831543|Serotonin Agents|serotonin agents|mesh-ancestor
65276330|NCT02831543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65276331|NCT02831543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276332|NCT02840591|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
65276333|NCT02840591|Nootropic Agents|nootropic agents|mesh-ancestor
65276334|NCT02667054|Anesthetics|anesthetics|mesh-list
65276335|NCT02667054|Anesthetics, Local|anesthetics, local|mesh-list
65276336|NCT02667054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65276337|NCT02667054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276338|NCT02667054|Sensory System Agents|sensory system agents|mesh-ancestor
65276339|NCT02667054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64473692|NCT01732640|Cisplatin|cisplatin|mesh-list
64473693|NCT01732640|Carboplatin|carboplatin|mesh-list
64473695|NCT01732640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64473696|NCT01732640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473697|NCT01732640|Tubulin Modulators|tubulin modulators|mesh-ancestor
64473698|NCT01732640|Antimitotic Agents|antimitotic agents|mesh-ancestor
64473699|NCT01732640|Mitosis Modulators|mitosis modulators|mesh-ancestor
64974523|NCT00242437|Thrombin|thrombin|mesh-list
64473730|NCT00234832|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64473732|NCT00259090|Anastrozole|anastrozole|mesh-list
64473733|NCT00259090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64473734|NCT00259090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473735|NCT00259090|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64473736|NCT00259090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64473737|NCT00259090|Hormone Antagonists|hormone antagonists|mesh-ancestor
64473738|NCT00259090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64473739|NCT00259090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473740|NCT00259090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64473741|NCT00259090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64473742|NCT00259090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473743|NCT00259090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473744|NCT00236938|Epoetin Alfa|epoetin alfa|mesh-list
65276340|NCT02662296|Idelalisib|idelalisib|mesh-list
65276341|NCT02662296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276342|NCT02662296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276343|NCT02662296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276344|NCT02662374|Nystatin|nystatin|mesh-list
65276345|NCT02662374|Calcium|calcium|mesh-list
65276346|NCT02662374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65276347|NCT02662374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276348|NCT02662374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65276349|NCT02662374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65276350|NCT02662374|Antifungal Agents|antifungal agents|mesh-ancestor
65276351|NCT02662374|Ionophores|ionophores|mesh-ancestor
65276352|NCT02662374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65276353|NCT02662374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276354|NCT05334251|Anesthetics|anesthetics|mesh-list
64728828|NCT00003728|Methylprednisolone|methylprednisolone|mesh-list
64473771|NCT00260962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64473772|NCT00260962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64473773|NCT00260962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473774|NCT00260962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64473775|NCT00260962|Serotonin Agents|serotonin agents|mesh-ancestor
64473777|NCT00237718|Tocopherols|tocopherols|mesh-list
64473778|NCT00237718|Tocotrienols|tocotrienols|mesh-list
64473779|NCT00237718|alpha-Tocopherol|alpha-tocopherol|mesh-list
64473780|NCT00237718|Thioctic Acid|thioctic acid|mesh-list
64473782|NCT00237718|Micronutrients|micronutrients|mesh-ancestor
64473783|NCT00237718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473784|NCT00237718|Antioxidants|antioxidants|mesh-ancestor
64473785|NCT00237718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471351|NCT04585711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64473786|NCT00237718|Protective Agents|protective agents|mesh-ancestor
64473787|NCT00237718|Vitamin B Complex|vitamin b complex|mesh-ancestor
64473788|NCT00238108|Melatonin|melatonin|mesh-list
64473789|NCT00238108|Antioxidants|antioxidants|mesh-ancestor
64473790|NCT00238108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473791|NCT00238108|Protective Agents|protective agents|mesh-ancestor
64473792|NCT00238108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473793|NCT00238108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64473794|NCT00266110|Trastuzumab|trastuzumab|mesh-list
64473795|NCT00266110|Vinorelbine|vinorelbine|mesh-list
64473796|NCT00266110|Sargramostim|sargramostim|mesh-list
64473797|NCT00266110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64473798|NCT00266110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473813|NCT00242632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64473814|NCT00242632|Dopamine Agents|dopamine agents|mesh-ancestor
64473815|NCT00242632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64473816|NCT00242632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473817|NCT00242632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473818|NCT00242632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64473819|NCT00242632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64473821|NCT01899430|Liraglutide|liraglutide|mesh-list
64473822|NCT01899430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64473823|NCT01899430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473824|NCT01899430|Incretins|incretins|mesh-ancestor
64473825|NCT01899430|Hormones|hormones|mesh-ancestor
64473826|NCT01899430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64473827|NCT00267670|Pentoxifylline|pentoxifylline|mesh-list
64473828|NCT00267670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65276355|NCT05334251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65276356|NCT05334251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276357|NCT00649350|Metformin|metformin|mesh-list
65276358|NCT00649350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65276359|NCT00649350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276360|NCT00649506|Nitrofurantoin|nitrofurantoin|mesh-list
65276361|NCT00649506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64473829|NCT00267670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473830|NCT00267670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473831|NCT00267670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64473832|NCT00267670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64473833|NCT00267670|Protective Agents|protective agents|mesh-ancestor
64473834|NCT00267670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473835|NCT00267670|Vasodilator Agents|vasodilator agents|mesh-ancestor
64473836|NCT00267670|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64473837|NCT00267670|Antioxidants|antioxidants|mesh-ancestor
64473838|NCT00247624|Eszopiclone|eszopiclone|mesh-list
64473839|NCT00247624|Fluoxetine|fluoxetine|mesh-list
64473840|NCT00247624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64473841|NCT00247624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64473842|NCT00247624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64473843|NCT00247624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473844|NCT00247624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64473845|NCT00247624|Serotonin Agents|serotonin agents|mesh-ancestor
64473846|NCT00247624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473847|NCT00247624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64473848|NCT00247624|Antidepressive Agents|antidepressive agents|mesh-ancestor
64473849|NCT00247624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64513658|NCT01457859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473850|NCT00247624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64473851|NCT00247624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64473852|NCT00247624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473853|NCT00247624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64473874|NCT00268762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473875|NCT00268762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473876|NCT00268762|Anticoagulants|anticoagulants|mesh-ancestor
64473877|NCT00268762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64473878|NCT00270634|Tacrolimus|tacrolimus|mesh-list
64473879|NCT00270634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64473880|NCT00270634|Immunologic Factors|immunologic factors|mesh-ancestor
64473881|NCT00270634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473882|NCT00270634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64473883|NCT00270634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473884|NCT00270634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473885|NCT04110340|Ciprofloxacin|ciprofloxacin|mesh-list
64473886|NCT04110340|Gentamicins|gentamicins|mesh-list
64473887|NCT04110340|Streptomycin|streptomycin|mesh-list
64473888|NCT04110340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64473889|NCT04110340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64473890|NCT04110340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64473891|NCT04110340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64473892|NCT04110340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473893|NCT04110340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473894|NCT04110340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473895|NCT04110340|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64473896|NCT04110340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64473897|NCT04110340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64473898|NCT00270790|Carboplatin|carboplatin|mesh-list
64473899|NCT00270790|Amifostine|amifostine|mesh-list
64473900|NCT00270790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473901|NCT00270790|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64473902|NCT00270790|Protective Agents|protective agents|mesh-ancestor
64473903|NCT00270790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473904|NCT00271570|Infliximab|infliximab|mesh-list
64473905|NCT00271570|Immunoglobulins|immunoglobulins|mesh-list
64473906|NCT00271570|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65276362|NCT00649506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65276363|NCT00649506|Renal Agents|renal agents|mesh-ancestor
65276364|NCT00649506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65276365|NCT00649038|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65276366|NCT00649038|Benazepril|benazepril|mesh-list
65276367|NCT00649038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65276368|NCT00649038|Diuretics|diuretics|mesh-ancestor
65276369|NCT00649038|Natriuretic Agents|natriuretic agents|mesh-ancestor
65276370|NCT00649038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276371|NCT00649038|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65276372|NCT00649038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65276373|NCT00649038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473907|NCT00271570|Antibodies|antibodies|mesh-list
64473908|NCT00271570|gamma-Globulins|gamma-globulins|mesh-list
64473909|NCT00271570|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64473941|NCT04751344|Bupivacaine|bupivacaine|mesh-list
64473942|NCT04751344|Anesthetics, Local|anesthetics, local|mesh-ancestor
64473943|NCT04751344|Anesthetics|anesthetics|mesh-ancestor
64473944|NCT04751344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64473945|NCT04751344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473946|NCT04751344|Sensory System Agents|sensory system agents|mesh-ancestor
64473947|NCT04751344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64473948|NCT00273910|Imiquimod|imiquimod|mesh-list
64473949|NCT00273910|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64473950|NCT00273910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64473951|NCT00273910|Immunologic Factors|immunologic factors|mesh-ancestor
64974784|NCT00067262|Valproic Acid|valproic acid|mesh-list
64473974|NCT01790464|Anesthetics, Local|anesthetics, local|mesh-ancestor
64473975|NCT01790464|Anesthetics|anesthetics|mesh-ancestor
64473976|NCT01790464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64473977|NCT01790464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473978|NCT01790464|Sensory System Agents|sensory system agents|mesh-ancestor
64473979|NCT01790464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64473980|NCT01790464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64473981|NCT01790464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64473982|NCT01790464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64473983|NCT01790464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64473984|NCT01790464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473985|NCT01790542|Iron|iron|mesh-list
64473986|NCT01790542|Trace Elements|trace elements|mesh-ancestor
64473987|NCT01790542|Micronutrients|micronutrients|mesh-ancestor
64473988|NCT01790542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473989|NCT01899820|Lumefantrine|lumefantrine|mesh-list
64473990|NCT01899820|Artemether|artemether|mesh-list
64473991|NCT01899820|Piperaquine|piperaquine|mesh-list
64473992|NCT01899820|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64473993|NCT01899820|Artenimol|artenimol|mesh-list
64473994|NCT01899820|Antimalarials|antimalarials|mesh-ancestor
64473995|NCT01899820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64473996|NCT01899820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64473997|NCT01899820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64473998|NCT02100748|Morphine|morphine|mesh-list
64513659|NCT01457859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64473999|NCT02100748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64474001|NCT02100748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64474002|NCT02100748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474003|NCT02100748|Analgesics|analgesics|mesh-ancestor
64474028|NCT00284518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64474030|NCT04339426|Atovaquone|atovaquone|mesh-list
64474031|NCT04339426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64474032|NCT04339426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64474033|NCT04339426|Antimalarials|antimalarials|mesh-ancestor
64474034|NCT04339426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64474035|NCT04339426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64474036|NCT04339426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276374|NCT00649038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65276375|NCT00649038|Protease Inhibitors|protease inhibitors|mesh-ancestor
65276376|NCT00649038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276377|NCT04169256|Bupivacaine|bupivacaine|mesh-list
65276378|NCT04169256|Anesthetics, Local|anesthetics, local|mesh-ancestor
65276379|NCT04169256|Anesthetics|anesthetics|mesh-ancestor
65276380|NCT04169256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65276384|NCT02658396|Bortezomib|bortezomib|mesh-list
65276441|NCT02657616|Vitamin K|vitamin k|mesh-list
65276442|NCT02657616|Anticoagulants|anticoagulants|mesh-list
65276443|NCT02657616|Vitamins|vitamins|mesh-ancestor
65276444|NCT02657616|Micronutrients|micronutrients|mesh-ancestor
65276445|NCT02657616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276446|NCT02657616|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65276447|NCT02657616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65276448|NCT02657616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276449|NCT02657616|Hemostatics|hemostatics|mesh-ancestor
65276450|NCT02657616|Coagulants|coagulants|mesh-ancestor
65276451|NCT05288777|Capecitabine|capecitabine|mesh-list
65276452|NCT05288777|Trastuzumab|trastuzumab|mesh-list
65276453|NCT05288777|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65276454|NCT05288777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65276455|NCT05288777|Antimetabolites|antimetabolites|mesh-ancestor
65276456|NCT05288777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276457|NCT05288777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276458|NCT05288777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64474037|NCT04339426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474038|NCT01899898|Anticonvulsants|anticonvulsants|mesh-list
64474039|NCT00287716|Pirfenidone|pirfenidone|mesh-list
64474040|NCT00287716|Analgesics|analgesics|mesh-ancestor
64474041|NCT00287716|Sensory System Agents|sensory system agents|mesh-ancestor
64474042|NCT00287716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64474043|NCT00287716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474044|NCT00287716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64474045|NCT00287716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64474046|NCT00287716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64474047|NCT00287716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64474048|NCT00287716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474050|NCT00287872|Bortezomib|bortezomib|mesh-list
64474051|NCT00287872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474052|NCT00287872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64474053|NCT00287872|Immunologic Factors|immunologic factors|mesh-ancestor
64474054|NCT00287872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474071|NCT00288574|Antidepressive Agents|antidepressive agents|mesh-ancestor
64474072|NCT00288574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64474073|NCT00288574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64474074|NCT00288574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64474075|NCT00288574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64474076|NCT04079218|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64474077|NCT04079218|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64474079|NCT04079218|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64474080|NCT04079218|Estrogens|estrogens|mesh-ancestor
64474081|NCT04079218|Hormones|hormones|mesh-ancestor
64474082|NCT04079218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64474083|NCT04079218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474084|NCT04079218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64474085|NCT04079218|Contraceptive Agents|contraceptive agents|mesh-ancestor
64474086|NCT04079218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64474087|NCT04079218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64474088|NCT04061590|Cisplatin|cisplatin|mesh-list
64474089|NCT04061590|Pembrolizumab|pembrolizumab|mesh-list
64474090|NCT04061590|Pemetrexed|pemetrexed|mesh-list
64474091|NCT04061590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474092|NCT04061590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64474093|NCT04061590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276459|NCT05288777|Tubulin Modulators|tubulin modulators|mesh-ancestor
65276460|NCT05288777|Antimitotic Agents|antimitotic agents|mesh-ancestor
65276461|NCT05288777|Mitosis Modulators|mitosis modulators|mesh-ancestor
65276462|NCT02657694|Sofosbuvir|sofosbuvir|mesh-list
65276463|NCT02657694|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65276464|NCT02657694|Ledipasvir|ledipasvir|mesh-list
65276465|NCT02657694|Velpatasvir|velpatasvir|mesh-list
65276466|NCT02657694|Antiviral Agents|antiviral agents|mesh-ancestor
65276467|NCT02657694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65276468|NCT02657460|Cisplatin|cisplatin|mesh-list
65276469|NCT02657460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276470|NCT00649896|Estradiol|estradiol|mesh-list
65276471|NCT00649896|Estrogens|estrogens|mesh-ancestor
65276472|NCT00649896|Hormones|hormones|mesh-ancestor
65276473|NCT00649896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65276474|NCT00649896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276475|NCT00649662|Ciprofloxacin|ciprofloxacin|mesh-list
65276476|NCT00649662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65276477|NCT00649662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65276478|NCT00649662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65276479|NCT00649662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65276480|NCT00649662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276481|NCT00649662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276482|NCT00649662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276483|NCT00649662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65276484|NCT00649662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65276485|NCT04188158|Capecitabine|capecitabine|mesh-list
65276486|NCT04188158|Oxaliplatin|oxaliplatin|mesh-list
65276487|NCT04188158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65276488|NCT04188158|Antimetabolites|antimetabolites|mesh-ancestor
65276489|NCT04188158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276490|NCT04188158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276491|NCT02831231|Xanomeline|xanomeline|mesh-list
65276492|NCT02831231|Trospium chloride|trospium chloride|mesh-list
65276493|NCT02831231|Parasympatholytics|parasympatholytics|mesh-ancestor
65276494|NCT02831231|Autonomic Agents|autonomic agents|mesh-ancestor
64474094|NCT04061590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474095|NCT04061590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64474096|NCT04061590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64474097|NCT01791088|Sirolimus|sirolimus|mesh-list
65276495|NCT02831231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276496|NCT02831231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026505|NCT03456466|Rituximab|rituximab|mesh-list
65276497|NCT02831231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65276498|NCT02831231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65276499|NCT02831231|Cholinergic Agents|cholinergic agents|mesh-ancestor
65276500|NCT02831231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65276501|NCT02831231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276502|NCT02831231|Urological Agents|urological agents|mesh-ancestor
65276503|NCT02831231|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65276504|NCT02831231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65276505|NCT02831231|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65276506|NCT02831231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65276507|NCT05234606|Pembrolizumab|pembrolizumab|mesh-list
65276508|NCT05234606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64474098|NCT01791088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64474099|NCT01791088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64474100|NCT01791088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64474101|NCT01791088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474102|NCT01791088|Antifungal Agents|antifungal agents|mesh-ancestor
64474103|NCT01791088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64474104|NCT01791088|Immunologic Factors|immunologic factors|mesh-ancestor
64474105|NCT01791088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474106|NCT00291226|Glycine|glycine|mesh-list
64474107|NCT00291226|Glycine Agents|glycine agents|mesh-ancestor
64474108|NCT00291226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64474109|NCT00291226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474110|NCT00291226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474111|NCT01791166|Antibodies|antibodies|mesh-list
64474124|NCT00291694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64474125|NCT00291694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64474126|NCT00291694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474127|NCT00292162|Metoprolol|metoprolol|mesh-list
64474128|NCT00292162|Carvedilol|carvedilol|mesh-list
64474129|NCT00292162|Ramipril|ramipril|mesh-list
64474130|NCT00292162|Enalapril|enalapril|mesh-list
64474131|NCT00292162|Lisinopril|lisinopril|mesh-list
64474132|NCT00292162|Bisoprolol|bisoprolol|mesh-list
64474133|NCT00292162|Perindopril|perindopril|mesh-list
64474134|NCT00292162|Captopril|captopril|mesh-list
64474135|NCT00292162|Spironolactone|spironolactone|mesh-list
64474136|NCT00292162|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64474137|NCT00292162|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
64474138|NCT00292162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64474139|NCT00292162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64474140|NCT00292162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64474141|NCT00292162|Sympatholytics|sympatholytics|mesh-ancestor
64474142|NCT00292162|Autonomic Agents|autonomic agents|mesh-ancestor
64474143|NCT00292162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64474144|NCT00292162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474145|NCT00292162|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64474146|NCT00292162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64474147|NCT00292162|Adrenergic Agents|adrenergic agents|mesh-ancestor
64474148|NCT00292162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64474149|NCT00292162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474150|NCT00292162|Hormone Antagonists|hormone antagonists|mesh-ancestor
64471354|NCT04585711|Sensory System Agents|sensory system agents|mesh-ancestor
64474151|NCT00292162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64474152|NCT00292162|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64474153|NCT00292162|Diuretics|diuretics|mesh-ancestor
65276509|NCT05234606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276511|NCT00649740|Anticonvulsants|anticonvulsants|mesh-ancestor
65276512|NCT00649740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65276513|NCT00649740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276514|NCT04209920|Chromium|chromium|mesh-list
65276515|NCT04209920|Nickel|nickel|mesh-list
65276516|NCT04209920|Trace Elements|trace elements|mesh-ancestor
65276517|NCT04209920|Micronutrients|micronutrients|mesh-ancestor
65276518|NCT04209920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276519|NCT00616694|Risedronic Acid|risedronic acid|mesh-list
65276520|NCT00616694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65276521|NCT00616694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65276522|NCT00616694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276523|NCT00616694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65276524|NCT00616694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276525|NCT00616694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65276526|NCT02660658|Dexmedetomidine|dexmedetomidine|mesh-list
65276527|NCT02660658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65276528|NCT02660658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65276529|NCT02660658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276530|NCT02660658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65276531|NCT02660658|Analgesics|analgesics|mesh-ancestor
65276532|NCT02660658|Sensory System Agents|sensory system agents|mesh-ancestor
65276533|NCT02660658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276534|NCT02660658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65276535|NCT02660658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65276536|NCT02660658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64474154|NCT00292162|Natriuretic Agents|natriuretic agents|mesh-ancestor
64474155|NCT00292162|Antioxidants|antioxidants|mesh-ancestor
64474156|NCT00292162|Protective Agents|protective agents|mesh-ancestor
64474157|NCT00292162|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64474158|NCT00292162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64474159|NCT00292162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64474160|NCT00292162|Vasodilator Agents|vasodilator agents|mesh-ancestor
64474161|NCT00292162|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64474162|NCT00292162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64474163|NCT00292162|Protease Inhibitors|protease inhibitors|mesh-ancestor
64474164|NCT00292162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64474165|NCT00292162|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64474166|NCT00296296|Cyclosporine|cyclosporine|mesh-list
64474167|NCT00296296|Tacrolimus|tacrolimus|mesh-list
64474168|NCT00296296|Cyclosporins|cyclosporins|mesh-list
64474169|NCT00296296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64474170|NCT00296296|Immunologic Factors|immunologic factors|mesh-ancestor
64474171|NCT00296296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474172|NCT00296296|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64474173|NCT00296296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276537|NCT02660658|Adrenergic Agents|adrenergic agents|mesh-ancestor
65276538|NCT02660658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65276539|NCT02660658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276540|NCT02660502|Insulin|insulin|mesh-list
65276541|NCT02660502|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65276542|NCT02660502|Insulin Lispro|insulin lispro|mesh-list
65276543|NCT02660502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65276544|NCT02660502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276545|NCT02660346|Vancomycin|vancomycin|mesh-list
65276546|NCT02660346|Daptomycin|daptomycin|mesh-list
65276547|NCT02660346|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
65276548|NCT02660346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65276549|NCT02660346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65276550|NCT04937738|Leucovorin|leucovorin|mesh-list
65276551|NCT04937738|Docetaxel|docetaxel|mesh-list
65276552|NCT04937738|Fluorouracil|fluorouracil|mesh-list
65276553|NCT04937738|Capecitabine|capecitabine|mesh-list
65276554|NCT04937738|Oxaliplatin|oxaliplatin|mesh-list
65276555|NCT04937738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276556|NCT04937738|Tubulin Modulators|tubulin modulators|mesh-ancestor
65276557|NCT04937738|Antimitotic Agents|antimitotic agents|mesh-ancestor
65276558|NCT04937738|Mitosis Modulators|mitosis modulators|mesh-ancestor
65276559|NCT04937738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276560|NCT04937738|Antimetabolites|antimetabolites|mesh-ancestor
65276561|NCT04937738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65276562|NCT04937738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65276563|NCT04937738|Immunologic Factors|immunologic factors|mesh-ancestor
65276564|NCT04937738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276565|NCT04937738|Antidotes|antidotes|mesh-ancestor
65276566|NCT04937738|Protective Agents|protective agents|mesh-ancestor
65276567|NCT04937738|Vitamin B Complex|vitamin b complex|mesh-ancestor
65276568|NCT04937738|Vitamins|vitamins|mesh-ancestor
65276569|NCT04937738|Micronutrients|micronutrients|mesh-ancestor
65276570|NCT00620438|Efavirenz|efavirenz|mesh-list
64474174|NCT00296296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474175|NCT00296296|Antifungal Agents|antifungal agents|mesh-ancestor
64474203|NCT00300430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64474204|NCT00300430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64474205|NCT00300430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64474206|NCT00300430|Antimetabolites|antimetabolites|mesh-ancestor
64474207|NCT00300430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474208|NCT00300430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64474209|NCT00300430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64474210|NCT00300430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64474211|NCT02104414|Epinephrine|epinephrine|mesh-list
65276571|NCT00620438|Nevirapine|nevirapine|mesh-list
65276572|NCT00620438|Rifampin|rifampin|mesh-list
65276573|NCT00620438|Lumefantrine|lumefantrine|mesh-list
65276574|NCT00620438|Artemether|artemether|mesh-list
65276575|NCT00620438|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65276576|NCT00620438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65276577|NCT00620438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65276578|NCT00620438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276579|NCT00620438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276580|NCT00620438|Antiviral Agents|antiviral agents|mesh-ancestor
65276581|NCT00620438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65276582|NCT00620438|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65276583|NCT00620438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65276584|NCT00620438|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65276585|NCT00620438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65276586|NCT00620438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65276587|NCT00620438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65276588|NCT00620438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64729063|NCT00004928|Calcitriol|calcitriol|mesh-list
64474212|NCT02104414|Bupivacaine|bupivacaine|mesh-list
64474213|NCT02104414|Anesthetics, Local|anesthetics, local|mesh-ancestor
64474214|NCT02104414|Anesthetics|anesthetics|mesh-ancestor
64474215|NCT02104414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64474216|NCT02104414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474217|NCT02104414|Sensory System Agents|sensory system agents|mesh-ancestor
64474218|NCT02104414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64474219|NCT02104414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64474220|NCT02104414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64474221|NCT02104414|Adrenergic Agents|adrenergic agents|mesh-ancestor
64474222|NCT02104414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64474223|NCT02104414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474224|NCT02104414|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64474225|NCT02104414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64474248|NCT02101918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64474249|NCT02101918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64474250|NCT02101918|Growth Substances|growth substances|mesh-ancestor
64474251|NCT02101918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474252|NCT02101918|Growth Inhibitors|growth inhibitors|mesh-ancestor
64474253|NCT02101918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474254|NCT00300742|Topiramate|topiramate|mesh-list
64474255|NCT00300742|Anticonvulsants|anticonvulsants|mesh-ancestor
64474256|NCT00300742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64474257|NCT00300742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474258|NCT00301756|Belinostat|belinostat|mesh-list
64474259|NCT00301756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474260|NCT00301756|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64474261|NCT00301756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64474262|NCT00301756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474263|NCT00302068|Sertraline|sertraline|mesh-list
64474264|NCT00302068|Antidepressive Agents|antidepressive agents|mesh-ancestor
64474265|NCT00302068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64474266|NCT00302068|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64474267|NCT00302068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64474268|NCT00302068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65276589|NCT00620438|Antitubercular Agents|antitubercular agents|mesh-ancestor
65276590|NCT00620438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65276591|NCT00620438|Leprostatic Agents|leprostatic agents|mesh-ancestor
65276592|NCT00620438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65276593|NCT00620438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65276594|NCT00620438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65276595|NCT00620438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65276596|NCT00620438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65276597|NCT00620438|Antimalarials|antimalarials|mesh-ancestor
65276598|NCT00620438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65276599|NCT00620438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65276600|NCT00891839|Rituximab|rituximab|mesh-list
65276601|NCT00891839|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65276602|NCT00891839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65276603|NCT00891839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276604|NCT00891839|Immunologic Factors|immunologic factors|mesh-ancestor
65276605|NCT00891839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276606|NCT00891839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65276607|NCT00891839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65276608|NCT00891839|Alkylating Agents|alkylating agents|mesh-ancestor
65276609|NCT00891839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276610|NCT00600756|Risperidone|risperidone|mesh-list
65276611|NCT00600756|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65276612|NCT00600756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65276613|NCT00600756|Serotonin Agents|serotonin agents|mesh-ancestor
65276614|NCT00600756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65276615|NCT00600756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276616|NCT00600756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276617|NCT00600756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65276618|NCT00600756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65276632|NCT04865042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65276633|NCT04865042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65276634|NCT04865042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65276635|NCT04865042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65276636|NCT04865042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65276637|NCT04865042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276638|NCT04865042|Antimanic Agents|antimanic agents|mesh-ancestor
65276639|NCT04245371|Lidocaine|lidocaine|mesh-list
65276640|NCT04245371|Anesthetics, Local|anesthetics, local|mesh-ancestor
65276641|NCT04245371|Anesthetics|anesthetics|mesh-ancestor
65276642|NCT04245371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65276643|NCT04245371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276644|NCT04245371|Sensory System Agents|sensory system agents|mesh-ancestor
65276645|NCT04245371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276646|NCT04245371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65276647|NCT04245371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65276648|NCT04245371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65276649|NCT04245371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65276650|NCT04245371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276651|NCT02657148|Contraceptive Agents|contraceptive agents|mesh-list
65276652|NCT02657148|Etonogestrel|etonogestrel|mesh-list
65276653|NCT02657148|Desogestrel|desogestrel|mesh-list
65276654|NCT02657148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65276655|NCT02657148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276656|NCT02657148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65276657|NCT02657148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65276658|NCT02657148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65276659|NCT02657148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65276660|NCT02657148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65276661|NCT02657148|Progestins|progestins|mesh-ancestor
65276662|NCT02657148|Hormones|hormones|mesh-ancestor
65276663|NCT02657148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65276664|NCT04247087|Vitamin K|vitamin k|mesh-list
64474269|NCT00302068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474270|NCT00302068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64474271|NCT00302068|Serotonin Agents|serotonin agents|mesh-ancestor
64474272|NCT00302068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474273|NCT00302848|Drospirenone|drospirenone|mesh-list
65276665|NCT04247087|Vitamin K 1|vitamin k 1|mesh-list
65276666|NCT04247087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65276667|NCT04247087|Vitamins|vitamins|mesh-ancestor
65276668|NCT04247087|Micronutrients|micronutrients|mesh-ancestor
65276669|NCT04247087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276670|NCT04247087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65276671|NCT04247087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65276672|NCT04247087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276673|NCT04247087|Hemostatics|hemostatics|mesh-ancestor
64729159|NCT00004346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64474274|NCT00302848|Contraceptive Agents|contraceptive agents|mesh-list
64474275|NCT00302848|Levonorgestrel|levonorgestrel|mesh-list
64474276|NCT00302848|Contraceptives, Oral|contraceptives, oral|mesh-list
64474278|NCT00302848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64474279|NCT00302848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474280|NCT00302848|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64474281|NCT00302848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64474282|NCT00302848|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64474309|NCT00142168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64474310|NCT00142168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64474311|NCT00142168|Growth Substances|growth substances|mesh-ancestor
64474312|NCT00142168|Growth Inhibitors|growth inhibitors|mesh-ancestor
64474314|NCT02501434|Calcium heparin|calcium heparin|mesh-list
64474315|NCT02501434|Anticoagulants|anticoagulants|mesh-ancestor
64474316|NCT02501434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64474317|NCT02501434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64474318|NCT02501434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474319|NCT00147316|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64474320|NCT00147316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64474321|NCT00147316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64474322|NCT00147316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474324|NCT00148798|Cetuximab|cetuximab|mesh-list
64474325|NCT00148798|Vinorelbine|vinorelbine|mesh-list
64474326|NCT00148798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474327|NCT00148798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64474328|NCT00148798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64474347|NCT00149734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64474348|NCT00149734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64474349|NCT00149734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64474351|NCT00198328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64474352|NCT00198328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474353|NCT00305578|Memantine|memantine|mesh-list
64474354|NCT00305578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64474355|NCT00305578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64474356|NCT00305578|Dopamine Agents|dopamine agents|mesh-ancestor
64474357|NCT00305578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64474358|NCT00305578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474359|NCT00305578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474360|NCT00305578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64474361|NCT00305578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64474362|NCT01492101|Etirinotecan pegol|etirinotecan pegol|mesh-list
64474363|NCT01492101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474364|NCT01492101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64474365|NCT01492101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64474366|NCT01492101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64474367|NCT01492101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474368|NCT01468311|Daclizumab|daclizumab|mesh-list
64474369|NCT01468311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64474370|NCT01468311|Immunologic Factors|immunologic factors|mesh-ancestor
64474371|NCT01468311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474372|NCT00306202|Dasatinib|dasatinib|mesh-list
64474373|NCT00306202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471356|NCT04585711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474374|NCT00306202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65276674|NCT04247087|Coagulants|coagulants|mesh-ancestor
65276675|NCT00649116|Metoprolol|metoprolol|mesh-list
65276676|NCT00649116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65276677|NCT00649116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65276678|NCT00649116|Sympatholytics|sympatholytics|mesh-ancestor
65276679|NCT00649116|Autonomic Agents|autonomic agents|mesh-ancestor
65276680|NCT00649116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276681|NCT00649116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276682|NCT00649116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65276683|NCT00649116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65276684|NCT00649116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65276685|NCT00649116|Adrenergic Agents|adrenergic agents|mesh-ancestor
65276686|NCT00649116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64729168|NCT00384800|Tegafur|tegafur|mesh-list
64474375|NCT00306202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64513660|NCT01890993|Liraglutide|liraglutide|mesh-list
64474376|NCT00306202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474378|NCT00325078|Dermatologic Agents|dermatologic agents|mesh-ancestor
64474379|NCT00325078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64474380|NCT00325078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64474381|NCT00325780|Pitavastatin|pitavastatin|mesh-list
64474382|NCT00325780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64474383|NCT00325780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64474408|NCT00326872|Maleic acid|maleic acid|mesh-list
64474409|NCT00326872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64474410|NCT00326872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474411|NCT00326872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474412|NCT00326872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64474413|NCT05266690|Dextrans|dextrans|mesh-list
64474414|NCT05266690|Anticoagulants|anticoagulants|mesh-ancestor
64474415|NCT05266690|Plasma Substitutes|plasma substitutes|mesh-ancestor
64474416|NCT05266690|Blood Substitutes|blood substitutes|mesh-ancestor
64474417|NCT01730534|Dapagliflozin|dapagliflozin|mesh-list
64474418|NCT01730534|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64474419|NCT01730534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474420|NCT01730534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64474421|NCT01730534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474422|NCT05266534|Terlipressin|terlipressin|mesh-list
64474423|NCT05266534|Carbetocin|carbetocin|mesh-list
64474424|NCT05266534|Oxytocics|oxytocics|mesh-ancestor
64474425|NCT05266534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64474426|NCT05266534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474427|NCT05266534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64474428|NCT05266534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64474429|NCT01730378|Vaccines|vaccines|mesh-list
64474430|NCT01730378|Immunologic Factors|immunologic factors|mesh-ancestor
64474431|NCT01730378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474432|NCT00331162|Alemtuzumab|alemtuzumab|mesh-list
64474433|NCT00331162|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64474434|NCT00331162|Immunologic Factors|immunologic factors|mesh-ancestor
64474435|NCT00331162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474436|NCT00331162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64474466|NCT00332644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64474467|NCT00332644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474469|NCT00332644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64474470|NCT00332644|Cholinergic Agents|cholinergic agents|mesh-ancestor
64474471|NCT00332644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64474472|NCT00332644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474473|NCT00332644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64474474|NCT00332644|Antidepressive Agents|antidepressive agents|mesh-ancestor
64474475|NCT00332644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65276687|NCT00649116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276688|NCT04459416|Analgesics, Opioid|analgesics, opioid|mesh-list
65276689|NCT04459416|Narcotics|narcotics|mesh-ancestor
65276690|NCT04459416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65276691|NCT04459416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276692|NCT04459416|Analgesics|analgesics|mesh-ancestor
65276693|NCT04459416|Sensory System Agents|sensory system agents|mesh-ancestor
65276694|NCT04459416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276695|NCT02652234|Endostar protein|endostar protein|mesh-list
65276696|NCT02652234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65276697|NCT02652234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65276698|NCT02652234|Growth Substances|growth substances|mesh-ancestor
65276699|NCT02652234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276700|NCT02652234|Growth Inhibitors|growth inhibitors|mesh-ancestor
65276701|NCT02652234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276702|NCT04211012|Paclitaxel|paclitaxel|mesh-list
65276703|NCT04211012|Cisplatin|cisplatin|mesh-list
65276704|NCT04211012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64729181|NCT00384800|Antimetabolites|antimetabolites|mesh-ancestor
64729183|NCT00384878|Leucovorin|leucovorin|mesh-list
64474476|NCT00332644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64474477|NCT00332644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64474478|NCT00332644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64474479|NCT00332644|Dopamine Agents|dopamine agents|mesh-ancestor
64474480|NCT00332644|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64474481|NCT00332644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64474503|NCT00333814|Glucocorticoids|glucocorticoids|mesh-ancestor
64474504|NCT00333814|Hormones|hormones|mesh-ancestor
64474505|NCT00333814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64474506|NCT00333814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64474507|NCT00333814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474508|NCT00333814|Protease Inhibitors|protease inhibitors|mesh-ancestor
64474509|NCT00333814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64474510|NCT00333814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474511|NCT01728584|Bromides|bromides|mesh-list
64474512|NCT01728584|Rocuronium|rocuronium|mesh-list
64474513|NCT01728584|Anticonvulsants|anticonvulsants|mesh-ancestor
64474514|NCT01728584|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64474515|NCT01728584|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64474516|NCT01728584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64474517|NCT01728584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64474518|NCT01728584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474519|NCT00315328|Atropine|atropine|mesh-list
64474520|NCT00315328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64474521|NCT00315328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64474522|NCT00315328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64474523|NCT00315328|Autonomic Agents|autonomic agents|mesh-ancestor
64471358|NCT04585711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64474524|NCT00315328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64474525|NCT00315328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474526|NCT00315328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64474527|NCT00315328|Respiratory System Agents|respiratory system agents|mesh-ancestor
64474528|NCT00315328|Mydriatics|mydriatics|mesh-ancestor
64474529|NCT00315328|Parasympatholytics|parasympatholytics|mesh-ancestor
65276705|NCT04211012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276706|NCT04211012|Tubulin Modulators|tubulin modulators|mesh-ancestor
65276707|NCT04211012|Antimitotic Agents|antimitotic agents|mesh-ancestor
65276708|NCT04211012|Mitosis Modulators|mitosis modulators|mesh-ancestor
65276709|NCT04211012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276710|NCT00649974|Valacyclovir|valacyclovir|mesh-list
65276711|NCT00649974|Antiviral Agents|antiviral agents|mesh-ancestor
65276712|NCT00649974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65276713|NCT02536872|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65276714|NCT02536872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65276715|NCT00620594|Dactolisib|dactolisib|mesh-list
65276716|NCT00620594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276717|NCT02655822|Atezolizumab|atezolizumab|mesh-list
65276718|NCT02655822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276719|NCT00650442|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65276720|NCT00650442|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65276721|NCT00650442|Estradiol|estradiol|mesh-list
65276722|NCT00650442|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65276723|NCT00650442|Estrogens|estrogens|mesh-ancestor
65276724|NCT00650442|Hormones|hormones|mesh-ancestor
65276725|NCT00650442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65276726|NCT00650442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276727|NCT00650442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65276728|NCT00650442|Contraceptive Agents|contraceptive agents|mesh-ancestor
65276729|NCT00650442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65276730|NCT00650442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65276732|NCT00890825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276733|NCT00890825|Tubulin Modulators|tubulin modulators|mesh-ancestor
65276734|NCT00890825|Antimitotic Agents|antimitotic agents|mesh-ancestor
65276735|NCT00890825|Mitosis Modulators|mitosis modulators|mesh-ancestor
65276736|NCT00890825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276737|NCT04760132|Vaccines|vaccines|mesh-list
65276738|NCT04760132|Immunologic Factors|immunologic factors|mesh-ancestor
65276739|NCT04760132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276740|NCT04248101|Silver Nitrate|silver nitrate|mesh-list
64729205|NCT02972762|Anesthetics|anesthetics|mesh-ancestor
64474530|NCT00315328|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64474531|NCT00315328|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64474532|NCT00315328|Cholinergic Agents|cholinergic agents|mesh-ancestor
64474533|NCT00315328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65276741|NCT04248101|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65276742|NCT04248101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65276743|NCT00649818|Lorazepam|lorazepam|mesh-list
65276744|NCT00649818|Anticonvulsants|anticonvulsants|mesh-ancestor
65276745|NCT00649818|Antiemetics|antiemetics|mesh-ancestor
65276746|NCT00649818|Autonomic Agents|autonomic agents|mesh-ancestor
65276747|NCT00649818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276748|NCT00649818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276749|NCT00649818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65276750|NCT00649818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65276751|NCT00649818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65276752|NCT00649818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64474534|NCT00315328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474535|NCT01522443|Prednisone|prednisone|mesh-list
64474536|NCT01522443|Mitoxantrone|mitoxantrone|mesh-list
64474537|NCT01522443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64474538|NCT01522443|Glucocorticoids|glucocorticoids|mesh-ancestor
64474539|NCT01522443|Hormones|hormones|mesh-ancestor
64474556|NCT00336232|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64474557|NCT00336232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64474558|NCT00336232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474560|NCT00336232|Coagulants|coagulants|mesh-ancestor
64474561|NCT00336700|Gemcitabine|gemcitabine|mesh-list
64474562|NCT00336700|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64474563|NCT00336700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64474565|NCT00336700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474566|NCT00336700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474567|NCT00336700|Antiviral Agents|antiviral agents|mesh-ancestor
64474568|NCT00336700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64474569|NCT00336700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64474570|NCT00336700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64474571|NCT00336700|Immunologic Factors|immunologic factors|mesh-ancestor
64474572|NCT00336700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474573|NCT00336700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64474574|NCT01468233|Adalimumab|adalimumab|mesh-list
64474575|NCT01468233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64474576|NCT01468233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64474577|NCT01754402|Dexamethasone|dexamethasone|mesh-list
64474578|NCT01754402|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64474579|NCT01754402|Pomalidomide|pomalidomide|mesh-list
64474580|NCT01754402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64474581|NCT01754402|Antiemetics|antiemetics|mesh-ancestor
64474582|NCT01754402|Autonomic Agents|autonomic agents|mesh-ancestor
64474583|NCT01754402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64474584|NCT01754402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474585|NCT01754402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64474586|NCT01754402|Glucocorticoids|glucocorticoids|mesh-ancestor
64474587|NCT01754402|Hormones|hormones|mesh-ancestor
64474588|NCT01754402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64474589|NCT01754402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64474590|NCT01754402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474591|NCT01754402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64474592|NCT01754402|Alkylating Agents|alkylating agents|mesh-ancestor
64474593|NCT01754402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474594|NCT01754402|Immunologic Factors|immunologic factors|mesh-ancestor
64474595|NCT01754402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64474596|NCT01754402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64474621|NCT01490697|Hormone Antagonists|hormone antagonists|mesh-ancestor
64474622|NCT01490697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64474623|NCT01490697|Luteolytic Agents|luteolytic agents|mesh-ancestor
64474624|NCT01490697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64474625|NCT01490697|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65276753|NCT00649818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65276754|NCT00649818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65276755|NCT00649818|GABA Modulators|gaba modulators|mesh-ancestor
65276756|NCT00649818|GABA Agents|gaba agents|mesh-ancestor
65276757|NCT00649818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65276758|NCT00649818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276759|NCT04246697|Acetaminophen|acetaminophen|mesh-list
65276760|NCT04246697|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65276761|NCT04246697|Morphine|morphine|mesh-list
65276762|NCT04246697|Oxycodone|oxycodone|mesh-list
65276763|NCT04246697|Gabapentin|gabapentin|mesh-list
65276764|NCT04246697|Bupivacaine|bupivacaine|mesh-list
65276765|NCT04246697|Anesthetics, Local|anesthetics, local|mesh-ancestor
65276766|NCT04246697|Anesthetics|anesthetics|mesh-ancestor
65276767|NCT04246697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65276768|NCT04246697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276769|NCT04246697|Sensory System Agents|sensory system agents|mesh-ancestor
65276770|NCT04246697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276771|NCT04246697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65276772|NCT04246697|Narcotics|narcotics|mesh-ancestor
65276773|NCT04246697|Analgesics|analgesics|mesh-ancestor
65276774|NCT04246697|Anticonvulsants|anticonvulsants|mesh-ancestor
65276775|NCT04246697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65276776|NCT04246697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65276777|NCT04246697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65276778|NCT04246697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65276779|NCT04246697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65276780|NCT04246697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65276781|NCT04246697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276782|NCT04246697|Antimanic Agents|antimanic agents|mesh-ancestor
65276783|NCT04246697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65276784|NCT04246697|Antipyretics|antipyretics|mesh-ancestor
65276785|NCT04246697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65276786|NCT04246697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65276787|NCT04246697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65276788|NCT04246697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65276794|NCT02830139|Antimetabolites|antimetabolites|mesh-ancestor
65276795|NCT02830139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276796|NCT02833025|Thrombin|thrombin|mesh-list
65276797|NCT02833025|Hemostatics|hemostatics|mesh-ancestor
65276798|NCT02833025|Coagulants|coagulants|mesh-ancestor
65276799|NCT02651610|Paclitaxel|paclitaxel|mesh-list
65276800|NCT02651610|Docetaxel|docetaxel|mesh-list
65276801|NCT02651610|Taxane|taxane|mesh-list
65276802|NCT02651610|Bavituximab|bavituximab|mesh-list
65276803|NCT02651610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65276804|NCT02651610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276805|NCT02651610|Tubulin Modulators|tubulin modulators|mesh-ancestor
65276806|NCT02651610|Antimitotic Agents|antimitotic agents|mesh-ancestor
65276807|NCT02651610|Mitosis Modulators|mitosis modulators|mesh-ancestor
65276808|NCT02651610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474626|NCT01490697|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64474627|NCT01490697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64474628|NCT01490697|Renal Agents|renal agents|mesh-ancestor
64474629|NCT01490697|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64474630|NCT01490697|Antitubercular Agents|antitubercular agents|mesh-ancestor
64474631|NCT01490697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64474632|NCT01490697|Antimetabolites|antimetabolites|mesh-ancestor
64474633|NCT01490697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474634|NCT01728194|Citalopram|citalopram|mesh-list
64474635|NCT01728194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64474636|NCT01728194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64474637|NCT01728194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64474638|NCT01728194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474639|NCT01728194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64474640|NCT01728194|Serotonin Agents|serotonin agents|mesh-ancestor
64474669|NCT01466673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64474670|NCT01466673|Estrogens|estrogens|mesh-ancestor
64474671|NCT01466673|Hormones|hormones|mesh-ancestor
64474672|NCT01466673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64474673|NCT01466673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474674|NCT01466673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64474675|NCT01466673|Contraceptive Agents|contraceptive agents|mesh-ancestor
64474676|NCT01466673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64474677|NCT01466673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64713988|NCT03043105|Cyclophosphamide|cyclophosphamide|mesh-list
64460198|NCT01695135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474678|NCT01466673|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64474679|NCT01466673|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64474680|NCT01466673|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64474681|NCT01466673|Progestins|progestins|mesh-ancestor
64474682|NCT01466673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64474683|NCT01466673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64474684|NCT01466673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64474711|NCT01753310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474712|NCT01753310|Cholinergic Agents|cholinergic agents|mesh-ancestor
64474713|NCT01753310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64474714|NCT01753310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474715|NCT01753310|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64474716|NCT01753310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64474718|NCT01521117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64474719|NCT01521117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64474720|NCT01521117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474721|NCT01521117|Cholinergic Agents|cholinergic agents|mesh-ancestor
64474722|NCT01521117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64474723|NCT01521117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276809|NCT02651610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65276811|NCT04208594|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65276812|NCT04208594|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65276813|NCT04208594|Adrenergic Agents|adrenergic agents|mesh-ancestor
65276814|NCT04208594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65276815|NCT04208594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276816|NCT04208594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276817|NCT04208594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65276818|NCT04208594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65276819|NCT04208594|Vasodilator Agents|vasodilator agents|mesh-ancestor
65276820|NCT04733144|Dexamethasone|dexamethasone|mesh-list
65276821|NCT04733144|Prednisolone|prednisolone|mesh-list
65276822|NCT04733144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65276823|NCT04733144|Antiemetics|antiemetics|mesh-ancestor
64336678|NCT02305069|Octreotide|octreotide|mesh-list
64474724|NCT01521117|Nootropic Agents|nootropic agents|mesh-ancestor
64474725|NCT01466595|Rifaximin|rifaximin|mesh-list
64474726|NCT01466595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64474727|NCT01466595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64474728|NCT01466595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64474729|NCT02073747|Albuterol|albuterol|mesh-list
64474730|NCT02073747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64474731|NCT02073747|Autonomic Agents|autonomic agents|mesh-ancestor
64474732|NCT02073747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64975565|NCT00250315|Dobutamine|dobutamine|mesh-list
64474747|NCT01465659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474748|NCT01465659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474749|NCT01462929|Bromides|bromides|mesh-list
64713989|NCT03043105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64713990|NCT03043105|Immunologic Factors|immunologic factors|mesh-ancestor
64474750|NCT01462929|Tiotropium Bromide|tiotropium bromide|mesh-list
64474751|NCT01462929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64474752|NCT01462929|Autonomic Agents|autonomic agents|mesh-ancestor
64474753|NCT01462929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64474754|NCT01462929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474755|NCT01462929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64474756|NCT01462929|Respiratory System Agents|respiratory system agents|mesh-ancestor
64474757|NCT01462929|Parasympatholytics|parasympatholytics|mesh-ancestor
64474758|NCT01462929|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64474759|NCT01462929|Cholinergic Agents|cholinergic agents|mesh-ancestor
64474760|NCT01462929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64474761|NCT01462929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474762|NCT01462929|Anticonvulsants|anticonvulsants|mesh-ancestor
64474763|NCT01462695|Sunitinib|sunitinib|mesh-list
64474764|NCT01462695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474765|NCT01462695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64474766|NCT01462695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64474767|NCT01462695|Growth Substances|growth substances|mesh-ancestor
64474768|NCT01462695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474769|NCT01462695|Growth Inhibitors|growth inhibitors|mesh-ancestor
64474770|NCT01462695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64474771|NCT01462695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64474772|NCT01462695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474773|NCT01465347|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
64474774|NCT01465347|Antioxidants|antioxidants|mesh-ancestor
64474775|NCT01465347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474776|NCT01465347|Protective Agents|protective agents|mesh-ancestor
64600829|NCT01274195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64474777|NCT01465347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474779|NCT01465347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474780|NCT01465191|Morphine|morphine|mesh-list
65276824|NCT04733144|Autonomic Agents|autonomic agents|mesh-ancestor
65276825|NCT04733144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276826|NCT04733144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276827|NCT04733144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65276828|NCT04733144|Glucocorticoids|glucocorticoids|mesh-ancestor
65276829|NCT04733144|Hormones|hormones|mesh-ancestor
65276830|NCT04733144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65276831|NCT04733144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65276832|NCT04733144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276833|NCT04724720|Famotidine|famotidine|mesh-list
65276834|NCT04724720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65276835|NCT04724720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65276838|NCT04724720|Histamine Agents|histamine agents|mesh-ancestor
65276886|NCT02648490|Anesthetics, Local|anesthetics, local|mesh-ancestor
65276887|NCT02648490|Anesthetics|anesthetics|mesh-ancestor
65276888|NCT02648490|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65276889|NCT02648490|Histamine Antagonists|histamine antagonists|mesh-ancestor
65276890|NCT02648490|Histamine Agents|histamine agents|mesh-ancestor
65276891|NCT02648490|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65276892|NCT04965272|Cariprazine|cariprazine|mesh-list
65276893|NCT04965272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65276894|NCT04965272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65276895|NCT04965272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65276896|NCT04965272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276897|NCT04965272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65276898|NCT02648412|Ketamine|ketamine|mesh-list
65276899|NCT02648412|Analgesics|analgesics|mesh-ancestor
65276900|NCT02648412|Sensory System Agents|sensory system agents|mesh-ancestor
65276901|NCT02648412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276902|NCT02648412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276903|NCT02648412|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65276904|NCT02648412|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65276905|NCT02648412|Anesthetics, General|anesthetics, general|mesh-ancestor
65276906|NCT02648412|Anesthetics|anesthetics|mesh-ancestor
65276907|NCT02648412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65276908|NCT02648412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65276909|NCT02648412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65276910|NCT02648412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65276911|NCT02648412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276912|NCT00650520|Bromocriptine|bromocriptine|mesh-list
65276913|NCT00650520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65276914|NCT00650520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65276915|NCT00650520|Hormone Antagonists|hormone antagonists|mesh-ancestor
65276916|NCT00650520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65276917|NCT00650520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276928|NCT00621218|Dermatologic Agents|dermatologic agents|mesh-ancestor
65276929|NCT02655276|Glycine|glycine|mesh-list
65276930|NCT02655276|Glycine Agents|glycine agents|mesh-ancestor
65276931|NCT02655276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65276932|NCT02655276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276933|NCT02655276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276934|NCT02832947|Rivaroxaban|rivaroxaban|mesh-list
65276935|NCT02832947|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65276936|NCT02832947|Antithrombins|antithrombins|mesh-ancestor
65276937|NCT02832947|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65276938|NCT02832947|Protease Inhibitors|protease inhibitors|mesh-ancestor
65276939|NCT02832947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276940|NCT02832947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276941|NCT02832947|Anticoagulants|anticoagulants|mesh-ancestor
65276942|NCT00651300|Parecoxib|parecoxib|mesh-list
65276943|NCT00651300|Valdecoxib|valdecoxib|mesh-list
65276944|NCT00651300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65276945|NCT00651300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65276946|NCT00651300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65276947|NCT00651300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276948|NCT00651300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65276949|NCT00651300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65276950|NCT00651300|Analgesics|analgesics|mesh-ancestor
64474781|NCT01465191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64474782|NCT01465191|Narcotics|narcotics|mesh-ancestor
64474783|NCT01465191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64474784|NCT01465191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474785|NCT01465191|Analgesics|analgesics|mesh-ancestor
64474786|NCT01465191|Sensory System Agents|sensory system agents|mesh-ancestor
64474787|NCT01465191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64474788|NCT01519947|Epoetin Alfa|epoetin alfa|mesh-list
64474789|NCT01519947|Hematinics|hematinics|mesh-ancestor
64474790|NCT01462227|Naltrexone|naltrexone|mesh-list
64474801|NCT03026205|Cetylpyridinium|cetylpyridinium|mesh-list
64474802|NCT03026205|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64474803|NCT03026205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64474804|NCT01519791|Methotrexate|methotrexate|mesh-list
64474805|NCT01519791|Certolizumab Pegol|certolizumab pegol|mesh-list
64474806|NCT01519791|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64474807|NCT01519791|Abortifacient Agents|abortifacient agents|mesh-ancestor
64474808|NCT01519791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64474809|NCT01519791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474810|NCT01519791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64474811|NCT01519791|Antimetabolites|antimetabolites|mesh-ancestor
64474812|NCT01519791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474813|NCT01519791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474814|NCT01519791|Dermatologic Agents|dermatologic agents|mesh-ancestor
64474815|NCT01519791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64474816|NCT01519791|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64474817|NCT01519791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64474818|NCT01519791|Immunologic Factors|immunologic factors|mesh-ancestor
64474819|NCT01519791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65276951|NCT00651300|Sensory System Agents|sensory system agents|mesh-ancestor
65276952|NCT00651300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276953|NCT00651300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276954|NCT00651300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65276955|NCT00651300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65276956|NCT00790010|Bevacizumab|bevacizumab|mesh-list
65276957|NCT00790010|Ipilimumab|ipilimumab|mesh-list
65276958|NCT00790010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65276959|NCT00790010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65276960|NCT00790010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65276961|NCT00790010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65276962|NCT00790010|Growth Substances|growth substances|mesh-ancestor
65276963|NCT00790010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276964|NCT00790010|Growth Inhibitors|growth inhibitors|mesh-ancestor
65276965|NCT00790010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65276966|NCT00790010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276967|NCT02828033|Rilonacept|rilonacept|mesh-list
65276968|NCT02828033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65276969|NCT00621998|Olanzapine|olanzapine|mesh-list
65276970|NCT00621998|Risperidone|risperidone|mesh-list
65276971|NCT00621998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65276972|NCT00621998|Serotonin Agents|serotonin agents|mesh-ancestor
65276973|NCT00621998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65276974|NCT00621998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276975|NCT00621998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276976|NCT00621998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65276977|NCT00621998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65276978|NCT00621998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65276979|NCT00621998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65276980|NCT00621998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65276981|NCT00621998|Dopamine Agents|dopamine agents|mesh-ancestor
65276982|NCT00621998|Antiemetics|antiemetics|mesh-ancestor
65276983|NCT00621998|Autonomic Agents|autonomic agents|mesh-ancestor
65276984|NCT00621998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65276989|NCT02655198|Fenfluramine|fenfluramine|mesh-list
65276990|NCT02655198|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65276991|NCT02655198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65276992|NCT02655198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65276993|NCT02655198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65276994|NCT02655198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65276995|NCT02655198|Serotonin Agents|serotonin agents|mesh-ancestor
65276996|NCT02655198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65276997|NCT00650052|Zonisamide|zonisamide|mesh-list
65276998|NCT00650052|Anticonvulsants|anticonvulsants|mesh-ancestor
65276999|NCT00650052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65277000|NCT00650052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65277001|NCT00650052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277002|NCT00650052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65277003|NCT00650052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277004|NCT00891527|Bevacizumab|bevacizumab|mesh-list
64729482|NCT00004466|Atorvastatin|atorvastatin|mesh-list
64474820|NCT01519791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64474821|NCT01439373|Interferons|interferons|mesh-list
64474822|NCT01439373|Ribavirin|ribavirin|mesh-list
64474823|NCT01439373|Interferon-alpha|interferon-alpha|mesh-list
64474824|NCT01439373|Interferon alpha-2|interferon alpha-2|mesh-list
64474825|NCT01439373|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64474826|NCT01439373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474827|NCT01439373|Antiviral Agents|antiviral agents|mesh-ancestor
64474828|NCT01439373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64474829|NCT01439373|Antimetabolites|antimetabolites|mesh-ancestor
64474830|NCT01439373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474831|NCT01439373|Immunologic Factors|immunologic factors|mesh-ancestor
64474832|NCT01439373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474833|NCT01461369|Diclofenac|diclofenac|mesh-list
64474834|NCT01461369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64474835|NCT01461369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64474836|NCT01461369|Analgesics|analgesics|mesh-ancestor
64474837|NCT01461369|Sensory System Agents|sensory system agents|mesh-ancestor
64474838|NCT01461369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64474839|NCT01461369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474840|NCT01461369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64474841|NCT01461369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64474842|NCT01461369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64474843|NCT01461369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64474844|NCT01461369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474845|NCT01727258|Fluorides|fluorides|mesh-list
64474846|NCT01727258|Cariostatic Agents|cariostatic agents|mesh-ancestor
64474847|NCT01727258|Protective Agents|protective agents|mesh-ancestor
64474848|NCT01727258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474849|NCT01781234|Insulin|insulin|mesh-list
64474850|NCT01781234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64474851|NCT01781234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474852|NCT01752842|Fenofibrate|fenofibrate|mesh-list
64474853|NCT01752842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64474854|NCT01752842|Antimetabolites|antimetabolites|mesh-ancestor
64474855|NCT01752842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474870|NCT04567407|Sensory System Agents|sensory system agents|mesh-ancestor
64474871|NCT04567407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64474872|NCT01519635|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64474873|NCT01519635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64474875|NCT01519635|Natriuretic Agents|natriuretic agents|mesh-ancestor
65277005|NCT00891527|Imatinib Mesylate|imatinib mesylate|mesh-list
65277006|NCT00891527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65277007|NCT00891527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65277008|NCT00891527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65277009|NCT00891527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65277010|NCT00891527|Growth Substances|growth substances|mesh-ancestor
65277011|NCT00891527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277012|NCT00891527|Growth Inhibitors|growth inhibitors|mesh-ancestor
65277013|NCT00891527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65277014|NCT00891527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277015|NCT00891527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277016|NCT03861078|Nicotine|nicotine|mesh-list
65277017|NCT03861078|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65277018|NCT03861078|Autonomic Agents|autonomic agents|mesh-ancestor
65277019|NCT03861078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277020|NCT03861078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277021|NCT03861078|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65277022|NCT03861078|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65277023|NCT03861078|Cholinergic Agents|cholinergic agents|mesh-ancestor
65277024|NCT03861078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65277025|NCT03861078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277058|NCT02832635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65277059|NCT02832635|Alkylating Agents|alkylating agents|mesh-ancestor
65277060|NCT02832635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277061|NCT02832635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65277062|NCT00650598|Diclofenac|diclofenac|mesh-list
65277063|NCT00650598|Valdecoxib|valdecoxib|mesh-list
65277064|NCT00650598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65277065|NCT00650598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65277066|NCT00650598|Analgesics|analgesics|mesh-ancestor
65277067|NCT00650598|Sensory System Agents|sensory system agents|mesh-ancestor
65277068|NCT00650598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277069|NCT00650598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277070|NCT00650598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65277071|NCT00650598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65277072|NCT00650598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65277073|NCT00650598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277074|NCT00650598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277075|NCT00650598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65277076|NCT00620204|Atorvastatin|atorvastatin|mesh-list
65277077|NCT00620204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65277078|NCT00620204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65277079|NCT00620204|Antimetabolites|antimetabolites|mesh-ancestor
65277080|NCT00620204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277081|NCT00620204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65277082|NCT00620204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65277083|NCT00620204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277084|NCT03867344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65277085|NCT03867344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277086|NCT02650596|Liraglutide|liraglutide|mesh-list
64474876|NCT01519635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474877|NCT01519635|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64474878|NCT01519635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64474879|NCT01519635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474880|NCT01519323|Vemurafenib|vemurafenib|mesh-list
64474881|NCT01519323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474882|NCT01519323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64474883|NCT01519323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64474884|NCT01519323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474885|NCT01519245|Tranexamic Acid|tranexamic acid|mesh-list
64474886|NCT01519245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64474887|NCT01519245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65277087|NCT02650596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65277088|NCT02650596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277089|NCT02650596|Incretins|incretins|mesh-ancestor
65277090|NCT02650596|Hormones|hormones|mesh-ancestor
65277091|NCT02650596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65277092|NCT02650518|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65277093|NCT02650518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65277094|NCT02832089|Carvedilol|carvedilol|mesh-list
65277095|NCT02832089|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65277096|NCT02832089|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65277097|NCT02832089|Adrenergic Agents|adrenergic agents|mesh-ancestor
65277098|NCT02832089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64474888|NCT01519245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474889|NCT01519245|Hemostatics|hemostatics|mesh-ancestor
64474890|NCT01519245|Coagulants|coagulants|mesh-ancestor
64474891|NCT01519167|Fentanyl|fentanyl|mesh-list
64474892|NCT01519167|Midazolam|midazolam|mesh-list
64474893|NCT01519167|Dexmedetomidine|dexmedetomidine|mesh-list
64474894|NCT01519167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64474895|NCT01519167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64474896|NCT01519167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474897|NCT01519167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64474898|NCT01519167|Analgesics|analgesics|mesh-ancestor
64474899|NCT01519167|Sensory System Agents|sensory system agents|mesh-ancestor
64474900|NCT01519167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64474901|NCT01519167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64513661|NCT01890993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64513662|NCT01890993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474902|NCT01519167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64474903|NCT01519167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64474904|NCT01519167|Adrenergic Agents|adrenergic agents|mesh-ancestor
64474905|NCT01519167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64474906|NCT01519167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474907|NCT01519167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64474908|NCT01519167|Narcotics|narcotics|mesh-ancestor
64474909|NCT01519167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64474910|NCT01519167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64474911|NCT01519167|Anesthetics, General|anesthetics, general|mesh-ancestor
64474912|NCT01519167|Anesthetics|anesthetics|mesh-ancestor
64474913|NCT01519167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64474936|NCT00318292|Anesthetics|anesthetics|mesh-ancestor
64474937|NCT00318292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64474938|NCT00318292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474939|NCT00318292|Sensory System Agents|sensory system agents|mesh-ancestor
64474940|NCT00318292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64474941|NCT00318292|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64474942|NCT00318292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64474943|NCT00318292|Adrenergic Agents|adrenergic agents|mesh-ancestor
64474944|NCT00318292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64474945|NCT00318292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474946|NCT00318292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64474947|NCT00318292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64474948|NCT00318292|Autonomic Agents|autonomic agents|mesh-ancestor
64474949|NCT00318292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64474950|NCT00318292|Respiratory System Agents|respiratory system agents|mesh-ancestor
64474951|NCT00318292|Mydriatics|mydriatics|mesh-ancestor
64474952|NCT00318292|Sympathomimetics|sympathomimetics|mesh-ancestor
64474953|NCT00318292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64474954|NCT01791868|Valproic Acid|valproic acid|mesh-list
64474955|NCT01791868|Anticonvulsants|anticonvulsants|mesh-ancestor
64474956|NCT01791868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64474957|NCT01791868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474958|NCT01791868|GABA Agents|gaba agents|mesh-ancestor
64474959|NCT01791868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65277099|NCT02832089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277100|NCT02832089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277101|NCT02832089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65277102|NCT02832089|Antioxidants|antioxidants|mesh-ancestor
65277103|NCT02832089|Protective Agents|protective agents|mesh-ancestor
65277104|NCT02832089|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65277105|NCT02832089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65277106|NCT02832089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65277107|NCT02832089|Vasodilator Agents|vasodilator agents|mesh-ancestor
65277108|NCT02832089|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65277109|NCT02832089|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65277110|NCT04247633|Palbociclib|palbociclib|mesh-list
65277111|NCT04247633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65277112|NCT04247633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65277113|NCT04247633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277114|NCT04247633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277116|NCT00891371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65277117|NCT04324229|Liraglutide|liraglutide|mesh-list
65277118|NCT04324229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65277119|NCT04324229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277120|NCT04324229|Incretins|incretins|mesh-ancestor
65277121|NCT04324229|Hormones|hormones|mesh-ancestor
65277122|NCT04324229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65277123|NCT04430894|Dexamethasone|dexamethasone|mesh-list
65277124|NCT04430894|Lenalidomide|lenalidomide|mesh-list
65277125|NCT04430894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65277126|NCT04430894|Antiemetics|antiemetics|mesh-ancestor
65277127|NCT04430894|Autonomic Agents|autonomic agents|mesh-ancestor
65277128|NCT04430894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277129|NCT04430894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277130|NCT04430894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64474960|NCT01791868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474961|NCT01791868|Antimanic Agents|antimanic agents|mesh-ancestor
64474962|NCT01791868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64474963|NCT01791868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64474964|NCT01791868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64474965|NCT03793114|Cosyntropin|cosyntropin|mesh-list
64474966|NCT03793114|Hormones|hormones|mesh-ancestor
64474967|NCT03793114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64474968|NCT03793114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474995|NCT00352612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65277131|NCT04430894|Glucocorticoids|glucocorticoids|mesh-ancestor
65277132|NCT04430894|Hormones|hormones|mesh-ancestor
65277133|NCT04430894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65277134|NCT04430894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65277135|NCT04430894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65277136|NCT04430894|Immunologic Factors|immunologic factors|mesh-ancestor
65277137|NCT04430894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65277138|NCT04430894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65277139|NCT04430894|Growth Substances|growth substances|mesh-ancestor
65277140|NCT04430894|Growth Inhibitors|growth inhibitors|mesh-ancestor
65277141|NCT04200456|Rozanolixizumab|rozanolixizumab|mesh-list
65277142|NCT04200456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65277143|NCT04200456|Immunologic Factors|immunologic factors|mesh-ancestor
65277144|NCT04200456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277145|NCT02829281|Triamcinolone|triamcinolone|mesh-list
65277146|NCT02829281|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64729630|NCT00003926|Melphalan|melphalan|mesh-list
64474996|NCT00352612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64474997|NCT00352612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64474998|NCT00352612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64474999|NCT00352612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475000|NCT00323362|Gemcitabine|gemcitabine|mesh-list
64475001|NCT00323362|Imatinib Mesylate|imatinib mesylate|mesh-list
64475002|NCT00323362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64475003|NCT00323362|Antimetabolites|antimetabolites|mesh-ancestor
64475004|NCT00323362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475005|NCT00323362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475006|NCT00323362|Antiviral Agents|antiviral agents|mesh-ancestor
64475007|NCT00323362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64475008|NCT00323362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475009|NCT00323362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64475010|NCT00323362|Immunologic Factors|immunologic factors|mesh-ancestor
64475011|NCT00323362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475012|NCT00323362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64475013|NCT00390364|Everolimus|everolimus|mesh-list
64475014|NCT00390364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475015|NCT00390364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64475016|NCT00390364|Immunologic Factors|immunologic factors|mesh-ancestor
64475042|NCT00392392|Mitosis Modulators|mitosis modulators|mesh-ancestor
64475043|NCT00392392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475044|NCT00392392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64475045|NCT00392392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64475046|NCT00392392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64475047|NCT00392392|Growth Substances|growth substances|mesh-ancestor
64475048|NCT00392392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475049|NCT00392392|Growth Inhibitors|growth inhibitors|mesh-ancestor
64475050|NCT01519089|Tofacitinib|tofacitinib|mesh-list
64513663|NCT01890993|Incretins|incretins|mesh-ancestor
64475051|NCT01519089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64475052|NCT01519089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475053|NCT01519089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475054|NCT00392704|Paclitaxel|paclitaxel|mesh-list
64475055|NCT00392704|Bevacizumab|bevacizumab|mesh-list
64475056|NCT00392704|Fluorouracil|fluorouracil|mesh-list
64475057|NCT00392704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64475058|NCT00392704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64475059|NCT00392704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475060|NCT00392704|Tubulin Modulators|tubulin modulators|mesh-ancestor
65277147|NCT02829281|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65277148|NCT02829281|Botulinum Toxins|botulinum toxins|mesh-list
65277149|NCT02829281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65277150|NCT02829281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65277151|NCT02829281|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65277152|NCT02829281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65277153|NCT02829281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65277154|NCT02829281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277155|NCT02829281|Cholinergic Agents|cholinergic agents|mesh-ancestor
65277156|NCT02829281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65277157|NCT02829281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277158|NCT02829281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65277159|NCT02829281|Glucocorticoids|glucocorticoids|mesh-ancestor
65277160|NCT02829281|Hormones|hormones|mesh-ancestor
65277161|NCT02829281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65277162|NCT02829281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65277163|NCT02829281|Immunologic Factors|immunologic factors|mesh-ancestor
65277164|NCT02829281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277165|NCT02829281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64475061|NCT00392704|Antimitotic Agents|antimitotic agents|mesh-ancestor
64475062|NCT00392704|Mitosis Modulators|mitosis modulators|mesh-ancestor
64975882|NCT00100269|Protective Agents|protective agents|mesh-ancestor
64475084|NCT00392782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64475085|NCT00392782|Immunologic Factors|immunologic factors|mesh-ancestor
64475086|NCT00392782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475087|NCT00392782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64475088|NCT00392782|Alkylating Agents|alkylating agents|mesh-ancestor
64475089|NCT00392782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64475090|NCT01518699|Moxifloxacin|moxifloxacin|mesh-list
64475091|NCT01518699|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64475092|NCT01518699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64475093|NCT01518699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64475094|NCT01518699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64475095|NCT01518699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64475096|NCT01518699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475097|NCT01518699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475098|NCT01518699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475099|NCT01518699|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64475100|NCT01518699|Contraceptive Agents|contraceptive agents|mesh-ancestor
64475101|NCT01518699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64475102|NCT01518699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475103|NCT01518699|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64475104|NCT01518699|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64471359|NCT04585711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64475105|NCT01518699|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64475106|NCT01518309|Pimavanserin|pimavanserin|mesh-list
64475107|NCT01518309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64475108|NCT01518309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64475109|NCT01518309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64475110|NCT01518309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64475111|NCT01518309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64975930|NCT00104013|Serotonin Agents|serotonin agents|mesh-ancestor
64475137|NCT00393796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475139|NCT00393796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65277166|NCT02829281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277167|NCT04210544|Caseins|caseins|mesh-list
65277168|NCT04210544|Chelating Agents|chelating agents|mesh-ancestor
65277169|NCT04210544|Sequestering Agents|sequestering agents|mesh-ancestor
65277170|NCT04210544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277171|NCT04168944|Lenvatinib|lenvatinib|mesh-list
65277172|NCT04168944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65277173|NCT04168944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65277174|NCT04168944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65277175|NCT04168944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277176|NCT04168944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277177|NCT04168944|Immunologic Factors|immunologic factors|mesh-ancestor
65277178|NCT04168944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277179|NCT02697032|Bicalutamide|bicalutamide|mesh-list
65277180|NCT02697032|Androgen Antagonists|androgen antagonists|mesh-ancestor
65027185|NCT00191763|Immunologic Factors|immunologic factors|mesh-ancestor
64475140|NCT00393796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475141|NCT00393796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475142|NCT00393874|Prazosin|prazosin|mesh-list
64475143|NCT00393874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64475144|NCT00393874|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64475145|NCT00393874|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64475146|NCT00393874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64475147|NCT00393874|Adrenergic Agents|adrenergic agents|mesh-ancestor
64475148|NCT00393874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64475149|NCT00393874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475150|NCT00393874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475151|NCT00394888|Dermatologic Agents|dermatologic agents|mesh-list
64475152|NCT01458171|Immunoglobulins|immunoglobulins|mesh-list
64475153|NCT01458171|Antibodies|antibodies|mesh-list
64475154|NCT01458171|gamma-Globulins|gamma-globulins|mesh-list
64475155|NCT01458171|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64475156|NCT01458171|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64475157|NCT01458171|Immunologic Factors|immunologic factors|mesh-ancestor
64475158|NCT01458171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475159|NCT00395044|Gabapentin|gabapentin|mesh-list
64475179|NCT01457703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64475180|NCT01457703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475181|NCT01457703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475182|NCT01457703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64475183|NCT01457703|Hormone Antagonists|hormone antagonists|mesh-ancestor
64475184|NCT01457703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64475185|NCT01457703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475186|NCT01457703|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64475187|NCT01457703|Fertility Agents|fertility agents|mesh-ancestor
64475188|NCT01457703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64475189|NCT01457703|Hormones|hormones|mesh-ancestor
64475190|NCT02076321|Acetaminophen|acetaminophen|mesh-list
64475191|NCT02076321|Ibuprofen|ibuprofen|mesh-list
64475192|NCT02076321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64475193|NCT02076321|Analgesics|analgesics|mesh-ancestor
64475194|NCT02076321|Sensory System Agents|sensory system agents|mesh-ancestor
64475195|NCT02076321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64475196|NCT02076321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475198|NCT02076321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64475199|NCT02076321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64475200|NCT02076321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65277181|NCT02697032|Hormone Antagonists|hormone antagonists|mesh-ancestor
65277182|NCT02697032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65277183|NCT02697032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277184|NCT02697032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65277185|NCT04409834|Heparin|heparin|mesh-list
65277186|NCT04409834|Calcium heparin|calcium heparin|mesh-list
65277187|NCT04409834|Enoxaparin|enoxaparin|mesh-list
65277188|NCT04409834|Enoxaparin sodium|enoxaparin sodium|mesh-list
65277189|NCT04409834|Clopidogrel|clopidogrel|mesh-list
65277190|NCT04409834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65277191|NCT04409834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65277192|NCT04409834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65277193|NCT04409834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65277194|NCT04409834|Purinergic Agents|purinergic agents|mesh-ancestor
65277195|NCT04409834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65277196|NCT04409834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277197|NCT04409834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277198|NCT04409834|Anticoagulants|anticoagulants|mesh-ancestor
65277199|NCT04409834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65277200|NCT04409834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65277201|NCT02647632|Ribavirin|ribavirin|mesh-list
65277202|NCT02647632|Sofosbuvir|sofosbuvir|mesh-list
65277203|NCT02647632|Grazoprevir|grazoprevir|mesh-list
65277204|NCT02647632|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65277205|NCT02647632|Antimetabolites|antimetabolites|mesh-ancestor
65277206|NCT02647632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277207|NCT02647632|Antiviral Agents|antiviral agents|mesh-ancestor
65277208|NCT02647632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65277209|NCT00621452|Aldesleukin|aldesleukin|mesh-list
65277210|NCT00621452|Cyclophosphamide|cyclophosphamide|mesh-list
64475201|NCT02076321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64475202|NCT02076321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475203|NCT02076321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475204|NCT00358462|Azithromycin|azithromycin|mesh-list
64475205|NCT00358462|Doxycycline|doxycycline|mesh-list
64475206|NCT00358462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64475207|NCT00358462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64475208|NCT00358462|Antimalarials|antimalarials|mesh-ancestor
64475209|NCT00358462|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64475210|NCT00358462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64475211|NCT03652870|Dexetimide|dexetimide|mesh-list
64475212|NCT03652870|Citalopram|citalopram|mesh-list
64475213|NCT03652870|Nortriptyline|nortriptyline|mesh-list
64475214|NCT03652870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64475215|NCT03652870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64475226|NCT03652870|Parasympatholytics|parasympatholytics|mesh-ancestor
65277211|NCT00621452|Interleukin-2|interleukin-2|mesh-list
65277212|NCT00621452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65277213|NCT00621452|Immunologic Factors|immunologic factors|mesh-ancestor
64729704|NCT00004640|Disinfectants|disinfectants|mesh-ancestor
64475227|NCT03652870|Autonomic Agents|autonomic agents|mesh-ancestor
64475228|NCT03652870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64475229|NCT03652870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64475230|NCT03652870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64475231|NCT03652870|Cholinergic Agents|cholinergic agents|mesh-ancestor
64475232|NCT03652870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64475233|NCT03652870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64475234|NCT03652870|Adrenergic Agents|adrenergic agents|mesh-ancestor
64475236|NCT01437267|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64475237|NCT01437267|Immunologic Factors|immunologic factors|mesh-ancestor
64475238|NCT01437267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475239|NCT01437111|Vitamin D|vitamin d|mesh-list
64475240|NCT01437111|Cholecalciferol|cholecalciferol|mesh-list
64475241|NCT01437111|Alendronate|alendronate|mesh-list
64475242|NCT01437111|Vitamins|vitamins|mesh-ancestor
64475243|NCT01437111|Micronutrients|micronutrients|mesh-ancestor
64475244|NCT01437111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475245|NCT01437111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64475246|NCT01437111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64475247|NCT04065555|Cetuximab|cetuximab|mesh-list
64475248|NCT04065555|Avelumab|avelumab|mesh-list
64475249|NCT04065555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64475250|NCT04065555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64475251|NCT04065555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475252|NCT04065555|Immunologic Factors|immunologic factors|mesh-ancestor
64475253|NCT04065555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475254|NCT00360724|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64475255|NCT00360724|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64475256|NCT00360724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64475257|NCT00360724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64475258|NCT00360724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475259|NCT00360724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64475260|NCT00360724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475261|NCT00360724|Analgesics|analgesics|mesh-ancestor
64475262|NCT00360724|Sensory System Agents|sensory system agents|mesh-ancestor
64475263|NCT00360724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64475264|NCT00360724|Antidepressive Agents|antidepressive agents|mesh-ancestor
64475265|NCT00360724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64475266|NCT00360724|Dopamine Agents|dopamine agents|mesh-ancestor
64475267|NCT00398398|Capecitabine|capecitabine|mesh-list
64475268|NCT00398398|Oxaliplatin|oxaliplatin|mesh-list
64475269|NCT00398398|Cetuximab|cetuximab|mesh-list
64475270|NCT00398398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64475271|NCT00398398|Antimetabolites|antimetabolites|mesh-ancestor
64475272|NCT00398398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475273|NCT00398398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475274|NCT00398398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64475275|NCT00398476|Fluticasone|fluticasone|mesh-list
64475277|NCT00398476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64976084|NCT00253474|Antiviral Agents|antiviral agents|mesh-ancestor
64475302|NCT01436643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475303|NCT01436643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64475304|NCT01436643|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64475305|NCT01436643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64475306|NCT01436643|Immunologic Factors|immunologic factors|mesh-ancestor
64475307|NCT04316494|Hydroxychloroquine|hydroxychloroquine|mesh-list
64475308|NCT04316494|Antimalarials|antimalarials|mesh-ancestor
64475309|NCT04316494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64475310|NCT04316494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64475311|NCT04316494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64475312|NCT04316494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475313|NCT04316494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475314|NCT04316494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64475315|NCT00361972|Lansoprazole|lansoprazole|mesh-list
64475316|NCT00361972|Dexlansoprazole|dexlansoprazole|mesh-list
64475317|NCT00361972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64475318|NCT00361972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64475319|NCT00361972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65277214|NCT00621452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277215|NCT00621452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65277216|NCT00621452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65277217|NCT00621452|Alkylating Agents|alkylating agents|mesh-ancestor
65277218|NCT00621452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277219|NCT00621452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475320|NCT00361972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475321|NCT00361972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475322|NCT00362440|Metformin|metformin|mesh-list
64475323|NCT00362440|Pioglitazone|pioglitazone|mesh-list
64475324|NCT00362440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64475325|NCT00362440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475345|NCT00366106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64475347|NCT00366106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64475349|NCT00366106|Hormones|hormones|mesh-ancestor
64475350|NCT00366106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64475351|NCT00366106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64475352|NCT00366106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475353|NCT00366106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64475354|NCT00366106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64475355|NCT00366106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64475356|NCT00366106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475357|NCT00366106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475358|NCT00368290|Modafinil|modafinil|mesh-list
64475359|NCT00368290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64475360|NCT00368290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475361|NCT00368290|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64475362|NCT00368290|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64475363|NCT00368290|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64475364|NCT00368290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475365|NCT00369226|Methotrexate|methotrexate|mesh-list
64475366|NCT00369226|Bortezomib|bortezomib|mesh-list
64475367|NCT00369226|Tacrolimus|tacrolimus|mesh-list
64475368|NCT00369226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64475369|NCT00369226|Abortifacient Agents|abortifacient agents|mesh-ancestor
64475370|NCT00369226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64475371|NCT00369226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475372|NCT00369226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64475373|NCT00369226|Antimetabolites|antimetabolites|mesh-ancestor
64475374|NCT00369226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475375|NCT00369226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475376|NCT00369226|Dermatologic Agents|dermatologic agents|mesh-ancestor
64475377|NCT00369226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475378|NCT00369226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64475379|NCT00369226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64475380|NCT00369226|Immunologic Factors|immunologic factors|mesh-ancestor
64475381|NCT00369226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64475382|NCT00369226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64475383|NCT00369226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64475384|NCT01416441|Aripiprazole|aripiprazole|mesh-list
64475385|NCT01416441|Antidepressive Agents|antidepressive agents|mesh-ancestor
64475386|NCT01416441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64475405|NCT00406276|Tubulin Modulators|tubulin modulators|mesh-ancestor
64475406|NCT00406276|Antimitotic Agents|antimitotic agents|mesh-ancestor
64475407|NCT00406276|Mitosis Modulators|mitosis modulators|mesh-ancestor
64475408|NCT00406276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475409|NCT00406276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64475410|NCT00406276|Immunologic Factors|immunologic factors|mesh-ancestor
64475411|NCT00406276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475412|NCT00408070|Paclitaxel|paclitaxel|mesh-list
64475413|NCT00408070|Bevacizumab|bevacizumab|mesh-list
64475414|NCT00408070|Carboplatin|carboplatin|mesh-list
64475415|NCT00408070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64475416|NCT00408070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475417|NCT00408070|Tubulin Modulators|tubulin modulators|mesh-ancestor
64475418|NCT00408070|Antimitotic Agents|antimitotic agents|mesh-ancestor
65277220|NCT00621452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65277221|NCT00621452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65277222|NCT00621452|Analgesics|analgesics|mesh-ancestor
65277223|NCT00621452|Sensory System Agents|sensory system agents|mesh-ancestor
65277224|NCT00621452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277225|NCT00621452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65277226|NCT00621452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65277227|NCT00621452|Antiviral Agents|antiviral agents|mesh-ancestor
65277228|NCT00621452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65277229|NCT04336748|Hydroxychloroquine|hydroxychloroquine|mesh-list
65277230|NCT04336748|Antimalarials|antimalarials|mesh-ancestor
65277231|NCT04336748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65277232|NCT04336748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64475419|NCT00408070|Mitosis Modulators|mitosis modulators|mesh-ancestor
64475420|NCT00408070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475421|NCT00408070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64475422|NCT00408070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64475423|NCT00408070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64475424|NCT00408070|Growth Substances|growth substances|mesh-ancestor
64475425|NCT00408070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475426|NCT00408070|Growth Inhibitors|growth inhibitors|mesh-ancestor
64475428|NCT00408460|Imatinib Mesylate|imatinib mesylate|mesh-list
64475429|NCT00408460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64475430|NCT00408460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475431|NCT00408460|Tubulin Modulators|tubulin modulators|mesh-ancestor
64475432|NCT00408460|Antimitotic Agents|antimitotic agents|mesh-ancestor
64475433|NCT00408460|Mitosis Modulators|mitosis modulators|mesh-ancestor
64475434|NCT00408460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475435|NCT00408460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64475436|NCT00408460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475437|NCT03675412|Caffeine|caffeine|mesh-list
64475438|NCT03675412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64475439|NCT03675412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475473|NCT00410488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64475474|NCT00410488|Vincristine|vincristine|mesh-list
64475475|NCT00410488|Ifosfamide|ifosfamide|mesh-list
64475476|NCT00410488|Dexrazoxane|dexrazoxane|mesh-list
64475477|NCT00410488|Palonosetron|palonosetron|mesh-list
64475478|NCT00410488|BB 1101|bb 1101|mesh-list
64475479|NCT00410488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64475480|NCT00410488|Antiemetics|antiemetics|mesh-ancestor
64475481|NCT00410488|Autonomic Agents|autonomic agents|mesh-ancestor
64976312|NCT00104442|Rivastigmine|rivastigmine|mesh-list
64475511|NCT01793350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475512|NCT01793350|Chelating Agents|chelating agents|mesh-ancestor
64475513|NCT01793350|Sequestering Agents|sequestering agents|mesh-ancestor
64475514|NCT01793350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475515|NCT03127774|Sodium thiosulfate|sodium thiosulfate|mesh-list
64475517|NCT03127774|Protective Agents|protective agents|mesh-ancestor
64475518|NCT03127774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475519|NCT03127774|Antioxidants|antioxidants|mesh-ancestor
64475520|NCT03127774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475521|NCT03127774|Antitubercular Agents|antitubercular agents|mesh-ancestor
64475522|NCT03127774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64475523|NCT03127774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64475524|NCT03127774|Chelating Agents|chelating agents|mesh-ancestor
64475525|NCT03127774|Sequestering Agents|sequestering agents|mesh-ancestor
64475526|NCT00416494|Bevacizumab|bevacizumab|mesh-list
64475527|NCT00416494|Capecitabine|capecitabine|mesh-list
64475545|NCT02845882|Doxorubicin|doxorubicin|mesh-list
64475546|NCT02845882|Methotrexate|methotrexate|mesh-list
64475547|NCT02845882|Etoposide|etoposide|mesh-list
64475548|NCT02845882|Vincristine|vincristine|mesh-list
64475549|NCT02845882|Daunorubicin|daunorubicin|mesh-list
64475550|NCT02845882|Asparaginase|asparaginase|mesh-list
64475551|NCT02845882|Mercaptopurine|mercaptopurine|mesh-list
65277233|NCT04336748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65277234|NCT04336748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277235|NCT04336748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277236|NCT04336748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65277237|NCT00651612|Timolol|timolol|mesh-list
65277238|NCT00651612|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65277239|NCT00651612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65277240|NCT00651612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65277241|NCT00651612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65277242|NCT00651612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65277243|NCT00651612|Adrenergic Agents|adrenergic agents|mesh-ancestor
65277244|NCT00651612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64475552|NCT02845882|Vindesine|vindesine|mesh-list
64475553|NCT02845882|Pegaspargase|pegaspargase|mesh-list
64475554|NCT02845882|BB 1101|bb 1101|mesh-list
64475555|NCT02845882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64475556|NCT02845882|Immunologic Factors|immunologic factors|mesh-ancestor
64475557|NCT02845882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475558|NCT02845882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64475559|NCT02845882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64475560|NCT02845882|Alkylating Agents|alkylating agents|mesh-ancestor
64475561|NCT02845882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475562|NCT02845882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475563|NCT02845882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64475564|NCT02845882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64475565|NCT02845882|Antiemetics|antiemetics|mesh-ancestor
64475566|NCT02845882|Autonomic Agents|autonomic agents|mesh-ancestor
64475567|NCT02845882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64475568|NCT02845882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64475569|NCT02845882|Glucocorticoids|glucocorticoids|mesh-ancestor
64475570|NCT02845882|Hormones|hormones|mesh-ancestor
64475571|NCT02845882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64475572|NCT02845882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64475573|NCT02845882|Protease Inhibitors|protease inhibitors|mesh-ancestor
64475574|NCT02845882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475575|NCT02845882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64475576|NCT02845882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64475577|NCT02845882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64475578|NCT02845882|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64475579|NCT02845882|Abortifacient Agents|abortifacient agents|mesh-ancestor
64475580|NCT02845882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64475581|NCT02845882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64475582|NCT02845882|Antimetabolites|antimetabolites|mesh-ancestor
64475583|NCT02845882|Dermatologic Agents|dermatologic agents|mesh-ancestor
64475584|NCT02845882|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64475585|NCT02845882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64475586|NCT02845882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64475587|NCT02845882|Antiviral Agents|antiviral agents|mesh-ancestor
64475611|NCT04749940|Laxatives|laxatives|mesh-ancestor
64475612|NCT04749940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64475613|NCT05286346|Tenofovir|tenofovir|mesh-list
64475614|NCT05286346|Antiviral Agents|antiviral agents|mesh-ancestor
64475615|NCT05286346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64475616|NCT05286346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64475617|NCT05286346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64475618|NCT05286346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475619|NCT05286346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475620|NCT05286346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64475621|NCT05286346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64475622|NCT05286268|Plasminogen|plasminogen|mesh-list
64475623|NCT05286268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64475624|NCT05286268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65277245|NCT00651612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277246|NCT00651612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277247|NCT00651612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65277248|NCT00651612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65277249|NCT00651612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65277250|NCT00651612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65277251|NCT00651612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65277252|NCT00650754|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65277253|NCT00650754|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65277254|NCT00650754|Immunologic Factors|immunologic factors|mesh-ancestor
65277255|NCT00650754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277256|NCT02831933|Valacyclovir|valacyclovir|mesh-list
65277257|NCT02831933|Nivolumab|nivolumab|mesh-list
65277258|NCT02831933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65277259|NCT02831933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475625|NCT05286268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475626|NCT00422032|Clofarabine|clofarabine|mesh-list
64475627|NCT00422032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64475628|NCT00422032|Antimetabolites|antimetabolites|mesh-ancestor
64475629|NCT00422032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475630|NCT00422032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475631|NCT01388920|Tesamorelin|tesamorelin|mesh-list
64475632|NCT01388920|Growth Substances|growth substances|mesh-ancestor
64475633|NCT01388920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475634|NCT00423358|Vitamin D|vitamin d|mesh-list
64475635|NCT00423358|Ergocalciferols|ergocalciferols|mesh-list
64475636|NCT00423358|Vitamins|vitamins|mesh-ancestor
64475637|NCT00423358|Micronutrients|micronutrients|mesh-ancestor
64475638|NCT00423358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475639|NCT00423358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64976452|NCT00070187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64475665|NCT00425386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475666|NCT00425386|Growth Inhibitors|growth inhibitors|mesh-ancestor
64475668|NCT01164202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475669|NCT01164202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64475670|NCT01164202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64475671|NCT01164202|Growth Substances|growth substances|mesh-ancestor
64475672|NCT01164202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475673|NCT01164202|Growth Inhibitors|growth inhibitors|mesh-ancestor
64475674|NCT01164202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64475675|NCT01164202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475676|NCT01164202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475677|NCT02112370|Epinephrine|epinephrine|mesh-list
64475678|NCT02112370|Racepinephrine|racepinephrine|mesh-list
64475679|NCT02112370|Ropivacaine|ropivacaine|mesh-list
64475680|NCT02112370|Epinephryl borate|epinephryl borate|mesh-list
64475681|NCT02112370|Anesthetics, Local|anesthetics, local|mesh-ancestor
64475682|NCT02112370|Anesthetics|anesthetics|mesh-ancestor
64475683|NCT02112370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64475684|NCT02112370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475685|NCT02112370|Sensory System Agents|sensory system agents|mesh-ancestor
64475686|NCT02112370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64475687|NCT02112370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64475688|NCT02112370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64475689|NCT02112370|Adrenergic Agents|adrenergic agents|mesh-ancestor
64976506|NCT00104598|Dopamine Agents|dopamine agents|mesh-ancestor
64475709|NCT00427336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64475710|NCT00427336|Alkylating Agents|alkylating agents|mesh-ancestor
65277260|NCT02831933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65277261|NCT02831933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277262|NCT02831933|Antiviral Agents|antiviral agents|mesh-ancestor
65277263|NCT02831933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65277264|NCT02650206|Liraglutide|liraglutide|mesh-list
65277265|NCT02650206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65277266|NCT02650206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277267|NCT02650206|Incretins|incretins|mesh-ancestor
65277268|NCT02650206|Hormones|hormones|mesh-ancestor
65277269|NCT02650206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65277270|NCT05368766|Diuretics|diuretics|mesh-list
65277271|NCT05368766|Natriuretic Agents|natriuretic agents|mesh-ancestor
65277272|NCT05368766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277273|NCT00891293|Fenofibrate|fenofibrate|mesh-list
64475711|NCT00427336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475712|NCT00427336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475713|NCT00427336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64475714|NCT00427336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64475715|NCT00427336|Antimetabolites|antimetabolites|mesh-ancestor
64475716|NCT00371176|Cycloserine|cycloserine|mesh-list
64475717|NCT00371176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64475718|NCT00371176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64475719|NCT00371176|Renal Agents|renal agents|mesh-ancestor
64475720|NCT00371176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64475721|NCT00371176|Antitubercular Agents|antitubercular agents|mesh-ancestor
64475722|NCT00371176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64475723|NCT00371176|Antimetabolites|antimetabolites|mesh-ancestor
64475724|NCT00371176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475725|NCT00427804|Calcitriol|calcitriol|mesh-list
64475726|NCT00427804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64461256|NCT00082888|Tipifarnib|tipifarnib|mesh-list
64475727|NCT00427804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475728|NCT00427804|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64475729|NCT00427804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64475730|NCT00427804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475731|NCT00427804|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64475732|NCT00427804|Vitamins|vitamins|mesh-ancestor
64475733|NCT00427804|Micronutrients|micronutrients|mesh-ancestor
64475734|NCT00427804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64475736|NCT00428584|Interferon-beta|interferon-beta|mesh-list
64475737|NCT00428584|Interferon beta-1a|interferon beta-1a|mesh-list
64475738|NCT00428584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475739|NCT00428584|Antiviral Agents|antiviral agents|mesh-ancestor
64475740|NCT00428584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64475741|NCT00428584|Immunologic Factors|immunologic factors|mesh-ancestor
64475742|NCT00428584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475765|NCT00455650|Mecamylamine|mecamylamine|mesh-list
64475766|NCT00455650|Varenicline|varenicline|mesh-list
64475767|NCT00455650|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64475768|NCT00455650|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64475769|NCT00455650|Cholinergic Agents|cholinergic agents|mesh-ancestor
64475770|NCT00455650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64475771|NCT00455650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475772|NCT00455650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475773|NCT00455650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64475775|NCT00455650|Autonomic Agents|autonomic agents|mesh-ancestor
64475776|NCT00455650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64475777|NCT00455650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64475778|NCT00455650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64475779|NCT00431626|Dutasteride|dutasteride|mesh-list
64475780|NCT00431626|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65277274|NCT00891293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65277275|NCT00891293|Antimetabolites|antimetabolites|mesh-ancestor
65277276|NCT00891293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277277|NCT00891293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65277278|NCT05368142|Cell Wall Skeleton|cell wall skeleton|mesh-list
65277279|NCT05368142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65277280|NCT05368142|Immunologic Factors|immunologic factors|mesh-ancestor
65277281|NCT05368142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277282|NCT00889421|Apremilast|apremilast|mesh-list
65277283|NCT00889421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65277284|NCT00889421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65277285|NCT00889421|Analgesics|analgesics|mesh-ancestor
65277286|NCT00889421|Sensory System Agents|sensory system agents|mesh-ancestor
65277287|NCT00889421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277288|NCT00889421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277289|NCT00889421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65277290|NCT00889421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65277291|NCT00889421|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65277292|NCT00889421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65277293|NCT00889421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277294|NCT00889421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277295|NCT02827643|Vitamin D|vitamin d|mesh-list
65277296|NCT02827643|Ergocalciferols|ergocalciferols|mesh-list
65277297|NCT02827643|Lamivudine|lamivudine|mesh-list
65277298|NCT02827643|Calcium|calcium|mesh-list
65277299|NCT02827643|Vitamins|vitamins|mesh-ancestor
64475781|NCT00431626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64475782|NCT00431626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475783|NCT00431626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475784|NCT00431626|Hormone Antagonists|hormone antagonists|mesh-ancestor
64475785|NCT00431626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64475786|NCT00431626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475787|NCT04388176|Compound 21|compound 21|mesh-list
64475788|NCT04388176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64475789|NCT00455962|Estradiol|estradiol|mesh-list
64475790|NCT00455962|Progesterone|progesterone|mesh-list
64475791|NCT00455962|Estrogens|estrogens|mesh-ancestor
64475792|NCT00455962|Hormones|hormones|mesh-ancestor
64475793|NCT00455962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64475794|NCT00455962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475795|NCT00455962|Progestins|progestins|mesh-ancestor
64475813|NCT00376948|Gemcitabine|gemcitabine|mesh-list
64475814|NCT00376948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64475815|NCT00376948|Genistein|genistein|mesh-list
64475816|NCT00376948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64475817|NCT00376948|Antimetabolites|antimetabolites|mesh-ancestor
64475818|NCT00376948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475819|NCT00376948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475820|NCT00376948|Antiviral Agents|antiviral agents|mesh-ancestor
65277300|NCT02827643|Micronutrients|micronutrients|mesh-ancestor
65277301|NCT02827643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277302|NCT02827643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65277303|NCT02827643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65277304|NCT02827643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64475821|NCT00376948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64475822|NCT00376948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475823|NCT00376948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64475824|NCT00376948|Immunologic Factors|immunologic factors|mesh-ancestor
64475825|NCT00376948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475826|NCT00376948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64475827|NCT00376948|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64475828|NCT00376948|Protective Agents|protective agents|mesh-ancestor
64475829|NCT00376948|Phytoestrogens|phytoestrogens|mesh-ancestor
64475830|NCT00376948|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64475831|NCT00376948|Estrogens|estrogens|mesh-ancestor
64475832|NCT00376948|Hormones|hormones|mesh-ancestor
64475833|NCT00376948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64475834|NCT03396874|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64475835|NCT03396874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64475836|NCT03396874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475837|NCT00438100|Capecitabine|capecitabine|mesh-list
64475838|NCT00438100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64475839|NCT00438100|Antimetabolites|antimetabolites|mesh-ancestor
64475840|NCT00438100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475841|NCT00438100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475842|NCT00456508|Ecallantide|ecallantide|mesh-list
64475843|NCT00456508|Analgesics|analgesics|mesh-ancestor
64475844|NCT00456508|Sensory System Agents|sensory system agents|mesh-ancestor
64475845|NCT00456508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64471364|NCT04581824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475846|NCT00456508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475847|NCT00456508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64461408|NCT03083704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475873|NCT00457366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64475874|NCT00457366|GABA Modulators|gaba modulators|mesh-ancestor
64475875|NCT00457366|GABA Agents|gaba agents|mesh-ancestor
64475877|NCT00457366|Parasympatholytics|parasympatholytics|mesh-ancestor
64475878|NCT00457366|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64475879|NCT00457366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64475880|NCT00457366|Cholinergic Agents|cholinergic agents|mesh-ancestor
64475881|NCT00457366|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64475882|NCT00457366|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64475883|NCT00457366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64475884|NCT00458848|Prednisone|prednisone|mesh-list
64475885|NCT00458848|Methylprednisolone|methylprednisolone|mesh-list
64475886|NCT00458848|Methotrexate|methotrexate|mesh-list
64475887|NCT00458848|Etoposide|etoposide|mesh-list
64475888|NCT00458848|Vincristine|vincristine|mesh-list
64475889|NCT00458848|Imatinib Mesylate|imatinib mesylate|mesh-list
64475890|NCT00458848|Daunorubicin|daunorubicin|mesh-list
64475891|NCT00458848|Asparaginase|asparaginase|mesh-list
64475892|NCT00458848|Mitoxantrone|mitoxantrone|mesh-list
64475893|NCT00458848|Mercaptopurine|mercaptopurine|mesh-list
64475894|NCT00458848|Idarubicin|idarubicin|mesh-list
64475895|NCT00458848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64475896|NCT00458848|Glucocorticoids|glucocorticoids|mesh-ancestor
64475897|NCT00458848|Hormones|hormones|mesh-ancestor
64475898|NCT00458848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64475899|NCT00458848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475931|NCT00438802|Alefacept|alefacept|mesh-list
64475932|NCT00438802|Dermatologic Agents|dermatologic agents|mesh-ancestor
64475933|NCT00438802|Immunologic Factors|immunologic factors|mesh-ancestor
64475934|NCT00438802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475935|NCT00377572|Omalizumab|omalizumab|mesh-list
64475936|NCT00377572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64475937|NCT00377572|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64475938|NCT00377572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64475939|NCT00377572|Respiratory System Agents|respiratory system agents|mesh-ancestor
64475940|NCT00377572|Immunologic Factors|immunologic factors|mesh-ancestor
64475941|NCT00377572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277305|NCT02827643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65277306|NCT02827643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277307|NCT02827643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277308|NCT02827643|Antiviral Agents|antiviral agents|mesh-ancestor
65277309|NCT02827643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64475942|NCT00438880|Rituximab|rituximab|mesh-list
64475971|NCT00381004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64475972|NCT00381004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64475973|NCT00381004|Alkylating Agents|alkylating agents|mesh-ancestor
64475974|NCT00381004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475975|NCT00381004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475976|NCT00381004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64475977|NCT00381004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64475978|NCT00381004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64475980|NCT00381550|Fludarabine|fludarabine|mesh-list
64475981|NCT00381550|Fludarabine phosphate|fludarabine phosphate|mesh-list
64475982|NCT00381550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475983|NCT00381550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64475984|NCT00381550|Antimetabolites|antimetabolites|mesh-ancestor
64475985|NCT00381550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475986|NCT00381550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64475987|NCT00381550|Immunologic Factors|immunologic factors|mesh-ancestor
64475988|NCT00381550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476013|NCT00381862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64476014|NCT00381862|Glucocorticoids|glucocorticoids|mesh-ancestor
64476015|NCT00381862|Hormones|hormones|mesh-ancestor
64476016|NCT00381862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64476017|NCT00381862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64476018|NCT00381862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476019|NCT00381862|Antimetabolites|antimetabolites|mesh-ancestor
64476020|NCT00381862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476021|NCT00381862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64476022|NCT00381862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64476023|NCT00381862|Immunologic Factors|immunologic factors|mesh-ancestor
64476024|NCT00381862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64476025|NCT00381862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64713994|NCT03043105|Alkylating Agents|alkylating agents|mesh-ancestor
64476026|NCT00381862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476028|NCT00381862|Protective Agents|protective agents|mesh-ancestor
64476029|NCT00381862|Vitamin B Complex|vitamin b complex|mesh-ancestor
64476030|NCT00381862|Vitamins|vitamins|mesh-ancestor
64476031|NCT00381862|Micronutrients|micronutrients|mesh-ancestor
64476032|NCT00381862|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64476033|NCT00381862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64476034|NCT00381862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64476035|NCT00381862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64476036|NCT00381862|Serotonin Agents|serotonin agents|mesh-ancestor
64476037|NCT00381862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64476038|NCT00464698|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64476039|NCT00464698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64476040|NCT00464698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64976846|NCT00258193|Enzyme Activators|enzyme activators|mesh-ancestor
64476059|NCT00465088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476061|NCT00465088|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64476062|NCT00465088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476063|NCT00465088|Vasodilator Agents|vasodilator agents|mesh-ancestor
64476064|NCT00465088|Vitamin B Complex|vitamin b complex|mesh-ancestor
64476065|NCT00465088|Vitamins|vitamins|mesh-ancestor
64476066|NCT00465088|Micronutrients|micronutrients|mesh-ancestor
64476067|NCT00465088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476068|NCT01796782|Capecitabine|capecitabine|mesh-list
64476069|NCT01796782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64476070|NCT01796782|Antimetabolites|antimetabolites|mesh-ancestor
64476071|NCT01796782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476072|NCT01796782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476073|NCT00466960|Paclitaxel|paclitaxel|mesh-list
64476074|NCT00466960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65277310|NCT02827643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65277311|NCT02827643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65277312|NCT02646774|Micafungin|micafungin|mesh-list
65277313|NCT02646774|Antifungal Agents|antifungal agents|mesh-ancestor
65277314|NCT02646774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65277315|NCT02647086|Metoprolol|metoprolol|mesh-list
65277316|NCT02647086|Midazolam|midazolam|mesh-list
65277317|NCT02647086|Caffeine|caffeine|mesh-list
65277318|NCT02647086|Omeprazole|omeprazole|mesh-list
65277319|NCT02647086|Warfarin|warfarin|mesh-list
65277320|NCT02647086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65277321|NCT02647086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65277322|NCT02647086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65277323|NCT02647086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277324|NCT02647086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65277325|NCT02647086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65277326|NCT02647086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65277327|NCT02647086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65277328|NCT02647086|Anesthetics, General|anesthetics, general|mesh-ancestor
65277329|NCT02647086|Anesthetics|anesthetics|mesh-ancestor
64476075|NCT00466960|Sargramostim|sargramostim|mesh-list
64476076|NCT00466960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64476077|NCT00466960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476078|NCT00466960|Tubulin Modulators|tubulin modulators|mesh-ancestor
64476079|NCT00466960|Antimitotic Agents|antimitotic agents|mesh-ancestor
64476080|NCT00466960|Mitosis Modulators|mitosis modulators|mesh-ancestor
64476081|NCT00466960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476082|NCT00466960|Immunologic Factors|immunologic factors|mesh-ancestor
64476083|NCT00466960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476084|NCT00383266|Carboplatin|carboplatin|mesh-list
64476085|NCT00383266|Pemetrexed|pemetrexed|mesh-list
64476086|NCT00383266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476087|NCT00383266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476088|NCT00383266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476089|NCT00383266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64476090|NCT00383266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64476091|NCT00384670|Vaccines|vaccines|mesh-list
64476092|NCT00384670|Immunologic Factors|immunologic factors|mesh-ancestor
64476093|NCT00384670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476094|NCT00467350|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64476095|NCT00467350|Laxatives|laxatives|mesh-ancestor
64476096|NCT00467350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64476097|NCT00444028|Loxapine|loxapine|mesh-list
64476098|NCT00444028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64476099|NCT00444028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64476120|NCT00445744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64476121|NCT00445744|Immunologic Factors|immunologic factors|mesh-ancestor
64476122|NCT00445744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476123|NCT00445744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64476124|NCT00445744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64476125|NCT00445744|Alkylating Agents|alkylating agents|mesh-ancestor
64476126|NCT00445744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476127|NCT00445744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476128|NCT00445744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64476129|NCT00445744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64476130|NCT00445744|Abortifacient Agents|abortifacient agents|mesh-ancestor
64476131|NCT00445744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64476132|NCT00445744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65277330|NCT02647086|GABA Modulators|gaba modulators|mesh-ancestor
65277331|NCT02647086|GABA Agents|gaba agents|mesh-ancestor
65277332|NCT02647086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65277333|NCT02647086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277335|NCT02647086|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65277336|NCT02647086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65277337|NCT02647086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277338|NCT02647086|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65277339|NCT02647086|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65277340|NCT02647086|Purinergic Agents|purinergic agents|mesh-ancestor
65277341|NCT02647086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65277342|NCT02647086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65277343|NCT02647086|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65277344|NCT02647086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65277345|NCT02647086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65277346|NCT02647086|Sympatholytics|sympatholytics|mesh-ancestor
65277347|NCT02647086|Autonomic Agents|autonomic agents|mesh-ancestor
65277348|NCT02647086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277349|NCT02647086|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64476133|NCT00445744|Antimetabolites|antimetabolites|mesh-ancestor
64476134|NCT00445744|Dermatologic Agents|dermatologic agents|mesh-ancestor
64476135|NCT00445744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476136|NCT00445744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64476137|NCT00445744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64476138|NCT00445744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64476139|NCT00468208|Abatacept|abatacept|mesh-list
64476140|NCT00468208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64476141|NCT00468208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476142|NCT00468208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476143|NCT00468208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64476144|NCT00468208|Immunologic Factors|immunologic factors|mesh-ancestor
64476145|NCT00468208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476146|NCT00468208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64476147|NCT00385138|Clopidogrel|clopidogrel|mesh-list
64476148|NCT00385138|Cangrelor|cangrelor|mesh-list
64476149|NCT00385138|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64476150|NCT00385138|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64476151|NCT00385138|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64476152|NCT00385138|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64476153|NCT00385138|Purinergic Agents|purinergic agents|mesh-ancestor
64476154|NCT00385138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64476155|NCT00385138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476186|NCT00470392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476188|NCT00470392|Interferon Inducers|interferon inducers|mesh-ancestor
64476189|NCT00470392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64476190|NCT00470392|Glucocorticoids|glucocorticoids|mesh-ancestor
64476192|NCT00470392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64476193|NCT00470548|Paclitaxel|paclitaxel|mesh-list
64476194|NCT00470548|Pemetrexed|pemetrexed|mesh-list
64476195|NCT00470548|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64476196|NCT00470548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64476197|NCT00470548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476198|NCT00470548|Tubulin Modulators|tubulin modulators|mesh-ancestor
64476199|NCT00470548|Antimitotic Agents|antimitotic agents|mesh-ancestor
65277350|NCT02647086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65277351|NCT02647086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65277352|NCT02647086|Adrenergic Agents|adrenergic agents|mesh-ancestor
65277353|NCT00651690|Botulinum Toxins|botulinum toxins|mesh-list
65277354|NCT00651690|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65277355|NCT00651690|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65277356|NCT00651690|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65277357|NCT00651690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64476200|NCT00470548|Mitosis Modulators|mitosis modulators|mesh-ancestor
64476201|NCT00470548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476202|NCT00470548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476203|NCT00470548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64476228|NCT00451048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476229|NCT00451048|Growth Inhibitors|growth inhibitors|mesh-ancestor
64476230|NCT00451048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64476231|NCT00451048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476232|NCT00451048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476233|NCT00388804|Leuprolide|leuprolide|mesh-list
64476234|NCT00388804|Goserelin|goserelin|mesh-list
64476235|NCT00388804|Flutamide|flutamide|mesh-list
64476236|NCT00388804|Bicalutamide|bicalutamide|mesh-list
64476237|NCT00388804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64476238|NCT00388804|Fertility Agents|fertility agents|mesh-ancestor
64476239|NCT00388804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64476240|NCT00388804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476241|NCT00388804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64476242|NCT00388804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476243|NCT00388804|Androgen Antagonists|androgen antagonists|mesh-ancestor
64476244|NCT00388804|Hormone Antagonists|hormone antagonists|mesh-ancestor
64476245|NCT00388804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64476246|NCT00389818|Prednisone|prednisone|mesh-list
64476247|NCT00389818|Cyclophosphamide|cyclophosphamide|mesh-list
64476248|NCT00389818|Rituximab|rituximab|mesh-list
64476250|NCT00389818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64476251|NCT00389818|Vincristine|vincristine|mesh-list
64476252|NCT00389818|Sargramostim|sargramostim|mesh-list
64476285|NCT00452374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64476286|NCT00452374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64476287|NCT00452374|Antimetabolites|antimetabolites|mesh-ancestor
64476288|NCT00452374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476289|NCT00452374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64476290|NCT00452374|Antiviral Agents|antiviral agents|mesh-ancestor
64476291|NCT00452374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64476292|NCT03286114|Pembrolizumab|pembrolizumab|mesh-list
64476293|NCT03286114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64977103|NCT00105144|Caspofungin|caspofungin|mesh-list
64476302|NCT00476242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476303|NCT00476242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64476304|NCT00476242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64476305|NCT00476242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64476306|NCT00476242|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64476307|NCT00476242|Sensory System Agents|sensory system agents|mesh-ancestor
64476308|NCT00476242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64476309|NCT00476788|Insulin|insulin|mesh-list
64476310|NCT00476788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64476311|NCT00476788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64476312|NCT00476788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476313|NCT01795144|Glucagon|glucagon|mesh-list
64476314|NCT01795144|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64476315|NCT01795144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64476316|NCT01795144|Hormones|hormones|mesh-ancestor
64476317|NCT01795144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64476318|NCT01795144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476319|NCT01795144|Incretins|incretins|mesh-ancestor
64476320|NCT01436175|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64476321|NCT01436175|Antidepressive Agents|antidepressive agents|mesh-list
64476322|NCT01436175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65277358|NCT00651690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277359|NCT00651690|Cholinergic Agents|cholinergic agents|mesh-ancestor
65277360|NCT00651690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65277361|NCT00651690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277362|NCT00651690|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65277363|NCT00651690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277364|NCT00651768|Budesonide|budesonide|mesh-list
65277365|NCT00651768|Formoterol Fumarate|formoterol fumarate|mesh-list
65277366|NCT00651768|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65277367|NCT00651768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65277368|NCT00651768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65277369|NCT00651768|Autonomic Agents|autonomic agents|mesh-ancestor
65277370|NCT00651768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277371|NCT00651768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476323|NCT01436175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64476324|NCT01436175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476325|NCT01436175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64476326|NCT01436175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64476327|NCT01436175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64476328|NCT01436175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476329|NCT01436175|Dopamine Agents|dopamine agents|mesh-ancestor
64476330|NCT01436175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64476333|NCT00453388|Cyclophosphamide|cyclophosphamide|mesh-list
64476334|NCT00453388|Fludarabine|fludarabine|mesh-list
64476335|NCT00453388|Fludarabine phosphate|fludarabine phosphate|mesh-list
64476336|NCT00453388|Cyclosporins|cyclosporins|mesh-list
64476337|NCT00453388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64476338|NCT00453388|Immunologic Factors|immunologic factors|mesh-ancestor
64476339|NCT00453388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476340|NCT00453388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64476341|NCT00453388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64476342|NCT00453388|Alkylating Agents|alkylating agents|mesh-ancestor
64476343|NCT00453388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476344|NCT00453388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476345|NCT00453388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64476346|NCT00453388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64476347|NCT00453388|Antimetabolites|antimetabolites|mesh-ancestor
64476348|NCT00453388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476349|NCT00453388|Antifungal Agents|antifungal agents|mesh-ancestor
64476350|NCT00453388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64476351|NCT00453388|Dermatologic Agents|dermatologic agents|mesh-ancestor
64476352|NCT00453388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64476353|NCT00453388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64476354|NCT00453388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64476355|NCT00453388|Antitubercular Agents|antitubercular agents|mesh-ancestor
64476356|NCT00453388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64476358|NCT04062123|Dexmedetomidine|dexmedetomidine|mesh-list
64476359|NCT04062123|Propofol|propofol|mesh-list
64476383|NCT00389974|Growth Substances|growth substances|mesh-ancestor
64476384|NCT00389974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476385|NCT00389974|Growth Inhibitors|growth inhibitors|mesh-ancestor
64476386|NCT00389974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64476387|NCT00389974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476388|NCT00389974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476390|NCT01453725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64476391|NCT01453725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64476392|NCT01453725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65277372|NCT00651768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65277373|NCT00651768|Respiratory System Agents|respiratory system agents|mesh-ancestor
65277374|NCT00651768|Glucocorticoids|glucocorticoids|mesh-ancestor
65277375|NCT00651768|Hormones|hormones|mesh-ancestor
65277376|NCT00651768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65277377|NCT00651768|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65277378|NCT00651768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65277379|NCT00651768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65277380|NCT00651768|Adrenergic Agents|adrenergic agents|mesh-ancestor
65277381|NCT00651768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65277382|NCT00651768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277383|NCT05660525|Nicotine|nicotine|mesh-list
65277384|NCT05660525|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65277385|NCT05660525|Autonomic Agents|autonomic agents|mesh-ancestor
65277386|NCT05660525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277387|NCT05660525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277388|NCT05660525|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65277389|NCT05660525|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65277390|NCT05660525|Cholinergic Agents|cholinergic agents|mesh-ancestor
65277391|NCT05660525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65277392|NCT05660525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277393|NCT00651846|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65277394|NCT00651846|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
65277395|NCT00651846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65277396|NCT00651846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277397|NCT00651846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64476393|NCT01453725|Immunologic Factors|immunologic factors|mesh-ancestor
64476394|NCT01453725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476395|NCT00454324|Paclitaxel|paclitaxel|mesh-list
64476396|NCT00454324|Carboplatin|carboplatin|mesh-list
64476397|NCT00454324|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64476398|NCT00454324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64476399|NCT00454324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476400|NCT00454324|Tubulin Modulators|tubulin modulators|mesh-ancestor
64476401|NCT00454324|Antimitotic Agents|antimitotic agents|mesh-ancestor
64476402|NCT00454324|Mitosis Modulators|mitosis modulators|mesh-ancestor
64476403|NCT00454324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476405|NCT02110264|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64476406|NCT02110264|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64476407|NCT02110264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476408|NCT02110264|Sensory System Agents|sensory system agents|mesh-ancestor
64476436|NCT00528190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476437|NCT00528190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476438|NCT00528190|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65277398|NCT00651846|Contraceptive Agents|contraceptive agents|mesh-ancestor
65277399|NCT00651846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65277400|NCT00651846|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65277401|NCT00651846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65277402|NCT00651846|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65277403|NCT00651846|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65277404|NCT00651846|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
65277405|NCT00651846|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65277406|NCT00651846|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64476439|NCT00528190|Hormone Antagonists|hormone antagonists|mesh-ancestor
64476440|NCT00528190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64476441|NCT00528190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476442|NCT00528190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64476443|NCT02334813|Dexamethasone|dexamethasone|mesh-list
64476444|NCT02334813|Prednisone|prednisone|mesh-list
64476445|NCT02334813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64476446|NCT02334813|Antiemetics|antiemetics|mesh-ancestor
64476447|NCT02334813|Autonomic Agents|autonomic agents|mesh-ancestor
64476448|NCT02334813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64476449|NCT02334813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476450|NCT02334813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64476451|NCT02334813|Glucocorticoids|glucocorticoids|mesh-ancestor
64476452|NCT02334813|Hormones|hormones|mesh-ancestor
64476453|NCT02334813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64476454|NCT02334813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64977288|NCT00261703|Cisplatin|cisplatin|mesh-list
64476475|NCT00478036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64476476|NCT00478036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476477|NCT00478036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476478|NCT00478036|Laxatives|laxatives|mesh-ancestor
64476479|NCT04048863|Imidacloprid|imidacloprid|mesh-list
64476480|NCT04048863|Cholinergic Agents|cholinergic agents|mesh-ancestor
64476481|NCT04048863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64476482|NCT04048863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476483|NCT04048863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476485|NCT04522557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476486|NCT04522557|Antiviral Agents|antiviral agents|mesh-ancestor
64476487|NCT04522557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64476488|NCT01453023|Fluticasone|fluticasone|mesh-list
64476489|NCT01453023|Xhance|xhance|mesh-list
64476490|NCT01453023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64476491|NCT01453023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64476492|NCT01453023|Autonomic Agents|autonomic agents|mesh-ancestor
64476493|NCT01453023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64476494|NCT01453023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476495|NCT01453023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64476496|NCT01453023|Respiratory System Agents|respiratory system agents|mesh-ancestor
64476497|NCT01453023|Dermatologic Agents|dermatologic agents|mesh-ancestor
64476498|NCT01453023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64476499|NCT01452789|Morphine|morphine|mesh-list
64476500|NCT01452789|Buprenorphine|buprenorphine|mesh-list
64476501|NCT01452789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64476502|NCT01452789|Narcotics|narcotics|mesh-ancestor
64476503|NCT01452789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64476504|NCT01452789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476505|NCT01452789|Analgesics|analgesics|mesh-ancestor
64476506|NCT01452789|Sensory System Agents|sensory system agents|mesh-ancestor
64476507|NCT01452789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64476508|NCT01452789|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64476509|NCT00478192|Conivaptan|conivaptan|mesh-list
64476529|NCT01414257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64476530|NCT00528268|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64476531|NCT00528268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476533|NCT00528580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64476534|NCT00528580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65277407|NCT04167306|Bupropion|bupropion|mesh-list
65277408|NCT04167306|Varenicline|varenicline|mesh-list
65277409|NCT04167306|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65277410|NCT04167306|Antidepressive Agents|antidepressive agents|mesh-ancestor
65277411|NCT04167306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65277412|NCT04167306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65277413|NCT04167306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65277414|NCT04167306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65277415|NCT04167306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277416|NCT04167306|Dopamine Agents|dopamine agents|mesh-ancestor
65277417|NCT04167306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65277418|NCT04167306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277419|NCT04167306|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65277420|NCT04167306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65277421|NCT04167306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277422|NCT04167306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65277423|NCT04167306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65277424|NCT04167306|Cholinergic Agents|cholinergic agents|mesh-ancestor
65277425|NCT04244591|Methylprednisolone|methylprednisolone|mesh-list
65277426|NCT04244591|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65277427|NCT04244591|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64729905|NCT00004772|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64729906|NCT00004772|Immunologic Factors|immunologic factors|mesh-ancestor
64476535|NCT00528580|Antimetabolites|antimetabolites|mesh-ancestor
64476536|NCT00528580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476537|NCT00528580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64476538|NCT00528580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64476539|NCT00528580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476540|NCT00529126|Epinephrine|epinephrine|mesh-list
64476541|NCT00529126|Bupivacaine|bupivacaine|mesh-list
64476542|NCT00529126|Anesthetics, Local|anesthetics, local|mesh-ancestor
64476543|NCT00529126|Anesthetics|anesthetics|mesh-ancestor
64476544|NCT00529126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64476545|NCT00529126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476546|NCT00529126|Sensory System Agents|sensory system agents|mesh-ancestor
64476547|NCT00529126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64476548|NCT00529126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64462083|NCT04591210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64476550|NCT00529126|Adrenergic Agents|adrenergic agents|mesh-ancestor
64476551|NCT00529126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64476552|NCT00529126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476553|NCT00529126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64476554|NCT00529126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64476556|NCT00529126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64476557|NCT00529126|Respiratory System Agents|respiratory system agents|mesh-ancestor
64476558|NCT00529126|Mydriatics|mydriatics|mesh-ancestor
64476559|NCT00529126|Sympathomimetics|sympathomimetics|mesh-ancestor
64476584|NCT00530764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64476585|NCT00530764|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65277428|NCT04244591|Prednisolone|prednisolone|mesh-list
65277429|NCT04244591|Prednisolone acetate|prednisolone acetate|mesh-list
65277430|NCT04244591|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65277431|NCT04244591|Prednisolone phosphate|prednisolone phosphate|mesh-list
65277432|NCT04244591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65277433|NCT04244591|Antiemetics|antiemetics|mesh-ancestor
65277434|NCT04244591|Autonomic Agents|autonomic agents|mesh-ancestor
65277435|NCT04244591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277436|NCT04244591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277437|NCT04244591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65277438|NCT04244591|Glucocorticoids|glucocorticoids|mesh-ancestor
65277439|NCT04244591|Hormones|hormones|mesh-ancestor
65277440|NCT04244591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65277441|NCT04244591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65277442|NCT04244591|Protective Agents|protective agents|mesh-ancestor
64729927|NCT00004778|Autonomic Agents|autonomic agents|mesh-ancestor
64476586|NCT00530764|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64476587|NCT00530764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64476588|NCT00530764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476589|NCT00530764|Hormones|hormones|mesh-ancestor
64476590|NCT00530764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64476591|NCT00532480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64476592|NCT00532480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64476593|NCT00532480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64476594|NCT00532480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64476595|NCT00532480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476596|NCT00532480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64476597|NCT00532480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476598|NCT00532480|Analgesics|analgesics|mesh-ancestor
64476599|NCT00532480|Sensory System Agents|sensory system agents|mesh-ancestor
64476600|NCT00532480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64476601|NCT00532480|Antidepressive Agents|antidepressive agents|mesh-ancestor
64476602|NCT00532480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64476603|NCT00532480|Dopamine Agents|dopamine agents|mesh-ancestor
64476604|NCT00483262|Bortezomib|bortezomib|mesh-list
64476605|NCT00483262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476606|NCT00483496|Titanium dioxide|titanium dioxide|mesh-list
64476607|NCT00483496|Sunscreening Agents|sunscreening agents|mesh-ancestor
64476608|NCT00483496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64476609|NCT00483496|Protective Agents|protective agents|mesh-ancestor
64977431|NCT02966288|Ibuprofen|ibuprofen|mesh-list
64476634|NCT04149574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476636|NCT01450761|Etoposide|etoposide|mesh-list
64476637|NCT01450761|Ipilimumab|ipilimumab|mesh-list
64476638|NCT01450761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476639|NCT01450761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64476640|NCT01450761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64476641|NCT01450761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64476642|NCT01450761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476643|NCT01450761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476644|NCT01450761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64476645|NCT01450761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64476646|NCT00491374|Mometasone Furoate|mometasone furoate|mesh-list
64476647|NCT00491374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64476648|NCT00491374|Dermatologic Agents|dermatologic agents|mesh-ancestor
64476649|NCT00491374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64476650|NCT00538642|Ziprasidone|ziprasidone|mesh-list
64476651|NCT00538642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64476652|NCT00538642|Serotonin Agents|serotonin agents|mesh-ancestor
65277443|NCT04244591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65277444|NCT04244591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65277445|NCT02649582|Temozolomide|temozolomide|mesh-list
65277446|NCT02649582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65277447|NCT02649582|Alkylating Agents|alkylating agents|mesh-ancestor
65277448|NCT02649582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277449|NCT02649582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65277450|NCT04167696|Cyclophosphamide|cyclophosphamide|mesh-list
65277451|NCT04167696|Fludarabine|fludarabine|mesh-list
65277452|NCT04167696|Fludarabine phosphate|fludarabine phosphate|mesh-list
65277453|NCT04167696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65277454|NCT04167696|Immunologic Factors|immunologic factors|mesh-ancestor
65277455|NCT04167696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277456|NCT04167696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65277457|NCT04167696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65277458|NCT04167696|Alkylating Agents|alkylating agents|mesh-ancestor
65277459|NCT04167696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729944|NCT00004784|Antimetabolites|antimetabolites|mesh-ancestor
64476653|NCT00538642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64476654|NCT00538642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476655|NCT00538642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476656|NCT00538642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64476674|NCT01450683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64476675|NCT01450683|Hormone Antagonists|hormone antagonists|mesh-ancestor
64476676|NCT01450683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64476677|NCT01450683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476678|NCT01450683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64476679|NCT01433055|Minocycline|minocycline|mesh-list
64476680|NCT01433055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64476681|NCT01433055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64476682|NCT01450137|Glucocorticoids|glucocorticoids|mesh-list
64476683|NCT01450137|Hormones|hormones|mesh-ancestor
64476684|NCT01450137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64476685|NCT01450137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476686|NCT04075149|Spironolactone|spironolactone|mesh-list
64476687|NCT04075149|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64476688|NCT04075149|Hormone Antagonists|hormone antagonists|mesh-ancestor
64476689|NCT04075149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64476690|NCT04075149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476691|NCT04075149|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64476692|NCT04075149|Diuretics|diuretics|mesh-ancestor
64476693|NCT04075149|Natriuretic Agents|natriuretic agents|mesh-ancestor
64476694|NCT01412229|Paclitaxel|paclitaxel|mesh-list
64476695|NCT01412229|Carboplatin|carboplatin|mesh-list
64476696|NCT01412229|Cetuximab|cetuximab|mesh-list
64476697|NCT01412229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64476698|NCT01412229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476699|NCT01412229|Tubulin Modulators|tubulin modulators|mesh-ancestor
64476700|NCT01412229|Antimitotic Agents|antimitotic agents|mesh-ancestor
64476701|NCT01412229|Mitosis Modulators|mitosis modulators|mesh-ancestor
64476702|NCT01412229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476703|NCT01412229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64476704|NCT01432275|Insulin|insulin|mesh-list
64476705|NCT01432275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65277460|NCT04167696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65277461|NCT04167696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65277462|NCT04167696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65277463|NCT04167696|Antimetabolites|antimetabolites|mesh-ancestor
65277464|NCT02827487|Celecoxib|celecoxib|mesh-list
65277465|NCT02827487|Tramadol|tramadol|mesh-list
65277466|NCT02827487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65277467|NCT02827487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65277468|NCT02827487|Analgesics|analgesics|mesh-ancestor
65277469|NCT02827487|Sensory System Agents|sensory system agents|mesh-ancestor
65277470|NCT02827487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277471|NCT02827487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277472|NCT02827487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65277473|NCT02827487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65277474|NCT02827487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65277475|NCT02827487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65277476|NCT02827487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027484|NCT00185250|Interferons|interferons|mesh-list
65277477|NCT02827487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729959|NCT00004802|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64729960|NCT00004802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476706|NCT01432275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476707|NCT01411995|Lidocaine|lidocaine|mesh-list
64476708|NCT01411995|Anesthetics, Local|anesthetics, local|mesh-ancestor
64476709|NCT01411995|Anesthetics|anesthetics|mesh-ancestor
64476710|NCT01411995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64476711|NCT01411995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476712|NCT01411995|Sensory System Agents|sensory system agents|mesh-ancestor
64476727|NCT01411215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64476728|NCT01411215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64476729|NCT01411215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64476730|NCT01411215|Immunologic Factors|immunologic factors|mesh-ancestor
64476731|NCT01449279|Ipilimumab|ipilimumab|mesh-list
64476732|NCT01449279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64476733|NCT01449279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476734|NCT01449279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64476735|NCT01449279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476736|NCT01431963|Lamotrigine|lamotrigine|mesh-list
64476737|NCT01431963|Anticonvulsants|anticonvulsants|mesh-ancestor
64476738|NCT01431963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64476739|NCT01431963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64476740|NCT01431963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476741|NCT01431963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64476742|NCT01431963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476743|NCT01431963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64476744|NCT01431963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64476745|NCT01431963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64476746|NCT01431963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64476747|NCT01431963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64476748|NCT01447407|Vaccines|vaccines|mesh-list
64476749|NCT01447407|Aluminum sulfate|aluminum sulfate|mesh-list
64476750|NCT01447407|Immunologic Factors|immunologic factors|mesh-ancestor
64476751|NCT01447407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277478|NCT02827487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65277479|NCT02827487|Narcotics|narcotics|mesh-ancestor
65277480|NCT02827487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65277481|NCT04098666|Metformin|metformin|mesh-list
65277482|NCT04098666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65277483|NCT04098666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277484|NCT02649504|Mycophenolic Acid|mycophenolic acid|mesh-list
65277485|NCT02649504|Dexamethasone|dexamethasone|mesh-list
65277486|NCT02649504|Rituximab|rituximab|mesh-list
65277487|NCT02649504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65277488|NCT02649504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65277489|NCT02649504|Immunologic Factors|immunologic factors|mesh-ancestor
65277490|NCT02649504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277491|NCT02649504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65277492|NCT02649504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64476752|NCT01447407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64476753|NCT01446237|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64476754|NCT01446237|Dermatologic Agents|dermatologic agents|mesh-ancestor
64476755|NCT00540982|Vinorelbine|vinorelbine|mesh-list
64476756|NCT00540982|Lidocaine|lidocaine|mesh-list
64476757|NCT00540982|Anesthetics, Local|anesthetics, local|mesh-ancestor
64476758|NCT00540982|Anesthetics|anesthetics|mesh-ancestor
64476759|NCT00540982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64476760|NCT00540982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476761|NCT00540982|Sensory System Agents|sensory system agents|mesh-ancestor
64476762|NCT00540982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64476763|NCT00540982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64476764|NCT00540982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64476765|NCT00540982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64476766|NCT00540982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64476767|NCT00540982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476768|NCT00540982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64476770|NCT00540982|Tubulin Modulators|tubulin modulators|mesh-ancestor
64476798|NCT00492544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476800|NCT00492622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64476801|NCT00492622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64476802|NCT00492622|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64476803|NCT00492622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476804|NCT00492622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471372|NCT04551495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476805|NCT00494494|Nepafenac|nepafenac|mesh-list
64476806|NCT00494494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64476807|NCT00494494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64476808|NCT00494494|Analgesics|analgesics|mesh-ancestor
64476809|NCT00494494|Sensory System Agents|sensory system agents|mesh-ancestor
64476810|NCT00494494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64476811|NCT00494494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476812|NCT00494494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64476813|NCT00494494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64476814|NCT03145558|Doxorubicin|doxorubicin|mesh-list
64476815|NCT03145558|Tirapazamine|tirapazamine|mesh-list
64476816|NCT03145558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64476817|NCT03145558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476818|NCT03145558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64977643|NCT04709029|Hormones|hormones|mesh-ancestor
64476831|NCT00498550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64476832|NCT00498550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476833|NCT00498550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476835|NCT00498550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64476836|NCT00498550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65277493|NCT02649504|Antiemetics|antiemetics|mesh-ancestor
65277494|NCT02649504|Autonomic Agents|autonomic agents|mesh-ancestor
65277495|NCT02649504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277496|NCT02649504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65277497|NCT02649504|Glucocorticoids|glucocorticoids|mesh-ancestor
65277498|NCT02649504|Hormones|hormones|mesh-ancestor
65277499|NCT02649504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65277500|NCT02649504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65277501|NCT02649504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65277502|NCT02649504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65277503|NCT02649504|Antitubercular Agents|antitubercular agents|mesh-ancestor
65277504|NCT02649504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65277505|NCT02649504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65277506|NCT02649504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277507|NCT02649504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277508|NCT03703856|Memantine|memantine|mesh-list
65277509|NCT03703856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65277510|NCT03703856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65277511|NCT03703856|Dopamine Agents|dopamine agents|mesh-ancestor
65277512|NCT03703856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65277513|NCT03703856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277514|NCT03703856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277515|NCT03703856|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65277516|NCT03703856|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65277517|NCT00650910|Lapatinib|lapatinib|mesh-list
65277518|NCT00650910|Digoxin|digoxin|mesh-list
65277519|NCT00650910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65277520|NCT00650910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64476837|NCT00498550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64476838|NCT00498550|GABA Antagonists|gaba antagonists|mesh-ancestor
64476839|NCT00498550|GABA Agents|gaba agents|mesh-ancestor
64476840|NCT00498628|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64476841|NCT00498628|Antidepressive Agents|antidepressive agents|mesh-ancestor
64476842|NCT00498628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64476843|NCT00498628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64476844|NCT00498628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64476845|NCT00498628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64476846|NCT00498628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476847|NCT01446159|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64476848|NCT01446159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64476849|NCT01446159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476850|NCT01446159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476851|NCT01446159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64476852|NCT01446159|Hormone Antagonists|hormone antagonists|mesh-ancestor
64476853|NCT01446159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65277521|NCT00650910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277522|NCT00650910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277523|NCT00650910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65277524|NCT00650910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65277525|NCT00650910|Protective Agents|protective agents|mesh-ancestor
64730021|NCT00005612|Tubulin Modulators|tubulin modulators|mesh-ancestor
64476854|NCT01446159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476856|NCT00499408|Cholecalciferol|cholecalciferol|mesh-list
64476857|NCT00499408|Vitamins|vitamins|mesh-ancestor
64476858|NCT00499408|Micronutrients|micronutrients|mesh-ancestor
64476859|NCT00499408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476860|NCT00499408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64476861|NCT00499408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64476862|NCT03019666|Niacinamide|niacinamide|mesh-list
64476863|NCT03019666|Niacin|niacin|mesh-list
64476864|NCT03019666|Nicotinic Acids|nicotinic acids|mesh-list
64476865|NCT03019666|Vitamin B Complex|vitamin b complex|mesh-ancestor
64476866|NCT03019666|Vitamins|vitamins|mesh-ancestor
64476867|NCT03019666|Micronutrients|micronutrients|mesh-ancestor
64476868|NCT03019666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476869|NCT03019666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64476870|NCT03019666|Antimetabolites|antimetabolites|mesh-ancestor
64476871|NCT03019666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476872|NCT03019666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64476873|NCT03019666|Vasodilator Agents|vasodilator agents|mesh-ancestor
64476874|NCT03495388|Oxycodone|oxycodone|mesh-list
64476875|NCT03495388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64476876|NCT03495388|Narcotics|narcotics|mesh-ancestor
64476877|NCT03495388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64476878|NCT03495388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476879|NCT03495388|Analgesics|analgesics|mesh-ancestor
64471373|NCT04551495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471374|NCT04551495|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64476880|NCT03495388|Sensory System Agents|sensory system agents|mesh-ancestor
64476931|NCT01445847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64476933|NCT01445847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64476934|NCT01445847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476936|NCT00502216|Varenicline|varenicline|mesh-list
64476937|NCT00502216|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64476938|NCT00502216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64476939|NCT00502216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476940|NCT00502216|Sensory System Agents|sensory system agents|mesh-ancestor
64476941|NCT00502216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64476942|NCT00502216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64476943|NCT00502216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64476944|NCT00502216|Cholinergic Agents|cholinergic agents|mesh-ancestor
64476945|NCT00502216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64476946|NCT00502216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476947|NCT00545662|Choline|choline|mesh-list
64476948|NCT00545662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64476949|NCT00545662|Lipotropic Agents|lipotropic agents|mesh-ancestor
64476950|NCT00545662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64476951|NCT00545662|Antimetabolites|antimetabolites|mesh-ancestor
64476952|NCT00545662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476953|NCT00545662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64476954|NCT00545662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64476955|NCT00545662|Nootropic Agents|nootropic agents|mesh-ancestor
64476956|NCT00545974|Memantine|memantine|mesh-list
64476957|NCT00545974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64476958|NCT00545974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64476959|NCT00545974|Dopamine Agents|dopamine agents|mesh-ancestor
64476960|NCT00545974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64476961|NCT00545974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476962|NCT00545974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476963|NCT00545974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64476964|NCT00545974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64476965|NCT00548470|Varenicline|varenicline|mesh-list
64476966|NCT00548470|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64476967|NCT00548470|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64730027|NCT00005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730028|NCT00005612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64730030|NCT00005612|Alkylating Agents|alkylating agents|mesh-ancestor
65277526|NCT00650910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277527|NCT02654730|Piperaquine|piperaquine|mesh-list
65277528|NCT02654730|Primaquine|primaquine|mesh-list
65277529|NCT02654730|Artenimol|artenimol|mesh-list
65277530|NCT02654730|Artemisinins|artemisinins|mesh-list
65277531|NCT02654730|Antimalarials|antimalarials|mesh-ancestor
65277532|NCT02654730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65277533|NCT02654730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65277534|NCT02654730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65277535|NCT00888329|Aprepitant|aprepitant|mesh-list
65277536|NCT00888329|Antiemetics|antiemetics|mesh-ancestor
65277537|NCT00888329|Autonomic Agents|autonomic agents|mesh-ancestor
65277538|NCT00888329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277539|NCT00888329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277540|NCT00888329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65277541|NCT00888329|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65277542|NCT00888329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65277543|NCT00888329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277544|NCT00652002|Budesonide|budesonide|mesh-list
65277545|NCT00652002|Formoterol Fumarate|formoterol fumarate|mesh-list
64476968|NCT00548470|Cholinergic Agents|cholinergic agents|mesh-ancestor
64476969|NCT00548470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64476970|NCT00548470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476971|NCT00548470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476972|NCT02675452|Itraconazole|itraconazole|mesh-list
64476973|NCT02675452|Azacitidine|azacitidine|mesh-list
64476974|NCT02675452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64476975|NCT02675452|Antimetabolites|antimetabolites|mesh-ancestor
64977779|NCT00265876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64476987|NCT02675452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64476988|NCT00509002|Gefitinib|gefitinib|mesh-list
64476989|NCT00509002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476990|NCT00509002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64476991|NCT00509002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476992|NCT00509002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476993|NCT00887380|Anastrozole|anastrozole|mesh-list
64476994|NCT00887380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64476995|NCT00887380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476997|NCT00887380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64476998|NCT00887380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476999|NCT00887380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477000|NCT00887380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64477001|NCT00887380|Hormone Antagonists|hormone antagonists|mesh-ancestor
64477002|NCT00887380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64477003|NCT00887380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477005|NCT00551200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477006|NCT00557284|Montelukast|montelukast|mesh-list
64477007|NCT00557284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64477008|NCT00557284|Respiratory System Agents|respiratory system agents|mesh-ancestor
64477009|NCT00557284|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65277546|NCT00652002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65277547|NCT00652002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65277548|NCT00652002|Autonomic Agents|autonomic agents|mesh-ancestor
65277549|NCT00652002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277550|NCT00652002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277551|NCT00652002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65277552|NCT00652002|Respiratory System Agents|respiratory system agents|mesh-ancestor
65277553|NCT00652002|Glucocorticoids|glucocorticoids|mesh-ancestor
65277554|NCT00652002|Hormones|hormones|mesh-ancestor
65277555|NCT00652002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65277556|NCT00652002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65277557|NCT00652002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65277558|NCT00652002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65277559|NCT00652002|Adrenergic Agents|adrenergic agents|mesh-ancestor
65277560|NCT00652002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65277561|NCT00652002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277563|NCT02646540|Furosemide|furosemide|mesh-list
65277564|NCT02646540|Tolvaptan|tolvaptan|mesh-list
65277565|NCT02646540|Diuretics|diuretics|mesh-list
65277566|NCT02646540|Natriuretic Agents|natriuretic agents|mesh-ancestor
64477010|NCT00557284|Hormone Antagonists|hormone antagonists|mesh-ancestor
64477011|NCT00557284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64477012|NCT00557284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477013|NCT00557284|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64477014|NCT00557284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64477015|NCT00557284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477016|NCT00557362|Voriconazole|voriconazole|mesh-list
64477017|NCT00557362|Natamycin|natamycin|mesh-list
64477018|NCT00557362|Antifungal Agents|antifungal agents|mesh-ancestor
64477019|NCT00557362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64477020|NCT00557362|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64477021|NCT00557362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64477022|NCT00557362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477023|NCT00557362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477024|NCT00557362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64477025|NCT00557362|Hormone Antagonists|hormone antagonists|mesh-ancestor
64477026|NCT00557362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64477027|NCT00557362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477028|NCT00557362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64477029|NCT00557362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64477030|NCT00557362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64477032|NCT00512278|Dermatologic Agents|dermatologic agents|mesh-ancestor
64477033|NCT00512278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64477034|NCT00512278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64477035|NCT01445535|Prednisone|prednisone|mesh-list
64477036|NCT01445535|Cyclophosphamide|cyclophosphamide|mesh-list
64477052|NCT01445535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64477053|NCT01445535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64477054|NCT01445535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477055|NCT01445535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64477056|NCT01445535|Glucocorticoids|glucocorticoids|mesh-ancestor
64477057|NCT01445535|Hormones|hormones|mesh-ancestor
65277567|NCT02646540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277568|NCT02646540|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65277569|NCT02646540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65277570|NCT02646540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277571|NCT02646540|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65277572|NCT02646540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65277573|NCT02646540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65277574|NCT00651066|Ritonavir|ritonavir|mesh-list
65277575|NCT00651066|Lopinavir|lopinavir|mesh-list
65277576|NCT00651066|Rifabutin|rifabutin|mesh-list
65277577|NCT00651066|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65277578|NCT00651066|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65277579|NCT00651066|Protease Inhibitors|protease inhibitors|mesh-ancestor
65277580|NCT00651066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277581|NCT00651066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277582|NCT00651066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65277583|NCT00651066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65277584|NCT00651066|Antiviral Agents|antiviral agents|mesh-ancestor
65277585|NCT00651066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64730064|NCT00385502|Hormone Antagonists|hormone antagonists|mesh-ancestor
64477058|NCT01445535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64477059|NCT01445535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64477060|NCT01445535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64477061|NCT01445535|Tubulin Modulators|tubulin modulators|mesh-ancestor
64477062|NCT01445535|Antimitotic Agents|antimitotic agents|mesh-ancestor
64477063|NCT01445535|Mitosis Modulators|mitosis modulators|mesh-ancestor
64477064|NCT01409031|Sildenafil Citrate|sildenafil citrate|mesh-list
64477065|NCT01409031|Vasodilator Agents|vasodilator agents|mesh-ancestor
64477066|NCT01409031|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64477067|NCT01409031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64477068|NCT01409031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477069|NCT01409031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477070|NCT01409031|Urological Agents|urological agents|mesh-ancestor
64477071|NCT01430403|Fluticasone|fluticasone|mesh-list
64477072|NCT01430403|Xhance|xhance|mesh-list
64477073|NCT01430403|Omalizumab|omalizumab|mesh-list
64477074|NCT01430403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64477075|NCT01430403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64477076|NCT01430403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64477077|NCT01430403|Autonomic Agents|autonomic agents|mesh-ancestor
64477078|NCT01430403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64477079|NCT01430403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477080|NCT01430403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64477081|NCT01430403|Respiratory System Agents|respiratory system agents|mesh-ancestor
64477082|NCT01430403|Dermatologic Agents|dermatologic agents|mesh-ancestor
64477083|NCT01430403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64477084|NCT01430403|Immunologic Factors|immunologic factors|mesh-ancestor
64477085|NCT01408641|Topiramate|topiramate|mesh-list
64477086|NCT01408641|Anticonvulsants|anticonvulsants|mesh-ancestor
64477087|NCT01408641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64477088|NCT01408641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477089|NCT01429077|Levodopa|levodopa|mesh-list
64477090|NCT01429077|Carbidopa|carbidopa|mesh-list
64477091|NCT01429077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65277586|NCT00651066|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65277587|NCT00651066|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65277588|NCT00651066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65277589|NCT00651066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65277590|NCT00651066|Antitubercular Agents|antitubercular agents|mesh-ancestor
65277591|NCT02646072|Ketorolac|ketorolac|mesh-list
65277592|NCT02646072|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65277593|NCT02646072|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65277651|NCT04167228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277652|NCT04167228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277653|NCT02687438|Mometasone Furoate|mometasone furoate|mesh-list
65277654|NCT02687438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65277655|NCT02687438|Dermatologic Agents|dermatologic agents|mesh-ancestor
65277656|NCT02687438|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65277657|NCT02537834|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
65277658|NCT02537834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65277659|NCT02537834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277660|NCT02537834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65277661|NCT02537834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277662|NCT02648958|Dexmedetomidine|dexmedetomidine|mesh-list
65277663|NCT02648958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65277664|NCT02648958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65277665|NCT02648958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277666|NCT02648958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64477092|NCT01429077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64477093|NCT01429077|Dopamine Agents|dopamine agents|mesh-ancestor
64477094|NCT01429077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64477095|NCT01429077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477096|NCT01429077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477097|NCT01429077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64477125|NCT04407975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64477126|NCT04407975|Respiratory System Agents|respiratory system agents|mesh-ancestor
64477127|NCT01428063|Interferons|interferons|mesh-list
64477129|NCT01428063|Interferon-alpha|interferon-alpha|mesh-list
64477130|NCT01428063|Interferon alpha-2|interferon alpha-2|mesh-list
64477131|NCT01428063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64477132|NCT01428063|Asunaprevir|asunaprevir|mesh-list
64477133|NCT01428063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477134|NCT01428063|Antiviral Agents|antiviral agents|mesh-ancestor
64477135|NCT01428063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64477136|NCT01428063|Antimetabolites|antimetabolites|mesh-ancestor
64477137|NCT01428063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477138|NCT01428063|Immunologic Factors|immunologic factors|mesh-ancestor
64477139|NCT01428063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477140|NCT01428063|Protease Inhibitors|protease inhibitors|mesh-ancestor
64477141|NCT01428063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477142|NCT00513292|Paclitaxel|paclitaxel|mesh-list
64477143|NCT00513292|Cyclophosphamide|cyclophosphamide|mesh-list
64477144|NCT00513292|Trastuzumab|trastuzumab|mesh-list
64977968|NCT00267709|Visilizumab|visilizumab|mesh-list
64477219|NCT00563290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477220|NCT00563290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64477221|NCT00563290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978043|NCT00268216|Dermatologic Agents|dermatologic agents|mesh-ancestor
64477242|NCT00520468|Cyclosporine|cyclosporine|mesh-list
64477244|NCT00520468|Epoetin Alfa|epoetin alfa|mesh-list
64477245|NCT00520468|Darbepoetin alfa|darbepoetin alfa|mesh-list
64477246|NCT00520468|Cyclosporins|cyclosporins|mesh-list
64477247|NCT00520468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64477248|NCT00520468|Glucocorticoids|glucocorticoids|mesh-ancestor
64477249|NCT00520468|Hormones|hormones|mesh-ancestor
64477250|NCT00520468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65277667|NCT02648958|Analgesics|analgesics|mesh-ancestor
65277668|NCT02648958|Sensory System Agents|sensory system agents|mesh-ancestor
65277669|NCT02648958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277670|NCT02648958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65277671|NCT02648958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65277672|NCT02648958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65277673|NCT02648958|Adrenergic Agents|adrenergic agents|mesh-ancestor
65277674|NCT02648958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65277675|NCT02648958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277676|NCT00887549|Pemetrexed|pemetrexed|mesh-list
65277677|NCT00887549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65277678|NCT00887549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277679|NCT00887549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277680|NCT00887549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65277681|NCT00887549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65277682|NCT04243811|Anesthetics|anesthetics|mesh-list
65277683|NCT04243811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65277684|NCT04243811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277685|NCT00638300|Dialysis Solutions|dialysis solutions|mesh-list
65277686|NCT00638300|Calcium|calcium|mesh-list
64730174|NCT00005762|Ritonavir|ritonavir|mesh-list
64477251|NCT00520468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477252|NCT00520468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64477253|NCT00520468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477254|NCT00520468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477255|NCT00520468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477256|NCT00520468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64477257|NCT00520468|Immunologic Factors|immunologic factors|mesh-ancestor
64477258|NCT00520468|Antifungal Agents|antifungal agents|mesh-ancestor
64477259|NCT00520468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64477260|NCT00520468|Dermatologic Agents|dermatologic agents|mesh-ancestor
64477261|NCT00520468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64477262|NCT00520468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64477264|NCT05560516|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64477265|NCT05560516|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64477266|NCT05560516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64477267|NCT05560516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64477268|NCT05560516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477269|NCT05560516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64477270|NCT05560516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477271|NCT05560516|Analgesics|analgesics|mesh-ancestor
64477272|NCT05560516|Sensory System Agents|sensory system agents|mesh-ancestor
64477273|NCT05560516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64477274|NCT05560516|Antidepressive Agents|antidepressive agents|mesh-ancestor
64477297|NCT01441635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64477298|NCT01441635|Progesterone|progesterone|mesh-list
64477299|NCT01441635|Estrogens|estrogens|mesh-ancestor
64477300|NCT01441635|Hormones|hormones|mesh-ancestor
64477301|NCT01441635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64477302|NCT01441635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477303|NCT01441635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65277687|NCT00638300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65277688|NCT00638300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277689|NCT00638300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65277690|NCT00887315|Cisplatin|cisplatin|mesh-list
64477304|NCT01441635|Contraceptive Agents|contraceptive agents|mesh-ancestor
64477305|NCT01441635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64477306|NCT01441635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64477308|NCT01441635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64477309|NCT01441635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64477310|NCT01441635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64477311|NCT01427907|Calcium|calcium|mesh-list
64477312|NCT01427907|Sevelamer|sevelamer|mesh-list
64477313|NCT01427907|Calcium acetate|calcium acetate|mesh-list
64477314|NCT01427907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64477315|NCT01427907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477316|NCT01427907|Chelating Agents|chelating agents|mesh-ancestor
64477317|NCT01427907|Sequestering Agents|sequestering agents|mesh-ancestor
64477318|NCT01427907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477319|NCT02985333|Dexamethasone|dexamethasone|mesh-list
64477320|NCT02985333|Paclitaxel|paclitaxel|mesh-list
64477321|NCT02985333|Cyclophosphamide|cyclophosphamide|mesh-list
64477322|NCT02985333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64477323|NCT02985333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477324|NCT02985333|Tubulin Modulators|tubulin modulators|mesh-ancestor
64477325|NCT02985333|Antimitotic Agents|antimitotic agents|mesh-ancestor
64477326|NCT02985333|Mitosis Modulators|mitosis modulators|mesh-ancestor
64477327|NCT02985333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477328|NCT02985333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64978140|NCT00268372|Antimetabolites|antimetabolites|mesh-ancestor
64477349|NCT01427751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64477350|NCT01427751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477351|NCT01427751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64477352|NCT01427751|Glucocorticoids|glucocorticoids|mesh-ancestor
64477353|NCT01427751|Hormones|hormones|mesh-ancestor
64477354|NCT01427751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64477355|NCT01427751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64477356|NCT01427751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477357|NCT01427751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64477358|NCT01427751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64477359|NCT01427751|Growth Substances|growth substances|mesh-ancestor
64477360|NCT01427751|Growth Inhibitors|growth inhibitors|mesh-ancestor
64477361|NCT01920061|Docetaxel|docetaxel|mesh-list
64477362|NCT01920061|Gedatolisib|gedatolisib|mesh-list
64477363|NCT01920061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477364|NCT01920061|Tubulin Modulators|tubulin modulators|mesh-ancestor
64477365|NCT01920061|Antimitotic Agents|antimitotic agents|mesh-ancestor
64477366|NCT01920061|Mitosis Modulators|mitosis modulators|mesh-ancestor
64477367|NCT01920061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477368|NCT01920061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64477369|NCT01920061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477370|NCT01426347|Vitamin D|vitamin d|mesh-list
64477371|NCT01426347|Ergocalciferols|ergocalciferols|mesh-list
64477373|NCT01426347|Micronutrients|micronutrients|mesh-ancestor
64477374|NCT01426347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477375|NCT01426347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64477376|NCT01426347|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64477378|NCT04415983|Clarithromycin|clarithromycin|mesh-list
64477379|NCT04415983|Nitazoxanide|nitazoxanide|mesh-list
64477380|NCT04415983|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64477382|NCT04415983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64477383|NCT04415983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64477384|NCT04415983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64477385|NCT04415983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64477386|NCT04415983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477387|NCT04415983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477406|NCT01426113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477408|NCT01426113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64477409|NCT01393899|Tofacitinib|tofacitinib|mesh-list
64477410|NCT01393899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64477411|NCT01393899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277691|NCT00887315|Docetaxel|docetaxel|mesh-list
65277692|NCT00887315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65277693|NCT00887315|Tubulin Modulators|tubulin modulators|mesh-ancestor
65277694|NCT00887315|Antimitotic Agents|antimitotic agents|mesh-ancestor
65277695|NCT00887315|Mitosis Modulators|mitosis modulators|mesh-ancestor
65277696|NCT00887315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277697|NCT02645994|Anesthetics|anesthetics|mesh-list
65277698|NCT02645994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65277699|NCT02645994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277700|NCT03014648|Atezolizumab|atezolizumab|mesh-list
65277701|NCT03014648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65277702|NCT02645058|Analgesics|analgesics|mesh-list
65277703|NCT02645058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277704|NCT02645058|Sensory System Agents|sensory system agents|mesh-ancestor
65277705|NCT02645058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64477412|NCT01393899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477413|NCT02078193|Abatacept|abatacept|mesh-list
64477414|NCT02078193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64477415|NCT02078193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477416|NCT02078193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477417|NCT02078193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64477418|NCT02078193|Immunologic Factors|immunologic factors|mesh-ancestor
64477419|NCT02078193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477420|NCT02078193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64477421|NCT01405911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64477422|NCT01405911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64477423|NCT01405911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477424|NCT01405911|Incretins|incretins|mesh-ancestor
64477425|NCT01405911|Hormones|hormones|mesh-ancestor
64477426|NCT01405911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64477427|NCT01405911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64477428|NCT01405911|Protease Inhibitors|protease inhibitors|mesh-ancestor
64477429|NCT01405911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477430|NCT01405911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477431|NCT01425801|Albuterol|albuterol|mesh-list
64477432|NCT01425801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64477433|NCT01425801|Autonomic Agents|autonomic agents|mesh-ancestor
64477434|NCT01425801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64477435|NCT01425801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477436|NCT01425801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64477437|NCT01425801|Respiratory System Agents|respiratory system agents|mesh-ancestor
64477438|NCT01425801|Tocolytic Agents|tocolytic agents|mesh-ancestor
64477439|NCT01425801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64477440|NCT01425801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64477441|NCT01425801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64477442|NCT01425801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64477455|NCT01392963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64477457|NCT01392963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64477458|NCT01392963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64477459|NCT01392963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477460|NCT01392963|Cholinergic Agents|cholinergic agents|mesh-ancestor
64477461|NCT01392963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64477462|NCT01392963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477463|NCT01392963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64477464|NCT01392963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64477465|NCT01392573|Insulin|insulin|mesh-list
64477466|NCT01392573|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64477467|NCT01392573|Liraglutide|liraglutide|mesh-list
65277706|NCT02644980|Anesthetics|anesthetics|mesh-list
65277707|NCT02644980|Propofol|propofol|mesh-list
65277708|NCT02644980|Etomidate|etomidate|mesh-list
65277709|NCT02644980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65277710|NCT02644980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277711|NCT02644980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65277712|NCT02644980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65277713|NCT02644980|Anesthetics, General|anesthetics, general|mesh-ancestor
65277714|NCT04187456|Midazolam|midazolam|mesh-list
65277715|NCT04187456|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65277716|NCT04187456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64477468|NCT01392573|Insulin, Long-Acting|insulin, long-acting|mesh-list
64477469|NCT01392573|Xultophy|xultophy|mesh-list
64477470|NCT01392573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64477471|NCT01392573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477472|NCT01392573|Incretins|incretins|mesh-ancestor
64477473|NCT01392573|Hormones|hormones|mesh-ancestor
64514721|NCT02395497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64477474|NCT01392573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64477475|NCT01392495|Imatinib Mesylate|imatinib mesylate|mesh-list
64477476|NCT01392495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477477|NCT01392495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64477478|NCT01392495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477479|NCT01392495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477480|NCT01405053|Rufinamide|rufinamide|mesh-list
64477481|NCT01405053|Anticonvulsants|anticonvulsants|mesh-list
64477482|NCT01405053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64477483|NCT01405053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64477484|NCT01405053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64477485|NCT01405053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477486|NCT01403805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64477487|NCT01403805|Immunologic Factors|immunologic factors|mesh-ancestor
64477488|NCT01403805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477489|NCT01392183|Diphenhydramine|diphenhydramine|mesh-list
64477490|NCT01392183|Sirolimus|sirolimus|mesh-list
64477491|NCT01392183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64477492|NCT01392183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64477493|NCT01392183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64477494|NCT01392183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477495|NCT01392183|Antifungal Agents|antifungal agents|mesh-ancestor
64477496|NCT01392183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64477497|NCT01392183|Immunologic Factors|immunologic factors|mesh-ancestor
64477498|NCT01392183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477499|NCT01392183|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64477500|NCT01392183|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64477501|NCT01392183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64477502|NCT01392183|Anesthetics, Local|anesthetics, local|mesh-ancestor
64477503|NCT01392183|Anesthetics|anesthetics|mesh-ancestor
64477504|NCT01392183|Sensory System Agents|sensory system agents|mesh-ancestor
64477517|NCT01402947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64477518|NCT01402947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64477519|NCT01402947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64477520|NCT01402947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64477522|NCT01402947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477523|NCT01402947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477524|NCT01402947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64477525|NCT01402947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64477526|NCT01402947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64477527|NCT01402947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64477528|NCT01402947|Analgesics|analgesics|mesh-ancestor
64477529|NCT01402947|Sensory System Agents|sensory system agents|mesh-ancestor
64477530|NCT01402947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64477531|NCT01402947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477532|NCT01402947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65277717|NCT04187456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65277718|NCT04187456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277719|NCT04187456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65277720|NCT04187456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65277721|NCT04187456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65277722|NCT04187456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65277723|NCT04187456|Anesthetics, General|anesthetics, general|mesh-ancestor
65277724|NCT04187456|Anesthetics|anesthetics|mesh-ancestor
65277725|NCT04187456|GABA Modulators|gaba modulators|mesh-ancestor
65277726|NCT04187456|GABA Agents|gaba agents|mesh-ancestor
65277727|NCT04187456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64477533|NCT01402947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64477534|NCT03025893|Sunitinib|sunitinib|mesh-list
64477535|NCT03025893|Lomustine|lomustine|mesh-list
64477536|NCT03025893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477537|NCT03025893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64477538|NCT03025893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64477539|NCT03025893|Growth Substances|growth substances|mesh-ancestor
64477540|NCT03025893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477541|NCT03025893|Growth Inhibitors|growth inhibitors|mesh-ancestor
64477542|NCT03025893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64477543|NCT03025893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477544|NCT03025893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477545|NCT03025893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64477546|NCT03025893|Alkylating Agents|alkylating agents|mesh-ancestor
64477547|NCT01402869|Lidocaine|lidocaine|mesh-list
64477548|NCT01402869|Epinephrine|epinephrine|mesh-list
64477549|NCT01402869|Prilocaine|prilocaine|mesh-list
64477550|NCT01402869|Anesthetics, Local|anesthetics, local|mesh-ancestor
64477551|NCT01402869|Anesthetics|anesthetics|mesh-ancestor
64477552|NCT01402869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64477553|NCT01402869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477554|NCT01402869|Sensory System Agents|sensory system agents|mesh-ancestor
64477555|NCT01402869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64477556|NCT01402869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64477557|NCT01402869|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64477558|NCT01402869|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64477559|NCT01402869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64477560|NCT01402869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477561|NCT01402869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64477562|NCT01402869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64477563|NCT01402869|Adrenergic Agents|adrenergic agents|mesh-ancestor
64477564|NCT01402869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64477565|NCT01402869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64978368|NCT00269542|Iron|iron|mesh-list
64477593|NCT01727024|Autonomic Agents|autonomic agents|mesh-ancestor
64477594|NCT01727024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64477595|NCT01727024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477596|NCT01727024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64477597|NCT01727024|Respiratory System Agents|respiratory system agents|mesh-ancestor
64477598|NCT01727024|Parasympatholytics|parasympatholytics|mesh-ancestor
64477600|NCT01727024|Cholinergic Agents|cholinergic agents|mesh-ancestor
64477601|NCT01727024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64477602|NCT01727024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477603|NCT04558736|Cyclophosphamide|cyclophosphamide|mesh-list
64477605|NCT04558736|Thymoglobulin|thymoglobulin|mesh-list
64477606|NCT04558736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64477607|NCT04558736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64477608|NCT04558736|Immunologic Factors|immunologic factors|mesh-ancestor
64477609|NCT04558736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477610|NCT04558736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64477611|NCT04558736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64477612|NCT04558736|Alkylating Agents|alkylating agents|mesh-ancestor
64477613|NCT04558736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277728|NCT04187456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277729|NCT02827331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65277730|NCT02827331|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
65277731|NCT02827331|Antidepressive Agents|antidepressive agents|mesh-list
65277732|NCT02827331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65277733|NCT02827331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65277734|NCT02827331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277735|NCT02827331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65277736|NCT02687204|Enoxaparin|enoxaparin|mesh-list
65277737|NCT02687204|Enoxaparin sodium|enoxaparin sodium|mesh-list
65277738|NCT02687204|Anticoagulants|anticoagulants|mesh-ancestor
64477614|NCT04558736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477626|NCT01422213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477627|NCT01422213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64477628|NCT01422213|Serotonin Agents|serotonin agents|mesh-ancestor
64477629|NCT01422213|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64477630|NCT01422213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64477631|NCT01422213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64477632|NCT01422213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64477633|NCT01390857|Valacyclovir|valacyclovir|mesh-list
64477634|NCT01390857|Antiviral Agents|antiviral agents|mesh-ancestor
64477635|NCT01390857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64477636|NCT04036305|Lidocaine|lidocaine|mesh-list
64477637|NCT04036305|Bupivacaine|bupivacaine|mesh-list
64477638|NCT04036305|Anesthetics, Local|anesthetics, local|mesh-ancestor
64477639|NCT04036305|Anesthetics|anesthetics|mesh-ancestor
64477640|NCT04036305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64477641|NCT04036305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477642|NCT04036305|Sensory System Agents|sensory system agents|mesh-ancestor
64477643|NCT04036305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64477644|NCT04036305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64477645|NCT04036305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64477646|NCT04036305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64477647|NCT04036305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64477648|NCT04036305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477649|NCT01725386|Capecitabine|capecitabine|mesh-list
64477650|NCT01725386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64477651|NCT01725386|Antimetabolites|antimetabolites|mesh-ancestor
64477652|NCT01725386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477653|NCT01725386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477654|NCT01402011|Lidocaine|lidocaine|mesh-list
64477655|NCT01402011|Anesthetics, Local|anesthetics, local|mesh-ancestor
64477656|NCT01402011|Anesthetics|anesthetics|mesh-ancestor
64477657|NCT01402011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64477658|NCT01402011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477659|NCT01402011|Sensory System Agents|sensory system agents|mesh-ancestor
64477660|NCT01402011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64477661|NCT01402011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64477662|NCT01402011|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64477663|NCT01402011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64477664|NCT01402011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64477665|NCT01402011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477666|NCT01421667|Rituximab|rituximab|mesh-list
64477667|NCT01421667|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64477668|NCT01421667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64477669|NCT01421667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477671|NCT01421667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477672|NCT01421667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64477684|NCT01421511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477685|NCT01891357|Paclitaxel|paclitaxel|mesh-list
64471377|NCT04551495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477686|NCT01891357|Trastuzumab|trastuzumab|mesh-list
65277739|NCT02687204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65277740|NCT02687204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65277741|NCT02687204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277742|NCT00650208|Lamotrigine|lamotrigine|mesh-list
65277743|NCT00650208|Anticonvulsants|anticonvulsants|mesh-ancestor
65277744|NCT00650208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65277745|NCT00650208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65277746|NCT00650208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730242|NCT00005804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64730243|NCT00005804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64730244|NCT00005804|Alkylating Agents|alkylating agents|mesh-ancestor
64730245|NCT00005804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730246|NCT00005804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730247|NCT00005804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64730248|NCT00005810|Carboplatin|carboplatin|mesh-list
64730249|NCT00005810|Docetaxel|docetaxel|mesh-list
64730250|NCT00005810|Estramustine|estramustine|mesh-list
64477687|NCT01891357|Lapatinib|lapatinib|mesh-list
64477688|NCT01891357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64477689|NCT01891357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477690|NCT01891357|Tubulin Modulators|tubulin modulators|mesh-ancestor
64477691|NCT01891357|Antimitotic Agents|antimitotic agents|mesh-ancestor
64477692|NCT01891357|Mitosis Modulators|mitosis modulators|mesh-ancestor
64477693|NCT01891357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477694|NCT01891357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64477695|NCT01891357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64477696|NCT01891357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477697|NCT01420965|Cyclophosphamide|cyclophosphamide|mesh-list
64477698|NCT01420965|Antibodies|antibodies|mesh-list
64477699|NCT01420965|Immunoglobulins|immunoglobulins|mesh-list
64477700|NCT01420965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64477701|NCT01420965|Immunologic Factors|immunologic factors|mesh-ancestor
64477702|NCT01420965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477703|NCT01420965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64477704|NCT01420965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64477705|NCT01420965|Alkylating Agents|alkylating agents|mesh-ancestor
64477706|NCT01420965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477707|NCT01420965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477708|NCT01420965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64477709|NCT04033575|Listerine|listerine|mesh-list
64477710|NCT04033575|Fluorides|fluorides|mesh-list
64477711|NCT04033575|Sodium Fluoride|sodium fluoride|mesh-list
64477712|NCT04033575|Tin Fluorides|tin fluorides|mesh-list
64477713|NCT04033575|Cariostatic Agents|cariostatic agents|mesh-ancestor
64477714|NCT04033575|Protective Agents|protective agents|mesh-ancestor
64477715|NCT04033575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477716|NCT04033575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64477717|NCT04033575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64477718|NCT03842085|Antibodies|antibodies|mesh-list
64477719|NCT03842085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64477720|NCT03842085|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64477721|NCT03842085|Immunologic Factors|immunologic factors|mesh-ancestor
64477722|NCT03842085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477723|NCT01390389|Ubiquinone|ubiquinone|mesh-list
64477724|NCT01390389|Coenzyme Q10|coenzyme q10|mesh-list
64477725|NCT01390389|Micronutrients|micronutrients|mesh-ancestor
64477726|NCT01390389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477727|NCT01390389|Vitamins|vitamins|mesh-ancestor
65277747|NCT00650208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65277748|NCT00650208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277749|NCT00650208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65277750|NCT00650208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65277751|NCT00650208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65277752|NCT00650208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65277753|NCT00650208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65277754|NCT02645370|Topiramate|topiramate|mesh-list
65277755|NCT02645370|Anticonvulsants|anticonvulsants|mesh-ancestor
65277756|NCT02645370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65277757|NCT02645370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277758|NCT00652392|Budesonide|budesonide|mesh-list
65277759|NCT00652392|Formoterol Fumarate|formoterol fumarate|mesh-list
65277760|NCT00652392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65277761|NCT00652392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65277762|NCT00652392|Autonomic Agents|autonomic agents|mesh-ancestor
65277763|NCT00652392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277764|NCT00652392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277765|NCT00652392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64730251|NCT00005810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730252|NCT00005810|Tubulin Modulators|tubulin modulators|mesh-ancestor
64477728|NCT03835533|Nivolumab|nivolumab|mesh-list
64477729|NCT03835533|Poly ICLC|poly iclc|mesh-list
64477730|NCT03835533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64477731|NCT03835533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477732|NCT03835533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64477733|NCT03835533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477734|NCT03835533|Interferon Inducers|interferon inducers|mesh-ancestor
64978537|NCT00270088|Epoetin Alfa|epoetin alfa|mesh-list
64477756|NCT01890967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477757|NCT01890967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64477758|NCT01890967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64477759|NCT01890967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477760|NCT01863667|Glimepiride|glimepiride|mesh-list
64471378|NCT04551495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64477761|NCT01863667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64477763|NCT01863667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477764|NCT01863667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64477765|NCT01863667|Immunologic Factors|immunologic factors|mesh-ancestor
64477766|NCT01614769|Glimepiride|glimepiride|mesh-list
64477767|NCT01614769|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64477768|NCT01614769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64477769|NCT01614769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477770|NCT01614769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64477771|NCT01614769|Immunologic Factors|immunologic factors|mesh-ancestor
64477773|NCT01614457|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64477774|NCT01614457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64477775|NCT01614457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477776|NCT01835431|Insulin|insulin|mesh-list
64477777|NCT01835431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64477778|NCT01835431|Insulin Aspart|insulin aspart|mesh-list
64477779|NCT01835431|Insulin, Long-Acting|insulin, long-acting|mesh-list
64477780|NCT01835431|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65277766|NCT00652392|Respiratory System Agents|respiratory system agents|mesh-ancestor
65277767|NCT00652392|Glucocorticoids|glucocorticoids|mesh-ancestor
65277768|NCT00652392|Hormones|hormones|mesh-ancestor
65277769|NCT00652392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65277770|NCT00652392|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65277771|NCT00652392|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65277772|NCT00652392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65277773|NCT00652392|Adrenergic Agents|adrenergic agents|mesh-ancestor
65277774|NCT00652392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65277775|NCT00652392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277776|NCT02645214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
65277777|NCT02645214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65277778|NCT02653638|Indomethacin|indomethacin|mesh-list
65277779|NCT02653638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65277780|NCT02653638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65277781|NCT02653638|Analgesics|analgesics|mesh-ancestor
65277782|NCT02653638|Sensory System Agents|sensory system agents|mesh-ancestor
65277783|NCT02653638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277784|NCT02653638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277785|NCT02653638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64477781|NCT01835431|Insulin Detemir|insulin detemir|mesh-list
64477782|NCT01835431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64477783|NCT01835431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477784|NCT01880593|Ketamine|ketamine|mesh-list
64477785|NCT01880593|Lithium Carbonate|lithium carbonate|mesh-list
64477786|NCT01880593|Analgesics|analgesics|mesh-ancestor
64477787|NCT01880593|Sensory System Agents|sensory system agents|mesh-ancestor
64477788|NCT01880593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64477789|NCT01880593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477790|NCT01880593|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64477808|NCT01880515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477809|NCT01880515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477810|NCT01400451|Ipilimumab|ipilimumab|mesh-list
64477811|NCT01400451|Vemurafenib|vemurafenib|mesh-list
64477812|NCT01400451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64477813|NCT01400451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477814|NCT01400451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64477815|NCT01400451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477816|NCT01400451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64477817|NCT01400451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477818|NCT01400139|Hydrocodone|hydrocodone|mesh-list
64477819|NCT01400139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64477820|NCT01400139|Narcotics|narcotics|mesh-ancestor
64477821|NCT01400139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64477822|NCT01400139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477823|NCT01400139|Analgesics|analgesics|mesh-ancestor
64477824|NCT01400139|Sensory System Agents|sensory system agents|mesh-ancestor
64477825|NCT01400139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64477826|NCT01400139|Antitussive Agents|antitussive agents|mesh-ancestor
64477827|NCT01400139|Respiratory System Agents|respiratory system agents|mesh-ancestor
64477828|NCT01399905|Carbidopa|carbidopa|mesh-list
64513666|NCT01457937|Interferons|interferons|mesh-list
64477829|NCT01399905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65277786|NCT02653638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65277787|NCT02653638|Gout Suppressants|gout suppressants|mesh-ancestor
65277788|NCT02653638|Tocolytic Agents|tocolytic agents|mesh-ancestor
65277789|NCT02653638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65277790|NCT02653638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65277791|NCT02653638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277792|NCT02653638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477830|NCT01399905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64477831|NCT01399905|Dopamine Agents|dopamine agents|mesh-ancestor
64477832|NCT01399905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64471379|NCT04551495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64477833|NCT01399905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477834|NCT01399905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477835|NCT01399905|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64477836|NCT01399905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477837|NCT01725308|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64477838|NCT01725308|Antidepressive Agents|antidepressive agents|mesh-ancestor
64477839|NCT01725308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64477840|NCT01725308|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64477841|NCT01725308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64477842|NCT01725308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64477843|NCT01725308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477844|NCT01724528|Allopurinol|allopurinol|mesh-list
64477882|NCT01860703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64477883|NCT01860703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64477898|NCT01388985|Immunologic Factors|immunologic factors|mesh-ancestor
64477899|NCT01388985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477901|NCT01388361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64477902|NCT01388361|Insulin Aspart|insulin aspart|mesh-list
64477903|NCT01388361|Liraglutide|liraglutide|mesh-list
64477904|NCT01388361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64513667|NCT01457937|Ribavirin|ribavirin|mesh-list
64471380|NCT04546009|Letrozole|letrozole|mesh-list
64471381|NCT04546009|Palbociclib|palbociclib|mesh-list
64471382|NCT04546009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477905|NCT01388361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477906|NCT01388361|Incretins|incretins|mesh-ancestor
64477907|NCT01388361|Hormones|hormones|mesh-ancestor
64477908|NCT01388361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64477909|NCT05368935|Nitazoxanide|nitazoxanide|mesh-list
64477910|NCT05368935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64477911|NCT05368935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64477912|NCT01399125|Rivastigmine|rivastigmine|mesh-list
64477913|NCT01399125|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64477914|NCT01399125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477915|NCT01399125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477916|NCT01399125|Cholinergic Agents|cholinergic agents|mesh-ancestor
64477917|NCT01399125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64477918|NCT01399125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477919|NCT01399125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64477920|NCT01399125|Protective Agents|protective agents|mesh-ancestor
64477921|NCT01399047|Mycophenolic Acid|mycophenolic acid|mesh-list
64477922|NCT01399047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64477923|NCT01399047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477924|NCT01399047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64477925|NCT01399047|Antitubercular Agents|antitubercular agents|mesh-ancestor
64477926|NCT01399047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64477927|NCT01399047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64477928|NCT01399047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477929|NCT01399047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477930|NCT01387347|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64477931|NCT01387347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64477932|NCT04040439|Dexmedetomidine|dexmedetomidine|mesh-list
64477933|NCT04040439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64477934|NCT04040439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64477935|NCT04040439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477936|NCT04040439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64477937|NCT04040439|Analgesics|analgesics|mesh-ancestor
65277793|NCT02644590|Melatonin|melatonin|mesh-list
65277794|NCT02644590|Antioxidants|antioxidants|mesh-ancestor
65277795|NCT02644590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277796|NCT02644590|Protective Agents|protective agents|mesh-ancestor
65277797|NCT02644590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277798|NCT02644590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65277799|NCT00910806|Nevirapine|nevirapine|mesh-list
64730299|NCT05296603|Lenvatinib|lenvatinib|mesh-list
64730300|NCT05296603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477938|NCT04040439|Sensory System Agents|sensory system agents|mesh-ancestor
64477939|NCT04040439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64978755|NCT00271804|Bortezomib|bortezomib|mesh-list
64477958|NCT01879579|Insulin|insulin|mesh-list
64477959|NCT01879579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64477960|NCT01879579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477961|NCT01386645|Acetylcysteine|acetylcysteine|mesh-list
64477962|NCT01386645|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64477963|NCT01386645|Antiviral Agents|antiviral agents|mesh-ancestor
64477964|NCT01386645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64477965|NCT01386645|Expectorants|expectorants|mesh-ancestor
64477966|NCT01386645|Respiratory System Agents|respiratory system agents|mesh-ancestor
64477967|NCT01386645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64477968|NCT01386645|Antioxidants|antioxidants|mesh-ancestor
64463504|NCT01904149|Tramadol|tramadol|mesh-list
64477969|NCT01386645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477970|NCT01386645|Protective Agents|protective agents|mesh-ancestor
64477971|NCT01386645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471383|NCT04546009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64477973|NCT01831765|Insulin|insulin|mesh-list
64477974|NCT01831765|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64477975|NCT01831765|Insulin Aspart|insulin aspart|mesh-list
64477976|NCT01831765|Insulin, Long-Acting|insulin, long-acting|mesh-list
64477977|NCT01831765|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64477978|NCT01831765|Insulin Detemir|insulin detemir|mesh-list
64477979|NCT01831765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64477980|NCT01831765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477981|NCT01830595|Lactoferrin|lactoferrin|mesh-list
64477982|NCT01830595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64477983|NCT01748162|Fluticasone|fluticasone|mesh-list
64477984|NCT01748162|Prednisolone|prednisolone|mesh-list
64477985|NCT01748162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64477986|NCT01748162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64477987|NCT01748162|Autonomic Agents|autonomic agents|mesh-ancestor
64477988|NCT01748162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64477989|NCT01748162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477990|NCT01748162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64477991|NCT01748162|Respiratory System Agents|respiratory system agents|mesh-ancestor
64477992|NCT01748162|Dermatologic Agents|dermatologic agents|mesh-ancestor
64477993|NCT01748162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64477994|NCT01748162|Glucocorticoids|glucocorticoids|mesh-ancestor
64477995|NCT01748162|Hormones|hormones|mesh-ancestor
64478026|NCT01777334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64478027|NCT01777334|Autonomic Agents|autonomic agents|mesh-ancestor
64478028|NCT01777334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478029|NCT01777334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478030|NCT01777334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64478031|NCT01777334|Respiratory System Agents|respiratory system agents|mesh-ancestor
64478032|NCT01777334|Parasympatholytics|parasympatholytics|mesh-ancestor
64478033|NCT01777334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64478034|NCT01777334|Cholinergic Agents|cholinergic agents|mesh-ancestor
64478035|NCT01777334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64478036|NCT01777334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478037|NCT03024879|Erythromycin|erythromycin|mesh-list
64478038|NCT03024879|Erythromycin Estolate|erythromycin estolate|mesh-list
64478085|NCT01776008|Goserelin|goserelin|mesh-list
64478086|NCT01776008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64478087|NCT01776008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478088|NCT01776008|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64478089|NCT01776008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65277800|NCT00910806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65277801|NCT00910806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65277802|NCT00910806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277803|NCT00910806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277804|NCT00910806|Antiviral Agents|antiviral agents|mesh-ancestor
65277805|NCT00910806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65277806|NCT00910806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65277807|NCT00910806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65277808|NCT00910806|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65277809|NCT00910806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65277810|NCT00652704|Doxycycline|doxycycline|mesh-list
64478090|NCT01776008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478091|NCT01776008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478092|NCT01776008|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64478093|NCT01776008|Hormone Antagonists|hormone antagonists|mesh-ancestor
64478094|NCT01776008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64478095|NCT01776008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478096|NCT01858363|Paclitaxel|paclitaxel|mesh-list
64478097|NCT01858363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64478098|NCT01858363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478099|NCT01858363|Tubulin Modulators|tubulin modulators|mesh-ancestor
64478100|NCT01858363|Antimitotic Agents|antimitotic agents|mesh-ancestor
64478101|NCT01858363|Mitosis Modulators|mitosis modulators|mesh-ancestor
64478102|NCT01858363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478103|NCT01877551|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
64478104|NCT01877551|Antiviral Agents|antiviral agents|mesh-ancestor
64478105|NCT01877551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64478106|NCT01877551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64478107|NCT01877551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64478108|NCT01396005|Buprenorphine|buprenorphine|mesh-list
64478109|NCT01396005|Methadone|methadone|mesh-list
64478110|NCT01396005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64478111|NCT01396005|Naloxone|naloxone|mesh-list
64478112|NCT01396005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64478113|NCT01396005|Narcotics|narcotics|mesh-ancestor
64478114|NCT01396005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64471385|NCT04546009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478115|NCT01396005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478116|NCT01396005|Analgesics|analgesics|mesh-ancestor
64478117|NCT01396005|Sensory System Agents|sensory system agents|mesh-ancestor
64478118|NCT01396005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478119|NCT01396005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64478120|NCT01396005|Antitussive Agents|antitussive agents|mesh-ancestor
64478121|NCT01396005|Respiratory System Agents|respiratory system agents|mesh-ancestor
64478122|NCT03024957|Dexmedetomidine|dexmedetomidine|mesh-list
64478123|NCT03024957|Morphine|morphine|mesh-list
64478124|NCT03024957|Bupivacaine|bupivacaine|mesh-list
64478125|NCT03024957|Anesthetics, Local|anesthetics, local|mesh-ancestor
64478155|NCT03025113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478156|NCT03025113|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64478157|NCT03025113|Antidepressive Agents|antidepressive agents|mesh-ancestor
64478158|NCT03025113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64478159|NCT03025113|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64478160|NCT03025113|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64478161|NCT03025113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64478162|NCT03025113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64478163|NCT03025113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64478164|NCT03025113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64478165|NCT03025113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64478166|NCT03025113|Adrenergic Agents|adrenergic agents|mesh-ancestor
64478167|NCT03025113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64478188|NCT01394991|Hematinics|hematinics|mesh-ancestor
64478190|NCT05368623|Autonomic Agents|autonomic agents|mesh-ancestor
65277811|NCT00652704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65277812|NCT00652704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65277813|NCT00652704|Antimalarials|antimalarials|mesh-ancestor
65277814|NCT00652704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65277815|NCT00652704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65277816|NCT00652782|Rolofylline|rolofylline|mesh-list
65277817|NCT00652782|Diuretics|diuretics|mesh-ancestor
65277818|NCT00652782|Natriuretic Agents|natriuretic agents|mesh-ancestor
65277819|NCT00652782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277820|NCT00653562|Zolpidem|zolpidem|mesh-list
65277821|NCT00653562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65277822|NCT00653562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65277823|NCT00653562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65277824|NCT00653562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277825|NCT00653562|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65277826|NCT00653562|GABA Agonists|gaba agonists|mesh-ancestor
65277827|NCT00653562|GABA Agents|gaba agents|mesh-ancestor
65277828|NCT00653562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65277829|NCT00653562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277830|NCT00887159|Cisplatin|cisplatin|mesh-list
65277831|NCT00887159|Etoposide|etoposide|mesh-list
65277832|NCT00887159|Etoposide phosphate|etoposide phosphate|mesh-list
65277833|NCT00887159|Podophyllotoxin|podophyllotoxin|mesh-list
65277834|NCT00887159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65277835|NCT00887159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478191|NCT05368623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478192|NCT05368623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478193|NCT01394523|Bupivacaine|bupivacaine|mesh-list
64478194|NCT01394523|Anesthetics, Local|anesthetics, local|mesh-ancestor
64478195|NCT01394523|Anesthetics|anesthetics|mesh-ancestor
64478196|NCT01394523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64478197|NCT01394523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478198|NCT01394523|Sensory System Agents|sensory system agents|mesh-ancestor
64478199|NCT01394523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478201|NCT05363553|Chelating Agents|chelating agents|mesh-ancestor
64478202|NCT05363553|Sequestering Agents|sequestering agents|mesh-ancestor
64478203|NCT05363553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478205|NCT01857583|Edoxaban|edoxaban|mesh-list
64478206|NCT01857583|Fondaparinux|fondaparinux|mesh-list
64478207|NCT01857583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64478208|NCT01857583|Antithrombins|antithrombins|mesh-ancestor
64478209|NCT01857583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64478210|NCT01857583|Protease Inhibitors|protease inhibitors|mesh-ancestor
64478211|NCT01857583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478212|NCT01857583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478213|NCT01857583|Anticoagulants|anticoagulants|mesh-ancestor
64478214|NCT01857583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64478215|NCT01857583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64478216|NCT04000347|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64478217|NCT04000347|Dermatologic Agents|dermatologic agents|mesh-ancestor
64478218|NCT00211185|Prednisone|prednisone|mesh-list
64478219|NCT00211185|Cyclophosphamide|cyclophosphamide|mesh-list
64478220|NCT00211185|Doxorubicin|doxorubicin|mesh-list
65277836|NCT00887159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65277837|NCT00887159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65277838|NCT00887159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65277839|NCT00887159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277840|NCT00887159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277841|NCT00887159|Keratolytic Agents|keratolytic agents|mesh-ancestor
65277842|NCT00887159|Dermatologic Agents|dermatologic agents|mesh-ancestor
64478221|NCT00211185|Vincristine|vincristine|mesh-list
64478222|NCT00211185|Denileukin diftitox|denileukin diftitox|mesh-list
64478223|NCT00211185|Lenograstim|lenograstim|mesh-list
64478224|NCT00211185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64478225|NCT00211185|Immunologic Factors|immunologic factors|mesh-ancestor
64478226|NCT00211185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979040|NCT00108186|Celecoxib|celecoxib|mesh-list
64478246|NCT00211185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64478247|NCT00219297|Epothilone B|epothilone b|mesh-list
64478248|NCT00219297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478249|NCT00219297|Tubulin Modulators|tubulin modulators|mesh-ancestor
64478250|NCT00219297|Antimitotic Agents|antimitotic agents|mesh-ancestor
64478251|NCT00219297|Mitosis Modulators|mitosis modulators|mesh-ancestor
64478252|NCT00219297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478253|NCT05631795|Fulvestrant|fulvestrant|mesh-list
64478254|NCT05631795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64478255|NCT05631795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478256|NCT05631795|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64478257|NCT05631795|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64478258|NCT05631795|Hormone Antagonists|hormone antagonists|mesh-ancestor
64478259|NCT05631795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64478260|NCT05631795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478261|NCT01857271|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64478262|NCT01857271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478263|NCT01857271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64478264|NCT01857271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514723|NCT02395497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478265|NCT01857271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478266|NCT01721486|Acetaminophen|acetaminophen|mesh-list
64478267|NCT01721486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64478268|NCT01721486|Analgesics|analgesics|mesh-ancestor
64478269|NCT01721486|Sensory System Agents|sensory system agents|mesh-ancestor
64478270|NCT01721486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478271|NCT01721486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478272|NCT01721486|Antipyretics|antipyretics|mesh-ancestor
64478273|NCT01721408|Imipenem|imipenem|mesh-list
64478275|NCT01721408|Cilastatin|cilastatin|mesh-list
64478276|NCT01721408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64478277|NCT01721408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64478278|NCT01721408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64478311|NCT04007055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64478312|NCT04007055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64478313|NCT04007055|Purinergic Agents|purinergic agents|mesh-ancestor
64478314|NCT04007055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64478315|NCT04007055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478316|NCT04007055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478337|NCT05634057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478338|NCT05634057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64478339|NCT05634057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64478340|NCT05634057|Adrenergic Agents|adrenergic agents|mesh-ancestor
64478341|NCT05634057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64478342|NCT05634057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478343|NCT05634057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64478344|NCT05634057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64478345|NCT05634057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64478347|NCT05634057|Sensory System Agents|sensory system agents|mesh-ancestor
64478348|NCT05634057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478349|NCT05634057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64478350|NCT05634057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65277843|NCT00887159|Tubulin Modulators|tubulin modulators|mesh-ancestor
65277844|NCT00887159|Antimitotic Agents|antimitotic agents|mesh-ancestor
65277845|NCT00887159|Mitosis Modulators|mitosis modulators|mesh-ancestor
65277846|NCT00887159|Immunologic Factors|immunologic factors|mesh-ancestor
65277847|NCT00887159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277848|NCT00650286|Modafinil|modafinil|mesh-list
65277849|NCT00650286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65277850|NCT00650286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277851|NCT00650286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64478351|NCT05634057|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64478352|NCT05634057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64478353|NCT05634057|Parasympatholytics|parasympatholytics|mesh-ancestor
64478354|NCT05634057|Autonomic Agents|autonomic agents|mesh-ancestor
64478355|NCT05634057|Vasodilator Agents|vasodilator agents|mesh-ancestor
64478356|NCT05634057|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64478358|NCT05634057|Protective Agents|protective agents|mesh-ancestor
64478360|NCT03596385|Atenolol|atenolol|mesh-list
64478361|NCT03596385|Carvedilol|carvedilol|mesh-list
64478362|NCT03596385|Bisoprolol|bisoprolol|mesh-list
64478363|NCT03596385|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64478364|NCT03596385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64478365|NCT03596385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64478366|NCT03596385|Sympatholytics|sympatholytics|mesh-ancestor
64478367|NCT03596385|Autonomic Agents|autonomic agents|mesh-ancestor
64478368|NCT03596385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478369|NCT03596385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478370|NCT03596385|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64478371|NCT03596385|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64478372|NCT03596385|Adrenergic Agents|adrenergic agents|mesh-ancestor
64478373|NCT03596385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64478374|NCT03596385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478375|NCT03596385|Antioxidants|antioxidants|mesh-ancestor
64478376|NCT03596385|Protective Agents|protective agents|mesh-ancestor
64478377|NCT03596385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64478378|NCT03596385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64478379|NCT03596385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64478380|NCT03596385|Vasodilator Agents|vasodilator agents|mesh-ancestor
64478381|NCT03596385|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64478401|NCT03784599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478402|NCT03784599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478403|NCT03784599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64478404|NCT03784599|Tubulin Modulators|tubulin modulators|mesh-ancestor
64478405|NCT03784599|Antimitotic Agents|antimitotic agents|mesh-ancestor
64478406|NCT03784599|Mitosis Modulators|mitosis modulators|mesh-ancestor
64478407|NCT01827943|Sirolimus|sirolimus|mesh-list
64478408|NCT01827943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64478409|NCT01827943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64478410|NCT01827943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64478411|NCT01827943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478412|NCT01827943|Antifungal Agents|antifungal agents|mesh-ancestor
64478413|NCT01827943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64478414|NCT01827943|Immunologic Factors|immunologic factors|mesh-ancestor
64478415|NCT01827943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478416|NCT02985255|Docetaxel|docetaxel|mesh-list
64478417|NCT02985255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478418|NCT02985255|Tubulin Modulators|tubulin modulators|mesh-ancestor
64478419|NCT02985255|Antimitotic Agents|antimitotic agents|mesh-ancestor
64478420|NCT02985255|Mitosis Modulators|mitosis modulators|mesh-ancestor
64478421|NCT02985255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478422|NCT00214851|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64478423|NCT00214851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64478424|NCT00217971|Dronabinol|dronabinol|mesh-list
64478425|NCT00217971|Hallucinogens|hallucinogens|mesh-ancestor
64478426|NCT00217971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478427|NCT00217971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64478428|NCT00217971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65277852|NCT00650286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65277853|NCT00650286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65277854|NCT00650286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277855|NCT02640846|Simendan|simendan|mesh-list
65277856|NCT02640846|Milrinone|milrinone|mesh-list
65277857|NCT02640846|Norepinephrine|norepinephrine|mesh-list
65277858|NCT02640846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64478429|NCT00217971|Analgesics|analgesics|mesh-ancestor
64478430|NCT00217971|Sensory System Agents|sensory system agents|mesh-ancestor
64478431|NCT00217971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478432|NCT00217971|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64478433|NCT00217971|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64478434|NCT00217971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64478435|NCT00217971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478436|NCT00217971|Hormones|hormones|mesh-ancestor
64979241|NCT00075452|Immunologic Factors|immunologic factors|mesh-ancestor
64478472|NCT01856257|Immunologic Factors|immunologic factors|mesh-ancestor
64478473|NCT01856257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478474|NCT01856257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64478475|NCT01856257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478476|NCT01856257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478477|NCT01856257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64478478|NCT01856257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478509|NCT00215943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64478510|NCT00215943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64478511|NCT00215943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478512|NCT00215943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64478513|NCT00215943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64478514|NCT00215943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64478516|NCT00215943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478517|NCT00215943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64478518|NCT00215943|Tubulin Modulators|tubulin modulators|mesh-ancestor
64478519|NCT00215943|Antimitotic Agents|antimitotic agents|mesh-ancestor
64478520|NCT00215943|Mitosis Modulators|mitosis modulators|mesh-ancestor
64478521|NCT00215943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64478522|NCT00215943|Immunologic Factors|immunologic factors|mesh-ancestor
64478523|NCT00215943|Leprostatic Agents|leprostatic agents|mesh-ancestor
64478542|NCT03593811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64478543|NCT03593811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478545|NCT03593811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64478546|NCT03593811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64478547|NCT03593811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64478548|NCT03593811|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64478549|NCT03593811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64478550|NCT03593811|Histamine Antagonists|histamine antagonists|mesh-ancestor
64478551|NCT03593811|Histamine Agents|histamine agents|mesh-ancestor
64478552|NCT03593811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64478553|NCT01827163|Paclitaxel|paclitaxel|mesh-list
64478554|NCT01827163|Trastuzumab|trastuzumab|mesh-list
64478555|NCT01827163|Lapatinib|lapatinib|mesh-list
64478556|NCT01827163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64478557|NCT01827163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478558|NCT01827163|Tubulin Modulators|tubulin modulators|mesh-ancestor
64478559|NCT01827163|Antimitotic Agents|antimitotic agents|mesh-ancestor
64478560|NCT01827163|Mitosis Modulators|mitosis modulators|mesh-ancestor
64478561|NCT01827163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478562|NCT01827163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64471386|NCT04546009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478563|NCT01827163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64478564|NCT01827163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478565|NCT00215553|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64478566|NCT00215553|Respiratory System Agents|respiratory system agents|mesh-ancestor
64478567|NCT00214461|Vaccines|vaccines|mesh-list
64713997|NCT03043105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64464107|NCT03071536|Furosemide|furosemide|mesh-list
64478568|NCT00214461|Immunologic Factors|immunologic factors|mesh-ancestor
65277859|NCT02640846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65277860|NCT02640846|Adrenergic Agents|adrenergic agents|mesh-ancestor
65277861|NCT02640846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65277862|NCT02640846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277863|NCT02640846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277864|NCT02640846|Sympathomimetics|sympathomimetics|mesh-ancestor
64478569|NCT00214461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478570|NCT03599973|Plasma-lyte 148|plasma-lyte 148|mesh-list
64478571|NCT03599973|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64478572|NCT03599973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64478573|NCT00211887|Interferons|interferons|mesh-list
64478574|NCT00211887|Interferon-beta|interferon-beta|mesh-list
64478575|NCT00211887|Interferon beta-1a|interferon beta-1a|mesh-list
64478576|NCT00211887|Glatiramer Acetate|glatiramer acetate|mesh-list
64478577|NCT00211887|(T,G)-A-L|(t,g)-a-l|mesh-list
64478578|NCT00211887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478591|NCT04002297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64478592|NCT04002297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478593|NCT04002297|Immunologic Factors|immunologic factors|mesh-ancestor
64478594|NCT04002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478595|NCT04002297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64478596|NCT04002297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64478597|NCT04002297|Alkylating Agents|alkylating agents|mesh-ancestor
64478598|NCT04002297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478599|NCT04002297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64478600|NCT04002297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478601|NCT03592485|Acetaminophen|acetaminophen|mesh-list
64478602|NCT03592485|Oxycodone|oxycodone|mesh-list
64478603|NCT03592485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64478604|NCT03592485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478605|NCT03592485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64478606|NCT03592485|Analgesics|analgesics|mesh-ancestor
64478607|NCT03592485|Sensory System Agents|sensory system agents|mesh-ancestor
64478608|NCT03592485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478609|NCT03592485|Antipyretics|antipyretics|mesh-ancestor
64478610|NCT03592485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64478612|NCT04199013|Fentanyl|fentanyl|mesh-list
64478613|NCT04199013|Ropivacaine|ropivacaine|mesh-list
64478614|NCT04199013|Anesthetics, Local|anesthetics, local|mesh-ancestor
64478615|NCT04199013|Anesthetics|anesthetics|mesh-ancestor
64478616|NCT04199013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64478617|NCT04199013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478618|NCT04199013|Sensory System Agents|sensory system agents|mesh-ancestor
64478619|NCT04199013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478620|NCT04199013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64478621|NCT04199013|Narcotics|narcotics|mesh-ancestor
64478622|NCT04199013|Analgesics|analgesics|mesh-ancestor
64478623|NCT04199013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64478624|NCT04199013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64478625|NCT04199013|Anesthetics, General|anesthetics, general|mesh-ancestor
64478626|NCT03989115|Osimertinib|osimertinib|mesh-list
64478627|NCT03989115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478628|NCT03989115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64478629|NCT03989115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478630|NCT03989115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478631|NCT04198467|Hyaluronic Acid|hyaluronic acid|mesh-list
64478632|NCT04198467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64478633|NCT04198467|Immunologic Factors|immunologic factors|mesh-ancestor
64478634|NCT04198467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478635|NCT04198467|Viscosupplements|viscosupplements|mesh-ancestor
64478636|NCT04198467|Protective Agents|protective agents|mesh-ancestor
64478637|NCT03599427|Lidocaine|lidocaine|mesh-list
64471387|NCT04546009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64478638|NCT03599427|Anesthetics, Local|anesthetics, local|mesh-ancestor
64478640|NCT03599427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64478641|NCT03599427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478642|NCT03599427|Sensory System Agents|sensory system agents|mesh-ancestor
64478643|NCT03599427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64713998|NCT03043105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64464188|NCT03824314|Fentanyl|fentanyl|mesh-list
64979450|NCT00109044|Citalopram|citalopram|mesh-list
65277865|NCT02640846|Autonomic Agents|autonomic agents|mesh-ancestor
65277866|NCT02640846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277867|NCT02640846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65277868|NCT02640846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65277869|NCT02640846|Vasodilator Agents|vasodilator agents|mesh-ancestor
65277870|NCT02640846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65277871|NCT02640846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65277872|NCT02640846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277873|NCT02640846|Protective Agents|protective agents|mesh-ancestor
65277874|NCT02640846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65277875|NCT02644044|Methotrexate|methotrexate|mesh-list
64478657|NCT01855789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478658|NCT01855789|Dermatologic Agents|dermatologic agents|mesh-ancestor
64478660|NCT01855789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64478661|NCT01855789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64478662|NCT01855789|Immunologic Factors|immunologic factors|mesh-ancestor
64478663|NCT01855789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64478664|NCT01855789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64478665|NCT04198233|Diazepam|diazepam|mesh-list
64478666|NCT04198233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64478667|NCT04198233|Anticonvulsants|anticonvulsants|mesh-ancestor
64478668|NCT04198233|Antiemetics|antiemetics|mesh-ancestor
64478669|NCT04198233|Autonomic Agents|autonomic agents|mesh-ancestor
64478670|NCT04198233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478671|NCT04198233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478672|NCT04198233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64478673|NCT04198233|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64478674|NCT04198233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64478675|NCT04198233|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64478676|NCT04198233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64478677|NCT04198233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64478678|NCT04198233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64478679|NCT04198233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64478680|NCT04198233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64478681|NCT04198233|Anesthetics, General|anesthetics, general|mesh-ancestor
64478682|NCT04198233|Anesthetics|anesthetics|mesh-ancestor
64478683|NCT04198233|GABA Modulators|gaba modulators|mesh-ancestor
64478684|NCT04198233|GABA Agents|gaba agents|mesh-ancestor
64478685|NCT04198233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64478686|NCT04198233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478688|NCT03987711|Apixaban|apixaban|mesh-list
64478689|NCT03987711|Anticoagulants|anticoagulants|mesh-ancestor
64478690|NCT03987711|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64478691|NCT03987711|Antithrombins|antithrombins|mesh-ancestor
64478692|NCT03987711|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64478693|NCT03987711|Protease Inhibitors|protease inhibitors|mesh-ancestor
64478694|NCT03987711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478695|NCT03987711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478696|NCT03591471|Prednisone|prednisone|mesh-list
64478697|NCT03591471|Benazepril|benazepril|mesh-list
64478698|NCT03591471|Heparin|heparin|mesh-list
64478699|NCT03591471|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64478700|NCT03591471|Tinzaparin|tinzaparin|mesh-list
64478701|NCT03591471|Dalteparin|dalteparin|mesh-list
64478702|NCT03591471|Calcium heparin|calcium heparin|mesh-list
64478703|NCT03591471|Dipyridamole|dipyridamole|mesh-list
64478704|NCT03591471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478705|NCT03591471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64478706|NCT03591471|Glucocorticoids|glucocorticoids|mesh-ancestor
64478707|NCT03591471|Hormones|hormones|mesh-ancestor
64478718|NCT03591471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64714000|NCT03043105|Hormones|hormones|mesh-ancestor
64478719|NCT03591471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64478720|NCT03591471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64478721|NCT03591471|Vasodilator Agents|vasodilator agents|mesh-ancestor
64478722|NCT04406805|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64478723|NCT04406805|Natriuretic Agents|natriuretic agents|mesh-ancestor
65277876|NCT02644044|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65277877|NCT02644044|Abortifacient Agents|abortifacient agents|mesh-ancestor
65277878|NCT02644044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65277879|NCT02644044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277880|NCT02644044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65277881|NCT02644044|Antimetabolites|antimetabolites|mesh-ancestor
65277882|NCT02644044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277883|NCT02644044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65277884|NCT02644044|Dermatologic Agents|dermatologic agents|mesh-ancestor
65277885|NCT02644044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478724|NCT04406805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478726|NCT01876381|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64478727|NCT01876381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478728|NCT01876381|Natriuretic Agents|natriuretic agents|mesh-ancestor
64478729|NCT01876381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478730|NCT03591003|Antibodies|antibodies|mesh-list
64478731|NCT03591003|Antibodies, Blocking|antibodies, blocking|mesh-list
64478732|NCT03591003|Immunologic Factors|immunologic factors|mesh-ancestor
64478733|NCT03591003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478734|NCT01875991|Etanercept|etanercept|mesh-list
64478735|NCT01875991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64478736|NCT01875991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64478737|NCT01875991|Analgesics|analgesics|mesh-ancestor
64478738|NCT01875991|Sensory System Agents|sensory system agents|mesh-ancestor
64478739|NCT01875991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478740|NCT01875991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478741|NCT01875991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64478742|NCT01875991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64478743|NCT01875991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64478744|NCT01875991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64478745|NCT01875991|Immunologic Factors|immunologic factors|mesh-ancestor
64478746|NCT04203927|Empagliflozin|empagliflozin|mesh-list
64478747|NCT04203927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64478748|NCT04203927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478749|NCT04203927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64478750|NCT04203927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478751|NCT01855243|Insulin|insulin|mesh-list
64478752|NCT01855243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64478753|NCT01855243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64478754|NCT01855243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478755|NCT04196829|Fluorides|fluorides|mesh-list
64478756|NCT04196829|Cariostatic Agents|cariostatic agents|mesh-ancestor
64478757|NCT04196829|Protective Agents|protective agents|mesh-ancestor
64478758|NCT04196829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478759|NCT01825837|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64478760|NCT01825837|Anticonvulsants|anticonvulsants|mesh-ancestor
64478761|NCT01825837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64478762|NCT01825837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64478763|NCT01825837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64478764|NCT01825837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478765|NCT01854697|Interferons|interferons|mesh-list
64478766|NCT01854697|Ribavirin|ribavirin|mesh-list
64478787|NCT01824823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478788|NCT01824823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478789|NCT03598725|Prednisone|prednisone|mesh-list
64478790|NCT03598725|Rituximab|rituximab|mesh-list
64478791|NCT03598725|Factor VIII|factor viii|mesh-list
64478792|NCT03598725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64478793|NCT03598725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478794|NCT03598725|Immunologic Factors|immunologic factors|mesh-ancestor
64478795|NCT03598725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478796|NCT03598725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64478797|NCT03598725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65277886|NCT02644044|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65277887|NCT02644044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65277888|NCT02644044|Immunologic Factors|immunologic factors|mesh-ancestor
65277889|NCT02644044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65277890|NCT02644044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65277891|NCT00652860|Doxorubicin|doxorubicin|mesh-list
65277892|NCT00652860|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65277893|NCT00652860|Ifosfamide|ifosfamide|mesh-list
65277894|NCT00652860|Molgramostim|molgramostim|mesh-list
65277895|NCT00652860|Mitomycins|mitomycins|mesh-list
65277896|NCT00652860|Mitomycin|mitomycin|mesh-list
65277897|NCT00652860|Sargramostim|sargramostim|mesh-list
65277898|NCT00652860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65277899|NCT00652860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65277900|NCT00652860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65277901|NCT00652860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65277902|NCT00652860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277903|NCT00652860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277904|NCT00652860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65277905|NCT00652860|Alkylating Agents|alkylating agents|mesh-ancestor
65277906|NCT00652860|Immunologic Factors|immunologic factors|mesh-ancestor
65277907|NCT00652860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277908|NCT00652860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65277909|NCT02536014|Dexmedetomidine|dexmedetomidine|mesh-list
65277910|NCT02536014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64730392|NCT02210702|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64478798|NCT03598725|Glucocorticoids|glucocorticoids|mesh-ancestor
64478799|NCT03598725|Hormones|hormones|mesh-ancestor
64478800|NCT03598725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64478801|NCT03598725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64478802|NCT03598725|Coagulants|coagulants|mesh-ancestor
64478803|NCT04766307|Interleukin-2|interleukin-2|mesh-list
64478804|NCT04766307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478805|NCT04766307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64478806|NCT04766307|Analgesics|analgesics|mesh-ancestor
64478807|NCT04766307|Sensory System Agents|sensory system agents|mesh-ancestor
64478808|NCT04766307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478809|NCT04766307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478810|NCT01875367|Trastuzumab|trastuzumab|mesh-list
64478811|NCT01875367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64478813|NCT04194957|Fluorouracil|fluorouracil|mesh-list
64478814|NCT04194957|Capecitabine|capecitabine|mesh-list
64478815|NCT04194957|Antimetabolites|antimetabolites|mesh-ancestor
64478816|NCT04194957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478817|NCT04194957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64478818|NCT04194957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478819|NCT04194957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64478820|NCT04194957|Immunologic Factors|immunologic factors|mesh-ancestor
64478821|NCT04194957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979627|NCT00280501|Sulpiride|sulpiride|mesh-list
65277911|NCT02536014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65277912|NCT02536014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277913|NCT02536014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65277914|NCT02536014|Analgesics|analgesics|mesh-ancestor
65277915|NCT02536014|Sensory System Agents|sensory system agents|mesh-ancestor
65277916|NCT02536014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277917|NCT02536014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65277918|NCT02536014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65277919|NCT02536014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65277920|NCT02536014|Adrenergic Agents|adrenergic agents|mesh-ancestor
65277921|NCT02536014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65277922|NCT02536014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277923|NCT02653014|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
65277925|NCT02653014|Hormone Antagonists|hormone antagonists|mesh-ancestor
65277926|NCT02653014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65277927|NCT02653014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277928|NCT02653014|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65277929|NCT02653014|Diuretics|diuretics|mesh-ancestor
65277930|NCT02653014|Natriuretic Agents|natriuretic agents|mesh-ancestor
65277931|NCT02653014|Hormones|hormones|mesh-ancestor
65277932|NCT00886613|Vaccines|vaccines|mesh-list
65277933|NCT00886613|Immunologic Factors|immunologic factors|mesh-ancestor
64478842|NCT04171167|Fluticasone|fluticasone|mesh-list
64478843|NCT04171167|Xhance|xhance|mesh-list
64478844|NCT04171167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64478845|NCT04171167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64478846|NCT04171167|Autonomic Agents|autonomic agents|mesh-ancestor
64478847|NCT04171167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478848|NCT04171167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478849|NCT04171167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64478850|NCT04171167|Respiratory System Agents|respiratory system agents|mesh-ancestor
64478851|NCT04171167|Dermatologic Agents|dermatologic agents|mesh-ancestor
64478852|NCT04171167|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64478853|NCT04406883|Simvastatin|simvastatin|mesh-list
64478854|NCT04406883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64478855|NCT04406883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64478856|NCT04406883|Antimetabolites|antimetabolites|mesh-ancestor
64478857|NCT04406883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478858|NCT04406883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64478859|NCT04406883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64478860|NCT04406883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478861|NCT04199325|Uric Acid|uric acid|mesh-list
64478862|NCT04199325|Antioxidants|antioxidants|mesh-ancestor
64478863|NCT04199325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478864|NCT04199325|Protective Agents|protective agents|mesh-ancestor
64478865|NCT04199325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478866|NCT03952299|Mandelic Acids|mandelic acids|mesh-list
64478867|NCT03952299|Oxybutynin|oxybutynin|mesh-list
64478868|NCT03952299|Parasympatholytics|parasympatholytics|mesh-ancestor
64478869|NCT03952299|Autonomic Agents|autonomic agents|mesh-ancestor
64478870|NCT03952299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277934|NCT00886613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277935|NCT00653016|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65277936|NCT00653016|Norelgestromin|norelgestromin|mesh-list
65277937|NCT00653016|Estradiol|estradiol|mesh-list
65277938|NCT00653016|Estrogens|estrogens|mesh-ancestor
65277939|NCT00653016|Hormones|hormones|mesh-ancestor
65277940|NCT00653016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65277941|NCT00653016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277942|NCT00653016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65277943|NCT00653016|Contraceptive Agents|contraceptive agents|mesh-ancestor
65277944|NCT00653016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65277945|NCT00653016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64478871|NCT03952299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478872|NCT03952299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64478873|NCT03952299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64478874|NCT03952299|Cholinergic Agents|cholinergic agents|mesh-ancestor
64478875|NCT03952299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64478876|NCT03952299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478877|NCT03952299|Urological Agents|urological agents|mesh-ancestor
64478878|NCT03952299|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64979680|NCT00280774|Memantine|memantine|mesh-list
64478896|NCT03597867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478897|NCT03597867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478898|NCT03597867|Gout Suppressants|gout suppressants|mesh-ancestor
64478900|NCT03597867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64478901|NCT03597555|Sodium Oxybate|sodium oxybate|mesh-list
64478902|NCT03597555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64478903|NCT03597555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64478904|NCT03597555|Anesthetics, General|anesthetics, general|mesh-ancestor
64478905|NCT03597555|Anesthetics|anesthetics|mesh-ancestor
64478906|NCT03597555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64478907|NCT03597555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478908|NCT03597477|Dexmedetomidine|dexmedetomidine|mesh-list
64478909|NCT03597477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64478910|NCT03597477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64478911|NCT03597477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478912|NCT03597477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64478913|NCT03597477|Analgesics|analgesics|mesh-ancestor
64478914|NCT03597477|Sensory System Agents|sensory system agents|mesh-ancestor
64478915|NCT03597477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478916|NCT03597477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64478917|NCT03597477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64478918|NCT03597477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64478919|NCT03597477|Adrenergic Agents|adrenergic agents|mesh-ancestor
64478920|NCT03597477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64478921|NCT03597477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478922|NCT04193319|Fluconazole|fluconazole|mesh-list
64478923|NCT04193319|Antifungal Agents|antifungal agents|mesh-ancestor
64478924|NCT04193319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64478925|NCT04193319|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64478926|NCT04193319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64478927|NCT04193319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478928|NCT04193319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478929|NCT04193319|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64478930|NCT04193319|Hormone Antagonists|hormone antagonists|mesh-ancestor
64478931|NCT04193319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64478932|NCT04193319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471389|NCT04546009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64471390|NCT04546009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277946|NCT00653016|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65277947|NCT00653016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65277948|NCT00886379|Vitamin D|vitamin d|mesh-list
65277949|NCT00886379|Ergocalciferols|ergocalciferols|mesh-list
65277950|NCT00886379|Cholecalciferol|cholecalciferol|mesh-list
65277951|NCT00886379|Vitamins|vitamins|mesh-list
65277952|NCT00886379|Micronutrients|micronutrients|mesh-ancestor
65277953|NCT00886379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277954|NCT00886379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65277955|NCT00886379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65277956|NCT00633581|Ascorbic Acid|ascorbic acid|mesh-list
65277957|NCT00633581|Vitamins|vitamins|mesh-ancestor
65277958|NCT00633581|Micronutrients|micronutrients|mesh-ancestor
65277959|NCT00633581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277960|NCT00633581|Antioxidants|antioxidants|mesh-ancestor
64730451|NCT04563962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64471391|NCT04546009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64478950|NCT04192617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64478951|NCT04026009|Vaccines|vaccines|mesh-list
64478952|NCT04026009|Immunologic Factors|immunologic factors|mesh-ancestor
64478953|NCT04026009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478954|NCT01874665|Ponatinib|ponatinib|mesh-list
64478955|NCT01874665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478956|NCT01874665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64478957|NCT01874665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478958|NCT01874665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478959|NCT04766151|Nitroglycerin|nitroglycerin|mesh-list
64478960|NCT04766151|Vasodilator Agents|vasodilator agents|mesh-ancestor
64478961|NCT04028739|Curcumin|curcumin|mesh-list
64478962|NCT04028739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64478963|NCT04028739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64478964|NCT04028739|Analgesics|analgesics|mesh-ancestor
64478965|NCT04028739|Sensory System Agents|sensory system agents|mesh-ancestor
64478966|NCT04028739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478967|NCT04028739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478968|NCT04028739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64478969|NCT04028739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64478970|NCT04028739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478971|NCT04028739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478972|NCT04028739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478973|NCT04028505|Terlipressin|terlipressin|mesh-list
64478974|NCT04028505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64478975|NCT04028505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64479003|NCT01873495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64479005|NCT01873495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64479006|NCT01873495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479007|NCT01873495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479008|NCT04027959|Vitamin B 12|vitamin b 12|mesh-list
64479009|NCT04027959|Hydroxocobalamin|hydroxocobalamin|mesh-list
64479010|NCT04027959|Vitamins|vitamins|mesh-ancestor
64479011|NCT04027959|Micronutrients|micronutrients|mesh-ancestor
64479012|NCT04027959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479013|NCT04027959|Vitamin B Complex|vitamin b complex|mesh-ancestor
64479014|NCT04027959|Hematinics|hematinics|mesh-ancestor
64479015|NCT04344951|Chloroquine|chloroquine|mesh-list
64479016|NCT04344951|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64479017|NCT04344951|Amebicides|amebicides|mesh-ancestor
64479018|NCT04344951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64479019|NCT04344951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64479020|NCT04344951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479021|NCT04344951|Antimalarials|antimalarials|mesh-ancestor
65277961|NCT00633581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277962|NCT00633581|Protective Agents|protective agents|mesh-ancestor
65277963|NCT02825147|Dexamethasone|dexamethasone|mesh-list
65277964|NCT02825147|Methotrexate|methotrexate|mesh-list
65277965|NCT02825147|Etoposide|etoposide|mesh-list
65277966|NCT02825147|Pegaspargase|pegaspargase|mesh-list
65277967|NCT02825147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65277968|NCT02825147|Antiemetics|antiemetics|mesh-ancestor
65277969|NCT02825147|Autonomic Agents|autonomic agents|mesh-ancestor
65277970|NCT02825147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65277971|NCT02825147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277972|NCT02825147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65277973|NCT02825147|Glucocorticoids|glucocorticoids|mesh-ancestor
65277974|NCT02825147|Hormones|hormones|mesh-ancestor
65277975|NCT02825147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65277976|NCT02825147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65277977|NCT02825147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65277978|NCT02825147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65277979|NCT02825147|Abortifacient Agents|abortifacient agents|mesh-ancestor
65277980|NCT02825147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64730466|NCT04929847|Emollients|emollients|mesh-list
64479022|NCT04344951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64979843|NCT00281593|Telmisartan|telmisartan|mesh-list
64479042|NCT02080455|Atorvastatin|atorvastatin|mesh-list
64479043|NCT02080455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64479044|NCT02080455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64479045|NCT02080455|Antimetabolites|antimetabolites|mesh-ancestor
64479046|NCT02080455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479047|NCT02080455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64479048|NCT02080455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64479049|NCT02080455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600900|NCT01279499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64479050|NCT01852591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64479051|NCT01852591|Immunologic Factors|immunologic factors|mesh-ancestor
64479052|NCT01852591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479054|NCT04021173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64479055|NCT04021173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64479056|NCT04021173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479057|NCT01852045|Botulinum Toxins|botulinum toxins|mesh-list
64479058|NCT01852045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64479059|NCT01852045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64479060|NCT01852045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64479061|NCT01852045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64479062|NCT01852045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479063|NCT01852045|Cholinergic Agents|cholinergic agents|mesh-ancestor
64479064|NCT01852045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64479065|NCT01852045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479066|NCT01852045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64479067|NCT01852045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64479068|NCT03960957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64479069|NCT03960957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64479070|NCT03960957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64479071|NCT03960957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65277981|NCT02825147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65277982|NCT02825147|Antimetabolites|antimetabolites|mesh-ancestor
65277983|NCT02825147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65277984|NCT02825147|Dermatologic Agents|dermatologic agents|mesh-ancestor
65277985|NCT02825147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65277986|NCT02825147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64479072|NCT03960957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479073|NCT03960957|Cholinergic Agents|cholinergic agents|mesh-ancestor
64479074|NCT03960957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64479102|NCT03950427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64479103|NCT03950427|Antidepressive Agents|antidepressive agents|mesh-ancestor
64479105|NCT03950427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64479106|NCT03950427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64479107|NCT03950427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64479108|NCT03950427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479109|NCT03950427|Dopamine Agents|dopamine agents|mesh-ancestor
64479110|NCT03950427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64479111|NCT03950427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479112|NCT03950427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64479113|NCT03950427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64479114|NCT03950427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479116|NCT01872715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64479117|NCT01872715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479118|NCT01872715|Antimalarials|antimalarials|mesh-ancestor
64479119|NCT01872715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64479120|NCT01872715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64479122|NCT03932643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479123|NCT01613599|Rituximab|rituximab|mesh-list
64479124|NCT01613599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64479126|NCT01613599|Immunologic Factors|immunologic factors|mesh-ancestor
64979953|NCT00281944|Leucovorin|leucovorin|mesh-list
64479141|NCT04024683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479142|NCT04024683|Sensory System Agents|sensory system agents|mesh-ancestor
64479143|NCT04024683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64479145|NCT04024527|Metronidazole|metronidazole|mesh-list
64479146|NCT04024527|Esomeprazole|esomeprazole|mesh-list
64479147|NCT04024527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64479148|NCT04024527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479149|NCT04024527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64479150|NCT04024527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64479151|NCT04024527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64479152|NCT04024527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64479153|NCT04024527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64479154|NCT04024527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479155|NCT04024527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479156|NCT01819129|Insulin|insulin|mesh-list
64479157|NCT01819129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64479158|NCT01819129|Insulin Glargine|insulin glargine|mesh-list
64479159|NCT01819129|Insulin Aspart|insulin aspart|mesh-list
64479160|NCT01819129|Insulin, Long-Acting|insulin, long-acting|mesh-list
64479161|NCT01819129|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64479162|NCT01819129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64479163|NCT01819129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479164|NCT04025775|Insulin|insulin|mesh-list
64464713|NCT02718118|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64479165|NCT04025775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64479166|NCT04025775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479167|NCT04022811|Tobramycin|tobramycin|mesh-list
64479168|NCT04022811|Dexamethasone|dexamethasone|mesh-list
64479169|NCT04022811|Bromfenac|bromfenac|mesh-list
64479170|NCT04022811|Hyaluronic Acid|hyaluronic acid|mesh-list
64479171|NCT04022811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64479172|NCT04022811|Antiemetics|antiemetics|mesh-ancestor
64479173|NCT04022811|Autonomic Agents|autonomic agents|mesh-ancestor
64479174|NCT04022811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64479175|NCT04022811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479176|NCT04022811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64479177|NCT04022811|Glucocorticoids|glucocorticoids|mesh-ancestor
64479178|NCT04022811|Hormones|hormones|mesh-ancestor
65277987|NCT02825147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65277988|NCT02825147|Immunologic Factors|immunologic factors|mesh-ancestor
65277989|NCT02825147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65277990|NCT02825147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65277991|NCT02825147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65277992|NCT02825147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65277993|NCT02825147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65277994|NCT02825225|Anesthetics|anesthetics|mesh-list
65277995|NCT02825225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65277996|NCT02825225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65277997|NCT00637949|Rofecoxib|rofecoxib|mesh-list
65277998|NCT00637949|Lumiracoxib|lumiracoxib|mesh-list
65277999|NCT00637949|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65278000|NCT00637949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65278001|NCT00637949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278002|NCT00637949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278003|NCT00637949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65278004|NCT00637949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65278005|NCT00637949|Analgesics|analgesics|mesh-ancestor
65278006|NCT00637949|Sensory System Agents|sensory system agents|mesh-ancestor
65278007|NCT00637949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65278008|NCT00637949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278009|NCT00637949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65278010|NCT00637949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65278011|NCT04242017|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64730492|NCT04173793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64479179|NCT04022811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64479180|NCT04022811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64479181|NCT04022811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479182|NCT04022811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64479183|NCT04022811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479219|NCT04145193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479220|NCT04145193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64479222|NCT04145193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64479257|NCT01849783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64479259|NCT01849783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479260|NCT01849783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479261|NCT01849783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64479262|NCT01849783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64479263|NCT01849783|Antiemetics|antiemetics|mesh-ancestor
64479264|NCT01849783|Autonomic Agents|autonomic agents|mesh-ancestor
64479290|NCT04170517|Progestins|progestins|mesh-ancestor
64479292|NCT04170517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64479293|NCT04170517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479294|NCT01848457|Methotrexate|methotrexate|mesh-list
65278012|NCT04242017|Luteolytic Agents|luteolytic agents|mesh-ancestor
65278013|NCT04242017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65278014|NCT04242017|Contraceptive Agents|contraceptive agents|mesh-ancestor
65278015|NCT04242017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65278016|NCT04242017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278017|NCT04242017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65278018|NCT04242017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65278019|NCT04242017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65278020|NCT05660135|Amlodipine|amlodipine|mesh-list
65278021|NCT05660135|Olmesartan|olmesartan|mesh-list
65278022|NCT05660135|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65278023|NCT05660135|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65278024|NCT05660135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65278025|NCT05660135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65278026|NCT05660135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65278027|NCT05660135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278028|NCT05660135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65278029|NCT05660135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278030|NCT05660135|Vasodilator Agents|vasodilator agents|mesh-ancestor
65278031|NCT05660135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65278032|NCT05660135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65278033|NCT05660135|Antimetabolites|antimetabolites|mesh-ancestor
64479295|NCT01848457|Pantoprazole|pantoprazole|mesh-list
64479296|NCT01848457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64479297|NCT01848457|Abortifacient Agents|abortifacient agents|mesh-ancestor
64479298|NCT01848457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64479299|NCT01848457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479300|NCT01848457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64479301|NCT01848457|Antimetabolites|antimetabolites|mesh-ancestor
64479302|NCT01848457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479303|NCT01848457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479304|NCT01848457|Dermatologic Agents|dermatologic agents|mesh-ancestor
64479305|NCT01848457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479306|NCT01848457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64479307|NCT01848457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64479308|NCT01848457|Immunologic Factors|immunologic factors|mesh-ancestor
64479309|NCT01848457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64479310|NCT01848457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64479311|NCT01848457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64980126|NCT00283114|Lintuzumab|lintuzumab|mesh-list
64479339|NCT01870921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479340|NCT01870921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479341|NCT00526474|Vorapaxar|vorapaxar|mesh-list
64479342|NCT00526474|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64479343|NCT01848145|Ofatumumab|ofatumumab|mesh-list
64479344|NCT01848145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479345|NCT00527644|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64600904|NCT01279499|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64479346|NCT00527644|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64479347|NCT00527644|beta-Endorphin|beta-endorphin|mesh-list
64479349|NCT00527644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65278034|NCT05660135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65278035|NCT05660135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65278036|NCT05660135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278037|NCT05660135|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65278038|NCT05660135|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65278039|NCT00599196|Rotigotine|rotigotine|mesh-list
65278040|NCT00599196|Dopamine Agonists|dopamine agonists|mesh-ancestor
65278041|NCT00599196|Dopamine Agents|dopamine agents|mesh-ancestor
65278042|NCT00599196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65278043|NCT00599196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278044|NCT00599196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278045|NCT04201145|Pembrolizumab|pembrolizumab|mesh-list
65278046|NCT04201145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65278047|NCT04201145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65278048|NCT02824601|Calcium|calcium|mesh-list
65278049|NCT02824601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65278050|NCT02824601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278051|NCT02643732|Methylphenidate|methylphenidate|mesh-list
65278052|NCT02643732|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65278053|NCT02643732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278054|NCT02643732|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65278055|NCT02643732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65278056|NCT02643732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64730540|NCT04173403|Ezetimibe|ezetimibe|mesh-list
64479350|NCT00527644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479351|NCT00527644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64479352|NCT00527644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479353|NCT01847443|Nicotine|nicotine|mesh-list
64479354|NCT01847443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64980171|NCT00283621|Doxorubicin|doxorubicin|mesh-list
64479384|NCT05621668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479385|NCT05621668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64479386|NCT05621434|Maleic acid|maleic acid|mesh-list
64479387|NCT05621434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479388|NCT05621434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479390|NCT04741204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64479391|NCT04741204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479392|NCT01870843|Citalopram|citalopram|mesh-list
64479393|NCT01870843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64479394|NCT01870843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64479395|NCT01870843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64479408|NCT01816477|Sensory System Agents|sensory system agents|mesh-ancestor
64513670|NCT01457937|Antiviral Agents|antiviral agents|mesh-ancestor
64513671|NCT01457937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479409|NCT01816477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64479410|NCT01846507|Tranexamic Acid|tranexamic acid|mesh-list
64479411|NCT01846507|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65278057|NCT02643732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278058|NCT02643732|Dopamine Agents|dopamine agents|mesh-ancestor
65278059|NCT02643732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65278060|NCT04876937|Dexmedetomidine|dexmedetomidine|mesh-list
65278061|NCT04876937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65278062|NCT04876937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65278063|NCT04876937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278064|NCT04876937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65278065|NCT04876937|Analgesics|analgesics|mesh-ancestor
65278066|NCT04876937|Sensory System Agents|sensory system agents|mesh-ancestor
65278067|NCT04876937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65278068|NCT04876937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65278119|NCT04165902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278120|NCT04165902|Viscosupplements|viscosupplements|mesh-ancestor
65278121|NCT04165902|Protective Agents|protective agents|mesh-ancestor
65278122|NCT04861181|Niraparib|niraparib|mesh-list
65278123|NCT04861181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65278124|NCT04861181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278125|NCT04861181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278126|NCT04861181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65278127|NCT00603512|Tofacitinib|tofacitinib|mesh-list
65278128|NCT00603512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65278129|NCT00603512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278130|NCT00603512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278131|NCT04167774|Paclitaxel|paclitaxel|mesh-list
65278132|NCT04167774|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65278133|NCT04167774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65278134|NCT04167774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65278135|NCT04167774|Tubulin Modulators|tubulin modulators|mesh-ancestor
65278136|NCT04167774|Antimitotic Agents|antimitotic agents|mesh-ancestor
65278137|NCT04167774|Mitosis Modulators|mitosis modulators|mesh-ancestor
65278138|NCT04167774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278139|NCT02640300|Clozapine|clozapine|mesh-list
65278140|NCT02640300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65278141|NCT02640300|Serotonin Agents|serotonin agents|mesh-ancestor
65278142|NCT02640300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64479412|NCT01846507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64479413|NCT01846507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479414|NCT01846507|Hemostatics|hemostatics|mesh-ancestor
64479415|NCT01846507|Coagulants|coagulants|mesh-ancestor
64479416|NCT01846039|Hyaluronic Acid|hyaluronic acid|mesh-list
64479417|NCT01846039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64479418|NCT01846039|Immunologic Factors|immunologic factors|mesh-ancestor
64479419|NCT01846039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479420|NCT01846039|Viscosupplements|viscosupplements|mesh-ancestor
64479421|NCT01846039|Protective Agents|protective agents|mesh-ancestor
64479422|NCT04699240|Clotrimazole|clotrimazole|mesh-list
64471403|NCT04539938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64471404|NCT04539938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479424|NCT04699240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64479425|NCT04699240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479426|NCT04699240|Antifungal Agents|antifungal agents|mesh-ancestor
64479427|NCT04699240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64479428|NCT04699240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64479429|NCT04699240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479430|NCT04699240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479431|NCT04699240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64479432|NCT04699240|Hormone Antagonists|hormone antagonists|mesh-ancestor
64479433|NCT04699240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64479434|NCT04699240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278143|NCT02640300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278144|NCT02640300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278145|NCT02640300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65278146|NCT02640300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65278147|NCT02640300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65278148|NCT02640300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65278149|NCT02640300|GABA Antagonists|gaba antagonists|mesh-ancestor
65278150|NCT02640300|GABA Agents|gaba agents|mesh-ancestor
65278151|NCT02640144|Hyaluronic Acid|hyaluronic acid|mesh-list
65278152|NCT02640144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65278153|NCT02640144|Immunologic Factors|immunologic factors|mesh-ancestor
65278154|NCT02640144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278155|NCT02640144|Viscosupplements|viscosupplements|mesh-ancestor
64479435|NCT04699240|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64479436|NCT04699240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64479437|NCT01610167|Listerine|listerine|mesh-list
64479438|NCT01610167|Fluorides|fluorides|mesh-list
64479439|NCT01610167|Sodium Fluoride|sodium fluoride|mesh-list
64479440|NCT01610167|Cariostatic Agents|cariostatic agents|mesh-ancestor
64479441|NCT01610167|Protective Agents|protective agents|mesh-ancestor
64479442|NCT01610167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479443|NCT01610167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64479444|NCT01610167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479445|NCT04478500|Minocycline|minocycline|mesh-list
64479446|NCT04478500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64479447|NCT04478500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479448|NCT01816243|Fentanyl|fentanyl|mesh-list
64479449|NCT01816243|Morphine|morphine|mesh-list
64479450|NCT01816243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64479451|NCT01816243|Narcotics|narcotics|mesh-ancestor
64479452|NCT01816243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64980255|NCT00284323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64479464|NCT05576896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64479465|NCT05576896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479466|NCT05576896|Antimalarials|antimalarials|mesh-ancestor
64479467|NCT05576896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64479468|NCT05576896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64479469|NCT05576896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479470|NCT05576896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479471|NCT05576896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479472|NCT05576896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64479473|NCT01845805|Azacitidine|azacitidine|mesh-list
64479474|NCT01845805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64479475|NCT01845805|Antimetabolites|antimetabolites|mesh-ancestor
64479476|NCT01845805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479477|NCT01845805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479478|NCT01845805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479479|NCT05575804|Capecitabine|capecitabine|mesh-list
64479480|NCT05575804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64479481|NCT05575804|Antimetabolites|antimetabolites|mesh-ancestor
64479482|NCT05575804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479483|NCT05575804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479484|NCT01845025|Fluticasone|fluticasone|mesh-list
64479486|NCT01845025|Formoterol Fumarate|formoterol fumarate|mesh-list
64479487|NCT01845025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64479488|NCT01845025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64479489|NCT01845025|Autonomic Agents|autonomic agents|mesh-ancestor
64479490|NCT01845025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64479491|NCT01845025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479492|NCT01845025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64479493|NCT01845025|Respiratory System Agents|respiratory system agents|mesh-ancestor
64479494|NCT01845025|Dermatologic Agents|dermatologic agents|mesh-ancestor
65278156|NCT02640144|Protective Agents|protective agents|mesh-ancestor
65278157|NCT02643186|Misoprostol|misoprostol|mesh-list
65278158|NCT02643186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65278159|NCT02643186|Abortifacient Agents|abortifacient agents|mesh-ancestor
65278160|NCT02643186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65278161|NCT02643186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278162|NCT02643186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65278163|NCT02643186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65278164|NCT02643186|Oxytocics|oxytocics|mesh-ancestor
65278165|NCT02652312|Diclofenac|diclofenac|mesh-list
65278166|NCT02652312|Fentanyl|fentanyl|mesh-list
65278167|NCT02652312|Dexmedetomidine|dexmedetomidine|mesh-list
65278168|NCT02652312|Ondansetron|ondansetron|mesh-list
65278169|NCT02652312|Propofol|propofol|mesh-list
65278170|NCT02652312|Desflurane|desflurane|mesh-list
65278171|NCT02652312|Atracurium|atracurium|mesh-list
65278172|NCT02652312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65278173|NCT02652312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65278174|NCT02652312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278175|NCT02652312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65278176|NCT02652312|Anesthetics, General|anesthetics, general|mesh-ancestor
65278177|NCT02652312|Anesthetics|anesthetics|mesh-ancestor
65278178|NCT02652312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65278179|NCT02652312|Analgesics|analgesics|mesh-ancestor
65278180|NCT02652312|Sensory System Agents|sensory system agents|mesh-ancestor
64730666|NCT00002905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64469909|NCT05629585|Durvalumab|durvalumab|mesh-list
64479495|NCT01845025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64479496|NCT01845025|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64479497|NCT01845025|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64479498|NCT01845025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64479499|NCT01845025|Adrenergic Agents|adrenergic agents|mesh-ancestor
64479500|NCT01845025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64479501|NCT01845025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479502|NCT04148872|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64479503|NCT04148872|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64479504|NCT04148872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64479505|NCT04148872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479506|NCT04148872|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64479507|NCT04148872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64479508|NCT04148872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479509|NCT04148872|Cholinergic Agents|cholinergic agents|mesh-ancestor
64479510|NCT04148872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64479512|NCT05072236|Anesthetics, Local|anesthetics, local|mesh-ancestor
64479513|NCT05072236|Anesthetics|anesthetics|mesh-ancestor
64479514|NCT05072236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64479515|NCT05072236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479516|NCT05072236|Sensory System Agents|sensory system agents|mesh-ancestor
64479548|NCT03667846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64479549|NCT03667846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479551|NCT03519412|Temozolomide|temozolomide|mesh-list
65278181|NCT02652312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65278182|NCT02652312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65278183|NCT02652312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65278184|NCT02652312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65278185|NCT02652312|Adrenergic Agents|adrenergic agents|mesh-ancestor
65278186|NCT02652312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65278187|NCT02652312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278188|NCT02652312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65278189|NCT02652312|Narcotics|narcotics|mesh-ancestor
65278190|NCT02652312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65278191|NCT02652312|Antiemetics|antiemetics|mesh-ancestor
65278192|NCT02652312|Autonomic Agents|autonomic agents|mesh-ancestor
65278193|NCT02652312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65278194|NCT02652312|Antipruritics|antipruritics|mesh-ancestor
64730690|NCT00002917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64730691|NCT00002917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730692|NCT00002917|Tubulin Modulators|tubulin modulators|mesh-ancestor
64730693|NCT00002917|Antimitotic Agents|antimitotic agents|mesh-ancestor
64479552|NCT03519412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64479553|NCT03519412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479554|NCT03519412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64479555|NCT03519412|Alkylating Agents|alkylating agents|mesh-ancestor
64479556|NCT03519412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513672|NCT01457937|Antimetabolites|antimetabolites|mesh-ancestor
64479557|NCT05174650|Atezolizumab|atezolizumab|mesh-list
64479569|NCT04616248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64479570|NCT04616248|Antibodies|antibodies|mesh-list
64479571|NCT04616248|Immunoglobulins|immunoglobulins|mesh-list
64479572|NCT04616248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64479573|NCT04616248|Poly ICLC|poly iclc|mesh-list
64479574|NCT04616248|Flt3 ligand protein|flt3 ligand protein|mesh-list
64479575|NCT04616248|Immunologic Factors|immunologic factors|mesh-ancestor
64479576|NCT04616248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479577|NCT04616248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479578|NCT04616248|Interferon Inducers|interferon inducers|mesh-ancestor
64479579|NCT04616248|Laxatives|laxatives|mesh-ancestor
64479580|NCT04616248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64479581|NCT04616248|Antiviral Agents|antiviral agents|mesh-ancestor
64479582|NCT04616248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479583|NCT04616248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64479584|NCT04616248|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64479585|NCT04616248|Protective Agents|protective agents|mesh-ancestor
64479586|NCT01798030|Vitamin D|vitamin d|mesh-list
64479587|NCT01798030|Vitamins|vitamins|mesh-ancestor
64479588|NCT01798030|Micronutrients|micronutrients|mesh-ancestor
64479589|NCT01798030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479590|NCT01798030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64479591|NCT03329950|Pembrolizumab|pembrolizumab|mesh-list
64479592|NCT03329950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64479593|NCT03329950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479594|NCT01814371|Mupirocin|mupirocin|mesh-list
64479595|NCT01814371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64479596|NCT01814371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479597|NCT01814371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64479598|NCT01814371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479599|NCT01814371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479600|NCT03232138|Sulforaphane|sulforaphane|mesh-list
64479601|NCT03232138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65278195|NCT02652312|Dermatologic Agents|dermatologic agents|mesh-ancestor
65278196|NCT02652312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65278197|NCT02652312|Serotonin Agents|serotonin agents|mesh-ancestor
65278198|NCT02652312|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65278199|NCT02652312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65278200|NCT02652312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65278201|NCT02652312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65278202|NCT02652312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65278203|NCT02652312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65278204|NCT02652312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65278205|NCT02652312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65278206|NCT02652312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479602|NCT03232138|Protective Agents|protective agents|mesh-ancestor
64479603|NCT03232138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479604|NCT03232138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479605|NCT01814137|Insulin|insulin|mesh-list
64479606|NCT01814137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64479607|NCT01814137|Insulin Aspart|insulin aspart|mesh-list
64479608|NCT01814137|Insulin, Long-Acting|insulin, long-acting|mesh-list
64479609|NCT01814137|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64479610|NCT01814137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64479611|NCT01814137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479612|NCT01813435|Aspirin|aspirin|mesh-list
64479613|NCT01813435|Clopidogrel|clopidogrel|mesh-list
64479614|NCT01813435|Ticagrelor|ticagrelor|mesh-list
64479615|NCT01813435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64479616|NCT01813435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64479617|NCT01813435|Analgesics|analgesics|mesh-ancestor
64479618|NCT01813435|Sensory System Agents|sensory system agents|mesh-ancestor
64479619|NCT01813435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64479620|NCT01813435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479621|NCT01813435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64479622|NCT01813435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64479623|NCT01813435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64980425|NCT00285727|Ropinirole|ropinirole|mesh-list
64479646|NCT01813357|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64479647|NCT01813357|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64479648|NCT01813357|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64479649|NCT01813357|Antimetabolites|antimetabolites|mesh-ancestor
64479650|NCT01813357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479651|NCT01813357|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64479652|NCT01813357|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64479653|NCT01813357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479654|NCT02346526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64479655|NCT02346526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479656|NCT03944902|Niraparib|niraparib|mesh-list
64479657|NCT03944902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64479658|NCT03944902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479659|NCT03944902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479660|NCT03944902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479661|NCT01811953|Metformin|metformin|mesh-list
64479662|NCT01811953|Empagliflozin|empagliflozin|mesh-list
64479663|NCT01811953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64479664|NCT01811953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479665|NCT01811953|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64479666|NCT01811953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479667|NCT03895762|Fentanyl|fentanyl|mesh-list
64479668|NCT03895762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64479669|NCT03895762|Narcotics|narcotics|mesh-ancestor
64479670|NCT03895762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64980490|NCT00077519|Tipifarnib|tipifarnib|mesh-list
64479705|NCT00997906|Carboplatin|carboplatin|mesh-list
64479706|NCT00997906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64479707|NCT00997906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65278207|NCT02652312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65278208|NCT02652312|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65278209|NCT02652312|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65278210|NCT02652312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65278211|NCT02652312|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65278212|NCT02652312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65278213|NCT02652312|Cholinergic Agents|cholinergic agents|mesh-ancestor
65278214|NCT04165512|Triamcinolone|triamcinolone|mesh-list
65278215|NCT04165512|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65278216|NCT04165512|Bupivacaine|bupivacaine|mesh-list
65278217|NCT04165512|Anesthetics, Local|anesthetics, local|mesh-ancestor
65278218|NCT04165512|Anesthetics|anesthetics|mesh-ancestor
65278219|NCT04165512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65278220|NCT04165512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278221|NCT04165512|Sensory System Agents|sensory system agents|mesh-ancestor
65278222|NCT04165512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65278223|NCT04165512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65278224|NCT04165512|Glucocorticoids|glucocorticoids|mesh-ancestor
65278225|NCT04165512|Hormones|hormones|mesh-ancestor
65278226|NCT04165512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65278227|NCT04165512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65278228|NCT04165512|Immunologic Factors|immunologic factors|mesh-ancestor
65278230|NCT02642874|Calcium Carbonate|calcium carbonate|mesh-list
65278231|NCT02642874|Calcium|calcium|mesh-list
65278232|NCT02642874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65278233|NCT02642874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278234|NCT02642874|Antacids|antacids|mesh-ancestor
65278235|NCT02642874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278236|NCT02642874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65278253|NCT00653952|Mitosis Modulators|mitosis modulators|mesh-ancestor
65278254|NCT00653952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278255|NCT00650364|Midodrine|midodrine|mesh-list
65278256|NCT00650364|Sympathomimetics|sympathomimetics|mesh-ancestor
65278257|NCT00650364|Autonomic Agents|autonomic agents|mesh-ancestor
65278258|NCT00650364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65278259|NCT00650364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278260|NCT00650364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65278261|NCT00650364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65278262|NCT00650364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64479708|NCT00997906|Tubulin Modulators|tubulin modulators|mesh-ancestor
64479709|NCT00997906|Antimitotic Agents|antimitotic agents|mesh-ancestor
64479710|NCT00997906|Mitosis Modulators|mitosis modulators|mesh-ancestor
64479711|NCT00997906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479736|NCT01798576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479738|NCT01798576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479739|NCT00565084|Ibuprofen|ibuprofen|mesh-list
64479740|NCT00565084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64479741|NCT00565084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64479742|NCT00565084|Analgesics|analgesics|mesh-ancestor
64479743|NCT00565084|Sensory System Agents|sensory system agents|mesh-ancestor
64479744|NCT00565084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64479745|NCT00565084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479746|NCT00565084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64479747|NCT00565084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64479748|NCT00565084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64479749|NCT00565084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479750|NCT00565084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479751|NCT01810783|Brexpiprazole|brexpiprazole|mesh-list
64479752|NCT01810783|Serotonin Agents|serotonin agents|mesh-ancestor
64479753|NCT01810783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64479754|NCT01810783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479755|NCT01810783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479756|NCT01810783|Dopamine Agonists|dopamine agonists|mesh-ancestor
64479757|NCT01810783|Dopamine Agents|dopamine agents|mesh-ancestor
64479758|NCT04170283|Zanubrutinib|zanubrutinib|mesh-list
64479759|NCT04170283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479760|NCT04170283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64479761|NCT04170283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980588|NCT00077597|Epoetin Alfa|epoetin alfa|mesh-list
64479796|NCT03481972|Antimalarials|antimalarials|mesh-ancestor
64479797|NCT03481972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64479798|NCT03481972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64479799|NCT03481972|Antiviral Agents|antiviral agents|mesh-ancestor
64479800|NCT03481972|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64479801|NCT03481972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64479802|NCT01868503|Lapatinib|lapatinib|mesh-list
64479803|NCT01868503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479804|NCT01868503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64479805|NCT01868503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479823|NCT04414969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479824|NCT03293680|Pembrolizumab|pembrolizumab|mesh-list
64479825|NCT03293680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64479826|NCT03293680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479827|NCT01609933|Interferons|interferons|mesh-list
64479828|NCT01609933|Ritonavir|ritonavir|mesh-list
64479829|NCT01609933|Ribavirin|ribavirin|mesh-list
64479830|NCT01609933|Interferon-alpha|interferon-alpha|mesh-list
64479831|NCT01609933|Interferon alpha-2|interferon alpha-2|mesh-list
64479832|NCT01609933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64479833|NCT01609933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479834|NCT01609933|Antiviral Agents|antiviral agents|mesh-ancestor
64479835|NCT01609933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479836|NCT01609933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64479837|NCT01609933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65278263|NCT00650364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65278264|NCT00650364|Adrenergic Agents|adrenergic agents|mesh-ancestor
65278265|NCT00650364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65278266|NCT00650364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278267|NCT04909697|Sivelestat|sivelestat|mesh-list
65278268|NCT04909697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65278269|NCT04909697|Protease Inhibitors|protease inhibitors|mesh-ancestor
65278270|NCT04909697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278271|NCT04909697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479838|NCT01609933|Protease Inhibitors|protease inhibitors|mesh-ancestor
64479839|NCT01609933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479840|NCT01609933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479841|NCT01609933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64479842|NCT01609933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64479843|NCT01609933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64479844|NCT01609933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64479845|NCT01609933|Antimetabolites|antimetabolites|mesh-ancestor
64479846|NCT01609933|Immunologic Factors|immunologic factors|mesh-ancestor
64479847|NCT01609933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479848|NCT05361772|Colchicine|colchicine|mesh-list
64479849|NCT05361772|Gout Suppressants|gout suppressants|mesh-ancestor
64479850|NCT05361772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64479851|NCT05361772|Tubulin Modulators|tubulin modulators|mesh-ancestor
64479852|NCT05361772|Antimitotic Agents|antimitotic agents|mesh-ancestor
64479853|NCT05361772|Mitosis Modulators|mitosis modulators|mesh-ancestor
64479854|NCT05361772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479855|NCT05361772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479856|NCT03031210|Amoxicillin|amoxicillin|mesh-list
64479857|NCT03031210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64479858|NCT03031210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479859|NCT03001882|Nivolumab|nivolumab|mesh-list
64479860|NCT03001882|Ipilimumab|ipilimumab|mesh-list
64479861|NCT03001882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64479862|NCT03001882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479864|NCT03001882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479865|NCT02958514|Tobramycin|tobramycin|mesh-list
64479866|NCT02958514|Dexamethasone|dexamethasone|mesh-list
64479891|NCT01841593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64479892|NCT01841593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479893|NCT01841593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64479894|NCT01841593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479895|NCT01841593|Vasodilator Agents|vasodilator agents|mesh-ancestor
64479896|NCT01841593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64479897|NCT01841593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64479898|NCT01841593|Antiviral Agents|antiviral agents|mesh-ancestor
64479899|NCT01841593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479900|NCT01841593|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64479901|NCT01841593|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64479902|NCT01841593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479903|NCT05236894|Nicotine|nicotine|mesh-list
64479904|NCT05236894|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64479905|NCT05236894|Autonomic Agents|autonomic agents|mesh-ancestor
64479906|NCT05236894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64479907|NCT05236894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479908|NCT05236894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64479909|NCT05236894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64479910|NCT05236894|Cholinergic Agents|cholinergic agents|mesh-ancestor
64479911|NCT05236894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64479912|NCT05236894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479913|NCT04507204|Methylphenidate|methylphenidate|mesh-list
64479914|NCT04507204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64479915|NCT04507204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945391|NCT05664789|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64479918|NCT04507204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65278272|NCT00654108|Ascorbic Acid|ascorbic acid|mesh-list
65278273|NCT00654108|Ciprofloxacin|ciprofloxacin|mesh-list
65278274|NCT00654108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65278275|NCT00654108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65278276|NCT00654108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65278277|NCT00654108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65278278|NCT00654108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278279|NCT00654108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730777|NCT00002941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64479919|NCT04507204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479920|NCT04507204|Dopamine Agents|dopamine agents|mesh-ancestor
64479921|NCT04507204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64479923|NCT05183854|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64479924|NCT05183854|Immunologic Factors|immunologic factors|mesh-ancestor
64479925|NCT05183854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479926|NCT02454322|Magnesium Sulfate|magnesium sulfate|mesh-list
64479927|NCT02454322|Analgesics|analgesics|mesh-ancestor
64479928|NCT02454322|Sensory System Agents|sensory system agents|mesh-ancestor
64479929|NCT02454322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64479930|NCT02454322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479931|NCT02454322|Anesthetics|anesthetics|mesh-ancestor
64479932|NCT02454322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64479933|NCT02454322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64479934|NCT02454322|Anticonvulsants|anticonvulsants|mesh-ancestor
64479935|NCT02454322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64479936|NCT02454322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64479937|NCT02454322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479938|NCT02454322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64479939|NCT02454322|Tocolytic Agents|tocolytic agents|mesh-ancestor
64479940|NCT02454322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64479942|NCT04505566|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64479943|NCT04505566|Lubricant Eye Drops|lubricant eye drops|mesh-list
64479944|NCT04505566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64479945|NCT04505566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64479946|NCT04505566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64479947|NCT04505566|Analgesics|analgesics|mesh-ancestor
64479948|NCT04505566|Sensory System Agents|sensory system agents|mesh-ancestor
64479949|NCT04505566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64479950|NCT04505566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479951|NCT04505566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64479952|NCT04505566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64479953|NCT04505566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64479954|NCT04505566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479955|NCT04505566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479956|NCT05076292|Glucagon|glucagon|mesh-list
64479957|NCT05076292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64479958|NCT05076292|Hormones|hormones|mesh-ancestor
64479959|NCT05076292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64479960|NCT05076292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479961|NCT04789330|Phenylephrine|phenylephrine|mesh-list
64479962|NCT04789330|Oxymetazoline|oxymetazoline|mesh-list
64479963|NCT04789330|Norepinephrine|norepinephrine|mesh-list
64479964|NCT04789330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64479965|NCT04789330|Mydriatics|mydriatics|mesh-ancestor
64479966|NCT04789330|Autonomic Agents|autonomic agents|mesh-ancestor
64479967|NCT04789330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64479968|NCT04789330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479969|NCT04789330|Sympathomimetics|sympathomimetics|mesh-ancestor
64479970|NCT04789330|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64479971|NCT04789330|Nasal Decongestants|nasal decongestants|mesh-ancestor
64479972|NCT04789330|Respiratory System Agents|respiratory system agents|mesh-ancestor
64479973|NCT04789330|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64479974|NCT04789330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64479975|NCT04789330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65278280|NCT00654108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65278281|NCT00654108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65278282|NCT00654108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65278283|NCT00654108|Antioxidants|antioxidants|mesh-ancestor
65278284|NCT00654108|Protective Agents|protective agents|mesh-ancestor
65278285|NCT00654108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278286|NCT00654108|Vitamins|vitamins|mesh-ancestor
65278287|NCT00654108|Micronutrients|micronutrients|mesh-ancestor
65278288|NCT02639598|Topiramate|topiramate|mesh-list
65278289|NCT02639598|Flunarizine|flunarizine|mesh-list
65278290|NCT02639598|Anticonvulsants|anticonvulsants|mesh-ancestor
65278291|NCT02639598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65278292|NCT02639598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278293|NCT02639598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65278294|NCT02639598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65278295|NCT02639598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278296|NCT02639598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65278297|NCT02639598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65278298|NCT02639598|Histamine Antagonists|histamine antagonists|mesh-ancestor
65028304|NCT05807035|Vaccines|vaccines|mesh-list
65278299|NCT02639598|Histamine Agents|histamine agents|mesh-ancestor
65278300|NCT02639598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65278301|NCT02639598|Vasodilator Agents|vasodilator agents|mesh-ancestor
65278302|NCT04907279|Aripiprazole|aripiprazole|mesh-list
65278303|NCT04907279|Antidepressive Agents|antidepressive agents|mesh-ancestor
65278304|NCT04907279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65278305|NCT04907279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65278306|NCT04907279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65278307|NCT04907279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65278308|NCT04907279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278309|NCT04907279|Dopamine Agonists|dopamine agonists|mesh-ancestor
65278310|NCT04907279|Dopamine Agents|dopamine agents|mesh-ancestor
65278311|NCT04907279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65278321|NCT02642718|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65278322|NCT02642718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65278323|NCT02642718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65278324|NCT02642718|Analgesics|analgesics|mesh-ancestor
65278325|NCT02642718|Sensory System Agents|sensory system agents|mesh-ancestor
65278326|NCT02642718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65278327|NCT02642718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278328|NCT02642718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64479976|NCT04789330|Adrenergic Agents|adrenergic agents|mesh-ancestor
64479977|NCT04789330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64479978|NCT04789330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479979|NCT04789330|Protective Agents|protective agents|mesh-ancestor
64479980|NCT02339038|Sofosbuvir|sofosbuvir|mesh-list
64479981|NCT02339038|Ledipasvir|ledipasvir|mesh-list
64479982|NCT02339038|Antiviral Agents|antiviral agents|mesh-ancestor
64479983|NCT02339038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479984|NCT04497298|Vaccines|vaccines|mesh-list
64479985|NCT04497298|Immunologic Factors|immunologic factors|mesh-ancestor
64479986|NCT04497298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479987|NCT04387786|Albuterol|albuterol|mesh-list
64479988|NCT04387786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64480003|NCT00569530|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
64480004|NCT00569530|Respiratory System Agents|respiratory system agents|mesh-ancestor
64480005|NCT04509622|Cytarabine|cytarabine|mesh-list
64480006|NCT04509622|Venetoclax|venetoclax|mesh-list
64480007|NCT04509622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64480008|NCT04509622|Antimetabolites|antimetabolites|mesh-ancestor
64480009|NCT04509622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480010|NCT04509622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480012|NCT04509622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64480013|NCT04509622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64480014|NCT04509622|Immunologic Factors|immunologic factors|mesh-ancestor
64480015|NCT04509622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480016|NCT00570700|Dasatinib|dasatinib|mesh-list
64480017|NCT00570700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480018|NCT00570700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64480019|NCT00570700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480020|NCT00570700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480021|NCT00573508|Solifenacin Succinate|solifenacin succinate|mesh-list
64480022|NCT00573508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64480023|NCT00573508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64480024|NCT00573508|Cholinergic Agents|cholinergic agents|mesh-ancestor
64480025|NCT00573508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64480026|NCT00573508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480027|NCT00573508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480028|NCT00573508|Urological Agents|urological agents|mesh-ancestor
64480029|NCT00574834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64480030|NCT00574834|Ramipril|ramipril|mesh-list
64480031|NCT00574834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64480032|NCT00574834|Diuretics|diuretics|mesh-ancestor
64480033|NCT00574834|Natriuretic Agents|natriuretic agents|mesh-ancestor
64480034|NCT00574834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480035|NCT00574834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64480036|NCT00574834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64480037|NCT00574834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480038|NCT00574834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64480039|NCT00574834|Protease Inhibitors|protease inhibitors|mesh-ancestor
64480040|NCT00574834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480041|NCT04259398|Propofol|propofol|mesh-list
64480042|NCT04259398|Sevoflurane|sevoflurane|mesh-list
64480043|NCT04259398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64480044|NCT04259398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64480045|NCT04259398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480046|NCT04259398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64480047|NCT04259398|Anesthetics, General|anesthetics, general|mesh-ancestor
64480048|NCT04259398|Anesthetics|anesthetics|mesh-ancestor
64980846|NCT00287950|Carboplatin|carboplatin|mesh-list
65278329|NCT02642718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65278330|NCT02642718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65278331|NCT02642718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278332|NCT02642718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278333|NCT02642484|Gabapentin|gabapentin|mesh-list
65278334|NCT02642484|Calcium Carbonate|calcium carbonate|mesh-list
65278335|NCT02642484|Calcium|calcium|mesh-list
64730837|NCT03668041|Antimanic Agents|antimanic agents|mesh-ancestor
64480059|NCT01592110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64480061|NCT01592110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64480062|NCT01592110|Dopamine Agents|dopamine agents|mesh-ancestor
64480063|NCT00578734|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64480064|NCT00578734|Respiratory System Agents|respiratory system agents|mesh-ancestor
64480065|NCT00578968|Tiotropium Bromide|tiotropium bromide|mesh-list
64480066|NCT00578968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64480067|NCT00578968|Autonomic Agents|autonomic agents|mesh-ancestor
64480068|NCT00578968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64480069|NCT00578968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480070|NCT00578968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64480071|NCT00578968|Respiratory System Agents|respiratory system agents|mesh-ancestor
64480072|NCT00578968|Parasympatholytics|parasympatholytics|mesh-ancestor
64480073|NCT00578968|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64480074|NCT00578968|Cholinergic Agents|cholinergic agents|mesh-ancestor
64480075|NCT00578968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64480076|NCT00578968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480077|NCT00579280|Valproic Acid|valproic acid|mesh-list
64480078|NCT00579280|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64480079|NCT00579280|Antidepressive Agents|antidepressive agents|mesh-ancestor
64480080|NCT00579280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64480082|NCT00579280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64480083|NCT00579280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64480084|NCT00579280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480085|NCT00579280|Anticonvulsants|anticonvulsants|mesh-ancestor
64480087|NCT00579280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480088|NCT00579280|GABA Agents|gaba agents|mesh-ancestor
64480089|NCT00579280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64480090|NCT00579280|Antimanic Agents|antimanic agents|mesh-ancestor
64480091|NCT00580294|Oxymorphone|oxymorphone|mesh-list
64480092|NCT00580294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64480093|NCT00580294|Narcotics|narcotics|mesh-ancestor
64480094|NCT00580294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64480095|NCT00580294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480096|NCT00580294|Analgesics|analgesics|mesh-ancestor
64480097|NCT00580294|Sensory System Agents|sensory system agents|mesh-ancestor
64480098|NCT00580294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64480099|NCT00580294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64480100|NCT00580372|Cyclophosphamide|cyclophosphamide|mesh-list
64480101|NCT00580372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64480102|NCT00580372|Immunologic Factors|immunologic factors|mesh-ancestor
64480103|NCT00580372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480104|NCT00580372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64480105|NCT00580372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64480106|NCT00580372|Alkylating Agents|alkylating agents|mesh-ancestor
64480107|NCT00580372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480108|NCT00580372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480109|NCT00580372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64480110|NCT02134210|Etanercept|etanercept|mesh-list
64480111|NCT02134210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64480112|NCT02134210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64480113|NCT02134210|Analgesics|analgesics|mesh-ancestor
64480128|NCT01866319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64480129|NCT01866319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480130|NCT01866319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64480131|NCT01866319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480132|NCT00607672|Candesartan|candesartan|mesh-list
64480134|NCT00607672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64480135|NCT00607672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65278336|NCT02642484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65278337|NCT02642484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278338|NCT02642484|Analgesics|analgesics|mesh-ancestor
65278339|NCT02642484|Sensory System Agents|sensory system agents|mesh-ancestor
65278340|NCT02642484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65278341|NCT02642484|Anticonvulsants|anticonvulsants|mesh-ancestor
65278342|NCT02642484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65278343|NCT02642484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65278344|NCT02642484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65278345|NCT02642484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65278346|NCT02642484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65278347|NCT02642484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65278348|NCT02642484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64730845|NCT00002965|Interferons|interferons|mesh-list
64480136|NCT00607672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64480137|NCT00607672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480138|NCT00607672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64480139|NCT00607672|Protease Inhibitors|protease inhibitors|mesh-ancestor
64480140|NCT00607672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480141|NCT01802515|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64480142|NCT01802515|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64945392|NCT05664789|Antiviral Agents|antiviral agents|mesh-ancestor
64480143|NCT01802515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64480144|NCT01802515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64480145|NCT01802515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480146|NCT01802515|Adrenergic Agents|adrenergic agents|mesh-ancestor
64480147|NCT01802515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64480148|NCT01802515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480150|NCT01802437|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64480151|NCT01802437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64480152|NCT01802437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64480153|NCT01802437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480154|NCT01802437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64480156|NCT01802437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471408|NCT04531982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64471409|NCT04531982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64480157|NCT01802437|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64480158|NCT01802437|Antidepressive Agents|antidepressive agents|mesh-ancestor
64480159|NCT01802437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64480160|NCT01802437|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64480161|NCT01802437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64480162|NCT01802437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480163|NCT00608062|Estradiol|estradiol|mesh-list
64480164|NCT00608062|Ganirelix|ganirelix|mesh-list
64480165|NCT00608062|Estrogens|estrogens|mesh-ancestor
64480166|NCT00608062|Hormones|hormones|mesh-ancestor
64480167|NCT00608062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64480168|NCT00608062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480183|NCT02202772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480185|NCT02202772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64480186|NCT02202772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480187|NCT02202772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64480188|NCT02202772|Immunologic Factors|immunologic factors|mesh-ancestor
64480189|NCT02202772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480190|NCT00582400|Arsenic Trioxide|arsenic trioxide|mesh-list
64480191|NCT00582400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480192|NCT01801735|Meloxicam|meloxicam|mesh-list
65278349|NCT02642484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278350|NCT02642484|Antimanic Agents|antimanic agents|mesh-ancestor
65278351|NCT02642484|Antacids|antacids|mesh-ancestor
65278352|NCT02642484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65278353|NCT00639392|Zoledronic Acid|zoledronic acid|mesh-list
65278354|NCT00639392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65278355|NCT00639392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278356|NCT04185350|Exenatide|exenatide|mesh-list
64480193|NCT01801735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64480194|NCT01801735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64480195|NCT01801735|Analgesics|analgesics|mesh-ancestor
64480196|NCT01801735|Sensory System Agents|sensory system agents|mesh-ancestor
64480197|NCT01801735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64480198|NCT01801735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480199|NCT01801735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64480200|NCT01801735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64480201|NCT01801735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64480202|NCT01801735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64480203|NCT01801735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480204|NCT01801735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480205|NCT01841359|Pramlintide|pramlintide|mesh-list
64480206|NCT01841359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64480207|NCT01841359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480208|NCT00612430|Bevacizumab|bevacizumab|mesh-list
64480209|NCT00612430|Etoposide|etoposide|mesh-list
64480210|NCT00612430|Etoposide phosphate|etoposide phosphate|mesh-list
64480211|NCT00612430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64480212|NCT00612430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480213|NCT00612430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64480214|NCT00612430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64480215|NCT00612430|Growth Substances|growth substances|mesh-ancestor
64480216|NCT00612430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480217|NCT00612430|Growth Inhibitors|growth inhibitors|mesh-ancestor
64480218|NCT00612430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64480219|NCT00612430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64480220|NCT00612430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64480221|NCT00612430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480222|NCT00612430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480225|NCT01571128|Antiviral Agents|antiviral agents|mesh-ancestor
64480226|NCT01571128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64480227|NCT01571128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64480228|NCT01571128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64480229|NCT01571128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480230|NCT01571128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480256|NCT01429168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64480257|NCT01429168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480259|NCT01429168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64480260|NCT01429168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64480261|NCT01429168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64480262|NCT01429168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480263|NCT01429168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480264|NCT00771160|Montelukast|montelukast|mesh-list
64480265|NCT00771160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64480266|NCT00771160|Respiratory System Agents|respiratory system agents|mesh-ancestor
64480267|NCT00771160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64480268|NCT00771160|Hormone Antagonists|hormone antagonists|mesh-ancestor
64480269|NCT00771160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64480270|NCT00771160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480271|NCT00771160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64480272|NCT00771160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64480273|NCT00771160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480274|NCT00756418|Theophylline|theophylline|mesh-list
64480275|NCT00756418|Montelukast|montelukast|mesh-list
64480276|NCT00756418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65278357|NCT04185350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65278358|NCT04185350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278359|NCT04185350|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65278360|NCT04185350|Incretins|incretins|mesh-ancestor
65278361|NCT04185350|Hormones|hormones|mesh-ancestor
64730865|NCT00002977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480277|NCT00756418|Respiratory System Agents|respiratory system agents|mesh-ancestor
64480278|NCT00756418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64480279|NCT00756418|Hormone Antagonists|hormone antagonists|mesh-ancestor
64480304|NCT00615472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64480305|NCT00615472|Narcotics|narcotics|mesh-ancestor
64480306|NCT00615472|Analgesics|analgesics|mesh-ancestor
64480307|NCT00615472|Sensory System Agents|sensory system agents|mesh-ancestor
64480308|NCT00615472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64480309|NCT00615472|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64480310|NCT00615784|Bexarotene|bexarotene|mesh-list
64480311|NCT00615784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480312|NCT00755794|Montelukast|montelukast|mesh-list
64480313|NCT00755794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64480314|NCT00755794|Respiratory System Agents|respiratory system agents|mesh-ancestor
64480315|NCT00755794|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64480316|NCT00755794|Hormone Antagonists|hormone antagonists|mesh-ancestor
64480317|NCT00755794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64480318|NCT00755794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480319|NCT00755794|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64480320|NCT00755794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64480321|NCT00755794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480322|NCT00652444|Simvastatin|simvastatin|mesh-list
64480323|NCT00652444|Ezetimibe|ezetimibe|mesh-list
64480324|NCT00652444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64480325|NCT00652444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64480326|NCT00652444|Antimetabolites|antimetabolites|mesh-ancestor
64480327|NCT00652444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480328|NCT00652444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64480355|NCT00489346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480356|NCT00489346|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64480357|NCT00489346|Hormone Antagonists|hormone antagonists|mesh-ancestor
64480358|NCT00489346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64480359|NCT00489346|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64945393|NCT05664789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64480360|NCT00489346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64480361|NCT00617188|Fulvestrant|fulvestrant|mesh-list
64480362|NCT00617188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64480363|NCT00617188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480364|NCT00617188|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64480365|NCT00617188|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64480366|NCT00617188|Hormone Antagonists|hormone antagonists|mesh-ancestor
64480367|NCT00617188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64480368|NCT00617188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480369|NCT00618436|Phenytoin|phenytoin|mesh-list
64480370|NCT00618436|Levetiracetam|levetiracetam|mesh-list
64480371|NCT00618436|Anticonvulsants|anticonvulsants|mesh-ancestor
64480372|NCT00618436|Nootropic Agents|nootropic agents|mesh-ancestor
64981195|NCT00291109|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64480409|NCT00619684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64480439|NCT00588406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64480440|NCT00588406|Cholinergic Agents|cholinergic agents|mesh-ancestor
64480442|NCT00668434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64480443|NCT00668434|Glucocorticoids|glucocorticoids|mesh-ancestor
64480444|NCT00668434|Hormones|hormones|mesh-ancestor
64480445|NCT00668434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64480446|NCT00668434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480447|NCT00668434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64480448|NCT00668434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480449|NCT00668902|Pantoprazole|pantoprazole|mesh-list
64480450|NCT00668902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64480451|NCT00668902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64480452|NCT00668902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65278362|NCT04185350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65278363|NCT00653172|Streptogramin A|streptogramin a|mesh-list
65278364|NCT00653172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65278365|NCT00653172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65278366|NCT02639520|Fosfomycin|fosfomycin|mesh-list
65278367|NCT02639520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65278368|NCT02639520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65278369|NCT02822729|Timolol|timolol|mesh-list
65278370|NCT02822729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65278371|NCT02822729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65278372|NCT02822729|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65278373|NCT02822729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65278374|NCT02822729|Adrenergic Agents|adrenergic agents|mesh-ancestor
64480453|NCT00668902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480454|NCT00668902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480455|NCT00589888|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64480470|NCT00621946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64480471|NCT00621946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64480472|NCT00621946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64480473|NCT00621946|Parasympatholytics|parasympatholytics|mesh-ancestor
64480474|NCT00621946|Autonomic Agents|autonomic agents|mesh-ancestor
64480475|NCT00621946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64480476|NCT00621946|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64480477|NCT00621946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64480478|NCT00621946|Cholinergic Agents|cholinergic agents|mesh-ancestor
64480479|NCT02139358|Gemcitabine|gemcitabine|mesh-list
64480480|NCT02139358|Trastuzumab|trastuzumab|mesh-list
64480481|NCT02139358|Pertuzumab|pertuzumab|mesh-list
64480482|NCT02139358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64480483|NCT02139358|Antimetabolites|antimetabolites|mesh-ancestor
64480484|NCT02139358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480485|NCT02139358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480486|NCT02139358|Antiviral Agents|antiviral agents|mesh-ancestor
64480487|NCT02139358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64480488|NCT02139358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480489|NCT02139358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64480490|NCT02139358|Immunologic Factors|immunologic factors|mesh-ancestor
64480491|NCT02139358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480492|NCT02139358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64480493|NCT02140372|Colchicine|colchicine|mesh-list
64480494|NCT02140372|Gout Suppressants|gout suppressants|mesh-ancestor
64480495|NCT02140372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64480496|NCT02140372|Tubulin Modulators|tubulin modulators|mesh-ancestor
64480497|NCT02140372|Antimitotic Agents|antimitotic agents|mesh-ancestor
64480498|NCT02140372|Mitosis Modulators|mitosis modulators|mesh-ancestor
64480499|NCT02140372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480500|NCT02140372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480502|NCT00670774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64480503|NCT00670774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64480504|NCT00670774|Immunologic Factors|immunologic factors|mesh-ancestor
64480505|NCT00670774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480506|NCT00672100|Ropivacaine|ropivacaine|mesh-list
64480507|NCT00672100|Anesthetics, Local|anesthetics, local|mesh-ancestor
64480508|NCT00672100|Anesthetics|anesthetics|mesh-ancestor
64945394|NCT05664789|Expectorants|expectorants|mesh-ancestor
64480509|NCT00672100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64480510|NCT00672100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480511|NCT00672100|Sensory System Agents|sensory system agents|mesh-ancestor
64480512|NCT00672100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64480513|NCT00593866|Gemcitabine|gemcitabine|mesh-list
64480514|NCT00593866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64981328|NCT00078845|Amifostine|amifostine|mesh-list
64480532|NCT00626626|Clofarabine|clofarabine|mesh-list
65278375|NCT02822729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65278376|NCT02822729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278377|NCT02822729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278378|NCT02822729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65278379|NCT02822729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65278380|NCT02642250|Metronidazole|metronidazole|mesh-list
65278381|NCT02642250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65278382|NCT02642250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65278383|NCT02642250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65278384|NCT02642250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65278385|NCT00653250|Celecoxib|celecoxib|mesh-list
65278386|NCT00653250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64470143|NCT05536349|Valacyclovir|valacyclovir|mesh-list
64480533|NCT00626626|Cyclophosphamide|cyclophosphamide|mesh-list
64480534|NCT00626626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64480535|NCT00626626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480536|NCT00626626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64480537|NCT00626626|Antimetabolites|antimetabolites|mesh-ancestor
64480538|NCT00626626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480539|NCT00626626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64480540|NCT00626626|Immunologic Factors|immunologic factors|mesh-ancestor
64480541|NCT00626626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480542|NCT00626626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64480543|NCT00626626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64480544|NCT00626626|Alkylating Agents|alkylating agents|mesh-ancestor
64480545|NCT00626626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64480546|NCT00626782|Ranibizumab|ranibizumab|mesh-list
64480547|NCT00626782|Mitomycins|mitomycins|mesh-list
64480548|NCT00626782|Mitomycin|mitomycin|mesh-list
64480549|NCT00626782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64480550|NCT00626782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64480551|NCT00626782|Growth Substances|growth substances|mesh-ancestor
64480552|NCT00626782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480553|NCT00626782|Growth Inhibitors|growth inhibitors|mesh-ancestor
64480554|NCT00626782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480555|NCT00626782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64480556|NCT00626782|Alkylating Agents|alkylating agents|mesh-ancestor
64480557|NCT00626782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480558|NCT00626782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64480559|NCT00626782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480560|NCT00594256|Sodium Oxybate|sodium oxybate|mesh-list
64480561|NCT00594256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64480562|NCT00594256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64480563|NCT00594256|Anesthetics, General|anesthetics, general|mesh-ancestor
64480564|NCT00594256|Anesthetics|anesthetics|mesh-ancestor
64480565|NCT00594256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64480566|NCT00594256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480567|NCT00627406|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64480568|NCT00627406|Buserelin|buserelin|mesh-list
64981381|NCT00275119|Antiviral Agents|antiviral agents|mesh-ancestor
64480592|NCT00674206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480593|NCT00595270|Vaccines|vaccines|mesh-list
64480594|NCT00595270|Immunologic Factors|immunologic factors|mesh-ancestor
64480595|NCT00595270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480596|NCT00628498|Defibrotide|defibrotide|mesh-list
64480597|NCT00628498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64480598|NCT00628498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64471412|NCT04531982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471413|NCT04531982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64480599|NCT00628498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480600|NCT00628498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64480601|NCT00629122|Clotrimazole|clotrimazole|mesh-list
65278387|NCT00653250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65278388|NCT00653250|Analgesics|analgesics|mesh-ancestor
65278389|NCT00653250|Sensory System Agents|sensory system agents|mesh-ancestor
65278390|NCT00653250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65278391|NCT00653250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278392|NCT00653250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65278393|NCT00653250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65278394|NCT00653250|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65278395|NCT00653250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65278396|NCT00653250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278397|NCT00653250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278398|NCT00638534|Telithromycin|telithromycin|mesh-list
65278399|NCT00638534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65278400|NCT00638534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65278401|NCT04240535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65278402|NCT04240535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65278403|NCT04240535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64730901|NCT00003397|Hormones|hormones|mesh-ancestor
64480603|NCT00629122|Nystatin|nystatin|mesh-list
64480604|NCT00629122|Tacrolimus|tacrolimus|mesh-list
64480605|NCT00629122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64480606|NCT00629122|Immunologic Factors|immunologic factors|mesh-ancestor
64480607|NCT00629122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480608|NCT00629122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64480609|NCT00629122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480610|NCT00629122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480611|NCT00629122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64480612|NCT00629122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64480613|NCT00629122|Antifungal Agents|antifungal agents|mesh-ancestor
64480614|NCT00629122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64480615|NCT00629122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64480616|NCT00629122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64480617|NCT00629122|Hormone Antagonists|hormone antagonists|mesh-ancestor
64480618|NCT00629122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64480619|NCT00629122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64981439|NCT00102765|Dermatologic Agents|dermatologic agents|mesh-ancestor
64480643|NCT00633256|Isoniazid|isoniazid|mesh-list
64480644|NCT00633256|Cycloserine|cycloserine|mesh-list
64480645|NCT00633256|Antitubercular Agents|antitubercular agents|mesh-ancestor
64480646|NCT00633256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64480647|NCT00633256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64480648|NCT00633256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64480649|NCT00633256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64480650|NCT00633256|Antimetabolites|antimetabolites|mesh-ancestor
64480651|NCT00633256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480652|NCT00633256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64480653|NCT00633256|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64480654|NCT00633256|Renal Agents|renal agents|mesh-ancestor
64480655|NCT00633256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64480656|NCT00634270|Sirolimus|sirolimus|mesh-list
64480657|NCT00634270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64480658|NCT00634270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64466231|NCT04746040|Autonomic Agents|autonomic agents|mesh-ancestor
64480659|NCT00634270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64480660|NCT00634270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480661|NCT00634270|Antifungal Agents|antifungal agents|mesh-ancestor
64480662|NCT00634270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65278404|NCT04240535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65278405|NCT04240535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278406|NCT04240535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65278407|NCT04240535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65278408|NCT04240535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278409|NCT04240535|Cholinergic Agents|cholinergic agents|mesh-ancestor
64480663|NCT00634270|Immunologic Factors|immunologic factors|mesh-ancestor
64480664|NCT00634270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480665|NCT00675922|Silver Nitrate|silver nitrate|mesh-list
64480666|NCT00675922|Mafenide|mafenide|mesh-list
64480667|NCT00675922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64480668|NCT00675922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64480686|NCT00600340|Mitosis Modulators|mitosis modulators|mesh-ancestor
64480687|NCT00600340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480688|NCT00600340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64480689|NCT00600340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64480690|NCT00600340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64480691|NCT00600340|Growth Substances|growth substances|mesh-ancestor
64480692|NCT00600340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480693|NCT00600340|Growth Inhibitors|growth inhibitors|mesh-ancestor
64480694|NCT00600340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64480695|NCT00600340|Antimetabolites|antimetabolites|mesh-ancestor
64480696|NCT01799356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64480697|NCT01799356|Moxifloxacin|moxifloxacin|mesh-list
64480698|NCT01799356|Metronidazole|metronidazole|mesh-list
64480699|NCT01799356|Ofloxacin|ofloxacin|mesh-list
64480700|NCT01799356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64480701|NCT01799356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64480702|NCT01799356|Antitubercular Agents|antitubercular agents|mesh-ancestor
64480703|NCT01799356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64480704|NCT01799356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64480705|NCT01799356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480706|NCT01799356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480707|NCT01799356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480708|NCT01799356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64480709|NCT01799356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64480710|NCT01799356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64480711|NCT01799356|Renal Agents|renal agents|mesh-ancestor
64480712|NCT01799356|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64480713|NCT01799356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64480714|NCT00602290|Methylphenidate|methylphenidate|mesh-list
64480715|NCT00602290|Citalopram|citalopram|mesh-list
64480716|NCT00602290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64480717|NCT00602290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480718|NCT00602290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64480719|NCT00602290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64480720|NCT00602290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64480721|NCT00602290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480722|NCT00602290|Dopamine Agents|dopamine agents|mesh-ancestor
64480723|NCT00602290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64480724|NCT00602290|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64480725|NCT00602290|Serotonin Agents|serotonin agents|mesh-ancestor
64480734|NCT00637780|Sensory System Agents|sensory system agents|mesh-ancestor
64480735|NCT00637780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64480736|NCT00637780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480737|NCT00637780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64471414|NCT04531982|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64480738|NCT00637780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64480739|NCT00637780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64480740|NCT01799902|Solifenacin Succinate|solifenacin succinate|mesh-list
64480741|NCT01799902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64480742|NCT01799902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64480743|NCT01799902|Cholinergic Agents|cholinergic agents|mesh-ancestor
64480744|NCT01799902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64480745|NCT01799902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278410|NCT04240535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65278411|NCT02638896|Sulfasalazine|sulfasalazine|mesh-list
65278412|NCT02638896|Celecoxib|celecoxib|mesh-list
65278413|NCT02638896|Etanercept|etanercept|mesh-list
65278414|NCT02638896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65278415|NCT02638896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65278416|NCT02638896|Analgesics|analgesics|mesh-ancestor
65278417|NCT02638896|Sensory System Agents|sensory system agents|mesh-ancestor
65278418|NCT02638896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65278419|NCT02638896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278420|NCT02638896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65278421|NCT02638896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65278422|NCT02638896|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65278423|NCT02638896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65278424|NCT02638896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278425|NCT02638896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278426|NCT02638896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65278427|NCT02638896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65278428|NCT02638896|Immunologic Factors|immunologic factors|mesh-ancestor
65278429|NCT02638896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65278430|NCT00653406|Risperidone|risperidone|mesh-list
64730926|NCT00002989|Melphalan|melphalan|mesh-list
64480746|NCT01799902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480747|NCT01799902|Urological Agents|urological agents|mesh-ancestor
64480748|NCT00602446|Deferasirox|deferasirox|mesh-list
64480749|NCT00602446|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64480750|NCT00602446|Chelating Agents|chelating agents|mesh-ancestor
64480751|NCT00602446|Sequestering Agents|sequestering agents|mesh-ancestor
64480752|NCT00602446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480754|NCT00681538|Analgesics|analgesics|mesh-ancestor
64480755|NCT00681538|Sensory System Agents|sensory system agents|mesh-ancestor
64480756|NCT00681538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64480757|NCT00681538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480758|NCT00602836|Cyclophosphamide|cyclophosphamide|mesh-list
64480760|NCT00602836|Lenalidomide|lenalidomide|mesh-list
64480761|NCT00602836|Pentostatin|pentostatin|mesh-list
64480762|NCT00602836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64480763|NCT00602836|Immunologic Factors|immunologic factors|mesh-ancestor
64480764|NCT00602836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480765|NCT00602836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64480766|NCT00602836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64480767|NCT00602836|Alkylating Agents|alkylating agents|mesh-ancestor
64480768|NCT00602836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480769|NCT00602836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480770|NCT00602836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64480771|NCT00602836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64480772|NCT00602836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64480773|NCT00602836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64480774|NCT00602836|Growth Substances|growth substances|mesh-ancestor
64480775|NCT00602836|Growth Inhibitors|growth inhibitors|mesh-ancestor
64480776|NCT00602836|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
64480777|NCT00602836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480778|NCT00683332|Tigecycline|tigecycline|mesh-list
65278431|NCT00653406|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65278432|NCT00653406|Serotonin Agents|serotonin agents|mesh-ancestor
65278433|NCT00653406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65278434|NCT00653406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278435|NCT00653406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278436|NCT00653406|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65278437|NCT00653406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65278438|NCT00653406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65278439|NCT00653406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65278440|NCT00653406|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65278441|NCT00653406|Dopamine Agents|dopamine agents|mesh-ancestor
64480779|NCT00683332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64480780|NCT00683332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64480781|NCT00683332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64480782|NCT00683332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480783|NCT00683332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480784|NCT00683410|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64480785|NCT00683410|Immunologic Factors|immunologic factors|mesh-ancestor
64480786|NCT00683410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480804|NCT00640822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64480806|NCT00640978|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64480807|NCT00640978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480808|NCT00640978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64471415|NCT04531982|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64471416|NCT04531982|Serotonin Agents|serotonin agents|mesh-ancestor
64471417|NCT04531982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64471418|NCT04531982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480809|NCT00640978|Immunologic Factors|immunologic factors|mesh-ancestor
64480810|NCT00640978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480811|NCT00640978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64480812|NCT00640978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480813|NCT00640978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480814|NCT00642694|Dexetimide|dexetimide|mesh-list
64480815|NCT00642694|Citalopram|citalopram|mesh-list
64480816|NCT00642694|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64480817|NCT00642694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64480818|NCT00642694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64480819|NCT00642694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480820|NCT00642694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64480822|NCT00642694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480823|NCT00642694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64480824|NCT00642694|Antidepressive Agents|antidepressive agents|mesh-ancestor
64480825|NCT00642694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64480826|NCT00642694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64480827|NCT00642694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64480828|NCT00642694|Parasympatholytics|parasympatholytics|mesh-ancestor
64480829|NCT00642694|Autonomic Agents|autonomic agents|mesh-ancestor
64480830|NCT00642694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64480831|NCT00642694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64480832|NCT00642694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64480833|NCT00642694|Cholinergic Agents|cholinergic agents|mesh-ancestor
64480835|NCT00705874|Gemcitabine|gemcitabine|mesh-list
64480836|NCT00705874|Bevacizumab|bevacizumab|mesh-list
64480837|NCT00705874|Sunitinib|sunitinib|mesh-list
64480838|NCT00705874|Docetaxel|docetaxel|mesh-list
64480839|NCT00705874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64480840|NCT00705874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64480856|NCT00705874|Antimitotic Agents|antimitotic agents|mesh-ancestor
64480857|NCT00705874|Mitosis Modulators|mitosis modulators|mesh-ancestor
64480858|NCT00705874|Antidotes|antidotes|mesh-ancestor
64480859|NCT00705874|Protective Agents|protective agents|mesh-ancestor
64480860|NCT00705874|Vitamin B Complex|vitamin b complex|mesh-ancestor
64480861|NCT00705874|Vitamins|vitamins|mesh-ancestor
65278442|NCT00638612|Valacyclovir|valacyclovir|mesh-list
65278443|NCT00638612|Antiviral Agents|antiviral agents|mesh-ancestor
65278444|NCT00638612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65278445|NCT00655200|Insulin Detemir|insulin detemir|mesh-list
65278446|NCT00655200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65278447|NCT00655200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278448|NCT04239755|Doxycycline|doxycycline|mesh-list
65278449|NCT04239755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65278451|NCT04239755|Antimalarials|antimalarials|mesh-ancestor
65278452|NCT04239755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65278453|NCT04239755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65278454|NCT04185194|Lidocaine|lidocaine|mesh-list
64480862|NCT00705874|Micronutrients|micronutrients|mesh-ancestor
64480863|NCT00705874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64480864|NCT00647998|Darbepoetin alfa|darbepoetin alfa|mesh-list
64480865|NCT00647998|Hematinics|hematinics|mesh-ancestor
64480866|NCT00649792|4-Aminopyridine|4-aminopyridine|mesh-list
64480867|NCT00649792|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64480868|NCT00649792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64480869|NCT00649792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480870|NCT00687076|Aspirin|aspirin|mesh-list
64480871|NCT00687076|Niacin|niacin|mesh-list
64480872|NCT00687076|Nicotinic Acids|nicotinic acids|mesh-list
64480873|NCT00687076|Clopidogrel|clopidogrel|mesh-list
64480874|NCT00687076|Ezetimibe|ezetimibe|mesh-list
64480875|NCT00687076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64480876|NCT00687076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64480877|NCT00687076|Analgesics|analgesics|mesh-ancestor
64480878|NCT00687076|Sensory System Agents|sensory system agents|mesh-ancestor
64480879|NCT00687076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64480880|NCT00687076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480881|NCT00687076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64480882|NCT00687076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64480883|NCT00687076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64480884|NCT00687076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64480885|NCT00687076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480886|NCT00687076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64480887|NCT00687076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64480888|NCT00687076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480890|NCT00687076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64480891|NCT00687076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64480892|NCT00687076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64480893|NCT00687076|Purinergic Agents|purinergic agents|mesh-ancestor
64480894|NCT00687076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64480895|NCT00687076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64480896|NCT00687076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64480897|NCT00687076|Antimetabolites|antimetabolites|mesh-ancestor
64480898|NCT00687076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64480899|NCT00687076|Vasodilator Agents|vasodilator agents|mesh-ancestor
64480900|NCT00687076|Vitamin B Complex|vitamin b complex|mesh-ancestor
64480902|NCT00687076|Micronutrients|micronutrients|mesh-ancestor
64480903|NCT00687544|Ribavirin|ribavirin|mesh-list
64480926|NCT00689572|Antipruritics|antipruritics|mesh-ancestor
64480927|NCT00689572|Dermatologic Agents|dermatologic agents|mesh-ancestor
64480928|NCT00689572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64480929|NCT00689572|Serotonin Agents|serotonin agents|mesh-ancestor
64480930|NCT00689572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64480931|NCT00689572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480932|NCT00689572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64480933|NCT00689572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64480934|NCT00689572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64480935|NCT00689572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64480936|NCT00689572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64480938|NCT01840579|Etoposide|etoposide|mesh-list
64480939|NCT01840579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64480940|NCT01840579|Carboplatin|carboplatin|mesh-list
64480942|NCT01840579|Pemetrexed|pemetrexed|mesh-list
65278455|NCT04185194|Anesthetics, Local|anesthetics, local|mesh-ancestor
65278456|NCT04185194|Anesthetics|anesthetics|mesh-ancestor
65278457|NCT04185194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65278458|NCT04185194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278459|NCT04185194|Sensory System Agents|sensory system agents|mesh-ancestor
65278460|NCT04185194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65278461|NCT04185194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65278462|NCT04185194|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65278463|NCT04185194|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65278464|NCT04185194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65278465|NCT04185194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480943|NCT01840579|Ipilimumab|ipilimumab|mesh-list
64480944|NCT01840579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64480945|NCT01840579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480946|NCT01840579|Tubulin Modulators|tubulin modulators|mesh-ancestor
64480947|NCT01840579|Antimitotic Agents|antimitotic agents|mesh-ancestor
64480948|NCT01840579|Mitosis Modulators|mitosis modulators|mesh-ancestor
64480949|NCT01840579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480950|NCT01840579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64480951|NCT01840579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64480952|NCT01840579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64480953|NCT01840579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480954|NCT01840579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64480955|NCT01840579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64480956|NCT01840579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64480957|NCT00651040|Prednisone|prednisone|mesh-list
64480958|NCT00651040|Prednisolone|prednisolone|mesh-list
64480959|NCT00651040|Methotrexate|methotrexate|mesh-list
64480960|NCT00651040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64480961|NCT00651040|Glucocorticoids|glucocorticoids|mesh-ancestor
64480990|NCT01801111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480992|NCT00691600|Sulfamethoxazole|sulfamethoxazole|mesh-list
64480993|NCT00691600|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64480994|NCT00691600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64480995|NCT00691600|Renal Agents|renal agents|mesh-ancestor
64480996|NCT00691600|Antimalarials|antimalarials|mesh-ancestor
64480997|NCT00691600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64480998|NCT00691600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64480999|NCT00691600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64481000|NCT00691600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481001|NCT00691600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481002|NCT00691600|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64481003|NCT00691600|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64481029|NCT00655642|Histamine Antagonists|histamine antagonists|mesh-ancestor
64481030|NCT00655642|Histamine Agents|histamine agents|mesh-ancestor
64481031|NCT00655642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64481032|NCT00655642|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64481033|NCT00655642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64481034|NCT00655642|Anesthetics, Local|anesthetics, local|mesh-ancestor
64481035|NCT00655642|Anesthetics|anesthetics|mesh-ancestor
64714003|NCT03043105|Leprostatic Agents|leprostatic agents|mesh-ancestor
64466615|NCT01536015|Rotigotine|rotigotine|mesh-list
64481036|NCT00655642|Sensory System Agents|sensory system agents|mesh-ancestor
64481037|NCT00656656|Dexamethasone|dexamethasone|mesh-list
64481038|NCT00656656|Rituximab|rituximab|mesh-list
64481039|NCT00656656|Azathioprine|azathioprine|mesh-list
64481040|NCT00656656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64481041|NCT00656656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481042|NCT00656656|Immunologic Factors|immunologic factors|mesh-ancestor
64481043|NCT00656656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481044|NCT00656656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64481045|NCT00656656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64481046|NCT00656656|Antiemetics|antiemetics|mesh-ancestor
65278466|NCT00876447|Botulinum Toxins|botulinum toxins|mesh-list
65278467|NCT00876447|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65278468|NCT00876447|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65278469|NCT00876447|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65278470|NCT00876447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65278471|NCT00876447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278472|NCT00876447|Cholinergic Agents|cholinergic agents|mesh-ancestor
65278473|NCT00876447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64481047|NCT00656656|Autonomic Agents|autonomic agents|mesh-ancestor
64481048|NCT00656656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64481049|NCT00656656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64481050|NCT00656656|Glucocorticoids|glucocorticoids|mesh-ancestor
64481051|NCT00656656|Hormones|hormones|mesh-ancestor
64481052|NCT00656656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64481053|NCT00656656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64481071|NCT00657280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481072|NCT00657280|Incretins|incretins|mesh-ancestor
64481073|NCT00657280|Hormones|hormones|mesh-ancestor
64481074|NCT00657280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64481075|NCT00657280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64481076|NCT00657280|Protease Inhibitors|protease inhibitors|mesh-ancestor
64481077|NCT00657280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481078|NCT00657280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481079|NCT00693160|Ketorolac|ketorolac|mesh-list
64481080|NCT00693160|Remifentanil|remifentanil|mesh-list
64481081|NCT00693160|Capsaicin|capsaicin|mesh-list
64481082|NCT00693160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64481083|NCT00693160|Narcotics|narcotics|mesh-ancestor
64481084|NCT00693160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64481085|NCT00693160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481086|NCT00693160|Analgesics|analgesics|mesh-ancestor
64481087|NCT00693160|Sensory System Agents|sensory system agents|mesh-ancestor
64481088|NCT00693160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64481089|NCT00693160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64481090|NCT00693160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64481091|NCT00693160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64481092|NCT00693160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64481093|NCT00693160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64481094|NCT00693160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481095|NCT00693160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481096|NCT00693160|Antipruritics|antipruritics|mesh-ancestor
64481097|NCT00693160|Dermatologic Agents|dermatologic agents|mesh-ancestor
64481098|NCT00695188|Methotrexate|methotrexate|mesh-list
64481099|NCT00695188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64481100|NCT00695188|Abortifacient Agents|abortifacient agents|mesh-ancestor
64481101|NCT00695188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64481102|NCT00695188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481103|NCT00695188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64481104|NCT00695188|Antimetabolites|antimetabolites|mesh-ancestor
64481105|NCT00695188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481106|NCT00695188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481107|NCT00695188|Dermatologic Agents|dermatologic agents|mesh-ancestor
64714004|NCT03043105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64481108|NCT00695188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481109|NCT00695188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64481122|NCT00695500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64481123|NCT00695500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481124|NCT00695500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481126|NCT00695578|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64481127|NCT00695578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64481128|NCT00695578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64481129|NCT01792102|Dexamethasone|dexamethasone|mesh-list
64481130|NCT01792102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64481132|NCT01792102|Autonomic Agents|autonomic agents|mesh-ancestor
65278474|NCT00876447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278475|NCT00876447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65278476|NCT00876447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65278477|NCT04239833|Gefitinib|gefitinib|mesh-list
65278478|NCT04239833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65278479|NCT04239833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65278480|NCT04239833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278481|NCT04239833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278482|NCT03513770|Ketorolac|ketorolac|mesh-list
65278483|NCT03513770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65278484|NCT03513770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65278485|NCT03513770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65278486|NCT03513770|Analgesics|analgesics|mesh-ancestor
65278487|NCT03513770|Sensory System Agents|sensory system agents|mesh-ancestor
65278488|NCT03513770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65278489|NCT03513770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481133|NCT01792102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64481134|NCT01792102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481135|NCT01792102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64481136|NCT01792102|Glucocorticoids|glucocorticoids|mesh-ancestor
64481137|NCT01792102|Hormones|hormones|mesh-ancestor
64481138|NCT01792102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64481139|NCT01792102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64481140|NCT01792102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481141|NCT02996734|Denosumab|denosumab|mesh-list
64481142|NCT02996734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64481143|NCT02996734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481144|NCT00699010|Oxycodone|oxycodone|mesh-list
64481145|NCT00699010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64481146|NCT00699010|Narcotics|narcotics|mesh-ancestor
64481147|NCT00699010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64481148|NCT00699010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481149|NCT00699010|Analgesics|analgesics|mesh-ancestor
64481150|NCT00699010|Sensory System Agents|sensory system agents|mesh-ancestor
64481151|NCT00699010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64481152|NCT00706810|Hydroxyurea|hydroxyurea|mesh-list
64481153|NCT00706810|Verapamil|verapamil|mesh-list
64481154|NCT00706810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481155|NCT00706810|Antisickling Agents|antisickling agents|mesh-ancestor
64481156|NCT00706810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481157|NCT00706810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481158|NCT00706810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64481159|NCT00706810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64481160|NCT00706810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64481161|NCT00706810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64481162|NCT00706810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64481163|NCT00706810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481164|NCT00706810|Vasodilator Agents|vasodilator agents|mesh-ancestor
64481165|NCT00661960|Efavirenz|efavirenz|mesh-list
64481166|NCT00661960|Raltegravir Potassium|raltegravir potassium|mesh-list
64481167|NCT00661960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64481168|NCT00661960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64481169|NCT00661960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481170|NCT00661960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481171|NCT00661960|Antiviral Agents|antiviral agents|mesh-ancestor
64481172|NCT00661960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64981985|NCT00119652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65278490|NCT03513770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65278491|NCT03513770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65278492|NCT03513770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65278493|NCT03513770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278494|NCT03513770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278495|NCT02638740|Mechlorethamine|mechlorethamine|mesh-list
65278496|NCT02638740|Alkylating Agents|alkylating agents|mesh-ancestor
65278497|NCT02638740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278498|NCT02638740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65278499|NCT02638740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65278500|NCT02823977|Dexmedetomidine|dexmedetomidine|mesh-list
65278501|NCT02823977|Ketamine|ketamine|mesh-list
65278502|NCT02823977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65278503|NCT02823977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65278504|NCT02823977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278505|NCT02823977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65278506|NCT02823977|Analgesics|analgesics|mesh-ancestor
65278507|NCT02823977|Sensory System Agents|sensory system agents|mesh-ancestor
65278508|NCT02823977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64731000|NCT00003001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481184|NCT00662818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64481185|NCT00662818|Analgesics|analgesics|mesh-ancestor
64481186|NCT00662818|Sensory System Agents|sensory system agents|mesh-ancestor
64481187|NCT00662818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64481188|NCT00662818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481189|NCT00662818|Antipyretics|antipyretics|mesh-ancestor
64481190|NCT00699556|Nicotine|nicotine|mesh-list
64481191|NCT00699556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64481192|NCT00699556|Autonomic Agents|autonomic agents|mesh-ancestor
64481193|NCT00699556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64481194|NCT00699556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481195|NCT00699556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64481196|NCT00699556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64481197|NCT00699556|Cholinergic Agents|cholinergic agents|mesh-ancestor
64481198|NCT00699556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64481199|NCT00699556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481201|NCT00700336|Pemetrexed|pemetrexed|mesh-list
64481202|NCT00700336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481204|NCT00700336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481205|NCT00700336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64481206|NCT00700336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64481207|NCT00701896|Nicotine|nicotine|mesh-list
64481208|NCT00701896|Varenicline|varenicline|mesh-list
64481209|NCT00701896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64481210|NCT00701896|Autonomic Agents|autonomic agents|mesh-ancestor
64481211|NCT00701896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64481212|NCT00701896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481213|NCT00701896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64481214|NCT00701896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64481215|NCT00701896|Cholinergic Agents|cholinergic agents|mesh-ancestor
64481216|NCT00701896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64481217|NCT00701896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481218|NCT01839487|Gemcitabine|gemcitabine|mesh-list
65278509|NCT02823977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65278510|NCT02823977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65278511|NCT02823977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65278512|NCT02823977|Adrenergic Agents|adrenergic agents|mesh-ancestor
65278513|NCT02823977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64731022|NCT00003421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64481219|NCT01839487|Dexamethasone|dexamethasone|mesh-list
64481220|NCT01839487|Paclitaxel|paclitaxel|mesh-list
64481221|NCT01839487|Enoxaparin|enoxaparin|mesh-list
64481222|NCT01839487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64481223|NCT01839487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481224|NCT01839487|Tubulin Modulators|tubulin modulators|mesh-ancestor
64481225|NCT01839487|Antimitotic Agents|antimitotic agents|mesh-ancestor
64481226|NCT01839487|Mitosis Modulators|mitosis modulators|mesh-ancestor
64481227|NCT01839487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481228|NCT01839487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64481229|NCT01839487|Antiemetics|antiemetics|mesh-ancestor
64481230|NCT01839487|Autonomic Agents|autonomic agents|mesh-ancestor
64481231|NCT01839487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64481232|NCT01839487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481233|NCT01839487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64481234|NCT01839487|Glucocorticoids|glucocorticoids|mesh-ancestor
64481235|NCT01839487|Hormones|hormones|mesh-ancestor
64982048|NCT00079820|Vaccines|vaccines|mesh-list
64481247|NCT01839487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64481248|NCT00665470|Aldesleukin|aldesleukin|mesh-list
64481249|NCT00665470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481250|NCT00665470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64481251|NCT00665470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64481252|NCT00665470|Antiviral Agents|antiviral agents|mesh-ancestor
64481253|NCT00665470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64481254|NCT00666406|Factor VIII|factor viii|mesh-list
64481255|NCT00666406|Coagulants|coagulants|mesh-ancestor
64481256|NCT02995954|Amlodipine|amlodipine|mesh-list
64481257|NCT02995954|Perindopril|perindopril|mesh-list
64481258|NCT02995954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64481259|NCT02995954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64481260|NCT02995954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64481261|NCT02995954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481262|NCT02995954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64481263|NCT02995954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481264|NCT02995954|Vasodilator Agents|vasodilator agents|mesh-ancestor
64481265|NCT02995954|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64481266|NCT02995954|Protease Inhibitors|protease inhibitors|mesh-ancestor
64481267|NCT02995954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481269|NCT01799941|Dextromethorphan|dextromethorphan|mesh-list
64481270|NCT01799941|Antitussive Agents|antitussive agents|mesh-ancestor
64481271|NCT01799941|Respiratory System Agents|respiratory system agents|mesh-ancestor
64481272|NCT01799941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64481273|NCT01799941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64481274|NCT01799941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64481275|NCT01799941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481276|NCT01799941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481277|NCT01799941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64481278|NCT01799941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64481279|NCT01799941|Adrenergic Agents|adrenergic agents|mesh-ancestor
64481280|NCT01799941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64481281|NCT01799941|Antimalarials|antimalarials|mesh-ancestor
64481282|NCT01799941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64481283|NCT01799941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64481284|NCT01799941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64481285|NCT01799941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481286|NCT01799941|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64481287|NCT01799941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64481288|NCT01799941|Cholinergic Agents|cholinergic agents|mesh-ancestor
64481289|NCT01799941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64481290|NCT01799941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64481291|NCT01799941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64481292|NCT01799941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65278514|NCT02823977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278515|NCT02823977|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65278516|NCT02823977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65278517|NCT02823977|Anesthetics, General|anesthetics, general|mesh-ancestor
65278518|NCT02823977|Anesthetics|anesthetics|mesh-ancestor
64481293|NCT01799941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64481294|NCT00702364|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64481295|NCT00702364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64481296|NCT00702364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64481297|NCT00702364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64982108|NCT00399659|Serotonin Agents|serotonin agents|mesh-ancestor
64481357|NCT02995330|Immunologic Factors|immunologic factors|mesh-ancestor
64481358|NCT02995330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481359|NCT02995330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64481360|NCT02995330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64481361|NCT02995330|Alkylating Agents|alkylating agents|mesh-ancestor
64481362|NCT02995330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481363|NCT02995330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481364|NCT02995330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64481365|NCT02995330|Androgens|androgens|mesh-ancestor
64481366|NCT02995330|Hormones|hormones|mesh-ancestor
64481367|NCT02995330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64481368|NCT02995330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64481369|NCT02995330|Anabolic Agents|anabolic agents|mesh-ancestor
64481370|NCT02990884|Ketamine|ketamine|mesh-list
64481371|NCT02990884|Analgesics|analgesics|mesh-ancestor
64481372|NCT02990884|Sensory System Agents|sensory system agents|mesh-ancestor
64481373|NCT02990884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64481374|NCT02990884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481375|NCT02990884|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64481376|NCT02990884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64481377|NCT02990884|Anesthetics, General|anesthetics, general|mesh-ancestor
64481379|NCT02990884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64481380|NCT02990884|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64481381|NCT02990884|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64481382|NCT02990884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64481383|NCT02990884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481384|NCT02990416|Pembrolizumab|pembrolizumab|mesh-list
64481385|NCT02990416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64481386|NCT02990416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481396|NCT02999776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64481397|NCT02999776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64481398|NCT02999776|Immunologic Factors|immunologic factors|mesh-ancestor
64481400|NCT02996656|Cefazolin|cefazolin|mesh-list
64481401|NCT02996656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64481402|NCT02996656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64481403|NCT04387630|Metformin|metformin|mesh-list
64481404|NCT04387630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64481405|NCT04387630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481406|NCT04270318|Pemetrexed|pemetrexed|mesh-list
64481407|NCT04270318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481408|NCT04270318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481409|NCT04270318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481410|NCT04270318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64481411|NCT04270318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64481412|NCT02999854|Cyclophosphamide|cyclophosphamide|mesh-list
64481413|NCT02999854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64481414|NCT02999854|Immunologic Factors|immunologic factors|mesh-ancestor
64481415|NCT02999854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481416|NCT02999854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64481417|NCT02999854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64481418|NCT02999854|Alkylating Agents|alkylating agents|mesh-ancestor
64481419|NCT02999854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481420|NCT02999854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481421|NCT02999854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64481422|NCT04270708|Dexmedetomidine|dexmedetomidine|mesh-list
64481423|NCT04270708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65278519|NCT02823977|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65278520|NCT02823977|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65278521|NCT00680511|Methamphetamine|methamphetamine|mesh-list
65278522|NCT00680511|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65278523|NCT00680511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278525|NCT00680511|Autonomic Agents|autonomic agents|mesh-ancestor
65278526|NCT00680511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65278527|NCT00680511|Dopamine Agents|dopamine agents|mesh-ancestor
65278528|NCT00680511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65278529|NCT00680511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278530|NCT00680511|Adrenergic Agents|adrenergic agents|mesh-ancestor
65278531|NCT00680511|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65278532|NCT00680511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65278533|NCT00680511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65278534|NCT00680511|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65278535|NCT00654576|Olanzapine|olanzapine|mesh-list
65278536|NCT00654576|Chlorpromazine|chlorpromazine|mesh-list
64481424|NCT04270708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64481425|NCT04270708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481426|NCT04270708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64481428|NCT04270708|Sensory System Agents|sensory system agents|mesh-ancestor
64481429|NCT04270708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64481430|NCT04270708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64481431|NCT04270708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64481432|NCT04270708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64481433|NCT04270708|Adrenergic Agents|adrenergic agents|mesh-ancestor
64481434|NCT04270708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64481435|NCT04270708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481437|NCT00704938|Cyclophosphamide|cyclophosphamide|mesh-list
64481438|NCT00704938|Fludarabine|fludarabine|mesh-list
64481439|NCT00704938|Fludarabine phosphate|fludarabine phosphate|mesh-list
64481440|NCT00704938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64481441|NCT00704938|Immunologic Factors|immunologic factors|mesh-ancestor
64481442|NCT00704938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481443|NCT00704938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64481444|NCT00704938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64481445|NCT00704938|Alkylating Agents|alkylating agents|mesh-ancestor
64481446|NCT00704938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481447|NCT00704938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481448|NCT00704938|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64481449|NCT00704938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64481450|NCT00704938|Antimetabolites|antimetabolites|mesh-ancestor
64982266|NCT00301483|Chrysarobin|chrysarobin|mesh-list
64481475|NCT02994082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64481476|NCT02994082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481477|NCT02995096|Sirolimus|sirolimus|mesh-list
64481478|NCT02995096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64481479|NCT02995096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64481480|NCT02995096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64481481|NCT02995096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481482|NCT02995096|Antifungal Agents|antifungal agents|mesh-ancestor
64481483|NCT02995096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64481484|NCT02995096|Immunologic Factors|immunologic factors|mesh-ancestor
64481485|NCT02995096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481486|NCT01275976|Complement C1s|complement c1s|mesh-list
65278537|NCT00654576|Risperidone|risperidone|mesh-list
65278538|NCT00654576|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65278539|NCT00654576|Clozapine|clozapine|mesh-list
64481487|NCT01275976|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64481488|NCT01275976|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
64481489|NCT01275976|Immunologic Factors|immunologic factors|mesh-ancestor
64481490|NCT01275976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481491|NCT01275976|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64481492|NCT01275976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64481493|NCT01270438|Leucovorin|leucovorin|mesh-list
64481494|NCT01270438|Bevacizumab|bevacizumab|mesh-list
64481495|NCT01270438|Fluorouracil|fluorouracil|mesh-list
64481496|NCT01270438|Oxaliplatin|oxaliplatin|mesh-list
64481497|NCT01270438|Calcium|calcium|mesh-list
64481498|NCT01270438|Levoleucovorin|levoleucovorin|mesh-list
64481499|NCT01270438|R04929097|r04929097|mesh-list
64481500|NCT01270438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64982327|NCT00086736|Eflornithine|eflornithine|mesh-list
64481510|NCT01270438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64481511|NCT01270438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64481512|NCT01270438|Immunologic Factors|immunologic factors|mesh-ancestor
64481513|NCT01270438|Antidotes|antidotes|mesh-ancestor
64481514|NCT01270438|Protective Agents|protective agents|mesh-ancestor
64481515|NCT01270438|Vitamin B Complex|vitamin b complex|mesh-ancestor
64481517|NCT01270438|Micronutrients|micronutrients|mesh-ancestor
64481518|NCT01270438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481520|NCT01270672|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
64481521|NCT01270672|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64481522|NCT01270672|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64481523|NCT01270672|Adrenergic Agents|adrenergic agents|mesh-ancestor
64481524|NCT01270672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64481525|NCT01270672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481526|NCT01270672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481527|NCT01270672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64481528|NCT01270672|Antioxidants|antioxidants|mesh-ancestor
64481529|NCT01270672|Protective Agents|protective agents|mesh-ancestor
64481530|NCT01270672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64481531|NCT01270672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64481532|NCT01270672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64481533|NCT01270672|Vasodilator Agents|vasodilator agents|mesh-ancestor
64481534|NCT01270672|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64481535|NCT01270672|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64481536|NCT01270672|Hallucinogens|hallucinogens|mesh-ancestor
64481537|NCT01270672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64481538|NCT01270672|Serotonin Agents|serotonin agents|mesh-ancestor
64481539|NCT01270672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64481540|NCT01270672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64481541|NCT01276210|Sorafenib|sorafenib|mesh-list
64481542|NCT01276210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481543|NCT01276210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64481544|NCT01276210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481545|NCT01276210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481546|NCT00727636|Vaccines|vaccines|mesh-list
64481547|NCT00727636|Immunologic Factors|immunologic factors|mesh-ancestor
64481548|NCT00727636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481549|NCT01270750|Bosentan|bosentan|mesh-list
64481550|NCT01270750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64481551|NCT01270750|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64481552|NCT01270750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481553|NCT00709696|Varenicline|varenicline|mesh-list
64481554|NCT00709696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64481555|NCT00709696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64481556|NCT00709696|Cholinergic Agents|cholinergic agents|mesh-ancestor
64481557|NCT00709696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64481558|NCT00709696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481559|NCT00709696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481560|NCT01270984|Imatinib Mesylate|imatinib mesylate|mesh-list
64481561|NCT01270984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481562|NCT01270984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64481563|NCT01270984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481564|NCT01270984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481587|NCT01271374|Olmesartan|olmesartan|mesh-list
64481588|NCT01271374|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
65278540|NCT00654576|Sulpiride|sulpiride|mesh-list
65278541|NCT00654576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65278542|NCT00654576|Serotonin Agents|serotonin agents|mesh-ancestor
65278543|NCT00654576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64481589|NCT01271374|Spironolactone|spironolactone|mesh-list
64481590|NCT01271374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64481591|NCT01271374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64481592|NCT01271374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64481593|NCT01271374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481594|NCT01271374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64481595|NCT01271374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481596|NCT01271374|Vasodilator Agents|vasodilator agents|mesh-ancestor
64481597|NCT01271374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64481598|NCT01271374|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64481599|NCT01271374|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64481600|NCT01271374|Diuretics|diuretics|mesh-ancestor
64481601|NCT01271374|Natriuretic Agents|natriuretic agents|mesh-ancestor
64481602|NCT01271374|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64481603|NCT01271374|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64481604|NCT01271374|Hormone Antagonists|hormone antagonists|mesh-ancestor
64481605|NCT01271374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64481606|NCT01271374|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64481607|NCT01276834|Everolimus|everolimus|mesh-list
64481608|NCT01276834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481609|NCT01276834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64481610|NCT01276834|Immunologic Factors|immunologic factors|mesh-ancestor
64481611|NCT01276834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481612|NCT01276912|Insulin Glargine|insulin glargine|mesh-list
64481613|NCT01276912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64481614|NCT01276912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481615|NCT00711490|Sirolimus|sirolimus|mesh-list
64481616|NCT00711490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64481617|NCT00711490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64481634|NCT00717418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481635|NCT00717418|Antifungal Agents|antifungal agents|mesh-ancestor
64481636|NCT00717418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64481637|NCT00717418|Dermatologic Agents|dermatologic agents|mesh-ancestor
64481638|NCT00717418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64481639|NCT00717418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64481640|NCT00717418|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64481641|NCT00717418|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64481644|NCT00717574|Sevoflurane|sevoflurane|mesh-list
64481645|NCT00717574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64481646|NCT00717574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64481647|NCT00717574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481648|NCT00717574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64481649|NCT00717574|Anesthetics, General|anesthetics, general|mesh-ancestor
64481650|NCT00717574|Anesthetics|anesthetics|mesh-ancestor
64481651|NCT00717574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64481652|NCT00717574|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64481653|NCT00717574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64481654|NCT00717574|Analgesics|analgesics|mesh-ancestor
64481655|NCT00717574|Sensory System Agents|sensory system agents|mesh-ancestor
64481656|NCT00717574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64481657|NCT04385602|Dexmedetomidine|dexmedetomidine|mesh-list
64481658|NCT04385602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64481659|NCT04385602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64481660|NCT04385602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481661|NCT04385602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64481662|NCT04385602|Analgesics|analgesics|mesh-ancestor
64481663|NCT04385602|Sensory System Agents|sensory system agents|mesh-ancestor
64481664|NCT04385602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64481665|NCT04385602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64481666|NCT04385602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64481667|NCT04385602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64481668|NCT04385602|Adrenergic Agents|adrenergic agents|mesh-ancestor
64481669|NCT04385602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64481670|NCT04385602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481672|NCT00719134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65278544|NCT00654576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278545|NCT00654576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278546|NCT00654576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65278547|NCT00654576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65278548|NCT00654576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65278549|NCT00654576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65278550|NCT00654576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65278551|NCT00654576|Dopamine Agents|dopamine agents|mesh-ancestor
65278552|NCT00654576|Antiemetics|antiemetics|mesh-ancestor
65278553|NCT00654576|Autonomic Agents|autonomic agents|mesh-ancestor
65278554|NCT00654576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65278555|NCT00654576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65278556|NCT00654576|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65278557|NCT00654576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65278558|NCT00654576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65278559|NCT00654576|Antidepressive Agents|antidepressive agents|mesh-ancestor
65278560|NCT00654576|GABA Antagonists|gaba antagonists|mesh-ancestor
65278561|NCT00654576|GABA Agents|gaba agents|mesh-ancestor
65278562|NCT00654576|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64481673|NCT00719134|Serotonin Agents|serotonin agents|mesh-ancestor
64481674|NCT00719134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64481675|NCT00719134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481676|NCT00719134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481677|NCT01277770|Thymoglobulin|thymoglobulin|mesh-list
64481694|NCT01773109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64481695|NCT01773109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481696|NCT01773109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481697|NCT01773109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481698|NCT01773109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64481699|NCT01772719|Zoledronic Acid|zoledronic acid|mesh-list
64481700|NCT01772719|Simvastatin|simvastatin|mesh-list
64481701|NCT01772719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64481702|NCT01772719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64481703|NCT01772719|Antimetabolites|antimetabolites|mesh-ancestor
64481704|NCT01772719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481705|NCT01772719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64481706|NCT01772719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64481707|NCT01772719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481708|NCT01772719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64481709|NCT01772719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481710|NCT05582265|Paclitaxel|paclitaxel|mesh-list
64481711|NCT05582265|Cisplatin|cisplatin|mesh-list
64481712|NCT05582265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64481713|NCT05582265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481714|NCT05582265|Tubulin Modulators|tubulin modulators|mesh-ancestor
64481715|NCT05582265|Antimitotic Agents|antimitotic agents|mesh-ancestor
64481716|NCT05582265|Mitosis Modulators|mitosis modulators|mesh-ancestor
64481717|NCT05582265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481718|NCT04144101|Etoricoxib|etoricoxib|mesh-list
64481719|NCT04144101|Aceclofenac|aceclofenac|mesh-list
64481720|NCT04144101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64481721|NCT04144101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64481722|NCT04144101|Analgesics|analgesics|mesh-ancestor
64481723|NCT04144101|Sensory System Agents|sensory system agents|mesh-ancestor
65278563|NCT00622622|Gemcitabine|gemcitabine|mesh-list
65278564|NCT00622622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65278565|NCT00622622|Antimetabolites|antimetabolites|mesh-ancestor
65278566|NCT00622622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278567|NCT00622622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65278568|NCT00622622|Antiviral Agents|antiviral agents|mesh-ancestor
65278569|NCT00622622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65278570|NCT00622622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481724|NCT04144101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64481725|NCT04144101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481726|NCT04144101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64481727|NCT04144101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64481728|NCT04144101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64481729|NCT04144101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64481730|NCT04144101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481731|NCT04144101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481732|NCT01278004|Ethosuximide|ethosuximide|mesh-list
64481733|NCT01278004|Anticonvulsants|anticonvulsants|mesh-ancestor
64481734|NCT01278238|Phenylephrine|phenylephrine|mesh-list
64481735|NCT01278238|Oxymetazoline|oxymetazoline|mesh-list
64481736|NCT01278238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64481737|NCT01278238|Mydriatics|mydriatics|mesh-ancestor
64481766|NCT01272310|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64481767|NCT01272310|Hydroxychloroquine|hydroxychloroquine|mesh-list
64481768|NCT01272310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481769|NCT01272310|Antiviral Agents|antiviral agents|mesh-ancestor
64481770|NCT01272310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64481771|NCT01272310|Antimetabolites|antimetabolites|mesh-ancestor
64481772|NCT01272310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481773|NCT01272310|Immunologic Factors|immunologic factors|mesh-ancestor
64481774|NCT01272310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481775|NCT01272310|Antimalarials|antimalarials|mesh-ancestor
64481776|NCT01272310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64481777|NCT01272310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64481778|NCT01272310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481779|NCT01272310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64481780|NCT05586477|Diphenhydramine|diphenhydramine|mesh-list
64481781|NCT05586477|Promethazine|promethazine|mesh-list
64481782|NCT05586477|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64467355|NCT01479621|Fluticasone|fluticasone|mesh-list
64481816|NCT01272778|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64481817|NCT01272778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64481818|NCT01272778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64481819|NCT01272778|GABA Modulators|gaba modulators|mesh-ancestor
64481820|NCT01272778|GABA Agents|gaba agents|mesh-ancestor
64481821|NCT01272778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64481822|NCT01272778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481823|NCT01272856|Abatacept|abatacept|mesh-list
64481824|NCT01272856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64481825|NCT01272856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982660|NCT00301912|Antimetabolites|antimetabolites|mesh-ancestor
64481888|NCT00733096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64481889|NCT00733096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64481890|NCT00733096|Immunologic Factors|immunologic factors|mesh-ancestor
64481892|NCT02991196|DS-8273a|ds-8273a|mesh-list
64481893|NCT02991196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64481894|NCT02991196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481895|NCT02991196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64481896|NCT02991196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481897|NCT01278784|Acetylcysteine|acetylcysteine|mesh-list
64481898|NCT01278784|Chitosan|chitosan|mesh-list
64481899|NCT01278784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64481900|NCT01278784|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64481936|NCT00722722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481937|NCT00723580|Risperidone|risperidone|mesh-list
64481938|NCT00723580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64481939|NCT00723580|Serotonin Agents|serotonin agents|mesh-ancestor
64481940|NCT00723580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64481941|NCT00723580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278571|NCT00622622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65278572|NCT00622622|Immunologic Factors|immunologic factors|mesh-ancestor
65278573|NCT00622622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278574|NCT00598650|Donepezil|donepezil|mesh-list
65278575|NCT00598650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65278576|NCT00598650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278577|NCT00598650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278578|NCT00598650|Cholinergic Agents|cholinergic agents|mesh-ancestor
65278579|NCT00598650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65278580|NCT00598650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278581|NCT00598650|Nootropic Agents|nootropic agents|mesh-ancestor
65278582|NCT04150731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65278583|NCT04150731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65278584|NCT04150731|Estradiol|estradiol|mesh-list
65278585|NCT04150731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65278586|NCT04150731|Estrogens|estrogens|mesh-ancestor
64415733|NCT05002127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278587|NCT04150731|Hormones|hormones|mesh-ancestor
65278588|NCT04150731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65278589|NCT04150731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278590|NCT04150731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65278591|NCT04150731|Contraceptive Agents|contraceptive agents|mesh-ancestor
65278592|NCT04150731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65278593|NCT04150731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65278594|NCT04763135|Mirtazapine|mirtazapine|mesh-list
65278617|NCT04763135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65278618|NCT04763135|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65278619|NCT02641938|Dexmedetomidine|dexmedetomidine|mesh-list
65278620|NCT02641938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65278621|NCT02641938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65278622|NCT02641938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278623|NCT02641938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65278624|NCT02641938|Analgesics|analgesics|mesh-ancestor
65278625|NCT02641938|Sensory System Agents|sensory system agents|mesh-ancestor
65278626|NCT02641938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65278627|NCT02641938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65278628|NCT02641938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65278629|NCT02641938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65278630|NCT02641938|Adrenergic Agents|adrenergic agents|mesh-ancestor
65278631|NCT02641938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65278632|NCT02641938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278633|NCT04249076|Clobetasol|clobetasol|mesh-list
65278634|NCT04249076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65278635|NCT04249076|Glucocorticoids|glucocorticoids|mesh-ancestor
65278636|NCT04249076|Hormones|hormones|mesh-ancestor
64481961|NCT00734344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64481963|NCT00734344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481964|NCT00734344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64481965|NCT00734344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64481966|NCT00734344|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64481967|NCT00734344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64481968|NCT00734344|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64481969|NCT00734344|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64481970|NCT00734344|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64481971|NCT00734344|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64481972|NCT00734344|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64481973|NCT00734344|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64481974|NCT04148937|Pembrolizumab|pembrolizumab|mesh-list
64481975|NCT04148937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64481976|NCT04148937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481977|NCT03021057|Pembrolizumab|pembrolizumab|mesh-list
64481978|NCT03021057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64481979|NCT03021057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481980|NCT00734500|Anidulafungin|anidulafungin|mesh-list
64481981|NCT00734500|Antifungal Agents|antifungal agents|mesh-ancestor
64481982|NCT00734500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64481983|NCT04143321|Empagliflozin|empagliflozin|mesh-list
64481984|NCT04143321|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64481985|NCT04143321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481986|NCT04143321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64481987|NCT04143321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481988|NCT00734968|Nitrofurantoin|nitrofurantoin|mesh-list
64481989|NCT00734968|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64481990|NCT00734968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64481991|NCT00734968|Renal Agents|renal agents|mesh-ancestor
64481992|NCT00734968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64481993|NCT00735436|Bevacizumab|bevacizumab|mesh-list
65278637|NCT04249076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65278638|NCT04249076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278639|NCT00681135|Olaflur|olaflur|mesh-list
65278640|NCT00681135|Cariostatic Agents|cariostatic agents|mesh-ancestor
65278641|NCT00681135|Protective Agents|protective agents|mesh-ancestor
65278642|NCT00681135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278643|NCT02821559|Bevacizumab|bevacizumab|mesh-list
65278644|NCT02821559|Oxaliplatin|oxaliplatin|mesh-list
65278645|NCT02821559|Raltitrexed|raltitrexed|mesh-list
65278646|NCT02821559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65278647|NCT02821559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65278648|NCT02821559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65278649|NCT02821559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65278650|NCT02821559|Growth Substances|growth substances|mesh-ancestor
65278651|NCT02821559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278652|NCT02821559|Growth Inhibitors|growth inhibitors|mesh-ancestor
65278653|NCT02821559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65278654|NCT02821559|Antimetabolites|antimetabolites|mesh-ancestor
65278655|NCT02821559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731127|NCT00003445|Docetaxel|docetaxel|mesh-list
64481994|NCT00735436|Irinotecan|irinotecan|mesh-list
64481995|NCT00735436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64481996|NCT00735436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481997|NCT00735436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64482009|NCT04143165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64482010|NCT04143165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482011|NCT04143165|Sensory System Agents|sensory system agents|mesh-ancestor
64482012|NCT04143165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64482013|NCT04143165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64482014|NCT04143165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64482015|NCT04143165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64482016|NCT04143165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64482017|NCT04143165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482018|NCT00735670|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64482019|NCT00735670|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64482020|NCT00735670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64482021|NCT00735670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64482022|NCT00735670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482023|NCT00735670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64482024|NCT00735670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482025|NCT00735670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64482026|NCT00735670|Antidepressive Agents|antidepressive agents|mesh-ancestor
64482027|NCT00735670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64482029|NCT00735826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482030|NCT00735826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64482031|NCT00735826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482032|NCT00735826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482033|NCT03916341|Nicotine|nicotine|mesh-list
64482034|NCT03916341|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64482035|NCT03916341|Autonomic Agents|autonomic agents|mesh-ancestor
64731145|NCT00003451|Growth Inhibitors|growth inhibitors|mesh-ancestor
65278656|NCT02821559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65278657|NCT02821559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278658|NCT00681213|Sirolimus|sirolimus|mesh-list
65278659|NCT00681213|Tacrolimus|tacrolimus|mesh-list
65278660|NCT00681213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65278661|NCT00681213|Immunologic Factors|immunologic factors|mesh-ancestor
65278662|NCT00681213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278663|NCT00681213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65278664|NCT00681213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278665|NCT00681213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278666|NCT00681213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65278667|NCT00681213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65278668|NCT00681213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65028672|NCT05180097|Hormones|hormones|mesh-ancestor
65278670|NCT00681213|Antifungal Agents|antifungal agents|mesh-ancestor
65278671|NCT02638506|Fentanyl|fentanyl|mesh-list
65278672|NCT02638506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64482036|NCT03916341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64482037|NCT03916341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482038|NCT03916341|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64482039|NCT03916341|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64482040|NCT03916341|Cholinergic Agents|cholinergic agents|mesh-ancestor
64482041|NCT03916341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64482042|NCT03916341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482043|NCT01276054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64482044|NCT01276054|Methylene Blue|methylene blue|mesh-list
64482045|NCT01276054|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
64482046|NCT01276054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482047|NCT01276054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482048|NCT01276054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64482049|NCT00724594|Acetylcysteine|acetylcysteine|mesh-list
64482050|NCT00724594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64482051|NCT00724594|Antiviral Agents|antiviral agents|mesh-ancestor
64482052|NCT00724594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64482053|NCT00724594|Expectorants|expectorants|mesh-ancestor
64482054|NCT00724594|Respiratory System Agents|respiratory system agents|mesh-ancestor
64482055|NCT00724594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64482056|NCT00724594|Antioxidants|antioxidants|mesh-ancestor
64482057|NCT00724594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482081|NCT04142151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64482082|NCT04142151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64482084|NCT04142151|Sensory System Agents|sensory system agents|mesh-ancestor
64482085|NCT04142151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64482086|NCT04142151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482087|NCT04142151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64482088|NCT04142151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64482089|NCT04142151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64482090|NCT04142151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64482091|NCT04142151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482092|NCT04142151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64482093|NCT04142151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64482094|NCT04142151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482095|NCT04142151|Antipyretics|antipyretics|mesh-ancestor
64482096|NCT04142151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64482098|NCT04142151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64482099|NCT04142151|Purinergic Agents|purinergic agents|mesh-ancestor
65278673|NCT02638506|Narcotics|narcotics|mesh-ancestor
65278674|NCT02638506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65278675|NCT02638506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278676|NCT02638506|Analgesics|analgesics|mesh-ancestor
65278677|NCT02638506|Sensory System Agents|sensory system agents|mesh-ancestor
65278678|NCT02638506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64482100|NCT04142151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64482101|NCT02985099|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64482102|NCT02985099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64482103|NCT02985099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64482104|NCT02985099|Antimetabolites|antimetabolites|mesh-ancestor
64482105|NCT02985099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482106|NCT02985099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64982946|NCT00087399|Antimanic Agents|antimanic agents|mesh-ancestor
64482136|NCT04141995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64482137|NCT04149483|Atorvastatin|atorvastatin|mesh-list
64482138|NCT04149483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64482139|NCT04149483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64482140|NCT04149483|Antimetabolites|antimetabolites|mesh-ancestor
64482141|NCT04149483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482142|NCT04149483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64482143|NCT04149483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64482144|NCT04149483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482145|NCT04149327|Amoxicillin|amoxicillin|mesh-list
64482146|NCT04149327|Metronidazole|metronidazole|mesh-list
64482147|NCT04149327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64482148|NCT04149327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64482149|NCT04149327|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64482150|NCT04149327|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64482151|NCT05582577|Bevacizumab|bevacizumab|mesh-list
64482152|NCT05582577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64482153|NCT05582577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482154|NCT05582577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64482155|NCT05582577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64482156|NCT05582577|Growth Substances|growth substances|mesh-ancestor
64982986|NCT00303550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64513673|NCT01457937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482174|NCT04149171|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64482175|NCT04149171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64482176|NCT04149171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482178|NCT04149171|Coagulants|coagulants|mesh-ancestor
64482180|NCT04140591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64482181|NCT04140591|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64482182|NCT04140591|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64482183|NCT04140591|Adrenergic Agents|adrenergic agents|mesh-ancestor
64482184|NCT04140591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64482185|NCT04140591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482186|NCT04140591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482187|NCT04140591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64482188|NCT04140591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64482189|NCT04140591|Vasodilator Agents|vasodilator agents|mesh-ancestor
64482190|NCT04140591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482191|NCT05582109|Lenvatinib|lenvatinib|mesh-list
64482192|NCT05582109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482193|NCT05582109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64482194|NCT05582109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482195|NCT05582109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482196|NCT03020901|Teicoplanin|teicoplanin|mesh-list
64482197|NCT03020901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64482198|NCT03020901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64482199|NCT04140201|Simvastatin|simvastatin|mesh-list
64482200|NCT04140201|Fenofibrate|fenofibrate|mesh-list
64482201|NCT04140201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64482202|NCT04140201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64482203|NCT04140201|Antimetabolites|antimetabolites|mesh-ancestor
64482204|NCT04140201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482205|NCT04140201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64482206|NCT04140201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65278679|NCT02638506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65278680|NCT02638506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65278681|NCT02638506|Anesthetics, General|anesthetics, general|mesh-ancestor
64482207|NCT04140201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482208|NCT05581875|Dexamethasone|dexamethasone|mesh-list
64482209|NCT05581875|Daratumumab|daratumumab|mesh-list
64482210|NCT05581875|Pomalidomide|pomalidomide|mesh-list
64482211|NCT05581875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64482212|NCT05581875|Antiemetics|antiemetics|mesh-ancestor
64482213|NCT05581875|Autonomic Agents|autonomic agents|mesh-ancestor
64482214|NCT05581875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64983035|NCT00120432|Autonomic Agents|autonomic agents|mesh-ancestor
64482231|NCT03945513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64482232|NCT03945513|Contraceptive Agents|contraceptive agents|mesh-ancestor
64482233|NCT03945513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64482234|NCT03945513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482235|NCT03945513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64482236|NCT03945513|Estrogens|estrogens|mesh-ancestor
64482237|NCT03945513|Hormones|hormones|mesh-ancestor
64482238|NCT03945513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64482239|NCT03945513|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64482240|NCT03945513|Hormone Antagonists|hormone antagonists|mesh-ancestor
64482241|NCT03945513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64482242|NCT03945513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482243|NCT04406025|Anesthetics|anesthetics|mesh-list
64482244|NCT04406025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64482245|NCT04406025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482246|NCT05587881|Vaccines|vaccines|mesh-list
64482247|NCT05587881|Immunologic Factors|immunologic factors|mesh-ancestor
64482248|NCT05587881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482249|NCT05582421|Diclofenac|diclofenac|mesh-list
64482250|NCT05582421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64482251|NCT05582421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64482252|NCT05582421|Analgesics|analgesics|mesh-ancestor
64482253|NCT05582421|Sensory System Agents|sensory system agents|mesh-ancestor
64482254|NCT05582421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64482255|NCT05582421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482256|NCT05582421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64482257|NCT05582421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64482258|NCT05582421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64482259|NCT05582421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482260|NCT05582421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482261|NCT03580473|Moxifloxacin|moxifloxacin|mesh-list
64482262|NCT03580473|Dexamethasone|dexamethasone|mesh-list
64482263|NCT03580473|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64482264|NCT03580473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64482265|NCT03580473|Antiemetics|antiemetics|mesh-ancestor
64482266|NCT03580473|Autonomic Agents|autonomic agents|mesh-ancestor
64482267|NCT03580473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64482268|NCT03580473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482269|NCT03580473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64482270|NCT03580473|Glucocorticoids|glucocorticoids|mesh-ancestor
64482271|NCT03580473|Hormones|hormones|mesh-ancestor
64482272|NCT03580473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64482295|NCT03581487|Immunologic Factors|immunologic factors|mesh-ancestor
64482296|NCT03581487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482297|NCT03581487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64471479|NCT04501718|Etoposide|etoposide|mesh-list
64471480|NCT04501718|Temozolomide|temozolomide|mesh-list
64471481|NCT04501718|Apatinib|apatinib|mesh-list
64471482|NCT04501718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64471483|NCT04501718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471484|NCT04501718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64471485|NCT04501718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64471486|NCT04501718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482298|NCT03581487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482299|NCT03897309|Vaccines|vaccines|mesh-list
64482300|NCT03897309|Immunologic Factors|immunologic factors|mesh-ancestor
64482301|NCT03897309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482302|NCT03588429|Sevoflurane|sevoflurane|mesh-list
64482303|NCT03588429|Isoflurane|isoflurane|mesh-list
64482304|NCT03588429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64482305|NCT03588429|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65278682|NCT02638506|Anesthetics|anesthetics|mesh-ancestor
65278683|NCT04745975|Gemcitabine|gemcitabine|mesh-list
65278684|NCT04745975|Paclitaxel|paclitaxel|mesh-list
65278685|NCT04745975|Vinorelbine|vinorelbine|mesh-list
65278686|NCT04745975|Capecitabine|capecitabine|mesh-list
65278687|NCT04745975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65278688|NCT04745975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482306|NCT03588429|Anesthetics, General|anesthetics, general|mesh-ancestor
64482307|NCT03588429|Anesthetics|anesthetics|mesh-ancestor
64482308|NCT03588429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64482309|NCT03588429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482310|NCT03580161|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
64482311|NCT03580161|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
64482312|NCT03580161|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
64482313|NCT03580161|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
64482314|NCT03580161|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64482315|NCT03580161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482317|NCT03588351|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64482332|NCT03585465|Cyclophosphamide|cyclophosphamide|mesh-list
64482333|NCT03585465|Capecitabine|capecitabine|mesh-list
64482335|NCT03585465|Vinblastine|vinblastine|mesh-list
64482336|NCT03585465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64482337|NCT03585465|Immunologic Factors|immunologic factors|mesh-ancestor
64482338|NCT03585465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482339|NCT03585465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64482340|NCT03585465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64482341|NCT03585465|Alkylating Agents|alkylating agents|mesh-ancestor
64482342|NCT03585465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482343|NCT03585465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482344|NCT03585465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64482345|NCT03585465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64482346|NCT03585465|Antimetabolites|antimetabolites|mesh-ancestor
64482347|NCT03585465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64482348|NCT03585465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64482349|NCT03585465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64482350|NCT03585465|Tubulin Modulators|tubulin modulators|mesh-ancestor
64482351|NCT03585465|Antimitotic Agents|antimitotic agents|mesh-ancestor
64482352|NCT03585465|Mitosis Modulators|mitosis modulators|mesh-ancestor
64482353|NCT03588273|Amoxicillin|amoxicillin|mesh-list
64482354|NCT03588273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64482355|NCT03588273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64482356|NCT03588039|Paclitaxel|paclitaxel|mesh-list
64482357|NCT03588039|Pembrolizumab|pembrolizumab|mesh-list
64471487|NCT04501718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471488|NCT04501718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64471489|NCT04501718|Alkylating Agents|alkylating agents|mesh-ancestor
64471490|NCT04501718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64471491|NCT04501705|Apatinib|apatinib|mesh-list
64482358|NCT03588039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64482359|NCT03588039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482360|NCT03588039|Tubulin Modulators|tubulin modulators|mesh-ancestor
64482361|NCT03588039|Antimitotic Agents|antimitotic agents|mesh-ancestor
64482362|NCT03588039|Mitosis Modulators|mitosis modulators|mesh-ancestor
64482363|NCT03588039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482364|NCT03588039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64482365|NCT02984865|Flurbiprofen|flurbiprofen|mesh-list
64482366|NCT02984865|Sufentanil|sufentanil|mesh-list
64482367|NCT02984865|Nalbuphine|nalbuphine|mesh-list
64482368|NCT02984865|Dsuvia|dsuvia|mesh-list
64482369|NCT02984865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64482370|NCT02984865|Narcotics|narcotics|mesh-ancestor
64482371|NCT02984865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64482372|NCT02984865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482373|NCT02984865|Analgesics|analgesics|mesh-ancestor
64482374|NCT02984865|Sensory System Agents|sensory system agents|mesh-ancestor
64482375|NCT02984865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64482376|NCT02984865|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64482408|NCT01611259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64482409|NCT01611259|Growth Substances|growth substances|mesh-ancestor
64482410|NCT01611259|Growth Inhibitors|growth inhibitors|mesh-ancestor
65278689|NCT04745975|Tubulin Modulators|tubulin modulators|mesh-ancestor
65278690|NCT04745975|Antimitotic Agents|antimitotic agents|mesh-ancestor
65278691|NCT04745975|Mitosis Modulators|mitosis modulators|mesh-ancestor
65278692|NCT04745975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278693|NCT04745975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64482411|NCT03586869|Leucovorin|leucovorin|mesh-list
64482412|NCT03586869|Paclitaxel|paclitaxel|mesh-list
64482413|NCT03586869|Cyclophosphamide|cyclophosphamide|mesh-list
64482414|NCT03586869|Bevacizumab|bevacizumab|mesh-list
64482415|NCT03586869|Fluorouracil|fluorouracil|mesh-list
64482416|NCT03586869|Capecitabine|capecitabine|mesh-list
64482417|NCT03586869|Oxaliplatin|oxaliplatin|mesh-list
64482418|NCT03586869|Avelumab|avelumab|mesh-list
64482419|NCT03586869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64983263|NCT00304993|Antimetabolites|antimetabolites|mesh-ancestor
64482435|NCT03586869|Growth Substances|growth substances|mesh-ancestor
64482436|NCT03586869|Growth Inhibitors|growth inhibitors|mesh-ancestor
64482437|NCT03586869|Antimetabolites|antimetabolites|mesh-ancestor
64482438|NCT03586869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64482439|NCT03586869|Antidotes|antidotes|mesh-ancestor
64482440|NCT03586869|Protective Agents|protective agents|mesh-ancestor
64482441|NCT03586869|Vitamin B Complex|vitamin b complex|mesh-ancestor
64482442|NCT03586869|Vitamins|vitamins|mesh-ancestor
64482443|NCT03586869|Micronutrients|micronutrients|mesh-ancestor
64482444|NCT01796197|Paclitaxel|paclitaxel|mesh-list
64482445|NCT01796197|Cyclophosphamide|cyclophosphamide|mesh-list
64482446|NCT01796197|Doxorubicin|doxorubicin|mesh-list
64482447|NCT01796197|Trastuzumab|trastuzumab|mesh-list
64482448|NCT01796197|Pertuzumab|pertuzumab|mesh-list
64482449|NCT01796197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64482450|NCT01796197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482451|NCT01796197|Tubulin Modulators|tubulin modulators|mesh-ancestor
64482452|NCT01796197|Antimitotic Agents|antimitotic agents|mesh-ancestor
64482453|NCT01796197|Mitosis Modulators|mitosis modulators|mesh-ancestor
64482454|NCT01796197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482455|NCT01796197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64714006|NCT03043105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64468033|NCT01475253|Anesthetics, Local|anesthetics, local|mesh-ancestor
64482456|NCT01796197|Immunologic Factors|immunologic factors|mesh-ancestor
64482457|NCT01796197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482458|NCT01796197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64482459|NCT01796197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64482460|NCT01796197|Alkylating Agents|alkylating agents|mesh-ancestor
64482461|NCT01796197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64482462|NCT01796197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64482463|NCT01796197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64482464|NCT01796197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64482465|NCT01796197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482466|NCT01796197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64482467|NCT03586791|Anesthetics|anesthetics|mesh-list
64482468|NCT03586791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64482469|NCT03586791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482470|NCT01795495|Magnesium Sulfate|magnesium sulfate|mesh-list
64482471|NCT01795495|Remifentanil|remifentanil|mesh-list
64482472|NCT01795495|Methadone|methadone|mesh-list
64482473|NCT01795495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64482474|NCT01795495|Narcotics|narcotics|mesh-ancestor
64482475|NCT01795495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64482476|NCT01795495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482493|NCT04765527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482494|NCT04765527|Protective Agents|protective agents|mesh-ancestor
64482495|NCT04765527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471492|NCT04501705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471493|NCT04501705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64471494|NCT04501705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64471495|NCT04501705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471496|NCT04485949|Temozolomide|temozolomide|mesh-list
64471497|NCT04485949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64471498|NCT04485949|Alkylating Agents|alkylating agents|mesh-ancestor
64471499|NCT04485949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471500|NCT04485949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471501|NCT04463394|Vasopressins|vasopressins|mesh-list
65278694|NCT04745975|Antimetabolites|antimetabolites|mesh-ancestor
65278695|NCT04745975|Antiviral Agents|antiviral agents|mesh-ancestor
65278696|NCT04745975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65278697|NCT04745975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278698|NCT04745975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65278699|NCT04745975|Immunologic Factors|immunologic factors|mesh-ancestor
65278700|NCT04745975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278701|NCT04150107|Insulin|insulin|mesh-list
64482497|NCT02947503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64482498|NCT02947503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482499|NCT03586323|Lidocaine|lidocaine|mesh-list
64482500|NCT03586323|Anesthetics, Local|anesthetics, local|mesh-ancestor
64482501|NCT03586323|Anesthetics|anesthetics|mesh-ancestor
64482502|NCT03586323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64482503|NCT03586323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482504|NCT03586323|Sensory System Agents|sensory system agents|mesh-ancestor
64482505|NCT03586323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64482506|NCT03586323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64482507|NCT03586323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64482508|NCT03586323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64482509|NCT03586323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64482510|NCT03586323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482511|NCT03586089|Diazepam|diazepam|mesh-list
64482512|NCT03586089|Phenobarbital|phenobarbital|mesh-list
64482513|NCT03586089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64482514|NCT03586089|Anticonvulsants|anticonvulsants|mesh-ancestor
64482515|NCT03586089|Antiemetics|antiemetics|mesh-ancestor
64482516|NCT03586089|Autonomic Agents|autonomic agents|mesh-ancestor
64482517|NCT03586089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64482518|NCT03586089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482519|NCT03586089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64482520|NCT03586089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64601097|NCT00763867|Urological Agents|urological agents|mesh-ancestor
64482535|NCT03586089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64482536|NCT03586089|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64482537|NCT03586089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64482538|NCT03586089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64482539|NCT01986881|Ertugliflozin|ertugliflozin|mesh-list
64482540|NCT01986881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64482541|NCT01986881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482542|NCT01986881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64482543|NCT01986881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471502|NCT04463394|Arginine Vasopressin|arginine vasopressin|mesh-list
64513657|NCT01457859|Antimetabolites|antimetabolites|mesh-ancestor
64471504|NCT04463394|Coagulants|coagulants|mesh-ancestor
64471505|NCT04463394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64471506|NCT04463394|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64471507|NCT04463394|Natriuretic Agents|natriuretic agents|mesh-ancestor
64471508|NCT04463394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471509|NCT04454905|Apatinib|apatinib|mesh-list
64471510|NCT04454905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471511|NCT04454905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64471512|NCT04454905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64471513|NCT04454905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471514|NCT04438512|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
64471515|NCT04438512|Hallucinogens|hallucinogens|mesh-ancestor
64471516|NCT04438512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471517|NCT04438512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64471518|NCT04438512|Serotonin Agents|serotonin agents|mesh-ancestor
64471519|NCT04438512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64471520|NCT04438512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482544|NCT04592653|Pembrolizumab|pembrolizumab|mesh-list
64482545|NCT04592653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64482546|NCT04592653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482547|NCT03580395|Paclitaxel|paclitaxel|mesh-list
64482548|NCT03580395|Apatinib|apatinib|mesh-list
64482549|NCT03580395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65278702|NCT04150107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65278703|NCT04150107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65278704|NCT04150107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278705|NCT02638428|Cytarabine|cytarabine|mesh-list
65278706|NCT02638428|Carboplatin|carboplatin|mesh-list
65278707|NCT02638428|Trastuzumab|trastuzumab|mesh-list
65278708|NCT02638428|Fludarabine|fludarabine|mesh-list
65278709|NCT02638428|Etoposide|etoposide|mesh-list
65278710|NCT02638428|Everolimus|everolimus|mesh-list
64601604|NCT03803449|Fentanyl|fentanyl|mesh-list
64482550|NCT03580395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482552|NCT03580395|Antimitotic Agents|antimitotic agents|mesh-ancestor
64482553|NCT03580395|Mitosis Modulators|mitosis modulators|mesh-ancestor
64482554|NCT03580395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482555|NCT03580395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64482556|NCT03580395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482558|NCT01770145|Carbidopa|carbidopa|mesh-list
64482559|NCT01770145|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64482560|NCT01770145|Trimethobenzamide|trimethobenzamide|mesh-list
64482568|NCT01770145|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64482569|NCT01770145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482570|NCT01770145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64482571|NCT01770145|Immunologic Factors|immunologic factors|mesh-ancestor
64482572|NCT01770145|Dopamine Agonists|dopamine agonists|mesh-ancestor
64482575|NCT01770145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64482576|NCT01770145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64482578|NCT01609543|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64482579|NCT01609543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482580|NCT01609543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64482581|NCT01609543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64471521|NCT04438512|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64471522|NCT04438512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64471523|NCT04438512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64471524|NCT04438512|Adrenergic Agents|adrenergic agents|mesh-ancestor
64471525|NCT04436601|Lactulose|lactulose|mesh-list
64471526|NCT04436601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64471527|NCT04397484|Lidocaine|lidocaine|mesh-list
64471528|NCT04397484|Epinephrine|epinephrine|mesh-list
64471529|NCT04397484|Racepinephrine|racepinephrine|mesh-list
64471530|NCT04397484|Levobupivacaine|levobupivacaine|mesh-list
64471531|NCT04397484|Epinephryl borate|epinephryl borate|mesh-list
64471532|NCT04397484|Anesthetics, Local|anesthetics, local|mesh-ancestor
64471533|NCT04397484|Anesthetics|anesthetics|mesh-ancestor
64471534|NCT04397484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64482582|NCT01609543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482583|NCT03580239|Everolimus|everolimus|mesh-list
64482584|NCT03580239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482585|NCT03580239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64482586|NCT03580239|Immunologic Factors|immunologic factors|mesh-ancestor
64482587|NCT03580239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482588|NCT03156153|Bumetanide|bumetanide|mesh-list
64482589|NCT03156153|Diuretics|diuretics|mesh-ancestor
64482590|NCT03156153|Natriuretic Agents|natriuretic agents|mesh-ancestor
64482591|NCT03156153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482592|NCT03156153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64482593|NCT03156153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64602340|NCT04634071|Autonomic Agents|autonomic agents|mesh-ancestor
64482594|NCT03156153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482595|NCT03156231|Acetazolamide|acetazolamide|mesh-list
64482596|NCT03156231|Anticonvulsants|anticonvulsants|mesh-ancestor
64482597|NCT03156231|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64482598|NCT03156231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482599|NCT03156231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482600|NCT03156231|Diuretics|diuretics|mesh-ancestor
64482601|NCT03156231|Natriuretic Agents|natriuretic agents|mesh-ancestor
64482602|NCT03156231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482603|NCT05702151|Morphine|morphine|mesh-list
64468185|NCT01474239|Bevacizumab|bevacizumab|mesh-list
64482604|NCT05702151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64482605|NCT05702151|Narcotics|narcotics|mesh-ancestor
65278711|NCT02638428|Sorafenib|sorafenib|mesh-list
65278712|NCT02638428|Dasatinib|dasatinib|mesh-list
65278713|NCT02638428|Ifosfamide|ifosfamide|mesh-list
65278714|NCT02638428|Axitinib|axitinib|mesh-list
65278715|NCT02638428|Vemurafenib|vemurafenib|mesh-list
65278716|NCT02638428|Crizotinib|crizotinib|mesh-list
64482606|NCT05702151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64482607|NCT05702151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482608|NCT05702151|Analgesics|analgesics|mesh-ancestor
64482609|NCT05702151|Sensory System Agents|sensory system agents|mesh-ancestor
64482610|NCT05702151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64482611|NCT05702073|Insulin Glargine|insulin glargine|mesh-list
64482612|NCT05702073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64602890|NCT02019069|Cytarabine|cytarabine|mesh-list
64482639|NCT03584841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482640|NCT03584841|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64482641|NCT03584841|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64482642|NCT03584841|Cholinergic Agents|cholinergic agents|mesh-ancestor
64482643|NCT03584841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64482644|NCT03584841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482645|NCT02000921|Nicotine|nicotine|mesh-list
64482646|NCT02000921|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64482647|NCT02000921|Autonomic Agents|autonomic agents|mesh-ancestor
64482648|NCT02000921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64482649|NCT02000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482650|NCT02000921|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64482651|NCT02000921|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64482652|NCT02000921|Cholinergic Agents|cholinergic agents|mesh-ancestor
64482653|NCT02000921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64482654|NCT02000921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482655|NCT03586947|Vitamin D|vitamin d|mesh-list
64482656|NCT03586947|Ergocalciferols|ergocalciferols|mesh-list
64482657|NCT03586947|Cholecalciferol|cholecalciferol|mesh-list
64482658|NCT03586947|Vitamins|vitamins|mesh-list
64482659|NCT03586947|Micronutrients|micronutrients|mesh-ancestor
64482660|NCT03586947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482661|NCT03586947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64482662|NCT03586947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64482663|NCT04405245|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64482664|NCT04405245|Latanoprost|latanoprost|mesh-list
64482665|NCT04405245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64482694|NCT03583749|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64482695|NCT03583749|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64482696|NCT03583749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64482697|NCT03583749|Antitubercular Agents|antitubercular agents|mesh-ancestor
64482698|NCT03020589|Tacrolimus|tacrolimus|mesh-list
64482699|NCT03020589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64603224|NCT03808961|Vitamin B Complex|vitamin b complex|mesh-list
64482700|NCT03020589|Immunologic Factors|immunologic factors|mesh-ancestor
64482701|NCT03020589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471535|NCT04397484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471537|NCT04397484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64471538|NCT04397484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64471539|NCT04397484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64482702|NCT03020589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64482703|NCT03020589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482704|NCT03020589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482734|NCT02092025|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64482735|NCT02092025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482737|NCT04405011|Antiviral Agents|antiviral agents|mesh-ancestor
64482738|NCT04405011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64482739|NCT01769443|Bortezomib|bortezomib|mesh-list
64482740|NCT01769443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482741|NCT03154827|Atezolizumab|atezolizumab|mesh-list
64482742|NCT03154827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482743|NCT01274182|Rituximab|rituximab|mesh-list
64482744|NCT01274182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64482745|NCT01274182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482746|NCT01274182|Immunologic Factors|immunologic factors|mesh-ancestor
64603538|NCT00770861|Vasodilator Agents|vasodilator agents|mesh-ancestor
64482747|NCT01274182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482748|NCT01274182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64482774|NCT01274104|Micronutrients|micronutrients|mesh-ancestor
65278717|NCT02638428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65278718|NCT02638428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65278719|NCT02638428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65278720|NCT02638428|Antimetabolites|antimetabolites|mesh-ancestor
65278721|NCT02638428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278722|NCT02638428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65278723|NCT02638428|Immunologic Factors|immunologic factors|mesh-ancestor
65278724|NCT02638428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278725|NCT02638428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65278726|NCT02638428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65278727|NCT02638428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65278728|NCT02638428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278729|NCT02638428|Antiviral Agents|antiviral agents|mesh-ancestor
65278730|NCT02638428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65278731|NCT02638428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64482775|NCT01274104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482776|NCT01274104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64482777|NCT01274104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64482778|NCT01279096|Dexamethasone|dexamethasone|mesh-list
64482779|NCT01279096|Etoposide|etoposide|mesh-list
64482780|NCT01279096|Asparaginase|asparaginase|mesh-list
64482781|NCT01279096|Mitoxantrone|mitoxantrone|mesh-list
64482782|NCT01279096|Clofarabine|clofarabine|mesh-list
64482783|NCT01279096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64482784|NCT01279096|Antiemetics|antiemetics|mesh-ancestor
64482785|NCT01279096|Autonomic Agents|autonomic agents|mesh-ancestor
64482786|NCT01279096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64482787|NCT01279096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482788|NCT01279096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64482789|NCT01279096|Glucocorticoids|glucocorticoids|mesh-ancestor
64482790|NCT01279096|Hormones|hormones|mesh-ancestor
64604608|NCT00534430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604682|NCT00849251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482804|NCT01272934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64482805|NCT01272934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64482806|NCT01272934|Analgesics|analgesics|mesh-ancestor
64482807|NCT01272934|Sensory System Agents|sensory system agents|mesh-ancestor
64482808|NCT01272934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64482809|NCT01272934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482810|NCT01272934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64482811|NCT01272934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64482812|NCT01272934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64482813|NCT01272934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605335|NCT02631772|Ribavirin|ribavirin|mesh-list
64482814|NCT01272934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482815|NCT01279252|Metronidazole|metronidazole|mesh-list
64482816|NCT01279252|Clarithromycin|clarithromycin|mesh-list
64482817|NCT01279252|Ciprofloxacin|ciprofloxacin|mesh-list
64482818|NCT01279252|Lansoprazole|lansoprazole|mesh-list
64482819|NCT01279252|Dexlansoprazole|dexlansoprazole|mesh-list
64482820|NCT01279252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64482821|NCT01279252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64482822|NCT01279252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64482823|NCT01279252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64482824|NCT01279252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64482825|NCT01279252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482826|NCT01279252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482827|NCT01279252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64605687|NCT05342818|Dopamine Agents|dopamine agents|mesh-ancestor
65278732|NCT02638428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65278733|NCT02638428|Alkylating Agents|alkylating agents|mesh-ancestor
65278734|NCT01003964|Gemcitabine|gemcitabine|mesh-list
65278735|NCT01003964|Cisplatin|cisplatin|mesh-list
65278736|NCT01003964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65278737|NCT01003964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65278738|NCT01003964|Antimetabolites|antimetabolites|mesh-ancestor
65278739|NCT01003964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278740|NCT01003964|Antiviral Agents|antiviral agents|mesh-ancestor
65278741|NCT01003964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65278742|NCT01003964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278743|NCT01003964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65278744|NCT01003964|Immunologic Factors|immunologic factors|mesh-ancestor
65278745|NCT01003964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278746|NCT02502786|Antibodies|antibodies|mesh-list
65278747|NCT02502786|Immunologic Factors|immunologic factors|mesh-ancestor
65278748|NCT02502786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278749|NCT02823743|Aspirin|aspirin|mesh-list
64482828|NCT01279252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64482829|NCT01279252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64482830|NCT01279252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64605828|NCT00868699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64482831|NCT01279252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482832|NCT01279252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64482833|NCT01279252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64482834|NCT01279252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64482835|NCT01279252|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64605973|NCT05315479|Meloxicam|meloxicam|mesh-list
64482836|NCT04385836|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64482837|NCT04385836|Protein C Inhibitor|protein c inhibitor|mesh-list
64482838|NCT04385836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64482839|NCT04385836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64482841|NCT04385836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482842|NCT04385836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482843|NCT05701215|Venetoclax|venetoclax|mesh-list
64482844|NCT05701215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482845|NCT01274260|Methylprednisolone|methylprednisolone|mesh-list
64482861|NCT01274260|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64482862|NCT01274260|Protective Agents|protective agents|mesh-ancestor
64482863|NCT01274260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64482864|NCT01274260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482865|NCT03154983|Docetaxel|docetaxel|mesh-list
64482866|NCT03154983|Apatinib|apatinib|mesh-list
64482867|NCT03154983|Tegafur|tegafur|mesh-list
64482868|NCT03154983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482870|NCT03154983|Antimitotic Agents|antimitotic agents|mesh-ancestor
64482871|NCT03154983|Mitosis Modulators|mitosis modulators|mesh-ancestor
64482872|NCT03154983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482873|NCT03154983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64607369|NCT01726465|Hormones|hormones|mesh-ancestor
64482874|NCT03154983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482875|NCT03154983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64482876|NCT03154983|Antimetabolites|antimetabolites|mesh-ancestor
64482877|NCT01983683|Vancomycin|vancomycin|mesh-list
64482878|NCT01983683|Oxazolidinones|oxazolidinones|mesh-list
64482880|NCT01983683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64482881|NCT01983683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64482882|NCT01983683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482883|NCT01983683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278750|NCT02823743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65278751|NCT02823743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65278752|NCT02823743|Analgesics|analgesics|mesh-ancestor
65278753|NCT02823743|Sensory System Agents|sensory system agents|mesh-ancestor
65278754|NCT02823743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65278755|NCT02823743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278756|NCT02823743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65278757|NCT02823743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65278758|NCT02823743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64482884|NCT03154515|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
64482886|NCT03154515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64482887|NCT03158025|Zolpidem|zolpidem|mesh-list
64482888|NCT03158025|Suvorexant|suvorexant|mesh-list
64482889|NCT03158025|Lemborexant|lemborexant|mesh-list
64608031|NCT05530122|Ustekinumab|ustekinumab|mesh-list
64482890|NCT03158025|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64482892|NCT03158025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64482893|NCT03158025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482894|NCT03158025|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64482895|NCT03158025|GABA Agonists|gaba agonists|mesh-ancestor
64482896|NCT03158025|GABA Agents|gaba agents|mesh-ancestor
64482897|NCT03158025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64482898|NCT03158025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482899|NCT03158025|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64471545|NCT04397484|Adrenergic Agents|adrenergic agents|mesh-ancestor
64471546|NCT04397484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64471547|NCT04397484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64471548|NCT04397484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64471578|NCT04310995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471579|NCT04310995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64471580|NCT04310995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482902|NCT01998893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482904|NCT01998893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482905|NCT01998893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64482906|NCT01791985|Letrozole|letrozole|mesh-list
64482907|NCT01791985|Anastrozole|anastrozole|mesh-list
64482908|NCT01791985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482909|NCT01791985|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64482910|NCT01791985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64482911|NCT01791985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482912|NCT01791985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482913|NCT01791985|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64482914|NCT01791985|Hormone Antagonists|hormone antagonists|mesh-ancestor
64482915|NCT01791985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64482916|NCT01791985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482917|NCT01791985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64482918|NCT04176497|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64482919|NCT04176497|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64608400|NCT00883103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64482920|NCT04176497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482921|NCT01791517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64482923|NCT03154281|Niraparib|niraparib|mesh-list
64482924|NCT03154281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482925|NCT03154281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64482926|NCT03154281|Immunologic Factors|immunologic factors|mesh-ancestor
64608602|NCT04337632|Mitosis Modulators|mitosis modulators|mesh-ancestor
64482927|NCT03154281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482928|NCT03154281|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64482929|NCT03154281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482930|NCT03154281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482931|NCT03157791|Simethicone|simethicone|mesh-list
64482932|NCT03157791|Antifoaming Agents|antifoaming agents|mesh-ancestor
64608819|NCT01048333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65278759|NCT02823743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65278760|NCT02823743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278761|NCT02823743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65278762|NCT02823743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65278763|NCT02823743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278764|NCT02823743|Antipyretics|antipyretics|mesh-ancestor
65278765|NCT00654888|Mitomycins|mitomycins|mesh-list
65278766|NCT00654888|Mitomycin|mitomycin|mesh-list
65278767|NCT00654888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65278768|NCT00654888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65278769|NCT00654888|Alkylating Agents|alkylating agents|mesh-ancestor
65278770|NCT00654888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278771|NCT00654888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65278772|NCT00654888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278773|NCT05299203|Verapamil|verapamil|mesh-list
65278774|NCT05299203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65278775|NCT05299203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65278776|NCT05299203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65278777|NCT05299203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278778|NCT05299203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65278779|NCT05299203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278780|NCT05299203|Vasodilator Agents|vasodilator agents|mesh-ancestor
65278781|NCT02638584|Rabeprazole|rabeprazole|mesh-list
65278782|NCT02638584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64731233|NCT00003031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482933|NCT03157791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608981|NCT01044745|Antimetabolites|antimetabolites|mesh-ancestor
64482934|NCT03157791|Emollients|emollients|mesh-ancestor
64482935|NCT03157791|Dermatologic Agents|dermatologic agents|mesh-ancestor
64482936|NCT05701059|Meloxicam|meloxicam|mesh-list
64482938|NCT05701059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64482939|NCT05701059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64609189|NCT01040689|Olodaterol|olodaterol|mesh-list
64609262|NCT04755712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64609336|NCT04334824|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64482940|NCT05701059|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64482941|NCT05701059|Histamine Antagonists|histamine antagonists|mesh-ancestor
64482942|NCT05701059|Histamine Agents|histamine agents|mesh-ancestor
64482943|NCT05701059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64482944|NCT05701059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482945|NCT05701059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482946|NCT05701059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64482947|NCT05701059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64609727|NCT03219359|Hormones|hormones|mesh-ancestor
64482972|NCT01272232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64610508|NCT00926263|Moxifloxacin|moxifloxacin|mesh-list
64482973|NCT01272232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482974|NCT01272232|Incretins|incretins|mesh-ancestor
65278783|NCT02638584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65278784|NCT02638584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65278785|NCT02638584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278786|NCT02638584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278787|NCT04208516|Dexamethasone|dexamethasone|mesh-list
65278788|NCT04208516|Lidocaine|lidocaine|mesh-list
65278789|NCT04208516|Dexmedetomidine|dexmedetomidine|mesh-list
65278790|NCT04208516|Ropivacaine|ropivacaine|mesh-list
65278791|NCT04208516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65278792|NCT04208516|Antiemetics|antiemetics|mesh-ancestor
65278793|NCT04208516|Autonomic Agents|autonomic agents|mesh-ancestor
65278794|NCT04208516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65278795|NCT04208516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278796|NCT04208516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65278797|NCT04208516|Glucocorticoids|glucocorticoids|mesh-ancestor
65278798|NCT04208516|Hormones|hormones|mesh-ancestor
65278799|NCT04208516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65278800|NCT04208516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65278801|NCT04208516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65278802|NCT04208516|Anesthetics, Local|anesthetics, local|mesh-ancestor
65278803|NCT04208516|Anesthetics|anesthetics|mesh-ancestor
64482975|NCT01272232|Hormones|hormones|mesh-ancestor
64482976|NCT01272232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64482977|NCT03157401|Tranexamic Acid|tranexamic acid|mesh-list
64482978|NCT03157401|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64610794|NCT03401593|Analgesics|analgesics|mesh-ancestor
64482979|NCT03157401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64482980|NCT03157401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482982|NCT03157401|Coagulants|coagulants|mesh-ancestor
64482984|NCT03153813|Antipruritics|antipruritics|mesh-ancestor
64482985|NCT03153813|Dermatologic Agents|dermatologic agents|mesh-ancestor
64610938|NCT01722305|Dexamethasone|dexamethasone|mesh-list
64611017|NCT01722539|Renal Agents|renal agents|mesh-ancestor
64482986|NCT03153813|Sensory System Agents|sensory system agents|mesh-ancestor
64482987|NCT03153813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64482988|NCT03153813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482989|NCT03156855|Bismuth|bismuth|mesh-list
64482991|NCT03156855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611316|NCT02909140|Autonomic Agents|autonomic agents|mesh-ancestor
64611385|NCT04364581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482992|NCT03156855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64482993|NCT00739960|Abatacept|abatacept|mesh-list
64482994|NCT00739960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64482995|NCT00739960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482996|NCT00739960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471581|NCT04310995|Vasodilator Agents|vasodilator agents|mesh-ancestor
64483013|NCT03153657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64483014|NCT03153657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483015|NCT03153657|Sequestering Agents|sequestering agents|mesh-ancestor
64483017|NCT01670955|Hematinics|hematinics|mesh-ancestor
64483018|NCT01670955|Vitamin B Complex|vitamin b complex|mesh-ancestor
64483019|NCT01670955|Vitamins|vitamins|mesh-ancestor
64483020|NCT01670955|Micronutrients|micronutrients|mesh-ancestor
64483021|NCT01670955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483022|NCT01275274|Tretinoin|tretinoin|mesh-list
65278804|NCT04208516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65278805|NCT04208516|Sensory System Agents|sensory system agents|mesh-ancestor
65278806|NCT04208516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65278807|NCT04208516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65278808|NCT04208516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65278809|NCT04208516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65278810|NCT04208516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278811|NCT04208516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65278812|NCT04208516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64483023|NCT01275274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483024|NCT01275274|Keratolytic Agents|keratolytic agents|mesh-ancestor
64483027|NCT01997333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64483028|NCT01997333|Antimetabolites|antimetabolites|mesh-ancestor
64612773|NCT03038308|Ropinirole|ropinirole|mesh-list
64612846|NCT00358293|Tizanidine|tizanidine|mesh-list
64483029|NCT01997333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483030|NCT01997333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483031|NCT01271920|Trastuzumab|trastuzumab|mesh-list
64612926|NCT04364321|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64483032|NCT01271920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64613068|NCT05285943|Hormones|hormones|mesh-ancestor
64483033|NCT01271920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483034|NCT01275352|Eplerenone|eplerenone|mesh-list
64483035|NCT01275352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
64483036|NCT01275352|Hormone Antagonists|hormone antagonists|mesh-ancestor
64483037|NCT01275352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64483038|NCT01275352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483039|NCT01275352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64483040|NCT01275352|Diuretics|diuretics|mesh-ancestor
64483041|NCT01275352|Natriuretic Agents|natriuretic agents|mesh-ancestor
64613215|NCT00967369|Carboplatin|carboplatin|mesh-list
64483042|NCT01275352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64483043|NCT01676259|Gemcitabine|gemcitabine|mesh-list
64483044|NCT01676259|Paclitaxel|paclitaxel|mesh-list
64483045|NCT01676259|Folfirinox|folfirinox|mesh-list
64613436|NCT02989714|Nivolumab|nivolumab|mesh-list
64483046|NCT01676259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64483047|NCT01676259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483048|NCT01676259|Tubulin Modulators|tubulin modulators|mesh-ancestor
64483081|NCT00746512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471582|NCT04310995|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64483082|NCT00746512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64483083|NCT00746512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483084|NCT05409027|Cortisone|cortisone|mesh-list
64483085|NCT05409027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64483086|NCT05409027|Glucocorticoids|glucocorticoids|mesh-list
64483112|NCT00753142|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64483113|NCT00753142|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64483114|NCT00753142|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64483116|NCT01279876|Melatonin|melatonin|mesh-list
64483117|NCT01279876|Antioxidants|antioxidants|mesh-ancestor
64483118|NCT01279876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483119|NCT01279876|Protective Agents|protective agents|mesh-ancestor
64483120|NCT01279876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483121|NCT01279876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64483122|NCT01996709|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64483123|NCT01996709|Contact Lens Solutions|contact lens solutions|mesh-list
64483124|NCT01996709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64483125|NCT01996709|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64483126|NCT01996709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64483127|NCT01996709|Disinfectants|disinfectants|mesh-ancestor
64483128|NCT00753220|Cyclophosphamide|cyclophosphamide|mesh-list
64483129|NCT00753220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64483130|NCT00753220|Immunologic Factors|immunologic factors|mesh-ancestor
64483131|NCT00753220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278813|NCT04208516|Analgesics|analgesics|mesh-ancestor
65278814|NCT04208516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65278815|NCT04208516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65278816|NCT04208516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65278817|NCT04208516|Adrenergic Agents|adrenergic agents|mesh-ancestor
65278818|NCT04208516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65278819|NCT02821169|Ropivacaine|ropivacaine|mesh-list
65278820|NCT02821169|Anesthetics, Local|anesthetics, local|mesh-ancestor
65278821|NCT02821169|Anesthetics|anesthetics|mesh-ancestor
65028824|NCT04833140|Estradiol|estradiol|mesh-list
65278822|NCT02821169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65278823|NCT02821169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278824|NCT02821169|Sensory System Agents|sensory system agents|mesh-ancestor
65278825|NCT02821169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65278826|NCT02820935|Itraconazole|itraconazole|mesh-list
65278827|NCT02820935|Rifampin|rifampin|mesh-list
65278828|NCT02820935|Antifungal Agents|antifungal agents|mesh-ancestor
65278829|NCT02820935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65278830|NCT02820935|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64483132|NCT00753220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64984070|NCT00083681|Dexamethasone|dexamethasone|mesh-list
64483146|NCT00763048|Triclosan|triclosan|mesh-list
64483147|NCT00763048|Fluorides|fluorides|mesh-list
64483148|NCT00763048|Cariostatic Agents|cariostatic agents|mesh-ancestor
64483149|NCT00763048|Protective Agents|protective agents|mesh-ancestor
64615132|NCT00636818|Adrenergic Agents|adrenergic agents|mesh-ancestor
64483150|NCT00763048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483151|NCT00763048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64483152|NCT00763048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64483153|NCT00763048|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64483154|NCT00763048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64483156|NCT00763048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483157|NCT00763048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64483159|NCT01278394|Antifungal Agents|antifungal agents|mesh-ancestor
64483160|NCT01278394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64483161|NCT00240916|Vaccines|vaccines|mesh-list
64483162|NCT00240916|Immunologic Factors|immunologic factors|mesh-ancestor
64483163|NCT00240916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483164|NCT01278160|Insulin|insulin|mesh-list
64483165|NCT01278160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64483166|NCT01278160|Metformin|metformin|mesh-list
64483167|NCT01278160|Insulin Aspart|insulin aspart|mesh-list
64483168|NCT01278160|Insulin, Long-Acting|insulin, long-acting|mesh-list
64483169|NCT01278160|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64483170|NCT01278160|Biphasic Insulins|biphasic insulins|mesh-list
64483171|NCT01278160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64483172|NCT01278160|Insulin, Isophane|insulin, isophane|mesh-list
64483173|NCT01278160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64483174|NCT01278160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483175|NCT00748072|Vasopressins|vasopressins|mesh-list
64483176|NCT00748072|Hemostatics|hemostatics|mesh-ancestor
64483177|NCT00748072|Coagulants|coagulants|mesh-ancestor
64483178|NCT00748072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64483179|NCT00748072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64483180|NCT00748072|Natriuretic Agents|natriuretic agents|mesh-ancestor
64483181|NCT00748072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483182|NCT01835587|Cc-486|cc-486|mesh-list
64483183|NCT01835587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483184|NCT01736917|Dexamethasone|dexamethasone|mesh-list
65278831|NCT02820935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65278832|NCT02820935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278833|NCT02820935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278834|NCT02820935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64731308|NCT00003541|Etoposide|etoposide|mesh-list
64483185|NCT01736917|Fosaprepitant|fosaprepitant|mesh-list
64483186|NCT01736917|Aprepitant|aprepitant|mesh-list
64483187|NCT01736917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64483188|NCT01736917|Antiemetics|antiemetics|mesh-ancestor
64483189|NCT01736917|Autonomic Agents|autonomic agents|mesh-ancestor
64483190|NCT01736917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64483191|NCT01736917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483193|NCT01736917|Glucocorticoids|glucocorticoids|mesh-ancestor
64483194|NCT01736917|Hormones|hormones|mesh-ancestor
64483195|NCT01736917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64483215|NCT01980875|Obinutuzumab|obinutuzumab|mesh-list
64483217|NCT01980875|Chlorambucil|chlorambucil|mesh-list
64616947|NCT03016039|Analgesics|analgesics|mesh-ancestor
64483218|NCT01980875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64483220|NCT01980875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617094|NCT03374176|Metronidazole|metronidazole|mesh-list
64617113|NCT03378076|FX006|fx006|mesh-list
64483221|NCT01980875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471583|NCT04310995|Diuretics|diuretics|mesh-ancestor
64483222|NCT01980875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64483223|NCT01980875|Alkylating Agents|alkylating agents|mesh-ancestor
64483224|NCT01967225|Linezolid|linezolid|mesh-list
64483225|NCT01967225|Tedizolid|tedizolid|mesh-list
64483226|NCT01967225|Tedizolid phosphate|tedizolid phosphate|mesh-list
64617313|NCT04579523|Antibodies|antibodies|mesh-list
64483227|NCT01967225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64483228|NCT01967225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64483229|NCT01967225|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64483230|NCT01967225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617611|NCT03593902|Prednisolone phosphate|prednisolone phosphate|mesh-list
64483231|NCT01967225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483232|NCT01967147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64483233|NCT01967147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64483242|NCT01765543|Antitubercular Agents|antitubercular agents|mesh-ancestor
64483243|NCT01765543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64483244|NCT01765543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64483245|NCT01765543|Leprostatic Agents|leprostatic agents|mesh-ancestor
64483246|NCT01765543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64483247|NCT01765543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64483248|NCT01765543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617980|NCT01097395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617981|NCT01097395|Antiviral Agents|antiviral agents|mesh-ancestor
64617982|NCT01097395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617983|NCT00467987|Testosterone|testosterone|mesh-list
64617984|NCT00467987|Androgens|androgens|mesh-ancestor
64617985|NCT00467987|Hormones|hormones|mesh-ancestor
64617986|NCT00467987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64617987|NCT00467987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483249|NCT01765543|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64483250|NCT01765543|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64483251|NCT01765543|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64483252|NCT01765543|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64483253|NCT01765543|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64483254|NCT01765543|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64483255|NCT01765543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483256|NCT01765543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64483258|NCT00248170|Anastrozole|anastrozole|mesh-list
64483259|NCT00248170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483260|NCT00248170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64618184|NCT03403504|Analgesics|analgesics|mesh-ancestor
64483261|NCT00248170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64483262|NCT00248170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64483263|NCT00248170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618331|NCT03023111|Molgramostim|molgramostim|mesh-list
64483264|NCT00248170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65278835|NCT02820935|Hormone Antagonists|hormone antagonists|mesh-ancestor
65278836|NCT02820935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65278837|NCT02820935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278838|NCT02820935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65278839|NCT02820935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65278840|NCT02820935|Antitubercular Agents|antitubercular agents|mesh-ancestor
65278841|NCT02820935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65278842|NCT02820935|Leprostatic Agents|leprostatic agents|mesh-ancestor
64731312|NCT00003541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483265|NCT00248170|Hormone Antagonists|hormone antagonists|mesh-ancestor
64483266|NCT00248170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64483267|NCT00248170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483268|NCT00248170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64483269|NCT01764997|Adalimumab|adalimumab|mesh-list
64483270|NCT01764997|Etanercept|etanercept|mesh-list
64483271|NCT01764997|Methotrexate|methotrexate|mesh-list
64483272|NCT01764997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64483273|NCT01764997|Abortifacient Agents|abortifacient agents|mesh-ancestor
64483274|NCT01764997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64483275|NCT01764997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483276|NCT01764997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64483277|NCT01764997|Antimetabolites|antimetabolites|mesh-ancestor
64618765|NCT01104025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483278|NCT01764997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483280|NCT01764997|Dermatologic Agents|dermatologic agents|mesh-ancestor
64471584|NCT04310995|Natriuretic Agents|natriuretic agents|mesh-ancestor
64483281|NCT01764997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64483282|NCT01764997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64483283|NCT01764997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64483284|NCT01764997|Immunologic Factors|immunologic factors|mesh-ancestor
64483285|NCT01764997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64619055|NCT04290676|Dexamethasone|dexamethasone|mesh-list
64483305|NCT01276756|Immunologic Factors|immunologic factors|mesh-ancestor
64483306|NCT01276756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483307|NCT01276756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64483309|NCT00246376|Fenofibrate|fenofibrate|mesh-list
64483310|NCT00246376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64483311|NCT00246376|Antimetabolites|antimetabolites|mesh-ancestor
64619479|NCT01926236|Antimetabolites|antimetabolites|mesh-ancestor
64619554|NCT00982280|Narcotics|narcotics|mesh-ancestor
64483312|NCT00246376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483313|NCT00246376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64483314|NCT00246376|Vasodilator Agents|vasodilator agents|mesh-ancestor
64483315|NCT00246376|Vitamin B Complex|vitamin b complex|mesh-ancestor
64483316|NCT00246376|Vitamins|vitamins|mesh-ancestor
64483317|NCT00246376|Micronutrients|micronutrients|mesh-ancestor
64483318|NCT00246376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483319|NCT03806062|Domperidone|domperidone|mesh-list
64483320|NCT03806062|Antiemetics|antiemetics|mesh-ancestor
64483321|NCT03806062|Autonomic Agents|autonomic agents|mesh-ancestor
64483322|NCT03806062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64483323|NCT03806062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483324|NCT03806062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64483325|NCT03806062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64619867|NCT04395170|Antibodies|antibodies|mesh-list
64619931|NCT03831464|Metformin|metformin|mesh-list
64483326|NCT03806062|Dopamine Agents|dopamine agents|mesh-ancestor
64483327|NCT03806062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64483328|NCT03806062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483329|NCT00754546|Formoterol Fumarate|formoterol fumarate|mesh-list
64483330|NCT00754546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64483332|NCT00754546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64483333|NCT00754546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483335|NCT00754546|Respiratory System Agents|respiratory system agents|mesh-ancestor
65278843|NCT02820935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65278844|NCT02820935|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65278845|NCT02820935|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65278846|NCT02820935|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65278847|NCT02820935|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65278848|NCT02820935|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65278849|NCT02820935|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65278850|NCT02626845|Rituximab|rituximab|mesh-list
65278851|NCT02626845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65278852|NCT02626845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65278853|NCT02626845|Immunologic Factors|immunologic factors|mesh-ancestor
65278854|NCT02626845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278855|NCT02626845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65278856|NCT02821247|Aflibercept|aflibercept|mesh-list
65278857|NCT02821247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65278858|NCT02821247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64483336|NCT00754546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64483337|NCT00754546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64620523|NCT03827642|Naloxone|naloxone|mesh-list
64483338|NCT00754546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64483339|NCT00754546|Adrenergic Agents|adrenergic agents|mesh-ancestor
64483340|NCT00754546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64620745|NCT03161912|Aflibercept|aflibercept|mesh-list
64483341|NCT00754546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483362|NCT00245050|Vitamin B Complex|vitamin b complex|mesh-ancestor
64483363|NCT00245050|Vitamins|vitamins|mesh-ancestor
64483364|NCT00245050|Micronutrients|micronutrients|mesh-ancestor
64483365|NCT00245050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483366|NCT04345588|Dexamethasone|dexamethasone|mesh-list
64483367|NCT04345588|Dexamethasone acetate|dexamethasone acetate|mesh-list
64483368|NCT04345588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64483369|NCT04345588|Antiemetics|antiemetics|mesh-ancestor
64483370|NCT04345588|Autonomic Agents|autonomic agents|mesh-ancestor
64483371|NCT04345588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64483372|NCT04345588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483373|NCT04345588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64483374|NCT04345588|Glucocorticoids|glucocorticoids|mesh-ancestor
64483375|NCT04345588|Hormones|hormones|mesh-ancestor
64483376|NCT04345588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64483377|NCT04345588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64621790|NCT01187017|Fludarabine|fludarabine|mesh-list
64483378|NCT04345588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483379|NCT03806374|Lidocaine|lidocaine|mesh-list
64483380|NCT03806374|Fentanyl|fentanyl|mesh-list
64483381|NCT03806374|Ketamine|ketamine|mesh-list
64483384|NCT03806374|Anesthetics, Local|anesthetics, local|mesh-ancestor
64483385|NCT03806374|Anesthetics|anesthetics|mesh-ancestor
64483386|NCT03806374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64622060|NCT05495100|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64483387|NCT03806374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483388|NCT03806374|Sensory System Agents|sensory system agents|mesh-ancestor
64483389|NCT03806374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64483390|NCT03806374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64483391|NCT03806374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64483392|NCT03806374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64483393|NCT03806374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64483394|NCT03806374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278859|NCT02821247|Growth Substances|growth substances|mesh-ancestor
65278860|NCT02821247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278861|NCT02821247|Growth Inhibitors|growth inhibitors|mesh-ancestor
65278862|NCT02821247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65278863|NCT00681525|Atorvastatin|atorvastatin|mesh-list
65278864|NCT00681525|Ezetimibe|ezetimibe|mesh-list
65278865|NCT00681525|Fenofibric acid|fenofibric acid|mesh-list
65278866|NCT00681525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65278867|NCT00681525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65278868|NCT00681525|Antimetabolites|antimetabolites|mesh-ancestor
65278869|NCT00681525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278870|NCT00681525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65278871|NCT00681525|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65278872|NCT00681525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278873|NCT00681603|Bevacizumab|bevacizumab|mesh-list
65278874|NCT00681603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65278875|NCT00681603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65278876|NCT00681603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65278877|NCT00681603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65278878|NCT00681603|Growth Substances|growth substances|mesh-ancestor
64483395|NCT03806374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64622585|NCT05599126|GABA Modulators|gaba modulators|mesh-ancestor
64483396|NCT03806374|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64483397|NCT03806374|Anesthetics, General|anesthetics, general|mesh-ancestor
64483399|NCT03806374|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64483418|NCT00756106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483420|NCT00243412|Rituximab|rituximab|mesh-list
64483421|NCT00243412|Methotrexate|methotrexate|mesh-list
64483422|NCT00243412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64483423|NCT00243412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483424|NCT00243412|Immunologic Factors|immunologic factors|mesh-ancestor
64483425|NCT00243412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483426|NCT00243412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64483427|NCT00243412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64483428|NCT00243412|Abortifacient Agents|abortifacient agents|mesh-ancestor
64623599|NCT05286190|Sensory System Agents|sensory system agents|mesh-ancestor
64483429|NCT00243412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64483430|NCT00243412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64483431|NCT00243412|Antimetabolites|antimetabolites|mesh-ancestor
64483432|NCT00243412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483433|NCT00243412|Dermatologic Agents|dermatologic agents|mesh-ancestor
64483434|NCT00243412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64483435|NCT00243412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64624051|NCT00268450|Antiviral Agents|antiviral agents|mesh-ancestor
64483436|NCT00243412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64483437|NCT00243412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64483438|NCT00243412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64483439|NCT00243412|Antiemetics|antiemetics|mesh-ancestor
64483440|NCT00243412|Autonomic Agents|autonomic agents|mesh-ancestor
64483441|NCT00243412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64483442|NCT00243412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64483443|NCT00243412|Glucocorticoids|glucocorticoids|mesh-ancestor
64624421|NCT02279654|Growth Inhibitors|growth inhibitors|mesh-ancestor
64483445|NCT00243412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65278879|NCT00681603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278880|NCT00681603|Growth Inhibitors|growth inhibitors|mesh-ancestor
65278881|NCT04239443|Apatinib|apatinib|mesh-list
65278882|NCT04239443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65278883|NCT04239443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65278884|NCT04239443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65278885|NCT04239443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278886|NCT04239443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278887|NCT04200599|Oxytocin|oxytocin|mesh-list
65278888|NCT04200599|Oxytocics|oxytocics|mesh-ancestor
65278889|NCT04200599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65278890|NCT04200599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278891|NCT02820077|Hemostatics|hemostatics|mesh-list
65278892|NCT02820077|Coagulants|coagulants|mesh-ancestor
65278893|NCT00681993|Cyclophosphamide|cyclophosphamide|mesh-list
65278894|NCT00681993|Carboplatin|carboplatin|mesh-list
64624506|NCT03252600|Antiemetics|antiemetics|mesh-ancestor
64624573|NCT00000160|Xenon|xenon|mesh-list
64483447|NCT00243412|Protective Agents|protective agents|mesh-ancestor
64483448|NCT00765232|Ketorolac|ketorolac|mesh-list
64483449|NCT00765232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64483450|NCT00765232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64626357|NCT04389554|Hemostatics|hemostatics|mesh-ancestor
64483480|NCT03805750|Sensory System Agents|sensory system agents|mesh-ancestor
64483481|NCT03805750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64483482|NCT03805750|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64483483|NCT03805750|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64626581|NCT00002176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984463|NCT00089193|Sargramostim|sargramostim|mesh-list
64483510|NCT00780208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64627009|NCT00002230|Hydroxyurea|hydroxyurea|mesh-list
64483511|NCT00780208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627157|NCT02393690|Trace Elements|trace elements|mesh-ancestor
64483512|NCT00780208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64483513|NCT00780208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64483514|NCT00780208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64483515|NCT00780208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483517|NCT00780208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64483518|NCT00243022|Vitamin B 12|vitamin b 12|mesh-list
64483519|NCT00243022|Hydroxocobalamin|hydroxocobalamin|mesh-list
64483520|NCT00243022|Vitamins|vitamins|mesh-ancestor
64483521|NCT00243022|Micronutrients|micronutrients|mesh-ancestor
64483522|NCT00243022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513676|NCT05021913|Anesthetics, Local|anesthetics, local|mesh-ancestor
64627308|NCT01460654|Testosterone|testosterone|mesh-list
64627372|NCT05751304|Ketamine|ketamine|mesh-list
64483525|NCT03805360|Ropivacaine|ropivacaine|mesh-list
64483526|NCT03805360|Anesthetics, Local|anesthetics, local|mesh-list
64483615|NCT00757822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64483617|NCT00758836|Ibuprofen|ibuprofen|mesh-list
64483618|NCT00758836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64483619|NCT00758836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64483620|NCT00758836|Analgesics|analgesics|mesh-ancestor
64483621|NCT00758836|Sensory System Agents|sensory system agents|mesh-ancestor
64483622|NCT00758836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64483623|NCT00758836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483624|NCT00758836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64483625|NCT00758836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64483626|NCT00758836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64483627|NCT00758836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629893|NCT04883242|Dexamethasone acetate|dexamethasone acetate|mesh-list
64629939|NCT04579510|Vaccines|vaccines|mesh-list
65278895|NCT00681993|Docetaxel|docetaxel|mesh-list
65278897|NCT00681993|Doxorubicin|doxorubicin|mesh-list
65278898|NCT00681993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65278899|NCT00681993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65278900|NCT00681993|Immunologic Factors|immunologic factors|mesh-ancestor
65278901|NCT00681993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278902|NCT00681993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65278903|NCT00681993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65278904|NCT00681993|Alkylating Agents|alkylating agents|mesh-ancestor
65278905|NCT00681993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278906|NCT00681993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65278907|NCT00681993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64483628|NCT00758836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483631|NCT00769600|Pemetrexed|pemetrexed|mesh-list
64483632|NCT00769600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483633|NCT00769600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64483634|NCT00769600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483647|NCT03809650|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64483648|NCT03809650|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64483649|NCT03809650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483650|NCT03809650|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64483651|NCT03809260|Metformin|metformin|mesh-list
64483652|NCT03809260|Vancomycin|vancomycin|mesh-list
64483653|NCT03809260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64483654|NCT03809260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483655|NCT03809260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64483656|NCT03809260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64483658|NCT01763905|Evolocumab|evolocumab|mesh-list
64483659|NCT01763905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64483660|NCT01763905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64483661|NCT01763905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64483663|NCT01763905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483664|NCT01763905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64483665|NCT01763905|Immunologic Factors|immunologic factors|mesh-ancestor
64631479|NCT00003592|Antimetabolites|antimetabolites|mesh-ancestor
64483666|NCT01763905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483667|NCT05743504|Paclitaxel|paclitaxel|mesh-list
64483668|NCT05743504|Cisplatin|cisplatin|mesh-list
64483669|NCT05743504|Atezolizumab|atezolizumab|mesh-list
64356915|NCT00540839|Xhance|xhance|mesh-list
64483670|NCT05743504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64483671|NCT05743504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483672|NCT05743504|Tubulin Modulators|tubulin modulators|mesh-ancestor
64483673|NCT05743504|Antimitotic Agents|antimitotic agents|mesh-ancestor
64483674|NCT05743504|Mitosis Modulators|mitosis modulators|mesh-ancestor
64483675|NCT05743504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483676|NCT03803254|Lenvatinib|lenvatinib|mesh-list
64483677|NCT03803254|Antibodies|antibodies|mesh-list
64483678|NCT03803254|Immunologic Factors|immunologic factors|mesh-ancestor
64483679|NCT03803254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483680|NCT03803254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483681|NCT03803254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64483682|NCT03803254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64483683|NCT03803254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483684|NCT04730999|Bevacizumab|bevacizumab|mesh-list
64483685|NCT04730999|Carboplatin|carboplatin|mesh-list
64483686|NCT04730999|Etoposide|etoposide|mesh-list
64483687|NCT04730999|Atezolizumab|atezolizumab|mesh-list
64483688|NCT04730999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64483689|NCT04730999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483690|NCT04730999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64483691|NCT04730999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64483707|NCT01977677|Alkylating Agents|alkylating agents|mesh-ancestor
65278908|NCT00681993|Tubulin Modulators|tubulin modulators|mesh-ancestor
65278909|NCT00681993|Antimitotic Agents|antimitotic agents|mesh-ancestor
65278910|NCT00681993|Mitosis Modulators|mitosis modulators|mesh-ancestor
65278911|NCT00681993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65278912|NCT00681993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65278913|NCT00681993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65278914|NCT00681993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65278915|NCT00681993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278916|NCT02819999|Etoposide|etoposide|mesh-list
64731381|NCT00002827|Immunologic Factors|immunologic factors|mesh-ancestor
64483708|NCT01977677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483709|NCT01977677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483710|NCT01977677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64483711|NCT01977677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64483712|NCT01977677|Antiviral Agents|antiviral agents|mesh-ancestor
64483713|NCT01977677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64483714|NCT04384744|Hormones|hormones|mesh-list
64483715|NCT04384744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64483716|NCT04384744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483717|NCT01736215|Epoetin Alfa|epoetin alfa|mesh-list
64483718|NCT01736215|Hematinics|hematinics|mesh-ancestor
64483719|NCT05743192|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64631899|NCT00003664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64483720|NCT05743192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64483721|NCT01786603|Rasagiline|rasagiline|mesh-list
64483722|NCT01786603|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64631952|NCT02308202|Doxazosin|doxazosin|mesh-list
64483723|NCT01786603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632023|NCT00003232|Prednisone|prednisone|mesh-list
64483724|NCT01786603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632176|NCT00003946|Danazol|danazol|mesh-list
64483725|NCT01786603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64714009|NCT03043105|Growth Inhibitors|growth inhibitors|mesh-ancestor
64483726|NCT01786603|Protective Agents|protective agents|mesh-ancestor
64632400|NCT04329130|Growth Substances|growth substances|mesh-ancestor
64632473|NCT00003994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64483727|NCT01786603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483729|NCT00786916|Anesthetics, Local|anesthetics, local|mesh-ancestor
64483730|NCT00786916|Anesthetics|anesthetics|mesh-ancestor
64483731|NCT00786916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64483732|NCT00786916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483733|NCT00786916|Sensory System Agents|sensory system agents|mesh-ancestor
64483734|NCT00786916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64483735|NCT00786916|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64483736|NCT00786916|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64483737|NCT00786916|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64632842|NCT00384826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483738|NCT00786916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64483739|NCT00786916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483741|NCT04414267|BCG Vaccine|bcg vaccine|mesh-list
64483771|NCT03802318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483772|NCT01758523|Dutasteride|dutasteride|mesh-list
64483773|NCT01758523|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64483774|NCT01758523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64483775|NCT01758523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64483776|NCT01758523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483777|NCT01758523|Hormone Antagonists|hormone antagonists|mesh-ancestor
64483778|NCT01758523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64483779|NCT01758523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483780|NCT00773422|Naltrexone|naltrexone|mesh-list
64483781|NCT00773422|Varenicline|varenicline|mesh-list
64483782|NCT00773422|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64483783|NCT00773422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64483838|NCT01757275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278917|NCT02819999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65278918|NCT02819999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65278919|NCT02819999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65278920|NCT02819999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65278921|NCT02819999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278922|NCT02819999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278923|NCT04173494|Danazol|danazol|mesh-list
65278924|NCT04173494|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
65278925|NCT04173494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65278926|NCT04173494|Hormone Antagonists|hormone antagonists|mesh-ancestor
65278927|NCT04173494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65278928|NCT04173494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278929|NCT04173494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65278930|NCT04173494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278931|NCT04173494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278932|NCT02819921|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65278933|NCT02819921|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65278934|NCT02819921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64483839|NCT01757275|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64483840|NCT01757275|Histamine Antagonists|histamine antagonists|mesh-ancestor
64483841|NCT01757275|Histamine Agents|histamine agents|mesh-ancestor
64483842|NCT01757275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64483843|NCT01757275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483844|NCT01757275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64984853|NCT00295165|Sargramostim|sargramostim|mesh-list
64483859|NCT00788008|Anesthetics|anesthetics|mesh-ancestor
64483860|NCT00788008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64483861|NCT00788008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483862|NCT00788008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64483863|NCT00788008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64483864|NCT00788008|Anesthetics, General|anesthetics, general|mesh-ancestor
64483865|NCT00788008|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64483866|NCT00760006|Ampicillin|ampicillin|mesh-list
64483867|NCT00760006|Sulbactam|sulbactam|mesh-list
64636148|NCT00103844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636214|NCT00047060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64483868|NCT00760006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64636286|NCT01411501|Sodium Citrate|sodium citrate|mesh-list
64483869|NCT00760006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64636442|NCT00257894|Baclofen|baclofen|mesh-list
64483870|NCT00760006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64483871|NCT00760006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64483872|NCT00760006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64483873|NCT00760006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483874|NCT01784965|Liraglutide|liraglutide|mesh-list
64483875|NCT01784965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64483876|NCT01784965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636669|NCT00118352|Antibodies|antibodies|mesh-list
64483877|NCT01784965|Incretins|incretins|mesh-ancestor
64483878|NCT01784965|Hormones|hormones|mesh-ancestor
64483879|NCT01784965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65278935|NCT02819921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65278936|NCT02819921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278937|NCT02819921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65278938|NCT02819921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278939|NCT02819921|Antidepressive Agents|antidepressive agents|mesh-ancestor
64483881|NCT05742724|Nabiximols|nabiximols|mesh-list
64483882|NCT05742724|Cannabidiol|cannabidiol|mesh-list
64636879|NCT02539368|Infliximab|infliximab|mesh-list
64483883|NCT05742724|Anticonvulsants|anticonvulsants|mesh-ancestor
64483884|NCT05742724|Hallucinogens|hallucinogens|mesh-ancestor
64483885|NCT05742724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483886|NCT05742724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64483887|NCT05742724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64483888|NCT05742724|Analgesics|analgesics|mesh-ancestor
64483889|NCT05742724|Sensory System Agents|sensory system agents|mesh-ancestor
64471586|NCT04310995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64483890|NCT05742724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64483891|NCT05742724|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64483892|NCT05742724|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64483893|NCT05742724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64483894|NCT05742724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483895|NCT05742724|Hormones|hormones|mesh-ancestor
64483896|NCT05742724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64637090|NCT01429987|Plecanatide|plecanatide|mesh-list
64483898|NCT01784419|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64483899|NCT01784419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64483900|NCT01784419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483903|NCT01784029|Vitamins|vitamins|mesh-ancestor
64483904|NCT01784029|Micronutrients|micronutrients|mesh-ancestor
64483914|NCT00789256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64483916|NCT00789256|Immunologic Factors|immunologic factors|mesh-ancestor
64483917|NCT00789256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483918|NCT01733329|Folic Acid|folic acid|mesh-list
64483919|NCT01733329|Misoprostol|misoprostol|mesh-list
64483920|NCT01733329|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64483921|NCT01733329|Abortifacient Agents|abortifacient agents|mesh-ancestor
64483922|NCT01733329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64483923|NCT01733329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483924|NCT01733329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64483925|NCT01733329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64483926|NCT01733329|Oxytocics|oxytocics|mesh-ancestor
64483927|NCT01733329|Hematinics|hematinics|mesh-ancestor
64483928|NCT01733329|Vitamin B Complex|vitamin b complex|mesh-ancestor
64483929|NCT01733329|Vitamins|vitamins|mesh-ancestor
64483930|NCT01733329|Micronutrients|micronutrients|mesh-ancestor
64483931|NCT02145676|Botulinum Toxins|botulinum toxins|mesh-list
64483932|NCT02145676|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64483933|NCT02145676|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64483934|NCT02145676|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64483935|NCT02145676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64483936|NCT02145676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483938|NCT02145676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64483939|NCT02145676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483940|NCT02145676|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64483941|NCT02145676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64483942|NCT05742568|Amoxicillin|amoxicillin|mesh-list
64483943|NCT05742568|Clarithromycin|clarithromycin|mesh-list
64483944|NCT05742568|Esomeprazole|esomeprazole|mesh-list
64483945|NCT05742568|Bismuth|bismuth|mesh-list
64483946|NCT05742568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64483947|NCT05742568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64483948|NCT05742568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64483949|NCT05742568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64483950|NCT05742568|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64483951|NCT05742568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64483952|NCT05742568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483953|NCT05742568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64483954|NCT05742568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64483955|NCT05742568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64483956|NCT05742568|Antacids|antacids|mesh-ancestor
65278940|NCT02819921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65278941|NCT00875979|Trastuzumab|trastuzumab|mesh-list
65278942|NCT00875979|Pertuzumab|pertuzumab|mesh-list
65278943|NCT00875979|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65278944|NCT00875979|Maytansine|maytansine|mesh-list
65278945|NCT00875979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65278946|NCT00875979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65278947|NCT00875979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65278948|NCT00875979|Tubulin Modulators|tubulin modulators|mesh-ancestor
65278949|NCT00875979|Antimitotic Agents|antimitotic agents|mesh-ancestor
65278950|NCT00875979|Mitosis Modulators|mitosis modulators|mesh-ancestor
65278951|NCT00875979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278952|NCT02818751|Citalopram|citalopram|mesh-list
65278953|NCT02818751|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65278954|NCT02818751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65278955|NCT02818751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64731412|NCT00003049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64638749|NCT03011567|Analgesics|analgesics|mesh-ancestor
64483957|NCT01607593|Sertraline|sertraline|mesh-list
64483958|NCT01607593|Antidepressive Agents|antidepressive agents|mesh-ancestor
64483959|NCT01607593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64483960|NCT01607593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64483961|NCT01607593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64471587|NCT04310995|Vitamin B Complex|vitamin b complex|mesh-ancestor
64483962|NCT01607593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64483963|NCT01607593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483984|NCT03837808|Nimotuzumab|nimotuzumab|mesh-list
64483985|NCT03837808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483986|NCT03837808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64483987|NCT02148874|Vaccines|vaccines|mesh-list
64483988|NCT02148874|Immunologic Factors|immunologic factors|mesh-ancestor
64483989|NCT02148874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483990|NCT01755091|Dronabinol|dronabinol|mesh-list
64483991|NCT01755091|Hallucinogens|hallucinogens|mesh-ancestor
64483992|NCT01755091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483993|NCT01755091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64483994|NCT01755091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64483995|NCT01755091|Analgesics|analgesics|mesh-ancestor
64483996|NCT01755091|Sensory System Agents|sensory system agents|mesh-ancestor
64639237|NCT02099006|Adrenergic Agents|adrenergic agents|mesh-ancestor
64639302|NCT01480297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64483997|NCT01755091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639377|NCT01482091|Fentanyl|fentanyl|mesh-list
64483999|NCT01755091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64484000|NCT01755091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64484001|NCT01755091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484003|NCT01755091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64484005|NCT00789802|Estradiol|estradiol|mesh-list
64484006|NCT00789802|Estrogens|estrogens|mesh-ancestor
64639748|NCT01283555|Tenofovir|tenofovir|mesh-list
64639892|NCT00353834|Insulin|insulin|mesh-list
64639893|NCT00353834|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64484008|NCT00789802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64484009|NCT00789802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639970|NCT00311246|Adalimumab|adalimumab|mesh-list
64484010|NCT00789802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64484011|NCT00789802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64484012|NCT00789802|Analgesics|analgesics|mesh-ancestor
65278956|NCT02818751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278957|NCT02818751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65278958|NCT02818751|Serotonin Agents|serotonin agents|mesh-ancestor
65278959|NCT02818751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278960|NCT02818751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65278961|NCT02818751|Antidepressive Agents|antidepressive agents|mesh-ancestor
65278962|NCT02818751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64484013|NCT00789802|Sensory System Agents|sensory system agents|mesh-ancestor
64484014|NCT00789802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484015|NCT00789802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64484016|NCT00789802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64484047|NCT01783015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484048|NCT01783015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484049|NCT01783015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64484050|NCT01783015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64484051|NCT01783015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64484084|NCT00790192|Antidepressive Agents|antidepressive agents|mesh-ancestor
64641409|NCT00455702|Cycloserine|cycloserine|mesh-list
64484085|NCT00790192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64484086|NCT00790192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64484088|NCT00790192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64641552|NCT00462332|Antiviral Agents|antiviral agents|mesh-ancestor
64484089|NCT00790192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484090|NCT00790192|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64484106|NCT01781611|Analgesics|analgesics|mesh-ancestor
64484107|NCT01781611|Sensory System Agents|sensory system agents|mesh-ancestor
64484108|NCT01781611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484109|NCT01781611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484110|NCT01781611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64484111|NCT01781611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64484112|NCT01781611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64484113|NCT01781611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64484114|NCT01781611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641825|NCT00537290|Rituximab|rituximab|mesh-list
64484115|NCT01781611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64484116|NCT01781611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64484117|NCT01781611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484118|NCT01781611|Antipyretics|antipyretics|mesh-ancestor
64484119|NCT01781611|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64484120|NCT01781611|Vasodilator Agents|vasodilator agents|mesh-ancestor
64484122|NCT03802084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64484123|NCT03802084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64484124|NCT03802084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64642186|NCT00489866|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64484125|NCT03802084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484126|NCT00790270|Ibuprofen|ibuprofen|mesh-list
64484128|NCT00790270|Cyclobenzaprine|cyclobenzaprine|mesh-list
64642336|NCT02208037|Antimetabolites|antimetabolites|mesh-ancestor
64484129|NCT00790270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64484130|NCT00790270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64484131|NCT00790270|Analgesics|analgesics|mesh-ancestor
64484132|NCT00790270|Sensory System Agents|sensory system agents|mesh-ancestor
64642488|NCT01795976|Analgesics|analgesics|mesh-ancestor
64484133|NCT00790270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484134|NCT00790270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484135|NCT00790270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64484137|NCT00790270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64484138|NCT00790270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484139|NCT00790270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484140|NCT00790270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64484141|NCT00790270|Antidepressive Agents|antidepressive agents|mesh-ancestor
64484142|NCT00790270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64484143|NCT00790270|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64484144|NCT00790270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64484174|NCT03800290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65278963|NCT04238975|Vaccines|vaccines|mesh-list
65278964|NCT04238975|Immunologic Factors|immunologic factors|mesh-ancestor
65278965|NCT04238975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278966|NCT00602420|Naproxen|naproxen|mesh-list
65278967|NCT00602420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65278968|NCT00602420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65278969|NCT00602420|Analgesics|analgesics|mesh-ancestor
65278970|NCT00602420|Sensory System Agents|sensory system agents|mesh-ancestor
65278971|NCT00602420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65278972|NCT00602420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278973|NCT00602420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65278974|NCT00602420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65278975|NCT00602420|Gout Suppressants|gout suppressants|mesh-ancestor
65278976|NCT00602420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64484176|NCT03800290|Respiratory System Agents|respiratory system agents|mesh-ancestor
64484177|NCT03800290|Sympathomimetics|sympathomimetics|mesh-ancestor
64484178|NCT05709184|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64484179|NCT05709184|Vancomycin|vancomycin|mesh-list
64484180|NCT05709184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64484181|NCT01753297|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64644007|NCT02129426|GABA Agents|gaba agents|mesh-ancestor
64484182|NCT01753297|Luteolytic Agents|luteolytic agents|mesh-ancestor
64484183|NCT01753297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64484184|NCT01753297|Contraceptive Agents|contraceptive agents|mesh-ancestor
64644168|NCT01571557|Dexamethasone|dexamethasone|mesh-list
64484185|NCT01753297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64513690|NCT05021913|Protective Agents|protective agents|mesh-ancestor
64513691|NCT05025423|Venetoclax|venetoclax|mesh-list
64513692|NCT05025423|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64513693|NCT05025423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513694|NCT05025423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64513695|NCT05025423|Alkylating Agents|alkylating agents|mesh-ancestor
64513696|NCT05025423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645031|NCT01589263|Tamsulosin|tamsulosin|mesh-list
64645089|NCT00676676|Androgens|androgens|mesh-ancestor
64513698|NCT04272255|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64513699|NCT04272255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64513700|NCT04272255|Antiemetics|antiemetics|mesh-ancestor
64513701|NCT04272255|Autonomic Agents|autonomic agents|mesh-ancestor
64370531|NCT02447185|Ranibizumab|ranibizumab|mesh-list
64513702|NCT04272255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64513703|NCT04272255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513704|NCT04272255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64513705|NCT04272255|Mydriatics|mydriatics|mesh-ancestor
64645540|NCT04386811|Calcitriol|calcitriol|mesh-list
64513706|NCT04272255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64513707|NCT04272255|Cholinergic Agents|cholinergic agents|mesh-ancestor
64513708|NCT04272255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64513709|NCT04272255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513710|NCT04272255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64645754|NCT00588536|Antidotes|antidotes|mesh-ancestor
64513711|NCT04272255|Parasympatholytics|parasympatholytics|mesh-ancestor
64513712|NCT01458015|Oxycodone|oxycodone|mesh-list
64513713|NCT01458015|Tapentadol|tapentadol|mesh-list
64985248|NCT00090246|Autonomic Agents|autonomic agents|mesh-ancestor
64513736|NCT05022927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64513737|NCT05022927|Growth Substances|growth substances|mesh-ancestor
64513738|NCT05022927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513739|NCT05022927|Growth Inhibitors|growth inhibitors|mesh-ancestor
64513740|NCT05026125|Remifentanil|remifentanil|mesh-list
64513741|NCT05026125|Anesthetics|anesthetics|mesh-list
64513742|NCT05026125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64513743|NCT05026125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646472|NCT01236053|Antimanic Agents|antimanic agents|mesh-ancestor
65278977|NCT00602420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278978|NCT00602420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278979|NCT04635605|Methylene Blue|methylene blue|mesh-list
65278980|NCT04635605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65278981|NCT04635605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278982|NCT02688374|Nicotine|nicotine|mesh-list
65278983|NCT02688374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65278984|NCT02688374|Autonomic Agents|autonomic agents|mesh-ancestor
65278985|NCT02688374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65278986|NCT02688374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278987|NCT02688374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65278988|NCT02688374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65278989|NCT02688374|Cholinergic Agents|cholinergic agents|mesh-ancestor
65278990|NCT02688374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65278991|NCT02688374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65278992|NCT02819375|Ketamine|ketamine|mesh-list
65278993|NCT02819375|Remifentanil|remifentanil|mesh-list
65278994|NCT02819375|Propofol|propofol|mesh-list
64731454|NCT00002833|Antiemetics|antiemetics|mesh-ancestor
64513744|NCT05026125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64513745|NCT05026125|Narcotics|narcotics|mesh-ancestor
64513746|NCT05026125|Analgesics|analgesics|mesh-ancestor
64646697|NCT03830684|Baicalein|baicalein|mesh-list
64513747|NCT05026125|Sensory System Agents|sensory system agents|mesh-ancestor
64513748|NCT05026125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64513749|NCT01891227|Capecitabine|capecitabine|mesh-list
64513750|NCT01891227|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64513751|NCT01891227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64513752|NCT01891227|Antimetabolites|antimetabolites|mesh-ancestor
64513753|NCT01891227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513754|NCT01891227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513755|NCT01891227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64513756|NCT01891227|Alkylating Agents|alkylating agents|mesh-ancestor
64513771|NCT04391439|Hormones|hormones|mesh-ancestor
64513772|NCT04391439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64646761|NCT01294319|Diuretics|diuretics|mesh-ancestor
64513773|NCT04391439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64513774|NCT04391439|Protective Agents|protective agents|mesh-ancestor
64513775|NCT04391439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64646881|NCT01276496|Paclitaxel|paclitaxel|mesh-list
64513776|NCT04391439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647030|NCT00709826|Antimetabolites|antimetabolites|mesh-ancestor
64513777|NCT02884245|Estrogens|estrogens|mesh-list
64513778|NCT02884245|Hormones|hormones|mesh-ancestor
64647111|NCT01278602|Rituximab|rituximab|mesh-list
64513779|NCT02884245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64647173|NCT01278758|Vadimezan|vadimezan|mesh-list
64513780|NCT02884245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513781|NCT01891461|Hemostatics|hemostatics|mesh-list
64513782|NCT01891461|Coagulants|coagulants|mesh-ancestor
64513783|NCT02842749|Everolimus|everolimus|mesh-list
64513784|NCT02842749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513785|NCT02842749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64513786|NCT02842749|Immunologic Factors|immunologic factors|mesh-ancestor
64513787|NCT02842749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513788|NCT04272567|Norepinephrine|norepinephrine|mesh-list
64513789|NCT04272567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64513790|NCT04272567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64647540|NCT01279616|Tacrolimus|tacrolimus|mesh-list
65278995|NCT02819375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65278996|NCT02819375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65278997|NCT02819375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65278998|NCT02819375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64513791|NCT04272567|Adrenergic Agents|adrenergic agents|mesh-ancestor
64513792|NCT04272567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64647689|NCT01274624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64513793|NCT04272567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647771|NCT00244712|Tenofovir|tenofovir|mesh-list
64513794|NCT04272567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513795|NCT04272567|Sympathomimetics|sympathomimetics|mesh-ancestor
64513796|NCT04272567|Autonomic Agents|autonomic agents|mesh-ancestor
64513797|NCT04272567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64513798|NCT04272567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64513800|NCT01891851|Simeprevir|simeprevir|mesh-list
64513801|NCT01891851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64513802|NCT01891851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64513803|NCT01891851|Protease Inhibitors|protease inhibitors|mesh-ancestor
64513804|NCT01891851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64513805|NCT01891851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513830|NCT01892241|Antiviral Agents|antiviral agents|mesh-ancestor
64647910|NCT01213199|Adapalene|adapalene|mesh-list
64513831|NCT01892241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64513833|NCT04391127|Ivermectin|ivermectin|mesh-list
64513834|NCT04391127|Antimalarials|antimalarials|mesh-ancestor
64513835|NCT04391127|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64513836|NCT04391127|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64513837|NCT04391127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64513838|NCT04391127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64513859|NCT01459809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64513860|NCT01459809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64513861|NCT01459809|Immunologic Factors|immunologic factors|mesh-ancestor
64513862|NCT01459887|Prednisone|prednisone|mesh-list
64649445|NCT00806078|Analgesics|analgesics|mesh-ancestor
64513863|NCT01459887|Cyclophosphamide|cyclophosphamide|mesh-list
64513864|NCT01459887|Doxorubicin|doxorubicin|mesh-list
64513865|NCT01459887|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64513866|NCT01459887|Vincristine|vincristine|mesh-list
64649593|NCT01330355|Gatifloxacin|gatifloxacin|mesh-list
64513867|NCT01459887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64513868|NCT01459887|Immunologic Factors|immunologic factors|mesh-ancestor
64649667|NCT01277159|Hormones|hormones|mesh-ancestor
64513869|NCT01459887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513870|NCT01459887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64513871|NCT01459887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64513872|NCT01459887|Alkylating Agents|alkylating agents|mesh-ancestor
64513873|NCT01459887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513874|NCT01459887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513875|NCT01459887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64513876|NCT01459887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64650030|NCT02348762|Glycine|glycine|mesh-list
64513877|NCT01459887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64513878|NCT01459887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64513879|NCT01459887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64513880|NCT01459887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64513881|NCT01459887|Glucocorticoids|glucocorticoids|mesh-ancestor
64714011|NCT00374647|Sirolimus|sirolimus|mesh-list
64650102|NCT02252432|Ketamine|ketamine|mesh-list
64513883|NCT01459887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64513884|NCT01459887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64985408|NCT00322660|Mydriatics|mydriatics|mesh-ancestor
64513902|NCT01892787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64513903|NCT01892787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64513904|NCT01892787|Autonomic Agents|autonomic agents|mesh-ancestor
64650177|NCT01495481|Adenosine|adenosine|mesh-list
64513905|NCT01892787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64513906|NCT01892787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650304|NCT05236634|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64513907|NCT01892787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64650380|NCT01387139|Anesthetics, General|anesthetics, general|mesh-ancestor
64650449|NCT00825734|Sorafenib|sorafenib|mesh-list
64513908|NCT01892787|Respiratory System Agents|respiratory system agents|mesh-ancestor
64513909|NCT01892787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65278999|NCT02819375|Anesthetics, General|anesthetics, general|mesh-ancestor
65279000|NCT02819375|Anesthetics|anesthetics|mesh-ancestor
65279001|NCT02819375|Analgesics|analgesics|mesh-ancestor
65279002|NCT02819375|Sensory System Agents|sensory system agents|mesh-ancestor
65279003|NCT02819375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65279004|NCT02819375|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65279005|NCT02819375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65279006|NCT02819375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64650601|NCT01392989|Cyclosporine|cyclosporine|mesh-list
64513910|NCT01892787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64513911|NCT01892787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64513912|NCT01892787|Adrenergic Agents|adrenergic agents|mesh-ancestor
64513913|NCT01892787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64513914|NCT01892787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513917|NCT01893723|Narcotics|narcotics|mesh-ancestor
64513918|NCT01893723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64513919|NCT01893723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513921|NCT01893723|Sensory System Agents|sensory system agents|mesh-ancestor
64650968|NCT02203019|Anesthetics|anesthetics|mesh-ancestor
64513922|NCT01893723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64513923|NCT01453959|Fludrocortisone|fludrocortisone|mesh-list
64651118|NCT03808610|Antimetabolites|antimetabolites|mesh-ancestor
64651192|NCT00890162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64513924|NCT01453959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64651342|NCT00839540|Caspofungin|caspofungin|mesh-list
64513926|NCT02675829|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64513927|NCT02675829|Maytansine|maytansine|mesh-list
64513928|NCT02675829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64513929|NCT02675829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513930|NCT02675829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64513931|NCT02675829|Tubulin Modulators|tubulin modulators|mesh-ancestor
64513932|NCT02675829|Antimitotic Agents|antimitotic agents|mesh-ancestor
64513933|NCT02675829|Mitosis Modulators|mitosis modulators|mesh-ancestor
64651412|NCT01203722|Antitubercular Agents|antitubercular agents|mesh-ancestor
64513934|NCT02675829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651487|NCT03215966|Tadalafil|tadalafil|mesh-list
64513936|NCT02669901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64471630|NCT04275180|Anticoagulants|anticoagulants|mesh-ancestor
64471631|NCT04275180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64471632|NCT04271332|Baclofen|baclofen|mesh-list
64471633|NCT04271332|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64471634|NCT04271332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471635|NCT04271332|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64471636|NCT04271332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64471637|NCT04271332|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64513947|NCT02327403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513948|NCT02327403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513949|NCT02327403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64513950|NCT02327403|Immunologic Factors|immunologic factors|mesh-ancestor
64513951|NCT02327403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513952|NCT02327403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64652139|NCT01836536|Bevacizumab|bevacizumab|mesh-list
64513954|NCT01893177|Immunologic Factors|immunologic factors|mesh-ancestor
64513955|NCT01893177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513956|NCT05740150|Taurolidine|taurolidine|mesh-list
64513957|NCT05740150|Heparin|heparin|mesh-list
64513958|NCT05740150|Calcium heparin|calcium heparin|mesh-list
64513959|NCT05740150|Anticoagulants|anticoagulants|mesh-ancestor
64513960|NCT05740150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513961|NCT05740150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64513962|NCT05740150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64513963|NCT05740150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64513964|NCT05740150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64513965|NCT05740150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513966|NCT05734612|Colchicine|colchicine|mesh-list
64513967|NCT05734612|Gout Suppressants|gout suppressants|mesh-ancestor
64513968|NCT05734612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64513969|NCT05734612|Tubulin Modulators|tubulin modulators|mesh-ancestor
65279007|NCT02819375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65279008|NCT02819375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279009|NCT02819375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65279010|NCT02819375|Narcotics|narcotics|mesh-ancestor
65279011|NCT02818985|Dexamethasone|dexamethasone|mesh-list
65279012|NCT02818985|Dexmedetomidine|dexmedetomidine|mesh-list
64652353|NCT02472756|Rituximab|rituximab|mesh-list
64513970|NCT05734612|Antimitotic Agents|antimitotic agents|mesh-ancestor
64513971|NCT05734612|Mitosis Modulators|mitosis modulators|mesh-ancestor
64513972|NCT05734612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513973|NCT05734612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513974|NCT02349867|Gemcitabine|gemcitabine|mesh-list
64513975|NCT02349867|Sorafenib|sorafenib|mesh-list
64513976|NCT02349867|Vorinostat|vorinostat|mesh-list
64514008|NCT02334735|Immunologic Factors|immunologic factors|mesh-ancestor
64514009|NCT02334735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514010|NCT02334735|Interferon Inducers|interferon inducers|mesh-ancestor
64514011|NCT02334735|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64514012|NCT02329600|Triamcinolone|triamcinolone|mesh-list
64514013|NCT02329600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64514014|NCT02329600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64514015|NCT02329600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64514016|NCT02329600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64514017|NCT02329600|Glucocorticoids|glucocorticoids|mesh-ancestor
64514018|NCT02329600|Hormones|hormones|mesh-ancestor
64653016|NCT02981303|Pembrolizumab|pembrolizumab|mesh-list
64514032|NCT02620761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514034|NCT02615691|BAX 855|bax 855|mesh-list
64653731|NCT03002675|Exenatide|exenatide|mesh-list
64514035|NCT02615691|Coagulants|coagulants|mesh-ancestor
64653859|NCT04716335|Harmine|harmine|mesh-list
64514036|NCT04758273|Vaccines|vaccines|mesh-list
64514037|NCT04758273|Immunologic Factors|immunologic factors|mesh-ancestor
64514038|NCT04758273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514039|NCT01729871|Vitamin K|vitamin k|mesh-list
64514040|NCT01729871|Rivaroxaban|rivaroxaban|mesh-list
64514041|NCT01729871|Vitamins|vitamins|mesh-ancestor
64514042|NCT01729871|Micronutrients|micronutrients|mesh-ancestor
64514043|NCT01729871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514044|NCT01729871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64514045|NCT01729871|Antithrombins|antithrombins|mesh-ancestor
64514046|NCT01729871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64514047|NCT01729871|Protease Inhibitors|protease inhibitors|mesh-ancestor
64514048|NCT01729871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514049|NCT01729871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514050|NCT01729871|Anticoagulants|anticoagulants|mesh-ancestor
64514051|NCT01729871|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64514052|NCT01729871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64514053|NCT01729871|Hemostatics|hemostatics|mesh-ancestor
64514054|NCT01729871|Coagulants|coagulants|mesh-ancestor
64514055|NCT02611323|Rituximab|rituximab|mesh-list
64471640|NCT04271332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64514056|NCT02611323|Obinutuzumab|obinutuzumab|mesh-list
64514057|NCT02611323|Venetoclax|venetoclax|mesh-list
64514058|NCT02611323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64514059|NCT02611323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514060|NCT02611323|Immunologic Factors|immunologic factors|mesh-ancestor
64514061|NCT02611323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985616|NCT00313261|Clevudine|clevudine|mesh-list
64514088|NCT01728779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64514089|NCT01728779|Protease Inhibitors|protease inhibitors|mesh-ancestor
64514090|NCT01728779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514091|NCT01728779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514092|NCT01728779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64514093|NCT01728779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64514094|NCT01728779|Antiviral Agents|antiviral agents|mesh-ancestor
64655025|NCT02449902|Estradiol|estradiol|mesh-list
64514095|NCT01728779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64514096|NCT01927120|Sirolimus|sirolimus|mesh-list
64514097|NCT01927120|Aldesleukin|aldesleukin|mesh-list
64514098|NCT01927120|Tacrolimus|tacrolimus|mesh-list
64514099|NCT01927120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64514100|NCT01927120|Immunologic Factors|immunologic factors|mesh-ancestor
64514101|NCT01927120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514102|NCT01927120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64514103|NCT01927120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279013|NCT02818985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65279014|NCT02818985|Antiemetics|antiemetics|mesh-ancestor
65279015|NCT02818985|Autonomic Agents|autonomic agents|mesh-ancestor
65279016|NCT02818985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65279017|NCT02818985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279018|NCT02818985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65279019|NCT02818985|Glucocorticoids|glucocorticoids|mesh-ancestor
65279020|NCT02818985|Hormones|hormones|mesh-ancestor
65279021|NCT02818985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65279022|NCT02818985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65279023|NCT02818985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279024|NCT02818985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65279025|NCT02818985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65279026|NCT02818985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65279027|NCT02818985|Analgesics|analgesics|mesh-ancestor
65279028|NCT02818985|Sensory System Agents|sensory system agents|mesh-ancestor
65279029|NCT02818985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65279030|NCT02818985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65279031|NCT02818985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65279032|NCT02818985|Adrenergic Agents|adrenergic agents|mesh-ancestor
65279033|NCT02818985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65279034|NCT02818985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279035|NCT03362060|Pembrolizumab|pembrolizumab|mesh-list
65279036|NCT03362060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65279037|NCT03362060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279038|NCT02815787|Glyburide|glyburide|mesh-list
65279039|NCT02815787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65279040|NCT02815787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279041|NCT00639938|Nevirapine|nevirapine|mesh-list
65279043|NCT00639938|Antibodies|antibodies|mesh-list
65279044|NCT00639938|gamma-Globulins|gamma-globulins|mesh-list
65279045|NCT00639938|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65279046|NCT00639938|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65279054|NCT00639938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65279055|NCT00639938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65279056|NCT00639938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65279057|NCT00639938|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65279058|NCT00639938|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65279059|NCT04456439|Diphenhydramine|diphenhydramine|mesh-list
65279060|NCT04456439|Promethazine|promethazine|mesh-list
65279061|NCT04456439|Remestemcel-l|remestemcel-l|mesh-list
65279062|NCT04456439|Hydrocortisone|hydrocortisone|mesh-list
65279063|NCT04456439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65279064|NCT04456439|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65279065|NCT04456439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64514104|NCT01927120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514105|NCT01927120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64514106|NCT01927120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64985675|NCT04984070|Metformin|metformin|mesh-list
64514131|NCT02573337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514132|NCT02573337|Sensory System Agents|sensory system agents|mesh-ancestor
64514133|NCT02573337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64514134|NCT02573337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64514135|NCT02573337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64656172|NCT01685411|Protective Agents|protective agents|mesh-ancestor
64656256|NCT02485158|Analgesics|analgesics|mesh-ancestor
64514136|NCT02573337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64514137|NCT02573337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64656323|NCT03018626|Tubulin Modulators|tubulin modulators|mesh-ancestor
64656396|NCT02873195|Bevacizumab|bevacizumab|mesh-list
64514138|NCT02573337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514139|NCT01728077|Brivaracetam|brivaracetam|mesh-list
64514140|NCT01728077|Anticonvulsants|anticonvulsants|mesh-ancestor
64514144|NCT01606007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64656618|NCT00993824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64514145|NCT01606007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656691|NCT00995072|Adrenergic Agents|adrenergic agents|mesh-ancestor
64656763|NCT03425006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64514146|NCT01606007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64514147|NCT01606007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514148|NCT01606007|Incretins|incretins|mesh-ancestor
64514149|NCT01606007|Hormones|hormones|mesh-ancestor
64514150|NCT01606007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64514151|NCT01606007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64514152|NCT01606007|Protease Inhibitors|protease inhibitors|mesh-ancestor
64514153|NCT01606007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514179|NCT01928290|Oxaliplatin|oxaliplatin|mesh-list
64514180|NCT01928290|Trastuzumab|trastuzumab|mesh-list
64514182|NCT01928290|Levoleucovorin|levoleucovorin|mesh-list
64514183|NCT01928290|Antimetabolites|antimetabolites|mesh-ancestor
64514184|NCT01928290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514185|NCT01928290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64514186|NCT01928290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514187|NCT01928290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64514188|NCT01928290|Immunologic Factors|immunologic factors|mesh-ancestor
64514189|NCT01928290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514190|NCT01928290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64514191|NCT01928290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64514192|NCT01928290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64658089|NCT02481375|Iron|iron|mesh-list
64514193|NCT01928290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514195|NCT01928290|Protective Agents|protective agents|mesh-ancestor
64514196|NCT01928290|Vitamin B Complex|vitamin b complex|mesh-ancestor
64471641|NCT04271332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471642|NCT04267978|Irinotecan|irinotecan|mesh-list
64514197|NCT01928290|Vitamins|vitamins|mesh-ancestor
65279066|NCT04456439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65279067|NCT04456439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279068|NCT04456439|Anesthetics, Local|anesthetics, local|mesh-ancestor
65279069|NCT04456439|Anesthetics|anesthetics|mesh-ancestor
65279070|NCT04456439|Sensory System Agents|sensory system agents|mesh-ancestor
65279071|NCT04456439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64514198|NCT01928290|Micronutrients|micronutrients|mesh-ancestor
64514199|NCT02282319|Dexmedetomidine|dexmedetomidine|mesh-list
64514200|NCT02282319|Chloroprocaine|chloroprocaine|mesh-list
64658375|NCT01138124|Gabapentin|gabapentin|mesh-list
64514227|NCT02766465|Busulfan|busulfan|mesh-list
64514228|NCT02766465|Alemtuzumab|alemtuzumab|mesh-list
64514229|NCT02766465|Tacrolimus|tacrolimus|mesh-list
64514230|NCT02766465|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64514231|NCT02766465|Thymoglobulin|thymoglobulin|mesh-list
64514232|NCT02766465|Lenograstim|lenograstim|mesh-list
64514233|NCT02766465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64514234|NCT02766465|Abortifacient Agents|abortifacient agents|mesh-ancestor
64514235|NCT02766465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64514236|NCT02766465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514237|NCT02766465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64514239|NCT02766465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514241|NCT02766465|Dermatologic Agents|dermatologic agents|mesh-ancestor
64514242|NCT02766465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514243|NCT02766465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64514244|NCT02766465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64514245|NCT02766465|Immunologic Factors|immunologic factors|mesh-ancestor
64514246|NCT02766465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64514247|NCT02766465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64514248|NCT02766465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64514249|NCT02766465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64514250|NCT02766465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64660845|NCT01312844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64514267|NCT02757885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514268|NCT02757885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64471643|NCT04267978|Temozolomide|temozolomide|mesh-list
64471644|NCT04267978|Endostatins|endostatins|mesh-list
64514269|NCT02757885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64514270|NCT02757885|Alkylating Agents|alkylating agents|mesh-ancestor
64514271|NCT02757885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661220|NCT01357148|Metformin|metformin|mesh-list
64514272|NCT02757885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64661359|NCT01766219|Micronutrients|micronutrients|mesh-ancestor
64661439|NCT04351724|Amebicides|amebicides|mesh-ancestor
64514273|NCT02757885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64661514|NCT03823287|Growth Inhibitors|growth inhibitors|mesh-ancestor
64514274|NCT02757885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64387135|NCT04132427|Cathartics|cathartics|mesh-ancestor
64514277|NCT02757885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514278|NCT02757885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64662111|NCT01811147|Norepinephrine|norepinephrine|mesh-list
64514279|NCT01928446|Lithium Carbonate|lithium carbonate|mesh-list
64514280|NCT01928446|Antidepressive Agents|antidepressive agents|mesh-ancestor
64514281|NCT01928446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64514282|NCT01928446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662253|NCT01332578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64514283|NCT01928446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514284|NCT01928446|Antimanic Agents|antimanic agents|mesh-ancestor
64514285|NCT01928446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64514286|NCT01928446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64514287|NCT01928446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514288|NCT02983383|Anesthetics|anesthetics|mesh-list
64514289|NCT02983383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64663301|NCT02724033|Anesthetics, Local|anesthetics, local|mesh-ancestor
64514290|NCT02983383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514291|NCT05733286|Suvorexant|suvorexant|mesh-list
64663526|NCT02265341|Ponatinib|ponatinib|mesh-list
64514292|NCT05733286|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64663751|NCT05654363|Morphine|morphine|mesh-list
64663829|NCT05442801|Tropicamide|tropicamide|mesh-list
64663902|NCT00553319|Amphetamine|amphetamine|mesh-list
65279072|NCT04456439|Antiemetics|antiemetics|mesh-ancestor
65279073|NCT04456439|Autonomic Agents|autonomic agents|mesh-ancestor
65279074|NCT04456439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64663975|NCT01871441|Alkylating Agents|alkylating agents|mesh-ancestor
64514293|NCT05733286|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64664051|NCT01649856|Rituximab|rituximab|mesh-list
64514294|NCT05733286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64664208|NCT02867865|Gemcitabine|gemcitabine|mesh-list
64664431|NCT01493180|Antioxidants|antioxidants|mesh-ancestor
64514325|NCT01929460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666266|NCT02802111|Albuterol|albuterol|mesh-list
64666267|NCT02802111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64666268|NCT02802111|Autonomic Agents|autonomic agents|mesh-ancestor
64666269|NCT02802111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64666270|NCT02802111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666271|NCT02802111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64666272|NCT02802111|Respiratory System Agents|respiratory system agents|mesh-ancestor
64666273|NCT02802111|Tocolytic Agents|tocolytic agents|mesh-ancestor
64514327|NCT01929460|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64514328|NCT01929460|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64514330|NCT02248701|Finasteride|finasteride|mesh-list
64514332|NCT02248701|Testosterone undecanoate|testosterone undecanoate|mesh-list
64666652|NCT02212106|Vaccines|vaccines|mesh-list
64514333|NCT02248701|Testosterone enanthate|testosterone enanthate|mesh-list
64514334|NCT02248701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64667173|NCT02999126|Remifentanil|remifentanil|mesh-list
64514335|NCT02248701|Androgens|androgens|mesh-ancestor
64514336|NCT02248701|Hormones|hormones|mesh-ancestor
64667395|NCT02248454|Insulin Lispro|insulin lispro|mesh-list
64667469|NCT03003416|Hormones|hormones|mesh-ancestor
64514337|NCT02248701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64514338|NCT02248701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514359|NCT05739682|Epinephrine|epinephrine|mesh-list
64514360|NCT05739682|Anesthetics|anesthetics|mesh-list
64514362|NCT05739682|Anesthetics, Local|anesthetics, local|mesh-list
64514363|NCT05739682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64514364|NCT05739682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514365|NCT05739682|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64514366|NCT05739682|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64514367|NCT05739682|Adrenergic Agents|adrenergic agents|mesh-ancestor
64514368|NCT05739682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64514411|NCT02727387|Irinotecan|irinotecan|mesh-list
64514413|NCT02727387|Vincristine|vincristine|mesh-list
64514414|NCT02727387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64514415|NCT02727387|Immunologic Factors|immunologic factors|mesh-ancestor
64514416|NCT02727387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514417|NCT02727387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64514418|NCT02727387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64514419|NCT02727387|Alkylating Agents|alkylating agents|mesh-ancestor
64514420|NCT02727387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514421|NCT02727387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514422|NCT02727387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64514423|NCT02727387|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64514424|NCT02727387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64514425|NCT02727387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514426|NCT02727387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64514427|NCT02727387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64514455|NCT05719714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514457|NCT05719714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514459|NCT05586789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64514460|NCT05586789|Antidepressive Agents|antidepressive agents|mesh-ancestor
64514461|NCT05586789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64514463|NCT02284516|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64986058|NCT03897868|Losartan|losartan|mesh-list
64514488|NCT01727141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64514489|NCT01727141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64714013|NCT00374647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64714014|NCT00374647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64674125|NCT04069221|Cobicistat|cobicistat|mesh-list
64714015|NCT00374647|Antitubercular Agents|antitubercular agents|mesh-ancestor
64714016|NCT00374647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64714017|NCT00374647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64674336|NCT02813642|Mitogens|mitogens|mesh-list
64714018|NCT00374647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279075|NCT04456439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65279076|NCT04456439|Histamine Antagonists|histamine antagonists|mesh-ancestor
65279077|NCT04456439|Histamine Agents|histamine agents|mesh-ancestor
65279078|NCT04456439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65279079|NCT04456439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279080|NCT04456439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65279081|NCT04456439|Antipruritics|antipruritics|mesh-ancestor
65279082|NCT04456439|Dermatologic Agents|dermatologic agents|mesh-ancestor
65279083|NCT04456439|Antiviral Agents|antiviral agents|mesh-ancestor
64674481|NCT03250520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64674785|NCT00378495|Miltefosine|miltefosine|mesh-list
64674936|NCT01379469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675009|NCT02658357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64675174|NCT02492295|Propofol|propofol|mesh-list
64714019|NCT00374647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714020|NCT00374647|Antifungal Agents|antifungal agents|mesh-ancestor
64714032|NCT02812771|Efinaconazole|efinaconazole|mesh-list
64677178|NCT05444699|Hormones|hormones|mesh-ancestor
64714034|NCT02812771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64714035|NCT02969876|Vortioxetine|vortioxetine|mesh-list
64677477|NCT00001989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677550|NCT00001095|Lamivudine|lamivudine|mesh-list
64677708|NCT05270057|Hormones|hormones|mesh-ancestor
64714037|NCT02969876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64714038|NCT02969876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64714039|NCT02969876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64714040|NCT02969876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64714041|NCT02969876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714042|NCT02969876|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64471649|NCT04267978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471650|NCT04267978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64714043|NCT02969876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64678147|NCT00002139|Azithromycin|azithromycin|mesh-list
64714044|NCT02969876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64678221|NCT00002319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64678293|NCT02293902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64714045|NCT02969876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678674|NCT00002451|Antimetabolites|antimetabolites|mesh-ancestor
64714046|NCT02969876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64714048|NCT02969876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64714049|NCT02969876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64679215|NCT00002559|Paclitaxel|paclitaxel|mesh-list
64679359|NCT00002583|Tubulin Modulators|tubulin modulators|mesh-ancestor
64714050|NCT02969876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64714051|NCT02969876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64714053|NCT02970032|Calcium heparin|calcium heparin|mesh-list
64714054|NCT02970032|Anticoagulants|anticoagulants|mesh-ancestor
64714055|NCT02970032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64714056|NCT02970032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64714057|NCT02970032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714058|NCT02813551|Torsemide|torsemide|mesh-list
64714059|NCT02813551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64680249|NCT04837014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64680250|NCT04837014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64680251|NCT04837014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64680252|NCT04837014|Gout Suppressants|gout suppressants|mesh-ancestor
64680253|NCT04837014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64680254|NCT04837014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680255|NCT04837014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680256|NCT04837014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64680258|NCT04837014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64680259|NCT04827745|Blinatumomab|blinatumomab|mesh-list
64680260|NCT04827745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680270|NCT04745026|Cannabidiol|cannabidiol|mesh-list
64680271|NCT04745026|Anticonvulsants|anticonvulsants|mesh-ancestor
64680301|NCT04735978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65279084|NCT04456439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65279085|NCT02815319|Dexamethasone|dexamethasone|mesh-list
65279086|NCT02815319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65279087|NCT02815319|Antiemetics|antiemetics|mesh-ancestor
65279088|NCT02815319|Autonomic Agents|autonomic agents|mesh-ancestor
65279089|NCT02815319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65279090|NCT02815319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279091|NCT02815319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65279092|NCT02815319|Glucocorticoids|glucocorticoids|mesh-ancestor
65279093|NCT02815319|Hormones|hormones|mesh-ancestor
65279094|NCT02815319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65279095|NCT02815319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65279096|NCT02815319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279097|NCT02815475|Curcumin|curcumin|mesh-list
65279098|NCT02815475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65279099|NCT02815475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65279100|NCT02815475|Analgesics|analgesics|mesh-ancestor
65279101|NCT02815475|Sensory System Agents|sensory system agents|mesh-ancestor
65279102|NCT02815475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65279103|NCT02815475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279104|NCT02815475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65279105|NCT02815475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65279106|NCT02815475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680302|NCT04735978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680303|NCT04735978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64986205|NCT04729868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64680640|NCT04068753|Niraparib|niraparib|mesh-list
64680641|NCT04068753|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64680642|NCT04068753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680643|NCT04068753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680644|NCT04068753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680645|NCT04005690|Olaparib|olaparib|mesh-list
64680646|NCT04005690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64680647|NCT04005690|Onvansertib|onvansertib|mesh-list
64680648|NCT04005690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680649|NCT04005690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986261|NCT00315016|Eplerenone|eplerenone|mesh-list
64680770|NCT03822663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64714081|NCT03053401|Anesthetics|anesthetics|mesh-list
64680776|NCT03801525|Venetoclax|venetoclax|mesh-list
64470583|NCT05169684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470584|NCT05169684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64470585|NCT05169684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64514491|NCT01727141|Cholinergic Agents|cholinergic agents|mesh-ancestor
64514492|NCT01727141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64514493|NCT01727141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514494|NCT01727141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514495|NCT02716311|Cetuximab|cetuximab|mesh-list
64514497|NCT02716311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64514499|NCT02716311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64514500|NCT02716311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279107|NCT02815475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279108|NCT02815475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279109|NCT00640796|Aldesleukin|aldesleukin|mesh-list
65279110|NCT00640796|Cyclophosphamide|cyclophosphamide|mesh-list
65279111|NCT00640796|Fludarabine|fludarabine|mesh-list
65279112|NCT00640796|Interleukin-2|interleukin-2|mesh-list
65279113|NCT00640796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65029098|NCT04075110|Montelukast|montelukast|mesh-list
65279114|NCT00640796|Immunologic Factors|immunologic factors|mesh-ancestor
64731541|NCT00003067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64514501|NCT02716311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514502|NCT05439694|Tranexamic Acid|tranexamic acid|mesh-list
64514503|NCT05439694|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64514504|NCT05439694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64514505|NCT05439694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514506|NCT05439694|Hemostatics|hemostatics|mesh-ancestor
64514507|NCT05439694|Coagulants|coagulants|mesh-ancestor
64514508|NCT02714439|Proflavine|proflavine|mesh-list
64514509|NCT02714439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64514510|NCT02714439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64514511|NCT02165007|Sirolimus|sirolimus|mesh-list
64514512|NCT02165007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64514513|NCT02165007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64514514|NCT02165007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64514515|NCT02165007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514516|NCT02165007|Antifungal Agents|antifungal agents|mesh-ancestor
64514517|NCT02165007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64514518|NCT02165007|Immunologic Factors|immunologic factors|mesh-ancestor
64514519|NCT02165007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514544|NCT01752023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514546|NCT01752023|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64514547|NCT01752023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64683269|NCT05479214|Metformin|metformin|mesh-list
64683339|NCT00000693|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64683416|NCT02329964|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64683567|NCT05681702|Sensory System Agents|sensory system agents|mesh-ancestor
64683862|NCT01707043|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64687088|NCT02508389|Avasopasem manganese|avasopasem manganese|mesh-list
64514566|NCT01726049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687166|NCT02974361|Ibuprofen|ibuprofen|mesh-list
64514567|NCT01726049|Urological Agents|urological agents|mesh-ancestor
64514568|NCT02162667|Trastuzumab|trastuzumab|mesh-list
64687385|NCT02268955|Sensory System Agents|sensory system agents|mesh-ancestor
64514569|NCT02162667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64514570|NCT02162667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514571|NCT01605617|Fesoterodine|fesoterodine|mesh-list
64514572|NCT01605617|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64514573|NCT01605617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64514574|NCT01605617|Cholinergic Agents|cholinergic agents|mesh-ancestor
64514575|NCT01605617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64687829|NCT01642212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64687975|NCT04665037|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64688047|NCT00550771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64688121|NCT05706701|Nicotine|nicotine|mesh-list
64688197|NCT05688215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688272|NCT04485065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688423|NCT04893629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64688577|NCT05588219|Cisplatin|cisplatin|mesh-list
64688739|NCT05303987|Propofol|propofol|mesh-list
64471653|NCT04267978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64514596|NCT02284828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64514597|NCT02284828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514599|NCT01751867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64691869|NCT04492358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691870|NCT03526874|Lidocaine|lidocaine|mesh-list
64691871|NCT03526874|Anesthetics, Local|anesthetics, local|mesh-ancestor
65279115|NCT00640796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279116|NCT00640796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65279117|NCT00640796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64691872|NCT03526874|Anesthetics|anesthetics|mesh-ancestor
64514600|NCT01751867|Antimetabolites|antimetabolites|mesh-ancestor
64514601|NCT01751867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514602|NCT01751867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514603|NCT01751867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514604|NCT02418195|Ketamine|ketamine|mesh-list
64514605|NCT02418195|Analgesics|analgesics|mesh-ancestor
64514606|NCT02418195|Sensory System Agents|sensory system agents|mesh-ancestor
64514607|NCT02418195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64514608|NCT02418195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514609|NCT02418195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64514610|NCT02418195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64514611|NCT02418195|Anesthetics, General|anesthetics, general|mesh-ancestor
64514612|NCT02418195|Anesthetics|anesthetics|mesh-ancestor
64514613|NCT02418195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64514614|NCT02418195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64514615|NCT02418195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64692527|NCT01975519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64692598|NCT02025439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64514616|NCT02418195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64692818|NCT01981772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64514617|NCT02418195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696331|NCT02263326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514643|NCT02712801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64514657|NCT02712723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514658|NCT02712723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514659|NCT02712723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64514660|NCT02712723|Hormone Antagonists|hormone antagonists|mesh-ancestor
64514661|NCT02712723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64514662|NCT02712723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514663|NCT02156739|Edetic Acid|edetic acid|mesh-list
64514664|NCT02156739|Pentetic Acid|pentetic acid|mesh-list
64514665|NCT02156739|Antidotes|antidotes|mesh-ancestor
64514666|NCT02156739|Protective Agents|protective agents|mesh-ancestor
64698270|NCT05722561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64698271|NCT05722561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64698272|NCT05722561|Cholinergic Agents|cholinergic agents|mesh-ancestor
64698273|NCT05722561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64698274|NCT05722561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423598|NCT05248945|Carbamazepine|carbamazepine|mesh-list
64698344|NCT05263986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698419|NCT02460133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64514683|NCT01751087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64514685|NCT01751087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64514686|NCT01751087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64701213|NCT00004077|Paclitaxel|paclitaxel|mesh-list
64701962|NCT00004431|GABA Agonists|gaba agonists|mesh-ancestor
64702330|NCT00005583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702406|NCT00005613|Carmustine|carmustine|mesh-list
64702488|NCT02974933|Pemetrexed|pemetrexed|mesh-list
64702557|NCT00005811|Topotecan|topotecan|mesh-list
64702630|NCT02163733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702710|NCT04829799|Analgesics|analgesics|mesh-ancestor
64702798|NCT00362869|Ofloxacin|ofloxacin|mesh-list
64702933|NCT00363259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64703690|NCT04341038|Antiemetics|antiemetics|mesh-ancestor
64945568|NCT05438043|Autonomic Agents|autonomic agents|mesh-ancestor
64703988|NCT02605304|Ledipasvir|ledipasvir|mesh-list
64704357|NCT02253654|Epoetin Alfa|epoetin alfa|mesh-list
64704643|NCT02564029|Autonomic Agents|autonomic agents|mesh-ancestor
64704721|NCT03926624|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64704870|NCT04341727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64705476|NCT05552287|Infliximab|infliximab|mesh-list
64705565|NCT05730907|Simendan|simendan|mesh-list
64514687|NCT01751087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64514689|NCT01751087|Vitamin B Complex|vitamin b complex|mesh-ancestor
64706679|NCT02694601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64514690|NCT01751087|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64707273|NCT05442931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64707274|NCT05442931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707275|NCT05442931|Anticonvulsants|anticonvulsants|mesh-ancestor
65279118|NCT00640796|Alkylating Agents|alkylating agents|mesh-ancestor
65279119|NCT00640796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279120|NCT00640796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279121|NCT00640796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65279122|NCT00640796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65279123|NCT00640796|Analgesics|analgesics|mesh-ancestor
65279124|NCT00640796|Sensory System Agents|sensory system agents|mesh-ancestor
65279125|NCT00640796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65279126|NCT00640796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65279127|NCT00640796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64707276|NCT05442931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64707277|NCT05442931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64514691|NCT01751087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64709578|NCT05055752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64709726|NCT00372853|Growth Inhibitors|growth inhibitors|mesh-ancestor
64710030|NCT02786719|Etoposide|etoposide|mesh-list
64710323|NCT02794441|Antiemetics|antiemetics|mesh-ancestor
64710558|NCT02956070|BB 1101|bb 1101|mesh-list
64710703|NCT05828966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435941|NCT04416399|Autonomic Agents|autonomic agents|mesh-ancestor
64710704|NCT05828966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64710705|NCT05828966|Tocolytic Agents|tocolytic agents|mesh-ancestor
64710706|NCT05828966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64710846|NCT05827549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436096|NCT01639729|Sufentanil|sufentanil|mesh-list
64710919|NCT05822934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710920|NCT05821972|Dexmedetomidine|dexmedetomidine|mesh-list
64710921|NCT05821972|Ketamine|ketamine|mesh-list
64710922|NCT05821972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64710923|NCT05821972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64710924|NCT05821972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710925|NCT05821972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64710926|NCT05821972|Analgesics|analgesics|mesh-ancestor
64710941|NCT05821296|Methamphetamine|methamphetamine|mesh-list
64710993|NCT05786066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64710994|NCT05786066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64710995|NCT05786066|Anesthetics, General|anesthetics, general|mesh-ancestor
64710997|NCT05786066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64710998|NCT05786066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64710999|NCT05786066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64711000|NCT05786066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64436237|NCT04846231|Antimetabolites|antimetabolites|mesh-ancestor
64711001|NCT05786066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711004|NCT05784753|Immunologic Factors|immunologic factors|mesh-ancestor
64711071|NCT05709990|Vitamin D|vitamin d|mesh-list
64711072|NCT05709990|Cholecalciferol|cholecalciferol|mesh-list
64711073|NCT05709990|Solifenacin Succinate|solifenacin succinate|mesh-list
64711144|NCT05678244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64711145|NCT05678244|Analgesics|analgesics|mesh-ancestor
64711146|NCT05678244|Sensory System Agents|sensory system agents|mesh-ancestor
64711147|NCT05678244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64711148|NCT05678244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711149|NCT05678244|Antipyretics|antipyretics|mesh-ancestor
64711150|NCT05676034|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64986660|NCT00316030|Bexarotene|bexarotene|mesh-list
64711235|NCT05641376|Adrenergic Agents|adrenergic agents|mesh-ancestor
64711236|NCT05641376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64711237|NCT05641376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711238|NCT05633602|Pembrolizumab|pembrolizumab|mesh-list
64711239|NCT05633602|Ramucirumab|ramucirumab|mesh-list
64711240|NCT05633602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64711241|NCT05633602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711243|NCT05615311|Ergocalciferols|ergocalciferols|mesh-list
64711244|NCT05615311|Cholecalciferol|cholecalciferol|mesh-list
64711245|NCT05615311|Vitamins|vitamins|mesh-list
64711246|NCT05615311|Micronutrients|micronutrients|mesh-ancestor
65279128|NCT00640796|Antiviral Agents|antiviral agents|mesh-ancestor
65279129|NCT00640796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65279130|NCT02687984|Risperidone|risperidone|mesh-list
65279131|NCT02687984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65279132|NCT02687984|Serotonin Agents|serotonin agents|mesh-ancestor
65279133|NCT02687984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65279134|NCT02687984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279135|NCT02687984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279136|NCT02687984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65279137|NCT02687984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65279138|NCT02687984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65279139|NCT02687984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65279140|NCT02687984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65279141|NCT02687984|Dopamine Agents|dopamine agents|mesh-ancestor
65279142|NCT02683148|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65279143|NCT02683148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65279144|NCT02683148|Immunologic Factors|immunologic factors|mesh-ancestor
64731565|NCT00003595|Immunologic Factors|immunologic factors|mesh-ancestor
64711247|NCT05615311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711248|NCT05615311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64711249|NCT05615311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64711250|NCT05607615|Betadex|betadex|mesh-list
64711251|NCT05607615|Sequestering Agents|sequestering agents|mesh-ancestor
64711252|NCT05607615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711253|NCT05593939|Niacinamide|niacinamide|mesh-list
64711255|NCT05593939|Nicotinic Acids|nicotinic acids|mesh-list
64711256|NCT05593939|Vitamin B Complex|vitamin b complex|mesh-ancestor
64711257|NCT05593939|Vitamins|vitamins|mesh-ancestor
64711258|NCT05593939|Micronutrients|micronutrients|mesh-ancestor
64711299|NCT05577845|Autonomic Agents|autonomic agents|mesh-ancestor
64711300|NCT05577845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64711313|NCT05536791|Dabigatran|dabigatran|mesh-list
64711447|NCT05400369|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64711449|NCT05400369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64711450|NCT05398367|Galactogogues|galactogogues|mesh-list
64711451|NCT05398367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436690|NCT03164473|Rituximab|rituximab|mesh-list
64471658|NCT04267887|Prednisone|prednisone|mesh-list
64711486|NCT05383716|Pembrolizumab|pembrolizumab|mesh-list
64711487|NCT05383716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64711488|NCT05383716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711489|NCT05378945|Varenicline|varenicline|mesh-list
64711490|NCT05378945|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64711491|NCT05378945|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64711492|NCT05378945|Cholinergic Agents|cholinergic agents|mesh-ancestor
64711493|NCT05378945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64711494|NCT05378945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711495|NCT05378945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711496|NCT05376319|Rituximab|rituximab|mesh-list
64711497|NCT05376319|Obinutuzumab|obinutuzumab|mesh-list
64711498|NCT05376319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64711499|NCT05376319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711530|NCT05358587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64711600|NCT05322252|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64711602|NCT05322252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64711603|NCT05322252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711604|NCT05322252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64711605|NCT05322252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65279145|NCT02683148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279146|NCT02684786|Lidocaine|lidocaine|mesh-list
65279147|NCT02684786|Reserpine|reserpine|mesh-list
65279148|NCT02684786|Anesthetics, Local|anesthetics, local|mesh-ancestor
65279149|NCT02684786|Anesthetics|anesthetics|mesh-ancestor
65279150|NCT02684786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65279151|NCT02684786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279152|NCT02684786|Sensory System Agents|sensory system agents|mesh-ancestor
65279153|NCT02684786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65279154|NCT02684786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65279155|NCT02684786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65279156|NCT02684786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65279157|NCT02684786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65279158|NCT02684786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279159|NCT02684786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65279160|NCT02684786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65279161|NCT02684786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65279162|NCT02684786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65279163|NCT02684786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65279164|NCT02684786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65279165|NCT02684786|Adrenergic Agents|adrenergic agents|mesh-ancestor
65279166|NCT02684786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65279167|NCT02683070|Tramadol|tramadol|mesh-list
65279168|NCT02683070|Ropivacaine|ropivacaine|mesh-list
65279169|NCT02683070|Anesthetics, Local|anesthetics, local|mesh-ancestor
65279170|NCT02683070|Anesthetics|anesthetics|mesh-ancestor
65279194|NCT05664074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279195|NCT05664074|Gout Suppressants|gout suppressants|mesh-ancestor
65279196|NCT05664074|Tocolytic Agents|tocolytic agents|mesh-ancestor
65279197|NCT05664074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65279198|NCT00634205|Doxorubicin|doxorubicin|mesh-list
65279199|NCT00634205|Valproic Acid|valproic acid|mesh-list
65279200|NCT00634205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65279201|NCT00634205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711682|NCT05246943|Fibrin fragment D|fibrin fragment d|mesh-list
64711683|NCT05246943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64711684|NCT05246943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64711685|NCT05246943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711686|NCT05246943|Hemostatics|hemostatics|mesh-ancestor
64711687|NCT05246943|Coagulants|coagulants|mesh-ancestor
64711688|NCT05239728|Pembrolizumab|pembrolizumab|mesh-list
64711689|NCT05239728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64711690|NCT05239728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711691|NCT05239468|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
64711749|NCT05096663|Dexamethasone acetate|dexamethasone acetate|mesh-list
64711750|NCT05096663|Docetaxel|docetaxel|mesh-list
64711751|NCT05096663|Pembrolizumab|pembrolizumab|mesh-list
64711752|NCT05096663|Pemetrexed|pemetrexed|mesh-list
64711753|NCT05096663|Ramucirumab|ramucirumab|mesh-list
64711754|NCT05096663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64711755|NCT05096663|Antibodies|antibodies|mesh-list
64711756|NCT05096663|Immunoglobulins|immunoglobulins|mesh-list
64711757|NCT05096663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64711758|NCT05096663|Lexatumumab|lexatumumab|mesh-list
64711759|NCT05096663|BB 1101|bb 1101|mesh-list
64711760|NCT05096663|Micronutrients|micronutrients|mesh-ancestor
64711761|NCT05096663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711762|NCT05096663|Immunologic Factors|immunologic factors|mesh-ancestor
64711763|NCT05096663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64711764|NCT05096663|Antiemetics|antiemetics|mesh-ancestor
64711765|NCT05096663|Autonomic Agents|autonomic agents|mesh-ancestor
64711766|NCT05096663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64711767|NCT05096663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64711768|NCT05096663|Glucocorticoids|glucocorticoids|mesh-ancestor
64711983|NCT04902950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711985|NCT04902950|Coagulants|coagulants|mesh-ancestor
64711986|NCT04901377|Dienogest|dienogest|mesh-list
64711987|NCT04901377|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64711988|NCT04901377|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64711989|NCT04901377|Estradiol|estradiol|mesh-list
64711990|NCT04901377|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64711991|NCT04901377|Estrogens|estrogens|mesh-ancestor
64711992|NCT04901377|Hormones|hormones|mesh-ancestor
64711993|NCT04901377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64711994|NCT04901377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711995|NCT04901377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64712123|NCT04704154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712124|NCT04703803|Lidocaine|lidocaine|mesh-list
64712125|NCT04703803|Anesthetics, Local|anesthetics, local|mesh-ancestor
64712126|NCT04703803|Anesthetics|anesthetics|mesh-ancestor
64712128|NCT04703803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712199|NCT04639180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712200|NCT04639180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64712201|NCT04639180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712202|NCT04639180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712203|NCT04630158|Lubricant Eye Drops|lubricant eye drops|mesh-list
64712204|NCT04630158|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64712205|NCT04630158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64712243|NCT04594694|Bezafibrate|bezafibrate|mesh-list
64712244|NCT04594694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64712245|NCT04594694|Antimetabolites|antimetabolites|mesh-ancestor
64712246|NCT04594694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712247|NCT04594694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64712248|NCT04586660|Denosumab|denosumab|mesh-list
64712249|NCT04586660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65279202|NCT00634205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65279203|NCT00634205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65279204|NCT00634205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279205|NCT00634205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279206|NCT00634205|Anticonvulsants|anticonvulsants|mesh-ancestor
65279207|NCT00634205|GABA Agents|gaba agents|mesh-ancestor
65279208|NCT00634205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65279209|NCT00634205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279210|NCT00634205|Antimanic Agents|antimanic agents|mesh-ancestor
65279211|NCT00634205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65279212|NCT00634205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65279213|NCT00634205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65279214|NCT04238195|Moxifloxacin|moxifloxacin|mesh-list
65279215|NCT04238195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65279216|NCT04238195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65279217|NCT04238195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65279218|NCT04238195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65279219|NCT04238195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279220|NCT04238195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279221|NCT04238195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279222|NCT02818049|Dimercaprol|dimercaprol|mesh-list
65279223|NCT02818049|Chelating Agents|chelating agents|mesh-ancestor
65279224|NCT02818049|Sequestering Agents|sequestering agents|mesh-ancestor
65279225|NCT02818049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279226|NCT02684708|Prednisone|prednisone|mesh-list
65279227|NCT02684708|Cyclophosphamide|cyclophosphamide|mesh-list
65279228|NCT02684708|Dacarbazine|dacarbazine|mesh-list
65279229|NCT02684708|Vincristine|vincristine|mesh-list
65279230|NCT02684708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64712250|NCT04586660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712251|NCT04586231|Lenvatinib|lenvatinib|mesh-list
64712252|NCT04586231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712253|NCT04586231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64712254|NCT04586231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712255|NCT04586231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712256|NCT04579224|Gemcitabine|gemcitabine|mesh-list
64712257|NCT04579224|Paclitaxel|paclitaxel|mesh-list
64712258|NCT04579224|Docetaxel|docetaxel|mesh-list
64712259|NCT04579224|Halichondrin B|halichondrin b|mesh-list
64712260|NCT04579224|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64712261|NCT04579224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64712262|NCT04579224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712263|NCT04579224|Tubulin Modulators|tubulin modulators|mesh-ancestor
64712264|NCT04579224|Antimitotic Agents|antimitotic agents|mesh-ancestor
64712265|NCT04579224|Mitosis Modulators|mitosis modulators|mesh-ancestor
64712266|NCT04579224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279231|NCT02684708|Immunologic Factors|immunologic factors|mesh-ancestor
65279232|NCT02684708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279233|NCT02684708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65279234|NCT02684708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65279235|NCT02684708|Alkylating Agents|alkylating agents|mesh-ancestor
65279236|NCT02684708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279237|NCT02684708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279238|NCT02684708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65279239|NCT02684708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65279240|NCT02684708|Glucocorticoids|glucocorticoids|mesh-ancestor
65279241|NCT02684708|Hormones|hormones|mesh-ancestor
65344907|NCT00423943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712267|NCT04579224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64945635|NCT05379322|Tofacitinib|tofacitinib|mesh-list
64712579|NCT04150042|Protective Agents|protective agents|mesh-ancestor
64712580|NCT04150042|Vitamin B Complex|vitamin b complex|mesh-ancestor
64712581|NCT04150042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64712582|NCT04150042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64712583|NCT04150042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64712584|NCT04150042|Hematinics|hematinics|mesh-ancestor
64712585|NCT04141644|Ipilimumab|ipilimumab|mesh-list
64712586|NCT04141644|Osimertinib|osimertinib|mesh-list
64712587|NCT04141644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64712588|NCT04141644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712589|NCT04141644|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64712590|NCT04141644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712591|NCT04141644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64712592|NCT04141644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712654|NCT04093323|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
64712655|NCT04093323|Celecoxib|celecoxib|mesh-list
64986893|NCT02571725|Olaparib|olaparib|mesh-list
64713352|NCT02913482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713421|NCT02785952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713422|NCT02785952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64713423|NCT02785952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713568|NCT02194829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64713569|NCT02194829|Immunologic Factors|immunologic factors|mesh-ancestor
64713570|NCT02194829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713599|NCT02193425|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64713600|NCT02193425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64713601|NCT02193425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986944|NCT00328900|Atropine|atropine|mesh-list
64495104|NCT01190878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64495287|NCT01105312|Letrozole|letrozole|mesh-list
64495464|NCT01200160|Niacin|niacin|mesh-list
64495538|NCT01221298|Ritonavir|ritonavir|mesh-list
64495684|NCT01158820|Diphenhydramine|diphenhydramine|mesh-list
64496139|NCT00861705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496440|NCT01872689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64496891|NCT01286818|Antidotes|antidotes|mesh-ancestor
64497037|NCT01927029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497188|NCT01928511|Interferons|interferons|mesh-list
64497260|NCT02977494|Bortezomib|bortezomib|mesh-list
64497261|NCT02977494|Daratumumab|daratumumab|mesh-list
64497262|NCT02977494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64497263|NCT02977494|Antiemetics|antiemetics|mesh-ancestor
64497264|NCT02977494|Autonomic Agents|autonomic agents|mesh-ancestor
64497347|NCT03712098|Hormones|hormones|mesh-ancestor
64497419|NCT00989781|beta-Endorphin|beta-endorphin|mesh-list
64497950|NCT05604729|Botulinum Toxins|botulinum toxins|mesh-list
64498098|NCT01354444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64498698|NCT01962792|Dexamethasone|dexamethasone|mesh-list
64498995|NCT01843205|Adrenergic Agents|adrenergic agents|mesh-ancestor
64499225|NCT04593329|Analgesics|analgesics|mesh-ancestor
64499524|NCT03009058|Fluorouracil|fluorouracil|mesh-list
64499611|NCT03399708|Apremilast|apremilast|mesh-list
65279242|NCT02684708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65279243|NCT02684708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65279244|NCT02684708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65279245|NCT02684708|Tubulin Modulators|tubulin modulators|mesh-ancestor
65279246|NCT02684708|Antimitotic Agents|antimitotic agents|mesh-ancestor
65279247|NCT02684708|Mitosis Modulators|mitosis modulators|mesh-ancestor
65279248|NCT02817503|Folic Acid|folic acid|mesh-list
65279249|NCT02817503|Vitamin B Complex|vitamin b complex|mesh-list
65279250|NCT02817503|Amlodipine|amlodipine|mesh-list
65279251|NCT02817503|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65279252|NCT02817503|Enalapril|enalapril|mesh-list
65279253|NCT02817503|Enalaprilat|enalaprilat|mesh-list
65279254|NCT02817503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65279255|NCT02817503|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65344908|NCT00736346|Paroxetine|paroxetine|mesh-list
64499679|NCT05097768|Dexamethasone|dexamethasone|mesh-list
64945668|NCT05329766|Fluorouracil|fluorouracil|mesh-list
64499825|NCT04697693|Antidepressive Agents|antidepressive agents|mesh-ancestor
64500053|NCT01441570|Vasodilator Agents|vasodilator agents|mesh-ancestor
64500127|NCT01546402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500355|NCT02731638|Natamycin|natamycin|mesh-list
64500427|NCT01497496|Lenalidomide|lenalidomide|mesh-list
64500502|NCT01498978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500575|NCT02209948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500654|NCT01470118|Dextrans|dextrans|mesh-list
64501095|NCT03383406|Cytarabine|cytarabine|mesh-list
64501310|NCT04947072|Anesthetics|anesthetics|mesh-list
64501386|NCT01825577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501459|NCT03007654|Chitosan|chitosan|mesh-list
64501538|NCT03630666|Hormones|hormones|mesh-list
64952309|NCT00395681|Propofol|propofol|mesh-list
64952399|NCT00057564|BB 1101|bb 1101|mesh-list
64954736|NCT00066417|Fludarabine|fludarabine|mesh-list
64955186|NCT00067743|Lenalidomide|lenalidomide|mesh-list
64505284|NCT01716208|Ofatumumab|ofatumumab|mesh-list
64505510|NCT03328728|Hylan|hylan|mesh-list
64506315|NCT03320928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507196|NCT02989558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64507351|NCT01782131|Voriconazole|voriconazole|mesh-list
64508235|NCT03300960|Contraceptive Agents|contraceptive agents|mesh-ancestor
64508310|NCT01993810|Immunoglobulins|immunoglobulins|mesh-list
64508311|NCT01993810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64508312|NCT01993810|Immunoglobulin G|immunoglobulin g|mesh-list
64508313|NCT01993810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64508314|NCT01993810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508315|NCT01993810|Tubulin Modulators|tubulin modulators|mesh-ancestor
64508316|NCT01993810|Antimitotic Agents|antimitotic agents|mesh-ancestor
64508317|NCT01993810|Mitosis Modulators|mitosis modulators|mesh-ancestor
64508318|NCT01993810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508319|NCT01993810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64508320|NCT01993810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64508321|NCT01993810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955483|NCT00203125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64508388|NCT05456256|Carboplatin|carboplatin|mesh-list
64508389|NCT05456256|Pemetrexed|pemetrexed|mesh-list
64508390|NCT05456256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508391|NCT05456256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508526|NCT02465814|Ulipristal acetate|ulipristal acetate|mesh-list
64955494|NCT00203281|Tacrolimus|tacrolimus|mesh-list
64509225|NCT01937026|Renal Agents|renal agents|mesh-ancestor
64955508|NCT00203281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64510241|NCT01455831|Tinzaparin|tinzaparin|mesh-list
64510314|NCT02555787|Tacrolimus|tacrolimus|mesh-list
64510465|NCT05826964|Vinorelbine|vinorelbine|mesh-list
64510818|NCT05823662|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64510819|NCT05823662|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64510820|NCT05823662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65279256|NCT02817503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65279257|NCT02817503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279258|NCT02817503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65279259|NCT02817503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279260|NCT02817503|Vasodilator Agents|vasodilator agents|mesh-ancestor
65279261|NCT02817503|Diuretics|diuretics|mesh-ancestor
65279262|NCT02817503|Natriuretic Agents|natriuretic agents|mesh-ancestor
64510821|NCT05823662|Adrenergic Agents|adrenergic agents|mesh-ancestor
64510822|NCT05823662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64510826|NCT05823363|Bupivacaine|bupivacaine|mesh-list
64955572|NCT00203554|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
64510920|NCT05781217|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64511155|NCT05633654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64511156|NCT05633654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511157|NCT05633654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64511158|NCT05633654|Antimetabolites|antimetabolites|mesh-ancestor
64511159|NCT05633654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511160|NCT05632627|Cannabidiol|cannabidiol|mesh-list
64511253|NCT05555732|Carboplatin|carboplatin|mesh-list
64511254|NCT05555732|Pembrolizumab|pembrolizumab|mesh-list
64511255|NCT05555732|Pemetrexed|pemetrexed|mesh-list
64511256|NCT05555732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511257|NCT05555732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64511258|NCT05555732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64511259|NCT05555732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511743|NCT05080322|Xhance|xhance|mesh-list
64471660|NCT04267887|Methyltestosterone|methyltestosterone|mesh-list
64471661|NCT04267887|Abiraterone Acetate|abiraterone acetate|mesh-list
64512385|NCT04449549|Antimitotic Agents|antimitotic agents|mesh-ancestor
64512386|NCT04449549|Mitosis Modulators|mitosis modulators|mesh-ancestor
64512387|NCT04449549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512389|NCT04447027|Lenalidomide|lenalidomide|mesh-list
64512390|NCT04447027|Azacitidine|azacitidine|mesh-list
64512391|NCT04447027|Romidepsin|romidepsin|mesh-list
64512392|NCT04447027|Cc-486|cc-486|mesh-list
64512393|NCT04447027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64512394|NCT04447027|Antiemetics|antiemetics|mesh-ancestor
64512395|NCT04447027|Autonomic Agents|autonomic agents|mesh-ancestor
64512396|NCT04447027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64512398|NCT04447027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64512492|NCT04322318|Etoposide phosphate|etoposide phosphate|mesh-list
64512494|NCT04322318|Topotecan|topotecan|mesh-list
64512495|NCT04322318|Podophyllotoxin|podophyllotoxin|mesh-list
64512496|NCT04322318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64512497|NCT04322318|Immunologic Factors|immunologic factors|mesh-ancestor
64512498|NCT04322318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512499|NCT04322318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64512500|NCT04322318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64512501|NCT04322318|Alkylating Agents|alkylating agents|mesh-ancestor
64512502|NCT04322318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512503|NCT04322318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512504|NCT04322318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64987094|NCT00123903|Protective Agents|protective agents|mesh-ancestor
64512627|NCT04161027|Pregabalin|pregabalin|mesh-list
64512628|NCT04161027|Analgesics|analgesics|mesh-ancestor
64512629|NCT04161027|Sensory System Agents|sensory system agents|mesh-ancestor
64512630|NCT04161027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64512631|NCT04161027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512632|NCT04161027|Anticonvulsants|anticonvulsants|mesh-ancestor
64512633|NCT04161027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64512634|NCT04161027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64955601|NCT00072033|Mitosis Modulators|mitosis modulators|mesh-ancestor
64512832|NCT03959085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64512833|NCT03959085|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64512834|NCT03959085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64512835|NCT03959085|Abortifacient Agents|abortifacient agents|mesh-ancestor
64512836|NCT03959085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64512837|NCT03959085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65279263|NCT02817503|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65279264|NCT02817503|Hematinics|hematinics|mesh-ancestor
65279265|NCT02817503|Vitamins|vitamins|mesh-ancestor
65279266|NCT02817503|Micronutrients|micronutrients|mesh-ancestor
65279267|NCT02817503|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65279268|NCT02817503|Protease Inhibitors|protease inhibitors|mesh-ancestor
65279269|NCT02817503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64512838|NCT03959085|Antimetabolites|antimetabolites|mesh-ancestor
64512839|NCT03959085|Dermatologic Agents|dermatologic agents|mesh-ancestor
64512840|NCT03959085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64512841|NCT03959085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64512842|NCT03959085|Antiviral Agents|antiviral agents|mesh-ancestor
64512843|NCT03959085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64512844|NCT03959085|Antidotes|antidotes|mesh-ancestor
64955603|NCT00203905|Bevacizumab|bevacizumab|mesh-list
64512916|NCT03889756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64512917|NCT03889756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64512919|NCT03889756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64512920|NCT03889756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64512921|NCT03889756|GABA Modulators|gaba modulators|mesh-ancestor
64512922|NCT03889756|GABA Agents|gaba agents|mesh-ancestor
64512923|NCT03887780|Rivaroxaban|rivaroxaban|mesh-list
64512924|NCT03887780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64955817|NCT00072345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64955818|NCT00072345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64955822|NCT00039455|Alvocidib|alvocidib|mesh-list
64955862|NCT00039494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64955925|NCT00072579|Sargramostim|sargramostim|mesh-list
64987209|NCT00083993|Sirolimus|sirolimus|mesh-list
64715034|NCT03795350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64715035|NCT03795350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64715036|NCT03795350|Cholinergic Agents|cholinergic agents|mesh-ancestor
64715037|NCT03795350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64715038|NCT03795350|Glucocorticoids|glucocorticoids|mesh-ancestor
64715039|NCT03795350|Hormones|hormones|mesh-ancestor
64715040|NCT03795350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64715041|NCT03118843|Velpatasvir|velpatasvir|mesh-list
64715042|NCT03118843|Antiviral Agents|antiviral agents|mesh-ancestor
64715043|NCT03118843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64715044|NCT03624062|Insulin|insulin|mesh-list
64715045|NCT03624062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64323305|NCT02688933|Insulin|insulin|mesh-list
64715442|NCT03187730|Cholinergic Agents|cholinergic agents|mesh-ancestor
64715443|NCT03187730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64715444|NCT03187730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715445|NCT03261193|Bupivacaine|bupivacaine|mesh-list
64715446|NCT03261193|Anesthetics, Local|anesthetics, local|mesh-ancestor
64715447|NCT03261193|Anesthetics|anesthetics|mesh-ancestor
64715448|NCT03261193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64715449|NCT03261193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715450|NCT03261193|Sensory System Agents|sensory system agents|mesh-ancestor
64715451|NCT03261193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715452|NCT00375661|Interferons|interferons|mesh-list
64715453|NCT00375661|Ribavirin|ribavirin|mesh-list
64715454|NCT00375661|Interferon-alpha|interferon-alpha|mesh-list
64715455|NCT00375661|Interferon alpha-2|interferon alpha-2|mesh-list
64327989|NCT00459745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328001|NCT02178761|Micronutrients|micronutrients|mesh-ancestor
64328002|NCT00492999|Leucovorin|leucovorin|mesh-list
64328003|NCT00492999|Dexamethasone|dexamethasone|mesh-list
64328004|NCT00492999|Fluorouracil|fluorouracil|mesh-list
64328005|NCT00492999|Oxaliplatin|oxaliplatin|mesh-list
64328006|NCT00492999|Irinotecan|irinotecan|mesh-list
64328007|NCT00492999|Floxuridine|floxuridine|mesh-list
64328008|NCT00492999|Calcium|calcium|mesh-list
64328009|NCT00492999|Levoleucovorin|levoleucovorin|mesh-list
64328163|NCT02182505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64328164|NCT02182505|Cholinergic Agents|cholinergic agents|mesh-ancestor
64328165|NCT02387619|Amlodipine|amlodipine|mesh-list
64328166|NCT02387619|Telmisartan|telmisartan|mesh-list
64328167|NCT02387619|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
64328337|NCT02403687|Cyclobenzaprine|cyclobenzaprine|mesh-list
64720609|NCT00000578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64720610|NCT00000578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279270|NCT02814461|Axitinib|axitinib|mesh-list
65279271|NCT02814461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279272|NCT02814461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65279273|NCT02814461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279274|NCT02814461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279275|NCT00875667|Fludarabine|fludarabine|mesh-list
64470973|NCT04912492|Ethanol|ethanol|mesh-list
64720611|NCT00000578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64720612|NCT00000578|Respiratory System Agents|respiratory system agents|mesh-ancestor
64720613|NCT00000578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64720614|NCT00000578|Autonomic Agents|autonomic agents|mesh-ancestor
64720615|NCT00000578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64720616|NCT00000578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64720617|NCT00000578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720618|NCT00000578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720619|NCT00000578|Vasodilator Agents|vasodilator agents|mesh-ancestor
64720620|NCT00000578|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64720621|NCT00000578|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64720622|NCT00000578|Purinergic Agents|purinergic agents|mesh-ancestor
64720640|NCT03774745|Luteolytic Agents|luteolytic agents|mesh-ancestor
64720641|NCT03774745|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64720642|NCT03774745|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64720643|NCT00000584|Immunoglobulins|immunoglobulins|mesh-list
64720644|NCT00000584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64720645|NCT00000584|Antibodies|antibodies|mesh-list
64720646|NCT00000584|Immunologic Factors|immunologic factors|mesh-ancestor
64720647|NCT00000584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720648|NCT00000590|Immunoglobulins|immunoglobulins|mesh-list
64720649|NCT00000590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64720650|NCT00000590|Antibodies|antibodies|mesh-list
64720651|NCT00000590|Immunologic Factors|immunologic factors|mesh-ancestor
64328578|NCT02403063|Cholinergic Agents|cholinergic agents|mesh-ancestor
64328579|NCT02403063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64328580|NCT02403063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328581|NCT02403063|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64328582|NCT02403063|Autonomic Agents|autonomic agents|mesh-ancestor
64328583|NCT02403063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64471662|NCT04267887|Hormones|hormones|mesh-list
64328624|NCT02179775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64328625|NCT02179775|Vasodilator Agents|vasodilator agents|mesh-ancestor
64328626|NCT02177435|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64328627|NCT02177435|Telmisartan|telmisartan|mesh-list
64328628|NCT02177435|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
64328629|NCT02177435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64328630|NCT02177435|Diuretics|diuretics|mesh-ancestor
64328631|NCT02177435|Natriuretic Agents|natriuretic agents|mesh-ancestor
64328632|NCT02177435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328633|NCT02177435|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64328634|NCT02177435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64328635|NCT02177435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720773|NCT00000638|Micronutrients|micronutrients|mesh-ancestor
64720774|NCT00000638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720775|NCT00000650|Ditiocarb|ditiocarb|mesh-list
64720776|NCT00000650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64720777|NCT00000650|Immunologic Factors|immunologic factors|mesh-ancestor
64720778|NCT00000650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720779|NCT00000650|Antiviral Agents|antiviral agents|mesh-ancestor
64720780|NCT00000650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720781|NCT00000650|Chelating Agents|chelating agents|mesh-ancestor
64720782|NCT00000650|Sequestering Agents|sequestering agents|mesh-ancestor
64720806|NCT00002168|Zidovudine|zidovudine|mesh-list
64720807|NCT00002168|Stavudine|stavudine|mesh-list
64720808|NCT00002168|Didanosine|didanosine|mesh-list
64720809|NCT00002168|Indinavir|indinavir|mesh-list
64720810|NCT00002168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64720811|NCT00002168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720812|NCT00002168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720813|NCT00002168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720814|NCT00002168|Antiviral Agents|antiviral agents|mesh-ancestor
64720815|NCT00002168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65279276|NCT00875667|Fludarabine phosphate|fludarabine phosphate|mesh-list
65279277|NCT00875667|Lenalidomide|lenalidomide|mesh-list
65279278|NCT00875667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64720816|NCT00002168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64720817|NCT00002168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64720818|NCT00002168|Antimetabolites|antimetabolites|mesh-ancestor
64720819|NCT00002168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64720820|NCT00002168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64720821|NCT00002168|Protease Inhibitors|protease inhibitors|mesh-ancestor
64720822|NCT00001442|Paclitaxel|paclitaxel|mesh-list
64720823|NCT00001442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64720824|NCT00001442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64720825|NCT00001442|Tubulin Modulators|tubulin modulators|mesh-ancestor
64720826|NCT00001442|Antimitotic Agents|antimitotic agents|mesh-ancestor
64720827|NCT00001442|Mitosis Modulators|mitosis modulators|mesh-ancestor
64720828|NCT00001442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720829|NCT00002174|Thalidomide|thalidomide|mesh-list
64720830|NCT00002174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64720831|NCT00002174|Immunologic Factors|immunologic factors|mesh-ancestor
64720832|NCT00002174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720833|NCT00002174|Leprostatic Agents|leprostatic agents|mesh-ancestor
64720834|NCT00002174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64720835|NCT00002174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720836|NCT00002174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64720837|NCT00002174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64720838|NCT00002174|Growth Substances|growth substances|mesh-ancestor
64720839|NCT00002174|Growth Inhibitors|growth inhibitors|mesh-ancestor
64720840|NCT00002174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64720841|NCT00000668|Ganciclovir|ganciclovir|mesh-list
64720842|NCT00000668|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64720866|NCT00000692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64328756|NCT02184299|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64328757|NCT02184299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64328758|NCT02184299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328759|NCT02184299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328760|NCT02184299|Antiviral Agents|antiviral agents|mesh-ancestor
64328761|NCT02184299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64328762|NCT02184299|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64328763|NCT02184299|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64328764|NCT02184299|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64328765|NCT02184299|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64328766|NCT00549679|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
64721011|NCT00002306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64721012|NCT00002306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721013|NCT00002306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64721014|NCT00002306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64721015|NCT00002210|Delavirdine|delavirdine|mesh-list
64721016|NCT00002210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64721017|NCT00002210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64721018|NCT00002210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721019|NCT00002210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721020|NCT00002210|Antiviral Agents|antiviral agents|mesh-ancestor
64721021|NCT00002210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721022|NCT00002210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64721023|NCT00002210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64721024|NCT00002216|Lamivudine|lamivudine|mesh-list
64721025|NCT00002216|Zidovudine|zidovudine|mesh-list
64721043|NCT00002216|Antitubercular Agents|antitubercular agents|mesh-ancestor
64721044|NCT00002216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64721045|NCT00002222|Valganciclovir|valganciclovir|mesh-list
64721046|NCT00002222|Antiviral Agents|antiviral agents|mesh-ancestor
64721047|NCT00002222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721048|NCT00002312|Zidovudine|zidovudine|mesh-list
64721049|NCT00002312|Delavirdine|delavirdine|mesh-list
64721050|NCT00002312|Antimetabolites|antimetabolites|mesh-ancestor
64721051|NCT00002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721052|NCT00002312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64721053|NCT00002312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64721054|NCT00002312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721055|NCT00002312|Antiviral Agents|antiviral agents|mesh-ancestor
65279279|NCT00875667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65279280|NCT00875667|Antimetabolites|antimetabolites|mesh-ancestor
65279281|NCT00875667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279282|NCT00875667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65279283|NCT00875667|Immunologic Factors|immunologic factors|mesh-ancestor
65279284|NCT00875667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279285|NCT00875667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64721056|NCT00002312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721057|NCT00002312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64721058|NCT00002312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64460348|NCT03813160|Sensory System Agents|sensory system agents|mesh-ancestor
64721059|NCT00002318|Doxorubicin|doxorubicin|mesh-list
64721060|NCT00002318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64721061|NCT00002318|Bleomycin|bleomycin|mesh-list
64721062|NCT00002318|Vincristine|vincristine|mesh-list
64721063|NCT00002318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64721064|NCT00002318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721065|NCT00002318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64721066|NCT00002318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64721067|NCT00002318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721068|NCT00002318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721069|NCT00002318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64721070|NCT00002318|Tubulin Modulators|tubulin modulators|mesh-ancestor
64721071|NCT00002318|Antimitotic Agents|antimitotic agents|mesh-ancestor
64328981|NCT02178137|Dermatologic Agents|dermatologic agents|mesh-ancestor
64328982|NCT02181023|Glycopyrrolate|glycopyrrolate|mesh-list
64328983|NCT02181023|Bromides|bromides|mesh-list
64328984|NCT02181023|Anticonvulsants|anticonvulsants|mesh-ancestor
64328985|NCT02181023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64328986|NCT02181023|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64328987|NCT02181023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64328988|NCT02181023|Cholinergic Agents|cholinergic agents|mesh-ancestor
64328989|NCT02181023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64328990|NCT02181023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329098|NCT02385435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64329099|NCT02385435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329101|NCT02753075|Cariostatic Agents|cariostatic agents|mesh-ancestor
64329102|NCT02753075|Protective Agents|protective agents|mesh-ancestor
64329103|NCT02753075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329104|NCT03133897|Dexamethasone|dexamethasone|mesh-list
64329105|NCT03133897|Prednisone|prednisone|mesh-list
64329160|NCT02332720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64329161|NCT05089175|Aspirin|aspirin|mesh-list
64329162|NCT05089175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64329163|NCT05089175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64329164|NCT05089175|Analgesics|analgesics|mesh-ancestor
64329165|NCT05089175|Sensory System Agents|sensory system agents|mesh-ancestor
64329166|NCT05089175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64721557|NCT03538015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64721558|NCT03538015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64721559|NCT03538015|Adrenergic Agents|adrenergic agents|mesh-ancestor
64721560|NCT03538015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64721570|NCT03538015|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64721571|NCT03538015|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64721573|NCT03342157|Sennosides|sennosides|mesh-list
64721574|NCT03342157|Antidiarrheals|antidiarrheals|mesh-ancestor
64721575|NCT03342157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64721576|NCT03342157|Laxatives|laxatives|mesh-ancestor
64721577|NCT04331210|Diclofenac|diclofenac|mesh-list
64721578|NCT04331210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64721579|NCT04331210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64721580|NCT04331210|Analgesics|analgesics|mesh-ancestor
64721581|NCT04331210|Sensory System Agents|sensory system agents|mesh-ancestor
64721582|NCT04331210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64721583|NCT04331210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721584|NCT04331210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64721585|NCT04331210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64460870|NCT03559348|Gemcitabine|gemcitabine|mesh-list
65279286|NCT00875667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65279287|NCT00875667|Growth Substances|growth substances|mesh-ancestor
65279288|NCT00875667|Growth Inhibitors|growth inhibitors|mesh-ancestor
64721586|NCT04331210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64721587|NCT04331210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721588|NCT04331210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721589|NCT00002426|Adefovir|adefovir|mesh-list
64721590|NCT00002426|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64721591|NCT00002426|Antiviral Agents|antiviral agents|mesh-ancestor
64329645|NCT02192411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64329646|NCT02192411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329647|NCT02192411|Sensory System Agents|sensory system agents|mesh-ancestor
64329648|NCT02192411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64329649|NCT02192411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64329650|NCT02192411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64329651|NCT02192411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64329652|NCT02192411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64329672|NCT02192723|Olanzapine|olanzapine|mesh-list
64329673|NCT02192723|Risperidone|risperidone|mesh-list
64329674|NCT02192723|Aripiprazole|aripiprazole|mesh-list
64329675|NCT02192723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64329676|NCT02192723|Ziprasidone|ziprasidone|mesh-list
64722142|NCT00002582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64722143|NCT00002582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64722144|NCT00002582|Fertility Agents|fertility agents|mesh-ancestor
64722145|NCT00002588|Etoposide|etoposide|mesh-list
64722146|NCT00002588|Topotecan|topotecan|mesh-list
64722147|NCT00002588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64987718|NCT00318955|Anesthetics, General|anesthetics, general|mesh-ancestor
64329904|NCT02030717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64329910|NCT02371473|Acetazolamide|acetazolamide|mesh-list
64722227|NCT00002618|Methotrexate|methotrexate|mesh-list
64722228|NCT00002618|Vincristine|vincristine|mesh-list
64722229|NCT00002618|Mercaptopurine|mercaptopurine|mesh-list
64722230|NCT00002618|Levoleucovorin|levoleucovorin|mesh-list
64722231|NCT00002618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64722232|NCT00002618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722233|NCT00002618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64722234|NCT00002618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64722235|NCT00002618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64722236|NCT00002618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722264|NCT00002618|Mitosis Modulators|mitosis modulators|mesh-ancestor
64329962|NCT02030639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329964|NCT00004897|Interferons|interferons|mesh-list
64329965|NCT00004897|Interferon-alpha|interferon-alpha|mesh-list
64329966|NCT00004897|Fluorouracil|fluorouracil|mesh-list
64329967|NCT00004897|Hydroxyurea|hydroxyurea|mesh-list
64329968|NCT00004897|Calcium|calcium|mesh-list
64329969|NCT00004897|Levoleucovorin|levoleucovorin|mesh-list
64329970|NCT00004897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329971|NCT00004897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64329972|NCT00004897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329973|NCT00004897|Antimetabolites|antimetabolites|mesh-ancestor
64329974|NCT00004897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329975|NCT00004897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64329976|NCT00004897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64329977|NCT00004897|Immunologic Factors|immunologic factors|mesh-ancestor
64329978|NCT00004897|Antiviral Agents|antiviral agents|mesh-ancestor
64329979|NCT00004897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64329980|NCT00004897|Antidotes|antidotes|mesh-ancestor
64329998|NCT00004231|Methotrexate|methotrexate|mesh-list
64330113|NCT00002371|Protease Inhibitors|protease inhibitors|mesh-ancestor
64330114|NCT02189681|Anesthetics|anesthetics|mesh-list
64330115|NCT02189681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64330116|NCT02189681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330117|NCT05715385|Bromfenac|bromfenac|mesh-list
64330118|NCT05715385|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64330147|NCT00263341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64330149|NCT03534869|Sensory System Agents|sensory system agents|mesh-ancestor
64330150|NCT03534869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330151|NCT03534869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330152|NCT02370849|Nimotuzumab|nimotuzumab|mesh-list
64722530|NCT00002720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279289|NCT02811185|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65279290|NCT02811185|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65279291|NCT02811185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279292|NCT02811341|Scopolamine|scopolamine|mesh-list
65279293|NCT02811341|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65279294|NCT02811341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64722542|NCT01821859|Growth Substances|growth substances|mesh-ancestor
64722543|NCT01821859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722544|NCT01821859|Growth Inhibitors|growth inhibitors|mesh-ancestor
64722545|NCT05600023|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64722546|NCT05600023|Nitrofurantoin|nitrofurantoin|mesh-list
64722547|NCT05600023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64722548|NCT05600023|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64722549|NCT05600023|Renal Agents|renal agents|mesh-ancestor
64722550|NCT01194427|Tamoxifen|tamoxifen|mesh-list
64722551|NCT01194427|Vorinostat|vorinostat|mesh-list
64471669|NCT04267887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722552|NCT01194427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64722553|NCT01194427|Hormone Antagonists|hormone antagonists|mesh-ancestor
64722558|NCT01194427|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64722560|NCT01194427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64722561|NCT01194427|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64722562|NCT01194427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64722563|NCT01194427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722564|NCT05599555|Vaccines|vaccines|mesh-list
64722565|NCT05599555|Immunologic Factors|immunologic factors|mesh-ancestor
64722566|NCT05599555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722568|NCT00002738|Trimetrexate|trimetrexate|mesh-list
64722569|NCT00002738|Calcium|calcium|mesh-list
64722570|NCT00002738|Levoleucovorin|levoleucovorin|mesh-list
64722571|NCT00002738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64722572|NCT00002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722573|NCT00002738|Antidotes|antidotes|mesh-ancestor
64722574|NCT00002738|Protective Agents|protective agents|mesh-ancestor
64722575|NCT00002738|Vitamin B Complex|vitamin b complex|mesh-ancestor
64722576|NCT00002738|Vitamins|vitamins|mesh-ancestor
64722577|NCT00002738|Micronutrients|micronutrients|mesh-ancestor
64722578|NCT00002738|Antifungal Agents|antifungal agents|mesh-ancestor
64722579|NCT00002738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64722580|NCT00002738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64722581|NCT00002738|Antimetabolites|antimetabolites|mesh-ancestor
64722582|NCT00002738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722583|NCT00002738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722584|NCT00002738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64722585|NCT00002738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64722586|NCT04706455|Hyaluronic Acid|hyaluronic acid|mesh-list
64722587|NCT04706455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64722588|NCT04706455|Immunologic Factors|immunologic factors|mesh-ancestor
64722589|NCT04706455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722590|NCT04706455|Viscosupplements|viscosupplements|mesh-ancestor
64722591|NCT04706455|Protective Agents|protective agents|mesh-ancestor
64722593|NCT00002744|Cytarabine|cytarabine|mesh-list
64722594|NCT00002744|Dexamethasone|dexamethasone|mesh-list
64722595|NCT00002744|Prednisone|prednisone|mesh-list
64722596|NCT00002744|Hydrocortisone|hydrocortisone|mesh-list
64722597|NCT00002744|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64722598|NCT00002744|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64722599|NCT00002744|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64722600|NCT00002744|Cyclophosphamide|cyclophosphamide|mesh-list
64722601|NCT00002744|Doxorubicin|doxorubicin|mesh-list
64722602|NCT00002744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64722603|NCT00002744|Methotrexate|methotrexate|mesh-list
64723390|NCT00459121|Carboplatin|carboplatin|mesh-list
64723391|NCT00459121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64723392|NCT00459121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723393|NCT00459121|Tubulin Modulators|tubulin modulators|mesh-ancestor
64723394|NCT00459121|Antimitotic Agents|antimitotic agents|mesh-ancestor
64723395|NCT00459121|Mitosis Modulators|mitosis modulators|mesh-ancestor
64723396|NCT00459121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723397|NCT00904423|Vitamin D|vitamin d|mesh-list
64723398|NCT00904423|Vitamins|vitamins|mesh-ancestor
64723399|NCT00904423|Micronutrients|micronutrients|mesh-ancestor
65279295|NCT02811341|Antiemetics|antiemetics|mesh-ancestor
65279296|NCT02811341|Autonomic Agents|autonomic agents|mesh-ancestor
65279297|NCT02811341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65279298|NCT02811341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279299|NCT02811341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65279300|NCT02811341|Mydriatics|mydriatics|mesh-ancestor
65279301|NCT02811341|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64731699|NCT00003619|Vitamins|vitamins|mesh-ancestor
64723405|NCT05328895|Histamine Agents|histamine agents|mesh-ancestor
64723406|NCT05328895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64471671|NCT04267887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723407|NCT05328895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723408|NCT05328895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723410|NCT00879619|Cortisone|cortisone|mesh-list
64723411|NCT00879619|Docetaxel|docetaxel|mesh-list
64723412|NCT00879619|Sunitinib|sunitinib|mesh-list
64723413|NCT00879619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723414|NCT00879619|Tubulin Modulators|tubulin modulators|mesh-ancestor
64723415|NCT00879619|Antimitotic Agents|antimitotic agents|mesh-ancestor
64723416|NCT00879619|Mitosis Modulators|mitosis modulators|mesh-ancestor
64723417|NCT00879619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723418|NCT00879619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64723419|NCT00879619|Glucocorticoids|glucocorticoids|mesh-ancestor
64723420|NCT00879619|Hormones|hormones|mesh-ancestor
64723421|NCT00879619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64723422|NCT00879619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723423|NCT00879619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64723424|NCT00879619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64723425|NCT00879619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64723426|NCT00879619|Growth Substances|growth substances|mesh-ancestor
64723427|NCT00879619|Growth Inhibitors|growth inhibitors|mesh-ancestor
64723428|NCT00879619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64723429|NCT00879619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64723430|NCT00822679|Eszopiclone|eszopiclone|mesh-list
64723431|NCT00822679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64723432|NCT00822679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64723433|NCT00822679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723434|NCT00323635|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64723435|NCT00323635|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64723436|NCT00323635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64723437|NCT00323635|Cholinergic Agents|cholinergic agents|mesh-ancestor
64723438|NCT00323635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723439|NCT00323635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723440|NCT00323635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723441|NCT00323635|Urological Agents|urological agents|mesh-ancestor
64723442|NCT05033522|Sorafenib|sorafenib|mesh-list
64723443|NCT05033522|Lenvatinib|lenvatinib|mesh-list
64723444|NCT05033522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723445|NCT05033522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64723446|NCT05033522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64723447|NCT05033522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723448|NCT00314353|Bevacizumab|bevacizumab|mesh-list
64724480|NCT00000541|Provitamins|provitamins|mesh-ancestor
64724481|NCT00000913|Ritonavir|ritonavir|mesh-list
64724482|NCT00000913|Nelfinavir|nelfinavir|mesh-list
64724483|NCT00000913|Saquinavir|saquinavir|mesh-list
64724484|NCT00000913|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64724485|NCT00000913|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64724486|NCT00000913|Protease Inhibitors|protease inhibitors|mesh-ancestor
64724487|NCT00000913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724488|NCT00000913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724489|NCT00000913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64724490|NCT00000913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64724491|NCT00000913|Antiviral Agents|antiviral agents|mesh-ancestor
64724492|NCT00000913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724493|NCT00000913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64724494|NCT00000913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64724495|NCT00000547|Enalapril|enalapril|mesh-list
65279302|NCT02811341|Cholinergic Agents|cholinergic agents|mesh-ancestor
65279303|NCT02811341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65279304|NCT02811341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279305|NCT02811341|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65279306|NCT02811341|Parasympatholytics|parasympatholytics|mesh-ancestor
65279307|NCT00682383|Docetaxel|docetaxel|mesh-list
65279308|NCT00682383|Etoposide|etoposide|mesh-list
65279309|NCT00682383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279310|NCT00682383|Tubulin Modulators|tubulin modulators|mesh-ancestor
65279311|NCT00682383|Antimitotic Agents|antimitotic agents|mesh-ancestor
65279312|NCT00682383|Mitosis Modulators|mitosis modulators|mesh-ancestor
65279313|NCT00682383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279314|NCT00682383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65279315|NCT00682383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65279316|NCT00682383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65279317|NCT00682383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279318|NCT04237493|Insulin|insulin|mesh-list
65279319|NCT04237493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65279320|NCT04237493|Metformin|metformin|mesh-list
65279321|NCT04237493|Insulin Glargine|insulin glargine|mesh-list
65279322|NCT04237493|Glimepiride|glimepiride|mesh-list
65279323|NCT04237493|Vildagliptin|vildagliptin|mesh-list
65279324|NCT04237493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65279325|NCT04237493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279326|NCT04237493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65279327|NCT04237493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65279328|NCT04237493|Immunologic Factors|immunologic factors|mesh-ancestor
65279329|NCT04237493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65279330|NCT04237493|Protease Inhibitors|protease inhibitors|mesh-ancestor
65279331|NCT04237493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279332|NCT04237493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279333|NCT00683319|Cyclophosphamide|cyclophosphamide|mesh-list
65279334|NCT00683319|Carboplatin|carboplatin|mesh-list
65279335|NCT00683319|Methotrexate|methotrexate|mesh-list
65279336|NCT00683319|Vincristine|vincristine|mesh-list
65279337|NCT00683319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65279338|NCT00683319|Immunologic Factors|immunologic factors|mesh-ancestor
65279340|NCT00683319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65279341|NCT00683319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65279342|NCT00683319|Alkylating Agents|alkylating agents|mesh-ancestor
65279343|NCT00683319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279344|NCT00683319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279345|NCT00683319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65279346|NCT00683319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65279347|NCT00683319|Abortifacient Agents|abortifacient agents|mesh-ancestor
65279348|NCT00683319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65279349|NCT00683319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65279351|NCT00683319|Dermatologic Agents|dermatologic agents|mesh-ancestor
65279352|NCT00683319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279353|NCT00683319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65279354|NCT00683319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65279355|NCT00683319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65279356|NCT00683319|Tubulin Modulators|tubulin modulators|mesh-ancestor
64731745|NCT00003937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731746|NCT00003937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64731747|NCT00003937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64731748|NCT00003937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731749|NCT00003937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731750|NCT00003937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731751|NCT00003937|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64731752|NCT00003937|Abortifacient Agents|abortifacient agents|mesh-ancestor
64731753|NCT00003937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64731754|NCT00003937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731755|NCT00003937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64731756|NCT00003937|Antimetabolites|antimetabolites|mesh-ancestor
64731757|NCT00003937|Dermatologic Agents|dermatologic agents|mesh-ancestor
64731758|NCT00003937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64731759|NCT00003937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64724496|NCT00000547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64724497|NCT00000547|Protease Inhibitors|protease inhibitors|mesh-ancestor
64724498|NCT00000547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724499|NCT00000547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724534|NCT03015896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64724535|NCT03015896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724536|NCT03015896|Immunologic Factors|immunologic factors|mesh-ancestor
64724537|NCT03015896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987993|NCT00085553|Tipifarnib|tipifarnib|mesh-list
65279357|NCT00683319|Antimitotic Agents|antimitotic agents|mesh-ancestor
65279358|NCT00683319|Mitosis Modulators|mitosis modulators|mesh-ancestor
65279359|NCT00634361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
65279360|NCT00634361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65279361|NCT00634361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65279362|NCT02810483|Topiramate|topiramate|mesh-list
65279363|NCT02810483|Anticonvulsants|anticonvulsants|mesh-ancestor
65279364|NCT02810483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64731760|NCT00003937|Immunologic Factors|immunologic factors|mesh-ancestor
64731761|NCT00003937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64731762|NCT00003937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64731763|NCT00003937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64731767|NCT00003937|Protective Agents|protective agents|mesh-ancestor
64731768|NCT00003937|Antimitotic Agents|antimitotic agents|mesh-ancestor
64731769|NCT00003937|Mitosis Modulators|mitosis modulators|mesh-ancestor
65279365|NCT02810483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279366|NCT00683865|Moxifloxacin|moxifloxacin|mesh-list
65279367|NCT00683865|Ofloxacin|ofloxacin|mesh-list
65279368|NCT00683865|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65279369|NCT00683865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65279370|NCT00683865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65279371|NCT00683865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65279372|NCT00683865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65279373|NCT00683865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279374|NCT00683865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279375|NCT00683865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279376|NCT00683865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65279377|NCT00683865|Contraceptive Agents|contraceptive agents|mesh-ancestor
65279378|NCT00683865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65279379|NCT00683865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279380|NCT00683865|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65279381|NCT00683865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65279382|NCT00683865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65279383|NCT00683865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65279384|NCT00683865|Renal Agents|renal agents|mesh-ancestor
65279385|NCT00683865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65279386|NCT00683865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65279387|NCT02813369|Naloxegol|naloxegol|mesh-list
65279388|NCT02813369|Laxatives|laxatives|mesh-list
65279389|NCT02813369|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65279390|NCT02813369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279391|NCT02813369|Sensory System Agents|sensory system agents|mesh-ancestor
65279392|NCT02813369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65279393|NCT02813369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65279394|NCT00683943|Lithium Carbonate|lithium carbonate|mesh-list
65279395|NCT00683943|Antidepressive Agents|antidepressive agents|mesh-ancestor
65279396|NCT00683943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65279397|NCT00683943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279398|NCT00683943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279399|NCT00683943|Antimanic Agents|antimanic agents|mesh-ancestor
65279401|NCT00683943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65279402|NCT00683943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279403|NCT05633147|Clarithromycin|clarithromycin|mesh-list
65279404|NCT05633147|Midazolam|midazolam|mesh-list
65279405|NCT05633147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65279406|NCT05633147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65279407|NCT05633147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65279408|NCT05633147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279409|NCT05633147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65279410|NCT05633147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64731808|NCT00003943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731809|NCT00003943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64731810|NCT00003943|Immunologic Factors|immunologic factors|mesh-ancestor
64731811|NCT00003943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731812|NCT00003943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64731813|NCT00003943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64731814|NCT00003943|Alkylating Agents|alkylating agents|mesh-ancestor
64731815|NCT00003943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64731816|NCT00003943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64320151|NCT02183779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64320152|NCT02183779|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64320153|NCT02183779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64320154|NCT02183779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320155|NCT02183779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320156|NCT02183779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64320157|NCT02183779|Hormone Antagonists|hormone antagonists|mesh-ancestor
64320158|NCT02183779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64724967|NCT00002305|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64724968|NCT00002305|Hormone Antagonists|hormone antagonists|mesh-ancestor
64724969|NCT00002305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64724970|NCT00002305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724971|NCT00002305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64724972|NCT00002305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64724973|NCT00002305|Amebicides|amebicides|mesh-ancestor
64724974|NCT00002305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64724975|NCT00002305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64724976|NCT00002305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64724977|NCT00002305|Antimetabolites|antimetabolites|mesh-ancestor
64724978|NCT00001081|Nitazoxanide|nitazoxanide|mesh-list
64724979|NCT00001081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64724980|NCT00001081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724982|NCT00002311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65279411|NCT05633147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65279412|NCT05633147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65279413|NCT05633147|Anesthetics, General|anesthetics, general|mesh-ancestor
65279414|NCT05633147|Anesthetics|anesthetics|mesh-ancestor
65279415|NCT05633147|GABA Modulators|gaba modulators|mesh-ancestor
65279416|NCT05633147|GABA Agents|gaba agents|mesh-ancestor
65279417|NCT05633147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65279418|NCT05633147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731817|NCT00003943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731818|NCT00003943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731819|NCT00003955|Dactinomycin|dactinomycin|mesh-list
64731820|NCT00003955|Cyclophosphamide|cyclophosphamide|mesh-list
64320159|NCT02183779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320160|NCT02183779|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64320161|NCT02183779|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64320162|NCT02184091|Nevirapine|nevirapine|mesh-list
64724983|NCT00002311|Immunologic Factors|immunologic factors|mesh-ancestor
64724984|NCT00002311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724985|NCT00002317|Leucovorin|leucovorin|mesh-list
64724986|NCT00002317|Trimetrexate|trimetrexate|mesh-list
64724987|NCT00002317|Calcium|calcium|mesh-list
64724988|NCT00002317|Levoleucovorin|levoleucovorin|mesh-list
64724989|NCT00002317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64724990|NCT00002317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724991|NCT00002317|Antidotes|antidotes|mesh-ancestor
64724992|NCT00002317|Protective Agents|protective agents|mesh-ancestor
64724993|NCT00002317|Vitamin B Complex|vitamin b complex|mesh-ancestor
64724994|NCT00002317|Vitamins|vitamins|mesh-ancestor
64724995|NCT00002317|Micronutrients|micronutrients|mesh-ancestor
64724996|NCT00002317|Antifungal Agents|antifungal agents|mesh-ancestor
64725774|NCT00003050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64725775|NCT00003050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64725776|NCT00003050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64726078|NCT00002227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64471673|NCT04267887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726079|NCT00002227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64726080|NCT00002227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64726081|NCT00002227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64726082|NCT00002227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64726083|NCT00002227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64726084|NCT00002227|Antimetabolites|antimetabolites|mesh-ancestor
64726085|NCT03689972|Natalizumab|natalizumab|mesh-list
64726086|NCT03689972|Immunologic Factors|immunologic factors|mesh-ancestor
64726087|NCT03689972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726088|NCT00002233|Lamivudine|lamivudine|mesh-list
64726089|NCT00002233|Abacavir|abacavir|mesh-list
64726090|NCT00002233|Indinavir|indinavir|mesh-list
64726091|NCT00002233|Amprenavir|amprenavir|mesh-list
64726092|NCT00002233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64333576|NCT03112551|Anticonvulsants|anticonvulsants|mesh-ancestor
64727808|NCT00002701|Mitoxantrone|mitoxantrone|mesh-list
64728376|NCT00004160|Antimitotic Agents|antimitotic agents|mesh-ancestor
64728377|NCT00004160|Mitosis Modulators|mitosis modulators|mesh-ancestor
64728378|NCT00004160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728379|NCT00004160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64728380|NCT00004160|Antimetabolites|antimetabolites|mesh-ancestor
64728432|NCT00003680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728433|NCT00003680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64728434|NCT00003680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64728435|NCT00003680|Alkylating Agents|alkylating agents|mesh-ancestor
65279419|NCT05633147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65279420|NCT05633147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65279421|NCT05633147|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65279422|NCT05633147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279423|NCT05633147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65279424|NCT05633147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65279425|NCT02813135|Carboplatin|carboplatin|mesh-list
65279426|NCT02813135|Nivolumab|nivolumab|mesh-list
64731821|NCT00003955|Irinotecan|irinotecan|mesh-list
64731822|NCT00003955|Vincristine|vincristine|mesh-list
64731823|NCT00003955|Sargramostim|sargramostim|mesh-list
64731824|NCT00003955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64731825|NCT00003955|Immunologic Factors|immunologic factors|mesh-ancestor
64731826|NCT00003955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731827|NCT00003955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64731828|NCT00003955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64731829|NCT00003955|Alkylating Agents|alkylating agents|mesh-ancestor
64320163|NCT02184091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64320165|NCT02184091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728436|NCT00003680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728437|NCT00003680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728438|NCT00003680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64728439|NCT00003680|Antimetabolites|antimetabolites|mesh-ancestor
64728440|NCT00003680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64728538|NCT00003386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728539|NCT00003386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64728540|NCT00003386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728541|NCT00003386|Tubulin Modulators|tubulin modulators|mesh-ancestor
64728542|NCT00003386|Antimitotic Agents|antimitotic agents|mesh-ancestor
64728543|NCT00003386|Mitosis Modulators|mitosis modulators|mesh-ancestor
64728544|NCT00003386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728545|NCT00003386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728546|NCT00003386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64728547|NCT00003386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64728548|NCT00003386|Alkylating Agents|alkylating agents|mesh-ancestor
64728549|NCT00003386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64728550|NCT00003386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64728878|NCT00003728|Antiviral Agents|antiviral agents|mesh-ancestor
64728879|NCT00003728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64728880|NCT00003728|Antidotes|antidotes|mesh-ancestor
64728881|NCT00003728|Protective Agents|protective agents|mesh-ancestor
64728882|NCT00003728|Vitamin B Complex|vitamin b complex|mesh-ancestor
64728883|NCT00003728|Vitamins|vitamins|mesh-ancestor
64728884|NCT00003728|Micronutrients|micronutrients|mesh-ancestor
64728885|NCT00003728|Tubulin Modulators|tubulin modulators|mesh-ancestor
64728886|NCT00003728|Antimitotic Agents|antimitotic agents|mesh-ancestor
64728887|NCT00003728|Mitosis Modulators|mitosis modulators|mesh-ancestor
64728888|NCT00003728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64728889|NCT00003728|Analgesics|analgesics|mesh-ancestor
64728890|NCT00003728|Sensory System Agents|sensory system agents|mesh-ancestor
64728891|NCT00004886|Docetaxel|docetaxel|mesh-list
64728892|NCT00004886|Dofequidar|dofequidar|mesh-list
65279427|NCT02813135|Irinotecan|irinotecan|mesh-list
65279428|NCT02813135|Temozolomide|temozolomide|mesh-list
65279429|NCT02813135|Topotecan|topotecan|mesh-list
65279430|NCT02813135|Olaparib|olaparib|mesh-list
65279431|NCT02813135|Adavosertib|adavosertib|mesh-list
65279432|NCT02813135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279433|NCT02813135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65279434|NCT02813135|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65279435|NCT02813135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279436|NCT02813135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65279437|NCT02813135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65279438|NCT02813135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279439|NCT02813135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65279440|NCT02813135|Alkylating Agents|alkylating agents|mesh-ancestor
65279441|NCT02813135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65279442|NCT02810015|Botulinum Toxins|botulinum toxins|mesh-list
65279443|NCT02810015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65279444|NCT02810015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65279445|NCT02810015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65279446|NCT02810015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65279447|NCT02810015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279448|NCT02810015|Cholinergic Agents|cholinergic agents|mesh-ancestor
65279449|NCT02810015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65279477|NCT02809937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65279478|NCT02809937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279479|NCT02812979|Albuterol|albuterol|mesh-list
65279480|NCT02812979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65279481|NCT02812979|Autonomic Agents|autonomic agents|mesh-ancestor
65279482|NCT02812979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65279483|NCT02812979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279484|NCT02812979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65279485|NCT02812979|Respiratory System Agents|respiratory system agents|mesh-ancestor
65279486|NCT02812979|Tocolytic Agents|tocolytic agents|mesh-ancestor
65279487|NCT02812979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64731872|NCT00003643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731880|NCT00003661|Melphalan|melphalan|mesh-list
64728893|NCT00004886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728894|NCT00004886|Tubulin Modulators|tubulin modulators|mesh-ancestor
64728895|NCT00004886|Antimitotic Agents|antimitotic agents|mesh-ancestor
64728896|NCT00004886|Mitosis Modulators|mitosis modulators|mesh-ancestor
64728897|NCT00004886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728919|NCT05477875|Sensory System Agents|sensory system agents|mesh-ancestor
64728920|NCT05477875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64728921|NCT05477875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728922|NCT05477875|Antipyretics|antipyretics|mesh-ancestor
64728923|NCT05477875|Hallucinogens|hallucinogens|mesh-ancestor
64728924|NCT05477875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64728925|NCT05477875|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64728926|NCT05477875|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64728927|NCT05477875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64728928|NCT05477875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728929|NCT05477875|Hormones|hormones|mesh-ancestor
64728930|NCT05477875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64728931|NCT05477875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64728932|NCT05477875|Narcotics|narcotics|mesh-ancestor
64728933|NCT05477875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64729112|NCT00003776|Abortifacient Agents|abortifacient agents|mesh-ancestor
64729113|NCT00003776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64729114|NCT00003776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64729115|NCT00003776|Antimetabolites|antimetabolites|mesh-ancestor
64729116|NCT00003776|Dermatologic Agents|dermatologic agents|mesh-ancestor
64729117|NCT00003776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64729118|NCT00003776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64729119|NCT00003776|Immunologic Factors|immunologic factors|mesh-ancestor
64729120|NCT00003776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64729121|NCT00003776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64729122|NCT00003776|Antidotes|antidotes|mesh-ancestor
64729123|NCT00003776|Protective Agents|protective agents|mesh-ancestor
64729124|NCT00003776|Vitamin B Complex|vitamin b complex|mesh-ancestor
64729281|NCT00003812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729283|NCT00003812|Antimitotic Agents|antimitotic agents|mesh-ancestor
64729284|NCT00003812|Mitosis Modulators|mitosis modulators|mesh-ancestor
64729285|NCT00003812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729325|NCT00004406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729344|NCT00005024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729345|NCT00005024|Antiemetics|antiemetics|mesh-ancestor
64729346|NCT00005024|Autonomic Agents|autonomic agents|mesh-ancestor
64729347|NCT00005024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64729348|NCT00005024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64729349|NCT00005024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64729350|NCT00005024|Serotonin Agents|serotonin agents|mesh-ancestor
64729351|NCT00005024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64729352|NCT00005030|Lonafarnib|lonafarnib|mesh-list
64729353|NCT00005030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731884|NCT00003661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731885|NCT00003661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279488|NCT02812979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65279489|NCT02812979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65279490|NCT02812979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65279491|NCT02812979|Adrenergic Agents|adrenergic agents|mesh-ancestor
65279492|NCT02812979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65279493|NCT02812979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279495|NCT02809469|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65279496|NCT02809469|Antithrombins|antithrombins|mesh-ancestor
65279497|NCT02809469|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65279498|NCT02809469|Protease Inhibitors|protease inhibitors|mesh-ancestor
65279499|NCT02809469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279500|NCT02809469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279501|NCT02809469|Anticoagulants|anticoagulants|mesh-ancestor
65279502|NCT02809079|Mycophenolic Acid|mycophenolic acid|mesh-list
65279503|NCT02809079|Prednisone|prednisone|mesh-list
65279504|NCT02809079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64731886|NCT00003661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64729354|NCT00005030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729355|NCT00004424|Fentanyl|fentanyl|mesh-list
64729356|NCT00004424|Midazolam|midazolam|mesh-list
64729357|NCT00004424|Propofol|propofol|mesh-list
64729358|NCT00004424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64729359|NCT00004424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64729360|NCT00004424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729361|NCT00004424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64729362|NCT00004424|Anesthetics, General|anesthetics, general|mesh-ancestor
64729363|NCT00004424|Anesthetics|anesthetics|mesh-ancestor
64729364|NCT00004424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64729365|NCT00004424|Narcotics|narcotics|mesh-ancestor
64729366|NCT00004424|Analgesics|analgesics|mesh-ancestor
64729367|NCT00004424|Sensory System Agents|sensory system agents|mesh-ancestor
64729368|NCT00004424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64729369|NCT00004424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64729370|NCT00004424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64729371|NCT00004424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64729372|NCT00004424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64729373|NCT00004424|GABA Modulators|gaba modulators|mesh-ancestor
64729374|NCT00004424|GABA Agents|gaba agents|mesh-ancestor
64729375|NCT00004424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64336693|NCT02332473|Molgramostim|molgramostim|mesh-list
64729409|NCT00005036|Protective Agents|protective agents|mesh-ancestor
64729410|NCT00005036|Vitamin B Complex|vitamin b complex|mesh-ancestor
64729411|NCT00005036|Vitamins|vitamins|mesh-ancestor
64729412|NCT00005036|Micronutrients|micronutrients|mesh-ancestor
64729413|NCT00004436|Prednisone|prednisone|mesh-list
64729414|NCT00004436|Leuprolide|leuprolide|mesh-list
64729415|NCT00004436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64729416|NCT00004436|Glucocorticoids|glucocorticoids|mesh-ancestor
64729417|NCT00004436|Hormones|hormones|mesh-ancestor
64736770|NCT05599919|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64729533|NCT04711915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64729534|NCT00005072|Interleukin-2|interleukin-2|mesh-list
64729535|NCT00005072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729536|NCT00005072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64729537|NCT00005072|Analgesics|analgesics|mesh-ancestor
64729538|NCT00005072|Sensory System Agents|sensory system agents|mesh-ancestor
64471204|NCT04696523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64471205|NCT04696523|Anesthetics, General|anesthetics, general|mesh-ancestor
64471206|NCT04696523|Anesthetics|anesthetics|mesh-ancestor
64471207|NCT04696523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64471210|NCT04688320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64731898|NCT00003661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64731899|NCT00003661|Glucocorticoids|glucocorticoids|mesh-ancestor
64731900|NCT00003661|Hormones|hormones|mesh-ancestor
65279505|NCT02809079|Glucocorticoids|glucocorticoids|mesh-ancestor
65279506|NCT02809079|Hormones|hormones|mesh-ancestor
65279507|NCT02809079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65279508|NCT02809079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279509|NCT02809079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65279510|NCT02809079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279511|NCT02809079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65279512|NCT02809079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65279513|NCT02809079|Antitubercular Agents|antitubercular agents|mesh-ancestor
65279514|NCT02809079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65279515|NCT02809079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65279516|NCT02809079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279517|NCT02809079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279518|NCT02812199|Lidocaine|lidocaine|mesh-list
65279519|NCT02812199|Epinephrine|epinephrine|mesh-list
65279520|NCT02812199|Racepinephrine|racepinephrine|mesh-list
65279521|NCT02812199|Epinephryl borate|epinephryl borate|mesh-list
64736777|NCT01645709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64320178|NCT02184247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64729539|NCT00005072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64729540|NCT00005072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729543|NCT00004496|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64729544|NCT00004496|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64729545|NCT00004496|beta-Endorphin|beta-endorphin|mesh-list
64729546|NCT00004496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64730093|NCT00005648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64730094|NCT00005648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730095|NCT00005648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64730096|NCT00005648|Immunologic Factors|immunologic factors|mesh-ancestor
64730097|NCT00005648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730098|NCT00005654|Metformin|metformin|mesh-list
64730099|NCT00005654|Clomiphene|clomiphene|mesh-list
64730100|NCT00005654|Enclomiphene|enclomiphene|mesh-list
64730101|NCT00005654|Zuclomiphene|zuclomiphene|mesh-list
64730102|NCT00005654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64730103|NCT00005654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730104|NCT00005654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64730105|NCT00005654|Hormone Antagonists|hormone antagonists|mesh-ancestor
64730106|NCT00005654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64730107|NCT00005654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65279522|NCT02812199|Anesthetics, Local|anesthetics, local|mesh-ancestor
65279523|NCT02812199|Anesthetics|anesthetics|mesh-ancestor
65279524|NCT02812199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65279525|NCT02812199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279526|NCT02812199|Sensory System Agents|sensory system agents|mesh-ancestor
65279527|NCT02812199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65279528|NCT02812199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65279529|NCT02812199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65279530|NCT02812199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65279531|NCT02812199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65279532|NCT02812199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279533|NCT02812199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65279534|NCT02812199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65279535|NCT02812199|Adrenergic Agents|adrenergic agents|mesh-ancestor
65279536|NCT02812199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65279537|NCT02812199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65279538|NCT02812199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65279539|NCT02812199|Autonomic Agents|autonomic agents|mesh-ancestor
65279540|NCT02812199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65279545|NCT02812043|Amorolfine|amorolfine|mesh-list
65279573|NCT02811731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65279574|NCT02811809|Leuprolide|leuprolide|mesh-list
65279575|NCT02811809|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65279576|NCT02811809|Fertility Agents|fertility agents|mesh-ancestor
65279577|NCT02811809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65279578|NCT02811809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279579|NCT02811809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65279580|NCT02811809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279581|NCT05569421|Budesonide|budesonide|mesh-list
64471291|NCT04615013|Leucovorin|leucovorin|mesh-list
64730108|NCT00005654|Fertility Agents|fertility agents|mesh-ancestor
64730142|NCT04456699|Capecitabine|capecitabine|mesh-list
64730143|NCT04456699|Olaparib|olaparib|mesh-list
64730145|NCT04456699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64730146|NCT04456699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730147|NCT04456699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64730148|NCT04456699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64730149|NCT04456699|Growth Substances|growth substances|mesh-ancestor
64730150|NCT04456699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988349|NCT00094341|Etanercept|etanercept|mesh-list
64730589|NCT03351361|Nivolumab|nivolumab|mesh-list
64730590|NCT03351361|Ipilimumab|ipilimumab|mesh-list
64730591|NCT03351361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64469833|NCT05683574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469834|NCT05683574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469835|NCT05683574|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64730592|NCT03351361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730593|NCT03351361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64730594|NCT03351361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730595|NCT03234907|Vedolizumab|vedolizumab|mesh-list
64730596|NCT03234907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64730597|NCT03228667|Pembrolizumab|pembrolizumab|mesh-list
64730599|NCT03228667|Durvalumab|durvalumab|mesh-list
64730600|NCT03228667|Avelumab|avelumab|mesh-list
64730601|NCT03228667|Atezolizumab|atezolizumab|mesh-list
64730602|NCT03228667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64730603|NCT03228667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64730604|NCT03228667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730605|NCT03228667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64730606|NCT03228667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730607|NCT03228667|Immunologic Factors|immunologic factors|mesh-ancestor
64730608|NCT03228667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730609|NCT03194893|Crizotinib|crizotinib|mesh-list
64730610|NCT03194893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730611|NCT03194893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64730612|NCT03194893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730613|NCT03194893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730616|NCT04330027|Mitogens|mitogens|mesh-list
64730617|NCT04330027|Mitosis Modulators|mitosis modulators|mesh-ancestor
64730618|NCT04330027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730619|NCT00002893|Leucovorin|leucovorin|mesh-list
64730620|NCT00002893|Fluorouracil|fluorouracil|mesh-list
64730621|NCT00002893|Raltitrexed|raltitrexed|mesh-list
64730622|NCT00002893|Calcium|calcium|mesh-list
64730623|NCT00002893|Levoleucovorin|levoleucovorin|mesh-list
64730624|NCT00002893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64730625|NCT00002893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730626|NCT00002893|Antimetabolites|antimetabolites|mesh-ancestor
64337909|NCT01445795|Antimetabolites|antimetabolites|mesh-ancestor
64730741|NCT02461927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730742|NCT02461927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64730743|NCT02461927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64730744|NCT02461927|Anesthetics, General|anesthetics, general|mesh-ancestor
64730746|NCT02461927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64730747|NCT02461927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64730748|NCT02461927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65279582|NCT05569421|Formoterol Fumarate|formoterol fumarate|mesh-list
65279583|NCT05569421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64730749|NCT02461927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64730750|NCT02461927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730751|NCT02461927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64731101|NCT00003013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64731102|NCT00003013|Immunologic Factors|immunologic factors|mesh-ancestor
64731103|NCT00003013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731104|NCT00003013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64731105|NCT00003013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64731106|NCT00003013|Alkylating Agents|alkylating agents|mesh-ancestor
64731107|NCT00003013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64418423|NCT05550415|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64418424|NCT05550415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418426|NCT02586727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64418427|NCT02586727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64418428|NCT02586727|Growth Substances|growth substances|mesh-ancestor
64418429|NCT02586727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731590|NCT00003073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731591|NCT00003073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731592|NCT00003073|Antiviral Agents|antiviral agents|mesh-ancestor
64731593|NCT00003073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64988449|NCT00321724|Cediranib|cediranib|mesh-list
64731610|NCT00003601|Fenretinide|fenretinide|mesh-list
64731611|NCT00003601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731612|NCT00003601|Keratolytic Agents|keratolytic agents|mesh-ancestor
64731613|NCT00003601|Dermatologic Agents|dermatologic agents|mesh-ancestor
64731743|NCT00003937|Dexrazoxane|dexrazoxane|mesh-list
64731744|NCT00003937|Razoxane|razoxane|mesh-list
64731845|NCT00003103|Docetaxel|docetaxel|mesh-list
64731846|NCT00003103|Oblimersen|oblimersen|mesh-list
64731847|NCT00003103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731848|NCT00003103|Tubulin Modulators|tubulin modulators|mesh-ancestor
64731849|NCT00003103|Antimitotic Agents|antimitotic agents|mesh-ancestor
64731850|NCT00003103|Mitosis Modulators|mitosis modulators|mesh-ancestor
64731851|NCT00003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731852|NCT00003109|Irinotecan|irinotecan|mesh-list
64731853|NCT00003109|Raltitrexed|raltitrexed|mesh-list
64731854|NCT00003109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64731855|NCT00003109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731856|NCT00003109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731857|NCT00003109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731858|NCT00003109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731859|NCT00003109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64731860|NCT00003109|Antimetabolites|antimetabolites|mesh-ancestor
64731861|NCT00003109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64731862|NCT00003643|Paclitaxel|paclitaxel|mesh-list
64731863|NCT00003643|Etoposide|etoposide|mesh-list
64731864|NCT00003643|Bleomycin|bleomycin|mesh-list
64731865|NCT00003643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64731866|NCT00003643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731867|NCT00003643|Tubulin Modulators|tubulin modulators|mesh-ancestor
64731868|NCT00003643|Antimitotic Agents|antimitotic agents|mesh-ancestor
64731869|NCT00003643|Mitosis Modulators|mitosis modulators|mesh-ancestor
64731870|NCT00003643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731871|NCT00003643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64731921|NCT00003115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731922|NCT00003115|Analgesics|analgesics|mesh-ancestor
64731923|NCT00003115|Sensory System Agents|sensory system agents|mesh-ancestor
64731924|NCT00003115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64731925|NCT00003667|Cyclophosphamide|cyclophosphamide|mesh-list
64731926|NCT00003667|Doxorubicin|doxorubicin|mesh-list
64731927|NCT00003667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64731928|NCT00003667|Vincristine|vincristine|mesh-list
64731929|NCT00003667|Dexrazoxane|dexrazoxane|mesh-list
64731930|NCT00003667|Razoxane|razoxane|mesh-list
64731931|NCT00003667|Glycerol|glycerol|mesh-list
64731932|NCT00003667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64731951|NCT00003667|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64731952|NCT00003673|Gemtuzumab|gemtuzumab|mesh-list
64731953|NCT00003673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64731954|NCT00003673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731955|NCT00003679|Tamoxifen|tamoxifen|mesh-list
64733098|NCT00004873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733099|NCT00004873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65279584|NCT05569421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65279585|NCT05569421|Autonomic Agents|autonomic agents|mesh-ancestor
65279586|NCT05569421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65279587|NCT05569421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279588|NCT05569421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65279589|NCT05569421|Respiratory System Agents|respiratory system agents|mesh-ancestor
65279590|NCT05569421|Glucocorticoids|glucocorticoids|mesh-ancestor
65279591|NCT05569421|Hormones|hormones|mesh-ancestor
65279592|NCT05569421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65279593|NCT05569421|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65279594|NCT05569421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65279595|NCT05569421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65279596|NCT05569421|Adrenergic Agents|adrenergic agents|mesh-ancestor
65279597|NCT05569421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65279598|NCT05569421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279599|NCT02808611|Propranolol|propranolol|mesh-list
65279600|NCT02808611|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65279601|NCT02808611|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65279602|NCT02808611|Adrenergic Agents|adrenergic agents|mesh-ancestor
65279603|NCT02808611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65279604|NCT02808611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279605|NCT02808611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279606|NCT02808611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65279607|NCT02808611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64733100|NCT00004873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64733101|NCT00004873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64733102|NCT00004873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733103|NCT00004879|Panitumumab|panitumumab|mesh-list
64733104|NCT00004879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64733105|NCT00004879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733106|NCT00004339|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
64733108|NCT00004339|Chelating Agents|chelating agents|mesh-ancestor
64733109|NCT00004339|Sequestering Agents|sequestering agents|mesh-ancestor
64733110|NCT00004339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733111|NCT00004339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733112|NCT00004339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64733113|NCT00004339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64733114|NCT00004339|Growth Substances|growth substances|mesh-ancestor
64733115|NCT00004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733116|NCT00004339|Growth Inhibitors|growth inhibitors|mesh-ancestor
64733117|NCT00004339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733118|NCT00003331|Leucovorin|leucovorin|mesh-list
64733119|NCT00003331|Fluorouracil|fluorouracil|mesh-list
64733120|NCT00003331|Topotecan|topotecan|mesh-list
64733121|NCT00003331|Calcium|calcium|mesh-list
64733122|NCT00003331|Levoleucovorin|levoleucovorin|mesh-list
64733123|NCT00003331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64733124|NCT00003331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733125|NCT00003331|Antimetabolites|antimetabolites|mesh-ancestor
65279608|NCT02808611|Vasodilator Agents|vasodilator agents|mesh-ancestor
65279609|NCT02808533|Topiramate|topiramate|mesh-list
65279610|NCT02808533|Anticonvulsants|anticonvulsants|mesh-ancestor
65279611|NCT02808533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65279612|NCT02808533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279613|NCT02811497|Azacitidine|azacitidine|mesh-list
65279614|NCT02811497|Durvalumab|durvalumab|mesh-list
65279615|NCT02811497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65279616|NCT02811497|Antimetabolites|antimetabolites|mesh-ancestor
65279617|NCT02811497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279618|NCT02811497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279619|NCT02811497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279620|NCT02811497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65279621|NCT00634439|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64733126|NCT00003331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733127|NCT00003331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64733128|NCT00003331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733129|NCT00003331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64733130|NCT00003331|Immunologic Factors|immunologic factors|mesh-ancestor
64733131|NCT00003331|Antidotes|antidotes|mesh-ancestor
64733154|NCT00004885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733155|NCT00004885|Antidotes|antidotes|mesh-ancestor
64733156|NCT00004885|Protective Agents|protective agents|mesh-ancestor
64733157|NCT00004885|Vitamin B Complex|vitamin b complex|mesh-ancestor
64733158|NCT00004885|Vitamins|vitamins|mesh-ancestor
64733159|NCT00004885|Micronutrients|micronutrients|mesh-ancestor
64733160|NCT00004891|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64733161|NCT00004891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64733162|NCT00004891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733163|NCT00003337|Epratuzumab|epratuzumab|mesh-list
64733164|NCT00003337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64733165|NCT00003337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733166|NCT00003343|Prednisone|prednisone|mesh-list
64733167|NCT00003343|Mitoxantrone|mitoxantrone|mesh-list
64733168|NCT00003343|Prinomastat|prinomastat|mesh-list
64733169|NCT00003343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64733247|NCT00004921|Cyclophosphamide|cyclophosphamide|mesh-list
64733248|NCT00004921|Carboplatin|carboplatin|mesh-list
64733249|NCT00004921|Melphalan|melphalan|mesh-list
64733250|NCT00004921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64733251|NCT00004921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733252|NCT00004921|Tubulin Modulators|tubulin modulators|mesh-ancestor
64733253|NCT00004921|Antimitotic Agents|antimitotic agents|mesh-ancestor
64733254|NCT00004921|Mitosis Modulators|mitosis modulators|mesh-ancestor
64733255|NCT00004921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733256|NCT00004921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64733257|NCT00004921|Immunologic Factors|immunologic factors|mesh-ancestor
64733258|NCT00004921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733259|NCT00004921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64733260|NCT00004921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64733261|NCT00004921|Alkylating Agents|alkylating agents|mesh-ancestor
64733262|NCT00004921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64733290|NCT00004993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64733291|NCT00004999|Lamivudine|lamivudine|mesh-list
64733292|NCT00004999|Zidovudine|zidovudine|mesh-list
64733293|NCT00004999|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64733294|NCT00004999|Capravirine|capravirine|mesh-list
64733295|NCT00004999|Nelfinavir|nelfinavir|mesh-list
64733296|NCT00004999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64733297|NCT00004999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64733298|NCT00004999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733299|NCT00004999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733300|NCT00004999|Antiviral Agents|antiviral agents|mesh-ancestor
65279622|NCT00634439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65279623|NCT00634439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65279624|NCT00634439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65279625|NCT00634439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279626|NCT00634439|Adrenergic Agents|adrenergic agents|mesh-ancestor
65279627|NCT00634439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65279628|NCT00634439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279629|NCT02807909|Itraconazole|itraconazole|mesh-list
65279630|NCT02807909|Diltiazem|diltiazem|mesh-list
65279631|NCT02807909|Antifungal Agents|antifungal agents|mesh-ancestor
64731988|NCT00384553|Rituximab|rituximab|mesh-list
64733301|NCT00004999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64733302|NCT00004999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64733303|NCT00004999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64733304|NCT00004999|Antimetabolites|antimetabolites|mesh-ancestor
64733305|NCT00004999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64733306|NCT00004999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64733307|NCT00004999|Protease Inhibitors|protease inhibitors|mesh-ancestor
64733308|NCT00003361|Decitabine|decitabine|mesh-list
64733309|NCT00003361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64733310|NCT00003361|Antimetabolites|antimetabolites|mesh-ancestor
64988663|NCT00332293|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64733796|NCT00004759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733797|NCT00004759|Antioxidants|antioxidants|mesh-ancestor
64733798|NCT00004759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733799|NCT00004771|Leuprolide|leuprolide|mesh-list
64733800|NCT00004771|Testosterone|testosterone|mesh-list
64733801|NCT00004771|Androgens|androgens|mesh-ancestor
64733802|NCT00004771|Hormones|hormones|mesh-ancestor
64733803|NCT00004771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64733804|NCT00004771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733805|NCT00004771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64733806|NCT00004771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733807|NCT00004771|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64733808|NCT00004771|Fertility Agents|fertility agents|mesh-ancestor
64733809|NCT00004771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64733810|NCT00004789|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
64733811|NCT00004789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733812|NCT00004789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733813|NCT00004795|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64733814|NCT00004795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64733815|NCT00004795|Immunologic Factors|immunologic factors|mesh-ancestor
64733816|NCT00004795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733817|NCT00004807|Topiramate|topiramate|mesh-list
64733818|NCT00004807|Dextromethorphan|dextromethorphan|mesh-list
64733819|NCT00004807|Donepezil|donepezil|mesh-list
64733820|NCT00004807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64733821|NCT00004807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733822|NCT00004807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733823|NCT00004807|Cholinergic Agents|cholinergic agents|mesh-ancestor
64733824|NCT00004807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64733825|NCT00004807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733826|NCT00004807|Nootropic Agents|nootropic agents|mesh-ancestor
64733827|NCT00004807|Anticonvulsants|anticonvulsants|mesh-ancestor
64733828|NCT00004807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64733829|NCT00004807|Antitussive Agents|antitussive agents|mesh-ancestor
64733981|NCT02105688|Antiviral Agents|antiviral agents|mesh-ancestor
64733982|NCT02105688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64733983|NCT02105454|Ribavirin|ribavirin|mesh-list
64733984|NCT02105454|Grazoprevir|grazoprevir|mesh-list
64733985|NCT02105454|Antimetabolites|antimetabolites|mesh-ancestor
64733986|NCT02105454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733987|NCT02105454|Antiviral Agents|antiviral agents|mesh-ancestor
64733988|NCT02105454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64733989|NCT02104752|Curcumin|curcumin|mesh-list
65279632|NCT02807909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65279633|NCT02807909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65279634|NCT02807909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65279635|NCT02807909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279636|NCT02807909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279637|NCT02807909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65279638|NCT02807909|Hormone Antagonists|hormone antagonists|mesh-ancestor
65279639|NCT02807909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65279640|NCT02807909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279641|NCT02807909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65279642|NCT02807909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65279643|NCT02807909|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65279644|NCT02807909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65279645|NCT02807909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65279646|NCT02807909|Vasodilator Agents|vasodilator agents|mesh-ancestor
64732000|NCT00003991|Antiviral Agents|antiviral agents|mesh-ancestor
64733990|NCT02104752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64733991|NCT02104752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64733992|NCT02104752|Analgesics|analgesics|mesh-ancestor
64733993|NCT02104752|Sensory System Agents|sensory system agents|mesh-ancestor
64733994|NCT02104752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64733995|NCT02104752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733996|NCT02104752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64733997|NCT02104752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64733998|NCT02104752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733999|NCT02104752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734000|NCT02104752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734001|NCT02128932|Insulin Glargine|insulin glargine|mesh-list
64734002|NCT02128932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64734003|NCT02128932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734004|NCT02128542|Sofosbuvir|sofosbuvir|mesh-list
64734005|NCT02128542|Antiviral Agents|antiviral agents|mesh-ancestor
64471674|NCT04267887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734006|NCT02128542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64734008|NCT02127372|Docetaxel|docetaxel|mesh-list
64734009|NCT02127372|Imatinib Mesylate|imatinib mesylate|mesh-list
64734010|NCT02127372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734011|NCT02127372|Tubulin Modulators|tubulin modulators|mesh-ancestor
64734012|NCT02127372|Antimitotic Agents|antimitotic agents|mesh-ancestor
64734013|NCT02127372|Mitosis Modulators|mitosis modulators|mesh-ancestor
64734014|NCT02127372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734015|NCT02127372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64734016|NCT02127372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734335|NCT02116530|Ondansetron|ondansetron|mesh-list
64734336|NCT02116530|Olanzapine|olanzapine|mesh-list
64734337|NCT02116530|Aprepitant|aprepitant|mesh-list
64734338|NCT02116530|Fosaprepitant|fosaprepitant|mesh-list
64734339|NCT02116530|Palonosetron|palonosetron|mesh-list
64734340|NCT02116530|Granisetron|granisetron|mesh-list
64734341|NCT02116530|Antiemetics|antiemetics|mesh-list
64734342|NCT02116530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64734343|NCT02116530|Immunologic Factors|immunologic factors|mesh-ancestor
64734344|NCT02116530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734345|NCT02116530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64734363|NCT02116530|Antipruritics|antipruritics|mesh-ancestor
64734364|NCT02116530|Dermatologic Agents|dermatologic agents|mesh-ancestor
65279647|NCT02808065|Mycophenolic Acid|mycophenolic acid|mesh-list
65279648|NCT02808065|Tacrolimus|tacrolimus|mesh-list
65279649|NCT02808065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65279650|NCT02808065|Immunologic Factors|immunologic factors|mesh-ancestor
65279651|NCT02808065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734365|NCT02116530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64734366|NCT02116530|Serotonin Agents|serotonin agents|mesh-ancestor
64734367|NCT02116530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64734368|NCT02116530|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64734369|NCT02116530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64734370|NCT02116530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64734371|NCT02116530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64734372|NCT02116530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64734373|NCT02116530|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64734406|NCT02114892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734407|NCT02114892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734408|NCT02114892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64734410|NCT02070744|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64734411|NCT02070744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64734412|NCT02070744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734413|NCT04741698|Propranolol|propranolol|mesh-list
64734541|NCT04723446|Chlorhexidine|chlorhexidine|mesh-list
64734542|NCT04723446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64734543|NCT04723446|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64734544|NCT04723446|Cetylpyridinium|cetylpyridinium|mesh-list
64734545|NCT04723446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64734546|NCT04723446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64734547|NCT04723446|Disinfectants|disinfectants|mesh-ancestor
64734548|NCT04723446|Dermatologic Agents|dermatologic agents|mesh-ancestor
64734549|NCT02082210|Ramucirumab|ramucirumab|mesh-list
64734550|NCT02082210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734551|NCT02107014|Naltrexone|naltrexone|mesh-list
64734552|NCT02107014|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64734553|NCT02107014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64734554|NCT02107014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734555|NCT02107014|Sensory System Agents|sensory system agents|mesh-ancestor
64734556|NCT02107014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64734557|NCT01624974|Montelukast|montelukast|mesh-list
64734558|NCT01624974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64734559|NCT01624974|Respiratory System Agents|respiratory system agents|mesh-ancestor
64734560|NCT01624974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64735059|NCT02052414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64735060|NCT02052414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64735061|NCT02052414|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64735062|NCT02052414|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64735063|NCT02052414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64735064|NCT02052414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735065|NCT02052414|Antimanic Agents|antimanic agents|mesh-ancestor
64735066|NCT02031276|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64735067|NCT02031276|Immunologic Factors|immunologic factors|mesh-ancestor
64735068|NCT02031276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735069|NCT01363440|Aflibercept|aflibercept|mesh-list
64735070|NCT01363440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64735071|NCT01363440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64735072|NCT01363440|Growth Substances|growth substances|mesh-ancestor
64735073|NCT01363440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735074|NCT01363440|Growth Inhibitors|growth inhibitors|mesh-ancestor
64735075|NCT01363440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735076|NCT02007096|Bupivacaine|bupivacaine|mesh-list
64735077|NCT02007096|Anesthetics, Local|anesthetics, local|mesh-ancestor
64735078|NCT02007096|Anesthetics|anesthetics|mesh-ancestor
64735079|NCT02007096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64735080|NCT02007096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735097|NCT02006706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64735098|NCT02006706|Abortifacient Agents|abortifacient agents|mesh-ancestor
64735099|NCT02006706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64735100|NCT02006706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64735101|NCT02006706|Antimetabolites|antimetabolites|mesh-ancestor
64735102|NCT02006706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735103|NCT02006706|Dermatologic Agents|dermatologic agents|mesh-ancestor
65279652|NCT02808065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65279653|NCT02808065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279654|NCT02808065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279655|NCT02808065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65279656|NCT02808065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279657|NCT02808065|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65279658|NCT02808065|Antitubercular Agents|antitubercular agents|mesh-ancestor
65279659|NCT02808065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65279660|NCT02808065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65279661|NCT00602030|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65279662|NCT00602030|Entinostat|entinostat|mesh-list
65279663|NCT00602030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279664|NCT00602030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64735104|NCT02006706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735105|NCT02006706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64735234|NCT02002884|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64735235|NCT02002884|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64735236|NCT02002884|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64735237|NCT02002884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64735238|NCT02002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735239|NCT02002884|Cholinergic Agents|cholinergic agents|mesh-ancestor
64735240|NCT02002884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64735241|NCT02002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735242|NCT02002884|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64735243|NCT02002884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64735244|NCT02023866|Cysteamine|cysteamine|mesh-list
64735245|NCT02023866|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
64735246|NCT02023866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735247|NCT01967940|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64735248|NCT01967940|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64735249|NCT01967940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64735250|NCT01967940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64735251|NCT01967940|Protease Inhibitors|protease inhibitors|mesh-ancestor
64735252|NCT01967940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735253|NCT01967940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735254|NCT01967940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64735255|NCT01967940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64735256|NCT01967940|Antiviral Agents|antiviral agents|mesh-ancestor
64735257|NCT01967940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64735258|NCT01990560|Mifepristone|mifepristone|mesh-list
64735259|NCT01990560|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64735260|NCT01990560|Abortifacient Agents|abortifacient agents|mesh-ancestor
64735261|NCT01990560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64735262|NCT01990560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735341|NCT01965834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64735342|NCT01996332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64735343|NCT01996332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735393|NCT01945866|Growth Substances|growth substances|mesh-ancestor
64735462|NCT01944774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735464|NCT04665648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64735465|NCT04665648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64735466|NCT04665648|Vasodilator Agents|vasodilator agents|mesh-ancestor
64735467|NCT04665648|Vitamin B Complex|vitamin b complex|mesh-ancestor
64735468|NCT04665648|Vitamins|vitamins|mesh-ancestor
64735469|NCT04665648|Micronutrients|micronutrients|mesh-ancestor
64735470|NCT04665648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735471|NCT01944462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64735661|NCT01959672|Immunologic Factors|immunologic factors|mesh-ancestor
64735662|NCT01959672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279665|NCT00602030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279666|NCT00602030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279667|NCT00602030|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65279668|NCT02804711|Vaccines|vaccines|mesh-list
65279669|NCT02804711|Immunologic Factors|immunologic factors|mesh-ancestor
65279670|NCT02804711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279671|NCT00640094|Melatonin|melatonin|mesh-list
65279672|NCT00640094|Antioxidants|antioxidants|mesh-ancestor
65279673|NCT00640094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279674|NCT00640094|Protective Agents|protective agents|mesh-ancestor
65279675|NCT00640094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735663|NCT01959672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64735664|NCT01959672|Antimetabolites|antimetabolites|mesh-ancestor
64735665|NCT01959672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735666|NCT01959672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735667|NCT01959672|Antiviral Agents|antiviral agents|mesh-ancestor
64735668|NCT01959672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64735669|NCT01959672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735670|NCT01959672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64735671|NCT01959672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64735672|NCT01959672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64735673|NCT01959672|Antidotes|antidotes|mesh-ancestor
64735674|NCT01959672|Protective Agents|protective agents|mesh-ancestor
64735675|NCT01959672|Vitamin B Complex|vitamin b complex|mesh-ancestor
64735676|NCT01959672|Vitamins|vitamins|mesh-ancestor
64735677|NCT01959672|Micronutrients|micronutrients|mesh-ancestor
64735678|NCT01959672|Hematinics|hematinics|mesh-ancestor
64735723|NCT01936974|Gemcitabine|gemcitabine|mesh-list
64735724|NCT01936974|Bevacizumab|bevacizumab|mesh-list
64735725|NCT01936974|Carboplatin|carboplatin|mesh-list
64735726|NCT01936974|Oxaliplatin|oxaliplatin|mesh-list
64735727|NCT01936974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64735728|NCT01936974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735729|NCT01936974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64735730|NCT01936974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64735731|NCT01936974|Growth Substances|growth substances|mesh-ancestor
64735756|NCT01959516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64735758|NCT01979016|Dermatologic Agents|dermatologic agents|mesh-ancestor
64735759|NCT01935336|Ponatinib|ponatinib|mesh-list
64735760|NCT01935336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989025|NCT00331786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64735781|NCT04411212|Immunologic Factors|immunologic factors|mesh-ancestor
64735814|NCT01957644|Antimetabolites|antimetabolites|mesh-ancestor
64735815|NCT01957644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735816|NCT01957644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735817|NCT01957644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735819|NCT01931202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64735820|NCT01931202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64735821|NCT01931202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64735822|NCT01931202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736634|NCT00755261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736635|NCT00755261|Growth Inhibitors|growth inhibitors|mesh-ancestor
64736636|NCT00755261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64736637|NCT00755261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64736638|NCT00755261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64736639|NCT00755261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736640|NCT00755261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736641|NCT03724877|Cholinergic Agents|cholinergic agents|mesh-list
64736642|NCT03724877|Muscarinic Antagonists|muscarinic antagonists|mesh-list
64736643|NCT03724877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64736644|NCT03724877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736645|NCT03724877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736646|NCT03724877|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65279676|NCT00640094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65279677|NCT04183634|Rotigotine|rotigotine|mesh-list
65279678|NCT04183634|Dopamine Agonists|dopamine agonists|mesh-ancestor
65279679|NCT04183634|Dopamine Agents|dopamine agents|mesh-ancestor
65279680|NCT04183634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65279681|NCT04183634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279682|NCT04183634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279683|NCT02804633|Acetaminophen|acetaminophen|mesh-list
65279684|NCT02804633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65279685|NCT02804633|Analgesics|analgesics|mesh-ancestor
65279686|NCT02804633|Sensory System Agents|sensory system agents|mesh-ancestor
65279687|NCT02804633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64736647|NCT00746603|Simvastatin|simvastatin|mesh-list
64736648|NCT00746603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64736649|NCT00746603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64736650|NCT00746603|Antimetabolites|antimetabolites|mesh-ancestor
64736651|NCT00746603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736652|NCT00746603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64736653|NCT00746603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64515183|NCT04494412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515184|NCT04494412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516726|NCT02346916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516727|NCT02346916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516728|NCT02458482|Albuterol|albuterol|mesh-list
64516729|NCT02458482|Ipratropium|ipratropium|mesh-list
64516730|NCT02458482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64516731|NCT02458482|Autonomic Agents|autonomic agents|mesh-ancestor
64516732|NCT02458482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516733|NCT02458482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516734|NCT02458482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64516735|NCT02458482|Respiratory System Agents|respiratory system agents|mesh-ancestor
64516736|NCT02458482|Tocolytic Agents|tocolytic agents|mesh-ancestor
64516737|NCT02458482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64516738|NCT02458482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64516739|NCT02458482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64516740|NCT02458482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64516741|NCT02458482|Adrenergic Agents|adrenergic agents|mesh-ancestor
64516742|NCT02458482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64516743|NCT02458482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516744|NCT02458482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64516745|NCT02458482|Cholinergic Agents|cholinergic agents|mesh-ancestor
64516746|NCT03273192|Adalimumab|adalimumab|mesh-list
64516747|NCT03273192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64516748|NCT03273192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64516749|NCT03269604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64516750|NCT03269604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64516751|NCT03269604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64516752|NCT03269604|Antitubercular Agents|antitubercular agents|mesh-ancestor
64516754|NCT02349178|Etoposide|etoposide|mesh-list
64516755|NCT02349178|Clofarabine|clofarabine|mesh-list
64516756|NCT02349178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64516757|NCT02349178|Immunologic Factors|immunologic factors|mesh-ancestor
64471676|NCT04267887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64516758|NCT02349178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516759|NCT02349178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64516760|NCT02349178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64516761|NCT02349178|Alkylating Agents|alkylating agents|mesh-ancestor
64516762|NCT02349178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516763|NCT02349178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516764|NCT02349178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64516765|NCT02349178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65279688|NCT02804633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279689|NCT02804633|Antipyretics|antipyretics|mesh-ancestor
65279690|NCT02807441|Aspirin|aspirin|mesh-list
65279691|NCT02807441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65279692|NCT02807441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65279693|NCT02807441|Analgesics|analgesics|mesh-ancestor
65279694|NCT02807441|Sensory System Agents|sensory system agents|mesh-ancestor
65279695|NCT02807441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65279696|NCT02807441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279697|NCT02807441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65279698|NCT02807441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65279699|NCT02807441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65279700|NCT02807441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65279701|NCT02807441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279702|NCT02807441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65279703|NCT02807441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65279704|NCT02807441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279705|NCT02807441|Antipyretics|antipyretics|mesh-ancestor
65279706|NCT02807285|Ocrelizumab|ocrelizumab|mesh-list
65279707|NCT02807285|Immunologic Factors|immunologic factors|mesh-ancestor
65279708|NCT02807285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279709|NCT02682680|Ezetimibe|ezetimibe|mesh-list
65279710|NCT02682680|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65029703|NCT02112916|Mercaptopurine|mercaptopurine|mesh-list
64516766|NCT02349178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64516767|NCT02349178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64516768|NCT02349178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64516769|NCT02349178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64516770|NCT02349178|Antimetabolites|antimetabolites|mesh-ancestor
64516771|NCT03970356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64516772|NCT03970356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64516773|NCT05075460|Azacitidine|azacitidine|mesh-list
64516774|NCT05075460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64516775|NCT05075460|Antimetabolites|antimetabolites|mesh-ancestor
64518912|NCT00071721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518913|NCT00071721|Antimanic Agents|antimanic agents|mesh-ancestor
64518914|NCT00071721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64518915|NCT00071721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64518916|NCT00071721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64518917|NCT03107208|Insulin Glargine|insulin glargine|mesh-list
64518918|NCT03107208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64518919|NCT03107208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518920|NCT05606055|Tenofovir|tenofovir|mesh-list
64518921|NCT05606055|Emtricitabine|emtricitabine|mesh-list
64518922|NCT05606055|Antiviral Agents|antiviral agents|mesh-ancestor
64518923|NCT05606055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64518924|NCT05606055|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64518925|NCT05606055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64518926|NCT05606055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736755|NCT00616343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64518961|NCT01896609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279712|NCT02682680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65279713|NCT02682680|Antimetabolites|antimetabolites|mesh-ancestor
65279714|NCT02682680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279715|NCT02682680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65279716|NCT02807207|Moxifloxacin|moxifloxacin|mesh-list
65279717|NCT02807207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65279718|NCT02807207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65279719|NCT02807207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65279720|NCT02807207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65279721|NCT02807207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279722|NCT02807207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279723|NCT02807207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279724|NCT02682758|Xenon|xenon|mesh-list
65279725|NCT02682758|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65279726|NCT02682758|Anesthetics, General|anesthetics, general|mesh-ancestor
65279727|NCT02682758|Anesthetics|anesthetics|mesh-ancestor
65279728|NCT02682758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65279729|NCT02682758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279730|NCT02682524|Aceclofenac|aceclofenac|mesh-list
65279731|NCT02682524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65279732|NCT02682524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65279733|NCT02682524|Analgesics|analgesics|mesh-ancestor
65279734|NCT02682524|Sensory System Agents|sensory system agents|mesh-ancestor
64518962|NCT01896609|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64518963|NCT01896609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64519006|NCT00158379|Antimitotic Agents|antimitotic agents|mesh-ancestor
64519007|NCT00158379|Mitosis Modulators|mitosis modulators|mesh-ancestor
64519008|NCT00158379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519010|NCT03228498|Lipotropic Agents|lipotropic agents|mesh-ancestor
64519011|NCT03228498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64519012|NCT03228498|Antimetabolites|antimetabolites|mesh-ancestor
64519013|NCT03228498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519381|NCT04484688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64519382|NCT04484688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519383|NCT04484688|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64519384|NCT04484688|Protease Inhibitors|protease inhibitors|mesh-ancestor
64519385|NCT04484688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519386|NCT00082017|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
64519387|NCT00082017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519388|NCT00082017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64519389|NCT00082017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64989195|NCT05831566|Budesonide|budesonide|mesh-list
64519409|NCT02451306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64519410|NCT02451306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64519411|NCT02451306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64519412|NCT02451306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64519413|NCT02451306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519414|NCT00167661|Alemtuzumab|alemtuzumab|mesh-list
64519415|NCT00167661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64519416|NCT00167661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279735|NCT02682524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65279736|NCT02682524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279737|NCT02682524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65279738|NCT02682524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65279739|NCT04183556|Naproxen|naproxen|mesh-list
65279740|NCT04183556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65279741|NCT04183556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65279742|NCT04183556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65279743|NCT04183556|Analgesics|analgesics|mesh-ancestor
65279744|NCT04183556|Sensory System Agents|sensory system agents|mesh-ancestor
65279745|NCT04183556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65279746|NCT04183556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279747|NCT04183556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65279748|NCT04183556|Gout Suppressants|gout suppressants|mesh-ancestor
65279749|NCT04183556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65279750|NCT04183556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279751|NCT04183556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279752|NCT00640952|Acamprosate|acamprosate|mesh-list
65279753|NCT00640952|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65279754|NCT02684240|Nitazoxanide|nitazoxanide|mesh-list
65279755|NCT02684240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65279756|NCT02684240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65279757|NCT02807051|Clarithromycin|clarithromycin|mesh-list
65279758|NCT02807051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65279759|NCT02807051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65279760|NCT02807051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65279761|NCT02807051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279762|NCT02807051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279763|NCT02807051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65279764|NCT02807051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64519417|NCT03220542|Amoxicillin|amoxicillin|mesh-list
64519418|NCT03220542|Clarithromycin|clarithromycin|mesh-list
64519419|NCT03220542|Sulforaphane|sulforaphane|mesh-list
64519420|NCT03220542|Esomeprazole|esomeprazole|mesh-list
64519421|NCT03220542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64519422|NCT03220542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64519423|NCT03220542|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64519424|NCT03220542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64519425|NCT03220542|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64519426|NCT03220542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519427|NCT03220542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519428|NCT03220542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64519429|NCT03220542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65279765|NCT02684084|Dexamethasone|dexamethasone|mesh-list
65279766|NCT02684084|Ranibizumab|ranibizumab|mesh-list
65279767|NCT02684084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65279768|NCT02684084|Antiemetics|antiemetics|mesh-ancestor
65279769|NCT02684084|Autonomic Agents|autonomic agents|mesh-ancestor
65279770|NCT02684084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64732137|NCT00004039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519430|NCT03220542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64519431|NCT03220542|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64519432|NCT03220542|Protective Agents|protective agents|mesh-ancestor
64519433|NCT03220542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519434|NCT03220542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519436|NCT03220152|Emtricitabine|emtricitabine|mesh-list
64519437|NCT03220152|Antiviral Agents|antiviral agents|mesh-ancestor
64519438|NCT03220152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64519439|NCT03220152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64519440|NCT03220152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64519441|NCT03220152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519442|NCT03220152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519443|NCT03220152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64519444|NCT03220152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64519764|NCT02404168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64519772|NCT04733937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519773|NCT02051452|Methylphenidate|methylphenidate|mesh-list
64519774|NCT02051452|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64520115|NCT03225690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520117|NCT03225690|Sensory System Agents|sensory system agents|mesh-ancestor
64520306|NCT03203070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64520307|NCT03203070|Antipyretics|antipyretics|mesh-ancestor
64520308|NCT03209856|Vitamin D|vitamin d|mesh-list
64484850|NCT01959503|Hemostatics|hemostatics|mesh-ancestor
64520309|NCT03209856|Calcitriol|calcitriol|mesh-list
64520310|NCT03209856|Vitamins|vitamins|mesh-ancestor
64520311|NCT03209856|Micronutrients|micronutrients|mesh-ancestor
64520312|NCT03209856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520313|NCT03209856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64520314|NCT03209856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64520315|NCT03209856|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64520316|NCT03209856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64520317|NCT03209856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520318|NCT03209856|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64520319|NCT02413918|Iloperidone|iloperidone|mesh-list
64520320|NCT02413918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64520321|NCT02413918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64520322|NCT02413918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64520323|NCT02413918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520324|NCT02413918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64520325|NCT03209622|Nicotine|nicotine|mesh-list
64520326|NCT03209622|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64520327|NCT03209622|Autonomic Agents|autonomic agents|mesh-ancestor
64520328|NCT03209622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520329|NCT03209622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520330|NCT03209622|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64520331|NCT03209622|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64520332|NCT03209622|Cholinergic Agents|cholinergic agents|mesh-ancestor
64520333|NCT03209622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64520334|NCT03209622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520335|NCT00354874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64520336|NCT00354874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64520337|NCT00354874|Autonomic Agents|autonomic agents|mesh-ancestor
64520338|NCT00354874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520463|NCT03208764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64520464|NCT03208764|Autonomic Agents|autonomic agents|mesh-ancestor
64520465|NCT03208764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520466|NCT03208764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520467|NCT03208764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64520468|NCT03208764|Respiratory System Agents|respiratory system agents|mesh-ancestor
64521223|NCT03197298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279771|NCT02684084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279772|NCT02684084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65279773|NCT02684084|Glucocorticoids|glucocorticoids|mesh-ancestor
65279774|NCT02684084|Hormones|hormones|mesh-ancestor
65279775|NCT02684084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65279776|NCT02684084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64521225|NCT00357448|Interleukin-2|interleukin-2|mesh-list
64521226|NCT00357448|Denileukin diftitox|denileukin diftitox|mesh-list
64521227|NCT00357448|Immunotoxins|immunotoxins|mesh-list
64521228|NCT00357448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521229|NCT00357448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64521230|NCT00357448|Analgesics|analgesics|mesh-ancestor
64521231|NCT00357448|Sensory System Agents|sensory system agents|mesh-ancestor
64521232|NCT00357448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64521233|NCT00357448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521234|NCT00357448|Immunologic Factors|immunologic factors|mesh-ancestor
64521235|NCT05715658|Dabigatran|dabigatran|mesh-list
64521236|NCT05715658|Antithrombins|antithrombins|mesh-ancestor
64521237|NCT05715658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64521238|NCT05715658|Protease Inhibitors|protease inhibitors|mesh-ancestor
64521239|NCT05715658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521240|NCT05715658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521241|NCT05715658|Anticoagulants|anticoagulants|mesh-ancestor
64521242|NCT02443194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64521243|NCT02443194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64471677|NCT04267887|Antioxidants|antioxidants|mesh-ancestor
64521244|NCT02443194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64521280|NCT00357604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64521281|NCT00357604|Antiviral Agents|antiviral agents|mesh-ancestor
64521477|NCT00358228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64521478|NCT00358228|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
64521479|NCT00358228|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64521480|NCT00358228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64521481|NCT00358228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521482|NCT00358228|Hormones|hormones|mesh-ancestor
64521483|NCT00358228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64521484|NCT00358228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521485|NCT05710198|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64521486|NCT05710198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64521634|NCT00030147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521635|NCT00030147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64521636|NCT00030147|Hormone Antagonists|hormone antagonists|mesh-ancestor
64989369|NCT05830071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64521681|NCT02434614|Tubulin Modulators|tubulin modulators|mesh-ancestor
64521682|NCT02434614|Antimitotic Agents|antimitotic agents|mesh-ancestor
64521683|NCT02434614|Mitosis Modulators|mitosis modulators|mesh-ancestor
64521684|NCT02434614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521685|NCT02434614|Antimetabolites|antimetabolites|mesh-ancestor
64521686|NCT02434614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64521687|NCT02434614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64521688|NCT02434614|Immunologic Factors|immunologic factors|mesh-ancestor
64521689|NCT02434614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521691|NCT05720260|Fulvestrant|fulvestrant|mesh-list
64521692|NCT05720260|Goserelin|goserelin|mesh-list
64521693|NCT05720260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64521694|NCT05720260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521695|NCT05720260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64521696|NCT05720260|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64521697|NCT05720260|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64521698|NCT05720260|Hormone Antagonists|hormone antagonists|mesh-ancestor
64521699|NCT05720260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64521700|NCT05720260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521701|NCT05720026|Docetaxel|docetaxel|mesh-list
64521702|NCT05720026|Trastuzumab|trastuzumab|mesh-list
64521703|NCT05720026|Pertuzumab|pertuzumab|mesh-list
64521704|NCT05720026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521705|NCT05720026|Tubulin Modulators|tubulin modulators|mesh-ancestor
65279777|NCT02684084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279778|NCT02684084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65279779|NCT02684084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65279780|NCT02684084|Growth Substances|growth substances|mesh-ancestor
65279781|NCT02684084|Growth Inhibitors|growth inhibitors|mesh-ancestor
65279782|NCT02684318|Olaparib|olaparib|mesh-list
64521706|NCT05720026|Antimitotic Agents|antimitotic agents|mesh-ancestor
64521707|NCT05720026|Mitosis Modulators|mitosis modulators|mesh-ancestor
64521708|NCT05720026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521709|NCT05720026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64521710|NCT04483674|Tenofovir|tenofovir|mesh-list
64521729|NCT02438982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521730|NCT02438982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521818|NCT05625802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521819|NCT05625802|Sensory System Agents|sensory system agents|mesh-ancestor
64521820|NCT05625802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64521822|NCT03187548|Caseins|caseins|mesh-list
64521823|NCT03187548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64521824|NCT03187548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521825|NCT03187548|Chelating Agents|chelating agents|mesh-ancestor
64521826|NCT03187548|Sequestering Agents|sequestering agents|mesh-ancestor
64521827|NCT03187548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521828|NCT02042326|Sirolimus|sirolimus|mesh-list
64521829|NCT02042326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64521830|NCT02042326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64521831|NCT02042326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64521832|NCT02042326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521833|NCT02042326|Antifungal Agents|antifungal agents|mesh-ancestor
64521834|NCT02042326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64521835|NCT02042326|Immunologic Factors|immunologic factors|mesh-ancestor
64521836|NCT02042326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521837|NCT05718544|Sufentanil|sufentanil|mesh-list
64521838|NCT05718544|Dexmedetomidine|dexmedetomidine|mesh-list
64521839|NCT05718544|Esketamine|esketamine|mesh-list
64521840|NCT05718544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64521841|NCT05718544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64521842|NCT05718544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521843|NCT05718544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64521844|NCT05718544|Analgesics|analgesics|mesh-ancestor
64521845|NCT05718544|Sensory System Agents|sensory system agents|mesh-ancestor
64521846|NCT05718544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64521847|NCT05718544|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64521848|NCT05718544|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64521849|NCT05718544|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64521850|NCT05718544|Adrenergic Agents|adrenergic agents|mesh-ancestor
64521851|NCT05718544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64523191|NCT01704287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523192|NCT01704287|Tubulin Modulators|tubulin modulators|mesh-ancestor
64523193|NCT01704287|Antimitotic Agents|antimitotic agents|mesh-ancestor
64523482|NCT02061514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64523483|NCT03183492|Vaccines|vaccines|mesh-list
64523484|NCT03183492|Immunologic Factors|immunologic factors|mesh-ancestor
64523485|NCT03183492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523486|NCT02424318|Topiramate|topiramate|mesh-list
64523487|NCT02424318|Anticonvulsants|anticonvulsants|mesh-ancestor
64523488|NCT02424318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64523489|NCT02424318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523490|NCT03179280|Insulin|insulin|mesh-list
64523491|NCT03179280|Insulin Aspart|insulin aspart|mesh-list
64523492|NCT03179280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64523493|NCT03179280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523494|NCT01681433|Prednisone|prednisone|mesh-list
64523495|NCT01681433|Abiraterone Acetate|abiraterone acetate|mesh-list
64523496|NCT01681433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64523497|NCT01681433|Glucocorticoids|glucocorticoids|mesh-ancestor
64523498|NCT01681433|Hormones|hormones|mesh-ancestor
64523499|NCT01681433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64523855|NCT02414490|Immunologic Factors|immunologic factors|mesh-ancestor
64523856|NCT02414490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523857|NCT01590017|Cisplatin|cisplatin|mesh-list
65279783|NCT02684318|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65279784|NCT02684318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279785|NCT02684318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279786|NCT02684318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279788|NCT02806817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65279789|NCT02806817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279790|NCT02806817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65279791|NCT02806817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65279792|NCT02806817|Growth Substances|growth substances|mesh-ancestor
65279793|NCT02806817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279794|NCT02806817|Growth Inhibitors|growth inhibitors|mesh-ancestor
65279795|NCT04182854|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65279796|NCT04182854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65279797|NCT04182854|Diuretics|diuretics|mesh-ancestor
65279798|NCT04182854|Natriuretic Agents|natriuretic agents|mesh-ancestor
65279799|NCT04182854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279800|NCT04182854|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65279801|NCT04182854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65279802|NCT04182854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279803|NCT02680808|Olorofim|olorofim|mesh-list
65279804|NCT02680808|Midazolam|midazolam|mesh-list
65279805|NCT02680808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65279806|NCT02680808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65279807|NCT02680808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65279808|NCT02680808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279809|NCT02680808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65279810|NCT02680808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65279811|NCT02680808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65279812|NCT02680808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64523858|NCT01590017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523859|NCT01700621|Vaccines|vaccines|mesh-list
64523860|NCT01700621|Immunologic Factors|immunologic factors|mesh-ancestor
64523861|NCT01700621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523862|NCT03178500|Clomiphene|clomiphene|mesh-list
64523863|NCT03178500|Enclomiphene|enclomiphene|mesh-list
64523864|NCT03178500|Zuclomiphene|zuclomiphene|mesh-list
64523865|NCT03178500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64523866|NCT03178500|Hormone Antagonists|hormone antagonists|mesh-ancestor
64523867|NCT03178500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64523868|NCT03178500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523869|NCT03178500|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64523888|NCT01699685|Glycopyrrolate|glycopyrrolate|mesh-list
64523889|NCT01699685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65279813|NCT02680808|Anesthetics, General|anesthetics, general|mesh-ancestor
65279814|NCT02680808|Anesthetics|anesthetics|mesh-ancestor
65279815|NCT02680808|GABA Modulators|gaba modulators|mesh-ancestor
65279816|NCT02680808|GABA Agents|gaba agents|mesh-ancestor
65279817|NCT02680808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65279818|NCT02680808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279819|NCT02680808|Antifungal Agents|antifungal agents|mesh-ancestor
65279820|NCT02680808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65279821|NCT05663684|Proxymetacaine|proxymetacaine|mesh-list
65279822|NCT05663684|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65279823|NCT05663684|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65279824|NCT05663684|Anesthetics, Local|anesthetics, local|mesh-ancestor
65279825|NCT05663684|Anesthetics|anesthetics|mesh-ancestor
65279826|NCT05663684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65279827|NCT05663684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279828|NCT05663684|Sensory System Agents|sensory system agents|mesh-ancestor
65279829|NCT05663684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65279830|NCT04004819|Rituximab|rituximab|mesh-list
65279831|NCT04004819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65279832|NCT04004819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279833|NCT04004819|Immunologic Factors|immunologic factors|mesh-ancestor
65279834|NCT04004819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279835|NCT04004819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65279836|NCT00641654|Interferons|interferons|mesh-list
65279837|NCT00641654|Ribavirin|ribavirin|mesh-list
65279838|NCT00641654|Interferon-alpha|interferon-alpha|mesh-list
65279839|NCT00641654|Interferon alpha-2|interferon alpha-2|mesh-list
65279840|NCT00641654|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65279841|NCT00641654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279842|NCT00641654|Antiviral Agents|antiviral agents|mesh-ancestor
65279843|NCT00641654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65029856|NCT01359956|Alkylating Agents|alkylating agents|mesh-ancestor
65279844|NCT00641654|Antimetabolites|antimetabolites|mesh-ancestor
64523890|NCT01699685|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64523891|NCT01699685|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64523892|NCT01699685|Cholinergic Agents|cholinergic agents|mesh-ancestor
64523893|NCT01699685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64523894|NCT01699685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523895|NCT01699685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524096|NCT02452060|Analgesics|analgesics|mesh-ancestor
64524097|NCT02452060|Sensory System Agents|sensory system agents|mesh-ancestor
64524098|NCT02452060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524099|NCT02452060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029857|NCT01359956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029874|NCT01306045|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65029875|NCT01306045|Sunitinib|sunitinib|mesh-list
65029876|NCT01306045|Lapatinib|lapatinib|mesh-list
65029877|NCT01306045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029878|NCT01306045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65029879|NCT01306045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422476|NCT05405725|Denosumab|denosumab|mesh-list
64422477|NCT05405725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64422478|NCT05405725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732213|NCT00003727|Immunologic Factors|immunologic factors|mesh-ancestor
65029880|NCT01306045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029881|NCT01306045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65029882|NCT01306045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65029883|NCT01306045|Growth Substances|growth substances|mesh-ancestor
65029884|NCT01306045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029885|NCT01306045|Growth Inhibitors|growth inhibitors|mesh-ancestor
65029886|NCT01198067|Pomalidomide|pomalidomide|mesh-list
65279845|NCT00641654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524100|NCT02452060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64524101|NCT02452060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64524102|NCT02452060|Anesthetics, General|anesthetics, general|mesh-ancestor
64524103|NCT02452060|Anesthetics|anesthetics|mesh-ancestor
64524104|NCT02452060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64524105|NCT02452060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64524106|NCT02452060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64525931|NCT00367822|Ropinirole|ropinirole|mesh-list
64525932|NCT00367822|Lisuride|lisuride|mesh-list
64525933|NCT00367822|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64526217|NCT02653144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526218|NCT02653144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64526219|NCT02653144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64526220|NCT02653144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64526221|NCT02653144|Analgesics|analgesics|mesh-ancestor
64526222|NCT02653144|Sensory System Agents|sensory system agents|mesh-ancestor
64526223|NCT02653144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64526224|NCT02653144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64526225|NCT02653144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64526226|NCT02653144|Adrenergic Agents|adrenergic agents|mesh-ancestor
64526744|NCT04116437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526746|NCT04103476|Estrogens|estrogens|mesh-list
64526747|NCT04103476|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64526748|NCT04103476|Hormones|hormones|mesh-ancestor
64989616|NCT05743270|Nivolumab|nivolumab|mesh-list
64526766|NCT01566149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64527022|NCT03162120|Flecainide|flecainide|mesh-list
64527169|NCT01558271|Hormones|hormones|mesh-ancestor
64471682|NCT04267887|Anabolic Agents|anabolic agents|mesh-ancestor
64471683|NCT04266730|Pembrolizumab|pembrolizumab|mesh-list
64527389|NCT01581307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64527756|NCT03164382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527757|NCT03164382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64527758|NCT03164382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527759|NCT03164382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527761|NCT03161340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65279846|NCT00641654|Immunologic Factors|immunologic factors|mesh-ancestor
65279847|NCT00641654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279849|NCT02826434|Poly ICLC|poly iclc|mesh-list
65279850|NCT02826434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65279851|NCT02826434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279852|NCT02826434|Interferon Inducers|interferon inducers|mesh-ancestor
65279853|NCT02826434|Immunologic Factors|immunologic factors|mesh-ancestor
65279854|NCT02826434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279855|NCT00549601|Rivastigmine|rivastigmine|mesh-list
65279856|NCT00549601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65279857|NCT00549601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279858|NCT00549601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279859|NCT00549601|Cholinergic Agents|cholinergic agents|mesh-ancestor
65279860|NCT00549601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65279861|NCT00549601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732221|NCT00003727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64527762|NCT03161340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64527763|NCT03161340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64527764|NCT03161340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527765|NCT03161340|Antifungal Agents|antifungal agents|mesh-ancestor
64527766|NCT03161340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64528244|NCT01522235|Immunologic Factors|immunologic factors|mesh-ancestor
64528245|NCT01522235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528246|NCT00125931|Pentazocine|pentazocine|mesh-list
64528247|NCT00125931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64528248|NCT00125931|Narcotics|narcotics|mesh-ancestor
64528249|NCT00125931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64528250|NCT00125931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528251|NCT00125931|Analgesics|analgesics|mesh-ancestor
64528252|NCT00125931|Sensory System Agents|sensory system agents|mesh-ancestor
64528295|NCT00130923|Risperidone|risperidone|mesh-list
64528296|NCT00130923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64528297|NCT00130923|Serotonin Agents|serotonin agents|mesh-ancestor
64528298|NCT00130923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64528299|NCT00130923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528300|NCT00130923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528301|NCT00130923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64528302|NCT00130923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64528303|NCT00130923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64528304|NCT00130923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64528305|NCT00130923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64528318|NCT00272337|Sensory System Agents|sensory system agents|mesh-ancestor
64528319|NCT00272337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64528320|NCT00272337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528321|NCT00272337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64528322|NCT00272337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64528323|NCT00272337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64528324|NCT00272337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64528325|NCT00272337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528326|NCT00272337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64528327|NCT00272337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64528328|NCT00272337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528330|NCT01535053|Calcium, Dietary|calcium, dietary|mesh-list
64528331|NCT01535053|Leucovorin|leucovorin|mesh-list
64528332|NCT01535053|Folic Acid|folic acid|mesh-list
64528333|NCT01535053|Dactinomycin|dactinomycin|mesh-list
64528334|NCT01535053|Methotrexate|methotrexate|mesh-list
64528335|NCT01535053|Calcium|calcium|mesh-list
64528336|NCT01535053|Levoleucovorin|levoleucovorin|mesh-list
65279862|NCT00549601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65279863|NCT00549601|Protective Agents|protective agents|mesh-ancestor
65279864|NCT02806349|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
65279865|NCT02806349|Cathartics|cathartics|mesh-ancestor
65279866|NCT02806349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65279867|NCT04184492|Insulin|insulin|mesh-list
65279868|NCT04184492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65279869|NCT04184492|Insulin Aspart|insulin aspart|mesh-list
65279870|NCT04184492|Insulin, Long-Acting|insulin, long-acting|mesh-list
65279871|NCT04184492|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65279872|NCT04184492|Biphasic Insulins|biphasic insulins|mesh-list
65279873|NCT04184492|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65279874|NCT04184492|Insulin, Isophane|insulin, isophane|mesh-list
65279875|NCT04184492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65279876|NCT04184492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279877|NCT02806115|Acetic Acid|acetic acid|mesh-list
65279878|NCT02806115|Retinol acetate|retinol acetate|mesh-list
64528337|NCT01535053|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64528338|NCT01535053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528339|NCT01535053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64528340|NCT01535053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64528341|NCT01535053|Abortifacient Agents|abortifacient agents|mesh-ancestor
64528343|NCT01535053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64528344|NCT01535053|Antimetabolites|antimetabolites|mesh-ancestor
64528345|NCT01535053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528346|NCT01535053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528347|NCT01535053|Dermatologic Agents|dermatologic agents|mesh-ancestor
64471684|NCT04266730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64528348|NCT01535053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528349|NCT01535053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64528350|NCT01535053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64528351|NCT01535053|Immunologic Factors|immunologic factors|mesh-ancestor
64528352|NCT01535053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64528353|NCT01535053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64528354|NCT01535053|Antidotes|antidotes|mesh-ancestor
64528355|NCT01535053|Protective Agents|protective agents|mesh-ancestor
64528384|NCT01578499|Bexarotene|bexarotene|mesh-list
64528385|NCT01578499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64528386|NCT01578499|Abortifacient Agents|abortifacient agents|mesh-ancestor
64528387|NCT01578499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64714114|NCT03043274|Purinergic Agents|purinergic agents|mesh-ancestor
64528388|NCT01578499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528389|NCT01578499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64528390|NCT01578499|Antimetabolites|antimetabolites|mesh-ancestor
64528391|NCT01578499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528392|NCT01578499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528393|NCT01578499|Dermatologic Agents|dermatologic agents|mesh-ancestor
64528394|NCT01578499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528549|NCT01664910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64528550|NCT01664910|Antimetabolites|antimetabolites|mesh-ancestor
64528551|NCT01664910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528552|NCT01664910|Dermatologic Agents|dermatologic agents|mesh-ancestor
64528553|NCT01664910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528554|NCT01664910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64528555|NCT01664910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64528556|NCT01664910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65279879|NCT02806115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65279880|NCT02806115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65279881|NCT02806115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65279882|NCT02806115|Immunologic Factors|immunologic factors|mesh-ancestor
65279883|NCT02806115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279884|NCT02806115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65279885|NCT02806115|Protective Agents|protective agents|mesh-ancestor
65279886|NCT02806115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279887|NCT02682134|Dexamethasone|dexamethasone|mesh-list
65279888|NCT02682134|Dexamethasone acetate|dexamethasone acetate|mesh-list
65279889|NCT02682134|Lidocaine|lidocaine|mesh-list
65279890|NCT02682134|BB 1101|bb 1101|mesh-list
65279891|NCT02682134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65279892|NCT02682134|Antiemetics|antiemetics|mesh-ancestor
65279893|NCT02682134|Autonomic Agents|autonomic agents|mesh-ancestor
65279894|NCT02682134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65279895|NCT02682134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279896|NCT02682134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65279897|NCT02682134|Glucocorticoids|glucocorticoids|mesh-ancestor
65279898|NCT02682134|Hormones|hormones|mesh-ancestor
65279899|NCT02682134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65279900|NCT02682134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65279901|NCT02682134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279902|NCT02682134|Protease Inhibitors|protease inhibitors|mesh-ancestor
65279903|NCT02682134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732254|NCT00004063|Antiviral Agents|antiviral agents|mesh-ancestor
64528557|NCT01664910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64528558|NCT01664910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64528559|NCT01664910|Alkylating Agents|alkylating agents|mesh-ancestor
64528560|NCT01664910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64528562|NCT00133575|Immunologic Factors|immunologic factors|mesh-ancestor
64528563|NCT00133575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528564|NCT00134043|Vorinostat|vorinostat|mesh-list
64528565|NCT00134043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528566|NCT00134043|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64528567|NCT00134043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64989793|NCT05675410|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64530127|NCT05799820|Bevacizumab|bevacizumab|mesh-list
64530128|NCT05799820|Capecitabine|capecitabine|mesh-list
64530129|NCT05799820|Oxaliplatin|oxaliplatin|mesh-list
64530130|NCT05799820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64294798|NCT02048293|Remifentanil|remifentanil|mesh-list
64530217|NCT05799079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530218|NCT05799079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530220|NCT05799053|Antiemetics|antiemetics|mesh-ancestor
64530221|NCT05799053|Autonomic Agents|autonomic agents|mesh-ancestor
64530222|NCT05799053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714117|NCT03043274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530223|NCT05799053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530224|NCT05799053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64530225|NCT05799053|Parasympatholytics|parasympatholytics|mesh-ancestor
65279904|NCT02682134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279905|NCT02682134|Anesthetics, Local|anesthetics, local|mesh-ancestor
65279906|NCT02682134|Anesthetics|anesthetics|mesh-ancestor
65279907|NCT02682134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65279908|NCT02682134|Sensory System Agents|sensory system agents|mesh-ancestor
65279909|NCT02682134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65279910|NCT02682134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65279911|NCT02682134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65279912|NCT02682134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65279913|NCT04236323|Remifentanil|remifentanil|mesh-list
65279914|NCT04236323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65279915|NCT04236323|Narcotics|narcotics|mesh-ancestor
65279916|NCT04236323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65279917|NCT04236323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029930|NCT00775749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65029931|NCT00775749|Cholinergic Agents|cholinergic agents|mesh-ancestor
65279919|NCT04236323|Sensory System Agents|sensory system agents|mesh-ancestor
65279920|NCT04236323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65279921|NCT04206163|Edotreotide|edotreotide|mesh-list
65279922|NCT04206163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65279923|NCT04206163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279924|NCT00909974|Micronutrients|micronutrients|mesh-list
65279925|NCT00909974|Trace Elements|trace elements|mesh-list
65279926|NCT00909974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279927|NCT05300347|Adenosine|adenosine|mesh-list
65279928|NCT05300347|Analgesics|analgesics|mesh-ancestor
65279929|NCT05300347|Sensory System Agents|sensory system agents|mesh-ancestor
65279930|NCT05300347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64732283|NCT00003163|Melphalan|melphalan|mesh-list
64530226|NCT05798936|Ethanol|ethanol|mesh-list
64530227|NCT05798936|Polidocanol|polidocanol|mesh-list
64530228|NCT05798936|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64530229|NCT05798936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64530230|NCT05798936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64530231|NCT05798936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530232|NCT05798936|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64530233|NCT05798936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64530234|NCT05798871|Erythritol|erythritol|mesh-list
64530235|NCT05798871|Vasodilator Agents|vasodilator agents|mesh-ancestor
64530236|NCT05798819|Paclitaxel|paclitaxel|mesh-list
64530237|NCT05798819|Bevacizumab|bevacizumab|mesh-list
64530238|NCT05798819|Carboplatin|carboplatin|mesh-list
64530239|NCT05798819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64530240|NCT05798819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530715|NCT05327023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530716|NCT05327023|Antifungal Agents|antifungal agents|mesh-ancestor
64530717|NCT05323786|Anesthetics|anesthetics|mesh-list
65279931|NCT05300347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279932|NCT05300347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65279933|NCT05300347|Vasodilator Agents|vasodilator agents|mesh-ancestor
65279934|NCT05300347|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65279935|NCT05300347|Purinergic Agonists|purinergic agonists|mesh-ancestor
65279936|NCT05300347|Purinergic Agents|purinergic agents|mesh-ancestor
65279937|NCT05300347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65279938|NCT05300347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279939|NCT04011241|Itraconazole|itraconazole|mesh-list
65279940|NCT04011241|Antifungal Agents|antifungal agents|mesh-ancestor
65279941|NCT04011241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65279942|NCT04011241|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65279943|NCT04011241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64732309|NCT00004087|Antibodies|antibodies|mesh-list
64732310|NCT00004087|Immunoglobulins|immunoglobulins|mesh-list
64732311|NCT00004087|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64732312|NCT00004087|Immunologic Factors|immunologic factors|mesh-ancestor
64732315|NCT00003757|Rituximab|rituximab|mesh-list
64530718|NCT05323786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64530719|NCT05323786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530720|NCT05304767|Xanomeline|xanomeline|mesh-list
64530721|NCT05304767|Trospium chloride|trospium chloride|mesh-list
64530722|NCT05304767|Parasympatholytics|parasympatholytics|mesh-ancestor
64530723|NCT05304767|Autonomic Agents|autonomic agents|mesh-ancestor
64530724|NCT05304767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64530725|NCT05304767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530726|NCT05304767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64530727|NCT05304767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64530728|NCT05304767|Cholinergic Agents|cholinergic agents|mesh-ancestor
64530729|NCT05304767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64530730|NCT05304767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530731|NCT05304767|Urological Agents|urological agents|mesh-ancestor
64530732|NCT05304767|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64530733|NCT05304767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64530734|NCT05304767|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64530735|NCT05304767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64530736|NCT05301062|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64530749|NCT05256069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64530750|NCT05256069|Vasodilator Agents|vasodilator agents|mesh-ancestor
64530751|NCT05255991|Treprostinil|treprostinil|mesh-list
64530752|NCT05255991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64530753|NCT05254002|Empagliflozin|empagliflozin|mesh-list
64530754|NCT05254002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64530755|NCT05254002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530756|NCT05254002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64530757|NCT05254002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530758|NCT05252416|Carboplatin|carboplatin|mesh-list
64530759|NCT05252416|Fulvestrant|fulvestrant|mesh-list
64530760|NCT05252416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530761|NCT05252416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64530762|NCT05252416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64530763|NCT05252416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64530799|NCT05218733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64532456|NCT02372292|Natriuretic Agents|natriuretic agents|mesh-ancestor
64532457|NCT02372292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532458|NCT02372292|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65279944|NCT04011241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65279945|NCT04011241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279946|NCT04011241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65279947|NCT04011241|Hormone Antagonists|hormone antagonists|mesh-ancestor
65279948|NCT04011241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65279949|NCT04011241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279950|NCT04011241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65279951|NCT00956059|Prednisone|prednisone|mesh-list
65279952|NCT00956059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65279953|NCT00956059|Glucocorticoids|glucocorticoids|mesh-ancestor
65279954|NCT00956059|Hormones|hormones|mesh-ancestor
65279955|NCT00956059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65279956|NCT00956059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279957|NCT00956059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65279958|NCT00956059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279959|NCT04010929|Pemetrexed|pemetrexed|mesh-list
65279960|NCT04010929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279961|NCT04010929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344909|NCT00736346|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64732323|NCT00003175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532459|NCT02372292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64989948|NCT05581589|Immunoconjugates|immunoconjugates|mesh-list
64532486|NCT04438980|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64532487|NCT04438980|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64532488|NCT04438980|Prednisolone|prednisolone|mesh-list
64532489|NCT04438980|Prednisolone acetate|prednisolone acetate|mesh-list
64532490|NCT04438980|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64532491|NCT04438980|Prednisolone phosphate|prednisolone phosphate|mesh-list
64532492|NCT04438980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64532493|NCT04438980|Antiemetics|antiemetics|mesh-ancestor
64532494|NCT04438980|Autonomic Agents|autonomic agents|mesh-ancestor
64532495|NCT04438980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64532496|NCT04438980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532497|NCT04438980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64532498|NCT04438980|Glucocorticoids|glucocorticoids|mesh-ancestor
64532499|NCT04438980|Hormones|hormones|mesh-ancestor
64532500|NCT04438980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64532501|NCT04438980|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64532502|NCT04438980|Protective Agents|protective agents|mesh-ancestor
64532503|NCT04438980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64532504|NCT04438980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532505|NCT03824847|Clarithromycin|clarithromycin|mesh-list
64532506|NCT03824847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64532507|NCT03824847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64989988|NCT05578092|Adagrasib|adagrasib|mesh-list
64533319|NCT01489891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64533320|NCT01489891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64533321|NCT01489891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64533322|NCT01489891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64533323|NCT01489891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64471687|NCT04251533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65279962|NCT04010929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279963|NCT04010929|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65279964|NCT04010929|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65279965|NCT00956215|Aprepitant|aprepitant|mesh-list
65279966|NCT00956215|Fosaprepitant|fosaprepitant|mesh-list
65279967|NCT00956215|Antiemetics|antiemetics|mesh-ancestor
65279968|NCT00956215|Autonomic Agents|autonomic agents|mesh-ancestor
65279969|NCT00956215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65279970|NCT00956215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279971|NCT00956215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64533324|NCT01489891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533325|NCT02342574|Olorofim|olorofim|mesh-list
64533326|NCT02342574|Antifungal Agents|antifungal agents|mesh-ancestor
64533327|NCT02342574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64533658|NCT04175886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533660|NCT02338674|Telbivudine|telbivudine|mesh-list
64533661|NCT02338674|Antiviral Agents|antiviral agents|mesh-ancestor
64533675|NCT02338518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64533676|NCT02338518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533677|NCT02338518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533678|NCT02338518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64533679|NCT01826838|Dasatinib|dasatinib|mesh-list
64533680|NCT01826838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533681|NCT01826838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64533682|NCT01826838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533683|NCT01826838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533684|NCT00365391|Bevacizumab|bevacizumab|mesh-list
64533685|NCT00365391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64533686|NCT00365391|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64533687|NCT00365391|Antibodies|antibodies|mesh-list
64533688|NCT00365391|Immunoglobulins|immunoglobulins|mesh-list
64533689|NCT00365391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64533690|NCT00365391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533691|NCT00365391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64533692|NCT00365391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64533693|NCT00365391|Growth Substances|growth substances|mesh-ancestor
64533694|NCT00365391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533695|NCT00365391|Growth Inhibitors|growth inhibitors|mesh-ancestor
64533696|NCT00365391|Immunologic Factors|immunologic factors|mesh-ancestor
64533697|NCT00365391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64533698|NCT00365391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533699|NCT00365391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533700|NCT03105180|Mannitol|mannitol|mesh-list
64533701|NCT03105180|Sorbitol|sorbitol|mesh-list
64533702|NCT03105180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64533703|NCT03105180|Diuretics|diuretics|mesh-ancestor
64533704|NCT03105180|Natriuretic Agents|natriuretic agents|mesh-ancestor
64533705|NCT03105180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533706|NCT03105180|Cathartics|cathartics|mesh-ancestor
64533707|NCT03105180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64533708|NCT02331030|Ropivacaine|ropivacaine|mesh-list
64533709|NCT02331030|Anesthetics, Local|anesthetics, local|mesh-ancestor
64533710|NCT02331030|Anesthetics|anesthetics|mesh-ancestor
64533711|NCT02331030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64533712|NCT02331030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533713|NCT02331030|Sensory System Agents|sensory system agents|mesh-ancestor
64533714|NCT02331030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64533715|NCT04270929|Folfirinox|folfirinox|mesh-list
64533716|NCT04270929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533717|NCT00401817|Bevacizumab|bevacizumab|mesh-list
64533718|NCT00401817|Rituximab|rituximab|mesh-list
64533719|NCT00401817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64533720|NCT00401817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533721|NCT00401817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64533722|NCT00401817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64990083|NCT05554328|Olaparib|olaparib|mesh-list
65279972|NCT00956215|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65279973|NCT00956215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65279974|NCT00956215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279975|NCT00640640|Bevacizumab|bevacizumab|mesh-list
65279976|NCT00640640|Ranibizumab|ranibizumab|mesh-list
65279977|NCT00640640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65279978|NCT00640640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279979|NCT00640640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65279980|NCT00640640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65279981|NCT00640640|Growth Substances|growth substances|mesh-ancestor
65279982|NCT00640640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279983|NCT00640640|Growth Inhibitors|growth inhibitors|mesh-ancestor
65279984|NCT00641030|Melphalan|melphalan|mesh-list
65279985|NCT00641030|Clofarabine|clofarabine|mesh-list
64732358|NCT00003181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64535768|NCT01563536|Protease Inhibitors|protease inhibitors|mesh-ancestor
64535769|NCT01563536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535770|NCT01563536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535813|NCT03022773|Carotenoids|carotenoids|mesh-list
64535814|NCT03022773|Antioxidants|antioxidants|mesh-ancestor
64990148|NCT05538897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535829|NCT02892591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64535830|NCT02892591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535831|NCT02892591|Analgesics|analgesics|mesh-ancestor
64535832|NCT02892591|Sensory System Agents|sensory system agents|mesh-ancestor
64535833|NCT02892591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64535834|NCT00470301|Paclitaxel|paclitaxel|mesh-list
64535835|NCT00470301|Cyclophosphamide|cyclophosphamide|mesh-list
64535836|NCT00470301|Doxorubicin|doxorubicin|mesh-list
64535837|NCT00470301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64535838|NCT00470301|Tipifarnib|tipifarnib|mesh-list
64535839|NCT00470301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64535840|NCT00470301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535841|NCT00470301|Tubulin Modulators|tubulin modulators|mesh-ancestor
64535842|NCT00470301|Antimitotic Agents|antimitotic agents|mesh-ancestor
64535843|NCT00470301|Mitosis Modulators|mitosis modulators|mesh-ancestor
64535844|NCT00470301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535845|NCT00470301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64535846|NCT00470301|Immunologic Factors|immunologic factors|mesh-ancestor
64535847|NCT00470301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535848|NCT00470301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64535849|NCT00470301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64535850|NCT00470301|Alkylating Agents|alkylating agents|mesh-ancestor
64714136|NCT00373789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64535851|NCT00470301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64535852|NCT00470301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64535853|NCT00470301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64535854|NCT00470301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64535855|NCT00470301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535856|NCT00544713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64535857|NCT00544713|Lubricant Eye Drops|lubricant eye drops|mesh-list
64535859|NCT00544713|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64535860|NCT00544713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64535861|NCT00544713|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64535862|NCT00544713|Protective Agents|protective agents|mesh-ancestor
64535863|NCT00544713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535864|NCT00544713|Laxatives|laxatives|mesh-ancestor
64535865|NCT00544713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64535866|NCT00545181|Metronidazole|metronidazole|mesh-list
64535867|NCT00545181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65279986|NCT00641030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65279987|NCT00641030|Alkylating Agents|alkylating agents|mesh-ancestor
65279988|NCT00641030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65279989|NCT00641030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65279990|NCT00641030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65279991|NCT00641030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65279992|NCT00641030|Immunologic Factors|immunologic factors|mesh-ancestor
65279993|NCT00641030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65279994|NCT00641030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65279996|NCT03973177|Phenol|phenol|mesh-list
65279997|NCT03973177|Methylprednisolone|methylprednisolone|mesh-list
65279998|NCT03973177|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65279999|NCT03973177|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64732373|NCT00004105|Antimitotic Agents|antimitotic agents|mesh-ancestor
64535868|NCT00545181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64535869|NCT00545181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64535870|NCT00545181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64535871|NCT01797315|Sirolimus|sirolimus|mesh-list
64535872|NCT01797315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64535873|NCT01797315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64535874|NCT01797315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64535875|NCT01797315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535876|NCT01797315|Antifungal Agents|antifungal agents|mesh-ancestor
64535877|NCT01797315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64535878|NCT01797315|Immunologic Factors|immunologic factors|mesh-ancestor
64535879|NCT01797315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535880|NCT00471705|Miltefosine|miltefosine|mesh-list
64535891|NCT00472797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535893|NCT00472797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64535894|NCT01458535|Ritonavir|ritonavir|mesh-list
64535895|NCT01458535|Ribavirin|ribavirin|mesh-list
64535896|NCT01458535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64535897|NCT01458535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64535898|NCT01458535|Protease Inhibitors|protease inhibitors|mesh-ancestor
64535899|NCT01458535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535900|NCT01458535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536012|NCT00474201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64536013|NCT00474201|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64536014|NCT00549393|Chlorhexidine|chlorhexidine|mesh-list
64536015|NCT00549393|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64536016|NCT00549393|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64536017|NCT00549393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64536018|NCT00549393|Disinfectants|disinfectants|mesh-ancestor
64536019|NCT00549393|Dermatologic Agents|dermatologic agents|mesh-ancestor
64536020|NCT00549783|Botulinum Toxins|botulinum toxins|mesh-list
64536021|NCT00549783|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64536022|NCT00549783|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64536023|NCT00549783|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64536024|NCT00549783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64536025|NCT00549783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536026|NCT00549783|Cholinergic Agents|cholinergic agents|mesh-ancestor
64536027|NCT00549783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64536028|NCT00549783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536029|NCT00549783|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64536122|NCT02985229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64536123|NCT02985229|Contraceptive Agents|contraceptive agents|mesh-ancestor
64536124|NCT02985229|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64536125|NCT02985229|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64536126|NCT02985229|Hormone Antagonists|hormone antagonists|mesh-ancestor
65280000|NCT03973177|Prednisolone|prednisolone|mesh-list
65280001|NCT03973177|Prednisolone acetate|prednisolone acetate|mesh-list
65280002|NCT03973177|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65280003|NCT03973177|Prednisolone phosphate|prednisolone phosphate|mesh-list
65280004|NCT03973177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65280005|NCT03973177|Antiemetics|antiemetics|mesh-ancestor
65280006|NCT03973177|Autonomic Agents|autonomic agents|mesh-ancestor
64536127|NCT02985229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64536128|NCT02985229|Luteolytic Agents|luteolytic agents|mesh-ancestor
64536129|NCT02985229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64536130|NCT02985229|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64536131|NCT00479115|Plerixafor|plerixafor|mesh-list
64536132|NCT00479115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64536133|NCT00479115|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64536134|NCT00479115|Antiviral Agents|antiviral agents|mesh-ancestor
64536135|NCT00479115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64536163|NCT01457053|Diuretics|diuretics|mesh-list
64536164|NCT01457053|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
64536165|NCT01457053|Natriuretic Agents|natriuretic agents|mesh-ancestor
64536166|NCT01457053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536167|NCT01457053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64536168|NCT01457053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536169|NCT01457053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64536170|NCT04082767|Midazolam|midazolam|mesh-list
64536171|NCT04082767|Dexmedetomidine|dexmedetomidine|mesh-list
64536172|NCT04082767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64536173|NCT04082767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64536174|NCT04082767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536559|NCT01584440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64536560|NCT01584440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64536561|NCT01584440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537037|NCT01573910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537038|NCT01573910|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64537040|NCT01573910|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64537375|NCT00501891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64537376|NCT00501891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537377|NCT00501891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64537378|NCT00501891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64537379|NCT00501891|Growth Substances|growth substances|mesh-ancestor
64537380|NCT00501891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537381|NCT00501891|Growth Inhibitors|growth inhibitors|mesh-ancestor
64537382|NCT00501891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64537383|NCT00501891|Alkylating Agents|alkylating agents|mesh-ancestor
64537384|NCT00501891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537397|NCT01798017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64537398|NCT01798017|Contraceptive Agents|contraceptive agents|mesh-ancestor
64537399|NCT01798017|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64537400|NCT01798017|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64537401|NCT01798017|Hormone Antagonists|hormone antagonists|mesh-ancestor
64537402|NCT01798017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64537403|NCT01798017|Luteolytic Agents|luteolytic agents|mesh-ancestor
64537404|NCT01798017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64537405|NCT01798017|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64537407|NCT00502905|Fludarabine phosphate|fludarabine phosphate|mesh-list
64537408|NCT00502905|Busulfan|busulfan|mesh-list
64537409|NCT00502905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537410|NCT00502905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64537411|NCT00502905|Antimetabolites|antimetabolites|mesh-ancestor
64537412|NCT00502905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537413|NCT00502905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64537414|NCT00502905|Immunologic Factors|immunologic factors|mesh-ancestor
64537415|NCT00502905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537416|NCT00502905|Alkylating Agents|alkylating agents|mesh-ancestor
64537417|NCT00502905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64537418|NCT00502905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64537419|NCT05418777|Trimethoprim|trimethoprim|mesh-list
65280007|NCT03973177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280008|NCT03973177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280009|NCT03973177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65280010|NCT03973177|Glucocorticoids|glucocorticoids|mesh-ancestor
65280011|NCT03973177|Hormones|hormones|mesh-ancestor
65280012|NCT03973177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65280013|NCT03973177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65280014|NCT03973177|Protective Agents|protective agents|mesh-ancestor
65280015|NCT03973177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65280016|NCT03973177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280017|NCT03973177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65280018|NCT03973177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65280019|NCT03973177|Disinfectants|disinfectants|mesh-ancestor
65280020|NCT03973177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65280021|NCT03973177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65280022|NCT03951493|Zoledronic Acid|zoledronic acid|mesh-list
65280023|NCT03951493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65280024|NCT03951493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280025|NCT00961909|Metformin|metformin|mesh-list
65280026|NCT00961909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65280027|NCT00961909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280028|NCT04115189|Sunitinib|sunitinib|mesh-list
65280029|NCT04115189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280030|NCT04115189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65280031|NCT04115189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65280032|NCT04115189|Growth Substances|growth substances|mesh-ancestor
65280033|NCT04115189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280034|NCT04115189|Growth Inhibitors|growth inhibitors|mesh-ancestor
64537420|NCT05418777|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64537421|NCT05418777|Sulfamethoxazole|sulfamethoxazole|mesh-list
64537422|NCT05418777|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64537423|NCT05418777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64537425|NCT05418777|Antimalarials|antimalarials|mesh-ancestor
64537426|NCT05418777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64537427|NCT05418777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64537428|NCT05418777|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64537429|NCT05418777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538275|NCT01549652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538277|NCT01549652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64538278|NCT01549652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64538279|NCT01549652|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64538280|NCT01549652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64538281|NCT01569464|Rotigotine|rotigotine|mesh-list
64538282|NCT01569464|Dopamine Agonists|dopamine agonists|mesh-ancestor
64538283|NCT01569464|Dopamine Agents|dopamine agents|mesh-ancestor
64538568|NCT00587769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280035|NCT04115189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65280036|NCT04115189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280037|NCT04115189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280038|NCT03940729|Chlorhexidine|chlorhexidine|mesh-list
65280039|NCT03940729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65280040|NCT03940729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65280041|NCT03940729|Disinfectants|disinfectants|mesh-ancestor
65280042|NCT02678234|Acetaminophen|acetaminophen|mesh-list
65280043|NCT02678234|Phenylephrine|phenylephrine|mesh-list
65280044|NCT02678234|Oxymetazoline|oxymetazoline|mesh-list
65280045|NCT02678234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280046|NCT02678234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65280047|NCT02678234|Analgesics|analgesics|mesh-ancestor
65280048|NCT02678234|Sensory System Agents|sensory system agents|mesh-ancestor
65280049|NCT02678234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280050|NCT02678234|Antipyretics|antipyretics|mesh-ancestor
65280051|NCT02678234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280052|NCT02678234|Protective Agents|protective agents|mesh-ancestor
65280053|NCT02678234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65280054|NCT02678234|Mydriatics|mydriatics|mesh-ancestor
65280055|NCT02678234|Autonomic Agents|autonomic agents|mesh-ancestor
65280056|NCT02678234|Sympathomimetics|sympathomimetics|mesh-ancestor
65280057|NCT02678234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64538570|NCT00587769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64538571|NCT00587769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538572|NCT00587769|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64538573|NCT00587769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64538574|NCT00587769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538575|NCT00587769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64538690|NCT01516892|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64538878|NCT00631449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64538879|NCT00631449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64538880|NCT00631449|Antiviral Agents|antiviral agents|mesh-ancestor
64538881|NCT00631449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64538882|NCT00631449|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64538883|NCT00631449|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64538884|NCT00631449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538885|NCT00631449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538886|NCT01546142|Deoxycholic Acid|deoxycholic acid|mesh-list
64538887|NCT01546142|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64538888|NCT01546142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64471691|NCT04251533|Mitosis Modulators|mitosis modulators|mesh-ancestor
64538889|NCT00632619|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
64538890|NCT00632619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538891|NCT01440101|Natalizumab|natalizumab|mesh-list
64538892|NCT01440101|Immunologic Factors|immunologic factors|mesh-ancestor
64538893|NCT01440101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538894|NCT01530464|Ambrisentan|ambrisentan|mesh-list
64539061|NCT00639717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64539062|NCT00639717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64539093|NCT04120961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64539094|NCT04120961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64539096|NCT04410263|Chelating Agents|chelating agents|mesh-ancestor
65280058|NCT02678234|Nasal Decongestants|nasal decongestants|mesh-ancestor
65280059|NCT02678234|Respiratory System Agents|respiratory system agents|mesh-ancestor
65280060|NCT02678234|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65280061|NCT02678234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65280062|NCT02678234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65280063|NCT02678234|Adrenergic Agents|adrenergic agents|mesh-ancestor
65280064|NCT02678234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65280065|NCT00601640|Eflornithine|eflornithine|mesh-list
65030082|NCT05208307|Autonomic Agents|autonomic agents|mesh-ancestor
65280066|NCT00601640|Diclofenac|diclofenac|mesh-list
65280067|NCT00601640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65280068|NCT00601640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65280069|NCT00601640|Analgesics|analgesics|mesh-ancestor
65280070|NCT00601640|Sensory System Agents|sensory system agents|mesh-ancestor
65280071|NCT00601640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280072|NCT00601640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280073|NCT00601640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64539097|NCT04410263|Sequestering Agents|sequestering agents|mesh-ancestor
64539098|NCT04410263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539099|NCT01444651|Tadalafil|tadalafil|mesh-list
64539100|NCT01444651|Vasodilator Agents|vasodilator agents|mesh-ancestor
64539101|NCT01444651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64539102|NCT01444651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64539103|NCT01444651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539165|NCT00678015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539166|NCT00678015|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64539167|NCT00678015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539168|NCT00678015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64539169|NCT00678015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64539170|NCT00678015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64539171|NCT00678015|Analgesics|analgesics|mesh-ancestor
64539172|NCT00678015|Sensory System Agents|sensory system agents|mesh-ancestor
64539173|NCT00678015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64539174|NCT00678015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64539175|NCT00678015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64539176|NCT01437995|Fluticasone|fluticasone|mesh-list
64539178|NCT01437995|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64539246|NCT00588159|Analgesics|analgesics|mesh-ancestor
64539247|NCT00588159|Sensory System Agents|sensory system agents|mesh-ancestor
64539248|NCT00588159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64539255|NCT00588159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64539257|NCT00588159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64539258|NCT00588159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539259|NCT00588159|Antimanic Agents|antimanic agents|mesh-ancestor
64539260|NCT00588159|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64539261|NCT00588159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64539262|NCT00588159|Anesthetics, Local|anesthetics, local|mesh-ancestor
64539263|NCT00588159|Anesthetics|anesthetics|mesh-ancestor
64539264|NCT00588159|Antiemetics|antiemetics|mesh-ancestor
64539265|NCT00588159|Autonomic Agents|autonomic agents|mesh-ancestor
64539266|NCT00588159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64539267|NCT00588159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64539268|NCT00588159|Histamine Antagonists|histamine antagonists|mesh-ancestor
64539269|NCT00588159|Histamine Agents|histamine agents|mesh-ancestor
64539283|NCT00680823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64539284|NCT00680823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539285|NCT00680823|Sensory System Agents|sensory system agents|mesh-ancestor
65280074|NCT00601640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65280075|NCT00601640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65280076|NCT00601640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280077|NCT00601640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280078|NCT00601640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280079|NCT00601640|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65280080|NCT00601640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65280081|NCT00601640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65280082|NCT00601640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65280083|NCT00601640|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
65280084|NCT02805725|Cyclophosphamide|cyclophosphamide|mesh-list
65280085|NCT02805725|Trabectedin|trabectedin|mesh-list
65280086|NCT02805725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65280087|NCT02805725|Immunologic Factors|immunologic factors|mesh-ancestor
65280088|NCT02805725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280089|NCT02805725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65280090|NCT02805725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65280091|NCT02805725|Alkylating Agents|alkylating agents|mesh-ancestor
64539286|NCT00680823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64539287|NCT00589329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64539288|NCT00589329|Metronidazole|metronidazole|mesh-list
64539289|NCT00589329|Erythromycin|erythromycin|mesh-list
64539290|NCT00589329|Erythromycin Estolate|erythromycin estolate|mesh-list
64539291|NCT00589329|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64539292|NCT00589329|Erythromycin stearate|erythromycin stearate|mesh-list
64539293|NCT00589329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64539294|NCT00589329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64539295|NCT00589329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64539296|NCT00589329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64539297|NCT00589329|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64539298|NCT00589329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539299|NCT00589329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539300|NCT01438957|Dexmedetomidine|dexmedetomidine|mesh-list
64539301|NCT01438957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64539302|NCT01438957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64539303|NCT01438957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539304|NCT01438957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64539305|NCT01438957|Analgesics|analgesics|mesh-ancestor
64539306|NCT01438957|Sensory System Agents|sensory system agents|mesh-ancestor
64539307|NCT01438957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64539308|NCT01438957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64539309|NCT01438957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64539310|NCT01438957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64539311|NCT01438957|Adrenergic Agents|adrenergic agents|mesh-ancestor
64539312|NCT01438957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64539313|NCT01438957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539314|NCT00589563|Sirolimus|sirolimus|mesh-list
64539315|NCT00589563|Cyclophosphamide|cyclophosphamide|mesh-list
64539316|NCT00589563|Melphalan|melphalan|mesh-list
64539317|NCT00589563|Methotrexate|methotrexate|mesh-list
64539318|NCT00589563|Fludarabine|fludarabine|mesh-list
64539319|NCT00589563|Fludarabine phosphate|fludarabine phosphate|mesh-list
64539320|NCT00589563|Etoposide|etoposide|mesh-list
64539321|NCT00589563|Tacrolimus|tacrolimus|mesh-list
64539322|NCT00589563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64539323|NCT00589563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64539324|NCT00589563|Immunologic Factors|immunologic factors|mesh-ancestor
64539325|NCT00589563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280092|NCT02805725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280093|NCT02805725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280094|NCT02805725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65280095|NCT05300191|Dialysis Solutions|dialysis solutions|mesh-list
65280096|NCT05300191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65280098|NCT03549715|Tremelimumab|tremelimumab|mesh-list
65280099|NCT03549715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65280100|NCT03549715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280101|NCT02803385|Analgesics, Opioid|analgesics, opioid|mesh-list
65280102|NCT02803385|Anesthetics|anesthetics|mesh-list
64732479|NCT00003799|Leucovorin|leucovorin|mesh-list
64539326|NCT00589563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64471692|NCT04251533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539391|NCT00654147|Emtricitabine|emtricitabine|mesh-list
64539392|NCT00654147|Raltegravir Potassium|raltegravir potassium|mesh-list
64539393|NCT00654147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64539394|NCT00654147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64539395|NCT00654147|Protease Inhibitors|protease inhibitors|mesh-ancestor
64539404|NCT00654147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64539405|NCT00654147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64539406|NCT00654147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64539407|NCT00654147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64539408|NCT01438489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64539409|NCT01438489|Immunologic Factors|immunologic factors|mesh-ancestor
64539410|NCT01438489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539411|NCT00654927|4-Aminopyridine|4-aminopyridine|mesh-list
64539412|NCT00654927|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64539413|NCT00654927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64539414|NCT00654927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539415|NCT00655083|MEN 11420|men 11420|mesh-list
64539416|NCT00655083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64539417|NCT00655083|Autonomic Agents|autonomic agents|mesh-ancestor
64539418|NCT00655083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64539419|NCT00655083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539420|NCT00655083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64539421|NCT00655083|Respiratory System Agents|respiratory system agents|mesh-ancestor
64539422|NCT01418209|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64539423|NCT01418209|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64539424|NCT01418209|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64539426|NCT01418209|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64539427|NCT01418209|Progesterone|progesterone|mesh-list
64539428|NCT01418209|Estrogens|estrogens|mesh-ancestor
64539429|NCT01418209|Hormones|hormones|mesh-ancestor
64539430|NCT01418209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64539431|NCT01418209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539432|NCT01418209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64539434|NCT01418209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64990577|NCT05141474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64539451|NCT01570361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64539452|NCT01417195|Menotropins|menotropins|mesh-list
64539453|NCT01417195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64539454|NCT01417195|Hormones|hormones|mesh-ancestor
64539455|NCT01417195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64539456|NCT01417195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539457|NCT01417195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64539458|NCT01417195|Fertility Agents|fertility agents|mesh-ancestor
64539459|NCT01417195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64539460|NCT00656487|Rimonabant|rimonabant|mesh-list
64539461|NCT00656487|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64539470|NCT01438411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64539471|NCT01438177|Chloroquine|chloroquine|mesh-list
64539472|NCT01438177|Cyclophosphamide|cyclophosphamide|mesh-list
64539473|NCT01438177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64539474|NCT01438177|Bortezomib|bortezomib|mesh-list
65280103|NCT02803385|Anesthetics, Local|anesthetics, local|mesh-list
65280104|NCT02803385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65280105|NCT02803385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280106|NCT02803385|Narcotics|narcotics|mesh-ancestor
65280107|NCT02803385|Analgesics|analgesics|mesh-ancestor
65280108|NCT02803385|Sensory System Agents|sensory system agents|mesh-ancestor
65280109|NCT02803385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280110|NCT00958321|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65280111|NCT00958321|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65280112|NCT00958321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539475|NCT01438177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64539476|NCT01438177|Immunologic Factors|immunologic factors|mesh-ancestor
64539477|NCT01438177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539478|NCT01438177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64471693|NCT04242238|Avelumab|avelumab|mesh-list
64471694|NCT04242238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64539479|NCT01438177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64539480|NCT01438177|Alkylating Agents|alkylating agents|mesh-ancestor
64539481|NCT01438177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539482|NCT01438177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64539483|NCT01438177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64539484|NCT01438177|Amebicides|amebicides|mesh-ancestor
64539485|NCT01438177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64539486|NCT01438177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64539487|NCT01438177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64539488|NCT01438177|Antimalarials|antimalarials|mesh-ancestor
64539489|NCT01442779|Interferons|interferons|mesh-list
64539490|NCT01442779|Interferon-alpha|interferon-alpha|mesh-list
64539491|NCT01442779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64539492|NCT01442779|Antiviral Agents|antiviral agents|mesh-ancestor
64539493|NCT01442779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64539494|NCT01442779|Immunologic Factors|immunologic factors|mesh-ancestor
64539495|NCT01442779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539496|NCT01436201|Dulaglutide|dulaglutide|mesh-list
64539497|NCT01436201|Digoxin|digoxin|mesh-list
64539498|NCT01436201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64539504|NCT01436201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64539505|NCT01437397|Bromides|bromides|mesh-list
64539506|NCT01437397|Formoterol Fumarate|formoterol fumarate|mesh-list
64539507|NCT01437397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64539508|NCT01437397|Autonomic Agents|autonomic agents|mesh-ancestor
64539509|NCT01437397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64539510|NCT01437397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539511|NCT01437397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64539512|NCT01437397|Respiratory System Agents|respiratory system agents|mesh-ancestor
64539513|NCT01437397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64539514|NCT01437397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64539515|NCT01437397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64539516|NCT01437397|Adrenergic Agents|adrenergic agents|mesh-ancestor
64539517|NCT01437397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64539518|NCT01437397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539519|NCT01437397|Anticonvulsants|anticonvulsants|mesh-ancestor
64539520|NCT04070833|Vitamin D|vitamin d|mesh-list
64539521|NCT04070833|Ergocalciferols|ergocalciferols|mesh-list
64539522|NCT04070833|Cholecalciferol|cholecalciferol|mesh-list
64539523|NCT04070833|Vitamins|vitamins|mesh-list
64539524|NCT04070833|Micronutrients|micronutrients|mesh-ancestor
64539525|NCT04070833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539526|NCT04070833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64539527|NCT04070833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64539528|NCT01442155|Capecitabine|capecitabine|mesh-list
64539541|NCT03026023|Antiviral Agents|antiviral agents|mesh-ancestor
64539542|NCT03026023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64539543|NCT01441765|Pidilizumab|pidilizumab|mesh-list
64539544|NCT01441765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64539545|NCT01441765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280113|NCT00642434|Metoprolol|metoprolol|mesh-list
65280114|NCT00642434|Carvedilol|carvedilol|mesh-list
65280115|NCT00642434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65280116|NCT00642434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65280117|NCT00642434|Sympatholytics|sympatholytics|mesh-ancestor
65280118|NCT00642434|Autonomic Agents|autonomic agents|mesh-ancestor
65280119|NCT00642434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280120|NCT00642434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280121|NCT00642434|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65280122|NCT00642434|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65280123|NCT00642434|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65280124|NCT00642434|Adrenergic Agents|adrenergic agents|mesh-ancestor
65280125|NCT00642434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65280126|NCT00642434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280127|NCT00642434|Antioxidants|antioxidants|mesh-ancestor
65280128|NCT00642434|Protective Agents|protective agents|mesh-ancestor
64732504|NCT00003211|Amifostine|amifostine|mesh-list
64539547|NCT01419665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64539548|NCT01419665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64539549|NCT01419665|Immunologic Factors|immunologic factors|mesh-ancestor
64539550|NCT01419665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539551|NCT01419665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64539552|NCT01436305|Mycophenolic Acid|mycophenolic acid|mesh-list
64539553|NCT01436305|Methylprednisolone|methylprednisolone|mesh-list
64539554|NCT01436305|Alemtuzumab|alemtuzumab|mesh-list
64539555|NCT01436305|Abatacept|abatacept|mesh-list
64539556|NCT01436305|Tacrolimus|tacrolimus|mesh-list
64539557|NCT01436305|Basiliximab|basiliximab|mesh-list
64539558|NCT01436305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64539559|NCT01436305|Immunologic Factors|immunologic factors|mesh-ancestor
64539560|NCT01436305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539561|NCT01436305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64539562|NCT01436305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539563|NCT01436305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539564|NCT01436305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64539565|NCT01436305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64539566|NCT01436305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64539567|NCT01436305|Antitubercular Agents|antitubercular agents|mesh-ancestor
64539568|NCT01436305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64539569|NCT01436305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64539570|NCT01436305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64539571|NCT01436305|Antiemetics|antiemetics|mesh-ancestor
64539572|NCT01436305|Autonomic Agents|autonomic agents|mesh-ancestor
64539573|NCT01436305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64539574|NCT01436305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64539575|NCT01436305|Glucocorticoids|glucocorticoids|mesh-ancestor
64990686|NCT05037032|Sensory System Agents|sensory system agents|mesh-ancestor
64540204|NCT04051957|Vasodilator Agents|vasodilator agents|mesh-ancestor
64540205|NCT04051957|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64540206|NCT04051957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540207|NCT05084196|Melatonin|melatonin|mesh-list
64540208|NCT05084196|Antioxidants|antioxidants|mesh-ancestor
64540209|NCT05084196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990749|NCT04981509|Listerine|listerine|mesh-list
64540230|NCT00591123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64540231|NCT00591123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540232|NCT04149990|Valsartan|valsartan|mesh-list
64540233|NCT04149990|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64540234|NCT04149990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65280129|NCT00642434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65280130|NCT00642434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65280131|NCT00642434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65280132|NCT00642434|Vasodilator Agents|vasodilator agents|mesh-ancestor
65280133|NCT00642434|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65280134|NCT00642434|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65280135|NCT05352373|Calcium|calcium|mesh-list
65280136|NCT05352373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65280137|NCT05352373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280138|NCT02677532|Acetaminophen|acetaminophen|mesh-list
65280139|NCT02677532|Sufentanil|sufentanil|mesh-list
65280140|NCT02677532|Morphine|morphine|mesh-list
65280141|NCT02677532|Dsuvia|dsuvia|mesh-list
65280142|NCT02677532|Levobupivacaine|levobupivacaine|mesh-list
65280143|NCT02677532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65280144|NCT02677532|Narcotics|narcotics|mesh-ancestor
65280145|NCT02677532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65280146|NCT02677532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280147|NCT02677532|Analgesics|analgesics|mesh-ancestor
64732515|NCT00003211|Tubulin Modulators|tubulin modulators|mesh-ancestor
64540235|NCT04149990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64540236|NCT04149990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64540237|NCT04149990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540238|NCT00591825|Cycloserine|cycloserine|mesh-list
64540239|NCT00591825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64540241|NCT00591825|Renal Agents|renal agents|mesh-ancestor
64540242|NCT00591825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64540243|NCT00591825|Antitubercular Agents|antitubercular agents|mesh-ancestor
64540244|NCT00591825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64540245|NCT00591825|Antimetabolites|antimetabolites|mesh-ancestor
64540246|NCT00591825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540247|NCT01429285|Hydromorphone|hydromorphone|mesh-list
64540248|NCT01429285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64540249|NCT01429285|Narcotics|narcotics|mesh-ancestor
64540250|NCT01429285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64540251|NCT01429285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540252|NCT01429285|Analgesics|analgesics|mesh-ancestor
64304962|NCT04440176|Vaccines|vaccines|mesh-list
64540414|NCT00661479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64540415|NCT00661479|Adrenergic Agents|adrenergic agents|mesh-ancestor
64540416|NCT00661479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64540417|NCT00661479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540418|NCT00661479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540626|NCT01543958|Chelating Agents|chelating agents|mesh-ancestor
64540627|NCT01543958|Sequestering Agents|sequestering agents|mesh-ancestor
64540628|NCT01543958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540629|NCT04880928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64540630|NCT04880928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64540631|NCT01411085|Risperidone|risperidone|mesh-list
64540632|NCT01411085|Desipramine|desipramine|mesh-list
64540824|NCT04200534|Nicotine|nicotine|mesh-list
64540825|NCT04200534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64540826|NCT04200534|Autonomic Agents|autonomic agents|mesh-ancestor
64540827|NCT04200534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64540828|NCT04200534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280148|NCT02677532|Sensory System Agents|sensory system agents|mesh-ancestor
65280149|NCT02677532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280150|NCT02677532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65280151|NCT02677532|Antipyretics|antipyretics|mesh-ancestor
65280152|NCT02677532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65280153|NCT02677532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65280154|NCT02677532|Anesthetics, General|anesthetics, general|mesh-ancestor
64540829|NCT04200534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64540830|NCT04200534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64540831|NCT04200534|Cholinergic Agents|cholinergic agents|mesh-ancestor
64540832|NCT04200534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64540833|NCT04200534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540834|NCT05392374|TIC10 compound|tic10 compound|mesh-list
64540867|NCT01204905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540868|NCT01204905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540869|NCT01204905|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64540870|NCT01204905|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64540871|NCT01204905|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64540872|NCT00691665|Fluticasone|fluticasone|mesh-list
64540873|NCT00691665|Xhance|xhance|mesh-list
64540874|NCT00691665|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64540875|NCT00691665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64541147|NCT01795131|Micronutrients|micronutrients|mesh-ancestor
64541148|NCT01795131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541149|NCT01795131|Vitamin B Complex|vitamin b complex|mesh-ancestor
64541150|NCT01795131|Hematinics|hematinics|mesh-ancestor
64541151|NCT03137004|Docetaxel|docetaxel|mesh-list
64541152|NCT03137004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541153|NCT03137004|Tubulin Modulators|tubulin modulators|mesh-ancestor
64541154|NCT03137004|Antimitotic Agents|antimitotic agents|mesh-ancestor
64541155|NCT03137004|Mitosis Modulators|mitosis modulators|mesh-ancestor
64497258|NCT02977494|Dexamethasone|dexamethasone|mesh-list
64541156|NCT03137004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541157|NCT03113994|Calcium, Dietary|calcium, dietary|mesh-list
64541159|NCT03113994|Coenzyme Q10|coenzyme q10|mesh-list
64541160|NCT03113994|Ubiquinone|ubiquinone|mesh-list
64541161|NCT03113994|Calcium Carbonate|calcium carbonate|mesh-list
64541162|NCT03113994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64541163|NCT03113994|Calcium|calcium|mesh-list
64541164|NCT03113994|Vitamins|vitamins|mesh-ancestor
64541165|NCT03113994|Micronutrients|micronutrients|mesh-ancestor
64541166|NCT03113994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541167|NCT03113994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64541168|NCT03113994|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64541209|NCT03110172|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64541210|NCT03110172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64541239|NCT05079672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64541240|NCT05079672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64541241|NCT05079672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541242|NCT05079672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64541243|NCT05079672|Analgesics|analgesics|mesh-ancestor
64541244|NCT05079672|Sensory System Agents|sensory system agents|mesh-ancestor
64541245|NCT05079672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64541246|NCT05079672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64541247|NCT05079672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64471695|NCT04242238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541248|NCT05079672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64541249|NCT05079672|Adrenergic Agents|adrenergic agents|mesh-ancestor
64541250|NCT05079672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64541251|NCT05079672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541252|NCT04766827|Paclitaxel|paclitaxel|mesh-list
64541253|NCT04766827|Docetaxel|docetaxel|mesh-list
64541254|NCT04766827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64541255|NCT04766827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64306032|NCT02382640|Febuxostat|febuxostat|mesh-list
64541326|NCT05063370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541395|NCT01399723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64541396|NCT01399723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541397|NCT04771962|Sevoflurane|sevoflurane|mesh-list
65280155|NCT02677532|Anesthetics|anesthetics|mesh-ancestor
65280156|NCT02677532|Anesthetics, Local|anesthetics, local|mesh-ancestor
65280157|NCT00641810|Caffeine|caffeine|mesh-list
65280158|NCT00641810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65280159|NCT00641810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280160|NCT00641810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65280161|NCT00641810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732545|NCT00003811|Etoposide|etoposide|mesh-list
64541398|NCT04771962|Desflurane|desflurane|mesh-list
64541399|NCT04771962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64541400|NCT04771962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64541401|NCT04771962|Anesthetics, General|anesthetics, general|mesh-ancestor
64541402|NCT04771962|Anesthetics|anesthetics|mesh-ancestor
64541403|NCT04771962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64541404|NCT04771962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541405|NCT04726098|Dexamethasone|dexamethasone|mesh-list
64541406|NCT04726098|Dexamethasone acetate|dexamethasone acetate|mesh-list
64541407|NCT04726098|BB 1101|bb 1101|mesh-list
64541408|NCT04726098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64541409|NCT04726098|Antiemetics|antiemetics|mesh-ancestor
64541443|NCT01383499|Parasympatholytics|parasympatholytics|mesh-ancestor
64541444|NCT01383499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64541445|NCT01383499|Cholinergic Agents|cholinergic agents|mesh-ancestor
64541446|NCT01383499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64541447|NCT01383499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541474|NCT04505670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541475|NCT04505670|Cholinergic Agents|cholinergic agents|mesh-ancestor
64541476|NCT04505670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64541477|NCT04505670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541478|NCT04505670|Nootropic Agents|nootropic agents|mesh-ancestor
64541479|NCT04505670|Dermatologic Agents|dermatologic agents|mesh-ancestor
64541480|NCT04505670|Sunscreening Agents|sunscreening agents|mesh-ancestor
64541481|NCT04505670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64541482|NCT04505670|Protective Agents|protective agents|mesh-ancestor
64541483|NCT04335084|Vitamin D|vitamin d|mesh-list
64541484|NCT04335084|Vitamins|vitamins|mesh-list
64541485|NCT04335084|Hydroxychloroquine|hydroxychloroquine|mesh-list
64541486|NCT04335084|Micronutrients|micronutrients|mesh-ancestor
64541526|NCT02995707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64541527|NCT02995707|Immunologic Factors|immunologic factors|mesh-ancestor
64541528|NCT02995707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541529|NCT02995707|Leprostatic Agents|leprostatic agents|mesh-ancestor
64541530|NCT02995707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64541531|NCT02995707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541532|NCT02995707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64541533|NCT02995707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64541534|NCT02995707|Growth Substances|growth substances|mesh-ancestor
64541535|NCT02995707|Growth Inhibitors|growth inhibitors|mesh-ancestor
64541536|NCT02995707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541537|NCT01270035|Adalimumab|adalimumab|mesh-list
64541538|NCT01270035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64541539|NCT01270035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64471696|NCT04233190|Budesonide|budesonide|mesh-list
64541540|NCT01396447|Cariprazine|cariprazine|mesh-list
64541541|NCT01396447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64541542|NCT01396447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64541543|NCT01396447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64541544|NCT01396447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541545|NCT01396447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64541546|NCT05738148|Vasopressins|vasopressins|mesh-list
64541547|NCT05738148|Arginine Vasopressin|arginine vasopressin|mesh-list
64541548|NCT05738148|Epinephrine|epinephrine|mesh-list
64541549|NCT05738148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64541550|NCT05738148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64541551|NCT05738148|Adrenergic Agents|adrenergic agents|mesh-ancestor
64541552|NCT05738148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64541676|NCT00716079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64541677|NCT00716079|Sympatholytics|sympatholytics|mesh-ancestor
64541678|NCT00716079|Autonomic Agents|autonomic agents|mesh-ancestor
64541679|NCT00716079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280162|NCT00641810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280163|NCT00641810|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65280164|NCT00641810|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65280165|NCT00641810|Purinergic Agents|purinergic agents|mesh-ancestor
65280166|NCT00641810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65280167|NCT02802995|Thrombin|thrombin|mesh-list
65280168|NCT02802995|Hemostatics|hemostatics|mesh-ancestor
65280169|NCT02802995|Coagulants|coagulants|mesh-ancestor
65280170|NCT00910052|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65280171|NCT00910052|Hemostatics|hemostatics|mesh-ancestor
65280172|NCT00910052|Coagulants|coagulants|mesh-ancestor
64541680|NCT00716079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541681|NCT00716079|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64541776|NCT04287660|Autonomic Agents|autonomic agents|mesh-ancestor
64541777|NCT04287660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64541778|NCT04287660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541779|NCT04287660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64541780|NCT04287660|Glucocorticoids|glucocorticoids|mesh-ancestor
64541840|NCT01395901|Ondansetron|ondansetron|mesh-list
64991004|NCT04759586|Prednisone|prednisone|mesh-list
64541852|NCT01395901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541854|NCT01395901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64541855|NCT01395901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64541856|NCT01395901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64541857|NCT01395901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64541858|NCT01395901|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64541859|NCT01395823|Vitamin D|vitamin d|mesh-list
64541860|NCT01395823|Ergocalciferols|ergocalciferols|mesh-list
64541861|NCT01395823|Vitamins|vitamins|mesh-ancestor
64541862|NCT01395823|Micronutrients|micronutrients|mesh-ancestor
64541863|NCT01395823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541864|NCT01395823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64541865|NCT01395823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64541866|NCT02993991|Durvalumab|durvalumab|mesh-list
64541867|NCT02993991|Mocetinostat|mocetinostat|mesh-list
64541868|NCT02993991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64541869|NCT02993991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541870|NCT02993991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64541871|NCT02993991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542010|NCT02794896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64542011|NCT02794896|Narcotics|narcotics|mesh-ancestor
64542012|NCT02794896|Analgesics|analgesics|mesh-ancestor
64542013|NCT02794896|Sensory System Agents|sensory system agents|mesh-ancestor
64542014|NCT02794896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64542015|NCT02794896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64542016|NCT02794896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64542017|NCT02794896|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64542018|NCT01271283|Lenalidomide|lenalidomide|mesh-list
64306795|NCT03061916|Disinfectants|disinfectants|mesh-ancestor
64542127|NCT01394185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64542128|NCT05375916|Hydromorphone|hydromorphone|mesh-list
64542129|NCT05375916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64542130|NCT05375916|Narcotics|narcotics|mesh-ancestor
64542131|NCT05375916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64542132|NCT05375916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542133|NCT05375916|Analgesics|analgesics|mesh-ancestor
64542134|NCT05375916|Sensory System Agents|sensory system agents|mesh-ancestor
64542197|NCT04540848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64471697|NCT04233190|Formoterol Fumarate|formoterol fumarate|mesh-list
64471698|NCT04233190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64542198|NCT04793100|Aflibercept|aflibercept|mesh-list
64542199|NCT04793100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64498305|NCT01267864|Ketorolac|ketorolac|mesh-list
64542200|NCT04793100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64542201|NCT04793100|Growth Substances|growth substances|mesh-ancestor
64542202|NCT04793100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280173|NCT02677376|Listerine|listerine|mesh-list
65280174|NCT02677376|Fluorides|fluorides|mesh-list
65280175|NCT02677376|Sodium Fluoride|sodium fluoride|mesh-list
65280176|NCT02677376|Cariostatic Agents|cariostatic agents|mesh-ancestor
65280177|NCT02677376|Protective Agents|protective agents|mesh-ancestor
65280178|NCT02677376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280179|NCT02677376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65280180|NCT02677376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65280181|NCT02800889|Pixantrone|pixantrone|mesh-list
65280182|NCT02800889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65280183|NCT02800889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65280184|NCT02800889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280185|NCT02800889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280186|NCT02800889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280187|NCT02803073|Methyltestosterone|methyltestosterone|mesh-list
65280188|NCT02803073|Testosterone|testosterone|mesh-list
65280189|NCT02803073|Testosterone undecanoate|testosterone undecanoate|mesh-list
65280190|NCT02803073|Testosterone enanthate|testosterone enanthate|mesh-list
65280191|NCT02803073|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65280192|NCT02803073|Androgens|androgens|mesh-ancestor
65280193|NCT02803073|Hormones|hormones|mesh-ancestor
64542203|NCT04793100|Growth Inhibitors|growth inhibitors|mesh-ancestor
64542204|NCT04793100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542205|NCT04760028|Anesthetics|anesthetics|mesh-list
64542206|NCT04760028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64542207|NCT04760028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542209|NCT05366101|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64542421|NCT04017013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64542422|NCT04017013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64542423|NCT04017013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64542424|NCT04017013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64542425|NCT04017013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542426|NCT01277913|Vitamin D|vitamin d|mesh-list
64542427|NCT01277913|Ergocalciferols|ergocalciferols|mesh-list
64542428|NCT01277913|Cholecalciferol|cholecalciferol|mesh-list
64542552|NCT01409837|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64542553|NCT01409837|Protective Agents|protective agents|mesh-ancestor
64542554|NCT01409837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542555|NCT01278459|Atorvastatin|atorvastatin|mesh-list
64542556|NCT01278459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64542557|NCT01278459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64542558|NCT01278459|Antimetabolites|antimetabolites|mesh-ancestor
64542559|NCT01278459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542560|NCT01278459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64991123|NCT04736173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542644|NCT01428713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64542645|NCT01428713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542646|NCT01428713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64542649|NCT03976375|Lenvatinib|lenvatinib|mesh-list
64542650|NCT03976375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542651|NCT03976375|Tubulin Modulators|tubulin modulators|mesh-ancestor
64542652|NCT03976375|Antimitotic Agents|antimitotic agents|mesh-ancestor
64542653|NCT03976375|Mitosis Modulators|mitosis modulators|mesh-ancestor
64484214|NCT01751113|Bromides|bromides|mesh-list
64542654|NCT03976375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280194|NCT02803073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65280195|NCT02803073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280196|NCT02803073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65280197|NCT02803073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280198|NCT02803073|Anabolic Agents|anabolic agents|mesh-ancestor
65280199|NCT00922532|Nitric Oxide|nitric oxide|mesh-list
65280200|NCT00922532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65280201|NCT00922532|Autonomic Agents|autonomic agents|mesh-ancestor
65280202|NCT00922532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280203|NCT00922532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280204|NCT00922532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65280205|NCT00922532|Respiratory System Agents|respiratory system agents|mesh-ancestor
65280206|NCT00922532|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65280207|NCT00922532|Antioxidants|antioxidants|mesh-ancestor
65280208|NCT00922532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280209|NCT00922532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65280210|NCT00922532|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65280211|NCT00922532|Vasodilator Agents|vasodilator agents|mesh-ancestor
65280212|NCT00922532|Gasotransmitters|gasotransmitters|mesh-ancestor
65280213|NCT00922532|Protective Agents|protective agents|mesh-ancestor
65280214|NCT05662904|Gemtuzumab|gemtuzumab|mesh-list
65280215|NCT05662904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65280216|NCT05662904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280217|NCT00642512|Dronabinol|dronabinol|mesh-list
65030235|NCT00164255|Pyrimethamine|pyrimethamine|mesh-list
65280218|NCT00642512|Ondansetron|ondansetron|mesh-list
65280219|NCT00642512|Antiemetics|antiemetics|mesh-ancestor
65280220|NCT00642512|Autonomic Agents|autonomic agents|mesh-ancestor
65280221|NCT00642512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280222|NCT00642512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280223|NCT00642512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65280224|NCT00642512|Antipruritics|antipruritics|mesh-ancestor
65280225|NCT00642512|Dermatologic Agents|dermatologic agents|mesh-ancestor
64542655|NCT03976375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64542656|NCT03976375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64542657|NCT03976375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542658|NCT01408043|Plerixafor|plerixafor|mesh-list
64542659|NCT01408043|Etoposide|etoposide|mesh-list
64542660|NCT01408043|Etoposide phosphate|etoposide phosphate|mesh-list
64542661|NCT01408043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64542662|NCT01408043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307424|NCT02420847|Ixazomib|ixazomib|mesh-list
65280226|NCT00642512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65280227|NCT00642512|Serotonin Agents|serotonin agents|mesh-ancestor
65280228|NCT00642512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64542696|NCT01523366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542697|NCT03024697|Anesthetics|anesthetics|mesh-list
64542698|NCT03024697|Anesthetics, Local|anesthetics, local|mesh-list
64542699|NCT03024697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64542700|NCT03024697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542767|NCT03984097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64542768|NCT03984097|Glucocorticoids|glucocorticoids|mesh-ancestor
64542769|NCT03984097|Hormones|hormones|mesh-ancestor
64542770|NCT03984097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64542771|NCT03984097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64542773|NCT03984097|Immunologic Factors|immunologic factors|mesh-ancestor
64542774|NCT03984097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64542775|NCT03984097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64542776|NCT03984097|Growth Substances|growth substances|mesh-ancestor
64543020|NCT04126200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64543021|NCT04126200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543022|NCT04126200|Immunologic Factors|immunologic factors|mesh-ancestor
64543023|NCT04126200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64543024|NCT04126200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64543025|NCT04126200|Growth Substances|growth substances|mesh-ancestor
64543026|NCT04126200|Growth Inhibitors|growth inhibitors|mesh-ancestor
64543027|NCT02467452|Tiotropium Bromide|tiotropium bromide|mesh-list
64543028|NCT02467452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64543029|NCT02467452|Autonomic Agents|autonomic agents|mesh-ancestor
64543095|NCT04195867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64543096|NCT04195867|Respiratory System Agents|respiratory system agents|mesh-ancestor
64543097|NCT04195867|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64543098|NCT04195867|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64543099|NCT04195867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64543100|NCT04195867|Adrenergic Agents|adrenergic agents|mesh-ancestor
64543101|NCT04195867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64543134|NCT04195243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543135|NCT04195243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64543136|NCT04195243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543138|NCT04195321|Oxymetazoline|oxymetazoline|mesh-list
64543139|NCT04195321|Norepinephrine|norepinephrine|mesh-list
64543230|NCT05286996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64543232|NCT04028869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64543233|NCT05092074|Sofosbuvir|sofosbuvir|mesh-list
64543234|NCT05092074|Velpatasvir|velpatasvir|mesh-list
64543235|NCT05092074|Antiviral Agents|antiviral agents|mesh-ancestor
64543236|NCT05092074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64543237|NCT02080273|Listerine|listerine|mesh-list
64543238|NCT02080273|Sodium Fluoride|sodium fluoride|mesh-list
64308025|NCT02085239|Anesthetics|anesthetics|mesh-ancestor
64543345|NCT04020133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64543346|NCT04020133|Adrenergic Agents|adrenergic agents|mesh-ancestor
64543347|NCT04020133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64543348|NCT04020133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543349|NCT04020133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64543350|NCT04020133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64543351|NCT04020133|Autonomic Agents|autonomic agents|mesh-ancestor
64543352|NCT04020133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64543353|NCT04020133|Respiratory System Agents|respiratory system agents|mesh-ancestor
64543354|NCT04020133|Mydriatics|mydriatics|mesh-ancestor
64543355|NCT04020133|Sympathomimetics|sympathomimetics|mesh-ancestor
64543356|NCT04020133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64543357|NCT04565574|Rifampin|rifampin|mesh-list
64543358|NCT04565574|Rabeprazole|rabeprazole|mesh-list
64543359|NCT04565574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64543360|NCT04565574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64543361|NCT04565574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64543362|NCT04565574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543532|NCT01275105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543534|NCT01275105|Autonomic Agents|autonomic agents|mesh-ancestor
64543535|NCT01275105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64543536|NCT01275105|Nasal Decongestants|nasal decongestants|mesh-ancestor
64543537|NCT01275105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64543538|NCT01275105|Respiratory System Agents|respiratory system agents|mesh-ancestor
64543539|NCT01275105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64543540|NCT01275105|Mydriatics|mydriatics|mesh-ancestor
65280229|NCT00642512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280230|NCT00642512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65280231|NCT00642512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65280232|NCT00642512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65280233|NCT00642512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64543541|NCT01275105|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64543542|NCT01275105|Protective Agents|protective agents|mesh-ancestor
64543543|NCT01270347|Levofloxacin|levofloxacin|mesh-list
64543544|NCT01270347|Ofloxacin|ofloxacin|mesh-list
64543545|NCT01270347|Tobramycin|tobramycin|mesh-list
64543546|NCT01270347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64543547|NCT01270347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64543578|NCT03412188|Hormones|hormones|mesh-ancestor
64543579|NCT03412188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64543580|NCT03412188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64543581|NCT03412188|Protective Agents|protective agents|mesh-ancestor
64543582|NCT03412188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64543583|NCT01278849|Vadimezan|vadimezan|mesh-list
64543584|NCT01278849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543585|NCT04949412|Vitamin D|vitamin d|mesh-list
64543586|NCT04949412|Vitamins|vitamins|mesh-ancestor
64543587|NCT04949412|Micronutrients|micronutrients|mesh-ancestor
64543588|NCT04949412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543589|NCT04949412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64543590|NCT04022473|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64543591|NCT04022473|Dermatologic Agents|dermatologic agents|mesh-ancestor
64543624|NCT03022747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64543625|NCT03022747|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64543627|NCT03022747|Protective Agents|protective agents|mesh-ancestor
64543628|NCT03022747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543629|NCT03928015|Analgesics|analgesics|mesh-list
64543630|NCT03928015|Dronabinol|dronabinol|mesh-list
64543631|NCT03928015|Sensory System Agents|sensory system agents|mesh-ancestor
64543632|NCT03928015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64543633|NCT03928015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543634|NCT03928015|Hallucinogens|hallucinogens|mesh-ancestor
64308371|NCT03224637|Antipyretics|antipyretics|mesh-ancestor
64543698|NCT00752973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543699|NCT00752973|Cholinergic Agents|cholinergic agents|mesh-ancestor
64543700|NCT00752973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64543701|NCT00752973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543702|NCT04025593|Prednisone|prednisone|mesh-list
64543703|NCT04025593|Cyclophosphamide|cyclophosphamide|mesh-list
64543704|NCT04025593|Rituximab|rituximab|mesh-list
64543705|NCT04025593|Doxorubicin|doxorubicin|mesh-list
64543706|NCT04025593|Vincristine|vincristine|mesh-list
64543707|NCT04025593|Lenalidomide|lenalidomide|mesh-list
64543708|NCT04025593|Decitabine|decitabine|mesh-list
64471700|NCT04233190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64543709|NCT04025593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64543710|NCT04025593|Immunologic Factors|immunologic factors|mesh-ancestor
64543711|NCT04025593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499816|NCT04697693|Citalopram|citalopram|mesh-list
64543737|NCT04025593|Antimetabolites|antimetabolites|mesh-ancestor
64543738|NCT01279707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64543739|NCT01279707|Epratuzumab|epratuzumab|mesh-list
64543752|NCT02957292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64543753|NCT02957292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64543754|NCT02957292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64543755|NCT02595060|Molgramostim|molgramostim|mesh-list
64543756|NCT02595060|Sargramostim|sargramostim|mesh-list
64543757|NCT02595060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543758|NCT02595060|Immunologic Factors|immunologic factors|mesh-ancestor
64543793|NCT03022123|Glucocorticoids|glucocorticoids|mesh-ancestor
64543795|NCT03022123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64543796|NCT03022123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64308547|NCT04485429|Heparin|heparin|mesh-list
64543820|NCT00722865|Growth Substances|growth substances|mesh-ancestor
64543821|NCT00722865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543822|NCT00722865|Growth Inhibitors|growth inhibitors|mesh-ancestor
64543823|NCT02700529|Ubenimex|ubenimex|mesh-list
64543824|NCT02700529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64543825|NCT02700529|Immunologic Factors|immunologic factors|mesh-ancestor
65280234|NCT00642512|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65280235|NCT00642512|Hallucinogens|hallucinogens|mesh-ancestor
65280236|NCT00642512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65280237|NCT00642512|Analgesics|analgesics|mesh-ancestor
65280238|NCT00642512|Sensory System Agents|sensory system agents|mesh-ancestor
65280239|NCT00642512|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65280240|NCT00642512|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65280241|NCT00642512|Hormones|hormones|mesh-ancestor
65280242|NCT00642512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65280243|NCT02802683|Phenylephrine|phenylephrine|mesh-list
65280244|NCT02802683|Oxymetazoline|oxymetazoline|mesh-list
65280245|NCT02802683|Bupivacaine|bupivacaine|mesh-list
65280246|NCT02802683|Levobupivacaine|levobupivacaine|mesh-list
65280247|NCT02802683|Anesthetics, Local|anesthetics, local|mesh-ancestor
65280248|NCT02802683|Anesthetics|anesthetics|mesh-ancestor
65280249|NCT02802683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65280250|NCT02802683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543826|NCT02700529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543827|NCT02700529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64543828|NCT02700529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64543829|NCT02700529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64543830|NCT02700529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543831|NCT02700529|Protease Inhibitors|protease inhibitors|mesh-ancestor
64543832|NCT02700529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543833|NCT02700529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543834|NCT02700529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64543835|NCT02700529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64543836|NCT02700529|Antiviral Agents|antiviral agents|mesh-ancestor
64543837|NCT04146493|Heparin|heparin|mesh-list
64543838|NCT04146493|Anticoagulants|anticoagulants|mesh-ancestor
64543839|NCT04146493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64543840|NCT04146493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64543841|NCT04146493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543842|NCT00723099|Cyclosporine|cyclosporine|mesh-list
64543843|NCT00723099|Mycophenolic Acid|mycophenolic acid|mesh-list
64543844|NCT00723099|Cyclophosphamide|cyclophosphamide|mesh-list
64543845|NCT00723099|Fludarabine|fludarabine|mesh-list
64308585|NCT02141035|Vitamins|vitamins|mesh-ancestor
64543870|NCT01508936|Respiratory System Agents|respiratory system agents|mesh-ancestor
64543871|NCT04146259|Alfacalcidol|alfacalcidol|mesh-list
64543872|NCT04146259|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
64543873|NCT04146259|Calcium Carbonate|calcium carbonate|mesh-list
64543874|NCT04146259|Calcium|calcium|mesh-list
64543875|NCT04146259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64543876|NCT04146259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543877|NCT04146259|Antacids|antacids|mesh-ancestor
64543878|NCT04146259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543879|NCT04146259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64543880|NCT04146259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64543881|NCT04146259|Vitamins|vitamins|mesh-ancestor
64543882|NCT04146259|Micronutrients|micronutrients|mesh-ancestor
64543883|NCT05100186|Dexamethasone|dexamethasone|mesh-list
64543884|NCT05100186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64543894|NCT05100186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543896|NCT04323462|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64543897|NCT04323462|Insulin Glargine|insulin glargine|mesh-list
64543930|NCT04142749|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64543931|NCT04142749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64543933|NCT04142749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543934|NCT01508702|Lesinurad|lesinurad|mesh-list
65280251|NCT02802683|Sensory System Agents|sensory system agents|mesh-ancestor
65280252|NCT02802683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280253|NCT02802683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65280254|NCT02802683|Mydriatics|mydriatics|mesh-ancestor
65280255|NCT02802683|Autonomic Agents|autonomic agents|mesh-ancestor
65280256|NCT02802683|Sympathomimetics|sympathomimetics|mesh-ancestor
65280257|NCT02802683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65280258|NCT02802683|Nasal Decongestants|nasal decongestants|mesh-ancestor
65280259|NCT02802683|Respiratory System Agents|respiratory system agents|mesh-ancestor
65280260|NCT02802683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64543935|NCT01508702|Gout Suppressants|gout suppressants|mesh-ancestor
64543936|NCT01508702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64543937|NCT01508702|Uricosuric Agents|uricosuric agents|mesh-ancestor
64543938|NCT01508702|Renal Agents|renal agents|mesh-ancestor
64543939|NCT04024813|Seladelpar|seladelpar|mesh-list
64543940|NCT04024813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64543941|NCT04024813|Antimetabolites|antimetabolites|mesh-ancestor
64308689|NCT03208335|Growth Inhibitors|growth inhibitors|mesh-ancestor
64500057|NCT05238012|Atorvastatin|atorvastatin|mesh-list
64543963|NCT01275339|Vasodilator Agents|vasodilator agents|mesh-ancestor
64543964|NCT01275339|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64543965|NCT01275339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64543966|NCT01275339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543967|NCT01275339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543968|NCT01275339|Urological Agents|urological agents|mesh-ancestor
64543969|NCT01520402|Warfarin|warfarin|mesh-list
64543970|NCT01520402|Anticoagulants|anticoagulants|mesh-list
64543971|NCT00738543|Povidone-Iodine|povidone-iodine|mesh-list
64543972|NCT00738543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64543973|NCT00738543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64543974|NCT05108220|Cannabidiol|cannabidiol|mesh-list
64543975|NCT05108220|Anticonvulsants|anticonvulsants|mesh-ancestor
64543976|NCT03027674|Nifedipine|nifedipine|mesh-list
64543977|NCT03027674|Sildenafil Citrate|sildenafil citrate|mesh-list
64543978|NCT03027674|Vasodilator Agents|vasodilator agents|mesh-ancestor
64543979|NCT03027674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64543980|NCT03027674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64543981|NCT03027674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543982|NCT03027674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543983|NCT03027674|Urological Agents|urological agents|mesh-ancestor
64543984|NCT03027674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64543985|NCT03027674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64543986|NCT03027674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64543987|NCT03027674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543988|NCT03027674|Tocolytic Agents|tocolytic agents|mesh-ancestor
64543989|NCT03027674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64543990|NCT04530630|Emtricitabine|emtricitabine|mesh-list
64543991|NCT04530630|Antiviral Agents|antiviral agents|mesh-ancestor
64543992|NCT04530630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64543993|NCT04530630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64544080|NCT04144933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64544081|NCT04144933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64544082|NCT04144933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64544083|NCT04144933|Anesthetics, General|anesthetics, general|mesh-ancestor
64544084|NCT04144933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64544085|NCT04144933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64544167|NCT05110482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544168|NCT04930458|Listerine|listerine|mesh-list
64544169|NCT04930458|Calcium|calcium|mesh-list
64544170|NCT04930458|Fluorides|fluorides|mesh-list
64544171|NCT04930458|Sodium Fluoride|sodium fluoride|mesh-list
64544172|NCT04930458|Fluorides, Topical|fluorides, topical|mesh-list
64544173|NCT04930458|Caseins|caseins|mesh-list
64544174|NCT04930458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64544175|NCT04930458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544176|NCT04930458|Cariostatic Agents|cariostatic agents|mesh-ancestor
64544177|NCT04930458|Protective Agents|protective agents|mesh-ancestor
65280261|NCT02802683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65280262|NCT02802683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65280263|NCT02802683|Adrenergic Agents|adrenergic agents|mesh-ancestor
65280264|NCT02802683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65280265|NCT02802683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280266|NCT02802683|Protective Agents|protective agents|mesh-ancestor
65280267|NCT00641264|Omeprazole|omeprazole|mesh-list
64544178|NCT04930458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64544210|NCT04022005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64544211|NCT04022005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64544212|NCT04022005|Antimetabolites|antimetabolites|mesh-ancestor
64544213|NCT04022005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544214|NCT04022005|Antiviral Agents|antiviral agents|mesh-ancestor
64544215|NCT04022005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544216|NCT04022005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544217|NCT04022005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64544218|NCT03943537|Insulin|insulin|mesh-list
64544219|NCT03943537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64544220|NCT03943537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544221|NCT05099250|Magnesium Sulfate|magnesium sulfate|mesh-list
64544222|NCT05099250|Bupivacaine|bupivacaine|mesh-list
64544283|NCT02080819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64544284|NCT02080819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64544285|NCT02080819|Dopamine Agents|dopamine agents|mesh-ancestor
64544286|NCT02080819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64544287|NCT02080819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544288|NCT02080819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544289|NCT02080819|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64544290|NCT02080819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544291|NCT05104788|Carboplatin|carboplatin|mesh-list
64544292|NCT05104788|Pemetrexed|pemetrexed|mesh-list
64544293|NCT05104788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544294|NCT05104788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544295|NCT05104788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544296|NCT05104788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64544297|NCT05104788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64544298|NCT04405843|Ivermectin|ivermectin|mesh-list
64544299|NCT04405843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64544300|NCT04405843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544301|NCT04316364|Paclitaxel|paclitaxel|mesh-list
64544302|NCT04316364|Carboplatin|carboplatin|mesh-list
64309059|NCT02447835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64544361|NCT03896737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64991464|NCT04394975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544382|NCT04685772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64544411|NCT03476317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544412|NCT03476317|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64544413|NCT03476317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64544414|NCT03476317|Antifungal Agents|antifungal agents|mesh-ancestor
64471701|NCT04233190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544415|NCT03476317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64544416|NCT03476317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64544417|NCT03476317|Hormone Antagonists|hormone antagonists|mesh-ancestor
64544418|NCT03476317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64544419|NCT03476317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544420|NCT03476317|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64544421|NCT03476317|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64544422|NCT03476317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64544423|NCT03476317|Laxatives|laxatives|mesh-ancestor
64544424|NCT03476317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64544425|NCT02658084|Trastuzumab|trastuzumab|mesh-list
64544426|NCT02658084|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64544427|NCT02658084|Vinorelbine|vinorelbine|mesh-list
64544456|NCT04527432|Immunologic Factors|immunologic factors|mesh-ancestor
64544457|NCT04527432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544458|NCT03912805|Botulinum Toxins|botulinum toxins|mesh-list
64544459|NCT03912805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65280268|NCT00641264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65280269|NCT00641264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65280270|NCT00641264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65280271|NCT00641264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280272|NCT00641264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280273|NCT05484167|Methyltestosterone|methyltestosterone|mesh-list
65280274|NCT05484167|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65280275|NCT05484167|Testosterone|testosterone|mesh-list
65280276|NCT05484167|Testosterone undecanoate|testosterone undecanoate|mesh-list
64732655|NCT00004183|Capecitabine|capecitabine|mesh-list
64544460|NCT03912805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64544461|NCT03912805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64544462|NCT03912805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64544475|NCT03630055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544511|NCT04030182|Micronutrients|micronutrients|mesh-ancestor
64544512|NCT04030182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544513|NCT04030182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64544514|NCT05109312|Acetaminophen|acetaminophen|mesh-list
64544515|NCT05109312|Ibuprofen|ibuprofen|mesh-list
64544516|NCT05109312|Bupivacaine|bupivacaine|mesh-list
64544517|NCT05109312|Anesthetics, Local|anesthetics, local|mesh-ancestor
64544518|NCT05109312|Anesthetics|anesthetics|mesh-ancestor
64544519|NCT05109312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64544520|NCT05109312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544521|NCT05109312|Sensory System Agents|sensory system agents|mesh-ancestor
64309285|NCT03197571|Vitamins|vitamins|mesh-ancestor
64544576|NCT04701060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64544577|NCT04701060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544578|NCT04701060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544579|NCT05116098|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
64544580|NCT05116098|Antioxidants|antioxidants|mesh-ancestor
64544581|NCT05116098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544582|NCT05116098|Protective Agents|protective agents|mesh-ancestor
64544583|NCT05116098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544584|NCT05116098|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64544585|NCT05116098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64544586|NCT05116098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544587|NCT05116098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64544588|NCT04464408|Favipiravir|favipiravir|mesh-list
64544589|NCT04464408|Antiviral Agents|antiviral agents|mesh-ancestor
64544590|NCT04464408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544591|NCT04339218|Carboplatin|carboplatin|mesh-list
64544592|NCT04339218|Pembrolizumab|pembrolizumab|mesh-list
64544593|NCT04339218|Pemetrexed|pemetrexed|mesh-list
64544594|NCT04339218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544595|NCT04339218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64544596|NCT04339218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309358|NCT03202719|Vaccines|vaccines|mesh-list
64544620|NCT04521582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64544621|NCT04521582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64544622|NCT04521582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64544623|NCT04521582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471702|NCT04233190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64471714|NCT04230252|Acetaminophen|acetaminophen|mesh-list
64544624|NCT04521582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64544625|NCT04521582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544626|NCT04521582|Vasodilator Agents|vasodilator agents|mesh-ancestor
64544627|NCT03588091|Docetaxel|docetaxel|mesh-list
64544628|NCT03588091|Trastuzumab|trastuzumab|mesh-list
64544629|NCT03588091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544630|NCT03588091|Tubulin Modulators|tubulin modulators|mesh-ancestor
64544631|NCT03588091|Antimitotic Agents|antimitotic agents|mesh-ancestor
64544643|NCT04436172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64544644|NCT04436172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544645|NCT04720326|Tacrolimus|tacrolimus|mesh-list
64544646|NCT04720326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65280277|NCT05484167|Testosterone enanthate|testosterone enanthate|mesh-list
65280278|NCT05484167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65280279|NCT05484167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280280|NCT05484167|Anabolic Agents|anabolic agents|mesh-ancestor
65280281|NCT05484167|Hormones|hormones|mesh-ancestor
65280282|NCT05484167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65280283|NCT05484167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280284|NCT05484167|Androgens|androgens|mesh-ancestor
65280285|NCT04183322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65280286|NCT04183322|Immunologic Factors|immunologic factors|mesh-ancestor
65280287|NCT04183322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280288|NCT04180982|Febuxostat|febuxostat|mesh-list
65280289|NCT04180982|Gout Suppressants|gout suppressants|mesh-ancestor
65280290|NCT04180982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65280291|NCT02802605|Bemiparin|bemiparin|mesh-list
64309411|NCT02446431|Anticonvulsants|anticonvulsants|mesh-ancestor
64544678|NCT04516902|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64544679|NCT04516902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64544680|NCT04516902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64544681|NCT04516902|Adrenergic Agents|adrenergic agents|mesh-ancestor
64544682|NCT04516902|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64544683|NCT04516902|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64544684|NCT03581149|Ascorbic Acid|ascorbic acid|mesh-list
64544685|NCT03581149|Picosulfate sodium|picosulfate sodium|mesh-list
64544686|NCT03581149|Magnesium citrate|magnesium citrate|mesh-list
64544687|NCT03581149|Laxatives|laxatives|mesh-list
64544688|NCT03581149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544761|NCT05040126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544762|NCT05040126|Antitubercular Agents|antitubercular agents|mesh-ancestor
64544763|NCT03217201|Methamphetamine|methamphetamine|mesh-list
64544764|NCT03217201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64544794|NCT05582317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64544795|NCT05582317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64544796|NCT05582317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544798|NCT03891355|Lenalidomide|lenalidomide|mesh-list
64544799|NCT03891355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64544800|NCT03891355|Antiemetics|antiemetics|mesh-ancestor
64544801|NCT03891355|Autonomic Agents|autonomic agents|mesh-ancestor
64544802|NCT03891355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64544803|NCT03891355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544804|NCT03891355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64544805|NCT03891355|Glucocorticoids|glucocorticoids|mesh-ancestor
64544806|NCT03891355|Hormones|hormones|mesh-ancestor
64544807|NCT03891355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64544808|NCT03891355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64544831|NCT03580291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544833|NCT03580291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544834|NCT02936388|Cisplatin|cisplatin|mesh-list
64544835|NCT02936388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544836|NCT03586141|Chrysarobin|chrysarobin|mesh-list
64544837|NCT03586141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64544838|NCT03586141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64544839|NCT03586141|Analgesics|analgesics|mesh-ancestor
64544840|NCT03586141|Sensory System Agents|sensory system agents|mesh-ancestor
64544841|NCT03586141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64544842|NCT03586141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544843|NCT03586141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64544844|NCT03586141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64544845|NCT03020563|Bupivacaine|bupivacaine|mesh-list
65280292|NCT02802605|Anticoagulants|anticoagulants|mesh-ancestor
65280293|NCT02800265|Sulforaphane|sulforaphane|mesh-list
65030312|NCT04899778|Iron|iron|mesh-list
65280294|NCT02800265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65280295|NCT02800265|Protective Agents|protective agents|mesh-ancestor
65280296|NCT02800265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280297|NCT02800265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280298|NCT02676986|Exemestane|exemestane|mesh-list
65280299|NCT02676986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280300|NCT02676986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65280301|NCT02676986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65280302|NCT02676986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544846|NCT03020563|Anesthetics, Local|anesthetics, local|mesh-ancestor
64544954|NCT05701813|Vitamins|vitamins|mesh-ancestor
64544955|NCT05701813|Micronutrients|micronutrients|mesh-ancestor
64544956|NCT05701813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544957|NCT03586219|Analgesics, Opioid|analgesics, opioid|mesh-list
64544958|NCT03586219|Narcotics|narcotics|mesh-ancestor
64544959|NCT03586219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64544960|NCT03586219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544961|NCT03586219|Analgesics|analgesics|mesh-ancestor
64544962|NCT03586219|Sensory System Agents|sensory system agents|mesh-ancestor
64544963|NCT03586219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64544964|NCT05118984|Azithromycin|azithromycin|mesh-list
64544965|NCT05118984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64544966|NCT05118984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544967|NCT04514328|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64544968|NCT04514328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64544969|NCT04514328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544970|NCT02802852|Lenograstim|lenograstim|mesh-list
64544971|NCT02802852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64544972|NCT02802852|Immunologic Factors|immunologic factors|mesh-ancestor
64544973|NCT02802852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544974|NCT03158389|Sirolimus|sirolimus|mesh-list
64544975|NCT03158389|Atezolizumab|atezolizumab|mesh-list
64545060|NCT03589495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545062|NCT03159559|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64545063|NCT03159559|Alprostadil|alprostadil|mesh-list
64545064|NCT03159559|Clopidogrel|clopidogrel|mesh-list
64545065|NCT03159559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471715|NCT04230252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64545066|NCT03159559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545098|NCT03583489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64545099|NCT03583489|Antipruritics|antipruritics|mesh-ancestor
64545100|NCT03583489|Dermatologic Agents|dermatologic agents|mesh-ancestor
64545101|NCT03583489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64545102|NCT03583489|Serotonin Agents|serotonin agents|mesh-ancestor
64545103|NCT03583489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64545104|NCT03583489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545105|NCT03583489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64545106|NCT03583489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64545107|NCT03583489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64545108|NCT03583489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64545180|NCT05122338|Lidocaine|lidocaine|mesh-list
64545181|NCT05122338|Ropivacaine|ropivacaine|mesh-list
64545182|NCT05122338|Esketamine|esketamine|mesh-list
64545183|NCT05122338|Anesthetics, Local|anesthetics, local|mesh-ancestor
64545184|NCT05122338|Anesthetics|anesthetics|mesh-ancestor
64545185|NCT05122338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64991750|NCT04190433|Lisinopril|lisinopril|mesh-list
64545224|NCT03589027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64545225|NCT03589027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64545226|NCT03589027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64545227|NCT03589027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64545228|NCT03874494|Aripiprazole|aripiprazole|mesh-list
64545229|NCT03874494|Brexpiprazole|brexpiprazole|mesh-list
64545230|NCT03874494|Antidepressive Agents|antidepressive agents|mesh-ancestor
65280303|NCT02676986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545231|NCT03874494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64545232|NCT03874494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64545233|NCT03874494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64545234|NCT03874494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64545235|NCT03874494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545236|NCT03874494|Dopamine Agonists|dopamine agonists|mesh-ancestor
64545237|NCT03874494|Dopamine Agents|dopamine agents|mesh-ancestor
64545238|NCT03874494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64545239|NCT03874494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545240|NCT03874494|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64545241|NCT03874494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64545242|NCT03874494|Serotonin Agents|serotonin agents|mesh-ancestor
64545243|NCT03874494|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64545307|NCT04510194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545308|NCT04510194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64545309|NCT03155971|Paclitaxel|paclitaxel|mesh-list
64545310|NCT03155971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64545311|NCT03155971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545312|NCT03155971|Tubulin Modulators|tubulin modulators|mesh-ancestor
64545313|NCT03155971|Antimitotic Agents|antimitotic agents|mesh-ancestor
64545314|NCT03155971|Mitosis Modulators|mitosis modulators|mesh-ancestor
64545315|NCT03155971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545316|NCT03582319|Formaldehyde|formaldehyde|mesh-list
64501393|NCT03375138|Abatacept|abatacept|mesh-list
64545317|NCT03582319|Disinfectants|disinfectants|mesh-ancestor
64545341|NCT03155893|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64545342|NCT03155893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64545343|NCT03155893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64545344|NCT03155893|Antiviral Agents|antiviral agents|mesh-ancestor
64545345|NCT03582007|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64545346|NCT03582007|Murepavadin|murepavadin|mesh-list
64545347|NCT03582007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64991801|NCT04172532|Peposertib|peposertib|mesh-list
64545456|NCT02788591|Sucralfate|sucralfate|mesh-list
64545457|NCT02788591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64545458|NCT02788591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64545459|NCT02788591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64545460|NCT02788591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545461|NCT02788591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545462|NCT05229042|Ricolinostat|ricolinostat|mesh-list
64545463|NCT05229042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545464|NCT05229042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64545465|NCT05229042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545466|NCT05229042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545467|NCT01670305|Photosensitizing Agents|photosensitizing agents|mesh-list
64545468|NCT01670305|Dermatologic Agents|dermatologic agents|mesh-ancestor
64545469|NCT03267498|Nivolumab|nivolumab|mesh-list
64545470|NCT03267498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545471|NCT03267498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64545472|NCT03267498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64545473|NCT03267498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545474|NCT03076164|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64545475|NCT03076164|Trametinib|trametinib|mesh-list
64545476|NCT03076164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545477|NCT03076164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64545504|NCT01670929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545505|NCT02673996|Phenylephrine|phenylephrine|mesh-list
64545506|NCT02673996|Isoproterenol|isoproterenol|mesh-list
64545507|NCT02673996|Oxymetazoline|oxymetazoline|mesh-list
64545513|NCT02673996|Sympathomimetics|sympathomimetics|mesh-ancestor
64545514|NCT02673996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64545515|NCT02673996|Nasal Decongestants|nasal decongestants|mesh-ancestor
64545516|NCT02673996|Respiratory System Agents|respiratory system agents|mesh-ancestor
64545517|NCT02673996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64545518|NCT02673996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64545519|NCT02673996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64545520|NCT02673996|Adrenergic Agents|adrenergic agents|mesh-ancestor
64545521|NCT02673996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64545522|NCT02673996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545523|NCT02673996|Protective Agents|protective agents|mesh-ancestor
64545524|NCT02673996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65280304|NCT02676986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65280305|NCT02676986|Hormone Antagonists|hormone antagonists|mesh-ancestor
65280306|NCT02676986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65280307|NCT02676986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280308|NCT02802215|Folic Acid|folic acid|mesh-list
65280309|NCT02802215|Metformin|metformin|mesh-list
64545525|NCT02673996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64545526|NCT02673996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64545612|NCT03154567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545613|NCT03154567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64545614|NCT03154567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64545615|NCT03154567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64545616|NCT03154567|Adrenergic Agents|adrenergic agents|mesh-ancestor
64545617|NCT03154567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64545618|NCT03154567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545619|NCT03154567|Urological Agents|urological agents|mesh-ancestor
64545620|NCT04310748|Anesthetics|anesthetics|mesh-list
64545621|NCT04310748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64545622|NCT04310748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545623|NCT03154645|Ibuprofen|ibuprofen|mesh-list
64545624|NCT03154645|Acetazolamide|acetazolamide|mesh-list
64545625|NCT03154645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64545626|NCT03154645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64545627|NCT03154645|Analgesics|analgesics|mesh-ancestor
64545628|NCT03154645|Sensory System Agents|sensory system agents|mesh-ancestor
64545629|NCT03154645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64545630|NCT03154645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545631|NCT03154645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64545632|NCT03154645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64545633|NCT03154645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64545634|NCT03154645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545668|NCT05222256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64545669|NCT05222256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64545670|NCT05222256|Autonomic Agents|autonomic agents|mesh-ancestor
64545671|NCT05222256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64545672|NCT05222256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64545673|NCT05222256|Respiratory System Agents|respiratory system agents|mesh-ancestor
64545675|NCT05222256|Sympathomimetics|sympathomimetics|mesh-ancestor
64545818|NCT03463525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545819|NCT01675128|Irinotecan|irinotecan|mesh-list
64545820|NCT01675128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64545821|NCT01675128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64545822|NCT01675128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545823|NCT01675128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545846|NCT04508244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64545847|NCT04508244|Adrenergic Agents|adrenergic agents|mesh-ancestor
64545848|NCT04508244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64545849|NCT04508244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545850|NCT04508244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545851|NCT04508244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64545852|NCT04508244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64471717|NCT04230252|Sensory System Agents|sensory system agents|mesh-ancestor
64545853|NCT04508244|Vasodilator Agents|vasodilator agents|mesh-ancestor
64545855|NCT03243175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64545856|NCT03243175|Antithrombins|antithrombins|mesh-ancestor
64545857|NCT03243175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64545858|NCT03243175|Protease Inhibitors|protease inhibitors|mesh-ancestor
64545920|NCT04404517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64545950|NCT01427309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545951|NCT01426373|Deoxycholic Acid|deoxycholic acid|mesh-list
64545952|NCT01426373|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64545953|NCT01426373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64545961|NCT03855007|Hydroxychloroquine|hydroxychloroquine|mesh-list
64545962|NCT03855007|Prednisone|prednisone|mesh-list
64545963|NCT03855007|Methotrexate|methotrexate|mesh-list
64545964|NCT03855007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64545965|NCT03855007|Glucocorticoids|glucocorticoids|mesh-ancestor
64545966|NCT03855007|Hormones|hormones|mesh-ancestor
65280310|NCT02802215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65280311|NCT02802215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280312|NCT02802215|Hematinics|hematinics|mesh-ancestor
65280313|NCT02802215|Vitamin B Complex|vitamin b complex|mesh-ancestor
65280314|NCT02802215|Vitamins|vitamins|mesh-ancestor
65280315|NCT02802215|Micronutrients|micronutrients|mesh-ancestor
65280316|NCT02799797|Sufentanil|sufentanil|mesh-list
65280317|NCT02799797|Dsuvia|dsuvia|mesh-list
65280318|NCT02799797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65280319|NCT02799797|Narcotics|narcotics|mesh-ancestor
65280320|NCT02799797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65280321|NCT02799797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280322|NCT02799797|Analgesics|analgesics|mesh-ancestor
65280323|NCT02799797|Sensory System Agents|sensory system agents|mesh-ancestor
65280324|NCT02799797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280325|NCT02799797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65280326|NCT02799797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65280327|NCT02799797|Anesthetics, General|anesthetics, general|mesh-ancestor
65280328|NCT02799797|Anesthetics|anesthetics|mesh-ancestor
65280329|NCT05663372|Eplerenone|eplerenone|mesh-list
65280330|NCT05663372|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65280331|NCT05663372|Hormone Antagonists|hormone antagonists|mesh-ancestor
65344910|NCT00736346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64545967|NCT03855007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64545968|NCT03855007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545969|NCT03855007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64545970|NCT03855007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310770|NCT02769247|Anesthetics|anesthetics|mesh-ancestor
64546025|NCT04404751|Hydroxocobalamin|hydroxocobalamin|mesh-list
64546026|NCT04404751|Iron|iron|mesh-list
64546027|NCT04404751|Vitamins|vitamins|mesh-ancestor
64546028|NCT04404751|Micronutrients|micronutrients|mesh-ancestor
64546029|NCT04404751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546030|NCT04404751|Trace Elements|trace elements|mesh-ancestor
64546031|NCT04404751|Hematinics|hematinics|mesh-ancestor
64546032|NCT04404751|Vitamin B Complex|vitamin b complex|mesh-ancestor
64546033|NCT01403051|Calcium, Dietary|calcium, dietary|mesh-list
64546034|NCT01403051|Vitamin D|vitamin d|mesh-list
64546035|NCT01403051|Ergocalciferols|ergocalciferols|mesh-list
64546036|NCT01403051|Cholecalciferol|cholecalciferol|mesh-list
64546037|NCT01403051|Vitamins|vitamins|mesh-list
64546038|NCT01403051|Calcium Carbonate|calcium carbonate|mesh-list
64546039|NCT01403051|Calcium|calcium|mesh-list
64546040|NCT01403051|Micronutrients|micronutrients|mesh-ancestor
64546041|NCT01403051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546042|NCT01403051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64546043|NCT01403051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64546044|NCT01403051|Antacids|antacids|mesh-ancestor
64471718|NCT04230252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64546058|NCT03841357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64546059|NCT03841357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546060|NCT03841357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546061|NCT03841357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64546062|NCT03841357|Immunologic Factors|immunologic factors|mesh-ancestor
64546089|NCT03754933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64546090|NCT03754933|Immunologic Factors|immunologic factors|mesh-ancestor
65280332|NCT05663372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65280333|NCT05663372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280334|NCT05663372|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65280335|NCT05663372|Diuretics|diuretics|mesh-ancestor
64546091|NCT03754933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546093|NCT03870919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546094|NCT03870919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64546095|NCT03870919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546096|NCT03870919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546097|NCT04747171|Dexmedetomidine|dexmedetomidine|mesh-list
64546098|NCT04747171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64546099|NCT04747171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64546100|NCT04747171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546102|NCT04747171|Analgesics|analgesics|mesh-ancestor
64546103|NCT04747171|Sensory System Agents|sensory system agents|mesh-ancestor
64546104|NCT04747171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64546105|NCT04747171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64546106|NCT04747171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64546107|NCT04747171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64546108|NCT04747171|Adrenergic Agents|adrenergic agents|mesh-ancestor
64546109|NCT04747171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64546110|NCT04747171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546111|NCT02082769|Allopurinol|allopurinol|mesh-list
64546112|NCT02082769|Febuxostat|febuxostat|mesh-list
64546144|NCT03745729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546145|NCT03745729|Gout Suppressants|gout suppressants|mesh-ancestor
64546146|NCT03745729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64546147|NCT03745729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64546148|NCT03745729|Antioxidants|antioxidants|mesh-ancestor
64546149|NCT03745729|Protective Agents|protective agents|mesh-ancestor
64546150|NCT03745729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546151|NCT04904952|Acetylcysteine|acetylcysteine|mesh-list
64546152|NCT04904952|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64546153|NCT04904952|Antiviral Agents|antiviral agents|mesh-ancestor
64546154|NCT04904952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64546155|NCT04904952|Expectorants|expectorants|mesh-ancestor
64546156|NCT04904952|Respiratory System Agents|respiratory system agents|mesh-ancestor
64546157|NCT04904952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64546222|NCT03742141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546223|NCT03742141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546225|NCT03441750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64546226|NCT03441750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546305|NCT03820141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64546307|NCT03651895|Metformin|metformin|mesh-list
64546308|NCT03651895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64311124|NCT03048110|Leprostatic Agents|leprostatic agents|mesh-ancestor
64546344|NCT03807037|Protective Agents|protective agents|mesh-ancestor
64546345|NCT03807037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546347|NCT03807037|Micronutrients|micronutrients|mesh-ancestor
64546355|NCT03805399|Sirolimus|sirolimus|mesh-list
64546356|NCT03805399|Paclitaxel|paclitaxel|mesh-list
64546357|NCT03805399|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64546358|NCT03805399|Capecitabine|capecitabine|mesh-list
64546359|NCT03805399|Everolimus|everolimus|mesh-list
64546360|NCT03805399|Apatinib|apatinib|mesh-list
64546361|NCT03805399|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64471719|NCT04230252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546362|NCT03805399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64546363|NCT03805399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546365|NCT03805399|Antimitotic Agents|antimitotic agents|mesh-ancestor
64546366|NCT03805399|Mitosis Modulators|mitosis modulators|mesh-ancestor
64546367|NCT03805399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546457|NCT01279551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546458|NCT01279551|Vasodilator Agents|vasodilator agents|mesh-ancestor
64546459|NCT03738696|Bupivacaine|bupivacaine|mesh-list
64546460|NCT03738696|Ropivacaine|ropivacaine|mesh-list
64546461|NCT03738696|Anesthetics, Local|anesthetics, local|mesh-ancestor
64546462|NCT03738696|Anesthetics|anesthetics|mesh-ancestor
64546463|NCT03738696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64546464|NCT03738696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280336|NCT05663372|Natriuretic Agents|natriuretic agents|mesh-ancestor
65280337|NCT05663372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65280338|NCT02802137|Timolol|timolol|mesh-list
65280339|NCT02802137|Dorzolamide|dorzolamide|mesh-list
65280340|NCT02802137|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65280341|NCT02802137|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65280342|NCT02802137|Adrenergic Agents|adrenergic agents|mesh-ancestor
65280343|NCT02802137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65280344|NCT02802137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280345|NCT02802137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280346|NCT02802137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65280347|NCT02802137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65280348|NCT02802137|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65280349|NCT02802137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280350|NCT04033562|Lidocaine|lidocaine|mesh-list
65280351|NCT04033562|Bupivacaine|bupivacaine|mesh-list
65280352|NCT04033562|Anesthetics, Local|anesthetics, local|mesh-ancestor
65280353|NCT04033562|Anesthetics|anesthetics|mesh-ancestor
65280354|NCT04033562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65280355|NCT04033562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546465|NCT03738696|Sensory System Agents|sensory system agents|mesh-ancestor
64546466|NCT03738696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64546554|NCT04412694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64546555|NCT04412694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546556|NCT04412694|Protease Inhibitors|protease inhibitors|mesh-ancestor
64546557|NCT04412694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546558|NCT04412694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546559|NCT03627715|Proxigermanium|proxigermanium|mesh-list
64546560|NCT03627715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546561|NCT03627715|Interferon Inducers|interferon inducers|mesh-ancestor
64546562|NCT03627715|Immunologic Factors|immunologic factors|mesh-ancestor
64546563|NCT03627715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546565|NCT00246753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546566|NCT00246753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64546567|NCT00246753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546568|NCT00246753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546569|NCT02083861|Oxymetazoline|oxymetazoline|mesh-list
64546570|NCT02083861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64546571|NCT02083861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64546572|NCT02083861|Adrenergic Agents|adrenergic agents|mesh-ancestor
64546573|NCT02083861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64546708|NCT03699319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64546709|NCT03699319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546710|NCT03699319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546711|NCT03699319|Antidotes|antidotes|mesh-ancestor
64546712|NCT03699319|Protective Agents|protective agents|mesh-ancestor
64546713|NCT03699319|Vitamin B Complex|vitamin b complex|mesh-ancestor
64471720|NCT04230252|Antipyretics|antipyretics|mesh-ancestor
64546715|NCT03699319|Micronutrients|micronutrients|mesh-ancestor
64546716|NCT03699319|Hematinics|hematinics|mesh-ancestor
64546717|NCT00754923|Sorafenib|sorafenib|mesh-list
64546718|NCT00754923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546719|NCT00754923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64546720|NCT00754923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546805|NCT03600649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65280356|NCT04033562|Sensory System Agents|sensory system agents|mesh-ancestor
65280357|NCT04033562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280358|NCT04033562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65280359|NCT04033562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64320494|NCT04766996|Omeprazole|omeprazole|mesh-list
64546806|NCT03600649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64546807|NCT03600649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64546808|NCT03600649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546810|NCT00244881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546811|NCT00244881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546812|NCT00244881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546813|NCT00244881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64546814|NCT00530517|Sumatriptan|sumatriptan|mesh-list
64546815|NCT00530517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64546816|NCT00530517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64546817|NCT00530517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64546818|NCT00530517|Serotonin Agents|serotonin agents|mesh-ancestor
64546850|NCT03765541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546851|NCT05123976|Olanzapine|olanzapine|mesh-list
64546852|NCT05123976|Antiemetics|antiemetics|mesh-ancestor
64546853|NCT05123976|Autonomic Agents|autonomic agents|mesh-ancestor
64546854|NCT05123976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64546855|NCT05123976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546856|NCT05123976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64546857|NCT05123976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64546858|NCT05123976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64546859|NCT05123976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64546860|NCT05123976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64546861|NCT05123976|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64546901|NCT00005803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64546902|NCT00005803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64547025|NCT01275729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64547026|NCT01275729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64547027|NCT01275729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547029|NCT00243867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64547030|NCT00243867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547031|NCT00243867|Tubulin Modulators|tubulin modulators|mesh-ancestor
64547032|NCT00243867|Antimitotic Agents|antimitotic agents|mesh-ancestor
64547033|NCT00243867|Mitosis Modulators|mitosis modulators|mesh-ancestor
64547034|NCT00243867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547035|NCT01679899|Vildagliptin|vildagliptin|mesh-list
64547036|NCT01679899|Gliclazide|gliclazide|mesh-list
64547037|NCT01679899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64547149|NCT01276353|Donepezil|donepezil|mesh-list
64547150|NCT01276353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64547151|NCT01276353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547152|NCT01276353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547153|NCT01276353|Cholinergic Agents|cholinergic agents|mesh-ancestor
64992331|NCT03861091|Risedronic Acid|risedronic acid|mesh-list
64547184|NCT01675609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64547185|NCT01675609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547186|NCT01675609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547187|NCT01673659|Mometasone Furoate|mometasone furoate|mesh-list
64547188|NCT01673659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64547189|NCT01673659|Dermatologic Agents|dermatologic agents|mesh-ancestor
64471735|NCT04217317|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64547190|NCT01673659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64547191|NCT00762177|Triclosan|triclosan|mesh-list
64547192|NCT00762177|Fluorides|fluorides|mesh-list
64547193|NCT00762177|Tin Fluorides|tin fluorides|mesh-list
64547194|NCT00762177|Cariostatic Agents|cariostatic agents|mesh-ancestor
64547195|NCT00762177|Protective Agents|protective agents|mesh-ancestor
64547196|NCT00762177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547197|NCT00762177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64547198|NCT00762177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64547199|NCT00762177|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64547200|NCT00762177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64547201|NCT00762177|Antimetabolites|antimetabolites|mesh-ancestor
64547202|NCT00762177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280360|NCT04033562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65280361|NCT04033562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65280362|NCT04033562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280363|NCT04032834|Budesonide|budesonide|mesh-list
65280364|NCT04032834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65280365|NCT04032834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65280366|NCT04032834|Autonomic Agents|autonomic agents|mesh-ancestor
65280367|NCT04032834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280368|NCT04032834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280369|NCT04032834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65280370|NCT04032834|Respiratory System Agents|respiratory system agents|mesh-ancestor
65280371|NCT04032834|Glucocorticoids|glucocorticoids|mesh-ancestor
65280373|NCT04032834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65280374|NCT02817191|Tobramycin|tobramycin|mesh-list
65280375|NCT02817191|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
64547226|NCT00777855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64547227|NCT00777855|Antitubercular Agents|antitubercular agents|mesh-ancestor
64547228|NCT00777855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64547229|NCT00777855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64547230|NCT00777855|Leprostatic Agents|leprostatic agents|mesh-ancestor
64547231|NCT00777855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64547232|NCT00777855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547233|NCT00777855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547234|NCT00777855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64547235|NCT00777855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64547236|NCT00777855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64547237|NCT00777855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64547238|NCT00777855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64547239|NCT00777855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64547240|NCT03523429|Blinatumomab|blinatumomab|mesh-list
64547241|NCT03523429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547242|NCT05125380|Acetic Acid|acetic acid|mesh-list
64547243|NCT05125380|Retinol acetate|retinol acetate|mesh-list
64547244|NCT05125380|Lugol's solution|lugol's solution|mesh-list
64547245|NCT05125380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64547246|NCT05125380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64547247|NCT05125380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64547248|NCT05125380|Immunologic Factors|immunologic factors|mesh-ancestor
64547249|NCT05125380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547250|NCT05125380|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64547251|NCT05125380|Protective Agents|protective agents|mesh-ancestor
64547252|NCT05125380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547287|NCT03807297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64547288|NCT03807297|Adrenergic Agents|adrenergic agents|mesh-ancestor
64547289|NCT03807297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64547290|NCT03807297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547291|NCT03807297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64547292|NCT03807297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64547294|NCT03573349|Analgesics|analgesics|mesh-ancestor
64547319|NCT03513445|Narcotics|narcotics|mesh-ancestor
64547320|NCT03513445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64547418|NCT00778869|Dermatologic Agents|dermatologic agents|mesh-ancestor
64547419|NCT00778869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64547420|NCT00778869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64547421|NCT05008536|Fludarabine|fludarabine|mesh-list
64992447|NCT03742414|Xhance|xhance|mesh-list
64547522|NCT04762147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65280376|NCT02817191|Dexamethasone|dexamethasone|mesh-list
65280377|NCT02817191|Dexamethasone acetate|dexamethasone acetate|mesh-list
65280378|NCT02817191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65280379|NCT02817191|BB 1101|bb 1101|mesh-list
65280380|NCT02817191|Dipivefrin|dipivefrin|mesh-list
64732762|NCT00003859|Etoposide|etoposide|mesh-list
64547523|NCT04762147|Anesthetics, General|anesthetics, general|mesh-ancestor
64547524|NCT04762147|Anesthetics|anesthetics|mesh-ancestor
64547525|NCT04762147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64547526|NCT04762147|Antipyretics|antipyretics|mesh-ancestor
64547527|NCT04273737|Amantadine|amantadine|mesh-list
64547528|NCT04273737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64547529|NCT04273737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64547530|NCT04273737|Antiviral Agents|antiviral agents|mesh-ancestor
64547531|NCT04273737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64547532|NCT04273737|Dopamine Agents|dopamine agents|mesh-ancestor
64547533|NCT04273737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64547567|NCT04325880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547568|NCT04325880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547569|NCT04325880|Urological Agents|urological agents|mesh-ancestor
64547570|NCT04325880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64547571|NCT04325880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64547572|NCT04325880|Cholinergic Agents|cholinergic agents|mesh-ancestor
64547573|NCT04325880|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64547574|NCT04325880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64547575|NCT04325880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64547576|NCT04846218|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64547832|NCT04702464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64547833|NCT04702464|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64547834|NCT04702464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64547835|NCT04702464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547836|NCT04702464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547837|NCT04702464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64547838|NCT04702464|Hormone Antagonists|hormone antagonists|mesh-ancestor
64547892|NCT05743725|Magnesium Sulfate|magnesium sulfate|mesh-list
64547893|NCT05743725|Dexmedetomidine|dexmedetomidine|mesh-list
64547894|NCT05743725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64547895|NCT05743725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64547896|NCT05743725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548213|NCT01500278|Certolizumab Pegol|certolizumab pegol|mesh-list
64992515|NCT03643822|Dexmedetomidine|dexmedetomidine|mesh-list
64548433|NCT03439267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548435|NCT00770133|Naphazoline|naphazoline|mesh-list
64548436|NCT00770133|Antipruritics|antipruritics|mesh-ancestor
64504536|NCT01622296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64548437|NCT00770133|Dermatologic Agents|dermatologic agents|mesh-ancestor
64548438|NCT00770133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64548439|NCT00770133|Histamine Antagonists|histamine antagonists|mesh-ancestor
64548440|NCT00770133|Histamine Agents|histamine agents|mesh-ancestor
64548441|NCT00770133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64548442|NCT00770133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313323|NCT04837664|Nystatin|nystatin|mesh-list
64548537|NCT01424813|Albuterol|albuterol|mesh-list
64548538|NCT01424813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64548539|NCT01424813|Autonomic Agents|autonomic agents|mesh-ancestor
64548540|NCT01424813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64548541|NCT01424813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548542|NCT01424813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64548543|NCT01424813|Respiratory System Agents|respiratory system agents|mesh-ancestor
64548544|NCT01424813|Tocolytic Agents|tocolytic agents|mesh-ancestor
64548545|NCT01424813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64548546|NCT01424813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64548547|NCT01424813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64548548|NCT01424813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64548549|NCT01424813|Adrenergic Agents|adrenergic agents|mesh-ancestor
64548550|NCT01424813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64548551|NCT01424813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548552|NCT03480061|Dexmedetomidine|dexmedetomidine|mesh-list
64548553|NCT03480061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64992559|NCT03606967|Durvalumab|durvalumab|mesh-list
64548938|NCT04383093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280381|NCT02817191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65280382|NCT02817191|Antiemetics|antiemetics|mesh-ancestor
65280383|NCT02817191|Autonomic Agents|autonomic agents|mesh-ancestor
65280384|NCT02817191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280385|NCT02817191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280386|NCT02817191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65280387|NCT02817191|Glucocorticoids|glucocorticoids|mesh-ancestor
65280388|NCT02817191|Hormones|hormones|mesh-ancestor
65280389|NCT02817191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65280390|NCT02817191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65280391|NCT02817191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548939|NCT04383093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548940|NCT04383093|Urological Agents|urological agents|mesh-ancestor
64548941|NCT04383093|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64548942|NCT04383093|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64548943|NCT04383093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64548944|NCT04383093|Adrenergic Agents|adrenergic agents|mesh-ancestor
64548945|NCT04383093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64548946|NCT04383093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548948|NCT05301660|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64548949|NCT05301660|Autonomic Agents|autonomic agents|mesh-ancestor
64548950|NCT05301660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64548951|NCT05301660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548952|NCT05301660|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64548953|NCT05301660|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64548954|NCT05301660|Cholinergic Agents|cholinergic agents|mesh-ancestor
64548955|NCT05301660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64549022|NCT05287308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64549023|NCT05287308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64549025|NCT00801723|Budesonide|budesonide|mesh-list
64549026|NCT00801723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64549027|NCT00801723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64549028|NCT00801723|Autonomic Agents|autonomic agents|mesh-ancestor
64549029|NCT00801723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64549030|NCT00801723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549031|NCT00801723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64549032|NCT00801723|Respiratory System Agents|respiratory system agents|mesh-ancestor
64549033|NCT00801723|Glucocorticoids|glucocorticoids|mesh-ancestor
64549034|NCT00801723|Hormones|hormones|mesh-ancestor
64992612|NCT03600701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549041|NCT05346211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64549042|NCT05346211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549237|NCT04460352|Carboplatin|carboplatin|mesh-list
64549238|NCT04460352|Fluorouracil|fluorouracil|mesh-list
64549239|NCT04460352|Oxaliplatin|oxaliplatin|mesh-list
64549240|NCT04460352|Calcium|calcium|mesh-list
64549241|NCT04460352|Levoleucovorin|levoleucovorin|mesh-list
64549242|NCT04460352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64549243|NCT04460352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549244|NCT04460352|Tubulin Modulators|tubulin modulators|mesh-ancestor
64549245|NCT04460352|Antimitotic Agents|antimitotic agents|mesh-ancestor
64549246|NCT04460352|Mitosis Modulators|mitosis modulators|mesh-ancestor
64549394|NCT05007873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549396|NCT05007873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549397|NCT05007873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64549398|NCT01474772|Pregabalin|pregabalin|mesh-list
64549399|NCT01474772|Analgesics|analgesics|mesh-ancestor
64549400|NCT01474772|Sensory System Agents|sensory system agents|mesh-ancestor
64549401|NCT01474772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64549402|NCT01474772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549403|NCT01474772|Anticonvulsants|anticonvulsants|mesh-ancestor
64549404|NCT01474772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64549405|NCT01474772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65280392|NCT02817191|Protease Inhibitors|protease inhibitors|mesh-ancestor
65280393|NCT02817191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280394|NCT02817191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280395|NCT02817191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65280396|NCT02817191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65280397|NCT02817191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65280398|NCT02817191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65280399|NCT02817191|Adrenergic Agents|adrenergic agents|mesh-ancestor
65280400|NCT02817191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65280401|NCT02636010|Pembrolizumab|pembrolizumab|mesh-list
65280402|NCT02636010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65280403|NCT02636010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732780|NCT00003865|Toremifene|toremifene|mesh-list
64549406|NCT01474772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549407|NCT01474772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64549408|NCT01474772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64549409|NCT01474772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64549410|NCT01474772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64549411|NCT01474772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64549412|NCT03082339|Cortisone|cortisone|mesh-list
64549413|NCT03082339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64549414|NCT03801759|Adefovir|adefovir|mesh-list
64549415|NCT03801759|Digoxin|digoxin|mesh-list
64549416|NCT03801759|Furosemide|furosemide|mesh-list
64549417|NCT03801759|Diuretics|diuretics|mesh-ancestor
64549418|NCT03801759|Natriuretic Agents|natriuretic agents|mesh-ancestor
64549419|NCT03801759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549420|NCT03801759|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64549421|NCT03801759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64549422|NCT03801759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549423|NCT03801759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64549424|NCT03801759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64549425|NCT03801759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549426|NCT03801759|Protective Agents|protective agents|mesh-ancestor
64549427|NCT03801759|Antiviral Agents|antiviral agents|mesh-ancestor
64549428|NCT03801759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64549429|NCT03801759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64549430|NCT03801759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64549431|NCT01421147|Insulin Lispro|insulin lispro|mesh-list
64549432|NCT01421147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64549433|NCT01421147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549434|NCT03082573|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64736757|NCT00616343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64549595|NCT05044962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64549596|NCT05044962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64549597|NCT05044962|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64992667|NCT03502733|Nivolumab|nivolumab|mesh-list
64549614|NCT04198506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549615|NCT04198506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64549616|NCT04198506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549617|NCT04198506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549618|NCT00775671|Metoprolol|metoprolol|mesh-list
64549619|NCT00775671|Nebivolol|nebivolol|mesh-list
64549620|NCT00775671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64549621|NCT00775671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64550272|NCT01399697|Abortifacient Agents|abortifacient agents|mesh-ancestor
64550273|NCT01399697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64550274|NCT01399697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550275|NCT01399697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64550276|NCT01399697|Antimetabolites|antimetabolites|mesh-ancestor
64550277|NCT01399697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550278|NCT01399697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550279|NCT01399697|Dermatologic Agents|dermatologic agents|mesh-ancestor
64550280|NCT01399697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64550281|NCT01399697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64550282|NCT01399697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64550283|NCT01399697|Immunologic Factors|immunologic factors|mesh-ancestor
64551027|NCT00839319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551028|NCT00839319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64551030|NCT03212989|Vorinostat|vorinostat|mesh-list
64551031|NCT03212989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551032|NCT03212989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64551033|NCT03212989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551034|NCT03212989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551035|NCT00868959|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64551036|NCT00868959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64551037|NCT00868959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64551038|NCT00868959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64551039|NCT00868959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551168|NCT04816890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551170|NCT01392677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64551171|NCT01392677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551172|NCT01392677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64551173|NCT01392677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551174|NCT00841971|Fluconazole|fluconazole|mesh-list
64551175|NCT00841971|Anidulafungin|anidulafungin|mesh-list
64551176|NCT00841971|Antifungal Agents|antifungal agents|mesh-ancestor
64551188|NCT00842751|Finasteride|finasteride|mesh-list
64551189|NCT00842751|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64551190|NCT00842751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64551191|NCT00842751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551192|NCT00842751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551193|NCT00842751|Hormone Antagonists|hormone antagonists|mesh-ancestor
64507295|NCT05211570|Azacitidine|azacitidine|mesh-list
64551194|NCT00842751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64551195|NCT00842751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551196|NCT00842751|Urological Agents|urological agents|mesh-ancestor
64551197|NCT03104010|Hormones|hormones|mesh-list
64401046|NCT03067883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551198|NCT03104010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64551199|NCT03104010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551200|NCT03907969|AZD7648|azd7648|mesh-list
64551201|NCT03907969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64551202|NCT03907969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551203|NCT03907969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551204|NCT04399213|Histamine|histamine|mesh-list
64551205|NCT04399213|Histamine phosphate|histamine phosphate|mesh-list
64551206|NCT04399213|Histamine Agonists|histamine agonists|mesh-ancestor
64551207|NCT04399213|Histamine Agents|histamine agents|mesh-ancestor
64551208|NCT04399213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64551209|NCT04399213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551210|NCT04399213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551211|NCT02154243|Midodrine|midodrine|mesh-list
64551212|NCT02154243|Sympathomimetics|sympathomimetics|mesh-ancestor
64551213|NCT02154243|Autonomic Agents|autonomic agents|mesh-ancestor
64551214|NCT02154243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64551215|NCT02154243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551216|NCT02154243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64551217|NCT02154243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64551218|NCT02154243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64551219|NCT02154243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64551220|NCT02154243|Adrenergic Agents|adrenergic agents|mesh-ancestor
64551221|NCT02154243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64551222|NCT02154243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551223|NCT03995004|Dexamethasone|dexamethasone|mesh-list
64551224|NCT03995004|Melatonin|melatonin|mesh-list
64551225|NCT03995004|Sodium sulfate|sodium sulfate|mesh-list
64551226|NCT03995004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64551227|NCT03995004|Antiemetics|antiemetics|mesh-ancestor
64551228|NCT03995004|Autonomic Agents|autonomic agents|mesh-ancestor
64551229|NCT03995004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64551230|NCT03995004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551231|NCT03995004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65280404|NCT05474027|Antihypertensive Agents|antihypertensive agents|mesh-list
65280405|NCT05474027|Tranexamic Acid|tranexamic acid|mesh-list
65280406|NCT05474027|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65280407|NCT05474027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65280408|NCT05474027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280409|NCT05474027|Hemostatics|hemostatics|mesh-ancestor
65280410|NCT05474027|Coagulants|coagulants|mesh-ancestor
65280411|NCT00546871|Immunoglobulins|immunoglobulins|mesh-list
65280412|NCT00546871|Antibodies|antibodies|mesh-list
65280413|NCT00546871|gamma-Globulins|gamma-globulins|mesh-list
65280414|NCT00546871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65280415|NCT00546871|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65280416|NCT00546871|Immunologic Factors|immunologic factors|mesh-ancestor
65280417|NCT00546871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280418|NCT00642824|Bevacizumab|bevacizumab|mesh-list
65280419|NCT00642824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64551232|NCT03995004|Glucocorticoids|glucocorticoids|mesh-ancestor
64551233|NCT03995004|Hormones|hormones|mesh-ancestor
64553787|NCT05045274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64553788|NCT05045274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553789|NCT05045274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64553790|NCT05045274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64553792|NCT05045274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64553793|NCT05045274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64553794|NCT05045274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64553795|NCT05045274|Purinergic Agents|purinergic agents|mesh-ancestor
64553796|NCT05045274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64553797|NCT05045274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64553798|NCT05045274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64553799|NCT05045274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64553800|NCT05045274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64553801|NCT05045274|Antimetabolites|antimetabolites|mesh-ancestor
64553802|NCT05045274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64553803|NCT05045274|Natriuretic Agents|natriuretic agents|mesh-ancestor
64553840|NCT01726725|Anesthetics|anesthetics|mesh-ancestor
64553841|NCT01726725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64318891|NCT02173951|Sequestering Agents|sequestering agents|mesh-ancestor
64471744|NCT04189263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64553901|NCT04151082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64553902|NCT04151082|Glucocorticoids|glucocorticoids|mesh-ancestor
64553903|NCT04151082|Hormones|hormones|mesh-ancestor
64318967|NCT05534672|Sirolimus|sirolimus|mesh-list
64554082|NCT00983905|Colchicine|colchicine|mesh-list
64554083|NCT00983905|Theophylline|theophylline|mesh-list
64554084|NCT00983905|Gout Suppressants|gout suppressants|mesh-ancestor
64554085|NCT00983905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64992854|NCT03198650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774827|NCT05316168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64774829|NCT05316168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774830|NCT05316168|Anesthetics, Local|anesthetics, local|mesh-ancestor
64774831|NCT05316168|Anesthetics|anesthetics|mesh-ancestor
64775163|NCT01783236|Analgesics|analgesics|mesh-ancestor
64775164|NCT01783236|Sensory System Agents|sensory system agents|mesh-ancestor
64775165|NCT01783236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64775166|NCT01783236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775167|NCT01783236|Antipyretics|antipyretics|mesh-ancestor
64775168|NCT01783470|Mirabegron|mirabegron|mesh-list
64775169|NCT01783470|Adrenergic Agents|adrenergic agents|mesh-list
64775170|NCT01783470|Adrenergic Agonists|adrenergic agonists|mesh-list
64775171|NCT01783470|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64775172|NCT01783470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65280420|NCT00642824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280421|NCT00642824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65280422|NCT00642824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65280423|NCT00642824|Growth Substances|growth substances|mesh-ancestor
65280424|NCT00642824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280425|NCT00642824|Growth Inhibitors|growth inhibitors|mesh-ancestor
65280426|NCT02679014|Petesicatib|petesicatib|mesh-list
65280427|NCT02679014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732805|NCT00004219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64775173|NCT01783470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64775174|NCT01783470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775175|NCT01783470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775176|NCT01783470|Urological Agents|urological agents|mesh-ancestor
64543868|NCT01508936|Reslizumab|reslizumab|mesh-list
64775207|NCT01785186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64775208|NCT01785186|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64775209|NCT01785186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64775210|NCT01785186|Antimetabolites|antimetabolites|mesh-ancestor
64775211|NCT01785186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64775212|NCT01785186|Vitamin B Complex|vitamin b complex|mesh-ancestor
64775213|NCT01785186|Vitamins|vitamins|mesh-ancestor
64775214|NCT01785186|Micronutrients|micronutrients|mesh-ancestor
64775215|NCT01785810|Maraviroc|maraviroc|mesh-list
64775216|NCT01785810|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64775217|NCT01785810|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64775349|NCT01811940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64775350|NCT01813734|Ponatinib|ponatinib|mesh-list
64775351|NCT01813734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775352|NCT01813734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64775353|NCT01813734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64775354|NCT01813734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775355|NCT01818414|Vitamins|vitamins|mesh-list
64775356|NCT01818414|Folic Acid|folic acid|mesh-list
64775357|NCT01818414|Misoprostol|misoprostol|mesh-list
64775358|NCT01818414|Micronutrients|micronutrients|mesh-ancestor
64775359|NCT01818414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775360|NCT01818414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64775361|NCT01818414|Abortifacient Agents|abortifacient agents|mesh-ancestor
64775362|NCT01818414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64775363|NCT01818414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64775364|NCT01818414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64775365|NCT01818414|Oxytocics|oxytocics|mesh-ancestor
64775366|NCT01818414|Hematinics|hematinics|mesh-ancestor
64775367|NCT01818414|Vitamin B Complex|vitamin b complex|mesh-ancestor
64775368|NCT01820754|Paclitaxel|paclitaxel|mesh-list
64775402|NCT01822548|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64544086|NCT04144933|Antipyretics|antipyretics|mesh-ancestor
64775403|NCT01822548|Protease Inhibitors|protease inhibitors|mesh-ancestor
64775404|NCT01822548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64775405|NCT01822548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775406|NCT01825122|Nadolol|nadolol|mesh-list
64775407|NCT01825122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64386926|NCT02384915|Anesthetics, Local|anesthetics, local|mesh-ancestor
64775502|NCT01842594|Immunologic Factors|immunologic factors|mesh-ancestor
64775704|NCT01878006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64775705|NCT01879332|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64775706|NCT01879332|Anticonvulsants|anticonvulsants|mesh-ancestor
64775707|NCT01879332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64775708|NCT01879332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64775794|NCT01643460|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64775795|NCT01643460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64775796|NCT01643460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775797|NCT01643460|Tubulin Modulators|tubulin modulators|mesh-ancestor
64775798|NCT01643460|Antimitotic Agents|antimitotic agents|mesh-ancestor
64775799|NCT01643460|Mitosis Modulators|mitosis modulators|mesh-ancestor
64775800|NCT01643460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775801|NCT01643460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65280428|NCT02679014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280429|NCT02801357|Lofexidine|lofexidine|mesh-list
65280430|NCT02801357|Buprenorphine|buprenorphine|mesh-list
65280431|NCT02801357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65280432|NCT02801357|Narcotics|narcotics|mesh-ancestor
65280433|NCT02801357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65280434|NCT02801357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775802|NCT01643460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64775803|NCT01643460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64775804|NCT01643460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776028|NCT04205838|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64776030|NCT04205838|Immunologic Factors|immunologic factors|mesh-ancestor
64776031|NCT04205838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776032|NCT04205838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64776033|NCT04205838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64776034|NCT04205838|Alkylating Agents|alkylating agents|mesh-ancestor
64776067|NCT01724346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776069|NCT01472562|Rituximab|rituximab|mesh-list
64776070|NCT01472562|Lenalidomide|lenalidomide|mesh-list
64776071|NCT01472562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64776072|NCT01472562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776125|NCT01890642|Sensory System Agents|sensory system agents|mesh-ancestor
64992997|NCT02978625|Nivolumab|nivolumab|mesh-list
64776236|NCT01912716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776239|NCT01920282|Vasodilator Agents|vasodilator agents|mesh-ancestor
64776240|NCT01920282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64776241|NCT01920282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64776242|NCT01920282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64776243|NCT01920282|Adrenergic Agents|adrenergic agents|mesh-ancestor
64776244|NCT01920282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64776245|NCT01920282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776297|NCT01937598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544988|NCT01236456|Cyclophosphamide|cyclophosphamide|mesh-list
64776298|NCT01937598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776299|NCT01942668|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64776300|NCT01942668|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64776301|NCT01942668|Estradiol|estradiol|mesh-list
64776302|NCT01942668|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64776303|NCT01942668|Progesterone|progesterone|mesh-list
64776304|NCT01942668|Estrogens|estrogens|mesh-ancestor
64776305|NCT01942668|Hormones|hormones|mesh-ancestor
64776306|NCT01942668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64776307|NCT01942668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776308|NCT01942668|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64776309|NCT01942668|Contraceptive Agents|contraceptive agents|mesh-ancestor
64776310|NCT01942668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64776311|NCT01942668|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64776312|NCT01942668|Progestins|progestins|mesh-ancestor
64776313|NCT01948518|Sildenafil Citrate|sildenafil citrate|mesh-list
64776314|NCT01948518|Vasodilator Agents|vasodilator agents|mesh-ancestor
64776315|NCT01948518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64776316|NCT01948518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64776317|NCT01948518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387771|NCT02769689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64776347|NCT01953432|Doxazosin|doxazosin|mesh-list
64776430|NCT05739630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776431|NCT05739630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64776432|NCT05739630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64776434|NCT05739474|Immunologic Factors|immunologic factors|mesh-ancestor
64776435|NCT05739474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776436|NCT05739006|Pembrolizumab|pembrolizumab|mesh-list
64776437|NCT05739006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64776438|NCT05739006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776439|NCT05738616|Lenvatinib|lenvatinib|mesh-list
64776440|NCT05738616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776441|NCT05738616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64776442|NCT05738616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280435|NCT02801357|Analgesics|analgesics|mesh-ancestor
65280436|NCT02801357|Sensory System Agents|sensory system agents|mesh-ancestor
65280437|NCT02801357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280438|NCT02801357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65280439|NCT02801357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65280440|NCT02801357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64776443|NCT05738616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776444|NCT05738460|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64776445|NCT05738460|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64776446|NCT05738460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64776477|NCT05736198|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64776478|NCT05736198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64776479|NCT05736198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64776480|NCT05736198|Adrenergic Agents|adrenergic agents|mesh-ancestor
64776481|NCT05736198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64776482|NCT05736198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776483|NCT05735028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64776484|NCT05735028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776485|NCT05735028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776486|NCT05733624|Cyclosporine|cyclosporine|mesh-list
64776487|NCT05733624|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64776488|NCT05733624|Cyclosporins|cyclosporins|mesh-list
64776489|NCT05733624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776490|NCT05733624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776491|NCT05733624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64993113|NCT02830724|Aldesleukin|aldesleukin|mesh-list
64389067|NCT03117595|Anesthetics, General|anesthetics, general|mesh-ancestor
64389068|NCT02039531|Mitogens|mitogens|mesh-list
64389069|NCT02039531|Hyaluronic Acid|hyaluronic acid|mesh-list
64389070|NCT02039531|Mitosis Modulators|mitosis modulators|mesh-ancestor
64389176|NCT03187795|Parasympatholytics|parasympatholytics|mesh-ancestor
64389177|NCT03187795|Autonomic Agents|autonomic agents|mesh-ancestor
64389178|NCT03187795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64389182|NCT02435563|Ritonavir|ritonavir|mesh-list
64389431|NCT02327663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64389432|NCT02327663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64389433|NCT02327663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64389434|NCT02327663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389435|NCT02327663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389436|NCT02327663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64389450|NCT02333123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64389451|NCT02333123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64389452|NCT02333123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389453|NCT02333123|Antipyretics|antipyretics|mesh-ancestor
64389469|NCT03145025|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
64389470|NCT03145025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64389687|NCT04996199|Zileuton|zileuton|mesh-list
64389688|NCT04996199|Carbamazepine|carbamazepine|mesh-list
64389716|NCT02432833|Immunologic Factors|immunologic factors|mesh-ancestor
64389717|NCT02432833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389718|NCT02432833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64389719|NCT02432833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389720|NCT02432833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389721|NCT02429323|Sevoflurane|sevoflurane|mesh-list
64389731|NCT02326103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64389732|NCT02326103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64389733|NCT02326103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993239|NCT02595879|Antiviral Agents|antiviral agents|mesh-ancestor
64389766|NCT03185143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389767|NCT03185143|Antipyretics|antipyretics|mesh-ancestor
64389768|NCT03185143|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64389769|NCT03185143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64389770|NCT03185143|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64389771|NCT03185143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64389773|NCT03185143|Serotonin Agents|serotonin agents|mesh-ancestor
64389794|NCT03442673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64389795|NCT03442673|Antimetabolites|antimetabolites|mesh-ancestor
64389796|NCT03442673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280441|NCT02801357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65280442|NCT02801357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65280443|NCT02801357|Adrenergic Agents|adrenergic agents|mesh-ancestor
64389825|NCT05076695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64389826|NCT05076695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389827|NCT05076695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64389828|NCT05076695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389829|NCT05076695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389830|NCT03143933|Fentanyl|fentanyl|mesh-list
64389831|NCT03143933|Propofol|propofol|mesh-list
64389832|NCT03143933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64389833|NCT03143933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64389834|NCT03143933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389835|NCT03143933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64389836|NCT03143933|Anesthetics, General|anesthetics, general|mesh-ancestor
64389837|NCT03143933|Anesthetics|anesthetics|mesh-ancestor
64389838|NCT03143933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64389839|NCT03143933|Narcotics|narcotics|mesh-ancestor
64389844|NCT02440243|Vaccines|vaccines|mesh-list
64389845|NCT02440243|Immunologic Factors|immunologic factors|mesh-ancestor
64389846|NCT02440243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389847|NCT04705259|Anti-Infective Agents|anti-infective agents|mesh-list
64389848|NCT04705259|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64389849|NCT05076461|Ondansetron|ondansetron|mesh-list
64389850|NCT05076461|Antiemetics|antiemetics|mesh-ancestor
64778590|NCT04967196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64778591|NCT04967196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778592|NCT04967196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64778593|NCT04967196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389996|NCT02431663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64389997|NCT02431663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64389998|NCT02431663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64389999|NCT02431663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390001|NCT03185845|Anticoagulants|anticoagulants|mesh-ancestor
64390002|NCT03182803|Antibodies|antibodies|mesh-list
64390003|NCT03182803|Immunologic Factors|immunologic factors|mesh-ancestor
64390004|NCT03182803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390005|NCT04596917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64390006|NCT04596917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64390007|NCT04596917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390008|NCT03185611|Rifaximin|rifaximin|mesh-list
64390009|NCT03185611|Azathioprine|azathioprine|mesh-list
64390010|NCT03185611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64390011|NCT03185611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64390012|NCT03185611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64778624|NCT04711824|Paclitaxel|paclitaxel|mesh-list
64390069|NCT03141593|Cholecalciferol|cholecalciferol|mesh-list
64390070|NCT03141593|Vitamins|vitamins|mesh-list
64390071|NCT03141593|Micronutrients|micronutrients|mesh-ancestor
64390072|NCT03141593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390073|NCT03141593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64390074|NCT03141593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64390075|NCT04102241|Hemay005|hemay005|mesh-list
64390076|NCT04102241|Dermatologic Agents|dermatologic agents|mesh-ancestor
64390077|NCT04102241|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64390078|NCT04102241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64390079|NCT04102241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64390088|NCT04667572|Riboflavin|riboflavin|mesh-list
64390089|NCT04667572|Vitamin B Complex|vitamin b complex|mesh-ancestor
64390090|NCT04667572|Vitamins|vitamins|mesh-ancestor
64390091|NCT04667572|Micronutrients|micronutrients|mesh-ancestor
64390092|NCT04667572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390093|NCT04667572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64390094|NCT04667572|Dermatologic Agents|dermatologic agents|mesh-ancestor
64390095|NCT04438733|Anastrozole|anastrozole|mesh-list
64390096|NCT04438733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64390098|NCT04438733|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64390104|NCT04438733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64390105|NCT04438733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390107|NCT04438811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64390108|NCT04438811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390110|NCT02427295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65280444|NCT02801357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65280445|NCT02801357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280446|NCT02676674|Vitamin D|vitamin d|mesh-list
65280447|NCT02676674|Cholecalciferol|cholecalciferol|mesh-list
65280448|NCT02676674|Vitamins|vitamins|mesh-ancestor
65280449|NCT02676674|Micronutrients|micronutrients|mesh-ancestor
65280450|NCT02676674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280451|NCT02676674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64390111|NCT02427295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64778806|NCT02828358|Antimitotic Agents|antimitotic agents|mesh-ancestor
64778807|NCT02828358|Mitosis Modulators|mitosis modulators|mesh-ancestor
64778808|NCT02828358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64778809|NCT02828358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64778810|NCT02828358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64778811|NCT02828358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64390230|NCT03142763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64390231|NCT03142763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64390232|NCT03142763|Nootropic Agents|nootropic agents|mesh-ancestor
64390233|NCT03511391|Pembrolizumab|pembrolizumab|mesh-list
64778882|NCT01869114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64778883|NCT01869114|Immunologic Factors|immunologic factors|mesh-ancestor
64778884|NCT01869114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778887|NCT05722782|Acetaminophen|acetaminophen|mesh-list
64778888|NCT05722782|Piroxicam|piroxicam|mesh-list
64390266|NCT03139487|Dalteparin|dalteparin|mesh-list
64390307|NCT03139253|Furazolidone|furazolidone|mesh-list
64390308|NCT03139253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64390309|NCT03139253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64390310|NCT03139253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64390311|NCT03139253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64390312|NCT03139253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390353|NCT00157937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64390354|NCT00157937|Vasodilator Agents|vasodilator agents|mesh-ancestor
64390355|NCT00157937|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64390356|NCT00157937|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64390357|NCT00157937|Purinergic Agents|purinergic agents|mesh-ancestor
64390358|NCT03139565|Vaccines|vaccines|mesh-list
64390359|NCT03139565|Immunologic Factors|immunologic factors|mesh-ancestor
64390360|NCT03139565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390361|NCT03139331|Irinotecan|irinotecan|mesh-list
64390362|NCT03139331|Temozolomide|temozolomide|mesh-list
64390363|NCT03139331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64390364|NCT03139331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64390365|NCT03139331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64390366|NCT03139331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390367|NCT03139331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390372|NCT04423601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64390373|NCT04423601|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64390374|NCT04423601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64390376|NCT04423601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390398|NCT04983095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390450|NCT02420899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390451|NCT02420899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64390453|NCT02420899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779076|NCT05665062|Alkylating Agents|alkylating agents|mesh-ancestor
64390465|NCT03194165|Raltegravir Potassium|raltegravir potassium|mesh-list
64390466|NCT03194165|Nevirapine|nevirapine|mesh-list
64390467|NCT03194165|Dolutegravir|dolutegravir|mesh-list
64390468|NCT03194165|Rilpivirine|rilpivirine|mesh-list
64390469|NCT03194165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64390470|NCT03194165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64390471|NCT03194165|Protease Inhibitors|protease inhibitors|mesh-ancestor
64390472|NCT03194165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64390473|NCT03194165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390474|NCT03194165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64390475|NCT03194165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64390476|NCT03194165|Antiviral Agents|antiviral agents|mesh-ancestor
64390477|NCT03194165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65280452|NCT02676674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64390478|NCT03194165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64390479|NCT03194165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64390480|NCT03194165|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64390481|NCT03194165|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64390482|NCT03194165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64390483|NCT03194165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64390484|NCT03194165|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64390485|NCT03194165|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64779179|NCT05436678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64779181|NCT05425056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64779182|NCT05425056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64779183|NCT05425056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64779184|NCT05425056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779185|NCT05425056|Antifungal Agents|antifungal agents|mesh-ancestor
64779186|NCT05425056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64779187|NCT05425056|Immunologic Factors|immunologic factors|mesh-ancestor
64779188|NCT05425056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779190|NCT05413122|Varenicline|varenicline|mesh-list
64779191|NCT05413122|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64779192|NCT05413122|Autonomic Agents|autonomic agents|mesh-ancestor
64779193|NCT05413122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64779194|NCT05413122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779195|NCT05413122|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64779196|NCT05413122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64779197|NCT05413122|Cholinergic Agents|cholinergic agents|mesh-ancestor
64779198|NCT05413122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64779199|NCT05413122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779200|NCT05352282|Fentanyl|fentanyl|mesh-list
64779201|NCT05352282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64779202|NCT05352282|Narcotics|narcotics|mesh-ancestor
64779203|NCT05352282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64779204|NCT05352282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779205|NCT05352282|Analgesics|analgesics|mesh-ancestor
64390571|NCT03106597|Amlodipine|amlodipine|mesh-list
64390625|NCT02423863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390626|NCT03178747|Methylene Blue|methylene blue|mesh-list
64390627|NCT03178747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64390628|NCT03178747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390629|NCT03519893|Losartan|losartan|mesh-list
64390723|NCT02416141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64390724|NCT02416141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390726|NCT02416141|Sensory System Agents|sensory system agents|mesh-ancestor
64390727|NCT02416141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64390728|NCT03138239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64779345|NCT04972110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779347|NCT04951206|Clobetasol|clobetasol|mesh-list
64779348|NCT04951206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64779349|NCT04951206|Glucocorticoids|glucocorticoids|mesh-ancestor
64779350|NCT04951206|Hormones|hormones|mesh-ancestor
64779351|NCT04951206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64779352|NCT04951206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779353|NCT04924062|Gemcitabine|gemcitabine|mesh-list
64779354|NCT04924062|Cisplatin|cisplatin|mesh-list
64779355|NCT04924062|Pembrolizumab|pembrolizumab|mesh-list
64779356|NCT04924062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779357|NCT04924062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64779358|NCT04924062|Antimetabolites|antimetabolites|mesh-ancestor
64779359|NCT04924062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779360|NCT04924062|Antiviral Agents|antiviral agents|mesh-ancestor
64390787|NCT04631393|Analgesics|analgesics|mesh-ancestor
64390788|NCT04631393|Sensory System Agents|sensory system agents|mesh-ancestor
64390790|NCT03180775|Glycine|glycine|mesh-list
64779412|NCT04599816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993647|NCT02003222|Antiviral Agents|antiviral agents|mesh-ancestor
64390847|NCT03140033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64390848|NCT03140033|Abortifacient Agents|abortifacient agents|mesh-ancestor
64390849|NCT03140033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64390850|NCT03140033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390851|NCT03140033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64390852|NCT03140033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64390853|NCT03140033|Oxytocics|oxytocics|mesh-ancestor
65280453|NCT00962299|Beclomethasone|beclomethasone|mesh-list
65280454|NCT00962299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65280455|NCT00962299|Glucocorticoids|glucocorticoids|mesh-ancestor
65280456|NCT00962299|Hormones|hormones|mesh-ancestor
65280457|NCT00962299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65280458|NCT00962299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280459|NCT00962299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64390854|NCT03140033|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64390855|NCT03140033|Histamine Antagonists|histamine antagonists|mesh-ancestor
64390856|NCT03140033|Histamine Agents|histamine agents|mesh-ancestor
64390857|NCT03140033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64390858|NCT03140033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390859|NCT05338931|Gossypol acetic acid|gossypol acetic acid|mesh-list
64390860|NCT05338931|Gossypol|gossypol|mesh-list
64390861|NCT05338931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64390870|NCT02706691|Infigratinib|infigratinib|mesh-list
64390871|NCT02706691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390872|NCT02419729|Estrogens|estrogens|mesh-list
64390873|NCT02419729|Hormones|hormones|mesh-ancestor
64390874|NCT02419729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64390875|NCT02419729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390876|NCT03697031|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64390877|NCT03697031|Hormones|hormones|mesh-ancestor
64390878|NCT03697031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64390879|NCT03697031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390880|NCT02419651|Diclofenac|diclofenac|mesh-list
64390881|NCT02419651|Tramadol|tramadol|mesh-list
64390882|NCT02419651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64390883|NCT02419651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64390884|NCT02419651|Analgesics|analgesics|mesh-ancestor
64390885|NCT02419651|Sensory System Agents|sensory system agents|mesh-ancestor
64390886|NCT02419651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64390887|NCT02419651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390888|NCT02419651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64390889|NCT02419651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64779507|NCT04416984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779508|NCT04416984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64779509|NCT04416984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64779510|NCT04416984|Alkylating Agents|alkylating agents|mesh-ancestor
64779511|NCT04416984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779512|NCT04416984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779513|NCT04416984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64779515|NCT04320342|Glycopyrrolate|glycopyrrolate|mesh-list
64779516|NCT04320342|Bromides|bromides|mesh-list
64779517|NCT04320342|Formoterol Fumarate|formoterol fumarate|mesh-list
64779518|NCT04320342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64779519|NCT04320342|Autonomic Agents|autonomic agents|mesh-ancestor
64779520|NCT04320342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64993701|NCT01912625|Paclitaxel|paclitaxel|mesh-list
64391028|NCT01990300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391029|NCT01990300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391031|NCT03135977|Apatinib|apatinib|mesh-list
64391032|NCT03135977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64391033|NCT03135977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64391041|NCT01966120|Dermatologic Agents|dermatologic agents|mesh-ancestor
64391042|NCT04850651|Fluconazole|fluconazole|mesh-list
64391043|NCT04850651|Antifungal Agents|antifungal agents|mesh-ancestor
64391044|NCT04850651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64993759|NCT00567580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64391104|NCT04643249|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64391105|NCT04643249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64391106|NCT04643249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64391107|NCT04643249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64391108|NCT04643249|Anesthetics, General|anesthetics, general|mesh-ancestor
64391110|NCT04643249|GABA Modulators|gaba modulators|mesh-ancestor
64391111|NCT04643249|GABA Agents|gaba agents|mesh-ancestor
64391112|NCT04643249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64391113|NCT04643249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280460|NCT00962299|Respiratory System Agents|respiratory system agents|mesh-ancestor
65280461|NCT02679092|Misoprostol|misoprostol|mesh-list
65280462|NCT02679092|Mifepristone|mifepristone|mesh-list
65280463|NCT02679092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65280464|NCT02679092|Abortifacient Agents|abortifacient agents|mesh-ancestor
64732848|NCT00003253|Paclitaxel|paclitaxel|mesh-list
64391118|NCT04643249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64391119|NCT04643249|Purinergic Agents|purinergic agents|mesh-ancestor
64391120|NCT04643249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64391121|NCT04643249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64391122|NCT04643249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64391123|NCT04643249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64391124|NCT04643249|Antidepressive Agents|antidepressive agents|mesh-ancestor
64391125|NCT04643249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64391126|NCT04643249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64391127|NCT04643249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64391128|NCT04643249|Dopamine Agents|dopamine agents|mesh-ancestor
64391129|NCT04643249|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64391165|NCT03116893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64391167|NCT03116893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64391168|NCT03116893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64391169|NCT03116893|Antitubercular Agents|antitubercular agents|mesh-ancestor
64391170|NCT03116893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64391171|NCT03116893|Leprostatic Agents|leprostatic agents|mesh-ancestor
64391172|NCT03116893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64391173|NCT03116893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64391174|NCT03116893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64391175|NCT03116893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64391234|NCT05737511|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64391235|NCT05737511|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64391237|NCT05737511|Antiemetics|antiemetics|mesh-ancestor
64391238|NCT05737511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64391239|NCT05737511|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64391240|NCT05737511|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64391241|NCT05737511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64391242|NCT05737511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391243|NCT05737511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64391244|NCT05737511|Nootropic Agents|nootropic agents|mesh-ancestor
64391245|NCT05737511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64391246|NCT05737511|GABA Modulators|gaba modulators|mesh-ancestor
64779854|NCT02420652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64779855|NCT02420652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64779856|NCT02420652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779857|NCT02420652|Antipyretics|antipyretics|mesh-ancestor
64779858|NCT02257242|Rituximab|rituximab|mesh-list
64779859|NCT02257242|Vincristine|vincristine|mesh-list
64779860|NCT02257242|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64779861|NCT02257242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64779862|NCT02257242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779863|NCT02257242|Immunologic Factors|immunologic factors|mesh-ancestor
64779864|NCT02257242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779865|NCT02257242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64779866|NCT02257242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64779867|NCT02257242|Tubulin Modulators|tubulin modulators|mesh-ancestor
64779868|NCT02257242|Antimitotic Agents|antimitotic agents|mesh-ancestor
64779869|NCT02257242|Mitosis Modulators|mitosis modulators|mesh-ancestor
64779870|NCT02257242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779871|NCT02257242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64779872|NCT02257242|Alkylating Agents|alkylating agents|mesh-ancestor
64779873|NCT02037048|Leucovorin|leucovorin|mesh-list
64779874|NCT02037048|Paclitaxel|paclitaxel|mesh-list
64779875|NCT02037048|Carboplatin|carboplatin|mesh-list
64779876|NCT02037048|Fluorouracil|fluorouracil|mesh-list
64779877|NCT02037048|Oxaliplatin|oxaliplatin|mesh-list
64779878|NCT02037048|Calcium|calcium|mesh-list
64779879|NCT02037048|Levoleucovorin|levoleucovorin|mesh-list
64779931|NCT01659606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64779932|NCT01659606|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64779970|NCT00596154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65280465|NCT02679092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65280466|NCT02679092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280467|NCT02679092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65280468|NCT02679092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65280469|NCT02679092|Oxytocics|oxytocics|mesh-ancestor
64391388|NCT02423239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64391390|NCT02449733|Tenofovir|tenofovir|mesh-list
64391391|NCT02449733|Emtricitabine|emtricitabine|mesh-list
64391392|NCT02449733|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64391393|NCT02449733|Antiviral Agents|antiviral agents|mesh-ancestor
64391394|NCT02449733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64391395|NCT02449733|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64391396|NCT02449733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64391397|NCT02449733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391398|NCT02449733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391399|NCT02449733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64391400|NCT02449733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64391401|NCT02417467|Nicotine|nicotine|mesh-list
64391437|NCT01680341|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64391439|NCT01680341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391440|NCT03177811|Acetazolamide|acetazolamide|mesh-list
64391441|NCT03177811|Anticonvulsants|anticonvulsants|mesh-ancestor
64391442|NCT03177811|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64391443|NCT03177811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391444|NCT03177811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391445|NCT03177811|Diuretics|diuretics|mesh-ancestor
64391446|NCT03177811|Natriuretic Agents|natriuretic agents|mesh-ancestor
64391447|NCT03177811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391448|NCT03175939|Fluorouracil|fluorouracil|mesh-list
64391449|NCT03175939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64391450|NCT03175939|Antimetabolites|antimetabolites|mesh-ancestor
64391451|NCT03175939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391452|NCT03175939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64391453|NCT03175939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64391454|NCT03175939|Immunologic Factors|immunologic factors|mesh-ancestor
64391455|NCT03175939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391456|NCT03199625|Antidepressive Agents|antidepressive agents|mesh-list
64391457|NCT03199625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64391558|NCT02412085|Golimumab|golimumab|mesh-list
64391559|NCT02412085|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64391560|NCT02412085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64391561|NCT02412085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64391562|NCT02412085|Immunologic Factors|immunologic factors|mesh-ancestor
64391566|NCT01679405|Afatinib|afatinib|mesh-list
64391567|NCT01679405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64391568|NCT01679405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64391569|NCT01679405|Antimetabolites|antimetabolites|mesh-ancestor
64391570|NCT01679405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391571|NCT01679405|Antiviral Agents|antiviral agents|mesh-ancestor
64391572|NCT01679405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64391573|NCT01679405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391574|NCT01679405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64391575|NCT01679405|Immunologic Factors|immunologic factors|mesh-ancestor
64391597|NCT00301457|Hormone Antagonists|hormone antagonists|mesh-ancestor
64391598|NCT00301457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64780213|NCT02486016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64780214|NCT02486016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64391666|NCT02416687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391667|NCT02416687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64391670|NCT02411695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64391671|NCT02411695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391672|NCT02411695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391673|NCT02411695|Dopamine Agonists|dopamine agonists|mesh-ancestor
64391674|NCT02411695|Dopamine Agents|dopamine agents|mesh-ancestor
64391675|NCT05093231|Pembrolizumab|pembrolizumab|mesh-list
64391676|NCT05093231|Olaparib|olaparib|mesh-list
64391677|NCT05093231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64391678|NCT05093231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280470|NCT02679092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65280471|NCT02679092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65280472|NCT02679092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64732856|NCT00004237|Doxorubicin|doxorubicin|mesh-list
64391679|NCT05093231|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64391716|NCT04413227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64391717|NCT04413227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64391719|NCT04413227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391720|NCT04413227|Growth Inhibitors|growth inhibitors|mesh-ancestor
64391721|NCT02410135|Mirabegron|mirabegron|mesh-list
64391765|NCT01989754|Canagliflozin|canagliflozin|mesh-list
64391766|NCT01989754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64391767|NCT01989754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391773|NCT01619878|Antimalarials|antimalarials|mesh-ancestor
64391774|NCT01619878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64391775|NCT01619878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64391776|NCT01619878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64391777|NCT02015104|BCG Vaccine|bcg vaccine|mesh-list
64391778|NCT02015104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64391779|NCT02015104|Immunologic Factors|immunologic factors|mesh-ancestor
64391780|NCT02015104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391781|NCT01989208|Sodium sulfate|sodium sulfate|mesh-list
64391837|NCT01261247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391838|NCT01261247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391839|NCT03233243|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64391840|NCT03233243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64391841|NCT03233243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64391842|NCT03233243|Antimetabolites|antimetabolites|mesh-ancestor
64391843|NCT03233243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391844|NCT03233243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64391845|NCT03233243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64391846|NCT03233243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391847|NCT02449655|Paclitaxel|paclitaxel|mesh-list
64391848|NCT02449655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64391849|NCT02449655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64391850|NCT02449655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64391851|NCT02449655|Tubulin Modulators|tubulin modulators|mesh-ancestor
64391852|NCT02449655|Antimitotic Agents|antimitotic agents|mesh-ancestor
64391934|NCT02449265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64391935|NCT02449265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64391936|NCT02449265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391937|NCT02449265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64391938|NCT02449265|Glucocorticoids|glucocorticoids|mesh-ancestor
64391939|NCT02449265|Hormones|hormones|mesh-ancestor
64391940|NCT02449265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64391941|NCT02449265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64391942|NCT02449265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64391943|NCT02449265|Tubulin Modulators|tubulin modulators|mesh-ancestor
64391951|NCT03196817|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64391952|NCT03196817|Anesthetics, Local|anesthetics, local|mesh-ancestor
64391953|NCT03196817|Anesthetics|anesthetics|mesh-ancestor
64391954|NCT03196817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64391955|NCT03196817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391956|NCT03196817|Sensory System Agents|sensory system agents|mesh-ancestor
64391957|NCT03196817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64391958|NCT03196817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64391959|NCT03196817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64391960|NCT03196817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64391961|NCT03196817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64391962|NCT03196817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391963|NCT03196817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64391967|NCT03196817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64391968|NCT03196817|Respiratory System Agents|respiratory system agents|mesh-ancestor
64391969|NCT05091359|Calcium|calcium|mesh-list
64391970|NCT05091359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64391971|NCT05091359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391972|NCT03593759|Prednisone|prednisone|mesh-list
64391973|NCT03593759|Prednisolone|prednisolone|mesh-list
64391974|NCT03593759|Methotrexate|methotrexate|mesh-list
65280473|NCT02679092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65280474|NCT02679092|Contraceptive Agents|contraceptive agents|mesh-ancestor
65280475|NCT02679092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65280476|NCT02679092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65280477|NCT02679092|Hormone Antagonists|hormone antagonists|mesh-ancestor
65280478|NCT02679092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65280479|NCT02679092|Luteolytic Agents|luteolytic agents|mesh-ancestor
65280480|NCT02679092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65280481|NCT02679092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65280482|NCT00642122|Budesonide|budesonide|mesh-list
65280483|NCT00642122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64471767|NCT04140396|Sensory System Agents|sensory system agents|mesh-ancestor
64392045|NCT05095571|Vasodilator Agents|vasodilator agents|mesh-ancestor
64392046|NCT02677181|Mycophenolic Acid|mycophenolic acid|mesh-list
64392047|NCT02677181|Methotrexate|methotrexate|mesh-list
64392048|NCT02677181|Thymoglobulin|thymoglobulin|mesh-list
64392049|NCT02677181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64392052|NCT02677181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392053|NCT02677181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64392054|NCT02677181|Antimetabolites|antimetabolites|mesh-ancestor
64392055|NCT02677181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392056|NCT02677181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64392057|NCT02677181|Dermatologic Agents|dermatologic agents|mesh-ancestor
64392058|NCT02677181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64392059|NCT02677181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64392060|NCT02677181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64392061|NCT02677181|Immunologic Factors|immunologic factors|mesh-ancestor
64392062|NCT02677181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64392063|NCT02677181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64392064|NCT02677181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64392065|NCT02677181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64392066|NCT02677181|Antitubercular Agents|antitubercular agents|mesh-ancestor
64392067|NCT02677181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64392068|NCT02677181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64392069|NCT05095025|Bupivacaine|bupivacaine|mesh-list
64392089|NCT05084027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64392090|NCT05084027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780755|NCT01962246|Antimetabolites|antimetabolites|mesh-ancestor
64780756|NCT01962246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780757|NCT01962246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780758|NCT02588586|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64780759|NCT02588586|Antiviral Agents|antiviral agents|mesh-ancestor
64780760|NCT02588586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64780761|NCT02592486|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64780762|NCT02592486|Immunologic Factors|immunologic factors|mesh-ancestor
64780763|NCT02592486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780764|NCT05370846|Anti-Infective Agents|anti-infective agents|mesh-list
64780765|NCT05370846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64780766|NCT04945122|Atorvastatin|atorvastatin|mesh-list
64780767|NCT04945122|Pitavastatin|pitavastatin|mesh-list
64780768|NCT04945122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64549435|NCT03082573|Hormones|hormones|mesh-ancestor
64780769|NCT04945122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64780770|NCT04945122|Antimetabolites|antimetabolites|mesh-ancestor
64780771|NCT04945122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780772|NCT04945122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64780773|NCT04945122|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64780774|NCT04945122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780776|NCT04227366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64780777|NCT04227366|Abortifacient Agents|abortifacient agents|mesh-ancestor
64392161|NCT01987102|Leucovorin|leucovorin|mesh-list
64392214|NCT03968939|Histamine Antagonists|histamine antagonists|mesh-ancestor
65280484|NCT00642122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65280485|NCT00642122|Autonomic Agents|autonomic agents|mesh-ancestor
65280486|NCT00642122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280487|NCT00642122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280488|NCT00642122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65280489|NCT00642122|Respiratory System Agents|respiratory system agents|mesh-ancestor
65280490|NCT00642122|Glucocorticoids|glucocorticoids|mesh-ancestor
65280491|NCT00642122|Hormones|hormones|mesh-ancestor
65280492|NCT00642122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65280493|NCT02817113|Fluorouracil|fluorouracil|mesh-list
65280494|NCT02817113|Cetuximab|cetuximab|mesh-list
64392215|NCT03968939|Histamine Agents|histamine agents|mesh-ancestor
64392216|NCT03968939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64392217|NCT03968939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64392218|NCT03968939|Antipruritics|antipruritics|mesh-ancestor
64392243|NCT05099471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392244|NCT05099471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64392245|NCT05099471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64392246|NCT05099471|Alkylating Agents|alkylating agents|mesh-ancestor
64392247|NCT05099471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392248|NCT05099471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64392249|NCT05099471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64392250|NCT05099471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64392251|NCT05099471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64392336|NCT05097365|Hydroxocobalamin|hydroxocobalamin|mesh-list
64392350|NCT01964560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64392351|NCT01964560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392352|NCT02659943|Cyclophosphamide|cyclophosphamide|mesh-list
64392353|NCT02659943|Fludarabine|fludarabine|mesh-list
64392354|NCT02659943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64392355|NCT02659943|Immunologic Factors|immunologic factors|mesh-ancestor
64392356|NCT02659943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392357|NCT02659943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64392358|NCT02659943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64392370|NCT01677299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392371|NCT04999631|Ethanol|ethanol|mesh-list
64392372|NCT04999631|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
64392373|NCT04999631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64392374|NCT04999631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64392375|NCT04999631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64392376|NCT04999631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392377|NCT04999631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64471768|NCT04140396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392389|NCT02718833|Glucocorticoids|glucocorticoids|mesh-ancestor
64392390|NCT02718833|Hormones|hormones|mesh-ancestor
64392391|NCT02718833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64392392|NCT02718833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64392393|NCT02718833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64392394|NCT02718833|Immunologic Factors|immunologic factors|mesh-ancestor
64392395|NCT02718833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64392396|NCT02718833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64392397|NCT02718833|Growth Substances|growth substances|mesh-ancestor
64392398|NCT02718833|Growth Inhibitors|growth inhibitors|mesh-ancestor
64392399|NCT04908293|Listerine|listerine|mesh-list
64392410|NCT01964326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64392411|NCT01964326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64392412|NCT01964326|Antimetabolites|antimetabolites|mesh-ancestor
64392413|NCT01964326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781042|NCT02517684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64781043|NCT02517684|Glucocorticoids|glucocorticoids|mesh-ancestor
64781044|NCT02517684|Hormones|hormones|mesh-ancestor
64781045|NCT02517684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65280495|NCT02817113|Antimetabolites|antimetabolites|mesh-ancestor
65280496|NCT02817113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280497|NCT02817113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65280498|NCT02817113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280499|NCT02817113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65280500|NCT02817113|Immunologic Factors|immunologic factors|mesh-ancestor
65280501|NCT02817113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781046|NCT02517684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781047|NCT02517684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64781048|NCT02517684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781049|NCT02517684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64781050|NCT02517684|Dermatologic Agents|dermatologic agents|mesh-ancestor
64781051|NCT02517684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64781052|NCT02517684|Antimetabolites|antimetabolites|mesh-ancestor
64781053|NCT02517684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781054|NCT02517684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64781055|NCT02517684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64781195|NCT05225610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392717|NCT05100719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392718|NCT05100719|Anticonvulsants|anticonvulsants|mesh-ancestor
64392720|NCT05100563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64392721|NCT05100563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64392722|NCT05100563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392723|NCT05100563|Sensory System Agents|sensory system agents|mesh-ancestor
64392724|NCT05100563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392725|NCT05100329|Mitoxantrone|mitoxantrone|mesh-list
64392726|NCT05100329|Analgesics|analgesics|mesh-ancestor
64392727|NCT05100329|Sensory System Agents|sensory system agents|mesh-ancestor
64392728|NCT05100329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392729|NCT05100329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392730|NCT05100329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781332|NCT02653560|Natriuretic Agents|natriuretic agents|mesh-ancestor
64781333|NCT02653560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781334|NCT02653560|Expectorants|expectorants|mesh-ancestor
64781335|NCT02653560|Respiratory System Agents|respiratory system agents|mesh-ancestor
64781336|NCT02653560|Cathartics|cathartics|mesh-ancestor
64781337|NCT02653560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64781338|NCT02653872|Itraconazole|itraconazole|mesh-list
64781339|NCT02653872|Verapamil|verapamil|mesh-list
64781340|NCT02653872|Diltiazem|diltiazem|mesh-list
64781341|NCT02653872|Antifungal Agents|antifungal agents|mesh-ancestor
64781342|NCT02653872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64781343|NCT02653872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64781344|NCT02653872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64781345|NCT02653872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781346|NCT02653872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781347|NCT02653872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64781348|NCT02653872|Hormone Antagonists|hormone antagonists|mesh-ancestor
64781349|NCT02653872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64781394|NCT02655354|Antiemetics|antiemetics|mesh-ancestor
64781395|NCT02655354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64781396|NCT02655354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64781397|NCT02655354|Histamine Antagonists|histamine antagonists|mesh-ancestor
64781398|NCT02655354|Histamine Agents|histamine agents|mesh-ancestor
64781399|NCT02655354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64781400|NCT02655354|Antipruritics|antipruritics|mesh-ancestor
64781401|NCT02655354|Dermatologic Agents|dermatologic agents|mesh-ancestor
64781402|NCT02655354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64781403|NCT02655354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64781404|NCT02655354|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64781405|NCT02655354|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64781406|NCT02655354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64781407|NCT02655354|Adrenergic Agents|adrenergic agents|mesh-ancestor
64781408|NCT02655354|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64781409|NCT02655354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64781410|NCT02655354|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65280502|NCT02817113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65280503|NCT02801201|Midazolam|midazolam|mesh-list
65280504|NCT02801201|Bupivacaine|bupivacaine|mesh-list
65280505|NCT02801201|Anesthetics, Local|anesthetics, local|mesh-ancestor
65280506|NCT02801201|Anesthetics|anesthetics|mesh-ancestor
65280507|NCT02801201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65280508|NCT02801201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280509|NCT02801201|Sensory System Agents|sensory system agents|mesh-ancestor
65280510|NCT02801201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64732888|NCT00003913|Methylprednisolone|methylprednisolone|mesh-list
64781411|NCT02655354|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64781412|NCT02655354|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64781413|NCT02655354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64781414|NCT02655354|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64781416|NCT02657928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781417|NCT02657928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64781418|NCT02657928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64781419|NCT02657928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781420|NCT02657928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781421|NCT02657928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64392860|NCT05106803|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64781538|NCT02709018|Losartan|losartan|mesh-list
64781539|NCT02709018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64393008|NCT03701711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64393009|NCT03701711|Growth Substances|growth substances|mesh-ancestor
64393010|NCT03701711|Growth Inhibitors|growth inhibitors|mesh-ancestor
64393011|NCT03701711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393012|NCT04481971|Prednisolone|prednisolone|mesh-list
64393013|NCT04481971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64393014|NCT04481971|Glucocorticoids|glucocorticoids|mesh-ancestor
64393016|NCT04481971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64393032|NCT03172741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64393033|NCT03172741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393034|NCT03172741|Hormones|hormones|mesh-ancestor
64393035|NCT03172741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64393036|NCT02702011|Empagliflozin|empagliflozin|mesh-list
64393044|NCT03170713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64393045|NCT03170713|Analgesics|analgesics|mesh-ancestor
64393046|NCT03170713|Sensory System Agents|sensory system agents|mesh-ancestor
64393047|NCT03170713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393048|NCT03170713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393049|NCT03170713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64393050|NCT03170713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64393051|NCT03170713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64393052|NCT03170713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393053|NCT03170713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393055|NCT02657369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393100|NCT05105009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393101|NCT05105009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64393102|NCT05105009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64393103|NCT05105009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393106|NCT05104931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64393128|NCT02397499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393185|NCT05094323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393186|NCT05094323|Sensory System Agents|sensory system agents|mesh-ancestor
64393187|NCT05094323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393188|NCT03170323|Cyclosporine|cyclosporine|mesh-list
64393320|NCT04196075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393322|NCT04196075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64393323|NCT04196075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64393324|NCT04196075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65280511|NCT02801201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65280512|NCT02801201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65280513|NCT02801201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65280514|NCT02801201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65280515|NCT02801201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65280516|NCT02801201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65280517|NCT02801201|Anesthetics, General|anesthetics, general|mesh-ancestor
64393326|NCT04196075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64393327|NCT03863483|Docetaxel|docetaxel|mesh-list
64393328|NCT03863483|Pemetrexed|pemetrexed|mesh-list
64393329|NCT03863483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393330|NCT03863483|Tubulin Modulators|tubulin modulators|mesh-ancestor
64393331|NCT03863483|Antimitotic Agents|antimitotic agents|mesh-ancestor
64393332|NCT03863483|Mitosis Modulators|mitosis modulators|mesh-ancestor
64393334|NCT03863483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393359|NCT03300479|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64393360|NCT03300479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64393361|NCT03300479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64393362|NCT03300479|Adrenergic Agents|adrenergic agents|mesh-ancestor
64393363|NCT03012425|Hydrocortisone|hydrocortisone|mesh-list
64393374|NCT03540875|Narcotics|narcotics|mesh-ancestor
64393375|NCT03540875|Analgesics|analgesics|mesh-ancestor
64393418|NCT05115149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393419|NCT05115149|Protective Agents|protective agents|mesh-ancestor
64393420|NCT05115149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393421|NCT05115149|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64393422|NCT05115149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393423|NCT04638803|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
64393424|NCT04638803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393425|NCT04592783|Antihypertensive Agents|antihypertensive agents|mesh-list
64393426|NCT04521881|Tranexamic Acid|tranexamic acid|mesh-list
64393427|NCT04521881|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64393428|NCT04521881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64393429|NCT04521881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393458|NCT05113511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64393476|NCT04161989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393478|NCT01986010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64393479|NCT01986010|Immunologic Factors|immunologic factors|mesh-ancestor
64393480|NCT01986010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393481|NCT01986010|Antacids|antacids|mesh-ancestor
64393503|NCT04414631|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64393504|NCT04414631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64393505|NCT04414631|Immunologic Factors|immunologic factors|mesh-ancestor
64393506|NCT04414631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393507|NCT03115255|Ranibizumab|ranibizumab|mesh-list
64393508|NCT03115255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64393509|NCT03115255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64393510|NCT03115255|Growth Substances|growth substances|mesh-ancestor
64393511|NCT03115255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393529|NCT02655419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64393530|NCT02655419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64393532|NCT02655419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64393533|NCT01962922|Tacrolimus|tacrolimus|mesh-list
64393534|NCT01962922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64782167|NCT02905578|Vitamins|vitamins|mesh-ancestor
64782168|NCT02905578|Micronutrients|micronutrients|mesh-ancestor
64782169|NCT02905578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782170|NCT02905578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64782171|NCT02905578|Antimetabolites|antimetabolites|mesh-ancestor
64782172|NCT02905578|Antiviral Agents|antiviral agents|mesh-ancestor
64782173|NCT02905578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64782174|NCT02905578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782175|NCT02905578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64782196|NCT00783510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64393628|NCT04416334|Sensory System Agents|sensory system agents|mesh-ancestor
64393629|NCT04416334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393630|NCT04416334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393631|NCT04416334|Antipyretics|antipyretics|mesh-ancestor
64393632|NCT04416334|Gout Suppressants|gout suppressants|mesh-ancestor
65280518|NCT02801201|GABA Modulators|gaba modulators|mesh-ancestor
65030551|NCT04224571|Rituximab|rituximab|mesh-list
65280519|NCT02801201|GABA Agents|gaba agents|mesh-ancestor
65280520|NCT02801201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65280521|NCT02801201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280522|NCT04182932|Vaccines|vaccines|mesh-list
65280523|NCT04182932|Immunologic Factors|immunologic factors|mesh-ancestor
65280524|NCT04182932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280525|NCT03951805|Insulin|insulin|mesh-list
65280526|NCT03951805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65280527|NCT03951805|Insulin Glargine|insulin glargine|mesh-list
65280528|NCT03951805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65280529|NCT03951805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280530|NCT02681198|Lofexidine|lofexidine|mesh-list
65280531|NCT02681198|Paroxetine|paroxetine|mesh-list
65280532|NCT02681198|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65280533|NCT02681198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65280534|NCT02681198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65280535|NCT02681198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280536|NCT02681198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65280537|NCT02681198|Serotonin Agents|serotonin agents|mesh-ancestor
65280538|NCT02681198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280539|NCT02681198|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65280540|NCT02681198|Antidepressive Agents|antidepressive agents|mesh-ancestor
65280541|NCT02681198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64393633|NCT04416334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64393641|NCT02403349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64393642|NCT02403349|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64393643|NCT02403349|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64393644|NCT02403349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393645|NCT02403349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64393646|NCT02403349|Sympatholytics|sympatholytics|mesh-ancestor
64782318|NCT02714634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782320|NCT02714634|Dermatologic Agents|dermatologic agents|mesh-ancestor
64782321|NCT02714634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782322|NCT02714634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64782323|NCT02714634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64782324|NCT02714634|Immunologic Factors|immunologic factors|mesh-ancestor
64782325|NCT02714634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64782326|NCT02714634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64782327|NCT02714634|Antimalarials|antimalarials|mesh-ancestor
64550954|NCT01396421|Dopamine Agents|dopamine agents|mesh-ancestor
64551010|NCT04760431|Taxane|taxane|mesh-list
64782328|NCT02714634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64782329|NCT02714634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64782330|NCT02714634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64782331|NCT02714634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64393751|NCT03727139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393752|NCT03727139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65280542|NCT02681198|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65280543|NCT02681198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65280544|NCT02681198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393753|NCT03727139|Protective Agents|protective agents|mesh-ancestor
64393754|NCT03727139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393755|NCT05120687|Cyclosporine|cyclosporine|mesh-list
64393756|NCT05120687|Mycophenolic Acid|mycophenolic acid|mesh-list
64393826|NCT02893241|Theodrenaline|theodrenaline|mesh-list
64393833|NCT02893241|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64393834|NCT02893241|Adrenergic Agents|adrenergic agents|mesh-ancestor
64393835|NCT02893241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64393836|NCT02893241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393837|NCT02893241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64393838|NCT02893241|Vasodilator Agents|vasodilator agents|mesh-ancestor
64393839|NCT02395237|Glimepiride|glimepiride|mesh-list
64393840|NCT02395237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64393841|NCT02395237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64393842|NCT02395237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393913|NCT01980940|Analgesics|analgesics|mesh-ancestor
64393914|NCT01980940|Sensory System Agents|sensory system agents|mesh-ancestor
64393940|NCT04752527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393941|NCT04752527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64393943|NCT05229497|Carboplatin|carboplatin|mesh-list
64393944|NCT05229497|Fluorouracil|fluorouracil|mesh-list
64393945|NCT05229497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393946|NCT05229497|Antimetabolites|antimetabolites|mesh-ancestor
64393976|NCT03169777|Antimetabolites|antimetabolites|mesh-ancestor
64393977|NCT03169777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64393978|NCT03169777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64393979|NCT03169777|Antidotes|antidotes|mesh-ancestor
64393980|NCT03169777|Protective Agents|protective agents|mesh-ancestor
64393981|NCT03169777|Vitamin B Complex|vitamin b complex|mesh-ancestor
64393982|NCT03169777|Vitamins|vitamins|mesh-ancestor
64393983|NCT03169777|Micronutrients|micronutrients|mesh-ancestor
64393984|NCT03169777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64393985|NCT03169777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64782858|NCT02821338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64782861|NCT02835846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64782862|NCT02835846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782864|NCT02844582|Cortisone|cortisone|mesh-list
64782865|NCT02844582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64782866|NCT02844582|Glucocorticoids|glucocorticoids|mesh-ancestor
64782867|NCT02844582|Hormones|hormones|mesh-ancestor
64782868|NCT02844582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64782869|NCT02844582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782870|NCT02844582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64394292|NCT03106363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394293|NCT03106363|Hallucinogens|hallucinogens|mesh-ancestor
64394294|NCT03106363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64394295|NCT03106363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64394296|NCT03106363|Analgesics|analgesics|mesh-ancestor
64394297|NCT03106363|Sensory System Agents|sensory system agents|mesh-ancestor
64394298|NCT03106363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64394299|NCT03106363|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64394300|NCT03106363|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64394301|NCT03106363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64394469|NCT03874091|Anesthetics|anesthetics|mesh-ancestor
64394470|NCT03874091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64394522|NCT04122287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64394523|NCT04122287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64394524|NCT04122287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394525|NCT04122287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394526|NCT04122287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394527|NCT04122287|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64394528|NCT04122287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64394543|NCT05746351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64394544|NCT05746351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64394545|NCT05746351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64394546|NCT05746351|Adrenergic Agents|adrenergic agents|mesh-ancestor
64394549|NCT05746351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65280545|NCT02681198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65280546|NCT02681198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65280547|NCT02681198|Sensory System Agents|sensory system agents|mesh-ancestor
65280548|NCT02681198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280549|NCT02681198|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65280550|NCT02681198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65280551|NCT02681198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65280552|NCT02681198|Adrenergic Agents|adrenergic agents|mesh-ancestor
65280553|NCT05597306|Venetoclax|venetoclax|mesh-list
65280554|NCT05597306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280555|NCT00962533|Telbivudine|telbivudine|mesh-list
65280556|NCT00962533|Antiviral Agents|antiviral agents|mesh-ancestor
65280557|NCT00962533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65280558|NCT00962533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65280559|NCT00962533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280560|NCT00962533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280561|NCT00642980|Clindamycin|clindamycin|mesh-list
65280562|NCT00642980|Clindamycin palmitate|clindamycin palmitate|mesh-list
65280563|NCT00642980|Clindamycin phosphate|clindamycin phosphate|mesh-list
64732933|NCT00003925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394570|NCT03115099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394571|NCT03115099|Incretins|incretins|mesh-ancestor
64394572|NCT03115099|Hormones|hormones|mesh-ancestor
64394573|NCT03115099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64394574|NCT03115099|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64394575|NCT03115099|Protease Inhibitors|protease inhibitors|mesh-ancestor
64394576|NCT03115099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394577|NCT03115099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394578|NCT03165097|ACT-709478|act-709478|mesh-list
64394579|NCT03165097|Midazolam|midazolam|mesh-list
64394580|NCT03165097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64394581|NCT03165097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64394739|NCT03161977|Mannitol|mannitol|mesh-list
64394740|NCT03161977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64394741|NCT03161977|Diuretics|diuretics|mesh-ancestor
64394742|NCT03161977|Natriuretic Agents|natriuretic agents|mesh-ancestor
64394743|NCT03161977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394744|NCT02683525|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64394745|NCT02683525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64394746|NCT02683525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394747|NCT02683525|Incretins|incretins|mesh-ancestor
64394748|NCT02683525|Hormones|hormones|mesh-ancestor
64394749|NCT02683525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64394750|NCT02683525|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64394751|NCT02683525|Protease Inhibitors|protease inhibitors|mesh-ancestor
64394752|NCT02683525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394756|NCT01976338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64394757|NCT01976338|Growth Substances|growth substances|mesh-ancestor
64394758|NCT01976338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394759|NCT01976338|Growth Inhibitors|growth inhibitors|mesh-ancestor
64394760|NCT01976338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394761|NCT02651987|Lanreotide|lanreotide|mesh-list
64394762|NCT02651987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394763|NCT05115773|Anesthetics|anesthetics|mesh-list
64394764|NCT05115773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65280564|NCT00642980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65280565|NCT00642980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65280566|NCT00642980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65280567|NCT00642980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280568|NCT00642980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280569|NCT02798159|Sildenafil Citrate|sildenafil citrate|mesh-list
65280570|NCT02798159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280571|NCT02798159|Vasodilator Agents|vasodilator agents|mesh-ancestor
65280572|NCT02798159|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65280573|NCT02798159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65280574|NCT02798159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280575|NCT02798159|Urological Agents|urological agents|mesh-ancestor
65280576|NCT00962767|Gemtuzumab|gemtuzumab|mesh-list
65280577|NCT00962767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65280578|NCT00962767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732952|NCT00004255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64394765|NCT05115773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394788|NCT01999114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394789|NCT01999114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64394790|NCT01999114|Contraceptive Agents|contraceptive agents|mesh-ancestor
64394874|NCT03161509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64394875|NCT03161509|Antimanic Agents|antimanic agents|mesh-ancestor
64395066|NCT05132777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64395067|NCT05132777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395068|NCT05422027|Dexamethasone|dexamethasone|mesh-list
64395069|NCT05422027|Dexamethasone acetate|dexamethasone acetate|mesh-list
64395070|NCT05422027|Lenalidomide|lenalidomide|mesh-list
64395071|NCT05422027|Bortezomib|bortezomib|mesh-list
64395072|NCT05422027|BB 1101|bb 1101|mesh-list
64395078|NCT05422027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64395079|NCT05422027|Glucocorticoids|glucocorticoids|mesh-ancestor
64395080|NCT05422027|Hormones|hormones|mesh-ancestor
64395081|NCT05422027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64395082|NCT05422027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64395083|NCT05422027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395084|NCT05422027|Protease Inhibitors|protease inhibitors|mesh-ancestor
64395085|NCT05422027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64395086|NCT05422027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395087|NCT05422027|Immunologic Factors|immunologic factors|mesh-ancestor
64395088|NCT05422027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64395089|NCT05422027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64395090|NCT05422027|Growth Substances|growth substances|mesh-ancestor
64395091|NCT05422027|Growth Inhibitors|growth inhibitors|mesh-ancestor
64395092|NCT05072821|Botulinum Toxins|botulinum toxins|mesh-list
64395093|NCT05072821|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64395094|NCT05072821|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64395095|NCT05072821|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64395129|NCT03163693|Dexmedetomidine|dexmedetomidine|mesh-list
64395130|NCT03163693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64395131|NCT03163693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64395132|NCT03163693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786417|NCT00002052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64786418|NCT00002052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786419|NCT00002058|Clofazimine|clofazimine|mesh-list
64786420|NCT00002058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64786421|NCT00002058|Leprostatic Agents|leprostatic agents|mesh-ancestor
64786422|NCT00002058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64786423|NCT00002058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65280579|NCT02678780|Lenvatinib|lenvatinib|mesh-list
65280580|NCT02678780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280581|NCT02678780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65280582|NCT02678780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280583|NCT02678780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280584|NCT00963001|Treprostinil|treprostinil|mesh-list
65280585|NCT00963001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65280586|NCT00643136|Pregabalin|pregabalin|mesh-list
64786424|NCT00002064|Clindamycin|clindamycin|mesh-list
64786425|NCT00002064|Clindamycin palmitate|clindamycin palmitate|mesh-list
64786426|NCT00002064|Clindamycin phosphate|clindamycin phosphate|mesh-list
64786427|NCT00002064|Pyrimethamine|pyrimethamine|mesh-list
64786428|NCT00002064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64786429|NCT00002064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786468|NCT00002094|Antiviral Agents|antiviral agents|mesh-ancestor
64786469|NCT00002094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786470|NCT00002100|Curdlan sulfate|curdlan sulfate|mesh-list
64786471|NCT00002100|Antimalarials|antimalarials|mesh-ancestor
64786472|NCT00002100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64786473|NCT00002100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64786474|NCT00002100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786475|NCT00002100|Antiviral Agents|antiviral agents|mesh-ancestor
64786476|NCT00002106|Ranitidine|ranitidine|mesh-list
64786477|NCT00002106|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
64786478|NCT00002106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64786479|NCT00002106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64786480|NCT00002106|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64786481|NCT00002106|Histamine Antagonists|histamine antagonists|mesh-ancestor
64786482|NCT00002106|Histamine Agents|histamine agents|mesh-ancestor
64786483|NCT00002106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64786484|NCT00002106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786485|NCT00002106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786486|NCT00002112|Fluconazole|fluconazole|mesh-list
64786487|NCT00002112|Nystatin|nystatin|mesh-list
64786488|NCT00002112|Antifungal Agents|antifungal agents|mesh-ancestor
64786489|NCT00002112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786490|NCT00002112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64786491|NCT00002112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64786492|NCT00002112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397602|NCT01952080|Teduglutide|teduglutide|mesh-list
64786508|NCT00002118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786509|NCT00002118|Antiviral Agents|antiviral agents|mesh-ancestor
64786510|NCT00002118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786511|NCT00002118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786512|NCT00002118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786513|NCT00002124|Lamivudine|lamivudine|mesh-list
64786514|NCT00002124|Zidovudine|zidovudine|mesh-list
64786515|NCT00002124|Delavirdine|delavirdine|mesh-list
64786516|NCT00002124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786517|NCT00002124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786518|NCT00002124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786548|NCT00002148|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64397650|NCT04154189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64786559|NCT00002154|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64786560|NCT00002154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786561|NCT00002154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786562|NCT00002154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64786563|NCT00002154|Protective Agents|protective agents|mesh-ancestor
64786564|NCT00002154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786565|NCT00002154|Antioxidants|antioxidants|mesh-ancestor
64786566|NCT00002154|Vitamin B Complex|vitamin b complex|mesh-ancestor
64786568|NCT00002154|Micronutrients|micronutrients|mesh-ancestor
64786569|NCT00002160|Ziconotide|ziconotide|mesh-list
64471775|NCT04119284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64786570|NCT00002160|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64786571|NCT00002160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64786572|NCT00002160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786600|NCT00002178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786602|NCT00002178|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786603|NCT00002178|Antiviral Agents|antiviral agents|mesh-ancestor
65280587|NCT00643136|Analgesics|analgesics|mesh-ancestor
65280588|NCT00643136|Sensory System Agents|sensory system agents|mesh-ancestor
65280589|NCT00643136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280590|NCT00643136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280591|NCT00643136|Anticonvulsants|anticonvulsants|mesh-ancestor
65280592|NCT00643136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65280593|NCT00643136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65280594|NCT00643136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280595|NCT00643136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65280596|NCT00643136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65280597|NCT00643136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65280598|NCT00643136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64732975|NCT00003283|Prednisone|prednisone|mesh-list
64786604|NCT00002178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786605|NCT00002178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64786606|NCT00002178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64786607|NCT00002178|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786608|NCT00002178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786609|NCT00002184|Lamivudine|lamivudine|mesh-list
64786610|NCT00002184|Zidovudine|zidovudine|mesh-list
64786611|NCT00002184|Stavudine|stavudine|mesh-list
64786612|NCT00002184|Adefovir|adefovir|mesh-list
64786613|NCT00002184|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64786614|NCT00002184|Nelfinavir|nelfinavir|mesh-list
64786615|NCT00002184|Saquinavir|saquinavir|mesh-list
64786616|NCT00002184|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786632|NCT00002190|Saquinavir|saquinavir|mesh-list
64786633|NCT00002190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786634|NCT00002190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786635|NCT00002190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786661|NCT00002208|Lamivudine|lamivudine|mesh-list
64786662|NCT00002208|Zidovudine|zidovudine|mesh-list
64786663|NCT00002208|Stavudine|stavudine|mesh-list
64786664|NCT00002208|Indinavir|indinavir|mesh-list
64786665|NCT00002208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786666|NCT00002208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786667|NCT00002208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786668|NCT00002208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786669|NCT00002208|Antiviral Agents|antiviral agents|mesh-ancestor
64786670|NCT00002208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786671|NCT00002208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786672|NCT00002208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786673|NCT00002208|Antimetabolites|antimetabolites|mesh-ancestor
64786674|NCT00002208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64786675|NCT00002208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64786676|NCT00002208|Protease Inhibitors|protease inhibitors|mesh-ancestor
64786690|NCT00002220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786691|NCT00002220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786692|NCT00002220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786693|NCT00002220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786694|NCT00002220|Antiviral Agents|antiviral agents|mesh-ancestor
64786695|NCT00002220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786717|NCT00002238|Interferons|interferons|mesh-list
64786718|NCT00002238|Zidovudine|zidovudine|mesh-list
64786719|NCT00002238|Interferon-beta|interferon-beta|mesh-list
64786720|NCT00002238|Interferon beta-1b|interferon beta-1b|mesh-list
64786721|NCT00002238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64786722|NCT00002238|Antiviral Agents|antiviral agents|mesh-ancestor
64786723|NCT00002238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786724|NCT00002238|Antimetabolites|antimetabolites|mesh-ancestor
64786725|NCT00002238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555360|NCT03092076|Ticagrelor|ticagrelor|mesh-list
64786726|NCT00002238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65280599|NCT00643136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65280600|NCT01563367|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65280601|NCT01563367|Hematinics|hematinics|mesh-ancestor
65280602|NCT00963313|Adalimumab|adalimumab|mesh-list
65280603|NCT00963313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65280604|NCT00963313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65280605|NCT02797145|Digoxin|digoxin|mesh-list
65280606|NCT02797145|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65280607|NCT02797145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65280608|NCT02797145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280609|NCT02797145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945433|NCT05633615|Antibodies|antibodies|mesh-list
64786727|NCT00002238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786728|NCT00002238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786729|NCT00002238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786730|NCT00002238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786731|NCT00002238|Immunologic Factors|immunologic factors|mesh-ancestor
64786732|NCT00002238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786733|NCT00002238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64786734|NCT00002250|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
64786735|NCT00002250|Immunologic Factors|immunologic factors|mesh-ancestor
64786736|NCT00002250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786737|NCT00002256|Zalcitabine|zalcitabine|mesh-list
64786741|NCT00002256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786742|NCT00002256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786743|NCT00002256|Antiviral Agents|antiviral agents|mesh-ancestor
64786744|NCT00002256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786745|NCT00002256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786746|NCT00002256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786747|NCT00002274|Didanosine|didanosine|mesh-list
64786748|NCT00002274|Antimetabolites|antimetabolites|mesh-ancestor
64786768|NCT00002286|Antimetabolites|antimetabolites|mesh-ancestor
64786769|NCT00002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786770|NCT00002286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786771|NCT00002286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786772|NCT00002286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786773|NCT00002286|Antiviral Agents|antiviral agents|mesh-ancestor
64786774|NCT00002286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786775|NCT00002286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786776|NCT00002286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786778|NCT00002292|Antifungal Agents|antifungal agents|mesh-ancestor
64786779|NCT00002292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786780|NCT00002292|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64786781|NCT00002292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64786782|NCT00002292|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64786783|NCT00002298|Ribavirin|ribavirin|mesh-list
64786784|NCT00002298|Antimetabolites|antimetabolites|mesh-ancestor
64786785|NCT00002298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786786|NCT00002298|Antiviral Agents|antiviral agents|mesh-ancestor
64786787|NCT00002298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786788|NCT00002304|Fluconazole|fluconazole|mesh-list
64786789|NCT00002304|Ketoconazole|ketoconazole|mesh-list
64786790|NCT00002304|Antifungal Agents|antifungal agents|mesh-ancestor
64786791|NCT00002304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786792|NCT00002304|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64786793|NCT00002304|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64786794|NCT00002304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786795|NCT00002304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786796|NCT00002304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64786797|NCT00002304|Hormone Antagonists|hormone antagonists|mesh-ancestor
64786798|NCT00002304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64786799|NCT00002304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786800|NCT00002304|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64945434|NCT05633615|Immunoglobulins|immunoglobulins|mesh-list
64786845|NCT00002340|Antimalarials|antimalarials|mesh-ancestor
64786846|NCT00002340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65280610|NCT02797145|Protective Agents|protective agents|mesh-ancestor
65280611|NCT02797145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280612|NCT02690129|Progesterone|progesterone|mesh-list
65280613|NCT02690129|Progestins|progestins|mesh-ancestor
65280614|NCT02690129|Hormones|hormones|mesh-ancestor
65280615|NCT02690129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65280616|NCT02690129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280617|NCT00883116|Paclitaxel|paclitaxel|mesh-list
65280618|NCT00883116|Doxorubicin|doxorubicin|mesh-list
65280619|NCT00883116|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65280620|NCT00883116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65280621|NCT00883116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280622|NCT00883116|Tubulin Modulators|tubulin modulators|mesh-ancestor
65280623|NCT00883116|Antimitotic Agents|antimitotic agents|mesh-ancestor
65280624|NCT00883116|Mitosis Modulators|mitosis modulators|mesh-ancestor
65280625|NCT00883116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280626|NCT00883116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65280627|NCT00883116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65280628|NCT00883116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64732999|NCT00004297|GABA Agents|gaba agents|mesh-ancestor
64786847|NCT00002340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64786848|NCT00002340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786849|NCT00002340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786850|NCT00002340|Antifungal Agents|antifungal agents|mesh-ancestor
64786851|NCT00002340|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64786852|NCT00002346|Adefovir|adefovir|mesh-list
64786853|NCT00002346|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64786854|NCT00002346|Antiviral Agents|antiviral agents|mesh-ancestor
64786855|NCT00002346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786856|NCT00002346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786857|NCT00002346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786858|NCT00002346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786859|NCT00002346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786860|NCT00002352|Lobucavir|lobucavir|mesh-list
64786861|NCT00002352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786862|NCT00002352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786863|NCT00002352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786864|NCT00002352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786874|NCT00002364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786875|NCT00002364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786876|NCT00002364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945435|NCT05633615|Immunoconjugates|immunoconjugates|mesh-list
64786877|NCT00002364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786878|NCT00002364|Antiviral Agents|antiviral agents|mesh-ancestor
64786879|NCT00002364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786902|NCT00002376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786903|NCT00002376|Antiviral Agents|antiviral agents|mesh-ancestor
64786904|NCT00002376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786905|NCT00002376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786906|NCT00002376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786907|NCT00002376|Antimetabolites|antimetabolites|mesh-ancestor
64786908|NCT00002376|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64786909|NCT00002376|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64786910|NCT00002376|Protease Inhibitors|protease inhibitors|mesh-ancestor
65280629|NCT00883116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280630|NCT02139397|Eflornithine|eflornithine|mesh-list
65280631|NCT02139397|Bortezomib|bortezomib|mesh-list
65280632|NCT02139397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280633|NCT02139397|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65280634|NCT02139397|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65280635|NCT02139397|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65280636|NCT02139397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786911|NCT00002382|Saquinavir|saquinavir|mesh-list
64786912|NCT00002382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64786913|NCT00002382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64786914|NCT00002382|Protease Inhibitors|protease inhibitors|mesh-ancestor
64786915|NCT00002382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786916|NCT00002382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786917|NCT00002382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786918|NCT00002382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786919|NCT00002382|Antiviral Agents|antiviral agents|mesh-ancestor
64786920|NCT00002382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786921|NCT00002382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64786922|NCT00002382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64786923|NCT00002388|Abacavir|abacavir|mesh-list
64786924|NCT00002388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786925|NCT00002388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786926|NCT00002388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786927|NCT00002388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786928|NCT00002388|Antiviral Agents|antiviral agents|mesh-ancestor
64786929|NCT00002388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786940|NCT00002400|Indinavir|indinavir|mesh-list
64786941|NCT00002400|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786942|NCT00002400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786977|NCT00002412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786978|NCT00002418|Nevirapine|nevirapine|mesh-list
64786979|NCT00002418|Didanosine|didanosine|mesh-list
64786980|NCT00002418|Stavudine|stavudine|mesh-list
64786981|NCT00002418|Emivirine|emivirine|mesh-list
64786982|NCT00002418|Hydroxyurea|hydroxyurea|mesh-list
64786983|NCT00002418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786984|NCT00002418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64787013|NCT00002430|Nelfinavir|nelfinavir|mesh-list
64787014|NCT00002430|Indinavir|indinavir|mesh-list
64471777|NCT04119284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787015|NCT00002430|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64787016|NCT00002430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64787017|NCT00002430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787018|NCT00002430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787019|NCT00002430|Antiviral Agents|antiviral agents|mesh-ancestor
64787020|NCT00002430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64787021|NCT00002430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64787022|NCT00002430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64787023|NCT00002430|Antimetabolites|antimetabolites|mesh-ancestor
64787024|NCT00002430|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64787025|NCT00002430|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64787026|NCT00002430|Protease Inhibitors|protease inhibitors|mesh-ancestor
64787027|NCT00002436|Lamivudine|lamivudine|mesh-list
64787028|NCT00002436|Zidovudine|zidovudine|mesh-list
64787029|NCT00002436|Zalcitabine|zalcitabine|mesh-list
64945436|NCT05633615|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64787030|NCT00002436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64787031|NCT00002436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64787032|NCT00002436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787033|NCT00002436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787034|NCT00002436|Antiviral Agents|antiviral agents|mesh-ancestor
64787035|NCT00002436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64787036|NCT00002436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64787037|NCT00002436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64787038|NCT00002436|Antimetabolites|antimetabolites|mesh-ancestor
64787039|NCT00002442|Lamivudine|lamivudine|mesh-list
64787040|NCT00002442|Stavudine|stavudine|mesh-list
64787041|NCT00002442|Nelfinavir|nelfinavir|mesh-list
64787042|NCT00002442|Indinavir|indinavir|mesh-list
64787043|NCT00002442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65280637|NCT02139397|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
65280638|NCT02139397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280639|NCT02139397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280640|NCT02795429|Spartalizumab|spartalizumab|mesh-list
65280641|NCT02795429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65280642|NCT02795429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280643|NCT02795429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280644|NCT00643292|Amoxicillin|amoxicillin|mesh-list
65280645|NCT00643292|Azithromycin|azithromycin|mesh-list
64787044|NCT00002442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64787045|NCT00002442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787046|NCT00002442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787047|NCT00002442|Antiviral Agents|antiviral agents|mesh-ancestor
64787048|NCT00002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64787049|NCT00002442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64787050|NCT00002442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64787097|NCT00002466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64787099|NCT00002466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787100|NCT00002466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787101|NCT00002466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64787102|NCT00002466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64555737|NCT03950609|Everolimus|everolimus|mesh-list
64787103|NCT00002466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64787104|NCT00002466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64787105|NCT00002466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787106|NCT00002466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64787140|NCT00002496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787141|NCT00002496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64787142|NCT00002496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64787143|NCT00002496|Immunologic Factors|immunologic factors|mesh-ancestor
64787144|NCT00002496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787145|NCT00002496|Trace Elements|trace elements|mesh-ancestor
64787146|NCT00002496|Micronutrients|micronutrients|mesh-ancestor
64787147|NCT00002502|Cytarabine|cytarabine|mesh-list
64787148|NCT00002502|Cyclophosphamide|cyclophosphamide|mesh-list
64787149|NCT00002502|Busulfan|busulfan|mesh-list
64787150|NCT00002502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64787151|NCT00002502|Immunologic Factors|immunologic factors|mesh-ancestor
64787152|NCT00002502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787153|NCT00002502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64787154|NCT00002502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64787155|NCT00002502|Alkylating Agents|alkylating agents|mesh-ancestor
64787156|NCT00002502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787157|NCT00002502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787158|NCT00002502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64787159|NCT00002502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64787160|NCT00002502|Antimetabolites|antimetabolites|mesh-ancestor
64787161|NCT00002502|Antiviral Agents|antiviral agents|mesh-ancestor
64787162|NCT00002502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64787163|NCT00002508|Carboplatin|carboplatin|mesh-list
64787164|NCT00002508|Etoposide|etoposide|mesh-list
64787165|NCT00002508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787166|NCT00002508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64398280|NCT05024825|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64787208|NCT00002514|Antimetabolites|antimetabolites|mesh-ancestor
64787209|NCT00002514|Dermatologic Agents|dermatologic agents|mesh-ancestor
64787210|NCT00002514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787211|NCT00002514|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64787212|NCT00002514|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64787213|NCT00002514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64787214|NCT00002514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64787215|NCT00002514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64787216|NCT00002514|Antiviral Agents|antiviral agents|mesh-ancestor
65280646|NCT00643292|Clavulanic Acid|clavulanic acid|mesh-list
65280647|NCT00643292|Clavulanic Acids|clavulanic acids|mesh-list
65280648|NCT00643292|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65280649|NCT00643292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65280650|NCT00643292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65280651|NCT00643292|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65280652|NCT00643292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280653|NCT00643292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787217|NCT00002514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64787219|NCT00002514|Protective Agents|protective agents|mesh-ancestor
64787220|NCT00002514|Vitamin B Complex|vitamin b complex|mesh-ancestor
64787221|NCT00002514|Vitamins|vitamins|mesh-ancestor
64787222|NCT00002514|Micronutrients|micronutrients|mesh-ancestor
64787223|NCT00002514|Tubulin Modulators|tubulin modulators|mesh-ancestor
64787224|NCT00002514|Antimitotic Agents|antimitotic agents|mesh-ancestor
64787225|NCT00002514|Mitosis Modulators|mitosis modulators|mesh-ancestor
64787226|NCT00002514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64787227|NCT00002514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64787228|NCT00002520|Nicotine|nicotine|mesh-list
64787229|NCT00002520|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64787230|NCT00002520|Autonomic Agents|autonomic agents|mesh-ancestor
64787231|NCT00002520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64787232|NCT00002520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787233|NCT00002520|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64787234|NCT00002520|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64787235|NCT00002520|Cholinergic Agents|cholinergic agents|mesh-ancestor
64787236|NCT00002520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64787237|NCT00002520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787238|NCT00002526|Doxorubicin|doxorubicin|mesh-list
64787276|NCT00002532|Antimetabolites|antimetabolites|mesh-ancestor
64787277|NCT00002532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787278|NCT00002532|Dermatologic Agents|dermatologic agents|mesh-ancestor
64787279|NCT00002532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787280|NCT00002532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64787281|NCT00002532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64787282|NCT00002532|Immunologic Factors|immunologic factors|mesh-ancestor
64787283|NCT00002532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64787284|NCT00002532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64787285|NCT00002532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64787286|NCT00002532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64471778|NCT04119284|Protective Agents|protective agents|mesh-ancestor
64471779|NCT04119284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787287|NCT00002532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64787288|NCT00002532|Antiviral Agents|antiviral agents|mesh-ancestor
64787289|NCT00002532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64787290|NCT00002532|Antidotes|antidotes|mesh-ancestor
64787291|NCT00002532|Protective Agents|protective agents|mesh-ancestor
64787334|NCT00002556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64787336|NCT00002556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787337|NCT00002556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787338|NCT00002556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64787339|NCT00002556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64787340|NCT00002556|Glucocorticoids|glucocorticoids|mesh-ancestor
64787341|NCT00002556|Hormones|hormones|mesh-ancestor
64787342|NCT00002556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64787343|NCT00002556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64787344|NCT00002556|Antiviral Agents|antiviral agents|mesh-ancestor
64787345|NCT00002556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64787346|NCT00002556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64787347|NCT00002556|Tubulin Modulators|tubulin modulators|mesh-ancestor
64787348|NCT00002556|Antimitotic Agents|antimitotic agents|mesh-ancestor
64787349|NCT00002556|Mitosis Modulators|mitosis modulators|mesh-ancestor
64787378|NCT00002580|Cyclophosphamide|cyclophosphamide|mesh-list
64787379|NCT00002580|Fluorouracil|fluorouracil|mesh-list
64787380|NCT00002580|Methotrexate|methotrexate|mesh-list
64787381|NCT00002580|Leuprolide|leuprolide|mesh-list
64787382|NCT00002580|Goserelin|goserelin|mesh-list
65280654|NCT02797067|Indomethacin|indomethacin|mesh-list
65280655|NCT02797067|Glycerol|glycerol|mesh-list
65280656|NCT02797067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65280657|NCT02797067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65280658|NCT02797067|Analgesics|analgesics|mesh-ancestor
65280659|NCT02797067|Sensory System Agents|sensory system agents|mesh-ancestor
65280660|NCT02797067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280661|NCT02797067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280662|NCT02797067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64787383|NCT00002580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64787384|NCT00002580|Immunologic Factors|immunologic factors|mesh-ancestor
64787385|NCT00002580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398475|NCT04434365|Aspirin|aspirin|mesh-list
64787389|NCT00002580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787390|NCT00002580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787391|NCT00002580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64787392|NCT00002580|Antimetabolites|antimetabolites|mesh-ancestor
64787393|NCT00002580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64787394|NCT00002580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64787395|NCT00002580|Abortifacient Agents|abortifacient agents|mesh-ancestor
64787422|NCT00002586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787423|NCT00002586|Keratolytic Agents|keratolytic agents|mesh-ancestor
64787424|NCT00002586|Dermatologic Agents|dermatologic agents|mesh-ancestor
64787426|NCT00002592|Busulfan|busulfan|mesh-list
64787427|NCT00002592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64787428|NCT00002592|Immunologic Factors|immunologic factors|mesh-ancestor
64787429|NCT00002592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787430|NCT00002592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64787431|NCT00002592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64787432|NCT00002592|Alkylating Agents|alkylating agents|mesh-ancestor
64787433|NCT00002592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787434|NCT00002592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787435|NCT00002592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64787436|NCT00002598|Interferons|interferons|mesh-list
64787437|NCT00002598|Cytarabine|cytarabine|mesh-list
64787438|NCT00002598|Interferon-alpha|interferon-alpha|mesh-list
64787439|NCT00002598|Cyclophosphamide|cyclophosphamide|mesh-list
64787440|NCT00002598|Methotrexate|methotrexate|mesh-list
64787441|NCT00002598|Etoposide|etoposide|mesh-list
64787442|NCT00002598|Mitoxantrone|mitoxantrone|mesh-list
64787443|NCT00002598|Sargramostim|sargramostim|mesh-list
64787468|NCT00002598|Sensory System Agents|sensory system agents|mesh-ancestor
64787469|NCT00002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64787470|NCT00002604|Carmustine|carmustine|mesh-list
64787471|NCT00002604|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64787472|NCT00002604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64787473|NCT00002604|Alkylating Agents|alkylating agents|mesh-ancestor
64787474|NCT00002604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787475|NCT00002604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787476|NCT00002604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787477|NCT00002610|Dactinomycin|dactinomycin|mesh-list
64787478|NCT00002610|Cyclophosphamide|cyclophosphamide|mesh-list
64787479|NCT00002610|Carboplatin|carboplatin|mesh-list
64787480|NCT00002610|Doxorubicin|doxorubicin|mesh-list
64787481|NCT00002610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64787482|NCT00002610|Etoposide|etoposide|mesh-list
64787483|NCT00002610|Vincristine|vincristine|mesh-list
64787484|NCT00002610|Lenograstim|lenograstim|mesh-list
64787485|NCT00002610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64787486|NCT00002610|Immunologic Factors|immunologic factors|mesh-ancestor
64787487|NCT00002610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787488|NCT00002610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64787489|NCT00002610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64787490|NCT00002610|Alkylating Agents|alkylating agents|mesh-ancestor
64787491|NCT00002610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787492|NCT00002610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787493|NCT00002610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64787494|NCT00002610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65280663|NCT02797067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65280664|NCT02797067|Gout Suppressants|gout suppressants|mesh-ancestor
65280665|NCT02797067|Tocolytic Agents|tocolytic agents|mesh-ancestor
65280666|NCT02797067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65280667|NCT02797067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65280668|NCT02797067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280669|NCT02797067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280670|NCT02797067|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65280671|NCT02797067|Protective Agents|protective agents|mesh-ancestor
65280672|NCT00655044|Insulin Detemir|insulin detemir|mesh-list
65280673|NCT00655044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65280674|NCT00655044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280675|NCT00963703|Rituximab|rituximab|mesh-list
64787495|NCT00002610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64787496|NCT00002610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64787497|NCT00002610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787498|NCT00002610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64787499|NCT00002610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64787500|NCT00002610|Tubulin Modulators|tubulin modulators|mesh-ancestor
64787501|NCT00002610|Antimitotic Agents|antimitotic agents|mesh-ancestor
64787533|NCT00002628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64787534|NCT00002628|Immunologic Factors|immunologic factors|mesh-ancestor
64787535|NCT00002628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787536|NCT00002628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64787537|NCT00002628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64787538|NCT00002628|Alkylating Agents|alkylating agents|mesh-ancestor
64787539|NCT00002628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64787541|NCT00002634|Cyclophosphamide|cyclophosphamide|mesh-list
64787542|NCT00002634|Doxorubicin|doxorubicin|mesh-list
64787543|NCT00002634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64787544|NCT00002634|Etoposide|etoposide|mesh-list
64787545|NCT00002634|Vincristine|vincristine|mesh-list
64787546|NCT00002634|Antibodies|antibodies|mesh-list
64787547|NCT00002634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64787548|NCT00002634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64787549|NCT00002634|Immunologic Factors|immunologic factors|mesh-ancestor
64787550|NCT00002634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787551|NCT00002634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64787552|NCT00002634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64787553|NCT00002634|Alkylating Agents|alkylating agents|mesh-ancestor
64787554|NCT00002634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787555|NCT00002634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787556|NCT00002634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64787557|NCT00002634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64787558|NCT00002634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64787592|NCT00002658|Mitoxantrone|mitoxantrone|mesh-list
64787593|NCT00002658|Idarubicin|idarubicin|mesh-list
64787594|NCT00002658|Tretinoin|tretinoin|mesh-list
64787595|NCT00002658|Thioguanine|thioguanine|mesh-list
64787596|NCT00002658|Amsacrine|amsacrine|mesh-list
64787597|NCT00002658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64787598|NCT00002658|Immunologic Factors|immunologic factors|mesh-ancestor
64787599|NCT00002658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787605|NCT00002658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64787606|NCT00002658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64787633|NCT00002676|Carmustine|carmustine|mesh-list
64787634|NCT00002676|Doxorubicin|doxorubicin|mesh-list
64787635|NCT00002676|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64787636|NCT00002676|Methotrexate|methotrexate|mesh-list
64787637|NCT00002676|Vincristine|vincristine|mesh-list
64787638|NCT00002676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64787639|NCT00002676|Immunologic Factors|immunologic factors|mesh-ancestor
64787640|NCT00002676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787641|NCT00002676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65280676|NCT00963703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65280677|NCT00963703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280678|NCT00963703|Immunologic Factors|immunologic factors|mesh-ancestor
65280679|NCT00963703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280680|NCT00963703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65280681|NCT00655122|Dalteparin|dalteparin|mesh-list
65280682|NCT00655122|Tinzaparin|tinzaparin|mesh-list
65280683|NCT00655122|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65280684|NCT00655122|Anticoagulants|anticoagulants|mesh-ancestor
65280685|NCT00655122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65280686|NCT00655122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65280687|NCT00655122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280688|NCT02638116|Omeprazole|omeprazole|mesh-list
65280689|NCT02638116|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64733063|NCT00003307|Amifostine|amifostine|mesh-list
64787642|NCT00002676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64787643|NCT00002676|Alkylating Agents|alkylating agents|mesh-ancestor
64787644|NCT00002676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787645|NCT00002676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787646|NCT00002676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64787647|NCT00002676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64787648|NCT00002676|Antiemetics|antiemetics|mesh-ancestor
64787649|NCT00002676|Autonomic Agents|autonomic agents|mesh-ancestor
64787650|NCT00002676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64787651|NCT00002676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64787652|NCT00002676|Glucocorticoids|glucocorticoids|mesh-ancestor
64787654|NCT00002676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64787655|NCT00002676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64787656|NCT00002676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64787657|NCT00002676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64787658|NCT00002676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64787659|NCT00002676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787660|NCT00002676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64471812|NCT04094961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471813|NCT04094961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64492400|NCT01887353|Ranolazine|ranolazine|mesh-list
64787699|NCT00002688|Mitoxantrone|mitoxantrone|mesh-list
64787700|NCT00002688|Cyclosporins|cyclosporins|mesh-list
64787701|NCT00002688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64787702|NCT00002688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787703|NCT00002688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64787704|NCT00002688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64787705|NCT00002688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787706|NCT00002688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787707|NCT00002688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64787708|NCT00002688|Immunologic Factors|immunologic factors|mesh-ancestor
64787709|NCT00002688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787744|NCT00002700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787745|NCT00002700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64787757|NCT00002700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64787758|NCT00002700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787759|NCT00002700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64787760|NCT00002700|Abortifacient Agents|abortifacient agents|mesh-ancestor
64787761|NCT00002700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64787762|NCT00002700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64787763|NCT00002700|Antimetabolites|antimetabolites|mesh-ancestor
64787764|NCT00002700|Dermatologic Agents|dermatologic agents|mesh-ancestor
64787765|NCT00002700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64787766|NCT00002700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65280690|NCT02638116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65280691|NCT02638116|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65280692|NCT02638116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280693|NCT02638116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280694|NCT04164264|Propofol|propofol|mesh-list
65280695|NCT04164264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64787799|NCT00002718|Antiemetics|antiemetics|mesh-ancestor
64787800|NCT00002718|Autonomic Agents|autonomic agents|mesh-ancestor
64787801|NCT00002718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64787802|NCT00002718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64787803|NCT00002718|Glucocorticoids|glucocorticoids|mesh-ancestor
64787804|NCT00002718|Hormones|hormones|mesh-ancestor
64787805|NCT00002718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64787806|NCT00002718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64787807|NCT00002718|Protective Agents|protective agents|mesh-ancestor
64787808|NCT00002730|Melphalan|melphalan|mesh-list
64787809|NCT00002730|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
64787844|NCT00002748|Sensory System Agents|sensory system agents|mesh-ancestor
64787845|NCT00002748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64787846|NCT00002748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787847|NCT00002748|Immunologic Factors|immunologic factors|mesh-ancestor
64787848|NCT00002754|Antibodies|antibodies|mesh-list
64787849|NCT00002754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64787850|NCT00002754|Immunologic Factors|immunologic factors|mesh-ancestor
64787851|NCT00002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787852|NCT00002760|Ketoconazole|ketoconazole|mesh-list
64787853|NCT00002760|Hydrocortisone|hydrocortisone|mesh-list
64787854|NCT00002760|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64787855|NCT00002760|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64787856|NCT00002760|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64787857|NCT00002760|Androgen Antagonists|androgen antagonists|mesh-list
64787858|NCT00002760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64787859|NCT00002760|Antifungal Agents|antifungal agents|mesh-ancestor
64787860|NCT00002760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64787861|NCT00002760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64787884|NCT00002772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64787885|NCT00002772|Immunologic Factors|immunologic factors|mesh-ancestor
64787886|NCT00002772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787887|NCT00002772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64787888|NCT00002772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64787889|NCT00002772|Alkylating Agents|alkylating agents|mesh-ancestor
64787890|NCT00002772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64787891|NCT00002772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64787892|NCT00002772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64787893|NCT00002772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64787894|NCT00002772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787895|NCT00002772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64787896|NCT00002772|Hormone Antagonists|hormone antagonists|mesh-ancestor
64787897|NCT00002772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64787898|NCT00002772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64787899|NCT00002772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64787900|NCT00002772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64787901|NCT00002772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64787903|NCT00002778|Immunologic Factors|immunologic factors|mesh-ancestor
64787904|NCT00002778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787905|NCT00002784|Tamoxifen|tamoxifen|mesh-list
64787906|NCT00002784|Cyclophosphamide|cyclophosphamide|mesh-list
64787907|NCT00002784|Doxorubicin|doxorubicin|mesh-list
64787908|NCT00002784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64787909|NCT00002784|Fluorouracil|fluorouracil|mesh-list
64787910|NCT00002784|Methotrexate|methotrexate|mesh-list
64787911|NCT00002784|Epirubicin|epirubicin|mesh-list
64787912|NCT00002784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64787913|NCT00002784|Immunologic Factors|immunologic factors|mesh-ancestor
64787914|NCT00002784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787915|NCT00002784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64787916|NCT00002784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64787917|NCT00002784|Alkylating Agents|alkylating agents|mesh-ancestor
64787918|NCT00002784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280696|NCT04164264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65280697|NCT04164264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280698|NCT04164264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65280699|NCT04164264|Anesthetics, General|anesthetics, general|mesh-ancestor
65280700|NCT04164264|Anesthetics|anesthetics|mesh-ancestor
65280701|NCT02795039|Fulvestrant|fulvestrant|mesh-list
65280702|NCT02795039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65280703|NCT02795039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280704|NCT02795039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65280705|NCT02795039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64427810|NCT02374099|Cc-486|cc-486|mesh-list
64787919|NCT00002784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787920|NCT00002784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64787921|NCT00002784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64787961|NCT00002790|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64787962|NCT00002790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64787963|NCT00002790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64787965|NCT05752110|Analgesics|analgesics|mesh-ancestor
64787966|NCT05752110|Sensory System Agents|sensory system agents|mesh-ancestor
64787967|NCT05752110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64787968|NCT05752110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787969|NCT05752110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64788001|NCT05749926|Immunologic Factors|immunologic factors|mesh-ancestor
64788002|NCT05749926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788003|NCT05749614|Lidocaine|lidocaine|mesh-list
64788004|NCT05749614|Anesthetics, Local|anesthetics, local|mesh-ancestor
64788005|NCT05749614|Anesthetics|anesthetics|mesh-ancestor
64788006|NCT05749614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64788007|NCT05749614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788008|NCT05749614|Sensory System Agents|sensory system agents|mesh-ancestor
64788054|NCT05543850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64788055|NCT05516628|Bevacizumab|bevacizumab|mesh-list
64788056|NCT05516628|Atezolizumab|atezolizumab|mesh-list
64788057|NCT05516628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64788058|NCT05516628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788059|NCT05516628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64788060|NCT05516628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64788061|NCT05516628|Growth Substances|growth substances|mesh-ancestor
64788062|NCT05516628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788099|NCT05391828|Histamine Antagonists|histamine antagonists|mesh-ancestor
64788101|NCT05391828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64788102|NCT05391828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788103|NCT05391828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788104|NCT05391828|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64788105|NCT05391828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64788106|NCT05391828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788107|NCT05360628|Allopurinol|allopurinol|mesh-list
64788108|NCT05360628|Antimetabolites|antimetabolites|mesh-ancestor
64788109|NCT05360628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788138|NCT05311176|Mitosis Modulators|mitosis modulators|mesh-ancestor
64788139|NCT05311176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788140|NCT05311176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64788141|NCT05309928|Amoxicillin|amoxicillin|mesh-list
64788142|NCT05309928|Probenecid|probenecid|mesh-list
64788152|NCT05296278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788153|NCT05296278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788154|NCT05271552|Dexmedetomidine|dexmedetomidine|mesh-list
64788155|NCT05271552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64788156|NCT05271552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64788157|NCT05271552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788158|NCT05271552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64788159|NCT05271552|Analgesics|analgesics|mesh-ancestor
64788160|NCT05271552|Sensory System Agents|sensory system agents|mesh-ancestor
65280706|NCT02795039|Hormone Antagonists|hormone antagonists|mesh-ancestor
65280707|NCT02795039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65280708|NCT02795039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280709|NCT02796833|SMOFlipid|smoflipid|mesh-list
65280710|NCT02796833|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65280711|NCT02796833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65280712|NCT02796833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65280713|NCT04009603|Metformin|metformin|mesh-list
64788161|NCT05271552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64788162|NCT05271552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64788163|NCT05271552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64788164|NCT05271552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64788165|NCT05271552|Adrenergic Agents|adrenergic agents|mesh-ancestor
64788166|NCT05271552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64788223|NCT04740294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64788225|NCT04740294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64788226|NCT04740294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64788227|NCT04740294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788228|NCT04740294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64788229|NCT04740294|Tocolytic Agents|tocolytic agents|mesh-ancestor
64788230|NCT04740294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64788231|NCT04705818|Durvalumab|durvalumab|mesh-list
64788232|NCT04705818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64788233|NCT04705818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788234|NCT04610736|Temozolomide|temozolomide|mesh-list
64788235|NCT04610736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64788236|NCT04610736|Alkylating Agents|alkylating agents|mesh-ancestor
64788237|NCT04610736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788238|NCT04610736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788239|NCT04609020|Lidocaine|lidocaine|mesh-list
64788240|NCT04609020|Anesthetics, Local|anesthetics, local|mesh-ancestor
64788241|NCT04609020|Anesthetics|anesthetics|mesh-ancestor
64788242|NCT04609020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64788243|NCT04609020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788244|NCT04609020|Sensory System Agents|sensory system agents|mesh-ancestor
64788245|NCT04609020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64788246|NCT04609020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64788247|NCT04609020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64788248|NCT04609020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64788249|NCT04609020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64788295|NCT04168710|Bupivacaine|bupivacaine|mesh-list
64788296|NCT04168710|Anesthetics, Local|anesthetics, local|mesh-ancestor
64788297|NCT04168710|Anesthetics|anesthetics|mesh-ancestor
64788298|NCT04168710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64788397|NCT03662022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64788398|NCT03662022|Antitubercular Agents|antitubercular agents|mesh-ancestor
64788399|NCT03662022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64788400|NCT03662022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64788406|NCT03662022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64788407|NCT03662022|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64788408|NCT03662022|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64788409|NCT03662022|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64788410|NCT03662022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64788411|NCT03652428|Gemcitabine|gemcitabine|mesh-list
64788412|NCT03652428|Paclitaxel|paclitaxel|mesh-list
64788413|NCT03652428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64788414|NCT03652428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788446|NCT03351348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788447|NCT03351348|Sensory System Agents|sensory system agents|mesh-ancestor
64788448|NCT03351348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64788449|NCT02972034|Pembrolizumab|pembrolizumab|mesh-list
64788450|NCT02972034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64788451|NCT02972034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788488|NCT01394016|Fulvestrant|fulvestrant|mesh-list
65280714|NCT04009603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65280715|NCT04009603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280716|NCT02635230|Aspirin|aspirin|mesh-list
65280786|NCT04032366|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65280787|NCT04032366|Antioxidants|antioxidants|mesh-ancestor
65280788|NCT04032366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280789|NCT04032366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65280790|NCT04032366|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65280791|NCT04032366|Vasodilator Agents|vasodilator agents|mesh-ancestor
65280792|NCT04032366|Gasotransmitters|gasotransmitters|mesh-ancestor
65280793|NCT04032366|Protective Agents|protective agents|mesh-ancestor
65280794|NCT02537600|Vemurafenib|vemurafenib|mesh-list
65280795|NCT02537600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280796|NCT02537600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65280797|NCT02537600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788489|NCT01394016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64788490|NCT01394016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788491|NCT01394016|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64788492|NCT01394016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64788493|NCT01394016|Hormone Antagonists|hormone antagonists|mesh-ancestor
64788494|NCT01394016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64788495|NCT01394016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788496|NCT01096368|Cyclophosphamide|cyclophosphamide|mesh-list
64788497|NCT01096368|Cisplatin|cisplatin|mesh-list
64788498|NCT01096368|Carboplatin|carboplatin|mesh-list
64788499|NCT01096368|Etoposide|etoposide|mesh-list
64788500|NCT01096368|Vincristine|vincristine|mesh-list
64788501|NCT01096368|Etoposide phosphate|etoposide phosphate|mesh-list
64788502|NCT01096368|Podophyllotoxin|podophyllotoxin|mesh-list
64788503|NCT01096368|Lenograstim|lenograstim|mesh-list
64788504|NCT01096368|Mesna|mesna|mesh-list
64788505|NCT01096368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64788506|NCT01096368|Immunologic Factors|immunologic factors|mesh-ancestor
64788507|NCT01096368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788508|NCT01096368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64788509|NCT01096368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64788510|NCT01096368|Alkylating Agents|alkylating agents|mesh-ancestor
64788532|NCT00577200|Sufentanil|sufentanil|mesh-list
64788533|NCT00577200|Propofol|propofol|mesh-list
64788547|NCT00577200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788548|NCT00577200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64788549|NCT00577200|Narcotics|narcotics|mesh-ancestor
64788550|NCT00577200|Analgesics|analgesics|mesh-ancestor
64788551|NCT00577200|Sensory System Agents|sensory system agents|mesh-ancestor
64788552|NCT00577200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64788553|NCT00002796|Interferons|interferons|mesh-list
64788554|NCT00002796|Interferon-gamma|interferon-gamma|mesh-list
64788555|NCT00002796|Indomethacin|indomethacin|mesh-list
64788556|NCT00002796|Fluorouracil|fluorouracil|mesh-list
64788557|NCT00002796|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64788558|NCT00002796|Antimetabolites|antimetabolites|mesh-ancestor
64788559|NCT00002796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788560|NCT00002796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64788561|NCT00002796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788562|NCT00002796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64788563|NCT00002796|Immunologic Factors|immunologic factors|mesh-ancestor
64788564|NCT00002796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788565|NCT00002796|Antiviral Agents|antiviral agents|mesh-ancestor
64788566|NCT00002796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64788567|NCT00002796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64788568|NCT00002796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64788569|NCT00002796|Analgesics|analgesics|mesh-ancestor
64788570|NCT00002796|Sensory System Agents|sensory system agents|mesh-ancestor
64788571|NCT00002796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64788572|NCT00002796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64788573|NCT00002796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64788574|NCT00002796|Gout Suppressants|gout suppressants|mesh-ancestor
65280798|NCT02537600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280799|NCT00684099|Docetaxel|docetaxel|mesh-list
65280800|NCT00684099|Pemetrexed|pemetrexed|mesh-list
65280801|NCT00684099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280802|NCT00684099|Tubulin Modulators|tubulin modulators|mesh-ancestor
65280803|NCT00684099|Antimitotic Agents|antimitotic agents|mesh-ancestor
65280804|NCT00684099|Mitosis Modulators|mitosis modulators|mesh-ancestor
65280805|NCT00684099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280806|NCT00684099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280807|NCT00684099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64733181|NCT00003343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788616|NCT00002814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788617|NCT00002814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64788618|NCT00002814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64788619|NCT00002814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788620|NCT00002826|Paclitaxel|paclitaxel|mesh-list
64788621|NCT00002826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64788622|NCT00002826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788623|NCT00002826|Tubulin Modulators|tubulin modulators|mesh-ancestor
64788624|NCT00002826|Antimitotic Agents|antimitotic agents|mesh-ancestor
64788625|NCT00002826|Mitosis Modulators|mitosis modulators|mesh-ancestor
64788656|NCT00002838|Antimetabolites|antimetabolites|mesh-ancestor
64788657|NCT00002844|Cyclophosphamide|cyclophosphamide|mesh-list
64788658|NCT00002844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64788659|NCT00002844|Immunologic Factors|immunologic factors|mesh-ancestor
64788660|NCT00002844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788661|NCT00002844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64788662|NCT00002844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64788663|NCT00002844|Alkylating Agents|alkylating agents|mesh-ancestor
64788664|NCT00002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788665|NCT00002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788666|NCT00002844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64788667|NCT00002862|Perillyl alcohol|perillyl alcohol|mesh-list
64788687|NCT00002868|Antimetabolites|antimetabolites|mesh-ancestor
64788713|NCT00002898|Cyclophosphamide|cyclophosphamide|mesh-list
64788714|NCT00002898|Ifosfamide|ifosfamide|mesh-list
64788715|NCT00002898|Carboplatin|carboplatin|mesh-list
64788716|NCT00002898|Etoposide|etoposide|mesh-list
64788717|NCT00002898|Vincristine|vincristine|mesh-list
64788718|NCT00002898|Epirubicin|epirubicin|mesh-list
64788719|NCT00002898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64788720|NCT00002898|Immunologic Factors|immunologic factors|mesh-ancestor
64788721|NCT00002898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788722|NCT00002898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64788723|NCT00002898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64788724|NCT00002898|Alkylating Agents|alkylating agents|mesh-ancestor
64788725|NCT00002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788726|NCT00002898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788735|NCT00002898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64788736|NCT00002898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64788737|NCT00002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64788738|NCT00002898|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64788739|NCT00002898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64788741|NCT00002904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64788742|NCT00002904|Alkylating Agents|alkylating agents|mesh-ancestor
64788743|NCT00002904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788744|NCT00002904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788745|NCT00002922|Paclitaxel|paclitaxel|mesh-list
64788781|NCT00002970|Cytarabine|cytarabine|mesh-list
64788782|NCT00002970|Hydrocortisone|hydrocortisone|mesh-list
64788783|NCT00002970|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64788784|NCT00002970|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64788810|NCT00002982|Cytarabine|cytarabine|mesh-list
64788811|NCT00002982|Carboplatin|carboplatin|mesh-list
64788812|NCT00002982|Etoposide|etoposide|mesh-list
64788813|NCT00002982|Melphalan|melphalan|mesh-list
65280808|NCT00684099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65280809|NCT04159896|Nivolumab|nivolumab|mesh-list
65280810|NCT04159896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65280811|NCT04159896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280812|NCT04159896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65344911|NCT00736346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64788814|NCT00002982|Ifosfamide|ifosfamide|mesh-list
64788815|NCT00002982|Carmustine|carmustine|mesh-list
64788816|NCT00002982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788817|NCT00002982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64788818|NCT00002982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64788819|NCT00002982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64788820|NCT00002982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788821|NCT00002982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788822|NCT00002982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64788823|NCT00002982|Antimetabolites|antimetabolites|mesh-ancestor
64788824|NCT00002982|Antiviral Agents|antiviral agents|mesh-ancestor
64788825|NCT00002982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64788826|NCT00002982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64788827|NCT00002982|Immunologic Factors|immunologic factors|mesh-ancestor
64788828|NCT00002982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788854|NCT00003000|Analgesics|analgesics|mesh-ancestor
64788855|NCT00003000|Sensory System Agents|sensory system agents|mesh-ancestor
64788856|NCT00003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64788857|NCT00003000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64788858|NCT00003000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64788859|NCT00003000|Anesthetics, General|anesthetics, general|mesh-ancestor
64788860|NCT00003000|Anesthetics|anesthetics|mesh-ancestor
64788861|NCT00003012|Cyclophosphamide|cyclophosphamide|mesh-list
64788862|NCT00003012|Fluorouracil|fluorouracil|mesh-list
64788863|NCT00003012|Methotrexate|methotrexate|mesh-list
64788864|NCT00003012|Epirubicin|epirubicin|mesh-list
64493418|NCT01880957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64493419|NCT01064830|Cyclosporine|cyclosporine|mesh-list
64493420|NCT01064830|Cyclosporins|cyclosporins|mesh-list
64493421|NCT01064830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493422|NCT01064830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471824|NCT04094961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64471825|NCT04094961|Growth Substances|growth substances|mesh-ancestor
64471826|NCT04094961|Growth Inhibitors|growth inhibitors|mesh-ancestor
64471935|NCT03982082|Dermatologic Agents|dermatologic agents|mesh-ancestor
64471936|NCT03979599|Magnesium Sulfate|magnesium sulfate|mesh-list
64471937|NCT03979599|Levobupivacaine|levobupivacaine|mesh-list
64788881|NCT00003012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64788882|NCT00003012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64471949|NCT03979599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64471950|NCT03979599|Tocolytic Agents|tocolytic agents|mesh-ancestor
64471951|NCT03979599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64471952|NCT03979599|Anesthetics, Local|anesthetics, local|mesh-ancestor
64471954|NCT03975647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471955|NCT03975647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471956|NCT03975647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64471958|NCT03966651|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64471959|NCT03966651|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64471960|NCT03966651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471961|NCT03946514|Losartan|losartan|mesh-list
64471962|NCT03946514|Amlodipine|amlodipine|mesh-list
64471963|NCT03946514|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64788883|NCT00003012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64788884|NCT00003012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64788885|NCT00003012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64788887|NCT00003018|Fluorouracil|fluorouracil|mesh-list
64788888|NCT00003018|Mitomycins|mitomycins|mesh-list
64788920|NCT00003054|Tubulin Modulators|tubulin modulators|mesh-ancestor
64788921|NCT00003054|Antimitotic Agents|antimitotic agents|mesh-ancestor
64788922|NCT00003054|Mitosis Modulators|mitosis modulators|mesh-ancestor
64788923|NCT00003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788924|NCT00003060|Cyclosporine|cyclosporine|mesh-list
64788925|NCT00003060|Cyclophosphamide|cyclophosphamide|mesh-list
64788926|NCT00003060|Busulfan|busulfan|mesh-list
64788927|NCT00003060|Methotrexate|methotrexate|mesh-list
65280813|NCT04159896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280814|NCT02635074|Cytarabine|cytarabine|mesh-list
65280815|NCT02635074|Idarubicin|idarubicin|mesh-list
65280816|NCT02635074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65280817|NCT02635074|Antimetabolites|antimetabolites|mesh-ancestor
65280818|NCT02635074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280819|NCT02635074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280820|NCT02635074|Antiviral Agents|antiviral agents|mesh-ancestor
65280821|NCT02635074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65280822|NCT02635074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65280823|NCT02635074|Immunologic Factors|immunologic factors|mesh-ancestor
65280824|NCT02635074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280825|NCT02635074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65280826|NCT02635074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64733203|NCT00004903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788928|NCT00003060|Cyclosporins|cyclosporins|mesh-list
64788929|NCT00003060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64788930|NCT00003060|Immunologic Factors|immunologic factors|mesh-ancestor
64471964|NCT03946514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64471965|NCT03946514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64788931|NCT00003060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788932|NCT00003060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64788970|NCT00003072|Protective Agents|protective agents|mesh-ancestor
64788971|NCT00003072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788972|NCT00003078|Fluorouracil|fluorouracil|mesh-list
64788973|NCT00003078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788974|NCT00003078|Antimetabolites|antimetabolites|mesh-ancestor
64788975|NCT00003078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788976|NCT00003078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64788977|NCT00003078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64788978|NCT00003078|Immunologic Factors|immunologic factors|mesh-ancestor
64789018|NCT00003108|Immunologic Factors|immunologic factors|mesh-ancestor
64789019|NCT00003108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789020|NCT00003114|Cyclophosphamide|cyclophosphamide|mesh-list
64789021|NCT00003114|Lomustine|lomustine|mesh-list
64789022|NCT00003114|Etoposide|etoposide|mesh-list
64789023|NCT00003114|Procarbazine|procarbazine|mesh-list
64789024|NCT00003114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789025|NCT00003114|Immunologic Factors|immunologic factors|mesh-ancestor
64789026|NCT00003114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789027|NCT00003114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64789105|NCT00003156|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64789106|NCT00003156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64789107|NCT00003156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789108|NCT00003156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789109|NCT00003156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789110|NCT00003174|Cladribine|cladribine|mesh-list
64789111|NCT00003174|Bryostatin 1|bryostatin 1|mesh-list
64789112|NCT00003174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789113|NCT00003174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789114|NCT00003174|Immunologic Factors|immunologic factors|mesh-ancestor
64789115|NCT00003174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789116|NCT00003174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64789156|NCT00003210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789157|NCT00003210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64789158|NCT00003210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64789159|NCT00003210|Growth Substances|growth substances|mesh-ancestor
64789160|NCT00003210|Growth Inhibitors|growth inhibitors|mesh-ancestor
64789161|NCT00003210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789162|NCT00003216|Gemcitabine|gemcitabine|mesh-list
65280827|NCT02635074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65280828|NCT02635074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280829|NCT02537366|Dexmedetomidine|dexmedetomidine|mesh-list
65280830|NCT02537366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65280831|NCT02537366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65280832|NCT02537366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280833|NCT02537366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65280834|NCT02537366|Analgesics|analgesics|mesh-ancestor
65280835|NCT02537366|Sensory System Agents|sensory system agents|mesh-ancestor
65280836|NCT02537366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280837|NCT02537366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65280838|NCT02537366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65280839|NCT02537366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65280840|NCT02537366|Adrenergic Agents|adrenergic agents|mesh-ancestor
65280841|NCT02537366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65280842|NCT02537366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280843|NCT00690417|Vitamin D|vitamin d|mesh-list
65280844|NCT00690417|Cholecalciferol|cholecalciferol|mesh-list
65280845|NCT00690417|Vitamins|vitamins|mesh-ancestor
65280846|NCT00690417|Micronutrients|micronutrients|mesh-ancestor
64733213|NCT00004357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64789163|NCT00003216|Fluorouracil|fluorouracil|mesh-list
64789164|NCT00003216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64789165|NCT00003216|Antimetabolites|antimetabolites|mesh-ancestor
64789166|NCT00003216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789167|NCT00003216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789168|NCT00003216|Antiviral Agents|antiviral agents|mesh-ancestor
64789169|NCT00003216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64789170|NCT00003216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789171|NCT00003216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789172|NCT00003216|Immunologic Factors|immunologic factors|mesh-ancestor
64789173|NCT00003216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789174|NCT00003234|Vinorelbine|vinorelbine|mesh-list
64789175|NCT00003234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64789176|NCT00003234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789177|NCT00003234|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789178|NCT00003234|Antimitotic Agents|antimitotic agents|mesh-ancestor
64789179|NCT00003234|Mitosis Modulators|mitosis modulators|mesh-ancestor
64789230|NCT00003294|Paclitaxel|paclitaxel|mesh-list
64789231|NCT00003294|Carboplatin|carboplatin|mesh-list
64789232|NCT00003294|Amifostine|amifostine|mesh-list
64789255|NCT00003336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64789256|NCT00003336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789257|NCT00003336|Immunologic Factors|immunologic factors|mesh-ancestor
64789258|NCT00003336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789259|NCT00003336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64400334|NCT02327923|Anesthetics|anesthetics|mesh-ancestor
64789274|NCT00003336|Protective Agents|protective agents|mesh-ancestor
64789277|NCT00003342|Carboplatin|carboplatin|mesh-list
64789278|NCT00003342|Doxorubicin|doxorubicin|mesh-list
64789279|NCT00003342|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64789280|NCT00003342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64789281|NCT00003342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789282|NCT00003342|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789283|NCT00003342|Antimitotic Agents|antimitotic agents|mesh-ancestor
64789284|NCT00003342|Mitosis Modulators|mitosis modulators|mesh-ancestor
65280847|NCT00690417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280848|NCT00690417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65280849|NCT00690417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65280850|NCT05434559|Insulin|insulin|mesh-list
65280851|NCT05434559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65280852|NCT05434559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280853|NCT00546637|Fesoterodine|fesoterodine|mesh-list
65280854|NCT00546637|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65280855|NCT00546637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64733233|NCT00004363|Natriuretic Agents|natriuretic agents|mesh-ancestor
64789285|NCT00003342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789286|NCT00003342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64789287|NCT00003342|Antimetabolites|antimetabolites|mesh-ancestor
64789288|NCT00003342|Antiviral Agents|antiviral agents|mesh-ancestor
64789289|NCT00003342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64789290|NCT00003342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789291|NCT00003342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789292|NCT00003342|Immunologic Factors|immunologic factors|mesh-ancestor
64789293|NCT00003342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789294|NCT00003342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64789295|NCT00003342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64789296|NCT00003342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64789297|NCT00003348|Carmustine|carmustine|mesh-list
64789298|NCT00003348|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64789299|NCT00003348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64789300|NCT00003348|Alkylating Agents|alkylating agents|mesh-ancestor
64789353|NCT00003402|Carmustine|carmustine|mesh-list
64789354|NCT00003402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64789355|NCT00003402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789356|NCT00003402|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789357|NCT00003402|Antimitotic Agents|antimitotic agents|mesh-ancestor
64789358|NCT00003402|Mitosis Modulators|mitosis modulators|mesh-ancestor
64789399|NCT00003414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789400|NCT00003414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64789401|NCT00003414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64471966|NCT03946514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64789402|NCT00003414|Alkylating Agents|alkylating agents|mesh-ancestor
64789403|NCT00003414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789404|NCT00003414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789405|NCT00003414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64789406|NCT00003414|Antiviral Agents|antiviral agents|mesh-ancestor
64789407|NCT00003414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64789408|NCT00003414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789409|NCT00003414|Antifungal Agents|antifungal agents|mesh-ancestor
64789410|NCT00003414|Dermatologic Agents|dermatologic agents|mesh-ancestor
64789411|NCT00003414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64789412|NCT00003414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64789413|NCT00003414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64789414|NCT00003426|Gemcitabine|gemcitabine|mesh-list
64789415|NCT00003426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64789416|NCT00003426|Antimetabolites|antimetabolites|mesh-ancestor
64789417|NCT00003426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789418|NCT00003426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789419|NCT00003426|Antiviral Agents|antiviral agents|mesh-ancestor
64789420|NCT00003426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64789421|NCT00003426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789422|NCT00003426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789423|NCT00003426|Immunologic Factors|immunologic factors|mesh-ancestor
64789424|NCT00003426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789425|NCT00003444|Interferons|interferons|mesh-list
64789426|NCT00003444|Interferon-alpha|interferon-alpha|mesh-list
64789427|NCT00003444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789428|NCT00003444|Antiviral Agents|antiviral agents|mesh-ancestor
64789429|NCT00003444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64789430|NCT00003444|Immunologic Factors|immunologic factors|mesh-ancestor
65280856|NCT00546637|Cholinergic Agents|cholinergic agents|mesh-ancestor
65280857|NCT00546637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65280858|NCT00546637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280860|NCT00546637|Urological Agents|urological agents|mesh-ancestor
65280929|NCT02789969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65280930|NCT02789969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280931|NCT02789969|Analgesics|analgesics|mesh-ancestor
65280932|NCT02789969|Sensory System Agents|sensory system agents|mesh-ancestor
65280933|NCT02789969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64733314|NCT00003367|Vitamin E|vitamin e|mesh-list
64789431|NCT00003444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789474|NCT00003552|Immunologic Factors|immunologic factors|mesh-ancestor
64789475|NCT00003552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789476|NCT00003552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64789477|NCT00003552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64789478|NCT00003552|Alkylating Agents|alkylating agents|mesh-ancestor
64789479|NCT00003552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789480|NCT00003552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789481|NCT00003552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64789483|NCT00003558|Paclitaxel|paclitaxel|mesh-list
64789536|NCT00003582|Protective Agents|protective agents|mesh-ancestor
64789538|NCT00003594|Fluorouracil|fluorouracil|mesh-list
64789539|NCT00003594|Oxaliplatin|oxaliplatin|mesh-list
64789540|NCT00003594|Irinotecan|irinotecan|mesh-list
64789541|NCT00003594|Calcium|calcium|mesh-list
64789542|NCT00003594|Levoleucovorin|levoleucovorin|mesh-list
64789543|NCT00003594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64789544|NCT00003594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789594|NCT00003624|Mitosis Modulators|mitosis modulators|mesh-ancestor
64789595|NCT00003624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789596|NCT00003624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64789597|NCT00003624|Protective Agents|protective agents|mesh-ancestor
64789598|NCT00003624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789599|NCT00003630|Arsenic Trioxide|arsenic trioxide|mesh-list
64789600|NCT00003630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789601|NCT00003636|Carboplatin|carboplatin|mesh-list
64789602|NCT00003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789603|NCT00003642|Fluorouracil|fluorouracil|mesh-list
64789604|NCT00003642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789605|NCT00003642|Antimetabolites|antimetabolites|mesh-ancestor
64789606|NCT00003642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789607|NCT00003642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64789608|NCT00003642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789609|NCT00003642|Immunologic Factors|immunologic factors|mesh-ancestor
64789610|NCT00003642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789633|NCT00003684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789634|NCT00003684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64789635|NCT00003684|Respiratory System Agents|respiratory system agents|mesh-ancestor
64789636|NCT00003684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64789637|NCT00003684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789638|NCT00003684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789639|NCT00003684|Vasodilator Agents|vasodilator agents|mesh-ancestor
64789640|NCT00003684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64789641|NCT00003684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64789642|NCT00003684|Purinergic Agents|purinergic agents|mesh-ancestor
64789643|NCT00003684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64789644|NCT00003690|Carboplatin|carboplatin|mesh-list
64789645|NCT00003690|Alvocidib|alvocidib|mesh-list
64789646|NCT00003690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789647|NCT00003690|Growth Inhibitors|growth inhibitors|mesh-ancestor
64789648|NCT00003690|Growth Substances|growth substances|mesh-ancestor
64789649|NCT00003690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789650|NCT00003690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64789651|NCT00003690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789652|NCT00003690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789653|NCT00003696|Paclitaxel|paclitaxel|mesh-list
64789654|NCT00003696|Etoposide|etoposide|mesh-list
64789655|NCT00003696|Cyclophosphamide|cyclophosphamide|mesh-list
64789656|NCT00003696|Carboplatin|carboplatin|mesh-list
64789657|NCT00003696|Doxorubicin|doxorubicin|mesh-list
64789658|NCT00003696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64789659|NCT00003696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64789660|NCT00003696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65280934|NCT02789969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65280935|NCT02789969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65280936|NCT02789969|Anesthetics, General|anesthetics, general|mesh-ancestor
65280937|NCT02789969|Anesthetics|anesthetics|mesh-ancestor
65280938|NCT00657852|Pamidronate|pamidronate|mesh-list
65280939|NCT00657852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65280940|NCT00657852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280941|NCT00691275|Ondansetron|ondansetron|mesh-list
65280942|NCT00691275|Antiemetics|antiemetics|mesh-ancestor
65280943|NCT00691275|Autonomic Agents|autonomic agents|mesh-ancestor
65280944|NCT00691275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280945|NCT00691275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733320|NCT00003367|Protective Agents|protective agents|mesh-ancestor
64789661|NCT00003696|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789662|NCT00003696|Antimitotic Agents|antimitotic agents|mesh-ancestor
64789663|NCT00003696|Mitosis Modulators|mitosis modulators|mesh-ancestor
64789664|NCT00003696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789665|NCT00003696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789666|NCT00003696|Immunologic Factors|immunologic factors|mesh-ancestor
64789667|NCT00003696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789668|NCT00003696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64789706|NCT00003744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64789707|NCT00003744|Antimetabolites|antimetabolites|mesh-ancestor
64789708|NCT00003744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789709|NCT00003744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789710|NCT00003744|Antiviral Agents|antiviral agents|mesh-ancestor
64789711|NCT00003744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64789712|NCT00003744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789713|NCT00003744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789714|NCT00003744|Immunologic Factors|immunologic factors|mesh-ancestor
64789744|NCT00003780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789746|NCT00003786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64789747|NCT00003786|Alkylating Agents|alkylating agents|mesh-ancestor
64789748|NCT00003786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789749|NCT00003786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789750|NCT00003792|Lenograstim|lenograstim|mesh-list
64789751|NCT00003792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64789752|NCT00003792|Immunologic Factors|immunologic factors|mesh-ancestor
64400806|NCT05635955|Anesthetics|anesthetics|mesh-ancestor
64789757|NCT00003798|Dermatologic Agents|dermatologic agents|mesh-ancestor
64789759|NCT00003804|Vincristine|vincristine|mesh-list
64789760|NCT00003804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64471967|NCT03946514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471968|NCT03946514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64789761|NCT00003804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789796|NCT00003834|Oxaliplatin|oxaliplatin|mesh-list
64789797|NCT00003834|Calcium|calcium|mesh-list
64789798|NCT00003834|Levoleucovorin|levoleucovorin|mesh-list
64789799|NCT00003834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64789800|NCT00003834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789801|NCT00003834|Antimetabolites|antimetabolites|mesh-ancestor
64789848|NCT00003852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64789849|NCT00003852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64789850|NCT00003852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64789851|NCT00003852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789852|NCT00003852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64789885|NCT00003870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64789886|NCT00003870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64789887|NCT00003870|Antimetabolites|antimetabolites|mesh-ancestor
64789888|NCT00003870|Dermatologic Agents|dermatologic agents|mesh-ancestor
64789889|NCT00003870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789890|NCT00003870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65280946|NCT00691275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65280947|NCT00691275|Antipruritics|antipruritics|mesh-ancestor
65280948|NCT00691275|Dermatologic Agents|dermatologic agents|mesh-ancestor
65280949|NCT00691275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65280950|NCT00691275|Serotonin Agents|serotonin agents|mesh-ancestor
65280951|NCT00691275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65280952|NCT00691275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280953|NCT00691275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65280954|NCT00691275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65280955|NCT00691275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65280956|NCT00691275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65280957|NCT00691275|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65280958|NCT00657930|Insulin Detemir|insulin detemir|mesh-list
65280959|NCT00657930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65280960|NCT00657930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280961|NCT00655512|Clobetasol|clobetasol|mesh-list
64789903|NCT00003888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789905|NCT00003888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64789906|NCT00003888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789907|NCT00003888|Immunologic Factors|immunologic factors|mesh-ancestor
64789932|NCT00003906|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64789933|NCT00003906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64789934|NCT00003906|Hormone Antagonists|hormone antagonists|mesh-ancestor
64789935|NCT00003906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64789936|NCT00003906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789937|NCT00003906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64789938|NCT00003906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789939|NCT00003906|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64789940|NCT00003906|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64789941|NCT00003906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64789942|NCT00003912|Carboplatin|carboplatin|mesh-list
64789943|NCT00003912|Doxorubicin|doxorubicin|mesh-list
64789944|NCT00003912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64789945|NCT00003912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789946|NCT00003912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64789947|NCT00003912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64789948|NCT00003912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64789949|NCT00003912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789950|NCT00003912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789951|NCT00003924|Interferons|interferons|mesh-list
64789952|NCT00003924|Interferon-alpha|interferon-alpha|mesh-list
64789960|NCT00003930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64789961|NCT00003930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789962|NCT00003930|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789995|NCT00003954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64789996|NCT00003954|Antitubercular Agents|antitubercular agents|mesh-ancestor
64789997|NCT00003954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64789998|NCT00003954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64789999|NCT00003954|Alkylating Agents|alkylating agents|mesh-ancestor
64790000|NCT00003954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64790002|NCT00003960|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64790003|NCT00003960|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64790004|NCT00003960|Prednisolone|prednisolone|mesh-list
64790005|NCT00003960|Prednisolone acetate|prednisolone acetate|mesh-list
64790037|NCT00003972|Cyclophosphamide|cyclophosphamide|mesh-list
64790038|NCT00003972|Carboplatin|carboplatin|mesh-list
64790039|NCT00003972|Melphalan|melphalan|mesh-list
64790040|NCT00003972|Busulfan|busulfan|mesh-list
64790041|NCT00003972|Thiotepa|thiotepa|mesh-list
65280962|NCT00655512|Pimecrolimus|pimecrolimus|mesh-list
65280963|NCT00655512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65280964|NCT00655512|Glucocorticoids|glucocorticoids|mesh-ancestor
65280965|NCT00655512|Hormones|hormones|mesh-ancestor
64790042|NCT00003972|Sargramostim|sargramostim|mesh-list
64790043|NCT00003972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64790044|NCT00003972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790045|NCT00003972|Tubulin Modulators|tubulin modulators|mesh-ancestor
64790046|NCT00003972|Antimitotic Agents|antimitotic agents|mesh-ancestor
64790047|NCT00003972|Mitosis Modulators|mitosis modulators|mesh-ancestor
64790048|NCT00003972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790049|NCT00003972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64790050|NCT00003972|Immunologic Factors|immunologic factors|mesh-ancestor
64790051|NCT00003972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790052|NCT00003972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64790053|NCT00003972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64790054|NCT00003972|Alkylating Agents|alkylating agents|mesh-ancestor
64790055|NCT00003972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64790056|NCT00003972|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64790057|NCT00003972|Hormone Antagonists|hormone antagonists|mesh-ancestor
64790058|NCT00003972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64790087|NCT00004014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64790088|NCT00004014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64790089|NCT00004014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64471970|NCT03946514|Vasodilator Agents|vasodilator agents|mesh-ancestor
64790090|NCT00004014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790091|NCT00004032|Interferons|interferons|mesh-list
64790092|NCT00004032|Interferon-gamma|interferon-gamma|mesh-list
64790093|NCT00004032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790094|NCT00004032|Antiviral Agents|antiviral agents|mesh-ancestor
64790101|NCT00004050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64790102|NCT00004050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790103|NCT00004056|Cytarabine|cytarabine|mesh-list
64790104|NCT00004056|Thioguanine|thioguanine|mesh-list
64790105|NCT00004056|Melphalan|melphalan|mesh-list
64790106|NCT00004056|Daunorubicin|daunorubicin|mesh-list
64790107|NCT00004056|Asparaginase|asparaginase|mesh-list
64790108|NCT00004056|Lenograstim|lenograstim|mesh-list
64790109|NCT00004056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64790142|NCT00004074|Trastuzumab|trastuzumab|mesh-list
64790143|NCT00004074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64790144|NCT00004074|Interleukin-12|interleukin-12|mesh-list
64790145|NCT00004074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790146|NCT00004074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64790147|NCT00004074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64790148|NCT00004074|Immunologic Factors|immunologic factors|mesh-ancestor
64790149|NCT00004074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790150|NCT00004074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64471976|NCT03946514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64471977|NCT03939767|Aflibercept|aflibercept|mesh-list
64471978|NCT03939767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64471979|NCT03939767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64471980|NCT03939767|Growth Substances|growth substances|mesh-ancestor
64471981|NCT03939767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471982|NCT03939767|Growth Inhibitors|growth inhibitors|mesh-ancestor
64471983|NCT03939767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471984|NCT03935958|Curcumin|curcumin|mesh-list
64471985|NCT03935958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64471986|NCT03935958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64471987|NCT03935958|Analgesics|analgesics|mesh-ancestor
64471988|NCT03935958|Sensory System Agents|sensory system agents|mesh-ancestor
64471989|NCT03935958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64471990|NCT03935958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471991|NCT03935958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64471992|NCT03935958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64790178|NCT00004104|Antiviral Agents|antiviral agents|mesh-ancestor
64790179|NCT00004104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64790180|NCT00004104|Immunologic Factors|immunologic factors|mesh-ancestor
64790181|NCT00004104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790182|NCT00004104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64790183|NCT00004104|Analgesics|analgesics|mesh-ancestor
64790184|NCT00004104|Sensory System Agents|sensory system agents|mesh-ancestor
64790185|NCT00004104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280966|NCT00655512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65280967|NCT00655512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280968|NCT00655512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65280969|NCT00655512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65280970|NCT00655512|Analgesics|analgesics|mesh-ancestor
65280971|NCT00655512|Sensory System Agents|sensory system agents|mesh-ancestor
65280972|NCT00655512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65280973|NCT00655512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65280974|NCT00655512|Dermatologic Agents|dermatologic agents|mesh-ancestor
64790186|NCT00004110|Etoposide|etoposide|mesh-list
64790187|NCT00004110|Isotretinoin|isotretinoin|mesh-list
64790188|NCT00004110|Antibodies|antibodies|mesh-list
64790189|NCT00004110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64790190|NCT00004110|Immunologic Factors|immunologic factors|mesh-ancestor
64790191|NCT00004110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790218|NCT00004128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64790219|NCT00004128|Alkylating Agents|alkylating agents|mesh-ancestor
64790220|NCT00004128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790221|NCT00004128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790222|NCT00004128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64945439|NCT05633615|Immunologic Factors|immunologic factors|mesh-ancestor
64790223|NCT00004128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64790224|NCT00004128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64790225|NCT00004128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64790226|NCT00004128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790227|NCT00004128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64790228|NCT00004128|Antimetabolites|antimetabolites|mesh-ancestor
64790229|NCT00004128|Antiviral Agents|antiviral agents|mesh-ancestor
64790230|NCT00004128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64790231|NCT00004128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64790232|NCT00004128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64790249|NCT00004164|Calcium|calcium|mesh-list
64790250|NCT00004164|Levoleucovorin|levoleucovorin|mesh-list
64790251|NCT00004164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790252|NCT00004164|Tubulin Modulators|tubulin modulators|mesh-ancestor
64790253|NCT00004164|Antimitotic Agents|antimitotic agents|mesh-ancestor
64790254|NCT00004164|Mitosis Modulators|mitosis modulators|mesh-ancestor
64790255|NCT00004164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790256|NCT00004164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64790286|NCT00004188|Vincristine|vincristine|mesh-list
64790287|NCT00004188|Topotecan|topotecan|mesh-list
64790288|NCT00004188|Isotretinoin|isotretinoin|mesh-list
64790289|NCT00004188|Lenograstim|lenograstim|mesh-list
64790290|NCT00004188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64790291|NCT00004188|Immunologic Factors|immunologic factors|mesh-ancestor
64790292|NCT00004188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790293|NCT00004188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64790294|NCT00004188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64790299|NCT00004188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64790300|NCT00004188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64790301|NCT00004188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64790302|NCT00004188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790303|NCT00004188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64790304|NCT00004188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64790305|NCT00004188|Tubulin Modulators|tubulin modulators|mesh-ancestor
64790306|NCT00004188|Antimitotic Agents|antimitotic agents|mesh-ancestor
64790307|NCT00004188|Mitosis Modulators|mitosis modulators|mesh-ancestor
64790308|NCT00004188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64790309|NCT00004188|Dermatologic Agents|dermatologic agents|mesh-ancestor
64790310|NCT00004194|Fludarabine|fludarabine|mesh-list
64790311|NCT00004194|Fludarabine phosphate|fludarabine phosphate|mesh-list
64790341|NCT00004206|Antidotes|antidotes|mesh-ancestor
64790342|NCT00004206|Protective Agents|protective agents|mesh-ancestor
64790343|NCT00004206|Vitamin B Complex|vitamin b complex|mesh-ancestor
64790344|NCT00004206|Vitamins|vitamins|mesh-ancestor
64790345|NCT00004206|Micronutrients|micronutrients|mesh-ancestor
64790346|NCT00004212|Exatecan|exatecan|mesh-list
65280975|NCT00655512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65280976|NCT00655512|Immunologic Factors|immunologic factors|mesh-ancestor
65280977|NCT00655512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65280978|NCT00655512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280979|NCT00655512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280981|NCT00644306|Prednisone|prednisone|mesh-list
65280982|NCT00644306|Melphalan|melphalan|mesh-list
65280983|NCT00644306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64733353|NCT00004393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733354|NCT00004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733355|NCT00004393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64733356|NCT00004393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64733357|NCT00004393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64733358|NCT00004393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64733359|NCT00004393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64733360|NCT00004393|Dopamine Agents|dopamine agents|mesh-ancestor
64790347|NCT00004212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64790348|NCT00004212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64790349|NCT00004212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790350|NCT00004212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790351|NCT00004212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790352|NCT00004218|Prednisolone|prednisolone|mesh-list
64790353|NCT00004218|Cyclophosphamide|cyclophosphamide|mesh-list
64790354|NCT00004218|Chlorambucil|chlorambucil|mesh-list
64790355|NCT00004218|Doxorubicin|doxorubicin|mesh-list
64790356|NCT00004218|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64790357|NCT00004218|Fludarabine|fludarabine|mesh-list
64790396|NCT00004224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64790397|NCT00004224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64790425|NCT00004248|Doxorubicin|doxorubicin|mesh-list
64790426|NCT00004248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64790427|NCT00004248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64790428|NCT00004248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790429|NCT00004248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64790430|NCT00004248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64790431|NCT00004248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790432|NCT00004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790433|NCT00004248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64790434|NCT00004248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64790435|NCT00004248|Antiviral Agents|antiviral agents|mesh-ancestor
64790436|NCT00004248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64790437|NCT00004254|Raltitrexed|raltitrexed|mesh-list
64790438|NCT00004254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64790439|NCT00004254|Antimetabolites|antimetabolites|mesh-ancestor
64401477|NCT03136237|Cyclosporins|cyclosporins|mesh-list
64790445|NCT00004260|Interleukin-12|interleukin-12|mesh-list
64790446|NCT00004260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64790447|NCT00004260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790448|NCT00004260|Immunologic Factors|immunologic factors|mesh-ancestor
64790449|NCT00004260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790481|NCT00004278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64790482|NCT00004278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64790483|NCT00004278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65280984|NCT00644306|Glucocorticoids|glucocorticoids|mesh-ancestor
65280985|NCT00644306|Hormones|hormones|mesh-ancestor
65280986|NCT00644306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65280987|NCT00644306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65280988|NCT00644306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65280989|NCT00644306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790484|NCT00004278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790486|NCT00004284|Potassium phosphate|potassium phosphate|mesh-list
64790487|NCT00004284|Diuretics|diuretics|mesh-ancestor
64790488|NCT00004284|Natriuretic Agents|natriuretic agents|mesh-ancestor
64790489|NCT00004284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790490|NCT00004284|Expectorants|expectorants|mesh-ancestor
64790538|NCT00004404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64790539|NCT00004404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64790540|NCT00004410|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
64790541|NCT00004410|Antiviral Agents|antiviral agents|mesh-ancestor
64790542|NCT00004410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64790543|NCT00004410|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64790544|NCT00004410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64790545|NCT00004416|Botulinum Toxins|botulinum toxins|mesh-list
64790546|NCT00004416|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64790547|NCT00004416|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64790548|NCT00004416|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64790549|NCT00004416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64790550|NCT00004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790592|NCT00004464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790593|NCT00004464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64790594|NCT00004464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64790595|NCT00004464|Alkylating Agents|alkylating agents|mesh-ancestor
64790596|NCT00004464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790597|NCT00004464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790598|NCT00004464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64790599|NCT00004482|Cyclosporine|cyclosporine|mesh-list
64790600|NCT00004482|Prednisone|prednisone|mesh-list
64790601|NCT00004482|Methylprednisolone|methylprednisolone|mesh-list
64790603|NCT00004482|Muromonab-CD3|muromonab-cd3|mesh-list
64790604|NCT00004482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64790605|NCT00004482|Glucocorticoids|glucocorticoids|mesh-ancestor
64790606|NCT00004482|Hormones|hormones|mesh-ancestor
64790607|NCT00004482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64790608|NCT00004482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790609|NCT00004482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64790610|NCT00004482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790611|NCT00004482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790645|NCT00004554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64790646|NCT00004554|Antidepressive Agents|antidepressive agents|mesh-ancestor
64790648|NCT00004554|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64790649|NCT00004554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64790650|NCT00004554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64790651|NCT00004554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790652|NCT00004554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64790653|NCT00004554|Serotonin Agents|serotonin agents|mesh-ancestor
64790654|NCT00004578|Ritonavir|ritonavir|mesh-list
64790655|NCT00004578|Lopinavir|lopinavir|mesh-list
64790656|NCT00004578|Lamivudine|lamivudine|mesh-list
64790657|NCT00004578|Stavudine|stavudine|mesh-list
64790658|NCT00004578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64471997|NCT03935295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64471998|NCT03935295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64471999|NCT03935295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64472000|NCT03935295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472001|NCT03935295|Cholinergic Agents|cholinergic agents|mesh-ancestor
64472002|NCT03935295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64472003|NCT03935295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472004|NCT03935295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64472005|NCT03935295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64472006|NCT03915444|Gemcitabine|gemcitabine|mesh-list
65280990|NCT00644306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65280991|NCT00644306|Alkylating Agents|alkylating agents|mesh-ancestor
65280992|NCT00644306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65280993|NCT00644306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65280994|NCT00644306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65280995|NCT00644306|Immunologic Factors|immunologic factors|mesh-ancestor
65280996|NCT00644306|Leprostatic Agents|leprostatic agents|mesh-ancestor
65280997|NCT00644306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64472007|NCT03915444|Paclitaxel|paclitaxel|mesh-list
64472008|NCT03915444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64790659|NCT00004578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64790660|NCT00004578|Protease Inhibitors|protease inhibitors|mesh-ancestor
64790661|NCT00004578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790662|NCT00004578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790663|NCT00004578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64790664|NCT00004578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64790665|NCT00004578|Antiviral Agents|antiviral agents|mesh-ancestor
64790666|NCT00004578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64790667|NCT00004578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64790668|NCT00004578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64790669|NCT00004578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64790670|NCT00004578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64790671|NCT00004578|Antimetabolites|antimetabolites|mesh-ancestor
64790672|NCT00004644|Acyclovir|acyclovir|mesh-list
64790673|NCT00004644|Antiviral Agents|antiviral agents|mesh-ancestor
64790674|NCT00004644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64790675|NCT00004650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64790764|NCT00004758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790828|NCT00004854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64790829|NCT00004854|Vasodilator Agents|vasodilator agents|mesh-ancestor
64790830|NCT00004854|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64790831|NCT00004854|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64790833|NCT00004860|Tegafur|tegafur|mesh-list
64790834|NCT00004860|Calcium|calcium|mesh-list
64790835|NCT00004860|Levoleucovorin|levoleucovorin|mesh-list
64790836|NCT00004860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64790837|NCT00004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790838|NCT00004860|Antidotes|antidotes|mesh-ancestor
64790839|NCT00004860|Protective Agents|protective agents|mesh-ancestor
64790919|NCT00004926|Micronutrients|micronutrients|mesh-ancestor
64790920|NCT00004926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790921|NCT00004926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64790922|NCT00004926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64790923|NCT00004926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790924|NCT00004932|Imatinib Mesylate|imatinib mesylate|mesh-list
64790925|NCT00004932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790943|NCT00004986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64790944|NCT00004986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64790946|NCT00004992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64790947|NCT00004992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790948|NCT00004998|Lamivudine|lamivudine|mesh-list
64790949|NCT00004998|Zidovudine|zidovudine|mesh-list
64790950|NCT00004998|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64790951|NCT00004998|Capravirine|capravirine|mesh-list
64790952|NCT00004998|Nelfinavir|nelfinavir|mesh-list
64401998|NCT02660359|Botulinum Toxins|botulinum toxins|mesh-list
64790956|NCT00004998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790958|NCT00004998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64790959|NCT00004998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64790960|NCT00004998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64790961|NCT00004998|Antimetabolites|antimetabolites|mesh-ancestor
64790962|NCT00004998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64790963|NCT00004998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64790964|NCT00004998|Protease Inhibitors|protease inhibitors|mesh-ancestor
64790966|NCT00005010|Pravastatin|pravastatin|mesh-list
64790967|NCT00005010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65280998|NCT00644306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65280999|NCT00644306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65281000|NCT00644306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65281001|NCT00644306|Growth Substances|growth substances|mesh-ancestor
65281002|NCT00644306|Growth Inhibitors|growth inhibitors|mesh-ancestor
65281003|NCT02634528|Insulin|insulin|mesh-list
65281004|NCT02634528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65281005|NCT02634528|Insulin, Isophane|insulin, isophane|mesh-list
65281006|NCT02634528|Isophane Insulin, Human|isophane insulin, human|mesh-list
65281007|NCT02634528|Isophane insulin, beef|isophane insulin, beef|mesh-list
65281008|NCT02634528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65281009|NCT02634528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281010|NCT02816411|Caseins|caseins|mesh-list
65281011|NCT02816411|Chelating Agents|chelating agents|mesh-ancestor
65281012|NCT02816411|Sequestering Agents|sequestering agents|mesh-ancestor
65281013|NCT02816411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281014|NCT00655590|Sildenafil Citrate|sildenafil citrate|mesh-list
65281015|NCT00655590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
64790968|NCT00005010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64790969|NCT00005010|Antimetabolites|antimetabolites|mesh-ancestor
64790970|NCT00005010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790971|NCT00005010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64790972|NCT00005010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64790973|NCT00005010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790974|NCT00005010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64790975|NCT00005010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64790976|NCT00005010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64790977|NCT00005022|Etoposide|etoposide|mesh-list
64790978|NCT00005022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790979|NCT00005022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64559561|NCT03598595|Docetaxel|docetaxel|mesh-list
64790980|NCT00005022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64790981|NCT00005022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64790982|NCT00005022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791009|NCT00005070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791011|NCT00005076|Irinotecan|irinotecan|mesh-list
64791012|NCT00005076|Cetuximab|cetuximab|mesh-list
64791013|NCT00005076|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64791014|NCT00005076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64791015|NCT00005076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791016|NCT00005076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791017|NCT00005076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791018|NCT00005076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64791019|NCT00005088|Cisplatin|cisplatin|mesh-list
64791020|NCT00005088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791021|NCT00005094|Celecoxib|celecoxib|mesh-list
64402065|NCT03062813|Immunologic Factors|immunologic factors|mesh-ancestor
64791030|NCT00005094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64791031|NCT00005094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64791032|NCT00005094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791033|NCT00005094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791034|NCT00005106|Lamivudine|lamivudine|mesh-list
64791035|NCT00005106|Zidovudine|zidovudine|mesh-list
64791036|NCT00005106|Abacavir|abacavir|mesh-list
64791037|NCT00005106|Stavudine|stavudine|mesh-list
64791060|NCT00005118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64791062|NCT00005118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64791063|NCT00005118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65281016|NCT00655590|Vasodilator Agents|vasodilator agents|mesh-ancestor
65281017|NCT00655590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65281018|NCT00655590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65281019|NCT00655590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281020|NCT00655590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281021|NCT00655590|Urological Agents|urological agents|mesh-ancestor
65281022|NCT02794025|Esmolol|esmolol|mesh-list
65281023|NCT02794025|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64791064|NCT00005118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64791065|NCT00005520|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64791066|NCT00005520|Candesartan|candesartan|mesh-list
64791067|NCT00005520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64791068|NCT00005520|Diuretics|diuretics|mesh-ancestor
64791069|NCT00005520|Natriuretic Agents|natriuretic agents|mesh-ancestor
64791070|NCT00005520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791071|NCT00005520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64791072|NCT00005520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64791073|NCT00005520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791074|NCT00005520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64791075|NCT00005520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64791076|NCT00005574|Gentamicins|gentamicins|mesh-list
64791077|NCT00005574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64791078|NCT00005574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64791079|NCT00005574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64791104|NCT00005586|Protective Agents|protective agents|mesh-ancestor
64791105|NCT00005586|Vitamin B Complex|vitamin b complex|mesh-ancestor
64791106|NCT00005586|Vitamins|vitamins|mesh-ancestor
64791107|NCT00005586|Micronutrients|micronutrients|mesh-ancestor
64791108|NCT00005592|Rituximab|rituximab|mesh-list
64791109|NCT00005592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64791110|NCT00005592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64791111|NCT00005592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791112|NCT00005592|Immunologic Factors|immunologic factors|mesh-ancestor
64791113|NCT00005592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791114|NCT00005592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64791115|NCT00005598|Azacitidine|azacitidine|mesh-list
64791116|NCT00005598|Amifostine|amifostine|mesh-list
64472016|NCT03915444|Antiviral Agents|antiviral agents|mesh-ancestor
64472017|NCT03915444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64472018|NCT03915444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472019|NCT03915444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64472020|NCT03915444|Immunologic Factors|immunologic factors|mesh-ancestor
64472021|NCT03915444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472022|NCT03892785|Prednisone|prednisone|mesh-list
64791117|NCT00005598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64791118|NCT00005598|Antimetabolites|antimetabolites|mesh-ancestor
64791119|NCT00005598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791120|NCT00005598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791121|NCT00005598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791122|NCT00005598|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64791123|NCT00005598|Protective Agents|protective agents|mesh-ancestor
64791124|NCT00005598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791125|NCT00005604|Aldesleukin|aldesleukin|mesh-list
64791126|NCT00005604|Interleukin-2|interleukin-2|mesh-list
64791127|NCT00005604|Interleukin-12|interleukin-12|mesh-list
64791128|NCT00005604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791129|NCT00005604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64559706|NCT04374903|Azithromycin|azithromycin|mesh-list
64791131|NCT00005604|Sensory System Agents|sensory system agents|mesh-ancestor
64791132|NCT00005604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64791133|NCT00005604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791134|NCT00005604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64791158|NCT00005622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791173|NCT00005646|Antimitotic Agents|antimitotic agents|mesh-ancestor
64791174|NCT00005646|Mitosis Modulators|mitosis modulators|mesh-ancestor
64791175|NCT00005646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281024|NCT02794025|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65281025|NCT02794025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65281026|NCT02794025|Adrenergic Agents|adrenergic agents|mesh-ancestor
65281027|NCT02794025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65281028|NCT02794025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281029|NCT02794025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281030|NCT00546481|Epoetin Alfa|epoetin alfa|mesh-list
65281031|NCT00546481|Hematinics|hematinics|mesh-ancestor
65281032|NCT02789813|Valproic Acid|valproic acid|mesh-list
65281033|NCT02789813|Anticonvulsants|anticonvulsants|mesh-ancestor
65281034|NCT02789813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281035|NCT02789813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281036|NCT02789813|GABA Agents|gaba agents|mesh-ancestor
65281037|NCT02789813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64791176|NCT00005652|Rituximab|rituximab|mesh-list
64791177|NCT00005652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64791178|NCT00005652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791179|NCT00005652|Immunologic Factors|immunologic factors|mesh-ancestor
64791180|NCT00005652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791181|NCT00005652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64791182|NCT00005658|Glycine|glycine|mesh-list
64791183|NCT00005658|Glycine Agents|glycine agents|mesh-ancestor
64791184|NCT00005658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64791185|NCT00005658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791186|NCT00005658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791187|NCT00005796|Vincristine|vincristine|mesh-list
64791188|NCT00005796|Lomustine|lomustine|mesh-list
64791189|NCT00005796|Procarbazine|procarbazine|mesh-list
64791190|NCT00005796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64791191|NCT00005796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791192|NCT00005796|Tubulin Modulators|tubulin modulators|mesh-ancestor
64791193|NCT00005796|Antimitotic Agents|antimitotic agents|mesh-ancestor
64791194|NCT00005796|Mitosis Modulators|mitosis modulators|mesh-ancestor
64791195|NCT00005796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791196|NCT00005796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64791197|NCT00005796|Alkylating Agents|alkylating agents|mesh-ancestor
64791198|NCT00005802|Cytarabine|cytarabine|mesh-list
64791199|NCT00005802|Aldesleukin|aldesleukin|mesh-list
64791200|NCT00005802|Hydrocortisone|hydrocortisone|mesh-list
64791243|NCT00354900|Coagulants|coagulants|mesh-ancestor
64791244|NCT00354900|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64791245|NCT00354900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64791246|NCT00354900|Protease Inhibitors|protease inhibitors|mesh-ancestor
64791247|NCT00354900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791248|NCT00354900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791249|NCT00355290|Vitamin K|vitamin k|mesh-list
64791250|NCT00355290|Vitamins|vitamins|mesh-ancestor
64791251|NCT00355290|Micronutrients|micronutrients|mesh-ancestor
64791285|NCT00355602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64402339|NCT04625530|Hemostatics|hemostatics|mesh-ancestor
64791290|NCT00355602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64791291|NCT00355602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64791292|NCT00355602|Antimalarials|antimalarials|mesh-ancestor
64791293|NCT00355602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64791294|NCT00355602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64791314|NCT00356226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64791316|NCT00356226|Autonomic Agents|autonomic agents|mesh-ancestor
64791317|NCT00356226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64791318|NCT00356226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64791319|NCT00356226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64791320|NCT00356226|Adrenergic Agents|adrenergic agents|mesh-ancestor
64791321|NCT00356226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65281038|NCT02789813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281039|NCT02789813|Antimanic Agents|antimanic agents|mesh-ancestor
65281040|NCT02789813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65281041|NCT02789813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65281042|NCT02789813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65281043|NCT02632578|Vaccines|vaccines|mesh-list
65281044|NCT02632578|Immunologic Factors|immunologic factors|mesh-ancestor
64733414|NCT00005029|Topotecan|topotecan|mesh-list
64791322|NCT00356226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791323|NCT00356460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64791324|NCT00356460|Antibodies|antibodies|mesh-list
64791325|NCT00356460|Immunoglobulins|immunoglobulins|mesh-list
64791326|NCT00356460|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64791327|NCT00356460|Mitogens|mitogens|mesh-list
64791328|NCT00356460|Immunologic Factors|immunologic factors|mesh-ancestor
64791329|NCT00356460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791330|NCT00356460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791331|NCT00356460|Mitosis Modulators|mitosis modulators|mesh-ancestor
64791332|NCT00356460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791333|NCT00356616|Tenofovir|tenofovir|mesh-list
64791334|NCT00356616|Abacavir|abacavir|mesh-list
64791335|NCT00356616|Antiviral Agents|antiviral agents|mesh-ancestor
64791336|NCT00356616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64791337|NCT00356616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64791338|NCT00356616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64791339|NCT00356616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791340|NCT00356616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791341|NCT00356616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64791342|NCT00356616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64791343|NCT00356772|Azithromycin|azithromycin|mesh-list
64791344|NCT00356772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64791345|NCT00356772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64791346|NCT00356850|Azithromycin|azithromycin|mesh-list
64791347|NCT00356850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64791348|NCT00356850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64791349|NCT00356928|Cyclophosphamide|cyclophosphamide|mesh-list
64791390|NCT00357084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64791391|NCT00357084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64791392|NCT00357084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64791393|NCT00357084|Protective Agents|protective agents|mesh-ancestor
64791395|NCT00357240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64791396|NCT00357240|Omeprazole|omeprazole|mesh-list
64791397|NCT00357240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64791398|NCT00357240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64791399|NCT00357240|Protease Inhibitors|protease inhibitors|mesh-ancestor
64791400|NCT00357240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791401|NCT00357240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791402|NCT00357240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64791403|NCT00357240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64791404|NCT00357240|Antiviral Agents|antiviral agents|mesh-ancestor
64791405|NCT00357240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64791406|NCT00357240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64791407|NCT00357240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64791433|NCT00357630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64791435|NCT00357630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791436|NCT00357630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791437|NCT00357630|Antiviral Agents|antiviral agents|mesh-ancestor
64791438|NCT00357630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64791439|NCT00357630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791440|NCT00357630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64791441|NCT00357630|Immunologic Factors|immunologic factors|mesh-ancestor
64791442|NCT00357630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791443|NCT00357708|Decitabine|decitabine|mesh-list
64791444|NCT00357708|Azacitidine|azacitidine|mesh-list
64791445|NCT00357708|Vorinostat|vorinostat|mesh-list
64791446|NCT00357708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64791447|NCT00357708|Antimetabolites|antimetabolites|mesh-ancestor
64791448|NCT00357708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281045|NCT02632578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281046|NCT04138251|Empagliflozin|empagliflozin|mesh-list
65281047|NCT04138251|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65281048|NCT04138251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281049|NCT04138251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65281050|NCT04138251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791449|NCT00357708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791450|NCT00357708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791451|NCT00357708|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64791453|NCT00357864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64791454|NCT00357864|Miotics|miotics|mesh-ancestor
64791455|NCT00357864|Autonomic Agents|autonomic agents|mesh-ancestor
64791456|NCT00357864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64791457|NCT00357864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791458|NCT00357864|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64791459|NCT00357864|Cholinergic Agents|cholinergic agents|mesh-ancestor
64791460|NCT00357864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64791461|NCT00357864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791462|NCT00357864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64791463|NCT00357864|Analgesics|analgesics|mesh-ancestor
64791464|NCT00357864|Sensory System Agents|sensory system agents|mesh-ancestor
64791465|NCT00357864|Protective Agents|protective agents|mesh-ancestor
64791466|NCT00357942|Morphine|morphine|mesh-list
64791467|NCT00357942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64791468|NCT00357942|Narcotics|narcotics|mesh-ancestor
64791469|NCT00357942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64791470|NCT00357942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791471|NCT00357942|Analgesics|analgesics|mesh-ancestor
64791472|NCT00357942|Sensory System Agents|sensory system agents|mesh-ancestor
64791518|NCT00358488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64791538|NCT00359658|Cyclosporine|cyclosporine|mesh-list
64791539|NCT00359658|Prednisolone|prednisolone|mesh-list
64791540|NCT00359658|Cyclosporins|cyclosporins|mesh-list
64791541|NCT00359658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791542|NCT00359658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791543|NCT00359658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64791544|NCT00359658|Immunologic Factors|immunologic factors|mesh-ancestor
64791545|NCT00359658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791546|NCT00359658|Antifungal Agents|antifungal agents|mesh-ancestor
64791547|NCT00359658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64791548|NCT00359658|Dermatologic Agents|dermatologic agents|mesh-ancestor
64791583|NCT00360438|Gout Suppressants|gout suppressants|mesh-ancestor
64791584|NCT00360438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64791585|NCT00360594|Acamprosate|acamprosate|mesh-list
64791586|NCT00360594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64791587|NCT00360750|Cytarabine|cytarabine|mesh-list
64791588|NCT00360750|Carboplatin|carboplatin|mesh-list
64791589|NCT00360750|Etoposide|etoposide|mesh-list
64791590|NCT00360750|Vincristine|vincristine|mesh-list
64791591|NCT00360750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791592|NCT00360750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64791616|NCT00361452|Adrenergic Agents|adrenergic agents|mesh-ancestor
64791617|NCT00361452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64791618|NCT00361452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791619|NCT00361452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791620|NCT00361452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64791621|NCT00361452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64791622|NCT00361452|Autonomic Agents|autonomic agents|mesh-ancestor
64791623|NCT00361452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64791624|NCT00361452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64791625|NCT00361452|Respiratory System Agents|respiratory system agents|mesh-ancestor
64791626|NCT00361452|Mydriatics|mydriatics|mesh-ancestor
64791627|NCT00361452|Sympathomimetics|sympathomimetics|mesh-ancestor
64791628|NCT00361452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64791667|NCT00362544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64791668|NCT00362544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64791669|NCT00362700|Clevudine|clevudine|mesh-list
64791670|NCT00362700|Antiviral Agents|antiviral agents|mesh-ancestor
64791671|NCT00362700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64791672|NCT00362778|Insulin|insulin|mesh-list
65281051|NCT00964171|Efavirenz|efavirenz|mesh-list
65281052|NCT00964171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65281053|NCT00964171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65281054|NCT00964171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281055|NCT00964171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281056|NCT00964171|Antiviral Agents|antiviral agents|mesh-ancestor
65281057|NCT00964171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65281058|NCT00964171|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65281059|NCT00964171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65281060|NCT00964171|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65281061|NCT00964171|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65281062|NCT00964171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65281063|NCT00964171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65281064|NCT04016246|Propofol|propofol|mesh-list
65281065|NCT04016246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65281066|NCT04016246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65281067|NCT04016246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281068|NCT04016246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65281069|NCT04016246|Anesthetics, General|anesthetics, general|mesh-ancestor
65281070|NCT04016246|Anesthetics|anesthetics|mesh-ancestor
65281071|NCT02789501|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64791673|NCT00362778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64791674|NCT00362778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791675|NCT00362934|Atorvastatin|atorvastatin|mesh-list
64791676|NCT00362934|Simvastatin|simvastatin|mesh-list
64791677|NCT00362934|Fenofibrate|fenofibrate|mesh-list
64791678|NCT00362934|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64791679|NCT00362934|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64791680|NCT00362934|Antimetabolites|antimetabolites|mesh-ancestor
64791681|NCT00362934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791682|NCT00362934|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64791683|NCT00362934|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64791684|NCT00362934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791685|NCT00363090|Prednisone|prednisone|mesh-list
64791686|NCT00363090|Cyclophosphamide|cyclophosphamide|mesh-list
64791687|NCT00363090|Doxorubicin|doxorubicin|mesh-list
64791688|NCT00363090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64791689|NCT00363090|Vincristine|vincristine|mesh-list
64791690|NCT00363090|Alemtuzumab|alemtuzumab|mesh-list
64791691|NCT00363090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64791732|NCT00364572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64791733|NCT00364572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64791734|NCT00364572|Analgesics|analgesics|mesh-ancestor
64791735|NCT00364572|Sensory System Agents|sensory system agents|mesh-ancestor
64791736|NCT00364572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64791737|NCT00364572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791738|NCT00364572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64791739|NCT00364572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64791856|NCT00367536|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64791858|NCT00367536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64791859|NCT00367536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281072|NCT04178876|Ethanol|ethanol|mesh-list
65281073|NCT04178876|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65281074|NCT04178876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65281075|NCT04178876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65281076|NCT04178876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281077|NCT02789579|Levofloxacin|levofloxacin|mesh-list
65281078|NCT02789579|Ofloxacin|ofloxacin|mesh-list
65281079|NCT02789579|Nitrofurantoin|nitrofurantoin|mesh-list
64791860|NCT00367536|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64791861|NCT00367536|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64791862|NCT00367536|Hormone Antagonists|hormone antagonists|mesh-ancestor
64514724|NCT02395497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791863|NCT00367536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64791864|NCT00367614|Pantoprazole|pantoprazole|mesh-list
64791865|NCT00367614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64791866|NCT00367614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64791867|NCT00367614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64791868|NCT00367614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791869|NCT00367614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791870|NCT00368160|Eszopiclone|eszopiclone|mesh-list
64791871|NCT00368160|Zopiclone|zopiclone|mesh-list
64791872|NCT00368160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64791873|NCT00368160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64791874|NCT00368160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791875|NCT00368238|Aspirin|aspirin|mesh-list
64791876|NCT00368238|Epoetin Alfa|epoetin alfa|mesh-list
64791877|NCT00368238|Clopidogrel|clopidogrel|mesh-list
64791878|NCT00368238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64791879|NCT00368238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64791880|NCT00368238|Analgesics|analgesics|mesh-ancestor
64791881|NCT00368238|Sensory System Agents|sensory system agents|mesh-ancestor
64791916|NCT00368862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791917|NCT00368862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64791918|NCT00368862|Serotonin Agents|serotonin agents|mesh-ancestor
64791919|NCT00368862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791920|NCT00368862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64791921|NCT00368862|Antidepressive Agents|antidepressive agents|mesh-ancestor
64791922|NCT00368862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64791923|NCT00368862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64791924|NCT00368862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64791925|NCT00368862|Dopamine Agents|dopamine agents|mesh-ancestor
64791926|NCT00368862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64791927|NCT00368862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64791928|NCT00369018|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64791929|NCT00369018|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
64791930|NCT00369018|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64791931|NCT00369018|Dermatologic Agents|dermatologic agents|mesh-ancestor
64791932|NCT00369096|Bemiparin|bemiparin|mesh-list
64791933|NCT00369096|Anticoagulants|anticoagulants|mesh-ancestor
64791934|NCT00369174|Rosiglitazone|rosiglitazone|mesh-list
64791935|NCT00369174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64791936|NCT00369174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791937|NCT00369252|Nimotuzumab|nimotuzumab|mesh-list
64791938|NCT00369252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64791939|NCT00369252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791940|NCT00369408|Naltrexone|naltrexone|mesh-list
64791941|NCT00369408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64791942|NCT00369408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64791943|NCT00369408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791944|NCT00369408|Sensory System Agents|sensory system agents|mesh-ancestor
64791945|NCT00369408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64791946|NCT00369798|Rolipram|rolipram|mesh-list
64791947|NCT00369798|Antidepressive Agents|antidepressive agents|mesh-ancestor
64791984|NCT00370422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64791985|NCT00370422|Glucocorticoids|glucocorticoids|mesh-ancestor
64791986|NCT00370422|Hormones|hormones|mesh-ancestor
64791987|NCT00370422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64791988|NCT00370500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65281080|NCT02789579|Cefuroxime|cefuroxime|mesh-list
65281081|NCT02789579|Cefuroxime axetil|cefuroxime axetil|mesh-list
65281082|NCT02789579|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65281083|NCT02789579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65281084|NCT02789579|Renal Agents|renal agents|mesh-ancestor
65281085|NCT02789579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65281086|NCT02789579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65281087|NCT02789579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65281088|NCT02789579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281089|NCT02789579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281090|NCT02789579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281091|NCT02789579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64733454|NCT00005575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64733455|NCT00005575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733456|NCT00005575|Adrenergic Agents|adrenergic agents|mesh-ancestor
64733457|NCT00005575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64733458|NCT00005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733459|NCT00005059|Paclitaxel|paclitaxel|mesh-list
64733460|NCT00005059|Carboplatin|carboplatin|mesh-list
64733461|NCT00005059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64472791|NCT02661035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64472792|NCT02661035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64791989|NCT00370500|Antidepressive Agents|antidepressive agents|mesh-ancestor
64791990|NCT00370500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64791991|NCT00370500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64791992|NCT00370500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64791993|NCT00370500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64791994|NCT00370500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791995|NCT00370656|Pregabalin|pregabalin|mesh-list
64791996|NCT00370656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64791997|NCT00370656|Amitriptyline|amitriptyline|mesh-list
64791998|NCT00370656|Analgesics|analgesics|mesh-ancestor
64791999|NCT00370656|Sensory System Agents|sensory system agents|mesh-ancestor
64792000|NCT00370656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64792001|NCT00370656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792002|NCT00370656|Anticonvulsants|anticonvulsants|mesh-ancestor
64792003|NCT00370656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64792004|NCT00370656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64792005|NCT00370656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792006|NCT00370656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64792034|NCT00370968|Dermatologic Agents|dermatologic agents|mesh-ancestor
64792036|NCT00371124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64792037|NCT00371124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64792038|NCT00371124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64792039|NCT00371124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64792040|NCT00371124|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64792041|NCT00371124|Autonomic Agents|autonomic agents|mesh-ancestor
64792042|NCT00371124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64792043|NCT00371124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792044|NCT00371124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64792045|NCT00371124|Respiratory System Agents|respiratory system agents|mesh-ancestor
65281092|NCT02789579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65281093|NCT04233203|Insulin|insulin|mesh-list
65281094|NCT04233203|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65281095|NCT04233203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65281096|NCT04233203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281097|NCT00959101|Metformin|metformin|mesh-list
65281098|NCT00959101|Repaglinide|repaglinide|mesh-list
65281099|NCT00959101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65281100|NCT00959101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281101|NCT04233359|Anesthetics|anesthetics|mesh-list
65281102|NCT04233359|Anesthetics, Local|anesthetics, local|mesh-list
65281103|NCT04233359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65281104|NCT04233359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281105|NCT04233359|Sensory System Agents|sensory system agents|mesh-ancestor
65281106|NCT04233359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281107|NCT00964327|Darunavir|darunavir|mesh-list
65281108|NCT00964327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65281109|NCT00964327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65281110|NCT00964327|Protease Inhibitors|protease inhibitors|mesh-ancestor
65281111|NCT00964327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472794|NCT02661035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472795|NCT02661035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64472797|NCT02661035|Alkylating Agents|alkylating agents|mesh-ancestor
64733464|NCT00005059|Antimitotic Agents|antimitotic agents|mesh-ancestor
64733465|NCT00005059|Mitosis Modulators|mitosis modulators|mesh-ancestor
64792046|NCT00371124|Mydriatics|mydriatics|mesh-ancestor
64514725|NCT02393157|Carboplatin|carboplatin|mesh-list
64792047|NCT00371124|Parasympatholytics|parasympatholytics|mesh-ancestor
64792048|NCT00371124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64792049|NCT00371124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64792050|NCT00371124|Cholinergic Agents|cholinergic agents|mesh-ancestor
64792051|NCT00371124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64792052|NCT00371124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792053|NCT00371592|Acyclovir|acyclovir|mesh-list
64792054|NCT00371592|Antiviral Agents|antiviral agents|mesh-ancestor
64792055|NCT00371592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64792056|NCT00371904|Rituximab|rituximab|mesh-list
64792057|NCT00371904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64792058|NCT00371904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792059|NCT00371904|Immunologic Factors|immunologic factors|mesh-ancestor
64792060|NCT00371904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792061|NCT00371904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64792062|NCT00372138|Thrombin|thrombin|mesh-list
64792063|NCT00372138|Hemostatics|hemostatics|mesh-ancestor
64792064|NCT00372138|Coagulants|coagulants|mesh-ancestor
64792065|NCT00372216|Clopidogrel|clopidogrel|mesh-list
64792066|NCT00372216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64792067|NCT00372216|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64792068|NCT00372216|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64792069|NCT00372216|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64792070|NCT00372216|Purinergic Agents|purinergic agents|mesh-ancestor
64792071|NCT00372216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65281112|NCT00964327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281113|NCT00964327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65281114|NCT00964327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65281115|NCT00964327|Antiviral Agents|antiviral agents|mesh-ancestor
65281116|NCT00964327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64792072|NCT00372216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792073|NCT00372216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792074|NCT00372294|Clindamycin|clindamycin|mesh-list
64792075|NCT00372294|Clindamycin palmitate|clindamycin palmitate|mesh-list
64792110|NCT00372762|Bumetanide|bumetanide|mesh-list
64792111|NCT00372762|Diuretics|diuretics|mesh-ancestor
64560674|NCT02085161|Parasympatholytics|parasympatholytics|mesh-ancestor
64792112|NCT00372762|Natriuretic Agents|natriuretic agents|mesh-ancestor
64792113|NCT00372762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792114|NCT00372762|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64792115|NCT00372762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64792116|NCT00372762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792117|NCT00373464|Etoricoxib|etoricoxib|mesh-list
64792118|NCT00373464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64792119|NCT00373464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64792120|NCT00373464|Analgesics|analgesics|mesh-ancestor
64792121|NCT00373464|Sensory System Agents|sensory system agents|mesh-ancestor
64792122|NCT00373464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64792123|NCT00373464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792124|NCT00373464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64792125|NCT00373464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64792126|NCT00373464|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64792127|NCT00373464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64792128|NCT00373464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792129|NCT00373464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792130|NCT00373542|Ropinirole|ropinirole|mesh-list
64792131|NCT00373542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64792132|NCT00373542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64792133|NCT00373542|Dopamine Agonists|dopamine agonists|mesh-ancestor
64514727|NCT02393157|Ifosfamide|ifosfamide|mesh-list
64792134|NCT00373542|Dopamine Agents|dopamine agents|mesh-ancestor
64792135|NCT00373542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64792136|NCT00373542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792137|NCT00373542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792138|NCT00373620|Paclitaxel|paclitaxel|mesh-list
64792139|NCT00373620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64792140|NCT00373620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792148|NCT00373776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792149|NCT00373776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64792174|NCT00375648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792175|NCT00376038|Metformin|metformin|mesh-list
64792176|NCT00376038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64792177|NCT00376038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792178|NCT00376272|Valsartan|valsartan|mesh-list
64792179|NCT00376272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64792180|NCT00376272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64792181|NCT00376272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64792182|NCT00376272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792183|NCT00376428|Gentamicins|gentamicins|mesh-list
64792184|NCT00376428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64560751|NCT01101867|Insulin Aspart|insulin aspart|mesh-list
64792185|NCT00376428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64792186|NCT00376428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64792187|NCT00376428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792188|NCT00376428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792189|NCT00376584|Niacin|niacin|mesh-list
64792190|NCT00376584|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64792191|NCT00376584|Antimetabolites|antimetabolites|mesh-ancestor
64792192|NCT00376584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792193|NCT00376584|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64792194|NCT00376584|Vasodilator Agents|vasodilator agents|mesh-ancestor
64792195|NCT00376584|Vitamin B Complex|vitamin b complex|mesh-ancestor
64792196|NCT00376584|Vitamins|vitamins|mesh-ancestor
64792197|NCT00376584|Micronutrients|micronutrients|mesh-ancestor
65281117|NCT05252546|Loperamide|loperamide|mesh-list
65281118|NCT05252546|Antidiarrheals|antidiarrheals|mesh-list
65281119|NCT05252546|Bentonite|bentonite|mesh-list
65031124|NCT04819399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65281120|NCT05252546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65281121|NCT05252546|Antidotes|antidotes|mesh-ancestor
65281122|NCT05252546|Protective Agents|protective agents|mesh-ancestor
65281123|NCT05252546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281125|NCT00644384|Keratolytic Agents|keratolytic agents|mesh-ancestor
65281126|NCT00644384|Dermatologic Agents|dermatologic agents|mesh-ancestor
65281127|NCT02637648|Sodium Oxybate|sodium oxybate|mesh-list
65281128|NCT02637648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65281129|NCT02637648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65281130|NCT02637648|Anesthetics, General|anesthetics, general|mesh-ancestor
65281131|NCT02637648|Anesthetics|anesthetics|mesh-ancestor
64792198|NCT00376584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792199|NCT00376662|Etidronic Acid|etidronic acid|mesh-list
64792200|NCT00376662|Hormones|hormones|mesh-list
64792201|NCT00376662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64792228|NCT00377442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64792230|NCT00377910|Lidocaine|lidocaine|mesh-list
64792231|NCT00377910|Polidocanol|polidocanol|mesh-list
64792232|NCT00377910|Anesthetics, Local|anesthetics, local|mesh-ancestor
64792233|NCT00377910|Anesthetics|anesthetics|mesh-ancestor
64792234|NCT00377910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64792235|NCT00377910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792236|NCT00377910|Sensory System Agents|sensory system agents|mesh-ancestor
64792237|NCT00377910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64792238|NCT00377910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64792239|NCT00377910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64792240|NCT00377910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64792241|NCT00377910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64792242|NCT00377910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792243|NCT00377910|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64792244|NCT00377910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64792245|NCT00377988|Contraceptive Agents|contraceptive agents|mesh-list
64792246|NCT00377988|Norgestimate|norgestimate|mesh-list
64792247|NCT00377988|Contraceptives, Oral|contraceptives, oral|mesh-list
64792248|NCT00377988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64792249|NCT00377988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792250|NCT00377988|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64792251|NCT00377988|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64792252|NCT00377988|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64792253|NCT00378066|Bevacizumab|bevacizumab|mesh-list
64792334|NCT00380406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64792335|NCT00380406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472028|NCT03892785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792336|NCT00380406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64792337|NCT00380406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792340|NCT00380484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64792341|NCT00380484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64792343|NCT00380484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64792365|NCT00380640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64792366|NCT00380640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64792367|NCT00380640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64792368|NCT00381030|Carvedilol|carvedilol|mesh-list
64792369|NCT00381030|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64792370|NCT00381030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64792371|NCT00381030|Adrenergic Agents|adrenergic agents|mesh-ancestor
64792372|NCT00381030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65281132|NCT02637648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65281133|NCT02637648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281134|NCT02815865|Oxytocin|oxytocin|mesh-list
65281135|NCT02815865|Dinoprostone|dinoprostone|mesh-list
65281136|NCT02815865|Oxytocics|oxytocics|mesh-ancestor
65281137|NCT02815865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65281138|NCT02815865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281139|NCT02673866|Pregabalin|pregabalin|mesh-list
65281140|NCT02673866|DS-1971a|ds-1971a|mesh-list
65281141|NCT02673866|Analgesics|analgesics|mesh-ancestor
65281142|NCT02673866|Sensory System Agents|sensory system agents|mesh-ancestor
65281143|NCT02673866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281144|NCT02673866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281145|NCT02673866|Anticonvulsants|anticonvulsants|mesh-ancestor
64792373|NCT00381030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792374|NCT00381030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792375|NCT00381030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64792376|NCT00381030|Antioxidants|antioxidants|mesh-ancestor
64792377|NCT00381030|Protective Agents|protective agents|mesh-ancestor
64792378|NCT00381030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64403449|NCT04436419|Thioctic Acid|thioctic acid|mesh-list
64792388|NCT00381264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792389|NCT00381264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64792390|NCT00381264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64792391|NCT00381264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64792392|NCT00381264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64792393|NCT00381264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64792394|NCT00381342|Exenatide|exenatide|mesh-list
64792395|NCT00381342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64792396|NCT00381342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792397|NCT00381342|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64792398|NCT00381342|Incretins|incretins|mesh-ancestor
64792399|NCT00381342|Hormones|hormones|mesh-ancestor
64792400|NCT00381342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64792401|NCT00381654|MP 412|mp 412|mesh-list
64792402|NCT00381654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792403|NCT00381654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64792411|NCT00381732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792413|NCT00382044|Darbepoetin alfa|darbepoetin alfa|mesh-list
64792414|NCT00382044|Hematinics|hematinics|mesh-ancestor
64792415|NCT00382356|Dutasteride|dutasteride|mesh-list
64792416|NCT00382356|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64514728|NCT02393157|Obinutuzumab|obinutuzumab|mesh-list
64792417|NCT00382356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64792418|NCT00382356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792419|NCT00382356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792420|NCT00382356|Hormone Antagonists|hormone antagonists|mesh-ancestor
64792421|NCT00382356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64792422|NCT00382356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792423|NCT00382668|Dasatinib|dasatinib|mesh-list
64792424|NCT00382668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792425|NCT00382668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64792426|NCT00382668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792427|NCT00382668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792428|NCT00382980|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64792429|NCT00382980|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64792430|NCT00382980|Immunologic Factors|immunologic factors|mesh-ancestor
64792431|NCT00382980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792432|NCT00382980|Antacids|antacids|mesh-ancestor
64792433|NCT00382980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792434|NCT00382980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64792435|NCT00383136|Tirofiban|tirofiban|mesh-list
65281146|NCT02673866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65281147|NCT02673866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65281148|NCT02673866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281149|NCT02673866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65281150|NCT02673866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65281151|NCT02673866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65281152|NCT02673866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65281153|NCT02673866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65281154|NCT02673866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65281155|NCT02673866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65281156|NCT00964561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65281157|NCT00964561|Ciprofloxacin|ciprofloxacin|mesh-list
65281158|NCT00964561|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64792436|NCT00383136|Abciximab|abciximab|mesh-list
64792437|NCT00383136|Anticoagulants|anticoagulants|mesh-ancestor
64792438|NCT00383136|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64792439|NCT00383136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64792440|NCT00383136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64792441|NCT00383136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792442|NCT00383214|Epratuzumab|epratuzumab|mesh-list
64792443|NCT00383214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64792456|NCT00383682|Morphine|morphine|mesh-list
64792457|NCT00383682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64792458|NCT00383682|Narcotics|narcotics|mesh-ancestor
64792459|NCT00383682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64792460|NCT00383682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792461|NCT00383682|Analgesics|analgesics|mesh-ancestor
64792462|NCT00383682|Sensory System Agents|sensory system agents|mesh-ancestor
64792463|NCT00383682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64792464|NCT00383682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64792465|NCT00383682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64792466|NCT00383682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64792467|NCT00383682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64792468|NCT00383682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792469|NCT00383916|Pantoprazole|pantoprazole|mesh-list
64792470|NCT00383916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64792471|NCT00383916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64792472|NCT00383916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64792473|NCT00383916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792474|NCT00383916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792475|NCT00383994|Rituximab|rituximab|mesh-list
64792476|NCT00383994|Sargramostim|sargramostim|mesh-list
64792477|NCT00383994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64792478|NCT00383994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792479|NCT00383994|Immunologic Factors|immunologic factors|mesh-ancestor
64792503|NCT00384540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64792504|NCT00384540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403575|NCT04121299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792512|NCT00384618|Vitamin E|vitamin e|mesh-list
64792513|NCT00384618|Pravastatin|pravastatin|mesh-list
64792514|NCT00384618|Vitamins|vitamins|mesh-ancestor
64792515|NCT00384618|Micronutrients|micronutrients|mesh-ancestor
64792516|NCT00384618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792517|NCT00384618|Antioxidants|antioxidants|mesh-ancestor
64792518|NCT00384618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792519|NCT00384618|Protective Agents|protective agents|mesh-ancestor
64792520|NCT00384618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64792521|NCT00384618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64792522|NCT00384618|Antimetabolites|antimetabolites|mesh-ancestor
64792523|NCT00384618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65281159|NCT00964561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65281160|NCT00964561|Antitubercular Agents|antitubercular agents|mesh-ancestor
65281161|NCT00964561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65281162|NCT00964561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65281163|NCT00964561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281164|NCT00964561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281165|NCT00964561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281166|NCT00964561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65281167|NCT00964561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65281168|NCT02793323|Anesthetics|anesthetics|mesh-list
65281169|NCT02793323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64733523|NCT00004489|Vitamin D|vitamin d|mesh-list
64792524|NCT00384618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64792525|NCT00384618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792526|NCT00384696|Nicotine|nicotine|mesh-list
64792527|NCT00384696|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64792528|NCT00384696|Autonomic Agents|autonomic agents|mesh-ancestor
64792529|NCT00384696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64792530|NCT00384696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792531|NCT00384696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64792532|NCT00384696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64792533|NCT00384696|Cholinergic Agents|cholinergic agents|mesh-ancestor
64792556|NCT00385710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792558|NCT00385710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64792559|NCT00385710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792560|NCT00385710|Antimanic Agents|antimanic agents|mesh-ancestor
64792561|NCT00385710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64792562|NCT00385710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64792563|NCT00385710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64792564|NCT00386178|Vitamin E|vitamin e|mesh-list
64792565|NCT00386178|Tocopherols|tocopherols|mesh-list
64792566|NCT00386178|Tocotrienols|tocotrienols|mesh-list
64792567|NCT00386178|alpha-Tocopherol|alpha-tocopherol|mesh-list
64792568|NCT00386178|gamma-Tocopherol|gamma-tocopherol|mesh-list
64792569|NCT00386178|Vitamins|vitamins|mesh-ancestor
64792570|NCT00386178|Micronutrients|micronutrients|mesh-ancestor
64792571|NCT00386178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792572|NCT00386178|Antioxidants|antioxidants|mesh-ancestor
64792573|NCT00386178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792583|NCT00421980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64792584|NCT00421980|Analgesics|analgesics|mesh-ancestor
64792585|NCT00421980|Sensory System Agents|sensory system agents|mesh-ancestor
64792586|NCT00421980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64792602|NCT00422526|Hormones|hormones|mesh-ancestor
64792603|NCT00422526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64792604|NCT00422526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792605|NCT00422604|Tiotropium Bromide|tiotropium bromide|mesh-list
64792606|NCT00422604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64792607|NCT00422604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64792608|NCT00422604|Autonomic Agents|autonomic agents|mesh-ancestor
64792609|NCT00422604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64792610|NCT00422604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792611|NCT00422604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64792612|NCT00422604|Respiratory System Agents|respiratory system agents|mesh-ancestor
64792613|NCT00422604|Parasympatholytics|parasympatholytics|mesh-ancestor
64792614|NCT00422604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64792615|NCT00422604|Cholinergic Agents|cholinergic agents|mesh-ancestor
64792616|NCT00422604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64792617|NCT00422604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792618|NCT00422604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64792619|NCT00422604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65281170|NCT02793323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281171|NCT00964639|Ropivacaine|ropivacaine|mesh-list
65281172|NCT00964639|Anesthetics, Local|anesthetics, local|mesh-ancestor
65281173|NCT00964639|Anesthetics|anesthetics|mesh-ancestor
65281174|NCT00964639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65281175|NCT00964639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281176|NCT00964639|Sensory System Agents|sensory system agents|mesh-ancestor
65281177|NCT00964639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281178|NCT00880620|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65281179|NCT00880620|Carbidopa|carbidopa|mesh-list
65281180|NCT00880620|Levodopa|levodopa|mesh-list
65281181|NCT00880620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65281182|NCT00880620|Immunologic Factors|immunologic factors|mesh-ancestor
65281183|NCT00880620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281184|NCT00880620|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65281185|NCT00880620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65281186|NCT00880620|Dopamine Agonists|dopamine agonists|mesh-ancestor
65281187|NCT00880620|Dopamine Agents|dopamine agents|mesh-ancestor
65281188|NCT00880620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64733536|NCT00005593|Fludarabine|fludarabine|mesh-list
64792620|NCT00422604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64792621|NCT00422604|Adrenergic Agents|adrenergic agents|mesh-ancestor
64792622|NCT00422682|Gemcitabine|gemcitabine|mesh-list
64792623|NCT00422682|Paclitaxel|paclitaxel|mesh-list
64792624|NCT00422682|Carboplatin|carboplatin|mesh-list
64792625|NCT00422682|Temozolomide|temozolomide|mesh-list
64792626|NCT00422682|Topotecan|topotecan|mesh-list
64792627|NCT00422682|Iniparib|iniparib|mesh-list
64792628|NCT00422682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64792629|NCT00422682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792630|NCT00422682|Tubulin Modulators|tubulin modulators|mesh-ancestor
64792631|NCT00422682|Antimitotic Agents|antimitotic agents|mesh-ancestor
64792664|NCT01799616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64792665|NCT01799616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792667|NCT01799850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64792668|NCT01799850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792669|NCT01792050|Paclitaxel|paclitaxel|mesh-list
64792670|NCT01792050|Docetaxel|docetaxel|mesh-list
64792671|NCT01792050|Tryptophan|tryptophan|mesh-list
64792672|NCT01792050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64472031|NCT03892785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64792673|NCT01792050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792674|NCT01792050|Tubulin Modulators|tubulin modulators|mesh-ancestor
64792675|NCT01792050|Antimitotic Agents|antimitotic agents|mesh-ancestor
64792676|NCT01792050|Mitosis Modulators|mitosis modulators|mesh-ancestor
64792677|NCT01792050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792678|NCT01792050|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64792679|NCT01792050|Antidepressive Agents|antidepressive agents|mesh-ancestor
64792680|NCT01792050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64792681|NCT01790100|Ribavirin|ribavirin|mesh-list
64792682|NCT01790100|Antimetabolites|antimetabolites|mesh-ancestor
64792683|NCT01790100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792684|NCT01790100|Antiviral Agents|antiviral agents|mesh-ancestor
64792685|NCT01790100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64792686|NCT01799460|Cyclosporine|cyclosporine|mesh-list
64792687|NCT01799460|Cyclophosphamide|cyclophosphamide|mesh-list
64792688|NCT01799460|Tacrolimus|tacrolimus|mesh-list
64792689|NCT01799460|Cyclosporins|cyclosporins|mesh-list
65281189|NCT00880620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281190|NCT00880620|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65281191|NCT00880620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281192|NCT00959335|Bicalutamide|bicalutamide|mesh-list
65281193|NCT00959335|Androgen Antagonists|androgen antagonists|mesh-ancestor
65281194|NCT00959335|Hormone Antagonists|hormone antagonists|mesh-ancestor
65281195|NCT00959335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65281196|NCT00959335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281198|NCT00644618|Gemcitabine|gemcitabine|mesh-list
65281199|NCT00644618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65281200|NCT00644618|Antimetabolites|antimetabolites|mesh-ancestor
65281201|NCT00644618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281202|NCT00644618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281203|NCT00644618|Antiviral Agents|antiviral agents|mesh-ancestor
65281204|NCT00644618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65281205|NCT00644618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281206|NCT00644618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65281207|NCT00644618|Immunologic Factors|immunologic factors|mesh-ancestor
65281208|NCT00644618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281209|NCT03967847|Ketorolac|ketorolac|mesh-list
65281210|NCT03967847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65281211|NCT03967847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64792690|NCT01799460|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64792691|NCT01799460|Glucocorticoids|glucocorticoids|mesh-list
64792692|NCT01799460|Immunologic Factors|immunologic factors|mesh-ancestor
64792693|NCT01799460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792733|NCT02998398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64792734|NCT02998320|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64792735|NCT02998320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64792736|NCT02998320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64792737|NCT02998320|Antiviral Agents|antiviral agents|mesh-ancestor
64792738|NCT02998320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64792751|NCT02996214|Paclitaxel|paclitaxel|mesh-list
64792752|NCT02996214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64792753|NCT02996214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792754|NCT02996214|Tubulin Modulators|tubulin modulators|mesh-ancestor
64792755|NCT02996214|Antimitotic Agents|antimitotic agents|mesh-ancestor
64792756|NCT02996214|Mitosis Modulators|mitosis modulators|mesh-ancestor
64792757|NCT02996214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792758|NCT02996214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64792759|NCT02996214|Antimetabolites|antimetabolites|mesh-ancestor
64792760|NCT02996214|Antiviral Agents|antiviral agents|mesh-ancestor
64792761|NCT02996214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64792762|NCT02996214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792763|NCT02996214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64792764|NCT02996214|Immunologic Factors|immunologic factors|mesh-ancestor
64792765|NCT02996214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792766|NCT02996058|Dexmedetomidine|dexmedetomidine|mesh-list
64792767|NCT02996058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65281212|NCT03967847|Analgesics|analgesics|mesh-ancestor
65281213|NCT03967847|Sensory System Agents|sensory system agents|mesh-ancestor
65281214|NCT03967847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281215|NCT03967847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281216|NCT03967847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65281217|NCT03967847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65281218|NCT03967847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64792768|NCT02996058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64403842|NCT04526197|Analgesics|analgesics|mesh-ancestor
64792773|NCT02996058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64792774|NCT02996058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64792775|NCT02996058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64792776|NCT02996058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64792777|NCT02996058|Adrenergic Agents|adrenergic agents|mesh-ancestor
64792778|NCT02996058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64792779|NCT02996058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792781|NCT02995512|Gout Suppressants|gout suppressants|mesh-ancestor
64792782|NCT02995512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64792784|NCT02995512|Antimitotic Agents|antimitotic agents|mesh-ancestor
64792785|NCT02995512|Mitosis Modulators|mitosis modulators|mesh-ancestor
64792786|NCT02995512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792787|NCT02995512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792788|NCT02994888|Cetuximab|cetuximab|mesh-list
64792789|NCT02994888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64792790|NCT02994888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792791|NCT02993718|Dexmedetomidine|dexmedetomidine|mesh-list
64792792|NCT02993718|Propofol|propofol|mesh-list
64792793|NCT02993718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64792794|NCT02993718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64792795|NCT02993718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792796|NCT02993718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64792797|NCT02993718|Anesthetics, General|anesthetics, general|mesh-ancestor
64792798|NCT02993718|Anesthetics|anesthetics|mesh-ancestor
64792799|NCT02993718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64792800|NCT02993718|Analgesics|analgesics|mesh-ancestor
64792801|NCT02993718|Sensory System Agents|sensory system agents|mesh-ancestor
64792802|NCT02993718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64792835|NCT02992548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64792836|NCT02992548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64792837|NCT02992548|Antimetabolites|antimetabolites|mesh-ancestor
64792838|NCT02992548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792839|NCT02992548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64792840|NCT02992548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64792852|NCT02991768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64792853|NCT02991768|Respiratory System Agents|respiratory system agents|mesh-ancestor
64792855|NCT02991768|Hormones|hormones|mesh-ancestor
64792880|NCT02999958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792882|NCT02999958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792883|NCT02999958|Vitamin B Complex|vitamin b complex|mesh-ancestor
64792884|NCT02999958|Vitamins|vitamins|mesh-ancestor
64792885|NCT02999958|Micronutrients|micronutrients|mesh-ancestor
64792886|NCT02999958|Nootropic Agents|nootropic agents|mesh-ancestor
64792887|NCT02999958|Antiviral Agents|antiviral agents|mesh-ancestor
64792888|NCT02999958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64792889|NCT02999958|Expectorants|expectorants|mesh-ancestor
64792890|NCT02999958|Respiratory System Agents|respiratory system agents|mesh-ancestor
64792891|NCT02999958|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64792892|NCT02999958|Antidotes|antidotes|mesh-ancestor
64792893|NCT02995746|Dexamethasone|dexamethasone|mesh-list
64792894|NCT02995746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64792895|NCT02995746|Antiemetics|antiemetics|mesh-ancestor
64792896|NCT02995746|Autonomic Agents|autonomic agents|mesh-ancestor
64792897|NCT02995746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64792898|NCT02995746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792899|NCT02995746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64792900|NCT02995746|Glucocorticoids|glucocorticoids|mesh-ancestor
64792901|NCT02995746|Hormones|hormones|mesh-ancestor
64792902|NCT02995746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65281219|NCT03967847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281220|NCT03967847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281221|NCT03747419|Avelumab|avelumab|mesh-list
65281222|NCT03747419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65281223|NCT03747419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281224|NCT04175990|Dydrogesterone|dydrogesterone|mesh-list
65281225|NCT04175990|Progestins|progestins|mesh-ancestor
65281226|NCT04175990|Hormones|hormones|mesh-ancestor
65281227|NCT04175990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65281228|NCT04175990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281229|NCT00959569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65281230|NCT00959569|Esmolol|esmolol|mesh-list
65281231|NCT00959569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65281232|NCT00959569|Adrenergic Agents|adrenergic agents|mesh-ancestor
65281233|NCT00959569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65281234|NCT00959569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281235|NCT00959569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281236|NCT00959569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65281237|NCT00881868|Clobetasol|clobetasol|mesh-list
65281238|NCT00881868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65281239|NCT00881868|Glucocorticoids|glucocorticoids|mesh-ancestor
65281240|NCT00881868|Hormones|hormones|mesh-ancestor
64733585|NCT00005089|Antimitotic Agents|antimitotic agents|mesh-ancestor
64792903|NCT02995746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64792904|NCT02995746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792905|NCT02990364|Lidocaine|lidocaine|mesh-list
64792906|NCT02990364|Anesthetics, Local|anesthetics, local|mesh-list
64792946|NCT01270932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64792947|NCT01270932|Glucocorticoids|glucocorticoids|mesh-ancestor
64792948|NCT01270932|Hormones|hormones|mesh-ancestor
64792949|NCT01270932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64792950|NCT01270932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64792951|NCT01270932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792952|NCT01270932|Protease Inhibitors|protease inhibitors|mesh-ancestor
64792953|NCT01270932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792954|NCT01270932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792955|NCT01270932|Immunologic Factors|immunologic factors|mesh-ancestor
64792956|NCT01270932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64792957|NCT01270932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64792958|NCT01270932|Growth Substances|growth substances|mesh-ancestor
64793001|NCT01271556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64793002|NCT01271556|Respiratory System Agents|respiratory system agents|mesh-ancestor
64793003|NCT01271556|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64793004|NCT01271556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64793005|NCT01271556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64793006|NCT01271556|Adrenergic Agents|adrenergic agents|mesh-ancestor
64793007|NCT01271556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64404106|NCT04930211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793046|NCT01273662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793048|NCT01273974|Immunologic Factors|immunologic factors|mesh-ancestor
65281241|NCT00881868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65281242|NCT00881868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281243|NCT04176068|Calcium|calcium|mesh-list
65281244|NCT04176068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65281245|NCT04176068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281246|NCT00959725|Infliximab|infliximab|mesh-list
65281247|NCT00959725|Dermatologic Agents|dermatologic agents|mesh-ancestor
65281248|NCT00959725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65281249|NCT00959725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65281250|NCT02789189|Gemcitabine|gemcitabine|mesh-list
65281251|NCT02789189|Nedaplatin|nedaplatin|mesh-list
65281252|NCT02789189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65281253|NCT02789189|Antimetabolites|antimetabolites|mesh-ancestor
65281254|NCT02789189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281255|NCT02789189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281256|NCT02789189|Antiviral Agents|antiviral agents|mesh-ancestor
64793049|NCT01273974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793050|NCT01274130|Metformin|metformin|mesh-list
64793051|NCT01274130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64793052|NCT01274130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793053|NCT01276080|Donepezil|donepezil|mesh-list
64793054|NCT01276080|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64793055|NCT01276080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64793056|NCT01276080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793057|NCT01276080|Cholinergic Agents|cholinergic agents|mesh-ancestor
64793058|NCT01276080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64793059|NCT01276080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793060|NCT01276080|Nootropic Agents|nootropic agents|mesh-ancestor
64793061|NCT01276548|Carboplatin|carboplatin|mesh-list
64793062|NCT01276548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793063|NCT01276704|Secoisolariciresinol|secoisolariciresinol|mesh-list
64793093|NCT01278576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64793094|NCT01278576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793096|NCT01279434|Vitamin E|vitamin e|mesh-list
64793108|NCT01279512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793109|NCT01279512|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64793110|NCT01279512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64793111|NCT01279512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793112|NCT01279668|Montelukast|montelukast|mesh-list
64793113|NCT01279668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64793114|NCT01279668|Respiratory System Agents|respiratory system agents|mesh-ancestor
64793115|NCT01279668|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64793116|NCT01279668|Hormone Antagonists|hormone antagonists|mesh-ancestor
64793117|NCT01279668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64793118|NCT01279668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793119|NCT01279668|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64793148|NCT01276236|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64793149|NCT01276236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793150|NCT01276236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64793151|NCT01276236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64793152|NCT01276236|Antiviral Agents|antiviral agents|mesh-ancestor
64793153|NCT01276236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64793154|NCT01276236|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64793155|NCT01275222|Everolimus|everolimus|mesh-list
64793156|NCT01275222|Imatinib Mesylate|imatinib mesylate|mesh-list
64793157|NCT01275222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793158|NCT01275222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65281257|NCT02789189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65281258|NCT02789189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281259|NCT02789189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65281260|NCT02789189|Immunologic Factors|immunologic factors|mesh-ancestor
65281261|NCT02789189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281262|NCT04234607|Carboplatin|carboplatin|mesh-list
65281263|NCT04234607|Etoposide|etoposide|mesh-list
65281264|NCT04234607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733627|NCT00004573|Ganciclovir|ganciclovir|mesh-list
64793159|NCT01275222|Immunologic Factors|immunologic factors|mesh-ancestor
64793160|NCT01275222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404232|NCT03807817|Ethanol|ethanol|mesh-list
64793167|NCT01275144|Autonomic Agents|autonomic agents|mesh-ancestor
64793168|NCT01275144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793169|NCT01275144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793170|NCT01275144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64793191|NCT01271010|Alkylating Agents|alkylating agents|mesh-ancestor
64793192|NCT01271010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793193|NCT01271010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793194|NCT01271010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64793195|NCT01271010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64793196|NCT01270620|Propofol|propofol|mesh-list
64793197|NCT01270620|Desflurane|desflurane|mesh-list
64793198|NCT01270620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64793199|NCT01270620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64793200|NCT01270620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793201|NCT01270620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64793202|NCT01270620|Anesthetics, General|anesthetics, general|mesh-ancestor
64793203|NCT01270620|Anesthetics|anesthetics|mesh-ancestor
64793204|NCT01270620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64793205|NCT01270464|Reslizumab|reslizumab|mesh-list
64793206|NCT01270464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64793207|NCT01270464|Respiratory System Agents|respiratory system agents|mesh-ancestor
64793208|NCT01279590|Atorvastatin|atorvastatin|mesh-list
64793209|NCT01279590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64793210|NCT01279590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64793211|NCT01279590|Antimetabolites|antimetabolites|mesh-ancestor
64793212|NCT01279590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793213|NCT01279590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64793214|NCT01279590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64793215|NCT01279590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64793216|NCT01271790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64793217|NCT01271790|Interferon-alpha|interferon-alpha|mesh-list
64793218|NCT01271790|Ribavirin|ribavirin|mesh-list
64793219|NCT01271790|Antiviral Agents|antiviral agents|mesh-ancestor
64793220|NCT01271790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64793221|NCT01271790|Immunologic Factors|immunologic factors|mesh-ancestor
64793222|NCT01271790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793223|NCT01271790|Antimetabolites|antimetabolites|mesh-ancestor
64793224|NCT01271790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793225|NCT01270152|Ascorbic Acid|ascorbic acid|mesh-list
64793226|NCT01270152|Antioxidants|antioxidants|mesh-ancestor
64793227|NCT01270152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793267|NCT00249444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64793268|NCT00249444|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64793269|NCT00249444|Histamine Antagonists|histamine antagonists|mesh-ancestor
64793270|NCT00249444|Histamine Agents|histamine agents|mesh-ancestor
64793271|NCT00249444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64793294|NCT00247962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64793296|NCT00247962|Sensory System Agents|sensory system agents|mesh-ancestor
64793297|NCT00247962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793298|NCT00247962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793299|NCT00247962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64793305|NCT00247416|Gemcitabine|gemcitabine|mesh-list
64793306|NCT00247416|Dexamethasone|dexamethasone|mesh-list
64793307|NCT00247416|Carboplatin|carboplatin|mesh-list
64793308|NCT00247416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64793309|NCT00247416|Antiemetics|antiemetics|mesh-ancestor
65281265|NCT04234607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65281266|NCT04234607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65281267|NCT04234607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65281268|NCT04234607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281269|NCT04234607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793310|NCT00247416|Autonomic Agents|autonomic agents|mesh-ancestor
64793311|NCT00247416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793312|NCT00247416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793313|NCT00247416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64793314|NCT00247416|Glucocorticoids|glucocorticoids|mesh-ancestor
64793316|NCT00247416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64793317|NCT00247416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64793318|NCT00247416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793319|NCT00247416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64793320|NCT00247416|Antimetabolites|antimetabolites|mesh-ancestor
64793321|NCT00247416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793322|NCT00247416|Antiviral Agents|antiviral agents|mesh-ancestor
64793323|NCT00247416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64793324|NCT00247416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64793325|NCT00247416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64793326|NCT00247416|Immunologic Factors|immunologic factors|mesh-ancestor
64793327|NCT00246012|Dacarbazine|dacarbazine|mesh-list
64793328|NCT00246012|Intetumumab|intetumumab|mesh-list
64793329|NCT00246012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64793363|NCT03805152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64793364|NCT03805152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64793365|NCT03805152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793366|NCT03805152|Cholinergic Agents|cholinergic agents|mesh-ancestor
64793367|NCT03805152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64793397|NCT03804372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793398|NCT03804372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64793399|NCT03804372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64793400|NCT03803124|Tolvaptan|tolvaptan|mesh-list
64793401|NCT03803124|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64793402|NCT03803124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793403|NCT03803124|Natriuretic Agents|natriuretic agents|mesh-ancestor
64793404|NCT03803124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793405|NCT03802032|Lidocaine|lidocaine|mesh-list
64793406|NCT03802032|Anesthetics, Local|anesthetics, local|mesh-ancestor
64793407|NCT03802032|Anesthetics|anesthetics|mesh-ancestor
64793408|NCT03802032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64793409|NCT03802032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793410|NCT03802032|Sensory System Agents|sensory system agents|mesh-ancestor
64793411|NCT03802032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793412|NCT03802032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64793413|NCT03802032|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64793414|NCT03802032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64793415|NCT03802032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64793416|NCT03802032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793417|NCT03801252|Azithromycin|azithromycin|mesh-list
64793418|NCT03801252|Cefazolin|cefazolin|mesh-list
64793419|NCT03801252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64793420|NCT03801252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64793421|NCT03800550|Clarithromycin|clarithromycin|mesh-list
64793422|NCT03800550|Bedaquiline|bedaquiline|mesh-list
64472037|NCT03892785|Dermatologic Agents|dermatologic agents|mesh-ancestor
64472038|NCT03892785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64793423|NCT03800550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64793424|NCT03800550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64793425|NCT03800550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64793426|NCT03800550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64793427|NCT03800550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793428|NCT03800550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64793429|NCT03800550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64793438|NCT03808818|Cholinergic Agents|cholinergic agents|mesh-ancestor
64793439|NCT03808818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65281270|NCT03955471|Niraparib|niraparib|mesh-list
65281271|NCT03955471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65281272|NCT03955471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281273|NCT03955471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281274|NCT03955471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281275|NCT02637726|Remifentanil|remifentanil|mesh-list
64793440|NCT03808818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793441|NCT03803202|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64793442|NCT03803202|Immunologic Factors|immunologic factors|mesh-ancestor
64793443|NCT03803202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793471|NCT04295772|Antiviral Agents|antiviral agents|mesh-ancestor
64793472|NCT04295772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64793473|NCT04295772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64793474|NCT04295772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793475|NCT04295772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64793476|NCT04295772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64793477|NCT04295772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64793478|NCT04209660|Pembrolizumab|pembrolizumab|mesh-list
64793479|NCT04209660|Lenvatinib|lenvatinib|mesh-list
64793480|NCT04209660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64793481|NCT04209660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793482|NCT04209660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64793483|NCT04209660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64793484|NCT04209660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793485|NCT04148430|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64793486|NCT04148430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64793487|NCT04096638|Atezolizumab|atezolizumab|mesh-list
64793488|NCT04096638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793489|NCT03467256|Cytarabine|cytarabine|mesh-list
64793490|NCT03467256|Dexamethasone|dexamethasone|mesh-list
64793491|NCT03467256|Cyclophosphamide|cyclophosphamide|mesh-list
64793492|NCT03467256|Fludarabine|fludarabine|mesh-list
64793493|NCT03467256|Etoposide|etoposide|mesh-list
64793533|NCT03017820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64793535|NCT03017820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793536|NCT03017820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793537|NCT03017820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64793538|NCT03017820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64793539|NCT03017820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64793540|NCT03017820|Antiviral Agents|antiviral agents|mesh-ancestor
64793541|NCT03017820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64793542|NCT03017820|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64793543|NCT03017820|Trace Elements|trace elements|mesh-ancestor
64793544|NCT03017820|Micronutrients|micronutrients|mesh-ancestor
64793545|NCT02458014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64793546|NCT02458014|Blinatumomab|blinatumomab|mesh-list
64793547|NCT02458014|Antibodies|antibodies|mesh-list
64793548|NCT02458014|Immunoglobulins|immunoglobulins|mesh-list
64793549|NCT02458014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64793550|NCT02458014|Muromonab-CD3|muromonab-cd3|mesh-list
64793551|NCT02458014|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64793552|NCT02458014|Immunologic Factors|immunologic factors|mesh-ancestor
64793553|NCT02458014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793554|NCT02458014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793555|NCT02458014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64793556|NCT02017704|Leucovorin|leucovorin|mesh-list
64793557|NCT02017704|Fluorouracil|fluorouracil|mesh-list
64793558|NCT02017704|Capecitabine|capecitabine|mesh-list
64793577|NCT01622322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793578|NCT01622322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64793579|NCT01622322|Analgesics|analgesics|mesh-ancestor
64793580|NCT01622322|Sensory System Agents|sensory system agents|mesh-ancestor
64793581|NCT01622322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793583|NCT05313282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793584|NCT05313282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64793585|NCT05313282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64793586|NCT05313282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793587|NCT05312034|Anti-Infective Agents|anti-infective agents|mesh-list
64793588|NCT05312034|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65281276|NCT02637726|Propofol|propofol|mesh-list
65281277|NCT02637726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65281278|NCT02637726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65281279|NCT02637726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281280|NCT02637726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65281281|NCT02637726|Anesthetics, General|anesthetics, general|mesh-ancestor
65281282|NCT02637726|Anesthetics|anesthetics|mesh-ancestor
65281283|NCT02637726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65281284|NCT02637726|Narcotics|narcotics|mesh-ancestor
65281285|NCT02637726|Analgesics|analgesics|mesh-ancestor
65281286|NCT02637726|Sensory System Agents|sensory system agents|mesh-ancestor
65281287|NCT02637726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281288|NCT04161768|Norfloxacin|norfloxacin|mesh-list
65281289|NCT04161768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65281290|NCT04161768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65281291|NCT04161768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65281292|NCT04161768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65281293|NCT04161768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733644|NCT00005119|Calcium|calcium|mesh-list
64793589|NCT05311722|Dexmedetomidine|dexmedetomidine|mesh-list
64793590|NCT05311722|Ketamine|ketamine|mesh-list
64793591|NCT05311722|Tramadol|tramadol|mesh-list
64793592|NCT05311722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64793593|NCT05311722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64793594|NCT05311722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793595|NCT05311722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64793596|NCT05311722|Analgesics|analgesics|mesh-ancestor
64793597|NCT05311722|Sensory System Agents|sensory system agents|mesh-ancestor
64793598|NCT05311722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793599|NCT05311722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64793600|NCT05311722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64793601|NCT05311722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64793602|NCT05311722|Adrenergic Agents|adrenergic agents|mesh-ancestor
64793603|NCT05311722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64793604|NCT05311722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793605|NCT05311722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64793606|NCT05311722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64793607|NCT05311722|Anesthetics, General|anesthetics, general|mesh-ancestor
64793608|NCT05311722|Anesthetics|anesthetics|mesh-ancestor
64793609|NCT05311722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64793610|NCT05311722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64793611|NCT05311722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64793612|NCT05311722|Narcotics|narcotics|mesh-ancestor
64793613|NCT05311254|Fosfomycin|fosfomycin|mesh-list
64793614|NCT05311254|Calcium|calcium|mesh-list
64793615|NCT05311254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64793616|NCT05311254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793617|NCT05311254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64793618|NCT05311254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64793619|NCT03215940|Dronabinol|dronabinol|mesh-list
64793620|NCT03215940|Cannabidiol|cannabidiol|mesh-list
64793621|NCT03215940|Anticonvulsants|anticonvulsants|mesh-ancestor
64793622|NCT03215940|Hallucinogens|hallucinogens|mesh-ancestor
64793623|NCT03215940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793624|NCT03215940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64793625|NCT03215940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64793626|NCT03215940|Analgesics|analgesics|mesh-ancestor
64793627|NCT03215940|Sensory System Agents|sensory system agents|mesh-ancestor
64793628|NCT03215940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281294|NCT04161768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281295|NCT04161768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281296|NCT04161768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65281297|NCT04161768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65281298|NCT05300282|Gemcitabine|gemcitabine|mesh-list
65281299|NCT05300282|Atezolizumab|atezolizumab|mesh-list
65281300|NCT05300282|Vinorelbine|vinorelbine|mesh-list
65281301|NCT05300282|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65281302|NCT05300282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65281303|NCT05300282|Antimetabolites|antimetabolites|mesh-ancestor
65281304|NCT05300282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281305|NCT05300282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281306|NCT05300282|Antiviral Agents|antiviral agents|mesh-ancestor
65281307|NCT05300282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65281308|NCT05300282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281309|NCT05300282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65281310|NCT05300282|Immunologic Factors|immunologic factors|mesh-ancestor
65281311|NCT05300282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281312|NCT05300282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65281313|NCT05300282|Tubulin Modulators|tubulin modulators|mesh-ancestor
65281314|NCT05300282|Antimitotic Agents|antimitotic agents|mesh-ancestor
64793713|NCT03216096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64793714|NCT03216096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64793715|NCT03214848|Contraceptive Agents|contraceptive agents|mesh-list
64793716|NCT03214848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64793717|NCT03214848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793718|NCT03214536|Ropivacaine|ropivacaine|mesh-list
64793719|NCT03214536|Anesthetics|anesthetics|mesh-ancestor
64793720|NCT03214536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64793721|NCT03214536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793722|NCT03214536|Anesthetics, Local|anesthetics, local|mesh-ancestor
64793723|NCT03214536|Sensory System Agents|sensory system agents|mesh-ancestor
64793724|NCT03214536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793725|NCT03214770|Calcium, Dietary|calcium, dietary|mesh-list
64793726|NCT03214770|Calcium|calcium|mesh-list
64793727|NCT03214770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64793728|NCT03214770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793729|NCT03214770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64793730|NCT03213834|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64793760|NCT03211728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793761|NCT03211728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793763|NCT03211728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64793764|NCT03211728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64793765|NCT03211728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793766|NCT03211728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64793767|NCT03211728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64793768|NCT03211728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64793769|NCT03211728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64793770|NCT03211728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64793771|NCT03211572|Tamoxifen|tamoxifen|mesh-list
64793772|NCT03211572|Anastrozole|anastrozole|mesh-list
65281315|NCT05300282|Mitosis Modulators|mitosis modulators|mesh-ancestor
65281316|NCT05300282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65281317|NCT05300282|Alkylating Agents|alkylating agents|mesh-ancestor
65281318|NCT02793011|Dexamethasone|dexamethasone|mesh-list
65281319|NCT02793011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64793773|NCT03211572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64793774|NCT03211572|Hormone Antagonists|hormone antagonists|mesh-ancestor
64793775|NCT03211572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64793776|NCT03211572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793777|NCT03211572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64793778|NCT03211572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793779|NCT03211572|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64793780|NCT03211572|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64793781|NCT03211572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64793782|NCT03211572|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64793783|NCT03211572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64793784|NCT03211572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64793785|NCT03211572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793822|NCT03210324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793823|NCT03210324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64793824|NCT03210324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64793825|NCT03210324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64793826|NCT03210324|Contraceptive Agents|contraceptive agents|mesh-ancestor
64793848|NCT01832922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64793849|NCT01832922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793850|NCT01832922|Immunologic Factors|immunologic factors|mesh-ancestor
64793851|NCT01832922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793852|NCT01832922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64793853|NCT01832922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64793854|NCT01832922|Alkylating Agents|alkylating agents|mesh-ancestor
64793855|NCT01832922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793857|NCT01833312|Buspirone|buspirone|mesh-list
64472040|NCT03892785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64472041|NCT03892785|Immunologic Factors|immunologic factors|mesh-ancestor
64793858|NCT01833312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64793859|NCT01833312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64793860|NCT01833312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64793861|NCT01833312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793862|NCT01833312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64793863|NCT01833312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64793864|NCT01833312|Serotonin Agents|serotonin agents|mesh-ancestor
64793865|NCT01833312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64793866|NCT01833312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793867|NCT01833312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64793868|NCT01833312|Narcotics|narcotics|mesh-ancestor
64793869|NCT01833312|Analgesics|analgesics|mesh-ancestor
64793870|NCT01833312|Sensory System Agents|sensory system agents|mesh-ancestor
64793871|NCT01833312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793872|NCT01833312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64793873|NCT01834014|Bevacizumab|bevacizumab|mesh-list
64793875|NCT01834014|Fluorouracil|fluorouracil|mesh-list
64793885|NCT01834014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793911|NCT01835340|Anesthetics, General|anesthetics, general|mesh-ancestor
64793912|NCT01836120|Docetaxel|docetaxel|mesh-list
64793913|NCT01836120|Raltitrexed|raltitrexed|mesh-list
64793914|NCT01836120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793915|NCT01836120|Tubulin Modulators|tubulin modulators|mesh-ancestor
64793916|NCT01836120|Antimitotic Agents|antimitotic agents|mesh-ancestor
64793917|NCT01836120|Mitosis Modulators|mitosis modulators|mesh-ancestor
64793918|NCT01836120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793919|NCT01836120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64793920|NCT01836120|Antimetabolites|antimetabolites|mesh-ancestor
64793921|NCT01836120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64793922|NCT01836120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64793923|NCT01836822|Dimercaprol|dimercaprol|mesh-list
64793924|NCT01836822|Chelating Agents|chelating agents|mesh-ancestor
64793925|NCT01836822|Sequestering Agents|sequestering agents|mesh-ancestor
64793926|NCT01836822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281320|NCT02793011|Antiemetics|antiemetics|mesh-ancestor
65281321|NCT02793011|Autonomic Agents|autonomic agents|mesh-ancestor
65281322|NCT02793011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281323|NCT02793011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281324|NCT02793011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65281325|NCT02793011|Glucocorticoids|glucocorticoids|mesh-ancestor
65281326|NCT02793011|Hormones|hormones|mesh-ancestor
65281327|NCT02793011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65281328|NCT02793011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65281329|NCT02793011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281330|NCT00965107|Thiopental|thiopental|mesh-list
65281331|NCT00965107|Propofol|propofol|mesh-list
65281332|NCT00965107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65281333|NCT00965107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65281334|NCT00965107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281335|NCT00965107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64733685|NCT00005641|Levoleucovorin|levoleucovorin|mesh-list
64793927|NCT01836900|Hemostatics|hemostatics|mesh-list
64793928|NCT01836900|Coagulants|coagulants|mesh-ancestor
64793929|NCT01837992|Primaquine|primaquine|mesh-list
64793930|NCT01837992|Antimalarials|antimalarials|mesh-ancestor
64793931|NCT01837992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64793932|NCT01837992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64793933|NCT01837992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64793934|NCT01838460|Lobeline|lobeline|mesh-list
64793974|NCT01838928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793975|NCT01839084|Isoflurane|isoflurane|mesh-list
64793976|NCT01839084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64793977|NCT01839084|Anesthetics, General|anesthetics, general|mesh-ancestor
64793978|NCT01839084|Anesthetics|anesthetics|mesh-ancestor
64793979|NCT01839084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64794012|NCT01839630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794013|NCT01839630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64794021|NCT01839864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794022|NCT01839864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794023|NCT01839864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64794024|NCT01839864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64794025|NCT01834248|Poly I-C|poly i-c|mesh-list
64794026|NCT01834248|Decitabine|decitabine|mesh-list
64794027|NCT01834248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64794029|NCT01834248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64794030|NCT01834248|Antimetabolites|antimetabolites|mesh-ancestor
64794031|NCT01834248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794062|NCT01836432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64794063|NCT01836432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794064|NCT01836432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64794065|NCT01836432|Immunologic Factors|immunologic factors|mesh-ancestor
64794066|NCT01836432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794067|NCT01836432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64794068|NCT01836432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64794070|NCT01836432|Protective Agents|protective agents|mesh-ancestor
64794071|NCT01836432|Vitamin B Complex|vitamin b complex|mesh-ancestor
64794072|NCT01836432|Vitamins|vitamins|mesh-ancestor
64794073|NCT01836432|Micronutrients|micronutrients|mesh-ancestor
64794074|NCT01720056|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64794075|NCT01720056|Verapamil|verapamil|mesh-list
64794076|NCT01720056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64794077|NCT01720056|Glucocorticoids|glucocorticoids|mesh-ancestor
64794078|NCT01720056|Hormones|hormones|mesh-ancestor
64794079|NCT01720056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65281336|NCT00965107|Anesthetics, General|anesthetics, general|mesh-ancestor
65281337|NCT00965107|Anesthetics|anesthetics|mesh-ancestor
65281338|NCT00965107|Anticonvulsants|anticonvulsants|mesh-ancestor
65281339|NCT00965107|GABA Modulators|gaba modulators|mesh-ancestor
65281340|NCT00965107|GABA Agents|gaba agents|mesh-ancestor
65281341|NCT00965107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65281342|NCT00965107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281343|NCT02788877|Aflibercept|aflibercept|mesh-list
65281344|NCT02788877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65281345|NCT02788877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65281346|NCT02788877|Growth Substances|growth substances|mesh-ancestor
65281347|NCT02788877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281348|NCT02788877|Growth Inhibitors|growth inhibitors|mesh-ancestor
65281349|NCT02788877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281350|NCT00959881|Donepezil|donepezil|mesh-list
65281351|NCT00959881|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65281352|NCT00959881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794112|NCT01721616|Azithromycin|azithromycin|mesh-list
64794113|NCT01721616|Cefazolin|cefazolin|mesh-list
64794114|NCT01721616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64794115|NCT01721616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64794116|NCT01721694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64794117|NCT01721694|Azithromycin|azithromycin|mesh-list
64794118|NCT01721694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64794119|NCT01721694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64794120|NCT01721694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64794121|NCT01722396|Vitamin D|vitamin d|mesh-list
64794122|NCT01722396|Vitamins|vitamins|mesh-ancestor
64794123|NCT01722396|Micronutrients|micronutrients|mesh-ancestor
64794124|NCT01722396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794125|NCT01722396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64794126|NCT01722630|Dopamine|dopamine|mesh-list
64794127|NCT01722630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64794128|NCT01722630|Sympathomimetics|sympathomimetics|mesh-ancestor
64794129|NCT01722630|Autonomic Agents|autonomic agents|mesh-ancestor
64794130|NCT01722630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794131|NCT01722630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794132|NCT01722630|Dopamine Agents|dopamine agents|mesh-ancestor
64794133|NCT01722630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64794134|NCT01722630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794135|NCT01722630|Protective Agents|protective agents|mesh-ancestor
64794136|NCT01722942|Amiodarone|amiodarone|mesh-list
64794137|NCT01722942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64794138|NCT01722942|Vasodilator Agents|vasodilator agents|mesh-ancestor
64794139|NCT01722942|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64794181|NCT01724268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64794182|NCT01724268|Glucocorticoids|glucocorticoids|mesh-ancestor
64794183|NCT01724268|Hormones|hormones|mesh-ancestor
64794184|NCT01724268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64794185|NCT01724268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64794186|NCT01724268|Autonomic Agents|autonomic agents|mesh-ancestor
64794200|NCT01724424|Protective Agents|protective agents|mesh-ancestor
64794201|NCT01724424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794202|NCT01724424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64794204|NCT01724814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64794205|NCT01724814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794206|NCT01725048|Mirtazapine|mirtazapine|mesh-list
64794207|NCT01725048|Citalopram|citalopram|mesh-list
64794208|NCT01725048|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64794209|NCT01725048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64562771|NCT04731467|Gemcitabine|gemcitabine|mesh-list
65281353|NCT00959881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281354|NCT00959881|Cholinergic Agents|cholinergic agents|mesh-ancestor
65281355|NCT00959881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65281356|NCT00959881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281357|NCT00959881|Nootropic Agents|nootropic agents|mesh-ancestor
65281358|NCT00959959|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
65281359|NCT00959959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281360|NCT00959959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281361|NCT03651011|Aflibercept|aflibercept|mesh-list
65281362|NCT03651011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65281363|NCT03651011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65281364|NCT03651011|Growth Substances|growth substances|mesh-ancestor
65281365|NCT03651011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281366|NCT03651011|Growth Inhibitors|growth inhibitors|mesh-ancestor
65281367|NCT03651011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281368|NCT00880542|Sorafenib|sorafenib|mesh-list
65281369|NCT00880542|Ifosfamide|ifosfamide|mesh-list
65281370|NCT00880542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281371|NCT00880542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64794210|NCT01725048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64794211|NCT01725048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794212|NCT01725048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64794213|NCT01725048|Serotonin Agents|serotonin agents|mesh-ancestor
64794220|NCT01725048|Histamine Agents|histamine agents|mesh-ancestor
64794221|NCT01725048|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64794222|NCT01725048|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64794223|NCT01725048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64794224|NCT01725048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64794225|NCT01725048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64794226|NCT01725048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64794227|NCT01725048|Adrenergic Agents|adrenergic agents|mesh-ancestor
64794228|NCT01725048|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64794229|NCT01725048|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64794230|NCT01725048|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64794231|NCT01725204|Dasatinib|dasatinib|mesh-list
64794232|NCT01725204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794233|NCT01725204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64794234|NCT01725204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794235|NCT01725204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794236|NCT01725360|Montelukast|montelukast|mesh-list
64794237|NCT01725360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64794238|NCT01725360|Respiratory System Agents|respiratory system agents|mesh-ancestor
64794239|NCT01725360|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64794240|NCT01725360|Hormone Antagonists|hormone antagonists|mesh-ancestor
64794241|NCT01725360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64794242|NCT01725360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794243|NCT01725360|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64794244|NCT01725360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64794245|NCT01725360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794246|NCT01725672|Metformin|metformin|mesh-list
64794247|NCT01725672|Glimepiride|glimepiride|mesh-list
64794248|NCT01725672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65281372|NCT00880542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281373|NCT00880542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281374|NCT00880542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65281375|NCT00880542|Alkylating Agents|alkylating agents|mesh-ancestor
65281376|NCT00960037|Vitamin D|vitamin d|mesh-list
65281377|NCT00960037|Cholecalciferol|cholecalciferol|mesh-list
65281378|NCT00960037|Vitamins|vitamins|mesh-ancestor
65281379|NCT00960037|Micronutrients|micronutrients|mesh-ancestor
65281380|NCT00960037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281381|NCT00960037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65281382|NCT00960037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65281383|NCT04161690|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65281384|NCT04161690|Ropivacaine|ropivacaine|mesh-list
65281385|NCT04161690|Anesthetics, Local|anesthetics, local|mesh-ancestor
65281386|NCT04161690|Anesthetics|anesthetics|mesh-ancestor
65281387|NCT04161690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65281388|NCT04161690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281389|NCT04161690|Sensory System Agents|sensory system agents|mesh-ancestor
65281390|NCT04161690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281391|NCT04161690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65281392|NCT04161690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65281393|NCT04161690|Analgesics|analgesics|mesh-ancestor
65281394|NCT04161690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65281395|NCT04161690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65281396|NCT05194969|Petrolatum|petrolatum|mesh-list
65281397|NCT05194969|Emollients|emollients|mesh-ancestor
64794270|NCT01726686|Anesthetics, Local|anesthetics, local|mesh-ancestor
64794272|NCT01726686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64794273|NCT01726686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794274|NCT01726686|Sensory System Agents|sensory system agents|mesh-ancestor
64794275|NCT01726686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794276|NCT01726764|Metformin|metformin|mesh-list
64794277|NCT01726764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64794278|NCT01726764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794279|NCT01726920|Naproxen|naproxen|mesh-list
64794280|NCT01726920|Naratriptan|naratriptan|mesh-list
64794281|NCT01726920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64794290|NCT01726920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64794291|NCT01726920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794292|NCT01726920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794293|NCT01726920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64794294|NCT01726920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64794295|NCT01726920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64794296|NCT01726920|Serotonin Agents|serotonin agents|mesh-ancestor
64794297|NCT01726920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64794298|NCT01727622|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64794299|NCT01727622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64794300|NCT01727622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281398|NCT05194969|Dermatologic Agents|dermatologic agents|mesh-ancestor
65281399|NCT00885534|Temozolomide|temozolomide|mesh-list
65281400|NCT00885534|Vinblastine|vinblastine|mesh-list
65281401|NCT00885534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281402|NCT00885534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65281403|NCT00885534|Alkylating Agents|alkylating agents|mesh-ancestor
65281404|NCT00885534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281405|NCT00885534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65281406|NCT00885534|Tubulin Modulators|tubulin modulators|mesh-ancestor
65281407|NCT00885534|Antimitotic Agents|antimitotic agents|mesh-ancestor
65281408|NCT00885534|Mitosis Modulators|mitosis modulators|mesh-ancestor
65281409|NCT05277038|Clonidine|clonidine|mesh-list
65281410|NCT05277038|Zopiclone|zopiclone|mesh-list
65281411|NCT05277038|Analgesics|analgesics|mesh-ancestor
65281412|NCT05277038|Sensory System Agents|sensory system agents|mesh-ancestor
65281413|NCT05277038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281414|NCT05277038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281415|NCT05277038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65281416|NCT05277038|Sympatholytics|sympatholytics|mesh-ancestor
65281417|NCT05277038|Autonomic Agents|autonomic agents|mesh-ancestor
65281418|NCT05277038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65281419|NCT05277038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65281420|NCT05277038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65281421|NCT05277038|Adrenergic Agents|adrenergic agents|mesh-ancestor
65281422|NCT05277038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65281423|NCT05277038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281424|NCT05277038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65281425|NCT05277038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65281426|NCT00960349|Cisplatin|cisplatin|mesh-list
65281427|NCT00960349|Capecitabine|capecitabine|mesh-list
65281428|NCT00960349|Cediranib|cediranib|mesh-list
65281429|NCT00960349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281430|NCT00960349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65281431|NCT00960349|Antimetabolites|antimetabolites|mesh-ancestor
65281434|NCT00960349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281439|NCT05375903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281440|NCT05375903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281441|NCT05375903|Interferon Inducers|interferon inducers|mesh-ancestor
65281442|NCT02670434|Pitavastatin|pitavastatin|mesh-list
65281443|NCT02670434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65281444|NCT02670434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65281445|NCT02670434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65281446|NCT02670434|Antimetabolites|antimetabolites|mesh-ancestor
65281447|NCT02670434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281505|NCT02788643|Sequestering Agents|sequestering agents|mesh-ancestor
65281506|NCT02788643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281507|NCT04175522|Immunoglobulins|immunoglobulins|mesh-list
65281508|NCT04175522|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65281509|NCT04175522|Antibodies|antibodies|mesh-list
65281510|NCT04175522|Immunoglobulin G|immunoglobulin g|mesh-list
65281511|NCT04175522|Immunologic Factors|immunologic factors|mesh-ancestor
65281512|NCT04175522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281513|NCT00960817|Aspirin|aspirin|mesh-list
65281514|NCT00960817|Dipyridamole|dipyridamole|mesh-list
64733842|NCT00385645|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64794301|NCT01728090|Hand Sanitizers|hand sanitizers|mesh-list
64794302|NCT01728090|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64794303|NCT01728090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64794304|NCT01728090|Disinfectants|disinfectants|mesh-ancestor
64794305|NCT01728480|Cisplatin|cisplatin|mesh-list
64794306|NCT01728480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794307|NCT01728948|Sorafenib|sorafenib|mesh-list
64794308|NCT01728948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794309|NCT01728948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64794310|NCT01728948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794376|NCT01049334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794379|NCT01048944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64794380|NCT01048944|Autonomic Agents|autonomic agents|mesh-ancestor
64794381|NCT01048944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794382|NCT01048944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794383|NCT01048944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64794384|NCT01048944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64794385|NCT01048944|Cholinergic Agents|cholinergic agents|mesh-ancestor
64472044|NCT03891953|Spartalizumab|spartalizumab|mesh-list
64472045|NCT03891953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64472046|NCT03891953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472047|NCT03891953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472048|NCT03870763|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64472049|NCT03870763|Dermatologic Agents|dermatologic agents|mesh-ancestor
64794450|NCT01042158|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64794451|NCT01042158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64794452|NCT01042158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794453|NCT01042158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794454|NCT01042158|Urological Agents|urological agents|mesh-ancestor
64794455|NCT01042158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64794456|NCT03405870|SMOFlipid|smoflipid|mesh-list
64794457|NCT03405870|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64794458|NCT03405870|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64794459|NCT03405870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64794460|NCT03409458|Avelumab|avelumab|mesh-list
64794461|NCT03409458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64794462|NCT03409458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794463|NCT03409068|Anesthetics|anesthetics|mesh-list
64794464|NCT03409068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64794465|NCT03409068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794466|NCT03408054|Nitroglycerin|nitroglycerin|mesh-list
64794467|NCT03408054|Oxytocin|oxytocin|mesh-list
64794468|NCT03408054|Oxytocics|oxytocics|mesh-ancestor
64794469|NCT03408054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64794470|NCT03408054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794471|NCT03408054|Vasodilator Agents|vasodilator agents|mesh-ancestor
64794472|NCT03407976|Pembrolizumab|pembrolizumab|mesh-list
64794473|NCT03407976|Apatinib|apatinib|mesh-list
64794474|NCT03407976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64794475|NCT03407976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794476|NCT03407976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64794477|NCT03407976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794511|NCT03403452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794512|NCT03403140|Etanercept|etanercept|mesh-list
64794513|NCT03403140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65281515|NCT00960817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65281516|NCT00960817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65281517|NCT00960817|Analgesics|analgesics|mesh-ancestor
65281518|NCT00960817|Sensory System Agents|sensory system agents|mesh-ancestor
65281519|NCT00960817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281520|NCT00960817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281521|NCT00960817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65281522|NCT00960817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65281523|NCT00960817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65281524|NCT00960817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65281525|NCT00960817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281526|NCT00960817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65281527|NCT00960817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65281528|NCT00960817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281529|NCT00960817|Antipyretics|antipyretics|mesh-ancestor
65281530|NCT00960817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65281531|NCT00960817|Vasodilator Agents|vasodilator agents|mesh-ancestor
64794514|NCT03403140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64794515|NCT03403140|Analgesics|analgesics|mesh-ancestor
64794516|NCT03403140|Sensory System Agents|sensory system agents|mesh-ancestor
64794517|NCT03403140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794518|NCT03403140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794519|NCT03403140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64794520|NCT03403140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64794521|NCT03403140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64794522|NCT03403140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64794565|NCT03402048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64794583|NCT03401346|Dopamine Agents|dopamine agents|mesh-ancestor
64794584|NCT03401346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64794585|NCT03401346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794586|NCT03401346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794587|NCT03401346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64794588|NCT03401346|Analgesics|analgesics|mesh-ancestor
64794589|NCT03401346|Sensory System Agents|sensory system agents|mesh-ancestor
64794590|NCT03401346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794591|NCT03401268|Immunoglobulins|immunoglobulins|mesh-list
64794592|NCT03401268|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64794593|NCT03401268|Antibodies|antibodies|mesh-list
64794594|NCT03401268|Immunologic Factors|immunologic factors|mesh-ancestor
64794595|NCT03401268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794596|NCT03400722|Clomiphene|clomiphene|mesh-list
64794597|NCT03400722|Hormones|hormones|mesh-list
64794598|NCT03400722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64794599|NCT03400722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794600|NCT03400722|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64794601|NCT03400722|Hormone Antagonists|hormone antagonists|mesh-ancestor
64794602|NCT03400722|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64794603|NCT03400722|Fertility Agents|fertility agents|mesh-ancestor
64794604|NCT03400722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64794605|NCT03400722|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64794606|NCT03400722|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64794607|NCT03400254|Hydroxychloroquine|hydroxychloroquine|mesh-list
64794608|NCT03400254|Gedatolisib|gedatolisib|mesh-list
64794609|NCT03400254|Antimalarials|antimalarials|mesh-ancestor
64794610|NCT03400254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64794611|NCT03400254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64794612|NCT03400254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65281532|NCT00965809|Dronabinol|dronabinol|mesh-list
65281533|NCT00965809|Hallucinogens|hallucinogens|mesh-ancestor
65281534|NCT00965809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281535|NCT00965809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65281536|NCT00965809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65281537|NCT00965809|Analgesics|analgesics|mesh-ancestor
65281538|NCT00965809|Sensory System Agents|sensory system agents|mesh-ancestor
65281539|NCT00965809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281540|NCT00965809|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65281541|NCT00965809|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65281542|NCT00965809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65281543|NCT00965809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281544|NCT00965809|Hormones|hormones|mesh-ancestor
65281545|NCT00965809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65281546|NCT00885378|Metformin|metformin|mesh-list
65281547|NCT00885378|Saxagliptin|saxagliptin|mesh-list
65281548|NCT00885378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65281549|NCT00885378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281550|NCT00885378|Incretins|incretins|mesh-ancestor
65281551|NCT00885378|Hormones|hormones|mesh-ancestor
64733870|NCT00005773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794613|NCT03400254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794614|NCT03400254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794615|NCT03400254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64794622|NCT03400020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794624|NCT00012012|Amifostine|amifostine|mesh-list
64794625|NCT00012012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64794626|NCT00012012|Protective Agents|protective agents|mesh-ancestor
64794627|NCT00012012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794628|NCT02240160|Nabiximols|nabiximols|mesh-list
64794629|NCT02240160|Analgesics|analgesics|mesh-ancestor
64794654|NCT02241096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64794655|NCT02241096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794656|NCT02241174|Sodium Hypochlorite|sodium hypochlorite|mesh-list
64563225|NCT03954899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64794658|NCT02241174|Disinfectants|disinfectants|mesh-ancestor
64794659|NCT02241174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64794660|NCT02241564|Sirolimus|sirolimus|mesh-list
64794661|NCT02241564|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
64794662|NCT02241564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794663|NCT02241564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794664|NCT02241564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64794665|NCT02241564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64794666|NCT02241564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64794667|NCT02241564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794668|NCT02241564|Antifungal Agents|antifungal agents|mesh-ancestor
64794669|NCT02241564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64794670|NCT02241564|Immunologic Factors|immunologic factors|mesh-ancestor
64794671|NCT02241564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794672|NCT02241876|Acetylcysteine|acetylcysteine|mesh-list
64794673|NCT02241876|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64794674|NCT02241876|Antiviral Agents|antiviral agents|mesh-ancestor
64794675|NCT02241876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64794676|NCT02241876|Expectorants|expectorants|mesh-ancestor
65281552|NCT00885378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65281553|NCT00885378|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65281554|NCT00885378|Protease Inhibitors|protease inhibitors|mesh-ancestor
65281555|NCT00885378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281556|NCT00885378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281557|NCT04095494|Nitrous Oxide|nitrous oxide|mesh-list
65281558|NCT04095494|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65281559|NCT04095494|Anesthetics, General|anesthetics, general|mesh-ancestor
65281560|NCT04095494|Anesthetics|anesthetics|mesh-ancestor
64733888|NCT00005779|Growth Substances|growth substances|mesh-ancestor
64794677|NCT02241876|Respiratory System Agents|respiratory system agents|mesh-ancestor
64794678|NCT02241876|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64794719|NCT02242812|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64794720|NCT02242812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794721|NCT02242812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64794722|NCT02242812|Sympatholytics|sympatholytics|mesh-ancestor
64794723|NCT02242812|Autonomic Agents|autonomic agents|mesh-ancestor
64794724|NCT02242812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794741|NCT02243124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64794742|NCT02243124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794743|NCT02243436|Cytarabine|cytarabine|mesh-list
64794744|NCT02243436|Methylprednisolone|methylprednisolone|mesh-list
64794745|NCT02243436|Etoposide|etoposide|mesh-list
64794746|NCT02243436|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64794747|NCT02243436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794748|NCT02243436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64794749|NCT02243436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64794750|NCT02243436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64794751|NCT02243436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794752|NCT02243436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405834|NCT04870541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64307356|NCT01369433|Capecitabine|capecitabine|mesh-list
64794764|NCT02243436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64794765|NCT02243436|Glucocorticoids|glucocorticoids|mesh-ancestor
64794766|NCT02243436|Hormones|hormones|mesh-ancestor
64794767|NCT02243436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64794768|NCT02243436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64794769|NCT02243436|Protective Agents|protective agents|mesh-ancestor
64794770|NCT02243436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64794771|NCT02243826|Nitrous Oxide|nitrous oxide|mesh-list
64794772|NCT02243826|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64794773|NCT02243826|Anesthetics, General|anesthetics, general|mesh-ancestor
64794774|NCT02243826|Anesthetics|anesthetics|mesh-ancestor
64794775|NCT02243826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64794776|NCT02243826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794777|NCT02243826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64794778|NCT02243826|Analgesics|analgesics|mesh-ancestor
64794779|NCT02243826|Sensory System Agents|sensory system agents|mesh-ancestor
64794780|NCT02243826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794781|NCT02244216|Fenoterol|fenoterol|mesh-list
64794782|NCT02244216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64794783|NCT02244216|Autonomic Agents|autonomic agents|mesh-ancestor
64794784|NCT02244216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794785|NCT02244216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794786|NCT02244216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64794787|NCT02244216|Respiratory System Agents|respiratory system agents|mesh-ancestor
64794788|NCT02244216|Sympathomimetics|sympathomimetics|mesh-ancestor
64794789|NCT02244216|Tocolytic Agents|tocolytic agents|mesh-ancestor
64794790|NCT02244216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64794791|NCT02244216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64794792|NCT02244216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64794793|NCT02244216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64794825|NCT02246244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281561|NCT04095494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65281562|NCT04095494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281563|NCT04095494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65281564|NCT04095494|Analgesics|analgesics|mesh-ancestor
65281565|NCT04095494|Sensory System Agents|sensory system agents|mesh-ancestor
65281566|NCT04095494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281567|NCT02537210|Mesalamine|mesalamine|mesh-list
65281568|NCT02537210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65281569|NCT02537210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65281570|NCT02537210|Analgesics|analgesics|mesh-ancestor
65281571|NCT02537210|Sensory System Agents|sensory system agents|mesh-ancestor
65281572|NCT02537210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281573|NCT02537210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281574|NCT02537210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65281575|NCT02537210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65281577|NCT01563289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65281578|NCT01563289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65281579|NCT01563289|Analgesics|analgesics|mesh-ancestor
65281580|NCT01563289|Sensory System Agents|sensory system agents|mesh-ancestor
65281581|NCT01563289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281582|NCT01563289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281583|NCT01563289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65281584|NCT01563289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65281585|NCT01563289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65281586|NCT01563289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281587|NCT01563289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794826|NCT02246244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64794827|NCT02246244|Antidepressive Agents|antidepressive agents|mesh-ancestor
64794828|NCT02246244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64794829|NCT02246712|Tramadol|tramadol|mesh-list
64794830|NCT02246712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64794831|NCT02246712|Narcotics|narcotics|mesh-ancestor
64794832|NCT02246712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64794833|NCT02246712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794834|NCT02246712|Analgesics|analgesics|mesh-ancestor
64794835|NCT02246712|Sensory System Agents|sensory system agents|mesh-ancestor
64794836|NCT02246712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794837|NCT02246868|Factor VIII|factor viii|mesh-list
64794838|NCT02246868|Coagulants|coagulants|mesh-ancestor
64794839|NCT02247258|Azathioprine|azathioprine|mesh-list
64794840|NCT02247258|Antimetabolites|antimetabolites|mesh-ancestor
64794841|NCT02247258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794842|NCT02247258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64794843|NCT02247258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794844|NCT02247258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64794845|NCT02247258|Immunologic Factors|immunologic factors|mesh-ancestor
65281588|NCT00960973|Menatetrenone|menatetrenone|mesh-list
65281589|NCT00960973|Hemostatics|hemostatics|mesh-ancestor
65281590|NCT00960973|Coagulants|coagulants|mesh-ancestor
65281591|NCT04099849|Zinc|zinc|mesh-list
65281592|NCT04099849|Trace Elements|trace elements|mesh-ancestor
65281593|NCT04099849|Micronutrients|micronutrients|mesh-ancestor
65281594|NCT04099849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281595|NCT00659100|Gabapentin|gabapentin|mesh-list
65281596|NCT00659100|Analgesics|analgesics|mesh-ancestor
65281597|NCT00659100|Sensory System Agents|sensory system agents|mesh-ancestor
65281598|NCT00659100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281599|NCT00659100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281600|NCT00659100|Anticonvulsants|anticonvulsants|mesh-ancestor
65281601|NCT00659100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65281602|NCT00659100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65281603|NCT00659100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65281604|NCT00659100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65281605|NCT00659100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65281606|NCT00659100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65281607|NCT00659100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65281608|NCT00659100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281609|NCT00659100|Antimanic Agents|antimanic agents|mesh-ancestor
65281610|NCT00659178|Doxorubicin|doxorubicin|mesh-list
64794846|NCT02247258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794878|NCT02247648|Analgesics|analgesics|mesh-ancestor
64794879|NCT02247648|Sensory System Agents|sensory system agents|mesh-ancestor
64794880|NCT02247648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794881|NCT02248428|Clarithromycin|clarithromycin|mesh-list
64794882|NCT02248428|Thalidomide|thalidomide|mesh-list
64794883|NCT02248428|Dexamethasone|dexamethasone|mesh-list
64794884|NCT02248428|Cyclophosphamide|cyclophosphamide|mesh-list
64794892|NCT02248428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794893|NCT02248428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64794894|NCT02248428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64794895|NCT02248428|Antiemetics|antiemetics|mesh-ancestor
64794896|NCT02248428|Autonomic Agents|autonomic agents|mesh-ancestor
64794897|NCT02248428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794898|NCT02248428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64794899|NCT02248428|Glucocorticoids|glucocorticoids|mesh-ancestor
64794901|NCT02248428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64794927|NCT02248506|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64794928|NCT02248506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64794929|NCT02248896|Telmisartan|telmisartan|mesh-list
64794930|NCT02248896|Antihypertensive Agents|antihypertensive agents|mesh-list
64794931|NCT02248896|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64794932|NCT02248896|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64794933|NCT02248896|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64794934|NCT02248896|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64794935|NCT02248896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794936|NCT02248896|Protease Inhibitors|protease inhibitors|mesh-ancestor
64794937|NCT02249130|Ritonavir|ritonavir|mesh-list
64794938|NCT02249130|Lamivudine|lamivudine|mesh-list
64794939|NCT02249130|Zidovudine|zidovudine|mesh-list
64794940|NCT02249130|Stavudine|stavudine|mesh-list
64794941|NCT02249130|Tipranavir|tipranavir|mesh-list
65281611|NCT00659178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65281612|NCT00659178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65281613|NCT00659178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281614|NCT00659178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65281615|NCT00659178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65281616|NCT00659178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281617|NCT00659178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281618|NCT02792621|Acipimox|acipimox|mesh-list
64733942|NCT02151786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64794942|NCT02249130|Delavirdine|delavirdine|mesh-list
64794943|NCT02249130|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64794944|NCT02249130|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64794945|NCT02249130|Protease Inhibitors|protease inhibitors|mesh-ancestor
64794946|NCT02249130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794987|NCT02242734|Hydrocodone|hydrocodone|mesh-list
64794988|NCT02242734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64794989|NCT02242734|Narcotics|narcotics|mesh-ancestor
64794990|NCT02242734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64795027|NCT02245308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64795028|NCT02245308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64795029|NCT02245308|Dopamine Agents|dopamine agents|mesh-ancestor
64795030|NCT02245308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64795031|NCT02245308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64795032|NCT02245308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795033|NCT02243358|Gemcitabine|gemcitabine|mesh-list
64795034|NCT02243358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64795035|NCT02243358|Antimetabolites|antimetabolites|mesh-ancestor
64795036|NCT02243358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795037|NCT02243358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64795038|NCT02243358|Antiviral Agents|antiviral agents|mesh-ancestor
64795039|NCT02243358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64795040|NCT02243358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795062|NCT00559104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64795063|NCT00559104|Alkylating Agents|alkylating agents|mesh-ancestor
64795064|NCT00559104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795065|NCT00559104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64795066|NCT00559104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64795067|NCT00559104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64795068|NCT00559104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64795069|NCT00559104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64795070|NCT00559104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795071|NCT00559104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64795072|NCT00558636|Paclitaxel|paclitaxel|mesh-list
64795073|NCT00558636|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64795074|NCT00558636|Carboplatin|carboplatin|mesh-list
64795075|NCT00558636|Sorafenib|sorafenib|mesh-list
64795076|NCT00558636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64795077|NCT00558636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64795078|NCT00558636|Tubulin Modulators|tubulin modulators|mesh-ancestor
64795079|NCT00558636|Antimitotic Agents|antimitotic agents|mesh-ancestor
64795080|NCT00558636|Mitosis Modulators|mitosis modulators|mesh-ancestor
64795081|NCT00558636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406178|NCT04341155|Hormones|hormones|mesh-ancestor
64795090|NCT00557622|Paroxetine|paroxetine|mesh-list
64795091|NCT00557622|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64795092|NCT00557622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64472052|NCT03870763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795093|NCT00557622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64795094|NCT00557622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795095|NCT00557622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64795096|NCT00557622|Serotonin Agents|serotonin agents|mesh-ancestor
64795097|NCT00557622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795098|NCT00557622|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64795099|NCT00557622|Antidepressive Agents|antidepressive agents|mesh-ancestor
65281619|NCT02792621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65281620|NCT02792621|Antimetabolites|antimetabolites|mesh-ancestor
65281621|NCT02792621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281622|NCT02792621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65281623|NCT04009759|Ketamine|ketamine|mesh-list
65281624|NCT04009759|Morphine|morphine|mesh-list
65281625|NCT04009759|Analgesics|analgesics|mesh-ancestor
65281626|NCT04009759|Sensory System Agents|sensory system agents|mesh-ancestor
65281627|NCT04009759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281628|NCT04009759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281629|NCT04009759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65281630|NCT04009759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65281631|NCT04009759|Anesthetics, General|anesthetics, general|mesh-ancestor
65281632|NCT04009759|Anesthetics|anesthetics|mesh-ancestor
65281633|NCT04009759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65281634|NCT04009759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64795100|NCT00557622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64795159|NCT00552240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64795160|NCT00552240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64795162|NCT00550836|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64795163|NCT00550836|Panitumumab|panitumumab|mesh-list
64795164|NCT00550836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64795165|NCT00550836|Antimetabolites|antimetabolites|mesh-ancestor
64795166|NCT00550836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795167|NCT00550836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64795168|NCT00550836|Antiviral Agents|antiviral agents|mesh-ancestor
64472054|NCT03869034|Fluorouracil|fluorouracil|mesh-list
64795169|NCT00550836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64795170|NCT00550836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795171|NCT00550836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64795172|NCT00550836|Immunologic Factors|immunologic factors|mesh-ancestor
64795173|NCT00550836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795174|NCT00550836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64795175|NCT00550836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64795177|NCT00550680|Hematinics|hematinics|mesh-ancestor
64795178|NCT00556920|Carvedilol|carvedilol|mesh-list
64795179|NCT00556920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64795180|NCT00556920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64795181|NCT00556920|Adrenergic Agents|adrenergic agents|mesh-ancestor
64795182|NCT00556920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64795183|NCT00556920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795184|NCT00556920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795185|NCT00556920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64795186|NCT00556920|Antioxidants|antioxidants|mesh-ancestor
64795187|NCT00556920|Protective Agents|protective agents|mesh-ancestor
64795188|NCT00556920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64795189|NCT00556920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64795190|NCT00556920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64795191|NCT00556920|Vasodilator Agents|vasodilator agents|mesh-ancestor
64795192|NCT00556920|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64795193|NCT00556920|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64795194|NCT00552708|Lisinopril|lisinopril|mesh-list
64795195|NCT00552708|Carvedilol|carvedilol|mesh-list
64795196|NCT00552708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64795224|NCT00556374|Hormone Antagonists|hormone antagonists|mesh-ancestor
64795225|NCT00556374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64795227|NCT03028350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64795228|NCT03029676|Fentanyl|fentanyl|mesh-list
65281635|NCT04009759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65281636|NCT04009759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65281637|NCT04009759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281638|NCT04009759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65281639|NCT04009759|Narcotics|narcotics|mesh-ancestor
65281640|NCT00645086|Clarithromycin|clarithromycin|mesh-list
65281703|NCT02791919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65281704|NCT02791919|Immunologic Factors|immunologic factors|mesh-ancestor
65281705|NCT02791919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281706|NCT02791919|Antiviral Agents|antiviral agents|mesh-ancestor
65281707|NCT02791919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65281708|NCT02791919|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65281709|NCT02791919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281710|NCT00966121|Propranolol|propranolol|mesh-list
65281711|NCT00966121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65281712|NCT00966121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65281713|NCT00966121|Adrenergic Agents|adrenergic agents|mesh-ancestor
65281714|NCT00966121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65281715|NCT00966121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281716|NCT00966121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281717|NCT00966121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65281718|NCT00966121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65281719|NCT00966121|Vasodilator Agents|vasodilator agents|mesh-ancestor
65281720|NCT02537288|Moxifloxacin|moxifloxacin|mesh-list
65281721|NCT02537288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65281722|NCT02537288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65281723|NCT02537288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65281724|NCT02537288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65281725|NCT02537288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281726|NCT02537288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281727|NCT02537288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281729|NCT00659412|Alefacept|alefacept|mesh-list
65281730|NCT00659412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65281731|NCT00659412|Abortifacient Agents|abortifacient agents|mesh-ancestor
65281732|NCT00659412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65281733|NCT00659412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281734|NCT00659412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65281735|NCT00659412|Antimetabolites|antimetabolites|mesh-ancestor
64734056|NCT02124564|Lacosamide|lacosamide|mesh-list
64795229|NCT03029676|Midazolam|midazolam|mesh-list
64795230|NCT03029676|Anesthetics|anesthetics|mesh-ancestor
64795231|NCT03029676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64795232|NCT03029676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795233|NCT03029676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64795234|NCT03029676|Narcotics|narcotics|mesh-ancestor
64795235|NCT03029676|Analgesics|analgesics|mesh-ancestor
64795236|NCT03029676|Sensory System Agents|sensory system agents|mesh-ancestor
65281736|NCT00659412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281737|NCT00659412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281738|NCT00659412|Dermatologic Agents|dermatologic agents|mesh-ancestor
65281739|NCT00659412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281740|NCT00659412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65281741|NCT00659412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65281742|NCT00659412|Immunologic Factors|immunologic factors|mesh-ancestor
65281743|NCT00659412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65281744|NCT00659412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65281745|NCT04176224|Edaravone|edaravone|mesh-list
65281746|NCT04176224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65281747|NCT04176224|Antioxidants|antioxidants|mesh-ancestor
65281748|NCT04176224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281749|NCT04176224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65281750|NCT04176224|Protective Agents|protective agents|mesh-ancestor
65281751|NCT04176224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281752|NCT00966199|Antihypertensive Agents|antihypertensive agents|mesh-list
64795237|NCT03029676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64795238|NCT03029676|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64795239|NCT03029676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64795240|NCT03029676|Anesthetics, General|anesthetics, general|mesh-ancestor
64795241|NCT03029676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64795242|NCT03029676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64795243|NCT03029676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64795244|NCT03029676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64795245|NCT03029676|GABA Modulators|gaba modulators|mesh-ancestor
64795246|NCT03029676|GABA Agents|gaba agents|mesh-ancestor
64795247|NCT03029676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64472055|NCT03869034|Oxaliplatin|oxaliplatin|mesh-list
64472056|NCT03869034|Antimetabolites|antimetabolites|mesh-ancestor
64795248|NCT03029676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795249|NCT04270344|Valsartan|valsartan|mesh-list
64795250|NCT04270344|Pitavastatin|pitavastatin|mesh-list
64795251|NCT04270344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64795266|NCT04271202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64795267|NCT04271202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795268|NCT04279392|Zoledronic Acid|zoledronic acid|mesh-list
64795269|NCT04279392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64795270|NCT04279392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795271|NCT04278846|Bupivacaine|bupivacaine|mesh-list
64795272|NCT04278846|Anesthetics, Local|anesthetics, local|mesh-ancestor
64795273|NCT04278846|Anesthetics|anesthetics|mesh-ancestor
64795274|NCT04278846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64795275|NCT04278846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795276|NCT04278846|Sensory System Agents|sensory system agents|mesh-ancestor
64795277|NCT04278846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64795278|NCT03839550|Apatinib|apatinib|mesh-list
64795279|NCT03839550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64795280|NCT03839550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64795281|NCT03839550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795282|NCT03839550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795283|NCT03839160|Morphine|morphine|mesh-list
64795284|NCT03839160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64795285|NCT03839160|Narcotics|narcotics|mesh-ancestor
64795301|NCT03834012|Hormones|hormones|mesh-ancestor
64795302|NCT03834012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64795303|NCT03834012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281753|NCT04158102|Bupivacaine|bupivacaine|mesh-list
65281754|NCT04158102|Anesthetics, Local|anesthetics, local|mesh-ancestor
65281755|NCT04158102|Anesthetics|anesthetics|mesh-ancestor
65281756|NCT04158102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65281757|NCT04158102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281758|NCT04158102|Sensory System Agents|sensory system agents|mesh-ancestor
65281759|NCT04158102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281760|NCT02689895|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65281761|NCT02689895|Antiviral Agents|antiviral agents|mesh-ancestor
65281762|NCT02689895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65281763|NCT00961363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65281764|NCT00961363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65281765|NCT00961363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281766|NCT00961363|Incretins|incretins|mesh-ancestor
65281767|NCT00961363|Hormones|hormones|mesh-ancestor
65281768|NCT00961363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65281769|NCT00961363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65281770|NCT00961363|Protease Inhibitors|protease inhibitors|mesh-ancestor
65281771|NCT00961363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734089|NCT02100228|Apixaban|apixaban|mesh-list
64795304|NCT03834012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64795305|NCT03834012|Respiratory System Agents|respiratory system agents|mesh-ancestor
64795306|NCT03833466|Metformin|metformin|mesh-list
64795307|NCT03833466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64795308|NCT03833466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795309|NCT03833388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64795310|NCT03833388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64795311|NCT03830034|Iron|iron|mesh-list
64795312|NCT03830034|Ferrous fumarate|ferrous fumarate|mesh-list
64795313|NCT03830034|Iron Chelating Agents|iron chelating agents|mesh-list
64795314|NCT03830034|Trace Elements|trace elements|mesh-ancestor
64795315|NCT03830034|Micronutrients|micronutrients|mesh-ancestor
64795316|NCT03830034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795317|NCT03830034|Chelating Agents|chelating agents|mesh-ancestor
64795318|NCT03830034|Sequestering Agents|sequestering agents|mesh-ancestor
64795319|NCT03830034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795320|NCT03838068|Anesthetics|anesthetics|mesh-list
64795321|NCT03838068|Procaine|procaine|mesh-list
64795322|NCT03838068|Anesthetics, Local|anesthetics, local|mesh-list
64795323|NCT03838068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795324|NCT03838068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64795361|NCT05444556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64795362|NCT05444556|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64795363|NCT05444556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64795364|NCT05444556|Adrenergic Agents|adrenergic agents|mesh-ancestor
64795365|NCT05444556|Antimalarials|antimalarials|mesh-ancestor
64795366|NCT05444556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64795367|NCT05444556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64795368|NCT05444556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64795369|NCT05444556|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64795370|NCT05444556|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64795371|NCT05444556|Cholinergic Agents|cholinergic agents|mesh-ancestor
64795372|NCT05444556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64795373|NCT05444556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64795374|NCT05444556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64795375|NCT05444556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65281772|NCT00961363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281773|NCT02633202|Cisplatin|cisplatin|mesh-list
65281774|NCT02633202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281775|NCT00645242|Fluconazole|fluconazole|mesh-list
65281776|NCT00645242|Antifungal Agents|antifungal agents|mesh-ancestor
65281777|NCT00645242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65281778|NCT00645242|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65281779|NCT00645242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65281780|NCT00645242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281781|NCT00645242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281782|NCT00645242|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65281783|NCT00645242|Hormone Antagonists|hormone antagonists|mesh-ancestor
65281784|NCT00645242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65281785|NCT00645242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281786|NCT00645242|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65281787|NCT00645242|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65281788|NCT00659568|Metformin|metformin|mesh-list
65281789|NCT00659568|Sirolimus|sirolimus|mesh-list
65281790|NCT00659568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65281791|NCT00659568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734110|NCT02099682|Dexlansoprazole|dexlansoprazole|mesh-list
64795376|NCT05444556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64795377|NCT05445804|Cannabidiol|cannabidiol|mesh-list
64795378|NCT05445804|Anticonvulsants|anticonvulsants|mesh-ancestor
64795379|NCT05440578|Bevacizumab|bevacizumab|mesh-list
64795380|NCT05440578|Olaparib|olaparib|mesh-list
64795381|NCT05440578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64795382|NCT05440578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64795416|NCT05768542|Autonomic Agents|autonomic agents|mesh-ancestor
64795417|NCT05768542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64795418|NCT05768542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795419|NCT05768542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64795420|NCT05768542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64514729|NCT02393157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64795421|NCT05768542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64795422|NCT05768542|Adrenergic Agents|adrenergic agents|mesh-ancestor
64795423|NCT05768542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64795424|NCT05768542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795426|NCT05768464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64795427|NCT05768464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64795459|NCT05768204|Prednisolone phosphate|prednisolone phosphate|mesh-list
64795460|NCT05768204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64795462|NCT05768204|Hormones|hormones|mesh-ancestor
64795463|NCT05768204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64795464|NCT05768204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795465|NCT05768204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64795466|NCT05768204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64795467|NCT05768204|Antiemetics|antiemetics|mesh-ancestor
64795468|NCT05768204|Autonomic Agents|autonomic agents|mesh-ancestor
64795469|NCT05768204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281792|NCT00659568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65281793|NCT00659568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65281794|NCT00659568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65281795|NCT00659568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281796|NCT00659568|Antifungal Agents|antifungal agents|mesh-ancestor
65281797|NCT00659568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65281798|NCT00659568|Immunologic Factors|immunologic factors|mesh-ancestor
65281799|NCT00961753|Ibuprofen|ibuprofen|mesh-list
64795491|NCT05767944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795493|NCT05767827|Epinephrine|epinephrine|mesh-list
64795494|NCT05767827|Racepinephrine|racepinephrine|mesh-list
64795495|NCT05767827|Dexmedetomidine|dexmedetomidine|mesh-list
64795496|NCT05767827|Ropivacaine|ropivacaine|mesh-list
64795497|NCT05767827|Epinephryl borate|epinephryl borate|mesh-list
64795498|NCT05767827|Anesthetics, Local|anesthetics, local|mesh-ancestor
64795499|NCT05767827|Anesthetics|anesthetics|mesh-ancestor
64795500|NCT05767827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64795501|NCT05767827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795502|NCT05767827|Sensory System Agents|sensory system agents|mesh-ancestor
64795503|NCT05767827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64795504|NCT05767827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64795505|NCT05767827|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64795506|NCT05767827|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64795507|NCT05767827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64795508|NCT05767827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795509|NCT05767827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64795510|NCT05767827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64795511|NCT05767827|Analgesics|analgesics|mesh-ancestor
64795512|NCT05767827|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64795513|NCT05767827|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64795514|NCT05767827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64795515|NCT05767827|Adrenergic Agents|adrenergic agents|mesh-ancestor
64795516|NCT05767827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64795517|NCT05767827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64795518|NCT05767827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64795519|NCT05767827|Autonomic Agents|autonomic agents|mesh-ancestor
64795520|NCT05767827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64795521|NCT05767827|Respiratory System Agents|respiratory system agents|mesh-ancestor
64795522|NCT05767827|Mydriatics|mydriatics|mesh-ancestor
64795523|NCT05767827|Sympathomimetics|sympathomimetics|mesh-ancestor
64795524|NCT05767827|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64795525|NCT05767749|Lidocaine|lidocaine|mesh-list
64795526|NCT05767749|Epinephrine|epinephrine|mesh-list
64795527|NCT05767749|Racepinephrine|racepinephrine|mesh-list
64795528|NCT05767749|Bupivacaine|bupivacaine|mesh-list
64795529|NCT05767749|Ropivacaine|ropivacaine|mesh-list
64795530|NCT05767749|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64795531|NCT05767749|Epinephryl borate|epinephryl borate|mesh-list
64795532|NCT05767749|Anesthetics, Local|anesthetics, local|mesh-ancestor
64795533|NCT05767749|Anesthetics|anesthetics|mesh-ancestor
64795607|NCT05767632|Adrenergic Agents|adrenergic agents|mesh-ancestor
64795608|NCT05767515|Inositol|inositol|mesh-list
64795609|NCT05767515|Acetylcarnitine|acetylcarnitine|mesh-list
64795610|NCT05767515|Metformin|metformin|mesh-list
64795611|NCT05767515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64795612|NCT05767515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795613|NCT05767515|Vitamin B Complex|vitamin b complex|mesh-ancestor
64795614|NCT05767515|Vitamins|vitamins|mesh-ancestor
64795615|NCT05767515|Micronutrients|micronutrients|mesh-ancestor
64795616|NCT05767515|Nootropic Agents|nootropic agents|mesh-ancestor
64795657|NCT05767060|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64795689|NCT05751343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64795690|NCT05751343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64795710|NCT05678348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64795711|NCT05678348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64795712|NCT05678348|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64795713|NCT05678348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795714|NCT05678348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795716|NCT05654818|Vitamins|vitamins|mesh-ancestor
64795717|NCT05654818|Micronutrients|micronutrients|mesh-ancestor
64795718|NCT05654818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281800|NCT00961753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65281801|NCT00961753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65281802|NCT00961753|Analgesics|analgesics|mesh-ancestor
65281803|NCT00961753|Sensory System Agents|sensory system agents|mesh-ancestor
65281804|NCT00961753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281805|NCT00961753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281806|NCT00961753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65281807|NCT00961753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65281808|NCT00961753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65281809|NCT00961753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281810|NCT00961753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281811|NCT04232813|Estradiol|estradiol|mesh-list
65281812|NCT04232813|Estrogens|estrogens|mesh-ancestor
65281813|NCT04232813|Hormones|hormones|mesh-ancestor
65281814|NCT04232813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65281815|NCT04232813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281816|NCT00659958|Zonisamide|zonisamide|mesh-list
65281817|NCT00659958|Anticonvulsants|anticonvulsants|mesh-ancestor
65281818|NCT00659958|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65281819|NCT00659958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65281820|NCT00659958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281821|NCT00659958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65281822|NCT00659958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281823|NCT00644774|Azithromycin|azithromycin|mesh-list
65281824|NCT00644774|Cefdinir|cefdinir|mesh-list
65281825|NCT00644774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65281826|NCT00644774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65281827|NCT00545779|Ibandronic Acid|ibandronic acid|mesh-list
65281828|NCT00545779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65281829|NCT00545779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281830|NCT00910442|Acetylcysteine|acetylcysteine|mesh-list
65281831|NCT00910442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65281832|NCT00910442|Antiviral Agents|antiviral agents|mesh-ancestor
65281833|NCT00910442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65281834|NCT00910442|Expectorants|expectorants|mesh-ancestor
65281835|NCT00910442|Respiratory System Agents|respiratory system agents|mesh-ancestor
65281837|NCT00910442|Antioxidants|antioxidants|mesh-ancestor
65281838|NCT00910442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281839|NCT00910442|Protective Agents|protective agents|mesh-ancestor
65281840|NCT00910442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281841|NCT00910442|Antidotes|antidotes|mesh-ancestor
65281842|NCT00660036|Etoposide|etoposide|mesh-list
65281843|NCT00660036|Mitoxantrone|mitoxantrone|mesh-list
65281844|NCT00660036|Gemtuzumab|gemtuzumab|mesh-list
65281845|NCT00660036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65281846|NCT00660036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281847|NCT00660036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65281848|NCT00660036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65281849|NCT00660036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281850|NCT00660036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281851|NCT00660036|Analgesics|analgesics|mesh-ancestor
65281852|NCT00660036|Sensory System Agents|sensory system agents|mesh-ancestor
64734176|NCT02096952|Methylphenidate|methylphenidate|mesh-list
64795719|NCT05654818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64795720|NCT05653050|Insulin|insulin|mesh-list
64795721|NCT05653050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64795722|NCT05653050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795761|NCT05621616|Adrenergic Agents|adrenergic agents|mesh-ancestor
64795762|NCT05621616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64795763|NCT05621616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795764|NCT05621616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795765|NCT05621616|Urological Agents|urological agents|mesh-ancestor
64795766|NCT05612074|Nitric Oxide|nitric oxide|mesh-list
64795767|NCT05612074|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64795768|NCT05612074|Autonomic Agents|autonomic agents|mesh-ancestor
64795769|NCT05612074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64795770|NCT05612074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795771|NCT05612074|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64795772|NCT05612074|Respiratory System Agents|respiratory system agents|mesh-ancestor
64795773|NCT05612074|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64795795|NCT05604599|Sensory System Agents|sensory system agents|mesh-ancestor
64795796|NCT05604599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64795797|NCT05604599|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64795798|NCT05604599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64795800|NCT05604599|Adrenergic Agents|adrenergic agents|mesh-ancestor
64795801|NCT05604599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64795802|NCT05604599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795803|NCT05604599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64795804|NCT05604599|Narcotics|narcotics|mesh-ancestor
64795805|NCT05604599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64795806|NCT05604599|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64795807|NCT05604599|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64795808|NCT05604599|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64795809|NCT05604599|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64795810|NCT05604599|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64795811|NCT05604599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64795812|NCT05604599|Cholinergic Agents|cholinergic agents|mesh-ancestor
64795813|NCT05602636|Midazolam|midazolam|mesh-list
64795814|NCT05602636|Bupivacaine|bupivacaine|mesh-list
64795827|NCT05602636|Anesthetics, General|anesthetics, general|mesh-ancestor
64795828|NCT05602636|GABA Modulators|gaba modulators|mesh-ancestor
64795829|NCT05602636|GABA Agents|gaba agents|mesh-ancestor
64795830|NCT05602636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64795831|NCT05602636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281853|NCT00660036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281854|NCT00660036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281855|NCT00660036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65281856|NCT02791373|Gemcitabine|gemcitabine|mesh-list
65281857|NCT02791373|Vinorelbine|vinorelbine|mesh-list
64734192|NCT02120664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64795832|NCT05602519|Fentanyl|fentanyl|mesh-list
64795833|NCT05602519|Propofol|propofol|mesh-list
64795834|NCT05602519|Rocuronium|rocuronium|mesh-list
64795835|NCT05602519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64795836|NCT05602519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64795837|NCT05602519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795838|NCT05602519|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64795839|NCT05602519|Anesthetics, General|anesthetics, general|mesh-ancestor
64795840|NCT05602519|Anesthetics|anesthetics|mesh-ancestor
64795841|NCT05602519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64795842|NCT05602519|Narcotics|narcotics|mesh-ancestor
64795871|NCT05543837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64795872|NCT05543837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795873|NCT05486026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64795874|NCT05486026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64795875|NCT05486026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64795876|NCT05486026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64406984|NCT05564403|Levoleucovorin|levoleucovorin|mesh-list
64795884|NCT05486026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64795885|NCT05486026|Antidepressive Agents|antidepressive agents|mesh-ancestor
64795886|NCT05486026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64795887|NCT05486026|Dopamine Agents|dopamine agents|mesh-ancestor
64795888|NCT05486026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64795889|NCT05486026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64795890|NCT05483465|Niacinamide|niacinamide|mesh-list
64795891|NCT05483465|Niacin|niacin|mesh-list
64795892|NCT05483465|Nicotinic Acids|nicotinic acids|mesh-list
64795893|NCT05483465|Vitamin B Complex|vitamin b complex|mesh-ancestor
64795894|NCT05483465|Vitamins|vitamins|mesh-ancestor
64795895|NCT05483465|Micronutrients|micronutrients|mesh-ancestor
64795906|NCT05468099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64795908|NCT05468099|Plasma Substitutes|plasma substitutes|mesh-ancestor
64795909|NCT05468099|Blood Substitutes|blood substitutes|mesh-ancestor
64795910|NCT05451940|Hydroxyurea|hydroxyurea|mesh-list
64795911|NCT05451940|Epoetin Alfa|epoetin alfa|mesh-list
64795912|NCT05451940|Hematinics|hematinics|mesh-list
64795913|NCT05451940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64795914|NCT05451940|Antisickling Agents|antisickling agents|mesh-ancestor
64795915|NCT05451940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795916|NCT05451940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795917|NCT05451940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64795918|NCT05419427|Denosumab|denosumab|mesh-list
64795919|NCT05419427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64795920|NCT05419427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795921|NCT05411107|Iloprost|iloprost|mesh-list
64795922|NCT05411107|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64795923|NCT05411107|Vasodilator Agents|vasodilator agents|mesh-ancestor
64795924|NCT05379686|Glucagon|glucagon|mesh-list
64564507|NCT00631007|Pioglitazone|pioglitazone|mesh-list
64795925|NCT05379686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64795926|NCT05379686|Hormones|hormones|mesh-ancestor
64401050|NCT03067883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64795927|NCT05379686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64795928|NCT05379686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795929|NCT05352672|Pembrolizumab|pembrolizumab|mesh-list
64795930|NCT05352672|Cemiplimab|cemiplimab|mesh-list
64795931|NCT05352672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64795932|NCT05352672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64795933|NCT05342844|Dexmedetomidine|dexmedetomidine|mesh-list
64795934|NCT05342844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64795935|NCT05342844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64795936|NCT05342844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795937|NCT05342844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64795938|NCT05342844|Analgesics|analgesics|mesh-ancestor
64795939|NCT05342844|Sensory System Agents|sensory system agents|mesh-ancestor
65281858|NCT02791373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65281859|NCT02791373|Antimetabolites|antimetabolites|mesh-ancestor
65281860|NCT02791373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281861|NCT02791373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281862|NCT02791373|Antiviral Agents|antiviral agents|mesh-ancestor
65281863|NCT02791373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65281864|NCT02791373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281865|NCT02791373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65281866|NCT02791373|Immunologic Factors|immunologic factors|mesh-ancestor
65281867|NCT02791373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281868|NCT02791373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65281869|NCT02791373|Tubulin Modulators|tubulin modulators|mesh-ancestor
65281870|NCT02791373|Antimitotic Agents|antimitotic agents|mesh-ancestor
65031877|NCT02901145|Cyclophosphamide|cyclophosphamide|mesh-list
65281871|NCT02791373|Mitosis Modulators|mitosis modulators|mesh-ancestor
64734199|NCT01627782|Sensory System Agents|sensory system agents|mesh-ancestor
64795940|NCT05342844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64795941|NCT05342844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64795942|NCT05342844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64795943|NCT05342844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64795944|NCT05342844|Adrenergic Agents|adrenergic agents|mesh-ancestor
64795960|NCT05301608|Psilocybin|psilocybin|mesh-list
64795961|NCT05301608|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
64795962|NCT05301608|Hallucinogens|hallucinogens|mesh-ancestor
64795963|NCT05301608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795964|NCT05301608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64795965|NCT05301608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64795966|NCT05301608|Serotonin Agents|serotonin agents|mesh-ancestor
64795967|NCT05301608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64795968|NCT05301608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795969|NCT05301608|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64795970|NCT05284019|Erenumab|erenumab|mesh-list
64795971|NCT05284019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64795972|NCT05284019|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64795973|NCT05284019|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64795997|NCT05257083|Cyclophosphamide|cyclophosphamide|mesh-list
64795998|NCT05257083|Fludarabine|fludarabine|mesh-list
64795999|NCT05257083|Lenalidomide|lenalidomide|mesh-list
64796000|NCT05257083|Bortezomib|bortezomib|mesh-list
64564578|NCT01920113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64796001|NCT05257083|Daratumumab|daratumumab|mesh-list
64796002|NCT05257083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64796003|NCT05257083|Immunologic Factors|immunologic factors|mesh-ancestor
64796004|NCT05257083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796014|NCT05257083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64796015|NCT05257083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64796016|NCT05257083|Glucocorticoids|glucocorticoids|mesh-ancestor
64796017|NCT05257083|Hormones|hormones|mesh-ancestor
64796018|NCT05257083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64796019|NCT05257083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64796020|NCT05257083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64796021|NCT05257083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64311569|NCT02090309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64311570|NCT03047096|Hyaluronic Acid|hyaluronic acid|mesh-list
64311571|NCT03047096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64311572|NCT03047096|Immunologic Factors|immunologic factors|mesh-ancestor
64311573|NCT03047096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796022|NCT05257083|Growth Substances|growth substances|mesh-ancestor
64796023|NCT05257083|Growth Inhibitors|growth inhibitors|mesh-ancestor
65281872|NCT03102047|Durvalumab|durvalumab|mesh-list
65281873|NCT03102047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65281874|NCT03102047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65281875|NCT00966745|Milrinone|milrinone|mesh-list
65281876|NCT00966745|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65281877|NCT00966745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65281878|NCT00966745|Vasodilator Agents|vasodilator agents|mesh-ancestor
65281879|NCT00966745|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65281880|NCT00966745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65281881|NCT00966745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281882|NCT00966745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281883|NCT00966745|Protective Agents|protective agents|mesh-ancestor
65281884|NCT00966745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281885|NCT02669030|Suvorexant|suvorexant|mesh-list
65281886|NCT02669030|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65281887|NCT02669030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65281888|NCT02669030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65281889|NCT02669030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281890|NCT02669030|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65281891|NCT02669030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64734215|NCT02119650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64796024|NCT05249634|Testosterone|testosterone|mesh-list
64796025|NCT05249634|Androgens|androgens|mesh-ancestor
64796026|NCT05249634|Hormones|hormones|mesh-ancestor
64796041|NCT05193370|Angiotensinogen|angiotensinogen|mesh-list
64796042|NCT05193370|Hemostatics|hemostatics|mesh-ancestor
64796043|NCT05193370|Coagulants|coagulants|mesh-ancestor
64796044|NCT05193370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64796045|NCT05193370|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64796046|NCT05193370|Natriuretic Agents|natriuretic agents|mesh-ancestor
64796047|NCT05193370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796048|NCT05193370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64796049|NCT05193370|Protease Inhibitors|protease inhibitors|mesh-ancestor
64796050|NCT05193370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796051|NCT05193370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796054|NCT05172947|Resveratrol|resveratrol|mesh-list
64796055|NCT05172947|Antioxidants|antioxidants|mesh-ancestor
64796056|NCT05172947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796057|NCT05172947|Protective Agents|protective agents|mesh-ancestor
64796058|NCT05172947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796059|NCT05172947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796060|NCT05172947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64796061|NCT05170607|Antibodies|antibodies|mesh-list
64796062|NCT05170607|Immunologic Factors|immunologic factors|mesh-ancestor
64796063|NCT05170607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796064|NCT05156710|Rituximab|rituximab|mesh-list
64796065|NCT05156710|Tacrolimus|tacrolimus|mesh-list
64796066|NCT05156710|Immunoglobulins|immunoglobulins|mesh-list
64796067|NCT05156710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64796068|NCT05156710|Antibodies|antibodies|mesh-list
64796069|NCT05156710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64796070|NCT05156710|gamma-Globulins|gamma-globulins|mesh-list
64796071|NCT05156710|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64407176|NCT03039101|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65281892|NCT02669030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281893|NCT02668796|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65281894|NCT02668796|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65281895|NCT02668796|Estradiol|estradiol|mesh-list
65281896|NCT02668796|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65281897|NCT02668796|Estrogens|estrogens|mesh-ancestor
65281898|NCT02668796|Hormones|hormones|mesh-ancestor
65281899|NCT02668796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65281900|NCT02668796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281901|NCT02668796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65281902|NCT02668796|Contraceptive Agents|contraceptive agents|mesh-ancestor
65281903|NCT02668796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65281904|NCT02668796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65281905|NCT00645320|Ziprasidone|ziprasidone|mesh-list
65281906|NCT00645320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65281907|NCT00645320|Serotonin Agents|serotonin agents|mesh-ancestor
65281908|NCT00645320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65281909|NCT00645320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281910|NCT00645320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281911|NCT00645320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65281912|NCT00645320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65281913|NCT00645320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65281914|NCT00645320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65281915|NCT00645320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65281916|NCT00645320|Dopamine Agents|dopamine agents|mesh-ancestor
65281917|NCT03938857|Fentanyl|fentanyl|mesh-list
65281918|NCT03938857|Dexmedetomidine|dexmedetomidine|mesh-list
65281919|NCT03938857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65281920|NCT03938857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65281921|NCT03938857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281922|NCT03938857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65281923|NCT03938857|Analgesics|analgesics|mesh-ancestor
65281932|NCT03938857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65281933|NCT03938857|Narcotics|narcotics|mesh-ancestor
65281934|NCT03938857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65281935|NCT03938857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65281936|NCT03938857|Anesthetics, General|anesthetics, general|mesh-ancestor
65281937|NCT03938857|Anesthetics|anesthetics|mesh-ancestor
64796082|NCT05147220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64796083|NCT05147220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64796084|NCT05147220|Analgesics|analgesics|mesh-ancestor
64796085|NCT05147220|Sensory System Agents|sensory system agents|mesh-ancestor
64796086|NCT05147220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64796087|NCT05147220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796088|NCT05147220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64796089|NCT05147220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64796090|NCT05147220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64796091|NCT05147220|Immunologic Factors|immunologic factors|mesh-ancestor
64796092|NCT05099718|Hyaluronic Acid|hyaluronic acid|mesh-list
64796093|NCT05099718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64796094|NCT05099718|Immunologic Factors|immunologic factors|mesh-ancestor
64796095|NCT05099718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796096|NCT05099718|Viscosupplements|viscosupplements|mesh-ancestor
64796097|NCT05099718|Protective Agents|protective agents|mesh-ancestor
64796098|NCT05081180|Lenvatinib|lenvatinib|mesh-list
64796099|NCT05081180|Avelumab|avelumab|mesh-list
64796100|NCT05081180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796101|NCT05081180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64796133|NCT05037812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796135|NCT05037812|Sensory System Agents|sensory system agents|mesh-ancestor
64796136|NCT05037812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64796137|NCT05037812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64796152|NCT05037812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64564729|NCT02943733|Temozolomide|temozolomide|mesh-list
64796154|NCT05037812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64796155|NCT05037812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796156|NCT05037812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64796157|NCT05037812|Sympatholytics|sympatholytics|mesh-ancestor
64796194|NCT04997993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796195|NCT04997993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796196|NCT04997993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64796197|NCT04997993|Immunologic Factors|immunologic factors|mesh-ancestor
64796243|NCT04759144|Insulin|insulin|mesh-list
64796244|NCT04759144|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64796245|NCT04759144|Insulin Aspart|insulin aspart|mesh-list
64796246|NCT04759144|Insulin, Long-Acting|insulin, long-acting|mesh-list
64796247|NCT04759144|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64796248|NCT04759144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64796249|NCT04759144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796275|NCT04677959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64796277|NCT04677959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64796278|NCT04677959|Adrenergic Agents|adrenergic agents|mesh-ancestor
64796279|NCT04677959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64796280|NCT04677959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796281|NCT04677959|Tocolytic Agents|tocolytic agents|mesh-ancestor
64796282|NCT04677959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64796284|NCT04671043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64796285|NCT04671043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796286|NCT04671043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64796287|NCT04671043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796288|NCT04671043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796289|NCT04671043|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64796290|NCT04671043|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64796291|NCT04671043|Purinergic Agents|purinergic agents|mesh-ancestor
64796292|NCT04671043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64796293|NCT04643002|Dexamethasone|dexamethasone|mesh-list
64796294|NCT04643002|Pomalidomide|pomalidomide|mesh-list
64796295|NCT04643002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64796296|NCT04643002|Antiemetics|antiemetics|mesh-ancestor
64796297|NCT04643002|Autonomic Agents|autonomic agents|mesh-ancestor
64796298|NCT04643002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64796299|NCT04643002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281938|NCT04160598|Fentanyl|fentanyl|mesh-list
65281939|NCT04160598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65281940|NCT04160598|Narcotics|narcotics|mesh-ancestor
65281941|NCT04160598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65281942|NCT04160598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281943|NCT04160598|Analgesics|analgesics|mesh-ancestor
65281944|NCT04160598|Sensory System Agents|sensory system agents|mesh-ancestor
65281945|NCT04160598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281946|NCT04160598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65281947|NCT04160598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65281948|NCT04160598|Anesthetics, General|anesthetics, general|mesh-ancestor
65281949|NCT04160598|Anesthetics|anesthetics|mesh-ancestor
65281950|NCT00967837|Insulin|insulin|mesh-list
65281951|NCT00967837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65281952|NCT00967837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65281953|NCT00967837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281954|NCT02668016|Atorvastatin|atorvastatin|mesh-list
65281955|NCT02668016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65281956|NCT02668016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65281957|NCT02668016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65281958|NCT02668016|Antimetabolites|antimetabolites|mesh-ancestor
65281959|NCT02668016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281960|NCT02668016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64796300|NCT04643002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64796301|NCT04643002|Glucocorticoids|glucocorticoids|mesh-ancestor
64796303|NCT04643002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64796304|NCT04643002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64796335|NCT04612920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64796337|NCT04612920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64796338|NCT04570293|Lidocaine|lidocaine|mesh-list
64796346|NCT04570293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64796348|NCT04570293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64796349|NCT04570293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796350|NCT04569084|Edaravone|edaravone|mesh-list
64796351|NCT04569084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64796352|NCT04569084|Antioxidants|antioxidants|mesh-ancestor
64796353|NCT04569084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796354|NCT04569084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64796355|NCT04569084|Protective Agents|protective agents|mesh-ancestor
64796356|NCT04569084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796357|NCT04560595|Caffeine|caffeine|mesh-list
64796392|NCT04520139|Antioxidants|antioxidants|mesh-ancestor
64796393|NCT04520139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796394|NCT04520139|Protective Agents|protective agents|mesh-ancestor
64796395|NCT04520139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796396|NCT04520139|Antidotes|antidotes|mesh-ancestor
64796397|NCT04512105|Venetoclax|venetoclax|mesh-list
64796398|NCT04512105|Pitavastatin|pitavastatin|mesh-list
64796399|NCT04512105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796400|NCT04512105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64796401|NCT04512105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65281961|NCT02668016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65281962|NCT03012971|Dexmedetomidine|dexmedetomidine|mesh-list
65281963|NCT03012971|Morphine|morphine|mesh-list
65281964|NCT03012971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65281965|NCT03012971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65281966|NCT03012971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281967|NCT03012971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65281968|NCT03012971|Analgesics|analgesics|mesh-ancestor
65281969|NCT03012971|Sensory System Agents|sensory system agents|mesh-ancestor
65281970|NCT03012971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281971|NCT03012971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65281972|NCT03012971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65281973|NCT03012971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64796402|NCT04512105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64796467|NCT04469959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64796468|NCT04469959|Immunologic Factors|immunologic factors|mesh-ancestor
64796469|NCT04469959|Dopamine Agonists|dopamine agonists|mesh-ancestor
64472063|NCT03869034|Antidotes|antidotes|mesh-ancestor
64472064|NCT03869034|Protective Agents|protective agents|mesh-ancestor
64472065|NCT03869034|Vitamin B Complex|vitamin b complex|mesh-ancestor
64472066|NCT03869034|Vitamins|vitamins|mesh-ancestor
64472067|NCT03869034|Micronutrients|micronutrients|mesh-ancestor
64472068|NCT03841097|Tacrolimus|tacrolimus|mesh-list
64472069|NCT03841097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64472070|NCT03841097|Immunologic Factors|immunologic factors|mesh-ancestor
64472071|NCT03841097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796476|NCT04434196|Obinutuzumab|obinutuzumab|mesh-list
64796477|NCT04434196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64796478|NCT04434196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796479|NCT04382898|Cemiplimab|cemiplimab|mesh-list
64796480|NCT04382898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64796481|NCT04382898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796482|NCT04381897|Acetylcysteine|acetylcysteine|mesh-list
64796483|NCT04381897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64796484|NCT04381897|Antiviral Agents|antiviral agents|mesh-ancestor
64796485|NCT04381897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64796506|NCT04330638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64796507|NCT04330638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64796508|NCT04330638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796509|NCT04291521|Ketamine|ketamine|mesh-list
64796510|NCT04291521|Propofol|propofol|mesh-list
64796511|NCT04291521|Etomidate|etomidate|mesh-list
64796512|NCT04291521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64796513|NCT04291521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64796514|NCT04291521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796515|NCT04291521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64796516|NCT04291521|Anesthetics, General|anesthetics, general|mesh-ancestor
64796517|NCT04291521|Anesthetics|anesthetics|mesh-ancestor
64796518|NCT04291521|Analgesics|analgesics|mesh-ancestor
64796519|NCT04291521|Sensory System Agents|sensory system agents|mesh-ancestor
64796529|NCT04288427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796530|NCT04288427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796531|NCT04288427|Hormone Antagonists|hormone antagonists|mesh-ancestor
64796532|NCT04288427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64796533|NCT04288427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796534|NCT04288427|Urological Agents|urological agents|mesh-ancestor
64796537|NCT04280601|Micronutrients|micronutrients|mesh-ancestor
64796538|NCT04280601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796539|NCT04280601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64796540|NCT04263064|Clonidine|clonidine|mesh-list
64796541|NCT04263064|Analgesics|analgesics|mesh-ancestor
64796542|NCT04263064|Sensory System Agents|sensory system agents|mesh-ancestor
64796543|NCT04263064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281974|NCT03012971|Adrenergic Agents|adrenergic agents|mesh-ancestor
65281975|NCT03012971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65281976|NCT03012971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281977|NCT03012971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65281978|NCT03012971|Narcotics|narcotics|mesh-ancestor
65281979|NCT00966901|Nicotine|nicotine|mesh-list
65281980|NCT00966901|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65281981|NCT00966901|Autonomic Agents|autonomic agents|mesh-ancestor
65281982|NCT00966901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65281983|NCT00966901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65281984|NCT00966901|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65281985|NCT00966901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65281986|NCT00966901|Cholinergic Agents|cholinergic agents|mesh-ancestor
65281987|NCT00966901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65281988|NCT00966901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65281989|NCT02668172|Pasireotide|pasireotide|mesh-list
65281990|NCT02668172|Hormones|hormones|mesh-ancestor
65281993|NCT00660270|Gemcitabine|gemcitabine|mesh-list
65282033|NCT00967057|Glucocorticoids|glucocorticoids|mesh-ancestor
65282034|NCT00967057|Hormones|hormones|mesh-ancestor
65282035|NCT00967057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65282036|NCT00967057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65282037|NCT00967057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282038|NCT00967057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65282039|NCT00967057|Abortifacient Agents|abortifacient agents|mesh-ancestor
65282040|NCT00967057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65282041|NCT00967057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65282042|NCT00967057|Antimetabolites|antimetabolites|mesh-ancestor
65282043|NCT00967057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282044|NCT00967057|Dermatologic Agents|dermatologic agents|mesh-ancestor
65282045|NCT00967057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282046|NCT00967057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65282047|NCT00967057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65282048|NCT00967057|Immunologic Factors|immunologic factors|mesh-ancestor
65282049|NCT00967057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65282050|NCT00967057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65282051|NCT00967057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65282052|NCT00967057|Tubulin Modulators|tubulin modulators|mesh-ancestor
65282053|NCT00967057|Antimitotic Agents|antimitotic agents|mesh-ancestor
65282054|NCT00967057|Mitosis Modulators|mitosis modulators|mesh-ancestor
65282055|NCT00967057|Analgesics|analgesics|mesh-ancestor
65282056|NCT00967057|Sensory System Agents|sensory system agents|mesh-ancestor
65282057|NCT00967057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65282058|NCT00967057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65282059|NCT00967057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65282060|NCT02633514|Etoposide|etoposide|mesh-list
65282061|NCT02633514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282062|NCT02633514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65282063|NCT02633514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65282064|NCT02633514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65282073|NCT00656214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65282074|NCT00656214|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65282075|NCT00656214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282076|NCT02790671|Firuglipel|firuglipel|mesh-list
65282077|NCT02790671|Itraconazole|itraconazole|mesh-list
65282078|NCT02790671|Antifungal Agents|antifungal agents|mesh-ancestor
65282079|NCT02790671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65282080|NCT02790671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65282081|NCT02790671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65282082|NCT02790671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282083|NCT02790671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282084|NCT02790671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65282085|NCT02790671|Hormone Antagonists|hormone antagonists|mesh-ancestor
65282086|NCT02790671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64796544|NCT04263064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796545|NCT04263064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64796546|NCT04263064|Sympatholytics|sympatholytics|mesh-ancestor
64796547|NCT04263064|Autonomic Agents|autonomic agents|mesh-ancestor
64796548|NCT04263064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64796549|NCT04263064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64796550|NCT04263064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64796590|NCT04131309|Hormones|hormones|mesh-ancestor
64796591|NCT04131309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64796592|NCT04131309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64796619|NCT04091217|Growth Inhibitors|growth inhibitors|mesh-ancestor
64796620|NCT04090567|Olaparib|olaparib|mesh-list
64796621|NCT04090567|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64796622|NCT04090567|Cediranib|cediranib|mesh-list
64796623|NCT04090567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796624|NCT04090567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796625|NCT04090567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796626|NCT04090567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64796627|NCT04061746|Plasma-lyte 148|plasma-lyte 148|mesh-list
64796628|NCT04061746|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64796629|NCT04061746|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64796630|NCT04049110|Dapagliflozin|dapagliflozin|mesh-list
64796631|NCT04049110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64796632|NCT04049110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796633|NCT04049110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64796634|NCT04049110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796635|NCT04046900|Metronidazole|metronidazole|mesh-list
64796636|NCT04046900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64796637|NCT04046900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64796638|NCT04046900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64796639|NCT04046900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64796640|NCT04040959|Niacinamide|niacinamide|mesh-list
64796642|NCT04040959|Nicotinic Acids|nicotinic acids|mesh-list
64796669|NCT03980561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64796670|NCT03980561|Cholinergic Agents|cholinergic agents|mesh-ancestor
64796671|NCT03980561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64796672|NCT03980561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796673|NCT03980561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796675|NCT03965689|Carboplatin|carboplatin|mesh-list
64796676|NCT03965689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64796677|NCT03965689|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64796678|NCT03965689|Pevonedistat|pevonedistat|mesh-list
64796679|NCT03965689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64796680|NCT03965689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796681|NCT03965689|Tubulin Modulators|tubulin modulators|mesh-ancestor
65282087|NCT02790671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282088|NCT02790671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65282089|NCT02790671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65282090|NCT02668094|Lidocaine|lidocaine|mesh-list
65282091|NCT02668094|Pregabalin|pregabalin|mesh-list
65282092|NCT02668094|Propofol|propofol|mesh-list
65282093|NCT02668094|Anesthetics, Local|anesthetics, local|mesh-ancestor
65282094|NCT02668094|Anesthetics|anesthetics|mesh-ancestor
65282095|NCT02668094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65282096|NCT02668094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282097|NCT02668094|Sensory System Agents|sensory system agents|mesh-ancestor
65282098|NCT02668094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65282099|NCT02668094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65282100|NCT02668094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65282101|NCT02668094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65282102|NCT02668094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65282103|NCT02668094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796682|NCT03965689|Antimitotic Agents|antimitotic agents|mesh-ancestor
64796683|NCT03965689|Mitosis Modulators|mitosis modulators|mesh-ancestor
64796684|NCT03965689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796685|NCT03960008|Doxorubicin|doxorubicin|mesh-list
64796686|NCT03960008|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64796687|NCT03960008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64796688|NCT03960008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796689|NCT03960008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64796690|NCT03960008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64796691|NCT03960008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796692|NCT03960008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796693|NCT03959423|Insulin|insulin|mesh-list
64472072|NCT03841097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64472073|NCT03841097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796694|NCT03959423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64796695|NCT03959423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796696|NCT03936998|Vancomycin|vancomycin|mesh-list
64796697|NCT03936998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64407828|NCT05065177|Vaccines|vaccines|mesh-list
64796736|NCT03786783|Razoxane|razoxane|mesh-list
64796737|NCT03786783|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
64796738|NCT03786783|Isotretinoin|isotretinoin|mesh-list
64796739|NCT03786783|Sargramostim|sargramostim|mesh-list
64796740|NCT03786783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64796741|NCT03786783|Immunologic Factors|immunologic factors|mesh-ancestor
64796742|NCT03786783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796743|NCT03786783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64796744|NCT03786783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64796745|NCT03786783|Alkylating Agents|alkylating agents|mesh-ancestor
64796746|NCT03786783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796747|NCT03786783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796748|NCT03786783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64796749|NCT03786783|Vitamins|vitamins|mesh-ancestor
64796750|NCT03786783|Micronutrients|micronutrients|mesh-ancestor
64796751|NCT03786783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64796778|NCT03670056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64796779|NCT03670056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796780|NCT03654833|Bevacizumab|bevacizumab|mesh-list
64796781|NCT03654833|Pembrolizumab|pembrolizumab|mesh-list
64796782|NCT03654833|Atezolizumab|atezolizumab|mesh-list
64796783|NCT03654833|Niraparib|niraparib|mesh-list
65282104|NCT02668094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65282105|NCT02668094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65282106|NCT02668094|Anesthetics, General|anesthetics, general|mesh-ancestor
65282107|NCT02668094|Analgesics|analgesics|mesh-ancestor
65282108|NCT02668094|Anticonvulsants|anticonvulsants|mesh-ancestor
65282109|NCT02668094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65282110|NCT02668094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65282111|NCT02668094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65282112|NCT02668094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65282113|NCT02668094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65282115|NCT00967135|Analgesics|analgesics|mesh-ancestor
65282116|NCT00967135|Sensory System Agents|sensory system agents|mesh-ancestor
65282117|NCT00967135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64734447|NCT02085252|Fertility Agents|fertility agents|mesh-ancestor
64796784|NCT03654833|Rucaparib|rucaparib|mesh-list
64796785|NCT03654833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64796786|NCT03654833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796787|NCT03654833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64796788|NCT03654833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64796789|NCT03654833|Growth Substances|growth substances|mesh-ancestor
64796790|NCT03654833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796791|NCT03654833|Growth Inhibitors|growth inhibitors|mesh-ancestor
64796792|NCT03654833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64796793|NCT03654833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796794|NCT03654833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796795|NCT03639935|Nivolumab|nivolumab|mesh-list
64796796|NCT03639935|Rucaparib|rucaparib|mesh-list
64796797|NCT03639935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64796798|NCT03639935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796799|NCT03639935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64796800|NCT03639935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796841|NCT03426904|Micronutrients|micronutrients|mesh-ancestor
64796842|NCT03383575|Azacitidine|azacitidine|mesh-list
64796843|NCT03383575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64796844|NCT03383575|Antimetabolites|antimetabolites|mesh-ancestor
64796845|NCT03383575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796846|NCT03383575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796847|NCT03383575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796848|NCT03332667|Vorinostat|vorinostat|mesh-list
64796849|NCT03332667|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64796850|NCT03332667|Dinutuximab|dinutuximab|mesh-list
64796851|NCT03332667|Sargramostim|sargramostim|mesh-list
64796852|NCT03332667|Immunologic Factors|immunologic factors|mesh-ancestor
64796853|NCT03332667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796854|NCT03332667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796855|NCT03332667|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64796856|NCT03332667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796857|NCT03332667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796899|NCT03141983|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64796901|NCT03075527|Durvalumab|durvalumab|mesh-list
64796902|NCT03075527|Tremelimumab|tremelimumab|mesh-list
64796903|NCT03075527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64796922|NCT02995252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64796923|NCT02995252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796924|NCT02995252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796925|NCT02995252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64796926|NCT02995252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64796927|NCT02995252|Hematinics|hematinics|mesh-ancestor
64796928|NCT02983578|Durvalumab|durvalumab|mesh-list
64796929|NCT02983578|Immunoglobulins|immunoglobulins|mesh-list
64796930|NCT02983578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64796931|NCT02983578|Immunoglobulin G|immunoglobulin g|mesh-list
65282118|NCT00967135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282119|NCT00967135|Anticonvulsants|anticonvulsants|mesh-ancestor
65282120|NCT00967135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65282121|NCT00967135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65282122|NCT00967135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282123|NCT00967135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65282124|NCT00967135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65282125|NCT00967135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65282126|NCT00967135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64796932|NCT02983578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64796933|NCT02983578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408035|NCT04821323|Analgesics|analgesics|mesh-ancestor
64796953|NCT02846623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796954|NCT02846623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64796955|NCT02844816|Atezolizumab|atezolizumab|mesh-list
64796956|NCT02844816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64796957|NCT02844816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796958|NCT02844816|Immunologic Factors|immunologic factors|mesh-ancestor
64796959|NCT02844816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796960|NCT02834637|Vaccines|vaccines|mesh-list
64796961|NCT02834637|Immunologic Factors|immunologic factors|mesh-ancestor
64796962|NCT02834637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796963|NCT02817360|Losartan|losartan|mesh-list
64796964|NCT02817360|Valsartan|valsartan|mesh-list
64796965|NCT02817360|Carvedilol|carvedilol|mesh-list
64796966|NCT02817360|Candesartan|candesartan|mesh-list
64796967|NCT02817360|Ramipril|ramipril|mesh-list
64796968|NCT02817360|Enalapril|enalapril|mesh-list
64796969|NCT02817360|Lisinopril|lisinopril|mesh-list
64796970|NCT02817360|Irbesartan|irbesartan|mesh-list
64796971|NCT02817360|Nebivolol|nebivolol|mesh-list
64796972|NCT02817360|Bisoprolol|bisoprolol|mesh-list
64796973|NCT02817360|Perindopril|perindopril|mesh-list
64796974|NCT02817360|Captopril|captopril|mesh-list
64796975|NCT02817360|Quinapril|quinapril|mesh-list
64796976|NCT02817360|Trandolapril|trandolapril|mesh-list
64796977|NCT02817360|Fosinopril|fosinopril|mesh-list
64796978|NCT02817360|Eprosartan|eprosartan|mesh-list
64796979|NCT02817360|Zofenopril|zofenopril|mesh-list
64796980|NCT02817360|Spirapril|spirapril|mesh-list
64796981|NCT02817360|Cilazapril|cilazapril|mesh-list
64796982|NCT02817360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64796983|NCT02817360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64796984|NCT02817360|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64796985|NCT02817360|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64797035|NCT02678377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797036|NCT02678377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64408158|NCT05042245|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64797063|NCT02659384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797064|NCT02659384|Antipyretics|antipyretics|mesh-ancestor
64797066|NCT02659306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64797067|NCT02659306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797068|NCT02591147|Fluorides|fluorides|mesh-list
64797069|NCT02591147|Cariostatic Agents|cariostatic agents|mesh-ancestor
64565639|NCT05793359|Prednisolone|prednisolone|mesh-list
64797070|NCT02591147|Protective Agents|protective agents|mesh-ancestor
64797071|NCT02591147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797072|NCT02588872|Hyaluronic Acid|hyaluronic acid|mesh-list
64797073|NCT02588872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64797074|NCT02588872|Immunologic Factors|immunologic factors|mesh-ancestor
64797075|NCT02588872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797076|NCT02588872|Viscosupplements|viscosupplements|mesh-ancestor
64797077|NCT02588872|Protective Agents|protective agents|mesh-ancestor
64797078|NCT02579161|Ciprofloxacin|ciprofloxacin|mesh-list
64797079|NCT02579161|Clindamycin|clindamycin|mesh-list
64797080|NCT02579161|Gentamicins|gentamicins|mesh-list
64797081|NCT02579161|Penicillins|penicillins|mesh-list
64797082|NCT02579161|Ampicillin|ampicillin|mesh-list
64797083|NCT02579161|Cephalosporins|cephalosporins|mesh-list
64797094|NCT02579161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64797095|NCT02579161|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65282127|NCT00967135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65282128|NCT02666768|Interferons|interferons|mesh-list
65282129|NCT02666768|Interferon-gamma|interferon-gamma|mesh-list
65282130|NCT02666768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282131|NCT02666768|Antiviral Agents|antiviral agents|mesh-ancestor
65282132|NCT02666768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65282133|NCT00967213|Ranibizumab|ranibizumab|mesh-list
65282134|NCT00967213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65282135|NCT00967213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65282136|NCT00967213|Growth Substances|growth substances|mesh-ancestor
65282137|NCT00967213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282138|NCT00967213|Growth Inhibitors|growth inhibitors|mesh-ancestor
65282139|NCT00967213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282140|NCT04160676|Ascorbic Acid|ascorbic acid|mesh-list
65282141|NCT04160676|Thiamine|thiamine|mesh-list
64797096|NCT02579161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64797097|NCT02538510|Pembrolizumab|pembrolizumab|mesh-list
64797098|NCT02538510|Vorinostat|vorinostat|mesh-list
64797099|NCT02538510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64797100|NCT02538510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797101|NCT02538510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64797102|NCT02538510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797103|NCT02538510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797104|NCT02537613|Obinutuzumab|obinutuzumab|mesh-list
64797105|NCT02537613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64797123|NCT02387203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64797124|NCT02387203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64797125|NCT02387203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797126|NCT02387203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797127|NCT02387203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64797128|NCT02387203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64797129|NCT02387203|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64797130|NCT02387203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64797131|NCT02387203|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64797132|NCT02381353|Bupivacaine|bupivacaine|mesh-list
64797133|NCT02381353|Anesthetics, Local|anesthetics, local|mesh-ancestor
64797134|NCT02381353|Anesthetics|anesthetics|mesh-ancestor
64797135|NCT02381353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64797136|NCT02381353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797137|NCT02381353|Sensory System Agents|sensory system agents|mesh-ancestor
64797138|NCT02381353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64797139|NCT02296229|Androgens|androgens|mesh-list
64797140|NCT02296229|Hormones|hormones|mesh-ancestor
64797141|NCT02296229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64797142|NCT02296229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797143|NCT02192398|Guanfacine|guanfacine|mesh-list
64797144|NCT02192398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64797145|NCT02192398|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64408251|NCT03094663|Mydriatics|mydriatics|mesh-ancestor
64797154|NCT01992653|Prednisone|prednisone|mesh-list
64797155|NCT01992653|Prednisolone|prednisolone|mesh-list
64797156|NCT01992653|Cyclophosphamide|cyclophosphamide|mesh-list
64797157|NCT01992653|Rituximab|rituximab|mesh-list
64797158|NCT01992653|Doxorubicin|doxorubicin|mesh-list
64797159|NCT01992653|Obinutuzumab|obinutuzumab|mesh-list
64797160|NCT01992653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64797161|NCT01992653|Immunologic Factors|immunologic factors|mesh-ancestor
64797162|NCT01992653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797163|NCT01992653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64797164|NCT01992653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64797165|NCT01992653|Alkylating Agents|alkylating agents|mesh-ancestor
64797166|NCT01992653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282142|NCT04160676|Hydrocortisone|hydrocortisone|mesh-list
65282143|NCT04160676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65282144|NCT04160676|Antioxidants|antioxidants|mesh-ancestor
65282145|NCT04160676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282146|NCT04160676|Protective Agents|protective agents|mesh-ancestor
65282147|NCT04160676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282148|NCT04160676|Vitamins|vitamins|mesh-ancestor
65282149|NCT04160676|Micronutrients|micronutrients|mesh-ancestor
65282150|NCT04160676|Vitamin B Complex|vitamin b complex|mesh-ancestor
65282151|NCT00660426|Gemcitabine|gemcitabine|mesh-list
65282152|NCT00660426|Capecitabine|capecitabine|mesh-list
65282153|NCT00660426|Oxaliplatin|oxaliplatin|mesh-list
65282154|NCT00660426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65282155|NCT00660426|Antimetabolites|antimetabolites|mesh-ancestor
65282156|NCT00660426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282157|NCT00660426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282158|NCT00660426|Antiviral Agents|antiviral agents|mesh-ancestor
65282159|NCT00660426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65282160|NCT00660426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282161|NCT00660426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65282162|NCT00660426|Immunologic Factors|immunologic factors|mesh-ancestor
65282163|NCT00660426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282164|NCT00967291|Ifosfamide|ifosfamide|mesh-list
64797167|NCT01992653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797168|NCT01992653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64797169|NCT01992653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64797182|NCT01972217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64797184|NCT01972217|Hormones|hormones|mesh-ancestor
64797185|NCT01972217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64797186|NCT01972217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797187|NCT01972217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64797188|NCT01972217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797189|NCT01972217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64797190|NCT01972217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797191|NCT01972217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797192|NCT01969578|Paclitaxel|paclitaxel|mesh-list
64797193|NCT01969578|Carboplatin|carboplatin|mesh-list
64797194|NCT01969578|Doxorubicin|doxorubicin|mesh-list
64797195|NCT01969578|Bicalutamide|bicalutamide|mesh-list
64797196|NCT01969578|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64797197|NCT01969578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64797198|NCT01969578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797199|NCT01969578|Tubulin Modulators|tubulin modulators|mesh-ancestor
64797200|NCT01969578|Antimitotic Agents|antimitotic agents|mesh-ancestor
64797201|NCT01969578|Mitosis Modulators|mitosis modulators|mesh-ancestor
64797202|NCT01969578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797203|NCT01969578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64797204|NCT01969578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64797205|NCT01969578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64797206|NCT01969578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797207|NCT01969578|Androgen Antagonists|androgen antagonists|mesh-ancestor
64797208|NCT01969578|Hormone Antagonists|hormone antagonists|mesh-ancestor
65282165|NCT00967291|Mitomycins|mitomycins|mesh-list
65282166|NCT00967291|Mitomycin|mitomycin|mesh-list
65282167|NCT00967291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65282168|NCT00967291|Alkylating Agents|alkylating agents|mesh-ancestor
65282169|NCT00967291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282170|NCT00967291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032179|NCT02897011|Methotrexate|methotrexate|mesh-list
65282171|NCT00967291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65282172|NCT00967291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65282173|NCT00967291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734507|NCT02066298|Parasympatholytics|parasympatholytics|mesh-ancestor
64797209|NCT01969578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64797210|NCT01969578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797211|NCT01969578|Luteolytic Agents|luteolytic agents|mesh-ancestor
64797228|NCT01850303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797229|NCT01850303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64797230|NCT01850303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64797231|NCT01763671|Paclitaxel|paclitaxel|mesh-list
64797232|NCT01763671|Docetaxel|docetaxel|mesh-list
64797233|NCT01763671|Bevacizumab|bevacizumab|mesh-list
64797234|NCT01763671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64797235|NCT01763671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797236|NCT01763671|Tubulin Modulators|tubulin modulators|mesh-ancestor
64797237|NCT01763671|Antimitotic Agents|antimitotic agents|mesh-ancestor
64797238|NCT01763671|Mitosis Modulators|mitosis modulators|mesh-ancestor
64797239|NCT01763671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797240|NCT01763671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64797241|NCT01763671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64797242|NCT01763671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64797243|NCT01763671|Growth Substances|growth substances|mesh-ancestor
64797244|NCT01763671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797245|NCT01763671|Growth Inhibitors|growth inhibitors|mesh-ancestor
64797246|NCT01750567|Metformin|metformin|mesh-list
64797247|NCT01750567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64797292|NCT00590122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797293|NCT00590122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797294|NCT00590122|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64797295|NCT00590122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797296|NCT00590122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64797297|NCT00590122|Immunologic Factors|immunologic factors|mesh-ancestor
64797298|NCT00590122|Dopamine Agonists|dopamine agonists|mesh-ancestor
64797300|NCT00309192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64797301|NCT00309192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64797327|NCT00295893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797329|NCT00295893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64797330|NCT00295893|Alkylating Agents|alkylating agents|mesh-ancestor
64797331|NCT00295893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64797344|NCT00110591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64797345|NCT01689246|Methylene Blue|methylene blue|mesh-list
64797346|NCT01689246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797347|NCT01689246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797348|NCT01685268|Prednisone|prednisone|mesh-list
64797349|NCT01685268|Prednisolone|prednisolone|mesh-list
64797350|NCT01685268|Abiraterone Acetate|abiraterone acetate|mesh-list
64797351|NCT01685268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64797352|NCT01685268|Glucocorticoids|glucocorticoids|mesh-ancestor
64797353|NCT01685268|Hormones|hormones|mesh-ancestor
64797354|NCT01685268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64797355|NCT01685268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797356|NCT01685268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64797357|NCT01685268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797358|NCT01685268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65282174|NCT00645398|Pregabalin|pregabalin|mesh-list
65282175|NCT00645398|Analgesics|analgesics|mesh-ancestor
65282176|NCT00645398|Sensory System Agents|sensory system agents|mesh-ancestor
65282177|NCT00645398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65282178|NCT00645398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282179|NCT00645398|Anticonvulsants|anticonvulsants|mesh-ancestor
65282180|NCT00645398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65282181|NCT00645398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65282182|NCT00645398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282183|NCT00645398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65282184|NCT00645398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65282185|NCT00645398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65282186|NCT00645398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65282187|NCT00645398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65282188|NCT00884832|Clonidine|clonidine|mesh-list
65282189|NCT00884832|Analgesics|analgesics|mesh-ancestor
65282190|NCT00884832|Sensory System Agents|sensory system agents|mesh-ancestor
65282191|NCT00884832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65282192|NCT00884832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282193|NCT00884832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64797359|NCT01685268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797360|NCT01685268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797361|NCT01685268|Hormone Antagonists|hormone antagonists|mesh-ancestor
64797362|NCT01685268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64797414|NCT01384578|Micronutrients|micronutrients|mesh-ancestor
64797415|NCT01384578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797416|NCT01384578|Antioxidants|antioxidants|mesh-ancestor
64797417|NCT01384578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797418|NCT01384578|Protective Agents|protective agents|mesh-ancestor
64797419|NCT01384578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64797420|NCT01384578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797421|NCT01384578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64797422|NCT01384578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64797423|NCT01384578|Vasodilator Agents|vasodilator agents|mesh-ancestor
64797424|NCT01384578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64797449|NCT01384799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797451|NCT01384812|Oxytocics|oxytocics|mesh-ancestor
64797452|NCT01384812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64797486|NCT01385020|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64797487|NCT01385020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64797488|NCT01385020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797489|NCT01385020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64797490|NCT01385020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64797491|NCT01385124|Cannabidiol|cannabidiol|mesh-list
64797492|NCT01385124|Anticonvulsants|anticonvulsants|mesh-ancestor
64797493|NCT01385228|Prednisone|prednisone|mesh-list
64797494|NCT01385228|Docetaxel|docetaxel|mesh-list
64797495|NCT01385228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797496|NCT01385228|Tubulin Modulators|tubulin modulators|mesh-ancestor
64472080|NCT03830866|Carboplatin|carboplatin|mesh-list
64472081|NCT03830866|Durvalumab|durvalumab|mesh-list
64472082|NCT03830866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797517|NCT01385527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65282194|NCT00884832|Sympatholytics|sympatholytics|mesh-ancestor
65282195|NCT00884832|Autonomic Agents|autonomic agents|mesh-ancestor
65282196|NCT00884832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65282197|NCT00884832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65282198|NCT00884832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65282199|NCT00884832|Adrenergic Agents|adrenergic agents|mesh-ancestor
65282200|NCT00884832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65282201|NCT00884832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282202|NCT00660582|Leucovorin|leucovorin|mesh-list
65282203|NCT00660582|Folic Acid|folic acid|mesh-list
65282204|NCT00660582|Fluorouracil|fluorouracil|mesh-list
65282205|NCT00660582|Oxaliplatin|oxaliplatin|mesh-list
65282206|NCT00660582|Cetuximab|cetuximab|mesh-list
65282207|NCT00660582|Levoleucovorin|levoleucovorin|mesh-list
65282208|NCT00660582|Antimetabolites|antimetabolites|mesh-ancestor
65282209|NCT00660582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282210|NCT00660582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65282211|NCT00660582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282212|NCT00660582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65282213|NCT00660582|Immunologic Factors|immunologic factors|mesh-ancestor
65282214|NCT00660582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282250|NCT02666534|Anesthetics, Local|anesthetics, local|mesh-ancestor
65282252|NCT02666534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65282253|NCT02666534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282254|NCT02666534|Sensory System Agents|sensory system agents|mesh-ancestor
65282255|NCT02666534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65282256|NCT02666534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64734575|NCT01624662|Respiratory System Agents|respiratory system agents|mesh-ancestor
64797519|NCT01385631|Ezetimibe|ezetimibe|mesh-list
64797520|NCT01385631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64797521|NCT01385631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64797522|NCT01385631|Antimetabolites|antimetabolites|mesh-ancestor
64797523|NCT01385631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797524|NCT01385631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64797525|NCT01385683|Clarithromycin|clarithromycin|mesh-list
64797526|NCT01385683|Dabigatran|dabigatran|mesh-list
64797527|NCT01385683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64797528|NCT01385683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64797529|NCT01385683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64797544|NCT01385735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797545|NCT01385826|Antibodies|antibodies|mesh-list
64797546|NCT01385826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64797547|NCT01385826|Immunologic Factors|immunologic factors|mesh-ancestor
64797548|NCT01385826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797549|NCT01385891|Etoposide|etoposide|mesh-list
64797550|NCT01385891|Clofarabine|clofarabine|mesh-list
64797561|NCT01385956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64797562|NCT01385956|Antimetabolites|antimetabolites|mesh-ancestor
64797563|NCT01385956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797564|NCT01385956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797565|NCT01385956|Antiviral Agents|antiviral agents|mesh-ancestor
64797566|NCT01385956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64797567|NCT01385956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797568|NCT01385956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64797569|NCT01385956|Immunologic Factors|immunologic factors|mesh-ancestor
64797570|NCT01385956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797571|NCT01385956|Hormones|hormones|mesh-ancestor
64797572|NCT01385956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64797573|NCT01386086|Aripiprazole|aripiprazole|mesh-list
64797574|NCT01386086|Antidepressive Agents|antidepressive agents|mesh-ancestor
64797575|NCT01386086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64797576|NCT01386086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64797577|NCT01386086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64797578|NCT01386086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64797579|NCT01386086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797580|NCT01386086|Dopamine Agonists|dopamine agonists|mesh-ancestor
64797581|NCT01386086|Dopamine Agents|dopamine agents|mesh-ancestor
64797582|NCT01386086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64797583|NCT01386086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797584|NCT01386086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64797585|NCT01386086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64797586|NCT01386086|Serotonin Agents|serotonin agents|mesh-ancestor
64797587|NCT01386086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64797588|NCT01386086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64797589|NCT01386086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64797590|NCT01386086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64797591|NCT01386151|Mitogens|mitogens|mesh-list
64797592|NCT01386151|Mitosis Modulators|mitosis modulators|mesh-ancestor
64797593|NCT01386151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797594|NCT01386164|Vaccines|vaccines|mesh-list
64797595|NCT01386164|Immunologic Factors|immunologic factors|mesh-ancestor
64472083|NCT03830866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64472115|NCT03780543|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
64797596|NCT01386164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797605|NCT01386177|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64797606|NCT01386177|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64797607|NCT01386177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65282257|NCT02666534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65282258|NCT02666534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65282259|NCT02666534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65282260|NCT02666534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282261|NCT02666534|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65282262|NCT02666534|Dermatologic Agents|dermatologic agents|mesh-ancestor
65282263|NCT02666534|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65282264|NCT02787473|Docetaxel|docetaxel|mesh-list
65282265|NCT02787473|Pemetrexed|pemetrexed|mesh-list
65282266|NCT02787473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282267|NCT02787473|Tubulin Modulators|tubulin modulators|mesh-ancestor
65282268|NCT02787473|Antimitotic Agents|antimitotic agents|mesh-ancestor
65282269|NCT02787473|Mitosis Modulators|mitosis modulators|mesh-ancestor
65282270|NCT02787473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282271|NCT02787473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282272|NCT02787473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65282273|NCT02787473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65282274|NCT00657306|Hydrocortisone|hydrocortisone|mesh-list
64734584|NCT02064894|Narcotics|narcotics|mesh-ancestor
64797608|NCT01386177|Adrenergic Agents|adrenergic agents|mesh-ancestor
64797609|NCT01386177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64797610|NCT01386177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64797611|NCT01386177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64797612|NCT01386177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64797614|NCT01386229|Etomidate|etomidate|mesh-list
64797622|NCT01386229|Anesthetics|anesthetics|mesh-ancestor
64797623|NCT01386229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64797624|NCT01386229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64797625|NCT01386229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64797626|NCT01386229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64797627|NCT01386229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797628|NCT01386229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64797629|NCT01386242|Interferons|interferons|mesh-list
64797630|NCT01386242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797631|NCT01386242|Antiviral Agents|antiviral agents|mesh-ancestor
64797632|NCT01386242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64797633|NCT01386255|Baclofen|baclofen|mesh-list
64797634|NCT01386255|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64797635|NCT01386255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797636|NCT01386255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64797637|NCT01386255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64797638|NCT01386255|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64797639|NCT01386255|GABA Agonists|gaba agonists|mesh-ancestor
64797640|NCT01386255|GABA Agents|gaba agents|mesh-ancestor
64797641|NCT01386255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64797642|NCT01386255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797643|NCT01386268|Factor VIII|factor viii|mesh-list
64797644|NCT01386268|Coagulants|coagulants|mesh-ancestor
64797645|NCT01386294|Tenofovir|tenofovir|mesh-list
64797646|NCT01386294|Antiviral Agents|antiviral agents|mesh-ancestor
64797647|NCT01386294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64797648|NCT01386294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64797649|NCT01386294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64797650|NCT01386294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797651|NCT01386294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282275|NCT00657306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65282276|NCT00967603|Sunitinib|sunitinib|mesh-list
65282277|NCT00967603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282278|NCT00967603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65282279|NCT00967603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65282280|NCT00967603|Growth Substances|growth substances|mesh-ancestor
65282281|NCT00967603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282282|NCT00967603|Growth Inhibitors|growth inhibitors|mesh-ancestor
65282283|NCT00967603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65282284|NCT00967603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282285|NCT00967603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282286|NCT00657384|Tranexamic Acid|tranexamic acid|mesh-list
65282287|NCT00657384|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65282288|NCT00657384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65282289|NCT00657384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282290|NCT00657384|Hemostatics|hemostatics|mesh-ancestor
65282291|NCT00657384|Coagulants|coagulants|mesh-ancestor
65282292|NCT00973453|Immunologic Factors|immunologic factors|mesh-list
64734605|NCT01624194|Oxytocics|oxytocics|mesh-ancestor
64797652|NCT01386294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64797653|NCT01386294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64797654|NCT01386333|Oxytocin|oxytocin|mesh-list
64797655|NCT01386333|Oxytocics|oxytocics|mesh-ancestor
64797656|NCT01386333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64797657|NCT01386333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797658|NCT01386346|Capecitabine|capecitabine|mesh-list
64797659|NCT01386346|Azacitidine|azacitidine|mesh-list
64797660|NCT01386346|Oxaliplatin|oxaliplatin|mesh-list
64797661|NCT01386346|Epirubicin|epirubicin|mesh-list
64797662|NCT01386346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64797663|NCT01386346|Antimetabolites|antimetabolites|mesh-ancestor
64797664|NCT01386346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797665|NCT01386346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797666|NCT01386346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797667|NCT01386346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64797668|NCT01386346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64797669|NCT01386346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64797670|NCT01386372|Tolvaptan|tolvaptan|mesh-list
64797671|NCT01386372|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64797703|NCT01386567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64797704|NCT01386567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797705|NCT01386567|Anabolic Agents|anabolic agents|mesh-ancestor
64797706|NCT01386567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64797707|NCT01386567|Hormone Antagonists|hormone antagonists|mesh-ancestor
64797708|NCT01386567|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64797709|NCT01386567|Fertility Agents|fertility agents|mesh-ancestor
64797710|NCT01386567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64797711|NCT01386567|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64797712|NCT01386567|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64797714|NCT01386580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64797715|NCT01386580|Trastuzumab|trastuzumab|mesh-list
64797716|NCT01386580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64797717|NCT01386580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797718|NCT01386580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64797719|NCT01386580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64797720|NCT01386580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282293|NCT00973453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282294|NCT00646880|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65282295|NCT00646880|Propiverine|propiverine|mesh-list
65282296|NCT00646880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65282297|NCT00646880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65282298|NCT00646880|Cholinergic Agents|cholinergic agents|mesh-ancestor
65282299|NCT00646880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65282300|NCT00646880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797721|NCT01386580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797722|NCT01386580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64797723|NCT01386593|Ciprofloxacin|ciprofloxacin|mesh-list
64797724|NCT01386593|Rifampin|rifampin|mesh-list
64797725|NCT01386593|Fluconazole|fluconazole|mesh-list
64797726|NCT01386593|Paroxetine|paroxetine|mesh-list
64797727|NCT01386593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64797728|NCT01386593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64797729|NCT01386593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64797730|NCT01386593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64797731|NCT01386593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797732|NCT01386593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797733|NCT01386593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797734|NCT01386593|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64797735|NCT01386593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64797736|NCT01386593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64797737|NCT01386593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64797738|NCT01386593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64797739|NCT01386593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64797740|NCT01386593|Serotonin Agents|serotonin agents|mesh-ancestor
64797741|NCT01386593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797751|NCT01386593|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64797752|NCT01386593|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64797753|NCT01386593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64797754|NCT01386593|Antitubercular Agents|antitubercular agents|mesh-ancestor
64797755|NCT01386593|Leprostatic Agents|leprostatic agents|mesh-ancestor
64797756|NCT01386593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64797774|NCT01386658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797775|NCT01386658|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64797776|NCT01386658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64797777|NCT01386658|Immunologic Factors|immunologic factors|mesh-ancestor
64797779|NCT01386671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64797780|NCT01386671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797781|NCT01386736|Vitamin D|vitamin d|mesh-list
64797782|NCT01386736|Vitamins|vitamins|mesh-ancestor
64797783|NCT01386736|Micronutrients|micronutrients|mesh-ancestor
64797784|NCT01386736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797785|NCT01386736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64797786|NCT01386853|Atorvastatin|atorvastatin|mesh-list
64797787|NCT01386853|Pitavastatin|pitavastatin|mesh-list
64797788|NCT01386853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64797789|NCT01386853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64797790|NCT01386853|Antimetabolites|antimetabolites|mesh-ancestor
64797791|NCT01386853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797792|NCT01386853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64797793|NCT01386853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64797794|NCT01386853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797795|NCT01386866|Motesanib diphosphate|motesanib diphosphate|mesh-list
64797796|NCT01386866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64797797|NCT01386866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797798|NCT01386866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797799|NCT01386879|Methylene Blue|methylene blue|mesh-list
64797800|NCT01386879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797801|NCT01386879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797820|NCT01386996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797822|NCT01387048|Azelaic acid|azelaic acid|mesh-list
65282301|NCT00646880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282302|NCT00646880|Urological Agents|urological agents|mesh-ancestor
65282303|NCT00646880|Parasympatholytics|parasympatholytics|mesh-ancestor
65282304|NCT00646880|Autonomic Agents|autonomic agents|mesh-ancestor
65282305|NCT00646880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65282306|NCT00910598|Glatiramer Acetate|glatiramer acetate|mesh-list
65282307|NCT00910598|(T,G)-A-L|(t,g)-a-l|mesh-list
65282308|NCT00910598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65282309|NCT00910598|Immunologic Factors|immunologic factors|mesh-ancestor
65282310|NCT00910598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282311|NCT00910598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65282312|NCT00910598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65282313|NCT00968461|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
65282314|NCT00968461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282315|NCT00968461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282316|NCT00968461|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65282317|NCT00968461|Protective Agents|protective agents|mesh-ancestor
65282318|NCT00968461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282319|NCT00968461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282320|NCT04157010|Methotrexate|methotrexate|mesh-list
65282321|NCT04157010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65282322|NCT04157010|Abortifacient Agents|abortifacient agents|mesh-ancestor
65282323|NCT04157010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65282324|NCT04157010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282325|NCT04157010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65282326|NCT04157010|Antimetabolites|antimetabolites|mesh-ancestor
65282327|NCT04157010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797823|NCT01387048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64797824|NCT01387048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64797825|NCT01387048|Analgesics|analgesics|mesh-ancestor
64797826|NCT01387048|Sensory System Agents|sensory system agents|mesh-ancestor
64797827|NCT01387048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64797842|NCT01387191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64797843|NCT01387191|Vasodilator Agents|vasodilator agents|mesh-ancestor
64797844|NCT01387204|Trametinib|trametinib|mesh-list
64797845|NCT01387204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797846|NCT01387204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64797847|NCT01387204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797848|NCT01387204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797849|NCT01387243|Orlistat|orlistat|mesh-list
64797850|NCT01387243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797851|NCT01387243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797852|NCT01387243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64797853|NCT01387243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64797854|NCT01387295|Capecitabine|capecitabine|mesh-list
64797855|NCT01387295|Oxaliplatin|oxaliplatin|mesh-list
65282328|NCT04157010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282329|NCT04157010|Dermatologic Agents|dermatologic agents|mesh-ancestor
65282330|NCT04157010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282331|NCT04157010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65282332|NCT04157010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65282333|NCT04157010|Immunologic Factors|immunologic factors|mesh-ancestor
65282334|NCT04157010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65282335|NCT04157010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65282336|NCT02632032|Insulin|insulin|mesh-list
65282337|NCT02632032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65282338|NCT02632032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65282339|NCT02632032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282340|NCT00973609|Folic Acid|folic acid|mesh-list
65282341|NCT00973609|Vitamin B Complex|vitamin b complex|mesh-list
65282342|NCT00973609|Bevacizumab|bevacizumab|mesh-list
65282343|NCT00973609|Fluorouracil|fluorouracil|mesh-list
65282344|NCT00973609|Capecitabine|capecitabine|mesh-list
65282345|NCT00973609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65282346|NCT00973609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282347|NCT00973609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65282348|NCT00973609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65282349|NCT00973609|Growth Substances|growth substances|mesh-ancestor
65282350|NCT00973609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282351|NCT00973609|Growth Inhibitors|growth inhibitors|mesh-ancestor
65282352|NCT00973609|Antimetabolites|antimetabolites|mesh-ancestor
65282353|NCT00973609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282354|NCT00973609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65282355|NCT00973609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65282356|NCT00973609|Immunologic Factors|immunologic factors|mesh-ancestor
65282357|NCT00973609|Hematinics|hematinics|mesh-ancestor
64797856|NCT01387295|Trastuzumab|trastuzumab|mesh-list
64797870|NCT01387399|Cisplatin|cisplatin|mesh-list
64797871|NCT01387399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797872|NCT01387425|Varenicline|varenicline|mesh-list
64797873|NCT01387425|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64797874|NCT01387425|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64797875|NCT01387425|Cholinergic Agents|cholinergic agents|mesh-ancestor
64797876|NCT01387425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64797877|NCT01387425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797878|NCT01387425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797879|NCT01387568|Lidocaine|lidocaine|mesh-list
64797880|NCT01387568|Anesthetics, Local|anesthetics, local|mesh-ancestor
64797881|NCT01387568|Anesthetics|anesthetics|mesh-ancestor
64797882|NCT01387568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64797883|NCT01387568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797884|NCT01387568|Sensory System Agents|sensory system agents|mesh-ancestor
65282358|NCT00973609|Vitamins|vitamins|mesh-ancestor
65282359|NCT00973609|Micronutrients|micronutrients|mesh-ancestor
65282360|NCT02537054|Aflibercept|aflibercept|mesh-list
65282361|NCT02537054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65282362|NCT02537054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65282363|NCT02537054|Growth Substances|growth substances|mesh-ancestor
65282364|NCT02537054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282365|NCT02537054|Growth Inhibitors|growth inhibitors|mesh-ancestor
65282366|NCT02537054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282367|NCT00973687|Dexamethasone|dexamethasone|mesh-list
65282368|NCT00973687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65282369|NCT00973687|Antiemetics|antiemetics|mesh-ancestor
65282370|NCT00973687|Autonomic Agents|autonomic agents|mesh-ancestor
65282371|NCT00973687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65282372|NCT00973687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797885|NCT01387568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64797886|NCT01387568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64797887|NCT01387568|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64797888|NCT01387568|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64797889|NCT01387568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64797890|NCT01387568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797891|NCT01387620|Hyaluronic Acid|hyaluronic acid|mesh-list
64797892|NCT01387620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64797893|NCT01387620|Immunologic Factors|immunologic factors|mesh-ancestor
64797894|NCT01387620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797895|NCT01387620|Viscosupplements|viscosupplements|mesh-ancestor
64797896|NCT01387620|Protective Agents|protective agents|mesh-ancestor
64797897|NCT01387880|Everolimus|everolimus|mesh-list
64797898|NCT01387880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797899|NCT01387880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64797900|NCT01387880|Immunologic Factors|immunologic factors|mesh-ancestor
64797901|NCT01387880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797902|NCT01387906|Bimatoprost|bimatoprost|mesh-list
64797903|NCT01387906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64797940|NCT01388075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64797941|NCT01388088|Amiloride|amiloride|mesh-list
64797942|NCT01388088|Spironolactone|spironolactone|mesh-list
64797943|NCT01388088|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64797944|NCT01388088|Hormone Antagonists|hormone antagonists|mesh-ancestor
64797945|NCT01388088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64797946|NCT01388088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797947|NCT01388088|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64797948|NCT01388088|Diuretics|diuretics|mesh-ancestor
64797949|NCT01388088|Natriuretic Agents|natriuretic agents|mesh-ancestor
64797950|NCT01388088|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
64797951|NCT01388088|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64797952|NCT01388088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64797953|NCT01388088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797954|NCT01388088|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64797955|NCT01388101|Antibodies|antibodies|mesh-list
64797956|NCT01388101|Immunologic Factors|immunologic factors|mesh-ancestor
64797957|NCT01388101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566546|NCT04265105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64566547|NCT04265105|Respiratory System Agents|respiratory system agents|mesh-ancestor
64566548|NCT04265105|Dermatologic Agents|dermatologic agents|mesh-ancestor
64797965|NCT01388153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64797966|NCT01388153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797967|NCT01388270|Heparin|heparin|mesh-list
64797968|NCT01388270|Calcium heparin|calcium heparin|mesh-list
64797969|NCT01388270|Anticoagulants|anticoagulants|mesh-ancestor
64797970|NCT01388270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65282373|NCT00973687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65282374|NCT00973687|Glucocorticoids|glucocorticoids|mesh-ancestor
65282375|NCT00973687|Hormones|hormones|mesh-ancestor
65282376|NCT00973687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65282377|NCT00973687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65282378|NCT00973687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282379|NCT02785757|Thrombin|thrombin|mesh-list
65282380|NCT02785757|Hemostatics|hemostatics|mesh-ancestor
65282381|NCT02785757|Coagulants|coagulants|mesh-ancestor
65282382|NCT00645554|Galantamine|galantamine|mesh-list
65282383|NCT00645554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65282384|NCT00645554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282385|NCT00645554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282386|NCT00645554|Cholinergic Agents|cholinergic agents|mesh-ancestor
65282387|NCT00645554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65282388|NCT00645554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797971|NCT01388270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64797980|NCT01388387|Immunologic Factors|immunologic factors|mesh-ancestor
64797981|NCT01388387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797982|NCT01388387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64797983|NCT01388387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797984|NCT01388387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797985|NCT01388413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64797986|NCT01388413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64797987|NCT01388439|Oseltamivir|oseltamivir|mesh-list
64797988|NCT01388439|Antiviral Agents|antiviral agents|mesh-ancestor
64797989|NCT01388439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64797990|NCT01388439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797991|NCT01388439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797992|NCT01388517|Vitamin D|vitamin d|mesh-list
64797993|NCT01388517|Calcitriol|calcitriol|mesh-list
64797994|NCT01388517|Petrolatum|petrolatum|mesh-list
64797995|NCT01388517|Tacrolimus|tacrolimus|mesh-list
64797996|NCT01388517|Vitamins|vitamins|mesh-ancestor
64797997|NCT01388517|Micronutrients|micronutrients|mesh-ancestor
64797998|NCT01388517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797999|NCT01388517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64798000|NCT01388517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64798001|NCT01388517|Immunologic Factors|immunologic factors|mesh-ancestor
64798002|NCT01388517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64798003|NCT01388517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798004|NCT01388517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798005|NCT01388517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64798006|NCT01388517|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64798007|NCT01388517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64798008|NCT01388517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64798009|NCT01388517|Emollients|emollients|mesh-ancestor
64798010|NCT01388517|Dermatologic Agents|dermatologic agents|mesh-ancestor
64798011|NCT01388582|Copper|copper|mesh-list
64798012|NCT01388582|Contraceptive Agents|contraceptive agents|mesh-list
64798013|NCT01388582|Levonorgestrel|levonorgestrel|mesh-list
64798014|NCT01388582|Etonogestrel|etonogestrel|mesh-list
64798015|NCT01388582|Desogestrel|desogestrel|mesh-list
64798016|NCT01388582|Contraceptives, Oral|contraceptives, oral|mesh-list
64798017|NCT01388582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64798018|NCT01388582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798019|NCT01388582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64798020|NCT01388582|Trace Elements|trace elements|mesh-ancestor
64798021|NCT01388582|Micronutrients|micronutrients|mesh-ancestor
64798022|NCT01388582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65282389|NCT00645554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65282390|NCT00645554|Autonomic Agents|autonomic agents|mesh-ancestor
65282391|NCT00645554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65282392|NCT00645554|Nootropic Agents|nootropic agents|mesh-ancestor
65282393|NCT02785601|Trazodone|trazodone|mesh-list
65282394|NCT02785601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65282395|NCT02785601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65282396|NCT02785601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65282397|NCT02785601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282398|NCT02785601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65282399|NCT02785601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65282400|NCT02785601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65282401|NCT02785601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65282402|NCT02785601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282403|NCT02785601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65282404|NCT02785601|Serotonin Agents|serotonin agents|mesh-ancestor
65282405|NCT02785601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65282406|NCT02785601|Antidepressive Agents|antidepressive agents|mesh-ancestor
65282407|NCT05299567|Azithromycin|azithromycin|mesh-list
64734715|NCT02043366|Narcotics|narcotics|mesh-ancestor
64798023|NCT01388582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64798066|NCT01388660|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64798067|NCT01388660|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64798068|NCT01388660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64798069|NCT01388660|Purinergic Agents|purinergic agents|mesh-ancestor
64798070|NCT01388660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64798071|NCT01388660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798072|NCT01388660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798073|NCT01388738|Cerebrolysin|cerebrolysin|mesh-list
64798074|NCT01388738|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64798075|NCT01388738|Nootropic Agents|nootropic agents|mesh-ancestor
64798076|NCT01388738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64798077|NCT01388738|Protective Agents|protective agents|mesh-ancestor
64798078|NCT01388738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798079|NCT01388842|Nitric Oxide|nitric oxide|mesh-list
64798080|NCT01388842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64798097|NCT01388855|Micronutrients|micronutrients|mesh-ancestor
64798098|NCT01388855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798099|NCT01388855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64409231|NCT05012137|Anesthetics|anesthetics|mesh-ancestor
64798107|NCT01389063|Maraviroc|maraviroc|mesh-list
64798108|NCT01389063|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64798109|NCT01389063|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64798110|NCT01389063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798111|NCT01389063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64798112|NCT01389063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64798113|NCT01389063|Antiviral Agents|antiviral agents|mesh-ancestor
64798114|NCT01389063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64798115|NCT01389063|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64798116|NCT01389167|Naltrexone|naltrexone|mesh-list
64798117|NCT01389167|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64798118|NCT01389167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64798119|NCT01389167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798120|NCT01389167|Sensory System Agents|sensory system agents|mesh-ancestor
65282408|NCT05299567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65282409|NCT05299567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65282410|NCT00660894|Leucovorin|leucovorin|mesh-list
65282411|NCT00660894|Tegafur|tegafur|mesh-list
65282412|NCT00660894|Calcium|calcium|mesh-list
65282413|NCT00660894|Levoleucovorin|levoleucovorin|mesh-list
65282414|NCT00660894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65282415|NCT00660894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282416|NCT00660894|Antidotes|antidotes|mesh-ancestor
65282417|NCT00660894|Protective Agents|protective agents|mesh-ancestor
65282418|NCT00660894|Vitamin B Complex|vitamin b complex|mesh-ancestor
65282419|NCT00660894|Vitamins|vitamins|mesh-ancestor
65282420|NCT00660894|Micronutrients|micronutrients|mesh-ancestor
65282421|NCT00660894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64734735|NCT02060370|Sunitinib|sunitinib|mesh-list
64798121|NCT01389167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64798122|NCT01389193|Ibudilast|ibudilast|mesh-list
64798123|NCT01389193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64798124|NCT01389193|Autonomic Agents|autonomic agents|mesh-ancestor
64798125|NCT01389193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64798126|NCT01389193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798127|NCT01389193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64798128|NCT01389193|Respiratory System Agents|respiratory system agents|mesh-ancestor
64798129|NCT01389193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64798130|NCT01389193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798131|NCT01389193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798132|NCT01389193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64798133|NCT01389193|Vasodilator Agents|vasodilator agents|mesh-ancestor
64798135|NCT01389206|Selexipag|selexipag|mesh-list
64798136|NCT01389206|Iloprost|iloprost|mesh-list
64798137|NCT01389206|Macitentan|macitentan|mesh-list
64798138|NCT01389206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64798139|NCT01389206|Vasodilator Agents|vasodilator agents|mesh-ancestor
64798140|NCT01389206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64798141|NCT01389206|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64798142|NCT01389206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798143|NCT01389206|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64798144|NCT01389206|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64798145|NCT01389271|Iloprost|iloprost|mesh-list
64798155|NCT01389388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798156|NCT01389401|Omeprazole|omeprazole|mesh-list
64798157|NCT01389401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64798158|NCT01389401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64798159|NCT01389401|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64798160|NCT01389401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798161|NCT01389401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798162|NCT01389414|Gemcitabine|gemcitabine|mesh-list
64798163|NCT01389414|Oxaliplatin|oxaliplatin|mesh-list
64798164|NCT01389414|Panitumumab|panitumumab|mesh-list
64798165|NCT01389414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64798166|NCT01389414|Antimetabolites|antimetabolites|mesh-ancestor
64409291|NCT04998253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64798180|NCT01389427|Vincristine|vincristine|mesh-list
64798181|NCT01389427|Rituximab|rituximab|mesh-list
64798182|NCT01389427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64798183|NCT01389427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64798184|NCT01389427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64566777|NCT03117816|Interferons|interferons|mesh-list
64798185|NCT01389427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798186|NCT01389427|Antifungal Agents|antifungal agents|mesh-ancestor
64798187|NCT01389427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64798188|NCT01389427|Immunologic Factors|immunologic factors|mesh-ancestor
64798189|NCT01389427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798190|NCT01389427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65282422|NCT00660894|Antimetabolites|antimetabolites|mesh-ancestor
65282423|NCT00660894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282424|NCT00660894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282425|NCT00660972|Tenofovir|tenofovir|mesh-list
65282426|NCT00660972|Emtricitabine|emtricitabine|mesh-list
65282427|NCT00660972|Raltegravir Potassium|raltegravir potassium|mesh-list
65282428|NCT00660972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65282429|NCT00660972|Antiviral Agents|antiviral agents|mesh-ancestor
65282430|NCT00660972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65282431|NCT00660972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65282432|NCT00660972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65282433|NCT00660972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282434|NCT00660972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282435|NCT00660972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64798191|NCT01389427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64798192|NCT01389427|Alkylating Agents|alkylating agents|mesh-ancestor
64798193|NCT01389427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798194|NCT01389427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64798195|NCT01389427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64798196|NCT01389427|Glucocorticoids|glucocorticoids|mesh-ancestor
64798198|NCT01389427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64798199|NCT01389427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64798200|NCT01389427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64798201|NCT01389427|Tubulin Modulators|tubulin modulators|mesh-ancestor
64798202|NCT01389427|Antimitotic Agents|antimitotic agents|mesh-ancestor
64798203|NCT01389427|Mitosis Modulators|mitosis modulators|mesh-ancestor
64798204|NCT01389427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64798205|NCT01389427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64798206|NCT01389427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64798207|NCT01389427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798208|NCT01389440|Gemcitabine|gemcitabine|mesh-list
64798209|NCT01389440|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64798210|NCT01389440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64798211|NCT01389440|Antimetabolites|antimetabolites|mesh-ancestor
64798212|NCT01389440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798213|NCT01389440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798214|NCT01389440|Antiviral Agents|antiviral agents|mesh-ancestor
64397929|NCT02362165|Bortezomib|bortezomib|mesh-list
64798215|NCT01389440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64798216|NCT01389440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798217|NCT01389440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64798218|NCT01389440|Immunologic Factors|immunologic factors|mesh-ancestor
64798219|NCT01389440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798220|NCT01389440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64798221|NCT01389505|Bevacizumab|bevacizumab|mesh-list
64798241|NCT01389544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64798243|NCT01389544|Narcotics|narcotics|mesh-ancestor
64798244|NCT01389544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64798245|NCT01389544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798246|NCT01389544|Analgesics|analgesics|mesh-ancestor
64798247|NCT01389544|Sensory System Agents|sensory system agents|mesh-ancestor
64798248|NCT01389544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64798249|NCT01389544|Antitussive Agents|antitussive agents|mesh-ancestor
64798250|NCT01389544|Respiratory System Agents|respiratory system agents|mesh-ancestor
64798251|NCT01389557|Primaquine|primaquine|mesh-list
64798252|NCT01389557|Piperaquine|piperaquine|mesh-list
64798253|NCT01389557|Artenimol|artenimol|mesh-list
64798254|NCT01389557|Antimalarials|antimalarials|mesh-ancestor
64798255|NCT01389557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65282436|NCT00660972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65282437|NCT00660972|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65282438|NCT00660972|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65282439|NCT02667470|Solifenacin Succinate|solifenacin succinate|mesh-list
65282440|NCT02667470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65282441|NCT02667470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65282442|NCT02667470|Cholinergic Agents|cholinergic agents|mesh-ancestor
65282443|NCT02667470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65282444|NCT02667470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282445|NCT02667470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798256|NCT01389557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64798257|NCT01389557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64798258|NCT01389609|Doxazosin|doxazosin|mesh-list
64798259|NCT01389609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64798260|NCT01389609|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64798261|NCT01389609|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64798262|NCT01389609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64798263|NCT01389609|Adrenergic Agents|adrenergic agents|mesh-ancestor
64798264|NCT01389609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64798265|NCT01389609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798266|NCT01389609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798267|NCT01389713|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64798268|NCT01389713|Clomiphene|clomiphene|mesh-list
64798269|NCT01389713|Enclomiphene|enclomiphene|mesh-list
64798270|NCT01389713|Zuclomiphene|zuclomiphene|mesh-list
64798271|NCT01389713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64798272|NCT01389713|Hormone Antagonists|hormone antagonists|mesh-ancestor
64798273|NCT01389713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64798274|NCT01389713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798275|NCT01389713|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64798276|NCT01389713|Fertility Agents|fertility agents|mesh-ancestor
64798277|NCT01389713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64798278|NCT01389713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64798279|NCT01389713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64798280|NCT01389713|Luteolytic Agents|luteolytic agents|mesh-ancestor
64798281|NCT01389713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64798282|NCT01389713|Contraceptive Agents|contraceptive agents|mesh-ancestor
64798293|NCT01389791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64798294|NCT01389791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798295|NCT01389791|Anesthetics|anesthetics|mesh-ancestor
64798296|NCT01389791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64798297|NCT01389791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64798298|NCT01389791|Anticonvulsants|anticonvulsants|mesh-ancestor
64798299|NCT01389791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64798300|NCT01389791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64409420|NCT03077503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64798314|NCT01389908|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64798315|NCT01389908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64798316|NCT01389908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64798317|NCT01389908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64798318|NCT01389908|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64798319|NCT01389908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64798320|NCT01389908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64798321|NCT01389908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798322|NCT01389908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64798323|NCT01389908|Serotonin Agents|serotonin agents|mesh-ancestor
64798324|NCT01390012|Dexamethasone|dexamethasone|mesh-list
64798325|NCT01390012|Dexamethasone acetate|dexamethasone acetate|mesh-list
64798327|NCT01390012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64798328|NCT01390012|Antiemetics|antiemetics|mesh-ancestor
64798329|NCT01390012|Autonomic Agents|autonomic agents|mesh-ancestor
64798330|NCT01390012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64798331|NCT01390012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282446|NCT02667470|Urological Agents|urological agents|mesh-ancestor
65282447|NCT05327699|Ketamine|ketamine|mesh-list
65282448|NCT05327699|Analgesics|analgesics|mesh-ancestor
65282449|NCT05327699|Sensory System Agents|sensory system agents|mesh-ancestor
65282450|NCT05327699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65282451|NCT05327699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282452|NCT05327699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65282453|NCT05327699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65282454|NCT05327699|Anesthetics, General|anesthetics, general|mesh-ancestor
65282455|NCT05327699|Anesthetics|anesthetics|mesh-ancestor
64798332|NCT01390012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64798333|NCT01390012|Glucocorticoids|glucocorticoids|mesh-ancestor
64798334|NCT01390012|Hormones|hormones|mesh-ancestor
64798335|NCT01390012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64798336|NCT01390012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64798337|NCT01390012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798338|NCT01390012|Protease Inhibitors|protease inhibitors|mesh-ancestor
64798339|NCT01390012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798340|NCT01390012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798341|NCT01390051|Tinzaparin|tinzaparin|mesh-list
64798342|NCT01390051|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64798343|NCT01390051|Dalteparin|dalteparin|mesh-list
64798344|NCT01390051|Anticoagulants|anticoagulants|mesh-ancestor
64798345|NCT01390051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64798346|NCT01390051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64798347|NCT01390051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798348|NCT01390311|Azacitidine|azacitidine|mesh-list
64798349|NCT01390311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64798350|NCT01390311|Antimetabolites|antimetabolites|mesh-ancestor
64798351|NCT01390311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798352|NCT01390311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798353|NCT01390311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798354|NCT01390324|Naproxen|naproxen|mesh-list
64798355|NCT01390324|Naratriptan|naratriptan|mesh-list
64798356|NCT01390324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64798357|NCT01390324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64798358|NCT01390324|Analgesics|analgesics|mesh-ancestor
64798382|NCT01390337|Immunologic Factors|immunologic factors|mesh-ancestor
64798383|NCT01390337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798384|NCT01390337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64798385|NCT01390337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64798386|NCT01390337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64798387|NCT01390337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798388|NCT01390480|Cholecalciferol|cholecalciferol|mesh-list
64798389|NCT01390480|Vitamin D|vitamin d|mesh-list
64798390|NCT01390480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64798391|NCT01390480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798392|NCT01390480|Vitamins|vitamins|mesh-ancestor
64798393|NCT01390480|Micronutrients|micronutrients|mesh-ancestor
64798394|NCT01390480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64798395|NCT01390506|Selenious Acid|selenious acid|mesh-list
64798396|NCT01390506|Sodium Selenite|sodium selenite|mesh-list
64798397|NCT01390506|Trace Elements|trace elements|mesh-ancestor
64798398|NCT01390506|Micronutrients|micronutrients|mesh-ancestor
64798399|NCT01390506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798400|NCT01390519|Everolimus|everolimus|mesh-list
64798401|NCT01390519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798402|NCT01390519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64798403|NCT01390519|Immunologic Factors|immunologic factors|mesh-ancestor
64798404|NCT01390519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798405|NCT01390571|Temozolomide|temozolomide|mesh-list
64567015|NCT02697253|Hormones|hormones|mesh-ancestor
64798406|NCT01390571|Olaparib|olaparib|mesh-list
64798407|NCT01390571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64798408|NCT01390571|Alkylating Agents|alkylating agents|mesh-ancestor
64798409|NCT01390571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282456|NCT05327699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65282457|NCT05327699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65282458|NCT05327699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65282459|NCT05327699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65282460|NCT05327699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282461|NCT04157478|Temozolomide|temozolomide|mesh-list
65282462|NCT04157478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65282463|NCT04157478|Alkylating Agents|alkylating agents|mesh-ancestor
65282464|NCT04157478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282465|NCT04157478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282466|NCT00647192|Eplerenone|eplerenone|mesh-list
65282467|NCT00647192|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65282468|NCT00647192|Hormone Antagonists|hormone antagonists|mesh-ancestor
65282469|NCT00647192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64798410|NCT01390571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798411|NCT01390571|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64798412|NCT01390571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798413|NCT01390623|Ceftriaxone|ceftriaxone|mesh-list
64798414|NCT01390623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64798415|NCT01390623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64798417|NCT01390662|Cholecalciferol|cholecalciferol|mesh-list
64798418|NCT01390662|Vitamins|vitamins|mesh-ancestor
64798419|NCT01390662|Micronutrients|micronutrients|mesh-ancestor
64798420|NCT01390662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798421|NCT01390662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64798422|NCT01390662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64798423|NCT01390766|Azathioprine|azathioprine|mesh-list
64798424|NCT01390766|Antimetabolites|antimetabolites|mesh-ancestor
64798425|NCT01390766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798458|NCT01390896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798459|NCT01390896|Anticoagulants|anticoagulants|mesh-ancestor
64798460|NCT01390896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64798461|NCT01390896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64798462|NCT01390922|Botulinum Toxins|botulinum toxins|mesh-list
64798463|NCT01390922|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64798464|NCT01390922|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64798465|NCT01390922|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64798466|NCT01390922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64798467|NCT01390922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798468|NCT01390922|Cholinergic Agents|cholinergic agents|mesh-ancestor
64798469|NCT01390922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64798470|NCT01390922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798471|NCT01390922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64798472|NCT01390922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64798473|NCT01390935|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
64798474|NCT01390935|Hormone Antagonists|hormone antagonists|mesh-ancestor
64798475|NCT01390935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64798476|NCT01390935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472120|NCT03780543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798477|NCT01390935|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64798478|NCT01390935|Diuretics|diuretics|mesh-ancestor
64798479|NCT01390935|Natriuretic Agents|natriuretic agents|mesh-ancestor
64798480|NCT01390961|Pheniramine|pheniramine|mesh-list
64798481|NCT01390961|Naphazoline|naphazoline|mesh-list
64798482|NCT01390961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282470|NCT00647192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282471|NCT00647192|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65282472|NCT00647192|Diuretics|diuretics|mesh-ancestor
65282473|NCT00647192|Natriuretic Agents|natriuretic agents|mesh-ancestor
65282474|NCT00647192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65282475|NCT00661206|Clopidogrel|clopidogrel|mesh-list
65282476|NCT00661206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65282477|NCT00661206|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65282478|NCT00661206|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65282479|NCT00661206|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65282480|NCT00661206|Purinergic Agents|purinergic agents|mesh-ancestor
65282481|NCT00661206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65282482|NCT00661206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282483|NCT00661206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282484|NCT05276960|Cholecalciferol|cholecalciferol|mesh-list
65282485|NCT05276960|Vitamin D|vitamin d|mesh-list
65282486|NCT05276960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65282487|NCT05276960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282488|NCT05276960|Vitamins|vitamins|mesh-ancestor
65282489|NCT05276960|Micronutrients|micronutrients|mesh-ancestor
65282490|NCT05276960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65282491|NCT02787317|Heparin|heparin|mesh-list
65282492|NCT02787317|Bivalirudin|bivalirudin|mesh-list
65282493|NCT02787317|Anticoagulants|anticoagulants|mesh-ancestor
65282494|NCT02787317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65282495|NCT02787317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65282496|NCT02787317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282497|NCT02787317|Antithrombins|antithrombins|mesh-ancestor
65282498|NCT02787317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65282499|NCT02787317|Protease Inhibitors|protease inhibitors|mesh-ancestor
65282500|NCT02787317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282501|NCT00645632|Doxorubicin|doxorubicin|mesh-list
65282502|NCT00645632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65282503|NCT00645632|Methotrexate|methotrexate|mesh-list
64798483|NCT01390961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64798484|NCT01390961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64798485|NCT01390961|Adrenergic Agents|adrenergic agents|mesh-ancestor
64798486|NCT01390961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64409619|NCT03072121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64798502|NCT01391052|Contraceptive Agents|contraceptive agents|mesh-ancestor
64798503|NCT01391052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65282504|NCT00645632|Ifosfamide|ifosfamide|mesh-list
65282505|NCT00645632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282506|NCT00645632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65282507|NCT00645632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65282508|NCT00645632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65282509|NCT00645632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282510|NCT00645632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282511|NCT00645632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65282512|NCT00645632|Abortifacient Agents|abortifacient agents|mesh-ancestor
65282513|NCT00645632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65282514|NCT00645632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282515|NCT00645632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65282516|NCT00645632|Antimetabolites|antimetabolites|mesh-ancestor
65282517|NCT00645632|Dermatologic Agents|dermatologic agents|mesh-ancestor
65282518|NCT00645632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65282519|NCT00645632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65282520|NCT00645632|Immunologic Factors|immunologic factors|mesh-ancestor
65282521|NCT00645632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65282522|NCT00645632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65282523|NCT00645632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65282524|NCT00645632|Alkylating Agents|alkylating agents|mesh-ancestor
65282525|NCT04156464|Lorazepam|lorazepam|mesh-list
65282526|NCT04156464|Phenobarbital|phenobarbital|mesh-list
65282527|NCT04156464|Anticonvulsants|anticonvulsants|mesh-ancestor
65282528|NCT04156464|Antiemetics|antiemetics|mesh-ancestor
65282529|NCT04156464|Autonomic Agents|autonomic agents|mesh-ancestor
65282530|NCT04156464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65282531|NCT04156464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282532|NCT04156464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65282533|NCT04156464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65282534|NCT04156464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65282535|NCT04156464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65282536|NCT04156464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65282537|NCT04156464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64734835|NCT02039778|Temozolomide|temozolomide|mesh-list
64798504|NCT01391052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798505|NCT01391052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64798506|NCT01391052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64798508|NCT01391104|Vasodilator Agents|vasodilator agents|mesh-ancestor
65282538|NCT04156464|GABA Modulators|gaba modulators|mesh-ancestor
65282539|NCT04156464|GABA Agents|gaba agents|mesh-ancestor
65282540|NCT04156464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65282541|NCT04156464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282542|NCT04156464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65282543|NCT04156464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65282544|NCT04156464|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65282545|NCT04156464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65282546|NCT04156464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65282547|NCT02607215|Vinorelbine|vinorelbine|mesh-list
65282548|NCT02607215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65282549|NCT02607215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282550|NCT02607215|Tubulin Modulators|tubulin modulators|mesh-ancestor
65282551|NCT02607215|Antimitotic Agents|antimitotic agents|mesh-ancestor
65282552|NCT02607215|Mitosis Modulators|mitosis modulators|mesh-ancestor
65282553|NCT02607215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282554|NCT00973999|Botulinum Toxins|botulinum toxins|mesh-list
65282555|NCT00973999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64798509|NCT01391104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64798510|NCT01391104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64798511|NCT01391104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798512|NCT01391104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798513|NCT01391104|Urological Agents|urological agents|mesh-ancestor
64798514|NCT01391156|Minoxidil|minoxidil|mesh-list
64798535|NCT01391221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64798537|NCT01391221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64798538|NCT01391221|Dopamine Agents|dopamine agents|mesh-ancestor
64798539|NCT01391260|Gefitinib|gefitinib|mesh-list
64798540|NCT01391260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798541|NCT01391260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64798542|NCT01391260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798543|NCT01391260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798544|NCT01391377|Niacin|niacin|mesh-list
64798555|NCT01391390|Antioxidants|antioxidants|mesh-ancestor
64798556|NCT01391390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798557|NCT01391390|Protective Agents|protective agents|mesh-ancestor
64798558|NCT01391390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798559|NCT01391390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64798560|NCT01391403|Artemisinins|artemisinins|mesh-list
64798561|NCT01391403|Artemisinin|artemisinin|mesh-list
64798562|NCT01391403|Antimalarials|antimalarials|mesh-ancestor
64798563|NCT01391403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64798564|NCT01391403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64798565|NCT01391403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64798566|NCT01391520|Deferiprone|deferiprone|mesh-list
64798567|NCT01391520|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64798568|NCT01391520|Chelating Agents|chelating agents|mesh-ancestor
64798569|NCT01391520|Sequestering Agents|sequestering agents|mesh-ancestor
64798570|NCT01391520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798571|NCT01391572|Fluorouracil|fluorouracil|mesh-list
64798572|NCT01391572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798573|NCT01391572|Antimetabolites|antimetabolites|mesh-ancestor
64798574|NCT01391572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798594|NCT01391689|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
64798595|NCT01391689|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65282556|NCT00973999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65282557|NCT00973999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282558|NCT00973999|Cholinergic Agents|cholinergic agents|mesh-ancestor
65282559|NCT00973999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65282560|NCT00973999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282561|NCT00968929|Streptokinase|streptokinase|mesh-list
65282562|NCT00968929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65282563|NCT00968929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65282564|NCT00968929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734884|NCT02038920|Vedolizumab|vedolizumab|mesh-list
64798596|NCT01391689|Protective Agents|protective agents|mesh-ancestor
64798597|NCT01391689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798598|NCT01391689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798599|NCT01391715|Rabeprazole|rabeprazole|mesh-list
64798600|NCT01391715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64798601|NCT01391715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64798602|NCT01391715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64798603|NCT01391715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798604|NCT01391715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798605|NCT01391845|Ulipristal acetate|ulipristal acetate|mesh-list
64798606|NCT01391845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64798607|NCT01391845|Contraceptive Agents|contraceptive agents|mesh-ancestor
64798608|NCT01391845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64798609|NCT01391845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409752|NCT05001919|Mitogens|mitogens|mesh-list
64798620|NCT01392079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64798621|NCT01392079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798622|NCT01392144|Nitric Oxide|nitric oxide|mesh-list
64798623|NCT01392144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64798624|NCT01392144|Autonomic Agents|autonomic agents|mesh-ancestor
64798625|NCT01392144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64798626|NCT01392144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798627|NCT01392144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64798628|NCT01392144|Respiratory System Agents|respiratory system agents|mesh-ancestor
64798629|NCT01392144|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64798630|NCT01392144|Antioxidants|antioxidants|mesh-ancestor
64798631|NCT01392144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798632|NCT01392144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64945442|NCT05633615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64798633|NCT01392144|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64798634|NCT01392144|Vasodilator Agents|vasodilator agents|mesh-ancestor
64798635|NCT01392144|Gasotransmitters|gasotransmitters|mesh-ancestor
64798636|NCT01392144|Protective Agents|protective agents|mesh-ancestor
64798655|NCT01392209|Growth Inhibitors|growth inhibitors|mesh-ancestor
64798656|NCT01392287|Memantine|memantine|mesh-list
64798657|NCT01392287|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64798658|NCT01392287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64798659|NCT01392287|Dopamine Agents|dopamine agents|mesh-ancestor
64798660|NCT01392287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64798661|NCT01392287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798662|NCT01392287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798663|NCT01392287|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64798664|NCT01392287|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64798665|NCT01392430|Azithromycin|azithromycin|mesh-list
64798666|NCT01392430|Dapsone|dapsone|mesh-list
64798667|NCT01392430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64798668|NCT01392430|Itraconazole|itraconazole|mesh-list
64798669|NCT01392430|Fluconazole|fluconazole|mesh-list
64798670|NCT01392430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64798671|NCT01392430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64798672|NCT01392430|Antifungal Agents|antifungal agents|mesh-ancestor
64798673|NCT01392430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64798674|NCT01392430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65282565|NCT00661596|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65282566|NCT00661596|Vasodilator Agents|vasodilator agents|mesh-ancestor
65282567|NCT00661596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65282568|NCT00661596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65282569|NCT00661596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282570|NCT00661596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282571|NCT00661596|Urological Agents|urological agents|mesh-ancestor
65282572|NCT00969085|Curcumin|curcumin|mesh-list
65282573|NCT00969085|Turmeric extract|turmeric extract|mesh-list
65282574|NCT00969085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65282575|NCT00969085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65282576|NCT00969085|Analgesics|analgesics|mesh-ancestor
65282577|NCT00969085|Sensory System Agents|sensory system agents|mesh-ancestor
65282578|NCT00969085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65282579|NCT00969085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798675|NCT01392430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409807|NCT04808687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798689|NCT01392430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64798691|NCT01392534|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64798692|NCT01392534|Telmisartan|telmisartan|mesh-list
64798693|NCT01392534|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
64798694|NCT01392534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64798695|NCT01392534|Diuretics|diuretics|mesh-ancestor
64798696|NCT01392534|Natriuretic Agents|natriuretic agents|mesh-ancestor
64798697|NCT01392534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798698|NCT01392534|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64798699|NCT01392534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64798700|NCT01392534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798701|NCT01392534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64798702|NCT01392534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64798703|NCT01392612|Epoetin Alfa|epoetin alfa|mesh-list
64798704|NCT01392612|Hematinics|hematinics|mesh-ancestor
64567329|NCT04975074|Iron|iron|mesh-list
64798705|NCT01392638|Sildenafil Citrate|sildenafil citrate|mesh-list
64798722|NCT01392755|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64798723|NCT01392755|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64798724|NCT01392755|Protease Inhibitors|protease inhibitors|mesh-ancestor
64798725|NCT01392755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798726|NCT01392755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798727|NCT01392755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64798728|NCT01392755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64798729|NCT01392755|Antiviral Agents|antiviral agents|mesh-ancestor
64798730|NCT01392755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64798731|NCT01392755|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64798732|NCT01392755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64798752|NCT01392794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64798753|NCT01392794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798755|NCT01392807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64798756|NCT01392807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798757|NCT01392807|Sensory System Agents|sensory system agents|mesh-ancestor
64798758|NCT01392807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64798759|NCT01392833|Prednisone|prednisone|mesh-list
64798760|NCT01392833|Methylprednisolone|methylprednisolone|mesh-list
64798761|NCT01392833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64798762|NCT01392833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64798763|NCT01392833|Prednisolone|prednisolone|mesh-list
64798764|NCT01392833|Prednisolone acetate|prednisolone acetate|mesh-list
64798765|NCT01392833|Azathioprine|azathioprine|mesh-list
65282580|NCT00969085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65282581|NCT00969085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65282582|NCT00969085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282583|NCT00969085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282584|NCT00969085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282585|NCT00969085|Antioxidants|antioxidants|mesh-ancestor
65282586|NCT00969085|Protective Agents|protective agents|mesh-ancestor
65282587|NCT00974155|Dexetimide|dexetimide|mesh-list
65282588|NCT00974155|Citalopram|citalopram|mesh-list
64798766|NCT01392833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64798767|NCT01392833|Prednisolone phosphate|prednisolone phosphate|mesh-list
64798768|NCT01392833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64798769|NCT01392833|Glucocorticoids|glucocorticoids|mesh-ancestor
64798770|NCT01392833|Hormones|hormones|mesh-ancestor
64798771|NCT01392833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64798772|NCT01392833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798773|NCT01392833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64798774|NCT01392833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567384|NCT01455883|Incretins|incretins|mesh-ancestor
64567385|NCT01455883|Hormones|hormones|mesh-ancestor
64798775|NCT01392833|Antiemetics|antiemetics|mesh-ancestor
64798776|NCT01392833|Autonomic Agents|autonomic agents|mesh-ancestor
64798777|NCT01392833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64798778|NCT01392833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64798779|NCT01392833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64798780|NCT01392833|Protective Agents|protective agents|mesh-ancestor
64798781|NCT01392833|Antimetabolites|antimetabolites|mesh-ancestor
64798802|NCT01392911|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64798803|NCT01392911|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64798804|NCT01392911|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64798805|NCT01392911|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64798806|NCT01392911|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64798807|NCT01392911|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64798808|NCT01393080|Nimotuzumab|nimotuzumab|mesh-list
64798809|NCT01393080|Cisplatin|cisplatin|mesh-list
64798810|NCT01393080|Paclitaxel|paclitaxel|mesh-list
64798811|NCT01393080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64798812|NCT01393080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798813|NCT01393080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64798814|NCT01393080|Tubulin Modulators|tubulin modulators|mesh-ancestor
64798815|NCT01393080|Antimitotic Agents|antimitotic agents|mesh-ancestor
64798816|NCT01393080|Mitosis Modulators|mitosis modulators|mesh-ancestor
64798817|NCT01393080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798818|NCT01393145|Fluticasone|fluticasone|mesh-list
64798819|NCT01393145|Xhance|xhance|mesh-list
64798820|NCT01393145|Formoterol Fumarate|formoterol fumarate|mesh-list
64798821|NCT01393145|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64798822|NCT01393145|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64798823|NCT01393145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64798824|NCT01393145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64798825|NCT01393145|Autonomic Agents|autonomic agents|mesh-ancestor
64798826|NCT01393145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64798827|NCT01393145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798828|NCT01393145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64798829|NCT01393145|Respiratory System Agents|respiratory system agents|mesh-ancestor
64798830|NCT01393145|Dermatologic Agents|dermatologic agents|mesh-ancestor
64798831|NCT01393145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64798832|NCT01393145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64798833|NCT01393145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64798834|NCT01393145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64798835|NCT01393145|Adrenergic Agents|adrenergic agents|mesh-ancestor
64798836|NCT01393145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64798837|NCT01393145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798838|NCT01393145|Glucocorticoids|glucocorticoids|mesh-ancestor
64798839|NCT01393145|Hormones|hormones|mesh-ancestor
64798840|NCT01393145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64798841|NCT01393145|Sympathomimetics|sympathomimetics|mesh-ancestor
65282589|NCT00974155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65282590|NCT00974155|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65282591|NCT00974155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65282592|NCT00974155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65282593|NCT00974155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282594|NCT00974155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65282595|NCT00974155|Serotonin Agents|serotonin agents|mesh-ancestor
65282596|NCT00974155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282597|NCT00974155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65282598|NCT00974155|Antidepressive Agents|antidepressive agents|mesh-ancestor
65282599|NCT00974155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65282600|NCT00974155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65282601|NCT00974155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65282602|NCT00974155|Parasympatholytics|parasympatholytics|mesh-ancestor
65282603|NCT00974155|Autonomic Agents|autonomic agents|mesh-ancestor
65282604|NCT00974155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65282605|NCT00974155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65282606|NCT00974155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65282607|NCT00974155|Cholinergic Agents|cholinergic agents|mesh-ancestor
65282608|NCT00974155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65282609|NCT00879996|Buprenorphine|buprenorphine|mesh-list
65282610|NCT00879996|Methadone|methadone|mesh-list
65282611|NCT00879996|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65282612|NCT00879996|Naloxone|naloxone|mesh-list
65282613|NCT00879996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65282614|NCT00879996|Narcotics|narcotics|mesh-ancestor
65282615|NCT00879996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65282616|NCT00879996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032626|NCT00170924|Valsartan|valsartan|mesh-list
65282617|NCT00879996|Analgesics|analgesics|mesh-ancestor
65282618|NCT00879996|Sensory System Agents|sensory system agents|mesh-ancestor
65282619|NCT00879996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65282620|NCT00879996|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65282621|NCT00879996|Antitussive Agents|antitussive agents|mesh-ancestor
64798842|NCT01393184|Nimotuzumab|nimotuzumab|mesh-list
64798843|NCT01393184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64798844|NCT01393184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798845|NCT01393288|Lorazepam|lorazepam|mesh-list
64798846|NCT01393288|Ondansetron|ondansetron|mesh-list
64798847|NCT01393288|Aprepitant|aprepitant|mesh-list
65282622|NCT00879996|Respiratory System Agents|respiratory system agents|mesh-ancestor
65282623|NCT00969163|Testosterone|testosterone|mesh-list
65282624|NCT00969163|Androgens|androgens|mesh-ancestor
65282625|NCT00969163|Hormones|hormones|mesh-ancestor
65282626|NCT00969163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65282627|NCT00969163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282628|NCT00873093|Leucovorin|leucovorin|mesh-list
65282629|NCT00873093|Cytarabine|cytarabine|mesh-list
65282630|NCT00873093|Prednisone|prednisone|mesh-list
65282631|NCT00873093|Hydrocortisone|hydrocortisone|mesh-list
64734950|NCT02036502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64734951|NCT02036502|Glucocorticoids|glucocorticoids|mesh-ancestor
64798848|NCT01393288|Antiemetics|antiemetics|mesh-ancestor
64798849|NCT01393288|Autonomic Agents|autonomic agents|mesh-ancestor
64798850|NCT01393288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64798874|NCT01393548|Phenylephrine|phenylephrine|mesh-list
64798875|NCT01393548|Oxymetazoline|oxymetazoline|mesh-list
64798876|NCT01393548|Pseudoephedrine|pseudoephedrine|mesh-list
64798877|NCT01393548|Ephedrine|ephedrine|mesh-list
64798878|NCT01393548|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64798879|NCT01393548|Mydriatics|mydriatics|mesh-ancestor
64798880|NCT01393548|Autonomic Agents|autonomic agents|mesh-ancestor
64798881|NCT01393548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64798882|NCT01393548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798883|NCT01393548|Sympathomimetics|sympathomimetics|mesh-ancestor
64798884|NCT01393548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64798885|NCT01393548|Nasal Decongestants|nasal decongestants|mesh-ancestor
64798886|NCT01393548|Respiratory System Agents|respiratory system agents|mesh-ancestor
64798887|NCT01393548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64798888|NCT01393548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64798889|NCT01393548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64798890|NCT01393548|Adrenergic Agents|adrenergic agents|mesh-ancestor
64798891|NCT01393548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64798892|NCT01393548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798893|NCT01393548|Protective Agents|protective agents|mesh-ancestor
64798894|NCT01393548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64798895|NCT01393548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64798896|NCT01393548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64798897|NCT01393548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64798898|NCT01393548|Histamine Antagonists|histamine antagonists|mesh-ancestor
64798899|NCT01393548|Histamine Agents|histamine agents|mesh-ancestor
64798900|NCT01393548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64798901|NCT01393574|Melatonin|melatonin|mesh-list
64798902|NCT01393574|Methylphenidate|methylphenidate|mesh-list
64798903|NCT01393574|Antioxidants|antioxidants|mesh-ancestor
64798904|NCT01393574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798905|NCT01393574|Protective Agents|protective agents|mesh-ancestor
64798906|NCT01393574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798907|NCT01393574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64798908|NCT01393574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64798909|NCT01393574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64798910|NCT01393574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64798911|NCT01393574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64798912|NCT01393574|Dopamine Agents|dopamine agents|mesh-ancestor
64798913|NCT01393574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64798914|NCT01393756|Lenalidomide|lenalidomide|mesh-list
64798915|NCT01393756|Immunologic Factors|immunologic factors|mesh-ancestor
64798916|NCT01393756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798917|NCT01393756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64410058|NCT05615987|Cholinergic Agents|cholinergic agents|mesh-ancestor
64798938|NCT01393782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798939|NCT01393795|Capsaicin|capsaicin|mesh-list
64798940|NCT01393795|Antipruritics|antipruritics|mesh-ancestor
64798941|NCT01393795|Dermatologic Agents|dermatologic agents|mesh-ancestor
64798942|NCT01393795|Sensory System Agents|sensory system agents|mesh-ancestor
64798986|NCT01394224|Anticonvulsants|anticonvulsants|mesh-ancestor
65282632|NCT00873093|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65282633|NCT00873093|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65282634|NCT00873093|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65282635|NCT00873093|Cyclophosphamide|cyclophosphamide|mesh-list
65282636|NCT00873093|Doxorubicin|doxorubicin|mesh-list
65282637|NCT00873093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65282638|NCT00873093|Methotrexate|methotrexate|mesh-list
65282639|NCT00873093|Etoposide|etoposide|mesh-list
65282640|NCT00873093|Vincristine|vincristine|mesh-list
65282641|NCT00873093|Bortezomib|bortezomib|mesh-list
65282642|NCT00873093|Asparaginase|asparaginase|mesh-list
65282643|NCT00873093|Pegaspargase|pegaspargase|mesh-list
65282644|NCT00873093|Etoposide phosphate|etoposide phosphate|mesh-list
65282645|NCT00873093|Levoleucovorin|levoleucovorin|mesh-list
65282646|NCT00873093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65282647|NCT00873093|Immunologic Factors|immunologic factors|mesh-ancestor
65282648|NCT00873093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282649|NCT00873093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65282650|NCT00873093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64798987|NCT01394224|Nootropic Agents|nootropic agents|mesh-ancestor
64798988|NCT01394263|Goserelin|goserelin|mesh-list
64798989|NCT01394263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64798990|NCT01394263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798991|NCT01394341|Liraglutide|liraglutide|mesh-list
64798992|NCT01394341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64798993|NCT01394341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798994|NCT01394341|Incretins|incretins|mesh-ancestor
64798995|NCT01394341|Hormones|hormones|mesh-ancestor
64798996|NCT01394341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64798997|NCT01394354|Dexamethasone|dexamethasone|mesh-list
64798998|NCT01394354|Dexamethasone acetate|dexamethasone acetate|mesh-list
64799006|NCT01394354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799008|NCT01394354|Glucocorticoids|glucocorticoids|mesh-ancestor
64799009|NCT01394354|Hormones|hormones|mesh-ancestor
64799010|NCT01394354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64799011|NCT01394354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64799012|NCT01394354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799013|NCT01394354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64799014|NCT01394354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64799015|NCT01394354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64799016|NCT01394354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799017|NCT01394354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799018|NCT01394354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64799019|NCT01394406|Ketamine|ketamine|mesh-list
64799020|NCT01394406|Analgesics|analgesics|mesh-ancestor
64799021|NCT01394406|Sensory System Agents|sensory system agents|mesh-ancestor
64799022|NCT01394406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64799023|NCT01394406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799024|NCT01394406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64799025|NCT01394406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64799026|NCT01394406|Anesthetics, General|anesthetics, general|mesh-ancestor
64799027|NCT01394406|Anesthetics|anesthetics|mesh-ancestor
64799028|NCT01394406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64799029|NCT01394406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64472122|NCT03780543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64799030|NCT01394406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64799031|NCT01394406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64799032|NCT01394406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282651|NCT00873093|Alkylating Agents|alkylating agents|mesh-ancestor
65282652|NCT00873093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282653|NCT00873093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282654|NCT00873093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65282655|NCT00873093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65282656|NCT00873093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65282657|NCT00873093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65282658|NCT00873093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282659|NCT00873093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65282660|NCT00873093|Glucocorticoids|glucocorticoids|mesh-ancestor
65282661|NCT00873093|Hormones|hormones|mesh-ancestor
65282662|NCT00873093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65282663|NCT00873093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65282664|NCT00873093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65282665|NCT00873093|Abortifacient Agents|abortifacient agents|mesh-ancestor
65282666|NCT00873093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65282667|NCT00873093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65282668|NCT00873093|Antimetabolites|antimetabolites|mesh-ancestor
65282669|NCT00873093|Dermatologic Agents|dermatologic agents|mesh-ancestor
65282670|NCT00873093|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65282671|NCT00873093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65282672|NCT00873093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65282673|NCT00873093|Antiviral Agents|antiviral agents|mesh-ancestor
65282674|NCT00873093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65282675|NCT00873093|Antidotes|antidotes|mesh-ancestor
65282676|NCT00873093|Protective Agents|protective agents|mesh-ancestor
65282677|NCT00873093|Vitamin B Complex|vitamin b complex|mesh-ancestor
65282678|NCT00873093|Vitamins|vitamins|mesh-ancestor
65282679|NCT00873093|Micronutrients|micronutrients|mesh-ancestor
65282680|NCT00873093|Tubulin Modulators|tubulin modulators|mesh-ancestor
65282681|NCT00873093|Antimitotic Agents|antimitotic agents|mesh-ancestor
65282682|NCT00873093|Mitosis Modulators|mitosis modulators|mesh-ancestor
65282683|NCT00969319|Factor VIII|factor viii|mesh-list
64799033|NCT01394419|Acetylcysteine|acetylcysteine|mesh-list
64799041|NCT01394419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799043|NCT01394419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799044|NCT01394419|Antidotes|antidotes|mesh-ancestor
64799045|NCT01394445|Physostigmine|physostigmine|mesh-list
64799046|NCT01394445|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64799047|NCT01394445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799048|NCT01394445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282684|NCT00969319|Coagulants|coagulants|mesh-ancestor
65282685|NCT02784899|Iloprost|iloprost|mesh-list
65282686|NCT02784899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65282687|NCT02784899|Vasodilator Agents|vasodilator agents|mesh-ancestor
65282688|NCT00974389|Bevacizumab|bevacizumab|mesh-list
65282689|NCT00974389|Tegafur|tegafur|mesh-list
65032696|NCT00171119|Valsartan|valsartan|mesh-list
65282690|NCT00974389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65282691|NCT00974389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282692|NCT00974389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65282693|NCT00974389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65282694|NCT00974389|Growth Substances|growth substances|mesh-ancestor
65282695|NCT00974389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282696|NCT00974389|Growth Inhibitors|growth inhibitors|mesh-ancestor
65282697|NCT00974389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65282698|NCT00974389|Antimetabolites|antimetabolites|mesh-ancestor
65282699|NCT00974389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282700|NCT00969397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
65282701|NCT00969397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65282702|NCT00969397|Growth Substances|growth substances|mesh-ancestor
65282703|NCT00969397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282704|NCT00969397|Growth Inhibitors|growth inhibitors|mesh-ancestor
65282705|NCT00969397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282706|NCT00647660|Nadolol|nadolol|mesh-list
65282707|NCT00647660|Bendroflumethiazide|bendroflumethiazide|mesh-list
65282708|NCT00647660|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65282709|NCT00647660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65282710|NCT00647660|Adrenergic Agents|adrenergic agents|mesh-ancestor
64799049|NCT01394445|Cholinergic Agents|cholinergic agents|mesh-ancestor
64799050|NCT01394445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64799051|NCT01394445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799052|NCT01394445|Miotics|miotics|mesh-ancestor
64799053|NCT01394445|Autonomic Agents|autonomic agents|mesh-ancestor
64799054|NCT01394445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64799055|NCT01394458|Ethanol|ethanol|mesh-list
64799056|NCT01394458|Heparin|heparin|mesh-list
64799057|NCT01394458|Citric Acid|citric acid|mesh-list
64799058|NCT01394458|Sodium Citrate|sodium citrate|mesh-list
64799059|NCT01394458|Anticoagulants|anticoagulants|mesh-ancestor
64799060|NCT01394458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64799061|NCT01394458|Chelating Agents|chelating agents|mesh-ancestor
64799062|NCT01394458|Sequestering Agents|sequestering agents|mesh-ancestor
64799063|NCT01394458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799064|NCT01394458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64799065|NCT01394458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64799066|NCT01394458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64799067|NCT01394458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64799068|NCT01394458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65282711|NCT00647660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65282712|NCT00647660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282713|NCT00647660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282714|NCT00647660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65282715|NCT00647660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65282716|NCT00647660|Sympatholytics|sympatholytics|mesh-ancestor
65282717|NCT00647660|Autonomic Agents|autonomic agents|mesh-ancestor
65282719|NCT00647660|Diuretics|diuretics|mesh-ancestor
65282778|NCT04033250|Chelating Agents|chelating agents|mesh-ancestor
65282779|NCT04033250|Sequestering Agents|sequestering agents|mesh-ancestor
65282780|NCT04033250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282781|NCT04033250|Antacids|antacids|mesh-ancestor
65282782|NCT02624973|Tamoxifen|tamoxifen|mesh-list
65282783|NCT02624973|Cyclophosphamide|cyclophosphamide|mesh-list
65282784|NCT02624973|Docetaxel|docetaxel|mesh-list
65282785|NCT02624973|Trastuzumab|trastuzumab|mesh-list
65282786|NCT02624973|Letrozole|letrozole|mesh-list
65282787|NCT02624973|Epirubicin|epirubicin|mesh-list
65282788|NCT02624973|Olaparib|olaparib|mesh-list
65282789|NCT02624973|Palbociclib|palbociclib|mesh-list
65282790|NCT02624973|Pertuzumab|pertuzumab|mesh-list
65282791|NCT02624973|Goserelin|goserelin|mesh-list
65282792|NCT02624973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65282793|NCT02624973|Immunologic Factors|immunologic factors|mesh-ancestor
65282794|NCT02624973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282795|NCT02624973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64799069|NCT01394458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799070|NCT01394471|Oxytocin|oxytocin|mesh-list
64799110|NCT01394731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64799111|NCT01394731|Narcotics|narcotics|mesh-ancestor
64799112|NCT01394731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64799113|NCT01394731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64799114|NCT01394757|Ketamine|ketamine|mesh-list
64799115|NCT01394757|Esketamine|esketamine|mesh-list
64799116|NCT01394757|Analgesics|analgesics|mesh-ancestor
64799117|NCT01394757|Sensory System Agents|sensory system agents|mesh-ancestor
64799118|NCT01394757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64799119|NCT01394757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799120|NCT01394757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64799132|NCT01394770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64799133|NCT01394770|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64799134|NCT01394770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64799135|NCT01394770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799136|NCT01394770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64799137|NCT01394770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799138|NCT01394770|Vasodilator Agents|vasodilator agents|mesh-ancestor
64799139|NCT01394796|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
64799141|NCT01394796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799142|NCT01394796|Protective Agents|protective agents|mesh-ancestor
64799143|NCT01394796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799144|NCT01394796|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64799145|NCT01394796|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64799146|NCT01394796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799147|NCT01394796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64799148|NCT01394835|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64799149|NCT01394835|Protein C Inhibitor|protein c inhibitor|mesh-list
64799150|NCT01394835|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64799151|NCT01394835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64799152|NCT01394835|Protease Inhibitors|protease inhibitors|mesh-ancestor
64799153|NCT01394835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799154|NCT01394835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567763|NCT01457989|Ezogabine|ezogabine|mesh-list
64799155|NCT01394848|Everolimus|everolimus|mesh-list
64799156|NCT01394848|Clopidogrel|clopidogrel|mesh-list
64799157|NCT01394848|Atorvastatin|atorvastatin|mesh-list
64799158|NCT01394848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64799159|NCT01394848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64799160|NCT01394848|Antimetabolites|antimetabolites|mesh-ancestor
64799161|NCT01394848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799162|NCT01394848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65282796|NCT02624973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65282797|NCT02624973|Alkylating Agents|alkylating agents|mesh-ancestor
65282798|NCT02624973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282799|NCT02624973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282800|NCT02624973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65282801|NCT02624973|Tubulin Modulators|tubulin modulators|mesh-ancestor
65282802|NCT02624973|Antimitotic Agents|antimitotic agents|mesh-ancestor
65282803|NCT02624973|Mitosis Modulators|mitosis modulators|mesh-ancestor
65282804|NCT02624973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65282805|NCT02624973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65282806|NCT02624973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65282807|NCT02624973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282808|NCT02624973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65282809|NCT02624973|Hormone Antagonists|hormone antagonists|mesh-ancestor
64735121|NCT02049138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64735122|NCT02049138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799163|NCT01394848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64799164|NCT01394848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799165|NCT01394848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799166|NCT01394848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64799188|NCT01394913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64799189|NCT01394913|Immunologic Factors|immunologic factors|mesh-ancestor
64799190|NCT01395069|Ketorolac|ketorolac|mesh-list
64799191|NCT01395069|Nepafenac|nepafenac|mesh-list
64799192|NCT01395069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64799193|NCT01395069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64799194|NCT01395069|Analgesics|analgesics|mesh-ancestor
64799195|NCT01395069|Sensory System Agents|sensory system agents|mesh-ancestor
64799196|NCT01395069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64799197|NCT01395069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799198|NCT01395069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64799199|NCT01395069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64799200|NCT01395069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64799201|NCT01395069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799202|NCT01395069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799203|NCT01395147|Vortioxetine|vortioxetine|mesh-list
64799204|NCT01395147|Antidepressive Agents|antidepressive agents|mesh-ancestor
64799233|NCT01395251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799234|NCT01395251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64799235|NCT01395251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799236|NCT01395290|Cholecalciferol|cholecalciferol|mesh-list
64799237|NCT01395290|Vitamin D|vitamin d|mesh-list
64799238|NCT01395290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64799239|NCT01395290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799240|NCT01395290|Vitamins|vitamins|mesh-ancestor
64799241|NCT01395290|Micronutrients|micronutrients|mesh-ancestor
64799242|NCT01395290|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64799243|NCT01395381|Albendazole|albendazole|mesh-list
64799244|NCT01395381|Anthelmintics|anthelmintics|mesh-ancestor
64799245|NCT01395381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64799246|NCT01395381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64799247|NCT01395381|Anticestodal Agents|anticestodal agents|mesh-ancestor
64799248|NCT01395381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64799249|NCT01395381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64799250|NCT01395381|Tubulin Modulators|tubulin modulators|mesh-ancestor
64799251|NCT01395381|Antimitotic Agents|antimitotic agents|mesh-ancestor
64799252|NCT01395381|Mitosis Modulators|mitosis modulators|mesh-ancestor
64799253|NCT01395381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282810|NCT02624973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65282811|NCT02624973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65282812|NCT02624973|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65282813|NCT02624973|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65282814|NCT02624973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65282815|NCT02624973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65282816|NCT02624973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65282817|NCT02624973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65282818|NCT02624973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65282819|NCT02624973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64735141|NCT02029638|Prednisone|prednisone|mesh-list
64799254|NCT01395381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799255|NCT01395420|Ceftazidime|ceftazidime|mesh-list
64799256|NCT01395420|Avibactam|avibactam|mesh-list
64799257|NCT01395420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64799258|NCT01395420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64799259|NCT01395420|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64799260|NCT01395420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799261|NCT01395420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799262|NCT01395433|Dexetimide|dexetimide|mesh-list
64799263|NCT01395433|Citalopram|citalopram|mesh-list
64799264|NCT01395433|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64799265|NCT01395433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64799297|NCT01395654|Rifampin|rifampin|mesh-list
64799298|NCT01395654|Isoniazid|isoniazid|mesh-list
64799299|NCT01395654|Pyrazinamide|pyrazinamide|mesh-list
64799300|NCT01395654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64799301|NCT01395654|Antitubercular Agents|antitubercular agents|mesh-ancestor
64799302|NCT01395654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64799303|NCT01395654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64799304|NCT01395654|Leprostatic Agents|leprostatic agents|mesh-ancestor
64472143|NCT03772314|Modafinil|modafinil|mesh-list
64799305|NCT01395654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64799306|NCT01395654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799307|NCT01395654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799308|NCT01395654|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64799309|NCT01395654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64799310|NCT01395654|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64799311|NCT01395654|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64799312|NCT01395654|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64799313|NCT01395654|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64799314|NCT01395654|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64799315|NCT01395654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64799316|NCT01395654|Antimetabolites|antimetabolites|mesh-ancestor
64799317|NCT01395654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64799318|NCT01395667|Leucovorin|leucovorin|mesh-list
64799319|NCT01395667|Fluorouracil|fluorouracil|mesh-list
64799320|NCT01395667|Oxaliplatin|oxaliplatin|mesh-list
64799321|NCT01395667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799322|NCT01395667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799323|NCT01395667|Antimetabolites|antimetabolites|mesh-ancestor
64799324|NCT01395667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799325|NCT01395667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64799326|NCT01395667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64799327|NCT01395667|Immunologic Factors|immunologic factors|mesh-ancestor
64799357|NCT01395849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64799359|NCT01395862|Fluticasone|fluticasone|mesh-list
64799360|NCT01395862|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64799361|NCT01395862|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64799362|NCT01395862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65282820|NCT00647816|Propranolol|propranolol|mesh-list
65282821|NCT00647816|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65282822|NCT00647816|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65282823|NCT00647816|Adrenergic Agents|adrenergic agents|mesh-ancestor
65282824|NCT00647816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65282825|NCT00647816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282826|NCT00647816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282827|NCT00647816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65282828|NCT00647816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65282829|NCT00647816|Vasodilator Agents|vasodilator agents|mesh-ancestor
65282830|NCT05182931|Trametinib|trametinib|mesh-list
65282831|NCT05182931|Dabrafenib|dabrafenib|mesh-list
65282832|NCT05182931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282833|NCT05182931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65282834|NCT05182931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282835|NCT05182931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282836|NCT00647894|Alprazolam|alprazolam|mesh-list
65282837|NCT00647894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65282838|NCT00647894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65282839|NCT00647894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282840|NCT00647894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65282841|NCT00647894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65282842|NCT00647894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65282843|NCT00647894|GABA Modulators|gaba modulators|mesh-ancestor
65032836|NCT00611572|GABA Agents|gaba agents|mesh-ancestor
65282844|NCT00647894|GABA Agents|gaba agents|mesh-ancestor
64799363|NCT01395862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64799364|NCT01395862|Autonomic Agents|autonomic agents|mesh-ancestor
64799365|NCT01395862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64799366|NCT01395862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799367|NCT01395862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64799368|NCT01395862|Respiratory System Agents|respiratory system agents|mesh-ancestor
64799369|NCT01395862|Dermatologic Agents|dermatologic agents|mesh-ancestor
64799370|NCT01395862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64799371|NCT01395862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64799372|NCT01395862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64799373|NCT01395862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64799374|NCT01395862|Adrenergic Agents|adrenergic agents|mesh-ancestor
64799375|NCT01395862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64799376|NCT01395862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799377|NCT01395862|Glucocorticoids|glucocorticoids|mesh-ancestor
64799378|NCT01395862|Hormones|hormones|mesh-ancestor
64799379|NCT01395862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64799380|NCT01395862|Sympathomimetics|sympathomimetics|mesh-ancestor
64799381|NCT01395875|Fluticasone|fluticasone|mesh-list
64799383|NCT01395875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64799384|NCT01395875|Cholinergic Antagonists|cholinergic antagonists|mesh-list
64799385|NCT01395875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64472144|NCT03772314|Amphetamine|amphetamine|mesh-list
65282845|NCT00647894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65282846|NCT00647894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282848|NCT02782559|Vasodilator Agents|vasodilator agents|mesh-ancestor
65282849|NCT02782559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65282850|NCT02782559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65282851|NCT02782559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282852|NCT02782559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282853|NCT02782559|Urological Agents|urological agents|mesh-ancestor
65282854|NCT00647972|Olanzapine|olanzapine|mesh-list
65282855|NCT00647972|Antiemetics|antiemetics|mesh-ancestor
65282856|NCT00647972|Autonomic Agents|autonomic agents|mesh-ancestor
65282857|NCT00647972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65282858|NCT00647972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282859|NCT00647972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65282860|NCT00647972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65282861|NCT00647972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65282862|NCT00647972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65282863|NCT00647972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65282864|NCT00647972|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65282865|NCT00647972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65282866|NCT00647972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65282867|NCT00647972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282868|NCT00647972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65282869|NCT00647972|Serotonin Agents|serotonin agents|mesh-ancestor
64799386|NCT01395875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64799387|NCT01395875|Autonomic Agents|autonomic agents|mesh-ancestor
64799388|NCT01395875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64799389|NCT01395875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799390|NCT01395875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64799432|NCT01395992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64799457|NCT01396291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64799458|NCT01396304|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64799459|NCT01396304|Calcium|calcium|mesh-list
64799460|NCT01396304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64799461|NCT01396304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799462|NCT01396304|Laxatives|laxatives|mesh-ancestor
64799463|NCT01396304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64799464|NCT01396564|Metformin|metformin|mesh-list
64472145|NCT03772314|Adderall|adderall|mesh-list
64472146|NCT03772314|Dextroamphetamine|dextroamphetamine|mesh-list
64799465|NCT01396564|Pioglitazone|pioglitazone|mesh-list
64799466|NCT01396564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64799467|NCT01396564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799468|NCT01396642|Emollients|emollients|mesh-list
64799469|NCT01396642|Dermatologic Agents|dermatologic agents|mesh-ancestor
64799470|NCT01396655|Docetaxel|docetaxel|mesh-list
64799471|NCT01396655|Doxorubicin|doxorubicin|mesh-list
64799472|NCT01396655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799473|NCT01396655|Tubulin Modulators|tubulin modulators|mesh-ancestor
64799474|NCT01396655|Antimitotic Agents|antimitotic agents|mesh-ancestor
65282870|NCT02782403|Axitinib|axitinib|mesh-list
65282871|NCT02782403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65282872|NCT02782403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65282873|NCT02782403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282874|NCT02782403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282875|NCT00646178|Adalimumab|adalimumab|mesh-list
65282876|NCT00646178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65282877|NCT00646178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65282878|NCT02624817|Glyburide|glyburide|mesh-list
65282879|NCT02624817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65282880|NCT02624817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282881|NCT02664116|Diclofenac|diclofenac|mesh-list
64799475|NCT01396655|Mitosis Modulators|mitosis modulators|mesh-ancestor
64799476|NCT01396655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799477|NCT01396655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64799478|NCT01396655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64799479|NCT01396655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64799480|NCT01396655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799481|NCT01396668|Gemcitabine|gemcitabine|mesh-list
64799492|NCT01396668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799493|NCT01396681|Gemcitabine|gemcitabine|mesh-list
64799515|NCT01396720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64799516|NCT01396720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799517|NCT01396720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64799518|NCT01396720|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64799519|NCT01396720|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64799520|NCT01396720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64799521|NCT01396720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799522|NCT01396720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64799523|NCT01396720|Serotonin Agents|serotonin agents|mesh-ancestor
64799524|NCT01396720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64568136|NCT01361217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64799525|NCT01396720|Antidepressive Agents|antidepressive agents|mesh-ancestor
64799526|NCT01396720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64799527|NCT01396720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64799528|NCT01396720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799529|NCT01396720|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64799531|NCT01396733|Antioxidants|antioxidants|mesh-ancestor
64799532|NCT01396733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799533|NCT01396733|Protective Agents|protective agents|mesh-ancestor
64799534|NCT01396733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799535|NCT01396733|Vitamin B Complex|vitamin b complex|mesh-ancestor
64799537|NCT01396733|Micronutrients|micronutrients|mesh-ancestor
64799538|NCT01397006|Pregabalin|pregabalin|mesh-list
64799539|NCT01397006|Analgesics|analgesics|mesh-ancestor
64799540|NCT01397006|Sensory System Agents|sensory system agents|mesh-ancestor
64799541|NCT01397006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64799542|NCT01397006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799543|NCT01397006|Anticonvulsants|anticonvulsants|mesh-ancestor
64799544|NCT01397006|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64799545|NCT01397006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64799589|NCT01397214|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64799590|NCT01397214|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64799591|NCT01397305|Pemetrexed|pemetrexed|mesh-list
64799592|NCT01397305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799593|NCT01397305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799594|NCT01397305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799595|NCT01397305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64799596|NCT01397305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64799597|NCT01397331|Propofol|propofol|mesh-list
64799598|NCT01397331|Isoflurane|isoflurane|mesh-list
64799603|NCT01397331|Anesthetics, General|anesthetics, general|mesh-ancestor
65282882|NCT02664116|Ketorolac|ketorolac|mesh-list
65282883|NCT02664116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65282884|NCT02664116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65282885|NCT02664116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65282886|NCT02664116|Analgesics|analgesics|mesh-ancestor
65282887|NCT02664116|Sensory System Agents|sensory system agents|mesh-ancestor
65282888|NCT02664116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65282889|NCT02664116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282890|NCT02664116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65282891|NCT02664116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65282892|NCT02664116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65282893|NCT02664116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282894|NCT02664116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282895|NCT00692601|Capsaicin|capsaicin|mesh-list
65282896|NCT00692601|Antipruritics|antipruritics|mesh-ancestor
65282897|NCT00692601|Dermatologic Agents|dermatologic agents|mesh-ancestor
65282898|NCT00692601|Sensory System Agents|sensory system agents|mesh-ancestor
65282899|NCT00692601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65282900|NCT00692601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282901|NCT02785055|Hydromorphone|hydromorphone|mesh-list
65282902|NCT02785055|Bupivacaine|bupivacaine|mesh-list
65282903|NCT02785055|Anesthetics, Local|anesthetics, local|mesh-ancestor
65282935|NCT02624505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65282936|NCT02624505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65282937|NCT02624505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65282938|NCT02624505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65282939|NCT02624505|Adrenergic Agents|adrenergic agents|mesh-ancestor
65282940|NCT02624505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65282941|NCT02624505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282942|NCT00969631|Metformin|metformin|mesh-list
65282943|NCT00969631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65282944|NCT00969631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282945|NCT02782481|Levodopa|levodopa|mesh-list
65282946|NCT02782481|Carbidopa|carbidopa|mesh-list
65282947|NCT02782481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65282948|NCT02782481|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65282949|NCT02782481|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65282950|NCT02782481|Dopamine Agents|dopamine agents|mesh-ancestor
65282951|NCT02782481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64735263|NCT01990560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64799605|NCT01397331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64799606|NCT05269290|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
64799607|NCT05269290|Antiviral Agents|antiviral agents|mesh-ancestor
64799608|NCT05269290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64799618|NCT05268718|Antifungal Agents|antifungal agents|mesh-ancestor
64799619|NCT05268718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64799620|NCT05268718|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64799621|NCT05268718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64799622|NCT05268718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799623|NCT05268718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799624|NCT05268718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64799625|NCT05268718|Hormone Antagonists|hormone antagonists|mesh-ancestor
64799626|NCT05268718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64799627|NCT05268718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799628|NCT05268718|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64799629|NCT05268627|Liraglutide|liraglutide|mesh-list
64799630|NCT05268627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64799631|NCT05268627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799632|NCT05268627|Incretins|incretins|mesh-ancestor
64799633|NCT05268627|Hormones|hormones|mesh-ancestor
64799634|NCT05268627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64799635|NCT05268601|Bamlanivimab|bamlanivimab|mesh-list
64799636|NCT05268601|Antiviral Agents|antiviral agents|mesh-ancestor
64799637|NCT05268601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64799638|NCT05268068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64799639|NCT05268068|Immunologic Factors|immunologic factors|mesh-ancestor
64472148|NCT03772314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799640|NCT05268068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799642|NCT05267977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64799643|NCT05267977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64799644|NCT05186558|Gemcitabine|gemcitabine|mesh-list
64799645|NCT05186558|Rituximab|rituximab|mesh-list
64799646|NCT05186558|Oxaliplatin|oxaliplatin|mesh-list
64799647|NCT05186558|Lenalidomide|lenalidomide|mesh-list
64799648|NCT05186558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64799649|NCT05186558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799650|NCT05186558|Immunologic Factors|immunologic factors|mesh-ancestor
64799651|NCT05186558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282952|NCT02782481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282953|NCT02782481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282954|NCT02782481|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65282955|NCT02782481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282956|NCT00648128|Clarithromycin|clarithromycin|mesh-list
65282957|NCT00648128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65282958|NCT00648128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65282959|NCT00648128|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65282960|NCT00648128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282961|NCT00648128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282962|NCT00648128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65282963|NCT00648128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65282964|NCT05342597|Edaravone|edaravone|mesh-list
65282965|NCT05342597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65282966|NCT05342597|Antioxidants|antioxidants|mesh-ancestor
65282967|NCT05342597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282968|NCT05342597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65282969|NCT05342597|Protective Agents|protective agents|mesh-ancestor
65282970|NCT05342597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282971|NCT02784821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65282972|NCT02784821|Gentamicins|gentamicins|mesh-list
65282973|NCT02784821|Ampicillin|ampicillin|mesh-list
65282974|NCT02784821|Cefotaxime|cefotaxime|mesh-list
65282975|NCT02784821|Cefoxitin|cefoxitin|mesh-list
65282976|NCT02784821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65282977|NCT02784821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65282978|NCT02784821|Antitubercular Agents|antitubercular agents|mesh-ancestor
65282979|NCT02784821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65282980|NCT02784821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65282981|NCT02784821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282982|NCT00693069|Clopidogrel|clopidogrel|mesh-list
64735280|NCT01999218|Incretins|incretins|mesh-ancestor
64799652|NCT05186558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64799653|NCT05186558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64799654|NCT05186558|Antimetabolites|antimetabolites|mesh-ancestor
64799655|NCT05186558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799656|NCT05186558|Antiviral Agents|antiviral agents|mesh-ancestor
64799657|NCT05186558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64799658|NCT05186558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799659|NCT05186558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64799660|NCT05186558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65282983|NCT00693069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65282984|NCT00693069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65282985|NCT00693069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65282986|NCT00693069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65282987|NCT00693069|Purinergic Agents|purinergic agents|mesh-ancestor
65282988|NCT00693069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65282989|NCT00693069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282990|NCT00693069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282991|NCT04949282|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65282992|NCT04949282|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65282993|NCT04949282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65282994|NCT00974935|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65282995|NCT00974935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65282996|NCT00974935|Immunologic Factors|immunologic factors|mesh-ancestor
65282997|NCT00974935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65282998|NCT00974935|Antacids|antacids|mesh-ancestor
65282999|NCT00974935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283000|NCT00974935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65283001|NCT00665808|Insulin|insulin|mesh-list
65283002|NCT00665808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65283003|NCT00665808|Insulin Detemir|insulin detemir|mesh-list
65283004|NCT00665808|Isophane Insulin, Human|isophane insulin, human|mesh-list
65283005|NCT00665808|Insulin, Isophane|insulin, isophane|mesh-list
65283006|NCT00665808|Isophane insulin, beef|isophane insulin, beef|mesh-list
65283007|NCT00665808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65283008|NCT00665808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283009|NCT04230083|Dienogest|dienogest|mesh-list
65283010|NCT04230083|Nandrolone|nandrolone|mesh-list
65283011|NCT04230083|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65283012|NCT04230083|Contraceptive Agents|contraceptive agents|mesh-ancestor
65283013|NCT04230083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65283025|NCT04230083|Anabolic Agents|anabolic agents|mesh-ancestor
65283026|NCT00645866|Docetaxel|docetaxel|mesh-list
65283027|NCT00645866|Capecitabine|capecitabine|mesh-list
65283028|NCT00645866|Epirubicin|epirubicin|mesh-list
65283029|NCT00645866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283030|NCT00645866|Tubulin Modulators|tubulin modulators|mesh-ancestor
65283031|NCT00645866|Antimitotic Agents|antimitotic agents|mesh-ancestor
65283032|NCT00645866|Mitosis Modulators|mitosis modulators|mesh-ancestor
65283033|NCT00645866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283034|NCT00645866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65283035|NCT00645866|Antimetabolites|antimetabolites|mesh-ancestor
65283036|NCT00645866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65283037|NCT00645866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65283038|NCT00645866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65283039|NCT00645866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283040|NCT05221151|Pregabalin|pregabalin|mesh-list
65283041|NCT05221151|Ondansetron|ondansetron|mesh-list
65283042|NCT05221151|Melatonin|melatonin|mesh-list
65283043|NCT05221151|Analgesics|analgesics|mesh-ancestor
65283044|NCT05221151|Sensory System Agents|sensory system agents|mesh-ancestor
65283045|NCT05221151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65283046|NCT05221151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283047|NCT05221151|Anticonvulsants|anticonvulsants|mesh-ancestor
65283048|NCT05221151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65283049|NCT05221151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65283050|NCT05221151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283051|NCT05221151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65283052|NCT05221151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65283053|NCT05221151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65283054|NCT05221151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65283055|NCT05221151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65283056|NCT05221151|Antioxidants|antioxidants|mesh-ancestor
65283057|NCT05221151|Protective Agents|protective agents|mesh-ancestor
65283058|NCT05221151|Antiemetics|antiemetics|mesh-ancestor
65283068|NCT04008043|Dexamethasone|dexamethasone|mesh-list
65283069|NCT04008043|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65283070|NCT04008043|Hydrocodone|hydrocodone|mesh-list
65283071|NCT04008043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65283072|NCT04008043|Antiemetics|antiemetics|mesh-ancestor
65283073|NCT04008043|Autonomic Agents|autonomic agents|mesh-ancestor
65283074|NCT04008043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65283075|NCT04008043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283077|NCT04008043|Glucocorticoids|glucocorticoids|mesh-ancestor
65283078|NCT04008043|Hormones|hormones|mesh-ancestor
65283079|NCT04008043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65283080|NCT04008043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65283081|NCT04008043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799661|NCT05186558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64799662|NCT05186558|Growth Substances|growth substances|mesh-ancestor
64799663|NCT05186558|Growth Inhibitors|growth inhibitors|mesh-ancestor
64799664|NCT05092698|Vitamin D|vitamin d|mesh-list
64799665|NCT05092698|Cholecalciferol|cholecalciferol|mesh-list
64799666|NCT05092698|Vitamins|vitamins|mesh-ancestor
64799667|NCT05092698|Micronutrients|micronutrients|mesh-ancestor
64799668|NCT05092698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799669|NCT05092698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64799670|NCT05092698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64799671|NCT04975269|Acetazolamide|acetazolamide|mesh-list
64799672|NCT04975269|Anticonvulsants|anticonvulsants|mesh-ancestor
64799673|NCT04975269|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64799674|NCT04975269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799675|NCT04975269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799696|NCT04604353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64799710|NCT04466540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799711|NCT04466540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799712|NCT04466540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64799713|NCT04453449|Midazolam|midazolam|mesh-list
64799714|NCT04453449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64799715|NCT04453449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64799716|NCT04453449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64799717|NCT04453449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799718|NCT04453449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64799719|NCT04453449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64799720|NCT04453449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64799721|NCT04453449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64799722|NCT04453449|Anesthetics, General|anesthetics, general|mesh-ancestor
64799723|NCT04453449|Anesthetics|anesthetics|mesh-ancestor
64799724|NCT04453449|GABA Modulators|gaba modulators|mesh-ancestor
64799725|NCT04453449|GABA Agents|gaba agents|mesh-ancestor
64799726|NCT04453449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64799727|NCT04453449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799728|NCT04415333|Butyric Acid|butyric acid|mesh-list
64799729|NCT04415333|Histamine Antagonists|histamine antagonists|mesh-ancestor
64799730|NCT04415333|Histamine Agents|histamine agents|mesh-ancestor
64799738|NCT04093596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799740|NCT04093596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64799741|NCT04093596|Alkylating Agents|alkylating agents|mesh-ancestor
64472149|NCT03772314|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64799742|NCT04093596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799743|NCT04093596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799744|NCT04093596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64799745|NCT03524170|Atezolizumab|atezolizumab|mesh-list
64799746|NCT03524170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799747|NCT03336983|Zoledronic Acid|zoledronic acid|mesh-list
64799748|NCT03336983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65283082|NCT04008043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65283083|NCT04008043|Analgesics|analgesics|mesh-ancestor
65283084|NCT04008043|Sensory System Agents|sensory system agents|mesh-ancestor
65283085|NCT04008043|Antipyretics|antipyretics|mesh-ancestor
65283086|NCT04008043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65283087|NCT04008043|Narcotics|narcotics|mesh-ancestor
65283088|NCT04008043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65283089|NCT04008043|Antitussive Agents|antitussive agents|mesh-ancestor
65283090|NCT04008043|Respiratory System Agents|respiratory system agents|mesh-ancestor
65283091|NCT04008043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65283092|NCT04008043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65283093|NCT02783183|Pregabalin|pregabalin|mesh-list
65283094|NCT02783183|Analgesics|analgesics|mesh-ancestor
65283095|NCT02783183|Sensory System Agents|sensory system agents|mesh-ancestor
65283096|NCT02783183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65283097|NCT02783183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283098|NCT02783183|Anticonvulsants|anticonvulsants|mesh-ancestor
65283099|NCT02783183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65283100|NCT02783183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65283101|NCT02783183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283102|NCT02783183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65283103|NCT02783183|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65283104|NCT02783183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65283105|NCT02783183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64799749|NCT03336983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799750|NCT03283813|Inositol|inositol|mesh-list
64799751|NCT03283813|Vitamin B Complex|vitamin b complex|mesh-ancestor
64799752|NCT03283813|Vitamins|vitamins|mesh-ancestor
64799754|NCT03283813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799755|NCT03283384|Letrozole|letrozole|mesh-list
64799756|NCT03283384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799757|NCT03283384|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64799758|NCT03283384|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64799759|NCT03283384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799760|NCT03283384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799761|NCT03283384|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64799762|NCT03283384|Hormone Antagonists|hormone antagonists|mesh-ancestor
64799763|NCT03283384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64799764|NCT03283384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799765|NCT03245827|Clomiphene|clomiphene|mesh-list
64799766|NCT03245827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64799767|NCT03245827|Hormone Antagonists|hormone antagonists|mesh-ancestor
64799778|NCT03129321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64799779|NCT03129321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64799780|NCT03129321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799781|NCT03129321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799782|NCT03129321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64799783|NCT03129321|Hormone Antagonists|hormone antagonists|mesh-ancestor
65222793|NCT04215159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283106|NCT02783183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65283107|NCT00693381|Mycophenolic Acid|mycophenolic acid|mesh-list
65283108|NCT00693381|Prednisone|prednisone|mesh-list
65283109|NCT00693381|Methylprednisolone|methylprednisolone|mesh-list
65283110|NCT00693381|Tacrolimus|tacrolimus|mesh-list
65283111|NCT00693381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65283112|NCT00693381|Glucocorticoids|glucocorticoids|mesh-ancestor
65283113|NCT00693381|Hormones|hormones|mesh-ancestor
65283114|NCT00693381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65283115|NCT00693381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283116|NCT00693381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65283117|NCT00693381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283118|NCT00693381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65283119|NCT00693381|Immunologic Factors|immunologic factors|mesh-ancestor
65283120|NCT00693381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65283121|NCT00693381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283122|NCT00693381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283123|NCT00693381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65283124|NCT00693381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65283125|NCT00693381|Antitubercular Agents|antitubercular agents|mesh-ancestor
65283126|NCT00693381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65283127|NCT00693381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65283128|NCT00693381|Antiemetics|antiemetics|mesh-ancestor
65283129|NCT00693381|Autonomic Agents|autonomic agents|mesh-ancestor
65283130|NCT00693381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65283131|NCT00693381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65283132|NCT00693381|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65283133|NCT00693381|Protective Agents|protective agents|mesh-ancestor
65283134|NCT05285891|Ocrelizumab|ocrelizumab|mesh-list
65283135|NCT05285891|Immunologic Factors|immunologic factors|mesh-ancestor
65283136|NCT05285891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283137|NCT00693615|Vaccines|vaccines|mesh-list
65283138|NCT00693615|Immunologic Factors|immunologic factors|mesh-ancestor
65283149|NCT00693771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283151|NCT00693849|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65283152|NCT00693849|Sertraline|sertraline|mesh-list
65283153|NCT00693849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65283154|NCT00693849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65283155|NCT00693849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65283156|NCT00693849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283157|NCT00693849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65283158|NCT00693849|Serotonin Agents|serotonin agents|mesh-ancestor
65283159|NCT00693849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283160|NCT00693849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65283161|NCT00693849|Antidepressive Agents|antidepressive agents|mesh-ancestor
65283162|NCT00693849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65283163|NCT00693849|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65283164|NCT00693927|Fludarabine|fludarabine|mesh-list
65283165|NCT00693927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283166|NCT00648362|Glimepiride|glimepiride|mesh-list
65283167|NCT00648362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65283168|NCT00648362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65283169|NCT00648362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283170|NCT00648362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65283171|NCT00648362|Immunologic Factors|immunologic factors|mesh-ancestor
65283172|NCT00648440|Midodrine|midodrine|mesh-list
65283173|NCT00648440|Sympathomimetics|sympathomimetics|mesh-ancestor
64799784|NCT03129321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64799785|NCT03129321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799786|NCT03107611|Pimecrolimus|pimecrolimus|mesh-list
64799787|NCT03107611|Tacrolimus|tacrolimus|mesh-list
64799788|NCT03107611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64799789|NCT03107611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64799790|NCT03107611|Analgesics|analgesics|mesh-ancestor
64799791|NCT03107611|Sensory System Agents|sensory system agents|mesh-ancestor
64799792|NCT03107611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64799793|NCT03107611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799794|NCT03107611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64799795|NCT03107611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64410937|NCT04982367|Paclitaxel|paclitaxel|mesh-list
64799810|NCT03040726|Serotonin Agents|serotonin agents|mesh-ancestor
64799811|NCT03040726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64799812|NCT03040726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799813|NCT02607956|Dolutegravir|dolutegravir|mesh-list
64799814|NCT02607956|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64799815|NCT02607956|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64799816|NCT02607956|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64799817|NCT02607956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799818|NCT02607956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799819|NCT02607956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64799820|NCT02607956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64799821|NCT02607956|Antiviral Agents|antiviral agents|mesh-ancestor
65283174|NCT00648440|Autonomic Agents|autonomic agents|mesh-ancestor
65283175|NCT00648440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65283176|NCT00648440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283177|NCT00648440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65283178|NCT00648440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65283179|NCT00648440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65283180|NCT00648440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65283181|NCT00648440|Adrenergic Agents|adrenergic agents|mesh-ancestor
65283182|NCT00648440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65283183|NCT00648440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283184|NCT00694005|Sirolimus|sirolimus|mesh-list
65283185|NCT00694005|Paclitaxel|paclitaxel|mesh-list
65283186|NCT00694005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65283187|NCT00694005|Everolimus|everolimus|mesh-list
65283188|NCT00694005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65283189|NCT00694005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283190|NCT00694005|Tubulin Modulators|tubulin modulators|mesh-ancestor
65283191|NCT00694005|Antimitotic Agents|antimitotic agents|mesh-ancestor
65283192|NCT00694005|Mitosis Modulators|mitosis modulators|mesh-ancestor
65283193|NCT00694005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283194|NCT00694005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65283195|NCT00694005|Immunologic Factors|immunologic factors|mesh-ancestor
65283196|NCT00694005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735503|NCT01960842|Levodopa|levodopa|mesh-list
64799822|NCT02607956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64799823|NCT02607956|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64568438|NCT02635555|Phenylephrine|phenylephrine|mesh-list
64799824|NCT02607956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64799825|NCT02499666|Clopidogrel|clopidogrel|mesh-list
64799826|NCT02499666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64799827|NCT02499666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64799828|NCT02499666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64799829|NCT02499666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64799830|NCT02499666|Purinergic Agents|purinergic agents|mesh-ancestor
64799831|NCT02499666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64799832|NCT02499666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799833|NCT02499666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799834|NCT02420912|Nivolumab|nivolumab|mesh-list
64799835|NCT02420912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64799836|NCT02420912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799837|NCT02420912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64799838|NCT02420912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799839|NCT02094716|Permethrin|permethrin|mesh-list
64799846|NCT00667329|Cyclophosphamide|cyclophosphamide|mesh-list
64799847|NCT00667329|Rituximab|rituximab|mesh-list
64799848|NCT00667329|Cladribine|cladribine|mesh-list
64799849|NCT00667329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64799850|NCT00667329|Immunologic Factors|immunologic factors|mesh-ancestor
64799851|NCT00667329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799852|NCT00667329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65283197|NCT00694005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65283198|NCT00694005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65283199|NCT00694005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65283200|NCT00694005|Antifungal Agents|antifungal agents|mesh-ancestor
65283201|NCT00975325|Yohimbine|yohimbine|mesh-list
65283202|NCT00975325|Mydriatics|mydriatics|mesh-ancestor
65283203|NCT00975325|Autonomic Agents|autonomic agents|mesh-ancestor
65283204|NCT00975325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65283205|NCT00975325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283206|NCT00975325|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65283207|NCT00975325|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65283208|NCT00975325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65283209|NCT00975325|Adrenergic Agents|adrenergic agents|mesh-ancestor
65283210|NCT00975325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65283211|NCT00975325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283212|NCT00975325|Urological Agents|urological agents|mesh-ancestor
65283213|NCT00910676|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65283214|NCT00910676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65283215|NCT00648518|Metformin|metformin|mesh-list
65283216|NCT00648518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65283217|NCT00648518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283218|NCT00648596|Sildenafil Citrate|sildenafil citrate|mesh-list
65283219|NCT00648596|Vasodilator Agents|vasodilator agents|mesh-ancestor
65283220|NCT00648596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65283221|NCT00648596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65033206|NCT00197886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65283222|NCT00648596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799853|NCT00667329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64799854|NCT00667329|Alkylating Agents|alkylating agents|mesh-ancestor
64799865|NCT05274438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64799866|NCT05274438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799867|NCT05274438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799868|NCT05274191|Maleic acid|maleic acid|mesh-list
64799869|NCT05274191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799870|NCT05274191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799871|NCT05274139|Cytarabine|cytarabine|mesh-list
64799872|NCT05274139|Dexamethasone|dexamethasone|mesh-list
64799873|NCT05274139|Temozolomide|temozolomide|mesh-list
64799874|NCT05274139|Fotemustine|fotemustine|mesh-list
64799875|NCT05274139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64799876|NCT05274139|Antiemetics|antiemetics|mesh-ancestor
64799877|NCT05274139|Autonomic Agents|autonomic agents|mesh-ancestor
64799878|NCT05274139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64799879|NCT05274139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799880|NCT05274139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64799881|NCT05274139|Glucocorticoids|glucocorticoids|mesh-ancestor
64799882|NCT05274139|Hormones|hormones|mesh-ancestor
65283223|NCT00648596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283224|NCT00648596|Urological Agents|urological agents|mesh-ancestor
65283225|NCT03921151|Mirtazapine|mirtazapine|mesh-list
65283226|NCT03921151|Antidepressive Agents|antidepressive agents|mesh-ancestor
65283227|NCT03921151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65283228|NCT03921151|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65283229|NCT03921151|Histamine Antagonists|histamine antagonists|mesh-ancestor
65283230|NCT03921151|Histamine Agents|histamine agents|mesh-ancestor
65283231|NCT03921151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65283232|NCT03921151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283233|NCT03921151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283234|NCT03921151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65283235|NCT03921151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65283236|NCT03921151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65283237|NCT03921151|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65283238|NCT03921151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65283239|NCT03921151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65283240|NCT03921151|Adrenergic Agents|adrenergic agents|mesh-ancestor
65283241|NCT03921151|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65283242|NCT03921151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65283243|NCT03921151|Serotonin Agents|serotonin agents|mesh-ancestor
65283244|NCT03921151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65283245|NCT04570436|Diazepam|diazepam|mesh-list
65283246|NCT04570436|Gabapentin|gabapentin|mesh-list
65283247|NCT04570436|Analgesics|analgesics|mesh-ancestor
65283248|NCT04570436|Sensory System Agents|sensory system agents|mesh-ancestor
65283249|NCT04570436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65283250|NCT04570436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283251|NCT04570436|Anticonvulsants|anticonvulsants|mesh-ancestor
65283252|NCT04570436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65283253|NCT04570436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64799883|NCT05274139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64799884|NCT05274139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64799885|NCT05274139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799886|NCT05274139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799887|NCT05274139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64799888|NCT05274139|Antimetabolites|antimetabolites|mesh-ancestor
64799889|NCT05274139|Antiviral Agents|antiviral agents|mesh-ancestor
64799890|NCT05274139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64799891|NCT05274139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64799892|NCT05274139|Immunologic Factors|immunologic factors|mesh-ancestor
65283254|NCT04570436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65283255|NCT04570436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65283256|NCT04570436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65283257|NCT04570436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65283258|NCT04570436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65283259|NCT04570436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283260|NCT04570436|Antimanic Agents|antimanic agents|mesh-ancestor
65283261|NCT04570436|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65283262|NCT04570436|Antiemetics|antiemetics|mesh-ancestor
65283263|NCT04570436|Autonomic Agents|autonomic agents|mesh-ancestor
64799893|NCT05274139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64799894|NCT05274139|Alkylating Agents|alkylating agents|mesh-ancestor
64799895|NCT05274113|Dexamethasone|dexamethasone|mesh-list
64799896|NCT05274113|Ropivacaine|ropivacaine|mesh-list
64799897|NCT05274113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64568517|NCT02763319|Rituximab|rituximab|mesh-list
64799898|NCT05274113|Antiemetics|antiemetics|mesh-ancestor
64799899|NCT05274113|Autonomic Agents|autonomic agents|mesh-ancestor
64799900|NCT05274113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64799901|NCT05274113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799902|NCT05274113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64799903|NCT05274113|Glucocorticoids|glucocorticoids|mesh-ancestor
64799904|NCT05274113|Hormones|hormones|mesh-ancestor
64799905|NCT05274113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64399540|NCT02338687|Calcium|calcium|mesh-list
64799906|NCT05274113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64799907|NCT05274113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799908|NCT05274113|Anesthetics, Local|anesthetics, local|mesh-ancestor
64799909|NCT05274113|Anesthetics|anesthetics|mesh-ancestor
64799910|NCT05274113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64799911|NCT05274113|Sensory System Agents|sensory system agents|mesh-ancestor
64799912|NCT05274100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64799913|NCT05274100|Immunologic Factors|immunologic factors|mesh-ancestor
64799914|NCT05274100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799915|NCT05273944|Doxorubicin|doxorubicin|mesh-list
64799916|NCT05273944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64799917|NCT05273944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64799918|NCT05273944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799968|NCT05271539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64799969|NCT05271539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64799970|NCT05271539|Growth Substances|growth substances|mesh-ancestor
64799971|NCT05271539|Growth Inhibitors|growth inhibitors|mesh-ancestor
64799972|NCT05271448|Losartan|losartan|mesh-list
64799973|NCT05271448|Valsartan|valsartan|mesh-list
64799974|NCT05271448|Candesartan|candesartan|mesh-list
64799975|NCT05271448|Ramipril|ramipril|mesh-list
64799977|NCT05271448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64799978|NCT05271448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64411135|NCT05016609|Sofosbuvir|sofosbuvir|mesh-list
64799991|NCT05271370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64799992|NCT05271370|Antiviral Agents|antiviral agents|mesh-ancestor
64799993|NCT05271370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64800017|NCT05271188|Sensory System Agents|sensory system agents|mesh-ancestor
64800018|NCT05271188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800019|NCT05271136|Sunscreening Agents|sunscreening agents|mesh-list
64800020|NCT05271136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64800021|NCT05271136|Protective Agents|protective agents|mesh-ancestor
64800022|NCT05271136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800023|NCT05271136|Dermatologic Agents|dermatologic agents|mesh-ancestor
64800024|NCT05271058|Dexamethasone|dexamethasone|mesh-list
64800025|NCT05271058|Dexamethasone acetate|dexamethasone acetate|mesh-list
64800026|NCT05271058|Triamcinolone|triamcinolone|mesh-list
64800027|NCT05271058|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64800028|NCT05271058|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64800029|NCT05271058|BB 1101|bb 1101|mesh-list
64800030|NCT05271058|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64800031|NCT05271058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65283264|NCT04570436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65283265|NCT04570436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65283266|NCT04570436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65283267|NCT04570436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65283268|NCT04570436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65283269|NCT04570436|Anesthetics, General|anesthetics, general|mesh-ancestor
65283270|NCT04570436|Anesthetics|anesthetics|mesh-ancestor
65283271|NCT04570436|GABA Modulators|gaba modulators|mesh-ancestor
65283272|NCT04570436|GABA Agents|gaba agents|mesh-ancestor
65283273|NCT05195645|Abatacept|abatacept|mesh-list
65283274|NCT05195645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65283275|NCT05195645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283276|NCT05195645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283277|NCT05195645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65283278|NCT05195645|Immunologic Factors|immunologic factors|mesh-ancestor
65283279|NCT05195645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283280|NCT05195645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64735592|NCT01939002|Interferons|interferons|mesh-list
64800032|NCT05271058|Antiemetics|antiemetics|mesh-ancestor
64800033|NCT05271058|Autonomic Agents|autonomic agents|mesh-ancestor
64800034|NCT05271058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800035|NCT05271058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800036|NCT05271058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64800037|NCT05271058|Glucocorticoids|glucocorticoids|mesh-ancestor
64800038|NCT05271058|Hormones|hormones|mesh-ancestor
64800039|NCT05271058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64800040|NCT05271058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64800058|NCT05270434|Morphine|morphine|mesh-list
64800059|NCT05270434|Buprenorphine|buprenorphine|mesh-list
64800060|NCT05270434|Analgesics|analgesics|mesh-list
64800061|NCT05270434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64800086|NCT05270343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64800087|NCT05270343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800088|NCT05270343|Vitamins|vitamins|mesh-ancestor
64800089|NCT05270343|Micronutrients|micronutrients|mesh-ancestor
64800090|NCT05270343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64800091|NCT05270018|Broncho-Vaxom|broncho-vaxom|mesh-list
64800092|NCT05270018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64800093|NCT05270018|Immunologic Factors|immunologic factors|mesh-ancestor
64800094|NCT05270018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800095|NCT05269654|Mannitol|mannitol|mesh-list
64800096|NCT05269654|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64800097|NCT05269654|Diuretics|diuretics|mesh-ancestor
64800098|NCT05269654|Natriuretic Agents|natriuretic agents|mesh-ancestor
64800099|NCT05269654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800100|NCT05253846|Fluorouracil|fluorouracil|mesh-list
64800101|NCT05253846|Oxaliplatin|oxaliplatin|mesh-list
64472151|NCT03772314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64800109|NCT05253846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800110|NCT05253846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64800111|NCT05253846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64800112|NCT05253846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800114|NCT05250141|Carbidopa|carbidopa|mesh-list
64800115|NCT05250141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64800116|NCT05250141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64800117|NCT05250141|Dopamine Agents|dopamine agents|mesh-ancestor
64800118|NCT05250141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64800145|NCT05248724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800146|NCT05248724|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65283281|NCT04171388|Micronutrients|micronutrients|mesh-list
65283282|NCT04171388|Trace Elements|trace elements|mesh-list
65283283|NCT04171388|Azithromycin|azithromycin|mesh-list
65283284|NCT04171388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65283285|NCT04171388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65283286|NCT04171388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283287|NCT05341193|Gemcitabine|gemcitabine|mesh-list
65283288|NCT05341193|Bevacizumab|bevacizumab|mesh-list
65283289|NCT05341193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65283290|NCT05341193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283291|NCT05341193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65283292|NCT05341193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65283293|NCT05341193|Growth Substances|growth substances|mesh-ancestor
65283294|NCT05341193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283295|NCT05341193|Growth Inhibitors|growth inhibitors|mesh-ancestor
65283296|NCT05341193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65033281|NCT00553345|Vitamin E|vitamin e|mesh-list
65283297|NCT05341193|Antimetabolites|antimetabolites|mesh-ancestor
65283298|NCT05341193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283299|NCT05341193|Antiviral Agents|antiviral agents|mesh-ancestor
65283300|NCT05341193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65283301|NCT05341193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283302|NCT05341193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65283303|NCT05341193|Immunologic Factors|immunologic factors|mesh-ancestor
65283305|NCT04229459|Cetuximab|cetuximab|mesh-list
64800147|NCT05248724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64800148|NCT05248724|Adrenergic Agents|adrenergic agents|mesh-ancestor
64800149|NCT05248724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64800150|NCT05248724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64800151|NCT05248724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64800152|NCT05248724|Autonomic Agents|autonomic agents|mesh-ancestor
64800153|NCT05248724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64800154|NCT05248724|Respiratory System Agents|respiratory system agents|mesh-ancestor
64800155|NCT05248724|Mydriatics|mydriatics|mesh-ancestor
64800156|NCT05248724|Sympathomimetics|sympathomimetics|mesh-ancestor
64800157|NCT05248724|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64800158|NCT05235737|Pembrolizumab|pembrolizumab|mesh-list
64800159|NCT05235737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64800160|NCT05235737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800161|NCT05232006|Niraparib|niraparib|mesh-list
64800162|NCT05232006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64800163|NCT05232006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800164|NCT05232006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800165|NCT05232006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800166|NCT05209841|Heparin|heparin|mesh-list
64800167|NCT05209841|Anticoagulants|anticoagulants|mesh-ancestor
64800168|NCT05209841|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64800213|NCT05165875|Sensory System Agents|sensory system agents|mesh-ancestor
64800214|NCT05165875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800215|NCT05165875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64800216|NCT05165875|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64800217|NCT05165875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65283306|NCT04229459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283307|NCT04229459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65283308|NCT04229459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65283309|NCT04229459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283310|NCT05165225|Cyclophosphamide|cyclophosphamide|mesh-list
65283311|NCT05165225|Docetaxel|docetaxel|mesh-list
65283312|NCT05165225|Epirubicin|epirubicin|mesh-list
65283313|NCT05165225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65283314|NCT05165225|Immunologic Factors|immunologic factors|mesh-ancestor
65283315|NCT05165225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283316|NCT05165225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65283317|NCT05165225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65283318|NCT05165225|Alkylating Agents|alkylating agents|mesh-ancestor
65283319|NCT05165225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283320|NCT05165225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283321|NCT05165225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65283322|NCT05165225|Tubulin Modulators|tubulin modulators|mesh-ancestor
65283323|NCT05165225|Antimitotic Agents|antimitotic agents|mesh-ancestor
65283324|NCT05165225|Mitosis Modulators|mitosis modulators|mesh-ancestor
65283325|NCT05165225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65283326|NCT05165225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65283327|NCT05165225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65283328|NCT05165225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283329|NCT04897022|Pembrolizumab|pembrolizumab|mesh-list
65283330|NCT04897022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65283331|NCT04897022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283332|NCT00980239|Bevacizumab|bevacizumab|mesh-list
65283333|NCT00980239|Cetuximab|cetuximab|mesh-list
65283334|NCT00980239|Oxaliplatin|oxaliplatin|mesh-list
65283352|NCT02665832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65283353|NCT02665832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283354|NCT02665832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65283355|NCT02665832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283356|NCT02665832|Vasodilator Agents|vasodilator agents|mesh-ancestor
65283357|NCT02665832|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65283358|NCT02665832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65283359|NCT02665832|Antimetabolites|antimetabolites|mesh-ancestor
65283360|NCT02665832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65283361|NCT02665832|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65283362|NCT02665832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735682|NCT01959672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64800218|NCT05165875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64800219|NCT05165875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800220|NCT05165875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64800221|NCT05162118|Nivolumab|nivolumab|mesh-list
64800222|NCT05162118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64800223|NCT05162118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800224|NCT05162118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64800225|NCT05162118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800226|NCT05155917|Insulin Glargine|insulin glargine|mesh-list
64800227|NCT05155917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64800228|NCT05155917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800229|NCT05142267|Oxycodone|oxycodone|mesh-list
64800230|NCT05142267|Naloxone|naloxone|mesh-list
64800231|NCT05142267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64800232|NCT05142267|Narcotics|narcotics|mesh-ancestor
64800233|NCT05142267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64800244|NCT05138029|Antiemetics|antiemetics|mesh-ancestor
64800245|NCT05138029|Autonomic Agents|autonomic agents|mesh-ancestor
64800246|NCT05138029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800247|NCT05138029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800248|NCT05138029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64800249|NCT05138029|Glucocorticoids|glucocorticoids|mesh-ancestor
64800250|NCT05138029|Hormones|hormones|mesh-ancestor
64800251|NCT05138029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64800252|NCT05138029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64800253|NCT05138029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800254|NCT05138029|Protease Inhibitors|protease inhibitors|mesh-ancestor
64800285|NCT05075122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64800286|NCT05075122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800287|NCT05075122|Immunologic Factors|immunologic factors|mesh-ancestor
64800288|NCT05075122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472152|NCT03772314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800290|NCT05067439|Caffeine|caffeine|mesh-list
64800291|NCT05067439|Omeprazole|omeprazole|mesh-list
64800292|NCT05067439|Abrocitinib|abrocitinib|mesh-list
64800293|NCT05067439|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64800294|NCT05067439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800295|NCT05067439|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64800296|NCT05067439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800297|NCT05067439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800298|NCT05067439|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64800337|NCT05052528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64800338|NCT05052528|Alkylating Agents|alkylating agents|mesh-ancestor
64800339|NCT05052528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800340|NCT05052528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800341|NCT05052528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65283363|NCT02665832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65283364|NCT02665832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65283365|NCT02781467|Cyclophosphamide|cyclophosphamide|mesh-list
65283366|NCT02781467|Fludarabine|fludarabine|mesh-list
65283367|NCT02781467|Interleukin-2|interleukin-2|mesh-list
65283368|NCT02781467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65283369|NCT02781467|Immunologic Factors|immunologic factors|mesh-ancestor
65283370|NCT02781467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033353|NCT00198354|Antimetabolites|antimetabolites|mesh-ancestor
65283371|NCT02781467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65283372|NCT02781467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65283373|NCT02781467|Alkylating Agents|alkylating agents|mesh-ancestor
65283374|NCT02781467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283375|NCT02781467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283376|NCT02781467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65283377|NCT02781467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65283378|NCT02781467|Analgesics|analgesics|mesh-ancestor
65283379|NCT02781467|Sensory System Agents|sensory system agents|mesh-ancestor
65283380|NCT02781467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65283381|NCT00648830|Clarithromycin|clarithromycin|mesh-list
65283382|NCT00648830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65283383|NCT00648830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65283384|NCT00648830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65283385|NCT00648830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283386|NCT00648830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283387|NCT00648830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65283388|NCT00648830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65283389|NCT00970567|Insulin|insulin|mesh-list
65283390|NCT00970567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65283391|NCT00970567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283392|NCT05341817|Letrozole|letrozole|mesh-list
65283393|NCT05341817|Mifepristone|mifepristone|mesh-list
65283402|NCT05341817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283403|NCT05341817|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65283404|NCT05341817|Abortifacient Agents|abortifacient agents|mesh-ancestor
65283405|NCT05341817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65283406|NCT05341817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65283407|NCT05341817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65283408|NCT05341817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65283409|NCT05341817|Contraceptive Agents|contraceptive agents|mesh-ancestor
65283410|NCT05341817|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65283411|NCT05341817|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65283412|NCT05341817|Luteolytic Agents|luteolytic agents|mesh-ancestor
65283413|NCT05341817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65283414|NCT05341817|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65283415|NCT02663570|Melatonin|melatonin|mesh-list
65283416|NCT02663570|Antioxidants|antioxidants|mesh-ancestor
65283417|NCT02663570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283418|NCT02663570|Protective Agents|protective agents|mesh-ancestor
65283419|NCT02663570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283420|NCT02663570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65283421|NCT00980473|Timolol|timolol|mesh-list
65283422|NCT00980473|Travoprost|travoprost|mesh-list
65283423|NCT00980473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65283424|NCT00980473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65283425|NCT00980473|Adrenergic Agents|adrenergic agents|mesh-ancestor
65283426|NCT00980473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65283450|NCT00980551|Vincristine|vincristine|mesh-list
65283451|NCT00980551|Topotecan|topotecan|mesh-list
65283452|NCT00980551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283453|NCT00980551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65283454|NCT00980551|Tubulin Modulators|tubulin modulators|mesh-ancestor
65283455|NCT00980551|Antimitotic Agents|antimitotic agents|mesh-ancestor
65283456|NCT00980551|Mitosis Modulators|mitosis modulators|mesh-ancestor
65283457|NCT00980551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283458|NCT00980551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65283459|NCT00980551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65283460|NCT00980551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283461|NCT02660060|Pramipexole|pramipexole|mesh-list
65283462|NCT02660060|Antioxidants|antioxidants|mesh-ancestor
65283463|NCT02660060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283464|NCT02660060|Protective Agents|protective agents|mesh-ancestor
65283465|NCT02660060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283466|NCT02660060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65283467|NCT02660060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65283468|NCT02660060|Dopamine Agonists|dopamine agonists|mesh-ancestor
65283469|NCT02660060|Dopamine Agents|dopamine agents|mesh-ancestor
65283470|NCT02660060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65283471|NCT04008979|Aspirin|aspirin|mesh-list
65283472|NCT04008979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65283473|NCT04008979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65283474|NCT04008979|Analgesics|analgesics|mesh-ancestor
65283475|NCT04008979|Sensory System Agents|sensory system agents|mesh-ancestor
65283476|NCT04008979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65283477|NCT04008979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283478|NCT04008979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65283479|NCT04008979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65283480|NCT04008979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65283481|NCT04008979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65283483|NCT04008979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65283492|NCT00970879|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65283493|NCT00970879|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65283494|NCT00970879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65283495|NCT00970879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65283496|NCT00970879|Renal Agents|renal agents|mesh-ancestor
65283497|NCT00970879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65283498|NCT05340803|Magnesium Sulfate|magnesium sulfate|mesh-list
65283499|NCT05340803|Midazolam|midazolam|mesh-list
65283500|NCT05340803|Dexmedetomidine|dexmedetomidine|mesh-list
65283501|NCT05340803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65283502|NCT05340803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65283503|NCT05340803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283504|NCT05340803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65283505|NCT05340803|Analgesics|analgesics|mesh-ancestor
65283506|NCT05340803|Sensory System Agents|sensory system agents|mesh-ancestor
65283507|NCT05340803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65283508|NCT05340803|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64735823|NCT01931202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64800342|NCT05052528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64800343|NCT05052528|Antimetabolites|antimetabolites|mesh-ancestor
64800344|NCT05051150|Epinephrine|epinephrine|mesh-list
64800345|NCT05051150|Racepinephrine|racepinephrine|mesh-list
64800346|NCT05051150|Epinephryl borate|epinephryl borate|mesh-list
64800347|NCT05051150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64800348|NCT05051150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64800349|NCT05051150|Adrenergic Agents|adrenergic agents|mesh-ancestor
64800350|NCT05051150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64800351|NCT05051150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800352|NCT05051150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800353|NCT05051150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64800354|NCT05051150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64800355|NCT05051150|Autonomic Agents|autonomic agents|mesh-ancestor
64800356|NCT05051150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800357|NCT05051150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64800358|NCT05051150|Respiratory System Agents|respiratory system agents|mesh-ancestor
64800360|NCT05051150|Sympathomimetics|sympathomimetics|mesh-ancestor
64800361|NCT05051150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64800372|NCT05045313|Uricosuric Agents|uricosuric agents|mesh-ancestor
64800373|NCT05045313|Gout Suppressants|gout suppressants|mesh-ancestor
64800374|NCT05045313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64800375|NCT05045313|Renal Agents|renal agents|mesh-ancestor
64800376|NCT05007561|Naltrexone|naltrexone|mesh-list
64800389|NCT04961801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64800390|NCT04961801|Antimetabolites|antimetabolites|mesh-ancestor
64800391|NCT04961801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800392|NCT04961801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800393|NCT04961801|Dermatologic Agents|dermatologic agents|mesh-ancestor
64800394|NCT04961801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800395|NCT04961801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64800396|NCT04961801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64800397|NCT04961801|Immunologic Factors|immunologic factors|mesh-ancestor
64800398|NCT04961801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64800399|NCT04961801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64800400|NCT04961801|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64800401|NCT04919564|Furosemide|furosemide|mesh-list
64800402|NCT04919564|Diuretics|diuretics|mesh-ancestor
64800403|NCT04919564|Natriuretic Agents|natriuretic agents|mesh-ancestor
64800404|NCT04919564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283509|NCT05340803|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65283510|NCT05340803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65283511|NCT05340803|Adrenergic Agents|adrenergic agents|mesh-ancestor
65283512|NCT05340803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65283513|NCT05340803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283514|NCT05340803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65283515|NCT05340803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65283516|NCT05340803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65283517|NCT05340803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65283518|NCT05340803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65283519|NCT05340803|Anesthetics, General|anesthetics, general|mesh-ancestor
65283520|NCT05340803|Anesthetics|anesthetics|mesh-ancestor
65283521|NCT05340803|GABA Modulators|gaba modulators|mesh-ancestor
65283522|NCT05340803|GABA Agents|gaba agents|mesh-ancestor
65283523|NCT05340803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65283524|NCT05340803|Anticonvulsants|anticonvulsants|mesh-ancestor
65283525|NCT05340803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65283526|NCT05340803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65283527|NCT05340803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65283528|NCT05340803|Tocolytic Agents|tocolytic agents|mesh-ancestor
65283529|NCT05340803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64800405|NCT04919564|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64800406|NCT04919564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64800407|NCT04919564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800408|NCT04886284|Ertapenem|ertapenem|mesh-list
64800409|NCT04886284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64800410|NCT04886284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64800411|NCT04870333|Ciclesonide|ciclesonide|mesh-list
64800412|NCT04870333|Niclosamide|niclosamide|mesh-list
64800413|NCT04870333|Glucocorticoids|glucocorticoids|mesh-ancestor
64800414|NCT04870333|Hormones|hormones|mesh-ancestor
64800415|NCT04870333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64800416|NCT04870333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800417|NCT04870333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64800418|NCT04870333|Anticestodal Agents|anticestodal agents|mesh-ancestor
64800419|NCT04870333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64800420|NCT04870333|Anthelmintics|anthelmintics|mesh-ancestor
64800421|NCT04870333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64800422|NCT04870333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64800423|NCT04870333|Antinematodal Agents|antinematodal agents|mesh-ancestor
64800424|NCT04835402|Pembrolizumab|pembrolizumab|mesh-list
64800425|NCT04835402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64800426|NCT04835402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800427|NCT04801641|Nabilone|nabilone|mesh-list
64800428|NCT04801641|Antiemetics|antiemetics|mesh-ancestor
64800429|NCT04801641|Autonomic Agents|autonomic agents|mesh-ancestor
64800435|NCT04801641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64800437|NCT04783376|Insulin|insulin|mesh-list
64800438|NCT04783376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64800439|NCT04783376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64800440|NCT04783376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800441|NCT04768829|Carbamide Peroxide|carbamide peroxide|mesh-list
64800442|NCT04768829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64800451|NCT04760912|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64800452|NCT04760912|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65283530|NCT02663258|Pembrolizumab|pembrolizumab|mesh-list
65283531|NCT02663258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65283532|NCT02663258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283533|NCT04033172|Fulvestrant|fulvestrant|mesh-list
65283534|NCT04033172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65283535|NCT04033172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283536|NCT04033172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65283537|NCT04033172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65283538|NCT04033172|Hormone Antagonists|hormone antagonists|mesh-ancestor
64800453|NCT04760912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800455|NCT04710641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800456|NCT04710641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64800457|NCT04710641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800458|NCT04710641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800459|NCT04706767|Lidocaine|lidocaine|mesh-list
64800460|NCT04706767|Dexmedetomidine|dexmedetomidine|mesh-list
64800461|NCT04706767|Anesthetics, Local|anesthetics, local|mesh-ancestor
64800462|NCT04706767|Anesthetics|anesthetics|mesh-ancestor
64800463|NCT04706767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64800464|NCT04706767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800465|NCT04706767|Sensory System Agents|sensory system agents|mesh-ancestor
64472156|NCT03772314|Dopamine Agents|dopamine agents|mesh-ancestor
64800466|NCT04706767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800467|NCT04706767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64800468|NCT04706767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64800469|NCT04706767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64800470|NCT04706767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64800471|NCT04706767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800472|NCT04706767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64800473|NCT04706767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64800474|NCT04706767|Analgesics|analgesics|mesh-ancestor
64800475|NCT04706767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64800476|NCT04706767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64800477|NCT04706767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64800478|NCT04706767|Adrenergic Agents|adrenergic agents|mesh-ancestor
64800479|NCT04706767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64800480|NCT04690686|Paclitaxel|paclitaxel|mesh-list
64800481|NCT04690686|Atezolizumab|atezolizumab|mesh-list
64800482|NCT04690686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64800483|NCT04690686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800484|NCT04690686|Tubulin Modulators|tubulin modulators|mesh-ancestor
64800485|NCT04690686|Antimitotic Agents|antimitotic agents|mesh-ancestor
64800486|NCT04690686|Mitosis Modulators|mitosis modulators|mesh-ancestor
64800487|NCT04690686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800488|NCT04682626|Cholecalciferol|cholecalciferol|mesh-list
64800489|NCT04682626|Vitamin D|vitamin d|mesh-list
64800490|NCT04682626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64800491|NCT04682626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800492|NCT04682626|Vitamins|vitamins|mesh-ancestor
64800493|NCT04682626|Micronutrients|micronutrients|mesh-ancestor
64800494|NCT04682626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64800495|NCT04604691|Blinatumomab|blinatumomab|mesh-list
64800496|NCT04604691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800497|NCT04580381|Natalizumab|natalizumab|mesh-list
64800498|NCT04580381|Immunologic Factors|immunologic factors|mesh-ancestor
64800499|NCT04580381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800500|NCT04530006|Amantadine|amantadine|mesh-list
64800501|NCT04530006|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64800518|NCT04476745|Cholecalciferol|cholecalciferol|mesh-list
64800519|NCT04476745|Vitamins|vitamins|mesh-ancestor
64800520|NCT04476745|Micronutrients|micronutrients|mesh-ancestor
64800521|NCT04476745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800522|NCT04476745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64800523|NCT04476745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64800524|NCT04433390|Naloxegol|naloxegol|mesh-list
64800525|NCT04433390|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65283539|NCT04033172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65283540|NCT04033172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283541|NCT00980707|Fluticasone|fluticasone|mesh-list
65283542|NCT00980707|Xhance|xhance|mesh-list
65283543|NCT00980707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65283544|NCT00980707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65283545|NCT00980707|Autonomic Agents|autonomic agents|mesh-ancestor
65283546|NCT00980707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65283547|NCT00980707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283548|NCT00980707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65283549|NCT00980707|Respiratory System Agents|respiratory system agents|mesh-ancestor
65283550|NCT00980707|Dermatologic Agents|dermatologic agents|mesh-ancestor
65283551|NCT00980707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65283552|NCT05340725|Dexmedetomidine|dexmedetomidine|mesh-list
65283553|NCT05340725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65283554|NCT05340725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65283555|NCT05340725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283556|NCT05340725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65283557|NCT05340725|Analgesics|analgesics|mesh-ancestor
65283558|NCT05340725|Sensory System Agents|sensory system agents|mesh-ancestor
65283559|NCT05340725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65283560|NCT05340725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65283561|NCT05340725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65283562|NCT05340725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65283563|NCT05340725|Adrenergic Agents|adrenergic agents|mesh-ancestor
65283564|NCT05340725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65283565|NCT05340725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800544|NCT04391608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64800545|NCT04391608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64800546|NCT04391608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800547|NCT04391608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800548|NCT04391608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64800549|NCT04391608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64800550|NCT04368091|Sirolimus|sirolimus|mesh-list
64800551|NCT04368091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64800552|NCT04368091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64800553|NCT04368091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64472157|NCT03772314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64472158|NCT03772314|Adrenergic Agents|adrenergic agents|mesh-ancestor
64800554|NCT04368091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800555|NCT04368091|Antifungal Agents|antifungal agents|mesh-ancestor
64800556|NCT04368091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64800557|NCT04368091|Immunologic Factors|immunologic factors|mesh-ancestor
64800558|NCT04368091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800559|NCT04328090|Anti-Infective Agents|anti-infective agents|mesh-list
65283566|NCT00970957|Bevacizumab|bevacizumab|mesh-list
65283567|NCT00970957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65283568|NCT00970957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283569|NCT00970957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65283570|NCT00970957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65283571|NCT00970957|Growth Substances|growth substances|mesh-ancestor
65283572|NCT00970957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283573|NCT00970957|Growth Inhibitors|growth inhibitors|mesh-ancestor
65283574|NCT00976105|Zolpidem|zolpidem|mesh-list
65283575|NCT00976105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65283576|NCT00976105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65283577|NCT00976105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65283578|NCT00976105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283579|NCT00976105|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65283580|NCT00976105|GABA Agonists|gaba agonists|mesh-ancestor
65283581|NCT00976105|GABA Agents|gaba agents|mesh-ancestor
65283582|NCT00976105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65283583|NCT00976105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283584|NCT00976261|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65283585|NCT00976261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65283586|NCT00976261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283587|NCT00976261|Incretins|incretins|mesh-ancestor
65283588|NCT00976261|Hormones|hormones|mesh-ancestor
65283589|NCT00976261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65283590|NCT00976261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65283591|NCT00976261|Protease Inhibitors|protease inhibitors|mesh-ancestor
65283592|NCT00976261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283593|NCT00976261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283594|NCT02662712|JNJ-56136379|jnj-56136379|mesh-list
65283595|NCT02662712|Antiviral Agents|antiviral agents|mesh-ancestor
65283596|NCT02662712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64800560|NCT04328090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64800581|NCT04245644|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64800582|NCT04245644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64569199|NCT04907838|BQ 788|bq 788|mesh-list
64800583|NCT04245644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800584|NCT04245644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64800585|NCT04245644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64800586|NCT04245644|Analgesics|analgesics|mesh-ancestor
64800587|NCT04245644|Sensory System Agents|sensory system agents|mesh-ancestor
64800588|NCT04245644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800589|NCT04245644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65283597|NCT00976651|Menotropins|menotropins|mesh-list
65283598|NCT00976651|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65283599|NCT00976651|Fertility Agents|fertility agents|mesh-ancestor
65283600|NCT00976651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65283601|NCT00976651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283602|NCT00971581|Ketoprofen|ketoprofen|mesh-list
65283603|NCT00971581|Omeprazole|omeprazole|mesh-list
65283604|NCT00971581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64735929|NCT03888755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64800590|NCT04245644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64800591|NCT04245644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64800592|NCT04245644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64800593|NCT04245644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800594|NCT04245644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64800595|NCT04245644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64800596|NCT04245644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800597|NCT04245644|Antipyretics|antipyretics|mesh-ancestor
64800598|NCT04245644|Protease Inhibitors|protease inhibitors|mesh-ancestor
64800599|NCT04238845|Vitamin A|vitamin a|mesh-list
64800600|NCT04238845|Vitamins|vitamins|mesh-ancestor
64800601|NCT04238845|Micronutrients|micronutrients|mesh-ancestor
64800611|NCT04108026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64800612|NCT04108026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800614|NCT04095104|Phentermine|phentermine|mesh-list
64800615|NCT04095104|Anticonvulsants|anticonvulsants|mesh-ancestor
64800616|NCT04095104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64800623|NCT04095104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800624|NCT04095104|Adrenergic Agents|adrenergic agents|mesh-ancestor
64800625|NCT04095104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64800626|NCT04095104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800627|NCT04074512|Copper|copper|mesh-list
64800628|NCT04074512|Trace Elements|trace elements|mesh-ancestor
64800629|NCT04074512|Micronutrients|micronutrients|mesh-ancestor
64800630|NCT04074512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800631|NCT04044729|Cannabidiol|cannabidiol|mesh-list
64800632|NCT04044729|Anticonvulsants|anticonvulsants|mesh-ancestor
64800633|NCT04008082|Lenvatinib|lenvatinib|mesh-list
64800634|NCT04008082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800635|NCT04008082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64800636|NCT04008082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800637|NCT04008082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800638|NCT03974243|Chiauranib|chiauranib|mesh-list
64800639|NCT03974243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800640|NCT03974243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64800641|NCT03974243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800642|NCT03974243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800643|NCT03967925|Prednisone|prednisone|mesh-list
64800644|NCT03967925|Prednisolone|prednisolone|mesh-list
64800645|NCT03967925|Rituximab|rituximab|mesh-list
64800646|NCT03967925|Belimumab|belimumab|mesh-list
64800647|NCT03967925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64800648|NCT03967925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800649|NCT03967925|Immunologic Factors|immunologic factors|mesh-ancestor
64800650|NCT03967925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800651|NCT03967925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64800652|NCT03967925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64800653|NCT03967925|Glucocorticoids|glucocorticoids|mesh-ancestor
64800654|NCT03967925|Hormones|hormones|mesh-ancestor
64800655|NCT03967925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64800656|NCT03967925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64800657|NCT03967925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64800658|NCT03954743|Vaccines|vaccines|mesh-list
64800659|NCT03954743|Immunologic Factors|immunologic factors|mesh-ancestor
64800660|NCT03954743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800661|NCT03932318|Azacitidine|azacitidine|mesh-list
64800663|NCT03932318|Lintuzumab|lintuzumab|mesh-list
64800664|NCT03932318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64800665|NCT03932318|Antimetabolites|antimetabolites|mesh-ancestor
64800666|NCT03932318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283605|NCT00971581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65283606|NCT00971581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65283607|NCT00971581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283608|NCT00971581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283609|NCT00971581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65283610|NCT00971581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65283611|NCT00971581|Analgesics|analgesics|mesh-ancestor
65283612|NCT00971581|Sensory System Agents|sensory system agents|mesh-ancestor
65283613|NCT00971581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65283614|NCT00971581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283615|NCT00971581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65283616|NCT00971581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65283617|NCT00971581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65283618|NCT02662322|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65283619|NCT02662322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65283620|NCT02662322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283621|NCT00971659|Insulin|insulin|mesh-list
65283622|NCT00971659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64800667|NCT03932318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800668|NCT03932318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800669|NCT03932318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64800670|NCT03913819|Cholinergic Antagonists|cholinergic antagonists|mesh-list
64800671|NCT03913819|Cholinergic Agents|cholinergic agents|mesh-ancestor
64800672|NCT03913819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64800673|NCT03913819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800674|NCT03913819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800675|NCT03883412|Liraglutide|liraglutide|mesh-list
64800676|NCT03883412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64800721|NCT03777462|Mitosis Modulators|mitosis modulators|mesh-ancestor
64800722|NCT03777462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800723|NCT03777462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64800724|NCT03777462|Antimetabolites|antimetabolites|mesh-ancestor
64800725|NCT03777462|Antiviral Agents|antiviral agents|mesh-ancestor
64800726|NCT03777462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64800727|NCT03777462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800728|NCT03777462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64800729|NCT03777462|Immunologic Factors|immunologic factors|mesh-ancestor
64800730|NCT03777462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800731|NCT03758170|Dexamethasone|dexamethasone|mesh-list
64800732|NCT03758170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64800733|NCT03758170|Antiemetics|antiemetics|mesh-ancestor
64800734|NCT03758170|Autonomic Agents|autonomic agents|mesh-ancestor
64800735|NCT03758170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800736|NCT03758170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800737|NCT03758170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64800738|NCT03758170|Glucocorticoids|glucocorticoids|mesh-ancestor
64800756|NCT03705338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64800757|NCT03705338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800758|NCT03705338|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64800760|NCT03704285|Anesthetics|anesthetics|mesh-list
64800761|NCT03704285|Anesthetics, General|anesthetics, general|mesh-list
64800762|NCT03704285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64800763|NCT03704285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64800764|NCT03704285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283623|NCT00971659|Metformin|metformin|mesh-list
65283624|NCT00971659|Insulin Glargine|insulin glargine|mesh-list
65283625|NCT00971659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65283626|NCT00971659|Exenatide|exenatide|mesh-list
65283627|NCT00971659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65283628|NCT00971659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283629|NCT00971659|Incretins|incretins|mesh-ancestor
65283630|NCT00971659|Hormones|hormones|mesh-ancestor
65283631|NCT00971659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65283632|NCT00971659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65283633|NCT00971659|Protease Inhibitors|protease inhibitors|mesh-ancestor
65283634|NCT00971659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283635|NCT00971659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283636|NCT00971659|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65283637|NCT00648986|Tazarotene|tazarotene|mesh-list
65283638|NCT00648986|Dermatologic Agents|dermatologic agents|mesh-ancestor
65283639|NCT00648986|Keratolytic Agents|keratolytic agents|mesh-ancestor
65283640|NCT00971815|Dexetimide|dexetimide|mesh-list
64735955|NCT00378833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800765|NCT03704285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64800766|NCT03696537|Fludarabine|fludarabine|mesh-list
64800767|NCT03696537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800768|NCT03665207|Insulin|insulin|mesh-list
64800769|NCT03665207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64800770|NCT03665207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800809|NCT03620903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800810|NCT03620903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64800811|NCT03563690|Celecoxib|celecoxib|mesh-list
64800812|NCT03563690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64800813|NCT03563690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64800814|NCT03563690|Analgesics|analgesics|mesh-ancestor
64800815|NCT03563690|Sensory System Agents|sensory system agents|mesh-ancestor
64800816|NCT03563690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800817|NCT03563690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800818|NCT03563690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64800819|NCT03563690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64800820|NCT03563690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64800821|NCT03563690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64800844|NCT03522584|Immunoglobulin G|immunoglobulin g|mesh-list
64800845|NCT03522584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64800846|NCT03522584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800847|NCT03522584|Immunologic Factors|immunologic factors|mesh-ancestor
64800848|NCT03522584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800849|NCT03522584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64800850|NCT03522584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472159|NCT03772314|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64800851|NCT03439124|Cephalosporins|cephalosporins|mesh-list
64800852|NCT03439124|Ceftobiprole|ceftobiprole|mesh-list
64800853|NCT03439124|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
64800854|NCT03439124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64800855|NCT03439124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64800856|NCT03410355|Cortisone|cortisone|mesh-list
64800857|NCT03410355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64800858|NCT03399617|Micronutrients|micronutrients|mesh-list
64800859|NCT03399617|Trace Elements|trace elements|mesh-list
64800860|NCT03399617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800861|NCT03386162|Fulvestrant|fulvestrant|mesh-list
64800862|NCT03386162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65283641|NCT00971815|Citalopram|citalopram|mesh-list
65283642|NCT00971815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65283643|NCT00971815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65283644|NCT00971815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65283645|NCT00971815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283646|NCT00971815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65283647|NCT00971815|Serotonin Agents|serotonin agents|mesh-ancestor
65283648|NCT00971815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283649|NCT00971815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65283650|NCT00971815|Antidepressive Agents|antidepressive agents|mesh-ancestor
65283651|NCT00971815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65283652|NCT00971815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65283653|NCT00971815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64800863|NCT03386162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800864|NCT03386162|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64800865|NCT03386162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64800866|NCT03386162|Hormone Antagonists|hormone antagonists|mesh-ancestor
64800867|NCT03386162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64800868|NCT03386162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800869|NCT03360214|Bupivacaine|bupivacaine|mesh-list
64800876|NCT03360214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800877|NCT03359239|Atezolizumab|atezolizumab|mesh-list
64800878|NCT03359239|Poly ICLC|poly iclc|mesh-list
64800879|NCT03359239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800880|NCT03359239|Interferon Inducers|interferon inducers|mesh-ancestor
64800902|NCT03317405|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64800904|NCT03317405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64800905|NCT03315039|Annamycin|annamycin|mesh-list
64800906|NCT03315039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64800907|NCT03315039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800908|NCT03289325|Dexmedetomidine|dexmedetomidine|mesh-list
64800909|NCT03289325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64800910|NCT03289325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64800911|NCT03289325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800912|NCT03289325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64800913|NCT03289325|Analgesics|analgesics|mesh-ancestor
64800914|NCT03289325|Sensory System Agents|sensory system agents|mesh-ancestor
64800915|NCT03289325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800916|NCT03289325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64800917|NCT03289325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64800918|NCT03289325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64800919|NCT03289325|Adrenergic Agents|adrenergic agents|mesh-ancestor
64800920|NCT03289325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64800921|NCT03289325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800922|NCT03276533|Lidocaine|lidocaine|mesh-list
64800923|NCT03276533|Dexmedetomidine|dexmedetomidine|mesh-list
64800924|NCT03276533|Anesthetics, Local|anesthetics, local|mesh-ancestor
64800925|NCT03276533|Anesthetics|anesthetics|mesh-ancestor
64800926|NCT03276533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64800927|NCT03276533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800928|NCT03276533|Sensory System Agents|sensory system agents|mesh-ancestor
64472160|NCT03772314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64800929|NCT03276533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800930|NCT03276533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64800957|NCT03203876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64800959|NCT03203876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64800960|NCT03203876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800961|NCT03191240|Vasopressins|vasopressins|mesh-list
65283654|NCT00971815|Parasympatholytics|parasympatholytics|mesh-ancestor
65283655|NCT00971815|Autonomic Agents|autonomic agents|mesh-ancestor
65283656|NCT00971815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65283657|NCT00971815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65283658|NCT00971815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65283659|NCT00971815|Cholinergic Agents|cholinergic agents|mesh-ancestor
65283660|NCT00981487|Ondansetron|ondansetron|mesh-list
65283661|NCT00981487|Antiemetics|antiemetics|mesh-ancestor
65283662|NCT00981487|Autonomic Agents|autonomic agents|mesh-ancestor
65283663|NCT00981487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64735989|NCT02994251|Mitomycins|mitomycins|mesh-list
64800962|NCT03191240|Arginine Vasopressin|arginine vasopressin|mesh-list
64800963|NCT03191240|Hemostatics|hemostatics|mesh-ancestor
64800965|NCT03191240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64800966|NCT03191240|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64800967|NCT03191240|Natriuretic Agents|natriuretic agents|mesh-ancestor
64800968|NCT03191240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800969|NCT03180294|Bupropion|bupropion|mesh-list
64800970|NCT03180294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64800971|NCT03180294|Antidepressive Agents|antidepressive agents|mesh-ancestor
64800972|NCT03180294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64800973|NCT03180294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64800974|NCT03180294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64800975|NCT03180294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64800976|NCT03180294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800977|NCT03180294|Dopamine Agents|dopamine agents|mesh-ancestor
64800978|NCT03180294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64800979|NCT03180294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800980|NCT03180294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64800981|NCT03180294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64800982|NCT03180294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800983|NCT03137173|Vancomycin|vancomycin|mesh-list
64800984|NCT03137173|Aztreonam|aztreonam|mesh-list
64800985|NCT03137173|Ceftobiprole|ceftobiprole|mesh-list
64800986|NCT03137173|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
64800987|NCT03137173|Cephalosporins|cephalosporins|mesh-list
64800988|NCT03137173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64800989|NCT03137173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64800990|NCT03071601|Lidocaine|lidocaine|mesh-list
64800991|NCT03071601|Epinephrine|epinephrine|mesh-list
64800992|NCT03071601|Prilocaine|prilocaine|mesh-list
64800993|NCT03071601|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64800994|NCT03071601|Anesthetics, Local|anesthetics, local|mesh-ancestor
64800995|NCT03071601|Anesthetics|anesthetics|mesh-ancestor
64800996|NCT03071601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64801043|NCT03055390|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64801044|NCT03055390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64801045|NCT03055390|Antiemetics|antiemetics|mesh-ancestor
64801046|NCT03055390|Autonomic Agents|autonomic agents|mesh-ancestor
64801047|NCT03055390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64801048|NCT03055390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801049|NCT03055390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64801050|NCT03055390|Mydriatics|mydriatics|mesh-ancestor
64801051|NCT03055390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64801052|NCT03055390|Cholinergic Agents|cholinergic agents|mesh-ancestor
64801053|NCT03055390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64801054|NCT03055390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801055|NCT03055390|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64801056|NCT03055390|Parasympatholytics|parasympatholytics|mesh-ancestor
64801057|NCT03012672|Cytarabine|cytarabine|mesh-list
64801058|NCT03012672|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
64801059|NCT03012672|Mitoxantrone|mitoxantrone|mesh-list
64801060|NCT03012672|Cladribine|cladribine|mesh-list
64801061|NCT03012672|Lenograstim|lenograstim|mesh-list
64801062|NCT03012672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64801063|NCT03012672|Antimetabolites|antimetabolites|mesh-ancestor
64801064|NCT03012672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283664|NCT00981487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283665|NCT00981487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65283666|NCT00981487|Antipruritics|antipruritics|mesh-ancestor
65283667|NCT00981487|Dermatologic Agents|dermatologic agents|mesh-ancestor
65283668|NCT00981487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65283669|NCT00981487|Serotonin Agents|serotonin agents|mesh-ancestor
65283670|NCT00981487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65283671|NCT00981487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801065|NCT03012672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801066|NCT03012672|Antiviral Agents|antiviral agents|mesh-ancestor
64801067|NCT03012672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64801068|NCT03012672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64801069|NCT03012672|Immunologic Factors|immunologic factors|mesh-ancestor
64801070|NCT03012672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801071|NCT03012672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64801072|NCT03012672|Analgesics|analgesics|mesh-ancestor
64801073|NCT03012672|Sensory System Agents|sensory system agents|mesh-ancestor
64801074|NCT03012672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64801075|NCT03012672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64801089|NCT03011775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801090|NCT03011775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64801092|NCT03011775|Antimetabolites|antimetabolites|mesh-ancestor
64801093|NCT03011775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801094|NCT03011775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64801095|NCT03011775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64801096|NCT03011775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801097|NCT03011775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64801098|NCT03011775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64801099|NCT03011775|Analgesics|analgesics|mesh-ancestor
64801100|NCT03011775|Sensory System Agents|sensory system agents|mesh-ancestor
64801101|NCT03011775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64801102|NCT03011775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64801103|NCT03011775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64801104|NCT03011775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64801105|NCT03011775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64801106|NCT03011775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64801107|NCT03011775|Antipyretics|antipyretics|mesh-ancestor
64801108|NCT03011775|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64801109|NCT03011775|Protease Inhibitors|protease inhibitors|mesh-ancestor
64801110|NCT03011775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64801111|NCT03011775|Sympatholytics|sympatholytics|mesh-ancestor
64801112|NCT03011775|Autonomic Agents|autonomic agents|mesh-ancestor
64801113|NCT03011775|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64801114|NCT03011775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64569720|NCT04899414|Dexamethasone|dexamethasone|mesh-list
64801115|NCT03011775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64801116|NCT03011775|Adrenergic Agents|adrenergic agents|mesh-ancestor
64801117|NCT03011775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64801131|NCT02924480|Lidocaine|lidocaine|mesh-list
64801132|NCT02924480|Anesthetics, Local|anesthetics, local|mesh-ancestor
64801133|NCT02924480|Anesthetics|anesthetics|mesh-ancestor
64801134|NCT02924480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64801135|NCT02924480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801136|NCT02924480|Sensory System Agents|sensory system agents|mesh-ancestor
64801137|NCT02924480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64801138|NCT02924480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64412213|NCT03490513|Anastrozole|anastrozole|mesh-list
64801148|NCT02889900|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64801149|NCT02889900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801150|NCT02889900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801151|NCT02889900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801152|NCT02889900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64801153|NCT02879942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
64801154|NCT02879942|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
65283672|NCT00981487|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65283673|NCT00981487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65283674|NCT00981487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65283675|NCT00981487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65283676|NCT00981487|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65283677|NCT00646568|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65283678|NCT00646568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65283679|NCT00646568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283680|NCT00971893|Methylprednisolone|methylprednisolone|mesh-list
65283681|NCT00971893|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65283682|NCT00971893|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65283683|NCT00971893|Prednisolone|prednisolone|mesh-list
65283684|NCT00971893|Prednisolone acetate|prednisolone acetate|mesh-list
65283685|NCT00971893|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64801155|NCT02879942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64801156|NCT02879942|Growth Substances|growth substances|mesh-ancestor
64801157|NCT02879942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801158|NCT02879942|Growth Inhibitors|growth inhibitors|mesh-ancestor
64801159|NCT02879942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801160|NCT02873819|Cyclophosphamide|cyclophosphamide|mesh-list
64801162|NCT02873819|Poly ICLC|poly iclc|mesh-list
64801163|NCT02873819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64801164|NCT02873819|Immunologic Factors|immunologic factors|mesh-ancestor
64801165|NCT02873819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801166|NCT02873819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64801167|NCT02873819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64801168|NCT02873819|Alkylating Agents|alkylating agents|mesh-ancestor
64801169|NCT02873819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801170|NCT02873819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801171|NCT02873819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64801172|NCT02873819|Interferon Inducers|interferon inducers|mesh-ancestor
64801173|NCT02863445|Levonorgestrel|levonorgestrel|mesh-list
64801174|NCT02863445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64801175|NCT02863445|Contraceptive Agents|contraceptive agents|mesh-ancestor
64801176|NCT02863445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64801177|NCT02863445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801178|NCT02863445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64801179|NCT02863445|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64801180|NCT02863445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64801181|NCT02810457|Paclitaxel|paclitaxel|mesh-list
64801182|NCT02810457|Bevacizumab|bevacizumab|mesh-list
64801183|NCT02810457|Carboplatin|carboplatin|mesh-list
64801184|NCT02810457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64472161|NCT03772314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64801185|NCT02810457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801186|NCT02810457|Tubulin Modulators|tubulin modulators|mesh-ancestor
64801187|NCT02810457|Antimitotic Agents|antimitotic agents|mesh-ancestor
64801223|NCT02711826|Acetaminophen|acetaminophen|mesh-list
64801224|NCT02711826|Diphenhydramine|diphenhydramine|mesh-list
64801225|NCT02711826|Promethazine|promethazine|mesh-list
64801226|NCT02711826|Mycophenolic Acid|mycophenolic acid|mesh-list
64801227|NCT02711826|Everolimus|everolimus|mesh-list
64801228|NCT02711826|Tacrolimus|tacrolimus|mesh-list
64801229|NCT02711826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64801230|NCT02711826|Immunologic Factors|immunologic factors|mesh-ancestor
64801231|NCT02711826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801232|NCT02711826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64801233|NCT02711826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801234|NCT02711826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801235|NCT02711826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64801236|NCT02711826|Analgesics|analgesics|mesh-ancestor
64801237|NCT02711826|Sensory System Agents|sensory system agents|mesh-ancestor
65283686|NCT00971893|Prednisolone phosphate|prednisolone phosphate|mesh-list
65283687|NCT00971893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65283688|NCT00971893|Antiemetics|antiemetics|mesh-ancestor
65283689|NCT00971893|Autonomic Agents|autonomic agents|mesh-ancestor
65283690|NCT00971893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65283691|NCT00971893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283692|NCT00971893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65283693|NCT00971893|Glucocorticoids|glucocorticoids|mesh-ancestor
64801238|NCT02711826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64801239|NCT02711826|Antipyretics|antipyretics|mesh-ancestor
64801240|NCT02711826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801241|NCT02711826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64801242|NCT02711826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64801243|NCT02711826|Antitubercular Agents|antitubercular agents|mesh-ancestor
64801244|NCT02711826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64801245|NCT02711826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64801246|NCT02711826|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64801247|NCT02711826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64801248|NCT02711826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64801249|NCT02711826|Anesthetics, Local|anesthetics, local|mesh-ancestor
64801250|NCT02711826|Anesthetics|anesthetics|mesh-ancestor
64801251|NCT02711826|Antiemetics|antiemetics|mesh-ancestor
64801252|NCT02711826|Autonomic Agents|autonomic agents|mesh-ancestor
64801253|NCT02711826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64801254|NCT02711826|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64801255|NCT02711826|Histamine Antagonists|histamine antagonists|mesh-ancestor
64801256|NCT02711826|Histamine Agents|histamine agents|mesh-ancestor
64801257|NCT02711826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64801258|NCT02711826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64801259|NCT02711826|Antipruritics|antipruritics|mesh-ancestor
64801260|NCT02711826|Dermatologic Agents|dermatologic agents|mesh-ancestor
64801270|NCT02666794|Bupivacaine|bupivacaine|mesh-list
64801271|NCT02666794|Anesthetics, Local|anesthetics, local|mesh-ancestor
64801272|NCT02666794|Anesthetics|anesthetics|mesh-ancestor
64801273|NCT02666794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64801274|NCT02666794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801275|NCT02666794|Sensory System Agents|sensory system agents|mesh-ancestor
64801276|NCT02666794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64801296|NCT02636322|Prednisone|prednisone|mesh-list
64801297|NCT02636322|Cortisone|cortisone|mesh-list
64801298|NCT02636322|Cyclophosphamide|cyclophosphamide|mesh-list
64801299|NCT02636322|Rituximab|rituximab|mesh-list
64801300|NCT02636322|Doxorubicin|doxorubicin|mesh-list
64801301|NCT02636322|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64801302|NCT02636322|Etoposide|etoposide|mesh-list
64801303|NCT02636322|Vincristine|vincristine|mesh-list
64801304|NCT02636322|Lenalidomide|lenalidomide|mesh-list
64801305|NCT02636322|Etoposide phosphate|etoposide phosphate|mesh-list
64801306|NCT02636322|Podophyllotoxin|podophyllotoxin|mesh-list
64801307|NCT02636322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64801308|NCT02636322|Antibodies|antibodies|mesh-list
64801309|NCT02636322|Immunoglobulins|immunoglobulins|mesh-list
64801310|NCT02636322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64801311|NCT02636322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64801312|NCT02636322|Immunologic Factors|immunologic factors|mesh-ancestor
64801313|NCT02636322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801314|NCT02636322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64801315|NCT02636322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64801316|NCT02636322|Alkylating Agents|alkylating agents|mesh-ancestor
64801317|NCT02636322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801318|NCT02636322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801319|NCT02636322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64801320|NCT02636322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64801321|NCT02636322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64801322|NCT02636322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64801323|NCT02636322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801324|NCT02636322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64801325|NCT02636322|Glucocorticoids|glucocorticoids|mesh-ancestor
64801326|NCT02636322|Hormones|hormones|mesh-ancestor
64801327|NCT02636322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65283694|NCT00971893|Hormones|hormones|mesh-ancestor
65283695|NCT00971893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65283696|NCT00971893|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65283697|NCT00971893|Protective Agents|protective agents|mesh-ancestor
65283698|NCT00971893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65283699|NCT00971893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283700|NCT05101187|Amphotericin B|amphotericin b|mesh-list
65283701|NCT05101187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65283702|NCT05101187|Olorofim|olorofim|mesh-list
65283703|NCT05101187|Amebicides|amebicides|mesh-ancestor
65283704|NCT05101187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65283705|NCT05101187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65283706|NCT05101187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65283707|NCT05101187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65283708|NCT05101187|Antifungal Agents|antifungal agents|mesh-ancestor
65283709|NCT02665208|Nicotine|nicotine|mesh-list
65283710|NCT02665208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65283711|NCT02665208|Autonomic Agents|autonomic agents|mesh-ancestor
65283712|NCT02665208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65283713|NCT02665208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283714|NCT02665208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65283715|NCT02665208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65283716|NCT02665208|Cholinergic Agents|cholinergic agents|mesh-ancestor
65283717|NCT02665208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65283718|NCT02665208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283719|NCT00977353|Citalopram|citalopram|mesh-list
64801328|NCT02636322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64801329|NCT02636322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64412398|NCT03117751|Cytarabine|cytarabine|mesh-list
64801343|NCT02619552|Certolizumab Pegol|certolizumab pegol|mesh-list
64801344|NCT02619552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64801345|NCT02619552|Glucocorticoids|glucocorticoids|mesh-ancestor
64801366|NCT02578368|Levoleucovorin|levoleucovorin|mesh-list
64801367|NCT02578368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801368|NCT02578368|Tubulin Modulators|tubulin modulators|mesh-ancestor
64801369|NCT02578368|Antimitotic Agents|antimitotic agents|mesh-ancestor
64801370|NCT02578368|Mitosis Modulators|mitosis modulators|mesh-ancestor
64801371|NCT02578368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801372|NCT02578368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801373|NCT02578368|Antimetabolites|antimetabolites|mesh-ancestor
64801374|NCT02578368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64801375|NCT02578368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64801376|NCT02578368|Immunologic Factors|immunologic factors|mesh-ancestor
64801377|NCT02578368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64801378|NCT02578368|Antidotes|antidotes|mesh-ancestor
64801379|NCT02578368|Protective Agents|protective agents|mesh-ancestor
64801380|NCT02578368|Vitamin B Complex|vitamin b complex|mesh-ancestor
64801381|NCT02578368|Vitamins|vitamins|mesh-ancestor
64801382|NCT02578368|Micronutrients|micronutrients|mesh-ancestor
64801383|NCT02575963|Cytarabine|cytarabine|mesh-list
64801384|NCT02575963|Lintuzumab|lintuzumab|mesh-list
64801385|NCT02575963|Furosemide|furosemide|mesh-list
65283720|NCT00977353|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65283721|NCT00977353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65283722|NCT00977353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65283723|NCT00977353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283724|NCT00977353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65283725|NCT00977353|Serotonin Agents|serotonin agents|mesh-ancestor
65283726|NCT00977353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283727|NCT00977353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65283728|NCT00977353|Antidepressive Agents|antidepressive agents|mesh-ancestor
65283729|NCT00977353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65283730|NCT00871923|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65283731|NCT00871923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283732|NCT00871923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65283733|NCT00871923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283734|NCT00871923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283735|NCT04170530|Oxaliplatin|oxaliplatin|mesh-list
65283736|NCT04170530|Irinotecan|irinotecan|mesh-list
64736052|NCT01340885|Adrenergic Agents|adrenergic agents|mesh-ancestor
64801386|NCT02575963|Spironolactone|spironolactone|mesh-list
64801387|NCT02575963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64801388|NCT02575963|Antimetabolites|antimetabolites|mesh-ancestor
64801389|NCT02575963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801390|NCT02575963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801391|NCT02575963|Antiviral Agents|antiviral agents|mesh-ancestor
64801392|NCT02575963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64801393|NCT02575963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64801394|NCT02575963|Immunologic Factors|immunologic factors|mesh-ancestor
64801395|NCT02575963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801396|NCT02575963|Diuretics|diuretics|mesh-ancestor
64801397|NCT02575963|Natriuretic Agents|natriuretic agents|mesh-ancestor
64801401|NCT02575963|Hormone Antagonists|hormone antagonists|mesh-ancestor
64801402|NCT02575963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64801403|NCT02575963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64801410|NCT02539225|Tubulin Modulators|tubulin modulators|mesh-ancestor
64801411|NCT02539225|Antimitotic Agents|antimitotic agents|mesh-ancestor
64801412|NCT02539225|Mitosis Modulators|mitosis modulators|mesh-ancestor
64801413|NCT02539225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801414|NCT02535650|Tipifarnib|tipifarnib|mesh-list
64801415|NCT02535650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801416|NCT02527681|Ceftobiprole|ceftobiprole|mesh-list
64801417|NCT02527681|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
64801418|NCT02527681|Cephalosporins|cephalosporins|mesh-list
64801419|NCT02527681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64801420|NCT02527681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64801421|NCT02526017|Nivolumab|nivolumab|mesh-list
64801422|NCT02526017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64570020|NCT04881006|Dapagliflozin|dapagliflozin|mesh-list
64801423|NCT02526017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801424|NCT02526017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64801425|NCT02526017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801426|NCT02516657|Liraglutide|liraglutide|mesh-list
64801427|NCT02516657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64801428|NCT02516657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801429|NCT02516657|Incretins|incretins|mesh-ancestor
64801430|NCT02516657|Hormones|hormones|mesh-ancestor
65283737|NCT04170530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283738|NCT04170530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65283739|NCT04170530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65283740|NCT04170530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283741|NCT04170530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283742|NCT02617017|Buspirone|buspirone|mesh-list
65283743|NCT02617017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65283744|NCT02617017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65283745|NCT02617017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65283746|NCT02617017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283747|NCT02617017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65283748|NCT02617017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65283749|NCT02617017|Serotonin Agents|serotonin agents|mesh-ancestor
65283750|NCT02617017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65283751|NCT02617017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283752|NCT02616861|Praliciguat|praliciguat|mesh-list
65283753|NCT02616861|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65283754|NCT02616861|Enzyme Activators|enzyme activators|mesh-ancestor
65283755|NCT02616861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283756|NCT02616861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65283757|NCT00981721|Cediranib|cediranib|mesh-list
65283758|NCT00981721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283759|NCT00981721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65283760|NCT00981721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283761|NCT00981721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283762|NCT04133337|Apatinib|apatinib|mesh-list
65283763|NCT04133337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283764|NCT04133337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65283765|NCT04133337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283766|NCT04133337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283767|NCT04133259|Tenofovir|tenofovir|mesh-list
65283768|NCT04133259|Entecavir|entecavir|mesh-list
65283769|NCT04133259|Antibodies|antibodies|mesh-list
64801431|NCT02516657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64801432|NCT02427581|Poly I-C|poly i-c|mesh-list
64801433|NCT02427581|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64801434|NCT02427581|Poly ICLC|poly iclc|mesh-list
64801435|NCT02427581|Interferon Inducers|interferon inducers|mesh-ancestor
64801436|NCT02427581|Immunologic Factors|immunologic factors|mesh-ancestor
64801437|NCT02427581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283770|NCT04133259|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65283771|NCT04133259|Immunologic Factors|immunologic factors|mesh-ancestor
65283772|NCT04133259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283773|NCT04133259|Antiviral Agents|antiviral agents|mesh-ancestor
65283774|NCT04133259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65283775|NCT04133259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65283776|NCT04133259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65283777|NCT04133259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283778|NCT04133259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283779|NCT04133259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65283780|NCT04133259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65283781|NCT02616315|Naltrexone|naltrexone|mesh-list
65283782|NCT02616315|Bupropion|bupropion|mesh-list
65283783|NCT02616315|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65283784|NCT02616315|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65283785|NCT02616315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283786|NCT02616315|Sensory System Agents|sensory system agents|mesh-ancestor
65283787|NCT02616315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65283788|NCT02616315|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65283789|NCT02616315|Antidepressive Agents|antidepressive agents|mesh-ancestor
64801438|NCT02427581|Laxatives|laxatives|mesh-ancestor
64801439|NCT02427581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64801440|NCT02427581|Antiviral Agents|antiviral agents|mesh-ancestor
64801441|NCT02427581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64801442|NCT02423525|Afatinib|afatinib|mesh-list
64801443|NCT02423525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801444|NCT02423525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64801445|NCT02423525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801446|NCT02423525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801447|NCT02369653|Apixaban|apixaban|mesh-list
64801448|NCT02369653|Anticoagulants|anticoagulants|mesh-list
64801449|NCT02369653|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64801450|NCT02369653|Antithrombins|antithrombins|mesh-ancestor
64801451|NCT02369653|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64801452|NCT02369653|Protease Inhibitors|protease inhibitors|mesh-ancestor
64801453|NCT02369653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801454|NCT02369653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801455|NCT02326974|Pertuzumab|pertuzumab|mesh-list
64472162|NCT03772314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64472163|NCT03760575|Pembrolizumab|pembrolizumab|mesh-list
64801456|NCT02326974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64801457|NCT02326974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801458|NCT02293109|Leucovorin|leucovorin|mesh-list
64801459|NCT02293109|Cytarabine|cytarabine|mesh-list
64801460|NCT02293109|Dexamethasone|dexamethasone|mesh-list
64801461|NCT02293109|Methylprednisolone|methylprednisolone|mesh-list
64801462|NCT02293109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64801463|NCT02293109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64801464|NCT02293109|Prednisolone|prednisolone|mesh-list
64801465|NCT02293109|Prednisolone acetate|prednisolone acetate|mesh-list
64801466|NCT02293109|Cyclophosphamide|cyclophosphamide|mesh-list
64801467|NCT02293109|Rituximab|rituximab|mesh-list
64801468|NCT02293109|Doxorubicin|doxorubicin|mesh-list
64801469|NCT02293109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64801479|NCT02293109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64801480|NCT02293109|Alkylating Agents|alkylating agents|mesh-ancestor
65283790|NCT02616315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65283791|NCT02616315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65283792|NCT02616315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65283793|NCT02616315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65283794|NCT02616315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283795|NCT02616315|Dopamine Agents|dopamine agents|mesh-ancestor
65283796|NCT02616315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65283797|NCT02616315|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65283798|NCT02616315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65283799|NCT02616315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283800|NCT02779283|Calcium, Dietary|calcium, dietary|mesh-list
65283801|NCT02779283|Leucovorin|leucovorin|mesh-list
65283802|NCT02779283|Folic Acid|folic acid|mesh-list
65283803|NCT02779283|Cytarabine|cytarabine|mesh-list
65283804|NCT02779283|Dexamethasone|dexamethasone|mesh-list
65283805|NCT02779283|Methylprednisolone|methylprednisolone|mesh-list
65283806|NCT02779283|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65283807|NCT02779283|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65283808|NCT02779283|Prednisolone|prednisolone|mesh-list
65283809|NCT02779283|Prednisolone acetate|prednisolone acetate|mesh-list
65283810|NCT02779283|Dexamethasone acetate|dexamethasone acetate|mesh-list
65283811|NCT02779283|Cyclophosphamide|cyclophosphamide|mesh-list
65283812|NCT02779283|Rituximab|rituximab|mesh-list
65283813|NCT02779283|Doxorubicin|doxorubicin|mesh-list
65283814|NCT02779283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65283815|NCT02779283|Methotrexate|methotrexate|mesh-list
65283816|NCT02779283|Vincristine|vincristine|mesh-list
65283817|NCT02779283|Sorafenib|sorafenib|mesh-list
65283818|NCT02779283|Sunitinib|sunitinib|mesh-list
65283819|NCT02779283|Dasatinib|dasatinib|mesh-list
65283820|NCT02779283|Idarubicin|idarubicin|mesh-list
65283821|NCT02779283|Ponatinib|ponatinib|mesh-list
65283822|NCT02779283|Idelalisib|idelalisib|mesh-list
64801481|NCT02293109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801482|NCT02293109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801483|NCT02293109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64801498|NCT02293109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64801499|NCT02293109|Abortifacient Agents|abortifacient agents|mesh-ancestor
64801500|NCT02293109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64801501|NCT02293109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64801502|NCT02293109|Antimetabolites|antimetabolites|mesh-ancestor
64801503|NCT02293109|Dermatologic Agents|dermatologic agents|mesh-ancestor
64801504|NCT02293109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64801505|NCT02293109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64801506|NCT02293109|Antiviral Agents|antiviral agents|mesh-ancestor
64801507|NCT02293109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64801508|NCT02293109|Antidotes|antidotes|mesh-ancestor
64801509|NCT02293109|Protective Agents|protective agents|mesh-ancestor
65283823|NCT02779283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65283824|NCT02779283|Antibodies|antibodies|mesh-list
65283825|NCT02779283|Immunoglobulins|immunoglobulins|mesh-list
65283826|NCT02779283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65283827|NCT02779283|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65283828|NCT02779283|Prednisolone phosphate|prednisolone phosphate|mesh-list
65283829|NCT02779283|BB 1101|bb 1101|mesh-list
65283830|NCT02779283|Calcium|calcium|mesh-list
65283831|NCT02779283|Levoleucovorin|levoleucovorin|mesh-list
65283832|NCT02779283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65283833|NCT02779283|Immunologic Factors|immunologic factors|mesh-ancestor
65283834|NCT02779283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283835|NCT02779283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64736150|NCT01216631|Prednisolone|prednisolone|mesh-list
64801510|NCT02293109|Vitamin B Complex|vitamin b complex|mesh-ancestor
64801512|NCT02293109|Micronutrients|micronutrients|mesh-ancestor
64801513|NCT02293109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64801514|NCT02293109|Tubulin Modulators|tubulin modulators|mesh-ancestor
64801515|NCT02293109|Antimitotic Agents|antimitotic agents|mesh-ancestor
64801516|NCT02293109|Mitosis Modulators|mitosis modulators|mesh-ancestor
64801517|NCT02293109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64801518|NCT02195986|Estradiol|estradiol|mesh-list
64801519|NCT02195986|Estrogens|estrogens|mesh-ancestor
64801520|NCT02195986|Hormones|hormones|mesh-ancestor
64801521|NCT02195986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64801522|NCT02195986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801523|NCT02183883|Afatinib|afatinib|mesh-list
64801524|NCT02183883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801525|NCT02183883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64801526|NCT02183883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801527|NCT02183883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801528|NCT01982630|Liraglutide|liraglutide|mesh-list
64801529|NCT01982630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64801530|NCT01982630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801531|NCT01982630|Incretins|incretins|mesh-ancestor
64801532|NCT01982630|Hormones|hormones|mesh-ancestor
64801533|NCT01982630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64801534|NCT01982448|Paclitaxel|paclitaxel|mesh-list
64801535|NCT01982448|Cisplatin|cisplatin|mesh-list
64801536|NCT01982448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64472164|NCT03760575|Pemetrexed|pemetrexed|mesh-list
64472165|NCT03760575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801544|NCT01951469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801545|NCT01951469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801546|NCT01951469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801547|NCT01951469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64801565|NCT01879228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64801567|NCT01879228|Protease Inhibitors|protease inhibitors|mesh-ancestor
64801568|NCT01879228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801569|NCT01879228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801570|NCT01779557|Dialysis Solutions|dialysis solutions|mesh-list
64801571|NCT01779557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64801572|NCT01740297|Ipilimumab|ipilimumab|mesh-list
64801573|NCT01740297|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
64801574|NCT01740297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64801575|NCT01740297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801576|NCT01740297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64801577|NCT01740297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801579|NCT01729754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64801580|NCT01729754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64801581|NCT01729754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64801582|NCT01729754|Analgesics|analgesics|mesh-ancestor
64801583|NCT01729754|Sensory System Agents|sensory system agents|mesh-ancestor
65283836|NCT02779283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65283837|NCT02779283|Alkylating Agents|alkylating agents|mesh-ancestor
65283838|NCT02779283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283839|NCT02779283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283840|NCT02779283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65283841|NCT02779283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65283842|NCT02779283|Antiemetics|antiemetics|mesh-ancestor
65283843|NCT02779283|Autonomic Agents|autonomic agents|mesh-ancestor
65283844|NCT02779283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65283845|NCT02779283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65283846|NCT02779283|Glucocorticoids|glucocorticoids|mesh-ancestor
65283847|NCT02779283|Hormones|hormones|mesh-ancestor
65283848|NCT02779283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65283849|NCT02779283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65283850|NCT02779283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65283851|NCT02779283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65283852|NCT02779283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65283853|NCT02779283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283854|NCT02779283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65283855|NCT02779283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65283856|NCT02779283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65283857|NCT02779283|Abortifacient Agents|abortifacient agents|mesh-ancestor
65283858|NCT02779283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65283859|NCT02779283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64801584|NCT01729754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64801585|NCT01729754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801586|NCT01729754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64801587|NCT01729754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64801588|NCT01729754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64801589|NCT01729754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64801590|NCT01729754|Immunologic Factors|immunologic factors|mesh-ancestor
64801591|NCT01622998|Nicotine|nicotine|mesh-list
64801592|NCT01622998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64801593|NCT01622998|Autonomic Agents|autonomic agents|mesh-ancestor
64801594|NCT01622998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64801595|NCT01622998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801596|NCT01622998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64801597|NCT01622998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64801598|NCT01622998|Cholinergic Agents|cholinergic agents|mesh-ancestor
64801599|NCT01622998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64801600|NCT01622998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801601|NCT01595620|Dronabinol|dronabinol|mesh-list
64801602|NCT01595620|Capsaicin|capsaicin|mesh-list
64801603|NCT01595620|Hallucinogens|hallucinogens|mesh-ancestor
64801604|NCT01595620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801605|NCT01595620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64801633|NCT01591629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65283860|NCT02779283|Antimetabolites|antimetabolites|mesh-ancestor
65283861|NCT02779283|Dermatologic Agents|dermatologic agents|mesh-ancestor
65283862|NCT02779283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65283863|NCT02779283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65283864|NCT02779283|Antiviral Agents|antiviral agents|mesh-ancestor
65283865|NCT02779283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65283866|NCT02779283|Antidotes|antidotes|mesh-ancestor
65283867|NCT02779283|Protective Agents|protective agents|mesh-ancestor
65283868|NCT02779283|Vitamin B Complex|vitamin b complex|mesh-ancestor
65283869|NCT02779283|Vitamins|vitamins|mesh-ancestor
65283870|NCT02779283|Micronutrients|micronutrients|mesh-ancestor
65283871|NCT02779283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65283872|NCT02779283|Tubulin Modulators|tubulin modulators|mesh-ancestor
65283873|NCT02779283|Antimitotic Agents|antimitotic agents|mesh-ancestor
65283874|NCT02779283|Mitosis Modulators|mitosis modulators|mesh-ancestor
65283875|NCT02779283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65283876|NCT02779283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65283877|NCT02779283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65283878|NCT02779283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65283879|NCT02779283|Growth Substances|growth substances|mesh-ancestor
65283880|NCT02779283|Growth Inhibitors|growth inhibitors|mesh-ancestor
65283881|NCT02779283|Hematinics|hematinics|mesh-ancestor
65283882|NCT02779283|Protease Inhibitors|protease inhibitors|mesh-ancestor
65283883|NCT02616003|Liraglutide|liraglutide|mesh-list
65283884|NCT02616003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64736196|NCT02687165|Analgesics|analgesics|mesh-ancestor
64801634|NCT01515306|Paclitaxel|paclitaxel|mesh-list
64801635|NCT01515306|Ramucirumab|ramucirumab|mesh-list
64801636|NCT01515306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64801637|NCT01515306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801638|NCT01515306|Tubulin Modulators|tubulin modulators|mesh-ancestor
64801639|NCT01515306|Antimitotic Agents|antimitotic agents|mesh-ancestor
64801640|NCT01515306|Mitosis Modulators|mitosis modulators|mesh-ancestor
64801641|NCT01515306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801642|NCT01513187|Interferons|interferons|mesh-list
64801643|NCT01513187|Interferon-alpha|interferon-alpha|mesh-list
64801644|NCT01513187|Interferon alpha-2|interferon alpha-2|mesh-list
64801645|NCT01513187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801646|NCT01513187|Antiviral Agents|antiviral agents|mesh-ancestor
64801647|NCT01513187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64801648|NCT01513187|Immunologic Factors|immunologic factors|mesh-ancestor
64801649|NCT01513187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801650|NCT01433965|Lenalidomide|lenalidomide|mesh-list
64801651|NCT01433965|Immunologic Factors|immunologic factors|mesh-ancestor
64801652|NCT01433965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801653|NCT01433965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64801654|NCT01433965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64801655|NCT01433965|Growth Substances|growth substances|mesh-ancestor
64801656|NCT01433965|Growth Inhibitors|growth inhibitors|mesh-ancestor
64801657|NCT01433965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801659|NCT01360593|Capecitabine|capecitabine|mesh-list
64801660|NCT01360593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64801661|NCT01360593|Antimetabolites|antimetabolites|mesh-ancestor
65283885|NCT02616003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283886|NCT02616003|Incretins|incretins|mesh-ancestor
65283887|NCT02616003|Hormones|hormones|mesh-ancestor
65283888|NCT02616003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65283889|NCT02661152|Nimorazole|nimorazole|mesh-list
65283890|NCT02661152|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65283891|NCT02661152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65283892|NCT02661152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65283893|NCT02661152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65283894|NCT00697671|Cyclophosphamide|cyclophosphamide|mesh-list
65283895|NCT00697671|Etoposide|etoposide|mesh-list
65283896|NCT00697671|Interleukin-2|interleukin-2|mesh-list
65283897|NCT00697671|Clofarabine|clofarabine|mesh-list
65283898|NCT00697671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65283899|NCT00697671|Immunologic Factors|immunologic factors|mesh-ancestor
65283900|NCT00697671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283901|NCT00697671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65283902|NCT00697671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65283903|NCT00697671|Alkylating Agents|alkylating agents|mesh-ancestor
65283904|NCT00697671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283905|NCT00697671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283906|NCT00697671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65283907|NCT00697671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65283908|NCT00697671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65283909|NCT00697671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65283910|NCT00697671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283911|NCT00697671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65283912|NCT00697671|Analgesics|analgesics|mesh-ancestor
65283913|NCT00697671|Sensory System Agents|sensory system agents|mesh-ancestor
65283914|NCT00697671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64801662|NCT01360593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801663|NCT01360593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801664|NCT01360593|Antiviral Agents|antiviral agents|mesh-ancestor
64801676|NCT01354977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64801678|NCT01334606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64801679|NCT01334606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801680|NCT01226732|Capecitabine|capecitabine|mesh-list
64801681|NCT01226732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64801682|NCT01226732|Antimetabolites|antimetabolites|mesh-ancestor
64801683|NCT01226732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801684|NCT01226732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801685|NCT00962988|Bupropion|bupropion|mesh-list
64801686|NCT00962988|Nicotine|nicotine|mesh-list
64801687|NCT00962988|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64801688|NCT00962988|Autonomic Agents|autonomic agents|mesh-ancestor
65283915|NCT00697671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65283916|NCT00697671|Antimetabolites|antimetabolites|mesh-ancestor
65283917|NCT03922945|Topiramate|topiramate|mesh-list
65283918|NCT03922945|Phentermine|phentermine|mesh-list
65283919|NCT03922945|Anticonvulsants|anticonvulsants|mesh-ancestor
65283920|NCT03922945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65283921|NCT03922945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283922|NCT03922945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65283923|NCT03922945|Appetite Depressants|appetite depressants|mesh-ancestor
65283924|NCT03922945|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65283925|NCT03922945|Sympathomimetics|sympathomimetics|mesh-ancestor
65283926|NCT03922945|Autonomic Agents|autonomic agents|mesh-ancestor
65283927|NCT03922945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65283928|NCT03922945|Adrenergic Agents|adrenergic agents|mesh-ancestor
65283929|NCT03922945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65283930|NCT03922945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283931|NCT04973345|Terbutaline|terbutaline|mesh-list
65283932|NCT04973345|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65283933|NCT04973345|Autonomic Agents|autonomic agents|mesh-ancestor
65283934|NCT04973345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65283935|NCT04973345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283936|NCT04973345|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65283937|NCT04973345|Respiratory System Agents|respiratory system agents|mesh-ancestor
65283938|NCT04973345|Sympathomimetics|sympathomimetics|mesh-ancestor
65283939|NCT04973345|Tocolytic Agents|tocolytic agents|mesh-ancestor
65283940|NCT04973345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64736243|NCT01133639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64801689|NCT00962988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64801690|NCT00962988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801691|NCT00962988|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64801692|NCT00962988|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64801693|NCT00962988|Cholinergic Agents|cholinergic agents|mesh-ancestor
64801694|NCT00962988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64801695|NCT00962988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801696|NCT00962988|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64801723|NCT00768820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64801725|NCT00768820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64801726|NCT00768820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64801732|NCT00678730|Analgesics|analgesics|mesh-ancestor
64801733|NCT00678730|Sensory System Agents|sensory system agents|mesh-ancestor
64801734|NCT00678730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64801735|NCT00678730|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64801736|NCT00678730|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64801737|NCT00678730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64801738|NCT00678730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801740|NCT00678730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65283941|NCT04973345|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65283942|NCT04973345|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65283943|NCT04973345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65283944|NCT04973345|Adrenergic Agents|adrenergic agents|mesh-ancestor
65283945|NCT04973345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65283946|NCT04973345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283947|NCT05236985|Oxytocin|oxytocin|mesh-list
65283948|NCT05236985|Oxytocics|oxytocics|mesh-ancestor
65283949|NCT05236985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65283950|NCT05236985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283951|NCT03922477|Atezolizumab|atezolizumab|mesh-list
65283952|NCT03922477|Magrolimab|magrolimab|mesh-list
65283953|NCT03922477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283954|NCT03922477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65283955|NCT05227391|Letrozole|letrozole|mesh-list
64736267|NCT02501759|Pentetic Acid|pentetic acid|mesh-list
64801741|NCT00600015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64801742|NCT00600015|Sorafenib|sorafenib|mesh-list
64801743|NCT00600015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801744|NCT00600015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64801745|NCT00600015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801746|NCT00600015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801763|NCT00447122|Antiviral Agents|antiviral agents|mesh-ancestor
64801764|NCT00447122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64801765|NCT00447122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801766|NCT00447122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64801767|NCT00447122|Immunologic Factors|immunologic factors|mesh-ancestor
64801768|NCT00447122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801769|NCT00447122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64801771|NCT00430040|Lisinopril|lisinopril|mesh-list
64801772|NCT00430040|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64801773|NCT00430040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64801774|NCT00430040|Adrenergic Agents|adrenergic agents|mesh-ancestor
64801775|NCT00430040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64801776|NCT00430040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801777|NCT00430040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801778|NCT00430040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64801779|NCT00430040|Antioxidants|antioxidants|mesh-ancestor
64801780|NCT00430040|Protective Agents|protective agents|mesh-ancestor
64801781|NCT00430040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64801782|NCT00430040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64801783|NCT00430040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64801784|NCT00430040|Vasodilator Agents|vasodilator agents|mesh-ancestor
64801785|NCT00430040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64801786|NCT00430040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64801787|NCT00430040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64801788|NCT00430040|Protease Inhibitors|protease inhibitors|mesh-ancestor
64801789|NCT00430040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801790|NCT00430040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64801791|NCT00290251|Ulipristal acetate|ulipristal acetate|mesh-list
64801792|NCT00290251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64801793|NCT00290251|Contraceptive Agents|contraceptive agents|mesh-ancestor
64801794|NCT00290251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64801802|NCT01397500|Testosterone|testosterone|mesh-list
64801803|NCT01397500|Androgens|androgens|mesh-ancestor
64801804|NCT01397500|Hormones|hormones|mesh-ancestor
64801805|NCT01397500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64801806|NCT01397500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801807|NCT01397513|Aspirin|aspirin|mesh-list
65283956|NCT05227391|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65283957|NCT05227391|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65283958|NCT05227391|Estradiol|estradiol|mesh-list
65283959|NCT05227391|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65283960|NCT05227391|Estrogens|estrogens|mesh-ancestor
65283961|NCT05227391|Hormones|hormones|mesh-ancestor
65283962|NCT05227391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65283963|NCT05227391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283964|NCT05227391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65283965|NCT05227391|Contraceptive Agents|contraceptive agents|mesh-ancestor
64801808|NCT01397513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64801809|NCT01397513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64801831|NCT01397799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801833|NCT01397994|Atenolol|atenolol|mesh-list
64801834|NCT01397994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64801835|NCT01397994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64801836|NCT01397994|Sympatholytics|sympatholytics|mesh-ancestor
64801837|NCT01397994|Autonomic Agents|autonomic agents|mesh-ancestor
64801838|NCT01397994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64801839|NCT01397994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801840|NCT01397994|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64801841|NCT01397994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64801842|NCT01397994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64801843|NCT01397994|Adrenergic Agents|adrenergic agents|mesh-ancestor
64801844|NCT01397994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64801845|NCT01397994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801846|NCT01397994|Vasodilator Agents|vasodilator agents|mesh-ancestor
64801847|NCT01397994|Vitamin B Complex|vitamin b complex|mesh-ancestor
64801848|NCT01397994|Vitamins|vitamins|mesh-ancestor
64801849|NCT01397994|Micronutrients|micronutrients|mesh-ancestor
64801850|NCT01398033|Paclitaxel|paclitaxel|mesh-list
64801851|NCT01398033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64801852|NCT01398033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801853|NCT01398033|Tubulin Modulators|tubulin modulators|mesh-ancestor
64801854|NCT01398033|Antimitotic Agents|antimitotic agents|mesh-ancestor
64801855|NCT01398033|Mitosis Modulators|mitosis modulators|mesh-ancestor
64801856|NCT01398033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801857|NCT01398046|Dasatinib|dasatinib|mesh-list
64801858|NCT01398046|Rabeprazole|rabeprazole|mesh-list
64801859|NCT01398046|Betaine|betaine|mesh-list
64801860|NCT01398046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801861|NCT01398046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64801862|NCT01398046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801863|NCT01398046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801892|NCT01398111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64801894|NCT01398111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64801895|NCT01398111|Adrenergic Agents|adrenergic agents|mesh-ancestor
64801896|NCT01398111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64801897|NCT01398111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801898|NCT01398111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64801899|NCT01398111|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64801900|NCT01398111|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64801901|NCT01398111|Cholinergic Agents|cholinergic agents|mesh-ancestor
64801902|NCT01398189|Clozapine|clozapine|mesh-list
64801903|NCT01398189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64801904|NCT01398189|Serotonin Agents|serotonin agents|mesh-ancestor
64801905|NCT01398189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64801906|NCT01398189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801907|NCT01398189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801908|NCT01398189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64801909|NCT01398189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64801910|NCT01398189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64801911|NCT01398189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64801912|NCT01398189|GABA Antagonists|gaba antagonists|mesh-ancestor
65283966|NCT05227391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65283967|NCT05227391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65283968|NCT05227391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283969|NCT05227391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65283970|NCT05227391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65283971|NCT05227391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283972|NCT05227391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283973|NCT05227391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65283974|NCT05227391|Hormone Antagonists|hormone antagonists|mesh-ancestor
64801913|NCT01398189|GABA Agents|gaba agents|mesh-ancestor
64801914|NCT01398202|Vitamin D|vitamin d|mesh-list
64801915|NCT01398202|Cholecalciferol|cholecalciferol|mesh-list
64801916|NCT01398202|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
64801917|NCT01398202|Calcifediol|calcifediol|mesh-list
64801918|NCT01398202|Vitamins|vitamins|mesh-ancestor
64801919|NCT01398202|Micronutrients|micronutrients|mesh-ancestor
64801920|NCT01398202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801921|NCT01398202|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64801922|NCT01398202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64801923|NCT01398267|Lisinopril|lisinopril|mesh-list
64801924|NCT01398267|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64801925|NCT01398267|Protease Inhibitors|protease inhibitors|mesh-ancestor
64801926|NCT01398267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801927|NCT01398267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801928|NCT01398267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64801929|NCT01398267|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64801938|NCT01398293|Protease Inhibitors|protease inhibitors|mesh-ancestor
64801939|NCT01398293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801968|NCT01398384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64801969|NCT01398384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801970|NCT01398384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64801971|NCT01398384|Respiratory System Agents|respiratory system agents|mesh-ancestor
64801972|NCT01398384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64801973|NCT01398384|Antioxidants|antioxidants|mesh-ancestor
64801974|NCT01398384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801975|NCT01398384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64801976|NCT01398384|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64801977|NCT01398384|Vasodilator Agents|vasodilator agents|mesh-ancestor
64801978|NCT01398384|Gasotransmitters|gasotransmitters|mesh-ancestor
64801979|NCT01398384|Protective Agents|protective agents|mesh-ancestor
64801980|NCT01398501|Sorafenib|sorafenib|mesh-list
64801981|NCT01398501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801982|NCT01398501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64801983|NCT01398501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802011|NCT01398618|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64802012|NCT01398618|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64802013|NCT01398618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64802014|NCT01398618|Antimetabolites|antimetabolites|mesh-ancestor
64802015|NCT01398618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64802016|NCT01398657|Androgens|androgens|mesh-list
64802017|NCT01398657|Hormones|hormones|mesh-ancestor
64802018|NCT01398657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64802019|NCT01398657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802020|NCT01398670|Insulin|insulin|mesh-list
64802021|NCT01398670|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64802022|NCT01398670|Insulin Lispro|insulin lispro|mesh-list
64802023|NCT01398670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64802024|NCT01398670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802025|NCT01398722|Insulin|insulin|mesh-list
64802026|NCT01398722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64802027|NCT01398722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64802028|NCT01398722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802029|NCT01398995|Insulin|insulin|mesh-list
64802030|NCT01398995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64802031|NCT01398995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802032|NCT01399086|Fulvestrant|fulvestrant|mesh-list
65283975|NCT00978211|Octreotide|octreotide|mesh-list
65283976|NCT00978211|Somatostatin|somatostatin|mesh-list
65033963|NCT00174200|Risperidone|risperidone|mesh-list
65283977|NCT00978211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65283978|NCT00978211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65283979|NCT00978211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65283980|NCT00978211|Hormones|hormones|mesh-ancestor
65283981|NCT00978211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65283982|NCT00978211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283983|NCT00867165|Ezetimibe|ezetimibe|mesh-list
65283984|NCT00867165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65283985|NCT00867165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65283986|NCT00867165|Antimetabolites|antimetabolites|mesh-ancestor
65283987|NCT00867165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283988|NCT00867165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65283989|NCT00981955|Caffeine|caffeine|mesh-list
65283990|NCT00981955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65283991|NCT00981955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65283992|NCT00981955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65283993|NCT00981955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65283994|NCT00981955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65283995|NCT00981955|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65283996|NCT00981955|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65283997|NCT00981955|Purinergic Agents|purinergic agents|mesh-ancestor
64802033|NCT01399086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64802034|NCT01399086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802035|NCT01399086|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64802036|NCT01399086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64802037|NCT01399086|Hormone Antagonists|hormone antagonists|mesh-ancestor
64802038|NCT01399086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64802039|NCT01399086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802040|NCT01399151|Vitamin D|vitamin d|mesh-list
64802060|NCT01399255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802062|NCT01399346|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64802063|NCT01399346|Insulin Aspart|insulin aspart|mesh-list
64802064|NCT01399346|Insulin, Long-Acting|insulin, long-acting|mesh-list
64413123|NCT04968613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802072|NCT01399450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802073|NCT01399450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64802074|NCT01399450|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64802075|NCT01399450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64802076|NCT01399450|Serotonin Agents|serotonin agents|mesh-ancestor
64802077|NCT01399450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64802078|NCT01399450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802079|NCT01399450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64802080|NCT01399450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64802081|NCT01399450|Dopamine Agents|dopamine agents|mesh-ancestor
64802082|NCT01399463|Paclitaxel|paclitaxel|mesh-list
64802083|NCT01399463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65283998|NCT00981955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65283999|NCT00972829|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65284000|NCT00972829|Ezetimibe|ezetimibe|mesh-list
65284001|NCT00972829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65284002|NCT00972829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65284003|NCT00972829|Antimetabolites|antimetabolites|mesh-ancestor
65284004|NCT00972829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284005|NCT00972829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65284006|NCT00972829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65284007|NCT00972829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65284008|NCT05037617|Oxytocin|oxytocin|mesh-list
65284009|NCT05037617|Oxytocics|oxytocics|mesh-ancestor
65284010|NCT05037617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65284011|NCT05037617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284012|NCT00972907|Nifedipine|nifedipine|mesh-list
65284013|NCT00972907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65284014|NCT00972907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65284015|NCT00972907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284016|NCT00972907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65284017|NCT00972907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802084|NCT01399463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802085|NCT01399463|Tubulin Modulators|tubulin modulators|mesh-ancestor
64802086|NCT01399463|Antimitotic Agents|antimitotic agents|mesh-ancestor
64802087|NCT01399463|Mitosis Modulators|mitosis modulators|mesh-ancestor
64802088|NCT01399463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802089|NCT01399515|Valproic Acid|valproic acid|mesh-list
64802090|NCT01399515|Anticonvulsants|anticonvulsants|mesh-ancestor
64802091|NCT01399515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802092|NCT01399515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802093|NCT01399515|GABA Agents|gaba agents|mesh-ancestor
64802094|NCT01399515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64802095|NCT01399515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570693|NCT02981069|Exenatide|exenatide|mesh-list
64802096|NCT01399515|Antimanic Agents|antimanic agents|mesh-ancestor
64802097|NCT01399515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64802098|NCT01399515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64802099|NCT01399515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64802100|NCT01399645|Insulin|insulin|mesh-list
64802111|NCT01399840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64802112|NCT01399840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802113|NCT01399840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802114|NCT01399840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802115|NCT01399853|Vaccines|vaccines|mesh-list
64802116|NCT01399853|Immunologic Factors|immunologic factors|mesh-ancestor
64802117|NCT01399853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802118|NCT01400009|Vitamin D|vitamin d|mesh-list
64802119|NCT01400009|Cholecalciferol|cholecalciferol|mesh-list
64802120|NCT01400009|Vitamins|vitamins|mesh-ancestor
64802121|NCT01400009|Micronutrients|micronutrients|mesh-ancestor
64802122|NCT01400009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802123|NCT01400009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64802124|NCT01400009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64802125|NCT01400022|Cortisone|cortisone|mesh-list
64802126|NCT01400022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65284018|NCT00972907|Vasodilator Agents|vasodilator agents|mesh-ancestor
65284019|NCT00972907|Tocolytic Agents|tocolytic agents|mesh-ancestor
65284020|NCT00972907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65284021|NCT02436707|Gemcitabine|gemcitabine|mesh-list
65284022|NCT02436707|Dexamethasone|dexamethasone|mesh-list
65284023|NCT02436707|Cyclophosphamide|cyclophosphamide|mesh-list
65284024|NCT02436707|Rituximab|rituximab|mesh-list
65284025|NCT02436707|Etoposide|etoposide|mesh-list
65284026|NCT02436707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65284027|NCT02436707|Immunologic Factors|immunologic factors|mesh-ancestor
65284028|NCT02436707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284029|NCT02436707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65284030|NCT02436707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65284031|NCT02436707|Alkylating Agents|alkylating agents|mesh-ancestor
65284032|NCT02436707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284033|NCT02436707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284034|NCT02436707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64802127|NCT01400074|Imatinib Mesylate|imatinib mesylate|mesh-list
64802128|NCT01400074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802129|NCT01400074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64802130|NCT01400074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802131|NCT01400074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802137|NCT01400165|Pindolol|pindolol|mesh-list
64802138|NCT01400165|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64802139|NCT01400165|Trazodone|trazodone|mesh-list
64802140|NCT01400165|Antidepressive Agents|antidepressive agents|mesh-ancestor
64802141|NCT01400165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64802142|NCT01400165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64802143|NCT01400165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64802144|NCT01400165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64802145|NCT01400165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802146|NCT01400165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64802147|NCT01400165|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64802148|NCT01400165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64802149|NCT01400165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64802150|NCT01400165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802151|NCT01400165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64802152|NCT01400165|Serotonin Agents|serotonin agents|mesh-ancestor
64802153|NCT01400165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64802154|NCT01400165|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64802155|NCT01400165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64802156|NCT01400165|Adrenergic Agents|adrenergic agents|mesh-ancestor
64802157|NCT01400165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64802158|NCT01400165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64802159|NCT01400165|Vasodilator Agents|vasodilator agents|mesh-ancestor
64802160|NCT01400191|Metformin|metformin|mesh-list
64802161|NCT01400191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64802162|NCT01400191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802163|NCT01400217|Beclomethasone|beclomethasone|mesh-list
64802164|NCT01400217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64802187|NCT01400464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64802189|NCT01400464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64802190|NCT01400464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802191|NCT01400568|Fluticasone|fluticasone|mesh-list
64802192|NCT01400568|Xhance|xhance|mesh-list
64802193|NCT01400568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64802194|NCT01400568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64802195|NCT01400568|Autonomic Agents|autonomic agents|mesh-ancestor
64802196|NCT01400568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65284035|NCT02436707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65284036|NCT02436707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65284037|NCT02436707|Antiemetics|antiemetics|mesh-ancestor
65284038|NCT02436707|Autonomic Agents|autonomic agents|mesh-ancestor
65284039|NCT02436707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65284040|NCT02436707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65284041|NCT02436707|Glucocorticoids|glucocorticoids|mesh-ancestor
65284042|NCT02436707|Hormones|hormones|mesh-ancestor
65284043|NCT02436707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65284044|NCT02436707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65284045|NCT02436707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64802197|NCT01400568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802198|NCT01400568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64802199|NCT01400568|Respiratory System Agents|respiratory system agents|mesh-ancestor
64802200|NCT01400568|Dermatologic Agents|dermatologic agents|mesh-ancestor
64802201|NCT01400568|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64802214|NCT01400646|Anticoagulants|anticoagulants|mesh-ancestor
64802215|NCT01400646|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64802216|NCT01400646|Antithrombins|antithrombins|mesh-ancestor
64802217|NCT01400646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64802218|NCT01400646|Protease Inhibitors|protease inhibitors|mesh-ancestor
64802219|NCT01400646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802220|NCT01400646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802221|NCT01400646|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64802222|NCT01400646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64802224|NCT01400646|Coagulants|coagulants|mesh-ancestor
64802225|NCT01400672|Imiquimod|imiquimod|mesh-list
64802226|NCT01400672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64802227|NCT01400672|Immunologic Factors|immunologic factors|mesh-ancestor
64802228|NCT01400672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802259|NCT01400750|Tobramycin|tobramycin|mesh-list
64802260|NCT01400750|Colistin|colistin|mesh-list
64802261|NCT01400750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64802262|NCT01400750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64802263|NCT01400750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64802264|NCT01400750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64802265|NCT01400750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802266|NCT01400750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802282|NCT01400828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802283|NCT01400828|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64802284|NCT01400828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64802285|NCT01400828|Histamine Antagonists|histamine antagonists|mesh-ancestor
64802286|NCT01400828|Histamine Agents|histamine agents|mesh-ancestor
64802297|NCT01400867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64802298|NCT01400867|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64802300|NCT01400867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802301|NCT01400945|Pantoprazole|pantoprazole|mesh-list
64802302|NCT01400945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64802303|NCT01400945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64802304|NCT01400945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64802305|NCT01400945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802306|NCT01400945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802307|NCT01401036|Umirolimus|umirolimus|mesh-list
64802308|NCT01401036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64802309|NCT01401036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64802310|NCT01401036|Immunologic Factors|immunologic factors|mesh-ancestor
64802311|NCT01401036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802312|NCT01401075|Viscum album peptide|viscum album peptide|mesh-list
64802313|NCT01401075|Doxifluridine|doxifluridine|mesh-list
64802314|NCT01401075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802315|NCT01401075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64472168|NCT03760575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802316|NCT01401075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65284046|NCT02436707|Antimetabolites|antimetabolites|mesh-ancestor
65284047|NCT02436707|Antiviral Agents|antiviral agents|mesh-ancestor
65284048|NCT02436707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65284049|NCT02436707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034038|NCT00203736|Antiviral Agents|antiviral agents|mesh-ancestor
65284050|NCT02436707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65284051|NCT02436707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65284052|NCT02436707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65284053|NCT04008433|Lidocaine|lidocaine|mesh-list
65284054|NCT04008433|Anesthetics, Local|anesthetics, local|mesh-ancestor
65284055|NCT04008433|Anesthetics|anesthetics|mesh-ancestor
65284056|NCT04008433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65284057|NCT04008433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284058|NCT04008433|Sensory System Agents|sensory system agents|mesh-ancestor
65284059|NCT04008433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65284060|NCT04008433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65284061|NCT04008433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65284062|NCT04008433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65284063|NCT04008433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65284064|NCT04008433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284065|NCT04132479|Amoxicillin|amoxicillin|mesh-list
65284066|NCT04132479|Clarithromycin|clarithromycin|mesh-list
65284067|NCT04132479|Tinidazole|tinidazole|mesh-list
65284068|NCT04132479|Rabeprazole|rabeprazole|mesh-list
65284069|NCT04132479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65284070|NCT04132479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65284071|NCT04132479|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65284072|NCT04132479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802317|NCT01401075|Antiviral Agents|antiviral agents|mesh-ancestor
64802318|NCT01401075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64802319|NCT01401075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64802320|NCT01401075|Antimetabolites|antimetabolites|mesh-ancestor
64802321|NCT01401075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802322|NCT01401075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64802323|NCT01401075|Immunologic Factors|immunologic factors|mesh-ancestor
64802324|NCT01401075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802325|NCT01401075|Appetite Stimulants|appetite stimulants|mesh-ancestor
64802340|NCT01401179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64802341|NCT01401192|Gemcitabine|gemcitabine|mesh-list
64802342|NCT01401192|Cisplatin|cisplatin|mesh-list
64802343|NCT01401192|Pemetrexed|pemetrexed|mesh-list
64802344|NCT01401192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802345|NCT01401192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64802346|NCT01401192|Antimetabolites|antimetabolites|mesh-ancestor
64802347|NCT01401192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802348|NCT01401192|Antiviral Agents|antiviral agents|mesh-ancestor
64802349|NCT01401192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65284073|NCT04132479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284074|NCT04132479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65284075|NCT04132479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65284076|NCT04132479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65284077|NCT04132479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65284078|NCT04132479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65284079|NCT04132479|Alkylating Agents|alkylating agents|mesh-ancestor
65284080|NCT04132479|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65284081|NCT04132479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65284082|NCT04132479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65284083|NCT00972985|Lorazepam|lorazepam|mesh-list
65284084|NCT00972985|Methylphenidate|methylphenidate|mesh-list
65284085|NCT00972985|Modafinil|modafinil|mesh-list
65284086|NCT00972985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65284087|NCT00972985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284088|NCT00972985|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65284089|NCT00972985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65284090|NCT00972985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65284091|NCT00972985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284092|NCT00972985|Dopamine Agents|dopamine agents|mesh-ancestor
65284093|NCT00972985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65284094|NCT00972985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64736396|NCT01009931|Protease Inhibitors|protease inhibitors|mesh-ancestor
64802350|NCT01401192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802351|NCT01401192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64802352|NCT01401192|Immunologic Factors|immunologic factors|mesh-ancestor
64802353|NCT01401192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802354|NCT01401192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64802355|NCT01401192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64802356|NCT01401387|Pancreatin|pancreatin|mesh-list
64802357|NCT01401387|Pancrelipase|pancrelipase|mesh-list
64802358|NCT01401387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64802359|NCT01401491|Clozapine|clozapine|mesh-list
64802360|NCT01401491|Fluvoxamine|fluvoxamine|mesh-list
64802361|NCT01401491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64802362|NCT01401491|Serotonin Agents|serotonin agents|mesh-ancestor
64802363|NCT01401491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64802364|NCT01401491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802365|NCT01401491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802366|NCT01401491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64802367|NCT01401491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64802368|NCT01401491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64802369|NCT01401491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64802385|NCT01401803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802386|NCT01401803|Cholinergic Agents|cholinergic agents|mesh-ancestor
64802406|NCT01402024|Autonomic Agents|autonomic agents|mesh-ancestor
64802407|NCT01402024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64802408|NCT01402024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802409|NCT01402024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65284095|NCT00972985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65284096|NCT00972985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65284097|NCT00972985|Anticonvulsants|anticonvulsants|mesh-ancestor
65284098|NCT00972985|Antiemetics|antiemetics|mesh-ancestor
65284099|NCT00972985|Autonomic Agents|autonomic agents|mesh-ancestor
65284100|NCT00972985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65284101|NCT00972985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65284102|NCT00972985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65284103|NCT00972985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65284104|NCT00972985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65284105|NCT00972985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65284106|NCT00972985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65284107|NCT00972985|GABA Modulators|gaba modulators|mesh-ancestor
65284108|NCT00972985|GABA Agents|gaba agents|mesh-ancestor
65284109|NCT00867087|Rituximab|rituximab|mesh-list
65284110|NCT00867087|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65284111|NCT00867087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65284112|NCT00867087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802410|NCT01402024|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64802411|NCT01402024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64802412|NCT01402024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802415|NCT01402076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64802416|NCT01402076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64802417|NCT01402076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64802418|NCT01402076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802419|NCT01402076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64802420|NCT01402076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64802421|NCT01402076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64802422|NCT01402076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64802423|NCT01402076|Anesthetics, General|anesthetics, general|mesh-ancestor
64802424|NCT01402076|Anesthetics|anesthetics|mesh-ancestor
64802425|NCT01402076|GABA Modulators|gaba modulators|mesh-ancestor
64802426|NCT01402076|GABA Agents|gaba agents|mesh-ancestor
64802427|NCT01402076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64802428|NCT01402076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802429|NCT01402076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64802430|NCT01402089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64802431|NCT01402089|Sunitinib|sunitinib|mesh-list
64802432|NCT01402089|Midazolam|midazolam|mesh-list
64802433|NCT01402089|Caffeine|caffeine|mesh-list
64802434|NCT01402089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64802435|NCT01402089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64802436|NCT01402089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64802437|NCT01402089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413525|NCT02577029|Tenofovir|tenofovir|mesh-list
64802453|NCT01402089|Growth Substances|growth substances|mesh-ancestor
64802454|NCT01402089|Growth Inhibitors|growth inhibitors|mesh-ancestor
64802455|NCT01402089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64802456|NCT01402089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64802457|NCT01402089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64802458|NCT01402089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64802459|NCT01402089|Purinergic Agents|purinergic agents|mesh-ancestor
64802460|NCT01402180|Nimotuzumab|nimotuzumab|mesh-list
64802475|NCT01402245|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64802477|NCT01402245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802479|NCT01402297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64802480|NCT01402297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65284113|NCT00867087|Immunologic Factors|immunologic factors|mesh-ancestor
65284114|NCT00867087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284115|NCT00867087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65284116|NCT00867087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65284117|NCT02778425|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65284118|NCT02778425|Somatostatin|somatostatin|mesh-list
65284119|NCT02778425|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65284120|NCT02778425|Adrenergic Agents|adrenergic agents|mesh-ancestor
65284121|NCT02778425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65284122|NCT02778425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284123|NCT02778425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736436|NCT00983645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802481|NCT01402297|Analgesics|analgesics|mesh-ancestor
64802482|NCT01402297|Sensory System Agents|sensory system agents|mesh-ancestor
64802483|NCT01402297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64802484|NCT01402297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802485|NCT01402297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64802486|NCT01402297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64802487|NCT01402297|Antioxidants|antioxidants|mesh-ancestor
64802488|NCT01402297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802489|NCT01402297|Protective Agents|protective agents|mesh-ancestor
64802490|NCT01402297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802491|NCT01402336|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64802492|NCT01402336|Cetrorelix|cetrorelix|mesh-list
64802493|NCT01402336|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64802494|NCT01402336|Hormones|hormones|mesh-ancestor
64802495|NCT01402336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64802496|NCT01402336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802520|NCT01402596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64802521|NCT01402596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64802522|NCT01402596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64802523|NCT01402596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802525|NCT01402596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64802526|NCT01402596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64802527|NCT01402596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64802528|NCT01402596|Anesthetics, General|anesthetics, general|mesh-ancestor
64802529|NCT01402596|Anesthetics|anesthetics|mesh-ancestor
64802530|NCT01402596|GABA Modulators|gaba modulators|mesh-ancestor
64802531|NCT01402596|GABA Agents|gaba agents|mesh-ancestor
64802532|NCT01402596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64802533|NCT01402596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802534|NCT01402622|Propofol|propofol|mesh-list
64802535|NCT01402622|Anesthetics|anesthetics|mesh-ancestor
64472169|NCT03760575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64802536|NCT01402622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64802537|NCT01402622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802538|NCT01402622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64802539|NCT01402622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64802540|NCT01402622|Anesthetics, General|anesthetics, general|mesh-ancestor
64802541|NCT01402674|Phentermine|phentermine|mesh-list
64802542|NCT01402674|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64802556|NCT01402843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64802557|NCT01402843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802558|NCT01402843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64802559|NCT01402843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64802560|NCT01402843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64802561|NCT01402843|Antimetabolites|antimetabolites|mesh-ancestor
64802562|NCT01402843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802563|NCT01402843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64802564|NCT01402882|Tranexamic Acid|tranexamic acid|mesh-list
64802565|NCT01402882|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65284125|NCT02778425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65284126|NCT04228757|Phytoestrogens|phytoestrogens|mesh-list
65284127|NCT04228757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65284128|NCT04228757|Estrogens|estrogens|mesh-ancestor
65284129|NCT04228757|Hormones|hormones|mesh-ancestor
65284130|NCT04228757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65284131|NCT04228757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284132|NCT04227431|Insulin|insulin|mesh-list
65284133|NCT04227431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65284134|NCT04227431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802566|NCT01402882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64802567|NCT01402882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802568|NCT01402882|Hemostatics|hemostatics|mesh-ancestor
64802569|NCT01402882|Coagulants|coagulants|mesh-ancestor
64802570|NCT01403025|Liraglutide|liraglutide|mesh-list
64802571|NCT01403025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64802572|NCT01403025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802573|NCT01403025|Incretins|incretins|mesh-ancestor
64802574|NCT01403025|Hormones|hormones|mesh-ancestor
64802575|NCT01403025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64802576|NCT01403103|Vitamin D|vitamin d|mesh-list
64802577|NCT01403103|Cholecalciferol|cholecalciferol|mesh-list
64802578|NCT01403103|Vitamins|vitamins|mesh-ancestor
64802579|NCT01403103|Micronutrients|micronutrients|mesh-ancestor
64802580|NCT01403103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802581|NCT01403103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64802582|NCT01403103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64802583|NCT01403168|Analgesics|analgesics|mesh-list
64802584|NCT01403168|Sensory System Agents|sensory system agents|mesh-ancestor
64802585|NCT01403168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64802586|NCT01403168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802587|NCT01403181|Ribavirin|ribavirin|mesh-list
64802588|NCT01403181|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64802589|NCT01403181|Antimetabolites|antimetabolites|mesh-ancestor
64802590|NCT01403181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802591|NCT01403181|Antiviral Agents|antiviral agents|mesh-ancestor
64802592|NCT01403181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64802593|NCT01403259|Oxaliplatin|oxaliplatin|mesh-list
64802594|NCT01403259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802595|NCT01403285|Cyclophosphamide|cyclophosphamide|mesh-list
64802596|NCT01403285|Molgramostim|molgramostim|mesh-list
64802597|NCT01403285|Imiquimod|imiquimod|mesh-list
64802598|NCT01403285|Sargramostim|sargramostim|mesh-list
64802599|NCT01403285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64802600|NCT01403285|Immunologic Factors|immunologic factors|mesh-ancestor
64802601|NCT01403285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802602|NCT01403285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64802603|NCT01403285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64802604|NCT01403285|Alkylating Agents|alkylating agents|mesh-ancestor
64802605|NCT01403285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802606|NCT01403285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802607|NCT01403285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64802608|NCT01403285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64802609|NCT01403285|Interferon Inducers|interferon inducers|mesh-ancestor
64802610|NCT01403363|Fentanyl|fentanyl|mesh-list
64802611|NCT01403363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64802612|NCT01403363|Narcotics|narcotics|mesh-ancestor
64802613|NCT01403363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64472170|NCT03760575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64802614|NCT01403363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802630|NCT01403415|Methotrexate|methotrexate|mesh-list
64802631|NCT01403415|Vincristine|vincristine|mesh-list
64802632|NCT01403415|Asparaginase|asparaginase|mesh-list
64802633|NCT01403415|Mitoxantrone|mitoxantrone|mesh-list
64802634|NCT01403415|Pegaspargase|pegaspargase|mesh-list
64802635|NCT01403415|BB 1101|bb 1101|mesh-list
64802636|NCT01403415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65284135|NCT04227041|Capecitabine|capecitabine|mesh-list
65284136|NCT04227041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65284137|NCT04227041|Antimetabolites|antimetabolites|mesh-ancestor
65284138|NCT04227041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284139|NCT04227041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284140|NCT05074823|Ketamine|ketamine|mesh-list
65284141|NCT05074823|Analgesics|analgesics|mesh-ancestor
65284142|NCT05074823|Sensory System Agents|sensory system agents|mesh-ancestor
65284143|NCT05074823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65284144|NCT05074823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284145|NCT05074823|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65284146|NCT05074823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65284147|NCT05074823|Anesthetics, General|anesthetics, general|mesh-ancestor
65284148|NCT05074823|Anesthetics|anesthetics|mesh-ancestor
65284149|NCT05074823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65284150|NCT05074823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65284151|NCT05074823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64736461|NCT00962429|Vitamins|vitamins|mesh-ancestor
64802637|NCT01403415|Antiemetics|antiemetics|mesh-ancestor
64802638|NCT01403415|Autonomic Agents|autonomic agents|mesh-ancestor
64802639|NCT01403415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64802640|NCT01403415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802641|NCT01403415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64802642|NCT01403415|Glucocorticoids|glucocorticoids|mesh-ancestor
64802643|NCT01403415|Hormones|hormones|mesh-ancestor
64802644|NCT01403415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64802645|NCT01403415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64802646|NCT01403415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802647|NCT01403415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64802648|NCT01403415|Abortifacient Agents|abortifacient agents|mesh-ancestor
64802649|NCT01403415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64802650|NCT01403415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64802651|NCT01403415|Antimetabolites|antimetabolites|mesh-ancestor
64802652|NCT01403415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802653|NCT01403415|Dermatologic Agents|dermatologic agents|mesh-ancestor
64802654|NCT01403415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802655|NCT01403415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64802656|NCT01403415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64802657|NCT01403415|Immunologic Factors|immunologic factors|mesh-ancestor
64802658|NCT01403415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64802659|NCT01403415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64802660|NCT01403415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64802661|NCT01403415|Tubulin Modulators|tubulin modulators|mesh-ancestor
64802662|NCT01403415|Antimitotic Agents|antimitotic agents|mesh-ancestor
64802663|NCT01403415|Mitosis Modulators|mitosis modulators|mesh-ancestor
64802664|NCT01403415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64802665|NCT01403415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64802666|NCT01403415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64802667|NCT01403415|Antifungal Agents|antifungal agents|mesh-ancestor
64802668|NCT01403415|Protease Inhibitors|protease inhibitors|mesh-ancestor
64802669|NCT01403415|Analgesics|analgesics|mesh-ancestor
64802670|NCT01403415|Sensory System Agents|sensory system agents|mesh-ancestor
64802671|NCT01403415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64802672|NCT01403415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64802673|NCT01403506|Acetylcysteine|acetylcysteine|mesh-list
64802674|NCT01403506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65284152|NCT05074823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65284153|NCT05074823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284154|NCT04226963|Ketamine|ketamine|mesh-list
65284155|NCT04226963|Analgesics|analgesics|mesh-ancestor
65284156|NCT04226963|Sensory System Agents|sensory system agents|mesh-ancestor
65284157|NCT04226963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65284158|NCT04226963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284159|NCT04226963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65284160|NCT04226963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65284161|NCT04226963|Anesthetics, General|anesthetics, general|mesh-ancestor
65284162|NCT04226963|Anesthetics|anesthetics|mesh-ancestor
65284163|NCT04226963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65284164|NCT04226963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65284165|NCT04226963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65284166|NCT04226963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65284167|NCT04226963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284168|NCT00545233|Pioglitazone|pioglitazone|mesh-list
65284169|NCT00545233|Ribavirin|ribavirin|mesh-list
65284170|NCT00545233|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65284171|NCT00545233|Antimetabolites|antimetabolites|mesh-ancestor
65284172|NCT00545233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284173|NCT00545233|Antiviral Agents|antiviral agents|mesh-ancestor
64736475|NCT02075411|Anesthetics, Local|anesthetics, local|mesh-ancestor
64802675|NCT01403506|Antiviral Agents|antiviral agents|mesh-ancestor
64802676|NCT01403506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64802677|NCT01403506|Expectorants|expectorants|mesh-ancestor
64802678|NCT01403506|Respiratory System Agents|respiratory system agents|mesh-ancestor
64802679|NCT01403506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64802680|NCT01403506|Antioxidants|antioxidants|mesh-ancestor
64802681|NCT01403506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802682|NCT01403506|Protective Agents|protective agents|mesh-ancestor
64802683|NCT01403506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802684|NCT01403506|Antidotes|antidotes|mesh-ancestor
64802685|NCT01403545|Curcumin|curcumin|mesh-list
64802686|NCT01403545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64802687|NCT01403545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64802688|NCT01403545|Analgesics|analgesics|mesh-ancestor
64802689|NCT01403545|Sensory System Agents|sensory system agents|mesh-ancestor
64802730|NCT01403844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802732|NCT01403896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64802733|NCT01403896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64802734|NCT01403896|Antiviral Agents|antiviral agents|mesh-ancestor
64802735|NCT01403896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64802736|NCT01403948|BI 836826|bi 836826|mesh-list
64802737|NCT01403948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64802738|NCT01403948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802739|NCT01404000|Charcoal|charcoal|mesh-list
64802740|NCT01404000|Antidotes|antidotes|mesh-ancestor
64802741|NCT01404000|Protective Agents|protective agents|mesh-ancestor
64802742|NCT01404000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802776|NCT01404130|Dermatologic Agents|dermatologic agents|mesh-ancestor
64571369|NCT01712815|Clevudine|clevudine|mesh-list
65284174|NCT00545233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65284175|NCT00545233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65284176|NCT00545233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284177|NCT02393248|Gemcitabine|gemcitabine|mesh-list
65284178|NCT02393248|Docetaxel|docetaxel|mesh-list
65284179|NCT02393248|Pembrolizumab|pembrolizumab|mesh-list
65284180|NCT02393248|Trastuzumab|trastuzumab|mesh-list
65284181|NCT02393248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284182|NCT02393248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64802777|NCT01404156|Leucovorin|leucovorin|mesh-list
64802778|NCT01404156|Paclitaxel|paclitaxel|mesh-list
64802779|NCT01404156|Docetaxel|docetaxel|mesh-list
64802780|NCT01404156|Carboplatin|carboplatin|mesh-list
64802781|NCT01404156|Fluorouracil|fluorouracil|mesh-list
64802782|NCT01404156|Oxaliplatin|oxaliplatin|mesh-list
64802783|NCT01404156|Epirubicin|epirubicin|mesh-list
64802784|NCT01404156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64802785|NCT01404156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802786|NCT01404156|Tubulin Modulators|tubulin modulators|mesh-ancestor
64802787|NCT01404156|Antimitotic Agents|antimitotic agents|mesh-ancestor
64802788|NCT01404156|Mitosis Modulators|mitosis modulators|mesh-ancestor
64802789|NCT01404156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802790|NCT01404156|Antimetabolites|antimetabolites|mesh-ancestor
64802791|NCT01404156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64802792|NCT01404156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64802806|NCT01404169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802807|NCT01404169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802808|NCT01404169|Cholinergic Agents|cholinergic agents|mesh-ancestor
64802809|NCT01404169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64802810|NCT01404169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802811|NCT01404169|Nootropic Agents|nootropic agents|mesh-ancestor
64802812|NCT01404182|Vaccines|vaccines|mesh-list
64802813|NCT01404182|Immunologic Factors|immunologic factors|mesh-ancestor
64802814|NCT01404182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802815|NCT01404312|Pyridoxine|pyridoxine|mesh-list
64802816|NCT01404312|Pyridoxal|pyridoxal|mesh-list
64802817|NCT01404312|Vitamin B 6|vitamin b 6|mesh-list
64802818|NCT01404312|Isoniazid|isoniazid|mesh-list
64802819|NCT01404312|Rifapentine|rifapentine|mesh-list
64802820|NCT01404312|Vitamins|vitamins|mesh-ancestor
64802821|NCT01404312|Micronutrients|micronutrients|mesh-ancestor
64802822|NCT01404312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802823|NCT01404312|Vitamin B Complex|vitamin b complex|mesh-ancestor
64802824|NCT01404312|Antitubercular Agents|antitubercular agents|mesh-ancestor
64802825|NCT01404312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64802834|NCT01404338|Halobetasol|halobetasol|mesh-list
64802835|NCT01404338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64802836|NCT01404364|Triamcinolone|triamcinolone|mesh-list
64802837|NCT01404364|Chlorpromazine|chlorpromazine|mesh-list
64802838|NCT01404364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64802839|NCT01404364|Glucocorticoids|glucocorticoids|mesh-ancestor
64802840|NCT01404364|Hormones|hormones|mesh-ancestor
64802841|NCT01404364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64802842|NCT01404364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802843|NCT01404364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802844|NCT01404364|Antiemetics|antiemetics|mesh-ancestor
64802845|NCT01404364|Autonomic Agents|autonomic agents|mesh-ancestor
64802846|NCT01404364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64802847|NCT01404364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64802848|NCT01404364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64802849|NCT01404364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64802850|NCT01404364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64802851|NCT01404364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64802852|NCT01404364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64571444|NCT04873440|Manganese|manganese|mesh-list
64802853|NCT01404364|Dopamine Agents|dopamine agents|mesh-ancestor
64802854|NCT01404364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64802855|NCT01404377|Ropivacaine|ropivacaine|mesh-list
64802856|NCT01404377|Anesthetics, Local|anesthetics, local|mesh-ancestor
64802858|NCT01404377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64802859|NCT01404377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284183|NCT02393248|Antimetabolites|antimetabolites|mesh-ancestor
65284184|NCT02393248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284185|NCT02393248|Antiviral Agents|antiviral agents|mesh-ancestor
65284186|NCT02393248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65284187|NCT02393248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65284188|NCT02393248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65284189|NCT02393248|Immunologic Factors|immunologic factors|mesh-ancestor
65284190|NCT02393248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284191|NCT02393248|Tubulin Modulators|tubulin modulators|mesh-ancestor
65284192|NCT02393248|Antimitotic Agents|antimitotic agents|mesh-ancestor
65284193|NCT02393248|Mitosis Modulators|mitosis modulators|mesh-ancestor
65284194|NCT02393248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65284195|NCT00601484|Tanezumab|tanezumab|mesh-list
65284196|NCT00601484|Analgesics|analgesics|mesh-ancestor
65284197|NCT00601484|Sensory System Agents|sensory system agents|mesh-ancestor
65284198|NCT00601484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65284199|NCT00601484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284200|NCT00978601|Analgesics|analgesics|mesh-list
65284201|NCT00978601|Sensory System Agents|sensory system agents|mesh-ancestor
65284202|NCT00978601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65284203|NCT00978601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284204|NCT00883896|Fezakinumab|fezakinumab|mesh-list
65284205|NCT00883896|Dermatologic Agents|dermatologic agents|mesh-ancestor
64802860|NCT01404377|Sensory System Agents|sensory system agents|mesh-ancestor
64802861|NCT01404377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64802862|NCT01404442|Midazolam|midazolam|mesh-list
64802863|NCT01404442|Ketamine|ketamine|mesh-list
64802864|NCT01404442|Analgesics|analgesics|mesh-ancestor
64802865|NCT01404442|Sensory System Agents|sensory system agents|mesh-ancestor
64802866|NCT01404442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64802874|NCT01404442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64802875|NCT01404442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64802876|NCT01404442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802877|NCT01404442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64802878|NCT01404442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64802879|NCT01404442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64802880|NCT01404442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64802881|NCT01404442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64802882|NCT01404442|GABA Modulators|gaba modulators|mesh-ancestor
64802883|NCT01404442|GABA Agents|gaba agents|mesh-ancestor
64802884|NCT01404468|Lidocaine|lidocaine|mesh-list
64802885|NCT01404468|Anesthetics, Local|anesthetics, local|mesh-ancestor
64802886|NCT01404468|Anesthetics|anesthetics|mesh-ancestor
64802887|NCT01404468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64802888|NCT01404468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802889|NCT01404468|Sensory System Agents|sensory system agents|mesh-ancestor
64802890|NCT01404468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64802891|NCT01404468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64802901|NCT01404598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64802902|NCT01404598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64802903|NCT01404598|Analgesics|analgesics|mesh-ancestor
64802904|NCT01404598|Sensory System Agents|sensory system agents|mesh-ancestor
65284206|NCT02778191|Carboplatin|carboplatin|mesh-list
65284207|NCT02778191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284208|NCT05170685|Nivolumab|nivolumab|mesh-list
65284209|NCT05170685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65284210|NCT05170685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284211|NCT05170685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65284212|NCT05170685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284213|NCT02778893|Thalidomide|thalidomide|mesh-list
65284214|NCT02778893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65284215|NCT02778893|Immunologic Factors|immunologic factors|mesh-ancestor
65284216|NCT02778893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284217|NCT02778893|Leprostatic Agents|leprostatic agents|mesh-ancestor
65284218|NCT02778893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65284219|NCT02778893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65284220|NCT02778893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64802905|NCT01404598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64802906|NCT01404598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802907|NCT01404598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64802908|NCT01404598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64802909|NCT01404598|Gout Suppressants|gout suppressants|mesh-ancestor
64802910|NCT01404598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64802911|NCT01404598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802912|NCT01404598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802913|NCT01404598|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64802914|NCT01404637|Tamsulosin|tamsulosin|mesh-list
64802915|NCT01404637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64802916|NCT01404637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64802917|NCT01404637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64802918|NCT01404637|Adrenergic Agents|adrenergic agents|mesh-ancestor
64802919|NCT01404637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64802920|NCT01404637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802921|NCT01404637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802922|NCT01404637|Urological Agents|urological agents|mesh-ancestor
64802923|NCT01404676|Glimepiride|glimepiride|mesh-list
64802924|NCT01404676|Vildagliptin|vildagliptin|mesh-list
64802925|NCT01404676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64802926|NCT01404676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64802927|NCT01404676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802928|NCT01404676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64802929|NCT01404676|Immunologic Factors|immunologic factors|mesh-ancestor
64802930|NCT01404676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64802931|NCT01404676|Protease Inhibitors|protease inhibitors|mesh-ancestor
64802932|NCT01404676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802933|NCT01404676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802934|NCT01404689|Dexmedetomidine|dexmedetomidine|mesh-list
64802935|NCT01404689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64802936|NCT01404689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64802937|NCT01404689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802938|NCT01404689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64802939|NCT01404689|Analgesics|analgesics|mesh-ancestor
64802940|NCT01404689|Sensory System Agents|sensory system agents|mesh-ancestor
64802941|NCT01404689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64802980|NCT01404767|Sympatholytics|sympatholytics|mesh-ancestor
64802981|NCT01404767|Autonomic Agents|autonomic agents|mesh-ancestor
64802982|NCT01404767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64802983|NCT01404767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802984|NCT01404767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64802985|NCT01404767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65284221|NCT02778893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65284222|NCT02778893|Growth Substances|growth substances|mesh-ancestor
65284223|NCT02778893|Growth Inhibitors|growth inhibitors|mesh-ancestor
65284224|NCT02778893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284225|NCT03920293|Ravulizumab|ravulizumab|mesh-list
65284226|NCT03920293|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65284227|NCT03920293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65284228|NCT03920293|Immunologic Factors|immunologic factors|mesh-ancestor
65284229|NCT03920293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284230|NCT02671864|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65284231|NCT02671864|Incretins|incretins|mesh-list
65284232|NCT02671864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284233|NCT02671864|Hormones|hormones|mesh-ancestor
65284234|NCT02671864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65284235|NCT00867009|Pemetrexed|pemetrexed|mesh-list
65284236|NCT00867009|Cetuximab|cetuximab|mesh-list
65284237|NCT00867009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284238|NCT00867009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65284239|NCT00867009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284240|NCT00867009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65284241|NCT00867009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65284242|NCT00867009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64736548|NCT01978535|Iron|iron|mesh-list
64802986|NCT01404767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64802987|NCT01404767|Adrenergic Agents|adrenergic agents|mesh-ancestor
64802988|NCT01404767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64802989|NCT01404767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802990|NCT01404793|Rocuronium|rocuronium|mesh-list
64802991|NCT01404793|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64802992|NCT01404793|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64802993|NCT01404793|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64802994|NCT01404793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64802995|NCT01404793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802996|NCT01404806|Dolutegravir|dolutegravir|mesh-list
64802997|NCT01404806|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64802998|NCT01404806|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64802999|NCT01404806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803000|NCT01404806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803001|NCT01404806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64803002|NCT01404806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64803014|NCT01404871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803015|NCT01404871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64803016|NCT01404871|Serotonin Agents|serotonin agents|mesh-ancestor
64803017|NCT01404871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803021|NCT01404871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64803022|NCT01404871|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64803023|NCT01404871|Analgesics|analgesics|mesh-ancestor
64803024|NCT01404871|Sensory System Agents|sensory system agents|mesh-ancestor
64803025|NCT01404871|Dopamine Agents|dopamine agents|mesh-ancestor
64803026|NCT01404871|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65284243|NCT00666042|Moxifloxacin|moxifloxacin|mesh-list
65284244|NCT00666042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65284245|NCT00666042|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65284246|NCT00666042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65284247|NCT00666042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65284248|NCT00666042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65284249|NCT00666042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65284250|NCT00666042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65284251|NCT00666042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65284252|NCT00666042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284253|NCT00666042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284254|NCT00666042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65284255|NCT00666042|Contraceptive Agents|contraceptive agents|mesh-ancestor
65284256|NCT00666042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65284257|NCT00666042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284258|NCT00666042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65284259|NCT00666042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65284260|NCT00666042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65284261|NCT02660840|Flupenthixol|flupenthixol|mesh-list
65284262|NCT02660840|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
65284263|NCT02660840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65284264|NCT02660840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65284265|NCT02660840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65284266|NCT02660840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284267|NCT02660840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65284268|NCT02660840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65284269|NCT02660840|Dopamine Agents|dopamine agents|mesh-ancestor
65284270|NCT02660840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65284271|NCT02660840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284272|NCT02777801|Entecavir|entecavir|mesh-list
64736553|NCT01978535|Hematinics|hematinics|mesh-ancestor
64803027|NCT01405079|Vinorelbine|vinorelbine|mesh-list
64803028|NCT01405079|Gefitinib|gefitinib|mesh-list
64803029|NCT01405079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803030|NCT01405079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64803031|NCT01405079|Tubulin Modulators|tubulin modulators|mesh-ancestor
64803032|NCT01405079|Antimitotic Agents|antimitotic agents|mesh-ancestor
64803033|NCT01405079|Mitosis Modulators|mitosis modulators|mesh-ancestor
64803034|NCT01405079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803035|NCT01405079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64803036|NCT01405079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803037|NCT01405118|Metformin|metformin|mesh-list
65284273|NCT02777801|Antiviral Agents|antiviral agents|mesh-ancestor
65284274|NCT02777801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65284275|NCT00649064|Ziprasidone|ziprasidone|mesh-list
65284276|NCT00649064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65284277|NCT00649064|Serotonin Agents|serotonin agents|mesh-ancestor
65284278|NCT00649064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65284279|NCT00649064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284280|NCT00649064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284281|NCT00649064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65284282|NCT00649064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65284283|NCT00649064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65284284|NCT00649064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65284285|NCT00649064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65284286|NCT00649064|Dopamine Agents|dopamine agents|mesh-ancestor
65284287|NCT04132713|Capecitabine|capecitabine|mesh-list
65284288|NCT04132713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65284289|NCT04132713|Antimetabolites|antimetabolites|mesh-ancestor
65284290|NCT04132713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284291|NCT04132713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284292|NCT04007341|Dexmedetomidine|dexmedetomidine|mesh-list
65284293|NCT04007341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65284294|NCT04007341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65284295|NCT04007341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284296|NCT04007341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65284297|NCT04007341|Analgesics|analgesics|mesh-ancestor
65284298|NCT04007341|Sensory System Agents|sensory system agents|mesh-ancestor
64803038|NCT01405118|Tofacitinib|tofacitinib|mesh-list
64803039|NCT01405118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64803040|NCT01405118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803041|NCT01405118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64803042|NCT01405118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803043|NCT01405118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803044|NCT01405131|Methylprednisolone|methylprednisolone|mesh-list
64803045|NCT01405131|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64803046|NCT01405131|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64803047|NCT01405131|Prednisolone|prednisolone|mesh-list
64803048|NCT01405131|Prednisolone acetate|prednisolone acetate|mesh-list
64803049|NCT01405131|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64803050|NCT01405131|Prednisolone phosphate|prednisolone phosphate|mesh-list
64803051|NCT01405131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64803052|NCT01405131|Antiemetics|antiemetics|mesh-ancestor
64803053|NCT01405131|Autonomic Agents|autonomic agents|mesh-ancestor
64803054|NCT01405131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64803055|NCT01405131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803056|NCT01405131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64803057|NCT01405131|Glucocorticoids|glucocorticoids|mesh-ancestor
64803058|NCT01405131|Hormones|hormones|mesh-ancestor
64803059|NCT01405131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65284299|NCT04007341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65284300|NCT04007341|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65284301|NCT04007341|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65284302|NCT04007341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65284303|NCT04007341|Adrenergic Agents|adrenergic agents|mesh-ancestor
65284304|NCT04007341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65284305|NCT04007341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284306|NCT02656082|Etanercept|etanercept|mesh-list
65284307|NCT02656082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65284308|NCT02656082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65284309|NCT02656082|Analgesics|analgesics|mesh-ancestor
65284310|NCT02656082|Sensory System Agents|sensory system agents|mesh-ancestor
65284311|NCT02656082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65284312|NCT02656082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284313|NCT02656082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65284314|NCT02656082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65284315|NCT02656082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65284316|NCT02656082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65284317|NCT02656082|Immunologic Factors|immunologic factors|mesh-ancestor
65284318|NCT04132635|Mitogens|mitogens|mesh-list
65284319|NCT04132635|Mitosis Modulators|mitosis modulators|mesh-ancestor
65284320|NCT04132635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284321|NCT03335488|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
65284322|NCT03335488|Glycerol|glycerol|mesh-list
65284323|NCT03335488|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65284324|NCT03335488|Protective Agents|protective agents|mesh-ancestor
65284346|NCT02777723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284347|NCT02777723|Viscosupplements|viscosupplements|mesh-ancestor
65284348|NCT02777723|Protective Agents|protective agents|mesh-ancestor
65284349|NCT00601250|Linagliptin|linagliptin|mesh-list
65284350|NCT00601250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65284351|NCT00601250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284352|NCT00601250|Incretins|incretins|mesh-ancestor
65284353|NCT00601250|Hormones|hormones|mesh-ancestor
65284354|NCT00601250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65284355|NCT00601250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65284356|NCT00601250|Protease Inhibitors|protease inhibitors|mesh-ancestor
65284357|NCT00601250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65284358|NCT00601250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284359|NCT04226885|Fentanyl|fentanyl|mesh-list
65284360|NCT04226885|Midazolam|midazolam|mesh-list
65284361|NCT04226885|Dexmedetomidine|dexmedetomidine|mesh-list
64803060|NCT01405131|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64803061|NCT01405131|Protective Agents|protective agents|mesh-ancestor
64803062|NCT01405131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64803063|NCT01405131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803064|NCT01405144|Fluorouracil|fluorouracil|mesh-list
64803065|NCT01405144|Antimetabolites|antimetabolites|mesh-ancestor
64803066|NCT01405144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803067|NCT01405144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64803068|NCT01405144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803069|NCT01405144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64803070|NCT01405144|Immunologic Factors|immunologic factors|mesh-ancestor
64803097|NCT01405170|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64803098|NCT01405170|Prednisolone phosphate|prednisolone phosphate|mesh-list
64803099|NCT01405170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64803100|NCT01405170|Antiemetics|antiemetics|mesh-ancestor
64803101|NCT01405170|Autonomic Agents|autonomic agents|mesh-ancestor
64803102|NCT01405170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64803103|NCT01405170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803104|NCT01405170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64803105|NCT01405170|Glucocorticoids|glucocorticoids|mesh-ancestor
64803107|NCT01405170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64803108|NCT01405170|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64803109|NCT01405170|Protective Agents|protective agents|mesh-ancestor
64803110|NCT01405170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64803111|NCT01405170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803112|NCT01405235|Paclitaxel|paclitaxel|mesh-list
64803113|NCT01405235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64803114|NCT01405235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64803115|NCT01405235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803116|NCT01405235|Tubulin Modulators|tubulin modulators|mesh-ancestor
64803117|NCT01405235|Antimitotic Agents|antimitotic agents|mesh-ancestor
64803118|NCT01405235|Mitosis Modulators|mitosis modulators|mesh-ancestor
64803119|NCT01405235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803120|NCT01405248|3-n-butylphthalide|3-n-butylphthalide|mesh-list
64803121|NCT01405248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64803122|NCT01405248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64803123|NCT01405248|Protective Agents|protective agents|mesh-ancestor
64803124|NCT01405248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803126|NCT01405326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64803127|NCT01405326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64803128|NCT01405339|Budesonide|budesonide|mesh-list
64803129|NCT01405339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64803130|NCT01405339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65284362|NCT04226885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65284363|NCT04226885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65284364|NCT04226885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284365|NCT04226885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65284366|NCT04226885|Analgesics|analgesics|mesh-ancestor
65284367|NCT04226885|Sensory System Agents|sensory system agents|mesh-ancestor
65284368|NCT04226885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65284369|NCT04226885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65284370|NCT04226885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65284371|NCT04226885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65284372|NCT04226885|Adrenergic Agents|adrenergic agents|mesh-ancestor
65284373|NCT04226885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65284374|NCT04226885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284375|NCT04226885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65284376|NCT04226885|Narcotics|narcotics|mesh-ancestor
65284377|NCT04226885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65284378|NCT04226885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65284379|NCT04226885|Anesthetics, General|anesthetics, general|mesh-ancestor
65284380|NCT04226885|Anesthetics|anesthetics|mesh-ancestor
65284381|NCT04226885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65284382|NCT04226885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64736673|NCT03426137|Analgesics|analgesics|mesh-ancestor
64803131|NCT01405339|Autonomic Agents|autonomic agents|mesh-ancestor
64803132|NCT01405339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64803133|NCT01405339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803134|NCT01405339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64803135|NCT01405339|Respiratory System Agents|respiratory system agents|mesh-ancestor
64803149|NCT01405430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64803150|NCT01405430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803151|NCT01405430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64803152|NCT01405430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64803153|NCT01405430|Growth Substances|growth substances|mesh-ancestor
64803154|NCT01405430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803155|NCT01405430|Growth Inhibitors|growth inhibitors|mesh-ancestor
64803156|NCT01405482|Botulinum Toxins|botulinum toxins|mesh-list
64803171|NCT01405573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803172|NCT01405573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64803173|NCT01405573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803174|NCT01405573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803176|NCT01405612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64803177|NCT01405612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64803178|NCT01405612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64803179|NCT01405612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803180|NCT01405612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64803181|NCT01405612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64803182|NCT01405612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64803183|NCT01405612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64803184|NCT01405612|Anesthetics, General|anesthetics, general|mesh-ancestor
64803185|NCT01405612|Anesthetics|anesthetics|mesh-ancestor
64803186|NCT01405612|GABA Modulators|gaba modulators|mesh-ancestor
64803187|NCT01405612|GABA Agents|gaba agents|mesh-ancestor
64803188|NCT01405612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65284383|NCT04226885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65284384|NCT04226885|GABA Modulators|gaba modulators|mesh-ancestor
65284385|NCT04226885|GABA Agents|gaba agents|mesh-ancestor
65284386|NCT00866775|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
65284387|NCT00866775|Anticonvulsants|anticonvulsants|mesh-ancestor
65284388|NCT00866775|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64803189|NCT01405612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803190|NCT01405807|Alemtuzumab|alemtuzumab|mesh-list
64803191|NCT01405807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64803192|NCT01405807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803193|NCT01405846|Gefitinib|gefitinib|mesh-list
64803194|NCT01405846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803195|NCT01405846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64803196|NCT01405846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803197|NCT01405846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803198|NCT01405872|Interferon beta-1a|interferon beta-1a|mesh-list
64803199|NCT01405872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64803200|NCT01405872|Immunologic Factors|immunologic factors|mesh-ancestor
64803201|NCT01405872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803202|NCT01405872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803203|NCT01405872|Antiviral Agents|antiviral agents|mesh-ancestor
64803204|NCT01405872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64803205|NCT01405989|Ketoconazole|ketoconazole|mesh-list
64803206|NCT01405989|Darexaban|darexaban|mesh-list
64803207|NCT01405989|Antifungal Agents|antifungal agents|mesh-ancestor
64803208|NCT01405989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64803209|NCT01405989|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64803210|NCT01405989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64803211|NCT01405989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803212|NCT01405989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803213|NCT01405989|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64803229|NCT01406002|Leprostatic Agents|leprostatic agents|mesh-ancestor
64803230|NCT01406002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64803231|NCT01406002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803232|NCT01406002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803233|NCT01406002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64803234|NCT01406002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64803235|NCT01406002|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64803236|NCT01406002|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64803237|NCT01406002|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64803238|NCT01406002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64803239|NCT01406002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64803240|NCT01406002|Antithrombins|antithrombins|mesh-ancestor
64803241|NCT01406002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64803242|NCT01406002|Protease Inhibitors|protease inhibitors|mesh-ancestor
64803243|NCT01406002|Anticoagulants|anticoagulants|mesh-ancestor
64803244|NCT01406080|Adapalene|adapalene|mesh-list
64803245|NCT01406080|Tretinoin|tretinoin|mesh-list
64803246|NCT01406080|Emollients|emollients|mesh-list
64803247|NCT01406080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64803248|NCT01406080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64803249|NCT01406080|Analgesics|analgesics|mesh-ancestor
64803250|NCT01406080|Sensory System Agents|sensory system agents|mesh-ancestor
64803251|NCT01406080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64803252|NCT01406080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803253|NCT01406080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64803254|NCT01406080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64803255|NCT01406080|Dermatologic Agents|dermatologic agents|mesh-ancestor
64803256|NCT01406080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803257|NCT01406080|Keratolytic Agents|keratolytic agents|mesh-ancestor
64803258|NCT01406132|Peficitinib|peficitinib|mesh-list
64803259|NCT01406132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803260|NCT01406132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803261|NCT01406132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64803262|NCT01406132|Immunologic Factors|immunologic factors|mesh-ancestor
64803263|NCT01406132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803264|NCT01406158|Solifenacin Succinate|solifenacin succinate|mesh-list
64803265|NCT01406158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65284389|NCT00866775|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65284390|NCT00866775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65284391|NCT00866775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284392|NCT02777411|Vaccines|vaccines|mesh-list
65284393|NCT02777411|Immunologic Factors|immunologic factors|mesh-ancestor
65284394|NCT02777411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284395|NCT02777489|Perindopril|perindopril|mesh-list
65284396|NCT02777489|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65284397|NCT02777489|Protease Inhibitors|protease inhibitors|mesh-ancestor
65284398|NCT02777489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64437361|NCT05438394|Melphalan|melphalan|mesh-list
64803266|NCT01406158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64803267|NCT01406158|Cholinergic Agents|cholinergic agents|mesh-ancestor
64803268|NCT01406158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64803269|NCT01406158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803270|NCT01406158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803271|NCT01406158|Urological Agents|urological agents|mesh-ancestor
64803272|NCT01406171|Isavuconazole|isavuconazole|mesh-list
64803273|NCT01406171|Midazolam|midazolam|mesh-list
64803274|NCT01406171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64803275|NCT01406171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64803276|NCT01406171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64803277|NCT01406171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803278|NCT01406171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64803279|NCT01406171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64803280|NCT01406171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64803281|NCT01406171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64803282|NCT01406171|Anesthetics, General|anesthetics, general|mesh-ancestor
64803283|NCT01406171|Anesthetics|anesthetics|mesh-ancestor
64803295|NCT01406262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64803306|NCT01406275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64803307|NCT01406275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64803308|NCT01406275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64803309|NCT01406275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803310|NCT01406275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803311|NCT01406301|PENTA|penta|mesh-list
64803312|NCT01406301|Fondaparinux|fondaparinux|mesh-list
64803313|NCT01406301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64803314|NCT01406301|Antithrombins|antithrombins|mesh-ancestor
64803315|NCT01406301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64803316|NCT01406301|Protease Inhibitors|protease inhibitors|mesh-ancestor
64803317|NCT01406301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803318|NCT01406301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803319|NCT01406301|Anticoagulants|anticoagulants|mesh-ancestor
64803320|NCT01406301|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64803321|NCT01406301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64803322|NCT01406327|Ambrisentan|ambrisentan|mesh-list
64803323|NCT01406327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64803324|NCT01406392|Misoprostol|misoprostol|mesh-list
64803325|NCT01406392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64803326|NCT01406392|Abortifacient Agents|abortifacient agents|mesh-ancestor
64803327|NCT01406392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64803328|NCT01406392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803329|NCT01406392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64803330|NCT01406392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64803331|NCT01406392|Oxytocics|oxytocics|mesh-ancestor
64803332|NCT01406431|Valsartan|valsartan|mesh-list
64803333|NCT01406431|Pitavastatin|pitavastatin|mesh-list
64803334|NCT01406431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64803335|NCT01406431|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64803336|NCT01406431|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64803337|NCT01406431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803338|NCT01406431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64803339|NCT01406431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65284399|NCT02777489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284400|NCT02777489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65284401|NCT02660762|Cytarabine|cytarabine|mesh-list
65284402|NCT02660762|Dexamethasone|dexamethasone|mesh-list
65284403|NCT02660762|Dexamethasone acetate|dexamethasone acetate|mesh-list
65284404|NCT02660762|Prednisone|prednisone|mesh-list
65284405|NCT02660762|Cyclophosphamide|cyclophosphamide|mesh-list
65284406|NCT02660762|Methotrexate|methotrexate|mesh-list
65284407|NCT02660762|Etoposide|etoposide|mesh-list
65284408|NCT02660762|Vincristine|vincristine|mesh-list
65284409|NCT02660762|Daunorubicin|daunorubicin|mesh-list
65284410|NCT02660762|Mercaptopurine|mercaptopurine|mesh-list
65284411|NCT02660762|Pegaspargase|pegaspargase|mesh-list
65284412|NCT02660762|Thioguanine|thioguanine|mesh-list
65284413|NCT02660762|BB 1101|bb 1101|mesh-list
65284414|NCT02660762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65284415|NCT02660762|Immunologic Factors|immunologic factors|mesh-ancestor
65284416|NCT02660762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284417|NCT02660762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65284418|NCT02660762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65284419|NCT02660762|Alkylating Agents|alkylating agents|mesh-ancestor
64803340|NCT01406431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64803341|NCT01406431|Antimetabolites|antimetabolites|mesh-ancestor
64803342|NCT01406431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803343|NCT01406431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64803344|NCT01406470|Immunoglobulins|immunoglobulins|mesh-list
64803345|NCT01406470|Antibodies|antibodies|mesh-list
64803346|NCT01406470|gamma-Globulins|gamma-globulins|mesh-list
64803347|NCT01406470|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64803354|NCT01406496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64803355|NCT01406496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803356|NCT01406522|Tacrine|tacrine|mesh-list
64803357|NCT01406522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64803358|NCT01406522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803359|NCT01406522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803360|NCT01406522|Cholinergic Agents|cholinergic agents|mesh-ancestor
64803361|NCT01406522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64803362|NCT01406522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803363|NCT01406522|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64803364|NCT01406522|Autonomic Agents|autonomic agents|mesh-ancestor
64803365|NCT01406522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64803366|NCT01406522|Nootropic Agents|nootropic agents|mesh-ancestor
64803367|NCT01406535|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
64803389|NCT01406678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803390|NCT01406678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64803391|NCT01406678|Narcotics|narcotics|mesh-ancestor
64803392|NCT01406678|Analgesics|analgesics|mesh-ancestor
64803393|NCT01406678|Sensory System Agents|sensory system agents|mesh-ancestor
64803394|NCT01406678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64803395|NCT01406678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64803396|NCT01406678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64803397|NCT01406678|Anesthetics, General|anesthetics, general|mesh-ancestor
64803398|NCT01406678|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64803399|NCT01406704|Thioctic Acid|thioctic acid|mesh-list
64803400|NCT01406704|Rosiglitazone|rosiglitazone|mesh-list
64803401|NCT01406704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64803402|NCT01406704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803403|NCT01406704|Antioxidants|antioxidants|mesh-ancestor
64803404|NCT01406704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284420|NCT02660762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284421|NCT02660762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284422|NCT02660762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65284423|NCT02660762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65284424|NCT02660762|Antiemetics|antiemetics|mesh-ancestor
65284426|NCT02660762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65284427|NCT02660762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65284428|NCT02660762|Glucocorticoids|glucocorticoids|mesh-ancestor
64803405|NCT01406704|Protective Agents|protective agents|mesh-ancestor
64803406|NCT01406704|Vitamin B Complex|vitamin b complex|mesh-ancestor
64803407|NCT01406704|Vitamins|vitamins|mesh-ancestor
64803408|NCT01406704|Micronutrients|micronutrients|mesh-ancestor
64803409|NCT01406782|Rituximab|rituximab|mesh-list
64803410|NCT01406782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64803411|NCT01406782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803412|NCT01406782|Immunologic Factors|immunologic factors|mesh-ancestor
64803413|NCT01406782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803414|NCT01406782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64803415|NCT01407016|Metronidazole|metronidazole|mesh-list
64803416|NCT01407016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64803417|NCT01407016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64803418|NCT01407016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64803429|NCT01407237|Protease Inhibitors|protease inhibitors|mesh-ancestor
64803447|NCT01407471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64803448|NCT01407471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803449|NCT01407471|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64803450|NCT01407471|Diuretics|diuretics|mesh-ancestor
64803451|NCT01407471|Natriuretic Agents|natriuretic agents|mesh-ancestor
64803452|NCT01407471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64803453|NCT01407471|Glucocorticoids|glucocorticoids|mesh-ancestor
64572048|NCT00256399|Alfuzosin|alfuzosin|mesh-list
64803454|NCT01407471|Hormones|hormones|mesh-ancestor
64803455|NCT01407484|Prednisone|prednisone|mesh-list
64803456|NCT01407484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64803457|NCT01407484|Glucocorticoids|glucocorticoids|mesh-ancestor
64803458|NCT01407484|Hormones|hormones|mesh-ancestor
64803459|NCT01407484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64803460|NCT01407484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803461|NCT01407484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64803462|NCT01407484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803463|NCT01407497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64803464|NCT01407679|Alitretinoin|alitretinoin|mesh-list
64803465|NCT01407679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803466|NCT01407679|Dermatologic Agents|dermatologic agents|mesh-ancestor
64803467|NCT01407822|Gemcitabine|gemcitabine|mesh-list
64803468|NCT01407822|Cisplatin|cisplatin|mesh-list
64803469|NCT01407822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64803470|NCT01407822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803471|NCT01407822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64803472|NCT01407822|Antimetabolites|antimetabolites|mesh-ancestor
64803473|NCT01407822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803474|NCT01407822|Antiviral Agents|antiviral agents|mesh-ancestor
64803475|NCT01407822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64803476|NCT01407822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803477|NCT01407822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64803478|NCT01407822|Immunologic Factors|immunologic factors|mesh-ancestor
64803479|NCT01407822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803480|NCT01407822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64803481|NCT01407848|Furosemide|furosemide|mesh-list
64803482|NCT01407848|Diuretics|diuretics|mesh-ancestor
64803483|NCT01407848|Natriuretic Agents|natriuretic agents|mesh-ancestor
64803484|NCT01407848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803485|NCT01407848|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64803486|NCT01407848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64803498|NCT01407887|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64803500|NCT01407887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803501|NCT01407887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803502|NCT01408004|Everolimus|everolimus|mesh-list
65284429|NCT02660762|Hormones|hormones|mesh-ancestor
65284430|NCT02660762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65284431|NCT02660762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65284432|NCT02660762|Protease Inhibitors|protease inhibitors|mesh-ancestor
65284433|NCT02660762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65284434|NCT02660762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65284435|NCT02660762|Abortifacient Agents|abortifacient agents|mesh-ancestor
65284436|NCT02660762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65284437|NCT02660762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65284438|NCT02660762|Antimetabolites|antimetabolites|mesh-ancestor
65284439|NCT02660762|Dermatologic Agents|dermatologic agents|mesh-ancestor
65284440|NCT02660762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65284441|NCT02660762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65284442|NCT02660762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64803521|NCT01408095|Glimepiride|glimepiride|mesh-list
64803522|NCT01408095|Globalagliatin|globalagliatin|mesh-list
64803523|NCT01408095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64803524|NCT01408095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64803525|NCT01408095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803526|NCT01408095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64803527|NCT01408095|Immunologic Factors|immunologic factors|mesh-ancestor
64803528|NCT01408095|Enzyme Activators|enzyme activators|mesh-ancestor
64803529|NCT01408095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572156|NCT01418001|Docetaxel|docetaxel|mesh-list
64803530|NCT01408160|Cytarabine|cytarabine|mesh-list
64803531|NCT01408160|Immunotoxins|immunotoxins|mesh-list
64803532|NCT01408160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64803533|NCT01408160|Antimetabolites|antimetabolites|mesh-ancestor
64803534|NCT01408160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803535|NCT01408160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803536|NCT01408160|Antiviral Agents|antiviral agents|mesh-ancestor
64803537|NCT01408160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64803538|NCT01408160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64803539|NCT01408160|Immunologic Factors|immunologic factors|mesh-ancestor
64803540|NCT01408160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803541|NCT01408173|Caffeine|caffeine|mesh-list
64803542|NCT01408173|Caffeine citrate|caffeine citrate|mesh-list
64803543|NCT01408173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803544|NCT01408173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64803545|NCT01408173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803546|NCT01408173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64803547|NCT01408173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472176|NCT03720522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64803548|NCT01408173|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64803549|NCT01408173|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64803550|NCT01408173|Purinergic Agents|purinergic agents|mesh-ancestor
64803557|NCT01408186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803558|NCT01408186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803559|NCT01408186|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64803560|NCT01408186|Histamine Antagonists|histamine antagonists|mesh-ancestor
64803561|NCT01408186|Histamine Agents|histamine agents|mesh-ancestor
64803572|NCT01408342|Rituximab|rituximab|mesh-list
64803573|NCT01408342|Alemtuzumab|alemtuzumab|mesh-list
64803574|NCT01408342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64803575|NCT01408342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803576|NCT01408342|Immunologic Factors|immunologic factors|mesh-ancestor
64803577|NCT01408342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803578|NCT01408342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64803579|NCT01408394|Ecopipam|ecopipam|mesh-list
65284443|NCT02660762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65284444|NCT02660762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65284445|NCT02660762|Antiviral Agents|antiviral agents|mesh-ancestor
65284446|NCT02660762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65284447|NCT02660762|Tubulin Modulators|tubulin modulators|mesh-ancestor
65284448|NCT02660762|Antimitotic Agents|antimitotic agents|mesh-ancestor
65284449|NCT02660762|Mitosis Modulators|mitosis modulators|mesh-ancestor
65284450|NCT02660762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65284451|NCT04006873|Ivacaftor|ivacaftor|mesh-list
65284452|NCT04006873|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65284453|NCT04006873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65284454|NCT04006873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284455|NCT02660684|Cyclosporine|cyclosporine|mesh-list
65284456|NCT02660684|Methotrexate|methotrexate|mesh-list
65284457|NCT02660684|Tacrolimus|tacrolimus|mesh-list
65284458|NCT02660684|Cyclosporins|cyclosporins|mesh-list
65284459|NCT02660684|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65284460|NCT02660684|Abortifacient Agents|abortifacient agents|mesh-ancestor
65284461|NCT02660684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65284462|NCT02660684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284463|NCT02660684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65284464|NCT02660684|Antimetabolites|antimetabolites|mesh-ancestor
65284465|NCT02660684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284466|NCT02660684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284467|NCT02660684|Dermatologic Agents|dermatologic agents|mesh-ancestor
65284468|NCT02660684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404158|NCT02680561|Xhance|xhance|mesh-list
64803580|NCT01408394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64803581|NCT01408394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64803582|NCT01408394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64803583|NCT01408394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803584|NCT01408394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64803585|NCT01408394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64803586|NCT01408394|Dopamine Agents|dopamine agents|mesh-ancestor
64803587|NCT01408394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64803588|NCT01408394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803589|NCT01408446|Menthol|menthol|mesh-list
64803590|NCT01408446|Antipruritics|antipruritics|mesh-ancestor
64803591|NCT01408446|Dermatologic Agents|dermatologic agents|mesh-ancestor
64803592|NCT01408498|Testosterone|testosterone|mesh-list
64803593|NCT01408498|Androgens|androgens|mesh-ancestor
64803594|NCT01408498|Hormones|hormones|mesh-ancestor
64803595|NCT01408498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64803596|NCT01408498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803597|NCT01408524|Diltiazem|diltiazem|mesh-list
64803598|NCT01408524|Labetalol|labetalol|mesh-list
64803599|NCT01408524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64803600|NCT01408524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64803601|NCT01408524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64514778|NCT05304364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284469|NCT02660684|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65284470|NCT02660684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65284471|NCT02660684|Immunologic Factors|immunologic factors|mesh-ancestor
65284472|NCT02660684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65284473|NCT02660684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65284474|NCT02660684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65284475|NCT02660684|Antifungal Agents|antifungal agents|mesh-ancestor
65284476|NCT02660684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65284477|NCT00982891|Morphine|morphine|mesh-list
65284478|NCT00982891|Hydromorphone|hydromorphone|mesh-list
65284479|NCT00982891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65284480|NCT00982891|Narcotics|narcotics|mesh-ancestor
65284481|NCT00982891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65284482|NCT00982891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284483|NCT00982891|Analgesics|analgesics|mesh-ancestor
65284484|NCT00982891|Sensory System Agents|sensory system agents|mesh-ancestor
65284485|NCT00982891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65284486|NCT02615223|Bicalutamide|bicalutamide|mesh-list
65284487|NCT02615223|Hormones|hormones|mesh-list
65284488|NCT02615223|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65284489|NCT02615223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65284490|NCT02615223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284491|NCT02615223|Androgen Antagonists|androgen antagonists|mesh-ancestor
65284492|NCT02615223|Hormone Antagonists|hormone antagonists|mesh-ancestor
65284493|NCT02615223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284494|NCT04132557|Methylphenidate|methylphenidate|mesh-list
65284495|NCT04132557|Amphetamine|amphetamine|mesh-list
65284496|NCT04132557|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65284497|NCT04132557|Dextroamphetamine|dextroamphetamine|mesh-list
65284498|NCT04132557|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64803602|NCT01408524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803603|NCT01408524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64803604|NCT01408524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803605|NCT01408524|Vasodilator Agents|vasodilator agents|mesh-ancestor
64803606|NCT01408524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64803607|NCT01408524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64803608|NCT01408524|Adrenergic Agents|adrenergic agents|mesh-ancestor
64803609|NCT01408524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64803610|NCT01408524|Sympathomimetics|sympathomimetics|mesh-ancestor
64803611|NCT01408524|Autonomic Agents|autonomic agents|mesh-ancestor
64803612|NCT01408524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64803613|NCT01408524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65034492|NCT04675528|Paclitaxel|paclitaxel|mesh-list
65284500|NCT04132557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284501|NCT04132557|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65284502|NCT04132557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65284503|NCT04132557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65284504|NCT04132557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284505|NCT04132557|Dopamine Agents|dopamine agents|mesh-ancestor
65284506|NCT04132557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65284507|NCT04132557|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65284508|NCT04132557|Adrenergic Agents|adrenergic agents|mesh-ancestor
65284509|NCT04132557|Sympathomimetics|sympathomimetics|mesh-ancestor
65284510|NCT04132557|Autonomic Agents|autonomic agents|mesh-ancestor
65284511|NCT04132557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65284512|NCT00978913|Cyclophosphamide|cyclophosphamide|mesh-list
65284513|NCT00978913|Vaccines|vaccines|mesh-list
65284514|NCT00978913|Immunologic Factors|immunologic factors|mesh-ancestor
65284515|NCT00978913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284516|NCT00978913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65284517|NCT00978913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65284518|NCT00978913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65284519|NCT00978913|Alkylating Agents|alkylating agents|mesh-ancestor
65284520|NCT00978913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284521|NCT00978913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284522|NCT00978913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65284523|NCT04227509|Pembrolizumab|pembrolizumab|mesh-list
65284524|NCT04227509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65284525|NCT04227509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803614|NCT01408524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64803615|NCT01408589|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64803616|NCT01408589|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64803617|NCT01408589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64803618|NCT01408589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64803619|NCT01408589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803629|NCT01408797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803630|NCT01408810|Infliximab|infliximab|mesh-list
64803631|NCT01408810|Dermatologic Agents|dermatologic agents|mesh-ancestor
64803632|NCT01408810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64803633|NCT01408810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64803634|NCT01408836|Prednisolone|prednisolone|mesh-list
64472177|NCT03720522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803651|NCT01408836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64803652|NCT01408836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64803653|NCT01408836|Protective Agents|protective agents|mesh-ancestor
64803654|NCT01408849|Omeprazole|omeprazole|mesh-list
64803655|NCT01408849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64803656|NCT01408849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65284526|NCT02778659|Zolpidem|zolpidem|mesh-list
65284527|NCT02778659|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65284528|NCT02778659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65284529|NCT02778659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65284530|NCT02778659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284531|NCT02778659|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65284532|NCT02778659|GABA Agonists|gaba agonists|mesh-ancestor
65284533|NCT02778659|GABA Agents|gaba agents|mesh-ancestor
65284534|NCT02778659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64803657|NCT01408849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64803658|NCT01408849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803659|NCT01408849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803660|NCT01408927|Aspirin|aspirin|mesh-list
64803661|NCT01408927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64803662|NCT01408927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64803663|NCT01408927|Analgesics|analgesics|mesh-ancestor
64803664|NCT01408927|Sensory System Agents|sensory system agents|mesh-ancestor
64803665|NCT01408927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64803666|NCT01408927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803667|NCT01408927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64803668|NCT01408927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64803669|NCT01408927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64803670|NCT01408927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64803671|NCT01408927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803672|NCT01408927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64803673|NCT01408927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64803674|NCT01408927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803675|NCT01408927|Antipyretics|antipyretics|mesh-ancestor
64803676|NCT01408953|Bevacizumab|bevacizumab|mesh-list
64803677|NCT01408953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64803678|NCT01408953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803679|NCT01408953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64803680|NCT01408953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64803681|NCT01408953|Growth Substances|growth substances|mesh-ancestor
64572275|NCT01455857|Exenatide|exenatide|mesh-list
64803682|NCT01408953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803683|NCT01408953|Growth Inhibitors|growth inhibitors|mesh-ancestor
64803684|NCT01408979|Magnesium Sulfate|magnesium sulfate|mesh-list
64803685|NCT01408979|Analgesics|analgesics|mesh-ancestor
64803686|NCT01408979|Sensory System Agents|sensory system agents|mesh-ancestor
64803687|NCT01408979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64803700|NCT01409005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64803702|NCT01409005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803703|NCT01409005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803704|NCT01409005|Antiviral Agents|antiviral agents|mesh-ancestor
64803714|NCT01409018|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64803715|NCT01409018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64803716|NCT01409018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803717|NCT01409018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803718|NCT01409018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64472178|NCT03720522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64803719|NCT01409018|Hormone Antagonists|hormone antagonists|mesh-ancestor
64803720|NCT01409018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64803721|NCT01409018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803722|NCT01409018|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64803723|NCT01409122|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64803724|NCT01409148|Antibodies|antibodies|mesh-list
64803725|NCT01409148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64803726|NCT01409148|Immunologic Factors|immunologic factors|mesh-ancestor
64803727|NCT01409148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803728|NCT01409174|Interferons|interferons|mesh-list
64803729|NCT01409174|Interferon-alpha|interferon-alpha|mesh-list
64803730|NCT01409174|Interferon alpha-2|interferon alpha-2|mesh-list
64803731|NCT01409174|Aldesleukin|aldesleukin|mesh-list
64803732|NCT01409174|Cisplatin|cisplatin|mesh-list
64514828|NCT01530009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65284535|NCT02778659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284536|NCT04072900|Imiquimod|imiquimod|mesh-list
65284537|NCT04072900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65284538|NCT04072900|Immunologic Factors|immunologic factors|mesh-ancestor
65284539|NCT04072900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284540|NCT04072900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284541|NCT04072900|Interferon Inducers|interferon inducers|mesh-ancestor
65284542|NCT00984763|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65284543|NCT00984763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65284544|NCT00984763|Immunologic Factors|immunologic factors|mesh-ancestor
65284545|NCT00984763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284546|NCT00984763|Antacids|antacids|mesh-ancestor
65284547|NCT00984763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284548|NCT00984763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65284549|NCT02578108|Lidocaine|lidocaine|mesh-list
65284550|NCT02578108|Anesthetics, Local|anesthetics, local|mesh-list
65284551|NCT02578108|Anesthetics|anesthetics|mesh-list
65284552|NCT02578108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65284553|NCT02578108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284554|NCT02578108|Sensory System Agents|sensory system agents|mesh-ancestor
65284555|NCT02578108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65284556|NCT02578108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65284557|NCT02578108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65284558|NCT02578108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65284559|NCT02578108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64514829|NCT01530009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64803733|NCT01409174|Temozolomide|temozolomide|mesh-list
64803734|NCT01409174|Ipilimumab|ipilimumab|mesh-list
64803735|NCT01409174|Interleukin-2|interleukin-2|mesh-list
64803736|NCT01409174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803737|NCT01409174|Antiviral Agents|antiviral agents|mesh-ancestor
64803738|NCT01409174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64803739|NCT01409174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64803740|NCT01409174|Alkylating Agents|alkylating agents|mesh-ancestor
64803741|NCT01409174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803742|NCT01409174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64803743|NCT01409174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64803744|NCT01409174|Immunologic Factors|immunologic factors|mesh-ancestor
64803745|NCT01409174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803746|NCT01409174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64803747|NCT01409174|Analgesics|analgesics|mesh-ancestor
64414817|NCT04914195|Leuprolide|leuprolide|mesh-list
64803755|NCT01409187|Aldesleukin|aldesleukin|mesh-list
64803756|NCT01409187|Ipilimumab|ipilimumab|mesh-list
64803758|NCT01409187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803759|NCT01409187|Antiviral Agents|antiviral agents|mesh-ancestor
65284560|NCT02578108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284561|NCT02776163|Docetaxel|docetaxel|mesh-list
65284562|NCT02776163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284563|NCT02776163|Tubulin Modulators|tubulin modulators|mesh-ancestor
65284564|NCT02776163|Antimitotic Agents|antimitotic agents|mesh-ancestor
65284565|NCT02776163|Mitosis Modulators|mitosis modulators|mesh-ancestor
65284566|NCT02776163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284567|NCT05325346|Argatroban|argatroban|mesh-list
65284568|NCT05325346|Antithrombins|antithrombins|mesh-ancestor
65284569|NCT05325346|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65284570|NCT05325346|Protease Inhibitors|protease inhibitors|mesh-ancestor
65284571|NCT05325346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65284572|NCT05325346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284574|NCT05325346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65284575|NCT00984997|Etoposide|etoposide|mesh-list
65284576|NCT00984997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284577|NCT00984997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65284578|NCT00984997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65284579|NCT00984997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65284580|NCT00984997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65284581|NCT00984997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284582|NCT00973219|Interferons|interferons|mesh-list
65284583|NCT00973219|Tenofovir|tenofovir|mesh-list
65284584|NCT00973219|Interferon-alpha|interferon-alpha|mesh-list
65284585|NCT00973219|Interferon alpha-2|interferon alpha-2|mesh-list
65284586|NCT00973219|Adefovir|adefovir|mesh-list
65284587|NCT00973219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65284588|NCT00973219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64514844|NCT01724021|Rituximab|rituximab|mesh-list
64803760|NCT01409187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64803761|NCT01409187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64803762|NCT01409187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64803763|NCT01409187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803764|NCT01409187|Immunologic Factors|immunologic factors|mesh-ancestor
64803765|NCT01409187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803766|NCT01409187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64803767|NCT01409187|Analgesics|analgesics|mesh-ancestor
64803768|NCT01409187|Sensory System Agents|sensory system agents|mesh-ancestor
64803769|NCT01409187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64803770|NCT01409187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64803771|NCT01409187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64803772|NCT01409278|Ropivacaine|ropivacaine|mesh-list
64803773|NCT01409278|Anesthetics, Local|anesthetics, local|mesh-ancestor
64803774|NCT01409278|Anesthetics|anesthetics|mesh-ancestor
64803775|NCT01409278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64803776|NCT01409278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284589|NCT00973219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284590|NCT00973219|Antiviral Agents|antiviral agents|mesh-ancestor
65284591|NCT00973219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65284592|NCT00973219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65284593|NCT00973219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65284594|NCT00973219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65284595|NCT00973219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284596|NCT00973219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64514856|NCT01724021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514857|NCT01724021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514858|NCT01724021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64514859|NCT01724021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64514860|NCT01724021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64514861|NCT01724021|Glucocorticoids|glucocorticoids|mesh-ancestor
64514862|NCT01724021|Hormones|hormones|mesh-ancestor
64736746|NCT00616577|Anesthetics, Local|anesthetics, local|mesh-ancestor
64803777|NCT01409278|Sensory System Agents|sensory system agents|mesh-ancestor
64803796|NCT01409408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64803797|NCT01409408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64803798|NCT01409408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803799|NCT01409408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64803800|NCT01409408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803801|NCT01409408|Vasodilator Agents|vasodilator agents|mesh-ancestor
64803802|NCT01409421|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64803803|NCT01409421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64803804|NCT01409499|Sorafenib|sorafenib|mesh-list
64803805|NCT01409499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803806|NCT01409499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64803807|NCT01409499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803808|NCT01409499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803809|NCT01409603|Naproxen|naproxen|mesh-list
64803810|NCT01409603|Darexaban|darexaban|mesh-list
64803811|NCT01409603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64803812|NCT01409603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64803813|NCT01409603|Analgesics|analgesics|mesh-ancestor
64803814|NCT01409603|Sensory System Agents|sensory system agents|mesh-ancestor
64803815|NCT01409603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64803816|NCT01409603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803824|NCT01409603|Antithrombins|antithrombins|mesh-ancestor
64803825|NCT01409603|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64803826|NCT01409603|Protease Inhibitors|protease inhibitors|mesh-ancestor
64803827|NCT01409603|Anticoagulants|anticoagulants|mesh-ancestor
64803828|NCT01409616|Aspirin|aspirin|mesh-list
64803829|NCT01409616|Salicylic Acid|salicylic acid|mesh-list
64803830|NCT01409616|Salicylates|salicylates|mesh-list
64803831|NCT01409616|Darexaban|darexaban|mesh-list
64803832|NCT01409616|Clopidogrel|clopidogrel|mesh-list
64803833|NCT01409616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64803835|NCT01409616|Analgesics|analgesics|mesh-ancestor
64803836|NCT01409616|Sensory System Agents|sensory system agents|mesh-ancestor
64803837|NCT01409616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64803838|NCT01409616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803846|NCT01409616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803848|NCT01409616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64803849|NCT01409616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64803850|NCT01409616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64803851|NCT01409616|Purinergic Agents|purinergic agents|mesh-ancestor
65284597|NCT00973219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65284598|NCT00973219|Immunologic Factors|immunologic factors|mesh-ancestor
65284599|NCT00973219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284600|NCT04194125|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
65284601|NCT04194125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65284602|NCT04194125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284603|NCT04973891|Metformin|metformin|mesh-list
65284604|NCT04973891|Canagliflozin|canagliflozin|mesh-list
64803852|NCT01409616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64803853|NCT01409616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64803854|NCT01409616|Antifungal Agents|antifungal agents|mesh-ancestor
64803855|NCT01409616|Keratolytic Agents|keratolytic agents|mesh-ancestor
64803856|NCT01409616|Dermatologic Agents|dermatologic agents|mesh-ancestor
64803857|NCT01409616|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64803858|NCT01409616|Antithrombins|antithrombins|mesh-ancestor
64803859|NCT01409616|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64803860|NCT01409616|Protease Inhibitors|protease inhibitors|mesh-ancestor
64803861|NCT01409616|Anticoagulants|anticoagulants|mesh-ancestor
64803862|NCT01409694|Vitamin D|vitamin d|mesh-list
64803863|NCT01409694|Ergocalciferols|ergocalciferols|mesh-list
64803864|NCT01409694|Cholecalciferol|cholecalciferol|mesh-list
64803865|NCT01409694|Vitamins|vitamins|mesh-list
64803866|NCT01409694|Memantine|memantine|mesh-list
64803867|NCT01409694|Micronutrients|micronutrients|mesh-ancestor
64803868|NCT01409694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803869|NCT01409694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64803870|NCT01409694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64803871|NCT01409694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64803872|NCT01409694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64803873|NCT01409694|Dopamine Agents|dopamine agents|mesh-ancestor
64803874|NCT01409694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64803875|NCT01409694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803876|NCT01409694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64803877|NCT01409694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64803878|NCT01409733|Doxorubicin|doxorubicin|mesh-list
64803879|NCT01409733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64803880|NCT01409733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803881|NCT01409733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64803882|NCT01409733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64803883|NCT01409733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803884|NCT01409733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803885|NCT01409772|Ethanol|ethanol|mesh-list
64414946|NCT02869217|Immunologic Factors|immunologic factors|mesh-ancestor
64803895|NCT01410162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803896|NCT01410162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803897|NCT01410201|Dexamethasone|dexamethasone|mesh-list
64803898|NCT01410201|Dexamethasone acetate|dexamethasone acetate|mesh-list
64803900|NCT01410201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64803901|NCT01410201|Antiemetics|antiemetics|mesh-ancestor
64803902|NCT01410201|Autonomic Agents|autonomic agents|mesh-ancestor
64803903|NCT01410201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64803904|NCT01410201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803905|NCT01410201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64803906|NCT01410201|Glucocorticoids|glucocorticoids|mesh-ancestor
64803907|NCT01410201|Hormones|hormones|mesh-ancestor
64803908|NCT01410201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64803909|NCT01410201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64803911|NCT01410201|Protease Inhibitors|protease inhibitors|mesh-ancestor
64803912|NCT01410201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803913|NCT01410201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803914|NCT01410214|Cisplatin|cisplatin|mesh-list
64803915|NCT01410214|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64803934|NCT01410630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64803935|NCT01410630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64803936|NCT01410630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803937|NCT01410630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803938|NCT01410682|Chlorhexidine|chlorhexidine|mesh-list
65284605|NCT04973891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65284606|NCT04973891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284607|NCT04973891|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65284608|NCT04973891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284609|NCT00983047|Docetaxel|docetaxel|mesh-list
65284610|NCT00983047|Nimotuzumab|nimotuzumab|mesh-list
64404693|NCT04910477|Atropine|atropine|mesh-list
64803939|NCT01410682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64803940|NCT01410682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64803941|NCT01410682|Disinfectants|disinfectants|mesh-ancestor
64803942|NCT01410708|Dasatinib|dasatinib|mesh-list
64803943|NCT01410708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803944|NCT01410708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64803945|NCT01410708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803946|NCT01410708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803947|NCT01410747|Tacrolimus|tacrolimus|mesh-list
64803948|NCT01410747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64803949|NCT01410747|Immunologic Factors|immunologic factors|mesh-ancestor
64803950|NCT01410747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803951|NCT01410747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64803973|NCT01411072|Immunologic Factors|immunologic factors|mesh-ancestor
64803974|NCT01411072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803976|NCT01411098|Etoposide phosphate|etoposide phosphate|mesh-list
64803977|NCT01411098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803978|NCT01411098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64803979|NCT01411098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64803980|NCT01411098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64803981|NCT01411098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803982|NCT01411098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803983|NCT01411111|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64803984|NCT01411111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64803985|NCT01411111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64803986|NCT01411111|Antimetabolites|antimetabolites|mesh-ancestor
64401051|NCT03067883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64472180|NCT03720522|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64803987|NCT01411111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803988|NCT01411111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64803989|NCT01411111|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64804038|NCT01411254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64804039|NCT01411254|Glucocorticoids|glucocorticoids|mesh-ancestor
64804040|NCT01411254|Hormones|hormones|mesh-ancestor
64804041|NCT01411254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64804042|NCT01411254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804043|NCT01411254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64804044|NCT01411254|Respiratory System Agents|respiratory system agents|mesh-ancestor
64804045|NCT01411280|Methylphenidate|methylphenidate|mesh-list
64804046|NCT01411280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64804047|NCT01411280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804048|NCT01411280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64804049|NCT01411280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64804050|NCT01411280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64804051|NCT01411280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804052|NCT01411280|Dopamine Agents|dopamine agents|mesh-ancestor
64804053|NCT01411280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64804054|NCT01411410|Paclitaxel|paclitaxel|mesh-list
64804055|NCT01411410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64804056|NCT01411410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572651|NCT04856124|Ketamine|ketamine|mesh-list
64804057|NCT01411410|Tubulin Modulators|tubulin modulators|mesh-ancestor
64804063|NCT01411423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64804064|NCT01411423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804065|NCT01411423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804090|NCT01411735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804092|NCT01411930|Olanzapine|olanzapine|mesh-list
64804093|NCT01411930|Aripiprazole|aripiprazole|mesh-list
65284611|NCT00983047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284612|NCT00983047|Tubulin Modulators|tubulin modulators|mesh-ancestor
65284613|NCT00983047|Antimitotic Agents|antimitotic agents|mesh-ancestor
65284614|NCT00983047|Mitosis Modulators|mitosis modulators|mesh-ancestor
65284615|NCT00983047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284616|NCT00983047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65284617|NCT00983125|Clonidine|clonidine|mesh-list
65284618|NCT00983125|Analgesics|analgesics|mesh-ancestor
65284619|NCT00983125|Sensory System Agents|sensory system agents|mesh-ancestor
65284620|NCT00983125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65284621|NCT00983125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284622|NCT00983125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65284623|NCT00983125|Sympatholytics|sympatholytics|mesh-ancestor
65284624|NCT00983125|Autonomic Agents|autonomic agents|mesh-ancestor
65284625|NCT00983125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65284626|NCT00983125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65284627|NCT00983125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65284628|NCT00983125|Adrenergic Agents|adrenergic agents|mesh-ancestor
64514878|NCT01724021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804094|NCT01411930|Antiemetics|antiemetics|mesh-ancestor
64804095|NCT01411930|Autonomic Agents|autonomic agents|mesh-ancestor
64804096|NCT01411930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64804097|NCT01411930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804098|NCT01411930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64804099|NCT01411930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64804100|NCT01411930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64804101|NCT01411930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64804102|NCT01411930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64804103|NCT01411930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64804165|NCT01412307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804166|NCT01412307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64804167|NCT01412307|Alkylating Agents|alkylating agents|mesh-ancestor
64804168|NCT01412307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804169|NCT01412385|Immunoglobulins|immunoglobulins|mesh-list
64804170|NCT01412385|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64804172|NCT01412385|gamma-Globulins|gamma-globulins|mesh-list
64804173|NCT01412385|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64804174|NCT01412385|Immunoglobulin G|immunoglobulin g|mesh-list
64804175|NCT01412385|Immunologic Factors|immunologic factors|mesh-ancestor
64804176|NCT01412385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804177|NCT01412411|Micronutrients|micronutrients|mesh-list
64804178|NCT01412411|Trace Elements|trace elements|mesh-list
64804179|NCT01412411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804180|NCT01412437|Verapamil|verapamil|mesh-list
64804181|NCT01412437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64804182|NCT01412437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64804190|NCT01412515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64804191|NCT01412515|Immunologic Factors|immunologic factors|mesh-ancestor
64804192|NCT01412515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804193|NCT01412567|Vaccines|vaccines|mesh-list
64804194|NCT01412567|Immunologic Factors|immunologic factors|mesh-ancestor
64804195|NCT01412567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804196|NCT01412632|Remifentanil|remifentanil|mesh-list
64804197|NCT01412632|Propofol|propofol|mesh-list
64804198|NCT01412632|Prilocaine|prilocaine|mesh-list
64804199|NCT01412632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64804200|NCT01412632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65284629|NCT00983125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65284630|NCT00983125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284631|NCT00988039|Raltegravir Potassium|raltegravir potassium|mesh-list
65284632|NCT00988039|Lopinavir|lopinavir|mesh-list
65284633|NCT00988039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65284634|NCT00988039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65284635|NCT00988039|Antiviral Agents|antiviral agents|mesh-ancestor
65284636|NCT00988039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65284637|NCT00988039|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65284638|NCT00988039|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65284639|NCT00988039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65284640|NCT00988039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284641|NCT00988039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65284642|NCT00988039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65284643|NCT00988039|Protease Inhibitors|protease inhibitors|mesh-ancestor
65284644|NCT00988039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65034640|NCT04230187|Antidotes|antidotes|mesh-ancestor
65284645|NCT00988039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65284646|NCT04855513|Metformin|metformin|mesh-list
65284647|NCT04855513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64514895|NCT02293096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804201|NCT01412632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804202|NCT01412632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64804203|NCT01412632|Anesthetics, General|anesthetics, general|mesh-ancestor
64804204|NCT01412632|Anesthetics|anesthetics|mesh-ancestor
64804205|NCT01412632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64804206|NCT01412632|Narcotics|narcotics|mesh-ancestor
64804207|NCT01412632|Analgesics|analgesics|mesh-ancestor
64804208|NCT01412632|Sensory System Agents|sensory system agents|mesh-ancestor
64804209|NCT01412632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64804210|NCT01412632|Anesthetics, Local|anesthetics, local|mesh-ancestor
64804211|NCT01412645|Resveratrol|resveratrol|mesh-list
64804212|NCT01412645|Antioxidants|antioxidants|mesh-ancestor
64804213|NCT01412645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804214|NCT01412645|Protective Agents|protective agents|mesh-ancestor
64804215|NCT01412645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804216|NCT01412645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804217|NCT01412645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64804218|NCT01412658|Caseins|caseins|mesh-list
64804219|NCT01412658|Glycerol|glycerol|mesh-list
64804220|NCT01412658|Chelating Agents|chelating agents|mesh-ancestor
64804288|NCT01413230|Micronutrients|micronutrients|mesh-ancestor
64804289|NCT01413230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64804291|NCT01413477|Betamethasone|betamethasone|mesh-list
64804292|NCT01413477|Betamethasone Valerate|betamethasone valerate|mesh-list
64804293|NCT01413477|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64804294|NCT01413477|Betamethasone benzoate|betamethasone benzoate|mesh-list
64804295|NCT01413477|Calcipotriene|calcipotriene|mesh-list
64804296|NCT01413477|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64804297|NCT01413477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64804298|NCT01413477|Glucocorticoids|glucocorticoids|mesh-ancestor
64804299|NCT01413477|Hormones|hormones|mesh-ancestor
64804300|NCT01413477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64804301|NCT01413477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284648|NCT04855513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284649|NCT02775773|Tranexamic Acid|tranexamic acid|mesh-list
65284650|NCT02775773|Oxytocin|oxytocin|mesh-list
65284651|NCT02775773|Oxytocics|oxytocics|mesh-ancestor
65284652|NCT02775773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65284653|NCT02775773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284654|NCT02775773|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65284655|NCT02775773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65284656|NCT02775773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284657|NCT02775773|Hemostatics|hemostatics|mesh-ancestor
65284658|NCT02775773|Coagulants|coagulants|mesh-ancestor
65284659|NCT00983203|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65284660|NCT00983203|Lubricant Eye Drops|lubricant eye drops|mesh-list
65284661|NCT00983203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65284662|NCT00988195|Doxorubicin|doxorubicin|mesh-list
65284663|NCT00988195|BCT-100|bct-100|mesh-list
64514917|NCT04223752|Tazobactam|tazobactam|mesh-list
64804302|NCT01413477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64804303|NCT01413477|Respiratory System Agents|respiratory system agents|mesh-ancestor
64804304|NCT01413477|Dermatologic Agents|dermatologic agents|mesh-ancestor
64804305|NCT01413477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64804306|NCT01413477|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64804307|NCT01413477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64804308|NCT01413477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804356|NCT01414140|Levonorgestrel|levonorgestrel|mesh-list
64804357|NCT01414140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64804358|NCT01414140|Contraceptive Agents|contraceptive agents|mesh-ancestor
64804359|NCT01414140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64804376|NCT01414465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804377|NCT01414465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64804378|NCT01414465|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64804379|NCT01414504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64804380|NCT01414504|Immunologic Factors|immunologic factors|mesh-ancestor
64804381|NCT01414504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804382|NCT01414530|Contraceptive Agents|contraceptive agents|mesh-list
64804383|NCT01414530|Contraceptives, Oral|contraceptives, oral|mesh-list
64804384|NCT01414530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64804385|NCT01414530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804386|NCT01414530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64804387|NCT01414556|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
64804388|NCT01414556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64804389|NCT01414556|Incretins|incretins|mesh-ancestor
64804390|NCT01414556|Hormones|hormones|mesh-ancestor
64804391|NCT01414556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64804392|NCT01414556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804393|NCT01414569|Dexamethasone|dexamethasone|mesh-list
64804394|NCT01414569|Dexamethasone acetate|dexamethasone acetate|mesh-list
64804395|NCT01414569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64804396|NCT01414569|Antiemetics|antiemetics|mesh-ancestor
64804397|NCT01414569|Autonomic Agents|autonomic agents|mesh-ancestor
64804398|NCT01414569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64804399|NCT01414569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804400|NCT01414569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64804401|NCT01414569|Glucocorticoids|glucocorticoids|mesh-ancestor
64804403|NCT01414569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64804404|NCT01414569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64804405|NCT01414569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804406|NCT01414608|Paclitaxel|paclitaxel|mesh-list
65284664|NCT00988195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65284665|NCT00988195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284666|NCT00988195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65284667|NCT00988195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65284668|NCT00988195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65284669|NCT00988195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284670|NCT00634985|Eletriptan|eletriptan|mesh-list
65284671|NCT00634985|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65284672|NCT00634985|Serotonin Agents|serotonin agents|mesh-ancestor
65284673|NCT00634985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65284674|NCT00634985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284675|NCT00634985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284676|NCT00985387|Solifenacin Succinate|solifenacin succinate|mesh-list
65284677|NCT00985387|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65284678|NCT00985387|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65284679|NCT00985387|Cholinergic Agents|cholinergic agents|mesh-ancestor
64514931|NCT04187404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804407|NCT01414608|Cisplatin|cisplatin|mesh-list
64804408|NCT01414608|Carboplatin|carboplatin|mesh-list
64804409|NCT01414608|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64804410|NCT01414608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64804454|NCT01414998|Cholinergic Agents|cholinergic agents|mesh-ancestor
64804455|NCT01414998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64804456|NCT01414998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804458|NCT01415011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804459|NCT01415011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64804460|NCT01415011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804461|NCT01415011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804462|NCT01415128|Rosiglitazone|rosiglitazone|mesh-list
64804463|NCT01415128|Desipramine|desipramine|mesh-list
64804464|NCT01415128|Omeprazole|omeprazole|mesh-list
64804465|NCT01415128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64804466|NCT01415128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64804467|NCT01415128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64804468|NCT01415128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804469|NCT01415128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804470|NCT01415128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64804471|NCT01415128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804472|NCT01415128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64804473|NCT01415128|Antidepressive Agents|antidepressive agents|mesh-ancestor
64415558|NCT04876807|Omeprazole|omeprazole|mesh-list
64804497|NCT01415336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64804498|NCT01415336|Alkylating Agents|alkylating agents|mesh-ancestor
64804499|NCT01415336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804500|NCT01415336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804501|NCT01415336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64804502|NCT01415336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64804503|NCT01415336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64804504|NCT01415336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64804505|NCT01415336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804506|NCT01415336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64804507|NCT01415336|Antimetabolites|antimetabolites|mesh-ancestor
64804508|NCT01415466|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64804509|NCT01415466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65222794|NCT04215159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284680|NCT00985387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65284681|NCT00985387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284682|NCT00985387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284683|NCT00985387|Urological Agents|urological agents|mesh-ancestor
65284684|NCT02776943|Hyaluronic Acid|hyaluronic acid|mesh-list
65284685|NCT02776943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65284686|NCT02776943|Immunologic Factors|immunologic factors|mesh-ancestor
65284687|NCT02776943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284688|NCT02776943|Viscosupplements|viscosupplements|mesh-ancestor
65284689|NCT02776943|Protective Agents|protective agents|mesh-ancestor
65284690|NCT04005781|Hydroxychloroquine|hydroxychloroquine|mesh-list
65284691|NCT04005781|Antimalarials|antimalarials|mesh-ancestor
65284692|NCT04005781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65284693|NCT04005781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65284694|NCT04005781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65284695|NCT04005781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65284696|NCT04005781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284697|NCT04005781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65284698|NCT04654351|Icatibant|icatibant|mesh-list
64514948|NCT04776850|Rituximab|rituximab|mesh-list
64804510|NCT01415466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64804511|NCT01415466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64804512|NCT01415466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804514|NCT01415505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64804515|NCT01415505|Nebivolol|nebivolol|mesh-list
64804516|NCT01415505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64804517|NCT01415505|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64804518|NCT01415505|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64804519|NCT01415505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804520|NCT01415505|Diuretics|diuretics|mesh-ancestor
64804521|NCT01415505|Natriuretic Agents|natriuretic agents|mesh-ancestor
64804522|NCT01415505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804523|NCT01415505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64804524|NCT01415505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64804525|NCT01415505|Vasodilator Agents|vasodilator agents|mesh-ancestor
64804526|NCT01415505|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64804527|NCT01415505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64804528|NCT01415505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64804529|NCT01415505|Adrenergic Agents|adrenergic agents|mesh-ancestor
64804530|NCT01415505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64804531|NCT01415557|Micronutrients|micronutrients|mesh-list
64804532|NCT01415557|Trace Elements|trace elements|mesh-list
64804540|NCT01415596|Respiratory System Agents|respiratory system agents|mesh-ancestor
64804541|NCT01415596|Tocolytic Agents|tocolytic agents|mesh-ancestor
64804542|NCT01415596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64804543|NCT01415596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64804544|NCT01415596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64804545|NCT01415596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64804546|NCT01415596|Adrenergic Agents|adrenergic agents|mesh-ancestor
64804547|NCT01415596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64804548|NCT01415596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804549|NCT01415687|Bisacodyl|bisacodyl|mesh-list
64804550|NCT01415687|Magnesium citrate|magnesium citrate|mesh-list
64804551|NCT01415687|Citric Acid|citric acid|mesh-list
65284699|NCT04654351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65284700|NCT04654351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65284701|NCT04654351|Analgesics|analgesics|mesh-ancestor
65284702|NCT04654351|Sensory System Agents|sensory system agents|mesh-ancestor
65284703|NCT04654351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65284704|NCT04654351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284705|NCT04654351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65284706|NCT04654351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65284707|NCT04654351|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
65284708|NCT04654351|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
65284709|NCT04654351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284710|NCT04654351|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65284711|NCT04654351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65284712|NCT04654351|Immunologic Factors|immunologic factors|mesh-ancestor
65284713|NCT00582556|Zoledronic Acid|zoledronic acid|mesh-list
65284714|NCT00582556|Leuprolide|leuprolide|mesh-list
65284715|NCT00582556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64804552|NCT01415687|Sodium Citrate|sodium citrate|mesh-list
64804553|NCT01415687|Anticoagulants|anticoagulants|mesh-ancestor
64804554|NCT01415687|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64804555|NCT01415687|Chelating Agents|chelating agents|mesh-ancestor
64804556|NCT01415687|Sequestering Agents|sequestering agents|mesh-ancestor
64804557|NCT01415687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804558|NCT01415687|Cathartics|cathartics|mesh-ancestor
64804559|NCT01415687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64804560|NCT01415687|Laxatives|laxatives|mesh-ancestor
64804561|NCT01415713|Leucovorin|leucovorin|mesh-list
64804562|NCT01415713|Gemcitabine|gemcitabine|mesh-list
64804563|NCT01415713|Oxaliplatin|oxaliplatin|mesh-list
64804580|NCT01415765|Cyclophosphamide|cyclophosphamide|mesh-list
64804581|NCT01415765|Rituximab|rituximab|mesh-list
64804582|NCT01415765|Doxorubicin|doxorubicin|mesh-list
64804583|NCT01415765|Etoposide|etoposide|mesh-list
64804584|NCT01415765|Vincristine|vincristine|mesh-list
64804585|NCT01415765|Pevonedistat|pevonedistat|mesh-list
64804586|NCT01415765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64804588|NCT01415765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804589|NCT01415765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64804590|NCT01415765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64804591|NCT01415765|Alkylating Agents|alkylating agents|mesh-ancestor
64804592|NCT01415765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804593|NCT01415765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804594|NCT01415765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64804595|NCT01415765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64804596|NCT01415765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64804597|NCT01415765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64804598|NCT01415765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64804599|NCT01415765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804600|NCT01415765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64804601|NCT01415765|Glucocorticoids|glucocorticoids|mesh-ancestor
64804602|NCT01415765|Hormones|hormones|mesh-ancestor
64804603|NCT01415765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64415671|NCT05531591|Serotonin Agents|serotonin agents|mesh-ancestor
64804607|NCT01415765|Antimitotic Agents|antimitotic agents|mesh-ancestor
64804608|NCT01415765|Mitosis Modulators|mitosis modulators|mesh-ancestor
64804609|NCT01415778|Bicalutamide|bicalutamide|mesh-list
64804610|NCT01415778|Androgen Antagonists|androgen antagonists|mesh-ancestor
64804611|NCT01415778|Hormone Antagonists|hormone antagonists|mesh-ancestor
65284716|NCT00582556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284717|NCT00582556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65284718|NCT00582556|Fertility Agents|fertility agents|mesh-ancestor
65284719|NCT00582556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65284720|NCT00582556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65284721|NCT00582556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284722|NCT02776397|Vitamin E|vitamin e|mesh-list
65284723|NCT02776397|Tocopherols|tocopherols|mesh-list
65284724|NCT02776397|alpha-Tocopherol|alpha-tocopherol|mesh-list
65284725|NCT02776397|Vitamins|vitamins|mesh-ancestor
65284726|NCT02776397|Micronutrients|micronutrients|mesh-ancestor
65284727|NCT02776397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284728|NCT02776397|Antioxidants|antioxidants|mesh-ancestor
65284729|NCT02776397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284730|NCT02776397|Protective Agents|protective agents|mesh-ancestor
65284731|NCT00985777|Vitamin E|vitamin e|mesh-list
65284732|NCT00985777|Tocopherols|tocopherols|mesh-list
65284733|NCT00985777|Tocotrienols|tocotrienols|mesh-list
65284734|NCT00985777|Vitamins|vitamins|mesh-ancestor
65284735|NCT00985777|Micronutrients|micronutrients|mesh-ancestor
65284736|NCT00985777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284737|NCT00985777|Antioxidants|antioxidants|mesh-ancestor
64804612|NCT01415778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64804613|NCT01415778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804614|NCT01415778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804615|NCT01415791|Bicalutamide|bicalutamide|mesh-list
64804616|NCT01415791|Androgen Antagonists|androgen antagonists|mesh-ancestor
64804617|NCT01415791|Hormone Antagonists|hormone antagonists|mesh-ancestor
64804618|NCT01415791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64804619|NCT01415791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804620|NCT01415791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804622|NCT01415895|Naltrexone|naltrexone|mesh-list
64804623|NCT01415895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64804655|NCT01416116|Sensory System Agents|sensory system agents|mesh-ancestor
64804656|NCT01416116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64472183|NCT03720522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64804657|NCT01416116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64804658|NCT01416116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64804659|NCT01416116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64804660|NCT01416116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64804721|NCT01416558|Mitosis Modulators|mitosis modulators|mesh-ancestor
64804722|NCT01416558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804724|NCT01416649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64804725|NCT01416649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804726|NCT01416649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64804727|NCT01416649|Incretins|incretins|mesh-ancestor
64804728|NCT01416649|Hormones|hormones|mesh-ancestor
64804729|NCT01416649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64804730|NCT01416662|Gemcitabine|gemcitabine|mesh-list
64804731|NCT01416662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64804732|NCT01416662|Antimetabolites|antimetabolites|mesh-ancestor
64573337|NCT02214615|Analgesics|analgesics|mesh-ancestor
64804733|NCT01416662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804734|NCT01416662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284738|NCT00985777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284739|NCT00985777|Protective Agents|protective agents|mesh-ancestor
65284740|NCT01563601|Carboplatin|carboplatin|mesh-list
65284741|NCT01563601|Etoposide|etoposide|mesh-list
65284742|NCT01563601|Etoposide phosphate|etoposide phosphate|mesh-list
65284743|NCT01563601|Obatoclax|obatoclax|mesh-list
65284744|NCT01563601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284745|NCT01563601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65284746|NCT01563601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65284747|NCT01563601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65284748|NCT01563601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65284749|NCT01563601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284750|NCT00988507|Artesunate|artesunate|mesh-list
65284751|NCT00988507|Ferroquine|ferroquine|mesh-list
65284752|NCT00988507|Antimalarials|antimalarials|mesh-ancestor
65284753|NCT00988507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65284754|NCT00988507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65284755|NCT00988507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65284756|NCT00988507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284757|NCT00988507|Antiviral Agents|antiviral agents|mesh-ancestor
65284758|NCT00988507|Schistosomicides|schistosomicides|mesh-ancestor
65284759|NCT00988507|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65284760|NCT00988507|Anthelmintics|anthelmintics|mesh-ancestor
65284761|NCT03131908|Pembrolizumab|pembrolizumab|mesh-list
65284762|NCT03131908|GSK2636771|gsk2636771|mesh-list
65284763|NCT03131908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65284764|NCT03131908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284765|NCT03131908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65284766|NCT03131908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65284767|NCT03131908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284768|NCT00985855|Etoposide|etoposide|mesh-list
65284769|NCT00985855|Cetuximab|cetuximab|mesh-list
64804735|NCT01416662|Antiviral Agents|antiviral agents|mesh-ancestor
64804736|NCT01416662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64804737|NCT01416662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804738|NCT01416662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64804739|NCT01416662|Immunologic Factors|immunologic factors|mesh-ancestor
64804740|NCT01416662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804741|NCT01416701|Vitamin D|vitamin d|mesh-list
64804751|NCT01416870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64804752|NCT01416870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804753|NCT01416870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804754|NCT01416883|Bicalutamide|bicalutamide|mesh-list
64804755|NCT01416883|Androgen Antagonists|androgen antagonists|mesh-ancestor
64804756|NCT01416883|Hormone Antagonists|hormone antagonists|mesh-ancestor
65284770|NCT00985855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284771|NCT00985855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65284772|NCT00985855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65284773|NCT00985855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65284774|NCT00985855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65284775|NCT00985855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284776|NCT00985855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65284777|NCT04226105|Insulin|insulin|mesh-list
65284778|NCT04226105|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65284779|NCT04226105|Insulin Aspart|insulin aspart|mesh-list
65284780|NCT04226105|Insulin, Long-Acting|insulin, long-acting|mesh-list
65284781|NCT04226105|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65284782|NCT04226105|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65284783|NCT04226105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65284784|NCT04226105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284785|NCT02776865|Lidocaine|lidocaine|mesh-list
65284786|NCT02776865|Anesthetics, Local|anesthetics, local|mesh-ancestor
65284787|NCT02776865|Anesthetics|anesthetics|mesh-ancestor
65284788|NCT02776865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65284789|NCT02776865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304116|NCT03067688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64804764|NCT01416948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64804765|NCT01416948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804766|NCT01416948|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64804767|NCT01416948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64804768|NCT01416948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64804769|NCT01416948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804771|NCT01416948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64804772|NCT01416948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64804773|NCT01416948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804774|NCT01416948|Cholinergic Agents|cholinergic agents|mesh-ancestor
64804775|NCT01416948|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64804776|NCT01416948|Autonomic Agents|autonomic agents|mesh-ancestor
64804777|NCT01416948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64804778|NCT01416948|Nootropic Agents|nootropic agents|mesh-ancestor
64804779|NCT01416961|Etoposide|etoposide|mesh-list
64804780|NCT01416961|Cisplatin|cisplatin|mesh-list
64804781|NCT01416961|Etoposide phosphate|etoposide phosphate|mesh-list
64804782|NCT01416961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64804783|NCT01416961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804784|NCT01416961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64804785|NCT01416961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64804786|NCT01416961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804787|NCT01416961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804788|NCT01416974|Cyclophosphamide|cyclophosphamide|mesh-list
64804789|NCT01416974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64804790|NCT01416974|Immunologic Factors|immunologic factors|mesh-ancestor
64804791|NCT01416974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804792|NCT01416974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64804793|NCT01416974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65284790|NCT02776865|Sensory System Agents|sensory system agents|mesh-ancestor
65284791|NCT02776865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65284792|NCT02776865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65284793|NCT02776865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65284794|NCT02776865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65284795|NCT02776865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65034790|NCT00204555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515055|NCT04034056|Obinutuzumab|obinutuzumab|mesh-list
64804794|NCT01416974|Alkylating Agents|alkylating agents|mesh-ancestor
64804795|NCT01416974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804796|NCT01416974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804797|NCT01416974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64804798|NCT01417013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64804799|NCT01417013|Lubricant Eye Drops|lubricant eye drops|mesh-list
64804800|NCT01417013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64804801|NCT01417065|Sirolimus|sirolimus|mesh-list
64804802|NCT01417065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64804803|NCT01417065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64804804|NCT01417065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64804805|NCT01417065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804806|NCT01417065|Antifungal Agents|antifungal agents|mesh-ancestor
64804817|NCT01417351|Vitamin D|vitamin d|mesh-list
64804818|NCT01417351|Ergocalciferols|ergocalciferols|mesh-list
64804819|NCT01417351|Cholecalciferol|cholecalciferol|mesh-list
64804820|NCT01417351|Vitamins|vitamins|mesh-list
64804821|NCT01417351|Micronutrients|micronutrients|mesh-ancestor
64804822|NCT01417351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804823|NCT01417351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64804824|NCT01417351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64804825|NCT01417364|Methyltestosterone|methyltestosterone|mesh-list
64804826|NCT01417364|Testosterone|testosterone|mesh-list
64804827|NCT01417364|Testosterone undecanoate|testosterone undecanoate|mesh-list
64804828|NCT01417364|Testosterone enanthate|testosterone enanthate|mesh-list
64804829|NCT01417364|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64804830|NCT01417364|Androgens|androgens|mesh-ancestor
64804831|NCT01417364|Hormones|hormones|mesh-ancestor
64804832|NCT01417364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64804853|NCT01417403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64804854|NCT01417403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804855|NCT01417403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804856|NCT01417403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64804857|NCT01417429|Galantamine|galantamine|mesh-list
64804858|NCT01417429|Nicotine|nicotine|mesh-list
64804859|NCT01417429|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64804860|NCT01417429|Autonomic Agents|autonomic agents|mesh-ancestor
64804861|NCT01417429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64804862|NCT01417429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804863|NCT01417429|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64804864|NCT01417429|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64804865|NCT01417429|Cholinergic Agents|cholinergic agents|mesh-ancestor
64804866|NCT01417429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64804867|NCT01417429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804868|NCT01417429|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64804869|NCT01417429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804870|NCT01417429|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64804871|NCT01417429|Nootropic Agents|nootropic agents|mesh-ancestor
64804872|NCT01417494|Leucovorin|leucovorin|mesh-list
64804873|NCT01417494|Bevacizumab|bevacizumab|mesh-list
64804874|NCT01417494|Fluorouracil|fluorouracil|mesh-list
64804875|NCT01417494|Oxaliplatin|oxaliplatin|mesh-list
64804922|NCT01417806|Topotecan|topotecan|mesh-list
64804923|NCT01417806|Pasireotide|pasireotide|mesh-list
64804924|NCT01417806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64804925|NCT01417806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64804926|NCT01417806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804927|NCT01417806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804928|NCT01417806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804929|NCT01417806|Hormones|hormones|mesh-ancestor
65284796|NCT02776865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284798|NCT02772653|Natriuretic Agents|natriuretic agents|mesh-ancestor
65284799|NCT02772653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284800|NCT00542269|Amlodipine|amlodipine|mesh-list
65284801|NCT00542269|Ramipril|ramipril|mesh-list
65284802|NCT00542269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65284803|NCT00542269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65284804|NCT00542269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65284805|NCT00542269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515065|NCT04708054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804930|NCT01417806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64804931|NCT01417806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804932|NCT01417858|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64804953|NCT01417949|Antiviral Agents|antiviral agents|mesh-ancestor
64804954|NCT01417949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64804955|NCT01418118|Dobutamine|dobutamine|mesh-list
64804956|NCT01418118|Epinephrine|epinephrine|mesh-list
64804957|NCT01418118|Norepinephrine|norepinephrine|mesh-list
64804958|NCT01418118|Dopexamine|dopexamine|mesh-list
64804959|NCT01418118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64804960|NCT01418118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64804961|NCT01418118|Adrenergic Agents|adrenergic agents|mesh-ancestor
64804962|NCT01418118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64804963|NCT01418118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804964|NCT01418118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804965|NCT01418118|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64804966|NCT01418118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64804967|NCT01418118|Autonomic Agents|autonomic agents|mesh-ancestor
64804968|NCT01418118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64804969|NCT01418118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64804970|NCT01418118|Respiratory System Agents|respiratory system agents|mesh-ancestor
64804971|NCT01418118|Mydriatics|mydriatics|mesh-ancestor
64804972|NCT01418118|Sympathomimetics|sympathomimetics|mesh-ancestor
64804973|NCT01418118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64804974|NCT01418118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64804975|NCT01418118|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64804988|NCT01418144|Anesthetics, Local|anesthetics, local|mesh-ancestor
64804990|NCT01418144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64804991|NCT01418144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804992|NCT01418144|Sensory System Agents|sensory system agents|mesh-ancestor
64804993|NCT01418144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64804994|NCT01418157|Acetazolamide|acetazolamide|mesh-list
64804995|NCT01418157|Anticonvulsants|anticonvulsants|mesh-ancestor
64804996|NCT01418157|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64804997|NCT01418157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804998|NCT01418157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804999|NCT01418157|Diuretics|diuretics|mesh-ancestor
64805027|NCT01418274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64805028|NCT01418274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64805029|NCT01418274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64805030|NCT01418274|Serotonin Agents|serotonin agents|mesh-ancestor
64805031|NCT01418274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805032|NCT01418274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64805033|NCT01418274|Antidepressive Agents|antidepressive agents|mesh-ancestor
64805034|NCT01418274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64805035|NCT01418417|Pantoprazole|pantoprazole|mesh-list
64805036|NCT01418417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64805037|NCT01418417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64805039|NCT01418417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805047|NCT01418443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64805048|NCT01418443|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64805049|NCT01418443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805050|NCT01418443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284806|NCT00542269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65284807|NCT00542269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284808|NCT00542269|Vasodilator Agents|vasodilator agents|mesh-ancestor
65284809|NCT00542269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65284810|NCT00542269|Protease Inhibitors|protease inhibitors|mesh-ancestor
65284811|NCT00542269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65284812|NCT02579434|Midazolam|midazolam|mesh-list
65284813|NCT02579434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65284814|NCT02579434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65284815|NCT02579434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65284816|NCT02579434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284817|NCT02579434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65284818|NCT02579434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65284819|NCT02579434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65284820|NCT02579434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65284821|NCT02579434|Anesthetics, General|anesthetics, general|mesh-ancestor
65284822|NCT02579434|Anesthetics|anesthetics|mesh-ancestor
65284823|NCT02579434|GABA Modulators|gaba modulators|mesh-ancestor
65284824|NCT02579434|GABA Agents|gaba agents|mesh-ancestor
65284825|NCT02579434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65284826|NCT02579434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284827|NCT00542191|Paclitaxel|paclitaxel|mesh-list
65284828|NCT00542191|Cyclophosphamide|cyclophosphamide|mesh-list
65284829|NCT00542191|Carboplatin|carboplatin|mesh-list
65284830|NCT00542191|Doxorubicin|doxorubicin|mesh-list
65284831|NCT00542191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65284832|NCT00542191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284833|NCT00542191|Tubulin Modulators|tubulin modulators|mesh-ancestor
65284834|NCT00542191|Antimitotic Agents|antimitotic agents|mesh-ancestor
65284835|NCT00542191|Mitosis Modulators|mitosis modulators|mesh-ancestor
65284836|NCT00542191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284837|NCT00542191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64805078|NCT01418586|Adrenergic Agents|adrenergic agents|mesh-ancestor
64805079|NCT01418586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64805080|NCT01418586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805081|NCT01418586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805082|NCT01418586|Urological Agents|urological agents|mesh-ancestor
64805083|NCT01418599|Alfuzosin|alfuzosin|mesh-list
64805084|NCT01418599|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64805085|NCT01418599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64805086|NCT01418599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64805087|NCT01418599|Adrenergic Agents|adrenergic agents|mesh-ancestor
65284838|NCT00542191|Immunologic Factors|immunologic factors|mesh-ancestor
65284839|NCT00542191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284840|NCT00542191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65284841|NCT00542191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65284842|NCT00542191|Alkylating Agents|alkylating agents|mesh-ancestor
65284843|NCT00542191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65284844|NCT00542191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65284845|NCT00542191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65284846|NCT00542191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65284847|NCT00542191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65284848|NCT00600938|Deferasirox|deferasirox|mesh-list
65284849|NCT00600938|Deferoxamine|deferoxamine|mesh-list
65284850|NCT00600938|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65284851|NCT00600938|Chelating Agents|chelating agents|mesh-ancestor
65284852|NCT00600938|Sequestering Agents|sequestering agents|mesh-ancestor
65284853|NCT00600938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284854|NCT00600938|Siderophores|siderophores|mesh-ancestor
65284855|NCT03061474|Niacinamide|niacinamide|mesh-list
65284856|NCT03061474|Niacin|niacin|mesh-list
65284857|NCT03061474|Nicotinic Acids|nicotinic acids|mesh-list
65284858|NCT03061474|Vitamin B Complex|vitamin b complex|mesh-ancestor
65284859|NCT03061474|Vitamins|vitamins|mesh-ancestor
65284860|NCT03061474|Micronutrients|micronutrients|mesh-ancestor
64805088|NCT01418599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64805089|NCT01418599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805090|NCT01418599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805091|NCT01418599|Urological Agents|urological agents|mesh-ancestor
64805122|NCT01418651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64805123|NCT01418729|Pravastatin|pravastatin|mesh-list
64805124|NCT01418729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64805125|NCT01418729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64805126|NCT01418729|Antimetabolites|antimetabolites|mesh-ancestor
64805127|NCT01418729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805128|NCT01418729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64805129|NCT01418729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64805130|NCT01418729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805131|NCT01418742|Doxycycline|doxycycline|mesh-list
64805132|NCT01418742|Panitumumab|panitumumab|mesh-list
64805133|NCT01418742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64805134|NCT01418742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64805135|NCT01418742|Antimalarials|antimalarials|mesh-ancestor
64805136|NCT01418742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64805137|NCT01418742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64805138|NCT01418742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64805139|NCT01418742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64805140|NCT01418794|Sirolimus|sirolimus|mesh-list
64805141|NCT01418794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64805142|NCT01418794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64805143|NCT01418794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64805144|NCT01418794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64805145|NCT01418794|Antifungal Agents|antifungal agents|mesh-ancestor
64805146|NCT01418794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64805147|NCT01418794|Immunologic Factors|immunologic factors|mesh-ancestor
64805148|NCT01418794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284861|NCT03061474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284862|NCT03061474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65284863|NCT03061474|Antimetabolites|antimetabolites|mesh-ancestor
65284864|NCT03061474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284865|NCT03061474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65284866|NCT03061474|Vasodilator Agents|vasodilator agents|mesh-ancestor
65284867|NCT00988663|Memantine|memantine|mesh-list
65284868|NCT00988663|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65284869|NCT00988663|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65284870|NCT00988663|Dopamine Agents|dopamine agents|mesh-ancestor
65284871|NCT00988663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65284872|NCT00988663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805149|NCT01419041|Crizotinib|crizotinib|mesh-list
64805150|NCT01419041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64805151|NCT01419041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64805152|NCT01419041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805153|NCT01419041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805154|NCT01419119|Cholecalciferol|cholecalciferol|mesh-list
64805155|NCT01419119|Vitamin D|vitamin d|mesh-list
64805156|NCT01419119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64805157|NCT01419119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64805158|NCT01419119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805167|NCT01419132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64805168|NCT01419132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805170|NCT01419262|Ergocalciferols|ergocalciferols|mesh-list
64805171|NCT01419262|Cholecalciferol|cholecalciferol|mesh-list
64805172|NCT01419262|Vitamins|vitamins|mesh-list
64805173|NCT01419262|Micronutrients|micronutrients|mesh-ancestor
64805174|NCT01419262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805182|NCT01419340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64805183|NCT01419340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805184|NCT01419340|Nootropic Agents|nootropic agents|mesh-ancestor
64805185|NCT01419353|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64805186|NCT01419353|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64805187|NCT01419353|Estradiol|estradiol|mesh-list
64805188|NCT01419353|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64805189|NCT01419353|Estrogens|estrogens|mesh-ancestor
64805190|NCT01419353|Hormones|hormones|mesh-ancestor
64805191|NCT01419353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64805192|NCT01419353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805193|NCT01419353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64805194|NCT01419353|Contraceptive Agents|contraceptive agents|mesh-ancestor
64805195|NCT01419353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64805196|NCT01419353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64805197|NCT01419366|Donepezil|donepezil|mesh-list
64805198|NCT01419366|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64805199|NCT01419366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805200|NCT01419366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805201|NCT01419366|Cholinergic Agents|cholinergic agents|mesh-ancestor
64805202|NCT01419366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64805203|NCT01419366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805204|NCT01419366|Nootropic Agents|nootropic agents|mesh-ancestor
64805205|NCT01419392|Sildenafil Citrate|sildenafil citrate|mesh-list
64805206|NCT01419392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805207|NCT01419392|Vasodilator Agents|vasodilator agents|mesh-ancestor
64805208|NCT01419392|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64805209|NCT01419392|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64805210|NCT01419392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805211|NCT01419392|Urological Agents|urological agents|mesh-ancestor
64805212|NCT01419405|Pregabalin|pregabalin|mesh-list
64805213|NCT01419405|Remifentanil|remifentanil|mesh-list
64805214|NCT01419405|Analgesics|analgesics|mesh-ancestor
65284873|NCT00988663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284874|NCT00988663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65284875|NCT00988663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65284877|NCT04072198|Bevacizumab|bevacizumab|mesh-list
65284878|NCT04072198|Nivolumab|nivolumab|mesh-list
65284879|NCT04072198|Oxaliplatin|oxaliplatin|mesh-list
65284880|NCT04072198|Irinotecan|irinotecan|mesh-list
65284881|NCT04072198|Fluorouracil|fluorouracil|mesh-list
65284882|NCT04072198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65284883|NCT04072198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515144|NCT04678336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64805215|NCT01419405|Sensory System Agents|sensory system agents|mesh-ancestor
64805216|NCT01419405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64805217|NCT01419405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805218|NCT01419405|Anticonvulsants|anticonvulsants|mesh-ancestor
64805219|NCT01419405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64805220|NCT01419405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64805221|NCT01419405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805222|NCT01419405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64805223|NCT01419405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64805224|NCT01419405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64805234|NCT01419548|Veliparib|veliparib|mesh-list
64805235|NCT01419548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64805236|NCT01419548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64805237|NCT01419548|Tubulin Modulators|tubulin modulators|mesh-ancestor
64805238|NCT01419548|Antimitotic Agents|antimitotic agents|mesh-ancestor
64805239|NCT01419548|Mitosis Modulators|mitosis modulators|mesh-ancestor
64805240|NCT01419548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805241|NCT01419548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64805242|NCT01419548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805243|NCT01419652|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64805244|NCT01419652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805245|NCT01419691|Auranofin|auranofin|mesh-list
64805246|NCT01419691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64805247|NCT01419730|Vitamin D|vitamin d|mesh-list
64805248|NCT01419730|Cholecalciferol|cholecalciferol|mesh-list
64805249|NCT01419730|Vitamins|vitamins|mesh-ancestor
64805250|NCT01419730|Micronutrients|micronutrients|mesh-ancestor
64805277|NCT01420094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64805278|NCT01420094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64805280|NCT01420094|Sensory System Agents|sensory system agents|mesh-ancestor
64805281|NCT01420094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64805282|NCT01420094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805283|NCT01420094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64805284|NCT01420094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64805285|NCT01420094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64805286|NCT01420094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64805287|NCT01420094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805288|NCT01420094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64805289|NCT01420094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64805290|NCT01420094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805291|NCT01420094|Antipyretics|antipyretics|mesh-ancestor
64805292|NCT01420159|Methoxyflurane|methoxyflurane|mesh-list
64805293|NCT01420159|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64805300|NCT01420302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64805301|NCT01420302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805335|NCT01420471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64805336|NCT01420471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805337|NCT01420471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64805338|NCT01420471|Immunologic Factors|immunologic factors|mesh-ancestor
64805339|NCT01420471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805386|NCT01420692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64805387|NCT01420692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805388|NCT01420822|Fluticasone|fluticasone|mesh-list
65284884|NCT04072198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65284885|NCT04072198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65284886|NCT04072198|Growth Substances|growth substances|mesh-ancestor
65284887|NCT04072198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284888|NCT04072198|Growth Inhibitors|growth inhibitors|mesh-ancestor
65284889|NCT04072198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65284890|NCT04072198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284891|NCT04072198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65284892|NCT04072198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65284893|NCT04072198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65284894|NCT04072198|Antidotes|antidotes|mesh-ancestor
65284895|NCT04072198|Protective Agents|protective agents|mesh-ancestor
65284896|NCT04072198|Vitamin B Complex|vitamin b complex|mesh-ancestor
65284897|NCT04072198|Vitamins|vitamins|mesh-ancestor
65284898|NCT04072198|Micronutrients|micronutrients|mesh-ancestor
65284899|NCT04072198|Antimetabolites|antimetabolites|mesh-ancestor
65284900|NCT04072198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65284901|NCT04072198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65284902|NCT04072198|Immunologic Factors|immunologic factors|mesh-ancestor
65284903|NCT02772419|Benralizumab|benralizumab|mesh-list
65284904|NCT02772419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65284905|NCT02772419|Respiratory System Agents|respiratory system agents|mesh-ancestor
65284906|NCT00543439|Factor VIII|factor viii|mesh-list
65284907|NCT00543439|Coagulants|coagulants|mesh-ancestor
65284908|NCT02772497|Aflibercept|aflibercept|mesh-list
65284909|NCT02772497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65284910|NCT02772497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65284911|NCT02772497|Growth Substances|growth substances|mesh-ancestor
65284912|NCT02772497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284913|NCT02772497|Growth Inhibitors|growth inhibitors|mesh-ancestor
65284914|NCT02772497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284915|NCT00582166|Rituximab|rituximab|mesh-list
65284916|NCT00582166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65284918|NCT00582166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284926|NCT02775539|Adrenergic Agents|adrenergic agents|mesh-ancestor
65284927|NCT02775539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65284928|NCT02775539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284929|NCT02775539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284930|NCT02775539|Urological Agents|urological agents|mesh-ancestor
65284931|NCT04840459|Bamlanivimab|bamlanivimab|mesh-list
65284932|NCT04840459|Antiviral Agents|antiviral agents|mesh-ancestor
65284933|NCT04840459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65284934|NCT04666961|Tamoxifen|tamoxifen|mesh-list
65284935|NCT04666961|Anastrozole|anastrozole|mesh-list
65284936|NCT04666961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65284937|NCT04666961|Hormone Antagonists|hormone antagonists|mesh-ancestor
65284938|NCT04666961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65284939|NCT04666961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284940|NCT04666961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65284941|NCT04666961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284942|NCT04666961|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65284943|NCT04666961|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64515192|NCT01949337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64515193|NCT01949337|Glucocorticoids|glucocorticoids|mesh-ancestor
64515194|NCT01949337|Hormones|hormones|mesh-ancestor
64515195|NCT01949337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64515196|NCT01949337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515197|NCT01949337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64515198|NCT01949337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515199|NCT03578146|Rivaroxaban|rivaroxaban|mesh-list
64515200|NCT03578146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64515201|NCT03578146|Antithrombins|antithrombins|mesh-ancestor
64515202|NCT03578146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64805389|NCT01420822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64805390|NCT01420822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64805391|NCT01420822|Autonomic Agents|autonomic agents|mesh-ancestor
64805392|NCT01420822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64805393|NCT01420822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805394|NCT01420822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64805395|NCT01420822|Respiratory System Agents|respiratory system agents|mesh-ancestor
64805396|NCT01420822|Dermatologic Agents|dermatologic agents|mesh-ancestor
64472184|NCT03720522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805397|NCT01420822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64805398|NCT01420900|Tacrine|tacrine|mesh-list
64805399|NCT01420900|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64805400|NCT01420900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805407|NCT01420900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65284944|NCT04666961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65284945|NCT04666961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65034938|NCT02830360|Amiodarone|amiodarone|mesh-list
65284946|NCT04666961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65284947|NCT04666961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65284948|NCT04666961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284949|NCT04006639|Analgesics|analgesics|mesh-list
65284950|NCT04006639|Sensory System Agents|sensory system agents|mesh-ancestor
65284951|NCT04006639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64515213|NCT04355832|Incretins|incretins|mesh-ancestor
64574021|NCT02135315|Isosorbide|isosorbide|mesh-list
64805409|NCT01420913|Pregabalin|pregabalin|mesh-list
64805410|NCT01420913|Analgesics|analgesics|mesh-ancestor
64805411|NCT01420913|Sensory System Agents|sensory system agents|mesh-ancestor
64805412|NCT01420913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64805413|NCT01420913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805414|NCT01420913|Anticonvulsants|anticonvulsants|mesh-ancestor
64805415|NCT01420913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64805416|NCT01420913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64805434|NCT01421121|Vaccines|vaccines|mesh-list
64805435|NCT01421121|Immunologic Factors|immunologic factors|mesh-ancestor
64805436|NCT01421121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805437|NCT01421160|Citric Acid|citric acid|mesh-list
64805438|NCT01421160|Sodium Citrate|sodium citrate|mesh-list
64805439|NCT01421160|Anticoagulants|anticoagulants|mesh-ancestor
64805440|NCT01421160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64805441|NCT01421160|Chelating Agents|chelating agents|mesh-ancestor
64805442|NCT01421160|Sequestering Agents|sequestering agents|mesh-ancestor
64805443|NCT01421160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805444|NCT01421173|Gemcitabine|gemcitabine|mesh-list
64805445|NCT01421173|Dexamethasone|dexamethasone|mesh-list
64805446|NCT01421173|Dexamethasone acetate|dexamethasone acetate|mesh-list
64805447|NCT01421173|Rituximab|rituximab|mesh-list
64805448|NCT01421173|Melphalan|melphalan|mesh-list
64805449|NCT01421173|Busulfan|busulfan|mesh-list
64805450|NCT01421173|Vorinostat|vorinostat|mesh-list
64805451|NCT01421173|BB 1101|bb 1101|mesh-list
64805452|NCT01421173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64805453|NCT01421173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64805454|NCT01421173|Immunologic Factors|immunologic factors|mesh-ancestor
64805455|NCT01421173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805456|NCT01421173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64805457|NCT01421173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64805458|NCT01421173|Antiemetics|antiemetics|mesh-ancestor
64805459|NCT01421173|Autonomic Agents|autonomic agents|mesh-ancestor
64805460|NCT01421173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64805461|NCT01421173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64805462|NCT01421173|Glucocorticoids|glucocorticoids|mesh-ancestor
64805463|NCT01421173|Hormones|hormones|mesh-ancestor
64805464|NCT01421173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64805465|NCT01421173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64805466|NCT01421173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64805467|NCT01421173|Antimetabolites|antimetabolites|mesh-ancestor
64805468|NCT01421173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805469|NCT01421173|Antiviral Agents|antiviral agents|mesh-ancestor
64805470|NCT01421173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64805471|NCT01421173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805472|NCT01421173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64805473|NCT01421173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64805474|NCT01421173|Alkylating Agents|alkylating agents|mesh-ancestor
64805494|NCT01421368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64805495|NCT01421368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805496|NCT01421368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805497|NCT01421368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64805498|NCT01421368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64805499|NCT01421368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64805500|NCT01421368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284952|NCT04006639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284953|NCT00601172|Dexamethasone|dexamethasone|mesh-list
65284954|NCT00601172|Ondansetron|ondansetron|mesh-list
65284955|NCT00601172|Casopitant|casopitant|mesh-list
65284956|NCT00601172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65284957|NCT00601172|Antiemetics|antiemetics|mesh-ancestor
65284958|NCT00601172|Autonomic Agents|autonomic agents|mesh-ancestor
65284959|NCT00601172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65284960|NCT00601172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65284961|NCT00601172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64515220|NCT01516593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64805501|NCT01421368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64805502|NCT01421368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64805503|NCT01421368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64805504|NCT01421368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64805529|NCT01421706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416606|NCT04853719|Antithrombins|antithrombins|mesh-ancestor
64805554|NCT01421927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64805555|NCT01421927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64805556|NCT01421927|Growth Substances|growth substances|mesh-ancestor
64805557|NCT01421927|Growth Inhibitors|growth inhibitors|mesh-ancestor
64805558|NCT01421927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64805560|NCT01421940|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64805561|NCT01421940|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64805562|NCT01421940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805563|NCT01421940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805564|NCT01421979|Caffeine|caffeine|mesh-list
64805565|NCT01421979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64805566|NCT01421979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805567|NCT01421979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64805568|NCT01421979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304148|NCT05728268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64805592|NCT01422096|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64805593|NCT01422096|Fertility Agents|fertility agents|mesh-ancestor
64805594|NCT01422096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64805595|NCT01422096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805596|NCT01422096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64805597|NCT01422096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64805598|NCT01422109|Aspirin|aspirin|mesh-list
64805599|NCT01422109|Clopidogrel|clopidogrel|mesh-list
64805600|NCT01422109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64805601|NCT01422109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64805602|NCT01422109|Analgesics|analgesics|mesh-ancestor
64805603|NCT01422109|Sensory System Agents|sensory system agents|mesh-ancestor
64805604|NCT01422109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64805605|NCT01422109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494091|NCT03701763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472187|NCT03712943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64805606|NCT01422109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64805607|NCT01422109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64805608|NCT01422109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64805609|NCT01422109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64805610|NCT01422109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805611|NCT01422109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64805612|NCT01422109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64805613|NCT01422109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805614|NCT01422109|Antipyretics|antipyretics|mesh-ancestor
64805615|NCT01422109|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64805616|NCT01422109|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64805617|NCT01422109|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64805618|NCT01422109|Purinergic Agents|purinergic agents|mesh-ancestor
64805619|NCT01422109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64805621|NCT01422122|Ergocalciferols|ergocalciferols|mesh-list
65284962|NCT00601172|Glucocorticoids|glucocorticoids|mesh-ancestor
65284963|NCT00601172|Hormones|hormones|mesh-ancestor
65284964|NCT00601172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65284965|NCT00601172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65284966|NCT00601172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284967|NCT00601172|Antipruritics|antipruritics|mesh-ancestor
65284968|NCT00601172|Dermatologic Agents|dermatologic agents|mesh-ancestor
65284969|NCT00601172|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65284970|NCT00601172|Serotonin Agents|serotonin agents|mesh-ancestor
65284971|NCT00601172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65284972|NCT00601172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284973|NCT00601172|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65284974|NCT00601172|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65284975|NCT00601172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65284976|NCT00601172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64805622|NCT01422122|Cholecalciferol|cholecalciferol|mesh-list
64805623|NCT01422122|Vitamins|vitamins|mesh-list
64805624|NCT01422122|Micronutrients|micronutrients|mesh-ancestor
64805625|NCT01422122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805626|NCT01422122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64805627|NCT01422122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64805628|NCT01422291|Acetaminophen|acetaminophen|mesh-list
64805629|NCT01422291|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
64805674|NCT01422590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65494092|NCT03673462|Vaccines|vaccines|mesh-list
64405221|NCT03052361|Autonomic Agents|autonomic agents|mesh-ancestor
64805690|NCT01422616|Urapidil|urapidil|mesh-list
64805691|NCT01422616|Enalaprilat|enalaprilat|mesh-list
64805692|NCT01422616|Enalapril|enalapril|mesh-list
64805693|NCT01422616|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64805694|NCT01422616|Nitroglycerin|nitroglycerin|mesh-list
64805695|NCT01422616|Esmolol|esmolol|mesh-list
64805696|NCT01422616|Glycerol|glycerol|mesh-list
64805697|NCT01422616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64805698|NCT01422616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64805699|NCT01422616|Sympatholytics|sympatholytics|mesh-ancestor
64805700|NCT01422616|Autonomic Agents|autonomic agents|mesh-ancestor
64805701|NCT01422616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64805702|NCT01422616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805703|NCT01422616|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64805704|NCT01422616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64574316|NCT01502787|Adrenergic Agents|adrenergic agents|mesh-ancestor
64805705|NCT01422616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64805706|NCT01422616|Adrenergic Agents|adrenergic agents|mesh-ancestor
64805707|NCT01422616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64805708|NCT01422616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805709|NCT01422616|Analgesics|analgesics|mesh-ancestor
64805710|NCT01422616|Sensory System Agents|sensory system agents|mesh-ancestor
64416781|NCT04842487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805743|NCT01422733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64805744|NCT01422733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64805745|NCT01422733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64805747|NCT01422785|Clindamycin palmitate|clindamycin palmitate|mesh-list
64805748|NCT01422785|Clindamycin phosphate|clindamycin phosphate|mesh-list
64805749|NCT01422785|Tretinoin|tretinoin|mesh-list
64805750|NCT01422785|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64805751|NCT01422785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64805752|NCT01422785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64805753|NCT01422785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65284977|NCT00601172|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65284978|NCT00601172|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65284979|NCT02772107|Temozolomide|temozolomide|mesh-list
65284980|NCT02772107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65284981|NCT02772107|Alkylating Agents|alkylating agents|mesh-ancestor
65284982|NCT02772107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65284983|NCT02772107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284984|NCT00986167|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65284985|NCT00986167|Antidepressive Agents|antidepressive agents|mesh-ancestor
65284986|NCT00986167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65284987|NCT00986167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65284988|NCT00986167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65284989|NCT00986167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65284990|NCT00986167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805780|NCT01423019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64805781|NCT01423019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64805782|NCT01423019|Nasal Decongestants|nasal decongestants|mesh-ancestor
64805783|NCT01423019|Respiratory System Agents|respiratory system agents|mesh-ancestor
64805784|NCT01423032|Fludarabine|fludarabine|mesh-list
64574384|NCT00156013|Antimetabolites|antimetabolites|mesh-ancestor
64805785|NCT01423032|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64805786|NCT01423032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64805787|NCT01423032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805788|NCT01423032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64805789|NCT01423032|Alkylating Agents|alkylating agents|mesh-ancestor
64805791|NCT01423123|Trastuzumab|trastuzumab|mesh-list
64805792|NCT01423123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64805793|NCT01423123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64805794|NCT01423123|Tubulin Modulators|tubulin modulators|mesh-ancestor
64805837|NCT01423305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64805838|NCT01423305|Respiratory System Agents|respiratory system agents|mesh-ancestor
64805839|NCT01423305|Glucocorticoids|glucocorticoids|mesh-ancestor
64805841|NCT01423305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64805842|NCT01423305|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64805843|NCT01423305|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64805844|NCT01423305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64805845|NCT01423305|Adrenergic Agents|adrenergic agents|mesh-ancestor
64805846|NCT01423305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65494093|NCT03673462|Immunologic Factors|immunologic factors|mesh-ancestor
64405315|NCT04901117|Antacids|antacids|mesh-ancestor
64416938|NCT02431533|Calcium|calcium|mesh-list
64805903|NCT01423708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64805904|NCT01423708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64805905|NCT01423708|Immunologic Factors|immunologic factors|mesh-ancestor
64805906|NCT01423708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805908|NCT01423747|Etoposide|etoposide|mesh-list
64805909|NCT01423747|Etoposide phosphate|etoposide phosphate|mesh-list
64805910|NCT01423747|Thiotepa|thiotepa|mesh-list
64805911|NCT01423747|Treosulfan|treosulfan|mesh-list
64805912|NCT01423747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417003|NCT02410551|Busulfan|busulfan|mesh-list
64805941|NCT01423864|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64805942|NCT01423864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64805943|NCT01423864|Prednisolone phosphate|prednisolone phosphate|mesh-list
64805944|NCT01423864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64805945|NCT01423864|Glucocorticoids|glucocorticoids|mesh-ancestor
64805946|NCT01423864|Hormones|hormones|mesh-ancestor
64805947|NCT01423864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64805948|NCT01423864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805949|NCT01423864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65284991|NCT00988897|Leucovorin|leucovorin|mesh-list
65284992|NCT00988897|Bevacizumab|bevacizumab|mesh-list
65284993|NCT00988897|Fluorouracil|fluorouracil|mesh-list
65284994|NCT00988897|Oxaliplatin|oxaliplatin|mesh-list
65284995|NCT00988897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65284996|NCT00988897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65284997|NCT00988897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65284998|NCT00988897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65284999|NCT00988897|Growth Substances|growth substances|mesh-ancestor
65285000|NCT00988897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285001|NCT00988897|Growth Inhibitors|growth inhibitors|mesh-ancestor
65285002|NCT00988897|Antimetabolites|antimetabolites|mesh-ancestor
65285003|NCT00988897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285004|NCT00988897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65285005|NCT00988897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65285006|NCT00988897|Immunologic Factors|immunologic factors|mesh-ancestor
65285007|NCT00988897|Antidotes|antidotes|mesh-ancestor
65285008|NCT00988897|Protective Agents|protective agents|mesh-ancestor
64805950|NCT01423864|Protective Agents|protective agents|mesh-ancestor
64805951|NCT01423864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64805952|NCT01423864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64805953|NCT01423864|Antiemetics|antiemetics|mesh-ancestor
64805954|NCT01423864|Autonomic Agents|autonomic agents|mesh-ancestor
64805955|NCT01423864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64417050|NCT04822909|Apremilast|apremilast|mesh-list
64805974|NCT01424124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64805999|NCT01424176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64806000|NCT01424176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64806001|NCT01424176|Dopamine Agonists|dopamine agonists|mesh-ancestor
64806002|NCT01424176|Dopamine Agents|dopamine agents|mesh-ancestor
64806003|NCT01424176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64806005|NCT01424241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64806006|NCT01424241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64806007|NCT01424241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806008|NCT01424319|Atrasentan|atrasentan|mesh-list
64806009|NCT01424319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806010|NCT01424319|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64806036|NCT01424332|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64806037|NCT01424332|Antithrombins|antithrombins|mesh-ancestor
64806038|NCT01424332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64806039|NCT01424332|Protease Inhibitors|protease inhibitors|mesh-ancestor
64806040|NCT01424332|Anticoagulants|anticoagulants|mesh-ancestor
64806041|NCT01424345|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64806042|NCT01424345|Immunologic Factors|immunologic factors|mesh-ancestor
64806111|NCT01424826|Antiviral Agents|antiviral agents|mesh-ancestor
64806112|NCT01424826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64806113|NCT01424826|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64806114|NCT01424826|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64806115|NCT01424826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806116|NCT01424826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806117|NCT01424826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64806118|NCT01424826|Antitubercular Agents|antitubercular agents|mesh-ancestor
64806119|NCT01424826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64806120|NCT01424826|Leprostatic Agents|leprostatic agents|mesh-ancestor
64806121|NCT01424826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64806122|NCT01424826|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64806123|NCT01424826|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64806124|NCT01424826|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65285009|NCT00988897|Vitamin B Complex|vitamin b complex|mesh-ancestor
65285010|NCT00988897|Vitamins|vitamins|mesh-ancestor
65285011|NCT00988897|Micronutrients|micronutrients|mesh-ancestor
65285012|NCT02775227|Hydrocortisone|hydrocortisone|mesh-list
65285013|NCT02775227|Pasireotide|pasireotide|mesh-list
65285014|NCT02775227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65285015|NCT02775227|Hormones|hormones|mesh-ancestor
65285016|NCT02775227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65285017|NCT02775227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285018|NCT02875132|Pembrolizumab|pembrolizumab|mesh-list
65285019|NCT02875132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65285020|NCT02875132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285021|NCT00984217|Panitumumab|panitumumab|mesh-list
65285022|NCT00984217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65285024|NCT00989053|Citalopram|citalopram|mesh-list
65285025|NCT00989053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65285026|NCT00989053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65285027|NCT00989053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65285028|NCT00989053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285029|NCT00989053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65285030|NCT00989053|Serotonin Agents|serotonin agents|mesh-ancestor
64806148|NCT01424891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64806149|NCT01424891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806150|NCT01425060|Contraceptive Agents|contraceptive agents|mesh-list
64806151|NCT01425060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64806173|NCT01425099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806174|NCT01425099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64806175|NCT01425099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64806176|NCT01425099|Antiviral Agents|antiviral agents|mesh-ancestor
64806207|NCT01425242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64806208|NCT01425242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806209|NCT01425242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64806210|NCT01425242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806211|NCT01425242|Vasodilator Agents|vasodilator agents|mesh-ancestor
64806213|NCT01425320|Adapalene|adapalene|mesh-list
64806214|NCT01425320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64806215|NCT01425320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64806216|NCT01425320|Analgesics|analgesics|mesh-ancestor
64417315|NCT02604589|Narcotics|narcotics|mesh-ancestor
64806239|NCT01425398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806240|NCT01425411|Valsartan|valsartan|mesh-list
64806241|NCT01425411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64806242|NCT01425411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64806243|NCT01425411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64806244|NCT01425411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806245|NCT01425424|Vitamin D|vitamin d|mesh-list
64806246|NCT01425424|Ergocalciferols|ergocalciferols|mesh-list
64806247|NCT01425424|Cholecalciferol|cholecalciferol|mesh-list
64806248|NCT01425424|Vitamins|vitamins|mesh-list
64806249|NCT01425424|Micronutrients|micronutrients|mesh-ancestor
64304150|NCT05728268|Antimitotic Agents|antimitotic agents|mesh-ancestor
64806304|NCT01425658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806305|NCT01425658|Analgesics|analgesics|mesh-ancestor
65285031|NCT00989053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285032|NCT00989053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65285033|NCT00989053|Antidepressive Agents|antidepressive agents|mesh-ancestor
65285034|NCT00989053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65285035|NCT04614493|Temozolomide|temozolomide|mesh-list
65285036|NCT04614493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65285037|NCT04614493|Alkylating Agents|alkylating agents|mesh-ancestor
65285038|NCT04614493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285039|NCT04614493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285040|NCT02841748|Pembrolizumab|pembrolizumab|mesh-list
65285041|NCT02841748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65285042|NCT02841748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285043|NCT04033094|Morphine|morphine|mesh-list
65285044|NCT04033094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65285045|NCT04033094|Narcotics|narcotics|mesh-ancestor
65285046|NCT04033094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65285047|NCT04033094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285048|NCT04033094|Analgesics|analgesics|mesh-ancestor
65285049|NCT04033094|Sensory System Agents|sensory system agents|mesh-ancestor
65285050|NCT04033094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285051|NCT04073758|Dexmedetomidine|dexmedetomidine|mesh-list
65285052|NCT04073758|Remifentanil|remifentanil|mesh-list
65285053|NCT04073758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65285054|NCT04073758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64806306|NCT01425658|Sensory System Agents|sensory system agents|mesh-ancestor
64806307|NCT01425658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806308|NCT01425658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64417408|NCT04796623|Fulvestrant|fulvestrant|mesh-list
65494095|NCT03649880|Misonidazole|misonidazole|mesh-list
64514731|NCT02393157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64806317|NCT01425658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64806318|NCT01425658|Adrenergic Agents|adrenergic agents|mesh-ancestor
64806319|NCT01425658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64806320|NCT01425658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806321|NCT01425697|Chlorhexidine|chlorhexidine|mesh-list
64806322|NCT01425697|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64806323|NCT01425697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64806324|NCT01425697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64806325|NCT01425697|Disinfectants|disinfectants|mesh-ancestor
64806326|NCT01425697|Dermatologic Agents|dermatologic agents|mesh-ancestor
64806327|NCT01425736|Cisplatin|cisplatin|mesh-list
64806328|NCT01425736|Docetaxel|docetaxel|mesh-list
64806329|NCT01425736|Fluorouracil|fluorouracil|mesh-list
64806330|NCT01425736|Nimotuzumab|nimotuzumab|mesh-list
64806331|NCT01425736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806332|NCT01425736|Tubulin Modulators|tubulin modulators|mesh-ancestor
64806333|NCT01425736|Antimitotic Agents|antimitotic agents|mesh-ancestor
64806334|NCT01425736|Mitosis Modulators|mitosis modulators|mesh-ancestor
64806335|NCT01425736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806336|NCT01425736|Antimetabolites|antimetabolites|mesh-ancestor
64806337|NCT01425736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65285055|NCT04073758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285056|NCT04073758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65285057|NCT04073758|Analgesics|analgesics|mesh-ancestor
65285058|NCT04073758|Sensory System Agents|sensory system agents|mesh-ancestor
65285059|NCT04073758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285060|NCT04073758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65285061|NCT04073758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65285062|NCT04073758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64806362|NCT05386290|Sensory System Agents|sensory system agents|mesh-ancestor
64806363|NCT05386290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806364|NCT05386290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806365|NCT05386290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64806366|NCT05386186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64806368|NCT05386186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64806369|NCT05386186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64806370|NCT05386186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806371|NCT05386186|Incretins|incretins|mesh-ancestor
64806372|NCT05386186|Hormones|hormones|mesh-ancestor
64806373|NCT05386186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64806374|NCT05386186|Protease Inhibitors|protease inhibitors|mesh-ancestor
64806375|NCT05386186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806376|NCT05386186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806377|NCT05386186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64417447|NCT04805827|Anticonvulsants|anticonvulsants|mesh-ancestor
64806401|NCT05386056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64806402|NCT05386056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806404|NCT05385900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806405|NCT05385887|Metronidazole|metronidazole|mesh-list
64806406|NCT05385887|Ciprofloxacin|ciprofloxacin|mesh-list
64806407|NCT05385887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64806408|NCT05385887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64806409|NCT05385887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64806410|NCT05385887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64806560|NCT04765371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806561|NCT04765371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806562|NCT04765371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64806563|NCT04765371|Glucocorticoids|glucocorticoids|mesh-ancestor
64806564|NCT04765371|Hormones|hormones|mesh-ancestor
64806565|NCT04765371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64806566|NCT04765371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64806567|NCT04765371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806568|NCT04765371|Protease Inhibitors|protease inhibitors|mesh-ancestor
64806569|NCT04765371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806570|NCT04765371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806571|NCT04765371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64806572|NCT04765371|Protective Agents|protective agents|mesh-ancestor
64806573|NCT04744363|Ustekinumab|ustekinumab|mesh-list
64806574|NCT04744363|Dermatologic Agents|dermatologic agents|mesh-ancestor
64806575|NCT04729517|Azelastine|azelastine|mesh-list
64806576|NCT04729517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64806577|NCT04729517|Autonomic Agents|autonomic agents|mesh-ancestor
64806578|NCT04729517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806579|NCT04729517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806580|NCT04729517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64806581|NCT04729517|Respiratory System Agents|respiratory system agents|mesh-ancestor
64304151|NCT05728268|Mitosis Modulators|mitosis modulators|mesh-ancestor
64806675|NCT04425902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64806676|NCT04425902|Respiratory System Agents|respiratory system agents|mesh-ancestor
64806677|NCT04425902|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64806678|NCT04425902|Hormone Antagonists|hormone antagonists|mesh-ancestor
64806679|NCT04425902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64806680|NCT04425902|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64806681|NCT04425902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64806682|NCT04425902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64806683|NCT04425902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65285063|NCT04073758|Adrenergic Agents|adrenergic agents|mesh-ancestor
65285064|NCT04073758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65285065|NCT04073758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285066|NCT04073758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65285067|NCT04073758|Narcotics|narcotics|mesh-ancestor
65285068|NCT02660606|Analgesics, Opioid|analgesics, opioid|mesh-list
65285069|NCT02660606|Narcotics|narcotics|mesh-ancestor
65285070|NCT02660606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65285071|NCT02660606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285072|NCT02660606|Analgesics|analgesics|mesh-ancestor
65285073|NCT02660606|Sensory System Agents|sensory system agents|mesh-ancestor
65285074|NCT02660606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285075|NCT00582010|Nitric Oxide|nitric oxide|mesh-list
65285076|NCT00582010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65285077|NCT00582010|Autonomic Agents|autonomic agents|mesh-ancestor
64806684|NCT04425902|Sympatholytics|sympatholytics|mesh-ancestor
64806685|NCT04425902|Autonomic Agents|autonomic agents|mesh-ancestor
64806686|NCT04425902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806687|NCT04425902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64806688|NCT04425902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64806689|NCT04425902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64806690|NCT04425902|Adrenergic Agents|adrenergic agents|mesh-ancestor
64806691|NCT04425902|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64806692|NCT04425902|Protective Agents|protective agents|mesh-ancestor
64806693|NCT04425902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64806694|NCT04425902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64806695|NCT04425902|Antimetabolites|antimetabolites|mesh-ancestor
64806722|NCT04203472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64806724|NCT04166071|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64806725|NCT04166071|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64806726|NCT04166071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806727|NCT04166071|Sensory System Agents|sensory system agents|mesh-ancestor
64806728|NCT04166071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806729|NCT04072146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64806730|NCT04072146|Varenicline|varenicline|mesh-list
64806731|NCT04072146|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64806732|NCT04072146|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64806733|NCT04072146|Cholinergic Agents|cholinergic agents|mesh-ancestor
64806734|NCT04072146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64806735|NCT04072146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806736|NCT04072146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806737|NCT03996265|Bupropion|bupropion|mesh-list
64806738|NCT03996265|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64806739|NCT03996265|Antidepressive Agents|antidepressive agents|mesh-ancestor
64806740|NCT03996265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64806741|NCT03996265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64806742|NCT03996265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64417834|NCT04784767|Saponin QA-21V1|saponin qa-21v1|mesh-list
64806796|NCT03759028|Antipyretics|antipyretics|mesh-ancestor
64806810|NCT03737292|Anesthetics, Local|anesthetics, local|mesh-ancestor
64806812|NCT03737292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64806813|NCT03737292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806814|NCT03737292|Sensory System Agents|sensory system agents|mesh-ancestor
64806815|NCT03737292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806816|NCT03734211|Evolocumab|evolocumab|mesh-list
64806817|NCT03734211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64806818|NCT03734211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65494098|NCT03649880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64806819|NCT03734211|Antimetabolites|antimetabolites|mesh-ancestor
65222798|NCT04215159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65285078|NCT00582010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285079|NCT00582010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285080|NCT00582010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65285081|NCT00582010|Respiratory System Agents|respiratory system agents|mesh-ancestor
65285082|NCT00582010|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65285083|NCT00582010|Antioxidants|antioxidants|mesh-ancestor
65285084|NCT00582010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285085|NCT00582010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65285086|NCT00582010|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65285087|NCT00582010|Vasodilator Agents|vasodilator agents|mesh-ancestor
65285088|NCT00582010|Gasotransmitters|gasotransmitters|mesh-ancestor
65285089|NCT00582010|Protective Agents|protective agents|mesh-ancestor
64806820|NCT03734211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806821|NCT03734211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64806822|NCT03730974|Snake venom protein C activator|snake venom protein c activator|mesh-list
64806823|NCT03730974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64806824|NCT03730974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64806825|NCT03730974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806826|NCT03713424|Clavulanic Acids|clavulanic acids|mesh-list
64806827|NCT03713424|Clavulanic Acid|clavulanic acid|mesh-list
64806828|NCT03713424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64575442|NCT01515657|Antipyretics|antipyretics|mesh-ancestor
64417923|NCT04589611|Amobarbital|amobarbital|mesh-list
64806848|NCT03512405|Antibodies|antibodies|mesh-list
64806849|NCT03512405|Immunoglobulins|immunoglobulins|mesh-list
64806850|NCT03512405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64806851|NCT03512405|Muromonab-CD3|muromonab-cd3|mesh-list
64806852|NCT03512405|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64806853|NCT03512405|Immunologic Factors|immunologic factors|mesh-ancestor
64806854|NCT03512405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806855|NCT03512405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806856|NCT03512405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64806857|NCT03495713|Nivolumab|nivolumab|mesh-list
64806858|NCT03495713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64806859|NCT03495713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806860|NCT03495713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64806861|NCT03495713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806862|NCT03444753|Nivolumab|nivolumab|mesh-list
64806863|NCT03444753|Ipilimumab|ipilimumab|mesh-list
64806864|NCT03444753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64806865|NCT03444753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806866|NCT03444753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64806867|NCT03444753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806868|NCT03142035|Dienogest|dienogest|mesh-list
64806869|NCT03142035|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64806870|NCT03142035|Contraceptive Agents|contraceptive agents|mesh-ancestor
64806871|NCT03142035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64806872|NCT03142035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806873|NCT03142035|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64806874|NCT03142035|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64806875|NCT03142035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64806876|NCT03142035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64806877|NCT03142035|Hormone Antagonists|hormone antagonists|mesh-ancestor
64806905|NCT02547662|Ichthammol|ichthammol|mesh-list
64806906|NCT02547662|BB 1101|bb 1101|mesh-list
64806907|NCT02547662|Glycine|glycine|mesh-list
64806908|NCT02547662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64806909|NCT02547662|Antiemetics|antiemetics|mesh-ancestor
64806910|NCT02547662|Autonomic Agents|autonomic agents|mesh-ancestor
64806911|NCT02547662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806912|NCT02547662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806913|NCT02547662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65285090|NCT00989209|Botulinum Toxins|botulinum toxins|mesh-list
65285091|NCT00989209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65285092|NCT00989209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65285093|NCT00989209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65285094|NCT00989209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65035092|NCT00176774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285095|NCT00989209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285096|NCT00989209|Cholinergic Agents|cholinergic agents|mesh-ancestor
65285097|NCT00989209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65285098|NCT00989209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285099|NCT00989209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65285100|NCT00989209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285101|NCT00649922|Adalimumab|adalimumab|mesh-list
65285102|NCT00649922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65285103|NCT00649922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65285104|NCT00986557|Ganciclovir|ganciclovir|mesh-list
65285105|NCT00986557|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65285106|NCT00986557|Foscarnet|foscarnet|mesh-list
65285107|NCT00986557|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
65285108|NCT00986557|Alemtuzumab|alemtuzumab|mesh-list
65285109|NCT00986557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65285110|NCT00986557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285111|NCT00986557|Antiviral Agents|antiviral agents|mesh-ancestor
65285112|NCT00986557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65285113|NCT00986557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65285114|NCT00986557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285115|NCT00986557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285116|NCT00986557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65285117|NCT00910754|Prednisone|prednisone|mesh-list
65285118|NCT00910754|Abiraterone Acetate|abiraterone acetate|mesh-list
65285119|NCT00910754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65285120|NCT00910754|Glucocorticoids|glucocorticoids|mesh-ancestor
64806914|NCT02547662|Glucocorticoids|glucocorticoids|mesh-ancestor
64806915|NCT02547662|Hormones|hormones|mesh-ancestor
64806916|NCT02547662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64806917|NCT02547662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64806918|NCT02547662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806919|NCT02547662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806920|NCT02547662|Protease Inhibitors|protease inhibitors|mesh-ancestor
64806921|NCT02547662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806922|NCT02547662|Immunologic Factors|immunologic factors|mesh-ancestor
64806923|NCT02547662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65285121|NCT00910754|Hormones|hormones|mesh-ancestor
65285122|NCT00910754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65285123|NCT00910754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285124|NCT00910754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65285125|NCT00910754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285126|NCT00910754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65285127|NCT00910754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285128|NCT00910754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285129|NCT00910754|Hormone Antagonists|hormone antagonists|mesh-ancestor
65285130|NCT00910754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65285131|NCT00649376|Fexofenadine|fexofenadine|mesh-list
65285132|NCT00649376|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65285133|NCT00649376|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65285134|NCT00649376|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65285135|NCT00649376|Histamine Antagonists|histamine antagonists|mesh-ancestor
65285136|NCT00649376|Histamine Agents|histamine agents|mesh-ancestor
65285137|NCT00649376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64515393|NCT04249596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64806924|NCT02547662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64806925|NCT02547662|Growth Substances|growth substances|mesh-ancestor
64806926|NCT02547662|Growth Inhibitors|growth inhibitors|mesh-ancestor
64806927|NCT02547662|Dermatologic Agents|dermatologic agents|mesh-ancestor
64806928|NCT02547662|Glycine Agents|glycine agents|mesh-ancestor
64806929|NCT02547662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64806930|NCT02246257|Metformin|metformin|mesh-list
64806931|NCT02246257|Losartan|losartan|mesh-list
64806932|NCT02246257|Simvastatin|simvastatin|mesh-list
64806933|NCT02246257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64806934|NCT02246257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806935|NCT02246257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64806936|NCT02246257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64806937|NCT02246257|Antimetabolites|antimetabolites|mesh-ancestor
64806938|NCT02246257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806939|NCT02246257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64806940|NCT02246257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64806941|NCT02246257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806942|NCT02246257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64806943|NCT02246257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64806944|NCT02246257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64806957|NCT02094794|Etoposide|etoposide|mesh-list
64806958|NCT02094794|Etoposide phosphate|etoposide phosphate|mesh-list
64806959|NCT02094794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64806960|NCT02094794|Immunologic Factors|immunologic factors|mesh-ancestor
64806961|NCT02094794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806962|NCT02094794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64806980|NCT01949714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64806981|NCT01949714|Adrenergic Agents|adrenergic agents|mesh-ancestor
64806982|NCT01949714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64806983|NCT01949714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806984|NCT01949714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806985|NCT01949714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64806986|NCT01949714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64806987|NCT01949714|Autonomic Agents|autonomic agents|mesh-ancestor
64806988|NCT01949714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285138|NCT00649376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285139|NCT00649376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285140|NCT02340676|Interleukin-2|interleukin-2|mesh-list
65285141|NCT02340676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285142|NCT02340676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65285143|NCT02340676|Analgesics|analgesics|mesh-ancestor
65285144|NCT02340676|Sensory System Agents|sensory system agents|mesh-ancestor
65285145|NCT02340676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285146|NCT02340676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285147|NCT04898621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65285148|NCT00649454|Metformin|metformin|mesh-list
65285149|NCT00649454|Glipizide|glipizide|mesh-list
65285150|NCT00649454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65285151|NCT00649454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285152|NCT03920215|Varenicline|varenicline|mesh-list
65285153|NCT03920215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65285154|NCT03920215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65285155|NCT03920215|Cholinergic Agents|cholinergic agents|mesh-ancestor
65285156|NCT03920215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65285157|NCT03920215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806989|NCT01949714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64806990|NCT01949714|Respiratory System Agents|respiratory system agents|mesh-ancestor
64806992|NCT01949714|Sympathomimetics|sympathomimetics|mesh-ancestor
64806993|NCT01949714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64806994|NCT01596621|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64807039|NCT00223145|Hormones|hormones|mesh-ancestor
64807040|NCT00223145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64807041|NCT00223145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807042|NCT00223145|Androgen Antagonists|androgen antagonists|mesh-ancestor
64807043|NCT00223145|Hormone Antagonists|hormone antagonists|mesh-ancestor
64807044|NCT01425827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64807045|NCT01425827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64807046|NCT01425827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64807047|NCT01425827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64807048|NCT01425827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807049|NCT01425827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64807050|NCT01425827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807051|NCT01425827|Analgesics|analgesics|mesh-ancestor
64807052|NCT01425827|Sensory System Agents|sensory system agents|mesh-ancestor
64807053|NCT01425827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807054|NCT01425827|Antidepressive Agents|antidepressive agents|mesh-ancestor
64807090|NCT01426087|Somatostatin|somatostatin|mesh-list
64807091|NCT01426087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64807093|NCT01426087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64807094|NCT01426087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807095|NCT01426100|Telmisartan|telmisartan|mesh-list
64807096|NCT01426100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64807097|NCT01426100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64807098|NCT01426100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64807099|NCT01426100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807100|NCT01426165|Magnesium Sulfate|magnesium sulfate|mesh-list
64807101|NCT01426165|Analgesics|analgesics|mesh-ancestor
65285158|NCT03920215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285159|NCT02655770|Liraglutide|liraglutide|mesh-list
65285160|NCT02655770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65285161|NCT02655770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285162|NCT02655770|Incretins|incretins|mesh-ancestor
65285163|NCT02655770|Hormones|hormones|mesh-ancestor
65285164|NCT02655770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65285165|NCT00986713|Amphotericin B|amphotericin b|mesh-list
65285166|NCT00986713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65285167|NCT00986713|Amebicides|amebicides|mesh-ancestor
65285168|NCT00986713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65285169|NCT00986713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65285171|NCT00986713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65285172|NCT00986713|Antifungal Agents|antifungal agents|mesh-ancestor
65285173|NCT02651870|Amlodipine|amlodipine|mesh-list
65285174|NCT02651870|Candesartan|candesartan|mesh-list
65285175|NCT02651870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64807102|NCT01426165|Sensory System Agents|sensory system agents|mesh-ancestor
64807103|NCT01426165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807104|NCT01426165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807105|NCT01426165|Anesthetics|anesthetics|mesh-ancestor
64807106|NCT01426165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64807107|NCT01426165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64807108|NCT01426165|Anticonvulsants|anticonvulsants|mesh-ancestor
64807109|NCT01426165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64418205|NCT02399475|Hormones|hormones|mesh-list
64807137|NCT01426399|Metformin|metformin|mesh-list
64807138|NCT01426399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64807139|NCT01426399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807140|NCT01426464|Latanoprost|latanoprost|mesh-list
64807141|NCT01426464|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64807142|NCT01426464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64807143|NCT01426490|Vitamins|vitamins|mesh-list
64807144|NCT01426490|Ascorbic Acid|ascorbic acid|mesh-list
64807145|NCT01426490|Folic Acid|folic acid|mesh-list
64807146|NCT01426490|Pyridoxine|pyridoxine|mesh-list
64807147|NCT01426490|Pyridoxal|pyridoxal|mesh-list
64807148|NCT01426490|Vitamin B 6|vitamin b 6|mesh-list
64807149|NCT01426490|Vitamin B Complex|vitamin b complex|mesh-list
64807150|NCT01426490|Micronutrients|micronutrients|mesh-ancestor
64807151|NCT01426490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807152|NCT01426490|Antioxidants|antioxidants|mesh-ancestor
64807153|NCT01426490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807154|NCT01426490|Protective Agents|protective agents|mesh-ancestor
64807155|NCT01426490|Hematinics|hematinics|mesh-ancestor
64807156|NCT01426542|Topiramate|topiramate|mesh-list
64807157|NCT01426542|Anticonvulsants|anticonvulsants|mesh-ancestor
65494099|NCT03649880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64472191|NCT03699631|Tacrolimus|tacrolimus|mesh-list
64807205|NCT01426880|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64807207|NCT01426906|Rifampin|rifampin|mesh-list
64807208|NCT01426906|Ketoconazole|ketoconazole|mesh-list
64807209|NCT01426906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64807210|NCT01426906|Antitubercular Agents|antitubercular agents|mesh-ancestor
64807211|NCT01426906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64807212|NCT01426906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64807213|NCT01426906|Leprostatic Agents|leprostatic agents|mesh-ancestor
64807214|NCT01426906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64807215|NCT01426906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807216|NCT01426906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807217|NCT01426906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64807238|NCT01426971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807250|NCT01426984|Methylphenidate|methylphenidate|mesh-list
65285176|NCT02651870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65285177|NCT02651870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65285178|NCT02651870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285179|NCT02651870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65285180|NCT02651870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285181|NCT02651870|Vasodilator Agents|vasodilator agents|mesh-ancestor
65285182|NCT02651870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65285183|NCT02651870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65285184|NCT02766803|Resveratrol|resveratrol|mesh-list
65285185|NCT02766803|Simvastatin|simvastatin|mesh-list
65285186|NCT02766803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65285187|NCT02766803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65285188|NCT02766803|Antimetabolites|antimetabolites|mesh-ancestor
65285189|NCT02766803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285190|NCT02766803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65285191|NCT02766803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65285192|NCT02766803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285193|NCT02766803|Antioxidants|antioxidants|mesh-ancestor
65285194|NCT02766803|Protective Agents|protective agents|mesh-ancestor
65285195|NCT02766803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285196|NCT02766803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65285197|NCT00650468|Mycophenolic Acid|mycophenolic acid|mesh-list
65285198|NCT00650468|Prednisone|prednisone|mesh-list
65285199|NCT00650468|Tacrolimus|tacrolimus|mesh-list
65285200|NCT00650468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65285201|NCT00650468|Glucocorticoids|glucocorticoids|mesh-ancestor
64807251|NCT01426984|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64807252|NCT01426984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807253|NCT01426984|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64807254|NCT01426984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64807255|NCT01426984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64807256|NCT01426984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807257|NCT01426984|Dopamine Agents|dopamine agents|mesh-ancestor
64807258|NCT01426984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64807259|NCT01427114|Prednisolone|prednisolone|mesh-list
64807260|NCT01427114|Cyclophosphamide|cyclophosphamide|mesh-list
64807261|NCT01427114|Rituximab|rituximab|mesh-list
64807262|NCT01427114|Vincristine|vincristine|mesh-list
64807263|NCT01427114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64807264|NCT01427114|Immunologic Factors|immunologic factors|mesh-ancestor
64807265|NCT01427114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807266|NCT01427114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65494100|NCT03592992|Morphine|morphine|mesh-list
65494101|NCT03592992|Hydromorphone|hydromorphone|mesh-list
64472192|NCT03699631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64807267|NCT01427114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65222799|NCT04215159|Immunologic Factors|immunologic factors|mesh-ancestor
65285202|NCT00650468|Hormones|hormones|mesh-ancestor
65285203|NCT00650468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65285204|NCT00650468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285205|NCT00650468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65285206|NCT00650468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285207|NCT00650468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65285208|NCT00650468|Immunologic Factors|immunologic factors|mesh-ancestor
65285209|NCT00650468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65285210|NCT00650468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285211|NCT00650468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285212|NCT00650468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65285213|NCT00650468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65285214|NCT00650468|Antitubercular Agents|antitubercular agents|mesh-ancestor
65285215|NCT00650468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65285216|NCT00650468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65285217|NCT02576080|Imatinib Mesylate|imatinib mesylate|mesh-list
65285218|NCT02576080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285219|NCT02576080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65285220|NCT02576080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285221|NCT02576080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285222|NCT04006483|Fluorides|fluorides|mesh-list
65285223|NCT04006483|Tin Fluorides|tin fluorides|mesh-list
65285224|NCT04006483|Cariostatic Agents|cariostatic agents|mesh-ancestor
65285225|NCT04006483|Protective Agents|protective agents|mesh-ancestor
65285226|NCT04006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285227|NCT02651792|Meperidine|meperidine|mesh-list
65285228|NCT02651792|Ketamine|ketamine|mesh-list
65285229|NCT02651792|Propofol|propofol|mesh-list
65285230|NCT02651792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65285231|NCT02651792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65285232|NCT02651792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285233|NCT02651792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65285234|NCT02651792|Anesthetics, General|anesthetics, general|mesh-ancestor
65285235|NCT02651792|Anesthetics|anesthetics|mesh-ancestor
65285236|NCT02651792|Analgesics|analgesics|mesh-ancestor
65285237|NCT02651792|Sensory System Agents|sensory system agents|mesh-ancestor
64807273|NCT01427114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64807274|NCT01427114|Tubulin Modulators|tubulin modulators|mesh-ancestor
65285238|NCT02651792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285239|NCT02651792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65285240|NCT02651792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65285241|NCT02651792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65285242|NCT02651792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65035238|NCT02296645|Ethanol|ethanol|mesh-list
65285243|NCT02651792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285244|NCT02651792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65285245|NCT02651792|Narcotics|narcotics|mesh-ancestor
65285246|NCT02651792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65285247|NCT04754815|Paclitaxel|paclitaxel|mesh-list
65285248|NCT04754815|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65285249|NCT04754815|Pembrolizumab|pembrolizumab|mesh-list
65285250|NCT04754815|Pemetrexed|pemetrexed|mesh-list
65285251|NCT04754815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65285252|NCT04754815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285253|NCT04754815|Tubulin Modulators|tubulin modulators|mesh-ancestor
65285254|NCT04754815|Antimitotic Agents|antimitotic agents|mesh-ancestor
65285255|NCT04754815|Mitosis Modulators|mitosis modulators|mesh-ancestor
65285256|NCT04754815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285257|NCT04754815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65285258|NCT04754815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285259|NCT04754815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65285260|NCT04754815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65285261|NCT00649532|Ondansetron|ondansetron|mesh-list
65285262|NCT00649532|Antiemetics|antiemetics|mesh-ancestor
65285263|NCT00649532|Autonomic Agents|autonomic agents|mesh-ancestor
65285264|NCT00649532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285265|NCT00649532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285266|NCT00649532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64515511|NCT01873131|Timolol|timolol|mesh-list
64807275|NCT01427114|Antimitotic Agents|antimitotic agents|mesh-ancestor
64807276|NCT01427114|Mitosis Modulators|mitosis modulators|mesh-ancestor
64807277|NCT01427114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64807278|NCT01427114|Glucocorticoids|glucocorticoids|mesh-ancestor
64807279|NCT01427114|Hormones|hormones|mesh-ancestor
64807280|NCT01427114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64807281|NCT01427114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64807282|NCT01427127|Ramosetron|ramosetron|mesh-list
64807283|NCT01427127|Antiemetics|antiemetics|mesh-ancestor
64807284|NCT01427127|Autonomic Agents|autonomic agents|mesh-ancestor
64807285|NCT01427127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807286|NCT01427127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807287|NCT01427127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65285267|NCT00649532|Antipruritics|antipruritics|mesh-ancestor
65285268|NCT00649532|Dermatologic Agents|dermatologic agents|mesh-ancestor
65285269|NCT00649532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65285270|NCT00649532|Serotonin Agents|serotonin agents|mesh-ancestor
65285271|NCT00649532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65285272|NCT00649532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285273|NCT00649532|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65285274|NCT00649532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65285275|NCT00649532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65285276|NCT00649532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65285277|NCT00649532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65285278|NCT02655614|Midazolam|midazolam|mesh-list
65285279|NCT02655614|Caffeine|caffeine|mesh-list
65285280|NCT02655614|Rabeprazole|rabeprazole|mesh-list
65285281|NCT02655614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65285282|NCT02655614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65285283|NCT02655614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65285284|NCT02655614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285285|NCT02655614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65285286|NCT02655614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65285287|NCT02655614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65285288|NCT02655614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65285289|NCT02655614|Anesthetics, General|anesthetics, general|mesh-ancestor
65285290|NCT02655614|Anesthetics|anesthetics|mesh-ancestor
65285291|NCT02655614|GABA Modulators|gaba modulators|mesh-ancestor
65285292|NCT02655614|GABA Agents|gaba agents|mesh-ancestor
65285293|NCT02655614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65285294|NCT02655614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285295|NCT02655614|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65285296|NCT02655614|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64807288|NCT01427127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64807289|NCT01427127|Serotonin Agents|serotonin agents|mesh-ancestor
64807290|NCT01427127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64807291|NCT01427127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807292|NCT01427192|Acetazolamide|acetazolamide|mesh-list
64807293|NCT01427192|Anticonvulsants|anticonvulsants|mesh-ancestor
64807294|NCT01427192|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64807295|NCT01427192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807296|NCT01427192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807297|NCT01427192|Diuretics|diuretics|mesh-ancestor
64807298|NCT01427192|Natriuretic Agents|natriuretic agents|mesh-ancestor
64807299|NCT01427192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807300|NCT01427205|Cetuximab|cetuximab|mesh-list
64807301|NCT01427205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64807302|NCT01427205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285297|NCT02655614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285298|NCT02655614|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65285299|NCT02655614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65285300|NCT02655614|Purinergic Agents|purinergic agents|mesh-ancestor
65285301|NCT02655614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65285302|NCT02655614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65285303|NCT02655614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65285304|NCT02772029|Apatinib|apatinib|mesh-list
65285305|NCT02772029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285306|NCT02772029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65285307|NCT02772029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285308|NCT02772029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285309|NCT02766725|Sildenafil Citrate|sildenafil citrate|mesh-list
65285310|NCT02766725|Vasodilator Agents|vasodilator agents|mesh-ancestor
65285311|NCT02766725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65285312|NCT02766725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65285313|NCT02766725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285314|NCT02766725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285315|NCT02766725|Urological Agents|urological agents|mesh-ancestor
65285316|NCT02658422|Montelukast|montelukast|mesh-list
65285317|NCT02658422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65285318|NCT02658422|Respiratory System Agents|respiratory system agents|mesh-ancestor
65285319|NCT02658422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64515580|NCT02461368|Hormones|hormones|mesh-ancestor
64807410|NCT01427985|Autonomic Agents|autonomic agents|mesh-ancestor
64807411|NCT01427985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64807412|NCT01427985|Respiratory System Agents|respiratory system agents|mesh-ancestor
64807413|NCT01427985|Mydriatics|mydriatics|mesh-ancestor
64807414|NCT01427985|Parasympatholytics|parasympatholytics|mesh-ancestor
64807415|NCT01427985|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64807416|NCT01427985|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64807417|NCT01427985|Cholinergic Agents|cholinergic agents|mesh-ancestor
64807418|NCT01427985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64807419|NCT01427985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807420|NCT01427985|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64807421|NCT01427985|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64807422|NCT01427985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64807423|NCT01428037|Misoprostol|misoprostol|mesh-list
64807424|NCT01428037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64807425|NCT01428037|Abortifacient Agents|abortifacient agents|mesh-ancestor
64807426|NCT01428037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64807427|NCT01428037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807458|NCT01428284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64807460|NCT01428375|Acetaminophen|acetaminophen|mesh-list
64807461|NCT01428375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64807462|NCT01428375|Analgesics|analgesics|mesh-ancestor
64807463|NCT01428375|Sensory System Agents|sensory system agents|mesh-ancestor
64807464|NCT01428375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807465|NCT01428375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807466|NCT01428375|Antipyretics|antipyretics|mesh-ancestor
64807467|NCT01428388|Bevacizumab|bevacizumab|mesh-list
65285320|NCT02658422|Hormone Antagonists|hormone antagonists|mesh-ancestor
65285321|NCT02658422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65285322|NCT02658422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285323|NCT02658422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65285324|NCT02658422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65285325|NCT02658422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285326|NCT02771795|Trastuzumab|trastuzumab|mesh-list
65285327|NCT02771795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65285328|NCT02771795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285329|NCT02655536|Bevacizumab|bevacizumab|mesh-list
65285330|NCT02655536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65285331|NCT02655536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65285332|NCT02655536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285333|NCT02655536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65285334|NCT02655536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65285335|NCT02655536|Growth Substances|growth substances|mesh-ancestor
65285336|NCT02655536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285337|NCT02655536|Growth Inhibitors|growth inhibitors|mesh-ancestor
65285338|NCT02655536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65285339|NCT02655536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285340|NCT02655536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285341|NCT02766647|Lenograstim|lenograstim|mesh-list
65285342|NCT02766647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65285343|NCT02766647|Immunologic Factors|immunologic factors|mesh-ancestor
65285344|NCT02766647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285345|NCT02651636|Folic Acid|folic acid|mesh-list
65285346|NCT02651636|Thioctic Acid|thioctic acid|mesh-list
65285347|NCT02651636|Inositol|inositol|mesh-list
65285348|NCT02651636|Hematinics|hematinics|mesh-ancestor
65285349|NCT02651636|Vitamin B Complex|vitamin b complex|mesh-ancestor
65285350|NCT02651636|Vitamins|vitamins|mesh-ancestor
64807468|NCT01428388|Ranibizumab|ranibizumab|mesh-list
64807469|NCT01428388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64807470|NCT01428388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418573|NCT02586025|Trastuzumab|trastuzumab|mesh-list
64807482|NCT01428414|Tubulin Modulators|tubulin modulators|mesh-ancestor
64807483|NCT01428414|Antimitotic Agents|antimitotic agents|mesh-ancestor
64807484|NCT01428414|Mitosis Modulators|mitosis modulators|mesh-ancestor
64807485|NCT01428414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406396|NCT02888041|Dinoprostone|dinoprostone|mesh-list
64807514|NCT01428492|Glucocorticoids|glucocorticoids|mesh-ancestor
64807515|NCT01428492|Hormones|hormones|mesh-ancestor
65285351|NCT02651636|Micronutrients|micronutrients|mesh-ancestor
65285352|NCT02651636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285353|NCT02651636|Antioxidants|antioxidants|mesh-ancestor
65285354|NCT02651636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285355|NCT02651636|Protective Agents|protective agents|mesh-ancestor
65285356|NCT02774993|Doxycycline|doxycycline|mesh-list
65285357|NCT02774993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65285358|NCT02774993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65285359|NCT02774993|Antimalarials|antimalarials|mesh-ancestor
65285360|NCT02774993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65285361|NCT02774993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65285362|NCT02774837|Tenofovir|tenofovir|mesh-list
65285363|NCT02774837|Telbivudine|telbivudine|mesh-list
65285364|NCT02774837|Antiviral Agents|antiviral agents|mesh-ancestor
65285365|NCT02774837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65285366|NCT02774837|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65285367|NCT02774837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65285368|NCT02774837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285369|NCT02774837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285370|NCT02774837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65285371|NCT02774837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65285372|NCT02658188|Gabapentin|gabapentin|mesh-list
65285373|NCT02658188|Analgesics|analgesics|mesh-ancestor
65285374|NCT02658188|Sensory System Agents|sensory system agents|mesh-ancestor
65285375|NCT02658188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807516|NCT01428492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64807517|NCT01428492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64807518|NCT01428492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807519|NCT01428518|Lamotrigine|lamotrigine|mesh-list
64807520|NCT01428518|Anticonvulsants|anticonvulsants|mesh-ancestor
64807521|NCT01428518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64807522|NCT01428518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64807523|NCT01428518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807524|NCT01428518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64807525|NCT01428518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807526|NCT01428518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64807527|NCT01428518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64807528|NCT01428518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64807529|NCT01428518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64807530|NCT01428518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64807531|NCT01428531|PENTA|penta|mesh-list
64807619|NCT01429337|Midostaurin|midostaurin|mesh-list
64807620|NCT01429337|Staurosporine|staurosporine|mesh-list
64807621|NCT01429337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807622|NCT01429337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64807623|NCT01429337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807690|NCT01429701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64807691|NCT01429701|Glucocorticoids|glucocorticoids|mesh-ancestor
64807692|NCT01429701|Hormones|hormones|mesh-ancestor
64807693|NCT01429701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65285376|NCT02658188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285377|NCT02658188|Anticonvulsants|anticonvulsants|mesh-ancestor
65285378|NCT02658188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65285379|NCT02658188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65285380|NCT02658188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65285381|NCT02658188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65285382|NCT02658188|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65285383|NCT02658188|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65285384|NCT02658188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65285385|NCT02658188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285386|NCT02658188|Antimanic Agents|antimanic agents|mesh-ancestor
65285387|NCT02771717|Budesonide|budesonide|mesh-list
65285388|NCT02771717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65285389|NCT02771717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65285390|NCT02771717|Autonomic Agents|autonomic agents|mesh-ancestor
65285391|NCT02771717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285392|NCT02771717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285393|NCT02771717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64807694|NCT01429701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807695|NCT01429701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64807696|NCT01429701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807697|NCT01429701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807698|NCT01429701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64807729|NCT01429831|Aripiprazole|aripiprazole|mesh-list
64807730|NCT01429831|Antidepressive Agents|antidepressive agents|mesh-ancestor
64807731|NCT01429831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64807732|NCT01429831|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64807733|NCT01429831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64807734|NCT01429831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64807735|NCT01429831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807777|NCT01429935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807778|NCT01430013|Endostar protein|endostar protein|mesh-list
64807779|NCT01430013|Endostatins|endostatins|mesh-list
64807780|NCT01430013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64807781|NCT01430013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64807782|NCT01430013|Growth Substances|growth substances|mesh-ancestor
64807783|NCT01430013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807784|NCT01430013|Growth Inhibitors|growth inhibitors|mesh-ancestor
64807785|NCT01430013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807786|NCT01430052|Gemcitabine|gemcitabine|mesh-list
64807787|NCT01430052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64807788|NCT01430052|Antimetabolites|antimetabolites|mesh-ancestor
64807789|NCT01430052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807790|NCT01430052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807791|NCT01430052|Antiviral Agents|antiviral agents|mesh-ancestor
64807792|NCT01430052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64807793|NCT01430052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807794|NCT01430052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64807795|NCT01430052|Immunologic Factors|immunologic factors|mesh-ancestor
64807796|NCT01430052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807797|NCT01430065|Tacrolimus|tacrolimus|mesh-list
64807798|NCT01430065|Peficitinib|peficitinib|mesh-list
64807816|NCT01430195|Dermatologic Agents|dermatologic agents|mesh-ancestor
64807818|NCT01430234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64807819|NCT01430260|Ciclesonide|ciclesonide|mesh-list
64807820|NCT01430260|Cetirizine|cetirizine|mesh-list
65285394|NCT02771717|Respiratory System Agents|respiratory system agents|mesh-ancestor
65285395|NCT02771717|Glucocorticoids|glucocorticoids|mesh-ancestor
65285396|NCT02771717|Hormones|hormones|mesh-ancestor
65285397|NCT02771717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65285398|NCT02655380|Ketamine|ketamine|mesh-list
65285399|NCT02655380|Remifentanil|remifentanil|mesh-list
65285400|NCT02655380|Analgesics|analgesics|mesh-ancestor
65285401|NCT02655380|Sensory System Agents|sensory system agents|mesh-ancestor
65285402|NCT02655380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285403|NCT02655380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285404|NCT02655380|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65285405|NCT02655380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65285406|NCT02655380|Anesthetics, General|anesthetics, general|mesh-ancestor
65285407|NCT02655380|Anesthetics|anesthetics|mesh-ancestor
65285408|NCT02655380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65285409|NCT02655380|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65285410|NCT02655380|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65285411|NCT02655380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65285412|NCT02655380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285413|NCT02655380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65285414|NCT02655380|Narcotics|narcotics|mesh-ancestor
65285415|NCT00580840|Certolizumab Pegol|certolizumab pegol|mesh-list
65285416|NCT00580840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65285417|NCT00580840|Immunologic Factors|immunologic factors|mesh-ancestor
65285418|NCT00580840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285419|NCT00580840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65285420|NCT00987103|Tacrolimus|tacrolimus|mesh-list
65285421|NCT00987103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65285422|NCT00987103|Immunologic Factors|immunologic factors|mesh-ancestor
64515680|NCT04084548|Sensory System Agents|sensory system agents|mesh-ancestor
64807821|NCT01430260|Levocetirizine|levocetirizine|mesh-list
64807822|NCT01430260|Glucocorticoids|glucocorticoids|mesh-ancestor
64807823|NCT01430260|Hormones|hormones|mesh-ancestor
64807824|NCT01430260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64807825|NCT01430260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807826|NCT01430260|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64807827|NCT01430260|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64807828|NCT01430260|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64807829|NCT01430260|Histamine Antagonists|histamine antagonists|mesh-ancestor
64807830|NCT01430260|Histamine Agents|histamine agents|mesh-ancestor
64807831|NCT01430260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64807832|NCT01430260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807833|NCT01430312|Azelaic acid|azelaic acid|mesh-list
64807834|NCT01430312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285423|NCT00987103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285424|NCT00987103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65285425|NCT00987103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285426|NCT00987103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285427|NCT02655458|Lenalidomide|lenalidomide|mesh-list
65285428|NCT02655458|Elotuzumab|elotuzumab|mesh-list
65285429|NCT02655458|Immunologic Factors|immunologic factors|mesh-ancestor
65285430|NCT02655458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285431|NCT02655458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65285432|NCT02655458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65285433|NCT02655458|Growth Substances|growth substances|mesh-ancestor
65285434|NCT02655458|Growth Inhibitors|growth inhibitors|mesh-ancestor
65285435|NCT02655458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285436|NCT04006093|Apixaban|apixaban|mesh-list
65285437|NCT04006093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65285438|NCT04006093|Antithrombins|antithrombins|mesh-ancestor
65285439|NCT04006093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65285440|NCT04006093|Protease Inhibitors|protease inhibitors|mesh-ancestor
65285441|NCT04006093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285442|NCT04006093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285443|NCT04006093|Anticoagulants|anticoagulants|mesh-ancestor
65285444|NCT02766257|Anesthetics|anesthetics|mesh-list
65285445|NCT02766257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65285446|NCT02766257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285447|NCT04005469|Treprostinil|treprostinil|mesh-list
65285448|NCT04005469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65285449|NCT02651324|Ketamine|ketamine|mesh-list
65285450|NCT02651324|Analgesics|analgesics|mesh-ancestor
65285451|NCT02651324|Sensory System Agents|sensory system agents|mesh-ancestor
65285452|NCT02651324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285453|NCT02651324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285454|NCT02651324|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64807835|NCT01430312|Dermatologic Agents|dermatologic agents|mesh-ancestor
64807836|NCT01430520|Citalopram|citalopram|mesh-list
64807837|NCT01430520|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64807838|NCT01430520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64807839|NCT01430520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64807840|NCT01430520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807841|NCT01430520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64807842|NCT01430520|Serotonin Agents|serotonin agents|mesh-ancestor
64807843|NCT01430520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807844|NCT01430520|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65285455|NCT02651324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65285456|NCT02651324|Anesthetics, General|anesthetics, general|mesh-ancestor
65285457|NCT02651324|Anesthetics|anesthetics|mesh-ancestor
65285458|NCT02651324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65285459|NCT02651324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65285460|NCT02651324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65285461|NCT02651324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65285462|NCT02651324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285463|NCT00662220|Ribavirin|ribavirin|mesh-list
65285464|NCT00662220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65285465|NCT00662220|Interferon-alpha|interferon-alpha|mesh-list
65285466|NCT00662220|Antimetabolites|antimetabolites|mesh-ancestor
65285467|NCT00662220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285468|NCT00662220|Antiviral Agents|antiviral agents|mesh-ancestor
65285469|NCT00662220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65285471|NCT00662220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285472|NCT02575924|Imidacloprid|imidacloprid|mesh-list
65285473|NCT02575924|Cholinergic Agents|cholinergic agents|mesh-ancestor
65285474|NCT02575924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65285475|NCT02575924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285476|NCT02575924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285477|NCT02651168|Aflibercept|aflibercept|mesh-list
65285478|NCT02651168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65285479|NCT02651168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65285480|NCT02651168|Growth Substances|growth substances|mesh-ancestor
65285481|NCT02651168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285482|NCT02651168|Growth Inhibitors|growth inhibitors|mesh-ancestor
65285483|NCT02651168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285484|NCT04073602|Trastuzumab|trastuzumab|mesh-list
65285485|NCT04073602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65285486|NCT04073602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285487|NCT00650000|Modafinil|modafinil|mesh-list
64807845|NCT01430520|Antidepressive Agents|antidepressive agents|mesh-ancestor
64807846|NCT01430520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64807847|NCT01430533|Azelaic acid|azelaic acid|mesh-list
64807848|NCT01430533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807849|NCT01430533|Dermatologic Agents|dermatologic agents|mesh-ancestor
64807850|NCT01430650|Saw palmetto extract|saw palmetto extract|mesh-list
64807851|NCT01430650|Urological Agents|urological agents|mesh-ancestor
64807852|NCT01430689|Vaccines|vaccines|mesh-list
64807853|NCT01430689|Immunologic Factors|immunologic factors|mesh-ancestor
64807854|NCT01430689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285488|NCT00650000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65285489|NCT00650000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285490|NCT00650000|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65285491|NCT00650000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65285492|NCT00650000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65285493|NCT00650000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285494|NCT02630862|Aspirin|aspirin|mesh-list
65285495|NCT02630862|Dipyridamole|dipyridamole|mesh-list
65285496|NCT02630862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65285497|NCT02630862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65285498|NCT02630862|Analgesics|analgesics|mesh-ancestor
65285499|NCT02630862|Sensory System Agents|sensory system agents|mesh-ancestor
65285500|NCT02630862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285501|NCT02630862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285502|NCT02630862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65285503|NCT02630862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65285504|NCT02630862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65285505|NCT02630862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65285506|NCT02630862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285507|NCT02630862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64515783|NCT02307526|Bromides|bromides|mesh-list
64807855|NCT01430793|Vitamin D|vitamin d|mesh-list
64807856|NCT01430793|Ergocalciferols|ergocalciferols|mesh-list
64807857|NCT01430793|Cholecalciferol|cholecalciferol|mesh-list
64807858|NCT01430793|Vitamins|vitamins|mesh-list
64807859|NCT01430793|Micronutrients|micronutrients|mesh-ancestor
64807860|NCT01430793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807861|NCT01430793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64807862|NCT01430793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64807863|NCT01430806|Dronedarone|dronedarone|mesh-list
64807864|NCT01430806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64807865|NCT01430910|Ceftazidime|ceftazidime|mesh-list
64807866|NCT01430910|Avibactam|avibactam|mesh-list
64807867|NCT01430910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64807868|NCT01430910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64807970|NCT01431326|Coagulants|coagulants|mesh-ancestor
64807971|NCT01431326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64807972|NCT01431326|Narcotics|narcotics|mesh-ancestor
64807973|NCT01431326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64807974|NCT01431326|Analgesics|analgesics|mesh-ancestor
64807975|NCT01431326|Sensory System Agents|sensory system agents|mesh-ancestor
64807976|NCT01431326|Anticoagulants|anticoagulants|mesh-ancestor
64807977|NCT01431326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64807978|NCT01431326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64807979|NCT01431326|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64807980|NCT01431326|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64807981|NCT01431326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64807982|NCT01431326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64807983|NCT01431326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64807984|NCT01431326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807985|NCT01431326|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64807986|NCT01431326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65285508|NCT02630862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65285509|NCT02630862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285510|NCT02630862|Antipyretics|antipyretics|mesh-ancestor
65285511|NCT02630862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65285512|NCT02630862|Vasodilator Agents|vasodilator agents|mesh-ancestor
65285513|NCT02536430|Ketorolac|ketorolac|mesh-list
65285514|NCT02536430|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65285515|NCT02536430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65285516|NCT02536430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65285517|NCT02536430|Analgesics|analgesics|mesh-ancestor
65285518|NCT02536430|Sensory System Agents|sensory system agents|mesh-ancestor
65285519|NCT02536430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285520|NCT02536430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285521|NCT02536430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65285522|NCT02536430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65285523|NCT02536430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65285524|NCT02536430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285525|NCT02536430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285526|NCT02631174|Antithrombins|antithrombins|mesh-list
65285527|NCT02631174|Antithrombin III|antithrombin iii|mesh-list
65285528|NCT02631174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65285529|NCT02631174|Protease Inhibitors|protease inhibitors|mesh-ancestor
65285530|NCT02631174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285531|NCT02631174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285532|NCT02631174|Anticoagulants|anticoagulants|mesh-ancestor
64807987|NCT01431326|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64807988|NCT01431326|Hormone Antagonists|hormone antagonists|mesh-ancestor
64807989|NCT01431326|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64807990|NCT01431326|Diuretics|diuretics|mesh-ancestor
64807991|NCT01431326|Natriuretic Agents|natriuretic agents|mesh-ancestor
64808068|NCT01431443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64808069|NCT01431443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808070|NCT01431443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64808071|NCT01431443|Respiratory System Agents|respiratory system agents|mesh-ancestor
64808095|NCT01431547|Immunologic Factors|immunologic factors|mesh-ancestor
64808096|NCT01431547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808097|NCT01431612|Phenylephrine|phenylephrine|mesh-list
64808098|NCT01431612|Oxymetazoline|oxymetazoline|mesh-list
64808099|NCT01431612|Esmolol|esmolol|mesh-list
64808100|NCT01431612|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64808101|NCT01431612|Mydriatics|mydriatics|mesh-ancestor
64808102|NCT01431612|Autonomic Agents|autonomic agents|mesh-ancestor
64419181|NCT04302181|Ropivacaine|ropivacaine|mesh-list
64808130|NCT01431742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64808131|NCT01431742|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64808132|NCT01431781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64808133|NCT01431781|Somatostatin|somatostatin|mesh-list
64808134|NCT01431781|Hormones|hormones|mesh-ancestor
64808135|NCT01431781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64808136|NCT01431781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285533|NCT04686929|Abatacept|abatacept|mesh-list
65285534|NCT04686929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65285535|NCT04686929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285536|NCT04686929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285537|NCT04686929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65285538|NCT04686929|Immunologic Factors|immunologic factors|mesh-ancestor
65285539|NCT04686929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285540|NCT04686929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65285541|NCT02765633|Cangrelor|cangrelor|mesh-list
65285542|NCT02765633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64515826|NCT00291525|Warfarin|warfarin|mesh-list
64808137|NCT01431833|Tedizolid phosphate|tedizolid phosphate|mesh-list
64808138|NCT01431833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64808139|NCT01431833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64808140|NCT01431924|Fluticasone|fluticasone|mesh-list
64808141|NCT01431924|Xhance|xhance|mesh-list
64808142|NCT01431924|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64808143|NCT01431924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64808144|NCT01431924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64808145|NCT01431924|Autonomic Agents|autonomic agents|mesh-ancestor
64808146|NCT01431924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64808147|NCT01431924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808148|NCT01431924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64484721|NCT01961297|Sodium Oxybate|sodium oxybate|mesh-list
64808232|NCT01432223|Mitosis Modulators|mitosis modulators|mesh-ancestor
64808233|NCT01432223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808235|NCT01432249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64808236|NCT01432249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64808237|NCT01432249|Analgesics|analgesics|mesh-ancestor
64808238|NCT01432249|Sensory System Agents|sensory system agents|mesh-ancestor
64808239|NCT01432249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64808240|NCT01432249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808260|NCT01432522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64484772|NCT01969721|Autonomic Agents|autonomic agents|mesh-ancestor
64808373|NCT01433445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64808374|NCT01433445|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64808376|NCT01433445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808377|NCT01433614|Paclitaxel|paclitaxel|mesh-list
64808378|NCT01433614|Capecitabine|capecitabine|mesh-list
64808379|NCT01433614|Epirubicin|epirubicin|mesh-list
64808380|NCT01433614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64808381|NCT01433614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64808437|NCT01434017|Droperidol|droperidol|mesh-list
64808438|NCT01434017|Ondansetron|ondansetron|mesh-list
64808439|NCT01434017|BB 1101|bb 1101|mesh-list
64808440|NCT01434017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64808441|NCT01434017|Antiemetics|antiemetics|mesh-ancestor
64808442|NCT01434017|Autonomic Agents|autonomic agents|mesh-ancestor
64808443|NCT01434017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64808444|NCT01434017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808445|NCT01434017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64808446|NCT01434017|Glucocorticoids|glucocorticoids|mesh-ancestor
64808462|NCT01434017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64808463|NCT01434017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64808464|NCT01434017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64808465|NCT01434017|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64808466|NCT01434017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64808467|NCT01434017|Dopamine Agents|dopamine agents|mesh-ancestor
64808468|NCT01434069|Leucovorin|leucovorin|mesh-list
64808469|NCT01434069|Fluorouracil|fluorouracil|mesh-list
64808470|NCT01434069|Pasireotide|pasireotide|mesh-list
64808471|NCT01434069|Antimetabolites|antimetabolites|mesh-ancestor
64808472|NCT01434069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808498|NCT01434134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64808499|NCT01434134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64808500|NCT01434134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65285543|NCT02765633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65285544|NCT02765633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65285545|NCT02765633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65285546|NCT02765633|Purinergic Agents|purinergic agents|mesh-ancestor
65285547|NCT02765633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65285548|NCT02765633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285549|NCT02765633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285550|NCT00581776|Dexamethasone|dexamethasone|mesh-list
65285551|NCT00581776|Cyclophosphamide|cyclophosphamide|mesh-list
65285552|NCT00581776|Rituximab|rituximab|mesh-list
65285553|NCT00581776|Doxorubicin|doxorubicin|mesh-list
65285554|NCT00581776|Vincristine|vincristine|mesh-list
65285555|NCT00581776|Bortezomib|bortezomib|mesh-list
65285556|NCT00581776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65285557|NCT00581776|Immunologic Factors|immunologic factors|mesh-ancestor
65285558|NCT00581776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808501|NCT01434134|Adrenergic Agents|adrenergic agents|mesh-ancestor
64808502|NCT01434134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808503|NCT01434134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808504|NCT01434134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64808505|NCT01434134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64808517|NCT01434147|Antimetabolites|antimetabolites|mesh-ancestor
64808518|NCT01434147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808520|NCT01434160|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64808521|NCT01434160|Contraceptive Agents|contraceptive agents|mesh-ancestor
64808522|NCT01434160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64808523|NCT01434160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808524|NCT01434160|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64808525|NCT01434160|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64808526|NCT01434160|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64808527|NCT01434173|Amoxicillin|amoxicillin|mesh-list
64808536|NCT01434173|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64808538|NCT01434173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64808539|NCT01434173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64808540|NCT01434173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64808541|NCT01434173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64808542|NCT01434173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808543|NCT01434173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64808544|NCT01434173|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64808545|NCT01434173|Contraceptive Agents|contraceptive agents|mesh-ancestor
64808546|NCT01434173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64808547|NCT01434173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808548|NCT01434173|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64808549|NCT01434173|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64808550|NCT01434173|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64808551|NCT01434173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64808552|NCT01434173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64808553|NCT01434173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64808554|NCT01434173|Antimalarials|antimalarials|mesh-ancestor
64808555|NCT01434173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64808556|NCT01434173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64808557|NCT01434173|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64808558|NCT01434173|Renal Agents|renal agents|mesh-ancestor
64808559|NCT01434173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64808560|NCT01434173|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64808561|NCT01434212|Interferons|interferons|mesh-list
64808562|NCT01434212|Ribavirin|ribavirin|mesh-list
65285559|NCT00581776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65285560|NCT00581776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65285561|NCT00581776|Alkylating Agents|alkylating agents|mesh-ancestor
65285562|NCT00581776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285563|NCT00581776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285564|NCT00581776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65285565|NCT00581776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65285566|NCT00581776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65285567|NCT00581776|Antiemetics|antiemetics|mesh-ancestor
65285568|NCT00581776|Autonomic Agents|autonomic agents|mesh-ancestor
65285569|NCT00581776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285570|NCT00581776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65285571|NCT00581776|Glucocorticoids|glucocorticoids|mesh-ancestor
65285572|NCT00581776|Hormones|hormones|mesh-ancestor
65285573|NCT00581776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65285574|NCT00581776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65285575|NCT00581776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65285576|NCT00581776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64808563|NCT01434212|Interferon-alpha|interferon-alpha|mesh-list
64808564|NCT01434212|Interferon alpha-2|interferon alpha-2|mesh-list
64808565|NCT01434212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64808566|NCT01434212|Antiviral Agents|antiviral agents|mesh-ancestor
64808567|NCT01434212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64808568|NCT01434212|Antimetabolites|antimetabolites|mesh-ancestor
64472197|NCT03699631|Antimetabolites|antimetabolites|mesh-ancestor
64407094|NCT04850417|Aspirin|aspirin|mesh-list
64808569|NCT01434212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808604|NCT01434394|Cetuximab|cetuximab|mesh-list
64808605|NCT01434394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64808606|NCT01434394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64808607|NCT01434459|Gemcitabine|gemcitabine|mesh-list
64808608|NCT01434459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64808609|NCT01434459|Antimetabolites|antimetabolites|mesh-ancestor
64808633|NCT01434862|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
64808634|NCT01434862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808635|NCT01434888|Timolol|timolol|mesh-list
64808636|NCT01434888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64808637|NCT01434888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64808638|NCT01434888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64808639|NCT01434888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64808640|NCT01434888|Adrenergic Agents|adrenergic agents|mesh-ancestor
64808641|NCT01434888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808642|NCT01434888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808643|NCT01434888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808644|NCT01434888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64808645|NCT01434888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64808646|NCT01434901|Bethanechol|bethanechol|mesh-list
64808647|NCT01434901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64808648|NCT01434901|Autonomic Agents|autonomic agents|mesh-ancestor
64808649|NCT01434901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64808650|NCT01434901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808651|NCT01434901|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64808700|NCT01435213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64808701|NCT01435213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64808702|NCT01435213|Adrenergic Agents|adrenergic agents|mesh-ancestor
65285577|NCT00581776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65285578|NCT00581776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285579|NCT00581776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65285580|NCT00581776|Tubulin Modulators|tubulin modulators|mesh-ancestor
65285581|NCT00581776|Antimitotic Agents|antimitotic agents|mesh-ancestor
65285582|NCT00581776|Mitosis Modulators|mitosis modulators|mesh-ancestor
65285583|NCT00662454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65285584|NCT00662454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65285585|NCT00662454|Levonorgestrel|levonorgestrel|mesh-list
65285586|NCT00662454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65285587|NCT00662454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65285588|NCT00662454|Estradiol|estradiol|mesh-list
65285589|NCT00662454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65285590|NCT00662454|Estrogens|estrogens|mesh-ancestor
65285591|NCT00662454|Hormones|hormones|mesh-ancestor
65285592|NCT00662454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65285593|NCT00662454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285594|NCT00662454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65285595|NCT00662454|Contraceptive Agents|contraceptive agents|mesh-ancestor
65285596|NCT00662454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65285597|NCT00662454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64515867|NCT01436968|Valacyclovir|valacyclovir|mesh-list
64808703|NCT01435213|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64808704|NCT01435213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64808705|NCT01435213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64808707|NCT01435252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64808733|NCT01435343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64808734|NCT01435343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64808735|NCT01435395|Bevacizumab|bevacizumab|mesh-list
64808736|NCT01435395|Temozolomide|temozolomide|mesh-list
64808737|NCT01435395|Bortezomib|bortezomib|mesh-list
64808738|NCT01435395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64808739|NCT01435395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64808740|NCT01435395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64808741|NCT01435395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64808742|NCT01435395|Growth Substances|growth substances|mesh-ancestor
64808743|NCT01435395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808744|NCT01435395|Growth Inhibitors|growth inhibitors|mesh-ancestor
64808745|NCT01435395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64808746|NCT01435395|Alkylating Agents|alkylating agents|mesh-ancestor
65494110|NCT03447808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494111|NCT03386240|Triclosan|triclosan|mesh-list
65494112|NCT03386240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64808747|NCT01435395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808748|NCT01435486|Caffeine|caffeine|mesh-list
64808749|NCT01435486|Caffeine citrate|caffeine citrate|mesh-list
64808750|NCT01435486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808786|NCT01435837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64808787|NCT01435837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808788|NCT01435837|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64577413|NCT01639599|Dopamine Agents|dopamine agents|mesh-ancestor
64808789|NCT01435837|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65285598|NCT00662454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65285599|NCT00662454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65285600|NCT00662454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65285601|NCT00662454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65285602|NCT04156152|Listerine|listerine|mesh-list
65285603|NCT04156152|Fluorides|fluorides|mesh-list
65285604|NCT04156152|Sodium Fluoride|sodium fluoride|mesh-list
65285605|NCT04156152|Cariostatic Agents|cariostatic agents|mesh-ancestor
65285606|NCT04156152|Protective Agents|protective agents|mesh-ancestor
65285607|NCT04156152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285608|NCT04156152|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65285609|NCT04156152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65285610|NCT00662610|Naproxen|naproxen|mesh-list
65285611|NCT00662610|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
65285612|NCT00662610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65285613|NCT00662610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64515885|NCT02461056|Ibuprofen|ibuprofen|mesh-list
64515886|NCT02461056|Hydromorphone|hydromorphone|mesh-list
64808790|NCT01435837|Purinergic Agents|purinergic agents|mesh-ancestor
64808791|NCT01435837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808794|NCT01435902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64808795|NCT01435902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64808796|NCT01435902|Autonomic Agents|autonomic agents|mesh-ancestor
64808797|NCT01435902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64808798|NCT01435902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808799|NCT01435902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64808800|NCT01435902|Respiratory System Agents|respiratory system agents|mesh-ancestor
64808801|NCT01435902|Dermatologic Agents|dermatologic agents|mesh-ancestor
64808802|NCT01435902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64808803|NCT01435915|Ropinirole|ropinirole|mesh-list
64808804|NCT01435915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64808805|NCT01435915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64808806|NCT01435915|Dopamine Agonists|dopamine agonists|mesh-ancestor
64808807|NCT01435915|Dopamine Agents|dopamine agents|mesh-ancestor
64808808|NCT01435915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808809|NCT01435915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808810|NCT01435915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808811|NCT01435941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64808812|NCT01435941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64808813|NCT01435941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64808830|NCT01435954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808831|NCT01435954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808832|NCT01435954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808833|NCT01435954|Urological Agents|urological agents|mesh-ancestor
64808834|NCT01435954|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64808835|NCT01435954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64808861|NCT01436188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64808863|NCT01436188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808864|NCT01436422|Vaccines|vaccines|mesh-list
64808865|NCT01436422|Immunologic Factors|immunologic factors|mesh-ancestor
64808866|NCT01436422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808867|NCT01436474|Varenicline|varenicline|mesh-list
64808868|NCT01436474|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64808869|NCT01436474|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64808870|NCT01436474|Cholinergic Agents|cholinergic agents|mesh-ancestor
64808871|NCT01436474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808872|NCT01436474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285614|NCT00662610|Analgesics|analgesics|mesh-ancestor
65285615|NCT00662610|Sensory System Agents|sensory system agents|mesh-ancestor
65285616|NCT00662610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285617|NCT00662610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285618|NCT00662610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65285619|NCT00662610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65285620|NCT00662610|Gout Suppressants|gout suppressants|mesh-ancestor
65285621|NCT00662610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65285622|NCT00662610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285623|NCT00662610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285624|NCT00662610|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65285626|NCT04225325|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65285627|NCT04225325|Emtricitabine|emtricitabine|mesh-list
65285628|NCT04225325|Darunavir|darunavir|mesh-list
65285629|NCT04225325|Cobicistat|cobicistat|mesh-list
64515901|NCT01173172|Boron|boron|mesh-list
64808873|NCT01436474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419963|NCT04697719|Antipyretics|antipyretics|mesh-ancestor
64808903|NCT01436578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64808904|NCT01436578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808906|NCT01436825|Coagulants|coagulants|mesh-ancestor
64808907|NCT01436838|Interferons|interferons|mesh-list
64808908|NCT01436838|Interferon-beta|interferon-beta|mesh-list
64808909|NCT01436838|Interferon beta-1b|interferon beta-1b|mesh-list
64808910|NCT01436838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64808911|NCT01436838|Antiviral Agents|antiviral agents|mesh-ancestor
64808912|NCT01436838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64808913|NCT01436838|Immunologic Factors|immunologic factors|mesh-ancestor
64808914|NCT01436838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809052|NCT01437670|Urological Agents|urological agents|mesh-ancestor
64809053|NCT01437696|Vitamin D|vitamin d|mesh-list
64809054|NCT01437696|Ergocalciferols|ergocalciferols|mesh-list
64809055|NCT01437696|Cholecalciferol|cholecalciferol|mesh-list
64809056|NCT01437696|Vitamins|vitamins|mesh-list
64809092|NCT01437826|Protective Agents|protective agents|mesh-ancestor
64809093|NCT01437826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809094|NCT01437826|Trace Elements|trace elements|mesh-ancestor
64809155|NCT01438112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64809156|NCT01438112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809157|NCT01438112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64809158|NCT01438112|Immunologic Factors|immunologic factors|mesh-ancestor
64809159|NCT01438112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809160|NCT01438112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64809161|NCT01438112|Alkylating Agents|alkylating agents|mesh-ancestor
64809162|NCT01438112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64809163|NCT01438112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64809164|NCT01438112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64809165|NCT01438190|Metformin|metformin|mesh-list
64809166|NCT01438190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64809167|NCT01438190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809168|NCT01438320|Quercetin|quercetin|mesh-list
64809169|NCT01438320|Antioxidants|antioxidants|mesh-ancestor
64809170|NCT01438320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809171|NCT01438320|Protective Agents|protective agents|mesh-ancestor
64809172|NCT01438320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809173|NCT05554393|Cytarabine|cytarabine|mesh-list
64809174|NCT05554393|Azacitidine|azacitidine|mesh-list
64809175|NCT05554393|Daunorubicin|daunorubicin|mesh-list
64809176|NCT05554393|Venetoclax|venetoclax|mesh-list
64809177|NCT05554393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64809178|NCT05554393|Antimetabolites|antimetabolites|mesh-ancestor
64809179|NCT05554393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285630|NCT04225325|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65285631|NCT04225325|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65285632|NCT04225325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285633|NCT04225325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285634|NCT04225325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65285635|NCT04225325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65285636|NCT04225325|Antiviral Agents|antiviral agents|mesh-ancestor
65285637|NCT04225325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65285638|NCT04225325|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65285639|NCT04225325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65285640|NCT04225325|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64809180|NCT05554393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809181|NCT05554393|Antiviral Agents|antiviral agents|mesh-ancestor
64809182|NCT05554393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64809183|NCT05554393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64809184|NCT05554393|Immunologic Factors|immunologic factors|mesh-ancestor
64809185|NCT05554393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809186|NCT05554393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809187|NCT05554393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64809188|NCT05554393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64809189|NCT05554393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64809190|NCT05525013|Simvastatin|simvastatin|mesh-list
64809191|NCT05525013|Calcium|calcium|mesh-list
64809192|NCT05525013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64809193|NCT05525013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809194|NCT05525013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64809207|NCT05418088|Fludarabine|fludarabine|mesh-list
64809208|NCT05418088|Fludarabine phosphate|fludarabine phosphate|mesh-list
64809209|NCT05418088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64809210|NCT05418088|Immunologic Factors|immunologic factors|mesh-ancestor
64809211|NCT05418088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809212|NCT05418088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64809213|NCT05418088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64809214|NCT05418088|Alkylating Agents|alkylating agents|mesh-ancestor
64809215|NCT05418088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809216|NCT05418088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809217|NCT05418088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64809245|NCT05370794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809247|NCT05343507|Analgesics|analgesics|mesh-ancestor
64809248|NCT05343507|Sensory System Agents|sensory system agents|mesh-ancestor
64809249|NCT05343507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64809250|NCT05343507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809251|NCT05343507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64809252|NCT05343507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64809253|NCT05343507|Anesthetics, General|anesthetics, general|mesh-ancestor
64809254|NCT05343507|Anesthetics|anesthetics|mesh-ancestor
64809255|NCT05343507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64809276|NCT05213832|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64809277|NCT05213832|Anesthetics, General|anesthetics, general|mesh-ancestor
64809278|NCT05213832|Anesthetics|anesthetics|mesh-ancestor
64809279|NCT05213832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64809280|NCT05213832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809281|NCT05197439|Dexmedetomidine|dexmedetomidine|mesh-list
64809282|NCT05197439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64809283|NCT05197439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64809284|NCT05197439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809300|NCT05164159|Anesthetics, General|anesthetics, general|mesh-ancestor
64809301|NCT05164159|Anesthetics|anesthetics|mesh-ancestor
64809302|NCT05164146|Propofol|propofol|mesh-list
64809303|NCT05164146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64809304|NCT05164146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64809305|NCT05164146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285641|NCT04225325|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65285642|NCT04225325|Protease Inhibitors|protease inhibitors|mesh-ancestor
65285643|NCT04225325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65285644|NCT04225325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65285645|NCT00649610|Diclofenac|diclofenac|mesh-list
65285646|NCT00649610|Valdecoxib|valdecoxib|mesh-list
65285647|NCT00649610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65285648|NCT00649610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65285649|NCT00649610|Analgesics|analgesics|mesh-ancestor
65285650|NCT00649610|Sensory System Agents|sensory system agents|mesh-ancestor
65285651|NCT00649610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285652|NCT00649610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285653|NCT00649610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65285654|NCT00649610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65285655|NCT00649610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65285656|NCT00649610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285657|NCT00649610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285658|NCT00649610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65285659|NCT02655146|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65285660|NCT02655146|Progesterone|progesterone|mesh-list
65285661|NCT02655146|Estradiol|estradiol|mesh-list
65285662|NCT02655146|Progestins|progestins|mesh-ancestor
65285663|NCT02655146|Hormones|hormones|mesh-ancestor
65285664|NCT02655146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65285665|NCT02655146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285666|NCT02655146|Luteolytic Agents|luteolytic agents|mesh-ancestor
65285667|NCT02655146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64809336|NCT05060731|Trace Elements|trace elements|mesh-ancestor
64809337|NCT05060731|Micronutrients|micronutrients|mesh-ancestor
64809338|NCT05060731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809339|NCT04965298|Lansoprazole|lansoprazole|mesh-list
64809340|NCT04965298|Dexlansoprazole|dexlansoprazole|mesh-list
64809341|NCT04965298|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64809342|NCT04965298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64809343|NCT04965298|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64809344|NCT04965298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809345|NCT04965298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809346|NCT04956939|Levodopa|levodopa|mesh-list
64809347|NCT04956939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64809348|NCT04956939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64809349|NCT04956939|Dopamine Agents|dopamine agents|mesh-ancestor
64420454|NCT02554981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809362|NCT04955470|Anesthetics, General|anesthetics, general|mesh-ancestor
64809363|NCT04955470|Anesthetics|anesthetics|mesh-ancestor
64809364|NCT04955470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64809365|NCT04955470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64809366|NCT04955470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65285668|NCT02655146|Contraceptive Agents|contraceptive agents|mesh-ancestor
65285669|NCT02655146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65285670|NCT02655146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65285671|NCT02655146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65285672|NCT02655146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285673|NCT02655146|Estrogens|estrogens|mesh-ancestor
65285674|NCT02774525|Ethanol|ethanol|mesh-list
65285675|NCT02774525|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65285676|NCT02774525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65285677|NCT02774525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65285678|NCT02774525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285679|NCT04167566|Artemisinins|artemisinins|mesh-list
65285680|NCT04167566|Artemisinin|artemisinin|mesh-list
65285681|NCT04167566|Antimalarials|antimalarials|mesh-ancestor
65285682|NCT04167566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65285683|NCT04167566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65285684|NCT04167566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65285685|NCT00650624|Valdecoxib|valdecoxib|mesh-list
64515958|NCT03290820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64809367|NCT04955470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64809368|NCT04955470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809369|NCT04955470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65494116|NCT03386240|Antimetabolites|antimetabolites|mesh-ancestor
65494117|NCT03386240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494118|NCT03386240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65494119|NCT03366766|Gemcitabine|gemcitabine|mesh-list
64809402|NCT04922567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64809403|NCT04922567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64809474|NCT04660799|Cyclophosphamide|cyclophosphamide|mesh-list
64809476|NCT04660799|Doxorubicin|doxorubicin|mesh-list
64809477|NCT04660799|Vincristine|vincristine|mesh-list
64809478|NCT04660799|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
64809479|NCT04660799|Histamine Antagonists|histamine antagonists|mesh-list
64809480|NCT04660799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64809481|NCT04660799|Immunologic Factors|immunologic factors|mesh-ancestor
64809482|NCT04660799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809483|NCT04660799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64809484|NCT04660799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64809485|NCT04660799|Alkylating Agents|alkylating agents|mesh-ancestor
64809502|NCT04660799|Mitosis Modulators|mitosis modulators|mesh-ancestor
64809503|NCT04660799|Sensory System Agents|sensory system agents|mesh-ancestor
64809504|NCT04660799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64809505|NCT04660799|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64809506|NCT04660799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64809507|NCT04660799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64809508|NCT04660799|Anesthetics, Local|anesthetics, local|mesh-ancestor
64809509|NCT04660799|Anesthetics|anesthetics|mesh-ancestor
64809510|NCT04660799|Antiemetics|antiemetics|mesh-ancestor
64809511|NCT04660799|Autonomic Agents|autonomic agents|mesh-ancestor
64809512|NCT04660799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64809513|NCT04660799|Histamine Agents|histamine agents|mesh-ancestor
64809514|NCT04660799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64809515|NCT04660799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64809516|NCT04660799|Antipruritics|antipruritics|mesh-ancestor
64809517|NCT04660799|Dermatologic Agents|dermatologic agents|mesh-ancestor
64809518|NCT04636632|Fosaprepitant|fosaprepitant|mesh-list
64809519|NCT04636632|Aprepitant|aprepitant|mesh-list
64809520|NCT04636632|Antiemetics|antiemetics|mesh-ancestor
65285686|NCT00650624|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65285687|NCT00650624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65285688|NCT00650624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285689|NCT00650624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285690|NCT00650624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65285691|NCT00650624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65285692|NCT00650624|Analgesics|analgesics|mesh-ancestor
65285693|NCT00650624|Sensory System Agents|sensory system agents|mesh-ancestor
65285694|NCT00650624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285695|NCT00650624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285696|NCT00650624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65285697|NCT00650624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65285698|NCT00666354|Methotrexate|methotrexate|mesh-list
65285699|NCT00666354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65285700|NCT00666354|Abortifacient Agents|abortifacient agents|mesh-ancestor
65285701|NCT00666354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65285702|NCT00666354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285703|NCT00666354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65285704|NCT00666354|Antimetabolites|antimetabolites|mesh-ancestor
64809521|NCT04636632|Autonomic Agents|autonomic agents|mesh-ancestor
64809522|NCT04636632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64809523|NCT04636632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809524|NCT04636632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64809549|NCT04588688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64809550|NCT04588688|Luteolytic Agents|luteolytic agents|mesh-ancestor
64809551|NCT04588688|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64809552|NCT04588688|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64809553|NCT04585542|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64809554|NCT04585542|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
64809555|NCT04585542|Laxatives|laxatives|mesh-ancestor
64809556|NCT04585542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64809557|NCT04585542|Chelating Agents|chelating agents|mesh-ancestor
64809558|NCT04585542|Sequestering Agents|sequestering agents|mesh-ancestor
64809559|NCT04585542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809561|NCT04502602|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64809562|NCT04502602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809563|NCT04502602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809564|NCT04502602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809565|NCT04375202|Colchicine|colchicine|mesh-list
64809566|NCT04375202|Gout Suppressants|gout suppressants|mesh-ancestor
64485511|NCT00838162|TMC-310911|tmc-310911|mesh-list
64809606|NCT04322552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64809607|NCT04322552|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64809608|NCT04322552|Protective Agents|protective agents|mesh-ancestor
64809609|NCT04322552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809610|NCT04322305|Pregabalin|pregabalin|mesh-list
64809611|NCT04322305|Analgesics|analgesics|mesh-ancestor
64809612|NCT04322305|Sensory System Agents|sensory system agents|mesh-ancestor
64809613|NCT04322305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64809614|NCT04322305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809615|NCT04322305|Anticonvulsants|anticonvulsants|mesh-ancestor
64809616|NCT04322305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64809617|NCT04322305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65285705|NCT00666354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285706|NCT00666354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285707|NCT00666354|Dermatologic Agents|dermatologic agents|mesh-ancestor
65285708|NCT00666354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285709|NCT00666354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65285710|NCT00666354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65285711|NCT00666354|Immunologic Factors|immunologic factors|mesh-ancestor
65285712|NCT00666354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65285713|NCT00666354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65285714|NCT02774291|Aldesleukin|aldesleukin|mesh-list
65285715|NCT02774291|Cyclophosphamide|cyclophosphamide|mesh-list
65285716|NCT02774291|Fludarabine|fludarabine|mesh-list
65285717|NCT02774291|Fludarabine phosphate|fludarabine phosphate|mesh-list
65285718|NCT02774291|Interleukin-2|interleukin-2|mesh-list
65285719|NCT02774291|Lenograstim|lenograstim|mesh-list
65285720|NCT02774291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65285721|NCT02774291|Immunologic Factors|immunologic factors|mesh-ancestor
65285722|NCT02774291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285723|NCT02774291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65285724|NCT02774291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65285725|NCT02774291|Alkylating Agents|alkylating agents|mesh-ancestor
64809618|NCT04322305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809697|NCT03558724|Bevacizumab|bevacizumab|mesh-list
64809698|NCT03558724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64809699|NCT03558724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809700|NCT03558724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64809701|NCT03558724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64809702|NCT03558724|Growth Substances|growth substances|mesh-ancestor
64809703|NCT03558724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809704|NCT03558724|Growth Inhibitors|growth inhibitors|mesh-ancestor
64809726|NCT03495960|Abortifacient Agents|abortifacient agents|mesh-ancestor
64809727|NCT03495960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64809728|NCT03495960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64809741|NCT03495960|Alkylating Agents|alkylating agents|mesh-ancestor
64809743|NCT03416127|Propolis|propolis|mesh-list
64809744|NCT03416127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64809745|NCT03416127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809746|NCT03416127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64809747|NCT03322865|Obinutuzumab|obinutuzumab|mesh-list
64809748|NCT03322865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64809749|NCT03322865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809750|NCT03293069|Deferiprone|deferiprone|mesh-list
64809751|NCT03293069|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64809752|NCT03293069|Chelating Agents|chelating agents|mesh-ancestor
64809753|NCT03293069|Sequestering Agents|sequestering agents|mesh-ancestor
65494120|NCT03366766|Cisplatin|cisplatin|mesh-list
65494121|NCT03366766|Nivolumab|nivolumab|mesh-list
65494122|NCT03366766|Pemetrexed|pemetrexed|mesh-list
65494123|NCT03366766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809754|NCT03293069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809755|NCT03255018|Pembrolizumab|pembrolizumab|mesh-list
64809756|NCT03255018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64809757|NCT03255018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809758|NCT03250975|Azithromycin|azithromycin|mesh-list
65285726|NCT02774291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285727|NCT02774291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285728|NCT02774291|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65285729|NCT02774291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65285730|NCT02774291|Antimetabolites|antimetabolites|mesh-ancestor
65285731|NCT02774291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65285732|NCT02774291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65285733|NCT02774291|Analgesics|analgesics|mesh-ancestor
65285734|NCT02774291|Sensory System Agents|sensory system agents|mesh-ancestor
65285735|NCT02774291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285736|NCT02774291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65285737|NCT02774291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65285738|NCT02774291|Antiviral Agents|antiviral agents|mesh-ancestor
65285739|NCT02774291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65285740|NCT02536352|Vitamins|vitamins|mesh-list
65285741|NCT02536352|Fluorides|fluorides|mesh-list
65285742|NCT02536352|Micronutrients|micronutrients|mesh-ancestor
65285743|NCT02536352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285744|NCT02536352|Cariostatic Agents|cariostatic agents|mesh-ancestor
65285745|NCT02536352|Protective Agents|protective agents|mesh-ancestor
65285746|NCT02773979|Chloroquine|chloroquine|mesh-list
64809759|NCT03250975|Budesonide|budesonide|mesh-list
64809760|NCT03250975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64809761|NCT03250975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64809762|NCT03250975|Autonomic Agents|autonomic agents|mesh-ancestor
64809763|NCT03250975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64809764|NCT03250975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809765|NCT03250975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64809766|NCT03250975|Respiratory System Agents|respiratory system agents|mesh-ancestor
64578391|NCT00032591|Coagulants|coagulants|mesh-ancestor
64809767|NCT03250975|Glucocorticoids|glucocorticoids|mesh-ancestor
64809782|NCT03227731|Emtricitabine|emtricitabine|mesh-list
64809783|NCT03227731|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64809784|NCT03227731|Antiviral Agents|antiviral agents|mesh-ancestor
64809785|NCT03227731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64809786|NCT03227731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64809787|NCT03227731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64809788|NCT03227731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420873|NCT02305797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64809817|NCT02986334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809818|NCT02986334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64809819|NCT02986334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64809820|NCT02986334|Analgesics|analgesics|mesh-ancestor
64809821|NCT02986334|Sensory System Agents|sensory system agents|mesh-ancestor
64809822|NCT02986334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64809823|NCT02986334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809824|NCT02986334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64809825|NCT02986334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64809826|NCT02986334|Gout Suppressants|gout suppressants|mesh-ancestor
64809827|NCT02986334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64809828|NCT02668289|Anesthetics|anesthetics|mesh-list
64809829|NCT02668289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64809830|NCT02668289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809831|NCT02655315|Deferiprone|deferiprone|mesh-list
65285747|NCT02773979|Amebicides|amebicides|mesh-ancestor
65285748|NCT02773979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65285749|NCT02773979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65285750|NCT02773979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65285751|NCT02773979|Antimalarials|antimalarials|mesh-ancestor
65285752|NCT02773979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65285753|NCT00662844|Vitamin D|vitamin d|mesh-list
65285754|NCT00662844|Cholecalciferol|cholecalciferol|mesh-list
65285755|NCT00662844|Vitamins|vitamins|mesh-ancestor
65285756|NCT00662844|Micronutrients|micronutrients|mesh-ancestor
65285757|NCT00662844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285758|NCT00662844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65285759|NCT00662844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65285760|NCT02650544|Mirtazapine|mirtazapine|mesh-list
65285761|NCT02650544|Antidepressive Agents|antidepressive agents|mesh-ancestor
65285762|NCT02650544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65285763|NCT02650544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65285764|NCT02650544|Histamine Antagonists|histamine antagonists|mesh-ancestor
65285765|NCT02650544|Histamine Agents|histamine agents|mesh-ancestor
65285766|NCT02650544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65285767|NCT02650544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285768|NCT02650544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285769|NCT02650544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65285770|NCT02650544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65285771|NCT02650544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65285772|NCT02650544|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64809832|NCT02655315|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64809833|NCT02655315|Chelating Agents|chelating agents|mesh-ancestor
64809834|NCT02655315|Sequestering Agents|sequestering agents|mesh-ancestor
64809842|NCT02436733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809844|NCT02436733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64809845|NCT02426502|Cyclosporine|cyclosporine|mesh-list
64809846|NCT02426502|Mycophenolic Acid|mycophenolic acid|mesh-list
64809847|NCT02426502|Prednisone|prednisone|mesh-list
64809848|NCT02426502|Azathioprine|azathioprine|mesh-list
64809849|NCT02426502|Antihypertensive Agents|antihypertensive agents|mesh-list
64809850|NCT02426502|Cyclosporins|cyclosporins|mesh-list
64809851|NCT02426502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64809852|NCT02426502|Glucocorticoids|glucocorticoids|mesh-ancestor
64809853|NCT02426502|Hormones|hormones|mesh-ancestor
64809854|NCT02426502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64809855|NCT02426502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809856|NCT02426502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64809857|NCT02426502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809858|NCT02426502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809859|NCT02426502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809860|NCT02426502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64472207|NCT03699631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65285773|NCT02650544|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65285774|NCT02650544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65285775|NCT02650544|Adrenergic Agents|adrenergic agents|mesh-ancestor
65285776|NCT02650544|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65285777|NCT02650544|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65285778|NCT02650544|Serotonin Agents|serotonin agents|mesh-ancestor
65285779|NCT02650544|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65285780|NCT02650388|Chrysarobin|chrysarobin|mesh-list
64809861|NCT02426502|Immunologic Factors|immunologic factors|mesh-ancestor
64809889|NCT02067182|Protease Inhibitors|protease inhibitors|mesh-ancestor
64809890|NCT02067182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809891|NCT02067182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809892|NCT02067182|Anticoagulants|anticoagulants|mesh-ancestor
64809893|NCT01877837|Fludarabine|fludarabine|mesh-list
64809894|NCT01877837|Fludarabine phosphate|fludarabine phosphate|mesh-list
64809895|NCT01877837|Melphalan|melphalan|mesh-list
64809896|NCT01877837|Alemtuzumab|alemtuzumab|mesh-list
64809897|NCT01877837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809898|NCT01877837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64809899|NCT01877837|Antimetabolites|antimetabolites|mesh-ancestor
64809900|NCT01877837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809927|NCT01375764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809928|NCT01375764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64809929|NCT01375764|Immunologic Factors|immunologic factors|mesh-ancestor
64809930|NCT01375764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809932|NCT00523341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64809933|NCT00523341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809934|NCT00364013|Panitumumab|panitumumab|mesh-list
64809935|NCT00364013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64485762|NCT01718509|Dopamine Agents|dopamine agents|mesh-ancestor
64472214|NCT03686150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472215|NCT03686150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64472216|NCT03686150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64472218|NCT03678233|Androgens|androgens|mesh-ancestor
64809965|NCT01438515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64809966|NCT01438515|Disinfectants|disinfectants|mesh-ancestor
64809967|NCT01438515|Dermatologic Agents|dermatologic agents|mesh-ancestor
64809968|NCT01438515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64809969|NCT01438515|Antimalarials|antimalarials|mesh-ancestor
64809970|NCT01438515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64810000|NCT01438580|Aspirin|aspirin|mesh-list
64810001|NCT01438580|Warfarin|warfarin|mesh-list
64810002|NCT01438580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64810003|NCT01438580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64810004|NCT01438580|Analgesics|analgesics|mesh-ancestor
64810005|NCT01438580|Sensory System Agents|sensory system agents|mesh-ancestor
64810006|NCT01438580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64810007|NCT01438580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810008|NCT01438580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64810009|NCT01438580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64810010|NCT01438580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64810011|NCT01438580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64810012|NCT01438580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810013|NCT01438580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64810046|NCT01438749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64810048|NCT01438749|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64810049|NCT01438749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64810050|NCT01438749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64810051|NCT01438749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64810052|NCT01438749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64810053|NCT01438749|Anesthetics, General|anesthetics, general|mesh-ancestor
64810054|NCT01438749|Anesthetics|anesthetics|mesh-ancestor
64810055|NCT01438749|GABA Modulators|gaba modulators|mesh-ancestor
64810056|NCT01438749|GABA Agents|gaba agents|mesh-ancestor
64810057|NCT01438749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64810058|NCT01438749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810059|NCT01438866|Fluorides|fluorides|mesh-list
65285781|NCT02650388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65285782|NCT02650388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65285783|NCT02650388|Analgesics|analgesics|mesh-ancestor
65285784|NCT02650388|Sensory System Agents|sensory system agents|mesh-ancestor
65285785|NCT02650388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285786|NCT02650388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285787|NCT02650388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65285788|NCT02650388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65285789|NCT00883740|Pregabalin|pregabalin|mesh-list
65285790|NCT00883740|Analgesics|analgesics|mesh-ancestor
65285791|NCT00883740|Sensory System Agents|sensory system agents|mesh-ancestor
65285792|NCT00883740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285793|NCT00883740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285794|NCT00883740|Anticonvulsants|anticonvulsants|mesh-ancestor
65285795|NCT00883740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65285796|NCT00883740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65285797|NCT00883740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285798|NCT00883740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65285799|NCT00883740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65285800|NCT00883740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65285801|NCT00883740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65285802|NCT00883740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65285803|NCT04183712|Gemcitabine|gemcitabine|mesh-list
65285804|NCT04183712|Oxaliplatin|oxaliplatin|mesh-list
65285805|NCT04183712|Afatinib|afatinib|mesh-list
65285806|NCT04183712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65285807|NCT04183712|Antimetabolites|antimetabolites|mesh-ancestor
64516063|NCT02006056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64810060|NCT01438866|Sodium Fluoride|sodium fluoride|mesh-list
64810061|NCT01438866|Fluorides, Topical|fluorides, topical|mesh-list
64810062|NCT01438866|Cariostatic Agents|cariostatic agents|mesh-ancestor
64810063|NCT01438866|Protective Agents|protective agents|mesh-ancestor
64810064|NCT01438866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810065|NCT01438944|Nicotine|nicotine|mesh-list
64810066|NCT01438944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64810067|NCT01438944|Autonomic Agents|autonomic agents|mesh-ancestor
64810068|NCT01438944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64810069|NCT01438944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810087|NCT01439152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64810088|NCT01439152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810089|NCT01439152|Tubulin Modulators|tubulin modulators|mesh-ancestor
64810090|NCT01439152|Antimitotic Agents|antimitotic agents|mesh-ancestor
64810091|NCT01439152|Mitosis Modulators|mitosis modulators|mesh-ancestor
64810092|NCT01439152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810093|NCT01439152|Immunologic Factors|immunologic factors|mesh-ancestor
64810094|NCT01439152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285808|NCT04183712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285809|NCT04183712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285810|NCT04183712|Antiviral Agents|antiviral agents|mesh-ancestor
65285811|NCT04183712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65285812|NCT04183712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285813|NCT04183712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65285814|NCT04183712|Immunologic Factors|immunologic factors|mesh-ancestor
65285815|NCT04183712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285816|NCT04183712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65285817|NCT02773199|Bupivacaine|bupivacaine|mesh-list
65285818|NCT02773199|Anesthetics, Local|anesthetics, local|mesh-ancestor
65285819|NCT02773199|Anesthetics|anesthetics|mesh-ancestor
65285820|NCT02773199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65285821|NCT02773199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285822|NCT02773199|Sensory System Agents|sensory system agents|mesh-ancestor
65285823|NCT02773199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285824|NCT02654834|Nitrous Oxide|nitrous oxide|mesh-list
65285825|NCT02654834|Anesthetics|anesthetics|mesh-list
65285826|NCT02654834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65285827|NCT02654834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285828|NCT02654834|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65285829|NCT02654834|Anesthetics, General|anesthetics, general|mesh-ancestor
65285830|NCT02654834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65285831|NCT02654834|Analgesics|analgesics|mesh-ancestor
65285832|NCT02654834|Sensory System Agents|sensory system agents|mesh-ancestor
65285833|NCT02654834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64810095|NCT01439178|Bevacizumab|bevacizumab|mesh-list
64810105|NCT01439191|Immunologic Factors|immunologic factors|mesh-ancestor
64810106|NCT01439191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810107|NCT01439191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64810108|NCT01439191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810109|NCT01439191|Tubulin Modulators|tubulin modulators|mesh-ancestor
64810110|NCT01439191|Antimitotic Agents|antimitotic agents|mesh-ancestor
64810111|NCT01439191|Mitosis Modulators|mitosis modulators|mesh-ancestor
64810112|NCT01439191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810113|NCT01439230|Donepezil|donepezil|mesh-list
64810114|NCT01439230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64810115|NCT01439230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810116|NCT01439230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810117|NCT01439230|Cholinergic Agents|cholinergic agents|mesh-ancestor
64810118|NCT01439230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64810119|NCT01439230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810120|NCT01439230|Nootropic Agents|nootropic agents|mesh-ancestor
64810121|NCT01439243|Donepezil|donepezil|mesh-list
64810122|NCT01439243|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64810123|NCT01439243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810124|NCT01439243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810125|NCT01439243|Cholinergic Agents|cholinergic agents|mesh-ancestor
65285834|NCT00656526|Lidocaine|lidocaine|mesh-list
65285835|NCT00656526|Anesthetics, Local|anesthetics, local|mesh-ancestor
65285836|NCT00656526|Anesthetics|anesthetics|mesh-ancestor
65285837|NCT00656526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65285838|NCT00656526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285839|NCT00656526|Sensory System Agents|sensory system agents|mesh-ancestor
65285840|NCT00656526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285841|NCT00656526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65285842|NCT00656526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65285843|NCT00656526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65285844|NCT00656526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65285845|NCT00656526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285846|NCT02765009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65285848|NCT02765009|Bumetanide|bumetanide|mesh-list
65285849|NCT02765009|Diuretics|diuretics|mesh-list
65285850|NCT02765009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65285851|NCT02765009|Natriuretic Agents|natriuretic agents|mesh-ancestor
65285852|NCT02765009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285853|NCT02765009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64516117|NCT03294252|Folic Acid|folic acid|mesh-list
64810126|NCT01439243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64810127|NCT01439243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810128|NCT01439243|Nootropic Agents|nootropic agents|mesh-ancestor
64810129|NCT01439399|Lidocaine|lidocaine|mesh-list
64810130|NCT01439399|Ketamine|ketamine|mesh-list
65494134|NCT03366766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65494135|NCT03366766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64472220|NCT03678233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64472221|NCT03678233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472222|NCT03666273|Pembrolizumab|pembrolizumab|mesh-list
64472223|NCT03666273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64472224|NCT03666273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472225|NCT03629327|Aspirin|aspirin|mesh-list
64472226|NCT03629327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64472227|NCT03629327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64472228|NCT03629327|Analgesics|analgesics|mesh-ancestor
64472229|NCT03629327|Sensory System Agents|sensory system agents|mesh-ancestor
64472230|NCT03629327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64472231|NCT03629327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472232|NCT03629327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64472261|NCT03610061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64810141|NCT01439399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810142|NCT01439399|Analgesics|analgesics|mesh-ancestor
64810143|NCT01439399|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64810144|NCT01439399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64810145|NCT01439399|Anesthetics, General|anesthetics, general|mesh-ancestor
64810146|NCT01439399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64810147|NCT01439399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64810148|NCT01439399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64810149|NCT01439438|Topiramate|topiramate|mesh-list
64810150|NCT01439438|Anticonvulsants|anticonvulsants|mesh-ancestor
64810151|NCT01439438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64810152|NCT01439438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810153|NCT01439542|Hormones|hormones|mesh-list
65285854|NCT02765009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65285855|NCT02765009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285856|NCT02765009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65285857|NCT02649920|Dinoprostone|dinoprostone|mesh-list
65285858|NCT02649920|Oxytocics|oxytocics|mesh-ancestor
65285859|NCT02649920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65285860|NCT02649920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285861|NCT00649688|Metoprolol|metoprolol|mesh-list
65285862|NCT00649688|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65285863|NCT00649688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65285864|NCT00649688|Diuretics|diuretics|mesh-ancestor
65285865|NCT00649688|Natriuretic Agents|natriuretic agents|mesh-ancestor
65285866|NCT00649688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285867|NCT00649688|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65285868|NCT00649688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65285869|NCT00649688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285870|NCT00649688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65285871|NCT00649688|Sympatholytics|sympatholytics|mesh-ancestor
65285872|NCT00649688|Autonomic Agents|autonomic agents|mesh-ancestor
65285873|NCT00649688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285874|NCT00649688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65285875|NCT00649688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65285876|NCT00649688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65285877|NCT00649688|Adrenergic Agents|adrenergic agents|mesh-ancestor
65285878|NCT00649688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65285879|NCT00667056|Tacrolimus|tacrolimus|mesh-list
65285880|NCT00667056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65285881|NCT00667056|Immunologic Factors|immunologic factors|mesh-ancestor
65285882|NCT00667056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285883|NCT00667056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65285884|NCT00667056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285885|NCT00667056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285886|NCT02764619|Spironolactone|spironolactone|mesh-list
65285887|NCT02764619|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65285888|NCT02764619|Hormone Antagonists|hormone antagonists|mesh-ancestor
65285889|NCT02764619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65285890|NCT02764619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285891|NCT02764619|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65285892|NCT02764619|Diuretics|diuretics|mesh-ancestor
65285893|NCT02764619|Natriuretic Agents|natriuretic agents|mesh-ancestor
65285894|NCT04032210|Zinc|zinc|mesh-list
65285895|NCT04032210|Fluorides|fluorides|mesh-list
65285896|NCT04032210|Cariostatic Agents|cariostatic agents|mesh-ancestor
65285897|NCT04032210|Protective Agents|protective agents|mesh-ancestor
65285898|NCT04032210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285899|NCT04032210|Trace Elements|trace elements|mesh-ancestor
65285900|NCT04032210|Micronutrients|micronutrients|mesh-ancestor
65285901|NCT04223219|Magnesium Sulfate|magnesium sulfate|mesh-list
65285902|NCT04223219|Fentanyl|fentanyl|mesh-list
64810154|NCT01439542|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64810168|NCT01439984|Antidepressive Agents|antidepressive agents|mesh-ancestor
64810169|NCT01439984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64810170|NCT01439984|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64810171|NCT01439984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64810172|NCT01439984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64810173|NCT01439984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810174|NCT01439984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64810175|NCT01439984|Serotonin Agents|serotonin agents|mesh-ancestor
64810176|NCT01439984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810177|NCT01440062|Vitamin D|vitamin d|mesh-list
64810178|NCT01440062|Ergocalciferols|ergocalciferols|mesh-list
64810179|NCT01440062|Cholecalciferol|cholecalciferol|mesh-list
64810180|NCT01440062|Vitamins|vitamins|mesh-list
64810181|NCT01440062|Micronutrients|micronutrients|mesh-ancestor
64810182|NCT01440062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810183|NCT01440062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64810184|NCT01440062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65494136|NCT03366766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65494137|NCT03308448|Epoetin Alfa|epoetin alfa|mesh-list
65494138|NCT03308448|Hematinics|hematinics|mesh-ancestor
65494139|NCT03299309|Vaccines|vaccines|mesh-list
65494140|NCT03299309|Immunologic Factors|immunologic factors|mesh-ancestor
65494141|NCT03299309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494142|NCT03254927|Cetuximab|cetuximab|mesh-list
65494143|NCT03254927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65494144|NCT03254927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494145|NCT03181100|Paclitaxel|paclitaxel|mesh-list
65494146|NCT03181100|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65494147|NCT03181100|Bevacizumab|bevacizumab|mesh-list
65494148|NCT03181100|Atezolizumab|atezolizumab|mesh-list
65494149|NCT03181100|Vemurafenib|vemurafenib|mesh-list
65494150|NCT03181100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65494151|NCT03181100|Endothelial Growth Factors|endothelial growth factors|mesh-list
65494152|NCT03181100|Antibodies|antibodies|mesh-list
64472262|NCT03610061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472296|NCT03606642|Clopidogrel|clopidogrel|mesh-list
64472297|NCT03606642|Ticagrelor|ticagrelor|mesh-list
64472298|NCT03606642|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64472299|NCT03606642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472300|NCT03606642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472301|NCT03606642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64472302|NCT03606642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64472303|NCT03606642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64472304|NCT03606642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64472305|NCT03606642|Purinergic Agents|purinergic agents|mesh-ancestor
64472306|NCT03606642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64472307|NCT03564691|Paclitaxel|paclitaxel|mesh-list
64472308|NCT03564691|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65285903|NCT04223219|Dexmedetomidine|dexmedetomidine|mesh-list
65285904|NCT04223219|Ketamine|ketamine|mesh-list
65285905|NCT04223219|Propofol|propofol|mesh-list
65285906|NCT04223219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65285907|NCT04223219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65285908|NCT04223219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285909|NCT04223219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65285910|NCT04223219|Anesthetics, General|anesthetics, general|mesh-ancestor
65285911|NCT04223219|Anesthetics|anesthetics|mesh-ancestor
65285912|NCT04223219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65285913|NCT04223219|Analgesics|analgesics|mesh-ancestor
65285914|NCT04223219|Sensory System Agents|sensory system agents|mesh-ancestor
65285915|NCT04223219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285916|NCT04223219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65285917|NCT04223219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65285918|NCT04223219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65285919|NCT04223219|Adrenergic Agents|adrenergic agents|mesh-ancestor
64516191|NCT02314546|Lidocaine|lidocaine|mesh-list
64472309|NCT03564691|Cisplatin|cisplatin|mesh-list
64472310|NCT03564691|Carboplatin|carboplatin|mesh-list
64810214|NCT01440309|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64810215|NCT01440309|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64810216|NCT01440309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64810217|NCT01440335|Fenoterol|fenoterol|mesh-list
64810218|NCT01440335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64810219|NCT01440335|Autonomic Agents|autonomic agents|mesh-ancestor
64810220|NCT01440335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64810221|NCT01440335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810222|NCT01440335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64810223|NCT01440335|Respiratory System Agents|respiratory system agents|mesh-ancestor
64810224|NCT01440335|Sympathomimetics|sympathomimetics|mesh-ancestor
64810225|NCT01440335|Tocolytic Agents|tocolytic agents|mesh-ancestor
64810226|NCT01440335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64810227|NCT01440335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64810228|NCT01440335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64810229|NCT01440335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65494153|NCT03181100|Immunoglobulins|immunoglobulins|mesh-list
65494154|NCT03181100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65494155|NCT03181100|Immunoglobulin G|immunoglobulin g|mesh-list
65494156|NCT03181100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65494157|NCT03181100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494158|NCT03181100|Tubulin Modulators|tubulin modulators|mesh-ancestor
65494159|NCT03181100|Antimitotic Agents|antimitotic agents|mesh-ancestor
65494160|NCT03181100|Mitosis Modulators|mitosis modulators|mesh-ancestor
65494161|NCT03181100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494162|NCT03181100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65494163|NCT03181100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65494164|NCT03181100|Growth Substances|growth substances|mesh-ancestor
65494165|NCT03181100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494166|NCT03181100|Growth Inhibitors|growth inhibitors|mesh-ancestor
65494167|NCT03181100|Immunologic Factors|immunologic factors|mesh-ancestor
65494168|NCT03181100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65494169|NCT03181100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472323|NCT03564691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64472324|NCT03564691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64472325|NCT03559192|Aticaprant|aticaprant|mesh-list
64472327|NCT03559192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472328|NCT03559192|Sensory System Agents|sensory system agents|mesh-ancestor
64810230|NCT01440335|Adrenergic Agents|adrenergic agents|mesh-ancestor
65285920|NCT04223219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65285921|NCT04223219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285922|NCT04223219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65285923|NCT04223219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65285924|NCT04223219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65285925|NCT04223219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65285926|NCT04223219|Narcotics|narcotics|mesh-ancestor
65285927|NCT04223219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65285928|NCT04223219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65285929|NCT04223219|Anticonvulsants|anticonvulsants|mesh-ancestor
65285930|NCT04223219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64516208|NCT02314546|Sensory System Agents|sensory system agents|mesh-ancestor
64810231|NCT01440335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64810232|NCT01440335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810233|NCT01440361|Belimumab|belimumab|mesh-list
64810234|NCT01440361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64810235|NCT01440361|Immunologic Factors|immunologic factors|mesh-ancestor
64810236|NCT01440361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810237|NCT01440400|Anesthetics|anesthetics|mesh-list
64810238|NCT01440400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64810239|NCT01440400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810240|NCT01440439|Insulin|insulin|mesh-list
64810241|NCT01440439|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64810242|NCT01440439|Insulin Glargine|insulin glargine|mesh-list
64810243|NCT01440439|Insulin Detemir|insulin detemir|mesh-list
64810244|NCT01440439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64810245|NCT01440439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810246|NCT01440582|Dexamethasone|dexamethasone|mesh-list
64810247|NCT01440582|Lenalidomide|lenalidomide|mesh-list
64810248|NCT01440582|Bortezomib|bortezomib|mesh-list
64810249|NCT01440582|Panobinostat|panobinostat|mesh-list
64810250|NCT01440582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64810251|NCT01440582|Antiemetics|antiemetics|mesh-ancestor
64810252|NCT01440582|Autonomic Agents|autonomic agents|mesh-ancestor
64810253|NCT01440582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64810254|NCT01440582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810255|NCT01440582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64810264|NCT01440582|Growth Substances|growth substances|mesh-ancestor
64810265|NCT01440582|Growth Inhibitors|growth inhibitors|mesh-ancestor
64810266|NCT01440582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64810267|NCT01440582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810268|NCT01440582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810269|NCT01440608|Albendazole|albendazole|mesh-list
64810270|NCT01440608|Anthelmintics|anthelmintics|mesh-ancestor
64810271|NCT01440608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64810272|NCT01440608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64810273|NCT01440608|Anticestodal Agents|anticestodal agents|mesh-ancestor
64810274|NCT01440608|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64810275|NCT01440608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64810276|NCT01440608|Tubulin Modulators|tubulin modulators|mesh-ancestor
64810277|NCT01440608|Antimitotic Agents|antimitotic agents|mesh-ancestor
64810278|NCT01440608|Mitosis Modulators|mitosis modulators|mesh-ancestor
64810279|NCT01440608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810280|NCT01440608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810281|NCT01440621|Pyridoxine|pyridoxine|mesh-list
64810282|NCT01440621|Modafinil|modafinil|mesh-list
64810283|NCT01440621|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64810284|NCT01440621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810285|NCT01440621|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64486126|NCT01713283|Sofosbuvir|sofosbuvir|mesh-list
65494185|NCT03039036|Abortifacient Agents|abortifacient agents|mesh-ancestor
64472329|NCT03559192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64472330|NCT03530124|Vaccines|vaccines|mesh-list
64810290|NCT01440621|Vitamins|vitamins|mesh-ancestor
65285931|NCT04223219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65285932|NCT04223219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65285933|NCT04223219|Tocolytic Agents|tocolytic agents|mesh-ancestor
65285934|NCT04223219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65285935|NCT02631252|Hydroxychloroquine|hydroxychloroquine|mesh-list
65285936|NCT02631252|Etoposide|etoposide|mesh-list
65285937|NCT02631252|Mitoxantrone|mitoxantrone|mesh-list
65285938|NCT02631252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65285939|NCT02631252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285940|NCT02631252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65285941|NCT02631252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65285942|NCT02631252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285943|NCT02631252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285944|NCT02631252|Antimalarials|antimalarials|mesh-ancestor
65285945|NCT02631252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65285946|NCT02631252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65285947|NCT02631252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64516220|NCT03289182|Rituximab|rituximab|mesh-list
64516221|NCT03289182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64516222|NCT03289182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410508|NCT05597839|Nivolumab|nivolumab|mesh-list
64810291|NCT01440621|Micronutrients|micronutrients|mesh-ancestor
64810292|NCT01440673|Aprepitant|aprepitant|mesh-list
64810293|NCT01440673|Antiemetics|antiemetics|mesh-ancestor
64810294|NCT01440673|Autonomic Agents|autonomic agents|mesh-ancestor
64810295|NCT01440673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64810296|NCT01440673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810297|NCT01440673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64810298|NCT01440673|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64810299|NCT01440673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64810300|NCT01440673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810302|NCT01440725|Mitosis Modulators|mitosis modulators|mesh-ancestor
64810303|NCT01440725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810304|NCT01440751|Mitomycins|mitomycins|mesh-list
64810305|NCT01440751|Mitomycin|mitomycin|mesh-list
64810306|NCT01440751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64810307|NCT01440751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810308|NCT01440751|Alkylating Agents|alkylating agents|mesh-ancestor
64810309|NCT01440751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810310|NCT01440751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64810311|NCT01440751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810312|NCT01440790|Vitamins|vitamins|mesh-list
64810313|NCT01440790|Ascorbic Acid|ascorbic acid|mesh-list
64810314|NCT01440790|Micronutrients|micronutrients|mesh-ancestor
64810315|NCT01440790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810316|NCT01440790|Antioxidants|antioxidants|mesh-ancestor
64810317|NCT01440790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810318|NCT01440790|Protective Agents|protective agents|mesh-ancestor
64810319|NCT01440829|N-Methylaspartate|n-methylaspartate|mesh-list
64810320|NCT01440829|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
64810321|NCT01440829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64810322|NCT01440829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64810346|NCT01440985|Autonomic Agents|autonomic agents|mesh-ancestor
64810347|NCT01440985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285948|NCT02631252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65285949|NCT02631252|Analgesics|analgesics|mesh-ancestor
65285950|NCT02631252|Sensory System Agents|sensory system agents|mesh-ancestor
65285951|NCT02631252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65285952|NCT02631252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285953|NCT02631408|Vancomycin|vancomycin|mesh-list
65285954|NCT02631408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65285955|NCT02631408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65285956|NCT02630394|Azithromycin|azithromycin|mesh-list
65285957|NCT02630394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65285958|NCT02630394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65285959|NCT04629443|Azacitidine|azacitidine|mesh-list
65285960|NCT04629443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65285961|NCT04629443|Antimetabolites|antimetabolites|mesh-ancestor
64516244|NCT02460510|Mannitol|mannitol|mesh-list
64810348|NCT01440985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810349|NCT01440985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64810350|NCT01440985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64810351|NCT01440985|Cholinergic Agents|cholinergic agents|mesh-ancestor
64810352|NCT01440985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64810353|NCT01440985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810355|NCT01440998|Carboplatin|carboplatin|mesh-list
64810365|NCT01440998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810366|NCT01441128|Crizotinib|crizotinib|mesh-list
64578994|NCT05286619|Antimetabolites|antimetabolites|mesh-ancestor
64810367|NCT01441128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810368|NCT01441128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64810369|NCT01441128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810370|NCT01441128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810371|NCT01441193|Vaccines|vaccines|mesh-list
64810402|NCT01441284|Antioxidants|antioxidants|mesh-ancestor
64810403|NCT01441284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810404|NCT01441284|Protective Agents|protective agents|mesh-ancestor
64810405|NCT01441284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810406|NCT01441284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64810407|NCT01441284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64810408|NCT01441284|Dopamine Agonists|dopamine agonists|mesh-ancestor
64810440|NCT01441505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810441|NCT01441505|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64810442|NCT01441505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64810443|NCT01441505|Anesthetics, General|anesthetics, general|mesh-ancestor
64810444|NCT01441505|Anesthetics|anesthetics|mesh-ancestor
64810445|NCT01441505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65494186|NCT03039036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65494187|NCT03039036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472331|NCT03530124|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64472333|NCT03530124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472335|NCT03527043|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64472336|NCT03527043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64472337|NCT03527043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64472338|NCT03527043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810446|NCT01441505|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64810447|NCT01441505|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64810448|NCT01441505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64810449|NCT01441505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810450|NCT01441505|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64810451|NCT01441505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64810452|NCT01441505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64810453|NCT01441505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64810454|NCT01441505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65285962|NCT04629443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285963|NCT04629443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65285964|NCT04629443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285965|NCT02771405|Ribavirin|ribavirin|mesh-list
65285966|NCT02771405|Sofosbuvir|sofosbuvir|mesh-list
65285967|NCT02771405|Simeprevir|simeprevir|mesh-list
65285968|NCT02771405|Ledipasvir|ledipasvir|mesh-list
64810489|NCT01441804|Immunologic Factors|immunologic factors|mesh-ancestor
64810490|NCT01441804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810491|NCT01441869|Metformin|metformin|mesh-list
64810492|NCT01441869|Saxagliptin|saxagliptin|mesh-list
64810493|NCT01441869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64810494|NCT01441869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810498|NCT01441869|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64810499|NCT01441869|Protease Inhibitors|protease inhibitors|mesh-ancestor
64810500|NCT01441869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810501|NCT01441869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810502|NCT01441908|Pravastatin|pravastatin|mesh-list
64810503|NCT01441908|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64810504|NCT01441908|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64810505|NCT01441908|Antimetabolites|antimetabolites|mesh-ancestor
64810506|NCT01441908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810507|NCT01441908|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64810522|NCT01441986|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64810524|NCT01441986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810525|NCT01441986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810526|NCT01441986|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64810527|NCT01441986|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64810528|NCT01441986|Antiviral Agents|antiviral agents|mesh-ancestor
64810529|NCT01441986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64810530|NCT01441986|Dopamine Agents|dopamine agents|mesh-ancestor
64810531|NCT01441986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64810532|NCT01441986|Analgesics|analgesics|mesh-ancestor
64810533|NCT01441986|Sensory System Agents|sensory system agents|mesh-ancestor
64810534|NCT01441986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64810535|NCT01442025|Infliximab|infliximab|mesh-list
64810536|NCT01442025|Dermatologic Agents|dermatologic agents|mesh-ancestor
64810537|NCT01442025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64810538|NCT01442025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64810539|NCT01442168|Atovaquone|atovaquone|mesh-list
64810540|NCT01442168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494188|NCT03039036|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65494189|NCT03039036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65494190|NCT03039036|Oxytocics|oxytocics|mesh-ancestor
65494191|NCT03025880|Gemcitabine|gemcitabine|mesh-list
65494192|NCT03025880|Pembrolizumab|pembrolizumab|mesh-list
65494193|NCT03025880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65494194|NCT03025880|Antimetabolites|antimetabolites|mesh-ancestor
65494195|NCT03025880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472339|NCT03527043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64472340|NCT03527043|Serotonin Agents|serotonin agents|mesh-ancestor
64472341|NCT03527043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472342|NCT03527043|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64472343|NCT03527043|Antidepressive Agents|antidepressive agents|mesh-ancestor
64472344|NCT03527043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64472345|NCT03521154|Osimertinib|osimertinib|mesh-list
64472346|NCT03521154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472347|NCT03521154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64472348|NCT03521154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472349|NCT03521154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472350|NCT03505723|Tranexamic Acid|tranexamic acid|mesh-list
64472351|NCT03505723|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64472352|NCT03505723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64810541|NCT01442168|Antimalarials|antimalarials|mesh-ancestor
64810542|NCT01442168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64810543|NCT01442168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64810544|NCT01442168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810563|NCT01442428|Dexamethasone|dexamethasone|mesh-list
64810564|NCT01442428|Naproxen|naproxen|mesh-list
64810565|NCT01442428|Atorvastatin|atorvastatin|mesh-list
65285969|NCT02771405|Antimetabolites|antimetabolites|mesh-ancestor
65285970|NCT02771405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285971|NCT02771405|Antiviral Agents|antiviral agents|mesh-ancestor
65285972|NCT02771405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65285973|NCT02771405|Protease Inhibitors|protease inhibitors|mesh-ancestor
65285974|NCT02771405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65285975|NCT00667758|Cetrorelix|cetrorelix|mesh-list
65285976|NCT00667758|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65285977|NCT00667758|Fertility Agents|fertility agents|mesh-ancestor
65285978|NCT00667758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65285979|NCT00667758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810566|NCT01442428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64810583|NCT01442428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810584|NCT01442428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64810585|NCT01442428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64810586|NCT01442428|Analgesics|analgesics|mesh-ancestor
64810587|NCT01442428|Sensory System Agents|sensory system agents|mesh-ancestor
64810588|NCT01442428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64810589|NCT01442428|Gout Suppressants|gout suppressants|mesh-ancestor
64810590|NCT01442428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64810592|NCT01442519|Mitomycin|mitomycin|mesh-list
64810593|NCT01442519|BCG Vaccine|bcg vaccine|mesh-list
64810594|NCT01442519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64810595|NCT01442519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810596|NCT01442519|Alkylating Agents|alkylating agents|mesh-ancestor
64810597|NCT01442519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810598|NCT01442519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64810599|NCT01442519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810600|NCT01442519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64810601|NCT01442519|Immunologic Factors|immunologic factors|mesh-ancestor
64810602|NCT01442519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810603|NCT01442532|Midazolam|midazolam|mesh-list
64810604|NCT01442532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65494196|NCT03025880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494197|NCT03025880|Antiviral Agents|antiviral agents|mesh-ancestor
65494198|NCT03025880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494199|NCT03025880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494200|NCT03025880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65494201|NCT03025880|Immunologic Factors|immunologic factors|mesh-ancestor
65494202|NCT03025880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494203|NCT03025880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65494204|NCT02962297|Vitamin E|vitamin e|mesh-list
65494205|NCT02962297|Vitamins|vitamins|mesh-ancestor
65494206|NCT02962297|Micronutrients|micronutrients|mesh-ancestor
65494207|NCT02962297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494208|NCT02962297|Antioxidants|antioxidants|mesh-ancestor
65494209|NCT02962297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494210|NCT02962297|Protective Agents|protective agents|mesh-ancestor
64810605|NCT01442532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64810654|NCT01442701|Antimetabolites|antimetabolites|mesh-ancestor
64810655|NCT01442701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810656|NCT01442701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64810657|NCT01442727|Selenium|selenium|mesh-list
64810658|NCT01442727|Selenious Acid|selenious acid|mesh-list
64810659|NCT01442727|Sodium Selenite|sodium selenite|mesh-list
64810660|NCT01442727|Antioxidants|antioxidants|mesh-ancestor
64810661|NCT01442727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810662|NCT01442727|Protective Agents|protective agents|mesh-ancestor
64810663|NCT01442727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810664|NCT01442727|Trace Elements|trace elements|mesh-ancestor
64810665|NCT01442727|Micronutrients|micronutrients|mesh-ancestor
64810666|NCT01442766|Donepezil|donepezil|mesh-list
64810667|NCT01442766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64810668|NCT01442766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810669|NCT01442766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285980|NCT00667758|Hormone Antagonists|hormone antagonists|mesh-ancestor
65285981|NCT00667758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65285982|NCT00542815|Sevelamer|sevelamer|mesh-list
65285983|NCT00542815|Chelating Agents|chelating agents|mesh-ancestor
65285984|NCT00542815|Sequestering Agents|sequestering agents|mesh-ancestor
64810670|NCT01442766|Cholinergic Agents|cholinergic agents|mesh-ancestor
64810671|NCT01442766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64810672|NCT01442766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810687|NCT01442909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810688|NCT01442909|Tubulin Modulators|tubulin modulators|mesh-ancestor
64810689|NCT01442909|Antimitotic Agents|antimitotic agents|mesh-ancestor
64810690|NCT01442909|Mitosis Modulators|mitosis modulators|mesh-ancestor
64810691|NCT01442909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810692|NCT01442909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810693|NCT01442909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64810694|NCT01442909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64810696|NCT01442935|Folic Acid|folic acid|mesh-list
64810697|NCT01442935|Bevacizumab|bevacizumab|mesh-list
64810719|NCT01442935|Hematinics|hematinics|mesh-ancestor
64810720|NCT01442935|Antimetabolites|antimetabolites|mesh-ancestor
64810721|NCT01442935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64810722|NCT01442935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64810723|NCT01442935|Immunologic Factors|immunologic factors|mesh-ancestor
64810724|NCT01442974|Gemcitabine|gemcitabine|mesh-list
64810725|NCT01442974|Paclitaxel|paclitaxel|mesh-list
64810726|NCT01442974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64810727|NCT01442974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810728|NCT01442974|Tubulin Modulators|tubulin modulators|mesh-ancestor
64810729|NCT01442974|Antimitotic Agents|antimitotic agents|mesh-ancestor
64810730|NCT01442974|Mitosis Modulators|mitosis modulators|mesh-ancestor
64810731|NCT01442974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810732|NCT01442974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64810733|NCT01442974|Antimetabolites|antimetabolites|mesh-ancestor
64810734|NCT01442974|Antiviral Agents|antiviral agents|mesh-ancestor
64810735|NCT01442974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64810736|NCT01442974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810737|NCT01442974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64810769|NCT01443065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810770|NCT01443065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64810771|NCT01443065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64810772|NCT01443065|Immunologic Factors|immunologic factors|mesh-ancestor
64810774|NCT01443104|Everolimus|everolimus|mesh-list
64810775|NCT01443104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810776|NCT01443104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64810777|NCT01443104|Immunologic Factors|immunologic factors|mesh-ancestor
64810778|NCT01443104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810779|NCT01443104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64810780|NCT01443104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64810781|NCT01443104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64810782|NCT01443104|Antifungal Agents|antifungal agents|mesh-ancestor
64810783|NCT01443117|Vaccines|vaccines|mesh-list
64810784|NCT01443117|Immunologic Factors|immunologic factors|mesh-ancestor
64810794|NCT01443169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810806|NCT01443208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64810807|NCT01443208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64810808|NCT01443208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810809|NCT01443208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64810810|NCT01443208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810811|NCT01443208|Antidepressive Agents|antidepressive agents|mesh-ancestor
64810812|NCT01443208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64810813|NCT01443221|Metformin|metformin|mesh-list
64810814|NCT01443221|Mitiglinide|mitiglinide|mesh-list
64810815|NCT01443221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64810816|NCT01443221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810817|NCT01443247|gamma-Globulins|gamma-globulins|mesh-list
64810818|NCT01443247|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64810819|NCT01443247|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64810820|NCT01443247|Immunologic Factors|immunologic factors|mesh-ancestor
64810821|NCT01443247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810823|NCT01443325|Anesthetics, Local|anesthetics, local|mesh-ancestor
65285985|NCT00542815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285986|NCT02762591|Pimavanserin|pimavanserin|mesh-list
65285987|NCT02762591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65285988|NCT02762591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65285989|NCT02762591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65285990|NCT02762591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65285991|NCT02762591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65285992|NCT02762591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65285993|NCT02762591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64516269|NCT02460354|Metformin|metformin|mesh-list
64810824|NCT01443325|Anesthetics|anesthetics|mesh-ancestor
64810825|NCT01443325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64810826|NCT01443325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810827|NCT01443325|Sensory System Agents|sensory system agents|mesh-ancestor
64810828|NCT01443325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64810829|NCT01443325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64810830|NCT01443325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64810831|NCT01443325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64810832|NCT01443325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64810833|NCT01443325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810834|NCT01443338|Acitretin|acitretin|mesh-list
64810835|NCT01443338|Keratolytic Agents|keratolytic agents|mesh-ancestor
64810836|NCT01443338|Dermatologic Agents|dermatologic agents|mesh-ancestor
65494211|NCT02939742|Betamethasone|betamethasone|mesh-list
64472353|NCT03505723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472354|NCT03505723|Hemostatics|hemostatics|mesh-ancestor
64472355|NCT03505723|Coagulants|coagulants|mesh-ancestor
64472356|NCT03492177|Selexipag|selexipag|mesh-list
64472357|NCT03492177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64810837|NCT01443377|Panitumumab|panitumumab|mesh-list
64810838|NCT01443377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64810839|NCT01443377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810840|NCT01443416|Vaccines|vaccines|mesh-list
64810841|NCT01443416|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64810842|NCT01443416|Immunologic Factors|immunologic factors|mesh-ancestor
64810843|NCT01443416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810844|NCT01443429|Beraprost|beraprost|mesh-list
64810845|NCT01443429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64810846|NCT01443429|Vasodilator Agents|vasodilator agents|mesh-ancestor
64810847|NCT01443520|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64810848|NCT01443520|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64421928|NCT02552225|Sensory System Agents|sensory system agents|mesh-ancestor
64810873|NCT01443676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64810874|NCT01443676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810875|NCT01443676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64810876|NCT01443676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64810877|NCT01443676|Growth Substances|growth substances|mesh-ancestor
64810878|NCT01443676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810935|NCT01444196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64810936|NCT01444196|Cholinergic Agents|cholinergic agents|mesh-ancestor
64810937|NCT01444196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64810938|NCT01444196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810939|NCT01444196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810940|NCT01444196|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64810941|NCT01444196|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64810942|NCT01444196|Histamine Antagonists|histamine antagonists|mesh-ancestor
64810943|NCT01444196|Histamine Agents|histamine agents|mesh-ancestor
64810944|NCT01444248|Metformin|metformin|mesh-list
64810945|NCT01444248|Glimepiride|glimepiride|mesh-list
64810946|NCT01444248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64422041|NCT05478083|Leuprolide|leuprolide|mesh-list
64579587|NCT01466660|Gefitinib|gefitinib|mesh-list
64810966|NCT01444521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810967|NCT01444521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810968|NCT01444547|Paclitaxel|paclitaxel|mesh-list
65285994|NCT02762591|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65285995|NCT02762591|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65285996|NCT02762591|Serotonin Agents|serotonin agents|mesh-ancestor
65285997|NCT02762591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65285998|NCT02762591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65285999|NCT02696369|Lidocaine|lidocaine|mesh-list
65286000|NCT02696369|Epinephrine|epinephrine|mesh-list
65286001|NCT02696369|Racepinephrine|racepinephrine|mesh-list
65286002|NCT02696369|Epinephryl borate|epinephryl borate|mesh-list
65286003|NCT02696369|Anesthetics, Local|anesthetics, local|mesh-ancestor
64516278|NCT02008942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810969|NCT01444547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64486607|NCT01904903|Pertuzumab|pertuzumab|mesh-list
64472361|NCT03485209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472362|NCT03485209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64472364|NCT03458221|Everolimus|everolimus|mesh-list
64472365|NCT03458221|Letrozole|letrozole|mesh-list
64472366|NCT03458221|Bicalutamide|bicalutamide|mesh-list
64472367|NCT03458221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472368|NCT03458221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64472369|NCT03458221|Immunologic Factors|immunologic factors|mesh-ancestor
64810970|NCT01444547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64810971|NCT01444547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810972|NCT01444547|Tubulin Modulators|tubulin modulators|mesh-ancestor
64810973|NCT01444547|Antimitotic Agents|antimitotic agents|mesh-ancestor
64810974|NCT01444547|Mitosis Modulators|mitosis modulators|mesh-ancestor
64810975|NCT01444547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810976|NCT01444586|Rivaroxaban|rivaroxaban|mesh-list
64810977|NCT01444586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64810978|NCT01444586|Antithrombins|antithrombins|mesh-ancestor
64810979|NCT01444586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64810980|NCT01444586|Protease Inhibitors|protease inhibitors|mesh-ancestor
64810981|NCT01444586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810982|NCT01444586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810983|NCT01444586|Anticoagulants|anticoagulants|mesh-ancestor
64810984|NCT01444612|Heparin|heparin|mesh-list
64810985|NCT01444612|Calcium heparin|calcium heparin|mesh-list
64810986|NCT01444612|Enoxaparin|enoxaparin|mesh-list
64810987|NCT01444612|Dalteparin|dalteparin|mesh-list
64810988|NCT01444612|Tinzaparin|tinzaparin|mesh-list
64810989|NCT01444612|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64810991|NCT01444612|Fondaparinux|fondaparinux|mesh-list
64810992|NCT01444612|Anticoagulants|anticoagulants|mesh-ancestor
64810993|NCT01444612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64810994|NCT01444612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64810995|NCT01444612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810996|NCT01444612|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64810997|NCT01444612|Antithrombins|antithrombins|mesh-ancestor
64810998|NCT01444612|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64810999|NCT01444612|Protease Inhibitors|protease inhibitors|mesh-ancestor
64811000|NCT01444612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811001|NCT01444677|Beta-lapachone|beta-lapachone|mesh-list
64811002|NCT01444677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64422088|NCT02551055|Serabelisib|serabelisib|mesh-list
64811014|NCT01444833|Candesartan|candesartan|mesh-list
64811015|NCT01444833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64811016|NCT01444833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64811017|NCT01444833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64811018|NCT01444833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811019|NCT01444846|Ebselen|ebselen|mesh-list
64811020|NCT01444846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64811021|NCT01444846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64811022|NCT01444846|Analgesics|analgesics|mesh-ancestor
64811023|NCT01444846|Sensory System Agents|sensory system agents|mesh-ancestor
64811024|NCT01444846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64811025|NCT01444846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286004|NCT02696369|Anesthetics|anesthetics|mesh-ancestor
65286005|NCT02696369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65286006|NCT02696369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286007|NCT02696369|Sensory System Agents|sensory system agents|mesh-ancestor
65286008|NCT02696369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516288|NCT03288636|Ritonavir|ritonavir|mesh-list
64811026|NCT01444846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64811027|NCT01444846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64811028|NCT01444846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64811029|NCT01444846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64811030|NCT01444846|Antioxidants|antioxidants|mesh-ancestor
64811031|NCT01444846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486632|NCT01709305|Glimepiride|glimepiride|mesh-list
64472377|NCT03458221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64472378|NCT03458221|Antifungal Agents|antifungal agents|mesh-ancestor
64472379|NCT03458221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64472380|NCT03458221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64472381|NCT03458221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64472382|NCT03458221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64472383|NCT03458221|Androgen Antagonists|androgen antagonists|mesh-ancestor
64472385|NCT03451487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64472394|NCT03410030|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64472395|NCT03410030|Cisplatin|cisplatin|mesh-list
64472396|NCT03410030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64811034|NCT01444846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811035|NCT01444846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64811036|NCT01444885|Amlodipine|amlodipine|mesh-list
64811037|NCT01444885|Nitroglycerin|nitroglycerin|mesh-list
64811038|NCT01444885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64811039|NCT01444885|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64811040|NCT01444885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64579665|NCT00120523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64811041|NCT01444885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811042|NCT01444885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64811043|NCT01444885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811044|NCT01444885|Vasodilator Agents|vasodilator agents|mesh-ancestor
64811045|NCT01444976|Midazolam|midazolam|mesh-list
64811046|NCT01444976|Anesthetics|anesthetics|mesh-ancestor
64811047|NCT01444976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64811048|NCT01444976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811049|NCT01444976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64811050|NCT01444976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64811051|NCT01444976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64811052|NCT01444976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64486699|NCT01903811|Antiemetics|antiemetics|mesh-ancestor
64811069|NCT01445106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494231|NCT02693535|Vemurafenib|vemurafenib|mesh-list
65494232|NCT02693535|Talazoparib|talazoparib|mesh-list
65494233|NCT02693535|Tucatinib|tucatinib|mesh-list
65494234|NCT02693535|Futibatinib|futibatinib|mesh-list
65494235|NCT02693535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65494236|NCT02693535|Entrectinib|entrectinib|mesh-list
65494237|NCT02693535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65494238|NCT02693535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494239|NCT02693535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65494240|NCT02693535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494241|NCT02693535|Immunologic Factors|immunologic factors|mesh-ancestor
65494242|NCT02693535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494243|NCT02693535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65494244|NCT02693535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65494245|NCT02693535|Growth Substances|growth substances|mesh-ancestor
65494246|NCT02693535|Growth Inhibitors|growth inhibitors|mesh-ancestor
65494247|NCT02693535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65494248|NCT02693535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494249|NCT02693535|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65494250|NCT02678572|Melphalan|melphalan|mesh-list
64472397|NCT03410030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472398|NCT03410030|Tubulin Modulators|tubulin modulators|mesh-ancestor
64472399|NCT03410030|Antimitotic Agents|antimitotic agents|mesh-ancestor
65286009|NCT02696369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65286010|NCT02696369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65286011|NCT02696369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65286012|NCT02696369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65286013|NCT02696369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286014|NCT02696369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65286015|NCT02696369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65286016|NCT02696369|Adrenergic Agents|adrenergic agents|mesh-ancestor
65286017|NCT02696369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65286018|NCT02696369|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65286019|NCT02696369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65286020|NCT02696369|Autonomic Agents|autonomic agents|mesh-ancestor
65286021|NCT02696369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65286022|NCT02696369|Respiratory System Agents|respiratory system agents|mesh-ancestor
65286023|NCT02696369|Mydriatics|mydriatics|mesh-ancestor
65286024|NCT02696369|Sympathomimetics|sympathomimetics|mesh-ancestor
65286025|NCT02696369|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65286026|NCT00663312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65286027|NCT00663312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64472400|NCT03410030|Mitosis Modulators|mitosis modulators|mesh-ancestor
64472401|NCT03410030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472402|NCT03410030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64472403|NCT03410030|Antimetabolites|antimetabolites|mesh-ancestor
64472404|NCT03410030|Antiviral Agents|antiviral agents|mesh-ancestor
64472405|NCT03410030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64472406|NCT03410030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472408|NCT03410030|Immunologic Factors|immunologic factors|mesh-ancestor
64472409|NCT03410030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811070|NCT01445119|Carboplatin|carboplatin|mesh-list
64811071|NCT01445119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811072|NCT01445210|Ropivacaine|ropivacaine|mesh-list
64811073|NCT01445210|Anesthetics, Local|anesthetics, local|mesh-ancestor
64811074|NCT01445210|Anesthetics|anesthetics|mesh-ancestor
64811075|NCT01445210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64811076|NCT01445210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811077|NCT01445210|Sensory System Agents|sensory system agents|mesh-ancestor
64811078|NCT01445210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64811079|NCT01445223|Ritonavir|ritonavir|mesh-list
64811080|NCT01445223|Lopinavir|lopinavir|mesh-list
64811081|NCT01445223|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64811082|NCT01445223|Efavirenz|efavirenz|mesh-list
64811083|NCT01445223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64811084|NCT01445223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64811085|NCT01445223|Protease Inhibitors|protease inhibitors|mesh-ancestor
64811086|NCT01445223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811087|NCT01445223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811088|NCT01445223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64811094|NCT01445223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64811095|NCT01445223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64811096|NCT01445223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64811097|NCT01445223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64811098|NCT01445223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64811099|NCT01445223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64811100|NCT01445223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65286028|NCT00663312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286029|NCT02636088|Cetuximab|cetuximab|mesh-list
65286030|NCT02636088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65286031|NCT02636088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286032|NCT02630160|Epinephrine|epinephrine|mesh-list
65286033|NCT02630160|Bupivacaine|bupivacaine|mesh-list
65286034|NCT02630160|Anesthetics, Local|anesthetics, local|mesh-ancestor
65286035|NCT02630160|Anesthetics|anesthetics|mesh-ancestor
64811101|NCT01445236|Cyclosporine|cyclosporine|mesh-list
64811102|NCT01445236|Tacrolimus|tacrolimus|mesh-list
64811103|NCT01445236|Cyclosporins|cyclosporins|mesh-list
64811104|NCT01445236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64811105|NCT01445236|Immunologic Factors|immunologic factors|mesh-ancestor
64811106|NCT01445236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811107|NCT01445236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64811108|NCT01445236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811109|NCT01445236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811110|NCT01445236|Antifungal Agents|antifungal agents|mesh-ancestor
64811111|NCT01445236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64811112|NCT01445236|Dermatologic Agents|dermatologic agents|mesh-ancestor
64811113|NCT01445236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64811114|NCT01445262|Levocetirizine|levocetirizine|mesh-list
64811115|NCT01445262|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64811116|NCT01445262|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64811117|NCT01445262|Histamine Antagonists|histamine antagonists|mesh-ancestor
64811118|NCT01445262|Histamine Agents|histamine agents|mesh-ancestor
64811119|NCT01445262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65494251|NCT02678572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65494252|NCT02678572|Alkylating Agents|alkylating agents|mesh-ancestor
65494253|NCT02678572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494254|NCT02678572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494255|NCT02678572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65494256|NCT02678572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65494257|NCT02678572|Immunologic Factors|immunologic factors|mesh-ancestor
65494258|NCT02678572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494259|NCT02595424|Carboplatin|carboplatin|mesh-list
65494260|NCT02595424|Capecitabine|capecitabine|mesh-list
65494261|NCT02595424|Etoposide|etoposide|mesh-list
65494262|NCT02595424|Temozolomide|temozolomide|mesh-list
65494263|NCT02595424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472410|NCT03410030|Antioxidants|antioxidants|mesh-ancestor
64472411|NCT03410030|Protective Agents|protective agents|mesh-ancestor
64472413|NCT03410030|Micronutrients|micronutrients|mesh-ancestor
64472414|NCT03382301|Cyclosporine|cyclosporine|mesh-list
64472415|NCT03382301|Cyclosporins|cyclosporins|mesh-list
64472416|NCT03382301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472417|NCT03382301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472418|NCT03382301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64472419|NCT03382301|Immunologic Factors|immunologic factors|mesh-ancestor
64472420|NCT03382301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472421|NCT03382301|Antifungal Agents|antifungal agents|mesh-ancestor
64472422|NCT03382301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64811120|NCT01445262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811121|NCT01445262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811123|NCT01445340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64811124|NCT01445340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811125|NCT01445379|Ipilimumab|ipilimumab|mesh-list
64811126|NCT01445379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64811127|NCT01445379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811128|NCT01445379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64811129|NCT01445379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811130|NCT01445392|Pemetrexed|pemetrexed|mesh-list
64811131|NCT01445392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64811132|NCT01445392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811133|NCT01445392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811172|NCT01445600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64811174|NCT01445639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64811175|NCT01445639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64811176|NCT01445639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286036|NCT02630160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65286037|NCT02630160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286038|NCT02630160|Sensory System Agents|sensory system agents|mesh-ancestor
64811177|NCT01445639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64811178|NCT01445639|Analgesics|analgesics|mesh-ancestor
64811179|NCT01445639|Sensory System Agents|sensory system agents|mesh-ancestor
64811180|NCT01445639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64811181|NCT01445639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64811182|NCT01445639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64811183|NCT01445639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64811184|NCT01445639|Adrenergic Agents|adrenergic agents|mesh-ancestor
64811185|NCT01445639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64811186|NCT01445639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811187|NCT01445691|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64811188|NCT01445691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64811189|NCT01445691|Dermatologic Agents|dermatologic agents|mesh-ancestor
65494264|NCT02595424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65494265|NCT02595424|Antimetabolites|antimetabolites|mesh-ancestor
65494266|NCT02595424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494267|NCT02595424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65494268|NCT02595424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65494269|NCT02595424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65494270|NCT02595424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494271|NCT02595424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65494272|NCT02595424|Alkylating Agents|alkylating agents|mesh-ancestor
65494273|NCT02581787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65494274|NCT02581787|Antibodies|antibodies|mesh-list
64811207|NCT01445860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64811208|NCT01445860|Antimetabolites|antimetabolites|mesh-ancestor
64811209|NCT01445860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811210|NCT01445860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64486884|NCT03216304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811219|NCT01445964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64811220|NCT01445964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64811222|NCT01445964|Autonomic Agents|autonomic agents|mesh-ancestor
64811223|NCT01445964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64811224|NCT01445964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811225|NCT01445964|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64811226|NCT01445964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64811227|NCT01445964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64811228|NCT01445964|Adrenergic Agents|adrenergic agents|mesh-ancestor
64811229|NCT01445964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64811230|NCT01445964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811231|NCT01446094|Regadenoson|regadenoson|mesh-list
64811232|NCT01446094|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64811233|NCT01446094|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64811234|NCT01446094|Purinergic Agonists|purinergic agonists|mesh-ancestor
64811235|NCT01446094|Purinergic Agents|purinergic agents|mesh-ancestor
64811236|NCT01446094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64811237|NCT01446094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811238|NCT01446094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811239|NCT01446107|Fluorides|fluorides|mesh-list
64811240|NCT01446107|Fluorides, Topical|fluorides, topical|mesh-list
64811241|NCT01446107|Cariostatic Agents|cariostatic agents|mesh-ancestor
64811242|NCT01446107|Protective Agents|protective agents|mesh-ancestor
64811243|NCT01446107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811244|NCT01446120|Insulin|insulin|mesh-list
64811245|NCT01446120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64811246|NCT01446120|Insulin, Isophane|insulin, isophane|mesh-list
64811258|NCT01446211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811259|NCT01446211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64811260|NCT01446211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64811261|NCT01446211|Alkylating Agents|alkylating agents|mesh-ancestor
64811262|NCT01446211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811263|NCT01446211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811264|NCT01446211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64811265|NCT01446211|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64811266|NCT01446211|Abortifacient Agents|abortifacient agents|mesh-ancestor
65286039|NCT02630160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65286040|NCT02630160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65286041|NCT02630160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65286042|NCT02630160|Adrenergic Agents|adrenergic agents|mesh-ancestor
65286043|NCT02630160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65286044|NCT02630160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286045|NCT02630160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65286046|NCT02630160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65286047|NCT02630160|Autonomic Agents|autonomic agents|mesh-ancestor
65286048|NCT02630160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65286049|NCT02630160|Respiratory System Agents|respiratory system agents|mesh-ancestor
65286050|NCT02630160|Mydriatics|mydriatics|mesh-ancestor
65286051|NCT02630160|Sympathomimetics|sympathomimetics|mesh-ancestor
64516318|NCT01959490|Docetaxel|docetaxel|mesh-list
64811267|NCT01446211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64811268|NCT01446211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64811270|NCT01446211|Dermatologic Agents|dermatologic agents|mesh-ancestor
64811271|NCT01446211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811272|NCT01446211|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64811273|NCT01446211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64811274|NCT01446211|Hormones|hormones|mesh-ancestor
64811275|NCT01446211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64811276|NCT01446211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64811277|NCT01446211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64811278|NCT01446211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64811279|NCT01446211|Protective Agents|protective agents|mesh-ancestor
64811280|NCT01446276|Resveratrol|resveratrol|mesh-list
64811281|NCT01446276|Antioxidants|antioxidants|mesh-ancestor
64811282|NCT01446276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811283|NCT01446276|Protective Agents|protective agents|mesh-ancestor
64811284|NCT01446276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811285|NCT01446276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811286|NCT01446276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64811287|NCT01446328|Olanzapine|olanzapine|mesh-list
64811288|NCT01446328|Aripiprazole|aripiprazole|mesh-list
64811299|NCT01446328|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64811300|NCT01446328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64811301|NCT01446328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64811302|NCT01446328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811303|NCT01446328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64811304|NCT01446328|Serotonin Agents|serotonin agents|mesh-ancestor
64811305|NCT01446328|Antidepressive Agents|antidepressive agents|mesh-ancestor
64811306|NCT01446328|Dopamine Agonists|dopamine agonists|mesh-ancestor
64811307|NCT01446328|Dopamine Agents|dopamine agents|mesh-ancestor
64811308|NCT01446328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64811309|NCT01446328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64811310|NCT01446328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64811322|NCT01446445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811324|NCT01446458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811325|NCT01446484|Cyclosporine|cyclosporine|mesh-list
64811326|NCT01446484|Sirolimus|sirolimus|mesh-list
64811327|NCT01446484|Mycophenolic Acid|mycophenolic acid|mesh-list
64811328|NCT01446484|Everolimus|everolimus|mesh-list
64811329|NCT01446484|Alemtuzumab|alemtuzumab|mesh-list
64811330|NCT01446484|Tacrolimus|tacrolimus|mesh-list
64811331|NCT01446484|Cyclosporins|cyclosporins|mesh-list
64811332|NCT01446484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64811333|NCT01446484|Immunologic Factors|immunologic factors|mesh-ancestor
64811334|NCT01446484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811335|NCT01446484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64811336|NCT01446484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286052|NCT02630160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65286053|NCT00668304|Moxifloxacin|moxifloxacin|mesh-list
65286054|NCT00668304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65286055|NCT00668304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65286056|NCT00668304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65286057|NCT00668304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65286058|NCT00668304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65286059|NCT00668304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286060|NCT00668304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286061|NCT00668304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286062|NCT00668304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65286063|NCT00668304|Contraceptive Agents|contraceptive agents|mesh-ancestor
65286064|NCT00668304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65286065|NCT00668304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286066|NCT00668304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65286067|NCT00668304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65286068|NCT00668304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65286069|NCT00542425|Teriparatide|teriparatide|mesh-list
65286070|NCT00542425|Abaloparatide|abaloparatide|mesh-list
65286071|NCT00542425|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
65286072|NCT00542425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65286073|NCT00542425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516348|NCT03288402|Caffeine|caffeine|mesh-list
64811337|NCT01446484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811338|NCT01446484|Antifungal Agents|antifungal agents|mesh-ancestor
64811339|NCT01446484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64811340|NCT01446484|Dermatologic Agents|dermatologic agents|mesh-ancestor
64579960|NCT00131677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64811341|NCT01446484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64811342|NCT01446484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811343|NCT01446484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64811344|NCT01446484|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64811345|NCT01446484|Antitubercular Agents|antitubercular agents|mesh-ancestor
64811346|NCT01446484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64811347|NCT01446484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64811348|NCT01446497|Timolol|timolol|mesh-list
64811349|NCT01446497|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64811350|NCT01446497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64811351|NCT01446497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64811352|NCT01446497|Adrenergic Agents|adrenergic agents|mesh-ancestor
64811353|NCT01446497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64811354|NCT01446497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811355|NCT01446497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811356|NCT01446497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64811357|NCT01446497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64811358|NCT01446497|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64811359|NCT01446497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64811360|NCT01446497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65286074|NCT00542425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65286075|NCT00668538|Miconazole|miconazole|mesh-list
65286076|NCT00668538|Clotrimazole|clotrimazole|mesh-list
65286077|NCT00668538|Antifungal Agents|antifungal agents|mesh-ancestor
65286078|NCT00668538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65286079|NCT00668538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65286080|NCT00668538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65286081|NCT00668538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286082|NCT00668538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286083|NCT00668538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65286084|NCT00668538|Hormone Antagonists|hormone antagonists|mesh-ancestor
65286085|NCT00668538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65286086|NCT00668538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286087|NCT00668538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64516356|NCT03288402|Purinergic Agents|purinergic agents|mesh-ancestor
64811409|NCT01447043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64811410|NCT01447043|Growth Substances|growth substances|mesh-ancestor
64811411|NCT01447043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811412|NCT01447043|Growth Inhibitors|growth inhibitors|mesh-ancestor
64811413|NCT01447043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811414|NCT01447069|Albuterol|albuterol|mesh-list
64811415|NCT01447069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64580035|NCT03139305|Incretins|incretins|mesh-ancestor
64811416|NCT01447069|Autonomic Agents|autonomic agents|mesh-ancestor
64811417|NCT01447069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64811418|NCT01447069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811419|NCT01447069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64811420|NCT01447069|Respiratory System Agents|respiratory system agents|mesh-ancestor
64811421|NCT01447069|Tocolytic Agents|tocolytic agents|mesh-ancestor
64811422|NCT01447069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64811423|NCT01447069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64811424|NCT01447069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64811425|NCT01447069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64811426|NCT01447069|Adrenergic Agents|adrenergic agents|mesh-ancestor
64422520|NCT02293395|Antipyretics|antipyretics|mesh-ancestor
64811435|NCT01447160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64811437|NCT01447173|Vitamins|vitamins|mesh-ancestor
64811438|NCT01447173|Micronutrients|micronutrients|mesh-ancestor
64811474|NCT01447394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811475|NCT01447485|Valsartan|valsartan|mesh-list
64811476|NCT01447485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64811477|NCT01447485|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64811478|NCT01447485|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64811486|NCT01447563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64811487|NCT01447563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64811489|NCT01447563|Purinergic Agents|purinergic agents|mesh-ancestor
64811490|NCT01447563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64811491|NCT01447563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811492|NCT01447563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422572|NCT05451095|Anesthetics|anesthetics|mesh-ancestor
64811512|NCT01447797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64811513|NCT01447797|Antimetabolites|antimetabolites|mesh-ancestor
64811514|NCT01447797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811515|NCT01447797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64811516|NCT01447797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64811517|NCT01447797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286088|NCT00668538|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65286089|NCT00668538|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65286090|NCT00668616|Paclitaxel|paclitaxel|mesh-list
65286091|NCT00668616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65286092|NCT00668616|Cyclophosphamide|cyclophosphamide|mesh-list
65286093|NCT00668616|Epirubicin|epirubicin|mesh-list
65286094|NCT00668616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65286095|NCT00668616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286096|NCT00668616|Tubulin Modulators|tubulin modulators|mesh-ancestor
65286097|NCT00668616|Antimitotic Agents|antimitotic agents|mesh-ancestor
65286098|NCT00668616|Mitosis Modulators|mitosis modulators|mesh-ancestor
64516371|NCT02011516|GABA Agonists|gaba agonists|mesh-ancestor
64811518|NCT01447797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64811519|NCT01447797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64811520|NCT01447797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64811521|NCT01447862|Ibutilide|ibutilide|mesh-list
64811522|NCT01447862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64811523|NCT01447875|Propofol|propofol|mesh-list
64811524|NCT01447875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64811525|NCT01447875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64811526|NCT01447875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811527|NCT01447875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64811528|NCT01447875|Anesthetics, General|anesthetics, general|mesh-ancestor
64811529|NCT01447875|Anesthetics|anesthetics|mesh-ancestor
64811530|NCT01447979|Pancrelipase|pancrelipase|mesh-list
64811531|NCT01447979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64811532|NCT01447992|Pancrelipase|pancrelipase|mesh-list
64811533|NCT01447992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64811534|NCT01448018|Ranibizumab|ranibizumab|mesh-list
64811535|NCT01448018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64811536|NCT01448018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64811537|NCT01448018|Growth Substances|growth substances|mesh-ancestor
64811538|NCT01448018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811539|NCT01448018|Growth Inhibitors|growth inhibitors|mesh-ancestor
64811540|NCT01448018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811541|NCT01448031|Esomeprazole|esomeprazole|mesh-list
64811542|NCT01448031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64811543|NCT01448031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64811544|NCT01448031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64811545|NCT01448031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811546|NCT01448031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811547|NCT01448070|Insulin|insulin|mesh-list
64811548|NCT01448070|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64811549|NCT01448070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64422641|NCT01728259|Bortezomib|bortezomib|mesh-list
64811560|NCT01448174|Atorvastatin|atorvastatin|mesh-list
64811561|NCT01448174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64811562|NCT01448174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64811563|NCT01448174|Antimetabolites|antimetabolites|mesh-ancestor
64811564|NCT01448174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811565|NCT01448174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64580183|NCT00252967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64487160|NCT03217474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811584|NCT01448291|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64811585|NCT01448317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64811586|NCT01448317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64811587|NCT01448317|Immunologic Factors|immunologic factors|mesh-ancestor
64811588|NCT01448317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811590|NCT01448330|Clopidogrel|clopidogrel|mesh-list
64811591|NCT01448330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64811592|NCT01448330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64811593|NCT01448330|Analgesics|analgesics|mesh-ancestor
64811594|NCT01448330|Sensory System Agents|sensory system agents|mesh-ancestor
64811595|NCT01448330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64811596|NCT01448330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286099|NCT00668616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286100|NCT00668616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65286101|NCT00668616|Immunologic Factors|immunologic factors|mesh-ancestor
65286102|NCT00668616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286103|NCT00668616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65286104|NCT00668616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65286105|NCT00668616|Alkylating Agents|alkylating agents|mesh-ancestor
65286106|NCT00668616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65286107|NCT00668616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65286108|NCT00668616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65286109|NCT00668616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65286110|NCT00668616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286111|NCT02763761|Prednisone|prednisone|mesh-list
65286112|NCT02763761|Methylprednisolone|methylprednisolone|mesh-list
65286113|NCT02763761|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65286114|NCT02763761|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65286115|NCT02763761|Prednisolone|prednisolone|mesh-list
65286116|NCT02763761|Prednisolone acetate|prednisolone acetate|mesh-list
65286117|NCT02763761|Infliximab|infliximab|mesh-list
65286118|NCT02763761|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65286119|NCT02763761|Prednisolone phosphate|prednisolone phosphate|mesh-list
65286120|NCT02763761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65286121|NCT02763761|Glucocorticoids|glucocorticoids|mesh-ancestor
65286122|NCT02763761|Hormones|hormones|mesh-ancestor
65286123|NCT02763761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65286124|NCT02763761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286125|NCT02763761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65286126|NCT02763761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286127|NCT02763761|Antiemetics|antiemetics|mesh-ancestor
65286128|NCT02763761|Autonomic Agents|autonomic agents|mesh-ancestor
64811597|NCT01448330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64811598|NCT01448330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64811599|NCT01448330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64811600|NCT01448330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64811601|NCT01448330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811602|NCT01448330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64811603|NCT01448330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64811604|NCT01448330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811605|NCT01448330|Antipyretics|antipyretics|mesh-ancestor
64811606|NCT01448330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64811607|NCT01448330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64811608|NCT01448330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64811609|NCT01448330|Purinergic Agents|purinergic agents|mesh-ancestor
64811610|NCT01448330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65286129|NCT02763761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65286130|NCT02763761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65286131|NCT02763761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65286132|NCT02763761|Protective Agents|protective agents|mesh-ancestor
65286133|NCT02763761|Dermatologic Agents|dermatologic agents|mesh-ancestor
65286134|NCT02763761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65286135|NCT04155918|Allopurinol|allopurinol|mesh-list
65286136|NCT04155918|Febuxostat|febuxostat|mesh-list
65286137|NCT04155918|Antimetabolites|antimetabolites|mesh-ancestor
65286138|NCT04155918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286139|NCT04155918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286140|NCT04155918|Gout Suppressants|gout suppressants|mesh-ancestor
65286141|NCT04155918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65286142|NCT04155918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65286143|NCT04155918|Antioxidants|antioxidants|mesh-ancestor
65286144|NCT04155918|Protective Agents|protective agents|mesh-ancestor
65286145|NCT04155918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286146|NCT02763839|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65286147|NCT02763839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64811611|NCT01448395|Avibactam|avibactam|mesh-list
64811612|NCT01448395|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64811613|NCT01448395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422694|NCT05443555|Antimanic Agents|antimanic agents|mesh-ancestor
64811626|NCT01448499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811627|NCT01448499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64811628|NCT01448499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64487225|NCT01832662|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64811644|NCT01448642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811645|NCT01448720|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64811646|NCT01448720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64811647|NCT01448720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64811648|NCT01448720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64811649|NCT01448720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811650|NCT01448720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64811651|NCT01448720|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64811652|NCT01448720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64811653|NCT01448720|Serotonin Agents|serotonin agents|mesh-ancestor
64811654|NCT01448720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64811655|NCT01448720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811656|NCT01448720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64811657|NCT01448720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64811658|NCT01448720|Dopamine Agents|dopamine agents|mesh-ancestor
64811659|NCT01448733|Clindamycin|clindamycin|mesh-list
64811660|NCT01448733|Clindamycin palmitate|clindamycin palmitate|mesh-list
64811661|NCT01448733|Clindamycin phosphate|clindamycin phosphate|mesh-list
64811663|NCT01448733|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64811664|NCT01448733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64811665|NCT01448733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494279|NCT02581787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472428|NCT03371017|Capecitabine|capecitabine|mesh-list
64472429|NCT03371017|Atezolizumab|atezolizumab|mesh-list
64472430|NCT03371017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472431|NCT03371017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64472432|NCT03371017|Antimetabolites|antimetabolites|mesh-ancestor
64472433|NCT03371017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811666|NCT01448733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64811667|NCT01448733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286148|NCT02763839|Immunologic Factors|immunologic factors|mesh-ancestor
65286149|NCT02763839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286150|NCT02763839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65286151|NCT02763839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65286152|NCT02763839|Dopamine Agonists|dopamine agonists|mesh-ancestor
65286153|NCT02763839|Dopamine Agents|dopamine agents|mesh-ancestor
65286154|NCT02763839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65286155|NCT02763839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286156|NCT00541099|Bevacizumab|bevacizumab|mesh-list
65286157|NCT00541099|Docetaxel|docetaxel|mesh-list
65286158|NCT00541099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65286159|NCT00541099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286160|NCT00541099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65286161|NCT00541099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65286162|NCT00541099|Growth Substances|growth substances|mesh-ancestor
65286163|NCT00541099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286164|NCT00541099|Growth Inhibitors|growth inhibitors|mesh-ancestor
65286165|NCT00541099|Tubulin Modulators|tubulin modulators|mesh-ancestor
65286166|NCT00541099|Antimitotic Agents|antimitotic agents|mesh-ancestor
65286167|NCT00541099|Mitosis Modulators|mitosis modulators|mesh-ancestor
65286168|NCT00541099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286169|NCT00580606|Glycerol|glycerol|mesh-list
65286170|NCT00580606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65286171|NCT00580606|Protective Agents|protective agents|mesh-ancestor
65286172|NCT00580606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286173|NCT05711641|Lidocaine|lidocaine|mesh-list
64811668|NCT01448733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811669|NCT01448733|Dermatologic Agents|dermatologic agents|mesh-ancestor
64811670|NCT01448733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811671|NCT01448733|Keratolytic Agents|keratolytic agents|mesh-ancestor
64811672|NCT01448746|Heparin|heparin|mesh-list
64811673|NCT01448746|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64811674|NCT01448746|Tinzaparin|tinzaparin|mesh-list
64811675|NCT01448746|Dalteparin|dalteparin|mesh-list
64811676|NCT01448746|Anticoagulants|anticoagulants|mesh-ancestor
64811711|NCT01448837|Luteolytic Agents|luteolytic agents|mesh-ancestor
64811712|NCT01448837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64811713|NCT01448837|Contraceptive Agents|contraceptive agents|mesh-ancestor
64811714|NCT01448837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64811715|NCT01448837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64811748|NCT01449188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811877|NCT01449617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64811879|NCT01449799|Xhance|xhance|mesh-list
64811880|NCT01449799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64811881|NCT01449799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64811882|NCT01449799|Autonomic Agents|autonomic agents|mesh-ancestor
64811883|NCT01449799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64811884|NCT01449799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811885|NCT01449799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65286174|NCT05711641|Anesthetics, Local|anesthetics, local|mesh-ancestor
65286175|NCT05711641|Anesthetics|anesthetics|mesh-ancestor
65286176|NCT05711641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65286177|NCT05711641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286178|NCT05711641|Sensory System Agents|sensory system agents|mesh-ancestor
65286179|NCT05711641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65286180|NCT05711641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65286181|NCT05711641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65286182|NCT05711641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65286183|NCT05711641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65286184|NCT05711641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286185|NCT02575768|Adenosine|adenosine|mesh-list
65286186|NCT02575768|Analgesics|analgesics|mesh-ancestor
65286187|NCT02575768|Sensory System Agents|sensory system agents|mesh-ancestor
65286188|NCT02575768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65286189|NCT02575768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286190|NCT02575768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65286191|NCT02575768|Vasodilator Agents|vasodilator agents|mesh-ancestor
65286192|NCT02575768|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65286193|NCT02575768|Purinergic Agonists|purinergic agonists|mesh-ancestor
65286194|NCT02575768|Purinergic Agents|purinergic agents|mesh-ancestor
65286195|NCT02575768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65286196|NCT02575768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286197|NCT00987493|Rituximab|rituximab|mesh-list
65286198|NCT00987493|Lenalidomide|lenalidomide|mesh-list
65286199|NCT00987493|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65286200|NCT00987493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65286201|NCT00987493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286202|NCT00987493|Immunologic Factors|immunologic factors|mesh-ancestor
65286203|NCT00987493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286204|NCT00987493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65286205|NCT00987493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65286206|NCT00987493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64811886|NCT01449799|Respiratory System Agents|respiratory system agents|mesh-ancestor
64811887|NCT01449799|Dermatologic Agents|dermatologic agents|mesh-ancestor
64811888|NCT01449799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64811889|NCT01449825|Bevacizumab|bevacizumab|mesh-list
64811890|NCT01449825|Sunitinib|sunitinib|mesh-list
64811891|NCT01449825|Sorafenib|sorafenib|mesh-list
65286207|NCT00987493|Growth Substances|growth substances|mesh-ancestor
65286208|NCT00987493|Growth Inhibitors|growth inhibitors|mesh-ancestor
65286209|NCT00987493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65286210|NCT00987493|Alkylating Agents|alkylating agents|mesh-ancestor
65286211|NCT00987493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286212|NCT02579356|Telmisartan|telmisartan|mesh-list
65286213|NCT02579356|Atorvastatin|atorvastatin|mesh-list
65286214|NCT02579356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65286215|NCT02579356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65286216|NCT02579356|Antimetabolites|antimetabolites|mesh-ancestor
65286217|NCT02579356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286218|NCT02579356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65286219|NCT02579356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65286220|NCT02579356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286221|NCT02579356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65286222|NCT02579356|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65286223|NCT02579356|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65286224|NCT03914170|Cetuximab|cetuximab|mesh-list
65286225|NCT03914170|Folfirinox|folfirinox|mesh-list
65286226|NCT03914170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65286227|NCT03914170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286228|NCT00663624|Insulin Aspart|insulin aspart|mesh-list
65286229|NCT00663624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65286230|NCT00663624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286231|NCT02577250|Ketamine|ketamine|mesh-list
65286232|NCT02577250|Analgesics|analgesics|mesh-ancestor
65286233|NCT02577250|Sensory System Agents|sensory system agents|mesh-ancestor
65286234|NCT02577250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65286235|NCT02577250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286236|NCT02577250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64516498|NCT03286296|Antibodies|antibodies|mesh-list
64811892|NCT01449825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64811893|NCT01449825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811894|NCT01449825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64811895|NCT01449825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64811896|NCT01449825|Growth Substances|growth substances|mesh-ancestor
64811897|NCT01449825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811898|NCT01449825|Growth Inhibitors|growth inhibitors|mesh-ancestor
64811899|NCT01449825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64811900|NCT01449825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811901|NCT01449825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811902|NCT01449877|Trimethoprim|trimethoprim|mesh-list
65286237|NCT02577250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65286238|NCT02577250|Anesthetics, General|anesthetics, general|mesh-ancestor
65286239|NCT02577250|Anesthetics|anesthetics|mesh-ancestor
65286240|NCT02577250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65286241|NCT02577250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65286242|NCT02577250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65286243|NCT02577250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65286244|NCT02577250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286245|NCT00668850|Insulin|insulin|mesh-list
65286246|NCT00668850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65286247|NCT00668850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65286248|NCT00668850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286249|NCT02762123|Flurbiprofen|flurbiprofen|mesh-list
65286250|NCT02762123|Digoxin|digoxin|mesh-list
65286251|NCT02762123|Midazolam|midazolam|mesh-list
65286252|NCT02762123|Omeprazole|omeprazole|mesh-list
65286253|NCT02762123|Montelukast|montelukast|mesh-list
65286254|NCT02762123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65286255|NCT02762123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64516524|NCT04755387|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65494280|NCT02581787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494281|NCT02518555|Vaccines|vaccines|mesh-list
65494282|NCT02518555|Immunologic Factors|immunologic factors|mesh-ancestor
65494283|NCT02518555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494284|NCT02027376|Docetaxel|docetaxel|mesh-list
65494285|NCT02027376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494286|NCT02027376|Tubulin Modulators|tubulin modulators|mesh-ancestor
64472434|NCT03371017|Antiviral Agents|antiviral agents|mesh-ancestor
64472440|NCT03301506|Seladelpar|seladelpar|mesh-list
64472441|NCT03301506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64811903|NCT01449877|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64811904|NCT01449877|Sulfamethoxazole|sulfamethoxazole|mesh-list
64811905|NCT01449877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64811906|NCT01449877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64811907|NCT01449877|Renal Agents|renal agents|mesh-ancestor
64811908|NCT01449877|Antimalarials|antimalarials|mesh-ancestor
64811909|NCT01449877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64811910|NCT01449877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64811911|NCT01449877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64811912|NCT01449877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811913|NCT01449877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811914|NCT01449877|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64811915|NCT01449877|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64811916|NCT01449877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64811917|NCT01449877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64811918|NCT01450163|Oxaliplatin|oxaliplatin|mesh-list
64811923|NCT01450163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64811924|NCT01450163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811926|NCT01450163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64811927|NCT01450163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64811928|NCT01450163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811929|NCT01450163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64811930|NCT01450163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64811931|NCT01450163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64811932|NCT01450163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65286256|NCT02762123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65286257|NCT02762123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286258|NCT02762123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65286259|NCT02762123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65286260|NCT02762123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65286261|NCT02762123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64811933|NCT01450163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64811934|NCT01450267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64811935|NCT01450995|Sumatriptan|sumatriptan|mesh-list
64811936|NCT01450995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64811937|NCT01450995|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64811938|NCT01450995|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64811939|NCT01450995|Serotonin Agents|serotonin agents|mesh-ancestor
64811940|NCT01450995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64811941|NCT01450995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811942|NCT01450995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811943|NCT01451320|Plasminogen|plasminogen|mesh-list
64811944|NCT01451320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64811945|NCT01451320|Streptokinase|streptokinase|mesh-list
64811946|NCT01451320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64811947|NCT01451320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64811948|NCT01451320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811949|NCT01451489|Cyclophosphamide|cyclophosphamide|mesh-list
64811950|NCT01451489|Tacrolimus|tacrolimus|mesh-list
64811951|NCT01451489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64811952|NCT01451489|Immunologic Factors|immunologic factors|mesh-ancestor
64811953|NCT01451489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811954|NCT01451489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64811955|NCT01451489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64811956|NCT01451489|Alkylating Agents|alkylating agents|mesh-ancestor
64811957|NCT01451489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811958|NCT01451489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811959|NCT01451489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64811960|NCT01451489|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64811961|NCT01451489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811962|NCT01451853|Ebselen|ebselen|mesh-list
64811963|NCT01451853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64811964|NCT01451853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64811965|NCT01451853|Analgesics|analgesics|mesh-ancestor
65494287|NCT02027376|Antimitotic Agents|antimitotic agents|mesh-ancestor
65494288|NCT02027376|Mitosis Modulators|mitosis modulators|mesh-ancestor
65494289|NCT02027376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811972|NCT01451853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64811973|NCT01451853|Antioxidants|antioxidants|mesh-ancestor
64811974|NCT01451853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811975|NCT01451853|Protective Agents|protective agents|mesh-ancestor
64811976|NCT01451853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64811977|NCT01451853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811978|NCT01451853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64811980|NCT01452243|Calcium|calcium|mesh-list
64811981|NCT01452243|Vitamins|vitamins|mesh-ancestor
64811982|NCT01452243|Micronutrients|micronutrients|mesh-ancestor
64811983|NCT01452243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811984|NCT01452243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64811985|NCT01452243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64811986|NCT01452256|Propofol|propofol|mesh-list
64811987|NCT01452256|Desflurane|desflurane|mesh-list
64811988|NCT01452256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64423057|NCT03929029|Nivolumab|nivolumab|mesh-list
64812005|NCT01452607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812007|NCT01452607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64812008|NCT01452607|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64812009|NCT01452607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64812010|NCT01452607|Antioxidants|antioxidants|mesh-ancestor
64812011|NCT01452607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812012|NCT01452607|Protective Agents|protective agents|mesh-ancestor
64812013|NCT01452607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64812014|NCT01452607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812015|NCT01452607|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65286262|NCT02762123|Anesthetics, General|anesthetics, general|mesh-ancestor
65286263|NCT02762123|Anesthetics|anesthetics|mesh-ancestor
65286264|NCT02762123|GABA Modulators|gaba modulators|mesh-ancestor
65286265|NCT02762123|GABA Agents|gaba agents|mesh-ancestor
65286266|NCT02762123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65286267|NCT02762123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286268|NCT02762123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65286269|NCT02762123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65286270|NCT02762123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65286271|NCT02762123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286272|NCT02762123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65286273|NCT02762123|Respiratory System Agents|respiratory system agents|mesh-ancestor
65286274|NCT02762123|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65286275|NCT02762123|Hormone Antagonists|hormone antagonists|mesh-ancestor
64516544|NCT00160173|Estradiol|estradiol|mesh-list
64516545|NCT00160173|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64812016|NCT01453062|Ofatumumab|ofatumumab|mesh-list
64812017|NCT01453062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812018|NCT01453283|Trabectedin|trabectedin|mesh-list
64812019|NCT01453283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64812021|NCT01453283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812022|NCT01453283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812023|NCT01454700|Insulin|insulin|mesh-list
64812024|NCT01454700|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64812025|NCT01454700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64812026|NCT01454700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812027|NCT01454869|Heparin|heparin|mesh-list
64812028|NCT01454869|Anticoagulants|anticoagulants|mesh-ancestor
64812029|NCT01454869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64812030|NCT01454869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64812031|NCT01454869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812032|NCT01455350|Lidocaine|lidocaine|mesh-list
64812033|NCT01455350|Anesthetics, Local|anesthetics, local|mesh-ancestor
64812034|NCT01455350|Anesthetics|anesthetics|mesh-ancestor
64812035|NCT01455350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64812036|NCT01455350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812037|NCT01455350|Sensory System Agents|sensory system agents|mesh-ancestor
64812038|NCT01455350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64812039|NCT01455350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64812040|NCT01455350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64812041|NCT01455350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64812042|NCT01455350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64812043|NCT01455350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812072|NCT01456585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812073|NCT01456585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64812074|NCT01456585|Immunologic Factors|immunologic factors|mesh-ancestor
64514732|NCT02393157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64812075|NCT01456585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812076|NCT01456650|Glyburide|glyburide|mesh-list
64812077|NCT01456650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64812078|NCT01456650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812079|NCT01457040|Etoposide|etoposide|mesh-list
64812080|NCT01457040|Etoposide phosphate|etoposide phosphate|mesh-list
64812081|NCT01457040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64812082|NCT01457040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812083|NCT01457040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64812084|NCT01457040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64812085|NCT01457040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812086|NCT01457040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286276|NCT02762123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65286277|NCT02762123|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65286278|NCT02762123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65286279|NCT02762123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65286280|NCT02762123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65286281|NCT02762123|Protective Agents|protective agents|mesh-ancestor
65286282|NCT02762123|Analgesics|analgesics|mesh-ancestor
65286283|NCT02762123|Sensory System Agents|sensory system agents|mesh-ancestor
65286284|NCT02762123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65286285|NCT02762123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65286286|NCT02762123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65286287|NCT02762123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65286288|NCT02762123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64812087|NCT01457508|Edetic Acid|edetic acid|mesh-list
64812088|NCT01457508|Pentetic Acid|pentetic acid|mesh-list
64812089|NCT01457508|Antidotes|antidotes|mesh-ancestor
64812090|NCT01457508|Protective Agents|protective agents|mesh-ancestor
64812091|NCT01457508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812092|NCT01457508|Chelating Agents|chelating agents|mesh-ancestor
64812093|NCT01457508|Sequestering Agents|sequestering agents|mesh-ancestor
64812094|NCT01457508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812096|NCT01457508|Anticoagulants|anticoagulants|mesh-ancestor
64812097|NCT01457508|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64812098|NCT01458431|Anesthetics|anesthetics|mesh-list
64812099|NCT01458431|Levobupivacaine|levobupivacaine|mesh-list
64812100|NCT01458431|Anesthetics, Local|anesthetics, local|mesh-list
64812101|NCT01458431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64812102|NCT01458431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812103|NCT01458431|Sensory System Agents|sensory system agents|mesh-ancestor
64812104|NCT01458431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423189|NCT05305105|Psilocybin|psilocybin|mesh-list
64812121|NCT01459445|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64812123|NCT01459445|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64812124|NCT01459445|Diuretics|diuretics|mesh-ancestor
64812125|NCT01459445|Natriuretic Agents|natriuretic agents|mesh-ancestor
64812126|NCT01460030|Cinacalcet|cinacalcet|mesh-list
64812127|NCT01460030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64812128|NCT01460030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812129|NCT01460030|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64812130|NCT01460030|Hormone Antagonists|hormone antagonists|mesh-ancestor
64812131|NCT01460030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64812132|NCT01460069|Liraglutide|liraglutide|mesh-list
64812133|NCT01460069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64812134|NCT01460069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812135|NCT01460069|Incretins|incretins|mesh-ancestor
64812136|NCT01460069|Hormones|hormones|mesh-ancestor
64812137|NCT01460069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64812138|NCT01460134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64812139|NCT01460134|Immunologic Factors|immunologic factors|mesh-ancestor
64812140|NCT01460134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812141|NCT01460212|Fluvoxamine|fluvoxamine|mesh-list
64812142|NCT01460212|Citalopram|citalopram|mesh-list
64812173|NCT01460355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64812174|NCT01460355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64812175|NCT01460420|Lenalidomide|lenalidomide|mesh-list
64812176|NCT01460420|Bortezomib|bortezomib|mesh-list
64812177|NCT01460420|Immunologic Factors|immunologic factors|mesh-ancestor
64812178|NCT01460420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812179|NCT01460420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64812180|NCT01460420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64812181|NCT01460420|Growth Substances|growth substances|mesh-ancestor
65286289|NCT02762123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65286290|NCT04153734|Paclitaxel|paclitaxel|mesh-list
65286291|NCT04153734|Carboplatin|carboplatin|mesh-list
65286292|NCT04153734|Pembrolizumab|pembrolizumab|mesh-list
65286293|NCT04153734|Pemetrexed|pemetrexed|mesh-list
65286294|NCT04153734|Cisplatin|cisplatin|mesh-list
65286295|NCT04153734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65286296|NCT04153734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286297|NCT04153734|Tubulin Modulators|tubulin modulators|mesh-ancestor
65286298|NCT04153734|Antimitotic Agents|antimitotic agents|mesh-ancestor
65286299|NCT04153734|Mitosis Modulators|mitosis modulators|mesh-ancestor
64516573|NCT02459574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64812182|NCT01460420|Growth Inhibitors|growth inhibitors|mesh-ancestor
64812183|NCT01460420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812184|NCT01460498|Azacitidine|azacitidine|mesh-list
64812185|NCT01460498|Decitabine|decitabine|mesh-list
64812186|NCT01460498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64812187|NCT01460498|Antimetabolites|antimetabolites|mesh-ancestor
64812188|NCT01460498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812189|NCT01460498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812190|NCT01460498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812191|NCT01460537|Gemcitabine|gemcitabine|mesh-list
64812192|NCT01460537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812193|NCT01460537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64812194|NCT01460537|Antimetabolites|antimetabolites|mesh-ancestor
64812195|NCT01460537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812214|NCT01460563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64812215|NCT01460563|Tocolytic Agents|tocolytic agents|mesh-ancestor
64812216|NCT01460563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64812218|NCT01460602|Bortezomib|bortezomib|mesh-list
64812219|NCT01460602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64812220|NCT01460602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812221|NCT01460602|Immunologic Factors|immunologic factors|mesh-ancestor
64812222|NCT01460602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812223|NCT01460602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64812224|NCT01460615|Hydrocortisone|hydrocortisone|mesh-list
64812225|NCT01460615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64812226|NCT01460667|Acetaminophen|acetaminophen|mesh-list
64812227|NCT01460667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64812228|NCT01460667|Analgesics|analgesics|mesh-ancestor
64812229|NCT01460667|Sensory System Agents|sensory system agents|mesh-ancestor
64423303|NCT05347069|Aspirin|aspirin|mesh-list
64812252|NCT01460888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812253|NCT01460888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812254|NCT01460979|Sirolimus|sirolimus|mesh-list
64812255|NCT01460979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64812256|NCT01460979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812257|NCT01460979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64812258|NCT01460979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812259|NCT01460979|Antifungal Agents|antifungal agents|mesh-ancestor
64812260|NCT01460979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64812261|NCT01460979|Immunologic Factors|immunologic factors|mesh-ancestor
64812262|NCT01460979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812263|NCT01461018|Immunoglobulins|immunoglobulins|mesh-list
64812264|NCT01461018|Antibodies|antibodies|mesh-list
64812265|NCT01461018|gamma-Globulins|gamma-globulins|mesh-list
64812266|NCT01461018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64812267|NCT01461018|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65494295|NCT02005289|Growth Substances|growth substances|mesh-ancestor
64472443|NCT03301506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472444|NCT03301506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64472446|NCT03290391|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64472447|NCT03290391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64514733|NCT02393157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812277|NCT01461174|Modafinil|modafinil|mesh-list
64812278|NCT01461174|Donepezil|donepezil|mesh-list
65286300|NCT04153734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286301|NCT04153734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65286302|NCT04153734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286303|NCT04153734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65286304|NCT04153734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65286305|NCT04073680|Canagliflozin|canagliflozin|mesh-list
65286306|NCT04073680|Serabelisib|serabelisib|mesh-list
65286307|NCT04073680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65286308|NCT04073680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286309|NCT04073680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65286310|NCT04073680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286311|NCT04073680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286312|NCT02761577|Acetylcysteine|acetylcysteine|mesh-list
65286313|NCT02761577|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65286314|NCT02761577|Antiviral Agents|antiviral agents|mesh-ancestor
65286315|NCT02761577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65286316|NCT02761577|Expectorants|expectorants|mesh-ancestor
65286317|NCT02761577|Respiratory System Agents|respiratory system agents|mesh-ancestor
65286318|NCT02761577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65286319|NCT02761577|Antioxidants|antioxidants|mesh-ancestor
65286320|NCT02761577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286321|NCT02761577|Protective Agents|protective agents|mesh-ancestor
65286322|NCT02761577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286323|NCT02761577|Antidotes|antidotes|mesh-ancestor
65286324|NCT00579982|Lamotrigine|lamotrigine|mesh-list
65286325|NCT00579982|Anticonvulsants|anticonvulsants|mesh-ancestor
64812279|NCT01461174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64812280|NCT01461174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812281|NCT01461174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812282|NCT01461174|Cholinergic Agents|cholinergic agents|mesh-ancestor
64812283|NCT01461174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64812284|NCT01461174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812292|NCT01461174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64812293|NCT01461174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64812294|NCT01461174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64812295|NCT01461460|Moxifloxacin|moxifloxacin|mesh-list
64812296|NCT01461460|Tedizolid|tedizolid|mesh-list
64812297|NCT01461460|Tedizolid phosphate|tedizolid phosphate|mesh-list
64812298|NCT01461460|Oxazolidinones|oxazolidinones|mesh-list
64812299|NCT01461460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64812300|NCT01461460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812301|NCT01461460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64812302|NCT01461460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64812303|NCT01461460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812304|NCT01461460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812305|NCT01461460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812306|NCT01461460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65286326|NCT00579982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65286327|NCT00579982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65286328|NCT00579982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286329|NCT00579982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65286330|NCT00579982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286331|NCT00579982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64812307|NCT01461577|Insulin Glargine|insulin glargine|mesh-list
64812308|NCT01461577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64812309|NCT01461577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812310|NCT01461616|Insulin|insulin|mesh-list
64812311|NCT01461616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64812312|NCT01461616|Insulin Glargine|insulin glargine|mesh-list
64812313|NCT01461616|Insulin Detemir|insulin detemir|mesh-list
64812314|NCT01461616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64812315|NCT01461616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812316|NCT01461746|Docetaxel|docetaxel|mesh-list
64812317|NCT01461746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812318|NCT01461746|Tubulin Modulators|tubulin modulators|mesh-ancestor
64812319|NCT01461746|Antimitotic Agents|antimitotic agents|mesh-ancestor
64812320|NCT01461746|Mitosis Modulators|mitosis modulators|mesh-ancestor
64812321|NCT01461746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812322|NCT01461759|Cisplatin|cisplatin|mesh-list
64812323|NCT01461759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812325|NCT01461772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812326|NCT01461876|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64812327|NCT01461876|Antiviral Agents|antiviral agents|mesh-ancestor
64812328|NCT01461876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812329|NCT01462006|Sirolimus|sirolimus|mesh-list
64812330|NCT01462006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64812331|NCT01462006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812332|NCT01462006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64812333|NCT01462006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812334|NCT01462006|Antifungal Agents|antifungal agents|mesh-ancestor
64812335|NCT01462006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64812336|NCT01462006|Immunologic Factors|immunologic factors|mesh-ancestor
64812337|NCT01462006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812338|NCT01462058|Vitamin D|vitamin d|mesh-list
64812339|NCT01462058|Cholecalciferol|cholecalciferol|mesh-list
64812340|NCT01462058|Vitamins|vitamins|mesh-ancestor
64812341|NCT01462058|Micronutrients|micronutrients|mesh-ancestor
65494296|NCT02005289|Growth Inhibitors|growth inhibitors|mesh-ancestor
65494297|NCT02005289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494298|NCT01924533|Paclitaxel|paclitaxel|mesh-list
65494299|NCT01924533|Olaparib|olaparib|mesh-list
64812376|NCT01462617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812378|NCT01462669|Anticonvulsants|anticonvulsants|mesh-ancestor
64812379|NCT01462669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64812380|NCT01462669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812381|NCT01462968|Heparin|heparin|mesh-list
64812382|NCT01462968|Anticoagulants|anticoagulants|mesh-ancestor
64812383|NCT01462968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64812384|NCT01462968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64812385|NCT01462968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812386|NCT01463046|Cytarabine|cytarabine|mesh-list
64812387|NCT01463046|Daunorubicin|daunorubicin|mesh-list
64812388|NCT01463046|Panobinostat|panobinostat|mesh-list
64812389|NCT01463046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64812390|NCT01463046|Antimetabolites|antimetabolites|mesh-ancestor
64812391|NCT01463046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812392|NCT01463046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812393|NCT01463046|Antiviral Agents|antiviral agents|mesh-ancestor
64812394|NCT01463046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812395|NCT01463046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64812396|NCT01463046|Immunologic Factors|immunologic factors|mesh-ancestor
64812397|NCT01463046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812398|NCT01463046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64812399|NCT01463046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64812400|NCT01463046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64812402|NCT01463046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65286332|NCT00579982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65286333|NCT00579982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65286334|NCT00579982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65286335|NCT00579982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65286336|NCT00596466|Pregabalin|pregabalin|mesh-list
65286337|NCT00596466|Analgesics|analgesics|mesh-ancestor
65286338|NCT00596466|Sensory System Agents|sensory system agents|mesh-ancestor
65286339|NCT00596466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65286340|NCT00596466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812403|NCT01463150|Clopidogrel|clopidogrel|mesh-list
64812404|NCT01463150|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64812405|NCT01463150|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64812406|NCT01463150|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64812407|NCT01463150|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64812408|NCT01463150|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64812409|NCT01463150|Purinergic Agents|purinergic agents|mesh-ancestor
64812410|NCT01463150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64487764|NCT01836094|Methylene Blue|methylene blue|mesh-list
64812432|NCT01463280|Lidocaine|lidocaine|mesh-list
64812433|NCT01463280|Anesthetics, Local|anesthetics, local|mesh-ancestor
64812434|NCT01463280|Anesthetics|anesthetics|mesh-ancestor
64812435|NCT01463280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64812436|NCT01463280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812437|NCT01463280|Sensory System Agents|sensory system agents|mesh-ancestor
64812438|NCT01463280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64812439|NCT01463280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64812440|NCT01463280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64812441|NCT01463280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65494302|NCT01924533|Tubulin Modulators|tubulin modulators|mesh-ancestor
64472448|NCT03290391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472449|NCT03290391|Sensory System Agents|sensory system agents|mesh-ancestor
64472450|NCT03290391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64472451|NCT03283878|Cefazolin|cefazolin|mesh-list
64472452|NCT03283878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64472453|NCT03283878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64472454|NCT03280030|Midostaurin|midostaurin|mesh-list
64472455|NCT03280030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812442|NCT01463280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64812443|NCT01463280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812444|NCT01463332|Dexmedetomidine|dexmedetomidine|mesh-list
64812445|NCT01463332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64812446|NCT01463332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64812447|NCT01463332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812448|NCT01463332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64812449|NCT01463332|Analgesics|analgesics|mesh-ancestor
64812450|NCT01463332|Sensory System Agents|sensory system agents|mesh-ancestor
64812451|NCT01463332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64812452|NCT01463332|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64812453|NCT01463332|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64812454|NCT01463332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64812455|NCT01463332|Adrenergic Agents|adrenergic agents|mesh-ancestor
64812456|NCT01463332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64812457|NCT01463332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812458|NCT01463371|Azithromycin|azithromycin|mesh-list
64812459|NCT01463371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64812460|NCT01463371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812461|NCT01463592|Iodine|iodine|mesh-list
64812462|NCT01463592|Interferons|interferons|mesh-list
64812463|NCT01463592|Ribavirin|ribavirin|mesh-list
64812464|NCT01463592|Interferon-alpha|interferon-alpha|mesh-list
64812465|NCT01463592|Interferon alpha-2|interferon alpha-2|mesh-list
64812466|NCT01463592|Cadexomer iodine|cadexomer iodine|mesh-list
64812467|NCT01463592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812468|NCT01463592|Antiviral Agents|antiviral agents|mesh-ancestor
64812469|NCT01463592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64487820|NCT00915538|Hormones|hormones|mesh-ancestor
64812498|NCT01463813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286341|NCT00596466|Anticonvulsants|anticonvulsants|mesh-ancestor
65286342|NCT00596466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65286343|NCT00596466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65286344|NCT00596466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286345|NCT00596466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65286346|NCT00596466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65286347|NCT00596466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65286348|NCT00596466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65286349|NCT00596466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65286350|NCT04071574|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64558494|NCT03814109|Niacin|niacin|mesh-list
64812499|NCT01463813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64812500|NCT01463813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64812501|NCT01463852|Vincristine|vincristine|mesh-list
64812502|NCT01463852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64812503|NCT01463852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812504|NCT01463852|Tubulin Modulators|tubulin modulators|mesh-ancestor
64812505|NCT01463852|Antimitotic Agents|antimitotic agents|mesh-ancestor
64812506|NCT01463852|Mitosis Modulators|mitosis modulators|mesh-ancestor
64812507|NCT01463852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812508|NCT01463865|Ropivacaine|ropivacaine|mesh-list
64812509|NCT01463865|Anesthetics, Local|anesthetics, local|mesh-ancestor
65494303|NCT01924533|Antimitotic Agents|antimitotic agents|mesh-ancestor
65494304|NCT01924533|Mitosis Modulators|mitosis modulators|mesh-ancestor
65494305|NCT01924533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494306|NCT01924533|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65494307|NCT01924533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494308|NCT01683955|Tranexamic Acid|tranexamic acid|mesh-list
65494309|NCT01683955|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65494310|NCT01683955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65494311|NCT01683955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494312|NCT01683955|Hemostatics|hemostatics|mesh-ancestor
64472456|NCT03280030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64472457|NCT03280030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472458|NCT03280030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472486|NCT03204188|Fludarabine|fludarabine|mesh-list
64812510|NCT01463865|Anesthetics|anesthetics|mesh-ancestor
64812511|NCT01463865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64812512|NCT01463865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812513|NCT01463865|Sensory System Agents|sensory system agents|mesh-ancestor
64812514|NCT01463865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64812515|NCT01463956|Interferons|interferons|mesh-list
64812516|NCT01463956|Ribavirin|ribavirin|mesh-list
64812517|NCT01463956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812518|NCT01463956|Antiviral Agents|antiviral agents|mesh-ancestor
64812519|NCT01463956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812520|NCT01463956|Antimetabolites|antimetabolites|mesh-ancestor
64812521|NCT01463956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812522|NCT01464008|Interferons|interferons|mesh-list
64812523|NCT01464008|Ribavirin|ribavirin|mesh-list
64812524|NCT01464008|Interferon-alpha|interferon-alpha|mesh-list
64812525|NCT01464008|Interferon alpha-2|interferon alpha-2|mesh-list
64812526|NCT01464008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64812527|NCT01464008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812528|NCT01464008|Antiviral Agents|antiviral agents|mesh-ancestor
64812529|NCT01464008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812569|NCT01464125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812570|NCT01464138|Clindamycin|clindamycin|mesh-list
64812571|NCT01464138|Clindamycin palmitate|clindamycin palmitate|mesh-list
64812572|NCT01464138|Clindamycin phosphate|clindamycin phosphate|mesh-list
64812573|NCT01464138|Fosmidomycin|fosmidomycin|mesh-list
64812574|NCT01464138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64812575|NCT01464138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812576|NCT01464138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65286351|NCT04071574|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65286352|NCT04071574|Cetrorelix|cetrorelix|mesh-list
65286353|NCT04071574|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65286354|NCT04071574|Hormones|hormones|mesh-ancestor
65286355|NCT04071574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65286356|NCT04071574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286357|NCT04071574|Luteolytic Agents|luteolytic agents|mesh-ancestor
65286358|NCT04071574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65286359|NCT04071574|Contraceptive Agents|contraceptive agents|mesh-ancestor
65286360|NCT04071574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65286361|NCT04071574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64516635|NCT01673217|Antimetabolites|antimetabolites|mesh-ancestor
64812577|NCT01464138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812578|NCT01464138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812579|NCT01464242|Meglumine Antimoniate|meglumine antimoniate|mesh-list
64812580|NCT01464242|Pentoxifylline|pentoxifylline|mesh-list
64812581|NCT01464242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64812582|NCT01464242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812583|NCT01464242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812584|NCT01464242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64812591|NCT01464242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64812592|NCT01464242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64812593|NCT01464242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812594|NCT01464281|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64812595|NCT01464281|Antiviral Agents|antiviral agents|mesh-ancestor
64812596|NCT01464281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812597|NCT01464450|Rivaroxaban|rivaroxaban|mesh-list
64812598|NCT01464450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64812599|NCT01464450|Antithrombins|antithrombins|mesh-ancestor
64812600|NCT01464450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64812601|NCT01464450|Protease Inhibitors|protease inhibitors|mesh-ancestor
64812602|NCT01464450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812603|NCT01464450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812604|NCT01464450|Anticoagulants|anticoagulants|mesh-ancestor
64812605|NCT01464476|Azimilide|azimilide|mesh-list
64812606|NCT01464476|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64812607|NCT01464476|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64812628|NCT01466608|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64812629|NCT01466608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64812630|NCT01466608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64812631|NCT01466608|Antimetabolites|antimetabolites|mesh-ancestor
64812632|NCT01466608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812633|NCT01466608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64812634|NCT01466608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64812635|NCT01466608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812636|NCT01466712|Beclomethasone|beclomethasone|mesh-list
64812637|NCT01466712|Formoterol Fumarate|formoterol fumarate|mesh-list
64812638|NCT01466712|Tiotropium Bromide|tiotropium bromide|mesh-list
64812639|NCT01466712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64812640|NCT01466712|Autonomic Agents|autonomic agents|mesh-ancestor
64812641|NCT01466712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64812642|NCT01466712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812643|NCT01466712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64812644|NCT01466712|Respiratory System Agents|respiratory system agents|mesh-ancestor
64812645|NCT01466712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64812646|NCT01466712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64812647|NCT01466712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64812648|NCT01466712|Adrenergic Agents|adrenergic agents|mesh-ancestor
64812649|NCT01466712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64812650|NCT01466712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812651|NCT01466712|Parasympatholytics|parasympatholytics|mesh-ancestor
64812652|NCT01466712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65286362|NCT04071574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65286363|NCT04071574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286364|NCT04071574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65286365|NCT04071574|Fertility Agents|fertility agents|mesh-ancestor
65286366|NCT04071574|Hormone Antagonists|hormone antagonists|mesh-ancestor
65286367|NCT02763059|Acetaminophen|acetaminophen|mesh-list
65286368|NCT02763059|Dexamethasone|dexamethasone|mesh-list
65286369|NCT02763059|Ibuprofen|ibuprofen|mesh-list
65286370|NCT02763059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65286371|NCT02763059|Antiemetics|antiemetics|mesh-ancestor
65286372|NCT02763059|Autonomic Agents|autonomic agents|mesh-ancestor
65286373|NCT02763059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65286374|NCT02763059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286375|NCT02763059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65286376|NCT02763059|Glucocorticoids|glucocorticoids|mesh-ancestor
65286377|NCT02763059|Hormones|hormones|mesh-ancestor
65286378|NCT02763059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65286379|NCT02763059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65286380|NCT02763059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286381|NCT02763059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65286382|NCT02763059|Analgesics|analgesics|mesh-ancestor
65286383|NCT02763059|Sensory System Agents|sensory system agents|mesh-ancestor
64516657|NCT01668849|Fentanyl|fentanyl|mesh-list
64812653|NCT01466712|Cholinergic Agents|cholinergic agents|mesh-ancestor
64812654|NCT01466712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64812655|NCT01466712|Glucocorticoids|glucocorticoids|mesh-ancestor
65494320|NCT01674140|Goserelin|goserelin|mesh-list
65494321|NCT01674140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494322|NCT01674140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494323|NCT01674140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64472492|NCT03203850|Sequestering Agents|sequestering agents|mesh-ancestor
64472493|NCT03203850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472495|NCT03194867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64472496|NCT03194867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472497|NCT03184870|Leucovorin|leucovorin|mesh-list
64472498|NCT03184870|Gemcitabine|gemcitabine|mesh-list
64472499|NCT03184870|Paclitaxel|paclitaxel|mesh-list
64472500|NCT03184870|Fluorouracil|fluorouracil|mesh-list
64472501|NCT03184870|Nivolumab|nivolumab|mesh-list
64472502|NCT03184870|Irinotecan|irinotecan|mesh-list
64472503|NCT03184870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64472504|NCT03184870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472505|NCT03184870|Tubulin Modulators|tubulin modulators|mesh-ancestor
64812686|NCT01466959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812687|NCT01467011|Mycophenolic Acid|mycophenolic acid|mesh-list
64812688|NCT01467011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64812689|NCT01467011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812690|NCT01467011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64812691|NCT01467011|Antitubercular Agents|antitubercular agents|mesh-ancestor
64812692|NCT01467011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64812693|NCT01467011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812694|NCT01467011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812695|NCT01467011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812696|NCT01467115|Leucovorin|leucovorin|mesh-list
64812697|NCT01467115|Docetaxel|docetaxel|mesh-list
65286384|NCT02763059|Antipyretics|antipyretics|mesh-ancestor
65286385|NCT02763059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65286386|NCT02763059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65286387|NCT02763059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65286388|NCT02763059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286389|NCT02763059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286390|NCT04222517|Hemostatics|hemostatics|mesh-list
65286391|NCT04222517|Coagulants|coagulants|mesh-ancestor
65286392|NCT00671112|Everolimus|everolimus|mesh-list
65286393|NCT00671112|Bortezomib|bortezomib|mesh-list
65286394|NCT00671112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286395|NCT00671112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65286396|NCT00671112|Immunologic Factors|immunologic factors|mesh-ancestor
64812698|NCT01467115|Fluorouracil|fluorouracil|mesh-list
64812699|NCT01467115|Cetuximab|cetuximab|mesh-list
64812700|NCT01467115|Epoetin Alfa|epoetin alfa|mesh-list
64812701|NCT01467115|Levoleucovorin|levoleucovorin|mesh-list
64812702|NCT01467115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812703|NCT01467115|Tubulin Modulators|tubulin modulators|mesh-ancestor
64812704|NCT01467115|Antimitotic Agents|antimitotic agents|mesh-ancestor
64812705|NCT01467115|Mitosis Modulators|mitosis modulators|mesh-ancestor
64812706|NCT01467115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812707|NCT01467115|Antimetabolites|antimetabolites|mesh-ancestor
64812708|NCT01467115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64812709|NCT01467115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64812710|NCT01467115|Immunologic Factors|immunologic factors|mesh-ancestor
64812711|NCT01467115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812712|NCT01467115|Antidotes|antidotes|mesh-ancestor
65494324|NCT01674140|Immunologic Factors|immunologic factors|mesh-ancestor
65494325|NCT01674140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494326|NCT01674140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65494327|NCT01674140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65494328|NCT01674140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494329|NCT01674140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65494330|NCT01674140|Hormone Antagonists|hormone antagonists|mesh-ancestor
65494331|NCT01674140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65494332|NCT01674140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65494333|NCT01674140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65494334|NCT01674140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64472506|NCT03184870|Antimitotic Agents|antimitotic agents|mesh-ancestor
64472507|NCT03184870|Mitosis Modulators|mitosis modulators|mesh-ancestor
64472508|NCT03184870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472509|NCT03184870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64472510|NCT03184870|Antimetabolites|antimetabolites|mesh-ancestor
64472511|NCT03184870|Antiviral Agents|antiviral agents|mesh-ancestor
64472512|NCT03184870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64472513|NCT03184870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472514|NCT03184870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64812749|NCT01467297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64812750|NCT01467297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64812751|NCT01467297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64812752|NCT01467297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812753|NCT01467297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812780|NCT01467401|Biphasic Insulins|biphasic insulins|mesh-list
64812781|NCT01467401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64812782|NCT01467401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812783|NCT01467414|Insulin|insulin|mesh-list
64812784|NCT01467414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64812785|NCT01467414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812786|NCT01467518|Dolutegravir|dolutegravir|mesh-list
64812787|NCT01467518|Methadone|methadone|mesh-list
64812788|NCT01467518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64812789|NCT01467518|Narcotics|narcotics|mesh-ancestor
65286397|NCT00671112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286398|NCT04857385|Hemostatics|hemostatics|mesh-list
65286399|NCT04857385|Coagulants|coagulants|mesh-ancestor
65286400|NCT00664014|Tolvaptan|tolvaptan|mesh-list
65286401|NCT00664014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65286402|NCT00664014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286403|NCT00664014|Natriuretic Agents|natriuretic agents|mesh-ancestor
64812790|NCT01467518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64423848|NCT05106127|Lenvatinib|lenvatinib|mesh-list
64812799|NCT01467518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812800|NCT01467518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812801|NCT01467518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64812802|NCT01467518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64812803|NCT01467518|Antiviral Agents|antiviral agents|mesh-ancestor
64812804|NCT01467518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812805|NCT01467531|Dolutegravir|dolutegravir|mesh-list
64812806|NCT01467531|Cabotegravir|cabotegravir|mesh-list
64812807|NCT01467531|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64812808|NCT01467531|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64812809|NCT01467531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812810|NCT01467531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812811|NCT01467531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64812812|NCT01467531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64812813|NCT01467531|Antiviral Agents|antiviral agents|mesh-ancestor
64812814|NCT01467531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494335|NCT01674140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64472551|NCT03138720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64812816|NCT01467596|Levobupivacaine|levobupivacaine|mesh-list
64812817|NCT01467596|Anesthetics, Local|anesthetics, local|mesh-ancestor
64812818|NCT01467596|Anesthetics|anesthetics|mesh-ancestor
64812819|NCT01467596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64812820|NCT01467596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812821|NCT01467596|Sensory System Agents|sensory system agents|mesh-ancestor
64812822|NCT01467596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64812823|NCT01467596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64812824|NCT01467596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64812825|NCT01467596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64812826|NCT01467596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64812827|NCT01467596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494357|NCT01345175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65494358|NCT01345175|Metronidazole|metronidazole|mesh-list
65494359|NCT01345175|Rifaximin|rifaximin|mesh-list
65494360|NCT01345175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65494361|NCT01345175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494362|NCT01345175|Antitubercular Agents|antitubercular agents|mesh-ancestor
65494363|NCT01345175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65494364|NCT01345175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65494365|NCT01345175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65494366|NCT01295645|Cidofovir|cidofovir|mesh-list
65494367|NCT01295645|Antiviral Agents|antiviral agents|mesh-ancestor
64472552|NCT03138720|Antimetabolites|antimetabolites|mesh-ancestor
64472553|NCT03138720|Antiviral Agents|antiviral agents|mesh-ancestor
64472554|NCT03138720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64472555|NCT03138720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472557|NCT03138720|Immunologic Factors|immunologic factors|mesh-ancestor
64472558|NCT03138720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472559|NCT03131726|Simvastatin|simvastatin|mesh-list
64812852|NCT01467986|Irinotecan|irinotecan|mesh-list
64812853|NCT01467986|Temozolomide|temozolomide|mesh-list
64812854|NCT01467986|Dasatinib|dasatinib|mesh-list
64812855|NCT01467986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64812856|NCT01467986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64812857|NCT01467986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812863|NCT01467986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812864|NCT01467986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64812865|NCT01467986|Antifungal Agents|antifungal agents|mesh-ancestor
64812866|NCT01467986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64812867|NCT01467986|Immunologic Factors|immunologic factors|mesh-ancestor
64812868|NCT01467986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286404|NCT00664014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286405|NCT02696915|Fentanyl|fentanyl|mesh-list
65286406|NCT02696915|Bupivacaine|bupivacaine|mesh-list
65286407|NCT02696915|Anesthetics, Local|anesthetics, local|mesh-ancestor
65286408|NCT02696915|Anesthetics|anesthetics|mesh-ancestor
65286409|NCT02696915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65286410|NCT02696915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286411|NCT02696915|Sensory System Agents|sensory system agents|mesh-ancestor
65286412|NCT02696915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65286413|NCT02696915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65286414|NCT02696915|Narcotics|narcotics|mesh-ancestor
65286415|NCT02696915|Analgesics|analgesics|mesh-ancestor
65286416|NCT02696915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65286417|NCT02696915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65286418|NCT02696915|Anesthetics, General|anesthetics, general|mesh-ancestor
65286419|NCT00911664|Vitamin D|vitamin d|mesh-list
65286420|NCT00911664|Ergocalciferols|ergocalciferols|mesh-list
65286421|NCT00911664|Cholecalciferol|cholecalciferol|mesh-list
65286422|NCT00911664|Vitamins|vitamins|mesh-list
65286423|NCT00911664|Micronutrients|micronutrients|mesh-ancestor
65286424|NCT00911664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286425|NCT00911664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65286426|NCT00911664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65286427|NCT04821817|Rocuronium|rocuronium|mesh-list
64812869|NCT01467986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64812870|NCT01468025|Naproxen|naproxen|mesh-list
64812871|NCT01468025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64812872|NCT01468025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64812873|NCT01468025|Analgesics|analgesics|mesh-ancestor
64812874|NCT01468025|Sensory System Agents|sensory system agents|mesh-ancestor
64812875|NCT01468025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64812876|NCT01468025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812877|NCT01468025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64812878|NCT01468025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64812879|NCT01468025|Gout Suppressants|gout suppressants|mesh-ancestor
65494368|NCT01295645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494369|NCT01295645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494370|NCT01295645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494371|NCT01257139|Docetaxel|docetaxel|mesh-list
64488294|NCT00921310|Sirolimus|sirolimus|mesh-list
65494382|NCT01046825|Prednisone|prednisone|mesh-list
65494383|NCT01046825|Cyclophosphamide|cyclophosphamide|mesh-list
65494384|NCT01046825|Doxorubicin|doxorubicin|mesh-list
65494385|NCT01046825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65494386|NCT01046825|Rituximab|rituximab|mesh-list
65494387|NCT01046825|Rasburicase|rasburicase|mesh-list
65494388|NCT01046825|Lenograstim|lenograstim|mesh-list
65494389|NCT01046825|Levoleucovorin|levoleucovorin|mesh-list
65494390|NCT01046825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65494391|NCT01046825|Glucocorticoids|glucocorticoids|mesh-ancestor
65494392|NCT01046825|Hormones|hormones|mesh-ancestor
64472577|NCT03113500|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64472579|NCT03113500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64472580|NCT03113500|Antibodies|antibodies|mesh-list
64472581|NCT03113500|Immunoglobulins|immunoglobulins|mesh-list
64472582|NCT03113500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65286428|NCT04821817|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65286429|NCT04821817|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65286430|NCT04821817|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65286431|NCT04821817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65286432|NCT04821817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286433|NCT00664170|Docetaxel|docetaxel|mesh-list
65286439|NCT02758067|Risperidone|risperidone|mesh-list
65286495|NCT02630004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65286496|NCT00129922|Paclitaxel|paclitaxel|mesh-list
65286497|NCT00129922|Cyclophosphamide|cyclophosphamide|mesh-list
65286498|NCT00129922|Fluorouracil|fluorouracil|mesh-list
65286499|NCT00129922|Epirubicin|epirubicin|mesh-list
65286500|NCT00129922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65286501|NCT00129922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286502|NCT00129922|Tubulin Modulators|tubulin modulators|mesh-ancestor
65286503|NCT00129922|Antimitotic Agents|antimitotic agents|mesh-ancestor
65286504|NCT00129922|Mitosis Modulators|mitosis modulators|mesh-ancestor
65286505|NCT00129922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286506|NCT00129922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65286507|NCT00129922|Immunologic Factors|immunologic factors|mesh-ancestor
65286508|NCT00129922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286509|NCT00129922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64472583|NCT03113500|Immunoconjugates|immunoconjugates|mesh-list
64472584|NCT03113500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64472585|NCT03113500|Immunologic Factors|immunologic factors|mesh-ancestor
64472586|NCT03113500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472587|NCT03113500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64472588|NCT03113500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64472589|NCT03113500|Alkylating Agents|alkylating agents|mesh-ancestor
64472590|NCT03113500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472591|NCT03113500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472592|NCT03113500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64472593|NCT03113500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64472594|NCT03113500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64472595|NCT03113500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64812880|NCT01468025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64812881|NCT01468025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812882|NCT01468025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812883|NCT01468038|Trazodone|trazodone|mesh-list
64812884|NCT01468038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64812885|NCT01468038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64812886|NCT01468038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64812887|NCT01468038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812888|NCT01468038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64812889|NCT01468038|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64812890|NCT01468038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64812891|NCT01468038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64812892|NCT01468038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812893|NCT01468038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64812894|NCT01468038|Serotonin Agents|serotonin agents|mesh-ancestor
64812895|NCT01468038|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64812896|NCT01468038|Antidepressive Agents|antidepressive agents|mesh-ancestor
64812897|NCT01468051|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64812898|NCT01468051|Vaccines|vaccines|mesh-list
64812899|NCT01468051|Immunologic Factors|immunologic factors|mesh-ancestor
64812900|NCT01468051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812901|NCT01468051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64812902|NCT01468051|Antacids|antacids|mesh-ancestor
64812903|NCT01468051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812904|NCT01468051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64812905|NCT01468155|Dabigatran|dabigatran|mesh-list
64812906|NCT01468155|Antithrombins|antithrombins|mesh-ancestor
64812907|NCT01468155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64812908|NCT01468155|Protease Inhibitors|protease inhibitors|mesh-ancestor
65494403|NCT01046825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494404|NCT01046825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65286510|NCT00129922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65286511|NCT00129922|Alkylating Agents|alkylating agents|mesh-ancestor
65286512|NCT00129922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65286513|NCT00129922|Antimetabolites|antimetabolites|mesh-ancestor
65286514|NCT00129922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65286515|NCT00129922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65286516|NCT00129922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65286517|NCT00129922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65286518|NCT00129922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286519|NCT03909295|Valsartan|valsartan|mesh-list
65286520|NCT03909295|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65286521|NCT03909295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65286522|NCT03909295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65286523|NCT03909295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65286524|NCT03909295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286525|NCT04153968|Retinol acetate|retinol acetate|mesh-list
65286526|NCT04153968|Protective Agents|protective agents|mesh-ancestor
65286527|NCT04153968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286528|NCT04153968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65494405|NCT01046825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65494406|NCT01046825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65494407|NCT01046825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65494408|NCT01046825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494409|NCT01046825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64472597|NCT03113500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64472598|NCT03113500|Glucocorticoids|glucocorticoids|mesh-ancestor
64472599|NCT03113500|Hormones|hormones|mesh-ancestor
64472600|NCT03113500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64472601|NCT03113500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64472602|NCT03113500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64472603|NCT03113500|Keratolytic Agents|keratolytic agents|mesh-ancestor
64472604|NCT03113500|Dermatologic Agents|dermatologic agents|mesh-ancestor
64472605|NCT03113500|Tubulin Modulators|tubulin modulators|mesh-ancestor
64472606|NCT03113500|Antimitotic Agents|antimitotic agents|mesh-ancestor
64472607|NCT03113500|Mitosis Modulators|mitosis modulators|mesh-ancestor
64472608|NCT03112590|Interferons|interferons|mesh-list
64472609|NCT03112590|Interferon-gamma|interferon-gamma|mesh-list
64472610|NCT03112590|Paclitaxel|paclitaxel|mesh-list
64472611|NCT03112590|Trastuzumab|trastuzumab|mesh-list
64472612|NCT03112590|Pertuzumab|pertuzumab|mesh-list
64472613|NCT03112590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64812916|NCT01468272|Formoterol Fumarate|formoterol fumarate|mesh-list
64812917|NCT01468272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64812918|NCT01468272|Autonomic Agents|autonomic agents|mesh-ancestor
64812919|NCT01468272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64812920|NCT01468272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812921|NCT01468272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64812922|NCT01468272|Respiratory System Agents|respiratory system agents|mesh-ancestor
64812923|NCT01468272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64812924|NCT01468272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64812925|NCT01468272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64812932|NCT01468272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64812933|NCT01468285|Betahistine|betahistine|mesh-list
65286529|NCT04153968|Immunologic Factors|immunologic factors|mesh-ancestor
65286530|NCT04153968|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65286531|NCT04153968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286532|NCT00671424|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
65286533|NCT00671424|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65286534|NCT00671424|Furosemide|furosemide|mesh-list
65286535|NCT00671424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65286536|NCT00671424|Diuretics|diuretics|mesh-ancestor
65286537|NCT00671424|Natriuretic Agents|natriuretic agents|mesh-ancestor
65286538|NCT00671424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286539|NCT00671424|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65286540|NCT00671424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65286541|NCT00671424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286542|NCT00671424|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65286543|NCT00671424|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65286544|NCT00671424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65286545|NCT00599924|Leucovorin|leucovorin|mesh-list
65286546|NCT00599924|Sunitinib|sunitinib|mesh-list
65286547|NCT00599924|Fluorouracil|fluorouracil|mesh-list
65286548|NCT00599924|Oxaliplatin|oxaliplatin|mesh-list
65286549|NCT00599924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286550|NCT00599924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65286551|NCT00599924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65286552|NCT00599924|Growth Substances|growth substances|mesh-ancestor
64812934|NCT01468285|Vasodilator Agents|vasodilator agents|mesh-ancestor
64812935|NCT01468285|Histamine Agonists|histamine agonists|mesh-ancestor
64812936|NCT01468285|Histamine Agents|histamine agents|mesh-ancestor
65494413|NCT01046825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494414|NCT01046825|Antidotes|antidotes|mesh-ancestor
65494415|NCT01046825|Protective Agents|protective agents|mesh-ancestor
65494416|NCT01046825|Vitamin B Complex|vitamin b complex|mesh-ancestor
65494417|NCT01046825|Vitamins|vitamins|mesh-ancestor
65494418|NCT01046825|Micronutrients|micronutrients|mesh-ancestor
65494419|NCT01046825|Hematinics|hematinics|mesh-ancestor
65494420|NCT01046825|Gout Suppressants|gout suppressants|mesh-ancestor
65494421|NCT00936936|Gemcitabine|gemcitabine|mesh-list
65494422|NCT00936936|Carboplatin|carboplatin|mesh-list
65494423|NCT00936936|Docetaxel|docetaxel|mesh-list
65494424|NCT00936936|Etoposide|etoposide|mesh-list
65494425|NCT00936936|Melphalan|melphalan|mesh-list
65494426|NCT00936936|Ifosfamide|ifosfamide|mesh-list
65494427|NCT00936936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494428|NCT00936936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65494429|NCT00936936|Antimetabolites|antimetabolites|mesh-ancestor
64472614|NCT03112590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472615|NCT03112590|Tubulin Modulators|tubulin modulators|mesh-ancestor
64472616|NCT03112590|Antimitotic Agents|antimitotic agents|mesh-ancestor
64472617|NCT03112590|Mitosis Modulators|mitosis modulators|mesh-ancestor
64812961|NCT01468441|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64812982|NCT01468571|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64812983|NCT01468571|Diuretics|diuretics|mesh-ancestor
64812984|NCT01468571|Natriuretic Agents|natriuretic agents|mesh-ancestor
64812985|NCT01468610|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64812986|NCT01468610|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65286553|NCT00599924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286554|NCT00599924|Growth Inhibitors|growth inhibitors|mesh-ancestor
65286555|NCT00599924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65286556|NCT00599924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286557|NCT00599924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286558|NCT00599924|Antimetabolites|antimetabolites|mesh-ancestor
65286559|NCT00599924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65286560|NCT00599924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65286561|NCT00599924|Immunologic Factors|immunologic factors|mesh-ancestor
65286562|NCT00599924|Antidotes|antidotes|mesh-ancestor
65286563|NCT00599924|Protective Agents|protective agents|mesh-ancestor
65286564|NCT00599924|Vitamin B Complex|vitamin b complex|mesh-ancestor
65286565|NCT00599924|Vitamins|vitamins|mesh-ancestor
65286566|NCT00599924|Micronutrients|micronutrients|mesh-ancestor
65286567|NCT02757209|Fluticasone|fluticasone|mesh-list
65286568|NCT02757209|Xhance|xhance|mesh-list
65286569|NCT02757209|Budesonide|budesonide|mesh-list
65286570|NCT02757209|Formoterol Fumarate|formoterol fumarate|mesh-list
65286571|NCT02757209|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65286572|NCT02757209|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65286573|NCT02757209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65286574|NCT02757209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65286575|NCT02757209|Autonomic Agents|autonomic agents|mesh-ancestor
65286576|NCT02757209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64812987|NCT01468610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64812988|NCT01468610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64812989|NCT01468610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812990|NCT01468610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64812991|NCT01468610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812992|NCT01468610|Antidepressive Agents|antidepressive agents|mesh-ancestor
64813004|NCT01468714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813005|NCT01468714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813006|NCT01468714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64813007|NCT01468714|Hormone Antagonists|hormone antagonists|mesh-ancestor
64813008|NCT01468714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64813009|NCT01468714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813010|NCT01468714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64813011|NCT01468740|Prednisone|prednisone|mesh-list
64813012|NCT01468740|Cyclophosphamide|cyclophosphamide|mesh-list
64813013|NCT01468740|Dacarbazine|dacarbazine|mesh-list
64813014|NCT01468740|Doxorubicin|doxorubicin|mesh-list
64813015|NCT01468740|Etoposide|etoposide|mesh-list
64813016|NCT01468740|Vincristine|vincristine|mesh-list
64813017|NCT01468740|Bleomycin|bleomycin|mesh-list
64813018|NCT01468740|Vinblastine|vinblastine|mesh-list
64813019|NCT01468740|Procarbazine|procarbazine|mesh-list
64813020|NCT01468740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64813021|NCT01468740|Immunologic Factors|immunologic factors|mesh-ancestor
64813022|NCT01468740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813023|NCT01468740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64813024|NCT01468740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64813039|NCT01468740|Tubulin Modulators|tubulin modulators|mesh-ancestor
65286577|NCT02757209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286578|NCT02757209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65286579|NCT02757209|Respiratory System Agents|respiratory system agents|mesh-ancestor
65286580|NCT02757209|Dermatologic Agents|dermatologic agents|mesh-ancestor
65286581|NCT02757209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65286582|NCT02757209|Glucocorticoids|glucocorticoids|mesh-ancestor
65286583|NCT02757209|Hormones|hormones|mesh-ancestor
65286584|NCT02757209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65286585|NCT02757209|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65286586|NCT02757209|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65286587|NCT02757209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65286588|NCT02757209|Adrenergic Agents|adrenergic agents|mesh-ancestor
64813040|NCT01468740|Antimitotic Agents|antimitotic agents|mesh-ancestor
64813041|NCT01468740|Mitosis Modulators|mitosis modulators|mesh-ancestor
64813042|NCT01469143|Insulin|insulin|mesh-list
64813043|NCT01469143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64813044|NCT01469143|Insulin Aspart|insulin aspart|mesh-list
64813045|NCT01469143|Insulin, Long-Acting|insulin, long-acting|mesh-list
64813046|NCT01469143|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64813047|NCT01469143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64813048|NCT01469143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813049|NCT01469169|Iloprost|iloprost|mesh-list
64813050|NCT01469169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64813051|NCT01469169|Vasodilator Agents|vasodilator agents|mesh-ancestor
64813052|NCT01469338|Prednisone|prednisone|mesh-list
64813053|NCT01469338|Octreotide|octreotide|mesh-list
64813054|NCT01469338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64813055|NCT01469338|Glucocorticoids|glucocorticoids|mesh-ancestor
64813081|NCT01469416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64813082|NCT01469416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64813083|NCT01469416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813084|NCT01469468|Simvastatin|simvastatin|mesh-list
64813085|NCT01469468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64813086|NCT01469468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64813087|NCT01469468|Antimetabolites|antimetabolites|mesh-ancestor
64813088|NCT01469468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813089|NCT01469468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64813090|NCT01469468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64813091|NCT01469468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813092|NCT01469481|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
64813093|NCT01469481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813094|NCT01469481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813095|NCT01469507|Hyaluronic Acid|hyaluronic acid|mesh-list
64813096|NCT01469507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64813097|NCT01469507|Immunologic Factors|immunologic factors|mesh-ancestor
64813098|NCT01469507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813193|NCT01469988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813194|NCT01470040|Aspirin|aspirin|mesh-list
64813195|NCT01470040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64813196|NCT01470040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64813197|NCT01470040|Analgesics|analgesics|mesh-ancestor
64813198|NCT01470040|Sensory System Agents|sensory system agents|mesh-ancestor
64813199|NCT01470040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64472618|NCT03112590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472619|NCT03112590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64472620|NCT03112590|Antiviral Agents|antiviral agents|mesh-ancestor
64472621|NCT03112590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64472622|NCT03085394|Tranexamic Acid|tranexamic acid|mesh-list
64813200|NCT01470040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813201|NCT01470040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64813202|NCT01470040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65286589|NCT02757209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65286590|NCT02757209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286591|NCT00670254|Hydrocortisone|hydrocortisone|mesh-list
65286592|NCT00670254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65036580|NCT00577018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65286593|NCT00581542|Moxifloxacin|moxifloxacin|mesh-list
65286594|NCT00581542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64813203|NCT01470040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64813220|NCT01470053|Respiratory System Agents|respiratory system agents|mesh-ancestor
64813221|NCT01470053|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64813222|NCT01470053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813223|NCT01470053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581856|NCT00122447|Antipyretics|antipyretics|mesh-ancestor
64813224|NCT01470053|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64813225|NCT01470053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64813226|NCT01470053|Histamine Antagonists|histamine antagonists|mesh-ancestor
64813227|NCT01470053|Histamine Agents|histamine agents|mesh-ancestor
64813228|NCT01470053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64813229|NCT01470092|Tibolone|tibolone|mesh-list
64813230|NCT01470092|Androgen Antagonists|androgen antagonists|mesh-ancestor
64813231|NCT01470092|Hormone Antagonists|hormone antagonists|mesh-ancestor
64813232|NCT01470092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64813233|NCT01470092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813234|NCT01470092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64813235|NCT01470092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64813236|NCT01470092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813237|NCT01470092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64813238|NCT01470092|Anabolic Agents|anabolic agents|mesh-ancestor
64813239|NCT01470092|Hormones|hormones|mesh-ancestor
64813240|NCT01470157|Ketamine|ketamine|mesh-list
64813241|NCT01470157|Analgesics|analgesics|mesh-ancestor
64813242|NCT01470157|Sensory System Agents|sensory system agents|mesh-ancestor
64813243|NCT01470157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64813264|NCT01470326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813265|NCT01470326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64813266|NCT01470339|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64813267|NCT01470339|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64813268|NCT01470339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64813269|NCT01470339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64813270|NCT01470339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813271|NCT01470339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64813272|NCT01470339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813274|NCT01470339|Sensory System Agents|sensory system agents|mesh-ancestor
64813275|NCT01470339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64813276|NCT01470339|Antidepressive Agents|antidepressive agents|mesh-ancestor
64813277|NCT01470339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64813278|NCT01470339|Dopamine Agents|dopamine agents|mesh-ancestor
64813279|NCT01470352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65494434|NCT00936936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64813291|NCT01470352|Dopamine Agents|dopamine agents|mesh-ancestor
64813292|NCT01470443|Oxaliplatin|oxaliplatin|mesh-list
64813301|NCT01470495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813302|NCT01470495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64813303|NCT01470495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813304|NCT01470495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813306|NCT01470690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64813307|NCT01470690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64813308|NCT01470690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64813309|NCT01470690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813310|NCT01470690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813311|NCT01470742|Capecitabine|capecitabine|mesh-list
64813312|NCT01470742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64813313|NCT01470742|Antimetabolites|antimetabolites|mesh-ancestor
64813314|NCT01470742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813315|NCT01470742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813316|NCT01470794|Flucytosine|flucytosine|mesh-list
65286595|NCT00581542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65286596|NCT00581542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65286597|NCT00581542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65286598|NCT00581542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286599|NCT00581542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813317|NCT01470794|Antifungal Agents|antifungal agents|mesh-ancestor
64813318|NCT01470794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64813319|NCT01470794|Antimetabolites|antimetabolites|mesh-ancestor
64813320|NCT01470794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813321|NCT01470807|Pancrelipase|pancrelipase|mesh-list
64813322|NCT01470807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64813323|NCT01470937|Acarbose|acarbose|mesh-list
64813359|NCT01471132|Oxaliplatin|oxaliplatin|mesh-list
64813360|NCT01471132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64813382|NCT01471158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813383|NCT01471158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64813384|NCT01471158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64813385|NCT01471158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64813386|NCT01471184|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64813387|NCT01471184|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64813388|NCT01471262|Liver Extracts|liver extracts|mesh-list
64813389|NCT01471262|Hematinics|hematinics|mesh-ancestor
64813390|NCT01471275|Metformin|metformin|mesh-list
64813391|NCT01471275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64813392|NCT01471275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813393|NCT01471418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64813394|NCT01471418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64813395|NCT01471418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813396|NCT01471470|Bevacizumab|bevacizumab|mesh-list
64813397|NCT01471470|Docetaxel|docetaxel|mesh-list
64813398|NCT01471470|Capecitabine|capecitabine|mesh-list
64813399|NCT01471470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64813400|NCT01471470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813401|NCT01471470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64813402|NCT01471470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64813403|NCT01471470|Growth Substances|growth substances|mesh-ancestor
64813404|NCT01471470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813405|NCT01471470|Growth Inhibitors|growth inhibitors|mesh-ancestor
64813406|NCT01471470|Tubulin Modulators|tubulin modulators|mesh-ancestor
64813407|NCT01471470|Antimitotic Agents|antimitotic agents|mesh-ancestor
64813408|NCT01471470|Mitosis Modulators|mitosis modulators|mesh-ancestor
64813409|NCT01471470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813410|NCT01471470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64813411|NCT01471470|Antimetabolites|antimetabolites|mesh-ancestor
64813412|NCT01471535|Interferons|interferons|mesh-list
64813413|NCT01471535|Interferon-alpha|interferon-alpha|mesh-list
64813414|NCT01471535|Interferon alpha-2|interferon alpha-2|mesh-list
64813415|NCT01471535|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64813416|NCT01471535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813417|NCT01471535|Antiviral Agents|antiviral agents|mesh-ancestor
64813429|NCT01471613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813430|NCT01471678|Tamsulosin|tamsulosin|mesh-list
64813431|NCT01471678|Dutasteride|dutasteride|mesh-list
64813432|NCT01471678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64813433|NCT01471678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64813434|NCT01471678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64813435|NCT01471678|Adrenergic Agents|adrenergic agents|mesh-ancestor
64813436|NCT01471678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64813437|NCT01471678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813438|NCT01471678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813439|NCT01471678|Urological Agents|urological agents|mesh-ancestor
64813440|NCT01471678|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64813441|NCT01471678|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64813442|NCT01471678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494448|NCT04478292|Carboplatin|carboplatin|mesh-list
65494449|NCT04478292|Doxorubicin|doxorubicin|mesh-list
64813451|NCT01471704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813452|NCT01471704|Vasodilator Agents|vasodilator agents|mesh-ancestor
64813453|NCT01471730|Thrombin|thrombin|mesh-list
64813454|NCT01471730|Hemostatics|hemostatics|mesh-ancestor
64813455|NCT01471730|Coagulants|coagulants|mesh-ancestor
65286600|NCT00581542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286601|NCT05338801|Menthol|menthol|mesh-list
65286602|NCT05338801|Antipruritics|antipruritics|mesh-ancestor
65286603|NCT05338801|Dermatologic Agents|dermatologic agents|mesh-ancestor
65286604|NCT02757287|Desogestrel|desogestrel|mesh-list
65286605|NCT02757287|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65286606|NCT02757287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65286607|NCT02757287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65286608|NCT02757287|Contraceptive Agents|contraceptive agents|mesh-ancestor
65286609|NCT02757287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65286610|NCT02757287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286611|NCT02757287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65286612|NCT02757287|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64813456|NCT01471808|Metformin|metformin|mesh-list
64813457|NCT01471808|Pioglitazone|pioglitazone|mesh-list
64813458|NCT01471808|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64813459|NCT01471808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64813460|NCT01471808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813461|NCT01471808|Incretins|incretins|mesh-ancestor
64813462|NCT01471808|Hormones|hormones|mesh-ancestor
64813463|NCT01471808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64813464|NCT01471808|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64813465|NCT01471808|Protease Inhibitors|protease inhibitors|mesh-ancestor
64813466|NCT01471808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813467|NCT01471808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813468|NCT01471821|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64813469|NCT01471821|Antiviral Agents|antiviral agents|mesh-ancestor
64813470|NCT01471821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64813471|NCT01471847|Capecitabine|capecitabine|mesh-list
64813472|NCT01471847|Trastuzumab|trastuzumab|mesh-list
64813473|NCT01471847|Lapatinib|lapatinib|mesh-list
64813474|NCT01471847|Dactolisib|dactolisib|mesh-list
64813475|NCT01471847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64813476|NCT01471847|Antimetabolites|antimetabolites|mesh-ancestor
64813477|NCT01471847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813478|NCT01471847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813479|NCT01471847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64813480|NCT01471847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64813493|NCT01471886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64813494|NCT01471886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813495|NCT01471886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813496|NCT01471886|Gout Suppressants|gout suppressants|mesh-ancestor
64813497|NCT01471899|Ketorolac|ketorolac|mesh-list
64813498|NCT01471899|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64813499|NCT01471899|Naproxen|naproxen|mesh-list
64813500|NCT01471899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64813501|NCT01471899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64813502|NCT01471899|Analgesics|analgesics|mesh-ancestor
64813503|NCT01471899|Sensory System Agents|sensory system agents|mesh-ancestor
64813504|NCT01471899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64813505|NCT01471899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494456|NCT04478292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65494457|NCT04478292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65494458|NCT04478292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813524|NCT01471990|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
64813525|NCT01471990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64813526|NCT01471990|Vasodilator Agents|vasodilator agents|mesh-ancestor
64813527|NCT01471990|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64813528|NCT01471990|Protective Agents|protective agents|mesh-ancestor
64813529|NCT01471990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813530|NCT01471990|Growth Substances|growth substances|mesh-ancestor
64813531|NCT01471990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65286613|NCT02757287|Progestins|progestins|mesh-ancestor
65286614|NCT02757287|Hormones|hormones|mesh-ancestor
65286615|NCT02757287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65286616|NCT02649686|Trastuzumab|trastuzumab|mesh-list
65286617|NCT02649686|Durvalumab|durvalumab|mesh-list
65286618|NCT02649686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65286619|NCT02649686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286620|NCT04729621|Denosumab|denosumab|mesh-list
65286621|NCT04729621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65286622|NCT04729621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286623|NCT02757365|Aspirin|aspirin|mesh-list
65286624|NCT02757365|Levofloxacin|levofloxacin|mesh-list
64813532|NCT01471990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813534|NCT01472016|Cetuximab|cetuximab|mesh-list
64813535|NCT01472016|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64813536|NCT01472016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813537|NCT01472016|Tubulin Modulators|tubulin modulators|mesh-ancestor
64813538|NCT01472016|Antimitotic Agents|antimitotic agents|mesh-ancestor
64813539|NCT01472016|Mitosis Modulators|mitosis modulators|mesh-ancestor
64813540|NCT01472016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813541|NCT01472016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64813542|NCT01472016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64424615|NCT02483611|Analgesics|analgesics|mesh-ancestor
64813556|NCT01472029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813558|NCT01472029|Vitamins|vitamins|mesh-ancestor
64813559|NCT01472029|Micronutrients|micronutrients|mesh-ancestor
64813560|NCT01472055|Fludarabine|fludarabine|mesh-list
64813561|NCT01472055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813562|NCT01472146|Doxorubicin|doxorubicin|mesh-list
64813563|NCT01472146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813564|NCT01472146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64813565|NCT01472146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64813566|NCT01472146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64813567|NCT01472146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813568|NCT01472146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813569|NCT01472263|Pentoxifylline|pentoxifylline|mesh-list
64813570|NCT01472263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64813585|NCT01472315|Contraceptive Agents|contraceptive agents|mesh-ancestor
64813586|NCT01472315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64813587|NCT01472315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813588|NCT01472315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64813589|NCT01472315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64813590|NCT01472315|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64813591|NCT01472315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64813592|NCT01472315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813593|NCT01472406|Pancrelipase|pancrelipase|mesh-list
64813594|NCT01472406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64813595|NCT01472497|Pioglitazone|pioglitazone|mesh-list
64813596|NCT01472497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64813597|NCT01472497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813598|NCT01472510|Ranibizumab|ranibizumab|mesh-list
64813599|NCT01472510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64813600|NCT01472510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64813601|NCT01472510|Growth Substances|growth substances|mesh-ancestor
64813602|NCT01472510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813603|NCT01472510|Growth Inhibitors|growth inhibitors|mesh-ancestor
64813604|NCT01472510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813605|NCT01472640|Liraglutide|liraglutide|mesh-list
64813624|NCT01472770|Antimetabolites|antimetabolites|mesh-ancestor
64813625|NCT01472770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813626|NCT01472770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813627|NCT01472770|Antiviral Agents|antiviral agents|mesh-ancestor
64813628|NCT01472770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64813629|NCT01472770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286625|NCT02757365|Ofloxacin|ofloxacin|mesh-list
65286626|NCT02757365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65286627|NCT02757365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65286628|NCT02757365|Analgesics|analgesics|mesh-ancestor
65286629|NCT02757365|Sensory System Agents|sensory system agents|mesh-ancestor
65286630|NCT02757365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65286631|NCT02757365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286632|NCT02757365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65286633|NCT02757365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65286634|NCT02757365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65286635|NCT02757365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65286636|NCT02757365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286637|NCT02757365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65286638|NCT02757365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65286639|NCT02757365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286640|NCT02757365|Antipyretics|antipyretics|mesh-ancestor
65286641|NCT02757365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65286642|NCT02757365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65286643|NCT02757365|Renal Agents|renal agents|mesh-ancestor
65286644|NCT02757365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65286645|NCT02757365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65286646|NCT02757365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65286647|NCT02757365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516911|NCT03263520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813630|NCT01472770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64813631|NCT01472770|Immunologic Factors|immunologic factors|mesh-ancestor
64813632|NCT01472770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813634|NCT01472783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64813635|NCT01472783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813636|NCT01472783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813637|NCT01472783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813638|NCT01472796|Vitamin D|vitamin d|mesh-list
64813639|NCT01472796|Cholecalciferol|cholecalciferol|mesh-list
64813640|NCT01472796|Vitamins|vitamins|mesh-ancestor
64813641|NCT01472796|Micronutrients|micronutrients|mesh-ancestor
64813642|NCT01472796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813643|NCT01472796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64813644|NCT01472796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64813645|NCT01472900|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64813646|NCT01472900|Dermatologic Agents|dermatologic agents|mesh-ancestor
64813647|NCT01472913|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64813648|NCT01472913|Hemostatics|hemostatics|mesh-ancestor
64813649|NCT01472913|Coagulants|coagulants|mesh-ancestor
64813672|NCT01473069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813674|NCT01473069|Hormone Antagonists|hormone antagonists|mesh-ancestor
64813675|NCT01473069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64813676|NCT01473069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813677|NCT01473069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64813678|NCT01473147|Exenatide|exenatide|mesh-list
65286648|NCT02757365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65286649|NCT02757365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65286650|NCT05321251|Insulin|insulin|mesh-list
65286651|NCT05321251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65286652|NCT05321251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286653|NCT02649530|LGK974|lgk974|mesh-list
65286654|NCT02649530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286655|NCT02649530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286656|NCT02575534|Procainamide|procainamide|mesh-list
65286657|NCT02575534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64813679|NCT01473147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64813680|NCT01473147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813681|NCT01473147|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64813682|NCT01473147|Incretins|incretins|mesh-ancestor
64813683|NCT01473147|Hormones|hormones|mesh-ancestor
64813684|NCT01473147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64813685|NCT01473173|Esomeprazole|esomeprazole|mesh-list
64813686|NCT01473173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64813687|NCT01473173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64813688|NCT01473173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64813689|NCT01473173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813690|NCT01473173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813691|NCT01473251|Bevacizumab|bevacizumab|mesh-list
64813692|NCT01473251|Ranibizumab|ranibizumab|mesh-list
64813693|NCT01473251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64813694|NCT01473251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813695|NCT01473251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64813696|NCT01473251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64813697|NCT01473251|Growth Substances|growth substances|mesh-ancestor
64813698|NCT01473251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813699|NCT01473251|Growth Inhibitors|growth inhibitors|mesh-ancestor
64813700|NCT01473277|Triamcinolone|triamcinolone|mesh-list
64813701|NCT01473277|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64813702|NCT01473277|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64813703|NCT01473277|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64813704|NCT01473277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64813705|NCT01473277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64813706|NCT01473277|Glucocorticoids|glucocorticoids|mesh-ancestor
64813707|NCT01473277|Hormones|hormones|mesh-ancestor
64813708|NCT01473277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64813709|NCT01473277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813710|NCT01473277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64813711|NCT01473277|Immunologic Factors|immunologic factors|mesh-ancestor
64813712|NCT01473277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813713|NCT01473277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813714|NCT01473277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64489072|NCT03854799|Avelumab|avelumab|mesh-list
64813724|NCT01473303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64813725|NCT01473303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813727|NCT01473303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813728|NCT01473303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64424792|NCT02491411|Glucocorticoids|glucocorticoids|mesh-ancestor
64813741|NCT01473316|Antifungal Agents|antifungal agents|mesh-ancestor
64813742|NCT01473316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64813743|NCT01473316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64813744|NCT01473316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64813745|NCT01473316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813746|NCT01473316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813747|NCT01473316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64813748|NCT01473316|Hormone Antagonists|hormone antagonists|mesh-ancestor
64945444|NCT05633615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813749|NCT01473316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65286658|NCT02575534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65286659|NCT02575534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65286660|NCT02575534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65286661|NCT02575534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286662|NCT02757443|Phosphocreatine|phosphocreatine|mesh-list
65286663|NCT02757443|Anesthetics|anesthetics|mesh-list
65286664|NCT02757443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65286665|NCT02757443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286666|NCT02757443|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65286667|NCT02757443|Protective Agents|protective agents|mesh-ancestor
65286669|NCT04071262|Abiraterone Acetate|abiraterone acetate|mesh-list
65286670|NCT04071262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65286671|NCT04071262|Glucocorticoids|glucocorticoids|mesh-ancestor
65286672|NCT04071262|Hormones|hormones|mesh-ancestor
65286673|NCT04071262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65286674|NCT04071262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286675|NCT04071262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65286676|NCT04071262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286677|NCT04071262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65286678|NCT04071262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286679|NCT04071262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286680|NCT04071262|Hormone Antagonists|hormone antagonists|mesh-ancestor
65286681|NCT04071262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64813750|NCT01473316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813751|NCT01473316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64813752|NCT01473472|Tenofovir|tenofovir|mesh-list
64813753|NCT01473472|Emtricitabine|emtricitabine|mesh-list
64813754|NCT01473472|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64813755|NCT01473472|Antiviral Agents|antiviral agents|mesh-ancestor
64813756|NCT01473472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64813757|NCT01473472|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64813758|NCT01473472|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64813759|NCT01473472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813760|NCT01473472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813761|NCT01473472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64813762|NCT01473472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64813763|NCT01473537|Calcium|calcium|mesh-list
64813764|NCT01473537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64813765|NCT01473537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813766|NCT01473797|Cladribine|cladribine|mesh-list
64813767|NCT01473797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813768|NCT01473797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64813769|NCT01473797|Immunologic Factors|immunologic factors|mesh-ancestor
64813770|NCT01473797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813771|NCT01473810|Endocine|endocine|mesh-list
64813772|NCT01473810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64813773|NCT01473810|Immunologic Factors|immunologic factors|mesh-ancestor
65286682|NCT04154982|Acetylcysteine|acetylcysteine|mesh-list
65286683|NCT04154982|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65286684|NCT04154982|Antiviral Agents|antiviral agents|mesh-ancestor
65286685|NCT04154982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65286686|NCT04154982|Expectorants|expectorants|mesh-ancestor
65286687|NCT04154982|Respiratory System Agents|respiratory system agents|mesh-ancestor
65286688|NCT04154982|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65286689|NCT04154982|Antioxidants|antioxidants|mesh-ancestor
65286690|NCT04154982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286691|NCT04154982|Protective Agents|protective agents|mesh-ancestor
64516971|NCT02456844|Sensory System Agents|sensory system agents|mesh-ancestor
64813774|NCT01473810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813775|NCT01473901|Temozolomide|temozolomide|mesh-list
64813776|NCT01473901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64813777|NCT01473901|Alkylating Agents|alkylating agents|mesh-ancestor
64813778|NCT01473901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813779|NCT01473901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813780|NCT01473914|Vitamins|vitamins|mesh-list
64813781|NCT01473914|Vitamin E|vitamin e|mesh-list
64813782|NCT01473914|Tocopherols|tocopherols|mesh-list
64813783|NCT01473914|Tocotrienols|tocotrienols|mesh-list
64813784|NCT01473914|alpha-Tocopherol|alpha-tocopherol|mesh-list
64813785|NCT01473914|Zinc|zinc|mesh-list
64813786|NCT01473914|Selenium|selenium|mesh-list
64813787|NCT01473914|Micronutrients|micronutrients|mesh-ancestor
64813788|NCT01473914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813789|NCT01473914|Trace Elements|trace elements|mesh-ancestor
64813790|NCT01473914|Antioxidants|antioxidants|mesh-ancestor
64489125|NCT01569152|Immunologic Factors|immunologic factors|mesh-ancestor
64813816|NCT01474304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64813817|NCT01474304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813819|NCT01474330|Pomalidomide|pomalidomide|mesh-list
64813820|NCT01474330|Immunologic Factors|immunologic factors|mesh-ancestor
64813821|NCT01474330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813822|NCT01474330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64813823|NCT01474330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64813824|NCT01474330|Growth Substances|growth substances|mesh-ancestor
64813825|NCT01474330|Growth Inhibitors|growth inhibitors|mesh-ancestor
64813826|NCT01474330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813827|NCT01474382|Phentolamine|phentolamine|mesh-list
64813828|NCT01474382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64813829|NCT01474382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64813830|NCT01474382|Adrenergic Agents|adrenergic agents|mesh-ancestor
64813831|NCT01474382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64813832|NCT01474382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813833|NCT01474382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813834|NCT01474382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64813835|NCT01474460|Vitamin K|vitamin k|mesh-list
64813836|NCT01474460|Vitamin K 1|vitamin k 1|mesh-list
64813837|NCT01474460|Vitamins|vitamins|mesh-ancestor
64813838|NCT01474460|Micronutrients|micronutrients|mesh-ancestor
64813839|NCT01474460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813840|NCT01474460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64813841|NCT01474460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64813842|NCT01474460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813843|NCT01474460|Hemostatics|hemostatics|mesh-ancestor
64813844|NCT01474460|Coagulants|coagulants|mesh-ancestor
64813845|NCT01474473|Calpastatin|calpastatin|mesh-list
64813846|NCT01474473|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64813847|NCT01474473|Protease Inhibitors|protease inhibitors|mesh-ancestor
64813848|NCT01474473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813849|NCT01474473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813850|NCT01474499|Sorbitol|sorbitol|mesh-list
64813851|NCT01474499|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
64813852|NCT01474499|Glycerol|glycerol|mesh-list
64813853|NCT01474499|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64813854|NCT01474499|Protective Agents|protective agents|mesh-ancestor
65286692|NCT04154982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286693|NCT04154982|Antidotes|antidotes|mesh-ancestor
65286694|NCT04154748|Omeprazole|omeprazole|mesh-list
65286695|NCT04154748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65286696|NCT04154748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65286697|NCT04154748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65286698|NCT04154748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286699|NCT04154748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286700|NCT02657096|Hybenx|hybenx|mesh-list
65286701|NCT02657096|Dental Disinfectants|dental disinfectants|mesh-ancestor
65286702|NCT02657096|Disinfectants|disinfectants|mesh-ancestor
65286703|NCT02657096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65286704|NCT02536742|Fulvestrant|fulvestrant|mesh-list
64813855|NCT01474499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813856|NCT01474499|Cathartics|cathartics|mesh-ancestor
64813857|NCT01474499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64813874|NCT01475019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813875|NCT01475019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813876|NCT01475019|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64813877|NCT01475019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64813878|NCT01475019|Antidepressive Agents|antidepressive agents|mesh-ancestor
64813893|NCT01475032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64813894|NCT01475032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813895|NCT01475032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64813897|NCT01475032|Hormones|hormones|mesh-ancestor
64472639|NCT03060434|Analgesics|analgesics|mesh-ancestor
64813898|NCT01475032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64813899|NCT01475227|Zinc|zinc|mesh-list
64813900|NCT01475227|Zinc Sulfate|zinc sulfate|mesh-list
64813901|NCT01475227|Trace Elements|trace elements|mesh-ancestor
64813902|NCT01475227|Micronutrients|micronutrients|mesh-ancestor
64813903|NCT01475227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813904|NCT01475227|Astringents|astringents|mesh-ancestor
64813905|NCT01475227|Dermatologic Agents|dermatologic agents|mesh-ancestor
64813906|NCT01475266|Apaziquone|apaziquone|mesh-list
64813907|NCT01475266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813908|NCT01475279|Warfarin|warfarin|mesh-list
64813909|NCT01475279|Anticoagulants|anticoagulants|mesh-ancestor
64813910|NCT01475318|Letrozole|letrozole|mesh-list
64813911|NCT01475318|Misoprostol|misoprostol|mesh-list
64813912|NCT01475318|Mifepristone|mifepristone|mesh-list
64813913|NCT01475318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813914|NCT01475318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64813915|NCT01475318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64813916|NCT01475318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813917|NCT01475318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813918|NCT01475318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64424984|NCT02448043|Bimatoprost|bimatoprost|mesh-list
64813923|NCT01475318|Abortifacient Agents|abortifacient agents|mesh-ancestor
64813924|NCT01475318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64813925|NCT01475318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64813926|NCT01475318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64813927|NCT01475318|Oxytocics|oxytocics|mesh-ancestor
64813928|NCT01475318|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64813929|NCT01475318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64813930|NCT01475318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64813931|NCT01475318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64813932|NCT01475318|Contraceptive Agents|contraceptive agents|mesh-ancestor
64813933|NCT01475318|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64813934|NCT01475318|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64813935|NCT01475318|Luteolytic Agents|luteolytic agents|mesh-ancestor
64813936|NCT01475318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64813937|NCT01475318|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64813938|NCT01475552|Abciximab|abciximab|mesh-list
64813939|NCT01475552|Clopidogrel|clopidogrel|mesh-list
65286705|NCT02536742|Palbociclib|palbociclib|mesh-list
65286706|NCT02536742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65286707|NCT02536742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286708|NCT02536742|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65286709|NCT02536742|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65286710|NCT02536742|Hormone Antagonists|hormone antagonists|mesh-ancestor
65286711|NCT02536742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65286712|NCT02536742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286713|NCT02536742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65286714|NCT02536742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286715|NCT02536742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286716|NCT00670410|Fludarabine|fludarabine|mesh-list
65286717|NCT00670410|Busulfan|busulfan|mesh-list
65286718|NCT00670410|Thymoglobulin|thymoglobulin|mesh-list
65286719|NCT00670410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286720|NCT00670410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286721|NCT00670410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65286722|NCT00670410|Immunologic Factors|immunologic factors|mesh-ancestor
65286723|NCT00670410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286724|NCT00670410|Alkylating Agents|alkylating agents|mesh-ancestor
65286725|NCT00670410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65286726|NCT00670410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65286727|NCT02756663|Dexamethasone|dexamethasone|mesh-list
65286728|NCT02756663|Panobinostat|panobinostat|mesh-list
65286729|NCT02756663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65286730|NCT02756663|Antiemetics|antiemetics|mesh-ancestor
65286731|NCT02756663|Autonomic Agents|autonomic agents|mesh-ancestor
65286732|NCT02756663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64813940|NCT01475552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813941|NCT01475552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489247|NCT02083107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64813968|NCT01475617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64813969|NCT01475617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64813970|NCT01475617|Vitamin B Complex|vitamin b complex|mesh-ancestor
64813971|NCT01475617|Hematinics|hematinics|mesh-ancestor
64813972|NCT01475656|Levetiracetam|levetiracetam|mesh-list
64813973|NCT01475656|Anticonvulsants|anticonvulsants|mesh-ancestor
64813974|NCT01475656|Nootropic Agents|nootropic agents|mesh-ancestor
64813975|NCT01475708|Doxycycline|doxycycline|mesh-list
64813976|NCT01475708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65494459|NCT04478292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472641|NCT03060434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64813977|NCT01475708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64813978|NCT01475708|Antimalarials|antimalarials|mesh-ancestor
64813979|NCT01475708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65286733|NCT02756663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286734|NCT02756663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65286735|NCT02756663|Glucocorticoids|glucocorticoids|mesh-ancestor
65286736|NCT02756663|Hormones|hormones|mesh-ancestor
65286737|NCT02756663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65286738|NCT02756663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65286739|NCT02756663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286740|NCT02756663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65286741|NCT02756663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286742|NCT02756663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286743|NCT02654678|Enalapril|enalapril|mesh-list
65286744|NCT02654678|Enalaprilat|enalaprilat|mesh-list
65286745|NCT02654678|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65286746|NCT02654678|Protease Inhibitors|protease inhibitors|mesh-ancestor
64517029|NCT03267654|Apatinib|apatinib|mesh-list
64813980|NCT01475708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64813981|NCT01475760|Chitosan|chitosan|mesh-list
64813982|NCT01475760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64813983|NCT01475760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64813984|NCT01475760|Antimetabolites|antimetabolites|mesh-ancestor
64813985|NCT01475760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813986|NCT01475760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64813987|NCT01475760|Chelating Agents|chelating agents|mesh-ancestor
64813988|NCT01475760|Sequestering Agents|sequestering agents|mesh-ancestor
64813989|NCT01475760|Hemostatics|hemostatics|mesh-ancestor
64814019|NCT01476124|Analgesics|analgesics|mesh-ancestor
64814020|NCT01476124|Sensory System Agents|sensory system agents|mesh-ancestor
64814021|NCT01476124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814022|NCT01476137|Trametinib|trametinib|mesh-list
64814023|NCT01476137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814024|NCT01476137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64814025|NCT01476137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814026|NCT01476137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814027|NCT01476176|Acetaminophen|acetaminophen|mesh-list
64814028|NCT01476176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64814029|NCT01476176|Analgesics|analgesics|mesh-ancestor
64814030|NCT01476176|Sensory System Agents|sensory system agents|mesh-ancestor
64814031|NCT01476176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814032|NCT01476176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814033|NCT01476176|Antipyretics|antipyretics|mesh-ancestor
64814034|NCT01476189|Acetaminophen|acetaminophen|mesh-list
64814035|NCT01476189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64814036|NCT01476189|Analgesics|analgesics|mesh-ancestor
64814037|NCT01476189|Sensory System Agents|sensory system agents|mesh-ancestor
64814038|NCT01476189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814039|NCT01476189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814040|NCT01476189|Antipyretics|antipyretics|mesh-ancestor
64814041|NCT01476215|Acetaminophen|acetaminophen|mesh-list
64814042|NCT01476215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64814043|NCT01476215|Analgesics|analgesics|mesh-ancestor
64814044|NCT01476215|Sensory System Agents|sensory system agents|mesh-ancestor
64814045|NCT01476215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814046|NCT01476215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814047|NCT01476215|Antipyretics|antipyretics|mesh-ancestor
64814048|NCT01476280|Palonosetron|palonosetron|mesh-list
64814049|NCT01476280|Ramosetron|ramosetron|mesh-list
64814050|NCT01476280|Antiemetics|antiemetics|mesh-ancestor
64814058|NCT01476280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64814059|NCT01476280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814060|NCT01476332|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64814061|NCT01476332|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65286747|NCT02654678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286748|NCT02654678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286749|NCT02654678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65286750|NCT05288023|Azithromycin|azithromycin|mesh-list
65286751|NCT05288023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65286752|NCT05288023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65286753|NCT00670566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65286754|NCT00670566|Irbesartan|irbesartan|mesh-list
65286755|NCT00670566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65286756|NCT00670566|Diuretics|diuretics|mesh-ancestor
65286757|NCT00670566|Natriuretic Agents|natriuretic agents|mesh-ancestor
65286758|NCT00670566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286759|NCT00670566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65286760|NCT00670566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65286761|NCT00670566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286762|NCT00670566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65286763|NCT00670566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65286764|NCT02629848|Paclitaxel|paclitaxel|mesh-list
65286765|NCT02629848|Carboplatin|carboplatin|mesh-list
65286766|NCT02629848|Motesanib diphosphate|motesanib diphosphate|mesh-list
65286767|NCT02629848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65286768|NCT02629848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814062|NCT01476358|Vitamin A|vitamin a|mesh-list
64814063|NCT01476358|Retinol palmitate|retinol palmitate|mesh-list
64814064|NCT01476358|Vitamins|vitamins|mesh-ancestor
64814065|NCT01476358|Micronutrients|micronutrients|mesh-ancestor
64814066|NCT01476358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814067|NCT01476358|Antioxidants|antioxidants|mesh-ancestor
64814068|NCT01476358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814069|NCT01476358|Protective Agents|protective agents|mesh-ancestor
64814070|NCT01476358|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65494460|NCT04478292|Antimetabolites|antimetabolites|mesh-ancestor
64814071|NCT01476358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814072|NCT01476410|Doxorubicin|doxorubicin|mesh-list
64814073|NCT01476410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64814074|NCT01476410|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64814075|NCT01476410|Dacarbazine|dacarbazine|mesh-list
64814076|NCT01476410|Vinblastine|vinblastine|mesh-list
64814077|NCT01476410|Antibodies|antibodies|mesh-list
65494461|NCT04478292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64472642|NCT03060434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472643|NCT03060434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64472644|NCT03060434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64489359|NCT03721653|Immunologic Factors|immunologic factors|mesh-ancestor
64472661|NCT03060434|Vasodilator Agents|vasodilator agents|mesh-ancestor
64472662|NCT03060434|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64472663|NCT03060434|Antioxidants|antioxidants|mesh-ancestor
64472664|NCT03036930|Vaccines|vaccines|mesh-list
64472665|NCT03036930|Immunologic Factors|immunologic factors|mesh-ancestor
64814078|NCT01476410|Immunoglobulins|immunoglobulins|mesh-list
64814079|NCT01476410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64814080|NCT01476410|Immunoconjugates|immunoconjugates|mesh-list
64814081|NCT01476410|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64814082|NCT01476410|Immunologic Factors|immunologic factors|mesh-ancestor
65286769|NCT02629848|Tubulin Modulators|tubulin modulators|mesh-ancestor
65286770|NCT02629848|Antimitotic Agents|antimitotic agents|mesh-ancestor
65286771|NCT02629848|Mitosis Modulators|mitosis modulators|mesh-ancestor
65286772|NCT02629848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286773|NCT02629848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65286774|NCT02629848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286775|NCT03912337|Erenumab|erenumab|mesh-list
65286776|NCT03912337|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65286777|NCT03912337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286778|NCT03912337|Analgesics|analgesics|mesh-ancestor
64814083|NCT01476410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814084|NCT01476410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64814085|NCT01476410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814086|NCT01476410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64814087|NCT01476410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64814088|NCT01476410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814089|NCT01476410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814090|NCT01476410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64814091|NCT01476410|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64814092|NCT01476410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64814093|NCT01476410|Alkylating Agents|alkylating agents|mesh-ancestor
64814094|NCT01476410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64814095|NCT01476410|Tubulin Modulators|tubulin modulators|mesh-ancestor
64814096|NCT01476410|Antimitotic Agents|antimitotic agents|mesh-ancestor
64814097|NCT01476410|Mitosis Modulators|mitosis modulators|mesh-ancestor
64814098|NCT01476488|Tacrolimus|tacrolimus|mesh-list
64814099|NCT01476488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64814100|NCT01476488|Immunologic Factors|immunologic factors|mesh-ancestor
64814101|NCT01476488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494462|NCT04478292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65494463|NCT04478292|Immunologic Factors|immunologic factors|mesh-ancestor
65494464|NCT04478292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494465|NCT04478292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65494466|NCT04478292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65494467|NCT04478292|Tubulin Modulators|tubulin modulators|mesh-ancestor
65494468|NCT04478292|Antimitotic Agents|antimitotic agents|mesh-ancestor
65494469|NCT04478292|Mitosis Modulators|mitosis modulators|mesh-ancestor
65494470|NCT04478292|Antidotes|antidotes|mesh-ancestor
65494471|NCT04478292|Protective Agents|protective agents|mesh-ancestor
65494472|NCT04478292|Antioxidants|antioxidants|mesh-ancestor
65494473|NCT04478292|Antitubercular Agents|antitubercular agents|mesh-ancestor
65494474|NCT04478292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64489427|NCT00929344|Dopamine Agents|dopamine agents|mesh-ancestor
64814114|NCT01476605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64814116|NCT01476683|Thiorphan|thiorphan|mesh-list
64814117|NCT01476683|Antidiarrheals|antidiarrheals|mesh-ancestor
64814118|NCT01476683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64814119|NCT01476683|Protease Inhibitors|protease inhibitors|mesh-ancestor
64814136|NCT01476787|Immunologic Factors|immunologic factors|mesh-ancestor
64814137|NCT01476787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814138|NCT01476787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64814139|NCT01476787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64814140|NCT01476787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64814141|NCT01476787|Growth Substances|growth substances|mesh-ancestor
64814142|NCT01476787|Growth Inhibitors|growth inhibitors|mesh-ancestor
64814143|NCT01476787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64814144|NCT01476787|Alkylating Agents|alkylating agents|mesh-ancestor
64814145|NCT01476787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814146|NCT01476800|Ketoconazole|ketoconazole|mesh-list
64814147|NCT01476800|Mirabegron|mirabegron|mesh-list
64814148|NCT01476800|Antifungal Agents|antifungal agents|mesh-ancestor
64814149|NCT01476800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64814150|NCT01476800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65286779|NCT03912337|Sensory System Agents|sensory system agents|mesh-ancestor
65286780|NCT03912337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65286781|NCT03912337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286782|NCT00650156|Adalimumab|adalimumab|mesh-list
64814151|NCT01476800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64814152|NCT01476800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814153|NCT01476800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814172|NCT01476813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814173|NCT01477021|Cyclophosphamide|cyclophosphamide|mesh-list
64814174|NCT01477021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64814175|NCT01477021|Immunologic Factors|immunologic factors|mesh-ancestor
64814176|NCT01477021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814198|NCT01477060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814199|NCT01477073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64814201|NCT01477073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64814202|NCT01477073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814203|NCT01477112|Beta Carotene|beta carotene|mesh-list
64814204|NCT01477112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814205|NCT01477112|Provitamins|provitamins|mesh-ancestor
64814206|NCT01477112|Vitamins|vitamins|mesh-ancestor
64814207|NCT01477112|Micronutrients|micronutrients|mesh-ancestor
64814208|NCT01477151|Anesthetics|anesthetics|mesh-list
64814209|NCT01477151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65494487|NCT01238328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814210|NCT01477151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814211|NCT01477190|Morphine|morphine|mesh-list
64814212|NCT01477190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64814213|NCT01477190|Narcotics|narcotics|mesh-ancestor
64814214|NCT01477190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64814215|NCT01477190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814216|NCT01477190|Analgesics|analgesics|mesh-ancestor
64814217|NCT01477190|Sensory System Agents|sensory system agents|mesh-ancestor
64814218|NCT01477190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814219|NCT01477203|Citalopram|citalopram|mesh-list
64814220|NCT01477203|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64814221|NCT01477203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64814222|NCT01477203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64814223|NCT01477203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814224|NCT01477203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64814225|NCT01477203|Serotonin Agents|serotonin agents|mesh-ancestor
64814226|NCT01477203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814242|NCT01477242|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64814243|NCT01477242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64814244|NCT01477242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64814245|NCT01477242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64814246|NCT01477242|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64814247|NCT01477268|Sertraline|sertraline|mesh-list
64814248|NCT01477268|Antidepressive Agents|antidepressive agents|mesh-list
64814249|NCT01477268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64814250|NCT01477268|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64814251|NCT01477268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64814252|NCT01477268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64814253|NCT01477268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814254|NCT01477268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64814255|NCT01477268|Serotonin Agents|serotonin agents|mesh-ancestor
64814256|NCT01477268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814257|NCT01477294|Caffeine|caffeine|mesh-list
64814258|NCT01477294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64814259|NCT01477294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814260|NCT01477294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64814261|NCT01477294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814262|NCT01477294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814263|NCT01477294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64814264|NCT01477294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64814265|NCT01477294|Purinergic Agents|purinergic agents|mesh-ancestor
64814266|NCT01477294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64814267|NCT01477385|Fluorides|fluorides|mesh-list
64814268|NCT01477385|Cariostatic Agents|cariostatic agents|mesh-ancestor
65286783|NCT00650156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65286784|NCT00650156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65286785|NCT02576782|Dexamethasone|dexamethasone|mesh-list
65286786|NCT02576782|Dexamethasone acetate|dexamethasone acetate|mesh-list
65286787|NCT02576782|Bupivacaine|bupivacaine|mesh-list
65286788|NCT02576782|BB 1101|bb 1101|mesh-list
65286789|NCT02576782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65286790|NCT02576782|Antiemetics|antiemetics|mesh-ancestor
65286791|NCT02576782|Autonomic Agents|autonomic agents|mesh-ancestor
65286792|NCT02576782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814269|NCT01477385|Protective Agents|protective agents|mesh-ancestor
64814270|NCT01477385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814271|NCT01477411|Digoxin|digoxin|mesh-list
64814272|NCT01477411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64814273|NCT01477411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64814274|NCT01477411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814275|NCT01477411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814276|NCT01477411|Protective Agents|protective agents|mesh-ancestor
64814277|NCT01477411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814278|NCT01477424|Warfarin|warfarin|mesh-list
64814279|NCT01477424|Anticoagulants|anticoagulants|mesh-ancestor
64814280|NCT01477476|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64814281|NCT01477476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64582898|NCT02579382|Vesatolimod|vesatolimod|mesh-list
64814282|NCT01477489|Veliparib|veliparib|mesh-list
64814283|NCT01477489|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64814284|NCT01477489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814285|NCT01477489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814286|NCT01477489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814287|NCT01477580|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64814288|NCT01477580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64814289|NCT01477580|Immunologic Factors|immunologic factors|mesh-ancestor
64814290|NCT01477580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814291|NCT01477580|Antacids|antacids|mesh-ancestor
64814292|NCT01477580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814293|NCT01477580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64814294|NCT01477606|Cytarabine|cytarabine|mesh-list
64814295|NCT01477606|Daunorubicin|daunorubicin|mesh-list
64814296|NCT01477606|Midostaurin|midostaurin|mesh-list
64814297|NCT01477606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64814308|NCT01477606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64814325|NCT01477632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64814327|NCT01477632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64814328|NCT01477736|Oxybutynin|oxybutynin|mesh-list
64814329|NCT01477736|Botulinum Toxins|botulinum toxins|mesh-list
64814330|NCT01477736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64814331|NCT01477736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64814332|NCT01477736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64814333|NCT01477736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64814334|NCT01477736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814335|NCT01477736|Cholinergic Agents|cholinergic agents|mesh-ancestor
64814336|NCT01477736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64814337|NCT01477736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814338|NCT01477736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64814339|NCT01477736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814340|NCT01477736|Parasympatholytics|parasympatholytics|mesh-ancestor
64814341|NCT01477736|Autonomic Agents|autonomic agents|mesh-ancestor
64814342|NCT01477736|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64814343|NCT01477736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64814344|NCT01477736|Urological Agents|urological agents|mesh-ancestor
64814345|NCT01477801|Cholecalciferol|cholecalciferol|mesh-list
64814346|NCT01477801|Vitamin D|vitamin d|mesh-list
64814347|NCT01477801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64814348|NCT01477801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814349|NCT01477801|Vitamins|vitamins|mesh-ancestor
64814350|NCT01477801|Micronutrients|micronutrients|mesh-ancestor
64814351|NCT01477801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64814352|NCT01477840|Misoprostol|misoprostol|mesh-list
65286793|NCT02576782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286794|NCT02576782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65286795|NCT02576782|Glucocorticoids|glucocorticoids|mesh-ancestor
65286796|NCT02576782|Hormones|hormones|mesh-ancestor
65286797|NCT02576782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65286798|NCT02576782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65286799|NCT02576782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286800|NCT02576782|Protease Inhibitors|protease inhibitors|mesh-ancestor
65286801|NCT02576782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286802|NCT02576782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286803|NCT02576782|Anesthetics, Local|anesthetics, local|mesh-ancestor
65286804|NCT02576782|Anesthetics|anesthetics|mesh-ancestor
65286805|NCT02576782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65286806|NCT02576782|Sensory System Agents|sensory system agents|mesh-ancestor
64814353|NCT01477840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64814354|NCT01477840|Abortifacient Agents|abortifacient agents|mesh-ancestor
64814355|NCT01477840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64814356|NCT01477840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814357|NCT01477840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64814358|NCT01477840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64814360|NCT01477931|Bupropion|bupropion|mesh-list
64814361|NCT01477931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64814362|NCT01477931|Antidepressive Agents|antidepressive agents|mesh-ancestor
64814379|NCT01477983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814381|NCT01478022|Isosorbide|isosorbide|mesh-list
64814382|NCT01478022|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64814383|NCT01478022|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64814384|NCT01478022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64814393|NCT01478022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814394|NCT01478022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814395|NCT01478022|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64814396|NCT01478022|Diuretics|diuretics|mesh-ancestor
64814397|NCT01478022|Natriuretic Agents|natriuretic agents|mesh-ancestor
64814398|NCT01478022|Vasodilator Agents|vasodilator agents|mesh-ancestor
64814399|NCT01478022|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64814400|NCT01478074|Cytarabine|cytarabine|mesh-list
64814401|NCT01478074|Fludarabine|fludarabine|mesh-list
64814402|NCT01478074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814403|NCT01478074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64814404|NCT01478074|Antimetabolites|antimetabolites|mesh-ancestor
64814405|NCT01478074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814406|NCT01478074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64814407|NCT01478074|Immunologic Factors|immunologic factors|mesh-ancestor
64814408|NCT01478074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814409|NCT01478074|Antiviral Agents|antiviral agents|mesh-ancestor
64814410|NCT01478074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64814411|NCT01478165|Palonosetron|palonosetron|mesh-list
64814412|NCT01478165|Anesthetics|anesthetics|mesh-list
64814413|NCT01478165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64814414|NCT01478165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814415|NCT01478165|Antiemetics|antiemetics|mesh-ancestor
64814416|NCT01478165|Autonomic Agents|autonomic agents|mesh-ancestor
64814417|NCT01478165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64425505|NCT02438371|Nifedipine|nifedipine|mesh-list
64814431|NCT01478230|Cholinergic Agents|cholinergic agents|mesh-ancestor
64814432|NCT01478230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64814433|NCT01478230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814434|NCT01478282|Rivaroxaban|rivaroxaban|mesh-list
64814435|NCT01478282|Dabigatran|dabigatran|mesh-list
64814436|NCT01478282|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65286807|NCT02629770|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65286808|NCT02629770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65286809|NCT02577094|Fludarabine|fludarabine|mesh-list
65286810|NCT02577094|Busulfan|busulfan|mesh-list
65286811|NCT02577094|Epratuzumab|epratuzumab|mesh-list
65286812|NCT02577094|Thymoglobulin|thymoglobulin|mesh-list
64562232|NCT03011463|Trospium chloride|trospium chloride|mesh-list
64814437|NCT01478282|Antithrombins|antithrombins|mesh-ancestor
64814438|NCT01478282|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64814439|NCT01478282|Protease Inhibitors|protease inhibitors|mesh-ancestor
64814440|NCT01478282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814441|NCT01478282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814442|NCT01478282|Anticoagulants|anticoagulants|mesh-ancestor
64814443|NCT01478308|Metformin|metformin|mesh-list
64814444|NCT01478308|Prednisone|prednisone|mesh-list
64814445|NCT01478308|Docetaxel|docetaxel|mesh-list
64814446|NCT01478308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64814447|NCT01478308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814448|NCT01478308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814449|NCT01478308|Tubulin Modulators|tubulin modulators|mesh-ancestor
64814450|NCT01478308|Antimitotic Agents|antimitotic agents|mesh-ancestor
64814451|NCT01478308|Mitosis Modulators|mitosis modulators|mesh-ancestor
64814452|NCT01478308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814453|NCT01478308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64814454|NCT01478308|Glucocorticoids|glucocorticoids|mesh-ancestor
64814455|NCT01478308|Hormones|hormones|mesh-ancestor
64814456|NCT01478308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64814457|NCT01478308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64814458|NCT01478386|Hyaluronic Acid|hyaluronic acid|mesh-list
64814459|NCT01478386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64814460|NCT01478386|Immunologic Factors|immunologic factors|mesh-ancestor
64814461|NCT01478386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814462|NCT01478386|Viscosupplements|viscosupplements|mesh-ancestor
64814463|NCT01478386|Protective Agents|protective agents|mesh-ancestor
64814464|NCT01478490|Metoprolol|metoprolol|mesh-list
65494488|NCT01238406|Pancrelipase|pancrelipase|mesh-list
64814476|NCT01478490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64814477|NCT01478490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814478|NCT01478490|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64472668|NCT03021486|Chlorpromazine|chlorpromazine|mesh-list
64472669|NCT03021486|Haloperidol decanoate|haloperidol decanoate|mesh-list
64814479|NCT01478490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64814488|NCT01478503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814490|NCT01478503|Urological Agents|urological agents|mesh-ancestor
64814491|NCT01478529|Mirabegron|mirabegron|mesh-list
64814492|NCT01478529|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64814493|NCT01478529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64814494|NCT01478529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64814495|NCT01478529|Adrenergic Agents|adrenergic agents|mesh-ancestor
64814496|NCT01478529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64814497|NCT01478529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814498|NCT01478529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814499|NCT01478529|Urological Agents|urological agents|mesh-ancestor
64814500|NCT01478568|Desipramine|desipramine|mesh-list
64814501|NCT01478568|Mirabegron|mirabegron|mesh-list
64814502|NCT01478568|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64814503|NCT01478568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64814504|NCT01478568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64814505|NCT01478568|Adrenergic Agents|adrenergic agents|mesh-ancestor
64814506|NCT01478568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64814507|NCT01478568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814508|NCT01478568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814509|NCT01478568|Urological Agents|urological agents|mesh-ancestor
64814510|NCT01478568|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64814511|NCT01478568|Antidepressive Agents|antidepressive agents|mesh-ancestor
64814512|NCT01478568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64814513|NCT01478568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814514|NCT01478568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64814515|NCT01478568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64814516|NCT01478568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65286813|NCT02577094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286814|NCT02577094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286815|NCT02577094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65286816|NCT02577094|Immunologic Factors|immunologic factors|mesh-ancestor
65286817|NCT02577094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286818|NCT02577094|Alkylating Agents|alkylating agents|mesh-ancestor
65286819|NCT02577094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65286820|NCT02577094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65286821|NCT02577094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65286822|NCT00649844|Ziprasidone|ziprasidone|mesh-list
65286823|NCT00649844|Clozapine|clozapine|mesh-list
65286824|NCT00649844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65286825|NCT00649844|Serotonin Agents|serotonin agents|mesh-ancestor
64814518|NCT01478607|Antipruritics|antipruritics|mesh-ancestor
64814519|NCT01478607|Dermatologic Agents|dermatologic agents|mesh-ancestor
64814520|NCT01478607|Sensory System Agents|sensory system agents|mesh-ancestor
64814521|NCT01478607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814522|NCT01478607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814523|NCT01478633|Galantamine|galantamine|mesh-list
64814524|NCT01478633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64814525|NCT01478633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814526|NCT01478633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814527|NCT01478633|Cholinergic Agents|cholinergic agents|mesh-ancestor
64814528|NCT01478633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64814529|NCT01478633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814530|NCT01478633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64814531|NCT01478633|Autonomic Agents|autonomic agents|mesh-ancestor
64814532|NCT01478633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814533|NCT01478633|Nootropic Agents|nootropic agents|mesh-ancestor
64814534|NCT01478685|Paclitaxel|paclitaxel|mesh-list
64814541|NCT01478685|Tubulin Modulators|tubulin modulators|mesh-ancestor
64814542|NCT01478685|Antimitotic Agents|antimitotic agents|mesh-ancestor
64814543|NCT01478685|Mitosis Modulators|mitosis modulators|mesh-ancestor
64814544|NCT01478685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814545|NCT01478685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64814568|NCT01478737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814570|NCT01478997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64814571|NCT01478997|Analgesics|analgesics|mesh-ancestor
64814572|NCT01478997|Sensory System Agents|sensory system agents|mesh-ancestor
64814573|NCT01478997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814574|NCT01478997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814575|NCT01478997|Antipyretics|antipyretics|mesh-ancestor
64814576|NCT01479023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64814577|NCT01479023|Immunologic Factors|immunologic factors|mesh-ancestor
64814578|NCT01479023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814579|NCT01479036|Docetaxel|docetaxel|mesh-list
64814580|NCT01479036|Epirubicin|epirubicin|mesh-list
64814581|NCT01479036|Endostatins|endostatins|mesh-list
64814582|NCT01479036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494489|NCT01238406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65494490|NCT03724890|Avelumab|avelumab|mesh-list
64814583|NCT01479036|Tubulin Modulators|tubulin modulators|mesh-ancestor
64814584|NCT01479036|Antimitotic Agents|antimitotic agents|mesh-ancestor
64814585|NCT01479036|Mitosis Modulators|mitosis modulators|mesh-ancestor
64814586|NCT01479036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814587|NCT01479036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64814588|NCT01479036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64814589|NCT01479036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64814590|NCT01479036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814591|NCT01479036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64814592|NCT01479036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64814593|NCT01479036|Growth Substances|growth substances|mesh-ancestor
65286826|NCT00649844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65286827|NCT00649844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286828|NCT00649844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286829|NCT00649844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65286830|NCT00649844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64562601|NCT04278287|Paclitaxel|paclitaxel|mesh-list
64814594|NCT01479036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814595|NCT01479036|Growth Inhibitors|growth inhibitors|mesh-ancestor
64814596|NCT01479075|Insulin|insulin|mesh-list
64814597|NCT01479075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64814598|NCT01479075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64814599|NCT01479075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814600|NCT01479088|Cinacalcet|cinacalcet|mesh-list
64814601|NCT01479088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64814611|NCT01479179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64814612|NCT01479179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814613|NCT01479192|Fenretinide|fenretinide|mesh-list
64814614|NCT01479192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814615|NCT01479192|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64814616|NCT01479192|Protective Agents|protective agents|mesh-ancestor
64814617|NCT01479192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814618|NCT01479231|Dexlansoprazole|dexlansoprazole|mesh-list
64814619|NCT01479231|Lansoprazole|lansoprazole|mesh-list
64814620|NCT01479231|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64814621|NCT01479231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64814622|NCT01479231|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64814623|NCT01479231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814624|NCT01479231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814625|NCT01479244|Molgramostim|molgramostim|mesh-list
64814626|NCT01479244|Sargramostim|sargramostim|mesh-list
64814627|NCT01479244|Immunologic Factors|immunologic factors|mesh-ancestor
64814628|NCT01479244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814629|NCT01479244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814630|NCT01479283|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64814631|NCT01479283|Cefazolin|cefazolin|mesh-list
64814632|NCT01479283|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64814633|NCT01479283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64489838|NCT04363060|Clavulanic Acid|clavulanic acid|mesh-list
64814654|NCT01479556|Analgesics|analgesics|mesh-ancestor
64814655|NCT01479556|Sensory System Agents|sensory system agents|mesh-ancestor
64814656|NCT01479556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814657|NCT01479556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814658|NCT01479556|Anticonvulsants|anticonvulsants|mesh-ancestor
64814659|NCT01479556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64814660|NCT01479556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64814661|NCT01479556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814662|NCT01479556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64814663|NCT01479556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64814664|NCT01479556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64814665|NCT01479556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64814666|NCT01479556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64814667|NCT01479634|Efavirenz|efavirenz|mesh-list
65494491|NCT03724890|Peposertib|peposertib|mesh-list
64814668|NCT01479634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64814687|NCT01479751|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64814689|NCT01479751|Anesthetics, General|anesthetics, general|mesh-ancestor
64814690|NCT01479751|Anesthetics|anesthetics|mesh-ancestor
64814691|NCT01479751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64814692|NCT01479751|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64814693|NCT01479751|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64814694|NCT01479751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64814695|NCT01479751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814696|NCT01479751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64814697|NCT01479751|Anticonvulsants|anticonvulsants|mesh-ancestor
64814698|NCT01479751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64814699|NCT01479751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64814700|NCT01479751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64814701|NCT01479751|Tocolytic Agents|tocolytic agents|mesh-ancestor
65286831|NCT00649844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65286832|NCT00649844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65286833|NCT00649844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65286834|NCT00649844|Dopamine Agents|dopamine agents|mesh-ancestor
65286835|NCT00649844|GABA Antagonists|gaba antagonists|mesh-ancestor
65286836|NCT00649844|GABA Agents|gaba agents|mesh-ancestor
65286837|NCT03912259|Emollients|emollients|mesh-list
65286838|NCT03912259|Dermatologic Agents|dermatologic agents|mesh-ancestor
65286839|NCT02656472|Tranexamic Acid|tranexamic acid|mesh-list
65286840|NCT02656472|Aminocaproic Acid|aminocaproic acid|mesh-list
65286841|NCT02656472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65286842|NCT02656472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65286843|NCT02656472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286844|NCT02656472|Hemostatics|hemostatics|mesh-ancestor
65286845|NCT02656472|Coagulants|coagulants|mesh-ancestor
65286846|NCT00665340|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65286847|NCT00665340|Vasodilator Agents|vasodilator agents|mesh-ancestor
65286848|NCT00665340|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65286849|NCT00665340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65286850|NCT00665340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286851|NCT00665340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286852|NCT00665340|Urological Agents|urological agents|mesh-ancestor
64814702|NCT01479751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64814703|NCT01479751|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64814704|NCT01479751|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64814705|NCT01479751|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64814706|NCT01479881|Cyclosporine|cyclosporine|mesh-list
64814707|NCT01479881|Simeprevir|simeprevir|mesh-list
64814708|NCT01479881|Tacrolimus|tacrolimus|mesh-list
64814744|NCT01480050|Temozolomide|temozolomide|mesh-list
64814745|NCT01480050|Mibefradil|mibefradil|mesh-list
64814746|NCT01480050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64814747|NCT01480050|Alkylating Agents|alkylating agents|mesh-ancestor
64814748|NCT01480050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814749|NCT01480050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814750|NCT01480050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64814751|NCT01480050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64814752|NCT01480050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64814753|NCT01480050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64814754|NCT01480050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814755|NCT01480050|Vasodilator Agents|vasodilator agents|mesh-ancestor
64814756|NCT01480050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64814757|NCT01480050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64814758|NCT01480050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814759|NCT01480063|4-Aminopyridine|4-aminopyridine|mesh-list
64814760|NCT01480063|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64814761|NCT01480063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64814762|NCT01480063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814763|NCT01480141|Afatinib|afatinib|mesh-list
64814764|NCT01480141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814765|NCT01480141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64814766|NCT01480141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814767|NCT01480141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286853|NCT00665418|Sevoflurane|sevoflurane|mesh-list
65286854|NCT00665418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65286855|NCT00665418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65286856|NCT00665418|Anesthetics, General|anesthetics, general|mesh-ancestor
65286857|NCT00665418|Anesthetics|anesthetics|mesh-ancestor
64517135|NCT02456454|Anticonvulsants|anticonvulsants|mesh-ancestor
64814768|NCT01480323|Aldesleukin|aldesleukin|mesh-list
64814769|NCT01480323|Ipilimumab|ipilimumab|mesh-list
64814770|NCT01480323|Interleukin-2|interleukin-2|mesh-list
64814771|NCT01480323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64814772|NCT01480323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814773|NCT01480323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64814849|NCT01480765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64814850|NCT01480765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64814851|NCT01480765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814852|NCT01480765|Anticonvulsants|anticonvulsants|mesh-ancestor
64814853|NCT01480765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64814854|NCT01480765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64814855|NCT01480765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64814856|NCT01480765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64814857|NCT01480765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64814858|NCT01480765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64814859|NCT01480778|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
64814860|NCT01480778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64814872|NCT01480791|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64814873|NCT01480791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64814874|NCT01480791|Diuretics|diuretics|mesh-ancestor
64814875|NCT01480791|Natriuretic Agents|natriuretic agents|mesh-ancestor
64583505|NCT01435460|Analgesics|analgesics|mesh-ancestor
64814876|NCT01480791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814877|NCT01480791|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64814878|NCT01480791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64814879|NCT01480791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814880|NCT01480817|Sorafenib|sorafenib|mesh-list
64814881|NCT01480817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814882|NCT01480817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64814883|NCT01480817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814896|NCT01480986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814897|NCT01480986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64814898|NCT01480986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64814899|NCT01480986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814900|NCT01480986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814901|NCT01480986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64814902|NCT01480986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64814903|NCT01481194|Dexamethasone|dexamethasone|mesh-list
64814904|NCT01481194|Cyclophosphamide|cyclophosphamide|mesh-list
64814905|NCT01481194|Doxorubicin|doxorubicin|mesh-list
64814906|NCT01481194|Lenalidomide|lenalidomide|mesh-list
64814907|NCT01481194|Bortezomib|bortezomib|mesh-list
64814908|NCT01481194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64814909|NCT01481194|Immunologic Factors|immunologic factors|mesh-ancestor
64814910|NCT01481194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814911|NCT01481194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64814912|NCT01481194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64814913|NCT01481194|Alkylating Agents|alkylating agents|mesh-ancestor
64814914|NCT01481194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814915|NCT01481194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814916|NCT01481194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64814917|NCT01481194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64814918|NCT01481194|Antiemetics|antiemetics|mesh-ancestor
64814919|NCT01481194|Autonomic Agents|autonomic agents|mesh-ancestor
64814920|NCT01481194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814921|NCT01481194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64814927|NCT01481194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64814928|NCT01481194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64814929|NCT01481194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814930|NCT01481194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64814931|NCT01481194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64814932|NCT01481194|Growth Substances|growth substances|mesh-ancestor
65286858|NCT00665418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65286859|NCT00665418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286860|NCT04058990|Paclitaxel|paclitaxel|mesh-list
65286861|NCT04058990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65286862|NCT04058990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64814933|NCT01481194|Growth Inhibitors|growth inhibitors|mesh-ancestor
64814935|NCT01481233|Gout Suppressants|gout suppressants|mesh-ancestor
64814936|NCT01481233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64814937|NCT01481233|Tubulin Modulators|tubulin modulators|mesh-ancestor
64814938|NCT01481233|Antimitotic Agents|antimitotic agents|mesh-ancestor
64814939|NCT01481233|Mitosis Modulators|mitosis modulators|mesh-ancestor
64814940|NCT01481233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814941|NCT01481233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814942|NCT01481259|Pemetrexed|pemetrexed|mesh-list
64814943|NCT01481259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814944|NCT01481259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814945|NCT01481259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814946|NCT01481259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64814947|NCT01481259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64814948|NCT01481311|Bromides|bromides|mesh-list
64814949|NCT01481311|Anticonvulsants|anticonvulsants|mesh-ancestor
64814950|NCT01481350|Sildenafil Citrate|sildenafil citrate|mesh-list
64814951|NCT01481350|Vasodilator Agents|vasodilator agents|mesh-ancestor
64814952|NCT01481350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64814953|NCT01481350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64814954|NCT01481350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814966|NCT01481454|Immunologic Factors|immunologic factors|mesh-ancestor
64814967|NCT01481454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814968|NCT01481519|Povidone-Iodine|povidone-iodine|mesh-list
64814969|NCT01481519|Dexamethasone|dexamethasone|mesh-list
64814970|NCT01481519|Dexamethasone acetate|dexamethasone acetate|mesh-list
64814971|NCT01481519|Povidone|povidone|mesh-list
64814972|NCT01481519|Lubricant Eye Drops|lubricant eye drops|mesh-list
64814973|NCT01481519|BB 1101|bb 1101|mesh-list
64814974|NCT01481519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64814975|NCT01481519|Antiemetics|antiemetics|mesh-ancestor
64814976|NCT01481519|Autonomic Agents|autonomic agents|mesh-ancestor
64814977|NCT01481519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814978|NCT01481519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814979|NCT01481519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64814980|NCT01481519|Glucocorticoids|glucocorticoids|mesh-ancestor
64814981|NCT01481519|Hormones|hormones|mesh-ancestor
64814982|NCT01481519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64814983|NCT01481519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64814984|NCT01481519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814985|NCT01481519|Protease Inhibitors|protease inhibitors|mesh-ancestor
64814986|NCT01481519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814987|NCT01481519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472672|NCT03021486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814988|NCT01481519|Plasma Substitutes|plasma substitutes|mesh-ancestor
64814989|NCT01481519|Blood Substitutes|blood substitutes|mesh-ancestor
64814990|NCT01481519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64814991|NCT01481519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64814997|NCT01481532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814999|NCT01481610|Diclofenac|diclofenac|mesh-list
64815000|NCT01481610|Lumiracoxib|lumiracoxib|mesh-list
64815001|NCT01481610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64815002|NCT01481610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64815003|NCT01481610|Analgesics|analgesics|mesh-ancestor
64815004|NCT01481610|Sensory System Agents|sensory system agents|mesh-ancestor
64815005|NCT01481610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64815006|NCT01481610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815007|NCT01481610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64815008|NCT01481610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64815009|NCT01481610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64815010|NCT01481610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815011|NCT01481610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815012|NCT01481610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64815013|NCT01481701|Oxaliplatin|oxaliplatin|mesh-list
64815014|NCT01481701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286863|NCT04058990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286864|NCT04058990|Tubulin Modulators|tubulin modulators|mesh-ancestor
65286865|NCT04058990|Antimitotic Agents|antimitotic agents|mesh-ancestor
65286866|NCT04058990|Mitosis Modulators|mitosis modulators|mesh-ancestor
65286867|NCT04058990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286868|NCT00595920|Vaccines|vaccines|mesh-list
65286869|NCT00595920|Immunologic Factors|immunologic factors|mesh-ancestor
65286870|NCT00595920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286871|NCT02654288|Gemcitabine|gemcitabine|mesh-list
65286872|NCT02654288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65286873|NCT02654288|Antimetabolites|antimetabolites|mesh-ancestor
65286874|NCT02654288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286875|NCT02654288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286876|NCT02654288|Antiviral Agents|antiviral agents|mesh-ancestor
64815015|NCT01481714|Picosulfate sodium|picosulfate sodium|mesh-list
64815016|NCT01481714|Magnesium Oxide|magnesium oxide|mesh-list
64815017|NCT01481714|Sodium Citrate|sodium citrate|mesh-list
64815018|NCT01481714|Citric Acid|citric acid|mesh-list
64815019|NCT01481714|Anticoagulants|anticoagulants|mesh-ancestor
64815020|NCT01481714|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64815021|NCT01481714|Chelating Agents|chelating agents|mesh-ancestor
64815022|NCT01481714|Sequestering Agents|sequestering agents|mesh-ancestor
64815023|NCT01481714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815024|NCT01481714|Cathartics|cathartics|mesh-ancestor
64815036|NCT01481831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64815037|NCT01481831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815038|NCT01481844|Amoxicillin|amoxicillin|mesh-list
64815039|NCT01481844|Metronidazole|metronidazole|mesh-list
64815040|NCT01481844|Clarithromycin|clarithromycin|mesh-list
64815041|NCT01481844|Tetracycline|tetracycline|mesh-list
64815042|NCT01481844|Tinidazole|tinidazole|mesh-list
64815043|NCT01481844|Lansoprazole|lansoprazole|mesh-list
64815044|NCT01481844|Dexlansoprazole|dexlansoprazole|mesh-list
64815045|NCT01481844|Bismuth|bismuth|mesh-list
64815046|NCT01481844|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
64815047|NCT01481844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64815048|NCT01481844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64815049|NCT01481844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64815050|NCT01481844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64815051|NCT01481844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64815052|NCT01481844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815053|NCT01481844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815054|NCT01481844|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64815055|NCT01481844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64815056|NCT01481844|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64815057|NCT01481844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64815058|NCT01481844|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64815059|NCT01481844|Antacids|antacids|mesh-ancestor
64815060|NCT01481844|Alkylating Agents|alkylating agents|mesh-ancestor
64815061|NCT01481844|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64815062|NCT01481844|Antidiarrheals|antidiarrheals|mesh-ancestor
64815077|NCT01481883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64815078|NCT01481883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815079|NCT01481883|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64815080|NCT01481883|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65494492|NCT03724890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64472673|NCT03021486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815081|NCT01481883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64815084|NCT01482052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815085|NCT01482104|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64815086|NCT01482104|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65286877|NCT02654288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65286878|NCT02654288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286879|NCT02654288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65286880|NCT02654288|Immunologic Factors|immunologic factors|mesh-ancestor
65286881|NCT02654288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815087|NCT01482104|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64815088|NCT01482104|Dermatologic Agents|dermatologic agents|mesh-ancestor
64815089|NCT01482117|Cilostazol|cilostazol|mesh-list
64815090|NCT01482117|Clopidogrel|clopidogrel|mesh-list
64815091|NCT01482117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64815092|NCT01482117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64815093|NCT01482117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64815094|NCT01482117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64815095|NCT01482117|Purinergic Agents|purinergic agents|mesh-ancestor
64815096|NCT01482117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64815097|NCT01482117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815098|NCT01482117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815099|NCT01482117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64815100|NCT01482117|Autonomic Agents|autonomic agents|mesh-ancestor
64490189|NCT00928642|Antiviral Agents|antiviral agents|mesh-ancestor
64815131|NCT01482338|Natriuretic Agents|natriuretic agents|mesh-ancestor
64815132|NCT01482338|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64815133|NCT01482338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64815134|NCT01482338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64815135|NCT01482338|Contraceptive Agents|contraceptive agents|mesh-ancestor
64815136|NCT01482338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64815137|NCT01482338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64815138|NCT01482338|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64815139|NCT01482338|Progestins|progestins|mesh-ancestor
64815140|NCT01482338|Hormones|hormones|mesh-ancestor
64815141|NCT01482377|Cetuximab|cetuximab|mesh-list
64815142|NCT01482377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64815143|NCT01482377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64815144|NCT01482377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815145|NCT01482377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64815146|NCT01482377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815147|NCT01482377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815148|NCT01482416|Estrogens|estrogens|mesh-list
64815149|NCT01482416|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64815150|NCT01482416|Hormones|hormones|mesh-ancestor
64815151|NCT01482416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64815152|NCT01482416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815153|NCT01482442|Sorafenib|sorafenib|mesh-list
64815154|NCT01482442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815155|NCT01482442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64815156|NCT01482442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815157|NCT01482442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815158|NCT01482468|Palonosetron|palonosetron|mesh-list
64815159|NCT01482468|Antiemetics|antiemetics|mesh-ancestor
64815160|NCT01482468|Autonomic Agents|autonomic agents|mesh-ancestor
64490253|NCT03777813|Vitamins|vitamins|mesh-ancestor
64815177|NCT01482559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815179|NCT01482624|Hyaluronic Acid|hyaluronic acid|mesh-list
64815180|NCT01482624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64815181|NCT01482624|Immunologic Factors|immunologic factors|mesh-ancestor
64815182|NCT01482624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815183|NCT01482624|Viscosupplements|viscosupplements|mesh-ancestor
64815184|NCT01482624|Protective Agents|protective agents|mesh-ancestor
64815185|NCT01482728|Dasatinib|dasatinib|mesh-list
64815186|NCT01482728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426260|NCT03905889|Growth Inhibitors|growth inhibitors|mesh-ancestor
64815200|NCT01482897|Prednisolone acetate|prednisolone acetate|mesh-list
64815201|NCT01482897|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64815202|NCT01482897|Prednisolone phosphate|prednisolone phosphate|mesh-list
64815203|NCT01482897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64815204|NCT01482897|Glucocorticoids|glucocorticoids|mesh-ancestor
64815205|NCT01482897|Hormones|hormones|mesh-ancestor
64815206|NCT01482897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64815207|NCT01482897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815208|NCT01482897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65286882|NCT02649140|Acetic Acid|acetic acid|mesh-list
65286883|NCT02649140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65286884|NCT02649140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65286885|NCT00665496|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65286886|NCT00665496|Vasodilator Agents|vasodilator agents|mesh-ancestor
65286887|NCT00665496|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65286888|NCT00665496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64815209|NCT01482897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815210|NCT01482897|Antiemetics|antiemetics|mesh-ancestor
64815211|NCT01482897|Autonomic Agents|autonomic agents|mesh-ancestor
64815212|NCT01482897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64815213|NCT01482897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64815214|NCT01482897|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64815215|NCT01482897|Protective Agents|protective agents|mesh-ancestor
64815216|NCT01482936|Oxycodone|oxycodone|mesh-list
64815217|NCT01482936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64815218|NCT01482936|Narcotics|narcotics|mesh-ancestor
64815219|NCT01482936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64815220|NCT01482936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815221|NCT01482936|Analgesics|analgesics|mesh-ancestor
64815222|NCT01482936|Sensory System Agents|sensory system agents|mesh-ancestor
64815223|NCT01482936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64815224|NCT01483014|Imatinib Mesylate|imatinib mesylate|mesh-list
64815225|NCT01483014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815226|NCT01483014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64815227|NCT01483014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815247|NCT01483248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64815273|NCT01483638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815274|NCT01483729|Ritonavir|ritonavir|mesh-list
64815275|NCT01483729|Lactams|lactams|mesh-list
64815276|NCT01483729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64815277|NCT01483729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64815278|NCT01483729|Protease Inhibitors|protease inhibitors|mesh-ancestor
64815279|NCT01483729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815280|NCT01483729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815281|NCT01483729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64815282|NCT01483729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64815283|NCT01483729|Antiviral Agents|antiviral agents|mesh-ancestor
64815284|NCT01483729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64815285|NCT01483729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64815286|NCT01483729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64815287|NCT01483729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64815288|NCT01483781|Canagliflozin|canagliflozin|mesh-list
64815289|NCT01483781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64815290|NCT01483781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815291|NCT01483781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64815292|NCT01483781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815293|NCT01483859|Liver Extracts|liver extracts|mesh-list
64815294|NCT01483859|Hematinics|hematinics|mesh-ancestor
64815295|NCT01483911|Gontivimab|gontivimab|mesh-list
64815296|NCT01483911|Antiviral Agents|antiviral agents|mesh-ancestor
64815297|NCT01483911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64815298|NCT01484015|Cefepime|cefepime|mesh-list
64815299|NCT01484015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64815308|NCT01484080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815309|NCT01484145|Terbinafine|terbinafine|mesh-list
64815310|NCT01484145|Antifungal Agents|antifungal agents|mesh-ancestor
64815311|NCT01484145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64815340|NCT01484262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64815341|NCT01484327|Carvedilol|carvedilol|mesh-list
64815342|NCT01484327|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64815343|NCT01484327|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64815344|NCT01484327|Adrenergic Agents|adrenergic agents|mesh-ancestor
64815345|NCT01484327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64815346|NCT01484327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815347|NCT01484327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815348|NCT01484327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64815349|NCT01484327|Antioxidants|antioxidants|mesh-ancestor
65286889|NCT00665496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286890|NCT00665496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286891|NCT00665496|Urological Agents|urological agents|mesh-ancestor
65036893|NCT01054248|Artesunate|artesunate|mesh-list
65286892|NCT02653898|Artesunate|artesunate|mesh-list
65286893|NCT02653898|Piperaquine|piperaquine|mesh-list
65286894|NCT02653898|Primaquine|primaquine|mesh-list
65286895|NCT02653898|Artenimol|artenimol|mesh-list
65286896|NCT02653898|Mefloquine|mefloquine|mesh-list
65286897|NCT02653898|Permethrin|permethrin|mesh-list
65286898|NCT02653898|Antimalarials|antimalarials|mesh-ancestor
64815350|NCT01484327|Protective Agents|protective agents|mesh-ancestor
64815351|NCT01484327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64815352|NCT01484327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65494495|NCT03724890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815353|NCT01484327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64815354|NCT01484327|Vasodilator Agents|vasodilator agents|mesh-ancestor
64815376|NCT01484717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64815377|NCT01484717|Cholinergic Agents|cholinergic agents|mesh-ancestor
64815378|NCT01484717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64815379|NCT01484717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815382|NCT01484756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815383|NCT01484964|Peficitinib|peficitinib|mesh-list
64815384|NCT01484964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815385|NCT01484964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815386|NCT01484964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64815387|NCT01484964|Immunologic Factors|immunologic factors|mesh-ancestor
64815388|NCT01484964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815389|NCT01484990|Levodopa|levodopa|mesh-list
64815390|NCT01484990|Carbidopa|carbidopa|mesh-list
64815391|NCT01484990|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64815392|NCT01484990|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64815393|NCT01484990|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64815394|NCT01484990|Dopamine Agents|dopamine agents|mesh-ancestor
64815395|NCT01484990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64815396|NCT01484990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815397|NCT01484990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815398|NCT01484990|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64815399|NCT01484990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815400|NCT01484990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64815401|NCT01484990|Immunologic Factors|immunologic factors|mesh-ancestor
64815402|NCT01484990|Dopamine Agonists|dopamine agonists|mesh-ancestor
64815403|NCT01485003|Natalizumab|natalizumab|mesh-list
64815404|NCT01485003|Immunologic Factors|immunologic factors|mesh-ancestor
64815405|NCT01485003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815406|NCT01485068|Paclitaxel|paclitaxel|mesh-list
64815407|NCT01485068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64815408|NCT01485068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815409|NCT01485068|Tubulin Modulators|tubulin modulators|mesh-ancestor
64815410|NCT01485068|Antimitotic Agents|antimitotic agents|mesh-ancestor
64815411|NCT01485068|Mitosis Modulators|mitosis modulators|mesh-ancestor
64815412|NCT01485068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815413|NCT01485081|Paclitaxel|paclitaxel|mesh-list
64815414|NCT01485081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64815415|NCT01485081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815416|NCT01485081|Tubulin Modulators|tubulin modulators|mesh-ancestor
64815417|NCT01485081|Antimitotic Agents|antimitotic agents|mesh-ancestor
64815418|NCT01485081|Mitosis Modulators|mitosis modulators|mesh-ancestor
64815419|NCT01485081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490464|NCT04601350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64815476|NCT01485315|Diuretics|diuretics|mesh-ancestor
64815477|NCT01485315|Natriuretic Agents|natriuretic agents|mesh-ancestor
64584109|NCT00330421|Sorafenib|sorafenib|mesh-list
64815478|NCT01485315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815479|NCT01485367|Adapalene|adapalene|mesh-list
64815480|NCT01485367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64815481|NCT01485367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65286899|NCT02653898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65286900|NCT02653898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65286901|NCT02653898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65286902|NCT02653898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815482|NCT01485367|Analgesics|analgesics|mesh-ancestor
64490525|NCT04358146|Antidiarrheals|antidiarrheals|mesh-ancestor
64815553|NCT01485692|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64815554|NCT01485692|Dopamine Agents|dopamine agents|mesh-ancestor
64815555|NCT01485692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64815556|NCT01485692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64815557|NCT01485692|Antipruritics|antipruritics|mesh-ancestor
64815558|NCT01485692|Dermatologic Agents|dermatologic agents|mesh-ancestor
64815559|NCT01485692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64815560|NCT01485692|Histamine Antagonists|histamine antagonists|mesh-ancestor
64815561|NCT01485692|Histamine Agents|histamine agents|mesh-ancestor
64815562|NCT01485692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64815563|NCT01485692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64815564|NCT01485692|Anesthetics, Local|anesthetics, local|mesh-ancestor
64815565|NCT01485692|Sensory System Agents|sensory system agents|mesh-ancestor
64815566|NCT01485718|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
64815576|NCT01485731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64815577|NCT01485731|Antiviral Agents|antiviral agents|mesh-ancestor
64815578|NCT01485731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64815579|NCT01485744|Leucovorin|leucovorin|mesh-list
64815580|NCT01485744|Fluorouracil|fluorouracil|mesh-list
64815581|NCT01485744|Oxaliplatin|oxaliplatin|mesh-list
64815582|NCT01485744|Irinotecan|irinotecan|mesh-list
64815583|NCT01485744|Folfirinox|folfirinox|mesh-list
64815584|NCT01485744|Antimetabolites|antimetabolites|mesh-ancestor
64815585|NCT01485744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815586|NCT01485744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64815587|NCT01485744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815588|NCT01485744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64815589|NCT01485744|Immunologic Factors|immunologic factors|mesh-ancestor
64815590|NCT01485744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815591|NCT01485744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64815592|NCT01485744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64815593|NCT01485744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815594|NCT01485744|Antidotes|antidotes|mesh-ancestor
64815595|NCT01485744|Protective Agents|protective agents|mesh-ancestor
64815596|NCT01485744|Vitamin B Complex|vitamin b complex|mesh-ancestor
64815597|NCT01485744|Vitamins|vitamins|mesh-ancestor
64815598|NCT01485744|Micronutrients|micronutrients|mesh-ancestor
64815599|NCT01485809|Gefitinib|gefitinib|mesh-list
64815600|NCT01485809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815601|NCT01485809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64815602|NCT01485809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815603|NCT01485809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815604|NCT01485822|Travoprost|travoprost|mesh-list
64815605|NCT01485822|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64815606|NCT01485822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64815607|NCT01485822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64815608|NCT01485835|Dexamethasone|dexamethasone|mesh-list
64815609|NCT01485835|Bortezomib|bortezomib|mesh-list
64815610|NCT01485835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64815611|NCT01485835|Antiemetics|antiemetics|mesh-ancestor
64815612|NCT01485835|Autonomic Agents|autonomic agents|mesh-ancestor
64815613|NCT01485835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64815614|NCT01485835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815615|NCT01485835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64815616|NCT01485835|Glucocorticoids|glucocorticoids|mesh-ancestor
64815617|NCT01485835|Hormones|hormones|mesh-ancestor
64815618|NCT01485835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64815625|NCT01485848|Antimitotic Agents|antimitotic agents|mesh-ancestor
64815626|NCT01485848|Mitosis Modulators|mitosis modulators|mesh-ancestor
64815627|NCT01485848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815628|NCT01485926|Carboplatin|carboplatin|mesh-list
64815629|NCT01485926|Docetaxel|docetaxel|mesh-list
64815630|NCT01485926|Trastuzumab|trastuzumab|mesh-list
64815631|NCT01485926|Lapatinib|lapatinib|mesh-list
64815632|NCT01485926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815633|NCT01485926|Tubulin Modulators|tubulin modulators|mesh-ancestor
64815634|NCT01485926|Antimitotic Agents|antimitotic agents|mesh-ancestor
64815635|NCT01485926|Mitosis Modulators|mitosis modulators|mesh-ancestor
64815636|NCT01485926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286903|NCT02653898|Antiviral Agents|antiviral agents|mesh-ancestor
65286904|NCT02653898|Schistosomicides|schistosomicides|mesh-ancestor
65286905|NCT02653898|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65286906|NCT02653898|Anthelmintics|anthelmintics|mesh-ancestor
65286907|NCT02653898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286908|NCT02653898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286909|NCT02629536|Acetylcysteine|acetylcysteine|mesh-list
65286910|NCT02629536|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65286911|NCT02629536|Antiviral Agents|antiviral agents|mesh-ancestor
65286912|NCT02629536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65286913|NCT02629536|Expectorants|expectorants|mesh-ancestor
65286914|NCT02629536|Respiratory System Agents|respiratory system agents|mesh-ancestor
65286915|NCT02629536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65286916|NCT02629536|Antioxidants|antioxidants|mesh-ancestor
65286917|NCT02629536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286918|NCT02629536|Protective Agents|protective agents|mesh-ancestor
65286919|NCT02629536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286920|NCT02629536|Antidotes|antidotes|mesh-ancestor
64426704|NCT01632891|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64815645|NCT01485939|Sensory System Agents|sensory system agents|mesh-ancestor
64815646|NCT01485939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64815647|NCT01485939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64815648|NCT01485939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64815649|NCT01485939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64815650|NCT01485939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64815651|NCT01485939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815653|NCT01485978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64815654|NCT01485978|Protease Inhibitors|protease inhibitors|mesh-ancestor
64815655|NCT01485978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815656|NCT01485978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815657|NCT01485978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64815658|NCT01486004|Simeprevir|simeprevir|mesh-list
64815659|NCT01486004|Antiviral Agents|antiviral agents|mesh-ancestor
64815660|NCT01486004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64815661|NCT01486004|Protease Inhibitors|protease inhibitors|mesh-ancestor
64815662|NCT01486004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815663|NCT01486004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815664|NCT01486017|Peficitinib|peficitinib|mesh-list
64815665|NCT01486017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815666|NCT01486017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815667|NCT01486017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64815668|NCT01486017|Immunologic Factors|immunologic factors|mesh-ancestor
64815669|NCT01486017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815670|NCT01486082|Amoxicillin|amoxicillin|mesh-list
64815671|NCT01486082|Clarithromycin|clarithromycin|mesh-list
64815672|NCT01486082|Omeprazole|omeprazole|mesh-list
64815673|NCT01486082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64815674|NCT01486082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64815675|NCT01486082|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64815676|NCT01486082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64815677|NCT01486082|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64815678|NCT01486082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815679|NCT01486082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815680|NCT01486082|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64815681|NCT01486082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65286921|NCT04071106|Betamethasone|betamethasone|mesh-list
65286922|NCT04071106|Calcipotriene|calcipotriene|mesh-list
65286923|NCT04071106|Petrolatum|petrolatum|mesh-list
65286924|NCT04071106|Turmeric extract|turmeric extract|mesh-list
65286925|NCT04071106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65286926|NCT04071106|Glucocorticoids|glucocorticoids|mesh-ancestor
65286927|NCT04071106|Hormones|hormones|mesh-ancestor
65286928|NCT04071106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65286929|NCT04071106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286930|NCT04071106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65286931|NCT04071106|Respiratory System Agents|respiratory system agents|mesh-ancestor
65286932|NCT04071106|Dermatologic Agents|dermatologic agents|mesh-ancestor
65286933|NCT04071106|Antioxidants|antioxidants|mesh-ancestor
65286934|NCT04071106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286935|NCT04071106|Protective Agents|protective agents|mesh-ancestor
65286936|NCT04071106|Emollients|emollients|mesh-ancestor
65286937|NCT00670722|Insulin|insulin|mesh-list
65286938|NCT00670722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65286939|NCT00670722|Insulin Aspart|insulin aspart|mesh-list
65286940|NCT00670722|Insulin, Long-Acting|insulin, long-acting|mesh-list
65286941|NCT00670722|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65286942|NCT00670722|Insulin Detemir|insulin detemir|mesh-list
65286943|NCT00670722|Biphasic Insulins|biphasic insulins|mesh-list
64517202|NCT01229943|Endothelial Growth Factors|endothelial growth factors|mesh-list
64815682|NCT01486082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64815683|NCT01486251|Axitinib|axitinib|mesh-list
64815684|NCT01486251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815685|NCT01486251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64815686|NCT01486251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815687|NCT01486251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815688|NCT01486381|Insulin Aspart|insulin aspart|mesh-list
64815689|NCT01486381|Biphasic Insulins|biphasic insulins|mesh-list
64815690|NCT01486381|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64815691|NCT01486381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64815692|NCT01486381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815693|NCT01486433|Aspirin|aspirin|mesh-list
64815755|NCT01486602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64815756|NCT01486602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815757|NCT01486602|Tubulin Modulators|tubulin modulators|mesh-ancestor
64815758|NCT01486602|Antimitotic Agents|antimitotic agents|mesh-ancestor
64815759|NCT01486602|Mitosis Modulators|mitosis modulators|mesh-ancestor
64815760|NCT01486602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815762|NCT01486706|Solifenacin Succinate|solifenacin succinate|mesh-list
64815763|NCT01486706|Analgesics|analgesics|mesh-ancestor
64815764|NCT01486706|Sensory System Agents|sensory system agents|mesh-ancestor
64815765|NCT01486706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64815766|NCT01486706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815767|NCT01486706|Anticonvulsants|anticonvulsants|mesh-ancestor
64815768|NCT01486706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64815769|NCT01486706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64815770|NCT01486706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64815771|NCT01486706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65286944|NCT00670722|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65286945|NCT00670722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65286946|NCT00670722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286947|NCT02648906|Choline|choline|mesh-list
65286948|NCT02648906|Lipotropic Agents|lipotropic agents|mesh-ancestor
65286949|NCT02648906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64815772|NCT01486706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64815773|NCT01486706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64815774|NCT01486706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64815775|NCT01486706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815776|NCT01486706|Antimanic Agents|antimanic agents|mesh-ancestor
64815777|NCT01486706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64815778|NCT01486706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64815779|NCT01486706|Cholinergic Agents|cholinergic agents|mesh-ancestor
64815780|NCT01486706|Urological Agents|urological agents|mesh-ancestor
64815781|NCT01486823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64815782|NCT01486823|Immunologic Factors|immunologic factors|mesh-ancestor
64815783|NCT01486823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815784|NCT01486862|Insulin Aspart|insulin aspart|mesh-list
64815785|NCT01486862|Biphasic Insulins|biphasic insulins|mesh-list
64815786|NCT01486862|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64815795|NCT01486888|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64815796|NCT01486888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64815797|NCT01486888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815798|NCT01486901|Insulin|insulin|mesh-list
64815799|NCT01486901|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64815800|NCT01486901|Isophane Insulin, Human|isophane insulin, human|mesh-list
64815801|NCT01486901|Insulin, Isophane|insulin, isophane|mesh-list
64815802|NCT01486901|Isophane insulin, beef|isophane insulin, beef|mesh-list
64815803|NCT01486901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64815804|NCT01486901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815805|NCT01486914|Insulin Aspart|insulin aspart|mesh-list
64815806|NCT01486914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64815807|NCT01486914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815808|NCT01486940|Insulin|insulin|mesh-list
64815809|NCT01486940|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64815810|NCT01486940|Insulin Aspart|insulin aspart|mesh-list
64815811|NCT01486940|Insulin Detemir|insulin detemir|mesh-list
64815812|NCT01486940|Isophane Insulin, Human|isophane insulin, human|mesh-list
64815813|NCT01486940|Insulin, Isophane|insulin, isophane|mesh-list
64815831|NCT01486979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64815832|NCT01486979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815833|NCT01486979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64815835|NCT01486979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64815836|NCT01486979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64815837|NCT01486992|Nimotuzumab|nimotuzumab|mesh-list
64815838|NCT01486992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64815839|NCT01486992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815840|NCT01487096|Teriflunomide|teriflunomide|mesh-list
64815841|NCT01487096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64815842|NCT01487096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64815843|NCT01487096|Analgesics|analgesics|mesh-ancestor
64815844|NCT01487096|Sensory System Agents|sensory system agents|mesh-ancestor
64815845|NCT01487096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64815846|NCT01487096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815847|NCT01487096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64815848|NCT01487096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64815849|NCT01487096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64815850|NCT01487096|Immunologic Factors|immunologic factors|mesh-ancestor
64815851|NCT01487135|Moxifloxacin|moxifloxacin|mesh-list
64815852|NCT01487135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64815853|NCT01487135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64815854|NCT01487135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64815855|NCT01487135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64815856|NCT01487135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815857|NCT01487135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815858|NCT01487135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286950|NCT02648906|Antimetabolites|antimetabolites|mesh-ancestor
65286951|NCT02648906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286952|NCT02648906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65286953|NCT02648906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65286954|NCT02648906|Nootropic Agents|nootropic agents|mesh-ancestor
64815859|NCT01487226|Paclitaxel|paclitaxel|mesh-list
64815860|NCT01487226|Cisplatin|cisplatin|mesh-list
64815861|NCT01487226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64815862|NCT01487226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815863|NCT01487226|Tubulin Modulators|tubulin modulators|mesh-ancestor
64815864|NCT01487226|Antimitotic Agents|antimitotic agents|mesh-ancestor
64815865|NCT01487226|Mitosis Modulators|mitosis modulators|mesh-ancestor
64815866|NCT01487226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815867|NCT01487278|Misoprostol|misoprostol|mesh-list
64815868|NCT01487278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64815869|NCT01487278|Abortifacient Agents|abortifacient agents|mesh-ancestor
64815870|NCT01487278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64815871|NCT01487278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815906|NCT01487421|Insulin Aspart|insulin aspart|mesh-list
64815907|NCT01487421|Insulin Detemir|insulin detemir|mesh-list
64815908|NCT01487421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64815909|NCT01487421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815910|NCT01487512|Hydromorphone|hydromorphone|mesh-list
64815911|NCT01487512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64815912|NCT01487512|Narcotics|narcotics|mesh-ancestor
64815913|NCT01487512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64815914|NCT01487512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815915|NCT01487512|Analgesics|analgesics|mesh-ancestor
64815916|NCT01487512|Sensory System Agents|sensory system agents|mesh-ancestor
64815917|NCT01487512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64815918|NCT01487564|Hydromorphone|hydromorphone|mesh-list
64815919|NCT01487564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64815920|NCT01487564|Narcotics|narcotics|mesh-ancestor
64815921|NCT01487564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64815922|NCT01487564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815923|NCT01487564|Analgesics|analgesics|mesh-ancestor
64815924|NCT01487564|Sensory System Agents|sensory system agents|mesh-ancestor
64815925|NCT01487564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64815926|NCT01487629|Bevacizumab|bevacizumab|mesh-list
64815927|NCT01487629|Ranibizumab|ranibizumab|mesh-list
64815928|NCT01487629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64815929|NCT01487629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815930|NCT01487629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64815931|NCT01487629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64815932|NCT01487629|Growth Substances|growth substances|mesh-ancestor
64815946|NCT01487798|Insulin|insulin|mesh-list
64815947|NCT01487798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64815948|NCT01487798|Insulin Aspart|insulin aspart|mesh-list
64815949|NCT01487798|Biphasic Insulins|biphasic insulins|mesh-list
64815950|NCT01487798|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64815951|NCT01487798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64815952|NCT01487798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815953|NCT01487811|Insulin Aspart|insulin aspart|mesh-list
64815976|NCT01488045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64815977|NCT01488045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64815978|NCT01488045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64815979|NCT01488045|GABA Modulators|gaba modulators|mesh-ancestor
64815980|NCT01488045|GABA Agents|gaba agents|mesh-ancestor
64815981|NCT01488045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64815982|NCT01488045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815983|NCT01488136|Diazoxide|diazoxide|mesh-list
64815984|NCT01488136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64815985|NCT01488136|Vasodilator Agents|vasodilator agents|mesh-ancestor
64815986|NCT01488201|Brodalumab|brodalumab|mesh-list
64815987|NCT01488201|Dermatologic Agents|dermatologic agents|mesh-ancestor
64815988|NCT01488227|Vitamin D|vitamin d|mesh-list
64815989|NCT01488227|Ergocalciferols|ergocalciferols|mesh-list
64815990|NCT01488227|Cholecalciferol|cholecalciferol|mesh-list
64815991|NCT01488227|Vitamins|vitamins|mesh-list
65494496|NCT03724890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815992|NCT01488227|Micronutrients|micronutrients|mesh-ancestor
64815993|NCT01488227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286955|NCT00670878|Gemcitabine|gemcitabine|mesh-list
65286956|NCT00670878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65286957|NCT00670878|Antimetabolites|antimetabolites|mesh-ancestor
65286958|NCT00670878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286959|NCT00670878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286960|NCT00670878|Antiviral Agents|antiviral agents|mesh-ancestor
65286961|NCT00670878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65286962|NCT00670878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286963|NCT00670878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65286964|NCT00670878|Immunologic Factors|immunologic factors|mesh-ancestor
64815994|NCT01488227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64815995|NCT01488227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64815996|NCT01488253|Sirolimus|sirolimus|mesh-list
64816017|NCT01488266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64816018|NCT01488266|Sertraline|sertraline|mesh-list
64816019|NCT01488266|Antidepressive Agents|antidepressive agents|mesh-list
64816020|NCT01488266|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64816021|NCT01488266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64816022|NCT01488266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64816023|NCT01488266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816024|NCT01488266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64816025|NCT01488266|Serotonin Agents|serotonin agents|mesh-ancestor
64816026|NCT01488266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816067|NCT01488396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64816068|NCT01488396|Cyclosporins|cyclosporins|mesh-list
64816069|NCT01488396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816070|NCT01488396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816071|NCT01488396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64816072|NCT01488396|Immunologic Factors|immunologic factors|mesh-ancestor
64816073|NCT01488396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816074|NCT01488396|Antifungal Agents|antifungal agents|mesh-ancestor
64816075|NCT01488396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64816076|NCT01488396|Dermatologic Agents|dermatologic agents|mesh-ancestor
64816077|NCT01488396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64816078|NCT01488396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64816079|NCT01488396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64816080|NCT01488526|Tenofovir|tenofovir|mesh-list
64816081|NCT01488526|Antiviral Agents|antiviral agents|mesh-ancestor
64816103|NCT01488552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816104|NCT01488552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64816105|NCT01488552|Immunologic Factors|immunologic factors|mesh-ancestor
64816106|NCT01488552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816107|NCT01488552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64816108|NCT01488565|Azacitidine|azacitidine|mesh-list
64816109|NCT01488565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64816110|NCT01488565|Antimetabolites|antimetabolites|mesh-ancestor
64816111|NCT01488565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816112|NCT01488565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816113|NCT01488565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816114|NCT01488656|Vitamin D|vitamin d|mesh-list
64816115|NCT01488656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64816116|NCT01488656|Antioxidants|antioxidants|mesh-list
64816117|NCT01488656|Vitamins|vitamins|mesh-ancestor
64816118|NCT01488656|Micronutrients|micronutrients|mesh-ancestor
64816142|NCT01488773|Adrenergic Agents|adrenergic agents|mesh-ancestor
64816143|NCT01488773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64816144|NCT01488773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816145|NCT01488773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64816146|NCT01488773|Hormone Antagonists|hormone antagonists|mesh-ancestor
64816147|NCT01488773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64816148|NCT01488773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64816149|NCT01488773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64816151|NCT01488838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816152|NCT01488955|Fosfomycin|fosfomycin|mesh-list
64816153|NCT01488955|Ibuprofen|ibuprofen|mesh-list
65036958|NCT00180947|Vinorelbine|vinorelbine|mesh-list
65286965|NCT00670878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286966|NCT02760095|Vitamin A|vitamin a|mesh-list
65286967|NCT02760095|Acetic Acid|acetic acid|mesh-list
65286968|NCT02760095|Retinol acetate|retinol acetate|mesh-list
65286969|NCT02760095|Zinc Sulfate|zinc sulfate|mesh-list
65286970|NCT02760095|Vitamins|vitamins|mesh-ancestor
65286972|NCT02760095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286973|NCT02760095|Protective Agents|protective agents|mesh-ancestor
65286974|NCT02760095|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65286975|NCT02760095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286976|NCT02760095|Astringents|astringents|mesh-ancestor
65286977|NCT02760095|Dermatologic Agents|dermatologic agents|mesh-ancestor
65286978|NCT02760095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65286979|NCT02760095|Immunologic Factors|immunologic factors|mesh-ancestor
65286980|NCT02760095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65286981|NCT02760095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65286982|NCT04418167|Dabrafenib|dabrafenib|mesh-list
65286983|NCT04418167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65286984|NCT04418167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65286985|NCT04418167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816154|NCT01488955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64816155|NCT01488955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64816203|NCT01489228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816205|NCT01489228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64816206|NCT01489228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64816207|NCT01489228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64816208|NCT01489319|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
64816209|NCT01489319|Sodium Salicylate|sodium salicylate|mesh-list
64816210|NCT01489319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64816211|NCT01489319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64816212|NCT01489319|Analgesics|analgesics|mesh-ancestor
64427298|NCT02424097|Listerine|listerine|mesh-list
64816224|NCT01489371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64816225|NCT01489371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816226|NCT01489371|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64816227|NCT01489371|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64816229|NCT01489371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816230|NCT01489371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64816231|NCT01489371|Immunologic Factors|immunologic factors|mesh-ancestor
64816232|NCT01489371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816233|NCT01489371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65494498|NCT01141452|Xhance|xhance|mesh-list
65494499|NCT01141452|Beclomethasone|beclomethasone|mesh-list
64472678|NCT03021486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64472679|NCT03021486|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64816234|NCT01489371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64816235|NCT01489371|Growth Substances|growth substances|mesh-ancestor
64816236|NCT01489371|Growth Inhibitors|growth inhibitors|mesh-ancestor
64816237|NCT01489410|Ethanol|ethanol|mesh-list
64816238|NCT01489410|Doxorubicin|doxorubicin|mesh-list
64816239|NCT01489410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64816240|NCT01489410|Ethiodized Oil|ethiodized oil|mesh-list
64816241|NCT01489410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64816242|NCT01489410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816243|NCT01489410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64816244|NCT01489410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64816245|NCT01489410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65286986|NCT04418167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65286987|NCT02576626|Glycopyrrolate|glycopyrrolate|mesh-list
65286988|NCT02576626|Albuterol|albuterol|mesh-list
65286989|NCT02576626|Ipratropium|ipratropium|mesh-list
65286990|NCT02576626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64816246|NCT01489410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816247|NCT01489410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64816248|NCT01489410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64816249|NCT01489410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64816250|NCT01489410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816251|NCT01489488|Riociguat|riociguat|mesh-list
64816261|NCT01489566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64816262|NCT01489566|Immunologic Factors|immunologic factors|mesh-ancestor
64816263|NCT01489566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816264|NCT01489566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64816265|NCT01489566|Alkylating Agents|alkylating agents|mesh-ancestor
64816266|NCT01489566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64816267|NCT01489566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816268|NCT01489592|Turmeric extract|turmeric extract|mesh-list
64816269|NCT01489592|Antioxidants|antioxidants|mesh-ancestor
64816270|NCT01489592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816271|NCT01489592|Protective Agents|protective agents|mesh-ancestor
64816272|NCT01489592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816274|NCT01489631|Gabapentin|gabapentin|mesh-list
64816275|NCT01489631|Bupivacaine|bupivacaine|mesh-list
64816301|NCT01489644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816303|NCT01489683|Anesthetics, Local|anesthetics, local|mesh-ancestor
64816304|NCT01489683|Anesthetics|anesthetics|mesh-ancestor
64816305|NCT01489683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64816306|NCT01489683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816307|NCT01489683|Sensory System Agents|sensory system agents|mesh-ancestor
64816308|NCT01489683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64816309|NCT01489683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64816310|NCT01489683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64816311|NCT01489683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64816312|NCT01489683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64584924|NCT01431950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64816313|NCT01489683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816314|NCT01489696|Tamsulosin|tamsulosin|mesh-list
64816315|NCT01489696|Mirabegron|mirabegron|mesh-list
64816316|NCT01489696|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64816317|NCT01489696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64816318|NCT01489696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64816319|NCT01489696|Adrenergic Agents|adrenergic agents|mesh-ancestor
64816320|NCT01489696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64816321|NCT01489696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816322|NCT01489696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816323|NCT01489696|Urological Agents|urological agents|mesh-ancestor
64427397|NCT02346721|Sofosbuvir|sofosbuvir|mesh-list
64816350|NCT01489865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816351|NCT01489865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64816352|NCT01489865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816353|NCT01489865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65494500|NCT01141452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65494501|NCT01141452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64816354|NCT01489865|Immunologic Factors|immunologic factors|mesh-ancestor
64816355|NCT01489865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816356|NCT01489865|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64816357|NCT01489865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816358|NCT01489904|Botulinum Toxins|botulinum toxins|mesh-list
64816359|NCT01489904|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64816360|NCT01489904|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64816361|NCT01489904|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64816362|NCT01489904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64816400|NCT01489943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64816401|NCT01489943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64816402|NCT01489943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64816403|NCT01489943|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65286991|NCT02576626|Autonomic Agents|autonomic agents|mesh-ancestor
65286992|NCT02576626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65286993|NCT02576626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65286994|NCT02576626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65286995|NCT02576626|Respiratory System Agents|respiratory system agents|mesh-ancestor
65286996|NCT02576626|Tocolytic Agents|tocolytic agents|mesh-ancestor
65286997|NCT02576626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65286998|NCT02576626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65286999|NCT02576626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65287000|NCT02576626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65287001|NCT02576626|Adrenergic Agents|adrenergic agents|mesh-ancestor
65287002|NCT02576626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65287003|NCT02576626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287004|NCT02576626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65287005|NCT02576626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64816404|NCT01489982|Zopiclone|zopiclone|mesh-list
64816405|NCT01489982|Doxepin|doxepin|mesh-list
64816406|NCT01489982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64816407|NCT01489982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64816408|NCT01489982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816409|NCT01489982|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64816410|NCT01489982|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64816411|NCT01489982|Antidepressive Agents|antidepressive agents|mesh-ancestor
64816412|NCT01489982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64816413|NCT01489982|Histamine Antagonists|histamine antagonists|mesh-ancestor
64816414|NCT01489982|Histamine Agents|histamine agents|mesh-ancestor
64816415|NCT01489982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64816416|NCT01489982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816417|NCT01489995|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
64816418|NCT01489995|Antiviral Agents|antiviral agents|mesh-ancestor
64816419|NCT01489995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64816420|NCT01489995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816421|NCT01489995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816422|NCT01490047|Etanercept|etanercept|mesh-list
64816430|NCT01490047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816431|NCT01490047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64816432|NCT01490047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64816433|NCT01490047|Analgesics|analgesics|mesh-ancestor
64816434|NCT01490047|Sensory System Agents|sensory system agents|mesh-ancestor
64816435|NCT01490047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64816436|NCT01490047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816437|NCT01490047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64816438|NCT01490047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64816439|NCT01490047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64816440|NCT01490047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64816441|NCT01490047|Immunologic Factors|immunologic factors|mesh-ancestor
64816442|NCT01490099|Insulin Detemir|insulin detemir|mesh-list
64816443|NCT01490099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64816444|NCT01490099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816445|NCT01490112|Insulin Aspart|insulin aspart|mesh-list
64816446|NCT01490112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64816447|NCT01490112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816448|NCT01490203|Edetic Acid|edetic acid|mesh-list
64816449|NCT01490203|Pentetic Acid|pentetic acid|mesh-list
64816450|NCT01490203|Antidotes|antidotes|mesh-ancestor
64816451|NCT01490203|Protective Agents|protective agents|mesh-ancestor
64816452|NCT01490203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816453|NCT01490203|Chelating Agents|chelating agents|mesh-ancestor
64816454|NCT01490203|Sequestering Agents|sequestering agents|mesh-ancestor
65287006|NCT02576626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65287007|NCT02576626|Cholinergic Agents|cholinergic agents|mesh-ancestor
65287008|NCT00877890|Exenatide|exenatide|mesh-list
65287009|NCT00877890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65287010|NCT00877890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287011|NCT00877890|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65287012|NCT00877890|Incretins|incretins|mesh-ancestor
65287013|NCT00877890|Hormones|hormones|mesh-ancestor
64491148|NCT03034408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64816467|NCT01490216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64816468|NCT01490229|Ezetimibe|ezetimibe|mesh-list
64816469|NCT01490229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64816470|NCT01490229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64816471|NCT01490229|Antimetabolites|antimetabolites|mesh-ancestor
64816472|NCT01490229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816473|NCT01490229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64816474|NCT01490255|Amlodipine|amlodipine|mesh-list
64816475|NCT01490255|Ranolazine|ranolazine|mesh-list
64816476|NCT01490255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64816477|NCT01490255|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64816478|NCT01490255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64816479|NCT01490255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816480|NCT01490255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64816481|NCT01490255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816482|NCT01490255|Vasodilator Agents|vasodilator agents|mesh-ancestor
64816483|NCT01490255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64816484|NCT01490268|Sufentanil|sufentanil|mesh-list
64816486|NCT01490268|Hydromorphone|hydromorphone|mesh-list
64816487|NCT01490268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64816488|NCT01490268|Narcotics|narcotics|mesh-ancestor
64816489|NCT01490268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64816490|NCT01490268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816517|NCT01490411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816518|NCT01490437|Dexamethasone|dexamethasone|mesh-list
64816520|NCT01490437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816521|NCT01490437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64816522|NCT01490437|Antiemetics|antiemetics|mesh-ancestor
64816523|NCT01490437|Autonomic Agents|autonomic agents|mesh-ancestor
64816524|NCT01490437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64816525|NCT01490437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64816526|NCT01490437|Glucocorticoids|glucocorticoids|mesh-ancestor
64816527|NCT01490437|Hormones|hormones|mesh-ancestor
64816528|NCT01490437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64816529|NCT01490437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64816530|NCT01490437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816531|NCT01490437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816532|NCT01490437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816533|NCT01490437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64816534|NCT01490437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64816535|NCT01490476|Everolimus|everolimus|mesh-list
64816563|NCT01490749|Oxaliplatin|oxaliplatin|mesh-list
64816564|NCT01490749|Everolimus|everolimus|mesh-list
65494503|NCT01141452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65494504|NCT01141452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816565|NCT01490749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816566|NCT01490749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64816567|NCT01490749|Antimetabolites|antimetabolites|mesh-ancestor
64816568|NCT01490749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816569|NCT01490749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64816570|NCT01490749|Immunologic Factors|immunologic factors|mesh-ancestor
64816571|NCT01490749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816572|NCT01490762|Insulin|insulin|mesh-list
64816573|NCT01490762|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64816574|NCT01490762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64816575|NCT01490762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816576|NCT01490905|Ibuprofen|ibuprofen|mesh-list
64816577|NCT01490905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64816578|NCT01490905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64816579|NCT01490905|Analgesics|analgesics|mesh-ancestor
65287014|NCT00877890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65287015|NCT04221971|Cyclophosphamide|cyclophosphamide|mesh-list
65287016|NCT04221971|Fludarabine|fludarabine|mesh-list
65287017|NCT04221971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65287018|NCT04221971|Immunologic Factors|immunologic factors|mesh-ancestor
65287019|NCT04221971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287020|NCT04221971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65287021|NCT04221971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65287022|NCT04221971|Alkylating Agents|alkylating agents|mesh-ancestor
64816580|NCT01490905|Sensory System Agents|sensory system agents|mesh-ancestor
64816581|NCT01490905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64816582|NCT01490905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816583|NCT01490905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64816584|NCT01490905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64816585|NCT01490905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64816586|NCT01490905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816587|NCT01490905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816588|NCT01490944|Iron|iron|mesh-list
64816589|NCT01490944|Folic Acid|folic acid|mesh-list
64816590|NCT01490944|Vitamin B 12|vitamin b 12|mesh-list
64816591|NCT01490944|Hydroxocobalamin|hydroxocobalamin|mesh-list
64816592|NCT01490944|Vitamin B Complex|vitamin b complex|mesh-list
64816593|NCT01490944|Trace Elements|trace elements|mesh-ancestor
64816594|NCT01490944|Micronutrients|micronutrients|mesh-ancestor
64816595|NCT01490944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816596|NCT01490944|Hematinics|hematinics|mesh-ancestor
64816597|NCT01490944|Vitamins|vitamins|mesh-ancestor
64816598|NCT01490996|Curcumin|curcumin|mesh-list
64816599|NCT01490996|Capecitabine|capecitabine|mesh-list
64816600|NCT01490996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64816601|NCT01490996|Antimetabolites|antimetabolites|mesh-ancestor
64491269|NCT00956254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64816627|NCT01491009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64816628|NCT01491009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816629|NCT01491009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64816630|NCT01491009|Narcotics|narcotics|mesh-ancestor
64816631|NCT01491009|Analgesics|analgesics|mesh-ancestor
64816632|NCT01491009|Sensory System Agents|sensory system agents|mesh-ancestor
64816633|NCT01491009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64816634|NCT01491048|Tacrine|tacrine|mesh-list
64816635|NCT01491048|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64816636|NCT01491048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816637|NCT01491048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816638|NCT01491048|Cholinergic Agents|cholinergic agents|mesh-ancestor
64816639|NCT01491048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64816640|NCT01491048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816641|NCT01491048|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64816642|NCT01491048|Autonomic Agents|autonomic agents|mesh-ancestor
64816643|NCT01491048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64816644|NCT01491048|Nootropic Agents|nootropic agents|mesh-ancestor
64816645|NCT01491061|Ranolazine|ranolazine|mesh-list
64816646|NCT01491061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64816647|NCT01491061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64816648|NCT01491061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816649|NCT01491100|Interferons|interferons|mesh-list
64816650|NCT01491100|Interferon-beta|interferon-beta|mesh-list
64816651|NCT01491100|Interferon beta-1b|interferon beta-1b|mesh-list
64816652|NCT01491100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816653|NCT01491100|Antiviral Agents|antiviral agents|mesh-ancestor
64816654|NCT01491100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64816655|NCT01491100|Immunologic Factors|immunologic factors|mesh-ancestor
64816656|NCT01491100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816657|NCT01491100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64816658|NCT01491139|Olaparib|olaparib|mesh-list
64816659|NCT01491139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816660|NCT01491139|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64816661|NCT01491139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65287023|NCT04221971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287024|NCT04221971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287025|NCT04221971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65287026|NCT02644694|Dexamethasone|dexamethasone|mesh-list
65287027|NCT02644694|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65287028|NCT02644694|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65287029|NCT02644694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65287030|NCT02644694|Antiemetics|antiemetics|mesh-ancestor
65287031|NCT02644694|Autonomic Agents|autonomic agents|mesh-ancestor
65287032|NCT02644694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65287033|NCT02644694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287034|NCT02644694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64427731|NCT02339155|Antiemetics|antiemetics|mesh-ancestor
64816681|NCT01491204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64816682|NCT01491204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816683|NCT01491204|Tubulin Modulators|tubulin modulators|mesh-ancestor
64816684|NCT01491204|Antimitotic Agents|antimitotic agents|mesh-ancestor
64816685|NCT01491204|Mitosis Modulators|mitosis modulators|mesh-ancestor
64816686|NCT01491204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816687|NCT01491217|Paclitaxel|paclitaxel|mesh-list
64816688|NCT01491217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64816689|NCT01491217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816690|NCT01491217|Tubulin Modulators|tubulin modulators|mesh-ancestor
64816691|NCT01491217|Antimitotic Agents|antimitotic agents|mesh-ancestor
64816692|NCT01491217|Mitosis Modulators|mitosis modulators|mesh-ancestor
64816693|NCT01491217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816695|NCT01491256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64816696|NCT01491256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64816697|NCT01491256|Antimetabolites|antimetabolites|mesh-ancestor
64816698|NCT01491256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816699|NCT01491256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64816700|NCT01491256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64816701|NCT01491256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816702|NCT01491295|Tenofovir|tenofovir|mesh-list
64816703|NCT01491295|Lamivudine|lamivudine|mesh-list
64816704|NCT01491295|Adefovir|adefovir|mesh-list
64816705|NCT01491295|Antiviral Agents|antiviral agents|mesh-ancestor
64816706|NCT01491295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64816707|NCT01491295|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64816708|NCT01491295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64816709|NCT01491295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557416|NCT05331144|Calcium Channel Blockers|calcium channel blockers|mesh-list
64557417|NCT05331144|Angiotensin II|angiotensin ii|mesh-list
64557418|NCT05331144|Giapreza|giapreza|mesh-list
64557419|NCT05331144|Calcium|calcium|mesh-list
64557420|NCT05331144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64557421|NCT05331144|Angiotensinogen|angiotensinogen|mesh-list
64557422|NCT05331144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64557423|NCT05331144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557424|NCT05331144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64557425|NCT05331144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64557426|NCT05331144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557427|NCT05331144|Vasodilator Agents|vasodilator agents|mesh-ancestor
64557428|NCT05331144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64557429|NCT05331144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64557430|NCT05331144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64557431|NCT05331144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64557432|NCT05331144|Protease Inhibitors|protease inhibitors|mesh-ancestor
64557433|NCT05331144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557434|NCT03580499|Vitamins|vitamins|mesh-list
64557435|NCT03580499|Vitamin B 6|vitamin b 6|mesh-list
64557436|NCT03580499|Pyridoxal|pyridoxal|mesh-list
64557437|NCT03580499|Pyridoxine|pyridoxine|mesh-list
65287035|NCT02644694|Glucocorticoids|glucocorticoids|mesh-ancestor
65287036|NCT02644694|Hormones|hormones|mesh-ancestor
65287037|NCT02644694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65287038|NCT02644694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65287039|NCT02644694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287040|NCT02644694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65287041|NCT02653742|Ketorolac|ketorolac|mesh-list
65287042|NCT02653742|Fentanyl|fentanyl|mesh-list
65287043|NCT02653742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65287044|NCT02653742|Narcotics|narcotics|mesh-ancestor
65287045|NCT02653742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65037031|NCT00209313|Acyclovir|acyclovir|mesh-list
65287046|NCT02653742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287047|NCT02653742|Analgesics|analgesics|mesh-ancestor
65287048|NCT02653742|Sensory System Agents|sensory system agents|mesh-ancestor
65287049|NCT02653742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65287050|NCT02653742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65287051|NCT02653742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65287052|NCT02653742|Anesthetics, General|anesthetics, general|mesh-ancestor
65287053|NCT02653742|Anesthetics|anesthetics|mesh-ancestor
64517312|NCT04643379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557438|NCT03580499|Vitamin B Complex|vitamin b complex|mesh-list
64557439|NCT03580499|Micronutrients|micronutrients|mesh-ancestor
64557440|NCT03580499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557441|NCT00951561|Ibuprofen|ibuprofen|mesh-list
64557442|NCT00951561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64557443|NCT00951561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64557444|NCT00951561|Analgesics|analgesics|mesh-ancestor
64557445|NCT00951561|Sensory System Agents|sensory system agents|mesh-ancestor
64557446|NCT00951561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64557463|NCT03076203|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64557470|NCT02943057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64557471|NCT02943057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64557472|NCT02943057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557473|NCT02943057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557474|NCT03581903|Vaccines|vaccines|mesh-list
64557475|NCT03581903|Immunologic Factors|immunologic factors|mesh-ancestor
64557476|NCT03581903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557477|NCT02783547|Azacitidine|azacitidine|mesh-list
64557478|NCT02783547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64557479|NCT02783547|Antimetabolites|antimetabolites|mesh-ancestor
64557480|NCT02783547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557481|NCT02783547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557482|NCT02783547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816771|NCT01492179|Anesthetics, Local|anesthetics, local|mesh-ancestor
64816772|NCT01492179|Anesthetics|anesthetics|mesh-ancestor
64816773|NCT01492179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64816774|NCT01492179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816775|NCT01492179|Sensory System Agents|sensory system agents|mesh-ancestor
64816776|NCT01492179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64816777|NCT01492179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64816778|NCT01492179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64816779|NCT01492179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64816780|NCT01492179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65287054|NCT02653742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65287055|NCT02653742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65287056|NCT02653742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65287057|NCT02653742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65287058|NCT02653742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65287059|NCT02653742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65287060|NCT02653742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287061|NCT02755259|Acetazolamide|acetazolamide|mesh-list
65287062|NCT02755259|Anticonvulsants|anticonvulsants|mesh-ancestor
65287063|NCT02755259|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65287064|NCT02755259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65287065|NCT02755259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287066|NCT02755259|Diuretics|diuretics|mesh-ancestor
65287067|NCT02755259|Natriuretic Agents|natriuretic agents|mesh-ancestor
65287068|NCT02755259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287069|NCT02575222|Nivolumab|nivolumab|mesh-list
65287070|NCT02575222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65287071|NCT02575222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287072|NCT02575222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65287073|NCT02575222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566454|NCT04451187|Zopiclone|zopiclone|mesh-list
64816781|NCT01492179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816782|NCT01492205|Insulin|insulin|mesh-list
64816783|NCT01492205|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64816784|NCT01492205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64816785|NCT01492205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816786|NCT01492218|Insulin|insulin|mesh-list
64816787|NCT01492218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64816788|NCT01492218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64816789|NCT01492218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816790|NCT01492387|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64816791|NCT01492387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64816792|NCT01492504|Asunaprevir|asunaprevir|mesh-list
64816793|NCT01492504|Protease Inhibitors|protease inhibitors|mesh-ancestor
64816794|NCT01492504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491447|NCT04278573|Vitamins|vitamins|mesh-ancestor
64816808|NCT01492608|Magnesium Sulfate|magnesium sulfate|mesh-list
64816809|NCT01492608|Analgesics|analgesics|mesh-ancestor
64816810|NCT01492608|Sensory System Agents|sensory system agents|mesh-ancestor
64816811|NCT01492608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64816812|NCT01492608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816813|NCT01492608|Anesthetics|anesthetics|mesh-ancestor
64816814|NCT01492608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64816815|NCT01492608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64816816|NCT01492608|Anticonvulsants|anticonvulsants|mesh-ancestor
64816817|NCT01492608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64816818|NCT01492608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64816819|NCT01492608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427945|NCT02337907|Cholinergic Agents|cholinergic agents|mesh-ancestor
64816823|NCT01492621|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64816824|NCT01492621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64816825|NCT01492621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65287074|NCT00680394|Misoprostol|misoprostol|mesh-list
65287075|NCT00680394|Mifepristone|mifepristone|mesh-list
65287076|NCT00680394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65287077|NCT00680394|Abortifacient Agents|abortifacient agents|mesh-ancestor
65287078|NCT00680394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65287079|NCT00680394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816826|NCT01492621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64816827|NCT01492621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816828|NCT01492621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64816829|NCT01492621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816830|NCT01492621|Antidepressive Agents|antidepressive agents|mesh-ancestor
64816832|NCT01492712|Propofol|propofol|mesh-list
64816833|NCT01492712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64816834|NCT01492712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64816835|NCT01492712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816836|NCT01492712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64816837|NCT01492712|Anesthetics, General|anesthetics, general|mesh-ancestor
64816838|NCT01492712|Anesthetics|anesthetics|mesh-ancestor
64816839|NCT01492725|Plasminogen|plasminogen|mesh-list
64816840|NCT01492725|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64816841|NCT01492725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64816842|NCT01492725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64585459|NCT00401401|Zalutumumab|zalutumumab|mesh-list
64816843|NCT01492725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816844|NCT01492881|Doxorubicin|doxorubicin|mesh-list
64816845|NCT01492881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64816846|NCT01492881|Bortezomib|bortezomib|mesh-list
64816847|NCT01492881|Vorinostat|vorinostat|mesh-list
64816848|NCT01492881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64491503|NCT00960622|Abacavir|abacavir|mesh-list
64816875|NCT01492920|Micronutrients|micronutrients|mesh-ancestor
65494508|NCT01141452|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64472682|NCT03021486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816876|NCT01492920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816877|NCT01492920|Nootropic Agents|nootropic agents|mesh-ancestor
64816878|NCT01492959|Insulin|insulin|mesh-list
64816879|NCT01492959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64816880|NCT01492959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64816881|NCT01492959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816882|NCT01492985|Vaccines|vaccines|mesh-list
64816883|NCT01492985|Immunologic Factors|immunologic factors|mesh-ancestor
64816884|NCT01492985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816885|NCT01493050|Calcium Carbonate|calcium carbonate|mesh-list
64816886|NCT01493050|Calcium|calcium|mesh-list
64816887|NCT01493050|Sevelamer|sevelamer|mesh-list
64816888|NCT01493050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64816889|NCT01493050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816890|NCT01493050|Antacids|antacids|mesh-ancestor
64428019|NCT02164929|Hormones|hormones|mesh-ancestor
64816908|NCT01493102|Hemostatics|hemostatics|mesh-ancestor
64816909|NCT01493102|Coagulants|coagulants|mesh-ancestor
64816910|NCT01493102|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64816911|NCT01493102|Natriuretic Agents|natriuretic agents|mesh-ancestor
64816912|NCT01493115|Insulin|insulin|mesh-list
64816933|NCT01493310|Tubulin Modulators|tubulin modulators|mesh-ancestor
64816934|NCT01493310|Antimitotic Agents|antimitotic agents|mesh-ancestor
64816935|NCT01493310|Mitosis Modulators|mitosis modulators|mesh-ancestor
64816936|NCT01493310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816937|NCT01493310|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64816938|NCT01493310|Abortifacient Agents|abortifacient agents|mesh-ancestor
64816939|NCT01493310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64816940|NCT01493310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816941|NCT01493310|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64816942|NCT01493310|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64816943|NCT01493310|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64816944|NCT01493310|Contraceptive Agents|contraceptive agents|mesh-ancestor
64816945|NCT01493310|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64816946|NCT01493310|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64816947|NCT01493310|Hormone Antagonists|hormone antagonists|mesh-ancestor
64428091|NCT02188719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65222800|NCT04215159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287080|NCT00680394|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65287081|NCT00680394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65287082|NCT00680394|Oxytocics|oxytocics|mesh-ancestor
65287083|NCT00680394|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65287084|NCT00680394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65287085|NCT00680394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65287086|NCT00680394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65287087|NCT00680394|Contraceptive Agents|contraceptive agents|mesh-ancestor
65287088|NCT00680394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65287089|NCT00680394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65287090|NCT00680394|Hormone Antagonists|hormone antagonists|mesh-ancestor
65287091|NCT00680394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65287092|NCT00680394|Luteolytic Agents|luteolytic agents|mesh-ancestor
65287093|NCT00680394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64517358|NCT03257124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816962|NCT01493440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64816964|NCT01493440|Tocolytic Agents|tocolytic agents|mesh-ancestor
64816965|NCT01493440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64816967|NCT01493479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64816968|NCT01493479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816969|NCT01493479|Immunologic Factors|immunologic factors|mesh-ancestor
64816970|NCT01493479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816971|NCT01493479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64816972|NCT01493570|BI 409306|bi 409306|mesh-list
64816973|NCT01493570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64816974|NCT01493570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816975|NCT01493570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816976|NCT01493622|Minocycline|minocycline|mesh-list
64816977|NCT01493622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64816978|NCT01493622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64816979|NCT01493635|Analgesics|analgesics|mesh-list
65494509|NCT01141452|Glucocorticoids|glucocorticoids|mesh-ancestor
64816999|NCT01493791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64817000|NCT01493791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817001|NCT01493791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64817003|NCT01493843|Bevacizumab|bevacizumab|mesh-list
64817004|NCT01493843|Carboplatin|carboplatin|mesh-list
64817005|NCT01493843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64817006|NCT01493843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817007|NCT01493843|Tubulin Modulators|tubulin modulators|mesh-ancestor
64817027|NCT01493986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64817028|NCT01493986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817029|NCT01493986|Sensory System Agents|sensory system agents|mesh-ancestor
64817030|NCT01493986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64817031|NCT01493999|Clopidogrel|clopidogrel|mesh-list
64817032|NCT01493999|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64817033|NCT01493999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64817034|NCT01493999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64817035|NCT01493999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64817036|NCT01493999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64817037|NCT01493999|Purinergic Agents|purinergic agents|mesh-ancestor
64817038|NCT01493999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64817039|NCT01493999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817040|NCT01493999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817041|NCT01494012|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64817042|NCT01494012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65287094|NCT00680394|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65287095|NCT04724044|Moxifloxacin|moxifloxacin|mesh-list
65287096|NCT04724044|Clarithromycin|clarithromycin|mesh-list
65287097|NCT04724044|Ceftriaxone|ceftriaxone|mesh-list
65287098|NCT04724044|Lactams|lactams|mesh-list
65287099|NCT04724044|beta-Lactams|beta-lactams|mesh-list
64517372|NCT04780659|Vaccines|vaccines|mesh-list
64817043|NCT01494012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817044|NCT01494090|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64817045|NCT01494090|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64817046|NCT01494090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64817047|NCT01494090|Antimetabolites|antimetabolites|mesh-ancestor
64817048|NCT01494090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817049|NCT01494090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64817050|NCT01494090|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64817051|NCT01494090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817052|NCT01494155|Hydroxychloroquine|hydroxychloroquine|mesh-list
64817069|NCT01494259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817070|NCT01494259|Sensory System Agents|sensory system agents|mesh-ancestor
64817071|NCT01494259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64817072|NCT01494259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64817073|NCT01494259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64817074|NCT01494259|Adrenergic Agents|adrenergic agents|mesh-ancestor
64817075|NCT01494259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64817076|NCT01494259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817077|NCT01494259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64817078|NCT01494259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64817080|NCT01494259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64817081|NCT01494259|Respiratory System Agents|respiratory system agents|mesh-ancestor
64817082|NCT01494259|Mydriatics|mydriatics|mesh-ancestor
64817083|NCT01494259|Sympathomimetics|sympathomimetics|mesh-ancestor
64817084|NCT01494259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64817085|NCT01494311|Lidocaine|lidocaine|mesh-list
64817086|NCT01494311|Tetracaine|tetracaine|mesh-list
64817087|NCT01494311|Anesthetics, Local|anesthetics, local|mesh-ancestor
64817088|NCT01494311|Anesthetics|anesthetics|mesh-ancestor
64817089|NCT01494311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64817090|NCT01494311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817091|NCT01494311|Sensory System Agents|sensory system agents|mesh-ancestor
64817092|NCT01494311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64817093|NCT01494311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64817094|NCT01494311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64817095|NCT01494311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64817096|NCT01494311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64817097|NCT01494311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817098|NCT01494363|Leucovorin|leucovorin|mesh-list
64817099|NCT01494363|Fluorouracil|fluorouracil|mesh-list
64817100|NCT01494363|Oxaliplatin|oxaliplatin|mesh-list
64817101|NCT01494363|Irinotecan|irinotecan|mesh-list
64817102|NCT01494363|Antimetabolites|antimetabolites|mesh-ancestor
64817103|NCT01494363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817104|NCT01494363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64817105|NCT01494363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817106|NCT01494363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64817107|NCT01494363|Immunologic Factors|immunologic factors|mesh-ancestor
64817108|NCT01494363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817109|NCT01494363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64817110|NCT01494363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64817111|NCT01494363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817112|NCT01494363|Antidotes|antidotes|mesh-ancestor
64817113|NCT01494363|Protective Agents|protective agents|mesh-ancestor
64817114|NCT01494363|Vitamin B Complex|vitamin b complex|mesh-ancestor
64817115|NCT01494363|Vitamins|vitamins|mesh-ancestor
64817116|NCT01494363|Micronutrients|micronutrients|mesh-ancestor
64817117|NCT01494402|Aspirin|aspirin|mesh-list
64817118|NCT01494402|Esomeprazole|esomeprazole|mesh-list
64817119|NCT01494402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64817120|NCT01494402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64817121|NCT01494402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64817122|NCT01494402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817123|NCT01494402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287100|NCT04724044|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65287101|NCT04724044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65287102|NCT04724044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65287103|NCT04724044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64567068|NCT03822559|Timolol|timolol|mesh-list
64817124|NCT01494402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64817125|NCT01494402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64817126|NCT01494402|Analgesics|analgesics|mesh-ancestor
64817131|NCT01494402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64817132|NCT01494402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64817142|NCT01494415|Antimitotic Agents|antimitotic agents|mesh-ancestor
64817143|NCT01494415|Mitosis Modulators|mitosis modulators|mesh-ancestor
64817144|NCT01494415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817145|NCT01494441|Calcium, Dietary|calcium, dietary|mesh-list
64817147|NCT01494441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64817148|NCT01494441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817149|NCT01494441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64817150|NCT01494597|Cyclosporine|cyclosporine|mesh-list
64817151|NCT01494597|Isavuconazole|isavuconazole|mesh-list
64817152|NCT01494597|Cyclosporins|cyclosporins|mesh-list
64817153|NCT01494597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817154|NCT01494597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817155|NCT01494597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64817156|NCT01494597|Immunologic Factors|immunologic factors|mesh-ancestor
64817157|NCT01494597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817158|NCT01494597|Antifungal Agents|antifungal agents|mesh-ancestor
64817159|NCT01494597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64817160|NCT01494597|Dermatologic Agents|dermatologic agents|mesh-ancestor
64817161|NCT01494597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64817162|NCT01494597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64817163|NCT01494636|Lidocaine|lidocaine|mesh-list
64817164|NCT01494636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64817165|NCT01494636|Anesthetics, Local|anesthetics, local|mesh-ancestor
64817166|NCT01494636|Anesthetics|anesthetics|mesh-ancestor
64817167|NCT01494636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64817168|NCT01494636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817169|NCT01494636|Sensory System Agents|sensory system agents|mesh-ancestor
64817170|NCT01494636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64817171|NCT01494636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64817172|NCT01494636|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64817173|NCT01494636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64817174|NCT01494636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64817175|NCT01494636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817176|NCT01494688|Paclitaxel|paclitaxel|mesh-list
64817177|NCT01494688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64817178|NCT01494688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817179|NCT01494688|Tubulin Modulators|tubulin modulators|mesh-ancestor
64817180|NCT01494688|Antimitotic Agents|antimitotic agents|mesh-ancestor
64817181|NCT01494688|Mitosis Modulators|mitosis modulators|mesh-ancestor
64817182|NCT01494688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817183|NCT01494714|Petrolatum|petrolatum|mesh-list
64817184|NCT01494714|Emollients|emollients|mesh-ancestor
64817185|NCT01494714|Dermatologic Agents|dermatologic agents|mesh-ancestor
64817186|NCT01494727|Amlodipine|amlodipine|mesh-list
64817187|NCT01494727|Valsartan|valsartan|mesh-list
64817188|NCT01494727|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
64817189|NCT01494727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64817190|NCT01494727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64817191|NCT01494727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64817192|NCT01494727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817193|NCT01494727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64817194|NCT01494727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817195|NCT01494727|Vasodilator Agents|vasodilator agents|mesh-ancestor
64817196|NCT01494727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64817210|NCT01494857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64817247|NCT01495117|Povidone-Iodine|povidone-iodine|mesh-list
64817248|NCT01495117|Povidone|povidone|mesh-list
64817249|NCT01495117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65287104|NCT04724044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65287105|NCT04724044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65287106|NCT04724044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287107|NCT04724044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287108|NCT04724044|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65287109|NCT04724044|Contraceptive Agents|contraceptive agents|mesh-ancestor
65287110|NCT04724044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65287111|NCT04724044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287112|NCT04724044|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65287113|NCT04724044|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65287114|NCT04724044|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65287115|NCT04724044|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65287116|NCT04724044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65287117|NCT04724044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65287118|NCT02768519|OTS167|ots167|mesh-list
65287119|NCT02768519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65287120|NCT02768519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65287121|NCT02768519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287122|NCT03530696|Palbociclib|palbociclib|mesh-list
65287123|NCT03530696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287124|NCT03530696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65287125|NCT03530696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517382|NCT03260634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64817250|NCT01495117|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64817310|NCT01495338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64817311|NCT01495338|Cetirizine|cetirizine|mesh-list
64817312|NCT01495338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64817313|NCT01495338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64817314|NCT01495338|Analgesics|analgesics|mesh-ancestor
64817315|NCT01495338|Sensory System Agents|sensory system agents|mesh-ancestor
64817316|NCT01495338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64817317|NCT01495338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817318|NCT01495338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64817319|NCT01495338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64817320|NCT01495338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64817321|NCT01495338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64817322|NCT01495338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64817323|NCT01495338|Histamine Antagonists|histamine antagonists|mesh-ancestor
64817324|NCT01495338|Histamine Agents|histamine agents|mesh-ancestor
64817325|NCT01495338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64817326|NCT01495338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817327|NCT01495351|Bortezomib|bortezomib|mesh-list
64817328|NCT01495351|Veliparib|veliparib|mesh-list
64817329|NCT01495351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817330|NCT01495351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64817331|NCT01495351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817332|NCT01495351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817333|NCT01495377|Remifentanil|remifentanil|mesh-list
65287126|NCT03530696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287127|NCT00671814|Linezolid|linezolid|mesh-list
65287128|NCT00671814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65287129|NCT00671814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65287130|NCT00671814|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65287131|NCT00671814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567210|NCT03829111|Nivolumab|nivolumab|mesh-list
64817334|NCT01495377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64817335|NCT01495377|Narcotics|narcotics|mesh-ancestor
64817336|NCT01495377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64817337|NCT01495377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817338|NCT01495377|Analgesics|analgesics|mesh-ancestor
64817339|NCT01495377|Sensory System Agents|sensory system agents|mesh-ancestor
64817340|NCT01495377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64817341|NCT01495403|Hydroxychloroquine|hydroxychloroquine|mesh-list
64817342|NCT01495403|Antimalarials|antimalarials|mesh-ancestor
64817343|NCT01495403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64817344|NCT01495403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64817345|NCT01495403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64817346|NCT01495403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817347|NCT01495403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817348|NCT01495403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64817349|NCT01495468|Hormones|hormones|mesh-list
64817350|NCT01495468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64817351|NCT01495468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817388|NCT01495845|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64817389|NCT01495845|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64817390|NCT01495845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64817391|NCT01495845|Purinergic Agents|purinergic agents|mesh-ancestor
64817392|NCT01495845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64817393|NCT01495845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817394|NCT01495845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817395|NCT01495884|Lapatinib|lapatinib|mesh-list
64817396|NCT01495884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817397|NCT01495884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64817398|NCT01495884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817399|NCT01495884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817400|NCT01495910|Abiraterone Acetate|abiraterone acetate|mesh-list
64817401|NCT01495910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817402|NCT01495910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64817403|NCT01495910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817404|NCT01495910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817405|NCT01495910|Hormone Antagonists|hormone antagonists|mesh-ancestor
64817406|NCT01495910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64817407|NCT01495910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817408|NCT01495910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64817409|NCT01495949|Thiopental|thiopental|mesh-list
64817410|NCT01495949|Etomidate|etomidate|mesh-list
64817411|NCT01495949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64491884|NCT00417664|GABA Agents|gaba agents|mesh-ancestor
64817425|NCT01495962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64817426|NCT01495962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64817427|NCT01495962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817428|NCT01495962|Cholinergic Agents|cholinergic agents|mesh-ancestor
64817437|NCT01496105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817438|NCT01496105|Sensory System Agents|sensory system agents|mesh-ancestor
64817439|NCT01496105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64817440|NCT01496105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64817441|NCT01496105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64817442|NCT01496105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64817443|NCT01496105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64817444|NCT01496105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817445|NCT01496196|Tranexamic Acid|tranexamic acid|mesh-list
64817446|NCT01496196|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64817447|NCT01496196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65287132|NCT00671814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287133|NCT02627430|Talazoparib|talazoparib|mesh-list
65287134|NCT02627430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65287135|NCT02627430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65287136|NCT02627430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287137|NCT02627430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287138|NCT02759393|Lansoprazole|lansoprazole|mesh-list
65287139|NCT02759393|Dexlansoprazole|dexlansoprazole|mesh-list
65287140|NCT02759393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65287141|NCT02759393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65287142|NCT02759393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65287143|NCT02759393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65287144|NCT02759393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287145|NCT02758925|Cytarabine|cytarabine|mesh-list
65287146|NCT02758925|Rituximab|rituximab|mesh-list
65287147|NCT02758925|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65287148|NCT02758925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65287149|NCT02758925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287150|NCT02758925|Immunologic Factors|immunologic factors|mesh-ancestor
65287151|NCT02758925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287152|NCT02758925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64817448|NCT01496196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817449|NCT01496196|Hemostatics|hemostatics|mesh-ancestor
64817450|NCT01496196|Coagulants|coagulants|mesh-ancestor
64817451|NCT01496261|Aspirin|aspirin|mesh-list
64817452|NCT01496261|Clopidogrel|clopidogrel|mesh-list
65494511|NCT01141452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64557641|NCT03067896|Anticonvulsants|anticonvulsants|mesh-ancestor
64817453|NCT01496261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64817454|NCT01496261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64817455|NCT01496261|Analgesics|analgesics|mesh-ancestor
64817456|NCT01496261|Sensory System Agents|sensory system agents|mesh-ancestor
64817457|NCT01496261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64817458|NCT01496261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817459|NCT01496261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64817460|NCT01496261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64817461|NCT01496261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64817462|NCT01496261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64817463|NCT01496261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817464|NCT01496261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64817465|NCT01496261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64817466|NCT01496261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817467|NCT01496261|Antipyretics|antipyretics|mesh-ancestor
64817468|NCT01496261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64817469|NCT01496261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64817470|NCT01496261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64817471|NCT01496261|Purinergic Agents|purinergic agents|mesh-ancestor
64817472|NCT01496261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64817473|NCT01496326|Ibuprofen|ibuprofen|mesh-list
64817474|NCT01496326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64817475|NCT01496326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64817476|NCT01496326|Analgesics|analgesics|mesh-ancestor
65287153|NCT02758925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65287154|NCT02758925|Antimetabolites|antimetabolites|mesh-ancestor
65287155|NCT02758925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287156|NCT02758925|Antiviral Agents|antiviral agents|mesh-ancestor
64517431|NCT04780347|Capecitabine|capecitabine|mesh-list
64817477|NCT01496326|Sensory System Agents|sensory system agents|mesh-ancestor
64817505|NCT01496521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817506|NCT01496521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64817507|NCT01496521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64817508|NCT01496521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64817509|NCT01496521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64817510|NCT01496521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817511|NCT01496521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64817512|NCT01496521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64817513|NCT01496521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817515|NCT01496534|Carboplatin|carboplatin|mesh-list
64817516|NCT01496534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557484|NCT02555007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64817517|NCT01496677|Tedizolid phosphate|tedizolid phosphate|mesh-list
64817518|NCT01496677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64817519|NCT01496677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64817520|NCT01496690|Pregabalin|pregabalin|mesh-list
64817521|NCT01496690|Analgesics|analgesics|mesh-ancestor
64817522|NCT01496690|Sensory System Agents|sensory system agents|mesh-ancestor
64817523|NCT01496690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64817524|NCT01496690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817525|NCT01496690|Anticonvulsants|anticonvulsants|mesh-ancestor
64817526|NCT01496690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64817527|NCT01496690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64817528|NCT01496690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817529|NCT01496690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64817530|NCT01496690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64817531|NCT01496690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64817532|NCT01496690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65494512|NCT00219557|Gemcitabine|gemcitabine|mesh-list
64817533|NCT01496690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64817535|NCT01496742|Bevacizumab|bevacizumab|mesh-list
64817536|NCT01496742|Carboplatin|carboplatin|mesh-list
64817537|NCT01496742|Pemetrexed|pemetrexed|mesh-list
64817538|NCT01496742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64817539|NCT01496742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817540|NCT01496742|Tubulin Modulators|tubulin modulators|mesh-ancestor
64817541|NCT01496742|Antimitotic Agents|antimitotic agents|mesh-ancestor
64817659|NCT01497470|Mitosis Modulators|mitosis modulators|mesh-ancestor
64817660|NCT01497470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817661|NCT01497483|Cyclosporine|cyclosporine|mesh-list
64817662|NCT01497483|Pravastatin|pravastatin|mesh-list
64817663|NCT01497483|Cyclosporins|cyclosporins|mesh-list
64817690|NCT01497535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64817691|NCT01497535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817693|NCT01497548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64817694|NCT01497548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817695|NCT01497548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64817696|NCT01497548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64817697|NCT01497548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64817698|NCT01497548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817699|NCT01497548|Dopamine Agents|dopamine agents|mesh-ancestor
64817700|NCT01497548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64817701|NCT01497561|Insulin|insulin|mesh-list
64817702|NCT01497561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64817703|NCT01497561|Insulin Detemir|insulin detemir|mesh-list
64817704|NCT01497561|Isophane Insulin, Human|isophane insulin, human|mesh-list
64817705|NCT01497561|Insulin, Isophane|insulin, isophane|mesh-list
64817706|NCT01497561|Isophane insulin, beef|isophane insulin, beef|mesh-list
64817707|NCT01497561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64817708|NCT01497561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817709|NCT01497574|Insulin|insulin|mesh-list
64817710|NCT01497574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64817711|NCT01497574|Insulin Glargine|insulin glargine|mesh-list
64817712|NCT01497574|Insulin Detemir|insulin detemir|mesh-list
65287157|NCT02758925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65287158|NCT02758925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65287159|NCT02758925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65287160|NCT02758925|Alkylating Agents|alkylating agents|mesh-ancestor
65287161|NCT00676260|Pioglitazone|pioglitazone|mesh-list
65287162|NCT00676260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65287163|NCT00676260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287164|NCT00652652|Furosemide|furosemide|mesh-list
65287165|NCT00652652|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65287166|NCT00652652|Diuretics|diuretics|mesh-ancestor
65287167|NCT00652652|Natriuretic Agents|natriuretic agents|mesh-ancestor
65287168|NCT00652652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287169|NCT00652652|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65287170|NCT00652652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65287171|NCT00652652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287172|NCT02768441|Dextroamphetamine|dextroamphetamine|mesh-list
65287173|NCT02768441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65287174|NCT02768441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287175|NCT02768441|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64817713|NCT01497574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64817714|NCT01497574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817715|NCT01497587|Insulin Detemir|insulin detemir|mesh-list
64817716|NCT01497587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64817717|NCT01497587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817718|NCT01497600|Insulin|insulin|mesh-list
64817719|NCT01497600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64817720|NCT01497600|Insulin Detemir|insulin detemir|mesh-list
64817721|NCT01497600|Isophane Insulin, Human|isophane insulin, human|mesh-list
64817722|NCT01497600|Insulin, Isophane|insulin, isophane|mesh-list
64817723|NCT01497600|Isophane insulin, beef|isophane insulin, beef|mesh-list
64817724|NCT01497600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64817725|NCT01497600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817726|NCT01497626|Bortezomib|bortezomib|mesh-list
64817727|NCT01497626|Lapatinib|lapatinib|mesh-list
64817728|NCT01497626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817729|NCT01497626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64817730|NCT01497626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817762|NCT01497977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817763|NCT01497990|Ertapenem|ertapenem|mesh-list
64817764|NCT01497990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64817765|NCT01497990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64817766|NCT01498003|Tirofiban|tirofiban|mesh-list
64817767|NCT01498003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64817768|NCT01498003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64817769|NCT01498003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817770|NCT01498003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64817771|NCT01498016|Busulfan|busulfan|mesh-list
64817772|NCT01498016|Alkylating Agents|alkylating agents|mesh-ancestor
64817773|NCT01498016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817774|NCT01498016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64817775|NCT01498016|Immunologic Factors|immunologic factors|mesh-ancestor
64817776|NCT01498016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817777|NCT01498016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64817778|NCT01498016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287176|NCT02768441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65287177|NCT02768441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65287178|NCT02768441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287179|NCT02768441|Dopamine Agents|dopamine agents|mesh-ancestor
65287180|NCT02768441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65287181|NCT02644616|Torsemide|torsemide|mesh-list
65287182|NCT02644616|Tolvaptan|tolvaptan|mesh-list
65287183|NCT02644616|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65287184|NCT02644616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287185|NCT02644616|Natriuretic Agents|natriuretic agents|mesh-ancestor
65287186|NCT02644616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287187|NCT02644616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65287188|NCT02644616|Diuretics|diuretics|mesh-ancestor
64517456|NCT02455440|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64817779|NCT01498016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64817780|NCT01498081|Tiotropium Bromide|tiotropium bromide|mesh-list
64817781|NCT01498081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64817782|NCT01498081|Autonomic Agents|autonomic agents|mesh-ancestor
64817783|NCT01498081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64817784|NCT01498081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817785|NCT01498081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64817786|NCT01498081|Respiratory System Agents|respiratory system agents|mesh-ancestor
64817787|NCT01498081|Parasympatholytics|parasympatholytics|mesh-ancestor
64817788|NCT01498081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64817789|NCT01498081|Cholinergic Agents|cholinergic agents|mesh-ancestor
64817790|NCT01498081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64817824|NCT01498718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817826|NCT01498783|Antimetabolites|antimetabolites|mesh-ancestor
64817827|NCT01498783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817828|NCT01498783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64817829|NCT01498783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817830|NCT01498783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64817831|NCT01498783|Immunologic Factors|immunologic factors|mesh-ancestor
64817832|NCT01498783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817833|NCT01498796|Ketorolac|ketorolac|mesh-list
64817834|NCT01498796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64817835|NCT01498796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64817836|NCT01498796|Analgesics|analgesics|mesh-ancestor
65494514|NCT00219557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65494515|NCT00219557|Antimetabolites|antimetabolites|mesh-ancestor
64817837|NCT01498796|Sensory System Agents|sensory system agents|mesh-ancestor
64817838|NCT01498796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64817839|NCT01498796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817840|NCT01498796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64817841|NCT01498796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64817842|NCT01498796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64817843|NCT01498796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817844|NCT01498796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817845|NCT01498809|Midodrine|midodrine|mesh-list
64817846|NCT01498809|Sympathomimetics|sympathomimetics|mesh-ancestor
64817847|NCT01498809|Autonomic Agents|autonomic agents|mesh-ancestor
64817848|NCT01498809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64817849|NCT01498809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817850|NCT01498809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64817851|NCT01498809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64428995|NCT05319431|Lenvatinib|lenvatinib|mesh-list
64817860|NCT01498835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64817861|NCT01498835|Growth Substances|growth substances|mesh-ancestor
65287189|NCT02644616|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65037182|NCT00181688|Anastrozole|anastrozole|mesh-list
65287190|NCT02644616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65287191|NCT02648048|Pirfenidone|pirfenidone|mesh-list
65287192|NCT02648048|Analgesics|analgesics|mesh-ancestor
65287193|NCT02648048|Sensory System Agents|sensory system agents|mesh-ancestor
65287194|NCT02648048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65287195|NCT02648048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287196|NCT02648048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65287197|NCT02648048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65287198|NCT02648048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65287199|NCT02648048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65287200|NCT02648048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287201|NCT00676416|Propofol|propofol|mesh-list
65287202|NCT00676416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64817862|NCT01498835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817863|NCT01498835|Growth Inhibitors|growth inhibitors|mesh-ancestor
64492238|NCT03317535|Anesthetics|anesthetics|mesh-list
64817894|NCT01498913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817896|NCT01498926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64817897|NCT01498926|Insulin Detemir|insulin detemir|mesh-list
64817898|NCT01498926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64817899|NCT01498926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817900|NCT01498939|Insulin Detemir|insulin detemir|mesh-list
64817901|NCT01498939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64817902|NCT01498939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817903|NCT01499004|Tofacitinib|tofacitinib|mesh-list
64817904|NCT01499004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64817905|NCT01499004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817927|NCT01499121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817928|NCT01499121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64817929|NCT01499121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64817930|NCT01499121|Growth Substances|growth substances|mesh-ancestor
64817931|NCT01499121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817932|NCT01499121|Growth Inhibitors|growth inhibitors|mesh-ancestor
64817933|NCT01499121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64817934|NCT01499121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817935|NCT01499121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817936|NCT01499225|Doxycycline|doxycycline|mesh-list
64817937|NCT01499225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64817938|NCT01499225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64817939|NCT01499225|Antimalarials|antimalarials|mesh-ancestor
64817940|NCT01499225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64817941|NCT01499225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64817942|NCT01499251|Temozolomide|temozolomide|mesh-list
64817943|NCT01499251|Macitentan|macitentan|mesh-list
64817944|NCT01499251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64817945|NCT01499251|Alkylating Agents|alkylating agents|mesh-ancestor
64817946|NCT01499251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817947|NCT01499251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817948|NCT01499251|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64817949|NCT01499251|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64817950|NCT01499251|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64817951|NCT01499407|Abciximab|abciximab|mesh-list
64817952|NCT01499407|Anticoagulants|anticoagulants|mesh-ancestor
64817953|NCT01499407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64817954|NCT01499433|Caspofungin|caspofungin|mesh-list
64817955|NCT01499433|Antifungal Agents|antifungal agents|mesh-ancestor
64817956|NCT01499433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64817957|NCT01499433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65287203|NCT00676416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65287204|NCT00676416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287205|NCT00676416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65287206|NCT00676416|Anesthetics, General|anesthetics, general|mesh-ancestor
65287207|NCT00676416|Anesthetics|anesthetics|mesh-ancestor
65287208|NCT00651326|Docetaxel|docetaxel|mesh-list
65287209|NCT00651326|Leuprolide|leuprolide|mesh-list
65287210|NCT00651326|Goserelin|goserelin|mesh-list
65287211|NCT00651326|Bicalutamide|bicalutamide|mesh-list
65287212|NCT00651326|Flutamide|flutamide|mesh-list
65287213|NCT00651326|Buserelin|buserelin|mesh-list
65287214|NCT00651326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287215|NCT00651326|Tubulin Modulators|tubulin modulators|mesh-ancestor
65287216|NCT00651326|Antimitotic Agents|antimitotic agents|mesh-ancestor
65287217|NCT00651326|Mitosis Modulators|mitosis modulators|mesh-ancestor
65287218|NCT00651326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817958|NCT01499433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817959|NCT01499446|Fluticasone|fluticasone|mesh-list
64817960|NCT01499446|Xhance|xhance|mesh-list
64817961|NCT01499446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64817962|NCT01499446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64817963|NCT01499446|Autonomic Agents|autonomic agents|mesh-ancestor
64817964|NCT01499446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64817965|NCT01499446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817966|NCT01499446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64817967|NCT01499446|Respiratory System Agents|respiratory system agents|mesh-ancestor
64817968|NCT01499446|Dermatologic Agents|dermatologic agents|mesh-ancestor
64817969|NCT01499446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64817971|NCT01499485|Anticonvulsants|anticonvulsants|mesh-ancestor
64817972|NCT01499485|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64817973|NCT01499485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817974|NCT01499485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818015|NCT01499693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818016|NCT01499693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818018|NCT01499758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64818019|NCT01499758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64818021|NCT01499758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818022|NCT01499758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64818023|NCT01499758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64818024|NCT01499758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818025|NCT01499771|Atorvastatin|atorvastatin|mesh-list
64818036|NCT01499953|PENTA|penta|mesh-list
64818037|NCT01499953|Rivaroxaban|rivaroxaban|mesh-list
65494516|NCT00219557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818038|NCT01499953|Fondaparinux|fondaparinux|mesh-list
64558092|NCT01012089|Daptomycin|daptomycin|mesh-list
64818039|NCT01499953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64818040|NCT01499953|Antithrombins|antithrombins|mesh-ancestor
64586657|NCT00394277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64818041|NCT01499953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64818042|NCT01499953|Protease Inhibitors|protease inhibitors|mesh-ancestor
64818043|NCT01499953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818044|NCT01499953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818045|NCT01499953|Anticoagulants|anticoagulants|mesh-ancestor
64818046|NCT01499953|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64818047|NCT01499953|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64818049|NCT01500005|Vitamins|vitamins|mesh-ancestor
64818050|NCT01500005|Micronutrients|micronutrients|mesh-ancestor
64818051|NCT01500005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818052|NCT01500005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64818053|NCT01500018|Phentermine|phentermine|mesh-list
64818054|NCT01500018|Ketamine|ketamine|mesh-list
65287219|NCT00651326|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65287220|NCT00651326|Fertility Agents|fertility agents|mesh-ancestor
65287221|NCT00651326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65287222|NCT00651326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287223|NCT00651326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65287224|NCT00651326|Androgen Antagonists|androgen antagonists|mesh-ancestor
65287225|NCT00651326|Hormone Antagonists|hormone antagonists|mesh-ancestor
65287226|NCT00651326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65287227|NCT04150536|Lidocaine|lidocaine|mesh-list
65287228|NCT04150536|Anesthetics, Local|anesthetics, local|mesh-ancestor
65287229|NCT04150536|Anesthetics|anesthetics|mesh-ancestor
65287230|NCT04150536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65287231|NCT04150536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287232|NCT04150536|Sensory System Agents|sensory system agents|mesh-ancestor
65287233|NCT04150536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65287234|NCT04150536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65287235|NCT04150536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65287236|NCT04150536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65287237|NCT04150536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65287238|NCT04150536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287239|NCT05167123|Calcium|calcium|mesh-list
65287240|NCT05167123|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65287241|NCT05167123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287242|NCT02644538|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65287243|NCT02644538|Antiviral Agents|antiviral agents|mesh-ancestor
64818055|NCT01500018|Analgesics|analgesics|mesh-ancestor
64818056|NCT01500018|Sensory System Agents|sensory system agents|mesh-ancestor
64818057|NCT01500018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64818058|NCT01500018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818059|NCT01500018|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64818060|NCT01500018|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64818061|NCT01500018|Anesthetics, General|anesthetics, general|mesh-ancestor
64818062|NCT01500018|Anesthetics|anesthetics|mesh-ancestor
64818063|NCT01500018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64818064|NCT01500018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64818065|NCT01500018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64818066|NCT01500018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64818067|NCT01500018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818068|NCT01500018|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64818069|NCT01500018|Appetite Depressants|appetite depressants|mesh-ancestor
64818070|NCT01500018|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64818071|NCT01500018|Sympathomimetics|sympathomimetics|mesh-ancestor
64818072|NCT01500018|Autonomic Agents|autonomic agents|mesh-ancestor
64818073|NCT01500018|Adrenergic Agents|adrenergic agents|mesh-ancestor
64818074|NCT01500070|Everolimus|everolimus|mesh-list
64818075|NCT01500070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287244|NCT02644538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65287245|NCT02576314|Sofosbuvir|sofosbuvir|mesh-list
65287246|NCT02576314|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
65287247|NCT02576314|Ledipasvir|ledipasvir|mesh-list
65287248|NCT02576314|Antiviral Agents|antiviral agents|mesh-ancestor
65287249|NCT02576314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65287250|NCT00650234|Metformin|metformin|mesh-list
65287251|NCT00650234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65287252|NCT00650234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287253|NCT00680940|Paclitaxel|paclitaxel|mesh-list
65287254|NCT00680940|Cisplatin|cisplatin|mesh-list
65287255|NCT00680940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65287256|NCT00680940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287257|NCT00680940|Tubulin Modulators|tubulin modulators|mesh-ancestor
65287258|NCT00680940|Antimitotic Agents|antimitotic agents|mesh-ancestor
65287259|NCT00680940|Mitosis Modulators|mitosis modulators|mesh-ancestor
64818076|NCT01500070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64818077|NCT01500070|Immunologic Factors|immunologic factors|mesh-ancestor
64818114|NCT01500473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64818115|NCT01500473|Contraceptive Agents|contraceptive agents|mesh-ancestor
64818116|NCT01500473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64818117|NCT01500473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818118|NCT01500473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64818119|NCT01500473|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64818120|NCT01500473|Progestins|progestins|mesh-ancestor
64818121|NCT01500473|Hormones|hormones|mesh-ancestor
64818122|NCT01500473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64818123|NCT01500538|Vorinostat|vorinostat|mesh-list
64818124|NCT01500538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818125|NCT01500538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64818126|NCT01500538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818127|NCT01500538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818128|NCT01500577|Nimesulide|nimesulide|mesh-list
64818129|NCT01500577|Simvastatin|simvastatin|mesh-list
64818130|NCT01500577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64818131|NCT01500577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64818132|NCT01500577|Antimetabolites|antimetabolites|mesh-ancestor
65494517|NCT00219557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558157|NCT00961233|Budesonide|budesonide|mesh-list
64818133|NCT01500577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818134|NCT01500577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64818135|NCT01500577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64818136|NCT01500577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818137|NCT01500577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64818138|NCT01500577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64818139|NCT01500577|Analgesics|analgesics|mesh-ancestor
64818140|NCT01500577|Sensory System Agents|sensory system agents|mesh-ancestor
64818141|NCT01500577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64818142|NCT01500577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818143|NCT01500577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64818144|NCT01500577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64818145|NCT01500577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64818146|NCT01500590|Ramipril|ramipril|mesh-list
64818147|NCT01500590|Irbesartan|irbesartan|mesh-list
64429293|NCT05247125|Protective Agents|protective agents|mesh-ancestor
64818169|NCT01500785|Protective Agents|protective agents|mesh-ancestor
64818170|NCT01500824|Crizotinib|crizotinib|mesh-list
64818171|NCT01500824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818172|NCT01500824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64818173|NCT01500824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492448|NCT01896557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65287260|NCT00680940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287261|NCT03472885|Eculizumab|eculizumab|mesh-list
65287262|NCT03472885|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65287263|NCT03472885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65287264|NCT03472885|Immunologic Factors|immunologic factors|mesh-ancestor
65287265|NCT03472885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287266|NCT02644304|Cabergoline|cabergoline|mesh-list
64818197|NCT01500837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64818198|NCT01500837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64818207|NCT01500850|Insulin, Isophane|insulin, isophane|mesh-list
64818208|NCT01500850|Isophane Insulin, Human|isophane insulin, human|mesh-list
64818209|NCT01500850|Isophane insulin, beef|isophane insulin, beef|mesh-list
64818210|NCT01500850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64818211|NCT01500850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818212|NCT01500863|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64818213|NCT01500863|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64818214|NCT01500863|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64818215|NCT01500863|Estradiol|estradiol|mesh-list
64818216|NCT01500863|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64818217|NCT01500863|Progesterone|progesterone|mesh-list
64818218|NCT01500863|Estrogens|estrogens|mesh-ancestor
64818219|NCT01500863|Hormones|hormones|mesh-ancestor
64818220|NCT01500863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64818221|NCT01500863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818222|NCT01500863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64818223|NCT01500863|Contraceptive Agents|contraceptive agents|mesh-ancestor
64818224|NCT01500863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64818225|NCT01500863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64818226|NCT01500863|Progestins|progestins|mesh-ancestor
64818227|NCT01500863|Luteolytic Agents|luteolytic agents|mesh-ancestor
64818228|NCT01500863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64818229|NCT01500863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818230|NCT01500915|Ranibizumab|ranibizumab|mesh-list
64818238|NCT01500928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64818239|NCT01500928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818240|NCT01500980|Chloroquine|chloroquine|mesh-list
64818241|NCT01500980|Primaquine|primaquine|mesh-list
64818242|NCT01500980|Amebicides|amebicides|mesh-ancestor
64818243|NCT01500980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64818244|NCT01500980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64818245|NCT01500980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64818246|NCT01500980|Antimalarials|antimalarials|mesh-ancestor
64818247|NCT01500980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64818248|NCT01500993|Fluorouracil|fluorouracil|mesh-list
64818249|NCT01500993|Capecitabine|capecitabine|mesh-list
64818250|NCT01500993|Antimetabolites|antimetabolites|mesh-ancestor
64818251|NCT01500993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818252|NCT01500993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64818253|NCT01500993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818254|NCT01500993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64818255|NCT01500993|Immunologic Factors|immunologic factors|mesh-ancestor
64818256|NCT01500993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818257|NCT01501032|Pancrelipase|pancrelipase|mesh-list
64818258|NCT01501032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64818259|NCT01501084|Exenatide|exenatide|mesh-list
64818260|NCT01501084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64818261|NCT01501084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818262|NCT01501084|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64818263|NCT01501084|Incretins|incretins|mesh-ancestor
64818264|NCT01501084|Hormones|hormones|mesh-ancestor
64818265|NCT01501084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64818266|NCT01501123|Midazolam|midazolam|mesh-list
64818267|NCT01501123|Haloperidol|haloperidol|mesh-list
64586886|NCT00376805|Fludarabine|fludarabine|mesh-list
64818282|NCT01501123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818283|NCT01501123|Antiemetics|antiemetics|mesh-ancestor
64818284|NCT01501123|Autonomic Agents|autonomic agents|mesh-ancestor
64818285|NCT01501123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64818286|NCT01501123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64818287|NCT01501123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65287267|NCT02644304|Clomiphene|clomiphene|mesh-list
65287268|NCT02644304|Enclomiphene|enclomiphene|mesh-list
65287269|NCT02644304|Zuclomiphene|zuclomiphene|mesh-list
65287270|NCT02644304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287271|NCT02644304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65287272|NCT02644304|Hormone Antagonists|hormone antagonists|mesh-ancestor
65287273|NCT02644304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65287274|NCT02644304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287275|NCT02644304|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65287276|NCT02644304|Fertility Agents|fertility agents|mesh-ancestor
65287277|NCT02644304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65287278|NCT02644304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65287279|NCT02644304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65287280|NCT02644304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65287281|NCT02644304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65287282|NCT02644304|Dopamine Agonists|dopamine agonists|mesh-ancestor
65287283|NCT02644304|Dopamine Agents|dopamine agents|mesh-ancestor
64818288|NCT01501123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64818289|NCT01501123|Dopamine Agents|dopamine agents|mesh-ancestor
64818290|NCT01501123|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64818291|NCT01501136|Gemcitabine|gemcitabine|mesh-list
64818292|NCT01501136|Dexamethasone|dexamethasone|mesh-list
64818293|NCT01501136|Dexamethasone acetate|dexamethasone acetate|mesh-list
64818294|NCT01501136|Cisplatin|cisplatin|mesh-list
64818295|NCT01501136|Etoposide|etoposide|mesh-list
64818296|NCT01501136|Etoposide phosphate|etoposide phosphate|mesh-list
64818297|NCT01501136|Ifosfamide|ifosfamide|mesh-list
64818298|NCT01501136|Isophosphamide mustard|isophosphamide mustard|mesh-list
64818299|NCT01501136|Pegaspargase|pegaspargase|mesh-list
64818300|NCT01501136|Asparaginase|asparaginase|mesh-list
64818301|NCT01501136|BB 1101|bb 1101|mesh-list
64818303|NCT01501136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64818304|NCT01501136|Antiemetics|antiemetics|mesh-ancestor
64818305|NCT01501136|Autonomic Agents|autonomic agents|mesh-ancestor
64818306|NCT01501136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64818307|NCT01501136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818308|NCT01501136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64818309|NCT01501136|Glucocorticoids|glucocorticoids|mesh-ancestor
64818310|NCT01501136|Hormones|hormones|mesh-ancestor
64818311|NCT01501136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64818312|NCT01501136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64818313|NCT01501136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818314|NCT01501136|Protease Inhibitors|protease inhibitors|mesh-ancestor
64818315|NCT01501136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818316|NCT01501136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818363|NCT01501253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64818364|NCT01501253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64818365|NCT01501253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818366|NCT01501253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64818367|NCT01501253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818368|NCT01501253|Vasodilator Agents|vasodilator agents|mesh-ancestor
64818370|NCT01501344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64818371|NCT01501344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818372|NCT01501370|Dexamethasone|dexamethasone|mesh-list
64818373|NCT01501370|Dexamethasone acetate|dexamethasone acetate|mesh-list
64818374|NCT01501370|Lenalidomide|lenalidomide|mesh-list
64818375|NCT01501370|Vorinostat|vorinostat|mesh-list
64818376|NCT01501370|BB 1101|bb 1101|mesh-list
64818377|NCT01501370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65287284|NCT02644304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65287285|NCT00681174|Acetaminophen|acetaminophen|mesh-list
65287286|NCT00681174|Morphine|morphine|mesh-list
65287287|NCT00681174|Remifentanil|remifentanil|mesh-list
65287288|NCT00681174|Oxycodone|oxycodone|mesh-list
65287289|NCT00681174|Propofol|propofol|mesh-list
65287290|NCT00681174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64818378|NCT01501370|Antiemetics|antiemetics|mesh-ancestor
64818392|NCT01501370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64818393|NCT01501370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64818394|NCT01501370|Growth Substances|growth substances|mesh-ancestor
64818395|NCT01501370|Growth Inhibitors|growth inhibitors|mesh-ancestor
64818396|NCT01501370|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64818398|NCT01501396|Megestrol Acetate|megestrol acetate|mesh-list
64818399|NCT01501396|Mirtazapine|mirtazapine|mesh-list
64818400|NCT01501396|Antidepressive Agents|antidepressive agents|mesh-ancestor
64818401|NCT01501396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64818402|NCT01501396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64818403|NCT01501396|Histamine Antagonists|histamine antagonists|mesh-ancestor
64818404|NCT01501396|Histamine Agents|histamine agents|mesh-ancestor
64818405|NCT01501396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64818406|NCT01501396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818407|NCT01501396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818408|NCT01501396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64818409|NCT01501396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64818410|NCT01501396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64818411|NCT01501396|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64818412|NCT01501396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64818413|NCT01501396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64818414|NCT01501396|Adrenergic Agents|adrenergic agents|mesh-ancestor
64818433|NCT01501422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818434|NCT01501435|Fenofibric acid|fenofibric acid|mesh-list
64818435|NCT01501435|Fenofibrate|fenofibrate|mesh-list
64818436|NCT01501435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64818437|NCT01501435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65494519|NCT00219557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64818467|NCT01501487|Antimitotic Agents|antimitotic agents|mesh-ancestor
64818468|NCT01501487|Mitosis Modulators|mitosis modulators|mesh-ancestor
64818469|NCT01501487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558384|NCT03861299|Anesthetics|anesthetics|mesh-list
64818470|NCT01501487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64818471|NCT01501500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64818472|NCT01501500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64818473|NCT01501500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64818474|NCT01501500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818475|NCT01501500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64818476|NCT01501500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64818477|NCT01501500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818478|NCT01501500|Cholinergic Agents|cholinergic agents|mesh-ancestor
64818479|NCT01501500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64818480|NCT01501591|Hydroxyzine|hydroxyzine|mesh-list
64818481|NCT01501591|Antipruritics|antipruritics|mesh-ancestor
64818482|NCT01501591|Dermatologic Agents|dermatologic agents|mesh-ancestor
64818504|NCT01501695|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64818505|NCT01501695|Dopamine Agents|dopamine agents|mesh-ancestor
64818506|NCT01501695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64818507|NCT01501695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818508|NCT01501708|Voriconazole|voriconazole|mesh-list
64818509|NCT01501708|Amphotericin B|amphotericin b|mesh-list
64818510|NCT01501708|Caspofungin|caspofungin|mesh-list
64818511|NCT01501708|Antifungal Agents|antifungal agents|mesh-ancestor
64818512|NCT01501708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64818513|NCT01501708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64818514|NCT01501708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64818515|NCT01501708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492677|NCT04763343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64818519|NCT01501708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64818521|NCT01501708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64818522|NCT01501708|Amebicides|amebicides|mesh-ancestor
64818523|NCT01501708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65287291|NCT00681174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65287292|NCT00681174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287293|NCT00681174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65287294|NCT00681174|Anesthetics, General|anesthetics, general|mesh-ancestor
65287295|NCT00681174|Anesthetics|anesthetics|mesh-ancestor
65287296|NCT00681174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65287297|NCT00681174|Narcotics|narcotics|mesh-ancestor
65287298|NCT00681174|Analgesics|analgesics|mesh-ancestor
65287299|NCT00681174|Sensory System Agents|sensory system agents|mesh-ancestor
65287300|NCT00681174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65287301|NCT00681174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65287302|NCT00681174|Antipyretics|antipyretics|mesh-ancestor
65287303|NCT02758769|Abatacept|abatacept|mesh-list
65287304|NCT02758769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65287305|NCT02758769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287306|NCT02758769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287307|NCT02758769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65287308|NCT02758769|Immunologic Factors|immunologic factors|mesh-ancestor
65287309|NCT02758769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473694|NCT01732640|Afatinib|afatinib|mesh-list
64818524|NCT01501708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64818525|NCT01501708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64818526|NCT01501747|Acetaminophen|acetaminophen|mesh-list
64818527|NCT01501747|Cephalexin|cephalexin|mesh-list
64818528|NCT01501747|Ibuprofen|ibuprofen|mesh-list
64818529|NCT01501747|Caffeine|caffeine|mesh-list
64818530|NCT01501747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64818531|NCT01501747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64818532|NCT01501747|Analgesics|analgesics|mesh-ancestor
64818533|NCT01501747|Sensory System Agents|sensory system agents|mesh-ancestor
64818534|NCT01501747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429697|NCT02366767|Insulin|insulin|mesh-list
64818546|NCT01501747|Purinergic Agents|purinergic agents|mesh-ancestor
64818547|NCT01501747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64818548|NCT01501747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64818549|NCT01501747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64818550|NCT01501760|Bevacizumab|bevacizumab|mesh-list
64818551|NCT01501760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64818552|NCT01501760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818553|NCT01501760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64818554|NCT01501760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64818555|NCT01501760|Growth Substances|growth substances|mesh-ancestor
64818556|NCT01501760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818557|NCT01501760|Growth Inhibitors|growth inhibitors|mesh-ancestor
64818558|NCT01501786|Ketamine|ketamine|mesh-list
64818559|NCT01501786|Propofol|propofol|mesh-list
64818560|NCT01501786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64818561|NCT01501786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64818562|NCT01501786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818563|NCT01501786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64818564|NCT01501786|Anesthetics, General|anesthetics, general|mesh-ancestor
64818565|NCT01501786|Anesthetics|anesthetics|mesh-ancestor
64818566|NCT01501786|Analgesics|analgesics|mesh-ancestor
64818567|NCT01501786|Sensory System Agents|sensory system agents|mesh-ancestor
64818568|NCT01501786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64818569|NCT01501786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64818570|NCT01501786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65287310|NCT02758769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65287311|NCT04150146|Rebamipide|rebamipide|mesh-list
65287312|NCT04150146|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65287313|NCT04150146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65287314|NCT04150146|Antioxidants|antioxidants|mesh-ancestor
65287315|NCT04150146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818571|NCT01501786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65494520|NCT00219557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818572|NCT01501786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64818573|NCT01501786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558457|NCT03844061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64818574|NCT01501799|Adapalene|adapalene|mesh-list
64818575|NCT01501799|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64818576|NCT01501799|Dermatologic Agents|dermatologic agents|mesh-ancestor
64818577|NCT01501799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64818578|NCT01501799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64818579|NCT01501799|Analgesics|analgesics|mesh-ancestor
64818580|NCT01501799|Sensory System Agents|sensory system agents|mesh-ancestor
64818581|NCT01501799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64818582|NCT01501799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818583|NCT01501799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64818584|NCT01501799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64818585|NCT01501890|Algestone|algestone|mesh-list
64818586|NCT01501890|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
64818587|NCT01501890|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
64818588|NCT01501890|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64818589|NCT01501890|Hormone Antagonists|hormone antagonists|mesh-ancestor
64818590|NCT01501890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64818591|NCT01501890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818592|NCT01501890|Progestins|progestins|mesh-ancestor
64818593|NCT01501890|Hormones|hormones|mesh-ancestor
64492730|NCT04614311|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64818669|NCT01502280|Protective Agents|protective agents|mesh-ancestor
64818670|NCT01502280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818672|NCT01502280|Micronutrients|micronutrients|mesh-ancestor
64818673|NCT01502280|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64818674|NCT01502280|Dermatologic Agents|dermatologic agents|mesh-ancestor
64818675|NCT01502358|Vaccines|vaccines|mesh-list
64818676|NCT01502358|Immunologic Factors|immunologic factors|mesh-ancestor
64818677|NCT01502358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818678|NCT01502592|Ipilimumab|ipilimumab|mesh-list
64818679|NCT01502592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64818680|NCT01502592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818681|NCT01502592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64818682|NCT01502592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818683|NCT01502605|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64818684|NCT01502605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64818685|NCT01502605|Dermatologic Agents|dermatologic agents|mesh-ancestor
64818686|NCT01502696|Interferon alpha-2|interferon alpha-2|mesh-list
64818687|NCT01502696|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64818688|NCT01502696|Antiviral Agents|antiviral agents|mesh-ancestor
64818689|NCT01502696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64818690|NCT01502696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818691|NCT01502774|Cyclosporine|cyclosporine|mesh-list
64818692|NCT01502774|Cyclosporins|cyclosporins|mesh-list
64818693|NCT01502774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818712|NCT01502878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64818713|NCT01502878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64818728|NCT01502904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818730|NCT01502904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64818731|NCT01502904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818732|NCT01502943|Atorvastatin|atorvastatin|mesh-list
64818733|NCT01502943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818734|NCT01502943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818735|NCT01502943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64818736|NCT01502943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64818737|NCT01502943|Antimetabolites|antimetabolites|mesh-ancestor
64818738|NCT01502943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64818739|NCT01502943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65287316|NCT04150146|Protective Agents|protective agents|mesh-ancestor
65287317|NCT04150146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287318|NCT04150146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65287319|NCT00652730|Buspirone|buspirone|mesh-list
65287320|NCT00652730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65287321|NCT00652730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64517598|NCT02353780|Analgesics|analgesics|mesh-ancestor
64818740|NCT01503008|Metformin|metformin|mesh-list
64818741|NCT01503008|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
64818742|NCT01503008|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64818743|NCT01503008|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
64818744|NCT01503008|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64818745|NCT01503008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818746|NCT01503008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818747|NCT01503008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818748|NCT01503008|Protease Inhibitors|protease inhibitors|mesh-ancestor
64818749|NCT01503060|Lidocaine|lidocaine|mesh-list
64818759|NCT01503060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64818760|NCT01503060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818762|NCT01503216|Cholecalciferol|cholecalciferol|mesh-list
64818763|NCT01503216|Ergocalciferols|ergocalciferols|mesh-list
64818764|NCT01503216|Vitamins|vitamins|mesh-ancestor
64818765|NCT01503216|Micronutrients|micronutrients|mesh-ancestor
64818766|NCT01503216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818767|NCT01503216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64818768|NCT01503216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64818769|NCT01503242|Cyclosporine|cyclosporine|mesh-list
64818770|NCT01503242|Mycophenolic Acid|mycophenolic acid|mesh-list
64818771|NCT01503242|Fludarabine|fludarabine|mesh-list
64818772|NCT01503242|Fludarabine phosphate|fludarabine phosphate|mesh-list
64818773|NCT01503242|Antibodies|antibodies|mesh-list
64818774|NCT01503242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64818775|NCT01503242|Cyclosporins|cyclosporins|mesh-list
64818776|NCT01503242|Immunologic Factors|immunologic factors|mesh-ancestor
64818777|NCT01503242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818778|NCT01503242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818779|NCT01503242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64818780|NCT01503242|Antimetabolites|antimetabolites|mesh-ancestor
64818781|NCT01503242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818782|NCT01503242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64818783|NCT01503242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818784|NCT01503242|Antifungal Agents|antifungal agents|mesh-ancestor
64818785|NCT01503242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64818792|NCT01503242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64818793|NCT01503359|Glycine|glycine|mesh-list
64818794|NCT01503359|Glycine Agents|glycine agents|mesh-ancestor
64818795|NCT01503359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64818796|NCT01503359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818797|NCT01503359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818798|NCT01503372|Leucovorin|leucovorin|mesh-list
64818799|NCT01503372|Oxaliplatin|oxaliplatin|mesh-list
64818800|NCT01503372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818801|NCT01503372|Antidotes|antidotes|mesh-ancestor
64818802|NCT01503372|Protective Agents|protective agents|mesh-ancestor
64818803|NCT01503372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494522|NCT00219557|Immunologic Factors|immunologic factors|mesh-ancestor
64558613|NCT03788759|Vitamins|vitamins|mesh-ancestor
64818804|NCT01503372|Vitamin B Complex|vitamin b complex|mesh-ancestor
64818805|NCT01503372|Vitamins|vitamins|mesh-ancestor
64818806|NCT01503372|Micronutrients|micronutrients|mesh-ancestor
64818807|NCT01503385|Celecoxib|celecoxib|mesh-list
64818808|NCT01503385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64818809|NCT01503385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64818810|NCT01503385|Analgesics|analgesics|mesh-ancestor
64818811|NCT01503385|Sensory System Agents|sensory system agents|mesh-ancestor
64818812|NCT01503385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64818813|NCT01503385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818814|NCT01503385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64818815|NCT01503385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64818826|NCT01503398|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64818827|NCT01503398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65287322|NCT00652730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65287323|NCT00652730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287324|NCT00652730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65287325|NCT00652730|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65287326|NCT00652730|Serotonin Agents|serotonin agents|mesh-ancestor
65287327|NCT00652730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64818828|NCT01503398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64818829|NCT01503398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64818830|NCT01503398|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64818831|NCT01503398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64818832|NCT01503398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64818833|NCT01503398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818834|NCT01503398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64818835|NCT01503398|Serotonin Agents|serotonin agents|mesh-ancestor
64818837|NCT01503424|Antiemetics|antiemetics|mesh-ancestor
64818838|NCT01503424|Autonomic Agents|autonomic agents|mesh-ancestor
64818839|NCT01503424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64818840|NCT01503424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818841|NCT01503424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64818842|NCT01503424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64818843|NCT01503424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64818844|NCT01503424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64818845|NCT01503424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64818846|NCT01503424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64818847|NCT01503424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64818848|NCT01503424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64818849|NCT01503424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818850|NCT01503424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64818851|NCT01503424|Serotonin Agents|serotonin agents|mesh-ancestor
64818852|NCT01503437|Olanzapine|olanzapine|mesh-list
64818853|NCT01503437|Antiemetics|antiemetics|mesh-ancestor
64818854|NCT01503437|Autonomic Agents|autonomic agents|mesh-ancestor
64818855|NCT01503437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64818856|NCT01503437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818857|NCT01503437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64818858|NCT01503437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64818859|NCT01503437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64818860|NCT01503437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64818861|NCT01503437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64818862|NCT01503437|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64818863|NCT01503437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64818874|NCT01503450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64818875|NCT01503450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64818876|NCT01503450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64818877|NCT01503450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64818878|NCT01503450|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64818896|NCT01503580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818897|NCT01503580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818900|NCT01503593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64818901|NCT01503593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818902|NCT01503658|Aspirin|aspirin|mesh-list
64818903|NCT01503658|Clopidogrel|clopidogrel|mesh-list
65494523|NCT00219557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818904|NCT01503658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64818905|NCT01503658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64818906|NCT01503658|Analgesics|analgesics|mesh-ancestor
64818907|NCT01503658|Sensory System Agents|sensory system agents|mesh-ancestor
64818908|NCT01503658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64818909|NCT01503658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818910|NCT01503658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64818911|NCT01503658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64818912|NCT01503658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64818913|NCT01503658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64818914|NCT01503658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818915|NCT01503658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65287328|NCT00652730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287329|NCT00652808|Naproxen|naproxen|mesh-list
65287330|NCT00652808|Valdecoxib|valdecoxib|mesh-list
65287331|NCT00652808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65287332|NCT00652808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65287333|NCT00652808|Analgesics|analgesics|mesh-ancestor
64818916|NCT01503658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64818917|NCT01503658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818918|NCT01503658|Antipyretics|antipyretics|mesh-ancestor
64818919|NCT01503658|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64818920|NCT01503658|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64818921|NCT01503658|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64818922|NCT01503658|Purinergic Agents|purinergic agents|mesh-ancestor
64818923|NCT01503658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64818924|NCT01503671|Atorvastatin|atorvastatin|mesh-list
64818925|NCT01503671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64818926|NCT01503671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64818927|NCT01503671|Antimetabolites|antimetabolites|mesh-ancestor
64818928|NCT01503671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818929|NCT01503671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64818930|NCT01503671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64818931|NCT01503671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818932|NCT01503736|Citric Acid|citric acid|mesh-list
64818933|NCT01503736|Sodium Citrate|sodium citrate|mesh-list
64818946|NCT01503788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64818947|NCT01503788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64818948|NCT01503788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64818949|NCT01503788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64818950|NCT01503788|Anesthetics, General|anesthetics, general|mesh-ancestor
64818953|NCT01503788|GABA Agents|gaba agents|mesh-ancestor
64818954|NCT01503788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64818955|NCT01503788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818956|NCT01503801|Nitric Oxide|nitric oxide|mesh-list
64818957|NCT01503801|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-list
64818984|NCT01503905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64818985|NCT01503905|Tubulin Modulators|tubulin modulators|mesh-ancestor
64818986|NCT01503905|Antimitotic Agents|antimitotic agents|mesh-ancestor
64818987|NCT01503905|Mitosis Modulators|mitosis modulators|mesh-ancestor
64818988|NCT01503905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64818989|NCT01503905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64818990|NCT01503905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64818991|NCT01503905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64818992|NCT01503905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494524|NCT00219557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64818993|NCT01503905|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64818994|NCT01503905|Hormone Antagonists|hormone antagonists|mesh-ancestor
64818995|NCT01503905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64818996|NCT01503905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64430140|NCT02514551|Ramucirumab|ramucirumab|mesh-list
64819004|NCT01503918|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64819005|NCT01503918|Antiviral Agents|antiviral agents|mesh-ancestor
64819006|NCT01503918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64819007|NCT01503918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64819008|NCT01503918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64819009|NCT01503918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819010|NCT01503983|Capecitabine|capecitabine|mesh-list
64493046|NCT01893281|Hormones|hormones|mesh-ancestor
64819027|NCT01504074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819029|NCT01504074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64819030|NCT01504074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64819031|NCT01504074|Adrenergic Agents|adrenergic agents|mesh-ancestor
64819032|NCT01504074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64819033|NCT01504074|Sympatholytics|sympatholytics|mesh-ancestor
64819034|NCT01504074|Autonomic Agents|autonomic agents|mesh-ancestor
64819035|NCT01504126|Propranolol|propranolol|mesh-list
64819036|NCT01504126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64819037|NCT01504126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64819038|NCT01504126|Adrenergic Agents|adrenergic agents|mesh-ancestor
64819039|NCT01504126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65287334|NCT00652808|Sensory System Agents|sensory system agents|mesh-ancestor
65287335|NCT00652808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65287336|NCT00652808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287337|NCT00652808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65287338|NCT00652808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64819040|NCT01504126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819041|NCT01504126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819042|NCT01504126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64819043|NCT01504126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64819044|NCT01504126|Vasodilator Agents|vasodilator agents|mesh-ancestor
64819045|NCT01504139|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64819046|NCT01504139|Estradiol|estradiol|mesh-list
64819047|NCT01504139|Progesterone|progesterone|mesh-list
64819048|NCT01504139|Estrogens|estrogens|mesh-ancestor
64819049|NCT01504139|Hormones|hormones|mesh-ancestor
64819050|NCT01504139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64819051|NCT01504139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819052|NCT01504139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64819053|NCT01504139|Progestins|progestins|mesh-ancestor
64819054|NCT01504178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64819055|NCT01504178|Levodopa|levodopa|mesh-list
64819056|NCT01504178|Apomorphine|apomorphine|mesh-list
64819057|NCT01504178|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
64819058|NCT01504178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64819059|NCT01504178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64819060|NCT01504178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64819061|NCT01504178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819062|NCT01504178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64819063|NCT01504178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819082|NCT01504256|Levoleucovorin|levoleucovorin|mesh-list
64819083|NCT01504256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819084|NCT01504256|Tubulin Modulators|tubulin modulators|mesh-ancestor
64819110|NCT01504321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64819111|NCT01504334|Pirfenidone|pirfenidone|mesh-list
64819112|NCT01504334|Analgesics|analgesics|mesh-ancestor
64819113|NCT01504334|Sensory System Agents|sensory system agents|mesh-ancestor
64819114|NCT01504334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64819115|NCT01504334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819116|NCT01504334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64819117|NCT01504334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64819118|NCT01504334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64819119|NCT01504334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64819120|NCT01504334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819121|NCT01504347|Vaccines|vaccines|mesh-list
64819122|NCT01504347|Immunologic Factors|immunologic factors|mesh-ancestor
64819123|NCT01504347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819124|NCT01504386|Ropivacaine|ropivacaine|mesh-list
64819125|NCT01504386|Anesthetics, Local|anesthetics, local|mesh-ancestor
64430271|NCT02507375|Pertuzumab|pertuzumab|mesh-list
64819147|NCT01504516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64819148|NCT01504516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819150|NCT01504542|Vaccines|vaccines|mesh-list
64819151|NCT01504542|Immunologic Factors|immunologic factors|mesh-ancestor
64819152|NCT01504542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819153|NCT01504581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64819184|NCT01504724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819185|NCT01504724|Growth Inhibitors|growth inhibitors|mesh-ancestor
64819186|NCT01504776|Bortezomib|bortezomib|mesh-list
65494525|NCT05282940|Levonorgestrel|levonorgestrel|mesh-list
65494526|NCT05282940|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65494527|NCT05282940|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64819187|NCT01504776|Panobinostat|panobinostat|mesh-list
64819188|NCT01504776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819189|NCT01504776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64819190|NCT01504776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64819191|NCT01504776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819192|NCT01504828|Ramipril|ramipril|mesh-list
64819193|NCT01504828|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64819194|NCT01504828|Protease Inhibitors|protease inhibitors|mesh-ancestor
64819195|NCT01504828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037326|NCT00585091|Oxymetazoline|oxymetazoline|mesh-list
65287339|NCT00652808|Gout Suppressants|gout suppressants|mesh-ancestor
65287340|NCT00652808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65287341|NCT00652808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65287342|NCT00652808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287343|NCT00652808|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65287344|NCT00635531|Alprazolam|alprazolam|mesh-list
65287345|NCT00635531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65287346|NCT00635531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64819196|NCT01504828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819197|NCT01504828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64819198|NCT01504906|Cyclosporine|cyclosporine|mesh-list
64819199|NCT01504906|Ticagrelor|ticagrelor|mesh-list
64819200|NCT01504906|Cyclosporins|cyclosporins|mesh-list
64819201|NCT01504906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64819202|NCT01504906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819203|NCT01504906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64493212|NCT03870399|Tamoxifen|tamoxifen|mesh-list
64819214|NCT01504906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64819215|NCT01504906|Purinergic Agents|purinergic agents|mesh-ancestor
64819216|NCT01504906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64819217|NCT01504984|Imatinib Mesylate|imatinib mesylate|mesh-list
64819218|NCT01504984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819219|NCT01504984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64819220|NCT01504984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64819221|NCT01504984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819222|NCT01505049|Vaccines|vaccines|mesh-list
64819223|NCT01505049|Immunologic Factors|immunologic factors|mesh-ancestor
64819224|NCT01505049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819225|NCT01505088|Benzalkonium Compounds|benzalkonium compounds|mesh-list
64819226|NCT01505088|Dexamethasone|dexamethasone|mesh-list
64819227|NCT01505088|Prednisolone|prednisolone|mesh-list
64819228|NCT01505088|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64819229|NCT01505088|Methylprednisolone|methylprednisolone|mesh-list
64819230|NCT01505088|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64819231|NCT01505088|Prednisolone acetate|prednisolone acetate|mesh-list
64819232|NCT01505088|Citric Acid|citric acid|mesh-list
64819233|NCT01505088|Sodium Citrate|sodium citrate|mesh-list
64819234|NCT01505088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64819235|NCT01505088|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64819236|NCT01505088|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64819237|NCT01505088|Prednisolone phosphate|prednisolone phosphate|mesh-list
64819238|NCT01505088|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64819239|NCT01505088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64819240|NCT01505088|Antiemetics|antiemetics|mesh-ancestor
64819241|NCT01505088|Autonomic Agents|autonomic agents|mesh-ancestor
64819242|NCT01505088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64819243|NCT01505088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819244|NCT01505088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64819245|NCT01505088|Glucocorticoids|glucocorticoids|mesh-ancestor
64819246|NCT01505088|Hormones|hormones|mesh-ancestor
64819247|NCT01505088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64430375|NCT04207619|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64819258|NCT01505088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64819260|NCT01505127|Clarithromycin|clarithromycin|mesh-list
64819261|NCT01505127|Lansoprazole|lansoprazole|mesh-list
64819262|NCT01505127|Dexlansoprazole|dexlansoprazole|mesh-list
64819263|NCT01505127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64819264|NCT01505127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64819265|NCT01505127|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64819266|NCT01505127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64819267|NCT01505127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819268|NCT01505127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64819269|NCT01505127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64819270|NCT01505127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64819271|NCT01505127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64819272|NCT01505127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65287347|NCT00635531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287348|NCT00635531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65287349|NCT00635531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65287350|NCT00635531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65287351|NCT00635531|GABA Modulators|gaba modulators|mesh-ancestor
65287352|NCT00635531|GABA Agents|gaba agents|mesh-ancestor
65287353|NCT00635531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65287354|NCT00635531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287355|NCT02535156|Risperidone|risperidone|mesh-list
65287356|NCT02535156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65287357|NCT02535156|Serotonin Agents|serotonin agents|mesh-ancestor
65287358|NCT02535156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65287359|NCT02535156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287360|NCT02535156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287361|NCT02535156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65287362|NCT02535156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65287363|NCT02535156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65287364|NCT02535156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65287365|NCT02535156|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65287366|NCT02535156|Dopamine Agents|dopamine agents|mesh-ancestor
65287367|NCT03417895|Apatinib|apatinib|mesh-list
65287368|NCT03417895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287369|NCT03417895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65287370|NCT03417895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517630|NCT00907101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64819273|NCT01505218|Propofol|propofol|mesh-list
64819274|NCT01505218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64819275|NCT01505218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64819276|NCT01505218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819277|NCT01505218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64819278|NCT01505218|Anesthetics, General|anesthetics, general|mesh-ancestor
64819292|NCT01505231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64819293|NCT01505231|Hemostatics|hemostatics|mesh-ancestor
64819294|NCT01505231|Coagulants|coagulants|mesh-ancestor
64819295|NCT01505231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64819296|NCT01505231|Natriuretic Agents|natriuretic agents|mesh-ancestor
64819298|NCT01505283|Sufentanil|sufentanil|mesh-list
64819299|NCT01505283|Anesthetics, Local|anesthetics, local|mesh-ancestor
64819300|NCT01505283|Anesthetics|anesthetics|mesh-ancestor
64819301|NCT01505283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64819302|NCT01505283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819303|NCT01505283|Sensory System Agents|sensory system agents|mesh-ancestor
64819304|NCT01505283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64819305|NCT01505283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64819306|NCT01505283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64819307|NCT01505283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64819308|NCT01505283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64819309|NCT01505283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819310|NCT01505283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64819311|NCT01505283|Narcotics|narcotics|mesh-ancestor
65287371|NCT03417895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287372|NCT05299164|Gemcitabine|gemcitabine|mesh-list
65287373|NCT05299164|Rituximab|rituximab|mesh-list
65287374|NCT05299164|Vinorelbine|vinorelbine|mesh-list
65287375|NCT05299164|Mitoxantrone|mitoxantrone|mesh-list
65287376|NCT05299164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64819312|NCT01505283|Analgesics|analgesics|mesh-ancestor
64819313|NCT01505283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64819322|NCT01505413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819324|NCT01505413|Antiviral Agents|antiviral agents|mesh-ancestor
64819325|NCT01505413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64819326|NCT01505413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64819327|NCT01505413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64819328|NCT01505413|Immunologic Factors|immunologic factors|mesh-ancestor
64819329|NCT01505413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819330|NCT01505413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64819331|NCT01505426|Metformin|metformin|mesh-list
64819332|NCT01505426|Ipragliflozin|ipragliflozin|mesh-list
64819333|NCT01505426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64819334|NCT01505426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819335|NCT01505426|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64819336|NCT01505426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819337|NCT01505439|Solifenacin Succinate|solifenacin succinate|mesh-list
64819338|NCT01505439|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64819339|NCT01505439|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64819340|NCT01505439|Cholinergic Agents|cholinergic agents|mesh-ancestor
64819341|NCT01505439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64819342|NCT01505439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819343|NCT01505439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819344|NCT01505439|Urological Agents|urological agents|mesh-ancestor
64819345|NCT01505504|Mirtazapine|mirtazapine|mesh-list
64819346|NCT01505504|Antidepressive Agents|antidepressive agents|mesh-ancestor
64819347|NCT01505504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64819348|NCT01505504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64819349|NCT01505504|Histamine Antagonists|histamine antagonists|mesh-ancestor
64819361|NCT01505504|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64819362|NCT01505504|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64819363|NCT01505504|Serotonin Agents|serotonin agents|mesh-ancestor
64819364|NCT01505504|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64819365|NCT01505777|Mosapride|mosapride|mesh-list
64819366|NCT01505777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64819367|NCT01505777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64819368|NCT01505777|Serotonin Agents|serotonin agents|mesh-ancestor
64819369|NCT01505777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64819370|NCT01505777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819371|NCT01505777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819372|NCT01505790|Clopidogrel|clopidogrel|mesh-list
64819373|NCT01505790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64819374|NCT01505790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64819375|NCT01505790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64819376|NCT01505790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64819377|NCT01505790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64819378|NCT01505790|Purinergic Agents|purinergic agents|mesh-ancestor
64819393|NCT01505920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819394|NCT01505920|Sensory System Agents|sensory system agents|mesh-ancestor
64819395|NCT01505920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64819396|NCT01505920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64819397|NCT01505920|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64819398|NCT01505920|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64819399|NCT01505920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64819400|NCT01505920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819401|NCT01505946|Thrombin|thrombin|mesh-list
64819402|NCT01505946|Hemostatics|hemostatics|mesh-ancestor
64819403|NCT01505946|Coagulants|coagulants|mesh-ancestor
64819404|NCT01505998|Amlodipine|amlodipine|mesh-list
64819405|NCT01505998|Benazepril|benazepril|mesh-list
64819406|NCT01505998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64819407|NCT01505998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65287377|NCT05299164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287378|NCT05299164|Immunologic Factors|immunologic factors|mesh-ancestor
65287379|NCT05299164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287380|NCT05299164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65287381|NCT05299164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65287382|NCT05299164|Antimetabolites|antimetabolites|mesh-ancestor
65287383|NCT05299164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287384|NCT05299164|Antiviral Agents|antiviral agents|mesh-ancestor
65287385|NCT05299164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65287386|NCT05299164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65287387|NCT05299164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65287388|NCT05299164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65287389|NCT05299164|Tubulin Modulators|tubulin modulators|mesh-ancestor
65287390|NCT05299164|Antimitotic Agents|antimitotic agents|mesh-ancestor
65287391|NCT05299164|Mitosis Modulators|mitosis modulators|mesh-ancestor
65287392|NCT05299164|Analgesics|analgesics|mesh-ancestor
65287393|NCT05299164|Sensory System Agents|sensory system agents|mesh-ancestor
65287394|NCT05299164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64819408|NCT01505998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64819409|NCT01505998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819410|NCT01505998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64819411|NCT01505998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819412|NCT01505998|Vasodilator Agents|vasodilator agents|mesh-ancestor
64819413|NCT01505998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64819414|NCT01505998|Protease Inhibitors|protease inhibitors|mesh-ancestor
64819415|NCT01505998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64819416|NCT01506011|Amlodipine|amlodipine|mesh-list
64819417|NCT01506011|Benazepril|benazepril|mesh-list
64819418|NCT01506011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64819419|NCT01506011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64819420|NCT01506011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64819421|NCT01506011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819422|NCT01506011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64493370|NCT05155137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64819455|NCT01506050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64819456|NCT01506050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64819457|NCT01506050|Histamine Antagonists|histamine antagonists|mesh-ancestor
64819459|NCT01506063|Levocetirizine|levocetirizine|mesh-list
64819460|NCT01506063|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64819461|NCT01506063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64819462|NCT01506063|Histamine Antagonists|histamine antagonists|mesh-ancestor
64819463|NCT01506063|Histamine Agents|histamine agents|mesh-ancestor
64819464|NCT01506063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64819465|NCT01506063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819466|NCT01506063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819467|NCT01506076|Levocetirizine|levocetirizine|mesh-list
64819468|NCT01506076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64819469|NCT01506076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64588073|NCT00535925|Aspirin|aspirin|mesh-list
64819470|NCT01506076|Histamine Antagonists|histamine antagonists|mesh-ancestor
64819471|NCT01506076|Histamine Agents|histamine agents|mesh-ancestor
64819472|NCT01506076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64819473|NCT01506076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819474|NCT01506076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287395|NCT05299164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65287396|NCT05299164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65287397|NCT01563835|Fentanyl|fentanyl|mesh-list
65287398|NCT01563835|Bupivacaine|bupivacaine|mesh-list
65287399|NCT01563835|Citric Acid|citric acid|mesh-list
65287400|NCT01563835|Sodium Citrate|sodium citrate|mesh-list
65287401|NCT01563835|Anesthetics, Local|anesthetics, local|mesh-ancestor
65287402|NCT01563835|Anesthetics|anesthetics|mesh-ancestor
65287403|NCT01563835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65287404|NCT01563835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287405|NCT01563835|Sensory System Agents|sensory system agents|mesh-ancestor
64517674|NCT02454348|Hemostatics|hemostatics|mesh-ancestor
64819475|NCT01506115|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
64819476|NCT01506115|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
64819477|NCT01506115|Trioxsalen|trioxsalen|mesh-list
64819478|NCT01506115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819479|NCT01506115|Dermatologic Agents|dermatologic agents|mesh-ancestor
64819480|NCT01506115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64819481|NCT01506167|Leucovorin|leucovorin|mesh-list
64819482|NCT01506167|Folic Acid|folic acid|mesh-list
64819483|NCT01506167|Bevacizumab|bevacizumab|mesh-list
64819484|NCT01506167|Fluorouracil|fluorouracil|mesh-list
64819485|NCT01506167|Capecitabine|capecitabine|mesh-list
64819486|NCT01506167|Oxaliplatin|oxaliplatin|mesh-list
64819487|NCT01506167|Irinotecan|irinotecan|mesh-list
64819488|NCT01506167|Levoleucovorin|levoleucovorin|mesh-list
64819489|NCT01506167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64819490|NCT01506167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819491|NCT01506167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64819505|NCT01506167|Protective Agents|protective agents|mesh-ancestor
64819506|NCT01506167|Vitamin B Complex|vitamin b complex|mesh-ancestor
64819507|NCT01506167|Vitamins|vitamins|mesh-ancestor
64819508|NCT01506167|Micronutrients|micronutrients|mesh-ancestor
64819509|NCT01506167|Hematinics|hematinics|mesh-ancestor
64819510|NCT01506336|Sunitinib|sunitinib|mesh-list
64819511|NCT01506336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819512|NCT01506336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64819513|NCT01506336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64819514|NCT01506336|Growth Substances|growth substances|mesh-ancestor
64819515|NCT01506336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819516|NCT01506336|Growth Inhibitors|growth inhibitors|mesh-ancestor
64819517|NCT01506336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64819518|NCT01506336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64819519|NCT01506336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819520|NCT01506388|Misoprostol|misoprostol|mesh-list
64819521|NCT01506388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64819522|NCT01506388|Abortifacient Agents|abortifacient agents|mesh-ancestor
64819523|NCT01506388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64819524|NCT01506388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819525|NCT01506388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64819526|NCT01506388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64819527|NCT01506388|Oxytocics|oxytocics|mesh-ancestor
64819528|NCT01506414|Rituximab|rituximab|mesh-list
64819529|NCT01506414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64819530|NCT01506414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819531|NCT01506414|Immunologic Factors|immunologic factors|mesh-ancestor
64819532|NCT01506414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819533|NCT01506414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64819534|NCT01506505|Aspirin|aspirin|mesh-list
64819535|NCT01506505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64819536|NCT01506505|Lisinopril|lisinopril|mesh-list
64819537|NCT01506505|Simvastatin|simvastatin|mesh-list
64819538|NCT01506505|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64819539|NCT01506505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64819540|NCT01506505|Antimetabolites|antimetabolites|mesh-ancestor
64819541|NCT01506505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819542|NCT01506505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64819543|NCT01506505|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65287406|NCT01563835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65287407|NCT01563835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65287408|NCT01563835|Narcotics|narcotics|mesh-ancestor
65287409|NCT01563835|Analgesics|analgesics|mesh-ancestor
65287410|NCT01563835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65287411|NCT01563835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65287412|NCT01563835|Anesthetics, General|anesthetics, general|mesh-ancestor
65287413|NCT01563835|Anticoagulants|anticoagulants|mesh-ancestor
65287414|NCT01563835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65287415|NCT01563835|Chelating Agents|chelating agents|mesh-ancestor
65287416|NCT01563835|Sequestering Agents|sequestering agents|mesh-ancestor
65287417|NCT01563835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287418|NCT02768207|Vemurafenib|vemurafenib|mesh-list
65287419|NCT02768207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819544|NCT01506505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64819545|NCT01506505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64588159|NCT00435929|Ritonavir|ritonavir|mesh-list
64819546|NCT01506505|Diuretics|diuretics|mesh-ancestor
64819548|NCT01506505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819549|NCT01506505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64819550|NCT01506505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64819551|NCT01506505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64819552|NCT01506505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64819553|NCT01506505|Analgesics|analgesics|mesh-ancestor
64819554|NCT01506505|Sensory System Agents|sensory system agents|mesh-ancestor
64819555|NCT01506505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64819556|NCT01506505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64819557|NCT01506505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64819558|NCT01506505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64819559|NCT01506505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64819560|NCT01506505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64819561|NCT01506505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64819562|NCT01506505|Antipyretics|antipyretics|mesh-ancestor
64819563|NCT01506505|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64819591|NCT01506622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64819592|NCT01506622|Narcotics|narcotics|mesh-ancestor
64819593|NCT01506622|Analgesics|analgesics|mesh-ancestor
64819594|NCT01506622|Sensory System Agents|sensory system agents|mesh-ancestor
64819595|NCT01506622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64819596|NCT01506622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64819597|NCT01506635|Timolol|timolol|mesh-list
64819598|NCT01506635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64819599|NCT01506635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64819600|NCT01506635|Adrenergic Agents|adrenergic agents|mesh-ancestor
64819601|NCT01506635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64819602|NCT01506635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819603|NCT01506635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819604|NCT01506635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64819605|NCT01506635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64819606|NCT01506713|Clopidogrel|clopidogrel|mesh-list
64819607|NCT01506713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64819608|NCT01506713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64819609|NCT01506713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64819610|NCT01506713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64819611|NCT01506713|Purinergic Agents|purinergic agents|mesh-ancestor
64819612|NCT01506713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64819613|NCT01506713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819614|NCT01506713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819615|NCT01506739|Donepezil|donepezil|mesh-list
64819616|NCT01506739|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64819617|NCT01506739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65287420|NCT02768207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65287421|NCT02768207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65287422|NCT02768207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287423|NCT02653196|Cyclosporine|cyclosporine|mesh-list
65287424|NCT02653196|Mycophenolic Acid|mycophenolic acid|mesh-list
65287425|NCT02653196|Fludarabine|fludarabine|mesh-list
65287426|NCT02653196|Etoposide|etoposide|mesh-list
65287427|NCT02653196|Melphalan|melphalan|mesh-list
65287428|NCT02653196|Alemtuzumab|alemtuzumab|mesh-list
64819618|NCT01506739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819619|NCT01506739|Cholinergic Agents|cholinergic agents|mesh-ancestor
64588228|NCT03595046|Dexamethasone|dexamethasone|mesh-list
64819620|NCT01506739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64819621|NCT01506739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819622|NCT01506739|Nootropic Agents|nootropic agents|mesh-ancestor
64819624|NCT01506752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64819643|NCT01506791|Pseudoephedrine|pseudoephedrine|mesh-list
64819645|NCT01506791|Desloratadine|desloratadine|mesh-list
64819646|NCT01506791|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64819647|NCT01506791|Cholinergic Agents|cholinergic agents|mesh-ancestor
64819648|NCT01506791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64819649|NCT01506791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819650|NCT01506791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819651|NCT01506791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64819652|NCT01506791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64819653|NCT01506791|Histamine Antagonists|histamine antagonists|mesh-ancestor
64819654|NCT01506791|Histamine Agents|histamine agents|mesh-ancestor
64819655|NCT01506791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64819656|NCT01506791|Autonomic Agents|autonomic agents|mesh-ancestor
64819657|NCT01506791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64819658|NCT01506791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64819659|NCT01506791|Respiratory System Agents|respiratory system agents|mesh-ancestor
64819660|NCT01506791|Nasal Decongestants|nasal decongestants|mesh-ancestor
64819661|NCT01506791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64493542|NCT04276545|Anesthetics|anesthetics|mesh-ancestor
64819674|NCT01506804|Autonomic Agents|autonomic agents|mesh-ancestor
64819675|NCT01506804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64819676|NCT01506804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819677|NCT01506804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64819678|NCT01506804|Glucocorticoids|glucocorticoids|mesh-ancestor
64819679|NCT01506804|Hormones|hormones|mesh-ancestor
64819680|NCT01506804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64819681|NCT01506804|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64819708|NCT01507064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64819709|NCT01507064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64819710|NCT01507064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819712|NCT01507077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64819713|NCT01507077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64819714|NCT01507077|Growth Substances|growth substances|mesh-ancestor
64819715|NCT01507077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819716|NCT01507077|Growth Inhibitors|growth inhibitors|mesh-ancestor
64819717|NCT01507077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819718|NCT01507194|Ondansetron|ondansetron|mesh-list
64819719|NCT01507194|Vestipitant|vestipitant|mesh-list
64819720|NCT01507194|Antiemetics|antiemetics|mesh-ancestor
64819721|NCT01507194|Autonomic Agents|autonomic agents|mesh-ancestor
64819722|NCT01507194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64819723|NCT01507194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819724|NCT01507194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64819725|NCT01507194|Antipruritics|antipruritics|mesh-ancestor
64819726|NCT01507194|Dermatologic Agents|dermatologic agents|mesh-ancestor
64819727|NCT01507194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64819728|NCT01507194|Serotonin Agents|serotonin agents|mesh-ancestor
64819745|NCT01507285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819746|NCT01507285|Incretins|incretins|mesh-ancestor
64819747|NCT01507285|Hormones|hormones|mesh-ancestor
64819748|NCT01507285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65287429|NCT02653196|Thiotepa|thiotepa|mesh-list
65287430|NCT02653196|Tacrolimus|tacrolimus|mesh-list
65287431|NCT02653196|Cyclosporins|cyclosporins|mesh-list
65287432|NCT02653196|Mitogens|mitogens|mesh-list
65287433|NCT02653196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287434|NCT02653196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819749|NCT01507311|Liraglutide|liraglutide|mesh-list
64819750|NCT01507311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64819751|NCT01507311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819752|NCT01507311|Incretins|incretins|mesh-ancestor
64819753|NCT01507311|Hormones|hormones|mesh-ancestor
64819754|NCT01507311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64819755|NCT01507337|Liraglutide|liraglutide|mesh-list
64819756|NCT01507337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64819757|NCT01507337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819758|NCT01507337|Incretins|incretins|mesh-ancestor
64819759|NCT01507337|Hormones|hormones|mesh-ancestor
64819760|NCT01507337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64819761|NCT01507363|Gabapentin|gabapentin|mesh-list
64819762|NCT01507363|Analgesics|analgesics|mesh-ancestor
64819763|NCT01507363|Sensory System Agents|sensory system agents|mesh-ancestor
64819764|NCT01507363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64819765|NCT01507363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819766|NCT01507363|Anticonvulsants|anticonvulsants|mesh-ancestor
64819767|NCT01507363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64819768|NCT01507363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64588383|NCT05630222|Acetaminophen|acetaminophen|mesh-list
64819808|NCT01507467|Nimorazole|nimorazole|mesh-list
64819809|NCT01507467|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64819810|NCT01507467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64819811|NCT01507467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64819812|NCT01507467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64819813|NCT01507480|Bevacizumab|bevacizumab|mesh-list
64819814|NCT01507480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64819815|NCT01507480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819816|NCT01507480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64819817|NCT01507480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64819818|NCT01507480|Growth Substances|growth substances|mesh-ancestor
64819819|NCT01507480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819820|NCT01507480|Growth Inhibitors|growth inhibitors|mesh-ancestor
64819821|NCT01507519|Sirolimus|sirolimus|mesh-list
64819822|NCT01507519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64819823|NCT01507519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64819824|NCT01507519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64819825|NCT01507519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819826|NCT01507519|Antifungal Agents|antifungal agents|mesh-ancestor
64819827|NCT01507519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64819828|NCT01507519|Immunologic Factors|immunologic factors|mesh-ancestor
64819829|NCT01507519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819830|NCT01507558|Dexamethasone|dexamethasone|mesh-list
64819831|NCT01507558|Dexamethasone acetate|dexamethasone acetate|mesh-list
64819832|NCT01507558|BB 1101|bb 1101|mesh-list
64819882|NCT01507740|Growth Inhibitors|growth inhibitors|mesh-ancestor
64819883|NCT01507740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64819884|NCT01507740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64819885|NCT01507740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819886|NCT01507792|Loratadine|loratadine|mesh-list
64819887|NCT01507792|Omeprazole|omeprazole|mesh-list
64819888|NCT01507792|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64819889|NCT01507792|Histamine|histamine|mesh-list
64819890|NCT01507792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64819891|NCT01507792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64819892|NCT01507792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64819893|NCT01507792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819894|NCT01507792|Antipruritics|antipruritics|mesh-ancestor
64819895|NCT01507792|Dermatologic Agents|dermatologic agents|mesh-ancestor
64819896|NCT01507792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64819897|NCT01507792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64819898|NCT01507792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64431043|NCT01645111|Clevidipine|clevidipine|mesh-list
64819908|NCT01507922|Parasympatholytics|parasympatholytics|mesh-ancestor
64819909|NCT01507922|Autonomic Agents|autonomic agents|mesh-ancestor
64819910|NCT01507922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65287435|NCT02653196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65287436|NCT02653196|Immunologic Factors|immunologic factors|mesh-ancestor
65287437|NCT02653196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287438|NCT02653196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65287439|NCT02653196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65287440|NCT02653196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65287441|NCT02653196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64819926|NCT01507974|Antimalarials|antimalarials|mesh-ancestor
64819927|NCT01507974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64819928|NCT01507974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64819929|NCT01507974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64819930|NCT01507974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64819931|NCT01507974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819932|NCT01507974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64819933|NCT01507974|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64819934|NCT01507974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64819935|NCT01507974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64819936|NCT01508000|Bevacizumab|bevacizumab|mesh-list
64819937|NCT01508000|Panitumumab|panitumumab|mesh-list
64819938|NCT01508000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64819939|NCT01508000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819940|NCT01508000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64819941|NCT01508000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64819942|NCT01508000|Growth Substances|growth substances|mesh-ancestor
64819943|NCT01508000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819944|NCT01508000|Growth Inhibitors|growth inhibitors|mesh-ancestor
64819946|NCT01508104|Dactolisib|dactolisib|mesh-list
64819947|NCT01508104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819948|NCT01508104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64819949|NCT01508104|Immunologic Factors|immunologic factors|mesh-ancestor
64819950|NCT01508104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819951|NCT01507610|Sumatriptan|sumatriptan|mesh-list
64819952|NCT01507610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64819953|NCT01507610|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64819954|NCT01507610|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64819955|NCT01507610|Serotonin Agents|serotonin agents|mesh-ancestor
64819956|NCT01507610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64472696|NCT02981628|Vincristine|vincristine|mesh-list
64472697|NCT02981628|Asparaginase|asparaginase|mesh-list
64472698|NCT02981628|Pegaspargase|pegaspargase|mesh-list
64472699|NCT02981628|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
64472700|NCT02981628|Calcium|calcium|mesh-list
64472701|NCT02981628|Levoleucovorin|levoleucovorin|mesh-list
64472708|NCT02981628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472710|NCT02981628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64472711|NCT02981628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64472712|NCT02981628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64472713|NCT02981628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64472714|NCT02981628|Abortifacient Agents|abortifacient agents|mesh-ancestor
64472715|NCT02981628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64472716|NCT02981628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64472717|NCT02981628|Antimetabolites|antimetabolites|mesh-ancestor
64472718|NCT02981628|Dermatologic Agents|dermatologic agents|mesh-ancestor
64472719|NCT02981628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472728|NCT02981628|Micronutrients|micronutrients|mesh-ancestor
64559510|NCT00004547|Paclitaxel|paclitaxel|mesh-list
64819957|NCT01507610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819958|NCT01507610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819959|NCT01508143|Misoprostol|misoprostol|mesh-list
64819960|NCT01508143|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64819961|NCT01508143|Abortifacient Agents|abortifacient agents|mesh-ancestor
64819962|NCT01508143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64819963|NCT01508143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819964|NCT01508143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64819965|NCT01508143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64819966|NCT01508143|Oxytocics|oxytocics|mesh-ancestor
64819967|NCT01508182|Metformin|metformin|mesh-list
65287442|NCT02653196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65287443|NCT02653196|Antifungal Agents|antifungal agents|mesh-ancestor
65287444|NCT02653196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65287445|NCT02653196|Dermatologic Agents|dermatologic agents|mesh-ancestor
65287446|NCT02653196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65287447|NCT02653196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65287448|NCT02653196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65287449|NCT02653196|Antitubercular Agents|antitubercular agents|mesh-ancestor
65287450|NCT02653196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65287451|NCT02653196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65287452|NCT02653196|Alkylating Agents|alkylating agents|mesh-ancestor
65287453|NCT02653196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65287454|NCT02653196|Mitosis Modulators|mitosis modulators|mesh-ancestor
65287455|NCT02653196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65287456|NCT05135845|Spartalizumab|spartalizumab|mesh-list
65287457|NCT05135845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65287458|NCT05135845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287459|NCT05135845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287460|NCT04479436|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
65287461|NCT04479436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65287462|NCT04479436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287463|NCT00677118|Cisplatin|cisplatin|mesh-list
65287464|NCT00677118|Fluorouracil|fluorouracil|mesh-list
65287465|NCT00677118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287466|NCT00677118|Antimetabolites|antimetabolites|mesh-ancestor
65287467|NCT00677118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287468|NCT00677118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65287469|NCT00677118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65287470|NCT00677118|Immunologic Factors|immunologic factors|mesh-ancestor
65287471|NCT00677118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287472|NCT02644226|Sevoflurane|sevoflurane|mesh-list
65287473|NCT02644226|Desflurane|desflurane|mesh-list
65287474|NCT02644226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65287475|NCT02644226|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64819977|NCT01508195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64819978|NCT01508195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819979|NCT01508221|Vitamin E|vitamin e|mesh-list
64819980|NCT01508221|Pentoxifylline|pentoxifylline|mesh-list
64819981|NCT01508221|Vitamins|vitamins|mesh-ancestor
65287476|NCT02644226|Anesthetics, General|anesthetics, general|mesh-ancestor
65287477|NCT02644226|Anesthetics|anesthetics|mesh-ancestor
65287478|NCT02644226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65287479|NCT02644226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287480|NCT02753855|Telavancin|telavancin|mesh-list
65287481|NCT02753855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65287482|NCT02753855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65287483|NCT04166383|Nivolumab|nivolumab|mesh-list
65287484|NCT04166383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65287485|NCT04166383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287486|NCT04166383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65287487|NCT04166383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287488|NCT02758691|Insulin|insulin|mesh-list
65287489|NCT02758691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65287490|NCT02758691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287491|NCT00714376|Docetaxel|docetaxel|mesh-list
65287492|NCT00714376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287493|NCT00714376|Tubulin Modulators|tubulin modulators|mesh-ancestor
64517755|NCT03244488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517756|NCT03244488|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64517761|NCT01969708|Bevacizumab|bevacizumab|mesh-list
64819982|NCT01508221|Micronutrients|micronutrients|mesh-ancestor
64819983|NCT01508221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819984|NCT01508221|Antioxidants|antioxidants|mesh-ancestor
64819985|NCT01508221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819986|NCT01508221|Protective Agents|protective agents|mesh-ancestor
64819987|NCT01508221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64819988|NCT01508221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494528|NCT05282940|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
65494529|NCT05282940|Estradiol|estradiol|mesh-list
65494530|NCT05282940|Estrogens|estrogens|mesh-ancestor
65494531|NCT05282940|Hormones|hormones|mesh-ancestor
65494532|NCT05282940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65494533|NCT05282940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494534|NCT05282940|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65494535|NCT05282940|Contraceptive Agents|contraceptive agents|mesh-ancestor
65494536|NCT05282940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65494537|NCT05282940|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65494538|NCT05282940|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65494539|NCT05282940|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65494540|NCT05282940|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65494541|NCT05282940|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65494542|NCT05282940|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
65494543|NCT05282940|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65494544|NCT05282940|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65494545|NCT01238562|Lenograstim|lenograstim|mesh-list
65494546|NCT01238562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65494547|NCT01238562|Immunologic Factors|immunologic factors|mesh-ancestor
65494548|NCT01238562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494549|NCT01329666|Vitamin D|vitamin d|mesh-list
65494550|NCT01329666|Cholecalciferol|cholecalciferol|mesh-list
65494551|NCT01329666|Vitamins|vitamins|mesh-ancestor
65494552|NCT01329666|Micronutrients|micronutrients|mesh-ancestor
65037479|NCT00216528|Dopamine Agents|dopamine agents|mesh-ancestor
65287494|NCT00714376|Antimitotic Agents|antimitotic agents|mesh-ancestor
65287495|NCT00714376|Mitosis Modulators|mitosis modulators|mesh-ancestor
65287496|NCT00714376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287498|NCT04068766|Anesthetics, Local|anesthetics, local|mesh-ancestor
65287499|NCT04068766|Anesthetics|anesthetics|mesh-ancestor
65287500|NCT04068766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65287501|NCT04068766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287502|NCT04068766|Sensory System Agents|sensory system agents|mesh-ancestor
65287503|NCT04068766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65287504|NCT03267199|Fibrinolytic Agents|fibrinolytic agents|mesh-list
65287505|NCT03267199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65287506|NCT03267199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287507|NCT04725695|Lidocaine|lidocaine|mesh-list
65287508|NCT04725695|Anesthetics, Local|anesthetics, local|mesh-ancestor
65287509|NCT04725695|Anesthetics|anesthetics|mesh-ancestor
65287510|NCT04725695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65287511|NCT04725695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287512|NCT04725695|Sensory System Agents|sensory system agents|mesh-ancestor
65287513|NCT04725695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65287514|NCT04725695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65287515|NCT04725695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65287516|NCT04725695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64517772|NCT03254784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65494553|NCT01329666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559586|NCT00006101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64819989|NCT01508221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64819990|NCT01508221|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64819991|NCT01508221|Vasodilator Agents|vasodilator agents|mesh-ancestor
64819992|NCT01508221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64819993|NCT01508260|Furosemide|furosemide|mesh-list
64819994|NCT01508260|Diuretics|diuretics|mesh-ancestor
64819995|NCT01508260|Natriuretic Agents|natriuretic agents|mesh-ancestor
64819996|NCT01508260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820009|NCT01508364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820011|NCT01508429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64820012|NCT01508429|Abortifacient Agents|abortifacient agents|mesh-ancestor
64820013|NCT01508429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64820014|NCT01508429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820015|NCT01508429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64820016|NCT01508429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64820017|NCT01508429|Oxytocics|oxytocics|mesh-ancestor
64820018|NCT01508468|Rituximab|rituximab|mesh-list
64820019|NCT01508468|Angiotensin II|angiotensin ii|mesh-list
64820020|NCT01508468|Giapreza|giapreza|mesh-list
64820021|NCT01508468|Calcium|calcium|mesh-list
64820022|NCT01508468|Diuretics|diuretics|mesh-list
64820023|NCT01508468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64820024|NCT01508468|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64517796|NCT03250494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287517|NCT04725695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65287518|NCT04725695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287519|NCT04151472|Ubiquinone|ubiquinone|mesh-list
65287520|NCT04151472|Idebenone|idebenone|mesh-list
65287521|NCT04151472|Antioxidants|antioxidants|mesh-ancestor
65287522|NCT04151472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287523|NCT04151472|Protective Agents|protective agents|mesh-ancestor
65287524|NCT04151472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287525|NCT04151472|Micronutrients|micronutrients|mesh-ancestor
65287526|NCT04123795|Certolizumab Pegol|certolizumab pegol|mesh-list
65287527|NCT04123795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65287528|NCT04123795|Immunologic Factors|immunologic factors|mesh-ancestor
65287529|NCT04123795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287530|NCT04123795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65287531|NCT04070794|Metformin|metformin|mesh-list
65287532|NCT04070794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65287533|NCT04070794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287534|NCT02695901|Chlorhexidine|chlorhexidine|mesh-list
65287535|NCT02695901|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65287536|NCT02695901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65287537|NCT02695901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65287538|NCT02695901|Disinfectants|disinfectants|mesh-ancestor
65287539|NCT02695901|Dermatologic Agents|dermatologic agents|mesh-ancestor
65287540|NCT00677664|Glatiramer Acetate|glatiramer acetate|mesh-list
65287541|NCT00677664|Mannitol|mannitol|mesh-list
65287542|NCT00677664|(T,G)-A-L|(t,g)-a-l|mesh-list
65287543|NCT00677664|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64517797|NCT03250494|Protease Inhibitors|protease inhibitors|mesh-ancestor
64517798|NCT03250494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64820025|NCT01508468|Angiotensinogen|angiotensinogen|mesh-list
64820026|NCT01508468|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
64820027|NCT01508468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64820028|NCT01508468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820029|NCT01508468|Immunologic Factors|immunologic factors|mesh-ancestor
64820030|NCT01508468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820031|NCT01508468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64820032|NCT01508468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64820033|NCT01508468|Natriuretic Agents|natriuretic agents|mesh-ancestor
64820034|NCT01508468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64820043|NCT01508468|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64820044|NCT01508494|Galantamine|galantamine|mesh-list
64820045|NCT01508494|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64820046|NCT01508494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64820047|NCT01508494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820048|NCT01508494|Cholinergic Agents|cholinergic agents|mesh-ancestor
65287544|NCT00677664|Diuretics|diuretics|mesh-ancestor
65287545|NCT00677664|Natriuretic Agents|natriuretic agents|mesh-ancestor
65287546|NCT00677664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287547|NCT00677664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65287548|NCT00677664|Immunologic Factors|immunologic factors|mesh-ancestor
65287549|NCT00677664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65287550|NCT00677664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64820049|NCT01508494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64820050|NCT01508494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820051|NCT01508494|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64820052|NCT01508494|Autonomic Agents|autonomic agents|mesh-ancestor
64820053|NCT01508494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64820054|NCT01508494|Nootropic Agents|nootropic agents|mesh-ancestor
64820055|NCT01508572|Bevacizumab|bevacizumab|mesh-list
64820056|NCT01508572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64820057|NCT01508572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820058|NCT01508572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64820059|NCT01508572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64820060|NCT01508572|Growth Substances|growth substances|mesh-ancestor
64820061|NCT01508572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820062|NCT01508572|Growth Inhibitors|growth inhibitors|mesh-ancestor
64820063|NCT01508611|Fluorides|fluorides|mesh-list
64820064|NCT01508611|Cariostatic Agents|cariostatic agents|mesh-ancestor
64820065|NCT01508611|Protective Agents|protective agents|mesh-ancestor
64820066|NCT01508611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820067|NCT01508637|Terazosin|terazosin|mesh-list
64820081|NCT01508663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820082|NCT01508663|Protease Inhibitors|protease inhibitors|mesh-ancestor
64820083|NCT01508663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64820084|NCT01508663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820085|NCT01508741|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64820086|NCT01508741|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64820087|NCT01508741|Dermatologic Agents|dermatologic agents|mesh-ancestor
64820088|NCT01508806|Liraglutide|liraglutide|mesh-list
64820089|NCT01508806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64820090|NCT01508806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820091|NCT01508806|Incretins|incretins|mesh-ancestor
64820092|NCT01508806|Hormones|hormones|mesh-ancestor
64820093|NCT01508806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64820094|NCT01508845|Vitamin D|vitamin d|mesh-list
64820095|NCT01508845|Ergocalciferols|ergocalciferols|mesh-list
64820096|NCT01508845|Cholecalciferol|cholecalciferol|mesh-list
64820097|NCT01508845|Vitamins|vitamins|mesh-list
64820098|NCT01508845|Micronutrients|micronutrients|mesh-ancestor
64820099|NCT01508845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820126|NCT01508897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64820127|NCT01508897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820128|NCT01508897|Incretins|incretins|mesh-ancestor
64820130|NCT01508897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64820131|NCT01508923|Liraglutide|liraglutide|mesh-list
64820132|NCT01508923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64820133|NCT01508923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820134|NCT01508923|Incretins|incretins|mesh-ancestor
64820135|NCT01508923|Hormones|hormones|mesh-ancestor
64820136|NCT01508923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64820137|NCT01508949|Liraglutide|liraglutide|mesh-list
64820138|NCT01508949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64820139|NCT01508949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820140|NCT01508949|Incretins|incretins|mesh-ancestor
64820141|NCT01508949|Hormones|hormones|mesh-ancestor
64820142|NCT01508949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64820143|NCT01509001|Metformin|metformin|mesh-list
64820144|NCT01509001|Glimepiride|glimepiride|mesh-list
64820145|NCT01509001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64820146|NCT01509001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588772|NCT03590444|Ranibizumab|ranibizumab|mesh-list
64820147|NCT01509001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64431290|NCT01615822|Artefenomel|artefenomel|mesh-list
64820160|NCT01509209|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64820161|NCT01509209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65287551|NCT02572492|Dexamethasone|dexamethasone|mesh-list
65287552|NCT02572492|Dexamethasone acetate|dexamethasone acetate|mesh-list
65287553|NCT02572492|Melphalan|melphalan|mesh-list
65287554|NCT02572492|BB 1101|bb 1101|mesh-list
65287555|NCT02572492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65287556|NCT02572492|Antiemetics|antiemetics|mesh-ancestor
65287557|NCT02572492|Autonomic Agents|autonomic agents|mesh-ancestor
65287558|NCT02572492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65287559|NCT02572492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287560|NCT02572492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65287561|NCT02572492|Glucocorticoids|glucocorticoids|mesh-ancestor
65287562|NCT02572492|Hormones|hormones|mesh-ancestor
65287563|NCT02572492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65287564|NCT02572492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65287565|NCT02572492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287566|NCT02572492|Protease Inhibitors|protease inhibitors|mesh-ancestor
64820162|NCT01509209|Histamine Antagonists|histamine antagonists|mesh-ancestor
64820163|NCT01509209|Histamine Agents|histamine agents|mesh-ancestor
64820164|NCT01509209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64820191|NCT01509300|Immunologic Factors|immunologic factors|mesh-ancestor
64820192|NCT01509300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820193|NCT01509300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64820194|NCT01509300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64820195|NCT01509300|Alkylating Agents|alkylating agents|mesh-ancestor
64820196|NCT01509300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820197|NCT01509300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820198|NCT01509300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64820199|NCT01509300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64820200|NCT01509300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64820201|NCT01509300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64820202|NCT01509300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64820203|NCT01509300|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64820204|NCT01509300|Antitubercular Agents|antitubercular agents|mesh-ancestor
64820205|NCT01509300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64820206|NCT01509300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64820207|NCT01509365|Clopidogrel|clopidogrel|mesh-list
64820208|NCT01509365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64820209|NCT01509365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64820210|NCT01509365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64820246|NCT01509521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64820248|NCT01509560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820249|NCT01509560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64820250|NCT01509560|Immunologic Factors|immunologic factors|mesh-ancestor
64820251|NCT01509560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820252|NCT01509599|Methyl salicylate|methyl salicylate|mesh-list
64820253|NCT01509599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64820254|NCT01509742|Liraglutide|liraglutide|mesh-list
64820255|NCT01509742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64820256|NCT01509742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820257|NCT01509742|Incretins|incretins|mesh-ancestor
64820258|NCT01509742|Hormones|hormones|mesh-ancestor
64820259|NCT01509742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64820260|NCT01509755|Liraglutide|liraglutide|mesh-list
64820261|NCT01509755|Glimepiride|glimepiride|mesh-list
64820262|NCT01509755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64820263|NCT01509755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820264|NCT01509755|Incretins|incretins|mesh-ancestor
64820265|NCT01509755|Hormones|hormones|mesh-ancestor
64820266|NCT01509755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65037558|NCT00216606|Topiramate|topiramate|mesh-list
65287567|NCT02572492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65287568|NCT02572492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287569|NCT02572492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65287570|NCT02572492|Alkylating Agents|alkylating agents|mesh-ancestor
65287571|NCT02572492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65287572|NCT02572492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65287573|NCT02572492|Immunologic Factors|immunologic factors|mesh-ancestor
65287574|NCT02753387|Chlorhexidine|chlorhexidine|mesh-list
65287575|NCT02753387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65287576|NCT02753387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65287577|NCT02753387|Disinfectants|disinfectants|mesh-ancestor
65287578|NCT00672282|Bicalutamide|bicalutamide|mesh-list
65287579|NCT00672282|Androgen Antagonists|androgen antagonists|mesh-ancestor
65287580|NCT00672282|Hormone Antagonists|hormone antagonists|mesh-ancestor
65287581|NCT00672282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65287582|NCT00672282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287583|NCT00672282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287584|NCT02753309|Sirolimus|sirolimus|mesh-list
65287585|NCT02753309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65287586|NCT02753309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65287587|NCT02753309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65287588|NCT02753309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287589|NCT02753309|Antifungal Agents|antifungal agents|mesh-ancestor
64517829|NCT03250338|Immunologic Factors|immunologic factors|mesh-ancestor
64820267|NCT01509755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64820268|NCT01509755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64820269|NCT01509755|Immunologic Factors|immunologic factors|mesh-ancestor
64820270|NCT01509911|Gemcitabine|gemcitabine|mesh-list
64820295|NCT01510015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820296|NCT01510015|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64820297|NCT01510015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64820298|NCT01510015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64820299|NCT01510015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64820300|NCT01510015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64820301|NCT01510015|Dopamine Agents|dopamine agents|mesh-ancestor
64820302|NCT01510093|Insulin Aspart|insulin aspart|mesh-list
64820303|NCT01510093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64820304|NCT01510093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820305|NCT01510132|Timolol|timolol|mesh-list
64820306|NCT01510132|Travoprost|travoprost|mesh-list
64820307|NCT01510132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64820308|NCT01510132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64820309|NCT01510132|Adrenergic Agents|adrenergic agents|mesh-ancestor
64820310|NCT01510132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64820311|NCT01510132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820312|NCT01510132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820313|NCT01510132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64820314|NCT01510132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64820315|NCT01510171|Ticagrelor|ticagrelor|mesh-list
65287590|NCT02753309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65287591|NCT02753309|Immunologic Factors|immunologic factors|mesh-ancestor
65287592|NCT02753309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287593|NCT04147728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
65287594|NCT04147728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65287595|NCT04147728|Growth Substances|growth substances|mesh-ancestor
65287596|NCT04147728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517853|NCT02355886|Gabapentin|gabapentin|mesh-list
64572912|NCT03040830|Hormones|hormones|mesh-ancestor
64820316|NCT01510171|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64820317|NCT01510171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64820318|NCT01510171|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64820319|NCT01510171|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64820320|NCT01510171|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64820321|NCT01510171|Purinergic Agents|purinergic agents|mesh-ancestor
64820322|NCT01510171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64820323|NCT01510171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820324|NCT01510171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820325|NCT01510288|Ipilimumab|ipilimumab|mesh-list
64820326|NCT01510288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64820327|NCT01510288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820328|NCT01510288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64820329|NCT01510288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820330|NCT01510366|Vaccines|vaccines|mesh-list
64820331|NCT01510366|Immunologic Factors|immunologic factors|mesh-ancestor
64820332|NCT01510366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820333|NCT01510431|Remestemcel-l|remestemcel-l|mesh-list
64820334|NCT01510431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64820335|NCT01510431|Antiviral Agents|antiviral agents|mesh-ancestor
64820336|NCT01510431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64820337|NCT01510509|Everolimus|everolimus|mesh-list
64820338|NCT01510509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820339|NCT01510509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64820340|NCT01510509|Immunologic Factors|immunologic factors|mesh-ancestor
64820349|NCT01510561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64820350|NCT01510561|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
64820351|NCT01510561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64820352|NCT01510561|Antimetabolites|antimetabolites|mesh-ancestor
64820353|NCT01510561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820354|NCT01510561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494104|NCT01039792|Vitamin B 12|vitamin b 12|mesh-list
64820386|NCT01510613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64820387|NCT01510613|Growth Substances|growth substances|mesh-ancestor
64820388|NCT01510613|Growth Inhibitors|growth inhibitors|mesh-ancestor
64820389|NCT01510626|Omalizumab|omalizumab|mesh-list
64820390|NCT01510626|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64820391|NCT01510626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64820392|NCT01510626|Respiratory System Agents|respiratory system agents|mesh-ancestor
64820393|NCT01510665|Magnesium citrate|magnesium citrate|mesh-list
64820394|NCT01510665|Cathartics|cathartics|mesh-ancestor
64820395|NCT01510665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64820396|NCT01510795|Spironolactone|spironolactone|mesh-list
64820397|NCT01510795|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64820398|NCT01510795|Hormone Antagonists|hormone antagonists|mesh-ancestor
64820399|NCT01510795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64820400|NCT01510795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494158|NCT01043926|Suvorexant|suvorexant|mesh-list
64820420|NCT01510990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820422|NCT01511003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64820423|NCT01511003|Immunologic Factors|immunologic factors|mesh-ancestor
64820424|NCT01511003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820425|NCT01511003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64820426|NCT01511003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64820427|NCT01511003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287597|NCT04147728|Growth Inhibitors|growth inhibitors|mesh-ancestor
65287598|NCT04147728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287599|NCT04544189|Fulvestrant|fulvestrant|mesh-list
65287600|NCT04544189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65287601|NCT04544189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287602|NCT04544189|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65287603|NCT04544189|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65287604|NCT04544189|Hormone Antagonists|hormone antagonists|mesh-ancestor
65287605|NCT04544189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65287606|NCT04544189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287607|NCT04330690|Artesunate|artesunate|mesh-list
65287608|NCT04330690|Dexamethasone|dexamethasone|mesh-list
65287609|NCT04330690|Imatinib Mesylate|imatinib mesylate|mesh-list
65287610|NCT04330690|Infliximab|infliximab|mesh-list
65287611|NCT04330690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65287612|NCT04330690|Antiemetics|antiemetics|mesh-ancestor
65287613|NCT04330690|Autonomic Agents|autonomic agents|mesh-ancestor
65287614|NCT04330690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65287615|NCT04330690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287616|NCT04330690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65287617|NCT04330690|Glucocorticoids|glucocorticoids|mesh-ancestor
65287618|NCT04330690|Hormones|hormones|mesh-ancestor
65287619|NCT04330690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65287620|NCT04330690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65287621|NCT04330690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287622|NCT04330690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65287623|NCT04330690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65287624|NCT04330690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820428|NCT01511029|Moxifloxacin|moxifloxacin|mesh-list
64820429|NCT01511029|Pramipexole|pramipexole|mesh-list
64820430|NCT01511029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64820431|NCT01511029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64820432|NCT01511029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64820433|NCT01511029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64820434|NCT01511029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64820435|NCT01511029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820436|NCT01511029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820437|NCT01511029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820438|NCT01511029|Antioxidants|antioxidants|mesh-ancestor
64820439|NCT01511029|Protective Agents|protective agents|mesh-ancestor
64820440|NCT01511029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64820441|NCT01511029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64820442|NCT01511029|Dopamine Agonists|dopamine agonists|mesh-ancestor
64820443|NCT01511029|Dopamine Agents|dopamine agents|mesh-ancestor
64820444|NCT01511029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64820445|NCT01511146|Gemcitabine|gemcitabine|mesh-list
65287625|NCT04330690|Dermatologic Agents|dermatologic agents|mesh-ancestor
65287626|NCT04330690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65287627|NCT04330690|Antimalarials|antimalarials|mesh-ancestor
65287628|NCT04330690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65287629|NCT04330690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65287630|NCT04330690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65287631|NCT04330690|Antiviral Agents|antiviral agents|mesh-ancestor
65287632|NCT04330690|Schistosomicides|schistosomicides|mesh-ancestor
65287633|NCT04330690|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65287634|NCT04330690|Anthelmintics|anthelmintics|mesh-ancestor
65287635|NCT03083041|Apatinib|apatinib|mesh-list
65287636|NCT03083041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287637|NCT03083041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65287638|NCT03083041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65287639|NCT03083041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287640|NCT00672360|Folic Acid|folic acid|mesh-list
65287641|NCT00672360|Hematinics|hematinics|mesh-ancestor
65287642|NCT00672360|Vitamin B Complex|vitamin b complex|mesh-ancestor
65287643|NCT00672360|Vitamins|vitamins|mesh-ancestor
65287644|NCT00672360|Micronutrients|micronutrients|mesh-ancestor
65287645|NCT00672360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287646|NCT02628522|Lidocaine|lidocaine|mesh-list
65287647|NCT02628522|Epinephrine|epinephrine|mesh-list
65287648|NCT02628522|Anesthetics, Local|anesthetics, local|mesh-ancestor
65287649|NCT02628522|Anesthetics|anesthetics|mesh-ancestor
65287650|NCT02628522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65287651|NCT02628522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287652|NCT02628522|Sensory System Agents|sensory system agents|mesh-ancestor
65287653|NCT02628522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65287654|NCT02628522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65287655|NCT02628522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65287656|NCT02628522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65287657|NCT02628522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65287658|NCT02628522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287659|NCT02628522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64517917|NCT04773717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287666|NCT02628522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65287667|NCT02628522|Respiratory System Agents|respiratory system agents|mesh-ancestor
65287668|NCT02628522|Mydriatics|mydriatics|mesh-ancestor
65287669|NCT02628522|Sympathomimetics|sympathomimetics|mesh-ancestor
65287670|NCT02628522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65287671|NCT02572336|Plasminogen|plasminogen|mesh-list
65287672|NCT02572336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65287673|NCT02572336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65287674|NCT02572336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65287675|NCT02572336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287677|NCT02750969|Anesthetics, Local|anesthetics, local|mesh-ancestor
65287678|NCT02750969|Anesthetics|anesthetics|mesh-ancestor
64820446|NCT01511146|Oxaliplatin|oxaliplatin|mesh-list
64820447|NCT01511146|Mitomycins|mitomycins|mesh-list
64820448|NCT01511146|Mitomycin|mitomycin|mesh-list
64820449|NCT01511146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64820450|NCT01511146|Antimetabolites|antimetabolites|mesh-ancestor
64820451|NCT01511146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820452|NCT01511146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820453|NCT01511146|Antiviral Agents|antiviral agents|mesh-ancestor
64820454|NCT01511146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64820455|NCT01511146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64820456|NCT01511146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64820457|NCT01511146|Immunologic Factors|immunologic factors|mesh-ancestor
64820458|NCT01511146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820459|NCT01511146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64820460|NCT01511146|Alkylating Agents|alkylating agents|mesh-ancestor
64820461|NCT01511146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64820462|NCT01511159|Insulin|insulin|mesh-list
64820463|NCT01511159|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64820464|NCT01511159|Liraglutide|liraglutide|mesh-list
64820465|NCT01511159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64820466|NCT01511159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820467|NCT01511159|Incretins|incretins|mesh-ancestor
64820468|NCT01511159|Hormones|hormones|mesh-ancestor
64820469|NCT01511159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64820470|NCT01511172|Metformin|metformin|mesh-list
64820471|NCT01511172|Liraglutide|liraglutide|mesh-list
64820472|NCT01511172|Glimepiride|glimepiride|mesh-list
64820473|NCT01511172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64820474|NCT01511172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820475|NCT01511172|Incretins|incretins|mesh-ancestor
64820505|NCT01511211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64820507|NCT01511211|Anesthetics, Local|anesthetics, local|mesh-ancestor
64820508|NCT01511211|Anesthetics|anesthetics|mesh-ancestor
64820509|NCT01511211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64820510|NCT01511211|Sensory System Agents|sensory system agents|mesh-ancestor
64820511|NCT01511237|Lamivudine|lamivudine|mesh-list
64820512|NCT01511237|Zidovudine|zidovudine|mesh-list
64820513|NCT01511237|Nevirapine|nevirapine|mesh-list
64820514|NCT01511237|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64820515|NCT01511237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64820516|NCT01511237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64820517|NCT01511237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820518|NCT01511237|Antiviral Agents|antiviral agents|mesh-ancestor
64820519|NCT01511237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64820520|NCT01511237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64820521|NCT01511237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64820522|NCT01511237|Antimetabolites|antimetabolites|mesh-ancestor
64820523|NCT01511237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64820524|NCT01511237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64820525|NCT01511263|Amiodarone|amiodarone|mesh-list
64820526|NCT01511263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64820527|NCT01511263|Diuretics|diuretics|mesh-list
65287679|NCT02750969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65287680|NCT02750969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287681|NCT02750969|Sensory System Agents|sensory system agents|mesh-ancestor
65287682|NCT02750969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65287683|NCT02750969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65287684|NCT02750969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65287685|NCT02750969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65287686|NCT02750969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64517927|NCT03243006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64517928|NCT03243006|Analgesics|analgesics|mesh-ancestor
64820528|NCT01511263|Natriuretic Agents|natriuretic agents|mesh-ancestor
64820529|NCT01511263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820530|NCT01511263|Vasodilator Agents|vasodilator agents|mesh-ancestor
64820531|NCT01511263|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64820532|NCT01511263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64820533|NCT01511263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820534|NCT01511263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64820558|NCT01511302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64820560|NCT01511302|Analgesics|analgesics|mesh-ancestor
64820561|NCT01511302|Sensory System Agents|sensory system agents|mesh-ancestor
64820562|NCT01511302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64820563|NCT01511302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64820564|NCT01511367|Fluticasone|fluticasone|mesh-list
64820565|NCT01511367|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64820566|NCT01511367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64820567|NCT01511367|Autonomic Agents|autonomic agents|mesh-ancestor
64820568|NCT01511367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64820569|NCT01511367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820570|NCT01511367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64820571|NCT01511367|Respiratory System Agents|respiratory system agents|mesh-ancestor
64820572|NCT01511367|Glucocorticoids|glucocorticoids|mesh-ancestor
64820573|NCT01511367|Hormones|hormones|mesh-ancestor
64820574|NCT01511367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64820575|NCT01511367|Sympathomimetics|sympathomimetics|mesh-ancestor
64820576|NCT01511367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64820577|NCT01511367|Dermatologic Agents|dermatologic agents|mesh-ancestor
64820578|NCT01511367|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64820579|NCT01511471|Ticagrelor|ticagrelor|mesh-list
64820580|NCT01511471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64820581|NCT01511471|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64820582|NCT01511471|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64820599|NCT01511562|Antimetabolites|antimetabolites|mesh-ancestor
64820600|NCT01511562|Antiviral Agents|antiviral agents|mesh-ancestor
64820601|NCT01511562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64820612|NCT01511692|Glimepiride|glimepiride|mesh-list
64820613|NCT01511692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64820614|NCT01511692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820615|NCT01511692|Incretins|incretins|mesh-ancestor
64820617|NCT01511692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64820618|NCT01511692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64820619|NCT01511692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64820620|NCT01511692|Immunologic Factors|immunologic factors|mesh-ancestor
64820621|NCT01511705|Ondansetron|ondansetron|mesh-list
64820622|NCT01511705|Antiemetics|antiemetics|mesh-ancestor
64820623|NCT01511705|Autonomic Agents|autonomic agents|mesh-ancestor
64820624|NCT01511705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64820625|NCT01511705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820626|NCT01511705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64820627|NCT01511705|Antipruritics|antipruritics|mesh-ancestor
64820628|NCT01511705|Dermatologic Agents|dermatologic agents|mesh-ancestor
64820629|NCT01511705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64820630|NCT01511705|Serotonin Agents|serotonin agents|mesh-ancestor
64820631|NCT01511705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65287687|NCT02750969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287688|NCT04067011|Doxycycline|doxycycline|mesh-list
65287689|NCT04067011|Ciprofloxacin|ciprofloxacin|mesh-list
65287690|NCT04067011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65287691|NCT04067011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65287692|NCT04067011|Antimalarials|antimalarials|mesh-ancestor
65287693|NCT04067011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65287694|NCT04067011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65287695|NCT04067011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65287696|NCT04067011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65287697|NCT04067011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65287698|NCT04067011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287699|NCT04067011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287700|NCT04067011|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65287701|NCT04067011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65287702|NCT04044859|Pembrolizumab|pembrolizumab|mesh-list
65287703|NCT04044859|Nivolumab|nivolumab|mesh-list
65287704|NCT04044859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65287705|NCT04044859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287706|NCT04044859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65287707|NCT04044859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820632|NCT01511705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820633|NCT01511705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64820634|NCT01511705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64820635|NCT01511705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64820636|NCT01511705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64820637|NCT01511705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64820638|NCT01511718|Ondansetron|ondansetron|mesh-list
64820639|NCT01511718|Antiemetics|antiemetics|mesh-ancestor
64820640|NCT01511718|Autonomic Agents|autonomic agents|mesh-ancestor
64820641|NCT01511718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64820642|NCT01511718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820660|NCT01511731|Histamine Agents|histamine agents|mesh-ancestor
64820661|NCT01511731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64820662|NCT01511731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820663|NCT01511731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820664|NCT01511757|Fluconazole|fluconazole|mesh-list
64820665|NCT01511757|Antifungal Agents|antifungal agents|mesh-ancestor
64820666|NCT01511757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64820667|NCT01511757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64820668|NCT01511757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64820669|NCT01511757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64820670|NCT01511757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820671|NCT01511757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64820672|NCT01511757|Hormone Antagonists|hormone antagonists|mesh-ancestor
64820673|NCT01511757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64820674|NCT01511757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820675|NCT01511757|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64820676|NCT01511757|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64820677|NCT01511770|Fluconazole|fluconazole|mesh-list
65287708|NCT00719056|Ciprofloxacin|ciprofloxacin|mesh-list
65287709|NCT00719056|Lactams|lactams|mesh-list
65287710|NCT00719056|Cephalosporins|cephalosporins|mesh-list
65287711|NCT00719056|Teicoplanin|teicoplanin|mesh-list
65287712|NCT00719056|beta-Lactams|beta-lactams|mesh-list
65287713|NCT00719056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65287714|NCT00719056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65287715|NCT00719056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65287716|NCT00719056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65287717|NCT00719056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65287718|NCT00719056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287719|NCT00719056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037701|NCT00209781|Renal Agents|renal agents|mesh-ancestor
65287720|NCT00719056|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65287721|NCT00719056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65287722|NCT04469699|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65287723|NCT04469699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65287724|NCT04469699|Dermatologic Agents|dermatologic agents|mesh-ancestor
65287725|NCT03475004|Bevacizumab|bevacizumab|mesh-list
65287726|NCT03475004|Pembrolizumab|pembrolizumab|mesh-list
65287727|NCT03475004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65287728|NCT03475004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287729|NCT03475004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65287730|NCT03475004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65287731|NCT03475004|Growth Substances|growth substances|mesh-ancestor
64820678|NCT01511770|Antifungal Agents|antifungal agents|mesh-ancestor
64820679|NCT01511770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64820680|NCT01511770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64820681|NCT01511770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64494312|NCT02182492|Hormones|hormones|mesh-ancestor
64820688|NCT01511770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64820689|NCT01511770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64820692|NCT01511822|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64820693|NCT01511822|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64820694|NCT01511822|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64820695|NCT01511822|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
64820696|NCT01511822|Estradiol|estradiol|mesh-list
64820697|NCT01511822|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64820718|NCT01511835|Inositol|inositol|mesh-list
64820719|NCT01511835|Hematinics|hematinics|mesh-ancestor
64820720|NCT01511835|Vitamins|vitamins|mesh-ancestor
64820721|NCT01511835|Micronutrients|micronutrients|mesh-ancestor
64820722|NCT01511835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820723|NCT01511848|Deferasirox|deferasirox|mesh-list
64820724|NCT01511848|Deferiprone|deferiprone|mesh-list
64820725|NCT01511848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64820726|NCT01511848|Chelating Agents|chelating agents|mesh-ancestor
64820727|NCT01511848|Sequestering Agents|sequestering agents|mesh-ancestor
64820728|NCT01511848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820729|NCT01511874|Leuprolide|leuprolide|mesh-list
64820730|NCT01511874|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64820731|NCT01511874|Fertility Agents|fertility agents|mesh-ancestor
65287732|NCT03475004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287733|NCT03475004|Growth Inhibitors|growth inhibitors|mesh-ancestor
65287734|NCT02695745|Celecoxib|celecoxib|mesh-list
65287735|NCT02695745|Capsaicin|capsaicin|mesh-list
65287736|NCT02695745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65287737|NCT02695745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65287738|NCT02695745|Analgesics|analgesics|mesh-ancestor
65287739|NCT02695745|Sensory System Agents|sensory system agents|mesh-ancestor
65287740|NCT02695745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65287741|NCT02695745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287742|NCT02695745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64574031|NCT02117297|Gemtuzumab|gemtuzumab|mesh-list
64820732|NCT01511874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64820733|NCT01511874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820734|NCT01511874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64820735|NCT01511874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820736|NCT01511887|Ibuprofen|ibuprofen|mesh-list
64820737|NCT01511887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64820738|NCT01511887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64820739|NCT01511887|Analgesics|analgesics|mesh-ancestor
64820740|NCT01511887|Sensory System Agents|sensory system agents|mesh-ancestor
64820741|NCT01511887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64820742|NCT01511887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820743|NCT01511887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64820744|NCT01511887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64820745|NCT01511887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64820746|NCT01511887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64820747|NCT01511887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820748|NCT01511991|Sevoflurane|sevoflurane|mesh-list
64820749|NCT01511991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64557485|NCT02555007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820750|NCT01511991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64820751|NCT01511991|Anesthetics, General|anesthetics, general|mesh-ancestor
64820752|NCT01511991|Anesthetics|anesthetics|mesh-ancestor
64431891|NCT04963439|Macitentan|macitentan|mesh-list
64820773|NCT01512147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64820774|NCT01512147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64820775|NCT01512147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820776|NCT01512147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64820777|NCT01512147|Anesthetics, General|anesthetics, general|mesh-ancestor
64820778|NCT01512147|Anesthetics|anesthetics|mesh-ancestor
64820779|NCT01512147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64820780|NCT01512147|Analgesics|analgesics|mesh-ancestor
64820781|NCT01512147|Sensory System Agents|sensory system agents|mesh-ancestor
64820782|NCT01512147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64820783|NCT01512147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64820784|NCT01512147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64820785|NCT01512147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64820786|NCT01512147|Adrenergic Agents|adrenergic agents|mesh-ancestor
64820787|NCT01512147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64820796|NCT01512173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820797|NCT01512173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64820798|NCT01512173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64820799|NCT01512173|Vasodilator Agents|vasodilator agents|mesh-ancestor
64820800|NCT01512199|Paclitaxel|paclitaxel|mesh-list
64820801|NCT01512199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64820802|NCT01512199|Trastuzumab|trastuzumab|mesh-list
64820803|NCT01512199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64820804|NCT01512199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64820805|NCT01512199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820806|NCT01512199|Tubulin Modulators|tubulin modulators|mesh-ancestor
64820807|NCT01512199|Antimitotic Agents|antimitotic agents|mesh-ancestor
64820808|NCT01512199|Mitosis Modulators|mitosis modulators|mesh-ancestor
64820835|NCT01512459|Antidepressive Agents|antidepressive agents|mesh-ancestor
65287743|NCT02695745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65287744|NCT02695745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65287745|NCT02695745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65287746|NCT02695745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65287747|NCT02695745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287748|NCT02695745|Antipruritics|antipruritics|mesh-ancestor
65287749|NCT02695745|Dermatologic Agents|dermatologic agents|mesh-ancestor
65287750|NCT00990067|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65287751|NCT00990067|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65287752|NCT00990067|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65287753|NCT00990067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65287754|NCT00990067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65287755|NCT00990067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517994|NCT05605587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64820836|NCT01512459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64820837|NCT01512485|Clopidogrel|clopidogrel|mesh-list
64820838|NCT01512485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64820839|NCT01512485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64820840|NCT01512485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64820841|NCT01512485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64820842|NCT01512485|Purinergic Agents|purinergic agents|mesh-ancestor
64820843|NCT01512485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64820844|NCT01512485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820845|NCT01512485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820846|NCT01512511|Nitrous Oxide|nitrous oxide|mesh-list
64820847|NCT01512511|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64820848|NCT01512511|Anesthetics, General|anesthetics, general|mesh-ancestor
64820849|NCT01512511|Anesthetics|anesthetics|mesh-ancestor
64820859|NCT01512537|Vitamins|vitamins|mesh-list
64820860|NCT01512537|Micronutrients|micronutrients|mesh-ancestor
64820861|NCT01512537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820862|NCT01512537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64820863|NCT01512537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64820864|NCT01512628|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
64820865|NCT01512628|Plasma Substitutes|plasma substitutes|mesh-ancestor
64820866|NCT01512628|Blood Substitutes|blood substitutes|mesh-ancestor
64820867|NCT01512680|Insulin|insulin|mesh-list
64820868|NCT01512680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64820869|NCT01512680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820870|NCT01512784|Vaccines|vaccines|mesh-list
64820871|NCT01512784|Immunologic Factors|immunologic factors|mesh-ancestor
64820872|NCT01512784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820873|NCT01512862|Calcitriol|calcitriol|mesh-list
64820874|NCT01512862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64820875|NCT01512862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820876|NCT01512862|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64820877|NCT01512862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64820878|NCT01512862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820879|NCT01512862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64820880|NCT01512862|Vitamins|vitamins|mesh-ancestor
64820881|NCT01512862|Micronutrients|micronutrients|mesh-ancestor
64820882|NCT01512862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64820883|NCT01512901|Betamethasone|betamethasone|mesh-list
64820884|NCT01512901|Betamethasone Valerate|betamethasone valerate|mesh-list
64820885|NCT01512901|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64820886|NCT01512901|Betamethasone benzoate|betamethasone benzoate|mesh-list
64820887|NCT01512901|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65287756|NCT00990067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65287757|NCT00990067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287758|NCT00990067|Analgesics|analgesics|mesh-ancestor
65287759|NCT00990067|Sensory System Agents|sensory system agents|mesh-ancestor
65287760|NCT00990067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65287761|NCT00990067|Antidepressive Agents|antidepressive agents|mesh-ancestor
65287762|NCT00990067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65287763|NCT00990067|Dopamine Agents|dopamine agents|mesh-ancestor
65287764|NCT00990067|Hallucinogens|hallucinogens|mesh-ancestor
65287765|NCT00990067|Serotonin Agents|serotonin agents|mesh-ancestor
65287766|NCT00990067|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65287767|NCT00990067|Adrenergic Agents|adrenergic agents|mesh-ancestor
65287768|NCT00719290|Hyaluronic Acid|hyaluronic acid|mesh-list
65287769|NCT00719290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65287770|NCT00719290|Immunologic Factors|immunologic factors|mesh-ancestor
65287771|NCT00719290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287772|NCT00719290|Viscosupplements|viscosupplements|mesh-ancestor
65287773|NCT00719290|Protective Agents|protective agents|mesh-ancestor
65287774|NCT00635921|Ziprasidone|ziprasidone|mesh-list
65287775|NCT00635921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65287776|NCT00635921|Serotonin Agents|serotonin agents|mesh-ancestor
65287777|NCT00635921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65287778|NCT00635921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287779|NCT00635921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287780|NCT00635921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65287781|NCT00635921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65287782|NCT00635921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65287783|NCT00635921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65287784|NCT00635921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65287785|NCT00635921|Dopamine Agents|dopamine agents|mesh-ancestor
65287786|NCT04166006|Interleukin-2|interleukin-2|mesh-list
65287787|NCT04166006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287788|NCT04166006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64518010|NCT03253224|Tocolytic Agents|tocolytic agents|mesh-ancestor
64820904|NCT01512953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64820905|NCT01512953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64820906|NCT01512953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64820907|NCT01512953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64820908|NCT01512953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820910|NCT01512966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64820911|NCT01512966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64820912|NCT01512966|Growth Substances|growth substances|mesh-ancestor
65287789|NCT04166006|Analgesics|analgesics|mesh-ancestor
65287790|NCT04166006|Sensory System Agents|sensory system agents|mesh-ancestor
65287791|NCT04166006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65287792|NCT04166006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287793|NCT04069858|Entecavir|entecavir|mesh-list
65287794|NCT04069858|Antiviral Agents|antiviral agents|mesh-ancestor
65287795|NCT04069858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65287796|NCT00710086|Remifentanil|remifentanil|mesh-list
65287797|NCT00710086|Hydromorphone|hydromorphone|mesh-list
64518047|NCT04773093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64518048|NCT04773093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64518049|NCT04773093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64518051|NCT01720043|Bortezomib|bortezomib|mesh-list
64820913|NCT01512966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820914|NCT01512966|Growth Inhibitors|growth inhibitors|mesh-ancestor
64820915|NCT01512966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820938|NCT01513070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64820939|NCT01513070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64820940|NCT01513070|Analgesics|analgesics|mesh-ancestor
64820941|NCT01513070|Sensory System Agents|sensory system agents|mesh-ancestor
64820942|NCT01513070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64820943|NCT01513070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820944|NCT01513070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64820945|NCT01513070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64820946|NCT01513070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64820947|NCT01513070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64820948|NCT01513070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820949|NCT01513070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64820950|NCT01513070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64820951|NCT01513070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64820952|NCT01513070|Antipyretics|antipyretics|mesh-ancestor
64820953|NCT01513070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64820954|NCT01513070|Diuretics|diuretics|mesh-ancestor
64820955|NCT01513070|Natriuretic Agents|natriuretic agents|mesh-ancestor
64820956|NCT01513070|Vasodilator Agents|vasodilator agents|mesh-ancestor
64820957|NCT01513070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64820958|NCT01513083|Trastuzumab|trastuzumab|mesh-list
64820959|NCT01513083|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64820960|NCT01513083|Maytansine|maytansine|mesh-list
64820961|NCT01513083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64820962|NCT01513083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820963|NCT01513083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64820964|NCT01513083|Tubulin Modulators|tubulin modulators|mesh-ancestor
65494556|NCT05255484|Antibodies|antibodies|mesh-list
64560335|NCT01072773|Antiemetics|antiemetics|mesh-ancestor
64821008|NCT01513603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64821009|NCT01513603|Immunologic Factors|immunologic factors|mesh-ancestor
64821010|NCT01513603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821011|NCT01513603|Analgesics|analgesics|mesh-ancestor
64821012|NCT01513603|Sensory System Agents|sensory system agents|mesh-ancestor
64821013|NCT01513603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64821014|NCT01513603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64821015|NCT01513603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64821016|NCT01513603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821017|NCT01513668|Acetaminophen|acetaminophen|mesh-list
64821018|NCT01513668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64821019|NCT01513668|Analgesics|analgesics|mesh-ancestor
64821020|NCT01513668|Sensory System Agents|sensory system agents|mesh-ancestor
64821041|NCT01513720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64821042|NCT01513720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821043|NCT01513720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64821044|NCT01513720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64821045|NCT01513720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64821046|NCT01513720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65287798|NCT00710086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65287799|NCT00710086|Narcotics|narcotics|mesh-ancestor
65287800|NCT00710086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65287801|NCT00710086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287802|NCT00710086|Analgesics|analgesics|mesh-ancestor
65287803|NCT00710086|Sensory System Agents|sensory system agents|mesh-ancestor
65287804|NCT00710086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65287805|NCT00652886|Oxandrolone|oxandrolone|mesh-list
65287806|NCT00652886|Androgens|androgens|mesh-ancestor
65344912|NCT00736346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518054|NCT02455362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64821047|NCT01513720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64821048|NCT01513772|Dexmedetomidine|dexmedetomidine|mesh-list
64821049|NCT01513772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64821050|NCT01513772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64821051|NCT01513772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821052|NCT01513772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64821054|NCT01513772|Sensory System Agents|sensory system agents|mesh-ancestor
64821055|NCT01513772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64494514|NCT05164770|Hormones|hormones|mesh-ancestor
64821113|NCT01514110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821115|NCT01514123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64432269|NCT01650194|Prednisone|prednisone|mesh-list
64821147|NCT01514227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64821148|NCT01514227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821150|NCT01514227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64821151|NCT01514227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64821152|NCT01514227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64821153|NCT01514227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821154|NCT01514227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64821155|NCT01514227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64821156|NCT01514227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821187|NCT01514695|Sensory System Agents|sensory system agents|mesh-ancestor
64821188|NCT01514695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64821189|NCT01514695|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64821190|NCT01514695|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64821191|NCT01514695|Anesthetics, General|anesthetics, general|mesh-ancestor
64821192|NCT01514695|Anesthetics|anesthetics|mesh-ancestor
65494557|NCT05255484|Immunologic Factors|immunologic factors|mesh-ancestor
64821193|NCT01514695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64821194|NCT01514695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64821225|NCT01514825|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64821226|NCT01514825|Antithrombins|antithrombins|mesh-ancestor
64821227|NCT01514825|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64821228|NCT01514825|Protease Inhibitors|protease inhibitors|mesh-ancestor
64821229|NCT01514825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821230|NCT01514825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821231|NCT01514825|Anticoagulants|anticoagulants|mesh-ancestor
64821232|NCT01514838|Acarbose|acarbose|mesh-list
64821233|NCT01514838|Ipragliflozin|ipragliflozin|mesh-list
64821234|NCT01514838|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64821235|NCT01514838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821236|NCT01514838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821237|NCT01514838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64821238|NCT01514838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821239|NCT01514838|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64821240|NCT01514851|Calcium Carbonate|calcium carbonate|mesh-list
64821241|NCT01514851|Calcium|calcium|mesh-list
64821242|NCT01514851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64821243|NCT01514851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821244|NCT01514851|Antacids|antacids|mesh-ancestor
64821245|NCT01514851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821246|NCT01514851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65287808|NCT00652886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65287809|NCT00652886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287810|NCT00652886|Anabolic Agents|anabolic agents|mesh-ancestor
65287811|NCT00539305|Methyltestosterone|methyltestosterone|mesh-list
65287812|NCT00539305|Testosterone|testosterone|mesh-list
65287813|NCT00539305|Testosterone undecanoate|testosterone undecanoate|mesh-list
65287814|NCT00539305|Testosterone enanthate|testosterone enanthate|mesh-list
65287815|NCT00539305|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65287816|NCT00539305|Androgens|androgens|mesh-ancestor
65287817|NCT00539305|Hormones|hormones|mesh-ancestor
65287818|NCT00539305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65287819|NCT00539305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287820|NCT00539305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65287821|NCT00539305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287822|NCT00539305|Anabolic Agents|anabolic agents|mesh-ancestor
65287823|NCT02643914|Nicotine|nicotine|mesh-list
65287824|NCT02643914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65287825|NCT02643914|Autonomic Agents|autonomic agents|mesh-ancestor
65287826|NCT02643914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65287827|NCT02643914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287828|NCT02643914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65287829|NCT02643914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65287830|NCT02643914|Cholinergic Agents|cholinergic agents|mesh-ancestor
65287831|NCT02643914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65287832|NCT02643914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287833|NCT00715702|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
65287834|NCT00715702|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64821247|NCT01514903|Sildenafil Citrate|sildenafil citrate|mesh-list
64821248|NCT01514903|Vasodilator Agents|vasodilator agents|mesh-ancestor
64821249|NCT01514903|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64821250|NCT01514903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64821251|NCT01514903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821252|NCT01514903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821253|NCT01514903|Urological Agents|urological agents|mesh-ancestor
64821254|NCT01514929|Moxifloxacin|moxifloxacin|mesh-list
64821255|NCT01514929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64821256|NCT01514929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64821257|NCT01514929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64821258|NCT01514929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64821259|NCT01514929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432394|NCT02284243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64821290|NCT01514968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65287835|NCT00715702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287836|NCT00715702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65287837|NCT00715702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65287838|NCT00715702|Antiviral Agents|antiviral agents|mesh-ancestor
65287839|NCT00715702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65287840|NCT04808999|Pembrolizumab|pembrolizumab|mesh-list
64821291|NCT01514968|Antiviral Agents|antiviral agents|mesh-ancestor
64821292|NCT01514968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64821293|NCT01514968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64821294|NCT01514981|Mogamulizumab|mogamulizumab|mesh-list
64821295|NCT01514981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821296|NCT01515020|Vancomycin|vancomycin|mesh-list
64821297|NCT01515020|Daptomycin|daptomycin|mesh-list
64821298|NCT01515020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64821299|NCT01515020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64821300|NCT01515228|Paclitaxel|paclitaxel|mesh-list
64821301|NCT01515228|Everolimus|everolimus|mesh-list
64821302|NCT01515228|Cilostazol|cilostazol|mesh-list
64821303|NCT01515228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64472744|NCT02949128|Ravulizumab|ravulizumab|mesh-list
64472745|NCT02949128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64472746|NCT02949128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64472747|NCT02949128|Immunologic Factors|immunologic factors|mesh-ancestor
64472748|NCT02949128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472749|NCT02944617|Micronutrients|micronutrients|mesh-list
64472750|NCT02944617|Trace Elements|trace elements|mesh-list
64472751|NCT02944617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472752|NCT02923115|Enoxaparin|enoxaparin|mesh-list
64472753|NCT02923115|Anticoagulants|anticoagulants|mesh-ancestor
64472754|NCT02923115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64472755|NCT02923115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64472756|NCT02923115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472757|NCT02910583|Venetoclax|venetoclax|mesh-list
64472758|NCT02910583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472759|NCT02820857|Bevacizumab|bevacizumab|mesh-list
64472760|NCT02820857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64472761|NCT02820857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472762|NCT02820857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64472763|NCT02820857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64472764|NCT02820857|Growth Substances|growth substances|mesh-ancestor
64472765|NCT02820857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821348|NCT01515579|Hormones|hormones|mesh-ancestor
64821349|NCT01515579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64821350|NCT01515592|Liraglutide|liraglutide|mesh-list
64821376|NCT01515813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64821377|NCT01515813|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64821378|NCT01515813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64821379|NCT01515813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821380|NCT01515813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821382|NCT01515813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64821383|NCT01515813|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64821384|NCT01515813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64821385|NCT01515813|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64821386|NCT01515813|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64821387|NCT01515813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64821388|NCT01515813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64821389|NCT01515813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64821390|NCT01515813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64821391|NCT01515813|Antimetabolites|antimetabolites|mesh-ancestor
64821392|NCT01515813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64821393|NCT01515813|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64821394|NCT01515826|Moxifloxacin|moxifloxacin|mesh-list
64821395|NCT01515826|Dexamethasone|dexamethasone|mesh-list
64821396|NCT01515826|Dexamethasone acetate|dexamethasone acetate|mesh-list
64821397|NCT01515826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65494576|NCT01238718|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65494578|NCT01238718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65494579|NCT01238718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287841|NCT04808999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65287842|NCT04808999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287843|NCT05359939|Choline|choline|mesh-list
65287844|NCT05359939|Lipotropic Agents|lipotropic agents|mesh-ancestor
65287845|NCT05359939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65287846|NCT05359939|Antimetabolites|antimetabolites|mesh-ancestor
65287847|NCT05359939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287848|NCT05359939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65287849|NCT05359939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65287850|NCT05359939|Nootropic Agents|nootropic agents|mesh-ancestor
65287851|NCT00990223|Eplerenone|eplerenone|mesh-list
65287852|NCT00990223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65287853|NCT00990223|Hormone Antagonists|hormone antagonists|mesh-ancestor
65287854|NCT00990223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65287855|NCT00990223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287856|NCT00990223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65287857|NCT00990223|Diuretics|diuretics|mesh-ancestor
65287858|NCT00990223|Natriuretic Agents|natriuretic agents|mesh-ancestor
65287859|NCT00990223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65287860|NCT00715780|Insulin|insulin|mesh-list
65287861|NCT00715780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65287862|NCT00715780|Insulin Aspart|insulin aspart|mesh-list
65287863|NCT00715780|Insulin, Long-Acting|insulin, long-acting|mesh-list
65287864|NCT00715780|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65287865|NCT00715780|Insulin Detemir|insulin detemir|mesh-list
65287866|NCT00715780|Biphasic Insulins|biphasic insulins|mesh-list
65287867|NCT00715780|Isophane Insulin, Human|isophane insulin, human|mesh-list
65494580|NCT01238796|Telavancin|telavancin|mesh-list
64821441|NCT01515839|Cholinergic Agents|cholinergic agents|mesh-ancestor
64821442|NCT01515839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64821443|NCT01515839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64821444|NCT01515839|Antiviral Agents|antiviral agents|mesh-ancestor
64821445|NCT01515839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64821446|NCT01515839|Expectorants|expectorants|mesh-ancestor
64821447|NCT01515839|Respiratory System Agents|respiratory system agents|mesh-ancestor
64821448|NCT01515839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64821449|NCT01515839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64821450|NCT01515839|Vasodilator Agents|vasodilator agents|mesh-ancestor
64821451|NCT01515852|Anesthetics|anesthetics|mesh-list
64821452|NCT01515852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64821453|NCT01515852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821454|NCT01515917|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64821455|NCT01515917|Nootropic Agents|nootropic agents|mesh-ancestor
64821456|NCT01515969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64821457|NCT01515969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821458|NCT01515969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64821459|NCT01515969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821460|NCT01515969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287868|NCT00715780|Insulin, Isophane|insulin, isophane|mesh-list
65287869|NCT00715780|Isophane insulin, beef|isophane insulin, beef|mesh-list
65287870|NCT00715780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65287871|NCT00715780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287872|NCT02652884|Betamethasone|betamethasone|mesh-list
65287873|NCT02652884|Betamethasone acetate|betamethasone acetate|mesh-list
65287874|NCT02652884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65287875|NCT02652884|Glucocorticoids|glucocorticoids|mesh-ancestor
65287876|NCT02652884|Hormones|hormones|mesh-ancestor
65287877|NCT02652884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65287878|NCT02652884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287879|NCT02652884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64821461|NCT01516060|Efavirenz|efavirenz|mesh-list
64821462|NCT01516060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64821463|NCT01516060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64821464|NCT01516060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821465|NCT01516060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821466|NCT01516060|Antiviral Agents|antiviral agents|mesh-ancestor
64821467|NCT01516060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64821468|NCT01516060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64821469|NCT01516060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64821479|NCT01516255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64821480|NCT01516255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64821481|NCT01516255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64821482|NCT01516255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64821483|NCT01516255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821484|NCT01516255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821485|NCT01516255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821486|NCT01516255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432626|NCT01850524|Ixazomib|ixazomib|mesh-list
64821505|NCT01516372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64821506|NCT01516372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64821507|NCT01516450|Belimumab|belimumab|mesh-list
64821508|NCT01516450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64821509|NCT01516450|Immunologic Factors|immunologic factors|mesh-ancestor
64821510|NCT01516450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821511|NCT01516463|Bacitracin|bacitracin|mesh-list
64821512|NCT01516463|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64821513|NCT01516463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64821514|NCT01516463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64821515|NCT01516554|Methyltestosterone|methyltestosterone|mesh-list
64821516|NCT01516554|Testosterone|testosterone|mesh-list
64821517|NCT01516554|Testosterone undecanoate|testosterone undecanoate|mesh-list
64821518|NCT01516554|Testosterone enanthate|testosterone enanthate|mesh-list
64821519|NCT01516554|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64821520|NCT01516554|Androgens|androgens|mesh-ancestor
64821521|NCT01516554|Hormones|hormones|mesh-ancestor
64821522|NCT01516554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64821523|NCT01516554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821524|NCT01516554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64821525|NCT01516554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821526|NCT01516554|Anabolic Agents|anabolic agents|mesh-ancestor
64821527|NCT01516567|Cyclophosphamide|cyclophosphamide|mesh-list
64821528|NCT01516567|Rituximab|rituximab|mesh-list
64821529|NCT01516567|Doxorubicin|doxorubicin|mesh-list
64821530|NCT01516567|Etoposide|etoposide|mesh-list
64821531|NCT01516567|Vincristine|vincristine|mesh-list
64821532|NCT01516567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64821533|NCT01516567|Immunologic Factors|immunologic factors|mesh-ancestor
64472766|NCT02820857|Growth Inhibitors|growth inhibitors|mesh-ancestor
64821534|NCT01516567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821535|NCT01516567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64821536|NCT01516567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64821537|NCT01516567|Alkylating Agents|alkylating agents|mesh-ancestor
65287880|NCT02652884|Respiratory System Agents|respiratory system agents|mesh-ancestor
65287881|NCT00990301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65287882|NCT00990301|Moexipril|moexipril|mesh-list
65287883|NCT00990301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65287884|NCT00990301|Diuretics|diuretics|mesh-ancestor
65287885|NCT00990301|Natriuretic Agents|natriuretic agents|mesh-ancestor
65287886|NCT00990301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287887|NCT00990301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65287888|NCT00990301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65287889|NCT00990301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287890|NCT00990301|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65287891|NCT00990301|Protease Inhibitors|protease inhibitors|mesh-ancestor
65287892|NCT00990301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65287893|NCT00715858|Doxycycline|doxycycline|mesh-list
65287894|NCT00715858|Rifampin|rifampin|mesh-list
65287895|NCT00715858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65287896|NCT00715858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65287897|NCT00715858|Antimalarials|antimalarials|mesh-ancestor
65287898|NCT00715858|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64821538|NCT01516567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821539|NCT01516567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821540|NCT01516567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64821563|NCT01516580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821565|NCT01516580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64821566|NCT01516580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64821567|NCT01516580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64821568|NCT01516580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64821569|NCT01516580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64821570|NCT01516580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821571|NCT01516580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64821572|NCT01516580|Abortifacient Agents|abortifacient agents|mesh-ancestor
64590213|NCT03939182|Abexinostat|abexinostat|mesh-list
64821573|NCT01516580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64821613|NCT01516840|Calcium heparin|calcium heparin|mesh-list
64821614|NCT01516840|Warfarin|warfarin|mesh-list
64821615|NCT01516840|Rivaroxaban|rivaroxaban|mesh-list
64821616|NCT01516840|Anticoagulants|anticoagulants|mesh-ancestor
64821617|NCT01516840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64821618|NCT01516840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64821619|NCT01516840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821620|NCT01516840|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64821621|NCT01516840|Antithrombins|antithrombins|mesh-ancestor
64821622|NCT01516840|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64821623|NCT01516840|Protease Inhibitors|protease inhibitors|mesh-ancestor
64821624|NCT01516840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821625|NCT01516866|Listerine|listerine|mesh-list
64821626|NCT01516866|Fluorides|fluorides|mesh-list
64821627|NCT01516866|Sodium Fluoride|sodium fluoride|mesh-list
64821628|NCT01516866|Cariostatic Agents|cariostatic agents|mesh-ancestor
64821629|NCT01516866|Protective Agents|protective agents|mesh-ancestor
64821630|NCT01516866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821631|NCT01516866|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64821632|NCT01516866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64821633|NCT01516944|Capecitabine|capecitabine|mesh-list
64821634|NCT01516944|Tegafur|tegafur|mesh-list
64821635|NCT01516944|Oxaliplatin|oxaliplatin|mesh-list
64821636|NCT01516944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65287899|NCT00715858|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65287900|NCT00715858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65287901|NCT00715858|Antitubercular Agents|antitubercular agents|mesh-ancestor
65287902|NCT00715858|Leprostatic Agents|leprostatic agents|mesh-ancestor
65287903|NCT00715858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65287904|NCT00715858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65287905|NCT00715858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287906|NCT00715858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65287907|NCT00715858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65287908|NCT00715858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65287909|NCT00715858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65287910|NCT00715858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65287911|NCT00715858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65287912|NCT02643680|Chlorhexidine|chlorhexidine|mesh-list
65287913|NCT02643680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65287914|NCT02643680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65287915|NCT02643680|Disinfectants|disinfectants|mesh-ancestor
65287916|NCT04696445|Morphine|morphine|mesh-list
65287917|NCT04696445|Oxycodone|oxycodone|mesh-list
65287918|NCT04696445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65287919|NCT04696445|Narcotics|narcotics|mesh-ancestor
65287920|NCT04696445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65287921|NCT04696445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287922|NCT04696445|Analgesics|analgesics|mesh-ancestor
65287923|NCT04696445|Sensory System Agents|sensory system agents|mesh-ancestor
65287924|NCT04696445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65287925|NCT05360953|Clonidine|clonidine|mesh-list
65287926|NCT05360953|Doxazosin|doxazosin|mesh-list
65287927|NCT05360953|Analgesics|analgesics|mesh-ancestor
65287928|NCT05360953|Sensory System Agents|sensory system agents|mesh-ancestor
64518167|NCT00734877|Antiemetics|antiemetics|mesh-ancestor
64821637|NCT01516944|Antimetabolites|antimetabolites|mesh-ancestor
64821649|NCT01517009|Capecitabine|capecitabine|mesh-list
64821650|NCT01517009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821651|NCT01517009|Tubulin Modulators|tubulin modulators|mesh-ancestor
64821652|NCT01517009|Antimitotic Agents|antimitotic agents|mesh-ancestor
64821653|NCT01517009|Mitosis Modulators|mitosis modulators|mesh-ancestor
64821654|NCT01517009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821655|NCT01517009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64821656|NCT01517009|Antimetabolites|antimetabolites|mesh-ancestor
64821657|NCT01517022|Nicotine|nicotine|mesh-list
64821658|NCT01517022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64821659|NCT01517022|Autonomic Agents|autonomic agents|mesh-ancestor
64432788|NCT01846624|Antimetabolites|antimetabolites|mesh-ancestor
64821668|NCT01517165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65287929|NCT05360953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65287930|NCT05360953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287931|NCT05360953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65287932|NCT05360953|Sympatholytics|sympatholytics|mesh-ancestor
65287933|NCT05360953|Autonomic Agents|autonomic agents|mesh-ancestor
65287934|NCT05360953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65287935|NCT05360953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65287936|NCT05360953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65287937|NCT05360953|Adrenergic Agents|adrenergic agents|mesh-ancestor
65287938|NCT05360953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65287939|NCT05360953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287940|NCT05360953|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65037924|NCT00216918|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64518186|NCT00734877|Growth Substances|growth substances|mesh-ancestor
64821669|NCT01517165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821670|NCT01517308|Interferons|interferons|mesh-list
64821671|NCT01517308|Ribavirin|ribavirin|mesh-list
64821672|NCT01517308|Interferon-alpha|interferon-alpha|mesh-list
64821673|NCT01517308|Interferon alpha-2|interferon alpha-2|mesh-list
64821674|NCT01517308|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64821675|NCT01517308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821676|NCT01517308|Antiviral Agents|antiviral agents|mesh-ancestor
64821677|NCT01517308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64821678|NCT01517308|Antimetabolites|antimetabolites|mesh-ancestor
64821679|NCT01517308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821680|NCT01517308|Immunologic Factors|immunologic factors|mesh-ancestor
64821681|NCT01517308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821682|NCT01517321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64821683|NCT01517321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64821684|NCT01517321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821685|NCT01517321|Incretins|incretins|mesh-ancestor
64821686|NCT01517321|Hormones|hormones|mesh-ancestor
64821687|NCT01517321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64821688|NCT01517321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64821689|NCT01517321|Protease Inhibitors|protease inhibitors|mesh-ancestor
64821690|NCT01517321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821691|NCT01517321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821692|NCT01517334|Minocycline|minocycline|mesh-list
64821693|NCT01517334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64821694|NCT01517334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64821695|NCT01517347|Interleukin-2|interleukin-2|mesh-list
64821696|NCT01517347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821697|NCT01517347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64821698|NCT01517347|Analgesics|analgesics|mesh-ancestor
64821699|NCT01517347|Sensory System Agents|sensory system agents|mesh-ancestor
64821700|NCT01517347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64821701|NCT01517347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821702|NCT01517360|Oxytocin|oxytocin|mesh-list
64821703|NCT01517360|Oxytocics|oxytocics|mesh-ancestor
64821704|NCT01517360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64821705|NCT01517360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821726|NCT01517399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64821727|NCT01517399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821728|NCT01517399|Anticoagulants|anticoagulants|mesh-ancestor
64432855|NCT02356562|Ritonavir|ritonavir|mesh-list
64821758|NCT01517555|Incretins|incretins|mesh-ancestor
64821759|NCT01517555|Hormones|hormones|mesh-ancestor
64821760|NCT01517555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64821761|NCT01517568|Liraglutide|liraglutide|mesh-list
64821762|NCT01517568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65287941|NCT05360953|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65287942|NCT05360953|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65287943|NCT02647424|Letrozole|letrozole|mesh-list
65287944|NCT02647424|Clomiphene|clomiphene|mesh-list
65287945|NCT02647424|Enclomiphene|enclomiphene|mesh-list
65287946|NCT02647424|Zuclomiphene|zuclomiphene|mesh-list
65287947|NCT02647424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65287948|NCT02647424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65287949|NCT02647424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65287950|NCT02647424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65287951|NCT02647424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518208|NCT00687765|Temozolomide|temozolomide|mesh-list
64821763|NCT01517568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821764|NCT01517568|Incretins|incretins|mesh-ancestor
64821765|NCT01517568|Hormones|hormones|mesh-ancestor
64821766|NCT01517568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64821767|NCT01517607|Mesalamine|mesalamine|mesh-list
64821768|NCT01517607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64821769|NCT01517607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64821770|NCT01517607|Analgesics|analgesics|mesh-ancestor
64821771|NCT01517607|Sensory System Agents|sensory system agents|mesh-ancestor
64821772|NCT01517607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64821773|NCT01517607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821774|NCT01517607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64821775|NCT01517607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64821776|NCT01517724|Bortezomib|bortezomib|mesh-list
64821798|NCT01517828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64821799|NCT01517828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64821800|NCT01517828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64821801|NCT01517828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821802|NCT01517828|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64821803|NCT01517828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64821804|NCT01517828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64821805|NCT01517828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64821806|NCT01517828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64821807|NCT01517828|GABA Modulators|gaba modulators|mesh-ancestor
64821808|NCT01517828|GABA Agents|gaba agents|mesh-ancestor
64821809|NCT01517854|Sildenafil Citrate|sildenafil citrate|mesh-list
64821810|NCT01517854|Vasodilator Agents|vasodilator agents|mesh-ancestor
64821811|NCT01517854|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64821812|NCT01517854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64821813|NCT01517854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821814|NCT01517854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821860|NCT01518166|Antimetabolites|antimetabolites|mesh-ancestor
64821861|NCT01518166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821862|NCT01518166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64821863|NCT01518166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64821864|NCT01518166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821865|NCT01518166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64821866|NCT01518166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472768|NCT02790710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64821867|NCT01518166|Incretins|incretins|mesh-ancestor
64821868|NCT01518166|Hormones|hormones|mesh-ancestor
64821869|NCT01518166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64821870|NCT01518166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64821871|NCT01518166|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64821872|NCT01518166|Protective Agents|protective agents|mesh-ancestor
64821873|NCT01518166|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64821874|NCT01518166|Protease Inhibitors|protease inhibitors|mesh-ancestor
64821875|NCT01518166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64821876|NCT01518166|Antifungal Agents|antifungal agents|mesh-ancestor
64821877|NCT01518166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64821878|NCT01518231|Aspirin|aspirin|mesh-list
65287952|NCT02647424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65287953|NCT02647424|Hormone Antagonists|hormone antagonists|mesh-ancestor
65287954|NCT02647424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65287955|NCT02647424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287956|NCT02647424|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65287957|NCT02647424|Fertility Agents|fertility agents|mesh-ancestor
65287958|NCT02647424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65287959|NCT02647424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65287960|NCT02647424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65287961|NCT02574754|Warfarin|warfarin|mesh-list
65287962|NCT02574754|Anticoagulants|anticoagulants|mesh-ancestor
65287963|NCT00719602|Ritonavir|ritonavir|mesh-list
65287964|NCT00719602|Lopinavir|lopinavir|mesh-list
65287965|NCT00719602|Lamivudine|lamivudine|mesh-list
65287966|NCT00719602|Zidovudine|zidovudine|mesh-list
65287967|NCT00719602|Nevirapine|nevirapine|mesh-list
65287968|NCT00719602|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65287969|NCT00719602|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65287970|NCT00719602|Protease Inhibitors|protease inhibitors|mesh-ancestor
65287971|NCT00719602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65287972|NCT00719602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65287973|NCT00719602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65287974|NCT00719602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65287975|NCT00719602|Antiviral Agents|antiviral agents|mesh-ancestor
65287976|NCT00719602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64518212|NCT00687765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821924|NCT01518465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821925|NCT01518465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64821927|NCT01518465|Hormones|hormones|mesh-ancestor
64821928|NCT01518465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64821929|NCT01518465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64821930|NCT01518465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821931|NCT01518465|Immunologic Factors|immunologic factors|mesh-ancestor
64821932|NCT01518465|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64821933|NCT01518465|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64821934|NCT01518465|Growth Substances|growth substances|mesh-ancestor
64821935|NCT01518465|Growth Inhibitors|growth inhibitors|mesh-ancestor
64821936|NCT01518465|Anticoagulants|anticoagulants|mesh-ancestor
64821937|NCT01518465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64821938|NCT01518465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64821939|NCT01518465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821940|NCT01518569|Urinastatin|urinastatin|mesh-list
64821962|NCT01518621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821963|NCT01518621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64821964|NCT01518621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821965|NCT01518621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821966|NCT01518634|Imipramine|imipramine|mesh-list
64821967|NCT01518634|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64821968|NCT01518634|Antidepressive Agents|antidepressive agents|mesh-ancestor
65287977|NCT00719602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65287978|NCT00719602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65287979|NCT00719602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65287980|NCT00719602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65287981|NCT00719602|Antimetabolites|antimetabolites|mesh-ancestor
65287982|NCT00719602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65287983|NCT00719602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65287984|NCT02652650|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65287985|NCT02652650|Norethindrone|norethindrone|mesh-list
65287986|NCT02652650|Norethindrone Acetate|norethindrone acetate|mesh-list
65287987|NCT02652650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65287988|NCT02652650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65287989|NCT02652650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65287990|NCT02652650|Contraceptive Agents|contraceptive agents|mesh-ancestor
65287991|NCT02652650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65287992|NCT02652650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65287993|NCT02652650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65287994|NCT02652650|Estrogens|estrogens|mesh-ancestor
64576445|NCT04803474|Hormones|hormones|mesh-list
64821969|NCT01518634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64821970|NCT01518634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64821971|NCT01518634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64821972|NCT01518634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64821973|NCT01518634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821974|NCT01518634|Adrenergic Agents|adrenergic agents|mesh-ancestor
64821975|NCT01518634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64821976|NCT01518634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821977|NCT01518712|Metformin|metformin|mesh-list
64822014|NCT01518959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64822015|NCT01518959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822016|NCT01518959|Vitamins|vitamins|mesh-ancestor
64822017|NCT01518959|Micronutrients|micronutrients|mesh-ancestor
64822018|NCT01518959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64822019|NCT01518998|Amlodipine|amlodipine|mesh-list
64822020|NCT01518998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64822021|NCT01518998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64822022|NCT01518998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64822023|NCT01518998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822024|NCT01518998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64822025|NCT01518998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822026|NCT01518998|Vasodilator Agents|vasodilator agents|mesh-ancestor
64822027|NCT01519011|Azacitidine|azacitidine|mesh-list
64822028|NCT01519011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64822029|NCT01519011|Antimetabolites|antimetabolites|mesh-ancestor
64329368|NCT00393991|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65095542|NCT00502073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65095543|NCT00502073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65095544|NCT01248923|Dexamethasone|dexamethasone|mesh-list
65095545|NCT01248923|Bortezomib|bortezomib|mesh-list
65095546|NCT01248923|Filanesib|filanesib|mesh-list
65095547|NCT01248923|Lenograstim|lenograstim|mesh-list
65095548|NCT01248923|Proteasome Inhibitors|proteasome inhibitors|mesh-list
65095549|NCT01248923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65095550|NCT01248923|Antiemetics|antiemetics|mesh-ancestor
65095551|NCT01248923|Autonomic Agents|autonomic agents|mesh-ancestor
65287995|NCT02652650|Hormones|hormones|mesh-ancestor
65287996|NCT02652650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65287997|NCT02652650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65287998|NCT02643602|Theophylline|theophylline|mesh-list
65287999|NCT02643602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65288000|NCT02643602|Autonomic Agents|autonomic agents|mesh-ancestor
65288001|NCT02643602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65288002|NCT02643602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288003|NCT02643602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65288004|NCT02643602|Respiratory System Agents|respiratory system agents|mesh-ancestor
65288005|NCT02643602|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65288006|NCT02643602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288007|NCT02643602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288008|NCT02643602|Vasodilator Agents|vasodilator agents|mesh-ancestor
65288009|NCT02643602|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65288010|NCT02643602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64518268|NCT03248700|Vitamins|vitamins|mesh-list
64518269|NCT03248700|Vitamin A|vitamin a|mesh-list
64518270|NCT03248700|Retinol palmitate|retinol palmitate|mesh-list
65095552|NCT01248923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095553|NCT01248923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095554|NCT01248923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65095555|NCT01248923|Glucocorticoids|glucocorticoids|mesh-ancestor
65095556|NCT01248923|Hormones|hormones|mesh-ancestor
65095557|NCT01248923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64668506|NCT01691690|Narcotics|narcotics|mesh-ancestor
65095559|NCT01248923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095560|NCT01248923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65095561|NCT01248923|Immunologic Factors|immunologic factors|mesh-ancestor
65095562|NCT01248923|Protease Inhibitors|protease inhibitors|mesh-ancestor
65095563|NCT01248923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095564|NCT01248923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095565|NCT01248923|Antimitotic Agents|antimitotic agents|mesh-ancestor
65095566|NCT01248923|Mitosis Modulators|mitosis modulators|mesh-ancestor
65095568|NCT01249001|Fosaprepitant|fosaprepitant|mesh-list
65095569|NCT01249001|Antiemetics|antiemetics|mesh-ancestor
65095570|NCT01249001|Autonomic Agents|autonomic agents|mesh-ancestor
65095571|NCT01249001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095572|NCT01249001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095573|NCT01249001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65095574|NCT01249001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65095575|NCT01249001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65095576|NCT01249001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095577|NCT00502112|Lenalidomide|lenalidomide|mesh-list
65095578|NCT00502112|Lintuzumab|lintuzumab|mesh-list
65095579|NCT00502112|Immunologic Factors|immunologic factors|mesh-ancestor
65095580|NCT00502112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095581|NCT00502112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65095582|NCT00502112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65095583|NCT00502112|Growth Substances|growth substances|mesh-ancestor
65095584|NCT00502112|Growth Inhibitors|growth inhibitors|mesh-ancestor
65095585|NCT00502112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095586|NCT00502112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65095587|NCT00502190|Silicon|silicon|mesh-list
65095588|NCT00502190|Trace Elements|trace elements|mesh-ancestor
65288011|NCT02643602|Purinergic Agents|purinergic agents|mesh-ancestor
65288012|NCT02643602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65288013|NCT00710320|Anesthetics|anesthetics|mesh-list
65288014|NCT00710320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65288015|NCT00710320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288016|NCT00716170|Glucagon|glucagon|mesh-list
64518272|NCT03248700|Micronutrients|micronutrients|mesh-ancestor
65095589|NCT00502190|Micronutrients|micronutrients|mesh-ancestor
65095590|NCT00502190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095591|NCT00502229|Metformin|metformin|mesh-list
65095592|NCT00502229|Clomiphene|clomiphene|mesh-list
65095593|NCT00502229|Enclomiphene|enclomiphene|mesh-list
65095594|NCT00502229|Zuclomiphene|zuclomiphene|mesh-list
65095595|NCT00502229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65095596|NCT00502229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095597|NCT00502229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65095598|NCT00502229|Hormone Antagonists|hormone antagonists|mesh-ancestor
65095599|NCT00502229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65095600|NCT00502229|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65095601|NCT00502229|Fertility Agents|fertility agents|mesh-ancestor
65095602|NCT00502229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65095603|NCT00502229|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65095604|NCT00502229|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65095605|NCT00502268|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
65095606|NCT00502268|Ergocalciferols|ergocalciferols|mesh-list
65095607|NCT00502268|Vitamins|vitamins|mesh-ancestor
65095608|NCT00502268|Micronutrients|micronutrients|mesh-ancestor
65095609|NCT00502268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095610|NCT00502268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65095611|NCT00502268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65095612|NCT00510081|Calcium|calcium|mesh-list
65095613|NCT00510081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65095614|NCT00510081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095615|NCT00502385|Cediranib|cediranib|mesh-list
65095616|NCT00502385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095617|NCT00502385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65095618|NCT00502385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095619|NCT00502385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095620|NCT00510159|Artesunate|artesunate|mesh-list
65095621|NCT00510159|Sulfalene|sulfalene|mesh-list
65095622|NCT00510159|Praziquantel|praziquantel|mesh-list
64668558|NCT01626092|Melphalan|melphalan|mesh-list
65095646|NCT02275130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65095648|NCT03459417|Sulpiride|sulpiride|mesh-list
65095649|NCT03459417|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65095650|NCT03459417|Narcotics|narcotics|mesh-ancestor
65095651|NCT03459417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65095652|NCT03459417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095654|NCT03459417|Sensory System Agents|sensory system agents|mesh-ancestor
65095655|NCT03459417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095656|NCT03459417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65095657|NCT03459417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65095658|NCT03459417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65095659|NCT03459417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65095660|NCT03459417|Dopamine Agents|dopamine agents|mesh-ancestor
65095661|NCT03459417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65095662|NCT03459417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095663|NCT03459417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65095664|NCT03459417|Antidepressive Agents|antidepressive agents|mesh-ancestor
65095665|NCT00502541|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
65095666|NCT00502541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65095667|NCT00502541|Glucocorticoids|glucocorticoids|mesh-ancestor
65095668|NCT00502541|Hormones|hormones|mesh-ancestor
64668618|NCT01921751|Capecitabine|capecitabine|mesh-list
65095681|NCT01249430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095682|NCT01249430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65095683|NCT01249430|Antimetabolites|antimetabolites|mesh-ancestor
65095684|NCT01249430|Antiviral Agents|antiviral agents|mesh-ancestor
65095685|NCT01249430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65095686|NCT01249430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65288017|NCT00716170|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
65288018|NCT00716170|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65288019|NCT00716170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65288020|NCT00716170|Hormones|hormones|mesh-ancestor
65288021|NCT00716170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65288022|NCT00716170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288023|NCT00716170|Incretins|incretins|mesh-ancestor
65288024|NCT02652806|Epoetin Alfa|epoetin alfa|mesh-list
65288025|NCT02652806|Hematinics|hematinics|mesh-ancestor
64518282|NCT03238482|Xhance|xhance|mesh-list
65095687|NCT01249430|Immunologic Factors|immunologic factors|mesh-ancestor
65095688|NCT01249430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095689|NCT01249430|Analgesics|analgesics|mesh-ancestor
65095690|NCT01249430|Sensory System Agents|sensory system agents|mesh-ancestor
65095691|NCT01249430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095692|NCT02952963|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
65095693|NCT02952963|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65095694|NCT02952963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65095695|NCT02952963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65095696|NCT02952963|Antimetabolites|antimetabolites|mesh-ancestor
65095697|NCT02952963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095698|NCT02952963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65095699|NCT02952963|Cathartics|cathartics|mesh-ancestor
65095700|NCT02952963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65095701|NCT00510939|Bortezomib|bortezomib|mesh-list
65095702|NCT00510939|Tipifarnib|tipifarnib|mesh-list
65095703|NCT00510939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095704|NCT00504062|Fluticasone|fluticasone|mesh-list
65095705|NCT00504062|Budesonide|budesonide|mesh-list
65095706|NCT00504062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65095707|NCT00504062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65095708|NCT00504062|Autonomic Agents|autonomic agents|mesh-ancestor
65095709|NCT00504062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095710|NCT00504062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095711|NCT00504062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65095712|NCT00504062|Respiratory System Agents|respiratory system agents|mesh-ancestor
65095713|NCT00504062|Dermatologic Agents|dermatologic agents|mesh-ancestor
65095714|NCT00504062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65095715|NCT00504062|Glucocorticoids|glucocorticoids|mesh-ancestor
65095716|NCT00504062|Hormones|hormones|mesh-ancestor
65095717|NCT00504062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65095718|NCT00504101|Bortezomib|bortezomib|mesh-list
65095719|NCT00504101|Melphalan|melphalan|mesh-list
64668703|NCT01924949|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64668704|NCT01924949|Ledipasvir|ledipasvir|mesh-list
64668705|NCT01924949|Antiviral Agents|antiviral agents|mesh-ancestor
65095728|NCT00504101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095729|NCT00504140|Interferons|interferons|mesh-list
65095730|NCT00504140|Interferon-alpha|interferon-alpha|mesh-list
65095731|NCT00504140|Etoposide|etoposide|mesh-list
65095732|NCT00504140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65095733|NCT00504140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095734|NCT00504140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65095735|NCT00504140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65095736|NCT00504140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095737|NCT00504140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095738|NCT00504140|Antiviral Agents|antiviral agents|mesh-ancestor
65095739|NCT00504140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65095740|NCT00504140|Immunologic Factors|immunologic factors|mesh-ancestor
65095741|NCT00504140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095742|NCT00511017|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
65095743|NCT00511017|Vitamins|vitamins|mesh-ancestor
65095744|NCT00511017|Micronutrients|micronutrients|mesh-ancestor
65095745|NCT00511017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095746|NCT00511017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65095747|NCT00511212|Immunoglobulins|immunoglobulins|mesh-list
65095748|NCT00511212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65095749|NCT00511212|Antibodies|antibodies|mesh-list
65288026|NCT04529135|Dexmedetomidine|dexmedetomidine|mesh-list
65288027|NCT04529135|Remifentanil|remifentanil|mesh-list
65288028|NCT04529135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65288029|NCT04529135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65288030|NCT04529135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288031|NCT04529135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65288032|NCT04529135|Analgesics|analgesics|mesh-ancestor
65288033|NCT04529135|Sensory System Agents|sensory system agents|mesh-ancestor
65288034|NCT04529135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65288035|NCT04529135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65095750|NCT00511212|gamma-Globulins|gamma-globulins|mesh-list
65095751|NCT00511212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65095752|NCT00511212|Immunologic Factors|immunologic factors|mesh-ancestor
65095753|NCT00511212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095754|NCT00510354|Imatinib Mesylate|imatinib mesylate|mesh-list
65095755|NCT00510354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095756|NCT00510354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65095757|NCT00510354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095758|NCT00510354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095759|NCT01241006|Dexamethasone|dexamethasone|mesh-list
65095760|NCT01241006|Prednisone|prednisone|mesh-list
65095761|NCT01241006|Glucocorticoids|glucocorticoids|mesh-list
65095762|NCT01241006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65095763|NCT01241006|Antiemetics|antiemetics|mesh-ancestor
65095764|NCT01241006|Autonomic Agents|autonomic agents|mesh-ancestor
65095765|NCT01241006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095766|NCT01241006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095767|NCT01241006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65095768|NCT01241006|Hormones|hormones|mesh-ancestor
65095769|NCT01241006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65095770|NCT01241006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65095771|NCT01241006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095772|NCT00510393|Everolimus|everolimus|mesh-list
65095773|NCT00510393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095774|NCT00510393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65095775|NCT00510393|Immunologic Factors|immunologic factors|mesh-ancestor
65095776|NCT00510393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095777|NCT01249547|Axitinib|axitinib|mesh-list
65095778|NCT01249547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095779|NCT01249547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65095780|NCT01249547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095781|NCT01249547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095783|NCT00511719|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65095784|NCT00511719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65095811|NCT00511602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65095812|NCT00511602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095813|NCT00511953|Gabapentin|gabapentin|mesh-list
65095814|NCT00511953|Analgesics|analgesics|mesh-ancestor
65095815|NCT00511953|Sensory System Agents|sensory system agents|mesh-ancestor
65095816|NCT00511953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095817|NCT00511953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095818|NCT00511953|Anticonvulsants|anticonvulsants|mesh-ancestor
65095819|NCT00511953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65095820|NCT00511953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65095821|NCT00511953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65095822|NCT00511953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65095823|NCT00511953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65095824|NCT00511953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65095825|NCT00511953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65095826|NCT00511953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095850|NCT02951754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095851|NCT02951754|Dopamine Agents|dopamine agents|mesh-ancestor
65095852|NCT02951754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65095854|NCT00504413|Midazolam|midazolam|mesh-list
65095855|NCT00504413|Methadone|methadone|mesh-list
65288036|NCT04529135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65288037|NCT04529135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65288038|NCT04529135|Adrenergic Agents|adrenergic agents|mesh-ancestor
65288039|NCT04529135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65288040|NCT04529135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288041|NCT04529135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65288042|NCT04529135|Narcotics|narcotics|mesh-ancestor
65288043|NCT02647190|Asparaginase|asparaginase|mesh-list
64518300|NCT03238482|Glucocorticoids|glucocorticoids|mesh-ancestor
65095856|NCT00504413|Bupropion|bupropion|mesh-list
65095857|NCT00504413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65095858|NCT00504413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65095859|NCT00504413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65095860|NCT00504413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095861|NCT00504413|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65095862|NCT00504413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65095863|NCT00504413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65095864|NCT00504413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65095865|NCT00504413|Anesthetics, General|anesthetics, general|mesh-ancestor
65095866|NCT00504413|Anesthetics|anesthetics|mesh-ancestor
65095867|NCT00504413|GABA Modulators|gaba modulators|mesh-ancestor
65095868|NCT00504413|GABA Agents|gaba agents|mesh-ancestor
65095869|NCT00504413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65095870|NCT00504413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095871|NCT00504413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65095872|NCT00504413|Antidepressive Agents|antidepressive agents|mesh-ancestor
65095873|NCT00504413|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65095874|NCT00504413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65095875|NCT00504413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65095876|NCT00504413|Dopamine Agents|dopamine agents|mesh-ancestor
64483558|NCT00780676|Dasatinib|dasatinib|mesh-list
65095877|NCT00504413|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64668850|NCT03837860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668851|NCT03837860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65095883|NCT00504413|Sensory System Agents|sensory system agents|mesh-ancestor
65095884|NCT00504413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095885|NCT00504413|Antitussive Agents|antitussive agents|mesh-ancestor
65095886|NCT00504413|Respiratory System Agents|respiratory system agents|mesh-ancestor
65095887|NCT00504413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65095888|NCT00504413|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65095889|NCT00504413|Protective Agents|protective agents|mesh-ancestor
65095890|NCT02951793|Psychotropic Drugs|psychotropic drugs|mesh-list
65095892|NCT01243658|Oxytocics|oxytocics|mesh-ancestor
65095893|NCT01243658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65095894|NCT01243658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095895|NCT01249664|Aflibercept|aflibercept|mesh-list
65095896|NCT01249664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65095897|NCT01249664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65095898|NCT01249664|Growth Substances|growth substances|mesh-ancestor
65095899|NCT01249664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095900|NCT01249664|Growth Inhibitors|growth inhibitors|mesh-ancestor
65095901|NCT01249664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095902|NCT00513162|Etoposide|etoposide|mesh-list
65095903|NCT00513162|Valproic Acid|valproic acid|mesh-list
65095904|NCT00513162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65095905|NCT00513162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095906|NCT00513162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65095907|NCT00513162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65095908|NCT00513162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095909|NCT00513162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095910|NCT00513162|Anticonvulsants|anticonvulsants|mesh-ancestor
65095911|NCT00513162|GABA Agents|gaba agents|mesh-ancestor
65095912|NCT00513162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65095913|NCT00513162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095914|NCT00513162|Antimanic Agents|antimanic agents|mesh-ancestor
65095915|NCT00513162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65288044|NCT02647190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288045|NCT00653042|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65288046|NCT00653042|Natriuretic Agents|natriuretic agents|mesh-ancestor
65288047|NCT00653042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288048|NCT04217447|Aspirin|aspirin|mesh-list
64518303|NCT03238482|Sympathomimetics|sympathomimetics|mesh-ancestor
65095916|NCT00513162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65095917|NCT00513162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65095918|NCT00513201|Insulin|insulin|mesh-list
65095919|NCT00513201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65095920|NCT00513201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65095921|NCT00513201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095922|NCT00512265|Acetylcysteine|acetylcysteine|mesh-list
65095923|NCT00512265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65095924|NCT00512265|Antiviral Agents|antiviral agents|mesh-ancestor
65095925|NCT00512265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65095926|NCT00512265|Expectorants|expectorants|mesh-ancestor
65095927|NCT00512265|Respiratory System Agents|respiratory system agents|mesh-ancestor
65095928|NCT00512265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65095929|NCT00512265|Antioxidants|antioxidants|mesh-ancestor
65095930|NCT00512265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095931|NCT00512265|Protective Agents|protective agents|mesh-ancestor
65095932|NCT00512265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095933|NCT00512265|Antidotes|antidotes|mesh-ancestor
65095934|NCT00513396|Isoniazid|isoniazid|mesh-list
65095935|NCT00513396|Antitubercular Agents|antitubercular agents|mesh-ancestor
65095936|NCT00513396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65095937|NCT00513396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65095938|NCT00513396|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65095939|NCT00513396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65095940|NCT00513396|Antimetabolites|antimetabolites|mesh-ancestor
64668852|NCT03837860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64668907|NCT03093207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095946|NCT01249274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65095947|NCT01249274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095948|NCT00513513|Ritonavir|ritonavir|mesh-list
65095949|NCT00513513|Darunavir|darunavir|mesh-list
65095950|NCT00513513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65095951|NCT00513513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65095952|NCT00513513|Protease Inhibitors|protease inhibitors|mesh-ancestor
65095953|NCT00513513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095954|NCT00513513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095955|NCT00513513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65095956|NCT00513513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65095957|NCT00513513|Antiviral Agents|antiviral agents|mesh-ancestor
65095958|NCT00513513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65095959|NCT00513513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65095960|NCT00513513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65095961|NCT00504959|Ranibizumab|ranibizumab|mesh-list
65095962|NCT00504959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65095963|NCT00504959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65095964|NCT00504959|Growth Substances|growth substances|mesh-ancestor
65095965|NCT00504959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095966|NCT00504959|Growth Inhibitors|growth inhibitors|mesh-ancestor
65095967|NCT00504959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095968|NCT00512616|Ceftriaxone|ceftriaxone|mesh-list
65095969|NCT00512616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65095970|NCT00512616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65095971|NCT00505037|Sevelamer|sevelamer|mesh-list
65095972|NCT00505037|Chelating Agents|chelating agents|mesh-ancestor
65095973|NCT00505037|Sequestering Agents|sequestering agents|mesh-ancestor
65095974|NCT00505037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095975|NCT00513552|Clarithromycin|clarithromycin|mesh-list
65095976|NCT00513552|Rifabutin|rifabutin|mesh-list
65095977|NCT00513552|Clofazimine|clofazimine|mesh-list
65095978|NCT00513552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65095979|NCT00513552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65095980|NCT00513552|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65095981|NCT00513552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095982|NCT00513552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288049|NCT04217447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65288050|NCT04217447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65288051|NCT04217447|Analgesics|analgesics|mesh-ancestor
65288052|NCT04217447|Sensory System Agents|sensory system agents|mesh-ancestor
65288053|NCT04217447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65288054|NCT04217447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288055|NCT04217447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65288056|NCT04217447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65288057|NCT04217447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65288058|NCT04217447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65288059|NCT04217447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288060|NCT04217447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65288061|NCT04217447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64518314|NCT03240822|Antibodies|antibodies|mesh-list
65095983|NCT00513552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65095984|NCT00513552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65095985|NCT00513552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65095986|NCT00513552|Antitubercular Agents|antitubercular agents|mesh-ancestor
65095987|NCT00513552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65095988|NCT00513552|Leprostatic Agents|leprostatic agents|mesh-ancestor
65095989|NCT00513630|Metformin|metformin|mesh-list
65095990|NCT00513630|Glipizide|glipizide|mesh-list
65095991|NCT00513630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65095992|NCT00513630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095993|NCT02275247|Ropivacaine|ropivacaine|mesh-list
65095994|NCT02275247|Anesthetics, Local|anesthetics, local|mesh-ancestor
65095995|NCT02275247|Anesthetics|anesthetics|mesh-ancestor
65095996|NCT02275247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65095997|NCT02275247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095998|NCT02275247|Sensory System Agents|sensory system agents|mesh-ancestor
64668908|NCT03093207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668954|NCT02342886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096013|NCT00513786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65096014|NCT00513786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65096015|NCT00513786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65096016|NCT00513786|Growth Substances|growth substances|mesh-ancestor
65096017|NCT00513786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096018|NCT00513786|Growth Inhibitors|growth inhibitors|mesh-ancestor
65096019|NCT00504491|Rituximab|rituximab|mesh-list
65096020|NCT00504491|Alemtuzumab|alemtuzumab|mesh-list
65096021|NCT00504491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65096022|NCT00504491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096023|NCT00504491|Immunologic Factors|immunologic factors|mesh-ancestor
65096024|NCT00504491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096025|NCT00504491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65096027|NCT00512811|Diuretics|diuretics|mesh-ancestor
65096028|NCT00512811|Natriuretic Agents|natriuretic agents|mesh-ancestor
65096029|NCT00512811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096030|NCT00512811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65096031|NCT00512811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65096032|NCT00512811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096033|NCT00513864|Morphine|morphine|mesh-list
65096034|NCT00513864|Codeine|codeine|mesh-list
65096035|NCT00513864|Dextromethorphan|dextromethorphan|mesh-list
65096036|NCT00513864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65096037|NCT00513864|Narcotics|narcotics|mesh-ancestor
65096038|NCT00513864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65096039|NCT00513864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096040|NCT00513864|Analgesics|analgesics|mesh-ancestor
65288062|NCT04217447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288063|NCT04217447|Antipyretics|antipyretics|mesh-ancestor
65288064|NCT04165850|Ciprofloxacin|ciprofloxacin|mesh-list
65288065|NCT04165850|Celecoxib|celecoxib|mesh-list
65288066|NCT04165850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65288067|NCT04165850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65288068|NCT04165850|Analgesics|analgesics|mesh-ancestor
65288069|NCT04165850|Sensory System Agents|sensory system agents|mesh-ancestor
65288070|NCT04165850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65288071|NCT04165850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288072|NCT04165850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65288073|NCT04165850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65288074|NCT04165850|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65288075|NCT04165850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65288076|NCT04165850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288077|NCT04165850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288078|NCT04165850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65288079|NCT04165850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65288080|NCT04165850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64518321|NCT03240822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096041|NCT00513864|Sensory System Agents|sensory system agents|mesh-ancestor
65096042|NCT00513864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65096043|NCT00513864|Antitussive Agents|antitussive agents|mesh-ancestor
65096044|NCT00513864|Respiratory System Agents|respiratory system agents|mesh-ancestor
65096045|NCT00513864|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65096046|NCT00513864|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65096047|NCT00513864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65096048|NCT00513864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096049|NCT01248884|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65096050|NCT01248884|Immunologic Factors|immunologic factors|mesh-ancestor
65096051|NCT01248884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096052|NCT00512850|Folic Acid|folic acid|mesh-list
65096053|NCT00512850|Hematinics|hematinics|mesh-ancestor
65096054|NCT00512850|Vitamin B Complex|vitamin b complex|mesh-ancestor
65096055|NCT00512850|Vitamins|vitamins|mesh-ancestor
65096075|NCT00505154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096076|NCT00505154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65096077|NCT00505154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65096078|NCT00505154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096079|NCT01246973|Curcumin|curcumin|mesh-list
65096080|NCT01246973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65096081|NCT01246973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65096082|NCT01246973|Analgesics|analgesics|mesh-ancestor
65096083|NCT01246973|Sensory System Agents|sensory system agents|mesh-ancestor
65096084|NCT01246973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65096085|NCT01246973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096086|NCT01246973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65096087|NCT01246973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65096088|NCT01246973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096089|NCT01246973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096090|NCT01246973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096091|NCT00514605|Antibodies|antibodies|mesh-list
65096092|NCT00514605|Immunoglobulins|immunoglobulins|mesh-list
65288081|NCT04165850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65288082|NCT04165850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288083|NCT04165850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65288084|NCT04165850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65288085|NCT00719758|Beraprost|beraprost|mesh-list
65288086|NCT00719758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65096093|NCT00514605|Immunologic Factors|immunologic factors|mesh-ancestor
65096094|NCT00514605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096095|NCT00513981|Leucovorin|leucovorin|mesh-list
65096096|NCT00513981|Methotrexate|methotrexate|mesh-list
65096097|NCT00513981|Calcium|calcium|mesh-list
65096098|NCT00513981|Levoleucovorin|levoleucovorin|mesh-list
65096099|NCT00513981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65096100|NCT00513981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628781|NCT00002638|Cyclophosphamide|cyclophosphamide|mesh-list
65096101|NCT00513981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65096102|NCT00513981|Abortifacient Agents|abortifacient agents|mesh-ancestor
65096103|NCT00513981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65096104|NCT00513981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64669002|NCT02389764|Nintedanib|nintedanib|mesh-list
65096121|NCT00505232|Immunologic Factors|immunologic factors|mesh-ancestor
65096122|NCT00505232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096123|NCT00514761|Capecitabine|capecitabine|mesh-list
65096124|NCT00514761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65096125|NCT00514761|Antimetabolites|antimetabolites|mesh-ancestor
65096126|NCT00514761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096127|NCT00514761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096128|NCT04695600|Botulinum Toxins|botulinum toxins|mesh-list
65096129|NCT04695600|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65096130|NCT04695600|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65096131|NCT04695600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65096132|NCT04695600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65096133|NCT04695600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096134|NCT04695600|Cholinergic Agents|cholinergic agents|mesh-ancestor
65096135|NCT04695600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65096136|NCT04695600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096137|NCT04695600|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65096138|NCT04695600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65096139|NCT01245140|Alitretinoin|alitretinoin|mesh-list
65096140|NCT01245140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096141|NCT01245140|Dermatologic Agents|dermatologic agents|mesh-ancestor
65096142|NCT02951637|Carboplatin|carboplatin|mesh-list
65096143|NCT02951637|Pemetrexed|pemetrexed|mesh-list
65096144|NCT02951637|Gefitinib|gefitinib|mesh-list
65096145|NCT02951637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096146|NCT02951637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096147|NCT02951637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096148|NCT02951637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65096149|NCT02951637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65096150|NCT02951637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65096151|NCT01245101|Raltegravir Potassium|raltegravir potassium|mesh-list
65096152|NCT01245101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65096153|NCT01245101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65096154|NCT01245101|Antiviral Agents|antiviral agents|mesh-ancestor
65096155|NCT01245101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65096156|NCT01245101|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65096157|NCT01245101|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65096158|NCT01245101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096159|NCT01245101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096160|NCT01245062|Trametinib|trametinib|mesh-list
65096161|NCT01245062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096162|NCT01245062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65096163|NCT01245062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096164|NCT01245062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096166|NCT01244984|Xhance|xhance|mesh-list
64669041|NCT01637090|Everolimus|everolimus|mesh-list
65096203|NCT00514293|Tretinoin|tretinoin|mesh-list
65096204|NCT00514293|Bexarotene|bexarotene|mesh-list
65096205|NCT00514293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096206|NCT00514293|Tubulin Modulators|tubulin modulators|mesh-ancestor
65288087|NCT00719758|Vasodilator Agents|vasodilator agents|mesh-ancestor
65288088|NCT02647268|Magnesium Sulfate|magnesium sulfate|mesh-list
65288089|NCT02647268|Oxytocin|oxytocin|mesh-list
65288090|NCT02647268|Oxytocics|oxytocics|mesh-ancestor
65288091|NCT02647268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64578022|NCT00097669|Vitamins|vitamins|mesh-ancestor
65096207|NCT00514293|Antimitotic Agents|antimitotic agents|mesh-ancestor
65096208|NCT00514293|Mitosis Modulators|mitosis modulators|mesh-ancestor
65096212|NCT00514293|Keratolytic Agents|keratolytic agents|mesh-ancestor
65096213|NCT00514293|Dermatologic Agents|dermatologic agents|mesh-ancestor
65096214|NCT02955641|Dexamethasone|dexamethasone|mesh-list
65096215|NCT02955641|Nepafenac|nepafenac|mesh-list
65096216|NCT02955641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65096217|NCT02955641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65096218|NCT02955641|Antiemetics|antiemetics|mesh-ancestor
65096219|NCT02955641|Autonomic Agents|autonomic agents|mesh-ancestor
65096220|NCT02955641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65096221|NCT02955641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096222|NCT02955641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65096223|NCT02955641|Glucocorticoids|glucocorticoids|mesh-ancestor
65096224|NCT02955641|Hormones|hormones|mesh-ancestor
65096225|NCT02955641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65096226|NCT02955641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65096227|NCT02955641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096228|NCT02955641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65096229|NCT02955641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65096230|NCT02955641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65096231|NCT02955641|Analgesics|analgesics|mesh-ancestor
65096232|NCT02955641|Sensory System Agents|sensory system agents|mesh-ancestor
64738418|NCT00002333|Saquinavir|saquinavir|mesh-list
65096233|NCT02955641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65096234|NCT01243268|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
65096235|NCT01243268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65096236|NCT01243268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65096237|NCT01243268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65096238|NCT01243268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096240|NCT00514995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65096241|NCT00514995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65096242|NCT00514995|Anesthetics, General|anesthetics, general|mesh-ancestor
65096243|NCT00514995|Anesthetics|anesthetics|mesh-ancestor
65096244|NCT00514995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65096245|NCT00514995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096246|NCT01242176|Empagliflozin|empagliflozin|mesh-list
65096247|NCT01242176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65096248|NCT01242176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096249|NCT01242176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65096250|NCT01242176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096251|NCT00515151|Ethanol|ethanol|mesh-list
65096252|NCT00515151|Octenidine|octenidine|mesh-list
65096253|NCT00515151|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65096254|NCT00515151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65096255|NCT00515151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65096256|NCT00515151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096257|NCT01241786|Lenalidomide|lenalidomide|mesh-list
65096258|NCT01241786|Azacitidine|azacitidine|mesh-list
65096259|NCT01241786|Immunologic Factors|immunologic factors|mesh-ancestor
65096260|NCT01241786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096261|NCT01241786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65096262|NCT01241786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65096263|NCT01241786|Growth Substances|growth substances|mesh-ancestor
65096264|NCT01241786|Growth Inhibitors|growth inhibitors|mesh-ancestor
65096265|NCT01241786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096266|NCT01241786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65096267|NCT01241786|Antimetabolites|antimetabolites|mesh-ancestor
65096268|NCT01241786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096269|NCT01241786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096270|NCT00514410|Folic Acid|folic acid|mesh-list
65096271|NCT00514410|Hematinics|hematinics|mesh-ancestor
64669205|NCT01602692|Lidocaine|lidocaine|mesh-list
65096278|NCT01241318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65096279|NCT01241318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65288092|NCT02647268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288093|NCT02647268|Analgesics|analgesics|mesh-ancestor
65288094|NCT02647268|Sensory System Agents|sensory system agents|mesh-ancestor
64578206|NCT01490060|Fosaprepitant|fosaprepitant|mesh-list
65096280|NCT01241318|Disinfectants|disinfectants|mesh-ancestor
65096281|NCT01241318|Dermatologic Agents|dermatologic agents|mesh-ancestor
65096282|NCT00514488|Imatinib Mesylate|imatinib mesylate|mesh-list
65096283|NCT00514488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096284|NCT00514488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65096285|NCT00514488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096286|NCT00514488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096287|NCT00514527|Oritavancin|oritavancin|mesh-list
65096288|NCT00514527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65096289|NCT00514527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65096290|NCT01241240|Timolol|timolol|mesh-list
65096291|NCT01241240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65096292|NCT01241240|Bimatoprost|bimatoprost|mesh-list
65096293|NCT01241240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65096294|NCT01241240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65096295|NCT01241240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65096296|NCT01241240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65096297|NCT01241240|Adrenergic Agents|adrenergic agents|mesh-ancestor
65096298|NCT01241240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65096299|NCT01241240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096300|NCT01241240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096301|NCT01241240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65096302|NCT01241240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65096303|NCT01241240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65096304|NCT01241240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65096305|NCT01241240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65096306|NCT02950623|Titanium dioxide|titanium dioxide|mesh-list
65096307|NCT02950623|Sunscreening Agents|sunscreening agents|mesh-ancestor
65096308|NCT02950623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65096309|NCT02950623|Protective Agents|protective agents|mesh-ancestor
65096310|NCT02950623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096311|NCT02950623|Dermatologic Agents|dermatologic agents|mesh-ancestor
65096312|NCT02950623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65096313|NCT00516009|Dexamethasone|dexamethasone|mesh-list
65096314|NCT00516009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65096315|NCT00516009|Antiemetics|antiemetics|mesh-ancestor
65096316|NCT00516009|Autonomic Agents|autonomic agents|mesh-ancestor
65096317|NCT00516009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65096318|NCT00516009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096319|NCT00516009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65096320|NCT00516009|Glucocorticoids|glucocorticoids|mesh-ancestor
65096322|NCT00516009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65096323|NCT00516009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65096324|NCT00516009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096325|NCT02950584|Titanium dioxide|titanium dioxide|mesh-list
65096326|NCT02950584|Sunscreening Agents|sunscreening agents|mesh-ancestor
65096327|NCT02950584|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65096328|NCT02950584|Protective Agents|protective agents|mesh-ancestor
65096329|NCT02950584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096330|NCT02950584|Dermatologic Agents|dermatologic agents|mesh-ancestor
65096331|NCT02950584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65096346|NCT03459144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65096348|NCT03459144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096349|NCT03459144|Growth Inhibitors|growth inhibitors|mesh-ancestor
65096350|NCT03459144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096351|NCT03459144|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65096352|NCT03459144|Dermatologic Agents|dermatologic agents|mesh-ancestor
65096353|NCT03459105|Bupivacaine|bupivacaine|mesh-list
65096354|NCT03459105|Anesthetics|anesthetics|mesh-list
65096355|NCT03459105|Anesthetics, Local|anesthetics, local|mesh-ancestor
65096356|NCT03459105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65096357|NCT03459105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096358|NCT03459105|Sensory System Agents|sensory system agents|mesh-ancestor
65096359|NCT03459105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65096360|NCT01240382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65096361|NCT01240382|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65096362|NCT01240382|Hyaluronic Acid|hyaluronic acid|mesh-list
65096363|NCT01240382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65288095|NCT02647268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65288096|NCT02647268|Anesthetics|anesthetics|mesh-ancestor
65288097|NCT02647268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65288098|NCT02647268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65288099|NCT02647268|Anticonvulsants|anticonvulsants|mesh-ancestor
65288100|NCT02647268|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65288101|NCT02647268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65288102|NCT02647268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288103|NCT02647268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65096364|NCT01240382|Immunologic Factors|immunologic factors|mesh-ancestor
65096365|NCT01240382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096366|NCT01240382|Viscosupplements|viscosupplements|mesh-ancestor
65096367|NCT01240382|Protective Agents|protective agents|mesh-ancestor
65096368|NCT01244828|Asenapine|asenapine|mesh-list
65096369|NCT01244828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65096370|NCT01244828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65096371|NCT01244828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65096372|NCT01244828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096373|NCT01244828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65096374|NCT00504192|Gemcitabine|gemcitabine|mesh-list
65096375|NCT00504192|Oxaliplatin|oxaliplatin|mesh-list
65096376|NCT00504192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65096377|NCT00504192|Antimetabolites|antimetabolites|mesh-ancestor
65096378|NCT00504192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096379|NCT00504192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096380|NCT00504192|Antiviral Agents|antiviral agents|mesh-ancestor
65096381|NCT00504192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65096382|NCT00504192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096383|NCT00504192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65096384|NCT00504192|Immunologic Factors|immunologic factors|mesh-ancestor
65096385|NCT00504192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096386|NCT01243346|Crenolanib|crenolanib|mesh-list
64738570|NCT00002135|Ganciclovir|ganciclovir|mesh-list
65096406|NCT00516243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096407|NCT00516243|Protective Agents|protective agents|mesh-ancestor
65096408|NCT00516243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096409|NCT00516243|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65096410|NCT00516243|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65096411|NCT00516243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096412|NCT00516243|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65096413|NCT01240889|Fluticasone|fluticasone|mesh-list
65096414|NCT01240889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65096415|NCT01240889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65096416|NCT01240889|Autonomic Agents|autonomic agents|mesh-ancestor
65096417|NCT01240889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65096418|NCT01240889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096419|NCT01240889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65096420|NCT01240889|Respiratory System Agents|respiratory system agents|mesh-ancestor
65096421|NCT01240889|Dermatologic Agents|dermatologic agents|mesh-ancestor
65096422|NCT01240889|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65096423|NCT00516282|Temozolomide|temozolomide|mesh-list
65096424|NCT00516282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65096425|NCT00516282|Alkylating Agents|alkylating agents|mesh-ancestor
65096426|NCT00516282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096427|NCT00516282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096428|NCT01249521|Bevacizumab|bevacizumab|mesh-list
65096429|NCT01249521|Trebananib|trebananib|mesh-list
65096430|NCT01249521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65096431|NCT01249521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096432|NCT01249521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65096433|NCT01249521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64669292|NCT03149991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65096454|NCT04519463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65096455|NCT04519463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64518370|NCT03238092|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65288104|NCT02647268|Tocolytic Agents|tocolytic agents|mesh-ancestor
65288105|NCT04218149|Bupivacaine|bupivacaine|mesh-list
65288106|NCT04218149|Anesthetics, Local|anesthetics, local|mesh-ancestor
65288107|NCT04218149|Anesthetics|anesthetics|mesh-ancestor
65288108|NCT04218149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65288109|NCT04218149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288110|NCT04218149|Sensory System Agents|sensory system agents|mesh-ancestor
65288111|NCT04218149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65288112|NCT04032860|Tenofovir|tenofovir|mesh-list
65288113|NCT04032860|Entecavir|entecavir|mesh-list
65288114|NCT04032860|Antiviral Agents|antiviral agents|mesh-ancestor
65288115|NCT04032860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65096456|NCT04519463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65096457|NCT04519463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65096458|NCT04519463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65096459|NCT04519463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096460|NCT04696848|Durvalumab|durvalumab|mesh-list
65096461|NCT04696848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64738644|NCT00002387|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65096462|NCT04696848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096463|NCT01244256|Gentamicins|gentamicins|mesh-list
65096464|NCT01244256|Clotrimazole|clotrimazole|mesh-list
65096465|NCT01244256|Miconazole|miconazole|mesh-list
65096466|NCT01244256|Beclomethasone|beclomethasone|mesh-list
65096467|NCT01244256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65096468|NCT01244256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65096469|NCT01244256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65096470|NCT01244256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096471|NCT01244256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096472|NCT01244256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65096473|NCT01244256|Glucocorticoids|glucocorticoids|mesh-ancestor
65096474|NCT01244256|Hormones|hormones|mesh-ancestor
65096475|NCT01244256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65096476|NCT01244256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096477|NCT01244256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65096478|NCT01244256|Respiratory System Agents|respiratory system agents|mesh-ancestor
65096479|NCT01244256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65096480|NCT01244256|Antifungal Agents|antifungal agents|mesh-ancestor
65096481|NCT01244256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65096482|NCT01244256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65096483|NCT01244256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65096484|NCT01244256|Hormone Antagonists|hormone antagonists|mesh-ancestor
65096485|NCT01244256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64669329|NCT01605890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65096507|NCT01249404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65096508|NCT01249404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65096509|NCT01249404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65096510|NCT01249404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096511|NCT01249404|Cholinergic Agents|cholinergic agents|mesh-ancestor
65096512|NCT01249404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65096513|NCT01249404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096514|NCT01249404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65096515|NCT01249404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65096516|NCT04511000|Atorvastatin|atorvastatin|mesh-list
65096517|NCT04511000|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65096518|NCT04511000|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65096519|NCT04511000|Antimetabolites|antimetabolites|mesh-ancestor
65096520|NCT04511000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096521|NCT04511000|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65096522|NCT04511000|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65288116|NCT04032860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65288117|NCT04032860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65288118|NCT04032860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288119|NCT04032860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288120|NCT04032860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65096523|NCT04511000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096524|NCT04519385|Dexamethasone|dexamethasone|mesh-list
65096525|NCT04519385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65096526|NCT04519385|Antiemetics|antiemetics|mesh-ancestor
65096527|NCT04519385|Autonomic Agents|autonomic agents|mesh-ancestor
65096528|NCT04519385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65096529|NCT04519385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096530|NCT04519385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65096531|NCT04519385|Glucocorticoids|glucocorticoids|mesh-ancestor
65096557|NCT04510649|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65096558|NCT04510649|Antitubercular Agents|antitubercular agents|mesh-ancestor
65096559|NCT04510649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65096560|NCT04510649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65096561|NCT04510649|Leprostatic Agents|leprostatic agents|mesh-ancestor
65096562|NCT04510649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65096563|NCT04510649|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65096564|NCT04510649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65096565|NCT04510649|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65096566|NCT04510649|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65096567|NCT04510649|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65096568|NCT04510649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65096569|NCT01249092|Pentoxifylline|pentoxifylline|mesh-list
65096570|NCT01249092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65096571|NCT01249092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096572|NCT01249092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096573|NCT01249092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65096574|NCT01249092|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65096575|NCT01249092|Protective Agents|protective agents|mesh-ancestor
65096576|NCT01249092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096577|NCT01249092|Vasodilator Agents|vasodilator agents|mesh-ancestor
65096578|NCT01249092|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65096579|NCT01249092|Antioxidants|antioxidants|mesh-ancestor
65096593|NCT02275182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096594|NCT01248780|Golimumab|golimumab|mesh-list
65096595|NCT01248780|Methotrexate|methotrexate|mesh-list
65096596|NCT01248780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65096597|NCT01248780|Abortifacient Agents|abortifacient agents|mesh-ancestor
65096598|NCT01248780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65096599|NCT01248780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096600|NCT01248780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65096601|NCT01248780|Antimetabolites|antimetabolites|mesh-ancestor
65096602|NCT01248780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096603|NCT01248780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096604|NCT01248780|Dermatologic Agents|dermatologic agents|mesh-ancestor
65096605|NCT01248780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096606|NCT01248780|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65096607|NCT01248780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65096608|NCT01248780|Immunologic Factors|immunologic factors|mesh-ancestor
65096609|NCT01248780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65096610|NCT01248780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65096611|NCT01248780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65096612|NCT01248780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65096613|NCT01248468|Aspirin|aspirin|mesh-list
65096614|NCT01248468|Acetaminophen|acetaminophen|mesh-list
65096615|NCT01248468|Sumatriptan|sumatriptan|mesh-list
65096616|NCT01248468|Caffeine|caffeine|mesh-list
65096617|NCT01248468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65096618|NCT01248468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65096619|NCT01248468|Analgesics|analgesics|mesh-ancestor
65096620|NCT01248468|Sensory System Agents|sensory system agents|mesh-ancestor
65096621|NCT01248468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65096622|NCT01248468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096623|NCT01248468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65288121|NCT04032860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65288122|NCT00716248|Bucillamine|bucillamine|mesh-list
65288123|NCT00716248|Methotrexate|methotrexate|mesh-list
65288124|NCT00716248|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65288125|NCT00716248|Abortifacient Agents|abortifacient agents|mesh-ancestor
65288126|NCT00716248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65288127|NCT00716248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288128|NCT00716248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65096624|NCT01248468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65096625|NCT01248468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65096626|NCT01248468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65096627|NCT01248468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096628|NCT01248468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65096629|NCT01248468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65096630|NCT01248468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096631|NCT01248468|Antipyretics|antipyretics|mesh-ancestor
65096632|NCT01248468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65096633|NCT01248468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65096634|NCT01248468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65096635|NCT01248468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65096636|NCT01248468|Purinergic Agents|purinergic agents|mesh-ancestor
65096637|NCT01248468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65096638|NCT01248468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65096639|NCT01248468|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65096671|NCT01246206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096672|NCT04510610|Decitabine|decitabine|mesh-list
65096673|NCT04510610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65096674|NCT04510610|Antimetabolites|antimetabolites|mesh-ancestor
65096675|NCT04510610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096676|NCT04510610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096677|NCT04510610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096678|NCT01246011|Warfarin|warfarin|mesh-list
65096679|NCT01246011|Argatroban|argatroban|mesh-list
65096680|NCT01246011|Anticoagulants|anticoagulants|mesh-ancestor
65096681|NCT01246011|Antithrombins|antithrombins|mesh-ancestor
64738881|NCT00002489|Leucovorin|leucovorin|mesh-list
64483576|NCT04345432|Analgesics|analgesics|mesh-ancestor
65096714|NCT01243944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096715|NCT01243944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65096716|NCT01243944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65096717|NCT01243944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65096718|NCT01243944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65096719|NCT01243944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65096720|NCT01243944|Alkylating Agents|alkylating agents|mesh-ancestor
65096721|NCT00516399|Povidone-Iodine|povidone-iodine|mesh-list
65096722|NCT00516399|Natamycin|natamycin|mesh-list
65096723|NCT00516399|Povidone|povidone|mesh-list
65096725|NCT00516399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65096726|NCT00516399|Plasma Substitutes|plasma substitutes|mesh-ancestor
65096727|NCT00516399|Blood Substitutes|blood substitutes|mesh-ancestor
65096728|NCT00516399|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65096729|NCT00516399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64669631|NCT04997525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096730|NCT00516399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65096731|NCT00516399|Antifungal Agents|antifungal agents|mesh-ancestor
65096732|NCT00516438|Topotecan|topotecan|mesh-list
65096733|NCT00516438|Olaparib|olaparib|mesh-list
65096734|NCT00516438|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65096735|NCT00516438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65096736|NCT00516438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65096737|NCT00516438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096738|NCT00516438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096739|NCT00516438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096740|NCT02275988|Clarithromycin|clarithromycin|mesh-list
65096741|NCT02275988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65096742|NCT02275988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65096743|NCT02275988|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65288129|NCT00716248|Antimetabolites|antimetabolites|mesh-ancestor
65288130|NCT00716248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288131|NCT00716248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288132|NCT00716248|Dermatologic Agents|dermatologic agents|mesh-ancestor
65288133|NCT00716248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288134|NCT00716248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65288135|NCT00716248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65288136|NCT00716248|Immunologic Factors|immunologic factors|mesh-ancestor
65288137|NCT00716248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65288138|NCT00716248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65288139|NCT00716248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65288140|NCT00716248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65288141|NCT00716248|Analgesics|analgesics|mesh-ancestor
64518386|NCT03247998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65096744|NCT02275988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096745|NCT02275988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096746|NCT02275988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65096747|NCT02275988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65096748|NCT02950155|Rituximab|rituximab|mesh-list
65096749|NCT02950155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65096750|NCT02950155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096751|NCT02950155|Immunologic Factors|immunologic factors|mesh-ancestor
65096752|NCT02950155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096753|NCT02950155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65096754|NCT00516672|Lapatinib|lapatinib|mesh-list
65096755|NCT00516672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096756|NCT00516672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65096758|NCT00516672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096759|NCT00516711|Sevoflurane|sevoflurane|mesh-list
65096760|NCT00516711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65096761|NCT00516711|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65096762|NCT00516711|Anesthetics, General|anesthetics, general|mesh-ancestor
65096763|NCT00516711|Anesthetics|anesthetics|mesh-ancestor
65096764|NCT00516711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65096765|NCT00516711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096766|NCT00516750|Doxorubicin|doxorubicin|mesh-list
65096767|NCT00516750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65096768|NCT00516750|Methotrexate|methotrexate|mesh-list
65096769|NCT00516750|Vinblastine|vinblastine|mesh-list
65096770|NCT00516750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096771|NCT00516750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65096772|NCT00516750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65096773|NCT00516750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65096774|NCT00516750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096775|NCT00516750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096776|NCT00516750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65096777|NCT00516750|Abortifacient Agents|abortifacient agents|mesh-ancestor
65096778|NCT00516750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65096779|NCT00516750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096780|NCT00516750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65096781|NCT00516750|Antimetabolites|antimetabolites|mesh-ancestor
65096782|NCT00516750|Dermatologic Agents|dermatologic agents|mesh-ancestor
65096783|NCT00516750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65096784|NCT00516750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65096785|NCT00516750|Immunologic Factors|immunologic factors|mesh-ancestor
65096786|NCT00516750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65096794|NCT00505427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096795|NCT00505427|Protective Agents|protective agents|mesh-ancestor
65096796|NCT00505427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288142|NCT00716248|Sensory System Agents|sensory system agents|mesh-ancestor
65288143|NCT00716248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65288144|NCT00716248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65288145|NCT00716248|Antioxidants|antioxidants|mesh-ancestor
65288146|NCT00716248|Protective Agents|protective agents|mesh-ancestor
65288147|NCT02643212|Rivaroxaban|rivaroxaban|mesh-list
65288148|NCT02643212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65288149|NCT02643212|Antithrombins|antithrombins|mesh-ancestor
65288150|NCT02643212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65288151|NCT02643212|Protease Inhibitors|protease inhibitors|mesh-ancestor
65288152|NCT02643212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288153|NCT02643212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288154|NCT02643212|Anticoagulants|anticoagulants|mesh-ancestor
65288155|NCT02642900|Nystatin|nystatin|mesh-list
65288156|NCT02642900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65288157|NCT02642900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65288158|NCT02642900|Antifungal Agents|antifungal agents|mesh-ancestor
64518397|NCT03248076|Sensory System Agents|sensory system agents|mesh-ancestor
65096797|NCT00505427|Vitamin B Complex|vitamin b complex|mesh-ancestor
65096798|NCT00505427|Vitamins|vitamins|mesh-ancestor
65096799|NCT00505427|Micronutrients|micronutrients|mesh-ancestor
65096800|NCT00506168|Capecitabine|capecitabine|mesh-list
65096801|NCT00506168|Irinotecan|irinotecan|mesh-list
65096802|NCT00506168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65096803|NCT00506168|Antimetabolites|antimetabolites|mesh-ancestor
65096804|NCT00506168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096805|NCT00506168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096806|NCT00506168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65096807|NCT00506168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65096808|NCT00506168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096809|NCT02950038|Nivolumab|nivolumab|mesh-list
65096810|NCT02950038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65096811|NCT02950038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096812|NCT02950038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65096813|NCT02950038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096814|NCT04510220|Ofatumumab|ofatumumab|mesh-list
65096815|NCT04510220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096816|NCT02949648|Nicotine|nicotine|mesh-list
65096817|NCT02949648|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65096818|NCT02949648|Autonomic Agents|autonomic agents|mesh-ancestor
65096819|NCT02949648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65096820|NCT02949648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096821|NCT02949648|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65096822|NCT02949648|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65096823|NCT02949648|Cholinergic Agents|cholinergic agents|mesh-ancestor
65096824|NCT02949648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65096825|NCT02949648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096826|NCT04510337|Magnesium Sulfate|magnesium sulfate|mesh-list
65096827|NCT04510337|Rocuronium|rocuronium|mesh-list
65096829|NCT04510337|Sensory System Agents|sensory system agents|mesh-ancestor
65096830|NCT04510337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64739019|NCT00002183|Antiviral Agents|antiviral agents|mesh-ancestor
65096831|NCT04510337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096832|NCT04510337|Anesthetics|anesthetics|mesh-ancestor
65096833|NCT04510337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65096834|NCT04510337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65096835|NCT04510337|Anticonvulsants|anticonvulsants|mesh-ancestor
65096836|NCT04510337|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65096837|NCT04510337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65288159|NCT02642900|Ionophores|ionophores|mesh-ancestor
65288160|NCT02642900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65288161|NCT02642900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288162|NCT02652728|Enalapril|enalapril|mesh-list
65288163|NCT02652728|Enalaprilat|enalaprilat|mesh-list
65288164|NCT02652728|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65288165|NCT02652728|Protease Inhibitors|protease inhibitors|mesh-ancestor
65288166|NCT02652728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518415|NCT03237936|Cyclosporine|cyclosporine|mesh-list
65096838|NCT04510337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096839|NCT04510337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65096840|NCT04510337|Tocolytic Agents|tocolytic agents|mesh-ancestor
65096841|NCT04510337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65096842|NCT04510337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65096843|NCT04510337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65096844|NCT04510337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65096845|NCT00516828|Cytarabine|cytarabine|mesh-list
65096846|NCT00516828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65096847|NCT00516828|Antimetabolites|antimetabolites|mesh-ancestor
65096868|NCT00516945|Antiviral Agents|antiviral agents|mesh-ancestor
65096869|NCT00516945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65096870|NCT00516945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65096871|NCT00516945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65096872|NCT02275598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65096873|NCT02275598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65096874|NCT02275598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096875|NCT00517062|Hormones|hormones|mesh-list
65096876|NCT00517062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65096877|NCT00517062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096878|NCT00517179|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65096879|NCT00517179|Vasodilator Agents|vasodilator agents|mesh-ancestor
65096880|NCT00517179|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65096881|NCT00517179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65096882|NCT00517179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096883|NCT00517179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096884|NCT00517179|Urological Agents|urological agents|mesh-ancestor
65096885|NCT00517218|Oblimersen|oblimersen|mesh-list
65096886|NCT00517218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096887|NCT00506207|Oxaliplatin|oxaliplatin|mesh-list
65096888|NCT00506207|Irinotecan|irinotecan|mesh-list
65096889|NCT00506207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096890|NCT00506207|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65096891|NCT00506207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65096892|NCT00506207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096893|NCT00506207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096894|NCT00517257|Atorvastatin|atorvastatin|mesh-list
65096895|NCT00517257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65096896|NCT00517257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65096897|NCT00517257|Antimetabolites|antimetabolites|mesh-ancestor
65096898|NCT00517257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096899|NCT00517257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65096900|NCT00517257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65096901|NCT00517257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096902|NCT00506246|Propofol|propofol|mesh-list
64669739|NCT03141359|Cisplatin|cisplatin|mesh-list
65096931|NCT00517725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65096932|NCT00517725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65096933|NCT00517725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65096934|NCT00517725|Vasodilator Agents|vasodilator agents|mesh-ancestor
65096935|NCT00517725|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65096936|NCT00517725|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65096937|NCT00517725|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65096938|NCT00517725|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65096939|NCT00517725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65096940|NCT00517725|Sympatholytics|sympatholytics|mesh-ancestor
65288167|NCT02652728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288168|NCT02652728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65288169|NCT00720148|Bortezomib|bortezomib|mesh-list
65288170|NCT00720148|Sunitinib|sunitinib|mesh-list
65288171|NCT00720148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288172|NCT00720148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65288173|NCT00720148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65288174|NCT00720148|Growth Substances|growth substances|mesh-ancestor
65288175|NCT00720148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518422|NCT03237936|Antifungal Agents|antifungal agents|mesh-ancestor
64518423|NCT03237936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65096941|NCT00517725|Autonomic Agents|autonomic agents|mesh-ancestor
65096942|NCT00517725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65096943|NCT00517725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65096944|NCT01240863|Hydrocodone|hydrocodone|mesh-list
65096945|NCT01240863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65096946|NCT01240863|Narcotics|narcotics|mesh-ancestor
65096947|NCT01240863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65096948|NCT01240863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096949|NCT01240863|Analgesics|analgesics|mesh-ancestor
65096950|NCT01240863|Sensory System Agents|sensory system agents|mesh-ancestor
65096951|NCT01240863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65096975|NCT00517764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65096977|NCT00517764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096978|NCT00517764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65096979|NCT00517764|Serotonin Agents|serotonin agents|mesh-ancestor
65096980|NCT00517764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096981|NCT00517764|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65096982|NCT00517764|Antidepressive Agents|antidepressive agents|mesh-ancestor
65096983|NCT00517764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65096984|NCT00517803|Micronutrients|micronutrients|mesh-list
65096985|NCT00517803|Trace Elements|trace elements|mesh-list
65096986|NCT00517803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096987|NCT04517435|Prednisone|prednisone|mesh-list
65096988|NCT04517435|Cyclophosphamide|cyclophosphamide|mesh-list
65096989|NCT04517435|Rituximab|rituximab|mesh-list
65096990|NCT04517435|Doxorubicin|doxorubicin|mesh-list
65096991|NCT04517435|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65096992|NCT04517435|Vincristine|vincristine|mesh-list
65096993|NCT04517435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65096994|NCT04517435|Immunologic Factors|immunologic factors|mesh-ancestor
65096995|NCT04517435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097011|NCT04517435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65097012|NCT04517435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65097013|NCT04517435|Tubulin Modulators|tubulin modulators|mesh-ancestor
65097014|NCT04517435|Antimitotic Agents|antimitotic agents|mesh-ancestor
65097015|NCT04517435|Mitosis Modulators|mitosis modulators|mesh-ancestor
65097016|NCT04516304|Equol|equol|mesh-list
65097017|NCT04516304|Phytoestrogens|phytoestrogens|mesh-ancestor
65097018|NCT04516304|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65097019|NCT04516304|Estrogens|estrogens|mesh-ancestor
65097020|NCT04516304|Hormones|hormones|mesh-ancestor
65097021|NCT04516304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65097022|NCT04516304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097023|NCT01242930|Niacinamide|niacinamide|mesh-list
65097024|NCT01242930|Lenalidomide|lenalidomide|mesh-list
65097025|NCT01242930|Imetelstat|imetelstat|mesh-list
65097026|NCT01242930|Motesanib diphosphate|motesanib diphosphate|mesh-list
65097027|NCT01242930|Immunologic Factors|immunologic factors|mesh-ancestor
65097028|NCT01242930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097029|NCT01242930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65097030|NCT01242930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65097031|NCT01242930|Growth Substances|growth substances|mesh-ancestor
65097032|NCT01242930|Growth Inhibitors|growth inhibitors|mesh-ancestor
65097033|NCT01242930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288176|NCT00720148|Growth Inhibitors|growth inhibitors|mesh-ancestor
65288177|NCT00720148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65288178|NCT00720148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288179|NCT00720148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288180|NCT00710788|Calcium Carbonate|calcium carbonate|mesh-list
65288181|NCT00710788|Calcium|calcium|mesh-list
65288182|NCT00710788|Sevelamer|sevelamer|mesh-list
65288183|NCT00710788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65288184|NCT00710788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288185|NCT00710788|Antacids|antacids|mesh-ancestor
65288186|NCT00710788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288187|NCT00710788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65288188|NCT00710788|Chelating Agents|chelating agents|mesh-ancestor
65288189|NCT00710788|Sequestering Agents|sequestering agents|mesh-ancestor
65288190|NCT03530189|Insulin|insulin|mesh-list
65288191|NCT03530189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65288192|NCT03530189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288193|NCT02646800|Micafungin|micafungin|mesh-list
65288194|NCT02646800|Antifungal Agents|antifungal agents|mesh-ancestor
65288195|NCT02646800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65288196|NCT02749409|Parecoxib|parecoxib|mesh-list
65288197|NCT02749409|Morphine|morphine|mesh-list
65288198|NCT02749409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65288199|NCT02749409|Narcotics|narcotics|mesh-ancestor
65288200|NCT02749409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65288201|NCT02749409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288202|NCT02749409|Analgesics|analgesics|mesh-ancestor
65288203|NCT02749409|Sensory System Agents|sensory system agents|mesh-ancestor
65288204|NCT02749409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65288205|NCT02749409|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65288206|NCT02749409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65288207|NCT02749409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097034|NCT01242930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097035|NCT01242930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097036|NCT01242930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65097037|NCT01242930|Vitamin B Complex|vitamin b complex|mesh-ancestor
65097038|NCT01242930|Vitamins|vitamins|mesh-ancestor
65097039|NCT01242930|Micronutrients|micronutrients|mesh-ancestor
65097040|NCT01241214|Cetirizine|cetirizine|mesh-list
65097041|NCT01241214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65097042|NCT01241214|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65097043|NCT01241214|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64669889|NCT03000309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65097071|NCT04515641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65097072|NCT04515641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288208|NCT02749409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288209|NCT02749409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65288210|NCT02749409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65288211|NCT02749409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65288212|NCT02749409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65288213|NCT03454529|Simvastatin|simvastatin|mesh-list
65288214|NCT03454529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65288215|NCT03454529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65288216|NCT03454529|Antimetabolites|antimetabolites|mesh-ancestor
64518462|NCT03102723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64518467|NCT03237312|Hormones|hormones|mesh-list
65097073|NCT04515641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097074|NCT04515641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65097075|NCT04515641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65097076|NCT04515641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65097077|NCT00518232|Methylphenidate|methylphenidate|mesh-list
65097078|NCT00518232|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65097079|NCT00518232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097080|NCT00518232|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65097081|NCT00518232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65097082|NCT00518232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65097083|NCT00518232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097084|NCT00518232|Dopamine Agents|dopamine agents|mesh-ancestor
65097085|NCT00518232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65097086|NCT00505505|Insulin|insulin|mesh-list
65097087|NCT00505505|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65097088|NCT00505505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65097089|NCT00505505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097090|NCT00518271|Sirolimus|sirolimus|mesh-list
65097091|NCT00518271|Tacrolimus|tacrolimus|mesh-list
65097092|NCT00518271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65097093|NCT00518271|Immunologic Factors|immunologic factors|mesh-ancestor
65097094|NCT00518271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097095|NCT00518271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65097096|NCT00518271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097097|NCT00518271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097098|NCT00518271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65097099|NCT00518271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65097121|NCT00518466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65097122|NCT00518466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097124|NCT00518583|Doxorubicin|doxorubicin|mesh-list
65097125|NCT00518583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65097126|NCT00518583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65097127|NCT00518583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097128|NCT00518583|Tubulin Modulators|tubulin modulators|mesh-ancestor
65097129|NCT00518583|Antimitotic Agents|antimitotic agents|mesh-ancestor
65097130|NCT00518583|Mitosis Modulators|mitosis modulators|mesh-ancestor
65097131|NCT00518583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097132|NCT00518583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65097133|NCT00518583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65097134|NCT00518583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65097136|NCT00519753|Timolol|timolol|mesh-list
65097137|NCT00519753|Travoprost|travoprost|mesh-list
65097138|NCT00519753|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65097139|NCT00519753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65097140|NCT00519753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097141|NCT00519753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65097142|NCT00519753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65097143|NCT00519753|Adrenergic Agents|adrenergic agents|mesh-ancestor
65097144|NCT00519753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65097145|NCT00519753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097146|NCT00519753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65288217|NCT03454529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288218|NCT03454529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65288219|NCT03454529|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65288220|NCT03454529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288221|NCT03449459|Amikacin|amikacin|mesh-list
65288222|NCT03449459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65288223|NCT03449459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65288224|NCT00653120|Propranolol|propranolol|mesh-list
65288225|NCT00653120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65288226|NCT00653120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65288227|NCT00653120|Adrenergic Agents|adrenergic agents|mesh-ancestor
65288228|NCT00653120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65288229|NCT00653120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288230|NCT00653120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518470|NCT00057681|Valproic Acid|valproic acid|mesh-list
65097147|NCT00519753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65097148|NCT00519870|Losartan|losartan|mesh-list
65097149|NCT00519870|Nifedipine|nifedipine|mesh-list
65097150|NCT00519870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65097151|NCT00519870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65097152|NCT00519870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65097153|NCT00519870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65097154|NCT00519870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097187|NCT04514588|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65097188|NCT04514588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65097189|NCT04514588|Purinergic Agents|purinergic agents|mesh-ancestor
65097190|NCT04514588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65097191|NCT00519987|Ketamine|ketamine|mesh-list
65097192|NCT00519987|Analgesics|analgesics|mesh-ancestor
65097193|NCT00519987|Sensory System Agents|sensory system agents|mesh-ancestor
65097198|NCT00519987|Anesthetics, General|anesthetics, general|mesh-ancestor
65097200|NCT00519987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65097201|NCT00519987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65097202|NCT00519987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64739412|NCT00002627|Paclitaxel|paclitaxel|mesh-list
65097203|NCT00519987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65097204|NCT00519987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097205|NCT02276300|Cyclophosphamide|cyclophosphamide|mesh-list
65097206|NCT02276300|Imiquimod|imiquimod|mesh-list
65097207|NCT02276300|Sargramostim|sargramostim|mesh-list
65097208|NCT02276300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65097209|NCT02276300|Immunologic Factors|immunologic factors|mesh-ancestor
65097210|NCT02276300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097211|NCT02276300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65097212|NCT02276300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65097213|NCT02276300|Alkylating Agents|alkylating agents|mesh-ancestor
65097214|NCT02276300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097215|NCT02276300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097216|NCT02276300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65097217|NCT02276300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65097218|NCT02276300|Interferon Inducers|interferon inducers|mesh-ancestor
65097219|NCT00520026|Lithium Carbonate|lithium carbonate|mesh-list
65097220|NCT00520026|Antidepressive Agents|antidepressive agents|mesh-ancestor
65097221|NCT00520026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65097222|NCT00520026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097223|NCT00520026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097224|NCT00520026|Antimanic Agents|antimanic agents|mesh-ancestor
65097225|NCT00520026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65288231|NCT00653120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65288232|NCT00653120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65288233|NCT00653120|Vasodilator Agents|vasodilator agents|mesh-ancestor
65288234|NCT00678132|Gemcitabine|gemcitabine|mesh-list
65288235|NCT00678132|Olaparib|olaparib|mesh-list
65288236|NCT00678132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288237|NCT00678132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65288238|NCT00678132|Antimetabolites|antimetabolites|mesh-ancestor
65288239|NCT00678132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288240|NCT00678132|Antiviral Agents|antiviral agents|mesh-ancestor
65288241|NCT00678132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65288242|NCT00678132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288243|NCT00678132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65288244|NCT00678132|Immunologic Factors|immunologic factors|mesh-ancestor
65288245|NCT00678132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288246|NCT00678132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65288247|NCT02789345|Osimertinib|osimertinib|mesh-list
65288248|NCT02789345|Ramucirumab|ramucirumab|mesh-list
65288249|NCT02789345|Necitumumab|necitumumab|mesh-list
65288250|NCT02789345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288251|NCT02789345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65288252|NCT02789345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288253|NCT02789345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288254|NCT02789345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65288255|NCT02772965|Methotrexate|methotrexate|mesh-list
65288256|NCT02772965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65097226|NCT00520026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65097227|NCT00520026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097229|NCT02955251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65097230|NCT02955251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097231|NCT02955251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65097232|NCT02955251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097233|NCT00518895|Dacarbazine|dacarbazine|mesh-list
65097234|NCT00518895|Oblimersen|oblimersen|mesh-list
65097235|NCT00518895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65097236|NCT00518895|Alkylating Agents|alkylating agents|mesh-ancestor
65097237|NCT00518895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097238|NCT00518895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097239|NCT00520104|Ketamine|ketamine|mesh-list
65097240|NCT00520104|Analgesics|analgesics|mesh-ancestor
65097241|NCT00520104|Sensory System Agents|sensory system agents|mesh-ancestor
65097242|NCT00520104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65097243|NCT00520104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097244|NCT00520104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65097245|NCT00520104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65097246|NCT00520104|Anesthetics, General|anesthetics, general|mesh-ancestor
65097247|NCT00520104|Anesthetics|anesthetics|mesh-ancestor
65288257|NCT02772965|Abortifacient Agents|abortifacient agents|mesh-ancestor
65288258|NCT02772965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65288259|NCT02772965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288260|NCT02772965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65288261|NCT02772965|Antimetabolites|antimetabolites|mesh-ancestor
65288262|NCT02772965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288263|NCT02772965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288264|NCT02772965|Dermatologic Agents|dermatologic agents|mesh-ancestor
65288265|NCT02772965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288266|NCT02772965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65288267|NCT02772965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65097248|NCT00520104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65097249|NCT00520104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65097250|NCT00520104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65097251|NCT00520104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65097252|NCT00520104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097253|NCT00519012|Sertraline|sertraline|mesh-list
65097254|NCT00519012|Paroxetine|paroxetine|mesh-list
65097255|NCT00519012|Antidepressive Agents|antidepressive agents|mesh-ancestor
65097256|NCT00519012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65097257|NCT00519012|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65097258|NCT00519012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65097264|NCT00519012|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64670128|NCT05357079|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65097265|NCT00519012|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65097266|NCT00519012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65097267|NCT00519012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097268|NCT00520260|Ketorolac|ketorolac|mesh-list
65097269|NCT00520260|Bromfenac|bromfenac|mesh-list
65097270|NCT00520260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65097271|NCT00520260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65097272|NCT00520260|Analgesics|analgesics|mesh-ancestor
65097273|NCT00520260|Sensory System Agents|sensory system agents|mesh-ancestor
65097274|NCT00520260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65097275|NCT00520260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097276|NCT00520260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65097277|NCT00520260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65097278|NCT00520260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65097279|NCT00520260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097280|NCT00520260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097282|NCT00520338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65097283|NCT00520338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65097284|NCT00520338|Analgesics|analgesics|mesh-ancestor
65097285|NCT00520338|Sensory System Agents|sensory system agents|mesh-ancestor
65097286|NCT00520338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65097287|NCT00520338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097288|NCT00520338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65097289|NCT00520338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65097290|NCT00520338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65097291|NCT00520338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65097292|NCT00520338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097293|NCT00520338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097294|NCT02594072|Goserelin|goserelin|mesh-list
65097295|NCT02594072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65097296|NCT02594072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097297|NCT00519051|Fluoxetine|fluoxetine|mesh-list
65097298|NCT00519051|Antidepressive Agents|antidepressive agents|mesh-list
64483629|NCT00758836|Antipyretics|antipyretics|mesh-ancestor
65097299|NCT00519051|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65097300|NCT00519051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65097301|NCT00519051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65288268|NCT02772965|Immunologic Factors|immunologic factors|mesh-ancestor
65288269|NCT02772965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65288270|NCT02772965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65288271|NCT00681720|Flumazenil|flumazenil|mesh-list
65288272|NCT00681720|Antidotes|antidotes|mesh-ancestor
65288273|NCT00681720|Protective Agents|protective agents|mesh-ancestor
65288274|NCT00681720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288275|NCT00681720|GABA Modulators|gaba modulators|mesh-ancestor
65288276|NCT00681720|GABA Agents|gaba agents|mesh-ancestor
65288277|NCT00681720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65288278|NCT00681720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288279|NCT00650312|Metformin|metformin|mesh-list
65288280|NCT00650312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65288281|NCT00650312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288282|NCT00538681|Pemetrexed|pemetrexed|mesh-list
64518523|NCT03247140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64518531|NCT03237546|Anesthetics|anesthetics|mesh-list
65097302|NCT00519051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097303|NCT00519051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65097304|NCT00519051|Serotonin Agents|serotonin agents|mesh-ancestor
65097305|NCT00519051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097306|NCT00519051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65097307|NCT00519051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65097308|NCT00519051|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65097309|NCT00519051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65097310|NCT00519051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097312|NCT00505700|Bortezomib|bortezomib|mesh-list
65097313|NCT00505700|Idarubicin|idarubicin|mesh-list
65097314|NCT00505700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65097315|NCT00505700|Antimetabolites|antimetabolites|mesh-ancestor
65097316|NCT00505700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097317|NCT00505700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097318|NCT00505700|Antiviral Agents|antiviral agents|mesh-ancestor
65097319|NCT00505700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65097320|NCT00505700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65097321|NCT00505700|Immunologic Factors|immunologic factors|mesh-ancestor
65097322|NCT00505700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097323|NCT00505700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64670194|NCT05293509|Dermatologic Agents|dermatologic agents|mesh-ancestor
64670195|NCT05293509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65097330|NCT00519207|Lidocaine|lidocaine|mesh-list
65097331|NCT00519207|Anesthetics, Local|anesthetics, local|mesh-ancestor
65097332|NCT00519207|Anesthetics|anesthetics|mesh-ancestor
65097333|NCT00519207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65097334|NCT00519207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097335|NCT00519207|Sensory System Agents|sensory system agents|mesh-ancestor
65097336|NCT00519207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65097337|NCT00519207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65097338|NCT00519207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65097339|NCT00519207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65097340|NCT00519207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65097341|NCT00519207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097342|NCT02590094|Bevacizumab|bevacizumab|mesh-list
65097343|NCT02590094|Aflibercept|aflibercept|mesh-list
65097344|NCT02590094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65097345|NCT02590094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097346|NCT02590094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65097347|NCT02590094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65288283|NCT00538681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288284|NCT00538681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288285|NCT00538681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288286|NCT00538681|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65288287|NCT00538681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65288288|NCT00650390|Adalimumab|adalimumab|mesh-list
65288289|NCT00650390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65288290|NCT00650390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65288291|NCT00681876|Bevacizumab|bevacizumab|mesh-list
65288292|NCT00681876|Cetuximab|cetuximab|mesh-list
65288293|NCT00681876|Irinotecan|irinotecan|mesh-list
65288294|NCT00681876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65288295|NCT00681876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288296|NCT00681876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65288297|NCT00681876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65288298|NCT00681876|Growth Substances|growth substances|mesh-ancestor
65288299|NCT00681876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288300|NCT00681876|Growth Inhibitors|growth inhibitors|mesh-ancestor
64518538|NCT03247296|Antiviral Agents|antiviral agents|mesh-ancestor
64739561|NCT00002681|Aldesleukin|aldesleukin|mesh-list
65097348|NCT02590094|Growth Substances|growth substances|mesh-ancestor
65097349|NCT02590094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097350|NCT02590094|Growth Inhibitors|growth inhibitors|mesh-ancestor
65097351|NCT00520455|Levonorgestrel|levonorgestrel|mesh-list
65097352|NCT00520455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65097353|NCT00520455|Contraceptive Agents|contraceptive agents|mesh-ancestor
65097354|NCT00520455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65097355|NCT00520455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097356|NCT00520455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65097357|NCT00520455|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65097358|NCT00520455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65097359|NCT02949258|Oxaliplatin|oxaliplatin|mesh-list
65097360|NCT02949258|Etoposide|etoposide|mesh-list
65097361|NCT02949258|Epirubicin|epirubicin|mesh-list
65097362|NCT02949258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097363|NCT02949258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65097364|NCT02949258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65097365|NCT02949258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65097366|NCT02949258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097367|NCT02949258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483630|NCT00769600|Itraconazole|itraconazole|mesh-list
65097368|NCT02949258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65097370|NCT04514081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65097371|NCT04514081|Antimetabolites|antimetabolites|mesh-ancestor
65097372|NCT04514081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097373|NCT04514081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097374|NCT04514081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097375|NCT00519246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65097376|NCT00519246|Analgesics, Opioid|analgesics, opioid|mesh-list
65097377|NCT00519246|Narcotics|narcotics|mesh-ancestor
65097378|NCT00519246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65097379|NCT00519246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097380|NCT00519246|Analgesics|analgesics|mesh-ancestor
65097381|NCT00519246|Sensory System Agents|sensory system agents|mesh-ancestor
65097390|NCT00519324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097392|NCT00520650|Antidepressive Agents|antidepressive agents|mesh-ancestor
65288301|NCT00681876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65288302|NCT00681876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65288303|NCT00681876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288304|NCT00681876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288305|NCT02226367|Prazosin|prazosin|mesh-list
65288306|NCT02226367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65288307|NCT02226367|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65288308|NCT02226367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64518557|NCT03237624|Hemostatics|hemostatics|mesh-ancestor
65097393|NCT00520650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65097394|NCT00520650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65097395|NCT00520650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65097396|NCT00520650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65097397|NCT00520650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097398|NCT00520650|Dopamine Agonists|dopamine agonists|mesh-ancestor
65097399|NCT00520650|Dopamine Agents|dopamine agents|mesh-ancestor
65097400|NCT00520650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65097401|NCT00520650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097402|NCT00520650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65097403|NCT00520650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65097404|NCT00520650|Serotonin Agents|serotonin agents|mesh-ancestor
65097405|NCT00520650|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65097406|NCT00520650|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65097407|NCT00520650|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65097408|NCT00520650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65097409|NCT00519363|Atorvastatin|atorvastatin|mesh-list
65097410|NCT00519363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65097411|NCT00519363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65097412|NCT00519363|Antimetabolites|antimetabolites|mesh-ancestor
65097413|NCT00519363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097414|NCT00519363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65097415|NCT00519363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65097416|NCT00519363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097417|NCT00519480|Metformin|metformin|mesh-list
65097418|NCT00519480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65097419|NCT00519480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097420|NCT02955056|Teriparatide|teriparatide|mesh-list
65097421|NCT02955056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739635|NCT00002747|Cobalt|cobalt|mesh-list
65097422|NCT02955056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65097423|NCT02955056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65097424|NCT02954939|Prednisone|prednisone|mesh-list
65097425|NCT02954939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65097426|NCT02954939|Glucocorticoids|glucocorticoids|mesh-ancestor
65097427|NCT02954939|Hormones|hormones|mesh-ancestor
65097428|NCT02954939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65097429|NCT02954939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097430|NCT02954939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65097431|NCT02954939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097432|NCT00519519|Omeprazole|omeprazole|mesh-list
65097433|NCT00519519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65097434|NCT00519519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65097435|NCT00519519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65097436|NCT00519519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670303|NCT03190005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097447|NCT02598557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097449|NCT00520806|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65097450|NCT00520806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097451|NCT00520806|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65097452|NCT00520806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65097453|NCT00505739|Mifepristone|mifepristone|mesh-list
65097454|NCT00505739|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65097455|NCT00505739|Abortifacient Agents|abortifacient agents|mesh-ancestor
65097456|NCT00505739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65288309|NCT02226367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65288310|NCT02226367|Adrenergic Agents|adrenergic agents|mesh-ancestor
65288311|NCT02226367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65288312|NCT02226367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097457|NCT00505739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097458|NCT00505739|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65097459|NCT00505739|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65097460|NCT00505739|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65097461|NCT00505739|Contraceptive Agents|contraceptive agents|mesh-ancestor
65097462|NCT00505739|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65097463|NCT00505739|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65097464|NCT00505739|Hormone Antagonists|hormone antagonists|mesh-ancestor
65097465|NCT00505739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65097466|NCT00505739|Luteolytic Agents|luteolytic agents|mesh-ancestor
65097467|NCT00505739|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65097468|NCT00505739|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65097469|NCT02948985|Cetuximab|cetuximab|mesh-list
65097470|NCT02948985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65097471|NCT02948985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097472|NCT04513457|Liver Extracts|liver extracts|mesh-list
65097473|NCT04513457|Hematinics|hematinics|mesh-ancestor
65097474|NCT00519675|Alitretinoin|alitretinoin|mesh-list
65097475|NCT00519675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097476|NCT00519675|Dermatologic Agents|dermatologic agents|mesh-ancestor
65097477|NCT00521040|Levocetirizine|levocetirizine|mesh-list
65097478|NCT00521040|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65097479|NCT00521040|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65097480|NCT00521040|Histamine Antagonists|histamine antagonists|mesh-ancestor
65097481|NCT00521040|Histamine Agents|histamine agents|mesh-ancestor
65097482|NCT00521040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65097483|NCT00521040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097484|NCT00521040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097485|NCT04513340|Levodopa|levodopa|mesh-list
65097486|NCT04513340|Carbidopa|carbidopa|mesh-list
65097487|NCT04513340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65097488|NCT04513340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65097489|NCT04513340|Dopamine Agents|dopamine agents|mesh-ancestor
65097490|NCT04513340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65097491|NCT04513340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097492|NCT04513340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097493|NCT04513340|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65097494|NCT04513340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097496|NCT05144945|Immunologic Factors|immunologic factors|mesh-ancestor
65097506|NCT04513379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65097507|NCT04513379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65097508|NCT04513379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65097509|NCT04513379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65097510|NCT04513379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65097511|NCT00521157|Naltrexone|naltrexone|mesh-list
65097512|NCT00521157|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65097513|NCT00521157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65097514|NCT00521157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097515|NCT00521157|Sensory System Agents|sensory system agents|mesh-ancestor
65097516|NCT00521157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65097517|NCT00505817|Leuprolide|leuprolide|mesh-list
65097518|NCT00505817|Cetrorelix|cetrorelix|mesh-list
65097519|NCT00505817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65097520|NCT00505817|Fertility Agents|fertility agents|mesh-ancestor
65097521|NCT00505817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65097522|NCT00505817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097523|NCT00505817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65097524|NCT00505817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097525|NCT00505817|Hormone Antagonists|hormone antagonists|mesh-ancestor
65097526|NCT00505817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65097527|NCT00521430|Cyclosporine|cyclosporine|mesh-list
65097528|NCT00521430|Methylprednisolone|methylprednisolone|mesh-list
65097529|NCT00521430|Methotrexate|methotrexate|mesh-list
65097530|NCT00521430|Fludarabine phosphate|fludarabine phosphate|mesh-list
65097531|NCT00521430|Fludarabine|fludarabine|mesh-list
65288313|NCT02226367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288314|NCT03885934|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65288315|NCT03885934|Immunologic Factors|immunologic factors|mesh-ancestor
65288316|NCT03885934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288317|NCT02159989|Aflibercept|aflibercept|mesh-list
65288318|NCT02159989|Endothelial Growth Factors|endothelial growth factors|mesh-list
65097532|NCT00521430|Busulfan|busulfan|mesh-list
65097533|NCT00521430|Cyclosporins|cyclosporins|mesh-list
65097534|NCT00521430|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65097535|NCT00521430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65097536|NCT00521430|Abortifacient Agents|abortifacient agents|mesh-ancestor
65097537|NCT00521430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65097538|NCT00521430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097539|NCT00521430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65097540|NCT00521430|Antimetabolites|antimetabolites|mesh-ancestor
65097541|NCT00521430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097542|NCT00521430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097543|NCT00521430|Dermatologic Agents|dermatologic agents|mesh-ancestor
65097544|NCT00521430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097545|NCT00521430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65097546|NCT00521430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65097547|NCT00521430|Immunologic Factors|immunologic factors|mesh-ancestor
65097548|NCT00521430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65097549|NCT00521430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65097550|NCT00521430|Antifungal Agents|antifungal agents|mesh-ancestor
65097551|NCT00521430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65097552|NCT00521430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65097553|NCT00521430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65097554|NCT00521430|Antiemetics|antiemetics|mesh-ancestor
65097555|NCT00521430|Autonomic Agents|autonomic agents|mesh-ancestor
65097556|NCT00521430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65097557|NCT00521430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65097558|NCT00521430|Glucocorticoids|glucocorticoids|mesh-ancestor
65097559|NCT00521430|Hormones|hormones|mesh-ancestor
65097574|NCT05146778|Dexmedetomidine|dexmedetomidine|mesh-list
65097575|NCT05146778|Analgesics, Opioid|analgesics, opioid|mesh-list
65097576|NCT05146778|Anesthetics|anesthetics|mesh-list
65097577|NCT05146778|Anesthetics, Local|anesthetics, local|mesh-ancestor
65097578|NCT05146778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65097579|NCT05146778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097580|NCT05146778|Sensory System Agents|sensory system agents|mesh-ancestor
65097581|NCT05146778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65097582|NCT05146778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65097583|NCT05146778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65097584|NCT05146778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65097585|NCT05146778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65097586|NCT05146778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097587|NCT05146778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65097588|NCT05146778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65097590|NCT05146778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65097591|NCT05146778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65097592|NCT05146778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65097593|NCT05146778|Adrenergic Agents|adrenergic agents|mesh-ancestor
65097594|NCT05146778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65097595|NCT05146778|Narcotics|narcotics|mesh-ancestor
65097596|NCT05146778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65097597|NCT05146778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65097598|NCT05146778|Anesthetics, General|anesthetics, general|mesh-ancestor
65097599|NCT05145764|Suvorexant|suvorexant|mesh-list
65097600|NCT05145764|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65097601|NCT05145764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65097602|NCT05145764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65097603|NCT05145764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097604|NCT05145764|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65097605|NCT05145764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65097606|NCT05145764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097607|NCT02948283|Metformin|metformin|mesh-list
65097608|NCT02948283|Ritonavir|ritonavir|mesh-list
65288319|NCT02159989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65288320|NCT02159989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65288321|NCT02159989|Growth Substances|growth substances|mesh-ancestor
65288322|NCT02159989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288323|NCT02159989|Growth Inhibitors|growth inhibitors|mesh-ancestor
64581096|NCT05588934|Caffeine|caffeine|mesh-list
65097609|NCT02948283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65097610|NCT02948283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097611|NCT02948283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65097612|NCT02948283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65097613|NCT02948283|Protease Inhibitors|protease inhibitors|mesh-ancestor
65097614|NCT02948283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097615|NCT02948283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097616|NCT02948283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65097617|NCT02948283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65097618|NCT02948283|Antiviral Agents|antiviral agents|mesh-ancestor
65097619|NCT02948283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64670415|NCT02249546|Antidotes|antidotes|mesh-ancestor
65097630|NCT04512638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65097631|NCT04512638|Disinfectants|disinfectants|mesh-ancestor
65097632|NCT04512638|Dermatologic Agents|dermatologic agents|mesh-ancestor
65097633|NCT00523185|Diazepam|diazepam|mesh-list
65097634|NCT00523185|Lorazepam|lorazepam|mesh-list
65097635|NCT00523185|Anticonvulsants|anticonvulsants|mesh-ancestor
65097636|NCT00523185|Antiemetics|antiemetics|mesh-ancestor
65097637|NCT00523185|Autonomic Agents|autonomic agents|mesh-ancestor
65097638|NCT00523185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65097639|NCT00523185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097640|NCT00523185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65097641|NCT00523185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65097642|NCT00523185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65097643|NCT00523185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65097644|NCT00523185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65097645|NCT00523185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65097647|NCT00523185|GABA Agents|gaba agents|mesh-ancestor
65097648|NCT00523185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65097649|NCT00523185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097650|NCT00523185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65097651|NCT00523185|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65097652|NCT00523185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65097653|NCT00523185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65097654|NCT00523185|Anesthetics, General|anesthetics, general|mesh-ancestor
65097655|NCT00523185|Anesthetics|anesthetics|mesh-ancestor
65097656|NCT04512404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
64630372|NCT01214083|Expectorants|expectorants|mesh-ancestor
65097657|NCT04512404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65097658|NCT04512404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65097659|NCT04512404|Antimetabolites|antimetabolites|mesh-ancestor
65097660|NCT04512404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097661|NCT04512404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097662|NCT04512404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65097663|NCT04693962|Mitogens|mitogens|mesh-list
65097664|NCT04693962|Mitosis Modulators|mitosis modulators|mesh-ancestor
65097665|NCT04693962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097666|NCT05144399|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65097667|NCT05144399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65097668|NCT00521703|Lidocaine|lidocaine|mesh-list
65097669|NCT00521703|Anesthetics, Local|anesthetics, local|mesh-ancestor
65097670|NCT00521703|Anesthetics|anesthetics|mesh-ancestor
65097671|NCT00521703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65097672|NCT00521703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097673|NCT00521703|Sensory System Agents|sensory system agents|mesh-ancestor
65097674|NCT00521703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65097675|NCT00521703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65097676|NCT00521703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65097677|NCT00521703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65097678|NCT00521703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65097679|NCT00521703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097680|NCT00521742|Pioglitazone|pioglitazone|mesh-list
65097681|NCT00521742|Glyburide|glyburide|mesh-list
65288324|NCT02159989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288325|NCT02628132|Paclitaxel|paclitaxel|mesh-list
65288326|NCT02628132|Durvalumab|durvalumab|mesh-list
65288327|NCT02628132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65288328|NCT02628132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288329|NCT02628132|Tubulin Modulators|tubulin modulators|mesh-ancestor
65288330|NCT02628132|Antimitotic Agents|antimitotic agents|mesh-ancestor
65288331|NCT02628132|Mitosis Modulators|mitosis modulators|mesh-ancestor
65097694|NCT00521781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65097695|NCT00521781|Hormones|hormones|mesh-ancestor
65097696|NCT00521781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65097697|NCT00521781|Hormone Antagonists|hormone antagonists|mesh-ancestor
65097698|NCT00521820|Pioglitazone|pioglitazone|mesh-list
65097699|NCT00521820|Glyburide|glyburide|mesh-list
65097700|NCT00521820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65097701|NCT00521820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097702|NCT00523263|Heparin|heparin|mesh-list
65097703|NCT00523263|Anticoagulants|anticoagulants|mesh-ancestor
65097704|NCT00523263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65097705|NCT00523263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65097706|NCT00523263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097707|NCT00521859|Fludarabine|fludarabine|mesh-list
65097708|NCT00521859|Fludarabine phosphate|fludarabine phosphate|mesh-list
65097709|NCT00521859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097710|NCT00521859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65097711|NCT00521859|Antimetabolites|antimetabolites|mesh-ancestor
65097712|NCT00521859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097713|NCT00521859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65097714|NCT00521859|Immunologic Factors|immunologic factors|mesh-ancestor
65097715|NCT00521859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097716|NCT02954822|Glimepiride|glimepiride|mesh-list
65097717|NCT02954822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65097718|NCT02954822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65097719|NCT02954822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097720|NCT02954822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65097721|NCT02954822|Immunologic Factors|immunologic factors|mesh-ancestor
65097722|NCT00522015|Rivastigmine|rivastigmine|mesh-list
65097723|NCT00522015|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65097724|NCT00522015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097725|NCT00522015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097726|NCT00522015|Cholinergic Agents|cholinergic agents|mesh-ancestor
65097727|NCT00522015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65097728|NCT00522015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097729|NCT00522015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65097730|NCT00522015|Protective Agents|protective agents|mesh-ancestor
65097731|NCT00523380|Doxorubicin|doxorubicin|mesh-list
65097732|NCT00523380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65097733|NCT00523380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65097734|NCT00523380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097735|NCT00523380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65097736|NCT00523380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65097737|NCT00523380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097738|NCT00523380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097739|NCT00523458|Efavirenz|efavirenz|mesh-list
65097751|NCT00523458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65097752|NCT00523458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65097753|NCT00523458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65097754|NCT00523458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65097755|NCT00507065|Amphetamine|amphetamine|mesh-list
65097756|NCT00507065|Adderall|adderall|mesh-list
65097757|NCT00507065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65097758|NCT00507065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097759|NCT00507065|Sympathomimetics|sympathomimetics|mesh-ancestor
65097760|NCT00507065|Autonomic Agents|autonomic agents|mesh-ancestor
65097761|NCT00507065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65097762|NCT00507065|Dopamine Agents|dopamine agents|mesh-ancestor
65097763|NCT00507065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65097764|NCT00507065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288332|NCT02628132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288333|NCT02628132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65288334|NCT02695355|Methylphenidate|methylphenidate|mesh-list
65288335|NCT02695355|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65288336|NCT02695355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288337|NCT02695355|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65288338|NCT02695355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65288339|NCT02695355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65288340|NCT02695355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288341|NCT02695355|Dopamine Agents|dopamine agents|mesh-ancestor
65288342|NCT02695355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65288343|NCT02573038|Aflibercept|aflibercept|mesh-list
65288344|NCT02573038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65288345|NCT02573038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65288346|NCT02573038|Growth Substances|growth substances|mesh-ancestor
65288347|NCT02573038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288348|NCT02573038|Growth Inhibitors|growth inhibitors|mesh-ancestor
64518581|NCT04485780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518582|NCT04485780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65097765|NCT00507065|Adrenergic Agents|adrenergic agents|mesh-ancestor
65097766|NCT00507065|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65097767|NCT00507065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65097768|NCT00507065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65097769|NCT00507065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65097770|NCT00522132|Artesunate|artesunate|mesh-list
65097771|NCT00522132|Antimalarials|antimalarials|mesh-ancestor
65097772|NCT00522132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65097773|NCT00522132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65097774|NCT00522132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65097775|NCT00522132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097776|NCT00522132|Antiviral Agents|antiviral agents|mesh-ancestor
65097777|NCT00522132|Schistosomicides|schistosomicides|mesh-ancestor
65097778|NCT00522132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65097779|NCT00522132|Anthelmintics|anthelmintics|mesh-ancestor
65097780|NCT00522210|Insulin|insulin|mesh-list
65097781|NCT00522210|Isophane Insulin, Human|isophane insulin, human|mesh-list
65097782|NCT00522210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65097783|NCT00522210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097784|NCT00522249|Interferons|interferons|mesh-list
65097785|NCT00522249|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65097786|NCT00522249|Interferon-alpha|interferon-alpha|mesh-list
65097787|NCT00522249|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65097788|NCT00522249|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65097789|NCT00522249|Sunitinib|sunitinib|mesh-list
65097790|NCT00522249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097791|NCT00522249|Antiviral Agents|antiviral agents|mesh-ancestor
65097792|NCT00522249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65097793|NCT00522249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65097794|NCT00522249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740012|NCT00382421|Analgesics|analgesics|mesh-ancestor
65097795|NCT00522249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097796|NCT00522249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65097797|NCT00522249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65288349|NCT02573038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288350|NCT02159755|Palbociclib|palbociclib|mesh-list
65288351|NCT02159755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288352|NCT02159755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65288353|NCT02159755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288354|NCT02159755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288355|NCT01822015|Cytarabine|cytarabine|mesh-list
65288356|NCT01822015|Sirolimus|sirolimus|mesh-list
65288357|NCT01822015|Idarubicin|idarubicin|mesh-list
64518599|NCT00059475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64518600|NCT00059475|Protective Agents|protective agents|mesh-ancestor
65097798|NCT00522249|Growth Substances|growth substances|mesh-ancestor
64670597|NCT04499573|Cytarabine|cytarabine|mesh-list
65097824|NCT00523692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65097825|NCT00523692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65097826|NCT00523692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65097827|NCT00523692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65097828|NCT00523692|Analgesics|analgesics|mesh-ancestor
65097829|NCT00523692|Sensory System Agents|sensory system agents|mesh-ancestor
65097830|NCT00523692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65097831|NCT00523692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65097832|NCT00523692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65097833|NCT05148689|Phenylephrine|phenylephrine|mesh-list
65097834|NCT05148689|Oxymetazoline|oxymetazoline|mesh-list
65097835|NCT05148689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65097836|NCT05148689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65097837|NCT05148689|Adrenergic Agents|adrenergic agents|mesh-ancestor
65097838|NCT05148689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65097839|NCT05148689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097840|NCT05148689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097841|NCT05148689|Sympathomimetics|sympathomimetics|mesh-ancestor
65097842|NCT05148689|Autonomic Agents|autonomic agents|mesh-ancestor
65097843|NCT05148689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65097844|NCT05148689|Nasal Decongestants|nasal decongestants|mesh-ancestor
65097845|NCT05148689|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65097846|NCT05148689|Respiratory System Agents|respiratory system agents|mesh-ancestor
65097847|NCT05148689|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65097848|NCT05148689|Mydriatics|mydriatics|mesh-ancestor
65097873|NCT00523887|Fentanyl|fentanyl|mesh-list
65097874|NCT00523887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65097875|NCT00523887|Narcotics|narcotics|mesh-ancestor
65097876|NCT00523887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65097877|NCT00523887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097878|NCT00523887|Analgesics|analgesics|mesh-ancestor
65097879|NCT00523887|Sensory System Agents|sensory system agents|mesh-ancestor
65097880|NCT00523887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65097881|NCT00523887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65097882|NCT00523887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65097883|NCT00523887|Anesthetics, General|anesthetics, general|mesh-ancestor
65097884|NCT00523887|Anesthetics|anesthetics|mesh-ancestor
65097885|NCT05145218|Paclitaxel|paclitaxel|mesh-list
65097886|NCT05145218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65097887|NCT05145218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097888|NCT05145218|Tubulin Modulators|tubulin modulators|mesh-ancestor
65097889|NCT05145218|Antimitotic Agents|antimitotic agents|mesh-ancestor
65097890|NCT05145218|Mitosis Modulators|mitosis modulators|mesh-ancestor
65097891|NCT05145218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097892|NCT00523926|Bedaquiline|bedaquiline|mesh-list
65097893|NCT00523926|Antitubercular Agents|antitubercular agents|mesh-ancestor
65097894|NCT00523926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65097895|NCT00523926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65097896|NCT05146271|Anesthetics|anesthetics|mesh-list
65097897|NCT05146271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64670745|NCT03226899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670746|NCT03226899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097903|NCT00522639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65288358|NCT01822015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65288359|NCT01822015|Antimetabolites|antimetabolites|mesh-ancestor
65288360|NCT01822015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288361|NCT01822015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288362|NCT01822015|Antiviral Agents|antiviral agents|mesh-ancestor
65288363|NCT01822015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65288364|NCT01822015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65288365|NCT01822015|Immunologic Factors|immunologic factors|mesh-ancestor
65288366|NCT01822015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518607|NCT02453802|Hemostatics|hemostatics|mesh-ancestor
64518608|NCT02453802|Coagulants|coagulants|mesh-ancestor
65097905|NCT05142098|Etoricoxib|etoricoxib|mesh-list
65097906|NCT05142098|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
65097907|NCT05142098|Glucocorticoids|glucocorticoids|mesh-list
65097908|NCT05142098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65097909|NCT05142098|Antiemetics|antiemetics|mesh-ancestor
65097910|NCT05142098|Autonomic Agents|autonomic agents|mesh-ancestor
65097911|NCT05142098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65097912|NCT05142098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097913|NCT05142098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65097914|NCT05142098|Hormones|hormones|mesh-ancestor
65097915|NCT05142098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65097916|NCT05142098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65097917|NCT05142098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097918|NCT05142098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65097919|NCT05142098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65097920|NCT05142098|Analgesics|analgesics|mesh-ancestor
65097921|NCT05142098|Sensory System Agents|sensory system agents|mesh-ancestor
65097922|NCT05142098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65097923|NCT05142098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65097924|NCT05142098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097925|NCT05142098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097926|NCT00523965|Amphotericin B|amphotericin b|mesh-list
65097927|NCT00523965|Paromomycin|paromomycin|mesh-list
65097928|NCT00523965|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65097929|NCT00523965|Miltefosine|miltefosine|mesh-list
65097930|NCT00523965|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
65097931|NCT00523965|Deoxycholic Acid|deoxycholic acid|mesh-list
65097932|NCT00523965|Amebicides|amebicides|mesh-ancestor
65097933|NCT00523965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65097934|NCT00523965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65097935|NCT00523965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65097936|NCT00523965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65097937|NCT00523965|Antifungal Agents|antifungal agents|mesh-ancestor
65097938|NCT00523965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097939|NCT00523965|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65097940|NCT00523965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65097941|NCT05141669|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65097942|NCT05141669|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65097943|NCT05141669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097944|NCT05141669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65097945|NCT05141669|Immunologic Factors|immunologic factors|mesh-ancestor
64630668|NCT04348370|Vaccines|vaccines|mesh-list
65097946|NCT05141669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097947|NCT05141240|Palbociclib|palbociclib|mesh-list
65097948|NCT05141240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097949|NCT05141240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65097950|NCT05141240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097951|NCT05141240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097952|NCT00524004|Immunoglobulin G|immunoglobulin g|mesh-list
65097953|NCT00524004|Immunologic Factors|immunologic factors|mesh-ancestor
65097954|NCT00524004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097955|NCT05148377|Heparin|heparin|mesh-list
65097956|NCT05148377|Anticoagulants|anticoagulants|mesh-ancestor
65288367|NCT01822015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65288368|NCT01822015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65288369|NCT01822015|Antifungal Agents|antifungal agents|mesh-ancestor
65288370|NCT01822015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65288371|NCT01822015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65288372|NCT01822015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288373|NCT00990535|Octreotide|octreotide|mesh-list
65288374|NCT00990535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65288375|NCT00990535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65288376|NCT00990535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288377|NCT05590897|Anti-Infective Agents|anti-infective agents|mesh-list
65288378|NCT05590897|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65288379|NCT00720304|Docetaxel|docetaxel|mesh-list
65288380|NCT00720304|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65288381|NCT00720304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288382|NCT00720304|Tubulin Modulators|tubulin modulators|mesh-ancestor
65288383|NCT00720304|Antimitotic Agents|antimitotic agents|mesh-ancestor
64518618|NCT02453802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64518619|NCT02453802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65097957|NCT05148377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65097958|NCT05148377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65097959|NCT05148377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097969|NCT00524160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65097970|NCT00524160|Anesthetics, General|anesthetics, general|mesh-ancestor
65097972|NCT00524199|Mesna|mesna|mesh-list
65097973|NCT00524199|Protective Agents|protective agents|mesh-ancestor
65097974|NCT00524199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097975|NCT00523068|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65097976|NCT00523068|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65097977|NCT00523068|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65097978|NCT00523068|Cholinergic Agents|cholinergic agents|mesh-ancestor
65097979|NCT00523068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65097980|NCT00523068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097981|NCT00523068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097982|NCT00523068|Urological Agents|urological agents|mesh-ancestor
65097983|NCT02276378|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65097984|NCT02276378|Telmisartan|telmisartan|mesh-list
65097985|NCT02276378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65097986|NCT02276378|Diuretics|diuretics|mesh-ancestor
65097987|NCT02276378|Natriuretic Agents|natriuretic agents|mesh-ancestor
65097988|NCT02276378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097989|NCT02276378|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65097990|NCT02276378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65097991|NCT02276378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097992|NCT02276378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65097993|NCT02276378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65097994|NCT04696250|Antineoplastic Agents|antineoplastic agents|mesh-list
65097995|NCT00524433|Tezosentan|tezosentan|mesh-list
65097996|NCT00524433|Vasodilator Agents|vasodilator agents|mesh-ancestor
65097997|NCT02947932|Indomethacin|indomethacin|mesh-list
65097998|NCT02947932|Resveratrol|resveratrol|mesh-list
65097999|NCT02947932|Antioxidants|antioxidants|mesh-ancestor
65098000|NCT02947932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098001|NCT02947932|Protective Agents|protective agents|mesh-ancestor
65098002|NCT02947932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098003|NCT02947932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288384|NCT00720304|Mitosis Modulators|mitosis modulators|mesh-ancestor
65288385|NCT00720304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288386|NCT00720304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65288387|NCT00720304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288388|NCT00682344|Levobupivacaine|levobupivacaine|mesh-list
65288389|NCT00682344|Anesthetics, Local|anesthetics, local|mesh-ancestor
65288390|NCT00682344|Anesthetics|anesthetics|mesh-ancestor
65288391|NCT00682344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65038372|NCT00217386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65288392|NCT00682344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288393|NCT00682344|Sensory System Agents|sensory system agents|mesh-ancestor
65288394|NCT00682344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65288395|NCT00990691|Desipramine|desipramine|mesh-list
65288396|NCT00990691|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65288397|NCT00990691|Antidepressive Agents|antidepressive agents|mesh-ancestor
65288398|NCT00990691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65288399|NCT00990691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344913|NCT00736346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64518635|NCT02028676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098004|NCT02947932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65098005|NCT02947932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65098006|NCT02947932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65098007|NCT02947932|Analgesics|analgesics|mesh-ancestor
65098008|NCT02947932|Sensory System Agents|sensory system agents|mesh-ancestor
65098009|NCT02947932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65098010|NCT02947932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65098011|NCT02947932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65098012|NCT02947932|Gout Suppressants|gout suppressants|mesh-ancestor
65098013|NCT02947932|Tocolytic Agents|tocolytic agents|mesh-ancestor
65098014|NCT02947932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65098015|NCT02947932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65098016|NCT05146154|Imipenem|imipenem|mesh-list
65098017|NCT05146154|Relebactam|relebactam|mesh-list
65098018|NCT05146154|Cilastatin|cilastatin|mesh-list
65098036|NCT00524667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65098037|NCT00524667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65098039|NCT00524706|Oxaliplatin|oxaliplatin|mesh-list
65098040|NCT00524706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098041|NCT00524706|Antidotes|antidotes|mesh-ancestor
65098042|NCT00524706|Protective Agents|protective agents|mesh-ancestor
65098043|NCT00524706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098044|NCT00524706|Vitamin B Complex|vitamin b complex|mesh-ancestor
65098045|NCT00524706|Vitamins|vitamins|mesh-ancestor
65098046|NCT00524706|Micronutrients|micronutrients|mesh-ancestor
65098047|NCT00507143|Irinotecan|irinotecan|mesh-list
65098048|NCT00507143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65098049|NCT00507143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65098050|NCT00507143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098051|NCT00507143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098052|NCT00507143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098053|NCT02947620|Metformin|metformin|mesh-list
65098054|NCT02947620|Atorvastatin|atorvastatin|mesh-list
65098055|NCT02947620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65098056|NCT02947620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098057|NCT02947620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65098058|NCT02947620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65288400|NCT00990691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288401|NCT00990691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65288402|NCT00990691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65288403|NCT00990691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65288404|NCT00990691|Adrenergic Agents|adrenergic agents|mesh-ancestor
65288405|NCT00990691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65344914|NCT00736346|Serotonin Agents|serotonin agents|mesh-ancestor
65098059|NCT02947620|Antimetabolites|antimetabolites|mesh-ancestor
65098060|NCT02947620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098061|NCT02947620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65098062|NCT02947620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65098063|NCT02947620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098064|NCT00525993|Etoricoxib|etoricoxib|mesh-list
65098065|NCT00525993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65098066|NCT00525993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65098067|NCT00525993|Analgesics|analgesics|mesh-ancestor
65098068|NCT00525993|Sensory System Agents|sensory system agents|mesh-ancestor
65098069|NCT00525993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65098070|NCT00525993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098089|NCT02947815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65098090|NCT02947815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65098091|NCT02947815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65098092|NCT02947815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098093|NCT02947815|Cholinergic Agents|cholinergic agents|mesh-ancestor
65098094|NCT02947815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65098095|NCT02947815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098096|NCT02947815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65098097|NCT02947815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65098098|NCT00507221|Albendazole|albendazole|mesh-list
65098099|NCT00507221|Praziquantel|praziquantel|mesh-list
65098100|NCT00507221|Anthelmintics|anthelmintics|mesh-ancestor
65098101|NCT00507221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65098102|NCT00507221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65098103|NCT00507221|Anticestodal Agents|anticestodal agents|mesh-ancestor
65098104|NCT00507221|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65098105|NCT00507221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65098106|NCT00507221|Tubulin Modulators|tubulin modulators|mesh-ancestor
65098107|NCT00507221|Antimitotic Agents|antimitotic agents|mesh-ancestor
65098108|NCT00507221|Mitosis Modulators|mitosis modulators|mesh-ancestor
65098109|NCT00507221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098110|NCT00507221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098111|NCT02947737|Gentamicins|gentamicins|mesh-list
65098112|NCT02947737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65098113|NCT02947737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65098114|NCT02947737|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65098115|NCT02947737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098116|NCT02947737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098117|NCT05146895|Imiquimod|imiquimod|mesh-list
65098118|NCT05146895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65098119|NCT05146895|Immunologic Factors|immunologic factors|mesh-ancestor
65098120|NCT05146895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098121|NCT05146895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098122|NCT05146895|Interferon Inducers|interferon inducers|mesh-ancestor
65098123|NCT05143073|Ethanol|ethanol|mesh-list
65098124|NCT05143073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65098125|NCT05143073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65098126|NCT05143073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65098127|NCT05143073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098135|NCT00524901|Epoetin Alfa|epoetin alfa|mesh-list
65098136|NCT00524901|Hematinics|hematinics|mesh-ancestor
65098137|NCT02954588|Pyridoxamine|pyridoxamine|mesh-list
65098138|NCT02954588|Vitamin B Complex|vitamin b complex|mesh-ancestor
64670971|NCT04153760|Analgesics|analgesics|mesh-ancestor
65098140|NCT02954588|Micronutrients|micronutrients|mesh-ancestor
65098141|NCT02954588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098142|NCT02954549|Vitamin D|vitamin d|mesh-list
65098143|NCT02954549|Cholecalciferol|cholecalciferol|mesh-list
65288406|NCT00990691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288407|NCT00678522|Atorvastatin|atorvastatin|mesh-list
65288408|NCT00678522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65288409|NCT00678522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65288410|NCT00678522|Antimetabolites|antimetabolites|mesh-ancestor
65288411|NCT00678522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288412|NCT00678522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65288413|NCT00678522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65288414|NCT00678522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288415|NCT04391855|Dexmedetomidine|dexmedetomidine|mesh-list
65288416|NCT04391855|Tramadol|tramadol|mesh-list
65288417|NCT04391855|Ropivacaine|ropivacaine|mesh-list
65288418|NCT04391855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65288419|NCT04391855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65288420|NCT04391855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288421|NCT04391855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65288422|NCT04391855|Analgesics|analgesics|mesh-ancestor
65288423|NCT04391855|Sensory System Agents|sensory system agents|mesh-ancestor
65288424|NCT04391855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64518659|NCT00061893|Celecoxib|celecoxib|mesh-list
64518660|NCT00061893|Cyclophosphamide|cyclophosphamide|mesh-list
65098144|NCT02954549|Vitamins|vitamins|mesh-ancestor
65098145|NCT02954549|Micronutrients|micronutrients|mesh-ancestor
65098146|NCT02954549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098147|NCT02954549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65098148|NCT02954549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65098149|NCT05145608|Lamotrigine|lamotrigine|mesh-list
65098150|NCT05145608|Anticonvulsants|anticonvulsants|mesh-list
65098151|NCT05145608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65098152|NCT05145608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65098153|NCT05145608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098154|NCT05145608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65098155|NCT05145608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098156|NCT05145608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65098157|NCT05145608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65098158|NCT05145608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65098159|NCT05145608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65098160|NCT05145608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65098161|NCT02946294|Epinephrine|epinephrine|mesh-list
65098162|NCT02946294|Racepinephrine|racepinephrine|mesh-list
65098163|NCT02946294|Bupivacaine|bupivacaine|mesh-list
65098164|NCT02946294|Epinephryl borate|epinephryl borate|mesh-list
65098165|NCT02946294|Anesthetics, Local|anesthetics, local|mesh-ancestor
65098166|NCT02946294|Anesthetics|anesthetics|mesh-ancestor
65098167|NCT02946294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65098168|NCT02946294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098169|NCT02946294|Sensory System Agents|sensory system agents|mesh-ancestor
64630890|NCT00003010|Marimastat|marimastat|mesh-list
65098170|NCT02946294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65098171|NCT02946294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65098172|NCT02946294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65098173|NCT02946294|Adrenergic Agents|adrenergic agents|mesh-ancestor
65098174|NCT02946294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65098175|NCT02946294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288425|NCT04391855|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65288426|NCT04391855|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65288427|NCT04391855|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65288428|NCT04391855|Adrenergic Agents|adrenergic agents|mesh-ancestor
65288429|NCT04391855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65288430|NCT04391855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288431|NCT04391855|Anesthetics, Local|anesthetics, local|mesh-ancestor
65288432|NCT04391855|Anesthetics|anesthetics|mesh-ancestor
65288433|NCT04391855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65288434|NCT04391855|Narcotics|narcotics|mesh-ancestor
65288435|NCT00716950|Losartan|losartan|mesh-list
65288436|NCT00716950|Valsartan|valsartan|mesh-list
65288437|NCT00716950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65288438|NCT00716950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65288439|NCT00716950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65098176|NCT02946294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65098177|NCT02946294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65098178|NCT02946294|Autonomic Agents|autonomic agents|mesh-ancestor
65098179|NCT02946294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65098180|NCT02946294|Respiratory System Agents|respiratory system agents|mesh-ancestor
65098181|NCT02946294|Mydriatics|mydriatics|mesh-ancestor
65098182|NCT02946294|Sympathomimetics|sympathomimetics|mesh-ancestor
65098183|NCT02946294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65098184|NCT05146232|Anesthetics|anesthetics|mesh-list
65098185|NCT05146232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65098220|NCT05143970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65098221|NCT05143970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098222|NCT05147090|Empagliflozin|empagliflozin|mesh-list
65098223|NCT05147090|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65098224|NCT05147090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098225|NCT05147090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65098245|NCT02947113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64740465|NCT00002987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098246|NCT02947113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65098248|NCT02276690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65098249|NCT02947269|Prucalopride|prucalopride|mesh-list
65098250|NCT02947269|Laxatives|laxatives|mesh-ancestor
65098251|NCT02947269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65098252|NCT02947269|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65098253|NCT02947269|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65098254|NCT02947269|Serotonin Agents|serotonin agents|mesh-ancestor
65098255|NCT02947269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65098256|NCT02947269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098257|NCT02947269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098258|NCT00526305|Cytarabine|cytarabine|mesh-list
65098259|NCT00526305|Dexamethasone|dexamethasone|mesh-list
65098260|NCT00526305|Prednisone|prednisone|mesh-list
65098261|NCT00526305|Hydrocortisone|hydrocortisone|mesh-list
65098262|NCT00526305|Cyclophosphamide|cyclophosphamide|mesh-list
65098263|NCT00526305|Vincristine|vincristine|mesh-list
65098264|NCT00526305|Daunorubicin|daunorubicin|mesh-list
65098265|NCT00526305|Asparaginase|asparaginase|mesh-list
65098266|NCT00526305|Mitoxantrone|mitoxantrone|mesh-list
65098267|NCT00526305|Mercaptopurine|mercaptopurine|mesh-list
65098268|NCT00526305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65098269|NCT00526305|Immunologic Factors|immunologic factors|mesh-ancestor
65098270|NCT00526305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098271|NCT00526305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65098272|NCT00526305|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65098273|NCT00526305|Alkylating Agents|alkylating agents|mesh-ancestor
65098274|NCT00526305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288440|NCT00716950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288441|NCT00716950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65288442|NCT00711178|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65288443|NCT00711178|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65288444|NCT00711178|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65288445|NCT00711178|Dermatologic Agents|dermatologic agents|mesh-ancestor
65288446|NCT00678756|Ketoconazole|ketoconazole|mesh-list
65288447|NCT00678756|Antifungal Agents|antifungal agents|mesh-ancestor
64518695|NCT02957019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518696|NCT02957019|Immunologic Factors|immunologic factors|mesh-ancestor
65098275|NCT00526305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098276|NCT00526305|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65098277|NCT00526305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65098278|NCT00526305|Antiemetics|antiemetics|mesh-ancestor
65098279|NCT00526305|Autonomic Agents|autonomic agents|mesh-ancestor
65098280|NCT00526305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65098296|NCT00526305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65098297|NCT00526305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098298|NCT00526305|Analgesics|analgesics|mesh-ancestor
65098299|NCT00526305|Sensory System Agents|sensory system agents|mesh-ancestor
65098300|NCT00526305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65098301|NCT02276768|Trimebutine|trimebutine|mesh-list
65098302|NCT02276768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65098303|NCT02276768|Parasympatholytics|parasympatholytics|mesh-ancestor
65098304|NCT02276768|Autonomic Agents|autonomic agents|mesh-ancestor
65098305|NCT02276768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65098306|NCT02276768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098307|NCT00526383|Antidepressive Agents|antidepressive agents|mesh-list
65098308|NCT00526383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
65098309|NCT00526383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65098310|NCT00525408|Docetaxel|docetaxel|mesh-list
65098311|NCT00525408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098312|NCT00525408|Tubulin Modulators|tubulin modulators|mesh-ancestor
65098313|NCT00525408|Antimitotic Agents|antimitotic agents|mesh-ancestor
65098314|NCT00525408|Mitosis Modulators|mitosis modulators|mesh-ancestor
65098315|NCT00525408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098316|NCT00525447|Dexamethasone|dexamethasone|mesh-list
65098317|NCT00525447|Lenalidomide|lenalidomide|mesh-list
65098318|NCT00525447|Dacetuzumab|dacetuzumab|mesh-list
65098319|NCT00525447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65098320|NCT00525447|Antiemetics|antiemetics|mesh-ancestor
65098321|NCT00525447|Autonomic Agents|autonomic agents|mesh-ancestor
65098322|NCT00525447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65098323|NCT00525447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098324|NCT00525447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65098325|NCT00525447|Glucocorticoids|glucocorticoids|mesh-ancestor
65098326|NCT00525447|Hormones|hormones|mesh-ancestor
65098327|NCT00525447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65098328|NCT00525447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65098329|NCT00525447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098330|NCT00525447|Immunologic Factors|immunologic factors|mesh-ancestor
65098331|NCT00525447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64671109|NCT02005601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64671161|NCT03468075|Protective Agents|protective agents|mesh-ancestor
65098339|NCT00525486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098340|NCT00525486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65098341|NCT00525486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098342|NCT00525486|Vasodilator Agents|vasodilator agents|mesh-ancestor
65098343|NCT00525486|Tocolytic Agents|tocolytic agents|mesh-ancestor
65098344|NCT00525486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65098345|NCT05145101|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65098346|NCT05145101|Immunologic Factors|immunologic factors|mesh-ancestor
65098347|NCT05145101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098348|NCT02946060|TEMPO|tempo|mesh-list
65098349|NCT02946060|Antioxidants|antioxidants|mesh-ancestor
65288448|NCT00678756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65288449|NCT00678756|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65288450|NCT00678756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65288451|NCT00678756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288452|NCT00678756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288453|NCT00678756|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65288454|NCT00678756|Hormone Antagonists|hormone antagonists|mesh-ancestor
65288455|NCT00678756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65288456|NCT00678756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518703|NCT02028754|Levofloxacin|levofloxacin|mesh-list
65098350|NCT02946060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098351|NCT02946060|Protective Agents|protective agents|mesh-ancestor
65098352|NCT02946060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098353|NCT00525564|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65098354|NCT00525564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65098355|NCT00525564|Autonomic Agents|autonomic agents|mesh-ancestor
65098356|NCT00525564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65098357|NCT00525564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098358|NCT00525564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65098359|NCT00525564|Respiratory System Agents|respiratory system agents|mesh-ancestor
65098360|NCT00525564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65098361|NCT00525564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65098362|NCT00525564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65098363|NCT00525564|Adrenergic Agents|adrenergic agents|mesh-ancestor
65098364|NCT00525564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65098365|NCT00525564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098366|NCT00525642|Cyclophosphamide|cyclophosphamide|mesh-list
65098367|NCT00525642|Docetaxel|docetaxel|mesh-list
65098368|NCT00525642|Doxorubicin|doxorubicin|mesh-list
65098369|NCT00525642|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65098370|NCT00525642|Epirubicin|epirubicin|mesh-list
65098371|NCT00525642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65098372|NCT00525642|Immunologic Factors|immunologic factors|mesh-ancestor
65098373|NCT00525642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098374|NCT00525642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65098375|NCT00525642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65098376|NCT00525642|Alkylating Agents|alkylating agents|mesh-ancestor
65098377|NCT00525642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098378|NCT00525642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098379|NCT00525642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65098380|NCT00525642|Tubulin Modulators|tubulin modulators|mesh-ancestor
65098381|NCT00525642|Antimitotic Agents|antimitotic agents|mesh-ancestor
65098382|NCT00525642|Mitosis Modulators|mitosis modulators|mesh-ancestor
65098409|NCT02945982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65098410|NCT02945982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098411|NCT02945982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098412|NCT02945982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65098413|NCT02945982|Antioxidants|antioxidants|mesh-ancestor
65098414|NCT02945982|Protective Agents|protective agents|mesh-ancestor
65098415|NCT02945982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65098416|NCT02945982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65098417|NCT02945982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65098418|NCT02945982|Vasodilator Agents|vasodilator agents|mesh-ancestor
65098419|NCT02945982|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65098420|NCT02945982|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65098421|NCT02954393|Amoxicillin|amoxicillin|mesh-list
65098422|NCT02954393|Metronidazole|metronidazole|mesh-list
65098423|NCT02954393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65098424|NCT02954393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65098425|NCT02954393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65098426|NCT02954393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65288457|NCT00678756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65288458|NCT02748395|Triamcinolone|triamcinolone|mesh-list
65288459|NCT02748395|Lidocaine|lidocaine|mesh-list
65288460|NCT02748395|Anesthetics, Local|anesthetics, local|mesh-ancestor
65288461|NCT02748395|Anesthetics|anesthetics|mesh-ancestor
65288462|NCT02748395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65288463|NCT02748395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038447|NCT00184496|Analgesics|analgesics|mesh-ancestor
65288464|NCT02748395|Sensory System Agents|sensory system agents|mesh-ancestor
65288465|NCT02748395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65288466|NCT02748395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65288467|NCT02748395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65288468|NCT02748395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65288469|NCT02748395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64518713|NCT02028754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65098427|NCT02954276|Sumatriptan|sumatriptan|mesh-list
65098428|NCT02954276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65098429|NCT02954276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65098430|NCT02954276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65098431|NCT02954276|Serotonin Agents|serotonin agents|mesh-ancestor
65098432|NCT02954276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671196|NCT03482583|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65098459|NCT00525759|Zoledronic Acid|zoledronic acid|mesh-list
65098460|NCT00525759|Cyclophosphamide|cyclophosphamide|mesh-list
65098461|NCT00525759|Docetaxel|docetaxel|mesh-list
64740687|NCT00003101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64740688|NCT03690869|Cemiplimab|cemiplimab|mesh-list
64740689|NCT03690869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64740690|NCT03690869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740701|NCT00003107|Interleukin-12|interleukin-12|mesh-list
64740702|NCT00003107|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64740703|NCT00003107|Immunologic Factors|immunologic factors|mesh-ancestor
64740704|NCT00003107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740705|NCT00003107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64740706|NCT00003107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64740711|NCT00003113|Lomustine|lomustine|mesh-list
65098462|NCT00525759|Fluorouracil|fluorouracil|mesh-list
65098463|NCT00525759|Epirubicin|epirubicin|mesh-list
65098464|NCT00525759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65098465|NCT00525759|Immunologic Factors|immunologic factors|mesh-ancestor
65098466|NCT00525759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098467|NCT00525759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65098468|NCT00525759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65098471|NCT00525759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098472|NCT00525759|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65098473|NCT00525759|Tubulin Modulators|tubulin modulators|mesh-ancestor
65098474|NCT00525759|Antimitotic Agents|antimitotic agents|mesh-ancestor
65098475|NCT00525759|Mitosis Modulators|mitosis modulators|mesh-ancestor
65098476|NCT00525759|Antimetabolites|antimetabolites|mesh-ancestor
65098477|NCT00525759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65098478|NCT00525759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65098479|NCT00525759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65098480|NCT00525759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65098481|NCT00525759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098482|NCT00525759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65098483|NCT00507962|Cisplatin|cisplatin|mesh-list
65098484|NCT00507962|Doxorubicin|doxorubicin|mesh-list
65098485|NCT00507962|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65098486|NCT00507962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098487|NCT00507962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65098488|NCT00507962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65288470|NCT02748395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288471|NCT02748395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65288472|NCT02748395|Glucocorticoids|glucocorticoids|mesh-ancestor
65288473|NCT02748395|Hormones|hormones|mesh-ancestor
65288474|NCT02748395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65288475|NCT02629224|Gabapentin|gabapentin|mesh-list
65288476|NCT02629224|Analgesics|analgesics|mesh-ancestor
65288477|NCT02629224|Sensory System Agents|sensory system agents|mesh-ancestor
65288478|NCT02629224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65288479|NCT02629224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288480|NCT02629224|Anticonvulsants|anticonvulsants|mesh-ancestor
65098489|NCT00507962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65098490|NCT00507962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098491|NCT00507962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098492|NCT00508040|Interferons|interferons|mesh-list
65098493|NCT00508040|Interferon-alpha|interferon-alpha|mesh-list
65098494|NCT00508040|Interferon alpha-2|interferon alpha-2|mesh-list
65098495|NCT00508040|Prednisone|prednisone|mesh-list
65098496|NCT00508040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65098497|NCT00508040|Glucocorticoids|glucocorticoids|mesh-ancestor
65098498|NCT00508040|Hormones|hormones|mesh-ancestor
65098499|NCT00508040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65098500|NCT00508040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098501|NCT00508040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65098502|NCT00508040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098503|NCT00508040|Antiviral Agents|antiviral agents|mesh-ancestor
65098504|NCT00508040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65098505|NCT00508040|Immunologic Factors|immunologic factors|mesh-ancestor
65098506|NCT00508664|Docetaxel|docetaxel|mesh-list
65098507|NCT00508664|Fluorouracil|fluorouracil|mesh-list
65098508|NCT00508664|Cetuximab|cetuximab|mesh-list
65098509|NCT00508664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098510|NCT00508664|Tubulin Modulators|tubulin modulators|mesh-ancestor
65098511|NCT00508664|Antimitotic Agents|antimitotic agents|mesh-ancestor
65098512|NCT00508664|Mitosis Modulators|mitosis modulators|mesh-ancestor
65098513|NCT00508664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098514|NCT00508664|Antimetabolites|antimetabolites|mesh-ancestor
65098515|NCT00508664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65098516|NCT00508664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65098517|NCT00508664|Immunologic Factors|immunologic factors|mesh-ancestor
65098518|NCT00508664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098519|NCT00508664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65098520|NCT02946684|Letrozole|letrozole|mesh-list
65098521|NCT02946684|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65098522|NCT02946684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098523|NCT02946684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65098524|NCT02946684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64483657|NCT01763905|Ezetimibe|ezetimibe|mesh-list
65098525|NCT02946684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098526|NCT02946684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65098527|NCT02946684|Hormone Antagonists|hormone antagonists|mesh-ancestor
65098528|NCT02946684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65098529|NCT02946684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098530|NCT02953379|Mometasone Furoate|mometasone furoate|mesh-list
65098531|NCT02953379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65098532|NCT02953379|Dermatologic Agents|dermatologic agents|mesh-ancestor
65098533|NCT02953379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65098534|NCT02946801|Listerine|listerine|mesh-list
65098535|NCT02946801|Sodium Fluoride|sodium fluoride|mesh-list
65098567|NCT00526695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098568|NCT00526929|Darbepoetin alfa|darbepoetin alfa|mesh-list
65098569|NCT00526929|Hematinics|hematinics|mesh-ancestor
65098570|NCT02953535|Sofosbuvir|sofosbuvir|mesh-list
65098571|NCT02953535|Antiviral Agents|antiviral agents|mesh-ancestor
65098572|NCT02953535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65288481|NCT02629224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65288482|NCT02629224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65288483|NCT02629224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65288484|NCT02629224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65288485|NCT02629224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65288486|NCT02629224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65288487|NCT02629224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65288488|NCT02629224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288489|NCT02629224|Antimanic Agents|antimanic agents|mesh-ancestor
65288490|NCT00711256|Sunscreening Agents|sunscreening agents|mesh-list
65288491|NCT00711256|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65288492|NCT00711256|Protective Agents|protective agents|mesh-ancestor
65288493|NCT00711256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288494|NCT00711256|Dermatologic Agents|dermatologic agents|mesh-ancestor
65288495|NCT04069234|Clopidogrel|clopidogrel|mesh-list
65288496|NCT04069234|Ticagrelor|ticagrelor|mesh-list
65288497|NCT04069234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65288498|NCT04069234|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65288499|NCT04069234|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65288500|NCT04069234|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65098573|NCT00526734|Melphalan|melphalan|mesh-list
65098574|NCT00526734|Immunologic Factors|immunologic factors|mesh-ancestor
65098575|NCT00526734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671355|NCT02396147|Relugolix|relugolix|mesh-list
65098592|NCT00508898|Calcitriol|calcitriol|mesh-list
65098593|NCT00508898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65098594|NCT00508898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098595|NCT00508898|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65098596|NCT00508898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65098597|NCT00508898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098598|NCT00508898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65098599|NCT00508898|Vitamins|vitamins|mesh-ancestor
65098600|NCT00508898|Micronutrients|micronutrients|mesh-ancestor
65098601|NCT00508898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65098602|NCT04692558|Hyaluronic Acid|hyaluronic acid|mesh-list
65098603|NCT04692558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65098604|NCT04692558|Immunologic Factors|immunologic factors|mesh-ancestor
65098605|NCT04692558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098606|NCT04692558|Viscosupplements|viscosupplements|mesh-ancestor
65098607|NCT04692558|Protective Agents|protective agents|mesh-ancestor
65098608|NCT02952599|Edoxaban|edoxaban|mesh-list
65098609|NCT02952599|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65098610|NCT02952599|Antithrombins|antithrombins|mesh-ancestor
64740844|NCT00003137|Irinotecan|irinotecan|mesh-list
65098611|NCT02952599|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65098612|NCT02952599|Protease Inhibitors|protease inhibitors|mesh-ancestor
65098613|NCT02952599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098614|NCT02952599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098615|NCT02952599|Anticoagulants|anticoagulants|mesh-ancestor
65098616|NCT00510419|Sumatriptan|sumatriptan|mesh-list
65098617|NCT00510419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65098618|NCT00510419|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65098619|NCT00510419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65098620|NCT00510419|Serotonin Agents|serotonin agents|mesh-ancestor
65288501|NCT04069234|Purinergic Agents|purinergic agents|mesh-ancestor
65288502|NCT04069234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65288503|NCT04069234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288504|NCT04069234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288505|NCT04374773|Dronabinol|dronabinol|mesh-list
65288506|NCT04374773|Hallucinogens|hallucinogens|mesh-ancestor
65288507|NCT04374773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288508|NCT04374773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64518758|NCT05287893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65098621|NCT00510419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65098622|NCT00510419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098623|NCT00510419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098624|NCT00510536|Acetaminophen|acetaminophen|mesh-list
65098625|NCT00510536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65098626|NCT00510536|Analgesics|analgesics|mesh-ancestor
65098627|NCT00510536|Sensory System Agents|sensory system agents|mesh-ancestor
65098628|NCT00510536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64671396|NCT01717742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65098646|NCT00510614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65098647|NCT00510614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65098648|NCT00510614|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65098649|NCT00510614|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65098650|NCT00510614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65098651|NCT00508976|Lidocaine|lidocaine|mesh-list
65098652|NCT00508976|Bupivacaine|bupivacaine|mesh-list
65098653|NCT00508976|Anesthetics, Local|anesthetics, local|mesh-ancestor
65098654|NCT00508976|Anesthetics|anesthetics|mesh-ancestor
65098655|NCT00508976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65098656|NCT00508976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098657|NCT00508976|Sensory System Agents|sensory system agents|mesh-ancestor
65098658|NCT00508976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65098659|NCT00508976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65098660|NCT00508976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65098661|NCT00508976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65098662|NCT00508976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65098663|NCT00508976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098664|NCT04692285|Zolpidem|zolpidem|mesh-list
65098665|NCT04692285|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65098666|NCT04692285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64483662|NCT01763905|Antimetabolites|antimetabolites|mesh-ancestor
65098667|NCT04692285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65098668|NCT04692285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098669|NCT04692285|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65098670|NCT04692285|GABA Agonists|gaba agonists|mesh-ancestor
65098671|NCT04692285|GABA Agents|gaba agents|mesh-ancestor
65098672|NCT04692285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65098673|NCT04692285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098674|NCT00509015|Artesunate|artesunate|mesh-list
65098675|NCT00509015|Pyrimethamine|pyrimethamine|mesh-list
65098676|NCT00509015|Primaquine|primaquine|mesh-list
65098677|NCT00509015|Sulfadoxine|sulfadoxine|mesh-list
65098678|NCT00509015|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65098679|NCT00509015|Antimalarials|antimalarials|mesh-ancestor
65098680|NCT00509015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65098681|NCT00509015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65098682|NCT00509015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65098683|NCT00509015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098684|NCT00509015|Antiviral Agents|antiviral agents|mesh-ancestor
64671450|NCT02068157|Trioxsalen|trioxsalen|mesh-list
65098713|NCT00527085|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65098714|NCT00527085|Hormone Antagonists|hormone antagonists|mesh-ancestor
65098715|NCT00527085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65098716|NCT00509327|Bisacodyl|bisacodyl|mesh-list
65098717|NCT00509327|Cathartics|cathartics|mesh-ancestor
65098718|NCT00509327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65098719|NCT00509327|Laxatives|laxatives|mesh-ancestor
65098720|NCT00509405|Potassium Citrate|potassium citrate|mesh-list
65288509|NCT04374773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65288510|NCT04374773|Analgesics|analgesics|mesh-ancestor
65288511|NCT04374773|Sensory System Agents|sensory system agents|mesh-ancestor
65288512|NCT04374773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65288513|NCT04374773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64518767|NCT01552434|Valproic Acid|valproic acid|mesh-list
65098721|NCT00509405|Diuretics|diuretics|mesh-ancestor
65098722|NCT00509405|Natriuretic Agents|natriuretic agents|mesh-ancestor
65098723|NCT00509405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098724|NCT00509405|Expectorants|expectorants|mesh-ancestor
65098725|NCT00509405|Respiratory System Agents|respiratory system agents|mesh-ancestor
65098726|NCT00509561|Capecitabine|capecitabine|mesh-list
65098727|NCT00509561|Cetuximab|cetuximab|mesh-list
65098728|NCT00509561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098729|NCT00509561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65098730|NCT00509561|Antimetabolites|antimetabolites|mesh-ancestor
65098732|NCT00509561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65098734|NCT00509639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65098735|NCT00509639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65098736|NCT00509639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65098737|NCT00509639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65098738|NCT00528177|Morphine|morphine|mesh-list
65098739|NCT00528177|Oxycodone|oxycodone|mesh-list
65098740|NCT00528177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65098741|NCT00528177|Narcotics|narcotics|mesh-ancestor
65098742|NCT00528177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65098743|NCT00528177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098744|NCT00528177|Analgesics|analgesics|mesh-ancestor
65098745|NCT00528177|Sensory System Agents|sensory system agents|mesh-ancestor
65098746|NCT00528177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65098747|NCT00509678|Rituximab|rituximab|mesh-list
65098748|NCT00509678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65098749|NCT00509678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098750|NCT00509678|Immunologic Factors|immunologic factors|mesh-ancestor
65098751|NCT00509678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098752|NCT00509678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65098753|NCT00528216|Capsaicin|capsaicin|mesh-list
65098754|NCT00528216|Antipruritics|antipruritics|mesh-ancestor
65098755|NCT00528216|Dermatologic Agents|dermatologic agents|mesh-ancestor
65098756|NCT00528216|Sensory System Agents|sensory system agents|mesh-ancestor
65098757|NCT00528216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65098758|NCT00528216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098759|NCT00528255|Misoprostol|misoprostol|mesh-list
65098760|NCT00528255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65098761|NCT00528255|Abortifacient Agents|abortifacient agents|mesh-ancestor
65098762|NCT00528255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65098763|NCT00528255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098764|NCT00528255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65098765|NCT00528255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65098767|NCT02953106|Fluticasone|fluticasone|mesh-list
65098768|NCT02953106|Azelastine|azelastine|mesh-list
65098769|NCT02953106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65098770|NCT02953106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65098771|NCT02953106|Autonomic Agents|autonomic agents|mesh-ancestor
65098772|NCT02953106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65098773|NCT02953106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098774|NCT02953106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65098775|NCT02953106|Respiratory System Agents|respiratory system agents|mesh-ancestor
65098776|NCT02953106|Dermatologic Agents|dermatologic agents|mesh-ancestor
65098777|NCT02953106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65098778|NCT02953106|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65098779|NCT02953106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098780|NCT02953106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098781|NCT02953106|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65098782|NCT02953106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65098783|NCT02953106|Histamine Antagonists|histamine antagonists|mesh-ancestor
65098784|NCT02953106|Histamine Agents|histamine agents|mesh-ancestor
65098785|NCT02953106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65098786|NCT02952989|Pembrolizumab|pembrolizumab|mesh-list
65098787|NCT02952989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65098788|NCT02952989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288514|NCT04374773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65288515|NCT04374773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65288516|NCT04374773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288517|NCT04374773|Hormones|hormones|mesh-ancestor
65288518|NCT04374773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65288519|NCT00720538|Thalidomide|thalidomide|mesh-list
65288520|NCT00720538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65288521|NCT00720538|Immunologic Factors|immunologic factors|mesh-ancestor
65288522|NCT00720538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288523|NCT00720538|Leprostatic Agents|leprostatic agents|mesh-ancestor
65288524|NCT00720538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65288525|NCT00720538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65288526|NCT00720538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65288527|NCT00720538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65288528|NCT00720538|Growth Substances|growth substances|mesh-ancestor
65288529|NCT00720538|Growth Inhibitors|growth inhibitors|mesh-ancestor
65288530|NCT00720538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288531|NCT00678990|Heparin|heparin|mesh-list
65288532|NCT00678990|Anticoagulants|anticoagulants|mesh-ancestor
65288533|NCT00678990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65288534|NCT00678990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65288535|NCT00678990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288536|NCT00679068|Bosentan|bosentan|mesh-list
65288537|NCT00679068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65288538|NCT00679068|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64583586|NCT01801449|Rilonacept|rilonacept|mesh-list
65098789|NCT00510926|Imatinib Mesylate|imatinib mesylate|mesh-list
65098790|NCT00510926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098791|NCT00510926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65098792|NCT00510926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098793|NCT00510926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098794|NCT00509834|Lactoferrin|lactoferrin|mesh-list
65098795|NCT00509834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65098796|NCT03459404|Sufentanil|sufentanil|mesh-list
65098797|NCT03459404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65098805|NCT03459404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65098806|NCT03459404|Anesthetics, General|anesthetics, general|mesh-ancestor
65098807|NCT03459404|Anesthetics|anesthetics|mesh-ancestor
65098808|NCT00527202|Botulinum Toxins|botulinum toxins|mesh-list
65098809|NCT00527202|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65098810|NCT00527202|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65098811|NCT00527202|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65098812|NCT00527202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65098813|NCT00527202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098814|NCT00527202|Cholinergic Agents|cholinergic agents|mesh-ancestor
65098815|NCT00527202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65098816|NCT00527202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098817|NCT00527202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65288539|NCT00679068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288541|NCT00679146|Colchicine|colchicine|mesh-list
65288542|NCT00679146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65288543|NCT00679146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65288544|NCT00679146|Analgesics|analgesics|mesh-ancestor
65288545|NCT00679146|Sensory System Agents|sensory system agents|mesh-ancestor
65288546|NCT00679146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65288547|NCT00679146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288548|NCT00679146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65288549|NCT00679146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65288550|NCT00679146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65288551|NCT00679146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288552|NCT00679146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288553|NCT00679146|Gout Suppressants|gout suppressants|mesh-ancestor
65288554|NCT00679146|Tubulin Modulators|tubulin modulators|mesh-ancestor
65288555|NCT00679146|Antimitotic Agents|antimitotic agents|mesh-ancestor
65288556|NCT00679146|Mitosis Modulators|mitosis modulators|mesh-ancestor
65288557|NCT00679146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288558|NCT00679224|Ambrisentan|ambrisentan|mesh-list
65288559|NCT00679224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65288560|NCT00990847|Procaterol|procaterol|mesh-list
65288561|NCT00990847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65288562|NCT00990847|Autonomic Agents|autonomic agents|mesh-ancestor
65288563|NCT00990847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65288564|NCT00990847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288565|NCT00990847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65288566|NCT00990847|Respiratory System Agents|respiratory system agents|mesh-ancestor
65288567|NCT00990847|Sympathomimetics|sympathomimetics|mesh-ancestor
65098818|NCT00527202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65098819|NCT00510965|Ranibizumab|ranibizumab|mesh-list
65098820|NCT00510965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65098821|NCT00510965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65098822|NCT00510965|Growth Substances|growth substances|mesh-ancestor
65098823|NCT00510965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098824|NCT00510965|Growth Inhibitors|growth inhibitors|mesh-ancestor
65098825|NCT00510965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098826|NCT00509990|Pimecrolimus|pimecrolimus|mesh-list
65098827|NCT00509990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65098828|NCT00509990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65098829|NCT00509990|Analgesics|analgesics|mesh-ancestor
65098830|NCT00509990|Sensory System Agents|sensory system agents|mesh-ancestor
65098831|NCT00509990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65098832|NCT00509990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098833|NCT00509990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65098834|NCT00509990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65098835|NCT00509990|Dermatologic Agents|dermatologic agents|mesh-ancestor
65288568|NCT00990847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65288569|NCT00990847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65288570|NCT00990847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65288571|NCT00990847|Adrenergic Agents|adrenergic agents|mesh-ancestor
65288572|NCT00990847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65288573|NCT00990847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288574|NCT00594516|Tapentadol|tapentadol|mesh-list
65288575|NCT00594516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65288576|NCT00594516|Narcotics|narcotics|mesh-ancestor
65288577|NCT00594516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65288578|NCT00594516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288579|NCT00594516|Analgesics|analgesics|mesh-ancestor
65288580|NCT00594516|Sensory System Agents|sensory system agents|mesh-ancestor
65288581|NCT00594516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65288582|NCT00594516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65288583|NCT00594516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65288584|NCT00594516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65288585|NCT00594516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288586|NCT00594516|Adrenergic Agents|adrenergic agents|mesh-ancestor
65288587|NCT00594516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65288588|NCT00682500|Calfactant|calfactant|mesh-list
65288589|NCT00682500|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
65288590|NCT00682500|Respiratory System Agents|respiratory system agents|mesh-ancestor
64518825|NCT04485702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65098836|NCT00509990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65098837|NCT00509990|Immunologic Factors|immunologic factors|mesh-ancestor
65098838|NCT00509990|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65098839|NCT00509990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098840|NCT00509990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098841|NCT03459911|Losartan|losartan|mesh-list
65098842|NCT03459911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65098843|NCT03459911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65098844|NCT03459911|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65098845|NCT03459911|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65098846|NCT03459911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098847|NCT03459833|Hyaluronic Acid|hyaluronic acid|mesh-list
65098848|NCT03459833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65098849|NCT03459833|Immunologic Factors|immunologic factors|mesh-ancestor
65098850|NCT03459833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098851|NCT03459833|Viscosupplements|viscosupplements|mesh-ancestor
65098852|NCT03459833|Protective Agents|protective agents|mesh-ancestor
65098853|NCT05648487|Antibodies|antibodies|mesh-list
65098854|NCT05648487|Immunologic Factors|immunologic factors|mesh-ancestor
65098855|NCT05648487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098856|NCT00511121|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65098857|NCT00511121|Imatinib Mesylate|imatinib mesylate|mesh-list
65098858|NCT00511121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098859|NCT00511121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65288591|NCT00538291|Capecitabine|capecitabine|mesh-list
65288592|NCT00538291|Cetuximab|cetuximab|mesh-list
65288593|NCT00538291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65288594|NCT00538291|Antimetabolites|antimetabolites|mesh-ancestor
65288595|NCT00538291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288596|NCT00538291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288597|NCT00538291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65288598|NCT00682578|Artesunate|artesunate|mesh-list
65288599|NCT00682578|Chloroquine|chloroquine|mesh-list
65288600|NCT00682578|Pyrimethamine|pyrimethamine|mesh-list
65288601|NCT00682578|Piperaquine|piperaquine|mesh-list
65288602|NCT00682578|Artenimol|artenimol|mesh-list
65288603|NCT00682578|Antimalarials|antimalarials|mesh-ancestor
65288604|NCT00682578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65288605|NCT00682578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65288606|NCT00682578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65288607|NCT00682578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288608|NCT00682578|Antiviral Agents|antiviral agents|mesh-ancestor
65288609|NCT00682578|Schistosomicides|schistosomicides|mesh-ancestor
65288610|NCT00682578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65288611|NCT00682578|Anthelmintics|anthelmintics|mesh-ancestor
65288612|NCT00682578|Amebicides|amebicides|mesh-ancestor
65288613|NCT00682578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65288614|NCT00682578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65288615|NCT00682578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288616|NCT00682578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288617|NCT00594906|Teriparatide|teriparatide|mesh-list
65288618|NCT00594906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65288619|NCT00594906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288620|NCT00594906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65288621|NCT02745431|Oxytocin|oxytocin|mesh-list
65098860|NCT00511121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098861|NCT00511121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098862|NCT00511121|Antiviral Agents|antiviral agents|mesh-ancestor
65098880|NCT04692051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098882|NCT00528723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65098883|NCT00528723|Autonomic Agents|autonomic agents|mesh-ancestor
65098884|NCT00528723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65098885|NCT00528723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098886|NCT00528723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65098887|NCT00528723|Respiratory System Agents|respiratory system agents|mesh-ancestor
65098888|NCT00528723|Tocolytic Agents|tocolytic agents|mesh-ancestor
65098889|NCT00528723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65098890|NCT00528723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65098891|NCT00528723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65098892|NCT00528723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65288622|NCT02745431|Oxytocics|oxytocics|mesh-ancestor
65288623|NCT02745431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65288624|NCT02745431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288625|NCT00682656|Azithromycin|azithromycin|mesh-list
65288626|NCT00682656|Meglumine Antimoniate|meglumine antimoniate|mesh-list
65288627|NCT00682656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65288628|NCT00682656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65288629|NCT00682656|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65288630|NCT00682656|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65288631|NCT05590117|Leucovorin|leucovorin|mesh-list
65288632|NCT05590117|Fluorouracil|fluorouracil|mesh-list
65288633|NCT05590117|Oxaliplatin|oxaliplatin|mesh-list
65288634|NCT05590117|Pentoxifylline|pentoxifylline|mesh-list
65288635|NCT05590117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288636|NCT05590117|Antimetabolites|antimetabolites|mesh-ancestor
65288637|NCT05590117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288638|NCT05590117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65288639|NCT05590117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288640|NCT05590117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65288641|NCT05590117|Immunologic Factors|immunologic factors|mesh-ancestor
65288642|NCT05590117|Antidotes|antidotes|mesh-ancestor
65288643|NCT05590117|Protective Agents|protective agents|mesh-ancestor
65288644|NCT05590117|Vitamin B Complex|vitamin b complex|mesh-ancestor
65288645|NCT05590117|Vitamins|vitamins|mesh-ancestor
65288646|NCT05590117|Micronutrients|micronutrients|mesh-ancestor
65288647|NCT05590117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65288653|NCT05590117|Antioxidants|antioxidants|mesh-ancestor
65288674|NCT03874715|Insulin|insulin|mesh-list
65288675|NCT03874715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65288676|NCT03874715|Insulin Glargine|insulin glargine|mesh-list
65288677|NCT03874715|Insulin Aspart|insulin aspart|mesh-list
65288678|NCT03874715|Insulin, Long-Acting|insulin, long-acting|mesh-list
65288679|NCT03874715|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65288680|NCT03874715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65288681|NCT03874715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288682|NCT00679458|Buprenorphine|buprenorphine|mesh-list
65288683|NCT00679458|Naloxone|naloxone|mesh-list
65288684|NCT00679458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65288685|NCT00679458|Narcotics|narcotics|mesh-ancestor
65288686|NCT00679458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65288687|NCT00679458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288688|NCT00679458|Analgesics|analgesics|mesh-ancestor
65288689|NCT00679458|Sensory System Agents|sensory system agents|mesh-ancestor
65288690|NCT00679458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65288691|NCT00679458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65288692|NCT04216511|Autoantibodies|autoantibodies|mesh-list
65288693|NCT04216511|Immunologic Factors|immunologic factors|mesh-ancestor
65288694|NCT04216511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288696|NCT02747537|Sorafenib|sorafenib|mesh-list
65288697|NCT02747537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65288698|NCT02747537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65288699|NCT02747537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288700|NCT02747537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288701|NCT02747537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288702|NCT02747537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65288703|NCT02747381|Alfacalcidol|alfacalcidol|mesh-list
65288704|NCT02747381|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65288705|NCT02747381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65288706|NCT02747381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288707|NCT02747381|Vitamins|vitamins|mesh-ancestor
65288708|NCT02747381|Micronutrients|micronutrients|mesh-ancestor
65288709|NCT00673218|Omalizumab|omalizumab|mesh-list
65288710|NCT00673218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65288711|NCT00673218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65288715|NCT00673296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288716|NCT00673296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65288717|NCT00673296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65288718|NCT00673296|Growth Substances|growth substances|mesh-ancestor
65288719|NCT00673296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288720|NCT00673296|Growth Inhibitors|growth inhibitors|mesh-ancestor
65288721|NCT04216355|Azacitidine|azacitidine|mesh-list
65288722|NCT04216355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64518964|NCT01896609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65098893|NCT00528723|Adrenergic Agents|adrenergic agents|mesh-ancestor
65098894|NCT00528723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65098895|NCT00528723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098896|NCT00510107|Oxaliplatin|oxaliplatin|mesh-list
65098897|NCT00510107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098898|NCT01580514|Exenatide|exenatide|mesh-list
65098899|NCT01580514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65098900|NCT01580514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098901|NCT01580514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65098902|NCT01580514|Incretins|incretins|mesh-ancestor
65098903|NCT01580514|Hormones|hormones|mesh-ancestor
65098904|NCT01580514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65098905|NCT00528918|Insulin glulisine|insulin glulisine|mesh-list
65098906|NCT00528918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65098907|NCT00528918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098908|NCT00515190|Oxaliplatin|oxaliplatin|mesh-list
65098909|NCT00515190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098910|NCT00511277|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65098911|NCT00511277|Antidepressive Agents|antidepressive agents|mesh-ancestor
65098912|NCT00511277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65098913|NCT00511277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65098914|NCT00511277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65098915|NCT00511277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65098916|NCT00511277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098917|NCT02953184|Vitamins|vitamins|mesh-list
65098918|NCT02953184|Vitamin B Complex|vitamin b complex|mesh-list
65098919|NCT02953184|Cyclophosphamide|cyclophosphamide|mesh-list
65098920|NCT02953184|Docetaxel|docetaxel|mesh-list
65098922|NCT02953184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65098923|NCT02953184|Dexrazoxane|dexrazoxane|mesh-list
65098924|NCT02953184|Razoxane|razoxane|mesh-list
65098925|NCT02953184|Pirarubicin|pirarubicin|mesh-list
65098926|NCT02953184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65098927|NCT02953184|Immunologic Factors|immunologic factors|mesh-ancestor
65098928|NCT02953184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098929|NCT02953184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65098930|NCT02953184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65098931|NCT02953184|Alkylating Agents|alkylating agents|mesh-ancestor
65098932|NCT02953184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098933|NCT02953184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098934|NCT02953184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65098935|NCT02953184|Micronutrients|micronutrients|mesh-ancestor
65098936|NCT02953184|Tubulin Modulators|tubulin modulators|mesh-ancestor
65098937|NCT02953184|Antimitotic Agents|antimitotic agents|mesh-ancestor
65098938|NCT02953184|Mitosis Modulators|mitosis modulators|mesh-ancestor
65098939|NCT02953184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65098940|NCT02953184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65098941|NCT02953184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65098942|NCT02953184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098943|NCT02953184|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65098944|NCT02953184|Protective Agents|protective agents|mesh-ancestor
65098945|NCT00515229|Amitriptyline|amitriptyline|mesh-list
65098946|NCT00515229|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65098947|NCT00515229|Antidepressive Agents|antidepressive agents|mesh-ancestor
65098948|NCT00515229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65098949|NCT00515229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65098950|NCT00515229|Analgesics|analgesics|mesh-ancestor
65098951|NCT00515229|Sensory System Agents|sensory system agents|mesh-ancestor
65098952|NCT00515229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65288723|NCT04216355|Antimetabolites|antimetabolites|mesh-ancestor
65288724|NCT04216355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288725|NCT04216355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288726|NCT04216355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288727|NCT00683124|Losartan|losartan|mesh-list
65288728|NCT00683124|Nebivolol|nebivolol|mesh-list
65288729|NCT00683124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65288730|NCT00683124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65288731|NCT00683124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65288732|NCT00683124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65288733|NCT00683124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288734|NCT00683124|Vasodilator Agents|vasodilator agents|mesh-ancestor
65288735|NCT00683124|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65288736|NCT00683124|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65288737|NCT00683124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65288738|NCT00683124|Adrenergic Agents|adrenergic agents|mesh-ancestor
65288739|NCT00683124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65288740|NCT00683124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288741|NCT02744729|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
65288742|NCT02744729|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65288743|NCT02744729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288744|NCT00683202|Aspirin|aspirin|mesh-list
65288745|NCT00683202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65288746|NCT00683202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65288747|NCT00683202|Analgesics|analgesics|mesh-ancestor
65288748|NCT00683202|Sensory System Agents|sensory system agents|mesh-ancestor
65288749|NCT00683202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65288750|NCT00683202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288751|NCT00683202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65288752|NCT00683202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65288753|NCT00683202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65288754|NCT00683202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65288756|NCT00683202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65288763|NCT00679536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288764|NCT00679536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288765|NCT00679536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65288766|NCT00679536|Immunologic Factors|immunologic factors|mesh-ancestor
65288767|NCT00679536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288768|NCT00679536|Alkylating Agents|alkylating agents|mesh-ancestor
65288769|NCT00679536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65098953|NCT00515229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098954|NCT00515229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65098955|NCT00515229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65098956|NCT00515229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65098957|NCT00515229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098958|NCT00515229|Adrenergic Agents|adrenergic agents|mesh-ancestor
65098959|NCT00515229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65098960|NCT00511316|Montelukast|montelukast|mesh-list
65098961|NCT00511316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65098962|NCT00511316|Respiratory System Agents|respiratory system agents|mesh-ancestor
65098963|NCT00511316|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65098964|NCT00511316|Hormone Antagonists|hormone antagonists|mesh-ancestor
64631707|NCT00003634|Oregovomab|oregovomab|mesh-list
65098965|NCT00511316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65098966|NCT00511316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098967|NCT00511316|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65098968|NCT00511316|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65098969|NCT00511316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098970|NCT00529269|Mycophenolic Acid|mycophenolic acid|mesh-list
65098971|NCT00529269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65098972|NCT00529269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098973|NCT00529269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65098974|NCT00529269|Antitubercular Agents|antitubercular agents|mesh-ancestor
65098975|NCT00529269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65098976|NCT00529269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65098977|NCT00529269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098992|NCT02944734|Candesartan cilexetil|candesartan cilexetil|mesh-list
65098993|NCT02944734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65098994|NCT02944734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65098995|NCT02944734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65098996|NCT02944734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098997|NCT02944734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65098998|NCT02944734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098999|NCT02944734|Vasodilator Agents|vasodilator agents|mesh-ancestor
65099000|NCT02944734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65099001|NCT02944734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65099003|NCT00510263|Prednisolone|prednisolone|mesh-list
65099004|NCT00510263|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65099005|NCT00510263|Methylprednisolone|methylprednisolone|mesh-list
65099006|NCT00510263|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65099007|NCT00510263|Prednisolone acetate|prednisolone acetate|mesh-list
65099008|NCT00510263|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65099009|NCT00510263|Prednisolone phosphate|prednisolone phosphate|mesh-list
65099010|NCT00510263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65099011|NCT00510263|Glucocorticoids|glucocorticoids|mesh-ancestor
65099012|NCT00510263|Hormones|hormones|mesh-ancestor
65099013|NCT00510263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65099014|NCT00510263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099015|NCT00510263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65099016|NCT00510263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099017|NCT00510263|Antiemetics|antiemetics|mesh-ancestor
65099018|NCT00510263|Autonomic Agents|autonomic agents|mesh-ancestor
65099019|NCT00510263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65099020|NCT00510263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65099021|NCT00510263|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65099022|NCT00510263|Protective Agents|protective agents|mesh-ancestor
65099023|NCT00510263|Antiviral Agents|antiviral agents|mesh-ancestor
65288770|NCT00679536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65288771|NCT00537979|Ergocalciferols|ergocalciferols|mesh-list
65288772|NCT00537979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65288773|NCT00537979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288774|NCT00537979|Vitamins|vitamins|mesh-ancestor
65288775|NCT00537979|Micronutrients|micronutrients|mesh-ancestor
65288776|NCT00537979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65288777|NCT00679614|Acetaminophen|acetaminophen|mesh-list
65288778|NCT00679614|Tramadol|tramadol|mesh-list
65288779|NCT00679614|Naloxone|naloxone|mesh-list
65288780|NCT00679614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65288781|NCT00679614|Analgesics|analgesics|mesh-ancestor
65288782|NCT00679614|Sensory System Agents|sensory system agents|mesh-ancestor
65288783|NCT00679614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65288784|NCT00679614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288785|NCT00679614|Antipyretics|antipyretics|mesh-ancestor
65288786|NCT00679614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65288787|NCT00679614|Narcotics|narcotics|mesh-ancestor
65099024|NCT00510263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65099025|NCT00511628|Risperidone|risperidone|mesh-list
65099026|NCT00511628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65099027|NCT00511628|Serotonin Agents|serotonin agents|mesh-ancestor
65099028|NCT00511628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65099029|NCT00511628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099030|NCT00511628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099031|NCT00511628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65099032|NCT00511628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65099033|NCT00511628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65099034|NCT00511628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65099035|NCT00511628|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65099036|NCT00511628|Dopamine Agents|dopamine agents|mesh-ancestor
65099037|NCT00529425|Ropivacaine|ropivacaine|mesh-list
65099071|NCT00513110|Caffeine|caffeine|mesh-list
65099072|NCT00513110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65099073|NCT00513110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099074|NCT00513110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65099075|NCT00513110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099076|NCT00513110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099077|NCT00513110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65099078|NCT00513110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65099079|NCT00513110|Purinergic Agents|purinergic agents|mesh-ancestor
65099091|NCT00511823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65099092|NCT00511823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099093|NCT00511823|Antiemetics|antiemetics|mesh-ancestor
65099094|NCT00511823|Autonomic Agents|autonomic agents|mesh-ancestor
65099095|NCT00511823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65099096|NCT00511823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65099097|NCT00511823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65099098|NCT00511823|Serotonin Agents|serotonin agents|mesh-ancestor
65099099|NCT00511823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65099100|NCT00511823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099101|NCT00511823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65099102|NCT00515736|Vitamins|vitamins|mesh-list
65099103|NCT00515736|Vitamin E|vitamin e|mesh-list
65099104|NCT00515736|Thiamine|thiamine|mesh-list
65099105|NCT00515736|Zinc|zinc|mesh-list
65099106|NCT00515736|Selenium|selenium|mesh-list
65099107|NCT00515736|Micronutrients|micronutrients|mesh-ancestor
65099108|NCT00515736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099109|NCT00515736|Trace Elements|trace elements|mesh-ancestor
65288788|NCT00679614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65288789|NCT00679614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65288790|NCT02744417|Bupropion|bupropion|mesh-list
65288791|NCT02744417|Nicotine|nicotine|mesh-list
65288792|NCT02744417|Varenicline|varenicline|mesh-list
65288793|NCT02744417|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65288794|NCT02744417|Autonomic Agents|autonomic agents|mesh-ancestor
65288795|NCT02744417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65288796|NCT02744417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288797|NCT02744417|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65288798|NCT02744417|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65288799|NCT02744417|Cholinergic Agents|cholinergic agents|mesh-ancestor
64519036|NCT00163293|Glucocorticoids|glucocorticoids|mesh-ancestor
64519037|NCT00163293|Hormones|hormones|mesh-ancestor
64519040|NCT00163293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65099110|NCT00515736|Antioxidants|antioxidants|mesh-ancestor
65099111|NCT00515736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099112|NCT00515736|Protective Agents|protective agents|mesh-ancestor
65099113|NCT00515736|Vitamin B Complex|vitamin b complex|mesh-ancestor
65099114|NCT00511940|Acamprosate|acamprosate|mesh-list
65099115|NCT00511940|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65099116|NCT00513149|Clopidogrel|clopidogrel|mesh-list
65099117|NCT00513149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65099118|NCT00513149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65099119|NCT00513149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65099120|NCT00513149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65099121|NCT00513149|Purinergic Agents|purinergic agents|mesh-ancestor
65099122|NCT00513149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65099123|NCT00513149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099124|NCT00513149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099125|NCT02944227|Ranibizumab|ranibizumab|mesh-list
65099126|NCT02944227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65099127|NCT02944227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65099128|NCT02944227|Growth Substances|growth substances|mesh-ancestor
65099129|NCT02944227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099130|NCT02944227|Growth Inhibitors|growth inhibitors|mesh-ancestor
65099131|NCT02944227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099132|NCT00513188|Leucovorin|leucovorin|mesh-list
65099133|NCT00513188|Cytarabine|cytarabine|mesh-list
65099134|NCT00513188|Prednisone|prednisone|mesh-list
65099135|NCT00513188|Cyclophosphamide|cyclophosphamide|mesh-list
65099136|NCT00513188|Doxorubicin|doxorubicin|mesh-list
65099137|NCT00513188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65099138|NCT00513188|Methotrexate|methotrexate|mesh-list
65099149|NCT00513188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099150|NCT00513188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65099151|NCT00513188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65099152|NCT00513188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65099153|NCT00513188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65099154|NCT00513188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099155|NCT00513188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65099156|NCT00513188|Glucocorticoids|glucocorticoids|mesh-ancestor
65099157|NCT00513188|Hormones|hormones|mesh-ancestor
65099158|NCT00513188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65099159|NCT00513188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65099160|NCT00513188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65099161|NCT00513188|Abortifacient Agents|abortifacient agents|mesh-ancestor
65099162|NCT00513188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65099163|NCT00513188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65099164|NCT00513188|Antimetabolites|antimetabolites|mesh-ancestor
65099165|NCT00513188|Dermatologic Agents|dermatologic agents|mesh-ancestor
65099166|NCT00513188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65288800|NCT02744417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65288801|NCT02744417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288802|NCT02744417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65288803|NCT02744417|Antidepressive Agents|antidepressive agents|mesh-ancestor
65288804|NCT02744417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65288805|NCT02744417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65288806|NCT02744417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65288807|NCT02744417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65288808|NCT02744417|Dopamine Agents|dopamine agents|mesh-ancestor
65288809|NCT02744417|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65288810|NCT02744417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65288811|NCT02744417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288812|NCT02629146|Fentanyl|fentanyl|mesh-list
65288813|NCT02629146|Midazolam|midazolam|mesh-list
64519048|NCT03228108|Ciprofloxacin|ciprofloxacin|mesh-list
64519049|NCT03228108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65099167|NCT00513188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65099168|NCT00513188|Antiviral Agents|antiviral agents|mesh-ancestor
65099169|NCT00513188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65099170|NCT00513188|Antidotes|antidotes|mesh-ancestor
65099171|NCT00513188|Protective Agents|protective agents|mesh-ancestor
65099172|NCT00513188|Vitamin B Complex|vitamin b complex|mesh-ancestor
65099173|NCT00513188|Vitamins|vitamins|mesh-ancestor
65099174|NCT00513188|Micronutrients|micronutrients|mesh-ancestor
65099175|NCT00513188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65099176|NCT00513188|Tubulin Modulators|tubulin modulators|mesh-ancestor
65099177|NCT00513188|Antimitotic Agents|antimitotic agents|mesh-ancestor
65099178|NCT00513188|Mitosis Modulators|mitosis modulators|mesh-ancestor
65099179|NCT00513266|Leucovorin|leucovorin|mesh-list
65099180|NCT00513266|Bevacizumab|bevacizumab|mesh-list
65099181|NCT00513266|Cetuximab|cetuximab|mesh-list
65099182|NCT00513266|Fluorouracil|fluorouracil|mesh-list
65099183|NCT00513266|Oxaliplatin|oxaliplatin|mesh-list
65099184|NCT00513266|Irinotecan|irinotecan|mesh-list
65099185|NCT00513266|Calcium|calcium|mesh-list
65099186|NCT00513266|Levoleucovorin|levoleucovorin|mesh-list
65099187|NCT00513266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65099188|NCT00513266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099189|NCT00513266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65099190|NCT00513266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65099191|NCT00513266|Growth Substances|growth substances|mesh-ancestor
65099192|NCT00513266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099193|NCT00513266|Growth Inhibitors|growth inhibitors|mesh-ancestor
65099194|NCT00513266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65099195|NCT00513266|Antimetabolites|antimetabolites|mesh-ancestor
65099196|NCT00513266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099197|NCT00513266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65099198|NCT00513266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65099199|NCT00513266|Immunologic Factors|immunologic factors|mesh-ancestor
65099200|NCT00513266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65099201|NCT00513266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65099202|NCT00513266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099203|NCT00513266|Antidotes|antidotes|mesh-ancestor
65099204|NCT00513266|Protective Agents|protective agents|mesh-ancestor
64671990|NCT03711188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64671992|NCT02366663|Cytarabine|cytarabine|mesh-list
65099210|NCT00513383|Carboplatin|carboplatin|mesh-list
65099211|NCT00513383|Fluorouracil|fluorouracil|mesh-list
65099212|NCT00513383|Panitumumab|panitumumab|mesh-list
65288814|NCT02629146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65288815|NCT02629146|Narcotics|narcotics|mesh-ancestor
65288816|NCT02629146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65288817|NCT02629146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288818|NCT02629146|Analgesics|analgesics|mesh-ancestor
65288819|NCT02629146|Sensory System Agents|sensory system agents|mesh-ancestor
65288820|NCT02629146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65288821|NCT02629146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65288822|NCT02629146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65288823|NCT02629146|Anesthetics, General|anesthetics, general|mesh-ancestor
65288824|NCT02629146|Anesthetics|anesthetics|mesh-ancestor
65288825|NCT02629146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65288826|NCT02629146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65288827|NCT02629146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65288828|NCT02629146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65288829|NCT02629146|GABA Modulators|gaba modulators|mesh-ancestor
65288830|NCT02629146|GABA Agents|gaba agents|mesh-ancestor
65288831|NCT02629146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65288832|NCT02629146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288833|NCT02744339|Riociguat|riociguat|mesh-list
65288834|NCT02744339|Enzyme Activators|enzyme activators|mesh-ancestor
65288835|NCT02744339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288836|NCT00991159|Bococizumab|bococizumab|mesh-list
65288837|NCT00991159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65288838|NCT00991159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65288839|NCT00991159|Antimetabolites|antimetabolites|mesh-ancestor
65344915|NCT00736346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099213|NCT00513383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65099214|NCT00513383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099215|NCT00513383|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741454|NCT00003995|Irinotecan|irinotecan|mesh-list
65099216|NCT00513383|Antimitotic Agents|antimitotic agents|mesh-ancestor
65099217|NCT00513383|Mitosis Modulators|mitosis modulators|mesh-ancestor
65099218|NCT00513383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099219|NCT00513383|Antimetabolites|antimetabolites|mesh-ancestor
65099220|NCT00513383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65099221|NCT00513383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65099222|NCT00513383|Immunologic Factors|immunologic factors|mesh-ancestor
65099223|NCT00513383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099224|NCT00513383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65099225|NCT00515892|Immunotoxin HA22|immunotoxin ha22|mesh-list
65099227|NCT00515892|Immunoglobulins|immunoglobulins|mesh-list
65099228|NCT00515892|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65099229|NCT00515892|Immunotoxins|immunotoxins|mesh-list
65099230|NCT00515892|Immunologic Factors|immunologic factors|mesh-ancestor
65099231|NCT00515892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099232|NCT00515892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099233|NCT00513539|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
65099234|NCT00513539|Trioxsalen|trioxsalen|mesh-list
65288840|NCT00991159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288841|NCT00991159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65288842|NCT00679770|Tavaborole|tavaborole|mesh-list
65288843|NCT00679770|Antifungal Agents|antifungal agents|mesh-ancestor
65288844|NCT00679770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65288845|NCT02744495|Betamethasone|betamethasone|mesh-list
65288846|NCT02744495|Droperidol|droperidol|mesh-list
65288847|NCT02744495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65099235|NCT00513539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099236|NCT00513539|Dermatologic Agents|dermatologic agents|mesh-ancestor
65099237|NCT00513539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65099238|NCT00511979|Insulin|insulin|mesh-list
65099239|NCT00511979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65099240|NCT00511979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65099241|NCT00511979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099242|NCT00513578|Sargramostim|sargramostim|mesh-list
65099243|NCT00513578|Freund's Adjuvant|freund's adjuvant|mesh-list
65099244|NCT00513578|Immunologic Factors|immunologic factors|mesh-ancestor
65099245|NCT00513578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099246|NCT00513578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65099247|NCT00513656|Oxycodone|oxycodone|mesh-list
65099248|NCT00513656|Naloxone|naloxone|mesh-list
65099249|NCT00513656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65099250|NCT00513656|Narcotics|narcotics|mesh-ancestor
65099251|NCT00513656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65099252|NCT00513656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099253|NCT00513656|Analgesics|analgesics|mesh-ancestor
65099254|NCT00513656|Sensory System Agents|sensory system agents|mesh-ancestor
65099255|NCT00513656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65099256|NCT00513656|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65099257|NCT00530127|Deferiprone|deferiprone|mesh-list
65099258|NCT00530127|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65099259|NCT00530127|Chelating Agents|chelating agents|mesh-ancestor
65099260|NCT00530127|Sequestering Agents|sequestering agents|mesh-ancestor
65099261|NCT00530127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099262|NCT04691934|Anesthetics|anesthetics|mesh-list
65099263|NCT04691934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65099264|NCT04691934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099265|NCT00512057|Allopurinol|allopurinol|mesh-list
65099266|NCT00512057|Antimetabolites|antimetabolites|mesh-ancestor
65099267|NCT00512057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099268|NCT00512057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099269|NCT00512057|Gout Suppressants|gout suppressants|mesh-ancestor
65099270|NCT00512057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65099271|NCT00512057|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65099272|NCT00512057|Antioxidants|antioxidants|mesh-ancestor
65099273|NCT00512057|Protective Agents|protective agents|mesh-ancestor
65099274|NCT00512057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099275|NCT00513929|Zinc Sulfate|zinc sulfate|mesh-list
65099297|NCT00512291|Antiemetics|antiemetics|mesh-ancestor
65099298|NCT00512291|Autonomic Agents|autonomic agents|mesh-ancestor
65099299|NCT00512291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65099300|NCT00512291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099301|NCT00512291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65099302|NCT00512291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65099303|NCT00512291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65099304|NCT00512291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65099305|NCT00512291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65099306|NCT00512291|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65099307|NCT00512291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65099308|NCT00512291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65099309|NCT00512291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099310|NCT00512291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65099311|NCT00512291|Serotonin Agents|serotonin agents|mesh-ancestor
65099312|NCT00512291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65099313|NCT00512291|Antidepressive Agents|antidepressive agents|mesh-ancestor
65099314|NCT00512291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65099315|NCT00512291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65288848|NCT02744495|Glucocorticoids|glucocorticoids|mesh-ancestor
65288849|NCT02744495|Hormones|hormones|mesh-ancestor
65288850|NCT02744495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65288851|NCT02744495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288852|NCT02744495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65288853|NCT02744495|Respiratory System Agents|respiratory system agents|mesh-ancestor
65288854|NCT02744495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65288855|NCT02744495|Antiemetics|antiemetics|mesh-ancestor
65288856|NCT02744495|Autonomic Agents|autonomic agents|mesh-ancestor
65288857|NCT02744495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65288858|NCT02744495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65288859|NCT02744495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65288860|NCT02744495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65288861|NCT02744495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65288862|NCT02744495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65288863|NCT02744495|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65288864|NCT02744495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65099316|NCT00512291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099317|NCT00514163|Gemcitabine|gemcitabine|mesh-list
65099318|NCT00514163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65099319|NCT00514163|Antimetabolites|antimetabolites|mesh-ancestor
65099320|NCT00514163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099321|NCT00514163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099322|NCT00514163|Antiviral Agents|antiviral agents|mesh-ancestor
65099323|NCT00514163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65099324|NCT00514163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099325|NCT00514163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65099326|NCT00514163|Immunologic Factors|immunologic factors|mesh-ancestor
65099327|NCT00514163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099328|NCT00514202|Dextroamphetamine|dextroamphetamine|mesh-list
65099342|NCT00512408|Hormones|hormones|mesh-ancestor
65099343|NCT00512408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65099344|NCT00512408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099345|NCT00530400|Cefuroxime|cefuroxime|mesh-list
65099346|NCT00530400|Cefuroxime axetil|cefuroxime axetil|mesh-list
65099347|NCT00530400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65099348|NCT00530400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65099349|NCT00531336|Bevacizumab|bevacizumab|mesh-list
65099350|NCT00531336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65099351|NCT00531336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099352|NCT00531336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65099353|NCT00531336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65099354|NCT00531336|Growth Substances|growth substances|mesh-ancestor
65099355|NCT00531336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099356|NCT00531336|Growth Inhibitors|growth inhibitors|mesh-ancestor
65099357|NCT00530478|Donepezil|donepezil|mesh-list
65099358|NCT00530478|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65099359|NCT00530478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099360|NCT00530478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099361|NCT00530478|Cholinergic Agents|cholinergic agents|mesh-ancestor
65099362|NCT00530478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65099363|NCT00530478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099364|NCT00530478|Nootropic Agents|nootropic agents|mesh-ancestor
65099365|NCT00530556|Zolpidem|zolpidem|mesh-list
65099366|NCT00530556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65099367|NCT00530556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65099368|NCT00530556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65288865|NCT02744495|Dopamine Agents|dopamine agents|mesh-ancestor
65288866|NCT02744495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65288867|NCT02744495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288868|NCT00683358|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65288869|NCT00683358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65288870|NCT00683358|Immunologic Factors|immunologic factors|mesh-ancestor
65288871|NCT00683358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288872|NCT00683436|Adipiplon|adipiplon|mesh-list
65288873|NCT00683436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65288874|NCT00683436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288875|NCT00683436|GABA Agonists|gaba agonists|mesh-ancestor
65288876|NCT00683436|GABA Agents|gaba agents|mesh-ancestor
65288877|NCT00683436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64519117|NCT03120234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64519118|NCT03120234|Adrenergic Agents|adrenergic agents|mesh-ancestor
65099369|NCT00530556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099370|NCT00530556|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65099372|NCT00530556|GABA Agents|gaba agents|mesh-ancestor
65099373|NCT00530556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65099374|NCT00530556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099375|NCT00512486|Benralizumab|benralizumab|mesh-list
65099376|NCT00512486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65099377|NCT00512486|Respiratory System Agents|respiratory system agents|mesh-ancestor
65099378|NCT00530595|Losartan|losartan|mesh-list
65099379|NCT00530595|Valsartan|valsartan|mesh-list
65099380|NCT00530595|Candesartan|candesartan|mesh-list
65099381|NCT00530595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65099382|NCT00530595|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65099383|NCT00530595|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65099384|NCT00530595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099385|NCT00530595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65099386|NCT02943759|Chlorhexidine|chlorhexidine|mesh-list
65099387|NCT02943759|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65099388|NCT02943759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65099389|NCT02943759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65099412|NCT00514397|Alkylating Agents|alkylating agents|mesh-ancestor
65099413|NCT00514397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099414|NCT00514397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099415|NCT00514397|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65099416|NCT00514397|Dermatologic Agents|dermatologic agents|mesh-ancestor
65099417|NCT02943603|Pembrolizumab|pembrolizumab|mesh-list
65099418|NCT02943603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65099419|NCT02943603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099420|NCT00531687|Gemcitabine|gemcitabine|mesh-list
65099422|NCT00531687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65099423|NCT00531687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099424|NCT00531687|Tubulin Modulators|tubulin modulators|mesh-ancestor
65099425|NCT00531687|Antimitotic Agents|antimitotic agents|mesh-ancestor
65099426|NCT00531687|Mitosis Modulators|mitosis modulators|mesh-ancestor
65099427|NCT00531687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099428|NCT00531687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65099429|NCT00531687|Antimetabolites|antimetabolites|mesh-ancestor
65099430|NCT00531687|Antiviral Agents|antiviral agents|mesh-ancestor
65099431|NCT00531687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65099432|NCT00531687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099433|NCT00531687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65099434|NCT00531687|Immunologic Factors|immunologic factors|mesh-ancestor
65099435|NCT00531687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099436|NCT00514475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65099437|NCT00514475|Immunologic Factors|immunologic factors|mesh-ancestor
65288878|NCT00683436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288879|NCT00683436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65288880|NCT00683436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65288881|NCT00683436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65288882|NCT00989443|Cidofovir|cidofovir|mesh-list
65288883|NCT00989443|Antiviral Agents|antiviral agents|mesh-ancestor
65288884|NCT00989443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65288885|NCT00989443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288886|NCT00989443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519132|NCT03227484|Empagliflozin|empagliflozin|mesh-list
65099438|NCT00514475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099439|NCT00512681|Oxaliplatin|oxaliplatin|mesh-list
65099440|NCT00512681|Irinotecan|irinotecan|mesh-list
65099441|NCT00512681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672166|NCT03211286|Coagulants|coagulants|mesh-ancestor
65099452|NCT00530868|Growth Substances|growth substances|mesh-ancestor
65099453|NCT00530868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099454|NCT00530868|Growth Inhibitors|growth inhibitors|mesh-ancestor
65099455|NCT00530868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65099456|NCT00530868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65099457|NCT00530868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099458|NCT00530868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099459|NCT00530868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65099460|NCT00530868|Hormone Antagonists|hormone antagonists|mesh-ancestor
65099461|NCT00530868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65099462|NCT00530907|Bevacizumab|bevacizumab|mesh-list
65099463|NCT00530907|Valproic Acid|valproic acid|mesh-list
65099464|NCT00530907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65099465|NCT00530907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099466|NCT00530907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65099467|NCT00530907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65099468|NCT00530907|Growth Substances|growth substances|mesh-ancestor
65099469|NCT00530907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099470|NCT00530907|Growth Inhibitors|growth inhibitors|mesh-ancestor
65099471|NCT00530907|Anticonvulsants|anticonvulsants|mesh-ancestor
65099472|NCT00530907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099473|NCT00530907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099474|NCT00530907|GABA Agents|gaba agents|mesh-ancestor
65099475|NCT00530907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65099476|NCT00530907|Antimanic Agents|antimanic agents|mesh-ancestor
65099477|NCT00530907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65099478|NCT00530907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65099479|NCT00530907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65099480|NCT00531024|Bevacizumab|bevacizumab|mesh-list
65099481|NCT00531024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65099482|NCT00531024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099483|NCT00531024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65099484|NCT00531024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65099485|NCT00531024|Growth Substances|growth substances|mesh-ancestor
65099486|NCT00531024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099487|NCT00531024|Growth Inhibitors|growth inhibitors|mesh-ancestor
65099488|NCT00512759|Nitroglycerin|nitroglycerin|mesh-list
65099489|NCT00512759|Vasodilator Agents|vasodilator agents|mesh-ancestor
65099490|NCT00514670|Hand Sanitizers|hand sanitizers|mesh-list
65099491|NCT00514670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65099492|NCT00514670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65099493|NCT00514670|Disinfectants|disinfectants|mesh-ancestor
65099494|NCT00531063|Everolimus|everolimus|mesh-list
65099495|NCT00531063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099496|NCT00531063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65099497|NCT00531063|Immunologic Factors|immunologic factors|mesh-ancestor
65099511|NCT02943369|Ticagrelor|ticagrelor|mesh-list
65099512|NCT02943369|Cangrelor|cangrelor|mesh-list
65099513|NCT02943369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65099514|NCT02943369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65099515|NCT02943369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65288887|NCT00683514|Cisplatin|cisplatin|mesh-list
65288888|NCT00683514|Vinorelbine|vinorelbine|mesh-list
65288889|NCT00683514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288890|NCT00683514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65288891|NCT00683514|Tubulin Modulators|tubulin modulators|mesh-ancestor
65288892|NCT00683514|Antimitotic Agents|antimitotic agents|mesh-ancestor
65099516|NCT02943369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65099517|NCT02943369|Purinergic Agents|purinergic agents|mesh-ancestor
65099518|NCT02943369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65099519|NCT02943369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099520|NCT02943369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099521|NCT00514748|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
65099522|NCT00514748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65099523|NCT00514748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65099525|NCT00514748|Sensory System Agents|sensory system agents|mesh-ancestor
65099526|NCT00514748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65099527|NCT00514748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099528|NCT00514748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65099529|NCT00514748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65099530|NCT00515957|Antibodies|antibodies|mesh-list
65099531|NCT00515957|Immunologic Factors|immunologic factors|mesh-ancestor
65099532|NCT00515957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099533|NCT02943642|Vorinostat|vorinostat|mesh-list
65099534|NCT02943642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099535|NCT02943642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65099536|NCT02943642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099537|NCT02943642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099538|NCT04695509|Propofol|propofol|mesh-list
65099539|NCT04695509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65099540|NCT04695509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65099541|NCT04695509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099542|NCT04695509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65099543|NCT04695509|Anesthetics, General|anesthetics, general|mesh-ancestor
65099544|NCT04695509|Anesthetics|anesthetics|mesh-ancestor
65099545|NCT02943135|Lidocaine|lidocaine|mesh-list
65099546|NCT02943135|Anesthetics, Local|anesthetics, local|mesh-ancestor
65099547|NCT02943135|Anesthetics|anesthetics|mesh-ancestor
65099548|NCT02943135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65099549|NCT02943135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099550|NCT02943135|Sensory System Agents|sensory system agents|mesh-ancestor
65099551|NCT02943135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65099552|NCT02943135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65099553|NCT02943135|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65099554|NCT02943135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65099555|NCT02943135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65099556|NCT02943135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099557|NCT02951234|Aspirin|aspirin|mesh-list
65099558|NCT02951234|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64672274|NCT02386319|Antioxidants|antioxidants|mesh-ancestor
65099561|NCT02951234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65099562|NCT02951234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65099563|NCT02951234|Analgesics|analgesics|mesh-ancestor
65099564|NCT02951234|Sensory System Agents|sensory system agents|mesh-ancestor
65099565|NCT02951234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65099566|NCT02951234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099567|NCT02951234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65099568|NCT02951234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65099569|NCT02951234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65099570|NCT02951234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65099571|NCT02951234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099572|NCT02951234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65099573|NCT02951234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65099574|NCT02951234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099575|NCT02951234|Antipyretics|antipyretics|mesh-ancestor
65099576|NCT02951234|Immunologic Factors|immunologic factors|mesh-ancestor
65099577|NCT02943252|Apatinib|apatinib|mesh-list
65099578|NCT02943252|Tegafur|tegafur|mesh-list
65099579|NCT02943252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099580|NCT02943252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65288893|NCT00683514|Mitosis Modulators|mitosis modulators|mesh-ancestor
65288894|NCT00683514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288895|NCT00683670|Cyclophosphamide|cyclophosphamide|mesh-list
65288896|NCT00683670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65288897|NCT00683670|Immunologic Factors|immunologic factors|mesh-ancestor
65288898|NCT00683670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288899|NCT00683670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65288900|NCT00683670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65288901|NCT00683670|Alkylating Agents|alkylating agents|mesh-ancestor
65288902|NCT00683670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288903|NCT00683670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288904|NCT00683670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65099581|NCT02943252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099582|NCT02943252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632325|NCT00003274|Sargramostim|sargramostim|mesh-list
65099583|NCT02943252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65099584|NCT02943252|Antimetabolites|antimetabolites|mesh-ancestor
65099585|NCT00514982|Adalimumab|adalimumab|mesh-list
65099586|NCT00514982|Mesalamine|mesalamine|mesh-list
65099587|NCT00514982|Mercaptopurine|mercaptopurine|mesh-list
65099588|NCT00514982|Infliximab|infliximab|mesh-list
65099589|NCT00514982|Tacrolimus|tacrolimus|mesh-list
65099590|NCT00514982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65099591|NCT00514982|Immunologic Factors|immunologic factors|mesh-ancestor
65099592|NCT00514982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099593|NCT00514982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65099594|NCT00514982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099595|NCT00514982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099596|NCT00514982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65099597|NCT00514982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65099598|NCT00514982|Dermatologic Agents|dermatologic agents|mesh-ancestor
65099599|NCT00514982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65099600|NCT00514982|Antimetabolites|antimetabolites|mesh-ancestor
65099601|NCT00514982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65099602|NCT00514982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099603|NCT00514982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65099604|NCT00514982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65099605|NCT00514982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65099606|NCT00514982|Analgesics|analgesics|mesh-ancestor
65099607|NCT00514982|Sensory System Agents|sensory system agents|mesh-ancestor
65099608|NCT00514982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65099609|NCT00531999|Ritonavir|ritonavir|mesh-list
65099610|NCT00531999|Lopinavir|lopinavir|mesh-list
65099611|NCT00531999|Raltegravir Potassium|raltegravir potassium|mesh-list
65099612|NCT00531999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65099613|NCT00531999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65099614|NCT00531999|Protease Inhibitors|protease inhibitors|mesh-ancestor
65099615|NCT00531999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099616|NCT00531999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099617|NCT00531999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65099618|NCT00531999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65099619|NCT00531999|Antiviral Agents|antiviral agents|mesh-ancestor
65099620|NCT00531999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65099621|NCT00531999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65099622|NCT00531999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65099623|NCT00531999|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65099624|NCT00531999|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65099625|NCT05319912|Molybdenum|molybdenum|mesh-list
65099626|NCT05319912|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
65099627|NCT05319912|Choline|choline|mesh-list
65099633|NCT05319912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099634|NCT05319912|Lipotropic Agents|lipotropic agents|mesh-ancestor
65288905|NCT05629325|Buspirone|buspirone|mesh-list
65288906|NCT05629325|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65288907|NCT05629325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65288908|NCT05629325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65288909|NCT05629325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288910|NCT05629325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65288911|NCT05629325|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65288912|NCT05629325|Serotonin Agents|serotonin agents|mesh-ancestor
65288913|NCT05629325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65288914|NCT05629325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519157|NCT01375374|Anticonvulsants|anticonvulsants|mesh-ancestor
65099635|NCT05319912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65099636|NCT05319912|Antimetabolites|antimetabolites|mesh-ancestor
65099637|NCT05319912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65099638|NCT05319912|Nootropic Agents|nootropic agents|mesh-ancestor
65099639|NCT05319912|Chelating Agents|chelating agents|mesh-ancestor
65099640|NCT05319912|Sequestering Agents|sequestering agents|mesh-ancestor
65099641|NCT05319912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65099642|NCT05319912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65099643|NCT05319912|Growth Substances|growth substances|mesh-ancestor
65099644|NCT05319912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099645|NCT05319912|Growth Inhibitors|growth inhibitors|mesh-ancestor
65099646|NCT05319912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099647|NCT05319912|Trace Elements|trace elements|mesh-ancestor
65099648|NCT05319912|Micronutrients|micronutrients|mesh-ancestor
65099649|NCT00515138|Rituximab|rituximab|mesh-list
65099650|NCT00515138|Carboplatin|carboplatin|mesh-list
65099651|NCT00515138|Etoposide|etoposide|mesh-list
65099652|NCT00515138|Bortezomib|bortezomib|mesh-list
65099653|NCT00515138|Ifosfamide|ifosfamide|mesh-list
65099654|NCT00515138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65099655|NCT00515138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099656|NCT00515138|Immunologic Factors|immunologic factors|mesh-ancestor
65099657|NCT00515138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099658|NCT00515138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65099659|NCT00515138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65099660|NCT00515138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65099661|NCT00515138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65099662|NCT00515138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099663|NCT00515138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099664|NCT00515138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65099665|NCT00515138|Alkylating Agents|alkylating agents|mesh-ancestor
65099667|NCT05319834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64741905|NCT00003305|Levoleucovorin|levoleucovorin|mesh-list
65099668|NCT05319834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65099670|NCT05319834|Sensory System Agents|sensory system agents|mesh-ancestor
65099671|NCT05319834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65099672|NCT05319834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099673|NCT05319834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65099674|NCT05319834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65099675|NCT05319834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65099676|NCT05319834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65099677|NCT05319834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099678|NCT05319834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65099679|NCT05319834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65099680|NCT05319834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099681|NCT05319834|Antipyretics|antipyretics|mesh-ancestor
65099701|NCT04695197|Artemether|artemether|mesh-list
65099702|NCT04695197|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65099703|NCT04695197|Pyronaridine|pyronaridine|mesh-list
65099704|NCT04695197|Antimalarials|antimalarials|mesh-ancestor
65099705|NCT04695197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65099706|NCT04695197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65099707|NCT04695197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65099708|NCT04695197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288915|NCT02629380|Hyaluronic Acid|hyaluronic acid|mesh-list
65288916|NCT02629380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65288917|NCT02629380|Immunologic Factors|immunologic factors|mesh-ancestor
65288918|NCT02629380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288919|NCT02629380|Viscosupplements|viscosupplements|mesh-ancestor
65288920|NCT02629380|Protective Agents|protective agents|mesh-ancestor
65099709|NCT04695197|Antiviral Agents|antiviral agents|mesh-ancestor
65099710|NCT04695197|Schistosomicides|schistosomicides|mesh-ancestor
65099711|NCT04695197|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65099712|NCT04695197|Anthelmintics|anthelmintics|mesh-ancestor
65099713|NCT00516152|Methotrexate|methotrexate|mesh-list
65099714|NCT00516152|Fludarabine phosphate|fludarabine phosphate|mesh-list
65099715|NCT00516152|Fludarabine|fludarabine|mesh-list
65099716|NCT00516152|Busulfan|busulfan|mesh-list
65099717|NCT00516152|Tacrolimus|tacrolimus|mesh-list
65099718|NCT00516152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65099719|NCT00516152|Abortifacient Agents|abortifacient agents|mesh-ancestor
65099720|NCT00516152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65099721|NCT00516152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099722|NCT00516152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65099723|NCT00516152|Antimetabolites|antimetabolites|mesh-ancestor
65099724|NCT00516152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099725|NCT00516152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099726|NCT00516152|Dermatologic Agents|dermatologic agents|mesh-ancestor
65099727|NCT00516152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099728|NCT00516152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65099729|NCT00516152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65099730|NCT00516152|Immunologic Factors|immunologic factors|mesh-ancestor
65099731|NCT00516152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65099732|NCT00516152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65099733|NCT00516152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65099734|NCT00516152|Alkylating Agents|alkylating agents|mesh-ancestor
65099735|NCT00516152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65099736|NCT00516152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65099737|NCT00516191|Doxorubicin|doxorubicin|mesh-list
65099747|NCT00516191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65099748|NCT00516191|Alkylating Agents|alkylating agents|mesh-ancestor
65099749|NCT00516191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65099750|NCT00516191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65099751|NCT00516191|Immunologic Factors|immunologic factors|mesh-ancestor
65099752|NCT00516191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099753|NCT00515450|Immunoglobulins|immunoglobulins|mesh-list
65099754|NCT00515450|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65099755|NCT00515450|Antibodies|antibodies|mesh-list
65099756|NCT00515450|gamma-Globulins|gamma-globulins|mesh-list
65099757|NCT00515450|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65099758|NCT00515450|Immunologic Factors|immunologic factors|mesh-ancestor
65099759|NCT00515450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099760|NCT00515489|Risperidone|risperidone|mesh-list
65099761|NCT00515489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65099762|NCT00515489|Serotonin Agents|serotonin agents|mesh-ancestor
65099763|NCT00515489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65099764|NCT00515489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099765|NCT00515489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099766|NCT00515489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65099767|NCT00515489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65099768|NCT00515489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65099769|NCT00515489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65099770|NCT00515489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65099771|NCT00515489|Dopamine Agents|dopamine agents|mesh-ancestor
65099772|NCT02941575|Methamphetamine|methamphetamine|mesh-list
65099773|NCT02941575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65099774|NCT02941575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099775|NCT02941575|Sympathomimetics|sympathomimetics|mesh-ancestor
65099776|NCT02941575|Autonomic Agents|autonomic agents|mesh-ancestor
65099777|NCT02941575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65099778|NCT02941575|Dopamine Agents|dopamine agents|mesh-ancestor
65099779|NCT02941575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65099780|NCT02941575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099781|NCT02941575|Adrenergic Agents|adrenergic agents|mesh-ancestor
65288921|NCT02743247|Mycophenolic Acid|mycophenolic acid|mesh-list
65288922|NCT02743247|Tacrolimus|tacrolimus|mesh-list
65288923|NCT02743247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65288924|NCT02743247|Immunologic Factors|immunologic factors|mesh-ancestor
65288925|NCT02743247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288926|NCT02743247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65288927|NCT02743247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288928|NCT02743247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288929|NCT02743247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65288930|NCT02743247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288931|NCT02743247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65288932|NCT02743247|Antitubercular Agents|antitubercular agents|mesh-ancestor
65288933|NCT02743247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65288934|NCT02743247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65288935|NCT00680160|Tavaborole|tavaborole|mesh-list
64519172|NCT04348786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65099782|NCT02941575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65099783|NCT02941575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65099784|NCT02941575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65099785|NCT02941575|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65099786|NCT02941731|Oseltamivir|oseltamivir|mesh-list
65099787|NCT02941731|Antiviral Agents|antiviral agents|mesh-ancestor
65099788|NCT02941731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65099789|NCT02941731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099790|NCT02941731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099791|NCT02951039|Edoxaban|edoxaban|mesh-list
65099792|NCT02951039|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65099793|NCT02951039|Antithrombins|antithrombins|mesh-ancestor
65099794|NCT02951039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65099795|NCT02951039|Protease Inhibitors|protease inhibitors|mesh-ancestor
65099796|NCT02951039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099797|NCT02951039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099798|NCT02951039|Anticoagulants|anticoagulants|mesh-ancestor
65099799|NCT02951117|Dexamethasone|dexamethasone|mesh-list
65099800|NCT02951117|Venetoclax|venetoclax|mesh-list
65099801|NCT02951117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65099802|NCT02951117|Antiemetics|antiemetics|mesh-ancestor
65099819|NCT00515684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65099821|NCT00515684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099822|NCT00515684|Growth Inhibitors|growth inhibitors|mesh-ancestor
65099823|NCT05317767|Vaccines|vaccines|mesh-list
65099824|NCT05317767|Immunologic Factors|immunologic factors|mesh-ancestor
65099825|NCT05317767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099826|NCT00515801|Glyburide|glyburide|mesh-list
65099827|NCT00515801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65099828|NCT00515801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099829|NCT05317611|Ondansetron|ondansetron|mesh-list
65099830|NCT05317611|Bupivacaine|bupivacaine|mesh-list
65099831|NCT05317611|Anesthetics, Local|anesthetics, local|mesh-ancestor
65099832|NCT05317611|Anesthetics|anesthetics|mesh-ancestor
65099833|NCT05317611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65099834|NCT05317611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099835|NCT05317611|Sensory System Agents|sensory system agents|mesh-ancestor
65099836|NCT05317611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65099837|NCT05317611|Antiemetics|antiemetics|mesh-ancestor
65099838|NCT05317611|Autonomic Agents|autonomic agents|mesh-ancestor
65099839|NCT05317611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65099840|NCT05317611|Antipruritics|antipruritics|mesh-ancestor
65099841|NCT05317611|Dermatologic Agents|dermatologic agents|mesh-ancestor
65099842|NCT05317611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65099843|NCT05317611|Serotonin Agents|serotonin agents|mesh-ancestor
65288936|NCT00680160|Antifungal Agents|antifungal agents|mesh-ancestor
65288937|NCT00680160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65288938|NCT00683982|Nitazoxanide|nitazoxanide|mesh-list
65288939|NCT00683982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65288940|NCT00683982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65288941|NCT02742623|Rivaroxaban|rivaroxaban|mesh-list
65288942|NCT02742623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65288943|NCT02742623|Antithrombins|antithrombins|mesh-ancestor
65288944|NCT02742623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65288945|NCT02742623|Protease Inhibitors|protease inhibitors|mesh-ancestor
65288946|NCT02742623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288947|NCT02742623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288948|NCT02742623|Anticoagulants|anticoagulants|mesh-ancestor
65288949|NCT00537823|Leucovorin|leucovorin|mesh-list
65288950|NCT00537823|Bevacizumab|bevacizumab|mesh-list
65288951|NCT00537823|Cetuximab|cetuximab|mesh-list
65288952|NCT00537823|Fluorouracil|fluorouracil|mesh-list
65288953|NCT00537823|Oxaliplatin|oxaliplatin|mesh-list
65288954|NCT00537823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65288955|NCT00537823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65288956|NCT00537823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65288957|NCT00537823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65288958|NCT00537823|Growth Substances|growth substances|mesh-ancestor
64519187|NCT04348786|Antacids|antacids|mesh-ancestor
65099844|NCT05317611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65099845|NCT05317611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099846|NCT05317611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65099847|NCT05317611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65099848|NCT05317611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65099849|NCT05317611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65099850|NCT05317572|Morphine|morphine|mesh-list
65099851|NCT05317572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65099852|NCT05317572|Narcotics|narcotics|mesh-ancestor
65099853|NCT05317572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65099854|NCT05317572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099855|NCT05317572|Analgesics|analgesics|mesh-ancestor
65099856|NCT05317572|Sensory System Agents|sensory system agents|mesh-ancestor
65099857|NCT05317572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65099858|NCT00516425|Cyclophosphamide|cyclophosphamide|mesh-list
65099859|NCT00516425|Doxorubicin|doxorubicin|mesh-list
65099860|NCT00516425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65099861|NCT00516425|Epirubicin|epirubicin|mesh-list
65099862|NCT00516425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65099863|NCT00516425|Immunologic Factors|immunologic factors|mesh-ancestor
65099887|NCT00516542|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65099888|NCT00516542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65099889|NCT00516542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099890|NCT00516542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099891|NCT00516542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65099892|NCT00516542|Hormone Antagonists|hormone antagonists|mesh-ancestor
65099893|NCT00516542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65099894|NCT00516542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099896|NCT03458481|Yimitasvir|yimitasvir|mesh-list
65099897|NCT03458481|Antiviral Agents|antiviral agents|mesh-ancestor
65099898|NCT03458481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65288959|NCT00537823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288960|NCT00537823|Growth Inhibitors|growth inhibitors|mesh-ancestor
65288961|NCT00537823|Antimetabolites|antimetabolites|mesh-ancestor
65288962|NCT00537823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288963|NCT00537823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65288964|NCT00537823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65288965|NCT00537823|Immunologic Factors|immunologic factors|mesh-ancestor
65288966|NCT00537823|Antidotes|antidotes|mesh-ancestor
65288967|NCT00537823|Protective Agents|protective agents|mesh-ancestor
65288968|NCT00537823|Vitamin B Complex|vitamin b complex|mesh-ancestor
65288969|NCT00537823|Vitamins|vitamins|mesh-ancestor
65288970|NCT00537823|Micronutrients|micronutrients|mesh-ancestor
65288971|NCT04139928|Magnesium citrate|magnesium citrate|mesh-list
65288972|NCT04139928|Magnesium Oxide|magnesium oxide|mesh-list
65099899|NCT02949752|Aripiprazole|aripiprazole|mesh-list
65099900|NCT02949752|Antidepressive Agents|antidepressive agents|mesh-ancestor
65099901|NCT02949752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65099902|NCT02949752|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65099903|NCT02949752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65099904|NCT02949752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65099905|NCT02949752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099906|NCT02949752|Dopamine Agonists|dopamine agonists|mesh-ancestor
65099907|NCT02949752|Dopamine Agents|dopamine agents|mesh-ancestor
65099908|NCT02949752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65099909|NCT02949752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099910|NCT02949752|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65099911|NCT02949752|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65099912|NCT02949752|Serotonin Agents|serotonin agents|mesh-ancestor
65099938|NCT02941224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099939|NCT00516854|Chlordiazepoxide|chlordiazepoxide|mesh-list
65099940|NCT00516854|Clidinium|clidinium|mesh-list
65099941|NCT00516854|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65099942|NCT00516854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65099943|NCT00516854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65099944|NCT00516854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099945|NCT00516854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65099946|NCT00516854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65099947|NCT00516854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65099948|NCT00516854|GABA Modulators|gaba modulators|mesh-ancestor
65099949|NCT00516854|GABA Agents|gaba agents|mesh-ancestor
65099950|NCT00516854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65099951|NCT00516854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099952|NCT00516854|Parasympatholytics|parasympatholytics|mesh-ancestor
65099953|NCT00516854|Autonomic Agents|autonomic agents|mesh-ancestor
65099954|NCT00516854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65099955|NCT02940990|Gemcitabine|gemcitabine|mesh-list
65099956|NCT02940990|Paclitaxel|paclitaxel|mesh-list
65099957|NCT02940990|Etoposide|etoposide|mesh-list
65099958|NCT02940990|Vinorelbine|vinorelbine|mesh-list
65099959|NCT02940990|Docetaxel|docetaxel|mesh-list
65099960|NCT02940990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65099961|NCT02940990|Carboplatin|carboplatin|mesh-list
65099962|NCT02940990|Pemetrexed|pemetrexed|mesh-list
65099963|NCT02940990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65099964|NCT02940990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099965|NCT02940990|Tubulin Modulators|tubulin modulators|mesh-ancestor
64742208|NCT00004901|Antimetabolites|antimetabolites|mesh-ancestor
65099971|NCT02940990|Antiviral Agents|antiviral agents|mesh-ancestor
65099972|NCT02940990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65099973|NCT02940990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099974|NCT02940990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65099975|NCT02940990|Immunologic Factors|immunologic factors|mesh-ancestor
65099976|NCT02940990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099977|NCT02940990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65288973|NCT04139928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288974|NCT04139928|Cathartics|cathartics|mesh-ancestor
65288975|NCT04139928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65288976|NCT04139928|Antacids|antacids|mesh-ancestor
65288977|NCT05589025|Eugenol|eugenol|mesh-list
65288978|NCT05589025|Zinc Oxide|zinc oxide|mesh-list
65288979|NCT05589025|Dermatologic Agents|dermatologic agents|mesh-ancestor
65288980|NCT05589025|Sunscreening Agents|sunscreening agents|mesh-ancestor
65288981|NCT05589025|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65288982|NCT05589025|Protective Agents|protective agents|mesh-ancestor
65288983|NCT05589025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288984|NCT05589025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64519223|NCT03221946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65099978|NCT02940990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65099979|NCT02940990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65099980|NCT02940990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65099981|NCT00518297|Raltegravir Potassium|raltegravir potassium|mesh-list
65099982|NCT00518297|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65099983|NCT00518297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65099984|NCT00518297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65099985|NCT00518297|Antiviral Agents|antiviral agents|mesh-ancestor
65099986|NCT00518297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65099987|NCT00518297|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65099988|NCT00518297|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65099989|NCT00518297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099990|NCT00518297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099991|NCT00518297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65099992|NCT00518297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65099993|NCT00518297|Protease Inhibitors|protease inhibitors|mesh-ancestor
65099994|NCT00518375|Cyclosporine|cyclosporine|mesh-list
65099996|NCT00518375|Cyclosporins|cyclosporins|mesh-list
65099997|NCT00518375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099998|NCT00518375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099999|NCT00518375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65100000|NCT00518375|Immunologic Factors|immunologic factors|mesh-ancestor
65100001|NCT00518375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100002|NCT00518375|Antifungal Agents|antifungal agents|mesh-ancestor
65100003|NCT00518375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65100004|NCT00518375|Dermatologic Agents|dermatologic agents|mesh-ancestor
65100005|NCT00518375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65100006|NCT00518375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65100007|NCT00518375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65100008|NCT00518375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65100009|NCT00518375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100010|NCT02942043|Bevacizumab|bevacizumab|mesh-list
65100011|NCT02942043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65100012|NCT02942043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100013|NCT02942043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65100014|NCT02942043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65100015|NCT02942043|Growth Substances|growth substances|mesh-ancestor
65100016|NCT02942043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100017|NCT02942043|Growth Inhibitors|growth inhibitors|mesh-ancestor
65100018|NCT00516971|Esomeprazole|esomeprazole|mesh-list
65100019|NCT00516971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65100020|NCT00516971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64672734|NCT01878656|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65100034|NCT00517283|Incretins|incretins|mesh-ancestor
65100035|NCT00517283|Hormones|hormones|mesh-ancestor
65100036|NCT00517283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65100037|NCT02940912|Apomorphine|apomorphine|mesh-list
65100038|NCT02940912|Emetics|emetics|mesh-ancestor
65100039|NCT02940912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100040|NCT02940912|Autonomic Agents|autonomic agents|mesh-ancestor
65100041|NCT02940912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65288985|NCT02742233|Saxagliptin|saxagliptin|mesh-list
65288986|NCT02742233|Incretins|incretins|mesh-ancestor
65288987|NCT02742233|Hormones|hormones|mesh-ancestor
65288988|NCT02742233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65288989|NCT02742233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65288990|NCT02742233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65038973|NCT00212043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288991|NCT02742233|Protease Inhibitors|protease inhibitors|mesh-ancestor
65288992|NCT02742233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65288993|NCT02742233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65288994|NCT02742233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65288995|NCT00673608|Deferasirox|deferasirox|mesh-list
65288996|NCT00673608|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65288997|NCT00673608|Chelating Agents|chelating agents|mesh-ancestor
65288998|NCT00673608|Sequestering Agents|sequestering agents|mesh-ancestor
65288999|NCT00673608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289000|NCT00537277|Insulin Aspart|insulin aspart|mesh-list
65289001|NCT00537277|Biphasic Insulins|biphasic insulins|mesh-list
65289002|NCT00537277|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65289003|NCT00537277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65289004|NCT00537277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289005|NCT02742467|Amlodipine|amlodipine|mesh-list
65289006|NCT02742467|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65289007|NCT02742467|Perindopril|perindopril|mesh-list
65289008|NCT02742467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65100042|NCT02940912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65100043|NCT02940912|Dopamine Agonists|dopamine agonists|mesh-ancestor
65100044|NCT02940912|Dopamine Agents|dopamine agents|mesh-ancestor
65100045|NCT02940912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65100046|NCT02940912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100047|NCT00517322|Ramipril|ramipril|mesh-list
65100048|NCT00517322|Irbesartan|irbesartan|mesh-list
65100049|NCT00517322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65100050|NCT00517322|Protease Inhibitors|protease inhibitors|mesh-ancestor
65100051|NCT00517322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100052|NCT00517322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100053|NCT00517322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65100054|NCT00517322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65100055|NCT00517322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65100056|NCT02939430|Atropine|atropine|mesh-list
65100057|NCT02939430|Neostigmine|neostigmine|mesh-list
65100058|NCT02939430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65100059|NCT02939430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65100060|NCT02939430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65100061|NCT02939430|Autonomic Agents|autonomic agents|mesh-ancestor
65100062|NCT02939430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100063|NCT02939430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100064|NCT02939430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65289009|NCT02742467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65289010|NCT02742467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65289011|NCT02742467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289012|NCT02742467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65289013|NCT02742467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289014|NCT02742467|Vasodilator Agents|vasodilator agents|mesh-ancestor
65289015|NCT02742467|Diuretics|diuretics|mesh-ancestor
64519262|NCT03229668|Anticonvulsants|anticonvulsants|mesh-ancestor
65100065|NCT02939430|Respiratory System Agents|respiratory system agents|mesh-ancestor
65100066|NCT02939430|Mydriatics|mydriatics|mesh-ancestor
65100067|NCT02939430|Parasympatholytics|parasympatholytics|mesh-ancestor
65100068|NCT02939430|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65100069|NCT02939430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65100070|NCT02939430|Cholinergic Agents|cholinergic agents|mesh-ancestor
65100080|NCT02940717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100082|NCT02940717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65100083|NCT02940717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65100084|NCT02940717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100085|NCT00517517|Hemagglutinins|hemagglutinins|mesh-list
65100086|NCT00517517|Agglutinins|agglutinins|mesh-ancestor
65100087|NCT00517517|Immunologic Factors|immunologic factors|mesh-ancestor
65100088|NCT00517517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100089|NCT02940756|Artesunate|artesunate|mesh-list
65100090|NCT02940756|Lumefantrine|lumefantrine|mesh-list
65100091|NCT02940756|Artemether|artemether|mesh-list
65100092|NCT02940756|Piperaquine|piperaquine|mesh-list
65100093|NCT02940756|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65100094|NCT02940756|Amodiaquine|amodiaquine|mesh-list
65100095|NCT02940756|Artenimol|artenimol|mesh-list
65100096|NCT02940756|Antimalarials|antimalarials|mesh-ancestor
65100097|NCT02940756|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65100098|NCT02940756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65100099|NCT02940756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65100100|NCT02940756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100101|NCT02940756|Antiviral Agents|antiviral agents|mesh-ancestor
65100102|NCT02940756|Schistosomicides|schistosomicides|mesh-ancestor
65100103|NCT02940756|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65100104|NCT02940756|Anthelmintics|anthelmintics|mesh-ancestor
65100105|NCT02939547|Betadex|betadex|mesh-list
65100106|NCT02939547|Sequestering Agents|sequestering agents|mesh-ancestor
65100107|NCT02939547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100108|NCT02941068|Fluconazole|fluconazole|mesh-list
65100109|NCT02941068|Caspofungin|caspofungin|mesh-list
65100110|NCT02941068|Antifungal Agents|antifungal agents|mesh-ancestor
65100111|NCT02941068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65100112|NCT02941068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65100113|NCT02941068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65100114|NCT02941068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100115|NCT02941068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100116|NCT02941068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65100117|NCT02941068|Hormone Antagonists|hormone antagonists|mesh-ancestor
65100118|NCT02941068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65100119|NCT02941068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100120|NCT02941068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65100121|NCT02941068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65100122|NCT00517712|Arsenic Trioxide|arsenic trioxide|mesh-list
65100123|NCT00517712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100124|NCT02939274|Verteporfin|verteporfin|mesh-list
65100125|NCT02939274|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65100126|NCT02939274|Dermatologic Agents|dermatologic agents|mesh-ancestor
65100127|NCT04694183|Paclitaxel|paclitaxel|mesh-list
65100128|NCT04694183|Antibodies|antibodies|mesh-list
65100129|NCT04694183|Immunoglobulins|immunoglobulins|mesh-list
65100130|NCT04694183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65100131|NCT04694183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100132|NCT04694183|Tubulin Modulators|tubulin modulators|mesh-ancestor
65100133|NCT04694183|Antimitotic Agents|antimitotic agents|mesh-ancestor
65289016|NCT02742467|Natriuretic Agents|natriuretic agents|mesh-ancestor
65289017|NCT02742467|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65289018|NCT02742467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65289019|NCT02742467|Protease Inhibitors|protease inhibitors|mesh-ancestor
65289020|NCT02742467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289021|NCT00684216|Tamoxifen|tamoxifen|mesh-list
65289022|NCT00684216|Capecitabine|capecitabine|mesh-list
65289023|NCT00684216|Letrozole|letrozole|mesh-list
65289024|NCT00684216|Anastrozole|anastrozole|mesh-list
65289025|NCT00684216|Exemestane|exemestane|mesh-list
64519267|NCT03229668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65100134|NCT04694183|Mitosis Modulators|mitosis modulators|mesh-ancestor
65100135|NCT04694183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672829|NCT01798394|Hormones|hormones|mesh-ancestor
64672885|NCT01815008|Antipyretics|antipyretics|mesh-ancestor
64672886|NCT01815008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64672887|NCT01815008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64672888|NCT01815008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64672889|NCT01815008|Purinergic Agents|purinergic agents|mesh-ancestor
64672890|NCT01815008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64672891|NCT01801124|Bupivacaine|bupivacaine|mesh-list
64672892|NCT01801124|Anesthetics, Local|anesthetics, local|mesh-ancestor
65100145|NCT00517946|Histamine Agents|histamine agents|mesh-ancestor
65100146|NCT00517946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65100147|NCT00517946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100148|NCT00517946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100149|NCT00517946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65100150|NCT00517946|Autonomic Agents|autonomic agents|mesh-ancestor
65100151|NCT00517946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100152|NCT00517946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65100153|NCT00517946|Respiratory System Agents|respiratory system agents|mesh-ancestor
65100154|NCT00517946|Nasal Decongestants|nasal decongestants|mesh-ancestor
65100155|NCT00517946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65100156|NCT00517946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65100157|NCT00517946|Sympathomimetics|sympathomimetics|mesh-ancestor
65100158|NCT00517946|Adrenergic Agents|adrenergic agents|mesh-ancestor
65100159|NCT04988685|Sirolimus|sirolimus|mesh-list
65100160|NCT04988685|Paclitaxel|paclitaxel|mesh-list
65100161|NCT04988685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65100162|NCT04988685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100163|NCT04988685|Tubulin Modulators|tubulin modulators|mesh-ancestor
65100164|NCT04988685|Antimitotic Agents|antimitotic agents|mesh-ancestor
65100165|NCT04988685|Mitosis Modulators|mitosis modulators|mesh-ancestor
65100166|NCT04988685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100167|NCT04988685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65100168|NCT04988685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65100169|NCT04988685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65100170|NCT04988685|Antifungal Agents|antifungal agents|mesh-ancestor
65100171|NCT04988685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65100172|NCT04988685|Immunologic Factors|immunologic factors|mesh-ancestor
65100173|NCT04988685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100174|NCT00517985|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64483740|NCT04414267|Vaccines|vaccines|mesh-list
65100175|NCT00517985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65100176|NCT00517985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65100177|NCT00517985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65100178|NCT00517985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100179|NCT00517985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65100180|NCT00517985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100181|NCT00517985|Analgesics|analgesics|mesh-ancestor
65100182|NCT00517985|Sensory System Agents|sensory system agents|mesh-ancestor
65100183|NCT00517985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100184|NCT00517985|Antidepressive Agents|antidepressive agents|mesh-ancestor
65100185|NCT00517985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65100186|NCT00517985|Dopamine Agents|dopamine agents|mesh-ancestor
65289026|NCT00684216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65289027|NCT00684216|Antimetabolites|antimetabolites|mesh-ancestor
65289028|NCT00684216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289029|NCT00684216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289030|NCT00684216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65289031|NCT00684216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65289032|NCT00684216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289033|NCT00684216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65289034|NCT00684216|Hormone Antagonists|hormone antagonists|mesh-ancestor
65289035|NCT00684216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65289036|NCT00684216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289037|NCT00684216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65289038|NCT00684216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65289039|NCT00684216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65289040|NCT00684216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65289041|NCT00684450|Protamines|protamines|mesh-list
65289042|NCT00684450|Heparin Antagonists|heparin antagonists|mesh-ancestor
65289043|NCT00684450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289044|NCT00684450|Coagulants|coagulants|mesh-ancestor
65289045|NCT00684528|Metformin|metformin|mesh-list
65100187|NCT04690920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65100188|NCT04690920|Remdesivir|remdesivir|mesh-list
65100189|NCT04690920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64672893|NCT01801124|Anesthetics|anesthetics|mesh-ancestor
65100197|NCT00518102|Growth Substances|growth substances|mesh-ancestor
65100198|NCT00518102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100200|NCT02939235|Metoclopramide|metoclopramide|mesh-list
65100202|NCT02939235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65100203|NCT02939235|Narcotics|narcotics|mesh-ancestor
65100204|NCT02939235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65100205|NCT02939235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100206|NCT02939235|Analgesics|analgesics|mesh-ancestor
65100207|NCT02939235|Sensory System Agents|sensory system agents|mesh-ancestor
65100208|NCT02939235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100209|NCT02939235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65100210|NCT02939235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65100211|NCT02939235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65100212|NCT02939235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65100213|NCT02939235|Purinergic Agents|purinergic agents|mesh-ancestor
65100214|NCT02939235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65100215|NCT02939235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100216|NCT02939235|Antiemetics|antiemetics|mesh-ancestor
65100217|NCT02939235|Autonomic Agents|autonomic agents|mesh-ancestor
65100218|NCT02939235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65100219|NCT02939235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65100220|NCT02939235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65100221|NCT02939235|Dopamine Agents|dopamine agents|mesh-ancestor
65100222|NCT00518141|Aspirin|aspirin|mesh-list
65100223|NCT00518141|Salicylic Acid|salicylic acid|mesh-list
65100224|NCT00518141|Salicylates|salicylates|mesh-list
65100225|NCT00518141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65100226|NCT00518141|Antifungal Agents|antifungal agents|mesh-ancestor
65100227|NCT00518141|Keratolytic Agents|keratolytic agents|mesh-ancestor
65289046|NCT00684528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65289047|NCT00684528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289048|NCT00684606|Oxytocin|oxytocin|mesh-list
65289049|NCT00684606|Oxytocics|oxytocics|mesh-ancestor
65289050|NCT00684606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65289051|NCT00684606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289052|NCT00684372|Leflunomide|leflunomide|mesh-list
65289053|NCT00684372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289054|NCT00684372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289055|NCT00684372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65289056|NCT00684372|Immunologic Factors|immunologic factors|mesh-ancestor
65289057|NCT00684372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289058|NCT00673686|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65289059|NCT00673686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65289060|NCT00673686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100228|NCT00518141|Dermatologic Agents|dermatologic agents|mesh-ancestor
65100229|NCT00518141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65100230|NCT00518141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65100231|NCT00518141|Analgesics|analgesics|mesh-ancestor
65100232|NCT00518141|Sensory System Agents|sensory system agents|mesh-ancestor
65100233|NCT00518141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100234|NCT00518141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100235|NCT00518141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65100236|NCT00518141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65100237|NCT00518141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65100238|NCT00518141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100239|NCT00518141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100240|NCT00518141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65100241|NCT00518141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65100242|NCT00518141|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65100243|NCT00518141|Antipyretics|antipyretics|mesh-ancestor
65100244|NCT02938962|Tranexamic Acid|tranexamic acid|mesh-list
65100245|NCT02938962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65100246|NCT02938962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65100247|NCT02938962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100248|NCT02938962|Hemostatics|hemostatics|mesh-ancestor
65100249|NCT02938962|Coagulants|coagulants|mesh-ancestor
65100250|NCT00519701|Hydroxyurea|hydroxyurea|mesh-list
65100251|NCT00519701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100252|NCT00519701|Antisickling Agents|antisickling agents|mesh-ancestor
65100253|NCT00519701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100254|NCT00519701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100255|NCT00519701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65100256|NCT00519116|Sirolimus|sirolimus|mesh-list
65100265|NCT00519116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65100266|NCT00519116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65100267|NCT00519116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100268|NCT00519116|Antifungal Agents|antifungal agents|mesh-ancestor
65100269|NCT04691076|Fentanyl|fentanyl|mesh-list
65100270|NCT04691076|Propofol|propofol|mesh-list
65100271|NCT04691076|Esketamine|esketamine|mesh-list
65100272|NCT04691076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65100273|NCT04691076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65100274|NCT04691076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100275|NCT04691076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65100276|NCT04691076|Anesthetics, General|anesthetics, general|mesh-ancestor
65100277|NCT04691076|Anesthetics|anesthetics|mesh-ancestor
65100278|NCT04691076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65100279|NCT04691076|Narcotics|narcotics|mesh-ancestor
65289061|NCT04334915|Cenicriviroc|cenicriviroc|mesh-list
65289062|NCT04334915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65289063|NCT04334915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289064|NCT04334915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65289065|NCT04334915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65289066|NCT04334915|Antiviral Agents|antiviral agents|mesh-ancestor
65289067|NCT04334915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65039054|NCT00188396|Citalopram|citalopram|mesh-list
65289068|NCT00991627|Atropine|atropine|mesh-list
65289069|NCT00991627|Ephedrine|ephedrine|mesh-list
65289070|NCT00991627|Pseudoephedrine|pseudoephedrine|mesh-list
65289071|NCT00991627|Morphine|morphine|mesh-list
65289072|NCT00991627|Bupivacaine|bupivacaine|mesh-list
65289073|NCT00991627|Anesthetics, Local|anesthetics, local|mesh-list
64519313|NCT03221634|Daratumumab|daratumumab|mesh-list
65100280|NCT04691076|Analgesics|analgesics|mesh-ancestor
65100281|NCT04691076|Sensory System Agents|sensory system agents|mesh-ancestor
65100282|NCT04691076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100283|NCT04691076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65100284|NCT04691076|Antidepressive Agents|antidepressive agents|mesh-ancestor
65100285|NCT04691076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65100286|NCT02949206|Thrombin|thrombin|mesh-list
65100287|NCT02949206|Hemostatics|hemostatics|mesh-ancestor
65100288|NCT02949206|Coagulants|coagulants|mesh-ancestor
65100289|NCT05108454|Micronutrients|micronutrients|mesh-list
65100290|NCT05108454|Trace Elements|trace elements|mesh-list
65100291|NCT05108454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100292|NCT02940561|Methotrexate|methotrexate|mesh-list
65100293|NCT02940561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65100294|NCT02940561|Abortifacient Agents|abortifacient agents|mesh-ancestor
65100295|NCT02940561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65100296|NCT02940561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100297|NCT02940561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65100298|NCT02940561|Antimetabolites|antimetabolites|mesh-ancestor
65100299|NCT02940561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100300|NCT02940561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100301|NCT02940561|Dermatologic Agents|dermatologic agents|mesh-ancestor
65100302|NCT02940561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100303|NCT02940561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65100304|NCT02940561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65100305|NCT02940561|Immunologic Factors|immunologic factors|mesh-ancestor
65100306|NCT02940561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65100307|NCT02940561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65100308|NCT02940366|Atorvastatin|atorvastatin|mesh-list
65100309|NCT02940366|Pitavastatin|pitavastatin|mesh-list
65100310|NCT02940366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65100311|NCT02940366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65100312|NCT02940366|Antimetabolites|antimetabolites|mesh-ancestor
65100313|NCT02940366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100314|NCT02940366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65100315|NCT02940366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65100316|NCT02940366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100317|NCT02940405|Ketorolac|ketorolac|mesh-list
65100318|NCT02940405|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65100319|NCT02940405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65100320|NCT02940405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65100321|NCT02940405|Analgesics|analgesics|mesh-ancestor
65100322|NCT02940405|Sensory System Agents|sensory system agents|mesh-ancestor
65100323|NCT02940405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100324|NCT02940405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100331|NCT02940444|Anticoagulants|anticoagulants|mesh-ancestor
65100332|NCT02940444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65100333|NCT02940444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65100334|NCT02940444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289074|NCT00991627|Anesthetics|anesthetics|mesh-list
65289075|NCT00991627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65289076|NCT00991627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289077|NCT00991627|Sensory System Agents|sensory system agents|mesh-ancestor
65289078|NCT00991627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65289079|NCT00991627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65289080|NCT00991627|Narcotics|narcotics|mesh-ancestor
65289081|NCT00991627|Analgesics|analgesics|mesh-ancestor
65289082|NCT00991627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65289083|NCT00991627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65289084|NCT00991627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65289085|NCT00991627|Autonomic Agents|autonomic agents|mesh-ancestor
65289086|NCT00991627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65289087|NCT00991627|Respiratory System Agents|respiratory system agents|mesh-ancestor
65289088|NCT00991627|Mydriatics|mydriatics|mesh-ancestor
64519329|NCT02374060|Antiemetics|antiemetics|mesh-ancestor
65100335|NCT00520052|Zoledronic Acid|zoledronic acid|mesh-list
65100336|NCT00520052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65100337|NCT00520052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100338|NCT04690647|Dexamethasone|dexamethasone|mesh-list
65100339|NCT04690647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
65100340|NCT04690647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65100341|NCT04690647|Antiemetics|antiemetics|mesh-ancestor
65100342|NCT04690647|Autonomic Agents|autonomic agents|mesh-ancestor
65100343|NCT04690647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100344|NCT04690647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100345|NCT04690647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65100346|NCT04690647|Glucocorticoids|glucocorticoids|mesh-ancestor
65100348|NCT04690647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65100349|NCT04690647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64742588|NCT00385463|Hormones|hormones|mesh-ancestor
65100350|NCT04690647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100351|NCT04690647|Analgesics|analgesics|mesh-ancestor
65100352|NCT04690647|Sensory System Agents|sensory system agents|mesh-ancestor
65100353|NCT00519467|Artesunate|artesunate|mesh-list
65100354|NCT00519467|Dapsone|dapsone|mesh-list
65100355|NCT00519467|Chlorproguanil|chlorproguanil|mesh-list
65100356|NCT00519467|Antimalarials|antimalarials|mesh-ancestor
65100357|NCT00519467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65100358|NCT00519467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65100359|NCT00519467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65100360|NCT00519467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100361|NCT00519467|Antiviral Agents|antiviral agents|mesh-ancestor
65100362|NCT00519467|Schistosomicides|schistosomicides|mesh-ancestor
65100363|NCT00519467|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65100364|NCT00519467|Anthelmintics|anthelmintics|mesh-ancestor
65100365|NCT00519467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65100366|NCT00519467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100367|NCT00519467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100368|NCT00519467|Leprostatic Agents|leprostatic agents|mesh-ancestor
65100369|NCT00519467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65100370|NCT02940483|Azacitidine|azacitidine|mesh-list
65100371|NCT02940483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65100372|NCT02940483|Antimetabolites|antimetabolites|mesh-ancestor
65100373|NCT02940483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100374|NCT02940483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100375|NCT02940483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100376|NCT04974684|Apixaban|apixaban|mesh-list
65100377|NCT04974684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65100378|NCT04974684|Antithrombins|antithrombins|mesh-ancestor
65100379|NCT04974684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65100380|NCT04974684|Protease Inhibitors|protease inhibitors|mesh-ancestor
65289089|NCT00991627|Parasympatholytics|parasympatholytics|mesh-ancestor
65289090|NCT00991627|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65289091|NCT00991627|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65289092|NCT00991627|Cholinergic Agents|cholinergic agents|mesh-ancestor
65289093|NCT00991627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65289094|NCT00991627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519335|NCT02374060|Hormones|hormones|mesh-ancestor
65100381|NCT04974684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100382|NCT04974684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100383|NCT04974684|Anticoagulants|anticoagulants|mesh-ancestor
65100384|NCT00520091|Celecoxib|celecoxib|mesh-list
65100385|NCT00520091|Irinotecan|irinotecan|mesh-list
65100386|NCT00520091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100387|NCT00520091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65100388|NCT00520091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65100389|NCT00520091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100390|NCT00520091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100391|NCT00520091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65100392|NCT00520091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65100393|NCT00520091|Analgesics|analgesics|mesh-ancestor
65100432|NCT00520442|Ibuprofen|ibuprofen|mesh-list
65100433|NCT00520442|Codeine|codeine|mesh-list
65100434|NCT00520442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65100435|NCT00520442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65100436|NCT00520442|Analgesics|analgesics|mesh-ancestor
65100437|NCT00520442|Sensory System Agents|sensory system agents|mesh-ancestor
65100438|NCT00520442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100439|NCT00520442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100440|NCT00520442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65100441|NCT00520442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65100442|NCT00520442|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65100443|NCT00520442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100444|NCT00520442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100445|NCT00520442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65100446|NCT00520442|Narcotics|narcotics|mesh-ancestor
65100447|NCT00520442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65100448|NCT00520442|Antitussive Agents|antitussive agents|mesh-ancestor
65100449|NCT00520442|Respiratory System Agents|respiratory system agents|mesh-ancestor
65100450|NCT02938572|Insulin Aspart|insulin aspart|mesh-list
65100451|NCT02938572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65100452|NCT02938572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100453|NCT02939898|Letrozole|letrozole|mesh-list
65100454|NCT02939898|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65100455|NCT02939898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100456|NCT02939898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65100457|NCT02939898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100458|NCT02939898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100459|NCT02939898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65100460|NCT02939898|Hormone Antagonists|hormone antagonists|mesh-ancestor
65100461|NCT02939898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65100462|NCT02939898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100463|NCT00520754|Levocetirizine|levocetirizine|mesh-list
65100464|NCT00520754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65100465|NCT00520754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65100466|NCT00520754|Histamine Antagonists|histamine antagonists|mesh-ancestor
65100467|NCT00520754|Histamine Agents|histamine agents|mesh-ancestor
65100468|NCT00520754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64633211|NCT00004900|Thiotepa|thiotepa|mesh-list
65100469|NCT00520754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100470|NCT00520754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100471|NCT02277132|Sildenafil Citrate|sildenafil citrate|mesh-list
65100472|NCT02277132|Vasodilator Agents|vasodilator agents|mesh-ancestor
65100473|NCT02277132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65100474|NCT02277132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65100475|NCT02277132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100476|NCT02277132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100477|NCT02277132|Urological Agents|urological agents|mesh-ancestor
65289095|NCT00991627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65289096|NCT00991627|Sympathomimetics|sympathomimetics|mesh-ancestor
65289097|NCT00991627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65289098|NCT00991627|Adrenergic Agents|adrenergic agents|mesh-ancestor
65289099|NCT00991627|Nasal Decongestants|nasal decongestants|mesh-ancestor
65289100|NCT03562871|Carboplatin|carboplatin|mesh-list
65100478|NCT00520949|Amoxicillin|amoxicillin|mesh-list
65100498|NCT00520949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65100499|NCT00520949|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65100500|NCT02938260|Metoprolol|metoprolol|mesh-list
65100501|NCT02938260|Diltiazem|diltiazem|mesh-list
65100502|NCT02938260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65100503|NCT02938260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65100504|NCT02938260|Sympatholytics|sympatholytics|mesh-ancestor
65100505|NCT02938260|Autonomic Agents|autonomic agents|mesh-ancestor
65100506|NCT02938260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100507|NCT02938260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100508|NCT02938260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65100509|NCT02938260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65100510|NCT02938260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65100511|NCT02938260|Adrenergic Agents|adrenergic agents|mesh-ancestor
65100512|NCT02938260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65100513|NCT02938260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100514|NCT02938260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65100515|NCT02938260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65100516|NCT02938260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65100517|NCT02938260|Vasodilator Agents|vasodilator agents|mesh-ancestor
65100518|NCT02938182|Clopidogrel|clopidogrel|mesh-list
65100519|NCT02938182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65100520|NCT02938182|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65100521|NCT02938182|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65100522|NCT02938182|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65100523|NCT02938182|Purinergic Agents|purinergic agents|mesh-ancestor
65100524|NCT02938182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65100525|NCT02938182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100526|NCT02938182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100527|NCT00521183|Tetrahydrouridine|tetrahydrouridine|mesh-list
65100528|NCT00521183|Antimetabolites|antimetabolites|mesh-ancestor
65100529|NCT00521183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100530|NCT00521612|Sevoflurane|sevoflurane|mesh-list
65100531|NCT00521612|Isoflurane|isoflurane|mesh-list
65100532|NCT00521612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65100533|NCT00521612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65100547|NCT00521300|Octreotide|octreotide|mesh-list
65100548|NCT00521300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65100549|NCT00521300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65100550|NCT00521300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100551|NCT00521690|Insulin Detemir|insulin detemir|mesh-list
65100552|NCT00521690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65100553|NCT00521690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100554|NCT00523133|Naltrexone|naltrexone|mesh-list
65100555|NCT00523133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65100556|NCT00523133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65100557|NCT00523133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100558|NCT00523133|Sensory System Agents|sensory system agents|mesh-ancestor
65100559|NCT00523133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100560|NCT02937792|Bupivacaine|bupivacaine|mesh-list
65100561|NCT02937792|Anesthetics, Local|anesthetics, local|mesh-ancestor
65100562|NCT02937792|Anesthetics|anesthetics|mesh-ancestor
65100563|NCT02937792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65100564|NCT02937792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100565|NCT02937792|Sensory System Agents|sensory system agents|mesh-ancestor
65100566|NCT02937792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100567|NCT02931474|Tesamorelin|tesamorelin|mesh-list
65100568|NCT02931474|Growth Substances|growth substances|mesh-ancestor
65100569|NCT02931474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100570|NCT02931357|Cetylpyridinium|cetylpyridinium|mesh-list
65100571|NCT02931357|Lidocaine|lidocaine|mesh-list
65100572|NCT02931357|Hyaluronic Acid|hyaluronic acid|mesh-list
65100573|NCT02931357|Anesthetics, Local|anesthetics, local|mesh-ancestor
65289101|NCT03562871|Pembrolizumab|pembrolizumab|mesh-list
65289102|NCT03562871|Pemetrexed|pemetrexed|mesh-list
65289103|NCT03562871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289104|NCT03562871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65289105|NCT03562871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289106|NCT03562871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289107|NCT03562871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65289108|NCT03562871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65289109|NCT00690222|Mydriatics|mydriatics|mesh-list
65289110|NCT00690222|Autonomic Agents|autonomic agents|mesh-ancestor
65289111|NCT00690222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65289112|NCT00690222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289113|NCT02736071|Celecoxib|celecoxib|mesh-list
65289114|NCT02736071|Tramadol|tramadol|mesh-list
65289115|NCT02736071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65289116|NCT02736071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65289117|NCT02736071|Analgesics|analgesics|mesh-ancestor
65289118|NCT02736071|Sensory System Agents|sensory system agents|mesh-ancestor
65289119|NCT02736071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65289120|NCT02736071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289121|NCT02736071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65289122|NCT02736071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65289123|NCT02736071|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65289124|NCT02736071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65289125|NCT02736071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289126|NCT02736071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289127|NCT02736071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65100574|NCT02931357|Anesthetics|anesthetics|mesh-ancestor
65100575|NCT02931357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64742811|NCT00386399|Mitomycins|mitomycins|mesh-list
65100576|NCT02931357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100577|NCT02931357|Sensory System Agents|sensory system agents|mesh-ancestor
65100578|NCT02931357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100579|NCT02931357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65100580|NCT02931357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65100581|NCT02931357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65100582|NCT02931357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65100583|NCT02931357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100584|NCT02931357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65100585|NCT02931357|Immunologic Factors|immunologic factors|mesh-ancestor
65100586|NCT02931357|Viscosupplements|viscosupplements|mesh-ancestor
65100587|NCT02931357|Protective Agents|protective agents|mesh-ancestor
65100588|NCT02931357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65100589|NCT02931357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65100590|NCT02937519|Cisplatin|cisplatin|mesh-list
65100591|NCT02937519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289128|NCT02736071|Narcotics|narcotics|mesh-ancestor
65289129|NCT02736071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65289130|NCT00690300|Docetaxel|docetaxel|mesh-list
65289131|NCT00690300|Oxaliplatin|oxaliplatin|mesh-list
65289132|NCT00690300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289133|NCT00690300|Tubulin Modulators|tubulin modulators|mesh-ancestor
65289137|NCT02741219|Sufentanil|sufentanil|mesh-list
65289198|NCT00690768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65289199|NCT00690768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289200|NCT00690768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65289201|NCT00690768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65289202|NCT00690768|Growth Substances|growth substances|mesh-ancestor
64519445|NCT03220464|Interferons|interferons|mesh-list
65100592|NCT00521963|Infliximab|infliximab|mesh-list
65100593|NCT00521963|Dermatologic Agents|dermatologic agents|mesh-ancestor
65100599|NCT02937402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100600|NCT02937363|Thioctic Acid|thioctic acid|mesh-list
65100601|NCT02937363|Antioxidants|antioxidants|mesh-ancestor
65100602|NCT02937363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100603|NCT02937363|Protective Agents|protective agents|mesh-ancestor
65100604|NCT02937363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100605|NCT02937363|Vitamin B Complex|vitamin b complex|mesh-ancestor
65100606|NCT02937363|Vitamins|vitamins|mesh-ancestor
65100607|NCT02937363|Micronutrients|micronutrients|mesh-ancestor
65100608|NCT02948348|Capecitabine|capecitabine|mesh-list
65100609|NCT02948348|Nivolumab|nivolumab|mesh-list
65100610|NCT02948348|Ipilimumab|ipilimumab|mesh-list
65100611|NCT02948348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65100612|NCT02948348|Antimetabolites|antimetabolites|mesh-ancestor
65100613|NCT02948348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100614|NCT02948348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100615|NCT02948348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65100616|NCT02948348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65100617|NCT04693910|Hormones|hormones|mesh-list
65100618|NCT04693910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65100619|NCT04693910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100620|NCT00522158|Atorvastatin|atorvastatin|mesh-list
65100621|NCT00522158|Simvastatin|simvastatin|mesh-list
65100622|NCT00522158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65100623|NCT00522158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65100624|NCT00522158|Antimetabolites|antimetabolites|mesh-ancestor
65100625|NCT00522158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100626|NCT00522158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65100627|NCT00522158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65100628|NCT00522158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100629|NCT02931123|Rifaximin|rifaximin|mesh-list
65100630|NCT02931123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65100631|NCT02931123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65100632|NCT02931123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65100633|NCT02936934|Morphine|morphine|mesh-list
65100634|NCT02936934|Oxycodone|oxycodone|mesh-list
65100635|NCT02936934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65100636|NCT02936934|Narcotics|narcotics|mesh-ancestor
65100637|NCT02936934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65100638|NCT02936934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100639|NCT02936934|Analgesics|analgesics|mesh-ancestor
65100640|NCT02936934|Sensory System Agents|sensory system agents|mesh-ancestor
65100641|NCT02936934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100642|NCT00522470|Rosiglitazone|rosiglitazone|mesh-list
65100643|NCT00522470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65100644|NCT00522470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100645|NCT00522509|Floxuridine|floxuridine|mesh-list
65100646|NCT00522509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65100647|NCT00522509|Antimetabolites|antimetabolites|mesh-ancestor
65100648|NCT00522509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100649|NCT00522509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100650|NCT00522587|Remifentanil|remifentanil|mesh-list
65100651|NCT00522587|Sevoflurane|sevoflurane|mesh-list
65100652|NCT00522587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65100653|NCT00522587|Narcotics|narcotics|mesh-ancestor
65100654|NCT00522587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65100655|NCT00522587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100656|NCT00522587|Analgesics|analgesics|mesh-ancestor
65100657|NCT00522587|Sensory System Agents|sensory system agents|mesh-ancestor
65100658|NCT00522587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100659|NCT00522587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65100660|NCT00522587|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65289203|NCT00690768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289204|NCT00690768|Growth Inhibitors|growth inhibitors|mesh-ancestor
65289205|NCT00690846|Adalimumab|adalimumab|mesh-list
65289206|NCT00690846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65289207|NCT00690846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65289208|NCT04683679|Pembrolizumab|pembrolizumab|mesh-list
65289209|NCT04683679|Olaparib|olaparib|mesh-list
65289210|NCT04683679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65289211|NCT04683679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289212|NCT04683679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65289213|NCT04683679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289214|NCT04683679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289215|NCT00685464|Abciximab|abciximab|mesh-list
65289216|NCT00685464|Anticoagulants|anticoagulants|mesh-ancestor
65100666|NCT00522665|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65100667|NCT00522665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65100668|NCT00522665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100669|NCT00522665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100670|NCT00522665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100671|NCT00522665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65100672|NCT00522665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65100673|NCT00522665|Immunologic Factors|immunologic factors|mesh-ancestor
65100674|NCT00522665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100675|NCT00522743|Hormones|hormones|mesh-list
65100676|NCT00522743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65100677|NCT00522743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100678|NCT02937012|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65100679|NCT02937012|Bezafibrate|bezafibrate|mesh-list
65100680|NCT02937012|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65100681|NCT02937012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65100682|NCT02937012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65100683|NCT02937012|Antimetabolites|antimetabolites|mesh-ancestor
65100684|NCT02937012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100685|NCT02937012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65100686|NCT00522782|Budesonide|budesonide|mesh-list
65100687|NCT00522782|Nitric Oxide|nitric oxide|mesh-list
65100688|NCT00522782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65100689|NCT00522782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65100690|NCT00522782|Autonomic Agents|autonomic agents|mesh-ancestor
65100691|NCT00522782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100692|NCT00522782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100693|NCT00522782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65100694|NCT00522782|Respiratory System Agents|respiratory system agents|mesh-ancestor
65100695|NCT00522782|Glucocorticoids|glucocorticoids|mesh-ancestor
65100696|NCT00522782|Hormones|hormones|mesh-ancestor
65100697|NCT00522782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65100698|NCT00522782|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65100699|NCT00522782|Antioxidants|antioxidants|mesh-ancestor
65100700|NCT00522782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100701|NCT00522782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65100702|NCT00522782|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65100703|NCT00522782|Vasodilator Agents|vasodilator agents|mesh-ancestor
65100704|NCT00522782|Gasotransmitters|gasotransmitters|mesh-ancestor
65100705|NCT00522782|Protective Agents|protective agents|mesh-ancestor
65100706|NCT00522821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65100707|NCT00522821|Immunoglobulins|immunoglobulins|mesh-list
65100708|NCT00522821|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65100709|NCT00522821|Antibodies|antibodies|mesh-list
65100710|NCT00522821|gamma-Globulins|gamma-globulins|mesh-list
65100711|NCT00522821|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65100712|NCT00522821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65289217|NCT00685464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65289218|NCT02740829|Glucagon|glucagon|mesh-list
65289219|NCT02740829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65289220|NCT02740829|Hormones|hormones|mesh-ancestor
65289221|NCT02740829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65289222|NCT02740829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289223|NCT00685542|Diacetylrhein|diacetylrhein|mesh-list
65289224|NCT00685542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65289225|NCT02741063|Oxytocin|oxytocin|mesh-list
65289226|NCT02741063|Oxytocics|oxytocics|mesh-ancestor
65289227|NCT02741063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65100713|NCT00522821|Immunologic Factors|immunologic factors|mesh-ancestor
65100714|NCT00522821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100715|NCT02936895|Vitamin D|vitamin d|mesh-list
65100716|NCT02936895|Cholecalciferol|cholecalciferol|mesh-list
65100717|NCT02936895|Vitamins|vitamins|mesh-ancestor
65100718|NCT02936895|Micronutrients|micronutrients|mesh-ancestor
65100719|NCT02936895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100720|NCT02936895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65100721|NCT02936895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65100722|NCT00522938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65100723|NCT00522938|Tosedostat|tosedostat|mesh-list
65100724|NCT00522938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100725|NCT00522938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65100726|NCT00522938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100727|NCT00522938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100728|NCT04694105|Dexamethasone|dexamethasone|mesh-list
65100729|NCT04694105|Dexmedetomidine|dexmedetomidine|mesh-list
65100746|NCT04694105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65100747|NCT04694105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65100749|NCT04694105|Adrenergic Agents|adrenergic agents|mesh-ancestor
65100750|NCT04694105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65100751|NCT04694105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100752|NCT02930733|Bupivacaine|bupivacaine|mesh-list
65100753|NCT02930733|Anesthetics, Local|anesthetics, local|mesh-ancestor
65100754|NCT02930733|Anesthetics|anesthetics|mesh-ancestor
65100755|NCT02930733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65100756|NCT02930733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100757|NCT02930733|Sensory System Agents|sensory system agents|mesh-ancestor
65100758|NCT02930733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100759|NCT00523055|Lidocaine|lidocaine|mesh-list
65100760|NCT00523055|Anesthetics, Local|anesthetics, local|mesh-ancestor
65100761|NCT00523055|Anesthetics|anesthetics|mesh-ancestor
65100762|NCT00523055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65100763|NCT00523055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100764|NCT00523055|Sensory System Agents|sensory system agents|mesh-ancestor
65100765|NCT00523055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100766|NCT00523055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65100767|NCT00523055|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65100768|NCT00523055|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65100769|NCT00523055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65100770|NCT00523055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100771|NCT00523289|Bupivacaine|bupivacaine|mesh-list
65100772|NCT00523289|Ropivacaine|ropivacaine|mesh-list
64673462|NCT00377091|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65100791|NCT04502667|Vitamin D|vitamin d|mesh-list
65100792|NCT04502667|Cholecalciferol|cholecalciferol|mesh-list
65100793|NCT04502667|Vitamins|vitamins|mesh-ancestor
65100794|NCT04502667|Micronutrients|micronutrients|mesh-ancestor
65100795|NCT04502667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100796|NCT04502667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65100797|NCT04502667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65100798|NCT00524498|Cisplatin|cisplatin|mesh-list
65100799|NCT00524498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289228|NCT02741063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289229|NCT04138836|Itraconazole|itraconazole|mesh-list
65289230|NCT04138836|Midazolam|midazolam|mesh-list
65289231|NCT04138836|Esomeprazole|esomeprazole|mesh-list
65289232|NCT04138836|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65289233|NCT04138836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65289234|NCT04138836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65289235|NCT04138836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289236|NCT04138836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65289237|NCT04138836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65289238|NCT04138836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65289239|NCT04138836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65289240|NCT04138836|Anesthetics, General|anesthetics, general|mesh-ancestor
65289241|NCT04138836|Anesthetics|anesthetics|mesh-ancestor
65289242|NCT04138836|GABA Modulators|gaba modulators|mesh-ancestor
65289243|NCT04138836|GABA Agents|gaba agents|mesh-ancestor
65289244|NCT04138836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64519475|NCT03206346|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
65100800|NCT00523406|Triamcinolone|triamcinolone|mesh-list
65100801|NCT00523406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65100802|NCT00523406|Glucocorticoids|glucocorticoids|mesh-ancestor
65100803|NCT00523406|Hormones|hormones|mesh-ancestor
65100804|NCT00523406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65100805|NCT00523406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100806|NCT00524615|Spironolactone|spironolactone|mesh-list
65100807|NCT00524615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65100808|NCT00524615|Hormone Antagonists|hormone antagonists|mesh-ancestor
65100809|NCT00524615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65100810|NCT00524615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100811|NCT00524615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65100812|NCT00524615|Diuretics|diuretics|mesh-ancestor
65100813|NCT00524615|Natriuretic Agents|natriuretic agents|mesh-ancestor
65100814|NCT00523445|Varenicline|varenicline|mesh-list
65100815|NCT00523445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65100816|NCT00523445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65100817|NCT00523445|Cholinergic Agents|cholinergic agents|mesh-ancestor
65100818|NCT00523445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65100819|NCT00523445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100820|NCT00523445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100821|NCT02936661|Tranexamic Acid|tranexamic acid|mesh-list
65100822|NCT02936661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65100823|NCT02936661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65100824|NCT02936661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100825|NCT02936661|Hemostatics|hemostatics|mesh-ancestor
65100826|NCT02936661|Coagulants|coagulants|mesh-ancestor
65100827|NCT02948075|Paclitaxel|paclitaxel|mesh-list
65100828|NCT02948075|Carboplatin|carboplatin|mesh-list
64673508|NCT04923776|Etoposide|etoposide|mesh-list
65100850|NCT04748172|Immunologic Factors|immunologic factors|mesh-ancestor
65100851|NCT04748172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100852|NCT00523757|Spironolactone|spironolactone|mesh-list
65100853|NCT00523757|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65100854|NCT00523757|Hormone Antagonists|hormone antagonists|mesh-ancestor
65100855|NCT00523757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65100856|NCT00523757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100857|NCT00523757|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65100858|NCT00523757|Diuretics|diuretics|mesh-ancestor
65100859|NCT00523757|Natriuretic Agents|natriuretic agents|mesh-ancestor
65289245|NCT04138836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289246|NCT04138836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65289247|NCT04138836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65289248|NCT04138836|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65289249|NCT04138836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289250|NCT04138836|Antifungal Agents|antifungal agents|mesh-ancestor
65289251|NCT04138836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65289252|NCT04138836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65289253|NCT04138836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65289254|NCT04138836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65289255|NCT04138836|Hormone Antagonists|hormone antagonists|mesh-ancestor
64519502|NCT03227016|Topotecan|topotecan|mesh-list
65100860|NCT00524693|Montelukast|montelukast|mesh-list
65100861|NCT00524693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65100862|NCT00524693|Respiratory System Agents|respiratory system agents|mesh-ancestor
65100863|NCT00524693|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65100864|NCT00524693|Hormone Antagonists|hormone antagonists|mesh-ancestor
64483800|NCT00774202|Immunologic Factors|immunologic factors|mesh-ancestor
65100865|NCT00524693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65100866|NCT00524693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100867|NCT00524693|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65100868|NCT00524693|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65100869|NCT00524693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100870|NCT02931201|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65100871|NCT02931201|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65100872|NCT02931201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100873|NCT02936427|Dexamethasone|dexamethasone|mesh-list
65100874|NCT02936427|Dexamethasone acetate|dexamethasone acetate|mesh-list
65100875|NCT02936427|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65100877|NCT02936427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65100878|NCT02936427|Antiemetics|antiemetics|mesh-ancestor
65100887|NCT02936427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100888|NCT02936427|Protease Inhibitors|protease inhibitors|mesh-ancestor
65100889|NCT02936427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100890|NCT02936427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100891|NCT00523913|Rosiglitazone|rosiglitazone|mesh-list
65100892|NCT00523913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65100893|NCT00523913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100894|NCT02947763|Metronidazole|metronidazole|mesh-list
65100895|NCT02947763|Ciprofloxacin|ciprofloxacin|mesh-list
65100896|NCT02947763|Minocycline|minocycline|mesh-list
65100897|NCT02947763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65100898|NCT02947763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65100899|NCT02947763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65100900|NCT02947763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65100901|NCT02947763|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65100902|NCT02947763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65100903|NCT02947763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100904|NCT02947763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100905|NCT02947763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100906|NCT02947763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65100907|NCT02947763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65100908|NCT00523952|Tacrolimus|tacrolimus|mesh-list
65100909|NCT00523952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65100910|NCT00523952|Immunologic Factors|immunologic factors|mesh-ancestor
65100911|NCT00523952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100912|NCT00523952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65100913|NCT00523952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100914|NCT00523952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100915|NCT00524069|Gemcitabine|gemcitabine|mesh-list
65100916|NCT00524069|Bevacizumab|bevacizumab|mesh-list
65289256|NCT04138836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65289257|NCT04138836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65289258|NCT00922584|Sorafenib|sorafenib|mesh-list
65289259|NCT00922584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289260|NCT00922584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65289261|NCT00922584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289262|NCT00922584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289263|NCT02735603|Moxifloxacin|moxifloxacin|mesh-list
64519505|NCT03227016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65100917|NCT00524069|Capecitabine|capecitabine|mesh-list
65100918|NCT00524069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65100919|NCT00524069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100920|NCT00524069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65100921|NCT00524069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65100922|NCT00524069|Growth Substances|growth substances|mesh-ancestor
65100923|NCT00524069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100924|NCT00524069|Growth Inhibitors|growth inhibitors|mesh-ancestor
65100925|NCT00524069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65100926|NCT00524069|Antimetabolites|antimetabolites|mesh-ancestor
65100927|NCT00524069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100928|NCT00524069|Antiviral Agents|antiviral agents|mesh-ancestor
65100929|NCT00524069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65100930|NCT00524069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100931|NCT00524069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65100932|NCT00524069|Immunologic Factors|immunologic factors|mesh-ancestor
65100933|NCT00524810|Docetaxel|docetaxel|mesh-list
65100934|NCT00524810|Doxorubicin|doxorubicin|mesh-list
65100935|NCT00524810|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65100936|NCT00524810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100937|NCT00524810|Tubulin Modulators|tubulin modulators|mesh-ancestor
65100938|NCT00524810|Antimitotic Agents|antimitotic agents|mesh-ancestor
65100939|NCT00524810|Mitosis Modulators|mitosis modulators|mesh-ancestor
65100940|NCT00524810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100941|NCT00524810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65100942|NCT00524810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65100943|NCT00524810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65100944|NCT00524810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100954|NCT00524966|Hemostatics|hemostatics|mesh-list
65100955|NCT00524966|Coagulants|coagulants|mesh-ancestor
65100956|NCT02276846|Paclitaxel|paclitaxel|mesh-list
65100957|NCT02276846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65100958|NCT02276846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100959|NCT02276846|Tubulin Modulators|tubulin modulators|mesh-ancestor
65100960|NCT02276846|Antimitotic Agents|antimitotic agents|mesh-ancestor
65100961|NCT02276846|Mitosis Modulators|mitosis modulators|mesh-ancestor
65100962|NCT02276846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100963|NCT02935725|Ketamine|ketamine|mesh-list
65100964|NCT02935725|Analgesics|analgesics|mesh-ancestor
65100965|NCT02935725|Sensory System Agents|sensory system agents|mesh-ancestor
65100966|NCT02935725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100967|NCT02935725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100968|NCT02935725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65100969|NCT02935725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65100970|NCT02935725|Anesthetics, General|anesthetics, general|mesh-ancestor
65100971|NCT02935725|Anesthetics|anesthetics|mesh-ancestor
65100972|NCT02935725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65100973|NCT02935725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65100974|NCT02935725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65100975|NCT02935725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65100976|NCT02935725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100977|NCT02935764|Leucovorin|leucovorin|mesh-list
65100978|NCT02935764|Fluorouracil|fluorouracil|mesh-list
65100979|NCT02935764|Irinotecan|irinotecan|mesh-list
65100980|NCT02935764|Antimetabolites|antimetabolites|mesh-ancestor
65222801|NCT04215159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65289264|NCT02735603|Naltrexone|naltrexone|mesh-list
65289265|NCT02735603|Bupropion|bupropion|mesh-list
65289266|NCT02735603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65289267|NCT02735603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65289268|NCT02735603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65289269|NCT02735603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65289270|NCT02735603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289271|NCT02735603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289272|NCT02735603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289273|NCT02735603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289274|NCT02735603|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65289275|NCT02735603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65289276|NCT02735603|Sensory System Agents|sensory system agents|mesh-ancestor
65289277|NCT02735603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65289278|NCT02735603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65289279|NCT02735603|Antidepressive Agents|antidepressive agents|mesh-ancestor
65289280|NCT02735603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65289281|NCT02735603|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65289282|NCT02735603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65289283|NCT02735603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65289284|NCT02735603|Dopamine Agents|dopamine agents|mesh-ancestor
65289285|NCT02735603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65289286|NCT02735603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65289287|NCT02735603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65289288|NCT00685776|Anacetrapib|anacetrapib|mesh-list
65289289|NCT00685776|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65289290|NCT00685776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65289291|NCT00685776|Antimetabolites|antimetabolites|mesh-ancestor
65289292|NCT00685776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289293|NCT00685776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65289294|NCT00685854|Ranibizumab|ranibizumab|mesh-list
65289295|NCT00685854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65289296|NCT00685854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65289297|NCT00685854|Growth Substances|growth substances|mesh-ancestor
64519513|NCT04748991|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65100981|NCT02935764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289298|NCT00685854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289299|NCT00685854|Growth Inhibitors|growth inhibitors|mesh-ancestor
65289300|NCT00685854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289301|NCT04138368|Psychotropic Drugs|psychotropic drugs|mesh-list
65289302|NCT04138290|Antidepressive Agents|antidepressive agents|mesh-list
65289303|NCT04138290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65289304|NCT04003207|Hormones|hormones|mesh-list
64519553|NCT02451072|Ketanserin|ketanserin|mesh-list
65100982|NCT02935764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65100983|NCT02935764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100984|NCT02935764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65100985|NCT02935764|Immunologic Factors|immunologic factors|mesh-ancestor
65100986|NCT02935764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100987|NCT02935764|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65100988|NCT02935764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65100989|NCT02935764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100990|NCT02935764|Antidotes|antidotes|mesh-ancestor
65100991|NCT02935764|Protective Agents|protective agents|mesh-ancestor
65100992|NCT02935764|Vitamin B Complex|vitamin b complex|mesh-ancestor
65100993|NCT02935764|Vitamins|vitamins|mesh-ancestor
65100994|NCT02935764|Micronutrients|micronutrients|mesh-ancestor
65100995|NCT02935998|Ziprasidone|ziprasidone|mesh-list
65100996|NCT02935998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65100997|NCT02935998|Serotonin Agents|serotonin agents|mesh-ancestor
65100998|NCT02935998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65100999|NCT02935998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101000|NCT02935998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101001|NCT02935998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65101002|NCT02935998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65101003|NCT02935998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65101004|NCT02935998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65101005|NCT02935998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65101006|NCT02935998|Dopamine Agents|dopamine agents|mesh-ancestor
65101007|NCT02930109|Cytarabine|cytarabine|mesh-list
65101008|NCT02930109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65101009|NCT02930109|Antimetabolites|antimetabolites|mesh-ancestor
65101010|NCT02930109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101011|NCT02930109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673690|NCT00376701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64673691|NCT00376701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64673692|NCT00376701|Growth Substances|growth substances|mesh-ancestor
64673694|NCT00376701|Growth Inhibitors|growth inhibitors|mesh-ancestor
65101017|NCT00524186|Leucovorin|leucovorin|mesh-list
65101018|NCT00524186|Fluorouracil|fluorouracil|mesh-list
65101019|NCT00524186|Irinotecan|irinotecan|mesh-list
65101020|NCT00524186|Sunitinib|sunitinib|mesh-list
65101021|NCT00524186|Calcium|calcium|mesh-list
65101022|NCT00524186|Levoleucovorin|levoleucovorin|mesh-list
65101023|NCT00524186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65101024|NCT00524186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101025|NCT00524186|Antimetabolites|antimetabolites|mesh-ancestor
65101026|NCT00524186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101027|NCT00524186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65101028|NCT00524186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101029|NCT00524186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65101030|NCT00524186|Immunologic Factors|immunologic factors|mesh-ancestor
65101031|NCT00524186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65101032|NCT00524186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65101033|NCT00524186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101034|NCT00524186|Antidotes|antidotes|mesh-ancestor
65101035|NCT00524186|Protective Agents|protective agents|mesh-ancestor
65101036|NCT00524186|Vitamin B Complex|vitamin b complex|mesh-ancestor
65101037|NCT00524186|Vitamins|vitamins|mesh-ancestor
65101038|NCT00524186|Micronutrients|micronutrients|mesh-ancestor
65101039|NCT00524186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65101040|NCT00524186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65101041|NCT00524186|Growth Substances|growth substances|mesh-ancestor
65101042|NCT00524186|Growth Inhibitors|growth inhibitors|mesh-ancestor
65101043|NCT00524186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65101044|NCT00525005|Docetaxel|docetaxel|mesh-list
65101045|NCT00525005|Oxaliplatin|oxaliplatin|mesh-list
65289305|NCT04003207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65289306|NCT04003207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289307|NCT04582435|Insulin|insulin|mesh-list
65289308|NCT04582435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65289309|NCT04582435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289310|NCT05295355|Bromides|bromides|mesh-list
65289311|NCT05295355|Tiotropium Bromide|tiotropium bromide|mesh-list
65289312|NCT05295355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65289313|NCT05295355|Autonomic Agents|autonomic agents|mesh-ancestor
65289314|NCT05295355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65289315|NCT05295355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289316|NCT05295355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65289317|NCT05295355|Respiratory System Agents|respiratory system agents|mesh-ancestor
65289318|NCT05295355|Parasympatholytics|parasympatholytics|mesh-ancestor
64519567|NCT02450994|Dexamethasone|dexamethasone|mesh-list
65101046|NCT00525005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101047|NCT00525005|Tubulin Modulators|tubulin modulators|mesh-ancestor
65101048|NCT00525005|Antimitotic Agents|antimitotic agents|mesh-ancestor
65101049|NCT00525005|Mitosis Modulators|mitosis modulators|mesh-ancestor
65101050|NCT00525005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101051|NCT02930031|Acetylcysteine|acetylcysteine|mesh-list
65101052|NCT02930031|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65101053|NCT02930031|Antiviral Agents|antiviral agents|mesh-ancestor
65101054|NCT02930031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65101055|NCT02930031|Expectorants|expectorants|mesh-ancestor
65101056|NCT02930031|Respiratory System Agents|respiratory system agents|mesh-ancestor
65101057|NCT02930031|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65101058|NCT02930031|Antioxidants|antioxidants|mesh-ancestor
65101059|NCT02930031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101060|NCT02930031|Protective Agents|protective agents|mesh-ancestor
65101061|NCT02930031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101062|NCT02930031|Antidotes|antidotes|mesh-ancestor
65101063|NCT00525200|Docetaxel|docetaxel|mesh-list
65101064|NCT00525200|Cisplatin|cisplatin|mesh-list
65101065|NCT00525200|Fluorouracil|fluorouracil|mesh-list
65101066|NCT00525200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101067|NCT00525200|Tubulin Modulators|tubulin modulators|mesh-ancestor
65101068|NCT00525200|Antimitotic Agents|antimitotic agents|mesh-ancestor
65101069|NCT00525200|Mitosis Modulators|mitosis modulators|mesh-ancestor
65101070|NCT00525200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101071|NCT00525200|Antimetabolites|antimetabolites|mesh-ancestor
65101072|NCT00525200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65101073|NCT00525200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65101074|NCT00525200|Immunologic Factors|immunologic factors|mesh-ancestor
65101075|NCT00525200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101076|NCT02930265|Liraglutide|liraglutide|mesh-list
65101077|NCT02930265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65101078|NCT02930265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101095|NCT02929797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65101096|NCT02929797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101097|NCT02929797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65101098|NCT02929797|Immunologic Factors|immunologic factors|mesh-ancestor
65101099|NCT02929797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101100|NCT00525239|Ritonavir|ritonavir|mesh-list
65101101|NCT00525239|Lopinavir|lopinavir|mesh-list
65101102|NCT00525239|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65101103|NCT00525239|Efavirenz|efavirenz|mesh-list
65101104|NCT00525239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65101105|NCT00525239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65101106|NCT00525239|Protease Inhibitors|protease inhibitors|mesh-ancestor
65101107|NCT00525239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289319|NCT05295355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65289320|NCT05295355|Cholinergic Agents|cholinergic agents|mesh-ancestor
65289321|NCT05295355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65289322|NCT05295355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289323|NCT05295355|Anticonvulsants|anticonvulsants|mesh-ancestor
65289324|NCT01564303|Acetylcysteine|acetylcysteine|mesh-list
65289325|NCT01564303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65101108|NCT00525239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101109|NCT00525239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65101110|NCT00525239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65101111|NCT00525239|Antiviral Agents|antiviral agents|mesh-ancestor
65101112|NCT00525239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65101113|NCT00525239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65101114|NCT00525239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65101115|NCT00525239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65101116|NCT00525239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65101117|NCT00525239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65101118|NCT00525239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65101119|NCT00525239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65101120|NCT00525239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65101121|NCT00525239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65101122|NCT02929914|Anti-Infective Agents|anti-infective agents|mesh-list
65101123|NCT02929914|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65101124|NCT02947334|Bococizumab|bococizumab|mesh-list
65101125|NCT02947334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65101126|NCT02947334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65101127|NCT02947334|Antimetabolites|antimetabolites|mesh-ancestor
65101128|NCT02947334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101129|NCT02947334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65101130|NCT00525278|Levocetirizine|levocetirizine|mesh-list
65101131|NCT00525278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65101132|NCT00525278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65101133|NCT00525278|Histamine Antagonists|histamine antagonists|mesh-ancestor
65101134|NCT00525278|Histamine Agents|histamine agents|mesh-ancestor
65101146|NCT02929719|Leprostatic Agents|leprostatic agents|mesh-ancestor
65101147|NCT02929719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65101148|NCT04325685|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
65101149|NCT04325685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65101150|NCT02929524|Ketamine|ketamine|mesh-list
65101151|NCT02929524|Analgesics|analgesics|mesh-ancestor
65101152|NCT02929524|Sensory System Agents|sensory system agents|mesh-ancestor
65101153|NCT02929524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65101154|NCT02929524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101155|NCT02929524|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65101156|NCT02929524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65101157|NCT02929524|Anesthetics, General|anesthetics, general|mesh-ancestor
65101158|NCT02929524|Anesthetics|anesthetics|mesh-ancestor
65101159|NCT02929524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65101160|NCT02929524|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65101161|NCT02929524|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65101162|NCT02929524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64483803|NCT00774202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65101163|NCT02929524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101164|NCT00525473|Azathioprine|azathioprine|mesh-list
65101165|NCT00525473|Antimetabolites|antimetabolites|mesh-ancestor
65101166|NCT00525473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101167|NCT00525473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65101168|NCT00525473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101169|NCT00525473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65101170|NCT00525473|Immunologic Factors|immunologic factors|mesh-ancestor
65101171|NCT00525473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101172|NCT00525473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65101173|NCT00526175|Cytarabine|cytarabine|mesh-list
65101174|NCT00526175|Prednisone|prednisone|mesh-list
65101175|NCT00526175|Cyclophosphamide|cyclophosphamide|mesh-list
65101176|NCT00526175|Methotrexate|methotrexate|mesh-list
65101177|NCT00526175|Vincristine|vincristine|mesh-list
65289326|NCT01564303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
65289327|NCT01564303|Antiviral Agents|antiviral agents|mesh-ancestor
65289328|NCT01564303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65289329|NCT01564303|Expectorants|expectorants|mesh-ancestor
65289330|NCT01564303|Respiratory System Agents|respiratory system agents|mesh-ancestor
65289331|NCT01564303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65289332|NCT01564303|Antioxidants|antioxidants|mesh-ancestor
64743450|NCT01915914|Xhance|xhance|mesh-list
65101178|NCT00526175|Daunorubicin|daunorubicin|mesh-list
65101179|NCT00526175|Asparaginase|asparaginase|mesh-list
65101180|NCT00526175|Mercaptopurine|mercaptopurine|mesh-list
65101181|NCT00526175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65101182|NCT00526175|Immunologic Factors|immunologic factors|mesh-ancestor
65101183|NCT00526175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101184|NCT00526175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65101185|NCT00526175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65101186|NCT00526175|Alkylating Agents|alkylating agents|mesh-ancestor
65101187|NCT00526175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101188|NCT00526175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101189|NCT00526175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65101190|NCT00526175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65101191|NCT00526175|Glucocorticoids|glucocorticoids|mesh-ancestor
65101192|NCT00526175|Hormones|hormones|mesh-ancestor
65101193|NCT00526175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65101194|NCT00526175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65101195|NCT00526175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65101212|NCT00526175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65101213|NCT02929563|Pantoprazole|pantoprazole|mesh-list
65101214|NCT02929563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65101215|NCT02929563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65101216|NCT02929563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65101217|NCT02929563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101218|NCT02929563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101219|NCT00525551|Acetylcysteine|acetylcysteine|mesh-list
65101220|NCT00525551|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65101221|NCT00525551|Antiviral Agents|antiviral agents|mesh-ancestor
65101222|NCT00525551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65101223|NCT00525551|Expectorants|expectorants|mesh-ancestor
65101224|NCT00525551|Respiratory System Agents|respiratory system agents|mesh-ancestor
65101225|NCT00525551|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65101226|NCT00525551|Antioxidants|antioxidants|mesh-ancestor
65101227|NCT00525551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101228|NCT00525551|Protective Agents|protective agents|mesh-ancestor
65101229|NCT00525551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101230|NCT00525551|Antidotes|antidotes|mesh-ancestor
65101231|NCT04288323|Diethylenetriamine|diethylenetriamine|mesh-list
65101232|NCT04288323|Edetic Acid|edetic acid|mesh-list
65101233|NCT04288323|Pentetic Acid|pentetic acid|mesh-list
65101234|NCT04288323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65101235|NCT04288323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101236|NCT04288323|Antidotes|antidotes|mesh-ancestor
65101237|NCT04288323|Protective Agents|protective agents|mesh-ancestor
65101238|NCT04288323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101240|NCT04288323|Sequestering Agents|sequestering agents|mesh-ancestor
65101241|NCT04288323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65101242|NCT04288323|Anticoagulants|anticoagulants|mesh-ancestor
65101243|NCT04288323|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65101244|NCT02946359|Bevacizumab|bevacizumab|mesh-list
65101245|NCT02946359|Crizotinib|crizotinib|mesh-list
65101246|NCT02946359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65101247|NCT02946359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101248|NCT02946359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65101249|NCT02946359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65101250|NCT02946359|Growth Substances|growth substances|mesh-ancestor
65101251|NCT02946359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101252|NCT02946359|Growth Inhibitors|growth inhibitors|mesh-ancestor
65101253|NCT02946359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65101254|NCT02946359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101255|NCT02946359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101271|NCT02946437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65289333|NCT01564303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289334|NCT01564303|Protective Agents|protective agents|mesh-ancestor
65289335|NCT01564303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289336|NCT01564303|Antidotes|antidotes|mesh-ancestor
65289337|NCT01564303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65289338|NCT01564303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289339|NCT00674232|Misoprostol|misoprostol|mesh-list
64887955|NCT01956591|Oxybutynin|oxybutynin|mesh-list
65101272|NCT02946437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101273|NCT02946437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65101274|NCT02946437|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65101276|NCT02946632|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65101277|NCT02946632|Dapagliflozin|dapagliflozin|mesh-list
65101278|NCT02946632|Glimepiride|glimepiride|mesh-list
65101279|NCT02946632|Saxagliptin|saxagliptin|mesh-list
65101280|NCT02946632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65101281|NCT02946632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101282|NCT02946632|Incretins|incretins|mesh-ancestor
65101283|NCT02946632|Hormones|hormones|mesh-ancestor
65101284|NCT02946632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65101285|NCT02946632|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65101286|NCT02946632|Protease Inhibitors|protease inhibitors|mesh-ancestor
65101287|NCT02946632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101288|NCT02946632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101289|NCT02946632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65101290|NCT02946632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65101291|NCT02946632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65101292|NCT02946632|Immunologic Factors|immunologic factors|mesh-ancestor
65101293|NCT02929134|Doxycycline|doxycycline|mesh-list
65101294|NCT02929134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65101295|NCT02929134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65101296|NCT02929134|Antimalarials|antimalarials|mesh-ancestor
65101297|NCT02929134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65101298|NCT02929134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65101299|NCT02929212|Acetaminophen|acetaminophen|mesh-list
65101300|NCT02929212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65101301|NCT02929212|Analgesics|analgesics|mesh-ancestor
65101302|NCT02929212|Sensory System Agents|sensory system agents|mesh-ancestor
65101303|NCT02929212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65101304|NCT02929212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101305|NCT02929212|Antipyretics|antipyretics|mesh-ancestor
65101306|NCT02929251|Adalimumab|adalimumab|mesh-list
65101307|NCT02929251|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65101308|NCT02929251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65101309|NCT02929251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65101310|NCT02929095|Midazolam|midazolam|mesh-list
65101311|NCT02929095|Dexmedetomidine|dexmedetomidine|mesh-list
65101312|NCT02929095|Remifentanil|remifentanil|mesh-list
65101313|NCT02929095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65101314|NCT02929095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65101315|NCT02929095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101317|NCT02929095|Analgesics|analgesics|mesh-ancestor
65101318|NCT02929095|Sensory System Agents|sensory system agents|mesh-ancestor
65101319|NCT02929095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65101327|NCT02929095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65101328|NCT02929095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65101329|NCT02929095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65101330|NCT02929095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65101331|NCT02929095|Anesthetics, General|anesthetics, general|mesh-ancestor
65101333|NCT02929095|GABA Modulators|gaba modulators|mesh-ancestor
65101334|NCT02929095|GABA Agents|gaba agents|mesh-ancestor
65101335|NCT02929095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65101336|NCT02929095|Narcotics|narcotics|mesh-ancestor
65101337|NCT02928861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65101338|NCT02928861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65101339|NCT02928861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101340|NCT00525668|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65101341|NCT00525668|Antioxidants|antioxidants|mesh-ancestor
65222802|NCT04215159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65289340|NCT00674232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65289341|NCT00674232|Abortifacient Agents|abortifacient agents|mesh-ancestor
65289342|NCT00674232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64519588|NCT02401048|Durvalumab|durvalumab|mesh-list
65101342|NCT00525668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101343|NCT00525668|Protective Agents|protective agents|mesh-ancestor
65101344|NCT00525668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101345|NCT00525668|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65101346|NCT00525668|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65101347|NCT00525668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101348|NCT00525668|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65101349|NCT00525707|Tezosentan|tezosentan|mesh-list
65101350|NCT00525707|Vasodilator Agents|vasodilator agents|mesh-ancestor
65101351|NCT00526214|Celecoxib|celecoxib|mesh-list
65101352|NCT00526214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65101353|NCT00526214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65101354|NCT00526214|Analgesics|analgesics|mesh-ancestor
65101355|NCT00526214|Sensory System Agents|sensory system agents|mesh-ancestor
65101356|NCT00526214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65101357|NCT00526214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101358|NCT00526214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65101359|NCT00526214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65101360|NCT00526214|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65101361|NCT00526214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65101362|NCT00526214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101363|NCT00526214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101364|NCT02928510|Idelalisib|idelalisib|mesh-list
65101365|NCT02928510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101366|NCT02928510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101367|NCT02928510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101368|NCT02946944|Sildenafil Citrate|sildenafil citrate|mesh-list
65101369|NCT02946944|Apixaban|apixaban|mesh-list
65101370|NCT02946944|Vasodilator Agents|vasodilator agents|mesh-ancestor
65101371|NCT02946944|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65101372|NCT02946944|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65101373|NCT02946944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101374|NCT02946944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101375|NCT02946944|Urological Agents|urological agents|mesh-ancestor
65101376|NCT02946944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65101377|NCT02946944|Antithrombins|antithrombins|mesh-ancestor
65101378|NCT02946944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65101379|NCT02946944|Protease Inhibitors|protease inhibitors|mesh-ancestor
65101380|NCT02946944|Anticoagulants|anticoagulants|mesh-ancestor
65101381|NCT02947061|Docetaxel|docetaxel|mesh-list
65101382|NCT02947061|Capecitabine|capecitabine|mesh-list
65101383|NCT02947061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101384|NCT02947061|Tubulin Modulators|tubulin modulators|mesh-ancestor
65101385|NCT02947061|Antimitotic Agents|antimitotic agents|mesh-ancestor
65101386|NCT02947061|Mitosis Modulators|mitosis modulators|mesh-ancestor
64673982|NCT03705273|Dexamethasone|dexamethasone|mesh-list
65101393|NCT02928315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65101394|NCT02928315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101395|NCT02928315|Anesthetics|anesthetics|mesh-ancestor
65101396|NCT02928315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65101397|NCT02928315|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65101398|NCT02928315|Anticonvulsants|anticonvulsants|mesh-ancestor
65101399|NCT02928315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65101400|NCT02928315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65101401|NCT02928315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101402|NCT02928315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65101403|NCT02928315|Tocolytic Agents|tocolytic agents|mesh-ancestor
65101404|NCT02928315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65101405|NCT00526409|Cytarabine|cytarabine|mesh-list
65101406|NCT00526409|Prednisolone|prednisolone|mesh-list
65101407|NCT00526409|Cyclophosphamide|cyclophosphamide|mesh-list
65101408|NCT00526409|Methotrexate|methotrexate|mesh-list
65101409|NCT00526409|Vincristine|vincristine|mesh-list
65101410|NCT00526409|Daunorubicin|daunorubicin|mesh-list
65101411|NCT00526409|Asparaginase|asparaginase|mesh-list
65101412|NCT00526409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65101413|NCT00526409|Immunologic Factors|immunologic factors|mesh-ancestor
65101414|NCT00526409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289343|NCT00674232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289344|NCT00674232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65289345|NCT00674232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65289346|NCT00674232|Oxytocics|oxytocics|mesh-ancestor
65289347|NCT00674310|Ropinirole|ropinirole|mesh-list
65289348|NCT00674310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65289349|NCT00674310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65101415|NCT00526409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65101416|NCT00526409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65101417|NCT00526409|Alkylating Agents|alkylating agents|mesh-ancestor
65101418|NCT00526409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101419|NCT00526409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101420|NCT00526409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65101421|NCT00526409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65101422|NCT00526409|Abortifacient Agents|abortifacient agents|mesh-ancestor
65101423|NCT00526409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65101424|NCT00526409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65101425|NCT00526409|Antimetabolites|antimetabolites|mesh-ancestor
65101426|NCT00526409|Dermatologic Agents|dermatologic agents|mesh-ancestor
65101427|NCT00526409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101428|NCT00526409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65101429|NCT00526409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65101430|NCT00526409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65101431|NCT00526409|Tubulin Modulators|tubulin modulators|mesh-ancestor
65101432|NCT00526409|Antimitotic Agents|antimitotic agents|mesh-ancestor
65101433|NCT00526409|Mitosis Modulators|mitosis modulators|mesh-ancestor
65101434|NCT00526409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65101435|NCT00526409|Glucocorticoids|glucocorticoids|mesh-ancestor
65101436|NCT00526409|Hormones|hormones|mesh-ancestor
65101437|NCT00526409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65101438|NCT00526409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65101439|NCT00526409|Antiviral Agents|antiviral agents|mesh-ancestor
65101440|NCT00526409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65101441|NCT00526409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65101442|NCT00526409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65101443|NCT00526409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65101444|NCT00526448|Ribavirin|ribavirin|mesh-list
65101445|NCT00526448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65101446|NCT00526448|Antimetabolites|antimetabolites|mesh-ancestor
65101447|NCT00526448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101448|NCT00526448|Antiviral Agents|antiviral agents|mesh-ancestor
65101449|NCT00526448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65101450|NCT02946671|Nivolumab|nivolumab|mesh-list
65101451|NCT02946671|Mogamulizumab|mogamulizumab|mesh-list
65101452|NCT02946671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65101453|NCT02946671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674055|NCT04350320|Colchicine|colchicine|mesh-list
64674120|NCT00554840|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64674121|NCT00554840|Cholinergic Agents|cholinergic agents|mesh-ancestor
64674122|NCT00554840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65101458|NCT02927886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65101459|NCT02927886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101460|NCT02927886|Cholinergic Agents|cholinergic agents|mesh-ancestor
65101461|NCT02927886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65101462|NCT02927886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101463|NCT02945280|Apixaban|apixaban|mesh-list
65101464|NCT02945280|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65101465|NCT02945280|Antithrombins|antithrombins|mesh-ancestor
65101466|NCT02945280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65101467|NCT02945280|Protease Inhibitors|protease inhibitors|mesh-ancestor
65101468|NCT02945280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101469|NCT02945280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101470|NCT02945280|Anticoagulants|anticoagulants|mesh-ancestor
65101471|NCT02945241|Vancomycin|vancomycin|mesh-list
65101472|NCT02945241|Cystatins|cystatins|mesh-list
65101473|NCT02945241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65101474|NCT02945241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65101475|NCT02945241|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65101476|NCT02945241|Protease Inhibitors|protease inhibitors|mesh-ancestor
65289350|NCT00674310|Dopamine Agonists|dopamine agonists|mesh-ancestor
65289351|NCT00674310|Dopamine Agents|dopamine agents|mesh-ancestor
65289352|NCT00674310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65289353|NCT00674310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289354|NCT00674310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289355|NCT00686010|Dalcetrapib|dalcetrapib|mesh-list
65289356|NCT00686010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65289357|NCT00686010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65289358|NCT00686010|Antimetabolites|antimetabolites|mesh-ancestor
65289359|NCT00686010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289360|NCT00686010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65289361|NCT05265247|Esomeprazole|esomeprazole|mesh-list
65289362|NCT05265247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65289363|NCT05265247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65289364|NCT05265247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65289365|NCT05265247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289366|NCT05265247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289367|NCT03823300|Aflibercept|aflibercept|mesh-list
65101477|NCT02945241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101478|NCT02945241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101479|NCT00526643|Gemcitabine|gemcitabine|mesh-list
65101480|NCT00526643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101481|NCT00526643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65101482|NCT00526643|Antimetabolites|antimetabolites|mesh-ancestor
65101483|NCT00526643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101484|NCT00526643|Antiviral Agents|antiviral agents|mesh-ancestor
65101485|NCT00526643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65101486|NCT00526643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101487|NCT00526643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65101488|NCT00526643|Immunologic Factors|immunologic factors|mesh-ancestor
65101489|NCT00526643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101491|NCT02945163|Lamivudine|lamivudine|mesh-list
65101492|NCT02945163|Efavirenz|efavirenz|mesh-list
65101493|NCT02945163|Antiviral Agents|antiviral agents|mesh-ancestor
65101494|NCT02945163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65101495|NCT02945163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65101496|NCT02945163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65101497|NCT02945163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101498|NCT02945163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101499|NCT02945163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65101500|NCT02945163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65101501|NCT02945163|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65101502|NCT02945163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65101503|NCT02945163|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65101504|NCT02945163|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65101505|NCT02945163|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65101506|NCT02945163|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65101507|NCT00526760|Dexmedetomidine|dexmedetomidine|mesh-list
65101508|NCT00526760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65101509|NCT00526760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65101510|NCT00526760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101511|NCT00526760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65101512|NCT00526760|Analgesics|analgesics|mesh-ancestor
65101513|NCT00526760|Sensory System Agents|sensory system agents|mesh-ancestor
65289368|NCT03823300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65289369|NCT03823300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65289370|NCT03823300|Growth Substances|growth substances|mesh-ancestor
65289371|NCT03823300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289372|NCT03823300|Growth Inhibitors|growth inhibitors|mesh-ancestor
65289373|NCT03823300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289374|NCT00537745|Naltrexone|naltrexone|mesh-list
65289375|NCT00537745|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65289376|NCT00537745|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65289377|NCT00537745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289378|NCT00537745|Sensory System Agents|sensory system agents|mesh-ancestor
65289379|NCT00537745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65289380|NCT00686322|Paclitaxel|paclitaxel|mesh-list
65289381|NCT00686322|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65289382|NCT00686322|Cisplatin|cisplatin|mesh-list
65289383|NCT00686322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65289384|NCT00686322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289385|NCT00686322|Tubulin Modulators|tubulin modulators|mesh-ancestor
65289386|NCT00686322|Antimitotic Agents|antimitotic agents|mesh-ancestor
65289387|NCT00686322|Mitosis Modulators|mitosis modulators|mesh-ancestor
64519614|NCT00178503|Methylphenidate|methylphenidate|mesh-list
64519621|NCT00178503|Dopamine Agents|dopamine agents|mesh-ancestor
65101514|NCT00526760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64674126|NCT04069221|Artefenomel|artefenomel|mesh-list
64674175|NCT04041453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64674176|NCT04041453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64674177|NCT04041453|Anthelmintics|anthelmintics|mesh-ancestor
65101522|NCT02927379|Ketamine|ketamine|mesh-list
65101523|NCT02927379|Bupivacaine|bupivacaine|mesh-list
65101524|NCT02927379|Anesthetics, Local|anesthetics, local|mesh-ancestor
65101525|NCT02927379|Anesthetics|anesthetics|mesh-ancestor
65101526|NCT02927379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65101527|NCT02927379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101528|NCT02927379|Sensory System Agents|sensory system agents|mesh-ancestor
65101529|NCT02927379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65101530|NCT02927379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65101531|NCT02927379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65101533|NCT02927379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65101534|NCT02927379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65101535|NCT02927379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65101536|NCT02927379|Adrenergic Agents|adrenergic agents|mesh-ancestor
65101537|NCT02927379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65101538|NCT02927379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101539|NCT02927379|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65101540|NCT02927379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65101541|NCT02927379|Anesthetics, General|anesthetics, general|mesh-ancestor
65101542|NCT02927379|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65101543|NCT02927379|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65101544|NCT00526877|Risperidone|risperidone|mesh-list
65101545|NCT00526877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65101546|NCT00526877|Serotonin Agents|serotonin agents|mesh-ancestor
65101547|NCT00526877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65101548|NCT00526877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101549|NCT00526877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289388|NCT00686322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289389|NCT02734511|Propofol|propofol|mesh-list
65289390|NCT02734511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65289391|NCT02734511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65289392|NCT02734511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289393|NCT02734511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65289394|NCT02734511|Anesthetics, General|anesthetics, general|mesh-ancestor
65289395|NCT02734511|Anesthetics|anesthetics|mesh-ancestor
65289396|NCT02739815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65289397|NCT02739815|Tranexamic Acid|tranexamic acid|mesh-list
65289398|NCT02739815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65289399|NCT02739815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65289400|NCT02739815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65289401|NCT02739815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289402|NCT02739815|Hemostatics|hemostatics|mesh-ancestor
65289403|NCT02739815|Coagulants|coagulants|mesh-ancestor
65289404|NCT00720616|Insulin|insulin|mesh-list
65289405|NCT00720616|Hormones|hormones|mesh-list
65289406|NCT00720616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65289407|NCT00720616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289408|NCT00720616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65289409|NCT00720772|Sodium thiosulfate|sodium thiosulfate|mesh-list
65101550|NCT00526877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65101551|NCT00526877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64743793|NCT01873950|Vasodilator Agents|vasodilator agents|mesh-ancestor
65101552|NCT00526877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65101553|NCT00526877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65101554|NCT00526877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65101555|NCT00526877|Dopamine Agents|dopamine agents|mesh-ancestor
65101556|NCT02927496|Doxycycline|doxycycline|mesh-list
65101557|NCT02927496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65101558|NCT02927496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65101559|NCT02927496|Antimalarials|antimalarials|mesh-ancestor
65101560|NCT02927496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65101561|NCT02927496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65101562|NCT02927535|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
65101563|NCT02927535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65101564|NCT00527033|Mirabegron|mirabegron|mesh-list
65101565|NCT00527033|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65101566|NCT00527033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65101567|NCT00527033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65101568|NCT00527033|Adrenergic Agents|adrenergic agents|mesh-ancestor
65101569|NCT00527033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65101570|NCT00527033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101571|NCT00527033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101572|NCT00527033|Urological Agents|urological agents|mesh-ancestor
65101573|NCT02945072|Sevoflurane|sevoflurane|mesh-list
65101574|NCT02945072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65101585|NCT04692896|Lidocaine|lidocaine|mesh-list
65101586|NCT04692896|Anesthetics, Local|anesthetics, local|mesh-ancestor
65101587|NCT04692896|Anesthetics|anesthetics|mesh-ancestor
65101588|NCT04692896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65101589|NCT04692896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289410|NCT00720772|Antidotes|antidotes|mesh-ancestor
65289411|NCT00720772|Protective Agents|protective agents|mesh-ancestor
65289412|NCT00720772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289413|NCT00720772|Antioxidants|antioxidants|mesh-ancestor
65289414|NCT00720772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289415|NCT00720772|Antitubercular Agents|antitubercular agents|mesh-ancestor
65289416|NCT00720772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65289417|NCT00720772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65289418|NCT00720772|Chelating Agents|chelating agents|mesh-ancestor
65289419|NCT00720772|Sequestering Agents|sequestering agents|mesh-ancestor
65289420|NCT00720850|Lenalidomide|lenalidomide|mesh-list
65289421|NCT00720850|Immunologic Factors|immunologic factors|mesh-ancestor
64519655|NCT02450838|Antacids|antacids|mesh-ancestor
65101590|NCT04692896|Sensory System Agents|sensory system agents|mesh-ancestor
65101591|NCT04692896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65101592|NCT04692896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65101593|NCT04692896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65101594|NCT04692896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65101595|NCT04692896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65101596|NCT04692896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101597|NCT00528008|Chlorhexidine|chlorhexidine|mesh-list
65101598|NCT00528008|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65101599|NCT00528008|Povidone-Iodine|povidone-iodine|mesh-list
65101600|NCT00528008|Povidone|povidone|mesh-list
65101601|NCT00528008|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65101602|NCT00528008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65101603|NCT00528008|Disinfectants|disinfectants|mesh-ancestor
65101604|NCT00528008|Dermatologic Agents|dermatologic agents|mesh-ancestor
65101605|NCT00528008|Plasma Substitutes|plasma substitutes|mesh-ancestor
65101606|NCT00528008|Blood Substitutes|blood substitutes|mesh-ancestor
65101607|NCT04692740|Chlorambucil|chlorambucil|mesh-list
65101608|NCT04692740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65101609|NCT04692740|Alkylating Agents|alkylating agents|mesh-ancestor
65101610|NCT04692740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101611|NCT04692740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101612|NCT02925000|Vinorelbine|vinorelbine|mesh-list
65101613|NCT02925000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65101614|NCT02925000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101615|NCT02925000|Tubulin Modulators|tubulin modulators|mesh-ancestor
65101616|NCT02925000|Antimitotic Agents|antimitotic agents|mesh-ancestor
65101617|NCT02925000|Mitosis Modulators|mitosis modulators|mesh-ancestor
65101618|NCT02925000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101619|NCT02926989|Plasma-lyte 148|plasma-lyte 148|mesh-list
65101620|NCT02926989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65101621|NCT02926989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65101622|NCT02945696|Ropivacaine|ropivacaine|mesh-list
65101623|NCT02945696|Anesthetics, Local|anesthetics, local|mesh-ancestor
65101624|NCT02945696|Anesthetics|anesthetics|mesh-ancestor
65101625|NCT02945696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65101626|NCT02945696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743865|NCT01894776|Maraviroc|maraviroc|mesh-list
65101627|NCT02945696|Sensory System Agents|sensory system agents|mesh-ancestor
65101628|NCT02945696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65101629|NCT02924766|Prednisone|prednisone|mesh-list
65101630|NCT02924766|Abiraterone Acetate|abiraterone acetate|mesh-list
65101631|NCT02924766|Niraparib|niraparib|mesh-list
65101632|NCT02924766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65101633|NCT02924766|Glucocorticoids|glucocorticoids|mesh-ancestor
65101634|NCT02924766|Hormones|hormones|mesh-ancestor
65101635|NCT02924766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65101636|NCT02924766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101637|NCT02924766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65101638|NCT02924766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289422|NCT00720850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289423|NCT00720850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65289424|NCT00720850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65289425|NCT00720850|Growth Substances|growth substances|mesh-ancestor
65289426|NCT00720850|Growth Inhibitors|growth inhibitors|mesh-ancestor
65289427|NCT00720850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289428|NCT05493995|Gemcitabine|gemcitabine|mesh-list
65101639|NCT02924766|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65101644|NCT02924766|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65101645|NCT00528281|Pemetrexed|pemetrexed|mesh-list
65101646|NCT00528281|Lapatinib|lapatinib|mesh-list
65101647|NCT00528281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101648|NCT00528281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101649|NCT00528281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101650|NCT00528281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65101651|NCT00528281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65101652|NCT00528281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65101653|NCT01580501|Sildenafil Citrate|sildenafil citrate|mesh-list
65101654|NCT01580501|Tadalafil|tadalafil|mesh-list
65101655|NCT01580501|Vasodilator Agents|vasodilator agents|mesh-ancestor
65101656|NCT01580501|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65101657|NCT01580501|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65101658|NCT01580501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101659|NCT01580501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101660|NCT01580501|Urological Agents|urological agents|mesh-ancestor
65101661|NCT02924532|Hormones|hormones|mesh-list
65101662|NCT02924532|Parathyroid Hormone|parathyroid hormone|mesh-list
65101663|NCT02924532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65101664|NCT02924532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101665|NCT02924532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65101666|NCT00528359|Olanzapine|olanzapine|mesh-list
65101667|NCT00528359|Risperidone|risperidone|mesh-list
65101668|NCT00528359|Aripiprazole|aripiprazole|mesh-list
65101669|NCT00528359|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65101670|NCT00528359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65101671|NCT00528359|Serotonin Agents|serotonin agents|mesh-ancestor
65101672|NCT00528359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65101673|NCT00528359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101674|NCT00528359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101675|NCT00528359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65101676|NCT00528359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65101677|NCT00528359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65101678|NCT00528359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65101679|NCT00528359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65101680|NCT00528359|Dopamine Agents|dopamine agents|mesh-ancestor
65101681|NCT00528359|Antiemetics|antiemetics|mesh-ancestor
65101682|NCT00528359|Autonomic Agents|autonomic agents|mesh-ancestor
65101683|NCT00528359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65101684|NCT00528359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65101685|NCT00528359|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65101686|NCT00528359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65101687|NCT00528359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65101688|NCT00528359|Antidepressive Agents|antidepressive agents|mesh-ancestor
65101689|NCT00528359|Dopamine Agonists|dopamine agonists|mesh-ancestor
65101690|NCT00528359|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65101691|NCT00528359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65101692|NCT00528359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65101693|NCT00528359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65101694|NCT02924727|Valsartan|valsartan|mesh-list
65101695|NCT02924727|Ramipril|ramipril|mesh-list
65101696|NCT02924727|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65101697|NCT02924727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65101698|NCT02924727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65101699|NCT02924727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65101700|NCT02924727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743935|NCT01852812|Montelukast|montelukast|mesh-list
65289429|NCT05493995|Paclitaxel|paclitaxel|mesh-list
65289430|NCT05493995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65289431|NCT05493995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289432|NCT05493995|Tubulin Modulators|tubulin modulators|mesh-ancestor
65289433|NCT05493995|Antimitotic Agents|antimitotic agents|mesh-ancestor
65289434|NCT05493995|Mitosis Modulators|mitosis modulators|mesh-ancestor
65289435|NCT05493995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101701|NCT02924727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65101702|NCT02924727|Protease Inhibitors|protease inhibitors|mesh-ancestor
65101703|NCT02924727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101704|NCT00527150|Varenicline|varenicline|mesh-list
65101705|NCT00527150|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65101706|NCT00527150|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64674295|NCT03848871|Hormones|hormones|mesh-ancestor
65101720|NCT00527267|Hormone Antagonists|hormone antagonists|mesh-ancestor
65101721|NCT00527267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65101722|NCT02924454|Metoprolol|metoprolol|mesh-list
65101723|NCT02924454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65101724|NCT02924454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65101725|NCT02924454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
65101726|NCT02924454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65101727|NCT02924454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65101728|NCT02924454|Sympatholytics|sympatholytics|mesh-ancestor
65101729|NCT02924454|Autonomic Agents|autonomic agents|mesh-ancestor
65101730|NCT02924454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65101731|NCT02924454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101732|NCT02924454|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65101733|NCT02924454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65101734|NCT02924454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65101735|NCT02924454|Adrenergic Agents|adrenergic agents|mesh-ancestor
65101736|NCT02924454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65101737|NCT02924454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101738|NCT02924454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65101739|NCT02924337|Moxifloxacin|moxifloxacin|mesh-list
65101740|NCT02924337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65101741|NCT02924337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65101742|NCT02924337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65101743|NCT02924337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65101744|NCT02924337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101745|NCT02924337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101746|NCT02924337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101747|NCT00528515|Propofol|propofol|mesh-list
65101748|NCT00528515|Desflurane|desflurane|mesh-list
65101749|NCT00528515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65101750|NCT00528515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65101751|NCT00528515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101752|NCT00528515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65101753|NCT00528515|Anesthetics, General|anesthetics, general|mesh-ancestor
65101754|NCT00528515|Anesthetics|anesthetics|mesh-ancestor
65101755|NCT00528515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65101756|NCT02923986|Dasatinib|dasatinib|mesh-list
65101757|NCT02923986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101758|NCT02923986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65101759|NCT02923986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101760|NCT02923986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101761|NCT02926248|Colchicine|colchicine|mesh-list
65101762|NCT02926248|Gout Suppressants|gout suppressants|mesh-ancestor
65101763|NCT02926248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65101764|NCT02926248|Tubulin Modulators|tubulin modulators|mesh-ancestor
65101765|NCT02926248|Antimitotic Agents|antimitotic agents|mesh-ancestor
65101766|NCT02926248|Mitosis Modulators|mitosis modulators|mesh-ancestor
65101776|NCT02926326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101777|NCT02926326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101779|NCT00528671|Anticoagulants|anticoagulants|mesh-ancestor
65101780|NCT00528827|Nicardipine|nicardipine|mesh-list
65101781|NCT00528827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65101782|NCT00528827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65101783|NCT00528827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65289436|NCT05493995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65289437|NCT05493995|Antimetabolites|antimetabolites|mesh-ancestor
65289438|NCT05493995|Antiviral Agents|antiviral agents|mesh-ancestor
65289439|NCT05493995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65289440|NCT05493995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289441|NCT05493995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65289442|NCT05493995|Immunologic Factors|immunologic factors|mesh-ancestor
65289443|NCT05493995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101784|NCT00528827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101785|NCT00528827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65101786|NCT00528827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101787|NCT00528827|Vasodilator Agents|vasodilator agents|mesh-ancestor
65101788|NCT02926170|Rivaroxaban|rivaroxaban|mesh-list
65101789|NCT02926170|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65101790|NCT02926170|Antithrombins|antithrombins|mesh-ancestor
65101791|NCT02926170|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65101792|NCT02926170|Protease Inhibitors|protease inhibitors|mesh-ancestor
65101793|NCT02926170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101794|NCT02926170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101795|NCT02926170|Anticoagulants|anticoagulants|mesh-ancestor
65101796|NCT04691765|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65101797|NCT04691765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65101798|NCT04691687|Furosemide|furosemide|mesh-list
65101799|NCT04691687|Diuretics|diuretics|mesh-ancestor
65101800|NCT04691687|Natriuretic Agents|natriuretic agents|mesh-ancestor
65101801|NCT04691687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101802|NCT04691687|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65101803|NCT04691687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65101804|NCT04691687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101805|NCT04107675|Cyclosporine|cyclosporine|mesh-list
65101806|NCT04107675|Cyclosporins|cyclosporins|mesh-list
65101807|NCT04107675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101808|NCT04107675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101810|NCT04107675|Immunologic Factors|immunologic factors|mesh-ancestor
65101811|NCT04107675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101812|NCT04107675|Antifungal Agents|antifungal agents|mesh-ancestor
65101813|NCT04107675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65101814|NCT04107675|Dermatologic Agents|dermatologic agents|mesh-ancestor
65101815|NCT04107675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65101816|NCT04107675|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65101817|NCT02923869|Bupivacaine|bupivacaine|mesh-list
65101818|NCT02923869|Levobupivacaine|levobupivacaine|mesh-list
65101819|NCT02923869|Anesthetics, Local|anesthetics, local|mesh-ancestor
65101820|NCT02923869|Anesthetics|anesthetics|mesh-ancestor
65101821|NCT02923869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65101822|NCT02923869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101823|NCT02923869|Sensory System Agents|sensory system agents|mesh-ancestor
65101824|NCT02923869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65101825|NCT02923791|Lenograstim|lenograstim|mesh-list
65101826|NCT02923791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65101827|NCT02923791|Immunologic Factors|immunologic factors|mesh-ancestor
65101828|NCT02923791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101829|NCT00527501|Travoprost|travoprost|mesh-list
65101830|NCT00527501|Brinzolamide|brinzolamide|mesh-list
65101831|NCT00527501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65101832|NCT00527501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65101833|NCT00527501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101838|NCT00527540|Interferon alpha-2|interferon alpha-2|mesh-list
65101839|NCT00527540|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65101840|NCT00527540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101841|NCT00527540|Antiviral Agents|antiviral agents|mesh-ancestor
65101842|NCT00527540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65101843|NCT00527540|Antimetabolites|antimetabolites|mesh-ancestor
65101844|NCT00527540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101845|NCT00527540|Immunologic Factors|immunologic factors|mesh-ancestor
65101846|NCT00527540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101847|NCT02926053|Cyclophosphamide|cyclophosphamide|mesh-list
65039423|NCT00220233|Diuretics|diuretics|mesh-ancestor
65289444|NCT03785158|Melatonin|melatonin|mesh-list
65289445|NCT03785158|Antioxidants|antioxidants|mesh-ancestor
65289446|NCT03785158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289447|NCT03785158|Protective Agents|protective agents|mesh-ancestor
65289448|NCT03785158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289449|NCT03785158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65289450|NCT05116891|Leucovorin|leucovorin|mesh-list
65289451|NCT05116891|Gemcitabine|gemcitabine|mesh-list
65289452|NCT05116891|Cisplatin|cisplatin|mesh-list
65289453|NCT05116891|Docetaxel|docetaxel|mesh-list
65289454|NCT05116891|Fluorouracil|fluorouracil|mesh-list
65289455|NCT05116891|Oxaliplatin|oxaliplatin|mesh-list
65289456|NCT05116891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289457|NCT05116891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65289458|NCT05116891|Antimetabolites|antimetabolites|mesh-ancestor
65289459|NCT05116891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289460|NCT05116891|Antiviral Agents|antiviral agents|mesh-ancestor
65101848|NCT02926053|Fludarabine|fludarabine|mesh-list
65101849|NCT02926053|Interleukin-2|interleukin-2|mesh-list
65101850|NCT02926053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65101851|NCT02926053|Immunologic Factors|immunologic factors|mesh-ancestor
65101852|NCT02926053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101853|NCT02926053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65101854|NCT02926053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65101855|NCT02926053|Alkylating Agents|alkylating agents|mesh-ancestor
65101856|NCT02926053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101857|NCT02926053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101858|NCT02926053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65101859|NCT02926053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65101860|NCT02926053|Analgesics|analgesics|mesh-ancestor
65101861|NCT02926053|Sensory System Agents|sensory system agents|mesh-ancestor
65101862|NCT02926053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65101863|NCT00527657|Thalidomide|thalidomide|mesh-list
65101864|NCT00527657|Temozolomide|temozolomide|mesh-list
65101865|NCT00527657|Lomustine|lomustine|mesh-list
65101866|NCT00527657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65101867|NCT00527657|Alkylating Agents|alkylating agents|mesh-ancestor
65101868|NCT00527657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101869|NCT00527657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101870|NCT00527657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65101871|NCT00527657|Immunologic Factors|immunologic factors|mesh-ancestor
65101872|NCT00527657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101873|NCT00527657|Leprostatic Agents|leprostatic agents|mesh-ancestor
65101874|NCT00527657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65101875|NCT00527657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65101876|NCT00527657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65101877|NCT00527657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65101878|NCT00527657|Growth Substances|growth substances|mesh-ancestor
65101879|NCT00527657|Growth Inhibitors|growth inhibitors|mesh-ancestor
65101880|NCT00528983|Azacitidine|azacitidine|mesh-list
65101881|NCT00528983|Cc-486|cc-486|mesh-list
65101882|NCT00528983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65101883|NCT00528983|Antimetabolites|antimetabolites|mesh-ancestor
65101884|NCT00528983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101885|NCT00528983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101886|NCT00528983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101887|NCT00529022|Carboplatin|carboplatin|mesh-list
65101888|NCT00529022|Azacitidine|azacitidine|mesh-list
65101889|NCT00529022|Valproic Acid|valproic acid|mesh-list
65289461|NCT05116891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65289462|NCT05116891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289463|NCT05116891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65289464|NCT05116891|Immunologic Factors|immunologic factors|mesh-ancestor
65289465|NCT05116891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289466|NCT05116891|Tubulin Modulators|tubulin modulators|mesh-ancestor
65289467|NCT05116891|Antimitotic Agents|antimitotic agents|mesh-ancestor
65289468|NCT05116891|Mitosis Modulators|mitosis modulators|mesh-ancestor
65289469|NCT05116891|Antidotes|antidotes|mesh-ancestor
65289470|NCT05116891|Protective Agents|protective agents|mesh-ancestor
65289471|NCT05116891|Vitamin B Complex|vitamin b complex|mesh-ancestor
65289472|NCT05116891|Vitamins|vitamins|mesh-ancestor
65289473|NCT05116891|Micronutrients|micronutrients|mesh-ancestor
65289474|NCT02739581|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65289475|NCT02739581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65289476|NCT02739581|Adrenergic Agents|adrenergic agents|mesh-ancestor
65289477|NCT02739581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65289478|NCT02739581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289479|NCT02739581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289480|NCT02733809|Sorafenib|sorafenib|mesh-list
65289481|NCT02733809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289482|NCT02733809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65289483|NCT02733809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101890|NCT00529022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101891|NCT00529022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65101892|NCT00529022|Antimetabolites|antimetabolites|mesh-ancestor
65101893|NCT00529022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101894|NCT00529022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101895|NCT00529022|Anticonvulsants|anticonvulsants|mesh-ancestor
65101896|NCT00529022|GABA Agents|gaba agents|mesh-ancestor
65101897|NCT00529022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65101898|NCT00529022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101899|NCT00529022|Antimanic Agents|antimanic agents|mesh-ancestor
65101910|NCT02925975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101911|NCT02925975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101912|NCT02925975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65101914|NCT02925975|Protective Agents|protective agents|mesh-ancestor
65101915|NCT02925975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65101916|NCT02925975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65101917|NCT02925975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65101918|NCT02925975|Vasodilator Agents|vasodilator agents|mesh-ancestor
65101919|NCT02925975|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65101920|NCT02925975|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65101921|NCT02945033|Aspirin|aspirin|mesh-list
65101922|NCT02945033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65101923|NCT02945033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65101924|NCT02945033|Analgesics|analgesics|mesh-ancestor
65101925|NCT02945033|Sensory System Agents|sensory system agents|mesh-ancestor
64744165|NCT01844700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65101926|NCT02945033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65101927|NCT02945033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289484|NCT02733809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289485|NCT00717340|Paclitaxel|paclitaxel|mesh-list
65289486|NCT00717340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65289487|NCT00717340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289488|NCT00717340|Tubulin Modulators|tubulin modulators|mesh-ancestor
65289489|NCT00717340|Antimitotic Agents|antimitotic agents|mesh-ancestor
65289490|NCT00717340|Mitosis Modulators|mitosis modulators|mesh-ancestor
64519724|NCT03225924|Prednisone|prednisone|mesh-list
65101928|NCT02945033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65101929|NCT02945033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65101930|NCT02945033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65101931|NCT02945033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65101932|NCT02945033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101933|NCT02945033|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65101934|NCT02945033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65101935|NCT02945033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101936|NCT02945033|Antipyretics|antipyretics|mesh-ancestor
65101937|NCT04231968|Ziresovir|ziresovir|mesh-list
65101938|NCT04231968|Antiviral Agents|antiviral agents|mesh-ancestor
65101939|NCT04231968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65101940|NCT00529295|Misoprostol|misoprostol|mesh-list
65101941|NCT00529295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65101942|NCT00529295|Abortifacient Agents|abortifacient agents|mesh-ancestor
65101943|NCT00529295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65101944|NCT00529295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101945|NCT00529295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65101946|NCT00529295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65101947|NCT00529295|Oxytocics|oxytocics|mesh-ancestor
65101948|NCT02922933|Entinostat|entinostat|mesh-list
64674567|NCT02301390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65101972|NCT00529646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65101973|NCT00529646|Serotonin Agents|serotonin agents|mesh-ancestor
65101974|NCT00529646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65101975|NCT00529646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101976|NCT00529646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101977|NCT00527930|Oxaliplatin|oxaliplatin|mesh-list
65101978|NCT00527930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101979|NCT00529841|Hydrocortisone|hydrocortisone|mesh-list
65101980|NCT00529841|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65101981|NCT00529841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65101982|NCT00529880|Cytarabine|cytarabine|mesh-list
65101983|NCT00529880|Fludarabine|fludarabine|mesh-list
65101984|NCT00529880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101985|NCT00529880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65101986|NCT00529880|Antimetabolites|antimetabolites|mesh-ancestor
65101987|NCT00529880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101988|NCT00529880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65101989|NCT00529880|Immunologic Factors|immunologic factors|mesh-ancestor
65101990|NCT00529880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101991|NCT00529880|Antiviral Agents|antiviral agents|mesh-ancestor
65101992|NCT00529880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65101993|NCT02925702|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65101994|NCT02925702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101995|NCT00531089|Rituximab|rituximab|mesh-list
65102013|NCT02922660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65102014|NCT02922660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65102015|NCT02922660|Anesthetics, General|anesthetics, general|mesh-ancestor
65102016|NCT02922660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65102017|NCT02922660|Narcotics|narcotics|mesh-ancestor
65102018|NCT02922660|Analgesics|analgesics|mesh-ancestor
65102019|NCT02922660|Sensory System Agents|sensory system agents|mesh-ancestor
65102020|NCT02922660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65102021|NCT02922660|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65102022|NCT02922465|Clopidogrel|clopidogrel|mesh-list
65102023|NCT02922465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65102024|NCT02922465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65102025|NCT02922465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65102026|NCT02922465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65289491|NCT00717340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289492|NCT02733887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65289493|NCT02733887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65289494|NCT02733887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289495|NCT00874848|Paclitaxel|paclitaxel|mesh-list
65289496|NCT00874848|Carboplatin|carboplatin|mesh-list
65289497|NCT00874848|Cetuximab|cetuximab|mesh-list
65289498|NCT00874848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65289499|NCT00874848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65289500|NCT00874848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289501|NCT00874848|Tubulin Modulators|tubulin modulators|mesh-ancestor
65289502|NCT00874848|Antimitotic Agents|antimitotic agents|mesh-ancestor
65289503|NCT00874848|Mitosis Modulators|mitosis modulators|mesh-ancestor
65289504|NCT00874848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289505|NCT00874848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65289506|NCT04912063|Azacitidine|azacitidine|mesh-list
65289507|NCT04912063|Venetoclax|venetoclax|mesh-list
65289508|NCT04912063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65289509|NCT04912063|Antimetabolites|antimetabolites|mesh-ancestor
65289510|NCT04912063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289511|NCT04912063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289512|NCT04912063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289513|NCT00691236|Zoledronic Acid|zoledronic acid|mesh-list
65289514|NCT00691236|Doxorubicin|doxorubicin|mesh-list
65289515|NCT00691236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65289516|NCT00691236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289517|NCT00691236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65289518|NCT00691236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65289519|NCT00691236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289520|NCT00691236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289521|NCT00691236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65289534|NCT05408065|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65289535|NCT05408065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65289536|NCT05408065|Glucocorticoids|glucocorticoids|mesh-ancestor
65289537|NCT05408065|Hormones|hormones|mesh-ancestor
65289538|NCT05408065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65289539|NCT05408065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102027|NCT02922465|Purinergic Agents|purinergic agents|mesh-ancestor
65102028|NCT02922465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65102029|NCT02922465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102030|NCT02922465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102031|NCT02944292|Propofol|propofol|mesh-list
65102032|NCT02944292|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65102033|NCT02944292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65102034|NCT02944292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102035|NCT02944292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65102037|NCT02944292|Anesthetics|anesthetics|mesh-ancestor
65102038|NCT02922426|Olanzapine|olanzapine|mesh-list
65102039|NCT02922426|Antiemetics|antiemetics|mesh-ancestor
65102040|NCT02922426|Autonomic Agents|autonomic agents|mesh-ancestor
65102041|NCT02922426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65102042|NCT02922426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102043|NCT02922426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65102044|NCT02922426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65102045|NCT02922426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65102046|NCT02922426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65102047|NCT02922426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65102048|NCT02922426|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65102049|NCT02922426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64674645|NCT03997851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65102060|NCT02925351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65102061|NCT02925351|Antimetabolites|antimetabolites|mesh-ancestor
65102062|NCT02925351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102063|NCT02925351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102065|NCT00531167|Adefovir|adefovir|mesh-list
65102066|NCT00531167|Entecavir|entecavir|mesh-list
65102067|NCT00531167|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65102068|NCT00531167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65102069|NCT00531167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102070|NCT00531167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102071|NCT00531167|Antiviral Agents|antiviral agents|mesh-ancestor
65102072|NCT00531167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65102073|NCT00531167|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65102074|NCT00531167|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65102075|NCT02922192|Antirheumatic Agents|antirheumatic agents|mesh-list
65102076|NCT02944214|Febuxostat|febuxostat|mesh-list
65102077|NCT02944214|Benzbromarone|benzbromarone|mesh-list
65102078|NCT02944214|Gout Suppressants|gout suppressants|mesh-ancestor
65102079|NCT02944214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65102080|NCT02944214|Uricosuric Agents|uricosuric agents|mesh-ancestor
65102081|NCT02944214|Renal Agents|renal agents|mesh-ancestor
65102082|NCT02922075|Amoxicillin|amoxicillin|mesh-list
65102083|NCT02922075|Chlorhexidine|chlorhexidine|mesh-list
65102084|NCT02922075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65102085|NCT02922075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65102086|NCT02922075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65102087|NCT02922075|Disinfectants|disinfectants|mesh-ancestor
65102088|NCT00531245|Oxaliplatin|oxaliplatin|mesh-list
65102089|NCT00531245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102090|NCT02922348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65102091|NCT02922348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65102092|NCT02922348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65102093|NCT02922348|Medroxyprogesterone|medroxyprogesterone|mesh-list
65102094|NCT02922348|Norgestimate|norgestimate|mesh-list
65102095|NCT02922348|Contraceptive Agents|contraceptive agents|mesh-list
65102096|NCT02922348|Contraceptives, Oral|contraceptives, oral|mesh-list
65102097|NCT02922348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65102098|NCT02922348|Hormones|hormones|mesh-list
65102099|NCT02922348|Estradiol|estradiol|mesh-list
65102100|NCT02922348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65102101|NCT02922348|Progestins|progestins|mesh-list
65222803|NCT04215159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65289540|NCT05408065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65289541|NCT05408065|Immunologic Factors|immunologic factors|mesh-ancestor
65289542|NCT05408065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289543|NCT05408065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289544|NCT05408065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65289545|NCT05408065|Viscosupplements|viscosupplements|mesh-ancestor
65289546|NCT05408065|Protective Agents|protective agents|mesh-ancestor
65289547|NCT00691392|Linezolid|linezolid|mesh-list
65289548|NCT00691392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65289549|NCT00691392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65289550|NCT00691392|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65289551|NCT00691392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289552|NCT00691392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289553|NCT02625168|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65289554|NCT02625168|Afatinib|afatinib|mesh-list
65289555|NCT02625168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289556|NCT02625168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65289557|NCT02625168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289558|NCT02625168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289559|NCT00717730|Vitamins|vitamins|mesh-list
65289560|NCT00717730|Folic Acid|folic acid|mesh-list
64519780|NCT02051452|Dopamine Agents|dopamine agents|mesh-ancestor
65102102|NCT02922348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65102103|NCT02922348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102104|NCT02922348|Estrogens|estrogens|mesh-ancestor
65102105|NCT02922348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65102106|NCT02922348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65102107|NCT02922348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64634905|NCT00004984|Insulin|insulin|mesh-list
65102108|NCT02922348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65102109|NCT02922348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65102111|NCT02922387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65102112|NCT02922387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65102113|NCT02922387|Cholinergic Agents|cholinergic agents|mesh-ancestor
65102114|NCT02922387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65102115|NCT02922387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102118|NCT00531323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65102119|NCT00531323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65102120|NCT00531323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102121|NCT00531323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102122|NCT00531323|Antiviral Agents|antiviral agents|mesh-ancestor
65102123|NCT00531323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65102124|NCT00531362|Aspirin|aspirin|mesh-list
65102125|NCT00531362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65102126|NCT00531362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65102127|NCT00531362|Analgesics|analgesics|mesh-ancestor
65102128|NCT00531362|Sensory System Agents|sensory system agents|mesh-ancestor
65102129|NCT00531362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65102130|NCT00531362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102131|NCT00531362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65102132|NCT00531362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65289561|NCT00717730|Hydroxocobalamin|hydroxocobalamin|mesh-list
65289562|NCT00717730|Vitamin B 12|vitamin b 12|mesh-list
65289563|NCT00717730|Vitamin B Complex|vitamin b complex|mesh-list
65289564|NCT00717730|Micronutrients|micronutrients|mesh-ancestor
65289565|NCT00717730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289566|NCT00717730|Hematinics|hematinics|mesh-ancestor
65289567|NCT00691470|Warfarin|warfarin|mesh-list
65289568|NCT00691470|Anticoagulants|anticoagulants|mesh-ancestor
65289569|NCT05407597|Icatibant|icatibant|mesh-list
65289570|NCT05407597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65289571|NCT05407597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65289572|NCT05407597|Analgesics|analgesics|mesh-ancestor
65289573|NCT05407597|Sensory System Agents|sensory system agents|mesh-ancestor
65289574|NCT05407597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65289575|NCT05407597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289576|NCT05407597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65289577|NCT05407597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65289578|NCT05407597|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
65289579|NCT05407597|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
65289580|NCT05407597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289581|NCT05407597|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65289582|NCT05407597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65289583|NCT05407597|Immunologic Factors|immunologic factors|mesh-ancestor
65289584|NCT05407207|Immunologic Factors|immunologic factors|mesh-list
65289585|NCT05407207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289586|NCT00717808|Tranilast|tranilast|mesh-list
65289587|NCT00717808|Anthranilic acid|anthranilic acid|mesh-list
65289588|NCT00717808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65289589|NCT00717808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65289590|NCT00717808|Analgesics|analgesics|mesh-ancestor
65289591|NCT00717808|Sensory System Agents|sensory system agents|mesh-ancestor
64519805|NCT02384200|Ampicillin|ampicillin|mesh-list
65102133|NCT00531362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65102134|NCT00531362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65102135|NCT00531362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102136|NCT00531362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65102137|NCT00531362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65102138|NCT00531362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102139|NCT00531362|Antipyretics|antipyretics|mesh-ancestor
65102140|NCT00531401|Farnesylthiosalicylic acid|farnesylthiosalicylic acid|mesh-list
65102141|NCT00531401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102142|NCT00531401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102143|NCT00531401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289592|NCT00717808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65289593|NCT00717808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289594|NCT00717808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65039571|NCT00220350|Leuprolide|leuprolide|mesh-list
65289595|NCT00717808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65289596|NCT00717808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65289597|NCT00717808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65102144|NCT00531440|Everolimus|everolimus|mesh-list
65102145|NCT00531440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102146|NCT00531440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65102147|NCT00531440|Immunologic Factors|immunologic factors|mesh-ancestor
65102148|NCT00531440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102149|NCT02944526|Ropivacaine|ropivacaine|mesh-list
65102150|NCT02944526|Anesthetics, Local|anesthetics, local|mesh-ancestor
65102151|NCT02944526|Anesthetics|anesthetics|mesh-ancestor
65102152|NCT02944526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65102153|NCT02944526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102154|NCT02944526|Sensory System Agents|sensory system agents|mesh-ancestor
65102155|NCT02944526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65102156|NCT04000854|Calcium|calcium|mesh-list
65102157|NCT04000854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65102158|NCT04000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102159|NCT00530387|Ibuprofen|ibuprofen|mesh-list
65102160|NCT00530387|Diclofenac|diclofenac|mesh-list
65102161|NCT00530387|Ketoprofen|ketoprofen|mesh-list
65102162|NCT00530387|Piroxicam|piroxicam|mesh-list
65102163|NCT00530387|Salicylates|salicylates|mesh-list
65102164|NCT00530387|Etofenamate|etofenamate|mesh-list
65102165|NCT00530387|Sunscreening Agents|sunscreening agents|mesh-list
65102166|NCT00530387|Homosalate|homosalate|mesh-list
65102167|NCT00530387|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
65102168|NCT00530387|Benzophenone|benzophenone|mesh-list
65102169|NCT00530387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65102170|NCT00530387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65102171|NCT00530387|Analgesics|analgesics|mesh-ancestor
65102201|NCT02944175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65102203|NCT02917746|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65102204|NCT02917746|Immunologic Factors|immunologic factors|mesh-ancestor
65102205|NCT02917746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102206|NCT02917746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102207|NCT02917746|Interferon Inducers|interferon inducers|mesh-ancestor
65102208|NCT00531557|Ritonavir|ritonavir|mesh-list
65102209|NCT00531557|Darunavir|darunavir|mesh-list
65102210|NCT00531557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65102211|NCT00531557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65102212|NCT00531557|Protease Inhibitors|protease inhibitors|mesh-ancestor
65102213|NCT00531557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102214|NCT00531557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102215|NCT00531557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65102218|NCT00531557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65102219|NCT00531557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65102220|NCT00531557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65102221|NCT00531596|Selegiline|selegiline|mesh-list
65102222|NCT00531596|Antidepressive Agents|antidepressive agents|mesh-ancestor
65102223|NCT00531596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65102224|NCT00531596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65102225|NCT00531596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65102226|NCT00531596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65102227|NCT00531596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102228|NCT00531596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102229|NCT00531596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65102230|NCT00531596|Protective Agents|protective agents|mesh-ancestor
65102231|NCT00531596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102232|NCT02943707|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65102233|NCT02943707|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65102234|NCT02943707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65102235|NCT00531635|Mycophenolic Acid|mycophenolic acid|mesh-list
65102236|NCT00531635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65102237|NCT00531635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102238|NCT00531635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65289598|NCT00717808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289599|NCT00717808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65289601|NCT00717808|Histamine Antagonists|histamine antagonists|mesh-ancestor
65289602|NCT00717808|Histamine Agents|histamine agents|mesh-ancestor
65289603|NCT00717808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64519840|NCT00183339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65102239|NCT00531635|Antitubercular Agents|antitubercular agents|mesh-ancestor
65102240|NCT00531635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65102241|NCT00531635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65102242|NCT00531635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102243|NCT00531635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102244|NCT02917551|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65102245|NCT02917551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65102246|NCT02917551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65102247|NCT02917551|Antitubercular Agents|antitubercular agents|mesh-ancestor
65102248|NCT00531674|Tocopherols|tocopherols|mesh-list
65102249|NCT00531674|Antioxidants|antioxidants|mesh-ancestor
65102250|NCT00531674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102251|NCT00531674|Protective Agents|protective agents|mesh-ancestor
65102252|NCT00531674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102254|NCT00531674|Micronutrients|micronutrients|mesh-ancestor
65102255|NCT00530972|Ribavirin|ribavirin|mesh-list
65102256|NCT00530972|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65102257|NCT00530972|Antimetabolites|antimetabolites|mesh-ancestor
65102258|NCT00530972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102259|NCT00530972|Antiviral Agents|antiviral agents|mesh-ancestor
65102260|NCT00530972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65102261|NCT02943317|Avelumab|avelumab|mesh-list
65102262|NCT02943317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65102263|NCT02943317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102264|NCT02943356|Tadalafil|tadalafil|mesh-list
65102265|NCT02943356|Vasodilator Agents|vasodilator agents|mesh-ancestor
65102266|NCT02943356|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65102267|NCT02943356|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65102268|NCT02943356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102269|NCT02943356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102270|NCT02943356|Urological Agents|urological agents|mesh-ancestor
65102271|NCT02917512|Cyclosporine|cyclosporine|mesh-list
65102272|NCT02917512|Cyclosporins|cyclosporins|mesh-list
65102273|NCT02917512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102286|NCT02943902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102288|NCT00531908|Diuretics|diuretics|mesh-ancestor
65102289|NCT00531908|Natriuretic Agents|natriuretic agents|mesh-ancestor
65102290|NCT00531908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102291|NCT00531908|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65102292|NCT00531908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65102293|NCT00531908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102294|NCT03403569|Triptolide|triptolide|mesh-list
65102295|NCT03403569|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
65102296|NCT03403569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102297|NCT03403569|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65102298|NCT03403569|Contraceptive Agents|contraceptive agents|mesh-ancestor
65102299|NCT03403569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65102300|NCT03403569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65102301|NCT03403569|Immunologic Factors|immunologic factors|mesh-ancestor
65102302|NCT03403569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65102303|NCT03403569|Alkylating Agents|alkylating agents|mesh-ancestor
65102304|NCT03403569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102305|NCT03403569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102307|NCT00531791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65102308|NCT00531791|Glucocorticoids|glucocorticoids|mesh-ancestor
65102309|NCT00531791|Hormones|hormones|mesh-ancestor
65102310|NCT00531791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65102311|NCT00531791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102312|NCT00531791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65102313|NCT00531791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289604|NCT00717808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65289605|NCT00717808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65289606|NCT00717808|Anticonvulsants|anticonvulsants|mesh-ancestor
65289607|NCT02738177|Isosorbide|isosorbide|mesh-list
65289608|NCT02738177|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65289609|NCT02738177|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65289610|NCT02738177|Misoprostol|misoprostol|mesh-list
65289611|NCT02738177|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65289612|NCT02738177|Abortifacient Agents|abortifacient agents|mesh-ancestor
65102314|NCT02921178|Omalizumab|omalizumab|mesh-list
65102315|NCT02921178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65102316|NCT02921178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65102317|NCT02921178|Respiratory System Agents|respiratory system agents|mesh-ancestor
65102318|NCT00531986|Lopinavir|lopinavir|mesh-list
65102319|NCT00531986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65102320|NCT00531986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64674903|NCT01882868|Vitamins|vitamins|mesh-ancestor
65102346|NCT05319899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65102347|NCT05319899|Growth Substances|growth substances|mesh-ancestor
65102348|NCT05319899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102349|NCT05319899|Growth Inhibitors|growth inhibitors|mesh-ancestor
65102350|NCT05319899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102351|NCT02920827|Dapivirine|dapivirine|mesh-list
65102352|NCT02920827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65102353|NCT02920827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65102354|NCT02920827|Antiviral Agents|antiviral agents|mesh-ancestor
65102355|NCT02920827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65102356|NCT02942888|Niacinamide|niacinamide|mesh-list
65102357|NCT02942888|Niacin|niacin|mesh-list
65102358|NCT02942888|Nicotinic Acids|nicotinic acids|mesh-list
65102359|NCT02942888|Vitamin B Complex|vitamin b complex|mesh-ancestor
65102360|NCT02942888|Vitamins|vitamins|mesh-ancestor
65102361|NCT02942888|Micronutrients|micronutrients|mesh-ancestor
65102362|NCT02942888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102363|NCT02942888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65102364|NCT02942888|Antimetabolites|antimetabolites|mesh-ancestor
65102365|NCT02942888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102366|NCT02942888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65102367|NCT02942888|Vasodilator Agents|vasodilator agents|mesh-ancestor
65102368|NCT02920905|Lidocaine|lidocaine|mesh-list
65102389|NCT02917200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65102390|NCT02917200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65102391|NCT02917200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65102392|NCT02917200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65102394|NCT02917200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102395|NCT02917200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102396|NCT02920515|Leuprolide|leuprolide|mesh-list
65102397|NCT02920515|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65102398|NCT02920515|Fertility Agents|fertility agents|mesh-ancestor
65102399|NCT02920515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65102400|NCT02920515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102401|NCT02920515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65102402|NCT02920515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102403|NCT02917005|Palbociclib|palbociclib|mesh-list
65102404|NCT02917005|Exemestane|exemestane|mesh-list
65102405|NCT02917005|Goserelin|goserelin|mesh-list
65102406|NCT02917005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102407|NCT02917005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65102408|NCT02917005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102409|NCT02917005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102410|NCT02917005|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65102411|NCT02917005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65102412|NCT02917005|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65102413|NCT02917005|Hormone Antagonists|hormone antagonists|mesh-ancestor
65102414|NCT02917005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65102415|NCT02917005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102416|NCT02917005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65102417|NCT02942810|Cefepime|cefepime|mesh-list
65102418|NCT02942810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65289613|NCT02738177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65289614|NCT02738177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289615|NCT02738177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65289616|NCT02738177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65289617|NCT02738177|Oxytocics|oxytocics|mesh-ancestor
65289618|NCT02738177|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65289619|NCT02738177|Diuretics|diuretics|mesh-ancestor
65289620|NCT02738177|Natriuretic Agents|natriuretic agents|mesh-ancestor
65289621|NCT02738177|Vasodilator Agents|vasodilator agents|mesh-ancestor
65289622|NCT02738177|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65289623|NCT02738177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289624|NCT04043806|Ivacaftor|ivacaftor|mesh-list
65289625|NCT04043806|Elexacaftor|elexacaftor|mesh-list
65289626|NCT04043806|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65289627|NCT04043806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65289628|NCT04043806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289629|NCT02737943|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65289630|NCT02737943|Analgesics|analgesics|mesh-list
65289631|NCT02737943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65289632|NCT02737943|Sensory System Agents|sensory system agents|mesh-ancestor
65289633|NCT02737943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65289634|NCT02737943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289635|NCT05290753|Erythromycin|erythromycin|mesh-list
65289636|NCT05290753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65289637|NCT05290753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65289638|NCT05290753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65289639|NCT05290753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65289640|NCT05290753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102430|NCT02941913|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65102431|NCT02941913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65102432|NCT02941913|Serotonin Agents|serotonin agents|mesh-ancestor
65102433|NCT02941913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65102434|NCT02941913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102436|NCT02942693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102437|NCT02942693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65102438|NCT02942693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102439|NCT02942693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102440|NCT02920593|Vitamin D|vitamin d|mesh-list
65102441|NCT02920593|Ergocalciferols|ergocalciferols|mesh-list
65102442|NCT02920593|Cholecalciferol|cholecalciferol|mesh-list
65102443|NCT02920593|Vitamins|vitamins|mesh-list
65102444|NCT02920593|Micronutrients|micronutrients|mesh-ancestor
65102445|NCT02920593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102446|NCT02920593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65102447|NCT02920593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65102448|NCT02942732|Cholecalciferol|cholecalciferol|mesh-list
65102449|NCT02942732|Vitamin D|vitamin d|mesh-list
65289641|NCT05290753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289642|NCT02737709|Paclitaxel|paclitaxel|mesh-list
65289643|NCT02737709|Carboplatin|carboplatin|mesh-list
65289644|NCT02737709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65289645|NCT02737709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289646|NCT02737709|Tubulin Modulators|tubulin modulators|mesh-ancestor
65289647|NCT02737709|Antimitotic Agents|antimitotic agents|mesh-ancestor
65289648|NCT02737709|Mitosis Modulators|mitosis modulators|mesh-ancestor
65289649|NCT02737709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289650|NCT02572960|Vitamin D|vitamin d|mesh-list
65289651|NCT02572960|Cholecalciferol|cholecalciferol|mesh-list
65289652|NCT02572960|Valsartan|valsartan|mesh-list
65289653|NCT02572960|Vitamins|vitamins|mesh-ancestor
65289654|NCT02572960|Micronutrients|micronutrients|mesh-ancestor
65289655|NCT02572960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289656|NCT02572960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65289657|NCT02572960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65289658|NCT02572960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65289659|NCT02572960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64519884|NCT01742897|Anesthetics|anesthetics|mesh-ancestor
65102450|NCT02942732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65102451|NCT02942732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102452|NCT02942732|Vitamins|vitamins|mesh-ancestor
65102453|NCT02942732|Micronutrients|micronutrients|mesh-ancestor
65102454|NCT02942732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64744692|NCT01810380|Serotonin Agents|serotonin agents|mesh-ancestor
65102456|NCT02942420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65102457|NCT02942420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65102458|NCT02942420|Analgesics|analgesics|mesh-ancestor
65102459|NCT02942420|Sensory System Agents|sensory system agents|mesh-ancestor
65102460|NCT02942420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65102461|NCT02942420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102462|NCT02942420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65102463|NCT02942420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65102464|NCT02942420|Antioxidants|antioxidants|mesh-ancestor
65102465|NCT02942420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102466|NCT02942420|Protective Agents|protective agents|mesh-ancestor
65102467|NCT02920359|Leuprolide|leuprolide|mesh-list
65102468|NCT02920359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64675036|NCT01280643|Leucovorin|leucovorin|mesh-list
65102481|NCT02941562|Antimetabolites|antimetabolites|mesh-ancestor
65102482|NCT02941562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102483|NCT02941562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65102484|NCT02941562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102485|NCT02941562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65102486|NCT02941562|Immunologic Factors|immunologic factors|mesh-ancestor
65102487|NCT02941562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102488|NCT02941562|Antidotes|antidotes|mesh-ancestor
65102489|NCT02941562|Protective Agents|protective agents|mesh-ancestor
65102490|NCT02941562|Vitamin B Complex|vitamin b complex|mesh-ancestor
65102491|NCT02941562|Vitamins|vitamins|mesh-ancestor
65102492|NCT02941562|Micronutrients|micronutrients|mesh-ancestor
65102493|NCT02916420|Dexamethasone|dexamethasone|mesh-list
65102494|NCT02916420|Pomalidomide|pomalidomide|mesh-list
65102495|NCT02916420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65102496|NCT02916420|Antiemetics|antiemetics|mesh-ancestor
65289660|NCT02572960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65289661|NCT02572960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289662|NCT04001959|Fluorides|fluorides|mesh-list
65289663|NCT04001959|Cariostatic Agents|cariostatic agents|mesh-ancestor
65289664|NCT04001959|Protective Agents|protective agents|mesh-ancestor
65289665|NCT04001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289666|NCT00721240|Montelukast|montelukast|mesh-list
65289667|NCT00721240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65289668|NCT00721240|Respiratory System Agents|respiratory system agents|mesh-ancestor
65289669|NCT00721240|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65289670|NCT00721240|Hormone Antagonists|hormone antagonists|mesh-ancestor
65289671|NCT00721240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65289672|NCT00721240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289673|NCT00721240|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65289674|NCT00721240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65289675|NCT00721240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289676|NCT02737319|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64519905|NCT02387554|Losartan|losartan|mesh-list
65102497|NCT02916420|Autonomic Agents|autonomic agents|mesh-ancestor
65102498|NCT02916420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65102499|NCT02916420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102500|NCT02916420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65102501|NCT02916420|Glucocorticoids|glucocorticoids|mesh-ancestor
65102502|NCT02916420|Hormones|hormones|mesh-ancestor
65102503|NCT02916420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65102504|NCT02916420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65102505|NCT02916420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102506|NCT02916420|Immunologic Factors|immunologic factors|mesh-ancestor
65102507|NCT02916420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65102508|NCT02916420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65102509|NCT02916420|Growth Substances|growth substances|mesh-ancestor
65102510|NCT02916420|Growth Inhibitors|growth inhibitors|mesh-ancestor
65102511|NCT02942381|Hydroxychloroquine|hydroxychloroquine|mesh-list
65102512|NCT02942381|Antimalarials|antimalarials|mesh-ancestor
65102513|NCT02942381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65102514|NCT02942381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65102515|NCT02942381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65102516|NCT02942381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102517|NCT02942381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102518|NCT02942381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65102519|NCT03458468|Tranexamic Acid|tranexamic acid|mesh-list
65102520|NCT03458468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65102521|NCT03458468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65102522|NCT03458468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675083|NCT02640573|Antisickling Agents|antisickling agents|mesh-ancestor
65102547|NCT02941016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102549|NCT03200379|Antiviral Agents|antiviral agents|mesh-list
65102550|NCT03200379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65102551|NCT02919735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65102552|NCT02941445|Metformin|metformin|mesh-list
65102553|NCT02941445|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65102554|NCT02941445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65102555|NCT02941445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102556|NCT02941445|Incretins|incretins|mesh-ancestor
65289677|NCT02737319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65289678|NCT02737319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65289679|NCT02737319|Antimetabolites|antimetabolites|mesh-ancestor
65289680|NCT02737319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289681|NCT02737319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65289682|NCT02737319|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65289683|NCT02737319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289684|NCT05624957|Lidocaine|lidocaine|mesh-list
65289685|NCT05624957|Epinephrine|epinephrine|mesh-list
65289686|NCT05624957|Racepinephrine|racepinephrine|mesh-list
65289687|NCT05624957|Epinephryl borate|epinephryl borate|mesh-list
65289688|NCT05624957|Anesthetics, Local|anesthetics, local|mesh-ancestor
65289689|NCT05624957|Anesthetics|anesthetics|mesh-ancestor
65289690|NCT05624957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65289691|NCT05624957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289692|NCT05624957|Sensory System Agents|sensory system agents|mesh-ancestor
65289693|NCT05624957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65289694|NCT05624957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65289695|NCT05624957|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65289696|NCT05624957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65289697|NCT05624957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65289698|NCT05624957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289699|NCT05624957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65289700|NCT05624957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65289701|NCT05624957|Adrenergic Agents|adrenergic agents|mesh-ancestor
65289702|NCT05624957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64519918|NCT02387554|Diuretics|diuretics|mesh-ancestor
65102557|NCT02941445|Hormones|hormones|mesh-ancestor
65102558|NCT02941445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65102559|NCT02941445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65102560|NCT02941445|Protease Inhibitors|protease inhibitors|mesh-ancestor
65102561|NCT02941445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102562|NCT02941445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102563|NCT02919501|Vortioxetine|vortioxetine|mesh-list
65102564|NCT02919501|Antidepressive Agents|antidepressive agents|mesh-ancestor
65102565|NCT02919501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65102566|NCT02919501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65102567|NCT02919501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65102568|NCT02919501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65102569|NCT02919501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102570|NCT02919501|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65102571|NCT02919501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65102586|NCT05317676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65102587|NCT05317676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222805|NCT04965493|Venetoclax|venetoclax|mesh-list
65289703|NCT05624957|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65289704|NCT05624957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65289705|NCT05624957|Autonomic Agents|autonomic agents|mesh-ancestor
65289706|NCT05624957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65289707|NCT05624957|Respiratory System Agents|respiratory system agents|mesh-ancestor
65289708|NCT05624957|Mydriatics|mydriatics|mesh-ancestor
65289709|NCT05624957|Sympathomimetics|sympathomimetics|mesh-ancestor
65289710|NCT05624957|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65289711|NCT00721552|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65289712|NCT00721552|Prednisolone|prednisolone|mesh-list
65289713|NCT00721552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65289714|NCT00721552|Methylprednisolone|methylprednisolone|mesh-list
65289715|NCT00721552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65289716|NCT00721552|Prednisolone acetate|prednisolone acetate|mesh-list
65289717|NCT00721552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65289718|NCT00721552|Prednisolone phosphate|prednisolone phosphate|mesh-list
65289719|NCT00721552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65289720|NCT00721552|Glucocorticoids|glucocorticoids|mesh-ancestor
65289721|NCT00721552|Hormones|hormones|mesh-ancestor
64519946|NCT01740323|Curcumin|curcumin|mesh-list
65102588|NCT05317676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65102589|NCT05317676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65102590|NCT05317676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65102591|NCT05317676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65102592|NCT05317676|Antiviral Agents|antiviral agents|mesh-ancestor
65102593|NCT05317676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65102594|NCT05317676|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65102595|NCT05317676|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65102596|NCT05317676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65102597|NCT05317676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102598|NCT05317676|Hormones|hormones|mesh-ancestor
65102599|NCT05317676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65102600|NCT02940821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65102601|NCT02940821|Fluorides|fluorides|mesh-list
65102602|NCT02940821|Tin Fluorides|tin fluorides|mesh-list
65102603|NCT02940821|Fluorophosphate|fluorophosphate|mesh-list
65102604|NCT02940821|Cariostatic Agents|cariostatic agents|mesh-ancestor
65102605|NCT02940821|Protective Agents|protective agents|mesh-ancestor
65102606|NCT02940821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102607|NCT02940821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65102608|NCT02940821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65102609|NCT02941601|Gemcitabine|gemcitabine|mesh-list
65102610|NCT02941601|Carboplatin|carboplatin|mesh-list
65102611|NCT02941601|Necitumumab|necitumumab|mesh-list
65102612|NCT02941601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102613|NCT02941601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65102614|NCT02941601|Antimetabolites|antimetabolites|mesh-ancestor
65102615|NCT02941601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102616|NCT02941601|Antiviral Agents|antiviral agents|mesh-ancestor
65102617|NCT02941601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65102618|NCT02941601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102619|NCT02941601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65102620|NCT02941601|Immunologic Factors|immunologic factors|mesh-ancestor
65102621|NCT02941601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102622|NCT02941601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65102623|NCT03160638|Azithromycin|azithromycin|mesh-list
65102634|NCT02919462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65102635|NCT02919462|Tubulin Modulators|tubulin modulators|mesh-ancestor
65289722|NCT00721552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65289723|NCT00721552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289724|NCT00721552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65289725|NCT00721552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289726|NCT00721552|Antiemetics|antiemetics|mesh-ancestor
65289727|NCT00721552|Autonomic Agents|autonomic agents|mesh-ancestor
65289728|NCT00721552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65289729|NCT00721552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65289730|NCT00721552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65289731|NCT00721552|Protective Agents|protective agents|mesh-ancestor
65289732|NCT00721552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65289733|NCT00721552|Incretins|incretins|mesh-ancestor
65289734|NCT00721552|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65289735|NCT00721552|Protease Inhibitors|protease inhibitors|mesh-ancestor
65289736|NCT00721552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289737|NCT00721552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289738|NCT04069078|Scopolamine|scopolamine|mesh-list
65289739|NCT04069078|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65289740|NCT04069078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65289741|NCT04069078|Antiemetics|antiemetics|mesh-ancestor
65289742|NCT04069078|Autonomic Agents|autonomic agents|mesh-ancestor
65289743|NCT04069078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65289744|NCT04069078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289745|NCT04069078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65102636|NCT02919462|Antimitotic Agents|antimitotic agents|mesh-ancestor
65102637|NCT02919462|Mitosis Modulators|mitosis modulators|mesh-ancestor
65102639|NCT02941367|Lixisenatide|lixisenatide|mesh-list
65102640|NCT02941367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65102641|NCT02941367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102642|NCT03153150|Warfarin|warfarin|mesh-list
65102643|NCT03153150|Rivaroxaban|rivaroxaban|mesh-list
65102644|NCT03153150|Dabigatran|dabigatran|mesh-list
65102645|NCT03153150|Apixaban|apixaban|mesh-list
65102646|NCT03153150|Edoxaban|edoxaban|mesh-list
65102647|NCT03153150|Acenocoumarol|acenocoumarol|mesh-list
65102648|NCT03153150|Phenindione|phenindione|mesh-list
65102649|NCT03153150|Anticoagulants|anticoagulants|mesh-ancestor
65102650|NCT03153150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65102651|NCT03153150|Antithrombins|antithrombins|mesh-ancestor
65102652|NCT03153150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65102653|NCT03153150|Protease Inhibitors|protease inhibitors|mesh-ancestor
65102654|NCT03153150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102655|NCT03153150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102656|NCT02916147|Propofol|propofol|mesh-list
65102657|NCT02916147|Sevoflurane|sevoflurane|mesh-list
65102658|NCT02916147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65102659|NCT02916147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65102660|NCT02916147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102661|NCT02916147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65102662|NCT02916147|Anesthetics, General|anesthetics, general|mesh-ancestor
65102663|NCT02916147|Anesthetics|anesthetics|mesh-ancestor
65102664|NCT02916147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65289746|NCT04069078|Mydriatics|mydriatics|mesh-ancestor
65289747|NCT04069078|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65289748|NCT04069078|Cholinergic Agents|cholinergic agents|mesh-ancestor
65289749|NCT04069078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65289750|NCT04069078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289751|NCT04069078|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65289752|NCT04069078|Parasympatholytics|parasympatholytics|mesh-ancestor
65289753|NCT02732249|Metronidazole|metronidazole|mesh-list
65289754|NCT02732249|Clarithromycin|clarithromycin|mesh-list
65289755|NCT02732249|Potassium Citrate|potassium citrate|mesh-list
65289756|NCT02732249|Esomeprazole|esomeprazole|mesh-list
65289757|NCT02732249|Bismuth|bismuth|mesh-list
65289758|NCT02732249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289759|NCT02732249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65289760|NCT02732249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65289761|NCT02732249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65289762|NCT02732249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65289763|NCT02732249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65289764|NCT02732249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65102665|NCT02916147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65102666|NCT05302388|Diphenhydramine|diphenhydramine|mesh-list
65102667|NCT05302388|Promethazine|promethazine|mesh-list
65102668|NCT05302388|Dexamethasone|dexamethasone|mesh-list
65102669|NCT05302388|Prednisolone|prednisolone|mesh-list
65102670|NCT05302388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65102671|NCT05302388|Methylprednisolone|methylprednisolone|mesh-list
65102672|NCT05302388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65102673|NCT05302388|Prednisolone acetate|prednisolone acetate|mesh-list
65102674|NCT05302388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65102675|NCT05302388|Prednisolone phosphate|prednisolone phosphate|mesh-list
65102676|NCT05302388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65102677|NCT05302388|Antiemetics|antiemetics|mesh-ancestor
65102678|NCT05302388|Autonomic Agents|autonomic agents|mesh-ancestor
64744928|NCT01762800|Hormones|hormones|mesh-ancestor
65102679|NCT05302388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65102680|NCT05302388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102681|NCT05302388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65102682|NCT05302388|Glucocorticoids|glucocorticoids|mesh-ancestor
64675261|NCT02413047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675262|NCT02413047|Dermatologic Agents|dermatologic agents|mesh-ancestor
64675263|NCT02413047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675264|NCT02413047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64675265|NCT02413047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64675266|NCT02413047|Immunologic Factors|immunologic factors|mesh-ancestor
64675267|NCT02413047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64675268|NCT02413047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65102694|NCT05302388|Sensory System Agents|sensory system agents|mesh-ancestor
65102695|NCT05302388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65102696|NCT05302388|Histamine Antagonists|histamine antagonists|mesh-ancestor
65102697|NCT05302388|Histamine Agents|histamine agents|mesh-ancestor
65102698|NCT05302388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65102699|NCT05302388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102700|NCT05302388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65102701|NCT05302388|Antipruritics|antipruritics|mesh-ancestor
65102702|NCT05302388|Dermatologic Agents|dermatologic agents|mesh-ancestor
65102703|NCT02919072|Ropivacaine|ropivacaine|mesh-list
65102704|NCT02919072|Chloroprocaine|chloroprocaine|mesh-list
65102705|NCT02919072|Anesthetics, Local|anesthetics, local|mesh-ancestor
65102706|NCT02919072|Anesthetics|anesthetics|mesh-ancestor
65289765|NCT02732249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65289766|NCT02732249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289767|NCT02732249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65289768|NCT02732249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65289769|NCT02732249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65289770|NCT02732249|Antacids|antacids|mesh-ancestor
65289771|NCT02732249|Diuretics|diuretics|mesh-ancestor
65289772|NCT02732249|Natriuretic Agents|natriuretic agents|mesh-ancestor
65289773|NCT02732249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289774|NCT02732249|Expectorants|expectorants|mesh-ancestor
65289775|NCT02732249|Respiratory System Agents|respiratory system agents|mesh-ancestor
65289776|NCT04561063|Sofosbuvir|sofosbuvir|mesh-list
65289777|NCT04561063|Nitazoxanide|nitazoxanide|mesh-list
65289778|NCT04561063|Antiviral Agents|antiviral agents|mesh-ancestor
64889724|NCT01968850|Vitamin D|vitamin d|mesh-list
65102707|NCT02919072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65102708|NCT02919072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102709|NCT02919072|Sensory System Agents|sensory system agents|mesh-ancestor
65102710|NCT02919072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65102711|NCT02941328|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
65102712|NCT02941328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65102713|NCT02941328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102714|NCT02941328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102715|NCT02941328|Cholinergic Agents|cholinergic agents|mesh-ancestor
65102716|NCT02941328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65102717|NCT02941328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102718|NCT02915796|Lenograstim|lenograstim|mesh-list
65102719|NCT02915796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65102720|NCT02915796|Immunologic Factors|immunologic factors|mesh-ancestor
65102721|NCT02915796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102722|NCT02915250|Insulin Lispro|insulin lispro|mesh-list
65102723|NCT02915250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65102724|NCT02915250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102725|NCT02277041|Misoprostol|misoprostol|mesh-list
65102726|NCT02277041|Carbetocin|carbetocin|mesh-list
65102727|NCT02277041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65102728|NCT02277041|Abortifacient Agents|abortifacient agents|mesh-ancestor
65102729|NCT02277041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65102730|NCT02277041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102731|NCT02277041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65102732|NCT02277041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65102733|NCT02277041|Oxytocics|oxytocics|mesh-ancestor
65102734|NCT02915289|Chlorhexidine|chlorhexidine|mesh-list
65102735|NCT02915289|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65102736|NCT02915289|Povidone-Iodine|povidone-iodine|mesh-list
65102737|NCT02915289|Povidone|povidone|mesh-list
65102738|NCT02915289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65102748|NCT02939417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102749|NCT02939417|Protective Agents|protective agents|mesh-ancestor
65102750|NCT02939417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102752|NCT05034536|Infliximab|infliximab|mesh-list
65102753|NCT05034536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65102754|NCT05034536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102755|NCT05034536|Dermatologic Agents|dermatologic agents|mesh-ancestor
65102756|NCT05034536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64745005|NCT01777152|Hormones|hormones|mesh-ancestor
65102757|NCT05034536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65102758|NCT02915094|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65102759|NCT02915094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65102760|NCT02915172|Capecitabine|capecitabine|mesh-list
65102761|NCT02915172|Lenvatinib|lenvatinib|mesh-list
65102762|NCT02915172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65102763|NCT02915172|Antimetabolites|antimetabolites|mesh-ancestor
65289779|NCT04561063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65289780|NCT04561063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65289781|NCT02732093|Lidocaine|lidocaine|mesh-list
65289782|NCT02732093|Anesthetics, Local|anesthetics, local|mesh-ancestor
65289783|NCT02732093|Anesthetics|anesthetics|mesh-ancestor
65289784|NCT02732093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65289785|NCT02732093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289786|NCT02732093|Sensory System Agents|sensory system agents|mesh-ancestor
65289787|NCT02732093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65289788|NCT02732093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65289789|NCT02732093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65289790|NCT02732093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65289791|NCT02732093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65289792|NCT02732093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289793|NCT00718276|Vitamin D|vitamin d|mesh-list
65289794|NCT00718276|Cholecalciferol|cholecalciferol|mesh-list
65289795|NCT00718276|Vitamins|vitamins|mesh-ancestor
65289796|NCT00718276|Micronutrients|micronutrients|mesh-ancestor
65289797|NCT00718276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289798|NCT00718276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64520018|NCT00094887|Antioxidants|antioxidants|mesh-ancestor
65102764|NCT02915172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102765|NCT02915172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102766|NCT02915172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65102767|NCT02915172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102768|NCT02938988|Anti-Infective Agents|anti-infective agents|mesh-list
65102769|NCT02938988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65102770|NCT02938988|Methylene Blue|methylene blue|mesh-list
65102771|NCT02938988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102772|NCT02938988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102773|NCT02915055|Acetaminophen|acetaminophen|mesh-list
65102774|NCT02915055|Ibuprofen|ibuprofen|mesh-list
65102775|NCT02915055|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65102776|NCT02915055|Oxycodone|oxycodone|mesh-list
65102777|NCT02915055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65102778|NCT02915055|Analgesics|analgesics|mesh-ancestor
65102779|NCT02915055|Sensory System Agents|sensory system agents|mesh-ancestor
65102780|NCT02915055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65102781|NCT02915055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102782|NCT02915055|Antipyretics|antipyretics|mesh-ancestor
65102783|NCT02915055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65102784|NCT02915055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65102785|NCT02915055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65102786|NCT02915055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65102787|NCT02915055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102788|NCT02915055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102789|NCT02915055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65102790|NCT02915055|Narcotics|narcotics|mesh-ancestor
65102791|NCT02915055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65102792|NCT01295827|Pembrolizumab|pembrolizumab|mesh-list
65102793|NCT01295827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65102794|NCT01295827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102795|NCT02918760|Gabapentin|gabapentin|mesh-list
65102796|NCT02918760|Analgesics|analgesics|mesh-ancestor
65289799|NCT00718276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65289800|NCT00718354|Cisplatin|cisplatin|mesh-list
65289801|NCT00718354|Carboplatin|carboplatin|mesh-list
65289802|NCT00718354|Fluorouracil|fluorouracil|mesh-list
65289803|NCT00718354|Capecitabine|capecitabine|mesh-list
65289804|NCT00718354|Oxaliplatin|oxaliplatin|mesh-list
65289805|NCT00718354|Epirubicin|epirubicin|mesh-list
65289806|NCT00718354|Enoxaparin|enoxaparin|mesh-list
65289807|NCT00718354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289808|NCT00718354|Antimetabolites|antimetabolites|mesh-ancestor
65289809|NCT00718354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289810|NCT00718354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65289811|NCT00718354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65289812|NCT00718354|Immunologic Factors|immunologic factors|mesh-ancestor
65102797|NCT02918760|Sensory System Agents|sensory system agents|mesh-ancestor
65102798|NCT02918760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65102799|NCT02918760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102800|NCT02918760|Anticonvulsants|anticonvulsants|mesh-ancestor
65102801|NCT02918760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65102802|NCT02918760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65102803|NCT02918760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65102804|NCT02918760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65102818|NCT03458078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65102819|NCT03458078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65102820|NCT03458078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65102821|NCT03458078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65102822|NCT03458078|Anesthetics, General|anesthetics, general|mesh-ancestor
65102823|NCT03458078|Anesthetics|anesthetics|mesh-ancestor
65102824|NCT03458078|GABA Modulators|gaba modulators|mesh-ancestor
65102825|NCT03458078|GABA Agents|gaba agents|mesh-ancestor
65102826|NCT03458078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65102827|NCT03458078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102828|NCT03458078|Analgesics|analgesics|mesh-ancestor
65102829|NCT03458078|Sensory System Agents|sensory system agents|mesh-ancestor
65102830|NCT03458078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65102831|NCT03458078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65102832|NCT03458078|Anticonvulsants|anticonvulsants|mesh-ancestor
65102833|NCT03458078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65102834|NCT03458078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65102835|NCT03458078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65102836|NCT03458078|Tocolytic Agents|tocolytic agents|mesh-ancestor
65102837|NCT03458078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65102838|NCT04690556|Ranibizumab|ranibizumab|mesh-list
65102839|NCT04690556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65102840|NCT04690556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65102841|NCT04690556|Growth Substances|growth substances|mesh-ancestor
65102842|NCT04690556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102843|NCT04690556|Growth Inhibitors|growth inhibitors|mesh-ancestor
65102844|NCT04690556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102845|NCT01294579|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65102847|NCT01294579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65102848|NCT01294579|Alkylating Agents|alkylating agents|mesh-ancestor
65102849|NCT01294579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102850|NCT01294579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102851|NCT02914626|Ranibizumab|ranibizumab|mesh-list
65102852|NCT02914626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65102866|NCT02918331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65102867|NCT02918331|Glucocorticoids|glucocorticoids|mesh-ancestor
65102868|NCT02918331|Hormones|hormones|mesh-ancestor
65102869|NCT02918331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65102870|NCT02918331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65102871|NCT02918331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102872|NCT02918331|Immunologic Factors|immunologic factors|mesh-ancestor
65289813|NCT00718354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289814|NCT00718354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65289815|NCT00718354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65289816|NCT00718354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65289817|NCT00718354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289818|NCT00718354|Anticoagulants|anticoagulants|mesh-ancestor
65102873|NCT02918331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65102874|NCT02918331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65102875|NCT02918331|Growth Substances|growth substances|mesh-ancestor
65102876|NCT02918331|Growth Inhibitors|growth inhibitors|mesh-ancestor
65102877|NCT02918136|Cortisone|cortisone|mesh-list
65102878|NCT02918136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65102879|NCT01294462|Aspirin|aspirin|mesh-list
65102880|NCT01294462|Clopidogrel|clopidogrel|mesh-list
65102881|NCT01294462|Ticagrelor|ticagrelor|mesh-list
65102882|NCT01294462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65102883|NCT01294462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65102884|NCT01294462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65102885|NCT01294462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65102886|NCT01294462|Purinergic Agents|purinergic agents|mesh-ancestor
65102887|NCT01294462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65102888|NCT01294462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102889|NCT01294462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102890|NCT01294462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65102891|NCT01294462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65102892|NCT01294462|Analgesics|analgesics|mesh-ancestor
65102893|NCT01294462|Sensory System Agents|sensory system agents|mesh-ancestor
65102894|NCT01294462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65102895|NCT01294462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65102896|NCT01294462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65102897|NCT01294462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65102898|NCT01294462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65102899|NCT01294462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65102900|NCT01294462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102901|NCT01294462|Antipyretics|antipyretics|mesh-ancestor
65102902|NCT01294423|Dapagliflozin|dapagliflozin|mesh-list
65102903|NCT01294423|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65102904|NCT01294423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102905|NCT01294423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65102906|NCT01294423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102907|NCT02910570|Liraglutide|liraglutide|mesh-list
65102908|NCT02910570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65102909|NCT02910570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102911|NCT02910570|Hormones|hormones|mesh-ancestor
65102912|NCT02910570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65102913|NCT03077685|Paclitaxel|paclitaxel|mesh-list
65102914|NCT03077685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65102915|NCT03077685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102926|NCT04817033|Anesthetics|anesthetics|mesh-list
65102927|NCT04817033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65102928|NCT04817033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102929|NCT04817033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65102930|NCT04817033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65102931|NCT04817033|Analgesics|analgesics|mesh-ancestor
65102932|NCT04817033|Sensory System Agents|sensory system agents|mesh-ancestor
65102933|NCT04817033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65102934|NCT04817033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65102935|NCT04817033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65102936|NCT04817033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65102937|NCT04817033|Adrenergic Agents|adrenergic agents|mesh-ancestor
65102938|NCT04817033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65102939|NCT04817033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102940|NCT04817033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65102941|NCT04817033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65102942|NCT04817033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65102943|NCT04817033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65102944|NCT04817033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65102945|NCT04817033|Anesthetics, General|anesthetics, general|mesh-ancestor
65289819|NCT00718354|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65289820|NCT00718354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65289821|NCT00536809|Capecitabine|capecitabine|mesh-list
65289822|NCT00536809|Oxaliplatin|oxaliplatin|mesh-list
65289823|NCT00536809|Lapatinib|lapatinib|mesh-list
65289824|NCT00536809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65289826|NCT00536809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289827|NCT00536809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289828|NCT00536809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65289829|NCT00536809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289830|NCT04189601|Complement System Proteins|complement system proteins|mesh-list
65289831|NCT04189601|Immunologic Factors|immunologic factors|mesh-ancestor
65289832|NCT04189601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289833|NCT04067986|Apatinib|apatinib|mesh-list
65289834|NCT04067986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289835|NCT04067986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64520056|NCT04645719|Sensory System Agents|sensory system agents|mesh-ancestor
65102946|NCT04817033|GABA Modulators|gaba modulators|mesh-ancestor
65102947|NCT04817033|GABA Agents|gaba agents|mesh-ancestor
65102948|NCT01292473|Omalizumab|omalizumab|mesh-list
65102949|NCT01292473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65102950|NCT01292473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65102951|NCT01292473|Respiratory System Agents|respiratory system agents|mesh-ancestor
65102952|NCT02938286|Epinephrine|epinephrine|mesh-list
65102953|NCT02938286|Carticaine|carticaine|mesh-list
65102954|NCT02938286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65102955|NCT02938286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65102956|NCT02938286|Adrenergic Agents|adrenergic agents|mesh-ancestor
65102957|NCT02938286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65102958|NCT02938286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102959|NCT02938286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102960|NCT02938286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65102961|NCT02938286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65102962|NCT02938286|Autonomic Agents|autonomic agents|mesh-ancestor
65102963|NCT02938286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65102964|NCT02938286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65102965|NCT02938286|Respiratory System Agents|respiratory system agents|mesh-ancestor
65102966|NCT02938286|Mydriatics|mydriatics|mesh-ancestor
65102967|NCT02938286|Sympathomimetics|sympathomimetics|mesh-ancestor
65102968|NCT02938286|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65102969|NCT02938286|Anesthetics, Local|anesthetics, local|mesh-ancestor
65102970|NCT02938286|Anesthetics|anesthetics|mesh-ancestor
65102971|NCT02938286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65102972|NCT02938286|Sensory System Agents|sensory system agents|mesh-ancestor
65102973|NCT01292239|Ribavirin|ribavirin|mesh-list
65102974|NCT01292239|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65102975|NCT01292239|Simeprevir|simeprevir|mesh-list
65102976|NCT01292239|Antimetabolites|antimetabolites|mesh-ancestor
65103010|NCT02937662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65103011|NCT02937662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65103012|NCT02937662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65103013|NCT02937662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103015|NCT01290757|Antithrombins|antithrombins|mesh-ancestor
65103016|NCT01290757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65103017|NCT01290757|Protease Inhibitors|protease inhibitors|mesh-ancestor
65103018|NCT01290757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675530|NCT02266797|Hormones|hormones|mesh-ancestor
65103036|NCT01290718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103037|NCT01290718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65103038|NCT04324294|Pancrelipase|pancrelipase|mesh-list
65103039|NCT04324294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65289836|NCT04067986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289837|NCT04067986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289838|NCT00536731|Budesonide|budesonide|mesh-list
65289839|NCT00536731|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65289840|NCT00536731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65289841|NCT00536731|Respiratory System Agents|respiratory system agents|mesh-ancestor
65289842|NCT00536731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65289843|NCT00536731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65289844|NCT00536731|Autonomic Agents|autonomic agents|mesh-ancestor
65103040|NCT02937896|Ketorolac|ketorolac|mesh-list
65103041|NCT02937896|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65103042|NCT02937896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65103043|NCT02937896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65103044|NCT02937896|Analgesics|analgesics|mesh-ancestor
65103045|NCT02937896|Sensory System Agents|sensory system agents|mesh-ancestor
65103046|NCT02937896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103047|NCT02937896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103048|NCT02937896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65103049|NCT02937896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65103050|NCT02937896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65103051|NCT02937896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103052|NCT02937896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103053|NCT02937896|Hemostatics|hemostatics|mesh-ancestor
65103054|NCT02937896|Coagulants|coagulants|mesh-ancestor
65103055|NCT02937896|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65103056|NCT02937896|Natriuretic Agents|natriuretic agents|mesh-ancestor
65103057|NCT04688151|Rituximab|rituximab|mesh-list
65103058|NCT04688151|Durvalumab|durvalumab|mesh-list
65103059|NCT04688151|Acalabrutinib|acalabrutinib|mesh-list
64745314|NCT01725126|Metformin|metformin|mesh-list
65103060|NCT04688151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65103061|NCT04688151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103062|NCT04688151|Immunologic Factors|immunologic factors|mesh-ancestor
65103063|NCT04688151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103064|NCT04688151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65103067|NCT02937779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65103068|NCT02937779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65103069|NCT02937779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65103070|NCT02937779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103071|NCT02937779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103091|NCT03457389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103093|NCT02890186|Propofol|propofol|mesh-list
65103094|NCT02890186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65103095|NCT02890186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65103096|NCT02890186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103097|NCT02890186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65103098|NCT02890186|Anesthetics, General|anesthetics, general|mesh-ancestor
65103099|NCT02890186|Anesthetics|anesthetics|mesh-ancestor
65103100|NCT02890186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65103101|NCT02890186|Narcotics|narcotics|mesh-ancestor
65103102|NCT02890186|Analgesics|analgesics|mesh-ancestor
65103103|NCT02890186|Sensory System Agents|sensory system agents|mesh-ancestor
65103104|NCT02890186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103105|NCT02909751|Tocotrienols|tocotrienols|mesh-list
65103106|NCT02909751|Vitamin E|vitamin e|mesh-list
65103107|NCT02909751|Tocopherols|tocopherols|mesh-list
65103108|NCT02909751|Docetaxel|docetaxel|mesh-list
65103109|NCT02909751|Cyclophosphamide|cyclophosphamide|mesh-list
65103110|NCT02909751|Trastuzumab|trastuzumab|mesh-list
65103111|NCT02909751|Epirubicin|epirubicin|mesh-list
65103112|NCT02909751|Pertuzumab|pertuzumab|mesh-list
65103113|NCT02909751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103114|NCT02909751|Tubulin Modulators|tubulin modulators|mesh-ancestor
65103115|NCT02909751|Antimitotic Agents|antimitotic agents|mesh-ancestor
65103116|NCT02909751|Mitosis Modulators|mitosis modulators|mesh-ancestor
65103117|NCT02909751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103118|NCT02909751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65103119|NCT02909751|Immunologic Factors|immunologic factors|mesh-ancestor
65289845|NCT00536731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65289846|NCT00536731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289847|NCT00536731|Glucocorticoids|glucocorticoids|mesh-ancestor
65289848|NCT00536731|Hormones|hormones|mesh-ancestor
65289849|NCT00536731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65103120|NCT02909751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103121|NCT02909751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65103122|NCT02909751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65103123|NCT02909751|Alkylating Agents|alkylating agents|mesh-ancestor
65103124|NCT02909751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65103125|NCT02909751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65103126|NCT02909751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65103127|NCT02909751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65103128|NCT02909751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65103129|NCT02909751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103130|NCT02909751|Antioxidants|antioxidants|mesh-ancestor
65103154|NCT01290601|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65103155|NCT01290601|Primaquine|primaquine|mesh-list
65103156|NCT01290601|Tafenoquine|tafenoquine|mesh-list
65103157|NCT01290601|Amebicides|amebicides|mesh-ancestor
65103158|NCT01290601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65103159|NCT01290601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65103160|NCT01290601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65103161|NCT01290601|Antimalarials|antimalarials|mesh-ancestor
65103162|NCT01290601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65103163|NCT01290601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65103164|NCT01290601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65103165|NCT01290601|Analgesics|analgesics|mesh-ancestor
65103166|NCT01290601|Sensory System Agents|sensory system agents|mesh-ancestor
65103167|NCT01290601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103168|NCT01290601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103169|NCT01290601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65103170|NCT01290601|Filaricides|filaricides|mesh-ancestor
65103171|NCT01290601|Antinematodal Agents|antinematodal agents|mesh-ancestor
65103172|NCT01290601|Anthelmintics|anthelmintics|mesh-ancestor
65103173|NCT02978391|Epinephrine|epinephrine|mesh-list
65103174|NCT02978391|Hemostatics|hemostatics|mesh-list
65103175|NCT02978391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65103176|NCT02978391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65103177|NCT02978391|Adrenergic Agents|adrenergic agents|mesh-ancestor
65103178|NCT02978391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65103179|NCT02978391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103180|NCT02978391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103181|NCT02978391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65103182|NCT02978391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65103183|NCT02978391|Autonomic Agents|autonomic agents|mesh-ancestor
65103184|NCT02978391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103185|NCT02978391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65103186|NCT02978391|Respiratory System Agents|respiratory system agents|mesh-ancestor
64401041|NCT03067883|Ritonavir|ritonavir|mesh-list
65103188|NCT02978391|Sympathomimetics|sympathomimetics|mesh-ancestor
65103189|NCT02978391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65103190|NCT02978391|Coagulants|coagulants|mesh-ancestor
65103191|NCT01290094|Ibandronic Acid|ibandronic acid|mesh-list
65103192|NCT01290094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65103193|NCT01290094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103194|NCT04688346|Epinephrine|epinephrine|mesh-list
65103195|NCT04688346|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65103196|NCT04688346|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65103197|NCT04688346|Adrenergic Agents|adrenergic agents|mesh-ancestor
65103198|NCT04688346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65103199|NCT04688346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103200|NCT04688346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103201|NCT04688346|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65103202|NCT04688346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65103203|NCT04688346|Autonomic Agents|autonomic agents|mesh-ancestor
65103204|NCT04688346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103205|NCT04688346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65103206|NCT04688346|Respiratory System Agents|respiratory system agents|mesh-ancestor
65103207|NCT04688346|Mydriatics|mydriatics|mesh-ancestor
65289850|NCT02571712|Timolol|timolol|mesh-list
65289851|NCT02571712|Bimatoprost|bimatoprost|mesh-list
65289852|NCT02571712|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65289853|NCT02571712|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65289854|NCT02571712|Adrenergic Agents|adrenergic agents|mesh-ancestor
65289855|NCT02571712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65289856|NCT02571712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289857|NCT02571712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289858|NCT02571712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65289859|NCT02571712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65289860|NCT02730845|Dexmedetomidine|dexmedetomidine|mesh-list
65289861|NCT02730845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65289862|NCT02730845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65289863|NCT02730845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289864|NCT02730845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65289865|NCT02730845|Analgesics|analgesics|mesh-ancestor
65289866|NCT02730845|Sensory System Agents|sensory system agents|mesh-ancestor
65289867|NCT02730845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65289868|NCT02730845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65289869|NCT02730845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65289870|NCT02730845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65289871|NCT02730845|Adrenergic Agents|adrenergic agents|mesh-ancestor
65289872|NCT02730845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65289873|NCT02730845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289874|NCT02730689|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65289875|NCT02730689|Ezetimibe|ezetimibe|mesh-list
65289876|NCT02730689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65289877|NCT02730689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65289878|NCT02730689|Antimetabolites|antimetabolites|mesh-ancestor
65289879|NCT02730689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289880|NCT02730689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65289881|NCT02730689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65289882|NCT02730689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289883|NCT03579316|Olaparib|olaparib|mesh-list
65289885|NCT03579316|Adavosertib|adavosertib|mesh-list
65289887|NCT03579316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289888|NCT03579316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289889|NCT02730533|Esomeprazole|esomeprazole|mesh-list
65289890|NCT02730533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65289891|NCT02730533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65289892|NCT02730533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65289893|NCT02730533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520118|NCT03225690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103208|NCT04688346|Sympathomimetics|sympathomimetics|mesh-ancestor
65103209|NCT04688346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65103210|NCT01289821|Leucovorin|leucovorin|mesh-list
65103211|NCT01289821|Folic Acid|folic acid|mesh-list
65103212|NCT01289821|Oxaliplatin|oxaliplatin|mesh-list
65103213|NCT01289821|Levoleucovorin|levoleucovorin|mesh-list
64483848|NCT00787852|Dasatinib|dasatinib|mesh-list
65103214|NCT01289821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103215|NCT01289821|Antidotes|antidotes|mesh-ancestor
65103216|NCT01289821|Protective Agents|protective agents|mesh-ancestor
65103217|NCT01289821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103218|NCT01289821|Vitamin B Complex|vitamin b complex|mesh-ancestor
65103219|NCT01289821|Vitamins|vitamins|mesh-ancestor
65103220|NCT01289821|Micronutrients|micronutrients|mesh-ancestor
65103221|NCT01289821|Hematinics|hematinics|mesh-ancestor
65103222|NCT02913768|Ondansetron|ondansetron|mesh-list
65103223|NCT02913768|Antiemetics|antiemetics|mesh-ancestor
65103224|NCT02913768|Autonomic Agents|autonomic agents|mesh-ancestor
65103225|NCT02913768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103226|NCT02913768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103227|NCT02913768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65103228|NCT02913768|Antipruritics|antipruritics|mesh-ancestor
65103229|NCT02913768|Dermatologic Agents|dermatologic agents|mesh-ancestor
65103230|NCT02913768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65103231|NCT02913768|Serotonin Agents|serotonin agents|mesh-ancestor
65103232|NCT02913768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65103233|NCT02913768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103234|NCT02913768|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65103235|NCT02913768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65103236|NCT02913768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65103237|NCT02913768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65103238|NCT02913768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65103239|NCT02971956|Pembrolizumab|pembrolizumab|mesh-list
65103240|NCT02971956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65103241|NCT02971956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103242|NCT01289782|Ribavirin|ribavirin|mesh-list
65103243|NCT01289782|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65103244|NCT01289782|Simeprevir|simeprevir|mesh-list
65103245|NCT01289782|Antimetabolites|antimetabolites|mesh-ancestor
65103246|NCT01289782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103247|NCT01289782|Antiviral Agents|antiviral agents|mesh-ancestor
65103248|NCT01289782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65103249|NCT01289782|Protease Inhibitors|protease inhibitors|mesh-ancestor
65103250|NCT01289782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103251|NCT02913417|Nivolumab|nivolumab|mesh-list
65103259|NCT02936492|Glucocorticoids|glucocorticoids|mesh-ancestor
65103260|NCT02936492|Hormones|hormones|mesh-ancestor
65103261|NCT02936492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65103262|NCT02936492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103263|NCT02913573|Bupivacaine|bupivacaine|mesh-list
65103264|NCT02913573|Anesthetics, Local|anesthetics, local|mesh-ancestor
65103265|NCT02913573|Anesthetics|anesthetics|mesh-ancestor
65103266|NCT02913573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65103267|NCT02913573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103268|NCT02913573|Sensory System Agents|sensory system agents|mesh-ancestor
65103269|NCT02913573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103270|NCT01289353|Carboplatin|carboplatin|mesh-list
65103271|NCT01289353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103272|NCT02913300|Lidocaine|lidocaine|mesh-list
65103273|NCT02913300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65103274|NCT02913300|Anesthetics, Local|anesthetics, local|mesh-ancestor
65103275|NCT02913300|Anesthetics|anesthetics|mesh-ancestor
65289894|NCT02730533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289895|NCT00536575|Bortezomib|bortezomib|mesh-list
65289896|NCT00536575|Sorafenib|sorafenib|mesh-list
65289897|NCT00536575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289898|NCT00536575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65289899|NCT00536575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289900|NCT00536575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289901|NCT00712114|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65289902|NCT00712114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65289903|NCT00712114|Immunologic Factors|immunologic factors|mesh-ancestor
65289904|NCT00712114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289905|NCT03214250|Gemcitabine|gemcitabine|mesh-list
65289907|NCT03214250|Nivolumab|nivolumab|mesh-list
65289908|NCT03214250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65289909|NCT03214250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289910|NCT03214250|Tubulin Modulators|tubulin modulators|mesh-ancestor
65289911|NCT03214250|Antimitotic Agents|antimitotic agents|mesh-ancestor
65103276|NCT02913300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65103277|NCT02913300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103278|NCT02913300|Sensory System Agents|sensory system agents|mesh-ancestor
65103279|NCT02913300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103280|NCT02913300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65103281|NCT02913300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65103282|NCT02913300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65103283|NCT02913300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65103284|NCT02913300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103285|NCT02936375|Cyclophosphamide|cyclophosphamide|mesh-list
65103286|NCT02936375|Azathioprine|azathioprine|mesh-list
65103287|NCT02936375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65103288|NCT02936375|Immunologic Factors|immunologic factors|mesh-ancestor
65103289|NCT02936375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103290|NCT02936375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65103291|NCT02936375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65103292|NCT02936375|Alkylating Agents|alkylating agents|mesh-ancestor
65103293|NCT02936375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103294|NCT02936375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103295|NCT02936375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65103296|NCT02936375|Antimetabolites|antimetabolites|mesh-ancestor
65103297|NCT02936375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65103298|NCT02913690|Vitamin E|vitamin e|mesh-list
65103299|NCT02913690|Vitamins|vitamins|mesh-ancestor
65103300|NCT02913690|Micronutrients|micronutrients|mesh-ancestor
65103301|NCT02913690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103302|NCT02913690|Antioxidants|antioxidants|mesh-ancestor
65103303|NCT02913690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103304|NCT02913690|Protective Agents|protective agents|mesh-ancestor
65103305|NCT01289119|Metformin|metformin|mesh-list
65103306|NCT01289119|Pioglitazone|pioglitazone|mesh-list
65103307|NCT01289119|Alogliptin|alogliptin|mesh-list
65103308|NCT01289119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65103309|NCT01289119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103310|NCT01289119|Incretins|incretins|mesh-ancestor
65103311|NCT01289119|Hormones|hormones|mesh-ancestor
65103312|NCT01289119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64675838|NCT04713891|Atezolizumab|atezolizumab|mesh-list
65103319|NCT01287832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65103320|NCT01287832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65103321|NCT02913066|Cisplatin|cisplatin|mesh-list
64520142|NCT01712009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65289912|NCT03214250|Mitosis Modulators|mitosis modulators|mesh-ancestor
65289913|NCT03214250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289914|NCT03214250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65289915|NCT03214250|Antimetabolites|antimetabolites|mesh-ancestor
65289916|NCT03214250|Antiviral Agents|antiviral agents|mesh-ancestor
65289917|NCT03214250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65289918|NCT03214250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289919|NCT03214250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65103322|NCT02913066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103323|NCT01287754|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65103324|NCT01287754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103325|NCT01287754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65103326|NCT01287754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103327|NCT01287754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103328|NCT02912793|Betadex|betadex|mesh-list
65103329|NCT02912793|Sequestering Agents|sequestering agents|mesh-ancestor
65103330|NCT02912793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103331|NCT02935751|Apixaban|apixaban|mesh-list
65103332|NCT02935751|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65103333|NCT02935751|Antithrombins|antithrombins|mesh-ancestor
65103334|NCT02935751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65103335|NCT02935751|Protease Inhibitors|protease inhibitors|mesh-ancestor
65103336|NCT02935751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103337|NCT02935751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103338|NCT02935751|Anticoagulants|anticoagulants|mesh-ancestor
65103339|NCT02935790|Nivolumab|nivolumab|mesh-list
65103340|NCT02935790|Ipilimumab|ipilimumab|mesh-list
65103341|NCT02935790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65103342|NCT02935790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103343|NCT02935790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65103344|NCT02935790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103345|NCT02912637|Xenon|xenon|mesh-list
65103346|NCT02912637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65103347|NCT02912637|Anesthetics, General|anesthetics, general|mesh-ancestor
65103348|NCT02912637|Anesthetics|anesthetics|mesh-ancestor
65103349|NCT02912637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65103350|NCT02912637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103351|NCT02912910|Labetalol|labetalol|mesh-list
65103352|NCT02912910|Nifedipine|nifedipine|mesh-list
65103353|NCT02912910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65103354|NCT02912910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65103355|NCT02912910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103356|NCT02912910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65103357|NCT02912910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103358|NCT02912910|Vasodilator Agents|vasodilator agents|mesh-ancestor
65103359|NCT02912910|Tocolytic Agents|tocolytic agents|mesh-ancestor
65103360|NCT02912910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65103361|NCT02912910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65103362|NCT02912910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65103363|NCT02912910|Adrenergic Agents|adrenergic agents|mesh-ancestor
65103364|NCT02912910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65103365|NCT02912910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65103366|NCT02912910|Sympathomimetics|sympathomimetics|mesh-ancestor
65103367|NCT02912910|Autonomic Agents|autonomic agents|mesh-ancestor
65103368|NCT02912910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103369|NCT02912910|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65103370|NCT02912910|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65103401|NCT02912520|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65103402|NCT02912520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65103403|NCT02935959|Midazolam|midazolam|mesh-list
65103404|NCT02935959|Dexmedetomidine|dexmedetomidine|mesh-list
65103405|NCT02935959|Ketamine|ketamine|mesh-list
65103406|NCT02935959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65103407|NCT02935959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65289920|NCT03214250|Immunologic Factors|immunologic factors|mesh-ancestor
65289921|NCT03214250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289922|NCT03214250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65289923|NCT03214250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65289924|NCT00722098|Cyclophosphamide|cyclophosphamide|mesh-list
65289925|NCT00722098|Vaccines|vaccines|mesh-list
65289926|NCT00722098|Immunologic Factors|immunologic factors|mesh-ancestor
65289927|NCT00722098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289928|NCT00722098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65289929|NCT00722098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65289930|NCT00722098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65289931|NCT00722098|Alkylating Agents|alkylating agents|mesh-ancestor
65289932|NCT00722098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289933|NCT00722098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289934|NCT00722098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65289935|NCT04186871|Abatacept|abatacept|mesh-list
65103408|NCT02935959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103409|NCT02935959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65103410|NCT02935959|Analgesics|analgesics|mesh-ancestor
65103411|NCT02935959|Sensory System Agents|sensory system agents|mesh-ancestor
65103412|NCT02935959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103413|NCT02935959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65103414|NCT02935959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65103415|NCT02935959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65103445|NCT02912247|Antibodies|antibodies|mesh-list
65103446|NCT02912247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65103447|NCT02912247|Immunologic Factors|immunologic factors|mesh-ancestor
65103448|NCT02912247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103449|NCT02912247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65103450|NCT02912247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65103451|NCT02935010|Amoxicillin|amoxicillin|mesh-list
65103452|NCT02935010|Metronidazole|metronidazole|mesh-list
65103453|NCT02935010|Clarithromycin|clarithromycin|mesh-list
65103454|NCT02935010|Levofloxacin|levofloxacin|mesh-list
65103455|NCT02935010|Ofloxacin|ofloxacin|mesh-list
65103456|NCT02935010|Potassium Citrate|potassium citrate|mesh-list
65103457|NCT02935010|Esomeprazole|esomeprazole|mesh-list
65103458|NCT02935010|Bismuth|bismuth|mesh-list
65103459|NCT02935010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103460|NCT02935010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65103461|NCT02935010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65103462|NCT02935010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65103463|NCT02935010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65103464|NCT02935010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65103469|NCT02935010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65103470|NCT02935010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65103471|NCT02935010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65103472|NCT02935010|Renal Agents|renal agents|mesh-ancestor
65103473|NCT02935010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65103474|NCT02935010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65103475|NCT02935010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103476|NCT02935010|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65103477|NCT02935010|Antacids|antacids|mesh-ancestor
65103478|NCT02935010|Diuretics|diuretics|mesh-ancestor
65103479|NCT02935010|Natriuretic Agents|natriuretic agents|mesh-ancestor
65103480|NCT02935010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103481|NCT02935010|Expectorants|expectorants|mesh-ancestor
65103482|NCT02935010|Respiratory System Agents|respiratory system agents|mesh-ancestor
65103483|NCT02935530|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65103484|NCT02935530|Tinzaparin|tinzaparin|mesh-list
65289936|NCT04186871|Branebrutinib|branebrutinib|mesh-list
65289937|NCT04186871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65289938|NCT04186871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289939|NCT04186871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890476|NCT01973868|Cetuximab|cetuximab|mesh-list
65103485|NCT02935530|Dalteparin|dalteparin|mesh-list
65103486|NCT02935530|Argatroban|argatroban|mesh-list
65103487|NCT02935530|Anticoagulants|anticoagulants|mesh-ancestor
65103488|NCT02935530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65103489|NCT02935530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65103490|NCT02935530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103491|NCT02935530|Antithrombins|antithrombins|mesh-ancestor
65103492|NCT02935530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65103493|NCT02935530|Protease Inhibitors|protease inhibitors|mesh-ancestor
65103494|NCT02935530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103495|NCT02935530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65103496|NCT02934464|Leucovorin|leucovorin|mesh-list
65103497|NCT02934464|Paclitaxel|paclitaxel|mesh-list
65103498|NCT02934464|Ramucirumab|ramucirumab|mesh-list
65103499|NCT02934464|Oxaliplatin|oxaliplatin|mesh-list
65103500|NCT02934464|Levoleucovorin|levoleucovorin|mesh-list
65103501|NCT02934464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65103502|NCT02934464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103503|NCT02934464|Tubulin Modulators|tubulin modulators|mesh-ancestor
65103504|NCT02934464|Antimitotic Agents|antimitotic agents|mesh-ancestor
65103505|NCT02934464|Mitosis Modulators|mitosis modulators|mesh-ancestor
65103506|NCT02934464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103507|NCT02934464|Antidotes|antidotes|mesh-ancestor
65103508|NCT02934464|Protective Agents|protective agents|mesh-ancestor
65103509|NCT02934464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103510|NCT02934464|Vitamin B Complex|vitamin b complex|mesh-ancestor
65103511|NCT02934464|Vitamins|vitamins|mesh-ancestor
65103512|NCT02934464|Micronutrients|micronutrients|mesh-ancestor
65103513|NCT02934035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65103514|NCT02934035|Citalopram|citalopram|mesh-list
65103515|NCT02934035|Fluoxetine|fluoxetine|mesh-list
65103516|NCT02934035|Paroxetine|paroxetine|mesh-list
65103517|NCT02934035|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65103518|NCT02934035|Antidepressive Agents|antidepressive agents|mesh-list
65103519|NCT02934035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65103520|NCT02934035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65103521|NCT02934035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64745740|NCT01737840|Histamine Agents|histamine agents|mesh-ancestor
65103522|NCT02934035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103523|NCT02934035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65103524|NCT02934035|Serotonin Agents|serotonin agents|mesh-ancestor
65103525|NCT02934035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103526|NCT02934035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65103527|NCT02934035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65103528|NCT02934035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103529|NCT02934035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64675981|NCT01648751|Estrogens|estrogens|mesh-list
65103533|NCT02934035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65103534|NCT02934035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65103535|NCT02934035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103536|NCT02934152|Amoxicillin|amoxicillin|mesh-list
65103537|NCT02934152|Clarithromycin|clarithromycin|mesh-list
65103538|NCT02934152|Rabeprazole|rabeprazole|mesh-list
65103539|NCT02934152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65103540|NCT02934152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65103541|NCT02934152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65103542|NCT02934152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103543|NCT02934152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103544|NCT02934152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65103545|NCT02934152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65103546|NCT02934152|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65103547|NCT02934152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65103548|NCT02934152|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65103549|NCT02935335|Menotropins|menotropins|mesh-list
65103550|NCT02935335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65103551|NCT02935335|Fertility Agents|fertility agents|mesh-ancestor
65289940|NCT04186871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65289941|NCT04186871|Immunologic Factors|immunologic factors|mesh-ancestor
65289942|NCT04186871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289943|NCT04186871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65289944|NCT04186871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65289945|NCT04186871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289946|NCT05245591|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
65289947|NCT05245591|Anticoagulants|anticoagulants|mesh-ancestor
65289948|NCT00992095|Buprenorphine|buprenorphine|mesh-list
65289949|NCT00992095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65289950|NCT00992095|Narcotics|narcotics|mesh-ancestor
65289951|NCT00992095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65289952|NCT00992095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289953|NCT00992095|Analgesics|analgesics|mesh-ancestor
65289954|NCT00992095|Sensory System Agents|sensory system agents|mesh-ancestor
65289955|NCT00992095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65289956|NCT00992095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65289957|NCT00653354|Valdecoxib|valdecoxib|mesh-list
65289958|NCT00653354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65289959|NCT00653354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65289960|NCT00653354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520182|NCT00201825|Docetaxel|docetaxel|mesh-list
65103552|NCT02935335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65103553|NCT02935335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103554|NCT02911662|Cephalexin|cephalexin|mesh-list
65103555|NCT02911662|Nitrofurantoin|nitrofurantoin|mesh-list
65103556|NCT02911662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65103557|NCT02911662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65103558|NCT02911662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65103559|NCT02911662|Renal Agents|renal agents|mesh-ancestor
65103560|NCT02935101|Prednisolone|prednisolone|mesh-list
65103561|NCT02935101|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65103562|NCT02935101|Methylprednisolone|methylprednisolone|mesh-list
65103563|NCT02935101|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65103564|NCT02935101|Prednisolone acetate|prednisolone acetate|mesh-list
65103565|NCT02935101|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65103566|NCT02935101|Prednisolone phosphate|prednisolone phosphate|mesh-list
65103567|NCT02935101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65103568|NCT02935101|Glucocorticoids|glucocorticoids|mesh-ancestor
65103569|NCT02935101|Hormones|hormones|mesh-ancestor
65103570|NCT02935101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65103571|NCT02935101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103572|NCT02935101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65103573|NCT02935101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103574|NCT02935101|Antiemetics|antiemetics|mesh-ancestor
65103575|NCT02935101|Autonomic Agents|autonomic agents|mesh-ancestor
65103576|NCT02935101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103577|NCT02935101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65103578|NCT02935101|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65103579|NCT02935101|Protective Agents|protective agents|mesh-ancestor
65103580|NCT04689971|Vitamins|vitamins|mesh-list
65103581|NCT04689971|Vitamin B Complex|vitamin b complex|mesh-list
65103582|NCT04689971|Micronutrients|micronutrients|mesh-ancestor
65103583|NCT04689971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103584|NCT02934945|Budesonide|budesonide|mesh-list
64676083|NCT01534143|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65289961|NCT00653354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289962|NCT00653354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65289963|NCT00653354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65289964|NCT00653354|Analgesics|analgesics|mesh-ancestor
65289965|NCT00653354|Sensory System Agents|sensory system agents|mesh-ancestor
65289966|NCT00653354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65289967|NCT00653354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289968|NCT00653354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65289969|NCT00653354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65289970|NCT00712504|Docetaxel|docetaxel|mesh-list
65289971|NCT00712504|Sunitinib|sunitinib|mesh-list
65289972|NCT00712504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65289973|NCT00712504|Tubulin Modulators|tubulin modulators|mesh-ancestor
65289974|NCT00712504|Antimitotic Agents|antimitotic agents|mesh-ancestor
65289975|NCT00712504|Mitosis Modulators|mitosis modulators|mesh-ancestor
64520190|NCT00201825|Antimetabolites|antimetabolites|mesh-ancestor
64676084|NCT01534143|Immunoglobulins|immunoglobulins|mesh-list
64676085|NCT01534143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676086|NCT01534143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64676087|NCT01534143|Antimetabolites|antimetabolites|mesh-ancestor
64676088|NCT01534143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676089|NCT01534143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64676090|NCT01534143|Immunologic Factors|immunologic factors|mesh-ancestor
65103597|NCT02934945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65103598|NCT02934945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65103599|NCT02934945|Adrenergic Agents|adrenergic agents|mesh-ancestor
65103601|NCT02934945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103602|NCT02933645|Insulin|insulin|mesh-list
65103603|NCT02933645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65103604|NCT02933645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65103605|NCT02933645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103606|NCT02911701|Acetaminophen|acetaminophen|mesh-list
65103607|NCT02911701|Ibuprofen|ibuprofen|mesh-list
65103608|NCT02911701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65103609|NCT02911701|Analgesics|analgesics|mesh-ancestor
65103610|NCT02911701|Sensory System Agents|sensory system agents|mesh-ancestor
65103611|NCT02911701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103612|NCT02911701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103613|NCT02911701|Antipyretics|antipyretics|mesh-ancestor
65103614|NCT02911701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65103615|NCT02911701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65103616|NCT02911701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65103617|NCT02911701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65103618|NCT02911701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103619|NCT02911701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103620|NCT02933684|Cycloserine|cycloserine|mesh-list
65103621|NCT02933684|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65103622|NCT02933684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65103623|NCT02933684|Renal Agents|renal agents|mesh-ancestor
65103624|NCT02933684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65103625|NCT02933684|Antitubercular Agents|antitubercular agents|mesh-ancestor
65103626|NCT02933684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65103627|NCT02933684|Antimetabolites|antimetabolites|mesh-ancestor
65103628|NCT02933684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103629|NCT02933333|Molgramostim|molgramostim|mesh-list
65103630|NCT02933333|Lenograstim|lenograstim|mesh-list
65103631|NCT02933333|Sargramostim|sargramostim|mesh-list
65103632|NCT02933333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65103633|NCT02933333|Immunologic Factors|immunologic factors|mesh-ancestor
65289976|NCT00712504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289977|NCT00712504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65289978|NCT00712504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65289979|NCT00712504|Growth Substances|growth substances|mesh-ancestor
65289980|NCT00712504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289981|NCT00712504|Growth Inhibitors|growth inhibitors|mesh-ancestor
65289982|NCT00712504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65289983|NCT00712504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65289984|NCT00653510|Insulin|insulin|mesh-list
65289985|NCT00653510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65289986|NCT00653510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65289987|NCT00653510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289988|NCT02694653|Acetaminophen|acetaminophen|mesh-list
65289989|NCT02694653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65289990|NCT02694653|Analgesics|analgesics|mesh-ancestor
65289991|NCT02694653|Sensory System Agents|sensory system agents|mesh-ancestor
65289992|NCT02694653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520203|NCT00202449|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65103634|NCT02933333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103635|NCT02933333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103636|NCT02670252|Cyclophosphamide|cyclophosphamide|mesh-list
65103637|NCT02670252|Busulfan|busulfan|mesh-list
65103638|NCT02670252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65103671|NCT02933099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103672|NCT02933099|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65103673|NCT02933099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64745890|NCT01686828|Testosterone enanthate|testosterone enanthate|mesh-list
65103674|NCT02933099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65103675|NCT02933099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65103676|NCT02933099|Serotonin Agents|serotonin agents|mesh-ancestor
65103677|NCT04630886|Lidocaine|lidocaine|mesh-list
65103678|NCT04630886|Epinephrine|epinephrine|mesh-list
65103679|NCT04630886|Tranexamic Acid|tranexamic acid|mesh-list
65103680|NCT04630886|Anesthetics, Local|anesthetics, local|mesh-ancestor
65103711|NCT02934906|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65103712|NCT02934906|Immunologic Factors|immunologic factors|mesh-ancestor
65103713|NCT02934906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103715|NCT02911350|Hormones|hormones|mesh-list
65103716|NCT02911350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65103717|NCT02911350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103718|NCT02911350|Tubulin Modulators|tubulin modulators|mesh-ancestor
65103719|NCT02911350|Antimitotic Agents|antimitotic agents|mesh-ancestor
65103720|NCT02911350|Mitosis Modulators|mitosis modulators|mesh-ancestor
65103721|NCT02911350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676167|NCT05715437|Sensory System Agents|sensory system agents|mesh-ancestor
65103734|NCT02911272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103735|NCT02932436|Empagliflozin|empagliflozin|mesh-list
65103736|NCT02932436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65103737|NCT02932436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103738|NCT02932436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65103739|NCT02932436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103740|NCT02932007|Chloroquine|chloroquine|mesh-list
65103741|NCT02932007|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65103742|NCT02932007|Amebicides|amebicides|mesh-ancestor
65103743|NCT02932007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65103744|NCT02932007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65289993|NCT02694653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65289994|NCT02694653|Antipyretics|antipyretics|mesh-ancestor
65344916|NCT00736346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65344917|NCT00736346|Antidepressive Agents|antidepressive agents|mesh-ancestor
65103745|NCT02932007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65103746|NCT02932007|Antimalarials|antimalarials|mesh-ancestor
64745967|NCT01565850|Antiviral Agents|antiviral agents|mesh-ancestor
65103747|NCT02932007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65103748|NCT02932007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65103750|NCT02932007|Analgesics|analgesics|mesh-ancestor
65103751|NCT02932007|Sensory System Agents|sensory system agents|mesh-ancestor
65103752|NCT02932007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103753|NCT02932007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103754|NCT02932007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65103755|NCT02932007|Filaricides|filaricides|mesh-ancestor
65103756|NCT02932007|Antinematodal Agents|antinematodal agents|mesh-ancestor
65103757|NCT02932007|Anthelmintics|anthelmintics|mesh-ancestor
65103758|NCT02910882|Gemcitabine|gemcitabine|mesh-list
65103759|NCT02910882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65103760|NCT02910882|Antimetabolites|antimetabolites|mesh-ancestor
65103761|NCT02910882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103762|NCT02910882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103763|NCT02910882|Antiviral Agents|antiviral agents|mesh-ancestor
65103764|NCT02910882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65103765|NCT02910882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103766|NCT02910882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65103767|NCT02910882|Immunologic Factors|immunologic factors|mesh-ancestor
65103768|NCT02910882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103769|NCT02910765|Methylene Blue|methylene blue|mesh-list
65103770|NCT02910765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103771|NCT02910765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103772|NCT02925026|Lactoferrin|lactoferrin|mesh-list
65103773|NCT02925026|Muramidase|muramidase|mesh-list
65103774|NCT02925026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65103775|NCT02665143|Nintedanib|nintedanib|mesh-list
65103776|NCT02665143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103811|NCT02924675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103812|NCT02924675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103813|NCT02924675|Anticonvulsants|anticonvulsants|mesh-ancestor
65103814|NCT02924675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65103815|NCT02924675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65103816|NCT02924675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103843|NCT01287520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103844|NCT01287520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103845|NCT01287520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103846|NCT01287520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65103847|NCT01287520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65103848|NCT01287520|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65103849|NCT01287520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65103850|NCT01287520|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65103851|NCT01287520|Histamine Antagonists|histamine antagonists|mesh-ancestor
65103852|NCT01287520|Histamine Agents|histamine agents|mesh-ancestor
65103853|NCT01287520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65103854|NCT01287520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103856|NCT00623740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65103880|NCT02924090|Etomidate|etomidate|mesh-list
65103881|NCT02924090|Analgesics|analgesics|mesh-ancestor
65103882|NCT02924090|Sensory System Agents|sensory system agents|mesh-ancestor
65103883|NCT02924090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103884|NCT02924090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103885|NCT02924090|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65103886|NCT02924090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65103887|NCT02924090|Anesthetics, General|anesthetics, general|mesh-ancestor
65103888|NCT02924090|Anesthetics|anesthetics|mesh-ancestor
65103889|NCT02924090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65103890|NCT02924090|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65103891|NCT02924090|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65103892|NCT02924090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65103893|NCT02924090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65289995|NCT00722956|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
65289996|NCT00722956|Atorvastatin|atorvastatin|mesh-list
65289997|NCT00722956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65289998|NCT00722956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65289999|NCT00722956|Antimetabolites|antimetabolites|mesh-ancestor
65290000|NCT00722956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290001|NCT00722956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65290002|NCT00722956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65290003|NCT00722956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290004|NCT00722956|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65290005|NCT00722956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65290006|NCT00722956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65290007|NCT00722956|Antiviral Agents|antiviral agents|mesh-ancestor
65290008|NCT00722956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290009|NCT00992173|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65290010|NCT00992173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290011|NCT00992173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290012|NCT00992173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290013|NCT00992173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65290014|NCT02729285|Ketorolac|ketorolac|mesh-list
65290015|NCT02729285|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65290016|NCT02729285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65290017|NCT02729285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65290018|NCT02729285|Analgesics|analgesics|mesh-ancestor
65290019|NCT02729285|Sensory System Agents|sensory system agents|mesh-ancestor
65344918|NCT00736346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65103894|NCT02924090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65103895|NCT04137770|Ketorolac|ketorolac|mesh-list
65103896|NCT04137770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65103897|NCT04137770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65103899|NCT04137770|Sensory System Agents|sensory system agents|mesh-ancestor
65103900|NCT04137770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103901|NCT04137770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103902|NCT04137770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65103903|NCT04137770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65103904|NCT04137770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65103905|NCT04137770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103906|NCT04137770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103907|NCT01286740|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
65103908|NCT01286740|Antiviral Agents|antiviral agents|mesh-ancestor
65103941|NCT02934204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103942|NCT02934204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65103943|NCT02934204|Antimetabolites|antimetabolites|mesh-ancestor
65290020|NCT02729285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65290021|NCT02729285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290022|NCT02729285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65290023|NCT02729285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65290024|NCT02729285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65290025|NCT02729285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520251|NCT00203931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65103944|NCT02934204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103945|NCT02934204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103946|NCT02934204|Dermatologic Agents|dermatologic agents|mesh-ancestor
65103947|NCT02934204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103948|NCT02934204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65103949|NCT02934204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65103950|NCT02934204|Immunologic Factors|immunologic factors|mesh-ancestor
65103951|NCT02934204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65103952|NCT02934204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65103953|NCT02934204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65103954|NCT02934204|Alkylating Agents|alkylating agents|mesh-ancestor
65103955|NCT01286077|Bortezomib|bortezomib|mesh-list
65103956|NCT01286077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103957|NCT05590936|Ondansetron|ondansetron|mesh-list
65103958|NCT05590936|Dimenhydrinate|dimenhydrinate|mesh-list
65103959|NCT05590936|Antiemetics|antiemetics|mesh-ancestor
65103960|NCT05590936|Autonomic Agents|autonomic agents|mesh-ancestor
65103961|NCT05590936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103962|NCT05590936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103963|NCT05590936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65103964|NCT05590936|Antipruritics|antipruritics|mesh-ancestor
65103965|NCT05590936|Dermatologic Agents|dermatologic agents|mesh-ancestor
65103966|NCT05590936|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65103967|NCT05590936|Serotonin Agents|serotonin agents|mesh-ancestor
65103968|NCT05590936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65103969|NCT05590936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103970|NCT05590936|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65103971|NCT05590936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65103972|NCT05590936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65103973|NCT05590936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65103974|NCT05590936|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65103975|NCT05590936|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65103976|NCT05590936|Histamine Antagonists|histamine antagonists|mesh-ancestor
65103977|NCT05590936|Histamine Agents|histamine agents|mesh-ancestor
65103978|NCT02933814|Bupivacaine|bupivacaine|mesh-list
65103979|NCT02933814|Anesthetics, Local|anesthetics, local|mesh-ancestor
65103980|NCT02933814|Anesthetics|anesthetics|mesh-ancestor
65103981|NCT02933814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65103982|NCT02933814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103983|NCT02933814|Sensory System Agents|sensory system agents|mesh-ancestor
65103984|NCT02933814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103985|NCT02933775|Cyclophosphamide|cyclophosphamide|mesh-list
65103986|NCT02933775|Fludarabine|fludarabine|mesh-list
65103987|NCT02933775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65103988|NCT02933775|Immunologic Factors|immunologic factors|mesh-ancestor
65103989|NCT02933775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103990|NCT02933775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65103991|NCT02933775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65103992|NCT02933775|Alkylating Agents|alkylating agents|mesh-ancestor
65103993|NCT02933775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103994|NCT02933775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103995|NCT02933775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65103996|NCT02923583|Abatacept|abatacept|mesh-list
65103997|NCT02923583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65103998|NCT02923583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103999|NCT02923583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104000|NCT02923583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65104001|NCT02923583|Immunologic Factors|immunologic factors|mesh-ancestor
65104002|NCT02923583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104003|NCT02923583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65104004|NCT02933580|JNJ-56136379|jnj-56136379|mesh-list
65290026|NCT02729285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290027|NCT00722176|Risperidone|risperidone|mesh-list
65290028|NCT00722176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65290029|NCT00722176|Serotonin Agents|serotonin agents|mesh-ancestor
65290030|NCT00722176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65344919|NCT00736346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65104005|NCT02933580|Antiviral Agents|antiviral agents|mesh-ancestor
65104006|NCT02933580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65104007|NCT02923388|Vitamins|vitamins|mesh-list
65104017|NCT02933658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64483880|NCT05742724|Dronabinol|dronabinol|mesh-list
65104018|NCT02933658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65104019|NCT02933658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65104020|NCT02933658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104021|NCT02933658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65104022|NCT02933658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104023|NCT02933658|Vasodilator Agents|vasodilator agents|mesh-ancestor
65104024|NCT02933658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65104025|NCT02933658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65104026|NCT02933658|Antimetabolites|antimetabolites|mesh-ancestor
65104027|NCT02933658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65104028|NCT02933658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65104029|NCT02933658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104030|NCT02933658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65104031|NCT02933658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65104032|NCT02933853|Insulin|insulin|mesh-list
65104033|NCT02933853|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65104034|NCT02933853|Insulin Aspart|insulin aspart|mesh-list
65104035|NCT02933853|Insulin, Long-Acting|insulin, long-acting|mesh-list
65104036|NCT02933853|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65104037|NCT02933853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65104038|NCT02933853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104039|NCT00532194|Cediranib|cediranib|mesh-list
65104040|NCT00532194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104041|NCT00532194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65104042|NCT00532194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104043|NCT00532194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104044|NCT00532272|Letrozole|letrozole|mesh-list
65104045|NCT00532272|Goserelin|goserelin|mesh-list
65104046|NCT00532272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104047|NCT00532272|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65104048|NCT00532272|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65104049|NCT00532272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104050|NCT00532272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104051|NCT00532272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65104052|NCT00532272|Hormone Antagonists|hormone antagonists|mesh-ancestor
65104053|NCT00532272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65104054|NCT00532272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104055|NCT00532272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65104056|NCT02922803|Calcium, Dietary|calcium, dietary|mesh-list
65104057|NCT02922803|Vitamin D|vitamin d|mesh-list
65104058|NCT02922803|Ergocalciferols|ergocalciferols|mesh-list
64676526|NCT05688371|Dexmedetomidine|dexmedetomidine|mesh-list
64676527|NCT05688371|Morphine|morphine|mesh-list
64676528|NCT05688371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65104068|NCT02834559|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65104069|NCT02834559|Tinzaparin|tinzaparin|mesh-list
65104070|NCT02834559|Dalteparin|dalteparin|mesh-list
65104071|NCT02834559|Antimetabolites|antimetabolites|mesh-ancestor
65104072|NCT02834559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104073|NCT02834559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65104074|NCT02834559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104075|NCT02834559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65104076|NCT02834559|Immunologic Factors|immunologic factors|mesh-ancestor
65104077|NCT02834559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104078|NCT02834559|Anticoagulants|anticoagulants|mesh-ancestor
65104079|NCT02834559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65104080|NCT02834559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65290031|NCT00722176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290032|NCT00722176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290033|NCT00722176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65104081|NCT02922686|Floxacillin|floxacillin|mesh-list
65104082|NCT02922686|Penicillin V|penicillin v|mesh-list
65104083|NCT02922686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65104084|NCT02922686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65104085|NCT02922491|Vitamin E|vitamin e|mesh-list
65104086|NCT02922491|Vitamins|vitamins|mesh-ancestor
65104087|NCT02922491|Micronutrients|micronutrients|mesh-ancestor
65104088|NCT02922491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104089|NCT02922491|Antioxidants|antioxidants|mesh-ancestor
65104090|NCT02922491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104091|NCT02922491|Protective Agents|protective agents|mesh-ancestor
65104092|NCT02922179|Insulin|insulin|mesh-list
65104093|NCT02922179|Insulin Detemir|insulin detemir|mesh-list
65104094|NCT02922179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65104095|NCT02922179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104096|NCT02921984|Docetaxel|docetaxel|mesh-list
65104097|NCT02921984|Pemetrexed|pemetrexed|mesh-list
65104098|NCT02921984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104099|NCT02921984|Tubulin Modulators|tubulin modulators|mesh-ancestor
65104100|NCT02921984|Antimitotic Agents|antimitotic agents|mesh-ancestor
65104101|NCT02921984|Mitosis Modulators|mitosis modulators|mesh-ancestor
65104102|NCT02921984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104103|NCT02921984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104104|NCT02921984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65104105|NCT02921984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65104106|NCT01285609|Paclitaxel|paclitaxel|mesh-list
65104107|NCT01285609|Carboplatin|carboplatin|mesh-list
65104108|NCT01285609|Ipilimumab|ipilimumab|mesh-list
65104109|NCT01285609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65104110|NCT01285609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104111|NCT01285609|Tubulin Modulators|tubulin modulators|mesh-ancestor
65104112|NCT01285609|Antimitotic Agents|antimitotic agents|mesh-ancestor
65104113|NCT01285609|Mitosis Modulators|mitosis modulators|mesh-ancestor
65104114|NCT01285609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104115|NCT01285609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65104116|NCT01285609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65104117|NCT03981341|Bazedoxifene|bazedoxifene|mesh-list
65104118|NCT03981341|Estrogens|estrogens|mesh-list
65104119|NCT03981341|Hormones|hormones|mesh-ancestor
65104120|NCT03981341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65104121|NCT03981341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104122|NCT03981341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65104139|NCT01285492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65104140|NCT01285492|Respiratory System Agents|respiratory system agents|mesh-ancestor
65104141|NCT01285492|Parasympatholytics|parasympatholytics|mesh-ancestor
65104142|NCT01285492|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65104143|NCT01285492|Cholinergic Agents|cholinergic agents|mesh-ancestor
65104144|NCT01285492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65104145|NCT01285492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104147|NCT01284634|Anticonvulsants|anticonvulsants|mesh-ancestor
65104148|NCT02932722|Anesthetics|anesthetics|mesh-list
65104149|NCT02932722|Propofol|propofol|mesh-list
65104150|NCT02932722|Sevoflurane|sevoflurane|mesh-list
65104151|NCT02932722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65104152|NCT02932722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104153|NCT02932722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65104154|NCT02932722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65104155|NCT02932722|Anesthetics, General|anesthetics, general|mesh-ancestor
65104156|NCT02932722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65104157|NCT02932722|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65104158|NCT02932761|Goserelin|goserelin|mesh-list
65104159|NCT02932761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65104160|NCT02932761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104161|NCT01283971|Adalimumab|adalimumab|mesh-list
65104162|NCT01283971|Methotrexate|methotrexate|mesh-list
65104163|NCT01283971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65104164|NCT01283971|Abortifacient Agents|abortifacient agents|mesh-ancestor
65104165|NCT01283971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65104166|NCT01283971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104167|NCT01283971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65290034|NCT00722176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65290035|NCT00722176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65290036|NCT00722176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65290037|NCT00722176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65290038|NCT00722176|Dopamine Agents|dopamine agents|mesh-ancestor
65290039|NCT02729441|Ramipril|ramipril|mesh-list
65290040|NCT02729441|Perindopril|perindopril|mesh-list
65290041|NCT02729441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65290042|NCT02729441|Protease Inhibitors|protease inhibitors|mesh-ancestor
65290043|NCT02729441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290044|NCT02729441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290045|NCT02729441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65290046|NCT04181333|Trastuzumab|trastuzumab|mesh-list
65290047|NCT04181333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65290048|NCT04181333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290049|NCT00712660|Antipsychotic Agents|antipsychotic agents|mesh-list
65290050|NCT00712660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65290051|NCT00712660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65290052|NCT00712660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290053|NCT00712660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65104168|NCT01283971|Antimetabolites|antimetabolites|mesh-ancestor
65104169|NCT01283971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104170|NCT01283971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104171|NCT01283971|Dermatologic Agents|dermatologic agents|mesh-ancestor
65104200|NCT02921360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104201|NCT02921360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65104202|NCT02921360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65104203|NCT02921360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104204|NCT02921360|Antipyretics|antipyretics|mesh-ancestor
65104205|NCT02932605|Cannabidiol|cannabidiol|mesh-list
65104206|NCT02932605|Anticonvulsants|anticonvulsants|mesh-ancestor
65104208|NCT02921204|Vitamins|vitamins|mesh-ancestor
65104209|NCT02921204|Micronutrients|micronutrients|mesh-ancestor
65104210|NCT02921204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104211|NCT02921204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65104212|NCT01283581|Vancomycin|vancomycin|mesh-list
65104213|NCT01283581|Linezolid|linezolid|mesh-list
65104214|NCT01283581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65104215|NCT01283581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65104216|NCT01283581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65104217|NCT01283581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676622|NCT00355277|Sensory System Agents|sensory system agents|mesh-ancestor
65104221|NCT01283542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65104222|NCT01283542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104223|NCT01283464|Vitamin A|vitamin a|mesh-list
65104224|NCT01283464|Tretinoin|tretinoin|mesh-list
65104225|NCT01283464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104226|NCT01283464|Keratolytic Agents|keratolytic agents|mesh-ancestor
65104227|NCT01283464|Dermatologic Agents|dermatologic agents|mesh-ancestor
65104228|NCT01283464|Vitamins|vitamins|mesh-ancestor
64483897|NCT01784419|Ivacaftor|ivacaftor|mesh-list
65104229|NCT01283464|Micronutrients|micronutrients|mesh-ancestor
65104230|NCT01283464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104231|NCT02932488|Sumatriptan|sumatriptan|mesh-list
65104232|NCT02932488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65290054|NCT00636545|Oblimersen|oblimersen|mesh-list
65290055|NCT00636545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290056|NCT00722488|Pevonedistat|pevonedistat|mesh-list
65290057|NCT00722488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290058|NCT00722488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290059|NCT00652106|Timolol|timolol|mesh-list
65290060|NCT00652106|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65290061|NCT00652106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64520286|NCT02450682|Antithrombins|antithrombins|mesh-ancestor
65104233|NCT02932488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65104234|NCT02932488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65104235|NCT02932488|Serotonin Agents|serotonin agents|mesh-ancestor
65104236|NCT02932488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65104237|NCT02932488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104238|NCT02932488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104239|NCT02921165|Aspirin|aspirin|mesh-list
65104240|NCT02921165|Analgesics|analgesics|mesh-list
65104241|NCT02921165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65104242|NCT02921165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65104243|NCT02921165|Sensory System Agents|sensory system agents|mesh-ancestor
65104244|NCT02921165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65104245|NCT02921165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104246|NCT02921165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65104247|NCT02921165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65104248|NCT02921165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65104249|NCT02921165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65104250|NCT02921165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104251|NCT02921165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65104252|NCT02921165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65104253|NCT02921165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104254|NCT02921165|Antipyretics|antipyretics|mesh-ancestor
65104255|NCT01283386|Cyclophosphamide|cyclophosphamide|mesh-list
65104256|NCT01283386|Chlorambucil|chlorambucil|mesh-list
65104257|NCT01283386|Rituximab|rituximab|mesh-list
65104258|NCT01283386|Fludarabine|fludarabine|mesh-list
65104259|NCT01283386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65104260|NCT01283386|Immunologic Factors|immunologic factors|mesh-ancestor
65104261|NCT01283386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104262|NCT01283386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65104263|NCT01283386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65104264|NCT01283386|Alkylating Agents|alkylating agents|mesh-ancestor
65104265|NCT01283386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104266|NCT01283386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104267|NCT01283386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65104268|NCT01283386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65104269|NCT02920931|Tenofovir|tenofovir|mesh-list
65104270|NCT02920931|Antiviral Agents|antiviral agents|mesh-ancestor
65104271|NCT02920931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65104272|NCT02920931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65104273|NCT02920931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64746489|NCT01547598|Timolol|timolol|mesh-list
65104275|NCT02920931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104276|NCT02920931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64676673|NCT02294604|Dermatologic Agents|dermatologic agents|mesh-ancestor
65104285|NCT01282801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65104286|NCT01282801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104287|NCT01282801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65104288|NCT01282801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104289|NCT01282801|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65104290|NCT01282801|Antidepressive Agents|antidepressive agents|mesh-ancestor
65104291|NCT01282801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65104292|NCT00532350|Tiotropium Bromide|tiotropium bromide|mesh-list
65104293|NCT00532350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65104294|NCT00532350|Autonomic Agents|autonomic agents|mesh-ancestor
65104295|NCT00532350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65290062|NCT00652106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65290063|NCT00652106|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65290064|NCT00652106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65290065|NCT00652106|Adrenergic Agents|adrenergic agents|mesh-ancestor
65290066|NCT00652106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65290067|NCT00652106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290068|NCT00652106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290069|NCT00652106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65290070|NCT00652106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65290071|NCT00652106|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65290072|NCT00652106|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65290073|NCT00652106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65290074|NCT00723268|Prednisolone|prednisolone|mesh-list
65290075|NCT00723268|Colchicine|colchicine|mesh-list
65290076|NCT00723268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65290077|NCT00723268|Glucocorticoids|glucocorticoids|mesh-ancestor
65290078|NCT00723268|Hormones|hormones|mesh-ancestor
65290079|NCT00723268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65290080|NCT00723268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290081|NCT00723268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65290116|NCT00578344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65290117|NCT00653588|Atorvastatin|atorvastatin|mesh-list
65290118|NCT00653588|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65290119|NCT00653588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65290120|NCT00653588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65040085|NCT00221481|GABA Agents|gaba agents|mesh-ancestor
65290121|NCT00653588|Antimetabolites|antimetabolites|mesh-ancestor
64891329|NCT01980849|Nadroparin|nadroparin|mesh-list
65104296|NCT00532350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104297|NCT00532350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65104298|NCT00532350|Respiratory System Agents|respiratory system agents|mesh-ancestor
65104299|NCT00532350|Parasympatholytics|parasympatholytics|mesh-ancestor
65104300|NCT00532350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65104301|NCT00532350|Cholinergic Agents|cholinergic agents|mesh-ancestor
65104302|NCT00532350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65104303|NCT00532350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104304|NCT02932566|Pirfenidone|pirfenidone|mesh-list
65104305|NCT02932566|Analgesics|analgesics|mesh-ancestor
65104306|NCT02932566|Sensory System Agents|sensory system agents|mesh-ancestor
65104307|NCT02932566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65104308|NCT02932566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104309|NCT02932566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65104310|NCT02932566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65104311|NCT02932566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65104312|NCT02932566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65104313|NCT02932566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104314|NCT00532389|Panobinostat|panobinostat|mesh-list
65104315|NCT00532389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104316|NCT00532389|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65104317|NCT00532389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104318|NCT00532389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104319|NCT02932644|Vitamin D|vitamin d|mesh-list
65104320|NCT02932644|Ergocalciferols|ergocalciferols|mesh-list
65104321|NCT02932644|Cholecalciferol|cholecalciferol|mesh-list
65104322|NCT02932644|Vitamins|vitamins|mesh-list
65104323|NCT02932644|Micronutrients|micronutrients|mesh-ancestor
65104324|NCT02932644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104325|NCT02932644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65104326|NCT02932644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65104327|NCT05466708|Dexmedetomidine|dexmedetomidine|mesh-list
65104328|NCT05466708|Ketamine|ketamine|mesh-list
65104329|NCT05466708|Esketamine|esketamine|mesh-list
65104330|NCT05466708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65104331|NCT05466708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65104332|NCT05466708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104333|NCT05466708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65104334|NCT05466708|Analgesics|analgesics|mesh-ancestor
65104335|NCT05466708|Sensory System Agents|sensory system agents|mesh-ancestor
65104336|NCT05466708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65104337|NCT05466708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65104338|NCT05466708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65104339|NCT05466708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65104340|NCT05466708|Adrenergic Agents|adrenergic agents|mesh-ancestor
65104350|NCT05466708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65104351|NCT02920502|Cholecalciferol|cholecalciferol|mesh-list
65104352|NCT02920502|Vitamin D|vitamin d|mesh-list
65104353|NCT02920502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65104354|NCT02920502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104355|NCT02920502|Vitamins|vitamins|mesh-ancestor
65104356|NCT02920502|Micronutrients|micronutrients|mesh-ancestor
65104357|NCT02920502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65104358|NCT01282216|Vaccines|vaccines|mesh-list
65104359|NCT01282216|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65104360|NCT01282216|Immunologic Factors|immunologic factors|mesh-ancestor
65104361|NCT01282216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104362|NCT01281865|Everolimus|everolimus|mesh-list
65104363|NCT01281865|Imatinib Mesylate|imatinib mesylate|mesh-list
65104364|NCT01281865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104365|NCT01281865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65290122|NCT00653588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290123|NCT00653588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65290124|NCT00653588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65290125|NCT00653588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290126|NCT00723346|Asparaginase|asparaginase|mesh-list
65290127|NCT00723346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290128|NCT02571400|Analgesics, Opioid|analgesics, opioid|mesh-list
65290129|NCT02571400|Analgesics|analgesics|mesh-list
65290130|NCT02571400|Narcotics|narcotics|mesh-ancestor
65290131|NCT02571400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64520348|NCT03209466|Chlorhexidine|chlorhexidine|mesh-list
65104366|NCT01281865|Immunologic Factors|immunologic factors|mesh-ancestor
65104367|NCT01281865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104368|NCT01281865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65104369|NCT01281865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104370|NCT01281865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104371|NCT02920658|Betamethasone|betamethasone|mesh-list
65104372|NCT02920658|Betamethasone Valerate|betamethasone valerate|mesh-list
65104373|NCT02920658|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65104374|NCT02920658|Betamethasone benzoate|betamethasone benzoate|mesh-list
65104375|NCT02920658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65104376|NCT02920658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65104377|NCT02920658|Glucocorticoids|glucocorticoids|mesh-ancestor
65104378|NCT02920658|Hormones|hormones|mesh-ancestor
65104379|NCT02920658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65104380|NCT02920658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104381|NCT02920658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65104382|NCT02920658|Respiratory System Agents|respiratory system agents|mesh-ancestor
65104383|NCT01281202|Vigabatrin|vigabatrin|mesh-list
65104384|NCT01281202|Anticonvulsants|anticonvulsants|mesh-ancestor
65104385|NCT01281202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104386|NCT01281202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104387|NCT01281202|GABA Agents|gaba agents|mesh-ancestor
65104388|NCT01281202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65104389|NCT01281202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104390|NCT01281124|Azacitidine|azacitidine|mesh-list
65104391|NCT01281124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65104392|NCT01281124|Antimetabolites|antimetabolites|mesh-ancestor
65104393|NCT01281124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104394|NCT01281124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104395|NCT01281124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104396|NCT00623857|Vitamins|vitamins|mesh-list
65104398|NCT00623857|Micronutrients|micronutrients|mesh-ancestor
65104399|NCT00623857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104400|NCT00623857|Trace Elements|trace elements|mesh-ancestor
65104401|NCT01280968|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65104402|NCT01280968|Vaccines|vaccines|mesh-list
65104403|NCT01280968|Nicotine|nicotine|mesh-list
65104404|NCT01280968|Immunologic Factors|immunologic factors|mesh-ancestor
65104405|NCT01280968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104406|NCT01280968|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65104407|NCT01280968|Autonomic Agents|autonomic agents|mesh-ancestor
65104420|NCT02932020|Prednisolone|prednisolone|mesh-list
64746639|NCT04714710|Canrenoic Acid|canrenoic acid|mesh-list
65104421|NCT02932020|Prednisolone acetate|prednisolone acetate|mesh-list
65104422|NCT02932020|Bupivacaine|bupivacaine|mesh-list
65104423|NCT02932020|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65104424|NCT02932020|Prednisolone phosphate|prednisolone phosphate|mesh-list
65104425|NCT02932020|Anesthetics, Local|anesthetics, local|mesh-ancestor
65104426|NCT02932020|Anesthetics|anesthetics|mesh-ancestor
65104427|NCT02932020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65104428|NCT02932020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104429|NCT02932020|Sensory System Agents|sensory system agents|mesh-ancestor
65104430|NCT02932020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65104431|NCT02932020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65290132|NCT02571400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290133|NCT02571400|Sensory System Agents|sensory system agents|mesh-ancestor
65290134|NCT02571400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65290135|NCT02641652|Sertraline|sertraline|mesh-list
65290136|NCT02641652|Antidepressive Agents|antidepressive agents|mesh-ancestor
65290137|NCT02641652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65290138|NCT02641652|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65290139|NCT02641652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65290140|NCT02641652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65290141|NCT02641652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520365|NCT01710527|Metformin|metformin|mesh-list
65104432|NCT02932020|Antiemetics|antiemetics|mesh-ancestor
65104433|NCT02932020|Autonomic Agents|autonomic agents|mesh-ancestor
65104434|NCT02932020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65104435|NCT02932020|Glucocorticoids|glucocorticoids|mesh-ancestor
65104436|NCT02932020|Hormones|hormones|mesh-ancestor
65104437|NCT02932020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65104438|NCT02932020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65104439|NCT02932020|Protective Agents|protective agents|mesh-ancestor
65104440|NCT02932020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65104441|NCT02932020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104442|NCT02920229|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65104443|NCT02920229|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65104444|NCT02920229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104445|NCT05466279|Midazolam|midazolam|mesh-list
65104446|NCT05466279|Propofol|propofol|mesh-list
65104447|NCT05466279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65104448|NCT05466279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64483902|NCT01784029|Cholecalciferol|cholecalciferol|mesh-list
65104449|NCT05466279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104450|NCT05466279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65104451|NCT05466279|Anesthetics, General|anesthetics, general|mesh-ancestor
65104453|NCT05466279|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65104454|NCT05466279|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65104455|NCT05466279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65104456|NCT05466279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65104457|NCT05466279|GABA Modulators|gaba modulators|mesh-ancestor
65104458|NCT05466279|GABA Agents|gaba agents|mesh-ancestor
65104459|NCT05466279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65104460|NCT05466279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104461|NCT01280656|Interferons|interferons|mesh-list
65104462|NCT01280656|Ribavirin|ribavirin|mesh-list
65104463|NCT01280656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65104464|NCT01280656|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65104465|NCT01280656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104466|NCT01280656|Antiviral Agents|antiviral agents|mesh-ancestor
65104467|NCT01280656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65104468|NCT01280656|Antimetabolites|antimetabolites|mesh-ancestor
65104469|NCT01280656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104470|NCT03741530|Glyburide|glyburide|mesh-list
64676852|NCT00000801|Vincristine|vincristine|mesh-list
65104486|NCT01280266|Udenafil|udenafil|mesh-list
65104487|NCT01280266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65104488|NCT01280266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65104489|NCT01280266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65104490|NCT01280266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104491|NCT01280266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65104492|NCT01280266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104493|NCT01280266|Vasodilator Agents|vasodilator agents|mesh-ancestor
65104494|NCT01280266|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65104495|NCT01280266|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65104496|NCT01280266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104497|NCT02919917|Midodrine|midodrine|mesh-list
65104498|NCT02919917|Sympathomimetics|sympathomimetics|mesh-ancestor
65290142|NCT02641652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65290143|NCT02641652|Serotonin Agents|serotonin agents|mesh-ancestor
65290144|NCT02641652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290145|NCT02626104|Lactoferrin|lactoferrin|mesh-list
65290146|NCT02626104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290147|NCT02571166|Valacyclovir|valacyclovir|mesh-list
65290148|NCT02571166|Antiviral Agents|antiviral agents|mesh-ancestor
65290149|NCT02571166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290150|NCT00686478|Interferons|interferons|mesh-list
65290151|NCT00686478|Interferon-alpha|interferon-alpha|mesh-list
65290152|NCT00686478|Interferon alpha-2|interferon alpha-2|mesh-list
64520367|NCT01710527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104499|NCT02919917|Autonomic Agents|autonomic agents|mesh-ancestor
65104500|NCT02919917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65104501|NCT02919917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104502|NCT02919917|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65104503|NCT02919917|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65104504|NCT02919917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65104505|NCT02919917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65104506|NCT02919917|Adrenergic Agents|adrenergic agents|mesh-ancestor
65104507|NCT02919917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65104508|NCT02919917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104510|NCT01279447|Anesthetics, Local|anesthetics, local|mesh-ancestor
65104511|NCT01279447|Anesthetics|anesthetics|mesh-ancestor
65104512|NCT01279447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65104513|NCT01279447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104514|NCT01279447|Sensory System Agents|sensory system agents|mesh-ancestor
65104515|NCT01279447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65104516|NCT02932254|Magnesium Sulfate|magnesium sulfate|mesh-list
65104517|NCT02932254|Analgesics|analgesics|mesh-ancestor
65104518|NCT02932254|Sensory System Agents|sensory system agents|mesh-ancestor
65104519|NCT02932254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65104520|NCT02932254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104521|NCT02932254|Anesthetics|anesthetics|mesh-ancestor
65104522|NCT02932254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65104524|NCT02932254|Anticonvulsants|anticonvulsants|mesh-ancestor
65104525|NCT02932254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65104526|NCT02932254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65104527|NCT02932254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104528|NCT02932254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65104529|NCT02932254|Tocolytic Agents|tocolytic agents|mesh-ancestor
65104530|NCT02932254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65104531|NCT02920190|Liraglutide|liraglutide|mesh-list
64676974|NCT00000279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104534|NCT02920190|Incretins|incretins|mesh-ancestor
65104535|NCT02920190|Hormones|hormones|mesh-ancestor
65104536|NCT02920190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65104537|NCT02919878|Gemcitabine|gemcitabine|mesh-list
65104538|NCT02919878|Capecitabine|capecitabine|mesh-list
65104539|NCT02919878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65104540|NCT02919878|Antimetabolites|antimetabolites|mesh-ancestor
65104541|NCT02919878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104542|NCT02919878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104543|NCT02919878|Antiviral Agents|antiviral agents|mesh-ancestor
65104544|NCT02919878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65104545|NCT02919878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104546|NCT02919878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65104547|NCT02919878|Immunologic Factors|immunologic factors|mesh-ancestor
65104548|NCT02919878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104549|NCT02931786|Ketamine|ketamine|mesh-list
65104550|NCT02931786|Propofol|propofol|mesh-list
65104551|NCT02931786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65104552|NCT02931786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65290153|NCT00686478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290154|NCT00686478|Antiviral Agents|antiviral agents|mesh-ancestor
65290155|NCT00686478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290156|NCT00686478|Immunologic Factors|immunologic factors|mesh-ancestor
65290157|NCT00686478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290158|NCT00723424|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
65290159|NCT00723424|Digoxin|digoxin|mesh-list
65290160|NCT00723424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65290161|NCT00723424|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65290162|NCT00723424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290163|NCT00723424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290164|NCT00723424|Protective Agents|protective agents|mesh-ancestor
65290165|NCT00723424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290166|NCT00723424|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65290167|NCT00723424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65290168|NCT00723424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65290169|NCT00723424|Antiviral Agents|antiviral agents|mesh-ancestor
65290170|NCT00723424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290171|NCT02641340|Fentanyl|fentanyl|mesh-list
65290172|NCT02641340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65104553|NCT02931786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104554|NCT02931786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65104555|NCT02931786|Anesthetics, General|anesthetics, general|mesh-ancestor
65104556|NCT02931786|Anesthetics|anesthetics|mesh-ancestor
65104557|NCT02931786|Analgesics|analgesics|mesh-ancestor
65104558|NCT02931786|Sensory System Agents|sensory system agents|mesh-ancestor
65104559|NCT02931786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65104560|NCT02931786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65104561|NCT02931786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65104562|NCT02931786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65104563|NCT02931786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65104564|NCT02931786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104565|NCT02919605|Pentamidine|pentamidine|mesh-list
65104566|NCT02919605|Antifungal Agents|antifungal agents|mesh-ancestor
65104567|NCT02919605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65104568|NCT02919605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65104569|NCT02919605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65104570|NCT02919605|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65104571|NCT00532428|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65104572|NCT00532428|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65104573|NCT00532428|Hormone Antagonists|hormone antagonists|mesh-ancestor
65104574|NCT00532428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65104575|NCT00532428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104576|NCT00532428|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65104577|NCT00532428|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65104578|NCT00532428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65104579|NCT05465733|Pemetrexed|pemetrexed|mesh-list
65104580|NCT05465733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104581|NCT05465733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104582|NCT05465733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290173|NCT02641340|Narcotics|narcotics|mesh-ancestor
65290174|NCT02641340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65290175|NCT02641340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290176|NCT02641340|Analgesics|analgesics|mesh-ancestor
65290177|NCT02641340|Sensory System Agents|sensory system agents|mesh-ancestor
65104583|NCT05465733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65104584|NCT05465733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65104585|NCT03673787|Atezolizumab|atezolizumab|mesh-list
65104586|NCT03673787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104587|NCT03571802|Simvastatin|simvastatin|mesh-list
65104588|NCT03571802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65104589|NCT03571802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65104590|NCT03571802|Antimetabolites|antimetabolites|mesh-ancestor
65104591|NCT03571802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104592|NCT03571802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65104593|NCT03571802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65104594|NCT03571802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104596|NCT02919332|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65104597|NCT02919332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65104598|NCT02919332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104599|NCT02919332|Antimetabolites|antimetabolites|mesh-ancestor
65104600|NCT02919332|Antiviral Agents|antiviral agents|mesh-ancestor
65104601|NCT02919332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65104602|NCT05465304|Azithromycin|azithromycin|mesh-list
65104603|NCT05465304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65104610|NCT02919371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65104611|NCT02919371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104612|NCT02919371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65104613|NCT02919371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65104614|NCT02919371|Growth Substances|growth substances|mesh-ancestor
65104615|NCT02919371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104616|NCT02919371|Growth Inhibitors|growth inhibitors|mesh-ancestor
65104617|NCT02919371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65104618|NCT02919371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104619|NCT02919371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104620|NCT02919449|Atezolizumab|atezolizumab|mesh-list
65104621|NCT02919449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104622|NCT04736901|Enoxaparin|enoxaparin|mesh-list
65104623|NCT04736901|Rivaroxaban|rivaroxaban|mesh-list
65104624|NCT04736901|Apixaban|apixaban|mesh-list
65104625|NCT04736901|Enoxaparin sodium|enoxaparin sodium|mesh-list
65104626|NCT04736901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65104627|NCT04736901|Antithrombins|antithrombins|mesh-ancestor
65104628|NCT04736901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65104629|NCT04736901|Protease Inhibitors|protease inhibitors|mesh-ancestor
65104630|NCT04736901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104631|NCT04736901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104632|NCT04736901|Anticoagulants|anticoagulants|mesh-ancestor
65104633|NCT04736901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65104634|NCT04736901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65104635|NCT02919176|Pioglitazone|pioglitazone|mesh-list
65104636|NCT02919176|Mirabegron|mirabegron|mesh-list
65104637|NCT02919176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65104638|NCT02919176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104639|NCT02919176|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65104640|NCT02919176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65104641|NCT02919176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65104642|NCT02919176|Adrenergic Agents|adrenergic agents|mesh-ancestor
65104643|NCT02919176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65104644|NCT02919176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104645|NCT02919176|Urological Agents|urological agents|mesh-ancestor
65104646|NCT04734678|Infliximab|infliximab|mesh-list
65104647|NCT04734678|Dermatologic Agents|dermatologic agents|mesh-ancestor
65104648|NCT04734678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65104649|NCT04734678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65104650|NCT02919059|Dapagliflozin|dapagliflozin|mesh-list
65104651|NCT02919059|Glimepiride|glimepiride|mesh-list
65104652|NCT02919059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65104653|NCT02919059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104654|NCT02919059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65104655|NCT02919059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290178|NCT02641340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65290179|NCT02641340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65290180|NCT02641340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65290181|NCT02641340|Anesthetics, General|anesthetics, general|mesh-ancestor
65290182|NCT02641340|Anesthetics|anesthetics|mesh-ancestor
65290183|NCT02625948|Tranexamic Acid|tranexamic acid|mesh-list
65290184|NCT02625948|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64891793|NCT01984177|Hormones|hormones|mesh-list
65104656|NCT02919059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65104657|NCT02919059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65104658|NCT02919059|Immunologic Factors|immunologic factors|mesh-ancestor
65104659|NCT04727775|Remdesivir|remdesivir|mesh-list
65104660|NCT04727775|Favipiravir|favipiravir|mesh-list
65104661|NCT04727775|Antimetabolites|antimetabolites|mesh-ancestor
65104662|NCT04727775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104663|NCT04727775|Antiviral Agents|antiviral agents|mesh-ancestor
65104664|NCT04727775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65104665|NCT02918825|Olanzapine|olanzapine|mesh-list
65104666|NCT02918825|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65104667|NCT02918825|Antiemetics|antiemetics|mesh-ancestor
65104668|NCT02918825|Autonomic Agents|autonomic agents|mesh-ancestor
65104669|NCT02918825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65104670|NCT02918825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104671|NCT02918825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65104672|NCT02918825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65104673|NCT02918825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65104674|NCT02918825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64677046|NCT00000297|Labetalol|labetalol|mesh-list
65104704|NCT02918747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65104705|NCT02918747|Antiemetics|antiemetics|mesh-ancestor
65104706|NCT02918747|Autonomic Agents|autonomic agents|mesh-ancestor
65104707|NCT02918747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65104708|NCT02918747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65104709|NCT02918747|Glucocorticoids|glucocorticoids|mesh-ancestor
65104710|NCT02918747|Hormones|hormones|mesh-ancestor
65104711|NCT02918747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65104712|NCT02918747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65104713|NCT02918747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65104714|NCT02918747|Antimetabolites|antimetabolites|mesh-ancestor
65104715|NCT02918747|Antiviral Agents|antiviral agents|mesh-ancestor
65104716|NCT02918747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65104717|NCT02918747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104718|NCT02918747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65104719|NCT02918747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65104720|NCT02918747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65104738|NCT00532545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104739|NCT00532545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65104740|NCT03778424|Rufinamide|rufinamide|mesh-list
65104741|NCT03778424|Anticonvulsants|anticonvulsants|mesh-ancestor
65104742|NCT03778424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65104743|NCT03778424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65104744|NCT03778424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65104745|NCT03778424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104746|NCT04687098|Idarubicin|idarubicin|mesh-list
65104747|NCT04687098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65104748|NCT04687098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104749|NCT04687098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65104750|NCT04687098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65104751|NCT04687098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104752|NCT04687098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104753|NCT00533520|Ranibizumab|ranibizumab|mesh-list
65104754|NCT00533520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65104755|NCT00533520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65104756|NCT00533520|Growth Substances|growth substances|mesh-ancestor
65104757|NCT00533520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104758|NCT00533520|Growth Inhibitors|growth inhibitors|mesh-ancestor
65104759|NCT00533520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104760|NCT03694262|Bevacizumab|bevacizumab|mesh-list
65104761|NCT03694262|Atezolizumab|atezolizumab|mesh-list
65290185|NCT02625948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65290186|NCT02625948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290187|NCT02625948|Hemostatics|hemostatics|mesh-ancestor
65290188|NCT02625948|Coagulants|coagulants|mesh-ancestor
65290189|NCT02571556|Dexamethasone|dexamethasone|mesh-list
65290190|NCT02571556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65290191|NCT02571556|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65290192|NCT02571556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65290193|NCT02571556|Antiemetics|antiemetics|mesh-ancestor
65290194|NCT02571556|Autonomic Agents|autonomic agents|mesh-ancestor
65290195|NCT02571556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65290196|NCT02571556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290197|NCT02571556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64891918|NCT01985373|Antibodies|antibodies|mesh-list
65104762|NCT03694262|Rucaparib|rucaparib|mesh-list
65104763|NCT03694262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65104764|NCT03694262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104765|NCT03694262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65104766|NCT03694262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65104767|NCT03694262|Growth Substances|growth substances|mesh-ancestor
65104768|NCT03694262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104769|NCT03694262|Growth Inhibitors|growth inhibitors|mesh-ancestor
65104770|NCT03694262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65104771|NCT03694262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104772|NCT03694262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104773|NCT05356104|Exenatide|exenatide|mesh-list
65104774|NCT05356104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65104775|NCT05356104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104776|NCT05356104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65104777|NCT05356104|Incretins|incretins|mesh-ancestor
65104778|NCT05356104|Hormones|hormones|mesh-ancestor
65104779|NCT05356104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65104781|NCT00533559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104782|NCT03685253|Niacinamide|niacinamide|mesh-list
65104783|NCT03685253|Vitamin B Complex|vitamin b complex|mesh-ancestor
65104784|NCT03685253|Vitamins|vitamins|mesh-ancestor
65104785|NCT03685253|Micronutrients|micronutrients|mesh-ancestor
65104786|NCT03685253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104787|NCT00532220|Ibandronic Acid|ibandronic acid|mesh-list
65104788|NCT00532220|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65104789|NCT00532220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104790|NCT00532584|Beclomethasone|beclomethasone|mesh-list
65104791|NCT00532584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65104792|NCT00532584|Glucocorticoids|glucocorticoids|mesh-ancestor
65104793|NCT00532584|Hormones|hormones|mesh-ancestor
65104794|NCT00532584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65104795|NCT00532584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104796|NCT00532584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65104797|NCT00532584|Respiratory System Agents|respiratory system agents|mesh-ancestor
65104798|NCT04687332|Tryptophan|tryptophan|mesh-list
65104799|NCT04687332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65104800|NCT04687332|Antidepressive Agents|antidepressive agents|mesh-ancestor
65104801|NCT04687332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65104803|NCT05467709|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65104804|NCT05467709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65104805|NCT05467709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65104806|NCT05467709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104807|NCT05467709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65104808|NCT05467709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65104809|NCT05467709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65104810|NCT05467709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65104811|NCT05467709|Anesthetics, General|anesthetics, general|mesh-ancestor
65290198|NCT02571556|Glucocorticoids|glucocorticoids|mesh-ancestor
65290199|NCT02571556|Hormones|hormones|mesh-ancestor
65290200|NCT02571556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65290201|NCT02571556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65290202|NCT02571556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290203|NCT02571556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65290204|NCT03635749|Atorvastatin|atorvastatin|mesh-list
65290205|NCT03635749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65344920|NCT00736346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64520421|NCT01709903|Glucocorticoids|glucocorticoids|mesh-ancestor
65104812|NCT05467709|Anesthetics|anesthetics|mesh-ancestor
65104813|NCT05467709|GABA Modulators|gaba modulators|mesh-ancestor
65104814|NCT05467709|GABA Agents|gaba agents|mesh-ancestor
65104815|NCT05467709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65104816|NCT05467709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104817|NCT00532623|Gemcitabine|gemcitabine|mesh-list
65104818|NCT00532623|Vinorelbine|vinorelbine|mesh-list
65104819|NCT00532623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65104820|NCT00532623|Antimetabolites|antimetabolites|mesh-ancestor
65104821|NCT00532623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104822|NCT00532623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104823|NCT00532623|Antiviral Agents|antiviral agents|mesh-ancestor
65104824|NCT00532623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65104825|NCT00532623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104826|NCT00532623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65104827|NCT00532623|Immunologic Factors|immunologic factors|mesh-ancestor
65104828|NCT00532623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104829|NCT00532623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65104830|NCT00532623|Tubulin Modulators|tubulin modulators|mesh-ancestor
65104831|NCT00532623|Antimitotic Agents|antimitotic agents|mesh-ancestor
65104832|NCT00532623|Mitosis Modulators|mitosis modulators|mesh-ancestor
65104833|NCT05467670|Doxorubicin|doxorubicin|mesh-list
65104834|NCT05467670|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65104835|NCT05467670|Pembrolizumab|pembrolizumab|mesh-list
65104836|NCT05467670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65104837|NCT05467670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104838|NCT05467670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65104839|NCT05467670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65104840|NCT05467670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104841|NCT05467670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104842|NCT05467670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65104844|NCT00532662|Analgesics|analgesics|mesh-ancestor
65104845|NCT00532662|Sensory System Agents|sensory system agents|mesh-ancestor
65104846|NCT00532662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65104847|NCT00532662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104848|NCT00532662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65104849|NCT00532662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65104850|NCT00532662|Anesthetics, General|anesthetics, general|mesh-ancestor
65104865|NCT05341167|Sympathomimetics|sympathomimetics|mesh-ancestor
65104866|NCT05341167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65104867|NCT05341167|Nasal Decongestants|nasal decongestants|mesh-ancestor
65104868|NCT05341167|Respiratory System Agents|respiratory system agents|mesh-ancestor
65104869|NCT05341167|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65104870|NCT05341167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65104871|NCT05341167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65104872|NCT05341167|Adrenergic Agents|adrenergic agents|mesh-ancestor
65104873|NCT05341167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65104874|NCT05341167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104875|NCT05341167|Protective Agents|protective agents|mesh-ancestor
65104876|NCT05467436|Analgesics|analgesics|mesh-list
65104877|NCT05467436|Anesthetics|anesthetics|mesh-list
65104878|NCT05467436|Anesthetics, Local|anesthetics, local|mesh-list
65104879|NCT05467436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65104880|NCT05467436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290206|NCT03635749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290207|NCT03635749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290208|NCT03635749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65290209|NCT03635749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65290210|NCT03635749|Antimetabolites|antimetabolites|mesh-ancestor
65290211|NCT03635749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65290212|NCT03752216|Niraparib|niraparib|mesh-list
65290213|NCT03752216|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65290214|NCT03752216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290215|NCT03752216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290216|NCT03752216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290217|NCT00691548|Cetuximab|cetuximab|mesh-list
65290218|NCT00691548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65290219|NCT00691548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290220|NCT00712738|Nifedipine|nifedipine|mesh-list
65290221|NCT00712738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65290222|NCT00712738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65290223|NCT00712738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290224|NCT00712738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65290225|NCT00712738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290226|NCT00712738|Vasodilator Agents|vasodilator agents|mesh-ancestor
65290227|NCT00712738|Tocolytic Agents|tocolytic agents|mesh-ancestor
65290228|NCT00712738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65290229|NCT00686556|Cyclosporine|cyclosporine|mesh-list
65290230|NCT00686556|Mycophenolic Acid|mycophenolic acid|mesh-list
65290231|NCT00686556|Cyclophosphamide|cyclophosphamide|mesh-list
65290232|NCT00686556|Fludarabine|fludarabine|mesh-list
65290233|NCT00686556|Cyclosporins|cyclosporins|mesh-list
65290234|NCT00686556|Lenograstim|lenograstim|mesh-list
65290235|NCT00686556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65290236|NCT00686556|Immunologic Factors|immunologic factors|mesh-ancestor
65290237|NCT00686556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290238|NCT00686556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65290247|NCT00686556|Dermatologic Agents|dermatologic agents|mesh-ancestor
65290248|NCT00686556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65290249|NCT00686556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65290250|NCT00686556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65290251|NCT00686556|Antitubercular Agents|antitubercular agents|mesh-ancestor
65290252|NCT00686556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65290253|NCT00686556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65290254|NCT04070482|Tenofovir|tenofovir|mesh-list
65290255|NCT04070482|Antiviral Agents|antiviral agents|mesh-ancestor
65290256|NCT04070482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290257|NCT04070482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65290258|NCT04070482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65290259|NCT04070482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290260|NCT04070482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290261|NCT04070482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65290262|NCT04070482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65290263|NCT04166786|Ethanol|ethanol|mesh-list
65104881|NCT05467436|Sensory System Agents|sensory system agents|mesh-ancestor
65104882|NCT05467436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65104883|NCT00533637|Cetirizine|cetirizine|mesh-list
65104884|NCT00533637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65104885|NCT00533637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65104886|NCT00533637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65104887|NCT00533637|Histamine Antagonists|histamine antagonists|mesh-ancestor
65104888|NCT00533637|Histamine Agents|histamine agents|mesh-ancestor
65104889|NCT00533637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65104890|NCT00533637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104891|NCT00533637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104892|NCT00533676|Oxymetazoline|oxymetazoline|mesh-list
65104893|NCT00533676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65104894|NCT00533676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65104895|NCT00533676|Adrenergic Agents|adrenergic agents|mesh-ancestor
65104896|NCT00533676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65104897|NCT00533676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104898|NCT00533676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104899|NCT00533676|Sympathomimetics|sympathomimetics|mesh-ancestor
65104900|NCT00533676|Autonomic Agents|autonomic agents|mesh-ancestor
65104901|NCT00533676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65104902|NCT00533676|Nasal Decongestants|nasal decongestants|mesh-ancestor
65104903|NCT00533676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65104904|NCT00533676|Respiratory System Agents|respiratory system agents|mesh-ancestor
65104905|NCT05467319|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65104907|NCT05466695|Sildenafil Citrate|sildenafil citrate|mesh-list
65104908|NCT05466695|Tadalafil|tadalafil|mesh-list
65104909|NCT05466695|Vasodilator Agents|vasodilator agents|mesh-ancestor
65104910|NCT05466695|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65104911|NCT05466695|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65104912|NCT05466695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104918|NCT05466578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104919|NCT04484610|Analgesics, Opioid|analgesics, opioid|mesh-list
65104920|NCT04484610|Narcotics|narcotics|mesh-ancestor
65104921|NCT04484610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65104922|NCT04484610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104923|NCT04484610|Analgesics|analgesics|mesh-ancestor
65104924|NCT04484610|Sensory System Agents|sensory system agents|mesh-ancestor
65104925|NCT04484610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65104926|NCT05321316|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65290264|NCT04166786|Methyltestosterone|methyltestosterone|mesh-list
65290265|NCT04166786|Petrolatum|petrolatum|mesh-list
65290266|NCT04166786|Testosterone|testosterone|mesh-list
65290267|NCT04166786|Testosterone undecanoate|testosterone undecanoate|mesh-list
65290268|NCT04166786|Testosterone enanthate|testosterone enanthate|mesh-list
65290269|NCT04166786|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65040233|NCT00412698|Rimonabant|rimonabant|mesh-list
65290270|NCT04166786|Androgens|androgens|mesh-ancestor
65290272|NCT04166786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65290273|NCT04166786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290274|NCT04166786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65290275|NCT04166786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290276|NCT04166786|Anabolic Agents|anabolic agents|mesh-ancestor
65290277|NCT04166786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65290278|NCT04166786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290279|NCT04166786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65290280|NCT04166786|Emollients|emollients|mesh-ancestor
65290281|NCT04166786|Dermatologic Agents|dermatologic agents|mesh-ancestor
65290282|NCT02727647|Factor VIII|factor viii|mesh-list
65104927|NCT05321316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65104928|NCT05321316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104929|NCT05466149|Aflutinib|aflutinib|mesh-list
65104930|NCT05466149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65104931|NCT05466149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104932|NCT05466149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104933|NCT00532701|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65104934|NCT00532701|Interferon-alpha|interferon-alpha|mesh-list
65104935|NCT00532701|Ribavirin|ribavirin|mesh-list
65104936|NCT00532701|Antiviral Agents|antiviral agents|mesh-ancestor
65104937|NCT00532701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65104938|NCT00532701|Immunologic Factors|immunologic factors|mesh-ancestor
65104939|NCT00532701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104940|NCT00532701|Antimetabolites|antimetabolites|mesh-ancestor
65104941|NCT00532701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104942|NCT01276639|Tofacitinib|tofacitinib|mesh-list
65104943|NCT01276639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65104944|NCT01276639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104945|NCT01276639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104946|NCT04449198|Resveratrol|resveratrol|mesh-list
65104947|NCT04449198|Antioxidants|antioxidants|mesh-ancestor
65104948|NCT04449198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104949|NCT04449198|Protective Agents|protective agents|mesh-ancestor
65104950|NCT04449198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104951|NCT04449198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104952|NCT04449198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65104954|NCT00532415|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65104955|NCT00532415|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65104956|NCT00532415|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65104957|NCT00532415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65104958|NCT00532415|Glucocorticoids|glucocorticoids|mesh-ancestor
65104959|NCT00532415|Hormones|hormones|mesh-ancestor
65104960|NCT00532415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65104961|NCT00532415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104962|NCT00532415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65104963|NCT00532415|Immunologic Factors|immunologic factors|mesh-ancestor
65104964|NCT00532415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290283|NCT02727647|Coagulants|coagulants|mesh-ancestor
65290284|NCT00723502|Amoxicillin|amoxicillin|mesh-list
65290285|NCT00723502|Finafloxacin|finafloxacin|mesh-list
65290286|NCT00723502|Fluoroquinolones|fluoroquinolones|mesh-list
65290287|NCT00723502|Esomeprazole|esomeprazole|mesh-list
65290288|NCT00723502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65290289|NCT00723502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290290|NCT00723502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65290291|NCT00723502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65290292|NCT00723502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65290293|NCT00723502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290294|NCT00723502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290295|NCT00723502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65290296|NCT00723502|Renal Agents|renal agents|mesh-ancestor
65290297|NCT00723502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65290298|NCT00723502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65290299|NCT00723502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290300|NCT00723502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65290301|NCT02727881|Squalamine|squalamine|mesh-list
65290302|NCT02727881|Ranibizumab|ranibizumab|mesh-list
65290303|NCT02727881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65290304|NCT02727881|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65290305|NCT02727881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65290306|NCT02727881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64520508|NCT03208452|Analgesics|analgesics|mesh-ancestor
65104965|NCT00532415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104966|NCT00532454|Tamoxifen|tamoxifen|mesh-list
65104968|NCT00532454|Hormone Antagonists|hormone antagonists|mesh-ancestor
65104969|NCT00532454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65104970|NCT00532454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104971|NCT00532454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65104972|NCT00532454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104973|NCT00532454|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65104974|NCT00532454|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65104975|NCT00532454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65104976|NCT01275625|Maraviroc|maraviroc|mesh-list
65104977|NCT01275625|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65104978|NCT01275625|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65104979|NCT01275625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104980|NCT01275625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65104981|NCT01275625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65104992|NCT05459792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65104993|NCT05459792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65104994|NCT05459792|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65104995|NCT05459792|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65104996|NCT05459792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65104997|NCT05459792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104998|NCT04686825|DA-8010|da-8010|mesh-list
65104999|NCT04686825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65290307|NCT02727881|Growth Substances|growth substances|mesh-ancestor
65290308|NCT02727881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290309|NCT02727881|Growth Inhibitors|growth inhibitors|mesh-ancestor
65290310|NCT02727881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290311|NCT02727881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65290312|NCT02727881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290313|NCT02727881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65105000|NCT04686825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65105001|NCT04686825|Cholinergic Agents|cholinergic agents|mesh-ancestor
65105002|NCT04686825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65105003|NCT04686825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105004|NCT04686825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105005|NCT00533988|Anti-Infective Agents|anti-infective agents|mesh-list
65105006|NCT00533988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65105007|NCT05281185|Factor VIII|factor viii|mesh-list
65105008|NCT05281185|Coagulants|coagulants|mesh-ancestor
65105009|NCT00532532|Tolperisone|tolperisone|mesh-list
65105010|NCT00532532|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65105011|NCT00532532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105012|NCT00532532|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65105013|NCT00532532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65105014|NCT00532571|Coenzyme Q10|coenzyme q10|mesh-list
65105015|NCT00532571|Vitamins|vitamins|mesh-ancestor
65105016|NCT00532571|Micronutrients|micronutrients|mesh-ancestor
65105017|NCT00532571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105018|NCT04322565|Colchicine|colchicine|mesh-list
65105019|NCT04322565|Gout Suppressants|gout suppressants|mesh-ancestor
65105020|NCT04322565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65105021|NCT04322565|Tubulin Modulators|tubulin modulators|mesh-ancestor
64747231|NCT04408326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65105022|NCT04322565|Antimitotic Agents|antimitotic agents|mesh-ancestor
65105023|NCT04322565|Mitosis Modulators|mitosis modulators|mesh-ancestor
65105024|NCT04322565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105025|NCT04322565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105026|NCT04312503|Olanzapine|olanzapine|mesh-list
65105027|NCT04312503|Risperidone|risperidone|mesh-list
65105028|NCT04312503|Aripiprazole|aripiprazole|mesh-list
65105029|NCT04312503|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65105030|NCT04312503|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65105031|NCT04312503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65105032|NCT04312503|Serotonin Agents|serotonin agents|mesh-ancestor
65105033|NCT04312503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65105034|NCT04312503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105035|NCT04312503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105036|NCT04312503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65105037|NCT04312503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65105038|NCT04312503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65105039|NCT04312503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65105040|NCT04312503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65105041|NCT04312503|Dopamine Agents|dopamine agents|mesh-ancestor
65105042|NCT04312503|Antiemetics|antiemetics|mesh-ancestor
65105043|NCT04312503|Autonomic Agents|autonomic agents|mesh-ancestor
65105044|NCT04312503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65105045|NCT04312503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65105046|NCT04312503|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64677418|NCT00001965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65105060|NCT00532688|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65105061|NCT00532688|Antiviral Agents|antiviral agents|mesh-ancestor
65105062|NCT00532688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65105063|NCT00532688|Expectorants|expectorants|mesh-ancestor
65105064|NCT00532688|Respiratory System Agents|respiratory system agents|mesh-ancestor
65105065|NCT00532688|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65105066|NCT00532688|Antioxidants|antioxidants|mesh-ancestor
65105067|NCT00532688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105068|NCT00532688|Protective Agents|protective agents|mesh-ancestor
65105069|NCT00532688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105070|NCT00532688|Antidotes|antidotes|mesh-ancestor
65105071|NCT00534144|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65105072|NCT00534144|Ferric gluconate|ferric gluconate|mesh-list
65105073|NCT00534144|Hematinics|hematinics|mesh-ancestor
65105074|NCT00534183|Haloperidol|haloperidol|mesh-list
65290314|NCT02727881|Protective Agents|protective agents|mesh-ancestor
65290315|NCT01564381|Resveratrol|resveratrol|mesh-list
65290316|NCT01564381|Antioxidants|antioxidants|mesh-ancestor
65290317|NCT01564381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290318|NCT01564381|Protective Agents|protective agents|mesh-ancestor
65290319|NCT01564381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290320|NCT01564381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290321|NCT01564381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65290322|NCT04164524|Gentamicins|gentamicins|mesh-list
65290323|NCT04164524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65290324|NCT04164524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290325|NCT04164524|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65290326|NCT04164524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290327|NCT04164524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290328|NCT00723658|Cytarabine|cytarabine|mesh-list
65290329|NCT00723658|Thalidomide|thalidomide|mesh-list
65290330|NCT00723658|Dexamethasone|dexamethasone|mesh-list
65290331|NCT00723658|Cyclophosphamide|cyclophosphamide|mesh-list
65290332|NCT00723658|Melphalan|melphalan|mesh-list
65290333|NCT00723658|Carmustine|carmustine|mesh-list
65290334|NCT00723658|Rituximab|rituximab|mesh-list
65290335|NCT00723658|Doxorubicin|doxorubicin|mesh-list
65290336|NCT00723658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65290337|NCT00723658|Etoposide|etoposide|mesh-list
65290338|NCT00723658|Bortezomib|bortezomib|mesh-list
65290339|NCT00723658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65290340|NCT00723658|Immunologic Factors|immunologic factors|mesh-ancestor
65290341|NCT00723658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290342|NCT00723658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65290343|NCT00723658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65290344|NCT00723658|Alkylating Agents|alkylating agents|mesh-ancestor
65290345|NCT00723658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290346|NCT00723658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290347|NCT00723658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65290348|NCT00723658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65290350|NCT00723658|Antiemetics|antiemetics|mesh-ancestor
65290351|NCT00723658|Autonomic Agents|autonomic agents|mesh-ancestor
64520536|NCT00355966|Abortifacient Agents|abortifacient agents|mesh-ancestor
65105075|NCT00534183|Olanzapine|olanzapine|mesh-list
65105076|NCT00534183|Risperidone|risperidone|mesh-list
65290352|NCT00723658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65290353|NCT00723658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65290354|NCT00723658|Glucocorticoids|glucocorticoids|mesh-ancestor
65290355|NCT00723658|Hormones|hormones|mesh-ancestor
65290356|NCT00723658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65290357|NCT00723658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65290358|NCT00723658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65290359|NCT00723658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65290360|NCT00723658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65290361|NCT00723658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290362|NCT00723658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65290363|NCT00723658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65290364|NCT00723658|Antimetabolites|antimetabolites|mesh-ancestor
65290365|NCT00723658|Antiviral Agents|antiviral agents|mesh-ancestor
65290366|NCT00723658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290367|NCT00723658|Leprostatic Agents|leprostatic agents|mesh-ancestor
65290368|NCT00723658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65290369|NCT00723658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65290370|NCT00723658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65290371|NCT00723658|Growth Substances|growth substances|mesh-ancestor
65290372|NCT00723658|Growth Inhibitors|growth inhibitors|mesh-ancestor
65290373|NCT04139850|Antiviral Agents|antiviral agents|mesh-list
65290374|NCT04139850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290375|NCT02638142|Furosemide|furosemide|mesh-list
65105077|NCT00534183|Haloperidol decanoate|haloperidol decanoate|mesh-list
65105078|NCT00534183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65105079|NCT00534183|Serotonin Agents|serotonin agents|mesh-ancestor
65105080|NCT00534183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65105081|NCT00534183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105082|NCT00534183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105083|NCT00534183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65105084|NCT00534183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65105085|NCT00534183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65105086|NCT00534183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65105087|NCT00534183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65105088|NCT00534183|Dopamine Agents|dopamine agents|mesh-ancestor
65105089|NCT00534183|Antiemetics|antiemetics|mesh-ancestor
65105090|NCT00534183|Autonomic Agents|autonomic agents|mesh-ancestor
65105091|NCT00534183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65105092|NCT00534183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65105093|NCT00534183|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65105094|NCT00534183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65105095|NCT00534183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65105096|NCT00534183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65105097|NCT04269408|Nicardipine|nicardipine|mesh-list
65105098|NCT04269408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65105099|NCT04269408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65105100|NCT04269408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65105101|NCT04269408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290376|NCT02638142|Diuretics|diuretics|mesh-ancestor
65290377|NCT02638142|Natriuretic Agents|natriuretic agents|mesh-ancestor
65290378|NCT02638142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290379|NCT02638142|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65290380|NCT02638142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65290381|NCT02638142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290382|NCT02727491|Dextromethorphan|dextromethorphan|mesh-list
65290383|NCT02727491|Antitussive Agents|antitussive agents|mesh-ancestor
65290384|NCT02727491|Respiratory System Agents|respiratory system agents|mesh-ancestor
65290385|NCT02727491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65290386|NCT02727491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65290387|NCT02727491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65290388|NCT02727491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290389|NCT02727491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290390|NCT03562195|Albuterol|albuterol|mesh-list
65290391|NCT03562195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65290392|NCT03562195|Autonomic Agents|autonomic agents|mesh-ancestor
65290393|NCT03562195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65290394|NCT03562195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290395|NCT03562195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65290396|NCT03562195|Respiratory System Agents|respiratory system agents|mesh-ancestor
65290397|NCT03562195|Tocolytic Agents|tocolytic agents|mesh-ancestor
65290398|NCT03562195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65290399|NCT03562195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65290400|NCT03562195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65290401|NCT03562195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65290402|NCT03562195|Adrenergic Agents|adrenergic agents|mesh-ancestor
64520596|NCT02451852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105102|NCT04269408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65105103|NCT04269408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105104|NCT04269408|Vasodilator Agents|vasodilator agents|mesh-ancestor
65105116|NCT04261218|Antimitotic Agents|antimitotic agents|mesh-ancestor
65105117|NCT04261218|Mitosis Modulators|mitosis modulators|mesh-ancestor
65105118|NCT04261218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105120|NCT04687449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65105121|NCT04687449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65105123|NCT04687449|Sensory System Agents|sensory system agents|mesh-ancestor
65105124|NCT04687449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65105125|NCT04687449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105126|NCT04687449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65105127|NCT04687449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65105128|NCT04687449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290403|NCT03562195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65290404|NCT03562195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290405|NCT00686868|Ofatumumab|ofatumumab|mesh-list
65290406|NCT00686868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290407|NCT00992329|Ciprofloxacin|ciprofloxacin|mesh-list
65290408|NCT00992329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65290409|NCT00992329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290410|NCT00992329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65290411|NCT00992329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65290412|NCT00992329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290413|NCT00992329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290414|NCT00992329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290415|NCT00992329|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65290416|NCT00992329|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65290417|NCT03650894|Nivolumab|nivolumab|mesh-list
65290418|NCT03650894|Ipilimumab|ipilimumab|mesh-list
65040377|NCT02277730|Respiratory System Agents|respiratory system agents|mesh-ancestor
64520624|NCT04485156|Isoniazid|isoniazid|mesh-list
65105129|NCT04687449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105130|NCT04687449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105131|NCT05258279|Carboplatin|carboplatin|mesh-list
65105132|NCT05258279|Pembrolizumab|pembrolizumab|mesh-list
65105133|NCT05258279|Pemetrexed|pemetrexed|mesh-list
65105134|NCT05258279|Lenvatinib|lenvatinib|mesh-list
65105135|NCT05258279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105136|NCT05258279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65105137|NCT05258279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105138|NCT05258279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105139|NCT05258279|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65105140|NCT05258279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65105141|NCT05258279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65105142|NCT00532818|Hydralazine|hydralazine|mesh-list
65105143|NCT00532818|Valproic Acid|valproic acid|mesh-list
65105144|NCT00532818|Anticonvulsants|anticonvulsants|mesh-ancestor
65105145|NCT00532818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105146|NCT00532818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105147|NCT00532818|GABA Agents|gaba agents|mesh-ancestor
65105148|NCT00532818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65105149|NCT00532818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105150|NCT00532818|Antimanic Agents|antimanic agents|mesh-ancestor
65105151|NCT00532818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65105152|NCT00532818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65105153|NCT00532818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65105154|NCT00532818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65105155|NCT00532818|Vasodilator Agents|vasodilator agents|mesh-ancestor
65105156|NCT05209035|Trazodone|trazodone|mesh-list
65105157|NCT05209035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65105158|NCT05209035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65105159|NCT05209035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65105160|NCT05209035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105161|NCT05209035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65105162|NCT05209035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65105163|NCT05209035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65105164|NCT05209035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65105165|NCT05209035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105166|NCT05209035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65290419|NCT03650894|Bicalutamide|bicalutamide|mesh-list
65290420|NCT03650894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65290421|NCT03650894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290422|NCT03650894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65290423|NCT03650894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290424|NCT03650894|Androgen Antagonists|androgen antagonists|mesh-ancestor
65290425|NCT03650894|Hormone Antagonists|hormone antagonists|mesh-ancestor
65290426|NCT03650894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65290427|NCT03650894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290428|NCT03090776|Ketamine|ketamine|mesh-list
65290429|NCT03090776|Analgesics|analgesics|mesh-ancestor
65290430|NCT03090776|Sensory System Agents|sensory system agents|mesh-ancestor
65290431|NCT03090776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65344921|NCT00736346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105167|NCT05209035|Serotonin Agents|serotonin agents|mesh-ancestor
65105168|NCT05209035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64677609|NCT00359333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677610|NCT00359333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64677611|NCT00359333|Immunologic Factors|immunologic factors|mesh-ancestor
64677612|NCT00359333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105173|NCT00534261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105175|NCT00534261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65105176|NCT00534261|Immunologic Factors|immunologic factors|mesh-ancestor
65105177|NCT00534261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105178|NCT00534261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65105179|NCT00532857|Gemcitabine|gemcitabine|mesh-list
65105180|NCT00532857|Paclitaxel|paclitaxel|mesh-list
65105181|NCT00532857|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65105182|NCT00532857|Trastuzumab|trastuzumab|mesh-list
65105183|NCT00532857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65105184|NCT00532857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105185|NCT00532857|Tubulin Modulators|tubulin modulators|mesh-ancestor
65105186|NCT00532857|Antimitotic Agents|antimitotic agents|mesh-ancestor
65105187|NCT00532857|Mitosis Modulators|mitosis modulators|mesh-ancestor
64483915|NCT00789256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65105188|NCT00532857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105189|NCT00532857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65105190|NCT00532857|Antimetabolites|antimetabolites|mesh-ancestor
65105191|NCT00532857|Antiviral Agents|antiviral agents|mesh-ancestor
65105192|NCT00532857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65105193|NCT00532857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105194|NCT00532857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65105195|NCT00532857|Immunologic Factors|immunologic factors|mesh-ancestor
65105196|NCT00532857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105197|NCT00532857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65105198|NCT05201300|Propofol|propofol|mesh-list
65105199|NCT05201300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65105200|NCT05201300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65105201|NCT05201300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105202|NCT05201300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65105203|NCT05201300|Anesthetics, General|anesthetics, general|mesh-ancestor
65105204|NCT05201300|Anesthetics|anesthetics|mesh-ancestor
65105205|NCT05152004|Amoxicillin|amoxicillin|mesh-list
65105206|NCT05152004|Metronidazole|metronidazole|mesh-list
65105207|NCT05152004|Clarithromycin|clarithromycin|mesh-list
65105208|NCT05152004|Rabeprazole|rabeprazole|mesh-list
65105209|NCT05152004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65105210|NCT05152004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65105211|NCT05152004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65105212|NCT05152004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65105213|NCT05152004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65290432|NCT03090776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290433|NCT03090776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65290434|NCT03090776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65290435|NCT03090776|Anesthetics, General|anesthetics, general|mesh-ancestor
65290436|NCT03090776|Anesthetics|anesthetics|mesh-ancestor
65290437|NCT03090776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65290438|NCT03090776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65290439|NCT03090776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65290440|NCT03090776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65290441|NCT03090776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290442|NCT02645864|Irinotecan|irinotecan|mesh-list
65290443|NCT02645864|Apatinib|apatinib|mesh-list
65290444|NCT02645864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65290445|NCT02645864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65290446|NCT02645864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290447|NCT02645864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520654|NCT04637620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105214|NCT05152004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105215|NCT05152004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105216|NCT05152004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65105217|NCT05152004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65105218|NCT05152004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65105219|NCT05152004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65105220|NCT05152004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65105221|NCT05132153|Milrinone|milrinone|mesh-list
65105222|NCT05132153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65105223|NCT05132153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65105224|NCT05132153|Vasodilator Agents|vasodilator agents|mesh-ancestor
65105225|NCT05132153|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65105226|NCT05132153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65105227|NCT05132153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105228|NCT05132153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105229|NCT05132153|Protective Agents|protective agents|mesh-ancestor
65105230|NCT05132153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105231|NCT00534378|Midazolam|midazolam|mesh-list
65105232|NCT00534378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65105233|NCT00534378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65105234|NCT00534378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65105235|NCT00534378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105236|NCT00534378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65105251|NCT05131997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105252|NCT05131997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65105253|NCT05131997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65105254|NCT05131997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105255|NCT00534456|Darbepoetin alfa|darbepoetin alfa|mesh-list
65105256|NCT00534456|Hematinics|hematinics|mesh-ancestor
65105257|NCT05104229|Aspirin|aspirin|mesh-list
65105258|NCT05104229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65105259|NCT05104229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65105260|NCT05104229|Analgesics|analgesics|mesh-ancestor
65105261|NCT05104229|Sensory System Agents|sensory system agents|mesh-ancestor
65105262|NCT05104229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65105263|NCT05104229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105264|NCT05104229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65290448|NCT02645864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290449|NCT02645864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65290450|NCT00674856|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
65290451|NCT00674856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65290452|NCT00674856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290453|NCT02574130|Amikacin|amikacin|mesh-list
65290454|NCT02574130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65290455|NCT02574130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290456|NCT00652184|Valacyclovir|valacyclovir|mesh-list
65290457|NCT00652184|Sorivudine|sorivudine|mesh-list
65290458|NCT00652184|Antiviral Agents|antiviral agents|mesh-ancestor
65290459|NCT00652184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290460|NCT00652184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290461|NCT00652184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290462|NCT02726867|Lacosamide|lacosamide|mesh-list
65290463|NCT02726867|Ketamine|ketamine|mesh-list
65290464|NCT02726867|Levetiracetam|levetiracetam|mesh-list
65290465|NCT02726867|Phenobarbital|phenobarbital|mesh-list
65290466|NCT02726867|Analgesics|analgesics|mesh-ancestor
65290467|NCT02726867|Sensory System Agents|sensory system agents|mesh-ancestor
65290468|NCT02726867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65290469|NCT02726867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290470|NCT02726867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65290471|NCT02726867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65290472|NCT02726867|Anesthetics, General|anesthetics, general|mesh-ancestor
65290473|NCT02726867|Anesthetics|anesthetics|mesh-ancestor
65290474|NCT02726867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65290475|NCT02726867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65105265|NCT05104229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65105266|NCT05104229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65105267|NCT05104229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65105268|NCT05104229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105269|NCT05104229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65105270|NCT05104229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65105271|NCT05104229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105272|NCT05104229|Antipyretics|antipyretics|mesh-ancestor
65105273|NCT04153032|Diltiazem|diltiazem|mesh-list
65105274|NCT04153032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65105275|NCT04153032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65105276|NCT04153032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65105277|NCT04153032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105278|NCT04153032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65105279|NCT04153032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105280|NCT04153032|Vasodilator Agents|vasodilator agents|mesh-ancestor
65105281|NCT00532961|Loteprednol Etabonate|loteprednol etabonate|mesh-list
65105282|NCT00532961|Tobramycin|tobramycin|mesh-list
65105283|NCT00532961|Dexamethasone|dexamethasone|mesh-list
65105284|NCT00532961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65290476|NCT02726867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65290477|NCT02726867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65290478|NCT02726867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290479|NCT02726867|Anticonvulsants|anticonvulsants|mesh-ancestor
65290480|NCT02726867|Nootropic Agents|nootropic agents|mesh-ancestor
65290481|NCT02726867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65290482|NCT02726867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65290483|NCT02726867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65290484|NCT02726867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65290485|NCT02726867|GABA Modulators|gaba modulators|mesh-ancestor
65290486|NCT02726867|GABA Agents|gaba agents|mesh-ancestor
65290487|NCT02726867|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65290488|NCT02726867|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65290489|NCT02726867|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65105285|NCT00532961|Antiemetics|antiemetics|mesh-ancestor
65105286|NCT00532961|Autonomic Agents|autonomic agents|mesh-ancestor
65105287|NCT00532961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65105288|NCT00532961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105289|NCT00532961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65105290|NCT00532961|Glucocorticoids|glucocorticoids|mesh-ancestor
65105291|NCT00532961|Hormones|hormones|mesh-ancestor
65105292|NCT00532961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65105293|NCT00532961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65105294|NCT00532961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105295|NCT00532961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65105296|NCT00532961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65105297|NCT00532961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65105298|NCT00534573|Amisulpride|amisulpride|mesh-list
65105309|NCT00534573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65105310|NCT00534573|Antidepressive Agents|antidepressive agents|mesh-ancestor
65105311|NCT00534573|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65105313|NCT04686890|Acetaminophen|acetaminophen|mesh-list
65105314|NCT04686890|Tramadol|tramadol|mesh-list
65105315|NCT04686890|Analgesics|analgesics|mesh-list
65105316|NCT04686890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65105317|NCT04686890|Sensory System Agents|sensory system agents|mesh-ancestor
65105318|NCT04686890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65105319|NCT04686890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105320|NCT04686890|Antipyretics|antipyretics|mesh-ancestor
65105321|NCT04686890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65105322|NCT04686890|Narcotics|narcotics|mesh-ancestor
65105323|NCT04686890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65105324|NCT00533039|Varespladib methyl|varespladib methyl|mesh-list
65105325|NCT00533039|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
65105326|NCT00533039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105327|NCT00533039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105328|NCT05103306|Empagliflozin|empagliflozin|mesh-list
65105329|NCT05103306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65105330|NCT05103306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105331|NCT05103306|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65105332|NCT05103306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105333|NCT05047952|Vortioxetine|vortioxetine|mesh-list
65105334|NCT05047952|Antidepressive Agents|antidepressive agents|mesh-ancestor
65105335|NCT05047952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65105336|NCT05047952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65105337|NCT05047952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65105338|NCT05047952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65105339|NCT05047952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105340|NCT05047952|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65290490|NCT00723970|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65290491|NCT00723970|Antidepressive Agents|antidepressive agents|mesh-ancestor
65290492|NCT00723970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65040450|NCT00124241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290494|NCT00723970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65290495|NCT00723970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65290496|NCT00723970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290497|NCT00873366|Tamoxifen|tamoxifen|mesh-list
65290498|NCT00873366|Dextromethorphan|dextromethorphan|mesh-list
65290499|NCT00873366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290500|NCT00873366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65290501|NCT00873366|Hormone Antagonists|hormone antagonists|mesh-ancestor
65290502|NCT00873366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65290503|NCT00873366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290504|NCT00873366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65290505|NCT00873366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290506|NCT00873366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64520715|NCT03223506|Antipyretics|antipyretics|mesh-ancestor
65105341|NCT05047952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65105342|NCT05047952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65105343|NCT05047952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105344|NCT05047952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65105345|NCT05047952|Serotonin Agents|serotonin agents|mesh-ancestor
65105346|NCT05047952|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65105347|NCT05047952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65105348|NCT05047952|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65105349|NCT05047952|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65105350|NCT00534651|Acetaminophen|acetaminophen|mesh-list
65105351|NCT00534651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65105352|NCT00534651|Analgesics|analgesics|mesh-ancestor
65105353|NCT00534651|Sensory System Agents|sensory system agents|mesh-ancestor
65105354|NCT00534651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65105355|NCT00534651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105356|NCT00534651|Antipyretics|antipyretics|mesh-ancestor
65105357|NCT05080959|Ropivacaine|ropivacaine|mesh-list
65105358|NCT05080959|Anesthetics, Local|anesthetics, local|mesh-ancestor
65105359|NCT05080959|Anesthetics|anesthetics|mesh-ancestor
65105360|NCT05080959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65105361|NCT05080959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105373|NCT04942730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65105374|NCT04942730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65105375|NCT04942730|Alkylating Agents|alkylating agents|mesh-ancestor
65105376|NCT04942730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105377|NCT04942730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105378|NCT04942730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65105379|NCT04942730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65105380|NCT04942730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105381|NCT04942730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65105382|NCT04942730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65105383|NCT04942730|Antitubercular Agents|antitubercular agents|mesh-ancestor
65105384|NCT04942730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65105385|NCT04942730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65105387|NCT01272193|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65105388|NCT01272193|Insulin Glargine|insulin glargine|mesh-list
65290507|NCT00873366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65290508|NCT00873366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65290509|NCT00873366|Antitussive Agents|antitussive agents|mesh-ancestor
65290510|NCT00873366|Respiratory System Agents|respiratory system agents|mesh-ancestor
65290511|NCT00873366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65290512|NCT00873366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65290513|NCT00873366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65290514|NCT00712894|Verapamil|verapamil|mesh-list
65290515|NCT00712894|Diltiazem|diltiazem|mesh-list
65290516|NCT00712894|Nitroglycerin|nitroglycerin|mesh-list
65290517|NCT00712894|Vasodilator Agents|vasodilator agents|mesh-ancestor
65290518|NCT00712894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64520732|NCT05716516|Estrogens|estrogens|mesh-ancestor
65105389|NCT01272193|Insulin Aspart|insulin aspart|mesh-list
65105390|NCT01272193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65105391|NCT01272193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105392|NCT04899206|Antidepressive Agents|antidepressive agents|mesh-list
65105393|NCT04899206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65105394|NCT04687163|Oxaliplatin|oxaliplatin|mesh-list
65105395|NCT04687163|Fluorouracil|fluorouracil|mesh-list
65105396|NCT04687163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105397|NCT04687163|Antimetabolites|antimetabolites|mesh-ancestor
65105398|NCT04687163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105399|NCT04687163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65105400|NCT04687163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65105401|NCT04687163|Immunologic Factors|immunologic factors|mesh-ancestor
65105402|NCT04687163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105404|NCT01270828|Analgesics|analgesics|mesh-ancestor
65105405|NCT01270828|Sensory System Agents|sensory system agents|mesh-ancestor
65105406|NCT01270828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65105407|NCT01270828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105408|NCT01270828|Anticonvulsants|anticonvulsants|mesh-ancestor
65105409|NCT01270828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65105410|NCT01270828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65105411|NCT01270828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105412|NCT01270828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65105413|NCT01270828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65105414|NCT01270828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65105415|NCT01270828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65105416|NCT01270828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65105417|NCT00533195|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
65105418|NCT00533195|Methoxsalen|methoxsalen|mesh-list
65105419|NCT00533195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65105420|NCT00533195|Dermatologic Agents|dermatologic agents|mesh-ancestor
65105421|NCT00533195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65105422|NCT03982407|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65105423|NCT03982407|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65105424|NCT03982407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105425|NCT01269385|Rituximab|rituximab|mesh-list
65105426|NCT01269385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65105427|NCT01269385|Alemtuzumab|alemtuzumab|mesh-list
65105436|NCT04687176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105438|NCT02071862|Docetaxel|docetaxel|mesh-list
65105439|NCT02071862|Everolimus|everolimus|mesh-list
65105440|NCT02071862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65105441|NCT02071862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105442|NCT02071862|Tubulin Modulators|tubulin modulators|mesh-ancestor
65105443|NCT02071862|Antimitotic Agents|antimitotic agents|mesh-ancestor
65105444|NCT02071862|Mitosis Modulators|mitosis modulators|mesh-ancestor
65105445|NCT02071862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105446|NCT02071862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65105447|NCT02071862|Immunologic Factors|immunologic factors|mesh-ancestor
65105448|NCT02071862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290519|NCT00712894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65290520|NCT00712894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65290521|NCT00712894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290522|NCT00712894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65290523|NCT00712894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290524|NCT00712894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65290525|NCT04164368|Lenalidomide|lenalidomide|mesh-list
65290526|NCT04164368|Immunologic Factors|immunologic factors|mesh-ancestor
65290527|NCT04164368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290528|NCT04164368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64892762|NCT01991158|Hormones|hormones|mesh-ancestor
65105449|NCT00535691|Tacrolimus|tacrolimus|mesh-list
65105450|NCT00535691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65105451|NCT00535691|Immunologic Factors|immunologic factors|mesh-ancestor
65105452|NCT00535691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105453|NCT00535691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65105454|NCT00535691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105455|NCT00535691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105456|NCT01268683|Glyburide|glyburide|mesh-list
65105457|NCT01268683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65105458|NCT01268683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105459|NCT02021474|Phenol|phenol|mesh-list
65105460|NCT02021474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65105461|NCT02021474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65105462|NCT02021474|Disinfectants|disinfectants|mesh-ancestor
65105463|NCT02021474|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65105464|NCT02021474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65105465|NCT01268293|Lenvatinib|lenvatinib|mesh-list
65105466|NCT01268293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105467|NCT01268293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65105468|NCT01268293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105469|NCT01268293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105470|NCT01803152|Gemcitabine|gemcitabine|mesh-list
65105471|NCT01803152|Imiquimod|imiquimod|mesh-list
65105472|NCT01803152|Vaccines|vaccines|mesh-list
64747686|NCT01418352|Serotonin Agents|serotonin agents|mesh-ancestor
65105473|NCT01803152|Immunologic Factors|immunologic factors|mesh-ancestor
65105474|NCT01803152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105475|NCT01803152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65105476|NCT01803152|Antimetabolites|antimetabolites|mesh-ancestor
65105477|NCT01803152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105478|NCT01803152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105479|NCT01803152|Antiviral Agents|antiviral agents|mesh-ancestor
65105480|NCT01803152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65105481|NCT01803152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105482|NCT01803152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65105483|NCT01803152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65105484|NCT01803152|Interferon Inducers|interferon inducers|mesh-ancestor
65105485|NCT04959825|Melatonin|melatonin|mesh-list
65105486|NCT04959825|Antioxidants|antioxidants|mesh-ancestor
65105487|NCT04959825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105488|NCT04959825|Protective Agents|protective agents|mesh-ancestor
65105489|NCT04959825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105490|NCT04959825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65105491|NCT05471453|Tocotrienols|tocotrienols|mesh-list
65105492|NCT05471453|Vitamin E|vitamin e|mesh-list
65105493|NCT05471453|Tocopherols|tocopherols|mesh-list
65105494|NCT05471453|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65105495|NCT05471453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65105496|NCT05471453|Immunologic Factors|immunologic factors|mesh-ancestor
65105509|NCT03457233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65105510|NCT03457233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105511|NCT03457233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65105512|NCT03457233|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65290529|NCT04164368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65290530|NCT04164368|Growth Substances|growth substances|mesh-ancestor
65290531|NCT04164368|Growth Inhibitors|growth inhibitors|mesh-ancestor
65290532|NCT04164368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290533|NCT02726555|Atorvastatin|atorvastatin|mesh-list
65290534|NCT02726555|Red yeast rice|red yeast rice|mesh-list
65290535|NCT02726555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65290536|NCT02726555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65290537|NCT02726555|Antimetabolites|antimetabolites|mesh-ancestor
65290538|NCT02726555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290539|NCT02726555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65290540|NCT02726555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65290541|NCT02726555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290542|NCT00536107|Docetaxel|docetaxel|mesh-list
65290543|NCT00536107|Gefitinib|gefitinib|mesh-list
65290544|NCT00536107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290545|NCT00536107|Tubulin Modulators|tubulin modulators|mesh-ancestor
65290546|NCT00536107|Antimitotic Agents|antimitotic agents|mesh-ancestor
65290547|NCT00536107|Mitosis Modulators|mitosis modulators|mesh-ancestor
65290548|NCT00536107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290549|NCT00536107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65105514|NCT03457233|Hormone Antagonists|hormone antagonists|mesh-ancestor
65105515|NCT00535808|Nitroprusside|nitroprusside|mesh-list
65105516|NCT00535808|Nitroglycerin|nitroglycerin|mesh-list
65105517|NCT00535808|Sevoflurane|sevoflurane|mesh-list
65105518|NCT00535808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65105519|NCT00535808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65105520|NCT00535808|Anesthetics, General|anesthetics, general|mesh-ancestor
65105521|NCT00535808|Anesthetics|anesthetics|mesh-ancestor
65105522|NCT00535808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65105523|NCT00535808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105524|NCT00535808|Vasodilator Agents|vasodilator agents|mesh-ancestor
65105525|NCT00535808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65105526|NCT00535808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65105527|NCT00535808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105528|NCT05471063|Fluconazole|fluconazole|mesh-list
65105529|NCT05471063|Amphotericin B|amphotericin b|mesh-list
65105530|NCT05471063|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65105531|NCT05471063|Flucytosine|flucytosine|mesh-list
65105532|NCT05471063|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
65105533|NCT05471063|Antifungal Agents|antifungal agents|mesh-ancestor
65105534|NCT05471063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65105535|NCT05471063|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65105536|NCT05471063|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65105537|NCT05471063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105538|NCT05471063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105539|NCT05471063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65105540|NCT05471063|Hormone Antagonists|hormone antagonists|mesh-ancestor
64483937|NCT02145676|Cholinergic Agents|cholinergic agents|mesh-ancestor
65105541|NCT05471063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65105542|NCT05471063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105543|NCT05471063|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65105544|NCT05471063|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65290550|NCT00536107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290551|NCT01022138|Cyclophosphamide|cyclophosphamide|mesh-list
65290552|NCT01022138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65290553|NCT01022138|Immunologic Factors|immunologic factors|mesh-ancestor
65290554|NCT01022138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290555|NCT01022138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65290556|NCT01022138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65290557|NCT01022138|Alkylating Agents|alkylating agents|mesh-ancestor
65290558|NCT01022138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290559|NCT01022138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290560|NCT01022138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65290561|NCT00724360|Trastuzumab|trastuzumab|mesh-list
65290562|NCT00724360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65105545|NCT05471063|Amebicides|amebicides|mesh-ancestor
65105546|NCT05471063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65105547|NCT05471063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65105548|NCT05471063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65105549|NCT05471063|Antimetabolites|antimetabolites|mesh-ancestor
65105550|NCT05471063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65105551|NCT05471063|Protease Inhibitors|protease inhibitors|mesh-ancestor
65105552|NCT05471063|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65105553|NCT05471063|Protective Agents|protective agents|mesh-ancestor
65105554|NCT05471063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105555|NCT04910100|Timolol|timolol|mesh-list
65105556|NCT04910100|Nebivolol|nebivolol|mesh-list
65105557|NCT04910100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65105558|NCT04910100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65105559|NCT04910100|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65105560|NCT04910100|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65105563|NCT04910100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105564|NCT04910100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105565|NCT04910100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65105566|NCT04910100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65105567|NCT04910100|Vasodilator Agents|vasodilator agents|mesh-ancestor
65105568|NCT04910100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65105569|NCT04910100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65105570|NCT04910100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65105571|NCT01268059|Paclitaxel|paclitaxel|mesh-list
65105572|NCT01268059|Carboplatin|carboplatin|mesh-list
65105573|NCT01268059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65105574|NCT01268059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105575|NCT01268059|Tubulin Modulators|tubulin modulators|mesh-ancestor
65105576|NCT01268059|Antimitotic Agents|antimitotic agents|mesh-ancestor
65105577|NCT01268059|Mitosis Modulators|mitosis modulators|mesh-ancestor
65105578|NCT01268059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105579|NCT01267825|Bupivacaine|bupivacaine|mesh-list
65105580|NCT01267825|Anesthetics, Local|anesthetics, local|mesh-ancestor
65105581|NCT01267825|Anesthetics|anesthetics|mesh-ancestor
65105582|NCT01267825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65105583|NCT01267825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105584|NCT01267825|Sensory System Agents|sensory system agents|mesh-ancestor
65105585|NCT01267825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65105586|NCT00536003|Progesterone|progesterone|mesh-list
65105587|NCT00536003|Progestins|progestins|mesh-ancestor
65105588|NCT00536003|Hormones|hormones|mesh-ancestor
65105589|NCT00536003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65105590|NCT00536003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105591|NCT00533091|Sifalimumab|sifalimumab|mesh-list
65105592|NCT00533091|Immunologic Factors|immunologic factors|mesh-ancestor
65105593|NCT00533091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105594|NCT00536042|Minocycline|minocycline|mesh-list
65105595|NCT00536042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65290563|NCT00724360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290564|NCT02637830|Fluorides|fluorides|mesh-list
65290565|NCT02637830|Fluorides, Topical|fluorides, topical|mesh-list
65290566|NCT02637830|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
65290567|NCT02637830|Cariostatic Agents|cariostatic agents|mesh-ancestor
65290568|NCT02637830|Protective Agents|protective agents|mesh-ancestor
65290569|NCT02637830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290571|NCT00687258|Vitamins|vitamins|mesh-ancestor
65290572|NCT00687258|Micronutrients|micronutrients|mesh-ancestor
65290573|NCT00687258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290574|NCT00687258|Antioxidants|antioxidants|mesh-ancestor
65290575|NCT00687258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290576|NCT00687258|Protective Agents|protective agents|mesh-ancestor
65290577|NCT04001569|Paclitaxel|paclitaxel|mesh-list
65290578|NCT04001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65290579|NCT04001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105596|NCT00536042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65105597|NCT01606384|Vasopressins|vasopressins|mesh-list
65105598|NCT01606384|Arginine Vasopressin|arginine vasopressin|mesh-list
65105599|NCT01606384|Hemostatics|hemostatics|mesh-ancestor
65105600|NCT01606384|Coagulants|coagulants|mesh-ancestor
65105601|NCT01606384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65105602|NCT01606384|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65105603|NCT01606384|Natriuretic Agents|natriuretic agents|mesh-ancestor
65105604|NCT01606384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105605|NCT01606462|Oxytocin|oxytocin|mesh-list
65105606|NCT01606462|Oxytocics|oxytocics|mesh-ancestor
65105607|NCT01606462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65105608|NCT01606462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105609|NCT05470595|Atezolizumab|atezolizumab|mesh-list
65105610|NCT05470595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105611|NCT01606540|Ibuprofen|ibuprofen|mesh-list
65105612|NCT01606540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65105613|NCT01606540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65105614|NCT01606540|Analgesics|analgesics|mesh-ancestor
65105615|NCT01606540|Sensory System Agents|sensory system agents|mesh-ancestor
65105616|NCT01606540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65105617|NCT01606540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105618|NCT01606540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65105619|NCT01606540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65105620|NCT01606540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65105621|NCT01606540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105622|NCT01606540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105623|NCT00533169|Tretinoin|tretinoin|mesh-list
65105624|NCT00533169|Isotretinoin|isotretinoin|mesh-list
65105625|NCT00533169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105626|NCT00533169|Keratolytic Agents|keratolytic agents|mesh-ancestor
65105627|NCT00533169|Dermatologic Agents|dermatologic agents|mesh-ancestor
65105628|NCT00593710|Losartan|losartan|mesh-list
65105629|NCT00593710|Atenolol|atenolol|mesh-list
65105630|NCT00593710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65105631|NCT00593710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65105632|NCT00593710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65105633|NCT00593710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65105647|NCT04885686|Hydrocortisone|hydrocortisone|mesh-list
65105648|NCT04885686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65105649|NCT04885686|Antiemetics|antiemetics|mesh-ancestor
65105650|NCT04885686|Autonomic Agents|autonomic agents|mesh-ancestor
65105651|NCT04885686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65105652|NCT04885686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105653|NCT04885686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65105654|NCT04885686|Glucocorticoids|glucocorticoids|mesh-ancestor
65290580|NCT04001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
65290581|NCT04001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
65290582|NCT04001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
65290583|NCT04001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290584|NCT00692016|Naproxen|naproxen|mesh-list
65290585|NCT00692016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65290586|NCT00692016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65105655|NCT04885686|Hormones|hormones|mesh-ancestor
65105656|NCT04885686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65105657|NCT04885686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65105658|NCT04885686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105659|NCT04885686|Disinfectants|disinfectants|mesh-ancestor
65105660|NCT04885686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65105661|NCT04885686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65105662|NCT04885686|Antifungal Agents|antifungal agents|mesh-ancestor
65105663|NCT00594217|Progesterone|progesterone|mesh-list
65105664|NCT00594217|Progestins|progestins|mesh-ancestor
65105665|NCT00594217|Hormones|hormones|mesh-ancestor
65105666|NCT00594217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65105667|NCT00594217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105668|NCT00536237|Niacin|niacin|mesh-list
65105669|NCT00536237|Niacinamide|niacinamide|mesh-list
65105670|NCT00536237|Nicotinic Acids|nicotinic acids|mesh-list
65105671|NCT00536237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105672|NCT00536237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105673|NCT00536237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65105674|NCT00536237|Antimetabolites|antimetabolites|mesh-ancestor
65105675|NCT00536237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65105676|NCT00536237|Vasodilator Agents|vasodilator agents|mesh-ancestor
65105677|NCT00536237|Vitamin B Complex|vitamin b complex|mesh-ancestor
65105678|NCT00536237|Vitamins|vitamins|mesh-ancestor
65105679|NCT00536237|Micronutrients|micronutrients|mesh-ancestor
65105680|NCT00533247|Celecoxib|celecoxib|mesh-list
65105681|NCT00533247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65105682|NCT00533247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65105683|NCT00533247|Analgesics|analgesics|mesh-ancestor
65105684|NCT00533247|Sensory System Agents|sensory system agents|mesh-ancestor
65105685|NCT00533247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65105686|NCT00533247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105687|NCT00533247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65105688|NCT00533247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65105689|NCT00533247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65105690|NCT00533247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65105691|NCT00533247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105692|NCT00533247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105693|NCT01260181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65105694|NCT01260181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105695|NCT01260181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65105696|NCT01260181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678067|NCT04983407|Antimetabolites|antimetabolites|mesh-ancestor
65105709|NCT02690064|Tocopherols|tocopherols|mesh-list
65105710|NCT02690064|Tocotrienols|tocotrienols|mesh-list
65105711|NCT02690064|alpha-Tocopherol|alpha-tocopherol|mesh-list
65105712|NCT02690064|Thioctic Acid|thioctic acid|mesh-list
65105713|NCT02690064|Ubiquinone|ubiquinone|mesh-list
65105714|NCT02690064|Resveratrol|resveratrol|mesh-list
65105715|NCT02690064|Antioxidants|antioxidants|mesh-list
65105716|NCT02690064|Micronutrients|micronutrients|mesh-ancestor
65105717|NCT02690064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105718|NCT02690064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105719|NCT02690064|Protective Agents|protective agents|mesh-ancestor
65105720|NCT02690064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105721|NCT02690064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65105722|NCT02690064|Vitamin B Complex|vitamin b complex|mesh-ancestor
65105723|NCT00594373|Tenofovir|tenofovir|mesh-list
65105724|NCT00594373|Antiviral Agents|antiviral agents|mesh-ancestor
65105725|NCT00594373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65105726|NCT00594373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65105727|NCT00594373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65290587|NCT00692016|Analgesics|analgesics|mesh-ancestor
65290588|NCT00692016|Sensory System Agents|sensory system agents|mesh-ancestor
65290589|NCT00692016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65290590|NCT00692016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290591|NCT00692016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65290592|NCT00692016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65290593|NCT00692016|Gout Suppressants|gout suppressants|mesh-ancestor
65290594|NCT00692016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65290595|NCT00692016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290596|NCT00692016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105728|NCT00594373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105729|NCT00594373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105730|NCT00594373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65105731|NCT00594373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65105732|NCT05470166|Lidocaine|lidocaine|mesh-list
65105733|NCT05470166|Anesthetics, Local|anesthetics, local|mesh-ancestor
65105734|NCT05470166|Anesthetics|anesthetics|mesh-ancestor
65105735|NCT05470166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65105736|NCT05470166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105737|NCT05470166|Sensory System Agents|sensory system agents|mesh-ancestor
65105738|NCT05470166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65105739|NCT05470166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65105740|NCT05470166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65105741|NCT05470166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65105742|NCT05470166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65105743|NCT05470166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105744|NCT02496585|Prednisone|prednisone|mesh-list
65105745|NCT02496585|Nintedanib|nintedanib|mesh-list
65105746|NCT02496585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65105747|NCT02496585|Glucocorticoids|glucocorticoids|mesh-ancestor
65105748|NCT02496585|Hormones|hormones|mesh-ancestor
65105749|NCT02496585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65105750|NCT02496585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105751|NCT02496585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65105752|NCT02496585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105753|NCT02496585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65105754|NCT02496585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105755|NCT02496585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105756|NCT01260142|Propofol|propofol|mesh-list
65105757|NCT01260142|Fospropofol|fospropofol|mesh-list
65105758|NCT01260142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65105759|NCT01260142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65105760|NCT01260142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105761|NCT01260142|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65105768|NCT05469659|Metformin|metformin|mesh-list
65105769|NCT05469659|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
65105770|NCT05469659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65105771|NCT05469659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105772|NCT05469659|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65105773|NCT05469659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105774|NCT01808820|Imiquimod|imiquimod|mesh-list
65105775|NCT01808820|Vaccines|vaccines|mesh-list
65105776|NCT01808820|Immunologic Factors|immunologic factors|mesh-ancestor
65105777|NCT01808820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105778|NCT01808820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65105779|NCT01808820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105780|NCT01808820|Interferon Inducers|interferon inducers|mesh-ancestor
65105781|NCT05469386|Methylphenidate|methylphenidate|mesh-list
65105782|NCT05469386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65105783|NCT05469386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290597|NCT03295981|Zoledronic Acid|zoledronic acid|mesh-list
65290598|NCT03295981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65290599|NCT03295981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290600|NCT02733107|Etoposide|etoposide|mesh-list
65290601|NCT02733107|Apatinib|apatinib|mesh-list
65290602|NCT02733107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65290603|NCT02733107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290604|NCT02733107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65290605|NCT02733107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65290606|NCT02733107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105784|NCT05469386|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65105785|NCT05469386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65105786|NCT05469386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65105787|NCT05469386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105788|NCT05469386|Dopamine Agents|dopamine agents|mesh-ancestor
65105789|NCT05469386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65105790|NCT01468896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65105791|NCT01468896|Cetuximab|cetuximab|mesh-list
65105792|NCT01468896|Interleukin-12|interleukin-12|mesh-list
65105793|NCT01468896|Antibodies|antibodies|mesh-list
65105794|NCT01468896|Immunoglobulins|immunoglobulins|mesh-list
65105795|NCT01468896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65105796|NCT01468896|Immunologic Factors|immunologic factors|mesh-ancestor
65105797|NCT01468896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105798|NCT01468896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105799|NCT01468896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65105800|NCT01468896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65105801|NCT01468896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65105802|NCT01468896|Growth Substances|growth substances|mesh-ancestor
65105803|NCT01468896|Growth Inhibitors|growth inhibitors|mesh-ancestor
65105804|NCT01462890|Paclitaxel|paclitaxel|mesh-list
65105805|NCT01462890|Bevacizumab|bevacizumab|mesh-list
65105806|NCT01462890|Carboplatin|carboplatin|mesh-list
65105807|NCT01462890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65105808|NCT01462890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105809|NCT01462890|Tubulin Modulators|tubulin modulators|mesh-ancestor
65105810|NCT01462890|Antimitotic Agents|antimitotic agents|mesh-ancestor
65105811|NCT01462890|Mitosis Modulators|mitosis modulators|mesh-ancestor
65105812|NCT01462890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105813|NCT01462890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65105814|NCT01462890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65105815|NCT01462890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65105816|NCT01462890|Growth Substances|growth substances|mesh-ancestor
65105817|NCT01462890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105818|NCT01462890|Growth Inhibitors|growth inhibitors|mesh-ancestor
65105819|NCT05469113|Repaglinide|repaglinide|mesh-list
65105820|NCT05469113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65105821|NCT05469113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105822|NCT01259713|Amphotericin B|amphotericin b|mesh-list
65105823|NCT01259713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65105824|NCT01259713|Amebicides|amebicides|mesh-ancestor
65105825|NCT01259713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65105826|NCT01259713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65105827|NCT01259713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65105828|NCT01259713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65105829|NCT01259713|Antifungal Agents|antifungal agents|mesh-ancestor
65105835|NCT05469035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105837|NCT05582590|Fludarabine|fludarabine|mesh-list
65105838|NCT05582590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65105839|NCT05582590|Immunologic Factors|immunologic factors|mesh-ancestor
65105840|NCT05582590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105841|NCT05582590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65105842|NCT05582590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65105843|NCT05582590|Alkylating Agents|alkylating agents|mesh-ancestor
65105844|NCT05582590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290607|NCT02733107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290608|NCT02733107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65290609|NCT00675012|Capecitabine|capecitabine|mesh-list
65290610|NCT00675012|Oxaliplatin|oxaliplatin|mesh-list
65290611|NCT00675012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65290612|NCT00675012|Antimetabolites|antimetabolites|mesh-ancestor
65290613|NCT00675012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290614|NCT00675012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290615|NCT00652262|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65290616|NCT00652262|Vasodilator Agents|vasodilator agents|mesh-ancestor
65290617|NCT00652262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65290618|NCT00652262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65290619|NCT00652262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290620|NCT00652262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290621|NCT00652262|Urological Agents|urological agents|mesh-ancestor
65290622|NCT02640794|Aspirin|aspirin|mesh-list
65290623|NCT02640794|Clopidogrel|clopidogrel|mesh-list
65290624|NCT02640794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65290625|NCT02640794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65290626|NCT02640794|Analgesics|analgesics|mesh-ancestor
65290627|NCT02640794|Sensory System Agents|sensory system agents|mesh-ancestor
65290628|NCT02640794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65290629|NCT02640794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290630|NCT02640794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65290631|NCT02640794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65290632|NCT02640794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65290633|NCT02640794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65290634|NCT02640794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290635|NCT02640794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65290636|NCT02640794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65290637|NCT02640794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290638|NCT02640794|Antipyretics|antipyretics|mesh-ancestor
65040638|NCT00192842|Curcumin|curcumin|mesh-list
65290639|NCT02640794|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65105845|NCT05582590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105846|NCT05582590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65105847|NCT05468879|Glimepiride|glimepiride|mesh-list
65105848|NCT05468879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65290640|NCT02640794|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65290641|NCT02640794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65290642|NCT02640794|Purinergic Agents|purinergic agents|mesh-ancestor
65290643|NCT02640794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65290644|NCT00724672|Adalimumab|adalimumab|mesh-list
65290645|NCT00724672|Etanercept|etanercept|mesh-list
65290646|NCT00724672|Infliximab|infliximab|mesh-list
65290647|NCT00724672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65290648|NCT00724672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65290649|NCT00724672|Dermatologic Agents|dermatologic agents|mesh-ancestor
65290650|NCT00724672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65290651|NCT00724672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65290652|NCT00724672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65290653|NCT00724672|Analgesics|analgesics|mesh-ancestor
65290654|NCT00724672|Sensory System Agents|sensory system agents|mesh-ancestor
65290655|NCT00724672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65290656|NCT00724672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290657|NCT00724672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65105849|NCT05468879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65105850|NCT05468879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105851|NCT05468879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64748059|NCT01400412|Ritonavir|ritonavir|mesh-list
65105852|NCT05468879|Immunologic Factors|immunologic factors|mesh-ancestor
65105853|NCT05471427|Docetaxel|docetaxel|mesh-list
65105854|NCT05471427|Taxane|taxane|mesh-list
65105855|NCT05471427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105856|NCT05471427|Tubulin Modulators|tubulin modulators|mesh-ancestor
65105857|NCT05471427|Antimitotic Agents|antimitotic agents|mesh-ancestor
65105858|NCT05471427|Mitosis Modulators|mitosis modulators|mesh-ancestor
65105859|NCT05471427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105860|NCT05558449|Midazolam|midazolam|mesh-list
65105861|NCT05558449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65105862|NCT05558449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65105863|NCT05558449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65105864|NCT05558449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105865|NCT05558449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65105866|NCT05558449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65105867|NCT05558449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65105868|NCT05558449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65105869|NCT05558449|Anesthetics, General|anesthetics, general|mesh-ancestor
65105870|NCT05558449|Anesthetics|anesthetics|mesh-ancestor
65105871|NCT05558449|GABA Modulators|gaba modulators|mesh-ancestor
65105872|NCT05558449|GABA Agents|gaba agents|mesh-ancestor
65105873|NCT05558449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65105874|NCT05558449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105875|NCT04326985|Hyaluronic Acid|hyaluronic acid|mesh-list
65105876|NCT04326985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65105877|NCT04326985|Immunologic Factors|immunologic factors|mesh-ancestor
65105878|NCT04326985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105879|NCT04326985|Viscosupplements|viscosupplements|mesh-ancestor
65105880|NCT04326985|Protective Agents|protective agents|mesh-ancestor
65105881|NCT00536393|Doxorubicin|doxorubicin|mesh-list
65105882|NCT00536393|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65105883|NCT00536393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65105884|NCT00536393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105885|NCT00536393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65105886|NCT00536393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65105887|NCT00536393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105888|NCT00536393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290658|NCT00724672|Immunologic Factors|immunologic factors|mesh-ancestor
65290659|NCT02624856|Dexamethasone|dexamethasone|mesh-list
65290660|NCT02624856|Bupivacaine|bupivacaine|mesh-list
65290661|NCT02624856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65290662|NCT02624856|Antiemetics|antiemetics|mesh-ancestor
65290663|NCT02624856|Autonomic Agents|autonomic agents|mesh-ancestor
65290664|NCT02624856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65290665|NCT02624856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290666|NCT02624856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65290667|NCT02624856|Glucocorticoids|glucocorticoids|mesh-ancestor
65290668|NCT02624856|Hormones|hormones|mesh-ancestor
65290669|NCT02624856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65290670|NCT02624856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65290671|NCT02624856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290672|NCT02624856|Anesthetics, Local|anesthetics, local|mesh-ancestor
65290673|NCT02624856|Anesthetics|anesthetics|mesh-ancestor
65290674|NCT02624856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65290675|NCT02624856|Sensory System Agents|sensory system agents|mesh-ancestor
65290676|NCT02646020|Loratadine|loratadine|mesh-list
65290677|NCT02646020|Aprepitant|aprepitant|mesh-list
65290678|NCT02646020|Fosaprepitant|fosaprepitant|mesh-list
65290679|NCT02646020|Desloratadine|desloratadine|mesh-list
65290680|NCT02646020|Antiemetics|antiemetics|mesh-ancestor
65290681|NCT02646020|Autonomic Agents|autonomic agents|mesh-ancestor
65290682|NCT02646020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65290683|NCT02646020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290684|NCT02646020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65290685|NCT02646020|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65290686|NCT02646020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65290687|NCT02646020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290688|NCT02646020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65105889|NCT00595543|Diclofenac|diclofenac|mesh-list
65105890|NCT00595543|Ketorolac|ketorolac|mesh-list
65105891|NCT00595543|Bromfenac|bromfenac|mesh-list
65105892|NCT00595543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65105893|NCT00595543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65105894|NCT00595543|Analgesics|analgesics|mesh-ancestor
65105895|NCT00595543|Sensory System Agents|sensory system agents|mesh-ancestor
65105896|NCT00595543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65105897|NCT00595543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105898|NCT00595543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65105899|NCT00595543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64678267|NCT00002337|Vesnarinone|vesnarinone|mesh-list
65105904|NCT04326868|Mebendazole|mebendazole|mesh-list
65105905|NCT04326868|Benzimidazole|benzimidazole|mesh-list
65105907|NCT04326868|Anthelmintics|anthelmintics|mesh-list
65290689|NCT02646020|Cholinergic Agents|cholinergic agents|mesh-ancestor
65290690|NCT02646020|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65290691|NCT02646020|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65290692|NCT02646020|Histamine Antagonists|histamine antagonists|mesh-ancestor
65290693|NCT02646020|Histamine Agents|histamine agents|mesh-ancestor
65290694|NCT02646020|Antipruritics|antipruritics|mesh-ancestor
65290695|NCT02646020|Dermatologic Agents|dermatologic agents|mesh-ancestor
65290696|NCT02646020|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65290697|NCT03735979|Argatroban|argatroban|mesh-list
65290698|NCT03735979|Eptifibatide|eptifibatide|mesh-list
65290699|NCT03735979|Antithrombins|antithrombins|mesh-ancestor
65290700|NCT03735979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65105908|NCT04326868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65105909|NCT04326868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65105910|NCT04326868|Anticestodal Agents|anticestodal agents|mesh-ancestor
65105911|NCT04326868|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65105912|NCT04326868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65105913|NCT04326868|Tubulin Modulators|tubulin modulators|mesh-ancestor
65105914|NCT04326868|Antimitotic Agents|antimitotic agents|mesh-ancestor
65105915|NCT04326868|Mitosis Modulators|mitosis modulators|mesh-ancestor
65105916|NCT04326868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105917|NCT04326868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105918|NCT04326868|Antinematodal Agents|antinematodal agents|mesh-ancestor
65105919|NCT04326868|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
65105920|NCT04326868|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65105921|NCT04326868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65105922|NCT04326868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65105923|NCT04326868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105924|NCT05458024|Vitamin D|vitamin d|mesh-list
65105925|NCT05458024|Ergocalciferols|ergocalciferols|mesh-list
65105926|NCT05458024|Cholecalciferol|cholecalciferol|mesh-list
65105927|NCT05458024|Vitamins|vitamins|mesh-list
65105928|NCT05458024|Micronutrients|micronutrients|mesh-ancestor
65105929|NCT05458024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748156|NCT01386606|Clomiphene|clomiphene|mesh-list
65105930|NCT05458024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65105931|NCT05458024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65105933|NCT00595972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65105934|NCT00595972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65105935|NCT00595972|Growth Substances|growth substances|mesh-ancestor
65105936|NCT00595972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105937|NCT00595972|Growth Inhibitors|growth inhibitors|mesh-ancestor
65105938|NCT00595972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105939|NCT00596050|Lidocaine|lidocaine|mesh-list
65105940|NCT00596050|Fentanyl|fentanyl|mesh-list
65105941|NCT00596050|Midazolam|midazolam|mesh-list
65105942|NCT00596050|Ketamine|ketamine|mesh-list
65105943|NCT00596050|Etomidate|etomidate|mesh-list
65105944|NCT00596050|Anesthetics, Local|anesthetics, local|mesh-ancestor
65105945|NCT00596050|Anesthetics|anesthetics|mesh-ancestor
65105946|NCT00596050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65105947|NCT00596050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105948|NCT00596050|Sensory System Agents|sensory system agents|mesh-ancestor
65105949|NCT00596050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65105950|NCT00596050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65105951|NCT00596050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65105952|NCT00596050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65105953|NCT00596050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65105954|NCT00596050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105955|NCT00596050|Analgesics|analgesics|mesh-ancestor
65105956|NCT00596050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65105957|NCT00596050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65105958|NCT00596050|Anesthetics, General|anesthetics, general|mesh-ancestor
65105959|NCT00596050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65105960|NCT00596050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65290701|NCT03735979|Protease Inhibitors|protease inhibitors|mesh-ancestor
65290702|NCT03735979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290703|NCT03735979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290704|NCT03735979|Anticoagulants|anticoagulants|mesh-ancestor
65290705|NCT03735979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65290706|NCT02733419|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65290707|NCT02733419|Enfuvirtide|enfuvirtide|mesh-list
65290708|NCT02733419|Antiviral Agents|antiviral agents|mesh-ancestor
65290709|NCT02733419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290710|NCT02733419|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65290711|NCT02733419|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65290712|NCT02733419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290713|NCT02733419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65290714|NCT00992797|Vitamin D|vitamin d|mesh-list
65290715|NCT00992797|Cholecalciferol|cholecalciferol|mesh-list
65290716|NCT00992797|Vitamins|vitamins|mesh-ancestor
65290718|NCT00992797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290719|NCT00992797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65290720|NCT00992797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65290721|NCT02725541|Trastuzumab|trastuzumab|mesh-list
65290722|NCT02725541|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65290723|NCT02725541|Maytansine|maytansine|mesh-list
65290724|NCT02725541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65290725|NCT02725541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290726|NCT02725541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65290727|NCT02725541|Tubulin Modulators|tubulin modulators|mesh-ancestor
65290728|NCT02725541|Antimitotic Agents|antimitotic agents|mesh-ancestor
65290729|NCT02725541|Mitosis Modulators|mitosis modulators|mesh-ancestor
65290730|NCT02725541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290731|NCT00911066|Azacitidine|azacitidine|mesh-list
65290732|NCT00911066|Pevonedistat|pevonedistat|mesh-list
65290733|NCT00911066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65290734|NCT00911066|Antimetabolites|antimetabolites|mesh-ancestor
65105961|NCT00596050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65105962|NCT00596050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65105963|NCT00596050|Narcotics|narcotics|mesh-ancestor
65105964|NCT00596050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65105965|NCT00596050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65105966|NCT00596050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65105967|NCT00596050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65105968|NCT00596050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65105969|NCT00596050|GABA Modulators|gaba modulators|mesh-ancestor
65290735|NCT00911066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290736|NCT00911066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290737|NCT00911066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290738|NCT02733341|Ticagrelor|ticagrelor|mesh-list
65290739|NCT02733341|Cangrelor|cangrelor|mesh-list
65290740|NCT02733341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65290741|NCT02733341|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65290742|NCT02733341|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65290743|NCT02733341|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65290744|NCT02733341|Purinergic Agents|purinergic agents|mesh-ancestor
65290745|NCT02733341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65290746|NCT02733341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290747|NCT02733341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290748|NCT00692172|Alefacept|alefacept|mesh-list
65290749|NCT00692172|Dermatologic Agents|dermatologic agents|mesh-ancestor
65290750|NCT00692172|Immunologic Factors|immunologic factors|mesh-ancestor
65290751|NCT00692172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290752|NCT00692250|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65290753|NCT00692250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65290754|NCT00692250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65290755|NCT00692250|Antimetabolites|antimetabolites|mesh-ancestor
65290756|NCT00692250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290757|NCT00692250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65290758|NCT03675139|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65290759|NCT03675139|Medroxyprogesterone|medroxyprogesterone|mesh-list
65290760|NCT03675139|Dydrogesterone|dydrogesterone|mesh-list
65290761|NCT03675139|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65290762|NCT03675139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65290763|NCT03675139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65290764|NCT03675139|Contraceptive Agents|contraceptive agents|mesh-ancestor
64520968|NCT03199170|Morphine|morphine|mesh-list
65105970|NCT00596050|GABA Agents|gaba agents|mesh-ancestor
65105971|NCT02888899|Loperamide|loperamide|mesh-list
65105972|NCT02888899|Antidiarrheals|antidiarrheals|mesh-list
64678401|NCT00002373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678402|NCT00002379|Lamivudine|lamivudine|mesh-list
65105976|NCT02888899|Cathartics|cathartics|mesh-ancestor
65105977|NCT05468645|Hemay005|hemay005|mesh-list
65105978|NCT05468645|Dermatologic Agents|dermatologic agents|mesh-ancestor
65105979|NCT05468645|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65105980|NCT05468645|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65105981|NCT05468645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105982|NCT05468645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105983|NCT00596128|Insulin|insulin|mesh-list
65290765|NCT03675139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65290766|NCT03675139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290767|NCT03675139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65290768|NCT03675139|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65290769|NCT03675139|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65290770|NCT03675139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65290771|NCT03675139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290772|NCT03675139|Progestins|progestins|mesh-ancestor
65290773|NCT03675139|Hormones|hormones|mesh-ancestor
65290774|NCT03675139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65290775|NCT02645552|Tranexamic Acid|tranexamic acid|mesh-list
65290776|NCT02645552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65290777|NCT02645552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65290778|NCT02645552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290779|NCT02645552|Hemostatics|hemostatics|mesh-ancestor
65290780|NCT02645552|Coagulants|coagulants|mesh-ancestor
65290781|NCT00692328|Levodopa|levodopa|mesh-list
65290782|NCT00692328|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65290783|NCT00692328|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65290784|NCT00692328|Dopamine Agents|dopamine agents|mesh-ancestor
65290785|NCT00692328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65290786|NCT00692328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290787|NCT00692328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290788|NCT03415828|Ethanol|ethanol|mesh-list
65290789|NCT03415828|Prednisolone|prednisolone|mesh-list
64526134|NCT01691885|Xhance|xhance|mesh-list
65290790|NCT03415828|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65290791|NCT03415828|Methylprednisolone|methylprednisolone|mesh-list
65290792|NCT03415828|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65290793|NCT03415828|Prednisolone acetate|prednisolone acetate|mesh-list
65290794|NCT03415828|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65290795|NCT03415828|Prednisolone phosphate|prednisolone phosphate|mesh-list
65344922|NCT00864058|Gabapentin|gabapentin|mesh-list
64521001|NCT05087914|Dopamine Agents|dopamine agents|mesh-ancestor
65105984|NCT00596128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65105985|NCT00596128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105986|NCT00596206|Leflunomide|leflunomide|mesh-list
65105987|NCT00596206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105988|NCT00596206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105989|NCT00596206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65105990|NCT00596206|Immunologic Factors|immunologic factors|mesh-ancestor
65290796|NCT03415828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65290797|NCT03415828|Glucocorticoids|glucocorticoids|mesh-ancestor
65290799|NCT03415828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65290800|NCT03415828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290801|NCT03415828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65290802|NCT03415828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290803|NCT03415828|Antiemetics|antiemetics|mesh-ancestor
65290804|NCT03415828|Autonomic Agents|autonomic agents|mesh-ancestor
65290805|NCT03415828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65290806|NCT03415828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65290807|NCT03415828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65290808|NCT03415828|Protective Agents|protective agents|mesh-ancestor
65290809|NCT03415828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65290810|NCT03415828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290811|NCT03415828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65290812|NCT00687648|Prednisolone|prednisolone|mesh-list
65290813|NCT00687648|Cyclophosphamide|cyclophosphamide|mesh-list
65290814|NCT00687648|Methotrexate|methotrexate|mesh-list
65290815|NCT00687648|Letrozole|letrozole|mesh-list
65290816|NCT00687648|Anastrozole|anastrozole|mesh-list
65290817|NCT00687648|Exemestane|exemestane|mesh-list
65105991|NCT00596206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105992|NCT00624130|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65105994|NCT00624130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65105995|NCT00624130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105996|NCT00624130|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65105997|NCT00624130|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65105998|NCT00624130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65105999|NCT00624130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65106000|NCT05468450|Polidocanol|polidocanol|mesh-list
65106001|NCT05468450|Sclerosing Solutions|sclerosing solutions|mesh-list
65106002|NCT05468450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65106003|NCT05399329|Palbociclib|palbociclib|mesh-list
65106004|NCT05399329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106005|NCT05399329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65106006|NCT05399329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106007|NCT05399329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106009|NCT00535860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65106010|NCT00535860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106011|NCT00535860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65106012|NCT00596479|Lenograstim|lenograstim|mesh-list
65106013|NCT00596479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65106014|NCT00596479|Immunologic Factors|immunologic factors|mesh-ancestor
65106015|NCT00596479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106016|NCT05468372|Amphotericin B|amphotericin b|mesh-list
65106017|NCT05468372|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65106018|NCT05468372|Posaconazole|posaconazole|mesh-list
65106019|NCT05468372|Amebicides|amebicides|mesh-ancestor
65106020|NCT05468372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65106021|NCT05468372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65106022|NCT05468372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65106023|NCT05468372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65106024|NCT05468372|Antifungal Agents|antifungal agents|mesh-ancestor
65106025|NCT05468372|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65290818|NCT00687648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65290819|NCT00687648|Immunologic Factors|immunologic factors|mesh-ancestor
65290820|NCT00687648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290821|NCT00687648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65290822|NCT00687648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65290823|NCT00687648|Alkylating Agents|alkylating agents|mesh-ancestor
65290824|NCT00687648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290825|NCT00687648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290826|NCT00687648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65290827|NCT00687648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65290828|NCT00687648|Abortifacient Agents|abortifacient agents|mesh-ancestor
65290829|NCT00687648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65290830|NCT00687648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65290831|NCT00687648|Antimetabolites|antimetabolites|mesh-ancestor
65290832|NCT00687648|Dermatologic Agents|dermatologic agents|mesh-ancestor
65290833|NCT00687648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290834|NCT00687648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65290835|NCT00687648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65290836|NCT00687648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65290837|NCT00687648|Glucocorticoids|glucocorticoids|mesh-ancestor
65290838|NCT00687648|Hormones|hormones|mesh-ancestor
65290839|NCT00687648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65290840|NCT00687648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65290841|NCT00687648|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65106026|NCT05468372|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65106027|NCT05468372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65106028|NCT05468372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106029|NCT05468372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106030|NCT05468372|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65106031|NCT05468372|Hormone Antagonists|hormone antagonists|mesh-ancestor
65106032|NCT05468372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65106033|NCT05468372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106034|NCT04207957|Olorofim|olorofim|mesh-list
65106035|NCT04207957|Antifungal Agents|antifungal agents|mesh-ancestor
65106036|NCT04207957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65106037|NCT00596557|Everolimus|everolimus|mesh-list
65106038|NCT00596557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106039|NCT00596557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65106040|NCT00596557|Immunologic Factors|immunologic factors|mesh-ancestor
65106041|NCT00596557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106042|NCT00596596|Prucalopride|prucalopride|mesh-list
65106043|NCT00596596|Laxatives|laxatives|mesh-ancestor
65106044|NCT00596596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65106049|NCT00596596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106050|NCT00596596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106052|NCT05468294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65106053|NCT05468294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290842|NCT00687648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65290843|NCT00687648|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65290844|NCT00687648|Hormone Antagonists|hormone antagonists|mesh-ancestor
65290845|NCT00725218|Flurbiprofen|flurbiprofen|mesh-list
65290846|NCT00725218|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
65290847|NCT00725218|Analgesics|analgesics|mesh-ancestor
65290848|NCT00725218|Sensory System Agents|sensory system agents|mesh-ancestor
65290849|NCT00725218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65290850|NCT00725218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290851|NCT00725218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65290852|NCT00725218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65290853|NCT00725218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65290854|NCT00725218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65290855|NCT00725218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65290856|NCT00725218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290857|NCT00725218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290858|NCT02732795|Morphine|morphine|mesh-list
65290859|NCT02732795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65290860|NCT02732795|Narcotics|narcotics|mesh-ancestor
65290861|NCT02732795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65290862|NCT02732795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290863|NCT02732795|Analgesics|analgesics|mesh-ancestor
65290864|NCT02732795|Sensory System Agents|sensory system agents|mesh-ancestor
65290865|NCT02732795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65290866|NCT05373004|Empagliflozin|empagliflozin|mesh-list
65106054|NCT05468294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65106055|NCT05468294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106056|NCT05312866|Acetaminophen|acetaminophen|mesh-list
65106057|NCT05312866|Dexamethasone|dexamethasone|mesh-list
65106058|NCT05312866|Magnesium Sulfate|magnesium sulfate|mesh-list
65106059|NCT05312866|Fentanyl|fentanyl|mesh-list
65106060|NCT05312866|Bupivacaine|bupivacaine|mesh-list
65106061|NCT05312866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65106062|NCT05312866|Antiemetics|antiemetics|mesh-ancestor
65106063|NCT05312866|Autonomic Agents|autonomic agents|mesh-ancestor
65106064|NCT05312866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65106065|NCT05312866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106066|NCT05312866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65106067|NCT05312866|Glucocorticoids|glucocorticoids|mesh-ancestor
65106068|NCT05312866|Hormones|hormones|mesh-ancestor
65106069|NCT05312866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65106070|NCT05312866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65106071|NCT05312866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106072|NCT05312866|Anesthetics, Local|anesthetics, local|mesh-ancestor
65106073|NCT05312866|Anesthetics|anesthetics|mesh-ancestor
65106074|NCT05312866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65106075|NCT05312866|Sensory System Agents|sensory system agents|mesh-ancestor
65106076|NCT05312866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65106077|NCT05312866|Narcotics|narcotics|mesh-ancestor
65106078|NCT05312866|Analgesics|analgesics|mesh-ancestor
65290867|NCT05373004|Enalapril|enalapril|mesh-list
65290868|NCT05373004|Enalaprilat|enalaprilat|mesh-list
65290869|NCT05373004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65290870|NCT05373004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290871|NCT05373004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65290872|NCT05373004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290873|NCT05373004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290874|NCT05373004|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65290875|NCT05373004|Protease Inhibitors|protease inhibitors|mesh-ancestor
65290876|NCT05373004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65290877|NCT00655616|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65290878|NCT00655616|Montelukast|montelukast|mesh-list
65290879|NCT00655616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65290880|NCT00655616|Autonomic Agents|autonomic agents|mesh-ancestor
65290881|NCT00655616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65290882|NCT00655616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290883|NCT00655616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65290884|NCT00655616|Respiratory System Agents|respiratory system agents|mesh-ancestor
65290885|NCT00655616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65290886|NCT00655616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65290887|NCT00655616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65290888|NCT00655616|Adrenergic Agents|adrenergic agents|mesh-ancestor
65290889|NCT00655616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65290890|NCT00655616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290891|NCT00655616|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65290892|NCT00655616|Hormone Antagonists|hormone antagonists|mesh-ancestor
65344923|NCT00864058|Analgesics|analgesics|mesh-ancestor
65106079|NCT05312866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65106080|NCT05312866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64748282|NCT01382940|Methylprednisolone|methylprednisolone|mesh-list
65106082|NCT05312866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65106083|NCT05312866|Antipyretics|antipyretics|mesh-ancestor
65106084|NCT05312866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65106085|NCT05312866|Anticonvulsants|anticonvulsants|mesh-ancestor
65106086|NCT05312866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65106087|NCT05312866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65106088|NCT05312866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106089|NCT05312866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65106090|NCT05312866|Tocolytic Agents|tocolytic agents|mesh-ancestor
65106091|NCT05312866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65106092|NCT04326790|Colchicine|colchicine|mesh-list
65106093|NCT04326790|Gout Suppressants|gout suppressants|mesh-ancestor
65106094|NCT04326790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65106095|NCT04326790|Tubulin Modulators|tubulin modulators|mesh-ancestor
65106096|NCT04326790|Antimitotic Agents|antimitotic agents|mesh-ancestor
65106097|NCT04326790|Mitosis Modulators|mitosis modulators|mesh-ancestor
65290893|NCT00655616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65290894|NCT00655616|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65290895|NCT00655616|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65290896|NCT00713440|Acetaminophen|acetaminophen|mesh-list
65290897|NCT00713440|Prednisolone|prednisolone|mesh-list
65290898|NCT00713440|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65290899|NCT00713440|Methylprednisolone|methylprednisolone|mesh-list
65290900|NCT00713440|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65290901|NCT00713440|Prednisolone acetate|prednisolone acetate|mesh-list
65290902|NCT00713440|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65290903|NCT00713440|Prednisolone phosphate|prednisolone phosphate|mesh-list
65290904|NCT00713440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65290905|NCT00713440|Glucocorticoids|glucocorticoids|mesh-ancestor
65290906|NCT00713440|Hormones|hormones|mesh-ancestor
65290907|NCT00713440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65290908|NCT00713440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290909|NCT00713440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65290910|NCT00713440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65290911|NCT00713440|Antiemetics|antiemetics|mesh-ancestor
65290912|NCT00713440|Autonomic Agents|autonomic agents|mesh-ancestor
65290913|NCT00713440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65290914|NCT00713440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65290915|NCT00713440|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65290916|NCT00713440|Protective Agents|protective agents|mesh-ancestor
64521130|NCT02444364|Incretins|incretins|mesh-ancestor
65106098|NCT04326790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106099|NCT04326790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106100|NCT00596986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65106101|NCT00596986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65106102|NCT00596986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65106103|NCT00596986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65106104|NCT00596986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106105|NCT00596986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65106106|NCT00596986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106107|NCT00596986|Analgesics|analgesics|mesh-ancestor
64483981|NCT03801226|Calcium|calcium|mesh-list
65106108|NCT00596986|Sensory System Agents|sensory system agents|mesh-ancestor
65106109|NCT00596986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65106110|NCT00596986|Antidepressive Agents|antidepressive agents|mesh-ancestor
65106111|NCT00596986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65106112|NCT00596986|Dopamine Agents|dopamine agents|mesh-ancestor
65106113|NCT00597064|Prednisone|prednisone|mesh-list
65106119|NCT00597064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65106120|NCT00597064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106122|NCT00597181|Mitomycin|mitomycin|mesh-list
65106123|NCT00597181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65106124|NCT00597181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106125|NCT00597181|Alkylating Agents|alkylating agents|mesh-ancestor
65290917|NCT00713440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65290918|NCT00713440|Analgesics|analgesics|mesh-ancestor
65290919|NCT00713440|Sensory System Agents|sensory system agents|mesh-ancestor
65290920|NCT00713440|Antipyretics|antipyretics|mesh-ancestor
65290921|NCT00993109|Valsartan|valsartan|mesh-list
65290922|NCT00993109|Nifedipine|nifedipine|mesh-list
65290923|NCT00993109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65290924|NCT00993109|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65290925|NCT00993109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65290926|NCT00993109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65290927|NCT00993109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65290928|NCT00993109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65290929|NCT00993109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65290930|NCT00993109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290931|NCT00993109|Vasodilator Agents|vasodilator agents|mesh-ancestor
65290932|NCT00993109|Tocolytic Agents|tocolytic agents|mesh-ancestor
65290933|NCT00993109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65290934|NCT02725229|Levobupivacaine|levobupivacaine|mesh-list
65290935|NCT02725229|Anesthetics, Local|anesthetics, local|mesh-ancestor
65290936|NCT02725229|Anesthetics|anesthetics|mesh-ancestor
65290937|NCT02725229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65106126|NCT00597181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106127|NCT00597181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65106128|NCT00597181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106129|NCT00597259|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65106130|NCT00597259|Entecavir|entecavir|mesh-list
65106131|NCT00597259|Antiviral Agents|antiviral agents|mesh-ancestor
65106132|NCT00597259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65106133|NCT05470764|Amlodipine|amlodipine|mesh-list
65106134|NCT05470764|Perindopril|perindopril|mesh-list
65106135|NCT05470764|Indapamide|indapamide|mesh-list
65106136|NCT05470764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65106137|NCT05470764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65106138|NCT05470764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65106139|NCT05470764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106140|NCT05470764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65106141|NCT05470764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106142|NCT05470764|Vasodilator Agents|vasodilator agents|mesh-ancestor
65106143|NCT05470764|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65106144|NCT05470764|Protease Inhibitors|protease inhibitors|mesh-ancestor
65106145|NCT05470764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106146|NCT05470764|Diuretics|diuretics|mesh-ancestor
65106147|NCT05470764|Natriuretic Agents|natriuretic agents|mesh-ancestor
65106148|NCT05470764|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65106149|NCT00597415|Celecoxib|celecoxib|mesh-list
65106150|NCT00597415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65106151|NCT00597415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65106152|NCT00597415|Analgesics|analgesics|mesh-ancestor
65106153|NCT00597415|Sensory System Agents|sensory system agents|mesh-ancestor
64748363|NCT01381692|Hormones|hormones|mesh-ancestor
65106154|NCT00597415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65106155|NCT00597415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106156|NCT00597415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65290938|NCT02725229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290939|NCT02725229|Sensory System Agents|sensory system agents|mesh-ancestor
65290940|NCT02725229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65290941|NCT00655772|Chlorine dioxide|chlorine dioxide|mesh-list
65290942|NCT00655772|Dental Disinfectants|dental disinfectants|mesh-ancestor
65290943|NCT00655772|Disinfectants|disinfectants|mesh-ancestor
65290944|NCT00655772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290945|NCT00675246|Betamethasone|betamethasone|mesh-list
65290946|NCT00675246|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
65290947|NCT00675246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65290948|NCT00675246|Glucocorticoids|glucocorticoids|mesh-ancestor
65290949|NCT00675246|Hormones|hormones|mesh-ancestor
65290950|NCT00675246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65290951|NCT00675246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290952|NCT00675246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65290953|NCT00675246|Respiratory System Agents|respiratory system agents|mesh-ancestor
65106157|NCT00597415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65106158|NCT00597415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65106159|NCT00597415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65106160|NCT00597415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106161|NCT00597415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106162|NCT00597688|Chlorhexidine|chlorhexidine|mesh-list
65106163|NCT00597688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65106164|NCT00597688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65106165|NCT00597688|Disinfectants|disinfectants|mesh-ancestor
65106166|NCT05470530|Dexamethasone|dexamethasone|mesh-list
65106167|NCT05470530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65106168|NCT05470530|Antiemetics|antiemetics|mesh-ancestor
65106169|NCT05470530|Autonomic Agents|autonomic agents|mesh-ancestor
65106170|NCT05470530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65106171|NCT05470530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106172|NCT05470530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65106173|NCT05470530|Glucocorticoids|glucocorticoids|mesh-ancestor
65106174|NCT05470530|Hormones|hormones|mesh-ancestor
65106175|NCT05470530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65106176|NCT05470530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65106177|NCT05470530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106178|NCT02891980|Vaccines|vaccines|mesh-list
65106179|NCT02891980|Immunologic Factors|immunologic factors|mesh-ancestor
65106180|NCT02891980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106181|NCT05467826|Ribavirin|ribavirin|mesh-list
65106182|NCT05467826|Sofosbuvir|sofosbuvir|mesh-list
65106184|NCT05467826|Velpatasvir|velpatasvir|mesh-list
65106185|NCT05467826|Antimetabolites|antimetabolites|mesh-ancestor
65106186|NCT05467826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106187|NCT05467826|Antiviral Agents|antiviral agents|mesh-ancestor
65106188|NCT05467826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65106189|NCT00598156|Bevacizumab|bevacizumab|mesh-list
65106190|NCT00598156|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65106191|NCT00598156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65106192|NCT00598156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106193|NCT00598156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65106194|NCT00598156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65106195|NCT00598156|Growth Substances|growth substances|mesh-ancestor
65106196|NCT00598156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106197|NCT00598156|Growth Inhibitors|growth inhibitors|mesh-ancestor
65106198|NCT00598156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65106199|NCT00598156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65290954|NCT00675246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65290955|NCT00675246|Autonomic Agents|autonomic agents|mesh-ancestor
65290956|NCT00675246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65290957|NCT04357366|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65290958|NCT04357366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65290959|NCT02732405|Grazoprevir|grazoprevir|mesh-list
65290960|NCT02732405|Antiviral Agents|antiviral agents|mesh-ancestor
65290961|NCT02732405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65290962|NCT04001725|Metformin|metformin|mesh-list
65290963|NCT04001725|Dexamethasone|dexamethasone|mesh-list
65290964|NCT04001725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65290965|NCT04001725|Antiemetics|antiemetics|mesh-ancestor
65290966|NCT04001725|Autonomic Agents|autonomic agents|mesh-ancestor
65290967|NCT04001725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65290968|NCT04001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65290969|NCT04001725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65290970|NCT04001725|Glucocorticoids|glucocorticoids|mesh-ancestor
65290971|NCT04001725|Hormones|hormones|mesh-ancestor
65290972|NCT04001725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65290973|NCT04001725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65291008|NCT05366062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291009|NCT05366062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291010|NCT05366062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65291011|NCT05366062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65291012|NCT02645240|Heparin|heparin|mesh-list
65291013|NCT02645240|Calcium heparin|calcium heparin|mesh-list
65291014|NCT02645240|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65291015|NCT02645240|Tinzaparin|tinzaparin|mesh-list
65291016|NCT02645240|Dalteparin|dalteparin|mesh-list
65291017|NCT02645240|Anticoagulants|anticoagulants|mesh-ancestor
65291018|NCT02645240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65291019|NCT02645240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65291020|NCT02645240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291021|NCT00688194|Letrozole|letrozole|mesh-list
65291022|NCT00688194|Fulvestrant|fulvestrant|mesh-list
65291023|NCT00688194|Lapatinib|lapatinib|mesh-list
65291024|NCT00688194|Anastrozole|anastrozole|mesh-list
65291025|NCT00688194|Exemestane|exemestane|mesh-list
65291026|NCT00688194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291027|NCT00688194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65291028|NCT00688194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65291029|NCT00688194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291030|NCT00688194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291031|NCT00688194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65291032|NCT00688194|Hormone Antagonists|hormone antagonists|mesh-ancestor
65291033|NCT00688194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65291034|NCT00688194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291035|NCT00688194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65291036|NCT00688194|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65291037|NCT00688194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65291038|NCT00653744|Atorvastatin|atorvastatin|mesh-list
65291039|NCT00653744|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65291040|NCT00653744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65291041|NCT00653744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65291042|NCT00653744|Antimetabolites|antimetabolites|mesh-ancestor
65291043|NCT00653744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291046|NCT00653744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291047|NCT03322267|Cisplatin|cisplatin|mesh-list
65291048|NCT03322267|Pembrolizumab|pembrolizumab|mesh-list
65291049|NCT03322267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291050|NCT03322267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65291051|NCT00652496|Bimatoprost|bimatoprost|mesh-list
65291052|NCT00652496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65291053|NCT00652496|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65291054|NCT00652496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65291055|NCT00688272|Ciprofloxacin|ciprofloxacin|mesh-list
65291056|NCT00688272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65291057|NCT00688272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65291058|NCT00688272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65291059|NCT00688272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65291060|NCT00688272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291061|NCT00688272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291062|NCT00688272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291063|NCT00688272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64521285|NCT00357604|Estrogens|estrogens|mesh-ancestor
65106200|NCT00598156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106201|NCT00598195|Ketamine|ketamine|mesh-list
65106202|NCT00598195|Analgesics|analgesics|mesh-ancestor
65106203|NCT00598195|Sensory System Agents|sensory system agents|mesh-ancestor
65106204|NCT00598195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65106205|NCT00598195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106206|NCT00598195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65106207|NCT00598195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65106208|NCT00598195|Anesthetics, General|anesthetics, general|mesh-ancestor
65106209|NCT00598195|Anesthetics|anesthetics|mesh-ancestor
65106210|NCT00598195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65106211|NCT00598195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65106212|NCT00598195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65106213|NCT00598195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65106214|NCT00598195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106215|NCT00598234|Celecoxib|celecoxib|mesh-list
65106216|NCT00598234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65106217|NCT00598234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65106218|NCT00598234|Analgesics|analgesics|mesh-ancestor
65106219|NCT00598234|Sensory System Agents|sensory system agents|mesh-ancestor
65106220|NCT00598234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65106221|NCT00598234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106222|NCT00598234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65106223|NCT00598234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65106224|NCT00598234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65106225|NCT00598234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65106226|NCT00598234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106227|NCT00598234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106229|NCT00598429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65106230|NCT00598429|Vasodilator Agents|vasodilator agents|mesh-ancestor
65106231|NCT00598429|Urological Agents|urological agents|mesh-ancestor
65106232|NCT00598624|Treosulfan|treosulfan|mesh-list
65106233|NCT00598624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65106234|NCT00598624|Alkylating Agents|alkylating agents|mesh-ancestor
65106235|NCT00598624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291064|NCT00688272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65291065|NCT00993343|Cyclosporine|cyclosporine|mesh-list
65291066|NCT00993343|Sirolimus|sirolimus|mesh-list
65291067|NCT00993343|Methotrexate|methotrexate|mesh-list
65291068|NCT00993343|Tacrolimus|tacrolimus|mesh-list
65291069|NCT00993343|Cyclosporins|cyclosporins|mesh-list
65291070|NCT00993343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65291071|NCT00993343|Abortifacient Agents|abortifacient agents|mesh-ancestor
65291072|NCT00993343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65291073|NCT00993343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291074|NCT00993343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65291075|NCT00993343|Antimetabolites|antimetabolites|mesh-ancestor
65291076|NCT00993343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291077|NCT00993343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291078|NCT00993343|Dermatologic Agents|dermatologic agents|mesh-ancestor
65291079|NCT00993343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291080|NCT00993343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65291081|NCT00993343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65291082|NCT00993343|Immunologic Factors|immunologic factors|mesh-ancestor
65291083|NCT00993343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65291084|NCT00993343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65291085|NCT00993343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65291086|NCT00993343|Antifungal Agents|antifungal agents|mesh-ancestor
65291087|NCT00993343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65291088|NCT00993343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65106236|NCT00598624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106237|NCT02891785|Antipain|antipain|mesh-list
65106238|NCT02891785|Protease Inhibitors|protease inhibitors|mesh-ancestor
65106239|NCT02891785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106240|NCT02891785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106241|NCT00598858|Prednisone|prednisone|mesh-list
65106242|NCT00598858|Cortisone|cortisone|mesh-list
65106243|NCT00598858|Docetaxel|docetaxel|mesh-list
65106244|NCT00598858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106245|NCT00598858|Tubulin Modulators|tubulin modulators|mesh-ancestor
65106246|NCT00598858|Antimitotic Agents|antimitotic agents|mesh-ancestor
65106247|NCT00598858|Mitosis Modulators|mitosis modulators|mesh-ancestor
65106248|NCT00598858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106249|NCT00598858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65106250|NCT00598858|Glucocorticoids|glucocorticoids|mesh-ancestor
65106251|NCT00598858|Hormones|hormones|mesh-ancestor
64678613|NCT00002217|Protease Inhibitors|protease inhibitors|mesh-ancestor
65106257|NCT05466305|Micronutrients|micronutrients|mesh-ancestor
65106258|NCT05466305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106259|NCT04207684|Testosterone|testosterone|mesh-list
65106260|NCT04207684|Androgens|androgens|mesh-ancestor
65106261|NCT04207684|Hormones|hormones|mesh-ancestor
65106262|NCT04207684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65106263|NCT04207684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106264|NCT02909400|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
65106265|NCT02909400|Antioxidants|antioxidants|mesh-ancestor
65291089|NCT00993343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65291090|NCT02974049|Ivermectin|ivermectin|mesh-list
65291091|NCT02974049|Albendazole|albendazole|mesh-list
65291092|NCT02974049|Diethylcarbamazine|diethylcarbamazine|mesh-list
65106266|NCT02909400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106267|NCT02909400|Protective Agents|protective agents|mesh-ancestor
65106268|NCT02909400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106269|NCT03092323|Pembrolizumab|pembrolizumab|mesh-list
65106270|NCT03092323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65106271|NCT03092323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106272|NCT02909478|Dexamethasone|dexamethasone|mesh-list
65106273|NCT02909478|Aprepitant|aprepitant|mesh-list
65106274|NCT02909478|Tropisetron|tropisetron|mesh-list
65106275|NCT02909478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65106276|NCT02909478|Antiemetics|antiemetics|mesh-ancestor
65106277|NCT02909478|Autonomic Agents|autonomic agents|mesh-ancestor
65106278|NCT02909478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65106279|NCT02909478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106280|NCT02909478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65106281|NCT02909478|Glucocorticoids|glucocorticoids|mesh-ancestor
65106282|NCT02909478|Hormones|hormones|mesh-ancestor
65106283|NCT02909478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65106284|NCT02909478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65106285|NCT02909478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106286|NCT02909478|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65106287|NCT02909478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65106288|NCT02909478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106289|NCT02909478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65106290|NCT02909478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65106291|NCT02909478|Serotonin Agents|serotonin agents|mesh-ancestor
65106292|NCT00536211|Metformin|metformin|mesh-list
65106293|NCT00536211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65106294|NCT00536211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106295|NCT00536705|Montelukast|montelukast|mesh-list
65106296|NCT00536705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65106297|NCT00536705|Respiratory System Agents|respiratory system agents|mesh-ancestor
65106298|NCT00536705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65106299|NCT00536705|Hormone Antagonists|hormone antagonists|mesh-ancestor
65106300|NCT00536705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65106301|NCT00536705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106302|NCT00536705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65106303|NCT00536705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65106304|NCT00536705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106305|NCT00624208|Droperidol|droperidol|mesh-list
65106306|NCT00624208|Ondansetron|ondansetron|mesh-list
65106307|NCT00624208|Antiemetics|antiemetics|mesh-ancestor
65106308|NCT00624208|Autonomic Agents|autonomic agents|mesh-ancestor
65106309|NCT00624208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65106310|NCT00624208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106311|NCT00624208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65106312|NCT00624208|Antipruritics|antipruritics|mesh-ancestor
65106313|NCT00624208|Dermatologic Agents|dermatologic agents|mesh-ancestor
65106314|NCT00624208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65106315|NCT00624208|Serotonin Agents|serotonin agents|mesh-ancestor
65106316|NCT00624208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65106317|NCT00624208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106318|NCT00624208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65106319|NCT00624208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65106320|NCT00624208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65106328|NCT00536783|Antidepressive Agents|antidepressive agents|mesh-ancestor
65106329|NCT00536783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65106330|NCT00536783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65106331|NCT00536783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65106332|NCT00536783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65106333|NCT00536783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106334|NCT02465164|Oxytocin|oxytocin|mesh-list
65106335|NCT02465164|Oxytocics|oxytocics|mesh-ancestor
65106336|NCT02465164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65106337|NCT02465164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106338|NCT04685642|Aspirin|aspirin|mesh-list
65106339|NCT04685642|Atorvastatin|atorvastatin|mesh-list
65291093|NCT02974049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65291094|NCT02974049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65291095|NCT02974049|Anthelmintics|anthelmintics|mesh-ancestor
65291096|NCT02974049|Anticestodal Agents|anticestodal agents|mesh-ancestor
65291097|NCT02974049|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65291098|NCT02974049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65291099|NCT02974049|Tubulin Modulators|tubulin modulators|mesh-ancestor
65291100|NCT02974049|Antimitotic Agents|antimitotic agents|mesh-ancestor
64521330|NCT00356824|Artesunate|artesunate|mesh-list
65106340|NCT04685642|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65106341|NCT04685642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65106342|NCT04685642|Analgesics|analgesics|mesh-ancestor
65106343|NCT04685642|Sensory System Agents|sensory system agents|mesh-ancestor
65106344|NCT04685642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65106345|NCT04685642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106346|NCT04685642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65106347|NCT04685642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65106348|NCT04685642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65106349|NCT04685642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65106350|NCT04685642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106351|NCT04685642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65106352|NCT04685642|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65106353|NCT04685642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106354|NCT04685642|Antipyretics|antipyretics|mesh-ancestor
65106355|NCT04685642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65106356|NCT04685642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65106357|NCT04685642|Antimetabolites|antimetabolites|mesh-ancestor
65106358|NCT04685642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65106359|NCT04685642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65106360|NCT05312346|Hydroxocobalamin|hydroxocobalamin|mesh-list
65106361|NCT05312346|Vitamin B 12|vitamin b 12|mesh-list
65106362|NCT05312346|Hematinics|hematinics|mesh-ancestor
65106363|NCT05312346|Vitamin B Complex|vitamin b complex|mesh-ancestor
65106364|NCT05312346|Vitamins|vitamins|mesh-ancestor
65106365|NCT05312346|Micronutrients|micronutrients|mesh-ancestor
65106366|NCT05312346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106367|NCT05568563|Ethyl Chloride|ethyl chloride|mesh-list
65106368|NCT05568563|Anesthetics, Local|anesthetics, local|mesh-ancestor
65106369|NCT05568563|Anesthetics|anesthetics|mesh-ancestor
65106370|NCT05568563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65106371|NCT05568563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106372|NCT05568563|Sensory System Agents|sensory system agents|mesh-ancestor
65106373|NCT05568563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65106374|NCT00536861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65106375|NCT00536861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106376|NCT00536861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64748590|NCT04347486|Atropine|atropine|mesh-list
65106378|NCT00536861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106379|NCT05469984|Gentamicins|gentamicins|mesh-list
65106380|NCT05469984|Ampicillin|ampicillin|mesh-list
65106381|NCT05469984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65106382|NCT05469984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65106383|NCT05469984|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65106384|NCT05469984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106385|NCT05469984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106386|NCT05312190|Progesterone|progesterone|mesh-list
65106387|NCT05312190|Progestins|progestins|mesh-ancestor
65106388|NCT05312190|Hormones|hormones|mesh-ancestor
65106389|NCT05312190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64678753|NCT04500899|Phenylephrine|phenylephrine|mesh-list
65106396|NCT00537173|Antimitotic Agents|antimitotic agents|mesh-ancestor
65106397|NCT00537173|Mitosis Modulators|mitosis modulators|mesh-ancestor
65106398|NCT00537173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106399|NCT00537173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64639184|NCT01454791|Diclofenac|diclofenac|mesh-list
65106400|NCT00537173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65106401|NCT00537173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65291101|NCT02974049|Mitosis Modulators|mitosis modulators|mesh-ancestor
65291102|NCT02974049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291103|NCT02974049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291104|NCT02974049|Filaricides|filaricides|mesh-ancestor
65291105|NCT02974049|Antinematodal Agents|antinematodal agents|mesh-ancestor
65291106|NCT02974049|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65291107|NCT02974049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291108|NCT02637284|BPC 157|bpc 157|mesh-list
65291109|NCT02637284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65291110|NCT02637284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65291111|NCT04138992|Bevacizumab|bevacizumab|mesh-list
65291112|NCT04138992|Cisplatin|cisplatin|mesh-list
65291113|NCT04138992|Docetaxel|docetaxel|mesh-list
65291114|NCT04138992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65291115|NCT04138992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291116|NCT04138992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65291117|NCT04138992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65291118|NCT04138992|Growth Substances|growth substances|mesh-ancestor
65291119|NCT04138992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291120|NCT04138992|Growth Inhibitors|growth inhibitors|mesh-ancestor
65291121|NCT04138992|Tubulin Modulators|tubulin modulators|mesh-ancestor
65291122|NCT04138992|Antimitotic Agents|antimitotic agents|mesh-ancestor
65291123|NCT04138992|Mitosis Modulators|mitosis modulators|mesh-ancestor
65291124|NCT04138992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291125|NCT04137588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65291126|NCT04137588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
65291127|NCT04137588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291128|NCT04137588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291129|NCT04137588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65291130|NCT04137588|Growth Substances|growth substances|mesh-ancestor
65291131|NCT04137588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291132|NCT04137588|Growth Inhibitors|growth inhibitors|mesh-ancestor
65106402|NCT00537173|Growth Substances|growth substances|mesh-ancestor
65106403|NCT00537173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106404|NCT00537173|Growth Inhibitors|growth inhibitors|mesh-ancestor
65106406|NCT02503839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65106407|NCT02503839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65106408|NCT02503839|Analgesics|analgesics|mesh-ancestor
65106409|NCT02503839|Sensory System Agents|sensory system agents|mesh-ancestor
65106410|NCT02503839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65106411|NCT02503839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291133|NCT02721329|Acetaminophen|acetaminophen|mesh-list
65291134|NCT02721329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65291135|NCT02721329|Analgesics|analgesics|mesh-ancestor
65291136|NCT02721329|Sensory System Agents|sensory system agents|mesh-ancestor
65291137|NCT02721329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65291138|NCT02721329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291139|NCT02721329|Antipyretics|antipyretics|mesh-ancestor
65291140|NCT02637128|Artesunate|artesunate|mesh-list
65291141|NCT02637128|Lumefantrine|lumefantrine|mesh-list
65291142|NCT02637128|Artemether|artemether|mesh-list
65291143|NCT02637128|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65291144|NCT02637128|Amodiaquine|amodiaquine|mesh-list
65291145|NCT02637128|Antimalarials|antimalarials|mesh-ancestor
65291146|NCT02637128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65291147|NCT02637128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65291148|NCT02637128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65291149|NCT02637128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291150|NCT02637128|Antiviral Agents|antiviral agents|mesh-ancestor
65291151|NCT02637128|Schistosomicides|schistosomicides|mesh-ancestor
65291152|NCT02637128|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65291153|NCT02637128|Anthelmintics|anthelmintics|mesh-ancestor
65291154|NCT02624622|Chlorhexidine|chlorhexidine|mesh-list
65291155|NCT02624622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65291156|NCT02624622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65291157|NCT02624622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65291158|NCT02624622|Disinfectants|disinfectants|mesh-ancestor
65291159|NCT02624622|Dermatologic Agents|dermatologic agents|mesh-ancestor
65291160|NCT00585247|Imiquimod|imiquimod|mesh-list
65291161|NCT00585247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65291162|NCT00585247|Immunologic Factors|immunologic factors|mesh-ancestor
65041121|NCT00223509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64521366|NCT01704755|Antiviral Agents|antiviral agents|mesh-ancestor
65106412|NCT02503839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65106413|NCT02503839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65106414|NCT02503839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65106415|NCT02503839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65106416|NCT02503839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106417|NCT02503839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106418|NCT05469750|Capecitabine|capecitabine|mesh-list
65106419|NCT05469750|Letrozole|letrozole|mesh-list
65106420|NCT05469750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65106421|NCT05469750|Antimetabolites|antimetabolites|mesh-ancestor
65106422|NCT05469750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106423|NCT05469750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106424|NCT05469750|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65106425|NCT05469750|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65106426|NCT05469750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291163|NCT00585247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291164|NCT00585247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291165|NCT00585247|Interferon Inducers|interferon inducers|mesh-ancestor
65291166|NCT04002349|Budesonide|budesonide|mesh-list
65291167|NCT04002349|Levocabastine|levocabastine|mesh-list
65291168|NCT04002349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65291169|NCT04002349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65291170|NCT04002349|Autonomic Agents|autonomic agents|mesh-ancestor
65291171|NCT04002349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65291172|NCT04002349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291173|NCT04002349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65291174|NCT04002349|Respiratory System Agents|respiratory system agents|mesh-ancestor
65291175|NCT04002349|Glucocorticoids|glucocorticoids|mesh-ancestor
65291176|NCT04002349|Hormones|hormones|mesh-ancestor
65106427|NCT05469750|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65106428|NCT05469750|Hormone Antagonists|hormone antagonists|mesh-ancestor
65106429|NCT05469750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65106430|NCT05469750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106431|NCT02143830|Cyclophosphamide|cyclophosphamide|mesh-list
65106432|NCT02143830|Busulfan|busulfan|mesh-list
65106433|NCT02143830|Fludarabine|fludarabine|mesh-list
65106434|NCT02143830|Thymoglobulin|thymoglobulin|mesh-list
65106435|NCT02143830|Lenograstim|lenograstim|mesh-list
65106436|NCT02143830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65106437|NCT02143830|Immunologic Factors|immunologic factors|mesh-ancestor
65106438|NCT02143830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106439|NCT02143830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65106440|NCT02143830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65106441|NCT02143830|Alkylating Agents|alkylating agents|mesh-ancestor
65106442|NCT02143830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106443|NCT02143830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106444|NCT02143830|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65106445|NCT02143830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65106446|NCT00537251|Insulin Glargine|insulin glargine|mesh-list
65106447|NCT00537251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65106448|NCT00537251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106449|NCT03457194|Vaccines|vaccines|mesh-list
65106450|NCT03457194|Immunologic Factors|immunologic factors|mesh-ancestor
65106452|NCT05478707|Dulaglutide|dulaglutide|mesh-list
65106453|NCT05478707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65106454|NCT05478707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106455|NCT05469204|Acetaminophen|acetaminophen|mesh-list
65106460|NCT05469204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65106461|NCT05469204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65106462|NCT05469204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106463|NCT05469204|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65106464|NCT05469204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65106465|NCT05469204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65106466|NCT05469204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65106467|NCT05469204|Anesthetics, General|anesthetics, general|mesh-ancestor
65106468|NCT05469204|Anesthetics|anesthetics|mesh-ancestor
65106469|NCT05469204|GABA Modulators|gaba modulators|mesh-ancestor
65106470|NCT05469204|GABA Agents|gaba agents|mesh-ancestor
65106471|NCT05469204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65106472|NCT05469204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106473|NCT05469204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65106474|NCT05469204|Analgesics|analgesics|mesh-ancestor
65106475|NCT05469204|Sensory System Agents|sensory system agents|mesh-ancestor
65106476|NCT05469204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65106477|NCT05469204|Antipyretics|antipyretics|mesh-ancestor
65106478|NCT05469204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65106479|NCT05469204|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65106480|NCT05469204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291177|NCT04002349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65291178|NCT04002349|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65291179|NCT04002349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65291180|NCT04002349|Histamine Antagonists|histamine antagonists|mesh-ancestor
65291181|NCT04002349|Histamine Agents|histamine agents|mesh-ancestor
65291182|NCT04002349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65291183|NCT04002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291184|NCT00688428|Aspirin|aspirin|mesh-list
65291185|NCT00688428|Esomeprazole|esomeprazole|mesh-list
65291186|NCT00688428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65291187|NCT00688428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65291188|NCT00688428|Analgesics|analgesics|mesh-ancestor
65291189|NCT00688428|Sensory System Agents|sensory system agents|mesh-ancestor
65291190|NCT00688428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65291191|NCT00688428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291192|NCT00688428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65291193|NCT00688428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65291194|NCT00688428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65106481|NCT05469204|Protective Agents|protective agents|mesh-ancestor
65106482|NCT05469165|Cyproheptadine|cyproheptadine|mesh-list
65106483|NCT05469165|Antipruritics|antipruritics|mesh-ancestor
65106484|NCT05469165|Dermatologic Agents|dermatologic agents|mesh-ancestor
65106485|NCT05469165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65106486|NCT05469165|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65106487|NCT05469165|Histamine Antagonists|histamine antagonists|mesh-ancestor
65106488|NCT05469165|Histamine Agents|histamine agents|mesh-ancestor
65106489|NCT05469165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65106490|NCT05469165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106491|NCT05469165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106492|NCT05469165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65106493|NCT05469165|Serotonin Agents|serotonin agents|mesh-ancestor
65106494|NCT05469165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65106495|NCT05398289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65106496|NCT05398289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65106497|NCT05398289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65106498|NCT05398289|Antitubercular Agents|antitubercular agents|mesh-ancestor
65106499|NCT02438722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65106500|NCT02438722|Cetuximab|cetuximab|mesh-list
65106501|NCT02438722|Afatinib|afatinib|mesh-list
65106502|NCT02438722|Antibodies|antibodies|mesh-list
65106503|NCT02438722|Immunoglobulins|immunoglobulins|mesh-list
65106504|NCT02438722|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65106505|NCT02438722|Immunologic Factors|immunologic factors|mesh-ancestor
65106506|NCT02438722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106507|NCT02438722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106508|NCT02438722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65106509|NCT02438722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106510|NCT02438722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106511|NCT04319926|Lidocaine|lidocaine|mesh-list
65106512|NCT04319926|Anesthetics, Local|anesthetics, local|mesh-ancestor
65106513|NCT04319926|Anesthetics|anesthetics|mesh-ancestor
65106514|NCT04319926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65106515|NCT04319926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106516|NCT04319926|Sensory System Agents|sensory system agents|mesh-ancestor
65106517|NCT04319926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65291195|NCT00688428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65291196|NCT00688428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291197|NCT00688428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65291198|NCT00688428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65291199|NCT00688428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291200|NCT00688428|Antipyretics|antipyretics|mesh-ancestor
65291201|NCT00688428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65291202|NCT00688428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65291203|NCT00688428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65291204|NCT03317158|Gemcitabine|gemcitabine|mesh-list
65291205|NCT03317158|Docetaxel|docetaxel|mesh-list
65291206|NCT03317158|Durvalumab|durvalumab|mesh-list
65291207|NCT03317158|Tremelimumab|tremelimumab|mesh-list
65291208|NCT03317158|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65291209|NCT03317158|BCG Vaccine|bcg vaccine|mesh-list
65291210|NCT03317158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65291211|NCT03317158|Antimetabolites|antimetabolites|mesh-ancestor
65291212|NCT03317158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291213|NCT03317158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291214|NCT03317158|Antiviral Agents|antiviral agents|mesh-ancestor
65106518|NCT04319926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65106519|NCT04319926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65106520|NCT04319926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65106521|NCT04319926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65106522|NCT04319926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106523|NCT05226871|Cetuximab|cetuximab|mesh-list
65106524|NCT05226871|Letrozole|letrozole|mesh-list
65106525|NCT05226871|Fulvestrant|fulvestrant|mesh-list
65106526|NCT05226871|Palbociclib|palbociclib|mesh-list
64748734|NCT03599466|Lisinopril|lisinopril|mesh-list
65106527|NCT05226871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65106529|NCT05226871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65106543|NCT01366612|Busulfan|busulfan|mesh-list
65106544|NCT01366612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106545|NCT01366612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65106546|NCT01366612|Antimetabolites|antimetabolites|mesh-ancestor
65106547|NCT01366612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106548|NCT01366612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65106549|NCT01366612|Immunologic Factors|immunologic factors|mesh-ancestor
65106550|NCT01366612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106551|NCT01366612|Antiviral Agents|antiviral agents|mesh-ancestor
65106552|NCT01366612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65106553|NCT01366612|Alkylating Agents|alkylating agents|mesh-ancestor
65106554|NCT01366612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65106555|NCT01366612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65106556|NCT01313923|Sirolimus|sirolimus|mesh-list
65106557|NCT01313923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65106558|NCT01313923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65106559|NCT01313923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65106560|NCT01313923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106561|NCT01313923|Antifungal Agents|antifungal agents|mesh-ancestor
65106562|NCT01313923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65106563|NCT01313923|Immunologic Factors|immunologic factors|mesh-ancestor
65106564|NCT01313923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106565|NCT01313884|Cyclophosphamide|cyclophosphamide|mesh-list
65106566|NCT01313884|Temozolomide|temozolomide|mesh-list
65106567|NCT01313884|Doxorubicin|doxorubicin|mesh-list
65291215|NCT03317158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65291216|NCT03317158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291217|NCT03317158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65291218|NCT03317158|Immunologic Factors|immunologic factors|mesh-ancestor
65291219|NCT03317158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291220|NCT03317158|Tubulin Modulators|tubulin modulators|mesh-ancestor
65291221|NCT03317158|Antimitotic Agents|antimitotic agents|mesh-ancestor
65291222|NCT03317158|Mitosis Modulators|mitosis modulators|mesh-ancestor
65291223|NCT03317158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65291224|NCT03317158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65291225|NCT02724761|Epinephrine|epinephrine|mesh-list
65291226|NCT02724761|Racepinephrine|racepinephrine|mesh-list
65291227|NCT02724761|Epinephryl borate|epinephryl borate|mesh-list
65291228|NCT02724761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65291229|NCT02724761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65291230|NCT02724761|Adrenergic Agents|adrenergic agents|mesh-ancestor
65291231|NCT02724761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65291232|NCT02724761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291233|NCT02724761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291234|NCT02724761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65291235|NCT02724761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65291236|NCT02724761|Autonomic Agents|autonomic agents|mesh-ancestor
65291237|NCT02724761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65291238|NCT02724761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65291239|NCT02724761|Respiratory System Agents|respiratory system agents|mesh-ancestor
65291240|NCT02724761|Mydriatics|mydriatics|mesh-ancestor
65291241|NCT02724761|Sympathomimetics|sympathomimetics|mesh-ancestor
65291242|NCT02724761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65291243|NCT04350190|Apatinib|apatinib|mesh-list
65291244|NCT04350190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291245|NCT04350190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65291248|NCT02721173|Clindamycin|clindamycin|mesh-list
65291258|NCT02721173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65291259|NCT02721173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65291260|NCT02721173|Analgesics|analgesics|mesh-ancestor
65291261|NCT02721173|Sensory System Agents|sensory system agents|mesh-ancestor
65291262|NCT02721173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65291263|NCT02721173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291264|NCT02721173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65291265|NCT02721173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65291266|NCT02721173|Dermatologic Agents|dermatologic agents|mesh-ancestor
65291267|NCT02721173|Keratolytic Agents|keratolytic agents|mesh-ancestor
65291268|NCT00713986|Tin Fluorides|tin fluorides|mesh-list
65291269|NCT00713986|Cariostatic Agents|cariostatic agents|mesh-ancestor
65291270|NCT00713986|Protective Agents|protective agents|mesh-ancestor
65291271|NCT00713986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291272|NCT00993733|Dialysis Solutions|dialysis solutions|mesh-list
65291273|NCT00993733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65291274|NCT00692640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65291275|NCT00692640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291276|NCT00692640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65291277|NCT00692640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291278|NCT00692640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291279|NCT04137432|Oxytocin|oxytocin|mesh-list
65291280|NCT04137432|Oxytocics|oxytocics|mesh-ancestor
65291281|NCT04137432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64521489|NCT05709028|Fosfomycin|fosfomycin|mesh-list
65106568|NCT01313884|Irinotecan|irinotecan|mesh-list
65106569|NCT01313884|Vincristine|vincristine|mesh-list
65106570|NCT01313884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65106571|NCT01313884|Immunologic Factors|immunologic factors|mesh-ancestor
65106572|NCT01313884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106573|NCT01313884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65106574|NCT01313884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65106575|NCT01313884|Alkylating Agents|alkylating agents|mesh-ancestor
65106576|NCT01313884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106577|NCT01313884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106578|NCT01313884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65106579|NCT01313884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65106580|NCT01313884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65106581|NCT01313884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65106582|NCT01313884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106583|NCT01313884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65106584|NCT01313884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65106585|NCT01313884|Tubulin Modulators|tubulin modulators|mesh-ancestor
65106586|NCT01313884|Antimitotic Agents|antimitotic agents|mesh-ancestor
65106587|NCT01313884|Mitosis Modulators|mitosis modulators|mesh-ancestor
65106588|NCT05180773|Bromocriptine|bromocriptine|mesh-list
65106589|NCT05180773|Rivaroxaban|rivaroxaban|mesh-list
65106590|NCT05180773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65106601|NCT05180773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106603|NCT05180773|Dopamine Agents|dopamine agents|mesh-ancestor
65291282|NCT04137432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291283|NCT00885170|Vitamin D|vitamin d|mesh-list
65291284|NCT00885170|Cholecalciferol|cholecalciferol|mesh-list
65291285|NCT00885170|Calcium|calcium|mesh-list
65291286|NCT00885170|Vitamins|vitamins|mesh-ancestor
65291287|NCT00885170|Micronutrients|micronutrients|mesh-ancestor
65291288|NCT00885170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291289|NCT00885170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65291290|NCT00885170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65291291|NCT05204290|Pembrolizumab|pembrolizumab|mesh-list
65291292|NCT05204290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65291293|NCT05204290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291294|NCT05342467|Dinoprostone|dinoprostone|mesh-list
65291295|NCT05342467|Gemeprost|gemeprost|mesh-list
65291296|NCT05342467|Oxytocics|oxytocics|mesh-ancestor
65291297|NCT05342467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65291298|NCT05342467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291299|NCT05342467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65291300|NCT05342467|Abortifacient Agents|abortifacient agents|mesh-ancestor
65291301|NCT02720783|Econazole|econazole|mesh-list
65291302|NCT02720783|Benzydamine|benzydamine|mesh-list
65291303|NCT02720783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65291304|NCT02720783|Antifungal Agents|antifungal agents|mesh-ancestor
65291305|NCT02720783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65291306|NCT02720783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65291307|NCT02720783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65291308|NCT02720783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521512|NCT01336530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65106604|NCT05180773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65106605|NCT00537524|Vaccines|vaccines|mesh-list
65106606|NCT00537524|Immunologic Factors|immunologic factors|mesh-ancestor
65106607|NCT00537524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106608|NCT00537563|Telithromycin|telithromycin|mesh-list
65106609|NCT00537563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65106610|NCT00537563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65106611|NCT00537602|Miglustat|miglustat|mesh-list
65106612|NCT00537602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106613|NCT00537602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106614|NCT00537602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65106615|NCT00537602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65106616|NCT00537602|Antiviral Agents|antiviral agents|mesh-ancestor
65106617|NCT00537602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65106618|NCT00537602|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65106619|NCT00537602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65106620|NCT00537602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106621|NCT01259284|Atorvastatin|atorvastatin|mesh-list
65106622|NCT01259284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65106623|NCT01259284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65106624|NCT01259284|Antimetabolites|antimetabolites|mesh-ancestor
65291309|NCT02720783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291310|NCT02720783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65291311|NCT02720783|Hormone Antagonists|hormone antagonists|mesh-ancestor
65291312|NCT02720783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65291313|NCT02720783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291314|NCT00714064|Edetic Acid|edetic acid|mesh-list
65291315|NCT00714064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65291316|NCT00714064|Pentetic Acid|pentetic acid|mesh-list
65291317|NCT00714064|Immunologic Factors|immunologic factors|mesh-ancestor
65291318|NCT00714064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041283|NCT00194402|Niacin|niacin|mesh-list
65291319|NCT00714064|Antidotes|antidotes|mesh-ancestor
65291320|NCT00714064|Protective Agents|protective agents|mesh-ancestor
65291321|NCT00714064|Chelating Agents|chelating agents|mesh-ancestor
65291322|NCT00714064|Sequestering Agents|sequestering agents|mesh-ancestor
65291323|NCT00714064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291324|NCT00714064|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65291325|NCT00714064|Anticoagulants|anticoagulants|mesh-ancestor
65291326|NCT00714064|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65291327|NCT02720705|Dexmedetomidine|dexmedetomidine|mesh-list
65291328|NCT02720705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65291329|NCT02720705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65106625|NCT01259284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106626|NCT01259284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65106627|NCT01259284|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65106628|NCT01259284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106629|NCT03457025|Antiviral Agents|antiviral agents|mesh-list
65106630|NCT03457025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65106631|NCT05123040|Prednisone|prednisone|mesh-list
65106632|NCT05123040|Methylprednisolone|methylprednisolone|mesh-list
65106633|NCT05123040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65106634|NCT05123040|Glucocorticoids|glucocorticoids|mesh-ancestor
65106635|NCT05123040|Hormones|hormones|mesh-ancestor
65106636|NCT05123040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65106637|NCT05123040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106638|NCT05123040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65106639|NCT05123040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106640|NCT05123040|Antiemetics|antiemetics|mesh-ancestor
65106641|NCT05123040|Autonomic Agents|autonomic agents|mesh-ancestor
65106642|NCT05123040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65106643|NCT05123040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65106644|NCT05123040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65106645|NCT05123040|Protective Agents|protective agents|mesh-ancestor
65106646|NCT00537836|Estradiol|estradiol|mesh-list
65106647|NCT00537836|Estrogens|estrogens|mesh-ancestor
65106648|NCT00537836|Hormones|hormones|mesh-ancestor
65106649|NCT00537836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65106650|NCT00537836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106651|NCT05338658|Pembrolizumab|pembrolizumab|mesh-list
65106652|NCT05338658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65106653|NCT05338658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291330|NCT02720705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291331|NCT02720705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65291332|NCT02720705|Analgesics|analgesics|mesh-ancestor
65291333|NCT02720705|Sensory System Agents|sensory system agents|mesh-ancestor
65291334|NCT02720705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65291335|NCT02720705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65291336|NCT02720705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65106654|NCT02277171|Nitric Oxide|nitric oxide|mesh-list
65106665|NCT02277171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65106666|NCT02277171|Vasodilator Agents|vasodilator agents|mesh-ancestor
65106667|NCT02277171|Gasotransmitters|gasotransmitters|mesh-ancestor
65106668|NCT02277171|Protective Agents|protective agents|mesh-ancestor
65106669|NCT00551564|Rosiglitazone|rosiglitazone|mesh-list
65106670|NCT00551564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65106671|NCT00551564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106672|NCT05105061|Ketamine|ketamine|mesh-list
65106673|NCT05105061|Analgesics|analgesics|mesh-ancestor
65106674|NCT05105061|Sensory System Agents|sensory system agents|mesh-ancestor
65106675|NCT05105061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65106676|NCT05105061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106677|NCT05105061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65106678|NCT05105061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65106679|NCT05105061|Anesthetics, General|anesthetics, general|mesh-ancestor
65106680|NCT05105061|Anesthetics|anesthetics|mesh-ancestor
65106681|NCT05105061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65106682|NCT05105061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65106683|NCT05105061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65106684|NCT05105061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65106685|NCT05105061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106686|NCT05056584|Glucagon|glucagon|mesh-list
65106687|NCT05056584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65106688|NCT05056584|Hormones|hormones|mesh-ancestor
64483998|NCT01755091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65106689|NCT05056584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65106690|NCT05056584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106691|NCT00551954|Acarbose|acarbose|mesh-list
65106692|NCT00551954|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65106693|NCT00551954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106694|NCT00551954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106695|NCT00551954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65106696|NCT00551954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106697|NCT00552149|Cetuximab|cetuximab|mesh-list
65106698|NCT00552149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65106699|NCT00552149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106700|NCT05467878|Anesthetics|anesthetics|mesh-list
65106701|NCT05467878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65106702|NCT05467878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106703|NCT00536640|Gemcitabine|gemcitabine|mesh-list
65106704|NCT00536640|Bevacizumab|bevacizumab|mesh-list
65106705|NCT00536640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65106706|NCT00536640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65106707|NCT00536640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106708|NCT00536640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65106709|NCT00536640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65106710|NCT00536640|Growth Substances|growth substances|mesh-ancestor
65106711|NCT00536640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106712|NCT00536640|Growth Inhibitors|growth inhibitors|mesh-ancestor
65106713|NCT00536640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65106714|NCT00536640|Antimetabolites|antimetabolites|mesh-ancestor
65106715|NCT00536640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106716|NCT00536640|Antiviral Agents|antiviral agents|mesh-ancestor
65106735|NCT00552266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65106736|NCT00552266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106737|NCT00552266|Dopamine Agents|dopamine agents|mesh-ancestor
65106738|NCT00552266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65106739|NCT04943757|Cyclophosphamide|cyclophosphamide|mesh-list
65291337|NCT02720705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65291338|NCT02720705|Adrenergic Agents|adrenergic agents|mesh-ancestor
65291339|NCT02720705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65291340|NCT02720705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291341|NCT02720471|Anesthetics|anesthetics|mesh-list
65291342|NCT02720471|Anesthetics, Local|anesthetics, local|mesh-list
65291343|NCT02720471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64521572|NCT00357682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65106740|NCT04943757|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65106741|NCT04943757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65106742|NCT04943757|Immunologic Factors|immunologic factors|mesh-ancestor
65106743|NCT04943757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106744|NCT04943757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65106745|NCT04943757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65106746|NCT04943757|Alkylating Agents|alkylating agents|mesh-ancestor
65106747|NCT04943757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748968|NCT04196400|Betamethasone|betamethasone|mesh-list
65106748|NCT04943757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106749|NCT04943757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65106750|NCT00552461|Rituximab|rituximab|mesh-list
65106751|NCT00552461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65106752|NCT00552461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106753|NCT00552461|Immunologic Factors|immunologic factors|mesh-ancestor
65106754|NCT00552461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106755|NCT00552461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65106756|NCT00552500|Valproic Acid|valproic acid|mesh-list
65106757|NCT00552500|Anticonvulsants|anticonvulsants|mesh-ancestor
64484002|NCT01755091|Hormones|hormones|mesh-ancestor
65106758|NCT00552500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106759|NCT00552500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106761|NCT00552500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65106762|NCT00552500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106763|NCT00552500|Antimanic Agents|antimanic agents|mesh-ancestor
65106764|NCT00552500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65106765|NCT00552500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65106766|NCT00552500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65106767|NCT01258738|Etanercept|etanercept|mesh-list
65106768|NCT01258738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64679161|NCT00002535|Analgesics|analgesics|mesh-ancestor
65106781|NCT00552656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65106782|NCT00552656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65106783|NCT00552656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106784|NCT00552656|Antifungal Agents|antifungal agents|mesh-ancestor
65106785|NCT00552656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65106786|NCT00552656|Immunologic Factors|immunologic factors|mesh-ancestor
65106787|NCT00552656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106788|NCT01824537|Vaccines|vaccines|mesh-list
65106789|NCT01824537|Immunologic Factors|immunologic factors|mesh-ancestor
65106790|NCT01824537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106791|NCT04863339|Tranexamic Acid|tranexamic acid|mesh-list
65106792|NCT04863339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65106793|NCT04863339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65106794|NCT04863339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106795|NCT04863339|Hemostatics|hemostatics|mesh-ancestor
65106796|NCT04863339|Coagulants|coagulants|mesh-ancestor
65106797|NCT04684277|Antidepressive Agents|antidepressive agents|mesh-list
65106798|NCT04684277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65106799|NCT00552734|Insulin|insulin|mesh-list
65106800|NCT00552734|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65106801|NCT00552734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65106802|NCT00552734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106803|NCT04608539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65106804|NCT04608539|Hematinics|hematinics|mesh-ancestor
65106805|NCT04543682|Iloprost|iloprost|mesh-list
65106806|NCT04543682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65106807|NCT04543682|Vasodilator Agents|vasodilator agents|mesh-ancestor
65106808|NCT04802616|Broncho-Vaxom|broncho-vaxom|mesh-list
65106809|NCT04802616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65291344|NCT02720471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291345|NCT02720471|Sensory System Agents|sensory system agents|mesh-ancestor
65291346|NCT02720471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65291347|NCT00688818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65291348|NCT00688818|Antidepressive Agents|antidepressive agents|mesh-ancestor
65291349|NCT00688818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65291350|NCT00688818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65106810|NCT04802616|Immunologic Factors|immunologic factors|mesh-ancestor
65106811|NCT04802616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106812|NCT01258660|Folic Acid|folic acid|mesh-list
65106813|NCT01258660|Vitamin B Complex|vitamin b complex|mesh-list
65106814|NCT01258660|Drospirenone|drospirenone|mesh-list
65106815|NCT01258660|Hematinics|hematinics|mesh-ancestor
65106816|NCT01258660|Vitamins|vitamins|mesh-ancestor
65106817|NCT01258660|Micronutrients|micronutrients|mesh-ancestor
65106818|NCT01258660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106819|NCT01258660|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65106820|NCT01258660|Hormone Antagonists|hormone antagonists|mesh-ancestor
65106821|NCT01258660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65106822|NCT01258660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65106823|NCT01258660|Diuretics|diuretics|mesh-ancestor
65106824|NCT01258660|Natriuretic Agents|natriuretic agents|mesh-ancestor
65106825|NCT04772274|Ustekinumab|ustekinumab|mesh-list
65106826|NCT04772274|Dermatologic Agents|dermatologic agents|mesh-ancestor
65106828|NCT04362527|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65106829|NCT04362527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65106830|NCT04362527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65106831|NCT04362527|Vasodilator Agents|vasodilator agents|mesh-ancestor
65106832|NCT04362527|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64484004|NCT00789802|Naproxen|naproxen|mesh-list
65106834|NCT04362527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679208|NCT00002553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65106843|NCT04758975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106845|NCT01614171|Hormones|hormones|mesh-list
65106846|NCT01614171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65106847|NCT01614171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106848|NCT05567367|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65106849|NCT05567367|Vasodilator Agents|vasodilator agents|mesh-ancestor
65106850|NCT05567367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65106851|NCT05567367|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65106852|NCT05567367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106853|NCT05567367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106854|NCT05567367|Urological Agents|urological agents|mesh-ancestor
65106855|NCT04291001|Ulipristal acetate|ulipristal acetate|mesh-list
65106856|NCT04291001|Etonogestrel|etonogestrel|mesh-list
65106857|NCT04291001|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65106858|NCT04291001|Contraceptive Agents|contraceptive agents|mesh-ancestor
65106859|NCT04291001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65106860|NCT04291001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106861|NCT04291001|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65106862|NCT04656951|Daratumumab|daratumumab|mesh-list
65106863|NCT04656951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106864|NCT04255160|Estradiol|estradiol|mesh-list
65106865|NCT04255160|Estrogens|estrogens|mesh-ancestor
65106866|NCT04255160|Hormones|hormones|mesh-ancestor
65106867|NCT04255160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65106868|NCT04255160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106869|NCT04173533|Azacitidine|azacitidine|mesh-list
65106870|NCT04173533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65106871|NCT04173533|Antimetabolites|antimetabolites|mesh-ancestor
65106872|NCT04173533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106873|NCT04173533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106874|NCT04173533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106875|NCT04158440|Paclitaxel|paclitaxel|mesh-list
65106876|NCT04158440|Docetaxel|docetaxel|mesh-list
65106877|NCT04158440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65106878|NCT04158440|Cisplatin|cisplatin|mesh-list
65106879|NCT04158440|Carboplatin|carboplatin|mesh-list
65106880|NCT04158440|Pemetrexed|pemetrexed|mesh-list
65291351|NCT00688818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65291352|NCT00688818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65291353|NCT00688818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291354|NCT00656006|Ribavirin|ribavirin|mesh-list
65291355|NCT00656006|Antimetabolites|antimetabolites|mesh-ancestor
65291356|NCT00656006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291357|NCT00656006|Antiviral Agents|antiviral agents|mesh-ancestor
65291358|NCT00656006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65291359|NCT00688896|Pravastatin|pravastatin|mesh-list
65291360|NCT00688896|Dalcetrapib|dalcetrapib|mesh-list
65291361|NCT00688896|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65291362|NCT00688896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65291363|NCT00688896|Antimetabolites|antimetabolites|mesh-ancestor
65291364|NCT00688896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291365|NCT00688896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65291366|NCT00688896|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65291367|NCT00688896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291368|NCT02724293|Pregabalin|pregabalin|mesh-list
65291369|NCT02724293|Analgesics|analgesics|mesh-ancestor
65291370|NCT02724293|Sensory System Agents|sensory system agents|mesh-ancestor
65291371|NCT02724293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65291372|NCT02724293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291373|NCT02724293|Anticonvulsants|anticonvulsants|mesh-ancestor
65106881|NCT04158440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65106882|NCT04158440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106883|NCT04158440|Tubulin Modulators|tubulin modulators|mesh-ancestor
65106884|NCT04158440|Antimitotic Agents|antimitotic agents|mesh-ancestor
65106885|NCT04158440|Mitosis Modulators|mitosis modulators|mesh-ancestor
65106886|NCT04158440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106887|NCT04158440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106888|NCT04158440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64679280|NCT00002571|Methotrexate|methotrexate|mesh-list
65106924|NCT01258348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65106934|NCT05136898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106935|NCT01258075|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65106936|NCT01258075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65106937|NCT01258075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65106938|NCT01258075|Antimetabolites|antimetabolites|mesh-ancestor
65106939|NCT01258075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106940|NCT01258075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65106941|NCT04687878|Insulin|insulin|mesh-list
65106942|NCT04687878|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65106943|NCT04687878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65106944|NCT04687878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106945|NCT05116774|Eculizumab|eculizumab|mesh-list
65106946|NCT05116774|Ravulizumab|ravulizumab|mesh-list
65106947|NCT05116774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65106948|NCT05116774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65106949|NCT05116774|Immunologic Factors|immunologic factors|mesh-ancestor
65106950|NCT05116774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106951|NCT01256671|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65106952|NCT01256671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65291374|NCT02724293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65291375|NCT02724293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65291376|NCT02724293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291377|NCT02724293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65291378|NCT02724293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65291379|NCT02724293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65291380|NCT02724293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65291381|NCT02724293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65291382|NCT05092828|Morphine|morphine|mesh-list
65291383|NCT05092828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65291384|NCT05092828|Narcotics|narcotics|mesh-ancestor
65291385|NCT05092828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65291386|NCT05092828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291387|NCT05092828|Analgesics|analgesics|mesh-ancestor
65291388|NCT05092828|Sensory System Agents|sensory system agents|mesh-ancestor
65291389|NCT05092828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65291390|NCT04137198|Sufentanil|sufentanil|mesh-list
65291391|NCT04137198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65291392|NCT04137198|Narcotics|narcotics|mesh-ancestor
65291393|NCT04137198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65291394|NCT04137198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291395|NCT04137198|Analgesics|analgesics|mesh-ancestor
65291396|NCT04137198|Sensory System Agents|sensory system agents|mesh-ancestor
65291397|NCT04137198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65291398|NCT04137198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65291399|NCT04137198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65291400|NCT04137198|Anesthetics, General|anesthetics, general|mesh-ancestor
65291401|NCT04137198|Anesthetics|anesthetics|mesh-ancestor
65291402|NCT00995293|Docetaxel|docetaxel|mesh-list
65291403|NCT00995293|Fluorouracil|fluorouracil|mesh-list
65291404|NCT00995293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291405|NCT00995293|Tubulin Modulators|tubulin modulators|mesh-ancestor
65291406|NCT00995293|Antimitotic Agents|antimitotic agents|mesh-ancestor
65291407|NCT00995293|Mitosis Modulators|mitosis modulators|mesh-ancestor
65291409|NCT00995293|Antimetabolites|antimetabolites|mesh-ancestor
65291414|NCT00692952|Benzalkonium Compounds|benzalkonium compounds|mesh-list
65291415|NCT00692952|Contraceptive Agents|contraceptive agents|mesh-list
65291416|NCT00692952|Nonoxynol|nonoxynol|mesh-list
65291417|NCT00692952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65291418|NCT00692952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291419|NCT00692952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65291420|NCT00692952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65291421|NCT00692952|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
65291422|NCT00692952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
65291423|NCT00692952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65291424|NCT00692952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65291425|NCT02639858|Docetaxel|docetaxel|mesh-list
65291426|NCT02639858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291427|NCT02639858|Tubulin Modulators|tubulin modulators|mesh-ancestor
65291428|NCT02639858|Antimitotic Agents|antimitotic agents|mesh-ancestor
65291429|NCT02639858|Mitosis Modulators|mitosis modulators|mesh-ancestor
65291430|NCT02639858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291431|NCT00689208|Atropine|atropine|mesh-list
65291432|NCT00689208|Physostigmine|physostigmine|mesh-list
64521640|NCT02709486|Tanezumab|tanezumab|mesh-list
65106953|NCT01256671|Immunologic Factors|immunologic factors|mesh-ancestor
65106954|NCT01256671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106955|NCT04687566|Memantine|memantine|mesh-list
65106956|NCT04687566|Dextromethorphan|dextromethorphan|mesh-list
65106957|NCT04687566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65106958|NCT04687566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65106959|NCT04687566|Dopamine Agents|dopamine agents|mesh-ancestor
65106960|NCT04687566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65106961|NCT04687566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106962|NCT04687566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106963|NCT04687566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65106964|NCT04687566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65106965|NCT04687566|Antitussive Agents|antitussive agents|mesh-ancestor
65106966|NCT04687566|Respiratory System Agents|respiratory system agents|mesh-ancestor
65106967|NCT01256593|Pregabalin|pregabalin|mesh-list
65106968|NCT01256593|Analgesics|analgesics|mesh-ancestor
65106969|NCT01256593|Sensory System Agents|sensory system agents|mesh-ancestor
65106970|NCT01256593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65106971|NCT01256593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106972|NCT01256593|Anticonvulsants|anticonvulsants|mesh-ancestor
65106973|NCT01256593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65106974|NCT01256593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65106975|NCT01256593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106976|NCT01256593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65106977|NCT01256593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65106978|NCT01256593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64484007|NCT00789802|Hormones|hormones|mesh-ancestor
65106979|NCT01256593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65106980|NCT01256593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65106994|NCT05507892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106995|NCT05491083|Pembrolizumab|pembrolizumab|mesh-list
65106996|NCT05491083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65106997|NCT05491083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106998|NCT04106999|Dexmedetomidine|dexmedetomidine|mesh-list
65106999|NCT04106999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65107000|NCT04106999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65291433|NCT00689208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65291434|NCT00689208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65291435|NCT00689208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65291508|NCT02723981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65291509|NCT02723981|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65291510|NCT02723981|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65291511|NCT02723981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65291512|NCT02723981|Purinergic Agents|purinergic agents|mesh-ancestor
65291513|NCT02723981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65291514|NCT02723981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291515|NCT02723981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65291516|NCT02723981|Antithrombins|antithrombins|mesh-ancestor
65291517|NCT02723981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65291518|NCT02723981|Protease Inhibitors|protease inhibitors|mesh-ancestor
65291519|NCT02723981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291520|NCT02723981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65291521|NCT02723981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65291522|NCT02723981|Hemostatics|hemostatics|mesh-ancestor
65291523|NCT02723981|Coagulants|coagulants|mesh-ancestor
65291524|NCT00912444|Cyclophosphamide|cyclophosphamide|mesh-list
65291525|NCT00912444|Docetaxel|docetaxel|mesh-list
65291526|NCT00912444|Doxorubicin|doxorubicin|mesh-list
65291527|NCT00912444|Epirubicin|epirubicin|mesh-list
65291528|NCT00912444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65291529|NCT00912444|Immunologic Factors|immunologic factors|mesh-ancestor
65291530|NCT00912444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291531|NCT00912444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65291532|NCT00912444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65291533|NCT00912444|Alkylating Agents|alkylating agents|mesh-ancestor
65291534|NCT00912444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107001|NCT04106999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107002|NCT04106999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65107003|NCT04106999|Analgesics|analgesics|mesh-ancestor
65107004|NCT04106999|Sensory System Agents|sensory system agents|mesh-ancestor
65107005|NCT04106999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65107006|NCT04106999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65107007|NCT04106999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65107008|NCT04106999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65107009|NCT04106999|Adrenergic Agents|adrenergic agents|mesh-ancestor
65107010|NCT04106999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65107011|NCT04106999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107012|NCT05478720|Diazooxonorleucine|diazooxonorleucine|mesh-list
65107013|NCT05478720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65107014|NCT05478720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107015|NCT05478720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65107016|NCT05478720|Antimetabolites|antimetabolites|mesh-ancestor
65107017|NCT05478720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107018|NCT05003089|Prednisolone|prednisolone|mesh-list
65107019|NCT05003089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65107020|NCT05003089|Glucocorticoids|glucocorticoids|mesh-ancestor
65291535|NCT00912444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291536|NCT00912444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65291537|NCT00912444|Tubulin Modulators|tubulin modulators|mesh-ancestor
65291538|NCT00912444|Antimitotic Agents|antimitotic agents|mesh-ancestor
65291539|NCT00912444|Mitosis Modulators|mitosis modulators|mesh-ancestor
65291540|NCT00912444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65291541|NCT00912444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65291542|NCT00912444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65291543|NCT00912444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041510|NCT00125918|Tadalafil|tadalafil|mesh-list
65291544|NCT02644525|Imatinib Mesylate|imatinib mesylate|mesh-list
65291545|NCT02644525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291546|NCT02644525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65291547|NCT02644525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291548|NCT02644525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291549|NCT00726700|Prednisone|prednisone|mesh-list
65291550|NCT00726700|Cyclophosphamide|cyclophosphamide|mesh-list
65291551|NCT00726700|Rituximab|rituximab|mesh-list
65107022|NCT05003089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65107023|NCT05003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107024|NCT05003089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65107025|NCT05003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107026|NCT04207021|Curcumin|curcumin|mesh-list
65107027|NCT04207021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65107057|NCT01255306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107058|NCT01255306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107059|NCT01254721|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65107060|NCT01254721|Antidepressive Agents|antidepressive agents|mesh-ancestor
65107061|NCT01254721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65107062|NCT01254721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65107063|NCT01254721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65107064|NCT01254721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65107065|NCT01254721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107067|NCT04005053|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65107068|NCT04005053|Antiviral Agents|antiviral agents|mesh-ancestor
65107069|NCT04005053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65107079|NCT04003805|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65107080|NCT04003805|Autonomic Agents|autonomic agents|mesh-ancestor
65107081|NCT04003805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65107082|NCT04003805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107083|NCT04003805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65107084|NCT04003805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65107085|NCT04003805|Cholinergic Agents|cholinergic agents|mesh-ancestor
65107086|NCT04003805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65107087|NCT04003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107088|NCT04842604|Azacitidine|azacitidine|mesh-list
65107089|NCT04842604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65107090|NCT04842604|Antimetabolites|antimetabolites|mesh-ancestor
65107091|NCT04842604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107092|NCT04842604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107093|NCT04842604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107095|NCT01254604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107096|NCT01254604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65107097|NCT01254604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65107098|NCT01254604|Adrenergic Agents|adrenergic agents|mesh-ancestor
65107099|NCT01254604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65291552|NCT00726700|Doxorubicin|doxorubicin|mesh-list
65291553|NCT00726700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65291554|NCT00726700|Vincristine|vincristine|mesh-list
65291555|NCT00726700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65291556|NCT00726700|Immunologic Factors|immunologic factors|mesh-ancestor
65291557|NCT00726700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291558|NCT00726700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65291559|NCT00726700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65291560|NCT00726700|Alkylating Agents|alkylating agents|mesh-ancestor
65291561|NCT00726700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291562|NCT00726700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291563|NCT00726700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65291564|NCT00726700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65291565|NCT00726700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65291566|NCT00726700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65291567|NCT00726700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65291568|NCT00726700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291569|NCT00726700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65291570|NCT00726700|Glucocorticoids|glucocorticoids|mesh-ancestor
65291571|NCT00726700|Hormones|hormones|mesh-ancestor
65291572|NCT00726700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65291573|NCT00726700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65291574|NCT00726700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65291575|NCT00726700|Tubulin Modulators|tubulin modulators|mesh-ancestor
65291576|NCT00726700|Antimitotic Agents|antimitotic agents|mesh-ancestor
65291577|NCT00726700|Mitosis Modulators|mitosis modulators|mesh-ancestor
65291578|NCT02723903|Fluoxetine|fluoxetine|mesh-list
64521773|NCT03117894|Morphine|morphine|mesh-list
65107100|NCT01254604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107101|NCT01254604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65107102|NCT01254604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65107103|NCT01220583|Cisplatin|cisplatin|mesh-list
65107104|NCT01220583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107105|NCT03911414|Inositol|inositol|mesh-list
65107106|NCT03911414|Acetylcysteine|acetylcysteine|mesh-list
65107107|NCT03911414|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65107108|NCT03911414|Antiviral Agents|antiviral agents|mesh-ancestor
65107109|NCT03911414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65107110|NCT03911414|Expectorants|expectorants|mesh-ancestor
65107111|NCT03911414|Respiratory System Agents|respiratory system agents|mesh-ancestor
65107112|NCT03911414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65107113|NCT03911414|Antioxidants|antioxidants|mesh-ancestor
65107114|NCT03911414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107115|NCT03911414|Protective Agents|protective agents|mesh-ancestor
65107116|NCT03911414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107117|NCT03911414|Antidotes|antidotes|mesh-ancestor
65107118|NCT03911414|Vitamin B Complex|vitamin b complex|mesh-ancestor
65291579|NCT02723903|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65291580|NCT02723903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65291581|NCT02723903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65291582|NCT02723903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291583|NCT02723903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65291584|NCT02723903|Serotonin Agents|serotonin agents|mesh-ancestor
65291585|NCT02723903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521802|NCT03117894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65107119|NCT03911414|Vitamins|vitamins|mesh-ancestor
64749340|NCT04021992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107120|NCT03911414|Micronutrients|micronutrients|mesh-ancestor
65107122|NCT03872180|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65107123|NCT03872180|Obinutuzumab|obinutuzumab|mesh-list
65107124|NCT03872180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107125|NCT03872180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65107126|NCT03872180|Alkylating Agents|alkylating agents|mesh-ancestor
65107127|NCT03872180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107128|NCT03872180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65107129|NCT04390698|Analgesics, Opioid|analgesics, opioid|mesh-list
65107130|NCT04390698|Anesthetics|anesthetics|mesh-list
65107131|NCT04390698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65107132|NCT04390698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107133|NCT04390698|Narcotics|narcotics|mesh-ancestor
65107134|NCT04390698|Analgesics|analgesics|mesh-ancestor
65107143|NCT04673578|Celecoxib|celecoxib|mesh-list
65107144|NCT04673578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65107145|NCT04673578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65107146|NCT04673578|Analgesics|analgesics|mesh-ancestor
65107147|NCT04673578|Sensory System Agents|sensory system agents|mesh-ancestor
65107148|NCT04673578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65107149|NCT04673578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107150|NCT04673578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65107151|NCT04673578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65107152|NCT04673578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65107153|NCT04673578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65107154|NCT04673578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107155|NCT04673578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107156|NCT05414058|Methylphenidate|methylphenidate|mesh-list
65107157|NCT05414058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65107158|NCT05414058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107159|NCT05414058|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65107160|NCT05414058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65107161|NCT05414058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65107162|NCT05414058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107163|NCT05414058|Dopamine Agents|dopamine agents|mesh-ancestor
65107164|NCT05414058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65107165|NCT03757403|Mebendazole|mebendazole|mesh-list
65107166|NCT03757403|Piperazine|piperazine|mesh-list
65107167|NCT03757403|Piperazine citrate|piperazine citrate|mesh-list
65107168|NCT03757403|DMP 777|dmp 777|mesh-list
65107169|NCT03757403|Antinematodal Agents|antinematodal agents|mesh-ancestor
65107170|NCT03757403|Anthelmintics|anthelmintics|mesh-ancestor
65107171|NCT03757403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65107172|NCT03757403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65107173|NCT03757403|Tubulin Modulators|tubulin modulators|mesh-ancestor
65107174|NCT03757403|Antimitotic Agents|antimitotic agents|mesh-ancestor
65107175|NCT03757403|Mitosis Modulators|mitosis modulators|mesh-ancestor
65107176|NCT03757403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107177|NCT03757403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107178|NCT03757403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107179|NCT03724019|Ketamine|ketamine|mesh-list
65107180|NCT03724019|Analgesics|analgesics|mesh-ancestor
65107181|NCT03724019|Sensory System Agents|sensory system agents|mesh-ancestor
65107182|NCT03724019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65107183|NCT03724019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291586|NCT02723903|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65291587|NCT02723903|Antidepressive Agents|antidepressive agents|mesh-ancestor
65291588|NCT02723903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65291589|NCT02723903|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65291590|NCT02723903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65291591|NCT02723903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291592|NCT00675714|Nandrolone Decanoate|nandrolone decanoate|mesh-list
65291593|NCT00675714|Itraconazole|itraconazole|mesh-list
65291594|NCT00675714|Fluconazole|fluconazole|mesh-list
65291653|NCT00729976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65291654|NCT00729976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291655|NCT00729976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291656|NCT00656318|Contraceptive Agents|contraceptive agents|mesh-list
65291657|NCT00656318|Contraceptives, Oral|contraceptives, oral|mesh-list
65291658|NCT00656318|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65291659|NCT00656318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65291660|NCT00656318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291661|NCT00656318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65291662|NCT02451553|Capecitabine|capecitabine|mesh-list
65291663|NCT02451553|Afatinib|afatinib|mesh-list
65291664|NCT02451553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65107184|NCT03724019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65107185|NCT03724019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65107186|NCT03724019|Anesthetics, General|anesthetics, general|mesh-ancestor
65107187|NCT03724019|Anesthetics|anesthetics|mesh-ancestor
65107188|NCT03724019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64749415|NCT04029012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64749416|NCT04029012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749417|NCT04025658|Oxytocin|oxytocin|mesh-list
64749418|NCT04025658|Oxytocics|oxytocics|mesh-ancestor
65107202|NCT03534284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107203|NCT03534284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65107204|NCT03534284|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65107205|NCT03534284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65107206|NCT03534284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65107207|NCT03534284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107208|NCT03534284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65107209|NCT03534284|Serotonin Agents|serotonin agents|mesh-ancestor
65107210|NCT03534284|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65107211|NCT03534284|Antidepressive Agents|antidepressive agents|mesh-ancestor
65107212|NCT01254292|Levonorgestrel|levonorgestrel|mesh-list
65107213|NCT01254292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65107214|NCT01254292|Contraceptive Agents|contraceptive agents|mesh-ancestor
65107215|NCT01254292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65107216|NCT01254292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107217|NCT01254292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65107218|NCT01254292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65107219|NCT01254292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65107220|NCT04105335|Pembrolizumab|pembrolizumab|mesh-list
65107221|NCT04105335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65107222|NCT04105335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107223|NCT04683458|Paclitaxel|paclitaxel|mesh-list
65107224|NCT04683458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65107225|NCT04683458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65107226|NCT04683458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107227|NCT04683458|Tubulin Modulators|tubulin modulators|mesh-ancestor
65107228|NCT04683458|Antimitotic Agents|antimitotic agents|mesh-ancestor
65107229|NCT04683458|Mitosis Modulators|mitosis modulators|mesh-ancestor
65107230|NCT04683458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107231|NCT01253317|Mecasermin|mecasermin|mesh-list
65107232|NCT01253317|Growth Substances|growth substances|mesh-ancestor
65107233|NCT01253317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107234|NCT00537537|Telbivudine|telbivudine|mesh-list
65107235|NCT00537537|Antiviral Agents|antiviral agents|mesh-ancestor
65107236|NCT00537537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65107237|NCT00537537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65107238|NCT00537537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107239|NCT00537537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107240|NCT04319770|Hyaluronic Acid|hyaluronic acid|mesh-list
65107241|NCT04319770|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65291665|NCT02451553|Antimetabolites|antimetabolites|mesh-ancestor
65291666|NCT02451553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291667|NCT02451553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291668|NCT02451553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65291669|NCT02451553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291670|NCT02636816|Carbetocin|carbetocin|mesh-list
65291671|NCT02636816|Oxytocics|oxytocics|mesh-ancestor
65291672|NCT02636816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65291673|NCT02636816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291674|NCT00730054|Clonidine|clonidine|mesh-list
65291675|NCT00730054|Remifentanil|remifentanil|mesh-list
65291676|NCT00730054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65291677|NCT00730054|Narcotics|narcotics|mesh-ancestor
65291678|NCT00730054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65291679|NCT00730054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291680|NCT00730054|Analgesics|analgesics|mesh-ancestor
64521888|NCT01464268|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65107242|NCT04319770|Immunologic Factors|immunologic factors|mesh-ancestor
65107243|NCT04319770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107244|NCT04319770|Viscosupplements|viscosupplements|mesh-ancestor
65107259|NCT04515901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65107261|NCT04515901|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65107262|NCT04515901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65107263|NCT04515901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65107264|NCT04515901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107267|NCT02605421|Thiotepa|thiotepa|mesh-list
65107268|NCT02605421|Carboplatin|carboplatin|mesh-list
65107269|NCT02605421|Etoposide|etoposide|mesh-list
65107270|NCT02605421|Lenograstim|lenograstim|mesh-list
65107271|NCT02605421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65107272|NCT02605421|Immunologic Factors|immunologic factors|mesh-ancestor
65107273|NCT02605421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107274|NCT02605421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65107275|NCT02605421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65107276|NCT02605421|Alkylating Agents|alkylating agents|mesh-ancestor
65107277|NCT02605421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107278|NCT02605421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107279|NCT02605421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65107280|NCT02605421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65107281|NCT02605421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65107282|NCT02605421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65107283|NCT02605421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107284|NCT02605421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65107285|NCT04320589|Dexmedetomidine|dexmedetomidine|mesh-list
65107286|NCT04320589|Anesthetics|anesthetics|mesh-list
65107287|NCT04320589|Anesthetics, General|anesthetics, general|mesh-list
65107288|NCT04320589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65107289|NCT04320589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65107290|NCT04320589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107291|NCT04320589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65107292|NCT04320589|Analgesics|analgesics|mesh-ancestor
65107293|NCT04320589|Sensory System Agents|sensory system agents|mesh-ancestor
65107294|NCT04320589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65107295|NCT04320589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65107296|NCT04320589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65107321|NCT02203643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107323|NCT02203643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65107324|NCT02203643|Alkylating Agents|alkylating agents|mesh-ancestor
65291681|NCT00730054|Sensory System Agents|sensory system agents|mesh-ancestor
65291682|NCT00730054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65291683|NCT00730054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65291684|NCT00730054|Sympatholytics|sympatholytics|mesh-ancestor
65291685|NCT00730054|Autonomic Agents|autonomic agents|mesh-ancestor
65291686|NCT00730054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65291687|NCT00730054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65291688|NCT00730054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65291689|NCT00730054|Adrenergic Agents|adrenergic agents|mesh-ancestor
65291690|NCT00730054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65291691|NCT00730054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291692|NCT00866619|Vaccines|vaccines|mesh-list
65291693|NCT00866619|Immunologic Factors|immunologic factors|mesh-ancestor
65291694|NCT00866619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291695|NCT00693108|Testosterone|testosterone|mesh-list
65291696|NCT00693108|Androgens|androgens|mesh-ancestor
65291697|NCT00693108|Hormones|hormones|mesh-ancestor
64521904|NCT05716906|Melatonin|melatonin|mesh-list
65107325|NCT02203643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107326|NCT02203643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107327|NCT02203643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65107328|NCT02203643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65107329|NCT02203643|Antiemetics|antiemetics|mesh-ancestor
65107330|NCT02203643|Autonomic Agents|autonomic agents|mesh-ancestor
65107331|NCT02203643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65107332|NCT02203643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65107333|NCT02203643|Glucocorticoids|glucocorticoids|mesh-ancestor
65107334|NCT02203643|Hormones|hormones|mesh-ancestor
65107335|NCT02203643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65107336|NCT02203643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65107337|NCT02203643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65107338|NCT02203643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65107339|NCT02203643|Growth Substances|growth substances|mesh-ancestor
65107340|NCT02203643|Growth Inhibitors|growth inhibitors|mesh-ancestor
65107341|NCT01252186|Contraceptive Agents|contraceptive agents|mesh-list
65107342|NCT01252186|Levonorgestrel|levonorgestrel|mesh-list
65107343|NCT01252186|Desogestrel|desogestrel|mesh-list
65107344|NCT01252186|Contraceptives, Oral|contraceptives, oral|mesh-list
65107345|NCT01252186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64679724|NCT05804747|Edoxaban|edoxaban|mesh-list
64383145|NCT02569437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64383208|NCT03175679|Tegafur|tegafur|mesh-list
65107346|NCT01252186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107347|NCT01252186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65107348|NCT01252186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65107349|NCT01252186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65107350|NCT01252186|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65107351|NCT01252186|Progestins|progestins|mesh-ancestor
65107352|NCT01252186|Hormones|hormones|mesh-ancestor
65107353|NCT01252186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65107354|NCT02188745|Letrozole|letrozole|mesh-list
65107355|NCT02188745|Anastrozole|anastrozole|mesh-list
65107356|NCT02188745|Exemestane|exemestane|mesh-list
65107357|NCT02188745|Estradiol|estradiol|mesh-list
65107358|NCT02188745|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65107359|NCT02188745|Estrogens|estrogens|mesh-ancestor
65107360|NCT02188745|Hormones|hormones|mesh-ancestor
65107361|NCT02188745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65107362|NCT02188745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291698|NCT00693108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65291699|NCT00693108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291700|NCT00884390|Factor VIII|factor viii|mesh-list
65291701|NCT00884390|Coagulants|coagulants|mesh-ancestor
65291702|NCT02723669|Acetylcysteine|acetylcysteine|mesh-list
65291703|NCT02723669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65291704|NCT02723669|Antiviral Agents|antiviral agents|mesh-ancestor
65291705|NCT02723669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65291706|NCT02723669|Expectorants|expectorants|mesh-ancestor
65291707|NCT02723669|Respiratory System Agents|respiratory system agents|mesh-ancestor
65291708|NCT02723669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65291709|NCT02723669|Antioxidants|antioxidants|mesh-ancestor
64521920|NCT00216099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65107363|NCT02188745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107364|NCT02188745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65107365|NCT02188745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107366|NCT02188745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107367|NCT02188745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65107368|NCT02188745|Hormone Antagonists|hormone antagonists|mesh-ancestor
65107369|NCT02188745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65107370|NCT01731782|Bupivacaine|bupivacaine|mesh-list
65107371|NCT01731782|Anesthetics, Local|anesthetics, local|mesh-ancestor
65107372|NCT01731782|Anesthetics|anesthetics|mesh-ancestor
65107373|NCT01731782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65107374|NCT01731782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107375|NCT01731782|Sensory System Agents|sensory system agents|mesh-ancestor
65107376|NCT01731782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65107377|NCT01251952|Denileukin diftitox|denileukin diftitox|mesh-list
65107378|NCT01251952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107379|NCT04356430|Prednisone|prednisone|mesh-list
65107380|NCT04356430|Goserelin|goserelin|mesh-list
65107381|NCT04356430|Abiraterone Acetate|abiraterone acetate|mesh-list
65107382|NCT04356430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65107383|NCT04356430|Glucocorticoids|glucocorticoids|mesh-ancestor
65107384|NCT04356430|Hormones|hormones|mesh-ancestor
65107385|NCT04356430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65107386|NCT04356430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107387|NCT04356430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65107388|NCT04356430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107389|NCT04356430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65107390|NCT04356430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107391|NCT04356430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107392|NCT04356430|Hormone Antagonists|hormone antagonists|mesh-ancestor
65107393|NCT04356430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65107394|NCT03974139|Metformin|metformin|mesh-list
65107395|NCT03974139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65107396|NCT03974139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107397|NCT04320238|Interferons|interferons|mesh-list
65107398|NCT04320238|Interferon-alpha|interferon-alpha|mesh-list
65107399|NCT04320238|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65107400|NCT04320238|Thymalfasin|thymalfasin|mesh-list
65107401|NCT04320238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107402|NCT04320238|Antiviral Agents|antiviral agents|mesh-ancestor
65107403|NCT04320238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65107404|NCT04320238|Immunologic Factors|immunologic factors|mesh-ancestor
65107405|NCT04320238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107406|NCT04320238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65107407|NCT01229072|Heparin|heparin|mesh-list
65107408|NCT01229072|Calcium heparin|calcium heparin|mesh-list
65107409|NCT01229072|Anticoagulants|anticoagulants|mesh-ancestor
65107410|NCT01229072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65107411|NCT01229072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64383209|NCT03175679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107429|NCT00532116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291710|NCT02723669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291711|NCT02723669|Protective Agents|protective agents|mesh-ancestor
65291712|NCT02723669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291713|NCT02723669|Antidotes|antidotes|mesh-ancestor
65291714|NCT02719379|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65291715|NCT02719379|Immunologic Factors|immunologic factors|mesh-ancestor
65291716|NCT02719379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291717|NCT00689442|Atorvastatin|atorvastatin|mesh-list
65107431|NCT04283513|Antimetabolites|antimetabolites|mesh-ancestor
65107432|NCT04283513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107433|NCT04283513|Antiviral Agents|antiviral agents|mesh-ancestor
65107434|NCT04283513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65107435|NCT01251367|Botulinum Toxins|botulinum toxins|mesh-list
65107436|NCT01251367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65107437|NCT01251367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65107438|NCT01251367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65107439|NCT01251367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65107440|NCT01251367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107441|NCT01251367|Cholinergic Agents|cholinergic agents|mesh-ancestor
65107442|NCT01251367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65107443|NCT01251367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107444|NCT01251367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65107445|NCT01251367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65107446|NCT03910998|Rocuronium|rocuronium|mesh-list
65107447|NCT03910998|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65107448|NCT03910998|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65107449|NCT03910998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65107450|NCT03910998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65107451|NCT03910998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107452|NCT04685148|Estradiol|estradiol|mesh-list
65107453|NCT04685148|Estrogens|estrogens|mesh-ancestor
65107454|NCT04685148|Hormones|hormones|mesh-ancestor
65107455|NCT04685148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65107456|NCT04685148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107457|NCT02888548|Botulinum Toxins|botulinum toxins|mesh-list
65107458|NCT02888548|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65107459|NCT02888548|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65107460|NCT02888548|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65107465|NCT02888548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107466|NCT02888548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65107467|NCT02888548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65107468|NCT04246684|Leucovorin|leucovorin|mesh-list
65107469|NCT04246684|Folic Acid|folic acid|mesh-list
65107470|NCT04246684|Capecitabine|capecitabine|mesh-list
65107471|NCT04246684|Fluorouracil|fluorouracil|mesh-list
65107472|NCT04246684|Oxaliplatin|oxaliplatin|mesh-list
65107473|NCT04246684|Levoleucovorin|levoleucovorin|mesh-list
65107474|NCT04246684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65107475|NCT04246684|Antimetabolites|antimetabolites|mesh-ancestor
65107476|NCT04246684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107477|NCT04246684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107478|NCT04246684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65107479|NCT04246684|Immunologic Factors|immunologic factors|mesh-ancestor
65107480|NCT04246684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107481|NCT04246684|Antidotes|antidotes|mesh-ancestor
65107482|NCT04246684|Protective Agents|protective agents|mesh-ancestor
65107483|NCT04246684|Vitamin B Complex|vitamin b complex|mesh-ancestor
65107484|NCT04246684|Vitamins|vitamins|mesh-ancestor
65107485|NCT04246684|Micronutrients|micronutrients|mesh-ancestor
65107486|NCT04246684|Hematinics|hematinics|mesh-ancestor
65107487|NCT03883893|Acetaminophen|acetaminophen|mesh-list
64749717|NCT04148820|Protease Inhibitors|protease inhibitors|mesh-ancestor
65107488|NCT03883893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65107489|NCT03883893|Analgesics|analgesics|mesh-ancestor
65107490|NCT03883893|Sensory System Agents|sensory system agents|mesh-ancestor
65107491|NCT03883893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65107492|NCT03883893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291718|NCT00689442|Dalcetrapib|dalcetrapib|mesh-list
65291719|NCT00689442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65291720|NCT00689442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65291721|NCT00689442|Antimetabolites|antimetabolites|mesh-ancestor
65291722|NCT00689442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291723|NCT00689442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65291724|NCT00689442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65291725|NCT00689442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291726|NCT02625636|Glucagon|glucagon|mesh-list
65291727|NCT02625636|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65291728|NCT02625636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65291729|NCT02625636|Hormones|hormones|mesh-ancestor
65291730|NCT02625636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65291731|NCT02625636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291732|NCT02625636|Incretins|incretins|mesh-ancestor
65291733|NCT03012100|Cyclophosphamide|cyclophosphamide|mesh-list
65291734|NCT03012100|Vaccines|vaccines|mesh-list
65291735|NCT03012100|Sargramostim|sargramostim|mesh-list
65291736|NCT03012100|Immunologic Factors|immunologic factors|mesh-ancestor
65291737|NCT03012100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291738|NCT03012100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65291739|NCT03012100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65107493|NCT03883893|Antipyretics|antipyretics|mesh-ancestor
65107494|NCT00537732|Omeprazole|omeprazole|mesh-list
65107495|NCT00537732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65107496|NCT00537732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65107497|NCT00537732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65107498|NCT00537732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107499|NCT00537732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107500|NCT04180436|Rivaroxaban|rivaroxaban|mesh-list
65107501|NCT04180436|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65107502|NCT04180436|Antithrombins|antithrombins|mesh-ancestor
65107503|NCT04180436|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65107504|NCT04180436|Protease Inhibitors|protease inhibitors|mesh-ancestor
65107505|NCT04180436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107506|NCT04180436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107507|NCT04180436|Anticoagulants|anticoagulants|mesh-ancestor
65107508|NCT01250119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65107509|NCT01250119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107510|NCT01250119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65107511|NCT01250119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679880|NCT05631236|Sympathomimetics|sympathomimetics|mesh-ancestor
64679919|NCT05627635|Protective Agents|protective agents|mesh-ancestor
64679920|NCT05627635|Vitamin B Complex|vitamin b complex|mesh-ancestor
64679921|NCT05627635|Vitamins|vitamins|mesh-ancestor
65107519|NCT04320277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107520|NCT04320277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65107521|NCT04320277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65107522|NCT04320277|Antiviral Agents|antiviral agents|mesh-ancestor
65107523|NCT04320277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65107524|NCT04320277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65107525|NCT04320277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65107526|NCT01250002|Lidocaine|lidocaine|mesh-list
65107527|NCT01250002|Anesthetics, Local|anesthetics, local|mesh-ancestor
65291740|NCT03012100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65291741|NCT03012100|Alkylating Agents|alkylating agents|mesh-ancestor
65291742|NCT03012100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291743|NCT03012100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291744|NCT03012100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65291745|NCT02379247|Paclitaxel|paclitaxel|mesh-list
65291746|NCT02379247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65291747|NCT02379247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291748|NCT02379247|Tubulin Modulators|tubulin modulators|mesh-ancestor
65291749|NCT02379247|Antimitotic Agents|antimitotic agents|mesh-ancestor
65291750|NCT02379247|Mitosis Modulators|mitosis modulators|mesh-ancestor
65291751|NCT02379247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291752|NCT00689520|Vitamin K|vitamin k|mesh-list
65291753|NCT00689520|Tinzaparin|tinzaparin|mesh-list
65291754|NCT00689520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65291755|NCT00689520|Dalteparin|dalteparin|mesh-list
65107528|NCT01250002|Anesthetics|anesthetics|mesh-ancestor
65107529|NCT01250002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65107530|NCT01250002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107531|NCT01250002|Sensory System Agents|sensory system agents|mesh-ancestor
65107532|NCT01250002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65107533|NCT01250002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65107534|NCT01250002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65107535|NCT01250002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65107536|NCT01250002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65107537|NCT01250002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107538|NCT04157153|Sirolimus|sirolimus|mesh-list
65107539|NCT04157153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65107540|NCT04157153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65107541|NCT04157153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65107542|NCT04157153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107543|NCT04157153|Antifungal Agents|antifungal agents|mesh-ancestor
65107544|NCT04157153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65107545|NCT04157153|Immunologic Factors|immunologic factors|mesh-ancestor
65107546|NCT04157153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107547|NCT05329116|Lidocaine|lidocaine|mesh-list
65107548|NCT05329116|Pentoxifylline|pentoxifylline|mesh-list
65107549|NCT05329116|Anesthetics, Local|anesthetics, local|mesh-ancestor
65107550|NCT05329116|Anesthetics|anesthetics|mesh-ancestor
65107551|NCT05329116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65107552|NCT05329116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107553|NCT05329116|Sensory System Agents|sensory system agents|mesh-ancestor
65107554|NCT05329116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65107555|NCT05329116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65107556|NCT05329116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65107557|NCT05329116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65107558|NCT05329116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65107559|NCT05329116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107560|NCT05329116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65107561|NCT05329116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107562|NCT05329116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65107563|NCT05329116|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65107564|NCT05329116|Protective Agents|protective agents|mesh-ancestor
65107565|NCT05329116|Vasodilator Agents|vasodilator agents|mesh-ancestor
65107566|NCT05329116|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65107577|NCT00537888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65291756|NCT00689520|Acenocoumarol|acenocoumarol|mesh-list
65291757|NCT00689520|Vitamins|vitamins|mesh-ancestor
65291758|NCT00689520|Micronutrients|micronutrients|mesh-ancestor
65291759|NCT00689520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291760|NCT00689520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65291761|NCT00689520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65291762|NCT00689520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291763|NCT00689520|Hemostatics|hemostatics|mesh-ancestor
65291764|NCT00689520|Coagulants|coagulants|mesh-ancestor
65291765|NCT00689520|Anticoagulants|anticoagulants|mesh-ancestor
64521976|NCT00218439|Serotonin Agents|serotonin agents|mesh-ancestor
65107578|NCT00537888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107579|NCT00537888|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65107580|NCT00537888|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65107581|NCT05264142|Voriconazole|voriconazole|mesh-list
65107582|NCT05264142|Fluvoxamine|fluvoxamine|mesh-list
65107583|NCT05264142|Omeprazole|omeprazole|mesh-list
65107584|NCT05264142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65107585|NCT05264142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65107586|NCT05264142|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65107587|NCT05264142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107588|NCT05264142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107589|NCT05264142|Antifungal Agents|antifungal agents|mesh-ancestor
65107590|NCT05264142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65107591|NCT05264142|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65107592|NCT05264142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65107593|NCT05264142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65107594|NCT05264142|Hormone Antagonists|hormone antagonists|mesh-ancestor
65107595|NCT05264142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65107596|NCT05264142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107597|NCT05264142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65107598|NCT05264142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65107599|NCT05264142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65107600|NCT05264142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65107601|NCT05264142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65107602|NCT05264142|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65107603|NCT05264142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65107604|NCT05264142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65107605|NCT05264142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65107606|NCT05264142|Serotonin Agents|serotonin agents|mesh-ancestor
65107607|NCT05264142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65107608|NCT05264142|Antidepressive Agents|antidepressive agents|mesh-ancestor
65107609|NCT05264142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65107610|NCT05264142|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65107611|NCT01246960|Leucovorin|leucovorin|mesh-list
65107612|NCT01246960|Fluorouracil|fluorouracil|mesh-list
65107613|NCT01246960|Oxaliplatin|oxaliplatin|mesh-list
65107614|NCT01246960|Ramucirumab|ramucirumab|mesh-list
65107615|NCT01246960|Antimetabolites|antimetabolites|mesh-ancestor
65107616|NCT01246960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107617|NCT01246960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65107618|NCT01246960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107619|NCT01246960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65107620|NCT01246960|Immunologic Factors|immunologic factors|mesh-ancestor
65107621|NCT01246960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107622|NCT01246960|Antidotes|antidotes|mesh-ancestor
65107623|NCT01246960|Protective Agents|protective agents|mesh-ancestor
65107624|NCT01246960|Vitamin B Complex|vitamin b complex|mesh-ancestor
65107625|NCT01246960|Vitamins|vitamins|mesh-ancestor
65107637|NCT00544986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107639|NCT03851588|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65107640|NCT03851588|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65107641|NCT03851588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107642|NCT03851588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291766|NCT00689520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65291767|NCT02723513|Xenon|xenon|mesh-list
65291768|NCT02723513|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65291769|NCT02723513|Anesthetics, General|anesthetics, general|mesh-ancestor
65291770|NCT02723513|Anesthetics|anesthetics|mesh-ancestor
65291771|NCT02723513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65291772|NCT02723513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041715|NCT00207363|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65291773|NCT02723279|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65291775|NCT02723279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65291776|NCT02723279|Cholinergic Agents|cholinergic agents|mesh-ancestor
65291777|NCT02723279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65291778|NCT02723279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291779|NCT02723279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291780|NCT02723279|Urological Agents|urological agents|mesh-ancestor
65291781|NCT02615301|Vitamin D|vitamin d|mesh-list
65291782|NCT02615301|Ergocalciferols|ergocalciferols|mesh-list
65291783|NCT02615301|Cholecalciferol|cholecalciferol|mesh-list
65291784|NCT02615301|Vitamins|vitamins|mesh-list
65291785|NCT02615301|Micronutrients|micronutrients|mesh-ancestor
65107643|NCT03851588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65107644|NCT03851588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65107645|NCT03851588|Antiviral Agents|antiviral agents|mesh-ancestor
65107646|NCT03851588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65107647|NCT05239182|Gemcitabine|gemcitabine|mesh-list
65107648|NCT05239182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65107649|NCT05239182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65107650|NCT05239182|Antimetabolites|antimetabolites|mesh-ancestor
65107651|NCT05239182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107652|NCT05239182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107653|NCT05239182|Antiviral Agents|antiviral agents|mesh-ancestor
65107654|NCT05239182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65107655|NCT05239182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107656|NCT05239182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65107657|NCT05239182|Immunologic Factors|immunologic factors|mesh-ancestor
65107658|NCT05239182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107659|NCT01244620|Sildenafil Citrate|sildenafil citrate|mesh-list
65107660|NCT01244620|Tadalafil|tadalafil|mesh-list
65107661|NCT01244620|Sitaxsentan|sitaxsentan|mesh-list
65107662|NCT01244620|Vasodilator Agents|vasodilator agents|mesh-ancestor
65107663|NCT01244620|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65107664|NCT01244620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65107665|NCT01244620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107666|NCT01244620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107667|NCT01244620|Urological Agents|urological agents|mesh-ancestor
65107668|NCT01244620|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65107669|NCT04319692|Acetic Acid|acetic acid|mesh-list
65107670|NCT04319692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65107671|NCT04319692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65107672|NCT00545142|Valproic Acid|valproic acid|mesh-list
65107673|NCT00545142|Aripiprazole|aripiprazole|mesh-list
65107674|NCT00545142|Antidepressive Agents|antidepressive agents|mesh-ancestor
65107675|NCT00545142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65107676|NCT00545142|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65107677|NCT00545142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65107678|NCT00545142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65107679|NCT00545142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107680|NCT00545142|Dopamine Agonists|dopamine agonists|mesh-ancestor
65291786|NCT02615301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291787|NCT02615301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65291788|NCT02615301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65291789|NCT02570230|Ketamine|ketamine|mesh-list
65291790|NCT02570230|Analgesics|analgesics|mesh-ancestor
65291791|NCT02570230|Sensory System Agents|sensory system agents|mesh-ancestor
65291792|NCT02570230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65291793|NCT02570230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291794|NCT02570230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65291795|NCT02570230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65291796|NCT02570230|Anesthetics, General|anesthetics, general|mesh-ancestor
65107681|NCT00545142|Dopamine Agents|dopamine agents|mesh-ancestor
65107682|NCT00545142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64680079|NCT05286814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680081|NCT05286814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64680082|NCT05286814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107696|NCT01267201|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65107697|NCT01267201|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65107698|NCT01267201|Prednisolone|prednisolone|mesh-list
65107699|NCT01267201|Prednisolone acetate|prednisolone acetate|mesh-list
65107700|NCT01267201|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65107701|NCT01267201|Prednisolone phosphate|prednisolone phosphate|mesh-list
65107702|NCT01267201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65107703|NCT01267201|Antiemetics|antiemetics|mesh-ancestor
65107704|NCT01267201|Autonomic Agents|autonomic agents|mesh-ancestor
65107705|NCT01267201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65107706|NCT01267201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107707|NCT01267201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65107708|NCT01267201|Glucocorticoids|glucocorticoids|mesh-ancestor
65107709|NCT01267201|Hormones|hormones|mesh-ancestor
64749951|NCT03155646|Clonidine|clonidine|mesh-list
65107710|NCT01267201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65107711|NCT01267201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65107712|NCT01267201|Protective Agents|protective agents|mesh-ancestor
65107713|NCT01267201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65107714|NCT01267201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107715|NCT03778931|Fulvestrant|fulvestrant|mesh-list
65107716|NCT03778931|Anastrozole|anastrozole|mesh-list
65107717|NCT03778931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65107718|NCT03778931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107719|NCT03778931|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65107720|NCT03778931|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65107721|NCT03778931|Hormone Antagonists|hormone antagonists|mesh-ancestor
65107722|NCT03778931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65107723|NCT03778931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107724|NCT03778931|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65107725|NCT03778931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65107726|NCT03778931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107727|NCT03778931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107728|NCT03736616|Cytarabine|cytarabine|mesh-list
65107729|NCT03736616|Rituximab|rituximab|mesh-list
65107730|NCT03736616|Carboplatin|carboplatin|mesh-list
65107731|NCT03736616|Etoposide|etoposide|mesh-list
65107732|NCT03736616|Melphalan|melphalan|mesh-list
65107733|NCT03736616|Ifosfamide|ifosfamide|mesh-list
65107734|NCT03736616|Carmustine|carmustine|mesh-list
65107735|NCT03736616|Acalabrutinib|acalabrutinib|mesh-list
65107736|NCT03736616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65107737|NCT03736616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107738|NCT03736616|Immunologic Factors|immunologic factors|mesh-ancestor
65107739|NCT03736616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680129|NCT05262400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64680130|NCT05262400|Hormone Antagonists|hormone antagonists|mesh-ancestor
64680131|NCT05262400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65291797|NCT02570230|Anesthetics|anesthetics|mesh-ancestor
65291798|NCT02570230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65291799|NCT02570230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65291800|NCT02570230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65291801|NCT02570230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65291802|NCT02570230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291803|NCT00693342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
65291804|NCT00693342|Immunologic Factors|immunologic factors|mesh-ancestor
65291805|NCT00693342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291806|NCT02718911|Durvalumab|durvalumab|mesh-list
65291807|NCT02718911|Tremelimumab|tremelimumab|mesh-list
65291808|NCT02718911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65291809|NCT02718911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291810|NCT00697905|Gemcitabine|gemcitabine|mesh-list
65291811|NCT00697905|Carboplatin|carboplatin|mesh-list
65107749|NCT03736616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65107750|NCT03736616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65107751|NCT03736616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65107752|NCT03736616|Alkylating Agents|alkylating agents|mesh-ancestor
65107753|NCT03736616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65107754|NCT03718403|Theophylline|theophylline|mesh-list
65107755|NCT03718403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65107756|NCT03718403|Autonomic Agents|autonomic agents|mesh-ancestor
65107757|NCT03718403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65107758|NCT03718403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107759|NCT03718403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65107760|NCT03718403|Respiratory System Agents|respiratory system agents|mesh-ancestor
65107761|NCT03718403|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65107762|NCT03718403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107763|NCT03718403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107764|NCT03718403|Vasodilator Agents|vasodilator agents|mesh-ancestor
65107765|NCT03718403|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65107766|NCT03718403|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65107767|NCT03718403|Purinergic Agents|purinergic agents|mesh-ancestor
65107768|NCT03718403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65107769|NCT00537966|Ritonavir|ritonavir|mesh-list
65107770|NCT00537966|Darunavir|darunavir|mesh-list
65107771|NCT00537966|Tenofovir|tenofovir|mesh-list
65107772|NCT00537966|Lamivudine|lamivudine|mesh-list
65107773|NCT00537966|Emtricitabine|emtricitabine|mesh-list
65107774|NCT00537966|Raltegravir Potassium|raltegravir potassium|mesh-list
65107775|NCT00537966|Dolutegravir|dolutegravir|mesh-list
65107776|NCT00537966|Abacavir|abacavir|mesh-list
65107777|NCT00537966|Cobicistat|cobicistat|mesh-list
65107778|NCT00537966|Rilpivirine|rilpivirine|mesh-list
65107779|NCT00537966|Elvitegravir|elvitegravir|mesh-list
65107780|NCT00537966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65107781|NCT00537966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65107782|NCT00537966|Protease Inhibitors|protease inhibitors|mesh-ancestor
65107783|NCT00537966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107784|NCT00537966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107785|NCT00537966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65107786|NCT00537966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65107787|NCT00537966|Antiviral Agents|antiviral agents|mesh-ancestor
65107788|NCT00537966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65107789|NCT00537966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65107790|NCT00537966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65107820|NCT00538005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107821|NCT00538005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107822|NCT03610412|Magnesium Oxide|magnesium oxide|mesh-list
65107823|NCT03610412|Antacids|antacids|mesh-ancestor
65291812|NCT00697905|Fluorouracil|fluorouracil|mesh-list
65291813|NCT00697905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291814|NCT00697905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65291815|NCT00697905|Antimetabolites|antimetabolites|mesh-ancestor
65291816|NCT00697905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291817|NCT00697905|Antiviral Agents|antiviral agents|mesh-ancestor
65291818|NCT00697905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65291819|NCT00697905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522030|NCT00109005|Lenalidomide|lenalidomide|mesh-list
65107824|NCT03610412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107825|NCT03610412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65107826|NCT00538044|Simvastatin|simvastatin|mesh-list
65107827|NCT00538044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65107828|NCT00538044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65107829|NCT00538044|Antimetabolites|antimetabolites|mesh-ancestor
65107830|NCT00538044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107831|NCT00538044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65107832|NCT00538044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65107833|NCT00538044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107834|NCT03504956|Metoprolol|metoprolol|mesh-list
65107835|NCT03504956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65107839|NCT03504956|Autonomic Agents|autonomic agents|mesh-ancestor
65107840|NCT03504956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65107841|NCT03504956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107842|NCT03504956|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65107843|NCT03504956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65107844|NCT03504956|Adrenergic Agents|adrenergic agents|mesh-ancestor
65107845|NCT03504956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65107846|NCT03504956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107847|NCT00545493|Tacrolimus|tacrolimus|mesh-list
65107848|NCT00545493|Immunoglobulins|immunoglobulins|mesh-list
65107849|NCT00545493|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65107850|NCT00545493|Antibodies|antibodies|mesh-list
65107851|NCT00545493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65107852|NCT00545493|Immunologic Factors|immunologic factors|mesh-ancestor
65107853|NCT00545493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107854|NCT00545493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65107855|NCT00545493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107856|NCT00545493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107857|NCT01266460|Vaccines|vaccines|mesh-list
65107858|NCT01266460|Immunologic Factors|immunologic factors|mesh-ancestor
65107859|NCT01266460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107860|NCT05119257|Antibodies|antibodies|mesh-list
65107861|NCT05119257|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65107862|NCT05119257|Immunologic Factors|immunologic factors|mesh-ancestor
65107863|NCT05119257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107864|NCT01266265|Treprostinil|treprostinil|mesh-list
65107865|NCT01266265|Bosentan|bosentan|mesh-list
65107866|NCT01266265|Ambrisentan|ambrisentan|mesh-list
65107867|NCT01266265|Epoprostenol|epoprostenol|mesh-list
65107868|NCT01266265|Sildenafil Citrate|sildenafil citrate|mesh-list
65107869|NCT01266265|Tadalafil|tadalafil|mesh-list
65107870|NCT01266265|Iloprost|iloprost|mesh-list
65107871|NCT01266265|Tezosentan|tezosentan|mesh-list
65107872|NCT01266265|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
65107873|NCT01266265|Vasodilator Agents|vasodilator agents|mesh-ancestor
65107874|NCT01266265|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65107875|NCT01266265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107876|NCT01266265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107877|NCT01266265|Urological Agents|urological agents|mesh-ancestor
65107878|NCT01266265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65107879|NCT01266265|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65107880|NCT01266265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65107881|NCT03338387|Acipimox|acipimox|mesh-list
65107882|NCT03338387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65107883|NCT03338387|Antimetabolites|antimetabolites|mesh-ancestor
65107884|NCT03338387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291820|NCT00697905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65291821|NCT00697905|Immunologic Factors|immunologic factors|mesh-ancestor
65291822|NCT00697905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291823|NCT02718755|Cytarabine|cytarabine|mesh-list
65291824|NCT02718755|Fludarabine|fludarabine|mesh-list
65291825|NCT02718755|Fludarabine phosphate|fludarabine phosphate|mesh-list
65291826|NCT02718755|Asparaginase|asparaginase|mesh-list
65291827|NCT02718755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291828|NCT02718755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65291829|NCT02718755|Antimetabolites|antimetabolites|mesh-ancestor
65291830|NCT02718755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291831|NCT02718755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65291832|NCT02718755|Immunologic Factors|immunologic factors|mesh-ancestor
65291833|NCT02718755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291834|NCT02718755|Antiviral Agents|antiviral agents|mesh-ancestor
65291835|NCT02718755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64522037|NCT00109005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107885|NCT03338387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65107886|NCT05112549|Nivolumab|nivolumab|mesh-list
65107887|NCT05112549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65107888|NCT05112549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107889|NCT05112549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65107890|NCT05112549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107891|NCT03268382|Doxorubicin|doxorubicin|mesh-list
65107892|NCT03268382|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65107893|NCT03268382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65107894|NCT03268382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107895|NCT03268382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65107896|NCT03268382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65107907|NCT01266148|Immunologic Factors|immunologic factors|mesh-ancestor
65107908|NCT01266148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107909|NCT01266148|Antifungal Agents|antifungal agents|mesh-ancestor
65107910|NCT01266148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65107911|NCT01266148|Dermatologic Agents|dermatologic agents|mesh-ancestor
65107912|NCT01266148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65107913|NCT01266148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65107914|NCT01266148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107915|NCT01266148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65107916|NCT01266148|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65107917|NCT01266148|Antitubercular Agents|antitubercular agents|mesh-ancestor
65107918|NCT01266148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65107919|NCT00538239|Sirolimus|sirolimus|mesh-list
65107920|NCT00538239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65107921|NCT00538239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65107922|NCT00538239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65107923|NCT00538239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107924|NCT00538239|Antifungal Agents|antifungal agents|mesh-ancestor
65107925|NCT00538239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65107926|NCT00538239|Immunologic Factors|immunologic factors|mesh-ancestor
65107927|NCT00538239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107928|NCT00538317|Tirofiban|tirofiban|mesh-list
65107929|NCT00538317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65107930|NCT00538317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65107931|NCT00538317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107932|NCT00538317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65107933|NCT01265953|Sulforaphane|sulforaphane|mesh-list
65107934|NCT01265953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65107935|NCT01265953|Protective Agents|protective agents|mesh-ancestor
65291836|NCT00730210|Parathyroid Hormone|parathyroid hormone|mesh-list
65291837|NCT00730210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65291838|NCT00730210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291839|NCT00730288|Vaccines|vaccines|mesh-list
65291840|NCT00730288|Immunologic Factors|immunologic factors|mesh-ancestor
65291841|NCT00730288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291842|NCT00872898|Memantine|memantine|mesh-list
65291843|NCT00872898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65291844|NCT00872898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65291845|NCT00872898|Dopamine Agents|dopamine agents|mesh-ancestor
65291846|NCT00872898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65291847|NCT00872898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291848|NCT00872898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522052|NCT05547100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64522054|NCT05547100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65107936|NCT01265953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107937|NCT01265953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107938|NCT01265875|Secretin|secretin|mesh-list
65107939|NCT01265875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65107940|NCT01265875|Hormones|hormones|mesh-ancestor
65107941|NCT01265875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65107942|NCT01265875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107943|NCT03202628|Dexamethasone|dexamethasone|mesh-list
65107944|NCT03202628|Dexamethasone acetate|dexamethasone acetate|mesh-list
65107945|NCT03202628|Pomalidomide|pomalidomide|mesh-list
65107946|NCT03202628|Ixazomib|ixazomib|mesh-list
65107947|NCT03202628|Ichthammol|ichthammol|mesh-list
65107948|NCT03202628|BB 1101|bb 1101|mesh-list
65107949|NCT03202628|Glycine|glycine|mesh-list
65107950|NCT03202628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65107951|NCT03202628|Antiemetics|antiemetics|mesh-ancestor
65107952|NCT03202628|Autonomic Agents|autonomic agents|mesh-ancestor
65107953|NCT03202628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65107954|NCT03202628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107955|NCT03202628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65107956|NCT03202628|Glucocorticoids|glucocorticoids|mesh-ancestor
65107967|NCT03202628|Growth Substances|growth substances|mesh-ancestor
65107968|NCT03202628|Growth Inhibitors|growth inhibitors|mesh-ancestor
65107969|NCT03202628|Dermatologic Agents|dermatologic agents|mesh-ancestor
65107970|NCT03202628|Glycine Agents|glycine agents|mesh-ancestor
65107971|NCT03202628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65107972|NCT00538395|Cyclophosphamide|cyclophosphamide|mesh-list
65107973|NCT00538395|Doxorubicin|doxorubicin|mesh-list
65107974|NCT00538395|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65107975|NCT00538395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65107976|NCT00538395|Immunologic Factors|immunologic factors|mesh-ancestor
65107977|NCT00538395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107978|NCT00538395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65107979|NCT00538395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65107980|NCT00538395|Alkylating Agents|alkylating agents|mesh-ancestor
65107981|NCT00538395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107982|NCT00538395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107983|NCT00538395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65107984|NCT00538395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65107985|NCT00538395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65107986|NCT00538395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65107987|NCT00538395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107988|NCT01265563|Acetylcysteine|acetylcysteine|mesh-list
65107989|NCT01265563|Silybin|silybin|mesh-list
65107990|NCT01265563|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65107991|NCT01265563|Antiviral Agents|antiviral agents|mesh-ancestor
65291849|NCT00872898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65291850|NCT00872898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65291852|NCT02723435|Staurosporine|staurosporine|mesh-list
65291853|NCT02723435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291854|NCT02723435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65291855|NCT02723435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291856|NCT02723435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291857|NCT02718677|Factor VIII|factor viii|mesh-list
65291858|NCT02718677|Coagulants|coagulants|mesh-ancestor
65291859|NCT04132011|Morphine|morphine|mesh-list
65291860|NCT04132011|Oxycodone|oxycodone|mesh-list
65291861|NCT04132011|Analgesics, Opioid|analgesics, opioid|mesh-list
65291862|NCT04132011|Hydromorphone|hydromorphone|mesh-list
65291863|NCT04132011|Narcotics|narcotics|mesh-ancestor
65291864|NCT04132011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65291865|NCT04132011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291866|NCT04132011|Analgesics|analgesics|mesh-ancestor
65291867|NCT04132011|Sensory System Agents|sensory system agents|mesh-ancestor
65291868|NCT04132011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65291869|NCT00693576|Simvastatin|simvastatin|mesh-list
65291870|NCT00693576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65291871|NCT00693576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65107992|NCT01265563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65107993|NCT01265563|Expectorants|expectorants|mesh-ancestor
65107994|NCT01265563|Respiratory System Agents|respiratory system agents|mesh-ancestor
65107995|NCT01265563|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65107996|NCT01265563|Antioxidants|antioxidants|mesh-ancestor
65107997|NCT01265563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107998|NCT01265563|Protective Agents|protective agents|mesh-ancestor
65107999|NCT01265563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108000|NCT01265563|Antidotes|antidotes|mesh-ancestor
65108001|NCT01265563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65108002|NCT01265563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108003|NCT01265056|Gabapentin|gabapentin|mesh-list
65108004|NCT01265056|Analgesics|analgesics|mesh-ancestor
65108005|NCT01265056|Sensory System Agents|sensory system agents|mesh-ancestor
65108006|NCT01265056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65108007|NCT01265056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108008|NCT01265056|Anticonvulsants|anticonvulsants|mesh-ancestor
65108009|NCT01265056|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65108010|NCT01265056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65108011|NCT01265056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65108012|NCT01265056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65108013|NCT01265056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65108014|NCT01265056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65108015|NCT01265056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65108016|NCT01265056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108051|NCT01264939|Antiemetics|antiemetics|mesh-ancestor
65108052|NCT01264939|Autonomic Agents|autonomic agents|mesh-ancestor
65108053|NCT01264939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65108054|NCT01264939|Histamine Agents|histamine agents|mesh-ancestor
65108055|NCT01264939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65108056|NCT01264939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108057|NCT01264939|Antipruritics|antipruritics|mesh-ancestor
65291872|NCT00693576|Antimetabolites|antimetabolites|mesh-ancestor
65291873|NCT00693576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291874|NCT00693576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65291875|NCT00693576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65291876|NCT00693576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291877|NCT04116047|Durvalumab|durvalumab|mesh-list
65291878|NCT04116047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291879|NCT04116047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65291880|NCT00693732|Citalopram|citalopram|mesh-list
65291881|NCT00693732|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65291882|NCT00693732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65291883|NCT00693732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65291884|NCT00693732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291885|NCT00693732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65291886|NCT00693732|Serotonin Agents|serotonin agents|mesh-ancestor
65291887|NCT00693732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291888|NCT00693732|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65291889|NCT00693732|Antidepressive Agents|antidepressive agents|mesh-ancestor
65291890|NCT00693732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65291891|NCT00689598|Spironolactone|spironolactone|mesh-list
64522089|NCT00044655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65108058|NCT01264939|Dermatologic Agents|dermatologic agents|mesh-ancestor
65108086|NCT02711969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108088|NCT01263925|Alprostadil|alprostadil|mesh-list
65108089|NCT01263925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65108090|NCT01263925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750351|NCT03152370|Leucovorin|leucovorin|mesh-list
65108091|NCT01263925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108092|NCT01263925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65108093|NCT01263925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65108094|NCT01263925|Protective Agents|protective agents|mesh-ancestor
65108095|NCT01263925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108096|NCT01263925|Vasodilator Agents|vasodilator agents|mesh-ancestor
65108097|NCT01263925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65108098|NCT01263925|Antioxidants|antioxidants|mesh-ancestor
65108099|NCT01263925|Urological Agents|urological agents|mesh-ancestor
65108100|NCT04323631|Hydroxychloroquine|hydroxychloroquine|mesh-list
65108101|NCT04323631|Antimalarials|antimalarials|mesh-ancestor
65108102|NCT04323631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65108103|NCT04323631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65108104|NCT04323631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65108113|NCT00546234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65108114|NCT00546234|Respiratory System Agents|respiratory system agents|mesh-ancestor
65108115|NCT00546234|Parasympatholytics|parasympatholytics|mesh-ancestor
65108116|NCT00546234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65108117|NCT00546234|Cholinergic Agents|cholinergic agents|mesh-ancestor
65108118|NCT00546234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65108119|NCT00546234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108120|NCT01263769|Axitinib|axitinib|mesh-list
65108121|NCT01263769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108122|NCT01263769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65291892|NCT00689598|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65291893|NCT00689598|Hormone Antagonists|hormone antagonists|mesh-ancestor
65291894|NCT00689598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65291895|NCT00689598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291896|NCT00689598|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65291897|NCT00689598|Diuretics|diuretics|mesh-ancestor
65291898|NCT00689598|Natriuretic Agents|natriuretic agents|mesh-ancestor
65291899|NCT04163354|Listerine|listerine|mesh-list
65291900|NCT04163354|Fluorides|fluorides|mesh-list
65291901|NCT04163354|Sodium Fluoride|sodium fluoride|mesh-list
65291902|NCT04163354|Fluorides, Topical|fluorides, topical|mesh-list
65291903|NCT04163354|Cariostatic Agents|cariostatic agents|mesh-ancestor
65291904|NCT04163354|Protective Agents|protective agents|mesh-ancestor
65291905|NCT04163354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291906|NCT04163354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65291907|NCT04163354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65291908|NCT04131621|Nivolumab|nivolumab|mesh-list
65291909|NCT04131621|Ipilimumab|ipilimumab|mesh-list
65291910|NCT04131621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65291911|NCT04131621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291912|NCT04131621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65108123|NCT01263769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108124|NCT01263769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108125|NCT02623439|Cyclophosphamide|cyclophosphamide|mesh-list
65108127|NCT02623439|Immunologic Factors|immunologic factors|mesh-ancestor
65108128|NCT02623439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108129|NCT02623439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65108130|NCT02623439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65108131|NCT02623439|Alkylating Agents|alkylating agents|mesh-ancestor
65108132|NCT02623439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108133|NCT02623439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108134|NCT02623439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65108135|NCT00539331|Paclitaxel|paclitaxel|mesh-list
65108136|NCT00539331|Carboplatin|carboplatin|mesh-list
65108137|NCT00539331|Cediranib|cediranib|mesh-list
65108138|NCT00539331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65108139|NCT00539331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108140|NCT00539331|Tubulin Modulators|tubulin modulators|mesh-ancestor
65108141|NCT00539331|Antimitotic Agents|antimitotic agents|mesh-ancestor
65108142|NCT00539331|Mitosis Modulators|mitosis modulators|mesh-ancestor
65108143|NCT00539331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108144|NCT00539331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65108145|NCT00539331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108146|NCT02236013|Cytarabine|cytarabine|mesh-list
65108147|NCT02236013|Daunorubicin|daunorubicin|mesh-list
65108148|NCT02236013|Idarubicin|idarubicin|mesh-list
65108149|NCT02236013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65108150|NCT02236013|Antimetabolites|antimetabolites|mesh-ancestor
65108151|NCT02236013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108152|NCT02236013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108153|NCT02236013|Antiviral Agents|antiviral agents|mesh-ancestor
65108154|NCT02236013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65108155|NCT02236013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65108156|NCT02236013|Immunologic Factors|immunologic factors|mesh-ancestor
65291913|NCT04131621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291914|NCT00689832|Fluticasone|fluticasone|mesh-list
65291915|NCT00689832|Tacrolimus|tacrolimus|mesh-list
65291916|NCT00689832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65291917|NCT00689832|Immunologic Factors|immunologic factors|mesh-ancestor
65291918|NCT00689832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291919|NCT00689832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65291920|NCT00689832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65291921|NCT00689832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291922|NCT00689832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65291923|NCT00689832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65291924|NCT00689832|Autonomic Agents|autonomic agents|mesh-ancestor
65291925|NCT00689832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65291926|NCT00689832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65291927|NCT00689832|Respiratory System Agents|respiratory system agents|mesh-ancestor
65291928|NCT00689832|Dermatologic Agents|dermatologic agents|mesh-ancestor
65291929|NCT00689832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65291930|NCT02718521|Isosorbide|isosorbide|mesh-list
65291931|NCT02718521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64522129|NCT05312242|Vitamins|vitamins|mesh-ancestor
65108157|NCT02236013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108158|NCT02236013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65108159|NCT02236013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65108160|NCT02236013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65108161|NCT02236013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108162|NCT00539409|Insulin|insulin|mesh-list
65108163|NCT00539409|Insulin Aspart|insulin aspart|mesh-list
65108164|NCT00539409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65108165|NCT00539409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64750396|NCT03150576|Paclitaxel|paclitaxel|mesh-list
65108166|NCT00539409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108168|NCT01263691|Immunologic Factors|immunologic factors|mesh-ancestor
65108169|NCT01263691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108170|NCT02178410|Vitamin D|vitamin d|mesh-list
65108171|NCT02178410|Ergocalciferols|ergocalciferols|mesh-list
65108172|NCT02178410|Cholecalciferol|cholecalciferol|mesh-list
65108173|NCT02178410|Vitamins|vitamins|mesh-list
65108194|NCT01715714|Pravastatin|pravastatin|mesh-list
65108195|NCT01715714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65108196|NCT01715714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65108197|NCT01715714|Antimetabolites|antimetabolites|mesh-ancestor
65108198|NCT01715714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108199|NCT01715714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65108200|NCT01715714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65108201|NCT01715714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108202|NCT01540253|Docetaxel|docetaxel|mesh-list
65108203|NCT01540253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108204|NCT01540253|Tubulin Modulators|tubulin modulators|mesh-ancestor
65108205|NCT01540253|Antimitotic Agents|antimitotic agents|mesh-ancestor
65108206|NCT01540253|Mitosis Modulators|mitosis modulators|mesh-ancestor
65108207|NCT01540253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108208|NCT01497392|Gemcitabine|gemcitabine|mesh-list
65108209|NCT01497392|Capecitabine|capecitabine|mesh-list
65108210|NCT01497392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65108211|NCT01497392|Antimetabolites|antimetabolites|mesh-ancestor
65108212|NCT01497392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291932|NCT02718521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65291933|NCT02718521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65291934|NCT02718521|Diuretics|diuretics|mesh-ancestor
65291935|NCT02718521|Natriuretic Agents|natriuretic agents|mesh-ancestor
65291936|NCT02718521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291937|NCT02718521|Vasodilator Agents|vasodilator agents|mesh-ancestor
65291938|NCT02718521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65291939|NCT02718521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291940|NCT02718599|Terlipressin|terlipressin|mesh-list
65291941|NCT02718599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65291942|NCT02718599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65291943|NCT00693966|Vaccines|vaccines|mesh-list
65291944|NCT00693966|Immunologic Factors|immunologic factors|mesh-ancestor
64522149|NCT00223821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65108213|NCT01497392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108214|NCT01497392|Antiviral Agents|antiviral agents|mesh-ancestor
65108215|NCT01497392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65108216|NCT01497392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108217|NCT01497392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65108218|NCT01497392|Immunologic Factors|immunologic factors|mesh-ancestor
65108219|NCT01497392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108220|NCT01310192|Choline|choline|mesh-list
65108221|NCT01310192|Lipotropic Agents|lipotropic agents|mesh-ancestor
65108222|NCT01310192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65108223|NCT01310192|Antimetabolites|antimetabolites|mesh-ancestor
65108224|NCT01310192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108225|NCT01310192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65108226|NCT01310192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65108227|NCT01310192|Nootropic Agents|nootropic agents|mesh-ancestor
65108228|NCT00539565|Prednisolone|prednisolone|mesh-list
65108229|NCT00539565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65108230|NCT00539565|Glucocorticoids|glucocorticoids|mesh-ancestor
65108231|NCT00539565|Hormones|hormones|mesh-ancestor
65108250|NCT00546507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65108251|NCT00546507|Analgesics|analgesics|mesh-ancestor
65108252|NCT00546507|Sensory System Agents|sensory system agents|mesh-ancestor
65108253|NCT00546507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65108254|NCT00546507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108255|NCT00546507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65108256|NCT00546507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65108257|NCT00546507|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65108258|NCT00546507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65108259|NCT00546507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108260|NCT00546507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108262|NCT00546546|Azathioprine|azathioprine|mesh-list
65108263|NCT00546546|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65108264|NCT00546546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65108265|NCT00546546|Abortifacient Agents|abortifacient agents|mesh-ancestor
65108266|NCT00546546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65108267|NCT00546546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108268|NCT00546546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65108269|NCT00546546|Antimetabolites|antimetabolites|mesh-ancestor
65108270|NCT00546546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108271|NCT00546546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108272|NCT00546546|Dermatologic Agents|dermatologic agents|mesh-ancestor
65108273|NCT00546546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108274|NCT00546546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65108275|NCT00546546|Immunologic Factors|immunologic factors|mesh-ancestor
65108276|NCT00546546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65108277|NCT00546546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65108278|NCT00659711|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65108279|NCT00659711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65291945|NCT00693966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291946|NCT00694044|Varenicline|varenicline|mesh-list
65291947|NCT00694044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65291948|NCT00694044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65291949|NCT00694044|Cholinergic Agents|cholinergic agents|mesh-ancestor
65291950|NCT00694044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65291951|NCT00694044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291952|NCT00694044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291953|NCT02722811|Etanercept|etanercept|mesh-list
65291954|NCT02722811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65291955|NCT02722811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65291956|NCT02722811|Analgesics|analgesics|mesh-ancestor
65291957|NCT02722811|Sensory System Agents|sensory system agents|mesh-ancestor
65291958|NCT02722811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65291959|NCT02722811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291960|NCT02722811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65291961|NCT02722811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65291962|NCT02722811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65291963|NCT02722811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65291964|NCT02722811|Immunologic Factors|immunologic factors|mesh-ancestor
65291965|NCT04136886|Cisplatin|cisplatin|mesh-list
65291966|NCT04136886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291967|NCT00534313|Abatacept|abatacept|mesh-list
65291968|NCT00534313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65291969|NCT00534313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291970|NCT00534313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291971|NCT00534313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65291972|NCT00534313|Immunologic Factors|immunologic factors|mesh-ancestor
64522163|NCT00359164|Growth Substances|growth substances|mesh-ancestor
65108280|NCT00659711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108281|NCT00659711|Incretins|incretins|mesh-ancestor
65108282|NCT00659711|Hormones|hormones|mesh-ancestor
65108283|NCT00659711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65108284|NCT00659711|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64680793|NCT03767933|Acetaminophen|acetaminophen|mesh-list
65108287|NCT00659711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108289|NCT02581007|Melphalan|melphalan|mesh-list
65108290|NCT02581007|Fludarabine|fludarabine|mesh-list
65108291|NCT02581007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65108292|NCT02581007|Immunologic Factors|immunologic factors|mesh-ancestor
65108293|NCT02581007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108294|NCT02581007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65108295|NCT02581007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65108296|NCT02581007|Alkylating Agents|alkylating agents|mesh-ancestor
65291973|NCT00534313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291974|NCT00534313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65291975|NCT00694200|Bevacizumab|bevacizumab|mesh-list
65291976|NCT00694200|Vinorelbine|vinorelbine|mesh-list
65291977|NCT00694200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65291978|NCT00694200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291979|NCT00694200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65291980|NCT00694200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65291981|NCT00694200|Growth Substances|growth substances|mesh-ancestor
65291982|NCT00694200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291983|NCT00694200|Growth Inhibitors|growth inhibitors|mesh-ancestor
65291984|NCT00694200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65291985|NCT00694200|Tubulin Modulators|tubulin modulators|mesh-ancestor
65291986|NCT00694200|Antimitotic Agents|antimitotic agents|mesh-ancestor
65291987|NCT00694200|Mitosis Modulators|mitosis modulators|mesh-ancestor
65291988|NCT00694200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65291989|NCT02722733|Cytarabine|cytarabine|mesh-list
65291990|NCT02722733|Lenograstim|lenograstim|mesh-list
65291991|NCT02722733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65291992|NCT02722733|Immunologic Factors|immunologic factors|mesh-ancestor
65291993|NCT02722733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65291994|NCT02722733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65291995|NCT02722733|Antimetabolites|antimetabolites|mesh-ancestor
65291996|NCT02722733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041946|NCT00472186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65291997|NCT02722733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65291998|NCT02722733|Antiviral Agents|antiviral agents|mesh-ancestor
65291999|NCT02722733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292000|NCT02722733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65292002|NCT02722421|Levonorgestrel|levonorgestrel|mesh-list
64522192|NCT00045435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65108297|NCT02581007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108298|NCT02581007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108299|NCT02581007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65108300|NCT00546741|Metformin|metformin|mesh-list
65108301|NCT00546741|Dapagliflozin|dapagliflozin|mesh-list
65108302|NCT00546741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65108303|NCT00546741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108304|NCT00546741|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65108305|NCT00546741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108306|NCT02540330|Fulvestrant|fulvestrant|mesh-list
65108307|NCT02540330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65292003|NCT02722421|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65292004|NCT02722421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65292005|NCT02722421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292006|NCT02722421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292007|NCT02722421|Antiviral Agents|antiviral agents|mesh-ancestor
65292008|NCT02722421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292009|NCT02722421|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65292010|NCT02722421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65292011|NCT02722421|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65292012|NCT02722421|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65292013|NCT02722421|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65292014|NCT02722421|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64522232|NCT00703326|Docetaxel|docetaxel|mesh-list
65108308|NCT02540330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108309|NCT02540330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65108310|NCT02540330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65108311|NCT02540330|Hormone Antagonists|hormone antagonists|mesh-ancestor
65108312|NCT02540330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65108313|NCT02540330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108314|NCT02467361|Pembrolizumab|pembrolizumab|mesh-list
65108315|NCT02467361|Nivolumab|nivolumab|mesh-list
65108316|NCT02467361|Ipilimumab|ipilimumab|mesh-list
65108317|NCT02467361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65108318|NCT02467361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108319|NCT02467361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65108320|NCT02467361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108321|NCT00546936|Ranibizumab|ranibizumab|mesh-list
65108322|NCT00546936|Verteporfin|verteporfin|mesh-list
65108323|NCT00546936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65108324|NCT00546936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65108325|NCT00546936|Growth Substances|growth substances|mesh-ancestor
65108326|NCT00546936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108327|NCT00546936|Growth Inhibitors|growth inhibitors|mesh-ancestor
65108328|NCT00546936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108329|NCT00546936|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65108330|NCT00546936|Dermatologic Agents|dermatologic agents|mesh-ancestor
65108331|NCT02231723|Leucovorin|leucovorin|mesh-list
65108332|NCT02231723|Gemcitabine|gemcitabine|mesh-list
65108333|NCT02231723|Paclitaxel|paclitaxel|mesh-list
65108334|NCT02231723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65108335|NCT02231723|Fluorouracil|fluorouracil|mesh-list
65108336|NCT02231723|Oxaliplatin|oxaliplatin|mesh-list
65108337|NCT02231723|Irinotecan|irinotecan|mesh-list
64680857|NCT03255070|Immunoconjugates|immunoconjugates|mesh-list
65108371|NCT04681937|Methylprednisolone|methylprednisolone|mesh-list
65108372|NCT04681937|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65108373|NCT04681937|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65108374|NCT04681937|Prednisolone|prednisolone|mesh-list
65108375|NCT04681937|Prednisolone acetate|prednisolone acetate|mesh-list
65108376|NCT04681937|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65108377|NCT04681937|Prednisolone phosphate|prednisolone phosphate|mesh-list
65108378|NCT04681937|Hyaluronic Acid|hyaluronic acid|mesh-list
65108379|NCT04681937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65108406|NCT00547092|Tadalafil|tadalafil|mesh-list
65108407|NCT00547092|Vasodilator Agents|vasodilator agents|mesh-ancestor
65108408|NCT00547092|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65108409|NCT00547092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65108410|NCT00547092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108411|NCT00547092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108412|NCT00547092|Urological Agents|urological agents|mesh-ancestor
65108413|NCT00547131|Temozolomide|temozolomide|mesh-list
65292015|NCT02722421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65292016|NCT02722421|Contraceptive Agents|contraceptive agents|mesh-ancestor
65292017|NCT02722421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65292018|NCT02722421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292019|NCT02722421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65292020|NCT02722421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65292021|NCT02722421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65292022|NCT02617290|Clopidogrel|clopidogrel|mesh-list
65292023|NCT02617290|Ticagrelor|ticagrelor|mesh-list
65292024|NCT02617290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65292025|NCT02617290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65292026|NCT02617290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65292027|NCT02617290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65292028|NCT02617290|Purinergic Agents|purinergic agents|mesh-ancestor
65292029|NCT02617290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65292030|NCT02617290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292031|NCT02617290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108414|NCT00547131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65108415|NCT00547131|Alkylating Agents|alkylating agents|mesh-ancestor
65108416|NCT00547131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108417|NCT00547131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108418|NCT01964495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65108419|NCT01964495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65108438|NCT00547287|Sildenafil Citrate|sildenafil citrate|mesh-list
65108439|NCT00547287|Tadalafil|tadalafil|mesh-list
65108440|NCT00547287|Vasodilator Agents|vasodilator agents|mesh-ancestor
65108441|NCT00547287|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65108442|NCT00547287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65108443|NCT00547287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108444|NCT00547287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108445|NCT00547287|Urological Agents|urological agents|mesh-ancestor
65108446|NCT01263106|Theophylline|theophylline|mesh-list
65108447|NCT01263106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65108448|NCT01263106|Autonomic Agents|autonomic agents|mesh-ancestor
65108449|NCT01263106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65108450|NCT01263106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108451|NCT01263106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65108452|NCT01263106|Respiratory System Agents|respiratory system agents|mesh-ancestor
65108453|NCT01263106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65108454|NCT01263106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108455|NCT01263106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108456|NCT01263106|Vasodilator Agents|vasodilator agents|mesh-ancestor
65108457|NCT01263106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65108458|NCT01263106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65108459|NCT01263106|Purinergic Agents|purinergic agents|mesh-ancestor
65108460|NCT01263106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65108461|NCT01263028|Ergocalciferols|ergocalciferols|mesh-list
65108462|NCT01263028|Vitamin D|vitamin d|mesh-list
65108463|NCT01263028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65108464|NCT01263028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108465|NCT01263028|Vitamins|vitamins|mesh-ancestor
65108466|NCT01263028|Micronutrients|micronutrients|mesh-ancestor
65108467|NCT01263028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65108469|NCT00547443|Carboplatin|carboplatin|mesh-list
65108470|NCT00547443|Sorafenib|sorafenib|mesh-list
65292032|NCT02717819|Vitamin D|vitamin d|mesh-list
65292033|NCT02717819|Vitamins|vitamins|mesh-ancestor
65292034|NCT02717819|Micronutrients|micronutrients|mesh-ancestor
65292035|NCT02717819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292036|NCT02717819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65292037|NCT02007655|Apixaban|apixaban|mesh-list
65292038|NCT02007655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65292039|NCT02007655|Antithrombins|antithrombins|mesh-ancestor
64522256|NCT02097849|Immunologic Factors|immunologic factors|mesh-ancestor
65108471|NCT00547443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65108472|NCT00547443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108473|NCT00547443|Tubulin Modulators|tubulin modulators|mesh-ancestor
65108474|NCT00547443|Antimitotic Agents|antimitotic agents|mesh-ancestor
65108475|NCT00547443|Mitosis Modulators|mitosis modulators|mesh-ancestor
64401031|NCT04858711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65108476|NCT00547443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108477|NCT00547443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65108514|NCT03809442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65108515|NCT03809442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108516|NCT03809442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65108517|NCT03809442|Glucocorticoids|glucocorticoids|mesh-ancestor
65108518|NCT03809442|Hormones|hormones|mesh-ancestor
65108519|NCT03809442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65108525|NCT03809442|Analgesics|analgesics|mesh-ancestor
65108526|NCT03809442|Sensory System Agents|sensory system agents|mesh-ancestor
65108527|NCT03809442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65108528|NCT03809442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65108529|NCT03809442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65108530|NCT03809442|Adrenergic Agents|adrenergic agents|mesh-ancestor
65108531|NCT03809442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65108532|NCT03809442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108533|NCT03809442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65108534|NCT03809442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65108535|NCT03809442|Anesthetics, General|anesthetics, general|mesh-ancestor
65108536|NCT03809442|Anesthetics|anesthetics|mesh-ancestor
65108537|NCT03809442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65108538|NCT03809442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65108539|NCT03809442|Anesthetics, Local|anesthetics, local|mesh-ancestor
65108541|NCT03809442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64750768|NCT03618654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108542|NCT03809442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65108543|NCT03809442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65108544|NCT03809442|GABA Modulators|gaba modulators|mesh-ancestor
65108545|NCT03809442|GABA Agents|gaba agents|mesh-ancestor
65108546|NCT03809442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65108547|NCT03809442|Narcotics|narcotics|mesh-ancestor
65108548|NCT00534729|Carboplatin|carboplatin|mesh-list
65108549|NCT00534729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108550|NCT00547989|Bupivacaine|bupivacaine|mesh-list
65108551|NCT00547989|Ropivacaine|ropivacaine|mesh-list
65108552|NCT00547989|Anesthetics, Local|anesthetics, local|mesh-ancestor
65108553|NCT00547989|Anesthetics|anesthetics|mesh-ancestor
65108554|NCT00547989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65108555|NCT00547989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108556|NCT00547989|Sensory System Agents|sensory system agents|mesh-ancestor
65108557|NCT00547989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65108558|NCT00534807|Rifampin|rifampin|mesh-list
65108559|NCT00534807|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65108560|NCT00534807|Antitubercular Agents|antitubercular agents|mesh-ancestor
65108561|NCT00534807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65108562|NCT00534807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65108563|NCT00534807|Leprostatic Agents|leprostatic agents|mesh-ancestor
65108564|NCT00534807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65108565|NCT00534807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108566|NCT00534807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108567|NCT00534807|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65108568|NCT00534807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65292040|NCT02007655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65292041|NCT02007655|Protease Inhibitors|protease inhibitors|mesh-ancestor
65292042|NCT02007655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292043|NCT02007655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292044|NCT02007655|Anticoagulants|anticoagulants|mesh-ancestor
65292045|NCT02611960|Gemcitabine|gemcitabine|mesh-list
65292046|NCT02611960|Capecitabine|capecitabine|mesh-list
65292047|NCT02611960|Docetaxel|docetaxel|mesh-list
65292048|NCT02611960|Pembrolizumab|pembrolizumab|mesh-list
65292049|NCT02611960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65292050|NCT02611960|Antimetabolites|antimetabolites|mesh-ancestor
65292051|NCT02611960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522263|NCT05513560|Pentoxifylline|pentoxifylline|mesh-list
65108569|NCT00534807|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65108570|NCT00534807|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65108571|NCT00534807|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65108572|NCT00534807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65108573|NCT00534846|Toremifene|toremifene|mesh-list
65108574|NCT00534846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65108575|NCT00534846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681114|NCT01787487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681115|NCT01787487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681116|NCT01653678|Vitamin D|vitamin d|mesh-list
64681117|NCT01653678|Ergocalciferols|ergocalciferols|mesh-list
65108583|NCT00548067|Valsartan|valsartan|mesh-list
65108584|NCT00548067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65108585|NCT00548067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65108586|NCT00548067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65108587|NCT00548067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65108588|NCT00548067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108589|NCT00548067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65108590|NCT00548067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108591|NCT00548067|Vasodilator Agents|vasodilator agents|mesh-ancestor
65108592|NCT00548067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65108593|NCT00548067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65108594|NCT00548067|Diuretics|diuretics|mesh-ancestor
65108595|NCT00548067|Natriuretic Agents|natriuretic agents|mesh-ancestor
65108596|NCT00548067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65108597|NCT02907749|Carvedilol|carvedilol|mesh-list
65108598|NCT02907749|Spironolactone|spironolactone|mesh-list
65108599|NCT02907749|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65108600|NCT02907749|Hormone Antagonists|hormone antagonists|mesh-ancestor
65108601|NCT02907749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65108602|NCT02907749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108603|NCT02907749|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65108604|NCT02907749|Diuretics|diuretics|mesh-ancestor
65108605|NCT02907749|Natriuretic Agents|natriuretic agents|mesh-ancestor
65108606|NCT02907749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65108607|NCT02907749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65108608|NCT02907749|Adrenergic Agents|adrenergic agents|mesh-ancestor
65108609|NCT02907749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65108610|NCT02907749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108611|NCT02907749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65108612|NCT02907749|Antioxidants|antioxidants|mesh-ancestor
65108613|NCT02907749|Protective Agents|protective agents|mesh-ancestor
65108614|NCT02907749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65108615|NCT02907749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65108616|NCT02907749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65108617|NCT02907749|Vasodilator Agents|vasodilator agents|mesh-ancestor
65108618|NCT02907749|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65108619|NCT02907749|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65292052|NCT02611960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292053|NCT02611960|Antiviral Agents|antiviral agents|mesh-ancestor
65292054|NCT02611960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292055|NCT02611960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292056|NCT02611960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65292057|NCT02611960|Immunologic Factors|immunologic factors|mesh-ancestor
65292058|NCT02611960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108621|NCT02907593|Calfactant|calfactant|mesh-list
65108622|NCT02907593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65108623|NCT02907593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65108624|NCT02907593|Autonomic Agents|autonomic agents|mesh-ancestor
65108625|NCT02907593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65108626|NCT02907593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108627|NCT02907593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65108628|NCT02907593|Respiratory System Agents|respiratory system agents|mesh-ancestor
65108629|NCT02907593|Glucocorticoids|glucocorticoids|mesh-ancestor
65108630|NCT02907593|Hormones|hormones|mesh-ancestor
65108655|NCT03781362|Antimetabolites|antimetabolites|mesh-ancestor
65108656|NCT03781362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108657|NCT03781362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108658|NCT04682249|Apatinib|apatinib|mesh-list
65108659|NCT04682249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108660|NCT04682249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65108661|NCT04682249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108662|NCT04682249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108663|NCT00548379|Vitamin D|vitamin d|mesh-list
65108664|NCT00548379|Vitamins|vitamins|mesh-ancestor
65108665|NCT00548379|Micronutrients|micronutrients|mesh-ancestor
65108666|NCT00548379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108667|NCT00548379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65108668|NCT04972617|Furosemide|furosemide|mesh-list
65108669|NCT04972617|Diuretics|diuretics|mesh-ancestor
65108670|NCT04972617|Natriuretic Agents|natriuretic agents|mesh-ancestor
65108671|NCT04972617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108672|NCT04972617|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65108673|NCT04972617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65108674|NCT04972617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108675|NCT04682210|Bevacizumab|bevacizumab|mesh-list
65108676|NCT04682210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65108677|NCT04682210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108678|NCT04682210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65108679|NCT04682210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65108680|NCT04682210|Growth Substances|growth substances|mesh-ancestor
65108707|NCT02907632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65108708|NCT02907632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108709|NCT02907437|Minocycline|minocycline|mesh-list
65108710|NCT02907437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65108711|NCT02907437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65108713|NCT01262872|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65108714|NCT01262872|Immunologic Factors|immunologic factors|mesh-ancestor
65108715|NCT01262872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108716|NCT04323280|Dexamethasone|dexamethasone|mesh-list
65108717|NCT04323280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65108718|NCT04323280|Antiemetics|antiemetics|mesh-ancestor
65108719|NCT04323280|Autonomic Agents|autonomic agents|mesh-ancestor
65108720|NCT04323280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65108721|NCT04323280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108722|NCT04323280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65108723|NCT04323280|Glucocorticoids|glucocorticoids|mesh-ancestor
65108724|NCT04323280|Hormones|hormones|mesh-ancestor
65108725|NCT04323280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65108726|NCT04323280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65108727|NCT04323280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108728|NCT00548574|Mesalamine|mesalamine|mesh-list
65108758|NCT02899364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65108759|NCT02899364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65108760|NCT02899364|Chelating Agents|chelating agents|mesh-ancestor
65108761|NCT02899364|Sequestering Agents|sequestering agents|mesh-ancestor
65292059|NCT02611960|Tubulin Modulators|tubulin modulators|mesh-ancestor
65292060|NCT02611960|Antimitotic Agents|antimitotic agents|mesh-ancestor
65292061|NCT02611960|Mitosis Modulators|mitosis modulators|mesh-ancestor
65292062|NCT02611960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65292063|NCT05298462|Antibodies|antibodies|mesh-list
65292064|NCT05298462|Immunologic Factors|immunologic factors|mesh-ancestor
65292065|NCT05298462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292066|NCT00730366|Chloroquine|chloroquine|mesh-list
65292067|NCT00730366|Pyrimethamine|pyrimethamine|mesh-list
65292068|NCT00730366|Sulfadoxine|sulfadoxine|mesh-list
65292069|NCT00730366|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65292070|NCT00730366|Amebicides|amebicides|mesh-ancestor
65292071|NCT00730366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65292072|NCT00730366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65292073|NCT00730366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292074|NCT00730366|Antimalarials|antimalarials|mesh-ancestor
65292075|NCT00730366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65292076|NCT00730366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65292077|NCT00730366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292078|NCT00730366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292079|NCT00730366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65292080|NCT00730366|Renal Agents|renal agents|mesh-ancestor
65292081|NCT02722343|Tenofovir|tenofovir|mesh-list
65292082|NCT02722343|Emtricitabine|emtricitabine|mesh-list
65292083|NCT02722343|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65292084|NCT02722343|Antiviral Agents|antiviral agents|mesh-ancestor
65292085|NCT02722343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65108762|NCT04206865|Valsartan|valsartan|mesh-list
65108763|NCT04206865|Vasodilator Agents|vasodilator agents|mesh-list
65108764|NCT04206865|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65108765|NCT04206865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65108766|NCT04206865|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65108767|NCT04206865|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65108768|NCT04206865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108769|NCT00535080|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65108776|NCT01262638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108777|NCT01262638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65108778|NCT01262638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108779|NCT01262638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65108780|NCT01262638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108781|NCT00535119|Paclitaxel|paclitaxel|mesh-list
65108782|NCT00535119|Carboplatin|carboplatin|mesh-list
65108783|NCT00535119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65108784|NCT00535119|Veliparib|veliparib|mesh-list
65108785|NCT00535119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65108786|NCT00535119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108787|NCT00535119|Tubulin Modulators|tubulin modulators|mesh-ancestor
65108788|NCT00535119|Antimitotic Agents|antimitotic agents|mesh-ancestor
65292086|NCT02722343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65292087|NCT02722343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65292088|NCT02722343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292089|NCT02722343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292090|NCT02722343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65292091|NCT02722343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65292092|NCT00694590|Plerixafor|plerixafor|mesh-list
65292093|NCT00694590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65292094|NCT00694590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65292095|NCT00694590|Antiviral Agents|antiviral agents|mesh-ancestor
65292096|NCT00694590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292097|NCT00730444|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65292098|NCT00730444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292099|NCT00730444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292100|NCT00730444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292101|NCT00730444|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65292102|NCT03903406|Dexamethasone|dexamethasone|mesh-list
65292103|NCT03903406|Lenalidomide|lenalidomide|mesh-list
65292104|NCT03903406|Ixazomib|ixazomib|mesh-list
65292105|NCT03903406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65292106|NCT03903406|Antiemetics|antiemetics|mesh-ancestor
64522339|NCT05280106|Citric Acid|citric acid|mesh-list
65108789|NCT00535119|Mitosis Modulators|mitosis modulators|mesh-ancestor
65108790|NCT00535119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108791|NCT00535119|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65108792|NCT00535119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108793|NCT00535158|Vitamin D|vitamin d|mesh-list
65108794|NCT00535158|Ergocalciferols|ergocalciferols|mesh-list
65108795|NCT00535158|Vitamins|vitamins|mesh-ancestor
65108796|NCT00535158|Micronutrients|micronutrients|mesh-ancestor
65108797|NCT00535158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108798|NCT00535158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65108799|NCT00535158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65108800|NCT03436992|Resveratrol|resveratrol|mesh-list
65108801|NCT03436992|Antioxidants|antioxidants|mesh-list
65108802|NCT03436992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108803|NCT03436992|Protective Agents|protective agents|mesh-ancestor
65108804|NCT03436992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108805|NCT03436992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108806|NCT03436992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65108807|NCT04083118|Listerine|listerine|mesh-list
65108808|NCT04083118|Fluorides|fluorides|mesh-list
65108809|NCT04083118|Sodium Fluoride|sodium fluoride|mesh-list
65108810|NCT04083118|Cariostatic Agents|cariostatic agents|mesh-ancestor
65108811|NCT04083118|Protective Agents|protective agents|mesh-ancestor
65108812|NCT04083118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108813|NCT04083118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65108814|NCT04083118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65108815|NCT04207450|Glutaral|glutaral|mesh-list
65108816|NCT04207450|Disinfectants|disinfectants|mesh-ancestor
65108817|NCT04207450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65108818|NCT04070443|Imatinib Mesylate|imatinib mesylate|mesh-list
65108819|NCT04070443|Ponatinib|ponatinib|mesh-list
65108820|NCT04070443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108821|NCT04070443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65292107|NCT03903406|Autonomic Agents|autonomic agents|mesh-ancestor
65292108|NCT03903406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65292109|NCT03903406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292110|NCT03903406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65292111|NCT03903406|Glucocorticoids|glucocorticoids|mesh-ancestor
65292112|NCT03903406|Hormones|hormones|mesh-ancestor
65292113|NCT03903406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65292114|NCT03903406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65292115|NCT03903406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292116|NCT03903406|Immunologic Factors|immunologic factors|mesh-ancestor
65292117|NCT03903406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65292118|NCT03903406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65292119|NCT03903406|Growth Substances|growth substances|mesh-ancestor
65108822|NCT04070443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108823|NCT04070443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108824|NCT04043494|Cytarabine|cytarabine|mesh-list
65108825|NCT04043494|Dexamethasone|dexamethasone|mesh-list
65108826|NCT04043494|Prednisone|prednisone|mesh-list
65108827|NCT04043494|Prednisolone|prednisolone|mesh-list
65108828|NCT04043494|Cyclophosphamide|cyclophosphamide|mesh-list
65108829|NCT04043494|Ifosfamide|ifosfamide|mesh-list
65108830|NCT04043494|Doxorubicin|doxorubicin|mesh-list
65108831|NCT04043494|Methotrexate|methotrexate|mesh-list
65108832|NCT04043494|Vincristine|vincristine|mesh-list
65108833|NCT04043494|Daunorubicin|daunorubicin|mesh-list
65108834|NCT04043494|Asparaginase|asparaginase|mesh-list
65108835|NCT04043494|Mercaptopurine|mercaptopurine|mesh-list
65108836|NCT04043494|Thioguanine|thioguanine|mesh-list
65108837|NCT04043494|Pegaspargase|pegaspargase|mesh-list
65108838|NCT04043494|Vindesine|vindesine|mesh-list
65108853|NCT04043494|Glucocorticoids|glucocorticoids|mesh-ancestor
65108855|NCT04043494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65108856|NCT04043494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65108857|NCT04043494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65108858|NCT04043494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65108859|NCT04043494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65108860|NCT04043494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108861|NCT04043494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65108862|NCT04043494|Abortifacient Agents|abortifacient agents|mesh-ancestor
65108863|NCT04043494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65108864|NCT04043494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65108865|NCT04043494|Antimetabolites|antimetabolites|mesh-ancestor
65108866|NCT04043494|Dermatologic Agents|dermatologic agents|mesh-ancestor
65108867|NCT04043494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65108868|NCT04043494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65108869|NCT04043494|Antiviral Agents|antiviral agents|mesh-ancestor
65108870|NCT04043494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65108871|NCT04043494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65108872|NCT04043494|Tubulin Modulators|tubulin modulators|mesh-ancestor
65108873|NCT04043494|Antimitotic Agents|antimitotic agents|mesh-ancestor
65108874|NCT04043494|Mitosis Modulators|mitosis modulators|mesh-ancestor
65108875|NCT02899286|BCT-100|bct-100|mesh-list
65108876|NCT02899286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108877|NCT04322422|Montelukast|montelukast|mesh-list
65108878|NCT04322422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65108879|NCT04322422|Respiratory System Agents|respiratory system agents|mesh-ancestor
65108880|NCT04322422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65108881|NCT04322422|Hormone Antagonists|hormone antagonists|mesh-ancestor
65108882|NCT04322422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65108883|NCT04322422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108884|NCT04322422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65108885|NCT04322422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65292120|NCT03903406|Growth Inhibitors|growth inhibitors|mesh-ancestor
65292121|NCT03903406|Protease Inhibitors|protease inhibitors|mesh-ancestor
65292122|NCT03903406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292123|NCT03903406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292124|NCT00594204|Varenicline|varenicline|mesh-list
65292125|NCT00594204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65292126|NCT00594204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65292127|NCT00594204|Cholinergic Agents|cholinergic agents|mesh-ancestor
65292128|NCT00594204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65292129|NCT00594204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292130|NCT00594204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292131|NCT04733092|Ethiodized Oil|ethiodized oil|mesh-list
65292132|NCT04733092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292133|NCT00999271|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
65292134|NCT00999271|Hormones|hormones|mesh-list
65292135|NCT00999271|Incretins|incretins|mesh-list
65292136|NCT00999271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65108886|NCT04322422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108888|NCT02899169|Hydroxyurea|hydroxyurea|mesh-list
65108889|NCT02899169|Arsenic Trioxide|arsenic trioxide|mesh-list
64681366|NCT00002643|Etoposide|etoposide|mesh-list
64681367|NCT00002643|Vincristine|vincristine|mesh-list
65108900|NCT00548964|Sensory System Agents|sensory system agents|mesh-ancestor
65108901|NCT00548964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65108902|NCT00548964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108903|NCT00548964|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65108904|NCT00548964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65108905|NCT00548964|Anesthetics, General|anesthetics, general|mesh-ancestor
65108906|NCT00548964|Anesthetics|anesthetics|mesh-ancestor
65108907|NCT00548964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65108908|NCT00548964|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65108909|NCT00548964|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65108910|NCT00548964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65108911|NCT00548964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108912|NCT00548964|Antidepressive Agents|antidepressive agents|mesh-ancestor
65108913|NCT00548964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65108914|NCT00548964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108915|NCT00548964|Antimanic Agents|antimanic agents|mesh-ancestor
65108916|NCT00548964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65108917|NCT03382938|Dexmedetomidine|dexmedetomidine|mesh-list
65108918|NCT03382938|Ropivacaine|ropivacaine|mesh-list
65108919|NCT03382938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65108920|NCT03382938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65108921|NCT03382938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108922|NCT03382938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65108923|NCT03382938|Analgesics|analgesics|mesh-ancestor
65108924|NCT03382938|Sensory System Agents|sensory system agents|mesh-ancestor
65108925|NCT03382938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65108926|NCT03382938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65108927|NCT03382938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65108928|NCT03382938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65108929|NCT03382938|Adrenergic Agents|adrenergic agents|mesh-ancestor
65108930|NCT03382938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65108931|NCT03382938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108932|NCT03382938|Anesthetics, Local|anesthetics, local|mesh-ancestor
65108933|NCT03382938|Anesthetics|anesthetics|mesh-ancestor
65108934|NCT00535353|Irinotecan|irinotecan|mesh-list
65292137|NCT00999271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292138|NCT00999271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65292139|NCT02716961|Gemcitabine|gemcitabine|mesh-list
65292140|NCT02716961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292141|NCT02716961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65292142|NCT02716961|Antimetabolites|antimetabolites|mesh-ancestor
65292143|NCT02716961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292144|NCT02716961|Antiviral Agents|antiviral agents|mesh-ancestor
65292145|NCT02716961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292146|NCT02716961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292147|NCT02716961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65292148|NCT02716961|Immunologic Factors|immunologic factors|mesh-ancestor
65292149|NCT02716961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292151|NCT02704156|Pembrolizumab|pembrolizumab|mesh-list
65292152|NCT02704156|Trametinib|trametinib|mesh-list
65292153|NCT02704156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65292154|NCT02704156|Antimetabolites|antimetabolites|mesh-ancestor
65292155|NCT02704156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292156|NCT02704156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292157|NCT02704156|Antiviral Agents|antiviral agents|mesh-ancestor
65292158|NCT02704156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292159|NCT02704156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108935|NCT00535353|Olaparib|olaparib|mesh-list
65108936|NCT00535353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65108937|NCT00535353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65108938|NCT00535353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108939|NCT00535353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108940|NCT00535353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108941|NCT00535353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65108942|NCT02898779|Primaquine|primaquine|mesh-list
65108943|NCT02898779|Antimalarials|antimalarials|mesh-ancestor
65108956|NCT00549120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65108957|NCT00549120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65108958|NCT00549120|Vasodilator Agents|vasodilator agents|mesh-ancestor
65108959|NCT00549120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65108961|NCT00549120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65108962|NCT00549120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65108963|NCT00549120|Respiratory System Agents|respiratory system agents|mesh-ancestor
65108964|NCT00549120|Tocolytic Agents|tocolytic agents|mesh-ancestor
65108965|NCT00549120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65108966|NCT00549120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65108967|NCT00549120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65108968|NCT00549120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65108969|NCT00549120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65108970|NCT00549120|Cholinergic Agents|cholinergic agents|mesh-ancestor
65108971|NCT04680884|Antifungal Agents|antifungal agents|mesh-list
65108972|NCT04680884|Clotrimazole|clotrimazole|mesh-list
65108973|NCT04680884|Miconazole|miconazole|mesh-list
65108974|NCT04680884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65108975|NCT04680884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65108976|NCT04680884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65108977|NCT04680884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65108978|NCT04680884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292160|NCT02704156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65292161|NCT02704156|Immunologic Factors|immunologic factors|mesh-ancestor
65292162|NCT02704156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292163|NCT02704156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65292164|NCT02704156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65292165|NCT00912678|Mycophenolic Acid|mycophenolic acid|mesh-list
65292166|NCT00912678|Tacrolimus|tacrolimus|mesh-list
65292167|NCT00912678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65292168|NCT00912678|Immunologic Factors|immunologic factors|mesh-ancestor
65292169|NCT00912678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292170|NCT00912678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65292171|NCT00912678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292172|NCT00912678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292173|NCT00912678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65292174|NCT00912678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292175|NCT00912678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65292176|NCT00912678|Antitubercular Agents|antitubercular agents|mesh-ancestor
65292177|NCT00912678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65292178|NCT00912678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292179|NCT00995839|Terlipressin|terlipressin|mesh-list
65292180|NCT00995839|Vasopressins|vasopressins|mesh-list
65292181|NCT00995839|Arginine Vasopressin|arginine vasopressin|mesh-list
65292182|NCT00995839|Hemostatics|hemostatics|mesh-ancestor
65292183|NCT00995839|Coagulants|coagulants|mesh-ancestor
65292184|NCT00995839|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65292185|NCT00995839|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65292186|NCT00995839|Natriuretic Agents|natriuretic agents|mesh-ancestor
65292187|NCT00995839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292188|NCT00995839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65292189|NCT00994513|Thioctic Acid|thioctic acid|mesh-list
65292190|NCT00994513|Antioxidants|antioxidants|mesh-ancestor
65292191|NCT00994513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292192|NCT00994513|Protective Agents|protective agents|mesh-ancestor
65292193|NCT00994513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108979|NCT04680884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108980|NCT04680884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65108981|NCT04680884|Hormone Antagonists|hormone antagonists|mesh-ancestor
65108982|NCT04680884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65108983|NCT04680884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292194|NCT00994513|Vitamin B Complex|vitamin b complex|mesh-ancestor
65292195|NCT00994513|Vitamins|vitamins|mesh-ancestor
65292196|NCT00994513|Micronutrients|micronutrients|mesh-ancestor
65292197|NCT02616744|Ibandronic Acid|ibandronic acid|mesh-list
65292198|NCT02616744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65292199|NCT02616744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292200|NCT04577404|Edaravone|edaravone|mesh-list
65292201|NCT04577404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64522444|NCT05232994|Esomeprazole|esomeprazole|mesh-list
64522445|NCT05232994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65108984|NCT04680884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65108985|NCT04680884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65108986|NCT00535470|Mechlorethamine|mechlorethamine|mesh-list
65108987|NCT00535470|Alkylating Agents|alkylating agents|mesh-ancestor
65108988|NCT00535470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108989|NCT00535470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65108991|NCT00535509|Cisplatin|cisplatin|mesh-list
65108992|NCT00535509|Docetaxel|docetaxel|mesh-list
65108993|NCT00535509|Trastuzumab|trastuzumab|mesh-list
65108994|NCT00535509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108995|NCT00535509|Tubulin Modulators|tubulin modulators|mesh-ancestor
65108996|NCT00535509|Antimitotic Agents|antimitotic agents|mesh-ancestor
65108997|NCT00535509|Mitosis Modulators|mitosis modulators|mesh-ancestor
65108998|NCT00535509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108999|NCT00535509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65109000|NCT01262365|Epratuzumab|epratuzumab|mesh-list
65109001|NCT01262365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65109002|NCT01262365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109003|NCT03244176|Avelumab|avelumab|mesh-list
65109004|NCT03244176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65109005|NCT03244176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109006|NCT00535665|Vaccines|vaccines|mesh-list
65109007|NCT00535665|Immunologic Factors|immunologic factors|mesh-ancestor
65109022|NCT01262287|Hormone Antagonists|hormone antagonists|mesh-ancestor
65109023|NCT01262287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65109024|NCT01262287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109026|NCT01262092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65109027|NCT01262092|Narcotics|narcotics|mesh-ancestor
65109028|NCT01262092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65109029|NCT01262092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109030|NCT01262092|Analgesics|analgesics|mesh-ancestor
65109031|NCT01262092|Sensory System Agents|sensory system agents|mesh-ancestor
65109032|NCT01262092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109033|NCT01262092|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65109034|NCT03898180|Pembrolizumab|pembrolizumab|mesh-list
65109035|NCT03898180|Lenvatinib|lenvatinib|mesh-list
65109036|NCT03898180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65109037|NCT03898180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109038|NCT03898180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65109039|NCT03898180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109040|NCT03898180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109041|NCT04680962|Rituximab|rituximab|mesh-list
65109042|NCT04680962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65109043|NCT04680962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109044|NCT04680962|Immunologic Factors|immunologic factors|mesh-ancestor
65109045|NCT04680962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109046|NCT04680962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65109047|NCT00549471|Botulinum Toxins|botulinum toxins|mesh-list
65109048|NCT00549471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65109049|NCT00549471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65109050|NCT00549471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65109051|NCT00549471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65109052|NCT00549471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109053|NCT00549471|Cholinergic Agents|cholinergic agents|mesh-ancestor
65109054|NCT00549471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65292202|NCT04577404|Antioxidants|antioxidants|mesh-ancestor
65292203|NCT04577404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292204|NCT04577404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65292205|NCT04577404|Protective Agents|protective agents|mesh-ancestor
65292206|NCT04577404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292207|NCT00995917|Vitamin K|vitamin k|mesh-list
65292208|NCT00995917|Vitamins|vitamins|mesh-ancestor
65292209|NCT00995917|Micronutrients|micronutrients|mesh-ancestor
65292210|NCT00995917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292211|NCT00995917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64522452|NCT02436798|Ondansetron|ondansetron|mesh-list
65109055|NCT00549471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109056|NCT00549471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65109057|NCT00549471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109058|NCT03088410|Zidovudine|zidovudine|mesh-list
65109059|NCT03088410|Nevirapine|nevirapine|mesh-list
65109060|NCT03088410|Antimetabolites|antimetabolites|mesh-ancestor
65109061|NCT03088410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109062|NCT03088410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64751314|NCT00089076|Ipilimumab|ipilimumab|mesh-list
65109063|NCT03088410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65109064|NCT03088410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109071|NCT02897765|Nivolumab|nivolumab|mesh-list
65109072|NCT02897765|Poly ICLC|poly iclc|mesh-list
65109073|NCT02897765|Immunologic Factors|immunologic factors|mesh-ancestor
65109074|NCT02897765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109075|NCT02897765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65109076|NCT02897765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109077|NCT02897765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65109078|NCT02897765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109079|NCT02897765|Interferon Inducers|interferon inducers|mesh-ancestor
65109080|NCT00549588|Sunscreening Agents|sunscreening agents|mesh-list
65109081|NCT00549588|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65109082|NCT00549588|Protective Agents|protective agents|mesh-ancestor
65109083|NCT00549588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109084|NCT00549588|Dermatologic Agents|dermatologic agents|mesh-ancestor
65109085|NCT04321642|Nitrous Oxide|nitrous oxide|mesh-list
65109086|NCT04321642|Entonox|entonox|mesh-list
65109087|NCT04321642|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65109088|NCT04321642|Anesthetics|anesthetics|mesh-ancestor
65109089|NCT04321642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65109090|NCT04321642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109091|NCT04321642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65109092|NCT04321642|Anesthetics, General|anesthetics, general|mesh-ancestor
65109093|NCT04321642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65109094|NCT04321642|Analgesics|analgesics|mesh-ancestor
65109095|NCT04321642|Sensory System Agents|sensory system agents|mesh-ancestor
65109096|NCT04321642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109097|NCT02897219|Ipragliflozin|ipragliflozin|mesh-list
65109098|NCT02897219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65109099|NCT02897219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109100|NCT02897219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65109101|NCT02897219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109102|NCT04321720|Mechlorethamine|mechlorethamine|mesh-list
65109103|NCT04321720|Alkylating Agents|alkylating agents|mesh-ancestor
65109104|NCT04321720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109105|NCT04321720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65109106|NCT04321720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109107|NCT04321837|Vitamin D|vitamin d|mesh-list
65109108|NCT04321837|Cholecalciferol|cholecalciferol|mesh-list
65109109|NCT04321837|Ibandronic Acid|ibandronic acid|mesh-list
65109110|NCT04321837|Vitamins|vitamins|mesh-ancestor
65109111|NCT04321837|Micronutrients|micronutrients|mesh-ancestor
65109112|NCT04321837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109113|NCT04321837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65292212|NCT00995917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65292213|NCT00995917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292214|NCT00995917|Hemostatics|hemostatics|mesh-ancestor
65292215|NCT00995917|Coagulants|coagulants|mesh-ancestor
65292216|NCT02616822|Resveratrol|resveratrol|mesh-list
65292217|NCT02616822|Antioxidants|antioxidants|mesh-ancestor
65292218|NCT02616822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292219|NCT02616822|Protective Agents|protective agents|mesh-ancestor
65292220|NCT02616822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292221|NCT02616822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292222|NCT02616822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65292223|NCT00912756|Cilostazol|cilostazol|mesh-list
65042176|NCT00226044|Omeprazole|omeprazole|mesh-list
65292224|NCT00912756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65292225|NCT00912756|Autonomic Agents|autonomic agents|mesh-ancestor
65292226|NCT00912756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65292227|NCT00912756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292228|NCT00912756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65292229|NCT00912756|Respiratory System Agents|respiratory system agents|mesh-ancestor
65292230|NCT00912756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65292231|NCT00912756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65292232|NCT00912756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292233|NCT00912756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65292234|NCT00912756|Vasodilator Agents|vasodilator agents|mesh-ancestor
65292235|NCT00912756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65292236|NCT00912756|Protective Agents|protective agents|mesh-ancestor
65292237|NCT00912756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65292238|NCT00912756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65292239|NCT00912756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292240|NCT04426240|Cyclosporine|cyclosporine|mesh-list
65292241|NCT04426240|Cyclosporins|cyclosporins|mesh-list
65292242|NCT04426240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292243|NCT04426240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292244|NCT04426240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65292245|NCT04426240|Immunologic Factors|immunologic factors|mesh-ancestor
65109114|NCT04321837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65109115|NCT02896829|Imatinib Mesylate|imatinib mesylate|mesh-list
65109116|NCT02896829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292246|NCT04426240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292247|NCT04426240|Antifungal Agents|antifungal agents|mesh-ancestor
65292248|NCT04426240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292249|NCT04426240|Dermatologic Agents|dermatologic agents|mesh-ancestor
65292250|NCT04426240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65292251|NCT04426240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65292252|NCT00995995|Rosiglitazone|rosiglitazone|mesh-list
65292253|NCT00995995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65292254|NCT00995995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292255|NCT00999349|Silymarin|silymarin|mesh-list
65292256|NCT00999349|Antioxidants|antioxidants|mesh-ancestor
65292257|NCT00999349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292258|NCT00999349|Protective Agents|protective agents|mesh-ancestor
65292259|NCT00999349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292260|NCT02621112|Imiquimod|imiquimod|mesh-list
64522497|NCT00358618|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65109117|NCT02896829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65109118|NCT02896829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109119|NCT02896829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109120|NCT00549666|Moxifloxacin|moxifloxacin|mesh-list
65109148|NCT00549666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65109149|NCT00549666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65109150|NCT00549666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109151|NCT00549666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109152|NCT04680923|Bupivacaine|bupivacaine|mesh-list
65109153|NCT04680923|Anesthetics, Local|anesthetics, local|mesh-ancestor
65109154|NCT04680923|Anesthetics|anesthetics|mesh-ancestor
65109155|NCT04680923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65109156|NCT04680923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109157|NCT04680923|Sensory System Agents|sensory system agents|mesh-ancestor
65109158|NCT04680923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109159|NCT04933383|Budesonide|budesonide|mesh-list
65109160|NCT04933383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65109161|NCT04933383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65109162|NCT04933383|Autonomic Agents|autonomic agents|mesh-ancestor
65109163|NCT04933383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109164|NCT04933383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109189|NCT00551577|Docetaxel|docetaxel|mesh-list
65109190|NCT00551577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109191|NCT00551577|Tubulin Modulators|tubulin modulators|mesh-ancestor
65109192|NCT00551577|Antimitotic Agents|antimitotic agents|mesh-ancestor
65109193|NCT00551577|Mitosis Modulators|mitosis modulators|mesh-ancestor
65109194|NCT00551577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109195|NCT04207723|Paroxetine|paroxetine|mesh-list
65109196|NCT04207723|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65109197|NCT04207723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65109198|NCT04207723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65109199|NCT04207723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109200|NCT04207723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65109201|NCT04207723|Serotonin Agents|serotonin agents|mesh-ancestor
65109202|NCT04207723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109203|NCT04207723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65109204|NCT04207723|Antidepressive Agents|antidepressive agents|mesh-ancestor
65109205|NCT04207723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65109206|NCT04207723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65109207|NCT04207723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65109208|NCT04207723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109209|NCT04321096|Camostat|camostat|mesh-list
65109210|NCT04321096|Protease Inhibitors|protease inhibitors|mesh-ancestor
65292261|NCT02621112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65292262|NCT02621112|Immunologic Factors|immunologic factors|mesh-ancestor
65292263|NCT02621112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292264|NCT02621112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292265|NCT02621112|Interferon Inducers|interferon inducers|mesh-ancestor
65292266|NCT04000789|Vitamins|vitamins|mesh-list
65292267|NCT04000789|Vitamin E|vitamin e|mesh-list
65292268|NCT04000789|Vitamin A|vitamin a|mesh-list
65292269|NCT04000789|Hyaluronic Acid|hyaluronic acid|mesh-list
65292270|NCT04000789|Micronutrients|micronutrients|mesh-ancestor
65292271|NCT04000789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292272|NCT04000789|Antioxidants|antioxidants|mesh-ancestor
65292273|NCT04000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292274|NCT04000789|Protective Agents|protective agents|mesh-ancestor
65292275|NCT04000789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65292276|NCT04000789|Immunologic Factors|immunologic factors|mesh-ancestor
65292277|NCT04000789|Viscosupplements|viscosupplements|mesh-ancestor
65109211|NCT04321096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681675|NCT00002733|Interferons|interferons|mesh-list
65109229|NCT04320706|Oxytocics|oxytocics|mesh-ancestor
65109230|NCT04320706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65109231|NCT04320706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109232|NCT03482479|Naltrexone|naltrexone|mesh-list
65109233|NCT03482479|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65109234|NCT03482479|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65109235|NCT03482479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109236|NCT03482479|Sensory System Agents|sensory system agents|mesh-ancestor
65109237|NCT03482479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109238|NCT00553709|Nicotine|nicotine|mesh-list
65109239|NCT00553709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65109240|NCT00553709|Autonomic Agents|autonomic agents|mesh-ancestor
65109241|NCT00553709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109242|NCT00553709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109243|NCT00553709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65109244|NCT00553709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65109245|NCT00553709|Cholinergic Agents|cholinergic agents|mesh-ancestor
65109246|NCT00553709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65109247|NCT00553709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109248|NCT00551733|Paclitaxel|paclitaxel|mesh-list
65109249|NCT00551733|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65109250|NCT00551733|Carboplatin|carboplatin|mesh-list
65109251|NCT00551733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
65109252|NCT00551733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65109253|NCT00551733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109254|NCT00551733|Tubulin Modulators|tubulin modulators|mesh-ancestor
65109255|NCT00551733|Antimitotic Agents|antimitotic agents|mesh-ancestor
65109256|NCT00551733|Mitosis Modulators|mitosis modulators|mesh-ancestor
65109257|NCT00551733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109258|NCT02896205|Mycophenolic Acid|mycophenolic acid|mesh-list
65109259|NCT02896205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65109260|NCT02896205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109261|NCT02896205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65109262|NCT02896205|Antitubercular Agents|antitubercular agents|mesh-ancestor
65109263|NCT02896205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65109264|NCT02896205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65109265|NCT02896205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109286|NCT00550095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65109287|NCT00550095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109288|NCT00551889|Celecoxib|celecoxib|mesh-list
65109289|NCT00551889|Cyclophosphamide|cyclophosphamide|mesh-list
65292278|NCT00697554|Vaccines|vaccines|mesh-list
65292279|NCT00697554|Immunologic Factors|immunologic factors|mesh-ancestor
65292280|NCT00697554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292281|NCT02329847|Nivolumab|nivolumab|mesh-list
65292282|NCT02329847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65292283|NCT02329847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292284|NCT02329847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65292285|NCT02329847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292286|NCT00731068|Mitogens|mitogens|mesh-list
65292287|NCT00731068|Mitosis Modulators|mitosis modulators|mesh-ancestor
65292288|NCT00731068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292289|NCT00866307|Cytarabine|cytarabine|mesh-list
65292290|NCT00866307|Dexamethasone|dexamethasone|mesh-list
65292291|NCT00866307|Dexamethasone acetate|dexamethasone acetate|mesh-list
65292292|NCT00866307|Prednisone|prednisone|mesh-list
65292293|NCT00866307|Cortisone|cortisone|mesh-list
64522528|NCT05050942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65109290|NCT00551889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65109291|NCT00551889|Immunologic Factors|immunologic factors|mesh-ancestor
65109292|NCT00551889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109293|NCT00551889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65109294|NCT00551889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65109295|NCT00551889|Alkylating Agents|alkylating agents|mesh-ancestor
65109296|NCT00551889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109297|NCT00551889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109298|NCT00551889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65109299|NCT00551889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65109300|NCT00551889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65109301|NCT00551889|Analgesics|analgesics|mesh-ancestor
65109302|NCT00551889|Sensory System Agents|sensory system agents|mesh-ancestor
65109303|NCT00551889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109304|NCT00551889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65109305|NCT00551889|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65109306|NCT00551889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65109307|NCT00551889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109308|NCT03455764|Trametinib|trametinib|mesh-list
65109309|NCT03455764|Dabrafenib|dabrafenib|mesh-list
65109310|NCT03455764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109311|NCT03455764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65109312|NCT03455764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109313|NCT03455764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109314|NCT04902495|Pemetrexed|pemetrexed|mesh-list
65109315|NCT04902495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109316|NCT04902495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109317|NCT04902495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109319|NCT04902495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65109321|NCT03433183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65109322|NCT03433183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65109323|NCT03433183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65109324|NCT03433183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109325|NCT03433183|Antifungal Agents|antifungal agents|mesh-ancestor
65109326|NCT03433183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65109327|NCT03433183|Immunologic Factors|immunologic factors|mesh-ancestor
65109328|NCT03433183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109329|NCT02895659|Norepinephrine|norepinephrine|mesh-list
65109330|NCT02895659|Epinephrine|epinephrine|mesh-list
65109331|NCT02895659|Racepinephrine|racepinephrine|mesh-list
65109332|NCT02895659|Epinephryl borate|epinephryl borate|mesh-list
65109333|NCT02895659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65292294|NCT00866307|Cyclophosphamide|cyclophosphamide|mesh-list
65292295|NCT00866307|Doxorubicin|doxorubicin|mesh-list
65292296|NCT00866307|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65292297|NCT00866307|Methotrexate|methotrexate|mesh-list
65292298|NCT00866307|Vincristine|vincristine|mesh-list
65292299|NCT00866307|Daunorubicin|daunorubicin|mesh-list
65292300|NCT00866307|Asparaginase|asparaginase|mesh-list
65292301|NCT00866307|Mercaptopurine|mercaptopurine|mesh-list
65292302|NCT00866307|Pegaspargase|pegaspargase|mesh-list
65292303|NCT00866307|Thioguanine|thioguanine|mesh-list
65292304|NCT00866307|BB 1101|bb 1101|mesh-list
65292305|NCT00866307|2-Aminopurine|2-aminopurine|mesh-list
65292306|NCT00866307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65292307|NCT00866307|Immunologic Factors|immunologic factors|mesh-ancestor
65292308|NCT00866307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292309|NCT00866307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65292310|NCT00866307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65292311|NCT00866307|Alkylating Agents|alkylating agents|mesh-ancestor
65292312|NCT00866307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292313|NCT00866307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292314|NCT00866307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65292315|NCT00866307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65292316|NCT00866307|Antiemetics|antiemetics|mesh-ancestor
65292317|NCT00866307|Autonomic Agents|autonomic agents|mesh-ancestor
65292318|NCT00866307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65292319|NCT00866307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65292320|NCT00866307|Glucocorticoids|glucocorticoids|mesh-ancestor
65292321|NCT00866307|Hormones|hormones|mesh-ancestor
65344925|NCT00864058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109334|NCT02895659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65109335|NCT02895659|Adrenergic Agents|adrenergic agents|mesh-ancestor
65109336|NCT02895659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65109337|NCT02895659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109338|NCT02895659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109339|NCT02895659|Sympathomimetics|sympathomimetics|mesh-ancestor
65109340|NCT02895659|Autonomic Agents|autonomic agents|mesh-ancestor
65109341|NCT02895659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109342|NCT02895659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65109343|NCT02895659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65109344|NCT02895659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65109345|NCT02895659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65109346|NCT02895659|Respiratory System Agents|respiratory system agents|mesh-ancestor
65109347|NCT02895659|Mydriatics|mydriatics|mesh-ancestor
65109348|NCT00552201|Tacrolimus|tacrolimus|mesh-list
65109349|NCT00552201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65109350|NCT00552201|Immunologic Factors|immunologic factors|mesh-ancestor
65109351|NCT00552201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109352|NCT00552201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65109353|NCT00552201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109354|NCT00552201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292322|NCT00866307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65292323|NCT00866307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65292324|NCT00866307|Protease Inhibitors|protease inhibitors|mesh-ancestor
65292325|NCT00866307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292326|NCT00866307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65292327|NCT00866307|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65292328|NCT00866307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65292329|NCT00866307|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65292330|NCT00866307|Abortifacient Agents|abortifacient agents|mesh-ancestor
65292331|NCT00866307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65292332|NCT00866307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65292333|NCT00866307|Antimetabolites|antimetabolites|mesh-ancestor
65292334|NCT00866307|Dermatologic Agents|dermatologic agents|mesh-ancestor
65292335|NCT00866307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65292336|NCT00866307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65292337|NCT00866307|Antiviral Agents|antiviral agents|mesh-ancestor
65292338|NCT00866307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292339|NCT00866307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65292340|NCT00866307|Tubulin Modulators|tubulin modulators|mesh-ancestor
65292341|NCT00866307|Antimitotic Agents|antimitotic agents|mesh-ancestor
65292342|NCT00866307|Mitosis Modulators|mitosis modulators|mesh-ancestor
65292343|NCT00731146|Anesthetics|anesthetics|mesh-list
65292344|NCT00731146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65292345|NCT00731146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292346|NCT02716415|Menthol|menthol|mesh-list
65292347|NCT02716415|Petrolatum|petrolatum|mesh-list
65292348|NCT02716415|Zinc Oxide|zinc oxide|mesh-list
65292349|NCT02716415|Antipruritics|antipruritics|mesh-ancestor
64522572|NCT00358930|Beta-lapachone|beta-lapachone|mesh-list
65109355|NCT03391882|Apomorphine|apomorphine|mesh-list
65109356|NCT03391882|Emetics|emetics|mesh-ancestor
65109357|NCT03391882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109358|NCT03391882|Autonomic Agents|autonomic agents|mesh-ancestor
65109359|NCT03391882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109360|NCT03391882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65109361|NCT03391882|Dopamine Agonists|dopamine agonists|mesh-ancestor
65109362|NCT03391882|Dopamine Agents|dopamine agents|mesh-ancestor
65109363|NCT03391882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65109364|NCT03391882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109365|NCT00550329|Glipizide|glipizide|mesh-list
65109366|NCT00550329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65109367|NCT00550329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109368|NCT00550485|Citalopram|citalopram|mesh-list
65109369|NCT00550485|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65109370|NCT00550485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65292350|NCT02716415|Dermatologic Agents|dermatologic agents|mesh-ancestor
65292351|NCT02716415|Emollients|emollients|mesh-ancestor
65292352|NCT02716415|Sunscreening Agents|sunscreening agents|mesh-ancestor
65292353|NCT02716415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65292354|NCT02716415|Protective Agents|protective agents|mesh-ancestor
65292355|NCT02716415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292356|NCT02616354|Imipenem|imipenem|mesh-list
65292357|NCT02616354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65292358|NCT02616354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292359|NCT00731224|Rivastigmine|rivastigmine|mesh-list
65292360|NCT00731224|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65292361|NCT00731224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292362|NCT00731224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292363|NCT00731224|Cholinergic Agents|cholinergic agents|mesh-ancestor
65292364|NCT00731224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65109371|NCT00550485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65109372|NCT00550485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109373|NCT00550485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65109374|NCT00550485|Serotonin Agents|serotonin agents|mesh-ancestor
65109375|NCT00550485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109376|NCT00550485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65109377|NCT00550485|Antidepressive Agents|antidepressive agents|mesh-ancestor
65109378|NCT00550485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65109379|NCT00550563|Cholecalciferol|cholecalciferol|mesh-list
65109380|NCT00550563|Vitamin D|vitamin d|mesh-list
65109401|NCT04680650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65109403|NCT02895113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65109404|NCT02895113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65109405|NCT02895113|Analgesics|analgesics|mesh-ancestor
65109406|NCT02895113|Sensory System Agents|sensory system agents|mesh-ancestor
65109407|NCT02895113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109408|NCT02895113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109409|NCT02895113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65109410|NCT02895113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65109411|NCT02895113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65109412|NCT02895113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65109413|NCT02895113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109414|NCT02895113|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65109415|NCT02895113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65109416|NCT02895113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109417|NCT02895113|Antipyretics|antipyretics|mesh-ancestor
65109418|NCT00552630|Penicillamine|penicillamine|mesh-list
65109419|NCT00552630|Antidotes|antidotes|mesh-ancestor
65109420|NCT00552630|Protective Agents|protective agents|mesh-ancestor
65109421|NCT00552630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109422|NCT00552630|Chelating Agents|chelating agents|mesh-ancestor
65109423|NCT00552630|Sequestering Agents|sequestering agents|mesh-ancestor
65109424|NCT00552630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109425|NCT00552630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65109426|NCT02894957|Varenicline|varenicline|mesh-list
65109427|NCT02894957|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65109428|NCT02894957|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65109429|NCT02894957|Cholinergic Agents|cholinergic agents|mesh-ancestor
65109430|NCT02894957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65109431|NCT02894957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109432|NCT02894957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109433|NCT00550992|Leucovorin|leucovorin|mesh-list
65109434|NCT00550992|Cytarabine|cytarabine|mesh-list
65109435|NCT00550992|Cyclosporine|cyclosporine|mesh-list
64681942|NCT04266197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292365|NCT00731224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292366|NCT00731224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65292367|NCT00731224|Protective Agents|protective agents|mesh-ancestor
65292368|NCT00531427|Buprenorphine|buprenorphine|mesh-list
65292369|NCT00531427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65292370|NCT00531427|Narcotics|narcotics|mesh-ancestor
65292371|NCT00531427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65292372|NCT00531427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292373|NCT00531427|Analgesics|analgesics|mesh-ancestor
65292374|NCT00531427|Sensory System Agents|sensory system agents|mesh-ancestor
65292375|NCT00531427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65292376|NCT00531427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65042321|NCT00196586|Antimetabolites|antimetabolites|mesh-ancestor
65292377|NCT00731302|Aspirin|aspirin|mesh-list
65292378|NCT00731302|Meloxicam|meloxicam|mesh-list
65292379|NCT00731302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65292380|NCT00731302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65292381|NCT00731302|Analgesics|analgesics|mesh-ancestor
65292382|NCT00731302|Sensory System Agents|sensory system agents|mesh-ancestor
65292383|NCT00731302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65292384|NCT00731302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292385|NCT00731302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65292386|NCT00731302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65292387|NCT00731302|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65292388|NCT00731302|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64522618|NCT04468360|Neurosteroids|neurosteroids|mesh-ancestor
64681944|NCT03942419|Atropine|atropine|mesh-list
64681945|NCT03942419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64681946|NCT03942419|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64681947|NCT03942419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64681948|NCT03942419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65109444|NCT00550992|Busulfan|busulfan|mesh-list
65109445|NCT00550992|Methotrexate|methotrexate|mesh-list
65109446|NCT00550992|Etoposide|etoposide|mesh-list
65109447|NCT00550992|Vincristine|vincristine|mesh-list
65109448|NCT00550992|Daunorubicin|daunorubicin|mesh-list
65109449|NCT00550992|Asparaginase|asparaginase|mesh-list
65109450|NCT00550992|Mitoxantrone|mitoxantrone|mesh-list
65109451|NCT00550992|Mercaptopurine|mercaptopurine|mesh-list
65109452|NCT00550992|Pegaspargase|pegaspargase|mesh-list
65109453|NCT00550992|Thioguanine|thioguanine|mesh-list
65109454|NCT00550992|Cyclosporins|cyclosporins|mesh-list
65109455|NCT00550992|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65109456|NCT00550992|Levoleucovorin|levoleucovorin|mesh-list
65109457|NCT00550992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65109458|NCT00550992|Immunologic Factors|immunologic factors|mesh-ancestor
65109459|NCT00550992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109460|NCT00550992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65109461|NCT00550992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65109462|NCT00550992|Alkylating Agents|alkylating agents|mesh-ancestor
65109463|NCT00550992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109464|NCT00550992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109465|NCT00550992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65292389|NCT00731302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292390|NCT00731302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65292391|NCT00731302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65292392|NCT00731302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292393|NCT00731302|Antipyretics|antipyretics|mesh-ancestor
65292394|NCT00731302|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65292395|NCT00871728|Itraconazole|itraconazole|mesh-list
65292396|NCT00871728|Antifungal Agents|antifungal agents|mesh-ancestor
65292397|NCT00871728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292398|NCT00871728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65292399|NCT00871728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65292400|NCT00871728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292401|NCT00871728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292402|NCT00871728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65292403|NCT00871728|Hormone Antagonists|hormone antagonists|mesh-ancestor
64522641|NCT02977000|Propranolol|propranolol|mesh-list
65109466|NCT00550992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65109467|NCT00550992|Glucocorticoids|glucocorticoids|mesh-ancestor
65109469|NCT00550992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65109470|NCT00550992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65109471|NCT00550992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65109472|NCT00550992|Abortifacient Agents|abortifacient agents|mesh-ancestor
65109473|NCT00550992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65109474|NCT00550992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65109475|NCT00550992|Antimetabolites|antimetabolites|mesh-ancestor
65109476|NCT00550992|Dermatologic Agents|dermatologic agents|mesh-ancestor
65109477|NCT00550992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109478|NCT00550992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65109479|NCT00550992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65109480|NCT00550992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65109481|NCT00550992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65109482|NCT00550992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65109483|NCT00550992|Antiviral Agents|antiviral agents|mesh-ancestor
65109484|NCT00550992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65109485|NCT00550992|Antidotes|antidotes|mesh-ancestor
65109486|NCT00550992|Protective Agents|protective agents|mesh-ancestor
65109487|NCT00550992|Vitamin B Complex|vitamin b complex|mesh-ancestor
65109488|NCT00550992|Vitamins|vitamins|mesh-ancestor
65109489|NCT00550992|Micronutrients|micronutrients|mesh-ancestor
65109490|NCT00550992|Tubulin Modulators|tubulin modulators|mesh-ancestor
65109491|NCT00550992|Antimitotic Agents|antimitotic agents|mesh-ancestor
65109492|NCT00550992|Mitosis Modulators|mitosis modulators|mesh-ancestor
65109493|NCT00550992|Antifungal Agents|antifungal agents|mesh-ancestor
65109494|NCT00550992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65109495|NCT00550992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109496|NCT00550992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65109497|NCT00550992|Analgesics|analgesics|mesh-ancestor
65109519|NCT00551265|Cyclophosphamide|cyclophosphamide|mesh-list
65109520|NCT00551265|Oregovomab|oregovomab|mesh-list
65109521|NCT00551265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65109522|NCT00551265|Antibodies|antibodies|mesh-list
65109523|NCT00551265|Immunoglobulins|immunoglobulins|mesh-list
65109524|NCT00551265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65109525|NCT00551265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65109526|NCT00551265|Immunologic Factors|immunologic factors|mesh-ancestor
65109527|NCT00551265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109528|NCT00551265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65109529|NCT00551265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65292404|NCT00871728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65292405|NCT00871728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292406|NCT00871728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65292407|NCT00731380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65292408|NCT00731380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292409|NCT00999427|Povidone-Iodine|povidone-iodine|mesh-list
65292410|NCT00999427|Povidone|povidone|mesh-list
65292411|NCT00999427|Plasma Substitutes|plasma substitutes|mesh-ancestor
65292412|NCT00999427|Blood Substitutes|blood substitutes|mesh-ancestor
65292413|NCT00999427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65292414|NCT00999427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292415|NCT04189211|Trastuzumab|trastuzumab|mesh-list
65292416|NCT04189211|Maytansine|maytansine|mesh-list
65292417|NCT04189211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65292418|NCT04189211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109530|NCT00551265|Alkylating Agents|alkylating agents|mesh-ancestor
65109531|NCT00551265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109532|NCT00551265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109533|NCT00551265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65109534|NCT02894606|Thymoglobulin|thymoglobulin|mesh-list
65109535|NCT02894606|Basiliximab|basiliximab|mesh-list
65109536|NCT02894606|Immunologic Factors|immunologic factors|mesh-ancestor
65109537|NCT02894606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109538|NCT02894606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65109539|NCT00551343|Exenatide|exenatide|mesh-list
65109540|NCT00551343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65109541|NCT00551343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484127|NCT00790270|Amitriptyline|amitriptyline|mesh-list
65109542|NCT00551343|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65109543|NCT00551343|Incretins|incretins|mesh-ancestor
65109545|NCT00551343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65109577|NCT02894645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109579|NCT02894645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65109580|NCT02894645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65109581|NCT02894645|Antiemetics|antiemetics|mesh-ancestor
65109582|NCT02894645|Autonomic Agents|autonomic agents|mesh-ancestor
65109583|NCT02894645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109584|NCT02894645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65109585|NCT02894645|Glucocorticoids|glucocorticoids|mesh-ancestor
65109586|NCT02894645|Hormones|hormones|mesh-ancestor
65109587|NCT02894645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65109588|NCT02894645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65109589|NCT02894645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64682034|NCT01636063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65109598|NCT02894645|Dermatologic Agents|dermatologic agents|mesh-ancestor
65109599|NCT02894645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65109600|NCT02894645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65109601|NCT02894645|Antiviral Agents|antiviral agents|mesh-ancestor
65109602|NCT02894645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65109603|NCT02894645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65109604|NCT02894645|Tubulin Modulators|tubulin modulators|mesh-ancestor
65109605|NCT02894645|Antimitotic Agents|antimitotic agents|mesh-ancestor
65109606|NCT02894645|Mitosis Modulators|mitosis modulators|mesh-ancestor
65109607|NCT00552747|Fenofibrate|fenofibrate|mesh-list
65109608|NCT00552747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65109609|NCT00552747|Antimetabolites|antimetabolites|mesh-ancestor
65109610|NCT00552747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109611|NCT00552747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65109612|NCT05427617|Fulvestrant|fulvestrant|mesh-list
65292419|NCT04189211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65292420|NCT04189211|Tubulin Modulators|tubulin modulators|mesh-ancestor
65292421|NCT04189211|Antimitotic Agents|antimitotic agents|mesh-ancestor
65292422|NCT04189211|Mitosis Modulators|mitosis modulators|mesh-ancestor
65292423|NCT04189211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292424|NCT00364780|XL647|xl647|mesh-list
65292425|NCT00364780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292426|NCT00364780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65292427|NCT00364780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292428|NCT00364780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292429|NCT00868998|Gemcitabine|gemcitabine|mesh-list
65292430|NCT00868998|Capecitabine|capecitabine|mesh-list
65292431|NCT00868998|Docetaxel|docetaxel|mesh-list
65109613|NCT05427617|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65109614|NCT05427617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65109615|NCT05427617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401032|NCT03068975|Alvimopan|alvimopan|mesh-list
65109617|NCT05427617|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65109618|NCT05427617|Hormone Antagonists|hormone antagonists|mesh-ancestor
65109619|NCT05427617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65109620|NCT05427617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109621|NCT05427617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109622|NCT05427617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109623|NCT05427500|Bupivacaine|bupivacaine|mesh-list
65109624|NCT05427500|Anesthetics, Local|anesthetics, local|mesh-ancestor
65109625|NCT05427500|Anesthetics|anesthetics|mesh-ancestor
65109626|NCT05427500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65109627|NCT05427500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109628|NCT05427500|Sensory System Agents|sensory system agents|mesh-ancestor
65109629|NCT05427500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109630|NCT05427383|Paclitaxel|paclitaxel|mesh-list
65109631|NCT05427383|Docetaxel|docetaxel|mesh-list
65109632|NCT05427383|Irinotecan|irinotecan|mesh-list
65109633|NCT05427383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65109634|NCT05427383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109635|NCT05427383|Tubulin Modulators|tubulin modulators|mesh-ancestor
65109636|NCT05427383|Antimitotic Agents|antimitotic agents|mesh-ancestor
65109637|NCT05427383|Mitosis Modulators|mitosis modulators|mesh-ancestor
65109638|NCT05427383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109639|NCT05427383|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65109640|NCT05427383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65109641|NCT05427383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109642|NCT04680221|Bupivacaine|bupivacaine|mesh-list
65109643|NCT04680221|Anesthetics, Local|anesthetics, local|mesh-ancestor
65109644|NCT04680221|Anesthetics|anesthetics|mesh-ancestor
65109645|NCT04680221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65109646|NCT04680221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109647|NCT04680221|Sensory System Agents|sensory system agents|mesh-ancestor
65109648|NCT04680221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109649|NCT05427305|Bevacizumab|bevacizumab|mesh-list
65109650|NCT05427305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64682128|NCT04218851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64682129|NCT04218851|Hormone Antagonists|hormone antagonists|mesh-ancestor
64682130|NCT04218851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64682131|NCT04218851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109657|NCT01099449|Oxaliplatin|oxaliplatin|mesh-list
65109658|NCT01099449|Magnesium Sulfate|magnesium sulfate|mesh-list
65109659|NCT01099449|Calcium|calcium|mesh-list
65109660|NCT01099449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65109661|NCT01099449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109662|NCT01099449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292432|NCT00868998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65292433|NCT00868998|Antimetabolites|antimetabolites|mesh-ancestor
65292434|NCT00868998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292435|NCT00868998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292436|NCT00868998|Antiviral Agents|antiviral agents|mesh-ancestor
65292437|NCT00868998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292438|NCT00868998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292439|NCT00868998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65292440|NCT00868998|Immunologic Factors|immunologic factors|mesh-ancestor
65292441|NCT00868998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292442|NCT00868998|Tubulin Modulators|tubulin modulators|mesh-ancestor
65292443|NCT00868998|Antimitotic Agents|antimitotic agents|mesh-ancestor
65292444|NCT00868998|Mitosis Modulators|mitosis modulators|mesh-ancestor
65292445|NCT00996151|Testosterone|testosterone|mesh-list
65292446|NCT00996151|Androgens|androgens|mesh-ancestor
65292447|NCT00996151|Hormones|hormones|mesh-ancestor
65292448|NCT00996151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65292449|NCT00996151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292450|NCT04131231|Aldesleukin|aldesleukin|mesh-list
65292451|NCT04131231|Methotrexate|methotrexate|mesh-list
65292452|NCT04131231|Interleukin-2|interleukin-2|mesh-list
65292453|NCT04131231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65292454|NCT04131231|Abortifacient Agents|abortifacient agents|mesh-ancestor
65292455|NCT04131231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65292456|NCT04131231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292457|NCT04131231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65292458|NCT04131231|Antimetabolites|antimetabolites|mesh-ancestor
64522683|NCT04343170|Epoetin Alfa|epoetin alfa|mesh-list
65109663|NCT01099449|Analgesics|analgesics|mesh-ancestor
65109664|NCT01099449|Sensory System Agents|sensory system agents|mesh-ancestor
65109665|NCT01099449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109666|NCT01099449|Anesthetics|anesthetics|mesh-ancestor
64751901|NCT03832452|Moxifloxacin|moxifloxacin|mesh-list
65109667|NCT01099449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65109668|NCT01099449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65109669|NCT01099449|Anticonvulsants|anticonvulsants|mesh-ancestor
65109670|NCT01099449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65109671|NCT01099449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65109672|NCT01099449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109673|NCT01099449|Tocolytic Agents|tocolytic agents|mesh-ancestor
65109674|NCT01099449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65109675|NCT04680143|Epoetin Alfa|epoetin alfa|mesh-list
65109676|NCT04680143|Hematinics|hematinics|mesh-ancestor
65109677|NCT05426798|Azacitidine|azacitidine|mesh-list
65109678|NCT05426798|Decitabine|decitabine|mesh-list
65109679|NCT05426798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65109680|NCT05426798|Antimetabolites|antimetabolites|mesh-ancestor
65292459|NCT04131231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292460|NCT04131231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292461|NCT04131231|Dermatologic Agents|dermatologic agents|mesh-ancestor
65292462|NCT04131231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292463|NCT04131231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65292464|NCT04131231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65292465|NCT04131231|Immunologic Factors|immunologic factors|mesh-ancestor
65292466|NCT04131231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65292467|NCT04131231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65292468|NCT04131231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65292469|NCT04131231|Analgesics|analgesics|mesh-ancestor
65292470|NCT04131231|Sensory System Agents|sensory system agents|mesh-ancestor
65292471|NCT04131231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65292472|NCT04131231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65292473|NCT04131231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65109681|NCT05426798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109682|NCT05426798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109683|NCT05426798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109684|NCT00436254|Molgramostim|molgramostim|mesh-list
65109685|NCT00436254|Sargramostim|sargramostim|mesh-list
65109686|NCT00436254|Immunologic Factors|immunologic factors|mesh-ancestor
65109687|NCT00436254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109688|NCT00436254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109689|NCT01234402|Capecitabine|capecitabine|mesh-list
65109690|NCT01234402|Ramucirumab|ramucirumab|mesh-list
65109691|NCT01234402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65109692|NCT01234402|Antimetabolites|antimetabolites|mesh-ancestor
65109693|NCT01234402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109694|NCT01234402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109695|NCT01260922|Donepezil|donepezil|mesh-list
65109696|NCT01260922|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65109697|NCT01260922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109698|NCT01260922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109699|NCT01260922|Cholinergic Agents|cholinergic agents|mesh-ancestor
65109700|NCT01260922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65109701|NCT01260922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109702|NCT01260922|Nootropic Agents|nootropic agents|mesh-ancestor
65109703|NCT01212094|Rituximab|rituximab|mesh-list
65109704|NCT01212094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65109705|NCT01212094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109706|NCT01212094|Immunologic Factors|immunologic factors|mesh-ancestor
65109707|NCT01212094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109708|NCT01212094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65109709|NCT04369794|BCG Vaccine|bcg vaccine|mesh-list
65109710|NCT04369794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65109711|NCT04369794|Immunologic Factors|immunologic factors|mesh-ancestor
65109724|NCT01211665|Methylprednisolone|methylprednisolone|mesh-list
65109725|NCT01211665|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65109726|NCT01211665|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65109727|NCT01211665|Prednisolone|prednisolone|mesh-list
65109728|NCT01211665|Prednisolone acetate|prednisolone acetate|mesh-list
65109729|NCT01211665|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65109730|NCT01211665|Prednisolone phosphate|prednisolone phosphate|mesh-list
65109731|NCT01211665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65109732|NCT01211665|Antiemetics|antiemetics|mesh-ancestor
65109733|NCT01211665|Autonomic Agents|autonomic agents|mesh-ancestor
65109734|NCT01211665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109735|NCT01211665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109736|NCT01211665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65109737|NCT01211665|Glucocorticoids|glucocorticoids|mesh-ancestor
65292474|NCT04131231|Antiviral Agents|antiviral agents|mesh-ancestor
65292475|NCT04131231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292476|NCT02716259|Fluorides|fluorides|mesh-list
65292477|NCT02716259|Sodium Fluoride|sodium fluoride|mesh-list
65292478|NCT02716259|Cariostatic Agents|cariostatic agents|mesh-ancestor
65292479|NCT02716259|Protective Agents|protective agents|mesh-ancestor
65292480|NCT02716259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292481|NCT00996229|Resveratrol|resveratrol|mesh-list
65292482|NCT00996229|Antioxidants|antioxidants|mesh-ancestor
65292483|NCT00996229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292484|NCT00996229|Protective Agents|protective agents|mesh-ancestor
65292485|NCT00996229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292486|NCT00996229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292487|NCT00996229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65109738|NCT01211665|Hormones|hormones|mesh-ancestor
65109739|NCT01211665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65109740|NCT01211665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65109741|NCT01211665|Protective Agents|protective agents|mesh-ancestor
65109742|NCT01211665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65109743|NCT01211665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109744|NCT04401176|Lidocaine|lidocaine|mesh-list
65109745|NCT04401176|Heparin|heparin|mesh-list
65109746|NCT04401176|Anesthetics, Local|anesthetics, local|mesh-ancestor
65109747|NCT04401176|Anesthetics|anesthetics|mesh-ancestor
65109748|NCT04401176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65109749|NCT04401176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109750|NCT04401176|Sensory System Agents|sensory system agents|mesh-ancestor
65109751|NCT04401176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109752|NCT04401176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65109753|NCT04401176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65109754|NCT04401176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65109755|NCT04401176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65109756|NCT04401176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109757|NCT04401176|Anticoagulants|anticoagulants|mesh-ancestor
65109758|NCT04401176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65109759|NCT04401176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65109820|NCT01232452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65109821|NCT05345613|Epinephrine|epinephrine|mesh-list
65109822|NCT05345613|Tranexamic Acid|tranexamic acid|mesh-list
65109823|NCT05345613|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65109824|NCT05345613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65109825|NCT05345613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109826|NCT05345613|Hemostatics|hemostatics|mesh-ancestor
65109827|NCT05345613|Coagulants|coagulants|mesh-ancestor
65109828|NCT05345613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65109829|NCT05345613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65109830|NCT05345613|Adrenergic Agents|adrenergic agents|mesh-ancestor
65109831|NCT05345613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65109832|NCT05345613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109833|NCT05345613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65109834|NCT05345613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65109835|NCT05345613|Autonomic Agents|autonomic agents|mesh-ancestor
65109836|NCT05345613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109837|NCT05345613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65109838|NCT05345613|Respiratory System Agents|respiratory system agents|mesh-ancestor
65109839|NCT05345613|Mydriatics|mydriatics|mesh-ancestor
65109840|NCT05345613|Sympathomimetics|sympathomimetics|mesh-ancestor
65109841|NCT05345613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64682262|NCT04120883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65109847|NCT01211197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109849|NCT00553137|Antifungal Agents|antifungal agents|mesh-ancestor
65292488|NCT02712671|Interferons|interferons|mesh-list
65292489|NCT02712671|Interferon-gamma|interferon-gamma|mesh-list
65292490|NCT02712671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292491|NCT02712671|Antiviral Agents|antiviral agents|mesh-ancestor
65292492|NCT02712671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292493|NCT02614833|Paclitaxel|paclitaxel|mesh-list
65292494|NCT02614833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65292495|NCT02614833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292496|NCT02614833|Tubulin Modulators|tubulin modulators|mesh-ancestor
65292497|NCT02614833|Antimitotic Agents|antimitotic agents|mesh-ancestor
65292498|NCT02614833|Mitosis Modulators|mitosis modulators|mesh-ancestor
65109850|NCT00553137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65109851|NCT00553137|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65109852|NCT00553137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65109853|NCT00553137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109854|NCT00553137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109855|NCT00553137|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65109856|NCT00553137|Hormone Antagonists|hormone antagonists|mesh-ancestor
65109857|NCT00553137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65109858|NCT00553137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109859|NCT00553137|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65109860|NCT00553137|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65109861|NCT04090775|Cyclophosphamide|cyclophosphamide|mesh-list
65109862|NCT04090775|Nivolumab|nivolumab|mesh-list
65109863|NCT04090775|Ipilimumab|ipilimumab|mesh-list
65109864|NCT04090775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65109865|NCT04090775|Immunologic Factors|immunologic factors|mesh-ancestor
65109866|NCT04090775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109867|NCT04090775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65109868|NCT04090775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65109869|NCT04090775|Alkylating Agents|alkylating agents|mesh-ancestor
65109870|NCT04090775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109871|NCT04090775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109872|NCT04090775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65109873|NCT04090775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65109874|NCT04090775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65109875|NCT01232296|Sorafenib|sorafenib|mesh-list
65109876|NCT01232296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109877|NCT01232296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65109878|NCT01232296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109879|NCT01232296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109880|NCT00554138|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65109881|NCT00554138|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65109882|NCT00554138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65109883|NCT00554138|Antimetabolites|antimetabolites|mesh-ancestor
65109884|NCT00554138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109885|NCT00554138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65109886|NCT00554138|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65109887|NCT00554138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109888|NCT01231555|Efavirenz|efavirenz|mesh-list
65109889|NCT01231555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64752127|NCT03302910|Diuretics|diuretics|mesh-list
65109890|NCT01231555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65109891|NCT01231555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109892|NCT01231555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109893|NCT01231555|Antiviral Agents|antiviral agents|mesh-ancestor
65109894|NCT01231555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65109895|NCT01231555|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65109896|NCT01231555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65109897|NCT01231555|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65109898|NCT01231555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64484136|NCT00790270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65292499|NCT02614833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292500|NCT00999505|Amantadine|amantadine|mesh-list
65292501|NCT00999505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65292502|NCT00999505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65292503|NCT00999505|Antiviral Agents|antiviral agents|mesh-ancestor
65292504|NCT00999505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292505|NCT00999505|Dopamine Agents|dopamine agents|mesh-ancestor
65292506|NCT00999505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65292507|NCT00999505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292508|NCT00999505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522756|NCT04276792|Analgesics, Opioid|analgesics, opioid|mesh-list
65109899|NCT01231555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65109900|NCT01231555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65109902|NCT04116528|Buprenorphine|buprenorphine|mesh-list
65109903|NCT04116528|Analgesics|analgesics|mesh-ancestor
65109904|NCT04116528|Sensory System Agents|sensory system agents|mesh-ancestor
65109905|NCT04116528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109906|NCT04116528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109914|NCT04116528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65109915|NCT04116528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109916|NCT04116528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65109917|NCT04116528|Narcotics|narcotics|mesh-ancestor
65109918|NCT04116528|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65109919|NCT05288907|Lidocaine|lidocaine|mesh-list
65109920|NCT05288907|Anesthetics, Local|anesthetics, local|mesh-ancestor
65109921|NCT05288907|Anesthetics|anesthetics|mesh-ancestor
65109922|NCT05288907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65109923|NCT05288907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109924|NCT05288907|Sensory System Agents|sensory system agents|mesh-ancestor
65109925|NCT05288907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109926|NCT05288907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65109927|NCT05288907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65109928|NCT05288907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65109929|NCT05288907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65109930|NCT05288907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109931|NCT03911336|Acetaminophen|acetaminophen|mesh-list
65109932|NCT03911336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65109933|NCT03911336|Ketoprofen|ketoprofen|mesh-list
65109934|NCT03911336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65109935|NCT03911336|Analgesics|analgesics|mesh-ancestor
65109936|NCT03911336|Sensory System Agents|sensory system agents|mesh-ancestor
65109937|NCT03911336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109938|NCT03911336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109939|NCT03911336|Antipyretics|antipyretics|mesh-ancestor
65109940|NCT03911336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65109941|NCT03911336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65109942|NCT03911336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65109943|NCT03911336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109944|NCT03911336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109945|NCT03850535|Cytarabine|cytarabine|mesh-list
65109946|NCT03850535|Daunorubicin|daunorubicin|mesh-list
65109947|NCT03850535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65109948|NCT03850535|Antimetabolites|antimetabolites|mesh-ancestor
65109949|NCT03850535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109950|NCT03850535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109951|NCT03850535|Antiviral Agents|antiviral agents|mesh-ancestor
65109952|NCT03850535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65109953|NCT03850535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65109954|NCT03850535|Immunologic Factors|immunologic factors|mesh-ancestor
65109955|NCT03850535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109956|NCT03850535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64752203|NCT03227562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65292509|NCT00999505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65292510|NCT00999505|Analgesics|analgesics|mesh-ancestor
65292511|NCT00999505|Sensory System Agents|sensory system agents|mesh-ancestor
65292512|NCT00999505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65292513|NCT00996385|Oxaliplatin|oxaliplatin|mesh-list
65292514|NCT00996385|Bortezomib|bortezomib|mesh-list
65292515|NCT00996385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292516|NCT00533845|Bupivacaine|bupivacaine|mesh-list
65292517|NCT00533845|Anesthetics, Local|anesthetics, local|mesh-ancestor
65292518|NCT00533845|Anesthetics|anesthetics|mesh-ancestor
65292519|NCT00533845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64752204|NCT03227562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752205|NCT03227562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752206|NCT03227562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64752207|NCT03227562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65109957|NCT03850535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65109958|NCT03850535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65109959|NCT03850535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109960|NCT03850301|Etifoxine|etifoxine|mesh-list
65109961|NCT03850301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65109962|NCT03850301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65109963|NCT03850301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65109964|NCT03850301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109965|NCT03850301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65109967|NCT05255367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65109968|NCT05255367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65109979|NCT03654053|Simvastatin|simvastatin|mesh-list
65109980|NCT03654053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65109981|NCT03654053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65109982|NCT03654053|Antimetabolites|antimetabolites|mesh-ancestor
65109983|NCT03654053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109984|NCT03654053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65109985|NCT03654053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65109986|NCT03654053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109987|NCT05189223|Buprenorphine|buprenorphine|mesh-list
65109988|NCT05189223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65109989|NCT05189223|Narcotics|narcotics|mesh-ancestor
65109990|NCT05189223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65109991|NCT05189223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109992|NCT05189223|Analgesics|analgesics|mesh-ancestor
65109993|NCT05189223|Sensory System Agents|sensory system agents|mesh-ancestor
65109994|NCT05189223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109995|NCT05189223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65109996|NCT03653000|Anesthetics|anesthetics|mesh-list
65109997|NCT03653000|Anesthetics, Local|anesthetics, local|mesh-list
65109998|NCT03653000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65109999|NCT03653000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110000|NCT03653000|Sensory System Agents|sensory system agents|mesh-ancestor
65110001|NCT03653000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65110002|NCT03639389|Morphine|morphine|mesh-list
65110003|NCT03639389|Analgesics|analgesics|mesh-list
65110004|NCT03639389|Bupivacaine|bupivacaine|mesh-list
65110005|NCT03639389|Anesthetics, Local|anesthetics, local|mesh-ancestor
65110006|NCT03639389|Anesthetics|anesthetics|mesh-ancestor
65110007|NCT03639389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65110008|NCT03639389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110009|NCT03639389|Sensory System Agents|sensory system agents|mesh-ancestor
65110010|NCT03639389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65110011|NCT03639389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65110012|NCT03639389|Narcotics|narcotics|mesh-ancestor
65110013|NCT03950739|Treprostinil|treprostinil|mesh-list
65110014|NCT03950739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65110015|NCT05172531|Cisatracurium|cisatracurium|mesh-list
65110016|NCT05172531|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65110017|NCT05172531|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65110018|NCT05172531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65292520|NCT00533845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292521|NCT00533845|Sensory System Agents|sensory system agents|mesh-ancestor
65292522|NCT00533845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65292523|NCT02752763|Dextrans|dextrans|mesh-list
65292524|NCT02752763|Povidone|povidone|mesh-list
65292525|NCT02752763|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65292526|NCT02752763|Lubricant Eye Drops|lubricant eye drops|mesh-list
65292527|NCT02752763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65292528|NCT02752763|Plasma Substitutes|plasma substitutes|mesh-ancestor
65292529|NCT02752763|Blood Substitutes|blood substitutes|mesh-ancestor
65292530|NCT02752763|Anticoagulants|anticoagulants|mesh-ancestor
65292531|NCT00857649|Memantine|memantine|mesh-list
65292532|NCT00857649|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65292533|NCT00857649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65292534|NCT00857649|Dopamine Agents|dopamine agents|mesh-ancestor
65292535|NCT00857649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65292536|NCT00857649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292537|NCT00857649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292538|NCT00857649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65292539|NCT00857649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65292540|NCT02752841|Vitamin D|vitamin d|mesh-list
65292541|NCT02752841|Vitamins|vitamins|mesh-ancestor
65292542|NCT02752841|Micronutrients|micronutrients|mesh-ancestor
65292543|NCT02752841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522771|NCT00053703|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65110019|NCT05172531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110020|NCT03570983|Cytarabine|cytarabine|mesh-list
65110021|NCT03570983|Etoposide|etoposide|mesh-list
65110022|NCT03570983|Melphalan|melphalan|mesh-list
65110023|NCT03570983|Carmustine|carmustine|mesh-list
65110024|NCT03570983|Allopurinol|allopurinol|mesh-list
65110025|NCT03570983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65110026|NCT03570983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110027|NCT03570983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65110028|NCT03570983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65110029|NCT03570983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752281|NCT03831984|Hyaluronic Acid|hyaluronic acid|mesh-list
65110030|NCT03570983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110031|NCT03570983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65110032|NCT03570983|Antimetabolites|antimetabolites|mesh-ancestor
65110033|NCT03570983|Antiviral Agents|antiviral agents|mesh-ancestor
65110034|NCT03570983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64682443|NCT02975843|Hormones|hormones|mesh-ancestor
65110042|NCT03570983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65110043|NCT03570983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65110044|NCT03570983|Antioxidants|antioxidants|mesh-ancestor
65110045|NCT03570983|Protective Agents|protective agents|mesh-ancestor
65110047|NCT03540758|Nicotinic Acids|nicotinic acids|mesh-list
65110048|NCT03540758|Niacinamide|niacinamide|mesh-list
65110049|NCT03540758|Diazoxide|diazoxide|mesh-list
65110050|NCT03540758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65110051|NCT03540758|Antimetabolites|antimetabolites|mesh-ancestor
65110052|NCT03540758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292544|NCT02752841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65292545|NCT03971669|Vaccines|vaccines|mesh-list
65292546|NCT03971669|Immunologic Factors|immunologic factors|mesh-ancestor
65292547|NCT03971669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292548|NCT02715869|Sevoflurane|sevoflurane|mesh-list
65292549|NCT02715869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65292550|NCT02715869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65292551|NCT02715869|Anesthetics, General|anesthetics, general|mesh-ancestor
65292552|NCT02715869|Anesthetics|anesthetics|mesh-ancestor
65292553|NCT02715869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65292554|NCT02715869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292555|NCT00532441|Docetaxel|docetaxel|mesh-list
65110053|NCT03540758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65110054|NCT03540758|Vasodilator Agents|vasodilator agents|mesh-ancestor
65110055|NCT03540758|Vitamin B Complex|vitamin b complex|mesh-ancestor
65110056|NCT03540758|Vitamins|vitamins|mesh-ancestor
65110057|NCT03540758|Micronutrients|micronutrients|mesh-ancestor
65110058|NCT03540758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110059|NCT03540758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65110060|NCT03187379|Bupivacaine|bupivacaine|mesh-list
65110061|NCT03187379|Anesthetics, Local|anesthetics, local|mesh-ancestor
65110062|NCT03187379|Anesthetics|anesthetics|mesh-ancestor
65110063|NCT03187379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65110064|NCT03187379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110065|NCT03187379|Sensory System Agents|sensory system agents|mesh-ancestor
65110066|NCT03187379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65110067|NCT03182231|Exenatide|exenatide|mesh-list
65110068|NCT03182231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65110069|NCT03182231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110070|NCT03182231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65110071|NCT03182231|Incretins|incretins|mesh-ancestor
65110072|NCT03182231|Hormones|hormones|mesh-ancestor
65110073|NCT03182231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65110074|NCT03182192|Exenatide|exenatide|mesh-list
65110075|NCT03182192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65110076|NCT03182192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110077|NCT03182192|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65110078|NCT03182192|Incretins|incretins|mesh-ancestor
65110079|NCT03182192|Hormones|hormones|mesh-ancestor
65110080|NCT03182192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65110081|NCT02964884|Lovastatin|lovastatin|mesh-list
65110082|NCT02964884|L 647318|l 647318|mesh-list
65110083|NCT02964884|Dihydromevinolin|dihydromevinolin|mesh-list
65110084|NCT02964884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65110085|NCT02964884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65110086|NCT02964884|Antimetabolites|antimetabolites|mesh-ancestor
65110087|NCT02964884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110088|NCT02964884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65110089|NCT02964884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65110090|NCT02964884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110091|NCT02837042|Pembrolizumab|pembrolizumab|mesh-list
65110092|NCT02837042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65110093|NCT02837042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110094|NCT05098470|Metformin|metformin|mesh-list
65110095|NCT05098470|Insulin Glargine|insulin glargine|mesh-list
65110096|NCT05098470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65110097|NCT05098470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110098|NCT02710643|Ofatumumab|ofatumumab|mesh-list
65110099|NCT02710643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110100|NCT05093205|Midazolam|midazolam|mesh-list
65110101|NCT05093205|Atorvastatin|atorvastatin|mesh-list
65110102|NCT05093205|Levonorgestrel|levonorgestrel|mesh-list
65110103|NCT05093205|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65110116|NCT05093205|GABA Agents|gaba agents|mesh-ancestor
65110117|NCT05093205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65110118|NCT05093205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292556|NCT00532441|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65292557|NCT00532441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292558|NCT00532441|Tubulin Modulators|tubulin modulators|mesh-ancestor
65292559|NCT00532441|Antimitotic Agents|antimitotic agents|mesh-ancestor
65292560|NCT00532441|Mitosis Modulators|mitosis modulators|mesh-ancestor
65292561|NCT00532441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292562|NCT00532441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65292563|NCT00532441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292564|NCT00999739|Vaccines|vaccines|mesh-list
65292565|NCT00999739|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65292566|NCT00999739|Immunologic Factors|immunologic factors|mesh-ancestor
65292567|NCT00999739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292568|NCT00996463|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
65292569|NCT00996463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65292570|NCT00996463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65292571|NCT00996463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292572|NCT00996463|Schistosomicides|schistosomicides|mesh-ancestor
65292573|NCT00996463|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64522809|NCT02975440|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65110119|NCT05093205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65110120|NCT05093205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65110121|NCT05093205|Antimetabolites|antimetabolites|mesh-ancestor
65110122|NCT05093205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65110123|NCT05093205|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65110124|NCT05093205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110125|NCT05093205|Estrogens|estrogens|mesh-ancestor
65110126|NCT05093205|Hormones|hormones|mesh-ancestor
65110127|NCT05093205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65110128|NCT05093205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65110129|NCT05093205|Contraceptive Agents|contraceptive agents|mesh-ancestor
65110130|NCT05093205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65110131|NCT05093205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65110132|NCT05093205|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65110133|NCT05093205|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65110134|NCT05093205|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65110135|NCT02623751|Exemestane|exemestane|mesh-list
65110136|NCT02623751|Entinostat|entinostat|mesh-list
65110137|NCT02623751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110138|NCT02623751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65110139|NCT02623751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65110140|NCT02623751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110141|NCT02623751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110142|NCT02623751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65110143|NCT02623751|Hormone Antagonists|hormone antagonists|mesh-ancestor
65110144|NCT02623751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65110145|NCT02623751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110146|NCT02623751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65110147|NCT02469155|Risperidone|risperidone|mesh-list
65110148|NCT02469155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65110149|NCT02469155|Serotonin Agents|serotonin agents|mesh-ancestor
65110150|NCT02469155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65110151|NCT02469155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110152|NCT02469155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110153|NCT02469155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65292574|NCT00996463|Anthelmintics|anthelmintics|mesh-ancestor
65292575|NCT00999817|Dextromethorphan|dextromethorphan|mesh-list
65292576|NCT00999817|Antitussive Agents|antitussive agents|mesh-ancestor
65292577|NCT00999817|Respiratory System Agents|respiratory system agents|mesh-ancestor
65292578|NCT00999817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65292579|NCT00999817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65292580|NCT00999817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65292581|NCT00999817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292582|NCT00999817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292583|NCT00857259|Everolimus|everolimus|mesh-list
65292584|NCT00857259|Ranibizumab|ranibizumab|mesh-list
65292585|NCT00857259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292586|NCT00857259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65292587|NCT00857259|Immunologic Factors|immunologic factors|mesh-ancestor
65292588|NCT00857259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522826|NCT04265872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110154|NCT02469155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65110155|NCT02469155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65110156|NCT02469155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65110157|NCT02469155|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65110158|NCT02469155|Dopamine Agents|dopamine agents|mesh-ancestor
65110159|NCT02465606|Triamcinolone|triamcinolone|mesh-list
65110160|NCT02465606|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65110161|NCT02465606|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65110162|NCT02465606|Hydrocortisone|hydrocortisone|mesh-list
65110163|NCT02465606|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65110164|NCT02465606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65110170|NCT02465606|Immunologic Factors|immunologic factors|mesh-ancestor
65110171|NCT02465606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110172|NCT02465606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110174|NCT05080530|Cholecalciferol|cholecalciferol|mesh-list
65110175|NCT05080530|Vitamins|vitamins|mesh-ancestor
65110176|NCT05080530|Micronutrients|micronutrients|mesh-ancestor
65110177|NCT05080530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110178|NCT05080530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65110179|NCT05080530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65110180|NCT00554177|Mifepristone|mifepristone|mesh-list
65110181|NCT00554177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65110182|NCT00554177|Abortifacient Agents|abortifacient agents|mesh-ancestor
65110183|NCT00554177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65110184|NCT00554177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110185|NCT00554177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65110186|NCT00554177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65110187|NCT00554177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65110188|NCT00554177|Contraceptive Agents|contraceptive agents|mesh-ancestor
65110189|NCT00554177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65110190|NCT00554177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65110191|NCT00554177|Hormone Antagonists|hormone antagonists|mesh-ancestor
65110192|NCT00554177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65110193|NCT00554177|Luteolytic Agents|luteolytic agents|mesh-ancestor
65110194|NCT00554177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65110195|NCT00554177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65110196|NCT03425565|Pembrolizumab|pembrolizumab|mesh-list
65110197|NCT03425565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65110198|NCT03425565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110199|NCT05073627|Dicloxacillin|dicloxacillin|mesh-list
65110201|NCT05073627|Antithrombins|antithrombins|mesh-ancestor
65110202|NCT05073627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65292589|NCT00857259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65292590|NCT00857259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65292591|NCT00857259|Growth Substances|growth substances|mesh-ancestor
65292592|NCT00857259|Growth Inhibitors|growth inhibitors|mesh-ancestor
65292593|NCT00868608|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65292594|NCT00868608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65292595|NCT00868608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292596|NCT00868608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65292597|NCT04000633|Lidocaine|lidocaine|mesh-list
65292598|NCT04000633|Anesthetics, Local|anesthetics, local|mesh-ancestor
65292599|NCT04000633|Anesthetics|anesthetics|mesh-ancestor
65292600|NCT04000633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65292601|NCT04000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292602|NCT04000633|Sensory System Agents|sensory system agents|mesh-ancestor
65292603|NCT04000633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65292604|NCT04000633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65292605|NCT04000633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65292606|NCT04000633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65292607|NCT04000633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65292608|NCT04000633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292609|NCT00994825|Simendan|simendan|mesh-list
65292610|NCT00994825|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65292611|NCT00994825|Vasodilator Agents|vasodilator agents|mesh-ancestor
64522844|NCT00233103|Sertraline|sertraline|mesh-list
65110203|NCT05073627|Protease Inhibitors|protease inhibitors|mesh-ancestor
65110204|NCT05073627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110205|NCT05073627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110206|NCT05073627|Anticoagulants|anticoagulants|mesh-ancestor
65110207|NCT05073627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65110208|NCT05073627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65110209|NCT04678739|Remdesivir|remdesivir|mesh-list
65110210|NCT04678739|Antimetabolites|antimetabolites|mesh-ancestor
65110211|NCT04678739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110212|NCT04678739|Antiviral Agents|antiviral agents|mesh-ancestor
65110213|NCT04678739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65110214|NCT03421353|Gemcitabine|gemcitabine|mesh-list
65110215|NCT03421353|Paclitaxel|paclitaxel|mesh-list
65110216|NCT03421353|Carboplatin|carboplatin|mesh-list
65110217|NCT03421353|Durvalumab|durvalumab|mesh-list
65110218|NCT03421353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65110219|NCT03421353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110220|NCT03421353|Tubulin Modulators|tubulin modulators|mesh-ancestor
65110221|NCT03421353|Antimitotic Agents|antimitotic agents|mesh-ancestor
65110222|NCT03421353|Mitosis Modulators|mitosis modulators|mesh-ancestor
65110223|NCT03421353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110224|NCT03421353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65110225|NCT03421353|Antimetabolites|antimetabolites|mesh-ancestor
65110226|NCT03421353|Antiviral Agents|antiviral agents|mesh-ancestor
65110227|NCT03421353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65110228|NCT03421353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292612|NCT00994825|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65292613|NCT00994825|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65292614|NCT00994825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292615|NCT00994825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292616|NCT00994825|Protective Agents|protective agents|mesh-ancestor
65292617|NCT00994825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292618|NCT02752529|Tacrolimus|tacrolimus|mesh-list
65292619|NCT02752529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65292620|NCT02752529|Immunologic Factors|immunologic factors|mesh-ancestor
65292621|NCT02752529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292622|NCT02752529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65292623|NCT02752529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292624|NCT02752529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292625|NCT00856635|Glatiramer Acetate|glatiramer acetate|mesh-list
65292626|NCT00856635|(T,G)-A-L|(t,g)-a-l|mesh-list
65292627|NCT00856635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65292628|NCT00856635|Immunologic Factors|immunologic factors|mesh-ancestor
65292629|NCT00856635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292630|NCT00856635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65292631|NCT00856635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65292632|NCT02620800|Leucovorin|leucovorin|mesh-list
65292633|NCT02620800|Paclitaxel|paclitaxel|mesh-list
65292634|NCT02620800|Bevacizumab|bevacizumab|mesh-list
64522864|NCT02433522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110229|NCT03421353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65110230|NCT03421353|Immunologic Factors|immunologic factors|mesh-ancestor
65110231|NCT03421353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110232|NCT03421353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65110233|NCT03230565|Ropivacaine|ropivacaine|mesh-list
65110234|NCT03230565|Anesthetics, Local|anesthetics, local|mesh-ancestor
64682698|NCT05735132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65110238|NCT03230565|Sensory System Agents|sensory system agents|mesh-ancestor
65110239|NCT03230565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65110241|NCT02389985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65110242|NCT02389985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110243|NCT02389985|Tubulin Modulators|tubulin modulators|mesh-ancestor
65110244|NCT02389985|Antimitotic Agents|antimitotic agents|mesh-ancestor
65110245|NCT02389985|Mitosis Modulators|mitosis modulators|mesh-ancestor
64484161|NCT01780987|Antithrombins|antithrombins|mesh-ancestor
65110246|NCT02389985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110247|NCT03147612|Cytarabine|cytarabine|mesh-list
65110248|NCT03147612|Cyclophosphamide|cyclophosphamide|mesh-list
65110249|NCT03147612|Rituximab|rituximab|mesh-list
65110250|NCT03147612|Methotrexate|methotrexate|mesh-list
65110251|NCT03147612|Vincristine|vincristine|mesh-list
65110252|NCT03147612|Blinatumomab|blinatumomab|mesh-list
65110253|NCT03147612|Ponatinib|ponatinib|mesh-list
65110254|NCT03147612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65110255|NCT03147612|Muromonab-CD3|muromonab-cd3|mesh-list
65110256|NCT03147612|Antibodies|antibodies|mesh-list
65110257|NCT03147612|Immunoglobulins|immunoglobulins|mesh-list
65110258|NCT03147612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65110259|NCT03147612|Lenograstim|lenograstim|mesh-list
65292635|NCT02620800|Oxaliplatin|oxaliplatin|mesh-list
65292636|NCT02620800|Calcium|calcium|mesh-list
65292637|NCT02620800|Levoleucovorin|levoleucovorin|mesh-list
65292638|NCT02620800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65292639|NCT02620800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292640|NCT02620800|Tubulin Modulators|tubulin modulators|mesh-ancestor
65292641|NCT02620800|Antimitotic Agents|antimitotic agents|mesh-ancestor
65292642|NCT02620800|Mitosis Modulators|mitosis modulators|mesh-ancestor
65110260|NCT03147612|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65110261|NCT03147612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65110262|NCT03147612|Immunologic Factors|immunologic factors|mesh-ancestor
65110263|NCT03147612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110264|NCT03147612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65110265|NCT03147612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65110266|NCT03147612|Alkylating Agents|alkylating agents|mesh-ancestor
65110267|NCT03147612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110268|NCT03147612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110269|NCT03147612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65110270|NCT03147612|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65110271|NCT03147612|Abortifacient Agents|abortifacient agents|mesh-ancestor
65110272|NCT03147612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65110273|NCT03147612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65110275|NCT03147612|Dermatologic Agents|dermatologic agents|mesh-ancestor
65110276|NCT03147612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110277|NCT03147612|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65110278|NCT03147612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65110279|NCT03147612|Antiviral Agents|antiviral agents|mesh-ancestor
65110280|NCT03147612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65110281|NCT03147612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65110282|NCT03147612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65110283|NCT03147612|Tubulin Modulators|tubulin modulators|mesh-ancestor
65110284|NCT03147612|Antimitotic Agents|antimitotic agents|mesh-ancestor
65110285|NCT03147612|Mitosis Modulators|mitosis modulators|mesh-ancestor
65110286|NCT03147612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65110287|NCT02377895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65110288|NCT02365649|Upadacitinib|upadacitinib|mesh-list
65110289|NCT02365649|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65110290|NCT02365649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65110291|NCT02365649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110292|NCT02365649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110293|NCT02365649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65110294|NCT03455075|Levonorgestrel|levonorgestrel|mesh-list
65110295|NCT03455075|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65110296|NCT03455075|Contraceptive Agents|contraceptive agents|mesh-ancestor
65110297|NCT03455075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65110298|NCT03455075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110299|NCT03455075|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65110300|NCT03455075|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65110301|NCT03455075|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65110302|NCT05007132|Trifluridine|trifluridine|mesh-list
65110303|NCT05007132|Bevacizumab|bevacizumab|mesh-list
65110304|NCT05007132|Panitumumab|panitumumab|mesh-list
65110305|NCT05007132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65110306|NCT05007132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110319|NCT04684017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65110320|NCT04684017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65110321|NCT04684017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65110322|NCT04684017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110323|NCT04684017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110324|NCT00554450|Dapagliflozin|dapagliflozin|mesh-list
65110325|NCT00554450|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65110326|NCT00554450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752585|NCT04198116|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64752586|NCT04198116|Cholinergic Agents|cholinergic agents|mesh-ancestor
64752587|NCT04198116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64752588|NCT04198116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292643|NCT02620800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292644|NCT02620800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65292645|NCT02620800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65292646|NCT02620800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65292647|NCT02620800|Growth Substances|growth substances|mesh-ancestor
65292648|NCT02620800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522895|NCT04342858|Listerine|listerine|mesh-list
64752589|NCT04198116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752590|NCT04198116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64752591|NCT04198116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64752592|NCT04198116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64752593|NCT04198116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64752594|NCT04198116|Adrenergic Agents|adrenergic agents|mesh-ancestor
65110327|NCT00554450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65110328|NCT00554450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110329|NCT00553020|Insulin Glargine|insulin glargine|mesh-list
65110330|NCT00553020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65110331|NCT00553020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110333|NCT00554528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65110334|NCT00554528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65110335|NCT00554528|Analgesics|analgesics|mesh-ancestor
65110336|NCT00554528|Sensory System Agents|sensory system agents|mesh-ancestor
65110337|NCT00554528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65110338|NCT00554528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110339|NCT00554528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65110340|NCT00554528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65110341|NCT00554528|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65110342|NCT00554528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65110343|NCT00554528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110344|NCT00554528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110345|NCT04683198|Carboplatin|carboplatin|mesh-list
65110346|NCT04683198|Etoposide|etoposide|mesh-list
65110347|NCT04683198|Apatinib|apatinib|mesh-list
65110348|NCT04683198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110382|NCT02884206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65110383|NCT02884206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682849|NCT01610011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682850|NCT01610011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682851|NCT00000399|Hormones|hormones|mesh-list
65110392|NCT02326454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110393|NCT02326454|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65110394|NCT02326454|Dermatologic Agents|dermatologic agents|mesh-ancestor
65110395|NCT02871219|Lenalidomide|lenalidomide|mesh-list
65110396|NCT02871219|Obinutuzumab|obinutuzumab|mesh-list
65110397|NCT02871219|Immunologic Factors|immunologic factors|mesh-ancestor
65110398|NCT02871219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110399|NCT02871219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64752660|NCT03162432|Vitamin D|vitamin d|mesh-list
65110400|NCT02871219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65110401|NCT02871219|Growth Substances|growth substances|mesh-ancestor
65110402|NCT02871219|Growth Inhibitors|growth inhibitors|mesh-ancestor
65110403|NCT02871219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110404|NCT02871219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65110405|NCT02324309|Insulin Lispro|insulin lispro|mesh-list
65110406|NCT02324309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65110407|NCT02324309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110408|NCT02306291|Cytarabine|cytarabine|mesh-list
65110409|NCT02306291|Etoposide|etoposide|mesh-list
65110410|NCT02306291|Mitoxantrone|mitoxantrone|mesh-list
65110411|NCT02306291|Idarubicin|idarubicin|mesh-list
65110412|NCT02306291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65110413|NCT02306291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110414|NCT02306291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65110415|NCT02306291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65110416|NCT02306291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110417|NCT02306291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292649|NCT02620800|Growth Inhibitors|growth inhibitors|mesh-ancestor
65292650|NCT02620800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65292651|NCT02620800|Antidotes|antidotes|mesh-ancestor
65292652|NCT02620800|Protective Agents|protective agents|mesh-ancestor
65292653|NCT02620800|Vitamin B Complex|vitamin b complex|mesh-ancestor
65292654|NCT02620800|Vitamins|vitamins|mesh-ancestor
65292655|NCT02620800|Micronutrients|micronutrients|mesh-ancestor
65292656|NCT04135014|Midazolam|midazolam|mesh-list
65292657|NCT04135014|Dexmedetomidine|dexmedetomidine|mesh-list
65292658|NCT04135014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65292659|NCT04135014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65292660|NCT04135014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292661|NCT04135014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65292662|NCT04135014|Analgesics|analgesics|mesh-ancestor
65292663|NCT04135014|Sensory System Agents|sensory system agents|mesh-ancestor
65292664|NCT04135014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65292665|NCT04135014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65292666|NCT04135014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65292667|NCT04135014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65292668|NCT04135014|Adrenergic Agents|adrenergic agents|mesh-ancestor
65292669|NCT04135014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65292670|NCT04135014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292671|NCT04135014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65110418|NCT02306291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65110419|NCT02306291|Antimetabolites|antimetabolites|mesh-ancestor
65110420|NCT02306291|Antiviral Agents|antiviral agents|mesh-ancestor
65110421|NCT02306291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65110422|NCT02306291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65110423|NCT02306291|Immunologic Factors|immunologic factors|mesh-ancestor
65110424|NCT02306291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110425|NCT02306291|Analgesics|analgesics|mesh-ancestor
65110426|NCT02306291|Sensory System Agents|sensory system agents|mesh-ancestor
65110427|NCT02306291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65110428|NCT02306291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65110429|NCT02302079|Ranibizumab|ranibizumab|mesh-list
65110430|NCT02302079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65110431|NCT02302079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65110432|NCT02302079|Growth Substances|growth substances|mesh-ancestor
65110433|NCT02302079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110434|NCT02302079|Growth Inhibitors|growth inhibitors|mesh-ancestor
65110435|NCT02302079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110436|NCT01210495|Axitinib|axitinib|mesh-list
65110437|NCT01210495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110438|NCT01210495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65110439|NCT01210495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110440|NCT01210495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110441|NCT02289716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65110442|NCT02289716|Immunologic Factors|immunologic factors|mesh-ancestor
65110443|NCT02289716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110444|NCT04678076|Ketoprofen|ketoprofen|mesh-list
65110445|NCT04678076|Ketoprofen lysine|ketoprofen lysine|mesh-list
65110446|NCT04678076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65292672|NCT04135014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65292673|NCT04135014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65292674|NCT04135014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65292675|NCT04135014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65292676|NCT04135014|Anesthetics, General|anesthetics, general|mesh-ancestor
65292677|NCT04135014|Anesthetics|anesthetics|mesh-ancestor
65292678|NCT04135014|GABA Modulators|gaba modulators|mesh-ancestor
65292679|NCT04135014|GABA Agents|gaba agents|mesh-ancestor
65292680|NCT00996697|Budesonide|budesonide|mesh-list
65042604|NCT00226668|Hormones|hormones|mesh-ancestor
65292681|NCT00996697|Formoterol Fumarate|formoterol fumarate|mesh-list
65292682|NCT00996697|Tiotropium Bromide|tiotropium bromide|mesh-list
65292683|NCT00996697|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65292684|NCT00996697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65292685|NCT00996697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64522924|NCT00255177|Abortifacient Agents|abortifacient agents|mesh-ancestor
65110447|NCT04678076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65110448|NCT04678076|Analgesics|analgesics|mesh-ancestor
65110471|NCT02224235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65110472|NCT02224235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110473|NCT02224235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65110474|NCT02224235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65110475|NCT02224235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65110476|NCT02224235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65110477|NCT02224235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110478|NCT02224235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65110479|NCT02224235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65110480|NCT02224235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110481|NCT02224235|Antipyretics|antipyretics|mesh-ancestor
65110482|NCT02529852|Prednisone|prednisone|mesh-list
65110483|NCT02529852|Cyclophosphamide|cyclophosphamide|mesh-list
65110484|NCT02529852|Doxorubicin|doxorubicin|mesh-list
65110485|NCT02529852|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65110486|NCT02529852|Vincristine|vincristine|mesh-list
65110487|NCT02529852|Lenalidomide|lenalidomide|mesh-list
65110488|NCT02529852|Obinutuzumab|obinutuzumab|mesh-list
65110489|NCT02529852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65110490|NCT02529852|Immunologic Factors|immunologic factors|mesh-ancestor
65110491|NCT02529852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110492|NCT02529852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65110493|NCT02529852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65110494|NCT02529852|Alkylating Agents|alkylating agents|mesh-ancestor
65110495|NCT02529852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110496|NCT02529852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110497|NCT02529852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65110498|NCT02529852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65110499|NCT02529852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65110500|NCT02529852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65110501|NCT02529852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110502|NCT02529852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65110503|NCT02529852|Glucocorticoids|glucocorticoids|mesh-ancestor
65110504|NCT02529852|Hormones|hormones|mesh-ancestor
65110505|NCT02529852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65110506|NCT02529852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65110507|NCT02529852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65110508|NCT02529852|Tubulin Modulators|tubulin modulators|mesh-ancestor
65110509|NCT02529852|Antimitotic Agents|antimitotic agents|mesh-ancestor
65110510|NCT02529852|Mitosis Modulators|mitosis modulators|mesh-ancestor
65110511|NCT02529852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65110512|NCT02529852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65110513|NCT02529852|Growth Substances|growth substances|mesh-ancestor
65292686|NCT00996697|Autonomic Agents|autonomic agents|mesh-ancestor
65292687|NCT00996697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65292688|NCT00996697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292689|NCT00996697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65292690|NCT00996697|Respiratory System Agents|respiratory system agents|mesh-ancestor
65292691|NCT00996697|Glucocorticoids|glucocorticoids|mesh-ancestor
65292692|NCT00996697|Hormones|hormones|mesh-ancestor
65292693|NCT00996697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65292694|NCT00996697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65292695|NCT00996697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65292696|NCT00996697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65292697|NCT00996697|Adrenergic Agents|adrenergic agents|mesh-ancestor
64522937|NCT00255177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65110514|NCT02529852|Growth Inhibitors|growth inhibitors|mesh-ancestor
65110515|NCT02529852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65110525|NCT02221232|Ethanol|ethanol|mesh-list
65110532|NCT02221232|Disinfectants|disinfectants|mesh-ancestor
65110533|NCT02221232|Dermatologic Agents|dermatologic agents|mesh-ancestor
65110534|NCT02206100|Enoxaparin|enoxaparin|mesh-list
65110535|NCT02206100|Anticoagulants|anticoagulants|mesh-ancestor
65110536|NCT02206100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65110537|NCT02206100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65110538|NCT02206100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110539|NCT01231516|Raltegravir Potassium|raltegravir potassium|mesh-list
65110540|NCT01231516|Dolutegravir|dolutegravir|mesh-list
65110541|NCT01231516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65110542|NCT01231516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65110543|NCT01231516|Antiviral Agents|antiviral agents|mesh-ancestor
65110544|NCT01231516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65110545|NCT01231516|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65110546|NCT01231516|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65110547|NCT01231516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110548|NCT01231516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110549|NCT01962636|Cyclosporine|cyclosporine|mesh-list
65110550|NCT01962636|Cyclophosphamide|cyclophosphamide|mesh-list
65110551|NCT01962636|Fludarabine|fludarabine|mesh-list
65110552|NCT01962636|Cyclosporins|cyclosporins|mesh-list
65110554|NCT01962636|Immunologic Factors|immunologic factors|mesh-ancestor
65110555|NCT01962636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110556|NCT01962636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65110557|NCT01962636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65110558|NCT01962636|Alkylating Agents|alkylating agents|mesh-ancestor
65110559|NCT01962636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110560|NCT01962636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110561|NCT01962636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65110562|NCT01962636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110563|NCT01962636|Antifungal Agents|antifungal agents|mesh-ancestor
65110564|NCT01962636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65110565|NCT01962636|Dermatologic Agents|dermatologic agents|mesh-ancestor
65110566|NCT01962636|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65110567|NCT01231321|Adalimumab|adalimumab|mesh-list
65110568|NCT01231321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65110569|NCT01231321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65110570|NCT01722240|Liraglutide|liraglutide|mesh-list
65110571|NCT01722240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65110572|NCT01722240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110573|NCT01722240|Incretins|incretins|mesh-ancestor
65110574|NCT01722240|Hormones|hormones|mesh-ancestor
65110575|NCT01722240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65110576|NCT01666080|Fludarabine|fludarabine|mesh-list
65110577|NCT01666080|Busulfan|busulfan|mesh-list
65110578|NCT01666080|Levetiracetam|levetiracetam|mesh-list
65110579|NCT01666080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292698|NCT00996697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65292699|NCT00996697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292700|NCT00996697|Parasympatholytics|parasympatholytics|mesh-ancestor
65292701|NCT00996697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65292702|NCT00996697|Cholinergic Agents|cholinergic agents|mesh-ancestor
65292703|NCT04526795|Cytarabine|cytarabine|mesh-list
65292704|NCT04526795|Fludarabine|fludarabine|mesh-list
65292705|NCT04526795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292706|NCT04526795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65292707|NCT04526795|Antimetabolites|antimetabolites|mesh-ancestor
65292708|NCT04526795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292709|NCT04526795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65292710|NCT04526795|Immunologic Factors|immunologic factors|mesh-ancestor
65292711|NCT04526795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292712|NCT04526795|Antiviral Agents|antiviral agents|mesh-ancestor
65292713|NCT04526795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292714|NCT00999973|Mitomycins|mitomycins|mesh-list
65292715|NCT00999973|Mitomycin|mitomycin|mesh-list
65292716|NCT00999973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65292717|NCT00999973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292718|NCT00999973|Alkylating Agents|alkylating agents|mesh-ancestor
65292719|NCT00999973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292720|NCT00999973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65292721|NCT00999973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110580|NCT01666080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110581|NCT01666080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65110582|NCT01666080|Immunologic Factors|immunologic factors|mesh-ancestor
65110583|NCT01666080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110584|NCT01666080|Alkylating Agents|alkylating agents|mesh-ancestor
65110585|NCT01666080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65110586|NCT01666080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65110587|NCT01666080|Anticonvulsants|anticonvulsants|mesh-ancestor
65110588|NCT01666080|Nootropic Agents|nootropic agents|mesh-ancestor
65110589|NCT01210222|Trebananib|trebananib|mesh-list
65110590|NCT01210222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65110591|NCT01210222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65110592|NCT01210222|Growth Substances|growth substances|mesh-ancestor
65110593|NCT01210222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110594|NCT01210222|Growth Inhibitors|growth inhibitors|mesh-ancestor
65110595|NCT01210222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110602|NCT01209949|Adapalene|adapalene|mesh-list
65110603|NCT01209949|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65110604|NCT01209949|Dermatologic Agents|dermatologic agents|mesh-ancestor
65110605|NCT01209949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64643411|NCT01398943|Antioxidants|antioxidants|mesh-list
65110606|NCT01209949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65110607|NCT01209949|Analgesics|analgesics|mesh-ancestor
65110608|NCT01209949|Sensory System Agents|sensory system agents|mesh-ancestor
65110609|NCT01209949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65110610|NCT01209949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292722|NCT02715947|Methotrexate|methotrexate|mesh-list
65292723|NCT02715947|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65292724|NCT02715947|Abortifacient Agents|abortifacient agents|mesh-ancestor
65292725|NCT02715947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65292726|NCT02715947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292727|NCT02715947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65292728|NCT02715947|Antimetabolites|antimetabolites|mesh-ancestor
65292729|NCT02715947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292730|NCT02715947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292731|NCT02715947|Dermatologic Agents|dermatologic agents|mesh-ancestor
65292732|NCT02715947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292733|NCT02715947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65292734|NCT02715947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65292735|NCT02715947|Immunologic Factors|immunologic factors|mesh-ancestor
65292736|NCT02715947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65292737|NCT02715947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65292738|NCT00856323|Tenofovir|tenofovir|mesh-list
65292739|NCT00856323|Emtricitabine|emtricitabine|mesh-list
65292740|NCT00856323|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65292741|NCT00856323|Antiviral Agents|antiviral agents|mesh-ancestor
65292742|NCT00856323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65110611|NCT01209949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65110612|NCT01209949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65110613|NCT04831593|Anesthetics|anesthetics|mesh-list
65110614|NCT04831593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65110615|NCT04831593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110616|NCT04667897|Ranibizumab|ranibizumab|mesh-list
65110617|NCT04667897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65110618|NCT04667897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65110619|NCT04667897|Growth Substances|growth substances|mesh-ancestor
65110620|NCT04667897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110621|NCT04667897|Growth Inhibitors|growth inhibitors|mesh-ancestor
65110622|NCT04667897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110623|NCT01209832|Midazolam|midazolam|mesh-list
65110624|NCT01209832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65110625|NCT01209832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65110626|NCT01209832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64752891|NCT05241054|Fentanyl|fentanyl|mesh-list
65110627|NCT01209832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110628|NCT01209832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65110629|NCT01209832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65110630|NCT01209832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65110631|NCT01209832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65110632|NCT01209832|Anesthetics, General|anesthetics, general|mesh-ancestor
65110634|NCT01209832|GABA Modulators|gaba modulators|mesh-ancestor
65110635|NCT01209832|GABA Agents|gaba agents|mesh-ancestor
65110636|NCT01209832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65110637|NCT01209832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110638|NCT04667819|Hyaluronic Acid|hyaluronic acid|mesh-list
65110639|NCT04667819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65110640|NCT04667819|Immunologic Factors|immunologic factors|mesh-ancestor
65110641|NCT04667819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110642|NCT04667819|Viscosupplements|viscosupplements|mesh-ancestor
65292743|NCT00856323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65292744|NCT00856323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65292745|NCT00856323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292746|NCT00856323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292747|NCT00856323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65292748|NCT00856323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65110643|NCT04667819|Protective Agents|protective agents|mesh-ancestor
65110644|NCT04683159|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65110645|NCT04683159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65110646|NCT04683159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65110647|NCT04683159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65110648|NCT04683159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65110649|NCT04683159|Adrenergic Agents|adrenergic agents|mesh-ancestor
65110650|NCT04683159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65110651|NCT04683159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110652|NCT04683159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110653|NCT01230892|Atenolol|atenolol|mesh-list
65110654|NCT01230892|Nebivolol|nebivolol|mesh-list
65110655|NCT01230892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65110656|NCT01230892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65110657|NCT01230892|Sympatholytics|sympatholytics|mesh-ancestor
65110658|NCT01230892|Autonomic Agents|autonomic agents|mesh-ancestor
65110659|NCT01230892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65110660|NCT01230892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683030|NCT00000483|Vitamin B Complex|vitamin b complex|mesh-ancestor
65110670|NCT01230892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65110671|NCT04667624|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
65110672|NCT04667624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65110673|NCT04667624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65110674|NCT04667624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65110675|NCT04667624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110676|NCT04667351|Fluorouracil|fluorouracil|mesh-list
65110677|NCT04667351|Antimetabolites|antimetabolites|mesh-ancestor
65110678|NCT04667351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110679|NCT04667351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65110680|NCT04667351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110681|NCT04667351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65110682|NCT04667351|Immunologic Factors|immunologic factors|mesh-ancestor
65110683|NCT04667351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110684|NCT01230814|Metronidazole|metronidazole|mesh-list
65110685|NCT01230814|Miconazole|miconazole|mesh-list
65110686|NCT01230814|Clotrimazole|clotrimazole|mesh-list
65110687|NCT01230814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65110688|NCT01230814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65110689|NCT01230814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65110690|NCT01230814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65110691|NCT01230814|Antifungal Agents|antifungal agents|mesh-ancestor
65110692|NCT01230814|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65110693|NCT01230814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65110694|NCT01230814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110695|NCT01230814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110696|NCT01230814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65110697|NCT01230814|Hormone Antagonists|hormone antagonists|mesh-ancestor
65110698|NCT01230814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64752967|NCT01922466|Loxoprofen|loxoprofen|mesh-list
65110699|NCT01230814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110700|NCT01230814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65110701|NCT01230814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65110702|NCT01230814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65110703|NCT01230307|Vitamin D|vitamin d|mesh-list
65110704|NCT01230307|Cholecalciferol|cholecalciferol|mesh-list
65110705|NCT01230307|Vitamins|vitamins|mesh-ancestor
65110706|NCT01230307|Micronutrients|micronutrients|mesh-ancestor
65110707|NCT01230307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110708|NCT01230307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65110709|NCT01230307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65292749|NCT00856245|Rituximab|rituximab|mesh-list
65292750|NCT00856245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65292751|NCT00856245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292752|NCT00856245|Immunologic Factors|immunologic factors|mesh-ancestor
65292753|NCT00856245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292754|NCT00856245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65292755|NCT00855933|Cetylpyridinium|cetylpyridinium|mesh-list
65292756|NCT00855933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65042674|NCT00226746|Paclitaxel|paclitaxel|mesh-list
65292757|NCT00855933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292758|NCT00994903|Simvastatin|simvastatin|mesh-list
65110710|NCT01209598|Palbociclib|palbociclib|mesh-list
65110711|NCT01209598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110712|NCT01209598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65110713|NCT01209598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110714|NCT01209598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110715|NCT00556634|Efavirenz|efavirenz|mesh-list
65110716|NCT00556634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65110717|NCT00556634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65110718|NCT00556634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110719|NCT00556634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110720|NCT00556634|Antiviral Agents|antiviral agents|mesh-ancestor
65110721|NCT00556634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65110740|NCT01209520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110741|NCT01209520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110742|NCT01209520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65110743|NCT01209520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65110744|NCT01209520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65110745|NCT01209520|Antimetabolites|antimetabolites|mesh-ancestor
65110746|NCT04805541|Tropicamide|tropicamide|mesh-list
65110747|NCT04805541|Mydriatics|mydriatics|mesh-list
65110748|NCT04805541|Autonomic Agents|autonomic agents|mesh-ancestor
65110749|NCT04805541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65110750|NCT04805541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110751|NCT04805541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65110752|NCT04805541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65110753|NCT04805541|Cholinergic Agents|cholinergic agents|mesh-ancestor
65110754|NCT04805541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65110755|NCT04805541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110756|NCT04784754|Melatonin|melatonin|mesh-list
65110757|NCT04784754|Antioxidants|antioxidants|mesh-ancestor
65110758|NCT04784754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110759|NCT04784754|Protective Agents|protective agents|mesh-ancestor
65110760|NCT04784754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110761|NCT04784754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65110762|NCT04666805|Tamoxifen|tamoxifen|mesh-list
65110763|NCT04666805|Toremifene|toremifene|mesh-list
65110764|NCT04666805|Letrozole|letrozole|mesh-list
65110765|NCT04666805|Anastrozole|anastrozole|mesh-list
65110766|NCT04666805|Exemestane|exemestane|mesh-list
65110767|NCT04666805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110768|NCT04666805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65110769|NCT04666805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65110770|NCT04666805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110771|NCT04666805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110772|NCT04666805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65110773|NCT04666805|Hormone Antagonists|hormone antagonists|mesh-ancestor
64753048|NCT01929252|Anesthetics|anesthetics|mesh-ancestor
65110774|NCT04666805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65110775|NCT04666805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110776|NCT04666805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65110777|NCT04666805|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64683162|NCT00000597|Anabolic Agents|anabolic agents|mesh-ancestor
65110809|NCT04721457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292759|NCT00994903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65292760|NCT00994903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65292761|NCT00994903|Antimetabolites|antimetabolites|mesh-ancestor
65292762|NCT00994903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292763|NCT00994903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65292764|NCT00994903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65292765|NCT00994903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110810|NCT04721457|Cariostatic Agents|cariostatic agents|mesh-ancestor
65110811|NCT04721457|Protective Agents|protective agents|mesh-ancestor
65110812|NCT04721457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110813|NCT04721457|Disinfectants|disinfectants|mesh-ancestor
65110814|NCT04665986|Docetaxel|docetaxel|mesh-list
65110815|NCT04665986|Vinorelbine|vinorelbine|mesh-list
65110816|NCT04665986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110817|NCT04665986|Tubulin Modulators|tubulin modulators|mesh-ancestor
65110818|NCT04665986|Antimitotic Agents|antimitotic agents|mesh-ancestor
65110819|NCT04665986|Mitosis Modulators|mitosis modulators|mesh-ancestor
65110820|NCT04665986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110821|NCT04665986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65110822|NCT04638309|Azacitidine|azacitidine|mesh-list
65110823|NCT04638309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65110824|NCT04638309|Antimetabolites|antimetabolites|mesh-ancestor
65110825|NCT04638309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110827|NCT04638309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110834|NCT04665830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110835|NCT04665830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65110836|NCT04683237|Liraglutide|liraglutide|mesh-list
65110837|NCT04683237|Megestrol|megestrol|mesh-list
65110838|NCT04683237|Megestrol Acetate|megestrol acetate|mesh-list
65110839|NCT04683237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65110840|NCT04683237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110841|NCT04683237|Incretins|incretins|mesh-ancestor
65110842|NCT04683237|Hormones|hormones|mesh-ancestor
65110843|NCT04683237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65110844|NCT04683237|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65110845|NCT04683237|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65110846|NCT04683237|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65110847|NCT04683237|Contraceptive Agents|contraceptive agents|mesh-ancestor
65110848|NCT04683237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65110849|NCT04683237|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65110850|NCT04683237|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65110851|NCT04683237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65110852|NCT04683237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110853|NCT04683237|Appetite Stimulants|appetite stimulants|mesh-ancestor
65110854|NCT04683237|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65110855|NCT04665362|Apatinib|apatinib|mesh-list
65110856|NCT04665362|Antibodies|antibodies|mesh-list
65110857|NCT04665362|Immunologic Factors|immunologic factors|mesh-ancestor
65110858|NCT04665362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110859|NCT04665362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110860|NCT04665362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65110861|NCT04665362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110862|NCT04665362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110863|NCT04665050|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65110864|NCT04665050|Immunologic Factors|immunologic factors|mesh-ancestor
65110865|NCT04665050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110866|NCT04665284|Empagliflozin|empagliflozin|mesh-list
65110867|NCT04665284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65110868|NCT04665284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110869|NCT04665284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65110870|NCT04665284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110871|NCT04432974|Anesthetics|anesthetics|mesh-list
65110872|NCT04432974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65110873|NCT04432974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110874|NCT04664894|Ribavirin|ribavirin|mesh-list
65110875|NCT04664894|Sofosbuvir|sofosbuvir|mesh-list
65292766|NCT00699777|Risedronic Acid|risedronic acid|mesh-list
65292767|NCT00699777|Etidronic Acid|etidronic acid|mesh-list
65292768|NCT00699777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65292769|NCT00699777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65292770|NCT00699777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292771|NCT00699777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65292772|NCT00699777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292773|NCT00699777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65292774|NCT00997009|Paclitaxel|paclitaxel|mesh-list
65292775|NCT00997009|Carboplatin|carboplatin|mesh-list
65292776|NCT00997009|Cetuximab|cetuximab|mesh-list
65292777|NCT00997009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65292778|NCT00997009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292779|NCT00997009|Tubulin Modulators|tubulin modulators|mesh-ancestor
65292780|NCT00997009|Antimitotic Agents|antimitotic agents|mesh-ancestor
65292781|NCT00997009|Mitosis Modulators|mitosis modulators|mesh-ancestor
65344926|NCT00864058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110876|NCT04664894|Velpatasvir|velpatasvir|mesh-list
65110877|NCT04664894|Antimetabolites|antimetabolites|mesh-ancestor
65110878|NCT04664894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110879|NCT04664894|Antiviral Agents|antiviral agents|mesh-ancestor
65110880|NCT04664894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65110881|NCT00557102|Leucovorin|leucovorin|mesh-list
65110882|NCT00557102|Fluorouracil|fluorouracil|mesh-list
65110883|NCT00557102|Irinotecan|irinotecan|mesh-list
65110884|NCT00557102|Cetuximab|cetuximab|mesh-list
65110885|NCT00557102|Calcium|calcium|mesh-list
65110886|NCT00557102|Levoleucovorin|levoleucovorin|mesh-list
65110887|NCT00557102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65110888|NCT00557102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110889|NCT00557102|Antimetabolites|antimetabolites|mesh-ancestor
65110890|NCT00557102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110891|NCT00557102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65110892|NCT00557102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110893|NCT00557102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64683265|NCT00000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110905|NCT04682691|Erythromycin Estolate|erythromycin estolate|mesh-list
65110906|NCT04682691|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65110907|NCT04682691|Erythromycin stearate|erythromycin stearate|mesh-list
65110908|NCT04682691|Metoclopramide|metoclopramide|mesh-list
65110909|NCT04682691|Antiemetics|antiemetics|mesh-ancestor
65110910|NCT04682691|Autonomic Agents|autonomic agents|mesh-ancestor
65110911|NCT04682691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65110912|NCT04682691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110913|NCT04682691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65110914|NCT04682691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65110915|NCT04682691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65110916|NCT04682691|Dopamine Agents|dopamine agents|mesh-ancestor
65110917|NCT04682691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65110918|NCT04682691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110919|NCT04682691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65110920|NCT04682691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65110921|NCT04682691|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65110922|NCT04682691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110923|NCT01209286|Blinatumomab|blinatumomab|mesh-list
65110924|NCT01209286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110925|NCT04663763|Capecitabine|capecitabine|mesh-list
65110926|NCT04663763|Oxaliplatin|oxaliplatin|mesh-list
65292782|NCT00997009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292783|NCT00997009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65292784|NCT02712125|Isosorbide|isosorbide|mesh-list
65292785|NCT02712125|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65292786|NCT02712125|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65292787|NCT02712125|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65292788|NCT02712125|Diuretics|diuretics|mesh-ancestor
65292789|NCT02712125|Natriuretic Agents|natriuretic agents|mesh-ancestor
65292790|NCT02712125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292791|NCT02712125|Vasodilator Agents|vasodilator agents|mesh-ancestor
65292792|NCT02712125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65292793|NCT02712125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292794|NCT00994981|Magnesium Sulfate|magnesium sulfate|mesh-list
65292795|NCT00994981|Analgesics|analgesics|mesh-ancestor
65292796|NCT00994981|Sensory System Agents|sensory system agents|mesh-ancestor
65292797|NCT00994981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65292798|NCT00994981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110928|NCT04663763|Immunologic Factors|immunologic factors|mesh-ancestor
65110929|NCT04663763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110930|NCT04663763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65110931|NCT04663763|Antimetabolites|antimetabolites|mesh-ancestor
65110932|NCT04663763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110933|NCT04663763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110934|NCT04351737|Dexamethasone|dexamethasone|mesh-list
65110935|NCT04351737|Prednisolone|prednisolone|mesh-list
65110936|NCT04351737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65110937|NCT04351737|Methylprednisolone|methylprednisolone|mesh-list
65110938|NCT04351737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65110939|NCT04351737|Prednisolone acetate|prednisolone acetate|mesh-list
65110940|NCT04351737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65110941|NCT04351737|Prednisolone phosphate|prednisolone phosphate|mesh-list
65110942|NCT04351737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65110943|NCT04351737|Antiemetics|antiemetics|mesh-ancestor
65110944|NCT04351737|Autonomic Agents|autonomic agents|mesh-ancestor
65110945|NCT04351737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65110946|NCT04351737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110947|NCT04351737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65110948|NCT04351737|Glucocorticoids|glucocorticoids|mesh-ancestor
65110949|NCT04351737|Hormones|hormones|mesh-ancestor
65110950|NCT04351737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65110951|NCT04351737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65110952|NCT04351737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110953|NCT04351737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65110954|NCT04351737|Protective Agents|protective agents|mesh-ancestor
65110955|NCT04347915|Clevudine|clevudine|mesh-list
65110956|NCT04347915|Antiviral Agents|antiviral agents|mesh-ancestor
65110957|NCT04347915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65110958|NCT04185051|Aticaprant|aticaprant|mesh-list
65110959|NCT04185051|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65110964|NCT04171050|Anesthetics, Local|anesthetics, local|mesh-list
65110965|NCT04171050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65110966|NCT04171050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110967|NCT04171050|Sensory System Agents|sensory system agents|mesh-ancestor
65110968|NCT04171050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65110970|NCT04662788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65110971|NCT04662788|Immunologic Factors|immunologic factors|mesh-ancestor
65110972|NCT04662788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110973|NCT04662866|Metformin|metformin|mesh-list
65292799|NCT00994981|Anesthetics|anesthetics|mesh-ancestor
65292800|NCT00994981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65292801|NCT00994981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65292802|NCT00994981|Anticonvulsants|anticonvulsants|mesh-ancestor
65292803|NCT00994981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65292804|NCT00994981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65292805|NCT00994981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292806|NCT00994981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65292807|NCT00994981|Tocolytic Agents|tocolytic agents|mesh-ancestor
64523054|NCT04614610|Sensory System Agents|sensory system agents|mesh-ancestor
65110974|NCT04662866|Pioglitazone|pioglitazone|mesh-list
65110975|NCT04662866|Empagliflozin|empagliflozin|mesh-list
65110976|NCT04662866|Linagliptin|linagliptin|mesh-list
65110977|NCT04662866|Biguanides|biguanides|mesh-list
65110978|NCT04662866|Protease Inhibitors|protease inhibitors|mesh-list
65110979|NCT04662866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65110980|NCT04662866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110981|NCT04662866|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65110982|NCT04662866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110983|NCT04662866|Incretins|incretins|mesh-ancestor
65110985|NCT04662866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65110986|NCT04662866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65110987|NCT04662866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110988|NCT04662476|Vitamin D|vitamin d|mesh-list
65110989|NCT04662476|Cholecalciferol|cholecalciferol|mesh-list
65110990|NCT04662476|Vitamins|vitamins|mesh-ancestor
65110991|NCT04662476|Micronutrients|micronutrients|mesh-ancestor
65110992|NCT04662476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110993|NCT04662476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65110994|NCT04662476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65110995|NCT03986424|Memantine|memantine|mesh-list
65110996|NCT03986424|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65110997|NCT03986424|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65110998|NCT03986424|Dopamine Agents|dopamine agents|mesh-ancestor
65110999|NCT03986424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65111000|NCT03986424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111001|NCT03986424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111002|NCT03986424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65111003|NCT03986424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65111004|NCT03918252|Nivolumab|nivolumab|mesh-list
65111005|NCT03918252|Ipilimumab|ipilimumab|mesh-list
65111006|NCT03918252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65111007|NCT03918252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111008|NCT03918252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65111009|NCT03918252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111010|NCT04662125|Acetaminophen|acetaminophen|mesh-list
65111011|NCT04662125|Prednisolone|prednisolone|mesh-list
65111012|NCT04662125|Pregabalin|pregabalin|mesh-list
65111013|NCT04662125|Caffeine|caffeine|mesh-list
65111014|NCT04662125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65111015|NCT04662125|Glucocorticoids|glucocorticoids|mesh-ancestor
65111016|NCT04662125|Hormones|hormones|mesh-ancestor
65111017|NCT04662125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65111018|NCT04662125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111019|NCT04662125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65111020|NCT04662125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111021|NCT04662125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65111022|NCT04662125|Analgesics|analgesics|mesh-ancestor
65111037|NCT04662125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111038|NCT04662125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65111039|NCT04662125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65111040|NCT04662125|Purinergic Agents|purinergic agents|mesh-ancestor
65111041|NCT04662125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65111042|NCT00557180|Beclomethasone|beclomethasone|mesh-list
65292808|NCT00994981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65292809|NCT02715479|Dolutegravir|dolutegravir|mesh-list
65292810|NCT02715479|BMS-955176|bms-955176|mesh-list
65292811|NCT02715479|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65292812|NCT02715479|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65292813|NCT02715479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292814|NCT02715479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292815|NCT02715479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65292816|NCT02715479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65292817|NCT02715479|Antiviral Agents|antiviral agents|mesh-ancestor
65292818|NCT02715479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292819|NCT01000441|Adalimumab|adalimumab|mesh-list
65292820|NCT01000441|Etanercept|etanercept|mesh-list
65292821|NCT01000441|Rituximab|rituximab|mesh-list
65292822|NCT01000441|Abatacept|abatacept|mesh-list
65292823|NCT01000441|Infliximab|infliximab|mesh-list
65292824|NCT01000441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65111044|NCT00557180|Tiotropium Bromide|tiotropium bromide|mesh-list
65111045|NCT00557180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65111046|NCT00557180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65111047|NCT00557180|Autonomic Agents|autonomic agents|mesh-ancestor
65111048|NCT00557180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65111049|NCT00557180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111050|NCT00557180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65111051|NCT00557180|Respiratory System Agents|respiratory system agents|mesh-ancestor
65111053|NCT00557180|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65111054|NCT00557180|Cholinergic Agents|cholinergic agents|mesh-ancestor
65111055|NCT00557180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65111056|NCT00557180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111057|NCT00557180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65111058|NCT00557180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65111059|NCT00557180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65111060|NCT00557180|Adrenergic Agents|adrenergic agents|mesh-ancestor
65111061|NCT00557180|Anticonvulsants|anticonvulsants|mesh-ancestor
65111062|NCT00557180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65111063|NCT00557180|Glucocorticoids|glucocorticoids|mesh-ancestor
65111064|NCT00557180|Hormones|hormones|mesh-ancestor
65111065|NCT00557180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65111066|NCT00557219|Fenoldopam|fenoldopam|mesh-list
65111067|NCT00557219|Ketanserin|ketanserin|mesh-list
65111068|NCT00557219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65111069|NCT00557219|Vasodilator Agents|vasodilator agents|mesh-ancestor
65111070|NCT00557219|Dopamine Agonists|dopamine agonists|mesh-ancestor
65111071|NCT00557219|Dopamine Agents|dopamine agents|mesh-ancestor
65111072|NCT00557219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65111073|NCT00557219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111074|NCT00557219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111075|NCT00557219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65111076|NCT00557219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65111077|NCT00557219|Serotonin Agents|serotonin agents|mesh-ancestor
65111078|NCT03818685|Capecitabine|capecitabine|mesh-list
65111080|NCT03818685|Ipilimumab|ipilimumab|mesh-list
65111081|NCT03818685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65111082|NCT03818685|Antimetabolites|antimetabolites|mesh-ancestor
65111083|NCT03818685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111098|NCT03798405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65111099|NCT04661696|Paclitaxel|paclitaxel|mesh-list
65111100|NCT04661696|Carboplatin|carboplatin|mesh-list
65111101|NCT04661696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65111102|NCT04661696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111103|NCT04661696|Tubulin Modulators|tubulin modulators|mesh-ancestor
65292825|NCT01000441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292826|NCT01000441|Immunologic Factors|immunologic factors|mesh-ancestor
65292827|NCT01000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292828|NCT01000441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65292829|NCT01000441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65292830|NCT01000441|Dermatologic Agents|dermatologic agents|mesh-ancestor
65292831|NCT01000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65042738|NCT00203723|Serotonin Agents|serotonin agents|mesh-ancestor
65292832|NCT01000441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65292833|NCT01000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65292834|NCT01000441|Analgesics|analgesics|mesh-ancestor
65292835|NCT01000441|Sensory System Agents|sensory system agents|mesh-ancestor
65292836|NCT01000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65292837|NCT01000441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65292838|NCT01000441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65292839|NCT01000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292840|NCT00997087|Flumazenil|flumazenil|mesh-list
65292841|NCT00997087|Antidotes|antidotes|mesh-ancestor
65292842|NCT00997087|Protective Agents|protective agents|mesh-ancestor
65292843|NCT00997087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292844|NCT00997087|GABA Modulators|gaba modulators|mesh-ancestor
65292845|NCT00997087|GABA Agents|gaba agents|mesh-ancestor
65292846|NCT00997087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65292847|NCT00997087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292848|NCT01000597|Fluticasone|fluticasone|mesh-list
65292849|NCT01000597|Xhance|xhance|mesh-list
65111104|NCT04661696|Antimitotic Agents|antimitotic agents|mesh-ancestor
65111105|NCT04661696|Mitosis Modulators|mitosis modulators|mesh-ancestor
65111106|NCT04661696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111107|NCT03776136|Pembrolizumab|pembrolizumab|mesh-list
65111108|NCT03776136|Lenvatinib|lenvatinib|mesh-list
65111109|NCT03776136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65111110|NCT03776136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111111|NCT03776136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65111112|NCT03776136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111113|NCT03776136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111114|NCT04661345|Coagulase|coagulase|mesh-list
65111115|NCT04661345|Coagulants|coagulants|mesh-ancestor
65111116|NCT00540072|Daptomycin|daptomycin|mesh-list
65111117|NCT00540072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65111118|NCT00540072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65111119|NCT03689946|Listerine|listerine|mesh-list
65111120|NCT03689946|Evolocumab|evolocumab|mesh-list
65111121|NCT03689946|Fluorides|fluorides|mesh-list
65111122|NCT03689946|Sodium Fluoride|sodium fluoride|mesh-list
65111123|NCT03689946|Cariostatic Agents|cariostatic agents|mesh-ancestor
65111124|NCT03689946|Protective Agents|protective agents|mesh-ancestor
65111125|NCT03689946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111126|NCT03689946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65111127|NCT03689946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292850|NCT01000597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65292851|NCT01000597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65292852|NCT01000597|Autonomic Agents|autonomic agents|mesh-ancestor
65292853|NCT01000597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65292854|NCT01000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292855|NCT01000597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65292856|NCT01000597|Respiratory System Agents|respiratory system agents|mesh-ancestor
65292857|NCT01000597|Dermatologic Agents|dermatologic agents|mesh-ancestor
65292858|NCT01000597|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65292859|NCT02751593|Dexamethasone|dexamethasone|mesh-list
65292860|NCT02751593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65292861|NCT02751593|Antiemetics|antiemetics|mesh-ancestor
65292862|NCT02751593|Autonomic Agents|autonomic agents|mesh-ancestor
65292863|NCT02751593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65292864|NCT02751593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292865|NCT02751593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65292866|NCT02751593|Glucocorticoids|glucocorticoids|mesh-ancestor
65292867|NCT02751593|Hormones|hormones|mesh-ancestor
65292868|NCT02751593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65344927|NCT00864058|Anticonvulsants|anticonvulsants|mesh-ancestor
64523117|NCT04594798|Hormones|hormones|mesh-ancestor
65111128|NCT03689946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65111129|NCT03689946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65111130|NCT03689946|Antimetabolites|antimetabolites|mesh-ancestor
65111131|NCT03689946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111132|NCT03689946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65111133|NCT04660916|Isotretinoin|isotretinoin|mesh-list
65111134|NCT04660916|Dermatologic Agents|dermatologic agents|mesh-ancestor
65111135|NCT01208233|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
65111136|NCT01208233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65111137|NCT01208233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65111138|NCT01208233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111139|NCT01208233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111140|NCT04660565|Prednisone|prednisone|mesh-list
65111141|NCT04660565|Belimumab|belimumab|mesh-list
65111142|NCT04660565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65111143|NCT04660565|Glucocorticoids|glucocorticoids|mesh-ancestor
65111144|NCT04660565|Hormones|hormones|mesh-ancestor
65111155|NCT05420935|Immunoglobulin E|immunoglobulin e|mesh-list
65111156|NCT05420935|Immunologic Factors|immunologic factors|mesh-ancestor
65111157|NCT05420935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111158|NCT01208038|Methyltestosterone|methyltestosterone|mesh-list
65111159|NCT01208038|Testosterone|testosterone|mesh-list
65111160|NCT01208038|Testosterone undecanoate|testosterone undecanoate|mesh-list
65111161|NCT01208038|Testosterone enanthate|testosterone enanthate|mesh-list
65111162|NCT01208038|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65111163|NCT01208038|Androgens|androgens|mesh-ancestor
65111164|NCT01208038|Hormones|hormones|mesh-ancestor
65111165|NCT01208038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65111166|NCT01208038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111167|NCT01208038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65111168|NCT01208038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111169|NCT01208038|Anabolic Agents|anabolic agents|mesh-ancestor
65111170|NCT04659785|Apatinib|apatinib|mesh-list
65292869|NCT02751593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65292870|NCT02751593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292871|NCT00997399|Panobinostat|panobinostat|mesh-list
65292872|NCT00997399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292873|NCT00997399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65292874|NCT00997399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292875|NCT00997399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292876|NCT00997477|Budesonide|budesonide|mesh-list
65292877|NCT00997477|Formoterol Fumarate|formoterol fumarate|mesh-list
65292878|NCT00997477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65292879|NCT00997477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65292880|NCT00997477|Autonomic Agents|autonomic agents|mesh-ancestor
65292881|NCT00997477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65292882|NCT00997477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292883|NCT00997477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65292884|NCT00997477|Respiratory System Agents|respiratory system agents|mesh-ancestor
65292885|NCT00997477|Glucocorticoids|glucocorticoids|mesh-ancestor
65292886|NCT00997477|Hormones|hormones|mesh-ancestor
65292887|NCT00997477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65292888|NCT00997477|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64523126|NCT02432664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64523130|NCT02432664|Anesthetics|anesthetics|mesh-ancestor
65111171|NCT04659785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111172|NCT04659785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65111173|NCT04659785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111174|NCT04659785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111175|NCT01207687|Bevacizumab|bevacizumab|mesh-list
65111176|NCT01207687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65111177|NCT01207687|Antibodies|antibodies|mesh-list
65111178|NCT01207687|Immunoglobulins|immunoglobulins|mesh-list
65111179|NCT01207687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65111180|NCT01207687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111181|NCT01207687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65111182|NCT01207687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65111183|NCT01207687|Growth Substances|growth substances|mesh-ancestor
65111184|NCT01207687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111185|NCT01207687|Growth Inhibitors|growth inhibitors|mesh-ancestor
65111186|NCT01207687|Immunologic Factors|immunologic factors|mesh-ancestor
65111187|NCT01207453|Milnacipran|milnacipran|mesh-list
65111188|NCT01207453|Levomilnacipran|levomilnacipran|mesh-list
65111189|NCT01207453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65111190|NCT01207453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65111191|NCT01207453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65111192|NCT01207453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111193|NCT01207453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65111194|NCT01207453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111195|NCT01207453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65111196|NCT01207453|Analgesics|analgesics|mesh-ancestor
65111197|NCT01207453|Sensory System Agents|sensory system agents|mesh-ancestor
65111198|NCT01207453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65292889|NCT00997477|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65292890|NCT00997477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65292891|NCT00997477|Adrenergic Agents|adrenergic agents|mesh-ancestor
65292892|NCT00997477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65292893|NCT00997477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292894|NCT01000831|Vaccines|vaccines|mesh-list
65111199|NCT01207453|Antidepressive Agents|antidepressive agents|mesh-ancestor
65111200|NCT01207453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65111201|NCT00540345|Interferons|interferons|mesh-list
65111202|NCT00540345|Ribavirin|ribavirin|mesh-list
65111203|NCT00540345|Interferon-alpha|interferon-alpha|mesh-list
65111204|NCT00540345|Interferon alpha-2|interferon alpha-2|mesh-list
65111205|NCT00540345|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65111206|NCT00540345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111207|NCT00540345|Antiviral Agents|antiviral agents|mesh-ancestor
65111208|NCT00540345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65111209|NCT00540345|Antimetabolites|antimetabolites|mesh-ancestor
65111218|NCT01207414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65111220|NCT00540384|Hematinics|hematinics|mesh-ancestor
65111221|NCT04659551|Cyclophosphamide|cyclophosphamide|mesh-list
65111222|NCT04659551|Nivolumab|nivolumab|mesh-list
65111223|NCT04659551|Epirubicin|epirubicin|mesh-list
65111224|NCT04659551|Exemestane|exemestane|mesh-list
65111225|NCT04659551|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65111226|NCT04659551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65111227|NCT04659551|Immunologic Factors|immunologic factors|mesh-ancestor
65111228|NCT04659551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753485|NCT00983814|Carbidopa|carbidopa|mesh-list
65111229|NCT04659551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65111230|NCT04659551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65111231|NCT04659551|Alkylating Agents|alkylating agents|mesh-ancestor
65111232|NCT04659551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111233|NCT04659551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111234|NCT04659551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65111235|NCT04659551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65111236|NCT04659551|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65111237|NCT04659551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65111238|NCT04659551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65111239|NCT04659551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65111240|NCT04659551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111241|NCT04659551|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65111242|NCT04659551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65111243|NCT04659551|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65111244|NCT04659551|Hormone Antagonists|hormone antagonists|mesh-ancestor
65111245|NCT04659551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65111246|NCT04659551|Luteolytic Agents|luteolytic agents|mesh-ancestor
65111247|NCT04659551|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65111248|NCT04659551|Contraceptive Agents|contraceptive agents|mesh-ancestor
65111249|NCT04659551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65111250|NCT04659551|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65111251|NCT04659551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65111252|NCT01207102|Paclitaxel|paclitaxel|mesh-list
65111253|NCT01207102|Carboplatin|carboplatin|mesh-list
65111254|NCT01207102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65111255|NCT01207102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65111256|NCT01207102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111257|NCT01207102|Tubulin Modulators|tubulin modulators|mesh-ancestor
65111258|NCT01207102|Antimitotic Agents|antimitotic agents|mesh-ancestor
65111259|NCT01207102|Mitosis Modulators|mitosis modulators|mesh-ancestor
65111260|NCT01207102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111261|NCT01206517|Asenapine|asenapine|mesh-list
65111262|NCT01206517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65111263|NCT01206517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65111264|NCT01206517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65111265|NCT01206517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111266|NCT01206517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65111267|NCT01206439|Nebivolol|nebivolol|mesh-list
65111268|NCT01206439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65111269|NCT01206439|Vasodilator Agents|vasodilator agents|mesh-ancestor
65111270|NCT01206439|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65111271|NCT01206439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65292895|NCT01000831|Immunologic Factors|immunologic factors|mesh-ancestor
65292896|NCT01000831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292897|NCT05170789|Dexamethasone|dexamethasone|mesh-list
65292898|NCT05170789|Elotuzumab|elotuzumab|mesh-list
65292899|NCT05170789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65292900|NCT05170789|Antiemetics|antiemetics|mesh-ancestor
65292901|NCT05170789|Autonomic Agents|autonomic agents|mesh-ancestor
65292902|NCT05170789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65292903|NCT05170789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292904|NCT05170789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65292905|NCT05170789|Glucocorticoids|glucocorticoids|mesh-ancestor
65042817|NCT00227136|Serotonin|serotonin|mesh-list
65292906|NCT05170789|Hormones|hormones|mesh-ancestor
65292907|NCT05170789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65292908|NCT05170789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65292909|NCT05170789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292910|NCT02693951|Cefotiam|cefotiam|mesh-list
65292911|NCT02693951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65292912|NCT02693951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292913|NCT00997711|Sirolimus|sirolimus|mesh-list
65292914|NCT00997711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65292915|NCT00997711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65292916|NCT00997711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65292917|NCT00997711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292918|NCT00997711|Antifungal Agents|antifungal agents|mesh-ancestor
65292919|NCT00997711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65292920|NCT00997711|Immunologic Factors|immunologic factors|mesh-ancestor
65292921|NCT00997711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292922|NCT01001143|Decitabine|decitabine|mesh-list
65292923|NCT01001143|Bexarotene|bexarotene|mesh-list
65292924|NCT01001143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65292925|NCT01001143|Antimetabolites|antimetabolites|mesh-ancestor
65292926|NCT01001143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292927|NCT01001143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292928|NCT01001143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292929|NCT02715167|Budesonide|budesonide|mesh-list
65292934|NCT02715167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292935|NCT02715167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65292936|NCT02715167|Respiratory System Agents|respiratory system agents|mesh-ancestor
65292937|NCT02715167|Glucocorticoids|glucocorticoids|mesh-ancestor
65292938|NCT02715167|Hormones|hormones|mesh-ancestor
65292939|NCT02715167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65292940|NCT03885661|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
65292941|NCT03885661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65292942|NCT03885661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65292943|NCT02620566|Bupivacaine|bupivacaine|mesh-list
65292944|NCT02620566|Anesthetics, Local|anesthetics, local|mesh-ancestor
65292945|NCT02620566|Anesthetics|anesthetics|mesh-ancestor
65292946|NCT02620566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65292947|NCT02620566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292948|NCT02620566|Sensory System Agents|sensory system agents|mesh-ancestor
65292949|NCT02620566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65292950|NCT00855465|Riociguat|riociguat|mesh-list
65292951|NCT00855465|Enzyme Activators|enzyme activators|mesh-ancestor
65292952|NCT00855465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292953|NCT02714699|Diclofenac|diclofenac|mesh-list
65292954|NCT02714699|Scopolamine|scopolamine|mesh-list
65292955|NCT02714699|Bromides|bromides|mesh-list
65292956|NCT02714699|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65292957|NCT02714699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65292958|NCT02714699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65292959|NCT02714699|Analgesics|analgesics|mesh-ancestor
65292960|NCT02714699|Sensory System Agents|sensory system agents|mesh-ancestor
65292961|NCT02714699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65292962|NCT02714699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292963|NCT02714699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65292964|NCT02714699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65292965|NCT02714699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65292966|NCT02714699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292967|NCT02714699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523209|NCT00118209|Prednisone|prednisone|mesh-list
65111272|NCT01206439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65111273|NCT01206439|Adrenergic Agents|adrenergic agents|mesh-ancestor
65111274|NCT01206439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65292968|NCT02714699|Anticonvulsants|anticonvulsants|mesh-ancestor
65292969|NCT02714699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65292970|NCT02714699|Antiemetics|antiemetics|mesh-ancestor
65292971|NCT02714699|Autonomic Agents|autonomic agents|mesh-ancestor
65292972|NCT02714699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65292973|NCT02714699|Mydriatics|mydriatics|mesh-ancestor
65292974|NCT02714699|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65292975|NCT02714699|Cholinergic Agents|cholinergic agents|mesh-ancestor
65292976|NCT02714699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65292977|NCT02714699|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65292978|NCT02714699|Parasympatholytics|parasympatholytics|mesh-ancestor
65292979|NCT01004419|Fulvestrant|fulvestrant|mesh-list
65292980|NCT01004419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65292981|NCT01004419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65292982|NCT01004419|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65292983|NCT01004419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65292984|NCT01004419|Hormone Antagonists|hormone antagonists|mesh-ancestor
65292985|NCT01004419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65292986|NCT01004419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292987|NCT02714855|Apixaban|apixaban|mesh-list
65292988|NCT02714855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64523229|NCT00118209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65111284|NCT00540501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111285|NCT00540501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111286|NCT00557453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65111287|NCT00557453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65111288|NCT00557453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65111289|NCT00557453|Antitubercular Agents|antitubercular agents|mesh-ancestor
65111290|NCT04658732|Dexmedetomidine|dexmedetomidine|mesh-list
65111291|NCT04658732|Gabapentin|gabapentin|mesh-list
65111292|NCT04658732|Alprazolam|alprazolam|mesh-list
65111293|NCT04658732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65111294|NCT04658732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65111295|NCT04658732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111296|NCT04658732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65111297|NCT04658732|Analgesics|analgesics|mesh-ancestor
65111298|NCT04658732|Sensory System Agents|sensory system agents|mesh-ancestor
65111299|NCT04658732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65111300|NCT04658732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65111301|NCT04658732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65111302|NCT04658732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65111303|NCT04658732|Adrenergic Agents|adrenergic agents|mesh-ancestor
65111304|NCT04658732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65111305|NCT04658732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111306|NCT04658732|Anticonvulsants|anticonvulsants|mesh-ancestor
65111307|NCT04658732|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65111308|NCT04658732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65111309|NCT04658732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65111310|NCT04658732|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65111311|NCT04658732|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65111312|NCT04658732|Antimanic Agents|antimanic agents|mesh-ancestor
65111313|NCT04658732|GABA Modulators|gaba modulators|mesh-ancestor
65111314|NCT04658732|GABA Agents|gaba agents|mesh-ancestor
65111315|NCT00540696|Darbepoetin alfa|darbepoetin alfa|mesh-list
65292989|NCT02714855|Antithrombins|antithrombins|mesh-ancestor
65292990|NCT02714855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65292991|NCT02714855|Protease Inhibitors|protease inhibitors|mesh-ancestor
65292992|NCT02714855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65292993|NCT02714855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65292994|NCT02714855|Anticoagulants|anticoagulants|mesh-ancestor
65292995|NCT02712203|Vaccines|vaccines|mesh-list
65292996|NCT02712203|Immunologic Factors|immunologic factors|mesh-ancestor
65292997|NCT02712203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65292998|NCT04189055|Irinotecan|irinotecan|mesh-list
65292999|NCT04189055|Cetuximab|cetuximab|mesh-list
65293000|NCT04189055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65293001|NCT04189055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65111316|NCT00540696|Hematinics|hematinics|mesh-ancestor
65111317|NCT04658420|Ketamine|ketamine|mesh-list
65111318|NCT04658420|Analgesics|analgesics|mesh-ancestor
65111319|NCT04658420|Sensory System Agents|sensory system agents|mesh-ancestor
65111320|NCT04658420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65111321|NCT04658420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111322|NCT04658420|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65111323|NCT04658420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65111324|NCT04658420|Anesthetics, General|anesthetics, general|mesh-ancestor
65111325|NCT04658420|Anesthetics|anesthetics|mesh-ancestor
65111326|NCT04658420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65111327|NCT04658420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65111328|NCT04658420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65111329|NCT04658420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65111330|NCT04658420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111331|NCT00540891|Alfuzosin|alfuzosin|mesh-list
65111332|NCT00540891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65111333|NCT00540891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65111334|NCT00540891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65111335|NCT00540891|Adrenergic Agents|adrenergic agents|mesh-ancestor
65111336|NCT00540891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65111337|NCT00540891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111338|NCT00540891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111339|NCT00540891|Urological Agents|urological agents|mesh-ancestor
65111340|NCT04658225|Chlorhexidine|chlorhexidine|mesh-list
65111352|NCT00540930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65111353|NCT00540930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65111354|NCT00540930|Growth Substances|growth substances|mesh-ancestor
65111355|NCT00540930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111356|NCT00540930|Growth Inhibitors|growth inhibitors|mesh-ancestor
65111357|NCT00540930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111359|NCT00541008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111360|NCT00541008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65111361|NCT00541008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65111362|NCT00541008|Growth Substances|growth substances|mesh-ancestor
65111363|NCT00541008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111364|NCT00541008|Growth Inhibitors|growth inhibitors|mesh-ancestor
65111365|NCT00541008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65111366|NCT00541008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111367|NCT00541008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111368|NCT00541047|Leuprolide|leuprolide|mesh-list
65111369|NCT00541047|Goserelin|goserelin|mesh-list
65111370|NCT00541047|Bicalutamide|bicalutamide|mesh-list
65111371|NCT00541047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65111372|NCT00541047|Fertility Agents|fertility agents|mesh-ancestor
65111373|NCT00541047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65111374|NCT00541047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111375|NCT00541047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65111376|NCT00541047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293002|NCT04189055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293003|NCT04189055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293004|NCT04189055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293005|NCT04189055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65293006|NCT00696930|Edotreotide|edotreotide|mesh-list
65293007|NCT00696930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65293008|NCT00696930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293009|NCT00598442|Darbepoetin alfa|darbepoetin alfa|mesh-list
65293010|NCT00598442|Hematinics|hematinics|mesh-ancestor
65293011|NCT02714543|Hydrocortisone|hydrocortisone|mesh-list
65293012|NCT02714543|Hyaluronic Acid|hyaluronic acid|mesh-list
65293013|NCT02714543|Antioxidants|antioxidants|mesh-list
65293014|NCT02714543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65293015|NCT02714543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65293016|NCT02714543|Immunologic Factors|immunologic factors|mesh-ancestor
65293017|NCT02714543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293018|NCT02714543|Viscosupplements|viscosupplements|mesh-ancestor
65293019|NCT02714543|Protective Agents|protective agents|mesh-ancestor
65293020|NCT02714543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293021|NCT02714231|Diclofenac|diclofenac|mesh-list
65293022|NCT02714231|Scopolamine|scopolamine|mesh-list
65293023|NCT02714231|Bromides|bromides|mesh-list
65293024|NCT02714231|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65293025|NCT02714231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64523269|NCT02213068|Tacrolimus|tacrolimus|mesh-list
65111377|NCT00541047|Androgen Antagonists|androgen antagonists|mesh-ancestor
65111378|NCT00541047|Hormone Antagonists|hormone antagonists|mesh-ancestor
65111379|NCT00541047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65111381|NCT00541086|Letrozole|letrozole|mesh-list
65111382|NCT00541086|Anastrozole|anastrozole|mesh-list
65111383|NCT00541086|Exemestane|exemestane|mesh-list
65111384|NCT00541086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111385|NCT00541086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111386|NCT00541086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65111387|NCT00541086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65111388|NCT00541086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111389|NCT00541086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65111390|NCT00541086|Hormone Antagonists|hormone antagonists|mesh-ancestor
65111391|NCT00541086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65111392|NCT00541086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111393|NCT00541086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65111394|NCT00541086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65111395|NCT00541086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65111396|NCT00541086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65111397|NCT04657484|Prednisolone|prednisolone|mesh-list
65111398|NCT04657484|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65111399|NCT04657484|Methylprednisolone|methylprednisolone|mesh-list
65111400|NCT04657484|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65111401|NCT04657484|Prednisolone acetate|prednisolone acetate|mesh-list
65111402|NCT04657484|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65293026|NCT02714231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65293027|NCT02714231|Analgesics|analgesics|mesh-ancestor
65293028|NCT02714231|Sensory System Agents|sensory system agents|mesh-ancestor
65293029|NCT02714231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65293030|NCT02714231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111403|NCT04657484|Prednisolone phosphate|prednisolone phosphate|mesh-list
65111404|NCT04657484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64683768|NCT05738408|Nicotine|nicotine|mesh-list
65111410|NCT04657484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111411|NCT04657484|Antiemetics|antiemetics|mesh-ancestor
65111412|NCT04657484|Autonomic Agents|autonomic agents|mesh-ancestor
65111413|NCT04657484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65111414|NCT04657484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65111415|NCT04657484|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65111416|NCT04657484|Protective Agents|protective agents|mesh-ancestor
65111417|NCT00541125|Leucovorin|leucovorin|mesh-list
65111419|NCT00541125|Fluorouracil|fluorouracil|mesh-list
65111420|NCT00541125|Irinotecan|irinotecan|mesh-list
65111421|NCT00541125|Calcium|calcium|mesh-list
65111422|NCT00541125|Levoleucovorin|levoleucovorin|mesh-list
65111423|NCT00541125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65111424|NCT00541125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111425|NCT00541125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65111426|NCT00541125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65111427|NCT00541125|Growth Substances|growth substances|mesh-ancestor
65111428|NCT00541125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111429|NCT00541125|Growth Inhibitors|growth inhibitors|mesh-ancestor
65111430|NCT00541125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65111431|NCT00541125|Antimetabolites|antimetabolites|mesh-ancestor
65111432|NCT00541125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111433|NCT00541125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65111434|NCT00541125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65111435|NCT00541125|Immunologic Factors|immunologic factors|mesh-ancestor
65111436|NCT00541125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65111437|NCT00541125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65111438|NCT00541125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111439|NCT00541125|Antidotes|antidotes|mesh-ancestor
65111440|NCT00541125|Protective Agents|protective agents|mesh-ancestor
65111441|NCT00541125|Vitamin B Complex|vitamin b complex|mesh-ancestor
65111442|NCT00541125|Vitamins|vitamins|mesh-ancestor
65111443|NCT00541125|Micronutrients|micronutrients|mesh-ancestor
65111444|NCT00541164|Ubiquinone|ubiquinone|mesh-list
65111445|NCT00541164|Coenzyme Q10|coenzyme q10|mesh-list
65111446|NCT00541164|Micronutrients|micronutrients|mesh-ancestor
65111447|NCT00541164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111448|NCT00541164|Vitamins|vitamins|mesh-ancestor
65111449|NCT00541281|Prednisone|prednisone|mesh-list
65111450|NCT00541281|Docetaxel|docetaxel|mesh-list
65111451|NCT00541281|Estramustine|estramustine|mesh-list
65111452|NCT00541281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111453|NCT00541281|Tubulin Modulators|tubulin modulators|mesh-ancestor
65111454|NCT00541281|Antimitotic Agents|antimitotic agents|mesh-ancestor
65111455|NCT00541281|Mitosis Modulators|mitosis modulators|mesh-ancestor
65111456|NCT00541281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111457|NCT00541281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65111458|NCT00541281|Glucocorticoids|glucocorticoids|mesh-ancestor
65111459|NCT00541281|Hormones|hormones|mesh-ancestor
65111460|NCT00541281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65111461|NCT00541281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111462|NCT00541281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65111463|NCT00541281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65111464|NCT00541281|Alkylating Agents|alkylating agents|mesh-ancestor
65111465|NCT00541320|2-(5-chlorothien-2-yl)-N-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|2-(5-chlorothien-2-yl)-n-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|mesh-list
65111466|NCT00541320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65111467|NCT00541320|Antithrombins|antithrombins|mesh-ancestor
65111468|NCT00541320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65111469|NCT00541320|Protease Inhibitors|protease inhibitors|mesh-ancestor
64683882|NCT05559164|Antimetabolites|antimetabolites|mesh-ancestor
64683883|NCT05559164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683884|NCT05559164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64683886|NCT05559164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293031|NCT02714231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65293032|NCT02714231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65293033|NCT02714231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65293034|NCT02714231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293035|NCT02714231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293036|NCT02714231|Anticonvulsants|anticonvulsants|mesh-ancestor
65111476|NCT04657172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65111477|NCT04657172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111478|NCT04657172|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65111479|NCT04657172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65111480|NCT04657172|Cholinergic Agents|cholinergic agents|mesh-ancestor
65111481|NCT04657172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65111482|NCT04657172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111483|NCT03199794|Factor VIII|factor viii|mesh-list
65111484|NCT03199794|Coagulants|coagulants|mesh-ancestor
65111485|NCT00541359|Bortezomib|bortezomib|mesh-list
65111486|NCT00541359|Topotecan|topotecan|mesh-list
65111487|NCT00541359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111488|NCT00541359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65111489|NCT00541359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65111490|NCT00541359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111491|NCT00541359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111492|NCT03096249|Oxytocin|oxytocin|mesh-list
65111493|NCT03096249|Oxytocics|oxytocics|mesh-ancestor
65111495|NCT03096249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111496|NCT04656665|Aspirin|aspirin|mesh-list
65111497|NCT04656665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65111498|NCT04656665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65111499|NCT04656665|Analgesics|analgesics|mesh-ancestor
65111500|NCT04656665|Sensory System Agents|sensory system agents|mesh-ancestor
65111501|NCT04656665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65111502|NCT04656665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111503|NCT04656665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65111504|NCT04656665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65111505|NCT04656665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65111506|NCT04656665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65111507|NCT04656665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111508|NCT04656665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65111509|NCT04656665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65111510|NCT04656665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111511|NCT04656665|Antipyretics|antipyretics|mesh-ancestor
65111512|NCT03014622|Botulinum Toxins|botulinum toxins|mesh-list
65111513|NCT03014622|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65111514|NCT03014622|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65111515|NCT03014622|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65111516|NCT03014622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65111517|NCT03014622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111518|NCT03014622|Cholinergic Agents|cholinergic agents|mesh-ancestor
65111519|NCT03014622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65111520|NCT03014622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111521|NCT03014622|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65111522|NCT03014622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65111523|NCT03013218|Paclitaxel|paclitaxel|mesh-list
65111524|NCT03013218|Rituximab|rituximab|mesh-list
65111525|NCT03013218|Pembrolizumab|pembrolizumab|mesh-list
65111526|NCT03013218|Trastuzumab|trastuzumab|mesh-list
65111527|NCT03013218|Ramucirumab|ramucirumab|mesh-list
65111528|NCT03013218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64753781|NCT04126278|Hormones|hormones|mesh-ancestor
65111529|NCT03013218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111530|NCT03013218|Tubulin Modulators|tubulin modulators|mesh-ancestor
65111531|NCT03013218|Antimitotic Agents|antimitotic agents|mesh-ancestor
65111532|NCT03013218|Mitosis Modulators|mitosis modulators|mesh-ancestor
65111533|NCT03013218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111534|NCT03013218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65111535|NCT03013218|Immunologic Factors|immunologic factors|mesh-ancestor
65111546|NCT00541515|Insulin|insulin|mesh-list
65111547|NCT00541515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65111548|NCT00541515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111549|NCT04655729|Infliximab|infliximab|mesh-list
65293037|NCT02714231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65293038|NCT02714231|Antiemetics|antiemetics|mesh-ancestor
65293039|NCT02714231|Autonomic Agents|autonomic agents|mesh-ancestor
65293040|NCT02714231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65293041|NCT02714231|Mydriatics|mydriatics|mesh-ancestor
65293042|NCT02714231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65293043|NCT02714231|Cholinergic Agents|cholinergic agents|mesh-ancestor
65111550|NCT04655729|Dermatologic Agents|dermatologic agents|mesh-ancestor
65111551|NCT04655729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65111552|NCT04655729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65111553|NCT00541554|Aripiprazole|aripiprazole|mesh-list
65111555|NCT00541554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65111556|NCT00541554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65111557|NCT00541554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65111558|NCT00541554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65111559|NCT00541554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111560|NCT00541554|Dopamine Agonists|dopamine agonists|mesh-ancestor
65111561|NCT00541554|Dopamine Agents|dopamine agents|mesh-ancestor
65111562|NCT00541554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65111563|NCT00541554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111564|NCT00541554|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65111565|NCT00541554|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65111566|NCT00541554|Serotonin Agents|serotonin agents|mesh-ancestor
65111567|NCT00541554|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65111568|NCT00541554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65111569|NCT00541554|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65111570|NCT00541554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65111571|NCT02881242|Trametinib|trametinib|mesh-list
65111572|NCT02881242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111573|NCT02881242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65111574|NCT02881242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111575|NCT02881242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111576|NCT04655183|Niraparib|niraparib|mesh-list
65111577|NCT04655183|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65111578|NCT04655183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111579|NCT04655183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111580|NCT04655183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111581|NCT00541710|Genistein|genistein|mesh-list
65111582|NCT00541710|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65111583|NCT00541710|Protective Agents|protective agents|mesh-ancestor
65111584|NCT00541710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111585|NCT00541710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111586|NCT00541710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65111587|NCT00541710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111588|NCT00541710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111589|NCT00541710|Phytoestrogens|phytoestrogens|mesh-ancestor
65111590|NCT00541710|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65111591|NCT00541710|Estrogens|estrogens|mesh-ancestor
65111592|NCT00541710|Hormones|hormones|mesh-ancestor
65111593|NCT00541710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65111594|NCT04654676|Vildagliptin|vildagliptin|mesh-list
65111595|NCT04654676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65111596|NCT04654676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111597|NCT04654676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65111598|NCT04654676|Protease Inhibitors|protease inhibitors|mesh-ancestor
65111599|NCT04654676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111600|NCT04654676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111607|NCT00541905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111608|NCT00541905|Cholinergic Agents|cholinergic agents|mesh-ancestor
65111609|NCT00541905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65111610|NCT00542022|Oxymetazoline|oxymetazoline|mesh-list
65111611|NCT00542022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65111612|NCT00542022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65111613|NCT00542022|Adrenergic Agents|adrenergic agents|mesh-ancestor
65111614|NCT00542022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65111615|NCT00542022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111616|NCT00542022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293044|NCT02714231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65293045|NCT02714231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65293046|NCT02714231|Parasympatholytics|parasympatholytics|mesh-ancestor
65293047|NCT00855309|Acyclovir|acyclovir|mesh-list
65293048|NCT00855309|Antiviral Agents|antiviral agents|mesh-ancestor
65293049|NCT00855309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65293050|NCT00532129|Rituximab|rituximab|mesh-list
65293051|NCT00532129|Chlorambucil|chlorambucil|mesh-list
65293052|NCT00532129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65293053|NCT00532129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293054|NCT00532129|Immunologic Factors|immunologic factors|mesh-ancestor
65293055|NCT00532129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293056|NCT00532129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65293057|NCT00532129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65293058|NCT00532129|Alkylating Agents|alkylating agents|mesh-ancestor
65293059|NCT00532129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293060|NCT04163276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65293061|NCT04163276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65293062|NCT04163276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293063|NCT04163588|Metolazone|metolazone|mesh-list
65293064|NCT04163588|Diuretics|diuretics|mesh-list
65293065|NCT04163588|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
65293066|NCT04163588|Natriuretic Agents|natriuretic agents|mesh-ancestor
65293067|NCT04163588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293068|NCT04163588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65293069|NCT04163588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293070|NCT04163588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65293071|NCT04163588|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65293072|NCT05167513|Metformin|metformin|mesh-list
65293073|NCT05167513|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65293074|NCT05167513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65293075|NCT05167513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293076|NCT05167513|Incretins|incretins|mesh-ancestor
65293077|NCT05167513|Hormones|hormones|mesh-ancestor
65111617|NCT00542022|Sympathomimetics|sympathomimetics|mesh-ancestor
65111618|NCT00542022|Autonomic Agents|autonomic agents|mesh-ancestor
65111619|NCT00542022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65111620|NCT00542022|Nasal Decongestants|nasal decongestants|mesh-ancestor
65111621|NCT00542022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65111622|NCT00542022|Respiratory System Agents|respiratory system agents|mesh-ancestor
65293078|NCT05167513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65293079|NCT05167513|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65293080|NCT05167513|Protease Inhibitors|protease inhibitors|mesh-ancestor
65293081|NCT05167513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293082|NCT05167513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293083|NCT00654056|Insulin|insulin|mesh-list
65293084|NCT00654056|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65293085|NCT00654056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65293086|NCT00654056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293087|NCT00854373|Hormones|hormones|mesh-list
65293088|NCT00854373|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65293089|NCT00854373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65293090|NCT00854373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293091|NCT00611507|Fluorouracil|fluorouracil|mesh-list
65293092|NCT00611507|Oxaliplatin|oxaliplatin|mesh-list
65293093|NCT00611507|Antimetabolites|antimetabolites|mesh-ancestor
65293094|NCT00611507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293095|NCT00611507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65293096|NCT00611507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293097|NCT00611507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65293098|NCT00611507|Immunologic Factors|immunologic factors|mesh-ancestor
65293099|NCT00611507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293100|NCT01001845|Vitamin E|vitamin e|mesh-list
65293101|NCT01001845|alpha-Tocopherol|alpha-tocopherol|mesh-list
65293102|NCT01001845|Tocopherols|tocopherols|mesh-list
65111623|NCT02546583|Chlorothiazide|chlorothiazide|mesh-list
65111626|NCT02546583|Diuretics|diuretics|mesh-list
65111627|NCT02546583|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
65111628|NCT02546583|Natriuretic Agents|natriuretic agents|mesh-ancestor
65111629|NCT02546583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111630|NCT02546583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65111631|NCT02546583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111632|NCT02546583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65111633|NCT02546583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65111634|NCT01205581|Vaccines|vaccines|mesh-list
65111635|NCT01205581|Immunologic Factors|immunologic factors|mesh-ancestor
65111636|NCT01205581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111637|NCT00542139|Betamethasone|betamethasone|mesh-list
65111638|NCT00542139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65111639|NCT00542139|Glucocorticoids|glucocorticoids|mesh-ancestor
65111640|NCT00542139|Hormones|hormones|mesh-ancestor
65111641|NCT00542139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65111642|NCT00542139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111643|NCT00542139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65111644|NCT00542139|Respiratory System Agents|respiratory system agents|mesh-ancestor
65111645|NCT02499354|Iron|iron|mesh-list
65111646|NCT02499354|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65111647|NCT02499354|Trace Elements|trace elements|mesh-ancestor
65293103|NCT01001845|Antioxidants|antioxidants|mesh-ancestor
65293104|NCT01001845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293105|NCT01001845|Protective Agents|protective agents|mesh-ancestor
65293106|NCT01001845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293107|NCT01001845|Vitamins|vitamins|mesh-ancestor
65293108|NCT01001845|Micronutrients|micronutrients|mesh-ancestor
65293109|NCT02635334|Montelukast|montelukast|mesh-list
65293110|NCT02635334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65293111|NCT02635334|Respiratory System Agents|respiratory system agents|mesh-ancestor
65293112|NCT02635334|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65293113|NCT02635334|Hormone Antagonists|hormone antagonists|mesh-ancestor
65293114|NCT02635334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65293115|NCT02635334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293116|NCT02635334|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64523363|NCT01703741|Testosterone|testosterone|mesh-list
65111648|NCT02499354|Micronutrients|micronutrients|mesh-ancestor
65111649|NCT02499354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111650|NCT02499354|Hematinics|hematinics|mesh-ancestor
65111651|NCT02499354|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65111652|NCT02499354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65111653|NCT00542295|Mebeverine|mebeverine|mesh-list
65111654|NCT00542295|Alverine|alverine|mesh-list
65111655|NCT00542295|Parasympatholytics|parasympatholytics|mesh-ancestor
65111656|NCT00542295|Autonomic Agents|autonomic agents|mesh-ancestor
65111657|NCT00542295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65111658|NCT00542295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111659|NCT00542295|Anticonvulsants|anticonvulsants|mesh-ancestor
65111660|NCT03454841|Ticagrelor|ticagrelor|mesh-list
65111661|NCT03454841|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65111662|NCT03454841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65111663|NCT03454841|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65111664|NCT03454841|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65111665|NCT03454841|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65111666|NCT03454841|Purinergic Agents|purinergic agents|mesh-ancestor
65111667|NCT03454841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64684078|NCT04173507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684080|NCT04173507|Immunologic Factors|immunologic factors|mesh-ancestor
65111673|NCT02293980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65111674|NCT02293980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111675|NCT02293980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65111676|NCT02293980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753941|NCT03012360|Linezolid|linezolid|mesh-list
65111677|NCT04653506|Acetaminophen|acetaminophen|mesh-list
65111678|NCT04653506|Ibuprofen|ibuprofen|mesh-list
65111679|NCT04653506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65111680|NCT04653506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65111681|NCT04653506|Analgesics|analgesics|mesh-ancestor
65111682|NCT04653506|Sensory System Agents|sensory system agents|mesh-ancestor
65111683|NCT04653506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65111684|NCT04653506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111685|NCT04653506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65111686|NCT04653506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65111687|NCT04653506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65111688|NCT04653506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111689|NCT04653506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111690|NCT04653506|Antipyretics|antipyretics|mesh-ancestor
65111691|NCT00542412|Riluzole|riluzole|mesh-list
65111692|NCT00542412|Anticonvulsants|anticonvulsants|mesh-ancestor
65111693|NCT00542412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65293117|NCT02635334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65293118|NCT02635334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293119|NCT00853905|Triamcinolone|triamcinolone|mesh-list
65293120|NCT00853905|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65293121|NCT00853905|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65293122|NCT00853905|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65293123|NCT00853905|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65293124|NCT00853905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65293125|NCT00853905|Glucocorticoids|glucocorticoids|mesh-ancestor
65293126|NCT00853905|Hormones|hormones|mesh-ancestor
65293127|NCT00853905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65293128|NCT00853905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111694|NCT00542412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65111695|NCT00542412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65111696|NCT00542412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111697|NCT00542412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111698|NCT00542412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65111699|NCT00542412|Protective Agents|protective agents|mesh-ancestor
65111700|NCT04653623|Tranexamic Acid|tranexamic acid|mesh-list
65111701|NCT04653623|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65111702|NCT04653623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65111703|NCT04653623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111704|NCT04653623|Hemostatics|hemostatics|mesh-ancestor
65111705|NCT04653623|Coagulants|coagulants|mesh-ancestor
65111706|NCT00542568|Epoetin Alfa|epoetin alfa|mesh-list
65111707|NCT00542568|Hematinics|hematinics|mesh-ancestor
65111708|NCT04653779|Metformin|metformin|mesh-list
65111709|NCT04653779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65111710|NCT04653779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111711|NCT00542607|Levocetirizine|levocetirizine|mesh-list
65111712|NCT00542607|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65111713|NCT00542607|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65111714|NCT00542607|Histamine Antagonists|histamine antagonists|mesh-ancestor
65111715|NCT00542607|Histamine Agents|histamine agents|mesh-ancestor
65111716|NCT00542607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65111717|NCT00542607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111718|NCT00542607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111719|NCT04685031|Clobetasol|clobetasol|mesh-list
65111720|NCT04685031|Nitroglycerin|nitroglycerin|mesh-list
65111721|NCT04685031|Vasodilator Agents|vasodilator agents|mesh-ancestor
65111722|NCT04685031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65111723|NCT04685031|Glucocorticoids|glucocorticoids|mesh-ancestor
65111724|NCT04685031|Hormones|hormones|mesh-ancestor
65111725|NCT04685031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65111726|NCT04685031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111727|NCT00542763|Mycophenolic Acid|mycophenolic acid|mesh-list
65111738|NCT01854684|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65111739|NCT01854684|Dermatologic Agents|dermatologic agents|mesh-ancestor
65111741|NCT00542802|Levetiracetam|levetiracetam|mesh-list
65111742|NCT00542802|Anticonvulsants|anticonvulsants|mesh-ancestor
65111743|NCT00542802|Nootropic Agents|nootropic agents|mesh-ancestor
65111744|NCT00542802|Antimanic Agents|antimanic agents|mesh-ancestor
65111745|NCT00542802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65111746|NCT00542802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65111747|NCT00542802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111748|NCT00542802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65111749|NCT00542802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65111750|NCT00542802|Analgesics|analgesics|mesh-ancestor
65111751|NCT00542802|Sensory System Agents|sensory system agents|mesh-ancestor
65111752|NCT00542802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65111753|NCT00542802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65111754|NCT00542802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65293129|NCT00853905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65293130|NCT00853905|Immunologic Factors|immunologic factors|mesh-ancestor
65293131|NCT00853905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293132|NCT00853905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293133|NCT00998101|Carboplatin|carboplatin|mesh-list
65293134|NCT00998101|Cetuximab|cetuximab|mesh-list
65293135|NCT00998101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293136|NCT00998101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65293137|NCT04234217|Niacin|niacin|mesh-list
65293138|NCT04234217|Niacinamide|niacinamide|mesh-list
65293139|NCT04234217|Nicotinic Acids|nicotinic acids|mesh-list
65293140|NCT04234217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65293141|NCT04234217|Antimetabolites|antimetabolites|mesh-ancestor
65293142|NCT04234217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293143|NCT04234217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65293144|NCT04234217|Vasodilator Agents|vasodilator agents|mesh-ancestor
65293145|NCT04234217|Vitamin B Complex|vitamin b complex|mesh-ancestor
65293146|NCT04234217|Vitamins|vitamins|mesh-ancestor
65293147|NCT04234217|Micronutrients|micronutrients|mesh-ancestor
65344929|NCT00864058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64523391|NCT02425254|Antipyretics|antipyretics|mesh-ancestor
65111755|NCT00542802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111756|NCT00542802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65111757|NCT00542802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65111758|NCT04652648|Hydroxychloroquine|hydroxychloroquine|mesh-list
65111759|NCT04652648|Antimalarials|antimalarials|mesh-ancestor
65111760|NCT04652648|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65111761|NCT04652648|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65111762|NCT04652648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65111763|NCT04652648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111764|NCT04652648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111765|NCT04652648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65111766|NCT00542841|Hydrocortisone|hydrocortisone|mesh-list
65111767|NCT00542841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65111768|NCT04652765|Bicalutamide|bicalutamide|mesh-list
65111769|NCT04652765|Camostat|camostat|mesh-list
65111770|NCT04652765|Androgen Antagonists|androgen antagonists|mesh-ancestor
65111771|NCT04652765|Hormone Antagonists|hormone antagonists|mesh-ancestor
65111772|NCT04652765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65111773|NCT04652765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111774|NCT04652765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111775|NCT04652765|Protease Inhibitors|protease inhibitors|mesh-ancestor
65111776|NCT04652765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111777|NCT04652765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111778|NCT04652765|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65111779|NCT04652765|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65111780|NCT00543075|Oblimersen|oblimersen|mesh-list
65111809|NCT01014546|Antioxidants|antioxidants|mesh-ancestor
65111810|NCT01014546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111811|NCT01014546|Protective Agents|protective agents|mesh-ancestor
65111812|NCT01014546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111813|NCT00543231|Oblimersen|oblimersen|mesh-list
65111814|NCT00543231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111815|NCT00557843|Bupivacaine|bupivacaine|mesh-list
65111816|NCT00557843|Anesthetics, Local|anesthetics, local|mesh-ancestor
65111817|NCT00557843|Anesthetics|anesthetics|mesh-ancestor
65293148|NCT04234217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293149|NCT01002079|Rifampin|rifampin|mesh-list
65293150|NCT01002079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65293151|NCT01002079|Antitubercular Agents|antitubercular agents|mesh-ancestor
65293152|NCT01002079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65293153|NCT01002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65293154|NCT01002079|Leprostatic Agents|leprostatic agents|mesh-ancestor
65293155|NCT01002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65293156|NCT01002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293157|NCT01002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293158|NCT01002079|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65293159|NCT01002079|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65293160|NCT01002079|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65293161|NCT01002079|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65293162|NCT01002079|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65293163|NCT01002079|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65293164|NCT02639624|Dialysis Solutions|dialysis solutions|mesh-list
65293165|NCT02639624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65293166|NCT05429567|Fentanyl|fentanyl|mesh-list
64523404|NCT02426736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111818|NCT00557843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65111819|NCT00557843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111820|NCT00557843|Sensory System Agents|sensory system agents|mesh-ancestor
65111821|NCT00557843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65111822|NCT04651556|Acetaminophen|acetaminophen|mesh-list
65111823|NCT04651556|Ketorolac|ketorolac|mesh-list
65111824|NCT04651556|Magnesium Sulfate|magnesium sulfate|mesh-list
65111825|NCT04651556|Bupivacaine|bupivacaine|mesh-list
65111826|NCT04651556|Anesthetics, Local|anesthetics, local|mesh-ancestor
65111827|NCT04651556|Anesthetics|anesthetics|mesh-ancestor
65111828|NCT04651556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64754090|NCT05608200|Lenvatinib|lenvatinib|mesh-list
65111829|NCT04651556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111830|NCT04651556|Sensory System Agents|sensory system agents|mesh-ancestor
65111837|NCT04651556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65111838|NCT04651556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65111839|NCT04651556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111840|NCT04651556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111841|NCT04651556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65111842|NCT04651556|Anticonvulsants|anticonvulsants|mesh-ancestor
65111843|NCT04651556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65111844|NCT04651556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65111845|NCT04651556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65111846|NCT04651556|Tocolytic Agents|tocolytic agents|mesh-ancestor
65111847|NCT04651556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65111848|NCT04651049|Propranolol|propranolol|mesh-list
65111849|NCT04651049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65111850|NCT04651049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65111851|NCT04651049|Adrenergic Agents|adrenergic agents|mesh-ancestor
65111852|NCT04651049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65111853|NCT04651049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111854|NCT04651049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293167|NCT05429567|Bupivacaine|bupivacaine|mesh-list
65293168|NCT05429567|Anesthetics, Local|anesthetics, local|mesh-ancestor
65293169|NCT05429567|Anesthetics|anesthetics|mesh-ancestor
65293170|NCT05429567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65293171|NCT05429567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293172|NCT05429567|Sensory System Agents|sensory system agents|mesh-ancestor
65293173|NCT05429567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65293174|NCT05429567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65293175|NCT05429567|Narcotics|narcotics|mesh-ancestor
65293176|NCT05429567|Analgesics|analgesics|mesh-ancestor
65293177|NCT05429567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65293178|NCT05429567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65293179|NCT05429567|Anesthetics, General|anesthetics, general|mesh-ancestor
65293180|NCT00868296|Pantoprazole|pantoprazole|mesh-list
65293181|NCT00868296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65293182|NCT00868296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65293183|NCT00868296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65293184|NCT00868296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293185|NCT00868296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293186|NCT01002157|Vitamin K|vitamin k|mesh-list
65293187|NCT01002157|Vitamin K 2|vitamin k 2|mesh-list
65293188|NCT01002157|Vitamin MK 7|vitamin mk 7|mesh-list
65293189|NCT01002157|Vitamins|vitamins|mesh-ancestor
65293190|NCT01002157|Micronutrients|micronutrients|mesh-ancestor
65293191|NCT01002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293192|NCT01002157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65293193|NCT01002157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65293194|NCT01002157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293195|NCT01002157|Hemostatics|hemostatics|mesh-ancestor
65293196|NCT01002157|Coagulants|coagulants|mesh-ancestor
65293197|NCT01004497|Cytarabine|cytarabine|mesh-list
65293198|NCT01004497|Dexamethasone|dexamethasone|mesh-list
65111855|NCT04651049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65111856|NCT04651049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65111857|NCT04651049|Vasodilator Agents|vasodilator agents|mesh-ancestor
65111859|NCT04651205|Vitamins|vitamins|mesh-ancestor
65111860|NCT04651205|Micronutrients|micronutrients|mesh-ancestor
65111861|NCT04651205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111862|NCT04651205|Vitamin B Complex|vitamin b complex|mesh-ancestor
65111863|NCT03456648|Apixaban|apixaban|mesh-list
65111864|NCT03456648|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65111865|NCT03456648|Antithrombins|antithrombins|mesh-ancestor
65111866|NCT03456648|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65111867|NCT03456648|Protease Inhibitors|protease inhibitors|mesh-ancestor
65111868|NCT03456648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111869|NCT03456648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111870|NCT03456648|Anticoagulants|anticoagulants|mesh-ancestor
65111871|NCT00557921|Aspirin|aspirin|mesh-list
65293199|NCT01004497|Dexamethasone acetate|dexamethasone acetate|mesh-list
65293200|NCT01004497|Cyclophosphamide|cyclophosphamide|mesh-list
65293201|NCT01004497|Vincristine|vincristine|mesh-list
65293202|NCT01004497|Daunorubicin|daunorubicin|mesh-list
65293203|NCT01004497|Dasatinib|dasatinib|mesh-list
65293204|NCT01004497|Mitoxantrone|mitoxantrone|mesh-list
65293205|NCT01004497|BB 1101|bb 1101|mesh-list
65293206|NCT01004497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65293207|NCT01004497|Immunologic Factors|immunologic factors|mesh-ancestor
65293208|NCT01004497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293209|NCT01004497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65293210|NCT01004497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65293211|NCT01004497|Alkylating Agents|alkylating agents|mesh-ancestor
65293212|NCT01004497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293213|NCT01004497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293214|NCT01004497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65293215|NCT01004497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65293216|NCT01004497|Antiemetics|antiemetics|mesh-ancestor
65293217|NCT01004497|Autonomic Agents|autonomic agents|mesh-ancestor
65293218|NCT01004497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65293219|NCT01004497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65293220|NCT01004497|Glucocorticoids|glucocorticoids|mesh-ancestor
65293222|NCT01004497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65293223|NCT01004497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65293224|NCT01004497|Protease Inhibitors|protease inhibitors|mesh-ancestor
65293225|NCT01004497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293226|NCT01004497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65293227|NCT01004497|Antimetabolites|antimetabolites|mesh-ancestor
65293245|NCT01004575|Cobalt|cobalt|mesh-list
65293249|NCT01004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293250|NCT02615730|Paclitaxel|paclitaxel|mesh-list
65293251|NCT02615730|GSK2636771|gsk2636771|mesh-list
65293252|NCT02615730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65293253|NCT02615730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293254|NCT02615730|Tubulin Modulators|tubulin modulators|mesh-ancestor
65293255|NCT02615730|Antimitotic Agents|antimitotic agents|mesh-ancestor
65293256|NCT02615730|Mitosis Modulators|mitosis modulators|mesh-ancestor
65293257|NCT02615730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293258|NCT02615730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65293259|NCT02615730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293260|NCT02711891|Loperamide|loperamide|mesh-list
65293261|NCT02711891|Antidiarrheals|antidiarrheals|mesh-list
65293262|NCT02711891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65293263|NCT02615496|Aflibercept|aflibercept|mesh-list
65293264|NCT02615496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65293265|NCT02615496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64523501|NCT01681433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65111872|NCT00557921|Omeprazole|omeprazole|mesh-list
65111873|NCT00557921|Clopidogrel|clopidogrel|mesh-list
65111874|NCT00557921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65111875|NCT00557921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65111876|NCT00557921|Analgesics|analgesics|mesh-ancestor
65111877|NCT00557921|Sensory System Agents|sensory system agents|mesh-ancestor
65111878|NCT00557921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65111879|NCT00557921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111880|NCT00557921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65111881|NCT00557921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65111882|NCT00557921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65111883|NCT00557921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65111884|NCT00557921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111885|NCT00557921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65111886|NCT00557921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65111887|NCT00557921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111893|NCT00557921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65111894|NCT00557921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65111895|NCT00557921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65111896|NCT00557921|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65111897|NCT02352558|Dexamethasone|dexamethasone|mesh-list
65111898|NCT02352558|Bortezomib|bortezomib|mesh-list
65111899|NCT02352558|Imatinib Mesylate|imatinib mesylate|mesh-list
65111900|NCT02352558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65111901|NCT02352558|Antiemetics|antiemetics|mesh-ancestor
65111902|NCT02352558|Autonomic Agents|autonomic agents|mesh-ancestor
65111903|NCT02352558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65111904|NCT02352558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111905|NCT02352558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65111906|NCT02352558|Glucocorticoids|glucocorticoids|mesh-ancestor
65111908|NCT02352558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65111909|NCT02352558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65111910|NCT02352558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111911|NCT02352558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65111912|NCT02352558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111913|NCT02352558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111914|NCT02324283|Propofol|propofol|mesh-list
65111915|NCT02324283|Desflurane|desflurane|mesh-list
65111916|NCT02324283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65111917|NCT02324283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65293266|NCT02615496|Growth Substances|growth substances|mesh-ancestor
65293267|NCT02615496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293268|NCT02615496|Growth Inhibitors|growth inhibitors|mesh-ancestor
65293269|NCT02615496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293270|NCT01004731|Gemcitabine|gemcitabine|mesh-list
65293271|NCT01004731|Carboplatin|carboplatin|mesh-list
65293272|NCT01004731|Cetuximab|cetuximab|mesh-list
65293273|NCT01004731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293274|NCT01004731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65293275|NCT01004731|Antimetabolites|antimetabolites|mesh-ancestor
65293276|NCT01004731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293277|NCT01004731|Antiviral Agents|antiviral agents|mesh-ancestor
65293278|NCT01004731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65293279|NCT01004731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293280|NCT01004731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65111918|NCT02324283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111919|NCT02324283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65111920|NCT02324283|Anesthetics, General|anesthetics, general|mesh-ancestor
65111921|NCT02324283|Anesthetics|anesthetics|mesh-ancestor
65111922|NCT02324283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65111924|NCT00557960|Adderall|adderall|mesh-list
65111925|NCT00557960|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65111926|NCT00557960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65111927|NCT00557960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65111928|NCT00557960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65111929|NCT00557960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111930|NCT00557960|Adrenergic Agents|adrenergic agents|mesh-ancestor
65111931|NCT00557960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65111932|NCT00557960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111933|NCT00557960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65111934|NCT00557960|Sympathomimetics|sympathomimetics|mesh-ancestor
65111935|NCT00557960|Autonomic Agents|autonomic agents|mesh-ancestor
65111936|NCT00557960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65111937|NCT00557960|Dopamine Agents|dopamine agents|mesh-ancestor
65111938|NCT00557960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65111939|NCT02311998|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65111940|NCT02311998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65111941|NCT02311998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111942|NCT02311998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65111943|NCT00558077|Metformin|metformin|mesh-list
65111944|NCT00558077|Clomiphene|clomiphene|mesh-list
65111945|NCT00558077|Enclomiphene|enclomiphene|mesh-list
65111946|NCT00558077|Zuclomiphene|zuclomiphene|mesh-list
65111947|NCT00558077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65111948|NCT00558077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111949|NCT00558077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65111950|NCT00558077|Hormone Antagonists|hormone antagonists|mesh-ancestor
65111951|NCT00558077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65111956|NCT00558077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65111957|NCT05077254|Mycophenolic Acid|mycophenolic acid|mesh-list
65111958|NCT05077254|Vaccines|vaccines|mesh-list
65111959|NCT05077254|Tacrolimus|tacrolimus|mesh-list
65111960|NCT05077254|Immunologic Factors|immunologic factors|mesh-ancestor
65111961|NCT05077254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111962|NCT05077254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65111963|NCT05077254|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65111964|NCT05077254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111965|NCT05077254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111966|NCT05077254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65111967|NCT05077254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293281|NCT01004731|Immunologic Factors|immunologic factors|mesh-ancestor
65293282|NCT01004731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293283|NCT01004731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65293284|NCT02714075|Zinc|zinc|mesh-list
65293285|NCT02714075|Iron|iron|mesh-list
65043197|NCT00204737|Prednisone|prednisone|mesh-list
65293286|NCT02714075|Zinc Sulfate|zinc sulfate|mesh-list
65293287|NCT02714075|Zinc Oxide|zinc oxide|mesh-list
65293288|NCT02714075|Citric Acid|citric acid|mesh-list
65293289|NCT02714075|Sodium Citrate|sodium citrate|mesh-list
65293290|NCT02714075|Anticoagulants|anticoagulants|mesh-ancestor
65293291|NCT02714075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65293292|NCT02714075|Chelating Agents|chelating agents|mesh-ancestor
65293293|NCT02714075|Sequestering Agents|sequestering agents|mesh-ancestor
65293294|NCT02714075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293295|NCT02714075|Trace Elements|trace elements|mesh-ancestor
65293296|NCT02714075|Micronutrients|micronutrients|mesh-ancestor
65293297|NCT02714075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293299|NCT02714075|Dermatologic Agents|dermatologic agents|mesh-ancestor
65293300|NCT02714075|Sunscreening Agents|sunscreening agents|mesh-ancestor
65293301|NCT02714075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65293302|NCT02714075|Protective Agents|protective agents|mesh-ancestor
65293303|NCT02636426|Sorafenib|sorafenib|mesh-list
65111968|NCT05077254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65111969|NCT05077254|Antitubercular Agents|antitubercular agents|mesh-ancestor
65111970|NCT05077254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65111971|NCT05077254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65111972|NCT00543504|Bevacizumab|bevacizumab|mesh-list
65111973|NCT00543504|Trastuzumab|trastuzumab|mesh-list
65111974|NCT00543504|Cetuximab|cetuximab|mesh-list
65111975|NCT00543504|Sunitinib|sunitinib|mesh-list
65111976|NCT00543504|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65111977|NCT00543504|Sorafenib|sorafenib|mesh-list
65111978|NCT00543504|Lapatinib|lapatinib|mesh-list
65111979|NCT00543504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65111980|NCT00543504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754228|NCT03826602|Metformin|metformin|mesh-list
65111981|NCT00543504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65111982|NCT00543504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65111983|NCT00543504|Growth Substances|growth substances|mesh-ancestor
65111984|NCT00543504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111985|NCT00543504|Growth Inhibitors|growth inhibitors|mesh-ancestor
65111986|NCT00543504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65111987|NCT00543504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111988|NCT00543504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111989|NCT00543933|Nitric Oxide|nitric oxide|mesh-list
65111990|NCT00543933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65111991|NCT00543933|Autonomic Agents|autonomic agents|mesh-ancestor
65111992|NCT00543933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65111993|NCT00543933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111994|NCT00543933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65111995|NCT00543933|Respiratory System Agents|respiratory system agents|mesh-ancestor
65111996|NCT00543933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65111998|NCT00543933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111999|NCT00543933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65112000|NCT00543933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65293304|NCT02636426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293305|NCT02636426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65293306|NCT02636426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293307|NCT02636426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293308|NCT02713763|Sunitinib|sunitinib|mesh-list
65293309|NCT02713763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293310|NCT02713763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65112001|NCT00543933|Vasodilator Agents|vasodilator agents|mesh-ancestor
65112002|NCT00543933|Gasotransmitters|gasotransmitters|mesh-ancestor
65112003|NCT00543933|Protective Agents|protective agents|mesh-ancestor
65112004|NCT00544011|Bevacizumab|bevacizumab|mesh-list
65112005|NCT00544011|Fluorouracil|fluorouracil|mesh-list
65112006|NCT00544011|Capecitabine|capecitabine|mesh-list
65112007|NCT00544011|Irinotecan|irinotecan|mesh-list
65112008|NCT00544011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65112009|NCT00544011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684373|NCT01715233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65112020|NCT00544011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65112021|NCT00544011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65112022|NCT00544011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112023|NCT00544050|Levetiracetam|levetiracetam|mesh-list
65112024|NCT00544050|Anticonvulsants|anticonvulsants|mesh-ancestor
65112025|NCT00544050|Nootropic Agents|nootropic agents|mesh-ancestor
65112026|NCT04649723|Rifampin|rifampin|mesh-list
65112027|NCT04649723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65112028|NCT04649723|Antitubercular Agents|antitubercular agents|mesh-ancestor
65112029|NCT04649723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65112030|NCT04649723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65112031|NCT04649723|Leprostatic Agents|leprostatic agents|mesh-ancestor
65112032|NCT04649723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65112033|NCT04649723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112034|NCT04649723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112035|NCT04649723|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65112036|NCT04649723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65112037|NCT04649723|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65112038|NCT04649723|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65112039|NCT04649723|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65112040|NCT04649723|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65112041|NCT02909088|Ecopipam|ecopipam|mesh-list
65112042|NCT02909088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65112043|NCT02909088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65112044|NCT02909088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65112045|NCT02909088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112046|NCT02909088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65112047|NCT02909088|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65112048|NCT02909088|Dopamine Agents|dopamine agents|mesh-ancestor
65112049|NCT02909088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65112050|NCT02909088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112051|NCT04649645|Nicotine|nicotine|mesh-list
65112052|NCT04649645|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65112053|NCT04649645|Autonomic Agents|autonomic agents|mesh-ancestor
65112054|NCT04649645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65112055|NCT04649645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112056|NCT04649645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65112057|NCT04649645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65112058|NCT04649645|Cholinergic Agents|cholinergic agents|mesh-ancestor
65112059|NCT04649645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65112060|NCT04649645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112061|NCT00544128|Ritonavir|ritonavir|mesh-list
65112062|NCT00544128|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65112063|NCT00544128|Tenofovir|tenofovir|mesh-list
65112064|NCT00544128|Lamivudine|lamivudine|mesh-list
65112065|NCT00544128|Emtricitabine|emtricitabine|mesh-list
65112066|NCT00544128|Abacavir|abacavir|mesh-list
65112067|NCT00544128|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65112068|NCT00544128|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65112069|NCT00544128|Protease Inhibitors|protease inhibitors|mesh-ancestor
65112070|NCT00544128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112071|NCT00544128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293311|NCT02713763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65293312|NCT02713763|Growth Substances|growth substances|mesh-ancestor
65293313|NCT02713763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293314|NCT02713763|Growth Inhibitors|growth inhibitors|mesh-ancestor
65293315|NCT02713763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65293316|NCT02713763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293317|NCT02713763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293318|NCT00867360|Mifepristone|mifepristone|mesh-list
65293319|NCT00867360|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65293320|NCT00867360|Abortifacient Agents|abortifacient agents|mesh-ancestor
65293321|NCT00867360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65293322|NCT00867360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112072|NCT00544128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65112087|NCT05476432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65112088|NCT05476432|Immunologic Factors|immunologic factors|mesh-ancestor
65112089|NCT05476432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112090|NCT05476432|Antidotes|antidotes|mesh-ancestor
65112091|NCT05476432|Protective Agents|protective agents|mesh-ancestor
65112092|NCT05476432|Vitamin B Complex|vitamin b complex|mesh-ancestor
65112093|NCT05476432|Vitamins|vitamins|mesh-ancestor
65112094|NCT05476432|Micronutrients|micronutrients|mesh-ancestor
65112095|NCT01239745|Exemestane|exemestane|mesh-list
65112096|NCT01239745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112097|NCT01239745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65112098|NCT01239745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65112099|NCT01239745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112100|NCT01239745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112101|NCT01239745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65112102|NCT01239745|Hormone Antagonists|hormone antagonists|mesh-ancestor
65112103|NCT01239745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65112104|NCT01239745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112105|NCT01239472|Everolimus|everolimus|mesh-list
65112106|NCT01239472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112107|NCT01239472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65112108|NCT01239472|Immunologic Factors|immunologic factors|mesh-ancestor
65112109|NCT01239472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112110|NCT00544284|Temozolomide|temozolomide|mesh-list
65112111|NCT00544284|Bortezomib|bortezomib|mesh-list
65112112|NCT00544284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65112113|NCT00544284|Alkylating Agents|alkylating agents|mesh-ancestor
65112114|NCT00544284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112115|NCT00544284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112116|NCT02888275|Dexmedetomidine|dexmedetomidine|mesh-list
65112117|NCT02888275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65112118|NCT02888275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65112119|NCT02888275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112120|NCT02888275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65112121|NCT02888275|Analgesics|analgesics|mesh-ancestor
65112122|NCT02888275|Sensory System Agents|sensory system agents|mesh-ancestor
65112123|NCT02888275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65112124|NCT02888275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65112125|NCT02888275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65112126|NCT02888275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65112127|NCT02888275|Adrenergic Agents|adrenergic agents|mesh-ancestor
65112128|NCT02888275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65112129|NCT02888275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112130|NCT01239394|Ofatumumab|ofatumumab|mesh-list
65112131|NCT01239394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112132|NCT03456531|Aspirin|aspirin|mesh-list
65112142|NCT03456531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65112143|NCT03456531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293323|NCT00867360|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65293324|NCT00867360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65293325|NCT00867360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65293326|NCT00867360|Contraceptive Agents|contraceptive agents|mesh-ancestor
65293327|NCT00867360|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65293328|NCT00867360|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65293329|NCT00867360|Hormone Antagonists|hormone antagonists|mesh-ancestor
65293330|NCT00867360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65293331|NCT00867360|Luteolytic Agents|luteolytic agents|mesh-ancestor
65293332|NCT00867360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65293333|NCT00867360|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65293334|NCT00656552|Citalopram|citalopram|mesh-list
65293335|NCT00656552|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65293336|NCT00656552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65293337|NCT00656552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65293338|NCT00656552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293339|NCT00656552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65293340|NCT00656552|Serotonin Agents|serotonin agents|mesh-ancestor
65293341|NCT00656552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293342|NCT00656552|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65293343|NCT00656552|Antidepressive Agents|antidepressive agents|mesh-ancestor
65293344|NCT00656552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65293345|NCT01004809|Dutasteride|dutasteride|mesh-list
65293346|NCT01004809|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65293347|NCT01004809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65293348|NCT01004809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523581|NCT04768439|Vitamin D|vitamin d|mesh-list
65112144|NCT03456531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65112145|NCT03456531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65112146|NCT03456531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112148|NCT02909049|Midazolam|midazolam|mesh-list
65112149|NCT02909049|Ketamine|ketamine|mesh-list
65112150|NCT02909049|Mepivacaine|mepivacaine|mesh-list
65112151|NCT02909049|Analgesics|analgesics|mesh-ancestor
65112152|NCT02909049|Sensory System Agents|sensory system agents|mesh-ancestor
65112153|NCT02909049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65112154|NCT02909049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112155|NCT02909049|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65112156|NCT02909049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65112157|NCT02909049|Anesthetics, General|anesthetics, general|mesh-ancestor
65112158|NCT02909049|Anesthetics|anesthetics|mesh-ancestor
65112159|NCT02909049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65112160|NCT02909049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65112161|NCT02909049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65293349|NCT01004809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293350|NCT01004809|Hormone Antagonists|hormone antagonists|mesh-ancestor
65293351|NCT01004809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65293352|NCT01004809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293353|NCT00883688|Bevacizumab|bevacizumab|mesh-list
65293354|NCT00883688|Lapatinib|lapatinib|mesh-list
65293355|NCT00883688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65293356|NCT00883688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293357|NCT00883688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65293358|NCT00883688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65293359|NCT00883688|Growth Substances|growth substances|mesh-ancestor
65293360|NCT00883688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293361|NCT00883688|Growth Inhibitors|growth inhibitors|mesh-ancestor
65293362|NCT00883688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65293363|NCT00883688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293364|NCT00883688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293365|NCT04191863|Valproic Acid|valproic acid|mesh-list
65293366|NCT04191863|Anticonvulsants|anticonvulsants|mesh-ancestor
65293367|NCT04191863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293368|NCT04191863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293369|NCT04191863|GABA Agents|gaba agents|mesh-ancestor
64523601|NCT03181464|Anesthetics, Local|anesthetics, local|mesh-ancestor
64523602|NCT03181464|Anesthetics|anesthetics|mesh-ancestor
65112162|NCT02909049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65112163|NCT02909049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112164|NCT02909049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65112165|NCT02909049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65112166|NCT02909049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65112167|NCT02909049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65112168|NCT02909049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65112169|NCT02909049|GABA Modulators|gaba modulators|mesh-ancestor
65112170|NCT02909049|GABA Agents|gaba agents|mesh-ancestor
65112171|NCT02909049|Anesthetics, Local|anesthetics, local|mesh-ancestor
65112172|NCT01229449|Acetaminophen|acetaminophen|mesh-list
65112173|NCT01229449|Ibuprofen|ibuprofen|mesh-list
65112174|NCT01229449|Codeine|codeine|mesh-list
65112175|NCT01229449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65112176|NCT01229449|Analgesics|analgesics|mesh-ancestor
65112177|NCT01229449|Sensory System Agents|sensory system agents|mesh-ancestor
65112178|NCT01229449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65112179|NCT01229449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112180|NCT01229449|Antipyretics|antipyretics|mesh-ancestor
65112181|NCT01229449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65112182|NCT01229449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65112183|NCT01229449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65112184|NCT01229449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65112185|NCT01229449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112186|NCT01229449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112187|NCT01229449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65112188|NCT01229449|Narcotics|narcotics|mesh-ancestor
65293370|NCT04191863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65293371|NCT04191863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293372|NCT04191863|Antimanic Agents|antimanic agents|mesh-ancestor
65293373|NCT04191863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65293374|NCT04191863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65293375|NCT04191863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65293376|NCT02636348|Vitamin D|vitamin d|mesh-list
65293377|NCT02636348|Calcium|calcium|mesh-list
65293378|NCT02636348|Vitamins|vitamins|mesh-ancestor
65293379|NCT02636348|Micronutrients|micronutrients|mesh-ancestor
65293380|NCT02636348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293381|NCT02636348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65293382|NCT02636348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65293383|NCT04219865|Edaravone|edaravone|mesh-list
65293384|NCT04219865|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65293385|NCT04219865|Antioxidants|antioxidants|mesh-ancestor
65293386|NCT04219865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293387|NCT04219865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65293388|NCT04219865|Protective Agents|protective agents|mesh-ancestor
65293389|NCT04219865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293390|NCT01002703|Prednisone|prednisone|mesh-list
65293391|NCT01002703|Lenalidomide|lenalidomide|mesh-list
65293392|NCT01002703|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65293393|NCT01002703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65112189|NCT01229449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65112190|NCT01229449|Antitussive Agents|antitussive agents|mesh-ancestor
65112191|NCT01229449|Respiratory System Agents|respiratory system agents|mesh-ancestor
65112192|NCT01238575|Guanfacine|guanfacine|mesh-list
65112193|NCT01238575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65112194|NCT01238575|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65112195|NCT01238575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65112196|NCT01238575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65112197|NCT01238575|Adrenergic Agents|adrenergic agents|mesh-ancestor
65112198|NCT01238575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65112205|NCT01237951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65112207|NCT01237951|Autonomic Agents|autonomic agents|mesh-ancestor
65112208|NCT01237951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65112209|NCT01237951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112210|NCT01237951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65112211|NCT01237951|Glucocorticoids|glucocorticoids|mesh-ancestor
65112212|NCT01237951|Hormones|hormones|mesh-ancestor
65112213|NCT01237951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65112214|NCT01237951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65112215|NCT01237951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112216|NCT01237951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65112218|NCT01237951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112219|NCT01237951|Antiviral Agents|antiviral agents|mesh-ancestor
65112220|NCT01237951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65112221|NCT01237951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112222|NCT01237951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65112223|NCT01237951|Immunologic Factors|immunologic factors|mesh-ancestor
65293394|NCT01002703|Glucocorticoids|glucocorticoids|mesh-ancestor
65293395|NCT01002703|Hormones|hormones|mesh-ancestor
65293396|NCT01002703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65293397|NCT01002703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293398|NCT01002703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65293399|NCT01002703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293400|NCT01002703|Immunologic Factors|immunologic factors|mesh-ancestor
65293401|NCT01002703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65293402|NCT01002703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65293403|NCT01002703|Growth Substances|growth substances|mesh-ancestor
65293404|NCT01002703|Growth Inhibitors|growth inhibitors|mesh-ancestor
65293405|NCT01002703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65293406|NCT01002703|Alkylating Agents|alkylating agents|mesh-ancestor
64523645|NCT03106740|Minocycline|minocycline|mesh-list
64523648|NCT03106818|Ketorolac|ketorolac|mesh-list
65112224|NCT01237951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65112225|NCT01237951|Alkylating Agents|alkylating agents|mesh-ancestor
65112226|NCT01237951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65112227|NCT02908581|Folic Acid|folic acid|mesh-list
65112228|NCT02908581|Vitamin B Complex|vitamin b complex|mesh-list
65112229|NCT02908581|Hematinics|hematinics|mesh-ancestor
65112230|NCT02908581|Vitamins|vitamins|mesh-ancestor
65112231|NCT02908581|Micronutrients|micronutrients|mesh-ancestor
65112232|NCT02908581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112233|NCT00544362|Fluorouracil|fluorouracil|mesh-list
65112234|NCT00544362|Cetuximab|cetuximab|mesh-list
65112235|NCT00544362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112236|NCT00544362|Antimetabolites|antimetabolites|mesh-ancestor
65112237|NCT00544362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112238|NCT00544362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65112239|NCT00544362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65112240|NCT00544362|Immunologic Factors|immunologic factors|mesh-ancestor
65112241|NCT00544362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112242|NCT00544362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65112243|NCT00553293|Hormones|hormones|mesh-list
65112244|NCT00553293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65112245|NCT00553293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65112246|NCT00553293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112247|NCT04648358|Dexamethasone|dexamethasone|mesh-list
65112248|NCT04648358|Bupivacaine|bupivacaine|mesh-list
65112249|NCT04648358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65112250|NCT04648358|Antiemetics|antiemetics|mesh-ancestor
65112251|NCT04648358|Autonomic Agents|autonomic agents|mesh-ancestor
65112252|NCT04648358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65112253|NCT04648358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112254|NCT04648358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65112255|NCT04648358|Glucocorticoids|glucocorticoids|mesh-ancestor
65112256|NCT04648358|Hormones|hormones|mesh-ancestor
65112257|NCT04648358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65112258|NCT04648358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65112259|NCT04648358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112260|NCT04648358|Anesthetics, Local|anesthetics, local|mesh-ancestor
65112261|NCT04648358|Anesthetics|anesthetics|mesh-ancestor
65112262|NCT04648358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65112263|NCT04648358|Sensory System Agents|sensory system agents|mesh-ancestor
65112264|NCT00544518|Metformin|metformin|mesh-list
65112265|NCT00544518|Benfluorex|benfluorex|mesh-list
65112266|NCT00544518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65112267|NCT00544518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112268|NCT00544518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65112269|NCT00544518|Antimetabolites|antimetabolites|mesh-ancestor
65293407|NCT01002703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293408|NCT02639234|Nivolumab|nivolumab|mesh-list
65293409|NCT02639234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65293410|NCT02639234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293411|NCT02639234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65293412|NCT02639234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293413|NCT00654290|Propranolol|propranolol|mesh-list
65293414|NCT00654290|Amiodarone|amiodarone|mesh-list
65293415|NCT00654290|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65293416|NCT00654290|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65293417|NCT00654290|Adrenergic Agents|adrenergic agents|mesh-ancestor
65293418|NCT00654290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65293419|NCT00654290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293420|NCT00654290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523666|NCT03106818|Anticonvulsants|anticonvulsants|mesh-ancestor
65112277|NCT02908698|Hormones|hormones|mesh-ancestor
65112278|NCT02908698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65112279|NCT02908698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112280|NCT02908698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65112281|NCT02908698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112282|NCT00544596|Acetic Acid|acetic acid|mesh-list
65112283|NCT00544596|Etoposide|etoposide|mesh-list
65112284|NCT00544596|Etoposide phosphate|etoposide phosphate|mesh-list
65112285|NCT00544596|Retinol acetate|retinol acetate|mesh-list
65112286|NCT00544596|Gossypol acetic acid|gossypol acetic acid|mesh-list
65112287|NCT00544596|Gossypol|gossypol|mesh-list
65112288|NCT00544596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112289|NCT00544596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65112290|NCT00544596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65112291|NCT00544596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65112292|NCT00544596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112293|NCT00544596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112294|NCT00544596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65112295|NCT00544596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65112296|NCT00544596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65112297|NCT00544596|Immunologic Factors|immunologic factors|mesh-ancestor
65112298|NCT00544596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112299|NCT00544596|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65112300|NCT00544596|Protective Agents|protective agents|mesh-ancestor
65112301|NCT00544596|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65112302|NCT00544596|Contraceptive Agents|contraceptive agents|mesh-ancestor
65112303|NCT00544596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65112304|NCT00544596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65112305|NCT00544596|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
65112306|NCT00544596|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
65112307|NCT02908191|Tenofovir|tenofovir|mesh-list
65112308|NCT02908191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65112309|NCT02908191|Entecavir|entecavir|mesh-list
65112310|NCT02908191|Antiviral Agents|antiviral agents|mesh-ancestor
65112311|NCT02908191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65112312|NCT02908191|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65112313|NCT02908191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65112314|NCT02908191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112315|NCT02908191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112316|NCT02908191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65112317|NCT02908191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65112318|NCT00544791|Melatonin|melatonin|mesh-list
65112319|NCT00544791|Antioxidants|antioxidants|mesh-ancestor
65293421|NCT00654290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65293422|NCT00654290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65293423|NCT00654290|Vasodilator Agents|vasodilator agents|mesh-ancestor
65293424|NCT00654290|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65293425|NCT00654290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65293426|NCT00654290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65293427|NCT00654290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65293428|NCT00654290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65293429|NCT00654290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293430|NCT00654290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65293431|NCT00654290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65293432|NCT00654290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65293433|NCT02713139|Metronidazole|metronidazole|mesh-list
65293434|NCT02713139|Clotrimazole|clotrimazole|mesh-list
65293435|NCT02713139|Miconazole|miconazole|mesh-list
65293436|NCT02713139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65293437|NCT02713139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65293438|NCT02713139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65293439|NCT02713139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65293440|NCT02713139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65293441|NCT02713139|Antifungal Agents|antifungal agents|mesh-ancestor
65293442|NCT02713139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65293443|NCT02713139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65293444|NCT02713139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293445|NCT02713139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112320|NCT00544791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112321|NCT00544791|Protective Agents|protective agents|mesh-ancestor
65112322|NCT00544791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112323|NCT00544791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65112324|NCT04647773|Pregabalin|pregabalin|mesh-list
65112325|NCT04647773|Analgesics|analgesics|mesh-ancestor
65112326|NCT04647773|Sensory System Agents|sensory system agents|mesh-ancestor
65112327|NCT04647773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65112328|NCT04647773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112329|NCT04647773|Anticonvulsants|anticonvulsants|mesh-ancestor
65112330|NCT04647773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65112331|NCT04647773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65112347|NCT01237678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65112349|NCT04647461|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65112350|NCT04647461|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65112351|NCT04647461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65112352|NCT04647461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65112353|NCT04647461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65112354|NCT04647461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65112355|NCT04647461|Adrenergic Agents|adrenergic agents|mesh-ancestor
65112356|NCT04647461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65293446|NCT02713139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65293447|NCT02713139|Hormone Antagonists|hormone antagonists|mesh-ancestor
65293448|NCT02713139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65293449|NCT02713139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293450|NCT02713139|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65293451|NCT02713139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65293453|NCT01005121|Gout Suppressants|gout suppressants|mesh-ancestor
65293454|NCT01005121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65293455|NCT01005121|Tubulin Modulators|tubulin modulators|mesh-ancestor
65293456|NCT01005121|Antimitotic Agents|antimitotic agents|mesh-ancestor
65293457|NCT01005121|Mitosis Modulators|mitosis modulators|mesh-ancestor
65293458|NCT01005121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293459|NCT01005121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293460|NCT02711579|Celecoxib|celecoxib|mesh-list
65293461|NCT02711579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65293462|NCT02711579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65293463|NCT02711579|Analgesics|analgesics|mesh-ancestor
65293464|NCT02711579|Sensory System Agents|sensory system agents|mesh-ancestor
65293465|NCT02711579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65293466|NCT02711579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523703|NCT01867606|Antibodies|antibodies|mesh-list
65112357|NCT04647461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112358|NCT04647461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112360|NCT01229371|Immunologic Factors|immunologic factors|mesh-ancestor
64513697|NCT04272255|Scopolamine|scopolamine|mesh-list
65112361|NCT01229371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112362|NCT02908152|Curcumin|curcumin|mesh-list
65112363|NCT02908152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65112364|NCT02908152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65112365|NCT02908152|Analgesics|analgesics|mesh-ancestor
65112366|NCT02908152|Sensory System Agents|sensory system agents|mesh-ancestor
65112367|NCT02908152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65112368|NCT02908152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112369|NCT02908152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65112370|NCT02908152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65112371|NCT02908152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112372|NCT02908152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112373|NCT02908152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112374|NCT01237327|Exemestane|exemestane|mesh-list
65112375|NCT01237327|Megestrol|megestrol|mesh-list
65112376|NCT01237327|Megestrol Acetate|megestrol acetate|mesh-list
65112377|NCT01237327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112378|NCT01237327|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65112379|NCT01237327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65112380|NCT01237327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112381|NCT01237327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112382|NCT01237327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65112383|NCT01237327|Hormone Antagonists|hormone antagonists|mesh-ancestor
65112393|NCT01237327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65112394|NCT01237327|Appetite Stimulants|appetite stimulants|mesh-ancestor
65112395|NCT01237327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65293467|NCT02711579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65293468|NCT02711579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65293469|NCT02711579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65293470|NCT02711579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65293471|NCT02711579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293472|NCT02711579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293473|NCT00611195|Remifentanil|remifentanil|mesh-list
65293474|NCT00611195|Propofol|propofol|mesh-list
65293475|NCT00611195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65293476|NCT00611195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65293477|NCT00611195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293478|NCT00611195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65293479|NCT00611195|Anesthetics, General|anesthetics, general|mesh-ancestor
65293480|NCT00611195|Anesthetics|anesthetics|mesh-ancestor
65293481|NCT00611195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65293482|NCT00611195|Narcotics|narcotics|mesh-ancestor
65293483|NCT00611195|Analgesics|analgesics|mesh-ancestor
65293484|NCT00611195|Sensory System Agents|sensory system agents|mesh-ancestor
64523719|NCT02415270|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64523730|NCT02415114|Resveratrol|resveratrol|mesh-list
65112396|NCT02907021|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65112397|NCT02907021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65112398|NCT02907021|Adrenergic Agents|adrenergic agents|mesh-ancestor
65112399|NCT02907021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65112400|NCT02907021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112401|NCT02907021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112402|NCT01237054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65112403|NCT01237054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65112404|NCT01237054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112405|NCT04647695|Interferons|interferons|mesh-list
65112406|NCT04647695|Interferon-beta|interferon-beta|mesh-list
65112407|NCT04647695|Remdesivir|remdesivir|mesh-list
65112408|NCT04647695|Interferon beta-1b|interferon beta-1b|mesh-list
65112409|NCT04647695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112410|NCT04647695|Antiviral Agents|antiviral agents|mesh-ancestor
65112411|NCT04647695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65112412|NCT04647695|Immunologic Factors|immunologic factors|mesh-ancestor
65112413|NCT04647695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112414|NCT04647695|Antimetabolites|antimetabolites|mesh-ancestor
65112415|NCT04647695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112416|NCT04647695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65112417|NCT04647344|Paclitaxel|paclitaxel|mesh-list
65112418|NCT04647344|Carboplatin|carboplatin|mesh-list
65112419|NCT04647344|Pemetrexed|pemetrexed|mesh-list
65112420|NCT04647344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65112421|NCT04647344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112422|NCT04647344|Tubulin Modulators|tubulin modulators|mesh-ancestor
65112423|NCT04647344|Antimitotic Agents|antimitotic agents|mesh-ancestor
65112424|NCT04647344|Mitosis Modulators|mitosis modulators|mesh-ancestor
65112425|NCT04647344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112426|NCT04647344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112427|NCT04647344|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65112428|NCT04647344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65112429|NCT02906748|Parathyroid Hormone|parathyroid hormone|mesh-list
65112430|NCT02906748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65293485|NCT00611195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65293486|NCT01008709|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65293487|NCT01008709|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
65293488|NCT01008709|beta-Endorphin|beta-endorphin|mesh-list
65293489|NCT01008709|Hormones|hormones|mesh-ancestor
65293490|NCT01008709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65293491|NCT01008709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293492|NCT01008709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65293493|NCT01008709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293494|NCT04117893|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65293495|NCT04117893|Hyaluronic Acid|hyaluronic acid|mesh-list
65293496|NCT04117893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65293497|NCT04117893|Immunologic Factors|immunologic factors|mesh-ancestor
64523737|NCT03178422|Nicotine|nicotine|mesh-list
64523738|NCT03178422|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64523750|NCT02414880|Rocuronium|rocuronium|mesh-list
65112431|NCT02906748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112432|NCT02907957|Anesthetics|anesthetics|mesh-list
65112433|NCT02907957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65112434|NCT02907957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112436|NCT04646876|Analgesics|analgesics|mesh-ancestor
65112437|NCT04646876|Sensory System Agents|sensory system agents|mesh-ancestor
65112438|NCT04646876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65112439|NCT04646876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112440|NCT04646876|Anesthetics|anesthetics|mesh-ancestor
65112441|NCT04646876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65112442|NCT04646876|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65112443|NCT04646876|Anticonvulsants|anticonvulsants|mesh-ancestor
65112444|NCT04646876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65112445|NCT04646876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65112446|NCT04646876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112463|NCT04646759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112464|NCT04646759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112465|NCT04646759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65112466|NCT04646759|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65112467|NCT04646759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65112468|NCT04646759|Hormone Antagonists|hormone antagonists|mesh-ancestor
65112469|NCT04646759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65112470|NCT04646759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112471|NCT02906514|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65112472|NCT02906514|Plasma Substitutes|plasma substitutes|mesh-ancestor
65112473|NCT02906514|Blood Substitutes|blood substitutes|mesh-ancestor
65112475|NCT04646135|Anticonvulsants|anticonvulsants|mesh-ancestor
65112476|NCT04646135|Antiemetics|antiemetics|mesh-ancestor
65112477|NCT04646135|Autonomic Agents|autonomic agents|mesh-ancestor
65112478|NCT04646135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65112479|NCT04646135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112480|NCT04646135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65112481|NCT04646135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65112482|NCT04646135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65112483|NCT04646135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65112484|NCT04646135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65112485|NCT04646135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65112486|NCT04646135|GABA Modulators|gaba modulators|mesh-ancestor
65112487|NCT04646135|GABA Agents|gaba agents|mesh-ancestor
65112488|NCT04646135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65293498|NCT04117893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293499|NCT04117893|Viscosupplements|viscosupplements|mesh-ancestor
65293500|NCT04117893|Protective Agents|protective agents|mesh-ancestor
65293501|NCT04117893|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65293502|NCT04117893|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65293503|NCT04117893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65293504|NCT04117893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293505|NCT04117893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65293506|NCT04117893|Analgesics|analgesics|mesh-ancestor
65043424|NCT00228891|Insulin|insulin|mesh-list
65293507|NCT04117893|Sensory System Agents|sensory system agents|mesh-ancestor
65293508|NCT04117893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65293509|NCT04117893|Antidepressive Agents|antidepressive agents|mesh-ancestor
65293510|NCT04117893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65293511|NCT04117893|Dopamine Agents|dopamine agents|mesh-ancestor
65293512|NCT02615574|Interferons|interferons|mesh-list
65293513|NCT02615574|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
65293514|NCT02615574|Celecoxib|celecoxib|mesh-list
65293515|NCT02615574|Vaccines|vaccines|mesh-list
65293516|NCT02615574|Immunologic Factors|immunologic factors|mesh-ancestor
65293517|NCT02615574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293518|NCT02615574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523751|NCT02414880|Neostigmine|neostigmine|mesh-list
64523764|NCT02423694|Dexetimide|dexetimide|mesh-list
65112489|NCT04646135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112490|NCT02906553|Nitroglycerin|nitroglycerin|mesh-list
65112491|NCT02906553|Vasodilator Agents|vasodilator agents|mesh-ancestor
65112492|NCT04682184|Propranolol|propranolol|mesh-list
65112493|NCT04682184|Pseudoephedrine|pseudoephedrine|mesh-list
65112494|NCT04682184|Ephedrine|ephedrine|mesh-list
65112495|NCT04682184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65112496|NCT04682184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65112497|NCT04682184|Adrenergic Agents|adrenergic agents|mesh-ancestor
65112498|NCT04682184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65112499|NCT04682184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112500|NCT04682184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112501|NCT04682184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65112502|NCT04682184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65112503|NCT04682184|Vasodilator Agents|vasodilator agents|mesh-ancestor
65112504|NCT04682184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65112505|NCT04682184|Autonomic Agents|autonomic agents|mesh-ancestor
65112529|NCT00558623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65112530|NCT00558623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112531|NCT00558623|Antacids|antacids|mesh-ancestor
65112532|NCT00558623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112533|NCT00558623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65112534|NCT00558662|Monensin|monensin|mesh-list
65112535|NCT00558662|Antifungal Agents|antifungal agents|mesh-ancestor
65112536|NCT00558662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65112537|NCT00558662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65112538|NCT00558662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65112539|NCT00558662|Coccidiostats|coccidiostats|mesh-ancestor
65293519|NCT02615574|Antiviral Agents|antiviral agents|mesh-ancestor
65293520|NCT02615574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65293521|NCT02615574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65293522|NCT02615574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65293523|NCT02615574|Analgesics|analgesics|mesh-ancestor
65293524|NCT02615574|Sensory System Agents|sensory system agents|mesh-ancestor
65293525|NCT02615574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65293526|NCT02615574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65293527|NCT02615574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65293528|NCT02615574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65293529|NCT02615574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65293530|NCT02615574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293531|NCT02615574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293532|NCT02708693|Triamcinolone|triamcinolone|mesh-list
65293533|NCT02708693|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65293534|NCT02708693|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65293535|NCT02708693|Lidocaine|lidocaine|mesh-list
65293536|NCT02708693|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64523772|NCT02423694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112540|NCT00558662|Proton Ionophores|proton ionophores|mesh-ancestor
65112541|NCT00558662|Uncoupling Agents|uncoupling agents|mesh-ancestor
65112542|NCT00558662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112543|NCT00558662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112544|NCT00558662|Ionophores|ionophores|mesh-ancestor
65112545|NCT00558662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65112546|NCT00558662|Sodium Ionophores|sodium ionophores|mesh-ancestor
65112547|NCT02905890|Norethindrone|norethindrone|mesh-list
65112548|NCT02905890|Norethindrone enanthate|norethindrone enanthate|mesh-list
65112549|NCT02905890|Norethindrone Acetate|norethindrone acetate|mesh-list
65112550|NCT02905890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65112551|NCT02905890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65112552|NCT02905890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65112553|NCT02905890|Contraceptive Agents|contraceptive agents|mesh-ancestor
65112554|NCT02905890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65112555|NCT02905890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684857|NCT00002925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112581|NCT02905695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65112584|NCT00558818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65112585|NCT04644341|Respiratory System Agents|respiratory system agents|mesh-list
65112586|NCT04681911|Gemcitabine|gemcitabine|mesh-list
65112587|NCT04681911|Paclitaxel|paclitaxel|mesh-list
65112588|NCT04681911|Vinorelbine|vinorelbine|mesh-list
65112589|NCT04681911|Carboplatin|carboplatin|mesh-list
65112590|NCT04681911|Capecitabine|capecitabine|mesh-list
65112591|NCT04681911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65112592|NCT04681911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112593|NCT04681911|Tubulin Modulators|tubulin modulators|mesh-ancestor
65112594|NCT04681911|Antimitotic Agents|antimitotic agents|mesh-ancestor
65112595|NCT04681911|Mitosis Modulators|mitosis modulators|mesh-ancestor
65112596|NCT04681911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112597|NCT04681911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65112598|NCT04681911|Antimetabolites|antimetabolites|mesh-ancestor
65112599|NCT04681911|Antiviral Agents|antiviral agents|mesh-ancestor
65112600|NCT04681911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65112601|NCT04681911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112602|NCT04681911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65293537|NCT02708693|Anesthetics, Local|anesthetics, local|mesh-ancestor
65293538|NCT02708693|Anesthetics|anesthetics|mesh-ancestor
65293539|NCT02708693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65293540|NCT02708693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293541|NCT02708693|Sensory System Agents|sensory system agents|mesh-ancestor
65293542|NCT02708693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65293543|NCT02708693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65293544|NCT02708693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65293545|NCT02708693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64523790|NCT02420418|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65112603|NCT04681911|Immunologic Factors|immunologic factors|mesh-ancestor
65112604|NCT04681911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112605|NCT02905539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65112606|NCT02905539|Hematinics|hematinics|mesh-ancestor
65112607|NCT02905734|Nicotine|nicotine|mesh-list
65112608|NCT02905734|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65112609|NCT02905734|Autonomic Agents|autonomic agents|mesh-ancestor
65112610|NCT02905734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65112622|NCT02905461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65112623|NCT02905461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112624|NCT02905305|Dexamethasone|dexamethasone|mesh-list
65112625|NCT02905305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65112626|NCT02905305|Antiemetics|antiemetics|mesh-ancestor
65112627|NCT02905305|Autonomic Agents|autonomic agents|mesh-ancestor
65112628|NCT02905305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65112629|NCT02905305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112630|NCT02905305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65112631|NCT02905305|Glucocorticoids|glucocorticoids|mesh-ancestor
65112632|NCT02905305|Hormones|hormones|mesh-ancestor
65112633|NCT02905305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65112634|NCT02905305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65112635|NCT02905305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112636|NCT02899182|Nitrous Oxide|nitrous oxide|mesh-list
65112637|NCT02899182|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65112638|NCT02899182|Anesthetics, General|anesthetics, general|mesh-ancestor
65112639|NCT02899182|Anesthetics|anesthetics|mesh-ancestor
65112640|NCT02899182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65112641|NCT02899182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112642|NCT02899182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65112643|NCT02899182|Analgesics|analgesics|mesh-ancestor
65112644|NCT02899182|Sensory System Agents|sensory system agents|mesh-ancestor
65112645|NCT02899182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65112646|NCT02905227|Zolmitriptan|zolmitriptan|mesh-list
65112647|NCT02905227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65112648|NCT02905227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65112649|NCT02905227|Serotonin Agents|serotonin agents|mesh-ancestor
65112650|NCT02905227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65112651|NCT02905227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112652|NCT02905227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112653|NCT04643483|Adalimumab|adalimumab|mesh-list
65112654|NCT04643483|Certolizumab Pegol|certolizumab pegol|mesh-list
65112655|NCT04643483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65112656|NCT04643483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64754908|NCT02730546|Vitamins|vitamins|mesh-ancestor
65112659|NCT04643483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112660|NCT00559052|Pancrelipase|pancrelipase|mesh-list
65112661|NCT00559052|Pancreatin|pancreatin|mesh-list
65112662|NCT00559052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65112663|NCT02899104|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65112664|NCT02899104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112665|NCT04643132|Ketamine|ketamine|mesh-list
65112666|NCT04643132|Esketamine|esketamine|mesh-list
65112667|NCT04643132|Analgesics|analgesics|mesh-ancestor
65112668|NCT04643132|Sensory System Agents|sensory system agents|mesh-ancestor
65112669|NCT04643132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65112670|NCT04643132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293546|NCT02708693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65293547|NCT02708693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293548|NCT02708693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65293549|NCT02708693|Glucocorticoids|glucocorticoids|mesh-ancestor
65293550|NCT02708693|Hormones|hormones|mesh-ancestor
65293551|NCT02708693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65293552|NCT02708693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65293553|NCT02708693|Immunologic Factors|immunologic factors|mesh-ancestor
65293554|NCT02708693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293555|NCT02638922|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65293556|NCT02638922|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65293557|NCT02638922|Trisequens|trisequens|mesh-list
65293558|NCT02638922|Norethindrone|norethindrone|mesh-list
65293559|NCT02638922|Estradiol|estradiol|mesh-list
65293560|NCT02638922|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65293561|NCT02638922|Estrogens|estrogens|mesh-ancestor
65293562|NCT02638922|Hormones|hormones|mesh-ancestor
65293563|NCT02638922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65293564|NCT02638922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293565|NCT02638922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64523800|NCT02414802|Tinzaparin|tinzaparin|mesh-list
65112671|NCT04643132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65112672|NCT04643132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65112673|NCT04643132|Anesthetics, General|anesthetics, general|mesh-ancestor
65112674|NCT04643132|Anesthetics|anesthetics|mesh-ancestor
65112675|NCT04643132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64684958|NCT00002961|Antimetabolites|antimetabolites|mesh-ancestor
65112683|NCT02899143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65112685|NCT02899026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65112686|NCT02899026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65112687|NCT02899026|Glucocorticoids|glucocorticoids|mesh-ancestor
65112688|NCT02899026|Hormones|hormones|mesh-ancestor
65112689|NCT02899026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65112690|NCT02899026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112691|NCT02899026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65112692|NCT02899026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112693|NCT02899026|Immunologic Factors|immunologic factors|mesh-ancestor
65112694|NCT00559169|Verapamil|verapamil|mesh-list
65112695|NCT00559169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65112696|NCT00559169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65112697|NCT00559169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65112698|NCT00559169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112699|NCT00559169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65112700|NCT00559169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112701|NCT00559169|Vasodilator Agents|vasodilator agents|mesh-ancestor
65112702|NCT04642664|Apatinib|apatinib|mesh-list
65112703|NCT04642664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112704|NCT04642664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65112705|NCT04642664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112706|NCT04642664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112707|NCT02904759|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65112708|NCT02904759|Hemostatics|hemostatics|mesh-ancestor
65112709|NCT02904759|Coagulants|coagulants|mesh-ancestor
65293566|NCT02638922|Contraceptive Agents|contraceptive agents|mesh-ancestor
65293567|NCT02638922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65293572|NCT01005199|Everolimus|everolimus|mesh-list
65293639|NCT01009021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65293640|NCT01009021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293641|NCT01009021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65293642|NCT01009021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65293643|NCT01009021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65293644|NCT01009021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293645|NCT01009021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293646|NCT01005433|Dexmedetomidine|dexmedetomidine|mesh-list
65293647|NCT01005433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65112710|NCT02904759|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65112711|NCT02904759|Natriuretic Agents|natriuretic agents|mesh-ancestor
65112712|NCT02904759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112713|NCT04642547|Lenvatinib|lenvatinib|mesh-list
65112714|NCT04642547|Gefitinib|gefitinib|mesh-list
65112715|NCT04642547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112716|NCT04642547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65112717|NCT04642547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112718|NCT04642547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112719|NCT02898792|Remifentanil|remifentanil|mesh-list
65112720|NCT02898792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65112721|NCT02898792|Narcotics|narcotics|mesh-ancestor
65112722|NCT02898792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65112723|NCT02898792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112724|NCT02898792|Analgesics|analgesics|mesh-ancestor
65112725|NCT02898792|Sensory System Agents|sensory system agents|mesh-ancestor
65112726|NCT02898792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65112727|NCT04642391|Cosyntropin|cosyntropin|mesh-list
65112728|NCT04642391|Hormones|hormones|mesh-ancestor
65112729|NCT04642391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65112730|NCT04642391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112731|NCT02904564|Fluorouracil|fluorouracil|mesh-list
65112732|NCT02904564|Antimetabolites|antimetabolites|mesh-ancestor
65112733|NCT02904564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112734|NCT02904564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65112735|NCT02904564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112736|NCT02904564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65112737|NCT02904564|Immunologic Factors|immunologic factors|mesh-ancestor
65112738|NCT02904564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112740|NCT04642001|Sodium Fluoride|sodium fluoride|mesh-list
65112741|NCT04642001|Cariostatic Agents|cariostatic agents|mesh-ancestor
65112742|NCT04642001|Protective Agents|protective agents|mesh-ancestor
65112750|NCT00559286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112752|NCT04640870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112753|NCT04640870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65112754|NCT04640870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112755|NCT04640870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112756|NCT04640831|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
65112757|NCT04640831|Hallucinogens|hallucinogens|mesh-ancestor
65112758|NCT04640831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112759|NCT04640831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65112760|NCT04640831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65112761|NCT04640831|Serotonin Agents|serotonin agents|mesh-ancestor
65112762|NCT04640831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65112763|NCT04640831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112764|NCT04640831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65112765|NCT02897934|Bupivacaine|bupivacaine|mesh-list
65112766|NCT02897934|Anesthetics, Local|anesthetics, local|mesh-ancestor
65112767|NCT02897934|Anesthetics|anesthetics|mesh-ancestor
65112768|NCT02897934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65112769|NCT02897934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112770|NCT02897934|Sensory System Agents|sensory system agents|mesh-ancestor
65112771|NCT02897934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65112772|NCT04640129|Interferons|interferons|mesh-list
65112773|NCT04640129|Tenofovir|tenofovir|mesh-list
65293648|NCT01005433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65293649|NCT01005433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293650|NCT01005433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65293651|NCT01005433|Analgesics|analgesics|mesh-ancestor
65293652|NCT01005433|Sensory System Agents|sensory system agents|mesh-ancestor
65293653|NCT01005433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65293654|NCT01005433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65293655|NCT01005433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65293656|NCT01005433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65043570|NCT00229125|Antiemetics|antiemetics|mesh-ancestor
65293657|NCT01005433|Adrenergic Agents|adrenergic agents|mesh-ancestor
65293658|NCT01005433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65293659|NCT01005433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293660|NCT00654446|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65293661|NCT00654446|Simvastatin|simvastatin|mesh-list
65293662|NCT00654446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65293663|NCT00654446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65293664|NCT00654446|Antimetabolites|antimetabolites|mesh-ancestor
65293665|NCT00654446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112774|NCT04640129|Interferon-alpha|interferon-alpha|mesh-list
65112775|NCT04640129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112776|NCT04640129|Antiviral Agents|antiviral agents|mesh-ancestor
65112777|NCT04640129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65112778|NCT04640129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65112779|NCT04640129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65112780|NCT04640129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112781|NCT04640129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112782|NCT04640129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65112783|NCT04640129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65112784|NCT04640129|Immunologic Factors|immunologic factors|mesh-ancestor
65112785|NCT04640129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112786|NCT02898012|Bevacizumab|bevacizumab|mesh-list
65112787|NCT02898012|Temozolomide|temozolomide|mesh-list
65112788|NCT02898012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65112789|NCT02898012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112790|NCT02898012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65112791|NCT02898012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65112792|NCT02898012|Growth Substances|growth substances|mesh-ancestor
65112793|NCT02898012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112794|NCT02898012|Growth Inhibitors|growth inhibitors|mesh-ancestor
65112795|NCT02898012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65112796|NCT02898012|Alkylating Agents|alkylating agents|mesh-ancestor
65112797|NCT02898012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112798|NCT04640324|Vitamin D|vitamin d|mesh-list
65112799|NCT04640324|Vitamins|vitamins|mesh-list
65112800|NCT04640324|Vitamin E|vitamin e|mesh-list
65112801|NCT04640324|Silybin|silybin|mesh-list
65112802|NCT04640324|Micronutrients|micronutrients|mesh-ancestor
65112803|NCT04640324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112804|NCT04640324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65112805|NCT04640324|Antioxidants|antioxidants|mesh-ancestor
65112806|NCT04640324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112808|NCT04640324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65112809|NCT04640324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293666|NCT00654446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65293667|NCT00654446|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65293668|NCT00654446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293669|NCT01003483|Orlistat|orlistat|mesh-list
65293670|NCT01003483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293671|NCT01003483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293672|NCT01003483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65293673|NCT01003483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65293674|NCT00592839|Estrogens|estrogens|mesh-list
65293675|NCT00592839|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64523924|NCT01697969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64523925|NCT01697969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64523927|NCT01697969|Histamine Agents|histamine agents|mesh-ancestor
65112828|NCT00559481|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65112829|NCT00559481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65112831|NCT00559481|Autonomic Agents|autonomic agents|mesh-ancestor
65112832|NCT00559481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65112833|NCT00559481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112834|NCT00559481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65112835|NCT00559481|Glucocorticoids|glucocorticoids|mesh-ancestor
65112836|NCT00559481|Hormones|hormones|mesh-ancestor
65112837|NCT00559481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65112838|NCT00559481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65112839|NCT00559481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112840|NCT00559481|Antifungal Agents|antifungal agents|mesh-ancestor
65112841|NCT00559481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65112842|NCT00559481|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65112843|NCT00559481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65112844|NCT00559481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112845|NCT00559481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112846|NCT00559481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65112847|NCT00559481|Hormone Antagonists|hormone antagonists|mesh-ancestor
65112848|NCT00559481|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65112849|NCT02897856|Midazolam|midazolam|mesh-list
65112850|NCT02897856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65112851|NCT02897856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65112852|NCT02897856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65112853|NCT02897856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112854|NCT02897856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65112855|NCT02897856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65112856|NCT02897856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65112857|NCT02897856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65112858|NCT02897856|Anesthetics, General|anesthetics, general|mesh-ancestor
65112859|NCT02897856|Anesthetics|anesthetics|mesh-ancestor
65112860|NCT02897856|GABA Modulators|gaba modulators|mesh-ancestor
65112861|NCT02897856|GABA Agents|gaba agents|mesh-ancestor
65112862|NCT02897856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65112863|NCT02897856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112864|NCT01236118|Ixekizumab|ixekizumab|mesh-list
65112865|NCT01236118|Dermatologic Agents|dermatologic agents|mesh-ancestor
65112866|NCT04206631|Doxycycline|doxycycline|mesh-list
65112867|NCT04206631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65112868|NCT04206631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65112885|NCT04639817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112886|NCT04639817|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65112887|NCT04639817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65112888|NCT04639817|Antimalarials|antimalarials|mesh-ancestor
65112889|NCT04639817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65112890|NCT04639817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65112891|NCT04639817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65293676|NCT00592839|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
65293677|NCT00592839|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
65293678|NCT00592839|Hormones|hormones|mesh-ancestor
65293679|NCT00592839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65293680|NCT00592839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293681|NCT01009177|Bosentan|bosentan|mesh-list
65293682|NCT01009177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65293683|NCT01009177|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65293684|NCT01009177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293685|NCT00598832|Adapalene|adapalene|mesh-list
65293686|NCT00598832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65293687|NCT00598832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65293688|NCT00598832|Analgesics|analgesics|mesh-ancestor
65293689|NCT00598832|Sensory System Agents|sensory system agents|mesh-ancestor
65293690|NCT00598832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65293691|NCT00598832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293692|NCT00598832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65293693|NCT00598832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65293694|NCT00598832|Dermatologic Agents|dermatologic agents|mesh-ancestor
65293695|NCT01003561|Anesthetics|anesthetics|mesh-list
65293696|NCT01003561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65293697|NCT01003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293698|NCT02711267|Acyclovir|acyclovir|mesh-list
65293699|NCT02711267|Antiviral Agents|antiviral agents|mesh-ancestor
65293700|NCT02711267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65293701|NCT04219553|Anti-Infective Agents|anti-infective agents|mesh-list
65293702|NCT04219553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65293703|NCT04459871|Thrombin|thrombin|mesh-list
65293704|NCT04459871|Hemostatics|hemostatics|mesh-ancestor
65293705|NCT04459871|Coagulants|coagulants|mesh-ancestor
65293706|NCT02708459|Morphine|morphine|mesh-list
64523937|NCT01697579|Ondansetron|ondansetron|mesh-list
65112892|NCT04639817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65112893|NCT04639817|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65112895|NCT01236001|Anticonvulsants|anticonvulsants|mesh-ancestor
65112896|NCT01236001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65112897|NCT01236001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65112898|NCT01236001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65112899|NCT01236001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112900|NCT02897466|Anti-Infective Agents|anti-infective agents|mesh-list
65112901|NCT02897466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65112902|NCT01229254|Amiodarone|amiodarone|mesh-list
65112903|NCT01229254|Betrixaban|betrixaban|mesh-list
65293707|NCT02708459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65293708|NCT02708459|Narcotics|narcotics|mesh-ancestor
65293709|NCT02708459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65293710|NCT02708459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293711|NCT02708459|Analgesics|analgesics|mesh-ancestor
65293712|NCT02708459|Sensory System Agents|sensory system agents|mesh-ancestor
65293713|NCT02708459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65293714|NCT01005979|Cyclophosphamide|cyclophosphamide|mesh-list
65293715|NCT01005979|Rituximab|rituximab|mesh-list
65293716|NCT01005979|Lenalidomide|lenalidomide|mesh-list
65293717|NCT01005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65293718|NCT01005979|Immunologic Factors|immunologic factors|mesh-ancestor
65293719|NCT01005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523964|NCT01697345|Testosterone|testosterone|mesh-list
64523966|NCT01697345|Hormones|hormones|mesh-ancestor
65112904|NCT01229254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65112905|NCT01229254|Vasodilator Agents|vasodilator agents|mesh-ancestor
65112906|NCT01229254|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65112907|NCT01229254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65112908|NCT01229254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112909|NCT01229254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65112910|NCT01229254|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65112911|NCT01229254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65112912|NCT01229254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112913|NCT01229254|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65112914|NCT01229254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65112915|NCT01229254|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65112916|NCT01229254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65112917|NCT01229254|Antithrombins|antithrombins|mesh-ancestor
65112918|NCT01229254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65112919|NCT01229254|Protease Inhibitors|protease inhibitors|mesh-ancestor
65112920|NCT01229254|Anticoagulants|anticoagulants|mesh-ancestor
65112921|NCT04639232|Probenecid|probenecid|mesh-list
65112922|NCT04639232|Uricosuric Agents|uricosuric agents|mesh-ancestor
65112923|NCT04639232|Gout Suppressants|gout suppressants|mesh-ancestor
65112924|NCT04639232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65112925|NCT04639232|Renal Agents|renal agents|mesh-ancestor
65112926|NCT01235728|Calcitriol|calcitriol|mesh-list
65112927|NCT01235728|MK 0873|mk 0873|mesh-list
65112928|NCT01235728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65112941|NCT00559676|Fluorouracil|fluorouracil|mesh-list
65112942|NCT00559676|Capecitabine|capecitabine|mesh-list
65112943|NCT00559676|Oxaliplatin|oxaliplatin|mesh-list
65112944|NCT00559676|Irinotecan|irinotecan|mesh-list
65112945|NCT00559676|Calcium|calcium|mesh-list
65112946|NCT00559676|Levoleucovorin|levoleucovorin|mesh-list
65112947|NCT00559676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65112948|NCT00559676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112949|NCT00559676|Antimetabolites|antimetabolites|mesh-ancestor
65112950|NCT00559676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112951|NCT00559676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65112952|NCT00559676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112953|NCT00559676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65112954|NCT00559676|Immunologic Factors|immunologic factors|mesh-ancestor
65112955|NCT00559676|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65112956|NCT00559676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65112957|NCT00559676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112958|NCT00559676|Antidotes|antidotes|mesh-ancestor
65112959|NCT00559676|Protective Agents|protective agents|mesh-ancestor
65112960|NCT00559676|Vitamin B Complex|vitamin b complex|mesh-ancestor
65112961|NCT00559676|Vitamins|vitamins|mesh-ancestor
65112962|NCT00559676|Micronutrients|micronutrients|mesh-ancestor
65112963|NCT04639271|Trastuzumab|trastuzumab|mesh-list
65293720|NCT01005979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65293721|NCT01005979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65293722|NCT01005979|Alkylating Agents|alkylating agents|mesh-ancestor
65293723|NCT01005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293724|NCT01005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293725|NCT01005979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65293726|NCT01005979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65293727|NCT01005979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65293728|NCT01005979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65293729|NCT01005979|Growth Substances|growth substances|mesh-ancestor
65293730|NCT01005979|Growth Inhibitors|growth inhibitors|mesh-ancestor
64523978|NCT03467386|Immunologic Factors|immunologic factors|mesh-ancestor
65112964|NCT04639271|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65112965|NCT04639271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65112966|NCT04639271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112967|NCT04681053|Ivermectin|ivermectin|mesh-list
65112968|NCT04681053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65112969|NCT04681053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65112970|NCT04639193|Acetazolamide|acetazolamide|mesh-list
65112971|NCT04639193|Eszopiclone|eszopiclone|mesh-list
65112972|NCT04639193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65112973|NCT04639193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65112974|NCT04639193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65112975|NCT04639193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65112976|NCT04639193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112977|NCT04639193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65112978|NCT04639193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112979|NCT04639193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65112980|NCT04639193|Antidepressive Agents|antidepressive agents|mesh-ancestor
65112981|NCT04639193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65112982|NCT04639193|Anticonvulsants|anticonvulsants|mesh-ancestor
65112983|NCT04639193|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65112984|NCT04639193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112985|NCT04639193|Diuretics|diuretics|mesh-ancestor
65112986|NCT04639193|Natriuretic Agents|natriuretic agents|mesh-ancestor
65112987|NCT04639193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65112988|NCT04639193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65112989|NCT01235689|Prednisone|prednisone|mesh-list
65112990|NCT01235689|Adalimumab|adalimumab|mesh-list
65112991|NCT01235689|Azathioprine|azathioprine|mesh-list
65112992|NCT01235689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65113001|NCT01235689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113002|NCT01235689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65113003|NCT01235689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65113004|NCT01235689|Immunologic Factors|immunologic factors|mesh-ancestor
65113005|NCT04638686|Lamivudine|lamivudine|mesh-list
65113006|NCT04638686|Dolutegravir|dolutegravir|mesh-list
65113007|NCT04638686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65113008|NCT04638686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65113009|NCT04638686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113010|NCT04638686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113011|NCT04638686|Antiviral Agents|antiviral agents|mesh-ancestor
65113012|NCT04638686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65113013|NCT04638686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65113014|NCT04638686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65113015|NCT04638686|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65113016|NCT04638686|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65113017|NCT04680819|Propolis|propolis|mesh-list
65113018|NCT04680819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65113019|NCT02896842|Imatinib Mesylate|imatinib mesylate|mesh-list
65113020|NCT02896842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043645|NCT00205751|Thalidomide|thalidomide|mesh-list
65293731|NCT00913029|Timolol|timolol|mesh-list
65293733|NCT00913029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65293734|NCT00913029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65293735|NCT00913029|Adrenergic Agents|adrenergic agents|mesh-ancestor
65293736|NCT00913029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65293737|NCT00913029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293738|NCT00913029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293739|NCT00913029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65293740|NCT00913029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65113021|NCT02896842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65113022|NCT02896842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113023|NCT02896842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113024|NCT00559715|Bevacizumab|bevacizumab|mesh-list
65113025|NCT00559715|Ranibizumab|ranibizumab|mesh-list
65113026|NCT00559715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65113027|NCT00559715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65113028|NCT00559715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65113029|NCT00559715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65113030|NCT00559715|Growth Substances|growth substances|mesh-ancestor
65113031|NCT00559715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113032|NCT00559715|Growth Inhibitors|growth inhibitors|mesh-ancestor
65113033|NCT02896803|Fluorouracil|fluorouracil|mesh-list
65113034|NCT02896803|Oxaliplatin|oxaliplatin|mesh-list
65113035|NCT02896803|Antimetabolites|antimetabolites|mesh-ancestor
65113036|NCT02896803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113037|NCT02896803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65113038|NCT02896803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65113039|NCT02896803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65113040|NCT02896803|Immunologic Factors|immunologic factors|mesh-ancestor
65113041|NCT02896803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113042|NCT02897037|Heparin|heparin|mesh-list
65113043|NCT02897037|Bivalirudin|bivalirudin|mesh-list
65113044|NCT02897037|Anticoagulants|anticoagulants|mesh-ancestor
65113045|NCT02897037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65113046|NCT02897037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65113047|NCT02897037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113048|NCT02897037|Antithrombins|antithrombins|mesh-ancestor
65113049|NCT02897037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65113050|NCT02897037|Protease Inhibitors|protease inhibitors|mesh-ancestor
65113051|NCT02897037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113052|NCT00553683|Cyclophosphamide|cyclophosphamide|mesh-list
65113053|NCT00553683|Poly ICLC|poly iclc|mesh-list
65113054|NCT00553683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65113055|NCT00553683|Immunologic Factors|immunologic factors|mesh-ancestor
65113056|NCT00553683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113057|NCT00553683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65113058|NCT00553683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65113059|NCT00553683|Alkylating Agents|alkylating agents|mesh-ancestor
65113068|NCT01228747|Levetiracetam|levetiracetam|mesh-list
65113069|NCT01228747|Anticonvulsants|anticonvulsants|mesh-ancestor
65113070|NCT01228747|Nootropic Agents|nootropic agents|mesh-ancestor
65113071|NCT02896413|Dexmedetomidine|dexmedetomidine|mesh-list
65113072|NCT02896413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65113073|NCT02896413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65113074|NCT02896413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113075|NCT02896413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65113076|NCT02896413|Analgesics|analgesics|mesh-ancestor
65113077|NCT02896413|Sensory System Agents|sensory system agents|mesh-ancestor
65113078|NCT02896413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65113079|NCT02896413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65113080|NCT02896413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65113081|NCT02896413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65113082|NCT02896413|Adrenergic Agents|adrenergic agents|mesh-ancestor
65113083|NCT02896413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65293741|NCT00913029|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65293742|NCT00913029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65293743|NCT01006057|Insulin|insulin|mesh-list
65293744|NCT01006057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65293745|NCT01006057|Insulin, Long-Acting|insulin, long-acting|mesh-list
65293746|NCT01006057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65293747|NCT01006057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293748|NCT00853125|Sunitinib|sunitinib|mesh-list
65293749|NCT00853125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293750|NCT00853125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65293751|NCT00853125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65293752|NCT00853125|Growth Substances|growth substances|mesh-ancestor
65293753|NCT00853125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293754|NCT00853125|Growth Inhibitors|growth inhibitors|mesh-ancestor
65293755|NCT00853125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65293756|NCT00853125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293757|NCT00853125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113084|NCT02896413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113085|NCT00553722|Eplerenone|eplerenone|mesh-list
65113086|NCT00553722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65113087|NCT00553722|Hormone Antagonists|hormone antagonists|mesh-ancestor
65113088|NCT00553722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65113089|NCT00553722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113090|NCT00553722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65113091|NCT00553722|Diuretics|diuretics|mesh-ancestor
65113092|NCT00553722|Natriuretic Agents|natriuretic agents|mesh-ancestor
65113093|NCT00553722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65113094|NCT01235338|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65113095|NCT01235338|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65113096|NCT01235338|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65113097|NCT01235338|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65113098|NCT01235338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65113099|NCT01235338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113100|NCT01235338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65113101|NCT01235338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113102|NCT01235338|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65113103|NCT01235338|Antidepressive Agents|antidepressive agents|mesh-ancestor
65113104|NCT01235338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65113105|NCT01235338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65113106|NCT01235338|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65113107|NCT01235338|Dopamine Agents|dopamine agents|mesh-ancestor
65113108|NCT01234675|Milnacipran|milnacipran|mesh-list
65113109|NCT01234675|Levomilnacipran|levomilnacipran|mesh-list
65113110|NCT01234675|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65113111|NCT01234675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65113112|NCT01234675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65113113|NCT01234675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113114|NCT01234675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65113115|NCT01234675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113116|NCT01234675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65113117|NCT01234675|Analgesics|analgesics|mesh-ancestor
65113118|NCT01234675|Sensory System Agents|sensory system agents|mesh-ancestor
65113119|NCT01234675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65113120|NCT01234675|Antidepressive Agents|antidepressive agents|mesh-ancestor
65293758|NCT02707913|Amlodipine|amlodipine|mesh-list
65293759|NCT02707913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65293760|NCT02707913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65293761|NCT02707913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65293762|NCT02707913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293763|NCT02707913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65293764|NCT02707913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293765|NCT02707913|Vasodilator Agents|vasodilator agents|mesh-ancestor
65293766|NCT02710877|Sufentanil|sufentanil|mesh-list
65293767|NCT02710877|Dsuvia|dsuvia|mesh-list
65293768|NCT02710877|Levobupivacaine|levobupivacaine|mesh-list
64524015|NCT02442700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64524022|NCT00619528|Alemtuzumab|alemtuzumab|mesh-list
65113121|NCT01234675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65113122|NCT02896101|Pimecrolimus|pimecrolimus|mesh-list
65113131|NCT02896101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65113132|NCT02896101|Dermatologic Agents|dermatologic agents|mesh-ancestor
65113133|NCT02896101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65113134|NCT02896101|Immunologic Factors|immunologic factors|mesh-ancestor
65113135|NCT02896101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65113136|NCT02896101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113137|NCT02896101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113138|NCT02896023|Menotropins|menotropins|mesh-list
65113139|NCT02896023|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65113140|NCT02896023|Fertility Agents|fertility agents|mesh-ancestor
65113141|NCT02896023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65113142|NCT02896023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113143|NCT04637633|Lubricant Eye Drops|lubricant eye drops|mesh-list
65113144|NCT04637633|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65113145|NCT04637633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65113146|NCT01228318|Zoledronic Acid|zoledronic acid|mesh-list
65113147|NCT01228318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65113148|NCT01228318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113149|NCT02895672|Exenatide|exenatide|mesh-list
65113150|NCT02895672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65113151|NCT02895672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113152|NCT02895672|Incretins|incretins|mesh-ancestor
65113153|NCT02895672|Hormones|hormones|mesh-ancestor
65113154|NCT02895672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65113155|NCT02895672|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65113156|NCT02895750|Metformin|metformin|mesh-list
65113157|NCT02895750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65113158|NCT02895750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113159|NCT01227967|Ribavirin|ribavirin|mesh-list
65113160|NCT01227967|Oseltamivir|oseltamivir|mesh-list
65113161|NCT01227967|Amantadine|amantadine|mesh-list
65113162|NCT01227967|Antimetabolites|antimetabolites|mesh-ancestor
65113163|NCT01227967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113164|NCT01227967|Antiviral Agents|antiviral agents|mesh-ancestor
65113165|NCT01227967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65113166|NCT01227967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113167|NCT01227967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65113168|NCT01227967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65113169|NCT01227967|Dopamine Agents|dopamine agents|mesh-ancestor
65113170|NCT01227967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65113171|NCT01227967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113172|NCT01227967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65113174|NCT01227967|Sensory System Agents|sensory system agents|mesh-ancestor
65113175|NCT01227967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65113176|NCT00560144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65113177|NCT00560144|Immunologic Factors|immunologic factors|mesh-ancestor
65113178|NCT00560144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113179|NCT04637204|Axitinib|axitinib|mesh-list
65293769|NCT02710877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65293770|NCT02710877|Narcotics|narcotics|mesh-ancestor
65293771|NCT02710877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65293772|NCT02710877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293773|NCT02710877|Analgesics|analgesics|mesh-ancestor
65293774|NCT02710877|Sensory System Agents|sensory system agents|mesh-ancestor
65293775|NCT02710877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65293776|NCT02710877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65293777|NCT02710877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65293778|NCT02710877|Anesthetics, General|anesthetics, general|mesh-ancestor
64524026|NCT00568672|Antiemetics|antiemetics|mesh-ancestor
65113180|NCT04637204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65113181|NCT04637204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65113182|NCT04637204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113183|NCT04637204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113184|NCT04637360|Calcitriol|calcitriol|mesh-list
65113185|NCT04637360|Cinacalcet|cinacalcet|mesh-list
65113186|NCT04637360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65113187|NCT04637360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113188|NCT04637360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65113189|NCT04637360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65113190|NCT04637360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113215|NCT04317508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113216|NCT04317508|Sensory System Agents|sensory system agents|mesh-ancestor
65113217|NCT04317508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65113218|NCT00560300|Vitamin D|vitamin d|mesh-list
65113219|NCT00560300|Cholecalciferol|cholecalciferol|mesh-list
65113220|NCT00560300|Calcitriol|calcitriol|mesh-list
65113221|NCT00560300|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
65113222|NCT00560300|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
65113223|NCT00560300|Calcium Carbonate|calcium carbonate|mesh-list
65113224|NCT00560300|Calcium|calcium|mesh-list
65113225|NCT00560300|Sevelamer|sevelamer|mesh-list
65113226|NCT00560300|Vitamins|vitamins|mesh-ancestor
65113227|NCT00560300|Micronutrients|micronutrients|mesh-ancestor
65113228|NCT00560300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113229|NCT00560300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65113230|NCT00560300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65113231|NCT00560300|Antacids|antacids|mesh-ancestor
65113232|NCT00560300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113233|NCT00560300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65113234|NCT00560300|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65113235|NCT00560300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65113236|NCT00560300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65113237|NCT00560300|Chelating Agents|chelating agents|mesh-ancestor
65113238|NCT00560300|Sequestering Agents|sequestering agents|mesh-ancestor
65113240|NCT02904369|Emtricitabine|emtricitabine|mesh-list
65113241|NCT02904369|Antiviral Agents|antiviral agents|mesh-ancestor
65113242|NCT02904369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64685543|NCT01743859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113245|NCT02904369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113246|NCT02904369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113247|NCT02904369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65113248|NCT02904369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65113250|NCT00560378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65113251|NCT00560378|Immunologic Factors|immunologic factors|mesh-ancestor
65113252|NCT00560378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113253|NCT00560378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65113254|NCT00560378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113255|NCT00560378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113256|NCT02895321|Listerine|listerine|mesh-list
65113257|NCT02895321|Sodium Fluoride|sodium fluoride|mesh-list
65113258|NCT02895321|Cariostatic Agents|cariostatic agents|mesh-ancestor
65113259|NCT02895321|Protective Agents|protective agents|mesh-ancestor
65113260|NCT02895321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293779|NCT02710877|Anesthetics|anesthetics|mesh-ancestor
65293780|NCT02710877|Anesthetics, Local|anesthetics, local|mesh-ancestor
65293781|NCT05550337|Trifarotene|trifarotene|mesh-list
65293782|NCT05550337|Dermatologic Agents|dermatologic agents|mesh-ancestor
65293783|NCT00530023|Insulin|insulin|mesh-list
65293784|NCT00530023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65293785|NCT00530023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293786|NCT02707445|Clopidogrel|clopidogrel|mesh-list
65293787|NCT02707445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65293788|NCT02707445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65293789|NCT02707445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65293790|NCT02707445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65293791|NCT02707445|Purinergic Agents|purinergic agents|mesh-ancestor
65293792|NCT02707445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65293793|NCT02707445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293794|NCT02707445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293795|NCT03999775|Calcium, Dietary|calcium, dietary|mesh-list
65293796|NCT03999775|Vitamin D|vitamin d|mesh-list
65293797|NCT03999775|Ergocalciferols|ergocalciferols|mesh-list
65293798|NCT03999775|Cholecalciferol|cholecalciferol|mesh-list
65293799|NCT03999775|Vitamins|vitamins|mesh-list
65293800|NCT03999775|Calcium|calcium|mesh-list
65293801|NCT03999775|Micronutrients|micronutrients|mesh-ancestor
65293802|NCT03999775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293803|NCT03999775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65293804|NCT03999775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65293805|NCT02706977|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65293806|NCT02706977|Carbidopa|carbidopa|mesh-list
65293807|NCT02706977|Levodopa|levodopa|mesh-list
64524040|NCT00568672|Serotonin Agents|serotonin agents|mesh-ancestor
65113261|NCT02895321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65113262|NCT02895321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65113263|NCT04635176|Dexamethasone|dexamethasone|mesh-list
65113264|NCT04635176|Epinephrine|epinephrine|mesh-list
65113265|NCT04635176|Bupivacaine|bupivacaine|mesh-list
65113266|NCT04635176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65113267|NCT04635176|Antiemetics|antiemetics|mesh-ancestor
65113268|NCT04635176|Autonomic Agents|autonomic agents|mesh-ancestor
65113269|NCT04635176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65113270|NCT04635176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113271|NCT04635176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65113272|NCT04635176|Glucocorticoids|glucocorticoids|mesh-ancestor
65113273|NCT04635176|Hormones|hormones|mesh-ancestor
65113274|NCT04635176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65113275|NCT04635176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65113276|NCT04635176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65113277|NCT04635176|Anesthetics, Local|anesthetics, local|mesh-ancestor
65293808|NCT02706977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65293809|NCT02706977|Immunologic Factors|immunologic factors|mesh-ancestor
65293810|NCT02706977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293811|NCT02706977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65293812|NCT02706977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65293813|NCT02706977|Dopamine Agonists|dopamine agonists|mesh-ancestor
65293815|NCT02706977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65293816|NCT02706977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293817|NCT02706977|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65293818|NCT02706977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293819|NCT05733715|Pembrolizumab|pembrolizumab|mesh-list
65293820|NCT05733715|Lenvatinib|lenvatinib|mesh-list
65293821|NCT05733715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65293822|NCT05733715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293823|NCT05733715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65293824|NCT05733715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293825|NCT05733715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293826|NCT02707211|Antibodies|antibodies|mesh-list
65293827|NCT02707211|Immunoglobulin M|immunoglobulin m|mesh-list
65293828|NCT02707211|Immunologic Factors|immunologic factors|mesh-ancestor
65293829|NCT02707211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293830|NCT01006525|Zolpidem|zolpidem|mesh-list
65293831|NCT01006525|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65293832|NCT01006525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65293833|NCT01006525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65293834|NCT01006525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293835|NCT01006525|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65293836|NCT01006525|GABA Agonists|gaba agonists|mesh-ancestor
65293837|NCT01006525|GABA Agents|gaba agents|mesh-ancestor
65293838|NCT01006525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65293840|NCT01006681|Vaccines|vaccines|mesh-list
65293851|NCT05733403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293852|NCT05733403|Sympathomimetics|sympathomimetics|mesh-ancestor
65293853|NCT05733403|Autonomic Agents|autonomic agents|mesh-ancestor
65293854|NCT05733403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65293855|NCT05733403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65293856|NCT03893903|Avelumab|avelumab|mesh-list
65293857|NCT03893903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65293858|NCT03893903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293859|NCT02706509|Tramadol|tramadol|mesh-list
65293860|NCT02706509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65293861|NCT02706509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524107|NCT02452060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65113278|NCT04635176|Anesthetics|anesthetics|mesh-ancestor
65113279|NCT04635176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65113280|NCT04635176|Sensory System Agents|sensory system agents|mesh-ancestor
65113281|NCT04635176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65113282|NCT04635176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65113283|NCT04635176|Adrenergic Agents|adrenergic agents|mesh-ancestor
65113284|NCT04635176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65113285|NCT04635176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113286|NCT04635176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65113287|NCT04635176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65113288|NCT04635176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65113289|NCT04635176|Respiratory System Agents|respiratory system agents|mesh-ancestor
65113290|NCT04635176|Mydriatics|mydriatics|mesh-ancestor
65113291|NCT04635176|Sympathomimetics|sympathomimetics|mesh-ancestor
65113292|NCT04635176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65113293|NCT02894892|Esomeprazole|esomeprazole|mesh-list
65113294|NCT02894892|Bismuth|bismuth|mesh-list
65113295|NCT02894892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65113296|NCT02894892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65113297|NCT02894892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65113298|NCT02894892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113299|NCT02894892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113300|NCT02894892|Antacids|antacids|mesh-ancestor
65113301|NCT04635566|Mebeverine|mebeverine|mesh-list
65113302|NCT04635566|Alverine|alverine|mesh-list
65113303|NCT04635566|Anticonvulsants|anticonvulsants|mesh-ancestor
65113304|NCT04635566|Parasympatholytics|parasympatholytics|mesh-ancestor
65113305|NCT04635566|Autonomic Agents|autonomic agents|mesh-ancestor
65113306|NCT04635566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65113307|NCT04635566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113308|NCT04635293|Simendan|simendan|mesh-list
65113309|NCT04635293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64685601|NCT01754389|Sirolimus|sirolimus|mesh-list
65113342|NCT00624676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65113343|NCT00624676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65113344|NCT00624676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65113345|NCT00624676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113346|NCT00624676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113348|NCT05655754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65113349|NCT05655754|Anesthetics, General|anesthetics, general|mesh-ancestor
65113350|NCT05655754|Anesthetics|anesthetics|mesh-ancestor
64685661|NCT01755949|Mitosis Modulators|mitosis modulators|mesh-ancestor
65113359|NCT04317235|Ropivacaine|ropivacaine|mesh-list
65113360|NCT04317235|Anesthetics, Local|anesthetics, local|mesh-ancestor
65113361|NCT04317235|Anesthetics|anesthetics|mesh-ancestor
65113362|NCT04317235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65113363|NCT04317235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113364|NCT04317235|Sensory System Agents|sensory system agents|mesh-ancestor
65113365|NCT04317235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65113366|NCT00560690|Metformin|metformin|mesh-list
65113367|NCT00560690|Interferons|interferons|mesh-list
65113368|NCT00560690|Ribavirin|ribavirin|mesh-list
65113369|NCT00560690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65293862|NCT02706509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65293863|NCT02706509|Narcotics|narcotics|mesh-ancestor
65293864|NCT02706509|Analgesics|analgesics|mesh-ancestor
65293865|NCT02706509|Sensory System Agents|sensory system agents|mesh-ancestor
65293866|NCT02706509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65293867|NCT02710409|Vaccines|vaccines|mesh-list
65293868|NCT02710409|Immunologic Factors|immunologic factors|mesh-ancestor
65293869|NCT02710409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293870|NCT00529087|Bromides|bromides|mesh-list
65293871|NCT00529087|Methylnaltrexone|methylnaltrexone|mesh-list
65293872|NCT00529087|Anticonvulsants|anticonvulsants|mesh-ancestor
65293873|NCT00529087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65293874|NCT00529087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293875|NCT00529087|Sensory System Agents|sensory system agents|mesh-ancestor
65293876|NCT00529087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65293877|NCT04318210|Tenofovir|tenofovir|mesh-list
65293878|NCT04318210|Emtricitabine|emtricitabine|mesh-list
65293879|NCT04318210|Antiviral Agents|antiviral agents|mesh-ancestor
65113370|NCT00560690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113371|NCT00560690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65113372|NCT00560690|Antiviral Agents|antiviral agents|mesh-ancestor
65113373|NCT00560690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65113374|NCT00560690|Antimetabolites|antimetabolites|mesh-ancestor
65113375|NCT00560690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113376|NCT01227421|Nitazoxanide|nitazoxanide|mesh-list
65113377|NCT01227421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65113378|NCT01227421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65113379|NCT02903901|Melatonin|melatonin|mesh-list
65113380|NCT02903901|Antioxidants|antioxidants|mesh-ancestor
65113381|NCT02903901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113382|NCT02903901|Protective Agents|protective agents|mesh-ancestor
65113383|NCT02903901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113384|NCT02903901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65113385|NCT04634981|Anesthetics|anesthetics|mesh-list
65113386|NCT04634981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65113387|NCT04634981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113388|NCT00553449|Rabeprazole|rabeprazole|mesh-list
65113389|NCT00553449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65113390|NCT00553449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65113391|NCT00553449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65113392|NCT00553449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113393|NCT00553449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113394|NCT05655130|Dexamethasone|dexamethasone|mesh-list
65113395|NCT05655130|Methylprednisolone|methylprednisolone|mesh-list
65113396|NCT05655130|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65113397|NCT05655130|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65113398|NCT05655130|Prednisolone|prednisolone|mesh-list
65113399|NCT05655130|Prednisolone acetate|prednisolone acetate|mesh-list
65113400|NCT05655130|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65113401|NCT05655130|Prednisolone phosphate|prednisolone phosphate|mesh-list
65113402|NCT05655130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65113403|NCT05655130|Antiemetics|antiemetics|mesh-ancestor
65113404|NCT05655130|Autonomic Agents|autonomic agents|mesh-ancestor
65113405|NCT05655130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65113406|NCT05655130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113407|NCT05655130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65113408|NCT05655130|Glucocorticoids|glucocorticoids|mesh-ancestor
65113409|NCT05655130|Hormones|hormones|mesh-ancestor
64755666|NCT02068092|Antioxidants|antioxidants|mesh-ancestor
65113410|NCT05655130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65043793|NCT00411125|Calcitonin|calcitonin|mesh-list
65293880|NCT04318210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65293881|NCT04318210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65293882|NCT04318210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65293883|NCT04318210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293884|NCT04318210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293886|NCT04318210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65293887|NCT04535141|Olanzapine|olanzapine|mesh-list
65293888|NCT04535141|Antiemetics|antiemetics|mesh-ancestor
65293889|NCT04535141|Autonomic Agents|autonomic agents|mesh-ancestor
65293890|NCT04535141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65293891|NCT04535141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293892|NCT04535141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65293893|NCT04535141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65293894|NCT04535141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65293895|NCT04535141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65293896|NCT04535141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65293897|NCT04535141|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65293898|NCT04535141|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65293899|NCT04535141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65113411|NCT05655130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65113412|NCT05655130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65113413|NCT05655130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65113414|NCT05655130|Protective Agents|protective agents|mesh-ancestor
65113415|NCT05658484|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65113416|NCT05658484|Dermatologic Agents|dermatologic agents|mesh-ancestor
65113472|NCT05427747|Cefotaxime|cefotaxime|mesh-list
65113473|NCT05427747|Cefoxitin|cefoxitin|mesh-list
65113474|NCT05427747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65113475|NCT05427747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65113476|NCT00445406|Bevacizumab|bevacizumab|mesh-list
65113477|NCT00445406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65113478|NCT00445406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65113479|NCT00445406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65113480|NCT00445406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65113481|NCT00445406|Growth Substances|growth substances|mesh-ancestor
65113482|NCT00445406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113483|NCT00445406|Growth Inhibitors|growth inhibitors|mesh-ancestor
65113484|NCT00445523|Interferons|interferons|mesh-list
65113485|NCT00445523|Interferon-alpha|interferon-alpha|mesh-list
65113486|NCT00445523|Vaccines|vaccines|mesh-list
65113487|NCT00445523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65113488|NCT00445523|Antiviral Agents|antiviral agents|mesh-ancestor
65113489|NCT00445523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65113490|NCT00445523|Immunologic Factors|immunologic factors|mesh-ancestor
65113491|NCT00445523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113492|NCT02903004|Gemcitabine|gemcitabine|mesh-list
65113493|NCT02903004|Paclitaxel|paclitaxel|mesh-list
65113494|NCT02903004|Carboplatin|carboplatin|mesh-list
65113495|NCT02903004|Doxorubicin|doxorubicin|mesh-list
65113496|NCT02903004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65113497|NCT02903004|Topotecan|topotecan|mesh-list
65113498|NCT02903004|Trabectedin|trabectedin|mesh-list
65113499|NCT02903004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65113500|NCT02903004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65113501|NCT02903004|Tubulin Modulators|tubulin modulators|mesh-ancestor
65293900|NCT04535141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293901|NCT04535141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65293902|NCT04535141|Serotonin Agents|serotonin agents|mesh-ancestor
65293903|NCT00611663|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65293904|NCT00611663|Immunologic Factors|immunologic factors|mesh-ancestor
65293905|NCT00611663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293906|NCT00870870|Gemcitabine|gemcitabine|mesh-list
65293907|NCT00870870|Carboplatin|carboplatin|mesh-list
65293908|NCT00870870|Cetuximab|cetuximab|mesh-list
65293909|NCT00870870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65293910|NCT00870870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293911|NCT00870870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65113502|NCT02903004|Antimitotic Agents|antimitotic agents|mesh-ancestor
65113503|NCT02903004|Mitosis Modulators|mitosis modulators|mesh-ancestor
65113504|NCT02903004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113505|NCT02903004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65113506|NCT02903004|Antimetabolites|antimetabolites|mesh-ancestor
65113507|NCT02903004|Antiviral Agents|antiviral agents|mesh-ancestor
65113508|NCT02903004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65113509|NCT02903004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113510|NCT02903004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65113511|NCT02903004|Immunologic Factors|immunologic factors|mesh-ancestor
65113512|NCT02903004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113513|NCT02903004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64685811|NCT01769209|Antimetabolites|antimetabolites|mesh-ancestor
65113576|NCT00446069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65113577|NCT00446069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113578|NCT00446069|Analgesics|analgesics|mesh-ancestor
65113579|NCT00446069|Sensory System Agents|sensory system agents|mesh-ancestor
65113580|NCT00446069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65113581|NCT02902653|Misoprostol|misoprostol|mesh-list
65113582|NCT02902653|Dinoprostone|dinoprostone|mesh-list
65113583|NCT02902653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65113584|NCT02902653|Abortifacient Agents|abortifacient agents|mesh-ancestor
65113585|NCT02902653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65113586|NCT02902653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113587|NCT02902653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65113588|NCT02902653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65113589|NCT02902653|Oxytocics|oxytocics|mesh-ancestor
65113590|NCT00446303|Azacitidine|azacitidine|mesh-list
65113591|NCT00446303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65113592|NCT00446303|Antimetabolites|antimetabolites|mesh-ancestor
65113593|NCT00446303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113594|NCT00446303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65113595|NCT00446303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113596|NCT01223404|Mecamylamine|mecamylamine|mesh-list
65113597|NCT01223404|Nicotine|nicotine|mesh-list
65113598|NCT01223404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65113599|NCT01223404|Autonomic Agents|autonomic agents|mesh-ancestor
64685905|NCT05473273|Progestins|progestins|mesh-ancestor
65113608|NCT01223404|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
65113609|NCT01223404|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65113610|NCT01223404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65113612|NCT00446420|Midazolam|midazolam|mesh-list
65113613|NCT00446420|Propofol|propofol|mesh-list
65113614|NCT00446420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65113615|NCT00446420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65113616|NCT00446420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113617|NCT00446420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65113618|NCT00446420|Anesthetics, General|anesthetics, general|mesh-ancestor
65113619|NCT00446420|Anesthetics|anesthetics|mesh-ancestor
65113620|NCT00446420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65113621|NCT00446420|Narcotics|narcotics|mesh-ancestor
65113622|NCT00446420|Analgesics|analgesics|mesh-ancestor
65113623|NCT00446420|Sensory System Agents|sensory system agents|mesh-ancestor
65293912|NCT00870870|Antimetabolites|antimetabolites|mesh-ancestor
65293913|NCT00870870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293914|NCT00870870|Antiviral Agents|antiviral agents|mesh-ancestor
65293915|NCT00870870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65293916|NCT00870870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293917|NCT00870870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65293918|NCT00870870|Immunologic Factors|immunologic factors|mesh-ancestor
65293919|NCT00870870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293920|NCT00870870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65293921|NCT04120636|Celecoxib|celecoxib|mesh-list
65293922|NCT04120636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65293923|NCT04120636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65293924|NCT04120636|Analgesics|analgesics|mesh-ancestor
65293925|NCT04120636|Sensory System Agents|sensory system agents|mesh-ancestor
65293926|NCT04120636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65113624|NCT00446420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65113625|NCT00446420|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65113626|NCT00446420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65113627|NCT00446420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65113628|NCT00446420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65113629|NCT00446420|GABA Modulators|gaba modulators|mesh-ancestor
65113630|NCT00446420|GABA Agents|gaba agents|mesh-ancestor
65113631|NCT00446420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65113632|NCT00446420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113633|NCT00446537|Methylphenidate|methylphenidate|mesh-list
65113634|NCT00446537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65113635|NCT00446537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113636|NCT00446537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65113637|NCT00446537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65113638|NCT00446537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65113639|NCT00446537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113640|NCT00446537|Dopamine Agents|dopamine agents|mesh-ancestor
65113641|NCT00446537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65113642|NCT00446576|Epoetin Alfa|epoetin alfa|mesh-list
65113643|NCT00446576|Hematinics|hematinics|mesh-ancestor
65113644|NCT02902302|Ibuprofen|ibuprofen|mesh-list
65113645|NCT02902302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65113646|NCT02902302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65113647|NCT02902302|Analgesics|analgesics|mesh-ancestor
65113648|NCT02902302|Sensory System Agents|sensory system agents|mesh-ancestor
65113649|NCT02902302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65113650|NCT02902302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113651|NCT02902302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65113652|NCT02902302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65113653|NCT02902302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65113654|NCT02902302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113655|NCT02902302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113656|NCT01223365|Hydrocodone|hydrocodone|mesh-list
65113657|NCT01223365|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65113658|NCT01223365|Narcotics|narcotics|mesh-ancestor
65113659|NCT01223365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65113660|NCT01223365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113661|NCT01223365|Analgesics|analgesics|mesh-ancestor
65113662|NCT01223365|Sensory System Agents|sensory system agents|mesh-ancestor
65113663|NCT01223365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65113664|NCT01223365|Antitussive Agents|antitussive agents|mesh-ancestor
65113665|NCT01223365|Respiratory System Agents|respiratory system agents|mesh-ancestor
65113682|NCT05657704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65293927|NCT04120636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293928|NCT04120636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65293929|NCT04120636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65293930|NCT04120636|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65293931|NCT04120636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65293932|NCT04120636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293933|NCT04120636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293934|NCT00731926|Vitamins|vitamins|mesh-list
65293935|NCT00731926|Vitamin E|vitamin e|mesh-list
65293936|NCT00731926|Micronutrients|micronutrients|mesh-ancestor
65293937|NCT00731926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293938|NCT00731926|Antioxidants|antioxidants|mesh-ancestor
65293939|NCT00731926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293940|NCT00731926|Protective Agents|protective agents|mesh-ancestor
65293941|NCT05053087|Ropivacaine|ropivacaine|mesh-list
65293942|NCT05053087|Anesthetics, Local|anesthetics, local|mesh-ancestor
65293943|NCT05053087|Anesthetics|anesthetics|mesh-ancestor
65293944|NCT05053087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65293945|NCT05053087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113683|NCT05657704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65113685|NCT05657704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65113686|NCT05657704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65113687|NCT00446771|Mannitol|mannitol|mesh-list
65113688|NCT00446771|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65113689|NCT00446771|Diuretics|diuretics|mesh-ancestor
65113690|NCT00446771|Natriuretic Agents|natriuretic agents|mesh-ancestor
65113691|NCT00446771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113692|NCT04317157|Caffeine|caffeine|mesh-list
65113693|NCT04317157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65113694|NCT04317157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113695|NCT04317157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65113696|NCT04317157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113697|NCT04317157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113698|NCT04317157|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65113699|NCT04317157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65113700|NCT04317157|Purinergic Agents|purinergic agents|mesh-ancestor
65113701|NCT04317157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65113702|NCT04317079|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
65113703|NCT04317079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65113704|NCT04317079|Antioxidants|antioxidants|mesh-ancestor
65113705|NCT04317079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113706|NCT04317079|Protective Agents|protective agents|mesh-ancestor
65113707|NCT04317079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113708|NCT04317079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65113709|NCT03277430|Tacrolimus|tacrolimus|mesh-list
65113710|NCT03277430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65113711|NCT03277430|Immunologic Factors|immunologic factors|mesh-ancestor
65113712|NCT03277430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113713|NCT03277430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65113714|NCT03277430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113715|NCT03277430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113716|NCT04699214|Endostar protein|endostar protein|mesh-list
65113717|NCT04699214|Endostatins|endostatins|mesh-list
65113718|NCT04699214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65113719|NCT04699214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65293946|NCT05053087|Sensory System Agents|sensory system agents|mesh-ancestor
65293947|NCT05053087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65293948|NCT00732082|Gemcitabine|gemcitabine|mesh-list
65293949|NCT00732082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65293950|NCT00732082|Antimetabolites|antimetabolites|mesh-ancestor
65293951|NCT00732082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293952|NCT00732082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293953|NCT00732082|Antiviral Agents|antiviral agents|mesh-ancestor
65293954|NCT00732082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65293955|NCT00732082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293956|NCT00732082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65293957|NCT00732082|Immunologic Factors|immunologic factors|mesh-ancestor
65293958|NCT00732082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293959|NCT00611741|Furosemide|furosemide|mesh-list
65293960|NCT00611741|Diuretics|diuretics|mesh-ancestor
65293961|NCT00611741|Natriuretic Agents|natriuretic agents|mesh-ancestor
65293962|NCT00611741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293963|NCT00611741|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65293964|NCT00611741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65293965|NCT00611741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293966|NCT02022982|Palbociclib|palbociclib|mesh-list
65293967|NCT02022982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293968|NCT02022982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65293969|NCT02022982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113720|NCT04699214|Growth Substances|growth substances|mesh-ancestor
65113721|NCT04699214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113722|NCT04699214|Growth Inhibitors|growth inhibitors|mesh-ancestor
65113723|NCT04699214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65113724|NCT02902380|Dexmedetomidine|dexmedetomidine|mesh-list
65113742|NCT01221727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65113743|NCT01221727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113744|NCT01221727|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65113745|NCT01221727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65113746|NCT01221727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65113747|NCT01221727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65113748|NCT01221727|Anesthetics, General|anesthetics, general|mesh-ancestor
65113749|NCT01221727|Anesthetics|anesthetics|mesh-ancestor
65113750|NCT01221727|GABA Modulators|gaba modulators|mesh-ancestor
65113751|NCT01221727|GABA Agents|gaba agents|mesh-ancestor
65113752|NCT01221727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65113753|NCT01221727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113754|NCT01221727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65113755|NCT01221181|Eculizumab|eculizumab|mesh-list
65113756|NCT01221181|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65113757|NCT01221181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65113758|NCT01221181|Immunologic Factors|immunologic factors|mesh-ancestor
65113759|NCT01221181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113760|NCT03277079|Ezetimibe|ezetimibe|mesh-list
65113761|NCT03277079|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65293970|NCT02022982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293971|NCT04134468|Gemcitabine|gemcitabine|mesh-list
65293972|NCT04134468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65293973|NCT04134468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65293974|NCT04134468|Antimetabolites|antimetabolites|mesh-ancestor
65293975|NCT04134468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293976|NCT04134468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65293977|NCT04134468|Antiviral Agents|antiviral agents|mesh-ancestor
65293978|NCT04134468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65293979|NCT04134468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65293980|NCT04134468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65293981|NCT04134468|Immunologic Factors|immunologic factors|mesh-ancestor
65293982|NCT04134468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293983|NCT02709863|Propofol|propofol|mesh-list
65293984|NCT02709863|Sevoflurane|sevoflurane|mesh-list
65293985|NCT02709863|Desflurane|desflurane|mesh-list
65293986|NCT02709863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65293987|NCT02709863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65113762|NCT03277079|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65113763|NCT03277079|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65113764|NCT03277079|Antimetabolites|antimetabolites|mesh-ancestor
65113765|NCT03277079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113766|NCT03277079|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65113767|NCT03277079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113768|NCT01220557|Insulin|insulin|mesh-list
65113769|NCT01220557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65113770|NCT01220557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113771|NCT04317001|Modafinil|modafinil|mesh-list
65113772|NCT04317001|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65113773|NCT04317001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113774|NCT04317001|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65113775|NCT04317001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65113776|NCT04317001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65113777|NCT04317001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113778|NCT05426499|Fluconazole|fluconazole|mesh-list
65113779|NCT05426499|Isavuconazole|isavuconazole|mesh-list
65113780|NCT05426499|Anidulafungin|anidulafungin|mesh-list
65113781|NCT05426499|Meropenem|meropenem|mesh-list
65113795|NCT05426499|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65113796|NCT05426499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65113797|NCT00446810|Benphothiamine|benphothiamine|mesh-list
65113798|NCT00446810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65113799|NCT00446810|Immunologic Factors|immunologic factors|mesh-ancestor
65113800|NCT00446810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113801|NCT00446810|Chelating Agents|chelating agents|mesh-ancestor
65113802|NCT00446810|Sequestering Agents|sequestering agents|mesh-ancestor
65113803|NCT00446810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113804|NCT05464420|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65113805|NCT05464420|Immunologic Factors|immunologic factors|mesh-ancestor
65113806|NCT05464420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113807|NCT01220167|Ondansetron|ondansetron|mesh-list
65113808|NCT01220167|Antiemetics|antiemetics|mesh-ancestor
65113809|NCT01220167|Autonomic Agents|autonomic agents|mesh-ancestor
65113810|NCT01220167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65113811|NCT01220167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113812|NCT01220167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65113813|NCT01220167|Antipruritics|antipruritics|mesh-ancestor
65293988|NCT02709863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293989|NCT02709863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65293990|NCT02709863|Anesthetics, General|anesthetics, general|mesh-ancestor
65293991|NCT02709863|Anesthetics|anesthetics|mesh-ancestor
65293992|NCT02709863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65293993|NCT02709863|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65293994|NCT03877237|Dapagliflozin|dapagliflozin|mesh-list
65293995|NCT03877237|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64524242|NCT02419170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64524243|NCT02419170|Alkylating Agents|alkylating agents|mesh-ancestor
65113814|NCT01220167|Dermatologic Agents|dermatologic agents|mesh-ancestor
65113815|NCT01220167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65113816|NCT01220167|Serotonin Agents|serotonin agents|mesh-ancestor
65113817|NCT01220167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65113818|NCT01220167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113819|NCT01220167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65113820|NCT01220167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65113821|NCT01220167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65113822|NCT01220167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65113823|NCT01220167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65113824|NCT00447239|Insulin|insulin|mesh-list
65113825|NCT00447239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65113826|NCT00447239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113827|NCT05425914|Vitamin D|vitamin d|mesh-list
65113828|NCT05425914|Lubricant Eye Drops|lubricant eye drops|mesh-list
65113829|NCT05425914|Vitamins|vitamins|mesh-ancestor
65113830|NCT05425914|Micronutrients|micronutrients|mesh-ancestor
65113831|NCT05425914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113832|NCT05425914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65113833|NCT05425914|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65113834|NCT05425914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65113835|NCT00447356|Interferons|interferons|mesh-list
65113836|NCT00447356|Interferon-alpha|interferon-alpha|mesh-list
65113837|NCT00447356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65113838|NCT00447356|Antiviral Agents|antiviral agents|mesh-ancestor
65113839|NCT00447356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65113840|NCT00447356|Immunologic Factors|immunologic factors|mesh-ancestor
65113841|NCT00447356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113842|NCT05425875|Dimercaprol|dimercaprol|mesh-list
65113868|NCT00553488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65113869|NCT00553488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113870|NCT03455322|Octreotide|octreotide|mesh-list
65113871|NCT03455322|Norepinephrine|norepinephrine|mesh-list
65113872|NCT03455322|Midodrine|midodrine|mesh-list
65113873|NCT03455322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65113874|NCT03455322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65113875|NCT03455322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65113876|NCT03455322|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65113877|NCT03455322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65113878|NCT03455322|Adrenergic Agents|adrenergic agents|mesh-ancestor
65113879|NCT03455322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65113880|NCT03455322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113881|NCT03455322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113882|NCT03455322|Sympathomimetics|sympathomimetics|mesh-ancestor
65113883|NCT03455322|Autonomic Agents|autonomic agents|mesh-ancestor
65113884|NCT03455322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65113885|NCT03455322|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65113886|NCT03455322|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65113887|NCT05425368|Fluorides|fluorides|mesh-list
65113888|NCT05425368|Cariostatic Agents|cariostatic agents|mesh-ancestor
65113889|NCT05425368|Protective Agents|protective agents|mesh-ancestor
65113890|NCT05425368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113911|NCT00448097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113912|NCT00448097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65113914|NCT00448214|Anticoagulants|anticoagulants|mesh-ancestor
65113915|NCT00448253|Immunoglobulins|immunoglobulins|mesh-list
65293996|NCT03877237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65293997|NCT03877237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65293998|NCT03877237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65293999|NCT02619786|Colistin|colistin|mesh-list
65294000|NCT02619786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65294001|NCT02619786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65294002|NCT00697086|Dronedarone|dronedarone|mesh-list
65294003|NCT00697086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65113916|NCT00448253|Immunologic Factors|immunologic factors|mesh-ancestor
65113917|NCT00448253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113918|NCT00448292|Naluzotan|naluzotan|mesh-list
65113919|NCT00448292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65113920|NCT00448292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65113921|NCT00448292|Serotonin Agents|serotonin agents|mesh-ancestor
65113922|NCT00448292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65113923|NCT00448292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113924|NCT00448292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113925|NCT02901561|Misoprostol|misoprostol|mesh-list
65113926|NCT02901561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65113927|NCT02901561|Abortifacient Agents|abortifacient agents|mesh-ancestor
65113928|NCT02901561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65113929|NCT02901561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113930|NCT02901561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65113931|NCT02901561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65113932|NCT02901561|Oxytocics|oxytocics|mesh-ancestor
65113933|NCT00448409|Sargramostim|sargramostim|mesh-list
65113934|NCT00448409|Immunologic Factors|immunologic factors|mesh-ancestor
65113935|NCT00448409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113936|NCT02901366|Dotinurad|dotinurad|mesh-list
65113937|NCT02901366|Uricosuric Agents|uricosuric agents|mesh-ancestor
65113938|NCT02901366|Gout Suppressants|gout suppressants|mesh-ancestor
65113939|NCT02901366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65113940|NCT02901366|Renal Agents|renal agents|mesh-ancestor
65113941|NCT03276689|Pregabalin|pregabalin|mesh-list
65113942|NCT03276689|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65113943|NCT03276689|Analgesics|analgesics|mesh-ancestor
65113944|NCT03276689|Sensory System Agents|sensory system agents|mesh-ancestor
65113945|NCT03276689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65113946|NCT03276689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113967|NCT01220128|Trastuzumab|trastuzumab|mesh-list
65113968|NCT01220128|Epirubicin|epirubicin|mesh-list
65113969|NCT01220128|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65113970|NCT01220128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65113971|NCT01220128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65113972|NCT01220128|Tubulin Modulators|tubulin modulators|mesh-ancestor
65113973|NCT01220128|Antimitotic Agents|antimitotic agents|mesh-ancestor
65113974|NCT01220128|Mitosis Modulators|mitosis modulators|mesh-ancestor
65113975|NCT01220128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113976|NCT01220128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65113977|NCT01220128|Immunologic Factors|immunologic factors|mesh-ancestor
65113978|NCT01220128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113979|NCT01220128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65113980|NCT01220128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65113981|NCT01220128|Alkylating Agents|alkylating agents|mesh-ancestor
65113982|NCT01220128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65113983|NCT01220128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65113984|NCT01220128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65113985|NCT01220128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65113986|NCT01220128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113987|NCT01220128|Antimetabolites|antimetabolites|mesh-ancestor
65113988|NCT01220128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65113989|NCT01220128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65113990|NCT01220128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65113991|NCT01220128|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65113992|NCT01220128|Hormone Antagonists|hormone antagonists|mesh-ancestor
65113993|NCT01220128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65113994|NCT04698941|Paclitaxel|paclitaxel|mesh-list
65294004|NCT04066660|Fucoidan|fucoidan|mesh-list
65294005|NCT04066660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65294006|NCT04066660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65294007|NCT04066660|Anticoagulants|anticoagulants|mesh-ancestor
65294008|NCT04066660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294009|NCT00697164|Epoetin Alfa|epoetin alfa|mesh-list
65294010|NCT00697164|Hematinics|hematinics|mesh-ancestor
65294011|NCT00694980|Etrolizumab|etrolizumab|mesh-list
65294012|NCT00694980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65113995|NCT04698941|Simvastatin|simvastatin|mesh-list
65113996|NCT04698941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65113997|NCT04698941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65113998|NCT04698941|Tubulin Modulators|tubulin modulators|mesh-ancestor
65113999|NCT04698941|Antimitotic Agents|antimitotic agents|mesh-ancestor
65114000|NCT04698941|Mitosis Modulators|mitosis modulators|mesh-ancestor
64686302|NCT04744571|Aspirin|aspirin|mesh-list
65114011|NCT02901288|Isoniazid|isoniazid|mesh-list
65114012|NCT02901288|Pyrazinamide|pyrazinamide|mesh-list
65114013|NCT02901288|Ethambutol|ethambutol|mesh-list
65114014|NCT02901288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65114015|NCT02901288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65114016|NCT02901288|Renal Agents|renal agents|mesh-ancestor
65114017|NCT02901288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65114018|NCT02901288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65114019|NCT02901288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65114020|NCT02901288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114021|NCT02901288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114022|NCT02901288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114023|NCT02901288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65114024|NCT02901288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65114025|NCT02901288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65114026|NCT02901288|Antitubercular Agents|antitubercular agents|mesh-ancestor
65114027|NCT02901288|Leprostatic Agents|leprostatic agents|mesh-ancestor
65114028|NCT02901288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65114029|NCT02901288|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65114030|NCT02901288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65114031|NCT02901288|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65114032|NCT02901288|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65114033|NCT02901288|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65114034|NCT02901288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65114035|NCT02901288|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65114036|NCT02901288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65114037|NCT02901288|Antimetabolites|antimetabolites|mesh-ancestor
65114038|NCT02901288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65114040|NCT00448643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114042|NCT05424393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65114043|NCT05424393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65114044|NCT05424393|Analgesics|analgesics|mesh-ancestor
65114045|NCT05424393|Sensory System Agents|sensory system agents|mesh-ancestor
65114046|NCT05424393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65114047|NCT05424393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114048|NCT05424393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65114049|NCT05424393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65114050|NCT05424393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65114051|NCT05424393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65114052|NCT05424393|Immunologic Factors|immunologic factors|mesh-ancestor
65114053|NCT00448838|Gemcitabine|gemcitabine|mesh-list
65114054|NCT00448838|Oxaliplatin|oxaliplatin|mesh-list
65114055|NCT00448838|Cetuximab|cetuximab|mesh-list
65114056|NCT00448838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65114057|NCT00448838|Antimetabolites|antimetabolites|mesh-ancestor
65114058|NCT00448838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114059|NCT00448838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114060|NCT00448838|Antiviral Agents|antiviral agents|mesh-ancestor
65114061|NCT00448838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65114062|NCT00448838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114063|NCT00448838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65114064|NCT00448838|Immunologic Factors|immunologic factors|mesh-ancestor
65294013|NCT00694980|Immunologic Factors|immunologic factors|mesh-ancestor
65294014|NCT00694980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294015|NCT00612755|Ribavirin|ribavirin|mesh-list
65294016|NCT00612755|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65294017|NCT00612755|Antimetabolites|antimetabolites|mesh-ancestor
65294018|NCT00612755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294019|NCT00612755|Antiviral Agents|antiviral agents|mesh-ancestor
65294020|NCT00612755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65294021|NCT04132674|Tenofovir|tenofovir|mesh-list
65294022|NCT04132674|Emtricitabine|emtricitabine|mesh-list
64524264|NCT02413554|Cholinergic Agents|cholinergic agents|mesh-ancestor
64524268|NCT02413554|Protective Agents|protective agents|mesh-ancestor
65114065|NCT00448838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114066|NCT00448838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65114086|NCT01219933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114087|NCT05373901|Tretinoin|tretinoin|mesh-list
65114088|NCT05373901|Dinutuximab|dinutuximab|mesh-list
65114089|NCT05373901|Isotretinoin|isotretinoin|mesh-list
65114090|NCT05373901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114091|NCT05373901|Keratolytic Agents|keratolytic agents|mesh-ancestor
65114092|NCT05373901|Dermatologic Agents|dermatologic agents|mesh-ancestor
65114094|NCT05368441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65114095|NCT05368441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65114096|NCT05368441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65114097|NCT05368441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114098|NCT05368441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65114099|NCT05368441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65114100|NCT05368441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65114101|NCT05368441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65114102|NCT05368441|Anesthetics, General|anesthetics, general|mesh-ancestor
65114103|NCT05368441|Anesthetics|anesthetics|mesh-ancestor
65114104|NCT05368441|GABA Modulators|gaba modulators|mesh-ancestor
65114105|NCT05368441|GABA Agents|gaba agents|mesh-ancestor
65114106|NCT05368441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65114107|NCT05368441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114108|NCT05468359|Cyclophosphamide|cyclophosphamide|mesh-list
65114109|NCT05468359|Bevacizumab|bevacizumab|mesh-list
65114111|NCT05468359|Atezolizumab|atezolizumab|mesh-list
65114112|NCT05468359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65114113|NCT05468359|Immunologic Factors|immunologic factors|mesh-ancestor
65114114|NCT05468359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114115|NCT05468359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65114116|NCT05468359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65114117|NCT05468359|Alkylating Agents|alkylating agents|mesh-ancestor
65114118|NCT05468359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114119|NCT05468359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114120|NCT05468359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65114121|NCT05468359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65114122|NCT05468359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65114123|NCT05468359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65114124|NCT05468359|Growth Substances|growth substances|mesh-ancestor
64686435|NCT01804465|Ipilimumab|ipilimumab|mesh-list
65114136|NCT01218802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65114137|NCT01218802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65114138|NCT01218802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114139|NCT05657041|Clopidogrel|clopidogrel|mesh-list
65114140|NCT05657041|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65114141|NCT05657041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65114142|NCT05657041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65114143|NCT05657041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65114144|NCT05657041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65114145|NCT05657041|Purinergic Agents|purinergic agents|mesh-ancestor
65114146|NCT05657041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65114147|NCT05657041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294023|NCT04132674|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65294024|NCT04132674|Antiviral Agents|antiviral agents|mesh-ancestor
65294025|NCT04132674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65294026|NCT04132674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65294027|NCT04132674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65294028|NCT04132674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65294029|NCT04132674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294030|NCT04132674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65294031|NCT04132674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65294032|NCT00612287|Buprenorphine|buprenorphine|mesh-list
64905631|NCT00006280|Tobramycin|tobramycin|mesh-list
65114148|NCT05657041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114149|NCT02887222|Bupivacaine|bupivacaine|mesh-list
65114150|NCT02887222|Anesthetics, Local|anesthetics, local|mesh-ancestor
65114151|NCT02887222|Anesthetics|anesthetics|mesh-ancestor
65114152|NCT02887222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65114153|NCT02887222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114154|NCT02887222|Sensory System Agents|sensory system agents|mesh-ancestor
65114155|NCT02887222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65114156|NCT01218646|Vaccines|vaccines|mesh-list
65114157|NCT01218646|Immunologic Factors|immunologic factors|mesh-ancestor
65114158|NCT01218646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114159|NCT00449423|Acipimox|acipimox|mesh-list
65114160|NCT00449423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65114161|NCT00449423|Antimetabolites|antimetabolites|mesh-ancestor
65114162|NCT00449423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114163|NCT00449423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65114164|NCT00449501|Budesonide|budesonide|mesh-list
65114165|NCT00449501|Formoterol Fumarate|formoterol fumarate|mesh-list
65114166|NCT00449501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65114167|NCT00449501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65114168|NCT00449501|Autonomic Agents|autonomic agents|mesh-ancestor
65114169|NCT00449501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65114170|NCT00449501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114171|NCT00449501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65114172|NCT00449501|Respiratory System Agents|respiratory system agents|mesh-ancestor
65114173|NCT00449501|Glucocorticoids|glucocorticoids|mesh-ancestor
65114175|NCT00449501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65114176|NCT00449501|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65114177|NCT00449501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65114178|NCT00449501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65114179|NCT00449501|Adrenergic Agents|adrenergic agents|mesh-ancestor
65114180|NCT00449501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65114181|NCT00449501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114182|NCT02900820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65114183|NCT02900820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65114184|NCT02900820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65114185|NCT02900820|Antitubercular Agents|antitubercular agents|mesh-ancestor
65114186|NCT01188772|Sofosbuvir|sofosbuvir|mesh-list
65114203|NCT00449618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65114204|NCT00449618|Analgesics|analgesics|mesh-ancestor
65114205|NCT00449618|Sensory System Agents|sensory system agents|mesh-ancestor
65114206|NCT00449618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65114207|NCT00449618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114208|NCT00449618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65114209|NCT00449618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65114210|NCT00449618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65114211|NCT00449618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65114212|NCT00449618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114213|NCT00449618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65114214|NCT00449618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65114215|NCT00449618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114216|NCT00449618|Antipyretics|antipyretics|mesh-ancestor
65294033|NCT00612287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65294035|NCT00612287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65294036|NCT00612287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294037|NCT00612287|Analgesics|analgesics|mesh-ancestor
65294038|NCT00612287|Sensory System Agents|sensory system agents|mesh-ancestor
65294039|NCT00612287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294040|NCT00612287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65294041|NCT00732784|Imatinib Mesylate|imatinib mesylate|mesh-list
65294042|NCT00732784|Calcium Carbonate|calcium carbonate|mesh-list
65294043|NCT00732784|Calcium|calcium|mesh-list
65294044|NCT00732784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65294045|NCT00732784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294046|NCT00732784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294047|NCT00732784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65294048|NCT00732784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524285|NCT02465632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114217|NCT01188538|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
65114218|NCT01188538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65114219|NCT01188538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65114220|NCT01188538|Analgesics|analgesics|mesh-ancestor
65114221|NCT01188538|Sensory System Agents|sensory system agents|mesh-ancestor
65114222|NCT01188538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65114223|NCT01188538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114224|NCT01188538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65114225|NCT01188538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65114226|NCT01188538|Dermatologic Agents|dermatologic agents|mesh-ancestor
65114227|NCT00449657|Gemcitabine|gemcitabine|mesh-list
65114228|NCT00449657|Paclitaxel|paclitaxel|mesh-list
65114229|NCT00449657|Carboplatin|carboplatin|mesh-list
65114230|NCT00449657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65114231|NCT00449657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114232|NCT00449657|Tubulin Modulators|tubulin modulators|mesh-ancestor
65114233|NCT00449657|Antimitotic Agents|antimitotic agents|mesh-ancestor
65114234|NCT00449657|Mitosis Modulators|mitosis modulators|mesh-ancestor
65114235|NCT00449657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114236|NCT00449657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65114237|NCT00449657|Antimetabolites|antimetabolites|mesh-ancestor
65114238|NCT00449657|Antiviral Agents|antiviral agents|mesh-ancestor
65114239|NCT00449657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65114240|NCT00449657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114241|NCT00449657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65114242|NCT00449657|Immunologic Factors|immunologic factors|mesh-ancestor
65114243|NCT00449657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114244|NCT04318444|Hydroxychloroquine|hydroxychloroquine|mesh-list
65114245|NCT04318444|Antimalarials|antimalarials|mesh-ancestor
65114253|NCT03276143|Apixaban|apixaban|mesh-list
65114254|NCT03276143|Anticoagulants|anticoagulants|mesh-ancestor
65114255|NCT03276143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65114256|NCT03276143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65114257|NCT03276143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114258|NCT03276143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65114259|NCT03276143|Antithrombins|antithrombins|mesh-ancestor
65114260|NCT03276143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65114261|NCT03276143|Protease Inhibitors|protease inhibitors|mesh-ancestor
65114262|NCT03276143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114263|NCT00449774|Lamotrigine|lamotrigine|mesh-list
65114264|NCT00449774|Anticonvulsants|anticonvulsants|mesh-list
65114265|NCT00449774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65294049|NCT00732784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294050|NCT00732784|Antacids|antacids|mesh-ancestor
65294051|NCT00732784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65294052|NCT04496219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65294053|NCT04496219|BCG Vaccine|bcg vaccine|mesh-list
65294054|NCT04496219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65294055|NCT04496219|Immunologic Factors|immunologic factors|mesh-ancestor
65294056|NCT04496219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294057|NCT02947126|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
65294058|NCT02947126|Pentetic Acid|pentetic acid|mesh-list
65294059|NCT02947126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65294060|NCT02947126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294061|NCT02947126|Antidotes|antidotes|mesh-ancestor
65294062|NCT02947126|Protective Agents|protective agents|mesh-ancestor
65294063|NCT02947126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294064|NCT02947126|Chelating Agents|chelating agents|mesh-ancestor
65294065|NCT02947126|Sequestering Agents|sequestering agents|mesh-ancestor
65294066|NCT02947126|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65294067|NCT04492553|Testosterone|testosterone|mesh-list
65294068|NCT04492553|Androgens|androgens|mesh-ancestor
65294069|NCT04492553|Hormones|hormones|mesh-ancestor
65294070|NCT04492553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65294071|NCT04492553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294072|NCT00871494|Azithromycin|azithromycin|mesh-list
65294073|NCT00871494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65294074|NCT00871494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65294075|NCT01007539|Choline|choline|mesh-list
65294076|NCT01007539|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
65114266|NCT00449774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65114267|NCT00449774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114268|NCT00449774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65114269|NCT00449774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114270|NCT00449774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65114271|NCT00449774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65114272|NCT00449774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65114273|NCT00449774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65114274|NCT00449774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65114275|NCT02900742|Gemcitabine|gemcitabine|mesh-list
65114276|NCT02900742|Docetaxel|docetaxel|mesh-list
65114277|NCT02900742|Pemetrexed|pemetrexed|mesh-list
65114278|NCT02900742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65114279|NCT02900742|Antimetabolites|antimetabolites|mesh-ancestor
65114280|NCT02900742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114281|NCT02900742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114282|NCT02900742|Antiviral Agents|antiviral agents|mesh-ancestor
65114283|NCT02900742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65114284|NCT02900742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114285|NCT02900742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65294077|NCT01007539|Lipotropic Agents|lipotropic agents|mesh-ancestor
65294078|NCT01007539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65294079|NCT01007539|Antimetabolites|antimetabolites|mesh-ancestor
65294080|NCT01007539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294081|NCT01007539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65294082|NCT01007539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65294083|NCT01007539|Nootropic Agents|nootropic agents|mesh-ancestor
65294084|NCT04951817|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65294085|NCT04951817|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65294086|NCT04951817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294087|NCT04137185|Hormones|hormones|mesh-list
65294088|NCT04137185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65294089|NCT04137185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294090|NCT00733174|Rosiglitazone|rosiglitazone|mesh-list
64524329|NCT02467504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65114286|NCT02900742|Immunologic Factors|immunologic factors|mesh-ancestor
65114287|NCT02900742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114288|NCT02900742|Tubulin Modulators|tubulin modulators|mesh-ancestor
65114289|NCT02900742|Antimitotic Agents|antimitotic agents|mesh-ancestor
65114290|NCT02900742|Mitosis Modulators|mitosis modulators|mesh-ancestor
65114291|NCT02900742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65114292|NCT02900742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65114293|NCT00449813|Pantoprazole|pantoprazole|mesh-list
65114294|NCT00449813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65114295|NCT00449813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65114296|NCT00449813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65114297|NCT00449813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114298|NCT00449813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114299|NCT01218100|Lisinopril|lisinopril|mesh-list
65114300|NCT01218100|Nebivolol|nebivolol|mesh-list
65114301|NCT01218100|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65114302|NCT01218100|Protease Inhibitors|protease inhibitors|mesh-ancestor
65114303|NCT01218100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114304|NCT01218100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114305|NCT01218100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65114306|NCT01218100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65114307|NCT01218100|Protective Agents|protective agents|mesh-ancestor
65114308|NCT01218100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114309|NCT01218100|Vasodilator Agents|vasodilator agents|mesh-ancestor
65114310|NCT01218100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65114311|NCT01218100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65114312|NCT01218100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65114313|NCT01218100|Adrenergic Agents|adrenergic agents|mesh-ancestor
64686598|NCT05324995|Analgesics|analgesics|mesh-ancestor
65114325|NCT00450008|Leprostatic Agents|leprostatic agents|mesh-ancestor
65114326|NCT00450008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65114327|NCT00450008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65114328|NCT00450008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65114329|NCT00450008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65114330|NCT00450008|Growth Substances|growth substances|mesh-ancestor
65114331|NCT00450008|Growth Inhibitors|growth inhibitors|mesh-ancestor
65114332|NCT02900469|Denosumab|denosumab|mesh-list
65114333|NCT02900469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65114334|NCT02900469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114335|NCT00450086|Budesonide|budesonide|mesh-list
65114336|NCT00450086|Mesalamine|mesalamine|mesh-list
65114337|NCT00450086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65114338|NCT00450086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65114339|NCT00450086|Autonomic Agents|autonomic agents|mesh-ancestor
65294091|NCT00733174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65294092|NCT00733174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294093|NCT00529789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65294094|NCT00529789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65294095|NCT00529789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65294096|NCT00529789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65294097|NCT00529789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114340|NCT00450086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65114341|NCT00450086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114342|NCT00450086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65114343|NCT00450086|Respiratory System Agents|respiratory system agents|mesh-ancestor
65114344|NCT00450086|Glucocorticoids|glucocorticoids|mesh-ancestor
65114345|NCT00450086|Hormones|hormones|mesh-ancestor
65114346|NCT00450086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65114347|NCT00450086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65114348|NCT00450086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65114349|NCT00450086|Analgesics|analgesics|mesh-ancestor
65114350|NCT00450086|Sensory System Agents|sensory system agents|mesh-ancestor
65114351|NCT00450086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65114352|NCT05422911|Abiraterone Acetate|abiraterone acetate|mesh-list
65114353|NCT05422911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114354|NCT05422911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65114355|NCT05422911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114356|NCT05422911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114357|NCT05422911|Hormone Antagonists|hormone antagonists|mesh-ancestor
65114358|NCT05422911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65114359|NCT05422911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114360|NCT05422911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65114361|NCT00450164|Nadolol|nadolol|mesh-list
65114362|NCT00450164|Prazosin|prazosin|mesh-list
65114363|NCT00450164|Isosorbide|isosorbide|mesh-list
65114364|NCT00450164|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65114365|NCT00450164|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65114366|NCT00450164|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65114367|NCT00450164|Diuretics|diuretics|mesh-ancestor
65114368|NCT00450164|Natriuretic Agents|natriuretic agents|mesh-ancestor
65114369|NCT00450164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114370|NCT00450164|Vasodilator Agents|vasodilator agents|mesh-ancestor
65114371|NCT00450164|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65114372|NCT00450164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114373|NCT00450164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65114374|NCT00450164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65114375|NCT00450164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65114376|NCT00450164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65114377|NCT00450164|Adrenergic Agents|adrenergic agents|mesh-ancestor
65114387|NCT02900430|Antifungal Agents|antifungal agents|mesh-list
65114388|NCT02900430|Clotrimazole|clotrimazole|mesh-list
65114389|NCT02900430|Miconazole|miconazole|mesh-list
65114390|NCT02900430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65114391|NCT02900430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65114392|NCT02900430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64756648|NCT00046566|Sequestering Agents|sequestering agents|mesh-ancestor
65114393|NCT02900430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65114394|NCT02900430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114395|NCT02900430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114396|NCT02900430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65114397|NCT02900430|Hormone Antagonists|hormone antagonists|mesh-ancestor
65114398|NCT02900430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65114399|NCT02900430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114400|NCT02900430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65114401|NCT02900430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65114402|NCT00450203|Bevacizumab|bevacizumab|mesh-list
65114403|NCT00450203|Capecitabine|capecitabine|mesh-list
65294098|NCT00529789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65294099|NCT00529789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294100|NCT00529789|Analgesics|analgesics|mesh-ancestor
65294101|NCT00529789|Sensory System Agents|sensory system agents|mesh-ancestor
65294102|NCT00529789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294103|NCT00529789|Antidepressive Agents|antidepressive agents|mesh-ancestor
65294104|NCT00529789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65294105|NCT00529789|Dopamine Agents|dopamine agents|mesh-ancestor
65044014|NCT00233025|Analgesics|analgesics|mesh-ancestor
64906187|NCT00008307|Melphalan|melphalan|mesh-list
65114404|NCT00450203|Epirubicin|epirubicin|mesh-list
65114405|NCT00450203|Lapatinib|lapatinib|mesh-list
65114406|NCT00450203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65114407|NCT00450203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114408|NCT00450203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65114409|NCT00450203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65114410|NCT00450203|Growth Substances|growth substances|mesh-ancestor
65114411|NCT00450203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114412|NCT00450203|Growth Inhibitors|growth inhibitors|mesh-ancestor
65114413|NCT00450203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65114414|NCT00450203|Antimetabolites|antimetabolites|mesh-ancestor
65114415|NCT00450203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114416|NCT00450203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65114417|NCT00450203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65114418|NCT00450203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65114419|NCT00450203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114420|NCT00450203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65114421|NCT00450281|Antibodies|antibodies|mesh-list
65114422|NCT00450281|Immunologic Factors|immunologic factors|mesh-ancestor
65114423|NCT00450281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114424|NCT04699097|Azithromycin|azithromycin|mesh-list
65114425|NCT04699097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65114426|NCT04699097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65114427|NCT04698746|Anesthetics|anesthetics|mesh-list
65114428|NCT04698746|Anesthetics, Local|anesthetics, local|mesh-list
65114429|NCT04698746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65114430|NCT04698746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114431|NCT04698746|Sensory System Agents|sensory system agents|mesh-ancestor
65114432|NCT04698746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65114433|NCT00450320|Sirolimus|sirolimus|mesh-list
65114434|NCT00450320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65114435|NCT00450320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65114436|NCT00450320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65114437|NCT00450320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114438|NCT00450320|Antifungal Agents|antifungal agents|mesh-ancestor
65114439|NCT00450320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65114440|NCT00450320|Immunologic Factors|immunologic factors|mesh-ancestor
65114441|NCT00450320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114442|NCT00450398|polysaccharide-K|polysaccharide-k|mesh-list
65114462|NCT04447989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114463|NCT04447989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114464|NCT04447989|Urological Agents|urological agents|mesh-ancestor
65114465|NCT00450827|Bevacizumab|bevacizumab|mesh-list
65114466|NCT00450827|Antibodies|antibodies|mesh-list
65114467|NCT00450827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65114468|NCT00450827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65114469|NCT00450827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114470|NCT00450827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65114471|NCT00450827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65114472|NCT00450827|Growth Substances|growth substances|mesh-ancestor
65114473|NCT00450827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114474|NCT00450827|Growth Inhibitors|growth inhibitors|mesh-ancestor
65114475|NCT00450827|Immunologic Factors|immunologic factors|mesh-ancestor
65114476|NCT00450944|Immunotoxins|immunotoxins|mesh-list
65114477|NCT00450944|Immunologic Factors|immunologic factors|mesh-ancestor
65114478|NCT00450944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114479|NCT00451061|Tamsulosin|tamsulosin|mesh-list
65294106|NCT04136028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65294107|NCT04136028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65294108|NCT00611819|Interferons|interferons|mesh-list
65294109|NCT00611819|Ribavirin|ribavirin|mesh-list
65294110|NCT00611819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65294111|NCT00611819|Interferon-alpha|interferon-alpha|mesh-list
65294112|NCT00611819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294113|NCT00611819|Antiviral Agents|antiviral agents|mesh-ancestor
65294114|NCT00611819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65294115|NCT00611819|Antimetabolites|antimetabolites|mesh-ancestor
65294116|NCT00611819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294117|NCT00611819|Immunologic Factors|immunologic factors|mesh-ancestor
65294118|NCT00611819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294119|NCT00577642|Zoledronic Acid|zoledronic acid|mesh-list
65294120|NCT00577642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65294121|NCT00577642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294122|NCT02619162|Letrozole|letrozole|mesh-list
65294123|NCT02619162|Nintedanib|nintedanib|mesh-list
65294124|NCT02619162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294125|NCT02619162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65294126|NCT02619162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65294127|NCT02619162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524358|NCT02418702|Ketamine|ketamine|mesh-list
64524359|NCT02418702|Analgesics|analgesics|mesh-ancestor
65114480|NCT00451061|Alfuzosin|alfuzosin|mesh-list
65114481|NCT00451061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65114482|NCT00451061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65114483|NCT00451061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65114484|NCT00451061|Adrenergic Agents|adrenergic agents|mesh-ancestor
65114485|NCT00451061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65114486|NCT00451061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114487|NCT00451061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114488|NCT00451061|Urological Agents|urological agents|mesh-ancestor
65114489|NCT02931383|Liraglutide|liraglutide|mesh-list
65114490|NCT02931383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65114491|NCT02931383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114492|NCT02931383|Incretins|incretins|mesh-ancestor
65114493|NCT02931383|Hormones|hormones|mesh-ancestor
65114494|NCT02931383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65114495|NCT04341441|Hydroxychloroquine|hydroxychloroquine|mesh-list
65114496|NCT04341441|Antimalarials|antimalarials|mesh-ancestor
65114497|NCT04341441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65114498|NCT04341441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65114502|NCT04341441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65114503|NCT01187953|Tacrolimus|tacrolimus|mesh-list
65114504|NCT01187953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65114505|NCT01187953|Immunologic Factors|immunologic factors|mesh-ancestor
65114506|NCT01187953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114507|NCT01187953|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65114508|NCT01187953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114509|NCT01187953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114510|NCT00624325|Interferons|interferons|mesh-list
65114511|NCT00624325|Interferon-alpha|interferon-alpha|mesh-list
65294128|NCT02619162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294129|NCT02619162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65294130|NCT02619162|Hormone Antagonists|hormone antagonists|mesh-ancestor
65294131|NCT02619162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65294132|NCT02619162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294133|NCT02619162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65294134|NCT04018690|Triamcinolone|triamcinolone|mesh-list
64524380|NCT02412930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65114512|NCT00624325|Interferon alpha-2|interferon alpha-2|mesh-list
65114513|NCT00624325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114514|NCT00624325|Antiviral Agents|antiviral agents|mesh-ancestor
65114515|NCT00624325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65114516|NCT00624325|Immunologic Factors|immunologic factors|mesh-ancestor
65114517|NCT00624325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114518|NCT04262817|Nicotine|nicotine|mesh-list
65114519|NCT04262817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65114520|NCT04262817|Autonomic Agents|autonomic agents|mesh-ancestor
65114521|NCT04262817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65114522|NCT04262817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114523|NCT04262817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65114524|NCT04262817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65114525|NCT04262817|Cholinergic Agents|cholinergic agents|mesh-ancestor
65114526|NCT04262817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65114527|NCT04262817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114528|NCT02931188|Anacetrapib|anacetrapib|mesh-list
65114529|NCT02931188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65114530|NCT02931188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65114531|NCT02931188|Antimetabolites|antimetabolites|mesh-ancestor
65114532|NCT02931188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114533|NCT02931188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65114534|NCT01217944|Ranibizumab|ranibizumab|mesh-list
65114535|NCT01217944|Verteporfin|verteporfin|mesh-list
65114536|NCT01217944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65114537|NCT01217944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65114538|NCT01217944|Growth Substances|growth substances|mesh-ancestor
65114539|NCT01217944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114540|NCT01217944|Growth Inhibitors|growth inhibitors|mesh-ancestor
65114541|NCT01217944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114542|NCT01217944|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65114543|NCT01217944|Dermatologic Agents|dermatologic agents|mesh-ancestor
65114544|NCT04689815|Arsenic Trioxide|arsenic trioxide|mesh-list
65114545|NCT04689815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114546|NCT01187446|Vorinostat|vorinostat|mesh-list
65114547|NCT01187446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114548|NCT01187446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65114549|NCT01187446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114550|NCT01187446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114551|NCT02931071|Plerixafor|plerixafor|mesh-list
65114552|NCT02931071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65114553|NCT02931071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65114554|NCT02931071|Antiviral Agents|antiviral agents|mesh-ancestor
65114555|NCT02931071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65114556|NCT01187407|Serotonin|serotonin|mesh-list
65114557|NCT01187407|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65114558|NCT01187407|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65114559|NCT01187407|Serotonin Agents|serotonin agents|mesh-ancestor
65114560|NCT01187407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65114561|NCT01187407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114562|NCT01187407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114563|NCT01187407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65114564|NCT01187407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65114565|NCT01186939|Azacitidine|azacitidine|mesh-list
65114566|NCT01186939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65114567|NCT01186939|Antimetabolites|antimetabolites|mesh-ancestor
65114568|NCT01186939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294135|NCT04018690|Ropivacaine|ropivacaine|mesh-list
65294136|NCT04018690|Anesthetics, Local|anesthetics, local|mesh-ancestor
65294137|NCT04018690|Anesthetics|anesthetics|mesh-ancestor
65294138|NCT04018690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65294139|NCT04018690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294140|NCT04018690|Sensory System Agents|sensory system agents|mesh-ancestor
65294141|NCT04018690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294142|NCT04018690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65294143|NCT04018690|Glucocorticoids|glucocorticoids|mesh-ancestor
65294144|NCT04018690|Hormones|hormones|mesh-ancestor
65294145|NCT04018690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65294146|NCT00697866|Vaccines|vaccines|mesh-list
65294147|NCT00697866|Immunologic Factors|immunologic factors|mesh-ancestor
65294148|NCT00697866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294149|NCT00733564|Lidocaine|lidocaine|mesh-list
65294150|NCT00733564|Propofol|propofol|mesh-list
65294151|NCT00733564|Sevoflurane|sevoflurane|mesh-list
65294152|NCT00733564|Anesthetics, Local|anesthetics, local|mesh-ancestor
64524388|NCT02418624|Carboplatin|carboplatin|mesh-list
64524389|NCT02418624|Olaparib|olaparib|mesh-list
65114569|NCT01186939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686850|NCT00559585|Abatacept|abatacept|mesh-list
65114591|NCT05321043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65114593|NCT02930954|Gemcitabine|gemcitabine|mesh-list
65114594|NCT02930954|Bevacizumab|bevacizumab|mesh-list
65114595|NCT02930954|Carboplatin|carboplatin|mesh-list
65114596|NCT02930954|Pemetrexed|pemetrexed|mesh-list
65114597|NCT02930954|Gefitinib|gefitinib|mesh-list
65114598|NCT02930954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65114599|NCT02930954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114600|NCT02930954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65114601|NCT02930954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65114602|NCT02930954|Growth Substances|growth substances|mesh-ancestor
65114603|NCT02930954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114604|NCT02930954|Growth Inhibitors|growth inhibitors|mesh-ancestor
65114605|NCT02930954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65114606|NCT02930954|Antimetabolites|antimetabolites|mesh-ancestor
65114607|NCT02930954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114608|NCT02930954|Antiviral Agents|antiviral agents|mesh-ancestor
65114609|NCT02930954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65114610|NCT02930954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114611|NCT02930954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65114612|NCT02930954|Immunologic Factors|immunologic factors|mesh-ancestor
65114613|NCT02930954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65114614|NCT02930954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65114615|NCT02930954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65114616|NCT04117659|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
65114617|NCT04117659|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65114618|NCT04117659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114619|NCT04117659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114621|NCT05289492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65114622|NCT05289492|Antiemetics|antiemetics|mesh-ancestor
65114623|NCT05289492|Autonomic Agents|autonomic agents|mesh-ancestor
65114624|NCT05289492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65114635|NCT02930057|Hormones|hormones|mesh-ancestor
65114636|NCT02930057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65114637|NCT02930057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294153|NCT00733564|Anesthetics|anesthetics|mesh-ancestor
65294154|NCT00733564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65294155|NCT00733564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294156|NCT00733564|Sensory System Agents|sensory system agents|mesh-ancestor
65294157|NCT00733564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294158|NCT00733564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65294159|NCT00733564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65294160|NCT00733564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64524406|NCT02440204|Anesthetics|anesthetics|mesh-ancestor
65114638|NCT02930057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65114639|NCT02930057|Respiratory System Agents|respiratory system agents|mesh-ancestor
65114640|NCT02929901|Caffeine|caffeine|mesh-list
65114641|NCT02929901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65114642|NCT02929901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114643|NCT02929901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65114644|NCT02929901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114645|NCT02929901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114646|NCT02929901|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65114647|NCT02929901|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65114648|NCT02929901|Purinergic Agents|purinergic agents|mesh-ancestor
65114649|NCT02929901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65114650|NCT02929706|Azathioprine|azathioprine|mesh-list
65114651|NCT02929706|Antimetabolites|antimetabolites|mesh-ancestor
65114652|NCT02929706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114653|NCT02929706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65114654|NCT02929706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114655|NCT02929706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65114656|NCT02929706|Immunologic Factors|immunologic factors|mesh-ancestor
65114657|NCT02929706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114658|NCT02929706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65114659|NCT03993132|Empagliflozin|empagliflozin|mesh-list
65114660|NCT03993132|Glucagon|glucagon|mesh-list
65114661|NCT03993132|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65114662|NCT03993132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65114663|NCT03993132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114664|NCT03993132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65114665|NCT03993132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114666|NCT03993132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65114667|NCT03993132|Hormones|hormones|mesh-ancestor
65114668|NCT03993132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65114669|NCT03993132|Incretins|incretins|mesh-ancestor
65114670|NCT00553878|Dutasteride|dutasteride|mesh-list
65114671|NCT00553878|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65114672|NCT00553878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65114673|NCT00553878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114674|NCT00553878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114675|NCT00553878|Hormone Antagonists|hormone antagonists|mesh-ancestor
65114676|NCT00553878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65114677|NCT00553878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114678|NCT05219409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65114679|NCT05219409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65114680|NCT05219409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114681|NCT05219409|Incretins|incretins|mesh-ancestor
65114682|NCT05219409|Hormones|hormones|mesh-ancestor
65114683|NCT05219409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65114684|NCT05219409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65114685|NCT05219409|Protease Inhibitors|protease inhibitors|mesh-ancestor
65114686|NCT05219409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114733|NCT02928692|Minocycline|minocycline|mesh-list
65114734|NCT02928692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65114735|NCT02928692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65114736|NCT04679142|Baclofen|baclofen|mesh-list
65114737|NCT04679142|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65294161|NCT00733564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65294162|NCT00733564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294163|NCT00733564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65294164|NCT00733564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65294165|NCT00733564|Anesthetics, General|anesthetics, general|mesh-ancestor
65294166|NCT00733564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65114738|NCT04679142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114739|NCT04679142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65114740|NCT04679142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65114741|NCT04679142|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65114742|NCT04679142|GABA Agonists|gaba agonists|mesh-ancestor
65114743|NCT04679142|GABA Agents|gaba agents|mesh-ancestor
65114744|NCT04679142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65114745|NCT04679142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114746|NCT02928419|Lenalidomide|lenalidomide|mesh-list
65114747|NCT02928419|Immunologic Factors|immunologic factors|mesh-ancestor
65114748|NCT02928419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114749|NCT02928419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65114750|NCT02928419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65114751|NCT02928419|Growth Substances|growth substances|mesh-ancestor
65114752|NCT02928419|Growth Inhibitors|growth inhibitors|mesh-ancestor
65114753|NCT02928419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114754|NCT03690921|Cisplatin|cisplatin|mesh-list
65114755|NCT03690921|Fluorouracil|fluorouracil|mesh-list
65114756|NCT03690921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114757|NCT03690921|Antimetabolites|antimetabolites|mesh-ancestor
65114758|NCT03690921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114759|NCT03690921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65114760|NCT03690921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65114761|NCT03690921|Immunologic Factors|immunologic factors|mesh-ancestor
65114762|NCT03690921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114763|NCT02928614|Liraglutide|liraglutide|mesh-list
65114764|NCT02928614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65114765|NCT02928614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114766|NCT02928614|Incretins|incretins|mesh-ancestor
65114767|NCT02928614|Hormones|hormones|mesh-ancestor
65114768|NCT02928614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65114769|NCT03685500|Emtricitabine|emtricitabine|mesh-list
65114770|NCT03685500|Darunavir|darunavir|mesh-list
65114771|NCT03685500|Cobicistat|cobicistat|mesh-list
65114772|NCT03685500|Antiviral Agents|antiviral agents|mesh-ancestor
65114773|NCT03685500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65114774|NCT03685500|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65114775|NCT03685500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65114776|NCT03685500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114777|NCT03685500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114778|NCT03685500|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65114779|NCT03685500|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65114780|NCT03685500|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65114781|NCT03685500|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65114789|NCT02928575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114791|NCT02928575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65114792|NCT02928575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65114793|NCT02928575|Growth Substances|growth substances|mesh-ancestor
65114794|NCT02928575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114795|NCT02928575|Growth Inhibitors|growth inhibitors|mesh-ancestor
65114796|NCT02928575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65114797|NCT02928575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114798|NCT02927951|Pregabalin|pregabalin|mesh-list
65114799|NCT02927951|Analgesics|analgesics|mesh-ancestor
65114800|NCT02927951|Sensory System Agents|sensory system agents|mesh-ancestor
65114801|NCT02927951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65114802|NCT02927951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114803|NCT02927951|Anticonvulsants|anticonvulsants|mesh-ancestor
65114804|NCT02927951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65114805|NCT02927951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65114806|NCT02927951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294167|NCT00733564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65294168|NCT00727870|Glycerol|glycerol|mesh-list
65294169|NCT00727870|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65294170|NCT00727870|Protective Agents|protective agents|mesh-ancestor
65294171|NCT00727870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294172|NCT01007695|Valproic Acid|valproic acid|mesh-list
65294173|NCT01007695|Anticonvulsants|anticonvulsants|mesh-ancestor
65294174|NCT01007695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65294175|NCT01007695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294176|NCT01007695|GABA Agents|gaba agents|mesh-ancestor
65044091|NCT00233337|Artemether|artemether|mesh-list
64524420|NCT02410590|Autonomic Agents|autonomic agents|mesh-ancestor
65114807|NCT02927951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65114808|NCT02927951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65114809|NCT02927951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65114810|NCT02927951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65114811|NCT02927951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65114812|NCT02927405|Gabapentin|gabapentin|mesh-list
65114813|NCT02927405|Analgesics|analgesics|mesh-ancestor
65114814|NCT02927405|Sensory System Agents|sensory system agents|mesh-ancestor
65114815|NCT02927405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65114816|NCT02927405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114817|NCT02927405|Anticonvulsants|anticonvulsants|mesh-ancestor
65114818|NCT02927405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65114819|NCT02927405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65114820|NCT02927405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65114821|NCT02927405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65114822|NCT02927405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65114823|NCT02927405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65114824|NCT02927405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65114825|NCT02927405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114826|NCT02927405|Antimanic Agents|antimanic agents|mesh-ancestor
65114827|NCT05005299|Cyclophosphamide|cyclophosphamide|mesh-list
65114828|NCT05005299|Fludarabine|fludarabine|mesh-list
65114829|NCT05005299|Venetoclax|venetoclax|mesh-list
65114830|NCT05005299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65114831|NCT05005299|Immunologic Factors|immunologic factors|mesh-ancestor
65114832|NCT05005299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114833|NCT05005299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65114834|NCT05005299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65114835|NCT05005299|Alkylating Agents|alkylating agents|mesh-ancestor
65114836|NCT05005299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114837|NCT05005299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114838|NCT05005299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65114839|NCT02927444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65114840|NCT02927444|Immunologic Factors|immunologic factors|mesh-ancestor
65114841|NCT02927444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114843|NCT02927522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65114844|NCT02927522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114845|NCT02927522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114846|NCT02927522|Cholinergic Agents|cholinergic agents|mesh-ancestor
65114847|NCT02927522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65114858|NCT02926976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114859|NCT02926976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65114860|NCT02926976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65114861|NCT02926976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65114862|NCT02926976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65114863|NCT02926976|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65114864|NCT02926976|Dopamine Agents|dopamine agents|mesh-ancestor
65114865|NCT02926976|Antidepressive Agents|antidepressive agents|mesh-ancestor
65114866|NCT02926976|Dopamine Agonists|dopamine agonists|mesh-ancestor
65114867|NCT02926976|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65114868|NCT02926976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65294177|NCT01007695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65294178|NCT01007695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294179|NCT01007695|Antimanic Agents|antimanic agents|mesh-ancestor
65294180|NCT01007695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65294181|NCT01007695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65294182|NCT01007695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65294183|NCT02709473|Remifentanil|remifentanil|mesh-list
65294184|NCT02709473|Propofol|propofol|mesh-list
65294185|NCT02709473|Rocuronium|rocuronium|mesh-list
65294186|NCT02709473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65294187|NCT02709473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65114869|NCT02926976|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65114870|NCT02926976|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65114871|NCT02926976|Anticonvulsants|anticonvulsants|mesh-ancestor
65114872|NCT02926976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114873|NCT02926976|GABA Agents|gaba agents|mesh-ancestor
65114874|NCT02926976|Antimanic Agents|antimanic agents|mesh-ancestor
65114875|NCT02926976|GABA Antagonists|gaba antagonists|mesh-ancestor
65114876|NCT02927015|Iproplatin|iproplatin|mesh-list
65114877|NCT02927015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114878|NCT04871607|Cytarabine|cytarabine|mesh-list
65114879|NCT04871607|Etoposide|etoposide|mesh-list
65114880|NCT04871607|Podophyllotoxin|podophyllotoxin|mesh-list
65114881|NCT04871607|Etoposide phosphate|etoposide phosphate|mesh-list
65114882|NCT04871607|Carmustine|carmustine|mesh-list
65114883|NCT04871607|Basiliximab|basiliximab|mesh-list
65114884|NCT04871607|Lenograstim|lenograstim|mesh-list
65114885|NCT04871607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65114886|NCT04871607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114887|NCT04871607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65114888|NCT04871607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65114889|NCT04871607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114890|NCT04871607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114891|NCT04871607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65114892|NCT04871607|Antimetabolites|antimetabolites|mesh-ancestor
65114893|NCT04871607|Antiviral Agents|antiviral agents|mesh-ancestor
65114894|NCT04871607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65114895|NCT04871607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65114896|NCT04871607|Immunologic Factors|immunologic factors|mesh-ancestor
65114897|NCT04871607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114898|NCT04871607|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65114899|NCT04871607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65114900|NCT04871607|Alkylating Agents|alkylating agents|mesh-ancestor
65114901|NCT04871607|Keratolytic Agents|keratolytic agents|mesh-ancestor
65114902|NCT04871607|Dermatologic Agents|dermatologic agents|mesh-ancestor
65114903|NCT04871607|Tubulin Modulators|tubulin modulators|mesh-ancestor
65114904|NCT04871607|Antimitotic Agents|antimitotic agents|mesh-ancestor
65114905|NCT04871607|Mitosis Modulators|mitosis modulators|mesh-ancestor
65114906|NCT04680195|Thalidomide|thalidomide|mesh-list
65114907|NCT04680195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65114908|NCT04680195|Immunologic Factors|immunologic factors|mesh-ancestor
65114909|NCT04680195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114910|NCT04680195|Leprostatic Agents|leprostatic agents|mesh-ancestor
65114911|NCT04680195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65114912|NCT04680195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65114913|NCT04680195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65114914|NCT04680195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64687206|NCT05688943|Anesthetics|anesthetics|mesh-list
65114932|NCT00553995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65114933|NCT00553995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65114934|NCT04798287|Adalimumab|adalimumab|mesh-list
65114935|NCT04798287|Etanercept|etanercept|mesh-list
65114936|NCT04798287|Golimumab|golimumab|mesh-list
65114937|NCT04798287|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
65114938|NCT04798287|Infliximab|infliximab|mesh-list
65114939|NCT04798287|Certolizumab Pegol|certolizumab pegol|mesh-list
65114940|NCT04798287|Tofacitinib|tofacitinib|mesh-list
65114941|NCT04798287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65114942|NCT04798287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65294188|NCT02709473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294189|NCT02709473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65294190|NCT02709473|Anesthetics, General|anesthetics, general|mesh-ancestor
65294191|NCT02709473|Anesthetics|anesthetics|mesh-ancestor
65294192|NCT02709473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65294193|NCT02709473|Narcotics|narcotics|mesh-ancestor
65294194|NCT02709473|Analgesics|analgesics|mesh-ancestor
65294195|NCT02709473|Sensory System Agents|sensory system agents|mesh-ancestor
65294196|NCT02709473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524441|NCT02517580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524442|NCT02517580|Hemostatics|hemostatics|mesh-ancestor
65114943|NCT04798287|Dermatologic Agents|dermatologic agents|mesh-ancestor
65114944|NCT04798287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65114945|NCT04798287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65114946|NCT04798287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65114947|NCT04798287|Analgesics|analgesics|mesh-ancestor
65114948|NCT04798287|Sensory System Agents|sensory system agents|mesh-ancestor
65114949|NCT04798287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65114950|NCT04798287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114951|NCT04798287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65114952|NCT04798287|Immunologic Factors|immunologic factors|mesh-ancestor
65114953|NCT04798287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65114954|NCT04798287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114955|NCT04798287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114956|NCT04689191|Vaccines|vaccines|mesh-list
65114957|NCT04689191|Immunologic Factors|immunologic factors|mesh-ancestor
65114958|NCT04689191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114959|NCT02925299|Insulin|insulin|mesh-list
65114960|NCT02925299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65114961|NCT02925299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114962|NCT02925416|Oritavancin|oritavancin|mesh-list
65114963|NCT02925416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65114964|NCT02925416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65114965|NCT02925533|Pembrolizumab|pembrolizumab|mesh-list
65114966|NCT02925533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65114967|NCT02925533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114968|NCT02917889|Caffeine|caffeine|mesh-list
65114969|NCT02917889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65114970|NCT02917889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114971|NCT02917889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65114972|NCT02917889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114973|NCT02917889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114980|NCT02917967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65114981|NCT02917967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114982|NCT02917967|Cholinergic Agents|cholinergic agents|mesh-ancestor
65114983|NCT02917967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65114984|NCT02917967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114985|NCT04485273|Anesthetics|anesthetics|mesh-list
65114986|NCT04485273|Sevoflurane|sevoflurane|mesh-list
65114987|NCT04485273|Bupivacaine|bupivacaine|mesh-list
65114988|NCT04485273|Anesthetics, Local|anesthetics, local|mesh-list
65114989|NCT04485273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65114990|NCT04485273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65114991|NCT04485273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114992|NCT04485273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65114993|NCT04485273|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65114994|NCT04485273|Anesthetics, General|anesthetics, general|mesh-ancestor
65114995|NCT04485273|Sensory System Agents|sensory system agents|mesh-ancestor
65114996|NCT04485273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65114997|NCT02205528|Metformin|metformin|mesh-list
65114998|NCT02205528|Liraglutide|liraglutide|mesh-list
65114999|NCT02205528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65115000|NCT02205528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115001|NCT02205528|Incretins|incretins|mesh-ancestor
65294197|NCT02709473|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65294198|NCT02709473|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65294199|NCT02709473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65294200|NCT00866658|Lixisenatide|lixisenatide|mesh-list
65294201|NCT00866658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65294202|NCT00866658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294203|NCT04942067|Dexamethasone|dexamethasone|mesh-list
65294204|NCT04942067|Dexamethasone acetate|dexamethasone acetate|mesh-list
65294205|NCT04942067|Lenalidomide|lenalidomide|mesh-list
64524451|NCT02412150|Remifentanil|remifentanil|mesh-list
64524452|NCT02412150|Desflurane|desflurane|mesh-list
65115002|NCT02205528|Hormones|hormones|mesh-ancestor
65115003|NCT02205528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65115004|NCT03532022|Dexamethasone|dexamethasone|mesh-list
65115005|NCT03532022|Prednisone|prednisone|mesh-list
65115006|NCT03532022|Prednisolone|prednisolone|mesh-list
65115007|NCT03532022|Hydrocortisone|hydrocortisone|mesh-list
65115008|NCT03532022|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65115009|NCT03532022|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65115010|NCT03532022|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65115011|NCT03532022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65115012|NCT03532022|Antiemetics|antiemetics|mesh-ancestor
65115013|NCT03532022|Autonomic Agents|autonomic agents|mesh-ancestor
65115014|NCT03532022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65115015|NCT03532022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115016|NCT03532022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65115017|NCT03532022|Glucocorticoids|glucocorticoids|mesh-ancestor
65115018|NCT03532022|Hormones|hormones|mesh-ancestor
65115019|NCT03532022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65115020|NCT03532022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65115021|NCT03532022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115022|NCT02200380|Plerixafor|plerixafor|mesh-list
65115023|NCT02200380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65115024|NCT02200380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65115025|NCT02200380|Antiviral Agents|antiviral agents|mesh-ancestor
65115026|NCT02200380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65115027|NCT02160678|Tazarotene|tazarotene|mesh-list
65115028|NCT02160678|Dermatologic Agents|dermatologic agents|mesh-ancestor
65115029|NCT02160678|Keratolytic Agents|keratolytic agents|mesh-ancestor
65115030|NCT02153502|Quinidine|quinidine|mesh-list
65115031|NCT02153502|Quinidine gluconate|quinidine gluconate|mesh-list
65115032|NCT02153502|Dextromethorphan|dextromethorphan|mesh-list
65115033|NCT02153502|Antitussive Agents|antitussive agents|mesh-ancestor
65115034|NCT02153502|Respiratory System Agents|respiratory system agents|mesh-ancestor
65115035|NCT02153502|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65115036|NCT02153502|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65115037|NCT02153502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65115038|NCT02153502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513799|NCT01891851|Ritonavir|ritonavir|mesh-list
65115039|NCT02153502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115041|NCT02153502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65115042|NCT02153502|Adrenergic Agents|adrenergic agents|mesh-ancestor
65115043|NCT02153502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65115067|NCT02130687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115069|NCT02130687|Autonomic Agents|autonomic agents|mesh-ancestor
65115070|NCT02130687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65115071|NCT02130687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65115072|NCT02130687|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65115073|NCT02130687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65115074|NCT01228656|Mometasone Furoate|mometasone furoate|mesh-list
65115075|NCT01228656|Salicylic Acid|salicylic acid|mesh-list
65115076|NCT01228656|Salicylates|salicylates|mesh-list
65115077|NCT01228656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65115078|NCT01228656|Dermatologic Agents|dermatologic agents|mesh-ancestor
65115079|NCT01228656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65115080|NCT01228656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65115081|NCT01228656|Antifungal Agents|antifungal agents|mesh-ancestor
65294206|NCT04942067|Daratumumab|daratumumab|mesh-list
65294207|NCT04942067|Pomalidomide|pomalidomide|mesh-list
65294208|NCT04942067|BB 1101|bb 1101|mesh-list
65294209|NCT04942067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65294210|NCT04942067|Antiemetics|antiemetics|mesh-ancestor
65294211|NCT04942067|Autonomic Agents|autonomic agents|mesh-ancestor
65294212|NCT04942067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294213|NCT04942067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294214|NCT04942067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65294215|NCT04942067|Glucocorticoids|glucocorticoids|mesh-ancestor
65294216|NCT04942067|Hormones|hormones|mesh-ancestor
65294217|NCT04942067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65294218|NCT04942067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65294219|NCT04942067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294220|NCT04942067|Protease Inhibitors|protease inhibitors|mesh-ancestor
65294221|NCT04942067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524460|NCT02412150|Sensory System Agents|sensory system agents|mesh-ancestor
64524469|NCT02412150|Narcotics|narcotics|mesh-ancestor
65115082|NCT01228656|Keratolytic Agents|keratolytic agents|mesh-ancestor
65115083|NCT01228656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65115084|NCT01228656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65115085|NCT01228656|Analgesics|analgesics|mesh-ancestor
65115086|NCT01228656|Sensory System Agents|sensory system agents|mesh-ancestor
65115087|NCT01228656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65115088|NCT01228656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115089|NCT01228656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65115090|NCT01228656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65115091|NCT01228656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115092|NCT01228656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115093|NCT02125266|Methotrexate|methotrexate|mesh-list
65115102|NCT02125266|Dermatologic Agents|dermatologic agents|mesh-ancestor
65115103|NCT02125266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115104|NCT02125266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65115105|NCT02125266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65115106|NCT02125266|Immunologic Factors|immunologic factors|mesh-ancestor
65115107|NCT02125266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65115108|NCT02125266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65115109|NCT02116998|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65115110|NCT02116998|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65115111|NCT02116998|Immunologic Factors|immunologic factors|mesh-ancestor
65115112|NCT02116998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115113|NCT02116998|Antacids|antacids|mesh-ancestor
65115114|NCT02116998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115115|NCT02116998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65115116|NCT02110368|Methyltestosterone|methyltestosterone|mesh-list
65115117|NCT02110368|Testosterone|testosterone|mesh-list
65115118|NCT02110368|Testosterone undecanoate|testosterone undecanoate|mesh-list
65115119|NCT02110368|Testosterone enanthate|testosterone enanthate|mesh-list
65115120|NCT02110368|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65115121|NCT02110368|Androgens|androgens|mesh-ancestor
65115122|NCT02110368|Hormones|hormones|mesh-ancestor
65115123|NCT02110368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65115124|NCT02110368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115125|NCT02110368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65115126|NCT02110368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115127|NCT02110368|Anabolic Agents|anabolic agents|mesh-ancestor
65115128|NCT02916485|Sirolimus|sirolimus|mesh-list
65115129|NCT02916485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65294222|NCT04942067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294223|NCT04942067|Immunologic Factors|immunologic factors|mesh-ancestor
65294224|NCT04942067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65294225|NCT04942067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65115130|NCT02916485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65115131|NCT02916485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65115132|NCT02916485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115133|NCT02916485|Antifungal Agents|antifungal agents|mesh-ancestor
65115134|NCT02916485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65115135|NCT02916485|Immunologic Factors|immunologic factors|mesh-ancestor
65115136|NCT02916485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115137|NCT01709214|Oxycodone|oxycodone|mesh-list
65115138|NCT01709214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65115139|NCT01709214|Narcotics|narcotics|mesh-ancestor
65115140|NCT01709214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65115141|NCT01709214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115142|NCT01709214|Analgesics|analgesics|mesh-ancestor
64757404|NCT01898676|Antimanic Agents|antimanic agents|mesh-ancestor
65115143|NCT01709214|Sensory System Agents|sensory system agents|mesh-ancestor
65115144|NCT01709214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65115145|NCT02916602|Losartan|losartan|mesh-list
65115146|NCT02916602|Amlodipine|amlodipine|mesh-list
65115147|NCT02916602|Chlorthalidone|chlorthalidone|mesh-list
65115148|NCT02916602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65115149|NCT02916602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65115150|NCT02916602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65115151|NCT02916602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115152|NCT02916602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65115153|NCT02916602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115154|NCT02916602|Vasodilator Agents|vasodilator agents|mesh-ancestor
65115155|NCT02916602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65115156|NCT02916602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65115157|NCT02916602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65115158|NCT02916602|Diuretics|diuretics|mesh-ancestor
65115167|NCT02916251|Incretins|incretins|mesh-ancestor
65115168|NCT02106546|Paclitaxel|paclitaxel|mesh-list
65115169|NCT02106546|Carboplatin|carboplatin|mesh-list
65115170|NCT02106546|Veliparib|veliparib|mesh-list
65115171|NCT02106546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65115172|NCT02106546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115173|NCT02106546|Tubulin Modulators|tubulin modulators|mesh-ancestor
65115174|NCT02106546|Antimitotic Agents|antimitotic agents|mesh-ancestor
65115175|NCT02106546|Mitosis Modulators|mitosis modulators|mesh-ancestor
65115176|NCT02106546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115177|NCT02106546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65115178|NCT02106546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115179|NCT02916173|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65115180|NCT02916173|Hormones|hormones|mesh-list
65115181|NCT02916173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65115182|NCT02916173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115183|NCT02916173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65115184|NCT02916134|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65115185|NCT02916134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65115186|NCT02104245|Ciprofloxacin|ciprofloxacin|mesh-list
65115187|NCT02104245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65115188|NCT02104245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65115189|NCT02104245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65115190|NCT02104245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65115191|NCT02104245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115192|NCT02104245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115193|NCT02104245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115194|NCT02104245|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65115195|NCT02104245|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65115196|NCT01699737|Glimepiride|glimepiride|mesh-list
65115197|NCT01699737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65115198|NCT01699737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65115199|NCT01699737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115200|NCT01699737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65115201|NCT01699737|Immunologic Factors|immunologic factors|mesh-ancestor
65115203|NCT04688723|Clopidogrel|clopidogrel|mesh-list
65294226|NCT04942067|Growth Substances|growth substances|mesh-ancestor
65294227|NCT04942067|Growth Inhibitors|growth inhibitors|mesh-ancestor
65294228|NCT01007773|Fentanyl|fentanyl|mesh-list
65294229|NCT01007773|Dexmedetomidine|dexmedetomidine|mesh-list
65294230|NCT01007773|Propofol|propofol|mesh-list
65294231|NCT01007773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65294232|NCT01007773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65294233|NCT01007773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294234|NCT01007773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65294235|NCT01007773|Anesthetics, General|anesthetics, general|mesh-ancestor
65294236|NCT01007773|Anesthetics|anesthetics|mesh-ancestor
65294237|NCT01007773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65294238|NCT01007773|Analgesics|analgesics|mesh-ancestor
65294239|NCT01007773|Sensory System Agents|sensory system agents|mesh-ancestor
65294240|NCT01007773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294241|NCT01007773|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65294242|NCT01007773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65294243|NCT01007773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65294244|NCT01007773|Adrenergic Agents|adrenergic agents|mesh-ancestor
65294245|NCT01007773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65294246|NCT01007773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294247|NCT01007773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65294248|NCT01007773|Narcotics|narcotics|mesh-ancestor
65294249|NCT01007773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65294250|NCT02615340|Melatonin|melatonin|mesh-list
65115204|NCT04688723|Ticagrelor|ticagrelor|mesh-list
65115205|NCT04688723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65115206|NCT04688723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65115207|NCT04688723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65115208|NCT04688723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65115209|NCT04688723|Purinergic Agents|purinergic agents|mesh-ancestor
65115210|NCT04688723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65115211|NCT04688723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115212|NCT04688723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115213|NCT04688723|Antithrombins|antithrombins|mesh-ancestor
65115214|NCT04688723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65115215|NCT04688723|Protease Inhibitors|protease inhibitors|mesh-ancestor
64757478|NCT00234078|Protective Agents|protective agents|mesh-ancestor
65115216|NCT04688723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115217|NCT04688723|Anticoagulants|anticoagulants|mesh-ancestor
65115218|NCT01699464|Timolol|timolol|mesh-list
65115219|NCT01699464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65115220|NCT01699464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65115221|NCT01699464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115222|NCT01699464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65115223|NCT01699464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65115224|NCT01699464|Adrenergic Agents|adrenergic agents|mesh-ancestor
65115236|NCT02102802|Serotonin Agents|serotonin agents|mesh-ancestor
65115237|NCT02102802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65115238|NCT02102802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115239|NCT02102802|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65294251|NCT02615340|Antioxidants|antioxidants|mesh-ancestor
65294252|NCT02615340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294253|NCT02615340|Protective Agents|protective agents|mesh-ancestor
65294254|NCT02615340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294255|NCT02615340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65294256|NCT04899791|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
65294257|NCT04899791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65294259|NCT04899791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294260|NCT04899791|Protective Agents|protective agents|mesh-ancestor
65294261|NCT04899791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294262|NCT04899791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65294263|NCT02615106|Endostar protein|endostar protein|mesh-list
65115240|NCT02102802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65115241|NCT02102802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65115242|NCT02102802|Adrenergic Agents|adrenergic agents|mesh-ancestor
65115243|NCT01694277|Sunitinib|sunitinib|mesh-list
65115244|NCT01694277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115245|NCT01694277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65115246|NCT01694277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65115247|NCT01694277|Growth Substances|growth substances|mesh-ancestor
65115248|NCT01694277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115249|NCT01694277|Growth Inhibitors|growth inhibitors|mesh-ancestor
65115250|NCT01694277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65115251|NCT01694277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64513832|NCT04391127|Hydroxychloroquine|hydroxychloroquine|mesh-list
65115252|NCT01694277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115253|NCT01669980|Vancomycin|vancomycin|mesh-list
65115254|NCT01669980|Ceftriaxone|ceftriaxone|mesh-list
65115255|NCT01669980|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
65115256|NCT01669980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65115257|NCT01669980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65115258|NCT02915666|Trametinib|trametinib|mesh-list
65115259|NCT02915666|Dabrafenib|dabrafenib|mesh-list
65115260|NCT02915666|Digoxin|digoxin|mesh-list
65115261|NCT02915666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115262|NCT02915666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65115263|NCT02915666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115264|NCT02915666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115265|NCT02915666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65115266|NCT02915666|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65115267|NCT02915666|Protective Agents|protective agents|mesh-ancestor
65115268|NCT02915666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115269|NCT02092935|Vancomycin|vancomycin|mesh-list
65115270|NCT02092935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65115271|NCT02092935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65115272|NCT01666977|Carboplatin|carboplatin|mesh-list
65115273|NCT01666977|Pemetrexed|pemetrexed|mesh-list
65115274|NCT01666977|Trebananib|trebananib|mesh-list
65115275|NCT01666977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115276|NCT01666977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115277|NCT01666977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115278|NCT01666977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65115279|NCT01666977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65115280|NCT01666977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65115281|NCT01666977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65115282|NCT01666977|Growth Substances|growth substances|mesh-ancestor
65115283|NCT01666977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115284|NCT01666977|Growth Inhibitors|growth inhibitors|mesh-ancestor
65115285|NCT02915354|Etanercept|etanercept|mesh-list
65115286|NCT02915354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65115287|NCT02915354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65115296|NCT02915354|Immunologic Factors|immunologic factors|mesh-ancestor
65294264|NCT02615106|Endostatins|endostatins|mesh-list
65294265|NCT02615106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65294266|NCT02615106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65294267|NCT02615106|Growth Substances|growth substances|mesh-ancestor
65294268|NCT02615106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294269|NCT02615106|Growth Inhibitors|growth inhibitors|mesh-ancestor
65294270|NCT02615106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294271|NCT04930237|Methylnaltrexone|methylnaltrexone|mesh-list
65294272|NCT04930237|Bisacodyl|bisacodyl|mesh-list
65294273|NCT04930237|Magnesium citrate|magnesium citrate|mesh-list
65294274|NCT04930237|Magnesium Oxide|magnesium oxide|mesh-list
65294275|NCT04930237|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
65294276|NCT04930237|Magnesium Hydroxide|magnesium hydroxide|mesh-list
65294277|NCT04930237|Calcium|calcium|mesh-list
65294278|NCT04930237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65294279|NCT04930237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294280|NCT04930237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294281|NCT04930237|Cathartics|cathartics|mesh-ancestor
65294282|NCT04930237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65294283|NCT04930237|Laxatives|laxatives|mesh-ancestor
65294284|NCT04930237|Antacids|antacids|mesh-ancestor
65294285|NCT04930237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65294286|NCT04930237|Sensory System Agents|sensory system agents|mesh-ancestor
65294287|NCT04930237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294288|NCT04930237|Antidiarrheals|antidiarrheals|mesh-ancestor
65294289|NCT02615262|Dexamethasone|dexamethasone|mesh-list
65294290|NCT02615262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65294291|NCT02615262|Antiemetics|antiemetics|mesh-ancestor
65294292|NCT02615262|Autonomic Agents|autonomic agents|mesh-ancestor
65294293|NCT02615262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294294|NCT02615262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294295|NCT02615262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64524515|NCT02417298|Sensory System Agents|sensory system agents|mesh-ancestor
65115297|NCT01661634|Ularitide|ularitide|mesh-list
65115298|NCT01661634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65115299|NCT01661634|Autonomic Agents|autonomic agents|mesh-ancestor
65115300|NCT01661634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65115301|NCT01661634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115302|NCT01661634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65115303|NCT01661634|Respiratory System Agents|respiratory system agents|mesh-ancestor
65115304|NCT01661634|Diuretics|diuretics|mesh-ancestor
65115305|NCT01661634|Natriuretic Agents|natriuretic agents|mesh-ancestor
65115306|NCT01661166|Fesoterodine|fesoterodine|mesh-list
65115307|NCT01661166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65115308|NCT01661166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65294296|NCT02615262|Glucocorticoids|glucocorticoids|mesh-ancestor
65294297|NCT02615262|Hormones|hormones|mesh-ancestor
65294298|NCT02615262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65294299|NCT02615262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65294300|NCT02615262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294301|NCT00733720|Naltrexone|naltrexone|mesh-list
65294302|NCT00733720|Buprenorphine|buprenorphine|mesh-list
65294303|NCT00733720|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65294304|NCT00733720|Naloxone|naloxone|mesh-list
65294305|NCT00733720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65294306|NCT00733720|Narcotics|narcotics|mesh-ancestor
65294307|NCT00733720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65294308|NCT00733720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294309|NCT00733720|Analgesics|analgesics|mesh-ancestor
65294310|NCT00733720|Sensory System Agents|sensory system agents|mesh-ancestor
65294311|NCT00733720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294312|NCT00733720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65294313|NCT00733720|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65294314|NCT05732389|Nivolumab|nivolumab|mesh-list
65115309|NCT01661166|Cholinergic Agents|cholinergic agents|mesh-ancestor
65115310|NCT01661166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65115311|NCT01661166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115312|NCT01661166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115313|NCT01661166|Urological Agents|urological agents|mesh-ancestor
65115314|NCT02915042|Dexmedetomidine|dexmedetomidine|mesh-list
65115315|NCT02915042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65115316|NCT02915042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65115317|NCT02915042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115318|NCT02915042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65115319|NCT02915042|Analgesics|analgesics|mesh-ancestor
65115320|NCT02915042|Sensory System Agents|sensory system agents|mesh-ancestor
65115321|NCT02915042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65115322|NCT02915042|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65115323|NCT02915042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65115324|NCT02915042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65115325|NCT02915042|Adrenergic Agents|adrenergic agents|mesh-ancestor
65115326|NCT02915042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65115327|NCT02915042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115329|NCT01658826|Pritelivir|pritelivir|mesh-list
65115330|NCT01658826|Antiviral Agents|antiviral agents|mesh-ancestor
65115331|NCT01658826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65115332|NCT01658826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115333|NCT01658826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115334|NCT02092077|Hormones|hormones|mesh-list
65115335|NCT02092077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65115336|NCT02092077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115337|NCT02914886|Insulin|insulin|mesh-list
65115338|NCT02914886|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65115339|NCT02914886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65115340|NCT02914886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115341|NCT01643226|Riboflavin|riboflavin|mesh-list
65115342|NCT01643226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65115343|NCT01643226|Vitamin B Complex|vitamin b complex|mesh-ancestor
65115344|NCT01643226|Vitamins|vitamins|mesh-ancestor
65115345|NCT01643226|Micronutrients|micronutrients|mesh-ancestor
65115346|NCT01643226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294315|NCT05732389|Ipilimumab|ipilimumab|mesh-list
65294316|NCT05732389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65294317|NCT05732389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294318|NCT05732389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65294319|NCT05732389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294320|NCT02624388|Genistein|genistein|mesh-list
65294321|NCT02624388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65294322|NCT02624388|Protective Agents|protective agents|mesh-ancestor
65294323|NCT02624388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294324|NCT02624388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294325|NCT02624388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64524564|NCT03177720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115347|NCT01643226|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65115348|NCT01643226|Dermatologic Agents|dermatologic agents|mesh-ancestor
65115349|NCT02914652|Albuterol|albuterol|mesh-list
65115350|NCT02914652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65115351|NCT02914652|Autonomic Agents|autonomic agents|mesh-ancestor
65115352|NCT02914652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65115353|NCT02914652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115354|NCT02914652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65115355|NCT02914652|Respiratory System Agents|respiratory system agents|mesh-ancestor
65115375|NCT02077881|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65115376|NCT02077881|Tryptophan|tryptophan|mesh-list
65115377|NCT02077881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65115378|NCT02077881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115379|NCT02077881|Tubulin Modulators|tubulin modulators|mesh-ancestor
65115380|NCT02077881|Antimitotic Agents|antimitotic agents|mesh-ancestor
65115381|NCT02077881|Mitosis Modulators|mitosis modulators|mesh-ancestor
65115382|NCT02077881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115383|NCT02077881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65115384|NCT02077881|Antimetabolites|antimetabolites|mesh-ancestor
65115385|NCT02077881|Antiviral Agents|antiviral agents|mesh-ancestor
65115386|NCT02077881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65115387|NCT02077881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115388|NCT02077881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65115389|NCT02077881|Immunologic Factors|immunologic factors|mesh-ancestor
65115390|NCT02077881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115391|NCT02077881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65115392|NCT02077881|Antidepressive Agents|antidepressive agents|mesh-ancestor
65115393|NCT02077881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65115394|NCT01632228|Bevacizumab|bevacizumab|mesh-list
65115395|NCT01632228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65115396|NCT01632228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115397|NCT01632228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65115398|NCT01632228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65115399|NCT01632228|Growth Substances|growth substances|mesh-ancestor
65115400|NCT01632228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115402|NCT01628094|Ritonavir|ritonavir|mesh-list
65115403|NCT01628094|Ribavirin|ribavirin|mesh-list
65115404|NCT01628094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65115405|NCT01628094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65115406|NCT01628094|Protease Inhibitors|protease inhibitors|mesh-ancestor
65115407|NCT01628094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115408|NCT01628094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115409|NCT01628094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65115410|NCT01628094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65115411|NCT01628094|Antiviral Agents|antiviral agents|mesh-ancestor
65115412|NCT01628094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65115431|NCT02914145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65115432|NCT02914145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65115434|NCT02914028|Tramadol|tramadol|mesh-list
65115435|NCT02914028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65115436|NCT02914028|Analgesics|analgesics|mesh-ancestor
65294326|NCT02624388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65294327|NCT02624388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294328|NCT02624388|Phytoestrogens|phytoestrogens|mesh-ancestor
65294329|NCT02624388|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65294330|NCT02624388|Estrogens|estrogens|mesh-ancestor
65294331|NCT02624388|Hormones|hormones|mesh-ancestor
65294332|NCT02624388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65294333|NCT00727948|Aspirin|aspirin|mesh-list
65294334|NCT00727948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65294335|NCT00727948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65294336|NCT00727948|Analgesics|analgesics|mesh-ancestor
65294337|NCT00727948|Sensory System Agents|sensory system agents|mesh-ancestor
65294338|NCT00727948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524575|NCT03175380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65115437|NCT02914028|Sensory System Agents|sensory system agents|mesh-ancestor
65115438|NCT02914028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65115439|NCT02914028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115440|NCT02914028|Antipyretics|antipyretics|mesh-ancestor
65115441|NCT02914028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65115442|NCT02914028|Narcotics|narcotics|mesh-ancestor
65115443|NCT02914028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64757699|NCT00250926|Dexamethasone acetate|dexamethasone acetate|mesh-list
65115444|NCT01566240|Paclitaxel|paclitaxel|mesh-list
65115445|NCT01566240|Carboplatin|carboplatin|mesh-list
65115446|NCT01566240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65115447|NCT01566240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115448|NCT01566240|Tubulin Modulators|tubulin modulators|mesh-ancestor
65115449|NCT01566240|Antimitotic Agents|antimitotic agents|mesh-ancestor
65115450|NCT01566240|Mitosis Modulators|mitosis modulators|mesh-ancestor
65115451|NCT01566240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115452|NCT02064426|Epoetin Alfa|epoetin alfa|mesh-list
65115453|NCT02064426|Hematinics|hematinics|mesh-ancestor
65115454|NCT00896493|Cyclosporine|cyclosporine|mesh-list
65115455|NCT00896493|Cyclosporins|cyclosporins|mesh-list
65115456|NCT00896493|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65115457|NCT00896493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115458|NCT00896493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115459|NCT00896493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65115460|NCT00896493|Immunologic Factors|immunologic factors|mesh-ancestor
65115461|NCT00896493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115462|NCT00896493|Antifungal Agents|antifungal agents|mesh-ancestor
65115463|NCT00896493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65115464|NCT00896493|Dermatologic Agents|dermatologic agents|mesh-ancestor
65115465|NCT00896493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65115466|NCT00896493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65115467|NCT02063997|Colchicine|colchicine|mesh-list
65115468|NCT02063997|Allopurinol|allopurinol|mesh-list
65115469|NCT02063997|Gout Suppressants|gout suppressants|mesh-ancestor
65115470|NCT02063997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64687774|NCT05592197|Lenvatinib|lenvatinib|mesh-list
65115479|NCT02063997|Antioxidants|antioxidants|mesh-ancestor
65115480|NCT02063997|Protective Agents|protective agents|mesh-ancestor
65115481|NCT02063997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115482|NCT00585507|Fulvestrant|fulvestrant|mesh-list
65115483|NCT00585507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65115484|NCT00585507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115485|NCT00585507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65115486|NCT00585507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65115487|NCT00585507|Hormone Antagonists|hormone antagonists|mesh-ancestor
65115488|NCT00585507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65115489|NCT00585507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115490|NCT02063685|Prednisone|prednisone|mesh-list
65294339|NCT00727948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294340|NCT00727948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65294341|NCT00727948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65294342|NCT00727948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65294343|NCT00727948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65294344|NCT00727948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294345|NCT00727948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65294346|NCT00727948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65294347|NCT00727948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65294348|NCT00727948|Antipyretics|antipyretics|mesh-ancestor
65294349|NCT01007851|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65294350|NCT01007851|Luteolytic Agents|luteolytic agents|mesh-ancestor
65294351|NCT01007851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65294352|NCT01007851|Contraceptive Agents|contraceptive agents|mesh-ancestor
64908566|NCT00000324|Tryptophan|tryptophan|mesh-list
65115491|NCT02063685|Cyclophosphamide|cyclophosphamide|mesh-list
65115492|NCT02063685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65115493|NCT02063685|Rituximab|rituximab|mesh-list
65115494|NCT02063685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65115495|NCT02063685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65115496|NCT02063685|Immunologic Factors|immunologic factors|mesh-ancestor
65115497|NCT02063685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115498|NCT02063685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65115499|NCT02063685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65115500|NCT02063685|Alkylating Agents|alkylating agents|mesh-ancestor
65115501|NCT02063685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115502|NCT02063685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115503|NCT02063685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65115504|NCT02063685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65115505|NCT02063685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65115506|NCT02063685|Glucocorticoids|glucocorticoids|mesh-ancestor
65115507|NCT02063685|Hormones|hormones|mesh-ancestor
65115508|NCT02063685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65115509|NCT02063685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65115511|NCT02063295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65115512|NCT02063295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65115513|NCT02063295|Growth Substances|growth substances|mesh-ancestor
65115514|NCT02063295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115515|NCT02063295|Growth Inhibitors|growth inhibitors|mesh-ancestor
65115516|NCT02063295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115517|NCT02057172|Liraglutide|liraglutide|mesh-list
65115518|NCT02057172|Exenatide|exenatide|mesh-list
65115519|NCT02057172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65115520|NCT02057172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115521|NCT02057172|Incretins|incretins|mesh-ancestor
65115522|NCT02057172|Hormones|hormones|mesh-ancestor
65115523|NCT02057172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65115524|NCT02057172|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65115525|NCT02894307|Rivaroxaban|rivaroxaban|mesh-list
65115526|NCT02894307|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65115527|NCT02894307|Antithrombins|antithrombins|mesh-ancestor
65115528|NCT02894307|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65115529|NCT02894307|Protease Inhibitors|protease inhibitors|mesh-ancestor
65115530|NCT02894307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115531|NCT02894307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115532|NCT02894307|Anticoagulants|anticoagulants|mesh-ancestor
65115533|NCT02052648|Bevacizumab|bevacizumab|mesh-list
65115534|NCT02052648|Temozolomide|temozolomide|mesh-list
65115535|NCT02052648|Tryptophan|tryptophan|mesh-list
65115536|NCT02052648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65115537|NCT02052648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294353|NCT01007851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65294354|NCT01007851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294355|NCT01007851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65294356|NCT01007851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65294357|NCT01007851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294358|NCT05580016|Plasminogen|plasminogen|mesh-list
65294359|NCT05580016|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65294360|NCT05580016|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64524604|NCT02409498|Anesthetics|anesthetics|mesh-ancestor
64524605|NCT02409498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64687816|NCT02608229|Antimetabolites|antimetabolites|mesh-ancestor
65115546|NCT02052648|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65115547|NCT02052648|Antidepressive Agents|antidepressive agents|mesh-ancestor
65115548|NCT02052648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65115549|NCT01186744|Tofacitinib|tofacitinib|mesh-list
65115550|NCT01186744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65115551|NCT01186744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115552|NCT01186744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115554|NCT02044341|Glycerol|glycerol|mesh-list
65115555|NCT02044341|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65115556|NCT02044341|Protective Agents|protective agents|mesh-ancestor
65115557|NCT02044341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115558|NCT02044341|Anesthetics, Local|anesthetics, local|mesh-ancestor
65115559|NCT02044341|Anesthetics|anesthetics|mesh-ancestor
65115560|NCT02044341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65115561|NCT02044341|Sensory System Agents|sensory system agents|mesh-ancestor
65115562|NCT02044341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65115563|NCT00555399|Temozolomide|temozolomide|mesh-list
65115564|NCT00555399|Vorinostat|vorinostat|mesh-list
65115565|NCT00555399|Isotretinoin|isotretinoin|mesh-list
65115566|NCT00555399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65115567|NCT00555399|Alkylating Agents|alkylating agents|mesh-ancestor
65115568|NCT00555399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115569|NCT00555399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115570|NCT00555399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65115571|NCT00555399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115572|NCT00555399|Dermatologic Agents|dermatologic agents|mesh-ancestor
65115573|NCT02912663|Magnesium Sulfate|magnesium sulfate|mesh-list
65115574|NCT02912663|Verapamil|verapamil|mesh-list
65115575|NCT02912663|Analgesics|analgesics|mesh-ancestor
65115576|NCT02912663|Sensory System Agents|sensory system agents|mesh-ancestor
65115577|NCT02912663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65115578|NCT02912663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115579|NCT02912663|Anesthetics|anesthetics|mesh-ancestor
65115580|NCT02912663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65115581|NCT02912663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65115582|NCT02912663|Anticonvulsants|anticonvulsants|mesh-ancestor
65115583|NCT02912663|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65115584|NCT02912663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65115585|NCT02912663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115586|NCT02912663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65115587|NCT02912663|Tocolytic Agents|tocolytic agents|mesh-ancestor
65115588|NCT02912663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65115589|NCT02912663|Vasodilator Agents|vasodilator agents|mesh-ancestor
65115590|NCT02894151|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65115591|NCT02894151|Medroxyprogesterone|medroxyprogesterone|mesh-list
65115592|NCT02894151|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65115593|NCT02894151|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65115594|NCT02894151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65115595|NCT02894151|Contraceptive Agents|contraceptive agents|mesh-ancestor
65115596|NCT02894151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65115597|NCT02894151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115598|NCT02894151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65294361|NCT05580016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294362|NCT05730673|Leronlimab|leronlimab|mesh-list
65294363|NCT05730673|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65294364|NCT05730673|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65294365|NCT05730673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294366|NCT05730673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65294367|NCT05730673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65294368|NCT05730673|Antiviral Agents|antiviral agents|mesh-ancestor
65294369|NCT05730673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65294370|NCT04134078|Nitric Oxide|nitric oxide|mesh-list
65294371|NCT04134078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65294372|NCT04134078|Autonomic Agents|autonomic agents|mesh-ancestor
65294373|NCT04134078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294374|NCT04134078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115599|NCT02894151|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65115600|NCT02894151|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65115601|NCT02894151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65115602|NCT02894151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115619|NCT02912702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65115621|NCT02912702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65115622|NCT02912702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65115623|NCT02912702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65115624|NCT02912702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115625|NCT02912702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115626|NCT02912702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65115627|NCT02912702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65115628|NCT02912702|Protective Agents|protective agents|mesh-ancestor
65115630|NCT02010333|Anesthetics, Local|anesthetics, local|mesh-ancestor
65115631|NCT02010333|Anesthetics|anesthetics|mesh-ancestor
65115632|NCT02010333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65115633|NCT02010333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115634|NCT02010333|Sensory System Agents|sensory system agents|mesh-ancestor
65115635|NCT02010333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65115636|NCT02008344|Favipiravir|favipiravir|mesh-list
65115637|NCT02008344|Antiviral Agents|antiviral agents|mesh-ancestor
65115638|NCT02008344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65115639|NCT02912156|Voriconazole|voriconazole|mesh-list
65115640|NCT02912156|Antifungal Agents|antifungal agents|mesh-ancestor
65115641|NCT02912156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65115642|NCT02912156|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65115643|NCT02912156|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65115644|NCT02912156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115645|NCT02912156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115646|NCT02912156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65115647|NCT02912156|Hormone Antagonists|hormone antagonists|mesh-ancestor
65115648|NCT02912156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65115649|NCT02912156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115650|NCT02912156|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65115651|NCT03455049|Andrographolide|andrographolide|mesh-list
65115652|NCT03455049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65115653|NCT03455049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65115654|NCT03455049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65115655|NCT03455049|Analgesics|analgesics|mesh-ancestor
65115656|NCT03455049|Sensory System Agents|sensory system agents|mesh-ancestor
65115657|NCT03455049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65115658|NCT03455049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115659|NCT03455049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65294375|NCT04134078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65294376|NCT04134078|Respiratory System Agents|respiratory system agents|mesh-ancestor
65294377|NCT04134078|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65294378|NCT04134078|Antioxidants|antioxidants|mesh-ancestor
65294379|NCT04134078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294380|NCT04134078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65294381|NCT04134078|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65294382|NCT04134078|Vasodilator Agents|vasodilator agents|mesh-ancestor
64524626|NCT02410746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524627|NCT02410746|Analgesics|analgesics|mesh-ancestor
65115660|NCT03455049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65115661|NCT03455049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65115662|NCT03455049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65115663|NCT03455049|Antiviral Agents|antiviral agents|mesh-ancestor
65115672|NCT02912234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65115673|NCT02912234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65115674|NCT02912234|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65115675|NCT02912234|Antithrombins|antithrombins|mesh-ancestor
65115676|NCT02912234|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65115677|NCT02912234|Protease Inhibitors|protease inhibitors|mesh-ancestor
65115678|NCT02912234|Anticoagulants|anticoagulants|mesh-ancestor
65115680|NCT04676139|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65115681|NCT04676139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65115682|NCT04676139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65115683|NCT04676139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115684|NCT04676139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65115685|NCT04676139|Serotonin Agents|serotonin agents|mesh-ancestor
65115686|NCT04676139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115687|NCT04676139|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65115688|NCT04676139|Antidepressive Agents|antidepressive agents|mesh-ancestor
65115689|NCT04676139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65115690|NCT04676139|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65115691|NCT04676139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65115692|NCT04676139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115693|NCT01999764|Retinol acetate|retinol acetate|mesh-list
65115694|NCT01999764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65115695|NCT01999764|Immunologic Factors|immunologic factors|mesh-ancestor
65115696|NCT01999764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115697|NCT01999764|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65115698|NCT01999764|Protective Agents|protective agents|mesh-ancestor
65115699|NCT01999764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115700|NCT02911961|Acetaminophen|acetaminophen|mesh-list
65115701|NCT02911961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65115702|NCT02911961|Analgesics|analgesics|mesh-ancestor
65115703|NCT02911961|Sensory System Agents|sensory system agents|mesh-ancestor
65115704|NCT02911961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65115705|NCT02911961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115706|NCT02911961|Antipyretics|antipyretics|mesh-ancestor
65115707|NCT01998828|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
65115708|NCT01998828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65115709|NCT01998828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115710|NCT01998828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115711|NCT04676061|Norethindrone|norethindrone|mesh-list
65115712|NCT04676061|Norethindrone Acetate|norethindrone acetate|mesh-list
65115713|NCT04676061|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65115714|NCT04676061|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65115715|NCT04676061|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65115716|NCT04676061|Contraceptive Agents|contraceptive agents|mesh-ancestor
65115717|NCT04676061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65115718|NCT04676061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115719|NCT04676061|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65294383|NCT04134078|Gasotransmitters|gasotransmitters|mesh-ancestor
65294384|NCT04134078|Protective Agents|protective agents|mesh-ancestor
65294385|NCT03871829|Dexamethasone|dexamethasone|mesh-list
65294386|NCT03871829|Dexamethasone acetate|dexamethasone acetate|mesh-list
65294387|NCT03871829|BB 1101|bb 1101|mesh-list
65294388|NCT03871829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65294389|NCT03871829|Antiemetics|antiemetics|mesh-ancestor
65294390|NCT03871829|Autonomic Agents|autonomic agents|mesh-ancestor
65294391|NCT03871829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294392|NCT03871829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115720|NCT04676061|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65115721|NCT04675944|Treprostinil|treprostinil|mesh-list
65115722|NCT04675944|Zamicastat|zamicastat|mesh-list
65115723|NCT04675944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65115724|NCT04675944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115725|NCT04675944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115726|NCT02911766|Chlorhexidine|chlorhexidine|mesh-list
65115739|NCT01989429|Vitamin D|vitamin d|mesh-list
65115740|NCT01989429|Vitamins|vitamins|mesh-ancestor
64758002|NCT00334074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65115741|NCT01989429|Micronutrients|micronutrients|mesh-ancestor
65115742|NCT01989429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115743|NCT01989429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65115744|NCT02911298|Metronidazole|metronidazole|mesh-list
65115745|NCT02911298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65115746|NCT02911298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65115747|NCT02911298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65115748|NCT02911298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65115749|NCT01983306|Dolcanatide|dolcanatide|mesh-list
65115750|NCT01983306|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65115751|NCT01983306|Enzyme Activators|enzyme activators|mesh-ancestor
65115752|NCT01983306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115753|NCT01983306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65115754|NCT01982175|Alemtuzumab|alemtuzumab|mesh-list
65115755|NCT01982175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65115756|NCT01982175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115757|NCT01975818|Epoetin Alfa|epoetin alfa|mesh-list
65115758|NCT01975818|Hematinics|hematinics|mesh-ancestor
65115759|NCT00555594|Bevacizumab|bevacizumab|mesh-list
65115760|NCT00555594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65115761|NCT00555594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115762|NCT00555594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65115763|NCT00555594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65115764|NCT00555594|Growth Substances|growth substances|mesh-ancestor
65115765|NCT00555594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115766|NCT00555594|Growth Inhibitors|growth inhibitors|mesh-ancestor
65115767|NCT01973049|Ribavirin|ribavirin|mesh-list
65115768|NCT01973049|Asunaprevir|asunaprevir|mesh-list
65115769|NCT01973049|Antimetabolites|antimetabolites|mesh-ancestor
65115770|NCT01973049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115771|NCT01973049|Antiviral Agents|antiviral agents|mesh-ancestor
65115772|NCT01973049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65115773|NCT01973049|Protease Inhibitors|protease inhibitors|mesh-ancestor
65115774|NCT01973049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115775|NCT01185964|Doxorubicin|doxorubicin|mesh-list
65115776|NCT01185964|Olaratumab|olaratumab|mesh-list
65115777|NCT01185964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65115778|NCT01185964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115779|NCT01185964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65115780|NCT01185964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65115781|NCT01185964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115782|NCT01185964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115783|NCT01972854|Riboflavin|riboflavin|mesh-list
65115784|NCT01972854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65115785|NCT01972854|Vitamin B Complex|vitamin b complex|mesh-ancestor
65115786|NCT01972854|Vitamins|vitamins|mesh-ancestor
65115787|NCT01972854|Micronutrients|micronutrients|mesh-ancestor
65115788|NCT01972854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115789|NCT01972854|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65294393|NCT03871829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65294394|NCT03871829|Glucocorticoids|glucocorticoids|mesh-ancestor
65294395|NCT03871829|Hormones|hormones|mesh-ancestor
65294396|NCT03871829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65294397|NCT03871829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65294398|NCT03871829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294399|NCT03871829|Protease Inhibitors|protease inhibitors|mesh-ancestor
65294400|NCT03871829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65294401|NCT03871829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294402|NCT00738556|Sirolimus|sirolimus|mesh-list
65294403|NCT00738556|Paclitaxel|paclitaxel|mesh-list
65294404|NCT00738556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65294405|NCT00738556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294406|NCT00738556|Tubulin Modulators|tubulin modulators|mesh-ancestor
64524643|NCT03177174|Mitosis Modulators|mitosis modulators|mesh-ancestor
65115790|NCT01972854|Dermatologic Agents|dermatologic agents|mesh-ancestor
65115791|NCT02550470|Sevoflurane|sevoflurane|mesh-list
65115808|NCT02910518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65115809|NCT02910518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115810|NCT02910518|Anticoagulants|anticoagulants|mesh-ancestor
65115811|NCT02910518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65115812|NCT02910518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65115813|NCT02910518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115814|NCT02910518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65115815|NCT02910518|Hormones|hormones|mesh-ancestor
65115816|NCT02910518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65115817|NCT01217437|Bevacizumab|bevacizumab|mesh-list
65115818|NCT01217437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65115819|NCT01217437|Irinotecan|irinotecan|mesh-list
65115820|NCT01217437|Temozolomide|temozolomide|mesh-list
65115821|NCT01217437|Camptothecin|camptothecin|mesh-list
65115822|NCT01217437|Endothelial Growth Factors|endothelial growth factors|mesh-list
65115823|NCT01217437|Antibodies|antibodies|mesh-list
65115824|NCT01217437|Immunoglobulins|immunoglobulins|mesh-list
65115825|NCT01217437|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65115826|NCT01217437|Immunoglobulin G|immunoglobulin g|mesh-list
65115827|NCT01217437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115828|NCT01217437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65115829|NCT01217437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65115830|NCT01217437|Growth Substances|growth substances|mesh-ancestor
65115831|NCT01217437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115832|NCT01217437|Growth Inhibitors|growth inhibitors|mesh-ancestor
65115833|NCT01217437|Immunologic Factors|immunologic factors|mesh-ancestor
65115834|NCT01217437|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65115835|NCT01217437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65115836|NCT01217437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115837|NCT01217437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115838|NCT01217437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65115839|NCT01217437|Alkylating Agents|alkylating agents|mesh-ancestor
65115840|NCT01217437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65115841|NCT00624364|Metformin|metformin|mesh-list
65115842|NCT00624364|Insulin Aspart|insulin aspart|mesh-list
65115843|NCT00624364|Biphasic Insulins|biphasic insulins|mesh-list
65115844|NCT00624364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65115845|NCT00624364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115846|NCT02910596|Bethanechol|bethanechol|mesh-list
65115847|NCT02910596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65115848|NCT02910596|Autonomic Agents|autonomic agents|mesh-ancestor
65115849|NCT02910596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65115850|NCT02910596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115851|NCT02910596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65044307|NCT00208520|Carbamazepine|carbamazepine|mesh-list
65294407|NCT00738556|Antimitotic Agents|antimitotic agents|mesh-ancestor
65294408|NCT00738556|Mitosis Modulators|mitosis modulators|mesh-ancestor
65294409|NCT00738556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294410|NCT00738556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65294411|NCT00738556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65294412|NCT00738556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65294413|NCT00738556|Antifungal Agents|antifungal agents|mesh-ancestor
65294414|NCT00738556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65294415|NCT00738556|Immunologic Factors|immunologic factors|mesh-ancestor
65294416|NCT00738556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294418|NCT00597584|Hematinics|hematinics|mesh-ancestor
65294419|NCT00529633|Thalidomide|thalidomide|mesh-list
65294420|NCT00529633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65115852|NCT02910596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65115853|NCT02910596|Cholinergic Agents|cholinergic agents|mesh-ancestor
65115854|NCT02910596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65115876|NCT04676997|Cyclophosphamide|cyclophosphamide|mesh-list
65115877|NCT04676997|Epirubicin|epirubicin|mesh-list
65115878|NCT04676997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65115879|NCT04676997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115880|NCT04676997|Tubulin Modulators|tubulin modulators|mesh-ancestor
65115881|NCT04676997|Antimitotic Agents|antimitotic agents|mesh-ancestor
65115882|NCT04676997|Mitosis Modulators|mitosis modulators|mesh-ancestor
65115883|NCT04676997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115884|NCT04676997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65115885|NCT04676997|Immunologic Factors|immunologic factors|mesh-ancestor
65115886|NCT04676997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115887|NCT04676997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65115888|NCT04676997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65115889|NCT04676997|Alkylating Agents|alkylating agents|mesh-ancestor
65115890|NCT04676997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65115891|NCT04676997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65115892|NCT04676997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65115893|NCT04676997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65115894|NCT04676997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115895|NCT02910206|Sufentanil|sufentanil|mesh-list
65115897|NCT02910206|Etomidate|etomidate|mesh-list
65115898|NCT02910206|Cisatracurium|cisatracurium|mesh-list
65115899|NCT02910206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65115900|NCT02910206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65115901|NCT02910206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115902|NCT02910206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65115903|NCT02910206|Anesthetics, General|anesthetics, general|mesh-ancestor
65115904|NCT02910206|Anesthetics|anesthetics|mesh-ancestor
65115905|NCT02910206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65115906|NCT02910206|Narcotics|narcotics|mesh-ancestor
65115907|NCT02910206|Analgesics|analgesics|mesh-ancestor
65115908|NCT02910206|Sensory System Agents|sensory system agents|mesh-ancestor
65115921|NCT04675086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65115922|NCT04675086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65115924|NCT02909972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65115925|NCT02909972|Antimetabolites|antimetabolites|mesh-ancestor
65115926|NCT02909972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115927|NCT02909972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115928|NCT02909972|Antiviral Agents|antiviral agents|mesh-ancestor
65115929|NCT02909972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65115930|NCT02909972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65115931|NCT02909972|Immunologic Factors|immunologic factors|mesh-ancestor
65115932|NCT02909972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115933|NCT02910050|Letrozole|letrozole|mesh-list
65115934|NCT02910050|Anastrozole|anastrozole|mesh-list
65115935|NCT02910050|Exemestane|exemestane|mesh-list
65294421|NCT00529633|Immunologic Factors|immunologic factors|mesh-ancestor
65294422|NCT00529633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294423|NCT00529633|Leprostatic Agents|leprostatic agents|mesh-ancestor
65294424|NCT00529633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65294425|NCT00529633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65294426|NCT00529633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65294427|NCT00529633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65294428|NCT00529633|Growth Substances|growth substances|mesh-ancestor
65294429|NCT00529633|Growth Inhibitors|growth inhibitors|mesh-ancestor
65294430|NCT00529633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294431|NCT01366144|Paclitaxel|paclitaxel|mesh-list
65294432|NCT01366144|Carboplatin|carboplatin|mesh-list
65294433|NCT01366144|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65294434|NCT01366144|Veliparib|veliparib|mesh-list
65294435|NCT01366144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65294436|NCT01366144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294437|NCT01366144|Tubulin Modulators|tubulin modulators|mesh-ancestor
65294438|NCT01366144|Antimitotic Agents|antimitotic agents|mesh-ancestor
65294439|NCT01366144|Mitosis Modulators|mitosis modulators|mesh-ancestor
65294440|NCT01366144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294441|NCT01366144|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65294442|NCT01366144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115936|NCT02910050|Bicalutamide|bicalutamide|mesh-list
65115937|NCT02910050|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65115938|NCT02910050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115939|NCT02910050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65115940|NCT02910050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115941|NCT02910050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115942|NCT02910050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65115943|NCT02910050|Hormone Antagonists|hormone antagonists|mesh-ancestor
65115944|NCT02910050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65115945|NCT02910050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115946|NCT02910050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65115947|NCT02910050|Androgen Antagonists|androgen antagonists|mesh-ancestor
65115948|NCT02909933|Metformin|metformin|mesh-list
65115949|NCT02909933|Liraglutide|liraglutide|mesh-list
65115950|NCT02909933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65115951|NCT02909933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115952|NCT02909933|Incretins|incretins|mesh-ancestor
65115953|NCT02909933|Hormones|hormones|mesh-ancestor
65115954|NCT02909933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65115955|NCT02910245|Prednisone|prednisone|mesh-list
65115956|NCT02910245|Mesalamine|mesalamine|mesh-list
65115957|NCT02910245|Mercaptopurine|mercaptopurine|mesh-list
65115958|NCT02910245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65115959|NCT02910245|Glucocorticoids|glucocorticoids|mesh-ancestor
65115960|NCT02910245|Hormones|hormones|mesh-ancestor
65115961|NCT02910245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65115962|NCT02910245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115963|NCT02910245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65115964|NCT02910245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115965|NCT02910245|Antimetabolites|antimetabolites|mesh-ancestor
65222806|NCT04965493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65294443|NCT00697944|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65294444|NCT00697944|Antifungal Agents|antifungal agents|mesh-ancestor
65294445|NCT00697944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65294446|NCT00697944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65294447|NCT00697944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65294448|NCT00657488|Thalidomide|thalidomide|mesh-list
65294449|NCT00657488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65294450|NCT00657488|Immunologic Factors|immunologic factors|mesh-ancestor
65294451|NCT00657488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294452|NCT00657488|Leprostatic Agents|leprostatic agents|mesh-ancestor
65294453|NCT00657488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65294454|NCT00657488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65294455|NCT00657488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65294456|NCT00657488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65294457|NCT00657488|Growth Substances|growth substances|mesh-ancestor
65294458|NCT00657488|Growth Inhibitors|growth inhibitors|mesh-ancestor
65294459|NCT00657488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294460|NCT00530335|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65294461|NCT00530335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65294462|NCT00530335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65294463|NCT00530335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65294464|NCT00530335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294465|NCT00530335|Adrenergic Agents|adrenergic agents|mesh-ancestor
65294466|NCT00530335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64524689|NCT03174288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65115966|NCT02910245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115967|NCT02910245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65115968|NCT02910245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65115969|NCT02910245|Immunologic Factors|immunologic factors|mesh-ancestor
65115970|NCT02910245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65115971|NCT02910245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115991|NCT01959282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65115992|NCT01959282|Immunologic Factors|immunologic factors|mesh-ancestor
65115993|NCT01959282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115994|NCT01959282|Vitamin B Complex|vitamin b complex|mesh-ancestor
65115995|NCT01959282|Vitamins|vitamins|mesh-ancestor
64513845|NCT05024253|Hemostatics|hemostatics|mesh-ancestor
65115996|NCT01959282|Micronutrients|micronutrients|mesh-ancestor
65115997|NCT01185301|Adalimumab|adalimumab|mesh-list
65115998|NCT01185301|Methotrexate|methotrexate|mesh-list
65115999|NCT01185301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65116000|NCT01185301|Abortifacient Agents|abortifacient agents|mesh-ancestor
65116001|NCT01185301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65116002|NCT01185301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116003|NCT01185301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65116004|NCT01185301|Antimetabolites|antimetabolites|mesh-ancestor
65116005|NCT01185301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116006|NCT01185301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294467|NCT00530335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294468|NCT00712270|Risperidone|risperidone|mesh-list
65294469|NCT00712270|Aripiprazole|aripiprazole|mesh-list
65294470|NCT00712270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65294471|NCT00712270|Serotonin Agents|serotonin agents|mesh-ancestor
65294472|NCT00712270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65294473|NCT00712270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294474|NCT00712270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294475|NCT00712270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65294476|NCT00712270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65294477|NCT00712270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65294478|NCT00712270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65294479|NCT00712270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65294480|NCT00712270|Dopamine Agents|dopamine agents|mesh-ancestor
65294481|NCT00712270|Antidepressive Agents|antidepressive agents|mesh-ancestor
65044385|NCT00208715|Modafinil|modafinil|mesh-list
65294482|NCT00712270|Dopamine Agonists|dopamine agonists|mesh-ancestor
65294483|NCT00712270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65294484|NCT00712270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65294485|NCT00712270|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65294486|NCT00712270|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65294487|NCT03860597|Memantine|memantine|mesh-list
65294488|NCT03860597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65294489|NCT03860597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65294490|NCT03860597|Dopamine Agents|dopamine agents|mesh-ancestor
65294491|NCT03860597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65294492|NCT03860597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294493|NCT03860597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294494|NCT03860597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65294495|NCT03860597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65116007|NCT01185301|Dermatologic Agents|dermatologic agents|mesh-ancestor
65116008|NCT01185301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116009|NCT01185301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65116010|NCT01185301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65116011|NCT01185301|Immunologic Factors|immunologic factors|mesh-ancestor
65116012|NCT01185301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65116013|NCT01185301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65116014|NCT01185301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65116015|NCT01216072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65116016|NCT01216072|Interferon beta-1b|interferon beta-1b|mesh-list
65116017|NCT01216072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65116018|NCT01216072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294496|NCT02614872|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65294497|NCT02614872|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65294498|NCT02614872|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65294499|NCT02614872|Protease Inhibitors|protease inhibitors|mesh-ancestor
65294500|NCT02614872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65294501|NCT02614872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294502|NCT00695604|Fluticasone|fluticasone|mesh-list
65294503|NCT00695604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65294504|NCT00695604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65294505|NCT00695604|Autonomic Agents|autonomic agents|mesh-ancestor
65294506|NCT00695604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294507|NCT00695604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294508|NCT00695604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65294509|NCT00695604|Respiratory System Agents|respiratory system agents|mesh-ancestor
65294510|NCT00695604|Dermatologic Agents|dermatologic agents|mesh-ancestor
65294511|NCT00695604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65294512|NCT00654524|Vitamin D|vitamin d|mesh-list
65294513|NCT00654524|Goserelin|goserelin|mesh-list
65294514|NCT00654524|Hormones|hormones|mesh-list
65294515|NCT00654524|Vitamins|vitamins|mesh-ancestor
65294516|NCT00654524|Micronutrients|micronutrients|mesh-ancestor
65294517|NCT00654524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294518|NCT00654524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65294519|NCT00654524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65294520|NCT00654524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65116019|NCT01216072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65116020|NCT01216072|Immunologic Factors|immunologic factors|mesh-ancestor
65116021|NCT01216072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116022|NCT01216072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65116023|NCT01940991|Botulinum Toxins|botulinum toxins|mesh-list
64688318|NCT01871077|Ketorolac|ketorolac|mesh-list
65116026|NCT01940991|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65116027|NCT01940991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65116028|NCT01940991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116030|NCT01940991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65116031|NCT01940991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116032|NCT01940991|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65116033|NCT01940991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65116034|NCT02909465|Midazolam|midazolam|mesh-list
65116035|NCT02909465|Ketamine|ketamine|mesh-list
65116036|NCT02909465|Haloperidol|haloperidol|mesh-list
65116037|NCT02909465|Haloperidol decanoate|haloperidol decanoate|mesh-list
65116038|NCT02909465|Analgesics|analgesics|mesh-ancestor
65116039|NCT02909465|Sensory System Agents|sensory system agents|mesh-ancestor
65116040|NCT02909465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65116041|NCT02909465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116042|NCT02909465|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65116043|NCT02909465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65116044|NCT02909465|Anesthetics, General|anesthetics, general|mesh-ancestor
65116045|NCT02909465|Anesthetics|anesthetics|mesh-ancestor
64758309|NCT01552590|Tolvaptan|tolvaptan|mesh-list
65294521|NCT00654524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294522|NCT05260619|Lenalidomide|lenalidomide|mesh-list
65294523|NCT05260619|Immunologic Factors|immunologic factors|mesh-ancestor
65294524|NCT05260619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294525|NCT05260619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65294526|NCT05260619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65294527|NCT05260619|Growth Substances|growth substances|mesh-ancestor
65294528|NCT05260619|Growth Inhibitors|growth inhibitors|mesh-ancestor
65294529|NCT05260619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294530|NCT00695682|Infliximab|infliximab|mesh-list
65294531|NCT00695682|Dermatologic Agents|dermatologic agents|mesh-ancestor
65294532|NCT00695682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65294533|NCT00695682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65294534|NCT00657566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65294535|NCT00657566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65294536|NCT00657566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65294537|NCT00657566|Antitubercular Agents|antitubercular agents|mesh-ancestor
65294538|NCT03828773|Fluconazole|fluconazole|mesh-list
65294539|NCT03828773|Posaconazole|posaconazole|mesh-list
65294540|NCT03828773|Antifungal Agents|antifungal agents|mesh-ancestor
65294541|NCT03828773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65294542|NCT03828773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65294543|NCT03828773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65294544|NCT03828773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65294545|NCT03828773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294546|NCT03828773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65116046|NCT02909465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65116047|NCT02909465|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65116048|NCT02909465|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65116049|NCT02909465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65116050|NCT02909465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116051|NCT02909465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65116052|NCT02909465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65116053|NCT02909465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65116054|NCT02909465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65116055|NCT02909465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65116056|NCT02909465|GABA Modulators|gaba modulators|mesh-ancestor
65116057|NCT02909465|GABA Agents|gaba agents|mesh-ancestor
65116058|NCT02909465|Antiemetics|antiemetics|mesh-ancestor
65116059|NCT02909465|Autonomic Agents|autonomic agents|mesh-ancestor
65116060|NCT02909465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65116061|NCT02909465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65116062|NCT02909465|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65116063|NCT02909465|Dopamine Agents|dopamine agents|mesh-ancestor
65116064|NCT02909465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65116065|NCT04312555|Alprostadil|alprostadil|mesh-list
65116066|NCT04312555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65116067|NCT04312555|Vasodilator Agents|vasodilator agents|mesh-ancestor
65116068|NCT04312555|Urological Agents|urological agents|mesh-ancestor
65294547|NCT03828773|Hormone Antagonists|hormone antagonists|mesh-ancestor
65294548|NCT03828773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65294549|NCT03828773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294550|NCT03828773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65294551|NCT03828773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65294552|NCT03828773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65294553|NCT03828773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65294554|NCT03828773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65294555|NCT00530257|Methylphenidate|methylphenidate|mesh-list
65294556|NCT00530257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65294557|NCT00530257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294558|NCT00530257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65294559|NCT00530257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65294560|NCT00530257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65294561|NCT00530257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294562|NCT00530257|Dopamine Agents|dopamine agents|mesh-ancestor
64524797|NCT02539342|Calcium|calcium|mesh-list
65116070|NCT01184989|Antithrombins|antithrombins|mesh-ancestor
65116071|NCT01184989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65116072|NCT01184989|Protease Inhibitors|protease inhibitors|mesh-ancestor
65116073|NCT01184989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116074|NCT01184989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116075|NCT01184989|Anticoagulants|anticoagulants|mesh-ancestor
65116077|NCT04674423|Antiviral Agents|antiviral agents|mesh-ancestor
65116078|NCT04674423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65116079|NCT04674423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65116080|NCT04674423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65116081|NCT04674423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116082|NCT04674423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116083|NCT04674423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65116084|NCT04674423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65116085|NCT00555867|Anastrozole|anastrozole|mesh-list
65116086|NCT00555867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65116087|NCT00555867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116088|NCT00555867|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65116089|NCT00555867|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65116090|NCT00555867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116091|NCT00555867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116092|NCT00555867|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65116093|NCT00555867|Hormone Antagonists|hormone antagonists|mesh-ancestor
65116094|NCT00555867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65116095|NCT00555867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116096|NCT00555984|Remifentanil|remifentanil|mesh-list
65116097|NCT00555984|Propofol|propofol|mesh-list
65116105|NCT00555984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65116107|NCT00555984|Analgesics|analgesics|mesh-ancestor
65116108|NCT00555984|Sensory System Agents|sensory system agents|mesh-ancestor
65116109|NCT00555984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65116110|NCT00555984|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65116111|NCT00555984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65116112|NCT03457337|Gefitinib|gefitinib|mesh-list
65116113|NCT03457337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116114|NCT03457337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65116115|NCT03457337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65294563|NCT00530257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65294564|NCT00738868|Cetuximab|cetuximab|mesh-list
65294565|NCT00738868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65294566|NCT00738868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294567|NCT00657644|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65294568|NCT00657644|Vasodilator Agents|vasodilator agents|mesh-ancestor
65294569|NCT00657644|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65294570|NCT00657644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65294571|NCT00657644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65294572|NCT00657644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294573|NCT00657644|Urological Agents|urological agents|mesh-ancestor
65294574|NCT00869778|Vaccines|vaccines|mesh-list
65294575|NCT00869778|Immunologic Factors|immunologic factors|mesh-ancestor
65294576|NCT00869778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294577|NCT04159610|Glycopyrrolate|glycopyrrolate|mesh-list
65294578|NCT04159610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65294579|NCT04159610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65294580|NCT04159610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64524813|NCT02542150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64524814|NCT02542150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524815|NCT02542462|Vaccines|vaccines|mesh-list
65116116|NCT03457337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116117|NCT02274779|Leuprolide|leuprolide|mesh-list
65116118|NCT02274779|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65116119|NCT02274779|Fertility Agents|fertility agents|mesh-ancestor
65116120|NCT02274779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65116121|NCT02274779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116122|NCT02274779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65116123|NCT02274779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116124|NCT01908738|Lidocaine|lidocaine|mesh-list
65116125|NCT01908738|Anesthetics, Local|anesthetics, local|mesh-ancestor
65116126|NCT01908738|Anesthetics|anesthetics|mesh-ancestor
65116127|NCT01908738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65116128|NCT01908738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116129|NCT01908738|Sensory System Agents|sensory system agents|mesh-ancestor
65116130|NCT01908738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65116131|NCT01908738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65116132|NCT01908738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65116133|NCT01908738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65116134|NCT01908738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65116135|NCT01908738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116136|NCT04673955|Cetuximab|cetuximab|mesh-list
65116137|NCT04673955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65116138|NCT04673955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116139|NCT01904409|Rifaximin|rifaximin|mesh-list
65116141|NCT01904409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65116142|NCT01904409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65116143|NCT01902381|Thioctic Acid|thioctic acid|mesh-list
65116144|NCT01902381|Antioxidants|antioxidants|mesh-ancestor
65116145|NCT01902381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116146|NCT01902381|Protective Agents|protective agents|mesh-ancestor
65116147|NCT01902381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294581|NCT04159610|Cholinergic Agents|cholinergic agents|mesh-ancestor
65294582|NCT04159610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65294583|NCT04159610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294584|NCT04159610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294585|NCT04162028|Ketamine|ketamine|mesh-list
65294586|NCT04162028|Analgesics|analgesics|mesh-ancestor
65294587|NCT04162028|Sensory System Agents|sensory system agents|mesh-ancestor
65294588|NCT04162028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294589|NCT04162028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294590|NCT04162028|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65294591|NCT04162028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65294592|NCT04162028|Anesthetics, General|anesthetics, general|mesh-ancestor
65294593|NCT04162028|Anesthetics|anesthetics|mesh-ancestor
65116148|NCT01902381|Vitamin B Complex|vitamin b complex|mesh-ancestor
65116149|NCT01902381|Vitamins|vitamins|mesh-ancestor
65116150|NCT01902381|Micronutrients|micronutrients|mesh-ancestor
65116151|NCT04673799|Denosumab|denosumab|mesh-list
65116152|NCT04673799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65116153|NCT04673799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116154|NCT04673487|Immunoglobulin G|immunoglobulin g|mesh-list
65116155|NCT04673487|Immunoglobulin M|immunoglobulin m|mesh-list
65116156|NCT04673487|Immunologic Factors|immunologic factors|mesh-ancestor
65116157|NCT04673487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116158|NCT01215955|Insulin Lispro|insulin lispro|mesh-list
65116159|NCT01215955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65116160|NCT01215955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116161|NCT05194592|Dapagliflozin|dapagliflozin|mesh-list
65116162|NCT05194592|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65116163|NCT05194592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116164|NCT05194592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65116165|NCT05194592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116166|NCT01871415|Metformin|metformin|mesh-list
65116185|NCT02277197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65116186|NCT02277197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116187|NCT00555087|Methyltestosterone|methyltestosterone|mesh-list
65116188|NCT00555087|Testosterone|testosterone|mesh-list
65116189|NCT00555087|Testosterone undecanoate|testosterone undecanoate|mesh-list
65116190|NCT00555087|Testosterone enanthate|testosterone enanthate|mesh-list
65116191|NCT00555087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65116192|NCT00555087|Androgens|androgens|mesh-ancestor
65116193|NCT00555087|Hormones|hormones|mesh-ancestor
65116194|NCT00555087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65116195|NCT00555087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116196|NCT00555087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65116197|NCT00555087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116198|NCT00555087|Anabolic Agents|anabolic agents|mesh-ancestor
65116199|NCT04673214|Acetaminophen|acetaminophen|mesh-list
65116200|NCT04673214|Azithromycin|azithromycin|mesh-list
65116201|NCT04673214|Ivermectin|ivermectin|mesh-list
65116202|NCT04673214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65116203|NCT04673214|Analgesics|analgesics|mesh-ancestor
65116204|NCT04673214|Sensory System Agents|sensory system agents|mesh-ancestor
65116205|NCT04673214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65116206|NCT04673214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116207|NCT04673214|Antipyretics|antipyretics|mesh-ancestor
65116208|NCT04673214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65116209|NCT04673214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65116210|NCT04673214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65116211|NCT00556023|Gemcitabine|gemcitabine|mesh-list
65116212|NCT00556023|Tremelimumab|tremelimumab|mesh-list
65116213|NCT00556023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65116214|NCT00556023|Antimetabolites|antimetabolites|mesh-ancestor
65116215|NCT00556023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524843|NCT04481100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65294594|NCT04162028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65294595|NCT04162028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65294596|NCT04162028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65294597|NCT04162028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65294598|NCT04162028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294599|NCT00656786|Vitamin K 3|vitamin k 3|mesh-list
65294600|NCT00656786|Vitamin K|vitamin k|mesh-list
65116216|NCT00556023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116217|NCT00556023|Antiviral Agents|antiviral agents|mesh-ancestor
65116218|NCT00556023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65116219|NCT00556023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116220|NCT00556023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65116221|NCT00556023|Immunologic Factors|immunologic factors|mesh-ancestor
65116222|NCT00556023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116223|NCT05011214|Ketamine|ketamine|mesh-list
65116224|NCT05011214|Sevoflurane|sevoflurane|mesh-list
65116225|NCT05011214|Esketamine|esketamine|mesh-list
65116226|NCT05011214|Analgesics|analgesics|mesh-ancestor
65116227|NCT05011214|Sensory System Agents|sensory system agents|mesh-ancestor
65116237|NCT05011214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65116238|NCT05011214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116239|NCT05011214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65116240|NCT05011214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65116241|NCT05011214|Antidepressive Agents|antidepressive agents|mesh-ancestor
65116242|NCT05011214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65116243|NCT00556062|Vaccines|vaccines|mesh-list
65116244|NCT00556062|Immunologic Factors|immunologic factors|mesh-ancestor
65116245|NCT00556062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116246|NCT04965155|Dexamethasone|dexamethasone|mesh-list
65116247|NCT04965155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65116248|NCT04965155|Antiemetics|antiemetics|mesh-ancestor
65116249|NCT04965155|Autonomic Agents|autonomic agents|mesh-ancestor
65116250|NCT04965155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65116251|NCT04965155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116252|NCT04965155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65116253|NCT04965155|Glucocorticoids|glucocorticoids|mesh-ancestor
65116254|NCT04965155|Hormones|hormones|mesh-ancestor
65116255|NCT04965155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65116256|NCT04965155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65116257|NCT04965155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116258|NCT04676763|Histamine|histamine|mesh-list
65116259|NCT04676763|Substance P|substance p|mesh-list
65116260|NCT04676763|Neurokinin A|neurokinin a|mesh-list
65116261|NCT04676763|Histamine Agonists|histamine agonists|mesh-ancestor
65116262|NCT04676763|Histamine Agents|histamine agents|mesh-ancestor
65116263|NCT04676763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65116264|NCT04676763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116265|NCT04676763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116266|NCT04672707|Bromhexine|bromhexine|mesh-list
65116267|NCT04672707|Expectorants|expectorants|mesh-ancestor
65116268|NCT04672707|Respiratory System Agents|respiratory system agents|mesh-ancestor
65116269|NCT04932083|Fentanyl|fentanyl|mesh-list
65116270|NCT04932083|Midazolam|midazolam|mesh-list
65116271|NCT04932083|Nalbuphine|nalbuphine|mesh-list
65116272|NCT04932083|Bupivacaine|bupivacaine|mesh-list
64758525|NCT00318708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116273|NCT04932083|Anesthetics, Local|anesthetics, local|mesh-ancestor
65116274|NCT04932083|Anesthetics|anesthetics|mesh-ancestor
65116275|NCT04932083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65116276|NCT04932083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116277|NCT04932083|Sensory System Agents|sensory system agents|mesh-ancestor
65116278|NCT04932083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65116279|NCT04932083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65116280|NCT04932083|Narcotics|narcotics|mesh-ancestor
65116281|NCT04932083|Analgesics|analgesics|mesh-ancestor
65116282|NCT04932083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65116283|NCT04932083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65116284|NCT04932083|Anesthetics, General|anesthetics, general|mesh-ancestor
65294601|NCT00656786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65294602|NCT00656786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65294603|NCT00656786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294604|NCT00656786|Hemostatics|hemostatics|mesh-ancestor
65294605|NCT00656786|Coagulants|coagulants|mesh-ancestor
65294606|NCT00656786|Vitamins|vitamins|mesh-ancestor
65294607|NCT00656786|Micronutrients|micronutrients|mesh-ancestor
65294608|NCT00656786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294609|NCT01008631|Sodium thiosulfate|sodium thiosulfate|mesh-list
65294610|NCT01008631|Antidotes|antidotes|mesh-ancestor
65294611|NCT01008631|Protective Agents|protective agents|mesh-ancestor
65294612|NCT01008631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294613|NCT01008631|Antioxidants|antioxidants|mesh-ancestor
65294614|NCT01008631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294615|NCT01008631|Antitubercular Agents|antitubercular agents|mesh-ancestor
65294616|NCT01008631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65294617|NCT01008631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65294618|NCT01008631|Chelating Agents|chelating agents|mesh-ancestor
65294619|NCT01008631|Sequestering Agents|sequestering agents|mesh-ancestor
65294620|NCT00734890|Bevacizumab|bevacizumab|mesh-list
65294621|NCT00734890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65294622|NCT00734890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294623|NCT00734890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65116285|NCT04932083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65116286|NCT04932083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65116287|NCT04932083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65116288|NCT04932083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65116289|NCT04932083|GABA Modulators|gaba modulators|mesh-ancestor
65116290|NCT04932083|GABA Agents|gaba agents|mesh-ancestor
65116291|NCT04932083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64513853|NCT05026593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116292|NCT04932083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116310|NCT04858490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65116311|NCT04858490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116312|NCT04858490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65116313|NCT04858490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65116314|NCT04858490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65116315|NCT04858490|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65116316|NCT04858490|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65116317|NCT04858490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65116318|NCT04858490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65116319|NCT04858490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65116320|NCT04858490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65116321|NCT04858490|Anesthetics, General|anesthetics, general|mesh-ancestor
65116322|NCT04858490|Anesthetics|anesthetics|mesh-ancestor
65116323|NCT04858490|GABA Modulators|gaba modulators|mesh-ancestor
65116324|NCT04858490|GABA Agents|gaba agents|mesh-ancestor
65116325|NCT04858490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65116326|NCT04858490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116328|NCT04790045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116329|NCT01655225|Pemetrexed|pemetrexed|mesh-list
65116330|NCT01655225|Letrozole|letrozole|mesh-list
65116331|NCT01655225|Fulvestrant|fulvestrant|mesh-list
65116332|NCT01655225|Midazolam|midazolam|mesh-list
65116333|NCT01655225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294624|NCT00734890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65294625|NCT00734890|Growth Substances|growth substances|mesh-ancestor
65294626|NCT00734890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294627|NCT00734890|Growth Inhibitors|growth inhibitors|mesh-ancestor
65294628|NCT05325190|Granisetron|granisetron|mesh-list
65294629|NCT05325190|Antiemetics|antiemetics|mesh-ancestor
65294630|NCT05325190|Autonomic Agents|autonomic agents|mesh-ancestor
65294631|NCT05325190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294632|NCT05325190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294633|NCT05325190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65294634|NCT05325190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65294635|NCT05325190|Serotonin Agents|serotonin agents|mesh-ancestor
65294636|NCT05325190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65294637|NCT05325190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294638|NCT02624310|Droxidopa|droxidopa|mesh-list
65294639|NCT02624310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65294640|NCT02624310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65294641|NCT00612521|Adenosine|adenosine|mesh-list
65294642|NCT00612521|Analgesics|analgesics|mesh-ancestor
64524871|NCT03173508|Diuretics|diuretics|mesh-ancestor
65116334|NCT01655225|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65116335|NCT01655225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65116336|NCT01655225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65116337|NCT01655225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116338|NCT01655225|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65116339|NCT01655225|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65116340|NCT01655225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65116341|NCT01655225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65116342|NCT01655225|Anesthetics, General|anesthetics, general|mesh-ancestor
65116343|NCT01655225|Anesthetics|anesthetics|mesh-ancestor
65116344|NCT01655225|GABA Modulators|gaba modulators|mesh-ancestor
65116345|NCT01655225|GABA Agents|gaba agents|mesh-ancestor
65116346|NCT01655225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65116347|NCT01655225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116348|NCT01655225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116349|NCT01655225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65116350|NCT01655225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64758598|NCT04751136|Cerebrolysin|cerebrolysin|mesh-list
65116351|NCT01655225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65116370|NCT01785771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65116371|NCT01785771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116372|NCT01785771|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65116373|NCT01785771|Incretins|incretins|mesh-ancestor
65116374|NCT01785771|Hormones|hormones|mesh-ancestor
65116375|NCT01785771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65116376|NCT04660760|Trifluridine|trifluridine|mesh-list
65116377|NCT04660760|Paclitaxel|paclitaxel|mesh-list
65116378|NCT04660760|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65116379|NCT04660760|Ramucirumab|ramucirumab|mesh-list
65116380|NCT04660760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65116381|NCT04660760|Antibodies|antibodies|mesh-list
65116382|NCT04660760|Immunoglobulins|immunoglobulins|mesh-list
65116383|NCT04660760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65116384|NCT04660760|Lexatumumab|lexatumumab|mesh-list
65116385|NCT04660760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65116386|NCT04660760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116387|NCT04660760|Tubulin Modulators|tubulin modulators|mesh-ancestor
65116388|NCT04660760|Antimitotic Agents|antimitotic agents|mesh-ancestor
65294643|NCT00612521|Sensory System Agents|sensory system agents|mesh-ancestor
65294644|NCT00612521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294645|NCT00612521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294646|NCT00612521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65294647|NCT00612521|Vasodilator Agents|vasodilator agents|mesh-ancestor
65294648|NCT00612521|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65294649|NCT00612521|Purinergic Agonists|purinergic agonists|mesh-ancestor
65294650|NCT00612521|Purinergic Agents|purinergic agents|mesh-ancestor
65294651|NCT00612521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65294652|NCT00612521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294653|NCT00735124|Gabapentin|gabapentin|mesh-list
65294654|NCT00735124|Analgesics|analgesics|mesh-ancestor
65294655|NCT00735124|Sensory System Agents|sensory system agents|mesh-ancestor
65294656|NCT00735124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294657|NCT00735124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294658|NCT00735124|Anticonvulsants|anticonvulsants|mesh-ancestor
65294659|NCT00735124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65294660|NCT00735124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65294661|NCT00735124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65294662|NCT00735124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65294663|NCT00735124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65294664|NCT00735124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65294665|NCT00735124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65294666|NCT00735124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524886|NCT02405364|Autonomic Agents|autonomic agents|mesh-ancestor
65116389|NCT04660760|Mitosis Modulators|mitosis modulators|mesh-ancestor
65116390|NCT04660760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116391|NCT04660760|Immunologic Factors|immunologic factors|mesh-ancestor
65116392|NCT04660760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116393|NCT04660760|Antimetabolites|antimetabolites|mesh-ancestor
65116394|NCT04660760|Antiviral Agents|antiviral agents|mesh-ancestor
65116395|NCT04660760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65116396|NCT01784874|Vaccines|vaccines|mesh-list
65116397|NCT01784874|Immunologic Factors|immunologic factors|mesh-ancestor
65116398|NCT01784874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116399|NCT04607252|Metformin|metformin|mesh-list
65116400|NCT04607252|Megestrol|megestrol|mesh-list
65116401|NCT04607252|Megestrol Acetate|megestrol acetate|mesh-list
65116402|NCT04607252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65116403|NCT04607252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116404|NCT04607252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65116405|NCT04607252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65116406|NCT04607252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65116407|NCT04607252|Contraceptive Agents|contraceptive agents|mesh-ancestor
65116408|NCT04607252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65116409|NCT04607252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65116410|NCT04607252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65294667|NCT00735124|Antimanic Agents|antimanic agents|mesh-ancestor
65294668|NCT04131348|Botulinum Toxins|botulinum toxins|mesh-list
65294669|NCT04131348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65294670|NCT04131348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65294671|NCT04131348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65294672|NCT04131348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65294673|NCT04131348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294674|NCT04131348|Cholinergic Agents|cholinergic agents|mesh-ancestor
65294675|NCT04131348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65294676|NCT04131348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524910|NCT02405130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64524915|NCT02405130|Mydriatics|mydriatics|mesh-ancestor
65116421|NCT01782729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116422|NCT01780428|Acetaminophen|acetaminophen|mesh-list
65116423|NCT01780428|Promethazine|promethazine|mesh-list
65116424|NCT01780428|Diphenhydramine|diphenhydramine|mesh-list
65116425|NCT01780428|Hydrocodone|hydrocodone|mesh-list
65116426|NCT01780428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65116427|NCT01780428|Analgesics|analgesics|mesh-ancestor
65116428|NCT01780428|Sensory System Agents|sensory system agents|mesh-ancestor
64758673|NCT00393978|Anticonvulsants|anticonvulsants|mesh-ancestor
65116429|NCT01780428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65116430|NCT01780428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116432|NCT01780428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65116433|NCT01780428|Narcotics|narcotics|mesh-ancestor
65116434|NCT01780428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65116435|NCT01780428|Antitussive Agents|antitussive agents|mesh-ancestor
65116436|NCT01780428|Respiratory System Agents|respiratory system agents|mesh-ancestor
65116437|NCT01780428|Antipruritics|antipruritics|mesh-ancestor
65116438|NCT01780428|Dermatologic Agents|dermatologic agents|mesh-ancestor
65116439|NCT01780428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64513855|NCT01459809|Metformin|metformin|mesh-list
65116440|NCT01780428|Histamine Antagonists|histamine antagonists|mesh-ancestor
65116441|NCT01780428|Histamine Agents|histamine agents|mesh-ancestor
65116442|NCT01780428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65116443|NCT01780428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116444|NCT01780428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65116445|NCT01780428|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65116446|NCT01780428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65116447|NCT01780428|Anesthetics, Local|anesthetics, local|mesh-ancestor
65116448|NCT01780428|Anesthetics|anesthetics|mesh-ancestor
65116449|NCT01780428|Antiemetics|antiemetics|mesh-ancestor
65116450|NCT01780428|Autonomic Agents|autonomic agents|mesh-ancestor
65116451|NCT01780428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65116452|NCT04671420|Rituximab|rituximab|mesh-list
65116453|NCT04671420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65116454|NCT04671420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116455|NCT04671420|Immunologic Factors|immunologic factors|mesh-ancestor
65116456|NCT04671420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116457|NCT04671420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65116458|NCT04573556|Lemborexant|lemborexant|mesh-list
65116459|NCT04573556|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65116460|NCT04573556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65116461|NCT04573556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116462|NCT04573556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65116463|NCT04573556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65116464|NCT04573556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65116465|NCT04573556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116466|NCT04671108|Hyaluronic Acid|hyaluronic acid|mesh-list
65116467|NCT04671108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65116468|NCT04671108|Immunologic Factors|immunologic factors|mesh-ancestor
65116469|NCT04671108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116470|NCT04671108|Viscosupplements|viscosupplements|mesh-ancestor
65294677|NCT04131348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65294678|NCT04131348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294679|NCT04246541|Acetaminophen|acetaminophen|mesh-list
65294680|NCT04246541|Ketorolac|ketorolac|mesh-list
65294681|NCT04246541|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65294682|NCT04246541|Oxycodone|oxycodone|mesh-list
65294683|NCT04246541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65294684|NCT04246541|Analgesics|analgesics|mesh-ancestor
65294685|NCT04246541|Sensory System Agents|sensory system agents|mesh-ancestor
65294686|NCT04246541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294687|NCT04246541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294688|NCT04246541|Antipyretics|antipyretics|mesh-ancestor
65294689|NCT04246541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65294690|NCT04246541|Narcotics|narcotics|mesh-ancestor
65294691|NCT04246541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65294692|NCT04246541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65294693|NCT04246541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65294694|NCT04246541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65294695|NCT04246541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65294696|NCT04246541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524921|NCT03171090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116471|NCT04671108|Protective Agents|protective agents|mesh-ancestor
65116472|NCT01779453|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
65116473|NCT01779453|Atorvastatin|atorvastatin|mesh-list
65116474|NCT01779453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65116475|NCT01779453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65116487|NCT01776606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65116488|NCT01776606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116490|NCT01776606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65116491|NCT01776606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116492|NCT01776606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65116493|NCT01776606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65116494|NCT04567160|Propofol|propofol|mesh-list
65116495|NCT04567160|Sevoflurane|sevoflurane|mesh-list
65116496|NCT04567160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65116497|NCT04567160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65116498|NCT04567160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116499|NCT04567160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65116500|NCT04567160|Anesthetics, General|anesthetics, general|mesh-ancestor
65116501|NCT04567160|Anesthetics|anesthetics|mesh-ancestor
64758816|NCT00459732|Zinc|zinc|mesh-list
65116502|NCT04567160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65116503|NCT04567160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65116504|NCT04545866|Budesonide|budesonide|mesh-list
65116505|NCT04545866|Poractant alfa|poractant alfa|mesh-list
65116506|NCT04545866|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65116507|NCT04545866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65116508|NCT04545866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65116509|NCT04545866|Autonomic Agents|autonomic agents|mesh-ancestor
65116510|NCT04545866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65116511|NCT04545866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116513|NCT04545866|Respiratory System Agents|respiratory system agents|mesh-ancestor
65116514|NCT04545866|Glucocorticoids|glucocorticoids|mesh-ancestor
65116515|NCT04545866|Hormones|hormones|mesh-ancestor
65294697|NCT04246541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294698|NCT05153395|Insulin|insulin|mesh-list
65294699|NCT05153395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65294700|NCT05153395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65294701|NCT05153395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294702|NCT04902859|Clonidine|clonidine|mesh-list
65116516|NCT04545866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65116517|NCT01774578|Gemcitabine|gemcitabine|mesh-list
65116518|NCT01774578|Docetaxel|docetaxel|mesh-list
65116519|NCT01774578|Pemetrexed|pemetrexed|mesh-list
65116520|NCT01774578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65116521|NCT01774578|Antimetabolites|antimetabolites|mesh-ancestor
65116522|NCT01774578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116523|NCT01774578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116524|NCT01774578|Antiviral Agents|antiviral agents|mesh-ancestor
65116525|NCT01774578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65116526|NCT01774578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116527|NCT01774578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65116528|NCT01774578|Immunologic Factors|immunologic factors|mesh-ancestor
65116529|NCT01774578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116530|NCT01774578|Tubulin Modulators|tubulin modulators|mesh-ancestor
65116531|NCT01774578|Antimitotic Agents|antimitotic agents|mesh-ancestor
65116532|NCT01774578|Mitosis Modulators|mitosis modulators|mesh-ancestor
65116533|NCT01774578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65116534|NCT01774578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65116535|NCT04543994|Remestemcel-l|remestemcel-l|mesh-list
65116536|NCT04543994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65116537|NCT04543994|Antiviral Agents|antiviral agents|mesh-ancestor
65116538|NCT04543994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65116552|NCT04670913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116553|NCT04670913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65116554|NCT04670913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116555|NCT04670913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116557|NCT04671069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65116558|NCT04671069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65116559|NCT04671069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65116560|NCT04671069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65116561|NCT04671069|Purinergic Agents|purinergic agents|mesh-ancestor
65116562|NCT04671069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65116563|NCT04671069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116564|NCT04671069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116565|NCT04322123|Azithromycin|azithromycin|mesh-list
65116566|NCT04322123|Hydroxychloroquine|hydroxychloroquine|mesh-list
65116567|NCT04322123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65116568|NCT04322123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65116569|NCT04322123|Antimalarials|antimalarials|mesh-ancestor
65116570|NCT04322123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65116571|NCT04322123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65116572|NCT04322123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116573|NCT04322123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116574|NCT04322123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65116575|NCT04259138|Vedolizumab|vedolizumab|mesh-list
65116576|NCT04259138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65116577|NCT01741155|Docetaxel|docetaxel|mesh-list
65116578|NCT01741155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116579|NCT01741155|Tubulin Modulators|tubulin modulators|mesh-ancestor
65116580|NCT01741155|Antimitotic Agents|antimitotic agents|mesh-ancestor
65116581|NCT01741155|Mitosis Modulators|mitosis modulators|mesh-ancestor
65116582|NCT01741155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116583|NCT04244630|Antioxidants|antioxidants|mesh-list
65116584|NCT04244630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116585|NCT04244630|Protective Agents|protective agents|mesh-ancestor
65116586|NCT04244630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116587|NCT04239053|Bupivacaine|bupivacaine|mesh-list
65116588|NCT04239053|Anesthetics, Local|anesthetics, local|mesh-ancestor
65116589|NCT04239053|Anesthetics|anesthetics|mesh-ancestor
65116590|NCT04239053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65116591|NCT04239053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116592|NCT04239053|Sensory System Agents|sensory system agents|mesh-ancestor
65294703|NCT04902859|Analgesics|analgesics|mesh-ancestor
65294704|NCT04902859|Sensory System Agents|sensory system agents|mesh-ancestor
65294705|NCT04902859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294706|NCT04902859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294707|NCT04902859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65294708|NCT04902859|Sympatholytics|sympatholytics|mesh-ancestor
65294709|NCT04902859|Autonomic Agents|autonomic agents|mesh-ancestor
65294710|NCT04902859|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65294711|NCT04902859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65294712|NCT04902859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65294713|NCT04902859|Adrenergic Agents|adrenergic agents|mesh-ancestor
65294714|NCT04902859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65294715|NCT04902859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294716|NCT05227313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65294717|NCT00711958|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65294718|NCT04180943|Bupivacaine|bupivacaine|mesh-list
65294719|NCT04180943|Anesthetics, Local|anesthetics, local|mesh-ancestor
65294720|NCT04180943|Anesthetics|anesthetics|mesh-ancestor
65294721|NCT04180943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65116593|NCT04239053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65116595|NCT01718145|Asunaprevir|asunaprevir|mesh-list
65116596|NCT01718145|Antimetabolites|antimetabolites|mesh-ancestor
65116597|NCT01718145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116598|NCT01718145|Antiviral Agents|antiviral agents|mesh-ancestor
65116599|NCT01718145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65116631|NCT01712451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116633|NCT01712217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116634|NCT01712217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65116635|NCT01712217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116636|NCT01712217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116637|NCT04669158|Idebenone|idebenone|mesh-list
65116638|NCT04669158|Antioxidants|antioxidants|mesh-ancestor
65116639|NCT04669158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116640|NCT04669158|Protective Agents|protective agents|mesh-ancestor
65116641|NCT04669158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116642|NCT04669821|Propofol|propofol|mesh-list
65116643|NCT04669821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65116651|NCT00532025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65116652|NCT00532025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116653|NCT00532025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116655|NCT04669392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65116656|NCT04669392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65116657|NCT04669392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65116658|NCT04669392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116660|NCT00532142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65116661|NCT00532142|Glucocorticoids|glucocorticoids|mesh-ancestor
65116662|NCT00532142|Hormones|hormones|mesh-ancestor
65116663|NCT00532142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65116664|NCT00532142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116665|NCT04749641|Vaccines|vaccines|mesh-list
65116666|NCT04749641|Immunologic Factors|immunologic factors|mesh-ancestor
65116667|NCT04749641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116668|NCT00533312|Niacin|niacin|mesh-list
65116669|NCT00533312|Niacinamide|niacinamide|mesh-list
65294722|NCT04180943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294723|NCT04180943|Sensory System Agents|sensory system agents|mesh-ancestor
65294724|NCT04180943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294725|NCT05011357|Phenylephrine|phenylephrine|mesh-list
65294726|NCT05011357|Oxymetazoline|oxymetazoline|mesh-list
65294727|NCT05011357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65294728|NCT05011357|Mydriatics|mydriatics|mesh-ancestor
65294729|NCT05011357|Autonomic Agents|autonomic agents|mesh-ancestor
65294730|NCT05011357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294731|NCT05011357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294732|NCT05011357|Sympathomimetics|sympathomimetics|mesh-ancestor
65294733|NCT05011357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65294734|NCT05011357|Nasal Decongestants|nasal decongestants|mesh-ancestor
65294735|NCT05011357|Respiratory System Agents|respiratory system agents|mesh-ancestor
65294736|NCT05011357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65294737|NCT05011357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65294738|NCT05011357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65294739|NCT05011357|Adrenergic Agents|adrenergic agents|mesh-ancestor
64524965|NCT02407548|Protective Agents|protective agents|mesh-ancestor
64524968|NCT01695317|Vitamins|vitamins|mesh-ancestor
65116670|NCT00533312|Nicotinic Acids|nicotinic acids|mesh-list
65116671|NCT00533312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65116672|NCT00533312|Antimetabolites|antimetabolites|mesh-ancestor
65116673|NCT00533312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116674|NCT00533312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65116675|NCT00533312|Vasodilator Agents|vasodilator agents|mesh-ancestor
65116676|NCT00533312|Vitamin B Complex|vitamin b complex|mesh-ancestor
65116677|NCT00533312|Vitamins|vitamins|mesh-ancestor
65116678|NCT00533312|Micronutrients|micronutrients|mesh-ancestor
65116679|NCT00533312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116680|NCT00533390|Efavirenz|efavirenz|mesh-list
65116681|NCT00533390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65116682|NCT00533390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65116683|NCT00533390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116684|NCT00533390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116685|NCT00533390|Antiviral Agents|antiviral agents|mesh-ancestor
65116686|NCT00533390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65116687|NCT00533390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65116688|NCT00533390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65116689|NCT00533390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65116690|NCT00533390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65116691|NCT00533390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65116692|NCT00533390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65116693|NCT00556296|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65116694|NCT00556296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65116695|NCT00556296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116696|NCT00556296|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65116697|NCT00556296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65116698|NCT00556296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65116699|NCT00556296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116700|NCT00556296|Dopamine Agents|dopamine agents|mesh-ancestor
65116701|NCT00556296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65116702|NCT04668456|Lidocaine|lidocaine|mesh-list
65116703|NCT04668456|Dexmedetomidine|dexmedetomidine|mesh-list
65116704|NCT04668456|Anesthetics, Local|anesthetics, local|mesh-ancestor
65294740|NCT05011357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65294741|NCT05011357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294742|NCT05011357|Protective Agents|protective agents|mesh-ancestor
65294743|NCT00711880|Nabiximols|nabiximols|mesh-list
65294744|NCT00711880|Analgesics|analgesics|mesh-ancestor
65294745|NCT00711880|Sensory System Agents|sensory system agents|mesh-ancestor
65294746|NCT00711880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294747|NCT00711880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116705|NCT04668456|Anesthetics|anesthetics|mesh-ancestor
65116706|NCT04668456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65116707|NCT04668456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116708|NCT04668456|Sensory System Agents|sensory system agents|mesh-ancestor
65116709|NCT04668456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65116710|NCT04668456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65116722|NCT04668456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65116723|NCT04693169|Choline|choline|mesh-list
65116724|NCT04693169|Lipotropic Agents|lipotropic agents|mesh-ancestor
65116725|NCT04693169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65116726|NCT04693169|Antimetabolites|antimetabolites|mesh-ancestor
65116727|NCT04693169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116728|NCT04693169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65116729|NCT04693169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65116730|NCT04693169|Nootropic Agents|nootropic agents|mesh-ancestor
65116732|NCT04668417|Immunologic Factors|immunologic factors|mesh-ancestor
65116733|NCT04668417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116734|NCT00556413|Leucovorin|leucovorin|mesh-list
65116735|NCT00556413|Fluorouracil|fluorouracil|mesh-list
65116736|NCT00556413|Oxaliplatin|oxaliplatin|mesh-list
65116737|NCT00556413|Irinotecan|irinotecan|mesh-list
65116738|NCT00556413|Cetuximab|cetuximab|mesh-list
65116739|NCT00556413|Calcium|calcium|mesh-list
65116740|NCT00556413|Levoleucovorin|levoleucovorin|mesh-list
65116741|NCT00556413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65116742|NCT00556413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116743|NCT00556413|Antimetabolites|antimetabolites|mesh-ancestor
65116744|NCT00556413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116745|NCT00556413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65116746|NCT00556413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116747|NCT00556413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65116748|NCT00556413|Immunologic Factors|immunologic factors|mesh-ancestor
65116749|NCT00556413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65116750|NCT00556413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65116751|NCT00556413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116752|NCT00556413|Antidotes|antidotes|mesh-ancestor
65116753|NCT00556413|Protective Agents|protective agents|mesh-ancestor
65116754|NCT00556413|Vitamin B Complex|vitamin b complex|mesh-ancestor
65116755|NCT00556413|Vitamins|vitamins|mesh-ancestor
65116756|NCT00556413|Micronutrients|micronutrients|mesh-ancestor
65116757|NCT00556413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65116758|NCT04668690|Mitoxantrone|mitoxantrone|mesh-list
65116759|NCT04668690|Analgesics|analgesics|mesh-ancestor
65116760|NCT04668690|Sensory System Agents|sensory system agents|mesh-ancestor
65116761|NCT04668690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65116762|NCT04668690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116763|NCT04668690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116764|NCT04668690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65116765|NCT04668690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65116766|NCT04668690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116767|NCT04668690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116768|NCT04622813|Acetaminophen|acetaminophen|mesh-list
65116769|NCT04622813|Ketoprofen|ketoprofen|mesh-list
65116770|NCT04622813|Nefopam|nefopam|mesh-list
65116771|NCT04622813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65116772|NCT04622813|Analgesics|analgesics|mesh-ancestor
65116773|NCT04622813|Sensory System Agents|sensory system agents|mesh-ancestor
65116774|NCT04622813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65116775|NCT04622813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116776|NCT04622813|Antipyretics|antipyretics|mesh-ancestor
65116802|NCT00533624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65294748|NCT02693483|Povidone-Iodine|povidone-iodine|mesh-list
65294749|NCT02693483|Povidone|povidone|mesh-list
65294750|NCT02693483|Plasma Substitutes|plasma substitutes|mesh-ancestor
65294751|NCT02693483|Blood Substitutes|blood substitutes|mesh-ancestor
65294752|NCT02693483|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65294753|NCT02693483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65294754|NCT04873063|Beclomethasone|beclomethasone|mesh-list
65294755|NCT04873063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65294756|NCT04873063|Glucocorticoids|glucocorticoids|mesh-ancestor
65116803|NCT00533624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116804|NCT00533624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65116805|NCT00533624|Antitubercular Agents|antitubercular agents|mesh-ancestor
65116806|NCT00533624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65116807|NCT00533624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65116808|NCT00533624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116809|NCT00533624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116811|NCT04562441|Axitinib|axitinib|mesh-list
65116812|NCT04562441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65116813|NCT04562441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116814|NCT04562441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65116815|NCT04562441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116816|NCT04562441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116817|NCT04659057|Lidocaine|lidocaine|mesh-list
65116818|NCT04659057|Dexmedetomidine|dexmedetomidine|mesh-list
65116819|NCT04659057|Anesthetics, Local|anesthetics, local|mesh-ancestor
65116820|NCT04659057|Anesthetics|anesthetics|mesh-ancestor
65116821|NCT04659057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65116822|NCT04659057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116823|NCT04659057|Sensory System Agents|sensory system agents|mesh-ancestor
65116824|NCT04659057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65116848|NCT04547153|Immunologic Factors|immunologic factors|mesh-ancestor
65116849|NCT04547153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116850|NCT00533741|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65116851|NCT00533741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65116852|NCT00533741|Immunologic Factors|immunologic factors|mesh-ancestor
65116853|NCT00533741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116854|NCT00533741|Antacids|antacids|mesh-ancestor
65116855|NCT00533741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116856|NCT00533741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65116857|NCT00533858|Losartan|losartan|mesh-list
65116858|NCT00533858|Lacidipine|lacidipine|mesh-list
65116859|NCT00533858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65116860|NCT00533858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65116861|NCT00533858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65116862|NCT00533858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65116863|NCT00533858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116864|NCT00533858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65116865|NCT00533858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65116866|NCT00533858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65116867|NCT00533858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116868|NCT04658355|Chlorhexidine|chlorhexidine|mesh-list
65116869|NCT04658355|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65116870|NCT04658355|Povidone-Iodine|povidone-iodine|mesh-list
65116871|NCT04658355|Povidone|povidone|mesh-list
65116872|NCT04658355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65116873|NCT04658355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65116874|NCT04658355|Disinfectants|disinfectants|mesh-ancestor
65116900|NCT00533936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116901|NCT00533936|Antimetabolites|antimetabolites|mesh-ancestor
65116902|NCT00533936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65116903|NCT00533936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65116905|NCT00557544|Metoclopramide|metoclopramide|mesh-list
65116906|NCT00557544|Antiemetics|antiemetics|mesh-ancestor
65116907|NCT00557544|Autonomic Agents|autonomic agents|mesh-ancestor
65116908|NCT00557544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65116909|NCT00557544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116910|NCT00557544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65294757|NCT04873063|Hormones|hormones|mesh-ancestor
65294758|NCT04873063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65294759|NCT04873063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294760|NCT04873063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65294761|NCT04873063|Respiratory System Agents|respiratory system agents|mesh-ancestor
65294762|NCT00739414|Panobinostat|panobinostat|mesh-list
65294763|NCT00739414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294764|NCT00739414|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65294765|NCT00739414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65294766|NCT00739414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294767|NCT00612599|Insulin Aspart|insulin aspart|mesh-list
65294768|NCT00612599|Biphasic Insulins|biphasic insulins|mesh-list
65294769|NCT00612599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65294770|NCT00612599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294771|NCT00735280|Heparin|heparin|mesh-list
65294772|NCT00735280|Calcium heparin|calcium heparin|mesh-list
65294773|NCT00735280|Anticoagulants|anticoagulants|mesh-ancestor
65294774|NCT00735280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65294775|NCT00735280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65294776|NCT00735280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294777|NCT00612989|Temozolomide|temozolomide|mesh-list
64525009|NCT02407314|Aspirin|aspirin|mesh-list
65116911|NCT00557544|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65116912|NCT00557544|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65116913|NCT00557544|Dopamine Agents|dopamine agents|mesh-ancestor
65116914|NCT00557544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65116915|NCT00557544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116916|NCT00557544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65116917|NCT00557544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65116918|NCT00557544|Analgesics|analgesics|mesh-ancestor
65116919|NCT00557544|Sensory System Agents|sensory system agents|mesh-ancestor
65116920|NCT00557544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65116921|NCT00557544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65116922|NCT00557544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65116923|NCT00557544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116924|NCT04667910|Ranibizumab|ranibizumab|mesh-list
64689225|NCT02721017|Fentanyl|fentanyl|mesh-list
65116952|NCT00534287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116953|NCT00534287|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65116955|NCT00534287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65116956|NCT04168502|Gemtuzumab|gemtuzumab|mesh-list
65116957|NCT04168502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65116958|NCT04168502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116959|NCT04166396|Resveratrol|resveratrol|mesh-list
65116960|NCT04166396|Antioxidants|antioxidants|mesh-ancestor
65116961|NCT04166396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116962|NCT04166396|Protective Agents|protective agents|mesh-ancestor
65116963|NCT04166396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116964|NCT04166396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116965|NCT04166396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65116966|NCT01215916|Pemetrexed|pemetrexed|mesh-list
65116967|NCT01215916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116968|NCT01215916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65294778|NCT00612989|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
65294779|NCT00612989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65294780|NCT00612989|Alkylating Agents|alkylating agents|mesh-ancestor
65294781|NCT00612989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294782|NCT00612989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294783|NCT00612989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65294784|NCT05215405|Venetoclax|venetoclax|mesh-list
65294785|NCT05215405|Navitoclax|navitoclax|mesh-list
65294786|NCT05215405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294787|NCT00613067|Citalopram|citalopram|mesh-list
64525019|NCT02407314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64525020|NCT02407314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64525025|NCT02407314|Antipyretics|antipyretics|mesh-ancestor
65116969|NCT01215916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116970|NCT01215916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65116994|NCT04083365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65116996|NCT04666623|Antidepressive Agents|antidepressive agents|mesh-ancestor
65116997|NCT04666623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65116998|NCT00534677|Octreotide|octreotide|mesh-list
65116999|NCT00534677|Terlipressin|terlipressin|mesh-list
65117000|NCT00534677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65117001|NCT00534677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65117002|NCT00534677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117003|NCT00534677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65117004|NCT00534677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65117005|NCT00556959|Clonidine|clonidine|mesh-list
65117006|NCT00556959|Analgesics|analgesics|mesh-ancestor
65117007|NCT00556959|Sensory System Agents|sensory system agents|mesh-ancestor
65117008|NCT00556959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65117009|NCT00556959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117010|NCT00556959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65117011|NCT00556959|Sympatholytics|sympatholytics|mesh-ancestor
65117012|NCT00556959|Autonomic Agents|autonomic agents|mesh-ancestor
65117013|NCT00556959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65117014|NCT00556959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65117015|NCT00556959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65117016|NCT00556959|Adrenergic Agents|adrenergic agents|mesh-ancestor
65117017|NCT00556959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65117018|NCT00556959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117019|NCT01184326|Everolimus|everolimus|mesh-list
65117020|NCT01184326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117021|NCT01184326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65117022|NCT01184326|Immunologic Factors|immunologic factors|mesh-ancestor
65117023|NCT01184326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117024|NCT01215253|Ranolazine|ranolazine|mesh-list
65117027|NCT01215253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117030|NCT03813875|Fentanyl|fentanyl|mesh-list
65117031|NCT03813875|Midazolam|midazolam|mesh-list
65117032|NCT03813875|Alfentanil|alfentanil|mesh-list
65117033|NCT03813875|Propofol|propofol|mesh-list
65117034|NCT03813875|Sevoflurane|sevoflurane|mesh-list
65117035|NCT03813875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65117036|NCT03813875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65117037|NCT03813875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117038|NCT03813875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65117039|NCT03813875|Anesthetics, General|anesthetics, general|mesh-ancestor
65117040|NCT03813875|Anesthetics|anesthetics|mesh-ancestor
65117041|NCT03813875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65117042|NCT03813875|Narcotics|narcotics|mesh-ancestor
65117043|NCT03813875|Analgesics|analgesics|mesh-ancestor
65117044|NCT03813875|Sensory System Agents|sensory system agents|mesh-ancestor
65117045|NCT03813875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65117046|NCT03813875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65117047|NCT03813875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65117048|NCT03813875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65294788|NCT00613067|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65294789|NCT00613067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65294790|NCT00613067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65294791|NCT00613067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294792|NCT00613067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65294793|NCT00613067|Serotonin Agents|serotonin agents|mesh-ancestor
65294794|NCT00613067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294795|NCT00613067|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65294796|NCT00613067|Antidepressive Agents|antidepressive agents|mesh-ancestor
65294797|NCT00613067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65294798|NCT04851301|Naloxone|naloxone|mesh-list
65294799|NCT04851301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65294800|NCT04851301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294801|NCT04851301|Sensory System Agents|sensory system agents|mesh-ancestor
65294802|NCT04851301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294803|NCT04649489|Bevacizumab|bevacizumab|mesh-list
65294804|NCT04649489|Atezolizumab|atezolizumab|mesh-list
65294805|NCT04649489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65294806|NCT04649489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65294807|NCT04649489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294808|NCT04649489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65294809|NCT04649489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65294810|NCT04649489|Growth Substances|growth substances|mesh-ancestor
65294811|NCT04649489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294812|NCT04649489|Growth Inhibitors|growth inhibitors|mesh-ancestor
65294813|NCT04649489|Immunologic Factors|immunologic factors|mesh-ancestor
65294814|NCT00613145|Capecitabine|capecitabine|mesh-list
65294815|NCT00613145|Sorafenib|sorafenib|mesh-list
64525028|NCT02407314|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65117049|NCT03813875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65117050|NCT03813875|GABA Modulators|gaba modulators|mesh-ancestor
65117051|NCT03813875|GABA Agents|gaba agents|mesh-ancestor
65117052|NCT03813875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65117053|NCT03813875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117054|NCT03813875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65117055|NCT03813875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65117056|NCT01183858|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65117057|NCT01183858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117058|NCT01183858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65117059|NCT01183858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117060|NCT01183858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117061|NCT05449522|Vitamin D|vitamin d|mesh-list
65117062|NCT05449522|Vitamins|vitamins|mesh-ancestor
65117063|NCT05449522|Micronutrients|micronutrients|mesh-ancestor
65294816|NCT00613145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65294817|NCT00613145|Antimetabolites|antimetabolites|mesh-ancestor
65294818|NCT00613145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294819|NCT00613145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294820|NCT00613145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65294821|NCT00613145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65294822|NCT00853047|Octreotide|octreotide|mesh-list
65294823|NCT00853047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65294824|NCT00853047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65294825|NCT00853047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294826|NCT04570085|Caffeine|caffeine|mesh-list
65294827|NCT04570085|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65294828|NCT04570085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294829|NCT04570085|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65294830|NCT04570085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65294831|NCT04570085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294832|NCT04570085|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65294833|NCT04570085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65294834|NCT04570085|Purinergic Agents|purinergic agents|mesh-ancestor
65294835|NCT04570085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64525061|NCT02701296|Mydriatics|mydriatics|mesh-ancestor
65117064|NCT05449522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117065|NCT05449522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65117066|NCT04665609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65117067|NCT03737981|Venetoclax|venetoclax|mesh-list
65117068|NCT03737981|Obinutuzumab|obinutuzumab|mesh-list
65117069|NCT03737981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117070|NCT03737981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65117071|NCT04665141|Omalizumab|omalizumab|mesh-list
65117072|NCT04665141|Benralizumab|benralizumab|mesh-list
65117073|NCT04665141|Reslizumab|reslizumab|mesh-list
65117074|NCT04665141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65117075|NCT04665141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65117076|NCT04665141|Respiratory System Agents|respiratory system agents|mesh-ancestor
65117077|NCT04665063|Cyclophosphamide|cyclophosphamide|mesh-list
65117078|NCT04665063|Fludarabine|fludarabine|mesh-list
65117079|NCT04665063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65117080|NCT04665063|Immunologic Factors|immunologic factors|mesh-ancestor
65117081|NCT04665063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117082|NCT04665063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65117083|NCT04665063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65117084|NCT04665063|Alkylating Agents|alkylating agents|mesh-ancestor
65117085|NCT04665063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117086|NCT04665063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117087|NCT04665063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65117088|NCT03646058|Buprenorphine|buprenorphine|mesh-list
65117089|NCT03646058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65117090|NCT03646058|Narcotics|narcotics|mesh-ancestor
65117091|NCT03646058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65117092|NCT03646058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117093|NCT03646058|Analgesics|analgesics|mesh-ancestor
65117094|NCT03646058|Sensory System Agents|sensory system agents|mesh-ancestor
65117095|NCT03646058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294836|NCT00529399|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65294837|NCT00529399|Aluminum sulfate|aluminum sulfate|mesh-list
65294838|NCT00529399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65294839|NCT00529399|Immunologic Factors|immunologic factors|mesh-ancestor
65294840|NCT00529399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294841|NCT00529399|Antacids|antacids|mesh-ancestor
65294842|NCT00529399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294843|NCT00529399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65294844|NCT05268419|Ethanol|ethanol|mesh-list
65294845|NCT05268419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65294846|NCT05268419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65294847|NCT05268419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65294848|NCT05268419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294849|NCT00852969|Niacin|niacin|mesh-list
65294850|NCT00852969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65294851|NCT00852969|Antimetabolites|antimetabolites|mesh-ancestor
64525079|NCT01582451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117096|NCT03646058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65117097|NCT04664595|Propofol|propofol|mesh-list
65117098|NCT04664595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65117116|NCT05335915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65117117|NCT05335915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117118|NCT05335915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65117119|NCT05335915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65117120|NCT05335915|Cholinergic Agents|cholinergic agents|mesh-ancestor
65117121|NCT05335915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65117122|NCT05335915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117123|NCT01215097|Linagliptin|linagliptin|mesh-list
65117124|NCT01215097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65117125|NCT01215097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117126|NCT01215097|Incretins|incretins|mesh-ancestor
65117127|NCT01215097|Hormones|hormones|mesh-ancestor
65117128|NCT01215097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65117129|NCT01215097|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65117130|NCT01215097|Protease Inhibitors|protease inhibitors|mesh-ancestor
65117131|NCT01215097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117132|NCT01215097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117133|NCT03554174|Psilocybin|psilocybin|mesh-list
65117134|NCT03554174|Hallucinogens|hallucinogens|mesh-ancestor
65117135|NCT03554174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117136|NCT03554174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65117137|NCT03527576|Dexamethasone|dexamethasone|mesh-list
65117138|NCT03527576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65117139|NCT03527576|Antiemetics|antiemetics|mesh-ancestor
65117140|NCT03527576|Autonomic Agents|autonomic agents|mesh-ancestor
65117141|NCT03527576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65117142|NCT03527576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117143|NCT03527576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65117144|NCT03527576|Glucocorticoids|glucocorticoids|mesh-ancestor
65117145|NCT03527576|Hormones|hormones|mesh-ancestor
65117146|NCT03527576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65117147|NCT03527576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65117148|NCT03527576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117149|NCT04664010|Vitamins|vitamins|mesh-list
65117150|NCT04664010|Ascorbic Acid|ascorbic acid|mesh-list
65117151|NCT04664010|Interferons|interferons|mesh-list
65117152|NCT04664010|Ribavirin|ribavirin|mesh-list
65117153|NCT04664010|Interferon-alpha|interferon-alpha|mesh-list
65117154|NCT04664010|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65117155|NCT04664010|Micronutrients|micronutrients|mesh-ancestor
65294852|NCT00852969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294853|NCT00852969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65294854|NCT00852969|Vasodilator Agents|vasodilator agents|mesh-ancestor
65044763|NCT01084330|Docetaxel|docetaxel|mesh-list
65294855|NCT00852969|Vitamin B Complex|vitamin b complex|mesh-ancestor
65294856|NCT00852969|Vitamins|vitamins|mesh-ancestor
65294857|NCT00852969|Micronutrients|micronutrients|mesh-ancestor
65294858|NCT00852969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294859|NCT00613457|Cytarabine|cytarabine|mesh-list
64525093|NCT03168828|Urological Agents|urological agents|mesh-ancestor
64525094|NCT02562898|Gemcitabine|gemcitabine|mesh-list
65117156|NCT04664010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117157|NCT04664010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117158|NCT04664010|Antiviral Agents|antiviral agents|mesh-ancestor
65117164|NCT04664010|Protective Agents|protective agents|mesh-ancestor
65117165|NCT04664127|Valacyclovir|valacyclovir|mesh-list
65117166|NCT04664127|Antiviral Agents|antiviral agents|mesh-ancestor
65117167|NCT04664127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65117168|NCT04664088|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65117169|NCT04664088|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65117170|NCT04664088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65117171|NCT04664088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65117172|NCT04664088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117173|NCT04664088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65117174|NCT04664088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117175|NCT04664088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65117176|NCT04664088|Antidepressive Agents|antidepressive agents|mesh-ancestor
65117177|NCT04664088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65117178|NCT04664244|Nimotuzumab|nimotuzumab|mesh-list
65117179|NCT04664244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65117180|NCT04664244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117181|NCT04663386|Budesonide|budesonide|mesh-list
65117182|NCT04663386|Formoterol Fumarate|formoterol fumarate|mesh-list
65117183|NCT04663386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65117184|NCT04663386|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65117185|NCT04663386|Autonomic Agents|autonomic agents|mesh-ancestor
65117186|NCT04663386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65117187|NCT04663386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117188|NCT04663386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65117189|NCT04663386|Respiratory System Agents|respiratory system agents|mesh-ancestor
65117190|NCT04663386|Glucocorticoids|glucocorticoids|mesh-ancestor
65117191|NCT04663386|Hormones|hormones|mesh-ancestor
65117192|NCT04663386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65117193|NCT04663386|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65117194|NCT04663386|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65117195|NCT04663386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65117196|NCT04663386|Adrenergic Agents|adrenergic agents|mesh-ancestor
65117197|NCT04663386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65117198|NCT04663386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117199|NCT03504488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65117200|NCT03504488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117201|NCT03504488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117202|NCT04663269|Dexamethasone|dexamethasone|mesh-list
65117203|NCT04663269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65117204|NCT04663269|Antiemetics|antiemetics|mesh-ancestor
65117205|NCT04663269|Autonomic Agents|autonomic agents|mesh-ancestor
65117206|NCT04663269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65117207|NCT04663269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117208|NCT04663269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65117209|NCT04663269|Glucocorticoids|glucocorticoids|mesh-ancestor
65117210|NCT04663269|Hormones|hormones|mesh-ancestor
65117211|NCT04663269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65117212|NCT04663269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65294860|NCT00613457|Dexamethasone|dexamethasone|mesh-list
65294861|NCT00613457|Prednisone|prednisone|mesh-list
65294862|NCT00613457|Cyclophosphamide|cyclophosphamide|mesh-list
65294863|NCT00613457|Ifosfamide|ifosfamide|mesh-list
65294864|NCT00613457|Doxorubicin|doxorubicin|mesh-list
65294865|NCT00613457|Methotrexate|methotrexate|mesh-list
65294866|NCT00613457|Etoposide|etoposide|mesh-list
65294867|NCT00613457|Vincristine|vincristine|mesh-list
65294868|NCT00613457|Daunorubicin|daunorubicin|mesh-list
65294869|NCT00613457|Asparaginase|asparaginase|mesh-list
65294870|NCT00613457|Mercaptopurine|mercaptopurine|mesh-list
65294871|NCT00613457|Thioguanine|thioguanine|mesh-list
65294872|NCT00613457|Vindesine|vindesine|mesh-list
65294873|NCT00613457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65294874|NCT00613457|Immunologic Factors|immunologic factors|mesh-ancestor
65294875|NCT00613457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294876|NCT00613457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65294877|NCT00613457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65294878|NCT00613457|Alkylating Agents|alkylating agents|mesh-ancestor
64525103|NCT02562898|Antimetabolites|antimetabolites|mesh-ancestor
65117213|NCT04663269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117214|NCT03312738|Everolimus|everolimus|mesh-list
65117215|NCT03312738|Exemestane|exemestane|mesh-list
65117216|NCT03312738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117217|NCT03312738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65117218|NCT03312738|Immunologic Factors|immunologic factors|mesh-ancestor
65117219|NCT03312738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117220|NCT03312738|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65117221|NCT03312738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65117222|NCT03312738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117223|NCT03312738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117224|NCT03312738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65117225|NCT03312738|Hormone Antagonists|hormone antagonists|mesh-ancestor
64689490|NCT04768231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65117233|NCT03303339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117234|NCT03303339|Antiviral Agents|antiviral agents|mesh-ancestor
65117235|NCT03303339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65117236|NCT03303339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65117237|NCT03303339|Immunologic Factors|immunologic factors|mesh-ancestor
65117238|NCT03303339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117239|NCT03303339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117240|NCT03303339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65117241|NCT03422471|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65117242|NCT03422471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117243|NCT03299946|Nivolumab|nivolumab|mesh-list
65117244|NCT03299946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65117245|NCT03299946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117246|NCT03299946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65117247|NCT03299946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117248|NCT00535340|Amibegron|amibegron|mesh-list
65117249|NCT00535340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65117250|NCT00535340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65117251|NCT00535340|Adrenergic Agents|adrenergic agents|mesh-ancestor
65117252|NCT00535340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65117253|NCT00535340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117254|NCT00535340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117255|NCT00535379|Sunitinib|sunitinib|mesh-list
65117256|NCT00535379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117257|NCT00535379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65117258|NCT00535379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65117259|NCT00535379|Growth Substances|growth substances|mesh-ancestor
65294879|NCT00613457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294880|NCT00613457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294881|NCT00613457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65294882|NCT00613457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65294883|NCT00613457|Antiemetics|antiemetics|mesh-ancestor
65294884|NCT00613457|Autonomic Agents|autonomic agents|mesh-ancestor
65294885|NCT00613457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65294886|NCT00613457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65294887|NCT00613457|Glucocorticoids|glucocorticoids|mesh-ancestor
65294888|NCT00613457|Hormones|hormones|mesh-ancestor
65294889|NCT00613457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65294890|NCT00613457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65294891|NCT00613457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65294892|NCT00613457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65294893|NCT00613457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65117260|NCT00535379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117261|NCT00535379|Growth Inhibitors|growth inhibitors|mesh-ancestor
65117262|NCT00535379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65117263|NCT00535379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117264|NCT00535379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117266|NCT00535418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117267|NCT00535418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65117268|NCT00535418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65117269|NCT00535418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117270|NCT00535418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117271|NCT00535418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65117272|NCT00535418|Hormone Antagonists|hormone antagonists|mesh-ancestor
65117273|NCT00535418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65117274|NCT00535418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117275|NCT03377543|Aspirin|aspirin|mesh-list
65117276|NCT03377543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65117277|NCT03377543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65117278|NCT03377543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65117279|NCT03377543|Analgesics|analgesics|mesh-ancestor
65117280|NCT03377543|Sensory System Agents|sensory system agents|mesh-ancestor
65117281|NCT03377543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65117282|NCT03377543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117283|NCT03377543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65117284|NCT03377543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65117285|NCT03377543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65117286|NCT03377543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117287|NCT03377543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65117288|NCT03377543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65117289|NCT03377543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117290|NCT03377543|Antipyretics|antipyretics|mesh-ancestor
65117291|NCT04679064|Gemcitabine|gemcitabine|mesh-list
65117292|NCT04679064|Paclitaxel|paclitaxel|mesh-list
65117305|NCT04679064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65117306|NCT04679064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65117307|NCT04679064|Growth Substances|growth substances|mesh-ancestor
65117308|NCT04679064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117309|NCT04679064|Growth Inhibitors|growth inhibitors|mesh-ancestor
65117310|NCT04679064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65117311|NCT04679064|Antimetabolites|antimetabolites|mesh-ancestor
65117312|NCT04679064|Antiviral Agents|antiviral agents|mesh-ancestor
65117313|NCT04679064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65117314|NCT04679064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65294894|NCT00613457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65294895|NCT00613457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65294896|NCT00613457|Abortifacient Agents|abortifacient agents|mesh-ancestor
65294897|NCT00613457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65294898|NCT00613457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65294899|NCT00613457|Antimetabolites|antimetabolites|mesh-ancestor
65294900|NCT00613457|Dermatologic Agents|dermatologic agents|mesh-ancestor
65294901|NCT00613457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65294902|NCT00613457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65294903|NCT00613457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65294904|NCT00613457|Antiviral Agents|antiviral agents|mesh-ancestor
65294905|NCT00613457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65294906|NCT00613457|Tubulin Modulators|tubulin modulators|mesh-ancestor
65294907|NCT00613457|Antimitotic Agents|antimitotic agents|mesh-ancestor
65294908|NCT00613457|Mitosis Modulators|mitosis modulators|mesh-ancestor
65294909|NCT04131582|Metformin|metformin|mesh-list
65294910|NCT04131582|Empagliflozin|empagliflozin|mesh-list
65294911|NCT04131582|Linagliptin|linagliptin|mesh-list
65294912|NCT04131582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65294913|NCT04131582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294914|NCT04131582|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65294915|NCT04131582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294916|NCT04131582|Incretins|incretins|mesh-ancestor
65294917|NCT04131582|Hormones|hormones|mesh-ancestor
64525135|NCT02565628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65117315|NCT04679064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64513882|NCT01459887|Hormones|hormones|mesh-ancestor
65117316|NCT04679064|Immunologic Factors|immunologic factors|mesh-ancestor
65117317|NCT04679064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65117318|NCT04679064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65117319|NCT04679064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65117320|NCT04679064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65117321|NCT04679064|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65117322|NCT01183780|Leucovorin|leucovorin|mesh-list
65117323|NCT01183780|Folic Acid|folic acid|mesh-list
65117324|NCT01183780|Fluorouracil|fluorouracil|mesh-list
65117325|NCT01183780|Irinotecan|irinotecan|mesh-list
65117326|NCT01183780|Ramucirumab|ramucirumab|mesh-list
65117327|NCT01183780|Levoleucovorin|levoleucovorin|mesh-list
65117328|NCT01183780|Antimetabolites|antimetabolites|mesh-ancestor
65117329|NCT01183780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117330|NCT01183780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65117331|NCT01183780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117332|NCT01183780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65117333|NCT01183780|Immunologic Factors|immunologic factors|mesh-ancestor
65117334|NCT01183780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117335|NCT01183780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65117336|NCT01183780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65117337|NCT01183780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117338|NCT01183780|Antidotes|antidotes|mesh-ancestor
65117339|NCT01183780|Protective Agents|protective agents|mesh-ancestor
65117340|NCT01183780|Vitamin B Complex|vitamin b complex|mesh-ancestor
65294918|NCT04131582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65294919|NCT04131582|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65294920|NCT04131582|Protease Inhibitors|protease inhibitors|mesh-ancestor
65294921|NCT04131582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65294922|NCT00521365|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65294923|NCT00521365|Antidepressive Agents|antidepressive agents|mesh-ancestor
65294924|NCT00521365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65294925|NCT00521365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65294926|NCT00521365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65294927|NCT00521365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65294928|NCT00521365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294929|NCT00695994|Gemcitabine|gemcitabine|mesh-list
65294930|NCT00695994|Carboplatin|carboplatin|mesh-list
65294931|NCT00695994|Docetaxel|docetaxel|mesh-list
65294932|NCT00695994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294933|NCT00695994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65294934|NCT00695994|Antimetabolites|antimetabolites|mesh-ancestor
65294935|NCT00695994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294937|NCT00695994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65294938|NCT00695994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65294939|NCT00695994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65294940|NCT00695994|Immunologic Factors|immunologic factors|mesh-ancestor
65294941|NCT00695994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294942|NCT00695994|Tubulin Modulators|tubulin modulators|mesh-ancestor
65294943|NCT00695994|Antimitotic Agents|antimitotic agents|mesh-ancestor
65294944|NCT00695994|Mitosis Modulators|mitosis modulators|mesh-ancestor
65294945|NCT00711802|Daptomycin|daptomycin|mesh-list
65294946|NCT00711802|Cloxacillin|cloxacillin|mesh-list
65294947|NCT00711802|Oxacillin|oxacillin|mesh-list
65294948|NCT00711802|Nafcillin|nafcillin|mesh-list
65294949|NCT00711802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65294950|NCT00711802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65117341|NCT01183780|Vitamins|vitamins|mesh-ancestor
65117342|NCT01183780|Micronutrients|micronutrients|mesh-ancestor
65117343|NCT01183780|Hematinics|hematinics|mesh-ancestor
65117344|NCT04679103|Eculizumab|eculizumab|mesh-list
65117345|NCT04679103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65117346|NCT04679103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65117347|NCT04679103|Immunologic Factors|immunologic factors|mesh-ancestor
65117348|NCT04679103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117349|NCT03250832|Bevacizumab|bevacizumab|mesh-list
65117350|NCT03250832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65117351|NCT03250832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117352|NCT03250832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65117353|NCT03250832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65117354|NCT03250832|Growth Substances|growth substances|mesh-ancestor
65294951|NCT00851877|Paclitaxel|paclitaxel|mesh-list
65294952|NCT00851877|Cetuximab|cetuximab|mesh-list
65294953|NCT00851877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65294954|NCT00851877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294955|NCT00851877|Tubulin Modulators|tubulin modulators|mesh-ancestor
65294956|NCT00851877|Antimitotic Agents|antimitotic agents|mesh-ancestor
65294957|NCT00851877|Mitosis Modulators|mitosis modulators|mesh-ancestor
65294958|NCT00851877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294959|NCT00851877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65294960|NCT00613223|Etoposide|etoposide|mesh-list
65294961|NCT00613223|Etoposide phosphate|etoposide phosphate|mesh-list
65294962|NCT00613223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65294963|NCT00613223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294964|NCT00613223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65294965|NCT00613223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65294966|NCT00613223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65294967|NCT00613223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294968|NCT00882908|Ribavirin|ribavirin|mesh-list
65294969|NCT00882908|Simeprevir|simeprevir|mesh-list
65294970|NCT00882908|Antimetabolites|antimetabolites|mesh-ancestor
65294971|NCT00882908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294972|NCT00882908|Antiviral Agents|antiviral agents|mesh-ancestor
65294973|NCT00882908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65294974|NCT00882908|Protease Inhibitors|protease inhibitors|mesh-ancestor
65294975|NCT00882908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65294976|NCT03580967|Vortioxetine|vortioxetine|mesh-list
65294977|NCT03580967|Antidepressive Agents|antidepressive agents|mesh-ancestor
65294978|NCT03580967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65294979|NCT03580967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65117355|NCT03250832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117356|NCT03250832|Growth Inhibitors|growth inhibitors|mesh-ancestor
65117357|NCT00535574|Bexarotene|bexarotene|mesh-list
65117365|NCT04678830|Antiviral Agents|antiviral agents|mesh-ancestor
65117366|NCT04678830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65117367|NCT01183468|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65117368|NCT01183468|Protein C Inhibitor|protein c inhibitor|mesh-list
65117369|NCT01183468|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65117370|NCT01183468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65117371|NCT01183468|Protease Inhibitors|protease inhibitors|mesh-ancestor
65117372|NCT01183468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117373|NCT01183468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117375|NCT03245021|Nivolumab|nivolumab|mesh-list
65117376|NCT03245021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65117377|NCT03245021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117378|NCT03245021|Immunologic Factors|immunologic factors|mesh-ancestor
65117379|NCT03245021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117380|NCT03245021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65294980|NCT03580967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65294981|NCT03580967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65294982|NCT03580967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65294983|NCT03580967|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65294984|NCT03580967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64525215|NCT02406690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65117381|NCT03245021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65117382|NCT03245021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117383|NCT04678791|Cisplatin|cisplatin|mesh-list
65117384|NCT04678791|Nimotuzumab|nimotuzumab|mesh-list
65117385|NCT04678791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117386|NCT04678791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65117387|NCT01183390|Anastrozole|anastrozole|mesh-list
65117388|NCT01183390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65117389|NCT01183390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117390|NCT01183390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65117391|NCT01183390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65117392|NCT01183390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117393|NCT01183390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117394|NCT01183390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65117395|NCT01183390|Hormone Antagonists|hormone antagonists|mesh-ancestor
65117396|NCT01183390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65117397|NCT01183390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117398|NCT02887807|Cyclosporine|cyclosporine|mesh-list
65117399|NCT02887807|Cyclosporins|cyclosporins|mesh-list
65117400|NCT02887807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117401|NCT02887807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117402|NCT02887807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65117403|NCT02887807|Immunologic Factors|immunologic factors|mesh-ancestor
65117404|NCT02887807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117405|NCT02887807|Antifungal Agents|antifungal agents|mesh-ancestor
65117406|NCT02887807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65117407|NCT02887807|Dermatologic Agents|dermatologic agents|mesh-ancestor
65117408|NCT02887807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65117409|NCT02887807|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65117410|NCT04662840|Anesthetics|anesthetics|mesh-list
65117411|NCT04662840|Anesthetics, Local|anesthetics, local|mesh-list
65117412|NCT04662840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65117413|NCT04662840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117414|NCT04662840|Sensory System Agents|sensory system agents|mesh-ancestor
65117415|NCT04662840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65117416|NCT03098589|Lenalidomide|lenalidomide|mesh-list
65117417|NCT03098589|Immunologic Factors|immunologic factors|mesh-ancestor
65117418|NCT03098589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117419|NCT03098589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65117420|NCT03098589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65117421|NCT03098589|Growth Substances|growth substances|mesh-ancestor
65117422|NCT03098589|Growth Inhibitors|growth inhibitors|mesh-ancestor
65117433|NCT04662177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65117434|NCT04662177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65117435|NCT04662177|Adrenergic Agents|adrenergic agents|mesh-ancestor
65117436|NCT04662177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65117437|NCT04662177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117438|NCT03026517|Phenformin|phenformin|mesh-list
65117439|NCT03026517|Trametinib|trametinib|mesh-list
65117440|NCT03026517|Dabrafenib|dabrafenib|mesh-list
64650229|NCT00862784|Antidotes|antidotes|mesh-ancestor
65117441|NCT03026517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117442|NCT03026517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65117443|NCT03026517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117444|NCT03026517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117445|NCT03026517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65117446|NCT03026517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117447|NCT00537953|Miltefosine|miltefosine|mesh-list
65117448|NCT00537953|Meglumine Antimoniate|meglumine antimoniate|mesh-list
65117449|NCT00537953|Antifungal Agents|antifungal agents|mesh-ancestor
65117450|NCT00537953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65294985|NCT03580967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65294986|NCT03580967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65294987|NCT03580967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65294988|NCT03580967|Serotonin Agents|serotonin agents|mesh-ancestor
65294989|NCT03580967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65294990|NCT03580967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65294991|NCT03580967|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65294992|NCT03580967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65294993|NCT00851799|Ritonavir|ritonavir|mesh-list
65294994|NCT00851799|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65294995|NCT00851799|Darunavir|darunavir|mesh-list
65294996|NCT00851799|Tenofovir|tenofovir|mesh-list
65294997|NCT00851799|Emtricitabine|emtricitabine|mesh-list
65294998|NCT00851799|Raltegravir Potassium|raltegravir potassium|mesh-list
65344930|NCT00864058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64525221|NCT04440696|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
64525225|NCT02974348|Acetaminophen|acetaminophen|mesh-list
65117451|NCT00537953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117452|NCT00537953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65117453|NCT00537953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65117454|NCT04662138|Antiviral Agents|antiviral agents|mesh-list
65117455|NCT04662138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65117456|NCT05226299|Capsaicin|capsaicin|mesh-list
65117457|NCT05226299|Antipruritics|antipruritics|mesh-ancestor
65117458|NCT05226299|Dermatologic Agents|dermatologic agents|mesh-ancestor
65117459|NCT05226299|Sensory System Agents|sensory system agents|mesh-ancestor
65117460|NCT05226299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65117461|NCT05226299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117462|NCT00557232|Bevacizumab|bevacizumab|mesh-list
65117463|NCT00557232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65117464|NCT00557232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117465|NCT00557232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65117466|NCT00557232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65117467|NCT00557232|Growth Substances|growth substances|mesh-ancestor
65117468|NCT00557232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117469|NCT00557232|Growth Inhibitors|growth inhibitors|mesh-ancestor
65117470|NCT02797119|Tranexamic Acid|tranexamic acid|mesh-list
65117471|NCT02797119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65117472|NCT02797119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65117473|NCT02797119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117474|NCT02797119|Hemostatics|hemostatics|mesh-ancestor
65117475|NCT02797119|Coagulants|coagulants|mesh-ancestor
65117476|NCT05161208|Varenicline|varenicline|mesh-list
65117477|NCT05161208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65117478|NCT05161208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65117479|NCT05161208|Cholinergic Agents|cholinergic agents|mesh-ancestor
65117480|NCT05161208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65117481|NCT05161208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117482|NCT05161208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117483|NCT02650986|Cyclophosphamide|cyclophosphamide|mesh-list
65117484|NCT02650986|Decitabine|decitabine|mesh-list
65117485|NCT02650986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65117486|NCT02650986|Immunologic Factors|immunologic factors|mesh-ancestor
64689757|NCT05431673|Antimalarials|antimalarials|mesh-ancestor
65117499|NCT00538070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65117500|NCT00538070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117501|NCT00538070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117502|NCT00538109|Imatinib Mesylate|imatinib mesylate|mesh-list
65117503|NCT00538109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65294999|NCT00851799|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65295000|NCT00851799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65295001|NCT00851799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65295002|NCT00851799|Protease Inhibitors|protease inhibitors|mesh-ancestor
65295003|NCT00851799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295004|NCT00851799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295005|NCT00851799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65295006|NCT00851799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65295007|NCT00851799|Antiviral Agents|antiviral agents|mesh-ancestor
65295008|NCT00851799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65295009|NCT00851799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65295010|NCT00851799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65295011|NCT00851799|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65295012|NCT00851799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65295013|NCT00851799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65295014|NCT00851799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65295016|NCT00711646|Analgesics|analgesics|mesh-ancestor
65295017|NCT00711646|Sensory System Agents|sensory system agents|mesh-ancestor
64525251|NCT03170310|Apatinib|apatinib|mesh-list
65117504|NCT00538109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65117505|NCT00538109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117506|NCT00538109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117507|NCT00538148|Telithromycin|telithromycin|mesh-list
65117508|NCT00538148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65117509|NCT00538148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65117510|NCT04661670|Salicylic Acid|salicylic acid|mesh-list
65117511|NCT04661670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65117512|NCT04661670|Antifungal Agents|antifungal agents|mesh-ancestor
65117513|NCT04661670|Keratolytic Agents|keratolytic agents|mesh-ancestor
65117514|NCT04661670|Dermatologic Agents|dermatologic agents|mesh-ancestor
65117515|NCT05119439|Misoprostol|misoprostol|mesh-list
65117516|NCT05119439|Mifepristone|mifepristone|mesh-list
65117517|NCT05119439|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65117518|NCT05119439|Abortifacient Agents|abortifacient agents|mesh-ancestor
65117519|NCT05119439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65117520|NCT05119439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117521|NCT05119439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65117522|NCT05119439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65117523|NCT05119439|Oxytocics|oxytocics|mesh-ancestor
65117524|NCT05119439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65117525|NCT05119439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65117526|NCT05119439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65117527|NCT05119439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65117528|NCT05119439|Contraceptive Agents|contraceptive agents|mesh-ancestor
65117529|NCT05119439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65117530|NCT05119439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65117531|NCT05119439|Hormone Antagonists|hormone antagonists|mesh-ancestor
65117532|NCT05119439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65117533|NCT05119439|Luteolytic Agents|luteolytic agents|mesh-ancestor
65117534|NCT05119439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65117535|NCT05119439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65117536|NCT05110391|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65117537|NCT05110391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65295018|NCT00711646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65295019|NCT00711646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295020|NCT00501826|Cytarabine|cytarabine|mesh-list
65295021|NCT00501826|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
65295022|NCT00501826|Dexamethasone|dexamethasone|mesh-list
65295023|NCT00501826|Dexamethasone acetate|dexamethasone acetate|mesh-list
65295024|NCT00501826|Prednisone|prednisone|mesh-list
65295025|NCT00501826|Cortisone|cortisone|mesh-list
65295026|NCT00501826|Cyclophosphamide|cyclophosphamide|mesh-list
65295027|NCT00501826|Doxorubicin|doxorubicin|mesh-list
65295028|NCT00501826|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65295029|NCT00501826|Methotrexate|methotrexate|mesh-list
65295030|NCT00501826|Vincristine|vincristine|mesh-list
65295031|NCT00501826|Venetoclax|venetoclax|mesh-list
65295032|NCT00501826|Asparaginase|asparaginase|mesh-list
65295033|NCT00501826|Mercaptopurine|mercaptopurine|mesh-list
65295034|NCT00501826|Pegaspargase|pegaspargase|mesh-list
65295035|NCT00501826|BB 1101|bb 1101|mesh-list
65295036|NCT00501826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65295037|NCT00501826|Immunologic Factors|immunologic factors|mesh-ancestor
65295038|NCT00501826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295039|NCT00501826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65295040|NCT00501826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65295041|NCT00501826|Alkylating Agents|alkylating agents|mesh-ancestor
65344931|NCT00864058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65117538|NCT05110391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117539|NCT00538187|Bortezomib|bortezomib|mesh-list
65117540|NCT00538187|Obatoclax|obatoclax|mesh-list
65117541|NCT00538187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117542|NCT00538187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117543|NCT00538187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117544|NCT04661709|Aspirin|aspirin|mesh-list
65117545|NCT04661709|Metoprolol|metoprolol|mesh-list
65117546|NCT04661709|Isosorbide|isosorbide|mesh-list
65117547|NCT04661709|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65117548|NCT04661709|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65117549|NCT04661709|Nitroglycerin|nitroglycerin|mesh-list
65117563|NCT04661709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117565|NCT04661709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65117566|NCT04661709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117567|NCT04661709|Antipyretics|antipyretics|mesh-ancestor
65117568|NCT04661709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65117569|NCT04661709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65117570|NCT04661709|Antimetabolites|antimetabolites|mesh-ancestor
65117571|NCT04661709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65117572|NCT04661709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65117573|NCT04661709|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65117574|NCT04661709|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65117575|NCT04661709|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65117576|NCT04661709|Purinergic Agents|purinergic agents|mesh-ancestor
65117577|NCT04661709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65117578|NCT04661709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65117579|NCT04661709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65117580|NCT04661709|Sympatholytics|sympatholytics|mesh-ancestor
65117581|NCT04661709|Autonomic Agents|autonomic agents|mesh-ancestor
65117582|NCT04661709|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65295042|NCT00501826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295043|NCT00501826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295044|NCT00501826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65295045|NCT00501826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65295046|NCT00501826|Antiemetics|antiemetics|mesh-ancestor
65295047|NCT00501826|Autonomic Agents|autonomic agents|mesh-ancestor
65295048|NCT00501826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65295049|NCT00501826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65295050|NCT00501826|Glucocorticoids|glucocorticoids|mesh-ancestor
65295051|NCT00501826|Hormones|hormones|mesh-ancestor
65295052|NCT00501826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65295053|NCT00501826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65295054|NCT00501826|Protease Inhibitors|protease inhibitors|mesh-ancestor
65295055|NCT00501826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295056|NCT00501826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65295057|NCT00501826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65295058|NCT00501826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65117583|NCT04661709|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65117584|NCT04661709|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65117585|NCT04661709|Adrenergic Agents|adrenergic agents|mesh-ancestor
65117586|NCT04661709|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65117587|NCT04661709|Diuretics|diuretics|mesh-ancestor
65117588|NCT04661709|Natriuretic Agents|natriuretic agents|mesh-ancestor
65117589|NCT04661709|Vasodilator Agents|vasodilator agents|mesh-ancestor
65117590|NCT04661709|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65117591|NCT02466867|Naftifine|naftifine|mesh-list
65117592|NCT02466867|Antifungal Agents|antifungal agents|mesh-ancestor
65117593|NCT02466867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65117594|NCT00538265|Mycophenolic Acid|mycophenolic acid|mesh-list
65117595|NCT00538265|Tacrolimus|tacrolimus|mesh-list
65117596|NCT00538265|Thymoglobulin|thymoglobulin|mesh-list
65117597|NCT00538265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65117598|NCT00538265|Immunologic Factors|immunologic factors|mesh-ancestor
65117599|NCT00538265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117600|NCT00538265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65117601|NCT00538265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117602|NCT00538265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117603|NCT00538265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65117604|NCT00538265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117605|NCT00538265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65117606|NCT00538265|Antitubercular Agents|antitubercular agents|mesh-ancestor
65117607|NCT00538265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65117608|NCT00538265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65117609|NCT02462811|Acetaminophen|acetaminophen|mesh-list
65117621|NCT02462811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65117623|NCT02462811|Respiratory System Agents|respiratory system agents|mesh-ancestor
65117624|NCT02462811|Antipruritics|antipruritics|mesh-ancestor
65117625|NCT02462811|Dermatologic Agents|dermatologic agents|mesh-ancestor
65117626|NCT02462811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65117627|NCT02462811|Histamine Antagonists|histamine antagonists|mesh-ancestor
65117628|NCT02462811|Histamine Agents|histamine agents|mesh-ancestor
65117629|NCT02462811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65117630|NCT02462811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117631|NCT02462811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65117632|NCT02462811|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65117633|NCT02462811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65117634|NCT02462811|Anesthetics, Local|anesthetics, local|mesh-ancestor
65117635|NCT02462811|Anesthetics|anesthetics|mesh-ancestor
65295059|NCT00501826|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65295060|NCT00501826|Abortifacient Agents|abortifacient agents|mesh-ancestor
65295061|NCT00501826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65295062|NCT00501826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65295063|NCT00501826|Antimetabolites|antimetabolites|mesh-ancestor
65295064|NCT00501826|Dermatologic Agents|dermatologic agents|mesh-ancestor
65117636|NCT02462811|Antiemetics|antiemetics|mesh-ancestor
65117637|NCT02462811|Autonomic Agents|autonomic agents|mesh-ancestor
65117638|NCT02462811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65117639|NCT00538382|Artesunate|artesunate|mesh-list
65117640|NCT00538382|Antimalarials|antimalarials|mesh-ancestor
65117641|NCT00538382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65117642|NCT00538382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65117643|NCT00538382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65117644|NCT00538382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117645|NCT00538382|Antiviral Agents|antiviral agents|mesh-ancestor
65117646|NCT00538382|Schistosomicides|schistosomicides|mesh-ancestor
65117647|NCT00538382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65117648|NCT00538382|Anthelmintics|anthelmintics|mesh-ancestor
65117649|NCT00538421|Propofol|propofol|mesh-list
65117650|NCT00538421|Sevoflurane|sevoflurane|mesh-list
65117651|NCT00538421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65117652|NCT00538421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65117653|NCT00538421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117654|NCT00538421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65117655|NCT00538421|Anesthetics, General|anesthetics, general|mesh-ancestor
65117656|NCT00538421|Anesthetics|anesthetics|mesh-ancestor
65117657|NCT00538421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65117658|NCT00538421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65117659|NCT04661475|Dexmedetomidine|dexmedetomidine|mesh-list
65117660|NCT04661475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65117661|NCT04661475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65117662|NCT04661475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117663|NCT04661475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65117664|NCT04661475|Analgesics|analgesics|mesh-ancestor
65117665|NCT04661475|Sensory System Agents|sensory system agents|mesh-ancestor
65117666|NCT04661475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65117667|NCT04661475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65117668|NCT04661475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65117669|NCT04661475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65117670|NCT04661475|Adrenergic Agents|adrenergic agents|mesh-ancestor
65117671|NCT04661475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65117672|NCT04661475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117673|NCT00538499|Fentanyl|fentanyl|mesh-list
65117674|NCT00538499|Bupivacaine|bupivacaine|mesh-list
65117675|NCT00538499|Anesthetics, Local|anesthetics, local|mesh-ancestor
65117676|NCT00538499|Anesthetics|anesthetics|mesh-ancestor
65117694|NCT00554346|Etoricoxib|etoricoxib|mesh-list
65117695|NCT00554346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65117696|NCT00554346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65117697|NCT00554346|Analgesics|analgesics|mesh-ancestor
65117698|NCT00554346|Sensory System Agents|sensory system agents|mesh-ancestor
65117699|NCT00554346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65117700|NCT00554346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117701|NCT00554346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65117702|NCT00554346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65117703|NCT00554346|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65117704|NCT00554346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65117705|NCT00554346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117706|NCT00554346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117707|NCT00538655|Modafinil|modafinil|mesh-list
65117708|NCT00538655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65117709|NCT00538655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117710|NCT00538655|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65117711|NCT00538655|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65117712|NCT00538655|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65117713|NCT00538655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117714|NCT00538694|Daptomycin|daptomycin|mesh-list
65117715|NCT00538694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65295065|NCT00501826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65295066|NCT00501826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65295067|NCT00501826|Antiviral Agents|antiviral agents|mesh-ancestor
65295068|NCT00501826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65295069|NCT00501826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65295070|NCT00501826|Tubulin Modulators|tubulin modulators|mesh-ancestor
65117716|NCT00538694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65117717|NCT02436096|Cyclobenzaprine|cyclobenzaprine|mesh-list
65117718|NCT02436096|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65117719|NCT02436096|Antidepressive Agents|antidepressive agents|mesh-ancestor
65117720|NCT02436096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65117721|NCT02436096|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65117722|NCT02436096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117723|NCT02436096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65117724|NCT02436096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65117725|NCT02436096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65117726|NCT02436096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65117727|NCT00538811|Interferons|interferons|mesh-list
65117728|NCT00538811|Ribavirin|ribavirin|mesh-list
65117729|NCT00538811|Interferon-alpha|interferon-alpha|mesh-list
65117730|NCT00538811|Interferon alpha-2|interferon alpha-2|mesh-list
65117731|NCT00538811|Interferon-gamma|interferon-gamma|mesh-list
65117732|NCT00538811|Amantadine|amantadine|mesh-list
65117733|NCT00538811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690042|NCT05193071|Antipyretics|antipyretics|mesh-ancestor
65117750|NCT04660773|Sensory System Agents|sensory system agents|mesh-ancestor
65117751|NCT04660773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65117752|NCT04660773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117753|NCT04660773|Anticonvulsants|anticonvulsants|mesh-ancestor
65117754|NCT04660773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65117755|NCT04660773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65117756|NCT04660773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117757|NCT04660773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65117758|NCT04660773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65117759|NCT04660773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65117760|NCT04660773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65117761|NCT04660773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65117762|NCT00538889|Citalopram|citalopram|mesh-list
65117763|NCT00538889|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65117764|NCT00538889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65117765|NCT00538889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65117766|NCT00538889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117767|NCT00538889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65117768|NCT00538889|Serotonin Agents|serotonin agents|mesh-ancestor
65117769|NCT00538889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117770|NCT00538889|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65117771|NCT00538889|Antidepressive Agents|antidepressive agents|mesh-ancestor
65117772|NCT00538889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65117773|NCT02413827|Ipilimumab|ipilimumab|mesh-list
65117774|NCT02413827|Poly ICLC|poly iclc|mesh-list
65117775|NCT02413827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65117776|NCT02413827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65117777|NCT02413827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117778|NCT02413827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65117779|NCT02413827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117780|NCT02413827|Interferon Inducers|interferon inducers|mesh-ancestor
65117781|NCT02413827|Immunologic Factors|immunologic factors|mesh-ancestor
65117782|NCT02413827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117783|NCT00538967|Doxycycline|doxycycline|mesh-list
65117784|NCT00538967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65117785|NCT00538967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65117786|NCT00538967|Antimalarials|antimalarials|mesh-ancestor
65117787|NCT00538967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65117788|NCT00538967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65117789|NCT00539123|Buprenorphine|buprenorphine|mesh-list
65117790|NCT00539123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65117791|NCT00539123|Narcotics|narcotics|mesh-ancestor
64690095|NCT01898689|Anesthetics|anesthetics|mesh-ancestor
65117818|NCT00539630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295071|NCT00501826|Antimitotic Agents|antimitotic agents|mesh-ancestor
65295072|NCT00501826|Mitosis Modulators|mitosis modulators|mesh-ancestor
65295073|NCT04117191|Tryptophan|tryptophan|mesh-list
65295074|NCT04117191|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65295075|NCT04117191|Antidepressive Agents|antidepressive agents|mesh-ancestor
65295076|NCT04117191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65295077|NCT00520975|Paclitaxel|paclitaxel|mesh-list
65295078|NCT00520975|Bevacizumab|bevacizumab|mesh-list
65117819|NCT00539630|Tubulin Modulators|tubulin modulators|mesh-ancestor
65117820|NCT00539630|Antimitotic Agents|antimitotic agents|mesh-ancestor
65117821|NCT00539630|Mitosis Modulators|mitosis modulators|mesh-ancestor
65117822|NCT00539630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117824|NCT04660461|Dexlansoprazole|dexlansoprazole|mesh-list
65117825|NCT04660461|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65117826|NCT04660461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65117827|NCT04660461|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65117828|NCT04660461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117829|NCT04660461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117830|NCT00539669|Docetaxel|docetaxel|mesh-list
65117831|NCT00539669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117832|NCT00539669|Tubulin Modulators|tubulin modulators|mesh-ancestor
65117833|NCT00539669|Antimitotic Agents|antimitotic agents|mesh-ancestor
65117834|NCT00539669|Mitosis Modulators|mitosis modulators|mesh-ancestor
65117835|NCT00539669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117836|NCT00554424|Lidocaine|lidocaine|mesh-list
65117837|NCT00554424|Anesthetics, Local|anesthetics, local|mesh-ancestor
65117838|NCT00554424|Anesthetics|anesthetics|mesh-ancestor
65117839|NCT00554424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64690155|NCT03970655|Bupivacaine|bupivacaine|mesh-list
65117870|NCT02341989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65117872|NCT02341989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117873|NCT02341989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65117874|NCT00540098|Paroxetine|paroxetine|mesh-list
65117875|NCT00540098|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65117876|NCT00540098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65117877|NCT00540098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65117878|NCT00540098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117879|NCT00540098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65117897|NCT00540137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65117898|NCT00540137|Antiviral Agents|antiviral agents|mesh-ancestor
65117899|NCT00540137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65117900|NCT00540137|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65117901|NCT00540137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65117902|NCT00540137|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65117903|NCT00540137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65117904|NCT00540137|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65117905|NCT00540137|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65117906|NCT04660110|Piperaquine|piperaquine|mesh-list
65117907|NCT04660110|Artenimol|artenimol|mesh-list
65117908|NCT04660110|Antimalarials|antimalarials|mesh-ancestor
65117909|NCT04660110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65117910|NCT04660110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65117911|NCT04660110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65117912|NCT02339064|Apomorphine|apomorphine|mesh-list
65117913|NCT02339064|Emetics|emetics|mesh-ancestor
65117914|NCT02339064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117915|NCT02339064|Autonomic Agents|autonomic agents|mesh-ancestor
65117916|NCT02339064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65117917|NCT02339064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65117918|NCT02339064|Dopamine Agonists|dopamine agonists|mesh-ancestor
65117919|NCT02339064|Dopamine Agents|dopamine agents|mesh-ancestor
65117920|NCT02339064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65117921|NCT02339064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117922|NCT02336685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65117923|NCT02336685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117924|NCT02336685|Immunologic Factors|immunologic factors|mesh-ancestor
65117925|NCT00540410|Artesunate|artesunate|mesh-list
65117926|NCT00540410|Lumefantrine|lumefantrine|mesh-list
65295079|NCT00520975|Carboplatin|carboplatin|mesh-list
65295080|NCT00520975|Trastuzumab|trastuzumab|mesh-list
65295081|NCT00520975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65295082|NCT00520975|Antibodies|antibodies|mesh-list
65295083|NCT00520975|Immunoglobulins|immunoglobulins|mesh-list
65295084|NCT00520975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65295085|NCT00520975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65295086|NCT00520975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117927|NCT00540410|Amodiaquine|amodiaquine|mesh-list
65117928|NCT00540410|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65117929|NCT00540410|Antimalarials|antimalarials|mesh-ancestor
65117930|NCT00540410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65117931|NCT00540410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65117932|NCT00540410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65117933|NCT00540410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117934|NCT00540410|Antiviral Agents|antiviral agents|mesh-ancestor
65117935|NCT00540410|Schistosomicides|schistosomicides|mesh-ancestor
64760188|NCT03117972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117936|NCT00540410|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65117937|NCT00540410|Anthelmintics|anthelmintics|mesh-ancestor
65117947|NCT00540605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65117949|NCT00540605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117950|NCT00540605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65117951|NCT00540605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65117952|NCT04659915|Metformin|metformin|mesh-list
65117953|NCT04659915|Prednisone|prednisone|mesh-list
65117954|NCT04659915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65117955|NCT04659915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117956|NCT04659915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65117957|NCT04659915|Glucocorticoids|glucocorticoids|mesh-ancestor
65117958|NCT04659915|Hormones|hormones|mesh-ancestor
65117959|NCT04659915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65117960|NCT04659915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65117961|NCT04659915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117962|NCT00557427|Fluoxetine|fluoxetine|mesh-list
65117963|NCT00557427|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65117964|NCT00557427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65117965|NCT00557427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65117966|NCT00557427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117967|NCT00557427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65117968|NCT00557427|Serotonin Agents|serotonin agents|mesh-ancestor
65117969|NCT00557427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117970|NCT00557427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65117971|NCT00557427|Antidepressive Agents|antidepressive agents|mesh-ancestor
65117972|NCT00557427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65117973|NCT00557427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65117974|NCT00557427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65117975|NCT00557427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117976|NCT00540800|Docetaxel|docetaxel|mesh-list
65117977|NCT00540800|Capecitabine|capecitabine|mesh-list
65117978|NCT00540800|Epirubicin|epirubicin|mesh-list
65117979|NCT00540800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117980|NCT00540800|Tubulin Modulators|tubulin modulators|mesh-ancestor
65117981|NCT00540800|Antimitotic Agents|antimitotic agents|mesh-ancestor
65117982|NCT00540800|Mitosis Modulators|mitosis modulators|mesh-ancestor
65117983|NCT00540800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117984|NCT00540800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65117985|NCT00540800|Antimetabolites|antimetabolites|mesh-ancestor
65117986|NCT00540800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65117987|NCT00540800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65117988|NCT00540800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65117989|NCT00540800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117990|NCT00540956|Cytarabine|cytarabine|mesh-list
65117991|NCT00540956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65117992|NCT00540956|Antimetabolites|antimetabolites|mesh-ancestor
65117993|NCT00540956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117994|NCT00540956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117995|NCT00540956|Antiviral Agents|antiviral agents|mesh-ancestor
65295087|NCT00520975|Tubulin Modulators|tubulin modulators|mesh-ancestor
65295088|NCT00520975|Antimitotic Agents|antimitotic agents|mesh-ancestor
65295089|NCT00520975|Mitosis Modulators|mitosis modulators|mesh-ancestor
65295090|NCT00520975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295091|NCT00520975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65295092|NCT00520975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65295093|NCT00520975|Growth Substances|growth substances|mesh-ancestor
64525322|NCT03169764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64525323|NCT03169764|Immunologic Factors|immunologic factors|mesh-ancestor
64914024|NCT04650581|Fulvestrant|fulvestrant|mesh-list
65117996|NCT00540956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65117997|NCT00540956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65117998|NCT00540956|Immunologic Factors|immunologic factors|mesh-ancestor
65117999|NCT00540956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118000|NCT00541073|Vitamin B 12|vitamin b 12|mesh-list
65118001|NCT00541073|Hydroxocobalamin|hydroxocobalamin|mesh-list
65118002|NCT00541073|Pemetrexed|pemetrexed|mesh-list
65118010|NCT00541073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65118011|NCT00541073|Vitamin B Complex|vitamin b complex|mesh-ancestor
65118013|NCT00541112|Leucovorin|leucovorin|mesh-list
65118014|NCT00541112|Fluorouracil|fluorouracil|mesh-list
65118015|NCT00541112|Capecitabine|capecitabine|mesh-list
65118016|NCT00541112|Oxaliplatin|oxaliplatin|mesh-list
65118017|NCT00541112|Cetuximab|cetuximab|mesh-list
65118018|NCT00541112|Calcium|calcium|mesh-list
65118019|NCT00541112|Levoleucovorin|levoleucovorin|mesh-list
65118020|NCT00541112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65118021|NCT00541112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118022|NCT00541112|Antimetabolites|antimetabolites|mesh-ancestor
65118023|NCT00541112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118024|NCT00541112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65118025|NCT00541112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118026|NCT00541112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65118027|NCT00541112|Immunologic Factors|immunologic factors|mesh-ancestor
65118028|NCT00541112|Antidotes|antidotes|mesh-ancestor
65118029|NCT00541112|Protective Agents|protective agents|mesh-ancestor
65118030|NCT00541112|Vitamin B Complex|vitamin b complex|mesh-ancestor
65118031|NCT00541112|Vitamins|vitamins|mesh-ancestor
65118032|NCT00541112|Micronutrients|micronutrients|mesh-ancestor
64513916|NCT01893723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65118033|NCT00541112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65118034|NCT04659525|Ezetimibe|ezetimibe|mesh-list
65118035|NCT04659525|Evolocumab|evolocumab|mesh-list
65118036|NCT04659525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65118037|NCT04659525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65118038|NCT04659525|Antimetabolites|antimetabolites|mesh-ancestor
65118039|NCT04659525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118040|NCT04659525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65118041|NCT02333643|Digoxin|digoxin|mesh-list
65118042|NCT02333643|Furosemide|furosemide|mesh-list
65118043|NCT02333643|Diuretics|diuretics|mesh-ancestor
65118044|NCT02333643|Natriuretic Agents|natriuretic agents|mesh-ancestor
65118045|NCT02333643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118046|NCT02333643|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65118047|NCT02333643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65118048|NCT02333643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118049|NCT02333643|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65118050|NCT02333643|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65118051|NCT02333643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118052|NCT02333643|Protective Agents|protective agents|mesh-ancestor
65118053|NCT00541463|Nelfinavir|nelfinavir|mesh-list
65118054|NCT00541463|Indinavir|indinavir|mesh-list
65118055|NCT00541463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118056|NCT00541463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65118057|NCT00541463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65118058|NCT00541463|Protease Inhibitors|protease inhibitors|mesh-ancestor
65118059|NCT00541463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118060|NCT00541463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65295094|NCT00520975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295095|NCT00520975|Growth Inhibitors|growth inhibitors|mesh-ancestor
65295096|NCT00520975|Immunologic Factors|immunologic factors|mesh-ancestor
65295097|NCT00614159|Ketamine|ketamine|mesh-list
65295098|NCT00614159|Propofol|propofol|mesh-list
65295099|NCT00614159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65295100|NCT00614159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65295101|NCT00614159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525329|NCT03169764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65118061|NCT00541463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65118062|NCT00541463|Antiviral Agents|antiviral agents|mesh-ancestor
65118063|NCT00541463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65118064|NCT02324985|Ibuprofen|ibuprofen|mesh-list
65118065|NCT02324985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65118066|NCT02324985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65118067|NCT02324985|Analgesics|analgesics|mesh-ancestor
65118068|NCT02324985|Sensory System Agents|sensory system agents|mesh-ancestor
65118069|NCT02324985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65118070|NCT02324985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118071|NCT02324985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65118072|NCT02324985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65118082|NCT04659642|Analgesics|analgesics|mesh-ancestor
65118083|NCT04659642|Sensory System Agents|sensory system agents|mesh-ancestor
65118084|NCT04659642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65118085|NCT04659642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65118086|NCT04659642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64760342|NCT00565266|Anticonvulsants|anticonvulsants|mesh-ancestor
65118087|NCT04659642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65118088|NCT04659642|Adrenergic Agents|adrenergic agents|mesh-ancestor
65118089|NCT04659642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65118090|NCT04659642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118091|NCT04659642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65118092|NCT04659642|Narcotics|narcotics|mesh-ancestor
65118093|NCT04659642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65118094|NCT04659642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65118095|NCT04659642|Anesthetics, General|anesthetics, general|mesh-ancestor
65118096|NCT04659642|Anesthetics|anesthetics|mesh-ancestor
65118097|NCT00541736|Nitroglycerin|nitroglycerin|mesh-list
65118098|NCT00541736|Vasodilator Agents|vasodilator agents|mesh-ancestor
65118099|NCT00541814|Cyclosporine|cyclosporine|mesh-list
65118100|NCT00541814|Cyclosporins|cyclosporins|mesh-list
65118101|NCT00541814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118102|NCT00541814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118103|NCT00541814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65118104|NCT00541814|Immunologic Factors|immunologic factors|mesh-ancestor
65118105|NCT00541814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118106|NCT00541814|Antifungal Agents|antifungal agents|mesh-ancestor
65118107|NCT00541814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65118108|NCT00541814|Dermatologic Agents|dermatologic agents|mesh-ancestor
65118109|NCT00541814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65118110|NCT00541814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65118111|NCT00541853|Candesartan|candesartan|mesh-list
65118112|NCT00541853|Candesartan cilexetil|candesartan cilexetil|mesh-list
65118113|NCT00541853|Cilnidipine|cilnidipine|mesh-list
65118114|NCT00541853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65118115|NCT00541853|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65118116|NCT00541853|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65118117|NCT00541853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118118|NCT00541853|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65118119|NCT00541853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65118120|NCT00541853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65118121|NCT00541853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118123|NCT02301234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65118124|NCT02301234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65118125|NCT02301234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65118126|NCT02301234|Analgesics|analgesics|mesh-ancestor
65295102|NCT00614159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65295103|NCT00614159|Anesthetics, General|anesthetics, general|mesh-ancestor
65295104|NCT00614159|Anesthetics|anesthetics|mesh-ancestor
65295105|NCT00614159|Analgesics|analgesics|mesh-ancestor
65295106|NCT00614159|Sensory System Agents|sensory system agents|mesh-ancestor
65295107|NCT00614159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65295108|NCT00614159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65295109|NCT00614159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65295110|NCT00614159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65295111|NCT00614159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65295112|NCT00614159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295113|NCT05042531|Azacitidine|azacitidine|mesh-list
65295114|NCT05042531|Dasatinib|dasatinib|mesh-list
65295115|NCT05042531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65295116|NCT05042531|Antimetabolites|antimetabolites|mesh-ancestor
64525337|NCT03169764|Antidotes|antidotes|mesh-ancestor
65118127|NCT02301234|Sensory System Agents|sensory system agents|mesh-ancestor
65118128|NCT02301234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65118129|NCT02301234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118130|NCT02301234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65118131|NCT02301234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65118132|NCT02301234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65118133|NCT02301234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65118134|NCT02301234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118135|NCT02301234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118136|NCT02301234|Immunologic Factors|immunologic factors|mesh-ancestor
65118147|NCT01214668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118148|NCT00542126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65118149|NCT00542126|Luteolytic Agents|luteolytic agents|mesh-ancestor
65118150|NCT00542126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65118151|NCT00542126|Contraceptive Agents|contraceptive agents|mesh-ancestor
65118152|NCT00542126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65118153|NCT00542126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118154|NCT00542126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65118155|NCT00542126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65118156|NCT00542126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118157|NCT00542165|Alfuzosin|alfuzosin|mesh-list
65118158|NCT00542165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65118159|NCT00542165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65118160|NCT00542165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65118161|NCT00542165|Adrenergic Agents|adrenergic agents|mesh-ancestor
65118162|NCT00542165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65118163|NCT00542165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118164|NCT00542165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118165|NCT00542165|Urological Agents|urological agents|mesh-ancestor
65118166|NCT00542243|Finasteride|finasteride|mesh-list
65118167|NCT00542243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65118168|NCT00542243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65118169|NCT00542243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118170|NCT00542243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118171|NCT00542243|Hormone Antagonists|hormone antagonists|mesh-ancestor
65118172|NCT00542243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65118173|NCT00542243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513920|NCT01893723|Analgesics|analgesics|mesh-ancestor
65118174|NCT00542243|Urological Agents|urological agents|mesh-ancestor
65118175|NCT00542399|Insulin Detemir|insulin detemir|mesh-list
65118176|NCT00542399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65295117|NCT05042531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295118|NCT05042531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295119|NCT05042531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295120|NCT05042531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65295121|NCT00851721|Factor VIII|factor viii|mesh-list
65295122|NCT00851721|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
65295123|NCT00851721|Coagulants|coagulants|mesh-ancestor
65295124|NCT04071119|Oxytocin|oxytocin|mesh-list
65295125|NCT04071119|Oxytocics|oxytocics|mesh-ancestor
64525351|NCT03874936|Autonomic Agents|autonomic agents|mesh-ancestor
64525356|NCT03874936|Hormones|hormones|mesh-ancestor
65118177|NCT00542399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118178|NCT00542555|Naproxen|naproxen|mesh-list
65118179|NCT00542555|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
65118180|NCT00542555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65118181|NCT00542555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65118182|NCT00542555|Analgesics|analgesics|mesh-ancestor
65118183|NCT00542555|Sensory System Agents|sensory system agents|mesh-ancestor
65118184|NCT00542555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65118185|NCT00542555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118186|NCT00542555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65118187|NCT00542555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65118188|NCT00542555|Gout Suppressants|gout suppressants|mesh-ancestor
65118189|NCT00542555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65118190|NCT00542555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118191|NCT00542555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118192|NCT00542555|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65118193|NCT00542711|Curcumin|curcumin|mesh-list
65118194|NCT00542711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65118195|NCT00542711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65118196|NCT00542711|Analgesics|analgesics|mesh-ancestor
65118197|NCT00542711|Sensory System Agents|sensory system agents|mesh-ancestor
65118198|NCT00542711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690514|NCT04184609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65118223|NCT00543023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118224|NCT00543023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65118225|NCT00543023|Vasodilator Agents|vasodilator agents|mesh-ancestor
65118227|NCT04648917|Antioxidants|antioxidants|mesh-ancestor
65118228|NCT04648917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118229|NCT04648917|Protective Agents|protective agents|mesh-ancestor
65118230|NCT04648917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118231|NCT00543179|Lanreotide|lanreotide|mesh-list
65118232|NCT00543179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118233|NCT00543218|Teriparatide|teriparatide|mesh-list
65118234|NCT00543218|Calcitonin|calcitonin|mesh-list
64760490|NCT05017194|Emodepside|emodepside|mesh-list
65118235|NCT00543218|Salmon calcitonin|salmon calcitonin|mesh-list
65118236|NCT00543218|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
65118238|NCT00543218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65118239|NCT00543218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118240|NCT00543218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65118241|NCT00543218|Vasodilator Agents|vasodilator agents|mesh-ancestor
65118242|NCT02252835|Colchicine|colchicine|mesh-list
65118243|NCT02252835|Febuxostat|febuxostat|mesh-list
65118244|NCT02252835|Gout Suppressants|gout suppressants|mesh-ancestor
65118245|NCT02252835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65118246|NCT02252835|Tubulin Modulators|tubulin modulators|mesh-ancestor
65118247|NCT02252835|Antimitotic Agents|antimitotic agents|mesh-ancestor
65118248|NCT02252835|Mitosis Modulators|mitosis modulators|mesh-ancestor
65118249|NCT02252835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118250|NCT02252835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118271|NCT03456713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65118272|NCT03456713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65118273|NCT03456713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65118274|NCT04648137|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65118275|NCT04648137|Hallucinogens|hallucinogens|mesh-ancestor
65295126|NCT04071119|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65295127|NCT04071119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295128|NCT02634476|Ethanol|ethanol|mesh-list
65295129|NCT02634476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65295130|NCT02634476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65295131|NCT02634476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65295132|NCT02634476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295133|NCT04385303|Lorecivivint|lorecivivint|mesh-list
65295134|NCT04385303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65295135|NCT00654602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65295136|NCT00654602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65295137|NCT00654602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65295138|NCT00654602|Antimetabolites|antimetabolites|mesh-ancestor
65295139|NCT00654602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295140|NCT00654602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65295141|NCT00654602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65295142|NCT00654602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295143|NCT00740194|Estradiol|estradiol|mesh-list
65295144|NCT00740194|Estrogens|estrogens|mesh-ancestor
65295145|NCT00740194|Hormones|hormones|mesh-ancestor
65295146|NCT00740194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65295147|NCT00740194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295148|NCT04159142|Paclitaxel|paclitaxel|mesh-list
64525359|NCT03874936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118276|NCT04648137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118277|NCT04648137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65118278|NCT04648137|Serotonin Agents|serotonin agents|mesh-ancestor
65118279|NCT04648137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65118280|NCT04648137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118281|NCT04648137|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65118282|NCT04648137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65118283|NCT04648137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65118284|NCT04648137|Adrenergic Agents|adrenergic agents|mesh-ancestor
65118285|NCT04648332|Bupivacaine|bupivacaine|mesh-list
65118286|NCT04648332|Anesthetics, Local|anesthetics, local|mesh-ancestor
65118287|NCT04648332|Anesthetics|anesthetics|mesh-ancestor
65118288|NCT04648332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65118289|NCT04648332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118290|NCT04648332|Sensory System Agents|sensory system agents|mesh-ancestor
65118291|NCT04648332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65118292|NCT00543335|Sorafenib|sorafenib|mesh-list
65118293|NCT00543335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118294|NCT00543335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65118295|NCT00543335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118296|NCT00543335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118297|NCT00543413|Enalapril|enalapril|mesh-list
65118298|NCT00543413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65118299|NCT00543413|Protease Inhibitors|protease inhibitors|mesh-ancestor
65118300|NCT00543413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222807|NCT04965493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295149|NCT04159142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65295150|NCT04159142|Carboplatin|carboplatin|mesh-list
65295151|NCT04159142|Capecitabine|capecitabine|mesh-list
65295152|NCT04159142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65295153|NCT04159142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295154|NCT04159142|Tubulin Modulators|tubulin modulators|mesh-ancestor
65295155|NCT04159142|Antimitotic Agents|antimitotic agents|mesh-ancestor
65295156|NCT04159142|Mitosis Modulators|mitosis modulators|mesh-ancestor
64525384|NCT02696850|Glucocorticoids|glucocorticoids|mesh-ancestor
65118301|NCT00543413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118302|NCT00543413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64690634|NCT05498389|Osimertinib|osimertinib|mesh-list
65118319|NCT00554775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65118320|NCT00554775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118321|NCT00554775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118322|NCT00543647|Fenofibrate|fenofibrate|mesh-list
65118323|NCT00543647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65118324|NCT00543647|Antimetabolites|antimetabolites|mesh-ancestor
65118325|NCT00543647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118326|NCT00543647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65118327|NCT04647669|Interferons|interferons|mesh-list
65118328|NCT04647669|Interferon-beta|interferon-beta|mesh-list
65118329|NCT04647669|Interferon beta-1a|interferon beta-1a|mesh-list
65118330|NCT04647669|Remdesivir|remdesivir|mesh-list
65118331|NCT04647669|Acalabrutinib|acalabrutinib|mesh-list
65118332|NCT04647669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118333|NCT04647669|Antiviral Agents|antiviral agents|mesh-ancestor
65118334|NCT04647669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65118335|NCT04647669|Immunologic Factors|immunologic factors|mesh-ancestor
65118336|NCT04647669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118337|NCT04647669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65118338|NCT04647669|Antimetabolites|antimetabolites|mesh-ancestor
65118339|NCT04647669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118340|NCT00543686|Fluticasone|fluticasone|mesh-list
65118341|NCT00543686|Montelukast|montelukast|mesh-list
65118342|NCT00543686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65118343|NCT00543686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65118344|NCT00543686|Autonomic Agents|autonomic agents|mesh-ancestor
65118345|NCT00543686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65118346|NCT00543686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118347|NCT00543686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65118348|NCT00543686|Respiratory System Agents|respiratory system agents|mesh-ancestor
65118349|NCT00543686|Dermatologic Agents|dermatologic agents|mesh-ancestor
65118350|NCT00543686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65118351|NCT00543686|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65118352|NCT00543686|Hormone Antagonists|hormone antagonists|mesh-ancestor
65118353|NCT00543686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65118354|NCT00543686|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65118355|NCT00543686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65118356|NCT00543686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118357|NCT00543842|Bevacizumab|bevacizumab|mesh-list
65118358|NCT00543842|Capecitabine|capecitabine|mesh-list
65118359|NCT00543842|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65118360|NCT00543842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65118361|NCT00543842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118362|NCT00543842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65118380|NCT04638816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65118381|NCT04638816|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65118382|NCT04638816|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65118383|NCT04638816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65118384|NCT04638816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118386|NCT04638816|Immunologic Factors|immunologic factors|mesh-ancestor
65118388|NCT04638816|Protective Agents|protective agents|mesh-ancestor
65118389|NCT00543959|Pioglitazone|pioglitazone|mesh-list
65118390|NCT00543959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65118391|NCT00543959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295157|NCT04159142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295158|NCT04159142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65295159|NCT04159142|Antimetabolites|antimetabolites|mesh-ancestor
65295160|NCT00654680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65295161|NCT00654680|Vasodilator Agents|vasodilator agents|mesh-ancestor
65295162|NCT00654680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65295164|NCT00654680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295165|NCT00654680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295166|NCT00654680|Urological Agents|urological agents|mesh-ancestor
65295167|NCT00520741|Lacosamide|lacosamide|mesh-list
65295168|NCT00520741|Anticonvulsants|anticonvulsants|mesh-ancestor
65295169|NCT00520741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65295170|NCT00520741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65295171|NCT00520741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65295172|NCT00520741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295173|NCT03682289|Durvalumab|durvalumab|mesh-list
65295174|NCT03682289|Olaparib|olaparib|mesh-list
65295175|NCT03682289|Adenosine|adenosine|mesh-list
65295176|NCT03682289|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65295177|NCT03682289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65295178|NCT03682289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295179|NCT03682289|Immunologic Factors|immunologic factors|mesh-ancestor
65295180|NCT03682289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295181|NCT03682289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65295182|NCT03682289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118392|NCT00544037|Interferons|interferons|mesh-list
65118393|NCT00544037|Interferon-beta|interferon-beta|mesh-list
65118394|NCT00544037|Interferon beta-1b|interferon beta-1b|mesh-list
65118395|NCT00544037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118396|NCT00544037|Antiviral Agents|antiviral agents|mesh-ancestor
65118397|NCT00544037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65118398|NCT00544037|Immunologic Factors|immunologic factors|mesh-ancestor
65118399|NCT00544037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118400|NCT00544037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65118401|NCT00544154|Certolizumab Pegol|certolizumab pegol|mesh-list
65118402|NCT00544154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65118403|NCT00544154|Immunologic Factors|immunologic factors|mesh-ancestor
65118404|NCT00544154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118405|NCT00544154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65118407|NCT04638582|Carboplatin|carboplatin|mesh-list
65118408|NCT04638582|Pembrolizumab|pembrolizumab|mesh-list
65118409|NCT04638582|Pemetrexed|pemetrexed|mesh-list
65118410|NCT04638582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65118411|NCT04638582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118412|NCT04638582|Tubulin Modulators|tubulin modulators|mesh-ancestor
65118413|NCT04638582|Antimitotic Agents|antimitotic agents|mesh-ancestor
65118414|NCT04638582|Mitosis Modulators|mitosis modulators|mesh-ancestor
65118415|NCT04638582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118416|NCT04638582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65295183|NCT03682289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295184|NCT03682289|Analgesics|analgesics|mesh-ancestor
65295185|NCT03682289|Sensory System Agents|sensory system agents|mesh-ancestor
65295186|NCT03682289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65295187|NCT03682289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65295188|NCT03682289|Vasodilator Agents|vasodilator agents|mesh-ancestor
65295189|NCT03682289|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64525416|NCT02601976|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64525417|NCT02601976|Antimetabolites|antimetabolites|mesh-ancestor
65118417|NCT04638582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118418|NCT04638582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65118419|NCT04638582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65118420|NCT00544193|Gemcitabine|gemcitabine|mesh-list
64690760|NCT05688475|Hormones|hormones|mesh-ancestor
65118428|NCT00544193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65118429|NCT00544193|Immunologic Factors|immunologic factors|mesh-ancestor
65118430|NCT00544193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118431|NCT00544232|Paclitaxel|paclitaxel|mesh-list
65118432|NCT00544232|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65118433|NCT00544232|Cyclophosphamide|cyclophosphamide|mesh-list
65118434|NCT00544232|Methotrexate|methotrexate|mesh-list
65118435|NCT00544232|Epirubicin|epirubicin|mesh-list
65118436|NCT00544232|Darbepoetin alfa|darbepoetin alfa|mesh-list
65118437|NCT00544232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65118438|NCT00544232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118439|NCT00544232|Tubulin Modulators|tubulin modulators|mesh-ancestor
65118440|NCT00544232|Antimitotic Agents|antimitotic agents|mesh-ancestor
65118441|NCT00544232|Mitosis Modulators|mitosis modulators|mesh-ancestor
65118442|NCT00544232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118443|NCT00544232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65118444|NCT00544232|Immunologic Factors|immunologic factors|mesh-ancestor
65118445|NCT00544232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118446|NCT00544232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65118447|NCT00544232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65118448|NCT00544232|Alkylating Agents|alkylating agents|mesh-ancestor
65118449|NCT00544232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65118450|NCT00544232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65118451|NCT00544232|Abortifacient Agents|abortifacient agents|mesh-ancestor
65118452|NCT00544232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65118453|NCT00544232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65118454|NCT00544232|Antimetabolites|antimetabolites|mesh-ancestor
65118455|NCT00544232|Dermatologic Agents|dermatologic agents|mesh-ancestor
65118456|NCT00544232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118457|NCT00544232|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64760725|NCT00609804|Sorafenib|sorafenib|mesh-list
65118458|NCT00544232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65118459|NCT00544232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65118460|NCT00544232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65118461|NCT00544232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65118462|NCT00544232|Hematinics|hematinics|mesh-ancestor
65118463|NCT01191268|Insulin|insulin|mesh-list
65118464|NCT01191268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65118465|NCT01191268|Insulin Glargine|insulin glargine|mesh-list
65118466|NCT01191268|Insulin Lispro|insulin lispro|mesh-list
65118467|NCT01191268|Dulaglutide|dulaglutide|mesh-list
65118468|NCT01191268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65118469|NCT01191268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118470|NCT04647552|Hydrocortisone|hydrocortisone|mesh-list
64513925|NCT02675829|Trastuzumab|trastuzumab|mesh-list
65118471|NCT04647552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65118472|NCT00544349|Leucovorin|leucovorin|mesh-list
65118473|NCT00544349|Fluorouracil|fluorouracil|mesh-list
65118474|NCT00544349|Oxaliplatin|oxaliplatin|mesh-list
65118475|NCT00544349|Cetuximab|cetuximab|mesh-list
65118476|NCT00544349|Calcium|calcium|mesh-list
65118477|NCT00544349|Levoleucovorin|levoleucovorin|mesh-list
65118478|NCT00544349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65118479|NCT00544349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118480|NCT00544349|Antimetabolites|antimetabolites|mesh-ancestor
65295190|NCT03682289|Purinergic Agonists|purinergic agonists|mesh-ancestor
65295191|NCT03682289|Purinergic Agents|purinergic agents|mesh-ancestor
65295192|NCT03682289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65295193|NCT00729118|Lenalidomide|lenalidomide|mesh-list
65295194|NCT00729118|Vorinostat|vorinostat|mesh-list
65295195|NCT00729118|Immunologic Factors|immunologic factors|mesh-ancestor
65295196|NCT00729118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295197|NCT00729118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65295198|NCT00729118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65295199|NCT00729118|Growth Substances|growth substances|mesh-ancestor
65295200|NCT00729118|Growth Inhibitors|growth inhibitors|mesh-ancestor
65295201|NCT00729118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295202|NCT00729118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65295203|NCT00729118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295204|NCT00729118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295205|NCT04064632|Darunavir|darunavir|mesh-list
65295206|NCT04064632|Cobicistat|cobicistat|mesh-list
65295207|NCT04064632|Rilpivirine|rilpivirine|mesh-list
65295208|NCT04064632|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
65295209|NCT04064632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65118481|NCT00544349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118482|NCT00544349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65118483|NCT00544349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118484|NCT00544349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65118485|NCT00544349|Immunologic Factors|immunologic factors|mesh-ancestor
65118486|NCT00544349|Antidotes|antidotes|mesh-ancestor
65118487|NCT00544349|Protective Agents|protective agents|mesh-ancestor
65118488|NCT00544349|Vitamin B Complex|vitamin b complex|mesh-ancestor
65118489|NCT00544349|Vitamins|vitamins|mesh-ancestor
65118500|NCT00544388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118501|NCT00544388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118502|NCT00544505|Cyclophosphamide|cyclophosphamide|mesh-list
65118504|NCT00544505|Epirubicin|epirubicin|mesh-list
65118505|NCT00544505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65118506|NCT00544505|Immunologic Factors|immunologic factors|mesh-ancestor
65118507|NCT00544505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118508|NCT00544505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65118509|NCT00544505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65118510|NCT00544505|Alkylating Agents|alkylating agents|mesh-ancestor
65118511|NCT00544505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118512|NCT00544505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118513|NCT00544505|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65118514|NCT00544505|Antimetabolites|antimetabolites|mesh-ancestor
65118515|NCT00544505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65118516|NCT00544505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65118517|NCT00544505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65118518|NCT00544505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65118519|NCT00544505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118520|NCT00544700|Bevacizumab|bevacizumab|mesh-list
65118521|NCT00544700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65118522|NCT00544700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118523|NCT00544700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65118524|NCT00544700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65118525|NCT00544700|Growth Substances|growth substances|mesh-ancestor
65118526|NCT00544700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118527|NCT00544700|Growth Inhibitors|growth inhibitors|mesh-ancestor
65295210|NCT04064632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65295211|NCT04064632|Protease Inhibitors|protease inhibitors|mesh-ancestor
65295212|NCT04064632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295213|NCT04064632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295214|NCT04064632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65295215|NCT04064632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65295216|NCT04064632|Antiviral Agents|antiviral agents|mesh-ancestor
65295217|NCT04064632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65295218|NCT04064632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65295219|NCT04064632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65295220|NCT04064632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65295221|NCT04064632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65295222|NCT00882518|Chlorpromazine|chlorpromazine|mesh-list
65295223|NCT00882518|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65295224|NCT00882518|Antidepressive Agents|antidepressive agents|mesh-ancestor
65295225|NCT00882518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64525443|NCT02395926|Choline|choline|mesh-list
65118528|NCT05824559|Bevacizumab|bevacizumab|mesh-list
65118529|NCT05824559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65118530|NCT05824559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118531|NCT05824559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65118532|NCT05824559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65118533|NCT05824559|Growth Substances|growth substances|mesh-ancestor
65118534|NCT05824559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118535|NCT05824559|Growth Inhibitors|growth inhibitors|mesh-ancestor
65118536|NCT05824494|Paclitaxel|paclitaxel|mesh-list
65118537|NCT05824494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65118538|NCT05824494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118539|NCT05824494|Tubulin Modulators|tubulin modulators|mesh-ancestor
65118540|NCT05824494|Antimitotic Agents|antimitotic agents|mesh-ancestor
65118541|NCT05824494|Mitosis Modulators|mitosis modulators|mesh-ancestor
65118542|NCT05824494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118543|NCT05824481|Lenvatinib|lenvatinib|mesh-list
65118544|NCT05824481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118545|NCT05824481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65118546|NCT05824481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118547|NCT05824481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118548|NCT05824468|Lenvatinib|lenvatinib|mesh-list
65118549|NCT05824468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118550|NCT05824468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65118551|NCT05824468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118552|NCT05824468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118553|NCT05824455|Irinotecan|irinotecan|mesh-list
65118558|NCT05824455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118559|NCT05824390|Rituximab|rituximab|mesh-list
65118560|NCT05824390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65118561|NCT05824390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118562|NCT05824390|Immunologic Factors|immunologic factors|mesh-ancestor
65118563|NCT05824390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118564|NCT05824390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65118565|NCT05824351|Propolis|propolis|mesh-list
65118566|NCT05824351|Pycnogenols|pycnogenols|mesh-list
65118567|NCT05824351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65118568|NCT05824351|Immunologic Factors|immunologic factors|mesh-ancestor
65118569|NCT05824351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118570|NCT05824351|Antioxidants|antioxidants|mesh-ancestor
65118571|NCT05824351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295226|NCT00882518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65295227|NCT00882518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65295228|NCT00882518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65295229|NCT00882518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295230|NCT00882518|Antiemetics|antiemetics|mesh-ancestor
65295231|NCT00882518|Autonomic Agents|autonomic agents|mesh-ancestor
65295232|NCT00882518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65295233|NCT00882518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65295234|NCT00882518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65295235|NCT00882518|Dopamine Agents|dopamine agents|mesh-ancestor
65295236|NCT00882518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65295237|NCT00882518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295239|NCT00882362|Antidepressive Agents|antidepressive agents|mesh-ancestor
65295240|NCT00882362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65295241|NCT00882362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65295242|NCT00882362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65295243|NCT00882362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64525459|NCT02402868|Anesthetics|anesthetics|mesh-ancestor
65118572|NCT05824351|Protective Agents|protective agents|mesh-ancestor
65118573|NCT05824351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65118574|NCT05824351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65118575|NCT05824338|Bupivacaine|bupivacaine|mesh-list
65118576|NCT05824338|Ropivacaine|ropivacaine|mesh-list
65118577|NCT05824338|Anesthetics|anesthetics|mesh-list
65118578|NCT05824338|Anesthetics, Local|anesthetics, local|mesh-ancestor
65118579|NCT05824338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65118580|NCT05824338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118581|NCT05824338|Sensory System Agents|sensory system agents|mesh-ancestor
65118582|NCT05824338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65118583|NCT05824156|Streptococcal polysaccharide type III group B|streptococcal polysaccharide type iii group b|mesh-list
65118584|NCT05824156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118585|NCT05824143|Carbamazepine|carbamazepine|mesh-list
65118586|NCT05824143|Anticonvulsants|anticonvulsants|mesh-ancestor
65118587|NCT05824143|Antimanic Agents|antimanic agents|mesh-ancestor
65118588|NCT05824143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65118589|NCT05824143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65118590|NCT05824143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118591|NCT05824143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65118592|NCT05824143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65118593|NCT05824143|Analgesics|analgesics|mesh-ancestor
65118594|NCT05824143|Sensory System Agents|sensory system agents|mesh-ancestor
65118595|NCT05824143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65118596|NCT05824143|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65118597|NCT05824143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65118598|NCT05824143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118599|NCT05824143|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65118600|NCT05824143|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65118601|NCT05824000|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65118602|NCT05824000|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65118603|NCT05823987|Lenvatinib|lenvatinib|mesh-list
65118604|NCT05823987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118605|NCT05823987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65118606|NCT05823987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118607|NCT05823987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118608|NCT05823961|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65118609|NCT05823961|Hyaluronic Acid|hyaluronic acid|mesh-list
65295244|NCT00882362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295245|NCT00882362|Dopamine Agonists|dopamine agonists|mesh-ancestor
65295246|NCT00882362|Dopamine Agents|dopamine agents|mesh-ancestor
65295247|NCT00882362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65295248|NCT00882362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295249|NCT00882362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65118610|NCT05823961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65118611|NCT05823961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65118612|NCT05823961|Immunologic Factors|immunologic factors|mesh-ancestor
65118613|NCT05823961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118614|NCT05823961|Viscosupplements|viscosupplements|mesh-ancestor
65118615|NCT05823961|Protective Agents|protective agents|mesh-ancestor
65118619|NCT05823883|Metformin|metformin|mesh-list
65118620|NCT05823883|Empagliflozin|empagliflozin|mesh-list
65118621|NCT05823883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65118622|NCT05823883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118623|NCT05823883|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65118624|NCT05823883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118625|NCT05823870|Metformin|metformin|mesh-list
65118626|NCT05823870|Empagliflozin|empagliflozin|mesh-list
65118636|NCT05823701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118637|NCT05823701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118638|NCT05823701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118639|NCT05823701|Analgesics|analgesics|mesh-ancestor
65118640|NCT05823701|Sensory System Agents|sensory system agents|mesh-ancestor
65118641|NCT05823701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65118642|NCT05823701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118643|NCT05823701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65118644|NCT05823701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65118645|NCT05823701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65118646|NCT05823675|Methylprednisolone|methylprednisolone|mesh-list
65118647|NCT05823675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65118648|NCT05823675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65118649|NCT05823675|Prednisolone|prednisolone|mesh-list
65118650|NCT05823675|Prednisolone acetate|prednisolone acetate|mesh-list
65118651|NCT05823675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65118652|NCT05823675|Prednisolone phosphate|prednisolone phosphate|mesh-list
65118653|NCT05823675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65118654|NCT05823675|Antiemetics|antiemetics|mesh-ancestor
65118655|NCT05823675|Autonomic Agents|autonomic agents|mesh-ancestor
65118656|NCT05823675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65118657|NCT05823675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118658|NCT05823675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65118659|NCT05823675|Glucocorticoids|glucocorticoids|mesh-ancestor
65118660|NCT05823675|Hormones|hormones|mesh-ancestor
65118661|NCT05823675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65118662|NCT05823675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65118663|NCT05823675|Protective Agents|protective agents|mesh-ancestor
65118664|NCT05823675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65118665|NCT05823675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118666|NCT05823623|Vinorelbine|vinorelbine|mesh-list
65118667|NCT05823623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65118668|NCT05823623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118669|NCT05823623|Tubulin Modulators|tubulin modulators|mesh-ancestor
65118670|NCT05823623|Antimitotic Agents|antimitotic agents|mesh-ancestor
65118671|NCT05823623|Mitosis Modulators|mitosis modulators|mesh-ancestor
65118672|NCT05823623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118673|NCT05823532|Infliximab|infliximab|mesh-list
65118674|NCT05823532|Dermatologic Agents|dermatologic agents|mesh-ancestor
65118675|NCT05823532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65118676|NCT05823532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65118677|NCT05823506|Tadalafil|tadalafil|mesh-list
65118678|NCT05823506|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
65118679|NCT05823506|Vasodilator Agents|vasodilator agents|mesh-ancestor
65118680|NCT05823506|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65118681|NCT05823506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118682|NCT05823506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513935|NCT02669901|Naloxone|naloxone|mesh-list
65295250|NCT00882362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65295251|NCT00882362|Serotonin Agents|serotonin agents|mesh-ancestor
65295252|NCT00882362|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65295253|NCT00882362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65295254|NCT00882362|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65295255|NCT00882362|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65295256|NCT00529243|Raltegravir Potassium|raltegravir potassium|mesh-list
65295257|NCT00529243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65295258|NCT00529243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64525482|NCT02395458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65118683|NCT05823506|Urological Agents|urological agents|mesh-ancestor
64760943|NCT00617058|Metformin|metformin|mesh-list
65118684|NCT05823480|Azacitidine|azacitidine|mesh-list
65118685|NCT05823480|Magrolimab|magrolimab|mesh-list
65118686|NCT05823480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65118687|NCT05823480|Antimetabolites|antimetabolites|mesh-ancestor
65118688|NCT05823480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118689|NCT05823480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118690|NCT05823480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118721|NCT05823311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65118722|NCT05823311|Antimetabolites|antimetabolites|mesh-ancestor
65118723|NCT05823311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118724|NCT05823311|Antiviral Agents|antiviral agents|mesh-ancestor
65118725|NCT05823311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65118726|NCT05823311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118727|NCT05823311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65118728|NCT05823311|Immunologic Factors|immunologic factors|mesh-ancestor
65118729|NCT05823311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118730|NCT05823311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65118731|NCT05823168|Anticonvulsants|anticonvulsants|mesh-list
65118732|NCT05823155|Penicillins|penicillins|mesh-list
65118733|NCT05823155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65118734|NCT05823155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65118735|NCT05823116|Vancomycin|vancomycin|mesh-list
65118736|NCT05823116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65118737|NCT05823116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65118749|NCT05822817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65118750|NCT05822817|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65118751|NCT05822765|Epinephrine|epinephrine|mesh-list
65118752|NCT05822765|Racepinephrine|racepinephrine|mesh-list
65118753|NCT05822765|Epinephryl borate|epinephryl borate|mesh-list
65118754|NCT05822765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65118755|NCT05822765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65118756|NCT05822765|Adrenergic Agents|adrenergic agents|mesh-ancestor
65118757|NCT05822765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65118758|NCT05822765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118759|NCT05822765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118760|NCT05822765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65118761|NCT05822765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65118762|NCT05822765|Autonomic Agents|autonomic agents|mesh-ancestor
65118763|NCT05822765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65118764|NCT05822765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65118765|NCT05822765|Respiratory System Agents|respiratory system agents|mesh-ancestor
65118766|NCT05822765|Mydriatics|mydriatics|mesh-ancestor
65118767|NCT05822765|Sympathomimetics|sympathomimetics|mesh-ancestor
65118768|NCT05822765|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65118770|NCT05822752|Lenvatinib|lenvatinib|mesh-list
65118771|NCT05822752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118772|NCT05822752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65118773|NCT05822752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118774|NCT05822752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118775|NCT05822713|Amisulpride|amisulpride|mesh-list
65118776|NCT05822713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65118777|NCT05822713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65118778|NCT05822713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65118779|NCT05822713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295259|NCT00529243|Antiviral Agents|antiviral agents|mesh-ancestor
65295260|NCT00529243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65295261|NCT00529243|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65295262|NCT00529243|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65295263|NCT00529243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295264|NCT00529243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295265|NCT00636935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65118780|NCT05822713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65118781|NCT05822713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65118782|NCT05822713|Dopamine Agents|dopamine agents|mesh-ancestor
65118783|NCT05822713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65118784|NCT05822713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118785|NCT05822713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65118786|NCT05822713|Antidepressive Agents|antidepressive agents|mesh-ancestor
65118787|NCT05822674|Metformin|metformin|mesh-list
65118788|NCT05822674|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65118789|NCT05822674|Empagliflozin|empagliflozin|mesh-list
65118790|NCT05822674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65118791|NCT05822674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118792|NCT05822674|Incretins|incretins|mesh-ancestor
65118793|NCT05822674|Hormones|hormones|mesh-ancestor
65118794|NCT05822674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65118795|NCT05822674|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65118796|NCT05822674|Protease Inhibitors|protease inhibitors|mesh-ancestor
65118797|NCT05822674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118798|NCT05822674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118799|NCT05822674|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65118800|NCT05822583|Abatacept|abatacept|mesh-list
65118801|NCT05822583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64691123|NCT04535401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118818|NCT05817474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65118819|NCT05817474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65118820|NCT05817474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65118821|NCT05817474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118822|NCT05817474|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65118823|NCT05817474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65118825|NCT05817474|Coagulants|coagulants|mesh-ancestor
65118826|NCT05814042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65118827|NCT05797090|Cardioplegic Solutions|cardioplegic solutions|mesh-list
65118828|NCT05797090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65118829|NCT05794503|Neostigmine|neostigmine|mesh-list
65118830|NCT05794503|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65118831|NCT05794503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118832|NCT05794503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118833|NCT05794503|Cholinergic Agents|cholinergic agents|mesh-ancestor
65118834|NCT05794503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65118835|NCT05794503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118836|NCT05794503|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65118837|NCT05794503|Autonomic Agents|autonomic agents|mesh-ancestor
65118838|NCT05794503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65118839|NCT05789082|Pembrolizumab|pembrolizumab|mesh-list
65118840|NCT05789082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65118841|NCT05789082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118842|NCT05784012|Niraparib|niraparib|mesh-list
65118843|NCT05784012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118844|NCT05784012|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65118845|NCT05784012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118846|NCT05784012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118847|NCT05780567|Tamoxifen|tamoxifen|mesh-list
65118848|NCT05780567|Letrozole|letrozole|mesh-list
65118849|NCT05780567|Anastrozole|anastrozole|mesh-list
65118850|NCT05780567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118851|NCT05780567|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65118852|NCT05780567|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65118853|NCT05780567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118854|NCT05780567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295266|NCT00636935|Clindamycin|clindamycin|mesh-list
65295267|NCT00636935|Clindamycin palmitate|clindamycin palmitate|mesh-list
65295268|NCT00636935|Clindamycin phosphate|clindamycin phosphate|mesh-list
65295269|NCT00636935|Dapsone|dapsone|mesh-list
65295270|NCT00636935|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65295271|NCT00636935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65295272|NCT00636935|Primaquine|primaquine|mesh-list
65295273|NCT00636935|Trimethoprim|trimethoprim|mesh-list
65295274|NCT00636935|Atovaquone|atovaquone|mesh-list
65295275|NCT00636935|Pentamidine|pentamidine|mesh-list
65295276|NCT00636935|Prednisone|prednisone|mesh-list
65295277|NCT00636935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65295278|NCT00636935|Glucocorticoids|glucocorticoids|mesh-ancestor
65295279|NCT00636935|Hormones|hormones|mesh-ancestor
65295280|NCT00636935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65295281|NCT00636935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295282|NCT00636935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65295283|NCT00636935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295284|NCT00636935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65295285|NCT00636935|Antitubercular Agents|antitubercular agents|mesh-ancestor
65295286|NCT00636935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65295287|NCT00636935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295288|NCT00636935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295289|NCT00636935|Antimalarials|antimalarials|mesh-ancestor
65295290|NCT00636935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65295291|NCT00636935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65295292|NCT00636935|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65295293|NCT00636935|Renal Agents|renal agents|mesh-ancestor
65295294|NCT00636935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65295295|NCT00636935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65295296|NCT00636935|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65295297|NCT00636935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65295298|NCT00636935|Leprostatic Agents|leprostatic agents|mesh-ancestor
65295299|NCT00636935|Antifungal Agents|antifungal agents|mesh-ancestor
65118855|NCT05780567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65118856|NCT05780567|Hormone Antagonists|hormone antagonists|mesh-ancestor
65118857|NCT05780567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64691190|NCT04365049|Paclitaxel|paclitaxel|mesh-list
65118875|NCT05767359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65118876|NCT05767359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65118877|NCT05767359|Alkylating Agents|alkylating agents|mesh-ancestor
65295300|NCT00636935|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65295301|NCT00654758|Paclitaxel|paclitaxel|mesh-list
65295302|NCT00654758|Carboplatin|carboplatin|mesh-list
65295303|NCT00654758|Volociximab|volociximab|mesh-list
65295304|NCT00654758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65295305|NCT00654758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65295306|NCT00654758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295307|NCT00654758|Tubulin Modulators|tubulin modulators|mesh-ancestor
65295308|NCT00654758|Antimitotic Agents|antimitotic agents|mesh-ancestor
65295309|NCT00654758|Mitosis Modulators|mitosis modulators|mesh-ancestor
65295310|NCT00654758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295311|NCT00654758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65295312|NCT00654758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64525529|NCT02616250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65118878|NCT05767359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118879|NCT05767359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118880|NCT05767359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65118881|NCT05767359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65118882|NCT05767359|Antimetabolites|antimetabolites|mesh-ancestor
65118883|NCT05756972|Carboplatin|carboplatin|mesh-list
65118884|NCT05756972|Pemetrexed|pemetrexed|mesh-list
65118885|NCT05756972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118886|NCT05756972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118887|NCT05756972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118888|NCT05756972|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65118889|NCT05756972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65118890|NCT05751629|Bevacizumab|bevacizumab|mesh-list
65118891|NCT05751629|Niraparib|niraparib|mesh-list
65118892|NCT05751629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65118893|NCT05751629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118894|NCT05751629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65118895|NCT05751629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65118896|NCT05751629|Growth Substances|growth substances|mesh-ancestor
65118897|NCT05751629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118898|NCT05751629|Growth Inhibitors|growth inhibitors|mesh-ancestor
65118899|NCT05751629|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65118900|NCT05751629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64513940|NCT01893099|Sorafenib|sorafenib|mesh-list
65118901|NCT05751629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118902|NCT05746273|Nicotine|nicotine|mesh-list
65118903|NCT05746273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65118904|NCT05746273|Autonomic Agents|autonomic agents|mesh-ancestor
65118905|NCT05746273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65118906|NCT05746273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118907|NCT05746273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64761170|NCT05766371|177Lu-PSMA-617|177lu-psma-617|mesh-list
65118908|NCT05746273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65118909|NCT05746273|Cholinergic Agents|cholinergic agents|mesh-ancestor
65118910|NCT05746273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65118911|NCT05746273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118920|NCT05728294|Anesthetics|anesthetics|mesh-ancestor
65118921|NCT05728294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65118922|NCT05728294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118923|NCT05728294|Sensory System Agents|sensory system agents|mesh-ancestor
65118924|NCT05728294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65118925|NCT05726916|Eculizumab|eculizumab|mesh-list
65118926|NCT05726916|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65118927|NCT05726916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65118928|NCT05726916|Immunologic Factors|immunologic factors|mesh-ancestor
65118929|NCT05726916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118930|NCT05714059|Insulin|insulin|mesh-list
65295313|NCT00654758|Growth Substances|growth substances|mesh-ancestor
65295314|NCT00654758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295315|NCT00654758|Growth Inhibitors|growth inhibitors|mesh-ancestor
65295316|NCT00654758|Immunologic Factors|immunologic factors|mesh-ancestor
65295317|NCT00656864|Pioglitazone|pioglitazone|mesh-list
65295318|NCT00656864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65295319|NCT00656864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295320|NCT00658268|Clodronic Acid|clodronic acid|mesh-list
65295321|NCT00658268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65295322|NCT00658268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295323|NCT00613613|Fenofibrate|fenofibrate|mesh-list
65295324|NCT00613613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65295325|NCT00613613|Antimetabolites|antimetabolites|mesh-ancestor
65295326|NCT00613613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295327|NCT00613613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65295328|NCT04298099|Ropivacaine|ropivacaine|mesh-list
65295329|NCT04298099|Anesthetics, Local|anesthetics, local|mesh-ancestor
65295330|NCT04298099|Anesthetics|anesthetics|mesh-ancestor
65295331|NCT04298099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65118931|NCT05714059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65118932|NCT05714059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118933|NCT05712278|Cytarabine|cytarabine|mesh-list
65118934|NCT05712278|Fludarabine|fludarabine|mesh-list
65118935|NCT05712278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118936|NCT05712278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65118937|NCT05712278|Antimetabolites|antimetabolites|mesh-ancestor
65118938|NCT05712278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118939|NCT05712278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65118940|NCT05712278|Immunologic Factors|immunologic factors|mesh-ancestor
65118941|NCT05712278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118942|NCT05712278|Antiviral Agents|antiviral agents|mesh-ancestor
65118943|NCT05712278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65118944|NCT05709977|Histamine Antagonists|histamine antagonists|mesh-list
65118945|NCT05709977|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
65118946|NCT05709977|Histamine Agents|histamine agents|mesh-ancestor
65118947|NCT05709977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65118948|NCT05709977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118949|NCT05709977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118950|NCT05705349|Islatravir|islatravir|mesh-list
65118951|NCT05705349|Antiviral Agents|antiviral agents|mesh-ancestor
65118952|NCT05705349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65118953|NCT05705349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118954|NCT05705349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118955|NCT05705349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65118956|NCT05705349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65118957|NCT05705349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65118958|NCT05704829|Trastuzumab|trastuzumab|mesh-list
65118959|NCT05704829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65118960|NCT05704829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118961|NCT05698095|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
65118962|NCT05698095|Hallucinogens|hallucinogens|mesh-ancestor
65118963|NCT05698095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118964|NCT05698095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65118965|NCT05698095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65118966|NCT05698095|Serotonin Agents|serotonin agents|mesh-ancestor
65118967|NCT05698095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65222808|NCT04965493|Immunologic Factors|immunologic factors|mesh-ancestor
65295332|NCT04298099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295333|NCT04298099|Sensory System Agents|sensory system agents|mesh-ancestor
65295334|NCT04298099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65295335|NCT02613195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65295336|NCT00850395|Maraviroc|maraviroc|mesh-list
65295337|NCT00850395|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65295338|NCT00850395|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65295339|NCT00850395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295340|NCT00850395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64525559|NCT05731258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525560|NCT04340908|Dapagliflozin|dapagliflozin|mesh-list
64525563|NCT04340908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65118968|NCT05698095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118969|NCT05698095|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65118973|NCT05686044|Phenserine|phenserine|mesh-list
65118974|NCT05686044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65118975|NCT05686044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118976|NCT05686044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118977|NCT05686044|Cholinergic Agents|cholinergic agents|mesh-ancestor
65118978|NCT05686044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65118979|NCT05686044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118980|NCT05685004|Temozolomide|temozolomide|mesh-list
64691303|NCT01987219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65118993|NCT05684276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118994|NCT05684276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65118995|NCT05684276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65118996|NCT05681572|Midazolam|midazolam|mesh-list
65118997|NCT05681572|Dexmedetomidine|dexmedetomidine|mesh-list
65118998|NCT05681572|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65118999|NCT05681572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65119000|NCT05681572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119001|NCT05681572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65119002|NCT05681572|Analgesics|analgesics|mesh-ancestor
65119003|NCT05681572|Sensory System Agents|sensory system agents|mesh-ancestor
65119004|NCT05681572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65119005|NCT05681572|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65119006|NCT05681572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65119007|NCT05681572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65119008|NCT05681572|Adrenergic Agents|adrenergic agents|mesh-ancestor
65119009|NCT05681572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65119010|NCT05681572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119011|NCT05681572|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65119012|NCT05681572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65119013|NCT05681572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65119014|NCT05681572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65119015|NCT05681572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65119016|NCT05681572|Anesthetics, General|anesthetics, general|mesh-ancestor
65119017|NCT05681572|Anesthetics|anesthetics|mesh-ancestor
65119018|NCT05681572|GABA Modulators|gaba modulators|mesh-ancestor
65119019|NCT05681572|GABA Agents|gaba agents|mesh-ancestor
65119020|NCT05671757|Daratumumab|daratumumab|mesh-list
65119021|NCT05671757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65119022|NCT05671757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119023|NCT05671757|Immunologic Factors|immunologic factors|mesh-ancestor
65119024|NCT05671757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119025|NCT05656664|Folic Acid|folic acid|mesh-list
65119026|NCT05656664|Hematinics|hematinics|mesh-ancestor
65119027|NCT05656664|Vitamin B Complex|vitamin b complex|mesh-ancestor
65119028|NCT05656664|Vitamins|vitamins|mesh-ancestor
65119029|NCT05656664|Micronutrients|micronutrients|mesh-ancestor
65119030|NCT05656664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119041|NCT05631093|Islatravir|islatravir|mesh-list
65295341|NCT00850395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65295342|NCT00850395|Antiviral Agents|antiviral agents|mesh-ancestor
65295343|NCT00850395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65295344|NCT00850395|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65295345|NCT04188431|Dexamethasone|dexamethasone|mesh-list
65295346|NCT04188431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65295347|NCT04188431|Antiemetics|antiemetics|mesh-ancestor
65295348|NCT04188431|Autonomic Agents|autonomic agents|mesh-ancestor
65295349|NCT04188431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65295350|NCT04188431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525568|NCT05730634|Antimetabolites|antimetabolites|mesh-ancestor
64525570|NCT05730634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65119042|NCT05631093|Antiviral Agents|antiviral agents|mesh-ancestor
65119043|NCT05631093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65119044|NCT05631093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119045|NCT05631093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119046|NCT05631093|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65119047|NCT05631093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65119048|NCT05631093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65119049|NCT05630755|Islatravir|islatravir|mesh-list
65119050|NCT05630755|Antiviral Agents|antiviral agents|mesh-ancestor
65119051|NCT05630755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65119052|NCT05630755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119053|NCT05630755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416666|NCT03040765|Denosumab|denosumab|mesh-list
65119066|NCT05608252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119067|NCT05608252|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65119068|NCT05608252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65119069|NCT05608252|Hormone Antagonists|hormone antagonists|mesh-ancestor
65119070|NCT05608252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65119071|NCT05608252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119072|NCT05601973|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
65119073|NCT05601973|Lazertinib|lazertinib|mesh-list
65119074|NCT05601973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65119075|NCT05601973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119076|NCT05601973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119077|NCT05601973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65119078|NCT05601973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119079|NCT05585398|Botulinum Toxins|botulinum toxins|mesh-list
65119080|NCT05585398|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65119081|NCT05585398|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65119082|NCT05585398|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65119083|NCT05585398|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65119084|NCT05585398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65119085|NCT05585398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119086|NCT05585398|Cholinergic Agents|cholinergic agents|mesh-ancestor
65119087|NCT05585398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65119088|NCT05585398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119089|NCT05585398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65119090|NCT05585398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65119091|NCT05567406|Belumosudil|belumosudil|mesh-list
65119092|NCT05567406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65119093|NCT05567406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119094|NCT05567406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119095|NCT05564221|Omalizumab|omalizumab|mesh-list
65119096|NCT05564221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65119097|NCT05564221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65119098|NCT05564221|Respiratory System Agents|respiratory system agents|mesh-ancestor
65119099|NCT05557877|Aspirin|aspirin|mesh-list
65119100|NCT05557877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65119101|NCT05557877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65119102|NCT05557877|Analgesics|analgesics|mesh-ancestor
65295351|NCT04188431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65295352|NCT04188431|Glucocorticoids|glucocorticoids|mesh-ancestor
65295353|NCT04188431|Hormones|hormones|mesh-ancestor
65295354|NCT04188431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65295355|NCT04188431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65295356|NCT04188431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295357|NCT04665947|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
65295358|NCT04665947|Chelating Agents|chelating agents|mesh-ancestor
64525576|NCT05705830|Serotonin Agents|serotonin agents|mesh-ancestor
65119103|NCT05557877|Sensory System Agents|sensory system agents|mesh-ancestor
65119104|NCT05557877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65119105|NCT05557877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119106|NCT05557877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65119107|NCT05557877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65119108|NCT05557877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65119109|NCT05557877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65119110|NCT05557877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119111|NCT05557877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64691435|NCT00373451|Heparin|heparin|mesh-list
65119129|NCT05477576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119130|NCT05477576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64761407|NCT05746650|Hormones|hormones|mesh-list
65119131|NCT05477576|Immunologic Factors|immunologic factors|mesh-ancestor
65119132|NCT05477576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119133|NCT05477576|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65119134|NCT05477576|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65119135|NCT05477576|Growth Substances|growth substances|mesh-ancestor
65119136|NCT05477576|Growth Inhibitors|growth inhibitors|mesh-ancestor
65119137|NCT05477576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65119138|NCT05477576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119139|NCT05477576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119140|NCT05477576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65119141|NCT05477576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65119142|NCT05410301|Bevacizumab|bevacizumab|mesh-list
65119143|NCT05410301|Lomustine|lomustine|mesh-list
65119144|NCT05410301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65119145|NCT05410301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119146|NCT05410301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65119147|NCT05410301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65119148|NCT05410301|Growth Substances|growth substances|mesh-ancestor
65119149|NCT05410301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119150|NCT05410301|Growth Inhibitors|growth inhibitors|mesh-ancestor
65119151|NCT05410301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65119152|NCT05410301|Alkylating Agents|alkylating agents|mesh-ancestor
65119153|NCT05410301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119154|NCT05395091|Denosumab|denosumab|mesh-list
65119155|NCT05395091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65119156|NCT05395091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119157|NCT05393037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65119158|NCT05393037|Immunologic Factors|immunologic factors|mesh-ancestor
65119159|NCT05393037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119160|NCT05389462|Gemcitabine|gemcitabine|mesh-list
65119161|NCT05389462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65119162|NCT05389462|Antimetabolites|antimetabolites|mesh-ancestor
65119163|NCT05389462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119164|NCT05389462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119165|NCT05389462|Antiviral Agents|antiviral agents|mesh-ancestor
65119166|NCT05389462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65119167|NCT05389462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119168|NCT05389462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65119169|NCT05389462|Immunologic Factors|immunologic factors|mesh-ancestor
65119170|NCT05389462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119171|NCT05388487|Complement Factor H|complement factor h|mesh-list
65295359|NCT04665947|Sequestering Agents|sequestering agents|mesh-ancestor
65295360|NCT04665947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295361|NCT03630809|Vaccines|vaccines|mesh-list
65295362|NCT03630809|Immunologic Factors|immunologic factors|mesh-ancestor
65295363|NCT03630809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295364|NCT00577720|Risedronic Acid|risedronic acid|mesh-list
65295365|NCT00577720|Etidronic Acid|etidronic acid|mesh-list
65295366|NCT00577720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65295367|NCT00577720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65295368|NCT00577720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295369|NCT00577720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65295370|NCT00577720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295371|NCT00577720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65295372|NCT00736294|Ramipril|ramipril|mesh-list
65295373|NCT00736294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65295374|NCT00736294|Protease Inhibitors|protease inhibitors|mesh-ancestor
65295375|NCT00736294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295376|NCT00736294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295377|NCT00736294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64525585|NCT05745714|Venetoclax|venetoclax|mesh-list
64525596|NCT05745714|Antiemetics|antiemetics|mesh-ancestor
65119182|NCT05382806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65119183|NCT05382806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119184|NCT05325866|Bemarituzumab|bemarituzumab|mesh-list
65119185|NCT05325866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65119198|NCT05297578|Vaccines|vaccines|mesh-list
65119199|NCT05297578|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65119200|NCT05297578|Immunologic Factors|immunologic factors|mesh-ancestor
65119201|NCT05297578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119202|NCT05293249|Methylprednisolone|methylprednisolone|mesh-list
65119203|NCT05293249|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65119204|NCT05293249|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65119205|NCT05293249|Prednisolone|prednisolone|mesh-list
65119206|NCT05293249|Prednisolone acetate|prednisolone acetate|mesh-list
65119207|NCT05293249|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65119208|NCT05293249|Prednisolone phosphate|prednisolone phosphate|mesh-list
65119209|NCT05293249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65119210|NCT05293249|Antiemetics|antiemetics|mesh-ancestor
65119211|NCT05293249|Autonomic Agents|autonomic agents|mesh-ancestor
65119212|NCT05293249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65119213|NCT05293249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119214|NCT05293249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65119215|NCT05293249|Glucocorticoids|glucocorticoids|mesh-ancestor
65119216|NCT05293249|Hormones|hormones|mesh-ancestor
65119217|NCT05293249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65119218|NCT05293249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65119219|NCT05293249|Protective Agents|protective agents|mesh-ancestor
65119220|NCT05293249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65119221|NCT05293249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119241|NCT05180474|Antibodies|antibodies|mesh-list
65119242|NCT05180474|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65119243|NCT05180474|Immunologic Factors|immunologic factors|mesh-ancestor
65295378|NCT00512707|Sildenafil Citrate|sildenafil citrate|mesh-list
65295379|NCT00512707|Testosterone|testosterone|mesh-list
65295380|NCT00512707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295381|NCT00512707|Androgens|androgens|mesh-ancestor
65295382|NCT00512707|Hormones|hormones|mesh-ancestor
65295383|NCT00512707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65295384|NCT00512707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295385|NCT00512707|Vasodilator Agents|vasodilator agents|mesh-ancestor
64525605|NCT05745714|Antimetabolites|antimetabolites|mesh-ancestor
64525606|NCT05745714|Antiviral Agents|antiviral agents|mesh-ancestor
64525608|NCT02974270|Leuprolide|leuprolide|mesh-list
65119244|NCT05180474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119245|NCT05173831|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65119246|NCT05173831|Hallucinogens|hallucinogens|mesh-ancestor
65119247|NCT05173831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119248|NCT05173831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65119249|NCT05173831|Serotonin Agents|serotonin agents|mesh-ancestor
65119250|NCT05173831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65119251|NCT05173831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119252|NCT05173831|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65119253|NCT05173831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65119254|NCT05173831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65119255|NCT05173831|Adrenergic Agents|adrenergic agents|mesh-ancestor
65119256|NCT05172934|Tenecteplase|tenecteplase|mesh-list
65119257|NCT05172934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65119258|NCT05172934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65119259|NCT05172934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119260|NCT05171816|Olaparib|olaparib|mesh-list
65119261|NCT05171816|Abiraterone Acetate|abiraterone acetate|mesh-list
65119262|NCT05171816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65119263|NCT05171816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119264|NCT05171816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119265|NCT05171816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119266|NCT05171816|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65119267|NCT05171816|Hormone Antagonists|hormone antagonists|mesh-ancestor
65119286|NCT05139017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65119287|NCT05139017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65119288|NCT05139017|Alkylating Agents|alkylating agents|mesh-ancestor
65119289|NCT05126966|Ranibizumab|ranibizumab|mesh-list
65119290|NCT05126966|Aflibercept|aflibercept|mesh-list
65119291|NCT05126966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65119292|NCT05126966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65119293|NCT05126966|Growth Substances|growth substances|mesh-ancestor
65119294|NCT05126966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119295|NCT05126966|Growth Inhibitors|growth inhibitors|mesh-ancestor
65119296|NCT05126966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119297|NCT05126784|Denosumab|denosumab|mesh-list
65119298|NCT05126784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65119299|NCT05126784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119300|NCT05111626|Nivolumab|nivolumab|mesh-list
65119301|NCT05111626|Bemarituzumab|bemarituzumab|mesh-list
65119302|NCT05111626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65119303|NCT05111626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119304|NCT05111626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65119305|NCT05111626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119306|NCT05109442|Atezolizumab|atezolizumab|mesh-list
65119307|NCT05109442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119308|NCT05106153|Zolpidem|zolpidem|mesh-list
65119309|NCT05106153|Suvorexant|suvorexant|mesh-list
65119310|NCT05106153|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65119311|NCT05106153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65119312|NCT05106153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65119313|NCT05106153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295386|NCT00512707|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65295387|NCT00512707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65295388|NCT00512707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295389|NCT00512707|Urological Agents|urological agents|mesh-ancestor
65295390|NCT00729274|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65295391|NCT05213221|Lenvatinib|lenvatinib|mesh-list
65295392|NCT05213221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295393|NCT05213221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65295394|NCT05213221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295395|NCT05213221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295396|NCT03471767|Dextromethorphan|dextromethorphan|mesh-list
65295397|NCT03471767|Bupropion|bupropion|mesh-list
65295398|NCT03471767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65295399|NCT03471767|Antidepressive Agents|antidepressive agents|mesh-ancestor
65295400|NCT03471767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65295401|NCT03471767|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65295402|NCT03471767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64525614|NCT02974270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119314|NCT05106153|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65119315|NCT05106153|GABA Agonists|gaba agonists|mesh-ancestor
65119316|NCT05106153|GABA Agents|gaba agents|mesh-ancestor
65119317|NCT05106153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65119318|NCT05106153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119319|NCT05106153|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65119320|NCT05094336|Docetaxel|docetaxel|mesh-list
65119321|NCT05094336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119322|NCT05094336|Tubulin Modulators|tubulin modulators|mesh-ancestor
65119323|NCT05094336|Antimitotic Agents|antimitotic agents|mesh-ancestor
65119324|NCT05094336|Mitosis Modulators|mitosis modulators|mesh-ancestor
64691633|NCT02882711|Ketamine|ketamine|mesh-list
65119346|NCT05058287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65119347|NCT05058287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119348|NCT05058287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65119350|NCT05058287|Hormones|hormones|mesh-ancestor
65119351|NCT05058287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65119352|NCT05058287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65119353|NCT05058287|Protective Agents|protective agents|mesh-ancestor
65119354|NCT05058287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65119355|NCT05058287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119356|NCT04998812|Ocrelizumab|ocrelizumab|mesh-list
65119357|NCT04998812|Immunologic Factors|immunologic factors|mesh-ancestor
65119358|NCT04998812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119359|NCT04974528|Insulin|insulin|mesh-list
65119360|NCT04974528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65119361|NCT04974528|Insulin Glargine|insulin glargine|mesh-list
65119362|NCT04974528|Insulin Aspart|insulin aspart|mesh-list
65119363|NCT04974528|Insulin Lispro|insulin lispro|mesh-list
65119364|NCT04974528|Insulin Detemir|insulin detemir|mesh-list
65119365|NCT04974528|Insulin glulisine|insulin glulisine|mesh-list
65119366|NCT04974528|Insulin, Short-Acting|insulin, short-acting|mesh-list
65119367|NCT04974528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65119368|NCT04974528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119369|NCT04968899|Dexamethasone|dexamethasone|mesh-list
65119370|NCT04968899|Immunoglobulins|immunoglobulins|mesh-list
65119371|NCT04968899|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65119372|NCT04968899|Antibodies|antibodies|mesh-list
65119373|NCT04968899|gamma-Globulins|gamma-globulins|mesh-list
65119374|NCT04968899|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65295403|NCT03471767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65295404|NCT03471767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295405|NCT03471767|Dopamine Agents|dopamine agents|mesh-ancestor
65295406|NCT03471767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65295407|NCT03471767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295408|NCT03471767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65295409|NCT03471767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65295410|NCT03471767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295411|NCT03471767|Antitussive Agents|antitussive agents|mesh-ancestor
65295412|NCT03471767|Respiratory System Agents|respiratory system agents|mesh-ancestor
65295413|NCT03471767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65295414|NCT03471767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65295415|NCT00849693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65295416|NCT00849693|Fluoxetine|fluoxetine|mesh-list
65295417|NCT00849693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65295418|NCT00849693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65295419|NCT00849693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65295420|NCT00849693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295421|NCT00849693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64525633|NCT04485052|Azacitidine|azacitidine|mesh-list
65119375|NCT04968899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65119376|NCT04968899|Antiemetics|antiemetics|mesh-ancestor
65119377|NCT04968899|Autonomic Agents|autonomic agents|mesh-ancestor
65119378|NCT04968899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65119379|NCT04968899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691692|NCT02802449|Vitamin D|vitamin d|mesh-list
65119407|NCT04963296|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65119408|NCT04963296|Protective Agents|protective agents|mesh-ancestor
65119409|NCT04963296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119410|NCT04963296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65119411|NCT04963296|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65119412|NCT04963296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65119413|NCT04963296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65119414|NCT04963296|Anesthetics, Local|anesthetics, local|mesh-ancestor
65119415|NCT04963296|Anesthetics|anesthetics|mesh-ancestor
65119416|NCT04963296|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65119417|NCT04963296|Histamine Antagonists|histamine antagonists|mesh-ancestor
65119418|NCT04963296|Histamine Agents|histamine agents|mesh-ancestor
65119419|NCT04963296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65119420|NCT04963296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761701|NCT05171660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761702|NCT05171660|Growth Inhibitors|growth inhibitors|mesh-ancestor
64761703|NCT05171660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64761704|NCT05171660|Antimetabolites|antimetabolites|mesh-ancestor
64761705|NCT05171660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761706|NCT05153239|Irinotecan|irinotecan|mesh-list
64761707|NCT05153239|Topotecan|topotecan|mesh-list
64761708|NCT05153239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65119421|NCT04963296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65119422|NCT04963296|Antipruritics|antipruritics|mesh-ancestor
65119454|NCT04943211|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65295422|NCT00849693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295423|NCT00849693|Analgesics|analgesics|mesh-ancestor
65295424|NCT00849693|Sensory System Agents|sensory system agents|mesh-ancestor
65295425|NCT00849693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65295426|NCT00849693|Antidepressive Agents|antidepressive agents|mesh-ancestor
65295427|NCT00849693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65295428|NCT00849693|Dopamine Agents|dopamine agents|mesh-ancestor
65295429|NCT00849693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65295430|NCT00849693|Serotonin Agents|serotonin agents|mesh-ancestor
65295431|NCT00849693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65295432|NCT00849693|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65295433|NCT00849693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65295434|NCT00849693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295435|NCT00736606|Simvastatin|simvastatin|mesh-list
65295436|NCT00736606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65295437|NCT00736606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65295438|NCT00736606|Antimetabolites|antimetabolites|mesh-ancestor
65295439|NCT00736606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295440|NCT00736606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65295441|NCT00736606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65295442|NCT00736606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295443|NCT00527605|Dutasteride|dutasteride|mesh-list
65295444|NCT00527605|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65295445|NCT00527605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65119455|NCT04943211|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65119456|NCT04943211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119457|NCT04943198|Vemurafenib|vemurafenib|mesh-list
65119458|NCT04943198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119459|NCT04943198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65119460|NCT04943198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119461|NCT04943198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119462|NCT04941105|Evolocumab|evolocumab|mesh-list
65119463|NCT04941105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65119464|NCT04941105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65119465|NCT04941105|Antimetabolites|antimetabolites|mesh-ancestor
65119466|NCT04941105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119467|NCT04941105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65119469|NCT04919226|Folic Acid|folic acid|mesh-list
65119470|NCT04919226|Fluorouracil|fluorouracil|mesh-list
65119471|NCT04919226|Capecitabine|capecitabine|mesh-list
65119501|NCT04884815|Hormones|hormones|mesh-ancestor
65119502|NCT04884815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65119503|NCT04884815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119504|NCT04884815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65119505|NCT04884815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119506|NCT04873102|Danazol|danazol|mesh-list
65119507|NCT04873102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65119508|NCT04873102|Hormone Antagonists|hormone antagonists|mesh-ancestor
65119509|NCT04873102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65295446|NCT00527605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295447|NCT00527605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295448|NCT00527605|Hormone Antagonists|hormone antagonists|mesh-ancestor
65295449|NCT00527605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65295450|NCT00527605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295451|NCT04865939|Gemcitabine|gemcitabine|mesh-list
65295452|NCT04865939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64525677|NCT04145674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65119510|NCT04873102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119511|NCT04860141|Gabapentin|gabapentin|mesh-list
65119512|NCT04860141|Analgesics|analgesics|mesh-ancestor
65119513|NCT04860141|Sensory System Agents|sensory system agents|mesh-ancestor
65119514|NCT04860141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65119515|NCT04860141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119516|NCT04860141|Anticonvulsants|anticonvulsants|mesh-ancestor
65119517|NCT04860141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65119518|NCT04860141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65119519|NCT04860141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65119520|NCT04860141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65119521|NCT04860141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65119522|NCT04860141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65119523|NCT04860141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64691846|NCT01716806|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65119545|NCT04813653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65119547|NCT04813653|Antifungal Agents|antifungal agents|mesh-ancestor
65119548|NCT04813653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65119549|NCT04813653|Dermatologic Agents|dermatologic agents|mesh-ancestor
65119550|NCT04813653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65119551|NCT04813653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65119552|NCT04803747|Tranexamic Acid|tranexamic acid|mesh-list
65119553|NCT04803747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65119554|NCT04803747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65119555|NCT04803747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119556|NCT04803747|Hemostatics|hemostatics|mesh-ancestor
65119557|NCT04803747|Coagulants|coagulants|mesh-ancestor
65119558|NCT04797780|Azacitidine|azacitidine|mesh-list
65119559|NCT04797780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65119560|NCT04797780|Antimetabolites|antimetabolites|mesh-ancestor
65119561|NCT04797780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119562|NCT04797780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119563|NCT04797780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119564|NCT04790474|Dexamethasone|dexamethasone|mesh-list
65119565|NCT04790474|Pomalidomide|pomalidomide|mesh-list
65119566|NCT04790474|Ixazomib|ixazomib|mesh-list
65119567|NCT04790474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65119568|NCT04790474|Antiemetics|antiemetics|mesh-ancestor
65119569|NCT04790474|Autonomic Agents|autonomic agents|mesh-ancestor
65119570|NCT04790474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65119571|NCT04790474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119572|NCT04790474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65119573|NCT04790474|Glucocorticoids|glucocorticoids|mesh-ancestor
65119574|NCT04790474|Hormones|hormones|mesh-ancestor
65119575|NCT04790474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65119576|NCT04790474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65119577|NCT04790474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119578|NCT04790474|Immunologic Factors|immunologic factors|mesh-ancestor
65119595|NCT04778410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65119596|NCT04778410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65119597|NCT04778410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119598|NCT04778410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119599|NCT04778410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65119600|NCT04778410|Antimetabolites|antimetabolites|mesh-ancestor
65119601|NCT04778410|Antiviral Agents|antiviral agents|mesh-ancestor
65119602|NCT04778410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65119603|NCT04778410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65295453|NCT04865939|Antimetabolites|antimetabolites|mesh-ancestor
65295454|NCT04865939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295455|NCT04865939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295457|NCT04865939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65295458|NCT04865939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295459|NCT04865939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65295460|NCT04865939|Immunologic Factors|immunologic factors|mesh-ancestor
65295461|NCT04865939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295462|NCT00741052|Azithromycin|azithromycin|mesh-list
65295463|NCT00741052|Ciprofloxacin|ciprofloxacin|mesh-list
65295464|NCT00741052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65295465|NCT00741052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65295466|NCT00741052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65295467|NCT00741052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65295468|NCT00741052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295469|NCT00741052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295470|NCT00741052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295471|NCT00741052|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65295472|NCT00741052|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65295473|NCT04116411|Valganciclovir|valganciclovir|mesh-list
65295474|NCT04116411|Temozolomide|temozolomide|mesh-list
65295475|NCT04116411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65295476|NCT04116411|Alkylating Agents|alkylating agents|mesh-ancestor
65295477|NCT04116411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295478|NCT04116411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119604|NCT04778410|Immunologic Factors|immunologic factors|mesh-ancestor
65119605|NCT04778410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119607|NCT04778410|Sensory System Agents|sensory system agents|mesh-ancestor
65119608|NCT04778410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65119609|NCT04778410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65119618|NCT04767594|Palbociclib|palbociclib|mesh-list
65119619|NCT04767594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119620|NCT04767594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65119621|NCT04767594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119622|NCT04767594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119624|NCT04766723|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65119625|NCT04766723|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65119626|NCT04766723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65119627|NCT04766723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65119628|NCT04766723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65119629|NCT04766723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119630|NCT04766723|Cholinergic Agents|cholinergic agents|mesh-ancestor
65119631|NCT04766723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65119632|NCT04766723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119633|NCT04766723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65119634|NCT04766723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65295479|NCT04116411|Antiviral Agents|antiviral agents|mesh-ancestor
65295480|NCT04116411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65295481|NCT00706953|Doxorubicin|doxorubicin|mesh-list
65295482|NCT00706953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65295483|NCT00706953|Bortezomib|bortezomib|mesh-list
65295484|NCT00706953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65295485|NCT00706953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295486|NCT00706953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64525711|NCT02397486|Pentoxifylline|pentoxifylline|mesh-list
65119635|NCT04762069|Lomustine|lomustine|mesh-list
65119636|NCT04762069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65119637|NCT04762069|Alkylating Agents|alkylating agents|mesh-ancestor
65119638|NCT04762069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119639|NCT04762069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119640|NCT04743570|Methylnaltrexone|methylnaltrexone|mesh-list
65119641|NCT04743570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65119642|NCT04743570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119643|NCT04743570|Sensory System Agents|sensory system agents|mesh-ancestor
65119644|NCT04743570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65119645|NCT04718025|Aspirin|aspirin|mesh-list
65119646|NCT04718025|Ticagrelor|ticagrelor|mesh-list
64761925|NCT04859829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64761926|NCT04859829|Antibodies|antibodies|mesh-list
64691974|NCT02301416|Topiramate|topiramate|mesh-list
65119663|NCT04718025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65119664|NCT04718025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65119665|NCT04718025|Purinergic Agents|purinergic agents|mesh-ancestor
65119666|NCT04718025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65119667|NCT04683640|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
65119668|NCT04683640|GABA Agents|gaba agents|mesh-ancestor
65119669|NCT04683640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65119670|NCT04683640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119671|NCT04683640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119672|NCT04666948|Vancomycin|vancomycin|mesh-list
65119673|NCT04666948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65119674|NCT04666948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65119675|NCT04660539|Mycophenolic Acid|mycophenolic acid|mesh-list
65119676|NCT04660539|Azathioprine|azathioprine|mesh-list
65119677|NCT04660539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65119678|NCT04660539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119679|NCT04660539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65119680|NCT04660539|Antitubercular Agents|antitubercular agents|mesh-ancestor
65119681|NCT04660539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65119682|NCT04660539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65119683|NCT04660539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119684|NCT04660539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119685|NCT04660539|Antimetabolites|antimetabolites|mesh-ancestor
65119686|NCT04660539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65119687|NCT04660539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65119688|NCT04660539|Immunologic Factors|immunologic factors|mesh-ancestor
65119689|NCT04660539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119690|NCT04660539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65119691|NCT04642430|Rivaroxaban|rivaroxaban|mesh-list
64762020|NCT04718181|Risdiplam|risdiplam|mesh-list
64762021|NCT04718181|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64762022|NCT04718181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64762023|NCT04718181|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64762024|NCT04718181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762026|NCT04718181|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65119704|NCT04609176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119705|NCT04603001|Azacitidine|azacitidine|mesh-list
65119706|NCT04603001|Venetoclax|venetoclax|mesh-list
65119707|NCT04603001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65119708|NCT04603001|Antimetabolites|antimetabolites|mesh-ancestor
65119709|NCT04603001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119710|NCT04603001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119711|NCT04603001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119712|NCT04593940|Remdesivir|remdesivir|mesh-list
65119713|NCT04593940|Cenicriviroc|cenicriviroc|mesh-list
65295487|NCT00706953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65295488|NCT00706953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295489|NCT00706953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295490|NCT03462017|Sildenafil Citrate|sildenafil citrate|mesh-list
65295491|NCT03462017|Acetylcholine|acetylcholine|mesh-list
65295492|NCT03462017|Vasodilator Agents|vasodilator agents|mesh-ancestor
65295493|NCT03462017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65295494|NCT03462017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65295495|NCT03462017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295496|NCT03462017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295497|NCT03462017|Urological Agents|urological agents|mesh-ancestor
65295498|NCT03462017|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65295499|NCT03462017|Cholinergic Agents|cholinergic agents|mesh-ancestor
65295500|NCT03462017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65295501|NCT03462017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295502|NCT00913419|Amitriptyline|amitriptyline|mesh-list
65295503|NCT00913419|Cyclobenzaprine|cyclobenzaprine|mesh-list
65295504|NCT00913419|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65295505|NCT00913419|Antidepressive Agents|antidepressive agents|mesh-ancestor
65295506|NCT00913419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64525718|NCT02397486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65119714|NCT04593940|Abatacept|abatacept|mesh-list
65119715|NCT04593940|Infliximab|infliximab|mesh-list
65119716|NCT04593940|Dermatologic Agents|dermatologic agents|mesh-ancestor
65119717|NCT04593940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65119718|NCT04593940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65119719|NCT04593940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65119720|NCT04593940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119721|NCT04593940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119722|NCT04593940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65119723|NCT04593940|Immunologic Factors|immunologic factors|mesh-ancestor
65119724|NCT04593940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119725|NCT04593940|Antimetabolites|antimetabolites|mesh-ancestor
64484498|NCT01964963|Alogliptin|alogliptin|mesh-list
65119737|NCT04562090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119738|NCT04562090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119739|NCT04562090|Urological Agents|urological agents|mesh-ancestor
65119740|NCT04557189|Ondansetron|ondansetron|mesh-list
65119741|NCT04557189|Antiemetics|antiemetics|mesh-ancestor
65119742|NCT04557189|Autonomic Agents|autonomic agents|mesh-ancestor
65119743|NCT04557189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65119744|NCT04557189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119745|NCT04557189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65119746|NCT04557189|Antipruritics|antipruritics|mesh-ancestor
65119747|NCT04557189|Dermatologic Agents|dermatologic agents|mesh-ancestor
65119748|NCT04557189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65119749|NCT04557189|Serotonin Agents|serotonin agents|mesh-ancestor
65119750|NCT04557189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65119751|NCT04557189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119752|NCT04557189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65119753|NCT04557189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65119754|NCT04557189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65119755|NCT04557189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65295507|NCT00913419|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65295508|NCT00913419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295509|NCT00913419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65295510|NCT00913419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65295511|NCT00913419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65295512|NCT00913419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65295513|NCT00913419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65295514|NCT00913419|Analgesics|analgesics|mesh-ancestor
65295515|NCT00913419|Sensory System Agents|sensory system agents|mesh-ancestor
65295516|NCT00913419|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65295517|NCT00913419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65295518|NCT00913419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65295519|NCT00913419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295520|NCT00913419|Adrenergic Agents|adrenergic agents|mesh-ancestor
64525739|NCT02393586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64525743|NCT02393586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65119756|NCT04557189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65119757|NCT04530838|Vaccines|vaccines|mesh-list
65119758|NCT04530838|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65119759|NCT04530838|Immunologic Factors|immunologic factors|mesh-ancestor
65119760|NCT04530838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119761|NCT04521686|Gemcitabine|gemcitabine|mesh-list
65119762|NCT04521686|Durvalumab|durvalumab|mesh-list
65119763|NCT04521686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119764|NCT04521686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65119765|NCT04521686|Antimetabolites|antimetabolites|mesh-ancestor
65119766|NCT04521686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119767|NCT04521686|Antiviral Agents|antiviral agents|mesh-ancestor
65119768|NCT04521686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65119769|NCT04521686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119770|NCT04521686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65119771|NCT04521686|Immunologic Factors|immunologic factors|mesh-ancestor
65119772|NCT04521686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119773|NCT04521686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65119774|NCT04442919|Morphine|morphine|mesh-list
65119775|NCT04442919|Methoxyflurane|methoxyflurane|mesh-list
65119776|NCT04442919|Ticagrelor|ticagrelor|mesh-list
65119777|NCT04442919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65119778|NCT04442919|Narcotics|narcotics|mesh-ancestor
65119779|NCT04442919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64762079|NCT04560972|LB100|lb100|mesh-list
65119780|NCT04442919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119781|NCT04442919|Analgesics|analgesics|mesh-ancestor
65119782|NCT04442919|Sensory System Agents|sensory system agents|mesh-ancestor
65119783|NCT04442919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65119784|NCT04442919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65119785|NCT04442919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65119786|NCT04442919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65119787|NCT04442919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64692130|NCT01994486|Sofosbuvir|sofosbuvir|mesh-list
65119803|NCT04424901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65119804|NCT04424901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119805|NCT04424901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119806|NCT04424901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65119807|NCT04424901|Vasodilator Agents|vasodilator agents|mesh-ancestor
65119808|NCT04415060|Sevoflurane|sevoflurane|mesh-list
65119810|NCT04415060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65295521|NCT00913419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65295522|NCT00711412|Capecitabine|capecitabine|mesh-list
65295523|NCT00711412|Oxaliplatin|oxaliplatin|mesh-list
65295524|NCT00711412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65295525|NCT00711412|Antimetabolites|antimetabolites|mesh-ancestor
65295526|NCT00711412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295527|NCT00711412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295528|NCT01840007|Metformin|metformin|mesh-list
65295529|NCT01840007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65295530|NCT01840007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295531|NCT03896659|Hydrocortisone|hydrocortisone|mesh-list
65295532|NCT03896659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65295533|NCT03885037|Infliximab|infliximab|mesh-list
65295534|NCT03885037|Dermatologic Agents|dermatologic agents|mesh-ancestor
65295535|NCT03885037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65295536|NCT03885037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65295537|NCT03746951|Ropivacaine|ropivacaine|mesh-list
65295538|NCT03746951|Anesthetics, Local|anesthetics, local|mesh-ancestor
65295539|NCT03746951|Anesthetics|anesthetics|mesh-ancestor
65295540|NCT03746951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65295541|NCT03746951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525755|NCT03453892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64525759|NCT00367120|Amoxicillin|amoxicillin|mesh-list
65119811|NCT04415060|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65119812|NCT04415060|Anesthetics, General|anesthetics, general|mesh-ancestor
65119813|NCT04415060|Anesthetics|anesthetics|mesh-ancestor
65119814|NCT04415060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65119815|NCT04415060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119816|NCT04410445|Nivolumab|nivolumab|mesh-list
65119817|NCT04410445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65119818|NCT04410445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119819|NCT04410445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65119820|NCT04410445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119821|NCT04408664|Cromolyn Sodium|cromolyn sodium|mesh-list
65119822|NCT04408664|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
65119823|NCT04408664|Immunologic Factors|immunologic factors|mesh-ancestor
65119824|NCT04408664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119825|NCT04408664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65119826|NCT04408664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65119827|NCT04408664|Respiratory System Agents|respiratory system agents|mesh-ancestor
65119828|NCT04397003|Durvalumab|durvalumab|mesh-list
65119829|NCT04397003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65119830|NCT04397003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119831|NCT04381091|Idebenone|idebenone|mesh-list
65119832|NCT04381091|Antioxidants|antioxidants|mesh-ancestor
65119833|NCT04381091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119834|NCT04381091|Protective Agents|protective agents|mesh-ancestor
65119835|NCT04381091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119836|NCT04293562|Cytarabine|cytarabine|mesh-list
65119837|NCT04293562|Deoxyglucose|deoxyglucose|mesh-list
65119838|NCT04293562|Hydrocortisone|hydrocortisone|mesh-list
65119839|NCT04293562|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65119840|NCT04293562|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65295542|NCT03746951|Sensory System Agents|sensory system agents|mesh-ancestor
65295543|NCT03746951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65295544|NCT00577408|Naltrexone|naltrexone|mesh-list
65295545|NCT00577408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65295546|NCT00577408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65295547|NCT00577408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295548|NCT00577408|Sensory System Agents|sensory system agents|mesh-ancestor
65295549|NCT00577408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65295550|NCT03391193|Vaccines|vaccines|mesh-list
65295551|NCT03391193|Immunologic Factors|immunologic factors|mesh-ancestor
65295552|NCT03391193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295553|NCT00741364|Vitamin D|vitamin d|mesh-list
65295554|NCT00741364|Cholecalciferol|cholecalciferol|mesh-list
65295555|NCT00741364|Vitamins|vitamins|mesh-ancestor
65295556|NCT00741364|Micronutrients|micronutrients|mesh-ancestor
65295557|NCT00741364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295558|NCT00741364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65295559|NCT00741364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65119841|NCT04293562|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65119842|NCT04293562|Methotrexate|methotrexate|mesh-list
65119843|NCT04293562|Etoposide|etoposide|mesh-list
65119844|NCT04293562|Etoposide phosphate|etoposide phosphate|mesh-list
65119845|NCT04293562|Daunorubicin|daunorubicin|mesh-list
65119846|NCT04293562|Asparaginase|asparaginase|mesh-list
65119847|NCT04293562|Mitoxantrone|mitoxantrone|mesh-list
65119848|NCT04293562|Podophyllotoxin|podophyllotoxin|mesh-list
65119849|NCT04293562|Gemtuzumab|gemtuzumab|mesh-list
65119850|NCT04293562|Dexrazoxane|dexrazoxane|mesh-list
65119867|NCT04293562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65119868|NCT04293562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65119869|NCT04293562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65119870|NCT04293562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65119871|NCT04293562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65119872|NCT04293562|Antiviral Agents|antiviral agents|mesh-ancestor
65119873|NCT04293562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65119874|NCT04293562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65119875|NCT04293562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65119876|NCT04293562|Analgesics|analgesics|mesh-ancestor
65119877|NCT04293562|Sensory System Agents|sensory system agents|mesh-ancestor
65119878|NCT04293562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65119879|NCT04293562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65119880|NCT04293562|Keratolytic Agents|keratolytic agents|mesh-ancestor
65119881|NCT04293562|Tubulin Modulators|tubulin modulators|mesh-ancestor
65119882|NCT04293562|Antimitotic Agents|antimitotic agents|mesh-ancestor
65119883|NCT04293562|Mitosis Modulators|mitosis modulators|mesh-ancestor
65119884|NCT04293562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64652718|NCT01722110|Analgesics|analgesics|mesh-ancestor
65119885|NCT04293562|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65119886|NCT04293562|Protective Agents|protective agents|mesh-ancestor
65119887|NCT04225312|Natalizumab|natalizumab|mesh-list
65119888|NCT04225312|Immunologic Factors|immunologic factors|mesh-ancestor
65119889|NCT04225312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119890|NCT04221542|Docetaxel|docetaxel|mesh-list
65119891|NCT04221542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119892|NCT04221542|Tubulin Modulators|tubulin modulators|mesh-ancestor
65119893|NCT04221542|Antimitotic Agents|antimitotic agents|mesh-ancestor
65119894|NCT04221542|Mitosis Modulators|mitosis modulators|mesh-ancestor
65119895|NCT04221542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119896|NCT04209205|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65119897|NCT04209205|Immunologic Factors|immunologic factors|mesh-ancestor
65295560|NCT03332303|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65295561|NCT03332303|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65295562|NCT03332303|Estradiol|estradiol|mesh-list
65295563|NCT03332303|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65295564|NCT03332303|Estrogens|estrogens|mesh-ancestor
65295565|NCT03332303|Hormones|hormones|mesh-ancestor
65295566|NCT03332303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65295567|NCT03332303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295568|NCT03332303|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65295569|NCT03332303|Contraceptive Agents|contraceptive agents|mesh-ancestor
65295570|NCT03332303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65295571|NCT03332303|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65295572|NCT00614471|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65295573|NCT00614471|Interferon-alpha|interferon-alpha|mesh-list
65295574|NCT00614471|Entecavir|entecavir|mesh-list
65295575|NCT00614471|Antiviral Agents|antiviral agents|mesh-ancestor
64525791|NCT02397330|Morphine|morphine|mesh-list
65119898|NCT04209205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119903|NCT04156347|Topotecan|topotecan|mesh-list
65119904|NCT04156347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65119905|NCT04156347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65119906|NCT04156347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119907|NCT04156347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119908|NCT04156347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119909|NCT04129086|Ketamine|ketamine|mesh-list
65119910|NCT04129086|Analgesics|analgesics|mesh-ancestor
65119911|NCT04129086|Sensory System Agents|sensory system agents|mesh-ancestor
65119912|NCT04129086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692249|NCT01966718|Hormones|hormones|mesh-ancestor
65119925|NCT04123366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65119926|NCT04123366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119927|NCT04123366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65119928|NCT04123366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119929|NCT04123366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762222|NCT04280692|Renal Agents|renal agents|mesh-ancestor
65119930|NCT04111978|Letrozole|letrozole|mesh-list
65119931|NCT04111978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119932|NCT04111978|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65119933|NCT04111978|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65119934|NCT04111978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119935|NCT04111978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119936|NCT04111978|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65119937|NCT04111978|Hormone Antagonists|hormone antagonists|mesh-ancestor
65119938|NCT04111978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65119939|NCT04111978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119940|NCT04108156|Ranibizumab|ranibizumab|mesh-list
65119941|NCT04108156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65119942|NCT04108156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65119943|NCT04108156|Growth Substances|growth substances|mesh-ancestor
65119944|NCT04108156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119945|NCT04108156|Growth Inhibitors|growth inhibitors|mesh-ancestor
65119946|NCT04108156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119947|NCT04062448|Rituximab|rituximab|mesh-list
65119948|NCT04062448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65119949|NCT04062448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119950|NCT04062448|Immunologic Factors|immunologic factors|mesh-ancestor
65119951|NCT04062448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119952|NCT04062448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65119953|NCT04003285|Pregnanolone|pregnanolone|mesh-list
65295576|NCT00614471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65295577|NCT00614471|Immunologic Factors|immunologic factors|mesh-ancestor
65295578|NCT00614471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295579|NCT05742256|Sufentanil|sufentanil|mesh-list
65295580|NCT05742256|Oxycodone|oxycodone|mesh-list
65295581|NCT05742256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65295582|NCT05742256|Narcotics|narcotics|mesh-ancestor
65295583|NCT05742256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65295584|NCT05742256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295585|NCT05742256|Analgesics|analgesics|mesh-ancestor
65295586|NCT05742256|Sensory System Agents|sensory system agents|mesh-ancestor
65295587|NCT05742256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65295588|NCT05742256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65295589|NCT05742256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65295590|NCT05742256|Anesthetics, General|anesthetics, general|mesh-ancestor
65295591|NCT05742256|Anesthetics|anesthetics|mesh-ancestor
65295592|NCT00828009|Paclitaxel|paclitaxel|mesh-list
65295593|NCT00828009|Cyclophosphamide|cyclophosphamide|mesh-list
65295594|NCT00828009|Bevacizumab|bevacizumab|mesh-list
65119954|NCT04003285|Anesthetics|anesthetics|mesh-ancestor
64513980|NCT02349867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119955|NCT04003285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65119956|NCT04003285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119957|NCT04000555|Vancomycin|vancomycin|mesh-list
65119958|NCT04000555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65119959|NCT04000555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65119960|NCT03994393|Durvalumab|durvalumab|mesh-list
65119961|NCT03994393|Tremelimumab|tremelimumab|mesh-list
65119962|NCT03994393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65119963|NCT03994393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119964|NCT03992404|Botulinum Toxins|botulinum toxins|mesh-list
65119965|NCT03992404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65119966|NCT03992404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65119967|NCT03992404|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65119968|NCT03992404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65119969|NCT03992404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65119970|NCT03992404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119971|NCT03992404|Cholinergic Agents|cholinergic agents|mesh-ancestor
65119995|NCT03867851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65119996|NCT03867851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65119997|NCT03867851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119998|NCT03836040|Erenumab|erenumab|mesh-list
65119999|NCT03836040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65120000|NCT03836040|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65120001|NCT03836040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120002|NCT03836040|Analgesics|analgesics|mesh-ancestor
65120003|NCT03836040|Sensory System Agents|sensory system agents|mesh-ancestor
65120004|NCT03836040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65120005|NCT03836040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120006|NCT03836040|Immunologic Factors|immunologic factors|mesh-ancestor
65120007|NCT03829501|Atezolizumab|atezolizumab|mesh-list
65120008|NCT03829501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120009|NCT03798639|Nivolumab|nivolumab|mesh-list
65120010|NCT03798639|Ipilimumab|ipilimumab|mesh-list
65120011|NCT03798639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65120012|NCT03798639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120013|NCT03798639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65120014|NCT03798639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295595|NCT00828009|Carboplatin|carboplatin|mesh-list
65295596|NCT00828009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65295597|NCT00828009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295598|NCT00828009|Tubulin Modulators|tubulin modulators|mesh-ancestor
65295599|NCT00828009|Antimitotic Agents|antimitotic agents|mesh-ancestor
65295600|NCT00828009|Mitosis Modulators|mitosis modulators|mesh-ancestor
65295601|NCT00828009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295602|NCT00828009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65295603|NCT00828009|Immunologic Factors|immunologic factors|mesh-ancestor
65295604|NCT00828009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045518|NCT02894554|Lamivudine|lamivudine|mesh-list
64525825|NCT03015610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64525827|NCT00422344|Sunitinib|sunitinib|mesh-list
65120015|NCT03774901|Avelumab|avelumab|mesh-list
65120016|NCT03774901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65120017|NCT03774901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120018|NCT03762018|Bevacizumab|bevacizumab|mesh-list
65120019|NCT03762018|Carboplatin|carboplatin|mesh-list
65120020|NCT03762018|Pemetrexed|pemetrexed|mesh-list
65120021|NCT03762018|Atezolizumab|atezolizumab|mesh-list
65120022|NCT03762018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65120050|NCT03737643|Growth Inhibitors|growth inhibitors|mesh-ancestor
65120051|NCT03737643|Immunologic Factors|immunologic factors|mesh-ancestor
65120052|NCT03737643|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65120053|NCT03737643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120055|NCT03682068|Carboplatin|carboplatin|mesh-list
65120056|NCT03682068|Durvalumab|durvalumab|mesh-list
65120057|NCT03682068|Tremelimumab|tremelimumab|mesh-list
65120058|NCT03682068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120059|NCT03682068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65120060|NCT03682068|Antimetabolites|antimetabolites|mesh-ancestor
65120061|NCT03682068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120062|NCT03682068|Antiviral Agents|antiviral agents|mesh-ancestor
65120063|NCT03682068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65120064|NCT03682068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120065|NCT03682068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65120066|NCT03682068|Immunologic Factors|immunologic factors|mesh-ancestor
65120067|NCT03682068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120068|NCT03682068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65120069|NCT03644186|Paclitaxel|paclitaxel|mesh-list
65120089|NCT03644186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65120091|NCT03533283|Obinutuzumab|obinutuzumab|mesh-list
65120092|NCT03533283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120093|NCT03533283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65120094|NCT03471143|Betadex|betadex|mesh-list
65120095|NCT03471143|Sequestering Agents|sequestering agents|mesh-ancestor
65120096|NCT03471143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120097|NCT03456882|RNS60|rns60|mesh-list
65120098|NCT03456882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65120099|NCT03456882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65120100|NCT03456882|Analgesics|analgesics|mesh-ancestor
65120101|NCT03456882|Sensory System Agents|sensory system agents|mesh-ancestor
65120102|NCT03456882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65120103|NCT03456882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120104|NCT03456882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65120105|NCT03456882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65120106|NCT03456882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65120108|NCT03433807|Antioxidants|antioxidants|mesh-ancestor
65120109|NCT03433807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120110|NCT03433807|Protective Agents|protective agents|mesh-ancestor
65120111|NCT03433807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120112|NCT03422328|Macitentan|macitentan|mesh-list
65120113|NCT03422328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65120114|NCT03422328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65295605|NCT00828009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65295606|NCT00828009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65295607|NCT00828009|Alkylating Agents|alkylating agents|mesh-ancestor
65295608|NCT00828009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65295609|NCT00828009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65295610|NCT00828009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65295611|NCT00828009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65295612|NCT00828009|Growth Substances|growth substances|mesh-ancestor
65295613|NCT00828009|Growth Inhibitors|growth inhibitors|mesh-ancestor
65295614|NCT00713596|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65295615|NCT00713596|Hemostatics|hemostatics|mesh-ancestor
65295616|NCT00713596|Coagulants|coagulants|mesh-ancestor
65295617|NCT00729664|Atezolizumab|atezolizumab|mesh-list
65295618|NCT00729664|BMS-936559|bms-936559|mesh-list
65295619|NCT00729664|Antibodies|antibodies|mesh-list
65295620|NCT00729664|Immunoglobulins|immunoglobulins|mesh-list
65295621|NCT00729664|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65295622|NCT00729664|Immunologic Factors|immunologic factors|mesh-ancestor
65295623|NCT00729664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295624|NCT00729664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525836|NCT00422344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120115|NCT03422328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120116|NCT03422328|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65120117|NCT03416179|Cytarabine|cytarabine|mesh-list
65120118|NCT03416179|Azacitidine|azacitidine|mesh-list
65120119|NCT03416179|Daunorubicin|daunorubicin|mesh-list
65120120|NCT03416179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65120121|NCT03416179|Antimetabolites|antimetabolites|mesh-ancestor
65120122|NCT03416179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120123|NCT03416179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120124|NCT03416179|Antiviral Agents|antiviral agents|mesh-ancestor
65120125|NCT03416179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64692460|NCT02925611|Anesthetics|anesthetics|mesh-ancestor
65120147|NCT03309150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120148|NCT03309150|Tubulin Modulators|tubulin modulators|mesh-ancestor
65120149|NCT03309150|Antimitotic Agents|antimitotic agents|mesh-ancestor
65120150|NCT03309150|Mitosis Modulators|mitosis modulators|mesh-ancestor
65120151|NCT03309150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120153|NCT03266783|Apixaban|apixaban|mesh-list
65120154|NCT03266783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65120156|NCT03266783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65120157|NCT03266783|Protease Inhibitors|protease inhibitors|mesh-ancestor
65120158|NCT03266783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120159|NCT03266783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120160|NCT03266783|Anticoagulants|anticoagulants|mesh-ancestor
65120161|NCT03251859|Ticagrelor|ticagrelor|mesh-list
65120162|NCT03251859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65120163|NCT03251859|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65120164|NCT03251859|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65120165|NCT03251859|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65120166|NCT03251859|Purinergic Agents|purinergic agents|mesh-ancestor
65120167|NCT03251859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65120168|NCT03251859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120169|NCT03251859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120170|NCT03250377|Brivaracetam|brivaracetam|mesh-list
65120171|NCT03250377|Anticonvulsants|anticonvulsants|mesh-ancestor
65295625|NCT00729664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65295626|NCT04229615|Apatinib|apatinib|mesh-list
65295627|NCT04229615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295628|NCT04229615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65295629|NCT04229615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295630|NCT04229615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295631|NCT00881894|Rotigotine|rotigotine|mesh-list
64525860|NCT00367276|Drospirenone|drospirenone|mesh-list
65120172|NCT03186638|Ibuprofen|ibuprofen|mesh-list
65120173|NCT03186638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65120174|NCT03186638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65120175|NCT03186638|Analgesics|analgesics|mesh-ancestor
65120176|NCT03186638|Sensory System Agents|sensory system agents|mesh-ancestor
65120177|NCT03186638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65120178|NCT03186638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120179|NCT03186638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65120199|NCT03043872|Tremelimumab|tremelimumab|mesh-list
65120200|NCT03043872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120201|NCT03043872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65120202|NCT03043872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65120203|NCT03043872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65120204|NCT03043872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120205|NCT03043872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120206|NCT03043872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65120207|NCT02990338|Dexamethasone|dexamethasone|mesh-list
65120208|NCT02990338|Pomalidomide|pomalidomide|mesh-list
65120209|NCT02990338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65120210|NCT02990338|Antiemetics|antiemetics|mesh-ancestor
65120211|NCT02990338|Autonomic Agents|autonomic agents|mesh-ancestor
65120212|NCT02990338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65120213|NCT02990338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120214|NCT02990338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65120215|NCT02990338|Glucocorticoids|glucocorticoids|mesh-ancestor
65120216|NCT02990338|Hormones|hormones|mesh-ancestor
65120217|NCT02990338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65120218|NCT02990338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65120219|NCT02990338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120220|NCT02990338|Immunologic Factors|immunologic factors|mesh-ancestor
65120221|NCT02990338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65120222|NCT02990338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65120223|NCT02990338|Growth Substances|growth substances|mesh-ancestor
65120224|NCT02990338|Growth Inhibitors|growth inhibitors|mesh-ancestor
65120225|NCT02923128|Sufentanil|sufentanil|mesh-list
65120226|NCT02923128|Dexmedetomidine|dexmedetomidine|mesh-list
65120227|NCT02923128|Dsuvia|dsuvia|mesh-list
65120228|NCT02923128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65120229|NCT02923128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65120230|NCT02923128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120231|NCT02923128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65120232|NCT02923128|Analgesics|analgesics|mesh-ancestor
65120233|NCT02923128|Sensory System Agents|sensory system agents|mesh-ancestor
65120234|NCT02923128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65120235|NCT02923128|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64692566|NCT01977781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65120264|NCT02852213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65120265|NCT02852213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65120266|NCT02793466|Durvalumab|durvalumab|mesh-list
65120267|NCT02793466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65120268|NCT02793466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65120269|NCT02793466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120270|NCT02793466|Immunologic Factors|immunologic factors|mesh-ancestor
65120271|NCT02793466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120272|NCT02774005|Idebenone|idebenone|mesh-list
65120273|NCT02774005|Antioxidants|antioxidants|mesh-ancestor
65120274|NCT02774005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120275|NCT02774005|Protective Agents|protective agents|mesh-ancestor
65120276|NCT02774005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295632|NCT00881894|Dopamine Agonists|dopamine agonists|mesh-ancestor
65295633|NCT00881894|Dopamine Agents|dopamine agents|mesh-ancestor
65295634|NCT00881894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65295635|NCT00881894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295636|NCT00881894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295637|NCT02638376|Riboflavin|riboflavin|mesh-list
65295638|NCT02638376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65295639|NCT02638376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65295640|NCT02638376|Vitamin B Complex|vitamin b complex|mesh-ancestor
65295641|NCT02638376|Vitamins|vitamins|mesh-ancestor
65295642|NCT02638376|Micronutrients|micronutrients|mesh-ancestor
65295643|NCT02638376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295644|NCT02638376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65295645|NCT02638376|Dermatologic Agents|dermatologic agents|mesh-ancestor
65295646|NCT00827931|Tranexamic Acid|tranexamic acid|mesh-list
65295647|NCT00827931|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65295648|NCT00827931|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65295649|NCT00827931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295650|NCT00827931|Hemostatics|hemostatics|mesh-ancestor
65295651|NCT00827931|Coagulants|coagulants|mesh-ancestor
64525863|NCT00367276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65120277|NCT02700828|Hydrocortisone|hydrocortisone|mesh-list
65120278|NCT02700828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65120279|NCT02700828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65120280|NCT02695771|Gemcitabine|gemcitabine|mesh-list
65120281|NCT02695771|Mitomycins|mitomycins|mesh-list
65120282|NCT02695771|Mitomycin|mitomycin|mesh-list
65120283|NCT02695771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65120284|NCT02695771|Antimetabolites|antimetabolites|mesh-ancestor
65120295|NCT02695771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65120296|NCT02568267|Entrectinib|entrectinib|mesh-list
65120297|NCT02568267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65120298|NCT02568267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120299|NCT02568267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120326|NCT02293954|Antibodies|antibodies|mesh-list
65120327|NCT02293954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65120328|NCT02293954|Immunologic Factors|immunologic factors|mesh-ancestor
65120329|NCT02293954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120330|NCT02259621|Paclitaxel|paclitaxel|mesh-list
65120331|NCT02259621|Carboplatin|carboplatin|mesh-list
65120332|NCT02259621|Nivolumab|nivolumab|mesh-list
65120333|NCT02259621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65120334|NCT02259621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120335|NCT02259621|Tubulin Modulators|tubulin modulators|mesh-ancestor
65120336|NCT02259621|Antimitotic Agents|antimitotic agents|mesh-ancestor
65120337|NCT02259621|Mitosis Modulators|mitosis modulators|mesh-ancestor
65120338|NCT02259621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120339|NCT02259621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65120340|NCT02259621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65120341|NCT02190305|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
65120342|NCT02190305|Immunologic Factors|immunologic factors|mesh-ancestor
65120343|NCT02190305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120344|NCT01941641|Capecitabine|capecitabine|mesh-list
65120345|NCT01941641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65295652|NCT04158674|Simendan|simendan|mesh-list
65295653|NCT04158674|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65295654|NCT04158674|Vasodilator Agents|vasodilator agents|mesh-ancestor
65295655|NCT04158674|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65295656|NCT04158674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65295657|NCT04158674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295658|NCT04158674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295659|NCT04158674|Protective Agents|protective agents|mesh-ancestor
65295660|NCT04158674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295661|NCT00526669|Capecitabine|capecitabine|mesh-list
65295662|NCT00526669|Lapatinib|lapatinib|mesh-list
65295663|NCT00526669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65295664|NCT00526669|Antimetabolites|antimetabolites|mesh-ancestor
65295665|NCT00526669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525881|NCT02689206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120346|NCT01941641|Antimetabolites|antimetabolites|mesh-ancestor
65120347|NCT01941641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120348|NCT01941641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120349|NCT01804634|Cyclophosphamide|cyclophosphamide|mesh-list
65120350|NCT01804634|Melphalan|melphalan|mesh-list
65120351|NCT01804634|Fludarabine|fludarabine|mesh-list
65120352|NCT01804634|Tacrolimus|tacrolimus|mesh-list
65120353|NCT01804634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65120354|NCT01804634|Immunologic Factors|immunologic factors|mesh-ancestor
65120355|NCT01804634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120356|NCT01804634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65120357|NCT01804634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65120358|NCT01804634|Alkylating Agents|alkylating agents|mesh-ancestor
65120359|NCT01804634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120360|NCT01804634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120361|NCT01804634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65120362|NCT01804634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65120363|NCT01804634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120364|NCT01792934|Bevacizumab|bevacizumab|mesh-list
65120365|NCT01792934|Irinotecan|irinotecan|mesh-list
65120366|NCT01792934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65120367|NCT01792934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653218|NCT01045694|Hormones|hormones|mesh-ancestor
65120368|NCT01792934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65120369|NCT01792934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65120370|NCT01792934|Growth Substances|growth substances|mesh-ancestor
65120371|NCT01792934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120372|NCT01792934|Growth Inhibitors|growth inhibitors|mesh-ancestor
65120373|NCT01792934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65120374|NCT01792934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65120383|NCT01749969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120384|NCT01749969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65120385|NCT01749969|Glucocorticoids|glucocorticoids|mesh-ancestor
65120386|NCT01749969|Hormones|hormones|mesh-ancestor
65120387|NCT01749969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65120388|NCT01749969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65120389|NCT01749969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120390|NCT01749969|Immunologic Factors|immunologic factors|mesh-ancestor
65120391|NCT01749969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65120392|NCT01749969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65120393|NCT01749969|Growth Substances|growth substances|mesh-ancestor
65120394|NCT01749969|Growth Inhibitors|growth inhibitors|mesh-ancestor
65120395|NCT01669915|Vitamin D|vitamin d|mesh-list
65120396|NCT01669915|Ergocalciferols|ergocalciferols|mesh-list
65120397|NCT01669915|Cholecalciferol|cholecalciferol|mesh-list
65295666|NCT00526669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295667|NCT00526669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65295668|NCT00526669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295669|NCT03640949|Methylprednisolone|methylprednisolone|mesh-list
65295670|NCT03640949|Vasopressins|vasopressins|mesh-list
65295671|NCT03640949|Arginine Vasopressin|arginine vasopressin|mesh-list
65295672|NCT03640949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65295673|NCT03640949|Antiemetics|antiemetics|mesh-ancestor
65295674|NCT03640949|Autonomic Agents|autonomic agents|mesh-ancestor
65295675|NCT03640949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65295676|NCT03640949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295677|NCT03640949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65295678|NCT03640949|Glucocorticoids|glucocorticoids|mesh-ancestor
65295679|NCT03640949|Hormones|hormones|mesh-ancestor
65295680|NCT03640949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65295681|NCT03640949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65295682|NCT03640949|Protective Agents|protective agents|mesh-ancestor
65295683|NCT03640949|Hemostatics|hemostatics|mesh-ancestor
65295684|NCT03640949|Coagulants|coagulants|mesh-ancestor
65295685|NCT03640949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65295686|NCT03640949|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65295687|NCT03640949|Natriuretic Agents|natriuretic agents|mesh-ancestor
65295688|NCT00827775|Carvedilol|carvedilol|mesh-list
65295689|NCT00827775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65295690|NCT00827775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65295691|NCT00827775|Adrenergic Agents|adrenergic agents|mesh-ancestor
65295692|NCT00827775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65295693|NCT00827775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295694|NCT00827775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295695|NCT00827775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65295696|NCT00827775|Antioxidants|antioxidants|mesh-ancestor
65295697|NCT00827775|Protective Agents|protective agents|mesh-ancestor
65295698|NCT00827775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65295699|NCT00827775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65295700|NCT00827775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65295701|NCT00827775|Vasodilator Agents|vasodilator agents|mesh-ancestor
65295705|NCT02544308|Lenalidomide|lenalidomide|mesh-list
65295706|NCT02544308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65295707|NCT02544308|Antiemetics|antiemetics|mesh-ancestor
65295708|NCT02544308|Autonomic Agents|autonomic agents|mesh-ancestor
65295709|NCT02544308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65295710|NCT02544308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295711|NCT02544308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65295712|NCT02544308|Glucocorticoids|glucocorticoids|mesh-ancestor
65295713|NCT02544308|Hormones|hormones|mesh-ancestor
64525934|NCT00367822|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64525935|NCT00367822|Dopamine Agonists|dopamine agonists|mesh-ancestor
65120398|NCT01669915|Vitamins|vitamins|mesh-list
65120399|NCT01669915|Micronutrients|micronutrients|mesh-ancestor
65120400|NCT01669915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120401|NCT01669915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65120402|NCT01669915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65120403|NCT01653223|Simvastatin|simvastatin|mesh-list
65120404|NCT01653223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65120405|NCT01653223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65120406|NCT01653223|Antimetabolites|antimetabolites|mesh-ancestor
65120407|NCT01653223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120408|NCT01653223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65120409|NCT01653223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65120410|NCT01653223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120411|NCT01549587|Listerine|listerine|mesh-list
65120412|NCT01549587|Cetylpyridinium|cetylpyridinium|mesh-list
65120413|NCT01549587|Fluorides|fluorides|mesh-list
65120414|NCT01549587|Sodium Fluoride|sodium fluoride|mesh-list
65120415|NCT01549587|Tin Fluorides|tin fluorides|mesh-list
65120416|NCT01549587|Cariostatic Agents|cariostatic agents|mesh-ancestor
65120417|NCT01549587|Protective Agents|protective agents|mesh-ancestor
65120418|NCT01549587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120419|NCT01549587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65120420|NCT01549587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65120421|NCT01478542|Rituximab|rituximab|mesh-list
65120422|NCT01478542|Vincristine|vincristine|mesh-list
65120423|NCT01478542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65120424|NCT01478542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120425|NCT01478542|Immunologic Factors|immunologic factors|mesh-ancestor
65120426|NCT01478542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120427|NCT01478542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65120428|NCT01478542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65120429|NCT01478542|Tubulin Modulators|tubulin modulators|mesh-ancestor
65120430|NCT01478542|Antimitotic Agents|antimitotic agents|mesh-ancestor
65120431|NCT01478542|Mitosis Modulators|mitosis modulators|mesh-ancestor
65120432|NCT01478542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120433|NCT01356290|Cytarabine|cytarabine|mesh-list
65120434|NCT01356290|Thalidomide|thalidomide|mesh-list
65120435|NCT01356290|Celecoxib|celecoxib|mesh-list
65120436|NCT01356290|Cyclophosphamide|cyclophosphamide|mesh-list
65120437|NCT01356290|Bevacizumab|bevacizumab|mesh-list
65120438|NCT01356290|Etoposide|etoposide|mesh-list
65120439|NCT01356290|Etoposide phosphate|etoposide phosphate|mesh-list
65120440|NCT01356290|Fenofibric acid|fenofibric acid|mesh-list
65120441|NCT01356290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65120442|NCT01356290|Immunologic Factors|immunologic factors|mesh-ancestor
64762728|NCT02894398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762729|NCT02894398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64762730|NCT02894398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64762731|NCT02894398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762732|NCT02894398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762733|NCT02894398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64762746|NCT02678052|Vedolizumab|vedolizumab|mesh-list
65120449|NCT01356290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65120450|NCT01356290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65120451|NCT01356290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65120452|NCT01356290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65295714|NCT02544308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65295715|NCT02544308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65295716|NCT02544308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295717|NCT02544308|Immunologic Factors|immunologic factors|mesh-ancestor
65295718|NCT02544308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65295719|NCT02544308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65295720|NCT02544308|Growth Substances|growth substances|mesh-ancestor
65295721|NCT02544308|Growth Inhibitors|growth inhibitors|mesh-ancestor
65295722|NCT00707187|Tadalafil|tadalafil|mesh-list
65295723|NCT00707187|Vasodilator Agents|vasodilator agents|mesh-ancestor
65295724|NCT00707187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65295725|NCT00707187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65295726|NCT00707187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295727|NCT00707187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525943|NCT03189706|Temozolomide|temozolomide|mesh-list
64525945|NCT03189706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65120453|NCT01356290|Growth Substances|growth substances|mesh-ancestor
65120454|NCT01356290|Growth Inhibitors|growth inhibitors|mesh-ancestor
65120455|NCT01356290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65120456|NCT01356290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65120457|NCT01356290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65120458|NCT01356290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120459|NCT01356290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65120460|NCT01356290|Antimetabolites|antimetabolites|mesh-ancestor
65120461|NCT01356290|Antiviral Agents|antiviral agents|mesh-ancestor
65120462|NCT01356290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65120463|NCT01356290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65120464|NCT01356290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65120465|NCT01356290|Analgesics|analgesics|mesh-ancestor
65120466|NCT01356290|Sensory System Agents|sensory system agents|mesh-ancestor
65120467|NCT01356290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65120468|NCT01356290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65120469|NCT01356290|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65120470|NCT01356290|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65120471|NCT01356290|Leprostatic Agents|leprostatic agents|mesh-ancestor
65120472|NCT01356290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65120473|NCT01356290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65120474|NCT01356290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65120475|NCT01356290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65120476|NCT01047540|Pritelivir|pritelivir|mesh-list
65120477|NCT01047540|Antiviral Agents|antiviral agents|mesh-ancestor
65120478|NCT01047540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65120479|NCT01047540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120480|NCT01047540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120481|NCT00521222|Fluticasone|fluticasone|mesh-list
65120482|NCT00521222|Xhance|xhance|mesh-list
65120483|NCT00521222|Albuterol|albuterol|mesh-list
65120484|NCT00521222|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65120485|NCT00521222|Ipratropium|ipratropium|mesh-list
65120486|NCT00521222|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65120487|NCT00521222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65120488|NCT00521222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65120489|NCT00521222|Autonomic Agents|autonomic agents|mesh-ancestor
65120490|NCT00521222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65120491|NCT00521222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120492|NCT00521222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65120493|NCT00521222|Respiratory System Agents|respiratory system agents|mesh-ancestor
65120494|NCT00521222|Dermatologic Agents|dermatologic agents|mesh-ancestor
65295728|NCT00707187|Urological Agents|urological agents|mesh-ancestor
65295729|NCT03998761|Progesterone|progesterone|mesh-list
65295730|NCT03998761|Dydrogesterone|dydrogesterone|mesh-list
65295731|NCT03998761|Progestins|progestins|mesh-ancestor
65295732|NCT03998761|Hormones|hormones|mesh-ancestor
65295733|NCT03998761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65295734|NCT03998761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295735|NCT00658580|Etoposide|etoposide|mesh-list
65295736|NCT00658580|Etoposide phosphate|etoposide phosphate|mesh-list
65295737|NCT00658580|Epirubicin|epirubicin|mesh-list
65295738|NCT00658580|Ifosfamide|ifosfamide|mesh-list
65295739|NCT00658580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295740|NCT00658580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65295741|NCT00658580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65295742|NCT00658580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65295743|NCT00658580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295744|NCT00658580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295745|NCT00658580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65295746|NCT00658580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65295747|NCT00658580|Alkylating Agents|alkylating agents|mesh-ancestor
65295748|NCT00729742|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65295749|NCT00729742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295750|NCT00729742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65295751|NCT00729742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295752|NCT00729742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295753|NCT03435107|Durvalumab|durvalumab|mesh-list
65295754|NCT03435107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65295755|NCT03435107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295756|NCT03612791|Atezolizumab|atezolizumab|mesh-list
65295757|NCT03612791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120495|NCT00521222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65120496|NCT00521222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65120497|NCT00521222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65120498|NCT00521222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65120499|NCT00521222|Adrenergic Agents|adrenergic agents|mesh-ancestor
65120500|NCT00521222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64692798|NCT01982695|Protective Agents|protective agents|mesh-ancestor
64514025|NCT02620761|Fenoldopam|fenoldopam|mesh-list
65120508|NCT00521222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65120509|NCT00521222|Sympathomimetics|sympathomimetics|mesh-ancestor
65120510|NCT00378482|Tremelimumab|tremelimumab|mesh-list
65120511|NCT00378482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120512|NCT00195091|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
65120513|NCT00195091|Chelating Agents|chelating agents|mesh-ancestor
65120514|NCT00195091|Sequestering Agents|sequestering agents|mesh-ancestor
65120515|NCT00195091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295758|NCT00827541|Tigecycline|tigecycline|mesh-list
65295759|NCT00827541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65295760|NCT00827541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65295761|NCT00827541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65295762|NCT00827541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295763|NCT00827541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295764|NCT05741866|Chlorhexidine|chlorhexidine|mesh-list
65120516|NCT00195091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120517|NCT00195091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65120518|NCT00195091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65120519|NCT00195091|Growth Substances|growth substances|mesh-ancestor
65120520|NCT00195091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120521|NCT00195091|Growth Inhibitors|growth inhibitors|mesh-ancestor
65120522|NCT00195091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120523|NCT00545012|Levetiracetam|levetiracetam|mesh-list
65120524|NCT00545012|Anticonvulsants|anticonvulsants|mesh-ancestor
65120525|NCT00545012|Nootropic Agents|nootropic agents|mesh-ancestor
65120526|NCT00545090|Ibandronic Acid|ibandronic acid|mesh-list
65120527|NCT00545090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65120528|NCT00545090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120529|NCT00545207|Ibandronic Acid|ibandronic acid|mesh-list
65120530|NCT00545207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65120531|NCT00545207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120533|NCT00545246|Aflibercept|aflibercept|mesh-list
65120534|NCT00545246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120535|NCT00545246|Tubulin Modulators|tubulin modulators|mesh-ancestor
65120536|NCT00545246|Antimitotic Agents|antimitotic agents|mesh-ancestor
65120537|NCT00545246|Mitosis Modulators|mitosis modulators|mesh-ancestor
65120538|NCT00545246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120539|NCT00545246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65120540|NCT00545246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65120541|NCT00545246|Growth Substances|growth substances|mesh-ancestor
65120542|NCT00545246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120543|NCT00545246|Growth Inhibitors|growth inhibitors|mesh-ancestor
65120544|NCT03456401|Sorafenib|sorafenib|mesh-list
65120545|NCT03456401|Sunitinib|sunitinib|mesh-list
65120546|NCT03456401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120547|NCT03456401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65120548|NCT03456401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120549|NCT03456401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120550|NCT03456401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65120551|NCT03456401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65120552|NCT03456401|Growth Substances|growth substances|mesh-ancestor
65120553|NCT03456401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120554|NCT03456401|Growth Inhibitors|growth inhibitors|mesh-ancestor
65120555|NCT00545480|Ibandronic Acid|ibandronic acid|mesh-list
65120556|NCT00545480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65120557|NCT00545480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120558|NCT04646694|Ketamine|ketamine|mesh-list
65120559|NCT04646694|Analgesics|analgesics|mesh-ancestor
65120560|NCT04646694|Sensory System Agents|sensory system agents|mesh-ancestor
65120561|NCT04646694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65120562|NCT04646694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120563|NCT04646694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65120564|NCT04646694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65120565|NCT04646694|Anesthetics, General|anesthetics, general|mesh-ancestor
65120566|NCT04646694|Anesthetics|anesthetics|mesh-ancestor
65120567|NCT04646694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65120568|NCT04646694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65120574|NCT04638036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120575|NCT00545519|Thymoglobulin|thymoglobulin|mesh-list
64762879|NCT02099175|Mitosis Modulators|mitosis modulators|mesh-ancestor
64762880|NCT02099175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762881|NCT02099175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64762882|NCT02099175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64762883|NCT02099175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64762884|NCT02099175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762885|NCT02099175|Antimetabolites|antimetabolites|mesh-ancestor
65295765|NCT05741866|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65295766|NCT05741866|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65295767|NCT05741866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65295768|NCT05741866|Disinfectants|disinfectants|mesh-ancestor
65295769|NCT05741866|Dermatologic Agents|dermatologic agents|mesh-ancestor
65295770|NCT03916601|Insulin|insulin|mesh-list
65295771|NCT03916601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65295772|NCT03916601|Insulin Aspart|insulin aspart|mesh-list
65295773|NCT03916601|Insulin, Long-Acting|insulin, long-acting|mesh-list
64525991|NCT01581281|Topiramate|topiramate|mesh-list
64525992|NCT01581281|Amitriptyline|amitriptyline|mesh-list
64762886|NCT02099175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64762887|NCT02099175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64762888|NCT02099175|Immunologic Factors|immunologic factors|mesh-ancestor
64762889|NCT02099175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762890|NCT02099175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64762891|NCT02099175|Antidotes|antidotes|mesh-ancestor
64762892|NCT02099175|Protective Agents|protective agents|mesh-ancestor
64762893|NCT02099175|Vitamin B Complex|vitamin b complex|mesh-ancestor
64762894|NCT02099175|Vitamins|vitamins|mesh-ancestor
64762895|NCT02099175|Micronutrients|micronutrients|mesh-ancestor
64762896|NCT02099175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64762897|NCT02099175|Alkylating Agents|alkylating agents|mesh-ancestor
64762898|NCT02019706|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
64762899|NCT02019706|Dopamine Agents|dopamine agents|mesh-ancestor
64762900|NCT02019706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64762901|NCT02019706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762902|NCT02019706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120577|NCT00545519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120578|NCT00545519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65120579|NCT00545558|Tenofovir|tenofovir|mesh-list
65120580|NCT00545558|Emtricitabine|emtricitabine|mesh-list
65120581|NCT00545558|Efavirenz|efavirenz|mesh-list
65120582|NCT00545558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65120583|NCT00545558|Antiviral Agents|antiviral agents|mesh-ancestor
65120584|NCT00545558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65120585|NCT00545558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65120586|NCT00545558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65120587|NCT00545558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120588|NCT00545558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120589|NCT00545558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65120590|NCT00545558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65120591|NCT00545558|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65120592|NCT00545558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65120593|NCT00545558|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65120594|NCT00545558|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65120595|NCT00545558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65120596|NCT00545558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65120597|NCT04684667|Propranolol|propranolol|mesh-list
65120598|NCT04684667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65120599|NCT04684667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65120600|NCT04684667|Adrenergic Agents|adrenergic agents|mesh-ancestor
65120601|NCT04684667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65120602|NCT04684667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120603|NCT04684667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120604|NCT04684667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65120605|NCT04684667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65120606|NCT04684667|Vasodilator Agents|vasodilator agents|mesh-ancestor
65120607|NCT00545675|Valproic Acid|valproic acid|mesh-list
65120608|NCT00545675|Aripiprazole|aripiprazole|mesh-list
65120609|NCT00545675|Antidepressive Agents|antidepressive agents|mesh-ancestor
65120610|NCT00545675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65120611|NCT00545675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65120612|NCT00545675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64692937|NCT01983020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65295774|NCT03916601|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65295775|NCT03916601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65295776|NCT03916601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295777|NCT00518323|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65295778|NCT00518323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65295779|NCT00518323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65295780|NCT00518323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65295781|NCT00518323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295782|NCT00518323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65295783|NCT00518323|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65120620|NCT00545675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65120621|NCT00545675|Serotonin Agents|serotonin agents|mesh-ancestor
65120622|NCT00545675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65120623|NCT00545675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65120624|NCT00545675|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65120625|NCT00545675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65120627|NCT00545675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120628|NCT00545675|GABA Agents|gaba agents|mesh-ancestor
65120629|NCT00545675|Antimanic Agents|antimanic agents|mesh-ancestor
65120630|NCT00545831|Taurolidine|taurolidine|mesh-list
65120631|NCT00545831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65120632|NCT00545831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65120633|NCT00545831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120634|NCT00545870|Bevacizumab|bevacizumab|mesh-list
65120635|NCT00545870|Ranibizumab|ranibizumab|mesh-list
65120636|NCT00545870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65120637|NCT00545870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120638|NCT00545870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65120639|NCT00545870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65120640|NCT00545870|Growth Substances|growth substances|mesh-ancestor
64762965|NCT01983241|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64762966|NCT01983241|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64762967|NCT01983241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64762968|NCT01983241|Protease Inhibitors|protease inhibitors|mesh-ancestor
64762969|NCT01983241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762970|NCT01983241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762973|NCT01946074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120641|NCT00545870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120642|NCT00545870|Growth Inhibitors|growth inhibitors|mesh-ancestor
65120643|NCT00545909|Ibandronic Acid|ibandronic acid|mesh-list
65120644|NCT00545909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65120645|NCT00545909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120646|NCT04645914|Nicotine|nicotine|mesh-list
65120647|NCT04645914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65120648|NCT04645914|Autonomic Agents|autonomic agents|mesh-ancestor
65120649|NCT04645914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65120650|NCT04645914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120651|NCT04645914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65120652|NCT04645914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65120653|NCT04645914|Cholinergic Agents|cholinergic agents|mesh-ancestor
65120654|NCT04645914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65120655|NCT04645914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120656|NCT00546065|Esomeprazole|esomeprazole|mesh-list
65120657|NCT00546065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65120658|NCT00546065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65120659|NCT00546065|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65120660|NCT00546065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120661|NCT00546065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120662|NCT00546143|Omalizumab|omalizumab|mesh-list
65120663|NCT00546143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65120664|NCT00546143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65120665|NCT00546143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65120666|NCT00546143|Respiratory System Agents|respiratory system agents|mesh-ancestor
65120667|NCT00546143|Immunologic Factors|immunologic factors|mesh-ancestor
65295784|NCT00518323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65295785|NCT00518323|Serotonin Agents|serotonin agents|mesh-ancestor
65295786|NCT00518323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65295787|NCT00518323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295788|NCT00518323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65295789|NCT00518323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65295790|NCT00518323|Dopamine Agents|dopamine agents|mesh-ancestor
65295791|NCT00707421|Fluorometholone|fluorometholone|mesh-list
65295792|NCT00707421|Ketorolac|ketorolac|mesh-list
65295793|NCT00707421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65295794|NCT00707421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65295795|NCT00707421|Analgesics|analgesics|mesh-ancestor
65295796|NCT00707421|Sensory System Agents|sensory system agents|mesh-ancestor
65295797|NCT00707421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65295798|NCT00707421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295799|NCT00707421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65295800|NCT00707421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65295801|NCT00707421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65295802|NCT00707421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295803|NCT00707421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295804|NCT00707421|Glucocorticoids|glucocorticoids|mesh-ancestor
65295805|NCT00707421|Hormones|hormones|mesh-ancestor
65344932|NCT00864058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65120668|NCT00546143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120669|NCT00560079|Allopurinol|allopurinol|mesh-list
65120670|NCT00560079|Dipyridamole|dipyridamole|mesh-list
65120671|NCT00560079|Antimetabolites|antimetabolites|mesh-ancestor
64693006|NCT02354378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653564|NCT03400592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120686|NCT00546494|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65120687|NCT00546494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65120688|NCT00546494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65120689|NCT00546494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120690|NCT00546494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65120691|NCT00546494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120692|NCT00546494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65120693|NCT00546494|Antidepressive Agents|antidepressive agents|mesh-ancestor
65120694|NCT00546494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65120696|NCT00546533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65120697|NCT00546533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65120698|NCT00546533|Analgesics|analgesics|mesh-ancestor
65120699|NCT00546533|Sensory System Agents|sensory system agents|mesh-ancestor
65120700|NCT00546533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65120701|NCT00546533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120702|NCT00546533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65120703|NCT00546533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65120704|NCT00546533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65120705|NCT00546533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65120706|NCT00546533|Immunologic Factors|immunologic factors|mesh-ancestor
65295806|NCT00707421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65295807|NCT00707421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65295808|NCT03570437|Paclitaxel|paclitaxel|mesh-list
65295809|NCT03570437|Olaparib|olaparib|mesh-list
65295810|NCT03570437|Cediranib|cediranib|mesh-list
65120707|NCT00558480|Vitamins|vitamins|mesh-list
65120708|NCT00558480|Vitamin A|vitamin a|mesh-list
65120709|NCT00558480|Retinol palmitate|retinol palmitate|mesh-list
65120710|NCT00558480|Micronutrients|micronutrients|mesh-ancestor
65120711|NCT00558480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120712|NCT00558480|Antioxidants|antioxidants|mesh-ancestor
65120713|NCT00558480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120714|NCT00558480|Protective Agents|protective agents|mesh-ancestor
65120715|NCT00558480|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65120716|NCT00558480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120717|NCT00546650|Sumatriptan|sumatriptan|mesh-list
65120718|NCT00546650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65120719|NCT00546650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65120720|NCT00546650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65120721|NCT00546650|Serotonin Agents|serotonin agents|mesh-ancestor
65120722|NCT00546650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65120723|NCT00546650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120724|NCT00546650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120725|NCT00546923|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65120726|NCT00546923|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65120727|NCT00546923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65120728|NCT00546923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65120751|NCT00547508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65120752|NCT00547508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120753|NCT00547508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120754|NCT00547508|Urological Agents|urological agents|mesh-ancestor
65120755|NCT00560274|Ribavirin|ribavirin|mesh-list
65120756|NCT00560274|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65120757|NCT00560274|Antimetabolites|antimetabolites|mesh-ancestor
65120758|NCT00560274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120759|NCT00560274|Antiviral Agents|antiviral agents|mesh-ancestor
65120760|NCT00560274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65120761|NCT00547547|Selenium|selenium|mesh-list
65120762|NCT00547547|Capecitabine|capecitabine|mesh-list
65120763|NCT00547547|Irinotecan|irinotecan|mesh-list
65120764|NCT00547547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65120765|NCT00547547|Antimetabolites|antimetabolites|mesh-ancestor
65120766|NCT00547547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120767|NCT00547547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120768|NCT00547547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65120769|NCT00547547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65120770|NCT00547547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120771|NCT00547547|Antioxidants|antioxidants|mesh-ancestor
65120772|NCT00547547|Protective Agents|protective agents|mesh-ancestor
65120773|NCT00547547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120774|NCT00547547|Trace Elements|trace elements|mesh-ancestor
65120775|NCT00547547|Micronutrients|micronutrients|mesh-ancestor
65120776|NCT00547625|Tadalafil|tadalafil|mesh-list
65120777|NCT00547625|Vasodilator Agents|vasodilator agents|mesh-ancestor
65120778|NCT00547625|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65120779|NCT00547625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65120780|NCT00547625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120781|NCT00547625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120799|NCT04636125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65120800|NCT04636125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65120801|NCT04636125|Antimalarials|antimalarials|mesh-ancestor
65120802|NCT04636125|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65120803|NCT04636125|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65120804|NCT04684628|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65120805|NCT04684628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65120806|NCT04684628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120807|NCT04636242|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65120808|NCT04636242|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65120809|NCT04636242|Dermatologic Agents|dermatologic agents|mesh-ancestor
65120810|NCT00548288|Pamidronate|pamidronate|mesh-list
65120811|NCT00548288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65295811|NCT03570437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65295812|NCT03570437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295813|NCT03570437|Tubulin Modulators|tubulin modulators|mesh-ancestor
65295814|NCT03570437|Antimitotic Agents|antimitotic agents|mesh-ancestor
65295815|NCT03570437|Mitosis Modulators|mitosis modulators|mesh-ancestor
65295816|NCT03570437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295817|NCT03570437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65295818|NCT03570437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295819|NCT03570437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65295820|NCT00826449|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65295821|NCT00826449|Dasatinib|dasatinib|mesh-list
65295822|NCT00826449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295823|NCT00826449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65295824|NCT00826449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295825|NCT00826449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295826|NCT03632213|Losartan|losartan|mesh-list
65295827|NCT03632213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65295828|NCT03632213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65295829|NCT03632213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65295830|NCT03632213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65295831|NCT03632213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295832|NCT00825825|Citalopram|citalopram|mesh-list
64526036|NCT02696226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120812|NCT00548288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120814|NCT04644354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65120815|NCT04644354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65120816|NCT04644354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120817|NCT04644354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65120818|NCT04644354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120819|NCT04644354|Vasodilator Agents|vasodilator agents|mesh-ancestor
65120820|NCT04644354|Tocolytic Agents|tocolytic agents|mesh-ancestor
65120821|NCT04644354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65120822|NCT00548483|Dexamethasone|dexamethasone|mesh-list
65120823|NCT00548483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65120824|NCT00548483|Antiemetics|antiemetics|mesh-ancestor
65120825|NCT00548483|Autonomic Agents|autonomic agents|mesh-ancestor
65120826|NCT00548483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65120827|NCT00548483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120828|NCT00548483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65120829|NCT00548483|Glucocorticoids|glucocorticoids|mesh-ancestor
65120830|NCT00548483|Hormones|hormones|mesh-ancestor
65120831|NCT00548483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65120832|NCT00548483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65120833|NCT00548483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120834|NCT04635852|Fentanyl|fentanyl|mesh-list
65120835|NCT04635852|Morphine|morphine|mesh-list
65120836|NCT04635852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65120837|NCT04635852|Narcotics|narcotics|mesh-ancestor
65120838|NCT04635852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65295833|NCT00825825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65295834|NCT00825825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65295835|NCT00825825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65295836|NCT00825825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295837|NCT00825825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65295838|NCT00825825|Serotonin Agents|serotonin agents|mesh-ancestor
65295839|NCT00825825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295840|NCT00825825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65295841|NCT00825825|Antidepressive Agents|antidepressive agents|mesh-ancestor
65295842|NCT00825825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65344933|NCT00864058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65344934|NCT00864058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64526061|NCT03167112|Vitamins|vitamins|mesh-ancestor
65120839|NCT04635852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120854|NCT00548561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120855|NCT00548561|Protective Agents|protective agents|mesh-ancestor
65120856|NCT00548561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120857|NCT00548561|Antimitotic Agents|antimitotic agents|mesh-ancestor
65120858|NCT00548561|Mitosis Modulators|mitosis modulators|mesh-ancestor
65120859|NCT04635696|Ethyl Chloride|ethyl chloride|mesh-list
65120860|NCT04635696|Anesthetics, Local|anesthetics, local|mesh-ancestor
65120861|NCT04635696|Anesthetics|anesthetics|mesh-ancestor
65120862|NCT04635696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65120863|NCT04635696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120864|NCT04635696|Sensory System Agents|sensory system agents|mesh-ancestor
65120865|NCT04635696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65120868|NCT00548678|Ketorolac|ketorolac|mesh-list
65120869|NCT00548678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65120870|NCT00548678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65120871|NCT00548678|Analgesics|analgesics|mesh-ancestor
65120872|NCT00548678|Sensory System Agents|sensory system agents|mesh-ancestor
65120873|NCT00548678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65120874|NCT00548678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120875|NCT00548678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65120876|NCT00548678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65120877|NCT00548678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65120878|NCT00548678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65120879|NCT00548678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120880|NCT00548678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65120881|NCT00548678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65120882|NCT00548678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120883|NCT00548678|Antipyretics|antipyretics|mesh-ancestor
65120884|NCT00548834|Certolizumab Pegol|certolizumab pegol|mesh-list
65120885|NCT00548834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65120886|NCT00548834|Immunologic Factors|immunologic factors|mesh-ancestor
65120887|NCT00548834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120888|NCT00548834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65120889|NCT04684199|Melatonin|melatonin|mesh-list
65120890|NCT04684199|Antioxidants|antioxidants|mesh-ancestor
65120891|NCT04684199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120892|NCT04684199|Protective Agents|protective agents|mesh-ancestor
65120893|NCT04684199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120894|NCT04684199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65120895|NCT00560586|Budesonide|budesonide|mesh-list
65120896|NCT00560586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65120897|NCT00560586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65120898|NCT00560586|Autonomic Agents|autonomic agents|mesh-ancestor
65120899|NCT00560586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65120900|NCT00560586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295843|NCT03802487|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65295844|NCT03802487|Charcoal|charcoal|mesh-list
65295845|NCT03802487|Antidotes|antidotes|mesh-ancestor
65295846|NCT03802487|Protective Agents|protective agents|mesh-ancestor
65295847|NCT03802487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295848|NCT03802487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65120901|NCT00560586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65120902|NCT00560586|Respiratory System Agents|respiratory system agents|mesh-ancestor
65120909|NCT00549068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120911|NCT00549068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120912|NCT00549068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65120913|NCT00549107|Simendan|simendan|mesh-list
65120914|NCT00549107|Milrinone|milrinone|mesh-list
65120915|NCT00549107|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65120916|NCT00549107|Vasodilator Agents|vasodilator agents|mesh-ancestor
65120917|NCT00549107|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65120918|NCT00549107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65120919|NCT00549107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120920|NCT00549107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120921|NCT00549107|Protective Agents|protective agents|mesh-ancestor
65120922|NCT00549107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120923|NCT00549107|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65120924|NCT00549146|Fluticasone|fluticasone|mesh-list
65120925|NCT00549146|Xhance|xhance|mesh-list
65120926|NCT00549146|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65120927|NCT00549146|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65120928|NCT00549146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65120929|NCT00549146|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65120930|NCT00549146|Autonomic Agents|autonomic agents|mesh-ancestor
65120931|NCT00549146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65120932|NCT00549146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120933|NCT00549146|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65120934|NCT00549146|Respiratory System Agents|respiratory system agents|mesh-ancestor
65120935|NCT00549146|Dermatologic Agents|dermatologic agents|mesh-ancestor
65120936|NCT00549146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65120937|NCT00549146|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65120938|NCT00549146|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65120939|NCT00549146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65120941|NCT00549146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65120942|NCT00549146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120943|NCT00549146|Glucocorticoids|glucocorticoids|mesh-ancestor
65120944|NCT00549146|Hormones|hormones|mesh-ancestor
65120945|NCT00549146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65120946|NCT00549146|Sympathomimetics|sympathomimetics|mesh-ancestor
65120947|NCT00549341|Botulinum Toxins|botulinum toxins|mesh-list
65120948|NCT00549341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65120949|NCT00549341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65120950|NCT00549341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120951|NCT00549341|Cholinergic Agents|cholinergic agents|mesh-ancestor
65120952|NCT00549341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65120953|NCT00549341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120954|NCT00549419|Dobutamine|dobutamine|mesh-list
65120955|NCT00549419|Norepinephrine|norepinephrine|mesh-list
65120956|NCT00549419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65120957|NCT00549419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65120958|NCT00549419|Adrenergic Agents|adrenergic agents|mesh-ancestor
65120959|NCT00549419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65120960|NCT00549419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120961|NCT00549419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120962|NCT00549419|Sympathomimetics|sympathomimetics|mesh-ancestor
65120963|NCT00549419|Autonomic Agents|autonomic agents|mesh-ancestor
65120964|NCT00549419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65120965|NCT00549419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65120966|NCT00549419|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65295849|NCT03802487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295850|NCT03802487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65295851|NCT00880334|Docetaxel|docetaxel|mesh-list
65295852|NCT00880334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295853|NCT00880334|Tubulin Modulators|tubulin modulators|mesh-ancestor
65295854|NCT00880334|Antimitotic Agents|antimitotic agents|mesh-ancestor
65295855|NCT00880334|Mitosis Modulators|mitosis modulators|mesh-ancestor
65295856|NCT00880334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295857|NCT01033565|Melatonin|melatonin|mesh-list
65295858|NCT01033565|Antioxidants|antioxidants|mesh-ancestor
65295859|NCT01033565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295860|NCT01033565|Protective Agents|protective agents|mesh-ancestor
64526083|NCT01578551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65120967|NCT00549419|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65120968|NCT00549419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65120969|NCT00549419|Protective Agents|protective agents|mesh-ancestor
65120970|NCT04643691|Losartan|losartan|mesh-list
65120971|NCT04643691|Spironolactone|spironolactone|mesh-list
65120990|NCT00549614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65120991|NCT00549614|Antimetabolites|antimetabolites|mesh-ancestor
65120992|NCT00549614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120993|NCT00549614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65120994|NCT04923542|Hormones|hormones|mesh-list
65120995|NCT04923542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65120996|NCT04923542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120997|NCT00559026|Dacarbazine|dacarbazine|mesh-list
65120998|NCT00559026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65120999|NCT00559026|Alkylating Agents|alkylating agents|mesh-ancestor
65121000|NCT00559026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121001|NCT00559026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121002|NCT00549887|Insulin|insulin|mesh-list
65121003|NCT00549887|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65121004|NCT00549887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65121005|NCT00549887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121006|NCT00549926|Atorvastatin|atorvastatin|mesh-list
65121007|NCT00549926|Pravastatin|pravastatin|mesh-list
65121008|NCT00549926|Pitavastatin|pitavastatin|mesh-list
65121009|NCT00549926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65121010|NCT00549926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65121011|NCT00549926|Antimetabolites|antimetabolites|mesh-ancestor
64763335|NCT04371978|Hormones|hormones|mesh-ancestor
65121012|NCT00549926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121013|NCT00549926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65121014|NCT00549926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65121015|NCT00549926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121016|NCT00549965|Risedronic Acid|risedronic acid|mesh-list
65121017|NCT00549965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65121018|NCT00549965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65121019|NCT00549965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121020|NCT00549965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65121021|NCT00549965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121022|NCT00549965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65121023|NCT00550004|Gemcitabine|gemcitabine|mesh-list
65121024|NCT00550004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65121036|NCT04634721|Anesthetics|anesthetics|mesh-ancestor
65121037|NCT04634721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65121038|NCT04634721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121039|NCT04634721|Sensory System Agents|sensory system agents|mesh-ancestor
65121040|NCT04634721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121041|NCT00550160|Artesunate|artesunate|mesh-list
65295861|NCT01033565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295862|NCT01033565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65295863|NCT00658892|Antibodies|antibodies|mesh-list
65295864|NCT00658892|Immunologic Factors|immunologic factors|mesh-ancestor
65295865|NCT00658892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295866|NCT00654914|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65295867|NCT00654914|Vasodilator Agents|vasodilator agents|mesh-ancestor
65295868|NCT00654914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65295869|NCT00654914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65295870|NCT00654914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295871|NCT00654914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295872|NCT00654914|Urological Agents|urological agents|mesh-ancestor
65295873|NCT00865566|Vaccines|vaccines|mesh-list
65295874|NCT00865566|Immunologic Factors|immunologic factors|mesh-ancestor
64526094|NCT01578551|Growth Inhibitors|growth inhibitors|mesh-ancestor
65121042|NCT00550160|Amodiaquine|amodiaquine|mesh-list
65121043|NCT00550160|Antimalarials|antimalarials|mesh-ancestor
65121044|NCT00550160|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65121045|NCT00550160|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65121046|NCT00550160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65121047|NCT00550160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121048|NCT00550160|Antiviral Agents|antiviral agents|mesh-ancestor
65121049|NCT00550160|Schistosomicides|schistosomicides|mesh-ancestor
65121050|NCT00550160|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65121051|NCT00550160|Anthelmintics|anthelmintics|mesh-ancestor
65121052|NCT00550199|Gemcitabine|gemcitabine|mesh-list
65121053|NCT00550199|Panobinostat|panobinostat|mesh-list
65121054|NCT00550199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65121055|NCT00550199|Antimetabolites|antimetabolites|mesh-ancestor
65121056|NCT00550199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121057|NCT00550199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121058|NCT00550199|Antiviral Agents|antiviral agents|mesh-ancestor
65121059|NCT00550199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65121060|NCT00550199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121061|NCT00550199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65121062|NCT00550199|Immunologic Factors|immunologic factors|mesh-ancestor
65121063|NCT00550199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121064|NCT00550199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65121065|NCT04643301|Liraglutide|liraglutide|mesh-list
65121066|NCT04643301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65121067|NCT04643301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121068|NCT04643301|Incretins|incretins|mesh-ancestor
65121069|NCT04643301|Hormones|hormones|mesh-ancestor
65121070|NCT04643301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65121071|NCT00550433|Bazedoxifene|bazedoxifene|mesh-list
65121072|NCT00550433|Estrogens|estrogens|mesh-list
65121073|NCT00550433|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65121074|NCT00550433|Hormones|hormones|mesh-ancestor
65121075|NCT00550433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65121076|NCT00550433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121077|NCT00550433|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65121078|NCT00550433|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65121079|NCT00550433|Hormone Antagonists|hormone antagonists|mesh-ancestor
65121080|NCT00550433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65121081|NCT04642989|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65121082|NCT04642989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65121083|NCT04898231|Methylprednisolone|methylprednisolone|mesh-list
65121084|NCT04898231|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65121085|NCT04898231|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65121086|NCT04898231|Prednisolone|prednisolone|mesh-list
65295875|NCT00865566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295876|NCT00658970|Tirbanibulin|tirbanibulin|mesh-list
65295877|NCT00658970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295878|NCT00658970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295879|NCT00710554|Nabiximols|nabiximols|mesh-list
65295880|NCT00710554|Analgesics|analgesics|mesh-ancestor
65295881|NCT00710554|Sensory System Agents|sensory system agents|mesh-ancestor
65295882|NCT00710554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65295883|NCT00710554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295884|NCT00659048|Ciclesonide|ciclesonide|mesh-list
65295885|NCT00659048|Glucocorticoids|glucocorticoids|mesh-ancestor
65295886|NCT00659048|Hormones|hormones|mesh-ancestor
65295887|NCT00659048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65295888|NCT00659048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295889|NCT00659048|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65295890|NCT02623920|Rituximab|rituximab|mesh-list
65295891|NCT02623920|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65295892|NCT02623920|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65295893|NCT02623920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65295894|NCT02623920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295895|NCT02623920|Immunologic Factors|immunologic factors|mesh-ancestor
64526105|NCT01692197|Glucocorticoids|glucocorticoids|mesh-ancestor
65121087|NCT04898231|Prednisolone acetate|prednisolone acetate|mesh-list
65121088|NCT04898231|Infliximab|infliximab|mesh-list
65121089|NCT04898231|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65121100|NCT04898231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65121101|NCT04898231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65121102|NCT04898231|Protective Agents|protective agents|mesh-ancestor
65121103|NCT04898231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65121104|NCT04898231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121105|NCT04898231|Dermatologic Agents|dermatologic agents|mesh-ancestor
65121106|NCT04898231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65121108|NCT04634058|Immunoglobulins|immunoglobulins|mesh-list
65121109|NCT04634058|Immunologic Factors|immunologic factors|mesh-ancestor
65121110|NCT04634058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121111|NCT00550628|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65121112|NCT00550628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65121113|NCT00550628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121114|NCT00560820|Deferasirox|deferasirox|mesh-list
65121115|NCT00560820|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65121116|NCT00560820|Chelating Agents|chelating agents|mesh-ancestor
65121117|NCT00560820|Sequestering Agents|sequestering agents|mesh-ancestor
65121118|NCT00560820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121119|NCT00550784|Paclitaxel|paclitaxel|mesh-list
65121120|NCT00550784|Cyclophosphamide|cyclophosphamide|mesh-list
65121121|NCT00550784|Melphalan|melphalan|mesh-list
65121122|NCT00550784|Topotecan|topotecan|mesh-list
65121123|NCT00550784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65121124|NCT00550784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121125|NCT00550784|Tubulin Modulators|tubulin modulators|mesh-ancestor
65121126|NCT00550784|Antimitotic Agents|antimitotic agents|mesh-ancestor
65121127|NCT00550784|Mitosis Modulators|mitosis modulators|mesh-ancestor
65121128|NCT00550784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295896|NCT02623920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295897|NCT02623920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65295898|NCT02623920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65295899|NCT02623920|Alkylating Agents|alkylating agents|mesh-ancestor
65295900|NCT02623920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295901|NCT00525499|Androgens|androgens|mesh-list
65295902|NCT00525499|Hormones|hormones|mesh-ancestor
65295903|NCT00525499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65295904|NCT00525499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295905|NCT04576546|Inositol|inositol|mesh-list
65295906|NCT04576546|Vitamin B Complex|vitamin b complex|mesh-ancestor
65295908|NCT04576546|Micronutrients|micronutrients|mesh-ancestor
65295909|NCT04576546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295910|NCT02617680|Nitric Oxide|nitric oxide|mesh-list
65295911|NCT02617680|Desflurane|desflurane|mesh-list
65295912|NCT02617680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65295913|NCT02617680|Autonomic Agents|autonomic agents|mesh-ancestor
65295914|NCT02617680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65295915|NCT02617680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295916|NCT02617680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65121129|NCT00550784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65121130|NCT00550784|Immunologic Factors|immunologic factors|mesh-ancestor
65121131|NCT00550784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121132|NCT00550784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65121133|NCT00550784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65121134|NCT00550784|Alkylating Agents|alkylating agents|mesh-ancestor
65121135|NCT00550784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65121136|NCT00550784|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65121137|NCT00550784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65121138|NCT00550784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121139|NCT00550901|Dexrazoxane|dexrazoxane|mesh-list
65121140|NCT00550901|Razoxane|razoxane|mesh-list
65121141|NCT00550901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121142|NCT00550901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65121143|NCT00550901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65121144|NCT00550901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65121145|NCT00550901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121146|NCT00550901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121147|NCT00550901|Protective Agents|protective agents|mesh-ancestor
65121148|NCT00550901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121149|NCT00550901|Antimitotic Agents|antimitotic agents|mesh-ancestor
65121150|NCT00550901|Mitosis Modulators|mitosis modulators|mesh-ancestor
65121151|NCT04633746|Endostatins|endostatins|mesh-list
65121152|NCT04633746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121153|NCT04633746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65121154|NCT04633746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65121155|NCT04633746|Growth Substances|growth substances|mesh-ancestor
65121167|NCT00551018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65121169|NCT04643106|Coagulants|coagulants|mesh-ancestor
65121170|NCT00551096|Gemcitabine|gemcitabine|mesh-list
65121171|NCT00551096|Capecitabine|capecitabine|mesh-list
65121172|NCT00551096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65121173|NCT00551096|Antimetabolites|antimetabolites|mesh-ancestor
65121174|NCT00551096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121175|NCT00551096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65295917|NCT02617680|Respiratory System Agents|respiratory system agents|mesh-ancestor
65295918|NCT02617680|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65295919|NCT02617680|Antioxidants|antioxidants|mesh-ancestor
65295920|NCT02617680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295921|NCT02617680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65295922|NCT02617680|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65295923|NCT02617680|Vasodilator Agents|vasodilator agents|mesh-ancestor
65295924|NCT02617680|Gasotransmitters|gasotransmitters|mesh-ancestor
65295925|NCT02617680|Protective Agents|protective agents|mesh-ancestor
65295926|NCT02617680|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65295927|NCT02617680|Anesthetics, General|anesthetics, general|mesh-ancestor
65295928|NCT02617680|Anesthetics|anesthetics|mesh-ancestor
65295929|NCT02617680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65295930|NCT02568280|Insulin|insulin|mesh-list
65295931|NCT02568280|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65295932|NCT02568280|Insulin Aspart|insulin aspart|mesh-list
65295933|NCT02568280|Insulin, Long-Acting|insulin, long-acting|mesh-list
64526147|NCT03166254|Pembrolizumab|pembrolizumab|mesh-list
65121176|NCT00551096|Antiviral Agents|antiviral agents|mesh-ancestor
65121177|NCT00551096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65121178|NCT00551096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654066|NCT02489448|Durvalumab|durvalumab|mesh-list
65121179|NCT00551096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65121180|NCT00551096|Immunologic Factors|immunologic factors|mesh-ancestor
65121181|NCT00551096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121182|NCT00551252|Gemcitabine|gemcitabine|mesh-list
65121183|NCT00551252|Imatinib Mesylate|imatinib mesylate|mesh-list
65121184|NCT00551252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65121185|NCT00551252|Antimetabolites|antimetabolites|mesh-ancestor
65121186|NCT00551252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121187|NCT00551252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121188|NCT00551252|Antiviral Agents|antiviral agents|mesh-ancestor
65121189|NCT00551252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65121190|NCT00551252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121191|NCT00551252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65121192|NCT00551252|Immunologic Factors|immunologic factors|mesh-ancestor
65121193|NCT00551252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121194|NCT00551252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65121195|NCT01125761|Clemastine|clemastine|mesh-list
65121196|NCT01125761|Dexamethasone|dexamethasone|mesh-list
65121197|NCT01125761|Dexamethasone acetate|dexamethasone acetate|mesh-list
65121198|NCT01125761|BB 1101|bb 1101|mesh-list
65121199|NCT01125761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65121200|NCT01125761|Antiemetics|antiemetics|mesh-ancestor
65121201|NCT01125761|Autonomic Agents|autonomic agents|mesh-ancestor
65121202|NCT01125761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121203|NCT01125761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121204|NCT01125761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65121205|NCT01125761|Glucocorticoids|glucocorticoids|mesh-ancestor
65121206|NCT01125761|Hormones|hormones|mesh-ancestor
65121207|NCT01125761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65121208|NCT01125761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65121209|NCT01125761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121210|NCT01125761|Protease Inhibitors|protease inhibitors|mesh-ancestor
65121211|NCT01125761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121212|NCT01125761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121213|NCT01125761|Antipruritics|antipruritics|mesh-ancestor
65121214|NCT01125761|Dermatologic Agents|dermatologic agents|mesh-ancestor
65121215|NCT01125761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65295934|NCT02568280|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65295935|NCT02568280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65295936|NCT02568280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295937|NCT00525265|Tolvaptan|tolvaptan|mesh-list
65295938|NCT00525265|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65295939|NCT00525265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295940|NCT00525265|Natriuretic Agents|natriuretic agents|mesh-ancestor
65295941|NCT00525265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295942|NCT04158830|Aspirin|aspirin|mesh-list
65295943|NCT04158830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65295944|NCT04158830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65295945|NCT04158830|Analgesics|analgesics|mesh-ancestor
65295946|NCT04158830|Sensory System Agents|sensory system agents|mesh-ancestor
65295947|NCT04158830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65295948|NCT04158830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295949|NCT04158830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65295950|NCT04158830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65295951|NCT04158830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65295952|NCT04158830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65295953|NCT04158830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295954|NCT04158830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64526162|NCT02651428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65121216|NCT01125761|Histamine Antagonists|histamine antagonists|mesh-ancestor
65121217|NCT01125761|Histamine Agents|histamine agents|mesh-ancestor
65121218|NCT01125761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65121219|NCT01125761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65121246|NCT00871013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65121247|NCT00871013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65121248|NCT00871013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65121249|NCT00871013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121250|NCT00871013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65121251|NCT00871013|Leprostatic Agents|leprostatic agents|mesh-ancestor
65121252|NCT00871013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65121253|NCT00871013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65121254|NCT00871013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65121255|NCT00871013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65121256|NCT00871013|Growth Substances|growth substances|mesh-ancestor
65121257|NCT00871013|Growth Inhibitors|growth inhibitors|mesh-ancestor
65121258|NCT04641780|Brexpiprazole|brexpiprazole|mesh-list
65121259|NCT04641780|Serotonin Agents|serotonin agents|mesh-ancestor
65121260|NCT04641780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65121261|NCT04641780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121262|NCT04641780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121263|NCT04641780|Dopamine Agonists|dopamine agonists|mesh-ancestor
65121264|NCT04641780|Dopamine Agents|dopamine agents|mesh-ancestor
65121265|NCT05431595|Valproic Acid|valproic acid|mesh-list
65121266|NCT05431595|Haloperidol|haloperidol|mesh-list
65121267|NCT05431595|Chlorpromazine|chlorpromazine|mesh-list
65121268|NCT05431595|Haloperidol decanoate|haloperidol decanoate|mesh-list
65121281|NCT05431595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295955|NCT04158830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65295956|NCT04158830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65295957|NCT04158830|Antipyretics|antipyretics|mesh-ancestor
65295958|NCT00659282|Insulin Aspart|insulin aspart|mesh-list
65295959|NCT00659282|Biphasic Insulins|biphasic insulins|mesh-list
65295960|NCT00659282|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65295961|NCT00659282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65295962|NCT00659282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295963|NCT02617758|Fentanyl|fentanyl|mesh-list
65295964|NCT02617758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65295965|NCT02617758|Narcotics|narcotics|mesh-ancestor
65295966|NCT02617758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65295967|NCT02617758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295968|NCT02617758|Analgesics|analgesics|mesh-ancestor
65295969|NCT02617758|Sensory System Agents|sensory system agents|mesh-ancestor
65295970|NCT02617758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65295971|NCT02617758|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65295972|NCT02617758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65295973|NCT02617758|Anesthetics, General|anesthetics, general|mesh-ancestor
65295974|NCT02617758|Anesthetics|anesthetics|mesh-ancestor
65295975|NCT00737542|Lidocaine|lidocaine|mesh-list
65295976|NCT00737542|Anesthetics, Local|anesthetics, local|mesh-ancestor
65295977|NCT00737542|Anesthetics|anesthetics|mesh-ancestor
65295978|NCT00737542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65295979|NCT00737542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65295980|NCT00737542|Sensory System Agents|sensory system agents|mesh-ancestor
65295981|NCT00737542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65295983|NCT00737542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65295984|NCT00737542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65295985|NCT00737542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65295986|NCT00737542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65295998|NCT00659594|Ciclesonide|ciclesonide|mesh-list
65295999|NCT00659594|Glucocorticoids|glucocorticoids|mesh-ancestor
65296000|NCT00659594|Hormones|hormones|mesh-ancestor
65296001|NCT00659594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65296002|NCT00659594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296003|NCT00659594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65296004|NCT05541016|Cisplatin|cisplatin|mesh-list
65296005|NCT05541016|Docetaxel|docetaxel|mesh-list
65296006|NCT05541016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296007|NCT05541016|Tubulin Modulators|tubulin modulators|mesh-ancestor
65296008|NCT05541016|Antimitotic Agents|antimitotic agents|mesh-ancestor
65296009|NCT05541016|Mitosis Modulators|mitosis modulators|mesh-ancestor
65296010|NCT05541016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296011|NCT04158050|Omalizumab|omalizumab|mesh-list
65296012|NCT04158050|Antibodies|antibodies|mesh-list
65296013|NCT04158050|Immunologic Factors|immunologic factors|mesh-ancestor
65296014|NCT04158050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296015|NCT04158050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64526227|NCT02653144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64526229|NCT02653144|Anesthetics, Local|anesthetics, local|mesh-ancestor
65121282|NCT05431595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65121283|NCT05431595|Anticonvulsants|anticonvulsants|mesh-ancestor
65121284|NCT05431595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121285|NCT05431595|GABA Agents|gaba agents|mesh-ancestor
65121286|NCT05431595|Antimanic Agents|antimanic agents|mesh-ancestor
65121288|NCT05408312|Immunologic Factors|immunologic factors|mesh-ancestor
65121289|NCT05408312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121290|NCT00559338|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65121291|NCT00559338|Natriuretic Agents|natriuretic agents|mesh-ancestor
65121292|NCT00559338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121293|NCT05340374|177Lu-PSMA-617|177lu-psma-617|mesh-list
65121294|NCT05340374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65121295|NCT05340374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121296|NCT04640883|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
65121297|NCT04640883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121298|NCT04640883|Immunologic Factors|immunologic factors|mesh-ancestor
65121299|NCT04640883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121300|NCT00553124|Vitamin E|vitamin e|mesh-list
65121301|NCT00553124|Selenium|selenium|mesh-list
65121302|NCT00553124|Vitamins|vitamins|mesh-ancestor
65121303|NCT00553124|Micronutrients|micronutrients|mesh-ancestor
65121304|NCT00553124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121305|NCT00553124|Antioxidants|antioxidants|mesh-ancestor
65121306|NCT00553124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121307|NCT00553124|Protective Agents|protective agents|mesh-ancestor
65121308|NCT00553124|Trace Elements|trace elements|mesh-ancestor
65121309|NCT04640181|Enoxaparin|enoxaparin|mesh-list
65121310|NCT04640181|Rivaroxaban|rivaroxaban|mesh-list
65121311|NCT04640181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65121312|NCT04640181|Antithrombins|antithrombins|mesh-ancestor
65121313|NCT04640181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65121314|NCT04640181|Protease Inhibitors|protease inhibitors|mesh-ancestor
65121315|NCT04640181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121316|NCT04640181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121317|NCT04640181|Anticoagulants|anticoagulants|mesh-ancestor
65121318|NCT04640181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65121319|NCT04640181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65121320|NCT05317364|Estradiol|estradiol|mesh-list
65121321|NCT05317364|Estrogens|estrogens|mesh-ancestor
64526244|NCT00118365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65296016|NCT04158050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65296017|NCT04158050|Respiratory System Agents|respiratory system agents|mesh-ancestor
65296018|NCT00659750|Ciclesonide|ciclesonide|mesh-list
65296019|NCT00659750|Glucocorticoids|glucocorticoids|mesh-ancestor
65296020|NCT00659750|Hormones|hormones|mesh-ancestor
65296021|NCT00659750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65296022|NCT00659750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296023|NCT00659750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65296024|NCT00697476|Topotecan|topotecan|mesh-list
65296025|NCT00697476|Vorinostat|vorinostat|mesh-list
65296026|NCT00697476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65296027|NCT00697476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65296028|NCT00697476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296029|NCT00697476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296030|NCT00697476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296031|NCT00697476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65296032|NCT00660062|Dexetimide|dexetimide|mesh-list
65296033|NCT00660062|Citalopram|citalopram|mesh-list
65296034|NCT00660062|Nortriptyline|nortriptyline|mesh-list
65296035|NCT00660062|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65296036|NCT00660062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65296037|NCT00660062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64526249|NCT03165240|Eplerenone|eplerenone|mesh-list
65121322|NCT05317364|Hormones|hormones|mesh-ancestor
65121323|NCT05317364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65121324|NCT05317364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121325|NCT00559455|Leucovorin|leucovorin|mesh-list
65121326|NCT00559455|Fluorouracil|fluorouracil|mesh-list
65121327|NCT00559455|Oxaliplatin|oxaliplatin|mesh-list
65121328|NCT00559455|Antimetabolites|antimetabolites|mesh-ancestor
65121329|NCT00559455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121330|NCT00559455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65121331|NCT00559455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121332|NCT00559455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65121333|NCT00559455|Immunologic Factors|immunologic factors|mesh-ancestor
65121334|NCT00559455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121354|NCT05209412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65121356|NCT05209412|Sensory System Agents|sensory system agents|mesh-ancestor
65121357|NCT05209412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121358|NCT05209412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121359|NCT05209412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65121360|NCT05209412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65121361|NCT05209412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65121362|NCT05209412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65121363|NCT05209412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65121364|NCT05209412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65121365|NCT05209412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121366|NCT05209412|Antipyretics|antipyretics|mesh-ancestor
65121367|NCT05209412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64526265|NCT01587079|Parasympatholytics|parasympatholytics|mesh-ancestor
65296038|NCT00660062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296039|NCT00660062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65296040|NCT00660062|Serotonin Agents|serotonin agents|mesh-ancestor
65296041|NCT00660062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296042|NCT00660062|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65296043|NCT00660062|Antidepressive Agents|antidepressive agents|mesh-ancestor
65296044|NCT00660062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65296045|NCT00660062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65296046|NCT00660062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65296047|NCT00660062|Parasympatholytics|parasympatholytics|mesh-ancestor
65296048|NCT00660062|Autonomic Agents|autonomic agents|mesh-ancestor
65296049|NCT00660062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65296050|NCT00660062|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65296051|NCT00660062|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65296052|NCT00660062|Cholinergic Agents|cholinergic agents|mesh-ancestor
65296053|NCT00660062|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65045963|NCT00414414|Prednisone|prednisone|mesh-list
65046004|NCT00239421|Xhance|xhance|mesh-list
65121368|NCT05209412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65121369|NCT05209412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65121370|NCT05209412|Purinergic Agents|purinergic agents|mesh-ancestor
65121371|NCT05209412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65121372|NCT05197322|Pembrolizumab|pembrolizumab|mesh-list
65121373|NCT05197322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65121374|NCT05197322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121375|NCT05186675|Epinephrine|epinephrine|mesh-list
65121376|NCT05186675|Racepinephrine|racepinephrine|mesh-list
65121377|NCT05186675|Epinephryl borate|epinephryl borate|mesh-list
65121378|NCT05186675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65121379|NCT05186675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65121380|NCT05186675|Adrenergic Agents|adrenergic agents|mesh-ancestor
65121381|NCT05186675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65121382|NCT05186675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121383|NCT05186675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121384|NCT05186675|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65121385|NCT05186675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65121386|NCT05186675|Autonomic Agents|autonomic agents|mesh-ancestor
65121387|NCT05186675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121388|NCT05186675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65121389|NCT05186675|Respiratory System Agents|respiratory system agents|mesh-ancestor
65121390|NCT05186675|Mydriatics|mydriatics|mesh-ancestor
65121391|NCT05186675|Sympathomimetics|sympathomimetics|mesh-ancestor
65121392|NCT05186675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65121406|NCT04639284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65121407|NCT04639284|Growth Substances|growth substances|mesh-ancestor
65121408|NCT04639284|Growth Inhibitors|growth inhibitors|mesh-ancestor
65121409|NCT04639284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121411|NCT00559689|Beclomethasone|beclomethasone|mesh-list
65121412|NCT00559689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65121413|NCT00559689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65121414|NCT00559689|Autonomic Agents|autonomic agents|mesh-ancestor
65121415|NCT00559689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121416|NCT00559689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121417|NCT00559689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65121418|NCT00559689|Respiratory System Agents|respiratory system agents|mesh-ancestor
65121419|NCT00559689|Glucocorticoids|glucocorticoids|mesh-ancestor
65296054|NCT00660062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65296055|NCT00660062|Adrenergic Agents|adrenergic agents|mesh-ancestor
65296057|NCT04063540|Diuretics|diuretics|mesh-ancestor
65296058|NCT04063540|Natriuretic Agents|natriuretic agents|mesh-ancestor
65296059|NCT04063540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296060|NCT04063540|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65296061|NCT04063540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65296062|NCT04063540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64526283|NCT02654860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526284|NCT02654860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65121420|NCT00559689|Hormones|hormones|mesh-ancestor
65121421|NCT00559689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65121422|NCT04629027|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65121423|NCT04629027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121424|NCT04629027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121425|NCT00561288|Acetaminophen|acetaminophen|mesh-list
65121426|NCT00561288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65121427|NCT00561288|Analgesics|analgesics|mesh-ancestor
65121428|NCT00561288|Sensory System Agents|sensory system agents|mesh-ancestor
65121429|NCT00561288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121430|NCT00561288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121431|NCT00561288|Antipyretics|antipyretics|mesh-ancestor
65121432|NCT00561327|Losartan|losartan|mesh-list
65121433|NCT00561327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65121434|NCT00561327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65121435|NCT00561327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65121436|NCT00561327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65121437|NCT00561327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121438|NCT00561522|Capecitabine|capecitabine|mesh-list
65121439|NCT00561522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65121440|NCT00561522|Antimetabolites|antimetabolites|mesh-ancestor
65121441|NCT00561522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121442|NCT00561522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121443|NCT03454620|Irinotecan|irinotecan|mesh-list
65121444|NCT03454620|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65121445|NCT03454620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65121446|NCT03454620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121447|NCT03454620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121448|NCT03454620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121449|NCT04628559|Dexmedetomidine|dexmedetomidine|mesh-list
65121450|NCT04628559|Ketamine|ketamine|mesh-list
65121451|NCT04628559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65121452|NCT04628559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65121453|NCT04628559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121454|NCT04628559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65121455|NCT04628559|Analgesics|analgesics|mesh-ancestor
65121468|NCT04628559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65121470|NCT04683341|Tenofovir|tenofovir|mesh-list
65121471|NCT04683341|Antiviral Agents|antiviral agents|mesh-ancestor
65121472|NCT04683341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65121473|NCT04683341|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65121474|NCT04683341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65121475|NCT04683341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121476|NCT04683341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121477|NCT04683341|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65121478|NCT04683341|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65121479|NCT04628676|Epinephrine|epinephrine|mesh-list
65121480|NCT04628676|Tranylcypromine|tranylcypromine|mesh-list
65121481|NCT04628676|Tranexamic Acid|tranexamic acid|mesh-list
65121482|NCT04628676|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65121483|NCT04628676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65121484|NCT04628676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121485|NCT04628676|Hemostatics|hemostatics|mesh-ancestor
65296063|NCT04063540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296064|NCT04063540|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65296065|NCT04063540|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65296066|NCT04161560|Cetuximab|cetuximab|mesh-list
65296067|NCT04161560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65296068|NCT04161560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296069|NCT00518011|Gemcitabine|gemcitabine|mesh-list
65296070|NCT00518011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65296071|NCT00518011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65296072|NCT00518011|Antimetabolites|antimetabolites|mesh-ancestor
65296073|NCT00518011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296074|NCT00518011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296075|NCT00518011|Antiviral Agents|antiviral agents|mesh-ancestor
65296076|NCT00518011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65296077|NCT00518011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296078|NCT00518011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65296079|NCT00518011|Immunologic Factors|immunologic factors|mesh-ancestor
65296080|NCT00518011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296081|NCT00518011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65296082|NCT00737776|Insulin Aspart|insulin aspart|mesh-list
65296083|NCT00737776|Biphasic Insulins|biphasic insulins|mesh-list
65296084|NCT00737776|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65296085|NCT00737776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65296086|NCT00737776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121486|NCT04628676|Coagulants|coagulants|mesh-ancestor
65121487|NCT04628676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65121488|NCT04628676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65121489|NCT04628676|Adrenergic Agents|adrenergic agents|mesh-ancestor
65121490|NCT04628676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65121491|NCT04628676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121492|NCT04628676|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65121493|NCT04628676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65121494|NCT04628676|Autonomic Agents|autonomic agents|mesh-ancestor
65121495|NCT04628676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121496|NCT04628676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65121497|NCT04628676|Respiratory System Agents|respiratory system agents|mesh-ancestor
65121498|NCT04628676|Mydriatics|mydriatics|mesh-ancestor
65121499|NCT04628676|Sympathomimetics|sympathomimetics|mesh-ancestor
65121500|NCT04628676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65121501|NCT04628676|Antidepressive Agents|antidepressive agents|mesh-ancestor
65121502|NCT04628676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65121503|NCT04628676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65121504|NCT04628676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121505|NCT04628676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65121506|NCT04628676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65121507|NCT04628676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65121508|NCT04628325|Furosemide|furosemide|mesh-list
65121509|NCT04628325|Diuretics|diuretics|mesh-ancestor
65121510|NCT04628325|Natriuretic Agents|natriuretic agents|mesh-ancestor
65296087|NCT02633930|Amoxicillin|amoxicillin|mesh-list
65296088|NCT02633930|Clarithromycin|clarithromycin|mesh-list
65296089|NCT02633930|Lansoprazole|lansoprazole|mesh-list
65296090|NCT02633930|Dexlansoprazole|dexlansoprazole|mesh-list
65296091|NCT02633930|Bismuth|bismuth|mesh-list
65296092|NCT02633930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65296093|NCT02633930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65296094|NCT02633930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65296095|NCT02633930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296096|NCT02633930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296097|NCT02633930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65296098|NCT02633930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65296099|NCT02633930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65296100|NCT02633930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65296101|NCT02633930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65296102|NCT02633930|Antacids|antacids|mesh-ancestor
65296103|NCT00698334|Rifampin|rifampin|mesh-list
65296104|NCT00698334|Pyrazinamide|pyrazinamide|mesh-list
65296105|NCT00698334|Ethambutol|ethambutol|mesh-list
65296106|NCT00698334|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65296107|NCT00698334|Antitubercular Agents|antitubercular agents|mesh-ancestor
65296108|NCT00698334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65296109|NCT00698334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65296110|NCT00698334|Leprostatic Agents|leprostatic agents|mesh-ancestor
65296111|NCT00698334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65296112|NCT00698334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121511|NCT04628325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121512|NCT04628325|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65121513|NCT04628325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65121514|NCT04628325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121515|NCT04657497|Camostat|camostat|mesh-list
65121516|NCT04657497|Protease Inhibitors|protease inhibitors|mesh-ancestor
65121524|NCT04971356|Ticagrelor|ticagrelor|mesh-list
65121525|NCT04971356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65121526|NCT04971356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65121527|NCT04971356|Analgesics|analgesics|mesh-ancestor
65121528|NCT04971356|Sensory System Agents|sensory system agents|mesh-ancestor
65121529|NCT04971356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121530|NCT04971356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121531|NCT04971356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65121532|NCT04971356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65121533|NCT04971356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65121534|NCT04971356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65121535|NCT04971356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121536|NCT04971356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65121537|NCT04971356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65121538|NCT04971356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121539|NCT04971356|Antipyretics|antipyretics|mesh-ancestor
65121540|NCT04971356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65296113|NCT00698334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296114|NCT00698334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65296115|NCT00698334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65296116|NCT00698334|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65296117|NCT00698334|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65296118|NCT00698334|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65296119|NCT00698334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65296120|NCT04161482|Furosemide|furosemide|mesh-list
65296121|NCT04161482|Diuretics|diuretics|mesh-ancestor
65296122|NCT04161482|Natriuretic Agents|natriuretic agents|mesh-ancestor
65296123|NCT04161482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296124|NCT04161482|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65296125|NCT04161482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65296126|NCT04161482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296128|NCT02623452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65296129|NCT02623452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296130|NCT02633696|Silybin|silybin|mesh-list
65296131|NCT02633696|Silymarin|silymarin|mesh-list
65296132|NCT02633696|Antioxidants|antioxidants|mesh-ancestor
65296133|NCT02633696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296134|NCT02633696|Protective Agents|protective agents|mesh-ancestor
65121541|NCT04971356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65121542|NCT04971356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65121543|NCT04971356|Purinergic Agents|purinergic agents|mesh-ancestor
65121544|NCT04971356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65121545|NCT01214395|Tea Tree Oil|tea tree oil|mesh-list
65121546|NCT01214395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65121547|NCT01214395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65121548|NCT01214239|Linagliptin|linagliptin|mesh-list
65121549|NCT01214239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65121550|NCT01214239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121551|NCT01214239|Incretins|incretins|mesh-ancestor
65121552|NCT01214239|Hormones|hormones|mesh-ancestor
64514066|NCT02608359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121553|NCT01214239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65121554|NCT01214239|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65121556|NCT01214239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121557|NCT01214239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121558|NCT01214044|Dexetimide|dexetimide|mesh-list
65121559|NCT01214044|Citalopram|citalopram|mesh-list
65121560|NCT01214044|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65121561|NCT01214044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65121562|NCT01214044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65121563|NCT01214044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121564|NCT01214044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65121565|NCT01214044|Serotonin Agents|serotonin agents|mesh-ancestor
65121566|NCT01214044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121567|NCT01214044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65121568|NCT01214044|Antidepressive Agents|antidepressive agents|mesh-ancestor
65121569|NCT01214044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65296135|NCT02633696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296136|NCT02633696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65296137|NCT02633696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296138|NCT02633852|Aflibercept|aflibercept|mesh-list
65296139|NCT02633852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65296140|NCT02633852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65296141|NCT02633852|Growth Substances|growth substances|mesh-ancestor
65296142|NCT02633852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296143|NCT02633852|Growth Inhibitors|growth inhibitors|mesh-ancestor
65296144|NCT02633852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296145|NCT02633774|Propafenone|propafenone|mesh-list
65296146|NCT02633774|Apixaban|apixaban|mesh-list
65296147|NCT02633774|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65296148|NCT02633774|Antithrombins|antithrombins|mesh-ancestor
65296149|NCT02633774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65296150|NCT02633774|Protease Inhibitors|protease inhibitors|mesh-ancestor
65296151|NCT02633774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296152|NCT02633774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296153|NCT02633774|Anticoagulants|anticoagulants|mesh-ancestor
65296154|NCT02633774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65296155|NCT02633774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65296156|NCT02633774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64526371|NCT00121251|Gemcitabine|gemcitabine|mesh-list
65121570|NCT01214044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65121571|NCT01214044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65121572|NCT01214044|Parasympatholytics|parasympatholytics|mesh-ancestor
65121573|NCT01214044|Autonomic Agents|autonomic agents|mesh-ancestor
65121574|NCT01214044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121575|NCT01214044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65121576|NCT01214044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65121577|NCT01214044|Cholinergic Agents|cholinergic agents|mesh-ancestor
65121578|NCT01213966|Artefenomel|artefenomel|mesh-list
65121579|NCT01213966|Antimalarials|antimalarials|mesh-ancestor
65121580|NCT01213966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65121581|NCT01213966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65121582|NCT01213966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65121583|NCT01213264|Anesthetics|anesthetics|mesh-list
65121584|NCT01213264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65121596|NCT04657107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65121597|NCT04657107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65121599|NCT04657107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65121600|NCT04657107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121601|NCT04657107|Antidepressive Agents|antidepressive agents|mesh-ancestor
65121602|NCT04657107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65121603|NCT00561717|Cetirizine|cetirizine|mesh-list
65121604|NCT00561717|Loratadine|loratadine|mesh-list
65121605|NCT00561717|Azelastine|azelastine|mesh-list
65121606|NCT00561717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65121607|NCT00561717|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65121608|NCT00561717|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65121609|NCT00561717|Histamine Antagonists|histamine antagonists|mesh-ancestor
65121610|NCT00561717|Histamine Agents|histamine agents|mesh-ancestor
65296157|NCT02633774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65296158|NCT02633618|Neurotropin|neurotropin|mesh-list
65296159|NCT02633618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65296160|NCT02633618|Immunologic Factors|immunologic factors|mesh-ancestor
65296161|NCT02633618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296162|NCT02633618|Analgesics|analgesics|mesh-ancestor
65296163|NCT02633618|Sensory System Agents|sensory system agents|mesh-ancestor
65296164|NCT02633618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65296165|NCT02633618|Anticonvulsants|anticonvulsants|mesh-ancestor
65296166|NCT00865020|Telmisartan|telmisartan|mesh-list
65296167|NCT00865020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65296168|NCT00865020|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65296169|NCT00865020|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64526391|NCT04339348|Lidocaine|lidocaine|mesh-list
65121611|NCT00561717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65121612|NCT00561717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121613|NCT00561717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121614|NCT00561717|Antipruritics|antipruritics|mesh-ancestor
64763944|NCT04340388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65121615|NCT00561717|Dermatologic Agents|dermatologic agents|mesh-ancestor
65121616|NCT00561717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65121617|NCT00561717|Autonomic Agents|autonomic agents|mesh-ancestor
65121618|NCT00561717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121619|NCT00561717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65121620|NCT00561717|Respiratory System Agents|respiratory system agents|mesh-ancestor
65121621|NCT00561717|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65121622|NCT00561717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121623|NCT00561756|Vaccines|vaccines|mesh-list
65121624|NCT00561756|Immunologic Factors|immunologic factors|mesh-ancestor
65121625|NCT00561756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121626|NCT04863950|Lomustine|lomustine|mesh-list
65121627|NCT04863950|Imipramine|imipramine|mesh-list
65121628|NCT04863950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65121629|NCT04863950|Alkylating Agents|alkylating agents|mesh-ancestor
65121630|NCT04863950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121631|NCT04863950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121632|NCT04863950|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65121633|NCT04863950|Antidepressive Agents|antidepressive agents|mesh-ancestor
65121634|NCT04863950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65121635|NCT04863950|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65121636|NCT04863950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65121637|NCT04863950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65121638|NCT04863950|Adrenergic Agents|adrenergic agents|mesh-ancestor
65121639|NCT04863950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65121640|NCT04863950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121641|NCT04824911|Aspirin|aspirin|mesh-list
65121642|NCT04824911|Clopidogrel|clopidogrel|mesh-list
65121643|NCT04824911|Atorvastatin|atorvastatin|mesh-list
65121644|NCT04824911|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65121645|NCT04824911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65121646|NCT04824911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65121647|NCT04824911|Analgesics|analgesics|mesh-ancestor
65121655|NCT04824911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121657|NCT04824911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65121658|NCT04824911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121659|NCT04824911|Antipyretics|antipyretics|mesh-ancestor
65121660|NCT04824911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65121661|NCT04824911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65121662|NCT04824911|Antimetabolites|antimetabolites|mesh-ancestor
65121663|NCT04824911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65222809|NCT04965493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296170|NCT00865020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296171|NCT00517933|Sildenafil Citrate|sildenafil citrate|mesh-list
65296172|NCT00517933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296173|NCT00517933|Vasodilator Agents|vasodilator agents|mesh-ancestor
65296174|NCT00517933|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65296175|NCT00517933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65296176|NCT00517933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296177|NCT00517933|Urological Agents|urological agents|mesh-ancestor
65296178|NCT02633384|Sorbitol|sorbitol|mesh-list
65296179|NCT02633384|SMOFlipid|smoflipid|mesh-list
65296180|NCT02633384|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65296181|NCT02633384|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65296182|NCT02633384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65296183|NCT02633384|Cathartics|cathartics|mesh-ancestor
65296184|NCT02633384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65296185|NCT02633462|Inositol|inositol|mesh-list
65296186|NCT02633462|Vitamin B Complex|vitamin b complex|mesh-ancestor
65296187|NCT02633462|Vitamins|vitamins|mesh-ancestor
65296188|NCT02633462|Micronutrients|micronutrients|mesh-ancestor
65296189|NCT02633462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296190|NCT02638064|Surgiflo|surgiflo|mesh-list
65296191|NCT02638064|Hemostatics|hemostatics|mesh-ancestor
65296192|NCT02638064|Coagulants|coagulants|mesh-ancestor
65296193|NCT04119336|Dexamethasone|dexamethasone|mesh-list
65296194|NCT04119336|Cyclophosphamide|cyclophosphamide|mesh-list
65296195|NCT04119336|Nivolumab|nivolumab|mesh-list
65121664|NCT04824911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65121665|NCT04824911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65121666|NCT04824911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65121667|NCT04824911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65121668|NCT04824911|Purinergic Agents|purinergic agents|mesh-ancestor
65121669|NCT04824911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65121670|NCT04683146|Chlorhexidine|chlorhexidine|mesh-list
65121671|NCT04683146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65121672|NCT04683146|Propranolol|propranolol|mesh-list
65121673|NCT04683146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65121674|NCT04683146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65121675|NCT04683146|Disinfectants|disinfectants|mesh-ancestor
65121676|NCT04683146|Dermatologic Agents|dermatologic agents|mesh-ancestor
65121677|NCT04683146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65121678|NCT04683146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65121679|NCT04683146|Adrenergic Agents|adrenergic agents|mesh-ancestor
65121680|NCT04683146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65121681|NCT04683146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121682|NCT04683146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121683|NCT04683146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65121684|NCT04683146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65121685|NCT04683146|Vasodilator Agents|vasodilator agents|mesh-ancestor
65121686|NCT04816877|Analgesics, Opioid|analgesics, opioid|mesh-list
65121687|NCT04816877|Narcotics|narcotics|mesh-ancestor
65121688|NCT04816877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65121689|NCT04816877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296196|NCT04119336|Ixazomib|ixazomib|mesh-list
65296197|NCT04119336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65296198|NCT04119336|Immunologic Factors|immunologic factors|mesh-ancestor
65296199|NCT04119336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296200|NCT04119336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65296201|NCT04119336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65296202|NCT04119336|Alkylating Agents|alkylating agents|mesh-ancestor
65296203|NCT04119336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296204|NCT04119336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296205|NCT04119336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65296206|NCT04119336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65296207|NCT04119336|Antiemetics|antiemetics|mesh-ancestor
65296208|NCT04119336|Autonomic Agents|autonomic agents|mesh-ancestor
65296209|NCT04119336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65296210|NCT04119336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65296211|NCT04119336|Glucocorticoids|glucocorticoids|mesh-ancestor
65296212|NCT04119336|Hormones|hormones|mesh-ancestor
65296213|NCT04119336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65296214|NCT04119336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65296215|NCT04119336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65296216|NCT04119336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65296217|NCT04119336|Protease Inhibitors|protease inhibitors|mesh-ancestor
64526413|NCT02664922|Ketamine|ketamine|mesh-list
65121690|NCT04816877|Analgesics|analgesics|mesh-ancestor
65121691|NCT04816877|Sensory System Agents|sensory system agents|mesh-ancestor
65121692|NCT04816877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121693|NCT04800302|Morphine|morphine|mesh-list
65121694|NCT04800302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65121695|NCT04800302|Narcotics|narcotics|mesh-ancestor
65121696|NCT04800302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65121697|NCT04800302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121698|NCT04800302|Analgesics|analgesics|mesh-ancestor
65121699|NCT04800302|Sensory System Agents|sensory system agents|mesh-ancestor
65121700|NCT04800302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121701|NCT04711304|Hyaluronic Acid|hyaluronic acid|mesh-list
65121702|NCT04711304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65121703|NCT04711304|Immunologic Factors|immunologic factors|mesh-ancestor
65121704|NCT04711304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121705|NCT04711304|Viscosupplements|viscosupplements|mesh-ancestor
65121706|NCT04711304|Protective Agents|protective agents|mesh-ancestor
65121707|NCT04710719|Triamcinolone|triamcinolone|mesh-list
65121708|NCT04710719|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65121709|NCT04710719|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65121710|NCT04710719|Fluorouracil|fluorouracil|mesh-list
65121711|NCT04710719|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65121712|NCT04710719|Antimetabolites|antimetabolites|mesh-ancestor
65121713|NCT04710719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694046|NCT04603937|Aflibercept|aflibercept|mesh-list
65121720|NCT04710719|Glucocorticoids|glucocorticoids|mesh-ancestor
65121721|NCT04710719|Hormones|hormones|mesh-ancestor
65121722|NCT04710719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65121723|NCT04710719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296218|NCT04119336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296219|NCT00114101|Lenalidomide|lenalidomide|mesh-list
65296220|NCT00114101|Melphalan|melphalan|mesh-list
65296221|NCT00114101|Mechlorethamine|mechlorethamine|mesh-list
65296222|NCT00114101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65296223|NCT00114101|Immunologic Factors|immunologic factors|mesh-ancestor
65296224|NCT00114101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296225|NCT00114101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65296226|NCT00114101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65296227|NCT00114101|Growth Substances|growth substances|mesh-ancestor
65296228|NCT00114101|Growth Inhibitors|growth inhibitors|mesh-ancestor
65296229|NCT00114101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296230|NCT00114101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65296231|NCT00114101|Alkylating Agents|alkylating agents|mesh-ancestor
65296232|NCT00114101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296233|NCT00114101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65296234|NCT00114101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65296235|NCT00655148|Vaccines|vaccines|mesh-list
65296236|NCT00655148|Immunologic Factors|immunologic factors|mesh-ancestor
65296237|NCT00655148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296238|NCT00857766|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65296239|NCT00857766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64526433|NCT02664922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64526435|NCT02666950|Cytarabine|cytarabine|mesh-list
65121724|NCT04627779|Flurbiprofen|flurbiprofen|mesh-list
65121725|NCT04627779|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
65121726|NCT04627779|Analgesics|analgesics|mesh-ancestor
65121727|NCT04627779|Sensory System Agents|sensory system agents|mesh-ancestor
65121728|NCT04627779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121729|NCT04627779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121730|NCT04627779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65121731|NCT04627779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65121732|NCT04627779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65121733|NCT04627779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65121734|NCT04627779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65121735|NCT04627779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121736|NCT04627779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121737|NCT04537598|Morphine|morphine|mesh-list
65121738|NCT04537598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65121739|NCT04537598|Narcotics|narcotics|mesh-ancestor
65121740|NCT04537598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65121741|NCT04537598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121742|NCT04537598|Analgesics|analgesics|mesh-ancestor
65121743|NCT04537598|Sensory System Agents|sensory system agents|mesh-ancestor
65121744|NCT04537598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121745|NCT04627467|Chloroquine|chloroquine|mesh-list
65121746|NCT04627467|Amebicides|amebicides|mesh-ancestor
65121747|NCT04627467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65121748|NCT04627467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65121749|NCT04627467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65121750|NCT04627467|Antimalarials|antimalarials|mesh-ancestor
65296240|NCT00857766|Autonomic Agents|autonomic agents|mesh-ancestor
65296241|NCT00857766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65296242|NCT00857766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296243|NCT00857766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65296244|NCT00857766|Respiratory System Agents|respiratory system agents|mesh-ancestor
65296245|NCT00857766|Glucocorticoids|glucocorticoids|mesh-ancestor
65296246|NCT00857766|Hormones|hormones|mesh-ancestor
65121751|NCT04627467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65121752|NCT04627623|Antibodies|antibodies|mesh-list
65121753|NCT04627623|Immunoglobulin G|immunoglobulin g|mesh-list
65121754|NCT04627623|Immunologic Factors|immunologic factors|mesh-ancestor
65121755|NCT04627623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121756|NCT04656249|Lenvatinib|lenvatinib|mesh-list
65121757|NCT04656249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121758|NCT04656249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65121759|NCT04656249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121760|NCT04656249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121761|NCT04481555|Azithromycin|azithromycin|mesh-list
65121762|NCT04481555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65121763|NCT04481555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65121764|NCT04682795|Insulin|insulin|mesh-list
64764094|NCT04332276|Sympathomimetics|sympathomimetics|mesh-ancestor
65121765|NCT04682795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65121766|NCT04682795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121767|NCT04396496|Daratumumab|daratumumab|mesh-list
65121768|NCT04396496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121769|NCT04655664|Vitamin D|vitamin d|mesh-list
65121770|NCT04655664|Ergocalciferols|ergocalciferols|mesh-list
65121771|NCT04655664|Cholecalciferol|cholecalciferol|mesh-list
65121772|NCT04655664|Vitamins|vitamins|mesh-list
65121773|NCT04655664|Micronutrients|micronutrients|mesh-ancestor
65121774|NCT04655664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121775|NCT04655664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65121776|NCT04655664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65121777|NCT04655508|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65121778|NCT04655508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65121779|NCT04655508|Autonomic Agents|autonomic agents|mesh-ancestor
65121780|NCT04655508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121781|NCT04655508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121782|NCT04655508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65121792|NCT04655040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121793|NCT04655040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121794|NCT04655040|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65121795|NCT04655040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65121796|NCT04655040|Purinergic Agents|purinergic agents|mesh-ancestor
65121797|NCT04655040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65121798|NCT04626765|Cyclophosphamide|cyclophosphamide|mesh-list
65121799|NCT04626765|Fludarabine|fludarabine|mesh-list
65121800|NCT04626765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65121801|NCT04626765|Immunologic Factors|immunologic factors|mesh-ancestor
65121802|NCT04626765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121803|NCT04626765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65121804|NCT04626765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65121805|NCT04626765|Alkylating Agents|alkylating agents|mesh-ancestor
65121806|NCT04626765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121807|NCT04626765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121808|NCT04626765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65121809|NCT04626726|Cyclophosphamide|cyclophosphamide|mesh-list
65121810|NCT04626726|Fludarabine|fludarabine|mesh-list
65121811|NCT04626726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65121812|NCT04626726|Immunologic Factors|immunologic factors|mesh-ancestor
65121813|NCT04626726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121814|NCT04626726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65121815|NCT04626726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65121816|NCT04626726|Alkylating Agents|alkylating agents|mesh-ancestor
65121817|NCT04626726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121818|NCT04626726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121819|NCT04626726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65121820|NCT04654962|Anesthetics|anesthetics|mesh-list
65296247|NCT00857766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65296248|NCT00857766|Sympathomimetics|sympathomimetics|mesh-ancestor
65296249|NCT04161404|Metformin|metformin|mesh-list
65296250|NCT04161404|Andrographolide|andrographolide|mesh-list
65296251|NCT04161404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65296252|NCT04161404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296253|NCT04161404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65296254|NCT04161404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65296255|NCT04161404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65296256|NCT04161404|Analgesics|analgesics|mesh-ancestor
65296257|NCT04161404|Sensory System Agents|sensory system agents|mesh-ancestor
65296258|NCT04161404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65296259|NCT04161404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65296260|NCT04161404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65296261|NCT04161404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65296262|NCT04161404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65296263|NCT04161404|Antiviral Agents|antiviral agents|mesh-ancestor
65296264|NCT04161404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65296265|NCT00517699|Cytarabine|cytarabine|mesh-list
65296266|NCT00517699|Rituximab|rituximab|mesh-list
65296267|NCT00517699|Methotrexate|methotrexate|mesh-list
65296268|NCT00517699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64526459|NCT02668432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64526460|NCT01687283|Fluticasone|fluticasone|mesh-list
65121821|NCT04654962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65121822|NCT04654962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121823|NCT04626414|Ferric maltol|ferric maltol|mesh-list
65121824|NCT04626414|Ferric Compounds|ferric compounds|mesh-list
65121825|NCT04626414|Hematinics|hematinics|mesh-ancestor
65121826|NCT04654416|Colchicine|colchicine|mesh-list
65121827|NCT04654416|Gout Suppressants|gout suppressants|mesh-ancestor
65121828|NCT04654416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65121829|NCT04654416|Tubulin Modulators|tubulin modulators|mesh-ancestor
65121830|NCT04654416|Antimitotic Agents|antimitotic agents|mesh-ancestor
65121831|NCT04654416|Mitosis Modulators|mitosis modulators|mesh-ancestor
65121832|NCT04654416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121833|NCT04654416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121834|NCT02906150|Cisplatin|cisplatin|mesh-list
65121835|NCT02906150|Carboplatin|carboplatin|mesh-list
65121836|NCT02906150|Pemetrexed|pemetrexed|mesh-list
65121837|NCT02906150|Thymalfasin|thymalfasin|mesh-list
65121838|NCT02906150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121839|NCT02906150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121840|NCT02906150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121841|NCT02906150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65121842|NCT02906150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65121843|NCT02906150|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65121844|NCT02906150|Immunologic Factors|immunologic factors|mesh-ancestor
64514073|NCT01729559|Enoxaparin|enoxaparin|mesh-list
65121845|NCT02906150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121846|NCT00561990|Nimotuzumab|nimotuzumab|mesh-list
65121847|NCT00561990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65296269|NCT00517699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296270|NCT00517699|Immunologic Factors|immunologic factors|mesh-ancestor
65296271|NCT00517699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296272|NCT00517699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65296273|NCT00517699|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65296274|NCT00517699|Abortifacient Agents|abortifacient agents|mesh-ancestor
64526480|NCT02669914|Durvalumab|durvalumab|mesh-list
65121876|NCT04626258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121877|NCT04626258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65121878|NCT04626258|Hormone Antagonists|hormone antagonists|mesh-ancestor
65121879|NCT04626258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65121880|NCT04626258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121881|NCT04626258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65121882|NCT04626258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65121883|NCT04681820|HH-GV-678|hh-gv-678|mesh-list
65121884|NCT04681820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65121885|NCT04681820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121886|NCT04681820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121887|NCT04626063|Acetaminophen|acetaminophen|mesh-list
65121888|NCT04626063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65121889|NCT04626063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65121890|NCT04626063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65121891|NCT04626063|Analgesics|analgesics|mesh-ancestor
65121892|NCT04626063|Sensory System Agents|sensory system agents|mesh-ancestor
64694247|NCT00355628|Narcotics|narcotics|mesh-ancestor
65121910|NCT04654182|Chlorhexidine|chlorhexidine|mesh-list
65121911|NCT04654182|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65121912|NCT04654182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65121913|NCT04654182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65121914|NCT04654182|Disinfectants|disinfectants|mesh-ancestor
65121915|NCT04654182|Dermatologic Agents|dermatologic agents|mesh-ancestor
64764243|NCT03035058|Vedolizumab|vedolizumab|mesh-list
65121916|NCT04654026|Aspirin|aspirin|mesh-list
65121917|NCT04654026|Clopidogrel|clopidogrel|mesh-list
65121918|NCT04654026|Ticagrelor|ticagrelor|mesh-list
65121919|NCT04654026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65121920|NCT04654026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65121921|NCT04654026|Analgesics|analgesics|mesh-ancestor
65121922|NCT04654026|Sensory System Agents|sensory system agents|mesh-ancestor
65121923|NCT04654026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121924|NCT04654026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121925|NCT04654026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65121926|NCT04654026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65121927|NCT04654026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65121928|NCT04654026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65121929|NCT04654026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121930|NCT04654026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65121931|NCT04654026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65121932|NCT04654026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121933|NCT04654026|Antipyretics|antipyretics|mesh-ancestor
65121934|NCT04654026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65121935|NCT04654026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65121936|NCT04654026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65121937|NCT04654026|Purinergic Agents|purinergic agents|mesh-ancestor
65121938|NCT04654026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65121939|NCT04625595|Methyldopa|methyldopa|mesh-list
65121940|NCT04625595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65121941|NCT04625595|Sympatholytics|sympatholytics|mesh-ancestor
65121942|NCT04625595|Autonomic Agents|autonomic agents|mesh-ancestor
65121943|NCT04625595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121944|NCT04625595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121945|NCT04625595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65121946|NCT04625595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65121947|NCT04625595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65121948|NCT04625595|Adrenergic Agents|adrenergic agents|mesh-ancestor
65121959|NCT02905058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65121960|NCT02905058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65296275|NCT00517699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65296276|NCT00517699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65296277|NCT00517699|Antimetabolites|antimetabolites|mesh-ancestor
65296278|NCT00517699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296279|NCT00517699|Dermatologic Agents|dermatologic agents|mesh-ancestor
65296280|NCT00517699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296281|NCT00517699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65296282|NCT00517699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65296283|NCT00517699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65296284|NCT00517699|Antiviral Agents|antiviral agents|mesh-ancestor
65296285|NCT00517699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65296286|NCT03096275|Glucocorticoids|glucocorticoids|mesh-list
65296287|NCT03096275|Hormones|hormones|mesh-ancestor
65121961|NCT02905058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121962|NCT02905058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121963|NCT04653792|Pregabalin|pregabalin|mesh-list
65121964|NCT04653792|Analgesics|analgesics|mesh-ancestor
65121965|NCT04653792|Sensory System Agents|sensory system agents|mesh-ancestor
65121966|NCT04653792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121967|NCT04653792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121968|NCT04653792|Anticonvulsants|anticonvulsants|mesh-ancestor
65121969|NCT04653792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65121970|NCT04653792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65121971|NCT04653792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121972|NCT04653792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65121973|NCT04653792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65121974|NCT04653792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65121975|NCT04653792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65121976|NCT04653792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65121977|NCT04624893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65121978|NCT04624893|Immunoconjugates|immunoconjugates|mesh-list
65121979|NCT04624893|Immunologic Factors|immunologic factors|mesh-ancestor
65121980|NCT04624893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121981|NCT00557700|Bromides|bromides|mesh-list
65121982|NCT00557700|Tiotropium Bromide|tiotropium bromide|mesh-list
65121983|NCT00557700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65121984|NCT00557700|Autonomic Agents|autonomic agents|mesh-ancestor
65121985|NCT00557700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121986|NCT00557700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121987|NCT00557700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65121988|NCT00557700|Respiratory System Agents|respiratory system agents|mesh-ancestor
65121989|NCT00557700|Parasympatholytics|parasympatholytics|mesh-ancestor
65121990|NCT00557700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65121991|NCT00557700|Cholinergic Agents|cholinergic agents|mesh-ancestor
65121992|NCT00557700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65121993|NCT00557700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121994|NCT00557700|Anticonvulsants|anticonvulsants|mesh-ancestor
65121995|NCT00557739|Mometasone Furoate|mometasone furoate|mesh-list
65121996|NCT00557739|Nortriptyline|nortriptyline|mesh-list
65121997|NCT00557739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65121998|NCT00557739|Dermatologic Agents|dermatologic agents|mesh-ancestor
65121999|NCT00557739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65122000|NCT00557739|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65122001|NCT00557739|Antidepressive Agents|antidepressive agents|mesh-ancestor
65122002|NCT00557739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65122003|NCT00557739|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65122004|NCT00557739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65122005|NCT00557739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65122006|NCT00557739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122007|NCT00557739|Adrenergic Agents|adrenergic agents|mesh-ancestor
65122008|NCT00557739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65296288|NCT03096275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65296289|NCT03096275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296290|NCT04161014|Nintedanib|nintedanib|mesh-list
65296291|NCT04161014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296292|NCT04161014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65296293|NCT04161014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296294|NCT04161014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296295|NCT04491643|Megestrol|megestrol|mesh-list
65296296|NCT04491643|Megestrol Acetate|megestrol acetate|mesh-list
65296297|NCT04491643|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65296298|NCT04491643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65296299|NCT04491643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65296300|NCT04491643|Antimetabolites|antimetabolites|mesh-ancestor
65296301|NCT04491643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296302|NCT04491643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65296303|NCT04491643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65296304|NCT04491643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296305|NCT04491643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65296306|NCT04491643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65296307|NCT04491643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65296308|NCT04491643|Contraceptive Agents|contraceptive agents|mesh-ancestor
65296309|NCT04491643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64526494|NCT04739410|Ivermectin|ivermectin|mesh-list
65122009|NCT00557739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122010|NCT02903888|Levonorgestrel|levonorgestrel|mesh-list
65122011|NCT02903888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65122022|NCT04624269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65122023|NCT04624269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122024|NCT04624269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122025|NCT04624269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65122026|NCT04652739|Prednisolone|prednisolone|mesh-list
65122028|NCT04652739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65122029|NCT04652739|Glucocorticoids|glucocorticoids|mesh-ancestor
65122030|NCT04652739|Hormones|hormones|mesh-ancestor
65122031|NCT04652739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65122032|NCT04652739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122033|NCT04652739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65122034|NCT04652739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65122035|NCT04652739|Protective Agents|protective agents|mesh-ancestor
65122036|NCT04652739|Antioxidants|antioxidants|mesh-ancestor
65122037|NCT04652739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122038|NCT04652739|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65122039|NCT04652739|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65122040|NCT02903498|Tegafur|tegafur|mesh-list
65122041|NCT02903498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65122042|NCT02903498|Antimetabolites|antimetabolites|mesh-ancestor
65122043|NCT02903498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122044|NCT02903498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65122045|NCT04652427|Dexmedetomidine|dexmedetomidine|mesh-list
65296310|NCT04491643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296311|NCT04491643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65296312|NCT04491643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65296313|NCT04491643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65296314|NCT04491643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296315|NCT04491643|Appetite Stimulants|appetite stimulants|mesh-ancestor
65122046|NCT04652427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65122047|NCT04652427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65122048|NCT04652427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122049|NCT04652427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65122050|NCT04652427|Analgesics|analgesics|mesh-ancestor
65122051|NCT04652427|Sensory System Agents|sensory system agents|mesh-ancestor
65122052|NCT04652427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122053|NCT04652427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65122054|NCT04652427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65122055|NCT04652427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65122056|NCT04652427|Adrenergic Agents|adrenergic agents|mesh-ancestor
65122057|NCT04652427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65122058|NCT04652427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122059|NCT04623879|Ivacaftor|ivacaftor|mesh-list
65122060|NCT04623879|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65122061|NCT04623879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65122062|NCT04623879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122063|NCT02903537|Vitamin D|vitamin d|mesh-list
65122064|NCT02903537|Cholecalciferol|cholecalciferol|mesh-list
65122065|NCT02903537|Interferons|interferons|mesh-list
65122066|NCT02903537|Interferon-beta|interferon-beta|mesh-list
65122067|NCT02903537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65122068|NCT02903537|Antiviral Agents|antiviral agents|mesh-ancestor
65122069|NCT02903537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65122070|NCT02903537|Immunologic Factors|immunologic factors|mesh-ancestor
65122071|NCT02903537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122072|NCT02903537|Vitamins|vitamins|mesh-ancestor
65122073|NCT02903537|Micronutrients|micronutrients|mesh-ancestor
65122074|NCT02903537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65122075|NCT02903537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65122089|NCT00562068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65122090|NCT00562068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65122091|NCT00562068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65122092|NCT00562068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65122093|NCT00562068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65122094|NCT00562068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122095|NCT00562068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65122096|NCT00562068|Tubulin Modulators|tubulin modulators|mesh-ancestor
65122097|NCT00562068|Antimitotic Agents|antimitotic agents|mesh-ancestor
65122098|NCT00562068|Mitosis Modulators|mitosis modulators|mesh-ancestor
65122099|NCT00562068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65122100|NCT00562068|Glucocorticoids|glucocorticoids|mesh-ancestor
65122102|NCT00562068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65122103|NCT00562068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65122104|NCT00562068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65122105|NCT00562185|Carboplatin|carboplatin|mesh-list
65122106|NCT00562185|Doxorubicin|doxorubicin|mesh-list
65122107|NCT00562185|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65122108|NCT00562185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65122109|NCT00562185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65122110|NCT00562185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65122111|NCT00562185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65122112|NCT00562185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122113|NCT00562185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122114|NCT00562224|Abexinostat|abexinostat|mesh-list
65122115|NCT00562224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65122116|NCT00562224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122117|NCT00562224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122118|NCT02903069|Temozolomide|temozolomide|mesh-list
65122119|NCT02903069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65296316|NCT04491643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65296317|NCT00699504|Moxifloxacin|moxifloxacin|mesh-list
65296318|NCT00699504|Cangrelor|cangrelor|mesh-list
65296319|NCT00699504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65296320|NCT00699504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65296321|NCT00699504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65296322|NCT00699504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65296323|NCT00699504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296324|NCT00699504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296325|NCT00699504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296326|NCT00699504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296327|NCT00699504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65296328|NCT00699504|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65296329|NCT00699504|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65296330|NCT00699504|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65296331|NCT00699504|Purinergic Agents|purinergic agents|mesh-ancestor
65296332|NCT00699504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65296333|NCT02997605|Prednisone|prednisone|mesh-list
65296334|NCT02997605|Hydrocortisone|hydrocortisone|mesh-list
65296335|NCT02997605|Glucocorticoids|glucocorticoids|mesh-list
65296336|NCT02997605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65296337|NCT02997605|Hormones|hormones|mesh-ancestor
65296338|NCT02997605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64526523|NCT00367978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65122120|NCT02903069|Alkylating Agents|alkylating agents|mesh-ancestor
65122121|NCT02903069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122122|NCT02903069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65122123|NCT04623840|Tadalafil|tadalafil|mesh-list
65122124|NCT04623840|Vasodilator Agents|vasodilator agents|mesh-ancestor
65122125|NCT04623840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65122126|NCT04623840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65122127|NCT04623840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122128|NCT04623840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122129|NCT04623840|Urological Agents|urological agents|mesh-ancestor
65122130|NCT02902640|Trimethoprim|trimethoprim|mesh-list
65122131|NCT02902640|Sulfamethoxazole|sulfamethoxazole|mesh-list
65122132|NCT02902640|Phenylpropanolamine|phenylpropanolamine|mesh-list
65122133|NCT02902640|Guaifenesin|guaifenesin|mesh-list
65122134|NCT02902640|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
65122135|NCT02902640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65122136|NCT02902640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65122149|NCT02902640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65122150|NCT02902640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65122151|NCT02902640|Adrenergic Agents|adrenergic agents|mesh-ancestor
65122152|NCT02902640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65122153|NCT02902640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122154|NCT02902640|Appetite Depressants|appetite depressants|mesh-ancestor
65122155|NCT02902640|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65296339|NCT02997605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296340|NCT02997605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65296341|NCT02997605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296342|NCT03767543|Insulin Glargine|insulin glargine|mesh-list
65296343|NCT03767543|Lixisenatide|lixisenatide|mesh-list
65296344|NCT03767543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65296345|NCT03767543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296346|NCT00857454|Testosterone|testosterone|mesh-list
65296347|NCT00857454|Androgens|androgens|mesh-ancestor
65296348|NCT00857454|Hormones|hormones|mesh-ancestor
64526548|NCT05339542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65122156|NCT02902640|Sympathomimetics|sympathomimetics|mesh-ancestor
65122157|NCT02902640|Autonomic Agents|autonomic agents|mesh-ancestor
65122158|NCT02902640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122159|NCT02902640|Nasal Decongestants|nasal decongestants|mesh-ancestor
65122160|NCT02902640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65122161|NCT02902523|Tenofovir|tenofovir|mesh-list
65122162|NCT02902523|Antiviral Agents|antiviral agents|mesh-ancestor
65122163|NCT02902523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65122164|NCT02902523|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65122165|NCT02902523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65122166|NCT02902523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122167|NCT02902523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122168|NCT02902523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65122169|NCT02902523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65122170|NCT02902289|Ibuprofen|ibuprofen|mesh-list
65122171|NCT02902289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65122172|NCT02902289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65122173|NCT02902289|Analgesics|analgesics|mesh-ancestor
65122174|NCT02902289|Sensory System Agents|sensory system agents|mesh-ancestor
65122175|NCT02902289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122176|NCT02902289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122177|NCT02902289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65122178|NCT02902289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65122179|NCT02902289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65122180|NCT02902289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122181|NCT02902289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122182|NCT02902133|Acetazolamide|acetazolamide|mesh-list
65122183|NCT02902133|Anticonvulsants|anticonvulsants|mesh-ancestor
65122184|NCT02902133|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65122185|NCT02902133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122186|NCT02902133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122187|NCT02902133|Diuretics|diuretics|mesh-ancestor
65122188|NCT02902133|Natriuretic Agents|natriuretic agents|mesh-ancestor
65122189|NCT02902133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122190|NCT04623021|Nafamostat|nafamostat|mesh-list
65122191|NCT04623021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65122192|NCT04623021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65122193|NCT04623021|Analgesics|analgesics|mesh-ancestor
65122194|NCT04623021|Sensory System Agents|sensory system agents|mesh-ancestor
65122195|NCT04623021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122196|NCT04623021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122197|NCT04623021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65122198|NCT04623021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65122206|NCT04623021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65122207|NCT04623021|Immunologic Factors|immunologic factors|mesh-ancestor
65122208|NCT02902055|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
65122209|NCT02902055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65122210|NCT02902055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122211|NCT02902055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764552|NCT03007992|Vinorelbine|vinorelbine|mesh-list
65122213|NCT02901977|Doxazosin|doxazosin|mesh-list
65122214|NCT02901977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65296349|NCT00857454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65296350|NCT00857454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296351|NCT00660140|Gemcitabine|gemcitabine|mesh-list
65046279|NCT00214058|Docetaxel|docetaxel|mesh-list
65296353|NCT00660140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296354|NCT00660140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65296355|NCT00660140|Antimetabolites|antimetabolites|mesh-ancestor
65296356|NCT00660140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296357|NCT00660140|Antiviral Agents|antiviral agents|mesh-ancestor
65296358|NCT00660140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65296359|NCT00660140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296360|NCT00660140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65296361|NCT00660140|Immunologic Factors|immunologic factors|mesh-ancestor
65296362|NCT00660140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296363|NCT03760991|Insulin Glargine|insulin glargine|mesh-list
65296364|NCT03760991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65296365|NCT03760991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296366|NCT00525031|Interferons|interferons|mesh-list
65296367|NCT00525031|Interferon-alpha|interferon-alpha|mesh-list
65296368|NCT00525031|Interferon alpha-2|interferon alpha-2|mesh-list
65296369|NCT00525031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65296370|NCT00525031|Temozolomide|temozolomide|mesh-list
65296371|NCT00525031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296372|NCT00525031|Antiviral Agents|antiviral agents|mesh-ancestor
65296373|NCT00525031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65122215|NCT02901977|Protease Inhibitors|protease inhibitors|mesh-ancestor
65122216|NCT02901977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122217|NCT02901977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122218|NCT02901977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65122219|NCT02901977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65122220|NCT02901977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65122221|NCT02901977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65122222|NCT02901977|Adrenergic Agents|adrenergic agents|mesh-ancestor
65122223|NCT02901977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65122224|NCT02901977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122225|NCT00553553|Morphine|morphine|mesh-list
65122226|NCT00553553|Remifentanil|remifentanil|mesh-list
65122227|NCT00553553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65122228|NCT00553553|Narcotics|narcotics|mesh-ancestor
65122229|NCT00553553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65122230|NCT00553553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122231|NCT00553553|Analgesics|analgesics|mesh-ancestor
65122232|NCT00553553|Sensory System Agents|sensory system agents|mesh-ancestor
65122233|NCT00553553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122234|NCT04622982|Vitamin D|vitamin d|mesh-list
65122235|NCT04622982|Vitamins|vitamins|mesh-ancestor
65122236|NCT04622982|Micronutrients|micronutrients|mesh-ancestor
65122237|NCT04622982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122238|NCT04622982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65122239|NCT04622202|Pregabalin|pregabalin|mesh-list
65122240|NCT04622202|Analgesics|analgesics|mesh-ancestor
65296374|NCT00525031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65296375|NCT00525031|Alkylating Agents|alkylating agents|mesh-ancestor
65296376|NCT00525031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296377|NCT00525031|Immunologic Factors|immunologic factors|mesh-ancestor
65296378|NCT00525031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296379|NCT00660374|Isophane Insulin, Human|isophane insulin, human|mesh-list
65296380|NCT00660374|Insulin, Isophane|insulin, isophane|mesh-list
65296381|NCT00660374|Isophane insulin, beef|isophane insulin, beef|mesh-list
65296382|NCT00660374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65296383|NCT00660374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296384|NCT00524485|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65296385|NCT00524485|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65296386|NCT00524485|Dermatologic Agents|dermatologic agents|mesh-ancestor
65296387|NCT00857220|Eszopiclone|eszopiclone|mesh-list
65296388|NCT00857220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65296389|NCT00857220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65296390|NCT00857220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296391|NCT00524173|Tenofovir|tenofovir|mesh-list
65296392|NCT00524173|Emtricitabine|emtricitabine|mesh-list
65296393|NCT00524173|Antiviral Agents|antiviral agents|mesh-ancestor
65296394|NCT00524173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65296395|NCT00524173|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65296396|NCT00524173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65296397|NCT00524173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296398|NCT00524173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296399|NCT00524173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65296400|NCT00524173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65296401|NCT02704481|Misoprostol|misoprostol|mesh-list
65296402|NCT02704481|Mifepristone|mifepristone|mesh-list
65296403|NCT02704481|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65296404|NCT02704481|Abortifacient Agents|abortifacient agents|mesh-ancestor
65296405|NCT02704481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65122241|NCT04622202|Sensory System Agents|sensory system agents|mesh-ancestor
65122242|NCT04622202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122243|NCT04622202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122244|NCT04622202|Anticonvulsants|anticonvulsants|mesh-ancestor
65122245|NCT04622202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65122246|NCT04622202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65122247|NCT04622202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122248|NCT04622202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65122249|NCT04622202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65296406|NCT02704481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296407|NCT02704481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65296408|NCT02704481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65296409|NCT02704481|Oxytocics|oxytocics|mesh-ancestor
65296410|NCT02704481|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65296411|NCT02704481|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65296412|NCT02704481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65296413|NCT02704481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65296414|NCT02704481|Contraceptive Agents|contraceptive agents|mesh-ancestor
65296415|NCT02704481|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64526610|NCT01683071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526611|NCT04707508|Metformin|metformin|mesh-list
65122250|NCT04622202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65122251|NCT04622202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65122252|NCT04622202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65122253|NCT04622358|Rabeprazole|rabeprazole|mesh-list
65122254|NCT04622358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65122255|NCT04622358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65122256|NCT04622358|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65122257|NCT04622358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122258|NCT04622358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122259|NCT02901587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65122260|NCT02901587|Antidepressive Agents|antidepressive agents|mesh-ancestor
65122261|NCT02901587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65122262|NCT02901587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65122263|NCT02901587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65122264|NCT02901587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65122277|NCT04621929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65122278|NCT04621929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122279|NCT04621929|Antimetabolites|antimetabolites|mesh-ancestor
65122280|NCT04621929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122281|NCT04621929|Gout Suppressants|gout suppressants|mesh-ancestor
65122282|NCT04621929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65122283|NCT04621929|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65122284|NCT04621929|Antioxidants|antioxidants|mesh-ancestor
65122285|NCT04621929|Protective Agents|protective agents|mesh-ancestor
65122286|NCT04621929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65122287|NCT04621929|Appetite Depressants|appetite depressants|mesh-ancestor
65122288|NCT04621929|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65122289|NCT04621929|Sympathomimetics|sympathomimetics|mesh-ancestor
65122290|NCT04621929|Autonomic Agents|autonomic agents|mesh-ancestor
65122291|NCT04621929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122292|NCT04621929|Adrenergic Agents|adrenergic agents|mesh-ancestor
65122293|NCT04621929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65122294|NCT02901353|Sirolimus|sirolimus|mesh-list
65122295|NCT02901353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65122296|NCT02901353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65122297|NCT02901353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65122298|NCT02901353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65122299|NCT02901353|Antifungal Agents|antifungal agents|mesh-ancestor
65122300|NCT02901353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65122301|NCT02901353|Immunologic Factors|immunologic factors|mesh-ancestor
65122302|NCT02901353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122303|NCT04621461|Zinc Sulfate|zinc sulfate|mesh-list
65122304|NCT04621461|Astringents|astringents|mesh-ancestor
65122305|NCT04621461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122306|NCT04621461|Dermatologic Agents|dermatologic agents|mesh-ancestor
65122307|NCT02901236|Bevacizumab|bevacizumab|mesh-list
65122308|NCT02901236|Mitomycins|mitomycins|mesh-list
65122309|NCT02901236|Mitomycin|mitomycin|mesh-list
65122310|NCT02901236|Antimetabolites|antimetabolites|mesh-list
65122311|NCT02901236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65122312|NCT02901236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65122313|NCT02901236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65296416|NCT02704481|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65296417|NCT02704481|Hormone Antagonists|hormone antagonists|mesh-ancestor
65296418|NCT02704481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65296419|NCT02704481|Luteolytic Agents|luteolytic agents|mesh-ancestor
65296420|NCT02704481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65296421|NCT02704481|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65296422|NCT02614482|Fesoterodine|fesoterodine|mesh-list
65296423|NCT02614482|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65296424|NCT02614482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64526620|NCT05145400|Lenalidomide|lenalidomide|mesh-list
64526622|NCT05145400|Antiemetics|antiemetics|mesh-ancestor
65122314|NCT02901236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65122315|NCT02901236|Growth Substances|growth substances|mesh-ancestor
65122316|NCT02901236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122317|NCT02901236|Growth Inhibitors|growth inhibitors|mesh-ancestor
65122318|NCT02901236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65122319|NCT02901236|Alkylating Agents|alkylating agents|mesh-ancestor
65122320|NCT02901236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122321|NCT02901236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65122322|NCT02901236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122323|NCT04621617|Midodrine|midodrine|mesh-list
65122324|NCT04621617|Sympathomimetics|sympathomimetics|mesh-ancestor
65122325|NCT04621617|Autonomic Agents|autonomic agents|mesh-ancestor
65122326|NCT04621617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122327|NCT04621617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122328|NCT04621617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65122329|NCT04621617|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65122330|NCT04621617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65122331|NCT04621617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65122354|NCT01212757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65122355|NCT01212757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65122357|NCT01212757|Growth Inhibitors|growth inhibitors|mesh-ancestor
65122358|NCT01212757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65122359|NCT00562419|Irinotecan|irinotecan|mesh-list
65122360|NCT00562419|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65122361|NCT00562419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65122362|NCT00562419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122363|NCT00562419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122364|NCT00562419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65122365|NCT00562458|Anastrozole|anastrozole|mesh-list
65122366|NCT00562458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65122367|NCT00562458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65122368|NCT00562458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65122369|NCT00562458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65122370|NCT00562458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122371|NCT00562458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122372|NCT00562458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65122373|NCT00562458|Hormone Antagonists|hormone antagonists|mesh-ancestor
65122374|NCT00562458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65122375|NCT00562458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122376|NCT02900729|Losartan|losartan|mesh-list
65122377|NCT02900729|Amlodipine|amlodipine|mesh-list
65122378|NCT02900729|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65122379|NCT02900729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65122380|NCT02900729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65122381|NCT02900729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65122399|NCT04621227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65122400|NCT04621227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65122401|NCT04621227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65122402|NCT04621227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122404|NCT04621227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65122405|NCT04621227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65296425|NCT02614482|Cholinergic Agents|cholinergic agents|mesh-ancestor
65046327|NCT00243984|Topiramate|topiramate|mesh-list
65296426|NCT02614482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65296427|NCT02614482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296428|NCT02614482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296429|NCT02614482|Urological Agents|urological agents|mesh-ancestor
65296430|NCT04713709|Naloxone|naloxone|mesh-list
65296431|NCT04713709|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65296432|NCT04713709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296433|NCT04713709|Sensory System Agents|sensory system agents|mesh-ancestor
65296434|NCT04713709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65296435|NCT00879710|Simvastatin|simvastatin|mesh-list
65296436|NCT00879710|Ezetimibe|ezetimibe|mesh-list
65296437|NCT00879710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65296438|NCT00879710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65296439|NCT00879710|Antimetabolites|antimetabolites|mesh-ancestor
65296440|NCT00879710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296441|NCT00879710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64526637|NCT01567865|Vaccines|vaccines|mesh-list
65122406|NCT04621227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65122407|NCT04621227|Anesthetics, General|anesthetics, general|mesh-ancestor
65122408|NCT04621227|Anesthetics|anesthetics|mesh-ancestor
65122409|NCT04621227|GABA Modulators|gaba modulators|mesh-ancestor
65122410|NCT04621227|GABA Agents|gaba agents|mesh-ancestor
65122411|NCT04621227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65122412|NCT04621227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122413|NCT04621227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65122414|NCT04621227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65122415|NCT04621227|Antimetabolites|antimetabolites|mesh-ancestor
65122416|NCT04621227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65122417|NCT04621227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65122418|NCT04621227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122419|NCT01190410|Certolizumab Pegol|certolizumab pegol|mesh-list
65122420|NCT01190410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65122421|NCT01190410|Immunologic Factors|immunologic factors|mesh-ancestor
65122422|NCT01190410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122423|NCT01190410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65122424|NCT01190254|Asenapine|asenapine|mesh-list
65122425|NCT01190254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65122426|NCT01190254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65122427|NCT01190254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65122428|NCT01190254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122429|NCT01190254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65122430|NCT04620954|Nivolumab|nivolumab|mesh-list
65122431|NCT04620954|Oregovomab|oregovomab|mesh-list
65122432|NCT04620954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65122433|NCT04620954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65122434|NCT04620954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65122435|NCT04620954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764776|NCT02987556|Insulin|insulin|mesh-list
65122436|NCT00562692|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65122447|NCT04621110|Analgesics|analgesics|mesh-ancestor
65122448|NCT04621110|Sensory System Agents|sensory system agents|mesh-ancestor
65122449|NCT04621110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122450|NCT04621110|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65122451|NCT04621110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65122452|NCT04621110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65296442|NCT00879710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65296443|NCT00879710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296444|NCT02703857|Cefoxitin|cefoxitin|mesh-list
65296445|NCT02703857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65296446|NCT02703857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65296447|NCT02623062|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
65296448|NCT02623062|Antacids|antacids|mesh-ancestor
65296449|NCT02623062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296450|NCT02623062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65296451|NCT00597506|Bevacizumab|bevacizumab|mesh-list
65296452|NCT00597506|Everolimus|everolimus|mesh-list
65296453|NCT00597506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65296454|NCT00597506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296455|NCT00597506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64526647|NCT05005000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65122453|NCT04621110|Adrenergic Agents|adrenergic agents|mesh-ancestor
65122454|NCT04621110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65122455|NCT04621110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122456|NCT04621110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65122457|NCT04621110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65122458|NCT04621110|Anesthetics, General|anesthetics, general|mesh-ancestor
65122459|NCT04621110|Anesthetics|anesthetics|mesh-ancestor
65122460|NCT04621110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65122461|NCT04621110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65122462|NCT04621110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65122463|NCT04621110|Narcotics|narcotics|mesh-ancestor
65122464|NCT04621110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65122465|NCT04621110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65122466|NCT04621110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65122467|NCT04621110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65122468|NCT04621110|GABA Modulators|gaba modulators|mesh-ancestor
65122469|NCT04621110|GABA Agents|gaba agents|mesh-ancestor
65122470|NCT04620720|Gabapentin|gabapentin|mesh-list
65122471|NCT04620720|Analgesics|analgesics|mesh-ancestor
65122472|NCT04620720|Sensory System Agents|sensory system agents|mesh-ancestor
65122473|NCT04620720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122474|NCT04620720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122475|NCT04620720|Anticonvulsants|anticonvulsants|mesh-ancestor
65122476|NCT04620720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65122477|NCT04620720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65122478|NCT04620720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65122479|NCT04620720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65122480|NCT04620720|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65122481|NCT04620720|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65122482|NCT04620720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65122483|NCT04620720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122484|NCT04620720|Antimanic Agents|antimanic agents|mesh-ancestor
65122485|NCT02900417|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65122486|NCT02900417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65122487|NCT02900417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122488|NCT02900417|Incretins|incretins|mesh-ancestor
65122489|NCT02900417|Hormones|hormones|mesh-ancestor
65122490|NCT02900417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65122491|NCT02900417|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65122492|NCT02900417|Protease Inhibitors|protease inhibitors|mesh-ancestor
65122493|NCT02900417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122494|NCT02900417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122495|NCT04620018|Amoxicillin|amoxicillin|mesh-list
65296456|NCT00597506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65296457|NCT00597506|Growth Substances|growth substances|mesh-ancestor
65296458|NCT00597506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296459|NCT00597506|Growth Inhibitors|growth inhibitors|mesh-ancestor
65296460|NCT00597506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65296461|NCT00597506|Immunologic Factors|immunologic factors|mesh-ancestor
65296462|NCT04711837|Propofol|propofol|mesh-list
65296463|NCT04711837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65296464|NCT04711837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65296465|NCT04711837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296466|NCT04711837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65296467|NCT04711837|Anesthetics, General|anesthetics, general|mesh-ancestor
65296468|NCT04711837|Anesthetics|anesthetics|mesh-ancestor
65296469|NCT03393611|Cytarabine|cytarabine|mesh-list
65296470|NCT03393611|Fludarabine|fludarabine|mesh-list
65296471|NCT03393611|Melphalan|melphalan|mesh-list
65296472|NCT03393611|Daunorubicin|daunorubicin|mesh-list
65296473|NCT03393611|Thymoglobulin|thymoglobulin|mesh-list
65296474|NCT03393611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296475|NCT03393611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65296476|NCT03393611|Antimetabolites|antimetabolites|mesh-ancestor
65296477|NCT03393611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296478|NCT03393611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65296479|NCT03393611|Immunologic Factors|immunologic factors|mesh-ancestor
65296480|NCT03393611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296481|NCT03393611|Antiviral Agents|antiviral agents|mesh-ancestor
65296482|NCT03393611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65296483|NCT03393611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65296484|NCT03393611|Alkylating Agents|alkylating agents|mesh-ancestor
65296485|NCT03393611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64526663|NCT01567163|Mitosis Modulators|mitosis modulators|mesh-ancestor
65122496|NCT04620018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65122497|NCT04620018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65122498|NCT02900105|Letrozole|letrozole|mesh-list
65122499|NCT02900105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65122500|NCT02900105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65122501|NCT02900105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65122502|NCT02900105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122527|NCT04619862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65122528|NCT04619862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65122529|NCT04619862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65122530|NCT04619862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65122531|NCT04619862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122532|NCT04619862|Antimanic Agents|antimanic agents|mesh-ancestor
65122534|NCT01190839|Dermatologic Agents|dermatologic agents|mesh-ancestor
65296486|NCT03393611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65296487|NCT03393611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65296488|NCT03393611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65296489|NCT03393611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296490|NCT04032548|Chlorhexidine|chlorhexidine|mesh-list
65296491|NCT04032548|Propolis|propolis|mesh-list
65296492|NCT04032548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65296493|NCT04032548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65296494|NCT04032548|Disinfectants|disinfectants|mesh-ancestor
65296495|NCT04032236|Caffeine|caffeine|mesh-list
65296496|NCT04032236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65296497|NCT04032236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296498|NCT04032236|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65296499|NCT04032236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296500|NCT04032236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296501|NCT04032236|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65296502|NCT04032236|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65296503|NCT04032236|Purinergic Agents|purinergic agents|mesh-ancestor
65296504|NCT04032236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65296505|NCT02313389|Rituximab|rituximab|mesh-list
65296506|NCT02313389|Methotrexate|methotrexate|mesh-list
65296507|NCT02313389|Temozolomide|temozolomide|mesh-list
65296508|NCT02313389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65296509|NCT02313389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296510|NCT02313389|Immunologic Factors|immunologic factors|mesh-ancestor
65296511|NCT02313389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296512|NCT02313389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65122535|NCT01190839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65122536|NCT01190839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65122537|NCT00562770|Valacyclovir|valacyclovir|mesh-list
65122538|NCT00562770|Valganciclovir|valganciclovir|mesh-list
65122539|NCT00562770|Antiviral Agents|antiviral agents|mesh-ancestor
65122540|NCT00562770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65122541|NCT05424692|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
65122542|NCT05424692|Fluorouracil|fluorouracil|mesh-list
65122543|NCT05424692|Oxaliplatin|oxaliplatin|mesh-list
65122544|NCT05424692|Irinotecan|irinotecan|mesh-list
65122545|NCT05424692|Cetuximab|cetuximab|mesh-list
65122546|NCT05424692|Antimetabolites|antimetabolites|mesh-ancestor
65122547|NCT05424692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122548|NCT05424692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65122549|NCT05424692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65122550|NCT05424692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65122551|NCT05424692|Immunologic Factors|immunologic factors|mesh-ancestor
65122572|NCT04618965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65122573|NCT04618965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122574|NCT01190449|Ofatumumab|ofatumumab|mesh-list
65122575|NCT01190449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65122576|NCT00562809|Irbesartan|irbesartan|mesh-list
65122577|NCT00562809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65296513|NCT02313389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65296514|NCT02313389|Abortifacient Agents|abortifacient agents|mesh-ancestor
65296515|NCT02313389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65296516|NCT02313389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65296517|NCT02313389|Antimetabolites|antimetabolites|mesh-ancestor
65296518|NCT02313389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296519|NCT02313389|Dermatologic Agents|dermatologic agents|mesh-ancestor
65296520|NCT02313389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296521|NCT02313389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65296522|NCT02313389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65296523|NCT02313389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65296524|NCT02313389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65296525|NCT02313389|Alkylating Agents|alkylating agents|mesh-ancestor
65296526|NCT00708682|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65296527|NCT00708682|Immunologic Factors|immunologic factors|mesh-ancestor
65296528|NCT00708682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296529|NCT02632916|Zoledronic Acid|zoledronic acid|mesh-list
65296530|NCT02632916|Denosumab|denosumab|mesh-list
65296531|NCT02632916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65296532|NCT02632916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296533|NCT00881504|Bevacizumab|bevacizumab|mesh-list
65296534|NCT00881504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65296535|NCT00881504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296538|NCT00881504|Growth Substances|growth substances|mesh-ancestor
65296561|NCT02096159|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65296562|NCT02096159|Sulfamethoxazole|sulfamethoxazole|mesh-list
65296563|NCT02096159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65296564|NCT02096159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65296565|NCT02096159|Renal Agents|renal agents|mesh-ancestor
65296566|NCT02096159|Antimalarials|antimalarials|mesh-ancestor
65296567|NCT02096159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65296568|NCT02096159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65296569|NCT02096159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64526767|NCT01566149|Adrenergic Agents|adrenergic agents|mesh-ancestor
65122578|NCT00562809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65122579|NCT00562809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65122580|NCT00562809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122581|NCT01190098|Lacosamide|lacosamide|mesh-list
65122582|NCT01190098|Anticonvulsants|anticonvulsants|mesh-ancestor
65122583|NCT01190098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65122584|NCT01190098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65122585|NCT01190098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65122586|NCT01190098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122587|NCT05312593|Chlorhexidine|chlorhexidine|mesh-list
65122588|NCT05312593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65122589|NCT05312593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65122590|NCT05312593|Disinfectants|disinfectants|mesh-ancestor
65122591|NCT04314739|Resveratrol|resveratrol|mesh-list
65122592|NCT04314739|Antioxidants|antioxidants|mesh-ancestor
65122593|NCT04314739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122594|NCT04314739|Protective Agents|protective agents|mesh-ancestor
65122595|NCT04314739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122596|NCT04314739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122597|NCT04314739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65122599|NCT02885740|Analgesics|analgesics|mesh-ancestor
65122600|NCT02885740|Sensory System Agents|sensory system agents|mesh-ancestor
65122601|NCT02885740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122602|NCT02885740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122603|NCT02885740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65122604|NCT02885740|Vasodilator Agents|vasodilator agents|mesh-ancestor
64694969|NCT05721170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65122608|NCT02885740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65122609|NCT02885740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122610|NCT05309785|Canagliflozin|canagliflozin|mesh-list
65122611|NCT05309785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65122612|NCT05309785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122613|NCT05309785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65122614|NCT05309785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122615|NCT01190020|Lubiprostone|lubiprostone|mesh-list
65122616|NCT01190020|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65122617|NCT01190020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65122618|NCT01190020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122619|NCT01189435|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65122620|NCT01189435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65122621|NCT01189435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65122622|NCT01189435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122623|NCT01189435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122625|NCT01165996|Azacitidine|azacitidine|mesh-list
65122626|NCT01165996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65122627|NCT01165996|Antimetabolites|antimetabolites|mesh-ancestor
65122628|NCT01165996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122629|NCT01165996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65122630|NCT01165996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122631|NCT04619433|Carboplatin|carboplatin|mesh-list
65122632|NCT04619433|Pemetrexed|pemetrexed|mesh-list
65122633|NCT04619433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296570|NCT02096159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296571|NCT02096159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296572|NCT02096159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65296573|NCT02096159|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65046470|NCT00240630|Naproxen|naproxen|mesh-list
65296575|NCT02096159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65296576|NCT02632136|Bupivacaine|bupivacaine|mesh-list
65296577|NCT02632136|Anesthetics, Local|anesthetics, local|mesh-ancestor
65296578|NCT02632136|Anesthetics|anesthetics|mesh-ancestor
65296579|NCT02632136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65296580|NCT02632136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296581|NCT02632136|Sensory System Agents|sensory system agents|mesh-ancestor
65296582|NCT02632136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65296583|NCT00660920|Ponatinib|ponatinib|mesh-list
65296584|NCT00660920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296585|NCT00660920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65296586|NCT00660920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526776|NCT03417388|Atorvastatin|atorvastatin|mesh-list
65122634|NCT04619433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122635|NCT04619433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122636|NCT04619433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65122637|NCT04619433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65122638|NCT04619160|Propofol|propofol|mesh-list
65122639|NCT04619160|Sevoflurane|sevoflurane|mesh-list
65122640|NCT04619160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65122641|NCT04619160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65122642|NCT04619160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122643|NCT04619160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65122644|NCT04619160|Anesthetics, General|anesthetics, general|mesh-ancestor
65122645|NCT04619160|Anesthetics|anesthetics|mesh-ancestor
65122646|NCT04619160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65122647|NCT04619160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65122648|NCT01165684|Insulin|insulin|mesh-list
65122649|NCT01165684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65122650|NCT01165684|Insulin Aspart|insulin aspart|mesh-list
65122651|NCT01165684|Insulin, Long-Acting|insulin, long-acting|mesh-list
65122652|NCT01165684|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65122653|NCT01165684|Insulin Detemir|insulin detemir|mesh-list
65122654|NCT01165684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65122655|NCT01165684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122656|NCT01189201|Linagliptin|linagliptin|mesh-list
65122657|NCT01189201|Empagliflozin|empagliflozin|mesh-list
65122658|NCT01189201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65122659|NCT01189201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122660|NCT01189201|Incretins|incretins|mesh-ancestor
65122661|NCT01189201|Hormones|hormones|mesh-ancestor
65122662|NCT01189201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65122663|NCT01189201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65122664|NCT01189201|Protease Inhibitors|protease inhibitors|mesh-ancestor
65122665|NCT01189201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122666|NCT01189201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122667|NCT01189201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65122668|NCT01188811|Thioctic Acid|thioctic acid|mesh-list
65122669|NCT01188811|Antioxidants|antioxidants|mesh-ancestor
65122670|NCT01188811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122671|NCT01188811|Protective Agents|protective agents|mesh-ancestor
65296587|NCT00660920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296588|NCT01936831|Vitamin B 6|vitamin b 6|mesh-list
65296589|NCT01936831|Pyridoxal|pyridoxal|mesh-list
65296590|NCT01936831|Pyridoxine|pyridoxine|mesh-list
65296591|NCT01936831|Isoniazid|isoniazid|mesh-list
65296592|NCT01936831|Vitamins|vitamins|mesh-ancestor
65296593|NCT01936831|Micronutrients|micronutrients|mesh-ancestor
65296594|NCT01936831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296595|NCT01936831|Vitamin B Complex|vitamin b complex|mesh-ancestor
65296596|NCT01936831|Antitubercular Agents|antitubercular agents|mesh-ancestor
65296597|NCT01936831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65296598|NCT01936831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65296599|NCT01936831|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65296600|NCT01936831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65296601|NCT01936831|Antimetabolites|antimetabolites|mesh-ancestor
65296602|NCT01936831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526806|NCT03382834|Tamoxifen|tamoxifen|mesh-list
65122672|NCT01188811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122673|NCT01188811|Vitamin B Complex|vitamin b complex|mesh-ancestor
65122674|NCT01188811|Vitamins|vitamins|mesh-ancestor
65122675|NCT01188811|Micronutrients|micronutrients|mesh-ancestor
65122676|NCT01183234|Methylphenidate|methylphenidate|mesh-list
65122684|NCT01183234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65122685|NCT04618497|Ketorolac|ketorolac|mesh-list
65122686|NCT04618497|Methoxyflurane|methoxyflurane|mesh-list
65122687|NCT04618497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65122688|NCT04618497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65122689|NCT04618497|Analgesics|analgesics|mesh-ancestor
65122690|NCT04618497|Sensory System Agents|sensory system agents|mesh-ancestor
65122691|NCT04618497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122692|NCT04618497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122693|NCT04618497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65122694|NCT04618497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65122695|NCT04618497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65122696|NCT04618497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122697|NCT04618497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122698|NCT04618497|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65122699|NCT04618497|Anesthetics, General|anesthetics, general|mesh-ancestor
65122700|NCT04618497|Anesthetics|anesthetics|mesh-ancestor
65122701|NCT04618497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65122702|NCT04618575|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65122703|NCT04618575|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65122704|NCT04618575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65122705|NCT04679948|Midazolam|midazolam|mesh-list
65122706|NCT04679948|Caffeine|caffeine|mesh-list
65122707|NCT04679948|Omeprazole|omeprazole|mesh-list
65122708|NCT04679948|Warfarin|warfarin|mesh-list
65122709|NCT04679948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65122710|NCT04679948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65122711|NCT04679948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65122712|NCT04679948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122713|NCT04679948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65122714|NCT04679948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65122715|NCT04679948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65122716|NCT04679948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65122717|NCT04679948|Anesthetics, General|anesthetics, general|mesh-ancestor
65122718|NCT04679948|Anesthetics|anesthetics|mesh-ancestor
65122719|NCT04679948|GABA Modulators|gaba modulators|mesh-ancestor
65122720|NCT04679948|GABA Agents|gaba agents|mesh-ancestor
65122721|NCT04679948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65122722|NCT04679948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296603|NCT01936831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65296604|NCT00615173|Cyclophosphamide|cyclophosphamide|mesh-list
65296605|NCT00615173|Azathioprine|azathioprine|mesh-list
65296606|NCT00615173|Tacrolimus|tacrolimus|mesh-list
65296607|NCT00615173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65296608|NCT00615173|Immunologic Factors|immunologic factors|mesh-ancestor
65296609|NCT00615173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296610|NCT00615173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65296611|NCT00615173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65296612|NCT00615173|Alkylating Agents|alkylating agents|mesh-ancestor
65296613|NCT00615173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296614|NCT00615173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296615|NCT00615173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65296616|NCT00615173|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65296617|NCT00615173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296618|NCT00615173|Antimetabolites|antimetabolites|mesh-ancestor
65296619|NCT00615173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65296620|NCT00660998|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65296621|NCT00660998|Vasodilator Agents|vasodilator agents|mesh-ancestor
64526807|NCT03382834|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65122723|NCT04679948|Anticoagulants|anticoagulants|mesh-ancestor
65122724|NCT04679948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65122725|NCT04679948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65122726|NCT04679948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122727|NCT04679948|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65122728|NCT04679948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65122729|NCT04679948|Purinergic Agents|purinergic agents|mesh-ancestor
65122730|NCT04679948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65122731|NCT04679948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65122732|NCT04679948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65122733|NCT04618536|Sunscreening Agents|sunscreening agents|mesh-list
65122734|NCT04618536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65122735|NCT04618536|Protective Agents|protective agents|mesh-ancestor
65122736|NCT04618536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122737|NCT04618536|Dermatologic Agents|dermatologic agents|mesh-ancestor
65122738|NCT04651959|Favipiravir|favipiravir|mesh-list
65122739|NCT04651959|Antiviral Agents|antiviral agents|mesh-ancestor
65122740|NCT04651959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65122741|NCT01165216|Paclitaxel|paclitaxel|mesh-list
65122742|NCT01165216|Carboplatin|carboplatin|mesh-list
65122743|NCT01165216|Ipilimumab|ipilimumab|mesh-list
65122744|NCT01165216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65122747|NCT01165216|Antimitotic Agents|antimitotic agents|mesh-ancestor
65122748|NCT01165216|Mitosis Modulators|mitosis modulators|mesh-ancestor
65122749|NCT01165216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122750|NCT01165216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65122751|NCT01165216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65122753|NCT04652115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65122754|NCT04652115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65122755|NCT04652115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122756|NCT04652115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65122757|NCT04618107|Anesthetics|anesthetics|mesh-list
65122758|NCT04618107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65122759|NCT04618107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122760|NCT05423015|Levan|levan|mesh-list
65296622|NCT00660998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65296623|NCT00660998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65296624|NCT00660998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296625|NCT00660998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296626|NCT00660998|Urological Agents|urological agents|mesh-ancestor
65296627|NCT00657254|Sorafenib|sorafenib|mesh-list
65296628|NCT00657254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296629|NCT00657254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65296630|NCT00657254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296631|NCT00657254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296632|NCT01455389|Diphenhydramine|diphenhydramine|mesh-list
65296633|NCT01455389|Promethazine|promethazine|mesh-list
65296634|NCT01455389|Dexamethasone|dexamethasone|mesh-list
64384675|NCT03177317|Hormones|hormones|mesh-ancestor
64526826|NCT02691702|Protective Agents|protective agents|mesh-ancestor
65122761|NCT05423015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65122762|NCT04618146|Morphine|morphine|mesh-list
65122763|NCT04618146|Bupivacaine|bupivacaine|mesh-list
65122764|NCT04618146|Anesthetics, Local|anesthetics, local|mesh-ancestor
65122765|NCT04618146|Anesthetics|anesthetics|mesh-ancestor
65122766|NCT04618146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65122767|NCT04618146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122768|NCT04618146|Sensory System Agents|sensory system agents|mesh-ancestor
65122769|NCT04618146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122770|NCT04618146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65122771|NCT04618146|Narcotics|narcotics|mesh-ancestor
65122772|NCT04618146|Analgesics|analgesics|mesh-ancestor
65122773|NCT04651842|Insulin|insulin|mesh-list
65122774|NCT04651842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65122775|NCT04651842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122776|NCT05421962|Fentanyl|fentanyl|mesh-list
65122777|NCT05421962|Ketamine|ketamine|mesh-list
65122778|NCT05421962|Analgesics|analgesics|mesh-ancestor
65122779|NCT05421962|Sensory System Agents|sensory system agents|mesh-ancestor
65122780|NCT05421962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122781|NCT05421962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122782|NCT05421962|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65122783|NCT05421962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65122784|NCT05421962|Anesthetics, General|anesthetics, general|mesh-ancestor
65122785|NCT05421962|Anesthetics|anesthetics|mesh-ancestor
65122786|NCT05421962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65122787|NCT05421962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65122788|NCT05421962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65122789|NCT05421962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65122790|NCT05421962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122791|NCT05421962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65122792|NCT05421962|Narcotics|narcotics|mesh-ancestor
65122793|NCT05421962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65122794|NCT00557817|Darbepoetin alfa|darbepoetin alfa|mesh-list
65122795|NCT00557817|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65122796|NCT00557817|Hematinics|hematinics|mesh-ancestor
65122797|NCT05419583|Aspirin|aspirin|mesh-list
65122798|NCT05419583|Warfarin|warfarin|mesh-list
65122799|NCT05419583|Apixaban|apixaban|mesh-list
65122800|NCT05419583|Anticoagulants|anticoagulants|mesh-list
65122801|NCT05419583|Edoxaban|edoxaban|mesh-list
65122802|NCT05419583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65122803|NCT05419583|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65122804|NCT05419583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65122805|NCT05419583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65122806|NCT05419583|Analgesics|analgesics|mesh-ancestor
65122807|NCT05419583|Sensory System Agents|sensory system agents|mesh-ancestor
65122808|NCT05419583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65296635|NCT01455389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65296636|NCT01455389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65296637|NCT01455389|Antiemetics|antiemetics|mesh-ancestor
65296638|NCT01455389|Autonomic Agents|autonomic agents|mesh-ancestor
65296639|NCT01455389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65296640|NCT01455389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296641|NCT01455389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65296642|NCT01455389|Glucocorticoids|glucocorticoids|mesh-ancestor
65296643|NCT01455389|Hormones|hormones|mesh-ancestor
65296644|NCT01455389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65296645|NCT01455389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65296646|NCT01455389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526837|NCT01564277|Antioxidants|antioxidants|mesh-ancestor
65122809|NCT05419583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122810|NCT05419583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65122811|NCT05419583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65122812|NCT05419583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65122813|NCT05419583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65122814|NCT05419583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122815|NCT05419583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65122816|NCT05419583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122818|NCT05419583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65122819|NCT05419583|Antithrombins|antithrombins|mesh-ancestor
65122823|NCT05419583|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65122824|NCT05419583|Antimetabolites|antimetabolites|mesh-ancestor
65122825|NCT05419583|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65122826|NCT05387408|Analgesics, Opioid|analgesics, opioid|mesh-list
65122828|NCT05387408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65122829|NCT05387408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122830|NCT05387408|Analgesics|analgesics|mesh-ancestor
65122831|NCT05387408|Sensory System Agents|sensory system agents|mesh-ancestor
65122832|NCT05387408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122833|NCT04617795|Insulin|insulin|mesh-list
65122834|NCT04617795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65122835|NCT04617795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122836|NCT05376761|Dexmedetomidine|dexmedetomidine|mesh-list
65122837|NCT05376761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64514122|NCT01728623|Lenvatinib|lenvatinib|mesh-list
65122838|NCT05376761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65122839|NCT05376761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122840|NCT05376761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65122841|NCT05376761|Analgesics|analgesics|mesh-ancestor
65122842|NCT05376761|Sensory System Agents|sensory system agents|mesh-ancestor
65122843|NCT05376761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122844|NCT05376761|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65122845|NCT05376761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65122846|NCT05376761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65122847|NCT05376761|Adrenergic Agents|adrenergic agents|mesh-ancestor
65122848|NCT05376761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65122849|NCT05376761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122850|NCT04617561|Methylprednisolone|methylprednisolone|mesh-list
65122851|NCT04617561|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65122852|NCT04617561|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65122853|NCT04617561|Prednisolone|prednisolone|mesh-list
65122854|NCT04617561|Prednisolone acetate|prednisolone acetate|mesh-list
65122855|NCT04617561|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65122856|NCT04617561|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65122857|NCT04617561|Prednisolone phosphate|prednisolone phosphate|mesh-list
65122858|NCT04617561|Glucocorticoids|glucocorticoids|mesh-list
65122859|NCT04617561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65122860|NCT04617561|Antiemetics|antiemetics|mesh-ancestor
65122861|NCT04617561|Autonomic Agents|autonomic agents|mesh-ancestor
65296647|NCT01455389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65296648|NCT01455389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296649|NCT01455389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296650|NCT01455389|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65296651|NCT01455389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65296652|NCT01455389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65296653|NCT01455389|Anesthetics, Local|anesthetics, local|mesh-ancestor
65296654|NCT01455389|Anesthetics|anesthetics|mesh-ancestor
65296655|NCT01455389|Sensory System Agents|sensory system agents|mesh-ancestor
65296656|NCT01455389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65296657|NCT01455389|Histamine Antagonists|histamine antagonists|mesh-ancestor
65122862|NCT04617561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122863|NCT04617561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122864|NCT04617561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65122865|NCT04617561|Hormones|hormones|mesh-ancestor
65122866|NCT04617561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65122867|NCT04617561|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65122868|NCT04617561|Protective Agents|protective agents|mesh-ancestor
65122869|NCT04617561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65122870|NCT04617561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65122871|NCT04617561|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65122872|NCT04617483|Vaccines|vaccines|mesh-list
65122873|NCT04617483|Immunologic Factors|immunologic factors|mesh-ancestor
65122874|NCT04617483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122875|NCT04617249|Anesthetics|anesthetics|mesh-list
65122876|NCT04617249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65122877|NCT04617249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122878|NCT05349383|Antineoplastic Agents|antineoplastic agents|mesh-list
65122879|NCT05349383|Antibodies|antibodies|mesh-list
65122880|NCT05349383|Immunoglobulins|immunoglobulins|mesh-list
65122881|NCT05349383|Immunoconjugates|immunoconjugates|mesh-list
65122882|NCT05349383|Immunologic Factors|immunologic factors|mesh-ancestor
65122883|NCT05349383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122884|NCT04617171|Benralizumab|benralizumab|mesh-list
65122885|NCT04617171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65122886|NCT04617171|Respiratory System Agents|respiratory system agents|mesh-ancestor
65122887|NCT00557934|Dobutamine|dobutamine|mesh-list
65122888|NCT00557934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65122890|NCT00557934|Autonomic Agents|autonomic agents|mesh-ancestor
65122891|NCT00557934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122892|NCT00557934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122913|NCT04617015|Anticonvulsants|anticonvulsants|mesh-ancestor
65122915|NCT04617015|Autonomic Agents|autonomic agents|mesh-ancestor
65122916|NCT04617015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122917|NCT04617015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122918|NCT04617015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65122919|NCT04617015|Respiratory System Agents|respiratory system agents|mesh-ancestor
65122920|NCT04617015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65122921|NCT04617015|Cholinergic Agents|cholinergic agents|mesh-ancestor
65122922|NCT04617015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65122923|NCT04617015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122925|NCT04650828|Antiviral Agents|antiviral agents|mesh-ancestor
65122926|NCT04650828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65122927|NCT04650828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65122928|NCT04650828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65122929|NCT04650828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122930|NCT04650828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122931|NCT04650828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65122932|NCT04650828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65122933|NCT04650555|Genistein|genistein|mesh-list
65122934|NCT04650555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65122935|NCT04650555|Protective Agents|protective agents|mesh-ancestor
65122936|NCT04650555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296658|NCT01455389|Histamine Agents|histamine agents|mesh-ancestor
65296659|NCT01455389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65296660|NCT01455389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65296661|NCT01455389|Antipruritics|antipruritics|mesh-ancestor
65296662|NCT01455389|Dermatologic Agents|dermatologic agents|mesh-ancestor
65296663|NCT00661076|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65296664|NCT00661076|Adefovir|adefovir|mesh-list
65296665|NCT00661076|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65296666|NCT00661076|Antiviral Agents|antiviral agents|mesh-ancestor
65296667|NCT00661076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65296668|NCT00661076|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65296669|NCT00661076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65296670|NCT00661076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296671|NCT00661076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296672|NCT04215965|Dialysis Solutions|dialysis solutions|mesh-list
65296673|NCT04215965|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65296674|NCT00661700|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65296675|NCT00661700|Vasodilator Agents|vasodilator agents|mesh-ancestor
65296676|NCT00661700|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65296677|NCT00661700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65296678|NCT00661700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296679|NCT00661700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296680|NCT00661700|Urological Agents|urological agents|mesh-ancestor
65296681|NCT00613769|Metronidazole|metronidazole|mesh-list
64526860|NCT01563185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65122937|NCT04650555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65122938|NCT04650555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65122939|NCT04650555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122940|NCT04650555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122941|NCT04650555|Phytoestrogens|phytoestrogens|mesh-ancestor
65122942|NCT04650555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65122943|NCT04650555|Estrogens|estrogens|mesh-ancestor
65122944|NCT04650555|Hormones|hormones|mesh-ancestor
65122945|NCT04650555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65122946|NCT04650321|Ocrelizumab|ocrelizumab|mesh-list
65122947|NCT04650321|Immunologic Factors|immunologic factors|mesh-ancestor
64695307|NCT05642923|Vitamin B Complex|vitamin b complex|mesh-ancestor
65122976|NCT05125796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122977|NCT05125796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65122978|NCT05125796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65122979|NCT05125796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65122980|NCT05125796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65122981|NCT05125796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122982|NCT05125796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65122983|NCT05125796|Analgesics|analgesics|mesh-ancestor
65122984|NCT05125796|Antipyretics|antipyretics|mesh-ancestor
64655880|NCT03028532|Fertility Agents|fertility agents|mesh-ancestor
65122985|NCT05125796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65122986|NCT05125796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65296682|NCT00613769|Trimethoprim|trimethoprim|mesh-list
65296683|NCT00613769|Sulfamethoxazole|sulfamethoxazole|mesh-list
65296684|NCT00613769|Cefuroxime|cefuroxime|mesh-list
65296685|NCT00613769|Cefuroxime axetil|cefuroxime axetil|mesh-list
65296686|NCT00613769|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65296687|NCT00613769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65296688|NCT00613769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65296689|NCT00613769|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65296690|NCT00613769|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65296691|NCT00613769|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65296692|NCT00613769|Renal Agents|renal agents|mesh-ancestor
65296693|NCT00613769|Antimalarials|antimalarials|mesh-ancestor
65296694|NCT00613769|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65296695|NCT00613769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296696|NCT00613769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296697|NCT00613769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65296698|NCT00613769|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65296699|NCT00613769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64526889|NCT03293368|Triamcinolone|triamcinolone|mesh-list
65122987|NCT05125796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65122988|NCT05125796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65122989|NCT05125796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122991|NCT05096117|Analgesics|analgesics|mesh-ancestor
65122992|NCT05096117|Sensory System Agents|sensory system agents|mesh-ancestor
65123000|NCT04616859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65123001|NCT04616859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65123002|NCT04616859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65123003|NCT04616859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123005|NCT04616586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123006|NCT05045612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65123007|NCT05045612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65123008|NCT04616352|Cefuroxime|cefuroxime|mesh-list
65123009|NCT04616352|Cefuroxime axetil|cefuroxime axetil|mesh-list
65123010|NCT04616352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65123011|NCT04616352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65123012|NCT00553943|Cytarabine|cytarabine|mesh-list
65123013|NCT00553943|Rituximab|rituximab|mesh-list
65123014|NCT00553943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65123015|NCT00553943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123016|NCT00553943|Immunologic Factors|immunologic factors|mesh-ancestor
65123017|NCT00553943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123018|NCT00553943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65123019|NCT00553943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65123020|NCT00553943|Antimetabolites|antimetabolites|mesh-ancestor
65123021|NCT00553943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123022|NCT00553943|Antiviral Agents|antiviral agents|mesh-ancestor
65123023|NCT00553943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65123024|NCT00553943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65123025|NCT00563160|Gemcitabine|gemcitabine|mesh-list
65123026|NCT00563160|Carboplatin|carboplatin|mesh-list
65123027|NCT00563160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123028|NCT00563160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65123029|NCT00563160|Antimetabolites|antimetabolites|mesh-ancestor
65123030|NCT00563160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123031|NCT00563160|Antiviral Agents|antiviral agents|mesh-ancestor
65123032|NCT00563160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65123033|NCT00563160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296700|NCT00661154|Bevacizumab|bevacizumab|mesh-list
65296701|NCT00661154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65296702|NCT00661154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296703|NCT00661154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65296704|NCT00661154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65296705|NCT00661154|Growth Substances|growth substances|mesh-ancestor
65296706|NCT00661154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296707|NCT00661154|Growth Inhibitors|growth inhibitors|mesh-ancestor
65296708|NCT00523705|Citalopram|citalopram|mesh-list
65296709|NCT00523705|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65296710|NCT00523705|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65296711|NCT00523705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65296712|NCT00523705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296713|NCT00523705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64526903|NCT03273712|Edotreotide|edotreotide|mesh-list
64526909|NCT04113317|Lenograstim|lenograstim|mesh-list
65123034|NCT00563160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65123035|NCT00563160|Immunologic Factors|immunologic factors|mesh-ancestor
65123036|NCT00563160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123037|NCT00563238|Metoprolol|metoprolol|mesh-list
65123038|NCT00563238|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65123039|NCT00563238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65123040|NCT00563238|Sympatholytics|sympatholytics|mesh-ancestor
65123041|NCT00563238|Autonomic Agents|autonomic agents|mesh-ancestor
65123042|NCT00563238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65123043|NCT00563238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123044|NCT00563238|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65123045|NCT00563238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65123046|NCT00563238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65123047|NCT00563238|Adrenergic Agents|adrenergic agents|mesh-ancestor
65123048|NCT00563238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65123049|NCT00563238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123051|NCT04616313|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65123052|NCT04616313|Anesthetics, General|anesthetics, general|mesh-ancestor
65123053|NCT04616313|Anesthetics|anesthetics|mesh-ancestor
65123054|NCT04616313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65123055|NCT04616313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123056|NCT04679558|Chlorhexidine|chlorhexidine|mesh-list
65123057|NCT04679558|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65123058|NCT04679558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65123059|NCT04679558|Disinfectants|disinfectants|mesh-ancestor
65123060|NCT04934228|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64695412|NCT00003159|Antimetabolites|antimetabolites|mesh-ancestor
65123072|NCT04934228|Sympatholytics|sympatholytics|mesh-ancestor
65123073|NCT04934228|Autonomic Agents|autonomic agents|mesh-ancestor
65123074|NCT04934228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65123075|NCT04934228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65123076|NCT04934228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65123077|NCT04934228|Adrenergic Agents|adrenergic agents|mesh-ancestor
65123078|NCT04934228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65123079|NCT03454503|Imatinib Mesylate|imatinib mesylate|mesh-list
65123080|NCT03454503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123081|NCT03454503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65123082|NCT03454503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123083|NCT03454503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123084|NCT04616391|Insulin|insulin|mesh-list
65123085|NCT04616391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65123086|NCT04616391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296714|NCT00523705|Serotonin Agents|serotonin agents|mesh-ancestor
65296715|NCT00523705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296716|NCT00523705|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65296717|NCT00523705|Antidepressive Agents|antidepressive agents|mesh-ancestor
65296718|NCT00523705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65296719|NCT00193427|Gemcitabine|gemcitabine|mesh-list
65296720|NCT00193427|Carboplatin|carboplatin|mesh-list
65296721|NCT00193427|Docetaxel|docetaxel|mesh-list
65296722|NCT00193427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046616|NCT00215579|Serotonin Agents|serotonin agents|mesh-ancestor
65296723|NCT00193427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65296724|NCT00193427|Antimetabolites|antimetabolites|mesh-ancestor
65296725|NCT00193427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296726|NCT00193427|Antiviral Agents|antiviral agents|mesh-ancestor
65296727|NCT00193427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65296728|NCT00193427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296729|NCT00193427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64925024|NCT00030979|Donepezil|donepezil|mesh-list
65123087|NCT04615962|Mometasone Furoate|mometasone furoate|mesh-list
65123088|NCT04615962|Hydrocortisone|hydrocortisone|mesh-list
65123089|NCT04615962|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65123090|NCT04615962|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65123091|NCT04615962|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65123092|NCT04615962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65123093|NCT04615962|Dermatologic Agents|dermatologic agents|mesh-ancestor
65123094|NCT04615962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65123095|NCT04881929|Docetaxel|docetaxel|mesh-list
65123096|NCT04881929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123097|NCT04881929|Tubulin Modulators|tubulin modulators|mesh-ancestor
65123098|NCT04881929|Antimitotic Agents|antimitotic agents|mesh-ancestor
65123099|NCT04881929|Mitosis Modulators|mitosis modulators|mesh-ancestor
65123100|NCT04881929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123101|NCT04615767|Inositol|inositol|mesh-list
65123102|NCT04615767|Vitamin B Complex|vitamin b complex|mesh-ancestor
65123103|NCT04615767|Vitamins|vitamins|mesh-ancestor
65123104|NCT04615767|Micronutrients|micronutrients|mesh-ancestor
65123105|NCT04615767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123106|NCT04863638|Vaccines|vaccines|mesh-list
65123107|NCT04863638|Immunologic Factors|immunologic factors|mesh-ancestor
65123108|NCT04863638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123109|NCT04615611|Albuterol|albuterol|mesh-list
65123110|NCT04615611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65123111|NCT04615611|Autonomic Agents|autonomic agents|mesh-ancestor
65123112|NCT04615611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65123113|NCT04615611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123114|NCT04615611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65123115|NCT04615611|Respiratory System Agents|respiratory system agents|mesh-ancestor
65123116|NCT04615611|Tocolytic Agents|tocolytic agents|mesh-ancestor
65123117|NCT04615611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65123118|NCT04615611|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65123119|NCT04615611|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65123120|NCT04615611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65123121|NCT04615611|Adrenergic Agents|adrenergic agents|mesh-ancestor
65123122|NCT04615611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65123123|NCT04615611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123124|NCT04615728|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65123125|NCT04615728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65123126|NCT04833959|Panitumumab|panitumumab|mesh-list
65123134|NCT04725812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65296730|NCT00193427|Immunologic Factors|immunologic factors|mesh-ancestor
65296731|NCT00193427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296732|NCT00193427|Tubulin Modulators|tubulin modulators|mesh-ancestor
65296733|NCT00193427|Antimitotic Agents|antimitotic agents|mesh-ancestor
65296734|NCT00193427|Mitosis Modulators|mitosis modulators|mesh-ancestor
65296735|NCT00665678|Paroxetine|paroxetine|mesh-list
65296736|NCT00665678|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65296737|NCT00665678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65296738|NCT00665678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65296739|NCT00665678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296740|NCT00665678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65296741|NCT00665678|Serotonin Agents|serotonin agents|mesh-ancestor
65296742|NCT00665678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296743|NCT00665678|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65296744|NCT00665678|Antidepressive Agents|antidepressive agents|mesh-ancestor
65296745|NCT00665678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65296746|NCT00665678|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65296747|NCT00665678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65296748|NCT00665678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296749|NCT05345327|Metformin|metformin|mesh-list
65296750|NCT05345327|Dapagliflozin|dapagliflozin|mesh-list
65296751|NCT05345327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65296752|NCT05345327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296753|NCT05345327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65296754|NCT05345327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296755|NCT00523549|Amlodipine|amlodipine|mesh-list
65296756|NCT00523549|Valsartan|valsartan|mesh-list
65296757|NCT00523549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65296758|NCT00523549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65296759|NCT00523549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65123135|NCT04725812|Immunologic Factors|immunologic factors|mesh-ancestor
65123136|NCT04725812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123137|NCT04713371|Cyclophosphamide|cyclophosphamide|mesh-list
65123138|NCT04713371|Pembrolizumab|pembrolizumab|mesh-list
65123139|NCT04713371|Ipilimumab|ipilimumab|mesh-list
65123140|NCT04713371|Sargramostim|sargramostim|mesh-list
65123141|NCT04713371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65123142|NCT04713371|Immunologic Factors|immunologic factors|mesh-ancestor
65123143|NCT04713371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123144|NCT04713371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65123145|NCT04713371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65123146|NCT04713371|Alkylating Agents|alkylating agents|mesh-ancestor
65123147|NCT04713371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296760|NCT00523549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296761|NCT00523549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65296762|NCT00523549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296763|NCT00523549|Vasodilator Agents|vasodilator agents|mesh-ancestor
65296764|NCT00523549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65296765|NCT00523549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65296766|NCT04215653|Rabeprazole|rabeprazole|mesh-list
65296767|NCT04215653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65296768|NCT04215653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65296769|NCT04215653|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65296770|NCT04215653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296771|NCT04215653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296772|NCT02706119|Insulin|insulin|mesh-list
65296773|NCT02706119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65296774|NCT02706119|Insulin Glargine|insulin glargine|mesh-list
65296775|NCT02706119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65296776|NCT02706119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296777|NCT02631668|Ferrous succinate|ferrous succinate|mesh-list
65296778|NCT02631668|Hematinics|hematinics|mesh-ancestor
65296779|NCT00665756|Mitomycins|mitomycins|mesh-list
65296780|NCT00665756|Mitomycin|mitomycin|mesh-list
65296781|NCT00665756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65296782|NCT00665756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296783|NCT00665756|Alkylating Agents|alkylating agents|mesh-ancestor
65296784|NCT00665756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296785|NCT00665756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65296786|NCT00665756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296787|NCT00661856|Genistein|genistein|mesh-list
65123148|NCT04713371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123149|NCT04713371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65123150|NCT04713371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65123151|NCT04713371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65123152|NCT04683614|Norepinephrine|norepinephrine|mesh-list
65123153|NCT04683614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65123154|NCT04683614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65123155|NCT04683614|Adrenergic Agents|adrenergic agents|mesh-ancestor
65123156|NCT04683614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65123157|NCT04683614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123158|NCT04683614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123159|NCT04683614|Sympathomimetics|sympathomimetics|mesh-ancestor
65123160|NCT04683614|Autonomic Agents|autonomic agents|mesh-ancestor
65123161|NCT04683614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65123162|NCT04683614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65123163|NCT04676087|Mogamulizumab|mogamulizumab|mesh-list
65123164|NCT04676087|Immunoglobulins|immunoglobulins|mesh-list
65123165|NCT04676087|Immunoglobulin G|immunoglobulin g|mesh-list
65296788|NCT00661856|Daidzein|daidzein|mesh-list
65296789|NCT00661856|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65296790|NCT00661856|Protective Agents|protective agents|mesh-ancestor
65296791|NCT00661856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296792|NCT00661856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296793|NCT00661856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65296794|NCT00661856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296795|NCT00661856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296796|NCT00661856|Phytoestrogens|phytoestrogens|mesh-ancestor
65296797|NCT00661856|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65296798|NCT00661856|Estrogens|estrogens|mesh-ancestor
65296799|NCT00661856|Hormones|hormones|mesh-ancestor
65296800|NCT00661856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65296801|NCT04215731|Leucovorin|leucovorin|mesh-list
65296802|NCT04215731|Bevacizumab|bevacizumab|mesh-list
65296803|NCT04215731|Fluorouracil|fluorouracil|mesh-list
65296804|NCT04215731|Oxaliplatin|oxaliplatin|mesh-list
65296805|NCT04215731|Irinotecan|irinotecan|mesh-list
65296806|NCT04215731|Levoleucovorin|levoleucovorin|mesh-list
65296807|NCT04215731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65296808|NCT04215731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296809|NCT04215731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65296810|NCT04215731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65296811|NCT04215731|Growth Substances|growth substances|mesh-ancestor
65296812|NCT04215731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296813|NCT04215731|Growth Inhibitors|growth inhibitors|mesh-ancestor
65296814|NCT04215731|Antimetabolites|antimetabolites|mesh-ancestor
65296815|NCT04215731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296816|NCT04215731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65296817|NCT04215731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65296818|NCT04215731|Immunologic Factors|immunologic factors|mesh-ancestor
65296819|NCT04215731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65296820|NCT04215731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65296821|NCT04215731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296822|NCT04215731|Antidotes|antidotes|mesh-ancestor
65296823|NCT04215731|Protective Agents|protective agents|mesh-ancestor
65296824|NCT04215731|Vitamin B Complex|vitamin b complex|mesh-ancestor
65296827|NCT00665834|Atorvastatin|atorvastatin|mesh-list
65296828|NCT00665834|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65296829|NCT00665834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65296830|NCT00665834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65296831|NCT00665834|Antimetabolites|antimetabolites|mesh-ancestor
65296832|NCT00665834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296833|NCT00665834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65296834|NCT00665834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65296835|NCT00665834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296836|NCT02704013|Oxybutynin|oxybutynin|mesh-list
65296837|NCT02704013|Parasympatholytics|parasympatholytics|mesh-ancestor
65296838|NCT02704013|Autonomic Agents|autonomic agents|mesh-ancestor
65296839|NCT02704013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65296840|NCT02704013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296841|NCT02704013|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65296842|NCT02704013|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65296843|NCT02704013|Cholinergic Agents|cholinergic agents|mesh-ancestor
65296844|NCT02704013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64527023|NCT03162120|Ranolazine|ranolazine|mesh-list
65123166|NCT04676087|Immunologic Factors|immunologic factors|mesh-ancestor
65123167|NCT04676087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123168|NCT04676087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123169|NCT04613700|Secretin|secretin|mesh-list
65123170|NCT04613700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65123171|NCT04613700|Hormones|hormones|mesh-ancestor
65123172|NCT04613700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65123173|NCT04613700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123174|NCT04675151|Phentolamine|phentolamine|mesh-list
65123175|NCT04675151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65123176|NCT04675151|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65123177|NCT04675151|Pilocarpine|pilocarpine|mesh-list
65123178|NCT04675151|Miotics|miotics|mesh-ancestor
65123179|NCT04675151|Autonomic Agents|autonomic agents|mesh-ancestor
65123180|NCT04675151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65123181|NCT04675151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123182|NCT04675151|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65123183|NCT04675151|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65123184|NCT04675151|Cholinergic Agents|cholinergic agents|mesh-ancestor
65123185|NCT04675151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65123186|NCT04675151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123187|NCT04675151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64765532|NCT00635232|Irbesartan|irbesartan|mesh-list
65123188|NCT04675151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65123189|NCT04675151|Adrenergic Agents|adrenergic agents|mesh-ancestor
65123190|NCT04675151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65123191|NCT00563355|Epoetin Alfa|epoetin alfa|mesh-list
65123192|NCT00563355|Hematinics|hematinics|mesh-ancestor
65123193|NCT00563394|Ofloxacin|ofloxacin|mesh-list
65123194|NCT00563394|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65123195|NCT00563394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65123206|NCT00563433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65123208|NCT00563433|Renal Agents|renal agents|mesh-ancestor
65123209|NCT00563433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65123210|NCT00563433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65123211|NCT00563433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65123212|NCT00563433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123213|NCT00563433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296845|NCT02704013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296846|NCT02704013|Urological Agents|urological agents|mesh-ancestor
65296847|NCT00665990|Cyclophosphamide|cyclophosphamide|mesh-list
65296848|NCT00665990|Bevacizumab|bevacizumab|mesh-list
65296849|NCT00665990|Sorafenib|sorafenib|mesh-list
65296850|NCT00665990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65296851|NCT00665990|Immunologic Factors|immunologic factors|mesh-ancestor
65296852|NCT00665990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296853|NCT00665990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65296854|NCT00665990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65296855|NCT00665990|Alkylating Agents|alkylating agents|mesh-ancestor
65296856|NCT00665990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296857|NCT00665990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296858|NCT00665990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65296859|NCT00665990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65296860|NCT00665990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65296861|NCT00665990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65296862|NCT00665990|Growth Substances|growth substances|mesh-ancestor
65296863|NCT00665990|Growth Inhibitors|growth inhibitors|mesh-ancestor
65296864|NCT00665990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65296865|NCT00665990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296866|NCT04289779|Atezolizumab|atezolizumab|mesh-list
65296867|NCT04289779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296868|NCT00666068|Hormones|hormones|mesh-list
65123214|NCT00563433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123215|NCT00563433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65123216|NCT00563433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65123217|NCT00563472|Desogestrel|desogestrel|mesh-list
65123218|NCT00563472|Progesterone|progesterone|mesh-list
65123219|NCT00563472|Progestins|progestins|mesh-ancestor
65123220|NCT00563472|Hormones|hormones|mesh-ancestor
65123221|NCT00563472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65123222|NCT00563472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123223|NCT00563472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65123224|NCT00563472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65123225|NCT00563472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65123226|NCT00563472|Contraceptive Agents|contraceptive agents|mesh-ancestor
65123227|NCT00563472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65123228|NCT00563472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65123229|NCT00563472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65123230|NCT04679597|Capecitabine|capecitabine|mesh-list
65123231|NCT04679597|Oxaliplatin|oxaliplatin|mesh-list
65123232|NCT04679597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65123233|NCT04679597|Antimetabolites|antimetabolites|mesh-ancestor
65123234|NCT04679597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123235|NCT04679597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123236|NCT04615910|Exenatide|exenatide|mesh-list
65123237|NCT04615910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65123238|NCT04615910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123239|NCT04615910|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65123240|NCT04615910|Incretins|incretins|mesh-ancestor
65296869|NCT00666068|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65296870|NCT00666068|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
65296871|NCT00666068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65296872|NCT00666068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296873|NCT00700102|Bevacizumab|bevacizumab|mesh-list
65296874|NCT00700102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65296875|NCT00700102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296876|NCT00700102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65296877|NCT00700102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65296878|NCT00700102|Growth Substances|growth substances|mesh-ancestor
65296879|NCT00700102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296880|NCT00700102|Growth Inhibitors|growth inhibitors|mesh-ancestor
65296881|NCT02705729|Methamphetamine|methamphetamine|mesh-list
65296882|NCT02705729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65296883|NCT02705729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296884|NCT02705729|Sympathomimetics|sympathomimetics|mesh-ancestor
65296885|NCT02705729|Autonomic Agents|autonomic agents|mesh-ancestor
65296886|NCT02705729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65296887|NCT02705729|Dopamine Agents|dopamine agents|mesh-ancestor
65296888|NCT02705729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65296889|NCT02705729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296890|NCT02705729|Adrenergic Agents|adrenergic agents|mesh-ancestor
65296891|NCT02705729|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65296892|NCT02705729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65296893|NCT02705729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65296894|NCT02705729|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65296895|NCT02705573|Mannitol|mannitol|mesh-list
65123241|NCT04615910|Hormones|hormones|mesh-ancestor
65123242|NCT04615910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65123243|NCT04609397|Hemay005|hemay005|mesh-list
65123244|NCT04609397|Dermatologic Agents|dermatologic agents|mesh-ancestor
65123245|NCT04609397|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65123246|NCT04609397|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65123247|NCT04609397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123248|NCT04609397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123249|NCT04587947|Valsartan|valsartan|mesh-list
65123250|NCT04587947|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65123251|NCT04587947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65123252|NCT04587947|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65123253|NCT04587947|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65123254|NCT04587947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123255|NCT04612998|Atropine|atropine|mesh-list
65123256|NCT04612998|Ephedrine|ephedrine|mesh-list
64695620|NCT00356083|Methadone|methadone|mesh-list
65296896|NCT02705573|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65296897|NCT02705573|Diuretics|diuretics|mesh-ancestor
65296898|NCT02705573|Natriuretic Agents|natriuretic agents|mesh-ancestor
65296899|NCT02705573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296900|NCT00613847|Trastuzumab|trastuzumab|mesh-list
65296901|NCT00613847|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
65296902|NCT00613847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65296903|NCT00613847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296904|NCT00613847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296905|NCT00516295|Cyclophosphamide|cyclophosphamide|mesh-list
65296906|NCT00516295|Bevacizumab|bevacizumab|mesh-list
65296907|NCT00516295|Vincristine|vincristine|mesh-list
65296908|NCT00516295|Topotecan|topotecan|mesh-list
65123272|NCT04612998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123273|NCT04612998|Antiemetics|antiemetics|mesh-ancestor
65123274|NCT04612998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65123275|NCT04612998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65123276|NCT04612998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65123277|NCT04612998|Dopamine Agents|dopamine agents|mesh-ancestor
65123278|NCT04612998|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65123279|NCT04612998|Sympathomimetics|sympathomimetics|mesh-ancestor
65123280|NCT04612998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65123281|NCT04612998|Adrenergic Agents|adrenergic agents|mesh-ancestor
65123282|NCT00563589|Cyclosporine|cyclosporine|mesh-list
65123283|NCT00563589|Mycophenolic Acid|mycophenolic acid|mesh-list
65123284|NCT00563589|Methotrexate|methotrexate|mesh-list
65123285|NCT00563589|Cyclosporins|cyclosporins|mesh-list
65123286|NCT00563589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65123287|NCT00563589|Abortifacient Agents|abortifacient agents|mesh-ancestor
65123288|NCT00563589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65123289|NCT00563589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123290|NCT00563589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65123291|NCT00563589|Antimetabolites|antimetabolites|mesh-ancestor
65123292|NCT00563589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123293|NCT00563589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123294|NCT00563589|Dermatologic Agents|dermatologic agents|mesh-ancestor
65123295|NCT00563589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123296|NCT00563589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65123297|NCT00563589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65123298|NCT00563589|Immunologic Factors|immunologic factors|mesh-ancestor
65123299|NCT00563589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65123300|NCT00563589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65123301|NCT00563589|Antifungal Agents|antifungal agents|mesh-ancestor
65123302|NCT00563589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65123303|NCT00563589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65123304|NCT00563589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65123305|NCT00563589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65123306|NCT00563589|Antitubercular Agents|antitubercular agents|mesh-ancestor
65123307|NCT00563589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65123308|NCT04484012|Acalabrutinib|acalabrutinib|mesh-list
65123309|NCT04484012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123310|NCT04465643|Nivolumab|nivolumab|mesh-list
65123311|NCT04465643|Ipilimumab|ipilimumab|mesh-list
65123312|NCT04465643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65123313|NCT04465643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123314|NCT04465643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65123315|NCT04465643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123323|NCT04612803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123324|NCT04612803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123326|NCT02204345|Carboplatin|carboplatin|mesh-list
65123327|NCT02204345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65123328|NCT02204345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123329|NCT02204345|Tubulin Modulators|tubulin modulators|mesh-ancestor
65296909|NCT00516295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65296910|NCT00516295|Antibodies|antibodies|mesh-list
65296911|NCT00516295|Immunoglobulins|immunoglobulins|mesh-list
65296912|NCT00516295|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65296913|NCT00516295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65296914|NCT00516295|Immunologic Factors|immunologic factors|mesh-ancestor
65296915|NCT00516295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296916|NCT00516295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65296917|NCT00516295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65296918|NCT00516295|Alkylating Agents|alkylating agents|mesh-ancestor
65296919|NCT00516295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296920|NCT00516295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123330|NCT02204345|Antimitotic Agents|antimitotic agents|mesh-ancestor
65123331|NCT02204345|Mitosis Modulators|mitosis modulators|mesh-ancestor
65123332|NCT02204345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123333|NCT02187302|Bevacizumab|bevacizumab|mesh-list
65123334|NCT02187302|Sunitinib|sunitinib|mesh-list
65123335|NCT02187302|Everolimus|everolimus|mesh-list
65123336|NCT02187302|Sorafenib|sorafenib|mesh-list
65123337|NCT02187302|Axitinib|axitinib|mesh-list
65123338|NCT02187302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65123339|NCT02187302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123340|NCT02187302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65123341|NCT02187302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65123342|NCT02187302|Growth Substances|growth substances|mesh-ancestor
65123343|NCT02187302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123344|NCT02187302|Growth Inhibitors|growth inhibitors|mesh-ancestor
65123345|NCT02187302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65123346|NCT02187302|Immunologic Factors|immunologic factors|mesh-ancestor
65123347|NCT02187302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65123348|NCT02187302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123349|NCT02187302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123350|NCT02179151|CKD732|ckd732|mesh-list
65123351|NCT02179151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65123352|NCT02179151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65123353|NCT02179151|Growth Substances|growth substances|mesh-ancestor
65123354|NCT02179151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123356|NCT02179151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123357|NCT04612257|Insulin|insulin|mesh-list
65123358|NCT04612257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65123359|NCT04612257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123360|NCT02160665|Tazarotene|tazarotene|mesh-list
65123361|NCT02160665|Dermatologic Agents|dermatologic agents|mesh-ancestor
65123362|NCT02160665|Keratolytic Agents|keratolytic agents|mesh-ancestor
65123363|NCT02138630|Capsaicin|capsaicin|mesh-list
65123364|NCT02138630|Antipruritics|antipruritics|mesh-ancestor
65123365|NCT02138630|Dermatologic Agents|dermatologic agents|mesh-ancestor
65123366|NCT02138630|Sensory System Agents|sensory system agents|mesh-ancestor
65123367|NCT02138630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65123368|NCT02138630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123369|NCT02137343|Capecitabine|capecitabine|mesh-list
65123370|NCT02137343|Rilotumumab|rilotumumab|mesh-list
65123371|NCT02137343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123372|NCT02137343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65123373|NCT02137343|Antimetabolites|antimetabolites|mesh-ancestor
65123374|NCT02137343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123375|NCT02137343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65123376|NCT02125253|Mometasone Furoate|mometasone furoate|mesh-list
65123377|NCT02125253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65123378|NCT02125253|Dermatologic Agents|dermatologic agents|mesh-ancestor
65123379|NCT02125253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65123380|NCT02114060|Vaccines|vaccines|mesh-list
65123381|NCT02114060|Immunologic Factors|immunologic factors|mesh-ancestor
65123382|NCT02114060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296921|NCT00516295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65296922|NCT00516295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65296923|NCT00516295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65296924|NCT00516295|Growth Substances|growth substances|mesh-ancestor
65296925|NCT00516295|Growth Inhibitors|growth inhibitors|mesh-ancestor
65296926|NCT00516295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65296927|NCT00516295|Tubulin Modulators|tubulin modulators|mesh-ancestor
65296928|NCT00516295|Antimitotic Agents|antimitotic agents|mesh-ancestor
65296929|NCT00516295|Mitosis Modulators|mitosis modulators|mesh-ancestor
64527115|NCT02930902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123383|NCT00560898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65123384|NCT02104388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65123385|NCT02104388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65123386|NCT04633044|Betaine|betaine|mesh-list
65123393|NCT02101268|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
65123394|NCT02101268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65123395|NCT02101268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123396|NCT02101268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123397|NCT04611438|Cannabidiol|cannabidiol|mesh-list
65123398|NCT04611438|Anticonvulsants|anticonvulsants|mesh-ancestor
65123399|NCT00563823|Vatalanib|vatalanib|mesh-list
65123400|NCT00563823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65123401|NCT00563823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123402|NCT00563823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123403|NCT00563862|Fluorouracil|fluorouracil|mesh-list
65123404|NCT00563862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123405|NCT00563862|Antimetabolites|antimetabolites|mesh-ancestor
65123406|NCT00563862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123407|NCT00563862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65123408|NCT00563862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65123409|NCT00563862|Immunologic Factors|immunologic factors|mesh-ancestor
65123410|NCT00563862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123411|NCT04611711|Decitabine|decitabine|mesh-list
65123412|NCT04611711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65123413|NCT04611711|Antimetabolites|antimetabolites|mesh-ancestor
65123414|NCT04611711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123415|NCT04611711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123416|NCT04611711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123417|NCT04632537|BCG Vaccine|bcg vaccine|mesh-list
65123418|NCT04632537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65123419|NCT04632537|Immunologic Factors|immunologic factors|mesh-ancestor
65123420|NCT04632537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123421|NCT02092922|Filanesib|filanesib|mesh-list
65123422|NCT02092922|Lenograstim|lenograstim|mesh-list
65123423|NCT02092922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65123424|NCT02092922|Immunologic Factors|immunologic factors|mesh-ancestor
65123425|NCT02092922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123426|NCT02092922|Antimitotic Agents|antimitotic agents|mesh-ancestor
65123427|NCT02092922|Mitosis Modulators|mitosis modulators|mesh-ancestor
65123428|NCT02092922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123429|NCT02092922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123430|NCT02092454|Benzocaine|benzocaine|mesh-list
65123431|NCT02092454|Anesthetics, Local|anesthetics, local|mesh-ancestor
65123432|NCT02092454|Anesthetics|anesthetics|mesh-ancestor
65123433|NCT02092454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65123434|NCT02092454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123435|NCT02092454|Sensory System Agents|sensory system agents|mesh-ancestor
65123436|NCT02092454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65123437|NCT02083289|Latanoprost|latanoprost|mesh-list
65123438|NCT02083289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65123439|NCT02083289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65123440|NCT02081300|Methyltestosterone|methyltestosterone|mesh-list
65123441|NCT02081300|Testosterone|testosterone|mesh-list
65123442|NCT02081300|Testosterone undecanoate|testosterone undecanoate|mesh-list
65123443|NCT02081300|Testosterone enanthate|testosterone enanthate|mesh-list
65296930|NCT00516295|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65296931|NCT00516295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65296932|NCT00516295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296933|NCT03362099|Bupropion|bupropion|mesh-list
65296934|NCT03362099|Varenicline|varenicline|mesh-list
65296935|NCT03362099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65296936|NCT03362099|Antidepressive Agents|antidepressive agents|mesh-ancestor
65296937|NCT03362099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64527124|NCT02824276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65123444|NCT02081300|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65123445|NCT02081300|Androgens|androgens|mesh-ancestor
65123446|NCT02081300|Hormones|hormones|mesh-ancestor
65123447|NCT02081300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65123448|NCT02081300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123449|NCT02081300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65123450|NCT02081300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123451|NCT02081300|Anabolic Agents|anabolic agents|mesh-ancestor
65123452|NCT02074007|Benzocaine|benzocaine|mesh-list
65123453|NCT02074007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123454|NCT02074007|Anesthetics, Local|anesthetics, local|mesh-ancestor
65123466|NCT00554918|Prednisolone|prednisolone|mesh-list
65123467|NCT00554918|Docetaxel|docetaxel|mesh-list
65123468|NCT00554918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123469|NCT00554918|Tubulin Modulators|tubulin modulators|mesh-ancestor
65123470|NCT00554918|Antimitotic Agents|antimitotic agents|mesh-ancestor
65123471|NCT00554918|Mitosis Modulators|mitosis modulators|mesh-ancestor
65123472|NCT00554918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123473|NCT00554918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65123474|NCT00554918|Glucocorticoids|glucocorticoids|mesh-ancestor
65123475|NCT00554918|Hormones|hormones|mesh-ancestor
65123476|NCT00554918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65123477|NCT00554918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123478|NCT00554918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65123479|NCT00554918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65123480|NCT04631874|Varenicline|varenicline|mesh-list
65123481|NCT04631874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65123482|NCT04631874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65123483|NCT04631874|Cholinergic Agents|cholinergic agents|mesh-ancestor
65123484|NCT04631874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65123485|NCT04631874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123486|NCT04631874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123487|NCT02057315|Ketoprofen|ketoprofen|mesh-list
64765824|NCT00682734|Antipruritics|antipruritics|mesh-ancestor
65123488|NCT02057315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65123489|NCT02057315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65123490|NCT02057315|Analgesics|analgesics|mesh-ancestor
65123491|NCT02057315|Sensory System Agents|sensory system agents|mesh-ancestor
65123492|NCT02057315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65123493|NCT02057315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123494|NCT02057315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65123495|NCT02057315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65123496|NCT02057315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65123497|NCT02057315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123498|NCT02057315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123499|NCT02047214|Bevacizumab|bevacizumab|mesh-list
65123500|NCT02047214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65123501|NCT02047214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123502|NCT02047214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65123503|NCT02047214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65123504|NCT02047214|Growth Substances|growth substances|mesh-ancestor
65123505|NCT02047214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123506|NCT02047214|Growth Inhibitors|growth inhibitors|mesh-ancestor
65123508|NCT02046395|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65123509|NCT02046395|Hydralazine|hydralazine|mesh-list
65123510|NCT02046395|Terazosin|terazosin|mesh-list
65123511|NCT02046395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65296938|NCT03362099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65296939|NCT03362099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65296940|NCT03362099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65296941|NCT03362099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296942|NCT03362099|Dopamine Agents|dopamine agents|mesh-ancestor
65296943|NCT03362099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65296944|NCT03362099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296945|NCT03362099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65046840|NCT02961816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296946|NCT03362099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65296947|NCT03362099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296948|NCT03362099|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65296949|NCT03362099|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65296950|NCT03362099|Cholinergic Agents|cholinergic agents|mesh-ancestor
65296951|NCT03861559|Mometasone Furoate|mometasone furoate|mesh-list
65296952|NCT03861559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65296953|NCT03861559|Dermatologic Agents|dermatologic agents|mesh-ancestor
65296954|NCT03861559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65296955|NCT02705651|Somatostatin|somatostatin|mesh-list
65296956|NCT02705651|Hormones|hormones|mesh-ancestor
65296957|NCT02705651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65296958|NCT02705651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296959|NCT00738088|Gliclazide|gliclazide|mesh-list
65296960|NCT00738088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65296961|NCT00738088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296962|NCT02703233|Nitrous Oxide|nitrous oxide|mesh-list
65296963|NCT02703233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65296964|NCT02703233|Anesthetics, General|anesthetics, general|mesh-ancestor
65296965|NCT02703233|Anesthetics|anesthetics|mesh-ancestor
65296966|NCT02703233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65296967|NCT02703233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296968|NCT02703233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65296969|NCT02703233|Analgesics|analgesics|mesh-ancestor
65296970|NCT02703233|Sensory System Agents|sensory system agents|mesh-ancestor
65296971|NCT02703233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65296972|NCT05740618|Mannitol|mannitol|mesh-list
65296975|NCT05740618|Natriuretic Agents|natriuretic agents|mesh-ancestor
65296976|NCT05740618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296977|NCT04152941|Olaparib|olaparib|mesh-list
65296978|NCT04152941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65296979|NCT04152941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65296980|NCT04152941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65296981|NCT04152941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527171|NCT01565707|Solifenacin Succinate|solifenacin succinate|mesh-list
65123512|NCT02046395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65123513|NCT02046395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65123514|NCT02046395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123515|NCT02046395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65123516|NCT02046395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123517|NCT02046395|Vasodilator Agents|vasodilator agents|mesh-ancestor
65123537|NCT02032277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65123538|NCT02032277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123539|NCT02032277|Tubulin Modulators|tubulin modulators|mesh-ancestor
65123540|NCT02032277|Antimitotic Agents|antimitotic agents|mesh-ancestor
65123541|NCT02032277|Mitosis Modulators|mitosis modulators|mesh-ancestor
65123542|NCT02032277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123543|NCT02032277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65123544|NCT02032277|Immunologic Factors|immunologic factors|mesh-ancestor
65123545|NCT02032277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123546|NCT02032277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65123547|NCT02032277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65123548|NCT02032277|Alkylating Agents|alkylating agents|mesh-ancestor
65123549|NCT02032277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65123550|NCT02032277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65123551|NCT02032277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65123552|NCT02032277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65123553|NCT02032277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123554|NCT02032277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65123555|NCT00560976|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65123556|NCT00560976|Ferric gluconate|ferric gluconate|mesh-list
65123557|NCT00560976|Hematinics|hematinics|mesh-ancestor
65123558|NCT02026349|Favipiravir|favipiravir|mesh-list
65123559|NCT02026349|Antiviral Agents|antiviral agents|mesh-ancestor
65123560|NCT02026349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65123561|NCT04611126|Cyclophosphamide|cyclophosphamide|mesh-list
65123562|NCT04611126|Nivolumab|nivolumab|mesh-list
65123563|NCT04611126|Fludarabine|fludarabine|mesh-list
65123564|NCT04611126|Fludarabine phosphate|fludarabine phosphate|mesh-list
65123565|NCT04611126|Ipilimumab|ipilimumab|mesh-list
65123566|NCT04611126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65123567|NCT04611126|Immunologic Factors|immunologic factors|mesh-ancestor
65123568|NCT04611126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123569|NCT04611126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65123570|NCT04611126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65123571|NCT04611126|Alkylating Agents|alkylating agents|mesh-ancestor
65123572|NCT04611126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123573|NCT04611126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123574|NCT04611126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65123591|NCT04611165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123593|NCT02014649|Zanamivir|zanamivir|mesh-list
65123594|NCT02014649|Antiviral Agents|antiviral agents|mesh-ancestor
65123595|NCT02014649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65123596|NCT02014649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123597|NCT02014649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123598|NCT02014142|Latanoprost|latanoprost|mesh-list
65123599|NCT02014142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65123600|NCT02014142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65123601|NCT04610580|Choline|choline|mesh-list
65123602|NCT04610580|Lipotropic Agents|lipotropic agents|mesh-ancestor
65123603|NCT04610580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65123604|NCT04610580|Antimetabolites|antimetabolites|mesh-ancestor
65222810|NCT04965493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65296982|NCT04062760|Diuretics|diuretics|mesh-list
65296983|NCT04062760|Natriuretic Agents|natriuretic agents|mesh-ancestor
65296984|NCT04062760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296985|NCT03384277|Cyclophosphamide|cyclophosphamide|mesh-list
65296986|NCT03384277|Rituximab|rituximab|mesh-list
65296987|NCT03384277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65296988|NCT03384277|Immunologic Factors|immunologic factors|mesh-ancestor
65296989|NCT03384277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65296990|NCT03384277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65296991|NCT03384277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65296992|NCT03384277|Alkylating Agents|alkylating agents|mesh-ancestor
65296993|NCT03384277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123605|NCT04610580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123606|NCT04610580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65123607|NCT04610580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65123608|NCT04610580|Nootropic Agents|nootropic agents|mesh-ancestor
65123609|NCT02009579|Nintedanib|nintedanib|mesh-list
65123610|NCT02009579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123611|NCT02009579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65123612|NCT02009579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123613|NCT02009579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123614|NCT04631250|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65123615|NCT04631250|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65123616|NCT04631250|Dermatologic Agents|dermatologic agents|mesh-ancestor
65123617|NCT01998035|Azacitidine|azacitidine|mesh-list
65123618|NCT01998035|Romidepsin|romidepsin|mesh-list
65123619|NCT01998035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65123620|NCT01998035|Antimetabolites|antimetabolites|mesh-ancestor
65123621|NCT01998035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123622|NCT01998035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123623|NCT01998035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123624|NCT01998035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65123625|NCT04611243|Vaccines|vaccines|mesh-list
65123626|NCT04611243|Immunologic Factors|immunologic factors|mesh-ancestor
65123627|NCT04611243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123628|NCT00564057|Candesartan|candesartan|mesh-list
65123629|NCT00564057|Lercanidipine|lercanidipine|mesh-list
65123630|NCT00564057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65123631|NCT00564057|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65123632|NCT00564057|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65123660|NCT01969838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65123661|NCT01969838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123662|NCT01969838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123663|NCT01967810|Bevacizumab|bevacizumab|mesh-list
65123664|NCT01967810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65123665|NCT01967810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123666|NCT01967810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65123667|NCT01967810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65123668|NCT01967810|Growth Substances|growth substances|mesh-ancestor
65123669|NCT01967810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123670|NCT01967810|Growth Inhibitors|growth inhibitors|mesh-ancestor
65123671|NCT01165138|Fluticasone|fluticasone|mesh-list
65123672|NCT01165138|Xhance|xhance|mesh-list
65123673|NCT01165138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65123674|NCT01165138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65123686|NCT04206358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123687|NCT00561093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65123688|NCT00561093|Pentoxifylline|pentoxifylline|mesh-list
65123689|NCT00561093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65123690|NCT00561093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123691|NCT00561093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123692|NCT00561093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65123693|NCT00561093|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65296994|NCT03384277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65296995|NCT03384277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65296996|NCT03384277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65296997|NCT04804007|Etoposide|etoposide|mesh-list
65296998|NCT04804007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65296999|NCT04804007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297000|NCT04804007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65297001|NCT04804007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65297002|NCT04804007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297003|NCT04804007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297005|NCT02702843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65297006|NCT02702843|Anesthetics, General|anesthetics, general|mesh-ancestor
65297007|NCT02702843|Anesthetics|anesthetics|mesh-ancestor
65297008|NCT02702843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65297009|NCT02702843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123694|NCT00561093|Protective Agents|protective agents|mesh-ancestor
65123695|NCT00561093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123696|NCT00561093|Vasodilator Agents|vasodilator agents|mesh-ancestor
65123697|NCT00561093|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65123698|NCT00561093|Antioxidants|antioxidants|mesh-ancestor
65123699|NCT01960010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65123700|NCT01960010|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65123701|NCT01165021|Folic Acid|folic acid|mesh-list
65123702|NCT01165021|Vitamin B 12|vitamin b 12|mesh-list
65123703|NCT01165021|Dexamethasone|dexamethasone|mesh-list
65123704|NCT01165021|Pemetrexed|pemetrexed|mesh-list
65123705|NCT01165021|Vitamins|vitamins|mesh-ancestor
65123706|NCT01165021|Micronutrients|micronutrients|mesh-ancestor
65123707|NCT01165021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123708|NCT01165021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65123709|NCT01165021|Antiemetics|antiemetics|mesh-ancestor
65123710|NCT01165021|Autonomic Agents|autonomic agents|mesh-ancestor
65123711|NCT01165021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65123712|NCT01165021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65123713|NCT01165021|Glucocorticoids|glucocorticoids|mesh-ancestor
65123714|NCT01165021|Hormones|hormones|mesh-ancestor
64766050|NCT00719160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65123715|NCT01165021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65123716|NCT01165021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65123717|NCT01165021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123718|NCT01165021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514143|NCT01606007|Saxagliptin|saxagliptin|mesh-list
65123719|NCT01165021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123720|NCT01165021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65123721|NCT01165021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65123723|NCT01165021|Vitamin B Complex|vitamin b complex|mesh-ancestor
65123724|NCT00561132|Vanadyl sulfate|vanadyl sulfate|mesh-list
65123725|NCT00561132|Magnesium Oxide|magnesium oxide|mesh-list
65123727|NCT00561132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123728|NCT00561132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65123729|NCT00561132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65123730|NCT00561132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123731|NCT01956812|Gemcitabine|gemcitabine|mesh-list
65123732|NCT01956812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65123733|NCT01956812|Antimetabolites|antimetabolites|mesh-ancestor
65123734|NCT01956812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123735|NCT01956812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123736|NCT01956812|Antiviral Agents|antiviral agents|mesh-ancestor
65123737|NCT01956812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65297010|NCT00516139|Lamotrigine|lamotrigine|mesh-list
65297011|NCT00516139|Anticonvulsants|anticonvulsants|mesh-ancestor
65297012|NCT00516139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65297013|NCT00516139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65297014|NCT00516139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297015|NCT00516139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65297016|NCT00516139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297017|NCT00516139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65297018|NCT00516139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65046916|NCT04664725|Repaglinide|repaglinide|mesh-list
65297019|NCT00516139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65297020|NCT00516139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65297021|NCT00516139|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65297022|NCT02704715|Anesthetics|anesthetics|mesh-list
65297023|NCT02704715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65297024|NCT02704715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297025|NCT00515827|Raltegravir Potassium|raltegravir potassium|mesh-list
65297026|NCT00515827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65297027|NCT00515827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65297028|NCT00515827|Antiviral Agents|antiviral agents|mesh-ancestor
65297029|NCT00515827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65297030|NCT00515827|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65297031|NCT00515827|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65123738|NCT01956812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696102|NCT03269435|Metoclopramide|metoclopramide|mesh-list
65123758|NCT01952990|Nasal Decongestants|nasal decongestants|mesh-ancestor
65123759|NCT01952990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65123760|NCT01952990|Respiratory System Agents|respiratory system agents|mesh-ancestor
65123761|NCT01952990|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65123762|NCT01952990|Mydriatics|mydriatics|mesh-ancestor
65123763|NCT01952990|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65123764|NCT01952990|Protective Agents|protective agents|mesh-ancestor
65123766|NCT04314310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65123767|NCT04314310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65123768|NCT04314310|Analgesics|analgesics|mesh-ancestor
65123769|NCT04314310|Sensory System Agents|sensory system agents|mesh-ancestor
65123770|NCT04314310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65123771|NCT04314310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123772|NCT04314310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65123773|NCT04314310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65123774|NCT04314310|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65123775|NCT04314310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123776|NCT04314310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123777|NCT04610307|Anesthetics|anesthetics|mesh-list
65123778|NCT04610307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65123779|NCT04610307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123780|NCT04610502|Immunoglobulins|immunoglobulins|mesh-list
65123781|NCT04610502|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65123782|NCT04610502|Antibodies|antibodies|mesh-list
65123783|NCT04610502|Immunologic Factors|immunologic factors|mesh-ancestor
65123784|NCT04610502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297032|NCT00515827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297033|NCT00515827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297035|NCT00615875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65297036|NCT00615875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65297037|NCT00615875|Analgesics|analgesics|mesh-ancestor
65297038|NCT00615875|Sensory System Agents|sensory system agents|mesh-ancestor
65297039|NCT00615875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65297040|NCT00615875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297041|NCT00615875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65297042|NCT00615875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65297043|NCT00615875|Gout Suppressants|gout suppressants|mesh-ancestor
65297044|NCT00615875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65297045|NCT00615875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297046|NCT00615875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297047|NCT02630888|Memantine|memantine|mesh-list
65297048|NCT02630888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65297049|NCT02630888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65297050|NCT02630888|Dopamine Agents|dopamine agents|mesh-ancestor
64527229|NCT01583179|Buprenorphine|buprenorphine|mesh-list
65123785|NCT01164475|Plerixafor|plerixafor|mesh-list
65123786|NCT01164475|Lenograstim|lenograstim|mesh-list
65123787|NCT01164475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64766134|NCT00728910|Vitamins|vitamins|mesh-ancestor
65123788|NCT01164475|Immunologic Factors|immunologic factors|mesh-ancestor
65123789|NCT01164475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123790|NCT01164475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65123791|NCT01164475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65123792|NCT01164475|Antiviral Agents|antiviral agents|mesh-ancestor
65123793|NCT01164475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64696162|NCT04477837|Apixaban|apixaban|mesh-list
65123824|NCT01163851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123825|NCT01163851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65123826|NCT01917383|Timolol|timolol|mesh-list
65123827|NCT01917383|Latanoprost|latanoprost|mesh-list
65123828|NCT01917383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65123829|NCT01917383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65123830|NCT01917383|Adrenergic Agents|adrenergic agents|mesh-ancestor
65123831|NCT01917383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65123832|NCT01917383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123833|NCT01917383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123834|NCT01917383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65123835|NCT01917383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65123836|NCT01917383|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65123848|NCT04629846|Pertuzumab|pertuzumab|mesh-list
65123849|NCT04629846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123850|NCT04629846|Tubulin Modulators|tubulin modulators|mesh-ancestor
65123851|NCT04629846|Antimitotic Agents|antimitotic agents|mesh-ancestor
65123852|NCT04629846|Mitosis Modulators|mitosis modulators|mesh-ancestor
65123853|NCT04629846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123854|NCT04629846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65123855|NCT01909427|Methotrexate|methotrexate|mesh-list
65123856|NCT01909427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65123857|NCT01909427|Abortifacient Agents|abortifacient agents|mesh-ancestor
65123858|NCT01909427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65123859|NCT01909427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123860|NCT01909427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65297051|NCT02630888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65297052|NCT02630888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297053|NCT02630888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297054|NCT02630888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65297055|NCT02630888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65297056|NCT00666302|Pimecrolimus|pimecrolimus|mesh-list
65297057|NCT00666302|Tacrolimus|tacrolimus|mesh-list
65297058|NCT00666302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65297059|NCT00666302|Immunologic Factors|immunologic factors|mesh-ancestor
65297060|NCT00666302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297061|NCT00666302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65297062|NCT00666302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297063|NCT00666302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297064|NCT00666302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65297065|NCT00666302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65297066|NCT00666302|Analgesics|analgesics|mesh-ancestor
64527246|NCT01582945|Anesthetics|anesthetics|mesh-ancestor
64527253|NCT01565083|Pertuzumab|pertuzumab|mesh-list
65123861|NCT01909427|Antimetabolites|antimetabolites|mesh-ancestor
65123862|NCT01909427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123863|NCT01909427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123864|NCT01909427|Dermatologic Agents|dermatologic agents|mesh-ancestor
65123865|NCT01909427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123866|NCT01909427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65123867|NCT01909427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65123868|NCT01909427|Immunologic Factors|immunologic factors|mesh-ancestor
65123869|NCT01909427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65123870|NCT01909427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65123871|NCT04629573|Anesthetics|anesthetics|mesh-list
65123872|NCT04629573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65123873|NCT04629573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123874|NCT00564174|Aspirin|aspirin|mesh-list
65123875|NCT00564174|Heparin|heparin|mesh-list
65123876|NCT00564174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65123877|NCT00564174|Tinzaparin|tinzaparin|mesh-list
65123878|NCT00564174|Dalteparin|dalteparin|mesh-list
65123879|NCT00564174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65123880|NCT00564174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65123881|NCT00564174|Analgesics|analgesics|mesh-ancestor
65123882|NCT00564174|Sensory System Agents|sensory system agents|mesh-ancestor
65123883|NCT00564174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65123884|NCT00564174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123885|NCT00564174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65123886|NCT00564174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65123887|NCT00564174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65123888|NCT00564174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65123889|NCT00564174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123890|NCT00564174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65123891|NCT00564174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65123892|NCT00564174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123893|NCT00564174|Antipyretics|antipyretics|mesh-ancestor
65123894|NCT00564174|Anticoagulants|anticoagulants|mesh-ancestor
65123895|NCT01163266|Vortioxetine|vortioxetine|mesh-list
65123896|NCT01163266|Antidepressive Agents|antidepressive agents|mesh-ancestor
65123897|NCT01163266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65123898|NCT01163266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65297067|NCT00666302|Sensory System Agents|sensory system agents|mesh-ancestor
65297068|NCT00666302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65297069|NCT00666302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65297070|NCT00666302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65297071|NCT00666302|Dermatologic Agents|dermatologic agents|mesh-ancestor
65297072|NCT00671372|Bevacizumab|bevacizumab|mesh-list
65297073|NCT00671372|Cetuximab|cetuximab|mesh-list
65297074|NCT00671372|Irinotecan|irinotecan|mesh-list
65297075|NCT00671372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65297076|NCT00671372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297077|NCT00671372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65297078|NCT00671372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65297079|NCT00671372|Growth Substances|growth substances|mesh-ancestor
65297080|NCT00671372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297081|NCT00671372|Growth Inhibitors|growth inhibitors|mesh-ancestor
64527262|NCT01555463|Azelaic acid|azelaic acid|mesh-list
65123899|NCT01163266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65123900|NCT01163266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65123901|NCT01163266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123902|NCT01163266|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65123918|NCT01870505|Letrozole|letrozole|mesh-list
65123919|NCT01870505|Exemestane|exemestane|mesh-list
65123920|NCT01870505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123921|NCT01870505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65123922|NCT01870505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65123923|NCT01870505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123924|NCT01870505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123925|NCT01870505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65123926|NCT01870505|Hormone Antagonists|hormone antagonists|mesh-ancestor
65123927|NCT01870505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65123928|NCT01870505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123929|NCT04629612|Anesthetics|anesthetics|mesh-list
65123930|NCT04629612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65123931|NCT04629612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123932|NCT00564213|Mitomycins|mitomycins|mesh-list
65123933|NCT00564213|Mitomycin|mitomycin|mesh-list
65123934|NCT00564213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65123935|NCT00564213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123936|NCT00564213|Alkylating Agents|alkylating agents|mesh-ancestor
65123937|NCT00564213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123938|NCT00564213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65123940|NCT01861847|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65123941|NCT01861847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65123942|NCT01861847|Immunologic Factors|immunologic factors|mesh-ancestor
65123943|NCT01861847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123944|NCT00564252|Finasteride|finasteride|mesh-list
65123945|NCT00564252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65123946|NCT00564252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65123947|NCT00564252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123948|NCT00564252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123949|NCT00564252|Hormone Antagonists|hormone antagonists|mesh-ancestor
65123950|NCT00564252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65123951|NCT00564252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123952|NCT00564252|Urological Agents|urological agents|mesh-ancestor
65123953|NCT04629144|Belimumab|belimumab|mesh-list
65123954|NCT04629144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65123955|NCT04629144|Immunologic Factors|immunologic factors|mesh-ancestor
65123956|NCT04629144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297082|NCT00671372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65297083|NCT00671372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65297084|NCT00671372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297085|NCT00671372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297086|NCT00856986|Metformin|metformin|mesh-list
65297087|NCT00856986|Liraglutide|liraglutide|mesh-list
65297088|NCT00856986|Insulin Detemir|insulin detemir|mesh-list
65297089|NCT00856986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65297090|NCT00856986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297091|NCT00856986|Incretins|incretins|mesh-ancestor
65297092|NCT00856986|Hormones|hormones|mesh-ancestor
65297093|NCT00856986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65297094|NCT00666692|Paclitaxel|paclitaxel|mesh-list
65297096|NCT00666692|Carboplatin|carboplatin|mesh-list
65297097|NCT00666692|Volociximab|volociximab|mesh-list
65297098|NCT00666692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65297099|NCT00666692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65297100|NCT00666692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297101|NCT00666692|Tubulin Modulators|tubulin modulators|mesh-ancestor
65297102|NCT00666692|Antimitotic Agents|antimitotic agents|mesh-ancestor
65123957|NCT01858883|Gemcitabine|gemcitabine|mesh-list
65123958|NCT01858883|Paclitaxel|paclitaxel|mesh-list
65123959|NCT01858883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65123976|NCT01847573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123977|NCT01847573|Coccidiostats|coccidiostats|mesh-ancestor
65123978|NCT01847573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65123979|NCT01847573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65123980|NCT01847573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65123981|NCT01847573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65123982|NCT01847573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123983|NCT01847573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123984|NCT01847573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65123985|NCT01847573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65123986|NCT01847573|Growth Substances|growth substances|mesh-ancestor
65123987|NCT01847573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123988|NCT01847573|Growth Inhibitors|growth inhibitors|mesh-ancestor
65123989|NCT04609254|Acetaminophen|acetaminophen|mesh-list
65123990|NCT04609254|Ibuprofen|ibuprofen|mesh-list
65123991|NCT04609254|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65123992|NCT04609254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65123993|NCT04609254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65123994|NCT04609254|Analgesics|analgesics|mesh-ancestor
65123995|NCT04609254|Sensory System Agents|sensory system agents|mesh-ancestor
65123996|NCT04609254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65123997|NCT04609254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123998|NCT04609254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65123999|NCT04609254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65124000|NCT04609254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65124001|NCT04609254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124002|NCT04609254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124003|NCT04609254|Antipyretics|antipyretics|mesh-ancestor
65124004|NCT01846481|Cocaine|cocaine|mesh-list
65124005|NCT01846481|Anesthetics, Local|anesthetics, local|mesh-ancestor
65124006|NCT01846481|Anesthetics|anesthetics|mesh-ancestor
65124007|NCT01846481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65124008|NCT01846481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527297|NCT01555073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65297103|NCT00666692|Mitosis Modulators|mitosis modulators|mesh-ancestor
65297104|NCT00666692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297105|NCT00666692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65297106|NCT00666692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65297107|NCT00666692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65297108|NCT00666692|Growth Substances|growth substances|mesh-ancestor
65297109|NCT00666692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297110|NCT00666692|Growth Inhibitors|growth inhibitors|mesh-ancestor
65297111|NCT00666692|Immunologic Factors|immunologic factors|mesh-ancestor
65297112|NCT00707746|Mipomersen|mipomersen|mesh-list
65297113|NCT00707746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65297114|NCT00707746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65297115|NCT00707746|Antimetabolites|antimetabolites|mesh-ancestor
65297116|NCT00707746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297117|NCT00707746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65297118|NCT00666770|Gabapentin|gabapentin|mesh-list
65297119|NCT00666770|Analgesics|analgesics|mesh-ancestor
65297120|NCT00666770|Sensory System Agents|sensory system agents|mesh-ancestor
65297121|NCT00666770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65297122|NCT00666770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297123|NCT00666770|Anticonvulsants|anticonvulsants|mesh-ancestor
65297124|NCT00666770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65297125|NCT00666770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65297126|NCT00666770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65297127|NCT00666770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65297128|NCT00666770|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65297129|NCT00666770|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65297130|NCT00666770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65297131|NCT00666770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297132|NCT00666770|Antimanic Agents|antimanic agents|mesh-ancestor
65297133|NCT04188353|Mannitol|mannitol|mesh-list
65297134|NCT04188353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65297135|NCT04188353|Diuretics|diuretics|mesh-ancestor
65297136|NCT04188353|Natriuretic Agents|natriuretic agents|mesh-ancestor
65297137|NCT04188353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297138|NCT03583697|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
65297139|NCT03583697|Natriuretic Agents|natriuretic agents|mesh-ancestor
65297140|NCT03583697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297141|NCT02630420|Cetuximab|cetuximab|mesh-list
65297142|NCT02630420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65297143|NCT02630420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297144|NCT00667082|Vorinostat|vorinostat|mesh-list
65297145|NCT00667082|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65297146|NCT00667082|Proteasome Inhibitors|proteasome inhibitors|mesh-list
65297147|NCT00667082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297148|NCT00667082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297149|NCT00667082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297150|NCT00667082|Protease Inhibitors|protease inhibitors|mesh-ancestor
65297151|NCT05343299|Lidocaine|lidocaine|mesh-list
65297152|NCT05343299|Ropivacaine|ropivacaine|mesh-list
65297153|NCT05343299|Anesthetics|anesthetics|mesh-list
65297154|NCT05343299|Anesthetics, Local|anesthetics, local|mesh-ancestor
65297155|NCT05343299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65297156|NCT05343299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297157|NCT05343299|Sensory System Agents|sensory system agents|mesh-ancestor
65297158|NCT05343299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124009|NCT01846481|Sensory System Agents|sensory system agents|mesh-ancestor
65124010|NCT01846481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124011|NCT01846481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65124012|NCT01846481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65124013|NCT01846481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65124014|NCT01846481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65124015|NCT01846481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124016|NCT01846481|Dopamine Agents|dopamine agents|mesh-ancestor
65124017|NCT01846481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65124030|NCT01811576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65124031|NCT01811576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124032|NCT01811498|Bevacizumab|bevacizumab|mesh-list
65124033|NCT01811498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65124034|NCT01811498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124035|NCT01811498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65124036|NCT01811498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65124037|NCT01811498|Growth Substances|growth substances|mesh-ancestor
65124038|NCT01811498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124039|NCT01811498|Growth Inhibitors|growth inhibitors|mesh-ancestor
65124040|NCT01804829|Immunoglobulins|immunoglobulins|mesh-list
65124041|NCT01804829|Antibodies|antibodies|mesh-list
65124042|NCT01804829|gamma-Globulins|gamma-globulins|mesh-list
65124043|NCT01804829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65124044|NCT01804829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65124045|NCT01804829|Immunoglobulin G|immunoglobulin g|mesh-list
65124046|NCT01804829|Immunologic Factors|immunologic factors|mesh-ancestor
65124047|NCT01804829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124048|NCT00565422|Citalopram|citalopram|mesh-list
65124049|NCT00565422|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65124050|NCT00565422|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65124051|NCT00565422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65124052|NCT00565422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297159|NCT05343299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65297160|NCT05343299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65297161|NCT05343299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65297162|NCT05343299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65297163|NCT05343299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297164|NCT00667160|Pimecrolimus|pimecrolimus|mesh-list
65297165|NCT00667160|Tacrolimus|tacrolimus|mesh-list
65297166|NCT00667160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65297167|NCT00667160|Immunologic Factors|immunologic factors|mesh-ancestor
65297168|NCT00667160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297169|NCT00667160|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65297170|NCT00667160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297171|NCT00667160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297172|NCT00667160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65297173|NCT00667160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65297174|NCT00667160|Analgesics|analgesics|mesh-ancestor
65297175|NCT00667160|Sensory System Agents|sensory system agents|mesh-ancestor
65297176|NCT00667160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65297177|NCT00667160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65297178|NCT00667160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65297179|NCT00667160|Dermatologic Agents|dermatologic agents|mesh-ancestor
65297181|NCT02701673|Gemcitabine|gemcitabine|mesh-list
65297182|NCT02701673|Azacitidine|azacitidine|mesh-list
65297183|NCT02701673|Melphalan|melphalan|mesh-list
65297184|NCT02701673|Busulfan|busulfan|mesh-list
65297185|NCT02701673|Belinostat|belinostat|mesh-list
65297186|NCT02701673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65297187|NCT02701673|Antimetabolites|antimetabolites|mesh-ancestor
65297188|NCT02701673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297189|NCT02701673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297190|NCT02701673|Antiviral Agents|antiviral agents|mesh-ancestor
65297191|NCT02701673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65297192|NCT02701673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297193|NCT02701673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65297194|NCT02701673|Immunologic Factors|immunologic factors|mesh-ancestor
65297195|NCT02701673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297197|NCT02701673|Alkylating Agents|alkylating agents|mesh-ancestor
65297198|NCT02701673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65297199|NCT02701673|Vitamin B Complex|vitamin b complex|mesh-ancestor
65297200|NCT02701673|Vitamins|vitamins|mesh-ancestor
65297201|NCT02701673|Micronutrients|micronutrients|mesh-ancestor
65297202|NCT02701673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65297203|NCT00522379|Rotigotine|rotigotine|mesh-list
65297204|NCT00522379|Dopamine Agonists|dopamine agonists|mesh-ancestor
65297205|NCT00522379|Dopamine Agents|dopamine agents|mesh-ancestor
65297206|NCT00522379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65297207|NCT00522379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297208|NCT00522379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297209|NCT00856830|Carboplatin|carboplatin|mesh-list
65297210|NCT00856830|Irinotecan|irinotecan|mesh-list
65297211|NCT00856830|Etoposide|etoposide|mesh-list
65297212|NCT00856830|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64527392|NCT01581307|Antidotes|antidotes|mesh-ancestor
65124053|NCT00565422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65124054|NCT00565422|Serotonin Agents|serotonin agents|mesh-ancestor
65124055|NCT00565422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124056|NCT00565422|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65124057|NCT00565422|Antidepressive Agents|antidepressive agents|mesh-ancestor
65124058|NCT00565422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65124059|NCT01802723|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65124060|NCT01802723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65124061|NCT01802723|Autonomic Agents|autonomic agents|mesh-ancestor
65124062|NCT01802723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124063|NCT01802723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124064|NCT01802723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65124065|NCT01802723|Respiratory System Agents|respiratory system agents|mesh-ancestor
65124066|NCT01802723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65124067|NCT01802723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65124068|NCT01802723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65124069|NCT01802723|Adrenergic Agents|adrenergic agents|mesh-ancestor
65124070|NCT01802723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65124071|NCT01802723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124072|NCT01789736|Travoprost|travoprost|mesh-list
65124073|NCT01789736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65124074|NCT01789736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65124075|NCT01789736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65124076|NCT00564330|Esomeprazole|esomeprazole|mesh-list
65124077|NCT00564330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65124078|NCT00564330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65124079|NCT00564330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65124080|NCT00564330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124096|NCT01780844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124097|NCT01780844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124098|NCT01780844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65124099|NCT01780844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65124100|NCT01780844|Antitubercular Agents|antitubercular agents|mesh-ancestor
65124101|NCT01780844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65124102|NCT01780844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65124103|NCT01779947|Estradiol|estradiol|mesh-list
65124104|NCT01779947|Estrogens|estrogens|mesh-ancestor
65124105|NCT01779947|Hormones|hormones|mesh-ancestor
65124106|NCT01779947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65124107|NCT01779947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124108|NCT00564408|Carbachol|carbachol|mesh-list
65124109|NCT00564408|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65124110|NCT00564408|Miotics|miotics|mesh-ancestor
65124111|NCT00564408|Autonomic Agents|autonomic agents|mesh-ancestor
65297213|NCT00856830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297214|NCT00856830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65297215|NCT00856830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65297216|NCT00856830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297217|NCT00856830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297218|NCT00856830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65297219|NCT00856830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65297220|NCT00856830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65297221|NCT00856830|Alkylating Agents|alkylating agents|mesh-ancestor
65297222|NCT02614404|Piperaquine|piperaquine|mesh-list
65124112|NCT00564408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124113|NCT00564408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124114|NCT00564408|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65124115|NCT00564408|Cholinergic Agents|cholinergic agents|mesh-ancestor
65124116|NCT00564408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65124117|NCT00564408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124118|NCT00564408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65124119|NCT00564408|Analgesics|analgesics|mesh-ancestor
65124120|NCT00564408|Sensory System Agents|sensory system agents|mesh-ancestor
65124121|NCT00564408|Protective Agents|protective agents|mesh-ancestor
65124122|NCT01773785|Docetaxel|docetaxel|mesh-list
65124123|NCT01773785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124124|NCT01773785|Tubulin Modulators|tubulin modulators|mesh-ancestor
65124125|NCT01773785|Antimitotic Agents|antimitotic agents|mesh-ancestor
65124126|NCT01773785|Mitosis Modulators|mitosis modulators|mesh-ancestor
65124127|NCT01773785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124128|NCT01758458|Interferons|interferons|mesh-list
65124129|NCT01758458|Aldesleukin|aldesleukin|mesh-list
65124130|NCT01758458|Interferon-beta|interferon-beta|mesh-list
65124131|NCT01758458|Interleukin-2|interleukin-2|mesh-list
65124132|NCT01758458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124133|NCT01758458|Antiviral Agents|antiviral agents|mesh-ancestor
65124134|NCT01758458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65124135|NCT01758458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65124136|NCT01758458|Analgesics|analgesics|mesh-ancestor
65124137|NCT01758458|Sensory System Agents|sensory system agents|mesh-ancestor
65124138|NCT01758458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124139|NCT01758458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124140|NCT01758458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65124141|NCT01758458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65124142|NCT01758458|Immunologic Factors|immunologic factors|mesh-ancestor
65124143|NCT04608981|Prednisolone|prednisolone|mesh-list
65124156|NCT04608981|Sensory System Agents|sensory system agents|mesh-ancestor
65124157|NCT04608981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65124158|NCT04608981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65124159|NCT04608981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124160|NCT04608981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124161|NCT01737905|Epinephrine|epinephrine|mesh-list
64766499|NCT00770874|Cisplatin|cisplatin|mesh-list
65124162|NCT01737905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65124163|NCT01737905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65124164|NCT01737905|Adrenergic Agents|adrenergic agents|mesh-ancestor
65124165|NCT01737905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65124166|NCT01737905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124167|NCT01737905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124168|NCT01737905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65124169|NCT01737905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65124170|NCT01737905|Autonomic Agents|autonomic agents|mesh-ancestor
65124171|NCT01737905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124172|NCT01737905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65124173|NCT01737905|Respiratory System Agents|respiratory system agents|mesh-ancestor
65124175|NCT01737905|Sympathomimetics|sympathomimetics|mesh-ancestor
65124176|NCT01737905|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65124177|NCT01730027|Montelukast|montelukast|mesh-list
65297223|NCT02614404|Artenimol|artenimol|mesh-list
65297224|NCT02614404|Imatinib Mesylate|imatinib mesylate|mesh-list
65297225|NCT02614404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297226|NCT02614404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65297227|NCT02614404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297228|NCT02614404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297229|NCT02614404|Antimalarials|antimalarials|mesh-ancestor
65297230|NCT02614404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65297231|NCT02614404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64483524|NCT00243022|Hematinics|hematinics|mesh-ancestor
65124178|NCT01730027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65124179|NCT01730027|Respiratory System Agents|respiratory system agents|mesh-ancestor
65124180|NCT01730027|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65124181|NCT01730027|Hormone Antagonists|hormone antagonists|mesh-ancestor
65124182|NCT01730027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65124183|NCT01730027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124184|NCT01730027|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65124185|NCT01730027|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65124186|NCT01730027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124187|NCT04608669|Acetaminophen|acetaminophen|mesh-list
65124188|NCT04608669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65124189|NCT04608669|Analgesics|analgesics|mesh-ancestor
65124190|NCT04608669|Sensory System Agents|sensory system agents|mesh-ancestor
65124191|NCT04608669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124192|NCT04608669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124193|NCT04608669|Antipyretics|antipyretics|mesh-ancestor
65124194|NCT00555230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65124195|NCT00555230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65124196|NCT00555230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65124197|NCT00555230|Antimetabolites|antimetabolites|mesh-ancestor
65124198|NCT00555230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124199|NCT00555230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65124200|NCT00555230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65124201|NCT00555230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124202|NCT04600089|Ketamine|ketamine|mesh-list
65124203|NCT04600089|Analgesics|analgesics|mesh-ancestor
65124204|NCT04600089|Sensory System Agents|sensory system agents|mesh-ancestor
64514155|NCT02304783|Piroxicam|piroxicam|mesh-list
65124229|NCT01698281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65124230|NCT01698281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65124231|NCT01698281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124232|NCT01698281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65124233|NCT01698281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65124234|NCT01698281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65124235|NCT01698281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124236|NCT01698281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124237|NCT00565461|Vaccines|vaccines|mesh-list
65124238|NCT00565461|Immunologic Factors|immunologic factors|mesh-ancestor
65124239|NCT00565461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124240|NCT01697072|Cisplatin|cisplatin|mesh-list
65124241|NCT01697072|Capecitabine|capecitabine|mesh-list
65124242|NCT01697072|Epirubicin|epirubicin|mesh-list
65124243|NCT01697072|Rilotumumab|rilotumumab|mesh-list
65124244|NCT01697072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124245|NCT01697072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65124246|NCT01697072|Antimetabolites|antimetabolites|mesh-ancestor
65124247|NCT01697072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124248|NCT01697072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65124249|NCT01697072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65124250|NCT01697072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65124251|NCT01697072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124252|NCT01697072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65124253|NCT00565500|Ibuprofen|ibuprofen|mesh-list
65124254|NCT00565500|Celecoxib|celecoxib|mesh-list
65124281|NCT01651871|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65297232|NCT02614404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65297233|NCT00522301|Sorafenib|sorafenib|mesh-list
65297234|NCT00522301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297235|NCT00522301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65297236|NCT00522301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297237|NCT00522301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297238|NCT00662636|Dasatinib|dasatinib|mesh-list
65297239|NCT00662636|Lapatinib|lapatinib|mesh-list
65297240|NCT00662636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297241|NCT00662636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65297242|NCT00662636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297243|NCT00662636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297244|NCT05726344|Lactulose|lactulose|mesh-list
64527423|NCT03028571|Vasodilator Agents|vasodilator agents|mesh-ancestor
65124282|NCT01651871|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65124283|NCT01651871|Histamine Antagonists|histamine antagonists|mesh-ancestor
65124284|NCT01651871|Histamine Agents|histamine agents|mesh-ancestor
65124285|NCT01651871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65124286|NCT01651871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124287|NCT01651871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124289|NCT04608006|Bupivacaine|bupivacaine|mesh-list
65124290|NCT04608006|Anesthetics, Local|anesthetics, local|mesh-ancestor
65124291|NCT04608006|Anesthetics|anesthetics|mesh-ancestor
65124292|NCT04608006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65124293|NCT04608006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124294|NCT04608006|Sensory System Agents|sensory system agents|mesh-ancestor
65124295|NCT04608006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124296|NCT04608006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65124297|NCT04608006|Narcotics|narcotics|mesh-ancestor
65124298|NCT04608006|Analgesics|analgesics|mesh-ancestor
65124299|NCT04608006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65124300|NCT04608006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65124301|NCT04608006|Anesthetics, General|anesthetics, general|mesh-ancestor
65124302|NCT04599621|Uric Acid|uric acid|mesh-list
65124303|NCT04599621|Antioxidants|antioxidants|mesh-ancestor
65124310|NCT00564525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65124311|NCT00564525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65124312|NCT00564525|Analgesics|analgesics|mesh-ancestor
65124313|NCT00564525|Sensory System Agents|sensory system agents|mesh-ancestor
65124314|NCT00564525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124315|NCT00564525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124316|NCT00564525|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65124317|NCT00564525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65124318|NCT00564525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65124319|NCT00564525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124320|NCT00564525|Adrenergic Agents|adrenergic agents|mesh-ancestor
65124321|NCT00564525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65124322|NCT04607733|Mirikizumab|mirikizumab|mesh-list
65124323|NCT04607733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65124324|NCT04607733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65124325|NCT04607733|Analgesics|analgesics|mesh-ancestor
65124326|NCT04607733|Sensory System Agents|sensory system agents|mesh-ancestor
65124327|NCT04607733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124328|NCT04607733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124329|NCT04607733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65124330|NCT04607733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65124331|NCT04607733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65124332|NCT04607733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65124334|NCT01632137|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65124335|NCT01632137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65124336|NCT01632137|Antioxidants|antioxidants|mesh-ancestor
65222811|NCT00775450|Vaccines|vaccines|mesh-list
65297245|NCT05726344|Bisacodyl|bisacodyl|mesh-list
65297246|NCT05726344|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65297247|NCT05726344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65297248|NCT05726344|Cathartics|cathartics|mesh-ancestor
65297249|NCT05726344|Laxatives|laxatives|mesh-ancestor
65297250|NCT00506389|Mirtazapine|mirtazapine|mesh-list
65297251|NCT00506389|Antidepressive Agents|antidepressive agents|mesh-ancestor
65297252|NCT00506389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65297253|NCT00506389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65297254|NCT00506389|Histamine Antagonists|histamine antagonists|mesh-ancestor
65297255|NCT00506389|Histamine Agents|histamine agents|mesh-ancestor
65297256|NCT00506389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64527435|NCT01535287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65124337|NCT01632137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124338|NCT01632137|Protective Agents|protective agents|mesh-ancestor
65124339|NCT01632137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124340|NCT01632137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124341|NCT00565539|Interferons|interferons|mesh-list
65124342|NCT00565539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124343|NCT00565539|Antiviral Agents|antiviral agents|mesh-ancestor
65124344|NCT00565539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65124345|NCT04599699|Androgens|androgens|mesh-list
65124346|NCT04599699|Hormones|hormones|mesh-ancestor
65124347|NCT04599699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65124348|NCT04599699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124349|NCT01563731|Antihypertensive Agents|antihypertensive agents|mesh-list
65124350|NCT01563731|Calcium Channel Blockers|calcium channel blockers|mesh-list
65124351|NCT01563731|Atorvastatin|atorvastatin|mesh-list
65124352|NCT01563731|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65124353|NCT01563731|Simvastatin|simvastatin|mesh-list
65124354|NCT01563731|Pravastatin|pravastatin|mesh-list
65124355|NCT01563731|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65124356|NCT01563731|Diuretics|diuretics|mesh-list
65124357|NCT01563731|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65124358|NCT01563731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65124359|NCT01563731|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
65124360|NCT01563731|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
65124361|NCT01563731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65124362|NCT01563731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124363|NCT01563731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65124364|NCT01563731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65124365|NCT01563731|Antimetabolites|antimetabolites|mesh-ancestor
65124366|NCT01563731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124367|NCT01563731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65124368|NCT01563731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65124385|NCT01516346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124387|NCT01303796|Decitabine|decitabine|mesh-list
65124388|NCT01303796|Sapacitabine|sapacitabine|mesh-list
65124389|NCT01303796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65124390|NCT01303796|Antimetabolites|antimetabolites|mesh-ancestor
65124391|NCT01303796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124392|NCT01303796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124393|NCT01303796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124394|NCT04598880|Picosulfate sodium|picosulfate sodium|mesh-list
65124395|NCT04598880|Magnesium citrate|magnesium citrate|mesh-list
65124396|NCT04598880|Cathartics|cathartics|mesh-ancestor
65124397|NCT04598880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65124398|NCT00194714|Vaccines|vaccines|mesh-list
65124399|NCT00194714|Immunologic Factors|immunologic factors|mesh-ancestor
65124400|NCT00194714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124401|NCT00564564|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65124402|NCT00564564|Clomipramine|clomipramine|mesh-list
65124403|NCT00564564|Antidepressive Agents|antidepressive agents|mesh-ancestor
65297257|NCT00506389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297258|NCT00506389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297259|NCT00506389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65297260|NCT00506389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65297261|NCT00506389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65297262|NCT00506389|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65297263|NCT00506389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65297264|NCT00506389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65297265|NCT00506389|Adrenergic Agents|adrenergic agents|mesh-ancestor
65297266|NCT00506389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65297267|NCT00506389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65297268|NCT00506389|Serotonin Agents|serotonin agents|mesh-ancestor
65297269|NCT00506389|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65297270|NCT00667472|Ranibizumab|ranibizumab|mesh-list
65297271|NCT00667472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65297272|NCT00667472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65297273|NCT00667472|Growth Substances|growth substances|mesh-ancestor
65297274|NCT00667472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297275|NCT00667472|Growth Inhibitors|growth inhibitors|mesh-ancestor
65297276|NCT00667472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297277|NCT05705128|Dexmedetomidine|dexmedetomidine|mesh-list
65297278|NCT05705128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65297279|NCT05705128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65297280|NCT05705128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297281|NCT05705128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65297282|NCT05705128|Analgesics|analgesics|mesh-ancestor
65297283|NCT05705128|Sensory System Agents|sensory system agents|mesh-ancestor
65297284|NCT05705128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64527447|NCT01549613|Vancomycin|vancomycin|mesh-list
65124404|NCT00564564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65124405|NCT00564564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65124406|NCT00564564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65124407|NCT00564564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65124408|NCT00564564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124409|NCT00564564|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65124410|NCT00564564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65124411|NCT00564564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65124412|NCT00564564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65124413|NCT00564564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124414|NCT00564564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65124415|NCT00564564|Serotonin Agents|serotonin agents|mesh-ancestor
65124416|NCT02894138|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65124417|NCT02894138|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65297285|NCT05705128|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65297286|NCT05705128|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65297287|NCT05705128|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65297288|NCT05705128|Adrenergic Agents|adrenergic agents|mesh-ancestor
65297289|NCT05705128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65297290|NCT05705128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297292|NCT00662714|Repaglinide|repaglinide|mesh-list
65297293|NCT00662714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65297294|NCT00662714|Insulin, Short-Acting|insulin, short-acting|mesh-list
65297295|NCT00662714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65297296|NCT00662714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297297|NCT00668018|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65297298|NCT00668018|Vasodilator Agents|vasodilator agents|mesh-ancestor
65297299|NCT00668018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65297300|NCT00668018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65297301|NCT00668018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297302|NCT00668018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297303|NCT00668018|Urological Agents|urological agents|mesh-ancestor
64527475|NCT01580293|Factor VIII|factor viii|mesh-list
65124418|NCT02894138|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65124419|NCT02894138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124420|NCT00565656|Bevacizumab|bevacizumab|mesh-list
65124421|NCT00565656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65124422|NCT00565656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124423|NCT00565656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65124424|NCT00565656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65124425|NCT00565656|Growth Substances|growth substances|mesh-ancestor
65124426|NCT00565656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124441|NCT00564603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65124443|NCT00564603|Protease Inhibitors|protease inhibitors|mesh-ancestor
65124444|NCT00564603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124445|NCT00564603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124447|NCT00555347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65124448|NCT00555347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124449|NCT00555347|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65124450|NCT00555347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65124451|NCT00555347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65124452|NCT00555347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124453|NCT00564642|Acetylcysteine|acetylcysteine|mesh-list
65124454|NCT00564642|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65124455|NCT00564642|Antiviral Agents|antiviral agents|mesh-ancestor
65124456|NCT00564642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65124457|NCT00564642|Expectorants|expectorants|mesh-ancestor
65124458|NCT00564642|Respiratory System Agents|respiratory system agents|mesh-ancestor
65124459|NCT00564642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65124461|NCT00564642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124462|NCT00564642|Protective Agents|protective agents|mesh-ancestor
65124463|NCT00564642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124464|NCT00564642|Antidotes|antidotes|mesh-ancestor
65124465|NCT00555386|Selenium|selenium|mesh-list
65124466|NCT00555386|Antioxidants|antioxidants|mesh-ancestor
65124467|NCT00555386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297304|NCT00871338|Vaccines|vaccines|mesh-list
65297305|NCT00871338|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65297306|NCT00871338|Immunologic Factors|immunologic factors|mesh-ancestor
65297307|NCT00871338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297308|NCT04130100|Hyaluronic Acid|hyaluronic acid|mesh-list
65297309|NCT04130100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65297310|NCT04130100|Immunologic Factors|immunologic factors|mesh-ancestor
65297311|NCT04130100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297312|NCT04130100|Viscosupplements|viscosupplements|mesh-ancestor
65297313|NCT04130100|Protective Agents|protective agents|mesh-ancestor
65124468|NCT00555386|Protective Agents|protective agents|mesh-ancestor
65124469|NCT00555386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124470|NCT00555386|Trace Elements|trace elements|mesh-ancestor
65124471|NCT00555386|Micronutrients|micronutrients|mesh-ancestor
65124472|NCT04676516|GSK-3326595|gsk-3326595|mesh-list
65124473|NCT04676516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124474|NCT04676516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124475|NCT04675697|Etoposide|etoposide|mesh-list
65124476|NCT04675697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65124477|NCT04675697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124478|NCT04675697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65124479|NCT04675697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65124480|NCT04675697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124481|NCT04675697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124482|NCT04606836|Bupivacaine|bupivacaine|mesh-list
65124483|NCT04606836|Anesthetics, Local|anesthetics, local|mesh-ancestor
65124484|NCT04606836|Anesthetics|anesthetics|mesh-ancestor
65124485|NCT04606836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65124486|NCT04606836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124487|NCT04606836|Sensory System Agents|sensory system agents|mesh-ancestor
64696872|NCT05436054|Cathartics|cathartics|mesh-ancestor
65124499|NCT04675619|Sensory System Agents|sensory system agents|mesh-ancestor
65124500|NCT04675619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124501|NCT04675619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124502|NCT04675619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65124503|NCT04675619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65124504|NCT04675619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65124506|NCT04675619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124507|NCT05305300|Vaccines|vaccines|mesh-list
65124508|NCT05305300|Somatomedin B|somatomedin b|mesh-list
65124509|NCT05305300|Immunologic Factors|immunologic factors|mesh-ancestor
65124510|NCT05305300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124511|NCT05305300|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65124512|NCT05305300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65124513|NCT05305300|Protease Inhibitors|protease inhibitors|mesh-ancestor
65124514|NCT05305300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124515|NCT05305300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124516|NCT04187755|Ceftazidime|ceftazidime|mesh-list
65124517|NCT04187755|Cefepime|cefepime|mesh-list
65124518|NCT04187755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65124519|NCT04187755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65124520|NCT00555542|Rituximab|rituximab|mesh-list
65124521|NCT00555542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65124522|NCT00555542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124523|NCT00555542|Immunologic Factors|immunologic factors|mesh-ancestor
65124524|NCT00555542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124525|NCT00555542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65124526|NCT04606563|Losartan|losartan|mesh-list
65124527|NCT04606563|Valsartan|valsartan|mesh-list
65124528|NCT04606563|Telmisartan|telmisartan|mesh-list
65124529|NCT04606563|Candesartan|candesartan|mesh-list
65124530|NCT04606563|Olmesartan|olmesartan|mesh-list
65124531|NCT04606563|Irbesartan|irbesartan|mesh-list
65124532|NCT04606563|Eprosartan|eprosartan|mesh-list
64766876|NCT00811434|Lactulose|lactulose|mesh-list
65124533|NCT04606563|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65124534|NCT04606563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65124535|NCT04606563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65297314|NCT00597116|Vinorelbine|vinorelbine|mesh-list
65297315|NCT00597116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65297316|NCT00597116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297317|NCT00597116|Tubulin Modulators|tubulin modulators|mesh-ancestor
65297318|NCT00597116|Antimitotic Agents|antimitotic agents|mesh-ancestor
65297319|NCT00597116|Mitosis Modulators|mitosis modulators|mesh-ancestor
65297320|NCT00597116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297322|NCT00668096|Vasodilator Agents|vasodilator agents|mesh-ancestor
65297323|NCT00668096|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65297324|NCT00668096|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65297325|NCT00668096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297326|NCT00668096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297327|NCT00668096|Urological Agents|urological agents|mesh-ancestor
65297328|NCT00514735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
65297329|NCT03332017|Obinutuzumab|obinutuzumab|mesh-list
65297330|NCT03332017|Zanubrutinib|zanubrutinib|mesh-list
65297331|NCT03332017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65297332|NCT03332017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297333|NCT03332017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65297334|NCT03332017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297335|NCT03332017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297336|NCT03252587|BMS-986165|bms-986165|mesh-list
65297337|NCT03252587|Dermatologic Agents|dermatologic agents|mesh-ancestor
65297338|NCT03252587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65124536|NCT04606563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65124537|NCT04606563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124538|NCT04606563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65124539|NCT04606563|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
65124540|NCT00565968|Sorafenib|sorafenib|mesh-list
65124541|NCT00565968|Melphalan|melphalan|mesh-list
65124542|NCT00565968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124543|NCT00565968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65124544|NCT00565968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124545|NCT00565968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124546|NCT00565968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65124547|NCT00565968|Alkylating Agents|alkylating agents|mesh-ancestor
65124548|NCT00565968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65124549|NCT00565968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65124550|NCT00565968|Immunologic Factors|immunologic factors|mesh-ancestor
64696939|NCT02256540|Estrogens|estrogens|mesh-ancestor
65124572|NCT01162486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65124573|NCT01162486|Leprostatic Agents|leprostatic agents|mesh-ancestor
65124574|NCT01162486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65124575|NCT01162486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124576|NCT01162486|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65124577|NCT01162486|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65124578|NCT01162486|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65124579|NCT01162486|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65222812|NCT00775450|Immunologic Factors|immunologic factors|mesh-ancestor
65297339|NCT03252587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297340|NCT03252587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297341|NCT02630264|Paclitaxel|paclitaxel|mesh-list
65297342|NCT02630264|Endostatins|endostatins|mesh-list
65297343|NCT02630264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65297344|NCT02630264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297345|NCT02630264|Tubulin Modulators|tubulin modulators|mesh-ancestor
65297346|NCT02630264|Antimitotic Agents|antimitotic agents|mesh-ancestor
65297347|NCT02630264|Mitosis Modulators|mitosis modulators|mesh-ancestor
65297348|NCT02630264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297349|NCT02630264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65297350|NCT02630264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65297351|NCT02630264|Growth Substances|growth substances|mesh-ancestor
65297352|NCT02630264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297353|NCT02630264|Growth Inhibitors|growth inhibitors|mesh-ancestor
65124580|NCT01162486|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65124581|NCT01162486|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65124583|NCT01162135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65124584|NCT01162135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65124585|NCT01162135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124586|NCT01162135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124587|NCT01162135|Protective Agents|protective agents|mesh-ancestor
65124588|NCT01162135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124589|NCT00555776|Gabapentin|gabapentin|mesh-list
65124590|NCT00555776|Analgesics|analgesics|mesh-ancestor
65124591|NCT00555776|Sensory System Agents|sensory system agents|mesh-ancestor
65124592|NCT00555776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124593|NCT00555776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124594|NCT00555776|Anticonvulsants|anticonvulsants|mesh-ancestor
65124595|NCT00555776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65124596|NCT00555776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65124597|NCT00555776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65124598|NCT00555776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65124599|NCT00555776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65124600|NCT00555776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65124601|NCT00555776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65124602|NCT00555776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124603|NCT00555776|Antimanic Agents|antimanic agents|mesh-ancestor
65124628|NCT01161472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65124629|NCT01161472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124630|NCT01161472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65124631|NCT01161472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65124632|NCT01161472|Cholinergic Agents|cholinergic agents|mesh-ancestor
65124633|NCT01161472|Urological Agents|urological agents|mesh-ancestor
65124634|NCT04675385|Hyaluronic Acid|hyaluronic acid|mesh-list
65124635|NCT04675385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65124636|NCT04675385|Immunologic Factors|immunologic factors|mesh-ancestor
65124637|NCT04675385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124638|NCT04675385|Viscosupplements|viscosupplements|mesh-ancestor
65124639|NCT04675385|Protective Agents|protective agents|mesh-ancestor
65124640|NCT04598061|Dexmedetomidine|dexmedetomidine|mesh-list
65124641|NCT04598061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65124642|NCT04598061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65124643|NCT04598061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124644|NCT04598061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65124645|NCT04598061|Analgesics|analgesics|mesh-ancestor
65124646|NCT04598061|Sensory System Agents|sensory system agents|mesh-ancestor
65124647|NCT04598061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65297354|NCT00668330|Calcium, Dietary|calcium, dietary|mesh-list
65297355|NCT00668330|Ibandronic Acid|ibandronic acid|mesh-list
65297356|NCT00668330|Alfacalcidol|alfacalcidol|mesh-list
65297357|NCT00668330|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65297358|NCT00668330|Calcium|calcium|mesh-list
65297359|NCT00668330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65297360|NCT00668330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297361|NCT00668330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65297362|NCT00668330|Vitamins|vitamins|mesh-ancestor
65297363|NCT00668330|Micronutrients|micronutrients|mesh-ancestor
65297364|NCT01012687|Perindopril|perindopril|mesh-list
65297365|NCT01012687|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65297366|NCT01012687|Protease Inhibitors|protease inhibitors|mesh-ancestor
65297367|NCT01012687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927893|NCT02734771|Prednisone|prednisone|mesh-list
65124648|NCT04598061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65124649|NCT04598061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65124650|NCT04598061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65124651|NCT04598061|Adrenergic Agents|adrenergic agents|mesh-ancestor
65124652|NCT04598061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65124653|NCT04598061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124654|NCT04674956|Gemcitabine|gemcitabine|mesh-list
65124655|NCT04674956|Paclitaxel|paclitaxel|mesh-list
65124656|NCT04674956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65124657|NCT04674956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124674|NCT00564720|Antimetabolites|antimetabolites|mesh-ancestor
65124675|NCT00564720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124676|NCT00564720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124677|NCT00564720|Antiviral Agents|antiviral agents|mesh-ancestor
65124678|NCT00564720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65124679|NCT00564720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64767027|NCT00824070|Gatifloxacin|gatifloxacin|mesh-list
64767046|NCT00824460|Iron|iron|mesh-list
65124680|NCT00564720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65124681|NCT00564720|Immunologic Factors|immunologic factors|mesh-ancestor
65124682|NCT00564720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124683|NCT00564720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65124684|NCT01160770|Clobazam|clobazam|mesh-list
65124685|NCT01160770|Anticonvulsants|anticonvulsants|mesh-ancestor
65124686|NCT01160770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65124687|NCT01160770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65124688|NCT01160770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65124689|NCT01160770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124690|NCT01160770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65124691|NCT01160770|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65124692|NCT01160770|GABA Agonists|gaba agonists|mesh-ancestor
65124693|NCT01160770|GABA Agents|gaba agents|mesh-ancestor
65124694|NCT01160770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65124695|NCT01160770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124696|NCT04632758|Crizotinib|crizotinib|mesh-list
65124697|NCT04632758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124698|NCT04632758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65124699|NCT04632758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124700|NCT04632758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124701|NCT00566046|Levetiracetam|levetiracetam|mesh-list
65124702|NCT00566046|Anticonvulsants|anticonvulsants|mesh-ancestor
65124703|NCT00566046|Nootropic Agents|nootropic agents|mesh-ancestor
65124704|NCT01160614|Oxycodone|oxycodone|mesh-list
65124705|NCT01160614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65124706|NCT01160614|Narcotics|narcotics|mesh-ancestor
65124707|NCT01160614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65124708|NCT01160614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124709|NCT01160614|Analgesics|analgesics|mesh-ancestor
65297368|NCT01012687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297369|NCT01012687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65297370|NCT00662948|Rituximab|rituximab|mesh-list
65297371|NCT00662948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65297372|NCT00662948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297373|NCT00662948|Immunologic Factors|immunologic factors|mesh-ancestor
65297374|NCT00662948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297375|NCT00662948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65297376|NCT00511147|Immunoglobulins|immunoglobulins|mesh-list
65297377|NCT00511147|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65297378|NCT00511147|gamma-Globulins|gamma-globulins|mesh-list
65297379|NCT00511147|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65297380|NCT00511147|Immunologic Factors|immunologic factors|mesh-ancestor
65297381|NCT00511147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297382|NCT00672464|Metformin|metformin|mesh-list
64527554|NCT01539083|Bortezomib|bortezomib|mesh-list
64928014|NCT00038545|Paclitaxel|paclitaxel|mesh-list
65124710|NCT01160614|Sensory System Agents|sensory system agents|mesh-ancestor
65124711|NCT01160614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124712|NCT00566124|Insulin|insulin|mesh-list
65124713|NCT00566124|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65124714|NCT00566124|Insulin Glargine|insulin glargine|mesh-list
65124715|NCT00566124|Insulin Detemir|insulin detemir|mesh-list
65124716|NCT00566124|Isophane Insulin, Human|isophane insulin, human|mesh-list
65124750|NCT04631822|Hormones|hormones|mesh-ancestor
65124751|NCT04631822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65124752|NCT04631822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65124753|NCT04631822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124754|NCT04605705|Chrysarobin|chrysarobin|mesh-list
65124755|NCT04605705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65124756|NCT04605705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65124757|NCT04605705|Analgesics|analgesics|mesh-ancestor
65124758|NCT04605705|Sensory System Agents|sensory system agents|mesh-ancestor
65124770|NCT00560963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65124771|NCT00560963|Immunologic Factors|immunologic factors|mesh-ancestor
65124772|NCT00560963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124773|NCT01159600|Empagliflozin|empagliflozin|mesh-list
65124774|NCT01159600|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65124775|NCT01159600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124776|NCT01159600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65124777|NCT01159600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124778|NCT04631627|Aspirin|aspirin|mesh-list
65124779|NCT04631627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65124780|NCT04631627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65124781|NCT04631627|Analgesics|analgesics|mesh-ancestor
65124782|NCT04631627|Sensory System Agents|sensory system agents|mesh-ancestor
65124783|NCT04631627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124784|NCT04631627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124785|NCT04631627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65124786|NCT04631627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65124787|NCT04631627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65124788|NCT04631627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65124789|NCT04631627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124790|NCT04631627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65124791|NCT04631627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65124792|NCT04631627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124793|NCT04631627|Antipyretics|antipyretics|mesh-ancestor
65124794|NCT04314193|Prednisolone|prednisolone|mesh-list
65124795|NCT04314193|Methotrexate|methotrexate|mesh-list
65297383|NCT00672464|Olanzapine|olanzapine|mesh-list
65297384|NCT00672464|Simvastatin|simvastatin|mesh-list
65297385|NCT00672464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65297386|NCT00672464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297387|NCT00672464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65297388|NCT00672464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65297389|NCT00672464|Antimetabolites|antimetabolites|mesh-ancestor
65124796|NCT04314193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65124797|NCT04314193|Abortifacient Agents|abortifacient agents|mesh-ancestor
65124798|NCT04314193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65124799|NCT04314193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124800|NCT04314193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65124801|NCT04314193|Antimetabolites|antimetabolites|mesh-ancestor
65124802|NCT04314193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124803|NCT04314193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124804|NCT04314193|Dermatologic Agents|dermatologic agents|mesh-ancestor
65124805|NCT04314193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124806|NCT04314193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65124807|NCT04314193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65124808|NCT04314193|Immunologic Factors|immunologic factors|mesh-ancestor
65124809|NCT04314193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65124810|NCT04314193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65124811|NCT04314193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65124812|NCT04314193|Glucocorticoids|glucocorticoids|mesh-ancestor
65124813|NCT04314193|Hormones|hormones|mesh-ancestor
65124814|NCT04314193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65124815|NCT04314193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65124817|NCT01159171|Capecitabine|capecitabine|mesh-list
65124818|NCT01159171|Oxaliplatin|oxaliplatin|mesh-list
65124819|NCT01159171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65124820|NCT01159171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124821|NCT01159171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64697220|NCT04329494|Antidotes|antidotes|mesh-ancestor
65124845|NCT04631315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124846|NCT04631315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65124847|NCT04631315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124848|NCT04631315|Antiemetics|antiemetics|mesh-ancestor
65124849|NCT04631315|Autonomic Agents|autonomic agents|mesh-ancestor
65124850|NCT04631315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124851|NCT04631315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65124852|NCT04631315|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65124853|NCT04631315|Protective Agents|protective agents|mesh-ancestor
65124854|NCT04631315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65124855|NCT04631315|Mydriatics|mydriatics|mesh-ancestor
65124856|NCT04631315|Sympathomimetics|sympathomimetics|mesh-ancestor
65124857|NCT04631315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65124858|NCT04631315|Nasal Decongestants|nasal decongestants|mesh-ancestor
65124859|NCT04631315|Respiratory System Agents|respiratory system agents|mesh-ancestor
65124860|NCT04631315|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65124861|NCT04631315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65124862|NCT04631315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65124863|NCT04631315|Adrenergic Agents|adrenergic agents|mesh-ancestor
65124864|NCT04631315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65124865|NCT04631315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124866|NCT04597203|Hydroquinone|hydroquinone|mesh-list
65124867|NCT04597203|Antioxidants|antioxidants|mesh-ancestor
65124868|NCT04597203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124869|NCT04597203|Protective Agents|protective agents|mesh-ancestor
65124870|NCT04597203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124871|NCT04597203|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65124872|NCT01158118|Plerixafor|plerixafor|mesh-list
65124888|NCT00566241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124890|NCT00561119|Paclitaxel|paclitaxel|mesh-list
65124891|NCT00561119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65124892|NCT00561119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124893|NCT00561119|Tubulin Modulators|tubulin modulators|mesh-ancestor
65124894|NCT00561119|Antimitotic Agents|antimitotic agents|mesh-ancestor
65124895|NCT00561119|Mitosis Modulators|mitosis modulators|mesh-ancestor
65222813|NCT00775450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297390|NCT00672464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297391|NCT00672464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65297392|NCT00672464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65297393|NCT00672464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297394|NCT00672464|Antiemetics|antiemetics|mesh-ancestor
65297395|NCT00672464|Autonomic Agents|autonomic agents|mesh-ancestor
65297396|NCT00672464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65297397|NCT00672464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65297398|NCT00672464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65124896|NCT00561119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124897|NCT00561119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65124898|NCT00561119|Antimetabolites|antimetabolites|mesh-ancestor
65124899|NCT00561119|Antiviral Agents|antiviral agents|mesh-ancestor
65124900|NCT00561119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65124901|NCT00561119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124902|NCT00561119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65124903|NCT00561119|Immunologic Factors|immunologic factors|mesh-ancestor
65124904|NCT00561119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124905|NCT00561197|Gossypol acetic acid|gossypol acetic acid|mesh-list
65124906|NCT00561197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65124907|NCT00561197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124908|NCT00561197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65124909|NCT00561197|Contraceptive Agents|contraceptive agents|mesh-ancestor
65124910|NCT00561197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65124911|NCT00561197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124912|NCT00561197|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
65124913|NCT00561197|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
65124914|NCT00561197|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65124915|NCT00564993|Dobutamine|dobutamine|mesh-list
65124916|NCT00564993|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65124917|NCT00564993|Sympathomimetics|sympathomimetics|mesh-ancestor
65124918|NCT00564993|Autonomic Agents|autonomic agents|mesh-ancestor
65124919|NCT00564993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124920|NCT00564993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124921|NCT00564993|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65124922|NCT00564993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65124923|NCT00564993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65124924|NCT00564993|Adrenergic Agents|adrenergic agents|mesh-ancestor
65124925|NCT00564993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65124926|NCT00564993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124927|NCT00564993|Protective Agents|protective agents|mesh-ancestor
65124928|NCT04629209|TIC10 compound|tic10 compound|mesh-list
65124929|NCT04629209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124930|NCT04595916|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
65124931|NCT04595916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65124932|NCT04595916|Antimetabolites|antimetabolites|mesh-ancestor
65124933|NCT04595916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124934|NCT04595916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65124951|NCT04595877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65124952|NCT04595877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65124953|NCT04595877|Analgesics|analgesics|mesh-ancestor
65124954|NCT04595877|Sensory System Agents|sensory system agents|mesh-ancestor
65124955|NCT04595877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124956|NCT04595877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124957|NCT04595877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65124958|NCT04595877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65124959|NCT04595877|Antipyretics|antipyretics|mesh-ancestor
65124960|NCT04595877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65124961|NCT04595877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124962|NCT00561509|Antidepressive Agents|antidepressive agents|mesh-list
65124963|NCT00561509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65124964|NCT03454646|Rivastigmine|rivastigmine|mesh-list
65124965|NCT03454646|Donepezil|donepezil|mesh-list
65124966|NCT03454646|Galantamine|galantamine|mesh-list
65124967|NCT03454646|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
65297399|NCT00672464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65297400|NCT00672464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65297401|NCT00672464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65297402|NCT00672464|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65124968|NCT03454646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124969|NCT03454646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124970|NCT03454646|Cholinergic Agents|cholinergic agents|mesh-ancestor
65124971|NCT03454646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65124972|NCT03454646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124973|NCT03454646|Nootropic Agents|nootropic agents|mesh-ancestor
65124974|NCT03454646|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65124975|NCT03454646|Autonomic Agents|autonomic agents|mesh-ancestor
65124976|NCT03454646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124977|NCT03454646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65124978|NCT03454646|Protective Agents|protective agents|mesh-ancestor
65124979|NCT00566553|Grape Seed Extract|grape seed extract|mesh-list
65124980|NCT00566553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65124981|NCT00566553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124982|NCT00566553|Antioxidants|antioxidants|mesh-ancestor
65124983|NCT00566553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124984|NCT00566553|Protective Agents|protective agents|mesh-ancestor
65124985|NCT00566553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124986|NCT01157182|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65124987|NCT01157182|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65124988|NCT01157182|Norethindrone|norethindrone|mesh-list
65124989|NCT01157182|Norethindrone Acetate|norethindrone acetate|mesh-list
65124990|NCT01157182|Estradiol|estradiol|mesh-list
65124991|NCT01157182|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65124992|NCT01157182|Estrogens|estrogens|mesh-ancestor
65124993|NCT01157182|Hormones|hormones|mesh-ancestor
65124994|NCT01157182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64697398|NCT03912428|Celecoxib|celecoxib|mesh-list
65125009|NCT01157065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125010|NCT00566592|Ethanol|ethanol|mesh-list
65125011|NCT00566592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65125012|NCT00566592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65125013|NCT00566592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65125014|NCT00566592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125015|NCT01156792|Montelukast|montelukast|mesh-list
65125016|NCT01156792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65125017|NCT01156792|Respiratory System Agents|respiratory system agents|mesh-ancestor
65125018|NCT01156792|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65125019|NCT01156792|Hormone Antagonists|hormone antagonists|mesh-ancestor
65125020|NCT01156792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65125021|NCT01156792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125022|NCT01156792|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65125023|NCT01156792|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65125024|NCT01156792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125025|NCT04604223|Pioglitazone|pioglitazone|mesh-list
65125026|NCT04604223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65125027|NCT04604223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125028|NCT04628624|Antioxidants|antioxidants|mesh-list
65125029|NCT04628624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125031|NCT04628624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125032|NCT04604028|Cyclophosphamide|cyclophosphamide|mesh-list
65125033|NCT04604028|Lenalidomide|lenalidomide|mesh-list
65125034|NCT04604028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65125035|NCT04604028|Immunologic Factors|immunologic factors|mesh-ancestor
65125036|NCT04604028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125037|NCT04604028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65125038|NCT04604028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65125039|NCT04604028|Alkylating Agents|alkylating agents|mesh-ancestor
65125040|NCT04604028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125041|NCT04604028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125042|NCT04604028|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65125043|NCT04604028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65125044|NCT04604028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65125045|NCT04604028|Growth Substances|growth substances|mesh-ancestor
65125046|NCT04604028|Growth Inhibitors|growth inhibitors|mesh-ancestor
65297403|NCT00672464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65297404|NCT00672464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65297405|NCT00672464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65297406|NCT00672464|Serotonin Agents|serotonin agents|mesh-ancestor
65297407|NCT02701595|Amoxicillin|amoxicillin|mesh-list
65297408|NCT02701595|Vancomycin|vancomycin|mesh-list
65297409|NCT02701595|Gentamicins|gentamicins|mesh-list
65297410|NCT02701595|Ceftriaxone|ceftriaxone|mesh-list
65297411|NCT02701595|Penicillins|penicillins|mesh-list
65297412|NCT02701595|Penicillin G|penicillin g|mesh-list
65297413|NCT02701595|Penicillin G Benzathine|penicillin g benzathine|mesh-list
65297414|NCT02701595|Penicillin G Procaine|penicillin g procaine|mesh-list
65297415|NCT02701595|Netilmicin|netilmicin|mesh-list
65297416|NCT02701595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65297417|NCT02701595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65125047|NCT01156480|Hydrocortisone|hydrocortisone|mesh-list
65125048|NCT01156480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65125049|NCT00561587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65125050|NCT00561587|Antidepressive Agents|antidepressive agents|mesh-ancestor
65125051|NCT00561587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65125052|NCT00561587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65125053|NCT00561587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65125063|NCT02884921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125066|NCT00561704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65125067|NCT00561704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65125068|NCT00561704|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65125069|NCT00561704|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65125070|NCT00561704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125071|NCT01156051|Guanfacine|guanfacine|mesh-list
65125072|NCT01156051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65125073|NCT01156051|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65125074|NCT01156051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65125075|NCT01156051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65125076|NCT01156051|Adrenergic Agents|adrenergic agents|mesh-ancestor
65125077|NCT01156051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65125078|NCT01156051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125079|NCT01156051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125080|NCT04595409|Ustekinumab|ustekinumab|mesh-list
65125081|NCT04595409|Dermatologic Agents|dermatologic agents|mesh-ancestor
65125082|NCT04628000|Vitamin D|vitamin d|mesh-list
65125083|NCT04628000|Ergocalciferols|ergocalciferols|mesh-list
65125084|NCT04628000|Cholecalciferol|cholecalciferol|mesh-list
65125085|NCT04628000|Vitamins|vitamins|mesh-list
65125086|NCT04628000|Micronutrients|micronutrients|mesh-ancestor
65125087|NCT04628000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125088|NCT04628000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65125089|NCT04628000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65125090|NCT01155661|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
65125091|NCT01155661|Serotonin|serotonin|mesh-list
65125092|NCT01155661|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65125093|NCT01155661|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65125094|NCT01155661|Serotonin Agents|serotonin agents|mesh-ancestor
65125095|NCT01155661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65125096|NCT01155661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125097|NCT01155661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125098|NCT01155661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65125099|NCT01155661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65125100|NCT01155661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65125101|NCT01155661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65125102|NCT01155661|Disinfectants|disinfectants|mesh-ancestor
65125103|NCT00565188|Adenosine|adenosine|mesh-list
65125104|NCT00565188|Analgesics|analgesics|mesh-ancestor
65125105|NCT00565188|Sensory System Agents|sensory system agents|mesh-ancestor
65297418|NCT02701595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65297419|NCT02701595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297420|NCT02701595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297421|NCT00668642|Dutasteride|dutasteride|mesh-list
65297422|NCT00668642|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65297423|NCT00668642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65297424|NCT00668642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297425|NCT00668642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297426|NCT00668642|Hormone Antagonists|hormone antagonists|mesh-ancestor
65297427|NCT00668642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65297428|NCT00668642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297429|NCT02698553|Bupropion|bupropion|mesh-list
64527598|NCT01536587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65125106|NCT00565188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125107|NCT00565188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125108|NCT00565188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65125109|NCT00565188|Vasodilator Agents|vasodilator agents|mesh-ancestor
65125110|NCT00565188|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65125111|NCT00565188|Purinergic Agonists|purinergic agonists|mesh-ancestor
65125112|NCT00565188|Purinergic Agents|purinergic agents|mesh-ancestor
65125113|NCT00565188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65125114|NCT00565188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125115|NCT04603833|Docetaxel|docetaxel|mesh-list
65125116|NCT04603833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125117|NCT04603833|Tubulin Modulators|tubulin modulators|mesh-ancestor
65125118|NCT04603833|Antimitotic Agents|antimitotic agents|mesh-ancestor
65125152|NCT01155583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65125153|NCT01155583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65125154|NCT01155583|Growth Substances|growth substances|mesh-ancestor
65125155|NCT01155583|Growth Inhibitors|growth inhibitors|mesh-ancestor
65125156|NCT01155583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65125157|NCT01155583|Antimetabolites|antimetabolites|mesh-ancestor
65125158|NCT01155583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125159|NCT01155583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125160|NCT04603131|Vaccines|vaccines|mesh-list
65125161|NCT04603131|Immunologic Factors|immunologic factors|mesh-ancestor
65125162|NCT04603131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125163|NCT04627181|Hydroxocobalamin|hydroxocobalamin|mesh-list
65125193|NCT00561899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65125194|NCT00561899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65125195|NCT01155388|Ferrous fumarate|ferrous fumarate|mesh-list
65125196|NCT01155388|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65125197|NCT01155388|Hematinics|hematinics|mesh-ancestor
65125198|NCT01155388|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65125199|NCT01155388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65125200|NCT01155388|Trace Elements|trace elements|mesh-ancestor
65125201|NCT01155388|Micronutrients|micronutrients|mesh-ancestor
65125202|NCT01155388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125203|NCT00565227|Docetaxel|docetaxel|mesh-list
65125204|NCT00565227|Vorinostat|vorinostat|mesh-list
65125205|NCT00565227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767553|NCT00905268|Idebenone|idebenone|mesh-list
65125206|NCT00565227|Tubulin Modulators|tubulin modulators|mesh-ancestor
65125207|NCT00565227|Antimitotic Agents|antimitotic agents|mesh-ancestor
65125208|NCT00565227|Mitosis Modulators|mitosis modulators|mesh-ancestor
65125209|NCT00565227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697623|NCT00376883|Pamidronate|pamidronate|mesh-list
65125233|NCT04601688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65125234|NCT04601688|Growth Substances|growth substances|mesh-ancestor
65125235|NCT04601688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297430|NCT02698553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65297431|NCT02698553|Antidepressive Agents|antidepressive agents|mesh-ancestor
65297432|NCT02698553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65297433|NCT02698553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65297434|NCT02698553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65297435|NCT02698553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65297436|NCT02698553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297437|NCT02698553|Dopamine Agents|dopamine agents|mesh-ancestor
65297438|NCT02698553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65297439|NCT02698553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297440|NCT02698553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65297441|NCT02698553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65297442|NCT02698553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297443|NCT00663182|Entecavir|entecavir|mesh-list
65297444|NCT00663182|Antiviral Agents|antiviral agents|mesh-ancestor
65297445|NCT00663182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65297446|NCT00616031|Paclitaxel|paclitaxel|mesh-list
65297447|NCT00616031|Carboplatin|carboplatin|mesh-list
65297448|NCT00616031|Nitroglycerin|nitroglycerin|mesh-list
65297449|NCT00616031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65297450|NCT00616031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297451|NCT00616031|Tubulin Modulators|tubulin modulators|mesh-ancestor
65297452|NCT00616031|Antimitotic Agents|antimitotic agents|mesh-ancestor
65297453|NCT00616031|Mitosis Modulators|mitosis modulators|mesh-ancestor
65297454|NCT00616031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297455|NCT00616031|Vasodilator Agents|vasodilator agents|mesh-ancestor
65297456|NCT04213937|Paclitaxel|paclitaxel|mesh-list
65125236|NCT04601688|Growth Inhibitors|growth inhibitors|mesh-ancestor
65125237|NCT04601688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65125238|NCT04601688|Antiemetics|antiemetics|mesh-ancestor
65125239|NCT04601688|Autonomic Agents|autonomic agents|mesh-ancestor
65125240|NCT04601688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125241|NCT04601688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65125242|NCT04601688|Glucocorticoids|glucocorticoids|mesh-ancestor
65125243|NCT04601688|Hormones|hormones|mesh-ancestor
65125244|NCT04601688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65125245|NCT04601688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65125246|NCT01154452|R04929097|r04929097|mesh-list
65125247|NCT01154452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125248|NCT01154452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125249|NCT04313452|Insulin|insulin|mesh-list
65125250|NCT04313452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65125251|NCT04313452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125252|NCT01154218|Crizotinib|crizotinib|mesh-list
65125253|NCT01154218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125254|NCT01154218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65125255|NCT01154218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297457|NCT04213937|Topotecan|topotecan|mesh-list
65297458|NCT04213937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65297459|NCT04213937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297460|NCT04213937|Tubulin Modulators|tubulin modulators|mesh-ancestor
65297461|NCT04213937|Antimitotic Agents|antimitotic agents|mesh-ancestor
65297462|NCT04213937|Mitosis Modulators|mitosis modulators|mesh-ancestor
65297463|NCT04213937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297464|NCT04213937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65297465|NCT04213937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65297466|NCT04213937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297467|NCT02701517|Cyclosporine|cyclosporine|mesh-list
65297468|NCT02701517|Methotrexate|methotrexate|mesh-list
65297469|NCT02701517|Alemtuzumab|alemtuzumab|mesh-list
65047367|NCT00217451|Clindamycin|clindamycin|mesh-list
65297470|NCT02701517|Cyclosporins|cyclosporins|mesh-list
65297471|NCT02701517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65297472|NCT02701517|Abortifacient Agents|abortifacient agents|mesh-ancestor
65297473|NCT02701517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65297474|NCT02701517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297475|NCT02701517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65297476|NCT02701517|Antimetabolites|antimetabolites|mesh-ancestor
65297477|NCT02701517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297478|NCT02701517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527638|NCT02655016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125256|NCT01154218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125257|NCT04625699|Durvalumab|durvalumab|mesh-list
65125258|NCT04625699|Tremelimumab|tremelimumab|mesh-list
65125259|NCT04625699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65125260|NCT04625699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125261|NCT04601142|Methylprednisolone|methylprednisolone|mesh-list
65125267|NCT04601142|Prednisolone phosphate|prednisolone phosphate|mesh-list
65125268|NCT04601142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65125269|NCT04601142|Antiemetics|antiemetics|mesh-ancestor
65125270|NCT04601142|Autonomic Agents|autonomic agents|mesh-ancestor
65125271|NCT04601142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125272|NCT04601142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125273|NCT04601142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65125274|NCT04601142|Glucocorticoids|glucocorticoids|mesh-ancestor
65125275|NCT04601142|Hormones|hormones|mesh-ancestor
65125276|NCT04601142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65125277|NCT04601142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65125278|NCT04601142|Protective Agents|protective agents|mesh-ancestor
65125279|NCT04601142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65125280|NCT04601142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125281|NCT04625543|Paclitaxel|paclitaxel|mesh-list
65125282|NCT04625543|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65125283|NCT04625543|Cisplatin|cisplatin|mesh-list
65125284|NCT04625543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65125285|NCT04625543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125286|NCT04625543|Tubulin Modulators|tubulin modulators|mesh-ancestor
65125287|NCT04625543|Antimitotic Agents|antimitotic agents|mesh-ancestor
65297479|NCT02701517|Dermatologic Agents|dermatologic agents|mesh-ancestor
65297480|NCT02701517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297481|NCT02701517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65297482|NCT02701517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65297483|NCT02701517|Immunologic Factors|immunologic factors|mesh-ancestor
65297484|NCT02701517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65297485|NCT02701517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65297486|NCT02701517|Antifungal Agents|antifungal agents|mesh-ancestor
65297487|NCT02701517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65297488|NCT02701517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65297489|NCT02701517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65297490|NCT02630108|Epirubicin|epirubicin|mesh-list
65297491|NCT02630108|Ethiodized Oil|ethiodized oil|mesh-list
65297492|NCT02630108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65297493|NCT02630108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297494|NCT02630108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65297495|NCT02630108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65297496|NCT02630108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297497|NCT02630108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297498|NCT00505921|Cytarabine|cytarabine|mesh-list
65297499|NCT00505921|Cyclophosphamide|cyclophosphamide|mesh-list
65297500|NCT00505921|Melphalan|melphalan|mesh-list
65297501|NCT00505921|Carmustine|carmustine|mesh-list
65297502|NCT00505921|Fludarabine|fludarabine|mesh-list
65297503|NCT00505921|Fludarabine phosphate|fludarabine phosphate|mesh-list
65297504|NCT00505921|Etoposide|etoposide|mesh-list
65297505|NCT00505921|Etoposide phosphate|etoposide phosphate|mesh-list
65297506|NCT00505921|Molgramostim|molgramostim|mesh-list
65125288|NCT04625543|Mitosis Modulators|mitosis modulators|mesh-ancestor
65125289|NCT04625543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125290|NCT04601259|Salicylic Acid|salicylic acid|mesh-list
65125291|NCT04601259|Salicylates|salicylates|mesh-list
65125292|NCT04601259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65125293|NCT04601259|Antifungal Agents|antifungal agents|mesh-ancestor
65125294|NCT04601259|Keratolytic Agents|keratolytic agents|mesh-ancestor
65125295|NCT04601259|Dermatologic Agents|dermatologic agents|mesh-ancestor
65125296|NCT04601259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65125297|NCT04601259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65125298|NCT04601259|Analgesics|analgesics|mesh-ancestor
65125299|NCT04601259|Sensory System Agents|sensory system agents|mesh-ancestor
65125300|NCT04601259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125301|NCT04601259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125302|NCT04601259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65125303|NCT04601259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65125304|NCT04601259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65125305|NCT04601259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125306|NCT04601259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125307|NCT00565383|Fentanyl|fentanyl|mesh-list
65125308|NCT00565383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65125309|NCT00565383|Narcotics|narcotics|mesh-ancestor
65297507|NCT00505921|Alemtuzumab|alemtuzumab|mesh-list
65297508|NCT00505921|Sargramostim|sargramostim|mesh-list
65297509|NCT00505921|Lenograstim|lenograstim|mesh-list
65297510|NCT00505921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65297511|NCT00505921|Immunologic Factors|immunologic factors|mesh-ancestor
65297512|NCT00505921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297513|NCT00505921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65297514|NCT00505921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64527687|NCT02677116|Irinotecan|irinotecan|mesh-list
64527688|NCT02677116|Vincristine|vincristine|mesh-list
65125310|NCT00565383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65125311|NCT00565383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125312|NCT00565383|Analgesics|analgesics|mesh-ancestor
65125313|NCT00565383|Sensory System Agents|sensory system agents|mesh-ancestor
65125314|NCT00565383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125315|NCT00565383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65125316|NCT00565383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65125317|NCT00565383|Anesthetics, General|anesthetics, general|mesh-ancestor
65125318|NCT00565383|Anesthetics|anesthetics|mesh-ancestor
65125319|NCT04625426|Protective Agents|protective agents|mesh-list
65125320|NCT04625426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125321|NCT04625114|Gabexate|gabexate|mesh-list
65125322|NCT04625114|Camostat|camostat|mesh-list
65125323|NCT04625114|Protease Inhibitors|protease inhibitors|mesh-ancestor
65125324|NCT04625114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125325|NCT04625114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125326|NCT04625114|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65125327|NCT04625114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65125328|NCT04625114|Anticoagulants|anticoagulants|mesh-ancestor
65125329|NCT00567099|Aripiprazole|aripiprazole|mesh-list
65125330|NCT00567099|Antidepressive Agents|antidepressive agents|mesh-ancestor
65125331|NCT00567099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65125332|NCT00567099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65125333|NCT00567099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65125345|NCT00567099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65125346|NCT00567099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65125347|NCT00567177|Cyclosporine|cyclosporine|mesh-list
65125348|NCT00567177|Cyclosporins|cyclosporins|mesh-list
65125349|NCT00567177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125350|NCT00567177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125351|NCT00567177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65125352|NCT00567177|Immunologic Factors|immunologic factors|mesh-ancestor
65125353|NCT00567177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125354|NCT00567177|Antifungal Agents|antifungal agents|mesh-ancestor
65125355|NCT00567177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65125356|NCT00567177|Dermatologic Agents|dermatologic agents|mesh-ancestor
65125357|NCT00567177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65125358|NCT00567177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65125359|NCT00567216|Nadolol|nadolol|mesh-list
65125360|NCT00567216|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64767700|NCT00928200|Cytarabine|cytarabine|mesh-list
65125361|NCT00567216|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65125362|NCT00567216|Adrenergic Agents|adrenergic agents|mesh-ancestor
65125363|NCT00567216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65125364|NCT00567216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125365|NCT00567216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125366|NCT00567216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65125367|NCT00567216|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65125368|NCT00567216|Sympatholytics|sympatholytics|mesh-ancestor
65125369|NCT00567216|Autonomic Agents|autonomic agents|mesh-ancestor
65125370|NCT00567216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125371|NCT00562055|Reboxetine|reboxetine|mesh-list
65125372|NCT00562055|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65125373|NCT00562055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65125374|NCT00562055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65125375|NCT00562055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65125376|NCT00562055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527695|NCT02677116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297515|NCT00505921|Alkylating Agents|alkylating agents|mesh-ancestor
65297516|NCT00505921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297517|NCT00505921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297518|NCT00505921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65297519|NCT00505921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65297520|NCT00505921|Antimetabolites|antimetabolites|mesh-ancestor
65297521|NCT00505921|Antiviral Agents|antiviral agents|mesh-ancestor
65297522|NCT00505921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65297523|NCT00505921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65125377|NCT00562055|Adrenergic Agents|adrenergic agents|mesh-ancestor
65125378|NCT00562055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65125379|NCT00562055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125380|NCT00562055|Antidepressive Agents|antidepressive agents|mesh-ancestor
65125381|NCT00562055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65125382|NCT04624217|Gemcitabine|gemcitabine|mesh-list
65125383|NCT04624217|Paclitaxel|paclitaxel|mesh-list
65125384|NCT04624217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65125385|NCT04624217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125386|NCT04624217|Tubulin Modulators|tubulin modulators|mesh-ancestor
65125387|NCT04624217|Antimitotic Agents|antimitotic agents|mesh-ancestor
65125388|NCT04624217|Mitosis Modulators|mitosis modulators|mesh-ancestor
65125389|NCT04624217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125390|NCT04624217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65125391|NCT04624217|Antimetabolites|antimetabolites|mesh-ancestor
65125392|NCT04624217|Antiviral Agents|antiviral agents|mesh-ancestor
65125393|NCT04624217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65125394|NCT04624217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125414|NCT00562133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65125415|NCT00562133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125416|NCT00567411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65125418|NCT00567411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65125419|NCT00567411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65125420|NCT00567411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65125421|NCT00567411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65125422|NCT00567411|Adrenergic Agents|adrenergic agents|mesh-ancestor
65125423|NCT00567411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65125424|NCT00567411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125425|NCT00567411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125426|NCT00562172|Metformin|metformin|mesh-list
65125427|NCT00562172|Insulin Glargine|insulin glargine|mesh-list
65125428|NCT00562172|Glimepiride|glimepiride|mesh-list
65125429|NCT00562172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65125430|NCT00562172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125431|NCT00562172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65125432|NCT00562172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65125433|NCT00562172|Immunologic Factors|immunologic factors|mesh-ancestor
65125434|NCT00567450|Ropivacaine|ropivacaine|mesh-list
65125435|NCT00567450|Mepivacaine|mepivacaine|mesh-list
65125436|NCT00567450|Anesthetics, Local|anesthetics, local|mesh-ancestor
65125437|NCT00567450|Anesthetics|anesthetics|mesh-ancestor
65125438|NCT00567450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65125439|NCT00567450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125440|NCT00567450|Sensory System Agents|sensory system agents|mesh-ancestor
65125441|NCT00567450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125442|NCT00567528|Ibuprofen|ibuprofen|mesh-list
65125443|NCT00567528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65125444|NCT00567528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65125445|NCT00567528|Analgesics|analgesics|mesh-ancestor
65125446|NCT00567528|Sensory System Agents|sensory system agents|mesh-ancestor
65125447|NCT00567528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125448|NCT00567528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697849|NCT00361244|Irinotecan|irinotecan|mesh-list
65125466|NCT04590612|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
65125467|NCT04590612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65297524|NCT00505921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65297525|NCT00505921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65297526|NCT00505921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297527|NCT00505921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65297528|NCT00505921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65297529|NCT04729205|Mitomycins|mitomycins|mesh-list
65297530|NCT04729205|Mitomycin|mitomycin|mesh-list
65297531|NCT04729205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65297532|NCT04729205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297533|NCT04729205|Alkylating Agents|alkylating agents|mesh-ancestor
65297534|NCT04729205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297535|NCT04729205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65297536|NCT04729205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297537|NCT00669344|Rivastigmine|rivastigmine|mesh-list
65297538|NCT00669344|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65297539|NCT00669344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297540|NCT00669344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297541|NCT00669344|Cholinergic Agents|cholinergic agents|mesh-ancestor
65297542|NCT00669344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65297543|NCT00669344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297544|NCT00669344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65297545|NCT00669344|Protective Agents|protective agents|mesh-ancestor
65125468|NCT04590612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65125469|NCT04590612|Dopamine Agents|dopamine agents|mesh-ancestor
65125470|NCT04590612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65125471|NCT04590612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125472|NCT04590612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125473|NCT04590612|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65125474|NCT04590612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125475|NCT04590612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65125476|NCT04590612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65125477|NCT04590612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65125478|NCT04590612|Serotonin Agents|serotonin agents|mesh-ancestor
65125479|NCT04590612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65125480|NCT04590612|Antidepressive Agents|antidepressive agents|mesh-ancestor
65125481|NCT04590612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65125482|NCT04590612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65125483|NCT04590612|Immunologic Factors|immunologic factors|mesh-ancestor
65125484|NCT04590612|Dopamine Agonists|dopamine agonists|mesh-ancestor
65125485|NCT00562250|Dapagliflozin|dapagliflozin|mesh-list
65125486|NCT00562250|Glimepiride|glimepiride|mesh-list
65125487|NCT00562250|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65125488|NCT00562250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125489|NCT00562250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65125490|NCT00562250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125491|NCT00562250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65125492|NCT00562250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65125493|NCT00562250|Immunologic Factors|immunologic factors|mesh-ancestor
65125494|NCT00562289|Aspirin|aspirin|mesh-list
65125495|NCT00562289|Dipyridamole|dipyridamole|mesh-list
65125496|NCT00562289|Rivaroxaban|rivaroxaban|mesh-list
65125497|NCT00562289|Apixaban|apixaban|mesh-list
65297546|NCT02701127|Niacinamide|niacinamide|mesh-list
65297547|NCT02701127|Niacin|niacin|mesh-list
65297548|NCT02701127|Nicotinic Acids|nicotinic acids|mesh-list
65297549|NCT02701127|Vitamin B Complex|vitamin b complex|mesh-ancestor
65297550|NCT02701127|Vitamins|vitamins|mesh-ancestor
65297551|NCT02701127|Micronutrients|micronutrients|mesh-ancestor
65297552|NCT02701127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297553|NCT02701127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65297554|NCT02701127|Antimetabolites|antimetabolites|mesh-ancestor
65297555|NCT02701127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297556|NCT02701127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65297557|NCT02701127|Vasodilator Agents|vasodilator agents|mesh-ancestor
65297558|NCT02700893|Atropine|atropine|mesh-list
65297559|NCT02700893|Sufentanil|sufentanil|mesh-list
65297560|NCT02700893|Propofol|propofol|mesh-list
65297561|NCT02700893|Atracurium|atracurium|mesh-list
65297562|NCT02700893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65297563|NCT02700893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65297564|NCT02700893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297565|NCT02700893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65297566|NCT02700893|Anesthetics, General|anesthetics, general|mesh-ancestor
65297567|NCT02700893|Anesthetics|anesthetics|mesh-ancestor
65297568|NCT02700893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65297569|NCT02700893|Narcotics|narcotics|mesh-ancestor
65297570|NCT02700893|Analgesics|analgesics|mesh-ancestor
65297571|NCT02700893|Sensory System Agents|sensory system agents|mesh-ancestor
65297572|NCT02700893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65297573|NCT02700893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65297574|NCT02700893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65297575|NCT02700893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65297576|NCT02700893|Autonomic Agents|autonomic agents|mesh-ancestor
65297577|NCT02700893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65297578|NCT02700893|Respiratory System Agents|respiratory system agents|mesh-ancestor
65297579|NCT02700893|Mydriatics|mydriatics|mesh-ancestor
65297580|NCT02700893|Parasympatholytics|parasympatholytics|mesh-ancestor
65297590|NCT04213781|Sufentanil|sufentanil|mesh-list
65297591|NCT04213781|Propofol|propofol|mesh-list
65297592|NCT04213781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65297593|NCT04213781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65297594|NCT04213781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297595|NCT04213781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65297596|NCT04213781|Anesthetics, General|anesthetics, general|mesh-ancestor
65297597|NCT04213781|Anesthetics|anesthetics|mesh-ancestor
65297598|NCT04213781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65297599|NCT04213781|Narcotics|narcotics|mesh-ancestor
65297600|NCT04213781|Analgesics|analgesics|mesh-ancestor
65297601|NCT04213781|Sensory System Agents|sensory system agents|mesh-ancestor
64527769|NCT03161574|Fluorouracil|fluorouracil|mesh-list
65125498|NCT00562289|Dabigatran|dabigatran|mesh-list
65125499|NCT00562289|Antivitamins K|antivitamins k|mesh-list
65125500|NCT00562289|Clopidogrel|clopidogrel|mesh-list
65125501|NCT00562289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65125502|NCT00562289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65125503|NCT00562289|Analgesics|analgesics|mesh-ancestor
65125504|NCT00562289|Sensory System Agents|sensory system agents|mesh-ancestor
65125505|NCT00562289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125506|NCT00562289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125520|NCT00562289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65125521|NCT00562289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65125522|NCT00562289|Antithrombins|antithrombins|mesh-ancestor
65125523|NCT00562289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65125524|NCT00562289|Protease Inhibitors|protease inhibitors|mesh-ancestor
65125525|NCT00562289|Anticoagulants|anticoagulants|mesh-ancestor
65125526|NCT00562289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65125527|NCT00562289|Vasodilator Agents|vasodilator agents|mesh-ancestor
65125529|NCT04313218|Carbetocin|carbetocin|mesh-list
65125530|NCT04313218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65125531|NCT04313218|Abortifacient Agents|abortifacient agents|mesh-ancestor
65125532|NCT04313218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65125533|NCT04313218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125534|NCT04313218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65125535|NCT04313218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65125536|NCT04313218|Oxytocics|oxytocics|mesh-ancestor
65125537|NCT00624871|Ascorbic Acid|ascorbic acid|mesh-list
65125538|NCT00624871|Ibuprofen|ibuprofen|mesh-list
65125539|NCT00624871|Vitamins|vitamins|mesh-ancestor
65125540|NCT00624871|Micronutrients|micronutrients|mesh-ancestor
65125541|NCT00624871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125542|NCT00624871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65125543|NCT00624871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65125544|NCT00624871|Analgesics|analgesics|mesh-ancestor
65125545|NCT00624871|Sensory System Agents|sensory system agents|mesh-ancestor
65125546|NCT00624871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125547|NCT00624871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65125548|NCT00624871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65125549|NCT00624871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65125550|NCT00624871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125551|NCT00624871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125552|NCT00624871|Antioxidants|antioxidants|mesh-ancestor
65125553|NCT00624871|Protective Agents|protective agents|mesh-ancestor
65125554|NCT04623086|Insulin|insulin|mesh-list
65125555|NCT04623086|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65125556|NCT04623086|Insulin Glargine|insulin glargine|mesh-list
65125557|NCT04623086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65125558|NCT04623086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125559|NCT01153984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65125560|NCT01153984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125561|NCT01153984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65125562|NCT01153984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125563|NCT01153984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125564|NCT04590183|Prednisolone|prednisolone|mesh-list
65297602|NCT04213781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65297603|NCT04213781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65297604|NCT00505687|Rotigotine|rotigotine|mesh-list
65297605|NCT00505687|Dopamine Agonists|dopamine agonists|mesh-ancestor
65297606|NCT00505687|Dopamine Agents|dopamine agents|mesh-ancestor
65297607|NCT00505687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65297608|NCT00505687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297609|NCT00505687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527778|NCT03161574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125565|NCT04590183|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65125566|NCT04590183|Methylprednisolone|methylprednisolone|mesh-list
65125567|NCT04590183|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65125581|NCT04590183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65125583|NCT04590183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125584|NCT04590183|Antiemetics|antiemetics|mesh-ancestor
65125585|NCT04590183|Autonomic Agents|autonomic agents|mesh-ancestor
65125586|NCT04590183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125587|NCT04590183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65125588|NCT04590183|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65125589|NCT04590183|Protective Agents|protective agents|mesh-ancestor
65125590|NCT04622618|Gabapentin|gabapentin|mesh-list
65125591|NCT04622618|Analgesics|analgesics|mesh-ancestor
65125592|NCT04622618|Sensory System Agents|sensory system agents|mesh-ancestor
65125593|NCT04622618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125594|NCT04622618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125595|NCT04622618|Anticonvulsants|anticonvulsants|mesh-ancestor
65125596|NCT04622618|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65125597|NCT04622618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65125598|NCT04622618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65125599|NCT04622618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65125600|NCT04622618|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65125601|NCT04622618|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65125602|NCT04622618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65125603|NCT04622618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125604|NCT04622618|Antimanic Agents|antimanic agents|mesh-ancestor
65125605|NCT04622891|Azithromycin|azithromycin|mesh-list
65125606|NCT04622891|Clarithromycin|clarithromycin|mesh-list
65125607|NCT04622891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65125608|NCT04622891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65125609|NCT04622891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65125610|NCT04622891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125611|NCT04622891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125612|NCT04622891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65125613|NCT04622891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65125614|NCT04622579|Rituximab|rituximab|mesh-list
65125615|NCT04622579|Lenalidomide|lenalidomide|mesh-list
65125616|NCT04622579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65125617|NCT04622579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125618|NCT04622579|Immunologic Factors|immunologic factors|mesh-ancestor
65125619|NCT04622579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125620|NCT04622579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65125621|NCT04622579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65125622|NCT04622579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65125623|NCT04622579|Growth Substances|growth substances|mesh-ancestor
65125624|NCT04622579|Growth Inhibitors|growth inhibitors|mesh-ancestor
65125625|NCT01153009|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65125626|NCT01153009|Vortioxetine|vortioxetine|mesh-list
65125627|NCT01153009|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64698023|NCT04829760|Psyllium|psyllium|mesh-list
65125648|NCT04622111|Metformin|metformin|mesh-list
65125649|NCT04622111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65125650|NCT04622111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125651|NCT04622033|Brodalumab|brodalumab|mesh-list
65125652|NCT04622033|Dermatologic Agents|dermatologic agents|mesh-ancestor
65125653|NCT01152580|Melatonin|melatonin|mesh-list
65125654|NCT01152580|Antioxidants|antioxidants|mesh-ancestor
65297610|NCT00669656|Vitamin D|vitamin d|mesh-list
65297611|NCT00669656|Cholecalciferol|cholecalciferol|mesh-list
65297612|NCT00669656|Vitamins|vitamins|mesh-list
65297613|NCT00669656|Vitamin E|vitamin e|mesh-list
65297614|NCT00669656|Tocopherols|tocopherols|mesh-list
65297615|NCT00669656|alpha-Tocopherol|alpha-tocopherol|mesh-list
65297616|NCT00669656|Selenium|selenium|mesh-list
65297617|NCT00669656|Lycopene|lycopene|mesh-list
65297618|NCT00669656|Daidzein|daidzein|mesh-list
65297619|NCT00669656|Micronutrients|micronutrients|mesh-ancestor
65297620|NCT00669656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527788|NCT05676216|Anesthetics, Local|anesthetics, local|mesh-ancestor
65125655|NCT01152580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125656|NCT01152580|Protective Agents|protective agents|mesh-ancestor
65125657|NCT01152580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125658|NCT01152580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64767996|NCT00976404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65125659|NCT04621799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65125660|NCT04621799|Hemostatics|hemostatics|mesh-ancestor
65125661|NCT04621799|Coagulants|coagulants|mesh-ancestor
65125662|NCT04621370|Capecitabine|capecitabine|mesh-list
65125663|NCT04621370|Durvalumab|durvalumab|mesh-list
65125664|NCT04621370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65125665|NCT04621370|Antimetabolites|antimetabolites|mesh-ancestor
65125666|NCT04621370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125667|NCT04621370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125668|NCT04621370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65125669|NCT04589130|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
65125670|NCT04589130|Naltrexone|naltrexone|mesh-list
65125671|NCT04589130|Bupropion|bupropion|mesh-list
65125672|NCT04589130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64658591|NCT02495103|Metformin|metformin|mesh-list
65125673|NCT04589130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65125674|NCT04589130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125675|NCT04589130|Sensory System Agents|sensory system agents|mesh-ancestor
65125676|NCT04589130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125677|NCT04589130|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65125678|NCT04589130|Antidepressive Agents|antidepressive agents|mesh-ancestor
65125701|NCT04621487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65125702|NCT04621487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65125703|NCT04621487|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65125704|NCT04621487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65125705|NCT04621487|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65125707|NCT01152190|Vasodilator Agents|vasodilator agents|mesh-ancestor
65125708|NCT01152190|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65125709|NCT01152190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65125710|NCT01152190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125711|NCT01152190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125712|NCT01152190|Urological Agents|urological agents|mesh-ancestor
65125713|NCT04621565|Hydrocortisone|hydrocortisone|mesh-list
65125714|NCT04621565|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65125715|NCT04621565|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65125716|NCT04621565|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65125717|NCT04621565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65125718|NCT01151410|Enalapril|enalapril|mesh-list
65125719|NCT01151410|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65125720|NCT01151410|Protease Inhibitors|protease inhibitors|mesh-ancestor
65125721|NCT01151410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125722|NCT01151410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125723|NCT01151410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65125724|NCT00562406|Ranibizumab|ranibizumab|mesh-list
65125725|NCT00562406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65125726|NCT00562406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65125727|NCT00562406|Growth Substances|growth substances|mesh-ancestor
65125728|NCT00562406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125729|NCT00562406|Growth Inhibitors|growth inhibitors|mesh-ancestor
65297621|NCT00669656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65297622|NCT00669656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65297623|NCT00669656|Antioxidants|antioxidants|mesh-ancestor
65297624|NCT00669656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297625|NCT00669656|Protective Agents|protective agents|mesh-ancestor
65297626|NCT00669656|Trace Elements|trace elements|mesh-ancestor
65297627|NCT00669656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65297628|NCT00669656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65297629|NCT00669656|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65297630|NCT00669656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297631|NCT00669656|Phytoestrogens|phytoestrogens|mesh-ancestor
65297632|NCT00669656|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65297633|NCT00669656|Estrogens|estrogens|mesh-ancestor
65297634|NCT00669656|Hormones|hormones|mesh-ancestor
65297635|NCT00669656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65297636|NCT00672776|Paroxetine|paroxetine|mesh-list
65297637|NCT00672776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65297638|NCT00672776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65297639|NCT00672776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65297640|NCT00672776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297641|NCT00672776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65297642|NCT00672776|Serotonin Agents|serotonin agents|mesh-ancestor
65297643|NCT00672776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297644|NCT00672776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65297645|NCT00672776|Antidepressive Agents|antidepressive agents|mesh-ancestor
65297646|NCT00672776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65297647|NCT00672776|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65297648|NCT00672776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65297649|NCT00672776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297650|NCT00616187|Interferons|interferons|mesh-list
65297651|NCT00616187|Interferon-beta|interferon-beta|mesh-list
65297652|NCT00616187|Atorvastatin|atorvastatin|mesh-list
65297653|NCT00616187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125730|NCT00562406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125741|NCT04588935|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65125742|NCT04588935|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65125743|NCT04588935|Adrenergic Agents|adrenergic agents|mesh-ancestor
65125744|NCT04588935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65222814|NCT05572684|Pembrolizumab|pembrolizumab|mesh-list
65297654|NCT00616187|Antiviral Agents|antiviral agents|mesh-ancestor
65297655|NCT00616187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65297656|NCT00616187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65297657|NCT00616187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65297658|NCT00616187|Antimetabolites|antimetabolites|mesh-ancestor
65297659|NCT00616187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297660|NCT00616187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64527856|NCT04574232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65125745|NCT04588935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125746|NCT04588935|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65125747|NCT04588935|Protease Inhibitors|protease inhibitors|mesh-ancestor
65125748|NCT04588935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125750|NCT00562523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125751|NCT00562523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65125752|NCT00562523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125753|NCT00562523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125754|NCT00562640|Cyclophosphamide|cyclophosphamide|mesh-list
65125755|NCT00562640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65125756|NCT00562640|Immunologic Factors|immunologic factors|mesh-ancestor
65125757|NCT00562640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125758|NCT00562640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65125759|NCT00562640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65125760|NCT00562640|Alkylating Agents|alkylating agents|mesh-ancestor
65125761|NCT00562640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125762|NCT00562640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125763|NCT00562640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65125764|NCT04649697|Clobetasol|clobetasol|mesh-list
65125765|NCT04649697|Rebamipide|rebamipide|mesh-list
65125766|NCT04649697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65125767|NCT04649697|Glucocorticoids|glucocorticoids|mesh-ancestor
65125768|NCT04649697|Hormones|hormones|mesh-ancestor
65125769|NCT04649697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65125770|NCT04649697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125771|NCT04649697|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65125772|NCT04649697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65125773|NCT04649697|Antioxidants|antioxidants|mesh-ancestor
65125774|NCT04649697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125775|NCT04649697|Protective Agents|protective agents|mesh-ancestor
65125776|NCT04649697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125777|NCT04649502|Metformin|metformin|mesh-list
65125778|NCT04649502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65125779|NCT04649502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125780|NCT04621253|Dipyrone|dipyrone|mesh-list
65125781|NCT04621253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65125782|NCT04621253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65125783|NCT04621253|Analgesics|analgesics|mesh-ancestor
65125784|NCT04621253|Sensory System Agents|sensory system agents|mesh-ancestor
65125785|NCT04621253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125786|NCT04621253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125787|NCT04621253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65125788|NCT04621253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65125789|NCT04621253|Antipyretics|antipyretics|mesh-ancestor
65125790|NCT00567762|Tacrolimus|tacrolimus|mesh-list
65125791|NCT00567762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65125792|NCT00567762|Immunologic Factors|immunologic factors|mesh-ancestor
65125793|NCT00567762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698195|NCT04211909|Sofosbuvir|sofosbuvir|mesh-list
65125809|NCT04691063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65125810|NCT04691063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65125811|NCT04691063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65125812|NCT04691063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125813|NCT04691063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125814|NCT05096702|Primaquine|primaquine|mesh-list
65125815|NCT05096702|Tafenoquine|tafenoquine|mesh-list
65125816|NCT05096702|Antimalarials|antimalarials|mesh-ancestor
65125817|NCT05096702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65297661|NCT00616187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65297662|NCT00616187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297663|NCT00616187|Immunologic Factors|immunologic factors|mesh-ancestor
65297664|NCT00616187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297665|NCT00663338|Rotigotine|rotigotine|mesh-list
65297666|NCT00663338|Dopamine Agonists|dopamine agonists|mesh-ancestor
65297667|NCT00663338|Dopamine Agents|dopamine agents|mesh-ancestor
65297668|NCT00663338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64527863|NCT05071716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64527870|NCT04557384|Ramucirumab|ramucirumab|mesh-list
65125818|NCT05096702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65125819|NCT05096702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65125820|NCT01151215|Anastrozole|anastrozole|mesh-list
65125821|NCT01151215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65125822|NCT01151215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125823|NCT01151215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65125824|NCT01151215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65125825|NCT01151215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125826|NCT01151215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125827|NCT01151215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65125828|NCT01151215|Hormone Antagonists|hormone antagonists|mesh-ancestor
65125829|NCT01151215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65125830|NCT01151215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125831|NCT04588389|Lidocaine|lidocaine|mesh-list
65125832|NCT04588389|Ropivacaine|ropivacaine|mesh-list
65125833|NCT04588389|Anesthetics, Local|anesthetics, local|mesh-ancestor
65125834|NCT04588389|Anesthetics|anesthetics|mesh-ancestor
65125835|NCT04588389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65125836|NCT04588389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125837|NCT04588389|Sensory System Agents|sensory system agents|mesh-ancestor
65125838|NCT04588389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125839|NCT04588389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65125840|NCT04588389|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65125841|NCT04588389|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65125842|NCT04588389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65125843|NCT04588389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125844|NCT00637234|Oxcarbazepine|oxcarbazepine|mesh-list
65125845|NCT00637234|Anticonvulsants|anticonvulsants|mesh-ancestor
65125846|NCT00637234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65125847|NCT00637234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65125848|NCT00637234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65125849|NCT00637234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125850|NCT00637234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65125885|NCT01151098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125886|NCT01151098|Analgesics|analgesics|mesh-ancestor
65125887|NCT01151098|Sensory System Agents|sensory system agents|mesh-ancestor
65125888|NCT01151098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125889|NCT01151098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64514214|NCT02282319|Anesthetics, Local|anesthetics, local|mesh-ancestor
65125890|NCT04587843|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
65125904|NCT04587843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125906|NCT04587843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65125907|NCT04587843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65125908|NCT04587843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65125909|NCT04587843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125910|NCT04587843|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65125911|NCT04619303|Dexamethasone|dexamethasone|mesh-list
65125912|NCT04619303|Bevacizumab|bevacizumab|mesh-list
65125913|NCT04619303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65125914|NCT04619303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125915|NCT04619303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65125916|NCT04619303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65297669|NCT00663338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297670|NCT00663338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297671|NCT02992015|Gemcitabine|gemcitabine|mesh-list
65297672|NCT02992015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65297673|NCT02992015|Antimetabolites|antimetabolites|mesh-ancestor
65297674|NCT02992015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297675|NCT02992015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297676|NCT02992015|Antiviral Agents|antiviral agents|mesh-ancestor
65297677|NCT02992015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65297678|NCT02992015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125917|NCT04619303|Growth Substances|growth substances|mesh-ancestor
65125918|NCT04619303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125919|NCT04619303|Growth Inhibitors|growth inhibitors|mesh-ancestor
65125920|NCT04619303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65125921|NCT04619303|Antiemetics|antiemetics|mesh-ancestor
65125922|NCT04619303|Autonomic Agents|autonomic agents|mesh-ancestor
65125923|NCT04619303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125924|NCT04619303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65125925|NCT04619303|Glucocorticoids|glucocorticoids|mesh-ancestor
65125926|NCT04619303|Hormones|hormones|mesh-ancestor
65125927|NCT04619303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65125928|NCT04619303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65125929|NCT04619537|Docetaxel|docetaxel|mesh-list
65125930|NCT04619537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125931|NCT04619537|Tubulin Modulators|tubulin modulators|mesh-ancestor
65125932|NCT04619537|Antimitotic Agents|antimitotic agents|mesh-ancestor
65125933|NCT04619537|Mitosis Modulators|mitosis modulators|mesh-ancestor
65125934|NCT04619537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125935|NCT04619381|Clopidogrel|clopidogrel|mesh-list
65125936|NCT04619381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65125937|NCT04619381|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65125938|NCT04619381|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65125939|NCT04619381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65125940|NCT04619381|Purinergic Agents|purinergic agents|mesh-ancestor
65125941|NCT04619381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65125942|NCT04619381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125943|NCT04619381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125944|NCT00568503|Bromides|bromides|mesh-list
65125945|NCT00568503|Tiotropium Bromide|tiotropium bromide|mesh-list
65125946|NCT00568503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65125947|NCT00568503|Autonomic Agents|autonomic agents|mesh-ancestor
65125948|NCT00568503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125949|NCT00568503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125950|NCT00568503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64698379|NCT03504410|Etoposide|etoposide|mesh-list
65125988|NCT04586790|Adrenergic Agents|adrenergic agents|mesh-ancestor
65125989|NCT04586790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65125990|NCT04586790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125991|NCT04586790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125992|NCT04586790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65125993|NCT04586790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65126004|NCT04586790|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65126005|NCT04586790|Natriuretic Agents|natriuretic agents|mesh-ancestor
65126006|NCT00568815|Rituximab|rituximab|mesh-list
65126007|NCT00568815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65126008|NCT00568815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126009|NCT00568815|Immunologic Factors|immunologic factors|mesh-ancestor
65126010|NCT00568815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126011|NCT00568815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65126012|NCT00568893|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
65126013|NCT00568893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65126014|NCT00568971|Docetaxel|docetaxel|mesh-list
65126015|NCT00568971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297679|NCT02992015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65297680|NCT02992015|Immunologic Factors|immunologic factors|mesh-ancestor
65297681|NCT02992015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297682|NCT01009567|Cabergoline|cabergoline|mesh-list
65297683|NCT01009567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65297684|NCT01009567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65297685|NCT01009567|Dopamine Agonists|dopamine agonists|mesh-ancestor
65297686|NCT01009567|Dopamine Agents|dopamine agents|mesh-ancestor
64930050|NCT00049114|Doxorubicin|doxorubicin|mesh-list
65126016|NCT00568971|Tubulin Modulators|tubulin modulators|mesh-ancestor
65126017|NCT00568971|Antimitotic Agents|antimitotic agents|mesh-ancestor
65126018|NCT00568971|Mitosis Modulators|mitosis modulators|mesh-ancestor
65126019|NCT00568971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126020|NCT00562913|Sorafenib|sorafenib|mesh-list
65126021|NCT00562913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126022|NCT00562913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65126023|NCT00562913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126024|NCT00562913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126025|NCT00569088|Mannitol|mannitol|mesh-list
65126026|NCT00569088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65126027|NCT00569088|Diuretics|diuretics|mesh-ancestor
65126028|NCT00569088|Natriuretic Agents|natriuretic agents|mesh-ancestor
65126029|NCT00569088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126030|NCT04586088|Apatinib|apatinib|mesh-list
65126031|NCT04586088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126032|NCT04586088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65126033|NCT04586088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126034|NCT04586088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126035|NCT00569244|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65126036|NCT00569244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65126037|NCT00569244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126039|NCT04586361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65126040|NCT04586361|Immunologic Factors|immunologic factors|mesh-ancestor
65126041|NCT04586361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126042|NCT04586361|Viscosupplements|viscosupplements|mesh-ancestor
65126043|NCT04586361|Protective Agents|protective agents|mesh-ancestor
65126045|NCT04618952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65126046|NCT04618952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126047|NCT04619069|Hormones|hormones|mesh-list
65126048|NCT04619069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65126049|NCT04619069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126050|NCT04585932|Leuprolide|leuprolide|mesh-list
65126051|NCT04585932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65126052|NCT04585932|Fertility Agents|fertility agents|mesh-ancestor
65126053|NCT04585932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65126054|NCT04585932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126055|NCT04585932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65126056|NCT04585932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126057|NCT00569400|Insulin|insulin|mesh-list
65126058|NCT00569400|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65126059|NCT00569400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65126060|NCT00569400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126061|NCT04618367|Lenvatinib|lenvatinib|mesh-list
65126078|NCT00562952|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65126079|NCT00562952|Adrenergic Agents|adrenergic agents|mesh-ancestor
65126080|NCT00562952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65126081|NCT05035316|Aspirin|aspirin|mesh-list
65126082|NCT05035316|Calcium|calcium|mesh-list
65126083|NCT05035316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65126084|NCT05035316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126085|NCT05035316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65126086|NCT05035316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65126087|NCT05035316|Analgesics|analgesics|mesh-ancestor
65126088|NCT05035316|Sensory System Agents|sensory system agents|mesh-ancestor
65126089|NCT05035316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65126090|NCT05035316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65126091|NCT05035316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65297687|NCT01009567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65297688|NCT01009567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297689|NCT01009567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297690|NCT00669812|Cytarabine|cytarabine|mesh-list
65297691|NCT00669812|Prednisolone|prednisolone|mesh-list
65297692|NCT00669812|Cyclophosphamide|cyclophosphamide|mesh-list
65297693|NCT00669812|Melphalan|melphalan|mesh-list
65297694|NCT00669812|Ifosfamide|ifosfamide|mesh-list
65126092|NCT05035316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65126093|NCT05035316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65126094|NCT05035316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126095|NCT05035316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65126096|NCT05035316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65126097|NCT05035316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126098|NCT05035316|Antipyretics|antipyretics|mesh-ancestor
65126099|NCT04618601|Spironolactone|spironolactone|mesh-list
65126100|NCT04618601|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65126101|NCT04618601|Hormone Antagonists|hormone antagonists|mesh-ancestor
65126102|NCT04618601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64768449|NCT01028820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65126103|NCT04618601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126104|NCT04618601|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65126105|NCT04618601|Diuretics|diuretics|mesh-ancestor
65126106|NCT04618601|Natriuretic Agents|natriuretic agents|mesh-ancestor
65126107|NCT00567918|Tacrolimus|tacrolimus|mesh-list
65126108|NCT00567918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65126109|NCT00567918|Immunologic Factors|immunologic factors|mesh-ancestor
65126110|NCT00567918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126111|NCT00567918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65126112|NCT00567918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126113|NCT00567918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126114|NCT00569712|Budesonide|budesonide|mesh-list
65126115|NCT00569712|Formoterol Fumarate|formoterol fumarate|mesh-list
65126116|NCT00569712|Dimercaprol|dimercaprol|mesh-list
65126147|NCT00569790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65126149|NCT00569790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126150|NCT00569790|Growth Inhibitors|growth inhibitors|mesh-ancestor
65126151|NCT00569790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65126152|NCT00569790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65126153|NCT00569790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126154|NCT00569790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126155|NCT00567957|Remifentanil|remifentanil|mesh-list
65126156|NCT00567957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65126157|NCT00567957|Narcotics|narcotics|mesh-ancestor
65126158|NCT00567957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65126185|NCT04617782|Nootropic Agents|nootropic agents|mesh-ancestor
65126186|NCT00569985|Cyclophosphamide|cyclophosphamide|mesh-list
65126187|NCT00569985|Carmustine|carmustine|mesh-list
65126188|NCT00569985|Etoposide|etoposide|mesh-list
65126189|NCT00569985|Etoposide phosphate|etoposide phosphate|mesh-list
65126190|NCT00569985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65126191|NCT00569985|Immunologic Factors|immunologic factors|mesh-ancestor
65126192|NCT00569985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126193|NCT00569985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65126194|NCT00569985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65126195|NCT00569985|Alkylating Agents|alkylating agents|mesh-ancestor
65126196|NCT00569985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126197|NCT00569985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126198|NCT00569985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65126199|NCT00569985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65126200|NCT00569985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65126201|NCT00569985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65126202|NCT00569985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126203|NCT04617626|Azithromycin|azithromycin|mesh-list
65126204|NCT04617626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65126205|NCT04617626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65126206|NCT04585230|Mineral Oil|mineral oil|mesh-list
65126207|NCT04585230|Emollients|emollients|mesh-ancestor
65297695|NCT00669812|Carmustine|carmustine|mesh-list
65297696|NCT00669812|Doxorubicin|doxorubicin|mesh-list
65297697|NCT00669812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65297698|NCT00669812|Methotrexate|methotrexate|mesh-list
65297699|NCT00669812|Etoposide|etoposide|mesh-list
65297700|NCT00669812|Vincristine|vincristine|mesh-list
65297701|NCT00669812|Epirubicin|epirubicin|mesh-list
65297702|NCT00669812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65297703|NCT00669812|Immunologic Factors|immunologic factors|mesh-ancestor
65297704|NCT00669812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297705|NCT00669812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65297706|NCT00669812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65297707|NCT00669812|Alkylating Agents|alkylating agents|mesh-ancestor
65297708|NCT00669812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297709|NCT00669812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297710|NCT00669812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65297711|NCT00669812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65297712|NCT00669812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65297713|NCT00669812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64527903|NCT05039736|Nivolumab|nivolumab|mesh-list
65126236|NCT00570375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65126238|NCT00570375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126239|NCT00568074|Repaglinide|repaglinide|mesh-list
65126240|NCT00568074|Acarbose|acarbose|mesh-list
65126241|NCT00568074|Gliquidone|gliquidone|mesh-list
65126242|NCT00568074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65126243|NCT00568074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126244|NCT00568074|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65126245|NCT00568074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126246|NCT00568074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126247|NCT00568113|Acetylcysteine|acetylcysteine|mesh-list
65126248|NCT00568113|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65126249|NCT00568113|Antiviral Agents|antiviral agents|mesh-ancestor
65126250|NCT00568113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65126251|NCT00568113|Expectorants|expectorants|mesh-ancestor
65126252|NCT00568113|Respiratory System Agents|respiratory system agents|mesh-ancestor
65126253|NCT00568113|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65126268|NCT00568152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65126269|NCT00568152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65126270|NCT00568152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126271|NCT00568152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65126272|NCT00568152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65126273|NCT00568152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126274|NCT00568152|Antipyretics|antipyretics|mesh-ancestor
65126275|NCT04610879|Carbamazepine|carbamazepine|mesh-list
65126276|NCT04610879|Levetiracetam|levetiracetam|mesh-list
65126277|NCT04610879|Anticonvulsants|anticonvulsants|mesh-ancestor
65126278|NCT04610879|Nootropic Agents|nootropic agents|mesh-ancestor
65126279|NCT04610879|Antimanic Agents|antimanic agents|mesh-ancestor
65126280|NCT04610879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65126281|NCT04610879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65126282|NCT04610879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126283|NCT04610879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65126284|NCT04610879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65126285|NCT04610879|Analgesics|analgesics|mesh-ancestor
65126286|NCT04610879|Sensory System Agents|sensory system agents|mesh-ancestor
65126287|NCT04610879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65126288|NCT04610879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65297714|NCT00669812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297715|NCT00669812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65297716|NCT00669812|Abortifacient Agents|abortifacient agents|mesh-ancestor
65297717|NCT00669812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65297718|NCT00669812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65297719|NCT00669812|Antimetabolites|antimetabolites|mesh-ancestor
65297720|NCT00669812|Dermatologic Agents|dermatologic agents|mesh-ancestor
65297721|NCT00669812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65297722|NCT00669812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65297723|NCT00669812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65297724|NCT00669812|Antiviral Agents|antiviral agents|mesh-ancestor
65297725|NCT00669812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65297726|NCT00669812|Tubulin Modulators|tubulin modulators|mesh-ancestor
65297727|NCT00669812|Antimitotic Agents|antimitotic agents|mesh-ancestor
65126289|NCT04610879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65126290|NCT04610879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126291|NCT04610879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65126292|NCT04610879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65126293|NCT04616729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65126294|NCT04616729|Luteolytic Agents|luteolytic agents|mesh-ancestor
65126295|NCT04616729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65126296|NCT04616729|Contraceptive Agents|contraceptive agents|mesh-ancestor
65126297|NCT04616729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65126298|NCT04616729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126299|NCT04616729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65126300|NCT04616729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65126301|NCT04616729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126302|NCT00570648|Hyaluronic Acid|hyaluronic acid|mesh-list
65126303|NCT00570648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65126304|NCT00570648|Immunologic Factors|immunologic factors|mesh-ancestor
65126305|NCT00570648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126306|NCT00570648|Viscosupplements|viscosupplements|mesh-ancestor
65126307|NCT00570648|Protective Agents|protective agents|mesh-ancestor
65126308|NCT00570726|Ranibizumab|ranibizumab|mesh-list
65126309|NCT00570726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65126310|NCT00570726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65126311|NCT00570726|Growth Substances|growth substances|mesh-ancestor
65126312|NCT00570726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126313|NCT00570726|Growth Inhibitors|growth inhibitors|mesh-ancestor
65126326|NCT00563069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65126327|NCT00563069|Anesthetics, General|anesthetics, general|mesh-ancestor
65126330|NCT00563069|GABA Agents|gaba agents|mesh-ancestor
65126331|NCT00563069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65126332|NCT00563069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126333|NCT04580355|Amoxicillin|amoxicillin|mesh-list
65126334|NCT04580355|Metronidazole|metronidazole|mesh-list
65126335|NCT04580355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65126336|NCT04580355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65126337|NCT04580355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65126338|NCT04580355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65126339|NCT00563108|Basiliximab|basiliximab|mesh-list
65126340|NCT00563108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65126341|NCT00563108|Immunologic Factors|immunologic factors|mesh-ancestor
65126342|NCT00563108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126343|NCT00570882|Sunitinib|sunitinib|mesh-list
65126344|NCT00570882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126345|NCT00570882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65126346|NCT00570882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65126347|NCT00570882|Growth Substances|growth substances|mesh-ancestor
65126348|NCT00570882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297728|NCT00669812|Mitosis Modulators|mitosis modulators|mesh-ancestor
65297729|NCT00669812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65297730|NCT00669812|Glucocorticoids|glucocorticoids|mesh-ancestor
65297731|NCT00669812|Hormones|hormones|mesh-ancestor
65297732|NCT00669812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65297733|NCT00669812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65297734|NCT02697851|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65297735|NCT02697851|Cobicistat|cobicistat|mesh-list
65297736|NCT02697851|Levonorgestrel|levonorgestrel|mesh-list
65297737|NCT02697851|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65297738|NCT02697851|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65297739|NCT02697851|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
65297740|NCT02697851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65297741|NCT02697851|Contraceptive Agents|contraceptive agents|mesh-ancestor
65297742|NCT02697851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64527929|NCT03160404|Zolpidem|zolpidem|mesh-list
64527931|NCT03160404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65126349|NCT00570882|Growth Inhibitors|growth inhibitors|mesh-ancestor
65126350|NCT00570882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65126351|NCT00570882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126352|NCT00570882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126353|NCT00563147|Sirolimus|sirolimus|mesh-list
65126354|NCT00563147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65126355|NCT00563147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65126356|NCT00563147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65126357|NCT00563147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126358|NCT00563147|Antifungal Agents|antifungal agents|mesh-ancestor
65126359|NCT00563147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65126360|NCT00563147|Immunologic Factors|immunologic factors|mesh-ancestor
65126361|NCT00563147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126362|NCT00570999|Mitogens|mitogens|mesh-list
65126363|NCT00570999|Mitosis Modulators|mitosis modulators|mesh-ancestor
65126364|NCT00570999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126365|NCT04616261|Formoterol Fumarate|formoterol fumarate|mesh-list
65126366|NCT04616261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65126367|NCT04616261|Autonomic Agents|autonomic agents|mesh-ancestor
65126368|NCT04616261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65126369|NCT04616261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126380|NCT00563225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126381|NCT00571116|Arsenic Trioxide|arsenic trioxide|mesh-list
65126382|NCT00571116|Disulfiram|disulfiram|mesh-list
65126383|NCT00571116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126384|NCT00571116|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65126385|NCT00571116|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65126386|NCT00571116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126387|NCT00571116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126388|NCT00571155|Levetiracetam|levetiracetam|mesh-list
65126389|NCT00571155|Anticonvulsants|anticonvulsants|mesh-ancestor
65126390|NCT00571155|Nootropic Agents|nootropic agents|mesh-ancestor
65126391|NCT04615481|Metronidazole|metronidazole|mesh-list
65126392|NCT04615481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65126393|NCT04615481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65126394|NCT04615481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65126395|NCT04615481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65126396|NCT04615403|Travoprost|travoprost|mesh-list
65126397|NCT04615403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65126398|NCT04614584|Mirtazapine|mirtazapine|mesh-list
64537522|NCT02130063|Iron|iron|mesh-list
65126399|NCT04614584|Methamphetamine|methamphetamine|mesh-list
65297743|NCT02697851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297744|NCT02697851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65297745|NCT02697851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65297746|NCT02697851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65297747|NCT02697851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65297748|NCT02697851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65297749|NCT02697851|Protease Inhibitors|protease inhibitors|mesh-ancestor
65297750|NCT02697851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297751|NCT02697851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297752|NCT02697851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65126400|NCT04614584|Antidepressive Agents|antidepressive agents|mesh-ancestor
65126401|NCT04614584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65126402|NCT04614584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65126403|NCT04614584|Histamine Antagonists|histamine antagonists|mesh-ancestor
65126404|NCT04614584|Histamine Agents|histamine agents|mesh-ancestor
65126405|NCT04614584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65126406|NCT04614584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126407|NCT04614584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126408|NCT04614584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65126409|NCT04614584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65126410|NCT04614584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65126411|NCT04614584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65126412|NCT04614584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65126413|NCT04614584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65126414|NCT04614584|Adrenergic Agents|adrenergic agents|mesh-ancestor
65126415|NCT04614584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65126416|NCT04614584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65126417|NCT04614584|Serotonin Agents|serotonin agents|mesh-ancestor
65126418|NCT04614584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65126419|NCT04614584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65126420|NCT04614584|Sympathomimetics|sympathomimetics|mesh-ancestor
65126421|NCT04614584|Autonomic Agents|autonomic agents|mesh-ancestor
65126422|NCT04614584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65126423|NCT04614584|Dopamine Agents|dopamine agents|mesh-ancestor
65126424|NCT04614584|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65126425|NCT04614584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65126426|NCT04614584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65126427|NCT04614584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65126429|NCT00563303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65126430|NCT00571506|Pioglitazone|pioglitazone|mesh-list
65126431|NCT00571506|Rosiglitazone|rosiglitazone|mesh-list
65126432|NCT00571506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65126433|NCT00571506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698863|NCT03836833|Lamivudine|lamivudine|mesh-list
65126458|NCT00571740|Oxaliplatin|oxaliplatin|mesh-list
65126459|NCT00571740|Calcium|calcium|mesh-list
65126460|NCT00571740|Levoleucovorin|levoleucovorin|mesh-list
65126461|NCT00571740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65126462|NCT00571740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126463|NCT00571740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65126464|NCT00571740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65126465|NCT00571740|Growth Substances|growth substances|mesh-ancestor
65126466|NCT00571740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126467|NCT00571740|Growth Inhibitors|growth inhibitors|mesh-ancestor
65126468|NCT00571740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65126469|NCT00571740|Antimetabolites|antimetabolites|mesh-ancestor
65126470|NCT00571740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126471|NCT00571740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65126472|NCT00571740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64659384|NCT00364143|Irinotecan|irinotecan|mesh-list
65126473|NCT00571740|Immunologic Factors|immunologic factors|mesh-ancestor
65126474|NCT00571740|Antidotes|antidotes|mesh-ancestor
65126475|NCT00571740|Protective Agents|protective agents|mesh-ancestor
65297753|NCT02697851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65297754|NCT02697851|Antiviral Agents|antiviral agents|mesh-ancestor
65297755|NCT02697851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65297756|NCT02697851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65297757|NCT02697851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65297758|NCT02697851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65297759|NCT02697851|Estrogens|estrogens|mesh-ancestor
65297760|NCT02697851|Hormones|hormones|mesh-ancestor
65297761|NCT02697851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65297762|NCT02697851|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65297763|NCT02697851|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
65297764|NCT02697851|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65297765|NCT02697851|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65297766|NCT01012843|Amoxicillin|amoxicillin|mesh-list
65297767|NCT01012843|Clavulanic Acid|clavulanic acid|mesh-list
65297768|NCT01012843|Clavulanic Acids|clavulanic acids|mesh-list
65297769|NCT01012843|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65297770|NCT01012843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65297771|NCT01012843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64527973|NCT04036188|Glucocorticoids|glucocorticoids|mesh-ancestor
65126476|NCT00571740|Vitamin B Complex|vitamin b complex|mesh-ancestor
65126477|NCT00571740|Vitamins|vitamins|mesh-ancestor
65126478|NCT00571740|Micronutrients|micronutrients|mesh-ancestor
65126479|NCT00563342|Ethanol|ethanol|mesh-list
65126480|NCT00563342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65126481|NCT00563342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65126482|NCT00563342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65126483|NCT00563342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126484|NCT04583046|Iloprost|iloprost|mesh-list
65126485|NCT04583046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65126499|NCT04613726|Autonomic Agents|autonomic agents|mesh-ancestor
65126500|NCT04613726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65126501|NCT04613726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126502|NCT04613726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65126503|NCT04613726|Antipruritics|antipruritics|mesh-ancestor
65126504|NCT04613726|Dermatologic Agents|dermatologic agents|mesh-ancestor
65126505|NCT04613726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65126506|NCT04613726|Serotonin Agents|serotonin agents|mesh-ancestor
65126507|NCT04613726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65126508|NCT04613726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126509|NCT04613726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65126510|NCT04613726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65126511|NCT04613726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65126512|NCT04613726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65126513|NCT04613726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65126514|NCT04613804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65126515|NCT04613804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126516|NCT04613804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126517|NCT04613102|Cannabidiol|cannabidiol|mesh-list
65126518|NCT04613102|Anticonvulsants|anticonvulsants|mesh-ancestor
65126519|NCT04613219|Tofacitinib|tofacitinib|mesh-list
65126520|NCT04613219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65126521|NCT04613219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297772|NCT01012843|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65297773|NCT01012843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297774|NCT01012843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297775|NCT00669890|Mycophenolic Acid|mycophenolic acid|mesh-list
65297776|NCT00669890|Cyclophosphamide|cyclophosphamide|mesh-list
65297778|NCT00669890|Methotrexate|methotrexate|mesh-list
65297779|NCT00669890|Gemtuzumab|gemtuzumab|mesh-list
65297780|NCT00669890|Tacrolimus|tacrolimus|mesh-list
65297781|NCT00669890|Thymoglobulin|thymoglobulin|mesh-list
65297782|NCT00669890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65297783|NCT00669890|Immunologic Factors|immunologic factors|mesh-ancestor
65297784|NCT00669890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297785|NCT00669890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65297786|NCT00669890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65297787|NCT00669890|Alkylating Agents|alkylating agents|mesh-ancestor
65297788|NCT00669890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297789|NCT00669890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297790|NCT00669890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65297791|NCT00669890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65297792|NCT00669890|Abortifacient Agents|abortifacient agents|mesh-ancestor
65297793|NCT00669890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65297794|NCT00669890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65297795|NCT00669890|Antimetabolites|antimetabolites|mesh-ancestor
65297796|NCT00669890|Dermatologic Agents|dermatologic agents|mesh-ancestor
65297797|NCT00669890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297798|NCT00669890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65297799|NCT00669890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65297800|NCT00669890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64528006|NCT02135874|Clofarabine|clofarabine|mesh-list
65126522|NCT04613219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126523|NCT00563615|Tegaserod|tegaserod|mesh-list
65126524|NCT00563615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65126525|NCT00563615|Serotonin Agents|serotonin agents|mesh-ancestor
65126526|NCT00563615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65126527|NCT00563615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126528|NCT00563615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126529|NCT00563654|Alfuzosin|alfuzosin|mesh-list
65126530|NCT00563654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65126531|NCT00563654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65126532|NCT00563654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65126533|NCT00563654|Adrenergic Agents|adrenergic agents|mesh-ancestor
65126534|NCT00563654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65126535|NCT00563654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126536|NCT00563654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297801|NCT00669890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65297802|NCT00669890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65297803|NCT00669890|Antitubercular Agents|antitubercular agents|mesh-ancestor
65297804|NCT00669890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65297805|NCT00669890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65297806|NCT00669890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65297807|NCT02697929|Neostigmine|neostigmine|mesh-list
65297808|NCT02697929|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64528036|NCT02135874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65126537|NCT00563654|Urological Agents|urological agents|mesh-ancestor
65126538|NCT04613180|Montelukast|montelukast|mesh-list
65126539|NCT04613180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65126540|NCT04613180|Respiratory System Agents|respiratory system agents|mesh-ancestor
65126541|NCT04613180|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64768898|NCT05821062|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64768899|NCT05821062|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64768900|NCT05821062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768901|NCT05821062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65126550|NCT00571935|Insulin Aspart|insulin aspart|mesh-list
65126551|NCT00571935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65126552|NCT00571935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126553|NCT00572013|Rituximab|rituximab|mesh-list
65126554|NCT00572013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65126555|NCT00572013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126556|NCT00572013|Immunologic Factors|immunologic factors|mesh-ancestor
65126557|NCT00572013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126558|NCT00572013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65126559|NCT04612634|Vaccines|vaccines|mesh-list
65126560|NCT04612634|Immunologic Factors|immunologic factors|mesh-ancestor
65126561|NCT04612634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126562|NCT04612556|Vaccines|vaccines|mesh-list
65126563|NCT04612556|Immunologic Factors|immunologic factors|mesh-ancestor
65126564|NCT04612556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126565|NCT04580199|Ethanol|ethanol|mesh-list
65126566|NCT04580199|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65126567|NCT04580199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65126568|NCT04580199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65126569|NCT04580199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126570|NCT00568347|Fluticasone|fluticasone|mesh-list
65126571|NCT00568347|Xhance|xhance|mesh-list
65126572|NCT00568347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65126573|NCT00568347|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65126574|NCT00568347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65126575|NCT00568347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65126576|NCT00568347|Autonomic Agents|autonomic agents|mesh-ancestor
65126577|NCT00568347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65126578|NCT00568347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126579|NCT00568347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65126580|NCT00568347|Respiratory System Agents|respiratory system agents|mesh-ancestor
65126581|NCT00568347|Dermatologic Agents|dermatologic agents|mesh-ancestor
65126582|NCT00568347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65126583|NCT00568347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65126584|NCT00568347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65126585|NCT00568347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65126586|NCT00568347|Adrenergic Agents|adrenergic agents|mesh-ancestor
65126587|NCT00568347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65126588|NCT00568347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126589|NCT00568347|Glucocorticoids|glucocorticoids|mesh-ancestor
65126590|NCT00568347|Hormones|hormones|mesh-ancestor
65126591|NCT00568347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65126592|NCT00568347|Sympathomimetics|sympathomimetics|mesh-ancestor
65126593|NCT04611971|Belimumab|belimumab|mesh-list
65126594|NCT04611971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65126595|NCT04611971|Immunologic Factors|immunologic factors|mesh-ancestor
65126596|NCT04611971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126597|NCT00572208|Gabapentin|gabapentin|mesh-list
65297809|NCT02697929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297810|NCT02697929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297811|NCT02697929|Cholinergic Agents|cholinergic agents|mesh-ancestor
65297812|NCT02697929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65297813|NCT02697929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297814|NCT02697929|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65297815|NCT02697929|Autonomic Agents|autonomic agents|mesh-ancestor
65297816|NCT02697929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65297817|NCT00505375|Abatacept|abatacept|mesh-list
65297818|NCT00505375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65297819|NCT00505375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297820|NCT00505375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297821|NCT00505375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65297822|NCT00505375|Immunologic Factors|immunologic factors|mesh-ancestor
65297823|NCT00505375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297824|NCT00505375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65297825|NCT02700347|Pyrazinamide|pyrazinamide|mesh-list
65297826|NCT02700347|Allopurinol|allopurinol|mesh-list
65297827|NCT02700347|Antimetabolites|antimetabolites|mesh-ancestor
65297828|NCT02700347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297829|NCT02700347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297830|NCT02700347|Gout Suppressants|gout suppressants|mesh-ancestor
65297831|NCT02700347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65297832|NCT02700347|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65297833|NCT02700347|Antioxidants|antioxidants|mesh-ancestor
64528044|NCT01531205|Leuprolide|leuprolide|mesh-list
65126598|NCT00572208|Analgesics|analgesics|mesh-ancestor
65126599|NCT00572208|Sensory System Agents|sensory system agents|mesh-ancestor
65126600|NCT00572208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65126601|NCT00572208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126602|NCT00572208|Anticonvulsants|anticonvulsants|mesh-ancestor
64699032|NCT01634178|Analgesics|analgesics|mesh-ancestor
65126615|NCT00572364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126616|NCT00572364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126618|NCT00563771|Gout Suppressants|gout suppressants|mesh-ancestor
65126619|NCT00563771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65126620|NCT04582032|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65126621|NCT04582032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65126622|NCT04582032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65126623|NCT04582032|Analgesics|analgesics|mesh-ancestor
65126624|NCT04582032|Sensory System Agents|sensory system agents|mesh-ancestor
65126625|NCT04582032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65126626|NCT04582032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126627|NCT04582032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65126628|NCT04582032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65126629|NCT00563849|Leflunomide|leflunomide|mesh-list
65126630|NCT00563849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126631|NCT00563849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297834|NCT02700347|Protective Agents|protective agents|mesh-ancestor
65297835|NCT02700347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297836|NCT02700347|Antitubercular Agents|antitubercular agents|mesh-ancestor
65297837|NCT02700347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65297838|NCT02700347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65297839|NCT00594932|Mycophenolic Acid|mycophenolic acid|mesh-list
65297840|NCT00594932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65297841|NCT00594932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297842|NCT00594932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65297843|NCT00594932|Antitubercular Agents|antitubercular agents|mesh-ancestor
65297844|NCT00594932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65297845|NCT00594932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65297846|NCT00594932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297847|NCT00594932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297848|NCT00616889|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65297849|NCT00616889|Antidepressive Agents|antidepressive agents|mesh-ancestor
65126632|NCT00563849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65126633|NCT00563849|Immunologic Factors|immunologic factors|mesh-ancestor
65126634|NCT00563849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126635|NCT04581876|Paclitaxel|paclitaxel|mesh-list
65126636|NCT04581876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65126637|NCT04581876|Raltitrexed|raltitrexed|mesh-list
65126638|NCT04581876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65126639|NCT04581876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126640|NCT04581876|Tubulin Modulators|tubulin modulators|mesh-ancestor
65126641|NCT04581876|Antimitotic Agents|antimitotic agents|mesh-ancestor
65126642|NCT04581876|Mitosis Modulators|mitosis modulators|mesh-ancestor
65126643|NCT04581876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126644|NCT04581876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65126645|NCT04581876|Antimetabolites|antimetabolites|mesh-ancestor
65126646|NCT04581876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65126647|NCT04581876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126648|NCT00563927|Fluorouracil|fluorouracil|mesh-list
65126649|NCT00563927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126650|NCT00563927|Antimetabolites|antimetabolites|mesh-ancestor
65126651|NCT00563927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126652|NCT00563927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65126653|NCT00563927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65126654|NCT00563927|Immunologic Factors|immunologic factors|mesh-ancestor
65126655|NCT00563927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126656|NCT01150123|Vaccines|vaccines|mesh-list
65126657|NCT01150123|Immunologic Factors|immunologic factors|mesh-ancestor
65126658|NCT01150123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126659|NCT00572559|Vancomycin|vancomycin|mesh-list
65126660|NCT00572559|Linezolid|linezolid|mesh-list
65126661|NCT00572559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65126662|NCT00572559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65126663|NCT00572559|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65126664|NCT00572559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64699097|NCT02465450|Hormones|hormones|mesh-ancestor
65126693|NCT04611776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65126694|NCT04611776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65126696|NCT00572637|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
65126697|NCT00572637|Protease Inhibitors|protease inhibitors|mesh-ancestor
65126698|NCT00572637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126699|NCT00572637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126700|NCT01149655|Aripiprazole|aripiprazole|mesh-list
65126701|NCT01149655|Antidepressive Agents|antidepressive agents|mesh-ancestor
65126702|NCT01149655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65297850|NCT00616889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65297851|NCT00616889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65297852|NCT00616889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65297853|NCT00616889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65297854|NCT00616889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297856|NCT00673088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65297857|NCT00673088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65297858|NCT00673088|Dopamine Agonists|dopamine agonists|mesh-ancestor
65297859|NCT00673088|Dopamine Agents|dopamine agents|mesh-ancestor
65297860|NCT00673088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65297861|NCT00673088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297862|NCT00673088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297863|NCT00504829|Atorvastatin|atorvastatin|mesh-list
65297864|NCT00504829|Fenofibrate|fenofibrate|mesh-list
65297865|NCT00504829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65297866|NCT00504829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65126703|NCT01149655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65126704|NCT01149655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65126705|NCT01149655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65126706|NCT01149655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126707|NCT01149655|Dopamine Agonists|dopamine agonists|mesh-ancestor
65126708|NCT01149655|Dopamine Agents|dopamine agents|mesh-ancestor
65126709|NCT01149655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65126710|NCT01149655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126711|NCT01149655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64699160|NCT05648058|Anesthetics|anesthetics|mesh-ancestor
65126727|NCT00575406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65126728|NCT00575406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65126729|NCT00575406|Alkylating Agents|alkylating agents|mesh-ancestor
65126730|NCT00575406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126731|NCT00575406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126732|NCT00575406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65126733|NCT00575406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65126734|NCT00575406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65126735|NCT00575406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65126736|NCT00575406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65126737|NCT00575406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126738|NCT00575406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65126739|NCT00575406|Glucocorticoids|glucocorticoids|mesh-ancestor
65126740|NCT00575406|Hormones|hormones|mesh-ancestor
65126741|NCT00575406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65126742|NCT00575406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65126743|NCT00575406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65126744|NCT00575406|Tubulin Modulators|tubulin modulators|mesh-ancestor
65126745|NCT00575406|Antimitotic Agents|antimitotic agents|mesh-ancestor
65126746|NCT00575406|Mitosis Modulators|mitosis modulators|mesh-ancestor
65126747|NCT01149538|Choline|choline|mesh-list
65126748|NCT01149538|Lipotropic Agents|lipotropic agents|mesh-ancestor
65126749|NCT01149538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65126750|NCT01149538|Antimetabolites|antimetabolites|mesh-ancestor
65126751|NCT01149538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126752|NCT01149538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65126753|NCT01149538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65126754|NCT01149538|Nootropic Agents|nootropic agents|mesh-ancestor
65126755|NCT01149460|Valacyclovir|valacyclovir|mesh-list
65126756|NCT01149460|Antiviral Agents|antiviral agents|mesh-ancestor
64514238|NCT02766465|Antimetabolites|antimetabolites|mesh-ancestor
65126759|NCT00575523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65126760|NCT00575523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65297867|NCT00504829|Antimetabolites|antimetabolites|mesh-ancestor
65297868|NCT00504829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297869|NCT00504829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65297870|NCT00504829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65297871|NCT00504829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297872|NCT02701205|Etanercept|etanercept|mesh-list
65297873|NCT02701205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65297874|NCT02701205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65297875|NCT02701205|Analgesics|analgesics|mesh-ancestor
65297876|NCT02701205|Sensory System Agents|sensory system agents|mesh-ancestor
65297877|NCT02701205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64528099|NCT01528709|Antimetabolites|antimetabolites|mesh-ancestor
64528104|NCT01527383|Vaccines|vaccines|mesh-list
65126761|NCT00575523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65126762|NCT00575523|Autonomic Agents|autonomic agents|mesh-ancestor
65126763|NCT00575523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65126764|NCT00575523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126765|NCT00575523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65126766|NCT00575523|Respiratory System Agents|respiratory system agents|mesh-ancestor
65126768|NCT00575523|Parasympatholytics|parasympatholytics|mesh-ancestor
65126769|NCT00575523|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65126770|NCT00575523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65126771|NCT00575523|Cholinergic Agents|cholinergic agents|mesh-ancestor
65126772|NCT00575523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65126773|NCT00575523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126774|NCT01149421|Dulaglutide|dulaglutide|mesh-list
65126786|NCT04600271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65126788|NCT04600271|Analgesics|analgesics|mesh-list
65126789|NCT04600271|Diuretics|diuretics|mesh-list
65126790|NCT04600271|Sensory System Agents|sensory system agents|mesh-ancestor
65126791|NCT04600271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65126792|NCT04600271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126793|NCT04600271|Natriuretic Agents|natriuretic agents|mesh-ancestor
65126794|NCT04600271|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65126795|NCT04600271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65126796|NCT04600271|Adrenergic Agents|adrenergic agents|mesh-ancestor
65126797|NCT04600271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65126798|NCT04600271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126799|NCT04600271|Sympathomimetics|sympathomimetics|mesh-ancestor
65126800|NCT04600271|Autonomic Agents|autonomic agents|mesh-ancestor
65126801|NCT04600271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65126802|NCT04600271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65126803|NCT04600271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65126804|NCT00575640|Hydralazine|hydralazine|mesh-list
65126805|NCT00575640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65126806|NCT00575640|Vasodilator Agents|vasodilator agents|mesh-ancestor
65126807|NCT04599959|Hydrocortisone|hydrocortisone|mesh-list
65126808|NCT04599959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65126809|NCT04579731|Lactitol|lactitol|mesh-list
65126810|NCT04579731|Cathartics|cathartics|mesh-ancestor
65126811|NCT04579731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65126812|NCT00565487|Capecitabine|capecitabine|mesh-list
65126813|NCT00565487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65126814|NCT00565487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65126815|NCT00565487|Antimetabolites|antimetabolites|mesh-ancestor
65126816|NCT00565487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126817|NCT00565487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126818|NCT00565487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65126819|NCT00565487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126820|NCT04600115|Adenosine|adenosine|mesh-list
65126821|NCT04600115|Regadenoson|regadenoson|mesh-list
65126822|NCT04600115|Analgesics|analgesics|mesh-ancestor
65126823|NCT04600115|Sensory System Agents|sensory system agents|mesh-ancestor
65297878|NCT02701205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297879|NCT02701205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65297880|NCT02701205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65297881|NCT02701205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65297882|NCT02701205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65297883|NCT02701205|Immunologic Factors|immunologic factors|mesh-ancestor
65297884|NCT00670436|Paclitaxel|paclitaxel|mesh-list
65297885|NCT00670436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65297886|NCT00670436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65297887|NCT00670436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297888|NCT00670436|Tubulin Modulators|tubulin modulators|mesh-ancestor
65297889|NCT00670436|Antimitotic Agents|antimitotic agents|mesh-ancestor
65297890|NCT00670436|Mitosis Modulators|mitosis modulators|mesh-ancestor
65297891|NCT00670436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297892|NCT02699879|Pirfenidone|pirfenidone|mesh-list
65297893|NCT02699879|Analgesics|analgesics|mesh-ancestor
65297894|NCT02699879|Sensory System Agents|sensory system agents|mesh-ancestor
65297895|NCT02699879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65297896|NCT02699879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297897|NCT02699879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65297898|NCT02699879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65297899|NCT02699879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65297900|NCT02699879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65297901|NCT02699879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126824|NCT04600115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65126825|NCT04600115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126826|NCT04600115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65126827|NCT04600115|Vasodilator Agents|vasodilator agents|mesh-ancestor
65126828|NCT04600115|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65126829|NCT04600115|Purinergic Agonists|purinergic agonists|mesh-ancestor
65126830|NCT04600115|Purinergic Agents|purinergic agents|mesh-ancestor
65126831|NCT04600115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64514240|NCT02766465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126832|NCT04600115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126833|NCT04600115|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65126834|NCT04600037|Pregabalin|pregabalin|mesh-list
65126835|NCT04600037|Analgesics|analgesics|mesh-ancestor
65126836|NCT04600037|Sensory System Agents|sensory system agents|mesh-ancestor
64699273|NCT05064085|Capecitabine|capecitabine|mesh-list
65126854|NCT00575796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126856|NCT00575835|Ergocalciferols|ergocalciferols|mesh-list
65126857|NCT00575835|Cholecalciferol|cholecalciferol|mesh-list
65126858|NCT00575835|Vitamins|vitamins|mesh-list
65126859|NCT00575835|Micronutrients|micronutrients|mesh-ancestor
65126860|NCT00575835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126861|NCT00575835|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65126862|NCT00575835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65126863|NCT00573222|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65126864|NCT00573222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65126865|NCT00573222|Respiratory System Agents|respiratory system agents|mesh-ancestor
65297902|NCT02699723|Itraconazole|itraconazole|mesh-list
65297903|NCT02699723|Arsenic Trioxide|arsenic trioxide|mesh-list
65297904|NCT02699723|Antifungal Agents|antifungal agents|mesh-ancestor
65297905|NCT02699723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65297906|NCT02699723|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65297907|NCT02699723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65297908|NCT02699723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65297909|NCT02699723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297910|NCT02699723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65297911|NCT02699723|Hormone Antagonists|hormone antagonists|mesh-ancestor
65297912|NCT02699723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65297913|NCT02699723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297914|NCT02699723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65297915|NCT02699723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297916|NCT02699645|Amlodipine|amlodipine|mesh-list
65297917|NCT02699645|Telmisartan|telmisartan|mesh-list
65297918|NCT02699645|Indapamide|indapamide|mesh-list
65297919|NCT02699645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65297920|NCT02699645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65297921|NCT02699645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65297922|NCT02699645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126866|NCT00575874|Pioglitazone|pioglitazone|mesh-list
65126867|NCT00575874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65126868|NCT00575874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126869|NCT03454217|Oxycodone|oxycodone|mesh-list
65126870|NCT03454217|Tramadol|tramadol|mesh-list
65126871|NCT03454217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65126872|NCT03454217|Narcotics|narcotics|mesh-ancestor
65126873|NCT03454217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65126874|NCT03454217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126875|NCT03454217|Analgesics|analgesics|mesh-ancestor
65126876|NCT03454217|Sensory System Agents|sensory system agents|mesh-ancestor
65126877|NCT03454217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65126878|NCT00575913|Alfuzosin|alfuzosin|mesh-list
65126879|NCT00575913|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65126880|NCT00575913|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65126881|NCT00575913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65126882|NCT00575913|Adrenergic Agents|adrenergic agents|mesh-ancestor
65126883|NCT00575913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65126884|NCT00575913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126885|NCT00575913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126886|NCT00575913|Urological Agents|urological agents|mesh-ancestor
65126887|NCT04579302|Bupivacaine|bupivacaine|mesh-list
65126888|NCT04579302|Anesthetics, Local|anesthetics, local|mesh-ancestor
65126889|NCT04579302|Anesthetics|anesthetics|mesh-ancestor
65126890|NCT04579302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65126906|NCT00565682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126908|NCT00575952|Doxorubicin|doxorubicin|mesh-list
64769272|NCT05500599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126909|NCT00575952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64769273|NCT05500599|Analgesics|analgesics|mesh-ancestor
64769274|NCT05500599|Sensory System Agents|sensory system agents|mesh-ancestor
65297923|NCT02699645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65297924|NCT02699645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297925|NCT02699645|Vasodilator Agents|vasodilator agents|mesh-ancestor
65297926|NCT02699645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65297927|NCT02699645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65297928|NCT02699645|Diuretics|diuretics|mesh-ancestor
65297929|NCT02699645|Natriuretic Agents|natriuretic agents|mesh-ancestor
65297930|NCT02699645|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65297931|NCT04152434|Erenumab|erenumab|mesh-list
65297932|NCT04152434|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65297933|NCT04152434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297934|NCT04152434|Analgesics|analgesics|mesh-ancestor
65297935|NCT04152434|Sensory System Agents|sensory system agents|mesh-ancestor
65297936|NCT04152434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65297937|NCT04152434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769275|NCT05500599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64769276|NCT05500599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65126910|NCT00575952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65126911|NCT00575952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126912|NCT00575952|Tubulin Modulators|tubulin modulators|mesh-ancestor
65126913|NCT00575952|Antimitotic Agents|antimitotic agents|mesh-ancestor
65126914|NCT00575952|Mitosis Modulators|mitosis modulators|mesh-ancestor
65126915|NCT00575952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126916|NCT00575952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65126917|NCT00575952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65126918|NCT00575952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65126919|NCT00575952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126921|NCT00573417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65126922|NCT00573417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126923|NCT00573417|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65126924|NCT00573417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65126925|NCT00573417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65126926|NCT00573417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126927|NCT00573495|BIRC5 protein, human|birc5 protein, human|mesh-list
65126928|NCT00573495|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65126929|NCT00573495|Protease Inhibitors|protease inhibitors|mesh-ancestor
65126930|NCT00573495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126931|NCT00573495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126932|NCT00565955|Montelukast|montelukast|mesh-list
65126933|NCT00565955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65126934|NCT00565955|Respiratory System Agents|respiratory system agents|mesh-ancestor
65126935|NCT00565955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65126936|NCT00565955|Hormone Antagonists|hormone antagonists|mesh-ancestor
65126937|NCT00565955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65126938|NCT00565955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126939|NCT00565955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65126940|NCT00565955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65126941|NCT00565955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126967|NCT00576069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65126968|NCT00576069|Autonomic Agents|autonomic agents|mesh-ancestor
65126969|NCT00576069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65126970|NCT00576069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65126971|NCT00576069|Respiratory System Agents|respiratory system agents|mesh-ancestor
65126972|NCT00576069|Dermatologic Agents|dermatologic agents|mesh-ancestor
65297938|NCT00615797|Penicillins|penicillins|mesh-list
65297939|NCT00615797|Penicillin V|penicillin v|mesh-list
65297940|NCT00615797|Haloperidol|haloperidol|mesh-list
65297941|NCT00615797|Haloperidol decanoate|haloperidol decanoate|mesh-list
65297942|NCT00615797|Immunoglobulins|immunoglobulins|mesh-list
65297943|NCT00615797|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65297944|NCT00615797|Antibodies|antibodies|mesh-list
65297945|NCT00615797|gamma-Globulins|gamma-globulins|mesh-list
65297946|NCT00615797|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65297947|NCT00615797|Immunologic Factors|immunologic factors|mesh-ancestor
65126973|NCT00576069|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65126974|NCT00576069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65126975|NCT00576069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65126976|NCT00576069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64769345|NCT05402293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64769346|NCT05402293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64769347|NCT05402293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126978|NCT00576069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65126979|NCT00576069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126980|NCT00576069|Sympathomimetics|sympathomimetics|mesh-ancestor
65126981|NCT00573690|Carboplatin|carboplatin|mesh-list
65126982|NCT00573690|Etoposide|etoposide|mesh-list
65126983|NCT00573690|Pemetrexed|pemetrexed|mesh-list
65126984|NCT00573690|Sorafenib|sorafenib|mesh-list
65126985|NCT00573690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126986|NCT00573690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65126987|NCT00573690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65126988|NCT00573690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65127017|NCT04597775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127018|NCT04597775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127019|NCT04597775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65127020|NCT00573885|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65127021|NCT00573885|Antioxidants|antioxidants|mesh-ancestor
65127022|NCT00573885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127023|NCT00573885|Protective Agents|protective agents|mesh-ancestor
65127024|NCT00573885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127025|NCT00573885|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65127026|NCT00573885|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65127027|NCT00573885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127028|NCT00573885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65127029|NCT04597424|Doxycycline|doxycycline|mesh-list
65127030|NCT04597424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65127031|NCT04597424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65127032|NCT04597424|Antimalarials|antimalarials|mesh-ancestor
65127033|NCT04597424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65127064|NCT00574041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65127065|NCT00566267|Simvastatin|simvastatin|mesh-list
65127066|NCT00566267|Ezetimibe|ezetimibe|mesh-list
65127067|NCT00566267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65127068|NCT00566267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65127069|NCT00566267|Antimetabolites|antimetabolites|mesh-ancestor
65127070|NCT00566267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127071|NCT00566267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65127072|NCT00566267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65127073|NCT00566267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127074|NCT00574353|Misonidazole|misonidazole|mesh-list
65127075|NCT00574353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127076|NCT00574353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65127077|NCT00574353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65127078|NCT00574353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65127079|NCT04596839|Remdesivir|remdesivir|mesh-list
65127080|NCT04596839|Antimetabolites|antimetabolites|mesh-ancestor
65127117|NCT04596488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127118|NCT04596488|Antiviral Agents|antiviral agents|mesh-ancestor
65127119|NCT04596488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64699591|NCT05444101|Autonomic Agents|autonomic agents|mesh-ancestor
65127135|NCT04595942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65127136|NCT04595942|Adrenergic Agents|adrenergic agents|mesh-ancestor
65297948|NCT00615797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297949|NCT00615797|Antiemetics|antiemetics|mesh-ancestor
65297950|NCT00615797|Autonomic Agents|autonomic agents|mesh-ancestor
65297951|NCT00615797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65297952|NCT00615797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65297953|NCT00615797|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65297954|NCT00615797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65297955|NCT00615797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65297956|NCT00615797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65297957|NCT00615797|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64528179|NCT00246519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65127137|NCT04595942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65127138|NCT04595942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127139|NCT04595942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65127140|NCT00566384|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65127141|NCT00566384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65127142|NCT00566384|Immunologic Factors|immunologic factors|mesh-ancestor
65127143|NCT00566384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127144|NCT00574743|Mycophenolic Acid|mycophenolic acid|mesh-list
65127145|NCT00574743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65127146|NCT00574743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127147|NCT00574743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65127148|NCT00574743|Antitubercular Agents|antitubercular agents|mesh-ancestor
65127149|NCT00574743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65127150|NCT00574743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65127151|NCT00574743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127152|NCT00574743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127154|NCT04595825|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65127155|NCT04595825|Immunologic Factors|immunologic factors|mesh-ancestor
65127156|NCT04595825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127157|NCT03453528|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65127158|NCT03453528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65127159|NCT03453528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127160|NCT04595318|Varenicline|varenicline|mesh-list
65127161|NCT04595318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65127162|NCT04595318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65127163|NCT04595318|Cholinergic Agents|cholinergic agents|mesh-ancestor
65127164|NCT04595318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65127165|NCT04595318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127166|NCT04595318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127167|NCT00577668|Thalidomide|thalidomide|mesh-list
65127168|NCT00577668|Dexamethasone|dexamethasone|mesh-list
65127169|NCT00577668|Melphalan|melphalan|mesh-list
65127170|NCT00577668|Bortezomib|bortezomib|mesh-list
65127171|NCT00577668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65127172|NCT00577668|Antiemetics|antiemetics|mesh-ancestor
65127173|NCT00577668|Autonomic Agents|autonomic agents|mesh-ancestor
65127174|NCT00577668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127175|NCT00577668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127176|NCT00577668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65127177|NCT00577668|Glucocorticoids|glucocorticoids|mesh-ancestor
65127178|NCT00577668|Hormones|hormones|mesh-ancestor
65127205|NCT01147744|Dermatologic Agents|dermatologic agents|mesh-ancestor
65127206|NCT01147744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65127207|NCT01147744|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65127208|NCT01147744|Hormone Antagonists|hormone antagonists|mesh-ancestor
65127209|NCT01147744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65127210|NCT01147744|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65127211|NCT01147744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65127212|NCT01147744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127213|NCT04313374|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65127214|NCT04313374|Morphine|morphine|mesh-list
65127215|NCT04313374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65127216|NCT04313374|Narcotics|narcotics|mesh-ancestor
65297958|NCT00615797|Dopamine Agents|dopamine agents|mesh-ancestor
65297959|NCT00615797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65297960|NCT00615797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297961|NCT00615797|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65297962|NCT00615797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65297963|NCT00615797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65297964|NCT00670670|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
65297965|NCT00670670|Caseins|caseins|mesh-list
65297966|NCT00670670|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65297967|NCT00670670|Serotonin Agents|serotonin agents|mesh-ancestor
65297968|NCT00670670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65297969|NCT00670670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528188|NCT00248547|Dexamethasone|dexamethasone|mesh-list
65127217|NCT04313374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65127218|NCT04313374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127219|NCT04313374|Analgesics|analgesics|mesh-ancestor
65127220|NCT04313374|Sensory System Agents|sensory system agents|mesh-ancestor
65127249|NCT01147393|Epratuzumab|epratuzumab|mesh-list
65127251|NCT01147393|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
65127252|NCT01147393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65127253|NCT01147393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127254|NCT01147393|Chelating Agents|chelating agents|mesh-ancestor
65127255|NCT01147393|Sequestering Agents|sequestering agents|mesh-ancestor
65127256|NCT01147393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127258|NCT00578097|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65127259|NCT00578097|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65127260|NCT00578097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65127261|NCT00578097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65127262|NCT00578097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127291|NCT04593836|Dermatologic Agents|dermatologic agents|mesh-ancestor
65127292|NCT04593836|Antiemetics|antiemetics|mesh-ancestor
65127293|NCT04593836|Autonomic Agents|autonomic agents|mesh-ancestor
65127294|NCT04593836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127295|NCT04593836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127296|NCT04593836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65127297|NCT04593836|Parasympatholytics|parasympatholytics|mesh-ancestor
65127299|NCT04593524|Vitamins|vitamins|mesh-ancestor
65127300|NCT04593524|Micronutrients|micronutrients|mesh-ancestor
65127301|NCT04593524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127302|NCT04593524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65127303|NCT00578526|Sunitinib|sunitinib|mesh-list
65127304|NCT00578526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127305|NCT00578526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65127306|NCT00578526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65127307|NCT00578526|Growth Substances|growth substances|mesh-ancestor
65127308|NCT00578526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127309|NCT00578526|Growth Inhibitors|growth inhibitors|mesh-ancestor
64769767|NCT04838379|Antiemetics|antiemetics|mesh-ancestor
64769768|NCT04838379|Autonomic Agents|autonomic agents|mesh-ancestor
64769769|NCT04838379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64769770|NCT04838379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769771|NCT04838379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64769772|NCT04838379|Glucocorticoids|glucocorticoids|mesh-ancestor
65127325|NCT00566891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127326|NCT00566891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65127327|NCT00566891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65127328|NCT00578721|Aspirin|aspirin|mesh-list
64699820|NCT04592419|Growth Substances|growth substances|mesh-ancestor
65127351|NCT00578760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65127352|NCT00578760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65127353|NCT00578760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65297970|NCT00670670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297971|NCT00670670|Chelating Agents|chelating agents|mesh-ancestor
65297972|NCT00670670|Sequestering Agents|sequestering agents|mesh-ancestor
65297973|NCT00705016|Fluorouracil|fluorouracil|mesh-list
65297974|NCT00705016|Cetuximab|cetuximab|mesh-list
65297975|NCT00705016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65297976|NCT00705016|Antimetabolites|antimetabolites|mesh-ancestor
65297977|NCT00705016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297978|NCT00705016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65297979|NCT00705016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65297980|NCT00705016|Immunologic Factors|immunologic factors|mesh-ancestor
64528201|NCT00248547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127354|NCT00578760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65127355|NCT00578760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127356|NCT00578760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65127357|NCT00578760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65127358|NCT00578760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127359|NCT00578760|Antipyretics|antipyretics|mesh-ancestor
65127360|NCT04592822|Dabigatran|dabigatran|mesh-list
65127361|NCT04592822|Antithrombins|antithrombins|mesh-ancestor
65127362|NCT04592822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65127363|NCT04592822|Protease Inhibitors|protease inhibitors|mesh-ancestor
65127364|NCT04592822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127365|NCT04592822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127366|NCT04592822|Anticoagulants|anticoagulants|mesh-ancestor
65127367|NCT00567047|Vildagliptin|vildagliptin|mesh-list
65127368|NCT00567047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65127369|NCT00567047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127370|NCT00567047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65127371|NCT00567047|Protease Inhibitors|protease inhibitors|mesh-ancestor
65127372|NCT00567047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127373|NCT00567047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127374|NCT04592666|Carboplatin|carboplatin|mesh-list
65127375|NCT04592666|Pemetrexed|pemetrexed|mesh-list
65127376|NCT04592666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127377|NCT04592666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127378|NCT04592666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127379|NCT04592666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65127406|NCT04592081|Autonomic Agents|autonomic agents|mesh-ancestor
65127407|NCT04592081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127408|NCT04592081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127409|NCT04592081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65127410|NCT04592081|Glucocorticoids|glucocorticoids|mesh-ancestor
65127411|NCT04592081|Hormones|hormones|mesh-ancestor
65127412|NCT04592081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65127413|NCT04592081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65127414|NCT04592081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127415|NCT04592081|Protease Inhibitors|protease inhibitors|mesh-ancestor
65127416|NCT04592081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127417|NCT04592081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127418|NCT00579969|Timolol|timolol|mesh-list
65127419|NCT00579969|Latanoprost|latanoprost|mesh-list
65127420|NCT00579969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65127421|NCT00579969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65127422|NCT00579969|Adrenergic Agents|adrenergic agents|mesh-ancestor
65127423|NCT00579969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65127424|NCT00579969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127425|NCT00579969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127426|NCT00579969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64699922|NCT00003423|Antiemetics|antiemetics|mesh-ancestor
65127444|NCT04591535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297981|NCT00705016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297982|NCT00705016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65297983|NCT00595868|Varenicline|varenicline|mesh-list
65297984|NCT00595868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65297985|NCT00595868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65297986|NCT00595868|Cholinergic Agents|cholinergic agents|mesh-ancestor
65297987|NCT00595868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65297988|NCT00595868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65297989|NCT00595868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297990|NCT02699801|Dexmedetomidine|dexmedetomidine|mesh-list
65297991|NCT02699801|Propofol|propofol|mesh-list
65297992|NCT02699801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65297993|NCT02699801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65297994|NCT02699801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65297995|NCT02699801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65297996|NCT02699801|Anesthetics, General|anesthetics, general|mesh-ancestor
65297997|NCT02699801|Anesthetics|anesthetics|mesh-ancestor
65297998|NCT02699801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65297999|NCT02699801|Analgesics|analgesics|mesh-ancestor
65298000|NCT02699801|Sensory System Agents|sensory system agents|mesh-ancestor
65298001|NCT02699801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65298002|NCT02699801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65298003|NCT02699801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65298004|NCT02699801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65298005|NCT02699801|Adrenergic Agents|adrenergic agents|mesh-ancestor
65298006|NCT02699801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65298007|NCT02699801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298008|NCT02727907|Interferons|interferons|mesh-list
65298009|NCT02727907|Interferon-beta|interferon-beta|mesh-list
65298010|NCT02727907|Interferon beta-1a|interferon beta-1a|mesh-list
65298011|NCT02727907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298012|NCT02727907|Antiviral Agents|antiviral agents|mesh-ancestor
65298013|NCT02727907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65298022|NCT00663728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298023|NCT00663728|Urological Agents|urological agents|mesh-ancestor
65298024|NCT01009801|Doxorubicin|doxorubicin|mesh-list
65298025|NCT01009801|Everolimus|everolimus|mesh-list
65298026|NCT01009801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65298027|NCT01009801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298028|NCT01009801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65298029|NCT01009801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65298030|NCT01009801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298031|NCT01009801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298032|NCT01009801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65298033|NCT01009801|Immunologic Factors|immunologic factors|mesh-ancestor
65298034|NCT01009801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298035|NCT00617045|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64528253|NCT00125931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127445|NCT04591535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127446|NCT04591535|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65127447|NCT04591535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127448|NCT04591535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65127449|NCT04591535|Immunologic Factors|immunologic factors|mesh-ancestor
65127450|NCT04591535|Dopamine Agonists|dopamine agonists|mesh-ancestor
65127451|NCT00580242|Lenalidomide|lenalidomide|mesh-list
65127452|NCT00580242|Bortezomib|bortezomib|mesh-list
65127453|NCT00580242|Immunologic Factors|immunologic factors|mesh-ancestor
65127454|NCT00580242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127455|NCT00580242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65127456|NCT00580242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65127457|NCT00580242|Growth Substances|growth substances|mesh-ancestor
65127458|NCT00580242|Growth Inhibitors|growth inhibitors|mesh-ancestor
65127459|NCT00580242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127461|NCT04591457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65127462|NCT04591457|Insulin Glargine|insulin glargine|mesh-list
65127463|NCT04591457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65127464|NCT04591457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127465|NCT00580320|Bortezomib|bortezomib|mesh-list
65127466|NCT00580320|Dacarbazine|dacarbazine|mesh-list
65127467|NCT00580320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127468|NCT00580320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64769877|NCT04761159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64769878|NCT04761159|Anesthetics, General|anesthetics, general|mesh-ancestor
64769879|NCT04761159|Anesthetics|anesthetics|mesh-ancestor
64769880|NCT04761159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64769881|NCT04761159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64769882|NCT04761159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64769892|NCT04721548|Minoxidil|minoxidil|mesh-list
65127470|NCT00580320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127471|NCT00580359|Capecitabine|capecitabine|mesh-list
65127472|NCT00580359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65127473|NCT00580359|Antimetabolites|antimetabolites|mesh-ancestor
65127474|NCT00580359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127475|NCT00580359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127476|NCT00580437|Dobutamine|dobutamine|mesh-list
65127477|NCT00580437|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65127478|NCT00580437|Sympathomimetics|sympathomimetics|mesh-ancestor
65127479|NCT00580437|Autonomic Agents|autonomic agents|mesh-ancestor
65127480|NCT00580437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127481|NCT00580437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127515|NCT04590638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65127516|NCT04590638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298036|NCT00617045|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65298037|NCT00617045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65298038|NCT00617045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65298039|NCT00617045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298040|NCT00617045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65298041|NCT00617045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298042|NCT00617045|Analgesics|analgesics|mesh-ancestor
65298043|NCT00617045|Sensory System Agents|sensory system agents|mesh-ancestor
65298044|NCT00617045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65298045|NCT00617045|Antidepressive Agents|antidepressive agents|mesh-ancestor
65298046|NCT00617045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65298047|NCT00617045|Dopamine Agents|dopamine agents|mesh-ancestor
65298048|NCT02629718|Paclitaxel|paclitaxel|mesh-list
65298049|NCT02629718|Carboplatin|carboplatin|mesh-list
65298050|NCT02629718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65298051|NCT02629718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298052|NCT02629718|Tubulin Modulators|tubulin modulators|mesh-ancestor
65127517|NCT04590638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127518|NCT04590638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65127519|NCT04590638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65127521|NCT04590638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127559|NCT00581139|Midazolam|midazolam|mesh-list
65127560|NCT00581139|Anesthetics|anesthetics|mesh-ancestor
65127561|NCT00581139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65127590|NCT00567710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65127591|NCT00567710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127592|NCT00567710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127593|NCT00567710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65127594|NCT00567710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65127595|NCT00567710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65127596|NCT00567710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65127597|NCT00567710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65127598|NCT00567710|Dopamine Agents|dopamine agents|mesh-ancestor
65127600|NCT04589429|Nalbuphine|nalbuphine|mesh-list
65127601|NCT04589429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65127602|NCT04589429|Narcotics|narcotics|mesh-ancestor
65127603|NCT04589429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64770027|NCT04522622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64770033|NCT04521478|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64770034|NCT04521478|Antidepressive Agents|antidepressive agents|mesh-ancestor
64770035|NCT04521478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65127625|NCT04589234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65127626|NCT04589234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127627|NCT04589234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65127628|NCT04589234|Immunologic Factors|immunologic factors|mesh-ancestor
65127629|NCT04589234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127630|NCT03453177|Fosfomycin|fosfomycin|mesh-list
65127631|NCT03453177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65127632|NCT03453177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65127633|NCT04594629|Nitroglycerin|nitroglycerin|mesh-list
65127634|NCT04594629|Vasodilator Agents|vasodilator agents|mesh-ancestor
65127635|NCT04588532|Doxepin|doxepin|mesh-list
65127636|NCT04588532|Histamine|histamine|mesh-list
65127637|NCT04588532|Histamine Agonists|histamine agonists|mesh-ancestor
64770103|NCT04332068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770105|NCT04298567|Rivaroxaban|rivaroxaban|mesh-list
64770106|NCT04298567|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64770107|NCT04298567|Antithrombins|antithrombins|mesh-ancestor
65298053|NCT02629718|Antimitotic Agents|antimitotic agents|mesh-ancestor
65298054|NCT02629718|Mitosis Modulators|mitosis modulators|mesh-ancestor
65298055|NCT02629718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298056|NCT01009879|Etanercept|etanercept|mesh-list
65298057|NCT01009879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65298058|NCT01009879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65298059|NCT01009879|Analgesics|analgesics|mesh-ancestor
65298121|NCT00663806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65298122|NCT01015339|Paclitaxel|paclitaxel|mesh-list
65298123|NCT01015339|Capecitabine|capecitabine|mesh-list
65298124|NCT01015339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65298125|NCT01015339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298126|NCT01015339|Tubulin Modulators|tubulin modulators|mesh-ancestor
65298127|NCT01015339|Antimitotic Agents|antimitotic agents|mesh-ancestor
65298128|NCT01015339|Mitosis Modulators|mitosis modulators|mesh-ancestor
65298129|NCT01015339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298130|NCT01015339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65298131|NCT01015339|Antimetabolites|antimetabolites|mesh-ancestor
65298132|NCT05110313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65298133|NCT05110313|Immunologic Factors|immunologic factors|mesh-ancestor
65298134|NCT05110313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298135|NCT02622906|Pasireotide|pasireotide|mesh-list
65298136|NCT02622906|Hormones|hormones|mesh-ancestor
65298137|NCT02622906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65298138|NCT02622906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298139|NCT00673556|Alefacept|alefacept|mesh-list
65298140|NCT00673556|Dermatologic Agents|dermatologic agents|mesh-ancestor
65298141|NCT00673556|Immunologic Factors|immunologic factors|mesh-ancestor
65298142|NCT00673556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298143|NCT00675896|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65298144|NCT00675896|Antidepressive Agents|antidepressive agents|mesh-ancestor
65298145|NCT00675896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65298146|NCT00675896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65298147|NCT00675896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65048039|NCT00219596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65298148|NCT00675896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65298166|NCT04061824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65298167|NCT04061824|Antimetabolites|antimetabolites|mesh-ancestor
65298168|NCT04061824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298169|NCT04061824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65298170|NCT04061824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65298171|NCT04061824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298172|NCT04061824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65298173|NCT04061824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65298174|NCT04061824|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65298175|NCT04061824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65298176|NCT04061824|Protease Inhibitors|protease inhibitors|mesh-ancestor
65298177|NCT04212533|Vitamin D|vitamin d|mesh-list
65298178|NCT04212533|Vitamins|vitamins|mesh-ancestor
65298179|NCT04212533|Micronutrients|micronutrients|mesh-ancestor
65298180|NCT04212533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298181|NCT04212533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65298182|NCT04155554|Tenofovir|tenofovir|mesh-list
65298183|NCT04155554|Lamivudine|lamivudine|mesh-list
65298184|NCT04155554|Emtricitabine|emtricitabine|mesh-list
65298185|NCT04155554|Dolutegravir|dolutegravir|mesh-list
65298186|NCT04155554|Abacavir|abacavir|mesh-list
64528401|NCT01561963|Rifampin|rifampin|mesh-list
64770108|NCT04298567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64770109|NCT04298567|Protease Inhibitors|protease inhibitors|mesh-ancestor
64770110|NCT04298567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64770111|NCT04298567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770112|NCT04298567|Anticoagulants|anticoagulants|mesh-ancestor
64770113|NCT04298567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64770114|NCT04298567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64770115|NCT04298567|Analgesics|analgesics|mesh-ancestor
65127666|NCT00567788|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65127667|NCT00567788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65127668|NCT00581607|Bosentan|bosentan|mesh-list
65127669|NCT00581607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65127700|NCT04588220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65127701|NCT04588220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65127702|NCT04588220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65127703|NCT04586543|Docetaxel|docetaxel|mesh-list
65127704|NCT04586543|Selegiline|selegiline|mesh-list
65127705|NCT04586543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127706|NCT04586543|Tubulin Modulators|tubulin modulators|mesh-ancestor
65127707|NCT04586543|Antimitotic Agents|antimitotic agents|mesh-ancestor
65127708|NCT04586543|Mitosis Modulators|mitosis modulators|mesh-ancestor
65127709|NCT04586543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127710|NCT04586543|Antidepressive Agents|antidepressive agents|mesh-ancestor
65127711|NCT04586543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65127743|NCT00566865|Gemfibrozil|gemfibrozil|mesh-list
65127744|NCT00566865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65127745|NCT00566865|Antimetabolites|antimetabolites|mesh-ancestor
65127746|NCT00566865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127747|NCT00566865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65127748|NCT00566865|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65127749|NCT00566865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65127750|NCT00566865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127751|NCT04585997|Omalizumab|omalizumab|mesh-list
65298187|NCT04155554|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65298188|NCT04155554|Triumeq|triumeq|mesh-list
65298189|NCT04155554|Antiviral Agents|antiviral agents|mesh-ancestor
65298190|NCT04155554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65298191|NCT04155554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65298192|NCT04155554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65298193|NCT04155554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298194|NCT04155554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298195|NCT04155554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65298196|NCT04155554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65298197|NCT04155554|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65298198|NCT04155554|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65298199|NCT00663884|Voglibose|voglibose|mesh-list
65298200|NCT00663884|Mitiglinide|mitiglinide|mesh-list
65298201|NCT00663884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65298202|NCT00663884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298203|NCT00663884|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65298204|NCT00663884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127752|NCT04585997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65127753|NCT04585997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65127754|NCT04585997|Respiratory System Agents|respiratory system agents|mesh-ancestor
65127755|NCT04593108|Letrozole|letrozole|mesh-list
65127756|NCT04593108|Misoprostol|misoprostol|mesh-list
65127757|NCT04593108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127758|NCT04593108|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65127759|NCT04593108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65127760|NCT04593108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700284|NCT00002835|Antimetabolites|antimetabolites|mesh-ancestor
65127771|NCT04593108|Oxytocics|oxytocics|mesh-ancestor
65127773|NCT04585334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65127774|NCT04585334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65127775|NCT04585334|Analgesics|analgesics|mesh-ancestor
65127776|NCT04585334|Sensory System Agents|sensory system agents|mesh-ancestor
65127777|NCT04585334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127778|NCT04585334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127779|NCT04585334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65127780|NCT04585334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65127781|NCT04585334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65127782|NCT04585334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127783|NCT04585334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127784|NCT04585412|Palonosetron|palonosetron|mesh-list
65127785|NCT04585412|Antiemetics|antiemetics|mesh-ancestor
65127786|NCT04585412|Autonomic Agents|autonomic agents|mesh-ancestor
65127787|NCT04585412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127788|NCT04585412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127789|NCT04585412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65127790|NCT04585412|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65127791|NCT04585412|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65127792|NCT04585412|Serotonin Agents|serotonin agents|mesh-ancestor
65127793|NCT04585412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65127794|NCT04585412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127795|NCT00567866|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65127796|NCT00567866|Antidepressive Agents|antidepressive agents|mesh-ancestor
65127797|NCT00567866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65127798|NCT00567866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65127799|NCT00567866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65127800|NCT00567866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65298205|NCT00663884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298206|NCT00856206|Rilonacept|rilonacept|mesh-list
65298207|NCT00856206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65298208|NCT03997279|Amoxicillin|amoxicillin|mesh-list
65298209|NCT03997279|Metronidazole|metronidazole|mesh-list
65298210|NCT03997279|Clarithromycin|clarithromycin|mesh-list
65298211|NCT03997279|Rabeprazole|rabeprazole|mesh-list
65298212|NCT03997279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65298213|NCT03997279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65298214|NCT03997279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65298215|NCT03997279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65298216|NCT03997279|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65298217|NCT03997279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298218|NCT03997279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298219|NCT03997279|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65298220|NCT03997279|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65298221|NCT03997279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65298222|NCT03997279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65048116|NCT00219869|Galantamine|galantamine|mesh-list
65298223|NCT03997279|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64528432|NCT04852003|Analgesics|analgesics|mesh-ancestor
64770259|NCT04067518|Pegaspargase|pegaspargase|mesh-list
64770260|NCT04067518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770261|NCT04033419|Memantine|memantine|mesh-list
64770262|NCT04033419|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64770263|NCT04033419|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64770264|NCT04033419|Dopamine Agents|dopamine agents|mesh-ancestor
64770265|NCT04033419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65127801|NCT00567866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127802|NCT04593030|Warfarin|warfarin|mesh-list
65127803|NCT04593030|Apixaban|apixaban|mesh-list
65127804|NCT04593030|Anticoagulants|anticoagulants|mesh-ancestor
65127805|NCT04593030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65127806|NCT04593030|Antithrombins|antithrombins|mesh-ancestor
65127807|NCT04593030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65127808|NCT04593030|Protease Inhibitors|protease inhibitors|mesh-ancestor
65127809|NCT04593030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127810|NCT04593030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127811|NCT00567983|Cyclosporine|cyclosporine|mesh-list
65127812|NCT00567983|Cyclosporins|cyclosporins|mesh-list
65127813|NCT00567983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127814|NCT00567983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127815|NCT00567983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65127816|NCT00567983|Immunologic Factors|immunologic factors|mesh-ancestor
65127847|NCT00566904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65127848|NCT00566904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65127849|NCT00566904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127850|NCT00566904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65127851|NCT00566904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65127852|NCT00566904|Analgesics|analgesics|mesh-ancestor
65127853|NCT00566904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65127854|NCT00566904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65127855|NCT00566904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65127856|NCT00566904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65127857|NCT00566904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65127858|NCT00566904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65298225|NCT00920998|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65298226|NCT00920998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298227|NCT00920998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298228|NCT00920998|Cholinergic Agents|cholinergic agents|mesh-ancestor
65298229|NCT00920998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65298230|NCT00920998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298231|NCT00920998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65298232|NCT00593112|Methylphenidate|methylphenidate|mesh-list
65298233|NCT00593112|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65298234|NCT00593112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127859|NCT00566904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127860|NCT00566904|Antipyretics|antipyretics|mesh-ancestor
65127878|NCT04584515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65127879|NCT04584515|Antitubercular Agents|antitubercular agents|mesh-ancestor
65127880|NCT04584515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65127881|NCT04584515|Leprostatic Agents|leprostatic agents|mesh-ancestor
65127882|NCT04584515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65127883|NCT04584515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65127884|NCT04584515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65127885|NCT04584515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65127886|NCT04584515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65127887|NCT04584515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65127888|NCT04584515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65127889|NCT04584710|Dactolisib|dactolisib|mesh-list
65127890|NCT04584710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127891|NCT04584671|Xenon|xenon|mesh-list
64700451|NCT00002865|Vitamins|vitamins|mesh-ancestor
65127909|NCT04592211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127910|NCT04592211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65127911|NCT04592211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65127912|NCT04592211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127913|NCT04583813|Empagliflozin|empagliflozin|mesh-list
65127914|NCT04583813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65127915|NCT04583813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127916|NCT04583813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65127917|NCT04583813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127919|NCT04576143|Docetaxel|docetaxel|mesh-list
65127920|NCT04576143|Cyclophosphamide|cyclophosphamide|mesh-list
65127921|NCT04576143|Epirubicin|epirubicin|mesh-list
65127922|NCT04576143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65127923|NCT04576143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127924|NCT04576143|Tubulin Modulators|tubulin modulators|mesh-ancestor
64770403|NCT03706690|Durvalumab|durvalumab|mesh-list
64770404|NCT03706690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64770405|NCT03706690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770406|NCT03636451|Lidocaine|lidocaine|mesh-list
64770407|NCT03636451|Vasopressins|vasopressins|mesh-list
64770408|NCT03636451|Arginine Vasopressin|arginine vasopressin|mesh-list
64770409|NCT03636451|Anesthetics, Local|anesthetics, local|mesh-ancestor
64770410|NCT03636451|Anesthetics|anesthetics|mesh-ancestor
64770411|NCT03636451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64770412|NCT03636451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770413|NCT03636451|Sensory System Agents|sensory system agents|mesh-ancestor
64770414|NCT03636451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64770415|NCT03636451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65127925|NCT04576143|Antimitotic Agents|antimitotic agents|mesh-ancestor
65127926|NCT04576143|Mitosis Modulators|mitosis modulators|mesh-ancestor
65127927|NCT04576143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127928|NCT04576143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65127929|NCT04576143|Immunologic Factors|immunologic factors|mesh-ancestor
65127930|NCT04576143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127931|NCT04576143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65298235|NCT00593112|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65298236|NCT00593112|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65298237|NCT00593112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65298238|NCT00593112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298239|NCT00593112|Dopamine Agents|dopamine agents|mesh-ancestor
65298240|NCT00593112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65298241|NCT05323565|Dexamethasone|dexamethasone|mesh-list
65298242|NCT05323565|Dexmedetomidine|dexmedetomidine|mesh-list
65298243|NCT05323565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65298244|NCT05323565|Antiemetics|antiemetics|mesh-ancestor
65298245|NCT05323565|Autonomic Agents|autonomic agents|mesh-ancestor
65298246|NCT05323565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65298247|NCT05323565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298248|NCT05323565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65298249|NCT05323565|Glucocorticoids|glucocorticoids|mesh-ancestor
65298250|NCT05323565|Hormones|hormones|mesh-ancestor
65298251|NCT05323565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65298252|NCT05323565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65298253|NCT05323565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127932|NCT04576143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65127933|NCT04576143|Alkylating Agents|alkylating agents|mesh-ancestor
65127934|NCT04576143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65127935|NCT04576143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65127936|NCT04576143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65127951|NCT04583111|Antiemetics|antiemetics|mesh-ancestor
65127952|NCT04583111|Autonomic Agents|autonomic agents|mesh-ancestor
65127953|NCT04583111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127954|NCT04583111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127955|NCT04583111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65127956|NCT04583111|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65127957|NCT04583111|Dopamine Agents|dopamine agents|mesh-ancestor
65127958|NCT04583111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65127959|NCT04583111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127960|NCT04583111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65127961|NCT04583111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65127962|NCT04583111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65127963|NCT04583111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65127964|NCT04583111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65127965|NCT04583111|Antidepressive Agents|antidepressive agents|mesh-ancestor
65127966|NCT01146613|Varenicline|varenicline|mesh-list
65127967|NCT01146613|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65127968|NCT01146613|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65127969|NCT01146613|Cholinergic Agents|cholinergic agents|mesh-ancestor
65127970|NCT01146613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65127971|NCT01146613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127972|NCT01146613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127973|NCT01145755|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65127974|NCT01145755|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65127975|NCT01145755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65127976|NCT01145755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65127977|NCT01145755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127978|NCT01145755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65298254|NCT05323565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298255|NCT05323565|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65298256|NCT05323565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65298257|NCT05323565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65298258|NCT05323565|Analgesics|analgesics|mesh-ancestor
65298259|NCT05323565|Sensory System Agents|sensory system agents|mesh-ancestor
65298260|NCT05323565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65298261|NCT05323565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65298262|NCT05323565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65298263|NCT05323565|Adrenergic Agents|adrenergic agents|mesh-ancestor
65298264|NCT05323565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65298265|NCT01015495|Ranibizumab|ranibizumab|mesh-list
65298266|NCT01015495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65298267|NCT01015495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65298268|NCT01015495|Growth Substances|growth substances|mesh-ancestor
65298269|NCT01015495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298270|NCT01015495|Growth Inhibitors|growth inhibitors|mesh-ancestor
65298271|NCT01015495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298272|NCT00676286|Choline|choline|mesh-list
65298273|NCT00676286|Lipotropic Agents|lipotropic agents|mesh-ancestor
65298274|NCT00676286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65127979|NCT01145755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127980|NCT01145755|Analgesics|analgesics|mesh-ancestor
65127981|NCT01145755|Sensory System Agents|sensory system agents|mesh-ancestor
65127982|NCT01145755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127983|NCT01145755|Antidepressive Agents|antidepressive agents|mesh-ancestor
65127984|NCT01145755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65127985|NCT01145755|Dopamine Agents|dopamine agents|mesh-ancestor
65127986|NCT04591743|Nicotine|nicotine|mesh-list
65127987|NCT04591743|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65127988|NCT04591743|Autonomic Agents|autonomic agents|mesh-ancestor
65127989|NCT04591743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127990|NCT04591743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127991|NCT04591743|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65127992|NCT04591743|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64770480|NCT03504163|Immunologic Factors|immunologic factors|mesh-ancestor
64770481|NCT03504163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770482|NCT03459807|Antihypertensive Agents|antihypertensive agents|mesh-list
64770483|NCT03454035|Palbociclib|palbociclib|mesh-list
64700546|NCT03504241|Mycophenolic Acid|mycophenolic acid|mesh-list
65128026|NCT00568217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128028|NCT00583323|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
64700610|NCT00003939|Trabectedin|trabectedin|mesh-list
64770570|NCT03070223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64770571|NCT03070223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64770600|NCT02979873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64770601|NCT02979873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64770602|NCT02979873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64770603|NCT02979873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128043|NCT00590928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128044|NCT00590928|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65128045|NCT00590928|Histamine Antagonists|histamine antagonists|mesh-ancestor
65128046|NCT00590928|Histamine Agents|histamine agents|mesh-ancestor
65298275|NCT00676286|Antimetabolites|antimetabolites|mesh-ancestor
65298276|NCT00676286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298277|NCT00676286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65298278|NCT00676286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65298279|NCT00676286|Nootropic Agents|nootropic agents|mesh-ancestor
65298280|NCT00699894|Ondansetron|ondansetron|mesh-list
65298281|NCT00699894|Aprepitant|aprepitant|mesh-list
65298282|NCT00699894|Antiemetics|antiemetics|mesh-ancestor
65298283|NCT00699894|Autonomic Agents|autonomic agents|mesh-ancestor
65298284|NCT00699894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65298285|NCT00699894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298286|NCT00699894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65298287|NCT00699894|Antipruritics|antipruritics|mesh-ancestor
65298288|NCT00699894|Dermatologic Agents|dermatologic agents|mesh-ancestor
65298289|NCT00699894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65128047|NCT00590928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65128048|NCT00590928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128049|NCT01145482|Insulin|insulin|mesh-list
65128082|NCT04582136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65128083|NCT04582136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128084|NCT04582136|Antifungal Agents|antifungal agents|mesh-ancestor
65128085|NCT04582136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65128086|NCT04582136|Immunologic Factors|immunologic factors|mesh-ancestor
65128087|NCT04582136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128089|NCT00591201|Dermatologic Agents|dermatologic agents|mesh-ancestor
64700686|NCT00003945|Topotecan|topotecan|mesh-list
65128119|NCT04575675|Protective Agents|protective agents|mesh-ancestor
65128120|NCT04575675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65128121|NCT04575675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65128122|NCT04575675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65128123|NCT04575675|Vasodilator Agents|vasodilator agents|mesh-ancestor
65128124|NCT04575675|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65128125|NCT04575675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65128126|NCT04575675|Hormone Antagonists|hormone antagonists|mesh-ancestor
65128127|NCT04575675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65128128|NCT04575675|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65128129|NCT04575675|Diuretics|diuretics|mesh-ancestor
65128130|NCT04575675|Natriuretic Agents|natriuretic agents|mesh-ancestor
65128131|NCT04575675|Hormones|hormones|mesh-ancestor
65128146|NCT00568412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128147|NCT00568529|Capecitabine|capecitabine|mesh-list
65128148|NCT00568529|Oxaliplatin|oxaliplatin|mesh-list
65128149|NCT00568529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65128150|NCT00568529|Antimetabolites|antimetabolites|mesh-ancestor
65128151|NCT00568529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128152|NCT00568529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128153|NCT00568568|Hormones|hormones|mesh-list
65128154|NCT00568568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65128155|NCT00568568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128156|NCT04575558|Azithromycin|azithromycin|mesh-list
65128157|NCT04575558|Hydroxychloroquine|hydroxychloroquine|mesh-list
65128158|NCT04575558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65128159|NCT04575558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65128160|NCT04575558|Antimalarials|antimalarials|mesh-ancestor
65128161|NCT04575558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65128162|NCT04575558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65128163|NCT04575558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128164|NCT04575558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128165|NCT04575558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65128166|NCT00568763|Sargramostim|sargramostim|mesh-list
65128167|NCT00568763|Immunologic Factors|immunologic factors|mesh-ancestor
65298290|NCT00699894|Serotonin Agents|serotonin agents|mesh-ancestor
65298291|NCT00699894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65298292|NCT00699894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298293|NCT00699894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65298294|NCT00699894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65298295|NCT00699894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65298296|NCT00699894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65048191|NCT00562198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298357|NCT00503581|Megestrol Acetate|megestrol acetate|mesh-list
65298358|NCT00503581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65298359|NCT00503581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65298360|NCT00503581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65128169|NCT00568841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65128170|NCT00568841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128171|NCT00568841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65128172|NCT00568841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128173|NCT00568841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128174|NCT00583869|Pregabalin|pregabalin|mesh-list
65128175|NCT00583869|Analgesics|analgesics|mesh-ancestor
65128176|NCT00583869|Sensory System Agents|sensory system agents|mesh-ancestor
65128177|NCT00583869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65128178|NCT00583869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128179|NCT00583869|Anticonvulsants|anticonvulsants|mesh-ancestor
65128180|NCT00583869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65128181|NCT00583869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65128182|NCT00583869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128183|NCT00583869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65128184|NCT00583869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65128185|NCT00583869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65128186|NCT00583869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65128187|NCT00583869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65128188|NCT00568880|Hydroxychloroquine|hydroxychloroquine|mesh-list
65128189|NCT00568880|Bortezomib|bortezomib|mesh-list
65128190|NCT00568880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128191|NCT00568880|Antimalarials|antimalarials|mesh-ancestor
65128192|NCT00568880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64700778|NCT00003993|Bryostatin 1|bryostatin 1|mesh-list
65128227|NCT00583986|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65128228|NCT00583986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65128229|NCT00583986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65128230|NCT00583986|Adrenergic Agents|adrenergic agents|mesh-ancestor
65128231|NCT00583986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65128232|NCT00583986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128233|NCT00569621|Moxaverine|moxaverine|mesh-list
65128234|NCT00569621|Parasympatholytics|parasympatholytics|mesh-ancestor
65128235|NCT00569621|Autonomic Agents|autonomic agents|mesh-ancestor
65128244|NCT00569699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128245|NCT00569699|Growth Inhibitors|growth inhibitors|mesh-ancestor
65128247|NCT00569816|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65128248|NCT00569816|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65128249|NCT00569816|Anesthetics, General|anesthetics, general|mesh-ancestor
65128250|NCT00569816|Anesthetics|anesthetics|mesh-ancestor
65128251|NCT00569816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65128252|NCT00569816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128253|NCT00570050|Insulin|insulin|mesh-list
65128254|NCT00570050|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65128255|NCT00570050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65128256|NCT00570050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128257|NCT03451500|Levodopa|levodopa|mesh-list
65128258|NCT03451500|Carbidopa|carbidopa|mesh-list
65128259|NCT03451500|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65128260|NCT03451500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65128261|NCT03451500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65128262|NCT03451500|Dopamine Agents|dopamine agents|mesh-ancestor
65128263|NCT03451500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65128264|NCT03451500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128265|NCT03451500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128266|NCT03451500|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65128267|NCT03451500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128268|NCT03451500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65128269|NCT03451500|Immunologic Factors|immunologic factors|mesh-ancestor
65128270|NCT03451500|Dopamine Agonists|dopamine agonists|mesh-ancestor
65128271|NCT00570245|Nitric Oxide|nitric oxide|mesh-list
65128272|NCT00570245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65128273|NCT00570245|Autonomic Agents|autonomic agents|mesh-ancestor
65128274|NCT00570245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65128275|NCT00570245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128276|NCT00570245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65128277|NCT00570245|Respiratory System Agents|respiratory system agents|mesh-ancestor
65298361|NCT00503581|Contraceptive Agents|contraceptive agents|mesh-ancestor
65298362|NCT00503581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65298363|NCT00503581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298364|NCT00503581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65298365|NCT00503581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65298366|NCT00503581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65298367|NCT00503581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298368|NCT00503581|Appetite Stimulants|appetite stimulants|mesh-ancestor
65298369|NCT00503581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65298370|NCT00677144|Capecitabine|capecitabine|mesh-list
65298371|NCT00677144|Oxaliplatin|oxaliplatin|mesh-list
65298372|NCT00677144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65298373|NCT00677144|Antimetabolites|antimetabolites|mesh-ancestor
65298374|NCT00677144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298376|NCT00703534|Lesogaberan|lesogaberan|mesh-list
65298377|NCT00703534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65128278|NCT00570245|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65128279|NCT00570245|Antioxidants|antioxidants|mesh-ancestor
65128280|NCT00570245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128281|NCT00570245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65128282|NCT00570245|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65128283|NCT00570245|Vasodilator Agents|vasodilator agents|mesh-ancestor
65128284|NCT00570245|Gasotransmitters|gasotransmitters|mesh-ancestor
65128285|NCT00570245|Protective Agents|protective agents|mesh-ancestor
65128286|NCT00570284|Panobinostat|panobinostat|mesh-list
65128287|NCT00570284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128288|NCT00570284|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65128289|NCT00570284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128290|NCT00570284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128291|NCT00570440|Levonorgestrel|levonorgestrel|mesh-list
65128292|NCT00570440|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65128293|NCT00570440|Contraceptive Agents|contraceptive agents|mesh-list
65128294|NCT00570440|Contraceptives, Oral|contraceptives, oral|mesh-list
65128295|NCT00570440|Estradiol|estradiol|mesh-list
65128296|NCT00570440|Estrogens|estrogens|mesh-ancestor
65128297|NCT00570440|Hormones|hormones|mesh-ancestor
65128298|NCT00570440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65128299|NCT00570440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128300|NCT00570440|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65128301|NCT00570440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65128302|NCT00570440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65128303|NCT00570440|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64700877|NCT00003591|Paclitaxel|paclitaxel|mesh-list
65128337|NCT00584493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770858|NCT01065558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65128338|NCT04580342|Propranolol|propranolol|mesh-list
65128339|NCT04580342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65128340|NCT04580342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65128341|NCT04580342|Adrenergic Agents|adrenergic agents|mesh-ancestor
65128342|NCT04580342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65128343|NCT04580342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700943|NCT00003603|Immunologic Factors|immunologic factors|mesh-ancestor
65128351|NCT00571142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128352|NCT00571142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65128353|NCT00571142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65128355|NCT00571142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128356|NCT00571142|Growth Inhibitors|growth inhibitors|mesh-ancestor
65128357|NCT00571142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65298378|NCT00703534|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65298379|NCT00703534|GABA Agonists|gaba agonists|mesh-ancestor
65298380|NCT00703534|GABA Agents|gaba agents|mesh-ancestor
65298381|NCT00703534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65298382|NCT00703534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298383|NCT00703534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298384|NCT00503425|Rituximab|rituximab|mesh-list
65298385|NCT00503425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65298386|NCT00503425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528604|NCT04641507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65128358|NCT00571142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65128359|NCT00571142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65128360|NCT00571142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65128361|NCT00571142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65128362|NCT00571142|GABA Modulators|gaba modulators|mesh-ancestor
65128363|NCT00571142|GABA Agents|gaba agents|mesh-ancestor
65128364|NCT00571142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65128365|NCT00571142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128366|NCT00584532|Genistein|genistein|mesh-list
65128367|NCT00584532|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65128368|NCT00584532|Protective Agents|protective agents|mesh-ancestor
65128369|NCT00584532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128370|NCT00584532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128371|NCT00584532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65128372|NCT00584532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128373|NCT00584532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128374|NCT00584532|Phytoestrogens|phytoestrogens|mesh-ancestor
65128375|NCT00584532|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65128376|NCT00584532|Estrogens|estrogens|mesh-ancestor
65128377|NCT00584532|Hormones|hormones|mesh-ancestor
65128378|NCT00584532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65128379|NCT00584571|Dexetimide|dexetimide|mesh-list
65128380|NCT00584571|Citalopram|citalopram|mesh-list
65128381|NCT00584571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65128382|NCT00584571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65128383|NCT00584571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65128384|NCT00584571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128385|NCT00584571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65128386|NCT00584571|Serotonin Agents|serotonin agents|mesh-ancestor
65128387|NCT00584571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128388|NCT00584571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65128389|NCT00584571|Antidepressive Agents|antidepressive agents|mesh-ancestor
65128390|NCT00584571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65128391|NCT00584571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65128392|NCT00584571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65128393|NCT00584571|Parasympatholytics|parasympatholytics|mesh-ancestor
65128394|NCT00584571|Autonomic Agents|autonomic agents|mesh-ancestor
65128395|NCT00584571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65128396|NCT00584571|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65128397|NCT00584571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65128398|NCT00584571|Cholinergic Agents|cholinergic agents|mesh-ancestor
65128399|NCT00584610|Copper|copper|mesh-list
65128400|NCT00584610|Levonorgestrel|levonorgestrel|mesh-list
65128401|NCT00584610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65128402|NCT00584610|Contraceptive Agents|contraceptive agents|mesh-ancestor
65128403|NCT00584610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65128404|NCT00584610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128405|NCT00584610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65128406|NCT00584610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65128407|NCT00584610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65128408|NCT00584610|Trace Elements|trace elements|mesh-ancestor
65128409|NCT00584610|Micronutrients|micronutrients|mesh-ancestor
65128410|NCT00571298|Gemcitabine|gemcitabine|mesh-list
65128411|NCT00571298|Sodium thiosulfate|sodium thiosulfate|mesh-list
65298387|NCT00503425|Immunologic Factors|immunologic factors|mesh-ancestor
65298388|NCT00503425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298389|NCT00503425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65298390|NCT00863772|Tanezumab|tanezumab|mesh-list
65298391|NCT00863772|Analgesics|analgesics|mesh-ancestor
65298392|NCT00863772|Sensory System Agents|sensory system agents|mesh-ancestor
65298393|NCT00863772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65298394|NCT00863772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298395|NCT01010425|Hormones|hormones|mesh-list
65298396|NCT01010425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65298397|NCT01010425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298398|NCT04914676|Cytarabine|cytarabine|mesh-list
65298399|NCT04914676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65298400|NCT04914676|Antimetabolites|antimetabolites|mesh-ancestor
65298401|NCT04914676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298402|NCT04914676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298403|NCT04914676|Antiviral Agents|antiviral agents|mesh-ancestor
65298404|NCT04914676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65298405|NCT04914676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65298406|NCT04914676|Immunologic Factors|immunologic factors|mesh-ancestor
64528612|NCT04641507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65128442|NCT04575519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128443|NCT04575519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65128444|NCT04575519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65128445|NCT04575519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65128446|NCT04575519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128447|NCT04575519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128448|NCT04575519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65128449|NCT04575519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65128450|NCT04575519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65128451|NCT04575519|Antipyretics|antipyretics|mesh-ancestor
65128452|NCT04573803|Phenytoin|phenytoin|mesh-list
65128453|NCT04573803|Levetiracetam|levetiracetam|mesh-list
65128454|NCT04573803|Anticonvulsants|anticonvulsants|mesh-ancestor
65128455|NCT04573803|Nootropic Agents|nootropic agents|mesh-ancestor
65128456|NCT04573803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65128457|NCT04573803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65128458|NCT04573803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65128485|NCT01143337|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65128486|NCT01143337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65128487|NCT01143337|Immunologic Factors|immunologic factors|mesh-ancestor
65128488|NCT01143337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65128489|NCT01143337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65128490|NCT04313023|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
65128491|NCT04313023|Respiratory System Agents|respiratory system agents|mesh-ancestor
65128492|NCT02883595|Thymalfasin|thymalfasin|mesh-list
65128493|NCT02883595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65128494|NCT02883595|Immunologic Factors|immunologic factors|mesh-ancestor
65128495|NCT02883595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128496|NCT01143259|Alvimopan|alvimopan|mesh-list
65128497|NCT01143259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65128498|NCT00571805|Varenicline|varenicline|mesh-list
65128499|NCT00571805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64528633|NCT00512070|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65298407|NCT04914676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298408|NCT00677300|Ritonavir|ritonavir|mesh-list
65298409|NCT00677300|Darunavir|darunavir|mesh-list
65298410|NCT00677300|Tenofovir|tenofovir|mesh-list
65298411|NCT00677300|Emtricitabine|emtricitabine|mesh-list
65298412|NCT00677300|Raltegravir Potassium|raltegravir potassium|mesh-list
65298413|NCT00677300|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65298414|NCT00677300|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65298415|NCT00677300|Protease Inhibitors|protease inhibitors|mesh-ancestor
65298416|NCT00677300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298417|NCT00677300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128500|NCT00571805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65128501|NCT00571805|Cholinergic Agents|cholinergic agents|mesh-ancestor
65128502|NCT00571805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65128503|NCT00571805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128504|NCT00571805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128505|NCT02883556|Pembrolizumab|pembrolizumab|mesh-list
65128506|NCT02883556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64701118|NCT00003633|Prednisone|prednisone|mesh-list
65128528|NCT00585156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65128529|NCT00585156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128530|NCT00585156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65128531|NCT00585156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65128532|NCT00585156|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65128533|NCT00585156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65128534|NCT00585156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128535|NCT00585156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128536|NCT01142596|Asenapine|asenapine|mesh-list
65128538|NCT01142596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65128539|NCT01142596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65128540|NCT01142596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128541|NCT01142596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65128542|NCT00572390|Estrogens|estrogens|mesh-list
65128543|NCT00572390|Hormones|hormones|mesh-ancestor
65128544|NCT00572390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65128545|NCT00572390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128546|NCT01142128|Esomeprazole|esomeprazole|mesh-list
65128547|NCT01142128|Pancrelipase|pancrelipase|mesh-list
65128548|NCT01142128|Pancreatin|pancreatin|mesh-list
65128549|NCT01142128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65128550|NCT01142128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65128551|NCT01142128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65128552|NCT01142128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128553|NCT01142128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128554|NCT04572867|Diuretics|diuretics|mesh-list
65128555|NCT04572867|Natriuretic Agents|natriuretic agents|mesh-ancestor
65128556|NCT04572867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128557|NCT01142089|Rifamycins|rifamycins|mesh-list
65128558|NCT01142089|Rifamycin SV|rifamycin sv|mesh-list
65128559|NCT01142089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65128560|NCT01142089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64701151|NCT00003639|Interferons|interferons|mesh-list
65128592|NCT00572819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65128593|NCT00572819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128594|NCT00572819|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65128595|NCT00572819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65128596|NCT00572819|Oxytocics|oxytocics|mesh-ancestor
65128597|NCT04580498|Paclitaxel|paclitaxel|mesh-list
65128598|NCT04580498|Carboplatin|carboplatin|mesh-list
65128599|NCT04580498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65128600|NCT04580498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128601|NCT04580498|Tubulin Modulators|tubulin modulators|mesh-ancestor
65128602|NCT04580498|Antimitotic Agents|antimitotic agents|mesh-ancestor
65128603|NCT04580498|Mitosis Modulators|mitosis modulators|mesh-ancestor
65298418|NCT00677300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65298419|NCT00677300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65298420|NCT00677300|Antiviral Agents|antiviral agents|mesh-ancestor
65298421|NCT00677300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65298422|NCT00677300|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65298423|NCT00677300|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65298424|NCT00677300|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65298425|NCT00677300|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65298426|NCT00677300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65298427|NCT00677300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65298428|NCT02628392|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65298429|NCT02628392|Firuglipel|firuglipel|mesh-list
65298430|NCT02628392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65298431|NCT02628392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298432|NCT02628392|Incretins|incretins|mesh-ancestor
65298433|NCT02628392|Hormones|hormones|mesh-ancestor
65298434|NCT02628392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64528644|NCT05661552|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64528645|NCT05661552|Antimetabolites|antimetabolites|mesh-ancestor
65128604|NCT04580498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128605|NCT03451110|Fluconazole|fluconazole|mesh-list
65128628|NCT03451110|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65128629|NCT03451110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65128630|NCT03451110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65128631|NCT03451110|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65128632|NCT03451110|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65128633|NCT03451110|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65128634|NCT03451110|Contraceptive Agents|contraceptive agents|mesh-ancestor
65128635|NCT03451110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65128636|NCT03451110|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65128637|NCT03451110|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65128638|NCT03451110|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
65128639|NCT03451110|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65128641|NCT00585741|Antiviral Agents|antiviral agents|mesh-ancestor
65128642|NCT00585741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65128643|NCT03450798|Anesthetics|anesthetics|mesh-list
65128644|NCT03450798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65128645|NCT03450798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128646|NCT00573326|Imatinib Mesylate|imatinib mesylate|mesh-list
65128647|NCT00573326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128648|NCT00573326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65128649|NCT00573326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128650|NCT00573326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128651|NCT01140061|MK 0873|mk 0873|mesh-list
65128662|NCT04312750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65128663|NCT04312750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65128664|NCT04312750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65128665|NCT04312750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65128666|NCT04312750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65128667|NCT04312750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128668|NCT00573404|Sunitinib|sunitinib|mesh-list
65128669|NCT00573404|Imatinib Mesylate|imatinib mesylate|mesh-list
65128670|NCT00573404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298435|NCT02628392|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65298436|NCT02628392|Protease Inhibitors|protease inhibitors|mesh-ancestor
65298437|NCT02628392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298438|NCT02628392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298439|NCT00664586|Masoprocol|masoprocol|mesh-list
65298440|NCT00664586|Antioxidants|antioxidants|mesh-ancestor
65298441|NCT00664586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298442|NCT00664586|Protective Agents|protective agents|mesh-ancestor
64528661|NCT04051203|Prednisolone acetate|prednisolone acetate|mesh-list
65128671|NCT00573404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65128672|NCT00573404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65128673|NCT00573404|Growth Substances|growth substances|mesh-ancestor
65128674|NCT00573404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128675|NCT00573404|Growth Inhibitors|growth inhibitors|mesh-ancestor
65128676|NCT00573404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65128677|NCT00573404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128678|NCT00573404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128679|NCT01139125|Cysteamine|cysteamine|mesh-list
65128680|NCT01139125|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
64514276|NCT02757885|Antisickling Agents|antisickling agents|mesh-ancestor
65128681|NCT01139125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128682|NCT01139047|Metronidazole|metronidazole|mesh-list
65128683|NCT01139047|Azelaic acid|azelaic acid|mesh-list
65128684|NCT01139047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65128685|NCT01139047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65128686|NCT01139047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65128687|NCT01139047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65128688|NCT01139047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128689|NCT01139047|Dermatologic Agents|dermatologic agents|mesh-ancestor
65128690|NCT01139008|Metronidazole|metronidazole|mesh-list
65128691|NCT01139008|Azelaic acid|azelaic acid|mesh-list
65128692|NCT01139008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65128693|NCT01139008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65128694|NCT01139008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65128695|NCT01139008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65128696|NCT01139008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128697|NCT01139008|Dermatologic Agents|dermatologic agents|mesh-ancestor
65128698|NCT00573599|Diphenhydramine|diphenhydramine|mesh-list
65128699|NCT00573599|Prochlorperazine|prochlorperazine|mesh-list
65128700|NCT00573599|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65128701|NCT00573599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65128702|NCT00573599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65128703|NCT00573599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128704|NCT00573599|Anesthetics, Local|anesthetics, local|mesh-ancestor
65128705|NCT00573599|Anesthetics|anesthetics|mesh-ancestor
65128706|NCT00573599|Sensory System Agents|sensory system agents|mesh-ancestor
65128707|NCT00573599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65128708|NCT00573599|Antiemetics|antiemetics|mesh-ancestor
65128709|NCT00573599|Autonomic Agents|autonomic agents|mesh-ancestor
65128710|NCT00573599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65128711|NCT00573599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65128712|NCT00573599|Histamine Antagonists|histamine antagonists|mesh-ancestor
65128713|NCT00573599|Histamine Agents|histamine agents|mesh-ancestor
64771238|NCT04944654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65128714|NCT00573599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65128738|NCT01138657|Glucocorticoids|glucocorticoids|mesh-ancestor
65128739|NCT01138657|Hormones|hormones|mesh-ancestor
65128740|NCT01138657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65128741|NCT01138657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128742|NCT01138657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65128743|NCT01138657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128744|NCT01138657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65128745|NCT01138501|Factor VIII|factor viii|mesh-list
65128746|NCT01138501|Coagulants|coagulants|mesh-ancestor
65128747|NCT01138150|Naproxen|naproxen|mesh-list
65128748|NCT01138150|Sumatriptan|sumatriptan|mesh-list
65128749|NCT01138150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65298443|NCT00664586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298444|NCT00664586|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65298445|NCT00664586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298446|NCT00664586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65048348|NCT00220298|Hormones|hormones|mesh-ancestor
65298447|NCT00664586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65298448|NCT00664586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65298449|NCT00664586|Analgesics|analgesics|mesh-ancestor
65298450|NCT00664586|Sensory System Agents|sensory system agents|mesh-ancestor
65298451|NCT00664586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65298452|NCT00664586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65298453|NCT00664586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65298454|NCT00502801|Doripenem|doripenem|mesh-list
65298455|NCT00502801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65298456|NCT00502801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65298457|NCT04154852|Folic Acid|folic acid|mesh-list
65298458|NCT04154852|Adalimumab|adalimumab|mesh-list
65128750|NCT01138150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65128751|NCT01138150|Analgesics|analgesics|mesh-ancestor
65128752|NCT01138150|Sensory System Agents|sensory system agents|mesh-ancestor
65128753|NCT01138150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65128754|NCT01138150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661809|NCT02841371|Chelating Agents|chelating agents|mesh-ancestor
65128755|NCT01138150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65128756|NCT01138150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65128757|NCT01138150|Gout Suppressants|gout suppressants|mesh-ancestor
65128758|NCT01138150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65128759|NCT01138150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128760|NCT01138150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128761|NCT01138150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65128762|NCT01138150|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65128763|NCT01138150|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65128764|NCT01138150|Serotonin Agents|serotonin agents|mesh-ancestor
65128765|NCT01138150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65128766|NCT00586092|Bevacizumab|bevacizumab|mesh-list
64701382|NCT00384657|Iron|iron|mesh-list
65128799|NCT00586131|Chelating Agents|chelating agents|mesh-ancestor
65128800|NCT00586131|Sequestering Agents|sequestering agents|mesh-ancestor
65128801|NCT00586131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128802|NCT00586287|Phenprocoumon|phenprocoumon|mesh-list
65128803|NCT00586287|Anticoagulants|anticoagulants|mesh-ancestor
65128804|NCT00586365|Naproxen|naproxen|mesh-list
65128805|NCT00586365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65128806|NCT00586365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65128807|NCT00586365|Analgesics|analgesics|mesh-ancestor
65128808|NCT00586365|Sensory System Agents|sensory system agents|mesh-ancestor
65128809|NCT00586365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65128810|NCT00586365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128842|NCT00574769|Tubulin Modulators|tubulin modulators|mesh-ancestor
65128843|NCT00574769|Antimitotic Agents|antimitotic agents|mesh-ancestor
65128844|NCT00574769|Mitosis Modulators|mitosis modulators|mesh-ancestor
65128845|NCT00574769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128846|NCT00574769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65128847|NCT00574769|Immunologic Factors|immunologic factors|mesh-ancestor
65128849|NCT00586443|Panitumumab|panitumumab|mesh-list
65128850|NCT00586443|Everolimus|everolimus|mesh-list
65128851|NCT00586443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65128852|NCT00586443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128853|NCT00586443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65128854|NCT00586443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65298459|NCT04154852|Methotrexate|methotrexate|mesh-list
65298460|NCT04154852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65298461|NCT04154852|Abortifacient Agents|abortifacient agents|mesh-ancestor
65298462|NCT04154852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65298463|NCT04154852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298464|NCT04154852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65298465|NCT04154852|Antimetabolites|antimetabolites|mesh-ancestor
65298466|NCT04154852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298467|NCT04154852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298468|NCT04154852|Dermatologic Agents|dermatologic agents|mesh-ancestor
65298469|NCT04154852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298470|NCT04154852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65298471|NCT04154852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65298472|NCT04154852|Immunologic Factors|immunologic factors|mesh-ancestor
65298473|NCT04154852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65298474|NCT04154852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65298475|NCT04154852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65298476|NCT04154852|Hematinics|hematinics|mesh-ancestor
65298477|NCT04154852|Vitamin B Complex|vitamin b complex|mesh-ancestor
65298478|NCT04154852|Vitamins|vitamins|mesh-ancestor
65298479|NCT04154852|Micronutrients|micronutrients|mesh-ancestor
65298480|NCT00921154|Ivermectin|ivermectin|mesh-list
65298481|NCT00921154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65128855|NCT00586443|Growth Substances|growth substances|mesh-ancestor
65128882|NCT03450057|Daratumumab|daratumumab|mesh-list
65128883|NCT03450057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128884|NCT01137682|Octreotide|octreotide|mesh-list
65128885|NCT01137682|Lanreotide|lanreotide|mesh-list
65128886|NCT01137682|Pasireotide|pasireotide|mesh-list
65128887|NCT01137682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65128888|NCT01137682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65128889|NCT01137682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128890|NCT01137682|Hormones|hormones|mesh-ancestor
65128891|NCT01137682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65128892|NCT01137682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128893|NCT00586794|Sildenafil Citrate|sildenafil citrate|mesh-list
65128894|NCT00586794|Vasodilator Agents|vasodilator agents|mesh-ancestor
65128895|NCT00586794|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65128896|NCT00586794|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65128897|NCT00586794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128898|NCT00586794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128899|NCT00586794|Urological Agents|urological agents|mesh-ancestor
65128900|NCT00586833|Neurotransmitter Agents|neurotransmitter agents|mesh-list
64701503|NCT00005031|Irofulven|irofulven|mesh-list
65128914|NCT00586911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65128915|NCT00586911|Antimetabolites|antimetabolites|mesh-ancestor
65128916|NCT00586911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128917|NCT00586911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65128918|NCT00575393|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
65128919|NCT00575393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65128920|NCT00575549|Dobutamine|dobutamine|mesh-list
65128921|NCT00575549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65128922|NCT00575549|Sympathomimetics|sympathomimetics|mesh-ancestor
65128923|NCT00575549|Autonomic Agents|autonomic agents|mesh-ancestor
65298482|NCT00921154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65298483|NCT01015651|Remifentanil|remifentanil|mesh-list
65298484|NCT01015651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65298485|NCT01015651|Narcotics|narcotics|mesh-ancestor
65298486|NCT01015651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65298487|NCT01015651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298488|NCT01015651|Analgesics|analgesics|mesh-ancestor
65298489|NCT01015651|Sensory System Agents|sensory system agents|mesh-ancestor
65298490|NCT01015651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65298491|NCT04907968|Carboplatin|carboplatin|mesh-list
65298492|NCT04907968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298493|NCT00674414|Trastuzumab|trastuzumab|mesh-list
65298494|NCT00674414|Everolimus|everolimus|mesh-list
65298495|NCT00674414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65298496|NCT00674414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298497|NCT00674414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65298498|NCT00674414|Immunologic Factors|immunologic factors|mesh-ancestor
65298499|NCT00674414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298500|NCT05570422|Cisplatin|cisplatin|mesh-list
65298501|NCT05570422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298502|NCT05272930|Dienogest|dienogest|mesh-list
65298503|NCT05272930|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65298504|NCT05272930|Contraceptive Agents|contraceptive agents|mesh-ancestor
65298505|NCT05272930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65298506|NCT05272930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298507|NCT05272930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65298508|NCT05272930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65298509|NCT05272930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65298510|NCT05272930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65298511|NCT05272930|Hormone Antagonists|hormone antagonists|mesh-ancestor
65298512|NCT05272930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64528706|NCT02662764|Dsuvia|dsuvia|mesh-list
65128924|NCT00575549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65128925|NCT00575549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128926|NCT00575549|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65128927|NCT00575549|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65128928|NCT00575549|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65128929|NCT00575549|Adrenergic Agents|adrenergic agents|mesh-ancestor
65128930|NCT00575549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65128931|NCT00575549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128932|NCT00575549|Protective Agents|protective agents|mesh-ancestor
65128933|NCT03453684|Vancomycin|vancomycin|mesh-list
65128934|NCT03453684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65128935|NCT03453684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65298513|NCT05272930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65298514|NCT05272930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298515|NCT00855894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65298516|NCT00855894|Pertuzumab|pertuzumab|mesh-list
65298517|NCT00855894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298518|NCT00855894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65298519|NCT00855894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298520|NCT00855894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298521|NCT00855894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64528738|NCT01518257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65128936|NCT00575627|Interferons|interferons|mesh-list
65128937|NCT00575627|Ribavirin|ribavirin|mesh-list
65128938|NCT00575627|Interferon-alpha|interferon-alpha|mesh-list
65128939|NCT00575627|Interferon alpha-2|interferon alpha-2|mesh-list
64771465|NCT01149876|Tretinoin|tretinoin|mesh-list
65128940|NCT00575627|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65128941|NCT00575627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128942|NCT00575627|Antiviral Agents|antiviral agents|mesh-ancestor
65128943|NCT00575627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65128944|NCT00575627|Antimetabolites|antimetabolites|mesh-ancestor
65128945|NCT00575627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128946|NCT00575627|Immunologic Factors|immunologic factors|mesh-ancestor
65128947|NCT00575627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128948|NCT00555854|Benzocaine|benzocaine|mesh-list
65128949|NCT00555854|Anesthetics, Local|anesthetics, local|mesh-ancestor
65128950|NCT00555854|Anesthetics|anesthetics|mesh-ancestor
65128951|NCT00555854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65128952|NCT00555854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128953|NCT00555854|Sensory System Agents|sensory system agents|mesh-ancestor
65128954|NCT00555854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65128955|NCT04674332|Insulin, Long-Acting|insulin, long-acting|mesh-list
65128956|NCT04674332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65128957|NCT04674332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128958|NCT00587145|Docetaxel|docetaxel|mesh-list
65128959|NCT00587145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128960|NCT00587145|Tubulin Modulators|tubulin modulators|mesh-ancestor
65128961|NCT00587145|Antimitotic Agents|antimitotic agents|mesh-ancestor
65128962|NCT00587145|Mitosis Modulators|mitosis modulators|mesh-ancestor
65128963|NCT00587145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128964|NCT04674176|Rifaximin|rifaximin|mesh-list
65128977|NCT00199797|Leucovorin|leucovorin|mesh-list
65128978|NCT00199797|Fluorouracil|fluorouracil|mesh-list
65128979|NCT00199797|Oxaliplatin|oxaliplatin|mesh-list
65128980|NCT00199797|Antimetabolites|antimetabolites|mesh-ancestor
65128981|NCT00199797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128982|NCT00199797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65128983|NCT00199797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128984|NCT00199797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65128985|NCT00199797|Immunologic Factors|immunologic factors|mesh-ancestor
65128986|NCT00199797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128988|NCT00199797|Protective Agents|protective agents|mesh-ancestor
65128989|NCT00199797|Vitamin B Complex|vitamin b complex|mesh-ancestor
65128990|NCT00199797|Vitamins|vitamins|mesh-ancestor
65128991|NCT00199797|Micronutrients|micronutrients|mesh-ancestor
65128992|NCT01137604|Bevacizumab|bevacizumab|mesh-list
65128993|NCT01137604|Lenvatinib|lenvatinib|mesh-list
65128994|NCT01137604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65128995|NCT01137604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128996|NCT01137604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65128997|NCT01137604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65128998|NCT01137604|Growth Substances|growth substances|mesh-ancestor
65128999|NCT01137604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129000|NCT01137604|Growth Inhibitors|growth inhibitors|mesh-ancestor
65129001|NCT01137604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65129002|NCT01137604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222815|NCT05572684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65298522|NCT02566096|Morphine|morphine|mesh-list
65298523|NCT02566096|Bupivacaine|bupivacaine|mesh-list
65298524|NCT02566096|Anesthetics, Local|anesthetics, local|mesh-list
65298525|NCT02566096|Anesthetics|anesthetics|mesh-list
65298526|NCT02566096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65298527|NCT02566096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298528|NCT02566096|Sensory System Agents|sensory system agents|mesh-ancestor
65298529|NCT02566096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65298530|NCT02566096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65298531|NCT02566096|Narcotics|narcotics|mesh-ancestor
65298532|NCT02566096|Analgesics|analgesics|mesh-ancestor
65298533|NCT04482244|Cannabidiol|cannabidiol|mesh-list
65298534|NCT04482244|Anticonvulsants|anticonvulsants|mesh-ancestor
65298535|NCT02622594|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65298536|NCT02622594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65298537|NCT02622594|Dermatologic Agents|dermatologic agents|mesh-ancestor
65298538|NCT02628860|Ferric Compounds|ferric compounds|mesh-list
65298539|NCT02628860|Hematinics|hematinics|mesh-ancestor
65298540|NCT00708357|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
65298541|NCT00708357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528747|NCT02391636|Carbetocin|carbetocin|mesh-list
65129003|NCT01137604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129004|NCT03454919|Palbociclib|palbociclib|mesh-list
65129005|NCT03454919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129006|NCT03454919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65129007|NCT03454919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129008|NCT03454919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129009|NCT00198822|Vitamin A|vitamin a|mesh-list
65129010|NCT00198822|Beta Carotene|beta carotene|mesh-list
65129011|NCT00198822|Carotenoids|carotenoids|mesh-list
65129012|NCT00198822|Vitamins|vitamins|mesh-ancestor
64771543|NCT01170390|Estradiol|estradiol|mesh-list
65129013|NCT00198822|Micronutrients|micronutrients|mesh-ancestor
65129014|NCT00198822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129015|NCT00198822|Antioxidants|antioxidants|mesh-ancestor
65129016|NCT00198822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129017|NCT00198822|Protective Agents|protective agents|mesh-ancestor
65129018|NCT00198822|Provitamins|provitamins|mesh-ancestor
65129019|NCT05214976|Paclitaxel|paclitaxel|mesh-list
65129020|NCT05214976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65129021|NCT05214976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129022|NCT05214976|Tubulin Modulators|tubulin modulators|mesh-ancestor
65129023|NCT05214976|Antimitotic Agents|antimitotic agents|mesh-ancestor
65129024|NCT05214976|Mitosis Modulators|mitosis modulators|mesh-ancestor
65129025|NCT05214976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129026|NCT05204134|Insulin|insulin|mesh-list
65129027|NCT05204134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64701611|NCT00004233|Calcium|calcium|mesh-list
65129060|NCT00197145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129061|NCT00197145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65129062|NCT00197145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65129063|NCT00197145|Antiviral Agents|antiviral agents|mesh-ancestor
65129064|NCT00197145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65129065|NCT04674137|Histamine|histamine|mesh-list
65129066|NCT04674137|Glutarimide|glutarimide|mesh-list
65129067|NCT04674137|Histamine Agonists|histamine agonists|mesh-ancestor
65129068|NCT04674137|Histamine Agents|histamine agents|mesh-ancestor
65129101|NCT00197106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129102|NCT01136746|Insulin|insulin|mesh-list
65129103|NCT01136746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65298542|NCT00708357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298543|NCT00855738|Topiramate|topiramate|mesh-list
65298544|NCT00855738|Pregabalin|pregabalin|mesh-list
65298545|NCT00855738|Lamotrigine|lamotrigine|mesh-list
65298546|NCT00855738|Zonisamide|zonisamide|mesh-list
65298547|NCT00855738|Gabapentin|gabapentin|mesh-list
65298548|NCT00855738|Levetiracetam|levetiracetam|mesh-list
65298549|NCT00855738|Tiagabine|tiagabine|mesh-list
65298550|NCT00855738|Analgesics|analgesics|mesh-ancestor
65298551|NCT00855738|Sensory System Agents|sensory system agents|mesh-ancestor
64528767|NCT02383212|Immunologic Factors|immunologic factors|mesh-ancestor
65129104|NCT01136746|Insulin Glargine|insulin glargine|mesh-list
65129105|NCT01136746|Insulin Lispro|insulin lispro|mesh-list
65129106|NCT01136746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65129107|NCT01136746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129108|NCT01136356|Morphine|morphine|mesh-list
65129109|NCT01136356|Buprenorphine|buprenorphine|mesh-list
65129110|NCT01136356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65129111|NCT01136356|Narcotics|narcotics|mesh-ancestor
65129112|NCT01136356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65129136|NCT00196326|Estrogens|estrogens|mesh-ancestor
65129137|NCT00196326|Hormones|hormones|mesh-ancestor
65129138|NCT00196326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65129139|NCT00196326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129140|NCT00196326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65129141|NCT00196326|Contraceptive Agents|contraceptive agents|mesh-ancestor
65129142|NCT00196326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65129143|NCT00196326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65129144|NCT00196326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65129145|NCT00196326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65129146|NCT00196326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65129147|NCT00587496|Aspirin|aspirin|mesh-list
65129148|NCT00587496|Valacyclovir|valacyclovir|mesh-list
65129149|NCT00587496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65129150|NCT00587496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65129151|NCT00587496|Analgesics|analgesics|mesh-ancestor
65129152|NCT00587496|Sensory System Agents|sensory system agents|mesh-ancestor
65129153|NCT00587496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65129154|NCT00587496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129155|NCT00587496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65129156|NCT00587496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65129157|NCT00587496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65129158|NCT00587496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65129159|NCT00587496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129160|NCT00587496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65129161|NCT00587496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65129162|NCT00587496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129163|NCT00587496|Antipyretics|antipyretics|mesh-ancestor
65129164|NCT00587496|Antiviral Agents|antiviral agents|mesh-ancestor
64701756|NCT00004317|Sulfadiazine|sulfadiazine|mesh-list
65129194|NCT01135498|Growth Inhibitors|growth inhibitors|mesh-ancestor
65129195|NCT01135498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65129196|NCT01135498|Antimetabolites|antimetabolites|mesh-ancestor
65129197|NCT01135498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129198|NCT01135498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65129199|NCT01135498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129200|NCT04610567|Methotrexate|methotrexate|mesh-list
65129201|NCT04610567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65129202|NCT04610567|Abortifacient Agents|abortifacient agents|mesh-ancestor
65129203|NCT04610567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65129204|NCT04610567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129205|NCT04610567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65129206|NCT04610567|Antimetabolites|antimetabolites|mesh-ancestor
65129207|NCT04610567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129208|NCT04610567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129215|NCT04610567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65129216|NCT02883439|Fluticasone|fluticasone|mesh-list
65298552|NCT00855738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65298553|NCT00855738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298554|NCT00855738|Anticonvulsants|anticonvulsants|mesh-ancestor
65298555|NCT00855738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65298556|NCT00855738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65298557|NCT00855738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298558|NCT00855738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65298559|NCT00855738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65298560|NCT00855738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64528777|NCT02391480|Venetoclax|venetoclax|mesh-list
65129217|NCT02883439|Xhance|xhance|mesh-list
65129218|NCT02883439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65129219|NCT02883439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65129220|NCT02883439|Autonomic Agents|autonomic agents|mesh-ancestor
65129221|NCT02883439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65129222|NCT02883439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129223|NCT02883439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65129224|NCT02883439|Respiratory System Agents|respiratory system agents|mesh-ancestor
65129225|NCT02883439|Dermatologic Agents|dermatologic agents|mesh-ancestor
65129226|NCT02883439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65129227|NCT00195507|Etanercept|etanercept|mesh-list
65129228|NCT00195507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65129229|NCT00195507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65129230|NCT00195507|Analgesics|analgesics|mesh-ancestor
65129231|NCT00195507|Sensory System Agents|sensory system agents|mesh-ancestor
65129232|NCT00195507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65129233|NCT00195507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129234|NCT00195507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65129235|NCT00195507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65129236|NCT00195507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65129237|NCT00195507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65129238|NCT00195507|Immunologic Factors|immunologic factors|mesh-ancestor
65129239|NCT00195429|Sirolimus|sirolimus|mesh-list
65129240|NCT00195429|Prednisone|prednisone|mesh-list
65129241|NCT00195429|Tacrolimus|tacrolimus|mesh-list
65129242|NCT00195429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65129243|NCT00195429|Glucocorticoids|glucocorticoids|mesh-ancestor
65129244|NCT00195429|Hormones|hormones|mesh-ancestor
65129245|NCT00195429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65129246|NCT00195429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129247|NCT00195429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65129248|NCT00195429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129249|NCT00195429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65129250|NCT00195429|Immunologic Factors|immunologic factors|mesh-ancestor
65129251|NCT00195429|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65129252|NCT00195429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129253|NCT00195429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129254|NCT00195429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65129255|NCT00195429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65129256|NCT00195429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65129257|NCT00195429|Antifungal Agents|antifungal agents|mesh-ancestor
65129258|NCT00195351|Metronidazole|metronidazole|mesh-list
65129259|NCT00195351|Ceftriaxone|ceftriaxone|mesh-list
65129260|NCT00195351|Tigecycline|tigecycline|mesh-list
65129261|NCT00195351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65129262|NCT00195351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65129263|NCT00195351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65129264|NCT00195351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65129265|NCT00195351|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65129266|NCT00195351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129267|NCT00195351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129268|NCT04609748|Nimesulide|nimesulide|mesh-list
65129269|NCT04609748|Cannabidiol|cannabidiol|mesh-list
65129270|NCT04609748|Anticonvulsants|anticonvulsants|mesh-ancestor
65129271|NCT04609748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65298561|NCT00855738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65298562|NCT00855738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65298563|NCT00855738|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65298564|NCT00855738|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65298565|NCT00855738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65298566|NCT00855738|Antimanic Agents|antimanic agents|mesh-ancestor
65298567|NCT00855738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65298568|NCT00855738|Nootropic Agents|nootropic agents|mesh-ancestor
64528786|NCT01531153|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65129272|NCT04609748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65129273|NCT04609748|Analgesics|analgesics|mesh-ancestor
65129274|NCT04609748|Sensory System Agents|sensory system agents|mesh-ancestor
65129275|NCT04609748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65129276|NCT04609748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129277|NCT04609748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65129278|NCT04609748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64701858|NCT00003771|Norethindrone|norethindrone|mesh-list
65129292|NCT00195273|Antifungal Agents|antifungal agents|mesh-ancestor
65129293|NCT00195273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65129294|NCT00195273|Dermatologic Agents|dermatologic agents|mesh-ancestor
65129295|NCT00195273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65129296|NCT00195273|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65129297|NCT00195273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65129298|NCT00195273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129299|NCT00195273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65129300|NCT00195273|Antitubercular Agents|antitubercular agents|mesh-ancestor
65129301|NCT00195273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65129302|NCT00564200|Dexamethasone|dexamethasone|mesh-list
65129303|NCT00564200|Fludarabine|fludarabine|mesh-list
65129304|NCT00564200|Bortezomib|bortezomib|mesh-list
65129305|NCT00564200|Melphalan|melphalan|mesh-list
65129306|NCT00564200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65129307|NCT00564200|Antiemetics|antiemetics|mesh-ancestor
65129308|NCT00564200|Autonomic Agents|autonomic agents|mesh-ancestor
65129309|NCT00564200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65129310|NCT00564200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129311|NCT00564200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65129312|NCT00564200|Glucocorticoids|glucocorticoids|mesh-ancestor
65129313|NCT00564200|Hormones|hormones|mesh-ancestor
65129314|NCT00564200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65129315|NCT00564200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65129316|NCT00564200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129317|NCT00564200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129318|NCT00564200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65129320|NCT00564200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65129321|NCT00564200|Alkylating Agents|alkylating agents|mesh-ancestor
65129322|NCT00564200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65129323|NCT00193479|Prednisone|prednisone|mesh-list
65129324|NCT00193479|Cyclophosphamide|cyclophosphamide|mesh-list
65129325|NCT00193479|Rituximab|rituximab|mesh-list
65129326|NCT00193479|Vincristine|vincristine|mesh-list
65129327|NCT00193479|Mitoxantrone|mitoxantrone|mesh-list
65129328|NCT00193479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65129329|NCT00193479|Immunologic Factors|immunologic factors|mesh-ancestor
65129330|NCT00193479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129331|NCT00193479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65129332|NCT00193479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65129333|NCT00193479|Alkylating Agents|alkylating agents|mesh-ancestor
65129334|NCT00193479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129335|NCT00193479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129336|NCT00193479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65129337|NCT00193479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65129338|NCT00193479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65129339|NCT00193479|Glucocorticoids|glucocorticoids|mesh-ancestor
65129340|NCT00193479|Hormones|hormones|mesh-ancestor
65129341|NCT00193479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65298569|NCT00855738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65298570|NCT00855738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65298571|NCT00855738|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
65298572|NCT00855738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65298573|NCT00855738|GABA Agents|gaba agents|mesh-ancestor
65298574|NCT02628002|Regadenoson|regadenoson|mesh-list
65298575|NCT02628002|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65298576|NCT02628002|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64528795|NCT01531153|Nootropic Agents|nootropic agents|mesh-ancestor
65129342|NCT00193479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65129361|NCT00193206|Mitosis Modulators|mitosis modulators|mesh-ancestor
65129362|NCT00193206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129363|NCT00193206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65129364|NCT00193206|Antimetabolites|antimetabolites|mesh-ancestor
65129365|NCT00193206|Antiviral Agents|antiviral agents|mesh-ancestor
65129366|NCT00193206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65129367|NCT00193206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129368|NCT00193206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65129369|NCT00193206|Immunologic Factors|immunologic factors|mesh-ancestor
65129370|NCT00193206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129371|NCT00193206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65129372|NCT00193206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65129373|NCT00193206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65129374|NCT00193050|Gemcitabine|gemcitabine|mesh-list
65129375|NCT00193050|Docetaxel|docetaxel|mesh-list
65129376|NCT00193050|Epirubicin|epirubicin|mesh-list
65129377|NCT00193050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65129378|NCT00193050|Antimetabolites|antimetabolites|mesh-ancestor
65129379|NCT00193050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129380|NCT00193050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129381|NCT00193050|Antiviral Agents|antiviral agents|mesh-ancestor
65129382|NCT00193050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65129383|NCT00193050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129384|NCT00193050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65129385|NCT00193050|Immunologic Factors|immunologic factors|mesh-ancestor
65129386|NCT00193050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129387|NCT00193050|Tubulin Modulators|tubulin modulators|mesh-ancestor
65129388|NCT00193050|Antimitotic Agents|antimitotic agents|mesh-ancestor
65129389|NCT00193050|Mitosis Modulators|mitosis modulators|mesh-ancestor
65129390|NCT00193050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65129391|NCT00193050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65129392|NCT00193050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65129393|NCT04608734|Midazolam|midazolam|mesh-list
65129394|NCT04608734|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65129395|NCT04608734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65129396|NCT04608734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65129397|NCT04608734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129398|NCT04608734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65129399|NCT04608734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65129400|NCT04608734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65129401|NCT04608734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65129437|NCT00192036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65129438|NCT00192036|Immunologic Factors|immunologic factors|mesh-ancestor
65129439|NCT00192036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129440|NCT00191724|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
65129442|NCT00191724|Protein C|protein c|mesh-list
65129443|NCT00191724|Anticoagulants|anticoagulants|mesh-ancestor
65129444|NCT00191724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65129445|NCT00191724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65129464|NCT00191646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129465|NCT00191451|Gemcitabine|gemcitabine|mesh-list
65129466|NCT00191451|Carboplatin|carboplatin|mesh-list
64771988|NCT01250730|Crizotinib|crizotinib|mesh-list
65129467|NCT00191451|Trastuzumab|trastuzumab|mesh-list
65129468|NCT00191451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129469|NCT00191451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65129470|NCT00191451|Antimetabolites|antimetabolites|mesh-ancestor
65222816|NCT05572684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298577|NCT02628002|Purinergic Agonists|purinergic agonists|mesh-ancestor
65298578|NCT02628002|Purinergic Agents|purinergic agents|mesh-ancestor
65298579|NCT02628002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65298580|NCT02628002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298581|NCT02628002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298582|NCT00665054|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65298583|NCT00665054|Vasodilator Agents|vasodilator agents|mesh-ancestor
65298584|NCT00665054|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65298585|NCT00665054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65298586|NCT00665054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298587|NCT00665054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298588|NCT00665054|Urological Agents|urological agents|mesh-ancestor
65298589|NCT02622672|Coenzyme Q10|coenzyme q10|mesh-list
65298590|NCT02622672|Micronutrients|micronutrients|mesh-ancestor
65129471|NCT00191451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129473|NCT00191451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65129474|NCT00191451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129475|NCT00191451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65129476|NCT00191451|Immunologic Factors|immunologic factors|mesh-ancestor
65129477|NCT00191451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129478|NCT00191451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65129479|NCT00191334|Gemcitabine|gemcitabine|mesh-list
65129480|NCT00191334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129481|NCT00191334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65129482|NCT00191334|Antimetabolites|antimetabolites|mesh-ancestor
65129483|NCT00191334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129484|NCT00191334|Antiviral Agents|antiviral agents|mesh-ancestor
65129485|NCT00191334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65129486|NCT00191334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129487|NCT00191334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65129488|NCT00191334|Immunologic Factors|immunologic factors|mesh-ancestor
65129489|NCT00191334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129490|NCT00191139|Gemcitabine|gemcitabine|mesh-list
65129491|NCT00191139|Cisplatin|cisplatin|mesh-list
65129492|NCT00191139|Docetaxel|docetaxel|mesh-list
65129493|NCT00191139|Etoposide|etoposide|mesh-list
65129494|NCT00191139|Etoposide phosphate|etoposide phosphate|mesh-list
65129495|NCT00191139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129496|NCT00191139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65129497|NCT00191139|Antimetabolites|antimetabolites|mesh-ancestor
65129498|NCT00191139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129499|NCT00191139|Antiviral Agents|antiviral agents|mesh-ancestor
65129500|NCT00191139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65129501|NCT00191139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129502|NCT00191139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65129503|NCT00191139|Immunologic Factors|immunologic factors|mesh-ancestor
65129526|NCT00564551|Calcium|calcium|mesh-list
65129527|NCT00564551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65129528|NCT00564551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129529|NCT00564551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65129530|NCT00190983|Pemetrexed|pemetrexed|mesh-list
65129531|NCT00190983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129532|NCT00190983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129533|NCT00190983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129534|NCT00190983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65129535|NCT00190983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65129536|NCT00190749|Olanzapine|olanzapine|mesh-list
65129537|NCT00190749|Risperidone|risperidone|mesh-list
65129538|NCT00190749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65129539|NCT00190749|Serotonin Agents|serotonin agents|mesh-ancestor
65298591|NCT02622672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298592|NCT02622672|Vitamins|vitamins|mesh-ancestor
65298593|NCT04152356|Sorafenib|sorafenib|mesh-list
65298594|NCT04152356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298595|NCT04152356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65298596|NCT04152356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298597|NCT04152356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298598|NCT04271956|Zanubrutinib|zanubrutinib|mesh-list
65298599|NCT04271956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048487|NCT04620031|Anesthetics, General|anesthetics, general|mesh-ancestor
65298600|NCT04271956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65298601|NCT04271956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298602|NCT04271956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298604|NCT05255146|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65298605|NCT05255146|Anesthetics, General|anesthetics, general|mesh-ancestor
65298606|NCT05255146|Anesthetics|anesthetics|mesh-ancestor
64528816|NCT01529749|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65129540|NCT00190749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65129541|NCT00190749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129542|NCT00190749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129543|NCT00190749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65129544|NCT00190749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64772059|NCT01263132|Vitamins|vitamins|mesh-ancestor
65129545|NCT00190749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65129546|NCT00190749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65129547|NCT00190749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65129548|NCT00190749|Dopamine Agents|dopamine agents|mesh-ancestor
65129549|NCT00190749|Antiemetics|antiemetics|mesh-ancestor
65129550|NCT00190749|Autonomic Agents|autonomic agents|mesh-ancestor
65129551|NCT00190749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65129552|NCT00190749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65129553|NCT00190749|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65129554|NCT00190749|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65129555|NCT00190749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65129556|NCT04607447|Dexamethasone|dexamethasone|mesh-list
65129579|NCT00190671|Immunologic Factors|immunologic factors|mesh-ancestor
65129580|NCT00190671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129581|NCT00190671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65129582|NCT00190671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65129583|NCT00190671|Alkylating Agents|alkylating agents|mesh-ancestor
65129584|NCT00190671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129585|NCT00190671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129586|NCT00190671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65129587|NCT00190671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129588|NCT00190671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65129589|NCT00190671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65129590|NCT04607525|Dexmedetomidine|dexmedetomidine|mesh-list
65129591|NCT04607525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65129592|NCT04607525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65129593|NCT04607525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129594|NCT04607525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65129595|NCT04607525|Analgesics|analgesics|mesh-ancestor
65129596|NCT04607525|Sensory System Agents|sensory system agents|mesh-ancestor
65129597|NCT04607525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65129598|NCT04607525|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65129599|NCT04607525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65129600|NCT04607525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65298607|NCT05255146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65298608|NCT05255146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298609|NCT05255146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65298610|NCT05255146|Analgesics|analgesics|mesh-ancestor
65298611|NCT05255146|Sensory System Agents|sensory system agents|mesh-ancestor
65298612|NCT05255146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65298613|NCT02628080|Atovaquone|atovaquone|mesh-list
65298614|NCT02628080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65298615|NCT02628080|Antimalarials|antimalarials|mesh-ancestor
65298616|NCT02628080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65298617|NCT02628080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65298618|NCT02628080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298619|NCT02628080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298620|NCT00678236|Gentamicins|gentamicins|mesh-list
65129601|NCT04607525|Adrenergic Agents|adrenergic agents|mesh-ancestor
65129602|NCT04607525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65129603|NCT04607525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129605|NCT00198276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64702187|NCT00363116|Daclizumab|daclizumab|mesh-list
65129635|NCT00564668|Insulin Aspart|insulin aspart|mesh-list
65129636|NCT00564668|Biphasic Insulins|biphasic insulins|mesh-list
65129637|NCT00564668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65129638|NCT00564668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129639|NCT00564707|Botulinum Toxins|botulinum toxins|mesh-list
65129640|NCT00564707|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65129641|NCT00564707|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65129642|NCT00564707|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65129643|NCT00564707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65129644|NCT00564707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129645|NCT00564707|Cholinergic Agents|cholinergic agents|mesh-ancestor
65129646|NCT00564707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65129647|NCT00564707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129648|NCT00564707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65129649|NCT00564707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65129680|NCT00589134|Hormone Antagonists|hormone antagonists|mesh-ancestor
65129681|NCT00589134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65129682|NCT00589134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129683|NCT00589251|Penicillins|penicillins|mesh-list
65129684|NCT00589251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65129685|NCT00589251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65129686|NCT00564824|Caffeine|caffeine|mesh-list
65129687|NCT00564824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65129688|NCT00564824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129689|NCT00564824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65129690|NCT00564824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772204|NCT01293396|Insulin, Long-Acting|insulin, long-acting|mesh-list
65129691|NCT00564824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129692|NCT00564824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65129693|NCT00564824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65129705|NCT04605107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65129706|NCT04605107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65129707|NCT04605107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129708|NCT00589953|Epoetin Alfa|epoetin alfa|mesh-list
65129709|NCT00589953|Hematinics|hematinics|mesh-ancestor
65129710|NCT00589992|Ibutilide|ibutilide|mesh-list
65129711|NCT00589992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65129712|NCT00590070|Adenosine|adenosine|mesh-list
65129713|NCT00590070|Nitroprusside|nitroprusside|mesh-list
65129714|NCT00590070|Analgesics|analgesics|mesh-ancestor
65129715|NCT00590070|Sensory System Agents|sensory system agents|mesh-ancestor
65129716|NCT00590070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65298621|NCT00678236|Cimetidine|cimetidine|mesh-list
65298622|NCT00678236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65298623|NCT00678236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65298624|NCT00678236|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65298625|NCT00678236|Histamine Antagonists|histamine antagonists|mesh-ancestor
65298626|NCT00678236|Histamine Agents|histamine agents|mesh-ancestor
65298627|NCT00678236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65298628|NCT00678236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298629|NCT00678236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298630|NCT00678236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65298631|NCT00678236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65298632|NCT00678236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298633|NCT00678236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65298634|NCT00678236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65298635|NCT00678236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65298636|NCT00678314|Ropivacaine|ropivacaine|mesh-list
64528846|NCT02666664|Antimetabolites|antimetabolites|mesh-ancestor
65129717|NCT00590070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129718|NCT00590070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65129719|NCT00590070|Vasodilator Agents|vasodilator agents|mesh-ancestor
65129720|NCT00590070|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65129721|NCT00590070|Purinergic Agonists|purinergic agonists|mesh-ancestor
65129722|NCT00590070|Purinergic Agents|purinergic agents|mesh-ancestor
65129723|NCT00590070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65129724|NCT00590070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129725|NCT00590070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65129726|NCT00590070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65129727|NCT00565019|Triamcinolone|triamcinolone|mesh-list
65129728|NCT00565019|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65129729|NCT00565019|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65129730|NCT00565019|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65129731|NCT00565019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65129732|NCT00565019|Glucocorticoids|glucocorticoids|mesh-ancestor
65129733|NCT00565019|Hormones|hormones|mesh-ancestor
65129734|NCT00565019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65129735|NCT00565019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129736|NCT00565019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65129737|NCT00565019|Immunologic Factors|immunologic factors|mesh-ancestor
65129738|NCT00565019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129739|NCT00565019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129740|NCT00565097|Lanreotide|lanreotide|mesh-list
65129741|NCT00565097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129742|NCT04604756|Losartan|losartan|mesh-list
65129743|NCT04604756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65129744|NCT04604756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65129745|NCT04604756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65129746|NCT04604756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65129747|NCT04604756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129748|NCT00590343|Vatalanib|vatalanib|mesh-list
65129749|NCT00590343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65129750|NCT00590343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129751|NCT00590343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129752|NCT04604678|Metformin|metformin|mesh-list
65129753|NCT04604678|Naltrexone|naltrexone|mesh-list
65129754|NCT04604678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65129755|NCT04604678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298637|NCT00678314|Anesthetics, Local|anesthetics, local|mesh-ancestor
65298638|NCT00678314|Anesthetics|anesthetics|mesh-ancestor
65298639|NCT00678314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65298640|NCT00678314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298641|NCT00678314|Sensory System Agents|sensory system agents|mesh-ancestor
65298642|NCT00678314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65298643|NCT02566720|Amantadine|amantadine|mesh-list
65298644|NCT02566720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64528862|NCT02386488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64528863|NCT02386488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129756|NCT04604678|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65129757|NCT04604678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65129758|NCT04604678|Sensory System Agents|sensory system agents|mesh-ancestor
64702336|NCT00005589|Cytarabine|cytarabine|mesh-list
65129787|NCT00565175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65129788|NCT00565175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129789|NCT00565175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129790|NCT00477165|Citalopram|citalopram|mesh-list
65129791|NCT00477165|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65129792|NCT00477165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65129793|NCT00477165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65129794|NCT00477165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129795|NCT00477165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65129796|NCT00477165|Serotonin Agents|serotonin agents|mesh-ancestor
65129797|NCT00477165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129798|NCT00477165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65129799|NCT00477165|Antidepressive Agents|antidepressive agents|mesh-ancestor
65129800|NCT00477165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65129801|NCT04604054|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65129802|NCT04604054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65129803|NCT04604054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129804|NCT00476229|Rituximab|rituximab|mesh-list
65129835|NCT00476151|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65129836|NCT00476151|Antidepressive Agents|antidepressive agents|mesh-ancestor
65129837|NCT00476151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65129838|NCT00476151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65129839|NCT00476151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65129840|NCT00476151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65129841|NCT00476151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65129842|NCT00476151|Adrenergic Agents|adrenergic agents|mesh-ancestor
65129843|NCT04603664|Cystatins|cystatins|mesh-list
65129844|NCT04603664|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65129845|NCT04603664|Protease Inhibitors|protease inhibitors|mesh-ancestor
65129846|NCT04603664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129859|NCT00474903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65129860|NCT00474903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129861|NCT00474903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65129862|NCT00474903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65129863|NCT00474903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65129864|NCT00474903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65129865|NCT00474903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65129866|NCT00474903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65129867|NCT00474903|Antipyretics|antipyretics|mesh-ancestor
65129868|NCT01134055|Ranibizumab|ranibizumab|mesh-list
65129869|NCT01134055|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65129870|NCT01134055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65129871|NCT01134055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65129872|NCT01134055|Growth Substances|growth substances|mesh-ancestor
65129873|NCT01134055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129874|NCT01134055|Growth Inhibitors|growth inhibitors|mesh-ancestor
65129875|NCT01134055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129876|NCT01134055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65129877|NCT00474708|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65298645|NCT02566720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65298646|NCT02566720|Antiviral Agents|antiviral agents|mesh-ancestor
65298647|NCT02566720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65298648|NCT02566720|Dopamine Agents|dopamine agents|mesh-ancestor
65298649|NCT02566720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65298650|NCT02566720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298651|NCT02566720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298652|NCT02566720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65298653|NCT02566720|Analgesics|analgesics|mesh-ancestor
65298654|NCT02566720|Sensory System Agents|sensory system agents|mesh-ancestor
65298655|NCT02566720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65298656|NCT00675194|Capecitabine|capecitabine|mesh-list
65298657|NCT00675194|Irinotecan|irinotecan|mesh-list
65298658|NCT00675194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298659|NCT00675194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65298660|NCT00675194|Antimetabolites|antimetabolites|mesh-ancestor
65298661|NCT00675194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298662|NCT00675194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65298663|NCT00675194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65298664|NCT00675194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298665|NCT00665522|Fentanyl|fentanyl|mesh-list
65298666|NCT00665522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65298667|NCT00665522|Narcotics|narcotics|mesh-ancestor
65298668|NCT00665522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65298669|NCT00665522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298670|NCT00665522|Analgesics|analgesics|mesh-ancestor
65298671|NCT00665522|Sensory System Agents|sensory system agents|mesh-ancestor
65129878|NCT00474708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65129879|NCT00474708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65129880|NCT00474708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65129881|NCT00474708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129882|NCT00474708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65129883|NCT00474708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129884|NCT00474708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65129885|NCT00474708|Antidepressive Agents|antidepressive agents|mesh-ancestor
65129886|NCT00474708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65129887|NCT00474240|Atorvastatin|atorvastatin|mesh-list
65129888|NCT00474240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65129889|NCT00474240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65129890|NCT00474240|Antimetabolites|antimetabolites|mesh-ancestor
65129891|NCT00474240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129892|NCT00474240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65129893|NCT00474240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65129894|NCT00474240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129895|NCT04602767|Phenylephrine|phenylephrine|mesh-list
65129896|NCT04602767|Vasopressins|vasopressins|mesh-list
65298672|NCT00665522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65298673|NCT00665522|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65298674|NCT00665522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65298675|NCT00665522|Anesthetics, General|anesthetics, general|mesh-ancestor
65298676|NCT00665522|Anesthetics|anesthetics|mesh-ancestor
65298677|NCT00675272|Hydrocortisone|hydrocortisone|mesh-list
65129897|NCT04602767|Arginine Vasopressin|arginine vasopressin|mesh-list
65129898|NCT04602767|Oxymetazoline|oxymetazoline|mesh-list
65129899|NCT04602767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65129900|NCT04602767|Mydriatics|mydriatics|mesh-ancestor
65129901|NCT04602767|Autonomic Agents|autonomic agents|mesh-ancestor
65129902|NCT04602767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65129903|NCT04602767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129904|NCT04602767|Sympathomimetics|sympathomimetics|mesh-ancestor
65129905|NCT04602767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65129906|NCT04602767|Nasal Decongestants|nasal decongestants|mesh-ancestor
65129907|NCT04602767|Respiratory System Agents|respiratory system agents|mesh-ancestor
65129928|NCT00473889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65129930|NCT00565214|Vitamins|vitamins|mesh-list
65129931|NCT00565214|Vitamin E|vitamin e|mesh-list
65129932|NCT00565214|Selenium|selenium|mesh-list
65129933|NCT00565214|Micronutrients|micronutrients|mesh-ancestor
65129934|NCT00565214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129935|NCT00565214|Antioxidants|antioxidants|mesh-ancestor
65129936|NCT00565214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129937|NCT00565214|Protective Agents|protective agents|mesh-ancestor
65129938|NCT00565214|Trace Elements|trace elements|mesh-ancestor
65129939|NCT00565253|Nitric Oxide|nitric oxide|mesh-list
65129940|NCT00565253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65129941|NCT00565253|Autonomic Agents|autonomic agents|mesh-ancestor
65129942|NCT00565253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65129943|NCT00565253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129944|NCT00565253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65129945|NCT00565253|Respiratory System Agents|respiratory system agents|mesh-ancestor
65129946|NCT00565253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65129947|NCT00565253|Antioxidants|antioxidants|mesh-ancestor
64662996|NCT01480232|Cholinergic Agents|cholinergic agents|mesh-ancestor
65129948|NCT00565253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129949|NCT00565253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65129950|NCT00565253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65129951|NCT00565253|Vasodilator Agents|vasodilator agents|mesh-ancestor
65129952|NCT00565253|Gasotransmitters|gasotransmitters|mesh-ancestor
65129953|NCT00565253|Protective Agents|protective agents|mesh-ancestor
65129954|NCT02277600|Darunavir|darunavir|mesh-list
65129955|NCT02277600|Cobicistat|cobicistat|mesh-list
65129956|NCT02277600|Fostemsavir|fostemsavir|mesh-list
65129957|NCT02277600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65129958|NCT02277600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65129959|NCT02277600|Protease Inhibitors|protease inhibitors|mesh-ancestor
65129960|NCT02277600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129961|NCT02277600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129962|NCT02277600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65129985|NCT02277717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65129986|NCT02277717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129987|NCT04601675|Dexamethasone|dexamethasone|mesh-list
65129988|NCT04601675|Ranibizumab|ranibizumab|mesh-list
65129989|NCT04601675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65129990|NCT04601675|Antiemetics|antiemetics|mesh-ancestor
65129991|NCT04601675|Autonomic Agents|autonomic agents|mesh-ancestor
65129992|NCT04601675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65129993|NCT04601675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129994|NCT04601675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65129995|NCT04601675|Glucocorticoids|glucocorticoids|mesh-ancestor
65129996|NCT04601675|Hormones|hormones|mesh-ancestor
65129997|NCT04601675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65129998|NCT04601675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65129999|NCT04601675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130000|NCT04601675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65130001|NCT04601675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65130002|NCT04601675|Growth Substances|growth substances|mesh-ancestor
65130003|NCT04601675|Growth Inhibitors|growth inhibitors|mesh-ancestor
65130004|NCT00565292|Anacetrapib|anacetrapib|mesh-list
65298678|NCT00675272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65298679|NCT00678626|Docetaxel|docetaxel|mesh-list
65298680|NCT00678626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298681|NCT00678626|Tubulin Modulators|tubulin modulators|mesh-ancestor
65298682|NCT00678626|Antimitotic Agents|antimitotic agents|mesh-ancestor
65298683|NCT00678626|Mitosis Modulators|mitosis modulators|mesh-ancestor
65298684|NCT00678626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298685|NCT00678704|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65298686|NCT00678704|Vasodilator Agents|vasodilator agents|mesh-ancestor
65130005|NCT00565292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65130006|NCT00565292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65130007|NCT00565292|Antimetabolites|antimetabolites|mesh-ancestor
65130008|NCT00565292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130009|NCT00565292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65130010|NCT01580865|Mycophenolic Acid|mycophenolic acid|mesh-list
65130011|NCT01580865|Tacrolimus|tacrolimus|mesh-list
65130012|NCT01580865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65130013|NCT01580865|Immunologic Factors|immunologic factors|mesh-ancestor
65130014|NCT01580865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130015|NCT01580865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65130016|NCT01580865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130029|NCT00473694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65130030|NCT00473694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65130031|NCT00473694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65130032|NCT00473694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130033|NCT00473694|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65130034|NCT00473694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130035|NCT00473694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130036|NCT00473694|Cholinergic Agents|cholinergic agents|mesh-ancestor
65130037|NCT00473694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65130038|NCT00473694|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65130039|NCT00473694|Autonomic Agents|autonomic agents|mesh-ancestor
65130040|NCT00473694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65130041|NCT00473694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65130042|NCT00473694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65130043|NCT00473694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65130044|NCT04601324|Fluticasone|fluticasone|mesh-list
65130045|NCT04601324|Xhance|xhance|mesh-list
65130046|NCT04601324|Azelastine|azelastine|mesh-list
65130047|NCT04601324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65130048|NCT04601324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65130049|NCT04601324|Autonomic Agents|autonomic agents|mesh-ancestor
65130050|NCT04601324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65130051|NCT04601324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130052|NCT04601324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65130053|NCT04601324|Respiratory System Agents|respiratory system agents|mesh-ancestor
65130054|NCT04601324|Dermatologic Agents|dermatologic agents|mesh-ancestor
65130055|NCT04601324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65130056|NCT04601324|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65130057|NCT04601324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130058|NCT04601324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130059|NCT04601324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65130060|NCT04601324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65130061|NCT04601324|Histamine Antagonists|histamine antagonists|mesh-ancestor
65130062|NCT04601324|Histamine Agents|histamine agents|mesh-ancestor
65130063|NCT04601324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65130064|NCT02215980|Dexamethasone|dexamethasone|mesh-list
65130065|NCT02215980|Lenalidomide|lenalidomide|mesh-list
65130066|NCT02215980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65130067|NCT02215980|Antiemetics|antiemetics|mesh-ancestor
65130068|NCT02215980|Autonomic Agents|autonomic agents|mesh-ancestor
65130069|NCT02215980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65130070|NCT02215980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130071|NCT02215980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65130072|NCT02215980|Glucocorticoids|glucocorticoids|mesh-ancestor
65130073|NCT02215980|Hormones|hormones|mesh-ancestor
65222818|NCT02699385|Antiemetics|antiemetics|mesh-ancestor
65298687|NCT00678704|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65298688|NCT00678704|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65130074|NCT02215980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65130075|NCT02215980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65130076|NCT02215980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130077|NCT02215980|Immunologic Factors|immunologic factors|mesh-ancestor
65130078|NCT02215980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64702660|NCT02483000|Immunologic Factors|immunologic factors|mesh-ancestor
65130096|NCT00582920|Zoledronic Acid|zoledronic acid|mesh-list
65130097|NCT00582920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65130098|NCT00582920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130099|NCT00473382|Ranibizumab|ranibizumab|mesh-list
65130100|NCT00473382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65130101|NCT00473382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65130102|NCT00473382|Growth Substances|growth substances|mesh-ancestor
65130103|NCT00473382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130104|NCT00473382|Growth Inhibitors|growth inhibitors|mesh-ancestor
65130105|NCT00473382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130106|NCT04576364|Magnesium Sulfate|magnesium sulfate|mesh-list
65130107|NCT04576364|Analgesics|analgesics|mesh-ancestor
65130108|NCT04576364|Sensory System Agents|sensory system agents|mesh-ancestor
65130109|NCT04576364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65130110|NCT04576364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130111|NCT04576364|Anesthetics|anesthetics|mesh-ancestor
65130112|NCT04576364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65130113|NCT04576364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65130114|NCT04576364|Anticonvulsants|anticonvulsants|mesh-ancestor
65130115|NCT04576364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65130116|NCT04576364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65130117|NCT04576364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130118|NCT04576364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65130119|NCT04576364|Tocolytic Agents|tocolytic agents|mesh-ancestor
65130120|NCT04576364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65130121|NCT02210325|Azithromycin|azithromycin|mesh-list
65130122|NCT02210325|Ceftriaxone|ceftriaxone|mesh-list
65130123|NCT02210325|Solithromycin|solithromycin|mesh-list
65130124|NCT02210325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65130125|NCT02210325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65130126|NCT00473265|Teriparatide|teriparatide|mesh-list
65130127|NCT00473265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65130128|NCT00473265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130129|NCT00473265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65130130|NCT00472641|Ziprasidone|ziprasidone|mesh-list
65130131|NCT00472641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65130132|NCT00472641|Serotonin Agents|serotonin agents|mesh-ancestor
65130133|NCT00472641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65130134|NCT00472641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130135|NCT00472641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130136|NCT00472641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65130137|NCT00472641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65130138|NCT00472641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64772656|NCT01351740|Ritonavir|ritonavir|mesh-list
65130139|NCT00472641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65130140|NCT00472641|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65130141|NCT00472641|Dopamine Agents|dopamine agents|mesh-ancestor
65130142|NCT04576208|Antidiarrheals|antidiarrheals|mesh-list
65130143|NCT04576208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65130144|NCT04571151|Halobetasol|halobetasol|mesh-list
65130145|NCT04571151|Calcipotriene|calcipotriene|mesh-list
65130146|NCT04571151|Dermatologic Agents|dermatologic agents|mesh-ancestor
65130147|NCT04571151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65130148|NCT01133977|Lenvatinib|lenvatinib|mesh-list
65130149|NCT01133977|Dacarbazine|dacarbazine|mesh-list
65130150|NCT01133977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130151|NCT01133977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65130152|NCT01133977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130153|NCT01133977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130154|NCT01133977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65130155|NCT01133977|Alkylating Agents|alkylating agents|mesh-ancestor
65130156|NCT00583193|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65130157|NCT00583193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65130158|NCT00583193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65298689|NCT00678704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298690|NCT00678704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298691|NCT00678704|Urological Agents|urological agents|mesh-ancestor
65298692|NCT00678782|Etanercept|etanercept|mesh-list
65298693|NCT00678782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65298694|NCT00678782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65298695|NCT00678782|Analgesics|analgesics|mesh-ancestor
65298696|NCT00678782|Sensory System Agents|sensory system agents|mesh-ancestor
65298697|NCT00678782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65298698|NCT00678782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298699|NCT00678782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65298700|NCT00678782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65298701|NCT00678782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65298702|NCT00678782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65298703|NCT00678782|Immunologic Factors|immunologic factors|mesh-ancestor
64528910|NCT01511939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65130159|NCT00583193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65130160|NCT00583193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130161|NCT00583193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65130162|NCT00583193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130163|NCT00583193|Analgesics|analgesics|mesh-ancestor
65130164|NCT00583193|Sensory System Agents|sensory system agents|mesh-ancestor
65130165|NCT00583193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65130166|NCT00583193|Antidepressive Agents|antidepressive agents|mesh-ancestor
65130167|NCT00583193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65130168|NCT00583193|Dopamine Agents|dopamine agents|mesh-ancestor
65130169|NCT01133821|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65130170|NCT01133821|Antidepressive Agents|antidepressive agents|mesh-ancestor
65130171|NCT01133821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65130172|NCT01133821|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65130173|NCT01133821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65130174|NCT01133821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65130175|NCT01133821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130176|NCT00583271|Ethanol|ethanol|mesh-list
65130177|NCT00583271|Triamcinolone|triamcinolone|mesh-list
65130178|NCT00583271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65130179|NCT00583271|Glucocorticoids|glucocorticoids|mesh-ancestor
65130180|NCT00583271|Hormones|hormones|mesh-ancestor
65130181|NCT00583271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65130182|NCT00583271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130183|NCT00583271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65130184|NCT00583271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65130185|NCT00583271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65130186|NCT04571229|Mifamurtide|mifamurtide|mesh-list
65130187|NCT04571229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65130188|NCT04571229|Immunologic Factors|immunologic factors|mesh-ancestor
65130189|NCT04571229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130190|NCT00583349|Paclitaxel|paclitaxel|mesh-list
65130191|NCT00583349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65130192|NCT00583349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130193|NCT00583349|Tubulin Modulators|tubulin modulators|mesh-ancestor
65130194|NCT00583349|Antimitotic Agents|antimitotic agents|mesh-ancestor
65130195|NCT00583349|Mitosis Modulators|mitosis modulators|mesh-ancestor
65130196|NCT00583349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130197|NCT01133665|Lenalidomide|lenalidomide|mesh-list
65130198|NCT01133665|Cetuximab|cetuximab|mesh-list
65130199|NCT01133665|Immunologic Factors|immunologic factors|mesh-ancestor
65130200|NCT01133665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298704|NCT04707352|Dapagliflozin|dapagliflozin|mesh-list
65298705|NCT04707352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65298706|NCT04707352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298707|NCT04707352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65298708|NCT04707352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298709|NCT04061200|Empagliflozin|empagliflozin|mesh-list
65298710|NCT04061200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65298711|NCT04061200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298712|NCT04061200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65298713|NCT04061200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298714|NCT00675350|Homoharringtonine|homoharringtonine|mesh-list
65298715|NCT00675350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65298716|NCT00675350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130201|NCT01133665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65130202|NCT01133665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65130203|NCT01133665|Growth Substances|growth substances|mesh-ancestor
65130204|NCT01133665|Growth Inhibitors|growth inhibitors|mesh-ancestor
65130205|NCT01133665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130206|NCT01133665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65130207|NCT00583427|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
65130208|NCT00583427|Anticoagulants|anticoagulants|mesh-ancestor
65130238|NCT00471354|Adrenergic Agents|adrenergic agents|mesh-ancestor
65130239|NCT00471354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65130240|NCT00471354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130241|NCT01133275|Prednisone|prednisone|mesh-list
65130242|NCT01133275|Lenalidomide|lenalidomide|mesh-list
65130243|NCT01133275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65130244|NCT01133275|Glucocorticoids|glucocorticoids|mesh-ancestor
65130245|NCT01133275|Hormones|hormones|mesh-ancestor
65130246|NCT01133275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65130247|NCT01133275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130248|NCT01133275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65130249|NCT01133275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130250|NCT01133275|Immunologic Factors|immunologic factors|mesh-ancestor
65130251|NCT01133275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64702860|NCT00430183|Fertility Agents|fertility agents|mesh-ancestor
65130262|NCT02882893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130263|NCT02882893|Cholinergic Agents|cholinergic agents|mesh-ancestor
65130264|NCT02882893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65130265|NCT02210364|Capecitabine|capecitabine|mesh-list
65130266|NCT02210364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65130267|NCT02210364|Antimetabolites|antimetabolites|mesh-ancestor
65130268|NCT02210364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130269|NCT02210364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130270|NCT00471315|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65130271|NCT00471315|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65130272|NCT00471315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65130273|NCT00471315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65130274|NCT00471315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130275|NCT00471315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65130276|NCT00471315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130277|NCT00471315|Analgesics|analgesics|mesh-ancestor
65130278|NCT00471315|Sensory System Agents|sensory system agents|mesh-ancestor
65130279|NCT00471315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65130280|NCT00471315|Antidepressive Agents|antidepressive agents|mesh-ancestor
65130281|NCT00471315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65130282|NCT00471315|Dopamine Agents|dopamine agents|mesh-ancestor
65130283|NCT00471237|Alendronate|alendronate|mesh-list
65298717|NCT00675350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65298718|NCT00675350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298719|NCT00675350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298720|NCT02565862|Metformin|metformin|mesh-list
65298721|NCT02565862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65298722|NCT02565862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298723|NCT00665600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65298724|NCT00665600|Albuterol|albuterol|mesh-list
65130284|NCT00471237|Teriparatide|teriparatide|mesh-list
65130285|NCT00471237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65130286|NCT00471237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130287|NCT00471237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65130288|NCT04570683|Nivolumab|nivolumab|mesh-list
65130289|NCT04570683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65130290|NCT04570683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130291|NCT04570683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65130292|NCT04570683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130293|NCT04570449|Fluoxetine|fluoxetine|mesh-list
65130294|NCT04570449|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65130295|NCT04570449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65130296|NCT04570449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65130297|NCT04570449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130298|NCT04570449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65130299|NCT04570449|Serotonin Agents|serotonin agents|mesh-ancestor
65130300|NCT04570449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130301|NCT04570449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65130302|NCT04570449|Antidepressive Agents|antidepressive agents|mesh-ancestor
65130303|NCT04570449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65130304|NCT04570449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65130305|NCT04570449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65130306|NCT04570449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130307|NCT00470847|Trastuzumab|trastuzumab|mesh-list
65130308|NCT00470847|Lapatinib|lapatinib|mesh-list
65130309|NCT00470847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65130310|NCT00470847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130311|NCT00470847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65130312|NCT00470847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130316|NCT00584090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65130317|NCT00584090|Cholinergic Agents|cholinergic agents|mesh-ancestor
65130318|NCT00584090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65130319|NCT00584090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130320|NCT00584090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130321|NCT00584090|Urological Agents|urological agents|mesh-ancestor
65130323|NCT00584168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65130324|NCT00584168|Antiemetics|antiemetics|mesh-ancestor
65130325|NCT00584168|Autonomic Agents|autonomic agents|mesh-ancestor
65130326|NCT00584168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65130327|NCT00584168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130328|NCT00584168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65130329|NCT00584168|Glucocorticoids|glucocorticoids|mesh-ancestor
65130330|NCT00584168|Hormones|hormones|mesh-ancestor
65130331|NCT00584168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65130332|NCT00584168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65130333|NCT00584168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130334|NCT00470535|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65130335|NCT00470535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130336|NCT00470535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65130337|NCT00470535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130338|NCT00470535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130339|NCT00470184|Capecitabine|capecitabine|mesh-list
65130340|NCT00470184|Oxaliplatin|oxaliplatin|mesh-list
65130341|NCT00470184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65130342|NCT00470184|Antimetabolites|antimetabolites|mesh-ancestor
65130343|NCT00470184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298725|NCT00665600|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65298726|NCT00665600|Autonomic Agents|autonomic agents|mesh-ancestor
65298727|NCT00665600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65298728|NCT00665600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298729|NCT00665600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65298730|NCT00665600|Respiratory System Agents|respiratory system agents|mesh-ancestor
65298731|NCT00665600|Tocolytic Agents|tocolytic agents|mesh-ancestor
65298732|NCT00665600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65298733|NCT00665600|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65298734|NCT00665600|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65298735|NCT00665600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65298736|NCT00665600|Adrenergic Agents|adrenergic agents|mesh-ancestor
65298737|NCT00665600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65298738|NCT00665600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298739|NCT04060888|Ustekinumab|ustekinumab|mesh-list
64528946|NCT04123561|BB 1101|bb 1101|mesh-list
65130344|NCT00470184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130345|NCT04570254|Vitamins|vitamins|mesh-list
65130346|NCT04570254|Vitamin E|vitamin e|mesh-list
65130347|NCT04570254|Acetylcysteine|acetylcysteine|mesh-list
65130348|NCT04570254|Pentoxifylline|pentoxifylline|mesh-list
65130349|NCT04570254|Melatonin|melatonin|mesh-list
65130350|NCT04570254|Antioxidants|antioxidants|mesh-list
65130351|NCT04570254|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65130352|NCT04570254|Micronutrients|micronutrients|mesh-ancestor
65130353|NCT04570254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130354|NCT04570254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130355|NCT04570254|Protective Agents|protective agents|mesh-ancestor
65130356|NCT04570254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65130357|NCT04570254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65130358|NCT04570254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130359|NCT04570254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65130360|NCT04570254|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65130361|NCT04570254|Vasodilator Agents|vasodilator agents|mesh-ancestor
65130362|NCT04570254|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65130363|NCT04570254|Antiviral Agents|antiviral agents|mesh-ancestor
65130364|NCT04570254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65130365|NCT04570254|Expectorants|expectorants|mesh-ancestor
65130366|NCT04570254|Respiratory System Agents|respiratory system agents|mesh-ancestor
65130367|NCT04570254|Antidotes|antidotes|mesh-ancestor
65130368|NCT00470067|Carboplatin|carboplatin|mesh-list
65130369|NCT00470067|Doxorubicin|doxorubicin|mesh-list
65130370|NCT00470067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65130371|NCT00470067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130372|NCT00470067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65130373|NCT00470067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65130374|NCT00470067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65130375|NCT00470067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130376|NCT00470067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130377|NCT00584636|Budesonide|budesonide|mesh-list
65130378|NCT00584636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65130379|NCT00584636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65130380|NCT00584636|Autonomic Agents|autonomic agents|mesh-ancestor
65130381|NCT00584636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65130382|NCT00584636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130390|NCT00479817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65130391|NCT00479817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130392|NCT00479817|Tubulin Modulators|tubulin modulators|mesh-ancestor
65130393|NCT00479817|Antimitotic Agents|antimitotic agents|mesh-ancestor
65130394|NCT00479817|Mitosis Modulators|mitosis modulators|mesh-ancestor
65298740|NCT04060888|Dermatologic Agents|dermatologic agents|mesh-ancestor
65298741|NCT00879398|Fesoterodine|fesoterodine|mesh-list
65298742|NCT00879398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65298743|NCT00879398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65298744|NCT00879398|Cholinergic Agents|cholinergic agents|mesh-ancestor
65298745|NCT00879398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65298746|NCT00879398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298747|NCT00879398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298748|NCT00879398|Urological Agents|urological agents|mesh-ancestor
65298750|NCT00679250|Levocetirizine|levocetirizine|mesh-list
64528961|NCT01510769|Febuxostat|febuxostat|mesh-list
65130395|NCT00479817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130396|NCT00479817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65130397|NCT00479817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65130398|NCT00479817|Growth Substances|growth substances|mesh-ancestor
65130399|NCT00479817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130400|NCT00479817|Growth Inhibitors|growth inhibitors|mesh-ancestor
65130402|NCT04575194|Naltrexone|naltrexone|mesh-list
65130403|NCT04575194|Bupropion|bupropion|mesh-list
65130404|NCT04575194|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65130405|NCT04575194|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65130406|NCT04575194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130407|NCT04575194|Sensory System Agents|sensory system agents|mesh-ancestor
65130408|NCT04575194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65130409|NCT04575194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65130410|NCT04575194|Incretins|incretins|mesh-ancestor
65130411|NCT04575194|Hormones|hormones|mesh-ancestor
65130412|NCT04575194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65130413|NCT04575194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65130414|NCT04575194|Antidepressive Agents|antidepressive agents|mesh-ancestor
65130415|NCT04575194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65130416|NCT04575194|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65130417|NCT04575194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65130418|NCT04575194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65130419|NCT04575194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130420|NCT04575194|Dopamine Agents|dopamine agents|mesh-ancestor
65130421|NCT04575194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65130422|NCT04575194|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65130423|NCT04575194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65130424|NCT04575194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130425|NCT00478179|Bupivacaine|bupivacaine|mesh-list
65130426|NCT00478179|Anesthetics, Local|anesthetics, local|mesh-ancestor
65130427|NCT00478179|Anesthetics|anesthetics|mesh-ancestor
65130428|NCT00478179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65130429|NCT00478179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130430|NCT00478179|Sensory System Agents|sensory system agents|mesh-ancestor
65130431|NCT00478179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65130432|NCT00585143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65130433|NCT00585143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65130434|NCT00585143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65130435|NCT00585143|Antimetabolites|antimetabolites|mesh-ancestor
65130436|NCT00585143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130437|NCT00585143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65130438|NCT00585143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65130439|NCT00585143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130440|NCT00585260|Mannitol|mannitol|mesh-list
65130441|NCT00585260|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65130442|NCT00585260|Diuretics|diuretics|mesh-ancestor
65130443|NCT00585260|Natriuretic Agents|natriuretic agents|mesh-ancestor
65130444|NCT00585260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130445|NCT00475020|Fludarabine|fludarabine|mesh-list
65130446|NCT00475020|Fludarabine phosphate|fludarabine phosphate|mesh-list
65130447|NCT00475020|Busulfan|busulfan|mesh-list
65130448|NCT00475020|Thymoglobulin|thymoglobulin|mesh-list
65298751|NCT00679250|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65298752|NCT00679250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65298753|NCT00679250|Histamine Antagonists|histamine antagonists|mesh-ancestor
65298754|NCT00679250|Histamine Agents|histamine agents|mesh-ancestor
65298755|NCT00679250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65298756|NCT00679250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298757|NCT00679250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298758|NCT00679250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65298759|NCT00696436|Valsartan|valsartan|mesh-list
65298760|NCT00696436|Olmesartan|olmesartan|mesh-list
65298761|NCT00696436|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65298762|NCT00696436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65298763|NCT00696436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65298764|NCT00696436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65298765|NCT00696436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130449|NCT00475020|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65130450|NCT00475020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130451|NCT00475020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65130458|NCT00475020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65130460|NCT00585455|Sertraline|sertraline|mesh-list
65130461|NCT00585455|Antidepressive Agents|antidepressive agents|mesh-ancestor
65130462|NCT00585455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65130463|NCT00585455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65130464|NCT00585455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65130465|NCT00585455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65130466|NCT00585455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130467|NCT00585455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65130468|NCT00585455|Serotonin Agents|serotonin agents|mesh-ancestor
65130469|NCT00585455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130470|NCT01083966|Bevacizumab|bevacizumab|mesh-list
65130471|NCT01083966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65130472|NCT01083966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130473|NCT01083966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65130474|NCT01083966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65130475|NCT01083966|Growth Substances|growth substances|mesh-ancestor
65130476|NCT01083966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130477|NCT01083966|Growth Inhibitors|growth inhibitors|mesh-ancestor
65130478|NCT01132807|Prednisone|prednisone|mesh-list
65130479|NCT01132807|Cyclophosphamide|cyclophosphamide|mesh-list
65130480|NCT01132807|Dacarbazine|dacarbazine|mesh-list
65130481|NCT01132807|Doxorubicin|doxorubicin|mesh-list
65130482|NCT01132807|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65130483|NCT01132807|Etoposide|etoposide|mesh-list
65130484|NCT01132807|Bleomycin|bleomycin|mesh-list
65130485|NCT01132807|Vinblastine|vinblastine|mesh-list
65130486|NCT01132807|Etoposide phosphate|etoposide phosphate|mesh-list
65130487|NCT01132807|Procarbazine|procarbazine|mesh-list
65130488|NCT01132807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65130489|NCT01132807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65130490|NCT01132807|Immunologic Factors|immunologic factors|mesh-ancestor
65130491|NCT01132807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130492|NCT01132807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65130493|NCT01132807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65130494|NCT01132807|Alkylating Agents|alkylating agents|mesh-ancestor
65130495|NCT01132807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130496|NCT01132807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130497|NCT01132807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65130498|NCT01132807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65298766|NCT00878072|Famciclovir|famciclovir|mesh-list
65298767|NCT00878072|Antiviral Agents|antiviral agents|mesh-ancestor
65298768|NCT00878072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65298769|NCT00878072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65298770|NCT00878072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298771|NCT00878072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298772|NCT00675740|Rosiglitazone|rosiglitazone|mesh-list
65298773|NCT00675740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65298774|NCT00675740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298775|NCT03045341|Naltrexone|naltrexone|mesh-list
65298776|NCT03045341|Bupropion|bupropion|mesh-list
65298777|NCT03045341|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65298778|NCT03045341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65298779|NCT03045341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298780|NCT03045341|Sensory System Agents|sensory system agents|mesh-ancestor
64936612|NCT05595109|Silymarin|silymarin|mesh-list
65130499|NCT01132807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65130500|NCT01132807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65130501|NCT01132807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130502|NCT01132807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65130503|NCT01132807|Glucocorticoids|glucocorticoids|mesh-ancestor
65130504|NCT01132807|Hormones|hormones|mesh-ancestor
65130505|NCT01132807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65130506|NCT01132807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65130507|NCT01132807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65130508|NCT01132807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65130509|NCT01132807|Tubulin Modulators|tubulin modulators|mesh-ancestor
65130510|NCT01132807|Antimitotic Agents|antimitotic agents|mesh-ancestor
65130511|NCT01132807|Mitosis Modulators|mitosis modulators|mesh-ancestor
65130512|NCT04569513|Parathyroid Hormone|parathyroid hormone|mesh-list
65130513|NCT04569513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65130514|NCT04569513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130515|NCT01089543|Rabeprazole|rabeprazole|mesh-list
65130516|NCT01089543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65130517|NCT01089543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65130518|NCT01089543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65130519|NCT01089543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130531|NCT01089504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130532|NCT01089504|GABA Modulators|gaba modulators|mesh-ancestor
65130533|NCT01089504|GABA Agents|gaba agents|mesh-ancestor
65130534|NCT01089504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64663613|NCT01485380|Analgesics|analgesics|mesh-ancestor
65130535|NCT01089504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65130536|NCT01089504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65130538|NCT03452696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65130539|NCT03452696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130540|NCT01088997|Milrinone|milrinone|mesh-list
65130541|NCT01088997|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65130542|NCT01088997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65130543|NCT01088997|Vasodilator Agents|vasodilator agents|mesh-ancestor
65130544|NCT01088997|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65130545|NCT01088997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65130546|NCT01088997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130547|NCT01088997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130548|NCT01088997|Protective Agents|protective agents|mesh-ancestor
65130549|NCT01088997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130550|NCT00586118|Propofol|propofol|mesh-list
65130551|NCT00586118|Sevoflurane|sevoflurane|mesh-list
65130552|NCT00586118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65222819|NCT02699385|Autonomic Agents|autonomic agents|mesh-ancestor
65298781|NCT03045341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65298782|NCT03045341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65298783|NCT03045341|Antidepressive Agents|antidepressive agents|mesh-ancestor
65298784|NCT03045341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65298785|NCT03045341|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65298786|NCT03045341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65298787|NCT03045341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64529000|NCT02382198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65130553|NCT00586118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65130554|NCT00586118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130555|NCT00586118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65130556|NCT00586118|Anesthetics, General|anesthetics, general|mesh-ancestor
65130557|NCT00586118|Anesthetics|anesthetics|mesh-ancestor
65130558|NCT00586118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65130559|NCT00586118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65130560|NCT01088529|Prednisone|prednisone|mesh-list
65130561|NCT01088529|Leuprolide|leuprolide|mesh-list
65130562|NCT01088529|Goserelin|goserelin|mesh-list
65130563|NCT01088529|Abiraterone Acetate|abiraterone acetate|mesh-list
65130564|NCT01088529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65130565|NCT01088529|Glucocorticoids|glucocorticoids|mesh-ancestor
65130566|NCT01088529|Hormones|hormones|mesh-ancestor
65130567|NCT01088529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65130568|NCT01088529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130569|NCT01088529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65130570|NCT01088529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130571|NCT01088529|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65130572|NCT01088529|Fertility Agents|fertility agents|mesh-ancestor
65130573|NCT01088529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65130574|NCT01088529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65130575|NCT01088529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130576|NCT01088529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130577|NCT01088529|Hormone Antagonists|hormone antagonists|mesh-ancestor
65130578|NCT01088529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65130579|NCT00586274|Fludarabine|fludarabine|mesh-list
65130580|NCT00586274|Alemtuzumab|alemtuzumab|mesh-list
65130581|NCT00586274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130588|NCT00586430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130589|NCT00586430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65130590|NCT00586430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65130591|NCT00586430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65130592|NCT00586430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65130593|NCT00586430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65130594|NCT00586430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65130595|NCT00586430|GABA Modulators|gaba modulators|mesh-ancestor
65130596|NCT00586430|GABA Agents|gaba agents|mesh-ancestor
65130597|NCT00586430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65130598|NCT00586430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130599|NCT04569279|Warfarin|warfarin|mesh-list
65130600|NCT04569279|Rivaroxaban|rivaroxaban|mesh-list
65130601|NCT04569279|Anticoagulants|anticoagulants|mesh-ancestor
65130602|NCT04569279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65130603|NCT04569279|Antithrombins|antithrombins|mesh-ancestor
65130604|NCT04569279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65130605|NCT04569279|Protease Inhibitors|protease inhibitors|mesh-ancestor
65130606|NCT04569279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130607|NCT04569279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130608|NCT04312204|Gemcitabine|gemcitabine|mesh-list
65130609|NCT04312204|Carboplatin|carboplatin|mesh-list
64663676|NCT01422434|Micronutrients|micronutrients|mesh-ancestor
65130611|NCT04312204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65130612|NCT04312204|Antimetabolites|antimetabolites|mesh-ancestor
65130613|NCT04312204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130614|NCT04312204|Antiviral Agents|antiviral agents|mesh-ancestor
65130615|NCT04312204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65298788|NCT03045341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298789|NCT03045341|Dopamine Agents|dopamine agents|mesh-ancestor
65298790|NCT03045341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65298791|NCT03045341|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65298792|NCT03045341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65298793|NCT03045341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298794|NCT00679484|Candesartan|candesartan|mesh-list
64529008|NCT02382432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65130616|NCT04312204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130617|NCT04312204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65130618|NCT04312204|Immunologic Factors|immunologic factors|mesh-ancestor
65130619|NCT04312204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130620|NCT04312282|Itraconazole|itraconazole|mesh-list
65130621|NCT04312282|Rifampin|rifampin|mesh-list
65130622|NCT04312282|Antifungal Agents|antifungal agents|mesh-ancestor
65130623|NCT04312282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65130624|NCT04312282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65130625|NCT04312282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65130626|NCT04312282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130627|NCT04312282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130628|NCT04312282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65130629|NCT04312282|Hormone Antagonists|hormone antagonists|mesh-ancestor
65130630|NCT04312282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65130631|NCT04312282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130632|NCT04312282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65130633|NCT04312282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65130634|NCT04312282|Antitubercular Agents|antitubercular agents|mesh-ancestor
65130635|NCT04312282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65130636|NCT04312282|Leprostatic Agents|leprostatic agents|mesh-ancestor
65130637|NCT04312282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65130638|NCT04312282|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65130639|NCT04312282|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65130640|NCT04312282|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65130641|NCT04312282|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65130642|NCT04312282|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65130643|NCT04312282|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65130644|NCT01087905|Nicotine|nicotine|mesh-list
65130645|NCT01087905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65130646|NCT01087905|Autonomic Agents|autonomic agents|mesh-ancestor
65130647|NCT01087905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65130648|NCT01087905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130649|NCT01087905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65130650|NCT01087905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65130654|NCT01087788|Certolizumab Pegol|certolizumab pegol|mesh-list
65130655|NCT01087788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65130656|NCT01087788|Immunologic Factors|immunologic factors|mesh-ancestor
65130657|NCT01087788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130658|NCT01087788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65130659|NCT00586976|Ropivacaine|ropivacaine|mesh-list
65130660|NCT00586976|Anesthetics, Local|anesthetics, local|mesh-ancestor
65130661|NCT00586976|Anesthetics|anesthetics|mesh-ancestor
65130662|NCT00586976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65130663|NCT00586976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130664|NCT00586976|Sensory System Agents|sensory system agents|mesh-ancestor
65130665|NCT00586976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65130666|NCT00587015|Immunotoxin HA22|immunotoxin ha22|mesh-list
65130667|NCT00587015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130669|NCT04568772|Proguanil|proguanil|mesh-list
65130670|NCT04568772|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
65130671|NCT04568772|Esomeprazole|esomeprazole|mesh-list
65130672|NCT04568772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65130673|NCT04568772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65130674|NCT04568772|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65130675|NCT04568772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298795|NCT00679484|Candesartan cilexetil|candesartan cilexetil|mesh-list
65298796|NCT00679484|Olmesartan|olmesartan|mesh-list
65298797|NCT00679484|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65298798|NCT00679484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65298799|NCT00679484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65298800|NCT00679484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65298801|NCT00679484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130676|NCT04568772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130677|NCT04568772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65130678|NCT04568772|Antimalarials|antimalarials|mesh-ancestor
65130679|NCT04568772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65130680|NCT04568772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65130681|NCT04568772|Antimetabolites|antimetabolites|mesh-ancestor
65130682|NCT04575389|Uric Acid|uric acid|mesh-list
65130683|NCT04575389|Antioxidants|antioxidants|mesh-ancestor
65130684|NCT04575389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130685|NCT04575389|Protective Agents|protective agents|mesh-ancestor
65130686|NCT04575389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130687|NCT01086150|Lidocaine|lidocaine|mesh-list
65130688|NCT01086150|Anesthetics, Local|anesthetics, local|mesh-ancestor
65130689|NCT01086150|Anesthetics|anesthetics|mesh-ancestor
65130690|NCT01086150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65130691|NCT01086150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130692|NCT01086150|Sensory System Agents|sensory system agents|mesh-ancestor
65130693|NCT01086150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65130694|NCT01086150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65130695|NCT01086150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65130696|NCT01086150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65130697|NCT01086150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65130698|NCT01086150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130699|NCT00587249|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65130700|NCT00587249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65130701|NCT00587249|Immunologic Factors|immunologic factors|mesh-ancestor
65130702|NCT00587249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130703|NCT00587249|Antacids|antacids|mesh-ancestor
65130704|NCT00587249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130705|NCT00587249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65130706|NCT00587327|Atosiban|atosiban|mesh-list
65130707|NCT00587327|Hormone Antagonists|hormone antagonists|mesh-ancestor
65130708|NCT00587327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65130709|NCT00587327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130710|NCT00587327|Tocolytic Agents|tocolytic agents|mesh-ancestor
65130711|NCT00587327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65130712|NCT00587444|Heparin|heparin|mesh-list
65130713|NCT00587444|Calcium heparin|calcium heparin|mesh-list
65130714|NCT00587444|Anticoagulants|anticoagulants|mesh-ancestor
65130715|NCT00587444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65130716|NCT00587444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65130717|NCT00587444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130718|NCT02278302|Ethanol|ethanol|mesh-list
65130719|NCT02278302|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
65130720|NCT02278302|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65130721|NCT02278302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64703304|NCT02535806|Vincristine|vincristine|mesh-list
65130741|NCT00587873|Calcium|calcium|mesh-list
65130742|NCT00587873|Levoleucovorin|levoleucovorin|mesh-list
65130743|NCT00587873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65130744|NCT00587873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130745|NCT00587873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65130746|NCT00587873|Abortifacient Agents|abortifacient agents|mesh-ancestor
65130747|NCT00587873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65130748|NCT00587873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65130749|NCT00587873|Antimetabolites|antimetabolites|mesh-ancestor
65130750|NCT00587873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130751|NCT00587873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130752|NCT00587873|Dermatologic Agents|dermatologic agents|mesh-ancestor
65298802|NCT00679640|Candesartan|candesartan|mesh-list
65298803|NCT00679640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65298804|NCT00679640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65298805|NCT00679640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65298806|NCT00679640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298807|NCT00921388|Varenicline|varenicline|mesh-list
65298808|NCT00921388|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64529021|NCT02382432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65130753|NCT00587873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130754|NCT00587873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65130755|NCT00587873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65130757|NCT00587873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65130758|NCT00587873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65130759|NCT00587873|Antidotes|antidotes|mesh-ancestor
65130760|NCT00587873|Protective Agents|protective agents|mesh-ancestor
65130761|NCT00587873|Vitamin B Complex|vitamin b complex|mesh-ancestor
65130762|NCT00587873|Vitamins|vitamins|mesh-ancestor
65130763|NCT00587873|Micronutrients|micronutrients|mesh-ancestor
65130764|NCT01084707|Nicotine|nicotine|mesh-list
65130765|NCT01084707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65130766|NCT01084707|Autonomic Agents|autonomic agents|mesh-ancestor
65130767|NCT01084707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65130768|NCT01084707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130769|NCT01084707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65130770|NCT01084707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65130771|NCT01084707|Cholinergic Agents|cholinergic agents|mesh-ancestor
65130772|NCT01084707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65130773|NCT01084707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130774|NCT02210598|Oxytocin|oxytocin|mesh-list
65130775|NCT02210598|Oxytocics|oxytocics|mesh-ancestor
65130776|NCT02210598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65130777|NCT02210598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703399|NCT02531971|Fentanyl|fentanyl|mesh-list
65130785|NCT04574960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65130786|NCT04574960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130787|NCT04574960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65130788|NCT04574960|Immunologic Factors|immunologic factors|mesh-ancestor
65130789|NCT04574960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130790|NCT03452657|Ranibizumab|ranibizumab|mesh-list
65130791|NCT03452657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65130792|NCT03452657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65130793|NCT03452657|Growth Substances|growth substances|mesh-ancestor
65130794|NCT03452657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130795|NCT03452657|Growth Inhibitors|growth inhibitors|mesh-ancestor
65130796|NCT03452657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130797|NCT03452501|Infliximab|infliximab|mesh-list
65130798|NCT03452501|Dermatologic Agents|dermatologic agents|mesh-ancestor
65130799|NCT03452501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65130800|NCT03452501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65130801|NCT01084083|Paclitaxel|paclitaxel|mesh-list
65130802|NCT01084083|Cetuximab|cetuximab|mesh-list
65130803|NCT01084083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65130804|NCT01084083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130805|NCT01084083|Tubulin Modulators|tubulin modulators|mesh-ancestor
65130806|NCT01084083|Antimitotic Agents|antimitotic agents|mesh-ancestor
65130807|NCT01084083|Mitosis Modulators|mitosis modulators|mesh-ancestor
64773330|NCT01515540|Anesthetics, Local|anesthetics, local|mesh-ancestor
65130808|NCT01084083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130809|NCT01084083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65130810|NCT00588302|Moexipril|moexipril|mesh-list
65130811|NCT00588302|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65130812|NCT00588302|Protease Inhibitors|protease inhibitors|mesh-ancestor
65130813|NCT00588302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130814|NCT00588302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130815|NCT00588302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65130816|NCT01084005|Linagliptin|linagliptin|mesh-list
65130817|NCT01084005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65130818|NCT01084005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298809|NCT00921388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65298810|NCT00921388|Cholinergic Agents|cholinergic agents|mesh-ancestor
65298811|NCT00921388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65298812|NCT00921388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298813|NCT00921388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298814|NCT04211987|Cytarabine|cytarabine|mesh-list
65298815|NCT04211987|Methotrexate|methotrexate|mesh-list
65298816|NCT04211987|Etoposide|etoposide|mesh-list
65298817|NCT04211987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65298818|NCT04211987|Antimetabolites|antimetabolites|mesh-ancestor
65298819|NCT04211987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298820|NCT04211987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298821|NCT04211987|Antiviral Agents|antiviral agents|mesh-ancestor
65298822|NCT04211987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65298823|NCT04211987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65298824|NCT04211987|Immunologic Factors|immunologic factors|mesh-ancestor
64529029|NCT04298463|Teicoplanin|teicoplanin|mesh-list
65130819|NCT01084005|Incretins|incretins|mesh-ancestor
65130820|NCT01084005|Hormones|hormones|mesh-ancestor
65130821|NCT01084005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65130822|NCT01084005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65130823|NCT01084005|Protease Inhibitors|protease inhibitors|mesh-ancestor
65130824|NCT01084005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130825|NCT01084005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130826|NCT01083810|Ritonavir|ritonavir|mesh-list
65130827|NCT01083810|Lopinavir|lopinavir|mesh-list
65130828|NCT01083810|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65130829|NCT01083810|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65130830|NCT01083810|Protease Inhibitors|protease inhibitors|mesh-ancestor
65130832|NCT01083810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130833|NCT01083810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65130834|NCT01083810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65130835|NCT01083810|Antiviral Agents|antiviral agents|mesh-ancestor
65130836|NCT01083810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65130837|NCT01083810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65130838|NCT01083810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65130839|NCT00588926|Remifentanil|remifentanil|mesh-list
65130840|NCT00588926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65130841|NCT00588926|Narcotics|narcotics|mesh-ancestor
65130842|NCT00588926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65130843|NCT00588926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130844|NCT00588926|Analgesics|analgesics|mesh-ancestor
65130845|NCT00588926|Sensory System Agents|sensory system agents|mesh-ancestor
64703437|NCT02464657|Antimetabolites|antimetabolites|mesh-ancestor
65130850|NCT00589082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65130851|NCT00589082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65130852|NCT00589082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130853|NCT00589082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130854|NCT00589238|Paclitaxel|paclitaxel|mesh-list
65130855|NCT00589238|Cyclophosphamide|cyclophosphamide|mesh-list
65130856|NCT00589238|Carboplatin|carboplatin|mesh-list
65130857|NCT00589238|Doxorubicin|doxorubicin|mesh-list
65130858|NCT00589238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65130859|NCT00589238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65130860|NCT00589238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130861|NCT00589238|Tubulin Modulators|tubulin modulators|mesh-ancestor
65130862|NCT00589238|Antimitotic Agents|antimitotic agents|mesh-ancestor
65130863|NCT00589238|Mitosis Modulators|mitosis modulators|mesh-ancestor
65298825|NCT04211987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298826|NCT04211987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65298827|NCT04211987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65298828|NCT04211987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65298829|NCT04211987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298830|NCT04211987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65298831|NCT04211987|Abortifacient Agents|abortifacient agents|mesh-ancestor
65298832|NCT04211987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65298833|NCT04211987|Dermatologic Agents|dermatologic agents|mesh-ancestor
65298834|NCT04211987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65298835|NCT04211987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65298836|NCT04211987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65298837|NCT04212065|Buprenorphine|buprenorphine|mesh-list
65298838|NCT04212065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65298839|NCT04212065|Narcotics|narcotics|mesh-ancestor
65298840|NCT04212065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65298841|NCT04212065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298842|NCT04212065|Analgesics|analgesics|mesh-ancestor
65298843|NCT04212065|Sensory System Agents|sensory system agents|mesh-ancestor
65298844|NCT04212065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65298845|NCT04212065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65298846|NCT02627534|Anti-Infective Agents|anti-infective agents|mesh-list
65298847|NCT02627534|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65298848|NCT02627456|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65298849|NCT02627456|Antimalarials|antimalarials|mesh-ancestor
65298850|NCT02627456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65298851|NCT02627456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65298852|NCT02627456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65298853|NCT00617513|Prucalopride|prucalopride|mesh-list
65298854|NCT00617513|Laxatives|laxatives|mesh-ancestor
65298855|NCT00617513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65130864|NCT00589238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130865|NCT00589238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65130866|NCT00589238|Immunologic Factors|immunologic factors|mesh-ancestor
65130867|NCT00589238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130868|NCT00589238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65130869|NCT00589238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65130870|NCT00589238|Alkylating Agents|alkylating agents|mesh-ancestor
65130871|NCT00589238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65130872|NCT00589238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65130873|NCT00589238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65130874|NCT00589238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65130875|NCT00589238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298856|NCT00617513|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65298857|NCT00617513|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65298858|NCT00617513|Serotonin Agents|serotonin agents|mesh-ancestor
65298859|NCT00617513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65298860|NCT00617513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298861|NCT00617513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298862|NCT04061512|Dexamethasone|dexamethasone|mesh-list
65298863|NCT04061512|Cyclophosphamide|cyclophosphamide|mesh-list
65298864|NCT04061512|Rituximab|rituximab|mesh-list
65298865|NCT04061512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65298866|NCT04061512|Immunologic Factors|immunologic factors|mesh-ancestor
65298867|NCT04061512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529085|NCT01527487|Docetaxel|docetaxel|mesh-list
65130876|NCT00589394|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65130877|NCT00589394|Immunologic Factors|immunologic factors|mesh-ancestor
65130878|NCT00589394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130879|NCT01083576|Gentamicins|gentamicins|mesh-list
65130880|NCT01083576|Paromomycin|paromomycin|mesh-list
65130881|NCT01083576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65130882|NCT01083576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65130883|NCT01083576|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65130884|NCT01083576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130885|NCT01083576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130886|NCT01083576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65130887|NCT01083576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65130888|NCT04568265|Entecavir|entecavir|mesh-list
65130889|NCT04568265|Antiviral Agents|antiviral agents|mesh-ancestor
65130890|NCT04568265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65130891|NCT04568304|Gemcitabine|gemcitabine|mesh-list
65130892|NCT04568304|Carboplatin|carboplatin|mesh-list
65130893|NCT04568304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130894|NCT04568304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65130895|NCT04568304|Antimetabolites|antimetabolites|mesh-ancestor
65130896|NCT04568304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130897|NCT04568304|Antiviral Agents|antiviral agents|mesh-ancestor
65130898|NCT04568304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65130899|NCT04568304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130900|NCT04568304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65130901|NCT04568304|Immunologic Factors|immunologic factors|mesh-ancestor
65130902|NCT04568304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130903|NCT01082640|Febuxostat|febuxostat|mesh-list
65130904|NCT01082640|Gout Suppressants|gout suppressants|mesh-ancestor
65130905|NCT01082640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65130906|NCT00589862|Clopidogrel|clopidogrel|mesh-list
65130907|NCT00589862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65130908|NCT00589862|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65130909|NCT00589862|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65130910|NCT00589862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65130911|NCT00589862|Purinergic Agents|purinergic agents|mesh-ancestor
65130912|NCT00589862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65130913|NCT00589862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130914|NCT00589862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130915|NCT00589901|Cyclophosphamide|cyclophosphamide|mesh-list
65130916|NCT00589901|Capecitabine|capecitabine|mesh-list
65130927|NCT00589901|Antimetabolites|antimetabolites|mesh-ancestor
65130928|NCT00590174|Aspirin|aspirin|mesh-list
65130929|NCT00590174|Clopidogrel|clopidogrel|mesh-list
65130930|NCT00590174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65130931|NCT00590174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65130932|NCT00590174|Analgesics|analgesics|mesh-ancestor
65130933|NCT00590174|Sensory System Agents|sensory system agents|mesh-ancestor
65130934|NCT00590174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65298868|NCT04061512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65298869|NCT04061512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65298870|NCT04061512|Alkylating Agents|alkylating agents|mesh-ancestor
65298871|NCT04061512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298872|NCT04061512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298873|NCT04061512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65298874|NCT04061512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65130935|NCT00590174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130936|NCT00590174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65130937|NCT00590174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65130938|NCT00590174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65130939|NCT00590174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65130940|NCT00590174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130941|NCT00590174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65130942|NCT00590174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65130943|NCT00590174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130944|NCT00590174|Antipyretics|antipyretics|mesh-ancestor
65130945|NCT00590174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65130946|NCT00590174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65130947|NCT00590174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65130948|NCT00590174|Purinergic Agents|purinergic agents|mesh-ancestor
65130949|NCT00590174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65130950|NCT00590213|Bicalutamide|bicalutamide|mesh-list
65130951|NCT00590213|Androgen Antagonists|androgen antagonists|mesh-ancestor
65130952|NCT00590213|Hormone Antagonists|hormone antagonists|mesh-ancestor
65130953|NCT00590213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65130954|NCT00590213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130955|NCT00590213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130956|NCT00590408|Ubiquinone|ubiquinone|mesh-list
64773486|NCT01542372|Prazosin|prazosin|mesh-list
65130957|NCT00590408|Coenzyme Q10|coenzyme q10|mesh-list
65130958|NCT00590408|Micronutrients|micronutrients|mesh-ancestor
65130959|NCT00590408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130960|NCT00590408|Vitamins|vitamins|mesh-ancestor
65130961|NCT00590447|Rituximab|rituximab|mesh-list
65130962|NCT00590447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65130963|NCT00590447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130964|NCT00590447|Immunologic Factors|immunologic factors|mesh-ancestor
65130965|NCT00590447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130966|NCT00590447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65130967|NCT01081626|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65130968|NCT01081626|Hormones|hormones|mesh-ancestor
65130969|NCT01081626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65130970|NCT01081626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130971|NCT01080768|Amlodipine|amlodipine|mesh-list
65130972|NCT01080768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65130973|NCT01080768|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65130974|NCT01080768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65130975|NCT01080768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130976|NCT01080768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65130977|NCT01080768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130978|NCT01080768|Vasodilator Agents|vasodilator agents|mesh-ancestor
65130983|NCT03452345|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65130984|NCT03452345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65130985|NCT03452345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130986|NCT03452345|Cholinergic Agents|cholinergic agents|mesh-ancestor
65130987|NCT03452345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65130989|NCT03452306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65130990|NCT03452306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130991|NCT01080300|Gabapentin|gabapentin|mesh-list
65130992|NCT01080300|Analgesics|analgesics|mesh-ancestor
65130993|NCT01080300|Sensory System Agents|sensory system agents|mesh-ancestor
65130994|NCT01080300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65130995|NCT01080300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130996|NCT01080300|Anticonvulsants|anticonvulsants|mesh-ancestor
65298875|NCT04061512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65298876|NCT04061512|Antiemetics|antiemetics|mesh-ancestor
65298877|NCT04061512|Autonomic Agents|autonomic agents|mesh-ancestor
65298878|NCT04061512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65298879|NCT04061512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65298880|NCT04061512|Glucocorticoids|glucocorticoids|mesh-ancestor
65298881|NCT04061512|Hormones|hormones|mesh-ancestor
65298882|NCT04061512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65298883|NCT04061512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65298884|NCT02627222|Vitamin A|vitamin a|mesh-list
65298885|NCT02627222|Provitamins|provitamins|mesh-list
65298886|NCT02627222|Vitamins|vitamins|mesh-ancestor
65298887|NCT02627222|Micronutrients|micronutrients|mesh-ancestor
65298888|NCT02627222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298889|NCT00594854|Diclofenac|diclofenac|mesh-list
65298890|NCT00594854|Arthrotec|arthrotec|mesh-list
65298891|NCT00594854|Misoprostol|misoprostol|mesh-list
65298892|NCT00594854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65298893|NCT00594854|Abortifacient Agents|abortifacient agents|mesh-ancestor
65298894|NCT00594854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64529098|NCT05030298|Temozolomide|temozolomide|mesh-list
65130997|NCT01080300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65130998|NCT01080300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65130999|NCT01080300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65131000|NCT01080300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65131001|NCT01080300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65131002|NCT01080300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65131003|NCT01080300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65131004|NCT01080300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131005|NCT01080300|Antimanic Agents|antimanic agents|mesh-ancestor
65131006|NCT02210715|Raltegravir Potassium|raltegravir potassium|mesh-list
65131007|NCT02210715|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65131008|NCT02210715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65131009|NCT02210715|Antiviral Agents|antiviral agents|mesh-ancestor
65131010|NCT02210715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65131011|NCT02210715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65131012|NCT02210715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65131013|NCT02210715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131014|NCT02210715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131015|NCT00590603|Ascorbic Acid|ascorbic acid|mesh-list
65131016|NCT00590603|Bortezomib|bortezomib|mesh-list
65131017|NCT00590603|Arsenic Trioxide|arsenic trioxide|mesh-list
65131018|NCT00590603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131019|NCT00590603|Antioxidants|antioxidants|mesh-ancestor
65131020|NCT00590603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131021|NCT00590603|Protective Agents|protective agents|mesh-ancestor
65131022|NCT00590603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131023|NCT00590603|Vitamins|vitamins|mesh-ancestor
65131024|NCT00590603|Micronutrients|micronutrients|mesh-ancestor
65131025|NCT01085097|Mycophenolic Acid|mycophenolic acid|mesh-list
65131026|NCT01085097|Prednisone|prednisone|mesh-list
65131027|NCT01085097|Methylprednisolone|methylprednisolone|mesh-list
65131028|NCT01085097|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65131029|NCT01085097|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65131030|NCT01085097|Prednisolone|prednisolone|mesh-list
65131031|NCT01085097|Prednisolone acetate|prednisolone acetate|mesh-list
65131032|NCT01085097|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65131033|NCT01085097|Prednisolone phosphate|prednisolone phosphate|mesh-list
65298895|NCT00594854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298896|NCT00594854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65048785|NCT00221624|Analgesics|analgesics|mesh-ancestor
65298897|NCT00594854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65298898|NCT00594854|Oxytocics|oxytocics|mesh-ancestor
65298899|NCT00594854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65298900|NCT00594854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65298901|NCT00594854|Analgesics|analgesics|mesh-ancestor
65298902|NCT00594854|Sensory System Agents|sensory system agents|mesh-ancestor
65298903|NCT00594854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65298904|NCT00594854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65298905|NCT00594854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65298906|NCT00594854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65298907|NCT00594854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298908|NCT00594854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298909|NCT00679718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65298910|NCT00679718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65298911|NCT00684632|Fentanyl|fentanyl|mesh-list
65298912|NCT00684632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64529119|NCT02381730|Aflibercept|aflibercept|mesh-list
65131034|NCT01085097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65131035|NCT01085097|Glucocorticoids|glucocorticoids|mesh-ancestor
65131036|NCT01085097|Hormones|hormones|mesh-ancestor
65131037|NCT01085097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65131038|NCT01085097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131039|NCT01085097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65131040|NCT01085097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131041|NCT01085097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65131042|NCT01085097|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65131043|NCT01085097|Antitubercular Agents|antitubercular agents|mesh-ancestor
65131044|NCT01085097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65131045|NCT01085097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65131046|NCT01085097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131047|NCT01085097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131048|NCT01085097|Antiemetics|antiemetics|mesh-ancestor
65131049|NCT01085097|Autonomic Agents|autonomic agents|mesh-ancestor
65131050|NCT01085097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65131068|NCT04567290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65131069|NCT04567290|Purinergic Agents|purinergic agents|mesh-ancestor
65131070|NCT04567290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65131071|NCT04567290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131072|NCT04567290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131073|NCT01084161|Morphine|morphine|mesh-list
65131074|NCT01084161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65131075|NCT01084161|Narcotics|narcotics|mesh-ancestor
65131076|NCT01084161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65131077|NCT01084161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131078|NCT01084161|Analgesics|analgesics|mesh-ancestor
65131079|NCT01084161|Sensory System Agents|sensory system agents|mesh-ancestor
65131080|NCT01084161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65131081|NCT01083615|Prednisone|prednisone|mesh-list
65131082|NCT01083615|Docetaxel|docetaxel|mesh-list
65131083|NCT01083615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131084|NCT01083615|Tubulin Modulators|tubulin modulators|mesh-ancestor
65131085|NCT01083615|Antimitotic Agents|antimitotic agents|mesh-ancestor
65298913|NCT00684632|Narcotics|narcotics|mesh-ancestor
65298914|NCT00684632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65298915|NCT00684632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298916|NCT00684632|Analgesics|analgesics|mesh-ancestor
65298917|NCT00684632|Sensory System Agents|sensory system agents|mesh-ancestor
65298918|NCT00684632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65298919|NCT00684632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65298920|NCT00684632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65298921|NCT00684632|Anesthetics, General|anesthetics, general|mesh-ancestor
65298922|NCT00684632|Anesthetics|anesthetics|mesh-ancestor
65298923|NCT00855582|Tadalafil|tadalafil|mesh-list
65298924|NCT00855582|Vasodilator Agents|vasodilator agents|mesh-ancestor
65298925|NCT00855582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65298926|NCT00855582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65298927|NCT00855582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298928|NCT00855582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298929|NCT00855582|Urological Agents|urological agents|mesh-ancestor
65298930|NCT00619541|Fluorouracil|fluorouracil|mesh-list
65298931|NCT00619541|Sorafenib|sorafenib|mesh-list
65298932|NCT00619541|Antimetabolites|antimetabolites|mesh-ancestor
65298933|NCT00619541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298934|NCT00619541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65298935|NCT00619541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529129|NCT00149799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65131086|NCT01083615|Mitosis Modulators|mitosis modulators|mesh-ancestor
65131087|NCT01083615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131088|NCT01083615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65131089|NCT01083615|Glucocorticoids|glucocorticoids|mesh-ancestor
65131090|NCT01083615|Hormones|hormones|mesh-ancestor
65131091|NCT01083615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65131092|NCT01083615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131093|NCT01083615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65131094|NCT00591188|Interferons|interferons|mesh-list
65131095|NCT00591188|Interferon-alpha|interferon-alpha|mesh-list
65131096|NCT00591188|Capecitabine|capecitabine|mesh-list
65131097|NCT00591188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65131098|NCT00591188|Antimetabolites|antimetabolites|mesh-ancestor
65131099|NCT00591188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131100|NCT00591188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131101|NCT00591188|Antiviral Agents|antiviral agents|mesh-ancestor
65131102|NCT00591188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65131103|NCT00591188|Immunologic Factors|immunologic factors|mesh-ancestor
65131104|NCT00591188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131105|NCT00591383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65131106|NCT00591383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131107|NCT00591383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65131108|NCT00591383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703710|NCT02563496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65131115|NCT01081782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131117|NCT01080222|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65298936|NCT00619541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65298937|NCT00619541|Immunologic Factors|immunologic factors|mesh-ancestor
65298938|NCT00619541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298939|NCT00619541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65298940|NCT00619541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65298941|NCT00680498|Ranibizumab|ranibizumab|mesh-list
65298942|NCT00680498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65298943|NCT00680498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65298944|NCT00680498|Growth Substances|growth substances|mesh-ancestor
65298945|NCT00680498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298946|NCT00680498|Growth Inhibitors|growth inhibitors|mesh-ancestor
65298947|NCT00680498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65298948|NCT00684866|Albuterol|albuterol|mesh-list
65298949|NCT00684866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65298950|NCT00684866|Autonomic Agents|autonomic agents|mesh-ancestor
65298951|NCT00684866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65298952|NCT00684866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298953|NCT00684866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65298954|NCT00684866|Respiratory System Agents|respiratory system agents|mesh-ancestor
65298955|NCT00684866|Tocolytic Agents|tocolytic agents|mesh-ancestor
65298956|NCT00684866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65298957|NCT00684866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65298958|NCT00684866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65298959|NCT00684866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65298960|NCT00684866|Adrenergic Agents|adrenergic agents|mesh-ancestor
65298961|NCT00684866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65298962|NCT00684866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298963|NCT00854724|Puerarin|puerarin|mesh-list
65298964|NCT00854724|Vasodilator Agents|vasodilator agents|mesh-ancestor
65298965|NCT00619697|Insulin|insulin|mesh-list
65298966|NCT00619697|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65298967|NCT00619697|Metformin|metformin|mesh-list
65298968|NCT00619697|Insulin Glargine|insulin glargine|mesh-list
65298969|NCT00619697|Insulin Aspart|insulin aspart|mesh-list
65298970|NCT00619697|Glimepiride|glimepiride|mesh-list
65298974|NCT00619697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298975|NCT00619697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65298976|NCT00619697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65298977|NCT00619697|Immunologic Factors|immunologic factors|mesh-ancestor
65298979|NCT00680654|Enzyme Activators|enzyme activators|mesh-ancestor
65298980|NCT00680654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65298981|NCT00680108|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65298982|NCT00680108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65131118|NCT01080222|Antimetabolites|antimetabolites|mesh-ancestor
65131119|NCT01080222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131120|NCT01080222|Antiviral Agents|antiviral agents|mesh-ancestor
65131121|NCT01080222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65131122|NCT03452267|Metformin|metformin|mesh-list
65131123|NCT03452267|Pioglitazone|pioglitazone|mesh-list
65131124|NCT03452267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65131125|NCT03452267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131126|NCT01088802|Carboplatin|carboplatin|mesh-list
65131127|NCT01088802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131128|NCT03451682|Procyanidin|procyanidin|mesh-list
65131129|NCT03451682|Antioxidants|antioxidants|mesh-ancestor
65131130|NCT03451682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131131|NCT03451682|Protective Agents|protective agents|mesh-ancestor
65131132|NCT03451682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131133|NCT02210754|Menthol|menthol|mesh-list
65131134|NCT02210754|Nicotine|nicotine|mesh-list
65131135|NCT02210754|Glycerol|glycerol|mesh-list
65131136|NCT02210754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65131137|NCT02210754|Autonomic Agents|autonomic agents|mesh-ancestor
65131138|NCT02210754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65131139|NCT02210754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131140|NCT02210754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65131141|NCT02210754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65131142|NCT02210754|Cholinergic Agents|cholinergic agents|mesh-ancestor
65131143|NCT02210754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65131144|NCT02210754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131145|NCT02210754|Antipruritics|antipruritics|mesh-ancestor
65131146|NCT02210754|Dermatologic Agents|dermatologic agents|mesh-ancestor
65131147|NCT02210754|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65131148|NCT02210754|Protective Agents|protective agents|mesh-ancestor
65131149|NCT04998279|Lenograstim|lenograstim|mesh-list
65131150|NCT04998279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65131151|NCT04998279|Immunologic Factors|immunologic factors|mesh-ancestor
65131152|NCT04998279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131153|NCT04574141|Melatonin|melatonin|mesh-list
65131154|NCT04574141|Antioxidants|antioxidants|mesh-ancestor
65131155|NCT04574141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131156|NCT04574141|Protective Agents|protective agents|mesh-ancestor
65131157|NCT04574141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131158|NCT04574141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65131159|NCT04998981|Fenofibrate|fenofibrate|mesh-list
65131160|NCT04998981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65131161|NCT04998981|Antimetabolites|antimetabolites|mesh-ancestor
65131162|NCT04998981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131163|NCT04998981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65131164|NCT04573049|Simendan|simendan|mesh-list
65131165|NCT04573049|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65131166|NCT04573049|Vasodilator Agents|vasodilator agents|mesh-ancestor
65131167|NCT04573049|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65131168|NCT04573049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65131169|NCT04573049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131170|NCT04573049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131171|NCT04573049|Protective Agents|protective agents|mesh-ancestor
65131172|NCT04573049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131173|NCT04572698|Endothelial Growth Factors|endothelial growth factors|mesh-list
65131174|NCT04572698|Growth Substances|growth substances|mesh-ancestor
65131175|NCT04572698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298983|NCT00680732|Folic Acid|folic acid|mesh-list
65298984|NCT00680732|Micronutrients|micronutrients|mesh-list
65298985|NCT00680732|Trace Elements|trace elements|mesh-list
65298986|NCT00680732|Chloroquine|chloroquine|mesh-list
65298987|NCT00680732|Pyrimethamine|pyrimethamine|mesh-list
65298988|NCT00680732|Hematinics|hematinics|mesh-ancestor
65298989|NCT00680732|Vitamin B Complex|vitamin b complex|mesh-ancestor
65298990|NCT00680732|Vitamins|vitamins|mesh-ancestor
65298991|NCT00680732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65298992|NCT00680732|Amebicides|amebicides|mesh-ancestor
65298993|NCT00680732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65298994|NCT00680732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65298995|NCT00680732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65298996|NCT00680732|Antimalarials|antimalarials|mesh-ancestor
65298997|NCT00680732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65298998|NCT00680732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65298999|NCT00680732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299000|NCT00680732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299001|NCT00698932|Saxagliptin|saxagliptin|mesh-list
65299002|NCT00698932|Incretins|incretins|mesh-ancestor
65299003|NCT00698932|Hormones|hormones|mesh-ancestor
65299004|NCT00698932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65299005|NCT00698932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299006|NCT00698932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65299007|NCT00698932|Protease Inhibitors|protease inhibitors|mesh-ancestor
65299008|NCT00698932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299009|NCT00698932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299010|NCT00698932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65299011|NCT02566252|Cromolyn Sodium|cromolyn sodium|mesh-list
65299012|NCT02566252|Albuterol|albuterol|mesh-list
65299013|NCT02566252|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
64529199|NCT00326781|Nicotine|nicotine|mesh-list
65131176|NCT04572620|Rituximab|rituximab|mesh-list
65131184|NCT04572620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131185|NCT04572620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65131186|NCT04572542|Paclitaxel|paclitaxel|mesh-list
65131187|NCT04572542|Apatinib|apatinib|mesh-list
65131188|NCT04572542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65131189|NCT04572542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131190|NCT04572542|Tubulin Modulators|tubulin modulators|mesh-ancestor
65131191|NCT04572542|Antimitotic Agents|antimitotic agents|mesh-ancestor
65131192|NCT04572542|Mitosis Modulators|mitosis modulators|mesh-ancestor
65131193|NCT04572542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131194|NCT04572542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65131195|NCT04572542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131196|NCT04991103|Dexamethasone|dexamethasone|mesh-list
65299014|NCT02566252|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65299015|NCT02566252|Autonomic Agents|autonomic agents|mesh-ancestor
65299016|NCT02566252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65299017|NCT02566252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299018|NCT02566252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65299019|NCT02566252|Respiratory System Agents|respiratory system agents|mesh-ancestor
65299020|NCT02566252|Tocolytic Agents|tocolytic agents|mesh-ancestor
65299021|NCT02566252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65299022|NCT02566252|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65299023|NCT02566252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65299024|NCT02566252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65299025|NCT02566252|Adrenergic Agents|adrenergic agents|mesh-ancestor
65299026|NCT02566252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64529230|NCT02979405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64529231|NCT02979405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64529236|NCT01791231|Canagliflozin|canagliflozin|mesh-list
65131197|NCT04991103|Lenalidomide|lenalidomide|mesh-list
65131198|NCT04991103|Bortezomib|bortezomib|mesh-list
65131199|NCT04991103|Daratumumab|daratumumab|mesh-list
65131200|NCT04991103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65131201|NCT04991103|Antiemetics|antiemetics|mesh-ancestor
65131202|NCT04991103|Autonomic Agents|autonomic agents|mesh-ancestor
65131203|NCT04991103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65131204|NCT04991103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131205|NCT04991103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65131206|NCT04991103|Glucocorticoids|glucocorticoids|mesh-ancestor
65131207|NCT04991103|Hormones|hormones|mesh-ancestor
65131208|NCT04991103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65131209|NCT04991103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65131210|NCT04991103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131211|NCT04991103|Immunologic Factors|immunologic factors|mesh-ancestor
65131212|NCT04991103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65131213|NCT04991103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65131214|NCT04991103|Growth Substances|growth substances|mesh-ancestor
65131215|NCT04991103|Growth Inhibitors|growth inhibitors|mesh-ancestor
65131216|NCT03451019|Sevelamer|sevelamer|mesh-list
65131217|NCT03451019|Chelating Agents|chelating agents|mesh-ancestor
65131218|NCT03451019|Sequestering Agents|sequestering agents|mesh-ancestor
65131219|NCT03451019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131220|NCT03450863|Insulin Aspart|insulin aspart|mesh-list
65131221|NCT03450863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65131222|NCT03450863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131223|NCT02211066|Clopidogrel|clopidogrel|mesh-list
65131224|NCT02211066|Ticagrelor|ticagrelor|mesh-list
65131225|NCT02211066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65131226|NCT02211066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65131227|NCT02211066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65131228|NCT02211066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65131229|NCT02211066|Purinergic Agents|purinergic agents|mesh-ancestor
65131230|NCT02211066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65131231|NCT02211066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131232|NCT02211066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131233|NCT04995978|Pioglitazone|pioglitazone|mesh-list
65131234|NCT04995978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65131235|NCT04995978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131236|NCT03450317|Aspirin|aspirin|mesh-list
65131237|NCT03450317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65131238|NCT03450317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65131239|NCT03450317|Analgesics|analgesics|mesh-ancestor
65299027|NCT02566252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299028|NCT02566252|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
65299029|NCT02566252|Immunologic Factors|immunologic factors|mesh-ancestor
65299030|NCT02566252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65299031|NCT00823719|Ofatumumab|ofatumumab|mesh-list
65299032|NCT00823719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65299033|NCT00823719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299034|NCT00823719|Immunologic Factors|immunologic factors|mesh-ancestor
65299035|NCT00823719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299036|NCT03953170|Teduglutide|teduglutide|mesh-list
65299037|NCT03953170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65299038|NCT03953170|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65299039|NCT03953170|Protective Agents|protective agents|mesh-ancestor
65299040|NCT03953170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299041|NCT00708591|Sirolimus|sirolimus|mesh-list
65299042|NCT00708591|Ketoconazole|ketoconazole|mesh-list
65299043|NCT00708591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65299044|NCT00708591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65299045|NCT00708591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65299046|NCT00708591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299047|NCT00708591|Antifungal Agents|antifungal agents|mesh-ancestor
65299049|NCT00708591|Immunologic Factors|immunologic factors|mesh-ancestor
65299050|NCT00708591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299051|NCT00708591|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65131240|NCT03450317|Sensory System Agents|sensory system agents|mesh-ancestor
65131241|NCT03450317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65131242|NCT03450317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131243|NCT03450317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65131253|NCT04565496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65131254|NCT04565496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131255|NCT03450161|Fentanyl|fentanyl|mesh-list
65131256|NCT03450161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65131257|NCT03450161|Narcotics|narcotics|mesh-ancestor
64773772|NCT05672784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65131258|NCT03450161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65131259|NCT03450161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131260|NCT03450161|Analgesics|analgesics|mesh-ancestor
65131261|NCT03450161|Sensory System Agents|sensory system agents|mesh-ancestor
65131262|NCT03450161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65131263|NCT03450161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65131264|NCT03450161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65131265|NCT03450161|Anesthetics, General|anesthetics, general|mesh-ancestor
65131266|NCT03450161|Anesthetics|anesthetics|mesh-ancestor
65131267|NCT04565184|Artesunate|artesunate|mesh-list
65131268|NCT04565184|Lumefantrine|lumefantrine|mesh-list
65131269|NCT04565184|Artemether|artemether|mesh-list
65131270|NCT04565184|Amodiaquine|amodiaquine|mesh-list
65131271|NCT04565184|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65131272|NCT04565184|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
65131273|NCT04565184|Antimalarials|antimalarials|mesh-ancestor
65131274|NCT04565184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65131275|NCT04565184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65131277|NCT04565184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299052|NCT00708591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65299053|NCT00708591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299054|NCT00708591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299055|NCT00708591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65299056|NCT00708591|Hormone Antagonists|hormone antagonists|mesh-ancestor
65299057|NCT00708591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65131278|NCT04565184|Antiviral Agents|antiviral agents|mesh-ancestor
65131279|NCT04565184|Schistosomicides|schistosomicides|mesh-ancestor
65131280|NCT04565184|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65131281|NCT04565184|Anthelmintics|anthelmintics|mesh-ancestor
65131282|NCT03452579|Bevacizumab|bevacizumab|mesh-list
65131283|NCT03452579|Nivolumab|nivolumab|mesh-list
65131284|NCT03452579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65131285|NCT03452579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131286|NCT03452579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65131287|NCT03452579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65131288|NCT03452579|Growth Substances|growth substances|mesh-ancestor
65131289|NCT03452579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131290|NCT03452579|Growth Inhibitors|growth inhibitors|mesh-ancestor
65131291|NCT03452579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65131292|NCT03452579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131293|NCT04997850|Lenvatinib|lenvatinib|mesh-list
65131294|NCT04997850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131295|NCT04997850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65131296|NCT04997850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131297|NCT04997850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131298|NCT03450629|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65131299|NCT03450629|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65131300|NCT03450629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65131301|NCT03450629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65131302|NCT03450629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65131303|NCT03450629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65131304|NCT03450629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65131305|NCT03450629|Adrenergic Agents|adrenergic agents|mesh-ancestor
65131306|NCT03450629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65131307|NCT03450629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131308|NCT03450629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131309|NCT03456947|Pregabalin|pregabalin|mesh-list
65131310|NCT03456947|Analgesics|analgesics|mesh-ancestor
65131316|NCT03456947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65131317|NCT03456947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131318|NCT03456947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65131319|NCT03456947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65131320|NCT03456947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65131321|NCT03456947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65131322|NCT03456947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65131323|NCT03456791|Protease Inhibitors|protease inhibitors|mesh-list
65131324|NCT03456791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131325|NCT03456791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131327|NCT04564638|Cyclosporins|cyclosporins|mesh-list
65131328|NCT04564638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131329|NCT04564638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131330|NCT04564638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65131331|NCT04564638|Immunologic Factors|immunologic factors|mesh-ancestor
64773857|NCT03729258|Amantadine|amantadine|mesh-list
65131332|NCT04564638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131334|NCT04564638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65131335|NCT04564638|Dermatologic Agents|dermatologic agents|mesh-ancestor
65131336|NCT04564638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65131337|NCT04564638|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65131338|NCT04564326|Fentanyl|fentanyl|mesh-list
65131339|NCT04564326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65131340|NCT04564326|Narcotics|narcotics|mesh-ancestor
65131341|NCT04564326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65131342|NCT04564326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131343|NCT04564326|Analgesics|analgesics|mesh-ancestor
65299058|NCT00708591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65299059|NCT04595266|Leucovorin|leucovorin|mesh-list
65299060|NCT04595266|Bevacizumab|bevacizumab|mesh-list
65299061|NCT04595266|Fluorouracil|fluorouracil|mesh-list
65299062|NCT04595266|Oxaliplatin|oxaliplatin|mesh-list
65299063|NCT04595266|Irinotecan|irinotecan|mesh-list
65299064|NCT04595266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65299065|NCT04595266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299066|NCT04595266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65299067|NCT04595266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65299068|NCT04595266|Growth Substances|growth substances|mesh-ancestor
65299069|NCT04595266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299070|NCT04595266|Growth Inhibitors|growth inhibitors|mesh-ancestor
65299071|NCT04595266|Antimetabolites|antimetabolites|mesh-ancestor
65299072|NCT04595266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299073|NCT04595266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65299074|NCT04595266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65299075|NCT04595266|Immunologic Factors|immunologic factors|mesh-ancestor
65299076|NCT04595266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65299077|NCT04595266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65299078|NCT04595266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299079|NCT04595266|Antidotes|antidotes|mesh-ancestor
65299080|NCT04595266|Protective Agents|protective agents|mesh-ancestor
65299081|NCT04595266|Vitamin B Complex|vitamin b complex|mesh-ancestor
65299082|NCT04595266|Vitamins|vitamins|mesh-ancestor
65299083|NCT04595266|Micronutrients|micronutrients|mesh-ancestor
65299084|NCT00708747|Immunoglobulins|immunoglobulins|mesh-list
65299085|NCT00708747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65299086|NCT00708747|Antibodies|antibodies|mesh-list
65299087|NCT00708747|Immunologic Factors|immunologic factors|mesh-ancestor
65299088|NCT00708747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299089|NCT00685022|Albuterol|albuterol|mesh-list
65131344|NCT04564326|Sensory System Agents|sensory system agents|mesh-ancestor
65131345|NCT04564326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65131346|NCT04564326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65131347|NCT04564326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65131348|NCT04564326|Anesthetics, General|anesthetics, general|mesh-ancestor
65131349|NCT04564326|Anesthetics|anesthetics|mesh-ancestor
65131351|NCT03453164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65131352|NCT03453164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131353|NCT03453164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65131354|NCT03453164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131355|NCT03450434|Histamine|histamine|mesh-list
65131356|NCT03450434|Glutarimide|glutarimide|mesh-list
65131357|NCT03450434|Histamine Agonists|histamine agonists|mesh-ancestor
65131358|NCT03450434|Histamine Agents|histamine agents|mesh-ancestor
65299090|NCT00685022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65299091|NCT00685022|Autonomic Agents|autonomic agents|mesh-ancestor
65299092|NCT00685022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65299093|NCT00685022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299094|NCT00685022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65299095|NCT00685022|Respiratory System Agents|respiratory system agents|mesh-ancestor
65299096|NCT00685022|Tocolytic Agents|tocolytic agents|mesh-ancestor
65299097|NCT00685022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65299098|NCT00685022|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65299099|NCT00685022|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65299100|NCT00685022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65299101|NCT00685022|Adrenergic Agents|adrenergic agents|mesh-ancestor
65299102|NCT00685022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65299103|NCT00685022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299104|NCT03787264|Venetoclax|venetoclax|mesh-list
65299105|NCT03787264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65299106|NCT03787264|Obinutuzumab|obinutuzumab|mesh-list
65299107|NCT03787264|Acalabrutinib|acalabrutinib|mesh-list
65299108|NCT03787264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299109|NCT03787264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65299110|NCT03787264|Alkylating Agents|alkylating agents|mesh-ancestor
65299111|NCT03787264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299112|NCT03787264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65299113|NCT00822237|Vaccines|vaccines|mesh-list
64529297|NCT02103855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131359|NCT03450434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65131360|NCT03450434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131361|NCT03450434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131362|NCT03450434|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65131363|NCT03450434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131364|NCT00198029|Hylan|hylan|mesh-list
65131365|NCT00198029|Viscosupplements|viscosupplements|mesh-ancestor
65131366|NCT00198029|Protective Agents|protective agents|mesh-ancestor
65131367|NCT00198029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131368|NCT02215122|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65131369|NCT02215122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65131370|NCT02215122|Autonomic Agents|autonomic agents|mesh-ancestor
65131371|NCT02215122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65131372|NCT02215122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131373|NCT02215122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65131374|NCT02215122|Respiratory System Agents|respiratory system agents|mesh-ancestor
65131375|NCT02215122|Glucocorticoids|glucocorticoids|mesh-ancestor
65131376|NCT02215122|Hormones|hormones|mesh-ancestor
65131377|NCT02215122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65131378|NCT02215122|Sympathomimetics|sympathomimetics|mesh-ancestor
65131379|NCT00196976|Edetic Acid|edetic acid|mesh-list
65131380|NCT00196976|Vaccines|vaccines|mesh-list
65131385|NCT00196976|Protective Agents|protective agents|mesh-ancestor
65131387|NCT00196976|Sequestering Agents|sequestering agents|mesh-ancestor
65299114|NCT00822237|Immunologic Factors|immunologic factors|mesh-ancestor
65299115|NCT00822237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299116|NCT00617747|Zolmitriptan|zolmitriptan|mesh-list
65299117|NCT00617747|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65299118|NCT00617747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65299119|NCT00617747|Serotonin Agents|serotonin agents|mesh-ancestor
65299120|NCT00617747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64529319|NCT01504841|Antiviral Agents|antiviral agents|mesh-ancestor
65131388|NCT00196976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131389|NCT00196976|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65131390|NCT00196976|Anticoagulants|anticoagulants|mesh-ancestor
65131391|NCT00196976|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65131392|NCT04563936|Goserelin|goserelin|mesh-list
65131393|NCT04563936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65131394|NCT04563936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131395|NCT04563975|Paclitaxel|paclitaxel|mesh-list
65131396|NCT04563975|Docetaxel|docetaxel|mesh-list
65131397|NCT04563975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65131398|NCT04563975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131399|NCT04563975|Tubulin Modulators|tubulin modulators|mesh-ancestor
65131400|NCT04563975|Antimitotic Agents|antimitotic agents|mesh-ancestor
65131401|NCT04563975|Mitosis Modulators|mitosis modulators|mesh-ancestor
65131402|NCT04563975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131403|NCT00196313|Levonorgestrel|levonorgestrel|mesh-list
65131404|NCT00196313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65131405|NCT00196313|Contraceptive Agents|contraceptive agents|mesh-ancestor
65131406|NCT00196313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65131407|NCT00196313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131408|NCT00196313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65131409|NCT00196313|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65131410|NCT00196313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65131411|NCT00195650|Adalimumab|adalimumab|mesh-list
65131412|NCT00195650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65131413|NCT00195650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65131414|NCT04563780|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
65131415|NCT04563780|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65131416|NCT04563780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131417|NCT04560894|Sorafenib|sorafenib|mesh-list
65131418|NCT04560894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131419|NCT04560894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65131420|NCT04560894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131421|NCT04560894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131422|NCT04560465|Tranexamic Acid|tranexamic acid|mesh-list
65131423|NCT04560465|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65131424|NCT04560465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65131425|NCT04560465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131427|NCT04560465|Coagulants|coagulants|mesh-ancestor
65131428|NCT00195494|Etanercept|etanercept|mesh-list
65131429|NCT00195494|Methotrexate|methotrexate|mesh-list
65131430|NCT00195494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65131431|NCT00195494|Abortifacient Agents|abortifacient agents|mesh-ancestor
65131432|NCT00195494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65131433|NCT00195494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131434|NCT00195494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65131435|NCT00195494|Antimetabolites|antimetabolites|mesh-ancestor
65131436|NCT00195494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131437|NCT00195494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131438|NCT00195494|Dermatologic Agents|dermatologic agents|mesh-ancestor
65131439|NCT00195494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131440|NCT00195494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65131441|NCT00195494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65131442|NCT00195494|Immunologic Factors|immunologic factors|mesh-ancestor
65131443|NCT00195494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65131444|NCT00195494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65131445|NCT00195494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65131446|NCT00195494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65131447|NCT00195494|Analgesics|analgesics|mesh-ancestor
65299121|NCT00617747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299122|NCT00617747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299124|NCT00685100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65299125|NCT00685100|Glucocorticoids|glucocorticoids|mesh-ancestor
65299126|NCT00685100|Hormones|hormones|mesh-ancestor
65299127|NCT00685100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65299128|NCT00685100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299129|NCT00708903|Moxifloxacin|moxifloxacin|mesh-list
65299130|NCT00708903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65299131|NCT00708903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65299132|NCT00708903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65299133|NCT00708903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65299134|NCT00708903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131448|NCT00195494|Sensory System Agents|sensory system agents|mesh-ancestor
65131449|NCT00195494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65131450|NCT00195494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65131451|NCT00195494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65131452|NCT00194987|Prednisone|prednisone|mesh-list
65131456|NCT00194987|gamma-Globulins|gamma-globulins|mesh-list
65131457|NCT00194987|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65131458|NCT00194987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65131459|NCT00194987|Glucocorticoids|glucocorticoids|mesh-ancestor
65131460|NCT00194987|Hormones|hormones|mesh-ancestor
65131461|NCT00194987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65131462|NCT00194987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131463|NCT00194987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65131464|NCT00194987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131465|NCT00194987|Immunologic Factors|immunologic factors|mesh-ancestor
65131466|NCT00194792|Paclitaxel|paclitaxel|mesh-list
65131467|NCT00194792|Vinorelbine|vinorelbine|mesh-list
65131468|NCT00194792|Capecitabine|capecitabine|mesh-list
65131469|NCT00194792|Methotrexate|methotrexate|mesh-list
65131470|NCT00194792|Exemestane|exemestane|mesh-list
65131471|NCT00194792|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65131472|NCT00194792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65131473|NCT00194792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131474|NCT00194792|Tubulin Modulators|tubulin modulators|mesh-ancestor
65131475|NCT00194792|Antimitotic Agents|antimitotic agents|mesh-ancestor
65131476|NCT00194792|Mitosis Modulators|mitosis modulators|mesh-ancestor
65131477|NCT00194792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131478|NCT00194792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65131479|NCT00194792|Antimetabolites|antimetabolites|mesh-ancestor
65131480|NCT00194792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65131481|NCT00194792|Abortifacient Agents|abortifacient agents|mesh-ancestor
65131482|NCT00194792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65131483|NCT00194792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131484|NCT00194792|Dermatologic Agents|dermatologic agents|mesh-ancestor
65131485|NCT00194792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131486|NCT00194792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65131487|NCT00194792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65131488|NCT00194792|Immunologic Factors|immunologic factors|mesh-ancestor
65131489|NCT00194792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65131490|NCT00194792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65131491|NCT00194792|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65131492|NCT00194792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65131493|NCT00194792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65131494|NCT00194792|Hormone Antagonists|hormone antagonists|mesh-ancestor
65131495|NCT00194792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65131496|NCT00194792|Luteolytic Agents|luteolytic agents|mesh-ancestor
65131497|NCT00194792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65299135|NCT00708903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299136|NCT00708903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299137|NCT00637091|Irinotecan|irinotecan|mesh-list
65299138|NCT00637091|Cetuximab|cetuximab|mesh-list
65299139|NCT00637091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65299140|NCT00637091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65299141|NCT00637091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299142|NCT00637091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299143|NCT00637091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299144|NCT00637091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65299145|NCT04213391|Sulforaphane|sulforaphane|mesh-list
65299146|NCT04213391|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65299147|NCT04213391|Protective Agents|protective agents|mesh-ancestor
65299148|NCT04213391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299149|NCT04213391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299150|NCT00709137|Amiloride|amiloride|mesh-list
65299151|NCT00709137|Spironolactone|spironolactone|mesh-list
65299152|NCT00709137|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65299153|NCT00709137|Hormone Antagonists|hormone antagonists|mesh-ancestor
65299154|NCT00709137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65299155|NCT00709137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299156|NCT00709137|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65299157|NCT00709137|Diuretics|diuretics|mesh-ancestor
64529341|NCT04861584|Gemcitabine|gemcitabine|mesh-list
65131498|NCT00194792|Contraceptive Agents|contraceptive agents|mesh-ancestor
64664573|NCT02213900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65131499|NCT00194792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65131500|NCT00194792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65131501|NCT02486367|Clopidogrel|clopidogrel|mesh-list
65131502|NCT02486367|Ticagrelor|ticagrelor|mesh-list
65131503|NCT02486367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65131504|NCT02486367|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65131505|NCT02486367|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65131506|NCT02486367|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65131507|NCT02486367|Purinergic Agents|purinergic agents|mesh-ancestor
65131508|NCT02486367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65131509|NCT02486367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131510|NCT02486367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131511|NCT00194675|Testosterone|testosterone|mesh-list
65131512|NCT00194675|Dutasteride|dutasteride|mesh-list
65131513|NCT00194675|Androgens|androgens|mesh-ancestor
65131514|NCT00194675|Hormones|hormones|mesh-ancestor
65131515|NCT00194675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65131516|NCT00194675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131517|NCT00194675|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65131518|NCT00194675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65131519|NCT00194675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131520|NCT00194675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131521|NCT00194675|Hormone Antagonists|hormone antagonists|mesh-ancestor
65299158|NCT00709137|Natriuretic Agents|natriuretic agents|mesh-ancestor
65299159|NCT00709137|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65299160|NCT00709137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65299161|NCT00709137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65299162|NCT00709137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299163|NCT00709137|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65131522|NCT00194012|Aripiprazole|aripiprazole|mesh-list
65131523|NCT00194012|Antidepressive Agents|antidepressive agents|mesh-ancestor
65131528|NCT00194012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131529|NCT00194012|Dopamine Agonists|dopamine agonists|mesh-ancestor
65131530|NCT00194012|Dopamine Agents|dopamine agents|mesh-ancestor
65131531|NCT00194012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65131532|NCT00194012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131533|NCT00194012|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65131534|NCT00194012|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65131535|NCT00194012|Serotonin Agents|serotonin agents|mesh-ancestor
65131536|NCT00194012|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65131537|NCT00194012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65131538|NCT00194012|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65131539|NCT00194012|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65131540|NCT04563351|Anesthetics|anesthetics|mesh-list
65131541|NCT04563351|Anesthetics, Local|anesthetics, local|mesh-list
65131542|NCT04563351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65131543|NCT04563351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131544|NCT04563351|Sensory System Agents|sensory system agents|mesh-ancestor
65131545|NCT04563351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65131546|NCT00192647|Ribavirin|ribavirin|mesh-list
65131547|NCT00192647|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65131548|NCT00192647|Interferon alpha-2|interferon alpha-2|mesh-list
65131549|NCT00192647|Antimetabolites|antimetabolites|mesh-ancestor
65131550|NCT00192647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131551|NCT00192647|Antiviral Agents|antiviral agents|mesh-ancestor
65131552|NCT00192647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65131553|NCT00192647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131554|NCT04560816|Moxifloxacin|moxifloxacin|mesh-list
65131555|NCT04560816|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
65131556|NCT04560816|Choline|choline|mesh-list
65131557|NCT04560816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65131558|NCT04560816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65131559|NCT04560816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65131560|NCT04560816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65131561|NCT04560816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131562|NCT04560816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131563|NCT04560816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131564|NCT04560816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131565|NCT04560816|Lipotropic Agents|lipotropic agents|mesh-ancestor
65131566|NCT04560816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65131567|NCT04560816|Antimetabolites|antimetabolites|mesh-ancestor
65131568|NCT04560816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65131569|NCT04560816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65131570|NCT04560816|Nootropic Agents|nootropic agents|mesh-ancestor
65131571|NCT04560816|Chelating Agents|chelating agents|mesh-ancestor
65131572|NCT04560816|Sequestering Agents|sequestering agents|mesh-ancestor
65131573|NCT04560816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65131574|NCT04560816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65131575|NCT04560816|Growth Substances|growth substances|mesh-ancestor
65131576|NCT04560816|Growth Inhibitors|growth inhibitors|mesh-ancestor
65131577|NCT04563429|Vitamin A|vitamin a|mesh-list
65131578|NCT04563429|Vitamins|vitamins|mesh-ancestor
65131579|NCT04563429|Micronutrients|micronutrients|mesh-ancestor
65131580|NCT04563429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131581|NCT00192023|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65131582|NCT00192023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65131583|NCT00192023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65131584|NCT00192023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65131585|NCT00192023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131586|NCT00192023|Adrenergic Agents|adrenergic agents|mesh-ancestor
65299164|NCT04150172|Rebamipide|rebamipide|mesh-list
65299165|NCT04150172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65299166|NCT04150172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65299167|NCT04150172|Antioxidants|antioxidants|mesh-ancestor
65299168|NCT04150172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299169|NCT04150172|Protective Agents|protective agents|mesh-ancestor
65299170|NCT04150172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299171|NCT04150172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299172|NCT02325011|Fluconazole|fluconazole|mesh-list
65299173|NCT02325011|Nabiximols|nabiximols|mesh-list
65299174|NCT02325011|Dronabinol|dronabinol|mesh-list
65299175|NCT02325011|Cannabidiol|cannabidiol|mesh-list
65299176|NCT02325011|Antifungal Agents|antifungal agents|mesh-ancestor
65299177|NCT02325011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65299178|NCT02325011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65299179|NCT02325011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65299180|NCT02325011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299181|NCT02325011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299182|NCT02325011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65299183|NCT02325011|Hormone Antagonists|hormone antagonists|mesh-ancestor
64529368|NCT02388594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65131587|NCT00192023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65131588|NCT00192023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131589|NCT00191984|Irinotecan|irinotecan|mesh-list
65131590|NCT00191984|Pemetrexed|pemetrexed|mesh-list
65131591|NCT00191984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65131592|NCT00191984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65131593|NCT00191984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704167|NCT05272202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131597|NCT00191984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65131598|NCT04560426|Parathyroid Hormone|parathyroid hormone|mesh-list
65131599|NCT04560426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65131600|NCT04560426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131601|NCT00191906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65131602|NCT00191906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65131603|NCT00191906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65131604|NCT00191906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65131605|NCT00191906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131606|NCT00191906|Adrenergic Agents|adrenergic agents|mesh-ancestor
65131607|NCT00191906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65131608|NCT00191906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131610|NCT00191789|Doxorubicin|doxorubicin|mesh-list
65131611|NCT00191789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131612|NCT00191789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65131613|NCT00191789|Antimetabolites|antimetabolites|mesh-ancestor
65131614|NCT00191789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131615|NCT00191789|Antiviral Agents|antiviral agents|mesh-ancestor
65131616|NCT00191789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65131617|NCT00191789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131618|NCT00191789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65131619|NCT00191789|Immunologic Factors|immunologic factors|mesh-ancestor
65131620|NCT00191789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131621|NCT00191789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65299184|NCT02325011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65299185|NCT02325011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299186|NCT02325011|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65299187|NCT02325011|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65299188|NCT02325011|Analgesics|analgesics|mesh-ancestor
65299189|NCT02325011|Sensory System Agents|sensory system agents|mesh-ancestor
65299190|NCT02325011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65299191|NCT02325011|Anticonvulsants|anticonvulsants|mesh-ancestor
65299192|NCT02325011|Hallucinogens|hallucinogens|mesh-ancestor
65299193|NCT02325011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65049088|NCT04611685|Tramadol|tramadol|mesh-list
65299194|NCT02325011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65299195|NCT02325011|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65299196|NCT02325011|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65299197|NCT02325011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65299199|NCT00577096|Thalidomide|thalidomide|mesh-list
65299200|NCT00577096|Dexamethasone|dexamethasone|mesh-list
65299201|NCT00577096|Cyclophosphamide|cyclophosphamide|mesh-list
65299202|NCT00577096|Melphalan|melphalan|mesh-list
65299203|NCT00577096|Cisplatin|cisplatin|mesh-list
65299204|NCT00577096|Doxorubicin|doxorubicin|mesh-list
65299205|NCT00577096|Etoposide|etoposide|mesh-list
65299206|NCT00577096|Vincristine|vincristine|mesh-list
65299207|NCT00577096|Heparin|heparin|mesh-list
65299208|NCT00577096|Calcium heparin|calcium heparin|mesh-list
65299209|NCT00577096|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65299210|NCT00577096|Tinzaparin|tinzaparin|mesh-list
65299211|NCT00577096|Dalteparin|dalteparin|mesh-list
65299212|NCT00577096|Epoetin Alfa|epoetin alfa|mesh-list
65299213|NCT00577096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65299214|NCT00577096|Immunologic Factors|immunologic factors|mesh-ancestor
65299215|NCT00577096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299216|NCT00577096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65299217|NCT00577096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65299218|NCT00577096|Alkylating Agents|alkylating agents|mesh-ancestor
65299219|NCT00577096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299220|NCT00577096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131622|NCT00191789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65131623|NCT00191789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65131624|NCT04559880|Tranexamic Acid|tranexamic acid|mesh-list
65299221|NCT00577096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65299222|NCT00577096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65299223|NCT00577096|Antiemetics|antiemetics|mesh-ancestor
65299224|NCT00577096|Autonomic Agents|autonomic agents|mesh-ancestor
65299225|NCT00577096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65299226|NCT00577096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65299227|NCT00577096|Glucocorticoids|glucocorticoids|mesh-ancestor
65299228|NCT00577096|Hormones|hormones|mesh-ancestor
65299229|NCT00577096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65299230|NCT00577096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65299231|NCT00577096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299232|NCT00577096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65299233|NCT00577096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65299234|NCT00577096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65299235|NCT00577096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65299236|NCT00577096|Tubulin Modulators|tubulin modulators|mesh-ancestor
64529406|NCT02379000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65131625|NCT04559880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65131626|NCT04559880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65131627|NCT04559880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131628|NCT04559880|Hemostatics|hemostatics|mesh-ancestor
65131629|NCT04559880|Coagulants|coagulants|mesh-ancestor
65131630|NCT00191282|Insulin|insulin|mesh-list
65131631|NCT00191282|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65131632|NCT00191282|Insulin Glargine|insulin glargine|mesh-list
65131633|NCT00191282|Insulin Lispro|insulin lispro|mesh-list
65131634|NCT00191282|Isophane Insulin, Human|isophane insulin, human|mesh-list
65131635|NCT00191282|Insulin, Isophane|insulin, isophane|mesh-list
65131636|NCT00191282|Isophane insulin, beef|isophane insulin, beef|mesh-list
65131637|NCT00191282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65131638|NCT00191282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131639|NCT04560231|Remdesivir|remdesivir|mesh-list
65131640|NCT04560231|Antimetabolites|antimetabolites|mesh-ancestor
65131641|NCT04560231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131642|NCT04560231|Antiviral Agents|antiviral agents|mesh-ancestor
65131643|NCT04560231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65131644|NCT00190775|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65131645|NCT00190775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65131646|NCT00190775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65131647|NCT00190775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65131648|NCT00190775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131649|NCT00190775|Adrenergic Agents|adrenergic agents|mesh-ancestor
65131650|NCT00190775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65131651|NCT00190775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131652|NCT00198263|Bleomycin|bleomycin|mesh-list
65131653|NCT00198263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65131654|NCT00198263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131655|NCT00198107|Cycloserine|cycloserine|mesh-list
65131656|NCT00198107|Aripiprazole|aripiprazole|mesh-list
65131657|NCT00198107|Antidepressive Agents|antidepressive agents|mesh-ancestor
65131658|NCT00198107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65131659|NCT00198107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65131660|NCT00198107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65131661|NCT00198107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65131662|NCT00198107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131663|NCT00198107|Dopamine Agonists|dopamine agonists|mesh-ancestor
65131669|NCT00198107|Serotonin Agents|serotonin agents|mesh-ancestor
65131670|NCT00198107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65299237|NCT00577096|Antimitotic Agents|antimitotic agents|mesh-ancestor
65299238|NCT00577096|Mitosis Modulators|mitosis modulators|mesh-ancestor
65299239|NCT00577096|Anticoagulants|anticoagulants|mesh-ancestor
65299240|NCT00577096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65299241|NCT00577096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65299242|NCT00577096|Hematinics|hematinics|mesh-ancestor
65299243|NCT00577096|Leprostatic Agents|leprostatic agents|mesh-ancestor
65299244|NCT00577096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65299245|NCT00577096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65299246|NCT00577096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65299247|NCT00577096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65299248|NCT00577096|Growth Substances|growth substances|mesh-ancestor
65299249|NCT00577096|Growth Inhibitors|growth inhibitors|mesh-ancestor
65299250|NCT02625506|Tramadol|tramadol|mesh-list
65299251|NCT02625506|Levobupivacaine|levobupivacaine|mesh-list
65299252|NCT02625506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65299253|NCT02625506|Narcotics|narcotics|mesh-ancestor
64529421|NCT00333177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65131671|NCT00198107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65131672|NCT00198107|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65131673|NCT00198107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65131674|NCT00198107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65131675|NCT00198107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65131676|NCT00198107|Renal Agents|renal agents|mesh-ancestor
65131677|NCT00198107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65131678|NCT00198107|Antitubercular Agents|antitubercular agents|mesh-ancestor
65131679|NCT00198107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65131680|NCT00198107|Antimetabolites|antimetabolites|mesh-ancestor
65131681|NCT00179660|Lenalidomide|lenalidomide|mesh-list
65131682|NCT00179660|Immunologic Factors|immunologic factors|mesh-ancestor
65131683|NCT00179660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131684|NCT00179660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65131685|NCT00179660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65131686|NCT00179660|Growth Substances|growth substances|mesh-ancestor
65131687|NCT00179660|Growth Inhibitors|growth inhibitors|mesh-ancestor
65131688|NCT00179660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131689|NCT00178256|Paclitaxel|paclitaxel|mesh-list
65131690|NCT00178256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65131691|NCT00178256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131692|NCT00178256|Tubulin Modulators|tubulin modulators|mesh-ancestor
65131693|NCT00178256|Antimitotic Agents|antimitotic agents|mesh-ancestor
65131694|NCT00178256|Mitosis Modulators|mitosis modulators|mesh-ancestor
65131695|NCT00178256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131696|NCT02211222|Lenvatinib|lenvatinib|mesh-list
65131697|NCT02211222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131698|NCT02211222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65131699|NCT02211222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131700|NCT02211222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131701|NCT00177164|Olanzapine|olanzapine|mesh-list
65131702|NCT00177164|Risperidone|risperidone|mesh-list
65131703|NCT00177164|Aripiprazole|aripiprazole|mesh-list
65131704|NCT00177164|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65131705|NCT00177164|Ziprasidone|ziprasidone|mesh-list
65131706|NCT00177164|Antipsychotic Agents|antipsychotic agents|mesh-list
65131707|NCT00177164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65131708|NCT00177164|Serotonin Agents|serotonin agents|mesh-ancestor
65131709|NCT00177164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65131710|NCT00177164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131711|NCT00177164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131712|NCT00177164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65299254|NCT02625506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65299255|NCT02625506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299256|NCT02625506|Analgesics|analgesics|mesh-ancestor
65299257|NCT02625506|Sensory System Agents|sensory system agents|mesh-ancestor
65299258|NCT02625506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65299259|NCT02625506|Anesthetics, Local|anesthetics, local|mesh-ancestor
65299260|NCT02625506|Anesthetics|anesthetics|mesh-ancestor
65299261|NCT04209959|Nifekalant|nifekalant|mesh-list
65299262|NCT04209959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65299263|NCT04209803|Minoxidil|minoxidil|mesh-list
65299264|NCT04209803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65299265|NCT04209803|Vasodilator Agents|vasodilator agents|mesh-ancestor
65299266|NCT02567032|Oxytocin|oxytocin|mesh-list
65299267|NCT02567032|Oxytocics|oxytocics|mesh-ancestor
65299268|NCT02567032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65299269|NCT02567032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299270|NCT00618059|Pilocarpine|pilocarpine|mesh-list
65299271|NCT00618059|Miotics|miotics|mesh-ancestor
65299272|NCT00618059|Autonomic Agents|autonomic agents|mesh-ancestor
65299273|NCT00618059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65299274|NCT00618059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299275|NCT00618059|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65299276|NCT00618059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65131713|NCT00177164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65131714|NCT00177164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65131715|NCT00177164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65131716|NCT00177164|Dopamine Agents|dopamine agents|mesh-ancestor
65131717|NCT00177164|Antiemetics|antiemetics|mesh-ancestor
65131718|NCT00177164|Autonomic Agents|autonomic agents|mesh-ancestor
65131719|NCT00177164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65131720|NCT00177164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65131721|NCT00177164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65131722|NCT00177164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65131723|NCT00177164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65131724|NCT00177164|Antidepressive Agents|antidepressive agents|mesh-ancestor
65131725|NCT00177164|Dopamine Agonists|dopamine agonists|mesh-ancestor
65131726|NCT00177164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65131727|NCT00177164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65131728|NCT00177164|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65131729|NCT00177164|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65131730|NCT04559841|Simvastatin|simvastatin|mesh-list
65131731|NCT04559841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65131732|NCT04559841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65131742|NCT02489942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131744|NCT04559568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65131745|NCT04559568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65131746|NCT04559568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65131747|NCT04559568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131748|NCT04559568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65131749|NCT04559568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65131750|NCT04559568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65131751|NCT04559568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65131752|NCT04559568|Anesthetics, General|anesthetics, general|mesh-ancestor
65131753|NCT04559568|Anesthetics|anesthetics|mesh-ancestor
65299277|NCT00618059|Cholinergic Agents|cholinergic agents|mesh-ancestor
65299278|NCT00618059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65299279|NCT00618059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299280|NCT00863304|Naproxen|naproxen|mesh-list
65299281|NCT00863304|Tanezumab|tanezumab|mesh-list
65299282|NCT00863304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65299283|NCT00863304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65299284|NCT00863304|Analgesics|analgesics|mesh-ancestor
65131754|NCT04559568|GABA Modulators|gaba modulators|mesh-ancestor
65131755|NCT04559568|GABA Agents|gaba agents|mesh-ancestor
65131756|NCT04559568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65131757|NCT04559568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131758|NCT00176462|Leucovorin|leucovorin|mesh-list
65131759|NCT00176462|Cytarabine|cytarabine|mesh-list
65131760|NCT00176462|Dexamethasone|dexamethasone|mesh-list
65131761|NCT00176462|Hydrocortisone|hydrocortisone|mesh-list
65131762|NCT00176462|Cyclophosphamide|cyclophosphamide|mesh-list
65131763|NCT00176462|Methotrexate|methotrexate|mesh-list
65131764|NCT00176462|Vincristine|vincristine|mesh-list
65131765|NCT00176462|Asparaginase|asparaginase|mesh-list
65131766|NCT00176462|Mercaptopurine|mercaptopurine|mesh-list
65131767|NCT00176462|Thioguanine|thioguanine|mesh-list
65131768|NCT00176462|Daunorubicin|daunorubicin|mesh-list
65131769|NCT00176462|Aminopterin|aminopterin|mesh-list
65131770|NCT00176462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65131771|NCT00176462|Immunologic Factors|immunologic factors|mesh-ancestor
65131772|NCT00176462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131773|NCT00176462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65131774|NCT00176462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65131775|NCT00176462|Alkylating Agents|alkylating agents|mesh-ancestor
65131776|NCT00176462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131777|NCT00176462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131778|NCT00176462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65131779|NCT00176462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65131780|NCT00176462|Antiemetics|antiemetics|mesh-ancestor
65131781|NCT00176462|Autonomic Agents|autonomic agents|mesh-ancestor
65131782|NCT00176462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65131783|NCT00176462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65131784|NCT00176462|Glucocorticoids|glucocorticoids|mesh-ancestor
65131785|NCT00176462|Hormones|hormones|mesh-ancestor
65131786|NCT00176462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65131787|NCT00176462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65131788|NCT00176462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65131789|NCT00176462|Abortifacient Agents|abortifacient agents|mesh-ancestor
65131790|NCT00176462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64514299|NCT02753283|Vitamin D|vitamin d|mesh-list
65131791|NCT00176462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65131792|NCT00176462|Antimetabolites|antimetabolites|mesh-ancestor
65131793|NCT00176462|Dermatologic Agents|dermatologic agents|mesh-ancestor
65131794|NCT00176462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131795|NCT00176462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65131796|NCT00176462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65131797|NCT00176462|Antiviral Agents|antiviral agents|mesh-ancestor
64704380|NCT02470741|Letrozole|letrozole|mesh-list
65131798|NCT00176462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65131800|NCT00176462|Protective Agents|protective agents|mesh-ancestor
65131801|NCT00176462|Vitamin B Complex|vitamin b complex|mesh-ancestor
65131802|NCT00176462|Vitamins|vitamins|mesh-ancestor
65131803|NCT00176462|Micronutrients|micronutrients|mesh-ancestor
65131804|NCT00176462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65131805|NCT00176462|Tubulin Modulators|tubulin modulators|mesh-ancestor
65131806|NCT00176462|Antimitotic Agents|antimitotic agents|mesh-ancestor
65131807|NCT00176462|Mitosis Modulators|mitosis modulators|mesh-ancestor
65131808|NCT00176462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65131809|NCT00176462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65131810|NCT00176462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65131811|NCT00175019|Allopurinol|allopurinol|mesh-list
65131812|NCT00175019|Febuxostat|febuxostat|mesh-list
65131813|NCT00175019|Antimetabolites|antimetabolites|mesh-ancestor
65131814|NCT00175019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131815|NCT00175019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299285|NCT00863304|Sensory System Agents|sensory system agents|mesh-ancestor
65299286|NCT00863304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65299287|NCT00863304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299288|NCT00863304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65299289|NCT00863304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65299290|NCT00863304|Gout Suppressants|gout suppressants|mesh-ancestor
65299291|NCT00863304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65299292|NCT00863304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131816|NCT00175019|Gout Suppressants|gout suppressants|mesh-ancestor
65131817|NCT00175019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65131818|NCT00175019|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65131819|NCT00175019|Antioxidants|antioxidants|mesh-ancestor
65131820|NCT00175019|Protective Agents|protective agents|mesh-ancestor
65131821|NCT00175019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131822|NCT00174941|Febuxostat|febuxostat|mesh-list
65131823|NCT00174941|Gout Suppressants|gout suppressants|mesh-ancestor
65131824|NCT00174941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65131825|NCT00171704|Tamoxifen|tamoxifen|mesh-list
65131826|NCT00171704|Letrozole|letrozole|mesh-list
65131827|NCT00171704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131828|NCT00171704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65131829|NCT00171704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65131830|NCT00171704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131831|NCT00171704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131832|NCT00171704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65131833|NCT00171704|Hormone Antagonists|hormone antagonists|mesh-ancestor
65131834|NCT00171704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65131835|NCT00171704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131836|NCT00171704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65131837|NCT00171704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65131838|NCT00171704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65131839|NCT00171704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65131840|NCT00171314|Zoledronic Acid|zoledronic acid|mesh-list
65131841|NCT00171314|Letrozole|letrozole|mesh-list
65131842|NCT00171314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131843|NCT00171314|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65131844|NCT00171314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65131845|NCT00171314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131846|NCT00171314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131847|NCT00171314|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65131848|NCT00171314|Hormone Antagonists|hormone antagonists|mesh-ancestor
65131849|NCT00171314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65131850|NCT00171314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131851|NCT00171314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65131852|NCT00171158|Imatinib Mesylate|imatinib mesylate|mesh-list
65131853|NCT00171158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131854|NCT00171158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65131855|NCT00171158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131856|NCT00171158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131857|NCT00170846|Everolimus|everolimus|mesh-list
64774377|NCT01668030|Bacitracin|bacitracin|mesh-list
65131858|NCT00170846|Azathioprine|azathioprine|mesh-list
65131859|NCT00170846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
65131860|NCT00170846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131861|NCT00170846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65131862|NCT00170846|Immunologic Factors|immunologic factors|mesh-ancestor
65131863|NCT00170846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514301|NCT02753283|Denosumab|denosumab|mesh-list
65131864|NCT00170846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131865|NCT00170846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131866|NCT00170846|Antimetabolites|antimetabolites|mesh-ancestor
65131867|NCT00170846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65131868|NCT00170846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65131870|NCT00476606|Nelfinavir|nelfinavir|mesh-list
65131871|NCT00476606|Indinavir|indinavir|mesh-list
65131872|NCT00476606|Saquinavir|saquinavir|mesh-list
65131877|NCT00476606|Didanosine|didanosine|mesh-list
65131878|NCT00476606|Efavirenz|efavirenz|mesh-list
65299293|NCT00863304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299294|NCT03603808|Vaccines|vaccines|mesh-list
65299295|NCT03603808|Immunologic Factors|immunologic factors|mesh-ancestor
65299296|NCT03603808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299297|NCT00695110|Methyltestosterone|methyltestosterone|mesh-list
65299298|NCT00695110|Testosterone|testosterone|mesh-list
65299299|NCT00695110|Testosterone undecanoate|testosterone undecanoate|mesh-list
65299300|NCT00695110|Testosterone enanthate|testosterone enanthate|mesh-list
65299301|NCT00695110|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65299302|NCT00695110|Androgens|androgens|mesh-ancestor
65299303|NCT00695110|Hormones|hormones|mesh-ancestor
65299304|NCT00695110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65299305|NCT00695110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299306|NCT00695110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65299307|NCT00695110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299308|NCT00695110|Anabolic Agents|anabolic agents|mesh-ancestor
65299309|NCT03374332|Gemtuzumab|gemtuzumab|mesh-list
65299310|NCT03374332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65299311|NCT03374332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299312|NCT03264352|Amlodipine|amlodipine|mesh-list
65299313|NCT03264352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65299314|NCT03264352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65299315|NCT03264352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65299316|NCT03264352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529470|NCT00295503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65131879|NCT00476606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65131880|NCT00476606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65131881|NCT00476606|Protease Inhibitors|protease inhibitors|mesh-ancestor
65131882|NCT00476606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131883|NCT00476606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131884|NCT00476606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65131885|NCT00476606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65131886|NCT00476606|Antiviral Agents|antiviral agents|mesh-ancestor
65131887|NCT00476606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65131888|NCT00476606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65131889|NCT00476606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65131890|NCT00476606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65131891|NCT00476606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65131892|NCT00476606|Antimetabolites|antimetabolites|mesh-ancestor
65131893|NCT00476606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65131894|NCT00476606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65131895|NCT00476606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65131896|NCT00476606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65131897|NCT00476606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65131898|NCT04562103|Epinephrine|epinephrine|mesh-list
65131899|NCT04562103|Ropivacaine|ropivacaine|mesh-list
65131900|NCT04562103|Anesthetics, Local|anesthetics, local|mesh-ancestor
65299317|NCT03264352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65299318|NCT03264352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299319|NCT03264352|Vasodilator Agents|vasodilator agents|mesh-ancestor
65299320|NCT04897919|Lumefantrine|lumefantrine|mesh-list
65299321|NCT04897919|Artemether|artemether|mesh-list
65299322|NCT04897919|Piperaquine|piperaquine|mesh-list
65299323|NCT04897919|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65299324|NCT04897919|Artenimol|artenimol|mesh-list
65299325|NCT04897919|Antimalarials|antimalarials|mesh-ancestor
65299326|NCT04897919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65299327|NCT04897919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65299328|NCT04897919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65299329|NCT00594386|Rotigotine|rotigotine|mesh-list
65299330|NCT00594386|Dopamine Agonists|dopamine agonists|mesh-ancestor
65299331|NCT00594386|Dopamine Agents|dopamine agents|mesh-ancestor
65299332|NCT00594386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65299333|NCT00594386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299334|NCT00594386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299335|NCT04857671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65299336|NCT04857671|Botulinum Toxins|botulinum toxins|mesh-list
65299337|NCT04857671|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65299338|NCT04857671|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65299339|NCT04857671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65299340|NCT04857671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65299341|NCT04857671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299342|NCT04857671|Cholinergic Agents|cholinergic agents|mesh-ancestor
65299343|NCT04857671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65131901|NCT04562103|Anesthetics|anesthetics|mesh-ancestor
65131902|NCT04562103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65131903|NCT04562103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131904|NCT04562103|Sensory System Agents|sensory system agents|mesh-ancestor
65131905|NCT04562103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65131906|NCT04562103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65131907|NCT04562103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65131908|NCT04562103|Adrenergic Agents|adrenergic agents|mesh-ancestor
65131909|NCT04562103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65131910|NCT04562103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131911|NCT04562103|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65131912|NCT04562103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65131913|NCT04562103|Autonomic Agents|autonomic agents|mesh-ancestor
65131914|NCT04562103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65131915|NCT04562103|Respiratory System Agents|respiratory system agents|mesh-ancestor
65131916|NCT04562103|Mydriatics|mydriatics|mesh-ancestor
65131917|NCT04562103|Sympathomimetics|sympathomimetics|mesh-ancestor
65131918|NCT04562103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65131919|NCT04561635|Micronutrients|micronutrients|mesh-list
65131920|NCT04561635|Trace Elements|trace elements|mesh-list
65299344|NCT04857671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299345|NCT04857671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65299346|NCT04857671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65299347|NCT03466450|Temozolomide|temozolomide|mesh-list
65299348|NCT03466450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65299350|NCT03466450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299351|NCT03466450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131921|NCT04561635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131922|NCT00479882|Simvastatin|simvastatin|mesh-list
65131923|NCT00479882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65131924|NCT00479882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65131925|NCT00479882|Antimetabolites|antimetabolites|mesh-ancestor
65131926|NCT00479882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131927|NCT00479882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65131928|NCT00479882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65131929|NCT00479882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131930|NCT00479765|Paclitaxel|paclitaxel|mesh-list
65131931|NCT00479765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65131932|NCT00479765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131933|NCT00479765|Tubulin Modulators|tubulin modulators|mesh-ancestor
65131934|NCT00479765|Antimitotic Agents|antimitotic agents|mesh-ancestor
65131936|NCT00479765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131937|NCT00479687|Hyaluronic Acid|hyaluronic acid|mesh-list
65131938|NCT00479687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65131939|NCT00479687|Immunologic Factors|immunologic factors|mesh-ancestor
65131940|NCT00479687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131941|NCT00479687|Viscosupplements|viscosupplements|mesh-ancestor
65131942|NCT00479687|Protective Agents|protective agents|mesh-ancestor
65131943|NCT00479336|Tolvaptan|tolvaptan|mesh-list
65131944|NCT00479336|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65131945|NCT00479336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131951|NCT00478244|Fludarabine phosphate|fludarabine phosphate|mesh-list
65131952|NCT00478244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65131953|NCT00478244|Immunologic Factors|immunologic factors|mesh-ancestor
65131954|NCT00478244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131955|NCT00478244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65131956|NCT00478244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65131957|NCT00478244|Alkylating Agents|alkylating agents|mesh-ancestor
65131958|NCT00478244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131959|NCT00478244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131960|NCT00478244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65131961|NCT00478244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65131962|NCT00478244|Antimetabolites|antimetabolites|mesh-ancestor
65131963|NCT00478205|Donepezil|donepezil|mesh-list
65131964|NCT00478205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65131965|NCT00478205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131966|NCT00478205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131967|NCT00478205|Cholinergic Agents|cholinergic agents|mesh-ancestor
65131968|NCT00478205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65131969|NCT00478205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131970|NCT00478205|Nootropic Agents|nootropic agents|mesh-ancestor
65131971|NCT00477971|Dexamethasone|dexamethasone|mesh-list
65131972|NCT00477971|Melphalan|melphalan|mesh-list
65131973|NCT00477971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65131974|NCT00477971|Antiemetics|antiemetics|mesh-ancestor
65131975|NCT00477971|Autonomic Agents|autonomic agents|mesh-ancestor
65131976|NCT00477971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65131977|NCT00477971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131978|NCT00477971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65131979|NCT00477971|Glucocorticoids|glucocorticoids|mesh-ancestor
65131980|NCT00477971|Hormones|hormones|mesh-ancestor
65131981|NCT00477971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65131982|NCT00477971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65131983|NCT00477971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131984|NCT00477971|Immunologic Factors|immunologic factors|mesh-ancestor
65299352|NCT00690560|Prednisone|prednisone|mesh-list
65299353|NCT00690560|Cyclophosphamide|cyclophosphamide|mesh-list
65299354|NCT00690560|Rituximab|rituximab|mesh-list
65299355|NCT00690560|Doxorubicin|doxorubicin|mesh-list
65299356|NCT00690560|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65299357|NCT00690560|Vincristine|vincristine|mesh-list
65299358|NCT00690560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65299359|NCT00690560|Immunologic Factors|immunologic factors|mesh-ancestor
65299360|NCT00690560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299361|NCT00690560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65299362|NCT00690560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65299363|NCT00690560|Alkylating Agents|alkylating agents|mesh-ancestor
65299364|NCT00690560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299365|NCT00690560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299366|NCT00690560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65299367|NCT00690560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65299368|NCT00690560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65299369|NCT00690560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64529499|NCT00298155|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65131985|NCT00477971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65131986|NCT00477971|Alkylating Agents|alkylating agents|mesh-ancestor
65131987|NCT00477971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131988|NCT00477971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65131989|NCT00477971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65131990|NCT00477464|Capecitabine|capecitabine|mesh-list
65131991|NCT00477464|Lapatinib|lapatinib|mesh-list
65131992|NCT00477464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65131993|NCT00477464|Antimetabolites|antimetabolites|mesh-ancestor
65131994|NCT00477464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131995|NCT00477464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131996|NCT00477464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65131997|NCT00477464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131998|NCT00477386|Decitabine|decitabine|mesh-list
65131999|NCT00477386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65132000|NCT00477386|Antimetabolites|antimetabolites|mesh-ancestor
65132001|NCT00477386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132002|NCT00477386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132003|NCT00477386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132004|NCT00477269|Imatinib Mesylate|imatinib mesylate|mesh-list
65132005|NCT00477269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132006|NCT00477269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65132007|NCT00477269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64774524|NCT01708122|Anesthetics|anesthetics|mesh-ancestor
65132008|NCT00477269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132009|NCT00476996|Methotrexate|methotrexate|mesh-list
65132010|NCT00476996|Leflunomide|leflunomide|mesh-list
65132011|NCT00476996|Ocrelizumab|ocrelizumab|mesh-list
65132012|NCT00476996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65132013|NCT00476996|Abortifacient Agents|abortifacient agents|mesh-ancestor
65132014|NCT00476996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65132015|NCT00476996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132029|NCT00476957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65132030|NCT00476957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65132031|NCT00476957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299370|NCT00690560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65299371|NCT00690560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299372|NCT00690560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65299373|NCT00690560|Glucocorticoids|glucocorticoids|mesh-ancestor
65299374|NCT00690560|Hormones|hormones|mesh-ancestor
65299375|NCT00690560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65132032|NCT00476957|Antifungal Agents|antifungal agents|mesh-ancestor
65132033|NCT00476957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65132034|NCT00476957|Immunologic Factors|immunologic factors|mesh-ancestor
65132035|NCT00476957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132036|NCT00475865|Teriflunomide|teriflunomide|mesh-list
65132037|NCT00475865|Glatiramer Acetate|glatiramer acetate|mesh-list
65132038|NCT00475865|(T,G)-A-L|(t,g)-a-l|mesh-list
65132039|NCT00475865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65132040|NCT00475865|Immunologic Factors|immunologic factors|mesh-ancestor
65132041|NCT00475865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132042|NCT00475865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65132043|NCT00475865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65132044|NCT00475865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65132045|NCT00475865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65132046|NCT00475865|Analgesics|analgesics|mesh-ancestor
65132047|NCT00475865|Sensory System Agents|sensory system agents|mesh-ancestor
65132048|NCT00475865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65132049|NCT00475865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65132050|NCT00475670|Paclitaxel|paclitaxel|mesh-list
65132051|NCT00475670|Docetaxel|docetaxel|mesh-list
65132052|NCT00475670|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65132053|NCT00475670|Trastuzumab|trastuzumab|mesh-list
65132054|NCT00475670|Taxane|taxane|mesh-list
65132055|NCT00475670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65132056|NCT00475670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132057|NCT00475670|Tubulin Modulators|tubulin modulators|mesh-ancestor
65132058|NCT00475670|Antimitotic Agents|antimitotic agents|mesh-ancestor
65132059|NCT00475670|Mitosis Modulators|mitosis modulators|mesh-ancestor
65132060|NCT00475670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132061|NCT00475670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65132062|NCT04556760|Prednisolone|prednisolone|mesh-list
65132063|NCT04556760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65132064|NCT04556760|Glucocorticoids|glucocorticoids|mesh-ancestor
65132065|NCT04556760|Hormones|hormones|mesh-ancestor
65132066|NCT04556760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65132067|NCT04556760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132068|NCT04556760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65132069|NCT04556760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132070|NCT00474929|Everolimus|everolimus|mesh-list
65132071|NCT00474929|Sorafenib|sorafenib|mesh-list
65132072|NCT00474929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132073|NCT00474929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65132074|NCT00474929|Immunologic Factors|immunologic factors|mesh-ancestor
65132075|NCT00474929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132076|NCT00474929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65132077|NCT00474929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704656|NCT05588336|Morphine|morphine|mesh-list
65132097|NCT00472199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132098|NCT00472199|Protective Agents|protective agents|mesh-ancestor
65132099|NCT00472199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132100|NCT00472199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65132101|NCT00472199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65132102|NCT00472199|Dopamine Agonists|dopamine agonists|mesh-ancestor
65132103|NCT00472199|Dopamine Agents|dopamine agents|mesh-ancestor
65132104|NCT00472199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65132106|NCT04556136|Vitamins|vitamins|mesh-ancestor
65132107|NCT04556136|Micronutrients|micronutrients|mesh-ancestor
65132108|NCT04556136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132109|NCT04556136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65132110|NCT00471887|Tremelimumab|tremelimumab|mesh-list
65132111|NCT00471887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132112|NCT04556058|Perindopril|perindopril|mesh-list
65132113|NCT04556058|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65132114|NCT04556058|Protease Inhibitors|protease inhibitors|mesh-ancestor
65132115|NCT04556058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299376|NCT00690560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65299377|NCT00690560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65299378|NCT00690560|Tubulin Modulators|tubulin modulators|mesh-ancestor
65299379|NCT00690560|Antimitotic Agents|antimitotic agents|mesh-ancestor
65299380|NCT00690560|Mitosis Modulators|mitosis modulators|mesh-ancestor
65299381|NCT00742690|Terlipressin|terlipressin|mesh-list
65299382|NCT00742690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65299383|NCT00742690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65299384|NCT00742768|Vitamins|vitamins|mesh-list
65299385|NCT00742768|Vitamin K|vitamin k|mesh-list
65299386|NCT00742768|Vitamin K 2|vitamin k 2|mesh-list
65299387|NCT00742768|Micronutrients|micronutrients|mesh-ancestor
65299388|NCT00742768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299389|NCT00742768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65299390|NCT00742768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65299391|NCT00742768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299392|NCT00742768|Hemostatics|hemostatics|mesh-ancestor
65132116|NCT04556058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132117|NCT04556058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65132118|NCT00470834|Bicalutamide|bicalutamide|mesh-list
65132119|NCT00470834|Dutasteride|dutasteride|mesh-list
65132120|NCT00470834|Androgen Antagonists|androgen antagonists|mesh-ancestor
65132121|NCT00470834|Hormone Antagonists|hormone antagonists|mesh-ancestor
65132122|NCT00470834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65132123|NCT00470834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132124|NCT00470834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132125|NCT00470834|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65132126|NCT00470834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65132127|NCT00470834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132128|NCT00470834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132129|NCT00470366|Paclitaxel|paclitaxel|mesh-list
65132130|NCT00470366|Ifosfamide|ifosfamide|mesh-list
65132131|NCT00470366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65132132|NCT00470366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132133|NCT00470366|Tubulin Modulators|tubulin modulators|mesh-ancestor
65132134|NCT00470366|Antimitotic Agents|antimitotic agents|mesh-ancestor
65132135|NCT00470366|Mitosis Modulators|mitosis modulators|mesh-ancestor
65132136|NCT00470366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132137|NCT00470366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65132138|NCT00470366|Alkylating Agents|alkylating agents|mesh-ancestor
65132139|NCT02212431|Cysteamine|cysteamine|mesh-list
65132140|NCT02212431|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
65132141|NCT02212431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132142|NCT00470093|Interferons|interferons|mesh-list
65132143|NCT00470093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132144|NCT00470093|Antiviral Agents|antiviral agents|mesh-ancestor
65132145|NCT00470093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65132146|NCT00470054|Dasatinib|dasatinib|mesh-list
65132147|NCT00470054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132148|NCT00470054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65132149|NCT00470054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132150|NCT00470054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132151|NCT00478595|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65132152|NCT00478595|Rimonabant|rimonabant|mesh-list
65132153|NCT00478595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65132154|NCT00478595|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65132155|NCT00478595|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65132156|NCT00478595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65299393|NCT00742768|Coagulants|coagulants|mesh-ancestor
65299394|NCT00862992|Cariprazine|cariprazine|mesh-list
65299395|NCT00862992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65299396|NCT00862992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65299397|NCT00862992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65299398|NCT00862992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299399|NCT00862992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65299400|NCT02565316|Sertraline|sertraline|mesh-list
65299401|NCT02565316|Antidepressive Agents|antidepressive agents|mesh-ancestor
65299402|NCT02565316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65299403|NCT02565316|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65299404|NCT02565316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65299405|NCT02565316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65299406|NCT02565316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299407|NCT02565316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65299408|NCT02565316|Serotonin Agents|serotonin agents|mesh-ancestor
65299409|NCT02565316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132157|NCT00478595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132159|NCT00478595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65132160|NCT00478595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132161|NCT04555707|Betamethasone|betamethasone|mesh-list
65132162|NCT04555707|Betamethasone Valerate|betamethasone valerate|mesh-list
65132163|NCT04555707|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65132164|NCT04555707|Betamethasone benzoate|betamethasone benzoate|mesh-list
65132165|NCT04555707|Apremilast|apremilast|mesh-list
65132166|NCT04555707|Calcipotriene|calcipotriene|mesh-list
65132167|NCT04555707|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65132168|NCT04555707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65132169|NCT04555707|Glucocorticoids|glucocorticoids|mesh-ancestor
65132170|NCT04555707|Hormones|hormones|mesh-ancestor
65132171|NCT04555707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65132172|NCT04555707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132173|NCT04555707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65132174|NCT04555707|Respiratory System Agents|respiratory system agents|mesh-ancestor
65132175|NCT04555707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65132176|NCT04555707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65132177|NCT04555707|Analgesics|analgesics|mesh-ancestor
65132178|NCT04555707|Sensory System Agents|sensory system agents|mesh-ancestor
65132179|NCT04555707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65132180|NCT04555707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65132181|NCT04555707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65132182|NCT04555707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65132183|NCT04555707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132184|NCT04555707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132185|NCT04555707|Dermatologic Agents|dermatologic agents|mesh-ancestor
65132186|NCT00474188|Dexamethasone|dexamethasone|mesh-list
65132187|NCT00474188|Lenalidomide|lenalidomide|mesh-list
65132188|NCT00474188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65132189|NCT00474188|Antiemetics|antiemetics|mesh-ancestor
65132190|NCT00474188|Autonomic Agents|autonomic agents|mesh-ancestor
65132191|NCT00474188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65132192|NCT00474188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132193|NCT00474188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65132194|NCT00474188|Glucocorticoids|glucocorticoids|mesh-ancestor
65132195|NCT00474188|Hormones|hormones|mesh-ancestor
65132196|NCT00474188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65299410|NCT00742846|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65299411|NCT00742846|Triamcinolone|triamcinolone|mesh-list
65299412|NCT00742846|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65299413|NCT00742846|Lidocaine|lidocaine|mesh-list
65299414|NCT00742846|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65299415|NCT00742846|Anesthetics, Local|anesthetics, local|mesh-ancestor
65299416|NCT00742846|Anesthetics|anesthetics|mesh-ancestor
64529555|NCT01498679|Dermatologic Agents|dermatologic agents|mesh-ancestor
65132197|NCT00474188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65132198|NCT00474188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132199|NCT00474188|Immunologic Factors|immunologic factors|mesh-ancestor
65132200|NCT00474188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65132201|NCT00474188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65132202|NCT00474188|Growth Substances|growth substances|mesh-ancestor
65132203|NCT00474188|Growth Inhibitors|growth inhibitors|mesh-ancestor
65132204|NCT01089647|Budesonide|budesonide|mesh-list
65132205|NCT01089647|Montelukast|montelukast|mesh-list
65132209|NCT01089647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65132210|NCT01089647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132212|NCT01089647|Respiratory System Agents|respiratory system agents|mesh-ancestor
65132213|NCT01089647|Glucocorticoids|glucocorticoids|mesh-ancestor
65132214|NCT01089647|Hormones|hormones|mesh-ancestor
65132215|NCT01089647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65132216|NCT01089647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65132217|NCT01089647|Hormone Antagonists|hormone antagonists|mesh-ancestor
65132218|NCT01089647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65132219|NCT01089647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65132220|NCT01089647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132221|NCT04673240|Botulinum Toxins|botulinum toxins|mesh-list
65132222|NCT04673240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65132223|NCT04673240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65132224|NCT04673240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65132225|NCT04673240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65132226|NCT04673240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132227|NCT04673240|Cholinergic Agents|cholinergic agents|mesh-ancestor
65132228|NCT04673240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65132229|NCT04673240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132230|NCT04673240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64774728|NCT01721226|Analgesics|analgesics|mesh-ancestor
65132231|NCT04673240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65132233|NCT01089608|Povidone|povidone|mesh-list
65132234|NCT01089608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65132235|NCT01089608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65132236|NCT01089608|Plasma Substitutes|plasma substitutes|mesh-ancestor
65132237|NCT01089608|Blood Substitutes|blood substitutes|mesh-ancestor
65132238|NCT04554654|Progesterone|progesterone|mesh-list
65132239|NCT04554654|Progestins|progestins|mesh-ancestor
65132240|NCT04554654|Hormones|hormones|mesh-ancestor
65132241|NCT04554654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65132242|NCT04554654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132243|NCT04554615|Insulin|insulin|mesh-list
65132244|NCT04554615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65132245|NCT04554615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132246|NCT01089413|Bevacizumab|bevacizumab|mesh-list
65132247|NCT01089413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65132248|NCT01089413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132249|NCT01089413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65132250|NCT01089413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65132251|NCT01089413|Growth Substances|growth substances|mesh-ancestor
65132252|NCT01089413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132253|NCT01089413|Growth Inhibitors|growth inhibitors|mesh-ancestor
65132254|NCT02212782|Linagliptin|linagliptin|mesh-list
65132255|NCT02212782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65132256|NCT02212782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132257|NCT02212782|Incretins|incretins|mesh-ancestor
65132258|NCT02212782|Hormones|hormones|mesh-ancestor
65132259|NCT02212782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65132260|NCT02212782|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65299417|NCT00742846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65299418|NCT00742846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299419|NCT00742846|Sensory System Agents|sensory system agents|mesh-ancestor
65299420|NCT00742846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65299421|NCT00742846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64529560|NCT01000467|Antimetabolites|antimetabolites|mesh-ancestor
65132261|NCT02212782|Protease Inhibitors|protease inhibitors|mesh-ancestor
65132262|NCT02212782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132263|NCT02212782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132264|NCT01088984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65132265|NCT01088984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65132266|NCT01088984|Alkylating Agents|alkylating agents|mesh-ancestor
65132267|NCT01088984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132268|NCT01088984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132269|NCT02212821|Erythromycin|erythromycin|mesh-list
65132270|NCT02212821|Erythromycin Estolate|erythromycin estolate|mesh-list
65132271|NCT02212821|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65132272|NCT02212821|Erythromycin stearate|erythromycin stearate|mesh-list
65132273|NCT02212821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65132274|NCT02212821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65132275|NCT02212821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65132278|NCT02212821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132280|NCT01088243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65132281|NCT01088243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65132282|NCT01088243|Analgesics|analgesics|mesh-ancestor
65132283|NCT01088243|Sensory System Agents|sensory system agents|mesh-ancestor
65132284|NCT01088243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65132285|NCT01088243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132286|NCT01088243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65132287|NCT01088243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65132288|NCT04672499|Cortisone|cortisone|mesh-list
65132289|NCT04672499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65132290|NCT04554303|Amlodipine|amlodipine|mesh-list
65132291|NCT04554303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65132292|NCT04554303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65132293|NCT04554303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65132294|NCT04554303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132295|NCT04554303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65132296|NCT04554303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132297|NCT04554303|Vasodilator Agents|vasodilator agents|mesh-ancestor
65132298|NCT01088048|Rituximab|rituximab|mesh-list
65132299|NCT01088048|Fludarabine|fludarabine|mesh-list
65132300|NCT01088048|Lenalidomide|lenalidomide|mesh-list
65132301|NCT01088048|Everolimus|everolimus|mesh-list
65132302|NCT01088048|Bortezomib|bortezomib|mesh-list
65132303|NCT01088048|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65132304|NCT01088048|Ofatumumab|ofatumumab|mesh-list
65132305|NCT01088048|Idelalisib|idelalisib|mesh-list
65132306|NCT01088048|Chlorambucil|chlorambucil|mesh-list
65132307|NCT01088048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65132308|NCT01088048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132309|NCT01088048|Immunologic Factors|immunologic factors|mesh-ancestor
65132310|NCT01088048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132311|NCT01088048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65132312|NCT01088048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132313|NCT01088048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65132314|NCT01088048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65132315|NCT01088048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65132316|NCT01088048|Growth Substances|growth substances|mesh-ancestor
65132317|NCT01088048|Growth Inhibitors|growth inhibitors|mesh-ancestor
65132318|NCT01088048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65132319|NCT01088048|Alkylating Agents|alkylating agents|mesh-ancestor
65132320|NCT01088048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132322|NCT01087970|Pemetrexed|pemetrexed|mesh-list
65132323|NCT01087970|Cetuximab|cetuximab|mesh-list
65132324|NCT01087970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132325|NCT01087970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132326|NCT01087970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299422|NCT00742846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65299423|NCT00742846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65299424|NCT00742846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65299425|NCT00742846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299426|NCT00742846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65299427|NCT00742846|Glucocorticoids|glucocorticoids|mesh-ancestor
65299428|NCT00742846|Hormones|hormones|mesh-ancestor
65299429|NCT00742846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65299430|NCT00742846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65299431|NCT00742846|Immunologic Factors|immunologic factors|mesh-ancestor
65299432|NCT00742846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299433|NCT00690872|Gemcitabine|gemcitabine|mesh-list
65299434|NCT00690872|Carboplatin|carboplatin|mesh-list
65299435|NCT00690872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299436|NCT00690872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65299437|NCT00690872|Antimetabolites|antimetabolites|mesh-ancestor
65299438|NCT00690872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299439|NCT00690872|Antiviral Agents|antiviral agents|mesh-ancestor
64529564|NCT01000467|Protective Agents|protective agents|mesh-ancestor
65132327|NCT01087970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65132328|NCT01087970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65132329|NCT01087970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65132330|NCT01087814|Efavirenz|efavirenz|mesh-list
65132331|NCT01087814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65132332|NCT01087814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65132333|NCT01087814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132334|NCT01087814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132335|NCT01087814|Antiviral Agents|antiviral agents|mesh-ancestor
65132336|NCT01087814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65132337|NCT01087814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65132338|NCT01087814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65132339|NCT01087814|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65132340|NCT01087814|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65132341|NCT01087814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65132342|NCT01087814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65132343|NCT01087502|Glimepiride|glimepiride|mesh-list
65132344|NCT01087502|Linagliptin|linagliptin|mesh-list
65132345|NCT01087502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65132346|NCT01087502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65132347|NCT01087502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132348|NCT01087502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65132353|NCT01087502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65132354|NCT01087502|Protease Inhibitors|protease inhibitors|mesh-ancestor
65132355|NCT01087502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132356|NCT01087502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132357|NCT02213211|Lumefantrine|lumefantrine|mesh-list
65132358|NCT02213211|Artemether|artemether|mesh-list
65132359|NCT02213211|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65132360|NCT02213211|Artemisinins|artemisinins|mesh-list
65132361|NCT02213211|Artemisinin|artemisinin|mesh-list
65132362|NCT02213211|Antimalarials|antimalarials|mesh-ancestor
65132363|NCT02213211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65132364|NCT02213211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65299440|NCT00690872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65299441|NCT00690872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299442|NCT00690872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65299443|NCT00690872|Immunologic Factors|immunologic factors|mesh-ancestor
65299444|NCT00690872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299445|NCT00694096|Sunitinib|sunitinib|mesh-list
65299446|NCT00694096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299447|NCT00694096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65299448|NCT00694096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65299449|NCT00694096|Growth Substances|growth substances|mesh-ancestor
65299450|NCT00694096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299451|NCT00694096|Growth Inhibitors|growth inhibitors|mesh-ancestor
65299452|NCT00694096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65299453|NCT00694096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299454|NCT00694096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299455|NCT04808531|Oxycodone|oxycodone|mesh-list
65299456|NCT04808531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65299457|NCT04808531|Narcotics|narcotics|mesh-ancestor
65299458|NCT04808531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65299459|NCT04808531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529596|NCT00343083|Paclitaxel|paclitaxel|mesh-list
65132365|NCT02213211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65132366|NCT01086410|Fluticasone|fluticasone|mesh-list
65132367|NCT01086410|Xhance|xhance|mesh-list
65132368|NCT01086410|Prednisolone|prednisolone|mesh-list
65132369|NCT01086410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65132370|NCT01086410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65132371|NCT01086410|Autonomic Agents|autonomic agents|mesh-ancestor
65132372|NCT01086410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65132373|NCT01086410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132374|NCT01086410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65132375|NCT01086410|Respiratory System Agents|respiratory system agents|mesh-ancestor
65132377|NCT01086410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65132378|NCT01086410|Glucocorticoids|glucocorticoids|mesh-ancestor
65132379|NCT01086410|Hormones|hormones|mesh-ancestor
65132380|NCT01086410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65132381|NCT01086410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65132382|NCT01086410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132383|NCT04553601|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65132384|NCT04553601|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65132385|NCT04553601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132387|NCT04553328|Anesthetics, Local|anesthetics, local|mesh-ancestor
65132388|NCT04553328|Anesthetics|anesthetics|mesh-ancestor
65132389|NCT04553328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65132390|NCT04553328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132391|NCT04553328|Sensory System Agents|sensory system agents|mesh-ancestor
65132392|NCT04553328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65132393|NCT01085591|Vancomycin|vancomycin|mesh-list
65132394|NCT01085591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65132395|NCT01085591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65132396|NCT04552977|Temozolomide|temozolomide|mesh-list
65132397|NCT04552977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65132398|NCT04552977|Alkylating Agents|alkylating agents|mesh-ancestor
65132399|NCT04552977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299460|NCT04808531|Analgesics|analgesics|mesh-ancestor
65299461|NCT04808531|Sensory System Agents|sensory system agents|mesh-ancestor
65299462|NCT04808531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65299463|NCT00690950|Dutasteride|dutasteride|mesh-list
65299464|NCT00690950|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65299465|NCT00690950|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65299466|NCT00690950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299467|NCT00690950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299468|NCT00690950|Hormone Antagonists|hormone antagonists|mesh-ancestor
65299469|NCT00690950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65299470|NCT00690950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299471|NCT02622126|Atropine|atropine|mesh-list
65299472|NCT02622126|Ephedrine|ephedrine|mesh-list
65299473|NCT02622126|Morphine|morphine|mesh-list
65299474|NCT02622126|Bupivacaine|bupivacaine|mesh-list
65299475|NCT02622126|Anesthetics, Local|anesthetics, local|mesh-ancestor
65299476|NCT02622126|Anesthetics|anesthetics|mesh-ancestor
65299477|NCT02622126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65299478|NCT02622126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299479|NCT02622126|Sensory System Agents|sensory system agents|mesh-ancestor
65299480|NCT02622126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65299481|NCT02622126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65299482|NCT02622126|Narcotics|narcotics|mesh-ancestor
65299483|NCT02622126|Analgesics|analgesics|mesh-ancestor
65299484|NCT02622126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65299485|NCT02622126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64529606|NCT00343785|Cyclosporine|cyclosporine|mesh-list
65132400|NCT04552977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132401|NCT01085201|Regadenoson|regadenoson|mesh-list
65132402|NCT01085201|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65132403|NCT01085201|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65132404|NCT01085201|Purinergic Agonists|purinergic agonists|mesh-ancestor
65132405|NCT01085201|Purinergic Agents|purinergic agents|mesh-ancestor
65132406|NCT01085201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65132407|NCT01085201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132408|NCT01085201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132409|NCT02213718|Sufentanil|sufentanil|mesh-list
65132410|NCT02213718|Propofol|propofol|mesh-list
65132411|NCT02213718|Desflurane|desflurane|mesh-list
65132412|NCT02213718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65132413|NCT02213718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65132414|NCT02213718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132415|NCT02213718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65132416|NCT02213718|Anesthetics, General|anesthetics, general|mesh-ancestor
65132417|NCT02213718|Anesthetics|anesthetics|mesh-ancestor
65132418|NCT02213718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65132419|NCT02213718|Narcotics|narcotics|mesh-ancestor
65132420|NCT02213718|Analgesics|analgesics|mesh-ancestor
65132421|NCT02213718|Sensory System Agents|sensory system agents|mesh-ancestor
64704997|NCT03260504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65299486|NCT02622126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65299487|NCT02622126|Autonomic Agents|autonomic agents|mesh-ancestor
65299488|NCT02622126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65299489|NCT02622126|Respiratory System Agents|respiratory system agents|mesh-ancestor
65299490|NCT02622126|Mydriatics|mydriatics|mesh-ancestor
65299491|NCT02622126|Parasympatholytics|parasympatholytics|mesh-ancestor
65299492|NCT02622126|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65299493|NCT02622126|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65299494|NCT02622126|Cholinergic Agents|cholinergic agents|mesh-ancestor
65299495|NCT02622126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65299496|NCT02622126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299497|NCT02622126|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64529628|NCT00343785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132428|NCT01085045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65132429|NCT01085045|Autonomic Agents|autonomic agents|mesh-ancestor
65132430|NCT01085045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65132431|NCT01085045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132432|NCT01085045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65132433|NCT01085045|Respiratory System Agents|respiratory system agents|mesh-ancestor
65132434|NCT01085045|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65132435|NCT01085045|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65132436|NCT01085045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65132437|NCT01085045|Adrenergic Agents|adrenergic agents|mesh-ancestor
65132438|NCT01085045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65132439|NCT01085045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132440|NCT01085045|Parasympatholytics|parasympatholytics|mesh-ancestor
65132441|NCT01085045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65132442|NCT01085045|Cholinergic Agents|cholinergic agents|mesh-ancestor
65132443|NCT01085045|Anticonvulsants|anticonvulsants|mesh-ancestor
65132444|NCT02213796|Meropenem|meropenem|mesh-list
65132445|NCT02213796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65132446|NCT02213796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65132447|NCT00179673|Lenalidomide|lenalidomide|mesh-list
65132448|NCT00179673|Immunologic Factors|immunologic factors|mesh-ancestor
65132449|NCT00179673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132450|NCT00179673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64665527|NCT04336917|Sensory System Agents|sensory system agents|mesh-ancestor
65132451|NCT00179673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65132452|NCT00179673|Growth Substances|growth substances|mesh-ancestor
65132453|NCT00179673|Growth Inhibitors|growth inhibitors|mesh-ancestor
65132454|NCT00179673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132456|NCT01084655|Docetaxel|docetaxel|mesh-list
65132457|NCT01084655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132458|NCT01084655|Tubulin Modulators|tubulin modulators|mesh-ancestor
65132459|NCT01084655|Antimitotic Agents|antimitotic agents|mesh-ancestor
65132460|NCT01084655|Mitosis Modulators|mitosis modulators|mesh-ancestor
65132461|NCT01084655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132462|NCT01084655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65132463|NCT01084655|Glucocorticoids|glucocorticoids|mesh-ancestor
65132464|NCT01084655|Hormones|hormones|mesh-ancestor
65132465|NCT01084655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65132466|NCT01084655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132467|NCT01084655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65132468|NCT04552431|Ciprofloxacin|ciprofloxacin|mesh-list
65132469|NCT04552431|Tamsulosin|tamsulosin|mesh-list
65132470|NCT04552431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65132471|NCT04552431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65132472|NCT04552431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65132473|NCT04552431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65132474|NCT04552431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132475|NCT04552431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299498|NCT02622126|Sympathomimetics|sympathomimetics|mesh-ancestor
65299499|NCT02622126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65299500|NCT02622126|Adrenergic Agents|adrenergic agents|mesh-ancestor
65299501|NCT04140188|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
65299502|NCT04140188|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65299503|NCT04140188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299504|NCT00685568|Celecoxib|celecoxib|mesh-list
65299505|NCT00685568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65299506|NCT00685568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65299507|NCT00685568|Analgesics|analgesics|mesh-ancestor
65299508|NCT00685568|Sensory System Agents|sensory system agents|mesh-ancestor
65299509|NCT00685568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65299510|NCT00685568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299511|NCT00685568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65299512|NCT00685568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65299513|NCT00685568|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65299514|NCT00685568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65299515|NCT00685568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299516|NCT00685568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299517|NCT02626208|ST 1435|st 1435|mesh-list
65299518|NCT02626208|Contraceptive Agents|contraceptive agents|mesh-list
65299519|NCT02626208|Estradiol|estradiol|mesh-list
65299520|NCT02626208|Estrogens|estrogens|mesh-ancestor
65299521|NCT02626208|Hormones|hormones|mesh-ancestor
65299522|NCT02626208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65299523|NCT02626208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299524|NCT02626208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65299525|NCT02626208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65299526|NCT02626208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65299527|NCT04210739|Betamethasone|betamethasone|mesh-list
65299528|NCT04210739|Betamethasone Valerate|betamethasone valerate|mesh-list
65299529|NCT04210739|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65299530|NCT04210739|Betamethasone benzoate|betamethasone benzoate|mesh-list
65299531|NCT04210739|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65132476|NCT04552431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132477|NCT04552431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65132478|NCT04552431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65132479|NCT04552431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65299532|NCT04210739|Glucocorticoids|glucocorticoids|mesh-ancestor
65299533|NCT04210739|Hormones|hormones|mesh-ancestor
65299534|NCT04210739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65299535|NCT04210739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299536|NCT04210739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65299537|NCT04210739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65299538|NCT04210739|Respiratory System Agents|respiratory system agents|mesh-ancestor
65299539|NCT00696540|Albuterol|albuterol|mesh-list
65299540|NCT00696540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65132480|NCT04552431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65132481|NCT04552431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65132482|NCT04552431|Adrenergic Agents|adrenergic agents|mesh-ancestor
65132483|NCT04552431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65132484|NCT04552431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132485|NCT04552431|Urological Agents|urological agents|mesh-ancestor
65132486|NCT01084538|Ergocalciferols|ergocalciferols|mesh-list
65132487|NCT01084538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65132488|NCT01084538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132489|NCT01084538|Vitamins|vitamins|mesh-ancestor
65132490|NCT01084538|Micronutrients|micronutrients|mesh-ancestor
65132494|NCT00179517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132495|NCT00179517|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65132496|NCT00179517|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65132497|NCT00179517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132498|NCT00179517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132499|NCT00179517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65132500|NCT00179517|Hormone Antagonists|hormone antagonists|mesh-ancestor
65132501|NCT00179517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65132502|NCT00179517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132503|NCT01083641|Estradiol|estradiol|mesh-list
65132504|NCT01083641|Estrogens|estrogens|mesh-ancestor
65132505|NCT01083641|Hormones|hormones|mesh-ancestor
65132506|NCT01083641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65132507|NCT01083641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132508|NCT00179010|Adenosine|adenosine|mesh-list
65132509|NCT00179010|Analgesics|analgesics|mesh-ancestor
65132510|NCT00179010|Sensory System Agents|sensory system agents|mesh-ancestor
65132511|NCT00179010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65132512|NCT00179010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132513|NCT00179010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65132514|NCT00179010|Vasodilator Agents|vasodilator agents|mesh-ancestor
65132515|NCT00179010|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65132516|NCT00179010|Purinergic Agonists|purinergic agonists|mesh-ancestor
65132517|NCT00179010|Purinergic Agents|purinergic agents|mesh-ancestor
65132518|NCT00179010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65132519|NCT00179010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132520|NCT01083602|Dexamethasone|dexamethasone|mesh-list
65132521|NCT01083602|Bortezomib|bortezomib|mesh-list
65132522|NCT01083602|Panobinostat|panobinostat|mesh-list
65132523|NCT01083602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65132524|NCT01083602|Antiemetics|antiemetics|mesh-ancestor
65132526|NCT01083602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65132527|NCT01083602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132528|NCT01083602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65132529|NCT01083602|Glucocorticoids|glucocorticoids|mesh-ancestor
64775027|NCT01750398|Androgens|androgens|mesh-ancestor
65132530|NCT01083602|Hormones|hormones|mesh-ancestor
65132531|NCT01083602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65132532|NCT01083602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65132533|NCT01083602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132534|NCT01083602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65132535|NCT01083602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132536|NCT01083602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132537|NCT00178464|Aspirin|aspirin|mesh-list
65132538|NCT00178464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65299541|NCT00696540|Autonomic Agents|autonomic agents|mesh-ancestor
65299542|NCT00696540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65299543|NCT00696540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299544|NCT00696540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65299545|NCT00696540|Respiratory System Agents|respiratory system agents|mesh-ancestor
65299546|NCT00696540|Tocolytic Agents|tocolytic agents|mesh-ancestor
65299547|NCT00696540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65299548|NCT00696540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65299549|NCT00696540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65299550|NCT00696540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65299551|NCT00696540|Adrenergic Agents|adrenergic agents|mesh-ancestor
65299552|NCT00696540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65299553|NCT00696540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299554|NCT04212845|Dexamethasone|dexamethasone|mesh-list
65299555|NCT04212845|Bupivacaine|bupivacaine|mesh-list
65299556|NCT04212845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65299557|NCT04212845|Antiemetics|antiemetics|mesh-ancestor
65299558|NCT04212845|Autonomic Agents|autonomic agents|mesh-ancestor
65299559|NCT04212845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65299560|NCT04212845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299561|NCT04212845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65299562|NCT04212845|Glucocorticoids|glucocorticoids|mesh-ancestor
65299563|NCT04212845|Hormones|hormones|mesh-ancestor
65132539|NCT00178464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65132540|NCT00178464|Analgesics|analgesics|mesh-ancestor
65132541|NCT00178464|Sensory System Agents|sensory system agents|mesh-ancestor
65132542|NCT00178464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65132543|NCT00178464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132544|NCT00178464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65132545|NCT00178464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65132546|NCT00178464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65132547|NCT00178464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65132548|NCT00178464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132549|NCT00178464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65132550|NCT00178464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65132551|NCT00178464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132552|NCT00178464|Antipyretics|antipyretics|mesh-ancestor
65132553|NCT04671914|Hyaluronic Acid|hyaluronic acid|mesh-list
65132554|NCT04671914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65132555|NCT04671914|Immunologic Factors|immunologic factors|mesh-ancestor
65132556|NCT04671914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132557|NCT04671914|Viscosupplements|viscosupplements|mesh-ancestor
65132558|NCT04671914|Protective Agents|protective agents|mesh-ancestor
65132559|NCT01083485|Oxycodone|oxycodone|mesh-list
65132560|NCT01083485|Naloxone|naloxone|mesh-list
65132561|NCT01083485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65132562|NCT01083485|Narcotics|narcotics|mesh-ancestor
65132565|NCT01083485|Analgesics|analgesics|mesh-ancestor
65132566|NCT01083485|Sensory System Agents|sensory system agents|mesh-ancestor
65132567|NCT01083485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65132568|NCT01083485|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65132569|NCT04551924|Ropivacaine|ropivacaine|mesh-list
65132570|NCT04551924|Anesthetics, Local|anesthetics, local|mesh-ancestor
65132571|NCT04551924|Anesthetics|anesthetics|mesh-ancestor
65299564|NCT04212845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65299565|NCT04212845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65299566|NCT04212845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299567|NCT04212845|Anesthetics, Local|anesthetics, local|mesh-ancestor
65299568|NCT04212845|Anesthetics|anesthetics|mesh-ancestor
65299569|NCT04212845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65299570|NCT04212845|Sensory System Agents|sensory system agents|mesh-ancestor
65299571|NCT00620165|Levetiracetam|levetiracetam|mesh-list
65299572|NCT00620165|Anticonvulsants|anticonvulsants|mesh-ancestor
65049474|NCT04606225|Losartan|losartan|mesh-list
65299573|NCT00620165|Nootropic Agents|nootropic agents|mesh-ancestor
65299574|NCT00685646|Zoledronic Acid|zoledronic acid|mesh-list
65299575|NCT00685646|Androgen Antagonists|androgen antagonists|mesh-list
65299576|NCT00685646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65299577|NCT00685646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299578|NCT00685646|Hormone Antagonists|hormone antagonists|mesh-ancestor
65299579|NCT00685646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65132572|NCT04551924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65132573|NCT04551924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132574|NCT04551924|Sensory System Agents|sensory system agents|mesh-ancestor
65132575|NCT04551924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65132577|NCT04671836|Anticonvulsants|anticonvulsants|mesh-ancestor
65132578|NCT04671836|Antiemetics|antiemetics|mesh-ancestor
65132579|NCT04671836|Autonomic Agents|autonomic agents|mesh-ancestor
65132580|NCT04671836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65132581|NCT04671836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132582|NCT04671836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65132583|NCT04671836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65132584|NCT04671836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65132585|NCT04671836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65132586|NCT04671836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65132587|NCT04671836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65132588|NCT04671836|GABA Modulators|gaba modulators|mesh-ancestor
65132589|NCT04671836|GABA Agents|gaba agents|mesh-ancestor
65132590|NCT04671836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65132591|NCT04671836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132592|NCT00556088|Paclitaxel|paclitaxel|mesh-list
65132593|NCT00556088|Bevacizumab|bevacizumab|mesh-list
65132594|NCT00556088|Carboplatin|carboplatin|mesh-list
65132595|NCT00556088|Panobinostat|panobinostat|mesh-list
65132596|NCT00556088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65132597|NCT00556088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132598|NCT00556088|Tubulin Modulators|tubulin modulators|mesh-ancestor
65132599|NCT00556088|Antimitotic Agents|antimitotic agents|mesh-ancestor
65132600|NCT00556088|Mitosis Modulators|mitosis modulators|mesh-ancestor
65132601|NCT00556088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132602|NCT00556088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65132603|NCT00556088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65132604|NCT00556088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65132605|NCT00556088|Growth Substances|growth substances|mesh-ancestor
65132606|NCT00556088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132607|NCT00556088|Growth Inhibitors|growth inhibitors|mesh-ancestor
65132608|NCT00556088|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65132609|NCT00556088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132646|NCT00177294|Citalopram|citalopram|mesh-list
65132647|NCT00177294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65299580|NCT00685958|Enoxaparin|enoxaparin|mesh-list
65299581|NCT00685958|Anticoagulants|anticoagulants|mesh-ancestor
65299582|NCT00685958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65299583|NCT00685958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65299584|NCT00685958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299585|NCT04138472|Lidocaine|lidocaine|mesh-list
65299586|NCT04138472|Fentanyl|fentanyl|mesh-list
65299587|NCT04138472|Dexmedetomidine|dexmedetomidine|mesh-list
65299588|NCT04138472|Anesthetics, Local|anesthetics, local|mesh-ancestor
65299589|NCT04138472|Anesthetics|anesthetics|mesh-ancestor
65299590|NCT04138472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64529721|NCT01525615|Parasympatholytics|parasympatholytics|mesh-ancestor
65132648|NCT00177294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65132649|NCT00177294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65132650|NCT00177294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132651|NCT00177294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65132652|NCT00177294|Serotonin Agents|serotonin agents|mesh-ancestor
65132653|NCT00177294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132654|NCT00177294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65132655|NCT00177294|Antidepressive Agents|antidepressive agents|mesh-ancestor
65132656|NCT00177294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65132657|NCT01082081|Acetaminophen|acetaminophen|mesh-list
65132658|NCT01082081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65132659|NCT01082081|Analgesics|analgesics|mesh-ancestor
65132660|NCT01082081|Sensory System Agents|sensory system agents|mesh-ancestor
65132661|NCT01082081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65132662|NCT01082081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132663|NCT01082081|Antipyretics|antipyretics|mesh-ancestor
65132664|NCT00177216|Zolpidem|zolpidem|mesh-list
65132665|NCT00177216|Citalopram|citalopram|mesh-list
65132666|NCT00177216|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65132667|NCT00177216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65132668|NCT00177216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65132669|NCT00177216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132670|NCT00177216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65132678|NCT00177216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65132679|NCT00177216|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65132680|NCT00177216|GABA Agonists|gaba agonists|mesh-ancestor
65132681|NCT00177216|GABA Agents|gaba agents|mesh-ancestor
65132682|NCT01081769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65132683|NCT01081769|Antipsychotic Agents|antipsychotic agents|mesh-list
65132684|NCT01081769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65132685|NCT01081769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65132686|NCT01081769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132687|NCT01081769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65132688|NCT01081769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65132689|NCT01081769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65132690|NCT01081769|Serotonin Agents|serotonin agents|mesh-ancestor
65132691|NCT01081769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65132692|NCT01081769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132693|NCT01081769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65132694|NCT01081769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65132695|NCT01081769|Dopamine Agents|dopamine agents|mesh-ancestor
65132697|NCT04551768|Antimetabolites|antimetabolites|mesh-ancestor
65132698|NCT04551768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132699|NCT04551768|Antiviral Agents|antiviral agents|mesh-ancestor
65132700|NCT04551768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65132701|NCT04671563|Tenofovir|tenofovir|mesh-list
65132702|NCT04671563|Antiviral Agents|antiviral agents|mesh-ancestor
65132703|NCT04671563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65132704|NCT04671563|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65132705|NCT04671563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65132706|NCT04671563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299591|NCT04138472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299592|NCT04138472|Sensory System Agents|sensory system agents|mesh-ancestor
65299593|NCT04138472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65299594|NCT04138472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65299595|NCT04138472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65299596|NCT04138472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65299597|NCT04138472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65299598|NCT04138472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299599|NCT04138472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65132707|NCT04671563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132708|NCT04671563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65132709|NCT04671563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65132710|NCT04551573|Rifapentine|rifapentine|mesh-list
65132711|NCT04551573|Rifampin|rifampin|mesh-list
65132712|NCT04551573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65132713|NCT04551573|Antitubercular Agents|antitubercular agents|mesh-ancestor
65132714|NCT04551573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65132715|NCT04551573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65132716|NCT04551573|Leprostatic Agents|leprostatic agents|mesh-ancestor
65132717|NCT04551573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65132718|NCT04551573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132719|NCT04551573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132720|NCT04551573|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65132721|NCT04551573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65132722|NCT04551573|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65132723|NCT04551573|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65132724|NCT04551573|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65132725|NCT04551573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65132726|NCT01081145|Guanfacine|guanfacine|mesh-list
65132727|NCT01081145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65132728|NCT01081145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65132729|NCT01081145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65132730|NCT01081145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65132731|NCT01081145|Adrenergic Agents|adrenergic agents|mesh-ancestor
65132732|NCT01081145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65132733|NCT01081145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132734|NCT01081145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132735|NCT00174915|Allopurinol|allopurinol|mesh-list
65132736|NCT00174915|Febuxostat|febuxostat|mesh-list
65132737|NCT00174915|Antimetabolites|antimetabolites|mesh-ancestor
65132738|NCT00174915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132739|NCT00174915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132742|NCT00174915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65132744|NCT00174915|Protective Agents|protective agents|mesh-ancestor
65132745|NCT00174915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132746|NCT01080716|Vaccines|vaccines|mesh-list
65132747|NCT01080716|Complement Factor H|complement factor h|mesh-list
65132748|NCT01080716|Immunologic Factors|immunologic factors|mesh-ancestor
65132749|NCT01080716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132750|NCT01080716|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65132751|NCT01080716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65132752|NCT04671446|Autoantibodies|autoantibodies|mesh-list
65132753|NCT04671446|Immunologic Factors|immunologic factors|mesh-ancestor
65132754|NCT04671446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132756|NCT04571489|Tegafur|tegafur|mesh-list
65132757|NCT04571489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65132758|NCT04571489|Antimetabolites|antimetabolites|mesh-ancestor
65132759|NCT04571489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132760|NCT04571489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132761|NCT04571489|Antiviral Agents|antiviral agents|mesh-ancestor
65132762|NCT04571489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65132763|NCT04571489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299600|NCT04138472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65299601|NCT04138472|Analgesics|analgesics|mesh-ancestor
65299602|NCT04138472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65299603|NCT04138472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65299604|NCT04138472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65299605|NCT04138472|Adrenergic Agents|adrenergic agents|mesh-ancestor
65299606|NCT04138472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65299607|NCT04138472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65299608|NCT04138472|Narcotics|narcotics|mesh-ancestor
65299609|NCT04138472|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65299610|NCT04138472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65299611|NCT04138472|Anesthetics, General|anesthetics, general|mesh-ancestor
65299612|NCT00620789|Dexetimide|dexetimide|mesh-list
65299613|NCT00620789|Citalopram|citalopram|mesh-list
65299614|NCT00620789|Antidepressive Agents|antidepressive agents|mesh-list
65299615|NCT00620789|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65299616|NCT00620789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65299617|NCT00620789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64529736|NCT00302133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132764|NCT04571489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65132765|NCT04571489|Immunologic Factors|immunologic factors|mesh-ancestor
65132766|NCT04571489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132767|NCT00172185|Teduglutide|teduglutide|mesh-list
65132768|NCT00172185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65132769|NCT00172185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65132770|NCT00172185|Protective Agents|protective agents|mesh-ancestor
65132771|NCT00172185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132772|NCT00171951|Pasireotide|pasireotide|mesh-list
65132773|NCT00171951|Hormones|hormones|mesh-ancestor
65132774|NCT00171951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65132775|NCT00171951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132776|NCT01080131|Triamcinolone|triamcinolone|mesh-list
65132777|NCT01080131|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65132778|NCT01080131|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65132779|NCT01080131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65132780|NCT01080131|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65132781|NCT01080131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65132782|NCT01080131|Glucocorticoids|glucocorticoids|mesh-ancestor
65132783|NCT01080131|Hormones|hormones|mesh-ancestor
65132784|NCT01080131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65132785|NCT01080131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132786|NCT01080131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65132787|NCT01080131|Immunologic Factors|immunologic factors|mesh-ancestor
65132788|NCT01080131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132789|NCT01080131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132790|NCT00171873|Octreotide|octreotide|mesh-list
65132791|NCT00171873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65132792|NCT00171873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65132793|NCT00171873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132794|NCT01087151|Rituximab|rituximab|mesh-list
65132795|NCT01087151|Navitoclax|navitoclax|mesh-list
65132796|NCT01087151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65132797|NCT01087151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132798|NCT01087151|Immunologic Factors|immunologic factors|mesh-ancestor
65132799|NCT01087151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132800|NCT01087151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65132801|NCT00171834|Epothilones|epothilones|mesh-list
65132802|NCT00171834|Epothilone B|epothilone b|mesh-list
65299618|NCT00620789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299619|NCT00620789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65299620|NCT00620789|Serotonin Agents|serotonin agents|mesh-ancestor
65299621|NCT00620789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299622|NCT00620789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65299623|NCT00620789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65299624|NCT00620789|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65299625|NCT00620789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64294466|NCT02817841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64529758|NCT02660580|Adalimumab|adalimumab|mesh-list
65132803|NCT00171834|Tubulin Modulators|tubulin modulators|mesh-ancestor
65132804|NCT00171834|Antimitotic Agents|antimitotic agents|mesh-ancestor
65132805|NCT00171834|Mitosis Modulators|mitosis modulators|mesh-ancestor
65132806|NCT00171834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132807|NCT00171834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132808|NCT04571996|Acetaminophen|acetaminophen|mesh-list
65132809|NCT04571996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65132810|NCT04571996|Analgesics|analgesics|mesh-ancestor
65132811|NCT04571996|Sensory System Agents|sensory system agents|mesh-ancestor
65132812|NCT04571996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65132813|NCT04571996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132814|NCT04571996|Antipyretics|antipyretics|mesh-ancestor
65132816|NCT00171249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132817|NCT00171249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65132818|NCT00171249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132819|NCT00171249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132821|NCT04671056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65132822|NCT04671056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132823|NCT01082549|Gemcitabine|gemcitabine|mesh-list
65132824|NCT01082549|Carboplatin|carboplatin|mesh-list
65132825|NCT01082549|Iniparib|iniparib|mesh-list
65132826|NCT01082549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132827|NCT01082549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65132828|NCT01082549|Antimetabolites|antimetabolites|mesh-ancestor
65132829|NCT01082549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132830|NCT01082549|Antiviral Agents|antiviral agents|mesh-ancestor
65132831|NCT01082549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65132832|NCT01082549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132833|NCT01082549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65132834|NCT01082549|Immunologic Factors|immunologic factors|mesh-ancestor
65132835|NCT01082549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132836|NCT01082549|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65132837|NCT04550949|Denosumab|denosumab|mesh-list
65132838|NCT04550949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65132839|NCT04550949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132840|NCT01085630|Pemetrexed|pemetrexed|mesh-list
65132841|NCT01085630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132842|NCT01085630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132843|NCT01085630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132844|NCT01085630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65132845|NCT01085630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65132846|NCT00171210|Deferasirox|deferasirox|mesh-list
65132847|NCT00171210|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65132848|NCT00171210|Chelating Agents|chelating agents|mesh-ancestor
65132849|NCT00171210|Sequestering Agents|sequestering agents|mesh-ancestor
65132850|NCT00171210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132851|NCT00171054|Amlodipine|amlodipine|mesh-list
65132852|NCT00171054|Valsartan|valsartan|mesh-list
65132853|NCT00171054|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65132854|NCT00171054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65132855|NCT00171054|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65132856|NCT00171054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65222820|NCT02699385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65299626|NCT00620789|Parasympatholytics|parasympatholytics|mesh-ancestor
65299627|NCT00620789|Autonomic Agents|autonomic agents|mesh-ancestor
65299628|NCT00620789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65299629|NCT00620789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65299630|NCT00620789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65299631|NCT00620789|Cholinergic Agents|cholinergic agents|mesh-ancestor
65299632|NCT00691184|Terbinafine|terbinafine|mesh-list
65299633|NCT00691184|Antifungal Agents|antifungal agents|mesh-ancestor
65299634|NCT00691184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65299635|NCT00691184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299636|NCT00691184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299637|NCT00854100|Cariprazine|cariprazine|mesh-list
65299638|NCT00854100|Antidepressive Agents|antidepressive agents|mesh-list
64529760|NCT02660580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65132857|NCT00171054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132858|NCT00171054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65132859|NCT00171054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132860|NCT00171054|Vasodilator Agents|vasodilator agents|mesh-ancestor
65132861|NCT00171054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65132862|NCT00171054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65132863|NCT00171054|Diuretics|diuretics|mesh-ancestor
65132864|NCT00171054|Natriuretic Agents|natriuretic agents|mesh-ancestor
65132865|NCT00171054|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65132866|NCT00174837|Tirapazamine|tirapazamine|mesh-list
65132867|NCT00174837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132868|NCT00179400|Pioglitazone|pioglitazone|mesh-list
65132869|NCT00179400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65132870|NCT00179400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132871|NCT04550793|Botulinum Toxins|botulinum toxins|mesh-list
65132872|NCT04550793|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65132873|NCT04550793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65132874|NCT04550793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132875|NCT04550793|Cholinergic Agents|cholinergic agents|mesh-ancestor
65132876|NCT04550793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65132877|NCT04550793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132878|NCT04990037|Folfirinox|folfirinox|mesh-list
65132879|NCT04990037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132880|NCT00479856|Paclitaxel|paclitaxel|mesh-list
65132881|NCT00479856|Docetaxel|docetaxel|mesh-list
65132882|NCT00479856|Capecitabine|capecitabine|mesh-list
65132883|NCT00479856|Lapatinib|lapatinib|mesh-list
65132884|NCT00479856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65132885|NCT00479856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132886|NCT00479856|Tubulin Modulators|tubulin modulators|mesh-ancestor
65132887|NCT00479856|Antimitotic Agents|antimitotic agents|mesh-ancestor
65132888|NCT00479856|Mitosis Modulators|mitosis modulators|mesh-ancestor
65132896|NCT04997759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132897|NCT04997759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132898|NCT04997759|Cholinergic Agents|cholinergic agents|mesh-ancestor
65132899|NCT04997759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65132900|NCT04997759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132901|NCT04997759|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65132902|NCT04997759|Autonomic Agents|autonomic agents|mesh-ancestor
65132903|NCT04997759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65132904|NCT00479466|Metformin|metformin|mesh-list
65132905|NCT00479466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65132906|NCT00479466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132907|NCT04991948|Pembrolizumab|pembrolizumab|mesh-list
65132908|NCT04991948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65132909|NCT04991948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132910|NCT04990778|Venetoclax|venetoclax|mesh-list
65132911|NCT04990778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299639|NCT00854100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65299640|NCT00854100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65299641|NCT00854100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65299642|NCT00854100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65299643|NCT00854100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299644|NCT00691262|Tacrolimus|tacrolimus|mesh-list
65299645|NCT00691262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65299646|NCT00691262|Immunologic Factors|immunologic factors|mesh-ancestor
65299647|NCT00691262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299648|NCT00691262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65299649|NCT00691262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299650|NCT00691262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299652|NCT00620867|Celecoxib|celecoxib|mesh-list
65299653|NCT00620867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65299654|NCT00620867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65299655|NCT00620867|Analgesics|analgesics|mesh-ancestor
65299656|NCT00620867|Sensory System Agents|sensory system agents|mesh-ancestor
65299657|NCT00620867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65299658|NCT00620867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299659|NCT00620867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65299660|NCT00620867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65299661|NCT00620867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65299662|NCT00620867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299663|NCT00620867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299664|NCT00620867|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65299665|NCT04271917|Acetaminophen|acetaminophen|mesh-list
65299666|NCT04271917|Ibuprofen|ibuprofen|mesh-list
65132912|NCT00479388|Niacin|niacin|mesh-list
65132913|NCT00479388|Atorvastatin|atorvastatin|mesh-list
65132914|NCT00479388|Simvastatin|simvastatin|mesh-list
65132915|NCT00479388|Calcium|calcium|mesh-list
65132916|NCT00479388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65132917|NCT00479388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132918|NCT00479388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65132919|NCT00479388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65132920|NCT00479388|Antimetabolites|antimetabolites|mesh-ancestor
65132921|NCT00479388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132922|NCT00479388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65132923|NCT00479388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65132924|NCT00479388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132925|NCT00479388|Vasodilator Agents|vasodilator agents|mesh-ancestor
65132926|NCT00479388|Vitamin B Complex|vitamin b complex|mesh-ancestor
65132927|NCT00479388|Vitamins|vitamins|mesh-ancestor
65132928|NCT00479388|Micronutrients|micronutrients|mesh-ancestor
65132929|NCT00479232|Decitabine|decitabine|mesh-list
65132930|NCT00479232|Vorinostat|vorinostat|mesh-list
65132931|NCT00479232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65132932|NCT00479232|Antimetabolites|antimetabolites|mesh-ancestor
65299667|NCT04271917|Cannabidiol|cannabidiol|mesh-list
65299668|NCT04271917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65299669|NCT04271917|Analgesics|analgesics|mesh-ancestor
65299670|NCT04271917|Sensory System Agents|sensory system agents|mesh-ancestor
65299671|NCT04271917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64529796|NCT02376192|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65132933|NCT00479232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132934|NCT00479232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132935|NCT00479232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132936|NCT00479232|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65132937|NCT00478881|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65132938|NCT00478881|Vasodilator Agents|vasodilator agents|mesh-ancestor
65132939|NCT00478881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65132940|NCT00478881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65132941|NCT00478881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132942|NCT00478881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132943|NCT00478881|Urological Agents|urological agents|mesh-ancestor
65132944|NCT00556127|Cytarabine|cytarabine|mesh-list
65132945|NCT00556127|Dexamethasone|dexamethasone|mesh-list
65132946|NCT00556127|Prednisone|prednisone|mesh-list
65132947|NCT00556127|Cyclophosphamide|cyclophosphamide|mesh-list
65132948|NCT00556127|Melphalan|melphalan|mesh-list
65132949|NCT00556127|Carmustine|carmustine|mesh-list
65132950|NCT00556127|Rituximab|rituximab|mesh-list
65132951|NCT00556127|Etoposide|etoposide|mesh-list
65132952|NCT00556127|Vincristine|vincristine|mesh-list
65132953|NCT00556127|Epirubicin|epirubicin|mesh-list
65132954|NCT00556127|Mitoxantrone|mitoxantrone|mesh-list
65132955|NCT00556127|Lenograstim|lenograstim|mesh-list
65132956|NCT00556127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65132957|NCT00556127|Immunologic Factors|immunologic factors|mesh-ancestor
65132958|NCT00556127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705503|NCT02616523|Narcotics|narcotics|mesh-ancestor
65132961|NCT00556127|Alkylating Agents|alkylating agents|mesh-ancestor
65132962|NCT00556127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132963|NCT00556127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132964|NCT00556127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65132965|NCT00556127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65132966|NCT00556127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65132967|NCT00556127|Antiemetics|antiemetics|mesh-ancestor
65132968|NCT00556127|Autonomic Agents|autonomic agents|mesh-ancestor
65132969|NCT00556127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65132970|NCT00556127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65132971|NCT00556127|Glucocorticoids|glucocorticoids|mesh-ancestor
65132972|NCT00556127|Hormones|hormones|mesh-ancestor
64514319|NCT01929460|Ciprofloxacin|ciprofloxacin|mesh-list
65132973|NCT00556127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65132974|NCT00556127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65132975|NCT00556127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65132976|NCT00556127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65132977|NCT00556127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65132978|NCT00556127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132979|NCT00556127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65132980|NCT00556127|Antimetabolites|antimetabolites|mesh-ancestor
64775479|NCT01835262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65132981|NCT00556127|Antiviral Agents|antiviral agents|mesh-ancestor
65132982|NCT00556127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65132983|NCT00556127|Tubulin Modulators|tubulin modulators|mesh-ancestor
65132984|NCT00556127|Antimitotic Agents|antimitotic agents|mesh-ancestor
65132985|NCT00556127|Mitosis Modulators|mitosis modulators|mesh-ancestor
65132986|NCT00556127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65132987|NCT00556127|Analgesics|analgesics|mesh-ancestor
65132988|NCT00556127|Sensory System Agents|sensory system agents|mesh-ancestor
65132989|NCT00556127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65132990|NCT00556205|Bevacizumab|bevacizumab|mesh-list
65132991|NCT00556205|Sunitinib|sunitinib|mesh-list
65132992|NCT00556205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65132993|NCT00556205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132994|NCT00556205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65132995|NCT00556205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65132996|NCT00556205|Growth Substances|growth substances|mesh-ancestor
65132997|NCT00556205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299672|NCT04271917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299673|NCT04271917|Antipyretics|antipyretics|mesh-ancestor
65299674|NCT04271917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65299675|NCT04271917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65299676|NCT04271917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65299677|NCT04271917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65299678|NCT04271917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299679|NCT04271917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299680|NCT04271917|Anticonvulsants|anticonvulsants|mesh-ancestor
65299681|NCT04122222|Vaccines|vaccines|mesh-list
65299682|NCT04122222|Immunologic Factors|immunologic factors|mesh-ancestor
65299683|NCT04122222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299684|NCT00686114|Paclitaxel|paclitaxel|mesh-list
65299685|NCT00686114|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65299686|NCT00686114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65299687|NCT00686114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299688|NCT00686114|Tubulin Modulators|tubulin modulators|mesh-ancestor
65132998|NCT00556205|Growth Inhibitors|growth inhibitors|mesh-ancestor
65132999|NCT00556205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65133000|NCT00556205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133001|NCT00556205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133002|NCT00478608|Sirolimus|sirolimus|mesh-list
65133003|NCT00478608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65133004|NCT00478608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65133005|NCT00478608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65133006|NCT00478608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133007|NCT00478608|Antifungal Agents|antifungal agents|mesh-ancestor
65133008|NCT00478608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65133009|NCT00478608|Immunologic Factors|immunologic factors|mesh-ancestor
65133010|NCT00478608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133011|NCT00478140|Trastuzumab|trastuzumab|mesh-list
65133012|NCT00478140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65133013|NCT00478140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133014|NCT00478023|Morphine|morphine|mesh-list
65133015|NCT00478023|Tapentadol|tapentadol|mesh-list
65133016|NCT00478023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65133017|NCT00478023|Narcotics|narcotics|mesh-ancestor
65133018|NCT00478023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65133019|NCT00478023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133020|NCT00478023|Analgesics|analgesics|mesh-ancestor
65133021|NCT00478023|Sensory System Agents|sensory system agents|mesh-ancestor
65133022|NCT00478023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133023|NCT00478023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65133024|NCT00478023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65133025|NCT00478023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65133026|NCT00478023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133027|NCT00478023|Adrenergic Agents|adrenergic agents|mesh-ancestor
65133028|NCT00478023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65133029|NCT00477750|Prednisone|prednisone|mesh-list
65133035|NCT00477750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65133037|NCT00477750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65133038|NCT00477750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133039|NCT00477750|Immunologic Factors|immunologic factors|mesh-ancestor
65133040|NCT00477750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65133041|NCT00477750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65133042|NCT00477750|Growth Substances|growth substances|mesh-ancestor
65133043|NCT00477750|Growth Inhibitors|growth inhibitors|mesh-ancestor
65299689|NCT00686114|Antimitotic Agents|antimitotic agents|mesh-ancestor
65299690|NCT00686114|Mitosis Modulators|mitosis modulators|mesh-ancestor
65299691|NCT00686114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299692|NCT00686114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65299693|NCT00686114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299694|NCT01015729|Esomeprazole|esomeprazole|mesh-list
65299695|NCT01015729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299696|NCT01015729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299697|NCT01015729|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65299698|NCT01015729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65299699|NCT01015729|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65133044|NCT00477750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65133045|NCT00477750|Alkylating Agents|alkylating agents|mesh-ancestor
65133046|NCT00477750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133047|NCT00477750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65133048|NCT00477750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65133049|NCT00477672|Pimavanserin|pimavanserin|mesh-list
65133050|NCT00477672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65133051|NCT00477672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65133052|NCT00477672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65133053|NCT00477672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65133054|NCT00477672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65133055|NCT00477672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133056|NCT00477672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65133057|NCT00477672|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65133058|NCT00477672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65133059|NCT00477672|Serotonin Agents|serotonin agents|mesh-ancestor
65133060|NCT00477672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65133061|NCT00477672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133062|NCT04549935|Prednisolone|prednisolone|mesh-list
65133063|NCT04549935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65133064|NCT04549935|Glucocorticoids|glucocorticoids|mesh-ancestor
65133065|NCT04549935|Hormones|hormones|mesh-ancestor
65133066|NCT04549935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65133067|NCT04549935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133068|NCT04549935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65133069|NCT04549935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133070|NCT00477633|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65133071|NCT00477633|Norethindrone|norethindrone|mesh-list
65133072|NCT00477633|Norethindrone Acetate|norethindrone acetate|mesh-list
65133073|NCT00477633|Estradiol|estradiol|mesh-list
65133074|NCT00477633|Estrogens|estrogens|mesh-ancestor
65133075|NCT00477633|Hormones|hormones|mesh-ancestor
65133076|NCT00477633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65133077|NCT00477633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133078|NCT00477633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65133079|NCT00477633|Contraceptive Agents|contraceptive agents|mesh-ancestor
65133080|NCT00477633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65133081|NCT00477633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65133082|NCT00477633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65133083|NCT00477633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65133084|NCT00477633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65133085|NCT04541823|Propofol|propofol|mesh-list
65133086|NCT04541823|Desflurane|desflurane|mesh-list
65133087|NCT04541823|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65133088|NCT04541823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65133089|NCT04541823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133090|NCT04541823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65133091|NCT04541823|Anesthetics, General|anesthetics, general|mesh-ancestor
65133092|NCT04541823|Anesthetics|anesthetics|mesh-ancestor
65133093|NCT04541823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65133094|NCT00556361|Ketamine|ketamine|mesh-list
65133095|NCT00556361|Analgesics|analgesics|mesh-ancestor
65299700|NCT00698724|Prednisolone acetate|prednisolone acetate|mesh-list
65299701|NCT00698724|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65299702|NCT00698724|Methylprednisolone|methylprednisolone|mesh-list
65299703|NCT00698724|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65299704|NCT00698724|Prednisolone|prednisolone|mesh-list
65299705|NCT00698724|Bromfenac|bromfenac|mesh-list
65299706|NCT00698724|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65299707|NCT00698724|Prednisolone phosphate|prednisolone phosphate|mesh-list
65299708|NCT00698724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65299709|NCT00698724|Antiemetics|antiemetics|mesh-ancestor
65299710|NCT00698724|Autonomic Agents|autonomic agents|mesh-ancestor
65299711|NCT00698724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65299712|NCT00698724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133096|NCT00556361|Sensory System Agents|sensory system agents|mesh-ancestor
65133097|NCT00556361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133098|NCT00556361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133099|NCT00556361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65133110|NCT04571606|Anesthetics|anesthetics|mesh-ancestor
65133111|NCT04571606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65133112|NCT04571606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133113|NCT04571606|Sensory System Agents|sensory system agents|mesh-ancestor
65133114|NCT04571606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133115|NCT02210117|Bevacizumab|bevacizumab|mesh-list
65133116|NCT02210117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65133118|NCT02210117|Ipilimumab|ipilimumab|mesh-list
65133119|NCT02210117|Endothelial Growth Factors|endothelial growth factors|mesh-list
65133120|NCT02210117|Antibodies|antibodies|mesh-list
65133121|NCT02210117|Immunoglobulins|immunoglobulins|mesh-list
65133122|NCT02210117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65133123|NCT02210117|Immunoglobulin G|immunoglobulin g|mesh-list
65133124|NCT02210117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133125|NCT02210117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65133126|NCT02210117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65133127|NCT02210117|Growth Substances|growth substances|mesh-ancestor
65133128|NCT02210117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133129|NCT02210117|Growth Inhibitors|growth inhibitors|mesh-ancestor
65133130|NCT02210117|Immunologic Factors|immunologic factors|mesh-ancestor
65133131|NCT02210117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65133132|NCT02210117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133133|NCT04541277|Cytarabine|cytarabine|mesh-list
65133134|NCT04541277|Azacitidine|azacitidine|mesh-list
65133135|NCT04541277|Decitabine|decitabine|mesh-list
65133136|NCT04541277|Idarubicin|idarubicin|mesh-list
65133137|NCT04541277|Lenograstim|lenograstim|mesh-list
65133138|NCT04541277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65133139|NCT04541277|Antimetabolites|antimetabolites|mesh-ancestor
65133140|NCT04541277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133141|NCT04541277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133142|NCT04541277|Antiviral Agents|antiviral agents|mesh-ancestor
65133143|NCT04541277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65133144|NCT04541277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65133145|NCT04541277|Immunologic Factors|immunologic factors|mesh-ancestor
65133146|NCT04541277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133147|NCT04541277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133148|NCT04541277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65133149|NCT04541277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65133150|NCT04541277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65133151|NCT04541277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65133152|NCT04995653|Vancomycin|vancomycin|mesh-list
65133153|NCT04995653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65133154|NCT04995653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65133155|NCT04540926|Cyclosporine|cyclosporine|mesh-list
65133156|NCT04540926|Cyclosporins|cyclosporins|mesh-list
65133157|NCT04540926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299713|NCT00698724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65299714|NCT00698724|Glucocorticoids|glucocorticoids|mesh-ancestor
65299715|NCT00698724|Hormones|hormones|mesh-ancestor
65299716|NCT00698724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65299717|NCT00698724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65299718|NCT00698724|Protective Agents|protective agents|mesh-ancestor
65299719|NCT00698724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65133158|NCT04540926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133159|NCT04540926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65133160|NCT04540926|Immunologic Factors|immunologic factors|mesh-ancestor
65133161|NCT04540926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133162|NCT04540926|Antifungal Agents|antifungal agents|mesh-ancestor
65133163|NCT04540926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65133164|NCT04540926|Dermatologic Agents|dermatologic agents|mesh-ancestor
65133165|NCT04540926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64705714|NCT04592809|Midazolam|midazolam|mesh-list
65133171|NCT04540965|Histamine Antagonists|histamine antagonists|mesh-ancestor
65133172|NCT04540965|Histamine Agents|histamine agents|mesh-ancestor
65133173|NCT04540965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65133174|NCT04540965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133175|NCT04540965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133176|NCT04570865|Dapagliflozin|dapagliflozin|mesh-list
65133177|NCT04570865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65133178|NCT04570865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133179|NCT04570865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65133180|NCT04570865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133181|NCT04570592|Dexamethasone|dexamethasone|mesh-list
65133182|NCT04570592|Granisetron|granisetron|mesh-list
65133183|NCT04570592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65133184|NCT04570592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65133185|NCT04570592|Antiemetics|antiemetics|mesh-ancestor
65133186|NCT04570592|Autonomic Agents|autonomic agents|mesh-ancestor
65133187|NCT04570592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133188|NCT04570592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133189|NCT04570592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65133190|NCT04570592|Glucocorticoids|glucocorticoids|mesh-ancestor
65133191|NCT04570592|Hormones|hormones|mesh-ancestor
65133192|NCT04570592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65133193|NCT04570592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65133194|NCT04570592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133195|NCT04570592|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65133196|NCT04570592|Serotonin Agents|serotonin agents|mesh-ancestor
65133197|NCT04570592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65133198|NCT04570592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133199|NCT02215395|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65133200|NCT02215395|Contraceptive Agents|contraceptive agents|mesh-list
65133201|NCT02215395|Estradiol|estradiol|mesh-list
65133202|NCT02215395|Estrogens|estrogens|mesh-ancestor
65133203|NCT02215395|Hormones|hormones|mesh-ancestor
65133204|NCT02215395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65133205|NCT02215395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133206|NCT02215395|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64775702|NCT01878006|Analgesics|analgesics|mesh-ancestor
65133207|NCT02215395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65133208|NCT02215395|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65133209|NCT02215395|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65133210|NCT02215395|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65133211|NCT02215434|Methyltestosterone|methyltestosterone|mesh-list
65133212|NCT02215434|Testosterone|testosterone|mesh-list
65133213|NCT02215434|Testosterone undecanoate|testosterone undecanoate|mesh-list
65133214|NCT02215434|Testosterone enanthate|testosterone enanthate|mesh-list
65133215|NCT02215434|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65133216|NCT02215434|Androgens|androgens|mesh-ancestor
65133217|NCT02215434|Hormones|hormones|mesh-ancestor
65133218|NCT02215434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65133219|NCT02215434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299720|NCT00698724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299721|NCT00698724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65049612|NCT04603573|Listerine|listerine|mesh-list
65299722|NCT00698724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65299724|NCT00698724|Sensory System Agents|sensory system agents|mesh-ancestor
65299725|NCT00698724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65299726|NCT00686192|Calcium Carbonate|calcium carbonate|mesh-list
65299727|NCT00686192|Calcium|calcium|mesh-list
65299728|NCT00686192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65299729|NCT00686192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299730|NCT00686192|Antacids|antacids|mesh-ancestor
65299731|NCT00686192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299732|NCT00686192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65299733|NCT04117776|Chlorhexidine|chlorhexidine|mesh-list
65299734|NCT04117776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65299735|NCT04117776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65299736|NCT04117776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65299737|NCT04117776|Disinfectants|disinfectants|mesh-ancestor
65299738|NCT04117776|Dermatologic Agents|dermatologic agents|mesh-ancestor
64529845|NCT02375880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133220|NCT02215434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65133221|NCT02215434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133222|NCT02215434|Anabolic Agents|anabolic agents|mesh-ancestor
65133223|NCT04561076|Myeloma Proteins|myeloma proteins|mesh-list
65133224|NCT04561076|Paraproteins|paraproteins|mesh-list
65133225|NCT04561076|Immunologic Factors|immunologic factors|mesh-ancestor
65133226|NCT04561076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133227|NCT02215473|Chlorhexidine|chlorhexidine|mesh-list
65133228|NCT02215473|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65133229|NCT02215473|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65133230|NCT02215473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65133231|NCT02215473|Disinfectants|disinfectants|mesh-ancestor
65133232|NCT02215473|Dermatologic Agents|dermatologic agents|mesh-ancestor
65133233|NCT04548219|Mirikizumab|mirikizumab|mesh-list
65133234|NCT04548219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65133235|NCT04548219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65133238|NCT04548219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133239|NCT04548219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133240|NCT04548219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65133242|NCT04548219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65133243|NCT04548219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65133244|NCT04547829|Lenograstim|lenograstim|mesh-list
65133245|NCT04547829|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65133246|NCT04547829|Immunologic Factors|immunologic factors|mesh-ancestor
65133247|NCT04547829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133248|NCT02211911|Bisacodyl|bisacodyl|mesh-list
65133249|NCT02211911|Picosulfate sodium|picosulfate sodium|mesh-list
65133250|NCT02211911|Cathartics|cathartics|mesh-ancestor
65133251|NCT02211911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65133252|NCT02211911|Laxatives|laxatives|mesh-ancestor
65133253|NCT01131676|Empagliflozin|empagliflozin|mesh-list
65133254|NCT01131676|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65133255|NCT01131676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133256|NCT01131676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65133257|NCT01131676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133258|NCT04560569|Antibodies|antibodies|mesh-list
65299739|NCT00922610|Epoetin Alfa|epoetin alfa|mesh-list
65299740|NCT00922610|Hematinics|hematinics|mesh-ancestor
65299741|NCT04117698|Ethambutol|ethambutol|mesh-list
65299742|NCT04117698|Antitubercular Agents|antitubercular agents|mesh-ancestor
65299743|NCT04117698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65299744|NCT04117698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65299745|NCT04118322|Peppermint oil|peppermint oil|mesh-list
65299746|NCT04118322|Antiemetics|antiemetics|mesh-ancestor
65299747|NCT04118322|Autonomic Agents|autonomic agents|mesh-ancestor
64529866|NCT04645602|Pembrolizumab|pembrolizumab|mesh-list
65133259|NCT04560569|Immunologic Factors|immunologic factors|mesh-ancestor
65133260|NCT04560569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133261|NCT04560101|Botulinum Toxins|botulinum toxins|mesh-list
65133262|NCT04560101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65133263|NCT04560101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65133264|NCT04560101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65133265|NCT04560101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65133266|NCT04560101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133267|NCT04560101|Cholinergic Agents|cholinergic agents|mesh-ancestor
65133268|NCT04560101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65133269|NCT04560101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133270|NCT04560101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65133271|NCT04560101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133272|NCT02214498|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65133273|NCT02214498|Enalapril|enalapril|mesh-list
65133274|NCT02214498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65133275|NCT02214498|Diuretics|diuretics|mesh-ancestor
65133276|NCT02214498|Natriuretic Agents|natriuretic agents|mesh-ancestor
65133277|NCT02214498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133278|NCT02214498|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65133279|NCT02214498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65133280|NCT02214498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133281|NCT02214498|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65133282|NCT02214498|Protease Inhibitors|protease inhibitors|mesh-ancestor
65133283|NCT02214498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133284|NCT04560218|Misoprostol|misoprostol|mesh-list
65133285|NCT04560218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65133286|NCT04560218|Abortifacient Agents|abortifacient agents|mesh-ancestor
65133287|NCT04560218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65133288|NCT04560218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133289|NCT04560218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65133290|NCT04560218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65133292|NCT05135104|Palbociclib|palbociclib|mesh-list
65133293|NCT05135104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133294|NCT05135104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65133295|NCT05135104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133296|NCT05135104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133297|NCT04540185|Neuroprotective Agents|neuroprotective agents|mesh-list
65133298|NCT04540185|Vaccines|vaccines|mesh-list
65133299|NCT04540185|Immunologic Factors|immunologic factors|mesh-ancestor
65133300|NCT04540185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133301|NCT04540185|Protective Agents|protective agents|mesh-ancestor
65133302|NCT01130272|Eluxadoline|eluxadoline|mesh-list
65133303|NCT01130272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65133304|NCT04546815|Daptomycin|daptomycin|mesh-list
65133305|NCT04546815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65133306|NCT04546815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65133307|NCT01129960|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
65133308|NCT01129960|Anticonvulsants|anticonvulsants|mesh-ancestor
65133309|NCT01129960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65133312|NCT01129960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133314|NCT04559165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65133315|NCT04559165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65133316|NCT04559165|Antimetabolites|antimetabolites|mesh-ancestor
65133317|NCT04559165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133318|NCT04559165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65133319|NCT04559165|Chelating Agents|chelating agents|mesh-ancestor
65299748|NCT04118322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65299749|NCT04118322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299750|NCT04118322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65299751|NCT04118322|Parasympatholytics|parasympatholytics|mesh-ancestor
65299752|NCT00698802|Insulin|insulin|mesh-list
65299753|NCT00698802|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65299754|NCT00698802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65299755|NCT00698802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299756|NCT04147013|Celecoxib|celecoxib|mesh-list
65299757|NCT04147013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65299758|NCT04147013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65299759|NCT04147013|Analgesics|analgesics|mesh-ancestor
65299760|NCT04147013|Sensory System Agents|sensory system agents|mesh-ancestor
65299761|NCT04147013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65299762|NCT04147013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299763|NCT04147013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64529870|NCT04645602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65133320|NCT04559165|Sequestering Agents|sequestering agents|mesh-ancestor
65133321|NCT04559165|Hemostatics|hemostatics|mesh-ancestor
65133322|NCT04559165|Coagulants|coagulants|mesh-ancestor
65133323|NCT04312048|Isosorbide|isosorbide|mesh-list
65133324|NCT04312048|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65133325|NCT04312048|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65133326|NCT04312048|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65133327|NCT04312048|Diuretics|diuretics|mesh-ancestor
65133328|NCT04312048|Natriuretic Agents|natriuretic agents|mesh-ancestor
65133329|NCT04312048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133330|NCT04312048|Vasodilator Agents|vasodilator agents|mesh-ancestor
65133331|NCT04312048|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65133332|NCT04312048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133333|NCT04311697|Phentolamine|phentolamine|mesh-list
65133334|NCT04311697|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
65133335|NCT04311697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65133336|NCT04311697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65133337|NCT04311697|Adrenergic Agents|adrenergic agents|mesh-ancestor
65133338|NCT04311697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65133339|NCT04311697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133340|NCT04311697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133341|NCT04311697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65133342|NCT04311697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65133343|NCT04311697|Vasodilator Agents|vasodilator agents|mesh-ancestor
65133344|NCT04311697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65133345|NCT04311697|Protective Agents|protective agents|mesh-ancestor
65133346|NCT00575861|Zileuton|zileuton|mesh-list
65133347|NCT00575861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65133348|NCT00575861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65133349|NCT00575861|Analgesics|analgesics|mesh-ancestor
65133350|NCT00575861|Sensory System Agents|sensory system agents|mesh-ancestor
65133351|NCT00575861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133352|NCT00575861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133353|NCT00575861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65133354|NCT00575861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65133355|NCT00575861|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65133356|NCT00575861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133357|NCT00575861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133358|NCT00575861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64775859|NCT05505630|GABA Modulators|gaba modulators|mesh-ancestor
65133359|NCT00575861|Hormone Antagonists|hormone antagonists|mesh-ancestor
65299764|NCT04147013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65299765|NCT04147013|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65299766|NCT04147013|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65299767|NCT04147013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299768|NCT04147013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299769|NCT00621647|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65299770|NCT00621647|Antidepressive Agents|antidepressive agents|mesh-ancestor
65299771|NCT00621647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65299772|NCT00621647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65299773|NCT00621647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65299774|NCT00621647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65299775|NCT00621647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299776|NCT02621970|Cisplatin|cisplatin|mesh-list
65299777|NCT02621970|Docetaxel|docetaxel|mesh-list
65133360|NCT00575861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65133362|NCT04547088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133363|NCT04547088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65133364|NCT04547088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133365|NCT04547088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133366|NCT01129882|Aripiprazole|aripiprazole|mesh-list
65133367|NCT01129882|Antidepressive Agents|antidepressive agents|mesh-ancestor
65133368|NCT01129882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65133369|NCT01129882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65133370|NCT01129882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65133371|NCT01129882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65133372|NCT01129882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133373|NCT01129882|Dopamine Agonists|dopamine agonists|mesh-ancestor
65133374|NCT01129882|Dopamine Agents|dopamine agents|mesh-ancestor
65133375|NCT01129882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65133376|NCT01129882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133377|NCT01129882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65133378|NCT01129882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65133380|NCT01129882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65133381|NCT01129882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65133386|NCT02278419|Antiviral Agents|antiviral agents|mesh-ancestor
65133387|NCT02278419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65133388|NCT02278419|Protease Inhibitors|protease inhibitors|mesh-ancestor
65133389|NCT02278419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133390|NCT02278419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133391|NCT04311580|Mitomycins|mitomycins|mesh-list
65133392|NCT04311580|Mitomycin|mitomycin|mesh-list
65133393|NCT04311580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65133394|NCT04311580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133395|NCT04311580|Alkylating Agents|alkylating agents|mesh-ancestor
65133396|NCT04311580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133397|NCT04311580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65133398|NCT04311580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133399|NCT02882737|Glucagon|glucagon|mesh-list
65133400|NCT02882737|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65133401|NCT02882737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65133402|NCT02882737|Hormones|hormones|mesh-ancestor
65133403|NCT02882737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65133404|NCT02882737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133405|NCT02882737|Incretins|incretins|mesh-ancestor
65133406|NCT02211950|Acarbose|acarbose|mesh-list
65133407|NCT02211950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65133408|NCT02211950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133409|NCT02211950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133410|NCT02211950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65299778|NCT02621970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299779|NCT02621970|Tubulin Modulators|tubulin modulators|mesh-ancestor
65299780|NCT02621970|Antimitotic Agents|antimitotic agents|mesh-ancestor
65299781|NCT02621970|Mitosis Modulators|mitosis modulators|mesh-ancestor
65299782|NCT02621970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299783|NCT00820755|Cetuximab|cetuximab|mesh-list
65299784|NCT00820755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65299785|NCT00820755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299786|NCT00700128|Frovatriptan|frovatriptan|mesh-list
65299787|NCT00700128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65299788|NCT00700128|Serotonin Agents|serotonin agents|mesh-ancestor
65299789|NCT00700128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65299790|NCT00700128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299791|NCT00700128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299792|NCT04662515|Warfarin|warfarin|mesh-list
65299793|NCT04662515|Rivaroxaban|rivaroxaban|mesh-list
65299794|NCT04662515|Dabigatran|dabigatran|mesh-list
65299795|NCT04662515|Apixaban|apixaban|mesh-list
65299796|NCT04662515|Edoxaban|edoxaban|mesh-list
65299797|NCT04662515|Anticoagulants|anticoagulants|mesh-ancestor
65299798|NCT04662515|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65299799|NCT04662515|Antithrombins|antithrombins|mesh-ancestor
65299800|NCT04662515|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65299801|NCT04662515|Protease Inhibitors|protease inhibitors|mesh-ancestor
65299802|NCT04662515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299803|NCT04662515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299804|NCT04660097|Etoposide|etoposide|mesh-list
65299805|NCT04660097|Etoposide phosphate|etoposide phosphate|mesh-list
65299806|NCT04660097|Durvalumab|durvalumab|mesh-list
65133411|NCT02211950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133412|NCT04539249|Magnesium Sulfate|magnesium sulfate|mesh-list
65133413|NCT04539249|Pentazocine|pentazocine|mesh-list
65133414|NCT04539249|Analgesics|analgesics|mesh-ancestor
65133415|NCT04539249|Sensory System Agents|sensory system agents|mesh-ancestor
65133416|NCT04539249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133417|NCT04539249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133418|NCT04539249|Anesthetics|anesthetics|mesh-ancestor
65133419|NCT04539249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65133420|NCT04539249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65133421|NCT04539249|Anticonvulsants|anticonvulsants|mesh-ancestor
65133422|NCT04539249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65133423|NCT04539249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65133424|NCT04539249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133425|NCT04539249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65133426|NCT04539249|Tocolytic Agents|tocolytic agents|mesh-ancestor
65133427|NCT04539249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65133428|NCT04539249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65133429|NCT04539249|Narcotics|narcotics|mesh-ancestor
65299807|NCT04660097|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65299808|NCT04660097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65299809|NCT04660097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299810|NCT04660097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65299811|NCT04660097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65299812|NCT04660097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299813|NCT04660097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299814|NCT04660097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65299815|NCT04660097|Immunologic Factors|immunologic factors|mesh-ancestor
65299816|NCT04660097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299817|NCT00621101|Sirolimus|sirolimus|mesh-list
65299818|NCT00621101|Ezetimibe|ezetimibe|mesh-list
65299819|NCT00621101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65299820|NCT00621101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65299821|NCT00621101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65299822|NCT00621101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299823|NCT00621101|Antifungal Agents|antifungal agents|mesh-ancestor
65299824|NCT00621101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65299825|NCT00621101|Immunologic Factors|immunologic factors|mesh-ancestor
65299826|NCT00621101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299827|NCT00621101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65299828|NCT00621101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65299829|NCT00621101|Antimetabolites|antimetabolites|mesh-ancestor
65299830|NCT00621101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299831|NCT00621101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65299832|NCT00709215|Cordycepin|cordycepin|mesh-list
65299833|NCT00709215|Pentostatin|pentostatin|mesh-list
65299834|NCT00709215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299835|NCT00709215|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65299836|NCT00709215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299837|NCT00709215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133430|NCT04539249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65133431|NCT04539249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65133432|NCT01129336|Zoledronic Acid|zoledronic acid|mesh-list
65133433|NCT01129336|Diphosphonates|diphosphonates|mesh-list
65133434|NCT01129336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65133435|NCT01129336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133436|NCT04559048|Tacrolimus|tacrolimus|mesh-list
65133437|NCT04559048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65133438|NCT04559048|Immunologic Factors|immunologic factors|mesh-ancestor
65133439|NCT04559048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133440|NCT04559048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65133441|NCT04559048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299838|NCT00709215|Antifungal Agents|antifungal agents|mesh-ancestor
65299839|NCT00709215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65299840|NCT00699036|Metformin|metformin|mesh-list
65299841|NCT00699036|Rosiglitazone|rosiglitazone|mesh-list
65299842|NCT00699036|Losartan|losartan|mesh-list
65299843|NCT00699036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65299844|NCT00699036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299845|NCT00699036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65299846|NCT00699036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65299847|NCT00699036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65299848|NCT00699036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65299849|NCT00699036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299850|NCT00709293|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65299851|NCT00709293|Immunologic Factors|immunologic factors|mesh-ancestor
65299852|NCT00709293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299853|NCT00709293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65299854|NCT00913497|Insulin|insulin|mesh-list
65299855|NCT00913497|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65299856|NCT00913497|Insulin Aspart|insulin aspart|mesh-list
65299857|NCT00913497|Insulin glulisine|insulin glulisine|mesh-list
65299858|NCT00913497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65299859|NCT00913497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299860|NCT00819741|Metformin|metformin|mesh-list
65299861|NCT00819741|Repaglinide|repaglinide|mesh-list
65133442|NCT04559048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133443|NCT04538820|Dexamethasone|dexamethasone|mesh-list
65133444|NCT04538820|Dexamethasone acetate|dexamethasone acetate|mesh-list
65133445|NCT04538820|BB 1101|bb 1101|mesh-list
65133446|NCT04538820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65133447|NCT04538820|Antiemetics|antiemetics|mesh-ancestor
65133448|NCT04538820|Autonomic Agents|autonomic agents|mesh-ancestor
65133449|NCT04538820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133450|NCT04538820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133451|NCT04538820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65133452|NCT04538820|Glucocorticoids|glucocorticoids|mesh-ancestor
65133453|NCT04538820|Hormones|hormones|mesh-ancestor
64514331|NCT02248701|Testosterone|testosterone|mesh-list
65133459|NCT04538820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133461|NCT00575978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65133462|NCT00575978|Vasodilator Agents|vasodilator agents|mesh-ancestor
65133463|NCT04546347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65133464|NCT02882932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65133465|NCT04539054|Caffeine|caffeine|mesh-list
65133466|NCT04539054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65133467|NCT04539054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133468|NCT04539054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65133469|NCT04539054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133470|NCT04539054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133471|NCT04539054|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65133472|NCT04539054|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65133473|NCT04539054|Purinergic Agents|purinergic agents|mesh-ancestor
65133474|NCT04539054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65133475|NCT00576017|Fentanyl|fentanyl|mesh-list
65299862|NCT00819741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65299863|NCT00819741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299864|NCT04208555|Terconazole|terconazole|mesh-list
65299865|NCT04208555|Antifungal Agents|antifungal agents|mesh-ancestor
65299866|NCT04208555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65299867|NCT00621725|Cediranib|cediranib|mesh-list
65299868|NCT00621725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299869|NCT00621725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65299870|NCT00621725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299871|NCT00621725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299872|NCT00862134|Docetaxel|docetaxel|mesh-list
65299873|NCT00862134|Lenograstim|lenograstim|mesh-list
65299874|NCT00862134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299875|NCT00862134|Tubulin Modulators|tubulin modulators|mesh-ancestor
65299876|NCT00862134|Antimitotic Agents|antimitotic agents|mesh-ancestor
65299877|NCT00862134|Mitosis Modulators|mitosis modulators|mesh-ancestor
65299878|NCT00862134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299879|NCT00862134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65299880|NCT00862134|Immunologic Factors|immunologic factors|mesh-ancestor
65299881|NCT00862134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299882|NCT00700284|Dapivirine|dapivirine|mesh-list
65299883|NCT00700284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65299884|NCT00700284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65299885|NCT00700284|Antiviral Agents|antiviral agents|mesh-ancestor
64529975|NCT04110301|Growth Substances|growth substances|mesh-ancestor
65133476|NCT00576017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65133477|NCT00576017|Narcotics|narcotics|mesh-ancestor
65133478|NCT00576017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65133479|NCT00576017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133480|NCT00576017|Analgesics|analgesics|mesh-ancestor
65133481|NCT00576017|Sensory System Agents|sensory system agents|mesh-ancestor
65133482|NCT00576017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133483|NCT00576017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65133484|NCT00576017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65133485|NCT00576017|Anesthetics, General|anesthetics, general|mesh-ancestor
65133486|NCT00576017|Anesthetics|anesthetics|mesh-ancestor
65133487|NCT04558697|Tea Tree Oil|tea tree oil|mesh-list
65133488|NCT04558697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65133489|NCT04558697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65133490|NCT04558580|Rufinamide|rufinamide|mesh-list
65133491|NCT04558580|Anticonvulsants|anticonvulsants|mesh-ancestor
65133492|NCT04558580|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65133493|NCT04558580|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65133494|NCT04558580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65133495|NCT04558580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133496|NCT02278458|Gemcitabine|gemcitabine|mesh-list
65133497|NCT02278458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65133498|NCT02278458|Antimetabolites|antimetabolites|mesh-ancestor
65133499|NCT02278458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133500|NCT02278458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133501|NCT02278458|Antiviral Agents|antiviral agents|mesh-ancestor
65299886|NCT00700284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65299887|NCT00618527|Interferons|interferons|mesh-list
65299888|NCT00618527|Interferon-beta|interferon-beta|mesh-list
65299889|NCT00618527|Interferon beta-1a|interferon beta-1a|mesh-list
65299890|NCT00618527|Mycophenolic Acid|mycophenolic acid|mesh-list
65299891|NCT00618527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299892|NCT00618527|Antiviral Agents|antiviral agents|mesh-ancestor
65299893|NCT00618527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65299894|NCT00618527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65299895|NCT00618527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65299896|NCT00618527|Antitubercular Agents|antitubercular agents|mesh-ancestor
65299897|NCT00618527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65299898|NCT00618527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299899|NCT00618527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299900|NCT00618527|Immunologic Factors|immunologic factors|mesh-ancestor
65299901|NCT00618527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299902|NCT00618527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65299903|NCT02691533|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65299904|NCT02691533|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65299905|NCT02691533|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64529997|NCT05800587|Antiviral Agents|antiviral agents|mesh-ancestor
64530008|NCT05800418|Ramucirumab|ramucirumab|mesh-list
65133502|NCT02278458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65133503|NCT02278458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133504|NCT02278458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65133505|NCT02278458|Immunologic Factors|immunologic factors|mesh-ancestor
65133506|NCT02278458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133507|NCT01128595|Fluticasone|fluticasone|mesh-list
65133509|NCT01128595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65133510|NCT01128595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65133511|NCT01128595|Autonomic Agents|autonomic agents|mesh-ancestor
65133512|NCT01128595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133513|NCT01128595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133514|NCT01128595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65133515|NCT01128595|Respiratory System Agents|respiratory system agents|mesh-ancestor
65133516|NCT01128595|Dermatologic Agents|dermatologic agents|mesh-ancestor
65133517|NCT01128595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65133518|NCT01128244|Pyridoxine|pyridoxine|mesh-list
65133519|NCT01128244|Pyridoxal|pyridoxal|mesh-list
65133520|NCT01128244|Vitamin B 6|vitamin b 6|mesh-list
65133521|NCT01128244|Vitamins|vitamins|mesh-ancestor
65133522|NCT01128244|Micronutrients|micronutrients|mesh-ancestor
64706066|NCT04074265|Ketorolac|ketorolac|mesh-list
65133529|NCT01127893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133531|NCT00576173|Tramadol|tramadol|mesh-list
65133532|NCT00576173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65133533|NCT00576173|Analgesics|analgesics|mesh-ancestor
65133534|NCT00576173|Sensory System Agents|sensory system agents|mesh-ancestor
65133535|NCT00576173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133536|NCT00576173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133537|NCT00576173|Antipyretics|antipyretics|mesh-ancestor
65133538|NCT00576173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65133539|NCT00576173|Narcotics|narcotics|mesh-ancestor
65133540|NCT00576173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65133541|NCT00625339|Lamivudine|lamivudine|mesh-list
65299906|NCT02691533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65299907|NCT00621881|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
65299908|NCT00621881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65299909|NCT00621881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299910|NCT04115982|Cholecalciferol|cholecalciferol|mesh-list
65299911|NCT04115982|Vitamin D|vitamin d|mesh-list
65299912|NCT04115982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65299913|NCT04115982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299914|NCT04115982|Vitamins|vitamins|mesh-ancestor
65299915|NCT04115982|Micronutrients|micronutrients|mesh-ancestor
65299916|NCT04115982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65299917|NCT00622037|Lubricant Eye Drops|lubricant eye drops|mesh-list
65299918|NCT00622037|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65299919|NCT00622037|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64530019|NCT05800366|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65133542|NCT00625339|Entecavir|entecavir|mesh-list
65133543|NCT00625339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65133544|NCT00625339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65133545|NCT00625339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133546|NCT00625339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133547|NCT00625339|Antiviral Agents|antiviral agents|mesh-ancestor
65133548|NCT00625339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65133549|NCT00625339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65133550|NCT00625339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65133551|NCT02215863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65133552|NCT02215863|Immunologic Factors|immunologic factors|mesh-ancestor
65133553|NCT02215863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133554|NCT04558463|Oseltamivir|oseltamivir|mesh-list
65133555|NCT04558463|Favipiravir|favipiravir|mesh-list
65133556|NCT04558463|Antiviral Agents|antiviral agents|mesh-ancestor
65133557|NCT04558463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65133558|NCT04558463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133559|NCT04558463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133560|NCT01126879|Genistein|genistein|mesh-list
65133561|NCT01126879|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65133562|NCT01126879|Protective Agents|protective agents|mesh-ancestor
65133563|NCT01126879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133564|NCT01126879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133565|NCT01126879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65133566|NCT01126879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133567|NCT01126879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133568|NCT01126879|Phytoestrogens|phytoestrogens|mesh-ancestor
65133569|NCT01126879|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65133570|NCT01126879|Estrogens|estrogens|mesh-ancestor
65133571|NCT01126879|Hormones|hormones|mesh-ancestor
65133572|NCT01126879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65133573|NCT04311658|Isosorbide|isosorbide|mesh-list
65133574|NCT04311658|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65133575|NCT04311658|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65133576|NCT04311658|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65133577|NCT04311658|Diuretics|diuretics|mesh-ancestor
65133578|NCT04311658|Natriuretic Agents|natriuretic agents|mesh-ancestor
65133579|NCT04311658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133580|NCT04311658|Vasodilator Agents|vasodilator agents|mesh-ancestor
65133581|NCT04311658|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64776078|NCT01472562|Growth Substances|growth substances|mesh-ancestor
65133582|NCT04311658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133583|NCT02882308|Durvalumab|durvalumab|mesh-list
65133584|NCT02882308|Olaparib|olaparib|mesh-list
65133585|NCT02882308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299920|NCT01010581|Folic Acid|folic acid|mesh-list
65299921|NCT01010581|Methotrexate|methotrexate|mesh-list
65299922|NCT01010581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65299923|NCT01010581|Abortifacient Agents|abortifacient agents|mesh-ancestor
65299924|NCT01010581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65299925|NCT01010581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299926|NCT01010581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65299927|NCT01010581|Antimetabolites|antimetabolites|mesh-ancestor
65299928|NCT01010581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299929|NCT01010581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299930|NCT01010581|Dermatologic Agents|dermatologic agents|mesh-ancestor
65299931|NCT01010581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299932|NCT01010581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65299933|NCT01010581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65299934|NCT01010581|Immunologic Factors|immunologic factors|mesh-ancestor
65299935|NCT01010581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65133586|NCT02882308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65133587|NCT02882308|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65133589|NCT02882308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133590|NCT00625456|Molgramostim|molgramostim|mesh-list
65133591|NCT00625456|Sargramostim|sargramostim|mesh-list
65133592|NCT00625456|Immunologic Factors|immunologic factors|mesh-ancestor
65133597|NCT04539444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133598|NCT00576329|Ketorolac|ketorolac|mesh-list
65133599|NCT00576329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65133600|NCT00576329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65133601|NCT00576329|Analgesics|analgesics|mesh-ancestor
65133602|NCT00576329|Sensory System Agents|sensory system agents|mesh-ancestor
65133603|NCT00576329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133604|NCT00576329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133605|NCT00576329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65133606|NCT00576329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65133607|NCT00576329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65133608|NCT00576329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133609|NCT00576329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133611|NCT02882581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65133612|NCT02882581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133613|NCT02882347|Somatostatin|somatostatin|mesh-list
65133614|NCT02882347|Hormones|hormones|mesh-ancestor
65133615|NCT02882347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65133616|NCT02882347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133617|NCT00576368|Insulin Glargine|insulin glargine|mesh-list
65133618|NCT00576368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65133619|NCT00576368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133620|NCT00637468|Aspirin|aspirin|mesh-list
65133621|NCT00637468|Heparin|heparin|mesh-list
65133622|NCT00637468|Acetazolamide|acetazolamide|mesh-list
65133623|NCT00637468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65133624|NCT00637468|Anticoagulants|anticoagulants|mesh-ancestor
65133625|NCT00637468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65133626|NCT00637468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65133627|NCT00637468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133628|NCT00637468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65133629|NCT00637468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65133630|NCT00637468|Analgesics|analgesics|mesh-ancestor
65133631|NCT00637468|Sensory System Agents|sensory system agents|mesh-ancestor
65133632|NCT00637468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65299936|NCT01010581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65299937|NCT01010581|Hematinics|hematinics|mesh-ancestor
65299938|NCT01010581|Vitamin B Complex|vitamin b complex|mesh-ancestor
65299939|NCT01010581|Vitamins|vitamins|mesh-ancestor
65299940|NCT01010581|Micronutrients|micronutrients|mesh-ancestor
65299941|NCT04382885|Cariprazine|cariprazine|mesh-list
65299942|NCT04382885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65299943|NCT04382885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65299944|NCT04382885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65299945|NCT04382885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299946|NCT04382885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65299947|NCT04208945|Colistin|colistin|mesh-list
65299948|NCT04208945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65299949|NCT04208945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65049837|NCT04599712|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
65299950|NCT01016041|Paclitaxel|paclitaxel|mesh-list
65299951|NCT01016041|Everolimus|everolimus|mesh-list
65299952|NCT01016041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65299953|NCT01016041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299954|NCT01016041|Tubulin Modulators|tubulin modulators|mesh-ancestor
65299955|NCT01016041|Antimitotic Agents|antimitotic agents|mesh-ancestor
65299956|NCT01016041|Mitosis Modulators|mitosis modulators|mesh-ancestor
65299957|NCT01016041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299958|NCT01016041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65299959|NCT01016041|Immunologic Factors|immunologic factors|mesh-ancestor
64530050|NCT05800340|Tubulin Modulators|tubulin modulators|mesh-ancestor
65133633|NCT00637468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133634|NCT00637468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65133635|NCT00637468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65133636|NCT00637468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65133637|NCT00637468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65133638|NCT00637468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133639|NCT00637468|Antipyretics|antipyretics|mesh-ancestor
65133640|NCT00637468|Anticonvulsants|anticonvulsants|mesh-ancestor
65133641|NCT00637468|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65133642|NCT00637468|Diuretics|diuretics|mesh-ancestor
65133643|NCT00637468|Natriuretic Agents|natriuretic agents|mesh-ancestor
65133644|NCT00637468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65133645|NCT00637468|Adrenergic Agents|adrenergic agents|mesh-ancestor
65133646|NCT00637468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65133647|NCT02278575|Antithrombins|antithrombins|mesh-list
65133648|NCT02278575|Antithrombin III|antithrombin iii|mesh-list
65133649|NCT02278575|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65133650|NCT02278575|Protease Inhibitors|protease inhibitors|mesh-ancestor
65133651|NCT02278575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133652|NCT02278575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133653|NCT02278575|Anticoagulants|anticoagulants|mesh-ancestor
65133654|NCT01126060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65133655|NCT01126060|Hemostatics|hemostatics|mesh-ancestor
65133656|NCT01126060|Coagulants|coagulants|mesh-ancestor
65133657|NCT01125748|Omalizumab|omalizumab|mesh-list
65133658|NCT01125748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65299960|NCT01016041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299962|NCT00622115|Anticoagulants|anticoagulants|mesh-ancestor
65299963|NCT00622115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65299964|NCT00622115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65299965|NCT00622115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299966|NCT02696837|Rocuronium|rocuronium|mesh-list
65299967|NCT02696837|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65299968|NCT02696837|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65299969|NCT02696837|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65299970|NCT02696837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65299971|NCT02696837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299972|NCT00490555|Methyltestosterone|methyltestosterone|mesh-list
65299973|NCT00490555|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65299974|NCT00490555|Medroxyprogesterone|medroxyprogesterone|mesh-list
65299975|NCT00490555|Testosterone|testosterone|mesh-list
65299976|NCT00490555|Testosterone undecanoate|testosterone undecanoate|mesh-list
65299977|NCT00490555|Testosterone enanthate|testosterone enanthate|mesh-list
65299978|NCT00490555|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65299979|NCT00490555|Dutasteride|dutasteride|mesh-list
65299980|NCT00490555|Androgens|androgens|mesh-ancestor
65299981|NCT00490555|Hormones|hormones|mesh-ancestor
65299982|NCT00490555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65299983|NCT00490555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65299984|NCT00490555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65133659|NCT01125748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65133660|NCT01125748|Respiratory System Agents|respiratory system agents|mesh-ancestor
65133662|NCT04558268|Prednisone|prednisone|mesh-list
65133663|NCT04558268|Progesterone|progesterone|mesh-list
65133664|NCT04558268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65133665|NCT04558268|Glucocorticoids|glucocorticoids|mesh-ancestor
65133666|NCT04558268|Hormones|hormones|mesh-ancestor
65133675|NCT04558268|Micronutrients|micronutrients|mesh-ancestor
65133676|NCT01125514|Furosemide|furosemide|mesh-list
65133677|NCT01125514|Diuretics|diuretics|mesh-ancestor
65133678|NCT01125514|Natriuretic Agents|natriuretic agents|mesh-ancestor
65133679|NCT01125514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133680|NCT01125514|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65133681|NCT01125514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65133682|NCT01125514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133683|NCT04545879|Allicin|allicin|mesh-list
65133684|NCT04545879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65133685|NCT04545879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65133686|NCT04545879|Antimetabolites|antimetabolites|mesh-ancestor
65133687|NCT04545879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133688|NCT04545879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65133689|NCT04545879|Antioxidants|antioxidants|mesh-ancestor
65133690|NCT04545879|Protective Agents|protective agents|mesh-ancestor
65133691|NCT04545879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133692|NCT04545879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65133693|NCT04545879|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65133694|NCT04578782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65299985|NCT00490555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65299986|NCT00490555|Anabolic Agents|anabolic agents|mesh-ancestor
65299987|NCT00490555|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65299988|NCT00490555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65299989|NCT00490555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65299990|NCT00490555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65299991|NCT00490555|Hormone Antagonists|hormone antagonists|mesh-ancestor
65299992|NCT00490555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65299993|NCT00490555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65299994|NCT00490555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65299995|NCT00490555|Contraceptive Agents|contraceptive agents|mesh-ancestor
65299996|NCT00490555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65299997|NCT00490555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65299998|NCT00490555|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65299999|NCT00490555|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65300000|NCT01014247|Moxifloxacin|moxifloxacin|mesh-list
65300001|NCT01014247|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65300002|NCT01014247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65300003|NCT01014247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65300004|NCT01014247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65300005|NCT01014247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65300006|NCT01014247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300007|NCT01014247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300008|NCT01014247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300009|NCT01014247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65300010|NCT01014247|Contraceptive Agents|contraceptive agents|mesh-ancestor
65300011|NCT01014247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65300012|NCT01014247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300013|NCT01014247|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65300014|NCT01014247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65300015|NCT01014247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65300016|NCT00049595|Prednisone|prednisone|mesh-list
65300018|NCT00049595|Dacarbazine|dacarbazine|mesh-list
65300025|NCT00049595|Procarbazine|procarbazine|mesh-list
65300026|NCT00049595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65300027|NCT00049595|Immunologic Factors|immunologic factors|mesh-ancestor
65300028|NCT00049595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300029|NCT00049595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65300030|NCT00049595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65300031|NCT00049595|Alkylating Agents|alkylating agents|mesh-ancestor
65300032|NCT00049595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300033|NCT00049595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530131|NCT05799820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530132|NCT05799820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65133695|NCT04578782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65133696|NCT04578782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65133697|NCT04578782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133698|NCT04578782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133699|NCT04578782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65133700|NCT04578782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65133701|NCT04578782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133702|NCT04578782|Cholinergic Agents|cholinergic agents|mesh-ancestor
65133703|NCT04578782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65133704|NCT04538391|Bupivacaine|bupivacaine|mesh-list
65133705|NCT04538391|Anesthetics, Local|anesthetics, local|mesh-ancestor
65133706|NCT04538391|Anesthetics|anesthetics|mesh-ancestor
65133707|NCT04538391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65133708|NCT04538391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133709|NCT04538391|Sensory System Agents|sensory system agents|mesh-ancestor
65133710|NCT04538391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133711|NCT04545801|Ketamine|ketamine|mesh-list
65133712|NCT04545801|Analgesics|analgesics|mesh-ancestor
65133713|NCT04545801|Sensory System Agents|sensory system agents|mesh-ancestor
65133714|NCT04545801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133715|NCT04545801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133716|NCT04545801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65133717|NCT04545801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65133718|NCT04545801|Anesthetics, General|anesthetics, general|mesh-ancestor
65133719|NCT04545801|Anesthetics|anesthetics|mesh-ancestor
65133720|NCT04545801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65133721|NCT04545801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65133722|NCT04545801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65133723|NCT04545801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65133724|NCT04545801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133725|NCT04558424|Ascorbic Acid|ascorbic acid|mesh-list
65133726|NCT04558424|Antioxidants|antioxidants|mesh-ancestor
65133727|NCT04558424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133728|NCT04558424|Protective Agents|protective agents|mesh-ancestor
65133729|NCT04558424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133730|NCT04558424|Vitamins|vitamins|mesh-ancestor
65133731|NCT04558424|Micronutrients|micronutrients|mesh-ancestor
65133732|NCT00576602|Epoetin Alfa|epoetin alfa|mesh-list
65133755|NCT02214810|Sensory System Agents|sensory system agents|mesh-ancestor
65133756|NCT02214810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133757|NCT01125046|Bevacizumab|bevacizumab|mesh-list
65133758|NCT01125046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65133759|NCT01125046|Antibodies|antibodies|mesh-list
65133760|NCT01125046|Immunoglobulins|immunoglobulins|mesh-list
65133761|NCT01125046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65133762|NCT01125046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133763|NCT01125046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65133764|NCT01125046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65133765|NCT01125046|Growth Substances|growth substances|mesh-ancestor
65133766|NCT01125046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133767|NCT01125046|Growth Inhibitors|growth inhibitors|mesh-ancestor
65133768|NCT01125046|Immunologic Factors|immunologic factors|mesh-ancestor
65300034|NCT00049595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65300035|NCT00049595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65300036|NCT00049595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65300037|NCT00049595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65300038|NCT00049595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300039|NCT00049595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65300040|NCT00049595|Glucocorticoids|glucocorticoids|mesh-ancestor
65300041|NCT00049595|Hormones|hormones|mesh-ancestor
65300042|NCT00049595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65300043|NCT00049595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65300044|NCT00049595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65300045|NCT00049595|Tubulin Modulators|tubulin modulators|mesh-ancestor
65300046|NCT00049595|Antimitotic Agents|antimitotic agents|mesh-ancestor
65300047|NCT00049595|Mitosis Modulators|mitosis modulators|mesh-ancestor
65300048|NCT00873860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65300049|NCT00873860|Immunologic Factors|immunologic factors|mesh-ancestor
65300050|NCT00873860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300051|NCT03854227|Docetaxel|docetaxel|mesh-list
65300052|NCT03854227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300053|NCT03854227|Tubulin Modulators|tubulin modulators|mesh-ancestor
65300054|NCT03854227|Antimitotic Agents|antimitotic agents|mesh-ancestor
65300055|NCT03854227|Mitosis Modulators|mitosis modulators|mesh-ancestor
64530140|NCT05799755|Nintedanib|nintedanib|mesh-list
65133769|NCT04557878|Mitogens|mitogens|mesh-list
65133770|NCT04557878|Mitosis Modulators|mitosis modulators|mesh-ancestor
65133771|NCT04557878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133772|NCT01124734|Temozolomide|temozolomide|mesh-list
65133773|NCT01124734|Interleukin-2|interleukin-2|mesh-list
65133774|NCT01124734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65133775|NCT01124734|Alkylating Agents|alkylating agents|mesh-ancestor
65133776|NCT01124734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133777|NCT01124734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133778|NCT01124734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65133779|NCT01124734|Analgesics|analgesics|mesh-ancestor
65133780|NCT01124734|Sensory System Agents|sensory system agents|mesh-ancestor
65133781|NCT01124734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133782|NCT01124734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133783|NCT04538976|Sildenafil Citrate|sildenafil citrate|mesh-list
65133784|NCT04538976|Vasodilator Agents|vasodilator agents|mesh-ancestor
65133788|NCT04538976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133789|NCT04538976|Urological Agents|urological agents|mesh-ancestor
65133790|NCT04545450|Methyltestosterone|methyltestosterone|mesh-list
65133791|NCT04545450|Testosterone|testosterone|mesh-list
65133792|NCT04545450|Testosterone undecanoate|testosterone undecanoate|mesh-list
65133793|NCT04545450|Testosterone enanthate|testosterone enanthate|mesh-list
65133794|NCT04545450|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65133795|NCT04545450|Dutasteride|dutasteride|mesh-list
65133796|NCT04545450|Androgens|androgens|mesh-ancestor
65133797|NCT04545450|Hormones|hormones|mesh-ancestor
65133798|NCT04545450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65133799|NCT04545450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133800|NCT04545450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65133801|NCT04545450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300056|NCT03854227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300057|NCT05368961|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
65300058|NCT05368961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65300059|NCT05368961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65300060|NCT05368961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300061|NCT05368961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65300062|NCT02626754|Sunitinib|sunitinib|mesh-list
65300063|NCT02626754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300064|NCT02626754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65300065|NCT02626754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65300066|NCT02626754|Growth Substances|growth substances|mesh-ancestor
65300067|NCT02626754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300068|NCT02626754|Growth Inhibitors|growth inhibitors|mesh-ancestor
65300069|NCT02626754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65300070|NCT02626754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300071|NCT02626754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300072|NCT00691886|Dexmedetomidine|dexmedetomidine|mesh-list
65300073|NCT00691886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65300074|NCT00691886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65300075|NCT00691886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300076|NCT00691886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65300077|NCT00691886|Analgesics|analgesics|mesh-ancestor
65300078|NCT00691886|Sensory System Agents|sensory system agents|mesh-ancestor
65300079|NCT00691886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65300080|NCT00691886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65300081|NCT00691886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65300082|NCT00691886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64530159|NCT05799612|Interferons|interferons|mesh-list
65133802|NCT04545450|Anabolic Agents|anabolic agents|mesh-ancestor
65133803|NCT04545450|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65133804|NCT04545450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65133805|NCT04545450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133806|NCT04545450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133807|NCT04545450|Hormone Antagonists|hormone antagonists|mesh-ancestor
65133808|NCT04579133|Durvalumab|durvalumab|mesh-list
65133809|NCT04579133|Olaparib|olaparib|mesh-list
65133810|NCT04579133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65133811|NCT04579133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133812|NCT04579133|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65133813|NCT04579133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133814|NCT04579133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133815|NCT00576914|Endostatins|endostatins|mesh-list
65133816|NCT00576914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65300083|NCT00691886|Adrenergic Agents|adrenergic agents|mesh-ancestor
65300084|NCT00691886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65300085|NCT00691886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300086|NCT04138004|Lubiprostone|lubiprostone|mesh-list
65300087|NCT04138004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65300088|NCT04138004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65300089|NCT04138004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133817|NCT00576914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65133818|NCT00576914|Growth Substances|growth substances|mesh-ancestor
65133819|NCT00576914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133820|NCT00576914|Growth Inhibitors|growth inhibitors|mesh-ancestor
65133821|NCT00576914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133822|NCT02212340|Remifentanil|remifentanil|mesh-list
65133823|NCT02212340|Desflurane|desflurane|mesh-list
65133824|NCT02212340|Propofol|propofol|mesh-list
65133825|NCT02212340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65133826|NCT02212340|Narcotics|narcotics|mesh-ancestor
65133827|NCT02212340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65133828|NCT02212340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133829|NCT02212340|Analgesics|analgesics|mesh-ancestor
65133830|NCT02212340|Sensory System Agents|sensory system agents|mesh-ancestor
65133831|NCT02212340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133832|NCT02212340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65133833|NCT02212340|Anesthetics, General|anesthetics, general|mesh-ancestor
65133834|NCT02212340|Anesthetics|anesthetics|mesh-ancestor
65133835|NCT02212340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65133836|NCT02212340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65133837|NCT01124617|Tapentadol|tapentadol|mesh-list
65133838|NCT01124617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65133839|NCT01124617|Narcotics|narcotics|mesh-ancestor
65133840|NCT01124617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65133841|NCT01124617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133842|NCT01124617|Analgesics|analgesics|mesh-ancestor
65133843|NCT01124617|Sensory System Agents|sensory system agents|mesh-ancestor
65133844|NCT01124617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133845|NCT01124617|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65133846|NCT01124617|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65133847|NCT01124617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65133848|NCT01124617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133849|NCT01124617|Adrenergic Agents|adrenergic agents|mesh-ancestor
65133850|NCT01124617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65133851|NCT04205890|Ketamine|ketamine|mesh-list
65133852|NCT04205890|Analgesics|analgesics|mesh-ancestor
65133853|NCT04205890|Sensory System Agents|sensory system agents|mesh-ancestor
65133854|NCT04205890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133855|NCT04205890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133856|NCT04205890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65133860|NCT04205890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65133861|NCT04205890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65133862|NCT04205890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65133863|NCT04205890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65133864|NCT04205890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133866|NCT00577109|Bevacizumab|bevacizumab|mesh-list
65133867|NCT00577109|Cetuximab|cetuximab|mesh-list
65133868|NCT00577109|Irinotecan|irinotecan|mesh-list
65133869|NCT00577109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65133870|NCT00577109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133871|NCT00577109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65133872|NCT00577109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65133873|NCT00577109|Growth Substances|growth substances|mesh-ancestor
65133874|NCT00577109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133875|NCT00577109|Growth Inhibitors|growth inhibitors|mesh-ancestor
65133876|NCT00577109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65133877|NCT00577109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65133878|NCT00577109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133879|NCT00577109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300090|NCT00621491|Warfarin|warfarin|mesh-list
65300091|NCT00621491|Anticoagulants|anticoagulants|mesh-list
65300092|NCT00622349|Gemcitabine|gemcitabine|mesh-list
65300093|NCT00622349|Cisplatin|cisplatin|mesh-list
65300094|NCT00622349|Docetaxel|docetaxel|mesh-list
65300095|NCT00622349|Ifosfamide|ifosfamide|mesh-list
65300096|NCT00622349|Isophosphamide mustard|isophosphamide mustard|mesh-list
65300097|NCT00622349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300098|NCT00622349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65300099|NCT00622349|Antimetabolites|antimetabolites|mesh-ancestor
65300100|NCT00622349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300101|NCT00622349|Antiviral Agents|antiviral agents|mesh-ancestor
65300102|NCT00622349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65300103|NCT00622349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300104|NCT00622349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65300105|NCT00622349|Immunologic Factors|immunologic factors|mesh-ancestor
65300106|NCT00622349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300107|NCT00622349|Tubulin Modulators|tubulin modulators|mesh-ancestor
65300108|NCT00622349|Antimitotic Agents|antimitotic agents|mesh-ancestor
65300109|NCT00622349|Mitosis Modulators|mitosis modulators|mesh-ancestor
65300110|NCT00622349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65300111|NCT00622349|Alkylating Agents|alkylating agents|mesh-ancestor
65300112|NCT00686816|Sucrose polyester|sucrose polyester|mesh-list
65300113|NCT00686816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65300114|NCT00686816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65300142|NCT02666105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300143|NCT02666105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65300144|NCT02666105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65300145|NCT02666105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300146|NCT02666105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133880|NCT00577109|Antidotes|antidotes|mesh-ancestor
65133881|NCT00577109|Protective Agents|protective agents|mesh-ancestor
65133882|NCT00577109|Vitamin B Complex|vitamin b complex|mesh-ancestor
65133883|NCT00577109|Vitamins|vitamins|mesh-ancestor
65133884|NCT00577109|Micronutrients|micronutrients|mesh-ancestor
65133885|NCT01124422|Fluticasone|fluticasone|mesh-list
65133886|NCT01124422|Xhance|xhance|mesh-list
65133887|NCT01124422|Bromides|bromides|mesh-list
65133888|NCT01124422|Tiotropium Bromide|tiotropium bromide|mesh-list
65133889|NCT01124422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65133890|NCT01124422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65133891|NCT01124422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65133892|NCT01124422|Autonomic Agents|autonomic agents|mesh-ancestor
65133893|NCT01124422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133894|NCT01124422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133895|NCT01124422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65133896|NCT01124422|Respiratory System Agents|respiratory system agents|mesh-ancestor
65133897|NCT01124422|Dermatologic Agents|dermatologic agents|mesh-ancestor
65133898|NCT01124422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65133899|NCT01124422|Parasympatholytics|parasympatholytics|mesh-ancestor
65133900|NCT01124422|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65133901|NCT01124422|Cholinergic Agents|cholinergic agents|mesh-ancestor
65133902|NCT01124422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65133903|NCT01124422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133904|NCT01124422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65133905|NCT01124422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65133906|NCT01124422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65133907|NCT01124422|Adrenergic Agents|adrenergic agents|mesh-ancestor
65133908|NCT01124422|Anticonvulsants|anticonvulsants|mesh-ancestor
65133909|NCT00625495|Esomeprazole|esomeprazole|mesh-list
65133910|NCT00625495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65133911|NCT00625495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65133912|NCT00625495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65133913|NCT00625495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133914|NCT00625495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133915|NCT02882425|Selexipag|selexipag|mesh-list
65133916|NCT02882425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65133917|NCT00577304|Nitroglycerin|nitroglycerin|mesh-list
65133918|NCT00577304|Vasodilator Agents|vasodilator agents|mesh-ancestor
65133919|NCT01124149|Mesalamine|mesalamine|mesh-list
65133920|NCT01124149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65133921|NCT01124149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65133922|NCT01124149|Analgesics|analgesics|mesh-ancestor
65133923|NCT01124149|Sensory System Agents|sensory system agents|mesh-ancestor
65133924|NCT01124149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133925|NCT01124149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133926|NCT01124149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65133927|NCT01124149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65133928|NCT04545099|Neostigmine|neostigmine|mesh-list
65133929|NCT04545099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65133930|NCT04545099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133932|NCT04545099|Cholinergic Agents|cholinergic agents|mesh-ancestor
65133933|NCT04545099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65133934|NCT04545099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133935|NCT04545099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65133936|NCT04545099|Autonomic Agents|autonomic agents|mesh-ancestor
65133937|NCT04545099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133939|NCT02882269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65133940|NCT02882269|Antimetabolites|antimetabolites|mesh-ancestor
65133941|NCT02882269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133942|NCT02882269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133943|NCT01122862|Chlorhexidine|chlorhexidine|mesh-list
65133944|NCT01122862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65133945|NCT01122862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65133946|NCT01122862|Disinfectants|disinfectants|mesh-ancestor
65133947|NCT04537767|Esmolol|esmolol|mesh-list
65133948|NCT04537767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65300147|NCT02666105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65300148|NCT02666105|Hormone Antagonists|hormone antagonists|mesh-ancestor
65300149|NCT02666105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65300150|NCT02666105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300151|NCT04138238|Sirolimus|sirolimus|mesh-list
65300152|NCT04138238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65300153|NCT04138238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65133949|NCT04537767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65133950|NCT04537767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65133951|NCT04537767|Adrenergic Agents|adrenergic agents|mesh-ancestor
65133952|NCT04537767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65133953|NCT04537767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133954|NCT04537767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133955|NCT01121926|Trazodone|trazodone|mesh-list
65133956|NCT01121926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65133957|NCT01121926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65133958|NCT01121926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65133959|NCT01121926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133960|NCT01121926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64776448|NCT05738382|Cetrorelix|cetrorelix|mesh-list
65133961|NCT01121926|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65133962|NCT01121926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65133963|NCT01121926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65133964|NCT01121926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133965|NCT01121926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65133966|NCT01121926|Serotonin Agents|serotonin agents|mesh-ancestor
65133967|NCT01121926|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65133968|NCT01121926|Antidepressive Agents|antidepressive agents|mesh-ancestor
65133969|NCT00577421|Risedronic Acid|risedronic acid|mesh-list
65133970|NCT00577421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65133971|NCT00577421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65133972|NCT00577421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133973|NCT00577421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65133974|NCT00577421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133975|NCT00577421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65133977|NCT00577694|Gemtuzumab|gemtuzumab|mesh-list
65133978|NCT00577694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65133979|NCT00577694|Antimetabolites|antimetabolites|mesh-ancestor
65133980|NCT00577694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133981|NCT00577694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133982|NCT00577694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65133983|NCT04537533|Tranexamic Acid|tranexamic acid|mesh-list
65133984|NCT04537533|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65133985|NCT04537533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65133986|NCT04537533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133987|NCT04537533|Hemostatics|hemostatics|mesh-ancestor
65133988|NCT04537533|Coagulants|coagulants|mesh-ancestor
65133989|NCT02216058|Sirolimus|sirolimus|mesh-list
65133990|NCT02216058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65133991|NCT02216058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65133992|NCT02216058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65133993|NCT02216058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133994|NCT02216058|Antifungal Agents|antifungal agents|mesh-ancestor
65133995|NCT02216058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65133996|NCT02216058|Immunologic Factors|immunologic factors|mesh-ancestor
65133997|NCT02216058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133998|NCT00577850|Alendronate|alendronate|mesh-list
65133999|NCT00577850|Risedronic Acid|risedronic acid|mesh-list
65134000|NCT00577850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64706539|NCT01192555|Alkylating Agents|alkylating agents|mesh-ancestor
65134015|NCT00577967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65134016|NCT00577967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65134017|NCT00577967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65134018|NCT00577967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65134019|NCT00577967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300154|NCT04138238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65300155|NCT04138238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300156|NCT04138238|Antifungal Agents|antifungal agents|mesh-ancestor
65300157|NCT04138238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65300158|NCT04138238|Immunologic Factors|immunologic factors|mesh-ancestor
65300159|NCT04138238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300160|NCT00622817|Epinephrine|epinephrine|mesh-list
65300161|NCT00622817|Xylometazoline|xylometazoline|mesh-list
65300162|NCT00622817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65300163|NCT00622817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65300164|NCT00622817|Adrenergic Agents|adrenergic agents|mesh-ancestor
65300165|NCT00622817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65300166|NCT00622817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300167|NCT00622817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300168|NCT00622817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65134020|NCT00577967|Antimanic Agents|antimanic agents|mesh-ancestor
65134021|NCT00578201|Cetuximab|cetuximab|mesh-list
65134022|NCT00578201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65134023|NCT00578201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134024|NCT04544319|Dapagliflozin|dapagliflozin|mesh-list
65134025|NCT04544319|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65134026|NCT04544319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134027|NCT04544319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65134028|NCT04544319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134029|NCT04578470|Vitamin D|vitamin d|mesh-list
65134030|NCT04578470|Vitamins|vitamins|mesh-ancestor
65134031|NCT04578470|Micronutrients|micronutrients|mesh-ancestor
65134032|NCT04578470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134033|NCT04578470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65134034|NCT00578435|Cyclophosphamide|cyclophosphamide|mesh-list
65134035|NCT00578435|Busulfan|busulfan|mesh-list
65134036|NCT00578435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65134037|NCT00578435|Immunologic Factors|immunologic factors|mesh-ancestor
65134038|NCT00578435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134039|NCT00578435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65134040|NCT00578435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65134041|NCT00578435|Alkylating Agents|alkylating agents|mesh-ancestor
65134042|NCT00578435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134043|NCT00578435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134044|NCT00578435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65134045|NCT04537065|Mydriatics|mydriatics|mesh-list
65134046|NCT04537065|Autonomic Agents|autonomic agents|mesh-ancestor
65134047|NCT04537065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65134048|NCT04537065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134049|NCT04544163|Lidocaine|lidocaine|mesh-list
65134050|NCT04544163|Magnesium Sulfate|magnesium sulfate|mesh-list
65134051|NCT04544163|Fentanyl|fentanyl|mesh-list
65134052|NCT04544163|Anesthetics, Local|anesthetics, local|mesh-ancestor
65134053|NCT04544163|Anesthetics|anesthetics|mesh-ancestor
65134054|NCT04544163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65134055|NCT04544163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134057|NCT04544163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65134058|NCT04544163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65134059|NCT04544163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65134060|NCT04544163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65134062|NCT04544163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134064|NCT04544163|Narcotics|narcotics|mesh-ancestor
65134065|NCT04544163|Analgesics|analgesics|mesh-ancestor
65134066|NCT04544163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65134067|NCT04544163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65300169|NCT00622817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65300170|NCT00622817|Autonomic Agents|autonomic agents|mesh-ancestor
65300171|NCT00622817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65300172|NCT00622817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65300173|NCT00622817|Respiratory System Agents|respiratory system agents|mesh-ancestor
65300174|NCT00622817|Mydriatics|mydriatics|mesh-ancestor
65300175|NCT00622817|Sympathomimetics|sympathomimetics|mesh-ancestor
65050057|NCT00252798|Paclitaxel|paclitaxel|mesh-list
65300176|NCT00622817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65300177|NCT00622817|Nasal Decongestants|nasal decongestants|mesh-ancestor
65300178|NCT02432417|Chloroquine|chloroquine|mesh-list
65300179|NCT02432417|Amebicides|amebicides|mesh-ancestor
65300180|NCT02432417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65300181|NCT02432417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65300182|NCT02432417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65300183|NCT02432417|Antimalarials|antimalarials|mesh-ancestor
65300184|NCT02432417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65300185|NCT00692120|Vitamin D|vitamin d|mesh-list
65300186|NCT00692120|Ergocalciferols|ergocalciferols|mesh-list
65300187|NCT00692120|Cholecalciferol|cholecalciferol|mesh-list
65300188|NCT00692120|Vitamins|vitamins|mesh-list
65300189|NCT00692120|Micronutrients|micronutrients|mesh-ancestor
65300190|NCT00692120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300191|NCT00692120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65134068|NCT04544163|Anesthetics, General|anesthetics, general|mesh-ancestor
65134069|NCT04544163|Anticonvulsants|anticonvulsants|mesh-ancestor
65134070|NCT04544163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65134071|NCT04544163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65134072|NCT04544163|Tocolytic Agents|tocolytic agents|mesh-ancestor
65134073|NCT04544163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65134074|NCT04543851|Carbon Fiber|carbon fiber|mesh-list
65134075|NCT04543851|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65134076|NCT04543851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134077|NCT00578591|Rituximab|rituximab|mesh-list
65134078|NCT00578591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65134079|NCT00578591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134080|NCT00578591|Immunologic Factors|immunologic factors|mesh-ancestor
65134081|NCT00578591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134082|NCT00578591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65134083|NCT04536948|Methyl salicylate|methyl salicylate|mesh-list
65134084|NCT04536948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65134085|NCT04543890|Etoposide|etoposide|mesh-list
65134086|NCT04543890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134087|NCT04543890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65134088|NCT04543890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65134089|NCT04543890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65134090|NCT04543890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134091|NCT04543890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134092|NCT04536831|Vitamin D|vitamin d|mesh-list
65134093|NCT04536831|Ergocalciferols|ergocalciferols|mesh-list
65134094|NCT04536831|Cholecalciferol|cholecalciferol|mesh-list
65134095|NCT04536831|Vitamins|vitamins|mesh-list
65134096|NCT04536831|Micronutrients|micronutrients|mesh-ancestor
65134097|NCT04536831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134098|NCT04536831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65300192|NCT00692120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65300193|NCT00819585|Colchicine|colchicine|mesh-list
65300194|NCT00819585|Allopurinol|allopurinol|mesh-list
65300195|NCT00819585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65300196|NCT00819585|Gout Suppressants|gout suppressants|mesh-ancestor
65300197|NCT00819585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65300198|NCT00819585|Tubulin Modulators|tubulin modulators|mesh-ancestor
65300199|NCT00819585|Antimitotic Agents|antimitotic agents|mesh-ancestor
65300200|NCT00819585|Mitosis Modulators|mitosis modulators|mesh-ancestor
64530291|NCT05795491|Antifungal Agents|antifungal agents|mesh-list
65134099|NCT04536831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65134100|NCT02214966|Telmisartan|telmisartan|mesh-list
65134101|NCT02214966|Ramipril|ramipril|mesh-list
65134102|NCT02214966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65134103|NCT02214966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65134104|NCT02214966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65134105|NCT02214966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134106|NCT02214966|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65134107|NCT02214966|Protease Inhibitors|protease inhibitors|mesh-ancestor
65134108|NCT02214966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134109|NCT04536558|Olanzapine|olanzapine|mesh-list
65134110|NCT04536558|Fosaprepitant|fosaprepitant|mesh-list
65134111|NCT04536558|Aprepitant|aprepitant|mesh-list
65134112|NCT04536558|Antiemetics|antiemetics|mesh-ancestor
65134113|NCT04536558|Autonomic Agents|autonomic agents|mesh-ancestor
65134114|NCT04536558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65134115|NCT04536558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134116|NCT04536558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65134117|NCT04536558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65134118|NCT04536558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65134119|NCT04536558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65134120|NCT04536558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65134121|NCT04536558|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65134122|NCT04536558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65134123|NCT04536558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65134124|NCT04536558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134125|NCT04536558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65134126|NCT04536558|Serotonin Agents|serotonin agents|mesh-ancestor
65134127|NCT04536558|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65134128|NCT04557137|Somatostatin|somatostatin|mesh-list
65134129|NCT04557137|Hormones|hormones|mesh-ancestor
65134130|NCT04557137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65134131|NCT04557137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134132|NCT04536675|Bromides|bromides|mesh-list
65134133|NCT04536675|Anticonvulsants|anticonvulsants|mesh-ancestor
65134160|NCT04535973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65134161|NCT04535973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134163|NCT04536051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65134164|NCT04536051|Analgesics|analgesics|mesh-ancestor
65134165|NCT04536051|Sensory System Agents|sensory system agents|mesh-ancestor
65134166|NCT04536051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65134167|NCT04536051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134168|NCT04536051|Antipyretics|antipyretics|mesh-ancestor
65134169|NCT02215005|Telmisartan|telmisartan|mesh-list
65134170|NCT02215005|Ramipril|ramipril|mesh-list
65134171|NCT02215005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65134172|NCT02215005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65134173|NCT02215005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65134174|NCT02215005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134175|NCT02215005|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65134176|NCT02215005|Protease Inhibitors|protease inhibitors|mesh-ancestor
65134177|NCT02215005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134178|NCT02215044|Gemcitabine|gemcitabine|mesh-list
65134179|NCT02215044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65134180|NCT02215044|Antimetabolites|antimetabolites|mesh-ancestor
65300201|NCT00819585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300202|NCT00819585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300203|NCT00819585|Antimetabolites|antimetabolites|mesh-ancestor
65300204|NCT00819585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300205|NCT00819585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65300206|NCT00819585|Antioxidants|antioxidants|mesh-ancestor
65300207|NCT00819585|Protective Agents|protective agents|mesh-ancestor
65300208|NCT00819585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300209|NCT00819585|Immunologic Factors|immunologic factors|mesh-ancestor
65300210|NCT00687206|Valsartan|valsartan|mesh-list
65300211|NCT00687206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65300212|NCT00687206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65300213|NCT00687206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65300214|NCT00687206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300215|NCT00687284|Insulin Detemir|insulin detemir|mesh-list
65300216|NCT00687284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65300217|NCT00687284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300218|NCT02358395|Sorafenib|sorafenib|mesh-list
65300219|NCT02358395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530300|NCT05795491|Hormone Antagonists|hormone antagonists|mesh-ancestor
65134181|NCT02215044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134182|NCT02215044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776675|NCT04883346|Liraglutide|liraglutide|mesh-list
65134200|NCT02216331|Antitubercular Agents|antitubercular agents|mesh-ancestor
65134201|NCT02216331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65134203|NCT02216331|Leprostatic Agents|leprostatic agents|mesh-ancestor
65134204|NCT02216331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65134205|NCT02216331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134206|NCT02216331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134207|NCT02216331|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65134208|NCT02216331|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65134209|NCT02216331|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65134210|NCT02216331|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65134211|NCT02216331|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65134212|NCT02216331|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65134213|NCT04535817|Omalizumab|omalizumab|mesh-list
65134214|NCT04535817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65134215|NCT04535817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65134216|NCT04535817|Respiratory System Agents|respiratory system agents|mesh-ancestor
65134217|NCT04578236|Tretinoin|tretinoin|mesh-list
65134218|NCT04578236|Captopril|captopril|mesh-list
65134219|NCT04578236|Isotretinoin|isotretinoin|mesh-list
65134220|NCT04578236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134221|NCT04578236|Keratolytic Agents|keratolytic agents|mesh-ancestor
65134222|NCT04578236|Dermatologic Agents|dermatologic agents|mesh-ancestor
65134223|NCT04578236|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65134224|NCT04578236|Protease Inhibitors|protease inhibitors|mesh-ancestor
65134225|NCT04578236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134226|NCT04578236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134227|NCT04578236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65134228|NCT04542759|Besifloxacin|besifloxacin|mesh-list
65134229|NCT04542759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65134230|NCT04542759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65134231|NCT04542759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65300220|NCT02358395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65300221|NCT02358395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300222|NCT02358395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300223|NCT00692354|Tosedostat|tosedostat|mesh-list
65300224|NCT00692354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300225|NCT00692354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300226|NCT03928847|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65300227|NCT03928847|Antioxidants|antioxidants|mesh-ancestor
65300228|NCT03928847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300229|NCT03928847|Protective Agents|protective agents|mesh-ancestor
65300230|NCT03928847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134232|NCT04542759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134233|NCT04542759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65134234|NCT04542759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65134235|NCT04542759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134236|NCT04542759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134237|NCT04542759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134238|NCT04542213|Insulin|insulin|mesh-list
65134239|NCT04542213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65134240|NCT04542213|Linagliptin|linagliptin|mesh-list
65134241|NCT04542213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65134245|NCT04542213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65134246|NCT04542213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65134247|NCT04542213|Protease Inhibitors|protease inhibitors|mesh-ancestor
65134248|NCT04542213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134249|NCT04542213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134251|NCT04542369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134252|NCT04542369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65134253|NCT04542369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65134254|NCT04542369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65134255|NCT04542369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134256|NCT04542369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134258|NCT04542252|Cyclosporins|cyclosporins|mesh-list
65134259|NCT04542252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134260|NCT04542252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134261|NCT04542252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65134262|NCT04542252|Immunologic Factors|immunologic factors|mesh-ancestor
65134263|NCT04542252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134264|NCT04542252|Antifungal Agents|antifungal agents|mesh-ancestor
65134265|NCT04542252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134266|NCT04542252|Dermatologic Agents|dermatologic agents|mesh-ancestor
65134267|NCT04542252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65134268|NCT04542252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65134269|NCT04555694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
65134270|NCT04555694|Cyclosporine|cyclosporine|mesh-list
65134271|NCT04555694|Dexamethasone|dexamethasone|mesh-list
65134272|NCT04555694|Cyclosporins|cyclosporins|mesh-list
65134273|NCT04555694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65134274|NCT04555694|Antiemetics|antiemetics|mesh-ancestor
65134275|NCT04555694|Autonomic Agents|autonomic agents|mesh-ancestor
65134276|NCT04555694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65134277|NCT04555694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134278|NCT04555694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65134280|NCT04555694|Hormones|hormones|mesh-ancestor
65134281|NCT04555694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65134282|NCT04555694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65134283|NCT04555694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134284|NCT04555694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134285|NCT04555694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134286|NCT04555694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65300231|NCT03928847|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65300232|NCT03928847|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65300233|NCT03928847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300234|NCT03928847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65300235|NCT02624726|Leucovorin|leucovorin|mesh-list
65300236|NCT02624726|Fluorouracil|fluorouracil|mesh-list
65300237|NCT02624726|Irinotecan|irinotecan|mesh-list
65300238|NCT02624726|Aflibercept|aflibercept|mesh-list
65300239|NCT02624726|Levoleucovorin|levoleucovorin|mesh-list
65300240|NCT02624726|Antimetabolites|antimetabolites|mesh-ancestor
65300241|NCT02624726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300242|NCT02624726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65300243|NCT02624726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300244|NCT02624726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64530328|NCT05787600|Disinfectants|disinfectants|mesh-ancestor
65134287|NCT04555694|Immunologic Factors|immunologic factors|mesh-ancestor
65134288|NCT04555694|Antifungal Agents|antifungal agents|mesh-ancestor
65134289|NCT04555694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134290|NCT04555694|Dermatologic Agents|dermatologic agents|mesh-ancestor
65134291|NCT04555694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65134292|NCT04555694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65134293|NCT04555694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65134294|NCT04532775|Methylprednisolone|methylprednisolone|mesh-list
65134295|NCT04532775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65134296|NCT04532775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65134297|NCT04532775|Prednisolone|prednisolone|mesh-list
65134298|NCT04532775|Prednisolone acetate|prednisolone acetate|mesh-list
65134299|NCT04532775|Magnesium Sulfate|magnesium sulfate|mesh-list
65134300|NCT04532775|Bupivacaine|bupivacaine|mesh-list
65134301|NCT04532775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65134302|NCT04532775|Prednisolone phosphate|prednisolone phosphate|mesh-list
65134303|NCT04532775|Anesthetics, Local|anesthetics, local|mesh-ancestor
65134304|NCT04532775|Anesthetics|anesthetics|mesh-ancestor
65134305|NCT04532775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65134306|NCT04532775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134307|NCT04532775|Sensory System Agents|sensory system agents|mesh-ancestor
65134308|NCT04532775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65134309|NCT04532775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65134310|NCT04532775|Antiemetics|antiemetics|mesh-ancestor
65134311|NCT04532775|Autonomic Agents|autonomic agents|mesh-ancestor
65134312|NCT04532775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65134313|NCT04532775|Glucocorticoids|glucocorticoids|mesh-ancestor
65134314|NCT04532775|Hormones|hormones|mesh-ancestor
65134315|NCT04532775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65134319|NCT04532775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134320|NCT04532775|Analgesics|analgesics|mesh-ancestor
65134321|NCT04532775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65134322|NCT04532775|Anticonvulsants|anticonvulsants|mesh-ancestor
65134323|NCT04532775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65134324|NCT04532775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65134325|NCT04532775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134326|NCT04532775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65134327|NCT04532775|Tocolytic Agents|tocolytic agents|mesh-ancestor
65134328|NCT04532775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65134329|NCT00579644|Minocycline|minocycline|mesh-list
65134330|NCT00579644|Methotrexate|methotrexate|mesh-list
65134331|NCT00579644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65134332|NCT00579644|Abortifacient Agents|abortifacient agents|mesh-ancestor
65134333|NCT00579644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65134334|NCT00579644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134335|NCT00579644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65134336|NCT00579644|Antimetabolites|antimetabolites|mesh-ancestor
65300245|NCT02624726|Immunologic Factors|immunologic factors|mesh-ancestor
65300246|NCT02624726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300247|NCT02624726|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65300248|NCT02624726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65300249|NCT02624726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300250|NCT02624726|Antidotes|antidotes|mesh-ancestor
65300251|NCT02624726|Protective Agents|protective agents|mesh-ancestor
65300252|NCT02624726|Vitamin B Complex|vitamin b complex|mesh-ancestor
65300253|NCT02624726|Vitamins|vitamins|mesh-ancestor
65300254|NCT02624726|Micronutrients|micronutrients|mesh-ancestor
65300255|NCT02624726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65300256|NCT02624726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65300257|NCT02624726|Growth Substances|growth substances|mesh-ancestor
65300258|NCT02624726|Growth Inhibitors|growth inhibitors|mesh-ancestor
65300259|NCT00681746|Flumazenil|flumazenil|mesh-list
65300260|NCT00681746|Antidotes|antidotes|mesh-ancestor
65300261|NCT00681746|Protective Agents|protective agents|mesh-ancestor
65300262|NCT00681746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300263|NCT00681746|GABA Modulators|gaba modulators|mesh-ancestor
65300264|NCT00681746|GABA Agents|gaba agents|mesh-ancestor
65300265|NCT00681746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65300266|NCT00681746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300267|NCT04265911|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65300268|NCT04265911|Immunologic Factors|immunologic factors|mesh-ancestor
65300269|NCT04265911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300270|NCT00819039|Ondansetron|ondansetron|mesh-list
65300271|NCT00819039|Aprepitant|aprepitant|mesh-list
65300272|NCT00819039|Antiemetics|antiemetics|mesh-ancestor
65300273|NCT00819039|Autonomic Agents|autonomic agents|mesh-ancestor
65134337|NCT00579644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134338|NCT00579644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134339|NCT00579644|Dermatologic Agents|dermatologic agents|mesh-ancestor
65134340|NCT00579644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134341|NCT00579644|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65134342|NCT00579644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65134343|NCT00579644|Immunologic Factors|immunologic factors|mesh-ancestor
65134344|NCT00579644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65134345|NCT00579644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65134346|NCT00579644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65134347|NCT00579644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134349|NCT04578158|Antioxidants|antioxidants|mesh-ancestor
65134350|NCT04578158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134351|NCT04578158|Protective Agents|protective agents|mesh-ancestor
65134352|NCT04578158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134353|NCT04532736|Mometasone Furoate|mometasone furoate|mesh-list
65134354|NCT04532736|Methylprednisolone|methylprednisolone|mesh-list
65134355|NCT04532736|Methotrexate|methotrexate|mesh-list
65134356|NCT04532736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65300274|NCT00819039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65300275|NCT00819039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300276|NCT00819039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65300277|NCT00819039|Antipruritics|antipruritics|mesh-ancestor
65300278|NCT00819039|Dermatologic Agents|dermatologic agents|mesh-ancestor
65300279|NCT00819039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65300280|NCT00819039|Serotonin Agents|serotonin agents|mesh-ancestor
65300281|NCT00819039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65300282|NCT00819039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300283|NCT00819039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65300284|NCT00819039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65300285|NCT00819039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65300286|NCT00819039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65300287|NCT00819039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65300288|NCT00819039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65300289|NCT00692510|Rosiglitazone|rosiglitazone|mesh-list
65300290|NCT00692510|Midazolam|midazolam|mesh-list
65300291|NCT00692510|Caffeine|caffeine|mesh-list
65300292|NCT00692510|Bupropion|bupropion|mesh-list
65300293|NCT00692510|Omeprazole|omeprazole|mesh-list
65134357|NCT04532736|Abortifacient Agents|abortifacient agents|mesh-ancestor
65134358|NCT04532736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65134359|NCT04532736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134360|NCT04532736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65134361|NCT04532736|Antimetabolites|antimetabolites|mesh-ancestor
65134362|NCT04532736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134363|NCT04532736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134364|NCT04532736|Dermatologic Agents|dermatologic agents|mesh-ancestor
65134365|NCT04532736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134366|NCT04532736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65134367|NCT04532736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65134368|NCT04532736|Immunologic Factors|immunologic factors|mesh-ancestor
65134369|NCT04532736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65134370|NCT04532736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65134371|NCT04532736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65134372|NCT04532736|Antiemetics|antiemetics|mesh-ancestor
65134373|NCT04532736|Autonomic Agents|autonomic agents|mesh-ancestor
65134374|NCT04532736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65134375|NCT04532736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65134376|NCT04532736|Glucocorticoids|glucocorticoids|mesh-ancestor
65134377|NCT04532736|Hormones|hormones|mesh-ancestor
65134378|NCT04532736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65134379|NCT04532736|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65134380|NCT04532736|Protective Agents|protective agents|mesh-ancestor
65134381|NCT04532736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65134382|NCT04555733|Lemborexant|lemborexant|mesh-list
65134383|NCT04555733|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65134384|NCT04555733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65134385|NCT04555733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134386|NCT04555733|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65134387|NCT04555733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65134390|NCT02216994|Mineral Oil|mineral oil|mesh-list
65134392|NCT02216994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65134393|NCT02216994|Emollients|emollients|mesh-ancestor
65134394|NCT02216994|Dermatologic Agents|dermatologic agents|mesh-ancestor
65134395|NCT02212613|Brexpiprazole|brexpiprazole|mesh-list
65300294|NCT00692510|Bilirubin|bilirubin|mesh-list
65300295|NCT00692510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65300296|NCT00692510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65300297|NCT00692510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65300298|NCT00692510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300299|NCT00692510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65300300|NCT00692510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65300301|NCT00692510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65300302|NCT00692510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65300303|NCT00692510|Anesthetics, General|anesthetics, general|mesh-ancestor
65300304|NCT00692510|Anesthetics|anesthetics|mesh-ancestor
65300305|NCT00692510|GABA Modulators|gaba modulators|mesh-ancestor
65300306|NCT00692510|GABA Agents|gaba agents|mesh-ancestor
65300307|NCT00692510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64530380|NCT05723874|Bosentan|bosentan|mesh-list
65134396|NCT02212613|Serotonin Agents|serotonin agents|mesh-ancestor
65134397|NCT02212613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65134398|NCT02212613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134399|NCT02212613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134400|NCT02212613|Dopamine Agonists|dopamine agonists|mesh-ancestor
65134401|NCT02212613|Dopamine Agents|dopamine agents|mesh-ancestor
65134402|NCT04532229|Nimotuzumab|nimotuzumab|mesh-list
65134403|NCT04532229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65134404|NCT04532229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134405|NCT02217189|Zinc Sulfate|zinc sulfate|mesh-list
65134406|NCT02217189|Astringents|astringents|mesh-ancestor
64776908|NCT02534376|Ezetimibe|ezetimibe|mesh-list
65134407|NCT02217189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134408|NCT02217189|Dermatologic Agents|dermatologic agents|mesh-ancestor
65134409|NCT00579956|Meropenem|meropenem|mesh-list
65134410|NCT00579956|Ceftazidime|ceftazidime|mesh-list
65134411|NCT00579956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65134412|NCT00579956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134413|NCT04555304|Paclitaxel|paclitaxel|mesh-list
65134414|NCT04555304|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65134415|NCT04555304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65134416|NCT04555304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134417|NCT04555304|Tubulin Modulators|tubulin modulators|mesh-ancestor
65134418|NCT04555304|Antimitotic Agents|antimitotic agents|mesh-ancestor
65134419|NCT04555304|Mitosis Modulators|mitosis modulators|mesh-ancestor
65134420|NCT04555304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134421|NCT04531800|Mitogens|mitogens|mesh-list
65134422|NCT04531800|Mitosis Modulators|mitosis modulators|mesh-ancestor
65134423|NCT04531800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134424|NCT00579995|Acetylcysteine|acetylcysteine|mesh-list
65134425|NCT00579995|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65134426|NCT00579995|Antiviral Agents|antiviral agents|mesh-ancestor
65134427|NCT00579995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134428|NCT00579995|Expectorants|expectorants|mesh-ancestor
65134429|NCT00579995|Respiratory System Agents|respiratory system agents|mesh-ancestor
65134430|NCT00579995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65134431|NCT00579995|Antioxidants|antioxidants|mesh-ancestor
65134432|NCT00579995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134433|NCT00579995|Protective Agents|protective agents|mesh-ancestor
65134434|NCT00579995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134435|NCT00579995|Antidotes|antidotes|mesh-ancestor
65134436|NCT04531371|Dexmedetomidine|dexmedetomidine|mesh-list
65134437|NCT04531371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65134438|NCT04531371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65134439|NCT04531371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134440|NCT04531371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65134441|NCT04531371|Analgesics|analgesics|mesh-ancestor
65134442|NCT04531371|Sensory System Agents|sensory system agents|mesh-ancestor
65300308|NCT00692510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300309|NCT00692510|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65300310|NCT00692510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65300311|NCT00692510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300312|NCT00692510|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65300313|NCT00692510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65300314|NCT00692510|Purinergic Agents|purinergic agents|mesh-ancestor
65300315|NCT00692510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65300316|NCT00692510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65300317|NCT00692510|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65300318|NCT00692510|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65300319|NCT00692510|Antidepressive Agents|antidepressive agents|mesh-ancestor
65300320|NCT00692510|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65300321|NCT00692510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65300322|NCT00692510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65300323|NCT00692510|Dopamine Agents|dopamine agents|mesh-ancestor
65300324|NCT00692510|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65300325|NCT00692510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65300326|NCT00692510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65300327|NCT00692510|Antioxidants|antioxidants|mesh-ancestor
65300328|NCT00692510|Protective Agents|protective agents|mesh-ancestor
65050211|NCT00566683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65300329|NCT00500539|Omalizumab|omalizumab|mesh-list
64530393|NCT05702333|Norepinephrine|norepinephrine|mesh-list
65134443|NCT04531371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65134444|NCT04531371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65134445|NCT04531371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65134446|NCT04531371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65134447|NCT04531371|Adrenergic Agents|adrenergic agents|mesh-ancestor
65134448|NCT04531371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65134449|NCT04531371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134450|NCT00580112|Dexamethasone|dexamethasone|mesh-list
65134451|NCT00580112|Trabectedin|trabectedin|mesh-list
65134452|NCT00580112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65134453|NCT00580112|Antiemetics|antiemetics|mesh-ancestor
65134454|NCT00580112|Autonomic Agents|autonomic agents|mesh-ancestor
65134455|NCT00580112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65134456|NCT00580112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134457|NCT00580112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65134458|NCT00580112|Glucocorticoids|glucocorticoids|mesh-ancestor
65134459|NCT00580112|Hormones|hormones|mesh-ancestor
65134460|NCT00580112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65134464|NCT00580112|Alkylating Agents|alkylating agents|mesh-ancestor
65134465|NCT00580112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134466|NCT04531332|Linezolid|linezolid|mesh-list
65134467|NCT04531332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65134468|NCT04531332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134469|NCT04531332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65300331|NCT00500539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65300332|NCT00500539|Respiratory System Agents|respiratory system agents|mesh-ancestor
65300333|NCT00687518|Epoetin Alfa|epoetin alfa|mesh-list
65300334|NCT00687518|Hematinics|hematinics|mesh-ancestor
65300335|NCT02303795|Warfarin|warfarin|mesh-list
65300336|NCT02303795|Rivaroxaban|rivaroxaban|mesh-list
65300337|NCT02303795|Anticoagulants|anticoagulants|mesh-ancestor
65300338|NCT02303795|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65300339|NCT02303795|Antithrombins|antithrombins|mesh-ancestor
65300340|NCT02303795|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64530414|NCT05702333|Protective Agents|protective agents|mesh-ancestor
65134470|NCT04531332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134471|NCT04531332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134472|NCT04530864|Dexamethasone|dexamethasone|mesh-list
65134473|NCT04530864|Dexamethasone acetate|dexamethasone acetate|mesh-list
65134474|NCT04530864|BB 1101|bb 1101|mesh-list
65134475|NCT04530864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65134476|NCT04530864|Antiemetics|antiemetics|mesh-ancestor
65134477|NCT04530864|Autonomic Agents|autonomic agents|mesh-ancestor
65134478|NCT04530864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65134479|NCT04530864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134480|NCT04530864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65134481|NCT04530864|Glucocorticoids|glucocorticoids|mesh-ancestor
65134482|NCT04530864|Hormones|hormones|mesh-ancestor
65134483|NCT04530864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65134484|NCT04530864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65134485|NCT04530864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134486|NCT04530864|Protease Inhibitors|protease inhibitors|mesh-ancestor
65134487|NCT04530864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134488|NCT04530864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134489|NCT00580190|Alprazolam|alprazolam|mesh-list
65134490|NCT00580190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65134491|NCT00580190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65134492|NCT00580190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134493|NCT00580190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65134494|NCT00580190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65134495|NCT00580190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65134496|NCT00580190|GABA Modulators|gaba modulators|mesh-ancestor
65134497|NCT00580190|GABA Agents|gaba agents|mesh-ancestor
65134498|NCT00580190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65134499|NCT00580190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134501|NCT04530903|Levobupivacaine|levobupivacaine|mesh-list
65134502|NCT04530903|Analgesics|analgesics|mesh-ancestor
65134503|NCT04530903|Sensory System Agents|sensory system agents|mesh-ancestor
65134504|NCT04530903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65134505|NCT04530903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134506|NCT04530903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65134507|NCT04530903|Sympatholytics|sympatholytics|mesh-ancestor
65134508|NCT04530903|Autonomic Agents|autonomic agents|mesh-ancestor
65134509|NCT04530903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65134510|NCT04530903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65134511|NCT04530903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65134512|NCT04530903|Adrenergic Agents|adrenergic agents|mesh-ancestor
65134513|NCT04530903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65134514|NCT04530903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134515|NCT04530903|Anesthetics, Local|anesthetics, local|mesh-ancestor
65134516|NCT04530903|Anesthetics|anesthetics|mesh-ancestor
65134517|NCT04530903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65134518|NCT04530474|Ivermectin|ivermectin|mesh-list
65134519|NCT04530474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65134520|NCT04530474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134521|NCT04554680|Trametinib|trametinib|mesh-list
65134522|NCT04554680|Dabrafenib|dabrafenib|mesh-list
65134523|NCT04554680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134524|NCT04554680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65134525|NCT04554680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222821|NCT02699385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300341|NCT02303795|Protease Inhibitors|protease inhibitors|mesh-ancestor
65300342|NCT02303795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300343|NCT02303795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300344|NCT04187417|Tetracaine|tetracaine|mesh-list
65300345|NCT04187417|Anesthetics, Local|anesthetics, local|mesh-ancestor
65300346|NCT04187417|Anesthetics|anesthetics|mesh-ancestor
65300347|NCT04187417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65300348|NCT04187417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300349|NCT04187417|Sensory System Agents|sensory system agents|mesh-ancestor
65300350|NCT04187417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65300351|NCT00818883|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65300352|NCT00818883|Chlorthalidone|chlorthalidone|mesh-list
65300353|NCT00818883|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65300354|NCT00818883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65300355|NCT00818883|Diuretics|diuretics|mesh-ancestor
65300356|NCT00818883|Natriuretic Agents|natriuretic agents|mesh-ancestor
64530423|NCT05684744|Antimetabolites|antimetabolites|mesh-ancestor
65134526|NCT04554680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134527|NCT00580424|Norethindrone|norethindrone|mesh-list
65134528|NCT00580424|Norethindrone Acetate|norethindrone acetate|mesh-list
65134529|NCT00580424|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65134530|NCT00580424|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65134531|NCT00580424|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65134532|NCT00580424|Contraceptive Agents|contraceptive agents|mesh-ancestor
64707063|NCT03697850|Atezolizumab|atezolizumab|mesh-list
65134549|NCT02882113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65134550|NCT02882113|Immunologic Factors|immunologic factors|mesh-ancestor
65134551|NCT02882113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134552|NCT02882113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65134553|NCT02882113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134554|NCT02882113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134555|NCT04530045|Piperacillin|piperacillin|mesh-list
65134556|NCT04530045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65134557|NCT04530045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134559|NCT01121536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65134560|NCT01121536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134561|NCT01121536|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65134562|NCT01121536|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65134563|NCT01121536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65134564|NCT01121536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134565|NCT00580619|Methyldopa|methyldopa|mesh-list
65134566|NCT00580619|Trimethaphan|trimethaphan|mesh-list
65134567|NCT00580619|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
65134568|NCT00580619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134569|NCT00580619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65134570|NCT00580619|Sympatholytics|sympatholytics|mesh-ancestor
65134571|NCT00580619|Autonomic Agents|autonomic agents|mesh-ancestor
65134572|NCT00580619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65134573|NCT00580619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134574|NCT00580619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65134575|NCT00580619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65134576|NCT00580619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65134577|NCT00580619|Adrenergic Agents|adrenergic agents|mesh-ancestor
65134578|NCT00580619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65134579|NCT00580619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65134580|NCT00580619|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
65134581|NCT00580619|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65300357|NCT00818883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300358|NCT00818883|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65300359|NCT00818883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65300360|NCT00818883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300361|NCT00818883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65300362|NCT00818883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65300363|NCT01014481|Tenofovir|tenofovir|mesh-list
65300364|NCT01014481|Lamivudine|lamivudine|mesh-list
65300365|NCT01014481|Efavirenz|efavirenz|mesh-list
65300366|NCT01014481|Antiviral Agents|antiviral agents|mesh-ancestor
65300367|NCT01014481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65300368|NCT01014481|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65300369|NCT01014481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65300370|NCT01014481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300371|NCT01014481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300372|NCT01014481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65300373|NCT01014481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65300374|NCT01014481|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65300375|NCT01014481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65300376|NCT01014481|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65300377|NCT01014481|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65300378|NCT01014481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65300379|NCT01014481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65300380|NCT02167763|Copper|copper|mesh-list
64714119|NCT03054805|Antacids|antacids|mesh-ancestor
65134582|NCT00580619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65134583|NCT00580619|Cholinergic Agents|cholinergic agents|mesh-ancestor
65134584|NCT00580619|Vasodilator Agents|vasodilator agents|mesh-ancestor
65134585|NCT04554524|Paclitaxel|paclitaxel|mesh-list
65134586|NCT04554524|Pembrolizumab|pembrolizumab|mesh-list
65134587|NCT04554524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65134588|NCT04554524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134589|NCT04554524|Tubulin Modulators|tubulin modulators|mesh-ancestor
65134590|NCT04554524|Antimitotic Agents|antimitotic agents|mesh-ancestor
65134594|NCT02212652|Vitamin D|vitamin d|mesh-list
65134595|NCT02212652|Ergocalciferols|ergocalciferols|mesh-list
65134596|NCT02212652|Cholecalciferol|cholecalciferol|mesh-list
65134597|NCT02212652|Vitamins|vitamins|mesh-list
65134598|NCT02212652|Micronutrients|micronutrients|mesh-ancestor
65134599|NCT02212652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134600|NCT02212652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65134601|NCT02212652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65134602|NCT02212769|Losartan|losartan|mesh-list
65134603|NCT02212769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65134604|NCT02212769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65134605|NCT02212769|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65134606|NCT02212769|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65134607|NCT02212769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300381|NCT02167763|Contraceptive Agents|contraceptive agents|mesh-list
65300382|NCT02167763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65300383|NCT02167763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300384|NCT02167763|Trace Elements|trace elements|mesh-ancestor
65300385|NCT02167763|Micronutrients|micronutrients|mesh-ancestor
65300386|NCT00508027|Simvastatin|simvastatin|mesh-list
65300387|NCT00508027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65300388|NCT00508027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65300389|NCT00508027|Antimetabolites|antimetabolites|mesh-ancestor
65300390|NCT00508027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300391|NCT00508027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65300392|NCT00508027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65300393|NCT00508027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300394|NCT01986101|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65300395|NCT01986101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65300396|NCT01986101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65300397|NCT01986101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65300398|NCT01986101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300399|NCT01986101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65300400|NCT01986101|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65300401|NCT01986101|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65300402|NCT01986101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65300403|NCT01986101|Adrenergic Agents|adrenergic agents|mesh-ancestor
65300404|NCT01986101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65300405|NCT01986101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300406|NCT01986101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65300407|NCT01986101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65300408|NCT01986101|Serotonin Agents|serotonin agents|mesh-ancestor
65300409|NCT01986101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65300410|NCT01986101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65134608|NCT02212808|Anti-Infective Agents|anti-infective agents|mesh-list
65134609|NCT02212808|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65134610|NCT02217852|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65134611|NCT02217852|Captopril|captopril|mesh-list
65134612|NCT02217852|Antihypertensive Agents|antihypertensive agents|mesh-list
65134613|NCT02217852|Nitrendipine|nitrendipine|mesh-list
65134614|NCT02217852|Diuretics|diuretics|mesh-ancestor
65134615|NCT02217852|Natriuretic Agents|natriuretic agents|mesh-ancestor
65134616|NCT02217852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134617|NCT02217852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65134618|NCT02217852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65134619|NCT02217852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300411|NCT01986101|Dopamine Agents|dopamine agents|mesh-ancestor
65300412|NCT00500149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65300413|NCT00500149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65300414|NCT00500149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300415|NCT00500149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65300416|NCT00500149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65300417|NCT00500149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65300418|NCT00500149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300419|NCT00500149|Dopamine Agents|dopamine agents|mesh-ancestor
65300420|NCT00500149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65300422|NCT00681902|Anesthetics, Local|anesthetics, local|mesh-ancestor
65300423|NCT00681902|Anesthetics|anesthetics|mesh-ancestor
65300424|NCT00681902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65300425|NCT00681902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300426|NCT00681902|Sensory System Agents|sensory system agents|mesh-ancestor
65300427|NCT00681902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65300428|NCT00681902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65300429|NCT00681902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65300430|NCT00681902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65300431|NCT00681902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65300432|NCT00681902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300433|NCT04185857|Olmesartan|olmesartan|mesh-list
65300434|NCT04185857|Canrenone|canrenone|mesh-list
65300435|NCT04185857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65300436|NCT04185857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65300437|NCT04185857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64530488|NCT05633381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65134620|NCT02217852|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65134621|NCT02217852|Protease Inhibitors|protease inhibitors|mesh-ancestor
65134622|NCT02217852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134623|NCT02217852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65134624|NCT02217852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65134625|NCT02217852|Vasodilator Agents|vasodilator agents|mesh-ancestor
65134626|NCT02217930|Moxifloxacin|moxifloxacin|mesh-list
65134627|NCT02217930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65134628|NCT02217930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134629|NCT02217930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65134630|NCT02217930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65134631|NCT02217930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134632|NCT02217930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134633|NCT02217930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134635|NCT04577846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65300438|NCT04185857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300439|NCT04185857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65300440|NCT04185857|Hormone Antagonists|hormone antagonists|mesh-ancestor
65300441|NCT04185857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65300442|NCT04185857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300443|NCT04185857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65300444|NCT04185857|Diuretics|diuretics|mesh-ancestor
65300445|NCT04185857|Natriuretic Agents|natriuretic agents|mesh-ancestor
65300446|NCT01016509|Insulin|insulin|mesh-list
65300447|NCT01016509|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65300448|NCT01016509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65300449|NCT01016509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300450|NCT00639119|Ropinirole|ropinirole|mesh-list
65300451|NCT00639119|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65300452|NCT00639119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65300453|NCT00639119|Dopamine Agonists|dopamine agonists|mesh-ancestor
65300454|NCT00639119|Dopamine Agents|dopamine agents|mesh-ancestor
65300455|NCT00639119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65300456|NCT00639119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300457|NCT00639119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300458|NCT01010893|Vaccines|vaccines|mesh-list
65300459|NCT01010893|Immunologic Factors|immunologic factors|mesh-ancestor
65300460|NCT01010893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300461|NCT01011127|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65300462|NCT01011127|Pravastatin|pravastatin|mesh-list
65300463|NCT01011127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65300464|NCT01011127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65134636|NCT04577846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134637|NCT04529811|Rifaximin|rifaximin|mesh-list
65134638|NCT04529811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65134639|NCT04529811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134640|NCT04529811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65134641|NCT02218047|Interferons|interferons|mesh-list
65134642|NCT02218047|Interferon-alpha|interferon-alpha|mesh-list
65134643|NCT02218047|Interferon alpha-2|interferon alpha-2|mesh-list
65134644|NCT02218047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134645|NCT02218047|Antiviral Agents|antiviral agents|mesh-ancestor
65134646|NCT02218047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134647|NCT02218047|Immunologic Factors|immunologic factors|mesh-ancestor
65134648|NCT02218047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134650|NCT00580814|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65134651|NCT00580814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134652|NCT00580814|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65134653|NCT00580814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65134654|NCT00580814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65134655|NCT00580814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300465|NCT01011127|Antimetabolites|antimetabolites|mesh-ancestor
65300466|NCT01011127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300467|NCT01011127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65300468|NCT01011127|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65300469|NCT01011127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300470|NCT00912548|Tamoxifen|tamoxifen|mesh-list
65300471|NCT00912548|Goserelin|goserelin|mesh-list
65300472|NCT00912548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65300473|NCT00912548|Hormone Antagonists|hormone antagonists|mesh-ancestor
65300474|NCT00912548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65050363|NCT00253188|Galantamine|galantamine|mesh-list
65300475|NCT00912548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300476|NCT00912548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65300477|NCT00912548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300478|NCT00912548|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65300479|NCT00912548|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65300480|NCT00912548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65300482|NCT01016665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65300483|NCT01016665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300484|NCT01016665|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65300485|NCT01016665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65300486|NCT01016665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134656|NCT00580814|Dopamine Agents|dopamine agents|mesh-ancestor
65134657|NCT00580814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65134658|NCT01120600|Vitamin D|vitamin d|mesh-list
65134659|NCT01120600|Cholecalciferol|cholecalciferol|mesh-list
65134660|NCT01120600|Calcium Carbonate|calcium carbonate|mesh-list
65134661|NCT01120600|Calcium|calcium|mesh-list
65134662|NCT01120600|Vitamins|vitamins|mesh-ancestor
65134663|NCT01120600|Micronutrients|micronutrients|mesh-ancestor
64707191|NCT00369356|Hormones|hormones|mesh-ancestor
65134666|NCT01120600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65134668|NCT01120600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134669|NCT01120600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65134670|NCT04577885|Rifampin|rifampin|mesh-list
65134671|NCT04577885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65134672|NCT04577885|Antitubercular Agents|antitubercular agents|mesh-ancestor
65134673|NCT04577885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65134674|NCT04577885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134675|NCT04577885|Leprostatic Agents|leprostatic agents|mesh-ancestor
65134676|NCT04577885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65134677|NCT04577885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134678|NCT04577885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134679|NCT04577885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65134680|NCT04577885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65134681|NCT04577885|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65134682|NCT04577885|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65134683|NCT04577885|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65134684|NCT04577885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65134685|NCT00580931|Niacinamide|niacinamide|mesh-list
65300487|NCT01016665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300488|NCT01016665|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65300489|NCT01016665|Hormone Antagonists|hormone antagonists|mesh-ancestor
65300490|NCT01016665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65300491|NCT01016665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300492|NCT00681980|Valproic Acid|valproic acid|mesh-list
65300493|NCT00681980|Anticonvulsants|anticonvulsants|mesh-ancestor
65300494|NCT00681980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300495|NCT00681980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300496|NCT00681980|GABA Agents|gaba agents|mesh-ancestor
65300497|NCT00681980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65300498|NCT00681980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300499|NCT00681980|Antimanic Agents|antimanic agents|mesh-ancestor
65300500|NCT00681980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65300501|NCT00681980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65300502|NCT00681980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65300503|NCT00692900|Docetaxel|docetaxel|mesh-list
64530581|NCT05477953|Nifurtimox|nifurtimox|mesh-list
65134686|NCT00580931|Niacin|niacin|mesh-list
65134687|NCT00580931|Nicotinic Acids|nicotinic acids|mesh-list
65134688|NCT00580931|Vitamin B Complex|vitamin b complex|mesh-ancestor
65134689|NCT00580931|Vitamins|vitamins|mesh-ancestor
65134690|NCT00580931|Micronutrients|micronutrients|mesh-ancestor
65134691|NCT00580931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134692|NCT00580931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65134693|NCT00580931|Antimetabolites|antimetabolites|mesh-ancestor
65134694|NCT00580931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134695|NCT00580931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65134696|NCT00580931|Vasodilator Agents|vasodilator agents|mesh-ancestor
65134697|NCT01120093|Bromides|bromides|mesh-list
65134698|NCT01120093|Formoterol Fumarate|formoterol fumarate|mesh-list
65134699|NCT01120093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65134700|NCT01120093|Autonomic Agents|autonomic agents|mesh-ancestor
65134701|NCT01120093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65134702|NCT01120093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134703|NCT01120093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65134704|NCT01120093|Respiratory System Agents|respiratory system agents|mesh-ancestor
65134705|NCT01120093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64777202|NCT02004366|Hormones|hormones|mesh-ancestor
65134707|NCT01120093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65134708|NCT01120093|Adrenergic Agents|adrenergic agents|mesh-ancestor
65134709|NCT01120093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65134710|NCT01120093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134711|NCT01120093|Anticonvulsants|anticonvulsants|mesh-ancestor
65134712|NCT00581009|Lithium Carbonate|lithium carbonate|mesh-list
65134713|NCT00581009|Sertraline|sertraline|mesh-list
65134714|NCT00581009|Antidepressive Agents|antidepressive agents|mesh-ancestor
65134715|NCT00581009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65134716|NCT00581009|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65134717|NCT00581009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65134718|NCT00581009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65134719|NCT00581009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514361|NCT05739682|Carticaine|carticaine|mesh-list
65134721|NCT00581009|Serotonin Agents|serotonin agents|mesh-ancestor
65134722|NCT00581009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134723|NCT00581009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134724|NCT00581009|Antimanic Agents|antimanic agents|mesh-ancestor
65300504|NCT00692900|Oxaliplatin|oxaliplatin|mesh-list
65300505|NCT00692900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300506|NCT00692900|Tubulin Modulators|tubulin modulators|mesh-ancestor
65300507|NCT00692900|Antimitotic Agents|antimitotic agents|mesh-ancestor
65300508|NCT00692900|Mitosis Modulators|mitosis modulators|mesh-ancestor
65300509|NCT00692900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300510|NCT03800381|Rifampin|rifampin|mesh-list
65300511|NCT03800381|Isoniazid|isoniazid|mesh-list
65300512|NCT03800381|Pyrazinamide|pyrazinamide|mesh-list
65134725|NCT00581009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65134726|NCT00581009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65134727|NCT02218359|Amikacin|amikacin|mesh-list
65134728|NCT02218359|Fosfomycin|fosfomycin|mesh-list
65134729|NCT02218359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65134730|NCT02218359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65134731|NCT02218359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134732|NCT02882191|Levonorgestrel|levonorgestrel|mesh-list
65134733|NCT02882191|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65134734|NCT02882191|Contraceptive Agents|contraceptive agents|mesh-ancestor
64707264|NCT05424523|Omalizumab|omalizumab|mesh-list
65134737|NCT02882191|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65134738|NCT02882191|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65134739|NCT02882191|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65134740|NCT02218398|Albuterol|albuterol|mesh-list
65134741|NCT02218398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65134742|NCT02218398|Autonomic Agents|autonomic agents|mesh-ancestor
65134743|NCT02218398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65134744|NCT02218398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134745|NCT02218398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65134746|NCT02218398|Respiratory System Agents|respiratory system agents|mesh-ancestor
65134747|NCT02218398|Tocolytic Agents|tocolytic agents|mesh-ancestor
65134748|NCT02218398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65134749|NCT02218398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65134750|NCT02218398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65134751|NCT02218398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65134752|NCT02218398|Adrenergic Agents|adrenergic agents|mesh-ancestor
65134753|NCT02218398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65134754|NCT02218398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134755|NCT02218671|Brotizolam|brotizolam|mesh-list
65134756|NCT02218671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65134757|NCT02218671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65134758|NCT02218671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134759|NCT01119937|Glycopyrrolate|glycopyrrolate|mesh-list
65134760|NCT01119937|Tiotropium Bromide|tiotropium bromide|mesh-list
65134761|NCT01119937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65134762|NCT01119937|Autonomic Agents|autonomic agents|mesh-ancestor
65134763|NCT01119937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65134764|NCT01119937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134765|NCT01119937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65134766|NCT01119937|Respiratory System Agents|respiratory system agents|mesh-ancestor
65134767|NCT01119937|Parasympatholytics|parasympatholytics|mesh-ancestor
65134768|NCT01119937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65134769|NCT01119937|Cholinergic Agents|cholinergic agents|mesh-ancestor
65134770|NCT01119937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65134771|NCT01119937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134772|NCT01119937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65134773|NCT01119937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65134774|NCT01119898|Diclofenac|diclofenac|mesh-list
65134775|NCT01119898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65134776|NCT01119898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65134777|NCT01119898|Analgesics|analgesics|mesh-ancestor
65134778|NCT01119898|Sensory System Agents|sensory system agents|mesh-ancestor
65134779|NCT01119898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65134780|NCT01119898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134781|NCT01119898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65134782|NCT01119898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65134783|NCT01119898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65134784|NCT01119898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300513|NCT03800381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65300514|NCT03800381|Antitubercular Agents|antitubercular agents|mesh-ancestor
65300515|NCT03800381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65300516|NCT03800381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65300517|NCT03800381|Leprostatic Agents|leprostatic agents|mesh-ancestor
65300518|NCT03800381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65300519|NCT03800381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300520|NCT03800381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300521|NCT03800381|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65300522|NCT03800381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65300523|NCT03800381|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65300524|NCT03800381|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65300525|NCT03800381|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65300526|NCT03800381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65300527|NCT03800381|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65134785|NCT01119898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134786|NCT01119859|Adalimumab|adalimumab|mesh-list
65134787|NCT01119859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65134788|NCT01119859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65134789|NCT02278926|Insulin|insulin|mesh-list
65134790|NCT02278926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65134791|NCT02278926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134792|NCT01119703|Vaccines|vaccines|mesh-list
65134793|NCT01119703|Immunologic Factors|immunologic factors|mesh-ancestor
65134794|NCT01119703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134795|NCT02882230|Dolutegravir|dolutegravir|mesh-list
65134796|NCT02882230|Rilpivirine|rilpivirine|mesh-list
65134797|NCT02882230|Elvitegravir|elvitegravir|mesh-list
65134798|NCT02882230|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65134799|NCT02882230|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65134800|NCT02882230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134801|NCT02882230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134802|NCT02882230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65134803|NCT02882230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65134804|NCT02882230|Antiviral Agents|antiviral agents|mesh-ancestor
65134805|NCT02882230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134806|NCT02882230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65134807|NCT02882230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65134819|NCT02881762|Antiviral Agents|antiviral agents|mesh-ancestor
65134820|NCT02881762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134821|NCT02881762|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65134823|NCT04561947|Mitosis Modulators|mitosis modulators|mesh-ancestor
65134824|NCT04561947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134825|NCT01118962|Lacosamide|lacosamide|mesh-list
65134826|NCT01118962|Anticonvulsants|anticonvulsants|mesh-ancestor
65134827|NCT01118962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65134828|NCT01118962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65134829|NCT01118962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65134830|NCT01118962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134831|NCT00581165|Etanercept|etanercept|mesh-list
65134832|NCT00581165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65134833|NCT00581165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65134834|NCT00581165|Analgesics|analgesics|mesh-ancestor
65134835|NCT00581165|Sensory System Agents|sensory system agents|mesh-ancestor
65134836|NCT00581165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65134837|NCT00581165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134838|NCT00581165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65300528|NCT03800381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65300529|NCT03800381|Antimetabolites|antimetabolites|mesh-ancestor
65300530|NCT03800381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65300531|NCT00489853|Budesonide|budesonide|mesh-list
65300532|NCT00489853|Formoterol Fumarate|formoterol fumarate|mesh-list
65300533|NCT00489853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65300534|NCT00489853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65300535|NCT00489853|Autonomic Agents|autonomic agents|mesh-ancestor
65300536|NCT00489853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65300537|NCT00489853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300538|NCT00489853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65300539|NCT00489853|Respiratory System Agents|respiratory system agents|mesh-ancestor
65300540|NCT00489853|Glucocorticoids|glucocorticoids|mesh-ancestor
65300541|NCT00489853|Hormones|hormones|mesh-ancestor
65300542|NCT00489853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65300543|NCT00489853|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65300544|NCT00489853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65300545|NCT00489853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65300546|NCT00489853|Adrenergic Agents|adrenergic agents|mesh-ancestor
65050443|NCT04591444|Fluorides|fluorides|mesh-list
65300547|NCT00489853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65300548|NCT00489853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300550|NCT00682136|Anesthetics, Local|anesthetics, local|mesh-ancestor
65300551|NCT00682136|Anesthetics|anesthetics|mesh-ancestor
64530615|NCT05418556|Aspirin|aspirin|mesh-list
65134839|NCT00581165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65134840|NCT00581165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65134841|NCT00581165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65134842|NCT00581165|Immunologic Factors|immunologic factors|mesh-ancestor
65134843|NCT05092984|Spironolactone|spironolactone|mesh-list
65134844|NCT05092984|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65134845|NCT05092984|Hormone Antagonists|hormone antagonists|mesh-ancestor
65134846|NCT05092984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65134847|NCT05092984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134848|NCT05092984|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65134849|NCT05092984|Diuretics|diuretics|mesh-ancestor
65134850|NCT05092984|Natriuretic Agents|natriuretic agents|mesh-ancestor
65134851|NCT02213159|Dexmedetomidine|dexmedetomidine|mesh-list
65134852|NCT02213159|Morphine|morphine|mesh-list
64777351|NCT02047032|Cholinergic Agents|cholinergic agents|mesh-ancestor
65134853|NCT02213159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65134854|NCT02213159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65134855|NCT02213159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134856|NCT02213159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65134857|NCT02213159|Analgesics|analgesics|mesh-ancestor
65134858|NCT02213159|Sensory System Agents|sensory system agents|mesh-ancestor
65134859|NCT02213159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65134860|NCT02213159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65134861|NCT02213159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65134862|NCT02213159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64530633|NCT05418556|Antipyretics|antipyretics|mesh-ancestor
65300552|NCT00682136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65300553|NCT00682136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300554|NCT00682136|Sensory System Agents|sensory system agents|mesh-ancestor
65300555|NCT00682136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65300556|NCT00693056|beta-Lactams|beta-lactams|mesh-list
65300557|NCT00693056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65300558|NCT00693056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65300559|NCT04137302|Hydrocortisone|hydrocortisone|mesh-list
65300560|NCT04137302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65300561|NCT04145336|Indomethacin|indomethacin|mesh-list
65300562|NCT04145336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64530634|NCT05418556|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65134863|NCT02213159|Adrenergic Agents|adrenergic agents|mesh-ancestor
65134864|NCT02213159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65134865|NCT02213159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134866|NCT02213159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65134867|NCT02213159|Narcotics|narcotics|mesh-ancestor
65134868|NCT01118455|Anticonvulsants|anticonvulsants|mesh-list
65134872|NCT02219100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65134873|NCT02219100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134874|NCT02219100|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65134876|NCT02219100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65134877|NCT02219100|Contraceptive Agents|contraceptive agents|mesh-ancestor
65134878|NCT02219100|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65134879|NCT02219100|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65134880|NCT02219100|Hormone Antagonists|hormone antagonists|mesh-ancestor
65134881|NCT02219100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65134882|NCT02219100|Luteolytic Agents|luteolytic agents|mesh-ancestor
65134883|NCT02219100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65134884|NCT02219100|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65134885|NCT01118377|Capecitabine|capecitabine|mesh-list
65134886|NCT01118377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65134887|NCT01118377|Antimetabolites|antimetabolites|mesh-ancestor
65134888|NCT01118377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134889|NCT01118377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134890|NCT02219178|Dexamethasone|dexamethasone|mesh-list
65134891|NCT02219178|Lenalidomide|lenalidomide|mesh-list
65134893|NCT02219178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65134894|NCT02219178|Antiemetics|antiemetics|mesh-ancestor
65134895|NCT02219178|Autonomic Agents|autonomic agents|mesh-ancestor
65134896|NCT02219178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65134897|NCT02219178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134898|NCT02219178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65134899|NCT02219178|Glucocorticoids|glucocorticoids|mesh-ancestor
65134900|NCT02219178|Hormones|hormones|mesh-ancestor
65134901|NCT02219178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65134902|NCT02219178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65134903|NCT02219178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134904|NCT02219178|Immunologic Factors|immunologic factors|mesh-ancestor
65134905|NCT02219178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65134906|NCT02219178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65134907|NCT02219178|Growth Substances|growth substances|mesh-ancestor
65134908|NCT02219178|Growth Inhibitors|growth inhibitors|mesh-ancestor
65134909|NCT02213315|Mavrilimumab|mavrilimumab|mesh-list
65134910|NCT02213315|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65134911|NCT02213315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65134912|NCT02213315|Immunologic Factors|immunologic factors|mesh-ancestor
65134913|NCT02213315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134914|NCT02219217|Dolutegravir|dolutegravir|mesh-list
65134915|NCT02219217|Cobicistat|cobicistat|mesh-list
64530641|NCT05400109|Fludarabine phosphate|fludarabine phosphate|mesh-list
64530642|NCT05400109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65300563|NCT04145336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65300564|NCT04145336|Analgesics|analgesics|mesh-ancestor
65300565|NCT04145336|Sensory System Agents|sensory system agents|mesh-ancestor
65300566|NCT04145336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65300567|NCT04145336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300568|NCT04145336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65300569|NCT04145336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65300570|NCT04145336|Gout Suppressants|gout suppressants|mesh-ancestor
65300571|NCT04145336|Tocolytic Agents|tocolytic agents|mesh-ancestor
65300572|NCT04145336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65300573|NCT04145336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65300574|NCT04145336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300575|NCT04145336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300576|NCT00499681|Letrozole|letrozole|mesh-list
65300577|NCT00499681|Lapatinib|lapatinib|mesh-list
65300578|NCT00499681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300579|NCT00499681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65300580|NCT00499681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65300581|NCT00499681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530643|NCT05400109|Immunologic Factors|immunologic factors|mesh-ancestor
65134916|NCT02219217|Elvitegravir|elvitegravir|mesh-list
65134917|NCT02219217|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65134918|NCT02219217|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65134919|NCT02219217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134920|NCT02219217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134921|NCT02219217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65134922|NCT02219217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65134923|NCT02219217|Antiviral Agents|antiviral agents|mesh-ancestor
65134924|NCT02219217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134925|NCT02219217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65134926|NCT02219217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65134927|NCT04577378|Itraconazole|itraconazole|mesh-list
65134928|NCT04577378|Tretinoin|tretinoin|mesh-list
65134930|NCT04577378|Antifungal Agents|antifungal agents|mesh-ancestor
65134931|NCT04577378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134932|NCT04577378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65134933|NCT04577378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65134934|NCT04577378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134935|NCT04577378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134936|NCT04577378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65134937|NCT04577378|Hormone Antagonists|hormone antagonists|mesh-ancestor
65134938|NCT04577378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65134939|NCT04577378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134940|NCT04577378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65134947|NCT02219412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65134948|NCT02219412|Analgesics|analgesics|mesh-ancestor
65134949|NCT02219412|Sensory System Agents|sensory system agents|mesh-ancestor
65134950|NCT02219412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65134951|NCT02219412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134952|NCT02219412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65300582|NCT00499681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300583|NCT00499681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65300584|NCT00499681|Hormone Antagonists|hormone antagonists|mesh-ancestor
65300585|NCT00499681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65300586|NCT00499681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300587|NCT00499681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65300588|NCT02687009|Niclosamide|niclosamide|mesh-list
65300589|NCT02687009|Anticestodal Agents|anticestodal agents|mesh-ancestor
65300590|NCT02687009|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65300591|NCT02687009|Anthelmintics|anthelmintics|mesh-ancestor
65300592|NCT02687009|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65300593|NCT02687009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65300594|NCT02687009|Antinematodal Agents|antinematodal agents|mesh-ancestor
65300595|NCT00693212|Methylphenidate|methylphenidate|mesh-list
65300596|NCT00693212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65300597|NCT00693212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300598|NCT00693212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65300599|NCT00693212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65300600|NCT00693212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65300601|NCT00693212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300602|NCT00693212|Dopamine Agents|dopamine agents|mesh-ancestor
65300603|NCT00693212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65300604|NCT00688298|Imidacloprid|imidacloprid|mesh-list
65300605|NCT00688298|Cholinergic Agents|cholinergic agents|mesh-ancestor
65300606|NCT00688298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65300607|NCT00688298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300608|NCT00688298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300609|NCT00499603|Paclitaxel|paclitaxel|mesh-list
65300610|NCT00499603|Cyclophosphamide|cyclophosphamide|mesh-list
65300611|NCT00499603|Fluorouracil|fluorouracil|mesh-list
65300612|NCT00499603|Epirubicin|epirubicin|mesh-list
65300613|NCT00499603|Everolimus|everolimus|mesh-list
65300614|NCT00499603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65300615|NCT00499603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300616|NCT00499603|Tubulin Modulators|tubulin modulators|mesh-ancestor
65300617|NCT00499603|Antimitotic Agents|antimitotic agents|mesh-ancestor
65134953|NCT02219412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65300618|NCT00499603|Mitosis Modulators|mitosis modulators|mesh-ancestor
65300619|NCT00499603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300620|NCT00499603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65300621|NCT00499603|Immunologic Factors|immunologic factors|mesh-ancestor
65300622|NCT00499603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300623|NCT00499603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65300624|NCT00499603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65300625|NCT00499603|Alkylating Agents|alkylating agents|mesh-ancestor
65300626|NCT00499603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65300627|NCT00499603|Antimetabolites|antimetabolites|mesh-ancestor
65300628|NCT00499603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65300629|NCT00499603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65300630|NCT00499603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65300631|NCT00499603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65300632|NCT00499603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300633|NCT01946711|Budesonide|budesonide|mesh-list
65300634|NCT01946711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65300635|NCT01946711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65300673|NCT00693524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65300674|NCT00693524|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65300675|NCT00693524|Antitubercular Agents|antitubercular agents|mesh-ancestor
65300676|NCT00693524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65300677|NCT00693524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65300678|NCT00693602|Asparaginase|asparaginase|mesh-list
65300679|NCT00693602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300680|NCT00682214|Vitamin D|vitamin d|mesh-list
65300681|NCT00682214|Cholecalciferol|cholecalciferol|mesh-list
65300682|NCT00682214|Vitamins|vitamins|mesh-ancestor
65300683|NCT00682214|Micronutrients|micronutrients|mesh-ancestor
65300684|NCT00682214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300685|NCT00682214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65300735|NCT00693758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65300736|NCT00693758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300737|NCT00693758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65300738|NCT00693758|Vasodilator Agents|vasodilator agents|mesh-ancestor
65300739|NCT00693758|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65300740|NCT00693758|Purinergic Agonists|purinergic agonists|mesh-ancestor
65300741|NCT00693758|Purinergic Agents|purinergic agents|mesh-ancestor
65300742|NCT00693758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65300743|NCT00693758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300744|NCT02625740|Paclitaxel|paclitaxel|mesh-list
65300745|NCT02625740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65300746|NCT02625740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300747|NCT02625740|Tubulin Modulators|tubulin modulators|mesh-ancestor
65300748|NCT02625740|Antimitotic Agents|antimitotic agents|mesh-ancestor
65300749|NCT02625740|Mitosis Modulators|mitosis modulators|mesh-ancestor
65300750|NCT02625740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300751|NCT00688922|Pravastatin|pravastatin|mesh-list
65300752|NCT00688922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64530800|NCT05218733|Anesthetics, General|anesthetics, general|mesh-ancestor
64530801|NCT05169593|Adalimumab|adalimumab|mesh-list
65134954|NCT02219412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65134955|NCT02219412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65134956|NCT02219412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134957|NCT02219412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65134958|NCT02219412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65134959|NCT02219412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134960|NCT02219412|Antipyretics|antipyretics|mesh-ancestor
65134961|NCT02219412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65134962|NCT02219412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65134963|NCT02219412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65134964|NCT02219412|Purinergic Agents|purinergic agents|mesh-ancestor
65134965|NCT02219412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65134966|NCT04577027|Travoprost|travoprost|mesh-list
65134967|NCT04577027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65134968|NCT02211690|Tenofovir|tenofovir|mesh-list
65134969|NCT02211690|Emtricitabine|emtricitabine|mesh-list
65134970|NCT02211690|Dolutegravir|dolutegravir|mesh-list
65134971|NCT02211690|Antiviral Agents|antiviral agents|mesh-ancestor
65134972|NCT02211690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134973|NCT02211690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65134974|NCT02211690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65134975|NCT02211690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134976|NCT02211690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134977|NCT02211690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65134978|NCT02211690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65134979|NCT02211690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65134980|NCT02211690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65134981|NCT04553393|Decitabine|decitabine|mesh-list
65134982|NCT04553393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65134983|NCT04553393|Antimetabolites|antimetabolites|mesh-ancestor
65134984|NCT04553393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134985|NCT04553393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134986|NCT04553393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134987|NCT02211846|Mirabegron|mirabegron|mesh-list
65300753|NCT00688922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65300754|NCT00688922|Antimetabolites|antimetabolites|mesh-ancestor
65300755|NCT00688922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300756|NCT00688922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65300757|NCT00688922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65300758|NCT00688922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300759|NCT00694148|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65300760|NCT00694148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65300761|NCT00694148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64530821|NCT05152147|Immunologic Factors|immunologic factors|mesh-ancestor
65134988|NCT02211846|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65134989|NCT02211846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65134990|NCT02211846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65134991|NCT02211846|Adrenergic Agents|adrenergic agents|mesh-ancestor
65134992|NCT02211846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65134993|NCT02211846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134994|NCT02211846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134995|NCT02211846|Urological Agents|urological agents|mesh-ancestor
65134996|NCT02219646|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65134997|NCT02219646|Vasodilator Agents|vasodilator agents|mesh-ancestor
65134998|NCT02219646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65134999|NCT02219646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65135000|NCT02219646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135001|NCT02219646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135002|NCT02219646|Urological Agents|urological agents|mesh-ancestor
65135003|NCT04553510|Bevacizumab|bevacizumab|mesh-list
65135004|NCT04553510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64668139|NCT02987465|Norepinephrine|norepinephrine|mesh-list
65135005|NCT04553510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135006|NCT04553510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65135007|NCT04553510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65135008|NCT04553510|Growth Substances|growth substances|mesh-ancestor
65135009|NCT04553510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707551|NCT04562792|Daunorubicin|daunorubicin|mesh-list
65135012|NCT03453281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65135013|NCT03453281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65135014|NCT03453281|Growth Substances|growth substances|mesh-ancestor
65135015|NCT03453281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135016|NCT03453281|Growth Inhibitors|growth inhibitors|mesh-ancestor
65135017|NCT03453281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135018|NCT01642134|Aspirin|aspirin|mesh-list
65135019|NCT01642134|Clopidogrel|clopidogrel|mesh-list
65135020|NCT01642134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65135021|NCT01642134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65135022|NCT01642134|Analgesics|analgesics|mesh-ancestor
65135023|NCT01642134|Sensory System Agents|sensory system agents|mesh-ancestor
65135024|NCT01642134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65135025|NCT01642134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135026|NCT01642134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65135027|NCT01642134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65135028|NCT01642134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65135029|NCT01642134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65135030|NCT01642134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135031|NCT01642134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65135032|NCT01642134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65135033|NCT01642134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135034|NCT01642134|Antipyretics|antipyretics|mesh-ancestor
65135035|NCT01642134|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65135036|NCT01642134|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65135037|NCT01642134|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65135038|NCT01642134|Purinergic Agents|purinergic agents|mesh-ancestor
65135039|NCT01642134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65300762|NCT00694148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300763|NCT00694148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65300764|NCT00694148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65300765|NCT00694148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300766|NCT00694148|Cholinergic Agents|cholinergic agents|mesh-ancestor
65300767|NCT00694148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65300768|NCT02626364|Crenolanib|crenolanib|mesh-list
65300769|NCT02626364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300770|NCT00694460|Vaccines|vaccines|mesh-list
65300771|NCT00694460|Immunologic Factors|immunologic factors|mesh-ancestor
65300772|NCT00694460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300773|NCT04776525|Doxorubicin|doxorubicin|mesh-list
65300774|NCT04776525|Ifosfamide|ifosfamide|mesh-list
64530832|NCT05145413|Cholinergic Agents|cholinergic agents|mesh-ancestor
65135040|NCT00581789|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65135041|NCT00581789|Sunitinib|sunitinib|mesh-list
65135042|NCT00581789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135043|NCT00581789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65135044|NCT00581789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135045|NCT00581789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135046|NCT00581789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65135047|NCT00581789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65135048|NCT00581789|Growth Substances|growth substances|mesh-ancestor
65135049|NCT00581789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135050|NCT00581789|Growth Inhibitors|growth inhibitors|mesh-ancestor
65135051|NCT02213588|Antioxidants|antioxidants|mesh-list
65135052|NCT02213588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135053|NCT02213588|Protective Agents|protective agents|mesh-ancestor
65135054|NCT02213588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135055|NCT01642524|Dextrans|dextrans|mesh-list
65135056|NCT01642524|Anticoagulants|anticoagulants|mesh-ancestor
65135057|NCT01642524|Plasma Substitutes|plasma substitutes|mesh-ancestor
65135058|NCT01642524|Blood Substitutes|blood substitutes|mesh-ancestor
65135059|NCT02213783|Imipenem|imipenem|mesh-list
65135060|NCT02213783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65135061|NCT02213783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65135062|NCT04552613|Carboplatin|carboplatin|mesh-list
65135063|NCT04552613|Pemetrexed|pemetrexed|mesh-list
65135064|NCT04552613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135065|NCT04552613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135066|NCT04552613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135067|NCT04552613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65135068|NCT04552613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65135069|NCT02213328|Tenofovir|tenofovir|mesh-list
65135070|NCT02213328|Emtricitabine|emtricitabine|mesh-list
65135071|NCT02213328|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65135072|NCT02213328|Antiviral Agents|antiviral agents|mesh-ancestor
65135073|NCT02213328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65135074|NCT02213328|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65135075|NCT02213328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65135076|NCT02213328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135077|NCT02213328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135078|NCT02213328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65135079|NCT02213328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65135080|NCT01117987|Imatinib Mesylate|imatinib mesylate|mesh-list
65135081|NCT01117987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135082|NCT01117987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65135086|NCT02219490|Ribavirin|ribavirin|mesh-list
65135087|NCT02219490|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65135088|NCT02219490|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65135089|NCT02219490|Protease Inhibitors|protease inhibitors|mesh-ancestor
65135090|NCT02219490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300775|NCT04776525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65300776|NCT04776525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300777|NCT04776525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65300778|NCT04776525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65300779|NCT04776525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300780|NCT04776525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300781|NCT04776525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65300782|NCT04776525|Alkylating Agents|alkylating agents|mesh-ancestor
65300783|NCT00689000|Tosedostat|tosedostat|mesh-list
65300784|NCT00689000|Glycine|glycine|mesh-list
65300785|NCT00689000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300786|NCT00689000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300787|NCT00689000|Glycine Agents|glycine agents|mesh-ancestor
65300788|NCT00689000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65300789|NCT00689000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300790|NCT00489541|Paclitaxel|paclitaxel|mesh-list
65300791|NCT00489541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65300792|NCT00489541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300793|NCT00489541|Tubulin Modulators|tubulin modulators|mesh-ancestor
65300794|NCT00489541|Antimitotic Agents|antimitotic agents|mesh-ancestor
65300795|NCT00489541|Mitosis Modulators|mitosis modulators|mesh-ancestor
65300796|NCT00489541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300797|NCT00689156|Cyclophosphamide|cyclophosphamide|mesh-list
65300798|NCT00689156|Docetaxel|docetaxel|mesh-list
65300799|NCT00689156|Epirubicin|epirubicin|mesh-list
65300800|NCT00689156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65300801|NCT00689156|Immunologic Factors|immunologic factors|mesh-ancestor
65300802|NCT00689156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300803|NCT00689156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65135091|NCT02219490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135092|NCT02219490|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65135093|NCT02219490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65135094|NCT02219490|Antiviral Agents|antiviral agents|mesh-ancestor
65135095|NCT02219490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65135096|NCT02219490|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65135097|NCT02219490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65135098|NCT02219490|Antimetabolites|antimetabolites|mesh-ancestor
65135099|NCT01117051|Prucalopride|prucalopride|mesh-list
65135100|NCT01117051|Laxatives|laxatives|mesh-ancestor
65135101|NCT01117051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65135102|NCT01117051|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65135103|NCT01117051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65135104|NCT01117051|Serotonin Agents|serotonin agents|mesh-ancestor
65135105|NCT01117051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65135106|NCT01117051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135107|NCT01117051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300804|NCT00689156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65300805|NCT00689156|Alkylating Agents|alkylating agents|mesh-ancestor
65300806|NCT00689156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300807|NCT00689156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300808|NCT00689156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65300809|NCT00689156|Tubulin Modulators|tubulin modulators|mesh-ancestor
65300810|NCT00689156|Antimitotic Agents|antimitotic agents|mesh-ancestor
65300811|NCT00689156|Mitosis Modulators|mitosis modulators|mesh-ancestor
65300812|NCT00689156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65300813|NCT00689156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65300814|NCT00689156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65300815|NCT00689156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300816|NCT04773873|Lithium Carbonate|lithium carbonate|mesh-list
65300817|NCT04773873|Antidepressive Agents|antidepressive agents|mesh-ancestor
65300818|NCT04773873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65300819|NCT04773873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530876|NCT05039801|Antibodies|antibodies|mesh-list
65135108|NCT02211417|Evening primrose oil|evening primrose oil|mesh-list
65135109|NCT02211417|Mineral Oil|mineral oil|mesh-list
65135110|NCT02211417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65135111|NCT02211417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65135112|NCT02211417|Analgesics|analgesics|mesh-ancestor
65135113|NCT02211417|Sensory System Agents|sensory system agents|mesh-ancestor
65135114|NCT02211417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65135115|NCT02211417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135116|NCT02211417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65135117|NCT02211417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65135118|NCT02211417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65135119|NCT02211417|Antimetabolites|antimetabolites|mesh-ancestor
65135120|NCT02211417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135121|NCT02211417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65135122|NCT02211417|Dermatologic Agents|dermatologic agents|mesh-ancestor
65135123|NCT02211417|Emollients|emollients|mesh-ancestor
65135124|NCT02279121|Taurolidine|taurolidine|mesh-list
65135125|NCT02279121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65135126|NCT02279121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65135127|NCT02279121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65135128|NCT02279121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135129|NCT02218164|Interferons|interferons|mesh-list
65135130|NCT02218164|Interferon-alpha|interferon-alpha|mesh-list
65135131|NCT02218164|Interferon alpha-2|interferon alpha-2|mesh-list
65135132|NCT02218164|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65135133|NCT02218164|Fluorouracil|fluorouracil|mesh-list
65135134|NCT02218164|Capecitabine|capecitabine|mesh-list
65135135|NCT02218164|Antimetabolites|antimetabolites|mesh-ancestor
65135136|NCT02218164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135137|NCT02218164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65135138|NCT02218164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135139|NCT02218164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65135140|NCT02218164|Immunologic Factors|immunologic factors|mesh-ancestor
65135141|NCT02218164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135142|NCT02218164|Antiviral Agents|antiviral agents|mesh-ancestor
65135143|NCT02218164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65135144|NCT04552067|Enoxaparin|enoxaparin|mesh-list
65135145|NCT04552067|Anticoagulants|anticoagulants|mesh-ancestor
65135146|NCT04552067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65135147|NCT04552067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65135148|NCT04552067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135149|NCT01643187|Vitamins|vitamins|mesh-list
65300820|NCT04773873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300821|NCT04773873|Antimanic Agents|antimanic agents|mesh-ancestor
65300822|NCT04773873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65300823|NCT04773873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65300824|NCT04773873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300825|NCT01016821|Oxycodone|oxycodone|mesh-list
65300826|NCT01016821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65300827|NCT01016821|Narcotics|narcotics|mesh-ancestor
65300828|NCT01016821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65300829|NCT01016821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300830|NCT01016821|Analgesics|analgesics|mesh-ancestor
65300831|NCT01016821|Sensory System Agents|sensory system agents|mesh-ancestor
65300832|NCT01016821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65300833|NCT01011205|Mycophenolic Acid|mycophenolic acid|mesh-list
65300834|NCT01011205|Methylprednisolone|methylprednisolone|mesh-list
65300835|NCT01011205|Tacrolimus|tacrolimus|mesh-list
65300836|NCT01011205|Basiliximab|basiliximab|mesh-list
65300837|NCT01011205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65300838|NCT01011205|Immunologic Factors|immunologic factors|mesh-ancestor
65300839|NCT01011205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300840|NCT01011205|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65300841|NCT01011205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300842|NCT01011205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300843|NCT01011205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65300844|NCT01011205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050742|NCT04587505|Morphine|morphine|mesh-list
65300845|NCT01011205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65135150|NCT01643187|Micronutrients|micronutrients|mesh-ancestor
65135151|NCT01643187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135152|NCT01643265|Caseins|caseins|mesh-list
65135153|NCT01643265|Chelating Agents|chelating agents|mesh-ancestor
65135154|NCT01643265|Sequestering Agents|sequestering agents|mesh-ancestor
65135155|NCT01643265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135165|NCT04551755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65135166|NCT04551755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65135167|NCT04551755|Antimalarials|antimalarials|mesh-ancestor
65135168|NCT04551755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65135169|NCT04551755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65135170|NCT01643499|Leucovorin|leucovorin|mesh-list
65135171|NCT01643499|Fluorouracil|fluorouracil|mesh-list
65135172|NCT01643499|Oxaliplatin|oxaliplatin|mesh-list
65135173|NCT01643499|Irinotecan|irinotecan|mesh-list
65135174|NCT01643499|Calcium|calcium|mesh-list
65135175|NCT01643499|Levoleucovorin|levoleucovorin|mesh-list
65135176|NCT01643499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65135177|NCT01643499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135178|NCT01643499|Antimetabolites|antimetabolites|mesh-ancestor
65135179|NCT01643499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135180|NCT01643499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65135181|NCT01643499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300846|NCT01011205|Antitubercular Agents|antitubercular agents|mesh-ancestor
65300847|NCT01011205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65300848|NCT01011205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65300849|NCT01011205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65300850|NCT01011205|Antiemetics|antiemetics|mesh-ancestor
65300851|NCT01011205|Autonomic Agents|autonomic agents|mesh-ancestor
65300852|NCT01011205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65300853|NCT01011205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65300854|NCT01011205|Glucocorticoids|glucocorticoids|mesh-ancestor
65300855|NCT01011205|Hormones|hormones|mesh-ancestor
65300856|NCT01011205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65300857|NCT01011205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65300858|NCT01011205|Protective Agents|protective agents|mesh-ancestor
65300859|NCT00809835|Galantamine|galantamine|mesh-list
65300860|NCT00809835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65300861|NCT00809835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300862|NCT00809835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300863|NCT00809835|Cholinergic Agents|cholinergic agents|mesh-ancestor
65300864|NCT00809835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65300865|NCT00809835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300866|NCT00809835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65300867|NCT00809835|Autonomic Agents|autonomic agents|mesh-ancestor
65300868|NCT00809835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65300869|NCT00809835|Nootropic Agents|nootropic agents|mesh-ancestor
65300870|NCT01014559|Oxycodone|oxycodone|mesh-list
65300871|NCT01014559|Naloxone|naloxone|mesh-list
65300872|NCT01014559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65300873|NCT01014559|Narcotics|narcotics|mesh-ancestor
65300874|NCT01014559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65300875|NCT01014559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135182|NCT01643499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65135183|NCT01643499|Immunologic Factors|immunologic factors|mesh-ancestor
65135184|NCT01643499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65135185|NCT01643499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65135186|NCT01643499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135187|NCT01643499|Antidotes|antidotes|mesh-ancestor
65135188|NCT01643499|Protective Agents|protective agents|mesh-ancestor
65135189|NCT01643499|Vitamin B Complex|vitamin b complex|mesh-ancestor
65135190|NCT01643499|Vitamins|vitamins|mesh-ancestor
65135191|NCT01643499|Micronutrients|micronutrients|mesh-ancestor
65135192|NCT01117012|Ivacaftor|ivacaftor|mesh-list
65135193|NCT01117012|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65135194|NCT01117012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65135195|NCT01117012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135196|NCT01116739|Fluorides|fluorides|mesh-list
65135197|NCT01116739|Fluorides, Topical|fluorides, topical|mesh-list
65135198|NCT01116739|Cariostatic Agents|cariostatic agents|mesh-ancestor
65300876|NCT01014559|Analgesics|analgesics|mesh-ancestor
65300877|NCT01014559|Sensory System Agents|sensory system agents|mesh-ancestor
65300878|NCT01014559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65300879|NCT01014559|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65300880|NCT00853242|Sevelamer|sevelamer|mesh-list
65300881|NCT00853242|Chelating Agents|chelating agents|mesh-ancestor
65300882|NCT00853242|Sequestering Agents|sequestering agents|mesh-ancestor
65300883|NCT00853242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300884|NCT04704063|Vitamin E|vitamin e|mesh-list
65300885|NCT04704063|Tocopherols|tocopherols|mesh-list
65300886|NCT04704063|Tocotrienols|tocotrienols|mesh-list
65300887|NCT04704063|Tocovid|tocovid|mesh-list
65300888|NCT04704063|Vitamins|vitamins|mesh-ancestor
65300889|NCT04704063|Micronutrients|micronutrients|mesh-ancestor
65300890|NCT04704063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300891|NCT04704063|Antioxidants|antioxidants|mesh-ancestor
65300892|NCT04704063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300893|NCT04704063|Protective Agents|protective agents|mesh-ancestor
65300894|NCT02609061|Alendronate|alendronate|mesh-list
65300895|NCT02609061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65300896|NCT02609061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300897|NCT00848250|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65300898|NCT00848250|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64530955|NCT04929626|Adrenergic Agents|adrenergic agents|mesh-ancestor
65135199|NCT01116739|Protective Agents|protective agents|mesh-ancestor
65135200|NCT01116739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135201|NCT01640496|Vitamin D|vitamin d|mesh-list
65135202|NCT01640496|Cholecalciferol|cholecalciferol|mesh-list
65135203|NCT01640496|Vitamins|vitamins|mesh-ancestor
65135204|NCT01640496|Micronutrients|micronutrients|mesh-ancestor
65135205|NCT01640496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135206|NCT01640496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65135207|NCT01640496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65135208|NCT04551248|Vaccines|vaccines|mesh-list
65135209|NCT04551248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65135210|NCT04551248|Immunologic Factors|immunologic factors|mesh-ancestor
65135211|NCT04551248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135212|NCT01640535|Cetirizine|cetirizine|mesh-list
65135213|NCT01640535|Montelukast|montelukast|mesh-list
65135214|NCT01640535|Levocetirizine|levocetirizine|mesh-list
65135215|NCT01640535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65135216|NCT01640535|Respiratory System Agents|respiratory system agents|mesh-ancestor
65135217|NCT01640535|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65135218|NCT01640535|Hormone Antagonists|hormone antagonists|mesh-ancestor
65135219|NCT01640535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65135220|NCT01640535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135221|NCT01640535|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65135222|NCT01640535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65135223|NCT01640535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135237|NCT04550858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135238|NCT04550858|Protective Agents|protective agents|mesh-ancestor
65135239|NCT04550858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135240|NCT04550858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300899|NCT00848250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300900|NCT00848250|Protease Inhibitors|protease inhibitors|mesh-ancestor
65300901|NCT00694694|Azithromycin|azithromycin|mesh-list
65300902|NCT00694694|Artesunate|artesunate|mesh-list
65300903|NCT00694694|Lumefantrine|lumefantrine|mesh-list
65300904|NCT00694694|Artemether|artemether|mesh-list
65300905|NCT00694694|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65300906|NCT00694694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65300907|NCT00694694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65300908|NCT00694694|Antimalarials|antimalarials|mesh-ancestor
65300909|NCT00694694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65300910|NCT00694694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65135242|NCT01640574|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65135243|NCT01640574|Piperaquine|piperaquine|mesh-list
65135244|NCT01640574|Artenimol|artenimol|mesh-list
65135245|NCT01640574|Artemisinins|artemisinins|mesh-list
65135246|NCT01640574|Amebicides|amebicides|mesh-ancestor
65135247|NCT01640574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65135248|NCT01640574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65135249|NCT01640574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65135250|NCT01640574|Antimalarials|antimalarials|mesh-ancestor
65135251|NCT01640574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65135252|NCT01640574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65135253|NCT01640574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65135254|NCT01640574|Analgesics|analgesics|mesh-ancestor
65135255|NCT01640574|Sensory System Agents|sensory system agents|mesh-ancestor
65135256|NCT01640574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65135257|NCT01640574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135258|NCT01640574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65135259|NCT01640574|Filaricides|filaricides|mesh-ancestor
65135260|NCT01640574|Antinematodal Agents|antinematodal agents|mesh-ancestor
65135261|NCT01640574|Anthelmintics|anthelmintics|mesh-ancestor
65135262|NCT01116427|Abatacept|abatacept|mesh-list
65135263|NCT01116427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65135264|NCT01116427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135265|NCT01116427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135266|NCT01116427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65135267|NCT01116427|Immunologic Factors|immunologic factors|mesh-ancestor
65135268|NCT01116427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135269|NCT01116427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65135270|NCT04529226|Haloperidol|haloperidol|mesh-list
65135271|NCT04529226|Pimozide|pimozide|mesh-list
65135272|NCT04529226|Olanzapine|olanzapine|mesh-list
65135273|NCT04529226|Risperidone|risperidone|mesh-list
65135274|NCT04529226|Haloperidol decanoate|haloperidol decanoate|mesh-list
65135275|NCT04529226|Clozapine|clozapine|mesh-list
65135276|NCT04529226|Amisulpride|amisulpride|mesh-list
65135277|NCT04529226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65135278|NCT04529226|Serotonin Agents|serotonin agents|mesh-ancestor
65135279|NCT04529226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65135280|NCT04529226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135281|NCT04529226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135282|NCT04529226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65135283|NCT04529226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65135284|NCT04529226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65135285|NCT04529226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65135286|NCT04529226|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65135287|NCT04529226|Dopamine Agents|dopamine agents|mesh-ancestor
65135293|NCT04529226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65135294|NCT04529226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65135295|NCT04529226|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65135296|NCT04529226|GABA Antagonists|gaba antagonists|mesh-ancestor
65135297|NCT04529226|GABA Agents|gaba agents|mesh-ancestor
65135298|NCT04529226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65135299|NCT04529226|Antidepressive Agents|antidepressive agents|mesh-ancestor
65135300|NCT04310683|Hormones|hormones|mesh-list
65300911|NCT00694694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300912|NCT00694694|Antiviral Agents|antiviral agents|mesh-ancestor
65300913|NCT00694694|Schistosomicides|schistosomicides|mesh-ancestor
65300914|NCT00694694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65300915|NCT00694694|Anthelmintics|anthelmintics|mesh-ancestor
65300916|NCT00700362|Insulin|insulin|mesh-list
65300917|NCT00700362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65300918|NCT00700362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300919|NCT04136600|Antibodies|antibodies|mesh-list
65300920|NCT04136600|Immunologic Factors|immunologic factors|mesh-ancestor
65300921|NCT04136600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300922|NCT00809757|Albuterol|albuterol|mesh-list
65300923|NCT00809757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65300924|NCT00809757|Autonomic Agents|autonomic agents|mesh-ancestor
65300925|NCT00809757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65300926|NCT00809757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135301|NCT04310683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65135302|NCT04310683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135303|NCT04550702|Mirabegron|mirabegron|mesh-list
65135304|NCT04550702|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65135305|NCT04550702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65135306|NCT04550702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65135307|NCT04550702|Adrenergic Agents|adrenergic agents|mesh-ancestor
65135308|NCT04550702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65135309|NCT04550702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135310|NCT04550702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135311|NCT04550702|Urological Agents|urological agents|mesh-ancestor
65135312|NCT01116232|Sirolimus|sirolimus|mesh-list
65135313|NCT01116232|Rituximab|rituximab|mesh-list
65135314|NCT01116232|Tacrolimus|tacrolimus|mesh-list
65135315|NCT01116232|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65135316|NCT01116232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65135317|NCT01116232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135318|NCT01116232|Immunologic Factors|immunologic factors|mesh-ancestor
65135319|NCT01116232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135320|NCT01116232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65135321|NCT01116232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65135322|NCT01116232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65135323|NCT01116232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135324|NCT01116232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135325|NCT01116232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65135326|NCT01116232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65135327|NCT01116232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65135328|NCT01116232|Antifungal Agents|antifungal agents|mesh-ancestor
65135329|NCT02214095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65135330|NCT04550351|Vaccines|vaccines|mesh-list
65135331|NCT04550351|Immunologic Factors|immunologic factors|mesh-ancestor
65135332|NCT04550351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135333|NCT04550234|Allopurinol|allopurinol|mesh-list
65135334|NCT04550234|Verinurad|verinurad|mesh-list
65135335|NCT04550234|Antimetabolites|antimetabolites|mesh-ancestor
65135336|NCT04550234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135337|NCT04550234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135338|NCT04550234|Gout Suppressants|gout suppressants|mesh-ancestor
65135339|NCT04550234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65135340|NCT04550234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65135341|NCT04550234|Antioxidants|antioxidants|mesh-ancestor
65135342|NCT04550234|Protective Agents|protective agents|mesh-ancestor
65135343|NCT04550234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135344|NCT01640691|Vaccines|vaccines|mesh-list
65135345|NCT01640691|Immunologic Factors|immunologic factors|mesh-ancestor
65300927|NCT00809757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65300928|NCT00809757|Respiratory System Agents|respiratory system agents|mesh-ancestor
65300929|NCT00809757|Tocolytic Agents|tocolytic agents|mesh-ancestor
65300930|NCT00809757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65300931|NCT00809757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65300932|NCT00809757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65300933|NCT00809757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65300934|NCT00809757|Adrenergic Agents|adrenergic agents|mesh-ancestor
65300935|NCT00809757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65300936|NCT00809757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300937|NCT00594464|Rotigotine|rotigotine|mesh-list
65300938|NCT00594464|Dopamine Agonists|dopamine agonists|mesh-ancestor
65300939|NCT00594464|Dopamine Agents|dopamine agents|mesh-ancestor
65300940|NCT00594464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65300941|NCT00594464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300942|NCT00594464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300943|NCT00682760|Botulinum Toxins|botulinum toxins|mesh-list
65300944|NCT00682760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65300945|NCT00682760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65135346|NCT01640691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135347|NCT01643889|Moxifloxacin|moxifloxacin|mesh-list
65135348|NCT01643889|Domperidone|domperidone|mesh-list
65135349|NCT01643889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65135350|NCT01643889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65135351|NCT01643889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65135352|NCT01643889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65135353|NCT01643889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135354|NCT01643889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135355|NCT01643889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135356|NCT01643889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135357|NCT01643889|Antiemetics|antiemetics|mesh-ancestor
65135358|NCT01643889|Autonomic Agents|autonomic agents|mesh-ancestor
65135360|NCT01643889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65135361|NCT01643889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65135362|NCT01643889|Dopamine Agents|dopamine agents|mesh-ancestor
65135363|NCT01643889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65135364|NCT04550078|Calcium, Dietary|calcium, dietary|mesh-list
65135365|NCT04550078|Calcium Carbonate|calcium carbonate|mesh-list
65135366|NCT04550078|Calcium|calcium|mesh-list
65135367|NCT04550078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65135368|NCT04550078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135369|NCT04550078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65135370|NCT04550078|Antacids|antacids|mesh-ancestor
65135371|NCT04550078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135372|NCT04550078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65135373|NCT01205035|Ranibizumab|ranibizumab|mesh-list
65135374|NCT01205035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65135375|NCT01205035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65135376|NCT01205035|Growth Substances|growth substances|mesh-ancestor
65135377|NCT01205035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135378|NCT01205035|Growth Inhibitors|growth inhibitors|mesh-ancestor
65135379|NCT01205035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135381|NCT04549844|Anesthetics, Local|anesthetics, local|mesh-ancestor
65135382|NCT04549844|Anesthetics|anesthetics|mesh-ancestor
65135383|NCT04549844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65300946|NCT00682760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65300947|NCT00682760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65300948|NCT00682760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300949|NCT00682760|Cholinergic Agents|cholinergic agents|mesh-ancestor
65300950|NCT00682760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65300951|NCT00682760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300952|NCT00682760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65300953|NCT00682760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65300954|NCT00689624|Leucovorin|leucovorin|mesh-list
65300955|NCT00689624|Fluorouracil|fluorouracil|mesh-list
65300956|NCT00689624|Oxaliplatin|oxaliplatin|mesh-list
65300957|NCT00689624|Irinotecan|irinotecan|mesh-list
65300958|NCT00689624|Cetuximab|cetuximab|mesh-list
65300959|NCT00689624|Antimetabolites|antimetabolites|mesh-ancestor
65300960|NCT00689624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65300961|NCT00689624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65300962|NCT00689624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65300963|NCT00689624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65300964|NCT00689624|Immunologic Factors|immunologic factors|mesh-ancestor
65300965|NCT00689624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135384|NCT04549844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135385|NCT04549844|Sensory System Agents|sensory system agents|mesh-ancestor
65135386|NCT04549844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65135387|NCT01644084|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65135388|NCT01644084|Plasma Substitutes|plasma substitutes|mesh-ancestor
65135389|NCT01644084|Blood Substitutes|blood substitutes|mesh-ancestor
65135390|NCT01204918|Riluzole|riluzole|mesh-list
65135391|NCT01204918|Anticonvulsants|anticonvulsants|mesh-ancestor
65135392|NCT01204918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65135393|NCT01204918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65135394|NCT01204918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65135395|NCT01204918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135396|NCT01204918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135397|NCT01204918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65135398|NCT01204918|Protective Agents|protective agents|mesh-ancestor
65135399|NCT04528797|Methylprednisolone|methylprednisolone|mesh-list
65135400|NCT04528797|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65135401|NCT04528797|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65135402|NCT04528797|Prednisolone|prednisolone|mesh-list
65135403|NCT04528797|Prednisolone acetate|prednisolone acetate|mesh-list
65135404|NCT04528797|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65135405|NCT04528797|Prednisolone phosphate|prednisolone phosphate|mesh-list
65135406|NCT04528797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65135407|NCT04528797|Antiemetics|antiemetics|mesh-ancestor
65135408|NCT04528797|Autonomic Agents|autonomic agents|mesh-ancestor
65135409|NCT04528797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65135410|NCT04528797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135411|NCT04528797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65135412|NCT04528797|Glucocorticoids|glucocorticoids|mesh-ancestor
65135413|NCT04528797|Hormones|hormones|mesh-ancestor
65135414|NCT04528797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65135415|NCT04528797|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65135416|NCT04528797|Protective Agents|protective agents|mesh-ancestor
65135417|NCT04528797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65300966|NCT00689624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65300967|NCT00689624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65300968|NCT00689624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65300969|NCT00689624|Antidotes|antidotes|mesh-ancestor
65300970|NCT00689624|Protective Agents|protective agents|mesh-ancestor
65300971|NCT00689624|Vitamin B Complex|vitamin b complex|mesh-ancestor
65300972|NCT00689624|Vitamins|vitamins|mesh-ancestor
65300973|NCT00689624|Micronutrients|micronutrients|mesh-ancestor
65300974|NCT00689624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65300975|NCT05755035|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65300976|NCT05755035|Immunoglobulins|immunoglobulins|mesh-list
65300977|NCT05755035|Antibodies|antibodies|mesh-list
65300978|NCT05755035|gamma-Globulins|gamma-globulins|mesh-list
65300979|NCT05755035|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65300980|NCT05755035|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65300981|NCT05755035|Immunoglobulin G|immunoglobulin g|mesh-list
65300982|NCT05755035|Immunologic Factors|immunologic factors|mesh-ancestor
65300983|NCT05755035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300984|NCT05326269|Terbutaline|terbutaline|mesh-list
65300985|NCT05326269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65300986|NCT05326269|Autonomic Agents|autonomic agents|mesh-ancestor
65300987|NCT05326269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65300988|NCT05326269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65300989|NCT05326269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65300990|NCT05326269|Respiratory System Agents|respiratory system agents|mesh-ancestor
65300991|NCT05326269|Sympathomimetics|sympathomimetics|mesh-ancestor
65300992|NCT05326269|Tocolytic Agents|tocolytic agents|mesh-ancestor
65300993|NCT05326269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65300994|NCT05326269|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65300995|NCT05326269|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65300996|NCT05326269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65300997|NCT05326269|Adrenergic Agents|adrenergic agents|mesh-ancestor
65300998|NCT05326269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65300999|NCT05326269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301001|NCT02624570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301002|NCT02624570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65301003|NCT02624570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135418|NCT04528797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135419|NCT00624481|Teriparatide|teriparatide|mesh-list
65301004|NCT02624570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301005|NCT04665453|Dexmedetomidine|dexmedetomidine|mesh-list
65301006|NCT04665453|Melatonin|melatonin|mesh-list
65301007|NCT04665453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65301008|NCT04665453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65301009|NCT04665453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301010|NCT04665453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65301011|NCT04665453|Analgesics|analgesics|mesh-ancestor
65301012|NCT04665453|Sensory System Agents|sensory system agents|mesh-ancestor
65135420|NCT00624481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65135421|NCT00624481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135422|NCT00624481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65135423|NCT04529187|Midazolam|midazolam|mesh-list
65135424|NCT04529187|Dexmedetomidine|dexmedetomidine|mesh-list
65135425|NCT04529187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65135426|NCT04529187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65135427|NCT04529187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135428|NCT04529187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65135429|NCT04529187|Analgesics|analgesics|mesh-ancestor
65135430|NCT04529187|Sensory System Agents|sensory system agents|mesh-ancestor
65135431|NCT04529187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65135432|NCT04529187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65135447|NCT04549415|Metformin|metformin|mesh-list
65135448|NCT04549415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65135449|NCT04549415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135450|NCT02214368|Propofol|propofol|mesh-list
65135451|NCT02214368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65135452|NCT02214368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65135453|NCT02214368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668583|NCT01694966|Methylene Blue|methylene blue|mesh-list
65135455|NCT02214368|Anesthetics, General|anesthetics, general|mesh-ancestor
65135456|NCT02214368|Anesthetics|anesthetics|mesh-ancestor
65135457|NCT01204294|Metformin|metformin|mesh-list
64777939|NCT02267772|Acetaminophen|acetaminophen|mesh-list
65135458|NCT01204294|Linagliptin|linagliptin|mesh-list
65135459|NCT01204294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65135460|NCT01204294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135461|NCT01204294|Incretins|incretins|mesh-ancestor
65135462|NCT01204294|Hormones|hormones|mesh-ancestor
65135463|NCT01204294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65135464|NCT01204294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65135465|NCT01204294|Protease Inhibitors|protease inhibitors|mesh-ancestor
65135466|NCT01204294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135467|NCT01204294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135468|NCT01182181|Anastrozole|anastrozole|mesh-list
65135469|NCT01182181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65135470|NCT01182181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135471|NCT01182181|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65135472|NCT01182181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65135473|NCT01182181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135474|NCT01182181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135475|NCT01182181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65135476|NCT01182181|Hormone Antagonists|hormone antagonists|mesh-ancestor
65135477|NCT01182181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65135478|NCT01182181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135479|NCT01181986|Exenatide|exenatide|mesh-list
65135480|NCT01181986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65135481|NCT01181986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135482|NCT01181986|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65135483|NCT01181986|Incretins|incretins|mesh-ancestor
65135484|NCT01181986|Hormones|hormones|mesh-ancestor
65135485|NCT01181986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65135486|NCT04315909|Vitamin E|vitamin e|mesh-list
65135487|NCT04315909|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65135488|NCT04315909|Vitamins|vitamins|mesh-ancestor
65135489|NCT04315909|Micronutrients|micronutrients|mesh-ancestor
65301013|NCT04665453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65301014|NCT04665453|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65301015|NCT04665453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65301016|NCT04665453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65301017|NCT04665453|Adrenergic Agents|adrenergic agents|mesh-ancestor
65301018|NCT04665453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65301019|NCT04665453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301020|NCT04665453|Antioxidants|antioxidants|mesh-ancestor
65301021|NCT04665453|Protective Agents|protective agents|mesh-ancestor
65301022|NCT00695240|Bupivacaine|bupivacaine|mesh-list
65301023|NCT00695240|Anesthetics, Local|anesthetics, local|mesh-ancestor
65301024|NCT00695240|Anesthetics|anesthetics|mesh-ancestor
65301025|NCT00695240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65301026|NCT00695240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135490|NCT04315909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135491|NCT04315909|Antioxidants|antioxidants|mesh-ancestor
65135492|NCT04315909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135493|NCT04315909|Protective Agents|protective agents|mesh-ancestor
65135494|NCT04315909|Hemostatics|hemostatics|mesh-ancestor
65135521|NCT04548284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135523|NCT04547894|Protease Inhibitors|protease inhibitors|mesh-ancestor
65135524|NCT04547894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135525|NCT04547894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135526|NCT01641315|Immunoglobulins|immunoglobulins|mesh-list
65135527|NCT01641315|Immunologic Factors|immunologic factors|mesh-ancestor
65135528|NCT01641315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135529|NCT01644825|Paclitaxel|paclitaxel|mesh-list
65135530|NCT01644825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65135531|NCT01644825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778022|NCT02283840|Anticonvulsants|anticonvulsants|mesh-ancestor
65135532|NCT01644825|Tubulin Modulators|tubulin modulators|mesh-ancestor
65135533|NCT01644825|Antimitotic Agents|antimitotic agents|mesh-ancestor
65135534|NCT01644825|Mitosis Modulators|mitosis modulators|mesh-ancestor
65135535|NCT01644825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135536|NCT01644864|Ropivacaine|ropivacaine|mesh-list
65135537|NCT01644864|Anesthetics, Local|anesthetics, local|mesh-ancestor
65135538|NCT01644864|Anesthetics|anesthetics|mesh-ancestor
65135539|NCT01644864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65135540|NCT01644864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135541|NCT01644864|Sensory System Agents|sensory system agents|mesh-ancestor
65135542|NCT01644864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65135543|NCT04547855|Temozolomide|temozolomide|mesh-list
65135544|NCT04547855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65135547|NCT04547855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135549|NCT01641510|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65135550|NCT01641510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65135551|NCT01641510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65135552|NCT01641510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65135553|NCT01641510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65135554|NCT01641510|Purinergic Agents|purinergic agents|mesh-ancestor
65135555|NCT01641510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65135556|NCT01641510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135557|NCT01641510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135558|NCT04547621|Temozolomide|temozolomide|mesh-list
65135559|NCT04547621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65135560|NCT04547621|Alkylating Agents|alkylating agents|mesh-ancestor
65135561|NCT04547621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135562|NCT04547621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135563|NCT01641549|Fibrinolytic Agents|fibrinolytic agents|mesh-list
65301027|NCT00695240|Sensory System Agents|sensory system agents|mesh-ancestor
65301028|NCT00695240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65301029|NCT00689702|Capecitabine|capecitabine|mesh-list
65301030|NCT00689702|Cetuximab|cetuximab|mesh-list
65301031|NCT00689702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65301032|NCT00689702|Antimetabolites|antimetabolites|mesh-ancestor
65301033|NCT00689702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301034|NCT00689702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301035|NCT00689702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65301036|NCT00689780|Midazolam|midazolam|mesh-list
65301037|NCT00689780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65301038|NCT00689780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65301039|NCT00689780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65135564|NCT01641549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65135565|NCT01641549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135566|NCT04547348|Denosumab|denosumab|mesh-list
65135567|NCT04547348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65135568|NCT04547348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135569|NCT04547426|Nicotine|nicotine|mesh-list
65135570|NCT04547426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65135571|NCT04547426|Autonomic Agents|autonomic agents|mesh-ancestor
65135572|NCT04547426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65135573|NCT04547426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135574|NCT04547426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65135575|NCT04547426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65135576|NCT04547426|Cholinergic Agents|cholinergic agents|mesh-ancestor
65135577|NCT04547426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65135578|NCT04547426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135579|NCT01641666|Ribavirin|ribavirin|mesh-list
65135580|NCT01641666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65135581|NCT01641666|Interferon-alpha|interferon-alpha|mesh-list
65135582|NCT01641666|Antimetabolites|antimetabolites|mesh-ancestor
65135583|NCT01641666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135584|NCT01641666|Antiviral Agents|antiviral agents|mesh-ancestor
65135585|NCT01641666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65135586|NCT01641666|Immunologic Factors|immunologic factors|mesh-ancestor
65135587|NCT01641666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135588|NCT01203787|Sorafenib|sorafenib|mesh-list
65135589|NCT01203787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135590|NCT01203787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65135591|NCT01203787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135592|NCT01203787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135593|NCT04547504|Pembrolizumab|pembrolizumab|mesh-list
65135594|NCT04547504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65135595|NCT04547504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135596|NCT01645254|Antimalarials|antimalarials|mesh-list
65135616|NCT01641783|Tubulin Modulators|tubulin modulators|mesh-ancestor
65135617|NCT01641783|Antimitotic Agents|antimitotic agents|mesh-ancestor
65135618|NCT01641783|Mitosis Modulators|mitosis modulators|mesh-ancestor
65135619|NCT01641783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135620|NCT02214602|Doxorubicin|doxorubicin|mesh-list
65135621|NCT02214602|Epirubicin|epirubicin|mesh-list
65135622|NCT02214602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65135623|NCT02214602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135624|NCT02214602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65135625|NCT02214602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65135626|NCT02214602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135627|NCT02214602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135628|NCT01646580|Ciclopirox|ciclopirox|mesh-list
65135629|NCT01646580|Antifungal Agents|antifungal agents|mesh-ancestor
65135630|NCT01646580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65301040|NCT00689780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301041|NCT00689780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65301042|NCT00689780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65301043|NCT00689780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65301044|NCT00689780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65301045|NCT00689780|Anesthetics, General|anesthetics, general|mesh-ancestor
65301046|NCT00689780|Anesthetics|anesthetics|mesh-ancestor
65301047|NCT00689780|GABA Modulators|gaba modulators|mesh-ancestor
64531157|NCT04420598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135631|NCT04546802|Grazoprevir|grazoprevir|mesh-list
65135632|NCT04546802|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65135633|NCT04546802|Antiviral Agents|antiviral agents|mesh-ancestor
65135634|NCT04546802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65135635|NCT01580033|Vaccines|vaccines|mesh-list
65135636|NCT01580033|Immunologic Factors|immunologic factors|mesh-ancestor
65135637|NCT01580033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135638|NCT04546373|Niraparib|niraparib|mesh-list
65135639|NCT04546373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65135640|NCT04546373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135641|NCT04546373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135642|NCT04546373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135643|NCT01645410|Atorvastatin|atorvastatin|mesh-list
65135644|NCT01645410|Calcium|calcium|mesh-list
65135645|NCT01645410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65135646|NCT01645410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135647|NCT01645410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65135648|NCT01645410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65135649|NCT01645410|Antimetabolites|antimetabolites|mesh-ancestor
65135650|NCT01645410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135651|NCT01645410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64708197|NCT05202158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65135667|NCT04546334|Tocolytic Agents|tocolytic agents|mesh-ancestor
65135668|NCT04546334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65135669|NCT02755272|Gemcitabine|gemcitabine|mesh-list
65135670|NCT02755272|Carboplatin|carboplatin|mesh-list
65135671|NCT02755272|Pembrolizumab|pembrolizumab|mesh-list
65135672|NCT02755272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135673|NCT02755272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65135674|NCT02755272|Antimetabolites|antimetabolites|mesh-ancestor
64668811|NCT01944293|Anesthetics|anesthetics|mesh-ancestor
65135675|NCT02755272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135676|NCT02755272|Antiviral Agents|antiviral agents|mesh-ancestor
65135677|NCT02755272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65135678|NCT02755272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135679|NCT02755272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65135680|NCT02755272|Immunologic Factors|immunologic factors|mesh-ancestor
65135681|NCT02755272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135682|NCT02755272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65135683|NCT04546256|Fluticasone|fluticasone|mesh-list
65135685|NCT04546256|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65135686|NCT04546256|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65135687|NCT04546256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65135688|NCT04546256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65135689|NCT04546256|Autonomic Agents|autonomic agents|mesh-ancestor
65135690|NCT04546256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65135691|NCT04546256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135692|NCT04546256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65135693|NCT04546256|Respiratory System Agents|respiratory system agents|mesh-ancestor
65135694|NCT04546256|Dermatologic Agents|dermatologic agents|mesh-ancestor
65135695|NCT04546256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65135696|NCT04546256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65135697|NCT04546256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65135698|NCT04546256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65135699|NCT04546256|Adrenergic Agents|adrenergic agents|mesh-ancestor
65135700|NCT04546256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65135701|NCT04546256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135702|NCT04546256|Glucocorticoids|glucocorticoids|mesh-ancestor
65301048|NCT00689780|GABA Agents|gaba agents|mesh-ancestor
65301049|NCT00689780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65301050|NCT00689780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301051|NCT00689858|Cilostazol|cilostazol|mesh-list
65301052|NCT00689858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65301053|NCT00689858|Autonomic Agents|autonomic agents|mesh-ancestor
65301054|NCT00689858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65301055|NCT00689858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301056|NCT00689858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65301057|NCT00689858|Respiratory System Agents|respiratory system agents|mesh-ancestor
65301058|NCT00689858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65301059|NCT00689858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64531169|NCT04411654|Hormones|hormones|mesh-ancestor
65135703|NCT04546256|Hormones|hormones|mesh-ancestor
65135704|NCT04546256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65135705|NCT04546256|Sympathomimetics|sympathomimetics|mesh-ancestor
65135706|NCT01645449|Atorvastatin|atorvastatin|mesh-list
65135707|NCT01645449|Calcium|calcium|mesh-list
64708254|NCT00370591|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65135730|NCT02214680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65135731|NCT02214680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65135732|NCT02214680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65135733|NCT02214680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65135734|NCT02756208|Vaccines|vaccines|mesh-list
65135735|NCT02756208|Immunologic Factors|immunologic factors|mesh-ancestor
65135736|NCT02756208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135737|NCT04545788|Linezolid|linezolid|mesh-list
65135738|NCT04545788|Cycloserine|cycloserine|mesh-list
65135739|NCT04545788|Bedaquiline|bedaquiline|mesh-list
65135740|NCT04545788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65135741|NCT04545788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65135742|NCT04545788|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65135743|NCT04545788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135744|NCT04545788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135745|NCT04545788|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65135746|NCT04545788|Renal Agents|renal agents|mesh-ancestor
65135747|NCT04545788|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65135749|NCT04545788|Antimetabolites|antimetabolites|mesh-ancestor
65135750|NCT02756013|Paclitaxel|paclitaxel|mesh-list
65135751|NCT02756013|Carboplatin|carboplatin|mesh-list
65135752|NCT02756013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65135753|NCT02756013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135754|NCT02756013|Tubulin Modulators|tubulin modulators|mesh-ancestor
65135755|NCT02756013|Antimitotic Agents|antimitotic agents|mesh-ancestor
65135756|NCT02756013|Mitosis Modulators|mitosis modulators|mesh-ancestor
65135757|NCT02756013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135758|NCT01680042|Phenytoin|phenytoin|mesh-list
65135779|NCT01680081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135780|NCT01680081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65135781|NCT01680081|Vasodilator Agents|vasodilator agents|mesh-ancestor
65135782|NCT01680081|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65135783|NCT01680081|Purinergic Agonists|purinergic agonists|mesh-ancestor
65135784|NCT01680081|Purinergic Agents|purinergic agents|mesh-ancestor
65135785|NCT01680081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65135786|NCT01680081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135787|NCT01646307|Atorvastatin|atorvastatin|mesh-list
65135788|NCT01646307|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65135789|NCT01646307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65135790|NCT01646307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65135791|NCT01646307|Antimetabolites|antimetabolites|mesh-ancestor
65135792|NCT01646307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135793|NCT01646307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65222822|NCT02699385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65301060|NCT00689858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301061|NCT00689858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65301062|NCT00689858|Vasodilator Agents|vasodilator agents|mesh-ancestor
65301063|NCT00689858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65301064|NCT00689858|Protective Agents|protective agents|mesh-ancestor
65301065|NCT00689858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65301066|NCT00689858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64944843|NCT03062826|Ticagrelor|ticagrelor|mesh-list
65135794|NCT01646307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65135795|NCT01646307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135796|NCT04544969|Gemcitabine|gemcitabine|mesh-list
65135797|NCT04544969|Cisplatin|cisplatin|mesh-list
65135798|NCT04544969|Docetaxel|docetaxel|mesh-list
65135799|NCT04544969|Fluorouracil|fluorouracil|mesh-list
65135800|NCT04544969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135801|NCT04544969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65135802|NCT04544969|Antimetabolites|antimetabolites|mesh-ancestor
65135803|NCT04544969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135804|NCT04544969|Antiviral Agents|antiviral agents|mesh-ancestor
65135805|NCT04544969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65135806|NCT04544969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135807|NCT04544969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65135808|NCT04544969|Immunologic Factors|immunologic factors|mesh-ancestor
65135809|NCT04544969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135810|NCT04544969|Tubulin Modulators|tubulin modulators|mesh-ancestor
65135811|NCT04544969|Antimitotic Agents|antimitotic agents|mesh-ancestor
65135812|NCT04544969|Mitosis Modulators|mitosis modulators|mesh-ancestor
65135819|NCT04541732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65135820|NCT04541732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65135821|NCT04541732|Anesthetics, General|anesthetics, general|mesh-ancestor
65135822|NCT01680471|Midazolam|midazolam|mesh-list
65135823|NCT01680471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65135824|NCT01680471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65135825|NCT01680471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65135826|NCT01680471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135827|NCT01680471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65135828|NCT01680471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65135829|NCT01680471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65135830|NCT01680471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65135831|NCT01680471|Anesthetics, General|anesthetics, general|mesh-ancestor
65135832|NCT01680471|Anesthetics|anesthetics|mesh-ancestor
65135833|NCT01680471|GABA Modulators|gaba modulators|mesh-ancestor
65135834|NCT01680471|GABA Agents|gaba agents|mesh-ancestor
65135835|NCT01680471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65135836|NCT01680471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135837|NCT02279316|Vitamin D|vitamin d|mesh-list
65135838|NCT02279316|Cholecalciferol|cholecalciferol|mesh-list
65135839|NCT02279316|Vitamins|vitamins|mesh-ancestor
65135840|NCT02279316|Micronutrients|micronutrients|mesh-ancestor
65135841|NCT02279316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135842|NCT02279316|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65135843|NCT02279316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65135844|NCT04544306|Anti-Infective Agents|anti-infective agents|mesh-list
65135845|NCT04544306|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65135846|NCT04544228|Ketamine|ketamine|mesh-list
65135847|NCT04544228|Bupivacaine|bupivacaine|mesh-list
65135848|NCT04544228|Neostigmine|neostigmine|mesh-list
65135849|NCT04544228|Anesthetics, Local|anesthetics, local|mesh-ancestor
65135850|NCT04544228|Anesthetics|anesthetics|mesh-ancestor
65135851|NCT04544228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65135852|NCT04544228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135853|NCT04544228|Sensory System Agents|sensory system agents|mesh-ancestor
65135854|NCT04544228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65135855|NCT04544228|Analgesics|analgesics|mesh-ancestor
65135856|NCT04544228|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65135857|NCT04544228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65135858|NCT04544228|Anesthetics, General|anesthetics, general|mesh-ancestor
65135859|NCT04544228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65301067|NCT00689858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301068|NCT00695630|Flumazenil|flumazenil|mesh-list
65301069|NCT00695630|Antidotes|antidotes|mesh-ancestor
65301070|NCT00695630|Protective Agents|protective agents|mesh-ancestor
65301071|NCT00695630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301072|NCT00695630|GABA Modulators|gaba modulators|mesh-ancestor
65050960|NCT00223418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65301073|NCT00695630|GABA Agents|gaba agents|mesh-ancestor
65301074|NCT00695630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65301075|NCT00695630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301076|NCT01614899|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65301077|NCT01614899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65301078|NCT01614899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65301079|NCT01614899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65301080|NCT01614899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301081|NCT01614899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65301082|NCT01614899|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65301083|NCT01614899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65135860|NCT04544228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65135861|NCT04544228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65135862|NCT04544228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135863|NCT04544228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65135864|NCT04544228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135865|NCT04544228|Cholinergic Agents|cholinergic agents|mesh-ancestor
65135866|NCT04544228|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65135867|NCT04544228|Autonomic Agents|autonomic agents|mesh-ancestor
65135868|NCT01646736|Cyclophosphamide|cyclophosphamide|mesh-list
65135869|NCT01646736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65135870|NCT01646736|Immunologic Factors|immunologic factors|mesh-ancestor
65135871|NCT01646736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135872|NCT01646736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65135873|NCT01646736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65135874|NCT01646736|Alkylating Agents|alkylating agents|mesh-ancestor
65135875|NCT01646736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135876|NCT01646736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135877|NCT01646736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65135878|NCT04542005|Albuterol|albuterol|mesh-list
65135879|NCT04542005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65135880|NCT04542005|Autonomic Agents|autonomic agents|mesh-ancestor
65135881|NCT04542005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65135882|NCT04542005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514380|NCT02462421|Canagliflozin|canagliflozin|mesh-list
65135896|NCT01646775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65135897|NCT01646775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135898|NCT01646775|Analgesics|analgesics|mesh-ancestor
65135899|NCT01646775|Sensory System Agents|sensory system agents|mesh-ancestor
65135900|NCT01646775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65135901|NCT01646775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65135902|NCT01646775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65135903|NCT01646775|Anesthetics, General|anesthetics, general|mesh-ancestor
65135904|NCT01646775|Anesthetics|anesthetics|mesh-ancestor
65135905|NCT01646853|Fluorouracil|fluorouracil|mesh-list
65135906|NCT01646853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135907|NCT01646853|Antimetabolites|antimetabolites|mesh-ancestor
65135908|NCT01646853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135909|NCT01646853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64531199|NCT04381832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531203|NCT04364230|Poly ICLC|poly iclc|mesh-list
64531204|NCT04364230|Immunologic Factors|immunologic factors|mesh-ancestor
65301084|NCT01614899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65301085|NCT01614899|Adrenergic Agents|adrenergic agents|mesh-ancestor
65301086|NCT01614899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65301087|NCT01614899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301088|NCT01614899|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65301089|NCT01614899|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65301090|NCT01614899|Serotonin Agents|serotonin agents|mesh-ancestor
65301091|NCT01614899|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65301092|NCT01614899|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65301093|NCT01614899|Dopamine Agents|dopamine agents|mesh-ancestor
65301094|NCT00690014|Probenecid|probenecid|mesh-list
65135910|NCT01646853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65135911|NCT01646853|Immunologic Factors|immunologic factors|mesh-ancestor
65135912|NCT01646853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135913|NCT01647165|Dexamethasone|dexamethasone|mesh-list
65135914|NCT01647165|Lenalidomide|lenalidomide|mesh-list
65135915|NCT01647165|Bortezomib|bortezomib|mesh-list
65135916|NCT01647165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65135917|NCT01647165|Antiemetics|antiemetics|mesh-ancestor
65135918|NCT01647165|Autonomic Agents|autonomic agents|mesh-ancestor
65135919|NCT01647165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65135920|NCT01647165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135921|NCT01647165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65135922|NCT01647165|Glucocorticoids|glucocorticoids|mesh-ancestor
65135923|NCT01647165|Hormones|hormones|mesh-ancestor
65135924|NCT01647165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65135925|NCT01647165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65135926|NCT01647165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135927|NCT01647165|Immunologic Factors|immunologic factors|mesh-ancestor
65135928|NCT01647165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65135929|NCT01647165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65135930|NCT01647165|Growth Substances|growth substances|mesh-ancestor
65135931|NCT01647165|Growth Inhibitors|growth inhibitors|mesh-ancestor
65135932|NCT01681134|Tacrolimus|tacrolimus|mesh-list
65135933|NCT01681134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65135934|NCT01681134|Immunologic Factors|immunologic factors|mesh-ancestor
65135935|NCT01681134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135936|NCT01681134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65135937|NCT01681134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135938|NCT01681134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135939|NCT04543916|Irinotecan|irinotecan|mesh-list
65135940|NCT04543916|Venetoclax|venetoclax|mesh-list
65135941|NCT04543916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65135942|NCT04543916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65135943|NCT04543916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708485|NCT03737461|Anesthetics, Local|anesthetics, local|mesh-ancestor
65135951|NCT04541147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65135952|NCT04541147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135953|NCT04541147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65135954|NCT04541147|Glucocorticoids|glucocorticoids|mesh-ancestor
65135955|NCT04541147|Hormones|hormones|mesh-ancestor
65135956|NCT04541147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65135957|NCT04541147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65135958|NCT04541147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135959|NCT04541147|Sensory System Agents|sensory system agents|mesh-ancestor
65135960|NCT04541303|Tranexamic Acid|tranexamic acid|mesh-list
65135961|NCT04541303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65135962|NCT04541303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65301095|NCT00690014|Uricosuric Agents|uricosuric agents|mesh-ancestor
65301096|NCT00690014|Gout Suppressants|gout suppressants|mesh-ancestor
65301097|NCT00690014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65301098|NCT00690014|Renal Agents|renal agents|mesh-ancestor
65301099|NCT00683306|Gefitinib|gefitinib|mesh-list
65301100|NCT00683306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301101|NCT00683306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65301102|NCT00683306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301103|NCT00683306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135963|NCT04541303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135964|NCT04541303|Hemostatics|hemostatics|mesh-ancestor
65135965|NCT04541303|Coagulants|coagulants|mesh-ancestor
65135966|NCT02214992|Telmisartan|telmisartan|mesh-list
65135967|NCT02214992|Ramipril|ramipril|mesh-list
65135968|NCT02214992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65135969|NCT02214992|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65135970|NCT02214992|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65135971|NCT02214992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135972|NCT02214992|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65135974|NCT02214992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135975|NCT04528095|Clozapine|clozapine|mesh-list
65135976|NCT04528095|Amisulpride|amisulpride|mesh-list
65135977|NCT04528095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65135978|NCT04528095|Serotonin Agents|serotonin agents|mesh-ancestor
65135979|NCT04528095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65135980|NCT04528095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135981|NCT04528095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135982|NCT04528095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65135983|NCT04528095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65135984|NCT04528095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65135985|NCT04528095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65135986|NCT04528095|GABA Antagonists|gaba antagonists|mesh-ancestor
65135987|NCT04528095|GABA Agents|gaba agents|mesh-ancestor
65135988|NCT04528095|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65135989|NCT04528095|Dopamine Agents|dopamine agents|mesh-ancestor
65135990|NCT04528095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65135991|NCT04528095|Antidepressive Agents|antidepressive agents|mesh-ancestor
65135992|NCT04528056|Sulfasalazine|sulfasalazine|mesh-list
65135993|NCT04528056|Ambrisentan|ambrisentan|mesh-list
65135994|NCT04528056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65135995|NCT04528056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65135996|NCT04528056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65135997|NCT04528056|Analgesics|analgesics|mesh-ancestor
65135998|NCT04528056|Sensory System Agents|sensory system agents|mesh-ancestor
65135999|NCT04528056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65136000|NCT04528056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136001|NCT04528056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65136002|NCT04528056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65136003|NCT04528056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65136004|NCT04528056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65136005|NCT04543565|Tenofovir|tenofovir|mesh-list
65136006|NCT04543565|Pradefovir|pradefovir|mesh-list
65136007|NCT04543565|Antiviral Agents|antiviral agents|mesh-ancestor
65136008|NCT04543565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65136009|NCT04543565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65136010|NCT04543565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65136011|NCT04543565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136012|NCT04543565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136025|NCT04543370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65136026|NCT04543370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65136027|NCT04543370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65136028|NCT04543370|Anesthetics, General|anesthetics, general|mesh-ancestor
65136029|NCT04543370|Anesthetics|anesthetics|mesh-ancestor
65136030|NCT04543370|GABA Modulators|gaba modulators|mesh-ancestor
65136031|NCT04543370|GABA Agents|gaba agents|mesh-ancestor
65136032|NCT04543370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65136033|NCT04543370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301104|NCT01475123|Nicorandil|nicorandil|mesh-list
65301105|NCT01475123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65301106|NCT01475123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65301107|NCT01475123|Vasodilator Agents|vasodilator agents|mesh-ancestor
65301108|NCT01475123|Vitamin B Complex|vitamin b complex|mesh-ancestor
65301109|NCT01475123|Vitamins|vitamins|mesh-ancestor
65301110|NCT01475123|Micronutrients|micronutrients|mesh-ancestor
65301111|NCT01475123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301112|NCT04135898|Bevacizumab|bevacizumab|mesh-list
65301113|NCT04135898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65301114|NCT04135898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301115|NCT04135898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65301116|NCT04135898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65301117|NCT04135898|Growth Substances|growth substances|mesh-ancestor
65301118|NCT04135898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301119|NCT04135898|Growth Inhibitors|growth inhibitors|mesh-ancestor
65301120|NCT04208399|JNJ-56136379|jnj-56136379|mesh-list
65136034|NCT04543370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65136035|NCT04543370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65136036|NCT04543370|Immunologic Factors|immunologic factors|mesh-ancestor
65136037|NCT01681563|Cyclophosphamide|cyclophosphamide|mesh-list
65136038|NCT01681563|Ofatumumab|ofatumumab|mesh-list
65136039|NCT01681563|Pentostatin|pentostatin|mesh-list
65136040|NCT01681563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65136041|NCT01681563|Immunologic Factors|immunologic factors|mesh-ancestor
65136042|NCT01681563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136043|NCT01681563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65136044|NCT01681563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65136045|NCT01681563|Alkylating Agents|alkylating agents|mesh-ancestor
65136046|NCT01681563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136047|NCT01681563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136048|NCT01681563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65136049|NCT01681563|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65136050|NCT01681563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136051|NCT01681680|Metformin|metformin|mesh-list
65136052|NCT01681680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65136053|NCT01681680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136054|NCT01647633|Calcium|calcium|mesh-list
65136055|NCT01647633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65136056|NCT01647633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778549|NCT05495568|Adalimumab|adalimumab|mesh-list
65136057|NCT01647672|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65136058|NCT01647672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136059|NCT01647984|Vitamins|vitamins|mesh-list
65136060|NCT01647984|Vitamin E|vitamin e|mesh-list
65136061|NCT01647984|Vitamin B Complex|vitamin b complex|mesh-list
65136062|NCT01647984|Micronutrients|micronutrients|mesh-ancestor
65136063|NCT01647984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136064|NCT01647984|Antioxidants|antioxidants|mesh-ancestor
65136065|NCT01647984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136066|NCT01647984|Protective Agents|protective agents|mesh-ancestor
65136067|NCT02215382|Atropine|atropine|mesh-list
65136068|NCT02215382|Neostigmine|neostigmine|mesh-list
65136069|NCT02215382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65136070|NCT02215382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65136071|NCT02215382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65136072|NCT02215382|Autonomic Agents|autonomic agents|mesh-ancestor
65136073|NCT02215382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65136074|NCT02215382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136075|NCT02215382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65136076|NCT02215382|Respiratory System Agents|respiratory system agents|mesh-ancestor
65301121|NCT04208399|Antiviral Agents|antiviral agents|mesh-ancestor
65301122|NCT04208399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65301123|NCT00912392|Carboplatin|carboplatin|mesh-list
65301124|NCT00912392|Etoposide|etoposide|mesh-list
65301125|NCT00912392|Endostar protein|endostar protein|mesh-list
65301126|NCT00912392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301127|NCT00912392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65301128|NCT00912392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65301129|NCT00912392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65301130|NCT00912392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301131|NCT00912392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301132|NCT00912392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65301133|NCT00912392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65301134|NCT00912392|Growth Substances|growth substances|mesh-ancestor
64531238|NCT04111458|Trametinib|trametinib|mesh-list
65136077|NCT02215382|Mydriatics|mydriatics|mesh-ancestor
65136088|NCT01682109|Antiviral Agents|antiviral agents|mesh-ancestor
65136089|NCT01682109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65136090|NCT02215148|Tolvaptan|tolvaptan|mesh-list
65136091|NCT02215148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65136092|NCT02215148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136093|NCT02215148|Natriuretic Agents|natriuretic agents|mesh-ancestor
65136094|NCT02215148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136095|NCT01682343|Calcium|calcium|mesh-list
65136096|NCT01682343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65136097|NCT01682343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136098|NCT01648257|Cabotegravir|cabotegravir|mesh-list
65136099|NCT01648257|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65136100|NCT01648257|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65136101|NCT01648257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136102|NCT01648257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136103|NCT01648257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65136104|NCT01648257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65136105|NCT01648257|Antiviral Agents|antiviral agents|mesh-ancestor
65136106|NCT01648257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65136107|NCT02215460|Chlorhexidine|chlorhexidine|mesh-list
65136108|NCT02215460|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65136109|NCT02215460|Azithromycin|azithromycin|mesh-list
65136110|NCT02215460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65136111|NCT02215460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65136112|NCT02215460|Disinfectants|disinfectants|mesh-ancestor
65136113|NCT02215460|Dermatologic Agents|dermatologic agents|mesh-ancestor
65136114|NCT02215460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65136115|NCT02215499|Sodium Oxybate|sodium oxybate|mesh-list
65136116|NCT02215499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65136117|NCT02215499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65136118|NCT02215499|Anesthetics, General|anesthetics, general|mesh-ancestor
65136119|NCT02215499|Anesthetics|anesthetics|mesh-ancestor
65136120|NCT02215499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65136121|NCT02215499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136122|NCT01648608|Exemestane|exemestane|mesh-list
65136123|NCT01648608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136124|NCT01648608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65136125|NCT01648608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65136126|NCT01648608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136127|NCT01648608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136128|NCT01648608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65136129|NCT01648608|Hormone Antagonists|hormone antagonists|mesh-ancestor
65136130|NCT01648608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65136131|NCT01648608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301135|NCT00912392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301136|NCT00912392|Growth Inhibitors|growth inhibitors|mesh-ancestor
65301137|NCT00690170|Ketamine|ketamine|mesh-list
65301138|NCT00690170|Nicotine|nicotine|mesh-list
65301139|NCT00690170|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65301140|NCT00690170|Autonomic Agents|autonomic agents|mesh-ancestor
65301141|NCT00690170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65301142|NCT00690170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301143|NCT00690170|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65301144|NCT00690170|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65301145|NCT00690170|Cholinergic Agents|cholinergic agents|mesh-ancestor
65301146|NCT00690170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65301147|NCT00690170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301148|NCT00690170|Analgesics|analgesics|mesh-ancestor
65301149|NCT00690170|Sensory System Agents|sensory system agents|mesh-ancestor
65301150|NCT00690170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65301151|NCT00690170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65301152|NCT00690170|Anesthetics, General|anesthetics, general|mesh-ancestor
65301153|NCT00690170|Anesthetics|anesthetics|mesh-ancestor
64531253|NCT04083144|Varenicline|varenicline|mesh-list
65136132|NCT02215538|Methylphenidate|methylphenidate|mesh-list
65136133|NCT02215538|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65136134|NCT02215538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136135|NCT02215538|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65136136|NCT02215538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65136137|NCT02215538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65136138|NCT02215538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136139|NCT02215538|Dopamine Agents|dopamine agents|mesh-ancestor
65136140|NCT02215538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65136141|NCT01682421|Dexamethasone|dexamethasone|mesh-list
65136153|NCT01682421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65136154|NCT01682421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65136155|NCT01682421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136156|NCT01682421|Protease Inhibitors|protease inhibitors|mesh-ancestor
65136157|NCT01682421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136158|NCT01682499|Calcium, Dietary|calcium, dietary|mesh-list
65136159|NCT01682499|Magnesium Sulfate|magnesium sulfate|mesh-list
65136160|NCT01682499|Calcium|calcium|mesh-list
65136161|NCT01682499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65136162|NCT01682499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136163|NCT01682499|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65136164|NCT01682499|Analgesics|analgesics|mesh-ancestor
65136165|NCT01682499|Sensory System Agents|sensory system agents|mesh-ancestor
65136166|NCT01682499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65136167|NCT01682499|Anesthetics|anesthetics|mesh-ancestor
65136168|NCT01682499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65136169|NCT01682499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65136170|NCT01682499|Anticonvulsants|anticonvulsants|mesh-ancestor
65136171|NCT01682499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65136172|NCT01682499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65136173|NCT01682499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136174|NCT01682499|Tocolytic Agents|tocolytic agents|mesh-ancestor
65136175|NCT01682499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65136176|NCT04539977|Cisplatin|cisplatin|mesh-list
65136177|NCT04539977|Etoposide|etoposide|mesh-list
65136178|NCT04539977|Etoposide phosphate|etoposide phosphate|mesh-list
65301154|NCT00690170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65301155|NCT00690170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65301156|NCT00690170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65301157|NCT00696098|Butyric Acid|butyric acid|mesh-list
65301158|NCT00696098|Histamine Antagonists|histamine antagonists|mesh-ancestor
65301159|NCT00696098|Histamine Agents|histamine agents|mesh-ancestor
65301160|NCT00696098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65301161|NCT00696098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301162|NCT00696098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301163|NCT02623478|Insulin Lispro|insulin lispro|mesh-list
65301164|NCT02623478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65301165|NCT02623478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301166|NCT00684164|Conivaptan|conivaptan|mesh-list
65136179|NCT04539977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136180|NCT04539977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65136181|NCT04539977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65136182|NCT04539977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65136183|NCT04539977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136184|NCT04539977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136185|NCT04540055|Anesthetics|anesthetics|mesh-list
65136186|NCT04540055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65136187|NCT04540055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136188|NCT01180660|Lidocaine|lidocaine|mesh-list
65136189|NCT01180660|Anesthetics, Local|anesthetics, local|mesh-ancestor
65136191|NCT01180660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65136192|NCT01180660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136193|NCT01180660|Sensory System Agents|sensory system agents|mesh-ancestor
65136194|NCT01180660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65136195|NCT01180660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65136196|NCT01180660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65136197|NCT01180660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65136198|NCT01180660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65136199|NCT01180660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136200|NCT01648881|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65136201|NCT01648881|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65136202|NCT01648881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136203|NCT01202227|Pregabalin|pregabalin|mesh-list
65136204|NCT01202227|Analgesics|analgesics|mesh-ancestor
65136205|NCT01202227|Sensory System Agents|sensory system agents|mesh-ancestor
65136213|NCT01202227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65136214|NCT01202227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65136215|NCT01202227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65136216|NCT01202227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65136217|NCT01682733|Botulinum Toxins|botulinum toxins|mesh-list
65136218|NCT01682733|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65136219|NCT01682733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65136220|NCT01682733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136221|NCT01682733|Cholinergic Agents|cholinergic agents|mesh-ancestor
65136222|NCT01682733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65136223|NCT01682733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136224|NCT04539314|Dexmedetomidine|dexmedetomidine|mesh-list
65136225|NCT04539314|Bupivacaine|bupivacaine|mesh-list
65136226|NCT04539314|Anesthetics, Local|anesthetics, local|mesh-ancestor
65136227|NCT04539314|Anesthetics|anesthetics|mesh-ancestor
65136228|NCT04539314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65136229|NCT04539314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136230|NCT04539314|Sensory System Agents|sensory system agents|mesh-ancestor
65136231|NCT04539314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65136232|NCT04539314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65301167|NCT00684164|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65301168|NCT00684164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301169|NCT00684164|Natriuretic Agents|natriuretic agents|mesh-ancestor
65301170|NCT00684164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301171|NCT04135508|Adalimumab|adalimumab|mesh-list
65301172|NCT04135508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65136233|NCT04539314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65136234|NCT04539314|Analgesics|analgesics|mesh-ancestor
65136235|NCT04539314|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65136236|NCT04539314|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65136237|NCT04539314|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65136238|NCT04539314|Adrenergic Agents|adrenergic agents|mesh-ancestor
65136239|NCT04539314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65136240|NCT04539314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136242|NCT01682772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65136243|NCT01682772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136244|NCT01682772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136245|NCT01682772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136246|NCT01649037|Terlipressin|terlipressin|mesh-list
65136247|NCT01649037|Epinephrine|epinephrine|mesh-list
65136248|NCT01649037|Racepinephrine|racepinephrine|mesh-list
65136249|NCT01649037|Norepinephrine|norepinephrine|mesh-list
65136250|NCT01649037|Epinephryl borate|epinephryl borate|mesh-list
65136251|NCT01649037|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65136252|NCT01649037|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65136253|NCT01649037|Adrenergic Agents|adrenergic agents|mesh-ancestor
65136254|NCT01649037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65136255|NCT01649037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136256|NCT01649037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136257|NCT01649037|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65136258|NCT01649037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65136259|NCT01649037|Autonomic Agents|autonomic agents|mesh-ancestor
65136260|NCT01649037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65136261|NCT01649037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65136262|NCT01649037|Respiratory System Agents|respiratory system agents|mesh-ancestor
65136264|NCT01649037|Sympathomimetics|sympathomimetics|mesh-ancestor
65136265|NCT01649037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65136266|NCT01649037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65136267|NCT04539119|Tenofovir|tenofovir|mesh-list
65136268|NCT04539119|Entecavir|entecavir|mesh-list
65136269|NCT04539119|Antiviral Agents|antiviral agents|mesh-ancestor
65136270|NCT04539119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65136271|NCT04539119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65136272|NCT04539119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64708810|NCT05032183|Antiemetics|antiemetics|mesh-ancestor
65136287|NCT02279511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65136288|NCT02279511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136290|NCT02279628|Ropivacaine|ropivacaine|mesh-list
65136291|NCT02279628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65136292|NCT02279628|Narcotics|narcotics|mesh-ancestor
65136293|NCT02279628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65136294|NCT02279628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136295|NCT02279628|Analgesics|analgesics|mesh-ancestor
65136296|NCT02279628|Sensory System Agents|sensory system agents|mesh-ancestor
65136297|NCT02279628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65136298|NCT02279628|Anesthetics, Local|anesthetics, local|mesh-ancestor
65136299|NCT02279628|Anesthetics|anesthetics|mesh-ancestor
65136300|NCT04542629|Trace Elements|trace elements|mesh-list
65136301|NCT04542629|Rituximab|rituximab|mesh-list
65136302|NCT04542629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65136303|NCT04542629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136304|NCT04542629|Immunologic Factors|immunologic factors|mesh-ancestor
65136305|NCT04542629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136306|NCT04542629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65136307|NCT04542629|Micronutrients|micronutrients|mesh-ancestor
65136308|NCT01683006|Rocuronium|rocuronium|mesh-list
65136309|NCT01683006|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65136310|NCT01683006|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65301173|NCT04135508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65301174|NCT02622854|Insulin|insulin|mesh-list
65301175|NCT02622854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65301176|NCT02622854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301177|NCT02616770|Perflubron|perflubron|mesh-list
65301178|NCT02616770|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65301179|NCT00499369|Leucovorin|leucovorin|mesh-list
65301180|NCT00499369|Bevacizumab|bevacizumab|mesh-list
65301181|NCT00499369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65301182|NCT00499369|Cetuximab|cetuximab|mesh-list
65301183|NCT00499369|Fluorouracil|fluorouracil|mesh-list
65301184|NCT00499369|Irinotecan|irinotecan|mesh-list
65301185|NCT00499369|Antibodies|antibodies|mesh-list
65301186|NCT00499369|Immunoglobulins|immunoglobulins|mesh-list
65301187|NCT00499369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65301188|NCT00499369|Levoleucovorin|levoleucovorin|mesh-list
65301189|NCT00499369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301190|NCT00499369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65301191|NCT00499369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65301192|NCT00499369|Growth Substances|growth substances|mesh-ancestor
65301193|NCT00499369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301194|NCT00499369|Growth Inhibitors|growth inhibitors|mesh-ancestor
65136311|NCT01683006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65136312|NCT01683006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65136313|NCT01683006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136314|NCT01683162|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65136315|NCT01683162|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65136316|NCT01683162|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65136317|NCT01683162|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65136318|NCT02215733|Telmisartan|telmisartan|mesh-list
65136319|NCT02215733|Diuretics|diuretics|mesh-list
65136320|NCT02215733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65136321|NCT02215733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65136322|NCT02215733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65136323|NCT02215733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65136324|NCT02215733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136325|NCT02215733|Natriuretic Agents|natriuretic agents|mesh-ancestor
65136326|NCT02215733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136327|NCT02215733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65136328|NCT02215733|Adrenergic Agents|adrenergic agents|mesh-ancestor
65136329|NCT02215733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65136330|NCT01202188|Glycopyrrolate|glycopyrrolate|mesh-list
65136331|NCT01202188|Tiotropium Bromide|tiotropium bromide|mesh-list
65136341|NCT01202188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65136342|NCT01202188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136343|NCT01202188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65136344|NCT01202188|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65136346|NCT01179919|Antiviral Agents|antiviral agents|mesh-ancestor
65136347|NCT01179919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65136348|NCT01179919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136349|NCT01179919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136350|NCT01201798|Prednisolone|prednisolone|mesh-list
65136351|NCT01201798|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65136352|NCT01201798|Methylprednisolone|methylprednisolone|mesh-list
65136353|NCT01201798|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65136354|NCT01201798|Prednisolone acetate|prednisolone acetate|mesh-list
65301195|NCT00499369|Immunologic Factors|immunologic factors|mesh-ancestor
65301196|NCT00499369|Antimetabolites|antimetabolites|mesh-ancestor
65301197|NCT00499369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301198|NCT00499369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65301199|NCT00499369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65301200|NCT00499369|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65301201|NCT00499369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65301202|NCT00499369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301203|NCT00499369|Antidotes|antidotes|mesh-ancestor
65301204|NCT00499369|Protective Agents|protective agents|mesh-ancestor
65301205|NCT00499369|Vitamin B Complex|vitamin b complex|mesh-ancestor
65301206|NCT00499369|Vitamins|vitamins|mesh-ancestor
64778840|NCT02272842|Vitamin B 12|vitamin b 12|mesh-list
65136355|NCT01201798|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65136356|NCT01201798|Prednisolone phosphate|prednisolone phosphate|mesh-list
65136358|NCT01201798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65136359|NCT01201798|Glucocorticoids|glucocorticoids|mesh-ancestor
65136360|NCT01201798|Hormones|hormones|mesh-ancestor
65136361|NCT01201798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65136362|NCT01201798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136363|NCT01201798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65136364|NCT01201798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136365|NCT01201798|Antiemetics|antiemetics|mesh-ancestor
65136366|NCT01201798|Autonomic Agents|autonomic agents|mesh-ancestor
65136367|NCT01201798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65136368|NCT01201798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65136369|NCT01201798|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65136370|NCT01201798|Protective Agents|protective agents|mesh-ancestor
65136371|NCT01201759|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
65136372|NCT01201759|Sodium Salicylate|sodium salicylate|mesh-list
65136373|NCT01201759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65136374|NCT01201759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65136375|NCT01201759|Analgesics|analgesics|mesh-ancestor
65136376|NCT01201759|Sensory System Agents|sensory system agents|mesh-ancestor
65136377|NCT01201759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65136378|NCT01201759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136379|NCT01201759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65136380|NCT01201759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65136381|NCT01201759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65136382|NCT01201759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136383|NCT01201759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136384|NCT04532684|Pregabalin|pregabalin|mesh-list
65136385|NCT04532684|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65136386|NCT04532684|Analgesics|analgesics|mesh-ancestor
65136387|NCT04532684|Sensory System Agents|sensory system agents|mesh-ancestor
65136388|NCT04532684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65136389|NCT04532684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136390|NCT04532684|Anticonvulsants|anticonvulsants|mesh-ancestor
65136391|NCT04532684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65136392|NCT04532684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65136393|NCT04532684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136394|NCT04532684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65136395|NCT04532684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65136412|NCT01200589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136413|NCT01200589|Immunologic Factors|immunologic factors|mesh-ancestor
65136414|NCT01200589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136415|NCT01200589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65136417|NCT01683552|Prednisone|prednisone|mesh-list
65136418|NCT01683552|Aprepitant|aprepitant|mesh-list
65136419|NCT01683552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65136420|NCT01683552|Glucocorticoids|glucocorticoids|mesh-ancestor
65136421|NCT01683552|Hormones|hormones|mesh-ancestor
65136422|NCT01683552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65301207|NCT00499369|Micronutrients|micronutrients|mesh-ancestor
65301208|NCT02616692|Sorafenib|sorafenib|mesh-list
65301209|NCT02616692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301210|NCT02616692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65301211|NCT02616692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301212|NCT02616692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301213|NCT01014637|Antifungal Agents|antifungal agents|mesh-list
65301214|NCT01014637|Clotrimazole|clotrimazole|mesh-list
65136423|NCT01683552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136424|NCT01683552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65136425|NCT01683552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136426|NCT01683552|Antiemetics|antiemetics|mesh-ancestor
65136427|NCT01683552|Autonomic Agents|autonomic agents|mesh-ancestor
65136428|NCT01683552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778916|NCT05722002|Acetaminophen|acetaminophen|mesh-list
65136430|NCT01683552|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65136431|NCT01683552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65136432|NCT01683552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136433|NCT01683552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65136434|NCT01683552|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65136435|NCT01683552|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65136436|NCT01683552|Histamine Antagonists|histamine antagonists|mesh-ancestor
65136437|NCT01683552|Histamine Agents|histamine agents|mesh-ancestor
65136438|NCT04532606|Anesthetics|anesthetics|mesh-list
65136439|NCT04532606|Propofol|propofol|mesh-list
65136440|NCT04532606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65136441|NCT04532606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136442|NCT04532606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65136443|NCT04532606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65136444|NCT04532606|Anesthetics, General|anesthetics, general|mesh-ancestor
65136445|NCT01649544|Amiodarone|amiodarone|mesh-list
65136446|NCT01649544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65136447|NCT01649544|Vasodilator Agents|vasodilator agents|mesh-ancestor
65136448|NCT01649544|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65136449|NCT01649544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65136450|NCT01649544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136451|NCT01649544|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65136452|NCT01649544|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65136453|NCT01649544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65136467|NCT01179334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65136468|NCT01179334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65136469|NCT01179334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136470|NCT01179334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136471|NCT01179334|Urological Agents|urological agents|mesh-ancestor
65136472|NCT01179334|Enzyme Activators|enzyme activators|mesh-ancestor
65136473|NCT01649622|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65136474|NCT01649622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65136475|NCT01649622|Alkylating Agents|alkylating agents|mesh-ancestor
65136476|NCT01649622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136477|NCT01649622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136478|NCT01683747|Tranexamic Acid|tranexamic acid|mesh-list
65136479|NCT01683747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65136480|NCT01683747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65136481|NCT01683747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136482|NCT01683747|Hemostatics|hemostatics|mesh-ancestor
65136483|NCT01683747|Coagulants|coagulants|mesh-ancestor
65136484|NCT01178671|Mirtazapine|mirtazapine|mesh-list
65136485|NCT01178671|Sertraline|sertraline|mesh-list
65136486|NCT01178671|Antidepressive Agents|antidepressive agents|mesh-ancestor
65136487|NCT01178671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65136488|NCT01178671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65136489|NCT01178671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65136490|NCT01178671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65136491|NCT01178671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136492|NCT01178671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65301215|NCT01014637|Miconazole|miconazole|mesh-list
65301216|NCT01014637|Amorolfine|amorolfine|mesh-list
65301217|NCT01014637|Ciclopirox|ciclopirox|mesh-list
65301218|NCT01014637|Keratolytic Agents|keratolytic agents|mesh-list
65301219|NCT01014637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65301220|NCT01014637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64531320|NCT03983850|Busulfan|busulfan|mesh-list
65136493|NCT01178671|Serotonin Agents|serotonin agents|mesh-ancestor
65136494|NCT01178671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136495|NCT01178671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65136496|NCT01178671|Histamine Antagonists|histamine antagonists|mesh-ancestor
65136497|NCT01178671|Histamine Agents|histamine agents|mesh-ancestor
65136498|NCT01178671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65136499|NCT01178671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64779018|NCT05715840|Paclitaxel|paclitaxel|mesh-list
65136500|NCT01178671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65136501|NCT01178671|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65136502|NCT01178671|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65136503|NCT01178671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65136504|NCT01178671|Adrenergic Agents|adrenergic agents|mesh-ancestor
65136505|NCT01178671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65136506|NCT01178671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65136507|NCT01178671|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65136508|NCT04532060|Anti-Infective Agents|anti-infective agents|mesh-list
65136509|NCT04532060|Nystatin|nystatin|mesh-list
65136510|NCT04532060|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65136511|NCT04532060|Antifungal Agents|antifungal agents|mesh-ancestor
65136512|NCT04532060|Ionophores|ionophores|mesh-ancestor
65136521|NCT01649739|Urological Agents|urological agents|mesh-ancestor
65136522|NCT04532333|Heparin|heparin|mesh-list
65136523|NCT04532333|Bivalirudin|bivalirudin|mesh-list
65136524|NCT04532333|Anticoagulants|anticoagulants|mesh-ancestor
65136525|NCT04532333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65136526|NCT04532333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65136527|NCT04532333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136528|NCT04532333|Antithrombins|antithrombins|mesh-ancestor
65136529|NCT04532333|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65136530|NCT04532333|Protease Inhibitors|protease inhibitors|mesh-ancestor
65136531|NCT04532333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136532|NCT01649895|Cycloserine|cycloserine|mesh-list
65136533|NCT01649895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65136534|NCT01649895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65136535|NCT01649895|Renal Agents|renal agents|mesh-ancestor
65136536|NCT01649895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65136537|NCT01649895|Antitubercular Agents|antitubercular agents|mesh-ancestor
65136538|NCT01649895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65136539|NCT01649895|Antimetabolites|antimetabolites|mesh-ancestor
65136540|NCT01649895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136541|NCT01649505|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65136542|NCT01649505|Hemostatics|hemostatics|mesh-ancestor
65136543|NCT01649505|Coagulants|coagulants|mesh-ancestor
65136544|NCT01178086|Rituximab|rituximab|mesh-list
65136545|NCT01178086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65136546|NCT01178086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136547|NCT01178086|Immunologic Factors|immunologic factors|mesh-ancestor
65136548|NCT01178086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136549|NCT01178086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65136550|NCT04531865|Mycophenolic Acid|mycophenolic acid|mesh-list
65136551|NCT04531865|Rituximab|rituximab|mesh-list
65136552|NCT04531865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65136553|NCT04531865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136554|NCT04531865|Immunologic Factors|immunologic factors|mesh-ancestor
65136555|NCT04531865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136556|NCT04531865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65136557|NCT04531865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65136558|NCT04531865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65136559|NCT04531865|Antitubercular Agents|antitubercular agents|mesh-ancestor
65136560|NCT04531865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65136561|NCT04531865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65136562|NCT04531865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136563|NCT04531865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136564|NCT01643070|Capecitabine|capecitabine|mesh-list
65301221|NCT01014637|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65301222|NCT01014637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65301223|NCT01014637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301224|NCT01014637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051113|NCT00223691|Tocolytic Agents|tocolytic agents|mesh-ancestor
65301225|NCT01014637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65301226|NCT01014637|Hormone Antagonists|hormone antagonists|mesh-ancestor
65301227|NCT01014637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65301228|NCT01014637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301229|NCT01014637|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65301230|NCT01014637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65301231|NCT01014637|Dermatologic Agents|dermatologic agents|mesh-ancestor
65301232|NCT00696566|Rifampin|rifampin|mesh-list
65301233|NCT00696566|Clopidogrel|clopidogrel|mesh-list
65301234|NCT00696566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65301235|NCT00696566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65301236|NCT00696566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65301237|NCT00696566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64531338|NCT03981900|Tofacitinib|tofacitinib|mesh-list
65136565|NCT01643070|Oxaliplatin|oxaliplatin|mesh-list
65136566|NCT01643070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65136567|NCT01643070|Antimetabolites|antimetabolites|mesh-ancestor
65136568|NCT01643070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136569|NCT01643070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136570|NCT01684059|Zinc Sulfate|zinc sulfate|mesh-list
65136571|NCT01684059|Astringents|astringents|mesh-ancestor
65136572|NCT01684059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136573|NCT01684059|Dermatologic Agents|dermatologic agents|mesh-ancestor
65136574|NCT04531748|Toremifene|toremifene|mesh-list
64779080|NCT05618808|Enoxaparin|enoxaparin|mesh-list
65136575|NCT04531748|Melatonin|melatonin|mesh-list
65136576|NCT04531748|Antioxidants|antioxidants|mesh-ancestor
65136577|NCT04531748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709127|NCT02747186|Anesthetics|anesthetics|mesh-ancestor
65136587|NCT04531748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65136589|NCT01177813|Empagliflozin|empagliflozin|mesh-list
65136590|NCT01177813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65136591|NCT01177813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136592|NCT01177813|Incretins|incretins|mesh-ancestor
65136593|NCT01177813|Hormones|hormones|mesh-ancestor
65136594|NCT01177813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65136595|NCT01177813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65136596|NCT01177813|Protease Inhibitors|protease inhibitors|mesh-ancestor
65136597|NCT01177813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136598|NCT01177813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136599|NCT01177813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65136600|NCT01684098|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
65136601|NCT01684098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65136602|NCT01684098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136603|NCT04315831|Buprenorphine|buprenorphine|mesh-list
65136604|NCT04315831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65136605|NCT04315831|Narcotics|narcotics|mesh-ancestor
65136606|NCT04315831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65301238|NCT00696566|Purinergic Agents|purinergic agents|mesh-ancestor
65301239|NCT00696566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65301240|NCT00696566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301241|NCT00696566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301242|NCT00696566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65301243|NCT00696566|Antitubercular Agents|antitubercular agents|mesh-ancestor
65301244|NCT00696566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65301245|NCT00696566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65301246|NCT00696566|Leprostatic Agents|leprostatic agents|mesh-ancestor
65301247|NCT00696566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65301248|NCT00696566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301249|NCT00696566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65301250|NCT00696566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65301251|NCT00696566|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65301252|NCT00696566|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65301253|NCT00696566|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65301254|NCT00696566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65301255|NCT01017133|Deoxyglucose|deoxyglucose|mesh-list
65136607|NCT04315831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136608|NCT04315831|Analgesics|analgesics|mesh-ancestor
65136609|NCT04315831|Sensory System Agents|sensory system agents|mesh-ancestor
65136610|NCT04315831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65136611|NCT04315831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65136612|NCT02216045|Ribavirin|ribavirin|mesh-list
65136613|NCT02216045|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65136614|NCT02216045|Interferon-alpha|interferon-alpha|mesh-list
65136615|NCT02216045|Antimetabolites|antimetabolites|mesh-ancestor
65136616|NCT02216045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136617|NCT02216045|Antiviral Agents|antiviral agents|mesh-ancestor
65136618|NCT02216045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65136619|NCT02216045|Immunologic Factors|immunologic factors|mesh-ancestor
65136620|NCT02216045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136621|NCT01684371|Tea Tree Oil|tea tree oil|mesh-list
65136622|NCT01684371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65136623|NCT01684371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65136624|NCT01684371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65136625|NCT04531397|Dapagliflozin|dapagliflozin|mesh-list
65136626|NCT04531397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65136627|NCT04531397|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65136628|NCT04531397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136630|NCT04531397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136631|NCT04531397|Protease Inhibitors|protease inhibitors|mesh-ancestor
65136632|NCT04531397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136633|NCT04531475|Lansoprazole|lansoprazole|mesh-list
65136634|NCT04531475|Dexlansoprazole|dexlansoprazole|mesh-list
65136635|NCT04531475|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65136636|NCT04531475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65136637|NCT04531475|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65136638|NCT04531475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136639|NCT04531475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136643|NCT01684449|Antimetabolites|antimetabolites|mesh-ancestor
65136644|NCT01684449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136645|NCT01684449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301256|NCT01017133|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65301257|NCT01017133|Fluorides|fluorides|mesh-list
65301258|NCT01017133|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65301259|NCT01017133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301260|NCT01017133|Cariostatic Agents|cariostatic agents|mesh-ancestor
65301261|NCT01017133|Protective Agents|protective agents|mesh-ancestor
65301262|NCT01017133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301263|NCT01017133|Antimetabolites|antimetabolites|mesh-ancestor
65301264|NCT01017133|Antiviral Agents|antiviral agents|mesh-ancestor
65301265|NCT01017133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65301266|NCT00869258|Gemcitabine|gemcitabine|mesh-list
65301267|NCT00869258|Capecitabine|capecitabine|mesh-list
65301268|NCT00869258|Docetaxel|docetaxel|mesh-list
65301269|NCT00869258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65301270|NCT00869258|Antimetabolites|antimetabolites|mesh-ancestor
65301271|NCT00869258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301272|NCT00869258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301273|NCT00869258|Antiviral Agents|antiviral agents|mesh-ancestor
65301274|NCT00869258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65136646|NCT01684449|Antiviral Agents|antiviral agents|mesh-ancestor
65136647|NCT01684449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65136648|NCT01684449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136649|NCT01684449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65136650|NCT01684449|Immunologic Factors|immunologic factors|mesh-ancestor
65136651|NCT01684449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136652|NCT01684449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65136653|NCT01684449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65136654|NCT01684449|Antifungal Agents|antifungal agents|mesh-ancestor
65136655|NCT04537403|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
65136656|NCT04537403|Chelating Agents|chelating agents|mesh-ancestor
65136657|NCT04537403|Sequestering Agents|sequestering agents|mesh-ancestor
65136658|NCT04537403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136659|NCT01684683|Theophylline|theophylline|mesh-list
65136660|NCT01684683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65136661|NCT01684683|Autonomic Agents|autonomic agents|mesh-ancestor
65136662|NCT01684683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65136663|NCT01684683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136664|NCT01684683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65136665|NCT01684683|Respiratory System Agents|respiratory system agents|mesh-ancestor
65136666|NCT01684683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65136667|NCT01684683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136668|NCT01684683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136669|NCT01684683|Vasodilator Agents|vasodilator agents|mesh-ancestor
65136670|NCT01684683|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65136671|NCT01684683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65136672|NCT01684683|Purinergic Agents|purinergic agents|mesh-ancestor
65136673|NCT01684683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65136674|NCT01684800|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65136675|NCT01684800|Hemostatics|hemostatics|mesh-ancestor
65136676|NCT01684800|Coagulants|coagulants|mesh-ancestor
65136677|NCT01684800|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65136678|NCT01684800|Natriuretic Agents|natriuretic agents|mesh-ancestor
65136679|NCT01684800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136680|NCT04531163|Acetylcysteine|acetylcysteine|mesh-list
65136681|NCT04531163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65136682|NCT04531163|Antiviral Agents|antiviral agents|mesh-ancestor
65301275|NCT00869258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301276|NCT00869258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65301277|NCT00869258|Immunologic Factors|immunologic factors|mesh-ancestor
65301278|NCT00869258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301279|NCT00869258|Tubulin Modulators|tubulin modulators|mesh-ancestor
65301280|NCT00869258|Antimitotic Agents|antimitotic agents|mesh-ancestor
65301281|NCT00869258|Mitosis Modulators|mitosis modulators|mesh-ancestor
65301282|NCT00696644|Teriparatide|teriparatide|mesh-list
65301283|NCT00696644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65301284|NCT00696644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301285|NCT00696644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65301286|NCT01017367|Antibodies|antibodies|mesh-list
65301287|NCT01017367|Immunologic Factors|immunologic factors|mesh-ancestor
65301288|NCT01017367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301289|NCT00696722|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65301290|NCT00696722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65136683|NCT04531163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65136684|NCT04531163|Expectorants|expectorants|mesh-ancestor
65136685|NCT04531163|Respiratory System Agents|respiratory system agents|mesh-ancestor
65136686|NCT04531163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65136687|NCT04531163|Antioxidants|antioxidants|mesh-ancestor
65136688|NCT04531163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136689|NCT04531163|Protective Agents|protective agents|mesh-ancestor
65136690|NCT04531163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136691|NCT04531163|Antidotes|antidotes|mesh-ancestor
65136692|NCT01684995|Nicotine|nicotine|mesh-list
65136693|NCT01684995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65136694|NCT01684995|Autonomic Agents|autonomic agents|mesh-ancestor
65136695|NCT01684995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65136696|NCT01684995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136697|NCT01684995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65136698|NCT01684995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65136699|NCT01684995|Cholinergic Agents|cholinergic agents|mesh-ancestor
65136700|NCT01684995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65136701|NCT01684995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136702|NCT01685502|Acarbose|acarbose|mesh-list
65136703|NCT01685502|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65136704|NCT01685502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136705|NCT01685502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136706|NCT01685502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65136707|NCT01685502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136708|NCT04527276|Chlorhexidine|chlorhexidine|mesh-list
65136709|NCT04527276|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65136710|NCT04527276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65136711|NCT04527276|Disinfectants|disinfectants|mesh-ancestor
65136716|NCT01200355|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65136717|NCT01200355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65136718|NCT01200355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65136719|NCT01200355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65136720|NCT01200355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65136721|NCT01200355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136722|NCT01200355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136723|NCT01200355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65136724|NCT01200355|Hormone Antagonists|hormone antagonists|mesh-ancestor
65136725|NCT01200355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65136726|NCT01200355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136727|NCT04527666|Anticoagulants|anticoagulants|mesh-list
65136729|NCT04530500|Hormones|hormones|mesh-ancestor
65222823|NCT02699385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65301291|NCT00696722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65301292|NCT00696722|Protease Inhibitors|protease inhibitors|mesh-ancestor
65301293|NCT00696722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301294|NCT00696722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301295|NCT00696722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65301296|NCT00696722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65301297|NCT00696722|Antiviral Agents|antiviral agents|mesh-ancestor
65301298|NCT00696722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65301299|NCT00696956|Paclitaxel|paclitaxel|mesh-list
65301300|NCT00696956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65301301|NCT00696956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301302|NCT00696956|Tubulin Modulators|tubulin modulators|mesh-ancestor
65301303|NCT00696956|Antimitotic Agents|antimitotic agents|mesh-ancestor
65301304|NCT00696956|Mitosis Modulators|mitosis modulators|mesh-ancestor
65136730|NCT04530500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65136731|NCT04530500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136732|NCT01685658|Acetaminophen|acetaminophen|mesh-list
65136733|NCT01685658|Ketoprofen|ketoprofen|mesh-list
65136734|NCT01685658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65136735|NCT01685658|Analgesics|analgesics|mesh-ancestor
65136736|NCT01685658|Sensory System Agents|sensory system agents|mesh-ancestor
65136737|NCT01685658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65136738|NCT01685658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136739|NCT01685658|Antipyretics|antipyretics|mesh-ancestor
65136740|NCT01685658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65136741|NCT01685658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65136742|NCT01685658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65136743|NCT01685658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65136744|NCT01685658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136745|NCT01685658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136746|NCT04530578|Heparin|heparin|mesh-list
65136747|NCT04530578|Calcium heparin|calcium heparin|mesh-list
65136748|NCT04530578|Enoxaparin|enoxaparin|mesh-list
65136749|NCT04530578|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65136750|NCT04530578|Tinzaparin|tinzaparin|mesh-list
65136751|NCT04530578|Dalteparin|dalteparin|mesh-list
65136752|NCT04530578|Anticoagulants|anticoagulants|mesh-ancestor
65136753|NCT04530578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65136754|NCT04530578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65136755|NCT04530578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136756|NCT01685853|Bisacodyl|bisacodyl|mesh-list
65136757|NCT01685853|Cathartics|cathartics|mesh-ancestor
65136758|NCT01685853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65136759|NCT01685853|Laxatives|laxatives|mesh-ancestor
65136760|NCT04530422|Azithromycin|azithromycin|mesh-list
65136761|NCT04530422|Hydroxychloroquine|hydroxychloroquine|mesh-list
65136762|NCT04530422|Sofosbuvir|sofosbuvir|mesh-list
65136763|NCT04530422|Oseltamivir|oseltamivir|mesh-list
65136764|NCT04530422|Ledipasvir|ledipasvir|mesh-list
65136765|NCT04530422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65136766|NCT04530422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65136767|NCT04530422|Antimalarials|antimalarials|mesh-ancestor
65136768|NCT04530422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65136769|NCT04530422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65136770|NCT04530422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136771|NCT04530422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136772|NCT04530422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65136773|NCT04530422|Antiviral Agents|antiviral agents|mesh-ancestor
65136774|NCT02887573|Mosapride|mosapride|mesh-list
65136775|NCT02887573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136776|NCT02887573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65136777|NCT02887573|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65136778|NCT02887573|Serotonin Agents|serotonin agents|mesh-ancestor
65136779|NCT02887573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65301305|NCT00696956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301306|NCT02616848|Everolimus|everolimus|mesh-list
65301307|NCT02616848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301308|NCT02616848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65301309|NCT02616848|Immunologic Factors|immunologic factors|mesh-ancestor
64531409|NCT03864419|Tubulin Modulators|tubulin modulators|mesh-ancestor
65136780|NCT02887573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136782|NCT01685892|Obinutuzumab|obinutuzumab|mesh-list
65136783|NCT01685892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136784|NCT01685892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65136785|NCT02887534|Tizanidine|tizanidine|mesh-list
65136786|NCT02887534|Analgesics|analgesics|mesh-ancestor
65136787|NCT02887534|Sensory System Agents|sensory system agents|mesh-ancestor
65136808|NCT01685931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65136809|NCT01685931|Serotonin Agents|serotonin agents|mesh-ancestor
65136810|NCT01685931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65136811|NCT01685931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136812|NCT01685931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65136813|NCT01685931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65136814|NCT01685931|Dopamine Agents|dopamine agents|mesh-ancestor
65136815|NCT01685970|Picosulfate sodium|picosulfate sodium|mesh-list
65136816|NCT01685970|Cathartics|cathartics|mesh-ancestor
65136817|NCT01685970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65136818|NCT04530617|Camostat|camostat|mesh-list
65136819|NCT04530617|Protease Inhibitors|protease inhibitors|mesh-ancestor
65136820|NCT04530617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136821|NCT04530617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136822|NCT04530617|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65136823|NCT04530617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65136824|NCT01686009|Ketamine|ketamine|mesh-list
65136825|NCT01686009|Analgesics|analgesics|mesh-ancestor
65136826|NCT01686009|Sensory System Agents|sensory system agents|mesh-ancestor
65136827|NCT01686009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65136828|NCT01686009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136829|NCT01686009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65136830|NCT01686009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65136831|NCT01686009|Anesthetics, General|anesthetics, general|mesh-ancestor
65136832|NCT01686009|Anesthetics|anesthetics|mesh-ancestor
65136833|NCT01686009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65136834|NCT01686009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65136835|NCT01686009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65136836|NCT01686009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65136837|NCT01686009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136838|NCT04536662|Dexamethasone|dexamethasone|mesh-list
65136843|NCT04536662|Autonomic Agents|autonomic agents|mesh-ancestor
65136844|NCT04536662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65136845|NCT04536662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136846|NCT04536662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65136847|NCT04536662|Glucocorticoids|glucocorticoids|mesh-ancestor
65136848|NCT04536662|Hormones|hormones|mesh-ancestor
65136849|NCT04536662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65136850|NCT04536662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65136851|NCT04536662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136852|NCT01686321|Rituximab|rituximab|mesh-list
65136853|NCT01686321|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65136854|NCT01686321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65136855|NCT01686321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136856|NCT01686321|Immunologic Factors|immunologic factors|mesh-ancestor
65136857|NCT01686321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136858|NCT01686321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65136859|NCT01686321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65136860|NCT01686321|Alkylating Agents|alkylating agents|mesh-ancestor
65136861|NCT01686321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136862|NCT01199731|Etravirine|etravirine|mesh-list
65136863|NCT01199731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65136864|NCT01199731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65136865|NCT01199731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136866|NCT01199731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301310|NCT02616848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301311|NCT02620124|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65301312|NCT02620124|Hormones|hormones|mesh-list
65301313|NCT02620124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65301314|NCT02620124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301315|NCT02620124|Luteolytic Agents|luteolytic agents|mesh-ancestor
65301316|NCT02620124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65301317|NCT02620124|Contraceptive Agents|contraceptive agents|mesh-ancestor
65301318|NCT02620124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65301319|NCT02620124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65301320|NCT02620124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65301321|NCT02620124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301322|NCT04134650|Metformin|metformin|mesh-list
65301323|NCT04134650|Linagliptin|linagliptin|mesh-list
65301324|NCT04134650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65301325|NCT04134650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301326|NCT04134650|Incretins|incretins|mesh-ancestor
65301327|NCT04134650|Hormones|hormones|mesh-ancestor
65301328|NCT04134650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65301329|NCT04134650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65301330|NCT04134650|Protease Inhibitors|protease inhibitors|mesh-ancestor
65301331|NCT04134650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531412|NCT03864419|Keratolytic Agents|keratolytic agents|mesh-ancestor
64531413|NCT03859427|Dexamethasone|dexamethasone|mesh-list
65136867|NCT01199731|Antiviral Agents|antiviral agents|mesh-ancestor
65136868|NCT01199731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65136869|NCT01686555|Venetoclax|venetoclax|mesh-list
65136870|NCT01686555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136871|NCT01686711|Pioglitazone|pioglitazone|mesh-list
65136872|NCT01686711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65136873|NCT01686711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136875|NCT01686789|Interferon-alpha|interferon-alpha|mesh-list
65136876|NCT01686789|Interferon alpha-2|interferon alpha-2|mesh-list
65136877|NCT01686789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65136878|NCT01686789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136879|NCT01686789|Antiviral Agents|antiviral agents|mesh-ancestor
65136880|NCT01686789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65136881|NCT01686789|Immunologic Factors|immunologic factors|mesh-ancestor
65136882|NCT01686789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136883|NCT02217683|Nitric Oxide|nitric oxide|mesh-list
65136884|NCT02217683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65136885|NCT02217683|Autonomic Agents|autonomic agents|mesh-ancestor
65136886|NCT02217683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65136887|NCT02217683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136888|NCT02217683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65136889|NCT02217683|Respiratory System Agents|respiratory system agents|mesh-ancestor
65136890|NCT02217683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65136891|NCT02217683|Antioxidants|antioxidants|mesh-ancestor
65136892|NCT02217683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136893|NCT02217683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65222824|NCT02699385|Dopamine Agents|dopamine agents|mesh-ancestor
65301332|NCT04134650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301333|NCT00488683|Vaccines|vaccines|mesh-list
65301334|NCT00488683|Immunologic Factors|immunologic factors|mesh-ancestor
65301335|NCT00488683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301336|NCT02563288|Dexmedetomidine|dexmedetomidine|mesh-list
65301337|NCT02563288|Esmolol|esmolol|mesh-list
64454227|NCT02030015|Miglustat|miglustat|mesh-list
65136894|NCT02217683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65136895|NCT02217683|Vasodilator Agents|vasodilator agents|mesh-ancestor
65136896|NCT02217683|Gasotransmitters|gasotransmitters|mesh-ancestor
65136897|NCT02217683|Protective Agents|protective agents|mesh-ancestor
65136898|NCT02217722|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65136899|NCT02217722|Amoxicillin|amoxicillin|mesh-list
65136900|NCT02217722|Metronidazole|metronidazole|mesh-list
65136901|NCT02217722|Doxycycline|doxycycline|mesh-list
65136902|NCT02217722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65136903|NCT02217722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65136904|NCT02217722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65136905|NCT02217722|Antimalarials|antimalarials|mesh-ancestor
65136906|NCT02217839|Octreotide|octreotide|mesh-list
65136907|NCT02217839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65136908|NCT02217839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65136909|NCT02217839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136910|NCT01687062|Fe(III)-EDTA|fe(iii)-edta|mesh-list
65136911|NCT01687062|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65136912|NCT01687062|Chelating Agents|chelating agents|mesh-ancestor
65136913|NCT01687062|Sequestering Agents|sequestering agents|mesh-ancestor
65136922|NCT02217956|Growth Inhibitors|growth inhibitors|mesh-ancestor
65136923|NCT01687140|Cycloserine|cycloserine|mesh-list
65136924|NCT01687140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65136925|NCT01687140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65136926|NCT01687140|Renal Agents|renal agents|mesh-ancestor
65136927|NCT01687140|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65136928|NCT01687140|Antitubercular Agents|antitubercular agents|mesh-ancestor
65136929|NCT01687140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65136930|NCT01687140|Antimetabolites|antimetabolites|mesh-ancestor
65136931|NCT01687140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136932|NCT04535960|Liraglutide|liraglutide|mesh-list
65136933|NCT04535960|Empagliflozin|empagliflozin|mesh-list
65136934|NCT04535960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65136935|NCT04535960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136936|NCT04535960|Incretins|incretins|mesh-ancestor
65136938|NCT04535960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65136939|NCT04535960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65136940|NCT04535960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136941|NCT04536428|Hemostatics|hemostatics|mesh-list
65136942|NCT04536428|Coagulants|coagulants|mesh-ancestor
65136943|NCT01687374|Hormones|hormones|mesh-list
65136944|NCT01687374|Parathyroid Hormone|parathyroid hormone|mesh-list
65136945|NCT01687374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65136946|NCT01687374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136947|NCT01687374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65136948|NCT04530188|Propofol|propofol|mesh-list
65136949|NCT04530188|Sevoflurane|sevoflurane|mesh-list
65136950|NCT04530188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65136951|NCT04530188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65136952|NCT04530188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136953|NCT04530188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65136954|NCT04530188|Anesthetics, General|anesthetics, general|mesh-ancestor
65136955|NCT04530188|Anesthetics|anesthetics|mesh-ancestor
65136956|NCT04530188|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65136957|NCT04530188|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65136958|NCT01687491|Enoxaparin|enoxaparin|mesh-list
65136959|NCT01687491|Anticoagulants|anticoagulants|mesh-ancestor
65136960|NCT01687491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65136961|NCT01687491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65136962|NCT01687491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136963|NCT04530227|Paclitaxel|paclitaxel|mesh-list
65136964|NCT04530227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65136965|NCT04530227|Pemetrexed|pemetrexed|mesh-list
65301338|NCT02563288|Adrenergic Agents|adrenergic agents|mesh-list
65301339|NCT02563288|Adrenergic Agonists|adrenergic agonists|mesh-list
65301340|NCT02563288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-list
65301341|NCT02563288|Adrenergic Antagonists|adrenergic antagonists|mesh-list
65301342|NCT02563288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65301343|NCT02563288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65301344|NCT02563288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301345|NCT02563288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65301346|NCT02563288|Analgesics|analgesics|mesh-ancestor
65301347|NCT02563288|Sensory System Agents|sensory system agents|mesh-ancestor
65301348|NCT02563288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65301349|NCT02563288|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65301350|NCT02563288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65301351|NCT02563288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301352|NCT02563288|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64531442|NCT03728972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136966|NCT04530227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65136967|NCT04530227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136968|NCT04530227|Tubulin Modulators|tubulin modulators|mesh-ancestor
65136969|NCT04530227|Antimitotic Agents|antimitotic agents|mesh-ancestor
65136970|NCT04530227|Mitosis Modulators|mitosis modulators|mesh-ancestor
65136971|NCT04530227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136972|NCT04530227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136973|NCT04530227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65136974|NCT04530227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65136975|NCT01199263|Paclitaxel|paclitaxel|mesh-list
65136976|NCT01199263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65136977|NCT01199263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65136978|NCT01199263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136991|NCT01688154|Proanthocyanidin|proanthocyanidin|mesh-list
65136992|NCT01688154|Procyanidin|procyanidin|mesh-list
65136993|NCT01688154|Antioxidants|antioxidants|mesh-ancestor
65136994|NCT01688154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136995|NCT01688154|Protective Agents|protective agents|mesh-ancestor
65136996|NCT01688154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136997|NCT01688154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65136998|NCT01688154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65136999|NCT01688154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65137000|NCT01688349|Glucocorticoids|glucocorticoids|mesh-list
65137001|NCT01688349|Hormones|hormones|mesh-ancestor
65137002|NCT01688349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65137003|NCT01688349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137004|NCT05138484|Chlorhexidine|chlorhexidine|mesh-list
65137005|NCT05138484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65137006|NCT05138484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65137007|NCT05138484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65137008|NCT05138484|Disinfectants|disinfectants|mesh-ancestor
65137009|NCT05138484|Dermatologic Agents|dermatologic agents|mesh-ancestor
65137010|NCT04535804|Aspirin|aspirin|mesh-list
65137011|NCT04535804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65137012|NCT04535804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65137013|NCT04535804|Analgesics|analgesics|mesh-ancestor
65137014|NCT04535804|Sensory System Agents|sensory system agents|mesh-ancestor
65137015|NCT04535804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65137016|NCT04535804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137017|NCT04535804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65137018|NCT04535804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65301353|NCT02563288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65301354|NCT00711269|Risperidone|risperidone|mesh-list
65301355|NCT00711269|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65301356|NCT00711269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65301357|NCT00711269|Serotonin Agents|serotonin agents|mesh-ancestor
65301358|NCT00711269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65301359|NCT00711269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301360|NCT00711269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301361|NCT00711269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65301362|NCT00711269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65301363|NCT00711269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65301364|NCT00711269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65301365|NCT00711269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65301366|NCT00711269|Dopamine Agents|dopamine agents|mesh-ancestor
65301367|NCT00711269|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65301368|NCT00711269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65301369|NCT00711269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65301370|NCT00711269|Adrenergic Agents|adrenergic agents|mesh-ancestor
65301371|NCT00711269|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65301372|NCT00711269|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65301373|NCT01014793|Cabergoline|cabergoline|mesh-list
65137019|NCT04535804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65137020|NCT04535804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65137021|NCT04535804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137022|NCT04535804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65137023|NCT04535804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65137024|NCT04535804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137025|NCT04535804|Antipyretics|antipyretics|mesh-ancestor
65137026|NCT04529525|Ivermectin|ivermectin|mesh-list
65137027|NCT04529525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65137028|NCT04529525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65137029|NCT02216409|Magrolimab|magrolimab|mesh-list
65137030|NCT02216409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65137031|NCT02216409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137032|NCT05126121|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65137033|NCT05126121|Amoxicillin|amoxicillin|mesh-list
65137034|NCT05126121|Clarithromycin|clarithromycin|mesh-list
65137035|NCT05126121|Levofloxacin|levofloxacin|mesh-list
65137036|NCT05126121|Ofloxacin|ofloxacin|mesh-list
65137037|NCT05126121|Tetracycline|tetracycline|mesh-list
65137038|NCT05126121|Tinidazole|tinidazole|mesh-list
65137039|NCT05126121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65137040|NCT05126121|Furazolidone|furazolidone|mesh-list
65137041|NCT05126121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65137042|NCT05126121|Antitubercular Agents|antitubercular agents|mesh-ancestor
65137043|NCT05126121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65137044|NCT05126121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709586|NCT04336189|Artenimol|artenimol|mesh-list
65137054|NCT05126121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65137055|NCT05126121|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65137056|NCT05126121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65137057|NCT05126121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65137058|NCT05126121|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65137059|NCT05126121|Alkylating Agents|alkylating agents|mesh-ancestor
65301374|NCT01014793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65301375|NCT01014793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65301376|NCT01014793|Dopamine Agonists|dopamine agonists|mesh-ancestor
65301377|NCT01014793|Dopamine Agents|dopamine agents|mesh-ancestor
65301378|NCT01014793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65301379|NCT01014793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301380|NCT01014793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301382|NCT00286169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301383|NCT00693472|Propranolol|propranolol|mesh-list
65137060|NCT02218658|Brotizolam|brotizolam|mesh-list
65137061|NCT02218658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65137062|NCT02218658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65137063|NCT02218658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137064|NCT01199068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65137065|NCT01199068|Efatutazone|efatutazone|mesh-list
65137066|NCT01199068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137067|NCT01199068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65137068|NCT01199068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137069|NCT01199068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137070|NCT04535700|Pioglitazone|pioglitazone|mesh-list
65137071|NCT04535700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65137072|NCT04535700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137073|NCT01198873|Dronedarone|dronedarone|mesh-list
65137074|NCT01198873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65137075|NCT01198795|Citalopram|citalopram|mesh-list
65137076|NCT01198795|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65137077|NCT01198795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65137078|NCT01198795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65137079|NCT01198795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137080|NCT01198795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65137081|NCT01198795|Serotonin Agents|serotonin agents|mesh-ancestor
65137082|NCT01198795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137083|NCT01198795|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65137084|NCT01198795|Antidepressive Agents|antidepressive agents|mesh-ancestor
65137085|NCT01198795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65137086|NCT04918017|Esomeprazole|esomeprazole|mesh-list
65137087|NCT04918017|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65137088|NCT04918017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65137089|NCT04918017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65137090|NCT04918017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137091|NCT04918017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137092|NCT02278913|Insulin|insulin|mesh-list
65137093|NCT02278913|Insulin Glargine|insulin glargine|mesh-list
65137094|NCT02278913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65137095|NCT02278913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65137096|NCT02278913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137097|NCT02216513|Deferoxamine|deferoxamine|mesh-list
65137098|NCT02216513|Siderophores|siderophores|mesh-ancestor
65137099|NCT02216513|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65137100|NCT02216513|Chelating Agents|chelating agents|mesh-ancestor
65137101|NCT02216513|Sequestering Agents|sequestering agents|mesh-ancestor
64779592|NCT03873402|Nivolumab|nivolumab|mesh-list
65137102|NCT02216513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137103|NCT02218775|Aticaprant|aticaprant|mesh-list
65137104|NCT02218775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65137105|NCT02218775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137106|NCT02218775|Sensory System Agents|sensory system agents|mesh-ancestor
65137107|NCT02218775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65137113|NCT02216552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137114|NCT02216552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65137115|NCT01198756|Vaccines|vaccines|mesh-list
65137116|NCT01198756|Immunologic Factors|immunologic factors|mesh-ancestor
65137117|NCT01198756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137118|NCT02216487|Irinotecan|irinotecan|mesh-list
65137119|NCT02216487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65137120|NCT02216487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65301384|NCT00693472|Haloperidol|haloperidol|mesh-list
65301385|NCT00693472|Haloperidol decanoate|haloperidol decanoate|mesh-list
65301386|NCT00693472|Cholinergic Antagonists|cholinergic antagonists|mesh-list
65301387|NCT00693472|Antiemetics|antiemetics|mesh-ancestor
65301388|NCT00693472|Autonomic Agents|autonomic agents|mesh-ancestor
65301389|NCT00693472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65301390|NCT00693472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301391|NCT00693472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65301392|NCT00693472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65301393|NCT00693472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65301394|NCT00693472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65301395|NCT00693472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65301396|NCT00693472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65301397|NCT00693472|Dopamine Agents|dopamine agents|mesh-ancestor
65301398|NCT00693472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65301399|NCT00693472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301400|NCT00693472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65301401|NCT00693472|Cholinergic Agents|cholinergic agents|mesh-ancestor
65301402|NCT00693472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65137121|NCT02216487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137122|NCT02216487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137123|NCT02216487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137124|NCT02218814|Bupivacaine|bupivacaine|mesh-list
65137125|NCT02218814|Anesthetics, Local|anesthetics, local|mesh-ancestor
65137126|NCT02218814|Anesthetics|anesthetics|mesh-ancestor
65137127|NCT02218814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65137128|NCT02218814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137129|NCT02218814|Sensory System Agents|sensory system agents|mesh-ancestor
65137130|NCT02218814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65137131|NCT02216565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65137132|NCT02216565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65137133|NCT02216565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65137134|NCT02216565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137135|NCT04534803|BCG Vaccine|bcg vaccine|mesh-list
65137136|NCT04534803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65137137|NCT04534803|Immunologic Factors|immunologic factors|mesh-ancestor
65137138|NCT04534803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137139|NCT01198132|Vitamin D|vitamin d|mesh-list
65137140|NCT01198132|Ergocalciferols|ergocalciferols|mesh-list
65137141|NCT01198132|Cholecalciferol|cholecalciferol|mesh-list
65137142|NCT01198132|Vitamins|vitamins|mesh-list
65137143|NCT01198132|Interferons|interferons|mesh-list
65137144|NCT01198132|Interferon-beta|interferon-beta|mesh-list
65137145|NCT01198132|Interferon beta-1a|interferon beta-1a|mesh-list
65137146|NCT01198132|Micronutrients|micronutrients|mesh-ancestor
65137147|NCT01198132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137148|NCT01198132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65137149|NCT01198132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65137150|NCT01198132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137151|NCT01198132|Antiviral Agents|antiviral agents|mesh-ancestor
65137152|NCT01198132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65137153|NCT01198132|Immunologic Factors|immunologic factors|mesh-ancestor
65137154|NCT01198132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65137155|NCT02219165|Immunoglobulins|immunoglobulins|mesh-list
65137156|NCT02219165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65137157|NCT02219165|Antibodies|antibodies|mesh-list
65137158|NCT02219165|Immunologic Factors|immunologic factors|mesh-ancestor
65301403|NCT00693472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65301404|NCT00693472|Adrenergic Agents|adrenergic agents|mesh-ancestor
65301405|NCT00693472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65301406|NCT00693472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65301407|NCT00693472|Vasodilator Agents|vasodilator agents|mesh-ancestor
65301408|NCT00498433|Amlodipine|amlodipine|mesh-list
65301409|NCT00498433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65301410|NCT00498433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65301411|NCT00498433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65301412|NCT00498433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301413|NCT00498433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65301414|NCT00498433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301415|NCT00498433|Vasodilator Agents|vasodilator agents|mesh-ancestor
65301416|NCT02689583|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64454557|NCT01977937|Gabapentin|gabapentin|mesh-list
65137159|NCT02219165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137160|NCT04534725|Interferons|interferons|mesh-list
65137161|NCT04534725|Interferon-alpha|interferon-alpha|mesh-list
65137162|NCT04534725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137163|NCT04534725|Antiviral Agents|antiviral agents|mesh-ancestor
65137164|NCT04534725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65137165|NCT04534725|Immunologic Factors|immunologic factors|mesh-ancestor
65137166|NCT04534725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137167|NCT04534478|Prednisone|prednisone|mesh-list
65137168|NCT04534478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65137169|NCT04534478|Glucocorticoids|glucocorticoids|mesh-ancestor
65137170|NCT04534478|Hormones|hormones|mesh-ancestor
65137171|NCT04534478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65137172|NCT04534478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137173|NCT04534478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65137174|NCT04534478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137175|NCT02216669|Imidazole|imidazole|mesh-list
65137176|NCT02216669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137177|NCT02216669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137178|NCT03772158|Cetirizine|cetirizine|mesh-list
64709731|NCT02885636|Autonomic Agents|autonomic agents|mesh-ancestor
65137184|NCT03772158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65137185|NCT03772158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137186|NCT03772158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137187|NCT01196416|Cisplatin|cisplatin|mesh-list
65137188|NCT01196416|Temozolomide|temozolomide|mesh-list
65137189|NCT01196416|Vinblastine|vinblastine|mesh-list
65137190|NCT01196416|R04929097|r04929097|mesh-list
65137191|NCT01196416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137192|NCT01196416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65137193|NCT01196416|Alkylating Agents|alkylating agents|mesh-ancestor
65137194|NCT01196416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137195|NCT01196416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65137196|NCT01196416|Tubulin Modulators|tubulin modulators|mesh-ancestor
65137197|NCT01196416|Antimitotic Agents|antimitotic agents|mesh-ancestor
65137198|NCT01196416|Mitosis Modulators|mitosis modulators|mesh-ancestor
65137199|NCT01196416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137200|NCT01196104|Insulin|insulin|mesh-list
65137201|NCT01196104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65137202|NCT01196104|Insulin Glargine|insulin glargine|mesh-list
65137203|NCT01196104|Insulin Aspart|insulin aspart|mesh-list
65137204|NCT01196104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65137205|NCT01196104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137206|NCT04534322|Dexamethasone|dexamethasone|mesh-list
65137207|NCT04534322|Melphalan|melphalan|mesh-list
65137208|NCT04534322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65137209|NCT04534322|Antiemetics|antiemetics|mesh-ancestor
65301417|NCT02689583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65301418|NCT02689583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65301419|NCT02689583|Antitubercular Agents|antitubercular agents|mesh-ancestor
65301420|NCT00746746|Interferons|interferons|mesh-list
65301421|NCT00746746|Interferon-alpha|interferon-alpha|mesh-list
65301422|NCT00746746|Interferon alpha-2|interferon alpha-2|mesh-list
65301423|NCT00746746|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65301424|NCT00746746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301425|NCT00746746|Antiviral Agents|antiviral agents|mesh-ancestor
65301426|NCT00746746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65301427|NCT00746746|Immunologic Factors|immunologic factors|mesh-ancestor
65301428|NCT00746746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301429|NCT00498355|Ranibizumab|ranibizumab|mesh-list
65301430|NCT00498355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65301431|NCT00498355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65301432|NCT00498355|Growth Substances|growth substances|mesh-ancestor
65301433|NCT00498355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301434|NCT00498355|Growth Inhibitors|growth inhibitors|mesh-ancestor
65301435|NCT00498355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301436|NCT04539223|Evolocumab|evolocumab|mesh-list
64484202|NCT00809848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65137210|NCT04534322|Autonomic Agents|autonomic agents|mesh-ancestor
65137211|NCT04534322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65137212|NCT04534322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137213|NCT04534322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65137214|NCT04534322|Glucocorticoids|glucocorticoids|mesh-ancestor
65137215|NCT04534322|Hormones|hormones|mesh-ancestor
64514430|NCT02727387|Mitosis Modulators|mitosis modulators|mesh-ancestor
65137216|NCT04534322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65137217|NCT04534322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65137218|NCT04534322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137219|NCT04534322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65137220|NCT04534322|Alkylating Agents|alkylating agents|mesh-ancestor
65137221|NCT04534322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137222|NCT04534322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65137223|NCT04534322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65137224|NCT04534322|Immunologic Factors|immunologic factors|mesh-ancestor
65137225|NCT02219672|Ritonavir|ritonavir|mesh-list
65137226|NCT02219672|Lopinavir|lopinavir|mesh-list
65137227|NCT02219672|Tenofovir|tenofovir|mesh-list
65137228|NCT02219672|Lamivudine|lamivudine|mesh-list
65137229|NCT02219672|Raltegravir Potassium|raltegravir potassium|mesh-list
65137230|NCT02219672|Triptolide|triptolide|mesh-list
65137231|NCT02219672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65137232|NCT02219672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65137233|NCT02219672|Protease Inhibitors|protease inhibitors|mesh-ancestor
65137234|NCT02219672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137235|NCT02219672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137236|NCT02219672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65137237|NCT02219672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65137238|NCT02219672|Antiviral Agents|antiviral agents|mesh-ancestor
65137239|NCT02219672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65137240|NCT02219672|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65137241|NCT02219672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65137242|NCT02219672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65137243|NCT02219672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65301437|NCT04539223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65301438|NCT04539223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65301439|NCT04539223|Antimetabolites|antimetabolites|mesh-ancestor
65301440|NCT04539223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301441|NCT04539223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65301442|NCT01011751|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65301443|NCT01011751|Leuprolide|leuprolide|mesh-list
65301444|NCT01011751|Flutamide|flutamide|mesh-list
65301445|NCT01011751|Cyproterone Acetate|cyproterone acetate|mesh-list
65301446|NCT01011751|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65301447|NCT01011751|Medroxyprogesterone|medroxyprogesterone|mesh-list
65301448|NCT01011751|Cyproterone|cyproterone|mesh-list
65301449|NCT01011751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65051337|NCT00224354|Analgesics|analgesics|mesh-ancestor
65301450|NCT01011751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65301451|NCT01011751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65301452|NCT01011751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301453|NCT01011751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65137244|NCT02219672|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65137245|NCT02219672|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65137246|NCT02219672|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
65137247|NCT02219672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137248|NCT02219672|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65137276|NCT04534452|Respiratory System Agents|respiratory system agents|mesh-ancestor
65137277|NCT04534452|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65137278|NCT04534452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65137279|NCT04534452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65137280|NCT04534452|Adrenergic Agents|adrenergic agents|mesh-ancestor
65137281|NCT04534452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64514431|NCT01753115|Ciprofloxacin|ciprofloxacin|mesh-list
65137282|NCT04534452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137283|NCT04534452|Protective Agents|protective agents|mesh-ancestor
65137285|NCT03016338|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65137286|NCT03016338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137287|NCT03016338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137288|NCT03016338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137289|NCT02219789|Fulvestrant|fulvestrant|mesh-list
65137290|NCT02219789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65137291|NCT02219789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137292|NCT02219789|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65137293|NCT02219789|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65137294|NCT02219789|Hormone Antagonists|hormone antagonists|mesh-ancestor
65137307|NCT04533867|Dermatologic Agents|dermatologic agents|mesh-ancestor
65137308|NCT04533867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65137309|NCT04533867|Serotonin Agents|serotonin agents|mesh-ancestor
65137310|NCT04533867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65137311|NCT04533867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137312|NCT04533867|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65137313|NCT04533867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65137314|NCT04533867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65137315|NCT04533867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65137316|NCT04533867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65137317|NCT04533867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65137318|NCT02219867|Ketamine|ketamine|mesh-list
65137319|NCT02219867|Analgesics|analgesics|mesh-ancestor
65301454|NCT01011751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301455|NCT01011751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65301456|NCT01011751|Antidepressive Agents|antidepressive agents|mesh-ancestor
65301457|NCT01011751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65301458|NCT01011751|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65301459|NCT01011751|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65301460|NCT01011751|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65301461|NCT01011751|Contraceptive Agents|contraceptive agents|mesh-ancestor
65301462|NCT01011751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65301463|NCT01011751|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65301464|NCT01011751|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65301465|NCT01011751|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65301466|NCT01011751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65301467|NCT01011751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301468|NCT01011751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65301470|NCT01011751|Androgen Antagonists|androgen antagonists|mesh-ancestor
65301471|NCT01011751|Hormone Antagonists|hormone antagonists|mesh-ancestor
65301472|NCT01011751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65301473|NCT03672695|Venetoclax|venetoclax|mesh-list
65301474|NCT03672695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301475|NCT02686619|Cyclosporine|cyclosporine|mesh-list
65301476|NCT02686619|Sirolimus|sirolimus|mesh-list
65301477|NCT02686619|Prednisolone|prednisolone|mesh-list
65301478|NCT02686619|Cyclosporins|cyclosporins|mesh-list
65301479|NCT02686619|Daclizumab|daclizumab|mesh-list
65301480|NCT02686619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301481|NCT02686619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301482|NCT02686619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65301483|NCT02686619|Immunologic Factors|immunologic factors|mesh-ancestor
65301484|NCT02686619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301485|NCT02686619|Antifungal Agents|antifungal agents|mesh-ancestor
64531577|NCT03289234|Edaravone|edaravone|mesh-list
65137320|NCT02219867|Sensory System Agents|sensory system agents|mesh-ancestor
65137321|NCT02219867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65137322|NCT02219867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137323|NCT02219867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65137324|NCT02219867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65137325|NCT02219867|Anesthetics, General|anesthetics, general|mesh-ancestor
65137326|NCT02219867|Anesthetics|anesthetics|mesh-ancestor
65137327|NCT02219867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65137328|NCT02219867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65301486|NCT02686619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65301487|NCT02686619|Dermatologic Agents|dermatologic agents|mesh-ancestor
65301488|NCT02686619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65301489|NCT02686619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65301490|NCT02686619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65301491|NCT02686619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65301492|NCT02686619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301493|NCT02686619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65301494|NCT02686619|Glucocorticoids|glucocorticoids|mesh-ancestor
65301495|NCT02686619|Hormones|hormones|mesh-ancestor
65301496|NCT02686619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65301497|NCT02686619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65301498|NCT00688636|Infliximab|infliximab|mesh-list
65137329|NCT02219867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65137330|NCT02219867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65137331|NCT02219867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137332|NCT04533906|Povidone-Iodine|povidone-iodine|mesh-list
65137333|NCT04533906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65137334|NCT04533906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65137335|NCT02219906|Resveratrol|resveratrol|mesh-list
65137336|NCT02219906|Antioxidants|antioxidants|mesh-ancestor
65137337|NCT02219906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137338|NCT02219906|Protective Agents|protective agents|mesh-ancestor
65137339|NCT02219906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137340|NCT02219906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137341|NCT02219906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65137342|NCT04533243|Fentanyl|fentanyl|mesh-list
65137343|NCT04533243|Morphine|morphine|mesh-list
65137344|NCT04533243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65137345|NCT04533243|Narcotics|narcotics|mesh-ancestor
65137346|NCT04533243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65137347|NCT04533243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137348|NCT04533243|Analgesics|analgesics|mesh-ancestor
65137349|NCT04533243|Sensory System Agents|sensory system agents|mesh-ancestor
65137350|NCT04533243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65137351|NCT04533243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65137352|NCT04533243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65137353|NCT04533243|Anesthetics, General|anesthetics, general|mesh-ancestor
65137354|NCT04533243|Anesthetics|anesthetics|mesh-ancestor
65137355|NCT04533321|Afatinib|afatinib|mesh-list
65137357|NCT04533321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65137367|NCT01195675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65137368|NCT01195675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137369|NCT01195675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137370|NCT01195675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137371|NCT01195675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137372|NCT01195675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65137373|NCT01195675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65137374|NCT04532931|Acetaminophen|acetaminophen|mesh-list
65137376|NCT04532931|Artesunate|artesunate|mesh-list
65137377|NCT04532931|Favipiravir|favipiravir|mesh-list
65137378|NCT04532931|Amodiaquine|amodiaquine|mesh-list
65137379|NCT04532931|Nitazoxanide|nitazoxanide|mesh-list
65137380|NCT04532931|Pyronaridine|pyronaridine|mesh-list
65137381|NCT04532931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65137382|NCT04532931|Analgesics|analgesics|mesh-ancestor
65137383|NCT04532931|Sensory System Agents|sensory system agents|mesh-ancestor
65137384|NCT04532931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65137385|NCT04532931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137386|NCT04532931|Antipyretics|antipyretics|mesh-ancestor
65137387|NCT04532931|Antiviral Agents|antiviral agents|mesh-ancestor
65137388|NCT04532931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65137389|NCT04532931|Antimalarials|antimalarials|mesh-ancestor
65137390|NCT04532931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65301499|NCT00688636|Dermatologic Agents|dermatologic agents|mesh-ancestor
65301500|NCT00688636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65301501|NCT00688636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65301502|NCT00870740|Daclizumab|daclizumab|mesh-list
65301503|NCT00870740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65301504|NCT00870740|Immunologic Factors|immunologic factors|mesh-ancestor
65301505|NCT00870740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301506|NCT02686853|Amphotericin B|amphotericin b|mesh-list
65301507|NCT02686853|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65301508|NCT02686853|Amebicides|amebicides|mesh-ancestor
65301509|NCT02686853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65301510|NCT02686853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65301511|NCT02686853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65301512|NCT02686853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65301513|NCT02686853|Antifungal Agents|antifungal agents|mesh-ancestor
65301514|NCT01017679|Gefitinib|gefitinib|mesh-list
65301515|NCT01017679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301516|NCT01017679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65301517|NCT01017679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301518|NCT01017679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301519|NCT04130672|Hemostatics|hemostatics|mesh-list
65301520|NCT04130672|Coagulants|coagulants|mesh-ancestor
65301521|NCT00743314|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
65301522|NCT00743314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65301523|NCT00743314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301524|NCT02685449|Insulin|insulin|mesh-list
65301525|NCT02685449|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65301526|NCT02685449|Insulin Aspart|insulin aspart|mesh-list
65301527|NCT02685449|Insulin Lispro|insulin lispro|mesh-list
65301528|NCT02685449|Insulin glulisine|insulin glulisine|mesh-list
65301529|NCT02685449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65301530|NCT02685449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301531|NCT00697034|Capsaicin|capsaicin|mesh-list
65301532|NCT00697034|Antipruritics|antipruritics|mesh-ancestor
65301533|NCT00697034|Dermatologic Agents|dermatologic agents|mesh-ancestor
65301534|NCT00697034|Sensory System Agents|sensory system agents|mesh-ancestor
65301535|NCT00697034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65137391|NCT04532931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65137392|NCT04532931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137393|NCT04532931|Schistosomicides|schistosomicides|mesh-ancestor
65137394|NCT04532931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65301536|NCT00697034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301537|NCT00506779|Paclitaxel|paclitaxel|mesh-list
65301538|NCT00506779|Imatinib Mesylate|imatinib mesylate|mesh-list
65301539|NCT00506779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65301540|NCT00506779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301541|NCT00506779|Tubulin Modulators|tubulin modulators|mesh-ancestor
65301542|NCT00506779|Antimitotic Agents|antimitotic agents|mesh-ancestor
65301543|NCT00506779|Mitosis Modulators|mitosis modulators|mesh-ancestor
65301544|NCT00506779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301545|NCT00506779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65301546|NCT00506779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301547|NCT04185233|Nitrous Oxide|nitrous oxide|mesh-list
65301548|NCT04185233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65301549|NCT04185233|Anesthetics, General|anesthetics, general|mesh-ancestor
65301550|NCT04185233|Anesthetics|anesthetics|mesh-ancestor
65301551|NCT04185233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65301552|NCT04185233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301553|NCT04185233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65301554|NCT04185233|Analgesics|analgesics|mesh-ancestor
65301555|NCT04185233|Sensory System Agents|sensory system agents|mesh-ancestor
65137395|NCT04532931|Anthelmintics|anthelmintics|mesh-ancestor
65137396|NCT01195363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65137397|NCT01195363|Antidepressive Agents|antidepressive agents|mesh-ancestor
65137398|NCT01195363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65137399|NCT01195363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65137400|NCT01195363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65137401|NCT01195363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65137402|NCT01195363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137403|NCT01195090|Pioglitazone|pioglitazone|mesh-list
65137404|NCT01195090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65137405|NCT01195090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65137406|NCT01195090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137407|NCT01195090|Incretins|incretins|mesh-ancestor
65137408|NCT01195090|Hormones|hormones|mesh-ancestor
65137409|NCT01195090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65137410|NCT01195090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65137411|NCT01195090|Protease Inhibitors|protease inhibitors|mesh-ancestor
65137412|NCT01195090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137413|NCT01195090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137414|NCT02213081|Ulipristal acetate|ulipristal acetate|mesh-list
64779982|NCT00281658|Paclitaxel|paclitaxel|mesh-list
65137415|NCT02213081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65137416|NCT02213081|Contraceptive Agents|contraceptive agents|mesh-ancestor
65137417|NCT02213081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65137418|NCT02213081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137419|NCT02213081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65137420|NCT02213627|Menotropins|menotropins|mesh-list
65137421|NCT02213627|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65137422|NCT02213627|Fertility Agents|fertility agents|mesh-ancestor
65137423|NCT02213627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64709971|NCT03002012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137429|NCT02216799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137430|NCT02216877|Magnesium Hydroxide|magnesium hydroxide|mesh-list
65137431|NCT02216877|Antacids|antacids|mesh-ancestor
65137432|NCT02216877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301556|NCT04185233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65301557|NCT04185077|Heparin|heparin|mesh-list
65301558|NCT04185077|Calcium heparin|calcium heparin|mesh-list
65301559|NCT04185077|Bivalirudin|bivalirudin|mesh-list
65301560|NCT04185077|Antithrombins|antithrombins|mesh-list
65301561|NCT04185077|Thrombin|thrombin|mesh-list
65301562|NCT04185077|Anticoagulants|anticoagulants|mesh-ancestor
65301563|NCT04185077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65301564|NCT04185077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65301565|NCT04185077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301566|NCT04185077|Hemostatics|hemostatics|mesh-ancestor
65301567|NCT04185077|Coagulants|coagulants|mesh-ancestor
65301568|NCT04185077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65301569|NCT04185077|Protease Inhibitors|protease inhibitors|mesh-ancestor
65301570|NCT04185077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301571|NCT02686385|Acetylcysteine|acetylcysteine|mesh-list
65301572|NCT02686385|Prednisolone|prednisolone|mesh-list
65301573|NCT02686385|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65301574|NCT02686385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65301575|NCT02686385|Glucocorticoids|glucocorticoids|mesh-ancestor
65301576|NCT02686385|Hormones|hormones|mesh-ancestor
65301577|NCT02686385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65301578|NCT02686385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301579|NCT02686385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64531666|NCT03078946|GABA Agents|gaba agents|mesh-ancestor
65137433|NCT02216877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65137434|NCT02214563|Vitamin D|vitamin d|mesh-list
65137435|NCT02214563|Ergocalciferols|ergocalciferols|mesh-list
65137436|NCT02214563|Cholecalciferol|cholecalciferol|mesh-list
65137437|NCT02214563|Vitamins|vitamins|mesh-list
65137438|NCT02214563|Micronutrients|micronutrients|mesh-ancestor
65137439|NCT02214563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137440|NCT02214563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65137441|NCT02214563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65137442|NCT01194973|Eculizumab|eculizumab|mesh-list
65137443|NCT01194973|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65137444|NCT01194973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65137445|NCT01194973|Immunologic Factors|immunologic factors|mesh-ancestor
65137446|NCT01194973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137447|NCT02218619|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
65137448|NCT02218619|Antiviral Agents|antiviral agents|mesh-ancestor
65137449|NCT02218619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65137450|NCT02218619|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65137451|NCT02218619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65137452|NCT02218697|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65137453|NCT02218697|Immunologic Factors|immunologic factors|mesh-ancestor
65137454|NCT02218697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137455|NCT02216747|Prednisone|prednisone|mesh-list
65137456|NCT02216747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65137457|NCT02216747|Glucocorticoids|glucocorticoids|mesh-ancestor
65137458|NCT02216747|Hormones|hormones|mesh-ancestor
65137459|NCT02216747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65137460|NCT02216747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137461|NCT02216747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65301580|NCT02686385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301581|NCT02686385|Protective Agents|protective agents|mesh-ancestor
65301582|NCT02686385|Antiviral Agents|antiviral agents|mesh-ancestor
65301583|NCT02686385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65301584|NCT02686385|Expectorants|expectorants|mesh-ancestor
65301585|NCT02686385|Respiratory System Agents|respiratory system agents|mesh-ancestor
65301586|NCT02686385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65301587|NCT02686385|Antioxidants|antioxidants|mesh-ancestor
65301588|NCT02686385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301589|NCT02686385|Antidotes|antidotes|mesh-ancestor
65301590|NCT02686151|Dexamethasone|dexamethasone|mesh-list
65137462|NCT02216747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137463|NCT02216786|Everolimus|everolimus|mesh-list
65137464|NCT02216786|Fulvestrant|fulvestrant|mesh-list
65137465|NCT02216786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137466|NCT02216786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65137467|NCT02216786|Immunologic Factors|immunologic factors|mesh-ancestor
65137468|NCT02216786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137469|NCT02216786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65137470|NCT02216786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65137471|NCT02216786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65137472|NCT02216786|Hormone Antagonists|hormone antagonists|mesh-ancestor
65137473|NCT02216786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65137474|NCT02279147|Neostigmine|neostigmine|mesh-list
65137475|NCT02279147|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65137476|NCT02279147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137477|NCT02279147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137478|NCT02279147|Cholinergic Agents|cholinergic agents|mesh-ancestor
65137479|NCT02279147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65137480|NCT02279147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137481|NCT02279147|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65137482|NCT02279147|Autonomic Agents|autonomic agents|mesh-ancestor
65137483|NCT02279147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65137484|NCT02279186|Tranexamic Acid|tranexamic acid|mesh-list
65137485|NCT02279186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65137486|NCT02279186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65137487|NCT02279186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137488|NCT02279186|Hemostatics|hemostatics|mesh-ancestor
65137489|NCT02279186|Coagulants|coagulants|mesh-ancestor
65137490|NCT01177540|Decitabine|decitabine|mesh-list
65137491|NCT01177540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65137492|NCT01177540|Antimetabolites|antimetabolites|mesh-ancestor
64780038|NCT02430090|Analgesics|analgesics|mesh-ancestor
65137493|NCT01177540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137499|NCT01177384|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65137500|NCT01177384|Glimepiride|glimepiride|mesh-list
65137502|NCT01177384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65137503|NCT01177384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137504|NCT01177384|Incretins|incretins|mesh-ancestor
65137505|NCT01177384|Hormones|hormones|mesh-ancestor
65137506|NCT01177384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65137507|NCT01177384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65137508|NCT01177384|Protease Inhibitors|protease inhibitors|mesh-ancestor
65137509|NCT01177384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137510|NCT01177384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137511|NCT01177384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65137512|NCT01177384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65137513|NCT01177384|Immunologic Factors|immunologic factors|mesh-ancestor
65137514|NCT01177384|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65137515|NCT01640093|Abiraterone Acetate|abiraterone acetate|mesh-list
65137516|NCT01640093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137517|NCT01640093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65137518|NCT01640093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137519|NCT01640093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301591|NCT02686151|Letrozole|letrozole|mesh-list
65301592|NCT02686151|Polygeline|polygeline|mesh-list
65301593|NCT02686151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65301594|NCT02686151|Antiemetics|antiemetics|mesh-ancestor
65301595|NCT02686151|Autonomic Agents|autonomic agents|mesh-ancestor
65301596|NCT02686151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65301597|NCT02686151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301598|NCT02686151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65301599|NCT02686151|Glucocorticoids|glucocorticoids|mesh-ancestor
65301600|NCT02686151|Hormones|hormones|mesh-ancestor
65301601|NCT02686151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65301602|NCT02686151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65301603|NCT02686151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301604|NCT02686151|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65301605|NCT02686151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65301606|NCT02686151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301607|NCT02686151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301608|NCT02686151|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65301609|NCT02686151|Hormone Antagonists|hormone antagonists|mesh-ancestor
65301610|NCT02686151|Plasma Substitutes|plasma substitutes|mesh-ancestor
65301611|NCT02686151|Blood Substitutes|blood substitutes|mesh-ancestor
65301612|NCT00868790|Metformin|metformin|mesh-list
65301613|NCT00868790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65301614|NCT00868790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301615|NCT00496483|Tacrolimus|tacrolimus|mesh-list
65301616|NCT00496483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65301617|NCT00496483|Immunologic Factors|immunologic factors|mesh-ancestor
65301618|NCT00496483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301619|NCT00496483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65301620|NCT00496483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301621|NCT00496483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137520|NCT01640093|Hormone Antagonists|hormone antagonists|mesh-ancestor
65137521|NCT01640093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65137522|NCT01640093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137523|NCT01640093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65137524|NCT01194154|Epoetin Alfa|epoetin alfa|mesh-list
65137525|NCT01194154|Hematinics|hematinics|mesh-ancestor
65137526|NCT01640210|Insulin|insulin|mesh-list
65137527|NCT01640210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65137528|NCT01640210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137529|NCT01640405|Bevacizumab|bevacizumab|mesh-list
65137530|NCT01640405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65137531|NCT01640405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137532|NCT01640405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65301622|NCT02614352|Candesartan|candesartan|mesh-list
65301623|NCT02614352|Atorvastatin|atorvastatin|mesh-list
65301624|NCT02614352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65301625|NCT02614352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65301626|NCT02614352|Antimetabolites|antimetabolites|mesh-ancestor
64531733|NCT02659059|Paclitaxel|paclitaxel|mesh-list
64531734|NCT02659059|Cisplatin|cisplatin|mesh-list
65137533|NCT01640405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65137534|NCT01640405|Growth Substances|growth substances|mesh-ancestor
65137535|NCT01640405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137536|NCT01640405|Growth Inhibitors|growth inhibitors|mesh-ancestor
65137537|NCT01640444|Bevacizumab|bevacizumab|mesh-list
65137538|NCT01640444|Cetuximab|cetuximab|mesh-list
65137539|NCT01640444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65137540|NCT01640444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137541|NCT01640444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65137542|NCT01640444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65137543|NCT01640444|Growth Substances|growth substances|mesh-ancestor
65137544|NCT01640444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137545|NCT01640444|Growth Inhibitors|growth inhibitors|mesh-ancestor
65137546|NCT01642433|Prazosin|prazosin|mesh-list
65137547|NCT01642433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65137548|NCT01642433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65137549|NCT01642433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65137550|NCT01642433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65137551|NCT01642433|Adrenergic Agents|adrenergic agents|mesh-ancestor
65137552|NCT01642433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65137553|NCT01642433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137554|NCT01642433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137555|NCT01642472|Ulipristal acetate|ulipristal acetate|mesh-list
65137556|NCT01642472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65137557|NCT01642472|Contraceptive Agents|contraceptive agents|mesh-ancestor
65137558|NCT01642472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65137559|NCT01642472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137560|NCT01642472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65137561|NCT01640639|Thalidomide|thalidomide|mesh-list
65137562|NCT01640639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65137577|NCT01642745|Mannitol|mannitol|mesh-list
65137578|NCT01642745|Methacholine Chloride|methacholine chloride|mesh-list
65137579|NCT01642745|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65137580|NCT01642745|Diuretics|diuretics|mesh-ancestor
65137581|NCT01642745|Natriuretic Agents|natriuretic agents|mesh-ancestor
65137582|NCT01642745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137583|NCT01642745|Miotics|miotics|mesh-ancestor
65137584|NCT01642745|Autonomic Agents|autonomic agents|mesh-ancestor
65137585|NCT01642745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65137586|NCT01642745|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65137587|NCT01642745|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
65137588|NCT01642745|Respiratory System Agents|respiratory system agents|mesh-ancestor
65137589|NCT01642745|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65137590|NCT01642745|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65137591|NCT01642745|Cholinergic Agents|cholinergic agents|mesh-ancestor
65137592|NCT01642745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65137593|NCT01642745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137594|NCT01640990|GW 328267|gw 328267|mesh-list
65137595|NCT01640990|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65137596|NCT01640990|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65137597|NCT01640990|Purinergic Agonists|purinergic agonists|mesh-ancestor
65137598|NCT01640990|Purinergic Agents|purinergic agents|mesh-ancestor
65137599|NCT01640990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65137600|NCT01640990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137601|NCT01640990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137602|NCT01642862|Simvastatin|simvastatin|mesh-list
65137603|NCT01642862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65137604|NCT01642862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65137605|NCT01642862|Antimetabolites|antimetabolites|mesh-ancestor
65137606|NCT01642862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137607|NCT01642862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65137608|NCT01642862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65137609|NCT01642862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301627|NCT02614352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301628|NCT02614352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65301629|NCT02614352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65301630|NCT02614352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301631|NCT02614352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65301632|NCT02614352|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65301633|NCT02614352|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65301634|NCT01018225|Darifenacin|darifenacin|mesh-list
65301635|NCT01018225|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65301636|NCT01018225|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65301637|NCT01018225|Cholinergic Agents|cholinergic agents|mesh-ancestor
65301638|NCT01018225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64531740|NCT02659059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137610|NCT01642940|Ticagrelor|ticagrelor|mesh-list
65137611|NCT01642940|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65137612|NCT01642940|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65137613|NCT01642940|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65137614|NCT01642940|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65137615|NCT01642940|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65137616|NCT01642940|Purinergic Agents|purinergic agents|mesh-ancestor
65137617|NCT01642940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65137618|NCT01642940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137619|NCT01642940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137620|NCT04497519|Hydroxychloroquine|hydroxychloroquine|mesh-list
65137636|NCT01641224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780188|NCT02480166|Antiviral Agents|antiviral agents|mesh-ancestor
65137638|NCT01643135|Tranexamic Acid|tranexamic acid|mesh-list
65137639|NCT01643135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65137640|NCT01643135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65137641|NCT01643135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137642|NCT01643135|Hemostatics|hemostatics|mesh-ancestor
65137643|NCT01643135|Coagulants|coagulants|mesh-ancestor
65137644|NCT01643135|Antidepressive Agents|antidepressive agents|mesh-ancestor
65137645|NCT01643135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65137646|NCT01643135|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65137647|NCT01643135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137648|NCT01643135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65137649|NCT01643135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65137650|NCT01643135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65137652|NCT01641341|Nitazoxanide|nitazoxanide|mesh-list
65137653|NCT01641341|Pancrelipase|pancrelipase|mesh-list
65137654|NCT01641341|Pancreatin|pancreatin|mesh-list
65137655|NCT01641341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65137656|NCT01641341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65137657|NCT01641341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65137658|NCT01641419|Dexamethasone|dexamethasone|mesh-list
65137659|NCT01641419|Dexamethasone acetate|dexamethasone acetate|mesh-list
65137660|NCT01641419|BB 1101|bb 1101|mesh-list
65137661|NCT01641419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65137662|NCT01641419|Antiemetics|antiemetics|mesh-ancestor
65137663|NCT01641419|Autonomic Agents|autonomic agents|mesh-ancestor
65137664|NCT01641419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65137665|NCT01641419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137666|NCT01641419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65137667|NCT01641419|Glucocorticoids|glucocorticoids|mesh-ancestor
65137668|NCT01641419|Hormones|hormones|mesh-ancestor
65137669|NCT01641419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65137670|NCT01641419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65137671|NCT01641419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137672|NCT01641419|Protease Inhibitors|protease inhibitors|mesh-ancestor
65137673|NCT01641419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301639|NCT01018225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301640|NCT01018225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301641|NCT01018225|Urological Agents|urological agents|mesh-ancestor
65301642|NCT03528551|Factor VIII|factor viii|mesh-list
65301643|NCT03528551|Coagulants|coagulants|mesh-ancestor
65301644|NCT02685137|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
65301645|NCT02685137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301646|NCT02685137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137674|NCT01641419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137675|NCT01643252|Riboflavin|riboflavin|mesh-list
65137676|NCT01643252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65137677|NCT01643252|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65137678|NCT01643252|Vitamin B Complex|vitamin b complex|mesh-ancestor
65137679|NCT01643252|Vitamins|vitamins|mesh-ancestor
65137680|NCT01643252|Micronutrients|micronutrients|mesh-ancestor
65137686|NCT01641458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65137688|NCT01641458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137689|NCT01641458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137690|NCT01641458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65137691|NCT01641458|Immunologic Factors|immunologic factors|mesh-ancestor
65137692|NCT01641458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137693|NCT01641536|Entecavir|entecavir|mesh-list
65137694|NCT01641536|Antiviral Agents|antiviral agents|mesh-ancestor
65137695|NCT01641536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65137696|NCT01641575|Gemcitabine|gemcitabine|mesh-list
65137697|NCT01641575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137698|NCT01641575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65137699|NCT01641575|Antimetabolites|antimetabolites|mesh-ancestor
65137700|NCT01641575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137701|NCT01641575|Antiviral Agents|antiviral agents|mesh-ancestor
65137702|NCT01641575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65137703|NCT01641575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137704|NCT01641575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65137705|NCT01641575|Immunologic Factors|immunologic factors|mesh-ancestor
65137706|NCT01641575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137707|NCT01643447|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
65137708|NCT01643447|Urinastatin|urinastatin|mesh-list
65137709|NCT01643447|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65137710|NCT01643447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65137711|NCT01643447|Protease Inhibitors|protease inhibitors|mesh-ancestor
65137712|NCT01643447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137713|NCT01643447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137714|NCT01643447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65137715|NCT01643603|Dasatinib|dasatinib|mesh-list
65137716|NCT01643603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137717|NCT01643603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65137718|NCT01643603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137719|NCT01643603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137720|NCT02279394|Dexamethasone|dexamethasone|mesh-list
65137721|NCT02279394|Lenalidomide|lenalidomide|mesh-list
65137722|NCT02279394|Elotuzumab|elotuzumab|mesh-list
65137723|NCT02279394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65137724|NCT02279394|Antiemetics|antiemetics|mesh-ancestor
65137725|NCT02279394|Autonomic Agents|autonomic agents|mesh-ancestor
65137726|NCT02279394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65137727|NCT02279394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137728|NCT02279394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65137729|NCT02279394|Glucocorticoids|glucocorticoids|mesh-ancestor
65137730|NCT02279394|Hormones|hormones|mesh-ancestor
65137731|NCT02279394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65137732|NCT02279394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65137733|NCT02279394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137734|NCT02279394|Immunologic Factors|immunologic factors|mesh-ancestor
65137735|NCT02279394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65137736|NCT02279394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65137737|NCT02279394|Growth Substances|growth substances|mesh-ancestor
65137738|NCT02279394|Growth Inhibitors|growth inhibitors|mesh-ancestor
65301647|NCT01012063|Epoetin Alfa|epoetin alfa|mesh-list
65301648|NCT01012063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65301649|NCT01012063|Hematinics|hematinics|mesh-ancestor
65301650|NCT03242915|Carboplatin|carboplatin|mesh-list
65301651|NCT03242915|Pembrolizumab|pembrolizumab|mesh-list
65301652|NCT03242915|Pemetrexed|pemetrexed|mesh-list
65301653|NCT03242915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301654|NCT03242915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65301655|NCT03242915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301656|NCT03242915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301657|NCT03242915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64531761|NCT02081378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137739|NCT02754011|Capecitabine|capecitabine|mesh-list
65137740|NCT02754011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65137741|NCT02754011|Antimetabolites|antimetabolites|mesh-ancestor
65137742|NCT02754011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137743|NCT02754011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137744|NCT02755844|Metformin|metformin|mesh-list
65137745|NCT02755844|Cyclophosphamide|cyclophosphamide|mesh-list
65137746|NCT02755844|Olaparib|olaparib|mesh-list
65137747|NCT02755844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65137748|NCT02755844|Immunologic Factors|immunologic factors|mesh-ancestor
65137749|NCT02755844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137750|NCT02755844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65137751|NCT02755844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65137756|NCT02755844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65137757|NCT02755844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65137758|NCT02755844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137759|NCT02756897|Venetoclax|venetoclax|mesh-list
65137760|NCT02756897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137761|NCT01601106|Prednisolone|prednisolone|mesh-list
65137762|NCT01601106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65137763|NCT01601106|Glucocorticoids|glucocorticoids|mesh-ancestor
65137764|NCT01601106|Hormones|hormones|mesh-ancestor
65137765|NCT01601106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65137766|NCT01601106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137767|NCT01601106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65137768|NCT01601106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137769|NCT02750540|Tenofovir|tenofovir|mesh-list
65137770|NCT02750540|Antiviral Agents|antiviral agents|mesh-ancestor
65137771|NCT02750540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65137772|NCT02750540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65137773|NCT02750540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65137774|NCT02750540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137775|NCT02750540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137776|NCT02750540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65137777|NCT02750540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65137778|NCT01601184|Temozolomide|temozolomide|mesh-list
65137779|NCT01601184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65137780|NCT01601184|Alkylating Agents|alkylating agents|mesh-ancestor
65137781|NCT01601184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137782|NCT01601184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137783|NCT01643759|Buprenorphine|buprenorphine|mesh-list
65137784|NCT01643759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65137785|NCT01643759|Narcotics|narcotics|mesh-ancestor
65137786|NCT01643759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65137787|NCT01643759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137788|NCT01643759|Analgesics|analgesics|mesh-ancestor
65137789|NCT01643759|Sensory System Agents|sensory system agents|mesh-ancestor
64780336|NCT02515890|GABA Modulators|gaba modulators|mesh-ancestor
65137790|NCT01643759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65137791|NCT01643759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65137793|NCT04488237|Vitamins|vitamins|mesh-ancestor
65137794|NCT04488237|Micronutrients|micronutrients|mesh-ancestor
65301658|NCT03242915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65301659|NCT00861744|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65301660|NCT00861744|Immunologic Factors|immunologic factors|mesh-ancestor
65301661|NCT00861744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301662|NCT02685059|Paclitaxel|paclitaxel|mesh-list
65301663|NCT02685059|Cyclophosphamide|cyclophosphamide|mesh-list
65301664|NCT02685059|Durvalumab|durvalumab|mesh-list
65301665|NCT02685059|Epirubicin|epirubicin|mesh-list
65301666|NCT02685059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65301667|NCT02685059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301668|NCT02685059|Tubulin Modulators|tubulin modulators|mesh-ancestor
65301669|NCT02685059|Antimitotic Agents|antimitotic agents|mesh-ancestor
65301670|NCT02685059|Mitosis Modulators|mitosis modulators|mesh-ancestor
65301671|NCT02685059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301672|NCT02685059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65301673|NCT02685059|Immunologic Factors|immunologic factors|mesh-ancestor
65301674|NCT02685059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301675|NCT02685059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65301676|NCT02685059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65301677|NCT02685059|Alkylating Agents|alkylating agents|mesh-ancestor
65301678|NCT02685059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65301679|NCT02685059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65301680|NCT02685059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65301681|NCT02685059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65301682|NCT02685059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65137795|NCT04488237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137796|NCT04488237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65137797|NCT04528628|Norepinephrine|norepinephrine|mesh-list
65137798|NCT04528628|Serotonin|serotonin|mesh-list
65137799|NCT04528628|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65137800|NCT04528628|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
65137801|NCT04528628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65137802|NCT04528628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65137803|NCT04528628|Adrenergic Agents|adrenergic agents|mesh-ancestor
65137804|NCT04528628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65137805|NCT04528628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137806|NCT04528628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137807|NCT04528628|Sympathomimetics|sympathomimetics|mesh-ancestor
65137808|NCT04528628|Autonomic Agents|autonomic agents|mesh-ancestor
65137809|NCT04528628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65137810|NCT04528628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65137811|NCT04528628|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65137812|NCT04528628|Serotonin Agents|serotonin agents|mesh-ancestor
65137813|NCT04528628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65137814|NCT04528628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65137815|NCT01680107|Cycloserine|cycloserine|mesh-list
65137816|NCT01680107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65137817|NCT01680107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65301683|NCT02685059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301685|NCT00603239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65301686|NCT00603239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301687|NCT00603239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65301688|NCT00603239|Incretins|incretins|mesh-ancestor
65301689|NCT00603239|Hormones|hormones|mesh-ancestor
65301690|NCT00603239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65301691|NCT00699114|Acetaminophen|acetaminophen|mesh-list
65301692|NCT00699114|Ibuprofen|ibuprofen|mesh-list
65301693|NCT00699114|Codeine|codeine|mesh-list
65301694|NCT00699114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65301695|NCT00699114|Analgesics|analgesics|mesh-ancestor
65301696|NCT00699114|Sensory System Agents|sensory system agents|mesh-ancestor
65301697|NCT00699114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65301698|NCT00699114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301699|NCT00699114|Antipyretics|antipyretics|mesh-ancestor
65301700|NCT00699114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65301701|NCT00699114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65301702|NCT00699114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65301703|NCT00699114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65301704|NCT00699114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301705|NCT00699114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301706|NCT00699114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65137818|NCT01680107|Renal Agents|renal agents|mesh-ancestor
65137819|NCT01680107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65137820|NCT01680107|Antitubercular Agents|antitubercular agents|mesh-ancestor
65137821|NCT01680107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65137831|NCT01680185|Isophane Insulin, Human|isophane insulin, human|mesh-list
65137833|NCT01680185|Isophane insulin, beef|isophane insulin, beef|mesh-list
65137834|NCT01680185|Insulin, Short-Acting|insulin, short-acting|mesh-list
65137835|NCT01680185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65137836|NCT01680185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137837|NCT01680263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65137838|NCT01680263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65137839|NCT01680263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65137840|NCT01680263|Analgesics|analgesics|mesh-ancestor
65137841|NCT01680263|Sensory System Agents|sensory system agents|mesh-ancestor
65137842|NCT01680263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65137843|NCT01680263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137844|NCT01680263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65137845|NCT01601730|Dexetimide|dexetimide|mesh-list
65137846|NCT01601730|Modafinil|modafinil|mesh-list
65137847|NCT01601730|Citalopram|citalopram|mesh-list
65137848|NCT01601730|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65137849|NCT01601730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65137850|NCT01601730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65137851|NCT01601730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137852|NCT01601730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65137853|NCT01601730|Serotonin Agents|serotonin agents|mesh-ancestor
65137854|NCT01601730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137855|NCT01601730|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65137856|NCT01601730|Antidepressive Agents|antidepressive agents|mesh-ancestor
64531818|NCT01505569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301707|NCT00699114|Narcotics|narcotics|mesh-ancestor
65301708|NCT00699114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65301709|NCT00699114|Antitussive Agents|antitussive agents|mesh-ancestor
65301710|NCT00699114|Respiratory System Agents|respiratory system agents|mesh-ancestor
65301711|NCT00639587|Cetirizine|cetirizine|mesh-list
65301712|NCT00639587|Ketotifen|ketotifen|mesh-list
65301713|NCT00639587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65301714|NCT00639587|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65301715|NCT00639587|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65301716|NCT00639587|Histamine Antagonists|histamine antagonists|mesh-ancestor
65301717|NCT00639587|Histamine Agents|histamine agents|mesh-ancestor
65301718|NCT00639587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65301719|NCT00639587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301720|NCT00639587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301721|NCT00639587|Antipruritics|antipruritics|mesh-ancestor
65301722|NCT00639587|Dermatologic Agents|dermatologic agents|mesh-ancestor
65301723|NCT00700518|Nitroglycerin|nitroglycerin|mesh-list
65301724|NCT00700518|Vasodilator Agents|vasodilator agents|mesh-ancestor
65301725|NCT00852540|Linezolid|linezolid|mesh-list
65301726|NCT00852540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65301727|NCT00852540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65301728|NCT00852540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65301729|NCT00852540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301730|NCT00852540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301731|NCT00701220|Atorvastatin|atorvastatin|mesh-list
65137857|NCT01601730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65137858|NCT01601730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65137859|NCT01601730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65137860|NCT01601730|Parasympatholytics|parasympatholytics|mesh-ancestor
65137861|NCT01601730|Autonomic Agents|autonomic agents|mesh-ancestor
65137862|NCT01601730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65137863|NCT01601730|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65137864|NCT01601730|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65137865|NCT01601730|Cholinergic Agents|cholinergic agents|mesh-ancestor
65137866|NCT01601730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65137867|NCT01601730|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65137868|NCT01601730|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65137869|NCT01601730|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65137870|NCT01644071|Dexetimide|dexetimide|mesh-list
65137871|NCT01644071|Citalopram|citalopram|mesh-list
65137872|NCT01644071|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65137873|NCT01644071|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65137874|NCT01644071|Parasympatholytics|parasympatholytics|mesh-ancestor
65137876|NCT01644071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65137877|NCT01644071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137878|NCT01644071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65137879|NCT01644071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65137880|NCT01644071|Cholinergic Agents|cholinergic agents|mesh-ancestor
65137881|NCT01644071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65301732|NCT00701220|Calcium|calcium|mesh-list
65301733|NCT00701220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65301734|NCT00701220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301735|NCT00701220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65301736|NCT00701220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65301737|NCT00701220|Antimetabolites|antimetabolites|mesh-ancestor
65301738|NCT00701220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301739|NCT00701220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64531841|NCT02375100|Sensory System Agents|sensory system agents|mesh-ancestor
65137882|NCT01644071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137883|NCT01644071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65137884|NCT01644071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65137885|NCT01644071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65137886|NCT01644071|Serotonin Agents|serotonin agents|mesh-ancestor
65137887|NCT01644071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65137889|NCT01644071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65137890|NCT01644110|Pomalidomide|pomalidomide|mesh-list
65137891|NCT01644110|Immunologic Factors|immunologic factors|mesh-ancestor
65137892|NCT01644110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137893|NCT01644110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65137894|NCT01644110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65137895|NCT01644110|Growth Substances|growth substances|mesh-ancestor
65137896|NCT01644110|Growth Inhibitors|growth inhibitors|mesh-ancestor
65137897|NCT01644110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137898|NCT01680536|Maraviroc|maraviroc|mesh-list
65137899|NCT01680536|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65137900|NCT01680536|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65137901|NCT01680536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137902|NCT01680536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65137903|NCT01680536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65137904|NCT01680536|Antiviral Agents|antiviral agents|mesh-ancestor
65137905|NCT01680536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65137906|NCT01680536|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65137907|NCT01602003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65137908|NCT01602003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65137909|NCT01602003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137910|NCT01602003|Incretins|incretins|mesh-ancestor
65137911|NCT01602003|Hormones|hormones|mesh-ancestor
65137912|NCT01602003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65137913|NCT01602003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65137914|NCT01602003|Protease Inhibitors|protease inhibitors|mesh-ancestor
65137915|NCT01602003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137916|NCT01602003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137917|NCT01193920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65137918|NCT01193920|Vaccines|vaccines|mesh-list
65137919|NCT01193920|Immunologic Factors|immunologic factors|mesh-ancestor
65137920|NCT01193920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137921|NCT01644773|Dasatinib|dasatinib|mesh-list
65137922|NCT01644773|Crizotinib|crizotinib|mesh-list
65137923|NCT01644773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137924|NCT01644773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65137925|NCT01644773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137926|NCT01644773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137927|NCT01602588|Hydroxychloroquine|hydroxychloroquine|mesh-list
65137928|NCT01602588|Antimalarials|antimalarials|mesh-ancestor
65137929|NCT01602588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65137930|NCT01602588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65137931|NCT01602588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65137932|NCT01602588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137933|NCT01602588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137934|NCT01602588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65137935|NCT01681550|Incretins|incretins|mesh-list
65137936|NCT01681550|Hormones|hormones|mesh-ancestor
65137937|NCT01681550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65301740|NCT00701220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65301741|NCT00701220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301742|NCT00701298|Interferons|interferons|mesh-list
65301743|NCT00701298|Interferon-alpha|interferon-alpha|mesh-list
65301744|NCT00701298|Interferon alpha-2|interferon alpha-2|mesh-list
65301745|NCT00701298|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65301746|NCT00701298|Decitabine|decitabine|mesh-list
65301747|NCT00701298|Azacitidine|azacitidine|mesh-list
65301748|NCT00701298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301749|NCT00701298|Antiviral Agents|antiviral agents|mesh-ancestor
65301750|NCT00701298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65301751|NCT00701298|Immunologic Factors|immunologic factors|mesh-ancestor
65301752|NCT00701298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301753|NCT00701298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65301754|NCT00701298|Antimetabolites|antimetabolites|mesh-ancestor
65301755|NCT00701298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301756|NCT00701298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301757|NCT00860574|Methotrexate|methotrexate|mesh-list
65301758|NCT00860574|Fludarabine phosphate|fludarabine phosphate|mesh-list
65301759|NCT00860574|Fludarabine|fludarabine|mesh-list
65301760|NCT00860574|Treosulfan|treosulfan|mesh-list
65301761|NCT00860574|Tacrolimus|tacrolimus|mesh-list
65301762|NCT00860574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65301763|NCT00860574|Abortifacient Agents|abortifacient agents|mesh-ancestor
65301764|NCT00860574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65301765|NCT00860574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301766|NCT00860574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65301767|NCT00860574|Antimetabolites|antimetabolites|mesh-ancestor
65301768|NCT00860574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301769|NCT00860574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301770|NCT00860574|Dermatologic Agents|dermatologic agents|mesh-ancestor
65301771|NCT00860574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301772|NCT00860574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65301773|NCT00860574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64780490|NCT02547012|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65137938|NCT01681550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137939|NCT01645085|Mannitol|mannitol|mesh-list
65137940|NCT01645085|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65137941|NCT01645085|Diuretics|diuretics|mesh-ancestor
65137942|NCT01645085|Natriuretic Agents|natriuretic agents|mesh-ancestor
65137943|NCT01645085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137944|NCT01645124|Hydroxyurea|hydroxyurea|mesh-list
65137945|NCT01645124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301774|NCT00860574|Immunologic Factors|immunologic factors|mesh-ancestor
65301775|NCT00860574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65301776|NCT00860574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65301777|NCT00860574|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65301778|NCT00860574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65301779|NCT00860574|Alkylating Agents|alkylating agents|mesh-ancestor
65301780|NCT00496015|Acetaminophen|acetaminophen|mesh-list
65301781|NCT00496015|Vaccines|vaccines|mesh-list
65301782|NCT00496015|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65301783|NCT00496015|Immunologic Factors|immunologic factors|mesh-ancestor
65301784|NCT00496015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301785|NCT00496015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65301786|NCT00496015|Analgesics|analgesics|mesh-ancestor
65301787|NCT00496015|Sensory System Agents|sensory system agents|mesh-ancestor
65301788|NCT00496015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65301789|NCT00496015|Antipyretics|antipyretics|mesh-ancestor
65301790|NCT01018381|Ethanol|ethanol|mesh-list
65301791|NCT01018381|Entecavir|entecavir|mesh-list
65301792|NCT01018381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65301793|NCT01018381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65301794|NCT01018381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65301795|NCT01018381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301796|NCT01018381|Antiviral Agents|antiviral agents|mesh-ancestor
65301797|NCT00487825|Methotrexate|methotrexate|mesh-list
65301798|NCT00487825|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65301799|NCT00487825|Abortifacient Agents|abortifacient agents|mesh-ancestor
65301800|NCT00487825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65301801|NCT00487825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301802|NCT00487825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65301803|NCT00487825|Antimetabolites|antimetabolites|mesh-ancestor
64531881|NCT01557517|Clobetasol|clobetasol|mesh-list
64531884|NCT01557517|Hormones|hormones|mesh-ancestor
65137946|NCT01645124|Antisickling Agents|antisickling agents|mesh-ancestor
65137947|NCT01645124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137948|NCT01645124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137949|NCT01645124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65137950|NCT01602861|Spironolactone|spironolactone|mesh-list
65137951|NCT01602861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65137952|NCT01602861|Hormone Antagonists|hormone antagonists|mesh-ancestor
65137953|NCT01602861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65137954|NCT01602861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137955|NCT01602861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65137956|NCT01602861|Diuretics|diuretics|mesh-ancestor
65301804|NCT00487825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301805|NCT00487825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301806|NCT00487825|Dermatologic Agents|dermatologic agents|mesh-ancestor
65301807|NCT00487825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301808|NCT00487825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65301809|NCT00487825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65301810|NCT00487825|Immunologic Factors|immunologic factors|mesh-ancestor
65301811|NCT00487825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65301812|NCT00487825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65301813|NCT00487747|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65301814|NCT00487747|Antiviral Agents|antiviral agents|mesh-ancestor
65301815|NCT00487747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65301816|NCT01012141|Docetaxel|docetaxel|mesh-list
65301817|NCT01012141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301818|NCT01012141|Tubulin Modulators|tubulin modulators|mesh-ancestor
65301819|NCT01012141|Antimitotic Agents|antimitotic agents|mesh-ancestor
65301820|NCT01012141|Mitosis Modulators|mitosis modulators|mesh-ancestor
65301821|NCT01012141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301822|NCT00487435|Tapentadol|tapentadol|mesh-list
65137957|NCT01602861|Natriuretic Agents|natriuretic agents|mesh-ancestor
65137958|NCT01681667|Ibuprofen|ibuprofen|mesh-list
65137959|NCT01681667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65137960|NCT01681667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65137968|NCT01681667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137969|NCT01681667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137970|NCT01600365|Ganciclovir|ganciclovir|mesh-list
65137971|NCT01600365|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65137972|NCT01600365|Lubricant Eye Drops|lubricant eye drops|mesh-list
65137973|NCT01600365|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65137974|NCT01600365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65137975|NCT01600365|Antiviral Agents|antiviral agents|mesh-ancestor
65137976|NCT01600365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65137977|NCT01600365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65137978|NCT01600365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137979|NCT01600365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137980|NCT01602900|Rolipram|rolipram|mesh-list
65137981|NCT01602900|Antidepressive Agents|antidepressive agents|mesh-ancestor
65137982|NCT01602900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65137983|NCT01602900|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65137984|NCT01602900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65137985|NCT01602900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137986|NCT01602900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137987|NCT01645241|Ganirelix|ganirelix|mesh-list
65137988|NCT01645241|Hormone Antagonists|hormone antagonists|mesh-ancestor
65137989|NCT01645241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65137990|NCT01645241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137991|NCT01602939|Cladribine|cladribine|mesh-list
65137992|NCT01602939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137993|NCT01602939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65137994|NCT01602939|Immunologic Factors|immunologic factors|mesh-ancestor
65137995|NCT01602939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137996|NCT01600404|Muscarinic Antagonists|muscarinic antagonists|mesh-list
65137997|NCT01600404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65137998|NCT01600404|Cholinergic Agents|cholinergic agents|mesh-ancestor
65137999|NCT01600404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65301823|NCT00487435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65301824|NCT00487435|Narcotics|narcotics|mesh-ancestor
65301825|NCT00487435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65301826|NCT00487435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301827|NCT00487435|Analgesics|analgesics|mesh-ancestor
65301828|NCT00487435|Sensory System Agents|sensory system agents|mesh-ancestor
65051723|NCT00413075|Belinostat|belinostat|mesh-list
65301829|NCT00487435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65301830|NCT00487435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65301831|NCT00487435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65301832|NCT00487435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65301833|NCT00487435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301834|NCT00487435|Adrenergic Agents|adrenergic agents|mesh-ancestor
65301835|NCT00487435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65301836|NCT00495625|Sunitinib|sunitinib|mesh-list
65301837|NCT00495625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301838|NCT00495625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65301839|NCT00495625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65301840|NCT00495625|Growth Substances|growth substances|mesh-ancestor
65301841|NCT00495625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301842|NCT00495625|Growth Inhibitors|growth inhibitors|mesh-ancestor
65301843|NCT00495625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65301844|NCT00495625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301845|NCT00495625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301846|NCT00847626|Chlorthalidone|chlorthalidone|mesh-list
65301847|NCT00847626|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65301848|NCT00847626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65301849|NCT00847626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65138000|NCT01600404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138001|NCT01600404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138002|NCT01603134|Allopurinol|allopurinol|mesh-list
65138003|NCT01603134|Antimetabolites|antimetabolites|mesh-ancestor
65138004|NCT01603134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138005|NCT01603134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138006|NCT01603134|Gout Suppressants|gout suppressants|mesh-ancestor
65138007|NCT01603134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65138008|NCT01603134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65138009|NCT01603134|Antioxidants|antioxidants|mesh-ancestor
65138010|NCT01603134|Protective Agents|protective agents|mesh-ancestor
64780578|NCT02572752|Nintedanib|nintedanib|mesh-list
65138011|NCT01603134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138012|NCT01603173|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65138013|NCT01603173|Antidepressive Agents|antidepressive agents|mesh-ancestor
65138014|NCT01603173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65138015|NCT01603173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65301850|NCT00847626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301851|NCT00847626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65301852|NCT00847626|Diuretics|diuretics|mesh-ancestor
65301853|NCT00847626|Natriuretic Agents|natriuretic agents|mesh-ancestor
65301854|NCT00847626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301855|NCT00847626|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65301856|NCT00847626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65301857|NCT04115904|Ibuprofen|ibuprofen|mesh-list
65301858|NCT04115904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65301859|NCT04115904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65301860|NCT04115904|Analgesics|analgesics|mesh-ancestor
65301861|NCT04115904|Sensory System Agents|sensory system agents|mesh-ancestor
65301862|NCT04115904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65301863|NCT04115904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301864|NCT04115904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65301865|NCT04115904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65301866|NCT04115904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65301867|NCT04115904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301868|NCT04115904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301869|NCT05297994|Vaccines|vaccines|mesh-list
64531956|NCT01496183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65138016|NCT01603173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65138017|NCT01603173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65138018|NCT01603173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138019|NCT01603212|Interferons|interferons|mesh-list
65138020|NCT01603212|Interferon-alpha|interferon-alpha|mesh-list
65138021|NCT01603212|Interferon alpha-2|interferon alpha-2|mesh-list
65138022|NCT01603212|Aldesleukin|aldesleukin|mesh-list
65138023|NCT01603212|Interleukin-2|interleukin-2|mesh-list
65138024|NCT01603212|Vemurafenib|vemurafenib|mesh-list
65138025|NCT01603212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138026|NCT01603212|Antiviral Agents|antiviral agents|mesh-ancestor
65138027|NCT01603212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64710585|NCT02958956|Pioglitazone|pioglitazone|mesh-list
65138052|NCT02484924|Purinergic Agents|purinergic agents|mesh-ancestor
65138053|NCT02484924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65138054|NCT02484924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138055|NCT02484924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138056|NCT01645826|Diltiazem|diltiazem|mesh-list
65138057|NCT01645826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65138058|NCT01645826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65138059|NCT01645826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65138060|NCT01645826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138061|NCT01645826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65138062|NCT01645826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138063|NCT01645826|Vasodilator Agents|vasodilator agents|mesh-ancestor
65138064|NCT01607034|Pramipexole|pramipexole|mesh-list
65138065|NCT01607034|Antioxidants|antioxidants|mesh-ancestor
65138066|NCT01607034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138067|NCT01607034|Protective Agents|protective agents|mesh-ancestor
65138068|NCT01607034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138069|NCT01607034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65301870|NCT05297994|Immunologic Factors|immunologic factors|mesh-ancestor
65301871|NCT05297994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301872|NCT04116138|Antisecretory factor|antisecretory factor|mesh-list
65301873|NCT04116138|Antidiarrheals|antidiarrheals|mesh-ancestor
65301874|NCT04116138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65301875|NCT00860262|Amlodipine|amlodipine|mesh-list
65301876|NCT00860262|Telmisartan|telmisartan|mesh-list
65301877|NCT00860262|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
65301878|NCT00860262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65301879|NCT00860262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65301880|NCT00860262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65301881|NCT00860262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301882|NCT00860262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65301883|NCT00860262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301884|NCT00860262|Vasodilator Agents|vasodilator agents|mesh-ancestor
65301885|NCT00860262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65301886|NCT00860262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65301887|NCT00700830|Insulin Detemir|insulin detemir|mesh-list
65301888|NCT00700830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65301889|NCT00700830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301890|NCT00860028|Varenicline|varenicline|mesh-list
65301891|NCT00860028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65301892|NCT00860028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65301893|NCT00860028|Cholinergic Agents|cholinergic agents|mesh-ancestor
65301894|NCT00860028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65301895|NCT00860028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531980|NCT02374008|Dexamethasone|dexamethasone|mesh-list
65138070|NCT01607034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65138071|NCT01607034|Dopamine Agonists|dopamine agonists|mesh-ancestor
65138072|NCT01607034|Dopamine Agents|dopamine agents|mesh-ancestor
65138073|NCT01607034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65138074|NCT01603251|Ivermectin|ivermectin|mesh-list
65138075|NCT01603251|Lumefantrine|lumefantrine|mesh-list
65138076|NCT01603251|Artemether|artemether|mesh-list
65138077|NCT01603251|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65138089|NCT01646294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138091|NCT01603758|Ezetimibe|ezetimibe|mesh-list
65138092|NCT01603758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65138093|NCT01603758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65138094|NCT01603758|Antimetabolites|antimetabolites|mesh-ancestor
65138095|NCT01603758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138096|NCT01603758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65138097|NCT01177228|Vedolizumab|vedolizumab|mesh-list
65138098|NCT01177228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65138099|NCT02279342|Febuxostat|febuxostat|mesh-list
65138100|NCT02279342|Gout Suppressants|gout suppressants|mesh-ancestor
65138101|NCT02279342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65138102|NCT01607307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65301896|NCT00860028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301897|NCT00701532|Modafinil|modafinil|mesh-list
65301898|NCT00701532|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65301899|NCT00701532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301900|NCT00701532|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65051790|NCT00225056|Docetaxel|docetaxel|mesh-list
65301901|NCT00701532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65301902|NCT00701532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65301903|NCT00701532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301904|NCT00846768|Olodaterol|olodaterol|mesh-list
65301905|NCT00846768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65301906|NCT00846768|Autonomic Agents|autonomic agents|mesh-ancestor
65301907|NCT00846768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65301908|NCT00846768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301909|NCT00846768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65301910|NCT00846768|Respiratory System Agents|respiratory system agents|mesh-ancestor
65301911|NCT00863798|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65301912|NCT00863798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65301913|NCT00863798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65301914|NCT00863798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65301915|NCT00863798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301916|NCT00863798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65301917|NCT00863798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301918|NCT00863798|Antidepressive Agents|antidepressive agents|mesh-ancestor
65301919|NCT00863798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65138103|NCT02279381|Chlorhexidine|chlorhexidine|mesh-list
65138104|NCT02279381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65138105|NCT02279381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65138106|NCT02279381|Disinfectants|disinfectants|mesh-ancestor
65138107|NCT01646567|Betamethasone|betamethasone|mesh-list
65138108|NCT01646567|Betamethasone Valerate|betamethasone valerate|mesh-list
65138109|NCT01646567|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65138110|NCT01646567|Betamethasone benzoate|betamethasone benzoate|mesh-list
65138111|NCT01646567|Calcipotriene|calcipotriene|mesh-list
65138112|NCT01646567|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65138113|NCT01646567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65138114|NCT01646567|Glucocorticoids|glucocorticoids|mesh-ancestor
65138115|NCT01646567|Hormones|hormones|mesh-ancestor
65138116|NCT01646567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65138117|NCT01646567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138118|NCT01646567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65138119|NCT01646567|Respiratory System Agents|respiratory system agents|mesh-ancestor
65138120|NCT01646567|Dermatologic Agents|dermatologic agents|mesh-ancestor
65138121|NCT01681979|Fluticasone|fluticasone|mesh-list
65138123|NCT01681979|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65138124|NCT01681979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65138125|NCT01681979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65301920|NCT00697658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65301921|NCT00697658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65301922|NCT00697658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65301923|NCT00697658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65301924|NCT00697658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301925|NCT00697658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65301926|NCT00697658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65301927|NCT00697658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65301928|NCT00697658|Serotonin Agents|serotonin agents|mesh-ancestor
65301929|NCT00697658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65301930|NCT00697658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301931|NCT00697658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65301932|NCT00697658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65301933|NCT00697658|Dopamine Agents|dopamine agents|mesh-ancestor
65301934|NCT00699426|Esomeprazole|esomeprazole|mesh-list
65301935|NCT00699426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65301936|NCT00699426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65301937|NCT00699426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65301938|NCT00699426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301939|NCT00699426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301940|NCT00593606|Rotigotine|rotigotine|mesh-list
65301941|NCT00593606|Dopamine Agonists|dopamine agonists|mesh-ancestor
65301942|NCT00593606|Dopamine Agents|dopamine agents|mesh-ancestor
65301943|NCT00593606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65301944|NCT00593606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301945|NCT00593606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301946|NCT02614118|Acetaminophen|acetaminophen|mesh-list
65301947|NCT02614118|Ketorolac|ketorolac|mesh-list
65301948|NCT02614118|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65301949|NCT02614118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64532031|NCT02373384|Antioxidants|antioxidants|mesh-ancestor
65138126|NCT01681979|Autonomic Agents|autonomic agents|mesh-ancestor
65138127|NCT01681979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65138128|NCT01681979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138129|NCT01681979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65138130|NCT01681979|Respiratory System Agents|respiratory system agents|mesh-ancestor
65138131|NCT01681979|Dermatologic Agents|dermatologic agents|mesh-ancestor
65138132|NCT01681979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65138133|NCT01681979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65138134|NCT01681979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65138135|NCT01681979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65138136|NCT01681979|Adrenergic Agents|adrenergic agents|mesh-ancestor
65138137|NCT01681979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65301950|NCT02614118|Analgesics|analgesics|mesh-ancestor
65301951|NCT02614118|Sensory System Agents|sensory system agents|mesh-ancestor
65301952|NCT02614118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65301953|NCT02614118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301954|NCT02614118|Antipyretics|antipyretics|mesh-ancestor
65301955|NCT02614118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65301956|NCT02614118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65301957|NCT02614118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65301958|NCT02614118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65301959|NCT02614118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532064|NCT02881086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65138138|NCT01681979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138139|NCT01646684|Pasireotide|pasireotide|mesh-list
65138140|NCT01646684|Hormones|hormones|mesh-ancestor
64710716|NCT05828836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138160|NCT01607580|Protective Agents|protective agents|mesh-ancestor
65138161|NCT01607580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65138162|NCT01607580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138163|NCT01604031|Lenalidomide|lenalidomide|mesh-list
65138164|NCT01604031|Immunologic Factors|immunologic factors|mesh-ancestor
65138165|NCT01604031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138166|NCT01604031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65138167|NCT01604031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65138168|NCT01604031|Growth Substances|growth substances|mesh-ancestor
65138169|NCT01604031|Growth Inhibitors|growth inhibitors|mesh-ancestor
65138170|NCT01604031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138171|NCT01647152|Ustekinumab|ustekinumab|mesh-list
65138172|NCT01647152|Dermatologic Agents|dermatologic agents|mesh-ancestor
65138173|NCT01604187|Fentanyl|fentanyl|mesh-list
65138174|NCT01604187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65138175|NCT01604187|Narcotics|narcotics|mesh-ancestor
65138176|NCT01604187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65138177|NCT01604187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138178|NCT01604187|Analgesics|analgesics|mesh-ancestor
65138179|NCT01604187|Sensory System Agents|sensory system agents|mesh-ancestor
65138180|NCT01604187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65138181|NCT01604187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65138182|NCT01604187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65138183|NCT01604187|Anesthetics, General|anesthetics, general|mesh-ancestor
65138184|NCT01604187|Anesthetics|anesthetics|mesh-ancestor
65138185|NCT01604382|Remifentanil|remifentanil|mesh-list
65138186|NCT01604382|Bupivacaine|bupivacaine|mesh-list
65138187|NCT01604382|Anesthetics|anesthetics|mesh-list
65138188|NCT01604382|Propofol|propofol|mesh-list
65138189|NCT01604382|Anesthetics, Local|anesthetics, local|mesh-ancestor
65138190|NCT01604382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65138191|NCT01604382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138192|NCT01604382|Sensory System Agents|sensory system agents|mesh-ancestor
65138193|NCT01604382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65138194|NCT01604382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64710818|NCT05827796|Antimetabolites|antimetabolites|mesh-ancestor
65138198|NCT01604382|Narcotics|narcotics|mesh-ancestor
65138199|NCT01604382|Analgesics|analgesics|mesh-ancestor
65138200|NCT01682408|Mannitol|mannitol|mesh-list
65138201|NCT01682408|Ranitidine|ranitidine|mesh-list
65138202|NCT01682408|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65138203|NCT01682408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65138204|NCT01682408|Diuretics|diuretics|mesh-ancestor
65138205|NCT01682408|Natriuretic Agents|natriuretic agents|mesh-ancestor
65138206|NCT01682408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138207|NCT01682408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65138208|NCT01682408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65138209|NCT01682408|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65138210|NCT01682408|Histamine Antagonists|histamine antagonists|mesh-ancestor
65138211|NCT01682408|Histamine Agents|histamine agents|mesh-ancestor
65138212|NCT01682408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65138213|NCT01682408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301960|NCT02614118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301961|NCT04134416|Donepezil|donepezil|mesh-list
65301962|NCT04134416|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65301963|NCT04134416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65301964|NCT04134416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301965|NCT04134416|Cholinergic Agents|cholinergic agents|mesh-ancestor
65301966|NCT04134416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65301967|NCT04134416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301968|NCT04134416|Nootropic Agents|nootropic agents|mesh-ancestor
65301969|NCT04134182|Nivolumab|nivolumab|mesh-list
65301970|NCT04134182|Ipilimumab|ipilimumab|mesh-list
65301971|NCT04134182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65301972|NCT04134182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301973|NCT04134182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65301974|NCT04134182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301976|NCT00870584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65301977|NCT00870584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65138214|NCT01607970|Oxytocin|oxytocin|mesh-list
65138215|NCT01607970|Oxytocics|oxytocics|mesh-ancestor
65138216|NCT01607970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65138217|NCT01607970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138218|NCT01608009|Paclitaxel|paclitaxel|mesh-list
65138219|NCT01608009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65138220|NCT01608009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138221|NCT01608009|Tubulin Modulators|tubulin modulators|mesh-ancestor
65138222|NCT01608009|Antimitotic Agents|antimitotic agents|mesh-ancestor
65138223|NCT01608009|Mitosis Modulators|mitosis modulators|mesh-ancestor
65138224|NCT01608009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138225|NCT01647347|Povidone-Iodine|povidone-iodine|mesh-list
65138226|NCT01647347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65138227|NCT01647347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65138228|NCT01682564|Candesartan cilexetil|candesartan cilexetil|mesh-list
65138229|NCT01682564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65138230|NCT01682564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65138231|NCT01682564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65138232|NCT01682564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138233|NCT01608360|Lidocaine|lidocaine|mesh-list
65138234|NCT01608360|Anesthetics, Local|anesthetics, local|mesh-ancestor
65138235|NCT01608360|Anesthetics|anesthetics|mesh-ancestor
64780775|NCT04227366|Methotrexate|methotrexate|mesh-list
65138236|NCT01608360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65138237|NCT01608360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138238|NCT01608360|Sensory System Agents|sensory system agents|mesh-ancestor
65138239|NCT01608360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65138240|NCT01608360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65138241|NCT01608360|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65138242|NCT01608360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65138243|NCT01608360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65138244|NCT01608360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138245|NCT01647659|Trametinib|trametinib|mesh-list
65138246|NCT01647659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138247|NCT01647659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65138248|NCT01647659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138249|NCT01647659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138250|NCT01604811|Tamsulosin|tamsulosin|mesh-list
65138251|NCT01604811|Saw palmetto extract|saw palmetto extract|mesh-list
65301978|NCT00870584|Respiratory System Agents|respiratory system agents|mesh-ancestor
65301979|NCT02614508|Ofatumumab|ofatumumab|mesh-list
65301980|NCT02614508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65301981|NCT02614508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65301982|NCT02614508|Immunologic Factors|immunologic factors|mesh-ancestor
65301983|NCT02614508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301984|NCT02616068|Loxoprofen|loxoprofen|mesh-list
65138252|NCT01604811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65138253|NCT01604811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65138254|NCT01604811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65138255|NCT01604811|Adrenergic Agents|adrenergic agents|mesh-ancestor
65138256|NCT01604811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65138257|NCT01604811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138258|NCT01604811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138259|NCT01604811|Urological Agents|urological agents|mesh-ancestor
65138260|NCT01683032|Methylphenidate|methylphenidate|mesh-list
65138261|NCT01683032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65138262|NCT01683032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138263|NCT01683032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65138264|NCT01683032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65138277|NCT01604928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138278|NCT01604928|Urological Agents|urological agents|mesh-ancestor
65138279|NCT01604928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65138280|NCT01604928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65138281|NCT01604928|Cholinergic Agents|cholinergic agents|mesh-ancestor
65138282|NCT01683149|Sorafenib|sorafenib|mesh-list
65138283|NCT01683149|Topotecan|topotecan|mesh-list
65138284|NCT01683149|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
65138285|NCT01683149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138286|NCT01683149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65138287|NCT01683149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138288|NCT01683149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138289|NCT01683149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65138290|NCT01608555|Tobramycin|tobramycin|mesh-list
65138291|NCT01608555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65138292|NCT01608555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65138293|NCT01605084|Ritonavir|ritonavir|mesh-list
65138294|NCT01605084|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65138295|NCT01605084|Darunavir|darunavir|mesh-list
65138296|NCT01605084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65138297|NCT01605084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65138298|NCT01605084|Protease Inhibitors|protease inhibitors|mesh-ancestor
65138299|NCT01605084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138300|NCT01605084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138301|NCT01605084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65138302|NCT01605084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65138303|NCT01605084|Antiviral Agents|antiviral agents|mesh-ancestor
65138304|NCT01605084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65138305|NCT01605084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65138306|NCT01605084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65138307|NCT01647893|Bivalirudin|bivalirudin|mesh-list
65138308|NCT01647893|Antithrombins|antithrombins|mesh-ancestor
65138309|NCT01647893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65138310|NCT01647893|Protease Inhibitors|protease inhibitors|mesh-ancestor
64780848|NCT05732064|Analgesics|analgesics|mesh-ancestor
65138311|NCT01647893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138312|NCT01647893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138313|NCT01647893|Anticoagulants|anticoagulants|mesh-ancestor
65138314|NCT01648010|Mitomycins|mitomycins|mesh-list
65138315|NCT01648010|Mitomycin|mitomycin|mesh-list
65138316|NCT01648010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65138317|NCT01648010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138318|NCT01648010|Alkylating Agents|alkylating agents|mesh-ancestor
65138319|NCT01648010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138320|NCT01648010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65138321|NCT01648010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138322|NCT01605318|Irinotecan|irinotecan|mesh-list
65138323|NCT01605318|Labetuzumab|labetuzumab|mesh-list
65138324|NCT01605318|Immunoconjugates|immunoconjugates|mesh-list
65138325|NCT01605318|Immunologic Factors|immunologic factors|mesh-ancestor
65301985|NCT02616068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65301986|NCT02616068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65301987|NCT02616068|Analgesics|analgesics|mesh-ancestor
65301988|NCT02616068|Sensory System Agents|sensory system agents|mesh-ancestor
65301989|NCT02616068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65301990|NCT02616068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301991|NCT02616068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65138326|NCT01605318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138330|NCT01605318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138331|NCT01605318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138332|NCT01605318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65138333|NCT01608711|Gemcitabine|gemcitabine|mesh-list
65138334|NCT01608711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65138335|NCT01608711|Antimetabolites|antimetabolites|mesh-ancestor
65138336|NCT01608711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138337|NCT01608711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138338|NCT01608711|Antiviral Agents|antiviral agents|mesh-ancestor
65138339|NCT01608711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65138340|NCT01608711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138341|NCT01608711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65138342|NCT01608711|Immunologic Factors|immunologic factors|mesh-ancestor
65138343|NCT01608711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138344|NCT01605357|Mannitol|mannitol|mesh-list
65138345|NCT01605357|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65138346|NCT01605357|Diuretics|diuretics|mesh-ancestor
65138347|NCT01605357|Natriuretic Agents|natriuretic agents|mesh-ancestor
65138348|NCT01605357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138349|NCT01648127|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
65138350|NCT01648127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65138351|NCT01648127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65138352|NCT01608750|Folic Acid|folic acid|mesh-list
65138353|NCT01608750|Hematinics|hematinics|mesh-ancestor
65138354|NCT01608750|Vitamin B Complex|vitamin b complex|mesh-ancestor
65138355|NCT01608750|Vitamins|vitamins|mesh-ancestor
65138356|NCT01608750|Micronutrients|micronutrients|mesh-ancestor
65138357|NCT01608750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138358|NCT01605513|Interferons|interferons|mesh-list
65138359|NCT01605513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138360|NCT01605513|Antiviral Agents|antiviral agents|mesh-ancestor
65138361|NCT01605513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65138362|NCT04528277|Isoniazid|isoniazid|mesh-list
65138363|NCT04528277|Rifapentine|rifapentine|mesh-list
65138364|NCT04528277|Antitubercular Agents|antitubercular agents|mesh-ancestor
65138365|NCT04528277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65138366|NCT04528277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65138367|NCT04528277|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65138368|NCT04528277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65138369|NCT04528277|Antimetabolites|antimetabolites|mesh-ancestor
65138370|NCT04528277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138371|NCT04528277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65138372|NCT04528277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65138373|NCT04528277|Leprostatic Agents|leprostatic agents|mesh-ancestor
65138374|NCT01683656|Niacin|niacin|mesh-list
65138375|NCT01683656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65138376|NCT01683656|Antimetabolites|antimetabolites|mesh-ancestor
65138377|NCT01683656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138378|NCT01683656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65138379|NCT01683656|Vasodilator Agents|vasodilator agents|mesh-ancestor
65138380|NCT01683656|Vitamin B Complex|vitamin b complex|mesh-ancestor
65138381|NCT01683656|Vitamins|vitamins|mesh-ancestor
65138382|NCT01683656|Micronutrients|micronutrients|mesh-ancestor
65138383|NCT01683656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138384|NCT01605864|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
65138385|NCT01605864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65138386|NCT01605864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65138387|NCT01608945|Hydrocortisone|hydrocortisone|mesh-list
65138388|NCT01608945|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65138389|NCT01608945|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65138390|NCT01608945|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65301992|NCT02616068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65301993|NCT04127084|Empagliflozin|empagliflozin|mesh-list
65301994|NCT04127084|Canagliflozin|canagliflozin|mesh-list
65301995|NCT04127084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65301996|NCT04127084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65301997|NCT04127084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65301998|NCT04127084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65301999|NCT00870194|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65302000|NCT00870194|Exenatide|exenatide|mesh-list
65302001|NCT00870194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65302002|NCT00870194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302003|NCT00870194|Incretins|incretins|mesh-ancestor
65302004|NCT00870194|Hormones|hormones|mesh-ancestor
65302005|NCT00870194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64532104|NCT02362308|Spironolactone|spironolactone|mesh-list
65138392|NCT01608984|Sufentanil|sufentanil|mesh-list
65138393|NCT01608984|Isoflurane|isoflurane|mesh-list
65138394|NCT01608984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65138395|NCT01608984|Narcotics|narcotics|mesh-ancestor
65138396|NCT01608984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65138397|NCT01608984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138398|NCT01608984|Analgesics|analgesics|mesh-ancestor
65138399|NCT01608984|Sensory System Agents|sensory system agents|mesh-ancestor
65138400|NCT01608984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65138401|NCT01608984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65138402|NCT01608984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65138407|NCT01648517|Carboplatin|carboplatin|mesh-list
65138408|NCT01648517|Docetaxel|docetaxel|mesh-list
65138409|NCT01648517|Vinorelbine|vinorelbine|mesh-list
65138410|NCT01648517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138411|NCT01648517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65138412|NCT01648517|Antimetabolites|antimetabolites|mesh-ancestor
65138413|NCT01648517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138414|NCT01648517|Antiviral Agents|antiviral agents|mesh-ancestor
65138415|NCT01648517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65138416|NCT01648517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138417|NCT01648517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65138418|NCT01648517|Immunologic Factors|immunologic factors|mesh-ancestor
65138419|NCT01648517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138420|NCT01648517|Tubulin Modulators|tubulin modulators|mesh-ancestor
65138421|NCT01648517|Antimitotic Agents|antimitotic agents|mesh-ancestor
65138422|NCT01648517|Mitosis Modulators|mitosis modulators|mesh-ancestor
65138423|NCT01648517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65138424|NCT01609101|Cobalt|cobalt|mesh-list
65138425|NCT01609101|Trace Elements|trace elements|mesh-ancestor
65138426|NCT01609101|Micronutrients|micronutrients|mesh-ancestor
65138427|NCT01609101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138428|NCT01648556|Prednisone|prednisone|mesh-list
65138429|NCT01648556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65138430|NCT01648556|Glucocorticoids|glucocorticoids|mesh-ancestor
65138431|NCT01648556|Hormones|hormones|mesh-ancestor
65138432|NCT01648556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65138433|NCT01648556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138434|NCT01648556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65138435|NCT01648556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138436|NCT01648595|Fentanyl|fentanyl|mesh-list
65138437|NCT01648595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65138438|NCT01648595|Narcotics|narcotics|mesh-ancestor
65138439|NCT01648595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65138440|NCT01648595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138441|NCT01648595|Analgesics|analgesics|mesh-ancestor
65138442|NCT01648595|Sensory System Agents|sensory system agents|mesh-ancestor
65302006|NCT00870194|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65302007|NCT00870194|Protease Inhibitors|protease inhibitors|mesh-ancestor
65302008|NCT00870194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302009|NCT00870194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302010|NCT00870194|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65302011|NCT00690430|Octreotide|octreotide|mesh-list
65302012|NCT00690430|Pasireotide|pasireotide|mesh-list
65302013|NCT00690430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65138443|NCT01648595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65138444|NCT01648595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65138445|NCT01648595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65138446|NCT01648595|Anesthetics, General|anesthetics, general|mesh-ancestor
65138447|NCT01648595|Anesthetics|anesthetics|mesh-ancestor
65138448|NCT01648634|Nebivolol|nebivolol|mesh-list
65138449|NCT01648634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65138450|NCT01648634|Vasodilator Agents|vasodilator agents|mesh-ancestor
65138451|NCT01648634|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65138452|NCT01648634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65138453|NCT01648634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65138454|NCT01648634|Adrenergic Agents|adrenergic agents|mesh-ancestor
65138455|NCT01648634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65138456|NCT01648634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138457|NCT01648634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138458|NCT01606059|Acetaminophen|acetaminophen|mesh-list
65138459|NCT01606059|Tramadol|tramadol|mesh-list
65138460|NCT01606059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65138461|NCT01606059|Analgesics|analgesics|mesh-ancestor
65138462|NCT01606059|Sensory System Agents|sensory system agents|mesh-ancestor
65138463|NCT01606059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780991|NCT03958344|Prednisolone|prednisolone|mesh-list
65138464|NCT01606059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138465|NCT01606059|Antipyretics|antipyretics|mesh-ancestor
65138466|NCT01606059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65138467|NCT01606059|Narcotics|narcotics|mesh-ancestor
65138468|NCT01606059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65138469|NCT01648712|Heparin|heparin|mesh-list
65138470|NCT01648712|Anticoagulants|anticoagulants|mesh-ancestor
65138471|NCT01648712|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65138472|NCT01648712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65138473|NCT01648712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138474|NCT01688544|Benzimidazole|benzimidazole|mesh-list
65138475|NCT01688544|Anthelmintics|anthelmintics|mesh-ancestor
65138476|NCT01688544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65138485|NCT01688583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65138486|NCT01688583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65138487|NCT01688583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65138488|NCT01688583|Anesthetics, General|anesthetics, general|mesh-ancestor
65138489|NCT01688583|Anesthetics|anesthetics|mesh-ancestor
65138490|NCT01648829|Atorvastatin|atorvastatin|mesh-list
65138491|NCT01648829|Pitavastatin|pitavastatin|mesh-list
65138492|NCT01648829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65138493|NCT01648829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65138494|NCT01648829|Antimetabolites|antimetabolites|mesh-ancestor
65138495|NCT01648829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138496|NCT01648829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65138497|NCT01648829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65138498|NCT01648829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138499|NCT01688700|Paclitaxel|paclitaxel|mesh-list
65138500|NCT01688700|Nimotuzumab|nimotuzumab|mesh-list
65138501|NCT01688700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65138502|NCT01688700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138503|NCT01688700|Tubulin Modulators|tubulin modulators|mesh-ancestor
65138504|NCT01688700|Antimitotic Agents|antimitotic agents|mesh-ancestor
65138505|NCT01688700|Mitosis Modulators|mitosis modulators|mesh-ancestor
65138506|NCT01688700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138507|NCT01688700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65138508|NCT01684085|Lorazepam|lorazepam|mesh-list
65138509|NCT01684085|Anticonvulsants|anticonvulsants|mesh-ancestor
65138510|NCT01684085|Antiemetics|antiemetics|mesh-ancestor
65302014|NCT00690430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65302015|NCT00690430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302016|NCT00690430|Hormones|hormones|mesh-ancestor
65302017|NCT00690430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65302018|NCT00690430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302019|NCT04126304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65302020|NCT04126304|Azithromycin|azithromycin|mesh-list
65138511|NCT01684085|Autonomic Agents|autonomic agents|mesh-ancestor
65138512|NCT01684085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65138513|NCT01684085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138514|NCT01684085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65138515|NCT01684085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65138516|NCT01684085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65138517|NCT01684085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65138518|NCT01684085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65138519|NCT01684085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65138520|NCT01684085|GABA Modulators|gaba modulators|mesh-ancestor
65138521|NCT01684085|GABA Agents|gaba agents|mesh-ancestor
65138522|NCT01684085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65138523|NCT01684085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138524|NCT05140512|Goserelin|goserelin|mesh-list
65138525|NCT05140512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65138526|NCT05140512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138527|NCT01684241|Vaccines|vaccines|mesh-list
65138528|NCT01684241|Immunologic Factors|immunologic factors|mesh-ancestor
65138529|NCT01684241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138530|NCT01688934|Naproxen|naproxen|mesh-list
65138531|NCT01688934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65138532|NCT01688934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65138533|NCT01688934|Analgesics|analgesics|mesh-ancestor
65138534|NCT01688934|Sensory System Agents|sensory system agents|mesh-ancestor
65138535|NCT01688934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65138536|NCT01688934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138537|NCT01688934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65138538|NCT01688934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65138539|NCT01688934|Gout Suppressants|gout suppressants|mesh-ancestor
65138540|NCT01688934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65138541|NCT01688934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138542|NCT01688934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138543|NCT01684319|Caseins|caseins|mesh-list
65138544|NCT01684319|Chelating Agents|chelating agents|mesh-ancestor
65138545|NCT01684319|Sequestering Agents|sequestering agents|mesh-ancestor
65138558|NCT02279615|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65138560|NCT02279615|Adrenergic Agents|adrenergic agents|mesh-ancestor
65138561|NCT02279615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65138562|NCT02279615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138563|NCT02279615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138564|NCT02279615|Urological Agents|urological agents|mesh-ancestor
65138565|NCT02279615|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65138566|NCT02279615|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65138567|NCT02279615|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65138568|NCT01689051|Glucagon|glucagon|mesh-list
65138569|NCT01689051|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65138570|NCT01689051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65138571|NCT01689051|Hormones|hormones|mesh-ancestor
65138572|NCT01689051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65138573|NCT01689051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138574|NCT01689051|Incretins|incretins|mesh-ancestor
65138575|NCT01689090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
65138576|NCT01689090|Citric Acid|citric acid|mesh-list
65138577|NCT01689090|Sodium Citrate|sodium citrate|mesh-list
65138578|NCT01689090|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
65138579|NCT01689090|Anticoagulants|anticoagulants|mesh-ancestor
65138580|NCT01689090|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65138581|NCT01689090|Chelating Agents|chelating agents|mesh-ancestor
65138582|NCT01689090|Sequestering Agents|sequestering agents|mesh-ancestor
65138583|NCT01689090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302021|NCT04126304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65302022|NCT02563054|Fluorouracil|fluorouracil|mesh-list
65302023|NCT02563054|Capecitabine|capecitabine|mesh-list
65302024|NCT02563054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302025|NCT02563054|Antimetabolites|antimetabolites|mesh-ancestor
65302026|NCT02563054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302027|NCT02563054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65302028|NCT02563054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65302029|NCT02563054|Immunologic Factors|immunologic factors|mesh-ancestor
65302030|NCT02563054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302031|NCT02614040|Plasma-lyte 148|plasma-lyte 148|mesh-list
65302032|NCT02614040|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65302033|NCT02614040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65302034|NCT00743470|Ritonavir|ritonavir|mesh-list
65302035|NCT00743470|Lopinavir|lopinavir|mesh-list
65302036|NCT00743470|Rifabutin|rifabutin|mesh-list
65302037|NCT00743470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65302038|NCT00743470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65302039|NCT00743470|Protease Inhibitors|protease inhibitors|mesh-ancestor
65302040|NCT00743470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302041|NCT00743470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138584|NCT01689090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65138585|NCT01689090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65138586|NCT01689090|Analgesics|analgesics|mesh-ancestor
65138587|NCT01689090|Sensory System Agents|sensory system agents|mesh-ancestor
65138588|NCT01689090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65138589|NCT01689090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138590|NCT01689090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65138591|NCT01689090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65138592|NCT01689090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138593|NCT01689129|Insulin|insulin|mesh-list
65138594|NCT01689129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65138595|NCT01689129|Insulin Glargine|insulin glargine|mesh-list
65138596|NCT01689129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65138597|NCT01689129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138598|NCT01689285|Valacyclovir|valacyclovir|mesh-list
65138599|NCT01689285|Antiviral Agents|antiviral agents|mesh-ancestor
65138600|NCT01689285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65138601|NCT01606527|Ibuprofen|ibuprofen|mesh-list
65138602|NCT01606527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65138603|NCT01606527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65138604|NCT01606527|Analgesics|analgesics|mesh-ancestor
65138605|NCT01606527|Sensory System Agents|sensory system agents|mesh-ancestor
65138606|NCT01606527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64711399|NCT05462236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138617|NCT01609413|Antacids|antacids|mesh-ancestor
65138618|NCT01609413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138619|NCT01609413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65138620|NCT02279966|Vortioxetine|vortioxetine|mesh-list
65138621|NCT02279966|Paroxetine|paroxetine|mesh-list
65138622|NCT02279966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65138623|NCT02279966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65138624|NCT02279966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65138625|NCT02279966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138626|NCT02279966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65302042|NCT00743470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65302043|NCT00743470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65302044|NCT00743470|Antiviral Agents|antiviral agents|mesh-ancestor
65302045|NCT00743470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65302046|NCT00743470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65302047|NCT00743470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65302048|NCT00743470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65302049|NCT00743470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65302050|NCT00743470|Antitubercular Agents|antitubercular agents|mesh-ancestor
65302051|NCT00688324|Acamprosate|acamprosate|mesh-list
65302052|NCT00688324|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65302053|NCT02619578|Remifentanil|remifentanil|mesh-list
65302054|NCT02619578|Propofol|propofol|mesh-list
65302055|NCT02619578|Vecuronium Bromide|vecuronium bromide|mesh-list
65302056|NCT02619578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64532152|NCT00310791|Levonorgestrel|levonorgestrel|mesh-list
65138627|NCT02279966|Serotonin Agents|serotonin agents|mesh-ancestor
65138628|NCT02279966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138629|NCT02279966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65138630|NCT02279966|Antidepressive Agents|antidepressive agents|mesh-ancestor
65138631|NCT02279966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65138632|NCT02279966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65138633|NCT02279966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65138634|NCT02279966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138635|NCT02279966|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65138636|NCT02279966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65138637|NCT02279966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65138638|NCT02279966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65138639|NCT02279966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65138640|NCT02279966|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65138641|NCT02279966|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65138642|NCT01684787|Ribavirin|ribavirin|mesh-list
65138643|NCT01684787|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65138644|NCT01684787|Interferon-alpha|interferon-alpha|mesh-list
65138645|NCT01684787|Antimetabolites|antimetabolites|mesh-ancestor
65138646|NCT01684787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138647|NCT01684787|Antiviral Agents|antiviral agents|mesh-ancestor
65138648|NCT01684787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65138649|NCT01684787|Immunologic Factors|immunologic factors|mesh-ancestor
65138650|NCT01684787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138651|NCT01649258|Granisetron|granisetron|mesh-list
65138652|NCT01649258|Fosaprepitant|fosaprepitant|mesh-list
65138653|NCT01649258|Aprepitant|aprepitant|mesh-list
65138654|NCT01649258|Antiemetics|antiemetics|mesh-ancestor
65138655|NCT01649258|Autonomic Agents|autonomic agents|mesh-ancestor
65138656|NCT01649258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65138657|NCT01649258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138658|NCT01649258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65138659|NCT01649258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65138660|NCT01649258|Serotonin Agents|serotonin agents|mesh-ancestor
65138661|NCT01649258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65138662|NCT01649258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138663|NCT01649258|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65138664|NCT01649336|Paclitaxel|paclitaxel|mesh-list
65138665|NCT01649336|Antimitotic Agents|antimitotic agents|mesh-list
65138666|NCT01649336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65138667|NCT01649336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138679|NCT01609491|Sympathomimetics|sympathomimetics|mesh-ancestor
65138680|NCT01609491|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65138681|NCT01609491|Nasal Decongestants|nasal decongestants|mesh-ancestor
65138682|NCT01609491|Respiratory System Agents|respiratory system agents|mesh-ancestor
65302057|NCT02619578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65302058|NCT02619578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302059|NCT02619578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65302060|NCT02619578|Anesthetics, General|anesthetics, general|mesh-ancestor
65302061|NCT02619578|Anesthetics|anesthetics|mesh-ancestor
65302062|NCT02619578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65302063|NCT02619578|Narcotics|narcotics|mesh-ancestor
65302064|NCT02619578|Analgesics|analgesics|mesh-ancestor
65302065|NCT02619578|Sensory System Agents|sensory system agents|mesh-ancestor
65302066|NCT02619578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65302067|NCT02619578|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65302068|NCT02619578|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65302069|NCT02619578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65302070|NCT02619578|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65302071|NCT02619578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65302072|NCT02619578|Cholinergic Agents|cholinergic agents|mesh-ancestor
65302073|NCT02619578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65302074|NCT02619578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302075|NCT02615912|Castor Oil|castor oil|mesh-list
65302076|NCT02615912|Cathartics|cathartics|mesh-ancestor
65302077|NCT02615912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65302078|NCT04123652|Lidocaine|lidocaine|mesh-list
65302079|NCT04123652|Ketamine|ketamine|mesh-list
65302080|NCT04123652|Anesthetics, Local|anesthetics, local|mesh-ancestor
65302081|NCT04123652|Anesthetics|anesthetics|mesh-ancestor
65302082|NCT04123652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65138683|NCT01609491|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65138684|NCT01609491|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65138685|NCT01609491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65138686|NCT01609491|Adrenergic Agents|adrenergic agents|mesh-ancestor
65138687|NCT01609491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65138688|NCT01609491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138689|NCT01609491|Protective Agents|protective agents|mesh-ancestor
64781223|NCT04511052|Carotenoids|carotenoids|mesh-list
65138690|NCT01606878|Cyclophosphamide|cyclophosphamide|mesh-list
65138691|NCT01606878|Doxorubicin|doxorubicin|mesh-list
65138692|NCT01606878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65138693|NCT01606878|Vincristine|vincristine|mesh-list
65138694|NCT01606878|Topotecan|topotecan|mesh-list
65138695|NCT01606878|Crizotinib|crizotinib|mesh-list
65138696|NCT01606878|Dexrazoxane|dexrazoxane|mesh-list
65138697|NCT01606878|Razoxane|razoxane|mesh-list
65138698|NCT01606878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65138699|NCT01606878|Immunologic Factors|immunologic factors|mesh-ancestor
65138700|NCT01606878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138701|NCT01606878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65138702|NCT01606878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65138703|NCT01606878|Alkylating Agents|alkylating agents|mesh-ancestor
65138704|NCT01606878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138705|NCT01606878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138706|NCT01606878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65138707|NCT01606878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65302083|NCT04123652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302084|NCT04123652|Sensory System Agents|sensory system agents|mesh-ancestor
65302085|NCT04123652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65302086|NCT04123652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65302087|NCT04123652|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65302088|NCT04123652|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65302089|NCT04123652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65302090|NCT04123652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302091|NCT04123652|Analgesics|analgesics|mesh-ancestor
64532187|NCT02362152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65138708|NCT01606878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65138709|NCT01606878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65138710|NCT01606878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138711|NCT01606878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65138712|NCT01606878|Tubulin Modulators|tubulin modulators|mesh-ancestor
65138713|NCT01606878|Antimitotic Agents|antimitotic agents|mesh-ancestor
65138714|NCT01606878|Mitosis Modulators|mitosis modulators|mesh-ancestor
65138715|NCT01606878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65138716|NCT01606878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65138717|NCT01606878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65138718|NCT01606878|Protective Agents|protective agents|mesh-ancestor
65138719|NCT01684865|Rituximab|rituximab|mesh-list
65138720|NCT01684865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65138721|NCT01684865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138722|NCT01684865|Immunologic Factors|immunologic factors|mesh-ancestor
65138723|NCT01684865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138724|NCT01684865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65138725|NCT01580163|Methadone|methadone|mesh-list
65138726|NCT01580163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65138727|NCT01580163|Narcotics|narcotics|mesh-ancestor
65138728|NCT01580163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65138729|NCT01580163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138730|NCT01580163|Analgesics|analgesics|mesh-ancestor
65138731|NCT01580163|Sensory System Agents|sensory system agents|mesh-ancestor
65138732|NCT01580163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65138744|NCT01609647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138746|NCT01580202|Entecavir|entecavir|mesh-list
65138747|NCT01580202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65138748|NCT01580202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65138749|NCT01580202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138750|NCT01580202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138751|NCT01580202|Antiviral Agents|antiviral agents|mesh-ancestor
65138752|NCT01580202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65138753|NCT01580202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65138754|NCT01580202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65138755|NCT01649570|Insulin Aspart|insulin aspart|mesh-list
65138756|NCT01649570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65138757|NCT01649570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138758|NCT01609881|Ketorolac|ketorolac|mesh-list
65138759|NCT01609881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65138760|NCT01609881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65138761|NCT01609881|Analgesics|analgesics|mesh-ancestor
65138762|NCT01609881|Sensory System Agents|sensory system agents|mesh-ancestor
65138763|NCT01609881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65138764|NCT01609881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138765|NCT01609881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65138766|NCT01609881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65138767|NCT01609881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65138768|NCT01609881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138769|NCT01609881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138770|NCT01609959|Valsartan|valsartan|mesh-list
65138771|NCT01609959|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65138772|NCT01609959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65302092|NCT04123652|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65302093|NCT04123652|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65302094|NCT04123652|Anesthetics, General|anesthetics, general|mesh-ancestor
65302095|NCT04123652|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65302096|NCT04123652|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65302097|NCT04123652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65302098|NCT00862940|Memantine|memantine|mesh-list
65302099|NCT00862940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65302100|NCT00862940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65302101|NCT00862940|Dopamine Agents|dopamine agents|mesh-ancestor
65302102|NCT00862940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65302103|NCT00862940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302104|NCT00862940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302105|NCT00862940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65302106|NCT00862940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65302107|NCT04122716|Liraglutide|liraglutide|mesh-list
65302108|NCT04122716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65302109|NCT04122716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302110|NCT04122716|Incretins|incretins|mesh-ancestor
65302111|NCT04122716|Hormones|hormones|mesh-ancestor
64532196|NCT01493531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138773|NCT01609959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65138774|NCT01609959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65138775|NCT01609959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138776|NCT01609998|Vaccines|vaccines|mesh-list
65138777|NCT01609998|Immunologic Factors|immunologic factors|mesh-ancestor
65138778|NCT01609998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138779|NCT01606098|Bevacizumab|bevacizumab|mesh-list
65138780|NCT01606098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65138781|NCT01606098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138782|NCT01606098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65138783|NCT01606098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65138784|NCT01606098|Growth Substances|growth substances|mesh-ancestor
65138785|NCT01606098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138786|NCT01606098|Growth Inhibitors|growth inhibitors|mesh-ancestor
65138787|NCT01649921|Interferons|interferons|mesh-list
65138788|NCT01649921|Interferon-gamma|interferon-gamma|mesh-list
65138789|NCT01649921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138790|NCT01649921|Antiviral Agents|antiviral agents|mesh-ancestor
65138791|NCT01649921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65138792|NCT01606566|Bleomycin|bleomycin|mesh-list
65138793|NCT01606566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65138794|NCT01606566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138818|NCT01602822|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65138820|NCT01602822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65138821|NCT01602822|Protease Inhibitors|protease inhibitors|mesh-ancestor
65138822|NCT01602822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138823|NCT01602822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138824|NCT01602822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65138825|NCT01602822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65138826|NCT01602822|Antiviral Agents|antiviral agents|mesh-ancestor
65138827|NCT01602822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65302112|NCT04122716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65302113|NCT00868166|Riluzole|riluzole|mesh-list
65302114|NCT00868166|Anticonvulsants|anticonvulsants|mesh-ancestor
65302115|NCT00868166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65302116|NCT00868166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65302117|NCT00868166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65302118|NCT00868166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302119|NCT00868166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302120|NCT00868166|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65302121|NCT00868166|Protective Agents|protective agents|mesh-ancestor
65302122|NCT00858780|Etanercept|etanercept|mesh-list
65302123|NCT00858780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65302124|NCT00858780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65302125|NCT00858780|Analgesics|analgesics|mesh-ancestor
65302126|NCT00858780|Sensory System Agents|sensory system agents|mesh-ancestor
65302127|NCT00858780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65302128|NCT00858780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302129|NCT00858780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65302130|NCT00858780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65302131|NCT00858780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65302132|NCT00858780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65302133|NCT00858780|Immunologic Factors|immunologic factors|mesh-ancestor
65302135|NCT02619266|Megestrol Acetate|megestrol acetate|mesh-list
65302136|NCT02619266|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65302137|NCT02619266|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65302138|NCT02619266|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65302139|NCT02619266|Contraceptive Agents|contraceptive agents|mesh-ancestor
65302140|NCT02619266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64532220|NCT02105415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65138828|NCT01602822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65138829|NCT01602822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65138830|NCT01602822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65138831|NCT01602822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65138832|NCT02273154|Buspirone|buspirone|mesh-list
65138833|NCT02273154|Paroxetine|paroxetine|mesh-list
65138834|NCT02273154|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65138835|NCT02273154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65138836|NCT02273154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64781362|NCT02655354|Mirtazapine|mirtazapine|mesh-list
65138837|NCT02273154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138838|NCT02273154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65138839|NCT02273154|Serotonin Agents|serotonin agents|mesh-ancestor
65138840|NCT02273154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138873|NCT02273271|Antiviral Agents|antiviral agents|mesh-ancestor
65302141|NCT02619266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302142|NCT02619266|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65302143|NCT02619266|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65302144|NCT02619266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65302145|NCT02619266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302146|NCT02619266|Appetite Stimulants|appetite stimulants|mesh-ancestor
65302147|NCT02619266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65302148|NCT00699062|Montelukast|montelukast|mesh-list
65302149|NCT00699062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65302150|NCT00699062|Respiratory System Agents|respiratory system agents|mesh-ancestor
65138874|NCT02273271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65138875|NCT02270307|Cyclophosphamide|cyclophosphamide|mesh-list
65138876|NCT02270307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65138877|NCT02270307|Immunologic Factors|immunologic factors|mesh-ancestor
65138878|NCT02270307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138879|NCT02270307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65138891|NCT02270424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65138892|NCT02270424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138893|NCT02270424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65138894|NCT02270424|Respiratory System Agents|respiratory system agents|mesh-ancestor
65138895|NCT02270424|Dermatologic Agents|dermatologic agents|mesh-ancestor
65138896|NCT02270424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65138897|NCT02270424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65138898|NCT02270424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65138899|NCT02270424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65138900|NCT02270424|Adrenergic Agents|adrenergic agents|mesh-ancestor
65138901|NCT02270424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65138902|NCT02270424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138903|NCT02270424|Glucocorticoids|glucocorticoids|mesh-ancestor
65138904|NCT02270424|Hormones|hormones|mesh-ancestor
65138905|NCT02270424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65138906|NCT02270424|Sympathomimetics|sympathomimetics|mesh-ancestor
65138907|NCT01686347|Ropivacaine|ropivacaine|mesh-list
65138908|NCT01686347|Anesthetics, Local|anesthetics, local|mesh-ancestor
65138909|NCT01686347|Anesthetics|anesthetics|mesh-ancestor
65138910|NCT01686347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65138911|NCT01686347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138912|NCT01686347|Sensory System Agents|sensory system agents|mesh-ancestor
65138913|NCT01686347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65138915|NCT05140655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65138916|NCT05140655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138917|NCT05140655|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65138918|NCT05140655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65138919|NCT05140655|Hormone Antagonists|hormone antagonists|mesh-ancestor
65138920|NCT05140655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65138921|NCT05140655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138922|NCT01688570|Cyproheptadine|cyproheptadine|mesh-list
65138923|NCT01688570|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65138924|NCT01688570|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65138925|NCT01688570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65138926|NCT01688570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65138927|NCT01688570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138928|NCT01688570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65138929|NCT01688570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138930|NCT01688570|Analgesics|analgesics|mesh-ancestor
65138931|NCT01688570|Sensory System Agents|sensory system agents|mesh-ancestor
65138932|NCT01688570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65138933|NCT01688570|Antidepressive Agents|antidepressive agents|mesh-ancestor
65138934|NCT01688570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65138935|NCT01688570|Dopamine Agents|dopamine agents|mesh-ancestor
65138936|NCT01688570|Antipruritics|antipruritics|mesh-ancestor
65302151|NCT00699062|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65302152|NCT00699062|Hormone Antagonists|hormone antagonists|mesh-ancestor
65302153|NCT00699062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65302154|NCT00699062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302155|NCT00699062|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65302156|NCT00699062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65302157|NCT00699062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302158|NCT02619032|Fentanyl|fentanyl|mesh-list
65302159|NCT02619032|Remifentanil|remifentanil|mesh-list
65302160|NCT02619032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65302161|NCT02619032|Narcotics|narcotics|mesh-ancestor
65302162|NCT02619032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65302163|NCT02619032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302164|NCT02619032|Analgesics|analgesics|mesh-ancestor
65302165|NCT02619032|Sensory System Agents|sensory system agents|mesh-ancestor
65302166|NCT02619032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65302167|NCT02619032|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65302168|NCT02619032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65302169|NCT02619032|Anesthetics, General|anesthetics, general|mesh-ancestor
65302170|NCT02619032|Anesthetics|anesthetics|mesh-ancestor
65302171|NCT00858234|Bortezomib|bortezomib|mesh-list
65302172|NCT00858234|Vorinostat|vorinostat|mesh-list
65302173|NCT00858234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302174|NCT00858234|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65302175|NCT00858234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532254|NCT04409483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65138937|NCT01688570|Dermatologic Agents|dermatologic agents|mesh-ancestor
65138938|NCT01688570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65138939|NCT01688570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65138940|NCT01688570|Histamine Antagonists|histamine antagonists|mesh-ancestor
65138941|NCT01688570|Histamine Agents|histamine agents|mesh-ancestor
65138964|NCT01688648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65138966|NCT01688648|Sensory System Agents|sensory system agents|mesh-ancestor
65138967|NCT01688648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65138968|NCT01688648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65138969|NCT01688648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65138970|NCT01688648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65138971|NCT01688648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65138972|NCT01688648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138973|NCT01688648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65138974|NCT01688648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65138975|NCT01688648|Analgesics|analgesics|mesh-ancestor
65138976|NCT01688648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65138977|NCT01688648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65138978|NCT01688648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65138979|NCT01688648|Adrenergic Agents|adrenergic agents|mesh-ancestor
65138980|NCT01688648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65138981|NCT01686659|Chrysarobin|chrysarobin|mesh-list
64532279|NCT02437110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65302176|NCT00858234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302177|NCT00697814|Clomiphene|clomiphene|mesh-list
65302178|NCT00697814|Enclomiphene|enclomiphene|mesh-list
65302179|NCT00697814|Zuclomiphene|zuclomiphene|mesh-list
65302180|NCT00697814|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65302181|NCT00697814|Hormone Antagonists|hormone antagonists|mesh-ancestor
65302182|NCT00697814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65302183|NCT00697814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302184|NCT00697814|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65302185|NCT00697814|Fertility Agents|fertility agents|mesh-ancestor
65138982|NCT01686659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65138983|NCT01686659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65138984|NCT01686659|Analgesics|analgesics|mesh-ancestor
65138985|NCT01686659|Sensory System Agents|sensory system agents|mesh-ancestor
65138986|NCT01686659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65138987|NCT01686659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138988|NCT01686659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65138989|NCT01686659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65138990|NCT02271126|Heparin|heparin|mesh-list
65138991|NCT02271126|Thromboplastin|thromboplastin|mesh-list
65138992|NCT02271126|Anticoagulants|anticoagulants|mesh-ancestor
65138993|NCT02271126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65138994|NCT02271126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64712015|NCT04889118|Pembrolizumab|pembrolizumab|mesh-list
65139007|NCT02271282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65139008|NCT02271282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139009|NCT02271282|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65139010|NCT02271282|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65139011|NCT02271282|Hormone Antagonists|hormone antagonists|mesh-ancestor
65139012|NCT02271282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65139013|NCT02271282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139014|NCT02271282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65139015|NCT01688960|Aflibercept|aflibercept|mesh-list
65139016|NCT01688960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65139017|NCT01688960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65139018|NCT01688960|Growth Substances|growth substances|mesh-ancestor
65139019|NCT01688960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139020|NCT01688960|Growth Inhibitors|growth inhibitors|mesh-ancestor
65139021|NCT01688960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139022|NCT02271360|Cabergoline|cabergoline|mesh-list
65139023|NCT02271360|Calcium Dobesilate|calcium dobesilate|mesh-list
65139024|NCT02271360|Calcium|calcium|mesh-list
65139025|NCT02271360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65139026|NCT02271360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139027|NCT02271360|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65139028|NCT02271360|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65139029|NCT02271360|Dopamine Agonists|dopamine agonists|mesh-ancestor
65139030|NCT02271360|Dopamine Agents|dopamine agents|mesh-ancestor
65139031|NCT02271360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65139032|NCT02271360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139033|NCT02271360|Hemostatics|hemostatics|mesh-ancestor
65139034|NCT02271360|Coagulants|coagulants|mesh-ancestor
65139035|NCT01687049|Red yeast rice|red yeast rice|mesh-list
65139036|NCT01687049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65139037|NCT01687049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65139038|NCT01687049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65139039|NCT01687049|Antimetabolites|antimetabolites|mesh-ancestor
65139040|NCT01687049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139041|NCT01687049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139042|NCT01687049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65139043|NCT02271399|Aspirin|aspirin|mesh-list
65139044|NCT02271399|Rivaroxaban|rivaroxaban|mesh-list
65302186|NCT00697814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65302187|NCT00697814|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65302188|NCT00697814|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65302189|NCT00862082|Sorafenib|sorafenib|mesh-list
65302190|NCT00862082|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65302191|NCT00862082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302192|NCT00862082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65302193|NCT00862082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302194|NCT00862082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302195|NCT00862082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65302196|NCT00862082|Alkylating Agents|alkylating agents|mesh-ancestor
65302197|NCT00849186|Sunitinib|sunitinib|mesh-list
65139045|NCT02271399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65139046|NCT02271399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65139047|NCT02271399|Analgesics|analgesics|mesh-ancestor
65139048|NCT02271399|Sensory System Agents|sensory system agents|mesh-ancestor
65139049|NCT02271399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65139050|NCT02271399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139051|NCT02271399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65139052|NCT02271399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65139053|NCT02271399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65139054|NCT02271399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65139055|NCT02271399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139056|NCT02271399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65139066|NCT02271438|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65139067|NCT02271438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65139068|NCT02271438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65139069|NCT02271438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65139070|NCT02271438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65139071|NCT02271438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139072|NCT02271438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139073|NCT02271438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139074|NCT02271438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65139075|NCT02271438|Contraceptive Agents|contraceptive agents|mesh-ancestor
65139076|NCT02271438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65139077|NCT02271438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139078|NCT02271438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65139079|NCT02271438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65139080|NCT02271438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65139082|NCT01687127|Vitamin B Complex|vitamin b complex|mesh-list
65139083|NCT01687127|Calcium|calcium|mesh-list
65139084|NCT01687127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65139085|NCT01687127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139086|NCT01687127|Hematinics|hematinics|mesh-ancestor
65139087|NCT01687127|Vitamins|vitamins|mesh-ancestor
65139088|NCT01687127|Micronutrients|micronutrients|mesh-ancestor
65139089|NCT02271555|Remifentanil|remifentanil|mesh-list
65139090|NCT02271555|Sevoflurane|sevoflurane|mesh-list
65139091|NCT02271555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65139092|NCT02271555|Narcotics|narcotics|mesh-ancestor
65139093|NCT02271555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65139094|NCT02271555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139095|NCT02271555|Analgesics|analgesics|mesh-ancestor
65139096|NCT02271555|Sensory System Agents|sensory system agents|mesh-ancestor
65139097|NCT02271555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65139098|NCT02271555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65139099|NCT02271555|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65139100|NCT02271555|Anesthetics, General|anesthetics, general|mesh-ancestor
65139101|NCT02271555|Anesthetics|anesthetics|mesh-ancestor
65139102|NCT01687205|Tenofovir|tenofovir|mesh-list
65139103|NCT01687205|Antiviral Agents|antiviral agents|mesh-ancestor
65302198|NCT00849186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302199|NCT00849186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65302200|NCT00849186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65302201|NCT00849186|Growth Substances|growth substances|mesh-ancestor
65302202|NCT00849186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302203|NCT00849186|Growth Inhibitors|growth inhibitors|mesh-ancestor
65302204|NCT00849186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65302205|NCT00849186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302206|NCT00849186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302207|NCT00692770|Sorafenib|sorafenib|mesh-list
65302208|NCT00692770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302209|NCT00692770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65302210|NCT00692770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302211|NCT00692770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302212|NCT00867308|Lenalidomide|lenalidomide|mesh-list
65302213|NCT00867308|Immunologic Factors|immunologic factors|mesh-ancestor
64532304|NCT02373072|Trimethobenzamide|trimethobenzamide|mesh-list
65139104|NCT01687205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65139105|NCT01687205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65139106|NCT01687205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65139107|NCT01687205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139108|NCT01687205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139109|NCT01687205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65139110|NCT01687205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65139111|NCT01689116|Moxifloxacin|moxifloxacin|mesh-list
65139112|NCT01689116|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65139113|NCT01689116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65139114|NCT01689116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65139115|NCT01689116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65139116|NCT01689116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65139117|NCT01689116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139118|NCT01689116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514462|NCT02284516|Lifitegrast|lifitegrast|mesh-list
65139119|NCT01689116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139120|NCT01689116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65139121|NCT01689116|Contraceptive Agents|contraceptive agents|mesh-ancestor
65139122|NCT01689116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65139123|NCT01689116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139137|NCT01687439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65139138|NCT01687439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65139139|NCT01687439|Growth Substances|growth substances|mesh-ancestor
65139140|NCT01687439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139141|NCT01687439|Growth Inhibitors|growth inhibitors|mesh-ancestor
65139142|NCT01588704|Bevacizumab|bevacizumab|mesh-list
65139143|NCT01588704|Pemetrexed|pemetrexed|mesh-list
65139144|NCT01588704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65139145|NCT01588704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139146|NCT01588704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65139147|NCT01588704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65139148|NCT01588704|Growth Substances|growth substances|mesh-ancestor
65139149|NCT01588704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139150|NCT01588704|Growth Inhibitors|growth inhibitors|mesh-ancestor
65139151|NCT01588704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139152|NCT01588704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139153|NCT01588704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65302214|NCT00867308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302215|NCT00867308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65302216|NCT00867308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65302217|NCT00867308|Growth Substances|growth substances|mesh-ancestor
65302218|NCT00867308|Growth Inhibitors|growth inhibitors|mesh-ancestor
65302219|NCT00867308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302220|NCT02618876|Nalbuphine|nalbuphine|mesh-list
65302221|NCT02618876|Bupivacaine|bupivacaine|mesh-list
65302222|NCT02618876|Anesthetics, Local|anesthetics, local|mesh-ancestor
65302223|NCT02618876|Anesthetics|anesthetics|mesh-ancestor
65302224|NCT02618876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65302225|NCT02618876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302226|NCT02618876|Sensory System Agents|sensory system agents|mesh-ancestor
64532320|NCT01572727|Paclitaxel|paclitaxel|mesh-list
65139154|NCT01588704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65139155|NCT01588743|Insulin Aspart|insulin aspart|mesh-list
65139156|NCT01588743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65139157|NCT01588743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139158|NCT01689311|Alprostadil|alprostadil|mesh-list
65139159|NCT01689311|Misoprostol|misoprostol|mesh-list
65139160|NCT01689311|Oxytocin|oxytocin|mesh-list
65139161|NCT01689311|Ergonovine|ergonovine|mesh-list
65139162|NCT01689311|Dinoprost|dinoprost|mesh-list
65139163|NCT01689311|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
65139164|NCT01689311|Oxytocics|oxytocics|mesh-ancestor
65139165|NCT01689311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65139166|NCT01689311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139167|NCT01689311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65139168|NCT01689311|Abortifacient Agents|abortifacient agents|mesh-ancestor
65139169|NCT01689311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65139170|NCT01689311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65139171|NCT01689311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65139172|NCT01689311|Vasodilator Agents|vasodilator agents|mesh-ancestor
65139173|NCT01689311|Urological Agents|urological agents|mesh-ancestor
65139174|NCT01588782|Ketoconazole|ketoconazole|mesh-list
65139175|NCT01588782|Antifungal Agents|antifungal agents|mesh-ancestor
65139176|NCT01588782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65139177|NCT01588782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65139178|NCT01588782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65139179|NCT01588782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139180|NCT01588782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139181|NCT01588782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65139182|NCT01588782|Hormone Antagonists|hormone antagonists|mesh-ancestor
65139183|NCT01588782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65139184|NCT01588782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139185|NCT01588782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65139203|NCT01687868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65139204|NCT01687868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65139205|NCT01687868|Adrenergic Agents|adrenergic agents|mesh-ancestor
65139206|NCT01687868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65139207|NCT01687868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139208|NCT01688024|Mitomycins|mitomycins|mesh-list
65139209|NCT01688024|Mitomycin|mitomycin|mesh-list
65139210|NCT01688024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65139211|NCT01688024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139212|NCT01688024|Alkylating Agents|alkylating agents|mesh-ancestor
65139213|NCT01688024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139214|NCT01688024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65139215|NCT01688024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139216|NCT01689623|Simeprevir|simeprevir|mesh-list
65139217|NCT01689623|Atorvastatin|atorvastatin|mesh-list
65139218|NCT01689623|Simvastatin|simvastatin|mesh-list
64532327|NCT02359266|Vitamin D|vitamin d|mesh-list
65302227|NCT02618876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65302228|NCT02618876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65302229|NCT02618876|Narcotics|narcotics|mesh-ancestor
65302230|NCT02618876|Analgesics|analgesics|mesh-ancestor
65302231|NCT04119752|Curcumin|curcumin|mesh-list
65302232|NCT04119752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65302233|NCT04119752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65302234|NCT04119752|Analgesics|analgesics|mesh-ancestor
65302235|NCT04119752|Sensory System Agents|sensory system agents|mesh-ancestor
65302236|NCT04119752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65302237|NCT04119752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302238|NCT04119752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65302239|NCT04119752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65302240|NCT04119752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302241|NCT04119752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302242|NCT04119752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302243|NCT00866918|Vitamins|vitamins|mesh-list
65302244|NCT00866918|Vitamin A|vitamin a|mesh-list
65302245|NCT00866918|Cytarabine|cytarabine|mesh-list
65302246|NCT00866918|Methotrexate|methotrexate|mesh-list
65139219|NCT01689623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65139220|NCT01689623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65139221|NCT01689623|Antimetabolites|antimetabolites|mesh-ancestor
65139222|NCT01689623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139223|NCT01689623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65139224|NCT01689623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65139225|NCT01689623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139226|NCT01689623|Antiviral Agents|antiviral agents|mesh-ancestor
65139227|NCT01689623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65139228|NCT01689623|Protease Inhibitors|protease inhibitors|mesh-ancestor
65139229|NCT01689662|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
65139230|NCT01689662|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65139231|NCT01689662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139232|NCT04055142|Cidofovir|cidofovir|mesh-list
65139233|NCT04055142|Antiviral Agents|antiviral agents|mesh-ancestor
65139234|NCT04055142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65139235|NCT04055142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139236|NCT04055142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139237|NCT02272647|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65139238|NCT02272647|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65139239|NCT02272647|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65139240|NCT02272647|Medroxyprogesterone|medroxyprogesterone|mesh-list
65139241|NCT02272647|Estradiol|estradiol|mesh-list
65139242|NCT02272647|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65139243|NCT02272647|Progesterone|progesterone|mesh-list
65139244|NCT02272647|Estrogens|estrogens|mesh-ancestor
65139245|NCT02272647|Hormones|hormones|mesh-ancestor
65139255|NCT02272647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65139256|NCT02272647|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65139257|NCT02272647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65139258|NCT02272647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139259|NCT02272764|Itraconazole|itraconazole|mesh-list
65139260|NCT02272764|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
65139261|NCT02272764|Antifungal Agents|antifungal agents|mesh-ancestor
65139262|NCT02272764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65302247|NCT00866918|Mercaptopurine|mercaptopurine|mesh-list
65302248|NCT00866918|Mitoxantrone|mitoxantrone|mesh-list
65302249|NCT00866918|Idarubicin|idarubicin|mesh-list
65302250|NCT00866918|Tretinoin|tretinoin|mesh-list
65302251|NCT00866918|Retinol palmitate|retinol palmitate|mesh-list
65302252|NCT00866918|Arsenic Trioxide|arsenic trioxide|mesh-list
65302253|NCT00866918|Micronutrients|micronutrients|mesh-ancestor
65302254|NCT00866918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302255|NCT00866918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65302256|NCT00866918|Abortifacient Agents|abortifacient agents|mesh-ancestor
65302257|NCT00866918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65302258|NCT00866918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65302259|NCT00866918|Antimetabolites|antimetabolites|mesh-ancestor
65302260|NCT00866918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302261|NCT00866918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302262|NCT00866918|Dermatologic Agents|dermatologic agents|mesh-ancestor
65302263|NCT00866918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302264|NCT00866918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65302265|NCT00866918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65302266|NCT00866918|Immunologic Factors|immunologic factors|mesh-ancestor
65302267|NCT00866918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65302268|NCT00866918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65302269|NCT00866918|Antiviral Agents|antiviral agents|mesh-ancestor
65139263|NCT02272764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65139264|NCT02272764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65139265|NCT02272764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139266|NCT02272764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139267|NCT02272764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65139268|NCT02272764|Hormone Antagonists|hormone antagonists|mesh-ancestor
65139269|NCT02272764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65139270|NCT02272764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139271|NCT02272764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65139273|NCT01689896|Androgens|androgens|mesh-ancestor
65139274|NCT01689896|Hormones|hormones|mesh-ancestor
65139275|NCT01689896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65139276|NCT01689896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139277|NCT01316094|Ipragliflozin|ipragliflozin|mesh-list
65139278|NCT01316094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65139279|NCT01316094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139280|NCT01316094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65139281|NCT01316094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139282|NCT01689935|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65139283|NCT01689935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65139284|NCT01689935|Dermatologic Agents|dermatologic agents|mesh-ancestor
65139285|NCT01316133|Tacrolimus|tacrolimus|mesh-list
65139286|NCT01316133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65139287|NCT01316133|Immunologic Factors|immunologic factors|mesh-ancestor
65139288|NCT01316133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139289|NCT01316133|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65139290|NCT01316133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139291|NCT01316133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139292|NCT05654064|Fentanyl|fentanyl|mesh-list
65302270|NCT00866918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65302271|NCT00866918|Analgesics|analgesics|mesh-ancestor
65302272|NCT00866918|Sensory System Agents|sensory system agents|mesh-ancestor
65052158|NCT00225992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302273|NCT00866918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65302274|NCT00866918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65302275|NCT00866918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65302276|NCT00866918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65302277|NCT00866918|Keratolytic Agents|keratolytic agents|mesh-ancestor
65302278|NCT00866918|Antioxidants|antioxidants|mesh-ancestor
65302279|NCT00866918|Protective Agents|protective agents|mesh-ancestor
65302280|NCT00866918|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65302281|NCT00861692|Argatroban|argatroban|mesh-list
65302282|NCT00861692|Antithrombins|antithrombins|mesh-ancestor
65302283|NCT00861692|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65302284|NCT00861692|Protease Inhibitors|protease inhibitors|mesh-ancestor
65302285|NCT00861692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302286|NCT00861692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302287|NCT00861692|Anticoagulants|anticoagulants|mesh-ancestor
65302288|NCT00861692|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65302289|NCT03131765|Poly I-C|poly i-c|mesh-list
65302290|NCT03131765|Antiviral Agents|antiviral agents|mesh-ancestor
65302291|NCT03131765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65302292|NCT03131765|Interferon Inducers|interferon inducers|mesh-ancestor
65302293|NCT03131765|Immunologic Factors|immunologic factors|mesh-ancestor
65139293|NCT05654064|Dexmedetomidine|dexmedetomidine|mesh-list
65139294|NCT05654064|Remifentanil|remifentanil|mesh-list
65139295|NCT05654064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65139296|NCT05654064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65139297|NCT05654064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139298|NCT05654064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65139299|NCT05654064|Analgesics|analgesics|mesh-ancestor
65139300|NCT05654064|Sensory System Agents|sensory system agents|mesh-ancestor
65139301|NCT05654064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65139302|NCT05654064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65139303|NCT05654064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65139304|NCT05654064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65139305|NCT05654064|Adrenergic Agents|adrenergic agents|mesh-ancestor
65139306|NCT05654064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65139307|NCT05654064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712549|NCT04169373|Upadacitinib|upadacitinib|mesh-list
65139327|NCT05653401|Sensory System Agents|sensory system agents|mesh-ancestor
65139328|NCT05653401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65139329|NCT05653401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65139330|NCT05653401|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65139331|NCT05653401|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65139332|NCT05653401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65139333|NCT05653401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139334|NCT05653401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65139335|NCT05653401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65302294|NCT03131765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302295|NCT02689037|Aspirin|aspirin|mesh-list
65302296|NCT02689037|Clopidogrel|clopidogrel|mesh-list
65302297|NCT02689037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65302298|NCT02689037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65302299|NCT02689037|Analgesics|analgesics|mesh-ancestor
65302300|NCT02689037|Sensory System Agents|sensory system agents|mesh-ancestor
65302301|NCT02689037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65302302|NCT02689037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302303|NCT02689037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65302304|NCT02689037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65302305|NCT02689037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65302306|NCT02689037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65302307|NCT02689037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302308|NCT02689037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65302309|NCT02689037|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65302310|NCT02689037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302311|NCT02689037|Antipyretics|antipyretics|mesh-ancestor
64532400|NCT00353301|Sirolimus|sirolimus|mesh-list
65139337|NCT05653401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65139338|NCT05653401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65139339|NCT05653401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65139340|NCT05653401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139342|NCT05653401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65139343|NCT05653401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65139344|NCT05653401|Tocolytic Agents|tocolytic agents|mesh-ancestor
65139345|NCT05653401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65139346|NCT01685255|Tamoxifen|tamoxifen|mesh-list
65139347|NCT01685255|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65139348|NCT01685255|Hormone Antagonists|hormone antagonists|mesh-ancestor
65139349|NCT01685255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65139350|NCT01685255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139351|NCT01685255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65139352|NCT01685255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139353|NCT01685255|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65139354|NCT01685255|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65139355|NCT01685255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65139357|NCT01680965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139358|NCT02272998|Ponatinib|ponatinib|mesh-list
65139359|NCT02272998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139360|NCT02272998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65139361|NCT02272998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139362|NCT02272998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139363|NCT01683188|Vemurafenib|vemurafenib|mesh-list
65139364|NCT01683188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139365|NCT01683188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65139366|NCT01683188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139377|NCT01380093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65139378|NCT01380093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139379|NCT01380093|Analgesics|analgesics|mesh-ancestor
65139380|NCT01380093|Sensory System Agents|sensory system agents|mesh-ancestor
65139381|NCT01380093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65139382|NCT01380093|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65139383|NCT01380093|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65139384|NCT01379937|Vaccines|vaccines|mesh-list
65302312|NCT02689037|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65302313|NCT02689037|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65302314|NCT02689037|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65302315|NCT02689037|Purinergic Agents|purinergic agents|mesh-ancestor
65302316|NCT02689037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65302317|NCT04184921|Aspirin|aspirin|mesh-list
65302318|NCT04184921|Osimertinib|osimertinib|mesh-list
64296974|NCT02646332|Lansoprazole|lansoprazole|mesh-list
65139385|NCT01379937|Immunologic Factors|immunologic factors|mesh-ancestor
65139386|NCT01379937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139387|NCT04820972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65139388|NCT03558854|Aspirin|aspirin|mesh-list
65139389|NCT03558854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65139390|NCT03558854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65139391|NCT03558854|Analgesics|analgesics|mesh-ancestor
65139392|NCT03558854|Sensory System Agents|sensory system agents|mesh-ancestor
65139393|NCT03558854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65139394|NCT03558854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139395|NCT03558854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65139396|NCT03558854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65139397|NCT03558854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65139398|NCT03558854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65139399|NCT03558854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139400|NCT03558854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65139401|NCT03558854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65139402|NCT03558854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139403|NCT03558854|Antipyretics|antipyretics|mesh-ancestor
65139404|NCT01335477|Nintedanib|nintedanib|mesh-list
65139405|NCT01335477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139406|NCT01335477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65139407|NCT01335477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139408|NCT01335477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139409|NCT03366272|Gemcitabine|gemcitabine|mesh-list
65139410|NCT03366272|Rituximab|rituximab|mesh-list
65139411|NCT03366272|Nivolumab|nivolumab|mesh-list
65139412|NCT03366272|Oxaliplatin|oxaliplatin|mesh-list
65139413|NCT03366272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65139414|NCT03366272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139415|NCT03366272|Immunologic Factors|immunologic factors|mesh-ancestor
64514468|NCT02721537|Vitamin B Complex|vitamin b complex|mesh-ancestor
65139416|NCT03366272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139417|NCT03366272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65139418|NCT03366272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65139419|NCT03366272|Antimetabolites|antimetabolites|mesh-ancestor
65139420|NCT03366272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139421|NCT03366272|Antiviral Agents|antiviral agents|mesh-ancestor
65139422|NCT03366272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65139423|NCT03366272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139424|NCT03366272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65139425|NCT03366272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65139426|NCT01371747|Losartan|losartan|mesh-list
65139427|NCT01371747|Spironolactone|spironolactone|mesh-list
65139428|NCT01371747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65139429|NCT01371747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65139430|NCT01371747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65139431|NCT01371747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64712697|NCT04058067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65139447|NCT01335399|Autonomic Agents|autonomic agents|mesh-ancestor
65139448|NCT01335399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65139449|NCT01335399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139450|NCT01335399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65139451|NCT01335399|Glucocorticoids|glucocorticoids|mesh-ancestor
65139452|NCT01335399|Hormones|hormones|mesh-ancestor
65139453|NCT01335399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65139454|NCT01335399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65139455|NCT01335399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139456|NCT01335399|Protease Inhibitors|protease inhibitors|mesh-ancestor
65302319|NCT04184921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65302320|NCT04184921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65302321|NCT04184921|Analgesics|analgesics|mesh-ancestor
65302322|NCT04184921|Sensory System Agents|sensory system agents|mesh-ancestor
65302323|NCT04184921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65302324|NCT04184921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302325|NCT04184921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65302326|NCT04184921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65302327|NCT04184921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65302328|NCT04184921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65302329|NCT04184921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302330|NCT04184921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65302331|NCT04184921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65302332|NCT04184921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302333|NCT04184921|Antipyretics|antipyretics|mesh-ancestor
65302334|NCT04184921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302335|NCT04184921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65302336|NCT00602927|Varenicline|varenicline|mesh-list
65302337|NCT00602927|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65302338|NCT00602927|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65302339|NCT00602927|Cholinergic Agents|cholinergic agents|mesh-ancestor
65302340|NCT00602927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65302341|NCT00602927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302342|NCT00602927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302343|NCT00639743|Tenecteplase|tenecteplase|mesh-list
65302344|NCT00639743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65302345|NCT00639743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65302346|NCT00639743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302347|NCT04186559|Pentoxifylline|pentoxifylline|mesh-list
65302348|NCT04186559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65302349|NCT04186559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302350|NCT04186559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302351|NCT04186559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65302352|NCT04186559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65302353|NCT04186559|Protective Agents|protective agents|mesh-ancestor
65302354|NCT04186559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302355|NCT04186559|Vasodilator Agents|vasodilator agents|mesh-ancestor
65302356|NCT04186559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65302357|NCT04186559|Antioxidants|antioxidants|mesh-ancestor
65302358|NCT00602537|Lithium Carbonate|lithium carbonate|mesh-list
65302359|NCT00602537|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65302360|NCT00602537|Antidepressive Agents|antidepressive agents|mesh-ancestor
65302361|NCT00602537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65302362|NCT00602537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532446|NCT03160248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139457|NCT01335399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139458|NCT01335399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139459|NCT01335399|Immunologic Factors|immunologic factors|mesh-ancestor
65139460|NCT01335399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65139461|NCT01335399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65139462|NCT01335399|Growth Substances|growth substances|mesh-ancestor
65139463|NCT01335399|Growth Inhibitors|growth inhibitors|mesh-ancestor
65139464|NCT04825262|Tacrolimus|tacrolimus|mesh-list
65139465|NCT04825262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65139466|NCT04825262|Immunologic Factors|immunologic factors|mesh-ancestor
65139467|NCT04825262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139468|NCT04825262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65139469|NCT04825262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139470|NCT04825262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139471|NCT01335009|Antibodies|antibodies|mesh-list
65139472|NCT01335009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65139473|NCT01335009|Immunologic Factors|immunologic factors|mesh-ancestor
65139474|NCT01335009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139475|NCT01332630|Diphenhydramine|diphenhydramine|mesh-list
65139476|NCT01332630|Dexamethasone|dexamethasone|mesh-list
65139477|NCT01332630|Ranitidine|ranitidine|mesh-list
65139478|NCT01332630|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65139479|NCT01332630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65139480|NCT01332630|Antiemetics|antiemetics|mesh-ancestor
65139481|NCT01332630|Autonomic Agents|autonomic agents|mesh-ancestor
65139482|NCT01332630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65139483|NCT01332630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139484|NCT01332630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65139485|NCT01332630|Glucocorticoids|glucocorticoids|mesh-ancestor
65139486|NCT01332630|Hormones|hormones|mesh-ancestor
65139487|NCT01332630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65139488|NCT01332630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65139489|NCT01332630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139490|NCT01332630|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65139491|NCT01332630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65139517|NCT01365507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139518|NCT02995694|Estradiol|estradiol|mesh-list
65139519|NCT02995694|Estrogens|estrogens|mesh-ancestor
65139520|NCT02995694|Hormones|hormones|mesh-ancestor
65139521|NCT02995694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65139522|NCT02995694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139523|NCT01365468|Everolimus|everolimus|mesh-list
65139524|NCT01365468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139525|NCT01365468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65139526|NCT01365468|Immunologic Factors|immunologic factors|mesh-ancestor
65139527|NCT01365468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139528|NCT04827836|Povidone-Iodine|povidone-iodine|mesh-list
65139529|NCT04827836|Povidone|povidone|mesh-list
65139530|NCT04827836|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65139531|NCT04827836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65139532|NCT04827836|Plasma Substitutes|plasma substitutes|mesh-ancestor
65139533|NCT04827836|Blood Substitutes|blood substitutes|mesh-ancestor
65139534|NCT04827836|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65139535|NCT04827836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65139536|NCT01357980|Botulinum Toxins|botulinum toxins|mesh-list
65139537|NCT01357980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65139538|NCT01357980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65139539|NCT01357980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65139540|NCT01357980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65302363|NCT00602537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302364|NCT00602537|Antimanic Agents|antimanic agents|mesh-ancestor
65302435|NCT04378621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65302436|NCT04378621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65302437|NCT04378621|Analgesics|analgesics|mesh-ancestor
65302438|NCT04378621|Sensory System Agents|sensory system agents|mesh-ancestor
65302439|NCT04378621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65302440|NCT04378621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302441|NCT04378621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65302442|NCT04378621|Immunologic Factors|immunologic factors|mesh-ancestor
65302443|NCT04378621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65302444|NCT04378621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302445|NCT04378621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302446|NCT04378621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65302447|NCT00869960|Ritonavir|ritonavir|mesh-list
65302448|NCT00869960|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65139545|NCT01357980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65139546|NCT01357980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65139547|NCT01332318|Diphenhydramine|diphenhydramine|mesh-list
65139548|NCT01332318|Promethazine|promethazine|mesh-list
65139549|NCT01332318|Gabapentin|gabapentin|mesh-list
65139550|NCT01332318|Analgesics|analgesics|mesh-ancestor
65139551|NCT01332318|Sensory System Agents|sensory system agents|mesh-ancestor
65139552|NCT01332318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65139553|NCT01332318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139554|NCT01332318|Anticonvulsants|anticonvulsants|mesh-ancestor
65139555|NCT01332318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65139556|NCT01332318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65139557|NCT01332318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65139558|NCT01332318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65139559|NCT01332318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65139560|NCT01332318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65139561|NCT01332318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65139562|NCT01332318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139563|NCT01332318|Antimanic Agents|antimanic agents|mesh-ancestor
65139564|NCT01332318|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65139565|NCT01332318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65139566|NCT01332318|Anesthetics, Local|anesthetics, local|mesh-ancestor
65139567|NCT01332318|Anesthetics|anesthetics|mesh-ancestor
65139568|NCT01332318|Antiemetics|antiemetics|mesh-ancestor
65139569|NCT01332318|Autonomic Agents|autonomic agents|mesh-ancestor
65139570|NCT01332318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65139571|NCT01332318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65139572|NCT01332318|Histamine Antagonists|histamine antagonists|mesh-ancestor
65139573|NCT01332318|Histamine Agents|histamine agents|mesh-ancestor
65139574|NCT01332318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65139575|NCT01332318|Antipruritics|antipruritics|mesh-ancestor
65139576|NCT01332318|Dermatologic Agents|dermatologic agents|mesh-ancestor
65139577|NCT04828226|Clonidine|clonidine|mesh-list
65139578|NCT04828226|Analgesics|analgesics|mesh-ancestor
65139579|NCT04828226|Sensory System Agents|sensory system agents|mesh-ancestor
65139580|NCT04828226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65139581|NCT04828226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139582|NCT04828226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65139583|NCT04828226|Sympatholytics|sympatholytics|mesh-ancestor
65139584|NCT04828226|Autonomic Agents|autonomic agents|mesh-ancestor
65139585|NCT04828226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65139586|NCT04828226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65139587|NCT04828226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65139588|NCT04828226|Adrenergic Agents|adrenergic agents|mesh-ancestor
65139589|NCT04828226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65139590|NCT04828226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139591|NCT01331109|Milnacipran|milnacipran|mesh-list
65139592|NCT01331109|Levomilnacipran|levomilnacipran|mesh-list
65302449|NCT00869960|Tenofovir|tenofovir|mesh-list
65302450|NCT00869960|Emtricitabine|emtricitabine|mesh-list
65302451|NCT00869960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65302452|NCT00869960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65302453|NCT00869960|Protease Inhibitors|protease inhibitors|mesh-ancestor
65302454|NCT00869960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302455|NCT00869960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302456|NCT00869960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65302457|NCT00869960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65302458|NCT00869960|Antiviral Agents|antiviral agents|mesh-ancestor
65302459|NCT00869960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65302460|NCT00869960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65302461|NCT00869960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65302462|NCT00869960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65302463|NCT00869960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65302464|NCT02618564|Sennosides|sennosides|mesh-list
65302465|NCT02618564|Laxatives|laxatives|mesh-ancestor
65302466|NCT02618564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65302467|NCT02615366|Tranexamic Acid|tranexamic acid|mesh-list
65139593|NCT01331109|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65139594|NCT01331109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65139595|NCT01331109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65139596|NCT01331109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139597|NCT01331109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65139598|NCT01331109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139599|NCT01331109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65139600|NCT01331109|Analgesics|analgesics|mesh-ancestor
65139601|NCT01331109|Sensory System Agents|sensory system agents|mesh-ancestor
65139602|NCT01331109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65139603|NCT01331109|Antidepressive Agents|antidepressive agents|mesh-ancestor
65139604|NCT01331109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65139605|NCT01357161|Paclitaxel|paclitaxel|mesh-list
65139606|NCT01357161|Carboplatin|carboplatin|mesh-list
65139607|NCT01357161|Adavosertib|adavosertib|mesh-list
65139608|NCT01357161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65139609|NCT01357161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139610|NCT01357161|Tubulin Modulators|tubulin modulators|mesh-ancestor
65139611|NCT01357161|Antimitotic Agents|antimitotic agents|mesh-ancestor
65139635|NCT02271503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139636|NCT02271503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65139638|NCT01350804|Abatacept|abatacept|mesh-list
65139639|NCT01350804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65139640|NCT01350804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139641|NCT01350804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139642|NCT01350804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65139643|NCT01350804|Immunologic Factors|immunologic factors|mesh-ancestor
65139644|NCT01350804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139645|NCT01350804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65139646|NCT02270957|Abatacept|abatacept|mesh-list
65139647|NCT02270957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65139648|NCT02270957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139649|NCT02270957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139650|NCT02270957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65139651|NCT02270957|Immunologic Factors|immunologic factors|mesh-ancestor
65302468|NCT02615366|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65302469|NCT02615366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65302470|NCT02615366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302471|NCT02615366|Hemostatics|hemostatics|mesh-ancestor
65302472|NCT02615366|Coagulants|coagulants|mesh-ancestor
65302473|NCT00699296|Panobinostat|panobinostat|mesh-list
65302474|NCT00699296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302475|NCT00699296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65302476|NCT00699296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302477|NCT00699296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302478|NCT04119674|Temozolomide|temozolomide|mesh-list
65302479|NCT04119674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65302480|NCT04119674|Alkylating Agents|alkylating agents|mesh-ancestor
65302481|NCT04119674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302482|NCT04119674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302483|NCT00494299|Sorafenib|sorafenib|mesh-list
65302484|NCT00494299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302485|NCT00494299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65139652|NCT02270957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139653|NCT02270957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65139654|NCT01348542|Trazodone|trazodone|mesh-list
64782178|NCT02905578|Protective Agents|protective agents|mesh-ancestor
65139655|NCT01348542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65139656|NCT01348542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65139657|NCT01348542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65139658|NCT01348542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139659|NCT01348542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65139660|NCT01348542|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65139673|NCT01193335|Immunologic Factors|immunologic factors|mesh-ancestor
65139674|NCT01193335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139675|NCT02893995|Treprostinil|treprostinil|mesh-list
65139676|NCT02893995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65139677|NCT01342887|Cyclosporine|cyclosporine|mesh-list
65139678|NCT01342887|Etoposide|etoposide|mesh-list
65139679|NCT01342887|Mitoxantrone|mitoxantrone|mesh-list
65139680|NCT01342887|Etoposide phosphate|etoposide phosphate|mesh-list
65139681|NCT01342887|Pravastatin|pravastatin|mesh-list
65139682|NCT01342887|Cyclosporins|cyclosporins|mesh-list
65139683|NCT01342887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65139684|NCT01342887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139685|NCT01342887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65139686|NCT01342887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65139687|NCT01342887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139688|NCT01342887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139689|NCT01342887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65139690|NCT01342887|Immunologic Factors|immunologic factors|mesh-ancestor
65139691|NCT01342887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139692|NCT01342887|Antifungal Agents|antifungal agents|mesh-ancestor
65139693|NCT01342887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65139694|NCT01342887|Dermatologic Agents|dermatologic agents|mesh-ancestor
65139695|NCT01342887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65139696|NCT01342887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65139697|NCT01342887|Analgesics|analgesics|mesh-ancestor
65139698|NCT01342887|Sensory System Agents|sensory system agents|mesh-ancestor
65139699|NCT01342887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65139700|NCT01342887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65139701|NCT01342887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65302486|NCT00494299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302487|NCT00494299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302488|NCT05298176|Carboplatin|carboplatin|mesh-list
65302489|NCT05298176|Pemetrexed|pemetrexed|mesh-list
65302490|NCT05298176|Osimertinib|osimertinib|mesh-list
65302491|NCT05298176|Afatinib|afatinib|mesh-list
65302492|NCT05298176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302493|NCT05298176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302494|NCT05298176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302495|NCT05298176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65302496|NCT05298176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65302497|NCT05298176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65302498|NCT02615288|Vitamin D|vitamin d|mesh-list
65302499|NCT02615288|Cholecalciferol|cholecalciferol|mesh-list
65302500|NCT02615288|Vitamins|vitamins|mesh-ancestor
65302501|NCT02615288|Micronutrients|micronutrients|mesh-ancestor
65302502|NCT02615288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302503|NCT02615288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65302504|NCT02615288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65302505|NCT02618096|Oxytocin|oxytocin|mesh-list
65302506|NCT02618096|Dinoprostone|dinoprostone|mesh-list
65302507|NCT02618096|Oxytocics|oxytocics|mesh-ancestor
65302508|NCT02618096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65302509|NCT02618096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139702|NCT01342887|Antimetabolites|antimetabolites|mesh-ancestor
65139703|NCT01342887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65139704|NCT01342887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65139705|NCT04445415|Antibodies|antibodies|mesh-list
65139706|NCT04445415|Immunologic Factors|immunologic factors|mesh-ancestor
65139707|NCT04445415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139708|NCT01342341|Chlorzoxazone|chlorzoxazone|mesh-list
65139709|NCT01342341|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65139710|NCT01342341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139711|NCT01342341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65139712|NCT01342341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65139714|NCT01340664|Canagliflozin|canagliflozin|mesh-list
65139715|NCT01340664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65139716|NCT01340664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139717|NCT01340664|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65139718|NCT01340664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139719|NCT01340625|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65139720|NCT01340625|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65139721|NCT01340625|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65139722|NCT01340625|Norethindrone|norethindrone|mesh-list
64713037|NCT03456076|Vinorelbine|vinorelbine|mesh-list
65139730|NCT01340625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65139731|NCT01340625|Contraceptive Agents|contraceptive agents|mesh-ancestor
65139732|NCT01340625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65139733|NCT01340625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65139734|NCT01340625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65139735|NCT01340625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65302510|NCT04134026|Epoetin Alfa|epoetin alfa|mesh-list
65302511|NCT04134026|Hematinics|hematinics|mesh-ancestor
65302512|NCT02963831|Cyclophosphamide|cyclophosphamide|mesh-list
65302513|NCT02963831|Durvalumab|durvalumab|mesh-list
65302514|NCT02963831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65302515|NCT02963831|Immunologic Factors|immunologic factors|mesh-ancestor
65302516|NCT02963831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302517|NCT02963831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64532600|NCT01552915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65139736|NCT01340625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65139737|NCT04823468|Cisplatin|cisplatin|mesh-list
65139738|NCT04823468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139739|NCT01340196|Tenofovir|tenofovir|mesh-list
65139740|NCT01340196|Antiviral Agents|antiviral agents|mesh-ancestor
65139741|NCT01340196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65139742|NCT01340196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65139743|NCT01340196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65139744|NCT01340196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139745|NCT01340196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139746|NCT01340196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65139747|NCT01340196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65139748|NCT02893332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65139749|NCT02893332|Gefitinib|gefitinib|mesh-list
65139750|NCT02893332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139751|NCT02893332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65139752|NCT02893332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139753|NCT02893332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139754|NCT04328493|Chloroquine|chloroquine|mesh-list
65139755|NCT04328493|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65139756|NCT04328493|Amebicides|amebicides|mesh-ancestor
65139757|NCT04328493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65139758|NCT04328493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65139759|NCT04328493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65139760|NCT04328493|Antimalarials|antimalarials|mesh-ancestor
65139761|NCT04328493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65139762|NCT04328493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65139763|NCT04328493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65139764|NCT04328493|Analgesics|analgesics|mesh-ancestor
65139765|NCT04328493|Sensory System Agents|sensory system agents|mesh-ancestor
65139766|NCT04328493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65139767|NCT04328493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139768|NCT04328493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65139769|NCT04328493|Filaricides|filaricides|mesh-ancestor
65139770|NCT04328493|Antinematodal Agents|antinematodal agents|mesh-ancestor
65139771|NCT04328493|Anthelmintics|anthelmintics|mesh-ancestor
65139772|NCT04396587|Sufentanil|sufentanil|mesh-list
65139773|NCT04396587|Oxycodone|oxycodone|mesh-list
65139774|NCT04396587|Hydromorphone|hydromorphone|mesh-list
65139775|NCT04396587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65139776|NCT04396587|Narcotics|narcotics|mesh-ancestor
65139777|NCT04396587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65139778|NCT04396587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139779|NCT04396587|Analgesics|analgesics|mesh-ancestor
65139780|NCT04396587|Sensory System Agents|sensory system agents|mesh-ancestor
65139781|NCT04396587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65139782|NCT04396587|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65139783|NCT04396587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65139784|NCT04396587|Anesthetics, General|anesthetics, general|mesh-ancestor
65139785|NCT04396587|Anesthetics|anesthetics|mesh-ancestor
65139786|NCT05139524|Immunoglobulin G|immunoglobulin g|mesh-list
65139787|NCT05139524|Immunologic Factors|immunologic factors|mesh-ancestor
65139788|NCT05139524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139789|NCT01327599|Timolol|timolol|mesh-list
65139790|NCT01327599|Travoprost|travoprost|mesh-list
65139791|NCT01327599|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65139801|NCT01193257|Prednisone|prednisone|mesh-list
65139802|NCT01193257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65139803|NCT01193257|Glucocorticoids|glucocorticoids|mesh-ancestor
65139804|NCT01193257|Hormones|hormones|mesh-ancestor
65139805|NCT01193257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65302518|NCT02963831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65302519|NCT02963831|Alkylating Agents|alkylating agents|mesh-ancestor
65302520|NCT02963831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302521|NCT02963831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302522|NCT02963831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65302523|NCT02963831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65302524|NCT00859898|Metformin|metformin|mesh-list
65302525|NCT00859898|Dapagliflozin|dapagliflozin|mesh-list
64532607|NCT01552915|Dopamine Agents|dopamine agents|mesh-ancestor
65139806|NCT01193257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139807|NCT01193257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65139808|NCT01193257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139810|NCT02893371|Carbamazepine|carbamazepine|mesh-list
65139811|NCT02893371|Oxcarbazepine|oxcarbazepine|mesh-list
65139812|NCT02893371|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65139813|NCT02893371|Valproic Acid|valproic acid|mesh-list
65139814|NCT02893371|Haloperidol|haloperidol|mesh-list
65139815|NCT02893371|Olanzapine|olanzapine|mesh-list
65139816|NCT02893371|Risperidone|risperidone|mesh-list
65139817|NCT02893371|Aripiprazole|aripiprazole|mesh-list
65139818|NCT02893371|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65139819|NCT02893371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65139820|NCT02893371|Ziprasidone|ziprasidone|mesh-list
65139821|NCT02893371|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65139822|NCT02893371|Clozapine|clozapine|mesh-list
65139823|NCT02893371|Asenapine|asenapine|mesh-list
65139824|NCT02893371|Perphenazine|perphenazine|mesh-list
65139825|NCT02893371|Lithium Carbonate|lithium carbonate|mesh-list
65139826|NCT02893371|Mirtazapine|mirtazapine|mesh-list
65139827|NCT02893371|Fluvoxamine|fluvoxamine|mesh-list
65139828|NCT02893371|Doxepin|doxepin|mesh-list
65139829|NCT02893371|Citalopram|citalopram|mesh-list
65139830|NCT02893371|Bupropion|bupropion|mesh-list
65139831|NCT02893371|Sertraline|sertraline|mesh-list
65139832|NCT02893371|Fluoxetine|fluoxetine|mesh-list
65139833|NCT02893371|Paroxetine|paroxetine|mesh-list
65139834|NCT02893371|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65139835|NCT02893371|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65139836|NCT02893371|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
65139837|NCT02893371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65139838|NCT02893371|Serotonin Agents|serotonin agents|mesh-ancestor
65139839|NCT02893371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65139840|NCT02893371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139841|NCT02893371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139842|NCT02893371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65139843|NCT02893371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65139844|NCT02893371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65139845|NCT02893371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65139846|NCT02893371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65139847|NCT02893371|Dopamine Agents|dopamine agents|mesh-ancestor
65139848|NCT02893371|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65139849|NCT02893371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65139850|NCT02893371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65139851|NCT02893371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65139852|NCT02893371|Antidepressive Agents|antidepressive agents|mesh-ancestor
65139853|NCT02893371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65139854|NCT02893371|Autonomic Agents|autonomic agents|mesh-ancestor
65139855|NCT02893371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65139856|NCT02893371|Antiemetics|antiemetics|mesh-ancestor
65139857|NCT02893371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65139858|NCT02893371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65139859|NCT02893371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65139860|NCT02893371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64713173|NCT03043430|Anesthetics|anesthetics|mesh-ancestor
65139871|NCT02893371|Anticonvulsants|anticonvulsants|mesh-ancestor
65139872|NCT02893371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65139873|NCT02893371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65139874|NCT02893371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65139876|NCT02893371|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65302526|NCT00859898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65302527|NCT00859898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302528|NCT00859898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65302529|NCT00859898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302530|NCT02684123|Apremilast|apremilast|mesh-list
65139877|NCT02893371|Histamine Antagonists|histamine antagonists|mesh-ancestor
65139878|NCT02893371|Histamine Agents|histamine agents|mesh-ancestor
65139879|NCT02893371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65139880|NCT02893371|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65139881|NCT02893371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65139882|NCT02893371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65139883|NCT02893371|Adrenergic Agents|adrenergic agents|mesh-ancestor
65139884|NCT02893371|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65139886|NCT02893371|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65139887|NCT02893371|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65139888|NCT02893371|GABA Antagonists|gaba antagonists|mesh-ancestor
65139889|NCT02893371|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65139890|NCT02893371|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65139891|NCT02893371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65139892|NCT02893371|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65139893|NCT02893371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65139894|NCT02893371|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65139895|NCT05138978|Listerine|listerine|mesh-list
65139896|NCT05138978|Sodium Fluoride|sodium fluoride|mesh-list
65139897|NCT05138978|Cariostatic Agents|cariostatic agents|mesh-ancestor
65139898|NCT05138978|Protective Agents|protective agents|mesh-ancestor
65139899|NCT05138978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139900|NCT05138978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65139901|NCT05138978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65139902|NCT05138861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65139903|NCT05138861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65139904|NCT02893176|Macitentan|macitentan|mesh-list
65139905|NCT02893176|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65139906|NCT02893176|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65139907|NCT02893176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139908|NCT02893176|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65139909|NCT01193218|Empagliflozin|empagliflozin|mesh-list
65139910|NCT01193218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65139911|NCT01193218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139912|NCT01193218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65139913|NCT01193218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139914|NCT01193101|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65139915|NCT01193101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65139916|NCT01193101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139917|NCT04328805|Ibuprofen|ibuprofen|mesh-list
65139918|NCT04328805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65139919|NCT04328805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65139920|NCT04328805|Analgesics|analgesics|mesh-ancestor
65139921|NCT04328805|Sensory System Agents|sensory system agents|mesh-ancestor
65139938|NCT01192399|Immunologic Factors|immunologic factors|mesh-ancestor
65139939|NCT01192399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139941|NCT04389294|Immunologic Factors|immunologic factors|mesh-ancestor
65139942|NCT04389294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139943|NCT01176916|Exemestane|exemestane|mesh-list
65139944|NCT01176916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139945|NCT01176916|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65139946|NCT01176916|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65139947|NCT01176916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139948|NCT01176916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139949|NCT01176916|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65139950|NCT01176916|Hormone Antagonists|hormone antagonists|mesh-ancestor
65139951|NCT01176916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65139952|NCT01176916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139953|NCT05382091|Naltrexone|naltrexone|mesh-list
65139954|NCT05382091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65302531|NCT02684123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65302532|NCT02684123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65302533|NCT02684123|Analgesics|analgesics|mesh-ancestor
65302534|NCT02684123|Sensory System Agents|sensory system agents|mesh-ancestor
65302535|NCT02684123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65302536|NCT02684123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302537|NCT02684123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65302538|NCT02684123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65302539|NCT02684123|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65302540|NCT02684123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65302541|NCT02684123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302542|NCT02684123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302543|NCT00638729|Clonidine|clonidine|mesh-list
65302544|NCT00638729|Midazolam|midazolam|mesh-list
65302545|NCT00638729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65302546|NCT00638729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65302547|NCT00638729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65302548|NCT00638729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302549|NCT00638729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65302550|NCT00638729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65302551|NCT00638729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65302552|NCT00638729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65302553|NCT00638729|Anesthetics, General|anesthetics, general|mesh-ancestor
65302554|NCT00638729|Anesthetics|anesthetics|mesh-ancestor
65302555|NCT00638729|GABA Modulators|gaba modulators|mesh-ancestor
65302556|NCT00638729|GABA Agents|gaba agents|mesh-ancestor
65139955|NCT05382091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65139956|NCT05382091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139957|NCT05382091|Sensory System Agents|sensory system agents|mesh-ancestor
65139958|NCT05382091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65139959|NCT02894268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65139960|NCT02894268|Doxycycline|doxycycline|mesh-list
65139961|NCT02894268|Furazolidone|furazolidone|mesh-list
65139962|NCT02894268|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
65139963|NCT02894268|Esomeprazole|esomeprazole|mesh-list
65139964|NCT02894268|Bismuth|bismuth|mesh-list
65139965|NCT02894268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65139966|NCT02894268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65139967|NCT02894268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65139968|NCT02894268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65139969|NCT02894268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139970|NCT02894268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139971|NCT02894268|Antimalarials|antimalarials|mesh-ancestor
65139972|NCT02894268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65139973|NCT02894268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65139974|NCT02894268|Antacids|antacids|mesh-ancestor
65139975|NCT02894268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65139976|NCT02894268|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65139977|NCT02894268|Renal Agents|renal agents|mesh-ancestor
65139978|NCT02894268|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65139979|NCT02894268|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65302557|NCT00638729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65302558|NCT00638729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302559|NCT00638729|Analgesics|analgesics|mesh-ancestor
65302560|NCT00638729|Sensory System Agents|sensory system agents|mesh-ancestor
65302561|NCT00638729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65302562|NCT00638729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65302563|NCT00638729|Sympatholytics|sympatholytics|mesh-ancestor
65302564|NCT00638729|Autonomic Agents|autonomic agents|mesh-ancestor
65302565|NCT00638729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65302566|NCT00638729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65302567|NCT00638729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65302568|NCT00638729|Adrenergic Agents|adrenergic agents|mesh-ancestor
65302569|NCT00697892|Ritonavir|ritonavir|mesh-list
65302570|NCT00697892|Lopinavir|lopinavir|mesh-list
65302571|NCT00697892|Efavirenz|efavirenz|mesh-list
65302572|NCT00697892|Lumefantrine|lumefantrine|mesh-list
65302573|NCT00697892|Artemether|artemether|mesh-list
65302574|NCT00697892|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65302575|NCT00697892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65302576|NCT00697892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65302578|NCT00697892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302579|NCT00697892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302580|NCT00697892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65302581|NCT00697892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65302582|NCT00697892|Antiviral Agents|antiviral agents|mesh-ancestor
65302583|NCT00697892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65302584|NCT00697892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65302585|NCT00697892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65302586|NCT00697892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65302587|NCT00697892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65302588|NCT00697892|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65302589|NCT00697892|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65302590|NCT00697892|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65302591|NCT00697892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64532650|NCT02360202|Clobetasol|clobetasol|mesh-list
65139980|NCT01600625|Minocycline|minocycline|mesh-list
65139991|NCT01327482|Antiviral Agents|antiviral agents|mesh-ancestor
65139992|NCT01327482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65302592|NCT00697892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65302593|NCT00697892|Antimalarials|antimalarials|mesh-ancestor
65302594|NCT00697892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65302595|NCT00697892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65302596|NCT00699452|Candesartan|candesartan|mesh-list
65302597|NCT00699452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65302598|NCT00699452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65302599|NCT00699452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65302600|NCT00699452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302601|NCT02683733|Aminosalicylic Acid|aminosalicylic acid|mesh-list
65302602|NCT02683733|Curcumin|curcumin|mesh-list
65302603|NCT02683733|Mesalamine|mesalamine|mesh-list
65302604|NCT02683733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65139993|NCT01327482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65139994|NCT01327482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65139995|NCT01327482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139996|NCT01327482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139998|NCT02893488|Dolutegravir|dolutegravir|mesh-list
65139999|NCT02893488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65140000|NCT02893488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65140001|NCT02893488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140002|NCT02893488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140003|NCT02893488|Antiviral Agents|antiviral agents|mesh-ancestor
65140004|NCT02893488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65140005|NCT02893488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65140006|NCT02893488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65140007|NCT02893488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65140008|NCT02893488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65140009|NCT04328883|Aspirin|aspirin|mesh-list
65140010|NCT04328883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65140011|NCT04328883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65140012|NCT04328883|Analgesics|analgesics|mesh-ancestor
65140013|NCT04328883|Sensory System Agents|sensory system agents|mesh-ancestor
65140015|NCT04328883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140016|NCT04328883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65140017|NCT04328883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65140018|NCT04328883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65140019|NCT04328883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65140020|NCT04328883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140021|NCT04328883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65140022|NCT04328883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65140023|NCT04328883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140024|NCT04328883|Antipyretics|antipyretics|mesh-ancestor
65140025|NCT01600235|Phenylephrine|phenylephrine|mesh-list
65140026|NCT01600235|Oxymetazoline|oxymetazoline|mesh-list
65140027|NCT01600235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65140028|NCT01600235|Mydriatics|mydriatics|mesh-ancestor
65140029|NCT01600235|Autonomic Agents|autonomic agents|mesh-ancestor
65140030|NCT01600235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65140031|NCT01600235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140032|NCT01600235|Sympathomimetics|sympathomimetics|mesh-ancestor
65140033|NCT01600235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65140034|NCT01600235|Nasal Decongestants|nasal decongestants|mesh-ancestor
65140035|NCT01600235|Respiratory System Agents|respiratory system agents|mesh-ancestor
65140036|NCT01600235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65140037|NCT01600235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65140038|NCT01600235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65140039|NCT01600235|Adrenergic Agents|adrenergic agents|mesh-ancestor
65140040|NCT01600235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65140041|NCT01600235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140042|NCT01600235|Protective Agents|protective agents|mesh-ancestor
65140043|NCT02893254|Adalimumab|adalimumab|mesh-list
65302605|NCT02683733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65302606|NCT02683733|Analgesics|analgesics|mesh-ancestor
65302607|NCT02683733|Sensory System Agents|sensory system agents|mesh-ancestor
65302608|NCT02683733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65302609|NCT02683733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302610|NCT02683733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65302611|NCT02683733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65302612|NCT02683733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302613|NCT02683733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302614|NCT02683733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302615|NCT02683733|Antitubercular Agents|antitubercular agents|mesh-ancestor
65302616|NCT02683733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65302617|NCT02683733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65302618|NCT02683655|Apatinib|apatinib|mesh-list
65302619|NCT02683655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302620|NCT02683655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65140044|NCT02893254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65140045|NCT02893254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65140046|NCT00592137|Calcium, Dietary|calcium, dietary|mesh-list
65140063|NCT04135092|Immunologic Factors|immunologic factors|mesh-ancestor
65140064|NCT04135092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140065|NCT04135092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65140066|NCT04135092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65140067|NCT04135092|Alkylating Agents|alkylating agents|mesh-ancestor
65140068|NCT04135092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140069|NCT04135092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65140070|NCT04135092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65140071|NCT04135092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65140072|NCT04135092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65140073|NCT04135092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65140074|NCT04135092|Antiviral Agents|antiviral agents|mesh-ancestor
65140075|NCT04135092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65140076|NCT00592215|Misoprostol|misoprostol|mesh-list
65140077|NCT00592215|Mifepristone|mifepristone|mesh-list
65140078|NCT00592215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65140079|NCT00592215|Abortifacient Agents|abortifacient agents|mesh-ancestor
65140080|NCT00592215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65140081|NCT00592215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140082|NCT00592215|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65140083|NCT00592215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65140084|NCT00592215|Oxytocics|oxytocics|mesh-ancestor
65140085|NCT00592215|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65140086|NCT00592215|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65140087|NCT00592215|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65140088|NCT00592215|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65140089|NCT00592215|Contraceptive Agents|contraceptive agents|mesh-ancestor
65140090|NCT00592215|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65140091|NCT00592215|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65140092|NCT00592215|Hormone Antagonists|hormone antagonists|mesh-ancestor
65140093|NCT00592215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65140094|NCT00592215|Luteolytic Agents|luteolytic agents|mesh-ancestor
65140095|NCT00592215|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65140096|NCT00592215|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65140097|NCT00592332|Alprazolam|alprazolam|mesh-list
65140098|NCT00592332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65140099|NCT00592332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65140100|NCT00592332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140101|NCT00592332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65302621|NCT02683655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302622|NCT02683655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302623|NCT00494221|Leucovorin|leucovorin|mesh-list
65302624|NCT00494221|Fluorouracil|fluorouracil|mesh-list
65302625|NCT00494221|Oxaliplatin|oxaliplatin|mesh-list
65302626|NCT00494221|Cediranib|cediranib|mesh-list
65302627|NCT00494221|Levoleucovorin|levoleucovorin|mesh-list
65302628|NCT00494221|Antimetabolites|antimetabolites|mesh-ancestor
65302629|NCT00494221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532708|NCT00322335|PENTA|penta|mesh-list
65140102|NCT00592332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65140103|NCT00592332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65140104|NCT00592332|GABA Modulators|gaba modulators|mesh-ancestor
65140105|NCT00592332|GABA Agents|gaba agents|mesh-ancestor
65140118|NCT01600274|Nandrolone|nandrolone|mesh-list
65140119|NCT01600274|Estrogens|estrogens|mesh-ancestor
65140120|NCT01600274|Hormones|hormones|mesh-ancestor
65140121|NCT01600274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65140122|NCT01600274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140123|NCT01600274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65140124|NCT01600274|Contraceptive Agents|contraceptive agents|mesh-ancestor
65140125|NCT01600274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65140126|NCT01600274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65140127|NCT01600274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65140128|NCT01600274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65140129|NCT01600274|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65140130|NCT01600274|Hormone Antagonists|hormone antagonists|mesh-ancestor
65140131|NCT01600274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65140132|NCT01600274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65140133|NCT01600274|Androgens|androgens|mesh-ancestor
65140134|NCT01600274|Anabolic Agents|anabolic agents|mesh-ancestor
65140135|NCT01176565|Nicardipine|nicardipine|mesh-list
65140136|NCT01176565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65140137|NCT01176565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65140138|NCT01176565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65140139|NCT01176565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140140|NCT01176565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65140141|NCT01176565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140142|NCT01176565|Vasodilator Agents|vasodilator agents|mesh-ancestor
65140143|NCT04374123|Antibodies|antibodies|mesh-list
65140144|NCT04374123|Immunoglobulin M|immunoglobulin m|mesh-list
65140145|NCT04374123|Immunologic Factors|immunologic factors|mesh-ancestor
65140146|NCT04374123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140147|NCT01113541|Ziprasidone|ziprasidone|mesh-list
65140148|NCT01113541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65140149|NCT01113541|Serotonin Agents|serotonin agents|mesh-ancestor
65140150|NCT01113541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65140151|NCT01113541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140152|NCT01113541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140153|NCT01113541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65140154|NCT01113541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65140155|NCT01113541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65140156|NCT01113541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65140157|NCT01113541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65140158|NCT01113541|Dopamine Agents|dopamine agents|mesh-ancestor
65140159|NCT00591708|Calcium, Dietary|calcium, dietary|mesh-list
65140160|NCT00591708|Citric Acid|citric acid|mesh-list
65140161|NCT00591708|Sodium Citrate|sodium citrate|mesh-list
65140162|NCT00591708|Calcium|calcium|mesh-list
65140163|NCT00591708|Calcium citrate malate|calcium citrate malate|mesh-list
65140164|NCT00591708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65140165|NCT00591708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140166|NCT00591708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65140167|NCT00591708|Anticoagulants|anticoagulants|mesh-ancestor
65140168|NCT00591708|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65140169|NCT00591708|Chelating Agents|chelating agents|mesh-ancestor
65140170|NCT00591708|Sequestering Agents|sequestering agents|mesh-ancestor
65302630|NCT00494221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65302631|NCT00494221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302632|NCT00494221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65302633|NCT00494221|Immunologic Factors|immunologic factors|mesh-ancestor
65302634|NCT00494221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302635|NCT00494221|Antidotes|antidotes|mesh-ancestor
65302636|NCT00494221|Protective Agents|protective agents|mesh-ancestor
65302637|NCT00494221|Vitamin B Complex|vitamin b complex|mesh-ancestor
65302638|NCT00494221|Vitamins|vitamins|mesh-ancestor
65302639|NCT00494221|Micronutrients|micronutrients|mesh-ancestor
65302640|NCT00494221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65302641|NCT00494221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302642|NCT00909935|Dexmedetomidine|dexmedetomidine|mesh-list
65302643|NCT00909935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65302644|NCT00909935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65302645|NCT00909935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302646|NCT00909935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65302647|NCT00909935|Analgesics|analgesics|mesh-ancestor
65302648|NCT00909935|Sensory System Agents|sensory system agents|mesh-ancestor
65052529|NCT00227123|Risperidone|risperidone|mesh-list
65302649|NCT00909935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65302650|NCT00909935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65302651|NCT00909935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65302652|NCT00909935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65140184|NCT01176058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65140185|NCT01176058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65140187|NCT02273765|Lamivudine|lamivudine|mesh-list
65140188|NCT02273765|Efavirenz|efavirenz|mesh-list
65140189|NCT02273765|Raltegravir Potassium|raltegravir potassium|mesh-list
65140190|NCT02273765|Antiviral Agents|antiviral agents|mesh-ancestor
65140191|NCT02273765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65140192|NCT02273765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65140193|NCT02273765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65140194|NCT02273765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140195|NCT02273765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140196|NCT02273765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65140197|NCT02273765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65140198|NCT02273765|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65140199|NCT02273765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65140200|NCT02273765|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65140201|NCT02273765|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65140202|NCT02273765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65140203|NCT02273765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65140204|NCT02273765|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65140205|NCT02273765|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65140206|NCT01607333|Lamotrigine|lamotrigine|mesh-list
65140207|NCT01607333|Anticonvulsants|anticonvulsants|mesh-ancestor
65140208|NCT01607333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65140209|NCT01607333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65140210|NCT01607333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302653|NCT00909935|Adrenergic Agents|adrenergic agents|mesh-ancestor
65302654|NCT00909935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65302655|NCT00909935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302656|NCT00857948|Ivermectin|ivermectin|mesh-list
65302657|NCT00857948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65302658|NCT00857948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65302659|NCT02688491|Sunitinib|sunitinib|mesh-list
65302660|NCT02688491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302661|NCT02688491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65302662|NCT02688491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65302663|NCT02688491|Growth Substances|growth substances|mesh-ancestor
65302664|NCT02688491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302665|NCT02688491|Growth Inhibitors|growth inhibitors|mesh-ancestor
65302666|NCT02688491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65302667|NCT02688491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302668|NCT02688491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140211|NCT01607333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65140212|NCT01607333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140213|NCT01607333|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65140214|NCT01607333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65140215|NCT01607333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65140216|NCT01607333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65140217|NCT01607333|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65140218|NCT01601093|Sulbactam|sulbactam|mesh-list
65140219|NCT01601093|Cefoperazone|cefoperazone|mesh-list
65140220|NCT01601093|Sulperazone|sulperazone|mesh-list
65140221|NCT01601093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65140222|NCT01601093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65140223|NCT01601093|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65140224|NCT01601093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140225|NCT01601093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140242|NCT02485418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65140243|NCT02485418|Anesthetics, General|anesthetics, general|mesh-ancestor
65140244|NCT02485418|Anesthetics|anesthetics|mesh-ancestor
65140245|NCT04366830|Remestemcel-l|remestemcel-l|mesh-list
65140246|NCT04366830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65140247|NCT04366830|Antiviral Agents|antiviral agents|mesh-ancestor
65140248|NCT04366830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65140249|NCT01175824|Insulin|insulin|mesh-list
65140250|NCT01175824|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65140251|NCT01175824|Insulin Glargine|insulin glargine|mesh-list
65140252|NCT01175824|Insulin Lispro|insulin lispro|mesh-list
65140253|NCT01175824|Protamines|protamines|mesh-list
65140254|NCT01175824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65140255|NCT01175824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140256|NCT01175824|Heparin Antagonists|heparin antagonists|mesh-ancestor
65140257|NCT01175824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140258|NCT01175824|Coagulants|coagulants|mesh-ancestor
65140259|NCT01175707|Vancomycin|vancomycin|mesh-list
65140260|NCT01175707|Daptomycin|daptomycin|mesh-list
65140261|NCT01175707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65140262|NCT01175707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65140263|NCT01112059|Doxycycline|doxycycline|mesh-list
65140264|NCT01112059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65140265|NCT01112059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65140266|NCT01112059|Antimalarials|antimalarials|mesh-ancestor
65140267|NCT01112059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65140268|NCT01112059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65140269|NCT01175668|Clonidine|clonidine|mesh-list
65140270|NCT01175668|Phenobarbital|phenobarbital|mesh-list
65140271|NCT01175668|Analgesics|analgesics|mesh-ancestor
65140272|NCT01175668|Sensory System Agents|sensory system agents|mesh-ancestor
65302669|NCT00857792|Regadenoson|regadenoson|mesh-list
65302670|NCT00857792|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65302671|NCT00857792|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65302672|NCT00857792|Purinergic Agonists|purinergic agonists|mesh-ancestor
65302673|NCT00857792|Purinergic Agents|purinergic agents|mesh-ancestor
65302674|NCT00857792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65140273|NCT01175668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65140274|NCT01175668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140275|NCT01175668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65140276|NCT01175668|Sympatholytics|sympatholytics|mesh-ancestor
65140277|NCT01175668|Autonomic Agents|autonomic agents|mesh-ancestor
65140278|NCT01175668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65140279|NCT01175668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65140280|NCT01175668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65140281|NCT01175668|Adrenergic Agents|adrenergic agents|mesh-ancestor
65140282|NCT01175668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65140283|NCT01175668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140284|NCT01175668|Anticonvulsants|anticonvulsants|mesh-ancestor
65140285|NCT01175668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65140286|NCT01175668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65140287|NCT01175668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65140288|NCT01175668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65140304|NCT01601327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65140305|NCT01601327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65140306|NCT01601327|Anabolic Agents|anabolic agents|mesh-ancestor
65140307|NCT01601327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65140308|NCT01601366|Contraceptive Agents|contraceptive agents|mesh-list
65140309|NCT01601366|Contraceptives, Oral|contraceptives, oral|mesh-list
65140310|NCT01601366|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65140311|NCT01601366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65140312|NCT01601366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140313|NCT01601366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65140314|NCT01607762|Olanzapine|olanzapine|mesh-list
65140315|NCT01607762|Risperidone|risperidone|mesh-list
65140316|NCT01607762|Aripiprazole|aripiprazole|mesh-list
65140317|NCT01607762|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65140318|NCT01607762|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65140319|NCT01607762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65140320|NCT01607762|Serotonin Agents|serotonin agents|mesh-ancestor
65140321|NCT01607762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65140322|NCT01607762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140323|NCT01607762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140324|NCT01607762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65140325|NCT01607762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65140326|NCT01607762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65140327|NCT01607762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65140328|NCT01607762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65140329|NCT01607762|Dopamine Agents|dopamine agents|mesh-ancestor
65140330|NCT01607762|Antiemetics|antiemetics|mesh-ancestor
65140331|NCT01607762|Autonomic Agents|autonomic agents|mesh-ancestor
65140332|NCT01607762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782859|NCT02835846|Estrogens|estrogens|mesh-list
65140333|NCT01607762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65140334|NCT01607762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65140335|NCT01607762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65140336|NCT01607762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65140337|NCT01607762|Antidepressive Agents|antidepressive agents|mesh-ancestor
65140338|NCT01607762|Dopamine Agonists|dopamine agonists|mesh-ancestor
65140339|NCT01607762|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65140340|NCT01607762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65140341|NCT01607762|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65140342|NCT01607762|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65140343|NCT04327947|Hyaluronic Acid|hyaluronic acid|mesh-list
65140344|NCT04327947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65140345|NCT04327947|Immunologic Factors|immunologic factors|mesh-ancestor
65140346|NCT04327947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140347|NCT04327947|Viscosupplements|viscosupplements|mesh-ancestor
65140369|NCT01607918|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65302675|NCT00857792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302676|NCT00857792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302677|NCT02613494|Glycopyrrolate|glycopyrrolate|mesh-list
65302678|NCT02613494|Scopolamine|scopolamine|mesh-list
65302679|NCT02613494|Bromides|bromides|mesh-list
65302680|NCT02613494|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65302681|NCT02613494|Anticonvulsants|anticonvulsants|mesh-ancestor
65302682|NCT02613494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65302683|NCT02613494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65302684|NCT02613494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65302685|NCT02613494|Cholinergic Agents|cholinergic agents|mesh-ancestor
65302686|NCT02613494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65302687|NCT02613494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302688|NCT02613494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302689|NCT02613494|Antiemetics|antiemetics|mesh-ancestor
65302690|NCT02613494|Autonomic Agents|autonomic agents|mesh-ancestor
65302691|NCT02613494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65302692|NCT02613494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65302693|NCT02613494|Mydriatics|mydriatics|mesh-ancestor
65302694|NCT02613494|Parasympatholytics|parasympatholytics|mesh-ancestor
65302695|NCT00699530|Cabergoline|cabergoline|mesh-list
65302696|NCT00699530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65140370|NCT01607996|Anesthetics|anesthetics|mesh-list
65140371|NCT01607996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65140372|NCT01607996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140373|NCT01601561|Insulin|insulin|mesh-list
65140374|NCT01601561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65140375|NCT01601561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65140376|NCT01601561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140377|NCT01601795|Sevoflurane|sevoflurane|mesh-list
65140378|NCT01601795|Isoflurane|isoflurane|mesh-list
65140379|NCT01601795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65140380|NCT01601795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65140381|NCT01601795|Anesthetics, General|anesthetics, general|mesh-ancestor
65140382|NCT01601795|Anesthetics|anesthetics|mesh-ancestor
65140383|NCT01601795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65140384|NCT01601795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140385|NCT01601912|Dexetimide|dexetimide|mesh-list
65140386|NCT01601912|Citalopram|citalopram|mesh-list
65140387|NCT01601912|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65140388|NCT01601912|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65140389|NCT01601912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65140390|NCT01601912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65140391|NCT01601912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140392|NCT01601912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65140393|NCT01601912|Serotonin Agents|serotonin agents|mesh-ancestor
65140394|NCT01601912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140395|NCT01601912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65140396|NCT01601912|Antidepressive Agents|antidepressive agents|mesh-ancestor
65140397|NCT01601912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65140398|NCT01601912|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65140399|NCT01601912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65140400|NCT01601912|Parasympatholytics|parasympatholytics|mesh-ancestor
65140401|NCT01601912|Autonomic Agents|autonomic agents|mesh-ancestor
65302697|NCT00699530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65302698|NCT00699530|Dopamine Agonists|dopamine agonists|mesh-ancestor
65302699|NCT00699530|Dopamine Agents|dopamine agents|mesh-ancestor
65302700|NCT00699530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65302701|NCT00699530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302702|NCT00699530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302703|NCT02617862|Anesthetics|anesthetics|mesh-list
65140402|NCT01601912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65140432|NCT01175473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65140433|NCT01111552|Aripiprazole|aripiprazole|mesh-list
65140434|NCT01111552|Citalopram|citalopram|mesh-list
65140435|NCT01111552|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65140436|NCT01111552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65140437|NCT01111552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65140438|NCT01111552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140439|NCT01111552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65140440|NCT01111552|Serotonin Agents|serotonin agents|mesh-ancestor
65140441|NCT01111552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140442|NCT01111552|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65140443|NCT01111552|Antidepressive Agents|antidepressive agents|mesh-ancestor
65140444|NCT01111552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65140445|NCT01111552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65140446|NCT01111552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65140447|NCT01111552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65140448|NCT01111552|Dopamine Agonists|dopamine agonists|mesh-ancestor
65140449|NCT01111552|Dopamine Agents|dopamine agents|mesh-ancestor
65140457|NCT01602185|Dextromethorphan|dextromethorphan|mesh-list
65140458|NCT01602185|Antitussive Agents|antitussive agents|mesh-list
65140459|NCT01602185|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65140460|NCT01602185|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65140461|NCT01602185|Dopamine Agents|dopamine agents|mesh-ancestor
65140462|NCT01602185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65140463|NCT01602185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140464|NCT01602185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140465|NCT01602185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65140466|NCT01602185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65140467|NCT01602185|Respiratory System Agents|respiratory system agents|mesh-ancestor
65140469|NCT01602302|Etanercept|etanercept|mesh-list
65140470|NCT01602302|Golimumab|golimumab|mesh-list
65140471|NCT01602302|Abatacept|abatacept|mesh-list
65140472|NCT01602302|Infliximab|infliximab|mesh-list
65140473|NCT01602302|Certolizumab Pegol|certolizumab pegol|mesh-list
65140474|NCT01602302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65140475|NCT01602302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65140476|NCT01602302|Dermatologic Agents|dermatologic agents|mesh-ancestor
65140477|NCT01602302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65140478|NCT01602302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65140479|NCT01602302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65140480|NCT01602302|Analgesics|analgesics|mesh-ancestor
65140481|NCT01602302|Sensory System Agents|sensory system agents|mesh-ancestor
65140482|NCT01602302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65140483|NCT01602302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140484|NCT01602302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65140485|NCT01602302|Immunologic Factors|immunologic factors|mesh-ancestor
65140486|NCT01602302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65140487|NCT01602302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140488|NCT01602302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65140489|NCT01602302|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65140490|NCT02893722|Oxytocin|oxytocin|mesh-list
65140491|NCT02893722|Atosiban|atosiban|mesh-list
65140492|NCT02893722|Oxytocics|oxytocics|mesh-ancestor
65140493|NCT02893722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65140494|NCT02893722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140495|NCT02893722|Hormone Antagonists|hormone antagonists|mesh-ancestor
65140496|NCT02893722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65140497|NCT02893722|Tocolytic Agents|tocolytic agents|mesh-ancestor
65140498|NCT01608269|Lamivudine|lamivudine|mesh-list
65302704|NCT02617862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65302705|NCT02617862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302706|NCT00601835|Vaccines|vaccines|mesh-list
65302707|NCT00601835|Immunologic Factors|immunologic factors|mesh-ancestor
65302708|NCT00601835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302709|NCT00640367|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65302710|NCT00640367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65302711|NCT00640367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65302712|NCT00640367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302713|NCT00697502|Capecitabine|capecitabine|mesh-list
65302714|NCT00697502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65302715|NCT00697502|Antimetabolites|antimetabolites|mesh-ancestor
65302716|NCT00697502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302717|NCT00697502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302718|NCT00857246|Irinotecan|irinotecan|mesh-list
65302719|NCT00857246|Cetuximab|cetuximab|mesh-list
65302720|NCT00857246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302721|NCT00857246|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65302722|NCT00857246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65302723|NCT00857246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532787|NCT01570387|Dexamethasone|dexamethasone|mesh-list
65140499|NCT01608269|Abacavir|abacavir|mesh-list
65140500|NCT01608269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65140501|NCT01608269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65140502|NCT01608269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140503|NCT01608269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140504|NCT01608269|Antiviral Agents|antiviral agents|mesh-ancestor
65140505|NCT01608269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65140506|NCT01608269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65140507|NCT01608269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65140508|NCT01608347|Folic Acid|folic acid|mesh-list
65140509|NCT01608347|Vitamin B Complex|vitamin b complex|mesh-list
65140510|NCT01608347|Hematinics|hematinics|mesh-ancestor
65140511|NCT01608347|Vitamins|vitamins|mesh-ancestor
65140512|NCT01608347|Micronutrients|micronutrients|mesh-ancestor
65140513|NCT01608347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140514|NCT04405284|Disinfectants|disinfectants|mesh-list
65140515|NCT04405284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65140516|NCT01608464|Cisplatin|cisplatin|mesh-list
65140517|NCT01608464|Docetaxel|docetaxel|mesh-list
65140518|NCT01608464|Fluorouracil|fluorouracil|mesh-list
65140519|NCT01608464|Irinotecan|irinotecan|mesh-list
65140520|NCT01608464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65140528|NCT01608464|Immunologic Factors|immunologic factors|mesh-ancestor
65140529|NCT01608464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140530|NCT01608464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65140531|NCT01608464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65140532|NCT01608464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140534|NCT01608698|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65140535|NCT01608698|Chlormadinone Acetate|chlormadinone acetate|mesh-list
65140536|NCT01608698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65140537|NCT01608698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65140538|NCT01608698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65140539|NCT01608698|Contraceptive Agents|contraceptive agents|mesh-ancestor
65140540|NCT01608698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65140541|NCT01608698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302724|NCT00857246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302725|NCT00857246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65302726|NCT00699686|Insulin Glargine|insulin glargine|mesh-list
65302727|NCT00699686|Insulin Detemir|insulin detemir|mesh-list
65302728|NCT00699686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65302729|NCT00699686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302730|NCT00640679|Clopidogrel|clopidogrel|mesh-list
65302731|NCT00640679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65302732|NCT00640679|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65302733|NCT00640679|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65302734|NCT00640679|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65302735|NCT00640679|Purinergic Agents|purinergic agents|mesh-ancestor
65302736|NCT00640679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65140542|NCT01608698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65140543|NCT01608698|Estrogens|estrogens|mesh-ancestor
65140544|NCT01608698|Hormones|hormones|mesh-ancestor
65140545|NCT01608698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65140546|NCT01608698|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65140547|NCT01608698|Hormone Antagonists|hormone antagonists|mesh-ancestor
65140548|NCT01608698|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65140549|NCT01608698|Diuretics|diuretics|mesh-ancestor
65140550|NCT01608698|Natriuretic Agents|natriuretic agents|mesh-ancestor
65140551|NCT01608698|Androgen Antagonists|androgen antagonists|mesh-ancestor
65140552|NCT01608698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65140553|NCT04310254|Edetic Acid|edetic acid|mesh-list
65140554|NCT04310254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65140555|NCT04310254|Pentetic Acid|pentetic acid|mesh-list
65140556|NCT04310254|Anticoagulants|anticoagulants|mesh-ancestor
65140557|NCT04310254|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65140558|NCT04310254|Chelating Agents|chelating agents|mesh-ancestor
65140559|NCT04310254|Sequestering Agents|sequestering agents|mesh-ancestor
65140560|NCT04310254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140562|NCT04310254|Protective Agents|protective agents|mesh-ancestor
65140563|NCT04310254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140564|NCT04310254|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65140565|NCT01603511|Charcoal|charcoal|mesh-list
65140566|NCT01603511|Antidotes|antidotes|mesh-ancestor
65140567|NCT01603511|Protective Agents|protective agents|mesh-ancestor
65140568|NCT01603511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140569|NCT01603745|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65140570|NCT01603745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65140571|NCT01603745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140572|NCT01174186|Adalimumab|adalimumab|mesh-list
65140573|NCT01174186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65140574|NCT01174186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65140575|NCT01609049|Ribavirin|ribavirin|mesh-list
65140576|NCT01609049|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65140577|NCT01609049|Antimetabolites|antimetabolites|mesh-ancestor
65140578|NCT01609049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140579|NCT01609049|Antiviral Agents|antiviral agents|mesh-ancestor
65140580|NCT01609049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65140581|NCT01609088|Erythritol|erythritol|mesh-list
65140582|NCT01609088|Vasodilator Agents|vasodilator agents|mesh-ancestor
65140583|NCT01609127|Capecitabine|capecitabine|mesh-list
65140584|NCT01609127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65140585|NCT01609127|Antimetabolites|antimetabolites|mesh-ancestor
65140586|NCT01609127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140587|NCT01609127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65140588|NCT01609166|Allopurinol|allopurinol|mesh-list
64451363|NCT04588233|Melatonin|melatonin|mesh-list
65140607|NCT00592566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65140608|NCT00592566|Antiemetics|antiemetics|mesh-ancestor
65302737|NCT00640679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302738|NCT00640679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302739|NCT02682953|Plerixafor|plerixafor|mesh-list
65302740|NCT02682953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65302741|NCT02682953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65302742|NCT02682953|Antiviral Agents|antiviral agents|mesh-ancestor
65302743|NCT02682953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65302744|NCT02683031|Ionophores|ionophores|mesh-list
65302745|NCT02683031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65302746|NCT02683031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302747|NCT04184141|Alprazolam|alprazolam|mesh-list
65302748|NCT04184141|Hydroxyzine|hydroxyzine|mesh-list
65302749|NCT04184141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65302750|NCT04184141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65302751|NCT04184141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140609|NCT00592566|Autonomic Agents|autonomic agents|mesh-ancestor
65140610|NCT00592566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65140611|NCT00592566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140612|NCT00592566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65140615|NCT00592566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65140616|NCT00592566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65140617|NCT00592566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65140618|NCT00592566|Hemostatics|hemostatics|mesh-ancestor
65140619|NCT00592566|Coagulants|coagulants|mesh-ancestor
65140620|NCT00592566|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65140621|NCT00592566|Natriuretic Agents|natriuretic agents|mesh-ancestor
65140622|NCT01111123|Halobetasol|halobetasol|mesh-list
65140623|NCT01111123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65140624|NCT01604330|Baclofen|baclofen|mesh-list
65140625|NCT01604330|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65140626|NCT01604330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140627|NCT01604330|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65140628|NCT01604330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65140629|NCT01604330|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65140630|NCT01604330|GABA Agonists|gaba agonists|mesh-ancestor
65140631|NCT01604330|GABA Agents|gaba agents|mesh-ancestor
65140632|NCT01604330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65140633|NCT01604330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140634|NCT00622830|Darapladib|darapladib|mesh-list
64783157|NCT02956122|Antiemetics|antiemetics|mesh-ancestor
65140635|NCT00622830|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
65140636|NCT00622830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140637|NCT00622830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140638|NCT01173679|Rituximab|rituximab|mesh-list
65140639|NCT01173679|Fludarabine|fludarabine|mesh-list
65140640|NCT01173679|Dasatinib|dasatinib|mesh-list
65140641|NCT01173679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65140642|NCT01173679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65140643|NCT01173679|Immunologic Factors|immunologic factors|mesh-ancestor
65140644|NCT01173679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140645|NCT01173679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64494841|NCT01143766|Analgesics|analgesics|mesh-ancestor
65140656|NCT01609439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65140658|NCT01110382|Meropenem|meropenem|mesh-list
65140659|NCT01110382|Clavulanic Acid|clavulanic acid|mesh-list
65140660|NCT01110382|Clavulanic Acids|clavulanic acids|mesh-list
65140661|NCT01110382|Doripenem|doripenem|mesh-list
65140662|NCT01110382|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65140663|NCT01110382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65140664|NCT01110382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65140665|NCT01110382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65302752|NCT04184141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65302753|NCT04184141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65302754|NCT04184141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65302755|NCT04184141|GABA Modulators|gaba modulators|mesh-ancestor
65302756|NCT04184141|GABA Agents|gaba agents|mesh-ancestor
65302757|NCT04184141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65302758|NCT04184141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140666|NCT01110382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140667|NCT01110382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140668|NCT00592917|Cholecalciferol|cholecalciferol|mesh-list
65140669|NCT00592917|Vitamin D|vitamin d|mesh-list
65140670|NCT00592917|Calcium Carbonate|calcium carbonate|mesh-list
65140671|NCT00592917|Calcium|calcium|mesh-list
65140672|NCT00592917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65140673|NCT00592917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140674|NCT00592917|Vitamins|vitamins|mesh-ancestor
65140675|NCT00592917|Micronutrients|micronutrients|mesh-ancestor
65140676|NCT00592917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65140677|NCT00592917|Antacids|antacids|mesh-ancestor
65140678|NCT00592917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140679|NCT00592917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65140680|NCT01609517|Bupivacaine|bupivacaine|mesh-list
65140681|NCT01609517|Anesthetics|anesthetics|mesh-list
65140682|NCT01609517|Anesthetics, Local|anesthetics, local|mesh-ancestor
65140683|NCT01609517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65140684|NCT01609517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140685|NCT01609517|Sensory System Agents|sensory system agents|mesh-ancestor
65140686|NCT01609517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65140687|NCT05265325|Epoetin Alfa|epoetin alfa|mesh-list
65140688|NCT05265325|Hematinics|hematinics|mesh-ancestor
65140689|NCT00593151|Interferons|interferons|mesh-list
65140690|NCT00593151|Interferon-alpha|interferon-alpha|mesh-list
65140691|NCT00593151|Interferon alpha-2|interferon alpha-2|mesh-list
65140692|NCT00593151|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65140693|NCT00593151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65140694|NCT00593151|Antiviral Agents|antiviral agents|mesh-ancestor
65140695|NCT00593151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65140696|NCT00593151|Immunologic Factors|immunologic factors|mesh-ancestor
65140697|NCT00593151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140698|NCT02489006|Olaparib|olaparib|mesh-list
65140699|NCT02489006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65140700|NCT02489006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140701|NCT02489006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140702|NCT02489006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65140703|NCT01173601|Serotonin|serotonin|mesh-list
65140704|NCT01173601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65140705|NCT01173601|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65140706|NCT01173601|Serotonin Agents|serotonin agents|mesh-ancestor
65140707|NCT01173601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65140708|NCT01173601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140709|NCT01173601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140710|NCT01173601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65140711|NCT01173601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65140725|NCT01173055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65140727|NCT01173055|Sensory System Agents|sensory system agents|mesh-ancestor
65140728|NCT01173055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65140729|NCT01173055|Antidepressive Agents|antidepressive agents|mesh-ancestor
65140730|NCT01173055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65140731|NCT00593463|Cycloserine|cycloserine|mesh-list
65140732|NCT00593463|Verapamil|verapamil|mesh-list
65140733|NCT00593463|Diltiazem|diltiazem|mesh-list
65140734|NCT00593463|Isradipine|isradipine|mesh-list
65140735|NCT00593463|Nifedipine|nifedipine|mesh-list
65140736|NCT00593463|Gabapentin|gabapentin|mesh-list
65140737|NCT00593463|Naloxone|naloxone|mesh-list
65140738|NCT00593463|Analgesics|analgesics|mesh-ancestor
65140739|NCT00593463|Sensory System Agents|sensory system agents|mesh-ancestor
65140740|NCT00593463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65140741|NCT00593463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140742|NCT00593463|Anticonvulsants|anticonvulsants|mesh-ancestor
65140743|NCT00593463|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65302759|NCT04184141|Antipruritics|antipruritics|mesh-ancestor
65302760|NCT04184141|Dermatologic Agents|dermatologic agents|mesh-ancestor
65302761|NCT04184141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65302762|NCT04184141|Histamine Antagonists|histamine antagonists|mesh-ancestor
65302763|NCT04184141|Histamine Agents|histamine agents|mesh-ancestor
65302764|NCT02682329|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65302765|NCT02682329|Carbamide Peroxide|carbamide peroxide|mesh-list
65302766|NCT02682329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65302767|NCT02682329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65302768|NCT00640991|Insulin|insulin|mesh-list
65302769|NCT00640991|Insulin Glargine|insulin glargine|mesh-list
65302770|NCT00640991|Insulin glulisine|insulin glulisine|mesh-list
65302771|NCT00640991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65302772|NCT00640991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302773|NCT00638807|Celecoxib|celecoxib|mesh-list
65302774|NCT00638807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65302775|NCT00638807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65302776|NCT00638807|Analgesics|analgesics|mesh-ancestor
65302777|NCT00638807|Sensory System Agents|sensory system agents|mesh-ancestor
65302778|NCT00638807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65140744|NCT00593463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65140745|NCT00593463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65140746|NCT00593463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65140747|NCT00593463|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65140748|NCT00593463|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65140749|NCT00593463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65140750|NCT00593463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140751|NCT00593463|Antimanic Agents|antimanic agents|mesh-ancestor
65140752|NCT00593463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65140753|NCT00593463|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65140754|NCT00593463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65140755|NCT00593463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65140756|NCT00593463|Vasodilator Agents|vasodilator agents|mesh-ancestor
65140757|NCT00593463|Tocolytic Agents|tocolytic agents|mesh-ancestor
65140758|NCT00593463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65140759|NCT00593463|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65140760|NCT00593463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65140761|NCT00593463|Renal Agents|renal agents|mesh-ancestor
65140762|NCT00593463|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65140763|NCT00593463|Antitubercular Agents|antitubercular agents|mesh-ancestor
65140764|NCT00593463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65140765|NCT00593463|Antimetabolites|antimetabolites|mesh-ancestor
65140766|NCT00593463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65140767|NCT00593463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65140768|NCT00593502|Oseltamivir|oseltamivir|mesh-list
65140769|NCT00593502|Antiviral Agents|antiviral agents|mesh-ancestor
65140770|NCT00593502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65140771|NCT00593502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140772|NCT00593502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140786|NCT00593580|Vitamin D|vitamin d|mesh-list
65140787|NCT00593580|Alendronate|alendronate|mesh-list
64783306|NCT03035760|Oxfendazole|oxfendazole|mesh-list
65140788|NCT00593580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65140789|NCT00593580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140790|NCT00593580|Vitamins|vitamins|mesh-ancestor
65140791|NCT00593580|Micronutrients|micronutrients|mesh-ancestor
65140792|NCT00593580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65140793|NCT04327011|Flucytosine|flucytosine|mesh-list
65302779|NCT00638807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302780|NCT00638807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65302781|NCT00638807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65302782|NCT00638807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65302783|NCT00638807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65302784|NCT00638807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302785|NCT00638807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302786|NCT00856856|Everolimus|everolimus|mesh-list
65302787|NCT00856856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302788|NCT00856856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65302789|NCT00856856|Immunologic Factors|immunologic factors|mesh-ancestor
65302790|NCT00856856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302791|NCT00782327|Losartan|losartan|mesh-list
65302792|NCT00782327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65302793|NCT00782327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65140794|NCT04327011|Antifungal Agents|antifungal agents|mesh-ancestor
65140795|NCT04327011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65140796|NCT04327011|Antimetabolites|antimetabolites|mesh-ancestor
65140797|NCT04327011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140798|NCT00593619|Iron|iron|mesh-list
65140799|NCT00593619|Dextrans|dextrans|mesh-list
65140800|NCT00593619|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65140801|NCT00593619|Iron-Dextran Complex|iron-dextran complex|mesh-list
65140802|NCT00593619|Trace Elements|trace elements|mesh-ancestor
65140803|NCT00593619|Micronutrients|micronutrients|mesh-ancestor
65140804|NCT00593619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140805|NCT00593619|Hematinics|hematinics|mesh-ancestor
65140806|NCT00593619|Anticoagulants|anticoagulants|mesh-ancestor
65140807|NCT00593619|Plasma Substitutes|plasma substitutes|mesh-ancestor
65140808|NCT00593619|Blood Substitutes|blood substitutes|mesh-ancestor
65140809|NCT00593658|Pentoxifylline|pentoxifylline|mesh-list
65140810|NCT00593658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65140811|NCT00593658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140812|NCT00593658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140813|NCT00593658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65140814|NCT00593658|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65140815|NCT00593658|Protective Agents|protective agents|mesh-ancestor
65140816|NCT00593658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140817|NCT00593658|Vasodilator Agents|vasodilator agents|mesh-ancestor
65140818|NCT00593658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65140819|NCT00593658|Antioxidants|antioxidants|mesh-ancestor
65140820|NCT00593697|Docetaxel|docetaxel|mesh-list
65140821|NCT00593697|Trastuzumab|trastuzumab|mesh-list
65140822|NCT00593697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65140823|NCT00593697|Tubulin Modulators|tubulin modulators|mesh-ancestor
65140824|NCT00593697|Antimitotic Agents|antimitotic agents|mesh-ancestor
65140825|NCT00593697|Mitosis Modulators|mitosis modulators|mesh-ancestor
65140826|NCT00593697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140827|NCT00593697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65140828|NCT01601522|Ranitidine|ranitidine|mesh-list
65140829|NCT01601522|Desloratadine|desloratadine|mesh-list
65140830|NCT01601522|Histamine Antagonists|histamine antagonists|mesh-list
65140831|NCT01601522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
65140832|NCT01601522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65140833|NCT01601522|Cholinergic Agents|cholinergic agents|mesh-ancestor
65140834|NCT01601522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65140847|NCT00593853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65140848|NCT00593853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140849|NCT00593853|Dopamine Agents|dopamine agents|mesh-ancestor
65140850|NCT00593853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65302794|NCT00782327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65302795|NCT00782327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65302796|NCT00782327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302797|NCT04124939|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65302798|NCT04124939|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65302799|NCT04124939|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65302800|NCT04124939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65302801|NCT04124939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302802|NCT04124939|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65302803|NCT04124939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65302804|NCT04124939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302805|NCT04124939|Cholinergic Agents|cholinergic agents|mesh-ancestor
65302806|NCT04124939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65302807|NCT00559091|Ribavirin|ribavirin|mesh-list
65302808|NCT00559091|Antimetabolites|antimetabolites|mesh-ancestor
65302809|NCT00559091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302810|NCT00559091|Antiviral Agents|antiviral agents|mesh-ancestor
65302811|NCT00559091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65302812|NCT02682017|Fucoidan|fucoidan|mesh-list
65302813|NCT02682017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65140851|NCT01607294|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
65140852|NCT01607294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65140853|NCT01607294|Antimetabolites|antimetabolites|mesh-ancestor
65140854|NCT01607294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140855|NCT01607294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65140856|NCT01607294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140857|NCT01607294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65140858|NCT01607294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140859|NCT00594087|Eszopiclone|eszopiclone|mesh-list
65140860|NCT00594087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65140861|NCT00594087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64783382|NCT03061812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140862|NCT00594087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140864|NCT00594126|Motesanib diphosphate|motesanib diphosphate|mesh-list
65140865|NCT00594126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140866|NCT00594126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140867|NCT00594126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65140868|NCT01605344|Leucovorin|leucovorin|mesh-list
65140869|NCT01605344|Fluorouracil|fluorouracil|mesh-list
65140870|NCT01605344|Irinotecan|irinotecan|mesh-list
65140871|NCT01605344|Atorvastatin|atorvastatin|mesh-list
65140872|NCT01605344|Antimetabolites|antimetabolites|mesh-ancestor
65140873|NCT01605344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140874|NCT01605344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65140875|NCT01605344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65140876|NCT01605344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65140877|NCT01605344|Immunologic Factors|immunologic factors|mesh-ancestor
65140878|NCT01605344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140879|NCT01605344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65140880|NCT01605344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65140881|NCT01605344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140882|NCT01605344|Antidotes|antidotes|mesh-ancestor
65302814|NCT02682017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65302815|NCT02682017|Anticoagulants|anticoagulants|mesh-ancestor
65302816|NCT02682017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302817|NCT04076579|Olaparib|olaparib|mesh-list
65302818|NCT04076579|Trabectedin|trabectedin|mesh-list
65302819|NCT04076579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65302820|NCT04076579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302821|NCT04076579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302822|NCT04076579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65140883|NCT01605344|Protective Agents|protective agents|mesh-ancestor
65140884|NCT01605344|Vitamin B Complex|vitamin b complex|mesh-ancestor
65140885|NCT01605344|Vitamins|vitamins|mesh-ancestor
65140886|NCT01605344|Micronutrients|micronutrients|mesh-ancestor
65140887|NCT01605344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65140888|NCT01605344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65140889|NCT01605344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65140890|NCT01605344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65140891|NCT02274155|Antibodies|antibodies|mesh-list
65140892|NCT02274155|Immunologic Factors|immunologic factors|mesh-ancestor
65140893|NCT02274155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140894|NCT00592410|Insulin|insulin|mesh-list
65140905|NCT04328064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140907|NCT04328064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65140908|NCT04328064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140909|NCT01605734|Sorafenib|sorafenib|mesh-list
65140910|NCT01605734|Chlorotrianisene|chlorotrianisene|mesh-list
65140911|NCT01605734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65140912|NCT01605734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65140913|NCT01605734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140914|NCT01605734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140915|NCT01605734|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65140916|NCT01605734|Estrogens|estrogens|mesh-ancestor
65140917|NCT01605734|Hormones|hormones|mesh-ancestor
65140918|NCT01605734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65140919|NCT01605734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140920|NCT01605734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65140921|NCT01605773|Glyburide|glyburide|mesh-list
65140922|NCT01605773|Repaglinide|repaglinide|mesh-list
65140923|NCT01605773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65140924|NCT01605773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140925|NCT00592527|Insulin Detemir|insulin detemir|mesh-list
65140926|NCT00592527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65140927|NCT00592527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140928|NCT00594555|Cytarabine|cytarabine|mesh-list
65140929|NCT00594555|Imatinib Mesylate|imatinib mesylate|mesh-list
65140930|NCT00594555|Cladribine|cladribine|mesh-list
65140931|NCT00594555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65140932|NCT00594555|Antimetabolites|antimetabolites|mesh-ancestor
65140933|NCT00594555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140934|NCT00594555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65140935|NCT00594555|Antiviral Agents|antiviral agents|mesh-ancestor
65140936|NCT00594555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65140937|NCT00594555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65140938|NCT00594555|Immunologic Factors|immunologic factors|mesh-ancestor
65140939|NCT00594555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140940|NCT00594555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65140941|NCT00594555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140942|NCT01605929|Mepivacaine|mepivacaine|mesh-list
65140943|NCT01605929|Anesthetics, Local|anesthetics, local|mesh-ancestor
65140944|NCT01605929|Anesthetics|anesthetics|mesh-ancestor
65140945|NCT01605929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65140946|NCT01605929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140947|NCT01605929|Sensory System Agents|sensory system agents|mesh-ancestor
65140948|NCT01605929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65140949|NCT02270606|Calcium, Dietary|calcium, dietary|mesh-list
65140950|NCT02270606|Leucovorin|leucovorin|mesh-list
65140951|NCT02270606|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
65302823|NCT04076579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65302824|NCT04076579|Alkylating Agents|alkylating agents|mesh-ancestor
65302825|NCT00603473|Gabapentin|gabapentin|mesh-list
65302826|NCT00603473|Analgesics|analgesics|mesh-ancestor
65302827|NCT00603473|Sensory System Agents|sensory system agents|mesh-ancestor
65302828|NCT00603473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65302829|NCT00603473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302830|NCT00603473|Anticonvulsants|anticonvulsants|mesh-ancestor
65302831|NCT00603473|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65302832|NCT00603473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65302833|NCT00603473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65302834|NCT00603473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65302835|NCT00603473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65302836|NCT00603473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65302837|NCT00603473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65302838|NCT00603473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302839|NCT00603473|Antimanic Agents|antimanic agents|mesh-ancestor
65302840|NCT02688023|Leucovorin|leucovorin|mesh-list
65302841|NCT02688023|Fluorouracil|fluorouracil|mesh-list
65302842|NCT02688023|Capecitabine|capecitabine|mesh-list
65302843|NCT02688023|Oxaliplatin|oxaliplatin|mesh-list
65302844|NCT02688023|Irinotecan|irinotecan|mesh-list
65302845|NCT02688023|Antimetabolites|antimetabolites|mesh-ancestor
64532897|NCT02355678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65140952|NCT02270606|Tetrahydrofolates|tetrahydrofolates|mesh-list
65140953|NCT02270606|Fluorouracil|fluorouracil|mesh-list
65140954|NCT02270606|Oxaliplatin|oxaliplatin|mesh-list
65140955|NCT02270606|Calcium|calcium|mesh-list
65140956|NCT02270606|Levoleucovorin|levoleucovorin|mesh-list
65140957|NCT02270606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65140958|NCT02270606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140959|NCT02270606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65140981|NCT01605968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65140982|NCT01606046|Anesthetics|anesthetics|mesh-list
65140983|NCT01606046|Ethyl Chloride|ethyl chloride|mesh-list
65140984|NCT01606046|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65140985|NCT01606046|Anesthetics, Local|anesthetics, local|mesh-list
65140986|NCT01606046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65140987|NCT01606046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140988|NCT01606046|Sensory System Agents|sensory system agents|mesh-ancestor
65140989|NCT01606046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65140990|NCT01606046|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65140991|NCT02892942|Cetrorelix|cetrorelix|mesh-list
65140992|NCT02892942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65140993|NCT02892942|Fertility Agents|fertility agents|mesh-ancestor
65140994|NCT02892942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65140995|NCT02892942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140996|NCT02892942|Hormone Antagonists|hormone antagonists|mesh-ancestor
65140997|NCT02892942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65140998|NCT00594867|Aspirin|aspirin|mesh-list
65140999|NCT00594867|Acetaminophen|acetaminophen|mesh-list
65141000|NCT00594867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65141001|NCT00594867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65141002|NCT00594867|Analgesics|analgesics|mesh-ancestor
65302846|NCT02688023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302847|NCT02688023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65302848|NCT02688023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302849|NCT02688023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65302850|NCT02688023|Immunologic Factors|immunologic factors|mesh-ancestor
65302851|NCT02688023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302852|NCT02688023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65302853|NCT02688023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65302854|NCT02688023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302855|NCT02688023|Antidotes|antidotes|mesh-ancestor
65302856|NCT02688023|Protective Agents|protective agents|mesh-ancestor
65302857|NCT02688023|Vitamin B Complex|vitamin b complex|mesh-ancestor
65302858|NCT02688023|Vitamins|vitamins|mesh-ancestor
65302859|NCT02688023|Micronutrients|micronutrients|mesh-ancestor
65302860|NCT00910013|Ropivacaine|ropivacaine|mesh-list
65302861|NCT00910013|Anesthetics, Local|anesthetics, local|mesh-ancestor
65302862|NCT00910013|Anesthetics|anesthetics|mesh-ancestor
64532919|NCT02351310|Glucocorticoids|glucocorticoids|mesh-ancestor
65141003|NCT00594867|Sensory System Agents|sensory system agents|mesh-ancestor
65141004|NCT00594867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65141005|NCT00594867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141006|NCT00594867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65141007|NCT00594867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65141008|NCT00594867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65141009|NCT00594867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65141010|NCT00594867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141011|NCT00594867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65141028|NCT02270918|Antithrombins|antithrombins|mesh-ancestor
65141029|NCT02270918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65141030|NCT02270918|Protease Inhibitors|protease inhibitors|mesh-ancestor
65141031|NCT02270918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141032|NCT02270918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141033|NCT02270918|Anticoagulants|anticoagulants|mesh-ancestor
65141034|NCT02270996|Anti-Infective Agents|anti-infective agents|mesh-list
65141035|NCT02270996|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65141037|NCT00595140|Dopamine|dopamine|mesh-list
65141038|NCT00595140|Cabergoline|cabergoline|mesh-list
65141039|NCT00595140|Somatostatin|somatostatin|mesh-list
65141040|NCT00595140|Dopamine Agonists|dopamine agonists|mesh-list
65141041|NCT00595140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65141042|NCT00595140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65141043|NCT00595140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141044|NCT00595140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65141045|NCT00595140|Sympathomimetics|sympathomimetics|mesh-ancestor
65141046|NCT00595140|Autonomic Agents|autonomic agents|mesh-ancestor
64674186|NCT02354508|Pasireotide|pasireotide|mesh-list
65141047|NCT00595140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65141048|NCT00595140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141050|NCT00595140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65141051|NCT00595140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141052|NCT00595140|Protective Agents|protective agents|mesh-ancestor
65141053|NCT00595140|Hormones|hormones|mesh-ancestor
65141054|NCT00595140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65141055|NCT00595140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65141056|NCT00595140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65141057|NCT02271035|Hyaluronic Acid|hyaluronic acid|mesh-list
65141058|NCT02271035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65141059|NCT02271035|Immunologic Factors|immunologic factors|mesh-ancestor
65302863|NCT00910013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65302864|NCT00910013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302865|NCT00910013|Sensory System Agents|sensory system agents|mesh-ancestor
65302866|NCT00910013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65302867|NCT04182191|Tenoxicam|tenoxicam|mesh-list
65302868|NCT04182191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65302869|NCT04182191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65302870|NCT04182191|Analgesics|analgesics|mesh-ancestor
65302871|NCT04182191|Sensory System Agents|sensory system agents|mesh-ancestor
65302872|NCT04182191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65302873|NCT04182191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302874|NCT04182191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65302875|NCT04182191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65302876|NCT04182191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65302877|NCT04182191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302878|NCT04182191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141060|NCT02271035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141061|NCT02271035|Viscosupplements|viscosupplements|mesh-ancestor
65141062|NCT02271035|Protective Agents|protective agents|mesh-ancestor
65141063|NCT01606358|Carboplatin|carboplatin|mesh-list
65141064|NCT01606358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141065|NCT02271113|Enoxaparin|enoxaparin|mesh-list
65141066|NCT02271113|Enoxaparin sodium|enoxaparin sodium|mesh-list
65141067|NCT02271113|Anticoagulants|anticoagulants|mesh-ancestor
65141068|NCT02271113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65141069|NCT02271113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65141070|NCT02271113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141071|NCT02271191|Nicardipine|nicardipine|mesh-list
65141072|NCT02271191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65141108|NCT01172938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65141109|NCT01172938|Immunologic Factors|immunologic factors|mesh-ancestor
65141110|NCT01172938|Leprostatic Agents|leprostatic agents|mesh-ancestor
65141122|NCT02271464|Immunologic Factors|immunologic factors|mesh-ancestor
65141123|NCT02271464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141124|NCT02271464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65141125|NCT02271464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65141126|NCT02271464|Alkylating Agents|alkylating agents|mesh-ancestor
65141127|NCT02271464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141128|NCT02271464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141129|NCT02271464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65141130|NCT02271464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65141131|NCT02271464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65141132|NCT02271464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65141133|NCT02271464|Growth Substances|growth substances|mesh-ancestor
65141134|NCT02271464|Growth Inhibitors|growth inhibitors|mesh-ancestor
65141135|NCT02271464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65141137|NCT04326894|Methotrexate|methotrexate|mesh-list
65141138|NCT04326894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65141139|NCT04326894|Abortifacient Agents|abortifacient agents|mesh-ancestor
65141140|NCT04326894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65141141|NCT04326894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141142|NCT04326894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65141143|NCT04326894|Antimetabolites|antimetabolites|mesh-ancestor
65141144|NCT04326894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141145|NCT04326894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141146|NCT04326894|Dermatologic Agents|dermatologic agents|mesh-ancestor
65141147|NCT04326894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302879|NCT02680379|Minocycline|minocycline|mesh-list
65302880|NCT02680379|Lovastatin|lovastatin|mesh-list
65302881|NCT02680379|L 647318|l 647318|mesh-list
65302882|NCT02680379|Dihydromevinolin|dihydromevinolin|mesh-list
65302883|NCT02680379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65302884|NCT02680379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65302885|NCT02680379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65302886|NCT02680379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65302887|NCT02680379|Antimetabolites|antimetabolites|mesh-ancestor
64532954|NCT04478448|Favipiravir|favipiravir|mesh-list
65141148|NCT04326894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65141149|NCT04326894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65141150|NCT04326894|Immunologic Factors|immunologic factors|mesh-ancestor
65141151|NCT04326894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65141152|NCT04326894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65141153|NCT02271542|Propofol|propofol|mesh-list
65141154|NCT02271542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65141155|NCT02271542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65141156|NCT02271542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141157|NCT02271542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65141158|NCT02271542|Anesthetics, General|anesthetics, general|mesh-ancestor
65141159|NCT02271542|Anesthetics|anesthetics|mesh-ancestor
65141160|NCT01109992|Regadenoson|regadenoson|mesh-list
65141161|NCT01109992|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65141162|NCT01109992|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65141163|NCT01109992|Purinergic Agonists|purinergic agonists|mesh-ancestor
65141164|NCT01109992|Purinergic Agents|purinergic agents|mesh-ancestor
65141165|NCT01109992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65141166|NCT01109992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141167|NCT01109992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141168|NCT02892357|Omeprazole|omeprazole|mesh-list
65141169|NCT02892357|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65141170|NCT02892357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65141171|NCT02892357|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65141172|NCT02892357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141173|NCT02892357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141174|NCT01109524|Cetuximab|cetuximab|mesh-list
65141175|NCT01109524|Vinorelbine|vinorelbine|mesh-list
65141195|NCT02271971|Micronutrients|micronutrients|mesh-ancestor
65141196|NCT02271971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141197|NCT02271971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65141198|NCT02271971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65141199|NCT01172821|Tiotropium Bromide|tiotropium bromide|mesh-list
65141200|NCT01172821|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65141201|NCT01172821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65141202|NCT01172821|Autonomic Agents|autonomic agents|mesh-ancestor
65141203|NCT01172821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65141204|NCT01172821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141205|NCT01172821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65141206|NCT01172821|Respiratory System Agents|respiratory system agents|mesh-ancestor
65141207|NCT01172821|Parasympatholytics|parasympatholytics|mesh-ancestor
65141208|NCT01172821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65141209|NCT01172821|Cholinergic Agents|cholinergic agents|mesh-ancestor
65141210|NCT01172821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65141211|NCT01172821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141212|NCT01172821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65141213|NCT01172821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65141214|NCT01172821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65141215|NCT01172821|Adrenergic Agents|adrenergic agents|mesh-ancestor
65141216|NCT01172275|Acetylcysteine|acetylcysteine|mesh-list
65141217|NCT01172275|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65141218|NCT01172275|Antiviral Agents|antiviral agents|mesh-ancestor
65141219|NCT01172275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65141220|NCT01172275|Expectorants|expectorants|mesh-ancestor
65141221|NCT01172275|Respiratory System Agents|respiratory system agents|mesh-ancestor
65141222|NCT01172275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65141223|NCT01172275|Antioxidants|antioxidants|mesh-ancestor
65222825|NCT02699385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65302888|NCT02680379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302889|NCT02680379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64532956|NCT04478448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65141224|NCT01172275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141225|NCT01172275|Protective Agents|protective agents|mesh-ancestor
65141226|NCT01172275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141227|NCT01172275|Antidotes|antidotes|mesh-ancestor
65141228|NCT05034952|Acetaminophen|acetaminophen|mesh-list
65141229|NCT05034952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65141230|NCT05034952|Analgesics|analgesics|mesh-ancestor
65141231|NCT05034952|Sensory System Agents|sensory system agents|mesh-ancestor
65141245|NCT02273102|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65141246|NCT02273102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141247|NCT02273102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141248|NCT02273102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65141249|NCT02273102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65141250|NCT02273102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65141251|NCT02273102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141252|NCT02272478|Decitabine|decitabine|mesh-list
65141253|NCT02272478|Gemtuzumab|gemtuzumab|mesh-list
65141254|NCT02272478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65141255|NCT02272478|Antimetabolites|antimetabolites|mesh-ancestor
65141256|NCT02272478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141257|NCT02272478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141258|NCT02272478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141259|NCT02272478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65141260|NCT02272517|Vortioxetine|vortioxetine|mesh-list
65141261|NCT02272517|Citalopram|citalopram|mesh-list
65141262|NCT02272517|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65141263|NCT02272517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65141264|NCT02272517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65141265|NCT02272517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141266|NCT02272517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65141267|NCT02272517|Serotonin Agents|serotonin agents|mesh-ancestor
65141268|NCT02272517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141269|NCT02272517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65141270|NCT02272517|Antidepressive Agents|antidepressive agents|mesh-ancestor
65141271|NCT02272517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65141272|NCT02272517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65141273|NCT02272517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65141274|NCT02272517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65141275|NCT02272517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65141276|NCT02272517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65141277|NCT02272517|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65141278|NCT02272517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65141279|NCT02272829|Analgesics, Opioid|analgesics, opioid|mesh-list
65141280|NCT02272829|Narcotics|narcotics|mesh-ancestor
65141281|NCT02272829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65141282|NCT02272829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141283|NCT02272829|Analgesics|analgesics|mesh-ancestor
65141284|NCT02272829|Sensory System Agents|sensory system agents|mesh-ancestor
65141285|NCT02272829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65141286|NCT00596115|Pramipexole|pramipexole|mesh-list
65141287|NCT00596115|Antioxidants|antioxidants|mesh-ancestor
65141288|NCT00596115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141289|NCT00596115|Protective Agents|protective agents|mesh-ancestor
65141290|NCT00596115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141308|NCT02273453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65141309|NCT02273453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65141310|NCT02273453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141311|NCT02273453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65141312|NCT02273453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65141313|NCT02273453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65141314|NCT02273453|GABA Modulators|gaba modulators|mesh-ancestor
65141315|NCT02273453|GABA Agents|gaba agents|mesh-ancestor
65141316|NCT02273453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65141317|NCT02273453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141318|NCT01108510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65141319|NCT01108510|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65302890|NCT02680379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65302891|NCT02680379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302892|NCT03996421|Ferrous fumarate|ferrous fumarate|mesh-list
65302893|NCT03996421|Trace Elements|trace elements|mesh-ancestor
65302894|NCT03996421|Micronutrients|micronutrients|mesh-ancestor
65302895|NCT03996421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302896|NCT00641693|Budesonide|budesonide|mesh-list
65302897|NCT00641693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65302898|NCT00641693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65302899|NCT00641693|Autonomic Agents|autonomic agents|mesh-ancestor
64297531|NCT05010668|Lenvatinib|lenvatinib|mesh-list
65141320|NCT01108510|Cobicistat|cobicistat|mesh-list
65141321|NCT01108510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65141322|NCT01108510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65141323|NCT01108510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141324|NCT01108510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141325|NCT01108510|Antiviral Agents|antiviral agents|mesh-ancestor
65141326|NCT01108510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65141327|NCT01108510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65141328|NCT01108510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65141329|NCT01108510|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65141330|NCT01108510|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65141331|NCT01108510|Protease Inhibitors|protease inhibitors|mesh-ancestor
65141332|NCT01108510|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65141333|NCT01108510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65141334|NCT02273258|Insulin|insulin|mesh-list
65141335|NCT02273258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65141336|NCT02273258|Insulin Lispro|insulin lispro|mesh-list
65141337|NCT02273258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65141338|NCT02273258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141339|NCT05015686|Vaccines|vaccines|mesh-list
65141340|NCT05015686|Immunologic Factors|immunologic factors|mesh-ancestor
65141341|NCT05015686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141342|NCT04327245|Tagatose|tagatose|mesh-list
65141343|NCT04327245|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65141344|NCT04327245|Chelating Agents|chelating agents|mesh-ancestor
65141345|NCT04327245|Sequestering Agents|sequestering agents|mesh-ancestor
65141346|NCT04327245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141347|NCT04327401|Dexamethasone|dexamethasone|mesh-list
65141348|NCT04327401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65141349|NCT04327401|Antiemetics|antiemetics|mesh-ancestor
65141350|NCT04327401|Autonomic Agents|autonomic agents|mesh-ancestor
65141359|NCT01340027|Solifenacin Succinate|solifenacin succinate|mesh-list
65141361|NCT01340027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65141362|NCT01340027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65141363|NCT01340027|Cholinergic Agents|cholinergic agents|mesh-ancestor
65141364|NCT01340027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65141365|NCT01340027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141366|NCT01340027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141367|NCT01340027|Urological Agents|urological agents|mesh-ancestor
65141368|NCT01340027|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65141369|NCT01340027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65141370|NCT01340027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65141371|NCT01340027|Adrenergic Agents|adrenergic agents|mesh-ancestor
65141372|NCT01107925|Clopidogrel|clopidogrel|mesh-list
65141373|NCT01107925|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65141374|NCT01107925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65141375|NCT01107925|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65141376|NCT01107925|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65141377|NCT01107925|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65141378|NCT01107925|Purinergic Agents|purinergic agents|mesh-ancestor
65141379|NCT01107925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65141380|NCT01107925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141381|NCT01107925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141382|NCT04310293|Hormones|hormones|mesh-list
64532967|NCT04478526|Sympathomimetics|sympathomimetics|mesh-ancestor
65302900|NCT00641693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65302901|NCT00641693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302902|NCT00641693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65302903|NCT00641693|Respiratory System Agents|respiratory system agents|mesh-ancestor
65302904|NCT00641693|Glucocorticoids|glucocorticoids|mesh-ancestor
65302905|NCT00641693|Hormones|hormones|mesh-ancestor
65302906|NCT00641693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65302907|NCT04183361|Cortisone|cortisone|mesh-list
65302908|NCT04183361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65302909|NCT02503774|Durvalumab|durvalumab|mesh-list
65302910|NCT02503774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65141383|NCT04310293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65141384|NCT04310293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141385|NCT01339559|Brivaracetam|brivaracetam|mesh-list
65141386|NCT01339559|Anticonvulsants|anticonvulsants|mesh-ancestor
65141387|NCT01588847|Sufentanil|sufentanil|mesh-list
65141388|NCT01588847|Bupivacaine|bupivacaine|mesh-list
65141389|NCT01588847|Anesthetics|anesthetics|mesh-list
65141390|NCT01588847|Propofol|propofol|mesh-list
65141391|NCT01588847|Sevoflurane|sevoflurane|mesh-list
65141392|NCT01588847|Rocuronium|rocuronium|mesh-list
65141393|NCT01588847|Anesthetics, Local|anesthetics, local|mesh-ancestor
65141394|NCT01588847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65141395|NCT01588847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141396|NCT01588847|Sensory System Agents|sensory system agents|mesh-ancestor
65141397|NCT01588847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65141398|NCT01588847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65141399|NCT01588847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65141400|NCT01588847|Anesthetics, General|anesthetics, general|mesh-ancestor
65141401|NCT01588847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65141402|NCT01588847|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65141403|NCT01588847|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65141404|NCT01588847|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65141405|NCT01588847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65141406|NCT01588847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65141407|NCT01588847|Narcotics|narcotics|mesh-ancestor
65141408|NCT01588847|Analgesics|analgesics|mesh-ancestor
65141409|NCT01588847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65141410|NCT00107900|Edoxaban|edoxaban|mesh-list
65141411|NCT00107900|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65141412|NCT00107900|Antithrombins|antithrombins|mesh-ancestor
65141413|NCT00107900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65141414|NCT00107900|Protease Inhibitors|protease inhibitors|mesh-ancestor
65141415|NCT00107900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64401033|NCT03068975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65141424|NCT00107315|Growth Substances|growth substances|mesh-ancestor
65141425|NCT00107315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141426|NCT00107315|Growth Inhibitors|growth inhibitors|mesh-ancestor
65141427|NCT00107315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65141428|NCT00107315|Antimetabolites|antimetabolites|mesh-ancestor
65141429|NCT00107315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141430|NCT01335971|Sulforaphane|sulforaphane|mesh-list
65141431|NCT01335971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65141432|NCT01335971|Protective Agents|protective agents|mesh-ancestor
65141433|NCT01335971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141434|NCT01335971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141435|NCT00107276|Cyclophosphamide|cyclophosphamide|mesh-list
65141436|NCT00107276|Capecitabine|capecitabine|mesh-list
65141437|NCT00107276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65141438|NCT00107276|Immunologic Factors|immunologic factors|mesh-ancestor
65141439|NCT00107276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141440|NCT00107276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65141441|NCT00107276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65141442|NCT00107276|Alkylating Agents|alkylating agents|mesh-ancestor
65302911|NCT02503774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302912|NCT02687867|Vitamin K|vitamin k|mesh-list
65302913|NCT02687867|Dabigatran|dabigatran|mesh-list
65302914|NCT02687867|Vitamins|vitamins|mesh-ancestor
65302915|NCT02687867|Micronutrients|micronutrients|mesh-ancestor
65302916|NCT02687867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302917|NCT02687867|Antithrombins|antithrombins|mesh-ancestor
65302918|NCT02687867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65302919|NCT02687867|Protease Inhibitors|protease inhibitors|mesh-ancestor
65302920|NCT02687867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302921|NCT02687867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302922|NCT02687867|Anticoagulants|anticoagulants|mesh-ancestor
65302923|NCT02687867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65302924|NCT02687867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65302925|NCT02687867|Hemostatics|hemostatics|mesh-ancestor
65302926|NCT02687867|Coagulants|coagulants|mesh-ancestor
65141443|NCT00107276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141444|NCT00107276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141445|NCT00107276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65141446|NCT00107276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65141447|NCT00107276|Antimetabolites|antimetabolites|mesh-ancestor
65141449|NCT01335698|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65141450|NCT01335698|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65141451|NCT01335698|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65141452|NCT01335698|Protease Inhibitors|protease inhibitors|mesh-ancestor
65141453|NCT01335698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141454|NCT01335698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141455|NCT01335698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65141456|NCT01335698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65141457|NCT01335698|Antiviral Agents|antiviral agents|mesh-ancestor
65141458|NCT01335698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65141459|NCT01335698|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65141460|NCT01335698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65141461|NCT00107198|Prednisone|prednisone|mesh-list
65141462|NCT00107198|Cortisone|cortisone|mesh-list
65141463|NCT00107198|Cyclophosphamide|cyclophosphamide|mesh-list
65141464|NCT00107198|Doxorubicin|doxorubicin|mesh-list
65141465|NCT00107198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64784001|NCT03485976|Ixekizumab|ixekizumab|mesh-list
65141466|NCT00107198|Vincristine|vincristine|mesh-list
65141467|NCT00107198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65141468|NCT00107198|Immunologic Factors|immunologic factors|mesh-ancestor
65141469|NCT00107198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141470|NCT00107198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65141471|NCT00107198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65141472|NCT00107198|Alkylating Agents|alkylating agents|mesh-ancestor
65141473|NCT00107198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141474|NCT00107198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141475|NCT00107198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65141476|NCT00107198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65141477|NCT00107198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65141478|NCT00107198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65141479|NCT00107198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141480|NCT00107198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65141481|NCT00107198|Glucocorticoids|glucocorticoids|mesh-ancestor
65141482|NCT00107198|Hormones|hormones|mesh-ancestor
65141511|NCT00598923|Topiramate|topiramate|mesh-list
65141512|NCT00598923|Phenytoin|phenytoin|mesh-list
65141513|NCT00598923|Anticonvulsants|anticonvulsants|mesh-ancestor
65141514|NCT00598923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65141515|NCT00598923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141516|NCT00598923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65141517|NCT00598923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65302927|NCT02681783|Aflibercept|aflibercept|mesh-list
65302928|NCT02681783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65302929|NCT02681783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65302930|NCT02681783|Growth Substances|growth substances|mesh-ancestor
65302931|NCT02681783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302932|NCT02681783|Growth Inhibitors|growth inhibitors|mesh-ancestor
65302933|NCT02681783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302934|NCT00486811|Oxycodone|oxycodone|mesh-list
65302935|NCT00486811|Tapentadol|tapentadol|mesh-list
65302936|NCT00486811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65302937|NCT00486811|Narcotics|narcotics|mesh-ancestor
65302938|NCT00486811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65302939|NCT00486811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302940|NCT00486811|Analgesics|analgesics|mesh-ancestor
65302941|NCT00486811|Sensory System Agents|sensory system agents|mesh-ancestor
65302942|NCT00486811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65302943|NCT00486811|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65302944|NCT00486811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65302945|NCT00486811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65302946|NCT00486811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141518|NCT00598923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65141519|NCT00598923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141520|NCT00598923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65141521|NCT00598923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65141522|NCT02892318|Atezolizumab|atezolizumab|mesh-list
65141523|NCT02892318|Guadecitabine|guadecitabine|mesh-list
65141524|NCT02892318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141525|NCT01334918|Regadenoson|regadenoson|mesh-list
65141529|NCT01334918|Purinergic Agonists|purinergic agonists|mesh-ancestor
65141530|NCT01334918|Purinergic Agents|purinergic agents|mesh-ancestor
65141531|NCT01334918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65141532|NCT01334918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141533|NCT01334918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141534|NCT01334918|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65141535|NCT00598962|Azithromycin|azithromycin|mesh-list
65141536|NCT00598962|Rifampin|rifampin|mesh-list
65141537|NCT00598962|Rifabutin|rifabutin|mesh-list
65141538|NCT00598962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64784054|NCT03532776|Podophyllotoxin|podophyllotoxin|mesh-list
65141539|NCT00598962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65141540|NCT00598962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65141541|NCT00598962|Antitubercular Agents|antitubercular agents|mesh-ancestor
65141542|NCT00598962|Leprostatic Agents|leprostatic agents|mesh-ancestor
65141543|NCT00598962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65141544|NCT00598962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141545|NCT00598962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141546|NCT00598962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65141547|NCT00598962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65141548|NCT00598962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65141549|NCT00598962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65141550|NCT00598962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65141551|NCT00598962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65141553|NCT01332968|Cyclophosphamide|cyclophosphamide|mesh-list
65302947|NCT00486811|Adrenergic Agents|adrenergic agents|mesh-ancestor
65302948|NCT00486811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65302949|NCT00921700|Acetaminophen|acetaminophen|mesh-list
65302950|NCT00921700|Ibuprofen|ibuprofen|mesh-list
65302951|NCT00921700|Codeine|codeine|mesh-list
65302952|NCT00921700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65302953|NCT00921700|Analgesics|analgesics|mesh-ancestor
65302954|NCT00921700|Sensory System Agents|sensory system agents|mesh-ancestor
65302955|NCT00921700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65302956|NCT00921700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302957|NCT00921700|Antipyretics|antipyretics|mesh-ancestor
65302958|NCT00921700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65302959|NCT00921700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65302960|NCT00921700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65302961|NCT00921700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65302962|NCT00921700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65302963|NCT00921700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533009|NCT02350530|Bevacizumab|bevacizumab|mesh-list
65141554|NCT01332968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65141555|NCT01332968|Rituximab|rituximab|mesh-list
65141556|NCT01332968|Doxorubicin|doxorubicin|mesh-list
65141557|NCT01332968|Vincristine|vincristine|mesh-list
65141558|NCT01332968|Obinutuzumab|obinutuzumab|mesh-list
65141559|NCT01332968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65141560|NCT01332968|Immunologic Factors|immunologic factors|mesh-ancestor
65141561|NCT01332968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141562|NCT01332968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65141563|NCT01332968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65141564|NCT01332968|Alkylating Agents|alkylating agents|mesh-ancestor
65141565|NCT01332968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141566|NCT01332968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141567|NCT01332968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65141568|NCT01332968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65141569|NCT01332968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65141570|NCT01332968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65141571|NCT01332968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65141572|NCT01332968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141573|NCT01332968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65141574|NCT01332968|Glucocorticoids|glucocorticoids|mesh-ancestor
65141575|NCT01332968|Hormones|hormones|mesh-ancestor
65141576|NCT01332968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65141577|NCT01332968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65141578|NCT01332968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65141579|NCT01332968|Tubulin Modulators|tubulin modulators|mesh-ancestor
65141580|NCT01332968|Antimitotic Agents|antimitotic agents|mesh-ancestor
65141581|NCT01332968|Mitosis Modulators|mitosis modulators|mesh-ancestor
65141582|NCT00599079|Azithromycin|azithromycin|mesh-list
65141583|NCT00599079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65141584|NCT00599079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65141585|NCT00599235|Hydralazine|hydralazine|mesh-list
65141586|NCT00599235|Sildenafil Citrate|sildenafil citrate|mesh-list
65141587|NCT00599235|Vasodilator Agents|vasodilator agents|mesh-ancestor
65141588|NCT00599235|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65141589|NCT00599235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65141590|NCT00599235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141591|NCT00599235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141592|NCT00599235|Urological Agents|urological agents|mesh-ancestor
65141593|NCT00599235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65302964|NCT00921700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65302965|NCT00921700|Narcotics|narcotics|mesh-ancestor
65302966|NCT00921700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65302967|NCT00921700|Antitussive Agents|antitussive agents|mesh-ancestor
65302968|NCT00921700|Respiratory System Agents|respiratory system agents|mesh-ancestor
65302969|NCT02678195|Amoxicillin|amoxicillin|mesh-list
65302970|NCT02678195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65141594|NCT00599274|Interferons|interferons|mesh-list
65141595|NCT00599274|Interferon-beta|interferon-beta|mesh-list
65141596|NCT00599274|Interferon beta-1a|interferon beta-1a|mesh-list
65141607|NCT01332227|Raltegravir Potassium|raltegravir potassium|mesh-list
65141608|NCT01332227|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65141609|NCT01332227|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65141610|NCT01332227|Protease Inhibitors|protease inhibitors|mesh-ancestor
65141611|NCT01332227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141612|NCT01332227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141613|NCT01332227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65141614|NCT01332227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65141615|NCT01332227|Antiviral Agents|antiviral agents|mesh-ancestor
65141616|NCT01332227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65141617|NCT01332227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65141618|NCT01332227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65141619|NCT01332227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65141620|NCT01332227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65141621|NCT01332227|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65141622|NCT01332227|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65141624|NCT01332149|Analgesics|analgesics|mesh-ancestor
65141625|NCT01332149|Sensory System Agents|sensory system agents|mesh-ancestor
65141626|NCT01332149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65141627|NCT01332149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141628|NCT01332149|Anticonvulsants|anticonvulsants|mesh-ancestor
65141629|NCT01332149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65141630|NCT01332149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65141631|NCT01332149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141632|NCT01332149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65141633|NCT01332149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65141634|NCT01332149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65141635|NCT01332149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65141636|NCT01332149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65141637|NCT01326702|Rituximab|rituximab|mesh-list
65141638|NCT01326702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65141639|NCT01326702|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65141641|NCT01326702|Antibodies|antibodies|mesh-list
65141642|NCT01326702|Immunoglobulins|immunoglobulins|mesh-list
65141643|NCT01326702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65141644|NCT01326702|Immunologic Factors|immunologic factors|mesh-ancestor
65141645|NCT01326702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141646|NCT01326702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141647|NCT01326702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65141648|NCT01326702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65141649|NCT01326702|Alkylating Agents|alkylating agents|mesh-ancestor
65141650|NCT01326702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141651|NCT01326702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65141652|NCT01326702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141653|NCT00599625|Pravastatin|pravastatin|mesh-list
65141654|NCT00599625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65141655|NCT00599625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65141656|NCT00599625|Antimetabolites|antimetabolites|mesh-ancestor
65141657|NCT00599625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141658|NCT00599625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65141659|NCT00599625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65141660|NCT00599625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141661|NCT05650697|Cannabidiol|cannabidiol|mesh-list
65141662|NCT05650697|Anticonvulsants|anticonvulsants|mesh-ancestor
65141673|NCT05649878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65141674|NCT05649878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141676|NCT05649878|Glucocorticoids|glucocorticoids|mesh-ancestor
65302971|NCT02678195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65302972|NCT03996577|Lidocaine|lidocaine|mesh-list
65302973|NCT03996577|Anesthetics, Local|anesthetics, local|mesh-ancestor
65302974|NCT03996577|Anesthetics|anesthetics|mesh-ancestor
65302975|NCT03996577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65141677|NCT05649878|Hormones|hormones|mesh-ancestor
65141678|NCT05649878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65141679|NCT05649878|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65141680|NCT05649878|Protective Agents|protective agents|mesh-ancestor
65141681|NCT05649878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65141682|NCT05649878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141683|NCT01327703|Pancreatin|pancreatin|mesh-list
65141684|NCT01327703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65141685|NCT01380080|Efavirenz|efavirenz|mesh-list
65141686|NCT01380080|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65141687|NCT01380080|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65141688|NCT01380080|Rifampin|rifampin|mesh-list
65141689|NCT01380080|Isoniazid|isoniazid|mesh-list
65141690|NCT01380080|Pyrazinamide|pyrazinamide|mesh-list
65141691|NCT01380080|Ethambutol|ethambutol|mesh-list
65141692|NCT01380080|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
65141693|NCT01380080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65141694|NCT01380080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65141695|NCT01380080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141696|NCT01380080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141697|NCT01380080|Antiviral Agents|antiviral agents|mesh-ancestor
65141698|NCT01380080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65141699|NCT01380080|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65141700|NCT01380080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65141701|NCT01380080|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65141702|NCT01380080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65141703|NCT01380080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65141704|NCT01380080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65141705|NCT01380080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65141706|NCT01380080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65141707|NCT01380080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65141708|NCT01380080|Antitubercular Agents|antitubercular agents|mesh-ancestor
65141709|NCT01380080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65141710|NCT01380080|Leprostatic Agents|leprostatic agents|mesh-ancestor
65141711|NCT01380080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65141712|NCT01380080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65141713|NCT01380080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65141714|NCT01380080|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65141715|NCT01380080|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65141716|NCT01380080|Antimetabolites|antimetabolites|mesh-ancestor
65141717|NCT01380080|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65141718|NCT01379573|Hydroxychloroquine|hydroxychloroquine|mesh-list
65141719|NCT01379573|Antimalarials|antimalarials|mesh-ancestor
65141720|NCT01379573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65141721|NCT01379573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65141722|NCT01379573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65141723|NCT01379573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141724|NCT01379573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141725|NCT01379573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65141737|NCT01371734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65141738|NCT01371734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65141739|NCT01371734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141740|NCT01371734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65141741|NCT01371734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141742|NCT01371734|Antidepressive Agents|antidepressive agents|mesh-ancestor
65141743|NCT01371734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65141744|NCT04328870|Oxytocin|oxytocin|mesh-list
65141745|NCT04328870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141746|NCT04328870|Oxytocics|oxytocics|mesh-ancestor
65141747|NCT04328870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65141748|NCT00591617|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65141749|NCT00591617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65302976|NCT03996577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302977|NCT03996577|Sensory System Agents|sensory system agents|mesh-ancestor
65302978|NCT03996577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65302979|NCT03996577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65302980|NCT03996577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65302981|NCT03996577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65302982|NCT03996577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65141750|NCT00591617|Narcotics|narcotics|mesh-ancestor
65141751|NCT00591617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65141752|NCT00591617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141753|NCT00591617|Analgesics|analgesics|mesh-ancestor
65141754|NCT00591617|Sensory System Agents|sensory system agents|mesh-ancestor
65141755|NCT00591617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65141756|NCT00591617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65141757|NCT01357889|rGLP-1 protein|rglp-1 protein|mesh-list
65141758|NCT01357889|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65141759|NCT01357889|Incretins|incretins|mesh-ancestor
65141760|NCT01357889|Hormones|hormones|mesh-ancestor
65141761|NCT01357889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65141762|NCT01357889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141763|NCT01357655|Dasatinib|dasatinib|mesh-list
65141764|NCT01357655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141765|NCT01357655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65141766|NCT01357655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141767|NCT01357655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141768|NCT01357616|Timolol|timolol|mesh-list
65141769|NCT01357616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65141770|NCT01357616|Brinzolamide|brinzolamide|mesh-list
65141771|NCT01357616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65141772|NCT01357616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65141773|NCT01357616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65141774|NCT01357616|Adrenergic Agents|adrenergic agents|mesh-ancestor
65141775|NCT01357616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65141776|NCT01357616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141777|NCT01357616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141778|NCT01357616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65141779|NCT01357616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65141780|NCT01357616|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65141781|NCT01357616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141782|NCT01351025|Atorvastatin|atorvastatin|mesh-list
65141783|NCT01351025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65141784|NCT01351025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65141785|NCT01351025|Antimetabolites|antimetabolites|mesh-ancestor
65141794|NCT01348763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65141795|NCT01348763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141796|NCT01348763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141797|NCT01348763|Antiviral Agents|antiviral agents|mesh-ancestor
65141798|NCT01348763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65141799|NCT01348763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65141800|NCT01348763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65141801|NCT01348763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65141802|NCT01348763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65141803|NCT01348763|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65141804|NCT01348763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65141805|NCT01348763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65141806|NCT01348763|Protease Inhibitors|protease inhibitors|mesh-ancestor
65141807|NCT01346540|Nintedanib|nintedanib|mesh-list
65141808|NCT01346540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141809|NCT01346540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65141810|NCT01346540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141811|NCT01346540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141812|NCT01342913|Fluticasone|fluticasone|mesh-list
65141813|NCT01342913|Xhance|xhance|mesh-list
65141814|NCT01342913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65141815|NCT01342913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65141816|NCT01342913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65141817|NCT01342913|Autonomic Agents|autonomic agents|mesh-ancestor
65302983|NCT03996577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302984|NCT02681705|Temozolomide|temozolomide|mesh-list
65302985|NCT02681705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65302986|NCT02681705|Alkylating Agents|alkylating agents|mesh-ancestor
65302987|NCT02681705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65302988|NCT02681705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65302989|NCT00921622|Vitamin D|vitamin d|mesh-list
65302990|NCT00921622|Vitamins|vitamins|mesh-list
65302991|NCT00921622|Micronutrients|micronutrients|mesh-ancestor
65302992|NCT00921622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302993|NCT00921622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65302994|NCT02681471|Mannitol|mannitol|mesh-list
65302995|NCT02681471|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65302996|NCT02681471|Diuretics|diuretics|mesh-ancestor
65302997|NCT02681471|Natriuretic Agents|natriuretic agents|mesh-ancestor
65302998|NCT02681471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65302999|NCT00642395|Bortezomib|bortezomib|mesh-list
65303000|NCT00642395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303001|NCT01018615|Silymarin|silymarin|mesh-list
65303002|NCT01018615|Antioxidants|antioxidants|mesh-ancestor
65303003|NCT01018615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303004|NCT01018615|Protective Agents|protective agents|mesh-ancestor
65303005|NCT01018615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141818|NCT01342913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65141819|NCT01342913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141820|NCT01342913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65141821|NCT01342913|Respiratory System Agents|respiratory system agents|mesh-ancestor
65141822|NCT01342913|Dermatologic Agents|dermatologic agents|mesh-ancestor
65141823|NCT01342913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65141824|NCT01342913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65141825|NCT01342913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65141826|NCT01342913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65141827|NCT01342913|Adrenergic Agents|adrenergic agents|mesh-ancestor
65141828|NCT01342913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65141829|NCT01342913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141830|NCT01342796|Vaccines|vaccines|mesh-list
64784364|NCT03930264|Azathioprine|azathioprine|mesh-list
65141831|NCT01342796|Immunologic Factors|immunologic factors|mesh-ancestor
65141832|NCT01342796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141833|NCT01342640|Epoetin Alfa|epoetin alfa|mesh-list
65141834|NCT01342640|Hematinics|hematinics|mesh-ancestor
65141835|NCT01342484|Linagliptin|linagliptin|mesh-list
65141836|NCT01342484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65141837|NCT01342484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141838|NCT01342484|Incretins|incretins|mesh-ancestor
65141840|NCT01342484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65141841|NCT01342484|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65141842|NCT01342484|Protease Inhibitors|protease inhibitors|mesh-ancestor
65141843|NCT01342484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141844|NCT01342484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141845|NCT01342445|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65141846|NCT01342445|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65303006|NCT00743782|Hormones|hormones|mesh-list
65303007|NCT00743782|Parathyroid Hormone|parathyroid hormone|mesh-list
65303008|NCT00743782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65303009|NCT00743782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303010|NCT00743782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65303011|NCT02678117|Magnesium Sulfate|magnesium sulfate|mesh-list
65303012|NCT02678117|Pregabalin|pregabalin|mesh-list
65303013|NCT02678117|Analgesics|analgesics|mesh-ancestor
65303014|NCT02678117|Sensory System Agents|sensory system agents|mesh-ancestor
65303015|NCT02678117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65303016|NCT02678117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303017|NCT02678117|Anticonvulsants|anticonvulsants|mesh-ancestor
65303018|NCT02678117|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65303019|NCT02678117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65303020|NCT02678117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303021|NCT02678117|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65303022|NCT02678117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65303023|NCT02678117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65303024|NCT02678117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65303025|NCT02678117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65052917|NCT00191308|Pemetrexed|pemetrexed|mesh-list
65303026|NCT02678117|Anesthetics|anesthetics|mesh-ancestor
65303027|NCT02678117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65303028|NCT02678117|Tocolytic Agents|tocolytic agents|mesh-ancestor
65303029|NCT02678117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65303030|NCT01018849|Vitamin D|vitamin d|mesh-list
65303031|NCT01018849|Cholecalciferol|cholecalciferol|mesh-list
65303032|NCT01018849|Vitamins|vitamins|mesh-ancestor
65303033|NCT01018849|Micronutrients|micronutrients|mesh-ancestor
65303034|NCT01018849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303035|NCT01018849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65303036|NCT01018849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65303046|NCT00747526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65303047|NCT00747526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303048|NCT00747526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303049|NCT00747604|Mecasermin|mecasermin|mesh-list
65303050|NCT00747604|Growth Substances|growth substances|mesh-ancestor
65303051|NCT00747604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303052|NCT02151604|Xenon|xenon|mesh-list
65303053|NCT02151604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65303054|NCT02151604|Anesthetics, General|anesthetics, general|mesh-ancestor
65303055|NCT02151604|Anesthetics|anesthetics|mesh-ancestor
65303056|NCT02151604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64533109|NCT02353182|Narcotics|narcotics|mesh-ancestor
65141847|NCT01342445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141848|NCT01342445|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64496110|NCT00861705|Doxorubicin|doxorubicin|mesh-list
65141860|NCT01342367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141861|NCT01342367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141862|NCT01342367|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65141863|NCT01342367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65141864|NCT01342367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141865|NCT01342367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141866|NCT01342367|Urological Agents|urological agents|mesh-ancestor
65141867|NCT01342211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65141868|NCT01342211|Bococizumab|bococizumab|mesh-list
65141869|NCT01342211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65141870|NCT01342211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65141871|NCT01342211|Antimetabolites|antimetabolites|mesh-ancestor
65141872|NCT01342211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141873|NCT01342211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141874|NCT01342211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65141875|NCT01342094|Timolol|timolol|mesh-list
65141876|NCT01342094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65141877|NCT01342094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65141878|NCT01342094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65141879|NCT01342094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65141880|NCT01342094|Adrenergic Agents|adrenergic agents|mesh-ancestor
65141881|NCT01342094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65141882|NCT01342094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141883|NCT01342094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141884|NCT01342094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65141885|NCT01342094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65141886|NCT01340768|Metformin|metformin|mesh-list
65141887|NCT01340768|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65141888|NCT01340768|Glimepiride|glimepiride|mesh-list
65141889|NCT01340768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65141890|NCT01340768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141891|NCT01340768|Incretins|incretins|mesh-ancestor
65141892|NCT01340768|Hormones|hormones|mesh-ancestor
65141893|NCT01340768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65141894|NCT01340768|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65141895|NCT01340768|Protease Inhibitors|protease inhibitors|mesh-ancestor
65141896|NCT01340768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141897|NCT01340768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141898|NCT01340768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65141899|NCT01340768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65141900|NCT01340768|Immunologic Factors|immunologic factors|mesh-ancestor
65141901|NCT01340300|Metformin|metformin|mesh-list
65141902|NCT01340300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65141903|NCT01340300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141904|NCT01107535|Palivizumab|palivizumab|mesh-list
65141905|NCT01107535|Antibodies|antibodies|mesh-list
65141906|NCT01107535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65141907|NCT01107535|Immunologic Factors|immunologic factors|mesh-ancestor
65303057|NCT02151604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303058|NCT00466921|Lenalidomide|lenalidomide|mesh-list
65303059|NCT00466921|Immunologic Factors|immunologic factors|mesh-ancestor
65303060|NCT00466921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303061|NCT00466921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65303062|NCT00466921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65303063|NCT00466921|Growth Substances|growth substances|mesh-ancestor
65303064|NCT00466921|Growth Inhibitors|growth inhibitors|mesh-ancestor
65303065|NCT00466921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303066|NCT00601523|Pramipexole|pramipexole|mesh-list
65303067|NCT00601523|Antioxidants|antioxidants|mesh-ancestor
65303068|NCT00601523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303069|NCT00601523|Protective Agents|protective agents|mesh-ancestor
65303070|NCT00601523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303071|NCT00601523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65303072|NCT00601523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65141908|NCT01107535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141909|NCT01107535|Antiviral Agents|antiviral agents|mesh-ancestor
65141910|NCT01107535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65141911|NCT02880943|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65141920|NCT04207632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65141921|NCT04207632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141923|NCT04207632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65141924|NCT00598338|Prucalopride|prucalopride|mesh-list
65141925|NCT00598338|Laxatives|laxatives|mesh-ancestor
65141926|NCT00598338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65141927|NCT00598338|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65141928|NCT00598338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65141929|NCT00598338|Serotonin Agents|serotonin agents|mesh-ancestor
65141930|NCT00598338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65141931|NCT00598338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141932|NCT00598338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141934|NCT00598572|Siderophores|siderophores|mesh-ancestor
65141935|NCT00598572|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65141936|NCT00598572|Chelating Agents|chelating agents|mesh-ancestor
65141937|NCT00598572|Sequestering Agents|sequestering agents|mesh-ancestor
65141938|NCT00598572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141939|NCT00599820|Bevacizumab|bevacizumab|mesh-list
65141940|NCT00599820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65141941|NCT00599820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141942|NCT00599820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65141943|NCT00599820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65141944|NCT00599820|Growth Substances|growth substances|mesh-ancestor
65141945|NCT00599820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141946|NCT00599820|Growth Inhibitors|growth inhibitors|mesh-ancestor
65141947|NCT00599898|Nifedipine|nifedipine|mesh-list
65141948|NCT00599898|Atosiban|atosiban|mesh-list
65141949|NCT00599898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65141950|NCT00599898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65141951|NCT00599898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141952|NCT00599898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65141953|NCT00599898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141954|NCT00599898|Vasodilator Agents|vasodilator agents|mesh-ancestor
65141955|NCT00599898|Tocolytic Agents|tocolytic agents|mesh-ancestor
65141956|NCT00599898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65141957|NCT00599898|Hormone Antagonists|hormone antagonists|mesh-ancestor
65141958|NCT00599898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65141959|NCT00600054|Nimotuzumab|nimotuzumab|mesh-list
65303073|NCT00601523|Dopamine Agonists|dopamine agonists|mesh-ancestor
65303074|NCT00601523|Dopamine Agents|dopamine agents|mesh-ancestor
65303075|NCT00601523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65303076|NCT00466687|Bevacizumab|bevacizumab|mesh-list
65303077|NCT00466687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65303078|NCT00466687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65303079|NCT00466687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303080|NCT00466687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65303081|NCT00466687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65141960|NCT00600054|Antibodies|antibodies|mesh-list
65141961|NCT00600054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65141962|NCT00600054|Immunologic Factors|immunologic factors|mesh-ancestor
65141963|NCT00600054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141964|NCT00600054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65141965|NCT00600054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141966|NCT00600210|Bevacizumab|bevacizumab|mesh-list
65141967|NCT00600210|Carboplatin|carboplatin|mesh-list
65141968|NCT00600210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65141969|NCT00600210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141970|NCT00600210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65141971|NCT00600210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65141972|NCT00600210|Growth Substances|growth substances|mesh-ancestor
65141973|NCT00600210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141974|NCT00600210|Growth Inhibitors|growth inhibitors|mesh-ancestor
65141975|NCT00600366|Insulin Aspart|insulin aspart|mesh-list
65141976|NCT00600366|Biphasic Insulins|biphasic insulins|mesh-list
64496238|NCT01282138|Anticoagulants|anticoagulants|mesh-ancestor
65141988|NCT00600600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141989|NCT00623064|Gemcitabine|gemcitabine|mesh-list
65141990|NCT00623064|Lapatinib|lapatinib|mesh-list
65141991|NCT00623064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141992|NCT00623064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65141993|NCT00623064|Antimetabolites|antimetabolites|mesh-ancestor
65141994|NCT00623064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141995|NCT00623064|Antiviral Agents|antiviral agents|mesh-ancestor
65141996|NCT00623064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65141997|NCT00623064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141998|NCT00623064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65141999|NCT00623064|Immunologic Factors|immunologic factors|mesh-ancestor
65142000|NCT00623064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142001|NCT00623064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65142002|NCT00623220|Nitrous Oxide|nitrous oxide|mesh-list
64675159|NCT01189071|Darifenacin|darifenacin|mesh-list
65142004|NCT00623220|Anesthetics, General|anesthetics, general|mesh-ancestor
65142005|NCT00623220|Anesthetics|anesthetics|mesh-ancestor
65142006|NCT00623220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65142007|NCT00623220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142008|NCT00623220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65142009|NCT00623220|Analgesics|analgesics|mesh-ancestor
65142010|NCT00623220|Sensory System Agents|sensory system agents|mesh-ancestor
65142011|NCT00623220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65142012|NCT00600912|SMOFlipid|smoflipid|mesh-list
65142013|NCT00600912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65142014|NCT00600912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65142015|NCT00600912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65142016|NCT00600990|Vestipitant|vestipitant|mesh-list
65142017|NCT00600990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65142018|NCT00600990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65142019|NCT00600990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142020|NCT00600990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142021|NCT00601302|Amlodipine|amlodipine|mesh-list
65142022|NCT00601302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65142023|NCT00601302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65142024|NCT00601302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65142025|NCT00601302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142026|NCT00601302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65303082|NCT00466687|Growth Substances|growth substances|mesh-ancestor
65303083|NCT00466687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303084|NCT00466687|Growth Inhibitors|growth inhibitors|mesh-ancestor
65303085|NCT00466687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65303086|NCT00466687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303087|NCT00466687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303088|NCT01522768|Paclitaxel|paclitaxel|mesh-list
65303089|NCT01522768|Afatinib|afatinib|mesh-list
65303090|NCT01522768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65303091|NCT01522768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303092|NCT01522768|Tubulin Modulators|tubulin modulators|mesh-ancestor
65303093|NCT01522768|Antimitotic Agents|antimitotic agents|mesh-ancestor
65303094|NCT01522768|Mitosis Modulators|mitosis modulators|mesh-ancestor
65303095|NCT01522768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303096|NCT01522768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65303097|NCT01522768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303098|NCT01759459|Lidocaine|lidocaine|mesh-list
65303099|NCT01759459|Anesthetics, Local|anesthetics, local|mesh-ancestor
65303100|NCT01759459|Anesthetics|anesthetics|mesh-ancestor
65303101|NCT01759459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65052981|NCT00229385|Ziprasidone|ziprasidone|mesh-list
65303103|NCT01759459|Sensory System Agents|sensory system agents|mesh-ancestor
65303104|NCT01759459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65303105|NCT01759459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65142027|NCT00601302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142028|NCT00601302|Vasodilator Agents|vasodilator agents|mesh-ancestor
65142029|NCT00601536|Lithium Carbonate|lithium carbonate|mesh-list
65142030|NCT00601536|Antidepressive Agents|antidepressive agents|mesh-ancestor
65142031|NCT00601536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65142032|NCT00601536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142033|NCT00601536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142034|NCT00601536|Antimanic Agents|antimanic agents|mesh-ancestor
65142035|NCT00601536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65142036|NCT00601536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65142037|NCT00601536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142038|NCT00601614|Temozolomide|temozolomide|mesh-list
65142039|NCT00601614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64496308|NCT05054868|Ketorolac|ketorolac|mesh-list
65142052|NCT00601692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142054|NCT00602004|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65142055|NCT00602004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65142056|NCT00602004|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65142057|NCT00602004|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65142058|NCT00602004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142060|NCT00602082|Streptozocin|streptozocin|mesh-list
65142061|NCT00602082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142062|NCT00602082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65142063|NCT00602082|Antimetabolites|antimetabolites|mesh-ancestor
65142064|NCT00602082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142065|NCT00602082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65303106|NCT01759459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65303107|NCT01759459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65303108|NCT01759459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65303109|NCT01759459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303110|NCT02562742|Ribavirin|ribavirin|mesh-list
65303111|NCT02562742|Antimetabolites|antimetabolites|mesh-ancestor
65303112|NCT02562742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303113|NCT02562742|Antiviral Agents|antiviral agents|mesh-ancestor
65303114|NCT02562742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65303115|NCT00466531|Cyclophosphamide|cyclophosphamide|mesh-list
65303116|NCT00466531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65303117|NCT00466531|Immunologic Factors|immunologic factors|mesh-ancestor
65303118|NCT00466531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303119|NCT00466531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65303120|NCT00466531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64533165|NCT02349204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64533166|NCT02349204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533167|NCT02349204|GABA Modulators|gaba modulators|mesh-ancestor
64533168|NCT02349204|GABA Agents|gaba agents|mesh-ancestor
64533169|NCT02349204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64533170|NCT02349204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533171|NCT02345616|Nitric Oxide|nitric oxide|mesh-list
64533172|NCT02345616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64533173|NCT02345616|Autonomic Agents|autonomic agents|mesh-ancestor
64533174|NCT02345616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65142066|NCT04327752|Dermatologic Agents|dermatologic agents|mesh-list
65142067|NCT01171963|Vaccines|vaccines|mesh-list
65142068|NCT01171963|Immunologic Factors|immunologic factors|mesh-ancestor
65142069|NCT01171963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142070|NCT01171183|Carvedilol|carvedilol|mesh-list
65142071|NCT01171183|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65142072|NCT01171183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65142073|NCT01171183|Adrenergic Agents|adrenergic agents|mesh-ancestor
65142074|NCT01171183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65142075|NCT01171183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142076|NCT01171183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142077|NCT01171183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65142078|NCT01171183|Antioxidants|antioxidants|mesh-ancestor
65142079|NCT01171183|Protective Agents|protective agents|mesh-ancestor
65142080|NCT01171183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65142081|NCT01171183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65142082|NCT01171183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65142083|NCT01171183|Vasodilator Agents|vasodilator agents|mesh-ancestor
65142084|NCT01171183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65142085|NCT01171183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65142086|NCT01169779|Metformin|metformin|mesh-list
65142087|NCT01169779|Lixisenatide|lixisenatide|mesh-list
65303121|NCT00466531|Alkylating Agents|alkylating agents|mesh-ancestor
65303122|NCT00466531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303123|NCT00466531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303124|NCT00466531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65303125|NCT00744016|Mesalamine|mesalamine|mesh-list
65303126|NCT00744016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65303127|NCT00744016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65303128|NCT00744016|Analgesics|analgesics|mesh-ancestor
65303129|NCT00744016|Sensory System Agents|sensory system agents|mesh-ancestor
65303130|NCT00744016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65303131|NCT00744016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303132|NCT00744016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65303133|NCT00744016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65303134|NCT04182737|Immunoglobulins|immunoglobulins|mesh-list
65303135|NCT04182737|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65303136|NCT04182737|Antibodies|antibodies|mesh-list
65303137|NCT04182737|Immunoglobulin M|immunoglobulin m|mesh-list
64533186|NCT00391989|Dasatinib|dasatinib|mesh-list
65142088|NCT01169779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65142089|NCT01169779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142090|NCT01169701|Mycophenolic Acid|mycophenolic acid|mesh-list
65142091|NCT01169701|Everolimus|everolimus|mesh-list
65142092|NCT01169701|Tacrolimus|tacrolimus|mesh-list
65142093|NCT01169701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65142094|NCT01169701|Immunologic Factors|immunologic factors|mesh-ancestor
65142095|NCT01169701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142096|NCT01169701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65142097|NCT01169701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142098|NCT01169701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142099|NCT01169701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142100|NCT01169701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65142107|NCT01167907|Anesthetics|anesthetics|mesh-ancestor
65142108|NCT01167907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65142109|NCT01167907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142110|NCT01167907|Sensory System Agents|sensory system agents|mesh-ancestor
65142111|NCT01167907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65142112|NCT01115491|Bevacizumab|bevacizumab|mesh-list
65142113|NCT01115491|Temozolomide|temozolomide|mesh-list
65142114|NCT01115491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65142115|NCT01115491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142116|NCT01115491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65142117|NCT01115491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65142118|NCT01115491|Growth Substances|growth substances|mesh-ancestor
65142119|NCT01115491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142120|NCT01115491|Growth Inhibitors|growth inhibitors|mesh-ancestor
65142121|NCT01115491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65142122|NCT01115491|Alkylating Agents|alkylating agents|mesh-ancestor
65142123|NCT01115491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142124|NCT01113931|Doxycycline|doxycycline|mesh-list
65142125|NCT01113931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65142126|NCT01113931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65142127|NCT01113931|Antimalarials|antimalarials|mesh-ancestor
65142128|NCT01113931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65142129|NCT01113931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65142130|NCT02881177|Oxytocin|oxytocin|mesh-list
65142131|NCT02881177|Oxytocics|oxytocics|mesh-ancestor
65142132|NCT02881177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65142133|NCT02881177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303138|NCT04182737|Immunoglobulin A|immunoglobulin a|mesh-list
65303139|NCT04182737|Immunologic Factors|immunologic factors|mesh-ancestor
65303140|NCT04182737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303141|NCT04181645|Gemcitabine|gemcitabine|mesh-list
65303142|NCT04181645|Paclitaxel|paclitaxel|mesh-list
65303143|NCT04181645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65303144|NCT04181645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303145|NCT04181645|Tubulin Modulators|tubulin modulators|mesh-ancestor
65303146|NCT04181645|Antimitotic Agents|antimitotic agents|mesh-ancestor
65303147|NCT04181645|Mitosis Modulators|mitosis modulators|mesh-ancestor
65303148|NCT04181645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142134|NCT02880787|Rocuronium|rocuronium|mesh-list
65142135|NCT02880787|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65142136|NCT02880787|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65142137|NCT02880787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65142138|NCT02880787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65142139|NCT02880787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142140|NCT01106677|Metformin|metformin|mesh-list
65142141|NCT01106677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65142142|NCT01106677|Canagliflozin|canagliflozin|mesh-list
65142143|NCT01106677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65142144|NCT01106677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142145|NCT01106677|Incretins|incretins|mesh-ancestor
65142146|NCT01106677|Hormones|hormones|mesh-ancestor
65142147|NCT01106677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65142148|NCT01106677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65142149|NCT01106677|Protease Inhibitors|protease inhibitors|mesh-ancestor
65142150|NCT01106677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142151|NCT01106677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142152|NCT01106677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65142153|NCT04309357|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65142154|NCT04309357|Plasminogen|plasminogen|mesh-list
65142155|NCT04309357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65142156|NCT04309357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65142157|NCT04309357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142158|NCT04985929|Sildenafil Citrate|sildenafil citrate|mesh-list
65142159|NCT04985929|Vasodilator Agents|vasodilator agents|mesh-ancestor
65142160|NCT04985929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65142161|NCT04985929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65142162|NCT04985929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142163|NCT04985929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142164|NCT04985929|Urological Agents|urological agents|mesh-ancestor
65142165|NCT04308343|Methotrexate|methotrexate|mesh-list
65142166|NCT04308343|Letrozole|letrozole|mesh-list
65142167|NCT04308343|Cetrorelix|cetrorelix|mesh-list
65142168|NCT04308343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65142169|NCT04308343|Abortifacient Agents|abortifacient agents|mesh-ancestor
65142179|NCT04308343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65142180|NCT04308343|Immunologic Factors|immunologic factors|mesh-ancestor
65142181|NCT04308343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65142182|NCT04308343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65142183|NCT04308343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65142184|NCT04308343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65142185|NCT04308343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65142186|NCT04308343|Hormone Antagonists|hormone antagonists|mesh-ancestor
65142187|NCT04308343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65142188|NCT04308343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65142189|NCT04308343|Fertility Agents|fertility agents|mesh-ancestor
65142190|NCT01099579|Ritonavir|ritonavir|mesh-list
65142191|NCT01099579|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65142192|NCT01099579|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65142193|NCT01099579|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65142194|NCT01099579|Protease Inhibitors|protease inhibitors|mesh-ancestor
65142195|NCT01099579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303149|NCT04181645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65303150|NCT04181645|Antimetabolites|antimetabolites|mesh-ancestor
65303151|NCT04181645|Antiviral Agents|antiviral agents|mesh-ancestor
65303152|NCT04181645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65303153|NCT04181645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303154|NCT04181645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65303155|NCT04181645|Immunologic Factors|immunologic factors|mesh-ancestor
65303156|NCT04181645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303157|NCT02679833|Vitamin B 12|vitamin b 12|mesh-list
65303158|NCT02679833|Hydroxocobalamin|hydroxocobalamin|mesh-list
65303159|NCT02679833|Vitamin B Complex|vitamin b complex|mesh-ancestor
65303160|NCT02679833|Vitamins|vitamins|mesh-ancestor
65303161|NCT02679833|Micronutrients|micronutrients|mesh-ancestor
65303162|NCT02679833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303163|NCT02679833|Hematinics|hematinics|mesh-ancestor
65303164|NCT00641927|Lithium Carbonate|lithium carbonate|mesh-list
65303165|NCT00641927|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65303166|NCT00641927|Antidepressive Agents|antidepressive agents|mesh-ancestor
65303167|NCT00641927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65303168|NCT00641927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303169|NCT00641927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303170|NCT00641927|Antimanic Agents|antimanic agents|mesh-ancestor
65142196|NCT01099579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142197|NCT01099579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65142198|NCT01099579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65142199|NCT01099579|Antiviral Agents|antiviral agents|mesh-ancestor
65142200|NCT01099579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65142201|NCT01099579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65142202|NCT01099579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65142203|NCT01103713|Azithromycin|azithromycin|mesh-list
65142204|NCT01103713|Chloroquine|chloroquine|mesh-list
65142205|NCT01103713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65142206|NCT01103713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65142207|NCT01103713|Amebicides|amebicides|mesh-ancestor
65142208|NCT01103713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65142209|NCT01103713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65142210|NCT01103713|Antimalarials|antimalarials|mesh-ancestor
65142211|NCT01103713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65142212|NCT01103245|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65142213|NCT01103245|Spironolactone|spironolactone|mesh-list
65142214|NCT01103245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65142215|NCT01103245|Diuretics|diuretics|mesh-ancestor
65142216|NCT01103245|Natriuretic Agents|natriuretic agents|mesh-ancestor
65142217|NCT01103245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142218|NCT01103245|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65142219|NCT01103245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65142220|NCT01103245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142221|NCT01103245|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65142222|NCT01103245|Hormone Antagonists|hormone antagonists|mesh-ancestor
65142223|NCT01103245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65142224|NCT01103245|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65142225|NCT02878837|Midazolam|midazolam|mesh-list
65142226|NCT02878837|Dexmedetomidine|dexmedetomidine|mesh-list
65142227|NCT02878837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65303171|NCT00641927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65303172|NCT00641927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65303173|NCT00641927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303174|NCT00641927|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65053058|NCT00257049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65303175|NCT00641927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65303176|NCT00641927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65303177|NCT00641927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65303178|NCT00641927|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65303179|NCT02677571|Morphine|morphine|mesh-list
65303180|NCT02677571|Levobupivacaine|levobupivacaine|mesh-list
65303181|NCT02677571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65303182|NCT02677571|Narcotics|narcotics|mesh-ancestor
65303183|NCT02677571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65303184|NCT02677571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303185|NCT02677571|Analgesics|analgesics|mesh-ancestor
65142228|NCT02878837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65142229|NCT02878837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142230|NCT02878837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65142231|NCT02878837|Analgesics|analgesics|mesh-ancestor
65142232|NCT02878837|Sensory System Agents|sensory system agents|mesh-ancestor
65142233|NCT02878837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65142242|NCT02878837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65142243|NCT02878837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65142244|NCT02878837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65142245|NCT02878837|Anesthetics, General|anesthetics, general|mesh-ancestor
65142246|NCT02878837|Anesthetics|anesthetics|mesh-ancestor
65142247|NCT02878837|GABA Modulators|gaba modulators|mesh-ancestor
65142248|NCT02878837|GABA Agents|gaba agents|mesh-ancestor
65142249|NCT02880007|Cisplatin|cisplatin|mesh-list
65142250|NCT02880007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142251|NCT04982029|Cannabidiol|cannabidiol|mesh-list
65142252|NCT04982029|Anticonvulsants|anticonvulsants|mesh-ancestor
65142253|NCT02880085|Lidocaine|lidocaine|mesh-list
65142254|NCT02880085|Anesthetics, Local|anesthetics, local|mesh-list
65142255|NCT02880085|Anesthetics|anesthetics|mesh-list
65142256|NCT02880085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65142257|NCT02880085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142258|NCT02880085|Sensory System Agents|sensory system agents|mesh-ancestor
65142259|NCT02880085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65142260|NCT02880085|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65142261|NCT02880085|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65142262|NCT02880085|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65142263|NCT02880085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65142264|NCT02880085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142265|NCT01098097|Ribavirin|ribavirin|mesh-list
65142266|NCT01098097|Antimetabolites|antimetabolites|mesh-ancestor
65142267|NCT01098097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142268|NCT01098097|Antiviral Agents|antiviral agents|mesh-ancestor
65142269|NCT01098097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65142270|NCT04407572|Vitamin D|vitamin d|mesh-list
65142271|NCT04407572|Vitamins|vitamins|mesh-list
65142272|NCT04407572|Vitamin B 12|vitamin b 12|mesh-list
65142273|NCT04407572|Hydroxocobalamin|hydroxocobalamin|mesh-list
65142274|NCT04407572|Micronutrients|micronutrients|mesh-ancestor
65142275|NCT04407572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142276|NCT04407572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65142277|NCT04407572|Vitamin B Complex|vitamin b complex|mesh-ancestor
65142278|NCT04407572|Hematinics|hematinics|mesh-ancestor
65303186|NCT02677571|Sensory System Agents|sensory system agents|mesh-ancestor
65303187|NCT02677571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65303188|NCT02677571|Anesthetics, Local|anesthetics, local|mesh-ancestor
65303189|NCT02677571|Anesthetics|anesthetics|mesh-ancestor
65303190|NCT04181567|S 20098|s 20098|mesh-list
65303191|NCT04181567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65303192|NCT04181567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65303193|NCT04181567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303194|NCT05664191|Simendan|simendan|mesh-list
65303195|NCT05664191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65303196|NCT05664191|Vasodilator Agents|vasodilator agents|mesh-ancestor
65303197|NCT05664191|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65303198|NCT05664191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65303199|NCT05664191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303200|NCT05664191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303201|NCT05664191|Protective Agents|protective agents|mesh-ancestor
65303202|NCT05664191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303203|NCT02676011|Atropine|atropine|mesh-list
65303204|NCT02676011|Succinylcholine|succinylcholine|mesh-list
65303205|NCT02676011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65303206|NCT02676011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65142279|NCT04328636|Magnesium Sulfate|magnesium sulfate|mesh-list
65142280|NCT04328636|Analgesics|analgesics|mesh-ancestor
65142281|NCT04328636|Sensory System Agents|sensory system agents|mesh-ancestor
65142282|NCT04328636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65142283|NCT04328636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142284|NCT04328636|Anesthetics|anesthetics|mesh-ancestor
65142285|NCT04328636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65142286|NCT04328636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65142287|NCT04328636|Anticonvulsants|anticonvulsants|mesh-ancestor
65142288|NCT04328636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65142289|NCT04328636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65142290|NCT04328636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142291|NCT04328636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65142292|NCT04328636|Tocolytic Agents|tocolytic agents|mesh-ancestor
65142293|NCT04328636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65142294|NCT02893826|Nimodipine|nimodipine|mesh-list
65142295|NCT02893826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65142296|NCT02893826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65142297|NCT02893826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65142298|NCT02893826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142299|NCT02893826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64496565|NCT01872611|Analgesics|analgesics|mesh-ancestor
65142317|NCT02893280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65142318|NCT02893280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65142319|NCT02893280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142320|NCT02893280|Antipyretics|antipyretics|mesh-ancestor
65142321|NCT02893280|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65142322|NCT02893280|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65142323|NCT02893280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65142324|NCT02893280|Purinergic Agents|purinergic agents|mesh-ancestor
65142325|NCT02893280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65142326|NCT02893280|Anticoagulants|anticoagulants|mesh-ancestor
65303207|NCT02676011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65303208|NCT02676011|Autonomic Agents|autonomic agents|mesh-ancestor
65303209|NCT02676011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65303210|NCT02676011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303211|NCT02676011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65303212|NCT02676011|Respiratory System Agents|respiratory system agents|mesh-ancestor
65303213|NCT02676011|Mydriatics|mydriatics|mesh-ancestor
65303214|NCT02676011|Parasympatholytics|parasympatholytics|mesh-ancestor
65303215|NCT02676011|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65303216|NCT02676011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65303217|NCT02676011|Cholinergic Agents|cholinergic agents|mesh-ancestor
65303218|NCT02676011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65303219|NCT02676011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303220|NCT02676011|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
65303221|NCT02676011|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65303222|NCT02676011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65303223|NCT05662943|Aflibercept|aflibercept|mesh-list
65303224|NCT05662943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65303225|NCT05662943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65303226|NCT05662943|Growth Substances|growth substances|mesh-ancestor
65303227|NCT05662943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303228|NCT05662943|Growth Inhibitors|growth inhibitors|mesh-ancestor
65303229|NCT05662943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303230|NCT05663255|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65303231|NCT05663255|Azithromycin|azithromycin|mesh-list
65142327|NCT04390802|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65142328|NCT04390802|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65142329|NCT04390802|Dermatologic Agents|dermatologic agents|mesh-ancestor
65142330|NCT04328480|Colchicine|colchicine|mesh-list
65142331|NCT04328480|Gout Suppressants|gout suppressants|mesh-ancestor
65142332|NCT04328480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65142333|NCT04328480|Tubulin Modulators|tubulin modulators|mesh-ancestor
65142334|NCT04328480|Antimitotic Agents|antimitotic agents|mesh-ancestor
65142335|NCT04328480|Mitosis Modulators|mitosis modulators|mesh-ancestor
65142336|NCT04328480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142337|NCT04328480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142338|NCT00592280|Pancrelipase|pancrelipase|mesh-list
65142339|NCT00592280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65142340|NCT02893124|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65142341|NCT02893124|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65142342|NCT02893124|Antiviral Agents|antiviral agents|mesh-ancestor
65142343|NCT02893124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65142344|NCT04348448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65142345|NCT04348448|Immunologic Factors|immunologic factors|mesh-ancestor
65142346|NCT04348448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142347|NCT02892812|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65142348|NCT02892812|Immunologic Factors|immunologic factors|mesh-ancestor
65142349|NCT02892812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142350|NCT00592670|Fluoxetine|fluoxetine|mesh-list
65142351|NCT00592670|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65303232|NCT05663255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65303233|NCT02678975|Copper|copper|mesh-list
65303234|NCT02678975|Temozolomide|temozolomide|mesh-list
65303235|NCT02678975|Lomustine|lomustine|mesh-list
65303236|NCT02678975|Disulfiram|disulfiram|mesh-list
65303237|NCT02678975|Alkylating Agents|alkylating agents|mesh-list
65303238|NCT02678975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65303239|NCT02678975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303240|NCT02678975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303241|NCT02678975|Trace Elements|trace elements|mesh-ancestor
65303242|NCT02678975|Micronutrients|micronutrients|mesh-ancestor
65303243|NCT02678975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303244|NCT02678975|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65303245|NCT02678975|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65303246|NCT02678975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303247|NCT02677415|Anesthetics|anesthetics|mesh-list
65303248|NCT02677415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
65303249|NCT02677415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65303250|NCT02677415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303251|NCT02677415|Anesthetics, General|anesthetics, general|mesh-ancestor
65303252|NCT00454051|Omalizumab|omalizumab|mesh-list
65303253|NCT00454051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65303254|NCT00454051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65303255|NCT00454051|Respiratory System Agents|respiratory system agents|mesh-ancestor
65303256|NCT04181489|Prednisolone|prednisolone|mesh-list
65303257|NCT04181489|Cyclophosphamide|cyclophosphamide|mesh-list
65303258|NCT04181489|Rituximab|rituximab|mesh-list
65303259|NCT04181489|Doxorubicin|doxorubicin|mesh-list
65303260|NCT04181489|Vincristine|vincristine|mesh-list
65303261|NCT04181489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65303262|NCT04181489|Immunologic Factors|immunologic factors|mesh-ancestor
65303263|NCT04181489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303264|NCT04181489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65303276|NCT04181489|Tubulin Modulators|tubulin modulators|mesh-ancestor
65303277|NCT04181489|Antimitotic Agents|antimitotic agents|mesh-ancestor
65303278|NCT04181489|Mitosis Modulators|mitosis modulators|mesh-ancestor
65303279|NCT04181489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65303280|NCT04181489|Glucocorticoids|glucocorticoids|mesh-ancestor
65303281|NCT04181489|Hormones|hormones|mesh-ancestor
65303282|NCT04181489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65303283|NCT04181489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65303284|NCT02537561|Gemcitabine|gemcitabine|mesh-list
65303285|NCT02537561|Cisplatin|cisplatin|mesh-list
65303286|NCT02537561|Talazoparib|talazoparib|mesh-list
65303287|NCT02537561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303288|NCT02537561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65303289|NCT02537561|Antimetabolites|antimetabolites|mesh-ancestor
65142352|NCT00592670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65142353|NCT00592670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65142354|NCT00592670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142355|NCT00592670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65142356|NCT00592670|Serotonin Agents|serotonin agents|mesh-ancestor
65142357|NCT00592670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142368|NCT04327232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142369|NCT04327232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65142371|NCT04327232|Natriuretic Agents|natriuretic agents|mesh-ancestor
65142372|NCT00593060|Sirolimus|sirolimus|mesh-list
65142373|NCT00593060|Cetuximab|cetuximab|mesh-list
65142374|NCT00593060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65142375|NCT00593060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142376|NCT00593060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65142377|NCT00593060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65142378|NCT00593060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65142379|NCT00593060|Antifungal Agents|antifungal agents|mesh-ancestor
65142380|NCT00593060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65142381|NCT00593060|Immunologic Factors|immunologic factors|mesh-ancestor
65142382|NCT00593060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142383|NCT00593138|Methylphenidate|methylphenidate|mesh-list
65142384|NCT00593138|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
65142385|NCT00593138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65142386|NCT00593138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142387|NCT00593138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65142388|NCT00593138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65142389|NCT00593138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65142390|NCT00593138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142391|NCT00593138|Dopamine Agents|dopamine agents|mesh-ancestor
65142392|NCT00593138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65142393|NCT00593294|Drospirenone|drospirenone|mesh-list
65142394|NCT00593294|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65142395|NCT00593294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142396|NCT00593294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65142397|NCT00593294|Hormone Antagonists|hormone antagonists|mesh-ancestor
65142398|NCT00593294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65142399|NCT00593294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65142400|NCT00593294|Diuretics|diuretics|mesh-ancestor
65142401|NCT00593294|Natriuretic Agents|natriuretic agents|mesh-ancestor
65142402|NCT00593294|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65142403|NCT00593294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65142404|NCT00593294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65142405|NCT00593294|Contraceptive Agents|contraceptive agents|mesh-ancestor
65142406|NCT00593294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65142407|NCT00593294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65142408|NCT00593294|Estrogens|estrogens|mesh-ancestor
64533339|NCT00396201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65303290|NCT02537561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303291|NCT02537561|Antiviral Agents|antiviral agents|mesh-ancestor
65303292|NCT02537561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65303293|NCT02537561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303294|NCT02537561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65303295|NCT02537561|Immunologic Factors|immunologic factors|mesh-ancestor
65303296|NCT02537561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303297|NCT02537561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65303298|NCT02676089|Tiotropium Bromide|tiotropium bromide|mesh-list
65303299|NCT02676089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65303300|NCT02676089|Autonomic Agents|autonomic agents|mesh-ancestor
65142409|NCT00593294|Hormones|hormones|mesh-ancestor
65142410|NCT00593996|Vitamin D|vitamin d|mesh-list
65142411|NCT00593996|Ergocalciferols|ergocalciferols|mesh-list
65142412|NCT00593996|Vitamins|vitamins|mesh-ancestor
65142413|NCT00593996|Micronutrients|micronutrients|mesh-ancestor
65142414|NCT00593996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142415|NCT00593996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65142416|NCT00593996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65142417|NCT00594542|Lidocaine|lidocaine|mesh-list
65142418|NCT00594542|Anesthetics, Local|anesthetics, local|mesh-ancestor
65142419|NCT00594542|Anesthetics|anesthetics|mesh-ancestor
65142420|NCT00594542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65142439|NCT00596336|Immunologic Factors|immunologic factors|mesh-ancestor
65142440|NCT00596336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142441|NCT00596336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142442|NCT00596336|Interferon Inducers|interferon inducers|mesh-ancestor
65142443|NCT00596414|Midazolam|midazolam|mesh-list
65142444|NCT00596414|Meperidine|meperidine|mesh-list
65142445|NCT00596414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65142446|NCT00596414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65142447|NCT00596414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65142448|NCT00596414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142449|NCT00596414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65142450|NCT00596414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65142451|NCT00596414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65142452|NCT00596414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65142453|NCT00596414|Anesthetics, General|anesthetics, general|mesh-ancestor
65142454|NCT00596414|Anesthetics|anesthetics|mesh-ancestor
65142455|NCT00596414|GABA Modulators|gaba modulators|mesh-ancestor
65142456|NCT00596414|GABA Agents|gaba agents|mesh-ancestor
65142457|NCT00596414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65142458|NCT00596414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142459|NCT00596414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65142460|NCT00596414|Narcotics|narcotics|mesh-ancestor
65142461|NCT00596414|Analgesics|analgesics|mesh-ancestor
65142462|NCT00596414|Sensory System Agents|sensory system agents|mesh-ancestor
65142463|NCT00596414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65142464|NCT00596648|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65142465|NCT00596648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142466|NCT00596648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65142467|NCT00596648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142468|NCT00596648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142469|NCT00596804|Veltuzumab|veltuzumab|mesh-list
65142470|NCT00596804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142471|NCT00622934|Epoetin Alfa|epoetin alfa|mesh-list
65142472|NCT00622934|Hematinics|hematinics|mesh-ancestor
65142473|NCT00597662|Icodextrin|icodextrin|mesh-list
65142474|NCT00597662|Dialysis Solutions|dialysis solutions|mesh-ancestor
65142475|NCT00597662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65142476|NCT00598052|Citalopram|citalopram|mesh-list
65142477|NCT00598052|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64496767|NCT03434340|Hormones|hormones|mesh-ancestor
65142486|NCT00598052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65142487|NCT04326296|Lenalidomide|lenalidomide|mesh-list
65303301|NCT02676089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65303302|NCT02676089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303303|NCT02676089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65303304|NCT02676089|Respiratory System Agents|respiratory system agents|mesh-ancestor
65303305|NCT02676089|Parasympatholytics|parasympatholytics|mesh-ancestor
65303306|NCT02676089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65303307|NCT02676089|Cholinergic Agents|cholinergic agents|mesh-ancestor
65303308|NCT02676089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65303309|NCT02676089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303310|NCT02679131|Belinostat|belinostat|mesh-list
65303311|NCT02679131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303312|NCT02679131|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65303313|NCT02679131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533352|NCT00360399|Citalopram|citalopram|mesh-list
65142488|NCT04326296|Antibodies|antibodies|mesh-list
65142489|NCT04326296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65142490|NCT04326296|Immunologic Factors|immunologic factors|mesh-ancestor
65142491|NCT04326296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142492|NCT04326296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65142493|NCT04326296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65142494|NCT04326296|Growth Substances|growth substances|mesh-ancestor
65142495|NCT04326296|Growth Inhibitors|growth inhibitors|mesh-ancestor
65142496|NCT04326296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142497|NCT00598676|Sirolimus|sirolimus|mesh-list
65142498|NCT00598676|Everolimus|everolimus|mesh-list
65142499|NCT00598676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142500|NCT00598676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65142501|NCT00598676|Immunologic Factors|immunologic factors|mesh-ancestor
65142502|NCT00598676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142503|NCT00598676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65142504|NCT00598676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65142505|NCT00598676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65142506|NCT00598676|Antifungal Agents|antifungal agents|mesh-ancestor
65142507|NCT00599222|Ranibizumab|ranibizumab|mesh-list
65142508|NCT00599222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65142509|NCT00599222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65142510|NCT00599222|Growth Substances|growth substances|mesh-ancestor
65142511|NCT00599222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142512|NCT00599222|Growth Inhibitors|growth inhibitors|mesh-ancestor
65142513|NCT00599222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142514|NCT00599534|Montelukast|montelukast|mesh-list
65142515|NCT00599534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65142516|NCT00599534|Respiratory System Agents|respiratory system agents|mesh-ancestor
65142517|NCT00599534|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65142518|NCT00599534|Hormone Antagonists|hormone antagonists|mesh-ancestor
65142519|NCT00599534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65142520|NCT00599534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142521|NCT00599534|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65142522|NCT00599534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65142523|NCT00599534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142524|NCT00600158|Lidocaine|lidocaine|mesh-list
65142525|NCT00600158|Hydromorphone|hydromorphone|mesh-list
65142526|NCT00600158|Bupivacaine|bupivacaine|mesh-list
65142527|NCT00600158|Anesthetics, Local|anesthetics, local|mesh-ancestor
65142528|NCT00600158|Anesthetics|anesthetics|mesh-ancestor
65142529|NCT00600158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65142530|NCT00600158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142531|NCT00600158|Sensory System Agents|sensory system agents|mesh-ancestor
65142532|NCT00600158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65142533|NCT00600158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65303314|NCT02679131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303315|NCT00484939|Bevacizumab|bevacizumab|mesh-list
65303316|NCT00484939|Capecitabine|capecitabine|mesh-list
65303317|NCT00484939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65303318|NCT00484939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303319|NCT00484939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65303320|NCT00484939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65303321|NCT00484939|Growth Substances|growth substances|mesh-ancestor
65303322|NCT00484939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303323|NCT00484939|Growth Inhibitors|growth inhibitors|mesh-ancestor
65303324|NCT00484939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65303325|NCT00484939|Antimetabolites|antimetabolites|mesh-ancestor
65303326|NCT00484939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303328|NCT00642161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65303329|NCT00642161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65303330|NCT00642161|Autonomic Agents|autonomic agents|mesh-ancestor
65303331|NCT00642161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65303332|NCT00642161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303333|NCT00642161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65303334|NCT00642161|Respiratory System Agents|respiratory system agents|mesh-ancestor
65303335|NCT00642161|Glucocorticoids|glucocorticoids|mesh-ancestor
65303336|NCT00642161|Hormones|hormones|mesh-ancestor
65303337|NCT00642161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65303338|NCT05663177|Vinorelbine|vinorelbine|mesh-list
65142534|NCT00600158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65142535|NCT00600158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65142536|NCT00600158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65142537|NCT00600158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142538|NCT00600158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65142539|NCT00600158|Narcotics|narcotics|mesh-ancestor
65142540|NCT00600158|Analgesics|analgesics|mesh-ancestor
65142541|NCT04325984|Dexamethasone|dexamethasone|mesh-list
65142542|NCT04325984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65142559|NCT00600548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65142560|NCT00600626|Insulin|insulin|mesh-list
65142561|NCT00600626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65142562|NCT00600626|Insulin Aspart|insulin aspart|mesh-list
65142563|NCT00600626|Insulin, Long-Acting|insulin, long-acting|mesh-list
65142564|NCT00600626|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65142565|NCT00600626|Biphasic Insulins|biphasic insulins|mesh-list
65142566|NCT00600626|Isophane Insulin, Human|isophane insulin, human|mesh-list
65142567|NCT00600626|Insulin, Isophane|insulin, isophane|mesh-list
65142568|NCT00600626|Isophane insulin, beef|isophane insulin, beef|mesh-list
65142569|NCT00600626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65142570|NCT00600626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142571|NCT00623168|Ribavirin|ribavirin|mesh-list
65142572|NCT00623168|Antimetabolites|antimetabolites|mesh-ancestor
65142573|NCT00623168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785102|NCT00577356|Tubulin Modulators|tubulin modulators|mesh-ancestor
65142574|NCT00623168|Antiviral Agents|antiviral agents|mesh-ancestor
65303339|NCT05663177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65303340|NCT05663177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303341|NCT05663177|Tubulin Modulators|tubulin modulators|mesh-ancestor
65303342|NCT05663177|Antimitotic Agents|antimitotic agents|mesh-ancestor
65303343|NCT05663177|Mitosis Modulators|mitosis modulators|mesh-ancestor
65303344|NCT05663177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303345|NCT00642551|Vitamin K 2|vitamin k 2|mesh-list
65303346|NCT00642551|Vitamin K|vitamin k|mesh-list
65303347|NCT00642551|Vitamin MK 7|vitamin mk 7|mesh-list
65303348|NCT00642551|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65303349|NCT00642551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65303350|NCT00642551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303351|NCT00642551|Hemostatics|hemostatics|mesh-ancestor
65303352|NCT00642551|Coagulants|coagulants|mesh-ancestor
65303353|NCT00642551|Vitamins|vitamins|mesh-ancestor
65303354|NCT00642551|Micronutrients|micronutrients|mesh-ancestor
65303355|NCT00642551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533390|NCT00361257|Minocycline|minocycline|mesh-list
65142575|NCT00623168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65142576|NCT00601016|Imiquimod|imiquimod|mesh-list
65142577|NCT00601016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65142578|NCT00601016|Immunologic Factors|immunologic factors|mesh-ancestor
65142579|NCT00601016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142580|NCT00601016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142581|NCT00601016|Interferon Inducers|interferon inducers|mesh-ancestor
65142582|NCT00601328|Calcitriol|calcitriol|mesh-list
65142583|NCT00601328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65142584|NCT00601328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142585|NCT00601328|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65142586|NCT00601328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65142587|NCT00601328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142588|NCT00601328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65142589|NCT00601328|Vitamins|vitamins|mesh-ancestor
65142590|NCT00601328|Micronutrients|micronutrients|mesh-ancestor
65142591|NCT00601328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65142592|NCT00601562|Zidovudine|zidovudine|mesh-list
65142593|NCT00601562|Antimetabolites|antimetabolites|mesh-ancestor
65142594|NCT00601562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142595|NCT00601562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65142596|NCT00601562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65142597|NCT00601562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142598|NCT00601562|Antiviral Agents|antiviral agents|mesh-ancestor
65142599|NCT00601562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65142600|NCT00601562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65142601|NCT00601562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65142634|NCT01096849|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65142635|NCT01096849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65142636|NCT01096849|Renal Agents|renal agents|mesh-ancestor
65142637|NCT01096849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65142638|NCT01096849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65142639|NCT01096849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65142640|NCT01096849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142641|NCT01096849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142642|NCT01096849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496932|NCT00635193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65142648|NCT01324388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65142649|NCT01324388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65142650|NCT01324388|Sympatholytics|sympatholytics|mesh-ancestor
65142651|NCT01324388|Autonomic Agents|autonomic agents|mesh-ancestor
65303356|NCT04181957|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65303357|NCT04181957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65303358|NCT04181957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303359|NCT04181957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65303360|NCT04181957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65303361|NCT04181957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65303362|NCT04181957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303363|NCT04181957|Dopamine Agents|dopamine agents|mesh-ancestor
65303364|NCT04181957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65303365|NCT00643409|Azithromycin|azithromycin|mesh-list
65303366|NCT00643409|Levofloxacin|levofloxacin|mesh-list
65303367|NCT00643409|Ofloxacin|ofloxacin|mesh-list
65303368|NCT00643409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65303369|NCT00643409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65303370|NCT00643409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65303371|NCT00643409|Renal Agents|renal agents|mesh-ancestor
65303372|NCT00643409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65303373|NCT00643409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65303374|NCT00643409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533402|NCT02341638|Aspirin|aspirin|mesh-list
65142652|NCT01324388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65142653|NCT01324388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142654|NCT01324388|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65142655|NCT01324388|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65142656|NCT01324388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65142657|NCT01324388|Adrenergic Agents|adrenergic agents|mesh-ancestor
65142658|NCT01324388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65142659|NCT01324388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142660|NCT01324388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65142661|NCT01324388|Protease Inhibitors|protease inhibitors|mesh-ancestor
65142662|NCT01324388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142663|NCT01324388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65142664|NCT01324388|Protective Agents|protective agents|mesh-ancestor
65142665|NCT01324388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65142666|NCT02878681|Ranibizumab|ranibizumab|mesh-list
65142667|NCT02878681|Aflibercept|aflibercept|mesh-list
65142668|NCT02878681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65142669|NCT02878681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65142670|NCT02878681|Growth Substances|growth substances|mesh-ancestor
65142671|NCT02878681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142672|NCT02878681|Growth Inhibitors|growth inhibitors|mesh-ancestor
65142673|NCT02878681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142674|NCT01324310|Ketoconazole|ketoconazole|mesh-list
65142675|NCT01324310|Romidepsin|romidepsin|mesh-list
65142676|NCT01324310|Antifungal Agents|antifungal agents|mesh-ancestor
65142677|NCT01324310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65142678|NCT01324310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65142679|NCT01324310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65142680|NCT01324310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142681|NCT01324310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142682|NCT01324310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65142683|NCT01324310|Hormone Antagonists|hormone antagonists|mesh-ancestor
65142684|NCT01324310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65303375|NCT00643409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303376|NCT00643409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303377|NCT00643409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65303378|NCT00643409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65303379|NCT04180007|Apatinib|apatinib|mesh-list
65303380|NCT04180007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303381|NCT04180007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65303382|NCT04180007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303383|NCT04180007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303384|NCT02675309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65303385|NCT02675309|Simvastatin|simvastatin|mesh-list
65303386|NCT02675309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65303387|NCT02675309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65303388|NCT02675309|Antimetabolites|antimetabolites|mesh-ancestor
65303389|NCT02675309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303390|NCT02675309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65303391|NCT02675309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65142685|NCT01324310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142686|NCT01324310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65142687|NCT01324310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65142688|NCT01324310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142689|NCT01102231|Cetuximab|cetuximab|mesh-list
65142690|NCT01102231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65142691|NCT01102231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142692|NCT01095835|Interferons|interferons|mesh-list
65142693|NCT01095835|Lamivudine|lamivudine|mesh-list
65142694|NCT01095835|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65142695|NCT01095835|Interferon-alpha|interferon-alpha|mesh-list
65142696|NCT01095835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142697|NCT01095835|Antiviral Agents|antiviral agents|mesh-ancestor
65142698|NCT01095835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65142699|NCT01095835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65142700|NCT01095835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65142701|NCT01095835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142702|NCT01095835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142703|NCT01095835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65142704|NCT01095835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65142705|NCT01095835|Immunologic Factors|immunologic factors|mesh-ancestor
65142706|NCT01095835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142707|NCT04908865|Belimumab|belimumab|mesh-list
65142708|NCT04908865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65142709|NCT04908865|Immunologic Factors|immunologic factors|mesh-ancestor
65142710|NCT04908865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142711|NCT01324232|Quinidine|quinidine|mesh-list
65142723|NCT01324232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65142724|NCT01324232|Antimalarials|antimalarials|mesh-ancestor
65142725|NCT01324232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65142726|NCT01324232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65142727|NCT01324232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65142728|NCT01324232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142729|NCT01324232|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65142730|NCT01324232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65142731|NCT01324232|Cholinergic Agents|cholinergic agents|mesh-ancestor
65142732|NCT01324232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65142733|NCT01324232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65142734|NCT01324232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65303392|NCT02675309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303393|NCT01025245|Remifentanil|remifentanil|mesh-list
65303394|NCT01025245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65303395|NCT01025245|Narcotics|narcotics|mesh-ancestor
65303396|NCT01025245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65303397|NCT01025245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303398|NCT01025245|Analgesics|analgesics|mesh-ancestor
65053285|NCT00199511|Mannitol|mannitol|mesh-list
65303399|NCT01025245|Sensory System Agents|sensory system agents|mesh-ancestor
65303400|NCT01025245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65303401|NCT02677259|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65303402|NCT02677259|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65303403|NCT02677259|Estradiol|estradiol|mesh-list
65142735|NCT01324232|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65142736|NCT01324232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65142738|NCT02878291|Immunologic Factors|immunologic factors|mesh-ancestor
65142739|NCT02878291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142740|NCT01323920|Methotrexate|methotrexate|mesh-list
65142741|NCT01323920|Bortezomib|bortezomib|mesh-list
65142742|NCT01323920|Tacrolimus|tacrolimus|mesh-list
65142743|NCT01323920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65142744|NCT01323920|Abortifacient Agents|abortifacient agents|mesh-ancestor
65142745|NCT01323920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65142746|NCT01323920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142747|NCT01323920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65142748|NCT01323920|Antimetabolites|antimetabolites|mesh-ancestor
65142749|NCT01323920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142750|NCT01323920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142751|NCT01323920|Dermatologic Agents|dermatologic agents|mesh-ancestor
65142752|NCT01323920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142753|NCT01323920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65142754|NCT01323920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65142755|NCT01323920|Immunologic Factors|immunologic factors|mesh-ancestor
65142756|NCT01323920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65142757|NCT01323920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65142758|NCT01323920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65142759|NCT01093885|Ambrisentan|ambrisentan|mesh-list
65142760|NCT01093885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65142761|NCT00597597|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65142762|NCT00597597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142763|NCT00597597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65142764|NCT00597597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142765|NCT00597597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142766|NCT02891967|Z 350|z 350|mesh-list
65142767|NCT02891967|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65142768|NCT02891967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65142769|NCT02891967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142770|NCT02891967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142771|NCT02891967|Hormone Antagonists|hormone antagonists|mesh-ancestor
65142772|NCT02891967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65142773|NCT02891967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142786|NCT00598533|Immunologic Factors|immunologic factors|mesh-ancestor
65142787|NCT00598533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142788|NCT00598533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65142789|NCT00598533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65142790|NCT00598533|Antimetabolites|antimetabolites|mesh-ancestor
65142791|NCT00598533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142792|NCT00598533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65142793|NCT00598533|Antioxidants|antioxidants|mesh-ancestor
65142794|NCT00598533|Protective Agents|protective agents|mesh-ancestor
65142796|NCT00598611|Desloratadine|desloratadine|mesh-list
64785330|NCT00074724|Dobutamine|dobutamine|mesh-list
65303404|NCT02677259|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65303405|NCT02677259|Progesterone|progesterone|mesh-list
65303406|NCT02677259|Estrogens|estrogens|mesh-ancestor
65303407|NCT02677259|Hormones|hormones|mesh-ancestor
65303408|NCT02677259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65303409|NCT02677259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303410|NCT02677259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65303411|NCT02677259|Contraceptive Agents|contraceptive agents|mesh-ancestor
65303412|NCT02677259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65303413|NCT02677259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65303414|NCT02677259|Progestins|progestins|mesh-ancestor
65303415|NCT02675387|Lidocaine|lidocaine|mesh-list
65142797|NCT00598611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65142798|NCT00598611|Cholinergic Agents|cholinergic agents|mesh-ancestor
65142799|NCT00598611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65142800|NCT00598611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142801|NCT00598611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142802|NCT00598611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65142803|NCT00598611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65142804|NCT00598611|Histamine Antagonists|histamine antagonists|mesh-ancestor
65142805|NCT00598611|Histamine Agents|histamine agents|mesh-ancestor
65142806|NCT00598611|Antipruritics|antipruritics|mesh-ancestor
65142807|NCT00598611|Dermatologic Agents|dermatologic agents|mesh-ancestor
65142808|NCT00598611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65142809|NCT00599937|Tretinoin|tretinoin|mesh-list
65142810|NCT00599937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142811|NCT00599937|Keratolytic Agents|keratolytic agents|mesh-ancestor
65142812|NCT00599937|Dermatologic Agents|dermatologic agents|mesh-ancestor
65142813|NCT00600093|Amantadine|amantadine|mesh-list
65142814|NCT00600093|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65142815|NCT00600093|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65142816|NCT00600093|Antiviral Agents|antiviral agents|mesh-ancestor
65142817|NCT00600093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65142818|NCT00600093|Dopamine Agents|dopamine agents|mesh-ancestor
65142819|NCT00600093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65142820|NCT00600093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142821|NCT00600093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142822|NCT00600093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65142823|NCT00600093|Analgesics|analgesics|mesh-ancestor
65142824|NCT00600093|Sensory System Agents|sensory system agents|mesh-ancestor
65142825|NCT00600093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65142826|NCT00600249|Docetaxel|docetaxel|mesh-list
65142827|NCT00600249|Cetuximab|cetuximab|mesh-list
65142828|NCT00600249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142829|NCT00600249|Tubulin Modulators|tubulin modulators|mesh-ancestor
65142830|NCT00600249|Antimitotic Agents|antimitotic agents|mesh-ancestor
65142831|NCT00600249|Mitosis Modulators|mitosis modulators|mesh-ancestor
65142832|NCT00600249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142833|NCT00600249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65142834|NCT00600405|Ibuprofen|ibuprofen|mesh-list
65142835|NCT00600405|Oxycodone|oxycodone|mesh-list
65142836|NCT00600405|Tamsulosin|tamsulosin|mesh-list
65142837|NCT00600405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65142844|NCT00600405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65142845|NCT00600405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65142846|NCT00600405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142847|NCT00600405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142848|NCT00600405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65142849|NCT00600405|Narcotics|narcotics|mesh-ancestor
65142850|NCT00600405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65142851|NCT00600405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65142852|NCT00600405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65142853|NCT00600405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65142854|NCT00600405|Adrenergic Agents|adrenergic agents|mesh-ancestor
65303416|NCT02675387|Anesthetics, Local|anesthetics, local|mesh-ancestor
65303417|NCT02675387|Anesthetics|anesthetics|mesh-ancestor
65303418|NCT02675387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65303419|NCT02675387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303420|NCT02675387|Sensory System Agents|sensory system agents|mesh-ancestor
65303421|NCT02675387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65303422|NCT02675387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65303423|NCT02675387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65303424|NCT02675387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65303425|NCT02675387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65303426|NCT02675387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303427|NCT02678507|Analgesics, Opioid|analgesics, opioid|mesh-list
65303428|NCT02678507|Narcotics|narcotics|mesh-ancestor
64533456|NCT02343666|Immunologic Factors|immunologic factors|mesh-ancestor
65142855|NCT00600405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65142856|NCT00600405|Urological Agents|urological agents|mesh-ancestor
65142857|NCT00600639|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65142858|NCT00600639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65142859|NCT00600639|Prednisolone|prednisolone|mesh-list
65142860|NCT00600639|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65142861|NCT00600639|Methylprednisolone|methylprednisolone|mesh-list
65142862|NCT00600639|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65142863|NCT00600639|Prednisolone acetate|prednisolone acetate|mesh-list
65142864|NCT00600639|Albuterol|albuterol|mesh-list
65142865|NCT00600639|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65142866|NCT00600639|Prednisolone phosphate|prednisolone phosphate|mesh-list
65142867|NCT00600639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65142868|NCT00600639|Antitubercular Agents|antitubercular agents|mesh-ancestor
65142869|NCT00600639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65142870|NCT00600639|Glucocorticoids|glucocorticoids|mesh-ancestor
65142871|NCT00600639|Hormones|hormones|mesh-ancestor
65142872|NCT00600639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65142873|NCT00600639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142874|NCT00600639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65142875|NCT00600639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142876|NCT00600639|Antiemetics|antiemetics|mesh-ancestor
65142877|NCT00600639|Autonomic Agents|autonomic agents|mesh-ancestor
65142878|NCT00600639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65142879|NCT00600639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65142880|NCT00600639|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65142881|NCT00600639|Protective Agents|protective agents|mesh-ancestor
65142882|NCT00600639|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65142883|NCT00600639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65142884|NCT00600639|Respiratory System Agents|respiratory system agents|mesh-ancestor
65142885|NCT00600639|Tocolytic Agents|tocolytic agents|mesh-ancestor
65142886|NCT00600639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65142887|NCT00600639|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65142888|NCT00600639|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65142889|NCT00600639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65142890|NCT00600639|Adrenergic Agents|adrenergic agents|mesh-ancestor
65142891|NCT00600639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65142892|NCT00600639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142893|NCT00600873|Pramipexole|pramipexole|mesh-list
65142894|NCT00600873|Antioxidants|antioxidants|mesh-ancestor
65142895|NCT00600873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142896|NCT00600873|Protective Agents|protective agents|mesh-ancestor
65142897|NCT00600873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142898|NCT00600873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65142899|NCT00600873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65142900|NCT00600873|Dopamine Agonists|dopamine agonists|mesh-ancestor
65303429|NCT02678507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65303430|NCT02678507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303431|NCT02678507|Analgesics|analgesics|mesh-ancestor
65303432|NCT02678507|Sensory System Agents|sensory system agents|mesh-ancestor
65303433|NCT02678507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65303434|NCT00464737|Rotigotine|rotigotine|mesh-list
65303435|NCT00464737|Dopamine Agonists|dopamine agonists|mesh-ancestor
65303436|NCT00464737|Dopamine Agents|dopamine agents|mesh-ancestor
65303437|NCT00464737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65303438|NCT00464737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303439|NCT00464737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303440|NCT05658887|Gabapentin|gabapentin|mesh-list
65303441|NCT05658887|Analgesics|analgesics|mesh-ancestor
65303442|NCT05658887|Sensory System Agents|sensory system agents|mesh-ancestor
65303443|NCT05658887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65142901|NCT00600873|Dopamine Agents|dopamine agents|mesh-ancestor
65142902|NCT00600873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65142903|NCT04325724|Dermatologic Agents|dermatologic agents|mesh-list
65142904|NCT04325490|Hydrocortisone|hydrocortisone|mesh-list
65142905|NCT04325490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65142906|NCT00601575|Lithium Carbonate|lithium carbonate|mesh-list
65142919|NCT00601887|Sensory System Agents|sensory system agents|mesh-ancestor
65142920|NCT00601887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65142921|NCT00601887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142922|NCT00601887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65142923|NCT00601887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65142924|NCT00601887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65142925|NCT00601887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65142926|NCT00601887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142927|NCT00601887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142928|NCT01325493|Ketamine|ketamine|mesh-list
65142929|NCT01325493|Analgesics|analgesics|mesh-ancestor
65142930|NCT01325493|Sensory System Agents|sensory system agents|mesh-ancestor
65142931|NCT01325493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65142932|NCT01325493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142933|NCT01325493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65142934|NCT01325493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65142935|NCT01325493|Anesthetics, General|anesthetics, general|mesh-ancestor
65142936|NCT01325493|Anesthetics|anesthetics|mesh-ancestor
65142937|NCT01325493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65142938|NCT01325493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65142939|NCT01325493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65142940|NCT01325493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65142941|NCT01325493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142942|NCT01325337|Bimatoprost|bimatoprost|mesh-list
65142943|NCT01325337|Minoxidil|minoxidil|mesh-list
65142944|NCT01325337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65142945|NCT01325337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65142946|NCT01325337|Vasodilator Agents|vasodilator agents|mesh-ancestor
64785496|NCT00000246|Flumazenil|flumazenil|mesh-list
65142947|NCT01324947|Pomalidomide|pomalidomide|mesh-list
65142948|NCT01324947|Immunologic Factors|immunologic factors|mesh-ancestor
65142949|NCT01324947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142950|NCT01324947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65142951|NCT01324947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65142952|NCT01324947|Growth Substances|growth substances|mesh-ancestor
65142953|NCT01324947|Growth Inhibitors|growth inhibitors|mesh-ancestor
65142954|NCT01324947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142955|NCT01101841|Paroxetine|paroxetine|mesh-list
65142956|NCT01101841|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65303444|NCT05658887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303445|NCT05658887|Anticonvulsants|anticonvulsants|mesh-ancestor
65303446|NCT05658887|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65303447|NCT05658887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65303448|NCT05658887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65303449|NCT05658887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65303450|NCT05658887|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65303451|NCT05658887|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65303452|NCT05658887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65303453|NCT05658887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303454|NCT05658887|Antimanic Agents|antimanic agents|mesh-ancestor
65303455|NCT02678585|Lidocaine|lidocaine|mesh-list
65303456|NCT02678585|Nalbuphine|nalbuphine|mesh-list
65303457|NCT02678585|Anesthetics, Local|anesthetics, local|mesh-ancestor
65142957|NCT01101841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65142958|NCT01101841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65142959|NCT01101841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142960|NCT01101841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65142962|NCT01101841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142963|NCT01101841|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65142964|NCT01101841|Antidepressive Agents|antidepressive agents|mesh-ancestor
65142965|NCT01101841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65142966|NCT01101841|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65142967|NCT01101841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65142988|NCT01324323|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65142989|NCT01324323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65142990|NCT01324323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65142992|NCT05344963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65142993|NCT05344963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142994|NCT05344963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65142995|NCT05344963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142996|NCT02879227|Cisplatin|cisplatin|mesh-list
65142997|NCT02879227|Oxaliplatin|oxaliplatin|mesh-list
65142998|NCT02879227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142999|NCT01323582|Azithromycin|azithromycin|mesh-list
65143000|NCT01323582|Erythromycin|erythromycin|mesh-list
65143001|NCT01323582|Erythromycin Estolate|erythromycin estolate|mesh-list
65143002|NCT01323582|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65143003|NCT01323582|Erythromycin stearate|erythromycin stearate|mesh-list
65143004|NCT01323582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65143005|NCT01323582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65143006|NCT01323582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65143007|NCT01323582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65143008|NCT01323582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143009|NCT01323582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143010|NCT05367765|Imatinib Mesylate|imatinib mesylate|mesh-list
65143011|NCT05367765|HH-GV-678|hh-gv-678|mesh-list
65143012|NCT05367765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143013|NCT05367765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65143014|NCT05367765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143015|NCT05367765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143016|NCT01323621|Fluticasone|fluticasone|mesh-list
65143017|NCT01323621|Xhance|xhance|mesh-list
65143018|NCT01323621|Albuterol|albuterol|mesh-list
65143019|NCT01323621|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65143020|NCT01323621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65143026|NCT01323621|Respiratory System Agents|respiratory system agents|mesh-ancestor
65143027|NCT01323621|Dermatologic Agents|dermatologic agents|mesh-ancestor
65143028|NCT01323621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65143029|NCT01323621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65303458|NCT02678585|Anesthetics|anesthetics|mesh-ancestor
65303459|NCT02678585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65303460|NCT02678585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303461|NCT02678585|Sensory System Agents|sensory system agents|mesh-ancestor
65303462|NCT02678585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65303463|NCT02678585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65303464|NCT02678585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65303465|NCT02678585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65303466|NCT02678585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65303467|NCT02678585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303468|NCT02678585|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65303469|NCT02678585|Narcotics|narcotics|mesh-ancestor
65303470|NCT02678585|Analgesics|analgesics|mesh-ancestor
65303471|NCT00453349|Moxifloxacin|moxifloxacin|mesh-list
65303472|NCT00453349|Metronidazole|metronidazole|mesh-list
65303473|NCT00453349|Levofloxacin|levofloxacin|mesh-list
65303474|NCT00453349|Ofloxacin|ofloxacin|mesh-list
65303475|NCT00453349|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64533498|NCT02336568|Oxytocin|oxytocin|mesh-list
65143030|NCT01323621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65143031|NCT01323621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65143032|NCT01323621|Adrenergic Agents|adrenergic agents|mesh-ancestor
65143033|NCT01323621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65143034|NCT01323621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143035|NCT01323621|Tocolytic Agents|tocolytic agents|mesh-ancestor
65143036|NCT01323621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65143037|NCT05645289|Alendronate|alendronate|mesh-list
65143038|NCT05645289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65143039|NCT05645289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143040|NCT01320033|Doxycycline|doxycycline|mesh-list
65143041|NCT01320033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65143042|NCT01320033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65143043|NCT01320033|Antimalarials|antimalarials|mesh-ancestor
65143044|NCT01320033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65143045|NCT01320033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65143046|NCT05644743|Gemcitabine|gemcitabine|mesh-list
65143047|NCT05644743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143048|NCT05644743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65143049|NCT05644743|Antimetabolites|antimetabolites|mesh-ancestor
65143050|NCT05644743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143051|NCT05644743|Antiviral Agents|antiviral agents|mesh-ancestor
65143052|NCT05644743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65143053|NCT05644743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143054|NCT05644743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65143055|NCT05644743|Immunologic Factors|immunologic factors|mesh-ancestor
65143056|NCT05644743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143057|NCT01317615|Paclitaxel|paclitaxel|mesh-list
65143058|NCT01317615|Carboplatin|carboplatin|mesh-list
65143059|NCT01317615|Everolimus|everolimus|mesh-list
65143060|NCT01317615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65143061|NCT01317615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143062|NCT01317615|Tubulin Modulators|tubulin modulators|mesh-ancestor
65143063|NCT01317615|Antimitotic Agents|antimitotic agents|mesh-ancestor
65143064|NCT01317615|Mitosis Modulators|mitosis modulators|mesh-ancestor
65143065|NCT01317615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143066|NCT01317615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65143067|NCT01317615|Immunologic Factors|immunologic factors|mesh-ancestor
65303476|NCT00453349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65303477|NCT00453349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65303478|NCT00453349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65303479|NCT00453349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65143068|NCT01317615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143069|NCT01078675|Calcium, Dietary|calcium, dietary|mesh-list
65143070|NCT01078675|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65143071|NCT01078675|Calcium|calcium|mesh-list
65143072|NCT01078675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65143073|NCT01078675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143074|NCT01078675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65143075|NCT01078675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65143076|NCT01078675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65143077|NCT01078675|Antimetabolites|antimetabolites|mesh-ancestor
65143078|NCT01078675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143079|NCT01078675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65143080|NCT01078675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65143081|NCT01078675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143082|NCT01100437|Naltrexone|naltrexone|mesh-list
65143083|NCT01100437|Morphine|morphine|mesh-list
65143084|NCT01100437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65143085|NCT01100437|Narcotics|narcotics|mesh-ancestor
65143086|NCT01100437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65143087|NCT01100437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143088|NCT01100437|Analgesics|analgesics|mesh-ancestor
65143089|NCT01100437|Sensory System Agents|sensory system agents|mesh-ancestor
65143090|NCT01100437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143112|NCT01321710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143113|NCT01321710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143114|NCT01321710|Antipyretics|antipyretics|mesh-ancestor
65143115|NCT01321008|Prednisone|prednisone|mesh-list
65143116|NCT01321008|Cyclophosphamide|cyclophosphamide|mesh-list
65143117|NCT01321008|Doxorubicin|doxorubicin|mesh-list
65143118|NCT01321008|Vincristine|vincristine|mesh-list
65143119|NCT01321008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65143120|NCT01321008|Immunologic Factors|immunologic factors|mesh-ancestor
65143121|NCT01321008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143122|NCT01321008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65143123|NCT01321008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65143124|NCT01321008|Alkylating Agents|alkylating agents|mesh-ancestor
65143125|NCT01321008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143126|NCT01321008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143127|NCT01321008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65143128|NCT01321008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65143129|NCT01321008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65143130|NCT01321008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65143131|NCT01321008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143132|NCT01321008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65143133|NCT01321008|Glucocorticoids|glucocorticoids|mesh-ancestor
65143134|NCT01321008|Hormones|hormones|mesh-ancestor
65143135|NCT01321008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65143136|NCT01321008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65143137|NCT01321008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65143138|NCT01321008|Tubulin Modulators|tubulin modulators|mesh-ancestor
65143139|NCT01321008|Antimitotic Agents|antimitotic agents|mesh-ancestor
65143140|NCT01321008|Mitosis Modulators|mitosis modulators|mesh-ancestor
65143141|NCT01323530|Capecitabine|capecitabine|mesh-list
65143142|NCT01323530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65143143|NCT01323530|Antimetabolites|antimetabolites|mesh-ancestor
65143144|NCT01323530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143145|NCT01323530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143159|NCT01320722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143161|NCT01320722|Gout Suppressants|gout suppressants|mesh-ancestor
65143162|NCT01320722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65143163|NCT01320722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65143164|NCT01320722|Antioxidants|antioxidants|mesh-ancestor
65143165|NCT01320722|Protective Agents|protective agents|mesh-ancestor
65143166|NCT01320722|Uricosuric Agents|uricosuric agents|mesh-ancestor
65143167|NCT01320722|Renal Agents|renal agents|mesh-ancestor
65143168|NCT01313559|Everolimus|everolimus|mesh-list
65143169|NCT01313559|Pasireotide|pasireotide|mesh-list
65303480|NCT00453349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303481|NCT00453349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303482|NCT00453349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303483|NCT00453349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65303484|NCT00453349|Contraceptive Agents|contraceptive agents|mesh-ancestor
64533522|NCT04594746|Amiodarone|amiodarone|mesh-list
65143170|NCT01313559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143171|NCT01313559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65143172|NCT01313559|Immunologic Factors|immunologic factors|mesh-ancestor
65143173|NCT01313559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143174|NCT01313559|Hormones|hormones|mesh-ancestor
65143175|NCT01313559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65143176|NCT05661279|Acetaminophen|acetaminophen|mesh-list
65143177|NCT05661279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65143178|NCT05661279|Analgesics|analgesics|mesh-ancestor
65143179|NCT05661279|Sensory System Agents|sensory system agents|mesh-ancestor
65143180|NCT05661279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143181|NCT05661279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143182|NCT05661279|Antipyretics|antipyretics|mesh-ancestor
65143183|NCT02890875|Ethanol|ethanol|mesh-list
65143185|NCT02890875|Anticoagulants|anticoagulants|mesh-ancestor
65143186|NCT02890875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65143187|NCT02890875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65143188|NCT02890875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143189|NCT02890875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65143190|NCT02890875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65143191|NCT02890875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65143192|NCT02890875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143193|NCT01312467|Metformin|metformin|mesh-list
65143194|NCT01312467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65143195|NCT01312467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143196|NCT01310127|Nepafenac|nepafenac|mesh-list
65143197|NCT01310127|Bromfenac|bromfenac|mesh-list
65143198|NCT01310127|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65143199|NCT01310127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65143200|NCT01310127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65143201|NCT01310127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65143202|NCT01310127|Analgesics|analgesics|mesh-ancestor
65143203|NCT01310127|Sensory System Agents|sensory system agents|mesh-ancestor
65143204|NCT01310127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143205|NCT01310127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143206|NCT01310127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65143207|NCT01310127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65143208|NCT01318902|Dexamethasone|dexamethasone|mesh-list
65143209|NCT01318902|Ixazomib|ixazomib|mesh-list
65143210|NCT01318902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65143211|NCT01318902|Antiemetics|antiemetics|mesh-ancestor
65143212|NCT01318902|Autonomic Agents|autonomic agents|mesh-ancestor
65143221|NCT01318902|Protease Inhibitors|protease inhibitors|mesh-ancestor
65143222|NCT01318902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143223|NCT01318902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143225|NCT01313858|Methotrexate|methotrexate|mesh-list
65143226|NCT01313858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65143227|NCT01313858|Abortifacient Agents|abortifacient agents|mesh-ancestor
65143228|NCT01313858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65143229|NCT01313858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143230|NCT01313858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65143231|NCT01313858|Antimetabolites|antimetabolites|mesh-ancestor
65143232|NCT01313858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143233|NCT01313858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143234|NCT01313858|Dermatologic Agents|dermatologic agents|mesh-ancestor
65143235|NCT01313858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143236|NCT01313858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65143237|NCT01313858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65143238|NCT01313858|Immunologic Factors|immunologic factors|mesh-ancestor
65143239|NCT01313858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65143240|NCT01313858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65143241|NCT01313858|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65143242|NCT01313858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65303485|NCT00453349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65303486|NCT00453349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303487|NCT00453349|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65303488|NCT00453349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65303489|NCT00453349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65303490|NCT00453349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65303491|NCT00453349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65303492|NCT00453349|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65303493|NCT00453349|Renal Agents|renal agents|mesh-ancestor
65303494|NCT00453349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65143243|NCT01313780|Oxycodone|oxycodone|mesh-list
65143244|NCT01313780|Naloxone|naloxone|mesh-list
65143245|NCT01313780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65143246|NCT01313780|Narcotics|narcotics|mesh-ancestor
65143247|NCT01313780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65143248|NCT01313780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143249|NCT01313780|Analgesics|analgesics|mesh-ancestor
65143250|NCT01313780|Sensory System Agents|sensory system agents|mesh-ancestor
65143251|NCT01313780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143252|NCT01313780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65143253|NCT01090453|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65143254|NCT01090453|Immunologic Factors|immunologic factors|mesh-ancestor
65143255|NCT01090453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143256|NCT01170364|Sibutramine|sibutramine|mesh-list
65143257|NCT01170364|Antidepressive Agents|antidepressive agents|mesh-ancestor
65143258|NCT01170364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65143260|NCT01170364|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65143261|NCT01170208|Insulin|insulin|mesh-list
65143262|NCT01170208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65143263|NCT01170208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143264|NCT02891018|Paclitaxel|paclitaxel|mesh-list
65143265|NCT02891018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65143266|NCT02891018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65143267|NCT02891018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143268|NCT02891018|Tubulin Modulators|tubulin modulators|mesh-ancestor
65143269|NCT02891018|Antimitotic Agents|antimitotic agents|mesh-ancestor
65143270|NCT02891018|Mitosis Modulators|mitosis modulators|mesh-ancestor
65143271|NCT02891018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143272|NCT01169350|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65143273|NCT01169350|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65143274|NCT01169350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143275|NCT01169038|Azithromycin|azithromycin|mesh-list
65143276|NCT01169038|Rifampin|rifampin|mesh-list
65143277|NCT01169038|Ethambutol|ethambutol|mesh-list
65143278|NCT01169038|Levofloxacin|levofloxacin|mesh-list
65143279|NCT01169038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65143284|NCT01169038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65143285|NCT01169038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143286|NCT01169038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143287|NCT01169038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65143288|NCT01169038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65143289|NCT01169038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65143290|NCT01169038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65143291|NCT01169038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65143292|NCT01169038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65143293|NCT01169038|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65143294|NCT01169038|Renal Agents|renal agents|mesh-ancestor
65143295|NCT01169038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65143296|NCT01169038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65143297|NCT01169038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143298|NCT01169038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65143299|NCT01169038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65143300|NCT00624754|Budesonide|budesonide|mesh-list
65143301|NCT00624754|Formoterol Fumarate|formoterol fumarate|mesh-list
65303495|NCT00453349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65303496|NCT02675153|Sirolimus|sirolimus|mesh-list
65303497|NCT02675153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65303498|NCT02675153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65303499|NCT02675153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65303500|NCT02675153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303501|NCT02675153|Antifungal Agents|antifungal agents|mesh-ancestor
65303502|NCT02675153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65303503|NCT02675153|Immunologic Factors|immunologic factors|mesh-ancestor
64533535|NCT02790138|Ciprofloxacin|ciprofloxacin|mesh-list
65143302|NCT00624754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65143303|NCT00624754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65143304|NCT00624754|Autonomic Agents|autonomic agents|mesh-ancestor
65143305|NCT00624754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143306|NCT00624754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143307|NCT00624754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65143308|NCT00624754|Respiratory System Agents|respiratory system agents|mesh-ancestor
65143309|NCT00624754|Glucocorticoids|glucocorticoids|mesh-ancestor
65143310|NCT00624754|Hormones|hormones|mesh-ancestor
65143311|NCT00624754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65143312|NCT00624754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65143313|NCT00624754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65143314|NCT00624754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65143315|NCT00624754|Adrenergic Agents|adrenergic agents|mesh-ancestor
65143316|NCT00624754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65143317|NCT00624754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143318|NCT01114828|Tolvaptan|tolvaptan|mesh-list
65143319|NCT01114828|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65143320|NCT01114828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143321|NCT01114828|Natriuretic Agents|natriuretic agents|mesh-ancestor
65143322|NCT01114828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143323|NCT01313312|Botulinum Toxins|botulinum toxins|mesh-list
65143324|NCT01313312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65143325|NCT01313312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65143326|NCT01313312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65143327|NCT01313312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65143328|NCT01313312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143329|NCT01313312|Cholinergic Agents|cholinergic agents|mesh-ancestor
65143330|NCT01313312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65143331|NCT01313312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143332|NCT01313312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65143333|NCT01313312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143334|NCT01114672|Ergocalciferols|ergocalciferols|mesh-list
65143335|NCT01114672|Vitamin D|vitamin d|mesh-list
65143336|NCT01114672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65143337|NCT01114672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143338|NCT01114672|Vitamins|vitamins|mesh-ancestor
65143339|NCT01114672|Micronutrients|micronutrients|mesh-ancestor
65143340|NCT01114672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65143341|NCT01114516|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65143342|NCT01114516|Clindamycin|clindamycin|mesh-list
65143343|NCT01114516|Clindamycin palmitate|clindamycin palmitate|mesh-list
65143344|NCT01114516|Clindamycin phosphate|clindamycin phosphate|mesh-list
65143345|NCT01114516|Cefazolin|cefazolin|mesh-list
65143346|NCT01114516|Indomethacin|indomethacin|mesh-list
65143347|NCT01114516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64497624|NCT00988533|Ivermectin|ivermectin|mesh-list
65143356|NCT01114516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143358|NCT01114516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65143359|NCT01114516|Gout Suppressants|gout suppressants|mesh-ancestor
65143360|NCT01114516|Tocolytic Agents|tocolytic agents|mesh-ancestor
65143361|NCT01114516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65143362|NCT01114516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65143363|NCT01313078|Asparaginase|asparaginase|mesh-list
65143364|NCT01313078|Pegaspargase|pegaspargase|mesh-list
65303504|NCT02675153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303505|NCT04179617|Nicotine|nicotine|mesh-list
65303506|NCT04179617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65303507|NCT04179617|Autonomic Agents|autonomic agents|mesh-ancestor
65303508|NCT04179617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65303509|NCT04179617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143365|NCT01313078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143366|NCT01114360|Melatonin|melatonin|mesh-list
65143367|NCT01114360|Antioxidants|antioxidants|mesh-ancestor
65143368|NCT01114360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143369|NCT01114360|Protective Agents|protective agents|mesh-ancestor
65143370|NCT01114360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143371|NCT01114360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65143372|NCT01310036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65143373|NCT01310036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143374|NCT01310036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65143375|NCT01310036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143376|NCT01310036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143377|NCT01075321|Lenalidomide|lenalidomide|mesh-list
65143378|NCT01075321|Everolimus|everolimus|mesh-list
65143379|NCT01075321|Immunologic Factors|immunologic factors|mesh-ancestor
65143380|NCT01075321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143381|NCT01075321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65143382|NCT01075321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65143383|NCT01075321|Growth Substances|growth substances|mesh-ancestor
65143384|NCT01075321|Growth Inhibitors|growth inhibitors|mesh-ancestor
65143385|NCT01075321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143386|NCT01075321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65143387|NCT01114204|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65143388|NCT01114204|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65143389|NCT01114204|Hematinics|hematinics|mesh-ancestor
65143390|NCT01114204|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65143391|NCT01114204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65143392|NCT01075243|Acetaminophen|acetaminophen|mesh-list
65143393|NCT01075243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65143394|NCT01075243|Analgesics|analgesics|mesh-ancestor
65143395|NCT01075243|Sensory System Agents|sensory system agents|mesh-ancestor
65143396|NCT01075243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143397|NCT01075243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143398|NCT01075243|Antipyretics|antipyretics|mesh-ancestor
65143399|NCT01078441|Dexamethasone|dexamethasone|mesh-list
65143400|NCT01078441|Cyclophosphamide|cyclophosphamide|mesh-list
65143401|NCT01078441|Doxorubicin|doxorubicin|mesh-list
65143402|NCT01078441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65143403|NCT01078441|Bortezomib|bortezomib|mesh-list
65143404|NCT01078441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65143405|NCT01078441|Immunologic Factors|immunologic factors|mesh-ancestor
65143406|NCT01078441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143407|NCT01078441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65143408|NCT01078441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65143409|NCT01078441|Alkylating Agents|alkylating agents|mesh-ancestor
65143410|NCT01078441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143411|NCT01078441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143412|NCT01078441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65143413|NCT01078441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65143420|NCT01078441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65143421|NCT01078441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65143422|NCT01078441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65143423|NCT01078441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65143424|NCT01078441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65143425|NCT01078441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143426|NCT05644184|Vaccines|vaccines|mesh-list
65143427|NCT05644184|Immunologic Factors|immunologic factors|mesh-ancestor
65143428|NCT05644184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143429|NCT00626665|Tadalafil|tadalafil|mesh-list
65143430|NCT00626665|Vasodilator Agents|vasodilator agents|mesh-ancestor
65143431|NCT00626665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65143432|NCT00626665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65143433|NCT00626665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303510|NCT04179617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65303511|NCT04179617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65303512|NCT04179617|Cholinergic Agents|cholinergic agents|mesh-ancestor
65303513|NCT04179617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65303514|NCT04179617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303515|NCT00464269|Brivaracetam|brivaracetam|mesh-list
65143434|NCT00626665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143435|NCT00626665|Urological Agents|urological agents|mesh-ancestor
65143436|NCT01090063|Ustekinumab|ustekinumab|mesh-list
65143437|NCT01090063|Dermatologic Agents|dermatologic agents|mesh-ancestor
65143438|NCT01306214|Empagliflozin|empagliflozin|mesh-list
65143439|NCT01306214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65143440|NCT01306214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143441|NCT01306214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65143442|NCT01306214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143443|NCT00623402|Interferons|interferons|mesh-list
65143444|NCT00623402|Sorafenib|sorafenib|mesh-list
65143445|NCT00623402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143446|NCT00623402|Antiviral Agents|antiviral agents|mesh-ancestor
65143447|NCT00623402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65143448|NCT00623402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65143449|NCT00623402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143450|NCT00623402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143451|NCT01077739|Leucovorin|leucovorin|mesh-list
65143452|NCT01077739|Bevacizumab|bevacizumab|mesh-list
65143453|NCT01077739|Fluorouracil|fluorouracil|mesh-list
65143454|NCT01077739|Capecitabine|capecitabine|mesh-list
65143455|NCT01077739|Oxaliplatin|oxaliplatin|mesh-list
65143456|NCT01077739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65143457|NCT01077739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143458|NCT01077739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65143459|NCT01077739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65143460|NCT01077739|Growth Substances|growth substances|mesh-ancestor
65143461|NCT01077739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143462|NCT01077739|Growth Inhibitors|growth inhibitors|mesh-ancestor
65143463|NCT01077739|Antimetabolites|antimetabolites|mesh-ancestor
65143464|NCT01077739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143465|NCT01077739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65143466|NCT01077739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65143467|NCT01077739|Immunologic Factors|immunologic factors|mesh-ancestor
65143468|NCT01077739|Antidotes|antidotes|mesh-ancestor
65143469|NCT01077739|Protective Agents|protective agents|mesh-ancestor
65143470|NCT01077739|Vitamin B Complex|vitamin b complex|mesh-ancestor
65143471|NCT01077739|Vitamins|vitamins|mesh-ancestor
65143472|NCT01077739|Micronutrients|micronutrients|mesh-ancestor
65143473|NCT01306058|Sorafenib|sorafenib|mesh-list
65143474|NCT01306058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143475|NCT01306058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65143476|NCT01306058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143477|NCT01306058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143478|NCT00626509|Sunitinib|sunitinib|mesh-list
65143479|NCT00626509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143480|NCT00626509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65143481|NCT00626509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65143482|NCT00626509|Growth Substances|growth substances|mesh-ancestor
65143483|NCT00626509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143484|NCT00626509|Growth Inhibitors|growth inhibitors|mesh-ancestor
65143487|NCT00626509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143488|NCT02877901|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65143489|NCT02877901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65143490|NCT02877901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65143491|NCT02877901|Cholinergic Agents|cholinergic agents|mesh-ancestor
65143492|NCT02877901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65143493|NCT02877901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143494|NCT02877901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143495|NCT02877901|Urological Agents|urological agents|mesh-ancestor
65143496|NCT04306159|Anesthetics|anesthetics|mesh-list
65143497|NCT04306159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65143498|NCT04306159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303516|NCT00464269|Anticonvulsants|anticonvulsants|mesh-ancestor
65303517|NCT00642863|Vitamin D|vitamin d|mesh-list
65303518|NCT00642863|Vitamins|vitamins|mesh-list
65303519|NCT00642863|Vitamin A|vitamin a|mesh-list
65303520|NCT00642863|Retinol palmitate|retinol palmitate|mesh-list
65303521|NCT00642863|Micronutrients|micronutrients|mesh-ancestor
65303522|NCT00642863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303523|NCT00642863|Antioxidants|antioxidants|mesh-ancestor
65143499|NCT01305200|Calcium|calcium|mesh-list
65143500|NCT01305200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65143501|NCT01305200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143502|NCT01304498|Vaccines|vaccines|mesh-list
65143503|NCT01304498|Immunologic Factors|immunologic factors|mesh-ancestor
65143504|NCT01304498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143505|NCT01074931|Ritonavir|ritonavir|mesh-list
65143506|NCT01074931|Lopinavir|lopinavir|mesh-list
65143507|NCT01074931|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65143508|NCT01074931|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65143509|NCT01074931|Protease Inhibitors|protease inhibitors|mesh-ancestor
65143510|NCT01074931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143511|NCT01074931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143512|NCT01074931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65143513|NCT01074931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65143514|NCT01074931|Antiviral Agents|antiviral agents|mesh-ancestor
65143515|NCT01074931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65143516|NCT01074931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65143517|NCT01074931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65143518|NCT04774159|Colchicine|colchicine|mesh-list
65143519|NCT04774159|Gout Suppressants|gout suppressants|mesh-ancestor
65143520|NCT04774159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65143521|NCT04774159|Tubulin Modulators|tubulin modulators|mesh-ancestor
65143522|NCT04774159|Antimitotic Agents|antimitotic agents|mesh-ancestor
65143523|NCT04774159|Mitosis Modulators|mitosis modulators|mesh-ancestor
65143524|NCT04774159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143525|NCT04774159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143526|NCT01303172|Gemcitabine|gemcitabine|mesh-list
65143527|NCT01303172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65143528|NCT01303172|Antimetabolites|antimetabolites|mesh-ancestor
65143529|NCT01303172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143530|NCT01303172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143531|NCT01303172|Antiviral Agents|antiviral agents|mesh-ancestor
65143532|NCT01303172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65143533|NCT01303172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143534|NCT01303172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65143535|NCT01303172|Immunologic Factors|immunologic factors|mesh-ancestor
65143536|NCT01303172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143537|NCT01302938|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65143538|NCT01302938|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65143539|NCT01302938|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65143540|NCT01302938|Cholinergic Agents|cholinergic agents|mesh-ancestor
65143541|NCT01302938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65143542|NCT01302938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143543|NCT01302938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143544|NCT01302938|Urological Agents|urological agents|mesh-ancestor
65143545|NCT01076647|Insulin|insulin|mesh-list
65143546|NCT01076647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65143547|NCT01076647|Insulin Glargine|insulin glargine|mesh-list
65143548|NCT01076647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65143549|NCT01076647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143550|NCT04306081|Evolocumab|evolocumab|mesh-list
64786058|NCT00000960|Zidovudine|zidovudine|mesh-list
65143551|NCT04306081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65143552|NCT04306081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65143553|NCT04306081|Antimetabolites|antimetabolites|mesh-ancestor
65143554|NCT04306081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143555|NCT04306081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65143556|NCT01074307|Bisoprolol|bisoprolol|mesh-list
65143568|NCT01076335|Docetaxel|docetaxel|mesh-list
65143569|NCT01076335|Leuprolide|leuprolide|mesh-list
65143570|NCT01076335|Goserelin|goserelin|mesh-list
65143571|NCT01076335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143572|NCT01076335|Tubulin Modulators|tubulin modulators|mesh-ancestor
65303524|NCT00642863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303525|NCT00642863|Protective Agents|protective agents|mesh-ancestor
65303526|NCT00642863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65303527|NCT00642863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303528|NCT00642863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65303529|NCT02674997|Factor VIII|factor viii|mesh-list
65143573|NCT01076335|Antimitotic Agents|antimitotic agents|mesh-ancestor
65143574|NCT01076335|Mitosis Modulators|mitosis modulators|mesh-ancestor
65143575|NCT01076335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143576|NCT01076335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65143577|NCT01076335|Fertility Agents|fertility agents|mesh-ancestor
65143578|NCT01076335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65143579|NCT01076335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143580|NCT01076335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65143581|NCT01309737|Tofacitinib|tofacitinib|mesh-list
65143582|NCT01309737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65143583|NCT01309737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143584|NCT01309737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143585|NCT01074229|Ropivacaine|ropivacaine|mesh-list
65143586|NCT01074229|Anesthetics, Local|anesthetics, local|mesh-ancestor
65143587|NCT01074229|Anesthetics|anesthetics|mesh-ancestor
65143588|NCT01074229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65143589|NCT01074229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143590|NCT01074229|Sensory System Agents|sensory system agents|mesh-ancestor
65143591|NCT01074229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143592|NCT01106014|Selexipag|selexipag|mesh-list
65143593|NCT01106014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65143594|NCT01105936|Acetaminophen|acetaminophen|mesh-list
65143595|NCT01105936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65143596|NCT01105936|Analgesics|analgesics|mesh-ancestor
65143597|NCT01105936|Sensory System Agents|sensory system agents|mesh-ancestor
65143598|NCT01105936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143599|NCT01105936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143600|NCT01105936|Antipyretics|antipyretics|mesh-ancestor
65143601|NCT01309659|Iron|iron|mesh-list
65143602|NCT01309659|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65143603|NCT01309659|Trace Elements|trace elements|mesh-ancestor
65143604|NCT01309659|Micronutrients|micronutrients|mesh-ancestor
65143605|NCT01309659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143606|NCT01309659|Hematinics|hematinics|mesh-ancestor
65143607|NCT04989166|Curcumin|curcumin|mesh-list
65143608|NCT04989166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65143609|NCT04989166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65143610|NCT04989166|Analgesics|analgesics|mesh-ancestor
65143611|NCT04989166|Sensory System Agents|sensory system agents|mesh-ancestor
65143612|NCT04989166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143613|NCT04989166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143614|NCT04989166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65143615|NCT04989166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65143616|NCT04989166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143617|NCT04989166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143618|NCT04989166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143619|NCT05320705|Dexmedetomidine|dexmedetomidine|mesh-list
64497911|NCT03393741|Taxane|taxane|mesh-list
65143630|NCT05320705|Adrenergic Agents|adrenergic agents|mesh-ancestor
65143631|NCT05320705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65143632|NCT05320705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143633|NCT04746235|Decitabine|decitabine|mesh-list
65143634|NCT04746235|Venetoclax|venetoclax|mesh-list
65143635|NCT04746235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65143636|NCT04746235|Antimetabolites|antimetabolites|mesh-ancestor
65143637|NCT04746235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143638|NCT04746235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143639|NCT04746235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143640|NCT01104766|Aripiprazole|aripiprazole|mesh-list
65143641|NCT01104766|Cariprazine|cariprazine|mesh-list
65143642|NCT01104766|Antidepressive Agents|antidepressive agents|mesh-ancestor
65143643|NCT01104766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65143644|NCT01104766|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65143645|NCT01104766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65303530|NCT02674997|Coagulants|coagulants|mesh-ancestor
65303531|NCT04178291|Erythritol|erythritol|mesh-list
65303532|NCT04178291|Vasodilator Agents|vasodilator agents|mesh-ancestor
65303533|NCT05372315|Dexamethasone|dexamethasone|mesh-list
65303534|NCT05372315|Dexamethasone acetate|dexamethasone acetate|mesh-list
65303535|NCT05372315|BB 1101|bb 1101|mesh-list
65303536|NCT05372315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65303537|NCT05372315|Antiemetics|antiemetics|mesh-ancestor
65303538|NCT05372315|Autonomic Agents|autonomic agents|mesh-ancestor
65303539|NCT05372315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65303540|NCT05372315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303541|NCT05372315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65303542|NCT05372315|Glucocorticoids|glucocorticoids|mesh-ancestor
65303543|NCT05372315|Hormones|hormones|mesh-ancestor
65303544|NCT05372315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65303545|NCT05372315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65303546|NCT05372315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303547|NCT05372315|Protease Inhibitors|protease inhibitors|mesh-ancestor
65303548|NCT05372315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494081|NCT03701763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65053439|NCT00410306|Hormones|hormones|mesh-ancestor
64533563|NCT02339844|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65143646|NCT01104766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65143647|NCT01104766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143648|NCT01104766|Dopamine Agonists|dopamine agonists|mesh-ancestor
65143649|NCT01104766|Dopamine Agents|dopamine agents|mesh-ancestor
65143650|NCT01104766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65143651|NCT01104766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143652|NCT01104766|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65143653|NCT01104766|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65143654|NCT01104766|Serotonin Agents|serotonin agents|mesh-ancestor
65143655|NCT01104766|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65143656|NCT01104766|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65143657|NCT01104766|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65143658|NCT01104766|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65143659|NCT02880280|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65143660|NCT02880280|Menotropins|menotropins|mesh-list
65143661|NCT02880280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65143662|NCT02880280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143663|NCT02880280|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65143664|NCT02880280|Fertility Agents|fertility agents|mesh-ancestor
65143665|NCT04862455|Pembrolizumab|pembrolizumab|mesh-list
65143666|NCT04862455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65143667|NCT04862455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143668|NCT01104376|Efavirenz|efavirenz|mesh-list
65143669|NCT01104376|Voriconazole|voriconazole|mesh-list
65143670|NCT01104376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65143671|NCT01104376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65143672|NCT01104376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143673|NCT01104376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143674|NCT01104376|Antiviral Agents|antiviral agents|mesh-ancestor
65143675|NCT01104376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65143676|NCT01104376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65303549|NCT05372315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303550|NCT00643643|Maraviroc|maraviroc|mesh-list
65303551|NCT00643643|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65303552|NCT00643643|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65303553|NCT00643643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303554|NCT00643643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65303555|NCT00643643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65303556|NCT00643643|Antiviral Agents|antiviral agents|mesh-ancestor
65303557|NCT00643643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65303558|NCT00643643|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65303559|NCT02676869|Pembrolizumab|pembrolizumab|mesh-list
65303560|NCT02676869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65303561|NCT02676869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303562|NCT02673047|Botulinum Toxins|botulinum toxins|mesh-list
65303563|NCT02673047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65303564|NCT02673047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65303565|NCT02673047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65303566|NCT02673047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65303567|NCT02673047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303568|NCT02673047|Cholinergic Agents|cholinergic agents|mesh-ancestor
65303569|NCT02673047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65303570|NCT02673047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303571|NCT02673047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65303572|NCT02673047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65303573|NCT05584319|Empagliflozin|empagliflozin|mesh-list
64464875|NCT05603884|Cytarabine|cytarabine|mesh-list
65143677|NCT01104376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65143678|NCT01104376|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65143679|NCT01104376|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65143680|NCT01104376|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65143689|NCT02875873|Methamphetamine|methamphetamine|mesh-list
65143690|NCT02875873|Plasma-lyte 148|plasma-lyte 148|mesh-list
65143691|NCT02875873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65143692|NCT02875873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143693|NCT02875873|Sympathomimetics|sympathomimetics|mesh-ancestor
65143694|NCT02875873|Autonomic Agents|autonomic agents|mesh-ancestor
65143695|NCT02875873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143696|NCT02875873|Dopamine Agents|dopamine agents|mesh-ancestor
65143697|NCT02875873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65143698|NCT02875873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143700|NCT02875873|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65143701|NCT02875873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65143702|NCT02875873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65143703|NCT02875873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65143705|NCT02875873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65143706|NCT01072357|Bevacizumab|bevacizumab|mesh-list
65143707|NCT01072357|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65303574|NCT05584319|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65303575|NCT05584319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303576|NCT05584319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65303577|NCT05584319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303578|NCT02676323|Leucovorin|leucovorin|mesh-list
65303579|NCT02676323|Cytarabine|cytarabine|mesh-list
65303580|NCT02676323|Hydrocortisone|hydrocortisone|mesh-list
65303581|NCT02676323|Methotrexate|methotrexate|mesh-list
65303582|NCT02676323|Fludarabine phosphate|fludarabine phosphate|mesh-list
65303583|NCT02676323|Fludarabine|fludarabine|mesh-list
65303584|NCT02676323|Panobinostat|panobinostat|mesh-list
65303585|NCT02676323|Levoleucovorin|levoleucovorin|mesh-list
64533610|NCT02339142|Prednisolone acetate|prednisolone acetate|mesh-list
65143708|NCT01072357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65143709|NCT01072357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143710|NCT01072357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65143711|NCT01072357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65143712|NCT01072357|Growth Substances|growth substances|mesh-ancestor
65143713|NCT01072357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143714|NCT01072357|Growth Inhibitors|growth inhibitors|mesh-ancestor
65143715|NCT01072357|Laxatives|laxatives|mesh-ancestor
65143716|NCT01072357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65143718|NCT01072201|Fluorides|fluorides|mesh-list
65143719|NCT01072201|Cariostatic Agents|cariostatic agents|mesh-ancestor
65143720|NCT01072201|Protective Agents|protective agents|mesh-ancestor
65143721|NCT01072201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143722|NCT01072201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65143723|NCT01072201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65143724|NCT01072201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65143725|NCT01072201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65143726|NCT01072201|Antimetabolites|antimetabolites|mesh-ancestor
65143727|NCT01072201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143728|NCT01072201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65143729|NCT02893709|Omeprazole|omeprazole|mesh-list
65143730|NCT02893709|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65143731|NCT02893709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65143732|NCT02893709|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65143733|NCT02893709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143734|NCT02893709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143735|NCT04972396|Metformin|metformin|mesh-list
65143736|NCT04972396|Digoxin|digoxin|mesh-list
65143737|NCT04972396|Warfarin|warfarin|mesh-list
65143738|NCT04972396|Atorvastatin|atorvastatin|mesh-list
65143739|NCT04972396|Levonorgestrel|levonorgestrel|mesh-list
65143740|NCT04972396|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65143741|NCT04972396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65143742|NCT04972396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143743|NCT04972396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65143744|NCT04972396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65143745|NCT04972396|Antimetabolites|antimetabolites|mesh-ancestor
65143746|NCT04972396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498037|NCT00981747|Losartan|losartan|mesh-list
65143758|NCT04972396|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65143759|NCT04972396|Protective Agents|protective agents|mesh-ancestor
65143760|NCT04972396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65143761|NCT04972396|Estrogens|estrogens|mesh-ancestor
65143762|NCT04972396|Hormones|hormones|mesh-ancestor
65143763|NCT04972396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65143764|NCT01089361|Ketamine|ketamine|mesh-list
65143765|NCT01089361|Analgesics|analgesics|mesh-ancestor
65143766|NCT01089361|Sensory System Agents|sensory system agents|mesh-ancestor
65143767|NCT01089361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143768|NCT01089361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143769|NCT01089361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65143770|NCT01089361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65303586|NCT02676323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303587|NCT02676323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65303588|NCT02676323|Abortifacient Agents|abortifacient agents|mesh-ancestor
65303589|NCT02676323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65303590|NCT02676323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65303591|NCT02676323|Antimetabolites|antimetabolites|mesh-ancestor
65303592|NCT02676323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303593|NCT02676323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303594|NCT02676323|Dermatologic Agents|dermatologic agents|mesh-ancestor
65143771|NCT01089361|Anesthetics, General|anesthetics, general|mesh-ancestor
65143772|NCT01089361|Anesthetics|anesthetics|mesh-ancestor
65143773|NCT01089361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65143774|NCT01089361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65143775|NCT01089361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65143776|NCT01089361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65143777|NCT01089361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714033|NCT02812771|Antifungal Agents|antifungal agents|mesh-ancestor
65143778|NCT01102972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65143780|NCT01102972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65143781|NCT01102972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65143783|NCT01102972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143784|NCT01102972|Antiviral Agents|antiviral agents|mesh-ancestor
65143785|NCT01102972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65143786|NCT01102972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65143787|NCT01102972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65143788|NCT01102972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65143789|NCT01102972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65143790|NCT01102972|Protease Inhibitors|protease inhibitors|mesh-ancestor
65143791|NCT04328753|Chlorhexidine|chlorhexidine|mesh-list
65143792|NCT04328753|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65143793|NCT04328753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65143794|NCT04328753|Disinfectants|disinfectants|mesh-ancestor
65143795|NCT02893553|Midodrine|midodrine|mesh-list
65143796|NCT02893553|Bromides|bromides|mesh-list
65143797|NCT02893553|Mirabegron|mirabegron|mesh-list
65143798|NCT02893553|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
65143799|NCT02893553|Anticonvulsants|anticonvulsants|mesh-ancestor
65143800|NCT02893553|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65143801|NCT02893553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65143802|NCT02893553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65143803|NCT02893553|Adrenergic Agents|adrenergic agents|mesh-ancestor
65143804|NCT02893553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65143805|NCT02893553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143806|NCT02893553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143807|NCT02893553|Urological Agents|urological agents|mesh-ancestor
65143808|NCT02893553|Sympathomimetics|sympathomimetics|mesh-ancestor
64498103|NCT03009526|Artenimol|artenimol|mesh-list
65143818|NCT01087489|Anesthetics, Local|anesthetics, local|mesh-ancestor
65143819|NCT01087489|Anesthetics|anesthetics|mesh-ancestor
65143820|NCT01087489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65143821|NCT01087489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143822|NCT01087489|Sensory System Agents|sensory system agents|mesh-ancestor
65143823|NCT01087489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143824|NCT01087489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65143825|NCT01087489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65143826|NCT01087489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65143827|NCT01087489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65143828|NCT01087489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143829|NCT04306627|Amlodipine|amlodipine|mesh-list
65143830|NCT04306627|Perindopril|perindopril|mesh-list
65143831|NCT04306627|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
65143832|NCT04306627|Atorvastatin|atorvastatin|mesh-list
65143833|NCT04306627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65303595|NCT02676323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303596|NCT02676323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65303597|NCT02676323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65303598|NCT02676323|Immunologic Factors|immunologic factors|mesh-ancestor
65303599|NCT02676323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65303600|NCT02676323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64533632|NCT02330952|Prednisone|prednisone|mesh-list
65143834|NCT04306627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65143835|NCT04306627|Antimetabolites|antimetabolites|mesh-ancestor
65143836|NCT04306627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143837|NCT04306627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65143838|NCT04306627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65143839|NCT04306627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143840|NCT04306627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65143841|NCT04306627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65143842|NCT04306627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65143843|NCT04306627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65143844|NCT04306627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143845|NCT04306627|Vasodilator Agents|vasodilator agents|mesh-ancestor
65143846|NCT04306627|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65143847|NCT04306627|Protease Inhibitors|protease inhibitors|mesh-ancestor
65143848|NCT04306471|Evolocumab|evolocumab|mesh-list
65143849|NCT04306471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65143850|NCT04306471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65143851|NCT04306471|Antimetabolites|antimetabolites|mesh-ancestor
65143852|NCT04306471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143853|NCT04306471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65143854|NCT04296253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65143856|NCT04296253|Mitosis Modulators|mitosis modulators|mesh-ancestor
65143857|NCT04296253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143858|NCT01082965|Donepezil|donepezil|mesh-list
65143859|NCT01082965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65143860|NCT01082965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143861|NCT01082965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143862|NCT01082965|Cholinergic Agents|cholinergic agents|mesh-ancestor
65143863|NCT01082965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65143864|NCT01082965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143865|NCT01082965|Nootropic Agents|nootropic agents|mesh-ancestor
65143866|NCT01102426|Dexamethasone|dexamethasone|mesh-list
65143867|NCT01102426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65143868|NCT01102426|Antiemetics|antiemetics|mesh-ancestor
65143869|NCT01102426|Autonomic Agents|autonomic agents|mesh-ancestor
65143870|NCT01102426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143871|NCT01102426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143872|NCT01102426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65143873|NCT01102426|Glucocorticoids|glucocorticoids|mesh-ancestor
65143887|NCT01101334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143888|NCT01101334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143889|NCT01327547|Maraviroc|maraviroc|mesh-list
65143890|NCT01327547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65143891|NCT01327547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65143892|NCT01327547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143893|NCT01327547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65143894|NCT01327547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65143895|NCT01327547|Antiviral Agents|antiviral agents|mesh-ancestor
65143896|NCT01327547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65143897|NCT01327547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65143898|NCT01308567|Prednisone|prednisone|mesh-list
65143899|NCT01308567|Docetaxel|docetaxel|mesh-list
65143900|NCT01308567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143901|NCT01308567|Tubulin Modulators|tubulin modulators|mesh-ancestor
65143902|NCT01308567|Antimitotic Agents|antimitotic agents|mesh-ancestor
65143903|NCT01308567|Mitosis Modulators|mitosis modulators|mesh-ancestor
65143904|NCT01308567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143905|NCT01308567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65143906|NCT01308567|Glucocorticoids|glucocorticoids|mesh-ancestor
65143907|NCT01308567|Hormones|hormones|mesh-ancestor
65303601|NCT02676323|Antiviral Agents|antiviral agents|mesh-ancestor
65303602|NCT02676323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65303603|NCT02676323|Antidotes|antidotes|mesh-ancestor
65303604|NCT02676323|Protective Agents|protective agents|mesh-ancestor
65303605|NCT02676323|Vitamin B Complex|vitamin b complex|mesh-ancestor
65303606|NCT02676323|Vitamins|vitamins|mesh-ancestor
65303607|NCT02676323|Micronutrients|micronutrients|mesh-ancestor
65303608|NCT02676323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65303609|NCT02676323|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65303610|NCT00643799|Celecoxib|celecoxib|mesh-list
65303611|NCT00643799|Naproxen|naproxen|mesh-list
65303612|NCT00643799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65303613|NCT00643799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65303614|NCT00643799|Analgesics|analgesics|mesh-ancestor
65303615|NCT00643799|Sensory System Agents|sensory system agents|mesh-ancestor
65303616|NCT00643799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65303617|NCT00643799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143908|NCT01308567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65143909|NCT01308567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143910|NCT01308567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65143911|NCT00592241|Insulin|insulin|mesh-list
65143912|NCT00592241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65143913|NCT00592241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65143914|NCT00592241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143915|NCT02890719|Ribavirin|ribavirin|mesh-list
65143916|NCT02890719|Grazoprevir|grazoprevir|mesh-list
64786433|NCT00002064|Antimalarials|antimalarials|mesh-ancestor
65143917|NCT02890719|Antimetabolites|antimetabolites|mesh-ancestor
65143918|NCT02890719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143919|NCT02890719|Antiviral Agents|antiviral agents|mesh-ancestor
65143920|NCT02890719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65143921|NCT04325061|Dexamethasone|dexamethasone|mesh-list
65143922|NCT04325061|Dexamethasone acetate|dexamethasone acetate|mesh-list
65143923|NCT04325061|BB 1101|bb 1101|mesh-list
65143924|NCT04325061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65143925|NCT04325061|Antiemetics|antiemetics|mesh-ancestor
65143926|NCT04325061|Autonomic Agents|autonomic agents|mesh-ancestor
65143928|NCT04325061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143929|NCT04325061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65143930|NCT04325061|Glucocorticoids|glucocorticoids|mesh-ancestor
65143931|NCT04325061|Hormones|hormones|mesh-ancestor
65143932|NCT04325061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65143933|NCT04325061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65143934|NCT04325061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143935|NCT04325061|Protease Inhibitors|protease inhibitors|mesh-ancestor
64498226|NCT04352062|Antioxidants|antioxidants|mesh-ancestor
65143949|NCT04365725|Antiviral Agents|antiviral agents|mesh-ancestor
65143950|NCT04365725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65143952|NCT01080391|Lenalidomide|lenalidomide|mesh-list
65143953|NCT01080391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65143954|NCT01080391|Antiemetics|antiemetics|mesh-ancestor
65143955|NCT01080391|Autonomic Agents|autonomic agents|mesh-ancestor
65143956|NCT01080391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143957|NCT01080391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143958|NCT01080391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65143959|NCT01080391|Glucocorticoids|glucocorticoids|mesh-ancestor
65143960|NCT01080391|Hormones|hormones|mesh-ancestor
65143961|NCT01080391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65143962|NCT01080391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65143963|NCT01080391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143964|NCT01080391|Immunologic Factors|immunologic factors|mesh-ancestor
65303618|NCT00643799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65303619|NCT00643799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65303620|NCT00643799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65303621|NCT00643799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65053514|NCT00236925|Hydrocortisone|hydrocortisone|mesh-list
65303622|NCT00643799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143965|NCT01080391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65143966|NCT01080391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65143967|NCT01080391|Growth Substances|growth substances|mesh-ancestor
65143968|NCT01080391|Growth Inhibitors|growth inhibitors|mesh-ancestor
65143969|NCT01070329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65143970|NCT01070329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65143971|NCT01070329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65143972|NCT01070329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65143973|NCT01070329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143974|NCT01070329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65143975|NCT01070329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143976|NCT01070329|Analgesics|analgesics|mesh-ancestor
65143977|NCT01070329|Sensory System Agents|sensory system agents|mesh-ancestor
65143978|NCT01070329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143979|NCT01070329|Antidepressive Agents|antidepressive agents|mesh-ancestor
65143980|NCT01070329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65143981|NCT01070329|Dopamine Agents|dopamine agents|mesh-ancestor
65143982|NCT04327427|Aspirin|aspirin|mesh-list
65143983|NCT04327427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65143984|NCT04327427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65143985|NCT04327427|Analgesics|analgesics|mesh-ancestor
65143986|NCT04327427|Sensory System Agents|sensory system agents|mesh-ancestor
65143987|NCT04327427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143988|NCT04327427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143989|NCT04327427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65143990|NCT04327427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65143991|NCT04327427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65143992|NCT04327427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65143993|NCT04327427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143994|NCT04327427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65144014|NCT02875717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65144015|NCT02875717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65144016|NCT02875717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65144017|NCT02875717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144018|NCT02875717|Antipyretics|antipyretics|mesh-ancestor
65144019|NCT04334837|Copper|copper|mesh-list
65144020|NCT04334837|Trace Elements|trace elements|mesh-ancestor
65144021|NCT04334837|Micronutrients|micronutrients|mesh-ancestor
65144022|NCT04334837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144023|NCT00593099|Bupropion|bupropion|mesh-list
65144024|NCT00593099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65144025|NCT00593099|Antidepressive Agents|antidepressive agents|mesh-ancestor
65144026|NCT00593099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65144027|NCT00593099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65144028|NCT00593099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65144029|NCT00593099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65144030|NCT00593099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144031|NCT00593099|Dopamine Agents|dopamine agents|mesh-ancestor
65144032|NCT00593099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65144033|NCT00593099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144034|NCT00593099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65144035|NCT00593099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65144036|NCT00593099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144037|NCT00593177|Parathyroid Hormone|parathyroid hormone|mesh-list
65144038|NCT00593177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65144039|NCT00593177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144040|NCT00593255|Insulin|insulin|mesh-list
65144041|NCT00593255|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65144042|NCT00593255|Insulin Aspart|insulin aspart|mesh-list
65144043|NCT00593255|Isophane Insulin, Human|isophane insulin, human|mesh-list
65144044|NCT00593255|Insulin, Isophane|insulin, isophane|mesh-list
65144045|NCT00593255|Isophane insulin, beef|isophane insulin, beef|mesh-list
65494082|NCT03701763|Analgesics|analgesics|mesh-ancestor
65303640|NCT05348213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65303641|NCT00643877|Oxaliplatin|oxaliplatin|mesh-list
65303731|NCT02537249|Adrenergic Agents|adrenergic agents|mesh-ancestor
65303732|NCT02537249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65303733|NCT02537249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303734|NCT00644111|Hydromorphone|hydromorphone|mesh-list
65303735|NCT00644111|Bupivacaine|bupivacaine|mesh-list
65303736|NCT00644111|Anesthetics, Local|anesthetics, local|mesh-ancestor
65303737|NCT00644111|Anesthetics|anesthetics|mesh-ancestor
65303738|NCT00644111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65144046|NCT00593255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65144047|NCT00593255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144048|NCT00593801|Epoetin Alfa|epoetin alfa|mesh-list
65144049|NCT00593801|Hematinics|hematinics|mesh-ancestor
65144050|NCT00593879|Mecamylamine|mecamylamine|mesh-list
65144051|NCT00593879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65144052|NCT00593879|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
65144082|NCT00594269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65144083|NCT00594269|Dopamine Agents|dopamine agents|mesh-ancestor
65144084|NCT00594269|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65144085|NCT00594269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65144086|NCT00594269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65144087|NCT00594269|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65144088|NCT00594269|Antidepressive Agents|antidepressive agents|mesh-ancestor
65144089|NCT00594269|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65144090|NCT00594269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65144091|NCT00594269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144092|NCT00594347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65144093|NCT00594347|Immunologic Factors|immunologic factors|mesh-ancestor
65144094|NCT00594347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144095|NCT04326959|Triamcinolone|triamcinolone|mesh-list
65144096|NCT04326959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65144097|NCT04326959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65144098|NCT04326959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65144113|NCT00594737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144114|NCT00594737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144115|NCT00594737|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65144116|NCT00594737|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65144118|NCT00595049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65144119|NCT00595049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65144120|NCT00595049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144121|NCT00595985|Sorafenib|sorafenib|mesh-list
65144122|NCT00595985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144123|NCT00595985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65144124|NCT00595985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144125|NCT00595985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144126|NCT00596063|Insulin|insulin|mesh-list
65144127|NCT00596063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65144128|NCT00596063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144129|NCT00596219|Celecoxib|celecoxib|mesh-list
65144130|NCT00596219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65144131|NCT00596219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65144132|NCT00596219|Analgesics|analgesics|mesh-ancestor
65144133|NCT00596219|Sensory System Agents|sensory system agents|mesh-ancestor
65144134|NCT00596219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65144135|NCT00596219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144136|NCT00596219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65144137|NCT00596219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65144138|NCT00596219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65144139|NCT00596219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65144140|NCT00596219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144141|NCT00596219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144142|NCT00596297|Bevacizumab|bevacizumab|mesh-list
65144143|NCT00596297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65144144|NCT00596297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144145|NCT00596297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65144146|NCT00596297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65303739|NCT00644111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303740|NCT00644111|Sensory System Agents|sensory system agents|mesh-ancestor
65303741|NCT00644111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65303742|NCT00644111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65303743|NCT00644111|Narcotics|narcotics|mesh-ancestor
65303744|NCT00644111|Analgesics|analgesics|mesh-ancestor
65303745|NCT00644891|Amoxicillin|amoxicillin|mesh-list
65303746|NCT00644891|Cefdinir|cefdinir|mesh-list
65303747|NCT00644891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65144148|NCT00596297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144149|NCT00596297|Growth Inhibitors|growth inhibitors|mesh-ancestor
65144150|NCT00596375|Lidocaine|lidocaine|mesh-list
65144151|NCT00596375|Anesthetics, Local|anesthetics, local|mesh-ancestor
65144152|NCT00596375|Anesthetics|anesthetics|mesh-ancestor
65144153|NCT00596375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65144154|NCT00596375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144155|NCT00596375|Sensory System Agents|sensory system agents|mesh-ancestor
65144156|NCT00596375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65144157|NCT00596375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65144173|NCT04326803|Immunologic Factors|immunologic factors|mesh-ancestor
65144174|NCT04326803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144176|NCT00597233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65144177|NCT00597233|Insulin Aspart|insulin aspart|mesh-list
65144178|NCT00597233|Isophane Insulin, Human|isophane insulin, human|mesh-list
65144179|NCT00597233|Insulin, Isophane|insulin, isophane|mesh-list
65144180|NCT00597233|Isophane insulin, beef|isophane insulin, beef|mesh-list
65144181|NCT00597233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65144182|NCT00597233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144183|NCT01064401|Interferons|interferons|mesh-list
65144184|NCT01064401|Interferon-beta|interferon-beta|mesh-list
65144185|NCT01064401|Interferon beta-1a|interferon beta-1a|mesh-list
65144186|NCT01064401|Daclizumab|daclizumab|mesh-list
65144187|NCT01064401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144188|NCT01064401|Antiviral Agents|antiviral agents|mesh-ancestor
65144189|NCT01064401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65144190|NCT01064401|Immunologic Factors|immunologic factors|mesh-ancestor
65144191|NCT01064401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144192|NCT01064401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65144193|NCT01064401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65144194|NCT00597389|Propranolol|propranolol|mesh-list
65144195|NCT00597389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65144196|NCT00597389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65144197|NCT00597389|Adrenergic Agents|adrenergic agents|mesh-ancestor
65144198|NCT00597389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65144199|NCT00597389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144200|NCT00597389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144201|NCT00597389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65144202|NCT00597389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65144203|NCT00597389|Vasodilator Agents|vasodilator agents|mesh-ancestor
65144204|NCT01306617|Ritonavir|ritonavir|mesh-list
65144205|NCT01306617|Ribavirin|ribavirin|mesh-list
65144206|NCT01306617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65144207|NCT01306617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65144208|NCT01306617|Protease Inhibitors|protease inhibitors|mesh-ancestor
65144209|NCT01306617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144210|NCT01306617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144211|NCT01306617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65144212|NCT01306617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65144213|NCT01306617|Antiviral Agents|antiviral agents|mesh-ancestor
65144214|NCT01306617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65144215|NCT01306617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65144216|NCT01306617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65144217|NCT01306617|Antimetabolites|antimetabolites|mesh-ancestor
65144218|NCT00597623|Adalimumab|adalimumab|mesh-list
65144228|NCT00598013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144229|NCT04303429|Capecitabine|capecitabine|mesh-list
65144230|NCT04303429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65144231|NCT04303429|Antimetabolites|antimetabolites|mesh-ancestor
65144232|NCT04303429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303748|NCT00644891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65303749|NCT05203445|Pembrolizumab|pembrolizumab|mesh-list
65303750|NCT05203445|Olaparib|olaparib|mesh-list
65303751|NCT05203445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65303752|NCT05203445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303753|NCT05203445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65303754|NCT05203445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303755|NCT05203445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303756|NCT04178057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65303757|NCT04178057|Antibodies|antibodies|mesh-list
65303758|NCT04178057|Immunoglobulins|immunoglobulins|mesh-list
65303759|NCT04178057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65303760|NCT04178057|Mitogens|mitogens|mesh-list
65303761|NCT04178057|Endothelial Growth Factors|endothelial growth factors|mesh-list
65303762|NCT04178057|Immunologic Factors|immunologic factors|mesh-ancestor
65303763|NCT04178057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303764|NCT04178057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303765|NCT04178057|Mitosis Modulators|mitosis modulators|mesh-ancestor
65303766|NCT04178057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303767|NCT04178057|Growth Substances|growth substances|mesh-ancestor
65303768|NCT04177043|Antibodies|antibodies|mesh-list
65303769|NCT04177043|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
65303770|NCT04177043|Immunologic Factors|immunologic factors|mesh-ancestor
65303771|NCT04177043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303772|NCT05179733|Rituximab|rituximab|mesh-list
65303773|NCT05179733|Lenalidomide|lenalidomide|mesh-list
65053660|NCT00174265|Asenapine|asenapine|mesh-list
65303774|NCT05179733|Zanubrutinib|zanubrutinib|mesh-list
65144233|NCT04303429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144234|NCT00598091|Gemcitabine|gemcitabine|mesh-list
65144235|NCT00598091|Dasatinib|dasatinib|mesh-list
65144236|NCT00598091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65144237|NCT00598091|Antimetabolites|antimetabolites|mesh-ancestor
65144238|NCT00598091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144239|NCT00598091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144240|NCT00598091|Antiviral Agents|antiviral agents|mesh-ancestor
65144241|NCT00598091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65144242|NCT00598091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144243|NCT00598091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65144244|NCT00598091|Immunologic Factors|immunologic factors|mesh-ancestor
65144245|NCT00598091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144246|NCT00598091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65144247|NCT00623415|Flupirtine|flupirtine|mesh-list
65144248|NCT00623415|Analgesics|analgesics|mesh-ancestor
65144249|NCT00623415|Sensory System Agents|sensory system agents|mesh-ancestor
65144250|NCT00623415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65144251|NCT00623415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144252|NCT04326725|Hydroxychloroquine|hydroxychloroquine|mesh-list
65144253|NCT04326725|Antimalarials|antimalarials|mesh-ancestor
65303775|NCT05179733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65303776|NCT05179733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303777|NCT05179733|Immunologic Factors|immunologic factors|mesh-ancestor
65303778|NCT05179733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303779|NCT05179733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65303780|NCT05179733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65303781|NCT05179733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65303782|NCT05179733|Growth Substances|growth substances|mesh-ancestor
65303783|NCT05179733|Growth Inhibitors|growth inhibitors|mesh-ancestor
65303784|NCT05179733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65303785|NCT05179733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303786|NCT05179733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303787|NCT02670785|Estradiol|estradiol|mesh-list
65144254|NCT04326725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65144255|NCT04326725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65144256|NCT04326725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65144257|NCT04326725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144258|NCT04326725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144259|NCT04326725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65144260|NCT01038427|Mometasone Furoate|mometasone furoate|mesh-list
65144261|NCT01038427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65144262|NCT01038427|Dermatologic Agents|dermatologic agents|mesh-ancestor
65144263|NCT01038427|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65144264|NCT00598169|Dexamethasone|dexamethasone|mesh-list
65144265|NCT00598169|Rituximab|rituximab|mesh-list
65144266|NCT00598169|Carboplatin|carboplatin|mesh-list
65144267|NCT00598169|Etoposide|etoposide|mesh-list
65144268|NCT00598169|Bortezomib|bortezomib|mesh-list
65144269|NCT00598169|Ifosfamide|ifosfamide|mesh-list
65144270|NCT00598169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65144271|NCT00598169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144272|NCT00598169|Immunologic Factors|immunologic factors|mesh-ancestor
65144273|NCT00598169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144274|NCT00598169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65144275|NCT00598169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65144276|NCT00598169|Antiemetics|antiemetics|mesh-ancestor
65144277|NCT00598169|Autonomic Agents|autonomic agents|mesh-ancestor
65144278|NCT00598169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65144279|NCT00598169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65144280|NCT00598169|Glucocorticoids|glucocorticoids|mesh-ancestor
65144281|NCT00598169|Hormones|hormones|mesh-ancestor
65144282|NCT00598169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65144283|NCT00598169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65144284|NCT00598169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65144285|NCT00598169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65144286|NCT00598169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65144287|NCT00598169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498570|NCT01309360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65144301|NCT00598403|Cefditoren|cefditoren|mesh-list
65144302|NCT00598403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65144303|NCT00598403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65144304|NCT00598403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65144305|NCT00598403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65144306|NCT00598403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144307|NCT00598403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144308|NCT00598403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144309|NCT00598403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65144310|NCT00598403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65144311|NCT00598637|Everolimus|everolimus|mesh-list
65144312|NCT00598637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144313|NCT00598637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65144314|NCT00598637|Immunologic Factors|immunologic factors|mesh-ancestor
65303788|NCT02670785|Estrogens|estrogens|mesh-ancestor
65303789|NCT02670785|Hormones|hormones|mesh-ancestor
65303790|NCT02670785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65303791|NCT02670785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303792|NCT02670317|Prednisone|prednisone|mesh-list
65303793|NCT02670317|Cyclophosphamide|cyclophosphamide|mesh-list
65303794|NCT02670317|Doxorubicin|doxorubicin|mesh-list
65303795|NCT02670317|Vincristine|vincristine|mesh-list
65303796|NCT02670317|Obinutuzumab|obinutuzumab|mesh-list
65303797|NCT02670317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65303798|NCT02670317|Immunologic Factors|immunologic factors|mesh-ancestor
65303799|NCT02670317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303800|NCT02670317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65303801|NCT02670317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65303802|NCT02670317|Alkylating Agents|alkylating agents|mesh-ancestor
65303803|NCT02670317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144315|NCT00598637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144316|NCT00598715|Sirolimus|sirolimus|mesh-list
65144317|NCT00598715|Paclitaxel|paclitaxel|mesh-list
65144318|NCT00598715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65144319|NCT00598715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144320|NCT00598715|Tubulin Modulators|tubulin modulators|mesh-ancestor
65144321|NCT00598715|Antimitotic Agents|antimitotic agents|mesh-ancestor
65144322|NCT00598715|Mitosis Modulators|mitosis modulators|mesh-ancestor
65144323|NCT00598715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144324|NCT00598715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65144325|NCT00598715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65144326|NCT00598715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65144327|NCT00598715|Antifungal Agents|antifungal agents|mesh-ancestor
65144328|NCT00598715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65144329|NCT00598715|Immunologic Factors|immunologic factors|mesh-ancestor
65144330|NCT00598715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144331|NCT00598793|Insulin|insulin|mesh-list
65144332|NCT00598793|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65144333|NCT00598793|Metformin|metformin|mesh-list
65144334|NCT00598793|Insulin Glargine|insulin glargine|mesh-list
65144335|NCT00598793|Pioglitazone|pioglitazone|mesh-list
65144336|NCT00598793|Insulin Aspart|insulin aspart|mesh-list
65144337|NCT00598793|Biphasic Insulins|biphasic insulins|mesh-list
65144338|NCT00598793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65144339|NCT00598793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144340|NCT01326845|Deferasirox|deferasirox|mesh-list
65144341|NCT01326845|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65144342|NCT01326845|Chelating Agents|chelating agents|mesh-ancestor
65144343|NCT01326845|Sequestering Agents|sequestering agents|mesh-ancestor
65144344|NCT01326845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144345|NCT01062763|Spironolactone|spironolactone|mesh-list
65144346|NCT01062763|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65144347|NCT01062763|Hormone Antagonists|hormone antagonists|mesh-ancestor
65144348|NCT01062763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65144349|NCT01062763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498639|NCT01374802|Protease Inhibitors|protease inhibitors|mesh-ancestor
65144374|NCT00599651|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65144375|NCT00599651|Respiratory System Agents|respiratory system agents|mesh-ancestor
65144376|NCT01048099|Trastuzumab|trastuzumab|mesh-list
65144378|NCT01048099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65144379|NCT01048099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144380|NCT00599807|Vitamin D|vitamin d|mesh-list
65144381|NCT00599807|Cholecalciferol|cholecalciferol|mesh-list
65144382|NCT00599807|Vitamins|vitamins|mesh-ancestor
65144383|NCT00599807|Micronutrients|micronutrients|mesh-ancestor
65303804|NCT02670317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303805|NCT02670317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65303806|NCT02670317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65303807|NCT02670317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65303808|NCT02670317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65303809|NCT02670317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303810|NCT02670317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65303811|NCT02670317|Glucocorticoids|glucocorticoids|mesh-ancestor
65303812|NCT02670317|Hormones|hormones|mesh-ancestor
65303813|NCT02670317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65303814|NCT02670317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65303815|NCT02670317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65303816|NCT02670317|Tubulin Modulators|tubulin modulators|mesh-ancestor
64533801|NCT02335164|Hemagglutinins|hemagglutinins|mesh-list
65144384|NCT00599807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144385|NCT00599807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65144386|NCT00599807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65144387|NCT00599885|Valsartan|valsartan|mesh-list
65144388|NCT00599885|Telmisartan|telmisartan|mesh-list
65144389|NCT00599885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65144390|NCT00599885|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65144391|NCT00599885|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65144392|NCT00599885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144393|NCT01303965|Sirolimus|sirolimus|mesh-list
65144394|NCT01303965|Lenalidomide|lenalidomide|mesh-list
65144395|NCT01303965|Tacrolimus|tacrolimus|mesh-list
65144396|NCT01303965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65144397|NCT01303965|Immunologic Factors|immunologic factors|mesh-ancestor
65144398|NCT01303965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144399|NCT01303965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65144400|NCT01303965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498704|NCT01962792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65144409|NCT01303965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65144410|NCT01303965|Antifungal Agents|antifungal agents|mesh-ancestor
65144412|NCT00600041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65144413|NCT00600041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65144414|NCT00600041|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65144415|NCT00600041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144416|NCT00600041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144417|NCT01045993|Analgesics|analgesics|mesh-list
65144418|NCT01045993|Sensory System Agents|sensory system agents|mesh-ancestor
65144419|NCT01045993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65144420|NCT01045993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144421|NCT00600509|Levetiracetam|levetiracetam|mesh-list
65144422|NCT00600509|Anticonvulsants|anticonvulsants|mesh-ancestor
65144423|NCT00600509|Nootropic Agents|nootropic agents|mesh-ancestor
65144424|NCT01326533|Hydroxychloroquine|hydroxychloroquine|mesh-list
65144425|NCT01326533|Antimalarials|antimalarials|mesh-ancestor
65144426|NCT01326533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65144427|NCT01326533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65144428|NCT01326533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65144429|NCT01326533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144430|NCT01326533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144431|NCT01326533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65144432|NCT00600587|Gemcitabine|gemcitabine|mesh-list
65144433|NCT00600587|Carboplatin|carboplatin|mesh-list
65144434|NCT00600587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65144435|NCT00600587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144436|NCT00600587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65144437|NCT00600587|Antimetabolites|antimetabolites|mesh-ancestor
65303817|NCT02670317|Antimitotic Agents|antimitotic agents|mesh-ancestor
65303818|NCT02670317|Mitosis Modulators|mitosis modulators|mesh-ancestor
65303819|NCT02670317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65303820|NCT02671565|Hyaluronic Acid|hyaluronic acid|mesh-list
65303821|NCT02671565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65303822|NCT02671565|Immunologic Factors|immunologic factors|mesh-ancestor
65303823|NCT02671565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303824|NCT02671565|Viscosupplements|viscosupplements|mesh-ancestor
65303825|NCT02671565|Protective Agents|protective agents|mesh-ancestor
65303826|NCT02537405|Rivaroxaban|rivaroxaban|mesh-list
65303827|NCT02537405|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65303828|NCT02537405|Antithrombins|antithrombins|mesh-ancestor
65303829|NCT02537405|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65303830|NCT02537405|Protease Inhibitors|protease inhibitors|mesh-ancestor
65303831|NCT02537405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303832|NCT02537405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144438|NCT00600587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144439|NCT00600587|Antiviral Agents|antiviral agents|mesh-ancestor
65144440|NCT00600587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65144441|NCT00600587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144442|NCT00600587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65144443|NCT00600587|Immunologic Factors|immunologic factors|mesh-ancestor
65144444|NCT00600587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144445|NCT00600587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65144446|NCT01045447|Insulin|insulin|mesh-list
65144447|NCT01045447|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65144448|NCT01045447|Insulin Glargine|insulin glargine|mesh-list
65144449|NCT01045447|Insulin Aspart|insulin aspart|mesh-list
65144450|NCT01045447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65144451|NCT01045447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144452|NCT00623207|Atropine|atropine|mesh-list
65144453|NCT00623207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65144454|NCT00623207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65144455|NCT00623207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65144456|NCT00623207|Autonomic Agents|autonomic agents|mesh-ancestor
65144457|NCT00623207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65144458|NCT00623207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144459|NCT00623207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65144460|NCT00623207|Respiratory System Agents|respiratory system agents|mesh-ancestor
65144461|NCT00623207|Mydriatics|mydriatics|mesh-ancestor
65144462|NCT00623207|Parasympatholytics|parasympatholytics|mesh-ancestor
65144463|NCT00623207|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65144464|NCT00623207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65144465|NCT00623207|Cholinergic Agents|cholinergic agents|mesh-ancestor
65144466|NCT00623207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65144467|NCT00623207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144486|NCT00601211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144487|NCT00601211|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65144488|NCT00601211|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65144489|NCT00601211|Cholinergic Agents|cholinergic agents|mesh-ancestor
65144490|NCT00601211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65144491|NCT00601211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144492|NCT00601289|Temozolomide|temozolomide|mesh-list
65144493|NCT00601289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65144494|NCT00601289|Alkylating Agents|alkylating agents|mesh-ancestor
65144495|NCT00601289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144496|NCT00601289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144497|NCT00601913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65144498|NCT00601913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303833|NCT02537405|Anticoagulants|anticoagulants|mesh-ancestor
65303834|NCT04175171|Trastuzumab|trastuzumab|mesh-list
65303835|NCT04175171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65303836|NCT04175171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303837|NCT04175093|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
65303838|NCT04175093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303839|NCT04175093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303840|NCT00645125|Amoxicillin|amoxicillin|mesh-list
65303841|NCT00645125|Cefdinir|cefdinir|mesh-list
65303842|NCT00645125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65303843|NCT00645125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65303844|NCT02669459|Imiquimod|imiquimod|mesh-list
65303845|NCT02669459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65303846|NCT02669459|Immunologic Factors|immunologic factors|mesh-ancestor
65303847|NCT02669459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303848|NCT02669459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303849|NCT02669459|Interferon Inducers|interferon inducers|mesh-ancestor
65303850|NCT04176887|Phenytoin|phenytoin|mesh-list
65144499|NCT00601913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65144500|NCT00601913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144501|NCT00601913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144502|NCT00601991|Aflibercept|aflibercept|mesh-list
65144503|NCT00601991|Endothelial Growth Factors|endothelial growth factors|mesh-list
65144504|NCT00601991|Growth Substances|growth substances|mesh-ancestor
65144505|NCT00601991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144506|NCT00601991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65144507|NCT00601991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65144508|NCT00601991|Growth Inhibitors|growth inhibitors|mesh-ancestor
65144509|NCT00601991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144510|NCT01301391|Maleic acid|maleic acid|mesh-list
65144511|NCT01301391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144512|NCT01301391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144513|NCT04325633|Naproxen|naproxen|mesh-list
65144514|NCT04325633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65144515|NCT04325633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65144516|NCT04325633|Analgesics|analgesics|mesh-ancestor
65144517|NCT04325633|Sensory System Agents|sensory system agents|mesh-ancestor
65144518|NCT04325633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65144519|NCT04325633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144520|NCT04325633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65144521|NCT04325633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65144522|NCT04325633|Gout Suppressants|gout suppressants|mesh-ancestor
65144523|NCT04325633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65144524|NCT04325633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144542|NCT05643651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65144543|NCT05643651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144544|NCT05643651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65144545|NCT05643651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65144546|NCT05643651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144547|NCT05643651|Antipyretics|antipyretics|mesh-ancestor
65144548|NCT05643651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65144549|NCT05643651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65144550|NCT05643651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65144551|NCT05643651|Purinergic Agents|purinergic agents|mesh-ancestor
65144552|NCT05643651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65144553|NCT05643651|Anticoagulants|anticoagulants|mesh-ancestor
65144554|NCT05643651|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65144555|NCT05643651|Antithrombins|antithrombins|mesh-ancestor
65053733|NCT00258336|Immunologic Factors|immunologic factors|mesh-ancestor
65303851|NCT04176887|Levetiracetam|levetiracetam|mesh-list
65303852|NCT04176887|Anticonvulsants|anticonvulsants|mesh-ancestor
65303853|NCT04176887|Nootropic Agents|nootropic agents|mesh-ancestor
65303854|NCT04176887|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65303855|NCT04176887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65303856|NCT04176887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65303857|NCT04176887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303858|NCT04176887|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65303859|NCT04176887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65303860|NCT04174937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65303861|NCT04174937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65303862|NCT00645203|Cefdinir|cefdinir|mesh-list
65303863|NCT00645203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65303864|NCT00645203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65303865|NCT02669303|Methylprednisolone|methylprednisolone|mesh-list
65303866|NCT02669303|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65303867|NCT02669303|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65303868|NCT02669303|Prednisolone|prednisolone|mesh-list
65144556|NCT05643651|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65144557|NCT05643651|Protease Inhibitors|protease inhibitors|mesh-ancestor
65144558|NCT05643651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65144559|NCT05643651|Hemostatics|hemostatics|mesh-ancestor
65144560|NCT05643651|Coagulants|coagulants|mesh-ancestor
65144561|NCT01061359|Epirubicin|epirubicin|mesh-list
65144562|NCT01061359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65144563|NCT01061359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144564|NCT01061359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65144565|NCT01061359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65144566|NCT01061359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144567|NCT01061359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144568|NCT05643417|Bevacizumab|bevacizumab|mesh-list
65144569|NCT05643417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65144570|NCT05643417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144571|NCT05643417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65144572|NCT05643417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65144573|NCT05643417|Growth Substances|growth substances|mesh-ancestor
65144574|NCT05643417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144575|NCT05643417|Growth Inhibitors|growth inhibitors|mesh-ancestor
65144576|NCT04303741|Apatinib|apatinib|mesh-list
65144577|NCT04303741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144578|NCT04303741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65144579|NCT04303741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144580|NCT04303741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144581|NCT00626977|Clonidine|clonidine|mesh-list
65144582|NCT00626977|Ropivacaine|ropivacaine|mesh-list
65144583|NCT00626977|Anesthetics, Local|anesthetics, local|mesh-ancestor
65144584|NCT00626977|Anesthetics|anesthetics|mesh-ancestor
65144594|NCT00626977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65144595|NCT00626977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65144596|NCT00626977|Adrenergic Agents|adrenergic agents|mesh-ancestor
65144597|NCT00626977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65144598|NCT00626977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144599|NCT04303819|Exenatide|exenatide|mesh-list
65144600|NCT04303819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65144601|NCT04303819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303869|NCT02669303|Prednisolone acetate|prednisolone acetate|mesh-list
65303870|NCT02669303|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65303871|NCT02669303|Prednisolone phosphate|prednisolone phosphate|mesh-list
65303872|NCT02669303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65303873|NCT02669303|Antiemetics|antiemetics|mesh-ancestor
65303874|NCT02669303|Autonomic Agents|autonomic agents|mesh-ancestor
65303875|NCT02669303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65303876|NCT02669303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303877|NCT02669303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65144602|NCT04303819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65144603|NCT04303819|Incretins|incretins|mesh-ancestor
65144604|NCT04303819|Hormones|hormones|mesh-ancestor
65144605|NCT04303819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65144606|NCT01301079|Ketamine|ketamine|mesh-list
65144607|NCT01301079|Analgesics|analgesics|mesh-ancestor
65144608|NCT01301079|Sensory System Agents|sensory system agents|mesh-ancestor
65144609|NCT01301079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65144610|NCT01301079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144611|NCT01301079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65144612|NCT01301079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65144613|NCT01301079|Anesthetics, General|anesthetics, general|mesh-ancestor
65144614|NCT01301079|Anesthetics|anesthetics|mesh-ancestor
65144615|NCT01301079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65144616|NCT01301079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65144617|NCT01301079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65144618|NCT01301079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65144619|NCT01301079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144620|NCT05271721|Dexamethasone|dexamethasone|mesh-list
65144621|NCT05271721|Dexamethasone acetate|dexamethasone acetate|mesh-list
65144622|NCT05271721|BB 1101|bb 1101|mesh-list
65144623|NCT05271721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65144624|NCT05271721|Antiemetics|antiemetics|mesh-ancestor
65144625|NCT05271721|Autonomic Agents|autonomic agents|mesh-ancestor
65144626|NCT05271721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65144627|NCT05271721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144628|NCT05271721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65144629|NCT05271721|Glucocorticoids|glucocorticoids|mesh-ancestor
65144630|NCT05271721|Hormones|hormones|mesh-ancestor
65144631|NCT05271721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65144632|NCT05271721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65144633|NCT05271721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144634|NCT05271721|Protease Inhibitors|protease inhibitors|mesh-ancestor
65144635|NCT05271721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144636|NCT05271721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144637|NCT01301001|Gabapentin|gabapentin|mesh-list
65144638|NCT01301001|Analgesics|analgesics|mesh-ancestor
65144639|NCT01301001|Sensory System Agents|sensory system agents|mesh-ancestor
65144640|NCT01301001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65144641|NCT01301001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144642|NCT01301001|Anticonvulsants|anticonvulsants|mesh-ancestor
65144643|NCT01301001|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65144644|NCT01301001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65144645|NCT01301001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65144646|NCT01301001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65144647|NCT01301001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65144648|NCT01301001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65144649|NCT01301001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65144668|NCT01035463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144669|NCT01035463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65144670|NCT01035463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65144671|NCT01035463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65144672|NCT01035463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65144673|NCT01035463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144674|NCT01035463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144675|NCT01035463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65303878|NCT02669303|Glucocorticoids|glucocorticoids|mesh-ancestor
65303879|NCT02669303|Hormones|hormones|mesh-ancestor
65303880|NCT02669303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65303881|NCT02669303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65303882|NCT02669303|Protective Agents|protective agents|mesh-ancestor
65303883|NCT02669303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65303884|NCT02669303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303885|NCT00645281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65144677|NCT01035463|Antiviral Agents|antiviral agents|mesh-ancestor
65144678|NCT01035463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65144679|NCT01035463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65144680|NCT01035463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65144681|NCT01035463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65144682|NCT01035463|Growth Substances|growth substances|mesh-ancestor
65144683|NCT01035463|Growth Inhibitors|growth inhibitors|mesh-ancestor
65144684|NCT01035463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65144685|NCT01035463|Alkylating Agents|alkylating agents|mesh-ancestor
65144686|NCT01035463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65144687|NCT01035463|Keratolytic Agents|keratolytic agents|mesh-ancestor
65144688|NCT01035463|Dermatologic Agents|dermatologic agents|mesh-ancestor
65144689|NCT01035463|Tubulin Modulators|tubulin modulators|mesh-ancestor
65144690|NCT01035463|Antimitotic Agents|antimitotic agents|mesh-ancestor
65144691|NCT01035463|Mitosis Modulators|mitosis modulators|mesh-ancestor
65144692|NCT01300923|Acamprosate|acamprosate|mesh-list
65144693|NCT01300923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65144694|NCT01300767|Contact Lens Solutions|contact lens solutions|mesh-list
65144695|NCT01300767|Disinfectants|disinfectants|mesh-ancestor
65144696|NCT01300767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65144697|NCT02890173|Eplerenone|eplerenone|mesh-list
65144698|NCT02890173|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65144699|NCT02890173|Hormone Antagonists|hormone antagonists|mesh-ancestor
65144700|NCT02890173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65144701|NCT02890173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144702|NCT02890173|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65144703|NCT02890173|Diuretics|diuretics|mesh-ancestor
65144704|NCT02890173|Natriuretic Agents|natriuretic agents|mesh-ancestor
65144705|NCT02890173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65144706|NCT01300455|Suvorexant|suvorexant|mesh-list
65144707|NCT01300455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65144708|NCT01300455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65144709|NCT01300455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65144710|NCT01300455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144731|NCT01101022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144732|NCT01101022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65144733|NCT01101022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65144734|NCT01101022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65144735|NCT01101022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144736|NCT01101022|Dopamine Agents|dopamine agents|mesh-ancestor
65144737|NCT01101022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65144738|NCT02879110|Sulforaphane|sulforaphane|mesh-list
65144739|NCT02879110|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65144740|NCT02879110|Protective Agents|protective agents|mesh-ancestor
65144741|NCT02879110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144742|NCT02879110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144743|NCT04207515|Anesthetics|anesthetics|mesh-list
65144744|NCT04207515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65144745|NCT04207515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144746|NCT01100944|Cyclophosphamide|cyclophosphamide|mesh-list
65144747|NCT01100944|Doxorubicin|doxorubicin|mesh-list
65144749|NCT01100944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65144750|NCT01100944|Immunologic Factors|immunologic factors|mesh-ancestor
65144751|NCT01100944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144752|NCT01100944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65144753|NCT01100944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65144754|NCT01100944|Alkylating Agents|alkylating agents|mesh-ancestor
65144755|NCT01100944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303886|NCT00645281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65303887|NCT00645281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65303888|NCT00645281|Cholinergic Agents|cholinergic agents|mesh-ancestor
65303889|NCT00645281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65303890|NCT00645281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303891|NCT00645281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303892|NCT00645281|Urological Agents|urological agents|mesh-ancestor
65303893|NCT02668679|Hormones|hormones|mesh-list
65303894|NCT02668679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65303895|NCT02668679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303896|NCT00645437|Levofloxacin|levofloxacin|mesh-list
65303897|NCT00645437|Ofloxacin|ofloxacin|mesh-list
65303898|NCT00645437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65144756|NCT01100944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144757|NCT01100944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65144758|NCT01100944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65144759|NCT01100944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65144760|NCT01100944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65144761|NCT01100944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144762|NCT01100944|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65144772|NCT04309708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65144773|NCT04309708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65144774|NCT04309708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65144775|NCT04309708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144776|NCT04309708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65144777|NCT04309708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144778|NCT04309708|Vasodilator Agents|vasodilator agents|mesh-ancestor
65144780|NCT01100086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65144781|NCT01100086|Narcotics|narcotics|mesh-ancestor
65144782|NCT01100086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65144783|NCT01100086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144784|NCT01100086|Analgesics|analgesics|mesh-ancestor
65144785|NCT01100086|Sensory System Agents|sensory system agents|mesh-ancestor
65144786|NCT01100086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65144787|NCT01297959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65144788|NCT00626080|Insulin|insulin|mesh-list
65144789|NCT00626080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65144790|NCT00626080|Insulin Detemir|insulin detemir|mesh-list
65144791|NCT00626080|Isophane Insulin, Human|isophane insulin, human|mesh-list
65144792|NCT00626080|Insulin, Isophane|insulin, isophane|mesh-list
65144793|NCT00626080|Isophane insulin, beef|isophane insulin, beef|mesh-list
65144794|NCT00626080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65144795|NCT00626080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144796|NCT04309240|Rivaroxaban|rivaroxaban|mesh-list
65144797|NCT04309240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65144798|NCT04309240|Antithrombins|antithrombins|mesh-ancestor
65144799|NCT04309240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65144800|NCT04309240|Protease Inhibitors|protease inhibitors|mesh-ancestor
65144801|NCT04309240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144802|NCT04309240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144803|NCT04309240|Anticoagulants|anticoagulants|mesh-ancestor
65144804|NCT01035229|Everolimus|everolimus|mesh-list
65144805|NCT01035229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144806|NCT01035229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65144807|NCT01035229|Immunologic Factors|immunologic factors|mesh-ancestor
65144808|NCT01035229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144809|NCT01059799|Insulin|insulin|mesh-list
65144810|NCT01059799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65144811|NCT01059799|Insulin Glargine|insulin glargine|mesh-list
65144812|NCT01059799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65144813|NCT01059799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303899|NCT00645437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65303900|NCT00645437|Renal Agents|renal agents|mesh-ancestor
65303901|NCT00645437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65303902|NCT00645437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65303903|NCT00645437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65303904|NCT00645437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303905|NCT00645437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303906|NCT00645437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303907|NCT00645437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65303908|NCT00645437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65303909|NCT02537171|Apatinib|apatinib|mesh-list
65303910|NCT02537171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303911|NCT02537171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64533892|NCT03111810|Hormones|hormones|mesh-ancestor
65144814|NCT04301869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65144815|NCT04301869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65144816|NCT04301479|Hydrocortisone|hydrocortisone|mesh-list
65144817|NCT04301479|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65144818|NCT04301479|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65144819|NCT04301479|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65144820|NCT04301479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65144821|NCT01106092|Vaccines|vaccines|mesh-list
65144822|NCT01106092|Immunologic Factors|immunologic factors|mesh-ancestor
64678000|NCT00001449|Micronutrients|micronutrients|mesh-ancestor
65144823|NCT01106092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144824|NCT04307290|Dexmedetomidine|dexmedetomidine|mesh-list
65144825|NCT04307290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65144826|NCT04307290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65144827|NCT04307290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144828|NCT04307290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65144829|NCT04307290|Analgesics|analgesics|mesh-ancestor
65144837|NCT04307290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144839|NCT01325207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65144840|NCT01325207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144841|NCT01324349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65144842|NCT01324349|Hemostatics|hemostatics|mesh-list
65144843|NCT01324349|Coagulants|coagulants|mesh-ancestor
65144844|NCT01095250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65144845|NCT01095250|Immunologic Factors|immunologic factors|mesh-ancestor
65144846|NCT01095250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144847|NCT01095094|Ritonavir|ritonavir|mesh-list
65144848|NCT01095094|Lopinavir|lopinavir|mesh-list
65144849|NCT01095094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65144850|NCT01095094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65144851|NCT01095094|Protease Inhibitors|protease inhibitors|mesh-ancestor
65144852|NCT01095094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144853|NCT01095094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144854|NCT01095094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65144855|NCT01095094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65144856|NCT01095094|Antiviral Agents|antiviral agents|mesh-ancestor
65144857|NCT01095094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65144858|NCT01095094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65144859|NCT01095094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65144860|NCT00623285|Pregabalin|pregabalin|mesh-list
65144861|NCT00623285|Analgesics|analgesics|mesh-ancestor
65144862|NCT00623285|Sensory System Agents|sensory system agents|mesh-ancestor
65144863|NCT00623285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65144864|NCT00623285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144865|NCT00623285|Anticonvulsants|anticonvulsants|mesh-ancestor
65144866|NCT00623285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65144867|NCT00623285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65303912|NCT02537171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303913|NCT02537171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303914|NCT00645515|Risperidone|risperidone|mesh-list
65303915|NCT00645515|Ziprasidone|ziprasidone|mesh-list
65303916|NCT00645515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65144868|NCT00623285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144869|NCT00623285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65144870|NCT00623285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65144871|NCT00623285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65144872|NCT00623285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65144873|NCT00623285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65144874|NCT01097044|Afamelanotide|afamelanotide|mesh-list
65144875|NCT01097044|Dermatologic Agents|dermatologic agents|mesh-ancestor
65144876|NCT01322009|Acetylcysteine|acetylcysteine|mesh-list
65144877|NCT01322009|Probenecid|probenecid|mesh-list
65144878|NCT01322009|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65144879|NCT01322009|Antiviral Agents|antiviral agents|mesh-ancestor
65144880|NCT01322009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65144881|NCT01322009|Expectorants|expectorants|mesh-ancestor
65144882|NCT01322009|Respiratory System Agents|respiratory system agents|mesh-ancestor
65144883|NCT01322009|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65144884|NCT01322009|Antioxidants|antioxidants|mesh-ancestor
65144885|NCT01322009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144886|NCT01322009|Protective Agents|protective agents|mesh-ancestor
65144887|NCT01322009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144888|NCT01322009|Antidotes|antidotes|mesh-ancestor
65144889|NCT01322009|Uricosuric Agents|uricosuric agents|mesh-ancestor
65144890|NCT01322009|Gout Suppressants|gout suppressants|mesh-ancestor
65144891|NCT01322009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65144892|NCT01322009|Renal Agents|renal agents|mesh-ancestor
65144893|NCT01320683|Leucovorin|leucovorin|mesh-list
65144894|NCT01320683|Bevacizumab|bevacizumab|mesh-list
65144895|NCT01320683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65144896|NCT01320683|Fluorouracil|fluorouracil|mesh-list
65144898|NCT01320683|Irinotecan|irinotecan|mesh-list
65144899|NCT01320683|Antibodies|antibodies|mesh-list
65144915|NCT01320683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65144916|NCT01320683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144917|NCT01320683|Antidotes|antidotes|mesh-ancestor
65144918|NCT01320683|Protective Agents|protective agents|mesh-ancestor
65144919|NCT01320683|Vitamin B Complex|vitamin b complex|mesh-ancestor
65144920|NCT01320683|Vitamins|vitamins|mesh-ancestor
65144921|NCT01320683|Micronutrients|micronutrients|mesh-ancestor
65144922|NCT01320293|Adalimumab|adalimumab|mesh-list
65144923|NCT01320293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65144924|NCT01320293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65144925|NCT01318811|Heparin|heparin|mesh-list
65144926|NCT01318811|Calcium heparin|calcium heparin|mesh-list
65144927|NCT01318811|Anticoagulants|anticoagulants|mesh-ancestor
65144928|NCT01318811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65144929|NCT01318811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65144930|NCT01318811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144931|NCT05644769|Lisinopril|lisinopril|mesh-list
65144932|NCT05644769|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65144933|NCT05644769|Protease Inhibitors|protease inhibitors|mesh-ancestor
65144934|NCT05644769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144935|NCT05644769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144936|NCT05644769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65144937|NCT05644769|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65144938|NCT05644769|Protective Agents|protective agents|mesh-ancestor
65144939|NCT05644769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144940|NCT05644691|Emollients|emollients|mesh-list
65144941|NCT05644691|Dermatologic Agents|dermatologic agents|mesh-ancestor
65144942|NCT01093846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65144943|NCT01093846|Immunologic Factors|immunologic factors|mesh-ancestor
65144944|NCT01093846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144945|NCT01093534|Solifenacin Succinate|solifenacin succinate|mesh-list
65144946|NCT01093534|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65144947|NCT01093534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65144948|NCT01093534|Cholinergic Agents|cholinergic agents|mesh-ancestor
65144949|NCT01093534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65144950|NCT01093534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144951|NCT01093534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303917|NCT00645515|Serotonin Agents|serotonin agents|mesh-ancestor
65303918|NCT00645515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65303919|NCT00645515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303920|NCT00645515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303921|NCT00645515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65303922|NCT00645515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65303923|NCT00645515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65303924|NCT00645515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65303925|NCT00645515|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65303926|NCT00645515|Dopamine Agents|dopamine agents|mesh-ancestor
65303927|NCT05076149|Ivacaftor|ivacaftor|mesh-list
65303928|NCT05076149|Elexacaftor|elexacaftor|mesh-list
65303929|NCT05076149|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65303930|NCT05076149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65303931|NCT05076149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303932|NCT00644735|Esomeprazole|esomeprazole|mesh-list
65303933|NCT00644735|Lansoprazole|lansoprazole|mesh-list
65303934|NCT00644735|Dexlansoprazole|dexlansoprazole|mesh-list
65303935|NCT00644735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65303936|NCT00644735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65303937|NCT00644735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65303938|NCT00644735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303939|NCT00644735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303940|NCT02667743|Paclitaxel|paclitaxel|mesh-list
65303941|NCT02667743|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65144952|NCT01093534|Urological Agents|urological agents|mesh-ancestor
65144953|NCT01314911|Oseltamivir|oseltamivir|mesh-list
65144954|NCT01314911|Antiviral Agents|antiviral agents|mesh-ancestor
65144955|NCT01314911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65144956|NCT01314911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144957|NCT01314911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144958|NCT01093222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65144959|NCT01093222|Sorafenib|sorafenib|mesh-list
64499247|NCT02520570|Protease Inhibitors|protease inhibitors|mesh-ancestor
65144968|NCT02878018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65144969|NCT02878018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144970|NCT02878018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65144971|NCT02878018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144972|NCT02878018|Immunologic Factors|immunologic factors|mesh-ancestor
65144973|NCT02878018|Protease Inhibitors|protease inhibitors|mesh-ancestor
65144974|NCT02878018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144976|NCT01313663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144977|NCT01313663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144978|NCT01313663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144979|NCT01313663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64787509|NCT00002616|Thiotepa|thiotepa|mesh-list
65144980|NCT01313663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65144981|NCT01092832|Voriconazole|voriconazole|mesh-list
65144982|NCT01092832|Antifungal Agents|antifungal agents|mesh-ancestor
65144983|NCT01092832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65303942|NCT02667743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65303943|NCT02667743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65303944|NCT02667743|Tubulin Modulators|tubulin modulators|mesh-ancestor
65303945|NCT02667743|Antimitotic Agents|antimitotic agents|mesh-ancestor
65303946|NCT02667743|Mitosis Modulators|mitosis modulators|mesh-ancestor
64533936|NCT02326584|Cytarabine|cytarabine|mesh-list
65144984|NCT01092832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65144985|NCT01092832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65144986|NCT01092832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144987|NCT01092832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144988|NCT01092832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65144989|NCT01092832|Hormone Antagonists|hormone antagonists|mesh-ancestor
65144990|NCT01092832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65144991|NCT01092832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144992|NCT01092832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65144993|NCT02878564|Praziquantel|praziquantel|mesh-list
65144994|NCT02878564|Anthelmintics|anthelmintics|mesh-ancestor
65144995|NCT02878564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65144996|NCT02878564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65144997|NCT04308070|Hemostatics|hemostatics|mesh-list
65144998|NCT04308070|Coagulants|coagulants|mesh-ancestor
65144999|NCT01313273|Ascorbic Acid|ascorbic acid|mesh-list
65145000|NCT01313273|Methyltestosterone|methyltestosterone|mesh-list
65145001|NCT01313273|Lanreotide|lanreotide|mesh-list
65145002|NCT01313273|Androgens|androgens|mesh-list
65145003|NCT01313273|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65145004|NCT01313273|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65145005|NCT01313273|Androgen Antagonists|androgen antagonists|mesh-list
65145006|NCT01313273|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
65145007|NCT01313273|Hormones|hormones|mesh-ancestor
65145008|NCT01313273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65145009|NCT01313273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145010|NCT01313273|Antioxidants|antioxidants|mesh-ancestor
65145011|NCT01313273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145012|NCT01313273|Protective Agents|protective agents|mesh-ancestor
65145013|NCT01313273|Vitamins|vitamins|mesh-ancestor
65145014|NCT01313273|Micronutrients|micronutrients|mesh-ancestor
65145015|NCT01313273|Estrogens|estrogens|mesh-ancestor
65145016|NCT01313273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65145017|NCT01313273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65145018|NCT01313273|Anabolic Agents|anabolic agents|mesh-ancestor
65145019|NCT01313273|Hormone Antagonists|hormone antagonists|mesh-ancestor
65145020|NCT01091974|Modafinil|modafinil|mesh-list
65145021|NCT01091974|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65145022|NCT01091974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145023|NCT01091974|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65145024|NCT01091974|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65145033|NCT01313117|Vitamins|vitamins|mesh-ancestor
65145034|NCT01313117|Micronutrients|micronutrients|mesh-ancestor
65145035|NCT01091662|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
65145036|NCT01091662|Anticonvulsants|anticonvulsants|mesh-ancestor
65145037|NCT01091662|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65145038|NCT01091662|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65145039|NCT01091662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65145040|NCT01091662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145041|NCT01312961|Fluticasone|fluticasone|mesh-list
65145042|NCT01312961|Xhance|xhance|mesh-list
65145043|NCT01312961|Albuterol|albuterol|mesh-list
65145044|NCT01312961|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65145045|NCT01312961|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65145046|NCT01312961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65145047|NCT01312961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65145048|NCT01312961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65145049|NCT01312961|Autonomic Agents|autonomic agents|mesh-ancestor
65145050|NCT01312961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65145051|NCT01312961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145052|NCT01312961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65145053|NCT01312961|Respiratory System Agents|respiratory system agents|mesh-ancestor
65145054|NCT01312961|Dermatologic Agents|dermatologic agents|mesh-ancestor
65145055|NCT01312961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65303947|NCT02667743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303948|NCT02666651|Tolvaptan|tolvaptan|mesh-list
65303949|NCT02666651|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65145056|NCT01312961|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65145057|NCT01312961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65145058|NCT01312961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65145059|NCT01312961|Adrenergic Agents|adrenergic agents|mesh-ancestor
65145060|NCT01312961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65145061|NCT01312961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145062|NCT01312961|Tocolytic Agents|tocolytic agents|mesh-ancestor
65145063|NCT01312961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65145064|NCT01312961|Immunologic Factors|immunologic factors|mesh-ancestor
65145065|NCT01312961|Glucocorticoids|glucocorticoids|mesh-ancestor
65145066|NCT01312961|Hormones|hormones|mesh-ancestor
65145067|NCT01312961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65145068|NCT01312961|Sympathomimetics|sympathomimetics|mesh-ancestor
65145069|NCT00626158|Gemcitabine|gemcitabine|mesh-list
65145070|NCT00626158|Capecitabine|capecitabine|mesh-list
65145071|NCT00626158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65145072|NCT00626158|Antimetabolites|antimetabolites|mesh-ancestor
65145073|NCT00626158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145074|NCT00626158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65145075|NCT00626158|Antiviral Agents|antiviral agents|mesh-ancestor
65145076|NCT00626158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65145077|NCT00626158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145078|NCT00626158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65145079|NCT00626158|Immunologic Factors|immunologic factors|mesh-ancestor
65145080|NCT00626158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145081|NCT01310777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65145082|NCT01310777|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65145083|NCT01310777|Brinzolamide|brinzolamide|mesh-list
65145084|NCT01310777|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65145085|NCT01310777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65145086|NCT01310777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65145087|NCT01310777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65145088|NCT01310777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65145089|NCT01310777|Adrenergic Agents|adrenergic agents|mesh-ancestor
65145090|NCT01310777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65145104|NCT01309997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145106|NCT01309841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65145107|NCT01309841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145108|NCT01309841|Sensory System Agents|sensory system agents|mesh-ancestor
65145109|NCT01309841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65145110|NCT01308749|Oxytocin|oxytocin|mesh-list
65145111|NCT01308749|Oxytocics|oxytocics|mesh-ancestor
65145112|NCT01308749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65145113|NCT01308749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145114|NCT01307891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65145115|NCT01307891|Paclitaxel|paclitaxel|mesh-list
65145116|NCT01307891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65145117|NCT01307891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65145118|NCT01307891|Tubulin Modulators|tubulin modulators|mesh-ancestor
65145119|NCT01307891|Antimitotic Agents|antimitotic agents|mesh-ancestor
65145120|NCT01307891|Mitosis Modulators|mitosis modulators|mesh-ancestor
65145121|NCT01307891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145122|NCT05644301|Minocycline|minocycline|mesh-list
65145124|NCT05644301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65145125|NCT05644301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65145126|NCT05644301|Analgesics|analgesics|mesh-ancestor
65145127|NCT05644301|Sensory System Agents|sensory system agents|mesh-ancestor
65145128|NCT05644301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64787653|NCT00002676|Hormones|hormones|mesh-ancestor
65145129|NCT05644301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145130|NCT05644301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65145131|NCT05644301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65145132|NCT05644301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65145133|NCT05644301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65145134|NCT05644301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145135|NCT05644301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145136|NCT05644301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65303950|NCT02666651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303951|NCT02666651|Natriuretic Agents|natriuretic agents|mesh-ancestor
65303952|NCT02666651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303953|NCT02671175|Piperaquine|piperaquine|mesh-list
65303954|NCT02671175|Artenimol|artenimol|mesh-list
65303955|NCT02671175|Artemisinins|artemisinins|mesh-list
65303956|NCT02671175|Antimalarials|antimalarials|mesh-ancestor
65303957|NCT02671175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65303958|NCT02671175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65303959|NCT02671175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65303960|NCT02671097|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65303961|NCT02671097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65303962|NCT02671097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65303963|NCT02671097|Antimetabolites|antimetabolites|mesh-ancestor
65303964|NCT02671097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303965|NCT02671097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65303966|NCT02671097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65303967|NCT02671097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65303968|NCT02667197|Analgesics, Opioid|analgesics, opioid|mesh-list
65303969|NCT02667197|Narcotics|narcotics|mesh-ancestor
64533943|NCT02326584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65145137|NCT05644301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65145138|NCT02890745|Empagliflozin|empagliflozin|mesh-list
65145139|NCT02890745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65145140|NCT02890745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145141|NCT02890745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65145142|NCT02890745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145143|NCT01307579|Fluconazole|fluconazole|mesh-list
65145144|NCT01307579|Caspofungin|caspofungin|mesh-list
65145145|NCT01307579|Antifungal Agents|antifungal agents|mesh-ancestor
65145146|NCT01307579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65145147|NCT01307579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65145148|NCT01307579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65145149|NCT01307579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145155|NCT01307579|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65145156|NCT01307579|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65145157|NCT01057693|Pregabalin|pregabalin|mesh-list
65145158|NCT01057693|Analgesics|analgesics|mesh-ancestor
65145159|NCT01057693|Sensory System Agents|sensory system agents|mesh-ancestor
65145160|NCT01057693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65145161|NCT01057693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145162|NCT01057693|Anticonvulsants|anticonvulsants|mesh-ancestor
65145163|NCT01057693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65145164|NCT01057693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65145165|NCT01057693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145166|NCT01057693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65145167|NCT01057693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65145168|NCT01057693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65145169|NCT01057693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65145170|NCT01057693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65145171|NCT04325009|Atorvastatin|atorvastatin|mesh-list
65145172|NCT04325009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65145173|NCT04325009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65145174|NCT04325009|Antimetabolites|antimetabolites|mesh-ancestor
65303970|NCT02667197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65303971|NCT02667197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303972|NCT02667197|Analgesics|analgesics|mesh-ancestor
65303973|NCT02667197|Sensory System Agents|sensory system agents|mesh-ancestor
65303974|NCT02667197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65303975|NCT00463567|Formoterol Fumarate|formoterol fumarate|mesh-list
65303976|NCT00463567|Tiotropium Bromide|tiotropium bromide|mesh-list
65303977|NCT00463567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65303978|NCT00463567|Autonomic Agents|autonomic agents|mesh-ancestor
65303979|NCT00463567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65303980|NCT00463567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303981|NCT00463567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65303982|NCT00463567|Respiratory System Agents|respiratory system agents|mesh-ancestor
65303983|NCT00463567|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65303984|NCT00463567|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65303985|NCT00463567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65303986|NCT00463567|Adrenergic Agents|adrenergic agents|mesh-ancestor
65303987|NCT00463567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65303988|NCT00463567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65303989|NCT00463567|Parasympatholytics|parasympatholytics|mesh-ancestor
65303990|NCT00463567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65303991|NCT00463567|Cholinergic Agents|cholinergic agents|mesh-ancestor
65145175|NCT04325009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145176|NCT04325009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65145177|NCT04325009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65145178|NCT04325009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145179|NCT01034137|Methotrexate|methotrexate|mesh-list
65145180|NCT01034137|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65145181|NCT01034137|Abortifacient Agents|abortifacient agents|mesh-ancestor
65145182|NCT01034137|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65145183|NCT01034137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145184|NCT01034137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65145185|NCT01034137|Antimetabolites|antimetabolites|mesh-ancestor
65145186|NCT01034137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145187|NCT01034137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65145188|NCT01034137|Dermatologic Agents|dermatologic agents|mesh-ancestor
65145189|NCT01034137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145190|NCT01034137|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65145191|NCT01034137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65145192|NCT01034137|Immunologic Factors|immunologic factors|mesh-ancestor
65145193|NCT01034137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65145194|NCT01034137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65145195|NCT04302805|Thymoglobulin|thymoglobulin|mesh-list
65145196|NCT04302805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65145197|NCT04302805|Immunologic Factors|immunologic factors|mesh-ancestor
65145198|NCT04302805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145199|NCT04302805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65145200|NCT04655755|Decitabine|decitabine|mesh-list
65145201|NCT04655755|Venetoclax|venetoclax|mesh-list
65145202|NCT04655755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65145203|NCT04655755|Antimetabolites|antimetabolites|mesh-ancestor
65303992|NCT00646061|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65303993|NCT00646061|Parasympatholytics|parasympatholytics|mesh-ancestor
65303994|NCT00646061|Autonomic Agents|autonomic agents|mesh-ancestor
65303995|NCT00646061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65303996|NCT00646061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65303997|NCT00646061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65303998|NCT00646061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65303999|NCT00646061|Cholinergic Agents|cholinergic agents|mesh-ancestor
65304000|NCT00646061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65304001|NCT00646061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145204|NCT04655755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145205|NCT04655755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65145206|NCT04655755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145207|NCT01056289|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65145208|NCT01056289|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65145209|NCT01056289|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65145210|NCT01056289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65145211|NCT01056289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145212|NCT01056289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65145213|NCT01056289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145214|NCT01056289|Antidepressive Agents|antidepressive agents|mesh-ancestor
65145226|NCT01033825|Ciclesonide|ciclesonide|mesh-list
65145227|NCT01033825|Dexamethasone|dexamethasone|mesh-list
65145228|NCT01033825|Dexamethasone acetate|dexamethasone acetate|mesh-list
65145229|NCT01033825|BB 1101|bb 1101|mesh-list
65145230|NCT01033825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65145231|NCT01033825|Antiemetics|antiemetics|mesh-ancestor
65145232|NCT01033825|Autonomic Agents|autonomic agents|mesh-ancestor
65145233|NCT01033825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65145234|NCT01033825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145235|NCT01033825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65145236|NCT01033825|Glucocorticoids|glucocorticoids|mesh-ancestor
65145237|NCT01033825|Hormones|hormones|mesh-ancestor
65145238|NCT01033825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65145239|NCT01033825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65145240|NCT01033825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65145241|NCT01033825|Protease Inhibitors|protease inhibitors|mesh-ancestor
65145242|NCT01033825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145243|NCT01033825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145244|NCT01033825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65145245|NCT01033747|Deferasirox|deferasirox|mesh-list
65145246|NCT01033747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65145247|NCT01033747|Chelating Agents|chelating agents|mesh-ancestor
65145248|NCT01033747|Sequestering Agents|sequestering agents|mesh-ancestor
65145249|NCT01033747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145250|NCT02875015|Lidocaine|lidocaine|mesh-list
65145251|NCT02875015|Bupivacaine|bupivacaine|mesh-list
65145252|NCT02875015|Anesthetics, Local|anesthetics, local|mesh-ancestor
65145253|NCT02875015|Anesthetics|anesthetics|mesh-ancestor
65145254|NCT02875015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65145255|NCT02875015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145256|NCT02875015|Sensory System Agents|sensory system agents|mesh-ancestor
65145257|NCT02875015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65145258|NCT02875015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65145259|NCT02875015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65145260|NCT02875015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64401034|NCT02034331|Acetylcholine|acetylcholine|mesh-list
65145261|NCT02875015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65145262|NCT02875015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145264|NCT01091428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65145265|NCT01091428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65145266|NCT01091428|Tubulin Modulators|tubulin modulators|mesh-ancestor
65304002|NCT00646841|Doxazosin|doxazosin|mesh-list
65304003|NCT00646841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65304004|NCT00646841|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65304005|NCT00646841|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65304006|NCT00646841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65304007|NCT00646841|Adrenergic Agents|adrenergic agents|mesh-ancestor
65304008|NCT00646841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65304009|NCT00646841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304010|NCT00646841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145267|NCT01091428|Antimitotic Agents|antimitotic agents|mesh-ancestor
65145268|NCT01091428|Mitosis Modulators|mitosis modulators|mesh-ancestor
65145269|NCT01091428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145270|NCT01096342|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
65145271|NCT01096342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65145272|NCT01096342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145273|NCT01096342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145274|NCT01096186|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65145276|NCT01096186|Levodopa|levodopa|mesh-list
65145277|NCT01096186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65145278|NCT01096186|Immunologic Factors|immunologic factors|mesh-ancestor
65145293|NCT01049503|Protective Agents|protective agents|mesh-ancestor
65145294|NCT01049503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145295|NCT04302649|Dialysis Solutions|dialysis solutions|mesh-list
65145296|NCT04302649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65145297|NCT04640779|Salicylates|salicylates|mesh-list
65145298|NCT04640779|Choline|choline|mesh-list
65145299|NCT04640779|Lipotropic Agents|lipotropic agents|mesh-ancestor
65145300|NCT04640779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65145301|NCT04640779|Antimetabolites|antimetabolites|mesh-ancestor
65145302|NCT04640779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145303|NCT04640779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65145304|NCT04640779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65145305|NCT04640779|Nootropic Agents|nootropic agents|mesh-ancestor
65145306|NCT04640779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65145307|NCT04640779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65145308|NCT04640779|Analgesics|analgesics|mesh-ancestor
65145309|NCT04640779|Sensory System Agents|sensory system agents|mesh-ancestor
65145310|NCT04640779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65145311|NCT04640779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145312|NCT04640779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65145313|NCT04640779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65145314|NCT04640779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65145315|NCT04640779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145316|NCT04301557|Capecitabine|capecitabine|mesh-list
65145317|NCT04301557|Oxaliplatin|oxaliplatin|mesh-list
65145318|NCT04301557|Antibodies|antibodies|mesh-list
65145319|NCT04301557|Immunologic Factors|immunologic factors|mesh-ancestor
65145320|NCT04301557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145321|NCT04301557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65145322|NCT04301557|Antimetabolites|antimetabolites|mesh-ancestor
65145323|NCT04301557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145324|NCT04301557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65145325|NCT02874313|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65145326|NCT02874313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145327|NCT01029535|Hyaluronic Acid|hyaluronic acid|mesh-list
65145328|NCT01029535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65145329|NCT01029535|Immunologic Factors|immunologic factors|mesh-ancestor
65145330|NCT01029535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145331|NCT01029535|Viscosupplements|viscosupplements|mesh-ancestor
65145332|NCT01029535|Protective Agents|protective agents|mesh-ancestor
65145333|NCT04301323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65145334|NCT04301323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65145335|NCT01028053|Flutemetamol|flutemetamol|mesh-list
65145336|NCT01028053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65145337|NCT01028053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304011|NCT04786067|Abatacept|abatacept|mesh-list
65304012|NCT04786067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65304013|NCT04786067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304014|NCT04786067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304015|NCT04786067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65304016|NCT04786067|Immunologic Factors|immunologic factors|mesh-ancestor
65304017|NCT04786067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304018|NCT04786067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65304019|NCT00646139|Tirbanibulin|tirbanibulin|mesh-list
65145339|NCT01023217|Adefovir|adefovir|mesh-list
65145340|NCT01023217|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65145341|NCT01023217|Entecavir|entecavir|mesh-list
65145352|NCT01095796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65145353|NCT01095796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65145354|NCT01095796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145355|NCT01095796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145356|NCT01095796|Antiviral Agents|antiviral agents|mesh-ancestor
65145357|NCT01095796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65145358|NCT01095796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65145359|NCT01095796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65145361|NCT01023061|Leuprolide|leuprolide|mesh-list
65145362|NCT01023061|Goserelin|goserelin|mesh-list
65145363|NCT01023061|Abiraterone Acetate|abiraterone acetate|mesh-list
65145364|NCT01023061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65145365|NCT01023061|Glucocorticoids|glucocorticoids|mesh-ancestor
65145366|NCT01023061|Hormones|hormones|mesh-ancestor
65145367|NCT01023061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65145368|NCT01023061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145369|NCT01023061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65145370|NCT01023061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65145371|NCT01023061|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65145372|NCT01023061|Fertility Agents|fertility agents|mesh-ancestor
65145373|NCT01023061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65145374|NCT01023061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65145375|NCT01023061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145376|NCT01023061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145377|NCT01023061|Hormone Antagonists|hormone antagonists|mesh-ancestor
65145378|NCT01023061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65145379|NCT01027897|Doripenem|doripenem|mesh-list
65145380|NCT01027897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65145381|NCT01027897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65145382|NCT01027351|Vaccines|vaccines|mesh-list
65145383|NCT01027351|Immunologic Factors|immunologic factors|mesh-ancestor
65145384|NCT01027351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145385|NCT05661045|Anesthetics|anesthetics|mesh-list
65145386|NCT05661045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65145387|NCT05661045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145388|NCT01294683|Niacin|niacin|mesh-list
65145389|NCT01294683|Niacinamide|niacinamide|mesh-list
65145390|NCT01294683|Nicotinic Acids|nicotinic acids|mesh-list
65145391|NCT01294683|Simvastatin|simvastatin|mesh-list
65145392|NCT01294683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65145393|NCT01294683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65145394|NCT01294683|Antimetabolites|antimetabolites|mesh-ancestor
65145395|NCT01294683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145396|NCT01294683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65145397|NCT01294683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65145398|NCT01294683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145399|NCT01294683|Vasodilator Agents|vasodilator agents|mesh-ancestor
65145400|NCT01294683|Vitamin B Complex|vitamin b complex|mesh-ancestor
65145401|NCT01294683|Vitamins|vitamins|mesh-ancestor
65145406|NCT01294449|Methotrexate|methotrexate|mesh-list
65145407|NCT01294449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65145408|NCT01294449|Antimetabolites|antimetabolites|mesh-ancestor
64678614|NCT00002223|Ritonavir|ritonavir|mesh-list
65145409|NCT01294449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145410|NCT01294449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304020|NCT00646139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304021|NCT00646139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304022|NCT00484159|Lidocaine|lidocaine|mesh-list
65304023|NCT00484159|Bupivacaine|bupivacaine|mesh-list
65304024|NCT00484159|Anesthetics, Local|anesthetics, local|mesh-ancestor
65304025|NCT00484159|Anesthetics|anesthetics|mesh-ancestor
65304026|NCT00484159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65304027|NCT00484159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534010|NCT02326038|Dopamine Agents|dopamine agents|mesh-ancestor
65145411|NCT01294449|Antiviral Agents|antiviral agents|mesh-ancestor
65145412|NCT01294449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65145413|NCT01294449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65145414|NCT01294449|Immunologic Factors|immunologic factors|mesh-ancestor
65145415|NCT01294449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145416|NCT01294449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65145417|NCT01294449|Antiemetics|antiemetics|mesh-ancestor
65145418|NCT01294449|Autonomic Agents|autonomic agents|mesh-ancestor
65145419|NCT01294449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65145420|NCT01294449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65145421|NCT01294449|Glucocorticoids|glucocorticoids|mesh-ancestor
64787964|NCT05752110|Ketamine|ketamine|mesh-list
65145422|NCT01294449|Hormones|hormones|mesh-ancestor
65145423|NCT01294449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65145424|NCT01294449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65145425|NCT01294449|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65145426|NCT01294449|Abortifacient Agents|abortifacient agents|mesh-ancestor
65145427|NCT01294449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65145428|NCT01294449|Dermatologic Agents|dermatologic agents|mesh-ancestor
65145429|NCT01294449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145430|NCT01294449|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65145431|NCT01294449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65145432|NCT01294449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65145433|NCT01293123|Tenofovir|tenofovir|mesh-list
65145434|NCT01293123|Emtricitabine|emtricitabine|mesh-list
65145435|NCT01293123|Efavirenz|efavirenz|mesh-list
65145436|NCT01293123|Raltegravir Potassium|raltegravir potassium|mesh-list
65145437|NCT01293123|Antiviral Agents|antiviral agents|mesh-ancestor
65145438|NCT01293123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65145439|NCT01293123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65145440|NCT01293123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65145441|NCT01293123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145442|NCT01293123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145443|NCT01293123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65145444|NCT01293123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65145445|NCT01293123|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65145446|NCT01293123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65145447|NCT01293123|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65145448|NCT01293123|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65145449|NCT01293123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65145450|NCT01293123|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65145451|NCT01293123|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65145452|NCT01293123|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65145453|NCT01292187|Calcitonin|calcitonin|mesh-list
65145454|NCT01292187|Salmon calcitonin|salmon calcitonin|mesh-list
65145455|NCT01292187|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
65145456|NCT01292187|Katacalcin|katacalcin|mesh-list
65145457|NCT01292187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65145458|NCT01292187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145459|NCT01292187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65145460|NCT01292187|Vasodilator Agents|vasodilator agents|mesh-ancestor
65145461|NCT01026493|Temozolomide|temozolomide|mesh-list
65145462|NCT01026493|Veliparib|veliparib|mesh-list
65145463|NCT01026493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65145464|NCT01026493|Alkylating Agents|alkylating agents|mesh-ancestor
65145465|NCT01026493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145466|NCT01026493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304028|NCT00484159|Sensory System Agents|sensory system agents|mesh-ancestor
65304029|NCT00484159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65304030|NCT00484159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65304031|NCT00484159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65304032|NCT00484159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65304033|NCT00484159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65304034|NCT00484159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304035|NCT02666417|Iron|iron|mesh-list
65304036|NCT02666417|Trace Elements|trace elements|mesh-ancestor
65304037|NCT02666417|Micronutrients|micronutrients|mesh-ancestor
65304038|NCT02666417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304039|NCT00910637|Gestodene|gestodene|mesh-list
65304040|NCT00910637|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65304041|NCT00910637|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65304042|NCT00910637|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65145467|NCT01026493|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65145468|NCT01026493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145469|NCT01291173|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65145470|NCT01291173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65145487|NCT01290315|Anticoagulants|anticoagulants|mesh-ancestor
65145488|NCT01290315|Plasma Substitutes|plasma substitutes|mesh-ancestor
65145489|NCT01290315|Blood Substitutes|blood substitutes|mesh-ancestor
65145490|NCT01289847|gamma-Globulins|gamma-globulins|mesh-list
65145491|NCT01289847|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65145492|NCT01289847|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65145493|NCT01289847|Immunologic Factors|immunologic factors|mesh-ancestor
65145494|NCT01289847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145495|NCT01021813|Suvorexant|suvorexant|mesh-list
65145496|NCT01021813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64788022|NCT05748990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65145497|NCT01021813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65145498|NCT01021813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65145499|NCT01021813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145500|NCT01021813|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65145501|NCT01021813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65145502|NCT01021813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145504|NCT01025635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65145505|NCT01025635|Dermatologic Agents|dermatologic agents|mesh-ancestor
65145506|NCT01021423|Lenalidomide|lenalidomide|mesh-list
65145507|NCT01021423|Immunologic Factors|immunologic factors|mesh-ancestor
65145508|NCT01021423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145509|NCT01021423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65145510|NCT01021423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65145511|NCT01021423|Growth Substances|growth substances|mesh-ancestor
65145512|NCT01021423|Growth Inhibitors|growth inhibitors|mesh-ancestor
65145513|NCT01021423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65145514|NCT01020877|Metronidazole|metronidazole|mesh-list
65145515|NCT01020877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65145516|NCT01020877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65145517|NCT01020877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65145518|NCT01020877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65145519|NCT01020799|Citalopram|citalopram|mesh-list
65145520|NCT01020799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65145521|NCT01020799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65145522|NCT01020799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65145523|NCT01020799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145524|NCT01020799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65145525|NCT01020799|Serotonin Agents|serotonin agents|mesh-ancestor
65145526|NCT01020799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304043|NCT00910637|Contraceptive Agents|contraceptive agents|mesh-ancestor
65304044|NCT00910637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65304045|NCT00910637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304046|NCT00910637|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65304047|NCT00910637|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65304048|NCT00910637|Progestins|progestins|mesh-ancestor
65304049|NCT00910637|Hormones|hormones|mesh-ancestor
65304050|NCT00910637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65304051|NCT00462865|Gemcitabine|gemcitabine|mesh-list
65304052|NCT00462865|Bevacizumab|bevacizumab|mesh-list
65304053|NCT00462865|Capecitabine|capecitabine|mesh-list
65304054|NCT00462865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65304055|NCT00462865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304056|NCT00462865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65304057|NCT00462865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65304058|NCT00462865|Growth Substances|growth substances|mesh-ancestor
65304059|NCT00462865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304060|NCT00462865|Growth Inhibitors|growth inhibitors|mesh-ancestor
65304061|NCT00462865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65304062|NCT00462865|Antimetabolites|antimetabolites|mesh-ancestor
65304063|NCT00462865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304064|NCT00462865|Antiviral Agents|antiviral agents|mesh-ancestor
65145527|NCT01020799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65145545|NCT02872597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65145546|NCT02872597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65145547|NCT02872597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145548|NCT02872597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65145549|NCT02872597|Protective Agents|protective agents|mesh-ancestor
65145550|NCT02872597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65145551|NCT02872597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65145552|NCT02872597|Respiratory System Agents|respiratory system agents|mesh-ancestor
65145553|NCT02872597|Tocolytic Agents|tocolytic agents|mesh-ancestor
65145554|NCT02872597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65145555|NCT02872597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65145557|NCT02872597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65145558|NCT02872597|Adrenergic Agents|adrenergic agents|mesh-ancestor
65145559|NCT02872597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65145560|NCT02872597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65145561|NCT02872597|Cholinergic Agents|cholinergic agents|mesh-ancestor
65145562|NCT02873065|Amoxicillin|amoxicillin|mesh-list
65145563|NCT02873065|Clarithromycin|clarithromycin|mesh-list
65145564|NCT02873065|Potassium Citrate|potassium citrate|mesh-list
65145565|NCT02873065|Bismuth|bismuth|mesh-list
65145566|NCT02873065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145567|NCT02873065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65145568|NCT02873065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65145569|NCT02873065|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65145570|NCT02873065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145571|NCT02873065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65145572|NCT02873065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65145573|NCT02873065|Antacids|antacids|mesh-ancestor
65304065|NCT00462865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65304066|NCT00462865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304067|NCT00462865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65304068|NCT00462865|Immunologic Factors|immunologic factors|mesh-ancestor
65304069|NCT02667353|Anesthetics|anesthetics|mesh-list
65304070|NCT02667353|Etomidate|etomidate|mesh-list
65304071|NCT02667353|Succinylcholine|succinylcholine|mesh-list
65145574|NCT02873065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65145575|NCT02873065|Diuretics|diuretics|mesh-ancestor
65145576|NCT02873065|Natriuretic Agents|natriuretic agents|mesh-ancestor
65145577|NCT02873065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145578|NCT02873065|Expectorants|expectorants|mesh-ancestor
65145579|NCT02873065|Respiratory System Agents|respiratory system agents|mesh-ancestor
65145580|NCT00628225|Bupropion|bupropion|mesh-list
65145581|NCT00628225|Nicotine|nicotine|mesh-list
65145582|NCT00628225|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65145583|NCT00628225|Autonomic Agents|autonomic agents|mesh-ancestor
65145584|NCT00628225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65145585|NCT00628225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145586|NCT00628225|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65145587|NCT00628225|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65145588|NCT00628225|Cholinergic Agents|cholinergic agents|mesh-ancestor
65145589|NCT00628225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65145598|NCT00628225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65145599|NCT00628225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65145601|NCT01014013|Ceftriaxone|ceftriaxone|mesh-list
65145602|NCT01014013|Ertapenem|ertapenem|mesh-list
65145603|NCT01014013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65145604|NCT01014013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65145605|NCT01013701|Fluticasone|fluticasone|mesh-list
65145606|NCT01013701|Xhance|xhance|mesh-list
65145607|NCT01013701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65145608|NCT01013701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65145609|NCT01013701|Autonomic Agents|autonomic agents|mesh-ancestor
65145610|NCT01013701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65145611|NCT01013701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145612|NCT01013701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65145613|NCT01013701|Respiratory System Agents|respiratory system agents|mesh-ancestor
65145614|NCT01013701|Dermatologic Agents|dermatologic agents|mesh-ancestor
65145615|NCT01013701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65145616|NCT01020019|Lofexidine|lofexidine|mesh-list
65145617|NCT01020019|Dronabinol|dronabinol|mesh-list
65145618|NCT01020019|Hallucinogens|hallucinogens|mesh-ancestor
65145619|NCT01020019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145620|NCT01020019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65145621|NCT01020019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65145622|NCT01020019|Analgesics|analgesics|mesh-ancestor
65145623|NCT01020019|Sensory System Agents|sensory system agents|mesh-ancestor
65145624|NCT01020019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65145625|NCT01020019|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65145626|NCT01020019|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65145627|NCT01020019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65145628|NCT01020019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145629|NCT01020019|Hormones|hormones|mesh-ancestor
64714047|NCT02969876|Serotonin Agents|serotonin agents|mesh-ancestor
65145630|NCT01020019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65145631|NCT01020019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65145632|NCT01020019|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65145633|NCT01020019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65145634|NCT01020019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65145635|NCT01020019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65145636|NCT01020019|Adrenergic Agents|adrenergic agents|mesh-ancestor
65145637|NCT00627835|Cisplatin|cisplatin|mesh-list
65145638|NCT00627835|Sorafenib|sorafenib|mesh-list
65145639|NCT00627835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65145640|NCT00627835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65145641|NCT00627835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145642|NCT00627835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145643|NCT01019317|Cytarabine|cytarabine|mesh-list
65145644|NCT01019317|Fludarabine|fludarabine|mesh-list
65145645|NCT01019317|Fludarabine phosphate|fludarabine phosphate|mesh-list
65145646|NCT01019317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053962|NCT04709094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65304072|NCT02667353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65304073|NCT02667353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304074|NCT02667353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65304075|NCT02667353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65145647|NCT01019317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65145648|NCT01019317|Antimetabolites|antimetabolites|mesh-ancestor
65145649|NCT01019317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145650|NCT01019317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65145651|NCT01019317|Immunologic Factors|immunologic factors|mesh-ancestor
65145652|NCT01019317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145653|NCT01019317|Antiviral Agents|antiviral agents|mesh-ancestor
65145668|NCT01288443|Atorvastatin|atorvastatin|mesh-list
65145669|NCT01288443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65145670|NCT01288443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65145671|NCT01288443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65145672|NCT01288443|Antimetabolites|antimetabolites|mesh-ancestor
65145673|NCT01288443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145674|NCT01288443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65145675|NCT01288443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65145676|NCT01288443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145677|NCT01288443|Immunologic Factors|immunologic factors|mesh-ancestor
65145678|NCT01288443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145679|NCT01288209|Ribavirin|ribavirin|mesh-list
65145680|NCT01288209|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65145681|NCT01288209|Simeprevir|simeprevir|mesh-list
65145682|NCT01288209|Antimetabolites|antimetabolites|mesh-ancestor
65145683|NCT01288209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145684|NCT01288209|Antiviral Agents|antiviral agents|mesh-ancestor
65145685|NCT01288209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65145686|NCT01288209|Protease Inhibitors|protease inhibitors|mesh-ancestor
65145687|NCT01288209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145688|NCT01287195|Omeprazole|omeprazole|mesh-list
65145689|NCT01287195|Muromonab-CD3|muromonab-cd3|mesh-list
65145690|NCT01287195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65145691|NCT01287195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65145692|NCT01287195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65145693|NCT01287195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145694|NCT01287195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145695|NCT01287195|Immunologic Factors|immunologic factors|mesh-ancestor
65145696|NCT01287195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145697|NCT01287195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65145698|NCT01287117|Omalizumab|omalizumab|mesh-list
65145699|NCT01287117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65145700|NCT01287117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65145701|NCT01287117|Respiratory System Agents|respiratory system agents|mesh-ancestor
65145702|NCT01287039|Reslizumab|reslizumab|mesh-list
65145703|NCT01287039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65145704|NCT01287039|Respiratory System Agents|respiratory system agents|mesh-ancestor
65145705|NCT05572203|Caseins|caseins|mesh-list
65145706|NCT05572203|Chelating Agents|chelating agents|mesh-ancestor
65145707|NCT05572203|Sequestering Agents|sequestering agents|mesh-ancestor
65145708|NCT05572203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145709|NCT01285401|Interferons|interferons|mesh-list
65145710|NCT01285401|Interferon-beta|interferon-beta|mesh-list
65145711|NCT01285401|Interferon beta-1a|interferon beta-1a|mesh-list
65145712|NCT01285401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65145713|NCT01285401|Antiviral Agents|antiviral agents|mesh-ancestor
65145714|NCT01285401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65145715|NCT01285401|Immunologic Factors|immunologic factors|mesh-ancestor
65145725|NCT01284621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145726|NCT01284621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145727|NCT01284621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65145728|NCT01284621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65145729|NCT01284621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65145730|NCT01284621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145731|NCT01283139|Sifalimumab|sifalimumab|mesh-list
65145732|NCT01283139|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65145733|NCT01283139|Immunologic Factors|immunologic factors|mesh-ancestor
65145734|NCT01283139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145735|NCT01281969|Immunoglobulins|immunoglobulins|mesh-list
65304076|NCT02667353|Anesthetics, General|anesthetics, general|mesh-ancestor
65304077|NCT02667353|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
65304078|NCT02667353|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65304079|NCT02667353|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65304080|NCT02667353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65304081|NCT00462709|Complement C1s|complement c1s|mesh-list
65304082|NCT00462709|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
65304083|NCT00462709|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
65304084|NCT00462709|Immunologic Factors|immunologic factors|mesh-ancestor
65304085|NCT00462709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304086|NCT00462709|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65304087|NCT00462709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65304088|NCT02664857|Vitamin D|vitamin d|mesh-list
65304089|NCT02664857|Ergocalciferols|ergocalciferols|mesh-list
65304090|NCT02664857|Cholecalciferol|cholecalciferol|mesh-list
65304091|NCT02664857|Vitamins|vitamins|mesh-list
65304092|NCT02664857|Micronutrients|micronutrients|mesh-ancestor
65304093|NCT02664857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304094|NCT02664857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65304095|NCT02664857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65304096|NCT02665871|Vaccines|vaccines|mesh-list
65304097|NCT02665871|Immunologic Factors|immunologic factors|mesh-ancestor
64534063|NCT02327676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65145736|NCT01281969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65145737|NCT01281969|Antibodies|antibodies|mesh-list
65145738|NCT01281969|gamma-Globulins|gamma-globulins|mesh-list
65145739|NCT01281969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65145740|NCT01281969|Immunologic Factors|immunologic factors|mesh-ancestor
65145741|NCT01281969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145742|NCT01281813|Ritonavir|ritonavir|mesh-list
65145743|NCT01281813|Darunavir|darunavir|mesh-list
65145744|NCT01281813|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65145745|NCT01281813|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65145746|NCT01281813|Protease Inhibitors|protease inhibitors|mesh-ancestor
65145747|NCT01281813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145748|NCT01281813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145749|NCT01281813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65145750|NCT01281813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65145751|NCT01281813|Antiviral Agents|antiviral agents|mesh-ancestor
65145752|NCT01281813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65145753|NCT01281813|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65145754|NCT01281813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65145755|NCT01090414|Idelalisib|idelalisib|mesh-list
65145756|NCT01090414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65145757|NCT01090414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145758|NCT01090414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145759|NCT01090102|Aminosalicylic Acid|aminosalicylic acid|mesh-list
65145760|NCT01090102|Mesalamine|mesalamine|mesh-list
65145761|NCT01090102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65145762|NCT01090102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65145763|NCT01090102|Analgesics|analgesics|mesh-ancestor
65145764|NCT01090102|Sensory System Agents|sensory system agents|mesh-ancestor
65304098|NCT02665871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304099|NCT00647543|Atorvastatin|atorvastatin|mesh-list
65304100|NCT00647543|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65304101|NCT00647543|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65304102|NCT00647543|Antimetabolites|antimetabolites|mesh-ancestor
65145765|NCT01090102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65145766|NCT01090102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145767|NCT01090102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65145768|NCT01090102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65145769|NCT01090102|Antitubercular Agents|antitubercular agents|mesh-ancestor
65145770|NCT01090102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65145771|NCT01090102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65145772|NCT01281189|Pramipexole|pramipexole|mesh-list
65145773|NCT01281189|Antioxidants|antioxidants|mesh-ancestor
65145774|NCT01281189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145775|NCT01281189|Protective Agents|protective agents|mesh-ancestor
65145776|NCT01281189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145777|NCT01281189|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65145778|NCT01281189|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65145779|NCT01281189|Dopamine Agonists|dopamine agonists|mesh-ancestor
65145780|NCT01281189|Dopamine Agents|dopamine agents|mesh-ancestor
65145781|NCT01281189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65145783|NCT04306666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65145795|NCT01087762|Certolizumab Pegol|certolizumab pegol|mesh-list
65145796|NCT01087762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65145797|NCT01087762|Immunologic Factors|immunologic factors|mesh-ancestor
65145798|NCT01087762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145799|NCT01087762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65145800|NCT04306354|Oxytocin|oxytocin|mesh-list
65145801|NCT04306354|Oxytocics|oxytocics|mesh-ancestor
65145802|NCT04306354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65145803|NCT04306354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145804|NCT04306276|Dienogest|dienogest|mesh-list
65145805|NCT04306276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65145806|NCT04306276|Contraceptive Agents|contraceptive agents|mesh-ancestor
65145807|NCT04306276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65145808|NCT04306276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145809|NCT04306276|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65145810|NCT04306276|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65145811|NCT04306276|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65145812|NCT04306276|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65145813|NCT04306276|Hormone Antagonists|hormone antagonists|mesh-ancestor
65145814|NCT04306276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65145815|NCT04306276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65145816|NCT04306276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65145817|NCT01078168|Acitretin|acitretin|mesh-list
65145818|NCT01078168|Keratolytic Agents|keratolytic agents|mesh-ancestor
65145819|NCT01078168|Dermatologic Agents|dermatologic agents|mesh-ancestor
65145820|NCT01086358|Naproxen|naproxen|mesh-list
65145821|NCT01086358|Sumatriptan|sumatriptan|mesh-list
65145822|NCT01086358|Naratriptan|naratriptan|mesh-list
65145823|NCT01086358|Zolmitriptan|zolmitriptan|mesh-list
65145824|NCT01086358|Rizatriptan|rizatriptan|mesh-list
65145825|NCT01086358|Eletriptan|eletriptan|mesh-list
65145826|NCT01086358|Almotriptan|almotriptan|mesh-list
65145827|NCT01086358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65145828|NCT01086358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65145829|NCT01086358|Analgesics|analgesics|mesh-ancestor
65145830|NCT01086358|Sensory System Agents|sensory system agents|mesh-ancestor
65145831|NCT01086358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65145832|NCT01086358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145833|NCT01086358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65145834|NCT01086358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65145835|NCT01086358|Gout Suppressants|gout suppressants|mesh-ancestor
65145836|NCT01086358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65145837|NCT01086358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145838|NCT01086358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145839|NCT01086358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65145840|NCT01086358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65145841|NCT01086358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65145842|NCT01086358|Serotonin Agents|serotonin agents|mesh-ancestor
65304103|NCT00647543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304104|NCT00647543|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65304105|NCT00647543|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65304106|NCT00647543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304107|NCT00647621|Phenytoin|phenytoin|mesh-list
65304108|NCT00647621|Anticonvulsants|anticonvulsants|mesh-ancestor
65304109|NCT00647621|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65304110|NCT00647621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65304111|NCT00647621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65304112|NCT00647621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304113|NCT00647621|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65304114|NCT00647621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65304115|NCT00461305|Drospirenone|drospirenone|mesh-list
65304116|NCT00461305|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65145843|NCT01086358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65145844|NCT01277601|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65145845|NCT01277601|Antiviral Agents|antiviral agents|mesh-ancestor
65145846|NCT01277601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65145847|NCT01277523|Tiotropium Bromide|tiotropium bromide|mesh-list
65145848|NCT01277523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65145862|NCT01081834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145863|NCT01081834|Incretins|incretins|mesh-ancestor
65145864|NCT01081834|Hormones|hormones|mesh-ancestor
65145865|NCT01081834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65145866|NCT01081834|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65145867|NCT01081834|Protease Inhibitors|protease inhibitors|mesh-ancestor
65145868|NCT01081834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145869|NCT01081834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145870|NCT01081834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65145871|NCT01079962|Atenolol|atenolol|mesh-list
65145872|NCT01079962|Bisoprolol|bisoprolol|mesh-list
65145873|NCT01079962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65145874|NCT01079962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65145875|NCT01079962|Sympatholytics|sympatholytics|mesh-ancestor
65145876|NCT01079962|Autonomic Agents|autonomic agents|mesh-ancestor
65145877|NCT01079962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65145878|NCT01079962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145879|NCT01079962|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65145880|NCT01079962|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65145881|NCT01079962|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65145882|NCT01079962|Adrenergic Agents|adrenergic agents|mesh-ancestor
65145883|NCT01079962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65145884|NCT01079962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145885|NCT01274637|Dalteparin|dalteparin|mesh-list
65145886|NCT01274637|Tinzaparin|tinzaparin|mesh-list
65145887|NCT01274637|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65145888|NCT01274637|Anticoagulants|anticoagulants|mesh-ancestor
65145889|NCT01274637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65145890|NCT01274637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65145891|NCT01274637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145892|NCT01079806|Entecavir|entecavir|mesh-list
65145893|NCT01079806|Antiviral Agents|antiviral agents|mesh-ancestor
65145894|NCT01079806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65145895|NCT02876770|Melatonin|melatonin|mesh-list
65145896|NCT02876770|Antioxidants|antioxidants|mesh-ancestor
65145897|NCT02876770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145898|NCT02876770|Protective Agents|protective agents|mesh-ancestor
65145899|NCT02876770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304117|NCT00461305|Hormone Antagonists|hormone antagonists|mesh-ancestor
65304118|NCT00461305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65304119|NCT00461305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304120|NCT00461305|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65304121|NCT00461305|Diuretics|diuretics|mesh-ancestor
65304122|NCT00461305|Natriuretic Agents|natriuretic agents|mesh-ancestor
65304123|NCT01022671|Belotecan|belotecan|mesh-list
65304124|NCT01022671|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65304125|NCT01022671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65304126|NCT01022671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304127|NCT01022671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304128|NCT01022671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304129|NCT01022749|Vaccines|vaccines|mesh-list
65304130|NCT01022749|Immunologic Factors|immunologic factors|mesh-ancestor
65304131|NCT01022749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304132|NCT00645905|Adalimumab|adalimumab|mesh-list
65304133|NCT00645905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65304134|NCT00645905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65304135|NCT00647777|Olanzapine|olanzapine|mesh-list
65304136|NCT00647777|Antiemetics|antiemetics|mesh-ancestor
64534119|NCT03110952|Vaccines|vaccines|mesh-list
65145900|NCT02876770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65145901|NCT01077622|Ofatumumab|ofatumumab|mesh-list
65145902|NCT01077622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65145903|NCT01313676|Fluticasone|fluticasone|mesh-list
65145904|NCT01313676|Xhance|xhance|mesh-list
65145905|NCT01313676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65145906|NCT01313676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65145907|NCT01313676|Autonomic Agents|autonomic agents|mesh-ancestor
65145908|NCT01313676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65145909|NCT01313676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500216|NCT01490788|Amitriptyline|amitriptyline|mesh-list
65145920|NCT00623376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65145921|NCT00623376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65145922|NCT00623376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65145923|NCT00623376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65145924|NCT00623376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65145925|NCT00623376|Hallucinogens|hallucinogens|mesh-ancestor
65145926|NCT00623376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65145927|NCT00623376|Analgesics|analgesics|mesh-ancestor
65145928|NCT00623376|Sensory System Agents|sensory system agents|mesh-ancestor
65145929|NCT00623376|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64679131|NCT04826237|Hormones|hormones|mesh-ancestor
65145930|NCT00623376|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65145931|NCT00623376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65145932|NCT00623376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145934|NCT00623376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65145935|NCT01313286|Globalagliatin|globalagliatin|mesh-list
65145936|NCT01313286|Enzyme Activators|enzyme activators|mesh-ancestor
65145937|NCT01313286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145938|NCT01313208|Etanercept|etanercept|mesh-list
65145939|NCT01313208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65145940|NCT01313208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65145941|NCT01313208|Analgesics|analgesics|mesh-ancestor
65145942|NCT01313208|Sensory System Agents|sensory system agents|mesh-ancestor
65304137|NCT00647777|Autonomic Agents|autonomic agents|mesh-ancestor
65304138|NCT00647777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65304139|NCT00647777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304140|NCT00647777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65304141|NCT00647777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65304142|NCT00647777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65304143|NCT00647777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65304144|NCT00647777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65304145|NCT00647777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65054036|NCT00266058|Antimalarials|antimalarials|mesh-ancestor
65304146|NCT00647777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65145943|NCT01313208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65145944|NCT01313208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145945|NCT01313208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65145946|NCT01313208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65145947|NCT01313208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65145948|NCT01313208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65145949|NCT01313208|Immunologic Factors|immunologic factors|mesh-ancestor
65145950|NCT01075984|Posaconazole|posaconazole|mesh-list
65145951|NCT01075984|Antifungal Agents|antifungal agents|mesh-ancestor
65145952|NCT01075984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65145953|NCT01075984|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65145954|NCT01075984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65145955|NCT01075984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65145956|NCT01075984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65145957|NCT01075984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65145958|NCT01075984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145959|NCT01075984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145960|NCT01075984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65145961|NCT01075984|Hormone Antagonists|hormone antagonists|mesh-ancestor
65145962|NCT01075984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65145963|NCT01075984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145964|NCT01024231|Nivolumab|nivolumab|mesh-list
65145965|NCT01024231|Ipilimumab|ipilimumab|mesh-list
65145966|NCT01024231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65145967|NCT01024231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65145968|NCT01024231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65145969|NCT01024231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145970|NCT04527991|Paclitaxel|paclitaxel|mesh-list
65145971|NCT04527991|Docetaxel|docetaxel|mesh-list
65145972|NCT04527991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65145973|NCT04527991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65145974|NCT04527991|Tubulin Modulators|tubulin modulators|mesh-ancestor
65145984|NCT01012999|Sensory System Agents|sensory system agents|mesh-ancestor
65145985|NCT01012999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65145986|NCT01012999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65145987|NCT01012999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65145988|NCT01012999|Anesthetics, General|anesthetics, general|mesh-ancestor
65145989|NCT01012999|Anesthetics|anesthetics|mesh-ancestor
65145990|NCT00637663|Lamivudine|lamivudine|mesh-list
65145991|NCT00637663|Entecavir|entecavir|mesh-list
65145992|NCT00637663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65145993|NCT00637663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65145994|NCT00637663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145995|NCT00637663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145996|NCT00637663|Antiviral Agents|antiviral agents|mesh-ancestor
65145997|NCT00637663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65145998|NCT00637663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65145999|NCT00637663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65146000|NCT01016977|Nicotinic Acids|nicotinic acids|mesh-list
65146001|NCT01016977|Clindamycin|clindamycin|mesh-list
65146002|NCT01016977|Clindamycin palmitate|clindamycin palmitate|mesh-list
65146003|NCT01016977|Clindamycin phosphate|clindamycin phosphate|mesh-list
65304147|NCT00647777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65304148|NCT00647777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304149|NCT00647777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65304151|NCT04173611|Bupivacaine|bupivacaine|mesh-list
65304152|NCT04173611|Anesthetics, Local|anesthetics, local|mesh-ancestor
65304153|NCT04173611|Anesthetics|anesthetics|mesh-ancestor
65304154|NCT04173611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65304155|NCT04173611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304156|NCT04173611|Sensory System Agents|sensory system agents|mesh-ancestor
65304157|NCT04173611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65304158|NCT02665637|Trastuzumab|trastuzumab|mesh-list
65304159|NCT02665637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64298735|NCT02091505|Ranibizumab|ranibizumab|mesh-list
65146005|NCT01016977|Tazarotene|tazarotene|mesh-list
65146006|NCT01016977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65146007|NCT01016977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65146008|NCT01016977|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65146009|NCT01016977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146010|NCT01016977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146011|NCT01016977|Dermatologic Agents|dermatologic agents|mesh-ancestor
65146012|NCT01016977|Keratolytic Agents|keratolytic agents|mesh-ancestor
65146013|NCT01016977|Vitamin B Complex|vitamin b complex|mesh-ancestor
65146014|NCT01016977|Vitamins|vitamins|mesh-ancestor
65146015|NCT01016977|Micronutrients|micronutrients|mesh-ancestor
65146016|NCT01016977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146017|NCT02871661|Amitriptyline|amitriptyline|mesh-list
65146018|NCT02871661|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65146019|NCT02871661|Antidepressive Agents|antidepressive agents|mesh-ancestor
65146020|NCT02871661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65146021|NCT02871661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65146022|NCT02871661|Analgesics|analgesics|mesh-ancestor
65146023|NCT02871661|Sensory System Agents|sensory system agents|mesh-ancestor
65146024|NCT02871661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65146025|NCT02871661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146026|NCT02871661|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65146027|NCT02871661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65146028|NCT02871661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65146029|NCT02871661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146030|NCT02871661|Adrenergic Agents|adrenergic agents|mesh-ancestor
65146031|NCT02871661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65146032|NCT01012765|Tiotropium Bromide|tiotropium bromide|mesh-list
65146033|NCT01012765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65146034|NCT01012765|Autonomic Agents|autonomic agents|mesh-ancestor
65146035|NCT01012765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65146036|NCT01012765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146037|NCT01012765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65146038|NCT01012765|Respiratory System Agents|respiratory system agents|mesh-ancestor
65146039|NCT01012765|Parasympatholytics|parasympatholytics|mesh-ancestor
65146040|NCT01012765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64500340|NCT01873170|Progestins|progestins|mesh-ancestor
65146052|NCT00627991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65146053|NCT00627991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65146054|NCT00627991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146055|NCT04205227|Pembrolizumab|pembrolizumab|mesh-list
65146056|NCT04205227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65146057|NCT04205227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146059|NCT01006291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65146060|NCT01006291|Insulin Glargine|insulin glargine|mesh-list
65146061|NCT01006291|Insulin, Long-Acting|insulin, long-acting|mesh-list
65146062|NCT01006291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65304160|NCT02665637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304161|NCT04733183|Dacarbazine|dacarbazine|mesh-list
65304162|NCT04733183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65304163|NCT04733183|Alkylating Agents|alkylating agents|mesh-ancestor
65304164|NCT04733183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304165|NCT04733183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304166|NCT00648011|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65304167|NCT00648011|Quinapril|quinapril|mesh-list
65304168|NCT00648011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65304169|NCT00648011|Diuretics|diuretics|mesh-ancestor
65304170|NCT00648011|Natriuretic Agents|natriuretic agents|mesh-ancestor
65304171|NCT00648011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304172|NCT00648011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65304173|NCT00648011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65304174|NCT00648011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304175|NCT00648011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65304176|NCT00648011|Protease Inhibitors|protease inhibitors|mesh-ancestor
65304177|NCT00648011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304178|NCT00646529|Budesonide|budesonide|mesh-list
64534149|NCT03143244|Anesthetics|anesthetics|mesh-ancestor
65146063|NCT01006291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146064|NCT04296175|Paclitaxel|paclitaxel|mesh-list
65146065|NCT04296175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65146066|NCT04296175|Carboplatin|carboplatin|mesh-list
65146067|NCT04296175|Epirubicin|epirubicin|mesh-list
65146068|NCT04296175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65146069|NCT04296175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146070|NCT04296175|Tubulin Modulators|tubulin modulators|mesh-ancestor
65146071|NCT04296175|Antimitotic Agents|antimitotic agents|mesh-ancestor
65146072|NCT04296175|Mitosis Modulators|mitosis modulators|mesh-ancestor
65146073|NCT04296175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146074|NCT04296175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65146075|NCT04296175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65146076|NCT04296175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65146077|NCT04296175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146078|NCT04420195|Tacrolimus|tacrolimus|mesh-list
65146079|NCT04420195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65146080|NCT04420195|Immunologic Factors|immunologic factors|mesh-ancestor
65146081|NCT04420195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146082|NCT04420195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65146083|NCT04420195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146084|NCT04420195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146085|NCT02871349|Propranolol|propranolol|mesh-list
65146086|NCT02871349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65146087|NCT02871349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65146088|NCT02871349|Adrenergic Agents|adrenergic agents|mesh-ancestor
65146089|NCT02871349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65146090|NCT02871349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146091|NCT02871349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146092|NCT02871349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65146093|NCT02871349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65146094|NCT02871349|Vasodilator Agents|vasodilator agents|mesh-ancestor
65146095|NCT01012609|Irinotecan|irinotecan|mesh-list
65146096|NCT01012609|Cetuximab|cetuximab|mesh-list
65304179|NCT00646529|Formoterol Fumarate|formoterol fumarate|mesh-list
65304180|NCT00646529|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65304181|NCT00646529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65304182|NCT00646529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65304183|NCT00646529|Autonomic Agents|autonomic agents|mesh-ancestor
65304184|NCT00646529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65304185|NCT00646529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146097|NCT01012609|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65146098|NCT01012609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65146099|NCT01012609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146100|NCT01012609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146101|NCT01012609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146102|NCT01012609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65146103|NCT04297501|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65146104|NCT04297501|Antiviral Agents|antiviral agents|mesh-ancestor
64500403|NCT02214628|Becaplermin|becaplermin|mesh-list
65146120|NCT01012219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65146121|NCT01012219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65146122|NCT01012219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146123|NCT01012219|Antipyretics|antipyretics|mesh-ancestor
65146124|NCT01012219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65146125|NCT01012219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65146126|NCT01012219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65146127|NCT01012219|Purinergic Agents|purinergic agents|mesh-ancestor
65146128|NCT01012219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65146129|NCT01012219|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65146130|NCT01012219|Antimetabolites|antimetabolites|mesh-ancestor
65146131|NCT01012219|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65146132|NCT01012219|Vasodilator Agents|vasodilator agents|mesh-ancestor
65146133|NCT01012219|Vitamin B Complex|vitamin b complex|mesh-ancestor
65146134|NCT01012219|Vitamins|vitamins|mesh-ancestor
65146135|NCT01012219|Micronutrients|micronutrients|mesh-ancestor
65146136|NCT01011907|Varenicline|varenicline|mesh-list
65146137|NCT01011907|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65146138|NCT01011907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65146139|NCT01011907|Cholinergic Agents|cholinergic agents|mesh-ancestor
65146140|NCT01011907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65146141|NCT01011907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146142|NCT01011907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146143|NCT01011673|Ketorolac|ketorolac|mesh-list
65146144|NCT01011673|Metoclopramide|metoclopramide|mesh-list
65146145|NCT01011673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65146146|NCT01011673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65146147|NCT01011673|Analgesics|analgesics|mesh-ancestor
65146148|NCT01011673|Sensory System Agents|sensory system agents|mesh-ancestor
65146149|NCT01011673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65146150|NCT01011673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146151|NCT01011673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65146152|NCT01011673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65146154|NCT01011673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146155|NCT01011673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146156|NCT01011673|Antiemetics|antiemetics|mesh-ancestor
65146157|NCT01011673|Autonomic Agents|autonomic agents|mesh-ancestor
65146158|NCT01011673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65146159|NCT01011673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65146160|NCT01011673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65146161|NCT01011673|Dopamine Agents|dopamine agents|mesh-ancestor
65146162|NCT01011673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65146163|NCT01311648|Factor VIII|factor viii|mesh-list
65146164|NCT01311648|Coagulants|coagulants|mesh-ancestor
65146165|NCT01011439|Maleic acid|maleic acid|mesh-list
65146166|NCT01011439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146167|NCT01011439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146168|NCT04406857|Capecitabine|capecitabine|mesh-list
65146183|NCT02871193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146184|NCT02871193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65146185|NCT02871193|Glucocorticoids|glucocorticoids|mesh-ancestor
65304186|NCT00646529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65304187|NCT00646529|Respiratory System Agents|respiratory system agents|mesh-ancestor
65304188|NCT00646529|Glucocorticoids|glucocorticoids|mesh-ancestor
65304189|NCT00646529|Hormones|hormones|mesh-ancestor
65304190|NCT00646529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65304191|NCT00646529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65304192|NCT00646529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65304193|NCT00646529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65304194|NCT00646529|Adrenergic Agents|adrenergic agents|mesh-ancestor
65304195|NCT00646529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65304196|NCT00646529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304197|NCT04171817|Chlorhexidine|chlorhexidine|mesh-list
65304198|NCT04171817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65304199|NCT04171817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65304200|NCT04171817|Disinfectants|disinfectants|mesh-ancestor
65304201|NCT00646607|Leucovorin|leucovorin|mesh-list
65304202|NCT00646607|Fluorouracil|fluorouracil|mesh-list
65304203|NCT00646607|Oxaliplatin|oxaliplatin|mesh-list
65304204|NCT00646607|Levoleucovorin|levoleucovorin|mesh-list
65304205|NCT00646607|Antimetabolites|antimetabolites|mesh-ancestor
65304206|NCT00646607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304207|NCT00646607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65304208|NCT00646607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304209|NCT00646607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65304210|NCT00646607|Immunologic Factors|immunologic factors|mesh-ancestor
65146187|NCT02871193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65146188|NCT02871193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65146189|NCT02871193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146190|NCT02871193|Anesthetics, Local|anesthetics, local|mesh-ancestor
65146191|NCT02871193|Anesthetics|anesthetics|mesh-ancestor
65146192|NCT02871193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65146193|NCT02871193|Sensory System Agents|sensory system agents|mesh-ancestor
65146194|NCT01310868|Carmustine|carmustine|mesh-list
65146195|NCT01310868|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65146196|NCT01310868|Levulinic acid|levulinic acid|mesh-list
65146197|NCT01310868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65146198|NCT01310868|Alkylating Agents|alkylating agents|mesh-ancestor
65146199|NCT01310868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146200|NCT01310868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146201|NCT01310868|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65146202|NCT01310868|Dermatologic Agents|dermatologic agents|mesh-ancestor
65146203|NCT01310868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146204|NCT01273155|Belinostat|belinostat|mesh-list
65146205|NCT01273155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146206|NCT01273155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65146207|NCT01273155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146208|NCT01273155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146209|NCT05557851|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
65146210|NCT05557851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65304211|NCT00646607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304212|NCT00646607|Antidotes|antidotes|mesh-ancestor
65304213|NCT00646607|Protective Agents|protective agents|mesh-ancestor
65304214|NCT00646607|Vitamin B Complex|vitamin b complex|mesh-ancestor
65304215|NCT00646607|Vitamins|vitamins|mesh-ancestor
65146211|NCT05557851|Alkylating Agents|alkylating agents|mesh-ancestor
65146212|NCT05557851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146213|NCT05557851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146214|NCT01005901|Glycopyrrolate|glycopyrrolate|mesh-list
65146215|NCT01005901|Bromides|bromides|mesh-list
65146216|NCT01005901|Anticonvulsants|anticonvulsants|mesh-ancestor
65146217|NCT01005901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65146218|NCT01005901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65146219|NCT01005901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65146220|NCT01005901|Cholinergic Agents|cholinergic agents|mesh-ancestor
65146221|NCT01005901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65146222|NCT01005901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146223|NCT01005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146224|NCT02889549|Clopidogrel|clopidogrel|mesh-list
65146225|NCT02889549|Ticagrelor|ticagrelor|mesh-list
65146226|NCT02889549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65146227|NCT02889549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65146242|NCT01309386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65146243|NCT01309386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65146244|NCT01309386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65146245|NCT01309386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65146246|NCT01309386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146247|NCT01309386|Adrenergic Agents|adrenergic agents|mesh-ancestor
65146248|NCT01309386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65146249|NCT04295317|Capecitabine|capecitabine|mesh-list
65146250|NCT04295317|Antibodies|antibodies|mesh-list
65146251|NCT04295317|Antibodies, Blocking|antibodies, blocking|mesh-list
65146252|NCT04295317|Immunologic Factors|immunologic factors|mesh-ancestor
65146253|NCT04295317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146254|NCT04295317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65146255|NCT04295317|Antimetabolites|antimetabolites|mesh-ancestor
65146256|NCT04295317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146257|NCT04295317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146258|NCT01266603|Aldesleukin|aldesleukin|mesh-list
65146259|NCT01266603|Interleukin-2|interleukin-2|mesh-list
65146260|NCT01266603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146261|NCT01266603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65146262|NCT01266603|Analgesics|analgesics|mesh-ancestor
65146263|NCT01266603|Sensory System Agents|sensory system agents|mesh-ancestor
65146264|NCT01266603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65146265|NCT01266603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146266|NCT01266603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65146267|NCT01266603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65146268|NCT01266603|Antiviral Agents|antiviral agents|mesh-ancestor
65146269|NCT01266603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65146271|NCT04295551|Lopinavir|lopinavir|mesh-list
65146272|NCT04295551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65146273|NCT04295551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65146274|NCT04295551|Protease Inhibitors|protease inhibitors|mesh-ancestor
65146275|NCT04295551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146276|NCT04295551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146277|NCT04295551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65146278|NCT04295551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65146279|NCT04295551|Antiviral Agents|antiviral agents|mesh-ancestor
65146280|NCT04295551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65146281|NCT04295551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65146282|NCT04295551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65146283|NCT01266291|Vigabatrin|vigabatrin|mesh-list
65146284|NCT01266291|Anticonvulsants|anticonvulsants|mesh-ancestor
65146285|NCT01266291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146286|NCT01266291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146287|NCT01266291|GABA Agents|gaba agents|mesh-ancestor
65146288|NCT01266291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64500589|NCT02981212|Hormones|hormones|mesh-ancestor
65146300|NCT01004185|Mesalamine|mesalamine|mesh-list
65146301|NCT01004185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65304216|NCT00646607|Micronutrients|micronutrients|mesh-ancestor
65304217|NCT00856544|Tofacitinib|tofacitinib|mesh-list
65304218|NCT00856544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65304219|NCT00856544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304220|NCT00856544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304221|NCT00648245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65304222|NCT00648323|Doxazosin|doxazosin|mesh-list
65304223|NCT00648323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65304224|NCT00648323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65304225|NCT00648323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65304226|NCT00648323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65304227|NCT00648323|Adrenergic Agents|adrenergic agents|mesh-ancestor
65304228|NCT00648323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65146302|NCT01004185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65146304|NCT01004185|Sensory System Agents|sensory system agents|mesh-ancestor
65146305|NCT01004185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65146306|NCT01004185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146307|NCT01004185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65146308|NCT01004185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65146309|NCT01004185|Antitubercular Agents|antitubercular agents|mesh-ancestor
65146310|NCT01004185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65146311|NCT01004185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65146312|NCT01265511|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65146313|NCT01265511|Antiviral Agents|antiviral agents|mesh-ancestor
65146314|NCT01265511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65146315|NCT01264965|Acetaminophen|acetaminophen|mesh-list
65146316|NCT01264965|Oxycodone|oxycodone|mesh-list
65146317|NCT01264965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65146318|NCT01264965|Analgesics|analgesics|mesh-ancestor
65146319|NCT01264965|Sensory System Agents|sensory system agents|mesh-ancestor
65146320|NCT01264965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65146321|NCT01264965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146322|NCT01264965|Antipyretics|antipyretics|mesh-ancestor
65146323|NCT01264965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65146324|NCT01264965|Narcotics|narcotics|mesh-ancestor
65146325|NCT01264965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65146326|NCT01264887|Tapentadol|tapentadol|mesh-list
65146327|NCT01264887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65146328|NCT01264887|Narcotics|narcotics|mesh-ancestor
65146329|NCT01264887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65146330|NCT01264887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146331|NCT01264887|Analgesics|analgesics|mesh-ancestor
65146332|NCT01264887|Sensory System Agents|sensory system agents|mesh-ancestor
65146333|NCT01264887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65146334|NCT01264887|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65146335|NCT01264887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65146336|NCT01264887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65146337|NCT01264887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146338|NCT01264887|Adrenergic Agents|adrenergic agents|mesh-ancestor
65146339|NCT01264887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65146340|NCT01011283|Azacitidine|azacitidine|mesh-list
65146341|NCT01011283|Decitabine|decitabine|mesh-list
65146342|NCT01011283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65146343|NCT01011283|Antimetabolites|antimetabolites|mesh-ancestor
65146344|NCT01011283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146345|NCT01011283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146346|NCT01011283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146347|NCT01263483|Inositol|inositol|mesh-list
65146348|NCT01263483|Alogliptin|alogliptin|mesh-list
65146349|NCT01263483|Voglibose|voglibose|mesh-list
65146350|NCT01263483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65146351|NCT01263483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146352|NCT01263483|Incretins|incretins|mesh-ancestor
65146353|NCT01263483|Hormones|hormones|mesh-ancestor
65304229|NCT00648323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304230|NCT00648323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304231|NCT00856388|Fludarabine|fludarabine|mesh-list
65304232|NCT00856388|Fludarabine phosphate|fludarabine phosphate|mesh-list
65304233|NCT00856388|Melphalan|melphalan|mesh-list
65304234|NCT00856388|Thymoglobulin|thymoglobulin|mesh-list
65304235|NCT00856388|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65304236|NCT00856388|Immunoglobulins|immunoglobulins|mesh-list
65304237|NCT00856388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304238|NCT00856388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65304239|NCT00856388|Antimetabolites|antimetabolites|mesh-ancestor
65304240|NCT00856388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304241|NCT00856388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65304242|NCT00856388|Immunologic Factors|immunologic factors|mesh-ancestor
65304243|NCT00856388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304244|NCT00856388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65304245|NCT00856388|Alkylating Agents|alkylating agents|mesh-ancestor
65304246|NCT00856388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65304247|NCT00648401|Verapamil|verapamil|mesh-list
65304248|NCT00648401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65304249|NCT00648401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65304250|NCT00648401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65304251|NCT00648401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304252|NCT00648401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65304253|NCT00648401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304254|NCT00648401|Vasodilator Agents|vasodilator agents|mesh-ancestor
65304255|NCT02663999|Diazepam|diazepam|mesh-list
64534215|NCT03026881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146354|NCT01263483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65146369|NCT01263093|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65146370|NCT01263093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65146371|NCT01263093|Purinergic Agents|purinergic agents|mesh-ancestor
65146372|NCT01263093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65146373|NCT01263093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146374|NCT01263093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146375|NCT01010971|Ciclesonide|ciclesonide|mesh-list
65146376|NCT01010971|Glucocorticoids|glucocorticoids|mesh-ancestor
65146377|NCT01010971|Hormones|hormones|mesh-ancestor
65146378|NCT01010971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65146379|NCT01010971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146380|NCT01010971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65146381|NCT01306656|Vitamin D|vitamin d|mesh-list
65146382|NCT01306656|Ergocalciferols|ergocalciferols|mesh-list
65146383|NCT01306656|Cholecalciferol|cholecalciferol|mesh-list
65146384|NCT01306656|Vitamins|vitamins|mesh-list
65146385|NCT01306656|Micronutrients|micronutrients|mesh-ancestor
65304256|NCT02663999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65304257|NCT02663999|Anticonvulsants|anticonvulsants|mesh-ancestor
65304258|NCT02663999|Antiemetics|antiemetics|mesh-ancestor
65304259|NCT02663999|Autonomic Agents|autonomic agents|mesh-ancestor
65304260|NCT02663999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65304261|NCT02663999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304262|NCT02663999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65304263|NCT02663999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65146386|NCT01306656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146387|NCT01306656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65146388|NCT01306656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65146389|NCT01003639|Aspirin|aspirin|mesh-list
65146390|NCT01003639|Acetaminophen|acetaminophen|mesh-list
65146391|NCT01003639|Ibuprofen|ibuprofen|mesh-list
65146392|NCT01003639|Naproxen|naproxen|mesh-list
65146393|NCT01003639|Acetazolamide|acetazolamide|mesh-list
65146394|NCT01003639|Codeine|codeine|mesh-list
65146395|NCT01003639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65146396|NCT01003639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65146397|NCT01003639|Analgesics|analgesics|mesh-ancestor
65146398|NCT01003639|Sensory System Agents|sensory system agents|mesh-ancestor
65146399|NCT01003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65146400|NCT01003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146401|NCT01003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65146402|NCT01003639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65146403|NCT01003639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65146404|NCT01003639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65146405|NCT01003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146406|NCT01003639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65146407|NCT01003639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65146409|NCT01003639|Antipyretics|antipyretics|mesh-ancestor
65146410|NCT01003639|Gout Suppressants|gout suppressants|mesh-ancestor
65146411|NCT01003639|Anticonvulsants|anticonvulsants|mesh-ancestor
65146412|NCT01003639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65146413|NCT01003639|Diuretics|diuretics|mesh-ancestor
65146414|NCT01003639|Natriuretic Agents|natriuretic agents|mesh-ancestor
65146415|NCT01003639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65146435|NCT04297033|Antimetabolites|antimetabolites|mesh-ancestor
65146436|NCT04297033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146437|NCT04297033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65146438|NCT04297033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65146439|NCT04297033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146440|NCT04294537|Anesthetics|anesthetics|mesh-list
65146441|NCT04294537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65146442|NCT04294537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146443|NCT04295629|Anesthetics|anesthetics|mesh-list
65146444|NCT04295629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65146445|NCT04295629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146446|NCT01306032|Cyclophosphamide|cyclophosphamide|mesh-list
65146448|NCT01306032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65146449|NCT01306032|Immunologic Factors|immunologic factors|mesh-ancestor
65146450|NCT01306032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146451|NCT01306032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65146452|NCT01306032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65146453|NCT01306032|Alkylating Agents|alkylating agents|mesh-ancestor
65146454|NCT01306032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146455|NCT01306032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146456|NCT01306032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65146457|NCT01306032|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65146458|NCT01306032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146459|NCT01263015|Lamivudine|lamivudine|mesh-list
65146460|NCT01263015|Abacavir|abacavir|mesh-list
65146461|NCT01263015|Dideoxynucleosides|dideoxynucleosides|mesh-list
65146462|NCT01263015|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65146463|NCT01263015|Dolutegravir|dolutegravir|mesh-list
65146464|NCT01263015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65304264|NCT02663999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65304265|NCT02663999|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65304266|NCT02663999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65304267|NCT02663999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65304268|NCT02663999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65304269|NCT02663999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65304270|NCT02663999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65304271|NCT02663999|Anesthetics, General|anesthetics, general|mesh-ancestor
65304272|NCT02663999|Anesthetics|anesthetics|mesh-ancestor
65304273|NCT02663999|GABA Modulators|gaba modulators|mesh-ancestor
65304274|NCT02663999|GABA Agents|gaba agents|mesh-ancestor
65304275|NCT02663999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65304276|NCT02663999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304277|NCT04171427|Lithium Carbonate|lithium carbonate|mesh-list
65304278|NCT04171427|Antidepressive Agents|antidepressive agents|mesh-ancestor
65304279|NCT04171427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65304280|NCT04171427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304281|NCT04171427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304282|NCT04171427|Antimanic Agents|antimanic agents|mesh-ancestor
65304283|NCT04171427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65304284|NCT04171427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65304285|NCT04171427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304286|NCT04171739|Itraconazole|itraconazole|mesh-list
65304287|NCT04171739|Olorofim|olorofim|mesh-list
65304288|NCT04171739|Rifampin|rifampin|mesh-list
65146465|NCT01263015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65146466|NCT01263015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146467|NCT01263015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146468|NCT01263015|Antiviral Agents|antiviral agents|mesh-ancestor
65146469|NCT01263015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65146470|NCT01263015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65146489|NCT04322175|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65146490|NCT04322175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65146492|NCT04322175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146493|NCT04321785|Caffeine|caffeine|mesh-list
65146494|NCT04321785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65146495|NCT04321785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146496|NCT04321785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65146497|NCT04321785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146498|NCT04321785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146499|NCT04321785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65146500|NCT04321785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65146501|NCT04321785|Purinergic Agents|purinergic agents|mesh-ancestor
65146502|NCT04321785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65146503|NCT01305408|Modafinil|modafinil|mesh-list
65146504|NCT01305408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65146505|NCT01305408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146506|NCT01305408|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65146507|NCT01305408|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65146508|NCT01305408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65304289|NCT04171739|Antifungal Agents|antifungal agents|mesh-ancestor
65304290|NCT04171739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65304291|NCT04171739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65304292|NCT04171739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65304293|NCT04171739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494083|NCT03701763|Sensory System Agents|sensory system agents|mesh-ancestor
65304294|NCT04171739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304295|NCT04171739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65304296|NCT04171739|Hormone Antagonists|hormone antagonists|mesh-ancestor
65304297|NCT04171739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65304298|NCT04171739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304299|NCT04171739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65304300|NCT04171739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65304301|NCT04171739|Antitubercular Agents|antitubercular agents|mesh-ancestor
65304302|NCT04171739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65146509|NCT01305408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146510|NCT01261611|Botulinum Toxins|botulinum toxins|mesh-list
65146511|NCT01261611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65146512|NCT01261611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65146513|NCT01261611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65146514|NCT01261611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64714062|NCT02813551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146515|NCT01261611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146516|NCT01261611|Cholinergic Agents|cholinergic agents|mesh-ancestor
65146517|NCT01261611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65146518|NCT01261611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146519|NCT01261611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65146520|NCT01261611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65146521|NCT04207125|Psychotropic Drugs|psychotropic drugs|mesh-list
65146522|NCT05576415|Varenicline|varenicline|mesh-list
65146539|NCT01304706|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
65146540|NCT01304706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65146541|NCT01304706|Glucocorticoids|glucocorticoids|mesh-ancestor
65146542|NCT01304706|Hormones|hormones|mesh-ancestor
65146543|NCT01304706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65146544|NCT01304706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146545|NCT05661240|Docetaxel|docetaxel|mesh-list
65146546|NCT05661240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146547|NCT05661240|Tubulin Modulators|tubulin modulators|mesh-ancestor
65146548|NCT05661240|Antimitotic Agents|antimitotic agents|mesh-ancestor
65146549|NCT05661240|Mitosis Modulators|mitosis modulators|mesh-ancestor
65146550|NCT05661240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146551|NCT05464719|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
65146552|NCT05464719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65146553|NCT05464719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146554|NCT05340465|Iron|iron|mesh-list
65146555|NCT05340465|Dextrans|dextrans|mesh-list
65146556|NCT05340465|Darbepoetin alfa|darbepoetin alfa|mesh-list
65146557|NCT05340465|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65146558|NCT05340465|Iron-Dextran Complex|iron-dextran complex|mesh-list
65146559|NCT05340465|Trace Elements|trace elements|mesh-ancestor
65146560|NCT05340465|Micronutrients|micronutrients|mesh-ancestor
65146561|NCT05340465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146562|NCT05340465|Hematinics|hematinics|mesh-ancestor
65146563|NCT05340465|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65146564|NCT05340465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65146565|NCT05340465|Anticoagulants|anticoagulants|mesh-ancestor
65304303|NCT04171739|Leprostatic Agents|leprostatic agents|mesh-ancestor
65304304|NCT04171739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65304305|NCT04171739|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65304306|NCT04171739|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65304307|NCT04171739|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65304308|NCT04171739|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65304309|NCT04171739|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65146566|NCT05340465|Plasma Substitutes|plasma substitutes|mesh-ancestor
65146567|NCT05340465|Blood Substitutes|blood substitutes|mesh-ancestor
65146568|NCT02889003|Pioglitazone|pioglitazone|mesh-list
65146569|NCT02889003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65146570|NCT02889003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146571|NCT01008553|Fentanyl|fentanyl|mesh-list
65146572|NCT01008553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65146573|NCT01008553|Narcotics|narcotics|mesh-ancestor
65146574|NCT01008553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65146575|NCT01008553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146576|NCT01008553|Analgesics|analgesics|mesh-ancestor
65146577|NCT01008553|Sensory System Agents|sensory system agents|mesh-ancestor
65146578|NCT01008553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65146579|NCT01008553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65146580|NCT01008553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65146581|NCT01008553|Anesthetics, General|anesthetics, general|mesh-ancestor
65146582|NCT01008553|Anesthetics|anesthetics|mesh-ancestor
65146583|NCT05226663|Fluorides|fluorides|mesh-list
65146584|NCT05226663|Cariostatic Agents|cariostatic agents|mesh-ancestor
65146595|NCT05141877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65146596|NCT05141877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65146598|NCT04978545|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65146599|NCT04978545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65146600|NCT04978545|Disinfectants|disinfectants|mesh-ancestor
65146601|NCT04901169|Angiotensin II|angiotensin ii|mesh-list
65146602|NCT04901169|Giapreza|giapreza|mesh-list
65146603|NCT04901169|Angiotensinogen|angiotensinogen|mesh-list
65146604|NCT04901169|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65146605|NCT04901169|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65146606|NCT04901169|Protease Inhibitors|protease inhibitors|mesh-ancestor
65146607|NCT04901169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146608|NCT04901169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146609|NCT04479267|Prednisone|prednisone|mesh-list
65146610|NCT04479267|Methylprednisolone|methylprednisolone|mesh-list
65146611|NCT04479267|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65146612|NCT04479267|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65146613|NCT04479267|Prednisolone|prednisolone|mesh-list
65146614|NCT04479267|Prednisolone acetate|prednisolone acetate|mesh-list
65146615|NCT04479267|Hydrocortisone|hydrocortisone|mesh-list
65146616|NCT04479267|Cortisone|cortisone|mesh-list
65146617|NCT04479267|Cyclophosphamide|cyclophosphamide|mesh-list
65146618|NCT04479267|Rituximab|rituximab|mesh-list
65146619|NCT04479267|Doxorubicin|doxorubicin|mesh-list
65146620|NCT04479267|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65146621|NCT04479267|Antibodies|antibodies|mesh-list
65146622|NCT04479267|Immunoglobulins|immunoglobulins|mesh-list
65146623|NCT04479267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65146624|NCT04479267|Immunoconjugates|immunoconjugates|mesh-list
65146625|NCT04479267|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65146626|NCT04479267|Prednisolone phosphate|prednisolone phosphate|mesh-list
65146627|NCT04479267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65146628|NCT04479267|Immunologic Factors|immunologic factors|mesh-ancestor
65146629|NCT04479267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146630|NCT04479267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65146631|NCT04479267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65146632|NCT04479267|Alkylating Agents|alkylating agents|mesh-ancestor
65146633|NCT04479267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146634|NCT04479267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146635|NCT04479267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65146636|NCT04479267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65146637|NCT04479267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65146638|NCT04479267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65304310|NCT04171739|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65304311|NCT02656121|Vitamin D|vitamin d|mesh-list
65304312|NCT02656121|Clomiphene|clomiphene|mesh-list
65304313|NCT02656121|Vitamins|vitamins|mesh-ancestor
65304314|NCT02656121|Micronutrients|micronutrients|mesh-ancestor
65146639|NCT04479267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65146640|NCT04479267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146641|NCT04479267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65146642|NCT04479267|Glucocorticoids|glucocorticoids|mesh-ancestor
65146644|NCT04479267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65146645|NCT04479267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65146646|NCT04479267|Antiemetics|antiemetics|mesh-ancestor
65146647|NCT04479267|Autonomic Agents|autonomic agents|mesh-ancestor
65146648|NCT04479267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65146649|NCT04479267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65146650|NCT04479267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65146651|NCT04479267|Protective Agents|protective agents|mesh-ancestor
65146652|NCT04439799|Methyltestosterone|methyltestosterone|mesh-list
65146653|NCT04439799|Testosterone|testosterone|mesh-list
65146654|NCT04439799|Testosterone undecanoate|testosterone undecanoate|mesh-list
65146681|NCT03764553|Fluorouracil|fluorouracil|mesh-list
65146682|NCT03764553|Capecitabine|capecitabine|mesh-list
65146683|NCT03764553|Oxaliplatin|oxaliplatin|mesh-list
65146684|NCT03764553|Irinotecan|irinotecan|mesh-list
65146685|NCT03764553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146686|NCT03764553|Antimetabolites|antimetabolites|mesh-ancestor
65146687|NCT03764553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146688|NCT03764553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65146689|NCT03764553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65146690|NCT03764553|Immunologic Factors|immunologic factors|mesh-ancestor
65146691|NCT03764553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146692|NCT03764553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65146693|NCT03764553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65146694|NCT03764553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146695|NCT03764553|Antidotes|antidotes|mesh-ancestor
65146696|NCT03764553|Protective Agents|protective agents|mesh-ancestor
65146697|NCT03764553|Vitamin B Complex|vitamin b complex|mesh-ancestor
65146698|NCT03764553|Vitamins|vitamins|mesh-ancestor
65146699|NCT03764553|Micronutrients|micronutrients|mesh-ancestor
65146700|NCT04320225|Dexamethasone|dexamethasone|mesh-list
65146701|NCT04320225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65146702|NCT04320225|Antiemetics|antiemetics|mesh-ancestor
65146703|NCT04320225|Autonomic Agents|autonomic agents|mesh-ancestor
65146704|NCT04320225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65146705|NCT04320225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146714|NCT03221751|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65146716|NCT03221751|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65146717|NCT03221751|Adrenergic Agents|adrenergic agents|mesh-ancestor
65146718|NCT03221751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65146719|NCT03221751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146720|NCT03221751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146721|NCT03219177|Analgesics, Opioid|analgesics, opioid|mesh-list
65146722|NCT03219177|Narcotics|narcotics|mesh-ancestor
65146723|NCT03219177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65146724|NCT03219177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146725|NCT03219177|Analgesics|analgesics|mesh-ancestor
65146726|NCT03219177|Sensory System Agents|sensory system agents|mesh-ancestor
65146727|NCT03219177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65146728|NCT01302834|Cetuximab|cetuximab|mesh-list
65146729|NCT01302834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146730|NCT01302834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65146731|NCT03048825|Colchicine|colchicine|mesh-list
65146732|NCT03048825|Spironolactone|spironolactone|mesh-list
65146733|NCT03048825|Gout Suppressants|gout suppressants|mesh-ancestor
65146734|NCT03048825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65146735|NCT03048825|Tubulin Modulators|tubulin modulators|mesh-ancestor
65146736|NCT03048825|Antimitotic Agents|antimitotic agents|mesh-ancestor
65146737|NCT03048825|Mitosis Modulators|mitosis modulators|mesh-ancestor
65146738|NCT03048825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146739|NCT03048825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146740|NCT03048825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65146741|NCT03048825|Hormone Antagonists|hormone antagonists|mesh-ancestor
65222826|NCT02699385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304315|NCT02656121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304316|NCT02656121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65304317|NCT02656121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65304318|NCT02656121|Hormone Antagonists|hormone antagonists|mesh-ancestor
65304319|NCT02656121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65304320|NCT02656121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65304321|NCT02656121|Fertility Agents|fertility agents|mesh-ancestor
65304322|NCT02656121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65304323|NCT02656121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65304324|NCT02656121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65304325|NCT00648713|Terbinafine|terbinafine|mesh-list
65304326|NCT00648713|Antifungal Agents|antifungal agents|mesh-ancestor
65304327|NCT00648713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65304328|NCT00648713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304329|NCT00648713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304330|NCT00649883|Vaccines|vaccines|mesh-list
65304331|NCT00649883|Immunologic Factors|immunologic factors|mesh-ancestor
65146742|NCT03048825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65146743|NCT03048825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146744|NCT03048825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65146745|NCT03048825|Diuretics|diuretics|mesh-ancestor
65146746|NCT03048825|Natriuretic Agents|natriuretic agents|mesh-ancestor
65146748|NCT02866071|Analgesics|analgesics|mesh-ancestor
65146749|NCT02866071|Sensory System Agents|sensory system agents|mesh-ancestor
65146750|NCT02866071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65146751|NCT02866071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146752|NCT02866071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65146753|NCT02866071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65146754|NCT02866071|Anesthetics, General|anesthetics, general|mesh-ancestor
65146755|NCT02866071|Anesthetics|anesthetics|mesh-ancestor
65146756|NCT02866071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65146757|NCT02866071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65146758|NCT02866071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65146759|NCT02866071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65146760|NCT02866071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146761|NCT05507775|Digoxin|digoxin|mesh-list
65146762|NCT05507775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65146763|NCT05507775|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65146764|NCT05507775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146765|NCT05507775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146766|NCT05507775|Protective Agents|protective agents|mesh-ancestor
65146767|NCT05507775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146768|NCT02890602|Prednisolone|prednisolone|mesh-list
65146769|NCT02890602|Cyclophosphamide|cyclophosphamide|mesh-list
65146770|NCT02890602|Vincristine|vincristine|mesh-list
65146771|NCT02890602|Darbepoetin alfa|darbepoetin alfa|mesh-list
65146782|NCT02890602|Tubulin Modulators|tubulin modulators|mesh-ancestor
65146783|NCT02890602|Antimitotic Agents|antimitotic agents|mesh-ancestor
65146784|NCT02890602|Mitosis Modulators|mitosis modulators|mesh-ancestor
65146785|NCT02890602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65146786|NCT02890602|Glucocorticoids|glucocorticoids|mesh-ancestor
65146787|NCT02890602|Hormones|hormones|mesh-ancestor
65146788|NCT02890602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65146789|NCT02890602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65146790|NCT02890602|Hematinics|hematinics|mesh-ancestor
65146791|NCT01259115|Ketoconazole|ketoconazole|mesh-list
65304332|NCT00649883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304333|NCT00648791|Finasteride|finasteride|mesh-list
65304334|NCT00648791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65304335|NCT00648791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65304336|NCT00648791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304337|NCT00648791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304338|NCT00648791|Hormone Antagonists|hormone antagonists|mesh-ancestor
65304339|NCT00648791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65304340|NCT00648791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304341|NCT00648791|Urological Agents|urological agents|mesh-ancestor
65304342|NCT00649181|Metolazone|metolazone|mesh-list
65146792|NCT01259115|Buprenorphine|buprenorphine|mesh-list
65146793|NCT01259115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65146794|NCT01259115|Narcotics|narcotics|mesh-ancestor
65146795|NCT01259115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65146796|NCT01259115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146797|NCT01259115|Analgesics|analgesics|mesh-ancestor
65146798|NCT01259115|Sensory System Agents|sensory system agents|mesh-ancestor
65146799|NCT01259115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65146800|NCT01259115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65146801|NCT01259115|Antifungal Agents|antifungal agents|mesh-ancestor
65146802|NCT01259115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65146803|NCT01259115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65146804|NCT01259115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65146805|NCT01259115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146806|NCT01259115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146807|NCT01259115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65146808|NCT01259115|Hormone Antagonists|hormone antagonists|mesh-ancestor
65146809|NCT01259115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65146810|NCT01259115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65146811|NCT01302054|Fesoterodine|fesoterodine|mesh-list
65146812|NCT01302054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65146813|NCT01302054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65146814|NCT01302054|Cholinergic Agents|cholinergic agents|mesh-ancestor
65146815|NCT01302054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65146816|NCT01302054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146817|NCT01302054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146818|NCT01302054|Urological Agents|urological agents|mesh-ancestor
65146819|NCT01300650|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65146820|NCT01300650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65146821|NCT01300572|Cyclosporine|cyclosporine|mesh-list
65146822|NCT01300572|Mycophenolic Acid|mycophenolic acid|mesh-list
65146823|NCT01300572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65146824|NCT01300572|Fludarabine|fludarabine|mesh-list
65146825|NCT01300572|Fludarabine phosphate|fludarabine phosphate|mesh-list
65146826|NCT01300572|Antibodies|antibodies|mesh-list
65146827|NCT01300572|Immunoglobulins|immunoglobulins|mesh-list
65146828|NCT01300572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65146829|NCT01300572|Cyclosporins|cyclosporins|mesh-list
65146830|NCT01300572|Immunologic Factors|immunologic factors|mesh-ancestor
65146831|NCT01300572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146832|NCT01300572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146833|NCT01300572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65146834|NCT01300572|Antimetabolites|antimetabolites|mesh-ancestor
65146857|NCT01258101|Immunologic Factors|immunologic factors|mesh-ancestor
65146858|NCT01258101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146859|NCT05640804|Dasatinib|dasatinib|mesh-list
65146860|NCT05640804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146861|NCT05640804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65146862|NCT05640804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146863|NCT05640804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146864|NCT00623688|Imidacloprid|imidacloprid|mesh-list
65304343|NCT00649181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65304344|NCT00649181|Diuretics|diuretics|mesh-ancestor
65304345|NCT00649181|Natriuretic Agents|natriuretic agents|mesh-ancestor
65304346|NCT00649181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304347|NCT00649181|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65304348|NCT00649181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65304349|NCT00649181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304350|NCT02655965|Clonidine|clonidine|mesh-list
65304351|NCT02655965|Ropivacaine|ropivacaine|mesh-list
65304352|NCT02655965|Anesthetics, Local|anesthetics, local|mesh-ancestor
65304353|NCT02655965|Anesthetics|anesthetics|mesh-ancestor
65304354|NCT02655965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65304355|NCT02655965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304356|NCT02655965|Sensory System Agents|sensory system agents|mesh-ancestor
65304357|NCT02655965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65304358|NCT02655965|Analgesics|analgesics|mesh-ancestor
65304359|NCT02655965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65304360|NCT02655965|Sympatholytics|sympatholytics|mesh-ancestor
65304361|NCT02655965|Autonomic Agents|autonomic agents|mesh-ancestor
65304362|NCT02655965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65304363|NCT02655965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65146865|NCT00623688|Cholinergic Agents|cholinergic agents|mesh-ancestor
65146866|NCT00623688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65146867|NCT00623688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146868|NCT00623688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146869|NCT01300260|Dulaglutide|dulaglutide|mesh-list
65146870|NCT01300260|Glucagon|glucagon|mesh-list
65146871|NCT01300260|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65146872|NCT01300260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65146873|NCT01300260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146874|NCT01300260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65146875|NCT01300260|Hormones|hormones|mesh-ancestor
65146876|NCT01300260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65146877|NCT01300260|Incretins|incretins|mesh-ancestor
65146878|NCT01256385|Sirolimus|sirolimus|mesh-list
65146879|NCT01256385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65146880|NCT01256385|Cetuximab|cetuximab|mesh-list
65146881|NCT01256385|Antibodies|antibodies|mesh-list
65146882|NCT01256385|Immunoglobulins|immunoglobulins|mesh-list
65146883|NCT01256385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65146884|NCT01256385|Immunologic Factors|immunologic factors|mesh-ancestor
65146885|NCT01256385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146886|NCT01256385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146887|NCT01256385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65146905|NCT01298778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65146906|NCT01298778|Analgesics|analgesics|mesh-ancestor
65146907|NCT01298778|Sensory System Agents|sensory system agents|mesh-ancestor
65146908|NCT01298778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65146909|NCT01298778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146910|NCT01298778|Antipyretics|antipyretics|mesh-ancestor
65146911|NCT01298778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65146912|NCT01298778|Narcotics|narcotics|mesh-ancestor
65146913|NCT01298778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65146914|NCT01298700|Bimatoprost|bimatoprost|mesh-list
65304364|NCT02655965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65054257|NCT00231140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65304365|NCT02655965|Adrenergic Agents|adrenergic agents|mesh-ancestor
65304366|NCT02655965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65304367|NCT02655965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304368|NCT04170179|Lenvatinib|lenvatinib|mesh-list
65304369|NCT04170179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304370|NCT04170179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65304371|NCT04170179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304372|NCT04170179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304373|NCT02659085|Ketamine|ketamine|mesh-list
65304374|NCT02659085|Analgesics|analgesics|mesh-ancestor
65304375|NCT02659085|Sensory System Agents|sensory system agents|mesh-ancestor
64534351|NCT00412425|Serotonin Agents|serotonin agents|mesh-ancestor
65146915|NCT01298700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65146916|NCT01298700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65146917|NCT01298700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65146918|NCT01297920|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65146919|NCT01297920|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65146920|NCT01297920|Brinzolamide|brinzolamide|mesh-list
65146921|NCT01297920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65146922|NCT01297920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65146923|NCT01297920|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65146924|NCT01297920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65146925|NCT01297920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65146926|NCT01297920|Adrenergic Agents|adrenergic agents|mesh-ancestor
65146927|NCT01297920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65146928|NCT01297920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146929|NCT01297920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146930|NCT01297920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65146931|NCT01297920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146932|NCT01255761|Certolizumab Pegol|certolizumab pegol|mesh-list
65146933|NCT01255761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65146934|NCT01255761|Immunologic Factors|immunologic factors|mesh-ancestor
65146935|NCT01255761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146936|NCT01255761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65146937|NCT01297062|Exenatide|exenatide|mesh-list
65146938|NCT01297062|Moxifloxacin|moxifloxacin|mesh-list
65146939|NCT01297062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65146940|NCT01297062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65146941|NCT01297062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65146942|NCT01297062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65146943|NCT01297062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146944|NCT01297062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146960|NCT01296672|Urological Agents|urological agents|mesh-ancestor
65146962|NCT01254669|Immunologic Factors|immunologic factors|mesh-ancestor
65146963|NCT01254669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146964|NCT04324476|Bevacizumab|bevacizumab|mesh-list
65146965|NCT04324476|Capecitabine|capecitabine|mesh-list
65146966|NCT04324476|Oxaliplatin|oxaliplatin|mesh-list
65146967|NCT04324476|Irinotecan|irinotecan|mesh-list
65146968|NCT04324476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65146969|NCT04324476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146970|NCT04324476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65146971|NCT04324476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65146972|NCT04324476|Growth Substances|growth substances|mesh-ancestor
65146973|NCT04324476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146974|NCT04324476|Growth Inhibitors|growth inhibitors|mesh-ancestor
65146975|NCT04324476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65146976|NCT04324476|Antimetabolites|antimetabolites|mesh-ancestor
65146977|NCT04324476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146978|NCT04324476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65304376|NCT02659085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65304377|NCT02659085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304378|NCT02659085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65304379|NCT02659085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65304380|NCT02659085|Anesthetics, General|anesthetics, general|mesh-ancestor
65304381|NCT02659085|Anesthetics|anesthetics|mesh-ancestor
65304382|NCT02659085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64534357|NCT05287503|Ambroxol|ambroxol|mesh-list
65146979|NCT04324476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65146980|NCT04324476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146981|NCT01295814|Adalimumab|adalimumab|mesh-list
65146982|NCT01295814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65146983|NCT01295814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65146984|NCT01254045|Oxytocin|oxytocin|mesh-list
65146985|NCT01254045|Oxytocics|oxytocics|mesh-ancestor
65146986|NCT01254045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65146987|NCT01254045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146988|NCT01075282|Metformin|metformin|mesh-list
65146989|NCT01075282|Insulin Glargine|insulin glargine|mesh-list
65146990|NCT01075282|Glimepiride|glimepiride|mesh-list
65146991|NCT01075282|Dulaglutide|dulaglutide|mesh-list
65146992|NCT01075282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65146993|NCT01075282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146994|NCT01075282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65146995|NCT01075282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65146996|NCT01075282|Immunologic Factors|immunologic factors|mesh-ancestor
65146997|NCT04324086|Calcium, Dietary|calcium, dietary|mesh-list
65146998|NCT04324086|Calcium|calcium|mesh-list
65146999|NCT04324086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65147000|NCT04324086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147001|NCT04324086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65147002|NCT01295034|Vitamin D|vitamin d|mesh-list
65147003|NCT01295034|Ergocalciferols|ergocalciferols|mesh-list
65147004|NCT01295034|Cholecalciferol|cholecalciferol|mesh-list
65147005|NCT01295034|Vitamins|vitamins|mesh-list
65147006|NCT01295034|Micronutrients|micronutrients|mesh-ancestor
64501284|NCT01804049|Metformin|metformin|mesh-list
65147027|NCT01077076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147028|NCT01077076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147029|NCT02876224|Bevacizumab|bevacizumab|mesh-list
65147030|NCT02876224|Atezolizumab|atezolizumab|mesh-list
65147031|NCT02876224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65147032|NCT02876224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147033|NCT02876224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65147034|NCT02876224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65147035|NCT02876224|Growth Substances|growth substances|mesh-ancestor
65147036|NCT02876224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147037|NCT02876224|Growth Inhibitors|growth inhibitors|mesh-ancestor
65147038|NCT01294644|Deoxycholic Acid|deoxycholic acid|mesh-list
65147039|NCT01294644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65147040|NCT01294644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65147041|NCT01253265|Ixekizumab|ixekizumab|mesh-list
65147042|NCT01253265|Dermatologic Agents|dermatologic agents|mesh-ancestor
65147043|NCT01293006|Suvorexant|suvorexant|mesh-list
65147044|NCT01293006|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65147045|NCT01293006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65147046|NCT01293006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65147047|NCT01293006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147048|NCT01293006|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65147049|NCT01293006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65147050|NCT01293006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147051|NCT01253187|Tetrahydrofolates|tetrahydrofolates|mesh-list
65147052|NCT01253187|Drospirenone|drospirenone|mesh-list
65147053|NCT01253187|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65147054|NCT01253187|Hormone Antagonists|hormone antagonists|mesh-ancestor
65147055|NCT01253187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65147056|NCT01253187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147057|NCT01253187|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65222827|NCT02700087|Famotidine|famotidine|mesh-list
65304383|NCT02659085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65304384|NCT02659085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65304385|NCT02659085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65304386|NCT02659085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304387|NCT04171193|Isoflurane|isoflurane|mesh-list
65304388|NCT04171193|Sertraline|sertraline|mesh-list
65304389|NCT04171193|Antidepressive Agents|antidepressive agents|mesh-ancestor
65147068|NCT01252953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147069|NCT01252953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65147070|NCT01252953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65147071|NCT01252953|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65147072|NCT01252953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147073|NCT01252563|Amlodipine|amlodipine|mesh-list
65147074|NCT01252563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65147075|NCT01252563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65147076|NCT01252563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65147077|NCT01252563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147078|NCT01252563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65147079|NCT01252563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147080|NCT01252563|Vasodilator Agents|vasodilator agents|mesh-ancestor
65147081|NCT01292226|Cyclosporine|cyclosporine|mesh-list
65147082|NCT01292226|Mycophenolic Acid|mycophenolic acid|mesh-list
65147083|NCT01292226|Antibodies|antibodies|mesh-list
65147084|NCT01292226|Cyclosporins|cyclosporins|mesh-list
65147085|NCT01292226|Immunologic Factors|immunologic factors|mesh-ancestor
65147086|NCT01292226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147087|NCT01292226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147088|NCT01292226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147089|NCT01292226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65147090|NCT01292226|Antifungal Agents|antifungal agents|mesh-ancestor
65147091|NCT01292226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65147092|NCT01292226|Dermatologic Agents|dermatologic agents|mesh-ancestor
65147093|NCT01292226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65147094|NCT01292226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65147095|NCT01292226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65147096|NCT01292226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147097|NCT01292226|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65147098|NCT01292226|Antitubercular Agents|antitubercular agents|mesh-ancestor
65147099|NCT01292226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65147100|NCT01075048|Irinotecan|irinotecan|mesh-list
65147101|NCT01075048|Cetuximab|cetuximab|mesh-list
65147102|NCT01075048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65147103|NCT01075048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65147104|NCT01075048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147105|NCT01075048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147106|NCT01075048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147107|NCT01075048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65147108|NCT01252251|Everolimus|everolimus|mesh-list
65147109|NCT01252251|Pasireotide|pasireotide|mesh-list
65147110|NCT01252251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147111|NCT01252251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65147112|NCT01252251|Immunologic Factors|immunologic factors|mesh-ancestor
65147113|NCT01252251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147114|NCT01252251|Hormones|hormones|mesh-ancestor
65147115|NCT01252251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65147116|NCT02888301|Clofarabine|clofarabine|mesh-list
65147117|NCT02888301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65147118|NCT02888301|Antimetabolites|antimetabolites|mesh-ancestor
65147119|NCT02888301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147120|NCT02888301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147121|NCT00624273|Sildenafil Citrate|sildenafil citrate|mesh-list
65147122|NCT00624273|Vasodilator Agents|vasodilator agents|mesh-ancestor
65147123|NCT00624273|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65147124|NCT00624273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65147141|NCT01074502|Analgesics|analgesics|mesh-ancestor
65147142|NCT01074502|Sensory System Agents|sensory system agents|mesh-ancestor
65147143|NCT01074502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65304390|NCT04171193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65304391|NCT04171193|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65304392|NCT04171193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65304393|NCT04171193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65304394|NCT04171193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304395|NCT04171193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65304396|NCT04171193|Serotonin Agents|serotonin agents|mesh-ancestor
65304397|NCT04171193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304398|NCT04171193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65304399|NCT04171193|Anesthetics, General|anesthetics, general|mesh-ancestor
65304400|NCT04171193|Anesthetics|anesthetics|mesh-ancestor
64534372|NCT03491631|Apatinib|apatinib|mesh-list
65147144|NCT01074502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147145|NCT01074502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65147146|NCT01074502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65147147|NCT01074502|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65147148|NCT01074502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65147149|NCT01074502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147150|NCT01074502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147151|NCT01251861|Bicalutamide|bicalutamide|mesh-list
65147152|NCT01251861|Androgen Antagonists|androgen antagonists|mesh-ancestor
65147153|NCT01251861|Hormone Antagonists|hormone antagonists|mesh-ancestor
65147154|NCT01251861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65147155|NCT01251861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147156|NCT01251861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147157|NCT04303312|Benzydamine|benzydamine|mesh-list
65147158|NCT04303312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65147159|NCT01285908|Norepinephrine|norepinephrine|mesh-list
65147160|NCT01285908|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65147161|NCT01285908|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65147162|NCT01285908|Adrenergic Agents|adrenergic agents|mesh-ancestor
65147163|NCT01285908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65147164|NCT01285908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147165|NCT01285908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147166|NCT01285908|Sympathomimetics|sympathomimetics|mesh-ancestor
65147167|NCT01285908|Autonomic Agents|autonomic agents|mesh-ancestor
65147168|NCT01285908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65147169|NCT01285908|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65147171|NCT01074268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65147172|NCT01074268|Insulin Aspart|insulin aspart|mesh-list
65147173|NCT01074268|Insulin Detemir|insulin detemir|mesh-list
65147174|NCT01074268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65147175|NCT01074268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147176|NCT01074190|Fentanyl|fentanyl|mesh-list
65147177|NCT01074190|Bupivacaine|bupivacaine|mesh-list
65147178|NCT01074190|Anesthetics, Local|anesthetics, local|mesh-ancestor
65147179|NCT01074190|Anesthetics|anesthetics|mesh-ancestor
65147180|NCT01074190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65147181|NCT01074190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147182|NCT01074190|Sensory System Agents|sensory system agents|mesh-ancestor
65147183|NCT01074190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65147200|NCT01072396|Respiratory System Agents|respiratory system agents|mesh-ancestor
65147201|NCT01072396|Parasympatholytics|parasympatholytics|mesh-ancestor
65147202|NCT01072396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65147203|NCT01072396|Cholinergic Agents|cholinergic agents|mesh-ancestor
65147204|NCT01072396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65147205|NCT01072396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147206|NCT01045096|Dexlansoprazole|dexlansoprazole|mesh-list
65147207|NCT01045096|Lansoprazole|lansoprazole|mesh-list
65147208|NCT01045096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65147209|NCT01045096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65147210|NCT01045096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65304401|NCT04171193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65304402|NCT02663141|Bevacizumab|bevacizumab|mesh-list
65304403|NCT02663141|Losartan|losartan|mesh-list
65304404|NCT02663141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65304405|NCT02663141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304406|NCT02663141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65304407|NCT02663141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65304408|NCT02663141|Growth Substances|growth substances|mesh-ancestor
65304409|NCT02663141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304410|NCT02663141|Growth Inhibitors|growth inhibitors|mesh-ancestor
65304411|NCT02663141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65304412|NCT02663141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65147211|NCT01045096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147212|NCT01045096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147213|NCT02876146|Albendazole|albendazole|mesh-list
65147214|NCT02876146|Benzimidazole|benzimidazole|mesh-list
65147215|NCT02876146|Anthelmintics|anthelmintics|mesh-ancestor
65147216|NCT02876146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65147217|NCT02876146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65147218|NCT02876146|Anticestodal Agents|anticestodal agents|mesh-ancestor
65147219|NCT02876146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65147220|NCT02876146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65147221|NCT02876146|Tubulin Modulators|tubulin modulators|mesh-ancestor
65147222|NCT02876146|Antimitotic Agents|antimitotic agents|mesh-ancestor
65147223|NCT02876146|Mitosis Modulators|mitosis modulators|mesh-ancestor
65147224|NCT02876146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147225|NCT02876146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147226|NCT02874586|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65147227|NCT02874586|Immunologic Factors|immunologic factors|mesh-ancestor
65147228|NCT02874586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147229|NCT02875756|Ivermectin|ivermectin|mesh-list
65147230|NCT02875756|Selamectin|selamectin|mesh-list
65147231|NCT02875756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65147232|NCT02875756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65147233|NCT02874820|Idazoxan|idazoxan|mesh-list
65147234|NCT02874820|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65147235|NCT02874820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65147236|NCT02874820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65147237|NCT02874820|Adrenergic Agents|adrenergic agents|mesh-ancestor
65147238|NCT02874820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65147239|NCT02874820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147240|NCT02874820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147241|NCT04305028|Aspirin|aspirin|mesh-list
65147242|NCT04305028|Rivaroxaban|rivaroxaban|mesh-list
65147243|NCT04305028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64501524|NCT03381066|Cisplatin|cisplatin|mesh-list
65147260|NCT04305028|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65147261|NCT04305028|Protease Inhibitors|protease inhibitors|mesh-ancestor
65147262|NCT04305028|Anticoagulants|anticoagulants|mesh-ancestor
65147263|NCT04304794|Antithyroid Agents|antithyroid agents|mesh-list
65147264|NCT04304794|Hormone Antagonists|hormone antagonists|mesh-ancestor
65147265|NCT04304794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65147266|NCT04304794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147267|NCT01283334|Carboplatin|carboplatin|mesh-list
65147268|NCT01283334|Cetuximab|cetuximab|mesh-list
65147269|NCT01283334|Everolimus|everolimus|mesh-list
65147270|NCT01283334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147271|NCT01283334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65147272|NCT01283334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65147273|NCT01283334|Immunologic Factors|immunologic factors|mesh-ancestor
65147274|NCT01283334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147275|NCT04304716|Anesthetics|anesthetics|mesh-list
65147276|NCT04304716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65304413|NCT02663141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65304414|NCT02663141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65304415|NCT02663141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304416|NCT04171349|Dexmedetomidine|dexmedetomidine|mesh-list
65304417|NCT04171349|Carticaine|carticaine|mesh-list
65147277|NCT04304716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147278|NCT01282476|Rituximab|rituximab|mesh-list
65147279|NCT01282476|Panobinostat|panobinostat|mesh-list
65147280|NCT01282476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65147281|NCT01282476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147282|NCT01282476|Immunologic Factors|immunologic factors|mesh-ancestor
65147283|NCT01282476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147284|NCT01282476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65147285|NCT01282476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65147286|NCT01282476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147287|NCT01282476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147288|NCT02889822|Alprostadil|alprostadil|mesh-list
65147289|NCT02889822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65147290|NCT02889822|Vasodilator Agents|vasodilator agents|mesh-ancestor
65147291|NCT02889822|Urological Agents|urological agents|mesh-ancestor
65147292|NCT01282164|Insulin|insulin|mesh-list
65147293|NCT01282164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65147294|NCT01282164|Glucagon|glucagon|mesh-list
65147295|NCT01282164|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65147296|NCT01282164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65147297|NCT01282164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147298|NCT01282164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65147299|NCT01282164|Hormones|hormones|mesh-ancestor
65147300|NCT01282164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65147301|NCT01282164|Incretins|incretins|mesh-ancestor
65147302|NCT01250379|Bevacizumab|bevacizumab|mesh-list
65147311|NCT01072630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65147312|NCT01072630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147313|NCT01072630|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65147314|NCT01072630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65147315|NCT01072630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65147316|NCT01072630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147317|NCT04302532|Ubiquinone|ubiquinone|mesh-list
65147318|NCT04302532|Coenzyme Q10|coenzyme q10|mesh-list
65147319|NCT04302532|Clomiphene|clomiphene|mesh-list
65147320|NCT04302532|Enclomiphene|enclomiphene|mesh-list
65147321|NCT04302532|Zuclomiphene|zuclomiphene|mesh-list
65147322|NCT04302532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65147323|NCT04302532|Hormone Antagonists|hormone antagonists|mesh-ancestor
65147324|NCT04302532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65147325|NCT04302532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147326|NCT04302532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65147327|NCT04302532|Fertility Agents|fertility agents|mesh-ancestor
65147328|NCT04302532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65147329|NCT04302532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65147330|NCT04302532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65147331|NCT04302532|Micronutrients|micronutrients|mesh-ancestor
65147332|NCT04302532|Vitamins|vitamins|mesh-ancestor
65147333|NCT01281306|Valsartan|valsartan|mesh-list
64714075|NCT02817763|Antipyretics|antipyretics|mesh-ancestor
65147334|NCT01281306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65147335|NCT01281306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65147336|NCT01281306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65147337|NCT01281306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65147338|NCT01281306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147339|NCT04304560|Dapagliflozin|dapagliflozin|mesh-list
65147340|NCT04304560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65147341|NCT04304560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147342|NCT04304560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65147343|NCT04304560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147344|NCT04643470|Zanubrutinib|zanubrutinib|mesh-list
65147345|NCT04643470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147346|NCT04643470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65304418|NCT04171349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65304419|NCT04171349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65304420|NCT04171349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304421|NCT04171349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65304422|NCT04171349|Analgesics|analgesics|mesh-ancestor
65304423|NCT04171349|Sensory System Agents|sensory system agents|mesh-ancestor
65304424|NCT04171349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65304425|NCT04171349|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65304426|NCT04171349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65304427|NCT04171349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65304428|NCT04171349|Adrenergic Agents|adrenergic agents|mesh-ancestor
65304429|NCT04171349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65304430|NCT04171349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304431|NCT04171349|Anesthetics, Local|anesthetics, local|mesh-ancestor
65304432|NCT04171349|Anesthetics|anesthetics|mesh-ancestor
65304433|NCT00650039|Valdecoxib|valdecoxib|mesh-list
65304434|NCT00650039|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65304435|NCT00650039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65304436|NCT00650039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304437|NCT00650039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304438|NCT00650039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65304439|NCT00650039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65304441|NCT00650039|Sensory System Agents|sensory system agents|mesh-ancestor
65304442|NCT00650039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65304443|NCT00650039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304444|NCT00650039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65304445|NCT00650039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65304446|NCT00649259|Oxybutynin|oxybutynin|mesh-list
65304447|NCT00649259|Parasympatholytics|parasympatholytics|mesh-ancestor
65304448|NCT00649259|Autonomic Agents|autonomic agents|mesh-ancestor
65304449|NCT00649259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65304450|NCT00649259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147347|NCT04643470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147348|NCT04643470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147349|NCT01250145|Teriparatide|teriparatide|mesh-list
65147350|NCT01250145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65147351|NCT01250145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147352|NCT01250145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65147353|NCT04319601|Rituximab|rituximab|mesh-list
65147354|NCT04319601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64958082|NCT00219856|Anesthetics|anesthetics|mesh-ancestor
65304451|NCT00649259|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65304452|NCT00649259|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65304453|NCT00649259|Cholinergic Agents|cholinergic agents|mesh-ancestor
65304454|NCT00649259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65304455|NCT00649259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304456|NCT00649259|Urological Agents|urological agents|mesh-ancestor
65304457|NCT04401059|Gefitinib|gefitinib|mesh-list
65304458|NCT04401059|Osimertinib|osimertinib|mesh-list
65147355|NCT04319601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147356|NCT04319601|Immunologic Factors|immunologic factors|mesh-ancestor
65147357|NCT04319601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147358|NCT04319601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65147359|NCT04640896|Lidocaine|lidocaine|mesh-list
65147360|NCT04640896|Bupivacaine|bupivacaine|mesh-list
65147361|NCT04640896|Anesthetics, Local|anesthetics, local|mesh-ancestor
65147362|NCT04640896|Anesthetics|anesthetics|mesh-ancestor
65147363|NCT04640896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65147364|NCT04640896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147365|NCT04640896|Sensory System Agents|sensory system agents|mesh-ancestor
65147366|NCT04640896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65147367|NCT04640896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65147381|NCT01037218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65147383|NCT01037218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147384|NCT01038856|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65147385|NCT01038856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147386|NCT01038856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65147388|NCT01038856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147389|NCT01269918|Dexmedetomidine|dexmedetomidine|mesh-list
65147390|NCT01269918|Remifentanil|remifentanil|mesh-list
65147391|NCT01269918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65147392|NCT01269918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65147393|NCT01269918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147394|NCT01269918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65147395|NCT01269918|Analgesics|analgesics|mesh-ancestor
65147396|NCT01269918|Sensory System Agents|sensory system agents|mesh-ancestor
65147397|NCT01269918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65147398|NCT01269918|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65147399|NCT01269918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65147400|NCT01269918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65147401|NCT01269918|Adrenergic Agents|adrenergic agents|mesh-ancestor
65147402|NCT01269918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65147403|NCT01269918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147404|NCT01269918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65147405|NCT01269918|Narcotics|narcotics|mesh-ancestor
65147406|NCT01036594|Ketoconazole|ketoconazole|mesh-list
65147407|NCT01036594|Dexamethasone|dexamethasone|mesh-list
65147408|NCT01036594|Dexamethasone acetate|dexamethasone acetate|mesh-list
65147409|NCT01036594|Hydrocortisone|hydrocortisone|mesh-list
65147410|NCT01036594|BB 1101|bb 1101|mesh-list
65147411|NCT01036594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65147412|NCT01036594|Antiemetics|antiemetics|mesh-ancestor
65147413|NCT01036594|Autonomic Agents|autonomic agents|mesh-ancestor
65147414|NCT01036594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65147415|NCT01036594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147416|NCT01036594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65147417|NCT01036594|Glucocorticoids|glucocorticoids|mesh-ancestor
65147418|NCT01036594|Hormones|hormones|mesh-ancestor
65147419|NCT01036594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65147420|NCT01036594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65147421|NCT01036594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147422|NCT01036594|Protease Inhibitors|protease inhibitors|mesh-ancestor
65147423|NCT01036594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147424|NCT01036594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147425|NCT01036594|Antifungal Agents|antifungal agents|mesh-ancestor
65147426|NCT01036594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65222828|NCT02700087|Ranitidine|ranitidine|mesh-list
65304459|NCT04401059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304460|NCT04401059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65304461|NCT04401059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304462|NCT04401059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304463|NCT02658773|Lidocaine|lidocaine|mesh-list
65304464|NCT02658773|Prilocaine|prilocaine|mesh-list
65304465|NCT02658773|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65304466|NCT02658773|Anesthetics, Local|anesthetics, local|mesh-ancestor
65304467|NCT02658773|Anesthetics|anesthetics|mesh-ancestor
65304468|NCT02658773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65304469|NCT02658773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304470|NCT02658773|Sensory System Agents|sensory system agents|mesh-ancestor
65304471|NCT02658773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65304472|NCT02658773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65304473|NCT02658773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65304474|NCT02658773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65304475|NCT02658773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65304476|NCT02658773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304477|NCT02658773|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65304478|NCT00648869|Metformin|metformin|mesh-list
65304479|NCT00648869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65304480|NCT00648869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304481|NCT04169945|Erythritol|erythritol|mesh-list
65304482|NCT04169945|Vasodilator Agents|vasodilator agents|mesh-ancestor
65304483|NCT04169867|Nivolumab|nivolumab|mesh-list
65304484|NCT04169867|Ipilimumab|ipilimumab|mesh-list
65304485|NCT04169867|Atezolizumab|atezolizumab|mesh-list
65304486|NCT04169867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65304487|NCT04169867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304488|NCT04169867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65304489|NCT04169867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304490|NCT02655029|Amlodipine|amlodipine|mesh-list
65304491|NCT02655029|Perindopril|perindopril|mesh-list
65304499|NCT02655029|Vasodilator Agents|vasodilator agents|mesh-ancestor
65304500|NCT02655029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65304501|NCT02655029|Protease Inhibitors|protease inhibitors|mesh-ancestor
65304502|NCT02655029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304503|NCT02655029|Diuretics|diuretics|mesh-ancestor
65304504|NCT02655029|Natriuretic Agents|natriuretic agents|mesh-ancestor
65304505|NCT02655029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65304506|NCT02536859|Insulin|insulin|mesh-list
65304507|NCT02536859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65147427|NCT01036594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65147439|NCT04304248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65147441|NCT04304248|Tubulin Modulators|tubulin modulators|mesh-ancestor
65147442|NCT04304248|Antimitotic Agents|antimitotic agents|mesh-ancestor
65147443|NCT04304248|Mitosis Modulators|mitosis modulators|mesh-ancestor
65147444|NCT04304248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147445|NCT01268046|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65147446|NCT01268046|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65147447|NCT01268046|Estradiol|estradiol|mesh-list
65147448|NCT01268046|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65147449|NCT01268046|Estrogens|estrogens|mesh-list
65147450|NCT01268046|Hormones|hormones|mesh-ancestor
65147451|NCT01268046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65147452|NCT01268046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147453|NCT01268046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65147454|NCT01268046|Contraceptive Agents|contraceptive agents|mesh-ancestor
65147455|NCT01268046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65147456|NCT01268046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65147457|NCT04732000|Acetylcysteine|acetylcysteine|mesh-list
65147458|NCT04732000|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65147459|NCT04732000|Antiviral Agents|antiviral agents|mesh-ancestor
65147460|NCT04732000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65147461|NCT04732000|Expectorants|expectorants|mesh-ancestor
65147462|NCT04732000|Respiratory System Agents|respiratory system agents|mesh-ancestor
65147463|NCT04732000|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65147464|NCT04732000|Antioxidants|antioxidants|mesh-ancestor
65147465|NCT04732000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147466|NCT04732000|Protective Agents|protective agents|mesh-ancestor
65147467|NCT04732000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147468|NCT04732000|Antidotes|antidotes|mesh-ancestor
65147469|NCT01267266|Hydrocortisone|hydrocortisone|mesh-list
65147470|NCT01267266|Saracatinib|saracatinib|mesh-list
65147471|NCT01267266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65147472|NCT01267266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147473|NCT01267266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147474|NCT01267266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147475|NCT01034176|Levofloxacin|levofloxacin|mesh-list
65147476|NCT01034176|Ofloxacin|ofloxacin|mesh-list
65147477|NCT01034176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65147478|NCT01034176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65147479|NCT01034176|Renal Agents|renal agents|mesh-ancestor
65147480|NCT01034176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65147481|NCT01034176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65147482|NCT01034176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65147483|NCT01034176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147484|NCT01034176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147485|NCT01034176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147486|NCT01034176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65147487|NCT01034176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65147488|NCT02889432|Melatonin|melatonin|mesh-list
65147489|NCT02889432|Antioxidants|antioxidants|mesh-ancestor
65147490|NCT02889432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501761|NCT03063021|Acetylcysteine|acetylcysteine|mesh-list
65147502|NCT01033942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65147503|NCT01033942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65147504|NCT01062256|Phenylpropanolamine|phenylpropanolamine|mesh-list
65147505|NCT01062256|Guaifenesin|guaifenesin|mesh-list
65222829|NCT02700087|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65304508|NCT02536859|Insulin Glargine|insulin glargine|mesh-list
65304509|NCT02536859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65304510|NCT02536859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304511|NCT02536937|Eliglustat|eliglustat|mesh-list
65304512|NCT02536937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147506|NCT01062256|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
65147507|NCT01062256|Expectorants|expectorants|mesh-ancestor
65147508|NCT01062256|Respiratory System Agents|respiratory system agents|mesh-ancestor
65147509|NCT01062256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65147510|NCT01062256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65147511|NCT01062256|Adrenergic Agents|adrenergic agents|mesh-ancestor
65147512|NCT01062256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65147513|NCT01062256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147514|NCT01062256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147515|NCT01062256|Appetite Depressants|appetite depressants|mesh-ancestor
65147516|NCT01062256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65147517|NCT01062256|Sympathomimetics|sympathomimetics|mesh-ancestor
65147518|NCT01062256|Autonomic Agents|autonomic agents|mesh-ancestor
65147519|NCT01062256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65147520|NCT01062256|Nasal Decongestants|nasal decongestants|mesh-ancestor
65147521|NCT01062256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65147522|NCT01029886|Liraglutide|liraglutide|mesh-list
65147523|NCT01029886|Exenatide|exenatide|mesh-list
65147524|NCT01029886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65147525|NCT01029886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147526|NCT01029886|Incretins|incretins|mesh-ancestor
65147527|NCT01029886|Hormones|hormones|mesh-ancestor
64714082|NCT03053401|Anesthetics, Local|anesthetics, local|mesh-list
65147528|NCT01029886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65147529|NCT01029886|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65147530|NCT01244061|Varenicline|varenicline|mesh-list
65147531|NCT01244061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65147532|NCT01244061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65147533|NCT01244061|Cholinergic Agents|cholinergic agents|mesh-ancestor
65147534|NCT01244061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65147535|NCT01244061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147536|NCT01244061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147537|NCT01243671|Adalimumab|adalimumab|mesh-list
65147538|NCT01243671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65147539|NCT01243671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65147540|NCT01240785|Metformin|metformin|mesh-list
65147541|NCT01240785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65147542|NCT01240785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147543|NCT01033240|Sorafenib|sorafenib|mesh-list
65147544|NCT01033240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147545|NCT01033240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65147546|NCT01033240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147547|NCT01033240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147548|NCT01032382|Gentamicins|gentamicins|mesh-list
65147549|NCT01032382|Paromomycin|paromomycin|mesh-list
65147550|NCT01032382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65147551|NCT01032382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65147552|NCT01032382|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65147553|NCT01032382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147562|NCT01029652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65147563|NCT01029652|Glucocorticoids|glucocorticoids|mesh-ancestor
65147564|NCT01029652|Hormones|hormones|mesh-ancestor
65147565|NCT01029652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65147566|NCT01029652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147567|NCT01029652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65147569|NCT01029652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147570|NCT01029652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147571|NCT01029340|Factor VIII|factor viii|mesh-list
65147572|NCT01029340|Coagulants|coagulants|mesh-ancestor
65147573|NCT01265550|Baclofen|baclofen|mesh-list
65147574|NCT01265550|Desipramine|desipramine|mesh-list
65147575|NCT01265550|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65147576|NCT01265550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147577|NCT01265550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65147578|NCT01265550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65147579|NCT01265550|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65147580|NCT01265550|GABA Agonists|gaba agonists|mesh-ancestor
65304513|NCT02536937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304515|NCT02654561|Calcium heparin|calcium heparin|mesh-list
65304516|NCT02654561|Anticoagulants|anticoagulants|mesh-ancestor
65304517|NCT02654561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65304518|NCT02654561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65304519|NCT02654561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147581|NCT01265550|GABA Agents|gaba agents|mesh-ancestor
65147582|NCT01265550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65147583|NCT01265550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147584|NCT01265550|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65147585|NCT01265550|Antidepressive Agents|antidepressive agents|mesh-ancestor
65147586|NCT01265550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65147587|NCT01265550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147588|NCT01265550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65147589|NCT01265550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65147590|NCT01265550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65147591|NCT01265550|Adrenergic Agents|adrenergic agents|mesh-ancestor
65147592|NCT01265394|Flutemetamol|flutemetamol|mesh-list
65147593|NCT01265394|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65147594|NCT01265394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147595|NCT01029262|Lenalidomide|lenalidomide|mesh-list
65147596|NCT01029262|Immunologic Factors|immunologic factors|mesh-ancestor
65147597|NCT01029262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147598|NCT01029262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65147599|NCT01029262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65147600|NCT01029262|Growth Substances|growth substances|mesh-ancestor
65147601|NCT01029262|Growth Inhibitors|growth inhibitors|mesh-ancestor
65147602|NCT01029262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147603|NCT01061710|Varenicline|varenicline|mesh-list
65147604|NCT01061710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65147605|NCT01061710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65147606|NCT01061710|Cholinergic Agents|cholinergic agents|mesh-ancestor
65147607|NCT01061710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65147608|NCT01061710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147609|NCT01061710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147610|NCT01028014|Pseudoephedrine|pseudoephedrine|mesh-list
65147611|NCT01028014|Ephedrine|ephedrine|mesh-list
65147612|NCT01028014|Cyclobenzaprine|cyclobenzaprine|mesh-list
65147613|NCT01028014|Imipramine|imipramine|mesh-list
65147614|NCT01028014|Tamsulosin|tamsulosin|mesh-list
65147615|NCT01028014|Solifenacin Succinate|solifenacin succinate|mesh-list
65147616|NCT01028014|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65147617|NCT01028014|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65147618|NCT01028014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65147619|NCT01028014|Adrenergic Agents|adrenergic agents|mesh-ancestor
65147620|NCT01028014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65147621|NCT01028014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147641|NCT01028014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65147642|NCT01028014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65147643|NCT01028014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65147644|NCT01028014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65147645|NCT01028014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65147646|NCT01264770|Adalimumab|adalimumab|mesh-list
65147647|NCT01264770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65147648|NCT01264770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65147649|NCT02873650|Dabrafenib|dabrafenib|mesh-list
65147650|NCT02873650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147651|NCT02873650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65147652|NCT02873650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147653|NCT02873650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147654|NCT01302080|Sertraline|sertraline|mesh-list
65147655|NCT01302080|Antidepressive Agents|antidepressive agents|mesh-ancestor
65147656|NCT01302080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65147657|NCT01302080|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65147658|NCT01302080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65147659|NCT01302080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65147660|NCT01302080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304520|NCT02654405|Butyric Acid|butyric acid|mesh-list
65304521|NCT02654405|Histamine Antagonists|histamine antagonists|mesh-ancestor
65304522|NCT02654405|Histamine Agents|histamine agents|mesh-ancestor
65304523|NCT02654405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65304524|NCT02654405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304525|NCT02654405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304526|NCT00649415|Valdecoxib|valdecoxib|mesh-list
65304527|NCT00649415|Piroxicam|piroxicam|mesh-list
65304528|NCT00649415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65304529|NCT00649415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65304530|NCT00649415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534493|NCT00427557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65147661|NCT01302080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65147662|NCT01302080|Serotonin Agents|serotonin agents|mesh-ancestor
65147663|NCT01302080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147664|NCT01032070|Etoposide|etoposide|mesh-list
65147665|NCT01032070|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65147666|NCT01032070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65147667|NCT01032070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147668|NCT01032070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65147669|NCT01032070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65147670|NCT01032070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147671|NCT01032070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147672|NCT01032070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65147673|NCT01237899|Eplerenone|eplerenone|mesh-list
65147674|NCT01237899|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65147675|NCT01237899|Hormone Antagonists|hormone antagonists|mesh-ancestor
65147691|NCT01263444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147692|NCT01263444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147694|NCT01263444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65147695|NCT01263444|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65147696|NCT01263444|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65147697|NCT01263444|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65147698|NCT01263444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147699|NCT01031836|Sifalimumab|sifalimumab|mesh-list
65147700|NCT01031836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65147701|NCT01031836|Immunologic Factors|immunologic factors|mesh-ancestor
65147702|NCT01031836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147703|NCT01237587|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65147704|NCT01237587|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65147705|NCT01237587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65147706|NCT01237587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65147707|NCT01237587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147708|NCT01237587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65147709|NCT01237587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147710|NCT01237587|Analgesics|analgesics|mesh-ancestor
65147711|NCT01237587|Sensory System Agents|sensory system agents|mesh-ancestor
65147712|NCT01237587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65147713|NCT01237587|Antidepressive Agents|antidepressive agents|mesh-ancestor
65147714|NCT01237587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65147715|NCT01237587|Dopamine Agents|dopamine agents|mesh-ancestor
65147716|NCT01031680|Dapagliflozin|dapagliflozin|mesh-list
65147717|NCT01031680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65147718|NCT01031680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147719|NCT01031680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65147720|NCT01031680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147721|NCT01031446|Paclitaxel|paclitaxel|mesh-list
65147722|NCT01031446|Everolimus|everolimus|mesh-list
65147723|NCT01031446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65147724|NCT01031446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147725|NCT01031446|Tubulin Modulators|tubulin modulators|mesh-ancestor
65304531|NCT00649415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304532|NCT00649415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65304533|NCT00649415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65304534|NCT00649415|Analgesics|analgesics|mesh-ancestor
65304535|NCT00649415|Sensory System Agents|sensory system agents|mesh-ancestor
65304536|NCT00649415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65304537|NCT00649415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304538|NCT00649415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65147726|NCT01031446|Antimitotic Agents|antimitotic agents|mesh-ancestor
65147727|NCT01031446|Mitosis Modulators|mitosis modulators|mesh-ancestor
65147728|NCT01031446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147729|NCT01031446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65147730|NCT01031446|Immunologic Factors|immunologic factors|mesh-ancestor
65147731|NCT01031446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147732|NCT01030900|Prednisone|prednisone|mesh-list
65147733|NCT01030900|Cyclophosphamide|cyclophosphamide|mesh-list
65147734|NCT01030900|Rituximab|rituximab|mesh-list
65147735|NCT01030900|Doxorubicin|doxorubicin|mesh-list
65147736|NCT01030900|Etoposide|etoposide|mesh-list
65147737|NCT01030900|Vincristine|vincristine|mesh-list
65147746|NCT01030900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147747|NCT01030900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65147748|NCT01030900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65147749|NCT01030900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65147750|NCT01030900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65147751|NCT01030900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65147752|NCT01030900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147753|NCT01030900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65147754|NCT01030900|Glucocorticoids|glucocorticoids|mesh-ancestor
65147755|NCT01030900|Hormones|hormones|mesh-ancestor
65147756|NCT01030900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65147757|NCT01030900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65147758|NCT01030900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65147759|NCT01030900|Tubulin Modulators|tubulin modulators|mesh-ancestor
65147760|NCT01030900|Antimitotic Agents|antimitotic agents|mesh-ancestor
65147761|NCT01030900|Mitosis Modulators|mitosis modulators|mesh-ancestor
65147762|NCT01030822|Vaccines|vaccines|mesh-list
65147763|NCT01030822|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65147764|NCT01030822|Immunologic Factors|immunologic factors|mesh-ancestor
65147765|NCT01030822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147766|NCT01026454|Valacyclovir|valacyclovir|mesh-list
65147767|NCT01026454|Acyclovir|acyclovir|mesh-list
65147768|NCT01026454|Antiviral Agents|antiviral agents|mesh-ancestor
65147769|NCT01026454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65147770|NCT01026220|Prednisone|prednisone|mesh-list
65147771|NCT01026220|Cyclophosphamide|cyclophosphamide|mesh-list
65147772|NCT01026220|Ifosfamide|ifosfamide|mesh-list
65147773|NCT01026220|Doxorubicin|doxorubicin|mesh-list
65147774|NCT01026220|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65147775|NCT01026220|Etoposide|etoposide|mesh-list
65147776|NCT01026220|Vincristine|vincristine|mesh-list
65147777|NCT01026220|Vinorelbine|vinorelbine|mesh-list
65147778|NCT01026220|Bleomycin|bleomycin|mesh-list
65147779|NCT01026220|Etoposide phosphate|etoposide phosphate|mesh-list
65147780|NCT01026220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65147781|NCT01026220|Immunologic Factors|immunologic factors|mesh-ancestor
65147782|NCT01026220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147783|NCT01026220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65147784|NCT01026220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65147785|NCT01026220|Alkylating Agents|alkylating agents|mesh-ancestor
65147786|NCT01026220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147787|NCT01026220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147788|NCT01026220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65147789|NCT01026220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65147790|NCT01026220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65147791|NCT01026220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65147792|NCT01026220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147793|NCT01026220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65304539|NCT00649415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65304540|NCT00650117|Fentanyl|fentanyl|mesh-list
65304541|NCT00650117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65304542|NCT00650117|Narcotics|narcotics|mesh-ancestor
65304543|NCT00650117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65304544|NCT00650117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304545|NCT00650117|Analgesics|analgesics|mesh-ancestor
65304546|NCT00650117|Sensory System Agents|sensory system agents|mesh-ancestor
65304547|NCT00650117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65304548|NCT00650117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65304549|NCT00650117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65304550|NCT00650117|Anesthetics, General|anesthetics, general|mesh-ancestor
65304551|NCT00650117|Anesthetics|anesthetics|mesh-ancestor
65304552|NCT00648947|Clopidogrel|clopidogrel|mesh-list
65304553|NCT00648947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65304554|NCT00648947|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65304555|NCT00648947|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65304556|NCT00648947|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65304557|NCT00648947|Purinergic Agents|purinergic agents|mesh-ancestor
65304558|NCT00648947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65304559|NCT00648947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304560|NCT00648947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147794|NCT01026220|Glucocorticoids|glucocorticoids|mesh-ancestor
65147795|NCT01026220|Hormones|hormones|mesh-ancestor
65147796|NCT01026220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65147797|NCT01026220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65147798|NCT01026220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65147799|NCT01026220|Tubulin Modulators|tubulin modulators|mesh-ancestor
65147800|NCT01026220|Antimitotic Agents|antimitotic agents|mesh-ancestor
65147801|NCT01026220|Mitosis Modulators|mitosis modulators|mesh-ancestor
65147802|NCT01026142|Capecitabine|capecitabine|mesh-list
65147803|NCT01026142|Trastuzumab|trastuzumab|mesh-list
65147804|NCT01026142|Pertuzumab|pertuzumab|mesh-list
64502060|NCT03001102|Povidone-Iodine|povidone-iodine|mesh-list
65147821|NCT01030666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65147822|NCT01030666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65147823|NCT01030666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147824|NCT01030666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147825|NCT01030666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65147826|NCT01030666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65147827|NCT01030666|Disinfectants|disinfectants|mesh-ancestor
65147828|NCT01030666|Dermatologic Agents|dermatologic agents|mesh-ancestor
65147829|NCT01030666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64790378|NCT00004218|Mitosis Modulators|mitosis modulators|mesh-ancestor
65147830|NCT01030666|Antimalarials|antimalarials|mesh-ancestor
65147831|NCT01030666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65147832|NCT01030666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65147833|NCT01023256|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65147834|NCT01023256|Immunologic Factors|immunologic factors|mesh-ancestor
65147835|NCT01023256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147837|NCT04304014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65147838|NCT04304014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65147839|NCT04304014|Renal Agents|renal agents|mesh-ancestor
65147840|NCT04304014|Antimalarials|antimalarials|mesh-ancestor
64534534|NCT00429507|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
65304561|NCT00649493|Rabeprazole|rabeprazole|mesh-list
65304562|NCT00649493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65304563|NCT00649493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65304564|NCT00649493|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65304565|NCT00649493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304566|NCT00649493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304567|NCT02654093|Cholecalciferol|cholecalciferol|mesh-list
65304568|NCT02654093|Vitamin D|vitamin d|mesh-list
65147841|NCT04304014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65147842|NCT04304014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65147843|NCT01058668|Cariprazine|cariprazine|mesh-list
65147844|NCT01058668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65147845|NCT01058668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65147846|NCT01058668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65147847|NCT01058668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147848|NCT01058668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65147849|NCT00623558|Docetaxel|docetaxel|mesh-list
65147850|NCT00623558|Cetuximab|cetuximab|mesh-list
65147851|NCT00623558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147852|NCT00623558|Tubulin Modulators|tubulin modulators|mesh-ancestor
65147853|NCT00623558|Antimitotic Agents|antimitotic agents|mesh-ancestor
65147854|NCT00623558|Mitosis Modulators|mitosis modulators|mesh-ancestor
65147855|NCT00623558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147856|NCT00623558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65147857|NCT01301066|Pravastatin|pravastatin|mesh-list
65147858|NCT01301066|Pitavastatin|pitavastatin|mesh-list
65147859|NCT01301066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65147860|NCT01301066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65147861|NCT01301066|Antimetabolites|antimetabolites|mesh-ancestor
65147862|NCT01301066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502127|NCT03372486|Anesthetics|anesthetics|mesh-ancestor
65147876|NCT05642624|Amebicides|amebicides|mesh-ancestor
65147877|NCT05642624|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65147878|NCT05642624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65147879|NCT05642624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65147880|NCT05642624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65147881|NCT05642624|Antifungal Agents|antifungal agents|mesh-ancestor
65147882|NCT05642624|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65147883|NCT05642624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65147884|NCT05027308|Teduglutide|teduglutide|mesh-list
65147885|NCT05027308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65147886|NCT05027308|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65147887|NCT05027308|Protective Agents|protective agents|mesh-ancestor
65147888|NCT05027308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147890|NCT04324346|Docetaxel|docetaxel|mesh-list
65147891|NCT04324346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65147892|NCT04324346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147893|NCT04324346|Tubulin Modulators|tubulin modulators|mesh-ancestor
65147894|NCT04324346|Antimitotic Agents|antimitotic agents|mesh-ancestor
65147895|NCT04324346|Mitosis Modulators|mitosis modulators|mesh-ancestor
65147896|NCT04324346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147897|NCT02890238|Sildenafil Citrate|sildenafil citrate|mesh-list
65147898|NCT02890238|Citric Acid|citric acid|mesh-list
65147899|NCT02890238|Sodium Citrate|sodium citrate|mesh-list
65147900|NCT02890238|Clomiphene|clomiphene|mesh-list
65147901|NCT02890238|Enclomiphene|enclomiphene|mesh-list
65147902|NCT02890238|Zuclomiphene|zuclomiphene|mesh-list
65147903|NCT02890238|Anticoagulants|anticoagulants|mesh-ancestor
65147904|NCT02890238|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65147905|NCT02890238|Chelating Agents|chelating agents|mesh-ancestor
65147906|NCT02890238|Sequestering Agents|sequestering agents|mesh-ancestor
65147907|NCT02890238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147908|NCT02890238|Vasodilator Agents|vasodilator agents|mesh-ancestor
65147909|NCT02890238|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65147910|NCT02890238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65147912|NCT02890238|Urological Agents|urological agents|mesh-ancestor
65147913|NCT02890238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65147914|NCT02890238|Hormone Antagonists|hormone antagonists|mesh-ancestor
65304569|NCT02654093|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65304570|NCT02654093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65304571|NCT02654093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304572|NCT02654093|Vitamins|vitamins|mesh-ancestor
65304573|NCT02654093|Micronutrients|micronutrients|mesh-ancestor
65304574|NCT02654093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65304575|NCT02654093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65304576|NCT02654093|Hormone Antagonists|hormone antagonists|mesh-ancestor
65304577|NCT02654093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65304578|NCT02654093|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65304579|NCT02654093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65304580|NCT04168619|Methotrexate|methotrexate|mesh-list
65304581|NCT04168619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65304582|NCT04168619|Abortifacient Agents|abortifacient agents|mesh-ancestor
65304583|NCT04168619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65304584|NCT04168619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304585|NCT04168619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65304587|NCT04168619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304588|NCT04168619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304589|NCT04168619|Dermatologic Agents|dermatologic agents|mesh-ancestor
65304590|NCT04168619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304591|NCT04168619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65304592|NCT04168619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65304593|NCT04168619|Immunologic Factors|immunologic factors|mesh-ancestor
65304594|NCT04168619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65304595|NCT04168619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65304596|NCT02654171|Ziresovir|ziresovir|mesh-list
65304597|NCT02654171|Antiviral Agents|antiviral agents|mesh-ancestor
65304598|NCT02654171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65304599|NCT00650195|Metolazone|metolazone|mesh-list
65304600|NCT00650195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65304601|NCT00650195|Diuretics|diuretics|mesh-ancestor
65304602|NCT00650195|Natriuretic Agents|natriuretic agents|mesh-ancestor
65304603|NCT00650195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304604|NCT00650195|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65304608|NCT04170959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65304609|NCT04170959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304610|NCT00848354|Etanercept|etanercept|mesh-list
65304611|NCT00848354|Methotrexate|methotrexate|mesh-list
65304612|NCT00848354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65304613|NCT00848354|Abortifacient Agents|abortifacient agents|mesh-ancestor
65304614|NCT00848354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65304615|NCT00848354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304616|NCT00848354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65304617|NCT00848354|Antimetabolites|antimetabolites|mesh-ancestor
65304618|NCT00848354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304619|NCT00848354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304620|NCT00848354|Dermatologic Agents|dermatologic agents|mesh-ancestor
65304621|NCT00848354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304622|NCT00848354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65304623|NCT00848354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64534582|NCT00375999|Docetaxel|docetaxel|mesh-list
65147915|NCT02890238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65147916|NCT02890238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147917|NCT02890238|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65147918|NCT02890238|Fertility Agents|fertility agents|mesh-ancestor
65147919|NCT02890238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65147920|NCT02890238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65147921|NCT02890238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65147922|NCT00627796|Lanreotide|lanreotide|mesh-list
65147923|NCT00627796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147924|NCT01299896|Bupropion|bupropion|mesh-list
65147925|NCT01299896|Nicotine|nicotine|mesh-list
65147926|NCT01299896|Varenicline|varenicline|mesh-list
65147927|NCT01299896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65147936|NCT01299896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65147937|NCT01299896|Antidepressive Agents|antidepressive agents|mesh-ancestor
65147938|NCT01299896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65147939|NCT01299896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65147940|NCT01299896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65147941|NCT01299896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65147943|NCT01299896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65147944|NCT01299896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65147945|NCT01299896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147946|NCT01299584|Remifentanil|remifentanil|mesh-list
65147947|NCT01299584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65147948|NCT01299584|Narcotics|narcotics|mesh-ancestor
65147949|NCT01299584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65147950|NCT01299584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147951|NCT01299584|Analgesics|analgesics|mesh-ancestor
65147952|NCT01299584|Sensory System Agents|sensory system agents|mesh-ancestor
65147953|NCT01299584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65147954|NCT01236573|Cyclophosphamide|cyclophosphamide|mesh-list
65147955|NCT01236573|Fludarabine|fludarabine|mesh-list
65147956|NCT01236573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65147957|NCT01236573|Immunologic Factors|immunologic factors|mesh-ancestor
65147958|NCT01236573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147959|NCT01236573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65147960|NCT01236573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65147961|NCT01236573|Alkylating Agents|alkylating agents|mesh-ancestor
65147962|NCT01236573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147963|NCT01236573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534592|NCT00375999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304624|NCT00848354|Immunologic Factors|immunologic factors|mesh-ancestor
65304625|NCT00848354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65304626|NCT00848354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65304627|NCT00848354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65304628|NCT00848354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65304629|NCT00848354|Analgesics|analgesics|mesh-ancestor
65304630|NCT00848354|Sensory System Agents|sensory system agents|mesh-ancestor
65304631|NCT00848354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65304632|NCT00848354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65304633|NCT00848354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65304634|NCT00600821|Paclitaxel|paclitaxel|mesh-list
65304635|NCT00600821|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65147964|NCT01236573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65147965|NCT04323228|Antioxidants|antioxidants|mesh-list
65147966|NCT04323228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147967|NCT04323228|Protective Agents|protective agents|mesh-ancestor
65147968|NCT04323228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147969|NCT04322760|Lidocaine|lidocaine|mesh-list
65147970|NCT04322760|Dexmedetomidine|dexmedetomidine|mesh-list
65147971|NCT04322760|Bupivacaine|bupivacaine|mesh-list
65147972|NCT04322760|Anesthetics, Local|anesthetics, local|mesh-ancestor
65147973|NCT04322760|Anesthetics|anesthetics|mesh-ancestor
65147974|NCT04322760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65147975|NCT04322760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147976|NCT04322760|Sensory System Agents|sensory system agents|mesh-ancestor
65147977|NCT04322760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65147978|NCT04322760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65147979|NCT04322760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65147980|NCT04322760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65147981|NCT04322760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65147982|NCT04322760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147983|NCT04322760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65147984|NCT04322760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65147985|NCT04322760|Analgesics|analgesics|mesh-ancestor
65147986|NCT04322760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65147987|NCT04322760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65147988|NCT04322760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65147989|NCT04322760|Adrenergic Agents|adrenergic agents|mesh-ancestor
65147990|NCT04322760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65147991|NCT04322214|Cobicistat|cobicistat|mesh-list
65147992|NCT04322214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65147993|NCT04322214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65148004|NCT01057810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148006|NCT01262352|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65148007|NCT01262352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65148008|NCT01262352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148010|NCT01299272|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65148011|NCT01299272|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65148012|NCT01299272|Serotonin Agents|serotonin agents|mesh-ancestor
65148013|NCT01299272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65148014|NCT01299272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148015|NCT01299272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148016|NCT01299272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65148017|NCT01299272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65148018|NCT01299116|Contraceptive Agents|contraceptive agents|mesh-list
65148019|NCT01299116|Etonogestrel|etonogestrel|mesh-list
65148020|NCT01299116|Contraceptives, Oral|contraceptives, oral|mesh-list
65148021|NCT01299116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65222830|NCT02700087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65304636|NCT00600821|Bevacizumab|bevacizumab|mesh-list
65304637|NCT00600821|Carboplatin|carboplatin|mesh-list
65304638|NCT00600821|Axitinib|axitinib|mesh-list
65304639|NCT00600821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65304640|NCT00600821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304641|NCT00600821|Tubulin Modulators|tubulin modulators|mesh-ancestor
65304642|NCT00600821|Antimitotic Agents|antimitotic agents|mesh-ancestor
65304643|NCT00600821|Mitosis Modulators|mitosis modulators|mesh-ancestor
65304644|NCT00600821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304645|NCT00600821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65304646|NCT00600821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65304647|NCT00600821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65304648|NCT00600821|Growth Substances|growth substances|mesh-ancestor
65304649|NCT00600821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304650|NCT00600821|Growth Inhibitors|growth inhibitors|mesh-ancestor
65304651|NCT00600821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65304652|NCT00600821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304653|NCT00699764|Vaccines|vaccines|mesh-list
64534608|NCT01488071|Serotonin Agents|serotonin agents|mesh-ancestor
65148022|NCT01299116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148023|NCT01299116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65148024|NCT01299116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65148025|NCT04207398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65148026|NCT04207398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65148027|NCT04207398|Adrenergic Agents|adrenergic agents|mesh-ancestor
65148028|NCT04207398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65148029|NCT04207398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148030|NCT04207398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148031|NCT01299038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65148032|NCT01299038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65148033|NCT01299038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65148034|NCT01299038|Antimetabolites|antimetabolites|mesh-ancestor
65148035|NCT01299038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148036|NCT01299038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65148037|NCT01299038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65148038|NCT01299038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148039|NCT04321278|Azithromycin|azithromycin|mesh-list
65148040|NCT04321278|Hydroxychloroquine|hydroxychloroquine|mesh-list
65148041|NCT04321278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65148042|NCT04321278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65148043|NCT04321278|Antimalarials|antimalarials|mesh-ancestor
65148044|NCT04321278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65148045|NCT04321278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65148046|NCT04321278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148047|NCT04321278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148048|NCT04321278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65148049|NCT01261338|Sucrose polyester|sucrose polyester|mesh-list
65148050|NCT01261338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65148051|NCT01261338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65148052|NCT01261338|Antimetabolites|antimetabolites|mesh-ancestor
65148053|NCT01261338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148062|NCT01260948|Nootropic Agents|nootropic agents|mesh-ancestor
65148063|NCT01025284|Lenograstim|lenograstim|mesh-list
65148064|NCT01025284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65148065|NCT01025284|Immunologic Factors|immunologic factors|mesh-ancestor
65148066|NCT01025284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304654|NCT00699764|Immunologic Factors|immunologic factors|mesh-ancestor
65304655|NCT00699764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304656|NCT02653703|Ethanol|ethanol|mesh-list
65304657|NCT02653703|Menthol|menthol|mesh-list
65304658|NCT02653703|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65148067|NCT02873026|Triamcinolone|triamcinolone|mesh-list
65148068|NCT02873026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65148069|NCT02873026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65148070|NCT02873026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65148071|NCT02873026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65148072|NCT02873026|Glucocorticoids|glucocorticoids|mesh-ancestor
65148073|NCT02873026|Hormones|hormones|mesh-ancestor
65148074|NCT02873026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65148075|NCT02873026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148076|NCT02873026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65148077|NCT02873026|Immunologic Factors|immunologic factors|mesh-ancestor
65148078|NCT02873026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148079|NCT02873026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148080|NCT01056718|Nebivolol|nebivolol|mesh-list
65148081|NCT01056718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65148082|NCT01056718|Vasodilator Agents|vasodilator agents|mesh-ancestor
65148083|NCT01056718|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65148084|NCT01056718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65148085|NCT01056718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65148087|NCT01056718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65148088|NCT01056718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148089|NCT01056718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148091|NCT01298570|Fluorouracil|fluorouracil|mesh-list
65148092|NCT01298570|Irinotecan|irinotecan|mesh-list
65148093|NCT01298570|Levoleucovorin|levoleucovorin|mesh-list
65148094|NCT01298570|Antimetabolites|antimetabolites|mesh-ancestor
65148095|NCT01298570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148096|NCT01298570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65148097|NCT01298570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148098|NCT01298570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65148099|NCT01298570|Immunologic Factors|immunologic factors|mesh-ancestor
65148100|NCT01298570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148101|NCT01298570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65148102|NCT01298570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65148103|NCT01298570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148104|NCT01298570|Antidotes|antidotes|mesh-ancestor
65148105|NCT01298570|Protective Agents|protective agents|mesh-ancestor
65148106|NCT01298570|Vitamin B Complex|vitamin b complex|mesh-ancestor
65148107|NCT01298570|Vitamins|vitamins|mesh-ancestor
65148108|NCT01298570|Micronutrients|micronutrients|mesh-ancestor
65148109|NCT01259856|Aspirin|aspirin|mesh-list
65148110|NCT01259856|Interferons|interferons|mesh-list
65148111|NCT01259856|Interferon-alpha|interferon-alpha|mesh-list
65148112|NCT01259856|Interferon alpha-2|interferon alpha-2|mesh-list
65148113|NCT01259856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65148114|NCT01259856|Hydroxyurea|hydroxyurea|mesh-list
65148115|NCT01259856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148116|NCT01259856|Antiviral Agents|antiviral agents|mesh-ancestor
65148117|NCT01259856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65148118|NCT01259856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65148119|NCT01259856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65148120|NCT01259856|Analgesics|analgesics|mesh-ancestor
65148121|NCT01259856|Sensory System Agents|sensory system agents|mesh-ancestor
65148122|NCT01259856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502381|NCT03368274|Glucocorticoids|glucocorticoids|mesh-ancestor
65148134|NCT01259856|Antisickling Agents|antisickling agents|mesh-ancestor
65148135|NCT01259856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65148136|NCT00624000|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65148137|NCT00624000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65148138|NCT00624000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65148139|NCT00624000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148141|NCT01259466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65148142|NCT01259466|Autonomic Agents|autonomic agents|mesh-ancestor
65148143|NCT01259466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65148144|NCT01259466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148145|NCT01259466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65148146|NCT01259466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65304659|NCT02653703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65304660|NCT02653703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65304661|NCT02653703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304662|NCT02653703|Antipruritics|antipruritics|mesh-ancestor
65304663|NCT02653703|Dermatologic Agents|dermatologic agents|mesh-ancestor
65304664|NCT00649571|Doxycycline|doxycycline|mesh-list
64959336|NCT04726657|Insulin|insulin|mesh-list
65148147|NCT01259466|Cholinergic Agents|cholinergic agents|mesh-ancestor
65148148|NCT01259466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65148149|NCT01259466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148150|NCT01259388|Lithium Carbonate|lithium carbonate|mesh-list
65148151|NCT01259388|Antidepressive Agents|antidepressive agents|mesh-ancestor
65148152|NCT01259388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65148153|NCT01259388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148154|NCT01259388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148155|NCT01259388|Antimanic Agents|antimanic agents|mesh-ancestor
65148156|NCT01259388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65148157|NCT01259388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65148158|NCT01259388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148160|NCT05525910|Ritonavir|ritonavir|mesh-list
65148161|NCT05525910|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64681483|NCT00002691|Leucovorin|leucovorin|mesh-list
65148162|NCT05525910|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65148163|NCT05525910|Protease Inhibitors|protease inhibitors|mesh-ancestor
65148164|NCT05525910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148165|NCT05525910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148166|NCT05525910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65148167|NCT05525910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65148168|NCT05525910|Antiviral Agents|antiviral agents|mesh-ancestor
65148169|NCT05525910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65148170|NCT05525910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65148171|NCT05525910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65148172|NCT00624078|Antivenins|antivenins|mesh-list
65148173|NCT00624078|Immunologic Factors|immunologic factors|mesh-ancestor
65148174|NCT00624078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148175|NCT05286528|Imatinib Mesylate|imatinib mesylate|mesh-list
65148176|NCT05286528|Dasatinib|dasatinib|mesh-list
65148177|NCT05286528|Ponatinib|ponatinib|mesh-list
65148178|NCT05286528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148179|NCT05286528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65148180|NCT05286528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148181|NCT05286528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148182|NCT04752696|Leucovorin|leucovorin|mesh-list
65148183|NCT04752696|Fluorouracil|fluorouracil|mesh-list
65148184|NCT04752696|Irinotecan|irinotecan|mesh-list
65148185|NCT04752696|Onvansertib|onvansertib|mesh-list
65148186|NCT04752696|Antimetabolites|antimetabolites|mesh-ancestor
65148187|NCT04752696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148195|NCT04752696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148196|NCT04752696|Antidotes|antidotes|mesh-ancestor
65148197|NCT04752696|Protective Agents|protective agents|mesh-ancestor
65148198|NCT04752696|Vitamin B Complex|vitamin b complex|mesh-ancestor
65148199|NCT04752696|Vitamins|vitamins|mesh-ancestor
65148200|NCT04752696|Micronutrients|micronutrients|mesh-ancestor
65148201|NCT04752696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65148202|NCT04554732|Mitogens|mitogens|mesh-list
65148203|NCT04554732|Mitosis Modulators|mitosis modulators|mesh-ancestor
65148204|NCT04554732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148205|NCT04481256|Paclitaxel|paclitaxel|mesh-list
65148206|NCT04481256|Carboplatin|carboplatin|mesh-list
65148207|NCT04481256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65148208|NCT04481256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148209|NCT04481256|Tubulin Modulators|tubulin modulators|mesh-ancestor
65148210|NCT04481256|Antimitotic Agents|antimitotic agents|mesh-ancestor
65148211|NCT04481256|Mitosis Modulators|mitosis modulators|mesh-ancestor
65148212|NCT04481256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148213|NCT04387110|Ocrelizumab|ocrelizumab|mesh-list
65148214|NCT04387110|Immunologic Factors|immunologic factors|mesh-ancestor
65148215|NCT04387110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148216|NCT03434418|Osimertinib|osimertinib|mesh-list
65148217|NCT03434418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304665|NCT00649571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65304666|NCT00649571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65304667|NCT00649571|Antimalarials|antimalarials|mesh-ancestor
65304668|NCT00649571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65304669|NCT00649571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65304670|NCT02662283|Acteoside|acteoside|mesh-list
65304671|NCT02662283|Prednisolone|prednisolone|mesh-list
65304672|NCT02662283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65304673|NCT02662283|Glucocorticoids|glucocorticoids|mesh-ancestor
65304674|NCT02662283|Hormones|hormones|mesh-ancestor
65304675|NCT02662283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65304676|NCT02662283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304677|NCT02662283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64534638|NCT01484873|Exenatide|exenatide|mesh-list
65148218|NCT03434418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65148219|NCT03434418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148220|NCT03434418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148221|NCT03377478|Sofosbuvir|sofosbuvir|mesh-list
65148222|NCT03377478|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65148223|NCT03377478|Velpatasvir|velpatasvir|mesh-list
65148224|NCT03377478|Antiviral Agents|antiviral agents|mesh-ancestor
65148225|NCT03377478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65148226|NCT03181932|Vancomycin|vancomycin|mesh-list
65148227|NCT03181932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65148228|NCT03181932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65148229|NCT02797470|Cytarabine|cytarabine|mesh-list
65148230|NCT02797470|Etoposide|etoposide|mesh-list
65148231|NCT02797470|Podophyllotoxin|podophyllotoxin|mesh-list
65148232|NCT02797470|Etoposide phosphate|etoposide phosphate|mesh-list
65148233|NCT02797470|Melphalan|melphalan|mesh-list
65148234|NCT02797470|Mechlorethamine|mechlorethamine|mesh-list
65148235|NCT02797470|Carmustine|carmustine|mesh-list
65148236|NCT02797470|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65148237|NCT02797470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65148238|NCT02797470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148239|NCT02797470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65148240|NCT02797470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65148241|NCT02797470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148242|NCT02797470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148243|NCT02797470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65148244|NCT02797470|Antimetabolites|antimetabolites|mesh-ancestor
65148245|NCT02797470|Antiviral Agents|antiviral agents|mesh-ancestor
65148246|NCT02797470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65148247|NCT02797470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65148248|NCT02797470|Immunologic Factors|immunologic factors|mesh-ancestor
65148249|NCT02797470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148250|NCT02797470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65148251|NCT02797470|Alkylating Agents|alkylating agents|mesh-ancestor
65148252|NCT02797470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65148253|NCT02797470|Keratolytic Agents|keratolytic agents|mesh-ancestor
65148254|NCT02797470|Dermatologic Agents|dermatologic agents|mesh-ancestor
65148255|NCT02797470|Tubulin Modulators|tubulin modulators|mesh-ancestor
65148256|NCT02797470|Antimitotic Agents|antimitotic agents|mesh-ancestor
65148257|NCT02797470|Mitosis Modulators|mitosis modulators|mesh-ancestor
65148272|NCT02888730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65148274|NCT01696734|Antiemetics|antiemetics|mesh-ancestor
65148275|NCT01696734|Autonomic Agents|autonomic agents|mesh-ancestor
65148276|NCT01696734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65148277|NCT01696734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148278|NCT01696734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65148279|NCT01696734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65148280|NCT01696734|Dopamine Agents|dopamine agents|mesh-ancestor
65148281|NCT01696734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65148282|NCT01696734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304678|NCT02662283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304679|NCT02662283|Protective Agents|protective agents|mesh-ancestor
65304680|NCT02662283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65304681|NCT02662283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65304682|NCT02662283|Antioxidants|antioxidants|mesh-ancestor
65304683|NCT02662283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304684|NCT02662283|Chelating Agents|chelating agents|mesh-ancestor
65304685|NCT02662283|Sequestering Agents|sequestering agents|mesh-ancestor
65304686|NCT02662283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65304687|NCT02662283|Immunologic Factors|immunologic factors|mesh-ancestor
65304688|NCT02657603|Lidocaine|lidocaine|mesh-list
65304689|NCT02657603|Anesthetics, Local|anesthetics, local|mesh-ancestor
65304690|NCT02657603|Anesthetics|anesthetics|mesh-ancestor
64534644|NCT01484873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64534645|NCT01486927|Factor VIII|factor viii|mesh-list
64534646|NCT01486927|Coagulants|coagulants|mesh-ancestor
64534647|NCT00379197|Naltrexone|naltrexone|mesh-list
65148283|NCT01598298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64790832|NCT00004860|Leucovorin|leucovorin|mesh-list
65148284|NCT01598298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65148285|NCT01598298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65148286|NCT01598298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65148287|NCT01598298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148289|NCT01598298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148290|NCT01598298|Analgesics|analgesics|mesh-ancestor
65148291|NCT01598298|Sensory System Agents|sensory system agents|mesh-ancestor
65148292|NCT01598298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65148293|NCT01598298|Antidepressive Agents|antidepressive agents|mesh-ancestor
65148294|NCT01598298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65148295|NCT01598298|Dopamine Agents|dopamine agents|mesh-ancestor
65148296|NCT02888652|Clopidogrel|clopidogrel|mesh-list
65148297|NCT02888652|Ticagrelor|ticagrelor|mesh-list
65148298|NCT02888652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65148299|NCT02888652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65148300|NCT02888652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65148301|NCT02888652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65148302|NCT02888652|Purinergic Agents|purinergic agents|mesh-ancestor
65148303|NCT02888652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65148304|NCT02888652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148305|NCT02888652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148306|NCT01235949|Acetaminophen|acetaminophen|mesh-list
65148307|NCT01235949|Ibuprofen|ibuprofen|mesh-list
65148308|NCT01235949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65148309|NCT01235949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65148310|NCT01235949|Analgesics|analgesics|mesh-ancestor
65148311|NCT01235949|Sensory System Agents|sensory system agents|mesh-ancestor
65148312|NCT01235949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65148313|NCT01235949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148314|NCT01235949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65148315|NCT01235949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65148316|NCT01235949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65148317|NCT01235949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502582|NCT03357900|Remifentanil|remifentanil|mesh-list
65148332|NCT01235793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148334|NCT05601648|Hallucinogens|hallucinogens|mesh-ancestor
65148335|NCT05601648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148336|NCT05601648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65148337|NCT01235715|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65304691|NCT02657603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65304692|NCT02657603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304693|NCT02657603|Sensory System Agents|sensory system agents|mesh-ancestor
65304694|NCT02657603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65304695|NCT02657603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65304696|NCT02657603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65304697|NCT02657603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65304698|NCT02657603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65304699|NCT02657603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304700|NCT02657447|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
65304701|NCT02657447|Chelating Agents|chelating agents|mesh-ancestor
65304702|NCT02657447|Sequestering Agents|sequestering agents|mesh-ancestor
65304703|NCT02657447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304704|NCT00649649|Quinapril|quinapril|mesh-list
65304705|NCT00649649|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65304706|NCT00649649|Protease Inhibitors|protease inhibitors|mesh-ancestor
65304707|NCT00649649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148338|NCT01235715|Hemostatics|hemostatics|mesh-ancestor
65148339|NCT01235715|Coagulants|coagulants|mesh-ancestor
65148340|NCT01235403|Lacosamide|lacosamide|mesh-list
65148341|NCT01235403|Anticonvulsants|anticonvulsants|mesh-ancestor
65148342|NCT01235403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65148343|NCT01235403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65148344|NCT01235403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65148345|NCT01235403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148346|NCT01024036|Siltuximab|siltuximab|mesh-list
65148347|NCT01024036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148348|NCT01234467|Rituximab|rituximab|mesh-list
65148349|NCT01234467|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65148350|NCT01234467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65148351|NCT01234467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148352|NCT01234467|Immunologic Factors|immunologic factors|mesh-ancestor
65148353|NCT01234467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148354|NCT01234467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65148355|NCT01234467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65148356|NCT01234467|Alkylating Agents|alkylating agents|mesh-ancestor
65148357|NCT01234467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148358|NCT01233999|Botulinum Toxins|botulinum toxins|mesh-list
65148359|NCT01233999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65148360|NCT01233999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65148361|NCT01233999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65148362|NCT01233999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65148363|NCT01233999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148364|NCT01233999|Cholinergic Agents|cholinergic agents|mesh-ancestor
65148365|NCT01233999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65148366|NCT01233999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148367|NCT01233999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65148368|NCT01233999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65148369|NCT01233687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65148370|NCT01233687|Rilotumumab|rilotumumab|mesh-list
65148371|NCT01233687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148372|NCT01233687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65148373|NCT01233687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304708|NCT00649649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304709|NCT00649649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65304710|NCT02657291|Ropivacaine|ropivacaine|mesh-list
65304711|NCT02657291|Anesthetics, Local|anesthetics, local|mesh-ancestor
65304712|NCT02657291|Anesthetics|anesthetics|mesh-ancestor
65304713|NCT02657291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65304714|NCT02657291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304715|NCT02657291|Sensory System Agents|sensory system agents|mesh-ancestor
65148374|NCT01233687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148375|NCT01233687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65148385|NCT01233609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65148386|NCT01233609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65148387|NCT01232283|Apremilast|apremilast|mesh-list
65148388|NCT01232283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65148389|NCT01232283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65148390|NCT01232283|Analgesics|analgesics|mesh-ancestor
65148391|NCT01232283|Sensory System Agents|sensory system agents|mesh-ancestor
65148392|NCT01232283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65148393|NCT01232283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148394|NCT01232283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65148395|NCT01232283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65148396|NCT01232283|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65148397|NCT01232283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65148398|NCT01232283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148399|NCT01232283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148400|NCT01232127|Ritonavir|ritonavir|mesh-list
65148401|NCT01232127|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65148402|NCT01232127|Tenofovir|tenofovir|mesh-list
65148403|NCT01232127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
65148404|NCT01232127|Famotidine|famotidine|mesh-list
65148405|NCT01232127|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65148406|NCT01232127|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65148407|NCT01232127|Protease Inhibitors|protease inhibitors|mesh-ancestor
65148408|NCT01232127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148409|NCT01232127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148410|NCT01232127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65148411|NCT01232127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65148412|NCT01232127|Antiviral Agents|antiviral agents|mesh-ancestor
65148413|NCT01232127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65148414|NCT01232127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65148415|NCT01232127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65148416|NCT01232127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65148417|NCT01232127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65148418|NCT01232127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65148419|NCT01232127|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65148420|NCT01232127|Histamine Antagonists|histamine antagonists|mesh-ancestor
65148421|NCT01232127|Histamine Agents|histamine agents|mesh-ancestor
65148422|NCT01232127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65148423|NCT01232127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148424|NCT01258608|Sorafenib|sorafenib|mesh-list
65148425|NCT01258608|Mapatumumab|mapatumumab|mesh-list
65148426|NCT01258608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148427|NCT01258608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65148428|NCT01258608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148429|NCT01258608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148430|NCT01231659|Everolimus|everolimus|mesh-list
65148431|NCT01231659|Letrozole|letrozole|mesh-list
65148432|NCT01231659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148433|NCT01231659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65148434|NCT01231659|Immunologic Factors|immunologic factors|mesh-ancestor
65148435|NCT01231659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148436|NCT01231659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65148437|NCT01231659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65148438|NCT01231659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148439|NCT01231659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148440|NCT01231659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65304716|NCT02657291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65304717|NCT00699920|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65304718|NCT00699920|Antimalarials|antimalarials|mesh-ancestor
65304719|NCT00699920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65304720|NCT00699920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65304721|NCT00699920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65304722|NCT02661893|Rifampin|rifampin|mesh-list
65304723|NCT02661893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65304724|NCT02661893|Antitubercular Agents|antitubercular agents|mesh-ancestor
65304725|NCT02661893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65304726|NCT02661893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65304727|NCT02661893|Leprostatic Agents|leprostatic agents|mesh-ancestor
65304728|NCT02661893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65304729|NCT02661893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304730|NCT02661893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304731|NCT02661893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65304732|NCT02661893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65304733|NCT02661893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65148441|NCT01231659|Hormone Antagonists|hormone antagonists|mesh-ancestor
64502696|NCT01623466|Levonorgestrel|levonorgestrel|mesh-list
65148454|NCT01054222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65148455|NCT01054222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148456|NCT01054222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148457|NCT01054222|Urological Agents|urological agents|mesh-ancestor
65148458|NCT01052428|Metoprolol|metoprolol|mesh-list
65148459|NCT01052428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65148460|NCT01052428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65148461|NCT01052428|Sympatholytics|sympatholytics|mesh-ancestor
65148462|NCT01052428|Autonomic Agents|autonomic agents|mesh-ancestor
65148463|NCT01052428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65148464|NCT01052428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148465|NCT01052428|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65148466|NCT01052428|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65148467|NCT01052428|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65148468|NCT01052428|Adrenergic Agents|adrenergic agents|mesh-ancestor
65148469|NCT01052428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65148470|NCT01052428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148471|NCT01052272|Allopurinol|allopurinol|mesh-list
65148472|NCT01052272|Candesartan|candesartan|mesh-list
65148473|NCT01052272|Candesartan cilexetil|candesartan cilexetil|mesh-list
65148474|NCT01052272|Ramipril|ramipril|mesh-list
65148475|NCT01052272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65148476|NCT01052272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65148477|NCT01052272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65148478|NCT01052272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148479|NCT01052272|Antimetabolites|antimetabolites|mesh-ancestor
65148480|NCT01052272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148481|NCT01052272|Gout Suppressants|gout suppressants|mesh-ancestor
65148482|NCT01052272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65148483|NCT01052272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65148484|NCT01052272|Antioxidants|antioxidants|mesh-ancestor
65148485|NCT01052272|Protective Agents|protective agents|mesh-ancestor
65148486|NCT01052272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148487|NCT01052272|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65148488|NCT01052272|Protease Inhibitors|protease inhibitors|mesh-ancestor
65304734|NCT02661893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65304735|NCT02661893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65304736|NCT02661893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65304737|NCT00855920|Indomethacin|indomethacin|mesh-list
65304738|NCT00855920|Rilonacept|rilonacept|mesh-list
65304739|NCT00855920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65304740|NCT00855920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65304741|NCT00855920|Analgesics|analgesics|mesh-ancestor
65304742|NCT00855920|Sensory System Agents|sensory system agents|mesh-ancestor
65304743|NCT00855920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65304744|NCT00855920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304745|NCT00855920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65304746|NCT00855920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65304747|NCT00855920|Gout Suppressants|gout suppressants|mesh-ancestor
65304748|NCT00855920|Tocolytic Agents|tocolytic agents|mesh-ancestor
65304749|NCT00855920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65304750|NCT00855920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65304751|NCT00855920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304752|NCT00855920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304753|NCT02657213|Insulin|insulin|mesh-list
65304754|NCT02657213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65304755|NCT02657213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65304756|NCT02657213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304757|NCT00649727|Oxybutynin|oxybutynin|mesh-list
65148489|NCT01257204|Interferons|interferons|mesh-list
65148490|NCT01257204|Ribavirin|ribavirin|mesh-list
65148491|NCT01257204|Interferon-alpha|interferon-alpha|mesh-list
65148492|NCT01257204|Interferon alpha-2|interferon alpha-2|mesh-list
65148493|NCT01257204|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65148494|NCT01257204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148495|NCT01257204|Antiviral Agents|antiviral agents|mesh-ancestor
65148496|NCT01257204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65148497|NCT01257204|Antimetabolites|antimetabolites|mesh-ancestor
65148498|NCT01257204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148499|NCT01257204|Immunologic Factors|immunologic factors|mesh-ancestor
65148500|NCT01257204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148501|NCT01231581|Gemcitabine|gemcitabine|mesh-list
65148502|NCT01231581|Trametinib|trametinib|mesh-list
65148503|NCT01231581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65148504|NCT01231581|Antimetabolites|antimetabolites|mesh-ancestor
65148516|NCT01050634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65148517|NCT01050634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65148518|NCT01050634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148519|NCT01050634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148520|NCT01050634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65148521|NCT01050634|Hormone Antagonists|hormone antagonists|mesh-ancestor
65148522|NCT01050634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65148523|NCT01050634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148524|NCT01020526|Pregabalin|pregabalin|mesh-list
65148525|NCT01020526|Analgesics|analgesics|mesh-ancestor
65148526|NCT01020526|Sensory System Agents|sensory system agents|mesh-ancestor
65148527|NCT01020526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64534726|NCT01512979|Metformin|metformin|mesh-list
65304758|NCT00649727|Parasympatholytics|parasympatholytics|mesh-ancestor
65304759|NCT00649727|Autonomic Agents|autonomic agents|mesh-ancestor
65304760|NCT00649727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65304761|NCT00649727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304762|NCT00649727|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65304763|NCT00649727|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65304764|NCT00649727|Cholinergic Agents|cholinergic agents|mesh-ancestor
65304765|NCT00649727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65304766|NCT00649727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304767|NCT00649727|Urological Agents|urological agents|mesh-ancestor
65304768|NCT00650273|Azithromycin|azithromycin|mesh-list
65304769|NCT00650273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65304770|NCT00650273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65148528|NCT01020526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148529|NCT01020526|Anticonvulsants|anticonvulsants|mesh-ancestor
65148530|NCT01020526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65148531|NCT01020526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65148532|NCT01020526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148533|NCT01020526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65148534|NCT01020526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65148535|NCT01020526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65148536|NCT01020526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65148537|NCT01020526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65148538|NCT01020448|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65148539|NCT01020448|Luteolytic Agents|luteolytic agents|mesh-ancestor
65148540|NCT01020448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65148541|NCT01020448|Contraceptive Agents|contraceptive agents|mesh-ancestor
65148542|NCT01020448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65148543|NCT01020448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148544|NCT01020448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65148545|NCT01020448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65148546|NCT01020448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148547|NCT04286230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65148548|NCT04286230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65148549|NCT04286230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65148550|NCT04286230|Antitubercular Agents|antitubercular agents|mesh-ancestor
65148551|NCT01256658|Lumefantrine|lumefantrine|mesh-list
65148552|NCT01256658|Artemether|artemether|mesh-list
65148553|NCT01256658|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65148554|NCT01256658|Antimalarials|antimalarials|mesh-ancestor
65148555|NCT01256658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65148556|NCT01256658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65148557|NCT01256658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65148558|NCT01256190|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65148559|NCT01256190|Fibrin Foam|fibrin foam|mesh-list
65148560|NCT01256190|Hemostatics|hemostatics|mesh-ancestor
65148561|NCT01256190|Coagulants|coagulants|mesh-ancestor
65148562|NCT02888574|Oxytocin|oxytocin|mesh-list
65148563|NCT02888574|Oxytocics|oxytocics|mesh-ancestor
65148564|NCT02888574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65148565|NCT02888574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148566|NCT01231503|Vaccines|vaccines|mesh-list
65148567|NCT01231503|Immunologic Factors|immunologic factors|mesh-ancestor
65148568|NCT01231503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148569|NCT01228071|Testosterone|testosterone|mesh-list
65148570|NCT01228071|Androgens|androgens|mesh-ancestor
65148580|NCT04319289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65148581|NCT04319289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65148582|NCT01008475|Irinotecan|irinotecan|mesh-list
65148583|NCT01008475|Cetuximab|cetuximab|mesh-list
65148584|NCT01008475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65304771|NCT00698126|Insulin|insulin|mesh-list
65304772|NCT00698126|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65304773|NCT00698126|Insulin Aspart|insulin aspart|mesh-list
65304774|NCT00698126|Biphasic Insulins|biphasic insulins|mesh-list
65304775|NCT00698126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65304776|NCT00698126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304777|NCT02661425|Immunoglobulins|immunoglobulins|mesh-list
65304778|NCT02661425|Immunologic Factors|immunologic factors|mesh-ancestor
65304779|NCT02661425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304780|NCT02656901|Anesthetics|anesthetics|mesh-list
65304781|NCT02656901|Sevoflurane|sevoflurane|mesh-list
65304782|NCT02656901|Desflurane|desflurane|mesh-list
65304783|NCT02656901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65304784|NCT02656901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148585|NCT01008475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65148586|NCT01008475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148587|NCT01008475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148588|NCT01008475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148589|NCT01008475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65148590|NCT01226745|Ceralifimod|ceralifimod|mesh-list
65148591|NCT01226745|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65148592|NCT01226745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148593|NCT01226745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65148594|NCT01226745|Immunologic Factors|immunologic factors|mesh-ancestor
65148595|NCT01226745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148596|NCT01226511|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65148597|NCT01226511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65148598|NCT01226511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65148599|NCT01226511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65148600|NCT01226511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148601|NCT01226511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65148602|NCT01226511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148603|NCT01226511|Analgesics|analgesics|mesh-ancestor
65148604|NCT01226511|Sensory System Agents|sensory system agents|mesh-ancestor
65148605|NCT01226511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65148606|NCT01226511|Antidepressive Agents|antidepressive agents|mesh-ancestor
65148607|NCT01226511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65148608|NCT01226511|Dopamine Agents|dopamine agents|mesh-ancestor
65148609|NCT01226043|Insulin Glargine|insulin glargine|mesh-list
65148610|NCT01226043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65148611|NCT01226043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148612|NCT01001377|Cetuximab|cetuximab|mesh-list
65148613|NCT01001377|Panitumumab|panitumumab|mesh-list
65148614|NCT01001377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65148615|NCT01001377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148616|NCT01225887|Nintedanib|nintedanib|mesh-list
65148617|NCT01225887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148618|NCT01225887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65148619|NCT01225887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148620|NCT01225887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148621|NCT01296932|BI 836826|bi 836826|mesh-list
65148622|NCT01296932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65148623|NCT01296932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148624|NCT01296698|Nicotine|nicotine|mesh-list
65148625|NCT01296698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65148626|NCT01296698|Autonomic Agents|autonomic agents|mesh-ancestor
65148627|NCT01296698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65148628|NCT01296698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148629|NCT01296698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65148630|NCT01296698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65148631|NCT01296698|Cholinergic Agents|cholinergic agents|mesh-ancestor
65304785|NCT02656901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65304786|NCT02656901|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65304787|NCT02656901|Anesthetics, General|anesthetics, general|mesh-ancestor
65304788|NCT00847886|Methotrexate|methotrexate|mesh-list
65304789|NCT00847886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65148632|NCT01296698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65148633|NCT01296698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148647|NCT01296152|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65148648|NCT01296152|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65148649|NCT01296152|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65148650|NCT01296152|Contraceptive Agents|contraceptive agents|mesh-ancestor
65148651|NCT01296152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65148652|NCT01296152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148653|NCT01296152|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65148654|NCT01296152|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65148655|NCT01296152|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65148656|NCT01296152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65148657|NCT01296152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148658|NCT04373317|Pimavanserin|pimavanserin|mesh-list
65148659|NCT04373317|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65148660|NCT04373317|Antidepressive Agents|antidepressive agents|mesh-ancestor
65148661|NCT04373317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65148662|NCT04373317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65148663|NCT04373317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65148664|NCT04373317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65148665|NCT04373317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148666|NCT04373317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65148667|NCT04373317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65148668|NCT04373317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65148669|NCT04373317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65148670|NCT04373317|Serotonin Agents|serotonin agents|mesh-ancestor
65148671|NCT04373317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65148672|NCT04373317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148673|NCT01002547|Vitamins|vitamins|mesh-list
65148674|NCT01002547|Vitamin E|vitamin e|mesh-list
65148675|NCT01002547|Tocopherols|tocopherols|mesh-list
65148676|NCT01002547|Tocotrienols|tocotrienols|mesh-list
65148677|NCT01002547|alpha-Tocopherol|alpha-tocopherol|mesh-list
65148678|NCT01002547|Pioglitazone|pioglitazone|mesh-list
65148679|NCT01002547|Micronutrients|micronutrients|mesh-ancestor
65148680|NCT01002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148681|NCT01002547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65148683|NCT01002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148684|NCT01002547|Protective Agents|protective agents|mesh-ancestor
65148685|NCT04295161|Abiraterone Acetate|abiraterone acetate|mesh-list
65148686|NCT04295161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148687|NCT04295161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65148688|NCT04295161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148689|NCT04295161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148690|NCT04295161|Hormone Antagonists|hormone antagonists|mesh-ancestor
65148691|NCT04295161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65148692|NCT04295161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148693|NCT04295161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65148694|NCT04325659|Lofexidine|lofexidine|mesh-list
64502958|NCT03363984|GABA Modulators|gaba modulators|mesh-ancestor
65148706|NCT04313881|Azacitidine|azacitidine|mesh-list
65148707|NCT04313881|Magrolimab|magrolimab|mesh-list
65148708|NCT04313881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65148709|NCT04313881|Antimetabolites|antimetabolites|mesh-ancestor
65148710|NCT04313881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148711|NCT04313881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148712|NCT04313881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148713|NCT04313881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65148714|NCT01007149|Omalizumab|omalizumab|mesh-list
65148715|NCT01007149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65148716|NCT01007149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65148717|NCT01007149|Respiratory System Agents|respiratory system agents|mesh-ancestor
65148718|NCT04433767|Nicotine|nicotine|mesh-list
65148719|NCT04433767|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65304790|NCT00847886|Abortifacient Agents|abortifacient agents|mesh-ancestor
65304791|NCT00847886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65304792|NCT00847886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304793|NCT00847886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65304794|NCT00847886|Antimetabolites|antimetabolites|mesh-ancestor
64534754|NCT01478321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65148720|NCT04433767|Autonomic Agents|autonomic agents|mesh-ancestor
65148721|NCT04433767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65148722|NCT04433767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148723|NCT04433767|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65148724|NCT04433767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65148725|NCT04433767|Cholinergic Agents|cholinergic agents|mesh-ancestor
65148726|NCT04433767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65148727|NCT04433767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148728|NCT00998335|Insulin|insulin|mesh-list
65148729|NCT00998335|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65148730|NCT00998335|Insulin Aspart|insulin aspart|mesh-list
65148731|NCT00998335|Insulin, Long-Acting|insulin, long-acting|mesh-list
65148732|NCT00998335|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65148733|NCT00998335|Insulin Detemir|insulin detemir|mesh-list
65148734|NCT00998335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65148735|NCT00998335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148736|NCT02871505|Penicillins|penicillins|mesh-list
65148737|NCT02871505|Penicillin G|penicillin g|mesh-list
65148738|NCT02871505|Penicillin G Benzathine|penicillin g benzathine|mesh-list
65148739|NCT02871505|Penicillin G Procaine|penicillin g procaine|mesh-list
65148740|NCT02871505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65148741|NCT02871505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65148742|NCT01294670|Etoposide|etoposide|mesh-list
65148743|NCT01294670|Vorinostat|vorinostat|mesh-list
65148744|NCT01294670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65148745|NCT01294670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148746|NCT01294670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65148747|NCT01294670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65148748|NCT01294670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148749|NCT01294670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148750|NCT01294670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65148751|NCT01006603|Glimepiride|glimepiride|mesh-list
65148752|NCT01006603|Saxagliptin|saxagliptin|mesh-list
65148753|NCT01006603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65148754|NCT01006603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65148755|NCT01006603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148756|NCT01006603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65148757|NCT01006603|Immunologic Factors|immunologic factors|mesh-ancestor
65148768|NCT00997321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65148769|NCT00997321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148771|NCT00997321|Anesthetics, General|anesthetics, general|mesh-ancestor
65148772|NCT00997321|Anesthetics|anesthetics|mesh-ancestor
65148773|NCT00997321|Analgesics|analgesics|mesh-ancestor
65148774|NCT00997321|Sensory System Agents|sensory system agents|mesh-ancestor
65148775|NCT00997321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65148776|NCT00997321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65148777|NCT00997321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65148778|NCT00997321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65148779|NCT00997321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65148780|NCT00997321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148781|NCT01294592|Tamsulosin|tamsulosin|mesh-list
65148782|NCT01294592|Dutasteride|dutasteride|mesh-list
65148783|NCT01294592|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65148784|NCT01294592|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65148785|NCT01294592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65148786|NCT01294592|Adrenergic Agents|adrenergic agents|mesh-ancestor
65148787|NCT01294592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65148788|NCT01294592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148789|NCT01294592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148790|NCT01294592|Urological Agents|urological agents|mesh-ancestor
65148791|NCT01294592|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65304795|NCT00847886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304796|NCT00847886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304797|NCT00847886|Dermatologic Agents|dermatologic agents|mesh-ancestor
65304798|NCT00847886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534762|NCT00383643|Sodium Oxybate|sodium oxybate|mesh-list
65148792|NCT01294592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65148793|NCT01294592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148794|NCT01294592|Hormone Antagonists|hormone antagonists|mesh-ancestor
65148795|NCT01294592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65148796|NCT00997243|Azacitidine|azacitidine|mesh-list
65148797|NCT00997243|Lintuzumab|lintuzumab|mesh-list
65148798|NCT00997243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65148799|NCT00997243|Antimetabolites|antimetabolites|mesh-ancestor
65148800|NCT00997243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148801|NCT00997243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148802|NCT00997243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148803|NCT00997243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65148804|NCT02869321|Fentanyl|fentanyl|mesh-list
65148805|NCT02869321|Morphine|morphine|mesh-list
65148806|NCT02869321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65148807|NCT02869321|Narcotics|narcotics|mesh-ancestor
65148808|NCT02869321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65148809|NCT02869321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148810|NCT02869321|Analgesics|analgesics|mesh-ancestor
65148811|NCT02869321|Sensory System Agents|sensory system agents|mesh-ancestor
65148812|NCT02869321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65148813|NCT02869321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65148814|NCT02869321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65148815|NCT02869321|Anesthetics, General|anesthetics, general|mesh-ancestor
65148816|NCT02869321|Anesthetics|anesthetics|mesh-ancestor
65148817|NCT01294436|Dapagliflozin|dapagliflozin|mesh-list
65148818|NCT01294436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65148819|NCT01294436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503088|NCT03355248|Narcotics|narcotics|mesh-ancestor
65148829|NCT01294358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148830|NCT01294358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65148831|NCT01294358|Immunologic Factors|immunologic factors|mesh-ancestor
65148832|NCT01294358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148834|NCT01224639|Immunologic Factors|immunologic factors|mesh-ancestor
65148835|NCT01224639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148836|NCT01293968|Diphenhydramine|diphenhydramine|mesh-list
65148837|NCT01293968|Promethazine|promethazine|mesh-list
65148838|NCT01293968|Ibuprofen|ibuprofen|mesh-list
65148839|NCT01293968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65148840|NCT01293968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65148841|NCT01293968|Analgesics|analgesics|mesh-ancestor
65148842|NCT01293968|Sensory System Agents|sensory system agents|mesh-ancestor
65148843|NCT01293968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65148844|NCT01293968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148845|NCT01293968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65148846|NCT01293968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65148847|NCT01293968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65148848|NCT01293968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148849|NCT01293968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148850|NCT01293968|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65148851|NCT01293968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65148852|NCT01293968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65148853|NCT01293968|Anesthetics, Local|anesthetics, local|mesh-ancestor
65148854|NCT01293968|Anesthetics|anesthetics|mesh-ancestor
65148855|NCT01293968|Antiemetics|antiemetics|mesh-ancestor
65148856|NCT01293968|Autonomic Agents|autonomic agents|mesh-ancestor
65148857|NCT01293968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65148858|NCT01293968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65148859|NCT01293968|Histamine Antagonists|histamine antagonists|mesh-ancestor
65148860|NCT01293968|Histamine Agents|histamine agents|mesh-ancestor
65148861|NCT01293968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65148862|NCT01293968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65148863|NCT01293968|Antipruritics|antipruritics|mesh-ancestor
65148864|NCT01293968|Dermatologic Agents|dermatologic agents|mesh-ancestor
65148865|NCT01293032|Tamoxifen|tamoxifen|mesh-list
65148866|NCT01293032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65304799|NCT00847886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65304800|NCT00847886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65304801|NCT00847886|Immunologic Factors|immunologic factors|mesh-ancestor
65304802|NCT00847886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65304803|NCT00847886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65304804|NCT00847808|Dexlansoprazole|dexlansoprazole|mesh-list
65304805|NCT00847808|Lansoprazole|lansoprazole|mesh-list
65304806|NCT00847808|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65054709|NCT02211079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65304807|NCT00847808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65148867|NCT01293032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148868|NCT01293032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65148869|NCT01293032|Hormone Antagonists|hormone antagonists|mesh-ancestor
65148870|NCT01293032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65148871|NCT01293032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148872|NCT01293032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65148873|NCT01293032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148874|NCT01293032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65148875|NCT01293032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65148876|NCT01293032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65148877|NCT01293032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65148878|NCT01293032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148879|NCT01224171|Vedolizumab|vedolizumab|mesh-list
65148880|NCT01224171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65148881|NCT01223937|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65148882|NCT01223937|Hemostatics|hemostatics|mesh-ancestor
65148883|NCT01223937|Coagulants|coagulants|mesh-ancestor
65148884|NCT01223937|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65148885|NCT01223937|Natriuretic Agents|natriuretic agents|mesh-ancestor
64503155|NCT02509546|Adenosine|adenosine|mesh-list
65148899|NCT00993967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148901|NCT01222533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65148902|NCT01222533|Autonomic Agents|autonomic agents|mesh-ancestor
65148903|NCT01222533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65148904|NCT01222533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148905|NCT01222533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65148906|NCT01222533|Respiratory System Agents|respiratory system agents|mesh-ancestor
65148907|NCT01222533|Parasympatholytics|parasympatholytics|mesh-ancestor
65148908|NCT01222533|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65148909|NCT01222533|Cholinergic Agents|cholinergic agents|mesh-ancestor
65148910|NCT01222533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65148911|NCT01222533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148913|NCT01221753|Docetaxel|docetaxel|mesh-list
65148914|NCT01221753|Fluorouracil|fluorouracil|mesh-list
65148915|NCT01221753|Cetuximab|cetuximab|mesh-list
65148916|NCT01221753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148917|NCT01221753|Tubulin Modulators|tubulin modulators|mesh-ancestor
65148918|NCT01221753|Antimitotic Agents|antimitotic agents|mesh-ancestor
65148919|NCT01221753|Mitosis Modulators|mitosis modulators|mesh-ancestor
65148920|NCT01221753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148921|NCT01221753|Antimetabolites|antimetabolites|mesh-ancestor
65148922|NCT01221753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65148923|NCT01221753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65148924|NCT01221753|Immunologic Factors|immunologic factors|mesh-ancestor
65148925|NCT01221753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148926|NCT01221753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65148927|NCT02888223|Factor VIII|factor viii|mesh-list
65148928|NCT02888223|Coagulants|coagulants|mesh-ancestor
65148929|NCT01014988|Zanamivir|zanamivir|mesh-list
65148930|NCT01014988|Antiviral Agents|antiviral agents|mesh-ancestor
65148931|NCT01014988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65148932|NCT01014988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148933|NCT01014988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148934|NCT01019980|Acetaminophen|acetaminophen|mesh-list
65148935|NCT01019980|Diclofenac|diclofenac|mesh-list
65148936|NCT01019980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65304808|NCT00847808|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65304809|NCT00847808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304810|NCT00847808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304811|NCT02656979|Latanoprost|latanoprost|mesh-list
65304812|NCT02656979|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64960674|NCT00132652|Lamivudine|lamivudine|mesh-list
65148937|NCT01019980|Analgesics|analgesics|mesh-ancestor
65148938|NCT01019980|Sensory System Agents|sensory system agents|mesh-ancestor
65148939|NCT01019980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65148940|NCT01019980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148941|NCT01019980|Antipyretics|antipyretics|mesh-ancestor
65148942|NCT01019980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65148943|NCT01019980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65148944|NCT01019980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65148945|NCT01019980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65148946|NCT01019980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148947|NCT01019980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148964|NCT01014442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65148965|NCT01014442|Antitubercular Agents|antitubercular agents|mesh-ancestor
65148966|NCT01014442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65148967|NCT01014442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65148968|NCT01014442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148969|NCT01014442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148970|NCT00996307|MF59 oil emulsion|mf59 oil emulsion|mesh-list
65148971|NCT00996307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65148972|NCT00996307|Immunologic Factors|immunologic factors|mesh-ancestor
65148973|NCT00996307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148974|NCT02869165|Estrogens|estrogens|mesh-list
65148975|NCT02869165|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65148976|NCT02869165|Hormones|hormones|mesh-ancestor
65148977|NCT02869165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65148978|NCT02869165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148980|NCT01219959|Dialysis Solutions|dialysis solutions|mesh-ancestor
65148981|NCT01219959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65148982|NCT00993421|Sibutramine|sibutramine|mesh-list
65148983|NCT00993421|Metoprolol|metoprolol|mesh-list
65148984|NCT00993421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65148985|NCT00993421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65148986|NCT00993421|Sympatholytics|sympatholytics|mesh-ancestor
65148987|NCT00993421|Autonomic Agents|autonomic agents|mesh-ancestor
65148988|NCT00993421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65148989|NCT00993421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148990|NCT00993421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65148991|NCT00993421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65148992|NCT00993421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65148993|NCT00993421|Adrenergic Agents|adrenergic agents|mesh-ancestor
65148994|NCT00993421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65148995|NCT00993421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148996|NCT00993421|Antidepressive Agents|antidepressive agents|mesh-ancestor
65148997|NCT00993421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65148998|NCT00993421|Appetite Depressants|appetite depressants|mesh-ancestor
65148999|NCT00993421|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65149000|NCT01014208|Rituximab|rituximab|mesh-list
65149001|NCT01014208|Ofatumumab|ofatumumab|mesh-list
65149002|NCT01014208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65149003|NCT01014208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149004|NCT01014208|Immunologic Factors|immunologic factors|mesh-ancestor
65149005|NCT01014208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149006|NCT01014208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65149007|NCT04205578|3-n-butylphthalide|3-n-butylphthalide|mesh-list
65149019|NCT00991939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65149020|NCT00991939|Glucocorticoids|glucocorticoids|mesh-ancestor
65149021|NCT00991939|Hormones|hormones|mesh-ancestor
65149022|NCT00991939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65149023|NCT00991939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65149024|NCT00991939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149025|NCT02868385|Praziquantel|praziquantel|mesh-list
65149026|NCT02868385|Anthelmintics|anthelmintics|mesh-ancestor
65149027|NCT02868385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65304813|NCT02656979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65304814|NCT04017455|Bevacizumab|bevacizumab|mesh-list
65304815|NCT04017455|Atezolizumab|atezolizumab|mesh-list
65304816|NCT04017455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65304817|NCT04017455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304818|NCT04017455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65304819|NCT04017455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65304820|NCT04017455|Growth Substances|growth substances|mesh-ancestor
65304821|NCT04017455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304822|NCT04017455|Growth Inhibitors|growth inhibitors|mesh-ancestor
65304823|NCT05298020|Gemcitabine|gemcitabine|mesh-list
65304824|NCT05298020|Paclitaxel|paclitaxel|mesh-list
65304825|NCT05298020|Endostar protein|endostar protein|mesh-list
65304826|NCT05298020|Endostatins|endostatins|mesh-list
65304827|NCT05298020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65304828|NCT05298020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304829|NCT05298020|Tubulin Modulators|tubulin modulators|mesh-ancestor
65304830|NCT05298020|Antimitotic Agents|antimitotic agents|mesh-ancestor
65304831|NCT05298020|Mitosis Modulators|mitosis modulators|mesh-ancestor
65304832|NCT05298020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304833|NCT05298020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65149028|NCT02868385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65149029|NCT00993265|Acetylcysteine|acetylcysteine|mesh-list
65149030|NCT00993265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65149031|NCT00993265|Antiviral Agents|antiviral agents|mesh-ancestor
65149032|NCT00993265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65149033|NCT00993265|Expectorants|expectorants|mesh-ancestor
65149034|NCT00993265|Respiratory System Agents|respiratory system agents|mesh-ancestor
65149035|NCT00993265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65149036|NCT00993265|Antioxidants|antioxidants|mesh-ancestor
65149037|NCT00993265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149038|NCT00993265|Protective Agents|protective agents|mesh-ancestor
65149039|NCT00993265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149040|NCT00993265|Antidotes|antidotes|mesh-ancestor
65149041|NCT00993031|Ritonavir|ritonavir|mesh-list
65149042|NCT00993031|Lopinavir|lopinavir|mesh-list
65149043|NCT00993031|Lamivudine|lamivudine|mesh-list
65149044|NCT00993031|Zidovudine|zidovudine|mesh-list
65149045|NCT00993031|Efavirenz|efavirenz|mesh-list
65149046|NCT00993031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65149047|NCT00993031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65149048|NCT00993031|Protease Inhibitors|protease inhibitors|mesh-ancestor
65149049|NCT00993031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149050|NCT00993031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149051|NCT00993031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65149052|NCT00993031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65149053|NCT00993031|Antiviral Agents|antiviral agents|mesh-ancestor
65149054|NCT00993031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65149055|NCT00993031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65149056|NCT00993031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65149057|NCT00993031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65149058|NCT00993031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65149059|NCT00993031|Antimetabolites|antimetabolites|mesh-ancestor
65149060|NCT00993031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65149061|NCT00993031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65149062|NCT00993031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65304834|NCT05298020|Antimetabolites|antimetabolites|mesh-ancestor
65304835|NCT05298020|Antiviral Agents|antiviral agents|mesh-ancestor
65304836|NCT05298020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65304837|NCT05298020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304838|NCT05298020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65304839|NCT05298020|Immunologic Factors|immunologic factors|mesh-ancestor
65304840|NCT05298020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304841|NCT05298020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65304842|NCT05298020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65149063|NCT00993031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65149064|NCT00993031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65149065|NCT01010776|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65149066|NCT01010776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65149067|NCT01010776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65149068|NCT01010776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65149069|NCT01010776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149070|NCT01010776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65149071|NCT01010776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65149072|NCT01010776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65149084|NCT04291729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65149085|NCT04291729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65149086|NCT04291729|Protease Inhibitors|protease inhibitors|mesh-ancestor
65149087|NCT04291729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149088|NCT04291729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149089|NCT04291729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65149090|NCT04291729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65149091|NCT04291729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65149092|NCT04291729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65149093|NCT02868931|Insulin|insulin|mesh-list
65149094|NCT02868931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65149095|NCT02868931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149096|NCT01018810|Interleukin-23|interleukin-23|mesh-list
65149097|NCT01018810|Antibodies|antibodies|mesh-list
65149098|NCT01018810|Immunoglobulins|immunoglobulins|mesh-list
65149099|NCT01018810|Immunologic Factors|immunologic factors|mesh-ancestor
65149100|NCT01018810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149101|NCT01018810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65149102|NCT01018810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65149103|NCT01018810|Growth Substances|growth substances|mesh-ancestor
65149104|NCT01018810|Growth Inhibitors|growth inhibitors|mesh-ancestor
65149105|NCT01018810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149106|NCT02867917|Psyllium|psyllium|mesh-list
65149108|NCT02867917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65149109|NCT01018732|Lactitol|lactitol|mesh-list
65149110|NCT01018732|Cathartics|cathartics|mesh-ancestor
65149111|NCT01018732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65149112|NCT01218867|Aldesleukin|aldesleukin|mesh-list
65149113|NCT01218867|Cyclophosphamide|cyclophosphamide|mesh-list
65149114|NCT01218867|Fludarabine|fludarabine|mesh-list
65149115|NCT01218867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65149116|NCT01218867|Immunologic Factors|immunologic factors|mesh-ancestor
65149117|NCT01218867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149118|NCT01218867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65149119|NCT01218867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65149120|NCT01218867|Alkylating Agents|alkylating agents|mesh-ancestor
65149121|NCT01218867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149122|NCT01218867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149123|NCT01218867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65149124|NCT01218867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65149125|NCT01218867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65149126|NCT01218867|Antiviral Agents|antiviral agents|mesh-ancestor
65149127|NCT01218867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65149128|NCT01018264|Solifenacin Succinate|solifenacin succinate|mesh-list
65149129|NCT01018264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64514534|NCT01752023|Cisplatin|cisplatin|mesh-list
65149130|NCT01018264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65149131|NCT01018264|Cholinergic Agents|cholinergic agents|mesh-ancestor
65304843|NCT05298020|Growth Substances|growth substances|mesh-ancestor
65304844|NCT05298020|Growth Inhibitors|growth inhibitors|mesh-ancestor
65304845|NCT04170647|Plasminogen|plasminogen|mesh-list
65304846|NCT04170647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65304847|NCT04170647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65304848|NCT04170647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149132|NCT01018264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65149133|NCT01018264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149134|NCT01018264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149135|NCT01018264|Urological Agents|urological agents|mesh-ancestor
65149136|NCT01018186|Fluticasone|fluticasone|mesh-list
65149138|NCT01018186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65149139|NCT01018186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65149140|NCT01018186|Autonomic Agents|autonomic agents|mesh-ancestor
65149157|NCT04566328|Autonomic Agents|autonomic agents|mesh-ancestor
65149158|NCT04566328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65149159|NCT04566328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149160|NCT04566328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65149161|NCT04566328|Glucocorticoids|glucocorticoids|mesh-ancestor
65149162|NCT04566328|Hormones|hormones|mesh-ancestor
65149163|NCT04566328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65149164|NCT04566328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65149165|NCT04566328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149166|NCT04566328|Protease Inhibitors|protease inhibitors|mesh-ancestor
65149167|NCT04566328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149168|NCT04566328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149169|NCT04566328|Immunologic Factors|immunologic factors|mesh-ancestor
65149170|NCT04566328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65149171|NCT04566328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65149172|NCT04566328|Growth Substances|growth substances|mesh-ancestor
65149173|NCT04566328|Growth Inhibitors|growth inhibitors|mesh-ancestor
65149174|NCT04566328|Dermatologic Agents|dermatologic agents|mesh-ancestor
65149175|NCT00992407|Risperidone|risperidone|mesh-list
65149176|NCT00992407|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65149177|NCT00992407|Serotonin Agents|serotonin agents|mesh-ancestor
65149178|NCT00992407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65149179|NCT00992407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149180|NCT00992407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149181|NCT00992407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65149182|NCT00992407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65149183|NCT00992407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65149184|NCT00992407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65149185|NCT00992407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65149186|NCT00992407|Dopamine Agents|dopamine agents|mesh-ancestor
65149188|NCT00986245|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65149189|NCT00986245|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65149190|NCT00986245|Dopamine Agonists|dopamine agonists|mesh-ancestor
65149191|NCT00986245|Dopamine Agents|dopamine agents|mesh-ancestor
65149192|NCT00986245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65149193|NCT00986245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149194|NCT00986245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149195|NCT00989833|Budesonide|budesonide|mesh-list
65149196|NCT00989833|Terbutaline|terbutaline|mesh-list
65149197|NCT00989833|Formoterol Fumarate|formoterol fumarate|mesh-list
65149198|NCT00989833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65149199|NCT00989833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65149200|NCT00989833|Autonomic Agents|autonomic agents|mesh-ancestor
65149201|NCT00989833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65149202|NCT00989833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945907|NCT05012189|Baloxavir|baloxavir|mesh-list
65149208|NCT00989833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65149209|NCT00989833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65149210|NCT00989833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65149211|NCT00989833|Adrenergic Agents|adrenergic agents|mesh-ancestor
65149212|NCT00989833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65149213|NCT00989833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149214|NCT00989833|Sympathomimetics|sympathomimetics|mesh-ancestor
65149215|NCT00989833|Tocolytic Agents|tocolytic agents|mesh-ancestor
65304849|NCT02661347|Risperidone|risperidone|mesh-list
65304850|NCT02661347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65304851|NCT02661347|Serotonin Agents|serotonin agents|mesh-ancestor
65304852|NCT02661347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65304853|NCT02661347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304854|NCT02661347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304855|NCT02661347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65304856|NCT02661347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65149216|NCT00989833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65149217|NCT04292119|Crizotinib|crizotinib|mesh-list
65149218|NCT04292119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149219|NCT04292119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65149220|NCT04292119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149221|NCT04292119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149222|NCT01218477|Dasatinib|dasatinib|mesh-list
65149223|NCT01218477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149224|NCT01218477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65149225|NCT01218477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149226|NCT01218477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149227|NCT01218009|Albuterol|albuterol|mesh-list
65149228|NCT01218009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65149229|NCT01218009|Autonomic Agents|autonomic agents|mesh-ancestor
65149230|NCT01218009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65149231|NCT01218009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149232|NCT01218009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65149233|NCT01218009|Respiratory System Agents|respiratory system agents|mesh-ancestor
65149234|NCT01218009|Tocolytic Agents|tocolytic agents|mesh-ancestor
65149235|NCT01218009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65149236|NCT01218009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65149237|NCT01218009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65149238|NCT01218009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65149239|NCT01218009|Adrenergic Agents|adrenergic agents|mesh-ancestor
65149240|NCT01218009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65149241|NCT01218009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149242|NCT02868151|Ascorbic Acid|ascorbic acid|mesh-list
65149243|NCT02868151|Vitamins|vitamins|mesh-ancestor
65149244|NCT02868151|Micronutrients|micronutrients|mesh-ancestor
65149245|NCT02868151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149246|NCT02868151|Antioxidants|antioxidants|mesh-ancestor
65149247|NCT02868151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149248|NCT02868151|Protective Agents|protective agents|mesh-ancestor
65149249|NCT01217307|Metformin|metformin|mesh-list
65149250|NCT01217307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65149251|NCT01217307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149252|NCT02868073|Vaccines|vaccines|mesh-list
65149253|NCT02868073|Immunologic Factors|immunologic factors|mesh-ancestor
65149254|NCT02868073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149255|NCT01013740|Capecitabine|capecitabine|mesh-list
65149256|NCT01013740|Vinorelbine|vinorelbine|mesh-list
65149257|NCT01013740|Lapatinib|lapatinib|mesh-list
64791813|NCT00366834|Glucocorticoids|glucocorticoids|mesh-ancestor
65149258|NCT01013740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65149260|NCT01013740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149261|NCT01013740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149262|NCT01013740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65149263|NCT01013740|Tubulin Modulators|tubulin modulators|mesh-ancestor
65149264|NCT01013740|Antimitotic Agents|antimitotic agents|mesh-ancestor
65149265|NCT01013740|Mitosis Modulators|mitosis modulators|mesh-ancestor
65149266|NCT01013740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65149267|NCT01013740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149268|NCT01217073|Metformin|metformin|mesh-list
65149269|NCT01217073|Pioglitazone|pioglitazone|mesh-list
65149270|NCT01217073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65149283|NCT01215981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149285|NCT01215435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65149286|NCT01215435|Insulin Aspart|insulin aspart|mesh-list
65149287|NCT01215435|Insulin, Long-Acting|insulin, long-acting|mesh-list
65222831|NCT02700087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65304857|NCT02661347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65304858|NCT02661347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65304859|NCT02661347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65304860|NCT02661347|Dopamine Agents|dopamine agents|mesh-ancestor
65304861|NCT00649805|Verapamil|verapamil|mesh-list
65304862|NCT00649805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65304863|NCT00649805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65304864|NCT00649805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65304865|NCT00649805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304866|NCT00649805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65304867|NCT00649805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304868|NCT00649805|Vasodilator Agents|vasodilator agents|mesh-ancestor
65304869|NCT02656589|Capecitabine|capecitabine|mesh-list
65304870|NCT02656589|Trastuzumab|trastuzumab|mesh-list
64534820|NCT00441285|Praziquantel|praziquantel|mesh-list
65149288|NCT01215435|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65149289|NCT01215435|Biphasic Insulins|biphasic insulins|mesh-list
65149290|NCT01215435|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65149291|NCT01215435|Insulin, Isophane|insulin, isophane|mesh-list
65149292|NCT01215435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65149293|NCT01215435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149294|NCT01215357|Ecopipam|ecopipam|mesh-list
65149295|NCT01215357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65149296|NCT01215357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65149297|NCT01215357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65149298|NCT01215357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149299|NCT01215357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65149300|NCT01215357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65149301|NCT01215357|Dopamine Agents|dopamine agents|mesh-ancestor
65149302|NCT01215357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65149303|NCT01215357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149304|NCT01017874|Pemetrexed|pemetrexed|mesh-list
65149305|NCT01017874|Gefitinib|gefitinib|mesh-list
65149306|NCT01017874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149307|NCT01017874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149308|NCT01017874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149309|NCT01017874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65149310|NCT01017874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65149311|NCT01017874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65149312|NCT00627952|Amlodipine|amlodipine|mesh-list
65149313|NCT00627952|Manidipine|manidipine|mesh-list
65149314|NCT00627952|Delapril|delapril|mesh-list
65149315|NCT00627952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65149316|NCT00627952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65149317|NCT00627952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65149318|NCT00627952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149319|NCT00627952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65149320|NCT00627952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149321|NCT00627952|Vasodilator Agents|vasodilator agents|mesh-ancestor
65149322|NCT00627952|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65149323|NCT00627952|Protease Inhibitors|protease inhibitors|mesh-ancestor
65149324|NCT00627952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149325|NCT01009840|Bortezomib|bortezomib|mesh-list
65149326|NCT01009840|Busulfan|busulfan|mesh-list
65149327|NCT01009840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149328|NCT01009840|Alkylating Agents|alkylating agents|mesh-ancestor
65149329|NCT01009840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149330|NCT01009840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65149331|NCT01009840|Immunologic Factors|immunologic factors|mesh-ancestor
65304871|NCT02656589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65304872|NCT02656589|Antimetabolites|antimetabolites|mesh-ancestor
65304873|NCT02656589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304874|NCT02656589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534835|NCT01796613|NuvaRing|nuvaring|mesh-list
65149332|NCT01009840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149333|NCT01009840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65149345|NCT04542148|Insulin Lispro|insulin lispro|mesh-list
65149346|NCT04542148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65149347|NCT04542148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149348|NCT02872090|Glycopyrrolate|glycopyrrolate|mesh-list
65149349|NCT02872090|Tiotropium Bromide|tiotropium bromide|mesh-list
65149350|NCT02872090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65149351|NCT02872090|Autonomic Agents|autonomic agents|mesh-ancestor
65149352|NCT02872090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65149353|NCT02872090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149354|NCT02872090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64514537|NCT01752023|Antimetabolites|antimetabolites|mesh-ancestor
65149356|NCT02872090|Parasympatholytics|parasympatholytics|mesh-ancestor
65149357|NCT02872090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65149358|NCT02872090|Cholinergic Agents|cholinergic agents|mesh-ancestor
65149359|NCT02872090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65149360|NCT02872090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149361|NCT02872090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65149362|NCT02872090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65149363|NCT00982657|Sunitinib|sunitinib|mesh-list
65149364|NCT00982657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149365|NCT00982657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65149366|NCT00982657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65149367|NCT00982657|Growth Substances|growth substances|mesh-ancestor
65149368|NCT00982657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149369|NCT00982657|Growth Inhibitors|growth inhibitors|mesh-ancestor
65149370|NCT00982657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65149371|NCT00982657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149372|NCT00982657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149373|NCT02867839|Oxaliplatin|oxaliplatin|mesh-list
65149374|NCT02867839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149375|NCT02867293|Anesthetics|anesthetics|mesh-list
65149376|NCT02867293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65149377|NCT02867293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149378|NCT01005316|Mycophenolic Acid|mycophenolic acid|mesh-list
65149379|NCT01005316|Prednisone|prednisone|mesh-list
65149380|NCT01005316|Tacrolimus|tacrolimus|mesh-list
65149381|NCT01005316|Immunoglobulins|immunoglobulins|mesh-list
65149382|NCT01005316|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65149383|NCT01005316|Antibodies|antibodies|mesh-list
65149384|NCT01005316|gamma-Globulins|gamma-globulins|mesh-list
65149385|NCT01005316|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65149386|NCT01005316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65149387|NCT01005316|Glucocorticoids|glucocorticoids|mesh-ancestor
65149388|NCT01005316|Hormones|hormones|mesh-ancestor
65149389|NCT01005316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65149390|NCT01005316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149391|NCT01005316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65149392|NCT01005316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149393|NCT01005316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65149394|NCT01005316|Immunologic Factors|immunologic factors|mesh-ancestor
65149395|NCT01005316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65149396|NCT01005316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149397|NCT01005316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149398|NCT01005316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65149399|NCT01005316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65149408|NCT00988429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149409|NCT01008904|Magnesium Oxide|magnesium oxide|mesh-list
65149411|NCT01008904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149412|NCT01008904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65149413|NCT04290793|Cyclophosphamide|cyclophosphamide|mesh-list
65149414|NCT04290793|Trastuzumab|trastuzumab|mesh-list
65149415|NCT04290793|Epirubicin|epirubicin|mesh-list
65149416|NCT04290793|Taxane|taxane|mesh-list
65304875|NCT02656589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65304876|NCT00600353|Dexamethasone|dexamethasone|mesh-list
65304877|NCT00600353|Aprepitant|aprepitant|mesh-list
65304878|NCT00600353|Palonosetron|palonosetron|mesh-list
65304879|NCT00600353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65304880|NCT00600353|Antiemetics|antiemetics|mesh-ancestor
65304881|NCT00600353|Autonomic Agents|autonomic agents|mesh-ancestor
65304882|NCT00600353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65304883|NCT00600353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304884|NCT00600353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65304885|NCT00600353|Glucocorticoids|glucocorticoids|mesh-ancestor
65304886|NCT00600353|Hormones|hormones|mesh-ancestor
65304887|NCT00600353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65304888|NCT00600353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65304889|NCT00600353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304890|NCT00600353|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65304891|NCT00600353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65149417|NCT04290793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65149418|NCT04290793|Immunologic Factors|immunologic factors|mesh-ancestor
65149419|NCT04290793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149420|NCT04290793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65149421|NCT04290793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65149422|NCT04290793|Alkylating Agents|alkylating agents|mesh-ancestor
65149423|NCT04290793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149424|NCT04290793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149425|NCT04290793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65149426|NCT04290793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65149427|NCT04290793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65149428|NCT04290793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65149429|NCT04290793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65149430|NCT04290793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149431|NCT01004614|Amlodipine|amlodipine|mesh-list
65149432|NCT01004614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65149433|NCT01004614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65149434|NCT01004614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65149435|NCT01004614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149436|NCT01004614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65149437|NCT01004614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149438|NCT01004614|Vasodilator Agents|vasodilator agents|mesh-ancestor
65149439|NCT04119037|Morphine|morphine|mesh-list
65149440|NCT04119037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65149441|NCT04119037|Narcotics|narcotics|mesh-ancestor
65149442|NCT04119037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65149443|NCT04119037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149444|NCT04119037|Analgesics|analgesics|mesh-ancestor
65149445|NCT04119037|Sensory System Agents|sensory system agents|mesh-ancestor
65149446|NCT04119037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65149447|NCT04297462|Oseltamivir|oseltamivir|mesh-list
65149448|NCT04297462|Antiviral Agents|antiviral agents|mesh-ancestor
65149449|NCT04297462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65149450|NCT04297462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149451|NCT04297462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149452|NCT00981409|Heparin|heparin|mesh-list
65149453|NCT00981409|Calcium heparin|calcium heparin|mesh-list
65149454|NCT00981409|PENTA|penta|mesh-list
65149455|NCT00981409|Fondaparinux|fondaparinux|mesh-list
65149456|NCT00981409|Anticoagulants|anticoagulants|mesh-ancestor
65149457|NCT00981409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65304892|NCT00600353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304893|NCT00600353|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65304894|NCT00600353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65304895|NCT00600353|Serotonin Agents|serotonin agents|mesh-ancestor
65304896|NCT02661191|Cholecalciferol|cholecalciferol|mesh-list
65304897|NCT02661191|Vitamin D|vitamin d|mesh-list
65304898|NCT02661191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65304899|NCT02661191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304900|NCT02661191|Vitamins|vitamins|mesh-ancestor
65304901|NCT02661191|Micronutrients|micronutrients|mesh-ancestor
65304902|NCT02661191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65304903|NCT00691210|Niacinamide|niacinamide|mesh-list
65304904|NCT00691210|Niacin|niacin|mesh-list
65304905|NCT00691210|Nicotinic Acids|nicotinic acids|mesh-list
65304906|NCT00691210|Etoposide|etoposide|mesh-list
65304907|NCT00691210|Vorinostat|vorinostat|mesh-list
65304908|NCT00691210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65304909|NCT00691210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304910|NCT00691210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65304911|NCT00691210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64534856|NCT01511107|Amoxicillin|amoxicillin|mesh-list
65149458|NCT00981409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65149459|NCT00981409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149460|NCT00981409|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65149461|NCT00981409|Antithrombins|antithrombins|mesh-ancestor
65149462|NCT00981409|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65149463|NCT00981409|Protease Inhibitors|protease inhibitors|mesh-ancestor
65149464|NCT00981409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149482|NCT01008748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149483|NCT00628732|Cyclophosphamide|cyclophosphamide|mesh-list
65149484|NCT00628732|Topotecan|topotecan|mesh-list
65149485|NCT00628732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65149486|NCT00628732|Immunologic Factors|immunologic factors|mesh-ancestor
65149487|NCT00628732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149488|NCT00628732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65149489|NCT00628732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65149490|NCT00628732|Alkylating Agents|alkylating agents|mesh-ancestor
65149491|NCT00628732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149492|NCT00628732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149493|NCT00628732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65149494|NCT00628732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65149495|NCT00628732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65149496|NCT00628732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149497|NCT04131829|Fluoxetine|fluoxetine|mesh-list
65149498|NCT04131829|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65149499|NCT04131829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65149500|NCT04131829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65149501|NCT04131829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149502|NCT04131829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65149503|NCT04131829|Serotonin Agents|serotonin agents|mesh-ancestor
65149504|NCT04131829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149505|NCT04131829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65149506|NCT04131829|Antidepressive Agents|antidepressive agents|mesh-ancestor
65149507|NCT04131829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65304912|NCT00691210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304913|NCT00691210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304914|NCT00691210|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65304915|NCT00691210|Vitamin B Complex|vitamin b complex|mesh-ancestor
65304916|NCT00691210|Vitamins|vitamins|mesh-ancestor
65304917|NCT00691210|Micronutrients|micronutrients|mesh-ancestor
65304918|NCT00691210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304919|NCT00691210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65304920|NCT00691210|Antimetabolites|antimetabolites|mesh-ancestor
65304921|NCT00691210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65304922|NCT00691210|Vasodilator Agents|vasodilator agents|mesh-ancestor
65304923|NCT02652065|Acetylcholine|acetylcholine|mesh-list
65304924|NCT02652065|Vasodilator Agents|vasodilator agents|mesh-ancestor
65304925|NCT02652065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65149508|NCT04131829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65149509|NCT04131829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65149510|NCT04131829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149511|NCT04205344|Bupivacaine|bupivacaine|mesh-list
65149512|NCT04205344|Anesthetics, Local|anesthetics, local|mesh-ancestor
65149513|NCT04205344|Anesthetics|anesthetics|mesh-ancestor
65149514|NCT04205344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65149515|NCT04205344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149516|NCT04205344|Sensory System Agents|sensory system agents|mesh-ancestor
65149517|NCT04205344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65149518|NCT00629317|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65149519|NCT00629317|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65149520|NCT00629317|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65149521|NCT00629317|Dermatologic Agents|dermatologic agents|mesh-ancestor
65149535|NCT00978757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149536|NCT01214421|Tolvaptan|tolvaptan|mesh-list
65149537|NCT01214421|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65149538|NCT01214421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149539|NCT01214421|Natriuretic Agents|natriuretic agents|mesh-ancestor
65149540|NCT01214421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149541|NCT01214187|Carbon Monoxide|carbon monoxide|mesh-list
65149542|NCT01214187|Antimetabolites|antimetabolites|mesh-ancestor
65149543|NCT01214187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149544|NCT01214187|Gasotransmitters|gasotransmitters|mesh-ancestor
65149545|NCT01214187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65149546|NCT01214187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149547|NCT02866903|Bevacizumab|bevacizumab|mesh-list
65149548|NCT02866903|Oxaliplatin|oxaliplatin|mesh-list
65149549|NCT02866903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65149550|NCT02866903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149551|NCT02866903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65149552|NCT02866903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65149553|NCT02866903|Growth Substances|growth substances|mesh-ancestor
65149554|NCT02866903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149555|NCT02866903|Growth Inhibitors|growth inhibitors|mesh-ancestor
65149556|NCT03945019|Infliximab|infliximab|mesh-list
65149557|NCT03945019|Dermatologic Agents|dermatologic agents|mesh-ancestor
65149558|NCT03945019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65149559|NCT03945019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65149560|NCT01003990|Ritonavir|ritonavir|mesh-list
65149561|NCT01003990|Lopinavir|lopinavir|mesh-list
65149562|NCT01003990|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65149563|NCT01003990|Tenofovir|tenofovir|mesh-list
65149564|NCT01003990|Emtricitabine|emtricitabine|mesh-list
65149565|NCT01003990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65149566|NCT01003990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65149567|NCT01003990|Protease Inhibitors|protease inhibitors|mesh-ancestor
65149568|NCT01003990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64401036|NCT02034331|Vasodilator Agents|vasodilator agents|mesh-ancestor
65304926|NCT02652065|Cholinergic Agents|cholinergic agents|mesh-ancestor
65304927|NCT02652065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65304928|NCT02652065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304929|NCT02652065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304930|NCT00650429|Ziprasidone|ziprasidone|mesh-list
65304931|NCT00650429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65304932|NCT00650429|Serotonin Agents|serotonin agents|mesh-ancestor
65304933|NCT00650429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65304934|NCT00650429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304935|NCT00650429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304936|NCT00650429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65304937|NCT00650429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64534890|NCT01484977|Lacosamide|lacosamide|mesh-list
65149569|NCT01003990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149571|NCT01003990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65149572|NCT01003990|Antiviral Agents|antiviral agents|mesh-ancestor
65149573|NCT01003990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65149574|NCT01003990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65149575|NCT01003990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65149576|NCT01003990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65149577|NCT01003990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65149578|NCT01002820|Ganaxolone|ganaxolone|mesh-list
65149579|NCT01002820|Neurosteroids|neurosteroids|mesh-ancestor
65149580|NCT01002820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65149581|NCT01002820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149582|NCT01002820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149588|NCT00628810|Leucovorin|leucovorin|mesh-list
65149589|NCT00628810|Bevacizumab|bevacizumab|mesh-list
65149590|NCT00628810|Fluorouracil|fluorouracil|mesh-list
65149591|NCT00628810|Irinotecan|irinotecan|mesh-list
65149592|NCT00628810|Calcium|calcium|mesh-list
65149593|NCT00628810|Levoleucovorin|levoleucovorin|mesh-list
65149594|NCT00628810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65149595|NCT00628810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149596|NCT00628810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65149597|NCT00628810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65149598|NCT00628810|Growth Substances|growth substances|mesh-ancestor
65149599|NCT00628810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149600|NCT00628810|Growth Inhibitors|growth inhibitors|mesh-ancestor
65149601|NCT00628810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65149602|NCT00628810|Antimetabolites|antimetabolites|mesh-ancestor
65149603|NCT00628810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149604|NCT00628810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65149605|NCT00628810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65149606|NCT00628810|Immunologic Factors|immunologic factors|mesh-ancestor
65149607|NCT00628810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65149608|NCT00628810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65149609|NCT00628810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149610|NCT00628810|Antidotes|antidotes|mesh-ancestor
65149611|NCT00628810|Protective Agents|protective agents|mesh-ancestor
65149612|NCT00628810|Vitamin B Complex|vitamin b complex|mesh-ancestor
65149613|NCT00628810|Vitamins|vitamins|mesh-ancestor
65149614|NCT00628810|Micronutrients|micronutrients|mesh-ancestor
65149615|NCT00975481|Alprazolam|alprazolam|mesh-list
65149616|NCT00975481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65149617|NCT00975481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65149618|NCT00975481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149619|NCT00975481|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65149620|NCT00975481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65149621|NCT00975481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65149622|NCT00975481|GABA Modulators|gaba modulators|mesh-ancestor
65149623|NCT00975481|GABA Agents|gaba agents|mesh-ancestor
65304938|NCT00650429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65304939|NCT00650429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65304940|NCT00650429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65304941|NCT00650429|Dopamine Agents|dopamine agents|mesh-ancestor
65304942|NCT00691132|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
65304943|NCT00691132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304944|NCT00691132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304945|NCT00691132|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65304946|NCT00691132|Protective Agents|protective agents|mesh-ancestor
65304947|NCT00691132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304948|NCT00691132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304949|NCT02651753|Calcium, Dietary|calcium, dietary|mesh-list
65304950|NCT02651753|Atorvastatin|atorvastatin|mesh-list
65304951|NCT02651753|Fenofibrate|fenofibrate|mesh-list
65304952|NCT02651753|Calcium|calcium|mesh-list
65304953|NCT02651753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65304954|NCT02651753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304955|NCT02651753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65304956|NCT02651753|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65304957|NCT02651753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65304958|NCT02651753|Antimetabolites|antimetabolites|mesh-ancestor
65304959|NCT02651753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304961|NCT02651753|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65304962|NCT02651753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304963|NCT00855218|Sorafenib|sorafenib|mesh-list
65304964|NCT00855218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304965|NCT00855218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65304966|NCT00855218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304967|NCT00855218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304968|NCT00748150|Vaccines|vaccines|mesh-list
64534906|NCT00445263|Tirofiban|tirofiban|mesh-list
65149624|NCT00975481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65149625|NCT00975481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149626|NCT01011868|Empagliflozin|empagliflozin|mesh-list
65149627|NCT01011868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65149628|NCT01011868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149629|NCT01011868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65149630|NCT01011868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149631|NCT04290013|Tranexamic Acid|tranexamic acid|mesh-list
65149632|NCT04290013|Norethindrone|norethindrone|mesh-list
65149633|NCT04290013|Norethindrone Acetate|norethindrone acetate|mesh-list
65149634|NCT04290013|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65149635|NCT04290013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65304969|NCT00748150|Immunologic Factors|immunologic factors|mesh-ancestor
65304970|NCT00748150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304971|NCT02651519|Ropivacaine|ropivacaine|mesh-list
65304972|NCT02651519|Anesthetics, Local|anesthetics, local|mesh-ancestor
65304973|NCT02651519|Anesthetics|anesthetics|mesh-ancestor
65304974|NCT02651519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65304975|NCT02651519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304976|NCT02651519|Sensory System Agents|sensory system agents|mesh-ancestor
65304977|NCT02651519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65304978|NCT02651441|Gemcitabine|gemcitabine|mesh-list
65304979|NCT02651441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65304980|NCT02651441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65304981|NCT02651441|Antimetabolites|antimetabolites|mesh-ancestor
64534934|NCT00456807|Vaccines|vaccines|mesh-list
65149636|NCT04290013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149638|NCT04290013|Coagulants|coagulants|mesh-ancestor
65149639|NCT04290013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65149640|NCT04290013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65149641|NCT04290013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65149642|NCT04290013|Contraceptive Agents|contraceptive agents|mesh-ancestor
65149643|NCT04290013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64682967|NCT01948388|Hormones|hormones|mesh-ancestor
65149644|NCT04290013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149645|NCT04290013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65149646|NCT04290013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65149648|NCT04288999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65149649|NCT04288999|Antimetabolites|antimetabolites|mesh-ancestor
65149650|NCT04288999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149651|NCT04288999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149652|NCT01213173|Metoprolol|metoprolol|mesh-list
65149653|NCT01213173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65149654|NCT01213173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65149655|NCT01213173|Sympatholytics|sympatholytics|mesh-ancestor
65149665|NCT04095715|Hemostatics|hemostatics|mesh-list
65149666|NCT04095715|Coagulants|coagulants|mesh-ancestor
65149667|NCT02866435|Potassium phosphate|potassium phosphate|mesh-list
65149668|NCT02866435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149669|NCT02866435|Cariostatic Agents|cariostatic agents|mesh-ancestor
65149670|NCT02866435|Protective Agents|protective agents|mesh-ancestor
65149671|NCT00973765|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65149672|NCT00973765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65149673|NCT00973765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65149674|NCT00973765|Renal Agents|renal agents|mesh-ancestor
65149675|NCT00973765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65149676|NCT00973765|Antimalarials|antimalarials|mesh-ancestor
65149677|NCT00973765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65149678|NCT00973765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65149679|NCT01211769|Naltrexone|naltrexone|mesh-list
65149680|NCT01211769|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65149681|NCT01211769|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65149682|NCT01211769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149683|NCT01211769|Sensory System Agents|sensory system agents|mesh-ancestor
65149684|NCT01211769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65149685|NCT04288765|Dexamethasone|dexamethasone|mesh-list
65149686|NCT04288765|Lenalidomide|lenalidomide|mesh-list
65149687|NCT04288765|Daratumumab|daratumumab|mesh-list
65149688|NCT04288765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65149689|NCT04288765|Antiemetics|antiemetics|mesh-ancestor
65149690|NCT04288765|Autonomic Agents|autonomic agents|mesh-ancestor
65149691|NCT04288765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65149692|NCT04288765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149693|NCT04288765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65304982|NCT02651441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304983|NCT02651441|Antiviral Agents|antiviral agents|mesh-ancestor
65304984|NCT02651441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65304985|NCT02651441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65304986|NCT02651441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65304987|NCT02651441|Immunologic Factors|immunologic factors|mesh-ancestor
65304988|NCT02651441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65304989|NCT01063348|Acetylcysteine|acetylcysteine|mesh-list
65304990|NCT01063348|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65304991|NCT01063348|Antiviral Agents|antiviral agents|mesh-ancestor
65304992|NCT01063348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65304993|NCT01063348|Expectorants|expectorants|mesh-ancestor
65304994|NCT01063348|Respiratory System Agents|respiratory system agents|mesh-ancestor
65304995|NCT01063348|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65304996|NCT01063348|Antioxidants|antioxidants|mesh-ancestor
64534944|NCT01475825|Mipomersen|mipomersen|mesh-list
65149694|NCT04288765|Glucocorticoids|glucocorticoids|mesh-ancestor
65149695|NCT04288765|Hormones|hormones|mesh-ancestor
65149696|NCT04288765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65149697|NCT04288765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65149698|NCT04288765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149699|NCT04288765|Immunologic Factors|immunologic factors|mesh-ancestor
65149700|NCT04288765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65149701|NCT04288765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65149702|NCT04288765|Growth Substances|growth substances|mesh-ancestor
65149703|NCT04288765|Growth Inhibitors|growth inhibitors|mesh-ancestor
65149704|NCT01211535|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65149705|NCT02863861|Dexmedetomidine|dexmedetomidine|mesh-list
65149706|NCT02863861|Ketamine|ketamine|mesh-list
65149707|NCT02863861|Propofol|propofol|mesh-list
65149708|NCT02863861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65149709|NCT02863861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64792264|NCT00378066|Antimetabolites|antimetabolites|mesh-ancestor
65149710|NCT02863861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149711|NCT02863861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65149712|NCT02863861|Anesthetics, General|anesthetics, general|mesh-ancestor
65149713|NCT02863861|Anesthetics|anesthetics|mesh-ancestor
65149714|NCT02863861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65149715|NCT02863861|Analgesics|analgesics|mesh-ancestor
65149716|NCT02863861|Sensory System Agents|sensory system agents|mesh-ancestor
65149717|NCT02863861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64683054|NCT01950260|Hormones|hormones|mesh-list
65149718|NCT02863861|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64946407|NCT04199026|Alkylating Agents|alkylating agents|mesh-ancestor
65149736|NCT03846505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65149737|NCT03846505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149738|NCT01011556|Teriparatide|teriparatide|mesh-list
65149739|NCT01011556|Hormones|hormones|mesh-list
65149740|NCT01011556|Parathyroid Hormone|parathyroid hormone|mesh-list
65149741|NCT01011556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65149742|NCT01011556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149743|NCT01011556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65149744|NCT01011556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65149745|NCT01211145|Oxazolidinones|oxazolidinones|mesh-list
65149746|NCT01211145|Zolmitriptan|zolmitriptan|mesh-list
65149747|NCT01211145|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65149748|NCT01211145|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65149749|NCT01211145|Serotonin Agents|serotonin agents|mesh-ancestor
65149750|NCT01211145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65149751|NCT01211145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304997|NCT01063348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65304998|NCT01063348|Protective Agents|protective agents|mesh-ancestor
65304999|NCT01063348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305000|NCT01063348|Antidotes|antidotes|mesh-ancestor
64961849|NCT00397332|Alefacept|alefacept|mesh-list
65149752|NCT01211145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149753|NCT01211145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65149754|NCT01211145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65149755|NCT01211145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149756|NCT00977665|Rasagiline|rasagiline|mesh-list
65149757|NCT00977665|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65149758|NCT00977665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149759|NCT00977665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149760|NCT00977665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65149761|NCT00977665|Protective Agents|protective agents|mesh-ancestor
65149762|NCT00977665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149763|NCT04298008|Durvalumab|durvalumab|mesh-list
65149764|NCT04298008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65149765|NCT04298008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149766|NCT00628342|Esomeprazole|esomeprazole|mesh-list
65149767|NCT00628342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65149768|NCT00628342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65149769|NCT00628342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65149770|NCT00628342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149771|NCT00628342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149772|NCT01210443|Sitaxsentan|sitaxsentan|mesh-list
65149773|NCT01210443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64946477|NCT04042233|Vancomycin|vancomycin|mesh-list
65149799|NCT01001572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65149800|NCT01001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149801|NCT01001572|Vasodilator Agents|vasodilator agents|mesh-ancestor
65149802|NCT01001572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65149803|NCT01001572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65149804|NCT04287205|Dydrogesterone|dydrogesterone|mesh-list
65149805|NCT04287205|Progestins|progestins|mesh-ancestor
65149807|NCT04287205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65149808|NCT04287205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149809|NCT00628576|Heparin|heparin|mesh-list
65149810|NCT00628576|Calcium heparin|calcium heparin|mesh-list
65149811|NCT00628576|Tinzaparin|tinzaparin|mesh-list
65149812|NCT00628576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65149813|NCT00628576|Dalteparin|dalteparin|mesh-list
65149814|NCT00628576|Anticoagulants|anticoagulants|mesh-ancestor
65149815|NCT00628576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65149816|NCT00628576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65149817|NCT00628576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149818|NCT01208337|Alemtuzumab|alemtuzumab|mesh-list
65149819|NCT01208337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65149820|NCT01208337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149821|NCT04370548|Clindamycin|clindamycin|mesh-list
65149822|NCT04370548|Clindamycin palmitate|clindamycin palmitate|mesh-list
65149823|NCT04370548|Clindamycin phosphate|clindamycin phosphate|mesh-list
65149848|NCT01208103|Immunoglobulins|immunoglobulins|mesh-list
65149849|NCT01208103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65149850|NCT01208103|Immunoglobulin G|immunoglobulin g|mesh-list
65149851|NCT01208103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149852|NCT01208103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65149853|NCT01208103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65149854|NCT01208103|Growth Substances|growth substances|mesh-ancestor
65149855|NCT01208103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149856|NCT01208103|Growth Inhibitors|growth inhibitors|mesh-ancestor
65149857|NCT01208103|Immunologic Factors|immunologic factors|mesh-ancestor
65149858|NCT01208103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65149859|NCT01208103|Antimetabolites|antimetabolites|mesh-ancestor
65149860|NCT01208103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149861|NCT01206777|Rituximab|rituximab|mesh-list
65149862|NCT01206777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65149863|NCT01206777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149864|NCT01206777|Immunologic Factors|immunologic factors|mesh-ancestor
65149865|NCT01206777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305001|NCT00855062|Minocycline|minocycline|mesh-list
65305002|NCT00855062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65305003|NCT00855062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65305004|NCT00744250|Pancrelipase|pancrelipase|mesh-list
65305005|NCT00744250|Pancreatin|pancreatin|mesh-list
65305006|NCT00744250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65305007|NCT02651207|Lidocaine|lidocaine|mesh-list
65305008|NCT02651207|Ethyl Chloride|ethyl chloride|mesh-list
65305009|NCT02651207|Contraceptive Agents|contraceptive agents|mesh-list
65305010|NCT02651207|Anesthetics, Local|anesthetics, local|mesh-ancestor
65305011|NCT02651207|Anesthetics|anesthetics|mesh-ancestor
65305012|NCT02651207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64534964|NCT00445887|Levonorgestrel|levonorgestrel|mesh-list
65149867|NCT01001494|Bromides|bromides|mesh-list
65149868|NCT01001494|Anticonvulsants|anticonvulsants|mesh-ancestor
65149869|NCT01205685|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65149870|NCT01205685|Letrozole|letrozole|mesh-list
65149871|NCT01205685|Goserelin|goserelin|mesh-list
65149872|NCT01205685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149873|NCT01205685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65149874|NCT01205685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946579|NCT03737240|Xultophy|xultophy|mesh-list
65149887|NCT01205529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65149888|NCT01205529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149890|NCT04294966|Hallucinogens|hallucinogens|mesh-ancestor
65149891|NCT04294966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149892|NCT04294966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65149893|NCT04294966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65149894|NCT04294966|Analgesics|analgesics|mesh-ancestor
65149895|NCT04294966|Sensory System Agents|sensory system agents|mesh-ancestor
65149896|NCT04294966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65149897|NCT04294966|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65149898|NCT04294966|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65149899|NCT04294966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65149900|NCT04294966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149901|NCT04294966|Hormones|hormones|mesh-ancestor
65149902|NCT04294966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65149903|NCT01205451|Botulinum Toxins|botulinum toxins|mesh-list
65149904|NCT01205451|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65149905|NCT01205451|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65149906|NCT01205451|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65149907|NCT01205451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65149908|NCT01205451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149909|NCT01205451|Cholinergic Agents|cholinergic agents|mesh-ancestor
65149910|NCT01205451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65149911|NCT01205451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149912|NCT01205451|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65149913|NCT01205451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65149914|NCT04294732|Bupivacaine|bupivacaine|mesh-list
65149915|NCT04294732|Anesthetics, Local|anesthetics, local|mesh-ancestor
65149916|NCT04294732|Anesthetics|anesthetics|mesh-ancestor
65149917|NCT04294732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65149918|NCT04294732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149919|NCT04294732|Sensory System Agents|sensory system agents|mesh-ancestor
65149920|NCT04294732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65149921|NCT02887677|Dapagliflozin|dapagliflozin|mesh-list
65149922|NCT02887677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65149923|NCT02887677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149924|NCT02887677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65149925|NCT02887677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149926|NCT01001104|Dulaglutide|dulaglutide|mesh-list
65149927|NCT01001104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65149928|NCT01001104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149929|NCT04204954|Ciprofloxacin|ciprofloxacin|mesh-list
64534974|NCT01473953|Liraglutide|liraglutide|mesh-list
65305013|NCT02651207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305014|NCT02651207|Sensory System Agents|sensory system agents|mesh-ancestor
65305015|NCT02651207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65305016|NCT02651207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65305017|NCT02651207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65305018|NCT02651207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65305019|NCT02651207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65305020|NCT02651207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534977|NCT01473953|Incretins|incretins|mesh-ancestor
65149930|NCT04204954|Tea Tree Oil|tea tree oil|mesh-list
65149931|NCT04204954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64946625|NCT03547908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65149946|NCT01202955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65149947|NCT01202955|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65149948|NCT01202955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149949|NCT01202955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149950|NCT01202877|Azacitidine|azacitidine|mesh-list
65149951|NCT01202877|Midostaurin|midostaurin|mesh-list
65149952|NCT01202877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65149953|NCT01202877|Antimetabolites|antimetabolites|mesh-ancestor
65149954|NCT01202877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149955|NCT01202877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149956|NCT01202877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149957|NCT01202877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65149958|NCT01202409|Panitumumab|panitumumab|mesh-list
65149959|NCT01202409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65149960|NCT01202409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149961|NCT01202175|Nebivolol|nebivolol|mesh-list
65149962|NCT01202175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65149963|NCT01202175|Vasodilator Agents|vasodilator agents|mesh-ancestor
65149964|NCT01202175|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65149965|NCT01202175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65149966|NCT01202175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65149967|NCT01202175|Adrenergic Agents|adrenergic agents|mesh-ancestor
65149968|NCT01202175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65149969|NCT01202175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149970|NCT01202175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149971|NCT01201785|Aspirin|aspirin|mesh-list
65149972|NCT01201785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65149973|NCT01201785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65149974|NCT01201785|Analgesics|analgesics|mesh-ancestor
65149975|NCT01201785|Sensory System Agents|sensory system agents|mesh-ancestor
65149976|NCT01201785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65149977|NCT01201785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149978|NCT01201785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65149979|NCT01201785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65149980|NCT01201785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65149981|NCT01201785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65149982|NCT01201785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149983|NCT01201785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65149984|NCT01201785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65149985|NCT01201785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149986|NCT01201785|Antipyretics|antipyretics|mesh-ancestor
65149987|NCT01200069|Ibuprofen|ibuprofen|mesh-list
65149988|NCT01200069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65149989|NCT01200069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65149990|NCT01200069|Analgesics|analgesics|mesh-ancestor
65150000|NCT01199289|Dermatologic Agents|dermatologic agents|mesh-ancestor
65150002|NCT01199055|Carboplatin|carboplatin|mesh-list
65150003|NCT01199055|Efatutazone|efatutazone|mesh-list
65150004|NCT01199055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65150005|NCT01199055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305021|NCT02651207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65305022|NCT02564536|Decitabine|decitabine|mesh-list
65305023|NCT02564536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65305024|NCT02564536|Antimetabolites|antimetabolites|mesh-ancestor
65305025|NCT02564536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305026|NCT02564536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150006|NCT01199055|Tubulin Modulators|tubulin modulators|mesh-ancestor
65150007|NCT01199055|Antimitotic Agents|antimitotic agents|mesh-ancestor
65150008|NCT01199055|Mitosis Modulators|mitosis modulators|mesh-ancestor
65150009|NCT01199055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150010|NCT01198587|Zinc Sulfate|zinc sulfate|mesh-list
65150011|NCT01198587|Astringents|astringents|mesh-ancestor
65150012|NCT01198587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150013|NCT01198587|Dermatologic Agents|dermatologic agents|mesh-ancestor
65150015|NCT01198509|Doxycycline|doxycycline|mesh-list
65150016|NCT01198509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65150017|NCT01198509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65150018|NCT01198509|Antimalarials|antimalarials|mesh-ancestor
65150019|NCT01198509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65150020|NCT01198509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65150021|NCT01198275|Amiodarone|amiodarone|mesh-list
65150022|NCT01198275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65150023|NCT01198275|Vasodilator Agents|vasodilator agents|mesh-ancestor
65150024|NCT01198275|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65150025|NCT01198275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65150026|NCT01198275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150027|NCT01198275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65150028|NCT01198275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65150029|NCT01198275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65150030|NCT01198275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150031|NCT01198275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65150032|NCT01198275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65150033|NCT01198275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65150034|NCT01197417|Magnesium Sulfate|magnesium sulfate|mesh-list
65150035|NCT01197417|Analgesics|analgesics|mesh-ancestor
65150036|NCT01197417|Sensory System Agents|sensory system agents|mesh-ancestor
65150037|NCT01197417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65150038|NCT01197417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150039|NCT01197417|Anesthetics|anesthetics|mesh-ancestor
65150040|NCT01197417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65150041|NCT01197417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65150042|NCT01197417|Anticonvulsants|anticonvulsants|mesh-ancestor
65150043|NCT01197417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65150044|NCT01197417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65150045|NCT01197417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150046|NCT01197417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65150047|NCT01197417|Tocolytic Agents|tocolytic agents|mesh-ancestor
65150048|NCT01197417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65150049|NCT00977431|Temozolomide|temozolomide|mesh-list
65150050|NCT00977431|Afatinib|afatinib|mesh-list
65150051|NCT00977431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65150052|NCT00977431|Alkylating Agents|alkylating agents|mesh-ancestor
65150053|NCT00977431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150054|NCT00977431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150055|NCT00977431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65150065|NCT04290169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150066|NCT04290169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65150067|NCT04290169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65150068|NCT02864095|Epinephrine|epinephrine|mesh-list
65150069|NCT02864095|Tranexamic Acid|tranexamic acid|mesh-list
65150070|NCT02864095|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65150071|NCT02864095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65150072|NCT02864095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150073|NCT02864095|Hemostatics|hemostatics|mesh-ancestor
65150074|NCT02864095|Coagulants|coagulants|mesh-ancestor
65150075|NCT02864095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65150076|NCT02864095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65305027|NCT02564536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305028|NCT00600119|Naloxegol|naloxegol|mesh-list
65305029|NCT00600119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65305030|NCT00600119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305031|NCT00600119|Sensory System Agents|sensory system agents|mesh-ancestor
65305032|NCT00600119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65305033|NCT00866294|Paroxetine|paroxetine|mesh-list
65305034|NCT00866294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65305035|NCT00866294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65305036|NCT00866294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65305037|NCT00866294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305038|NCT00866294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65305039|NCT00866294|Serotonin Agents|serotonin agents|mesh-ancestor
65305040|NCT00866294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305041|NCT00866294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65305042|NCT00866294|Antidepressive Agents|antidepressive agents|mesh-ancestor
65305043|NCT00866294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65305044|NCT00866294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65305045|NCT00866294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65150077|NCT02864095|Adrenergic Agents|adrenergic agents|mesh-ancestor
65150078|NCT02864095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65150079|NCT02864095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150080|NCT02864095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65150081|NCT02864095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65150082|NCT02864095|Autonomic Agents|autonomic agents|mesh-ancestor
65150083|NCT02864095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65150084|NCT02864095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65150085|NCT02864095|Respiratory System Agents|respiratory system agents|mesh-ancestor
65150086|NCT02864095|Mydriatics|mydriatics|mesh-ancestor
65150087|NCT02864095|Sympathomimetics|sympathomimetics|mesh-ancestor
65150088|NCT02864095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65150089|NCT00977197|Pregabalin|pregabalin|mesh-list
65150090|NCT00977197|Analgesics|analgesics|mesh-ancestor
65150091|NCT00977197|Sensory System Agents|sensory system agents|mesh-ancestor
65150092|NCT00977197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65150093|NCT00977197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150094|NCT00977197|Anticonvulsants|anticonvulsants|mesh-ancestor
65150095|NCT00977197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65150096|NCT00977197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65150097|NCT00977197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150098|NCT00977197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65150099|NCT00977197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65150100|NCT00977197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65150101|NCT00977197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65150102|NCT00977197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65150103|NCT04288219|Nifedipine|nifedipine|mesh-list
65150104|NCT04288219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65150105|NCT04288219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65150106|NCT04288219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150107|NCT04288219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65150108|NCT04288219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150109|NCT04288219|Vasodilator Agents|vasodilator agents|mesh-ancestor
65305046|NCT00866294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305047|NCT02660255|Cannabidiol|cannabidiol|mesh-list
65305048|NCT02660255|Anticonvulsants|anticonvulsants|mesh-ancestor
65305049|NCT00649103|Quinapril|quinapril|mesh-list
65150110|NCT04288219|Tocolytic Agents|tocolytic agents|mesh-ancestor
65150111|NCT04288219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65150112|NCT04064359|Antibodies|antibodies|mesh-list
65150113|NCT04064359|Immunoconjugates|immunoconjugates|mesh-list
65150114|NCT04064359|Immunologic Factors|immunologic factors|mesh-ancestor
65150115|NCT04064359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150116|NCT00974233|Rituximab|rituximab|mesh-list
65150117|NCT00974233|Lenalidomide|lenalidomide|mesh-list
65150118|NCT00974233|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65150119|NCT00974233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65150130|NCT00974233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150132|NCT00972595|Antiemetics|antiemetics|mesh-ancestor
65150133|NCT00972595|Autonomic Agents|autonomic agents|mesh-ancestor
65150134|NCT00972595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65150135|NCT00972595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150136|NCT00972595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65150137|NCT00972595|Antipruritics|antipruritics|mesh-ancestor
65150138|NCT00972595|Dermatologic Agents|dermatologic agents|mesh-ancestor
65150139|NCT00972595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65150140|NCT00972595|Serotonin Agents|serotonin agents|mesh-ancestor
65150141|NCT00972595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65150142|NCT00972595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150143|NCT00972595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65150144|NCT00972595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65150145|NCT00972595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65150146|NCT00972595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65150147|NCT00972595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65150148|NCT01196091|Antimalarials|antimalarials|mesh-list
65150149|NCT01196091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65150150|NCT01196091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65150151|NCT01196091|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65150152|NCT01196091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65150153|NCT01196091|Analgesics|analgesics|mesh-ancestor
65150154|NCT01196091|Sensory System Agents|sensory system agents|mesh-ancestor
65150155|NCT01196091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65150156|NCT01196091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150157|NCT01196091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65150158|NCT01196091|Immunologic Factors|immunologic factors|mesh-ancestor
65150159|NCT01196091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65150160|NCT01196091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65150161|NCT01196091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65150162|NCT00972283|Insulin|insulin|mesh-list
65150163|NCT00972283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65150164|NCT00972283|Insulin Glargine|insulin glargine|mesh-list
65150165|NCT00972283|Insulin Aspart|insulin aspart|mesh-list
65150166|NCT00972283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65150167|NCT00972283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150168|NCT01194219|Apremilast|apremilast|mesh-list
65150169|NCT01194219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65150170|NCT01194219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65150171|NCT01194219|Analgesics|analgesics|mesh-ancestor
65150172|NCT01194219|Sensory System Agents|sensory system agents|mesh-ancestor
65150173|NCT01194219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65150174|NCT01194219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150175|NCT01194219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65150176|NCT01194219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65150177|NCT01194219|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65150178|NCT01194219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65150179|NCT01194219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150180|NCT01194219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150181|NCT05366049|Acetaminophen|acetaminophen|mesh-list
65150182|NCT05366049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65150183|NCT05366049|Analgesics|analgesics|mesh-ancestor
65150200|NCT00969709|Sensory System Agents|sensory system agents|mesh-ancestor
65150201|NCT00969709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65150202|NCT01193517|Capecitabine|capecitabine|mesh-list
65150203|NCT01193517|Azacitidine|azacitidine|mesh-list
65150205|NCT01193517|Oxaliplatin|oxaliplatin|mesh-list
65150206|NCT01193517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65150207|NCT01193517|Antimetabolites|antimetabolites|mesh-ancestor
65305050|NCT00649103|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65305051|NCT00649103|Protease Inhibitors|protease inhibitors|mesh-ancestor
65305052|NCT00649103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305053|NCT00649103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305054|NCT00649103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65305055|NCT02660177|Dipyrone|dipyrone|mesh-list
64535012|NCT01544179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150208|NCT01193517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150209|NCT01193517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150210|NCT01193517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150211|NCT02863705|Timolol|timolol|mesh-list
65150212|NCT02863705|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65150213|NCT02863705|Bimatoprost|bimatoprost|mesh-list
65150214|NCT02863705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65150215|NCT02863705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65150216|NCT02863705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65150217|NCT02863705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65150218|NCT02863705|Adrenergic Agents|adrenergic agents|mesh-ancestor
65150219|NCT02863705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65150220|NCT02863705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150221|NCT02863705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150222|NCT02863705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65150223|NCT02863705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65150224|NCT02863705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65150225|NCT02863705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65150226|NCT02863705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65150227|NCT01193283|Cyclosporine|cyclosporine|mesh-list
65150228|NCT01193283|Cyclophosphamide|cyclophosphamide|mesh-list
64792783|NCT02995512|Tubulin Modulators|tubulin modulators|mesh-ancestor
65150229|NCT01193283|Cyclosporins|cyclosporins|mesh-list
65150230|NCT01193283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65150232|NCT01193283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150233|NCT01193283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65150234|NCT01193283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65150235|NCT01193283|Alkylating Agents|alkylating agents|mesh-ancestor
65150236|NCT01193283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150237|NCT01193283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150238|NCT01193283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65150239|NCT01193283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150240|NCT01193283|Antifungal Agents|antifungal agents|mesh-ancestor
65150251|NCT02863471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150252|NCT02863471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65150253|NCT02863471|Immunologic Factors|immunologic factors|mesh-ancestor
65150254|NCT02863471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150255|NCT01193127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65150256|NCT01193127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65150257|NCT01193127|Mydriatics|mydriatics|mesh-list
65150258|NCT01193127|Autonomic Agents|autonomic agents|mesh-ancestor
65150259|NCT01193127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65150260|NCT01193127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150261|NCT01192815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65150262|NCT01192815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150263|NCT01192815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65150264|NCT01192815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150265|NCT01192815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150266|NCT01192191|Fluticasone|fluticasone|mesh-list
65150267|NCT01192191|Xhance|xhance|mesh-list
65150268|NCT01192191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65150269|NCT01192191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65150270|NCT01192191|Autonomic Agents|autonomic agents|mesh-ancestor
65150271|NCT01192191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65150272|NCT01192191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150273|NCT01192191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65150274|NCT01192191|Respiratory System Agents|respiratory system agents|mesh-ancestor
65150275|NCT01192191|Dermatologic Agents|dermatologic agents|mesh-ancestor
65150276|NCT01192191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65150277|NCT01307267|Rituximab|rituximab|mesh-list
65150278|NCT01307267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65305056|NCT02660177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65305057|NCT02660177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65305058|NCT02660177|Analgesics|analgesics|mesh-ancestor
65305059|NCT02660177|Sensory System Agents|sensory system agents|mesh-ancestor
65305060|NCT02660177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65305061|NCT02660177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305062|NCT02660177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65305063|NCT02660177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65305064|NCT02660177|Antipyretics|antipyretics|mesh-ancestor
65305065|NCT00701246|Folic Acid|folic acid|mesh-list
65305066|NCT00701246|Vitamin B Complex|vitamin b complex|mesh-list
65305067|NCT00701246|Hematinics|hematinics|mesh-ancestor
65305068|NCT00701246|Vitamins|vitamins|mesh-ancestor
65305069|NCT00701246|Micronutrients|micronutrients|mesh-ancestor
65305070|NCT00701246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305071|NCT02648711|Leucovorin|leucovorin|mesh-list
65305072|NCT02648711|Bevacizumab|bevacizumab|mesh-list
65150279|NCT01307267|Immunoglobulin G|immunoglobulin g|mesh-list
65150280|NCT01307267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65150281|NCT01307267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150282|NCT01307267|Immunologic Factors|immunologic factors|mesh-ancestor
65150283|NCT01307267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150284|NCT01307267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65150285|NCT01307111|Misoprostol|misoprostol|mesh-list
65150286|NCT01307111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65150287|NCT01307111|Abortifacient Agents|abortifacient agents|mesh-ancestor
65150288|NCT01307111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65150289|NCT01307111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150290|NCT01307111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65150291|NCT01307111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65150292|NCT01307111|Oxytocics|oxytocics|mesh-ancestor
65150293|NCT01191801|Cytarabine|cytarabine|mesh-list
65150294|NCT01191801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65150295|NCT01191801|Antimetabolites|antimetabolites|mesh-ancestor
65150296|NCT01191801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150297|NCT01191801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150298|NCT01191801|Antiviral Agents|antiviral agents|mesh-ancestor
65150299|NCT01191801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65150300|NCT01191801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65150301|NCT01191801|Immunologic Factors|immunologic factors|mesh-ancestor
65150302|NCT01191801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150303|NCT01306643|Idelalisib|idelalisib|mesh-list
65150304|NCT01306643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683640|NCT03363893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65150318|NCT00624663|Rivastigmine|rivastigmine|mesh-list
65150319|NCT00624663|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65150320|NCT00624663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150321|NCT00624663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150322|NCT00624663|Cholinergic Agents|cholinergic agents|mesh-ancestor
65150323|NCT00624663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65150324|NCT00624663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150325|NCT00624663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65150326|NCT00624663|Protective Agents|protective agents|mesh-ancestor
65150327|NCT02890823|Cholecalciferol|cholecalciferol|mesh-list
65150328|NCT02890823|Vitamin D|vitamin d|mesh-list
65150329|NCT02890823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65150330|NCT02890823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150331|NCT02890823|Vitamins|vitamins|mesh-ancestor
65150332|NCT02890823|Micronutrients|micronutrients|mesh-ancestor
65150333|NCT02890823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65150334|NCT02887443|Midazolam|midazolam|mesh-list
65150335|NCT02887443|Idebenone|idebenone|mesh-list
65305073|NCT02648711|Oxaliplatin|oxaliplatin|mesh-list
65305074|NCT02648711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65305075|NCT02648711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305076|NCT02648711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65305077|NCT02648711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65305078|NCT02648711|Growth Substances|growth substances|mesh-ancestor
65305079|NCT02648711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305080|NCT02648711|Growth Inhibitors|growth inhibitors|mesh-ancestor
65305081|NCT02648711|Antidotes|antidotes|mesh-ancestor
65305082|NCT02648711|Protective Agents|protective agents|mesh-ancestor
65305083|NCT02648711|Vitamin B Complex|vitamin b complex|mesh-ancestor
65305084|NCT02648711|Vitamins|vitamins|mesh-ancestor
65305085|NCT02648711|Micronutrients|micronutrients|mesh-ancestor
65305086|NCT00854360|Beclomethasone|beclomethasone|mesh-list
65305087|NCT00854360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65305088|NCT00854360|Glucocorticoids|glucocorticoids|mesh-ancestor
65305089|NCT00854360|Hormones|hormones|mesh-ancestor
65305090|NCT00854360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65305091|NCT00854360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305092|NCT00854360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65305093|NCT00854360|Respiratory System Agents|respiratory system agents|mesh-ancestor
65305094|NCT00650351|Ciprofloxacin|ciprofloxacin|mesh-list
65305095|NCT00650351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65305096|NCT00650351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65305097|NCT00650351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65305098|NCT00650351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65305099|NCT00650351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305100|NCT00650351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305101|NCT00650351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535034|NCT01482169|Adenosine|adenosine|mesh-list
65150336|NCT02887443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65150337|NCT02887443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65150338|NCT02887443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65150339|NCT02887443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150340|NCT02887443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65150341|NCT02887443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65150342|NCT02887443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65150343|NCT02887443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65150344|NCT02887443|Anesthetics, General|anesthetics, general|mesh-ancestor
65150345|NCT02887443|Anesthetics|anesthetics|mesh-ancestor
65150346|NCT02887443|GABA Modulators|gaba modulators|mesh-ancestor
65150347|NCT02887443|GABA Agents|gaba agents|mesh-ancestor
65150348|NCT02887443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65150349|NCT02887443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150350|NCT02887443|Antioxidants|antioxidants|mesh-ancestor
65150351|NCT02887443|Protective Agents|protective agents|mesh-ancestor
65150352|NCT05359263|Dapagliflozin|dapagliflozin|mesh-list
65305102|NCT00650351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65305103|NCT00650351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65305104|NCT02648633|Nivolumab|nivolumab|mesh-list
65305105|NCT02648633|Valproic Acid|valproic acid|mesh-list
65305106|NCT02648633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65305107|NCT02648633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055012|NCT00233558|Adalimumab|adalimumab|mesh-list
65305108|NCT02648633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65494084|NCT03701763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65305109|NCT02648633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305110|NCT02648633|Anticonvulsants|anticonvulsants|mesh-ancestor
65305111|NCT02648633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305112|NCT02648633|GABA Agents|gaba agents|mesh-ancestor
65305113|NCT02648633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65305114|NCT02648633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305115|NCT02648633|Antimanic Agents|antimanic agents|mesh-ancestor
65305116|NCT02648633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65305117|NCT02648633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65305118|NCT02648633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65305119|NCT00853970|Bromfenac|bromfenac|mesh-list
65305120|NCT00853970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65305121|NCT00853970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65305122|NCT00853970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65305123|NCT00853970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65305124|NCT00853970|Analgesics|analgesics|mesh-ancestor
65150353|NCT05359263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65150354|NCT05359263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150355|NCT05359263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65150356|NCT05359263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150357|NCT05655273|Tacrolimus|tacrolimus|mesh-list
65150358|NCT05655273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65150359|NCT05655273|Immunologic Factors|immunologic factors|mesh-ancestor
65150360|NCT05655273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150361|NCT05655273|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65150362|NCT05655273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150363|NCT05655273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150364|NCT01305941|Trastuzumab|trastuzumab|mesh-list
65150365|NCT01305941|Everolimus|everolimus|mesh-list
65150366|NCT01305941|Vinorelbine|vinorelbine|mesh-list
65150367|NCT01305941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64947067|NCT02409342|Gemcitabine|gemcitabine|mesh-list
65150380|NCT05658549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65150381|NCT05658549|Expectorants|expectorants|mesh-ancestor
65150382|NCT05658549|Respiratory System Agents|respiratory system agents|mesh-ancestor
65150383|NCT05658549|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65150384|NCT05658549|Antioxidants|antioxidants|mesh-ancestor
65150385|NCT05658549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150386|NCT05658549|Protective Agents|protective agents|mesh-ancestor
65150387|NCT05658549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150388|NCT05658549|Antidotes|antidotes|mesh-ancestor
65150389|NCT02887365|Tegafur|tegafur|mesh-list
65305125|NCT00853970|Sensory System Agents|sensory system agents|mesh-ancestor
65305126|NCT00853970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65305127|NCT00853970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305128|NCT00853970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65150390|NCT02887365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65150391|NCT02887365|Antimetabolites|antimetabolites|mesh-ancestor
65150392|NCT02887365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150393|NCT02887365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150394|NCT05658159|Vitamin D|vitamin d|mesh-list
65150395|NCT05658159|Ergocalciferols|ergocalciferols|mesh-list
65150396|NCT05658159|Cholecalciferol|cholecalciferol|mesh-list
65150397|NCT05658159|Vitamins|vitamins|mesh-list
65150398|NCT05658159|Micronutrients|micronutrients|mesh-ancestor
65150399|NCT05658159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150400|NCT05658159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65150401|NCT05658159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65150402|NCT01305239|Exemestane|exemestane|mesh-list
65150403|NCT01305239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150404|NCT01305239|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65150405|NCT01305239|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65150406|NCT01305239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150407|NCT01305239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150408|NCT01305239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65150409|NCT01305239|Hormone Antagonists|hormone antagonists|mesh-ancestor
65150410|NCT01305239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65150411|NCT01305239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150412|NCT04317183|Miconazole|miconazole|mesh-list
65150413|NCT04317183|Antifungal Agents|antifungal agents|mesh-ancestor
65150414|NCT04317183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65150415|NCT04317183|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65150416|NCT04317183|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65150417|NCT04317183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150418|NCT04317183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150419|NCT04317183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65150420|NCT04317183|Hormone Antagonists|hormone antagonists|mesh-ancestor
65150421|NCT04317183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65150422|NCT04317183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150423|NCT04317183|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65150424|NCT04317183|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65150425|NCT01304693|Ranibizumab|ranibizumab|mesh-list
65150426|NCT01304693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65150427|NCT01304693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65150428|NCT01304693|Growth Substances|growth substances|mesh-ancestor
65150439|NCT01304147|Anesthetics, General|anesthetics, general|mesh-ancestor
65150440|NCT01304147|Anesthetics|anesthetics|mesh-ancestor
65150441|NCT01304147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65150442|NCT01304147|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65150443|NCT01304147|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65150444|NCT01304147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65150445|NCT01304147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150446|NCT05661227|Dexmedetomidine|dexmedetomidine|mesh-list
65150447|NCT05661227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65150448|NCT05661227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65150449|NCT05661227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150450|NCT05661227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65150451|NCT05661227|Analgesics|analgesics|mesh-ancestor
65150452|NCT05661227|Sensory System Agents|sensory system agents|mesh-ancestor
65150453|NCT05661227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401037|NCT02034331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65150454|NCT05661227|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65150456|NCT05661227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65150457|NCT05661227|Adrenergic Agents|adrenergic agents|mesh-ancestor
65150458|NCT05661227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65150459|NCT05661227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150460|NCT01303445|Omeprazole|omeprazole|mesh-list
65150461|NCT01303445|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
65150462|NCT01303445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65305129|NCT00853970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65305130|NCT00651287|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65305131|NCT00651287|Quinapril|quinapril|mesh-list
65305132|NCT00651287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65305133|NCT00651287|Diuretics|diuretics|mesh-ancestor
65305134|NCT00651287|Natriuretic Agents|natriuretic agents|mesh-ancestor
65305135|NCT00651287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305136|NCT00651287|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65305137|NCT00651287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64535092|NCT01462435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150463|NCT01303445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65150464|NCT01303445|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65150465|NCT01303445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150466|NCT01303445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150467|NCT01303445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65150468|NCT01188681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65150469|NCT01188681|Immunoglobulin G|immunoglobulin g|mesh-list
65150470|NCT01188681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65150471|NCT01188681|Alkylating Agents|alkylating agents|mesh-ancestor
65150472|NCT01188681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150473|NCT01188681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150474|NCT01188681|Immunologic Factors|immunologic factors|mesh-ancestor
65150475|NCT01188681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150476|NCT01302899|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65150477|NCT01302899|Ramipril|ramipril|mesh-list
65150478|NCT01302899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65150479|NCT01302899|Diuretics|diuretics|mesh-ancestor
65150480|NCT01302899|Natriuretic Agents|natriuretic agents|mesh-ancestor
65150481|NCT01302899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150482|NCT01302899|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65150483|NCT01302899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65150484|NCT01302899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150485|NCT01302899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65150486|NCT01302899|Protease Inhibitors|protease inhibitors|mesh-ancestor
65150487|NCT01302899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150488|NCT01187901|Sulindac|sulindac|mesh-list
65150489|NCT01187901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65150490|NCT01187901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150491|NCT01187901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65150501|NCT01187901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65150502|NCT01187901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65150503|NCT01302119|Tavaborole|tavaborole|mesh-list
65150504|NCT01302119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65150505|NCT01302119|Antifungal Agents|antifungal agents|mesh-ancestor
65150506|NCT01302119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65150507|NCT01301729|Paclitaxel|paclitaxel|mesh-list
65150508|NCT01301729|Docetaxel|docetaxel|mesh-list
65150509|NCT01301729|Trastuzumab|trastuzumab|mesh-list
65150510|NCT01301729|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65150511|NCT01301729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150512|NCT01301729|Tubulin Modulators|tubulin modulators|mesh-ancestor
65150513|NCT01301729|Antimitotic Agents|antimitotic agents|mesh-ancestor
65150514|NCT01301729|Mitosis Modulators|mitosis modulators|mesh-ancestor
65150515|NCT01301729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150516|NCT01301729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65150517|NCT05643677|Irinotecan|irinotecan|mesh-list
65150518|NCT05643677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65150519|NCT05643677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65150520|NCT05643677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150521|NCT05643677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150522|NCT05643677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150523|NCT02890589|Chromium|chromium|mesh-list
65150524|NCT02890589|Everolimus|everolimus|mesh-list
65150525|NCT02890589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150526|NCT02890589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65305138|NCT00651287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305139|NCT00651287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65305140|NCT00651287|Protease Inhibitors|protease inhibitors|mesh-ancestor
65305141|NCT00651287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305142|NCT02650427|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65305143|NCT02650427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65305144|NCT02650427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305145|NCT02650427|Incretins|incretins|mesh-ancestor
65305146|NCT02650427|Hormones|hormones|mesh-ancestor
65305147|NCT02650427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65305148|NCT02650427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65305149|NCT02650427|Protease Inhibitors|protease inhibitors|mesh-ancestor
65305150|NCT02650427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150528|NCT02890589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150529|NCT02890589|Trace Elements|trace elements|mesh-ancestor
65150530|NCT02890589|Micronutrients|micronutrients|mesh-ancestor
65150531|NCT01301027|Pioglitazone|pioglitazone|mesh-list
65150532|NCT01301027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65150533|NCT01301027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150534|NCT04207385|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65150535|NCT04207385|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65150536|NCT04207385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65150537|NCT04207385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65150538|NCT04207385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150539|NCT04207385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65150540|NCT04207385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150541|NCT04207385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65150542|NCT04207385|Antidepressive Agents|antidepressive agents|mesh-ancestor
65150543|NCT04207385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65150544|NCT01185171|Gefitinib|gefitinib|mesh-list
65150545|NCT01185171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150546|NCT01185171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65150547|NCT01185171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150548|NCT01185171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150549|NCT05641883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
65150550|NCT02886897|Antibodies|antibodies|mesh-list
65150551|NCT02886897|Immunologic Factors|immunologic factors|mesh-ancestor
65150552|NCT02886897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150553|NCT05641649|Valproic Acid|valproic acid|mesh-list
65150554|NCT05641649|Anticonvulsants|anticonvulsants|mesh-ancestor
65150555|NCT05641649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150556|NCT05641649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150565|NCT01184859|Hemostatics|hemostatics|mesh-ancestor
65150566|NCT01184859|Coagulants|coagulants|mesh-ancestor
65150567|NCT01184859|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65150568|NCT01184859|Natriuretic Agents|natriuretic agents|mesh-ancestor
65150569|NCT01184859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150570|NCT02890511|Paclitaxel|paclitaxel|mesh-list
65150571|NCT02890511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65150572|NCT02890511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150573|NCT02890511|Tubulin Modulators|tubulin modulators|mesh-ancestor
65150574|NCT02890511|Antimitotic Agents|antimitotic agents|mesh-ancestor
65150575|NCT02890511|Mitosis Modulators|mitosis modulators|mesh-ancestor
65150576|NCT02890511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150577|NCT01184079|Vaccines|vaccines|mesh-list
65150578|NCT01184079|Immunologic Factors|immunologic factors|mesh-ancestor
65150579|NCT01184079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150580|NCT05333289|Vaccines|vaccines|mesh-list
65150581|NCT05333289|Immunologic Factors|immunologic factors|mesh-ancestor
65150582|NCT05333289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305151|NCT02650427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305152|NCT02644811|Anesthetics|anesthetics|mesh-list
65305153|NCT02644811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65305154|NCT02644811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305155|NCT00651443|Galiximab|galiximab|mesh-list
65305156|NCT00651443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65305157|NCT00651443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305158|NCT00650897|Citalopram|citalopram|mesh-list
65305159|NCT00650897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65305160|NCT00650897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65305161|NCT00650897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65305162|NCT00650897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305163|NCT00650897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65305164|NCT00650897|Serotonin Agents|serotonin agents|mesh-ancestor
65305165|NCT00650897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305166|NCT00650897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65305167|NCT00650897|Antidepressive Agents|antidepressive agents|mesh-ancestor
65305168|NCT00650897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65305169|NCT02644499|Folic Acid|folic acid|mesh-list
65305170|NCT02644499|Hydroxychloroquine|hydroxychloroquine|mesh-list
65305171|NCT02644499|Prednisolone|prednisolone|mesh-list
65305172|NCT02644499|Methotrexate|methotrexate|mesh-list
65305173|NCT02644499|Leflunomide|leflunomide|mesh-list
65305174|NCT02644499|Glucocorticoids|glucocorticoids|mesh-list
65305175|NCT02644499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65305176|NCT02644499|Abortifacient Agents|abortifacient agents|mesh-ancestor
65305177|NCT02644499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65305178|NCT02644499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305179|NCT02644499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65150583|NCT01289990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65150584|NCT01289990|Empagliflozin|empagliflozin|mesh-list
65150585|NCT01289990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65150586|NCT01289990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150587|NCT01289990|Incretins|incretins|mesh-ancestor
65150588|NCT01289990|Hormones|hormones|mesh-ancestor
65150589|NCT01289990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65150590|NCT01289990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65150591|NCT01289990|Protease Inhibitors|protease inhibitors|mesh-ancestor
65150592|NCT01289990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150593|NCT01289990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150594|NCT01289990|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65150595|NCT01190007|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
65150596|NCT01190007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65305180|NCT02644499|Antimetabolites|antimetabolites|mesh-ancestor
65305181|NCT02644499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055084|NCT04670497|Sympathomimetics|sympathomimetics|mesh-ancestor
65305182|NCT02644499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305183|NCT02644499|Dermatologic Agents|dermatologic agents|mesh-ancestor
65305184|NCT02644499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305185|NCT02644499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65305186|NCT02644499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65305187|NCT02644499|Immunologic Factors|immunologic factors|mesh-ancestor
65305188|NCT02644499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65305189|NCT02644499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65150597|NCT01190007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65150598|NCT01190007|Antimetabolites|antimetabolites|mesh-ancestor
65150599|NCT01190007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150600|NCT01190007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65150601|NCT01190007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65150602|NCT01190007|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65150603|NCT01190007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65150604|NCT01190007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65150605|NCT01190007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150606|NCT01190007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65150607|NCT01190007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150608|NCT01300247|Cyclophosphamide|cyclophosphamide|mesh-list
65150609|NCT01300247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65150611|NCT01300247|Obinutuzumab|obinutuzumab|mesh-list
65150612|NCT01300247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65150613|NCT01300247|Immunologic Factors|immunologic factors|mesh-ancestor
65150614|NCT01300247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150615|NCT01300247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65150616|NCT01300247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65150617|NCT01300247|Alkylating Agents|alkylating agents|mesh-ancestor
65150618|NCT01300247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947325|NCT05772377|Cisplatin|cisplatin|mesh-list
65150633|NCT02890277|Coagulants|coagulants|mesh-ancestor
65150634|NCT01289678|Interleukin-2|interleukin-2|mesh-list
65150635|NCT01289678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150636|NCT01289678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65150637|NCT01289678|Analgesics|analgesics|mesh-ancestor
65150638|NCT01289678|Sensory System Agents|sensory system agents|mesh-ancestor
65150639|NCT01289678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65150640|NCT01289678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150641|NCT02890082|Tamoxifen|tamoxifen|mesh-list
65150642|NCT02890082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65150643|NCT02890082|Hormone Antagonists|hormone antagonists|mesh-ancestor
65150644|NCT02890082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65150645|NCT02890082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150646|NCT02890082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65150647|NCT02890082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150648|NCT02890082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65150649|NCT02890082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65150650|NCT02890082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65150651|NCT01183221|Oxytocin|oxytocin|mesh-list
65150652|NCT01183221|Oxytocics|oxytocics|mesh-ancestor
65150653|NCT01183221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65150654|NCT01183221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150655|NCT01183143|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65150656|NCT01183143|Hormones|hormones|mesh-ancestor
65150657|NCT01183143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65150658|NCT01183143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150659|NCT01183065|Folic Acid|folic acid|mesh-list
65150660|NCT01183065|Vitamin B 12|vitamin b 12|mesh-list
65150661|NCT01183065|Hydroxocobalamin|hydroxocobalamin|mesh-list
65150662|NCT01183065|Vitamins|vitamins|mesh-ancestor
65305190|NCT02644499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65305191|NCT02644499|Hormones|hormones|mesh-ancestor
65305192|NCT02644499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65150663|NCT01183065|Micronutrients|micronutrients|mesh-ancestor
65150664|NCT01183065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150665|NCT01183065|Hematinics|hematinics|mesh-ancestor
65150666|NCT01183065|Vitamin B Complex|vitamin b complex|mesh-ancestor
65150667|NCT01182441|Warfarin|warfarin|mesh-list
65150668|NCT01182441|Anticoagulants|anticoagulants|mesh-ancestor
65150669|NCT01182285|Valproic Acid|valproic acid|mesh-list
65150670|NCT01182285|Anticonvulsants|anticonvulsants|mesh-ancestor
65150671|NCT01182285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150672|NCT01182285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150673|NCT01182285|GABA Agents|gaba agents|mesh-ancestor
65150674|NCT01182285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65150675|NCT01182285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150676|NCT01182285|Antimanic Agents|antimanic agents|mesh-ancestor
65150678|NCT01182285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65150679|NCT01182285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65150681|NCT04315935|Butorphanol|butorphanol|mesh-list
65150682|NCT04315935|Propofol|propofol|mesh-list
65150683|NCT04315935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65150700|NCT01182207|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65150701|NCT01182207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65150702|NCT01182207|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65150703|NCT01182207|Estradiol|estradiol|mesh-list
65150704|NCT01182207|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65150705|NCT01182207|Estrogens|estrogens|mesh-ancestor
65150706|NCT01182207|Hormones|hormones|mesh-ancestor
65150707|NCT01182207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65150708|NCT01182207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150709|NCT01182207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65150710|NCT01182207|Contraceptive Agents|contraceptive agents|mesh-ancestor
65150711|NCT01182207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65150712|NCT01182207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65150713|NCT01182207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65150714|NCT01182207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65150715|NCT01182207|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65150716|NCT01182207|Hormone Antagonists|hormone antagonists|mesh-ancestor
65150717|NCT01182207|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65150718|NCT01182207|Diuretics|diuretics|mesh-ancestor
65150719|NCT01182207|Natriuretic Agents|natriuretic agents|mesh-ancestor
65150720|NCT01181895|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65150721|NCT01181895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65150722|NCT01181895|Autonomic Agents|autonomic agents|mesh-ancestor
65150723|NCT01181895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65150724|NCT01181895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150725|NCT01181895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65150726|NCT01181895|Respiratory System Agents|respiratory system agents|mesh-ancestor
65150727|NCT01181895|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65150728|NCT01181895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65150729|NCT01181895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65150730|NCT01181895|Adrenergic Agents|adrenergic agents|mesh-ancestor
65150731|NCT01181895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65150732|NCT01181895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150733|NCT01181271|Sirolimus|sirolimus|mesh-list
65150734|NCT01181271|Cyclophosphamide|cyclophosphamide|mesh-list
65150735|NCT01181271|Busulfan|busulfan|mesh-list
65150736|NCT01181271|Methotrexate|methotrexate|mesh-list
65150737|NCT01181271|Fludarabine|fludarabine|mesh-list
65150738|NCT01181271|Etoposide|etoposide|mesh-list
65150739|NCT01181271|Tacrolimus|tacrolimus|mesh-list
65150740|NCT01181271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65150741|NCT01181271|Immunologic Factors|immunologic factors|mesh-ancestor
65150742|NCT01181271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150743|NCT01181271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64947447|NCT05766800|Carboplatin|carboplatin|mesh-list
65150760|NCT01181271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65150761|NCT01181271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65150762|NCT01181271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65150763|NCT01181271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65150764|NCT01181271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65150765|NCT01181271|Antifungal Agents|antifungal agents|mesh-ancestor
65150766|NCT00624741|Pergolide|pergolide|mesh-list
65305193|NCT02644499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65305194|NCT02644499|Antimalarials|antimalarials|mesh-ancestor
65305195|NCT02644499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65305196|NCT02644499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65305197|NCT02644499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65305198|NCT02644499|Hematinics|hematinics|mesh-ancestor
65305199|NCT02644499|Vitamin B Complex|vitamin b complex|mesh-ancestor
65305200|NCT02644499|Vitamins|vitamins|mesh-ancestor
65305201|NCT02644499|Micronutrients|micronutrients|mesh-ancestor
65305202|NCT00652691|Cyclophosphamide|cyclophosphamide|mesh-list
65305203|NCT00652691|Carboplatin|carboplatin|mesh-list
65150767|NCT00624741|Dopamine Agonists|dopamine agonists|mesh-ancestor
65150768|NCT00624741|Dopamine Agents|dopamine agents|mesh-ancestor
65150769|NCT00624741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65150770|NCT00624741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150771|NCT00624741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150772|NCT01180647|Naltrexone|naltrexone|mesh-list
65150773|NCT01180647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65150774|NCT01180647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65150775|NCT01180647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150776|NCT01180647|Sensory System Agents|sensory system agents|mesh-ancestor
65150777|NCT01180647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65150778|NCT03692065|Apixaban|apixaban|mesh-list
65150779|NCT03692065|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65150780|NCT03692065|Antithrombins|antithrombins|mesh-ancestor
65150781|NCT03692065|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65150782|NCT03692065|Protease Inhibitors|protease inhibitors|mesh-ancestor
65150783|NCT03692065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150784|NCT03692065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150785|NCT03692065|Anticoagulants|anticoagulants|mesh-ancestor
65150786|NCT01178853|Warfarin|warfarin|mesh-list
65150787|NCT01178853|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65150788|NCT01178853|Pitavastatin|pitavastatin|mesh-list
65150789|NCT01178853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65150790|NCT01178853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65150791|NCT01178853|Antimetabolites|antimetabolites|mesh-ancestor
65150792|NCT01178853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150793|NCT01178853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65150794|NCT01178853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65150795|NCT01178853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150796|NCT01178853|Anticoagulants|anticoagulants|mesh-ancestor
65150797|NCT04286035|Bupivacaine|bupivacaine|mesh-list
65150798|NCT04286035|Anesthetics, Local|anesthetics, local|mesh-ancestor
64947507|NCT05734794|Rituximab|rituximab|mesh-list
65150812|NCT00629473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65150813|NCT00629473|Antiemetics|antiemetics|mesh-ancestor
65150814|NCT00629473|Autonomic Agents|autonomic agents|mesh-ancestor
65150815|NCT00629473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65150816|NCT00629473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150817|NCT00629473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65150818|NCT00629473|Glucocorticoids|glucocorticoids|mesh-ancestor
65150819|NCT00629473|Hormones|hormones|mesh-ancestor
65150820|NCT00629473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65150821|NCT00629473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65150822|NCT00629473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150823|NCT00629473|Protease Inhibitors|protease inhibitors|mesh-ancestor
65150824|NCT00629473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150825|NCT00629473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150827|NCT04046107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65150828|NCT04046107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150829|NCT04286503|Ritonavir|ritonavir|mesh-list
65150830|NCT04286503|Lopinavir|lopinavir|mesh-list
65150831|NCT04286503|Chloroquine|chloroquine|mesh-list
65150832|NCT04286503|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65150833|NCT04286503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65150834|NCT04286503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65150835|NCT04286503|Protease Inhibitors|protease inhibitors|mesh-ancestor
65305204|NCT00652691|Topotecan|topotecan|mesh-list
65305205|NCT00652691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65305206|NCT00652691|Immunologic Factors|immunologic factors|mesh-ancestor
65305207|NCT00652691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305208|NCT00652691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65305209|NCT00652691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65305210|NCT00652691|Alkylating Agents|alkylating agents|mesh-ancestor
65305211|NCT00652691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305212|NCT00652691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305213|NCT00652691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65305214|NCT00652691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65150836|NCT04286503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150837|NCT04286503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150838|NCT04286503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65150839|NCT04286503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65150840|NCT04286503|Antiviral Agents|antiviral agents|mesh-ancestor
65150841|NCT04286503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65150842|NCT04286503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65150843|NCT04286503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65150844|NCT04286503|Amebicides|amebicides|mesh-ancestor
65150845|NCT04286503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65150846|NCT04286503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65150847|NCT04286503|Antimalarials|antimalarials|mesh-ancestor
65150848|NCT04286503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65150849|NCT04286503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65150850|NCT04286503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65150851|NCT04286503|Analgesics|analgesics|mesh-ancestor
65150852|NCT04286503|Sensory System Agents|sensory system agents|mesh-ancestor
65150853|NCT04286503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65150854|NCT04286503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150855|NCT04286503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65150856|NCT04286503|Filaricides|filaricides|mesh-ancestor
65150857|NCT04286503|Antinematodal Agents|antinematodal agents|mesh-ancestor
65150858|NCT04286503|Anthelmintics|anthelmintics|mesh-ancestor
65150859|NCT03792841|Etanercept|etanercept|mesh-list
65150883|NCT00976573|Carboplatin|carboplatin|mesh-list
65150884|NCT00976573|Everolimus|everolimus|mesh-list
65150885|NCT00976573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65150886|NCT00976573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150887|NCT00976573|Tubulin Modulators|tubulin modulators|mesh-ancestor
65150888|NCT00976573|Antimitotic Agents|antimitotic agents|mesh-ancestor
65150889|NCT00976573|Mitosis Modulators|mitosis modulators|mesh-ancestor
65150890|NCT00976573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150891|NCT00976573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65150892|NCT00976573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65150893|NCT00976573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65150894|NCT00976573|Growth Substances|growth substances|mesh-ancestor
65150895|NCT00976573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150896|NCT00976573|Growth Inhibitors|growth inhibitors|mesh-ancestor
65150897|NCT00976573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65150898|NCT00976573|Immunologic Factors|immunologic factors|mesh-ancestor
65150899|NCT03661723|Bevacizumab|bevacizumab|mesh-list
65150900|NCT03661723|Pembrolizumab|pembrolizumab|mesh-list
65150901|NCT03661723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65150902|NCT03661723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150903|NCT03661723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65150904|NCT03661723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65150905|NCT03661723|Growth Substances|growth substances|mesh-ancestor
65150906|NCT03661723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150907|NCT03661723|Growth Inhibitors|growth inhibitors|mesh-ancestor
65150909|NCT00629863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150910|NCT00629863|Antimetabolites|antimetabolites|mesh-ancestor
65150911|NCT00629863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305215|NCT00652691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65305216|NCT00652691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305217|NCT02649179|Ropivacaine|ropivacaine|mesh-list
65305218|NCT02649179|Anesthetics, Local|anesthetics, local|mesh-ancestor
65305219|NCT02649179|Anesthetics|anesthetics|mesh-ancestor
65305220|NCT02649179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65305221|NCT02649179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305222|NCT02649179|Sensory System Agents|sensory system agents|mesh-ancestor
65305223|NCT02649179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65305224|NCT02644577|Metformin|metformin|mesh-list
65305225|NCT02644577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65305226|NCT02644577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305227|NCT02644421|Lidocaine|lidocaine|mesh-list
65305228|NCT02644421|Anesthetics, Local|anesthetics, local|mesh-ancestor
65305229|NCT02644421|Anesthetics|anesthetics|mesh-ancestor
65305230|NCT02644421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65305231|NCT02644421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305232|NCT02644421|Sensory System Agents|sensory system agents|mesh-ancestor
65305233|NCT02644421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65305234|NCT02644421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65305235|NCT02644421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65305236|NCT02644421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65305237|NCT02644421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65305238|NCT02644421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305239|NCT00651599|Drospirenone|drospirenone|mesh-list
65150912|NCT00629863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65150928|NCT00976495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65150929|NCT00630019|Moxifloxacin|moxifloxacin|mesh-list
65150930|NCT00630019|Levofloxacin|levofloxacin|mesh-list
65150931|NCT00630019|Ofloxacin|ofloxacin|mesh-list
65150932|NCT00630019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65150933|NCT00630019|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65150934|NCT00630019|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65150935|NCT00630019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65150936|NCT00630019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65150937|NCT00630019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65150938|NCT00630019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65150939|NCT00630019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150940|NCT00630019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150941|NCT00630019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150942|NCT00630019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65150943|NCT00630019|Contraceptive Agents|contraceptive agents|mesh-ancestor
65150944|NCT00630019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65150945|NCT00630019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150946|NCT00630019|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65150947|NCT00630019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65150948|NCT00630019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65150949|NCT00630019|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65150950|NCT00630019|Renal Agents|renal agents|mesh-ancestor
65305240|NCT00651599|Estradiol|estradiol|mesh-list
65305241|NCT00651599|Estrogens|estrogens|mesh-ancestor
65305242|NCT00651599|Hormones|hormones|mesh-ancestor
65305243|NCT00651599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65305244|NCT00651599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305245|NCT00651599|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65305246|NCT00651599|Hormone Antagonists|hormone antagonists|mesh-ancestor
65305247|NCT00651599|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65305248|NCT00651599|Diuretics|diuretics|mesh-ancestor
65305249|NCT00651599|Natriuretic Agents|natriuretic agents|mesh-ancestor
65305250|NCT02647151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65305251|NCT02647151|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65305252|NCT02647151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65305253|NCT02647151|Dermatologic Agents|dermatologic agents|mesh-ancestor
65305254|NCT02649335|Propranolol|propranolol|mesh-list
65305255|NCT02649335|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65305256|NCT02649335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65305257|NCT02649335|Adrenergic Agents|adrenergic agents|mesh-ancestor
65305258|NCT02649335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65305259|NCT02649335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305260|NCT02649335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150951|NCT00630019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65150952|NCT00630019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65150953|NCT00998296|Nintedanib|nintedanib|mesh-list
65150954|NCT00998296|Afatinib|afatinib|mesh-list
65150955|NCT00998296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150956|NCT00998296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65150957|NCT00998296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150958|NCT00998296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150959|NCT01178073|Ambrisentan|ambrisentan|mesh-list
65150960|NCT01178073|Tadalafil|tadalafil|mesh-list
65150961|NCT01178073|Vasodilator Agents|vasodilator agents|mesh-ancestor
65150962|NCT01178073|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65150963|NCT01178073|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65150964|NCT01178073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150965|NCT01178073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150966|NCT01178073|Urological Agents|urological agents|mesh-ancestor
65150967|NCT01178073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65150968|NCT00997984|Guanfacine|guanfacine|mesh-list
65150969|NCT00997984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65150970|NCT00997984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65150980|NCT01177293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65150981|NCT01177293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150982|NCT01177293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65150983|NCT01177293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150984|NCT01177293|Vasodilator Agents|vasodilator agents|mesh-ancestor
65150985|NCT02886429|Dexmedetomidine|dexmedetomidine|mesh-list
65150986|NCT02886429|Bupivacaine|bupivacaine|mesh-list
65150987|NCT02886429|Anesthetics, Local|anesthetics, local|mesh-ancestor
65150988|NCT02886429|Anesthetics|anesthetics|mesh-ancestor
65150989|NCT02886429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65150990|NCT02886429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150991|NCT02886429|Sensory System Agents|sensory system agents|mesh-ancestor
65305261|NCT02649335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65305262|NCT02649335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65305263|NCT02649335|Vasodilator Agents|vasodilator agents|mesh-ancestor
65305264|NCT02644187|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65305265|NCT02644187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65305266|NCT02644187|Dermatologic Agents|dermatologic agents|mesh-ancestor
65305267|NCT00651131|Daptomycin|daptomycin|mesh-list
65305268|NCT00651131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65305269|NCT00651131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65305270|NCT04167137|Atezolizumab|atezolizumab|mesh-list
65150992|NCT02886429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65150993|NCT02886429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65150994|NCT02886429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65150995|NCT02886429|Analgesics|analgesics|mesh-ancestor
65150996|NCT02886429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65150997|NCT02886429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65150998|NCT02886429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65150999|NCT02886429|Adrenergic Agents|adrenergic agents|mesh-ancestor
65151000|NCT02886429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65151001|NCT02886429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151002|NCT01299389|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65151003|NCT01299389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65151004|NCT01299389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65151005|NCT01299389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65151006|NCT01299389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151007|NCT01299389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65151008|NCT01299389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65151009|NCT01299389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65151010|NCT01299389|Serotonin Agents|serotonin agents|mesh-ancestor
65151011|NCT01299389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65151012|NCT01299389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151013|NCT01299389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65151014|NCT01299389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65151015|NCT01299389|Dopamine Agents|dopamine agents|mesh-ancestor
65151016|NCT02886351|Nitrous Oxide|nitrous oxide|mesh-list
65151017|NCT02886351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65151018|NCT02886351|Anesthetics, General|anesthetics, general|mesh-ancestor
65151019|NCT02886351|Anesthetics|anesthetics|mesh-ancestor
65151020|NCT02886351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65151021|NCT02886351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151022|NCT02886351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65151023|NCT02886351|Analgesics|analgesics|mesh-ancestor
65151024|NCT02886351|Sensory System Agents|sensory system agents|mesh-ancestor
65151025|NCT02886351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65151026|NCT00976027|Vaccines|vaccines|mesh-list
65151027|NCT00976027|Immunologic Factors|immunologic factors|mesh-ancestor
65151028|NCT00976027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151029|NCT01298765|Buprenorphine|buprenorphine|mesh-list
65151030|NCT01298765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65151031|NCT01298765|Narcotics|narcotics|mesh-ancestor
65151032|NCT01298765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65151033|NCT01298765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151034|NCT01298765|Analgesics|analgesics|mesh-ancestor
65151035|NCT01298765|Sensory System Agents|sensory system agents|mesh-ancestor
64947732|NCT05458479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65151043|NCT04296214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151045|NCT04296370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151046|NCT04296370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65151047|NCT04296370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151048|NCT04296370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151049|NCT00997438|Thioctic Acid|thioctic acid|mesh-list
65151050|NCT00997438|Antioxidants|antioxidants|mesh-ancestor
65151051|NCT00997438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151052|NCT00997438|Protective Agents|protective agents|mesh-ancestor
65151053|NCT00997438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151054|NCT00997438|Vitamin B Complex|vitamin b complex|mesh-ancestor
65305271|NCT04167137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305272|NCT02649413|Prednisone|prednisone|mesh-list
65305273|NCT02649413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65305274|NCT02649413|Glucocorticoids|glucocorticoids|mesh-ancestor
65305275|NCT02649413|Hormones|hormones|mesh-ancestor
65305276|NCT02649413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65305277|NCT02649413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305278|NCT02649413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65305279|NCT02649413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305280|NCT02643563|Epinephrine|epinephrine|mesh-list
65305281|NCT02643563|Bupivacaine|bupivacaine|mesh-list
65305282|NCT02643563|Ropivacaine|ropivacaine|mesh-list
65305283|NCT02643563|Anesthetics, Local|anesthetics, local|mesh-ancestor
65305284|NCT02643563|Anesthetics|anesthetics|mesh-ancestor
65305285|NCT02643563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65305286|NCT02643563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305287|NCT02643563|Sensory System Agents|sensory system agents|mesh-ancestor
65305288|NCT02643563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65305289|NCT02643563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65305290|NCT02643563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65305291|NCT02643563|Adrenergic Agents|adrenergic agents|mesh-ancestor
65305292|NCT02643563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65305293|NCT02643563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305294|NCT02643563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65151055|NCT00997438|Vitamins|vitamins|mesh-ancestor
65151056|NCT00997438|Micronutrients|micronutrients|mesh-ancestor
65151057|NCT00997126|Alfentanil|alfentanil|mesh-list
65151058|NCT00997126|Propofol|propofol|mesh-list
65151059|NCT00997126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65151060|NCT00997126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65151061|NCT00997126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151062|NCT00997126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65151063|NCT00997126|Anesthetics, General|anesthetics, general|mesh-ancestor
65151064|NCT00997126|Anesthetics|anesthetics|mesh-ancestor
65151065|NCT00997126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65151066|NCT00997126|Narcotics|narcotics|mesh-ancestor
65151067|NCT00997126|Analgesics|analgesics|mesh-ancestor
65151068|NCT00997126|Sensory System Agents|sensory system agents|mesh-ancestor
65151069|NCT00997126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65151070|NCT01000636|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65151071|NCT01000636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65151072|NCT01000636|Dermatologic Agents|dermatologic agents|mesh-ancestor
65151073|NCT04433494|Tamoxifen|tamoxifen|mesh-list
65151074|NCT04433494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65151075|NCT04433494|Hormone Antagonists|hormone antagonists|mesh-ancestor
65151076|NCT04433494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65151077|NCT04433494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151078|NCT04433494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65151079|NCT04433494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151080|NCT04433494|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65151081|NCT04433494|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65305295|NCT02643563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65305296|NCT02643563|Autonomic Agents|autonomic agents|mesh-ancestor
65305297|NCT02643563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65305298|NCT02643563|Respiratory System Agents|respiratory system agents|mesh-ancestor
65305299|NCT02643563|Mydriatics|mydriatics|mesh-ancestor
65305300|NCT02643563|Sympathomimetics|sympathomimetics|mesh-ancestor
65305301|NCT02643563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65305302|NCT00651209|Tenofovir|tenofovir|mesh-list
65305303|NCT00651209|Antiviral Agents|antiviral agents|mesh-ancestor
65305304|NCT00651209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65305305|NCT00651209|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65305306|NCT00651209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65305307|NCT00651209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305308|NCT00651209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151082|NCT04433494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65151083|NCT01000480|Pemetrexed|pemetrexed|mesh-list
65151084|NCT01000480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151085|NCT01000480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151086|NCT01000480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151087|NCT01000480|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65151088|NCT01000480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65151089|NCT02862691|Acetaminophen|acetaminophen|mesh-list
65151090|NCT02862691|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65151091|NCT02862691|Oxycodone|oxycodone|mesh-list
65151092|NCT02862691|Analgesics|analgesics|mesh-list
65151093|NCT02862691|Bupivacaine|bupivacaine|mesh-list
65151094|NCT02862691|Anesthetics, Local|anesthetics, local|mesh-list
65151095|NCT02862691|Anesthetics|anesthetics|mesh-list
65151096|NCT02862691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65151097|NCT02862691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151098|NCT02862691|Sensory System Agents|sensory system agents|mesh-ancestor
65151099|NCT02862691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65151100|NCT02862691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65151101|NCT02862691|Antipyretics|antipyretics|mesh-ancestor
65151102|NCT02862691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65151103|NCT02862691|Narcotics|narcotics|mesh-ancestor
65151114|NCT00965341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65151116|NCT00965341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65151117|NCT00965341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151118|NCT00965341|Anabolic Agents|anabolic agents|mesh-ancestor
65151119|NCT01175811|Insulin|insulin|mesh-list
65151120|NCT01175811|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65151121|NCT01175811|Insulin Glargine|insulin glargine|mesh-list
65151122|NCT01175811|Insulin Lispro|insulin lispro|mesh-list
64793691|NCT03216408|Botulinum Toxins|botulinum toxins|mesh-list
65151123|NCT01175811|Insulin, Isophane|insulin, isophane|mesh-list
65151124|NCT01175811|Biphasic Insulins|biphasic insulins|mesh-list
65151125|NCT01175811|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
65151126|NCT01175811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65151127|NCT01175811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151129|NCT00965263|Anesthetics, Local|anesthetics, local|mesh-ancestor
65151130|NCT00965263|Anesthetics|anesthetics|mesh-ancestor
65151131|NCT00965263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65151132|NCT00965263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151133|NCT00965263|Sensory System Agents|sensory system agents|mesh-ancestor
65151134|NCT00965263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65151135|NCT00965263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65151136|NCT00965263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65151137|NCT00965263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65151138|NCT00965263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65305309|NCT00651209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65305310|NCT00651209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65305311|NCT00652925|Celecoxib|celecoxib|mesh-list
65305312|NCT00652925|Naproxen|naproxen|mesh-list
65305313|NCT00652925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65305314|NCT00652925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65305315|NCT00652925|Analgesics|analgesics|mesh-ancestor
65305316|NCT00652925|Sensory System Agents|sensory system agents|mesh-ancestor
65305317|NCT00652925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65305318|NCT00652925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305319|NCT00652925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65305320|NCT00652925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65305321|NCT00652925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65305322|NCT00652925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65305323|NCT00652925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305324|NCT00652925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305325|NCT00652925|Gout Suppressants|gout suppressants|mesh-ancestor
65305326|NCT00653003|Leflunomide|leflunomide|mesh-list
65305327|NCT00653003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535270|NCT00448227|Famciclovir|famciclovir|mesh-list
65151139|NCT00965263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151140|NCT00965263|Dopamine Agents|dopamine agents|mesh-ancestor
65151141|NCT00965263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65151142|NCT02886195|Pemetrexed|pemetrexed|mesh-list
65151143|NCT02886195|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65151144|NCT02886195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151145|NCT02886195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151146|NCT02886195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151147|NCT02886195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65151148|NCT02886195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65151149|NCT02886195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65151150|NCT03637543|Nivolumab|nivolumab|mesh-list
65151151|NCT03637543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65151152|NCT03637543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151153|NCT03637543|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65151154|NCT03637543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151155|NCT02862769|Lidocaine|lidocaine|mesh-list
65151156|NCT02862769|Anesthetics, Local|anesthetics, local|mesh-ancestor
65151157|NCT02862769|Anesthetics|anesthetics|mesh-ancestor
65151158|NCT02862769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65151159|NCT02862769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151160|NCT02862769|Sensory System Agents|sensory system agents|mesh-ancestor
65151161|NCT02862769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65151162|NCT02862769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65151163|NCT02862769|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65151164|NCT02862769|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65151165|NCT02862769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64947863|NCT04916418|Ropivacaine|ropivacaine|mesh-list
65151182|NCT01298531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65151183|NCT01298531|Analgesics|analgesics|mesh-ancestor
65151184|NCT01298531|Sensory System Agents|sensory system agents|mesh-ancestor
65151185|NCT01298531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65151186|NCT01298531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151187|NCT01298531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65305328|NCT00653003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305329|NCT00653003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65305330|NCT00653003|Immunologic Factors|immunologic factors|mesh-ancestor
65305331|NCT00653003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305332|NCT02643719|Topiramate|topiramate|mesh-list
65305333|NCT02643719|Naproxen|naproxen|mesh-list
65305335|NCT02643719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65305336|NCT02643719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65305337|NCT02643719|Analgesics|analgesics|mesh-ancestor
65305338|NCT02643719|Sensory System Agents|sensory system agents|mesh-ancestor
65305339|NCT02643719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65305340|NCT02643719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305341|NCT02643719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65305342|NCT02643719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65305343|NCT02643719|Gout Suppressants|gout suppressants|mesh-ancestor
65305344|NCT02643719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65305345|NCT02643719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305346|NCT02643719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305347|NCT02643719|Anticonvulsants|anticonvulsants|mesh-ancestor
65305348|NCT02643719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65305349|NCT02643719|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65305350|NCT02643719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65305351|NCT02643719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65305352|NCT02643719|Serotonin Agents|serotonin agents|mesh-ancestor
65305353|NCT02643719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65305354|NCT02649101|Thalidomide|thalidomide|mesh-list
65305355|NCT02649101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65305356|NCT02649101|Immunologic Factors|immunologic factors|mesh-ancestor
65305357|NCT02649101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305358|NCT02649101|Leprostatic Agents|leprostatic agents|mesh-ancestor
65305359|NCT02649101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65305360|NCT02649101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65305361|NCT02649101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65305362|NCT02649101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65305369|NCT00700154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65305370|NCT00700154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305371|NCT00651911|Rasburicase|rasburicase|mesh-list
65305372|NCT00651911|Gout Suppressants|gout suppressants|mesh-ancestor
65305373|NCT00651911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65305374|NCT02643407|Docetaxel|docetaxel|mesh-list
65305375|NCT02643407|Nedaplatin|nedaplatin|mesh-list
65305376|NCT02643407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305377|NCT02643407|Tubulin Modulators|tubulin modulators|mesh-ancestor
65305378|NCT02643407|Antimitotic Agents|antimitotic agents|mesh-ancestor
65305379|NCT02643407|Mitosis Modulators|mitosis modulators|mesh-ancestor
65305380|NCT02643407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305381|NCT02643329|Gliclazide|gliclazide|mesh-list
65305382|NCT02643329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65305383|NCT02643329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305384|NCT03245489|Aspirin|aspirin|mesh-list
65305385|NCT03245489|Pembrolizumab|pembrolizumab|mesh-list
65305386|NCT03245489|Clopidogrel|clopidogrel|mesh-list
65305387|NCT03245489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65305388|NCT03245489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151188|NCT01298531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65151189|NCT01298531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65151190|NCT01298531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65151191|NCT01298531|Immunologic Factors|immunologic factors|mesh-ancestor
65151192|NCT02862145|Dexamethasone|dexamethasone|mesh-list
65151193|NCT02862145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65151194|NCT02862145|Antiemetics|antiemetics|mesh-ancestor
65151195|NCT02862145|Autonomic Agents|autonomic agents|mesh-ancestor
65151196|NCT02862145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65151197|NCT02862145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151198|NCT02862145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65151200|NCT02862145|Hormones|hormones|mesh-ancestor
65151201|NCT02862145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65151202|NCT02862145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65151203|NCT02862145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151204|NCT01174173|Ranolazine|ranolazine|mesh-list
65151205|NCT01174173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65151206|NCT01174173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65151207|NCT01174173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151208|NCT00964795|Aflibercept|aflibercept|mesh-list
65151209|NCT00964795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65151210|NCT00964795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65151211|NCT00964795|Growth Substances|growth substances|mesh-ancestor
65151212|NCT00964795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151213|NCT00964795|Growth Inhibitors|growth inhibitors|mesh-ancestor
65151214|NCT00964795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151215|NCT01173471|Niacinamide|niacinamide|mesh-list
65151216|NCT01173471|Vitamin B Complex|vitamin b complex|mesh-ancestor
65151217|NCT01173471|Vitamins|vitamins|mesh-ancestor
65151218|NCT01173471|Micronutrients|micronutrients|mesh-ancestor
65151219|NCT01173471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151220|NCT01172847|Oseltamivir|oseltamivir|mesh-list
65151221|NCT01172847|Rimantadine|rimantadine|mesh-list
65151222|NCT01172847|Antiviral Agents|antiviral agents|mesh-ancestor
65151223|NCT01172847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65151236|NCT00966355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65151237|NCT00966355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151239|NCT01172535|Lopinavir|lopinavir|mesh-list
65305389|NCT03245489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65305390|NCT03245489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65305391|NCT03245489|Analgesics|analgesics|mesh-ancestor
65305392|NCT03245489|Sensory System Agents|sensory system agents|mesh-ancestor
65305393|NCT03245489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65305394|NCT03245489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305395|NCT03245489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65305396|NCT03245489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65305397|NCT03245489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65305398|NCT03245489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65305399|NCT03245489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305400|NCT03245489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65305401|NCT03245489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65305402|NCT03245489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305403|NCT03245489|Antipyretics|antipyretics|mesh-ancestor
65305404|NCT03245489|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65305405|NCT03245489|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65305406|NCT03245489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65305407|NCT03245489|Purinergic Agents|purinergic agents|mesh-ancestor
65305408|NCT03245489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65055308|NCT00234572|Lanreotide|lanreotide|mesh-list
65305410|NCT02643017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65305411|NCT02643017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65305412|NCT02643017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535350|NCT00531453|Protease Inhibitors|protease inhibitors|mesh-ancestor
65151240|NCT01172535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65151241|NCT01172535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65151242|NCT01172535|Protease Inhibitors|protease inhibitors|mesh-ancestor
65151243|NCT01172535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151244|NCT01172535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151245|NCT01172535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65151246|NCT01172535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65151247|NCT01172535|Antiviral Agents|antiviral agents|mesh-ancestor
65151248|NCT01172535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65151249|NCT01172535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65151250|NCT01172535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65151251|NCT05160493|Pregabalin|pregabalin|mesh-list
65151252|NCT05160493|Ketamine|ketamine|mesh-list
65151253|NCT05160493|Esketamine|esketamine|mesh-list
65151254|NCT05160493|Analgesics|analgesics|mesh-ancestor
65151255|NCT05160493|Sensory System Agents|sensory system agents|mesh-ancestor
65151256|NCT05160493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65151257|NCT05160493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151258|NCT05160493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65151259|NCT05160493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65151260|NCT05160493|Anesthetics, General|anesthetics, general|mesh-ancestor
65151261|NCT05160493|Anesthetics|anesthetics|mesh-ancestor
65305413|NCT02643017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65305414|NCT02643017|Analgesics|analgesics|mesh-ancestor
65305415|NCT02643017|Sensory System Agents|sensory system agents|mesh-ancestor
65305416|NCT02643017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65305417|NCT02643017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65305418|NCT02643017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65305419|NCT02643017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65305420|NCT02643017|Adrenergic Agents|adrenergic agents|mesh-ancestor
65305421|NCT02643017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65305422|NCT02643017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305423|NCT02643173|Anesthetics|anesthetics|mesh-list
65305424|NCT02643173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
65305425|NCT02643173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65305426|NCT02643173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305427|NCT02643173|Anesthetics, General|anesthetics, general|mesh-ancestor
64535372|NCT01590758|Pexiganan|pexiganan|mesh-list
65151262|NCT05160493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65151263|NCT05160493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65151264|NCT05160493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65151265|NCT05160493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65151266|NCT05160493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151267|NCT05160493|Anticonvulsants|anticonvulsants|mesh-ancestor
65151268|NCT05160493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64514552|NCT02986906|Triamcinolone|triamcinolone|mesh-list
65151269|NCT05160493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65151270|NCT05160493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65151271|NCT05160493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65151272|NCT05160493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65151273|NCT05160493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65151274|NCT05160493|Antidepressive Agents|antidepressive agents|mesh-ancestor
65151275|NCT00966277|Dalteparin|dalteparin|mesh-list
65151276|NCT00966277|Tinzaparin|tinzaparin|mesh-list
65151277|NCT00966277|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65151278|NCT00966277|Anticoagulants|anticoagulants|mesh-ancestor
65151279|NCT00966277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65151280|NCT00966277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65151281|NCT00966277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151282|NCT04324307|Gemcitabine|gemcitabine|mesh-list
65151283|NCT04324307|Paclitaxel|paclitaxel|mesh-list
65151284|NCT04324307|Fluorouracil|fluorouracil|mesh-list
65151285|NCT04324307|Oxaliplatin|oxaliplatin|mesh-list
65151286|NCT04324307|Irinotecan|irinotecan|mesh-list
65151293|NCT04324307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151295|NCT04324307|Antimetabolites|antimetabolites|mesh-ancestor
65151296|NCT04324307|Antiviral Agents|antiviral agents|mesh-ancestor
65151297|NCT04324307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65151298|NCT04324307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151299|NCT04324307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65151300|NCT04324307|Immunologic Factors|immunologic factors|mesh-ancestor
65151301|NCT04324307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151302|NCT04324307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65151303|NCT04324307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65151304|NCT01297517|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65151305|NCT01297517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65151306|NCT01297517|Brinzolamide|brinzolamide|mesh-list
65151307|NCT01297517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65151308|NCT01297517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65151309|NCT01297517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65305428|NCT02646137|Chlorotrianisene|chlorotrianisene|mesh-list
65305429|NCT02646137|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65305430|NCT02646137|Estrogens|estrogens|mesh-ancestor
65305431|NCT02646137|Hormones|hormones|mesh-ancestor
65305432|NCT02646137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65305433|NCT02646137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305434|NCT02646137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65305435|NCT02646137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305436|NCT00653549|Torsemide|torsemide|mesh-list
65305437|NCT00653549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65305438|NCT00653549|Diuretics|diuretics|mesh-ancestor
64535387|NCT01692626|Pimecrolimus|pimecrolimus|mesh-list
65151310|NCT01297517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65151311|NCT01297517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65151312|NCT01297517|Adrenergic Agents|adrenergic agents|mesh-ancestor
65151313|NCT01297517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65151314|NCT01297517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151315|NCT01297517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151316|NCT01297517|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65151317|NCT01297517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151318|NCT01296347|Ketamine|ketamine|mesh-list
65151319|NCT01296347|Analgesics|analgesics|mesh-ancestor
65151320|NCT01296347|Sensory System Agents|sensory system agents|mesh-ancestor
65151321|NCT01296347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65151322|NCT01296347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151323|NCT01296347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65151324|NCT01296347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65151325|NCT01296347|Anesthetics, General|anesthetics, general|mesh-ancestor
65151326|NCT01296347|Anesthetics|anesthetics|mesh-ancestor
65151327|NCT01296347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65151328|NCT01296347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65151329|NCT01296347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65151330|NCT01296347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65151331|NCT01296347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151332|NCT01296035|Panitumumab|panitumumab|mesh-list
65151333|NCT01296035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65151334|NCT01296035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151335|NCT01294787|Glycopyrrolate|glycopyrrolate|mesh-list
65151336|NCT01294787|Bromides|bromides|mesh-list
65151337|NCT01294787|Tiotropium Bromide|tiotropium bromide|mesh-list
65151338|NCT01294787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65151339|NCT01294787|Autonomic Agents|autonomic agents|mesh-ancestor
65151340|NCT01294787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65151341|NCT01294787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151342|NCT01294787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65151343|NCT01294787|Respiratory System Agents|respiratory system agents|mesh-ancestor
65151344|NCT01294787|Parasympatholytics|parasympatholytics|mesh-ancestor
65151345|NCT01294787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65151346|NCT01294787|Cholinergic Agents|cholinergic agents|mesh-ancestor
65151347|NCT01294787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65151348|NCT01294787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151349|NCT01294787|Anticonvulsants|anticonvulsants|mesh-ancestor
65151350|NCT01294787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65151351|NCT01294787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65151353|NCT01294553|Rosiglitazone|rosiglitazone|mesh-list
65151354|NCT01294553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64948053|NCT04702256|Antiemetics|antiemetics|mesh-ancestor
65151376|NCT01293695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151377|NCT01293539|Melphalan|melphalan|mesh-list
65151378|NCT01293539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65151379|NCT01293539|Alkylating Agents|alkylating agents|mesh-ancestor
65151380|NCT01293539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151381|NCT01293539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305439|NCT00653549|Natriuretic Agents|natriuretic agents|mesh-ancestor
65305440|NCT00653549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305441|NCT00653549|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65305442|NCT00653549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64535398|NCT01692626|Immunologic Factors|immunologic factors|mesh-ancestor
65151382|NCT01293539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65151383|NCT01293539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65151384|NCT01293539|Immunologic Factors|immunologic factors|mesh-ancestor
65151385|NCT01293539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151386|NCT01292837|Levetiracetam|levetiracetam|mesh-list
65151387|NCT01292837|Anticonvulsants|anticonvulsants|mesh-ancestor
65151388|NCT01292837|Nootropic Agents|nootropic agents|mesh-ancestor
65151389|NCT00965731|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65151390|NCT00965731|Crizotinib|crizotinib|mesh-list
65151391|NCT00965731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151392|NCT00965731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65151393|NCT00965731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151394|NCT00965731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151395|NCT03248479|Azacitidine|azacitidine|mesh-list
65151396|NCT03248479|Magrolimab|magrolimab|mesh-list
65151397|NCT03248479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65151398|NCT03248479|Antimetabolites|antimetabolites|mesh-ancestor
65151399|NCT03248479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151400|NCT03248479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151401|NCT03248479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151402|NCT03248479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65151403|NCT00630175|Zolpidem|zolpidem|mesh-list
65151404|NCT00630175|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65151405|NCT00630175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64948120|NCT04622553|Mexiletine|mexiletine|mesh-list
65151416|NCT00965575|Protective Agents|protective agents|mesh-ancestor
65151417|NCT00965575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151418|NCT00965575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65151419|NCT00965497|Citalopram|citalopram|mesh-list
65151420|NCT00965497|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65151421|NCT00965497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65151422|NCT00965497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65151423|NCT00965497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151424|NCT00965497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65151425|NCT00965497|Serotonin Agents|serotonin agents|mesh-ancestor
65151426|NCT00965497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151427|NCT00965497|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65151428|NCT00965497|Antidepressive Agents|antidepressive agents|mesh-ancestor
65151429|NCT00965497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65151430|NCT00963937|Sumatriptan|sumatriptan|mesh-list
65151431|NCT00963937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65151432|NCT00963937|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65151433|NCT00963937|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65151434|NCT00963937|Serotonin Agents|serotonin agents|mesh-ancestor
65151435|NCT00963937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65151436|NCT00963937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151437|NCT00963937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151438|NCT01170663|Paclitaxel|paclitaxel|mesh-list
65151439|NCT01170663|Ramucirumab|ramucirumab|mesh-list
65151440|NCT01170663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65151441|NCT01170663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151442|NCT01170663|Tubulin Modulators|tubulin modulators|mesh-ancestor
65151443|NCT01170663|Antimitotic Agents|antimitotic agents|mesh-ancestor
65151444|NCT01170663|Mitosis Modulators|mitosis modulators|mesh-ancestor
65151445|NCT01170663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151446|NCT04315155|Nivolumab|nivolumab|mesh-list
65151447|NCT04315155|Ipilimumab|ipilimumab|mesh-list
65151448|NCT04315155|Belinostat|belinostat|mesh-list
65151449|NCT04315155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65151450|NCT04315155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151451|NCT04315155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65151452|NCT04315155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151453|NCT04315155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65305443|NCT00653549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305444|NCT02642861|Cyclobenzaprine|cyclobenzaprine|mesh-list
65305445|NCT02642861|Calcium Carbonate|calcium carbonate|mesh-list
65305446|NCT02642861|Calcium|calcium|mesh-list
65305447|NCT02642861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65305448|NCT02642861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305449|NCT02642861|Antacids|antacids|mesh-ancestor
65305450|NCT02642861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305451|NCT02642861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65305452|NCT02642861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65305453|NCT02642861|Antidepressive Agents|antidepressive agents|mesh-ancestor
65305454|NCT02642861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65305455|NCT02642861|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65305456|NCT02642861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65305457|NCT02642861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65305458|NCT02642861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65305459|NCT02642861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65305460|NCT02641457|Ranibizumab|ranibizumab|mesh-list
65305461|NCT02641457|Aflibercept|aflibercept|mesh-list
64535404|NCT00535587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151454|NCT04315155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151455|NCT01170273|Vitamin D|vitamin d|mesh-list
65151456|NCT01170273|Vitamins|vitamins|mesh-ancestor
65151457|NCT01170273|Micronutrients|micronutrients|mesh-ancestor
65151458|NCT01170273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151459|NCT01170273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65151460|NCT01170039|Lubiprostone|lubiprostone|mesh-list
65151461|NCT01170039|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65151462|NCT01170039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65151463|NCT01170039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151464|NCT01286558|Amlodipine|amlodipine|mesh-list
65151465|NCT01286558|Telmisartan|telmisartan|mesh-list
65151466|NCT01286558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65151467|NCT01286558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65151468|NCT01286558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65151479|NCT01286168|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65151480|NCT01286168|Sodium Hypochlorite|sodium hypochlorite|mesh-list
65151481|NCT01286168|Eusol|eusol|mesh-list
65151482|NCT01286168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65151483|NCT01286168|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65151484|NCT01286168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65151485|NCT01286168|Disinfectants|disinfectants|mesh-ancestor
65151486|NCT01286168|Dermatologic Agents|dermatologic agents|mesh-ancestor
65151487|NCT05582096|Tirzepatide|tirzepatide|mesh-list
65151488|NCT05582096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65151489|NCT05582096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151490|NCT05582096|Incretins|incretins|mesh-ancestor
65151491|NCT05582096|Hormones|hormones|mesh-ancestor
65151492|NCT05582096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65151493|NCT02889692|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65151495|NCT02889692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151496|NCT02889692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65151497|NCT02889692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151498|NCT02889692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151499|NCT05569382|Verapamil|verapamil|mesh-list
65305462|NCT02641457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65305463|NCT02641457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65305464|NCT02641457|Growth Substances|growth substances|mesh-ancestor
65305465|NCT02641457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305466|NCT02641457|Growth Inhibitors|growth inhibitors|mesh-ancestor
65305467|NCT02641457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305468|NCT02642939|Mifepristone|mifepristone|mesh-list
65305469|NCT02642939|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65305470|NCT02642939|Abortifacient Agents|abortifacient agents|mesh-ancestor
65305471|NCT02642939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65305472|NCT02642939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151500|NCT05569382|Bisoprolol|bisoprolol|mesh-list
65151501|NCT05569382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65151502|NCT05569382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65151503|NCT05569382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65151504|NCT05569382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151505|NCT05569382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65151506|NCT05569382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151507|NCT05569382|Vasodilator Agents|vasodilator agents|mesh-ancestor
65151508|NCT05569382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65151509|NCT05569382|Sympatholytics|sympatholytics|mesh-ancestor
65151510|NCT05569382|Autonomic Agents|autonomic agents|mesh-ancestor
65151511|NCT05569382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65151512|NCT05569382|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65151513|NCT05569382|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65151514|NCT05569382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65151515|NCT05569382|Adrenergic Agents|adrenergic agents|mesh-ancestor
65151516|NCT05569382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65151517|NCT00963547|Trastuzumab|trastuzumab|mesh-list
65151518|NCT00963547|Lapatinib|lapatinib|mesh-list
65151519|NCT00963547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65151520|NCT00963547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151521|NCT00963547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65151522|NCT00963547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151523|NCT00963547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151524|NCT01285310|Thalidomide|thalidomide|mesh-list
65151525|NCT01285310|Apremilast|apremilast|mesh-list
65151526|NCT01285310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65151527|NCT01285310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65151528|NCT01285310|Analgesics|analgesics|mesh-ancestor
65151529|NCT01285310|Sensory System Agents|sensory system agents|mesh-ancestor
65151530|NCT01285310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64948236|NCT04490057|Bupropion|bupropion|mesh-list
65151539|NCT01285310|Immunologic Factors|immunologic factors|mesh-ancestor
65151540|NCT01285310|Leprostatic Agents|leprostatic agents|mesh-ancestor
65151541|NCT01285310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65151542|NCT01285310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65151543|NCT01285310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65151544|NCT01285310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65151545|NCT01285310|Growth Substances|growth substances|mesh-ancestor
65151546|NCT01285310|Growth Inhibitors|growth inhibitors|mesh-ancestor
65151547|NCT01285310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151548|NCT01254630|Vaccines|vaccines|mesh-list
65151549|NCT01254630|Immunologic Factors|immunologic factors|mesh-ancestor
65151550|NCT01254630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151551|NCT01253304|Dulaglutide|dulaglutide|mesh-list
65151552|NCT01253304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65151553|NCT01253304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151554|NCT04319484|Lenvatinib|lenvatinib|mesh-list
65151555|NCT04319484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151556|NCT04319484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65151557|NCT04319484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151558|NCT04319484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305473|NCT02642939|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65305474|NCT02642939|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65305475|NCT02642939|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65305476|NCT02642939|Contraceptive Agents|contraceptive agents|mesh-ancestor
65305477|NCT02642939|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65305478|NCT02642939|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65305479|NCT02642939|Hormone Antagonists|hormone antagonists|mesh-ancestor
65151559|NCT01253226|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65151560|NCT01253226|Immunologic Factors|immunologic factors|mesh-ancestor
65151561|NCT01253226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151562|NCT01252134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65151563|NCT00624312|Epoetin Alfa|epoetin alfa|mesh-list
65151564|NCT00624312|Hematinics|hematinics|mesh-ancestor
65151565|NCT01250418|Ketamine|ketamine|mesh-list
65151566|NCT01250418|Analgesics|analgesics|mesh-ancestor
64514554|NCT02986906|Glucocorticoids|glucocorticoids|mesh-ancestor
65151567|NCT01250418|Sensory System Agents|sensory system agents|mesh-ancestor
65151568|NCT01250418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65151569|NCT01250418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151570|NCT01250418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65151571|NCT01250418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65151572|NCT01250418|Anesthetics, General|anesthetics, general|mesh-ancestor
65151573|NCT01250418|Anesthetics|anesthetics|mesh-ancestor
65151574|NCT01250418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65151575|NCT01250418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65151576|NCT01250418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65151577|NCT01250418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65151578|NCT01250418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151579|NCT05494398|Acetylcysteine|acetylcysteine|mesh-list
65151580|NCT05494398|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65151581|NCT05494398|Antiviral Agents|antiviral agents|mesh-ancestor
65151582|NCT05494398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65151583|NCT05494398|Expectorants|expectorants|mesh-ancestor
65151584|NCT05494398|Respiratory System Agents|respiratory system agents|mesh-ancestor
65151585|NCT05494398|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65151586|NCT05494398|Antioxidants|antioxidants|mesh-ancestor
65151587|NCT05494398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151588|NCT05494398|Protective Agents|protective agents|mesh-ancestor
65151589|NCT05494398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151590|NCT05494398|Antidotes|antidotes|mesh-ancestor
65151591|NCT05491356|Plasminogen|plasminogen|mesh-list
65151592|NCT05491356|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65151593|NCT05491356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65151594|NCT05491356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65151595|NCT05491356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151618|NCT01292057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65151619|NCT01292057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151620|NCT01292057|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65151621|NCT01292057|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65151622|NCT01292057|Serotonin Agents|serotonin agents|mesh-ancestor
65151623|NCT01292057|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65151624|NCT01292057|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65151625|NCT01292057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65151626|NCT01292057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65151627|NCT01290887|Reslizumab|reslizumab|mesh-list
65151628|NCT01290887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65151629|NCT01290887|Respiratory System Agents|respiratory system agents|mesh-ancestor
65151630|NCT01290731|Interferons|interferons|mesh-list
65151631|NCT01290731|Ribavirin|ribavirin|mesh-list
65151632|NCT01290731|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65151633|NCT01290731|Simeprevir|simeprevir|mesh-list
65151634|NCT01290731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151635|NCT01290731|Antiviral Agents|antiviral agents|mesh-ancestor
65151636|NCT01290731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65151637|NCT01290731|Antimetabolites|antimetabolites|mesh-ancestor
65151638|NCT01290731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151639|NCT01290731|Protease Inhibitors|protease inhibitors|mesh-ancestor
65151640|NCT01290731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305480|NCT02642939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65305481|NCT02642939|Luteolytic Agents|luteolytic agents|mesh-ancestor
65305482|NCT02642939|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65305483|NCT02642939|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65305485|NCT02641301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65305486|NCT02641301|Narcotics|narcotics|mesh-ancestor
65305487|NCT02641301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65151641|NCT01290341|Naftifine|naftifine|mesh-list
65151642|NCT01290341|Antifungal Agents|antifungal agents|mesh-ancestor
65151643|NCT01290341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65151644|NCT01290263|Bevacizumab|bevacizumab|mesh-list
65151645|NCT01290263|Trebananib|trebananib|mesh-list
65151646|NCT01290263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65151647|NCT01290263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151648|NCT01290263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64948361|NCT04240106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65151660|NCT02890199|Bupivacaine|bupivacaine|mesh-list
65151661|NCT02890199|Anesthetics, Local|anesthetics, local|mesh-ancestor
65151662|NCT02890199|Anesthetics|anesthetics|mesh-ancestor
65151663|NCT02890199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65151664|NCT02890199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151665|NCT02890199|Sensory System Agents|sensory system agents|mesh-ancestor
65151666|NCT02890199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65151667|NCT02890199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65151668|NCT02890199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65151669|NCT02890199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65151670|NCT02890199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65151671|NCT02890199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151672|NCT01289639|Pioglitazone|pioglitazone|mesh-list
65151673|NCT01289639|Fenofibrate|fenofibrate|mesh-list
65151674|NCT01289639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65151675|NCT01289639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151676|NCT01289639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65151677|NCT01289639|Antimetabolites|antimetabolites|mesh-ancestor
65151678|NCT01289639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151679|NCT01289639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65151680|NCT01288937|Milnacipran|milnacipran|mesh-list
65151681|NCT01288937|Levomilnacipran|levomilnacipran|mesh-list
65151682|NCT01288937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65151683|NCT01288937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65151684|NCT01288937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65151685|NCT01288937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151686|NCT01288937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65151687|NCT01288937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151688|NCT01288937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65151689|NCT01288937|Analgesics|analgesics|mesh-ancestor
65151690|NCT01288937|Sensory System Agents|sensory system agents|mesh-ancestor
65151691|NCT01288937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65151692|NCT01288937|Antidepressive Agents|antidepressive agents|mesh-ancestor
65151693|NCT01288937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65151694|NCT01288469|Atorvastatin|atorvastatin|mesh-list
65151695|NCT01288469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65151696|NCT01288469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65151697|NCT01288469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65151698|NCT01288469|Antimetabolites|antimetabolites|mesh-ancestor
65151699|NCT01288469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151700|NCT01288469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65151701|NCT01288469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65151702|NCT01288469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151703|NCT01288469|Immunologic Factors|immunologic factors|mesh-ancestor
65151704|NCT01288469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151705|NCT01288079|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65151706|NCT01288079|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65151707|NCT01288079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65305488|NCT02641301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305489|NCT02641301|Analgesics|analgesics|mesh-ancestor
65305490|NCT02641301|Sensory System Agents|sensory system agents|mesh-ancestor
65305491|NCT02641301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65305492|NCT03679949|Oxycodone|oxycodone|mesh-list
65305493|NCT03679949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65305494|NCT03679949|Narcotics|narcotics|mesh-ancestor
65151708|NCT01288079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65151713|NCT01288079|Sensory System Agents|sensory system agents|mesh-ancestor
65151714|NCT01288079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65151715|NCT01288079|Antidepressive Agents|antidepressive agents|mesh-ancestor
65151717|NCT01288079|Dopamine Agents|dopamine agents|mesh-ancestor
65151718|NCT01287221|Riboflavin|riboflavin|mesh-list
65151719|NCT01287221|Rifampin|rifampin|mesh-list
65151721|NCT01287221|Micronutrients|micronutrients|mesh-ancestor
65151722|NCT01287221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151723|NCT01287221|Vitamin B Complex|vitamin b complex|mesh-ancestor
65151724|NCT01287221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65151725|NCT01287221|Antitubercular Agents|antitubercular agents|mesh-ancestor
65151726|NCT01287221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65151727|NCT01287221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65151728|NCT01287221|Leprostatic Agents|leprostatic agents|mesh-ancestor
65151729|NCT01287221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65151730|NCT01287221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151731|NCT01287221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151732|NCT01287221|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65151733|NCT01287221|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65151734|NCT01287221|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65151735|NCT01287221|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65151736|NCT01287221|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65151737|NCT01287221|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65151738|NCT01287221|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65151739|NCT01287221|Dermatologic Agents|dermatologic agents|mesh-ancestor
65151740|NCT05660213|Bevacizumab|bevacizumab|mesh-list
65151741|NCT05660213|Atezolizumab|atezolizumab|mesh-list
65151742|NCT05660213|Apatinib|apatinib|mesh-list
65151743|NCT05660213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65151744|NCT05660213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151745|NCT05660213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65151746|NCT05660213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65151747|NCT05660213|Growth Substances|growth substances|mesh-ancestor
65151748|NCT05660213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151749|NCT05660213|Growth Inhibitors|growth inhibitors|mesh-ancestor
65151750|NCT05660213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65151751|NCT05660213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151752|NCT05660213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151753|NCT01167153|Amlodipine|amlodipine|mesh-list
65151754|NCT01167153|Valsartan|valsartan|mesh-list
65151755|NCT01167153|Nifedipine|nifedipine|mesh-list
65151756|NCT01167153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65151757|NCT01167153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65151758|NCT01167153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65151759|NCT01167153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151760|NCT01167153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65151761|NCT01167153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151762|NCT01167153|Vasodilator Agents|vasodilator agents|mesh-ancestor
65151763|NCT01167153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65151764|NCT01167153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65151765|NCT01167153|Tocolytic Agents|tocolytic agents|mesh-ancestor
65151766|NCT01167153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65151767|NCT01166763|Vitamin D|vitamin d|mesh-list
65151768|NCT01166763|Cholecalciferol|cholecalciferol|mesh-list
65151769|NCT01166763|Vitamins|vitamins|mesh-ancestor
65151770|NCT01166763|Micronutrients|micronutrients|mesh-ancestor
65151771|NCT01166763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151772|NCT01166763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65151773|NCT01166763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65151774|NCT02885961|Dabigatran|dabigatran|mesh-list
65305495|NCT03679949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65305496|NCT03679949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305497|NCT03679949|Analgesics|analgesics|mesh-ancestor
65305498|NCT03679949|Sensory System Agents|sensory system agents|mesh-ancestor
65305499|NCT03679949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65305500|NCT02640989|Vaccines|vaccines|mesh-list
65305501|NCT02640989|Immunologic Factors|immunologic factors|mesh-ancestor
65305502|NCT02640989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305503|NCT02645747|Aflibercept|aflibercept|mesh-list
64964759|NCT00162799|Triflusal|triflusal|mesh-list
65151775|NCT02885961|Antithrombins|antithrombins|mesh-ancestor
65151776|NCT02885961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65151777|NCT02885961|Protease Inhibitors|protease inhibitors|mesh-ancestor
65151778|NCT02885961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151792|NCT00630097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65151793|NCT00630097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151795|NCT01165281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65151796|NCT01165281|Narcotics|narcotics|mesh-ancestor
65151797|NCT01165281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65151798|NCT01165281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151799|NCT01165281|Analgesics|analgesics|mesh-ancestor
65151800|NCT01165281|Sensory System Agents|sensory system agents|mesh-ancestor
65151801|NCT01165281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65151802|NCT02860897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65151803|NCT02860897|Estrogens|estrogens|mesh-ancestor
65151804|NCT02860897|Hormones|hormones|mesh-ancestor
65151805|NCT02860897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65151806|NCT02860897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151807|NCT02860819|Gemcitabine|gemcitabine|mesh-list
65151808|NCT02860819|Carboplatin|carboplatin|mesh-list
65151809|NCT02860819|Veliparib|veliparib|mesh-list
65151810|NCT02860819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151811|NCT02860819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65151812|NCT02860819|Antimetabolites|antimetabolites|mesh-ancestor
65151813|NCT02860819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151814|NCT02860819|Antiviral Agents|antiviral agents|mesh-ancestor
65151815|NCT02860819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65151816|NCT02860819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151817|NCT02860819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65151818|NCT02860819|Immunologic Factors|immunologic factors|mesh-ancestor
65151819|NCT02860819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151820|NCT02860819|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65151821|NCT04284007|Dexamethasone|dexamethasone|mesh-list
65151822|NCT04284007|Dexamethasone acetate|dexamethasone acetate|mesh-list
65151823|NCT04284007|Levobupivacaine|levobupivacaine|mesh-list
65151824|NCT04284007|BB 1101|bb 1101|mesh-list
65151825|NCT04284007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65151826|NCT04284007|Antiemetics|antiemetics|mesh-ancestor
65151827|NCT04284007|Autonomic Agents|autonomic agents|mesh-ancestor
65151828|NCT04284007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65151829|NCT04284007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151830|NCT04284007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65151831|NCT04284007|Glucocorticoids|glucocorticoids|mesh-ancestor
65151832|NCT04284007|Hormones|hormones|mesh-ancestor
65151833|NCT04284007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65151834|NCT04284007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65151835|NCT04284007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151836|NCT04284007|Protease Inhibitors|protease inhibitors|mesh-ancestor
65151861|NCT00960661|Insulin|insulin|mesh-list
65151862|NCT00960661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65151863|NCT00960661|Metformin|metformin|mesh-list
65151864|NCT00960661|Exenatide|exenatide|mesh-list
65151865|NCT00960661|Insulin Lispro|insulin lispro|mesh-list
65151866|NCT00960661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65151867|NCT00960661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151868|NCT00960661|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65151869|NCT00960661|Incretins|incretins|mesh-ancestor
65151870|NCT00960661|Hormones|hormones|mesh-ancestor
65305504|NCT02645747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65305505|NCT02645747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65305506|NCT02645747|Growth Substances|growth substances|mesh-ancestor
65305507|NCT02645747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305508|NCT02645747|Growth Inhibitors|growth inhibitors|mesh-ancestor
65305509|NCT02645747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305510|NCT00653237|Chlorhexidine|chlorhexidine|mesh-list
65305511|NCT00653237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65305512|NCT00653237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65305513|NCT00653237|Disinfectants|disinfectants|mesh-ancestor
65305514|NCT00653315|Tramadol|tramadol|mesh-list
65305515|NCT00653315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65305516|NCT00653315|Narcotics|narcotics|mesh-ancestor
65305517|NCT00653315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65305518|NCT00653315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305519|NCT00653315|Analgesics|analgesics|mesh-ancestor
65305520|NCT00653315|Sensory System Agents|sensory system agents|mesh-ancestor
65305521|NCT00653315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65305522|NCT02640833|Venetoclax|venetoclax|mesh-list
65305523|NCT02640833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305524|NCT00653393|Tranylcypromine|tranylcypromine|mesh-list
65305525|NCT00653393|Antidepressive Agents|antidepressive agents|mesh-ancestor
65305526|NCT00653393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65305527|NCT00653393|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65305528|NCT00653393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305529|NCT00653393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305530|NCT00653393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64535463|NCT01502371|Mometasone Furoate|mometasone furoate|mesh-list
65151871|NCT00960661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65151873|NCT00960193|Gout Suppressants|gout suppressants|mesh-ancestor
65151874|NCT00960193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65151875|NCT00960193|Tubulin Modulators|tubulin modulators|mesh-ancestor
65151876|NCT00960193|Antimitotic Agents|antimitotic agents|mesh-ancestor
65151877|NCT00960193|Mitosis Modulators|mitosis modulators|mesh-ancestor
65151878|NCT00960193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151879|NCT00960193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151880|NCT00960115|Cyclophosphamide|cyclophosphamide|mesh-list
65151881|NCT00960115|Immunologic Factors|immunologic factors|mesh-ancestor
65151882|NCT00960115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151883|NCT00960115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65151884|NCT00960115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65151885|NCT00960115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65151886|NCT00960115|Alkylating Agents|alkylating agents|mesh-ancestor
65151887|NCT00960115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151888|NCT00960115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151889|NCT00960115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65151893|NCT00959647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65305531|NCT00653393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65305532|NCT00653393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65305533|NCT00653393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305534|NCT02645903|Morphine|morphine|mesh-list
65305535|NCT02645903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65305536|NCT02645903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305537|NCT02645903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65305538|NCT02645903|Narcotics|narcotics|mesh-ancestor
65305539|NCT02645903|Analgesics|analgesics|mesh-ancestor
65305540|NCT02645903|Sensory System Agents|sensory system agents|mesh-ancestor
65305541|NCT02645903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65305542|NCT02645981|Sorafenib|sorafenib|mesh-list
65305543|NCT02645981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305544|NCT02645981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65305545|NCT02645981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305546|NCT02645981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305547|NCT02535767|Primaquine|primaquine|mesh-list
65305548|NCT02535767|Antimalarials|antimalarials|mesh-ancestor
65305549|NCT02535767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64964899|NCT00053339|Tamoxifen|tamoxifen|mesh-list
65151894|NCT00959647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65151895|NCT00959647|Growth Substances|growth substances|mesh-ancestor
65151896|NCT00959647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151897|NCT00959647|Growth Inhibitors|growth inhibitors|mesh-ancestor
65151899|NCT00957853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65151900|NCT00957853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151901|NCT02725567|Ivacaftor|ivacaftor|mesh-list
65151902|NCT02725567|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65151903|NCT02725567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65151904|NCT02725567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151905|NCT02859571|Oxytocin|oxytocin|mesh-list
65151906|NCT02859571|Oxytocics|oxytocics|mesh-ancestor
65151907|NCT02859571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65151908|NCT02859571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151909|NCT00956839|Vitamin D|vitamin d|mesh-list
65151910|NCT00956839|Ergocalciferols|ergocalciferols|mesh-list
65151911|NCT00956839|Cholecalciferol|cholecalciferol|mesh-list
65151912|NCT00956839|Vitamins|vitamins|mesh-list
65151913|NCT00956839|Micronutrients|micronutrients|mesh-ancestor
65151914|NCT00956839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151915|NCT00956839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65151916|NCT00956839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65151917|NCT00956293|Cyclosporine|cyclosporine|mesh-list
65151918|NCT00956293|Mycophenolic Acid|mycophenolic acid|mesh-list
65151919|NCT00956293|Everolimus|everolimus|mesh-list
65151920|NCT00956293|Cyclosporins|cyclosporins|mesh-list
65151921|NCT00956293|Basiliximab|basiliximab|mesh-list
65151922|NCT00956293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151923|NCT00956293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151924|NCT00956293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65151925|NCT00956293|Immunologic Factors|immunologic factors|mesh-ancestor
65151926|NCT00956293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151927|NCT00956293|Antifungal Agents|antifungal agents|mesh-ancestor
65151928|NCT00956293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65151929|NCT00956293|Dermatologic Agents|dermatologic agents|mesh-ancestor
65151930|NCT00956293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65151931|NCT00956293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65305550|NCT02535767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65305551|NCT02535767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65305552|NCT02640443|Sulfamethoxazole|sulfamethoxazole|mesh-list
65305553|NCT02640443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65055456|NCT00234962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65305554|NCT02640365|Leucovorin|leucovorin|mesh-list
65305555|NCT02640365|Bevacizumab|bevacizumab|mesh-list
65305556|NCT02640365|Irinotecan|irinotecan|mesh-list
65305557|NCT02640365|Camptothecin|camptothecin|mesh-list
65305558|NCT02640365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65305559|NCT02640365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305560|NCT02640365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65305561|NCT02640365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65305562|NCT02640365|Growth Substances|growth substances|mesh-ancestor
65305563|NCT02640365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305564|NCT02640365|Growth Inhibitors|growth inhibitors|mesh-ancestor
65305565|NCT02640365|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65305566|NCT02640365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65305567|NCT02640365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305568|NCT02640365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305570|NCT02640365|Protective Agents|protective agents|mesh-ancestor
65305571|NCT02640365|Vitamin B Complex|vitamin b complex|mesh-ancestor
65305572|NCT02640365|Vitamins|vitamins|mesh-ancestor
65305573|NCT02640365|Micronutrients|micronutrients|mesh-ancestor
65305574|NCT02640365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65305575|NCT02642003|Lenograstim|lenograstim|mesh-list
65305576|NCT02642003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65151932|NCT00956293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151933|NCT00956293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65151934|NCT00956293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65151935|NCT00956293|Antitubercular Agents|antitubercular agents|mesh-ancestor
65151936|NCT00956293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65151937|NCT04282291|Morphine|morphine|mesh-list
65151938|NCT04282291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65151939|NCT04282291|Narcotics|narcotics|mesh-ancestor
65151940|NCT04282291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65151941|NCT04282291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151942|NCT04282291|Analgesics|analgesics|mesh-ancestor
65151943|NCT04282291|Sensory System Agents|sensory system agents|mesh-ancestor
65151944|NCT04282291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65151945|NCT02859103|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65151946|NCT02859103|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65151947|NCT02859103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65151948|NCT02859103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65151949|NCT02859103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151950|NCT02859103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65151951|NCT02859103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151952|NCT02859103|Antidepressive Agents|antidepressive agents|mesh-ancestor
65151953|NCT02859103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65151954|NCT02869009|Aspirin|aspirin|mesh-list
65305577|NCT02642003|Immunologic Factors|immunologic factors|mesh-ancestor
65305578|NCT02642003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305579|NCT02641847|Gemcitabine|gemcitabine|mesh-list
65305580|NCT02641847|Cyclophosphamide|cyclophosphamide|mesh-list
65305581|NCT02641847|Docetaxel|docetaxel|mesh-list
65305582|NCT02641847|Doxorubicin|doxorubicin|mesh-list
65305583|NCT02641847|Epirubicin|epirubicin|mesh-list
65305584|NCT02641847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65305585|NCT02641847|Immunologic Factors|immunologic factors|mesh-ancestor
65305586|NCT02641847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151955|NCT02869009|Clopidogrel|clopidogrel|mesh-list
65151956|NCT02869009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65151957|NCT02869009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65151958|NCT02869009|Analgesics|analgesics|mesh-ancestor
65151959|NCT02869009|Sensory System Agents|sensory system agents|mesh-ancestor
65151960|NCT02869009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65151961|NCT02869009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151971|NCT02869009|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65151972|NCT02869009|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65151973|NCT02869009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65151974|NCT02869009|Purinergic Agents|purinergic agents|mesh-ancestor
65151975|NCT02869009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65151976|NCT01164579|Methotrexate|methotrexate|mesh-list
65151977|NCT01164579|Tofacitinib|tofacitinib|mesh-list
65151978|NCT01164579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65151979|NCT01164579|Abortifacient Agents|abortifacient agents|mesh-ancestor
65151980|NCT01164579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65151981|NCT01164579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151982|NCT01164579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65151983|NCT01164579|Antimetabolites|antimetabolites|mesh-ancestor
65151984|NCT01164579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151985|NCT01164579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151986|NCT01164579|Dermatologic Agents|dermatologic agents|mesh-ancestor
65151987|NCT01164579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151988|NCT01164579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65151989|NCT01164579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65151990|NCT01164579|Immunologic Factors|immunologic factors|mesh-ancestor
65151991|NCT01164579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65151992|NCT01164579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65151993|NCT01164579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65151994|NCT02859259|Fostemsavir|fostemsavir|mesh-list
65151995|NCT02859259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65151996|NCT02859259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65151997|NCT02859259|Antiviral Agents|antiviral agents|mesh-ancestor
65151998|NCT02859259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65151999|NCT02859259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65152000|NCT02859259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65152001|NCT02859259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152002|NCT02530489|Paclitaxel|paclitaxel|mesh-list
65152003|NCT02530489|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65152004|NCT02530489|Atezolizumab|atezolizumab|mesh-list
65152005|NCT02530489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65152006|NCT02530489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65152007|NCT02530489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152008|NCT02530489|Tubulin Modulators|tubulin modulators|mesh-ancestor
65152009|NCT02530489|Antimitotic Agents|antimitotic agents|mesh-ancestor
65152010|NCT02530489|Mitosis Modulators|mitosis modulators|mesh-ancestor
65152011|NCT02530489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152012|NCT02530489|Immunologic Factors|immunologic factors|mesh-ancestor
65152013|NCT02530489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152014|NCT02857777|Esketamine|esketamine|mesh-list
65152015|NCT02857777|Antidepressive Agents|antidepressive agents|mesh-ancestor
65152016|NCT02857777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65152017|NCT00630643|Muromonab-CD3|muromonab-cd3|mesh-list
65152018|NCT00630643|Immunologic Factors|immunologic factors|mesh-ancestor
65152019|NCT00630643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152021|NCT03202849|Vitamin D|vitamin d|mesh-list
65305587|NCT02641847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65305588|NCT02641847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65305589|NCT02641847|Alkylating Agents|alkylating agents|mesh-ancestor
65305590|NCT02641847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305591|NCT02641847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305592|NCT02641847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65305593|NCT02641847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65305594|NCT02641847|Antimetabolites|antimetabolites|mesh-ancestor
65305595|NCT02641847|Antiviral Agents|antiviral agents|mesh-ancestor
65305596|NCT02641847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65305597|NCT02641847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305598|NCT02641847|Tubulin Modulators|tubulin modulators|mesh-ancestor
65305599|NCT02641847|Antimitotic Agents|antimitotic agents|mesh-ancestor
65305600|NCT02641847|Mitosis Modulators|mitosis modulators|mesh-ancestor
65305601|NCT02641847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65305602|NCT02641847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65305603|NCT02641847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65305604|NCT00599027|Mometasone Furoate|mometasone furoate|mesh-list
65152022|NCT03202849|Ergocalciferols|ergocalciferols|mesh-list
65152023|NCT03202849|Cholecalciferol|cholecalciferol|mesh-list
65152024|NCT03202849|Vitamins|vitamins|mesh-list
65152025|NCT03202849|Micronutrients|micronutrients|mesh-ancestor
65152026|NCT03202849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152027|NCT03202849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64948726|NCT03323463|Immunologic Factors|immunologic factors|mesh-ancestor
65152046|NCT01246986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65152047|NCT01246986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152048|NCT01246986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152049|NCT01164501|Empagliflozin|empagliflozin|mesh-list
65152050|NCT01164501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65152051|NCT01164501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152052|NCT01164501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65152053|NCT01164501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152054|NCT01163721|Ranolazine|ranolazine|mesh-list
65152055|NCT01163721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65152056|NCT01163721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65152057|NCT01163721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152058|NCT03150511|Tesamorelin|tesamorelin|mesh-list
65152059|NCT03150511|Growth Substances|growth substances|mesh-ancestor
65152060|NCT03150511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152061|NCT00958243|Vaccines|vaccines|mesh-list
65152062|NCT00958243|Immunologic Factors|immunologic factors|mesh-ancestor
65152063|NCT00958243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152064|NCT01241760|Interferons|interferons|mesh-list
65152065|NCT01241760|Ribavirin|ribavirin|mesh-list
65152066|NCT01241760|Interferon-alpha|interferon-alpha|mesh-list
65152067|NCT01241760|Interferon alpha-2|interferon alpha-2|mesh-list
65152068|NCT01241760|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65152069|NCT01241760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152070|NCT01241760|Antiviral Agents|antiviral agents|mesh-ancestor
65152071|NCT01241760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65152072|NCT01241760|Antimetabolites|antimetabolites|mesh-ancestor
65152073|NCT01241760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152074|NCT01241760|Immunologic Factors|immunologic factors|mesh-ancestor
65152075|NCT01241760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152076|NCT04280263|Caffeine|caffeine|mesh-list
65305605|NCT00599027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65305606|NCT00599027|Dermatologic Agents|dermatologic agents|mesh-ancestor
65305607|NCT00599027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65305608|NCT00652379|Octreotide|octreotide|mesh-list
65305609|NCT00652379|Lanreotide|lanreotide|mesh-list
65305610|NCT00652379|Somatostatin|somatostatin|mesh-list
65305611|NCT00652379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65305612|NCT00652379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65305613|NCT00652379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305614|NCT00652379|Hormones|hormones|mesh-ancestor
65305615|NCT00652379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65305616|NCT00652379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305617|NCT04164797|Endostar protein|endostar protein|mesh-list
65305618|NCT04164797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65305619|NCT04164797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65305620|NCT04164797|Growth Substances|growth substances|mesh-ancestor
65305621|NCT04164797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305622|NCT04164797|Growth Inhibitors|growth inhibitors|mesh-ancestor
65305623|NCT04164797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305624|NCT00654017|Sildenafil Citrate|sildenafil citrate|mesh-list
65305625|NCT00654017|Vasodilator Agents|vasodilator agents|mesh-ancestor
65305626|NCT00654017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65305627|NCT00654017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65305628|NCT00654017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305629|NCT00654017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305630|NCT00654017|Urological Agents|urological agents|mesh-ancestor
65305631|NCT02639819|Aminocaproic Acid|aminocaproic acid|mesh-list
65305632|NCT02639819|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65305633|NCT02639819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65305634|NCT02639819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152077|NCT04280263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65152078|NCT04280263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152079|NCT04280263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65152080|NCT04280263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152081|NCT04280263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152082|NCT04280263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65152083|NCT04280263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65152084|NCT04280263|Purinergic Agents|purinergic agents|mesh-ancestor
65152099|NCT02140255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65152100|NCT02140255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65152101|NCT02140255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65305635|NCT02639819|Hemostatics|hemostatics|mesh-ancestor
65305636|NCT02639819|Coagulants|coagulants|mesh-ancestor
65305637|NCT02639741|Vitamins|vitamins|mesh-list
65305638|NCT02639741|Ascorbic Acid|ascorbic acid|mesh-list
65305639|NCT02639741|Melatonin|melatonin|mesh-list
65152102|NCT02140255|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65152103|NCT02140255|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65152104|NCT02140255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65152105|NCT02140255|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65152106|NCT02140255|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65152107|NCT00953329|Alefacept|alefacept|mesh-list
65152108|NCT00953329|Dermatologic Agents|dermatologic agents|mesh-ancestor
65152109|NCT00953329|Immunologic Factors|immunologic factors|mesh-ancestor
65152110|NCT00953329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152111|NCT02857153|Urapidil|urapidil|mesh-list
65152112|NCT02857153|Phenylephrine|phenylephrine|mesh-list
65152113|NCT02857153|Oxymetazoline|oxymetazoline|mesh-list
65152114|NCT02857153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65152115|NCT02857153|Mydriatics|mydriatics|mesh-ancestor
65152116|NCT02857153|Autonomic Agents|autonomic agents|mesh-ancestor
65152117|NCT02857153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65152118|NCT02857153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152119|NCT02857153|Sympathomimetics|sympathomimetics|mesh-ancestor
65152120|NCT02857153|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65152121|NCT02857153|Nasal Decongestants|nasal decongestants|mesh-ancestor
65152122|NCT02857153|Respiratory System Agents|respiratory system agents|mesh-ancestor
65152123|NCT02857153|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65152124|NCT02857153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65152125|NCT02857153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65152126|NCT02857153|Adrenergic Agents|adrenergic agents|mesh-ancestor
65152127|NCT02857153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65152128|NCT02857153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152129|NCT02857153|Protective Agents|protective agents|mesh-ancestor
65152130|NCT02857153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65152131|NCT02857153|Vasodilator Agents|vasodilator agents|mesh-ancestor
65152132|NCT02857153|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65152133|NCT02857153|Serotonin Agents|serotonin agents|mesh-ancestor
65152134|NCT02857153|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65152135|NCT02857153|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65152136|NCT02857153|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65152137|NCT00953017|Bisacodyl|bisacodyl|mesh-list
65152138|NCT00953017|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65152139|NCT00953017|Lubiprostone|lubiprostone|mesh-list
65152140|NCT00953017|Cathartics|cathartics|mesh-ancestor
65152141|NCT00953017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65152142|NCT00953017|Laxatives|laxatives|mesh-ancestor
65152143|NCT00953017|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65152144|NCT00953017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65152145|NCT00953017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152162|NCT00955279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65152163|NCT00955279|Immunologic Factors|immunologic factors|mesh-ancestor
65152164|NCT00955279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152165|NCT02857309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65152166|NCT02857309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
65152167|NCT02857309|Mineralocorticoids|mineralocorticoids|mesh-list
65152168|NCT02857309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794733|NCT02243124|Antiemetics|antiemetics|mesh-ancestor
65152169|NCT02857309|Hormone Antagonists|hormone antagonists|mesh-ancestor
65152170|NCT02857309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65152171|NCT02857309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152172|NCT02857309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65152173|NCT02857309|Diuretics|diuretics|mesh-ancestor
65152174|NCT02857309|Natriuretic Agents|natriuretic agents|mesh-ancestor
65152176|NCT04261231|Anesthetics|anesthetics|mesh-list
65152177|NCT04261231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65152178|NCT04261231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152179|NCT02857465|Dexamethasone|dexamethasone|mesh-list
65152180|NCT02857465|Dexamethasone acetate|dexamethasone acetate|mesh-list
65152181|NCT02857465|Sufentanil|sufentanil|mesh-list
65152183|NCT02857465|Ropivacaine|ropivacaine|mesh-list
65152184|NCT02857465|BB 1101|bb 1101|mesh-list
65152185|NCT02857465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65152186|NCT02857465|Antiemetics|antiemetics|mesh-ancestor
65305640|NCT02639741|Micronutrients|micronutrients|mesh-ancestor
65305641|NCT02639741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305642|NCT02639741|Antioxidants|antioxidants|mesh-ancestor
65305643|NCT02639741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305644|NCT02639741|Protective Agents|protective agents|mesh-ancestor
65305645|NCT02639741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65305646|NCT04164719|Cyclobenzaprine|cyclobenzaprine|mesh-list
65152187|NCT02857465|Autonomic Agents|autonomic agents|mesh-ancestor
65152188|NCT02857465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65152189|NCT02857465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152190|NCT02857465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65152191|NCT02857465|Glucocorticoids|glucocorticoids|mesh-ancestor
65152192|NCT02857465|Hormones|hormones|mesh-ancestor
65152193|NCT02857465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65152194|NCT02857465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65152195|NCT02857465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152196|NCT02857465|Protease Inhibitors|protease inhibitors|mesh-ancestor
65152197|NCT02857465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152198|NCT02857465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152199|NCT02857465|Anesthetics, Local|anesthetics, local|mesh-ancestor
65152200|NCT02857465|Anesthetics|anesthetics|mesh-ancestor
65152201|NCT02857465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65152202|NCT02857465|Sensory System Agents|sensory system agents|mesh-ancestor
65152203|NCT02857465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64948914|NCT02531126|Ozanimod|ozanimod|mesh-list
65152215|NCT04206618|Teriparatide|teriparatide|mesh-list
65152216|NCT04206618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65152217|NCT04206618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152218|NCT04206618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65152219|NCT01239732|Paclitaxel|paclitaxel|mesh-list
65152220|NCT01239732|Bevacizumab|bevacizumab|mesh-list
65152221|NCT01239732|Carboplatin|carboplatin|mesh-list
65152222|NCT01239732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65152223|NCT01239732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152224|NCT01239732|Tubulin Modulators|tubulin modulators|mesh-ancestor
65152225|NCT01239732|Antimitotic Agents|antimitotic agents|mesh-ancestor
65152226|NCT01239732|Mitosis Modulators|mitosis modulators|mesh-ancestor
65152227|NCT01239732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152228|NCT01239732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65152229|NCT01239732|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65152230|NCT01239732|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65152231|NCT01239732|Growth Substances|growth substances|mesh-ancestor
65152232|NCT01239732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152233|NCT01239732|Growth Inhibitors|growth inhibitors|mesh-ancestor
65152234|NCT02856919|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65152235|NCT02856919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65152236|NCT02856919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65152237|NCT02856919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65152239|NCT02856919|Adrenergic Agents|adrenergic agents|mesh-ancestor
65152240|NCT02856919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65152241|NCT02856919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152242|NCT02856919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794805|NCT02244294|Urological Agents|urological agents|mesh-ancestor
65152243|NCT00947011|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65152244|NCT00947011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65152245|NCT00947011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152246|NCT00947011|Incretins|incretins|mesh-ancestor
65152247|NCT00947011|Hormones|hormones|mesh-ancestor
65152248|NCT00947011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65152249|NCT00947011|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65152250|NCT00947011|Protease Inhibitors|protease inhibitors|mesh-ancestor
65152251|NCT00947011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152252|NCT00947011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152253|NCT02856685|Mitoxantrone|mitoxantrone|mesh-list
65152254|NCT02856685|Analgesics|analgesics|mesh-ancestor
65152255|NCT02856685|Sensory System Agents|sensory system agents|mesh-ancestor
65305647|NCT04164719|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65305648|NCT04164719|Antidepressive Agents|antidepressive agents|mesh-ancestor
65305649|NCT04164719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65305650|NCT04164719|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65305651|NCT04164719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305652|NCT04164719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65305653|NCT04164719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65305654|NCT04164719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65305655|NCT04164719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65305656|NCT01149083|Carboplatin|carboplatin|mesh-list
65305657|NCT01149083|Veliparib|veliparib|mesh-list
64535565|NCT00536601|Carmustine|carmustine|mesh-list
65152256|NCT02856685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65152257|NCT02856685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152258|NCT02856685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152259|NCT02856685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65152260|NCT02856685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65152261|NCT02856685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152262|NCT02856685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152263|NCT01962415|Fludarabine|fludarabine|mesh-list
65152264|NCT01962415|Melphalan|melphalan|mesh-list
65152265|NCT01962415|Alemtuzumab|alemtuzumab|mesh-list
65152266|NCT01962415|Thiotepa|thiotepa|mesh-list
65152267|NCT01962415|Hydroxyurea|hydroxyurea|mesh-list
65152268|NCT01962415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503321|NCT00709098|Vasodilator Agents|vasodilator agents|mesh-ancestor
65152301|NCT02853799|Insulin|insulin|mesh-list
65152302|NCT02853799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65152303|NCT02853799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152304|NCT01236534|Lubiprostone|lubiprostone|mesh-list
65152305|NCT01236534|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65152306|NCT01236534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64514560|NCT05658562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152307|NCT01236534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152308|NCT01235598|Certolizumab Pegol|certolizumab pegol|mesh-list
65152312|NCT01235598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65152314|NCT01235442|Clobetasol|clobetasol|mesh-list
65152315|NCT01235442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65152316|NCT01235442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64794900|NCT02248428|Hormones|hormones|mesh-ancestor
65152317|NCT01235442|Analgesics|analgesics|mesh-ancestor
65152318|NCT01235442|Sensory System Agents|sensory system agents|mesh-ancestor
65152319|NCT01235442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65152320|NCT01235442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152321|NCT01235442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65152323|NCT01235442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65152324|NCT01235442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65152325|NCT01235442|Immunologic Factors|immunologic factors|mesh-ancestor
65152326|NCT01235442|Glucocorticoids|glucocorticoids|mesh-ancestor
65152327|NCT01235442|Hormones|hormones|mesh-ancestor
65152328|NCT01235442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65152329|NCT01163253|Tofacitinib|tofacitinib|mesh-list
65152330|NCT01163253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65152331|NCT01163253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152332|NCT01163253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152333|NCT01162863|Lubiprostone|lubiprostone|mesh-list
65152334|NCT01162863|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65152335|NCT01162863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65152336|NCT01162863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152337|NCT05304039|Nitric Oxide|nitric oxide|mesh-list
65152338|NCT05304039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65152339|NCT05304039|Autonomic Agents|autonomic agents|mesh-ancestor
65152340|NCT05304039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65152341|NCT05304039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305658|NCT01149083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305659|NCT01149083|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65305660|NCT01149083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305661|NCT01149083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305662|NCT00654173|Atorvastatin|atorvastatin|mesh-list
65305663|NCT00654173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65305664|NCT00654173|Simvastatin|simvastatin|mesh-list
65305665|NCT00654173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65305666|NCT00654173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65305667|NCT00654173|Antimetabolites|antimetabolites|mesh-ancestor
65305668|NCT00654173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305669|NCT00654173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65152342|NCT05304039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65152343|NCT05304039|Respiratory System Agents|respiratory system agents|mesh-ancestor
65152344|NCT05304039|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65152345|NCT05304039|Antioxidants|antioxidants|mesh-ancestor
65152346|NCT05304039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152347|NCT05304039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65152348|NCT05304039|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65152349|NCT05304039|Vasodilator Agents|vasodilator agents|mesh-ancestor
65152350|NCT05304039|Gasotransmitters|gasotransmitters|mesh-ancestor
65152351|NCT05304039|Protective Agents|protective agents|mesh-ancestor
65152352|NCT01162473|Caseins|caseins|mesh-list
65152353|NCT01162473|Chelating Agents|chelating agents|mesh-ancestor
65152354|NCT01162473|Sequestering Agents|sequestering agents|mesh-ancestor
65152355|NCT01162473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152356|NCT01162239|Varenicline|varenicline|mesh-list
65152357|NCT01162239|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65152358|NCT01162239|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65152359|NCT01162239|Cholinergic Agents|cholinergic agents|mesh-ancestor
65152360|NCT01162239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65152361|NCT01162239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152362|NCT01162239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152363|NCT01161537|Ivacaftor|ivacaftor|mesh-list
65152364|NCT01161537|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65152365|NCT01161537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65152366|NCT01161537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152367|NCT04314297|Durvalumab|durvalumab|mesh-list
65152368|NCT04314297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65152369|NCT04314297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152370|NCT04124133|Hyaluronic Acid|hyaluronic acid|mesh-list
65152371|NCT04124133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65152372|NCT04124133|Immunologic Factors|immunologic factors|mesh-ancestor
65152373|NCT04124133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152374|NCT04124133|Viscosupplements|viscosupplements|mesh-ancestor
65152375|NCT04124133|Protective Agents|protective agents|mesh-ancestor
65152376|NCT01233258|Factor VIII|factor viii|mesh-list
65152377|NCT01233258|Coagulants|coagulants|mesh-ancestor
65152378|NCT01232790|Acetylcysteine|acetylcysteine|mesh-list
65152379|NCT01232790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65152380|NCT01232790|Antiviral Agents|antiviral agents|mesh-ancestor
65152381|NCT01232790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65152385|NCT01232790|Antioxidants|antioxidants|mesh-ancestor
65152386|NCT01232790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152387|NCT01232790|Protective Agents|protective agents|mesh-ancestor
65152388|NCT01232790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152389|NCT01232790|Antidotes|antidotes|mesh-ancestor
65152390|NCT01232556|Gemcitabine|gemcitabine|mesh-list
65152391|NCT01232556|Rituximab|rituximab|mesh-list
65152392|NCT01232556|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65152393|NCT01232556|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65152394|NCT01232556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65152395|NCT01232556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305670|NCT00654173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65305671|NCT00654173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305672|NCT02645279|Midazolam|midazolam|mesh-list
65305673|NCT02645279|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65305674|NCT02645279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65305675|NCT02645279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65305676|NCT02645279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305677|NCT02645279|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65305678|NCT02645279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65305679|NCT02645279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65305680|NCT02645279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65305681|NCT02645279|Anesthetics, General|anesthetics, general|mesh-ancestor
65305682|NCT02645279|Anesthetics|anesthetics|mesh-ancestor
65305683|NCT02645279|GABA Modulators|gaba modulators|mesh-ancestor
65305684|NCT02645279|GABA Agents|gaba agents|mesh-ancestor
65305685|NCT02645279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65152396|NCT01232556|Immunologic Factors|immunologic factors|mesh-ancestor
65152397|NCT01232556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152398|NCT01232556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65152399|NCT01232556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65152400|NCT01232556|Antimetabolites|antimetabolites|mesh-ancestor
65152401|NCT01232556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152402|NCT01232556|Antiviral Agents|antiviral agents|mesh-ancestor
65152403|NCT01232556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65152404|NCT01232556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152405|NCT01232556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65152406|NCT01232556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65152407|NCT01232556|Alkylating Agents|alkylating agents|mesh-ancestor
65152408|NCT01232556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65152409|NCT00946153|Lenvatinib|lenvatinib|mesh-list
65152410|NCT00946153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152411|NCT00946153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65152412|NCT00946153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152413|NCT00946153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152414|NCT01914367|Vaccines|vaccines|mesh-list
65152415|NCT01914367|Immunologic Factors|immunologic factors|mesh-ancestor
65152416|NCT01914367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152417|NCT01160289|Tadalafil|tadalafil|mesh-list
65152418|NCT01160289|Vasodilator Agents|vasodilator agents|mesh-ancestor
65152419|NCT01160289|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65152420|NCT01160289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65152421|NCT01160289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152422|NCT01160289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152423|NCT01160289|Urological Agents|urological agents|mesh-ancestor
65152424|NCT01159665|Plasminogen|plasminogen|mesh-list
65152425|NCT01159665|Fibrinolysin|fibrinolysin|mesh-list
65152426|NCT01159665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65152427|NCT01159665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65152428|NCT01159665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152429|NCT01158261|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65152430|NCT01158261|Hemostatics|hemostatics|mesh-ancestor
65152431|NCT01158261|Coagulants|coagulants|mesh-ancestor
65152432|NCT01157169|Buprenorphine|buprenorphine|mesh-list
65152433|NCT01157169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65152434|NCT01157169|Narcotics|narcotics|mesh-ancestor
65152435|NCT01157169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65152436|NCT01157169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152437|NCT01157169|Analgesics|analgesics|mesh-ancestor
65152438|NCT01157169|Sensory System Agents|sensory system agents|mesh-ancestor
65152439|NCT01157169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65305686|NCT02645279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305687|NCT04164329|Anesthetics|anesthetics|mesh-list
65305688|NCT04164329|Anesthetics, General|anesthetics, general|mesh-list
65305689|NCT04164329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65305690|NCT04164329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305691|NCT02639039|Cortisone|cortisone|mesh-list
65305692|NCT02639039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65305693|NCT00655265|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65305694|NCT00655265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65305695|NCT00655265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65305696|NCT00655265|Antimetabolites|antimetabolites|mesh-ancestor
65305697|NCT00655265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305698|NCT00655265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65305699|NCT02562664|Metformin|metformin|mesh-list
65305700|NCT02562664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65305701|NCT02562664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305702|NCT00654407|Atorvastatin|atorvastatin|mesh-list
65305703|NCT00654407|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65305704|NCT00654407|Simvastatin|simvastatin|mesh-list
65305705|NCT00654407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65305706|NCT00654407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65305707|NCT00654407|Antimetabolites|antimetabolites|mesh-ancestor
65152440|NCT01157169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65152441|NCT04313907|Clonazepam|clonazepam|mesh-list
65152442|NCT04313907|Anticonvulsants|anticonvulsants|mesh-ancestor
65152443|NCT04313907|GABA Modulators|gaba modulators|mesh-ancestor
65152444|NCT04313907|GABA Agents|gaba agents|mesh-ancestor
65152445|NCT04313907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65152446|NCT04313907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152447|NCT04313907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152448|NCT01231620|Oseltamivir|oseltamivir|mesh-list
65152449|NCT01231620|Zanamivir|zanamivir|mesh-list
65152450|NCT01231620|Antiviral Agents|antiviral agents|mesh-ancestor
65152451|NCT01231620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65152452|NCT01231620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152453|NCT01231620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152454|NCT01809691|Bicalutamide|bicalutamide|mesh-list
65152455|NCT01809691|Androgen Antagonists|androgen antagonists|mesh-ancestor
65152469|NCT01231464|Dermatologic Agents|dermatologic agents|mesh-ancestor
65152470|NCT01231464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65152472|NCT01156311|Dermatologic Agents|dermatologic agents|mesh-ancestor
65152473|NCT01156311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65152474|NCT01156311|Immunologic Factors|immunologic factors|mesh-ancestor
65152475|NCT01156311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152476|NCT04281745|Botulinum Toxins|botulinum toxins|mesh-list
65152477|NCT04281745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65152478|NCT04281745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65152479|NCT04281745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65152480|NCT04281745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65152481|NCT04281745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152482|NCT04281745|Cholinergic Agents|cholinergic agents|mesh-ancestor
65152483|NCT04281745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65152484|NCT04281745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152485|NCT04281745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65305708|NCT00654407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305709|NCT00654407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65305710|NCT00654407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65305711|NCT00654407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305712|NCT00691054|Paclitaxel|paclitaxel|mesh-list
65305713|NCT00691054|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65305714|NCT00691054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65305715|NCT00691054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305716|NCT00691054|Tubulin Modulators|tubulin modulators|mesh-ancestor
65305717|NCT00691054|Antimitotic Agents|antimitotic agents|mesh-ancestor
65305718|NCT00691054|Mitosis Modulators|mitosis modulators|mesh-ancestor
65305719|NCT00691054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305720|NCT00598871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65305721|NCT00598871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65305722|NCT00744406|Sertraline|sertraline|mesh-list
65305723|NCT00744406|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65305724|NCT00744406|Antidepressive Agents|antidepressive agents|mesh-list
65305725|NCT00744406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65305726|NCT00744406|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65305727|NCT00744406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65305728|NCT00744406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65305729|NCT00744406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305730|NCT00744406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65305731|NCT00744406|Serotonin Agents|serotonin agents|mesh-ancestor
65305732|NCT00744406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152486|NCT04281745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65152488|NCT01155531|Telenzepine|telenzepine|mesh-list
65152489|NCT01155531|Antidepressive Agents|antidepressive agents|mesh-ancestor
65152490|NCT01155531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65152491|NCT01155531|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65152492|NCT01155531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65152493|NCT01155531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65152494|NCT01155531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152495|NCT01155531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65152496|NCT01155531|Serotonin Agents|serotonin agents|mesh-ancestor
65152497|NCT01155531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152498|NCT01155531|Parasympatholytics|parasympatholytics|mesh-ancestor
65152499|NCT01155531|Autonomic Agents|autonomic agents|mesh-ancestor
65152500|NCT01155531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65152501|NCT01155219|Latanoprost|latanoprost|mesh-list
65152502|NCT01155219|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65152503|NCT01155219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65152504|NCT01098955|Varenicline|varenicline|mesh-list
65152505|NCT01098955|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65152506|NCT01098955|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65152507|NCT01098955|Cholinergic Agents|cholinergic agents|mesh-ancestor
65152508|NCT01098955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65305733|NCT00744406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65305734|NCT00744406|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65305735|NCT00690820|Pancrelipase|pancrelipase|mesh-list
65305736|NCT00690820|Pancreatin|pancreatin|mesh-list
65305737|NCT00690820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65305738|NCT02562508|Vaccines|vaccines|mesh-list
65305739|NCT02562508|Immunologic Factors|immunologic factors|mesh-ancestor
65305740|NCT02562508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305741|NCT00689338|Fluconazole|fluconazole|mesh-list
65305742|NCT00689338|Voriconazole|voriconazole|mesh-list
65305743|NCT00689338|Anidulafungin|anidulafungin|mesh-list
65305744|NCT00689338|Antifungal Agents|antifungal agents|mesh-ancestor
65305745|NCT00689338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65305746|NCT00689338|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65305747|NCT00689338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65305748|NCT00689338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305749|NCT00689338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152509|NCT01098955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152510|NCT01098955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152511|NCT00631033|Metformin|metformin|mesh-list
65152512|NCT00631033|Diazoxide|diazoxide|mesh-list
65152513|NCT00631033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65152514|NCT00631033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152515|NCT00631033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65152516|NCT00631033|Vasodilator Agents|vasodilator agents|mesh-ancestor
65152517|NCT01155063|Exemestane|exemestane|mesh-list
65152535|NCT01154673|Raltegravir Potassium|raltegravir potassium|mesh-list
65152536|NCT01154673|Maraviroc|maraviroc|mesh-list
65152537|NCT01154673|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65152538|NCT01154673|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65152539|NCT01154673|Protease Inhibitors|protease inhibitors|mesh-ancestor
65152540|NCT01154673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152541|NCT01154673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152542|NCT01154673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65152543|NCT01154673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65152544|NCT01154673|Antiviral Agents|antiviral agents|mesh-ancestor
65152545|NCT01154673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65152546|NCT01154673|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65152547|NCT01154673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65152548|NCT01154673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65152549|NCT01154673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65152550|NCT01154673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65152551|NCT01154673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65152552|NCT01154673|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65152553|NCT01154673|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65152554|NCT01154673|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65152556|NCT02884713|Levofloxacin|levofloxacin|mesh-list
65152557|NCT02884713|Ofloxacin|ofloxacin|mesh-list
65152558|NCT02884713|Esomeprazole|esomeprazole|mesh-list
65152559|NCT02884713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65152560|NCT02884713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65152561|NCT02884713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65152562|NCT02884713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152563|NCT02884713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152564|NCT02884713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65152565|NCT02884713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65152566|NCT02884713|Antimalarials|antimalarials|mesh-ancestor
65152567|NCT02884713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65152568|NCT02884713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65305750|NCT00689338|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65305751|NCT00689338|Hormone Antagonists|hormone antagonists|mesh-ancestor
65305752|NCT00689338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65305753|NCT00689338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305754|NCT00689338|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65305755|NCT00689338|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65305756|NCT00689338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65305757|NCT00686998|Olanzapine|olanzapine|mesh-list
65305758|NCT00686998|Antiemetics|antiemetics|mesh-ancestor
65305759|NCT00686998|Autonomic Agents|autonomic agents|mesh-ancestor
65305760|NCT00686998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65305761|NCT00686998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305762|NCT00686998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65305763|NCT00686998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65305764|NCT00686998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65305765|NCT00686998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65305766|NCT00686998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65305767|NCT00686998|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65305768|NCT00686998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65305769|NCT00686998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65305770|NCT00686998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305771|NCT00686998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65305772|NCT00686998|Serotonin Agents|serotonin agents|mesh-ancestor
65305773|NCT00744640|Gemcitabine|gemcitabine|mesh-list
65305774|NCT00744640|Capecitabine|capecitabine|mesh-list
65305775|NCT00744640|Oxaliplatin|oxaliplatin|mesh-list
65305776|NCT00744640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65305777|NCT00744640|Antimetabolites|antimetabolites|mesh-ancestor
65305778|NCT00744640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305779|NCT00744640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305791|NCT00848718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305792|NCT00848718|Tubulin Modulators|tubulin modulators|mesh-ancestor
65305793|NCT00848718|Antimitotic Agents|antimitotic agents|mesh-ancestor
65305794|NCT00848718|Mitosis Modulators|mitosis modulators|mesh-ancestor
65305795|NCT00848718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305796|NCT00848718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65305797|NCT00848718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305798|NCT02612844|Insulin Aspart|insulin aspart|mesh-list
65305799|NCT02612844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65305800|NCT02612844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305801|NCT00883337|Interferons|interferons|mesh-list
65305802|NCT00883337|Interferon-beta|interferon-beta|mesh-list
65305803|NCT00883337|Interferon beta-1a|interferon beta-1a|mesh-list
65305804|NCT00883337|Teriflunomide|teriflunomide|mesh-list
65305805|NCT00883337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305806|NCT00883337|Antiviral Agents|antiviral agents|mesh-ancestor
65305807|NCT00883337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65305808|NCT00883337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65305809|NCT00883337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65305810|NCT00883337|Analgesics|analgesics|mesh-ancestor
65305811|NCT00883337|Sensory System Agents|sensory system agents|mesh-ancestor
65305812|NCT00883337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65152569|NCT02884713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65152570|NCT02884713|Renal Agents|renal agents|mesh-ancestor
65152571|NCT02884713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65152572|NCT02884713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65152573|NCT02884713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152574|NCT02884713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65152575|NCT02884713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65152576|NCT01154127|Glycopyrrolate|glycopyrrolate|mesh-list
65152577|NCT01154127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65152578|NCT01154127|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65152592|NCT01228734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65152593|NCT01228734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152594|NCT01228734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65152595|NCT01228734|Immunologic Factors|immunologic factors|mesh-ancestor
65152596|NCT01228734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152597|NCT01228734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65152598|NCT01228734|Antidotes|antidotes|mesh-ancestor
65152599|NCT01228734|Protective Agents|protective agents|mesh-ancestor
65152600|NCT01228734|Vitamin B Complex|vitamin b complex|mesh-ancestor
65152601|NCT01228734|Vitamins|vitamins|mesh-ancestor
65152602|NCT01228734|Micronutrients|micronutrients|mesh-ancestor
65152603|NCT01228734|Hematinics|hematinics|mesh-ancestor
65152604|NCT01153971|Rituximab|rituximab|mesh-list
65152605|NCT01153971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65152606|NCT01153971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152607|NCT01153971|Immunologic Factors|immunologic factors|mesh-ancestor
64470664|NCT05086250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65152608|NCT01153971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152609|NCT01153971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65152610|NCT01153893|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65152611|NCT01153893|Immunologic Factors|immunologic factors|mesh-ancestor
65152612|NCT01153893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305813|NCT00883337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305814|NCT00883337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65305815|NCT00883337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65305816|NCT00883337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65305817|NCT00883337|Immunologic Factors|immunologic factors|mesh-ancestor
65305818|NCT00883337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65305819|NCT04163783|Zanubrutinib|zanubrutinib|mesh-list
65305820|NCT04163783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305821|NCT04163783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65305822|NCT04163783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305823|NCT04163783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305824|NCT00654485|Atorvastatin|atorvastatin|mesh-list
65305825|NCT00654485|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65305826|NCT00654485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65305827|NCT00654485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65305828|NCT00654485|Antimetabolites|antimetabolites|mesh-ancestor
65305829|NCT00654485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305830|NCT00654485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64535713|NCT00540579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152613|NCT00951379|Pioglitazone|pioglitazone|mesh-list
65152614|NCT00951379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65152615|NCT00951379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152616|NCT01153815|Botulinum Toxins|botulinum toxins|mesh-list
65152617|NCT01153815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65152618|NCT01153815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65152619|NCT01153815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64795176|NCT00550680|Epoetin Alfa|epoetin alfa|mesh-list
65152620|NCT01153815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65152621|NCT01153815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152622|NCT01153815|Cholinergic Agents|cholinergic agents|mesh-ancestor
65152623|NCT01153815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65152624|NCT01153815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152625|NCT01153815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65152626|NCT01153815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65152628|NCT01153425|Teriparatide|teriparatide|mesh-list
65152629|NCT01153425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65152630|NCT01153425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152631|NCT01153425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65152632|NCT01153269|Ritonavir|ritonavir|mesh-list
65152633|NCT01153269|Lopinavir|lopinavir|mesh-list
65152634|NCT01153269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65152635|NCT01153269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65152636|NCT01153269|Protease Inhibitors|protease inhibitors|mesh-ancestor
65152637|NCT01153269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152638|NCT01153269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152639|NCT01153269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65152640|NCT01153269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64949345|NCT00039351|Hormones|hormones|mesh-ancestor
65152653|NCT02884635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152654|NCT02884635|Dermatologic Agents|dermatologic agents|mesh-ancestor
65152655|NCT02884635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152656|NCT02884635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65152657|NCT02884635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65152658|NCT02884635|Immunologic Factors|immunologic factors|mesh-ancestor
65152659|NCT02884635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65152660|NCT02884635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65305831|NCT00654485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65305832|NCT00654485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305833|NCT00837876|Sorafenib|sorafenib|mesh-list
65305834|NCT00837876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305835|NCT00837876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65305836|NCT00837876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305837|NCT00837876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305838|NCT00655421|Tolonium Chloride|tolonium chloride|mesh-list
65305839|NCT00655421|Hemostatics|hemostatics|mesh-ancestor
65305840|NCT00655421|Coagulants|coagulants|mesh-ancestor
65305841|NCT00655421|Heparin Antagonists|heparin antagonists|mesh-ancestor
65305842|NCT00655421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305843|NCT00707070|Acitretin|acitretin|mesh-list
65305844|NCT00707070|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65305845|NCT00707070|Immunologic Factors|immunologic factors|mesh-ancestor
65305846|NCT00707070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305847|NCT00707070|Keratolytic Agents|keratolytic agents|mesh-ancestor
65305848|NCT00707070|Dermatologic Agents|dermatologic agents|mesh-ancestor
65305849|NCT00686920|Rifaximin|rifaximin|mesh-list
65305850|NCT00686920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65305851|NCT00686920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65305852|NCT00686920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65305853|NCT02562118|Letrozole|letrozole|mesh-list
65305854|NCT02562118|Lenvatinib|lenvatinib|mesh-list
65305855|NCT02562118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305856|NCT02562118|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65305857|NCT02562118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65305858|NCT02562118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65305859|NCT02562118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305860|NCT02562118|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65305861|NCT02562118|Hormone Antagonists|hormone antagonists|mesh-ancestor
65305862|NCT02562118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65305863|NCT02562118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305864|NCT02562118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65152661|NCT02884479|Docetaxel|docetaxel|mesh-list
65305870|NCT00744718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65305871|NCT00744718|Growth Substances|growth substances|mesh-ancestor
65305872|NCT00744718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305873|NCT00744718|Growth Inhibitors|growth inhibitors|mesh-ancestor
65305874|NCT00741910|Semapimod|semapimod|mesh-list
65305875|NCT00741910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65305876|NCT00741910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65305877|NCT00741910|Analgesics|analgesics|mesh-ancestor
65305878|NCT00741910|Sensory System Agents|sensory system agents|mesh-ancestor
65305879|NCT00741910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65305880|NCT00741910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535779|NCT01690052|Cevimeline|cevimeline|mesh-list
65152662|NCT02884479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152663|NCT02884479|Tubulin Modulators|tubulin modulators|mesh-ancestor
65152664|NCT02884479|Antimitotic Agents|antimitotic agents|mesh-ancestor
65152665|NCT02884479|Mitosis Modulators|mitosis modulators|mesh-ancestor
65152666|NCT02884479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152667|NCT01152021|Dexmedetomidine|dexmedetomidine|mesh-list
65152668|NCT01152021|Propofol|propofol|mesh-list
65152669|NCT01152021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65152670|NCT01152021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65152671|NCT01152021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152672|NCT01152021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65152673|NCT01152021|Anesthetics, General|anesthetics, general|mesh-ancestor
65152674|NCT01152021|Anesthetics|anesthetics|mesh-ancestor
65152675|NCT01152021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65152676|NCT01152021|Analgesics|analgesics|mesh-ancestor
65152677|NCT01152021|Sensory System Agents|sensory system agents|mesh-ancestor
65152678|NCT01152021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65152679|NCT01152021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65152680|NCT01152021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65152681|NCT01152021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65152682|NCT01152021|Adrenergic Agents|adrenergic agents|mesh-ancestor
65152683|NCT01152021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65152684|NCT01152021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152685|NCT01151085|Voriconazole|voriconazole|mesh-list
65152686|NCT01151085|Antifungal Agents|antifungal agents|mesh-ancestor
65152687|NCT01151085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65152688|NCT01151085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65152689|NCT01151085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65152690|NCT01151085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152691|NCT01151085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152692|NCT01151085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65152693|NCT01151085|Hormone Antagonists|hormone antagonists|mesh-ancestor
65152694|NCT01151085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65152695|NCT01151085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152696|NCT01151085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65152697|NCT01149369|Aprepitant|aprepitant|mesh-list
65152698|NCT01149369|Antiemetics|antiemetics|mesh-ancestor
65152699|NCT01149369|Autonomic Agents|autonomic agents|mesh-ancestor
65152700|NCT01149369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65152717|NCT01740427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65152718|NCT00879931|Methylprednisolone|methylprednisolone|mesh-list
65152719|NCT00879931|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65152720|NCT00879931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65152721|NCT00879931|Prednisolone|prednisolone|mesh-list
65152722|NCT00879931|Prednisolone acetate|prednisolone acetate|mesh-list
65152723|NCT00879931|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65152724|NCT00879931|Prednisolone phosphate|prednisolone phosphate|mesh-list
65152725|NCT00879931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65152726|NCT00879931|Antiemetics|antiemetics|mesh-ancestor
65152727|NCT00879931|Autonomic Agents|autonomic agents|mesh-ancestor
65305881|NCT00741910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65305882|NCT00741910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65305883|NCT00741910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65305884|NCT00741910|Immunologic Factors|immunologic factors|mesh-ancestor
65305885|NCT00845832|Rituximab|rituximab|mesh-list
65305886|NCT00845832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65305887|NCT00845832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305888|NCT00845832|Immunologic Factors|immunologic factors|mesh-ancestor
65305889|NCT00845832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305890|NCT00845832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65305891|NCT00703482|Coenzyme Q10|coenzyme q10|mesh-list
65305892|NCT00703482|Ubiquinone|ubiquinone|mesh-list
65305893|NCT00703482|Fenofibrate|fenofibrate|mesh-list
65305894|NCT00703482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65305895|NCT00703482|Antimetabolites|antimetabolites|mesh-ancestor
65305896|NCT00703482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305897|NCT00703482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65305898|NCT00703482|Vitamins|vitamins|mesh-ancestor
65305899|NCT00703482|Micronutrients|micronutrients|mesh-ancestor
65305900|NCT00703482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305901|NCT00885755|Capecitabine|capecitabine|mesh-list
65305902|NCT00885755|Trastuzumab|trastuzumab|mesh-list
65305903|NCT00885755|Taxane|taxane|mesh-list
65305904|NCT00885755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65305905|NCT00885755|Antimetabolites|antimetabolites|mesh-ancestor
65305906|NCT00885755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65305907|NCT00885755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305908|NCT00885755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65305909|NCT00749710|Clopidogrel|clopidogrel|mesh-list
65305910|NCT00749710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65305911|NCT00749710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65305912|NCT00749710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65305924|NCT04058236|Polygeline|polygeline|mesh-list
65305925|NCT04058236|Plasma Substitutes|plasma substitutes|mesh-ancestor
65305996|NCT00837330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65305997|NCT00837330|Growth Inhibitors|growth inhibitors|mesh-ancestor
65305998|NCT00837330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65305999|NCT00703638|Pemetrexed|pemetrexed|mesh-list
65306000|NCT00703638|Sorafenib|sorafenib|mesh-list
65306001|NCT00703638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306002|NCT00703638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306003|NCT00703638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306004|NCT00703638|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65306005|NCT00703638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65306006|NCT00703638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65306007|NCT02581943|Paclitaxel|paclitaxel|mesh-list
65306008|NCT02581943|Carboplatin|carboplatin|mesh-list
65306009|NCT02581943|Pembrolizumab|pembrolizumab|mesh-list
65306010|NCT02581943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65306011|NCT02581943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65306012|NCT02581943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306013|NCT02581943|Tubulin Modulators|tubulin modulators|mesh-ancestor
65306014|NCT02581943|Antimitotic Agents|antimitotic agents|mesh-ancestor
65306015|NCT02581943|Mitosis Modulators|mitosis modulators|mesh-ancestor
65306016|NCT02581943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306017|NCT02581943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65306018|NCT02637479|Deoxyglucose|deoxyglucose|mesh-list
65306019|NCT02637479|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65306020|NCT02637479|Antimetabolites|antimetabolites|mesh-ancestor
65306021|NCT02637479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306022|NCT02637479|Antiviral Agents|antiviral agents|mesh-ancestor
65306023|NCT02637479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65306024|NCT02637479|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65306025|NCT00885365|Tobramycin|tobramycin|mesh-list
65306026|NCT00885365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65306027|NCT00885365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65306028|NCT00827112|Ritonavir|ritonavir|mesh-list
65306029|NCT00827112|Lopinavir|lopinavir|mesh-list
65306030|NCT00827112|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65306031|NCT00827112|Darunavir|darunavir|mesh-list
65306032|NCT00827112|Tenofovir|tenofovir|mesh-list
65306033|NCT00827112|Emtricitabine|emtricitabine|mesh-list
65152728|NCT00879931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65152729|NCT00879931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306034|NCT00827112|Maraviroc|maraviroc|mesh-list
65306035|NCT00827112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65306036|NCT00827112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65306037|NCT00827112|Protease Inhibitors|protease inhibitors|mesh-ancestor
65306038|NCT00827112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306039|NCT00827112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306040|NCT00827112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65306041|NCT00827112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65306042|NCT00827112|Antiviral Agents|antiviral agents|mesh-ancestor
65306043|NCT00827112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65306044|NCT00827112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65306045|NCT00827112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65306046|NCT00827112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65306047|NCT00827112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65306048|NCT00827112|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65306049|NCT00827112|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65306050|NCT00827112|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65306051|NCT00689104|Mirabegron|mirabegron|mesh-list
65306052|NCT00689104|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65306053|NCT00689104|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65306054|NCT00689104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65306055|NCT00689104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65306056|NCT00689104|Adrenergic Agents|adrenergic agents|mesh-ancestor
65306057|NCT00689104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65306058|NCT00689104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306059|NCT00689104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152730|NCT00879931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65152731|NCT00879931|Glucocorticoids|glucocorticoids|mesh-ancestor
65152732|NCT00879931|Hormones|hormones|mesh-ancestor
65152733|NCT00879931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65152734|NCT00879931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65152735|NCT00879931|Protective Agents|protective agents|mesh-ancestor
65152736|NCT00879931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65152737|NCT00879931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152738|NCT01737619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65152739|NCT01227564|Saponin QA-21V1|saponin qa-21v1|mesh-list
65152740|NCT01227564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65152741|NCT01227564|Immunologic Factors|immunologic factors|mesh-ancestor
65152742|NCT01227564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152743|NCT00739141|Cyclophosphamide|cyclophosphamide|mesh-list
65152744|NCT00739141|Thiotepa|thiotepa|mesh-list
65152745|NCT00739141|Fludarabine|fludarabine|mesh-list
65152746|NCT00739141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65152747|NCT00739141|Immunologic Factors|immunologic factors|mesh-ancestor
65152748|NCT00739141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152749|NCT00739141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65306060|NCT00689104|Urological Agents|urological agents|mesh-ancestor
65306061|NCT00689104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65306062|NCT00689104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65306063|NCT00689104|Cholinergic Agents|cholinergic agents|mesh-ancestor
65306064|NCT02118467|Phenylephrine|phenylephrine|mesh-list
65306065|NCT02118467|Vasopressins|vasopressins|mesh-list
65306066|NCT02118467|Arginine Vasopressin|arginine vasopressin|mesh-list
65306067|NCT02118467|Epinephrine|epinephrine|mesh-list
65306068|NCT02118467|Oxymetazoline|oxymetazoline|mesh-list
65306069|NCT02118467|Norepinephrine|norepinephrine|mesh-list
65306070|NCT02118467|Synephrine|synephrine|mesh-list
65306071|NCT02118467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65306072|NCT02118467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65306073|NCT02118467|Adrenergic Agents|adrenergic agents|mesh-ancestor
65306074|NCT02118467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65306075|NCT02118467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306076|NCT02118467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306077|NCT02118467|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65306078|NCT02118467|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65306079|NCT02118467|Autonomic Agents|autonomic agents|mesh-ancestor
65306080|NCT02118467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65152750|NCT00739141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65152751|NCT00739141|Alkylating Agents|alkylating agents|mesh-ancestor
65152752|NCT00739141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152753|NCT00739141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152754|NCT00739141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65152755|NCT01148979|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64949459|NCT00039585|Imatinib Mesylate|imatinib mesylate|mesh-list
65152764|NCT01735825|Paclitaxel|paclitaxel|mesh-list
65152765|NCT01735825|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64795327|NCT05440734|Melatonin|melatonin|mesh-list
65152767|NCT01735825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65152768|NCT01735825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152769|NCT01735825|Tubulin Modulators|tubulin modulators|mesh-ancestor
65152770|NCT01735825|Antimitotic Agents|antimitotic agents|mesh-ancestor
65152771|NCT01735825|Mitosis Modulators|mitosis modulators|mesh-ancestor
65152772|NCT01735825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152773|NCT01735825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65152774|NCT01735825|Immunologic Factors|immunologic factors|mesh-ancestor
65152775|NCT01735825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152776|NCT01148511|Ranibizumab|ranibizumab|mesh-list
65152777|NCT01148511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65152778|NCT01148511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65152779|NCT01148511|Growth Substances|growth substances|mesh-ancestor
65152780|NCT01148511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152781|NCT01148511|Growth Inhibitors|growth inhibitors|mesh-ancestor
65152782|NCT01148511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152783|NCT02860117|Ketamine|ketamine|mesh-list
65152784|NCT02860117|Analgesics|analgesics|mesh-ancestor
65152785|NCT02860117|Sensory System Agents|sensory system agents|mesh-ancestor
65152786|NCT02860117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65152787|NCT02860117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152788|NCT02860117|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65152789|NCT02860117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65152790|NCT02860117|Anesthetics, General|anesthetics, general|mesh-ancestor
65152791|NCT02860117|Anesthetics|anesthetics|mesh-ancestor
65306081|NCT02118467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65306082|NCT02118467|Respiratory System Agents|respiratory system agents|mesh-ancestor
65306083|NCT02118467|Mydriatics|mydriatics|mesh-ancestor
65306084|NCT02118467|Sympathomimetics|sympathomimetics|mesh-ancestor
65306085|NCT02118467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65306086|NCT02118467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65306087|NCT02118467|Nasal Decongestants|nasal decongestants|mesh-ancestor
65306088|NCT02118467|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65306089|NCT02118467|Protective Agents|protective agents|mesh-ancestor
65306090|NCT02118467|Hemostatics|hemostatics|mesh-ancestor
65306091|NCT02118467|Coagulants|coagulants|mesh-ancestor
65306092|NCT02118467|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65306093|NCT02118467|Natriuretic Agents|natriuretic agents|mesh-ancestor
65306094|NCT00702156|Bisoprolol|bisoprolol|mesh-list
65306095|NCT00702156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65306096|NCT00702156|Sympatholytics|sympatholytics|mesh-ancestor
65306097|NCT00702156|Autonomic Agents|autonomic agents|mesh-ancestor
65306098|NCT00702156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65306099|NCT00702156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306100|NCT00702156|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65306101|NCT00702156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65306102|NCT00702156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65306103|NCT00702156|Adrenergic Agents|adrenergic agents|mesh-ancestor
65306104|NCT00702156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65306105|NCT00702156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306106|NCT02638415|Carvedilol|carvedilol|mesh-list
65306107|NCT02638415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65306108|NCT02638415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65306128|NCT00689026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65306129|NCT00689026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306130|NCT00598559|Acetaminophen|acetaminophen|mesh-list
65306131|NCT00598559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65306132|NCT00598559|Analgesics|analgesics|mesh-ancestor
65306133|NCT00598559|Sensory System Agents|sensory system agents|mesh-ancestor
65306134|NCT00598559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65306135|NCT00598559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306136|NCT00598559|Antipyretics|antipyretics|mesh-ancestor
65306137|NCT00686686|Infliximab|infliximab|mesh-list
65306138|NCT00686686|Dermatologic Agents|dermatologic agents|mesh-ancestor
65306139|NCT00686686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65306140|NCT00686686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65306141|NCT02637167|Rifaximin|rifaximin|mesh-list
65306142|NCT02637167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65306143|NCT02637167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65306144|NCT02637167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65306145|NCT04057300|Aspirin|aspirin|mesh-list
65306146|NCT04057300|Clopidogrel|clopidogrel|mesh-list
65306147|NCT04057300|Ticagrelor|ticagrelor|mesh-list
65306148|NCT04057300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65306149|NCT04057300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65306150|NCT04057300|Analgesics|analgesics|mesh-ancestor
65306151|NCT04057300|Sensory System Agents|sensory system agents|mesh-ancestor
65152792|NCT02860117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65152793|NCT02860117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65152794|NCT02860117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65152795|NCT02860117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65152796|NCT02860117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152797|NCT02853253|SMOFlipid|smoflipid|mesh-list
65152798|NCT02853253|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65152799|NCT02853253|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65152800|NCT02853253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65152801|NCT04269187|Theophylline|theophylline|mesh-list
65152802|NCT04269187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65152803|NCT04269187|Autonomic Agents|autonomic agents|mesh-ancestor
65152804|NCT04269187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65152805|NCT04269187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152806|NCT04269187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65152807|NCT04269187|Respiratory System Agents|respiratory system agents|mesh-ancestor
65152808|NCT04269187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65152809|NCT04269187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152810|NCT04269187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152811|NCT04269187|Vasodilator Agents|vasodilator agents|mesh-ancestor
65152812|NCT04269187|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65152813|NCT04269187|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65152814|NCT04269187|Purinergic Agents|purinergic agents|mesh-ancestor
65152815|NCT04269187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65152816|NCT04269109|Analgesics, Opioid|analgesics, opioid|mesh-list
65152817|NCT04269109|Narcotics|narcotics|mesh-ancestor
65152818|NCT04269109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64949518|NCT00020189|Analgesics|analgesics|mesh-ancestor
65306152|NCT04057300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65306153|NCT04057300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306154|NCT04057300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65306155|NCT04057300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65306156|NCT04057300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65306157|NCT04057300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65306158|NCT04057300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306159|NCT04057300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65306160|NCT04057300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65306161|NCT04057300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306162|NCT04057300|Antipyretics|antipyretics|mesh-ancestor
65306163|NCT04057300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65306164|NCT04057300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65152848|NCT04268563|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65152849|NCT04268563|Protease Inhibitors|protease inhibitors|mesh-ancestor
65152850|NCT04268563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152851|NCT04268563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152852|NCT01225146|Ranibizumab|ranibizumab|mesh-list
65152853|NCT01225146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65152854|NCT01225146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65152855|NCT01225146|Growth Substances|growth substances|mesh-ancestor
65152856|NCT01225146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152857|NCT01225146|Growth Inhibitors|growth inhibitors|mesh-ancestor
65152858|NCT01225146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152859|NCT01223196|Pioglitazone|pioglitazone|mesh-list
65152860|NCT01223196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65152861|NCT01223196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152862|NCT01222416|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
65152863|NCT01222416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152875|NCT01218594|Growth Substances|growth substances|mesh-ancestor
65152876|NCT01218594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152877|NCT01218594|Growth Inhibitors|growth inhibitors|mesh-ancestor
65152878|NCT01218594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152879|NCT01610557|Bevacizumab|bevacizumab|mesh-list
65152880|NCT01610557|Ranibizumab|ranibizumab|mesh-list
65152881|NCT01610557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65152882|NCT01610557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152883|NCT01610557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65152884|NCT01610557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65152885|NCT01610557|Growth Substances|growth substances|mesh-ancestor
65152886|NCT01610557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152887|NCT01610557|Growth Inhibitors|growth inhibitors|mesh-ancestor
65152888|NCT00943735|Fesoterodine|fesoterodine|mesh-list
65152889|NCT00943735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65152890|NCT00943735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65152891|NCT00943735|Cholinergic Agents|cholinergic agents|mesh-ancestor
65152892|NCT00943735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65152893|NCT00943735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152894|NCT00943735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152895|NCT00943735|Urological Agents|urological agents|mesh-ancestor
65152896|NCT00489307|Dexamethasone|dexamethasone|mesh-list
65152897|NCT00489307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65152898|NCT00489307|Antiemetics|antiemetics|mesh-ancestor
65152899|NCT00489307|Autonomic Agents|autonomic agents|mesh-ancestor
65152900|NCT00489307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65152901|NCT00489307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152903|NCT00489307|Glucocorticoids|glucocorticoids|mesh-ancestor
65152904|NCT00489307|Hormones|hormones|mesh-ancestor
65152905|NCT00489307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65306165|NCT04057300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65306166|NCT04057300|Purinergic Agents|purinergic agents|mesh-ancestor
65306167|NCT04057300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65306168|NCT00655967|Acamprosate|acamprosate|mesh-list
65306169|NCT00655967|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65306170|NCT00750100|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65306171|NCT00750100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65306172|NCT00750100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306173|NCT00655109|Fluticasone|fluticasone|mesh-list
65306174|NCT00655109|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
65306175|NCT00655109|Lubricant Eye Drops|lubricant eye drops|mesh-list
65306176|NCT00655109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65306177|NCT00655109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65306178|NCT00655109|Autonomic Agents|autonomic agents|mesh-ancestor
65306179|NCT00655109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65306180|NCT00655109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306181|NCT00655109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65306182|NCT00655109|Respiratory System Agents|respiratory system agents|mesh-ancestor
65306183|NCT00655109|Dermatologic Agents|dermatologic agents|mesh-ancestor
65306184|NCT00655109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65306185|NCT00655109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65306186|NCT00655109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65306187|NCT00655109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65306188|NCT00655109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65306189|NCT00655109|Analgesics|analgesics|mesh-ancestor
65306190|NCT00655109|Sensory System Agents|sensory system agents|mesh-ancestor
65306191|NCT00655109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65306192|NCT00655109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65152906|NCT00489307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65152907|NCT00489307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152908|NCT00943111|Eliglustat|eliglustat|mesh-list
65152909|NCT00943111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152910|NCT00943111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152911|NCT01147497|Misoprostol|misoprostol|mesh-list
65152912|NCT01147497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65152913|NCT01147497|Abortifacient Agents|abortifacient agents|mesh-ancestor
64795473|NCT05768191|Insulin|insulin|mesh-list
65152914|NCT01147497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65152915|NCT01147497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152916|NCT01147497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65152917|NCT01147497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65152919|NCT01147341|Certolizumab Pegol|certolizumab pegol|mesh-list
65152920|NCT01147341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65152921|NCT01147341|Immunologic Factors|immunologic factors|mesh-ancestor
65152922|NCT01147341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152923|NCT01147341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65152924|NCT00950755|Tositumomab I-131|tositumomab i-131|mesh-list
65152925|NCT00950755|Antibodies|antibodies|mesh-list
65306193|NCT00655109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65306194|NCT00655109|Histamine Antagonists|histamine antagonists|mesh-ancestor
65306195|NCT00655109|Histamine Agents|histamine agents|mesh-ancestor
65306196|NCT00655109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65306197|NCT00655109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306198|NCT02632877|Pirfenidone|pirfenidone|mesh-list
65306199|NCT02632877|Ketanserin|ketanserin|mesh-list
65306200|NCT02632877|Analgesics|analgesics|mesh-ancestor
65306201|NCT02632877|Sensory System Agents|sensory system agents|mesh-ancestor
65306202|NCT02632877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65306203|NCT02632877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306204|NCT02632877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65306205|NCT02632877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65306206|NCT02632877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65306207|NCT02632877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65306208|NCT02632877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306209|NCT02632877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65306210|NCT02632877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65306211|NCT02632877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65306212|NCT02632877|Serotonin Agents|serotonin agents|mesh-ancestor
65306213|NCT02632877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65306214|NCT02632877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306215|NCT00656123|Cyclophosphamide|cyclophosphamide|mesh-list
65306216|NCT00656123|Molgramostim|molgramostim|mesh-list
65306217|NCT00656123|Sargramostim|sargramostim|mesh-list
65306218|NCT00656123|Immunologic Factors|immunologic factors|mesh-ancestor
65306219|NCT00656123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306220|NCT00656123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65306221|NCT00656123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65306222|NCT00656123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65306237|NCT00657449|Analgesics|analgesics|mesh-ancestor
65306238|NCT00657449|Sensory System Agents|sensory system agents|mesh-ancestor
65306239|NCT00657449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65306240|NCT00657449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306241|NCT00657449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65306242|NCT00657449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65306243|NCT04160195|Cyclophosphamide|cyclophosphamide|mesh-list
65306244|NCT04160195|Fludarabine|fludarabine|mesh-list
65306245|NCT04160195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65306246|NCT04160195|Immunologic Factors|immunologic factors|mesh-ancestor
65306247|NCT04160195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306248|NCT04160195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65306249|NCT04160195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65306250|NCT04160195|Alkylating Agents|alkylating agents|mesh-ancestor
65306251|NCT04160195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306252|NCT04160195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306253|NCT04160195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65306254|NCT00911261|Oxymorphone|oxymorphone|mesh-list
65306255|NCT00911261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65306256|NCT00911261|Narcotics|narcotics|mesh-ancestor
65306257|NCT00911261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65306258|NCT00911261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306259|NCT00911261|Analgesics|analgesics|mesh-ancestor
65306260|NCT00911261|Sensory System Agents|sensory system agents|mesh-ancestor
65306262|NCT00911261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65306286|NCT00750724|Protective Agents|protective agents|mesh-ancestor
65306287|NCT00752518|Bortezomib|bortezomib|mesh-list
65306288|NCT00752518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306289|NCT00752596|Azimilide|azimilide|mesh-list
65306290|NCT00752596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65306291|NCT00752596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65306292|NCT00752596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65306293|NCT00752596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306294|NCT00752596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65306295|NCT00752596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306296|NCT00750802|Lorazepam|lorazepam|mesh-list
65306297|NCT00750802|Anticonvulsants|anticonvulsants|mesh-ancestor
65306298|NCT00750802|Antiemetics|antiemetics|mesh-ancestor
65306299|NCT00750802|Autonomic Agents|autonomic agents|mesh-ancestor
65306300|NCT00750802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65306301|NCT00750802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306302|NCT00750802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65306303|NCT00750802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65306304|NCT00750802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65306305|NCT00750802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65306306|NCT00750802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65306307|NCT00750802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65306308|NCT00750802|GABA Modulators|gaba modulators|mesh-ancestor
65306309|NCT00750802|GABA Agents|gaba agents|mesh-ancestor
65306310|NCT00750802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65494085|NCT03701763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056201|NCT00236366|Analgesics|analgesics|mesh-ancestor
65306311|NCT00750802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306312|NCT00751270|Valacyclovir|valacyclovir|mesh-list
65306313|NCT00751270|Antiviral Agents|antiviral agents|mesh-ancestor
65306314|NCT00751270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65306315|NCT00751504|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65306316|NCT00751504|Antidepressive Agents|antidepressive agents|mesh-ancestor
65306326|NCT00683878|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
65306327|NCT00683878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65306328|NCT00683878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306329|NCT00683878|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65306330|NCT00683878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306331|NCT00884741|Bevacizumab|bevacizumab|mesh-list
65306332|NCT00884741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65306333|NCT00884741|Temozolomide|temozolomide|mesh-list
65306334|NCT00884741|Endothelial Growth Factors|endothelial growth factors|mesh-list
65306335|NCT00884741|Antibodies|antibodies|mesh-list
65306336|NCT00884741|Immunoglobulins|immunoglobulins|mesh-list
65306337|NCT00884741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65306338|NCT00884741|Immunoglobulin G|immunoglobulin g|mesh-list
65306339|NCT00884741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306340|NCT00884741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65306341|NCT00884741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65306342|NCT00884741|Growth Substances|growth substances|mesh-ancestor
65306343|NCT00884741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306344|NCT00884741|Growth Inhibitors|growth inhibitors|mesh-ancestor
65306345|NCT00884741|Immunologic Factors|immunologic factors|mesh-ancestor
64536228|NCT00554463|Etoposide|etoposide|mesh-list
65152926|NCT00950755|Immunologic Factors|immunologic factors|mesh-ancestor
65152927|NCT00950755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152928|NCT00950755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152929|NCT01147107|Efavirenz|efavirenz|mesh-list
65152958|NCT01146873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65152959|NCT01146873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65152960|NCT01146873|Protease Inhibitors|protease inhibitors|mesh-ancestor
65152961|NCT01146873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152962|NCT01146873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152963|NCT01146873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65152964|NCT01146873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65152965|NCT01146873|Antiviral Agents|antiviral agents|mesh-ancestor
65152966|NCT01146873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65152967|NCT01146873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65152968|NCT01146873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65152969|NCT01146873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65152970|NCT01146873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65152971|NCT01146873|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65152972|NCT01146873|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65152973|NCT01146873|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65152991|NCT01146795|Growth Inhibitors|growth inhibitors|mesh-ancestor
65152992|NCT01146561|Tanezumab|tanezumab|mesh-list
65152993|NCT01146561|Analgesics|analgesics|mesh-ancestor
65152994|NCT01146561|Sensory System Agents|sensory system agents|mesh-ancestor
65152995|NCT01146561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65152996|NCT01146561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152997|NCT00942175|Esomeprazole|esomeprazole|mesh-list
65152998|NCT00942175|Omeprazole|omeprazole|mesh-list
65152999|NCT00942175|Lansoprazole|lansoprazole|mesh-list
65153000|NCT00942175|Dexlansoprazole|dexlansoprazole|mesh-list
65153001|NCT00942175|Clopidogrel|clopidogrel|mesh-list
65153002|NCT00942175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65153003|NCT00942175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65306346|NCT00884741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65306347|NCT00884741|Alkylating Agents|alkylating agents|mesh-ancestor
65306348|NCT00884741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306349|NCT00657527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65306350|NCT00657527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65306351|NCT00657527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65306352|NCT00657527|Antimetabolites|antimetabolites|mesh-ancestor
65306353|NCT00657527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306354|NCT00657527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65306355|NCT00657527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65306356|NCT00657527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306357|NCT00598481|Busulfan|busulfan|mesh-list
65306358|NCT00598481|Alkylating Agents|alkylating agents|mesh-ancestor
65306359|NCT00598481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306360|NCT00598481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65306361|NCT00598481|Immunologic Factors|immunologic factors|mesh-ancestor
65306362|NCT00598481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306363|NCT00598481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65306364|NCT00598481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306365|NCT00598481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65306366|NCT04159649|Letrozole|letrozole|mesh-list
65306367|NCT04159649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306368|NCT04159649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65306369|NCT04159649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65306370|NCT04159649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306371|NCT04159649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306372|NCT04159649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65306373|NCT04159649|Hormone Antagonists|hormone antagonists|mesh-ancestor
65344935|NCT00864058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153004|NCT00942175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65153005|NCT00942175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65153006|NCT00942175|Purinergic Agents|purinergic agents|mesh-ancestor
65153007|NCT00942175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65153008|NCT00942175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153009|NCT00942175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153010|NCT00942175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65153011|NCT00942175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65153012|NCT00942175|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65153013|NCT00942175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153014|NCT01145625|Minoxidil|minoxidil|mesh-list
65153015|NCT01145625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65153016|NCT01145625|Vasodilator Agents|vasodilator agents|mesh-ancestor
65306374|NCT04159649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65306375|NCT04159649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306376|NCT00880763|Interferons|interferons|mesh-list
65306377|NCT00880763|Ribavirin|ribavirin|mesh-list
65306378|NCT00880763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306379|NCT00880763|Antiviral Agents|antiviral agents|mesh-ancestor
65306380|NCT00880763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65306381|NCT00880763|Antimetabolites|antimetabolites|mesh-ancestor
65306382|NCT00880763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306383|NCT00884273|Goserelin|goserelin|mesh-list
65153017|NCT02855203|Pembrolizumab|pembrolizumab|mesh-list
65153018|NCT02855203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65153019|NCT02855203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153020|NCT01489813|Genistein|genistein|mesh-list
65153021|NCT01489813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65153022|NCT01489813|Protective Agents|protective agents|mesh-ancestor
65153023|NCT01489813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153024|NCT01489813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153025|NCT01489813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65153026|NCT01489813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153027|NCT01489813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153028|NCT01489813|Phytoestrogens|phytoestrogens|mesh-ancestor
65153029|NCT01489813|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65153030|NCT01489813|Estrogens|estrogens|mesh-ancestor
65153031|NCT01489813|Hormones|hormones|mesh-ancestor
65153050|NCT02852083|Alkylating Agents|alkylating agents|mesh-ancestor
65153051|NCT00602407|Cilostazol|cilostazol|mesh-list
65153052|NCT00602407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65153053|NCT00602407|Autonomic Agents|autonomic agents|mesh-ancestor
65153054|NCT00602407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65153055|NCT00602407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153056|NCT00602407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65153057|NCT00602407|Respiratory System Agents|respiratory system agents|mesh-ancestor
65153058|NCT00602407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65153059|NCT00602407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65153060|NCT00602407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153061|NCT00602407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65153062|NCT00602407|Vasodilator Agents|vasodilator agents|mesh-ancestor
65153063|NCT00602407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65153064|NCT00602407|Protective Agents|protective agents|mesh-ancestor
65153065|NCT00602407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65153066|NCT00602407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65153067|NCT00602407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153068|NCT00950599|Saxagliptin|saxagliptin|mesh-list
65153069|NCT00950599|Incretins|incretins|mesh-ancestor
65153070|NCT00950599|Hormones|hormones|mesh-ancestor
65153071|NCT00950599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65153072|NCT00950599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153073|NCT00950599|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65153074|NCT00950599|Protease Inhibitors|protease inhibitors|mesh-ancestor
65153075|NCT00950599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153076|NCT00950599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153077|NCT00950599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65153078|NCT01143207|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65153079|NCT01143207|Medroxyprogesterone|medroxyprogesterone|mesh-list
65153080|NCT01143207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65153081|NCT01143207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65153082|NCT01143207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65153083|NCT01143207|Contraceptive Agents|contraceptive agents|mesh-ancestor
65153084|NCT01143207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65153085|NCT01143207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153086|NCT01143207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64949808|NCT00021242|Docetaxel|docetaxel|mesh-list
65153101|NCT01143051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65153102|NCT01143051|Autonomic Agents|autonomic agents|mesh-ancestor
65306384|NCT00884273|Bicalutamide|bicalutamide|mesh-list
65306385|NCT00884273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65306386|NCT00884273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306387|NCT00884273|Androgen Antagonists|androgen antagonists|mesh-ancestor
65306388|NCT00884273|Hormone Antagonists|hormone antagonists|mesh-ancestor
65306389|NCT00884273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65306390|NCT00884273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306391|NCT00657761|Enfuvirtide|enfuvirtide|mesh-list
65306392|NCT00657761|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65306393|NCT00657761|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65306394|NCT00657761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306395|NCT00657761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65306396|NCT00657761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65306397|NCT00657761|Antiviral Agents|antiviral agents|mesh-ancestor
65306398|NCT00657761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65306399|NCT00657839|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65306400|NCT00657839|Vasodilator Agents|vasodilator agents|mesh-ancestor
65306401|NCT00657839|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65306402|NCT00657839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65306403|NCT00657839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306404|NCT00657839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536286|NCT01456039|Romidepsin|romidepsin|mesh-list
65153103|NCT01143051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65153104|NCT01143051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65153105|NCT01143051|Respiratory System Agents|respiratory system agents|mesh-ancestor
65153106|NCT01143051|Mydriatics|mydriatics|mesh-ancestor
65153107|NCT01143051|Sympathomimetics|sympathomimetics|mesh-ancestor
65153108|NCT01143051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65153109|NCT05199597|Atropine|atropine|mesh-list
65153110|NCT05199597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65153111|NCT05199597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65153112|NCT05199597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65153113|NCT05199597|Autonomic Agents|autonomic agents|mesh-ancestor
65153114|NCT05199597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65153115|NCT05199597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153116|NCT05199597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65153117|NCT05199597|Respiratory System Agents|respiratory system agents|mesh-ancestor
65153118|NCT05199597|Mydriatics|mydriatics|mesh-ancestor
65153119|NCT05199597|Parasympatholytics|parasympatholytics|mesh-ancestor
65153120|NCT05199597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65153121|NCT05199597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65153122|NCT05199597|Cholinergic Agents|cholinergic agents|mesh-ancestor
65153123|NCT05199597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65153124|NCT05199597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153125|NCT01142193|Topiramate|topiramate|mesh-list
65153126|NCT01142193|Anticonvulsants|anticonvulsants|mesh-ancestor
65153127|NCT01142193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65153128|NCT01142193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153129|NCT01139775|Pemetrexed|pemetrexed|mesh-list
65153130|NCT01139775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153131|NCT01139775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153132|NCT01139775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306405|NCT00657839|Urological Agents|urological agents|mesh-ancestor
65306406|NCT00884117|Oseltamivir|oseltamivir|mesh-list
65306407|NCT00884117|Antiviral Agents|antiviral agents|mesh-ancestor
65306408|NCT00884117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65306409|NCT00884117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306410|NCT00884117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306411|NCT04159181|Lactulose|lactulose|mesh-list
65306412|NCT04159181|Picosulfate sodium|picosulfate sodium|mesh-list
65306413|NCT04159181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65306414|NCT04159181|Cathartics|cathartics|mesh-ancestor
65306415|NCT00884039|Hydrocortisone|hydrocortisone|mesh-list
65306416|NCT00884039|Anecortave|anecortave|mesh-list
65306417|NCT00884039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65306418|NCT00884039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65306419|NCT00884039|Growth Substances|growth substances|mesh-ancestor
65306420|NCT00884039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306421|NCT00884039|Growth Inhibitors|growth inhibitors|mesh-ancestor
65306422|NCT00884039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306423|NCT00884039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65306424|NCT00657995|Pancrelipase|pancrelipase|mesh-list
65153133|NCT01139775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65153134|NCT01139775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65153135|NCT01283516|Ceritinib|ceritinib|mesh-list
64795715|NCT05654818|Vitamin D|vitamin d|mesh-list
65153136|NCT01283516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153137|NCT01283516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65153138|NCT01283516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153139|NCT01283516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153140|NCT05367063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65153141|NCT05367063|Canagliflozin|canagliflozin|mesh-list
65153142|NCT05367063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65153143|NCT05367063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153144|NCT05367063|Incretins|incretins|mesh-ancestor
65153145|NCT05367063|Hormones|hormones|mesh-ancestor
65153146|NCT05367063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65153164|NCT01282814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65153165|NCT01282814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153166|NCT01282814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65153167|NCT01282814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153168|NCT01282814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65153169|NCT01282814|Antidepressive Agents|antidepressive agents|mesh-ancestor
65153170|NCT01282814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65153171|NCT00941863|Sorafenib|sorafenib|mesh-list
65153172|NCT00941863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153173|NCT00941863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65153174|NCT00941863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153175|NCT00941863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153176|NCT00602173|Cilostazol|cilostazol|mesh-list
65153177|NCT00602173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65153178|NCT00602173|Autonomic Agents|autonomic agents|mesh-ancestor
65153179|NCT00602173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65153180|NCT00602173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153181|NCT00602173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65153182|NCT00602173|Respiratory System Agents|respiratory system agents|mesh-ancestor
65153183|NCT00602173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65153184|NCT00602173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65222832|NCT02700087|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65306425|NCT00657995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65306426|NCT02632565|Lidocaine|lidocaine|mesh-list
65306427|NCT02632565|Anesthetics, Local|anesthetics, local|mesh-ancestor
65306428|NCT02632565|Anesthetics|anesthetics|mesh-ancestor
65306429|NCT02632565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65306430|NCT02632565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306431|NCT02632565|Sensory System Agents|sensory system agents|mesh-ancestor
65306432|NCT02632565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65306433|NCT02632565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65306434|NCT02632565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65306435|NCT02632565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65306436|NCT02632565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65306437|NCT02632565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306438|NCT04158947|Trastuzumab|trastuzumab|mesh-list
65306439|NCT04158947|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65306440|NCT04158947|Afatinib|afatinib|mesh-list
65306441|NCT04158947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65306442|NCT04158947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306443|NCT04158947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65306444|NCT04158947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306445|NCT04158947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306446|NCT04158947|Tubulin Modulators|tubulin modulators|mesh-ancestor
65306447|NCT04158947|Antimitotic Agents|antimitotic agents|mesh-ancestor
65306448|NCT04158947|Mitosis Modulators|mitosis modulators|mesh-ancestor
65306449|NCT00835770|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65306450|NCT00835770|Dermatologic Agents|dermatologic agents|mesh-ancestor
65306451|NCT00835770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65306452|NCT00835770|Immunologic Factors|immunologic factors|mesh-ancestor
65306453|NCT00835770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306454|NCT04163237|Sorafenib|sorafenib|mesh-list
65306455|NCT04163237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306456|NCT04163237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65306457|NCT04163237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306458|NCT04163237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306459|NCT00880685|Memantine|memantine|mesh-list
65306460|NCT00880685|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65306461|NCT00880685|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65306462|NCT00880685|Dopamine Agents|dopamine agents|mesh-ancestor
65306463|NCT00880685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65306464|NCT00880685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306465|NCT00880685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306466|NCT00880685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65306467|NCT00880685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65306468|NCT02612298|Metoprolol|metoprolol|mesh-list
65306469|NCT02612298|Arotinolol|arotinolol|mesh-list
65306470|NCT02612298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65306471|NCT02612298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65306472|NCT02612298|Sympatholytics|sympatholytics|mesh-ancestor
65306473|NCT02612298|Autonomic Agents|autonomic agents|mesh-ancestor
65306474|NCT02612298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65306475|NCT02612298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306476|NCT02612298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65306477|NCT02612298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65306478|NCT02612298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65306479|NCT02612298|Adrenergic Agents|adrenergic agents|mesh-ancestor
64536371|NCT01459913|Ribavirin|ribavirin|mesh-list
65153185|NCT00602173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153186|NCT00602173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65153187|NCT00602173|Vasodilator Agents|vasodilator agents|mesh-ancestor
65153188|NCT00602173|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65153189|NCT00602173|Protective Agents|protective agents|mesh-ancestor
65153190|NCT00602173|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65153191|NCT00602173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65153193|NCT02852239|Dabrafenib|dabrafenib|mesh-list
65153194|NCT02852239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153195|NCT02852239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65153196|NCT02852239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153197|NCT02852239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153198|NCT01282424|Idelalisib|idelalisib|mesh-list
65153213|NCT01281956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153214|NCT01279850|Pregabalin|pregabalin|mesh-list
65153215|NCT01279850|Analgesics|analgesics|mesh-ancestor
65153216|NCT01279850|Sensory System Agents|sensory system agents|mesh-ancestor
65153217|NCT01279850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65153218|NCT01279850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153219|NCT01279850|Anticonvulsants|anticonvulsants|mesh-ancestor
65153220|NCT01279850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65153221|NCT01279850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65153222|NCT01279850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153223|NCT01279850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65153224|NCT01279850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65153225|NCT01279850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65153226|NCT01279850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65153227|NCT01279850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65153228|NCT00604357|Sirolimus|sirolimus|mesh-list
65153229|NCT00604357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65153230|NCT00604357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65153231|NCT00604357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65153232|NCT00604357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153233|NCT00604357|Antifungal Agents|antifungal agents|mesh-ancestor
65153234|NCT00604357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65153235|NCT00604357|Immunologic Factors|immunologic factors|mesh-ancestor
65306480|NCT02612298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65306481|NCT02612298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306482|NCT02612298|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65306483|NCT00880607|Morphine|morphine|mesh-list
65306484|NCT00880607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65306485|NCT00880607|Narcotics|narcotics|mesh-ancestor
65306486|NCT00880607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65306487|NCT00880607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306488|NCT00880607|Analgesics|analgesics|mesh-ancestor
65306489|NCT00880607|Sensory System Agents|sensory system agents|mesh-ancestor
65306490|NCT00880607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65306491|NCT00656435|Bevacizumab|bevacizumab|mesh-list
65306492|NCT00656435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65306493|NCT00656435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306494|NCT00656435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65306495|NCT00656435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65306496|NCT00656435|Growth Substances|growth substances|mesh-ancestor
65306497|NCT00656435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306498|NCT00656435|Growth Inhibitors|growth inhibitors|mesh-ancestor
64536387|NCT01458275|Hormones|hormones|mesh-ancestor
65153236|NCT00604357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153237|NCT00602719|Zolpidem|zolpidem|mesh-list
65153238|NCT00602719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65153239|NCT00602719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65153240|NCT00602719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65153241|NCT00602719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153242|NCT00602719|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65153243|NCT00602719|GABA Agonists|gaba agonists|mesh-ancestor
65153244|NCT00602719|GABA Agents|gaba agents|mesh-ancestor
65153245|NCT00602719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65153246|NCT00602719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153247|NCT00604435|Docetaxel|docetaxel|mesh-list
65153248|NCT00604435|Epirubicin|epirubicin|mesh-list
65153249|NCT00604435|Endostatins|endostatins|mesh-list
65153250|NCT00604435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153251|NCT00604435|Tubulin Modulators|tubulin modulators|mesh-ancestor
65153252|NCT00604435|Antimitotic Agents|antimitotic agents|mesh-ancestor
65153253|NCT00604435|Mitosis Modulators|mitosis modulators|mesh-ancestor
65153254|NCT00604435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153255|NCT00604435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65153256|NCT00604435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65153274|NCT01218516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153275|NCT01218516|Tubulin Modulators|tubulin modulators|mesh-ancestor
65153276|NCT01218516|Antimitotic Agents|antimitotic agents|mesh-ancestor
65153277|NCT01218516|Mitosis Modulators|mitosis modulators|mesh-ancestor
65153278|NCT01218516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153279|NCT01218516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153280|NCT01218516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65153281|NCT01218516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65153284|NCT00938431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65153285|NCT00938431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65153286|NCT00938431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65153287|NCT00938431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153288|NCT05381389|Bupivacaine|bupivacaine|mesh-list
65306499|NCT02636231|Endostatins|endostatins|mesh-list
65306500|NCT02636231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65306501|NCT02636231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65306502|NCT02636231|Growth Substances|growth substances|mesh-ancestor
65306503|NCT02636231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306504|NCT02636231|Growth Inhibitors|growth inhibitors|mesh-ancestor
65306505|NCT02636231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306506|NCT00658463|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65306507|NCT00658463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65306508|NCT00658463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65306509|NCT00658463|Antimetabolites|antimetabolites|mesh-ancestor
65153289|NCT05381389|Anesthetics, Local|anesthetics, local|mesh-ancestor
65153290|NCT05381389|Anesthetics|anesthetics|mesh-ancestor
65153291|NCT05381389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65153292|NCT05381389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153293|NCT05381389|Sensory System Agents|sensory system agents|mesh-ancestor
65153294|NCT05381389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65153295|NCT00949117|Cyproheptadine|cyproheptadine|mesh-list
65153296|NCT00949117|Antipruritics|antipruritics|mesh-ancestor
65153297|NCT00949117|Dermatologic Agents|dermatologic agents|mesh-ancestor
65153298|NCT00949117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65153299|NCT00949117|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65153300|NCT00949117|Histamine Antagonists|histamine antagonists|mesh-ancestor
65153301|NCT00949117|Histamine Agents|histamine agents|mesh-ancestor
65153302|NCT00949117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65153303|NCT00949117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153304|NCT00949117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153305|NCT00949117|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65153306|NCT00949117|Serotonin Agents|serotonin agents|mesh-ancestor
65153307|NCT00949117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65153308|NCT04312347|Tamoxifen|tamoxifen|mesh-list
65153309|NCT04312347|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65153310|NCT04312347|Hormone Antagonists|hormone antagonists|mesh-ancestor
65153311|NCT04312347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65153312|NCT04312347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153313|NCT04312347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65153314|NCT04312347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153328|NCT05379283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65153329|NCT05379283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65153330|NCT05379283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65153331|NCT05379283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153332|NCT01218438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65153333|NCT01218438|Immunoglobulins|immunoglobulins|mesh-list
65153334|NCT01218438|Antibodies|antibodies|mesh-list
65153335|NCT01218438|gamma-Globulins|gamma-globulins|mesh-list
65153336|NCT01218438|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65153337|NCT01218438|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65153338|NCT01218438|Immunoglobulin G|immunoglobulin g|mesh-list
65153339|NCT01218438|Immunologic Factors|immunologic factors|mesh-ancestor
65153340|NCT01218438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153342|NCT00605995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65153343|NCT00605995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65153344|NCT00605995|Antimetabolites|antimetabolites|mesh-ancestor
65153345|NCT00605995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153346|NCT00605995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65153347|NCT00605995|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65153348|NCT00605995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153349|NCT00604591|Tolcapone|tolcapone|mesh-list
65153350|NCT00604591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65153351|NCT00604591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65153352|NCT00604591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65153353|NCT00604591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153354|NCT00604591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153356|NCT02691156|Bilirubin|bilirubin|mesh-list
65306510|NCT00658463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306511|NCT00658463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65306512|NCT00658463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65306513|NCT00658463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306514|NCT00656591|Methotrexate|methotrexate|mesh-list
65306515|NCT00656591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65306516|NCT00656591|Abortifacient Agents|abortifacient agents|mesh-ancestor
65306517|NCT00656591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65306518|NCT00656591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306519|NCT00656591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65306520|NCT00656591|Antimetabolites|antimetabolites|mesh-ancestor
65306521|NCT00656591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306522|NCT00656591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306523|NCT00656591|Dermatologic Agents|dermatologic agents|mesh-ancestor
65306524|NCT00656591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306525|NCT00656591|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65306526|NCT00656591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65306527|NCT00656591|Immunologic Factors|immunologic factors|mesh-ancestor
65306528|NCT00656591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65306529|NCT00656591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65306530|NCT00658931|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65306531|NCT00658931|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65306532|NCT00658931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65056444|NCT00236834|Ofloxacin|ofloxacin|mesh-list
65306533|NCT00658931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65306534|NCT00658931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536418|NCT01453595|Dactolisib|dactolisib|mesh-list
65153357|NCT02691156|Antimetabolites|antimetabolites|mesh-ancestor
65153358|NCT02691156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153359|NCT02691156|Gasotransmitters|gasotransmitters|mesh-ancestor
65153360|NCT02691156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65153361|NCT02691156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153362|NCT02691156|Antioxidants|antioxidants|mesh-ancestor
65153363|NCT02691156|Protective Agents|protective agents|mesh-ancestor
65153364|NCT00603031|Glucagon|glucagon|mesh-list
65153365|NCT00603031|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
65153366|NCT00603031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65153367|NCT00603031|Hormones|hormones|mesh-ancestor
65153368|NCT00603031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65153369|NCT00603031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153370|NCT00603031|Incretins|incretins|mesh-ancestor
65153371|NCT05379049|Adalimumab|adalimumab|mesh-list
65153372|NCT05379049|Etanercept|etanercept|mesh-list
65153373|NCT05379049|Infliximab|infliximab|mesh-list
65153374|NCT05379049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65306535|NCT00658931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65306536|NCT00658931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306538|NCT00658931|Sensory System Agents|sensory system agents|mesh-ancestor
65306539|NCT00658931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65306540|NCT00658931|Antidepressive Agents|antidepressive agents|mesh-ancestor
65306541|NCT00658931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65306542|NCT00658931|Dopamine Agents|dopamine agents|mesh-ancestor
65306543|NCT00834912|Tramadol|tramadol|mesh-list
65306544|NCT00834912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65306545|NCT00834912|Narcotics|narcotics|mesh-ancestor
65306546|NCT00834912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65306547|NCT00834912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306548|NCT00834912|Analgesics|analgesics|mesh-ancestor
65306549|NCT00834912|Sensory System Agents|sensory system agents|mesh-ancestor
65306550|NCT00834912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65306551|NCT02535689|Tofacitinib|tofacitinib|mesh-list
65306552|NCT02535689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65306553|NCT02535689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536437|NCT01453049|Glimepiride|glimepiride|mesh-list
65153375|NCT05379049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65153376|NCT05379049|Dermatologic Agents|dermatologic agents|mesh-ancestor
65153377|NCT05379049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64950081|NCT00049413|Rituximab|rituximab|mesh-list
65153382|NCT05379049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65153383|NCT05379049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153384|NCT05379049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65153385|NCT05379049|Immunologic Factors|immunologic factors|mesh-ancestor
65153386|NCT02851459|Vaccines|vaccines|mesh-list
65153387|NCT02851459|Immunologic Factors|immunologic factors|mesh-ancestor
65153388|NCT02851459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153389|NCT00603343|Propiverine|propiverine|mesh-list
65153390|NCT00603343|Parasympatholytics|parasympatholytics|mesh-ancestor
65153391|NCT00603343|Autonomic Agents|autonomic agents|mesh-ancestor
65153392|NCT00603343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65153393|NCT00603343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153394|NCT00603343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65153395|NCT00603343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65153396|NCT00603343|Cholinergic Agents|cholinergic agents|mesh-ancestor
65153397|NCT00603343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65153398|NCT00603343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153399|NCT00603343|Urological Agents|urological agents|mesh-ancestor
65153400|NCT01277510|Cinacalcet|cinacalcet|mesh-list
65153401|NCT01277510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65153402|NCT01277510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153403|NCT01277510|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65153404|NCT01277510|Hormone Antagonists|hormone antagonists|mesh-ancestor
65153405|NCT01277510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65153406|NCT00937495|Bortezomib|bortezomib|mesh-list
65153407|NCT00937495|Vorinostat|vorinostat|mesh-list
65153408|NCT00937495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153409|NCT00937495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65153410|NCT00937495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153411|NCT00937495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153412|NCT04265833|Calcium|calcium|mesh-list
65153413|NCT04265833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65153414|NCT04265833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153415|NCT02851303|Morphine|morphine|mesh-list
65306554|NCT02535689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306555|NCT02632331|Gabapentin|gabapentin|mesh-list
65306556|NCT02632331|Analgesics|analgesics|mesh-ancestor
65306557|NCT02632331|Sensory System Agents|sensory system agents|mesh-ancestor
65306558|NCT02632331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65306559|NCT02632331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306560|NCT02632331|Anticonvulsants|anticonvulsants|mesh-ancestor
65306561|NCT02632331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65306562|NCT02632331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65306563|NCT02632331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65306564|NCT02632331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65306565|NCT02632331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65306566|NCT02632331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65306567|NCT02632331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65306568|NCT02632331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306569|NCT02632331|Antimanic Agents|antimanic agents|mesh-ancestor
65306570|NCT04162535|Lidocaine|lidocaine|mesh-list
65306571|NCT04162535|Propofol|propofol|mesh-list
65306572|NCT04162535|Anesthetics|anesthetics|mesh-list
65306573|NCT04162535|Sevoflurane|sevoflurane|mesh-list
65306574|NCT04162535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
65306575|NCT04162535|Anesthetics, Local|anesthetics, local|mesh-ancestor
65306576|NCT04162535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65306577|NCT04162535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306578|NCT04162535|Sensory System Agents|sensory system agents|mesh-ancestor
65306579|NCT04162535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65306580|NCT04162535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65306581|NCT04162535|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65306582|NCT04162535|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65306583|NCT04162535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65153416|NCT02851303|Methadone|methadone|mesh-list
65153418|NCT02851303|Narcotics|narcotics|mesh-ancestor
65153419|NCT02851303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65153420|NCT02851303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153421|NCT02851303|Analgesics|analgesics|mesh-ancestor
65153422|NCT02851303|Sensory System Agents|sensory system agents|mesh-ancestor
65153423|NCT02851303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65153424|NCT02851303|Antitussive Agents|antitussive agents|mesh-ancestor
65153425|NCT02851303|Respiratory System Agents|respiratory system agents|mesh-ancestor
65153426|NCT00606541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65153427|NCT00606541|Antidepressive Agents|antidepressive agents|mesh-ancestor
65153428|NCT00606541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65153429|NCT00606541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65306584|NCT04162535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306585|NCT04162535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65306586|NCT04162535|Anesthetics, General|anesthetics, general|mesh-ancestor
65306587|NCT04162535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65306588|NCT04162535|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65306589|NCT02632019|Gemcitabine|gemcitabine|mesh-list
65306590|NCT02632019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65306591|NCT02632019|Antimetabolites|antimetabolites|mesh-ancestor
65306592|NCT02632019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306593|NCT02632019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306594|NCT02632019|Antiviral Agents|antiviral agents|mesh-ancestor
65306595|NCT02632019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65306596|NCT02632019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306597|NCT02632019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65306598|NCT02632019|Immunologic Factors|immunologic factors|mesh-ancestor
65306599|NCT02632019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306600|NCT00883493|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65306601|NCT00883493|Lithium Carbonate|lithium carbonate|mesh-list
65306602|NCT00883493|Antidepressive Agents|antidepressive agents|mesh-ancestor
65306603|NCT00883493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65306604|NCT00883493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65056504|NCT00269568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65306605|NCT00883493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65306606|NCT00883493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65306607|NCT00883493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306608|NCT00883493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306609|NCT00883493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306610|NCT00883493|Antimanic Agents|antimanic agents|mesh-ancestor
65306611|NCT04158713|Piperaquine|piperaquine|mesh-list
65306612|NCT04158713|Artenimol|artenimol|mesh-list
65306613|NCT04158713|Antimalarials|antimalarials|mesh-ancestor
65306614|NCT04158713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65306615|NCT04158713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65306616|NCT04158713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65306617|NCT00659321|Nicotine|nicotine|mesh-list
65306618|NCT00659321|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65306619|NCT00659321|Autonomic Agents|autonomic agents|mesh-ancestor
65153430|NCT00606541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65153431|NCT00606541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65306620|NCT00659321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65306621|NCT00659321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306622|NCT00659321|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65306623|NCT00659321|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65306624|NCT00659321|Cholinergic Agents|cholinergic agents|mesh-ancestor
65306625|NCT00659321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65306626|NCT00659321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306627|NCT00659399|PENTA|penta|mesh-list
65306628|NCT00659399|Fondaparinux|fondaparinux|mesh-list
65306629|NCT00659399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65306630|NCT00659399|Antithrombins|antithrombins|mesh-ancestor
65306631|NCT00659399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65306632|NCT00659399|Protease Inhibitors|protease inhibitors|mesh-ancestor
65306633|NCT00659399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306634|NCT00659399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306635|NCT00659399|Anticoagulants|anticoagulants|mesh-ancestor
65306636|NCT00659399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65306637|NCT00659399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65306638|NCT00659477|Insulin Glargine|insulin glargine|mesh-list
65306639|NCT00659477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65306640|NCT00659477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306641|NCT00911339|Atorvastatin|atorvastatin|mesh-list
65306642|NCT00911339|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65306643|NCT00911339|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65306644|NCT00911339|Antimetabolites|antimetabolites|mesh-ancestor
65306645|NCT00911339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306646|NCT00911339|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65306647|NCT00911339|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65306648|NCT00911339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306649|NCT04158167|Oxytocin|oxytocin|mesh-list
65306650|NCT04158167|Oxytocics|oxytocics|mesh-ancestor
65306651|NCT04158167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65306663|NCT02635607|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65306664|NCT02635607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65306665|NCT02635607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306666|NCT02635607|Hormones|hormones|mesh-ancestor
65306667|NCT02635607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65306668|NCT02635607|Hormone Antagonists|hormone antagonists|mesh-ancestor
65306669|NCT00660257|Vaccines|vaccines|mesh-list
65306670|NCT00660257|Immunologic Factors|immunologic factors|mesh-ancestor
65306671|NCT00660257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306672|NCT00844428|Eculizumab|eculizumab|mesh-list
65306673|NCT00844428|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65306674|NCT00844428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65306675|NCT00844428|Immunologic Factors|immunologic factors|mesh-ancestor
65306676|NCT00844428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306677|NCT00660335|Secretin|secretin|mesh-list
65306678|NCT00660335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65306679|NCT00660335|Hormones|hormones|mesh-ancestor
65306680|NCT00660335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65306681|NCT00660335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306682|NCT00707772|Ribavirin|ribavirin|mesh-list
65306683|NCT00707772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65306684|NCT00707772|Interferon-alpha|interferon-alpha|mesh-list
65306685|NCT00707772|Antimetabolites|antimetabolites|mesh-ancestor
65306686|NCT00707772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306687|NCT00707772|Antiviral Agents|antiviral agents|mesh-ancestor
65153432|NCT00606541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153433|NCT00936715|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65153434|NCT00936715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65153435|NCT00936715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65153436|NCT00936715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153437|NCT00936715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153438|NCT00936715|Antiviral Agents|antiviral agents|mesh-ancestor
65153439|NCT00936715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65153440|NCT00936715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65153441|NCT00936715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65153442|NCT05378503|Topiramate|topiramate|mesh-list
65153443|NCT05378503|Phentermine|phentermine|mesh-list
65153444|NCT05378503|Anticonvulsants|anticonvulsants|mesh-ancestor
65153445|NCT05378503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65153446|NCT05378503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153447|NCT05378503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65153448|NCT05378503|Appetite Depressants|appetite depressants|mesh-ancestor
65153452|NCT05378503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65153453|NCT05378503|Adrenergic Agents|adrenergic agents|mesh-ancestor
65153454|NCT05378503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65153455|NCT05378503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153456|NCT05378191|Vaccines|vaccines|mesh-list
65153457|NCT05378191|Immunologic Factors|immunologic factors|mesh-ancestor
65153458|NCT05378191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306688|NCT00707772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65306689|NCT00707772|Immunologic Factors|immunologic factors|mesh-ancestor
65306690|NCT00707772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306691|NCT00834834|Fluoxetine|fluoxetine|mesh-list
65306692|NCT00834834|Citalopram|citalopram|mesh-list
65306693|NCT00834834|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65306694|NCT00834834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65306695|NCT00834834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65306696|NCT00834834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306697|NCT00834834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65306698|NCT00834834|Serotonin Agents|serotonin agents|mesh-ancestor
65306699|NCT00834834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306700|NCT00834834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65306701|NCT00834834|Antidepressive Agents|antidepressive agents|mesh-ancestor
65306702|NCT00834834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65306703|NCT00834834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65306704|NCT00834834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65306705|NCT00834834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306706|NCT00834366|Tramadol|tramadol|mesh-list
65306707|NCT00834366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65306708|NCT00834366|Narcotics|narcotics|mesh-ancestor
65306709|NCT00834366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65306710|NCT00834366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306711|NCT00834366|Analgesics|analgesics|mesh-ancestor
65306712|NCT00834366|Sensory System Agents|sensory system agents|mesh-ancestor
65306713|NCT00834366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65153459|NCT00605137|Insulin|insulin|mesh-list
65153460|NCT00605137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65153461|NCT00605137|Insulin Detemir|insulin detemir|mesh-list
65153462|NCT00605137|Isophane Insulin, Human|isophane insulin, human|mesh-list
65153463|NCT00605137|Insulin, Isophane|insulin, isophane|mesh-list
65153464|NCT00605137|Isophane insulin, beef|isophane insulin, beef|mesh-list
65153465|NCT00605137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65153466|NCT00605137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153467|NCT00606775|Carvedilol|carvedilol|mesh-list
65153468|NCT00606775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65153469|NCT00606775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65153470|NCT00606775|Adrenergic Agents|adrenergic agents|mesh-ancestor
65153471|NCT00606775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65153472|NCT00606775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153473|NCT00606775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153474|NCT00606775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65153475|NCT00606775|Antioxidants|antioxidants|mesh-ancestor
65153476|NCT00606775|Protective Agents|protective agents|mesh-ancestor
65153477|NCT00606775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65153478|NCT00606775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65153479|NCT00606775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65153480|NCT00606775|Vasodilator Agents|vasodilator agents|mesh-ancestor
65306714|NCT00704574|Insulin Detemir|insulin detemir|mesh-list
65306715|NCT00704574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65306716|NCT00704574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306717|NCT00660647|Adalimumab|adalimumab|mesh-list
65306718|NCT00660647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65306719|NCT00660647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65306720|NCT04156451|Furosemide|furosemide|mesh-list
65306721|NCT04156451|Diuretics|diuretics|mesh-ancestor
65306722|NCT04156451|Natriuretic Agents|natriuretic agents|mesh-ancestor
65153481|NCT00606775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65153482|NCT00606775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65153483|NCT00605371|Lamotrigine|lamotrigine|mesh-list
65153484|NCT00605371|Anticonvulsants|anticonvulsants|mesh-list
65153485|NCT00605371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65153486|NCT00605371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65153487|NCT00605371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153488|NCT00605371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65153489|NCT00605371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153490|NCT00605371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65153491|NCT00605371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65153492|NCT00605371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65153493|NCT00605371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65153494|NCT00605371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65153495|NCT04267549|Paclitaxel|paclitaxel|mesh-list
65153496|NCT04267549|Apatinib|apatinib|mesh-list
65153497|NCT04267549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65153498|NCT04267549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153499|NCT04267549|Tubulin Modulators|tubulin modulators|mesh-ancestor
65153500|NCT04267549|Antimitotic Agents|antimitotic agents|mesh-ancestor
65153501|NCT04267549|Mitosis Modulators|mitosis modulators|mesh-ancestor
65153502|NCT04267549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153503|NCT04267549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64796081|NCT05147220|Teriflunomide|teriflunomide|mesh-list
65153504|NCT04267549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153505|NCT01267994|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65153506|NCT01267994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65153507|NCT02850913|Doxycycline|doxycycline|mesh-list
65153508|NCT02850913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65153509|NCT02850913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65153510|NCT02850913|Antimalarials|antimalarials|mesh-ancestor
65153511|NCT02850913|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65153512|NCT02850913|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65153513|NCT00934843|Methylprednisolone|methylprednisolone|mesh-list
65153514|NCT00934843|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65153515|NCT00934843|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65153516|NCT00934843|Prednisolone|prednisolone|mesh-list
65153517|NCT00934843|Prednisolone acetate|prednisolone acetate|mesh-list
65153518|NCT00934843|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65153519|NCT00934843|Prednisolone phosphate|prednisolone phosphate|mesh-list
65153520|NCT00934843|Glucocorticoids|glucocorticoids|mesh-list
65153525|NCT00934843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153527|NCT00934843|Hormones|hormones|mesh-ancestor
65153528|NCT00934843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65153529|NCT00934843|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65153530|NCT00934843|Protective Agents|protective agents|mesh-ancestor
65153531|NCT00934843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65153532|NCT00934843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153533|NCT00605605|Dextromethorphan|dextromethorphan|mesh-list
65153534|NCT00605605|Antitussive Agents|antitussive agents|mesh-ancestor
65153535|NCT00605605|Respiratory System Agents|respiratory system agents|mesh-ancestor
65153536|NCT00605605|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65153537|NCT00605605|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65153538|NCT00605605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65153539|NCT00605605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153540|NCT00605605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153541|NCT04267237|Atezolizumab|atezolizumab|mesh-list
65153542|NCT04267237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306723|NCT04156451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306724|NCT04156451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65306725|NCT04156451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65306726|NCT04156451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306727|NCT00660725|Gemcitabine|gemcitabine|mesh-list
65306728|NCT00660725|Oxaliplatin|oxaliplatin|mesh-list
65306729|NCT00660725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65306730|NCT00660725|Antimetabolites|antimetabolites|mesh-ancestor
65306731|NCT00660725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306732|NCT00660725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306733|NCT00660725|Antiviral Agents|antiviral agents|mesh-ancestor
65306734|NCT00660725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65306735|NCT00660725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306736|NCT00660725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65306737|NCT00660725|Immunologic Factors|immunologic factors|mesh-ancestor
65306738|NCT00660725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306739|NCT00844194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65306740|NCT00844194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65344936|NCT00864058|Antimanic Agents|antimanic agents|mesh-ancestor
65153543|NCT00605683|Cabergoline|cabergoline|mesh-list
65153544|NCT00605683|Pramipexole|pramipexole|mesh-list
65153545|NCT00605683|Ropinirole|ropinirole|mesh-list
65153546|NCT00605683|Bromocriptine|bromocriptine|mesh-list
65153547|NCT00605683|Lisuride|lisuride|mesh-list
65153548|NCT00605683|Apomorphine|apomorphine|mesh-list
65153549|NCT00605683|Pergolide|pergolide|mesh-list
65153550|NCT00605683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65153551|NCT00605683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65153552|NCT00605683|Dopamine Agonists|dopamine agonists|mesh-ancestor
65153553|NCT00605683|Dopamine Agents|dopamine agents|mesh-ancestor
65153554|NCT00605683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65153555|NCT00605683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153556|NCT00605683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153557|NCT00605683|Antioxidants|antioxidants|mesh-ancestor
65153558|NCT00605683|Protective Agents|protective agents|mesh-ancestor
65153559|NCT00605683|Hormone Antagonists|hormone antagonists|mesh-ancestor
65153560|NCT00605683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65153561|NCT00605683|Emetics|emetics|mesh-ancestor
65153562|NCT00605683|Autonomic Agents|autonomic agents|mesh-ancestor
65153563|NCT00605683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65153564|NCT00605683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65153565|NCT00605683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65153566|NCT00605683|Serotonin Agents|serotonin agents|mesh-ancestor
65153567|NCT01266902|Rilpivirine|rilpivirine|mesh-list
65153568|NCT01266902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65153569|NCT01266902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65153570|NCT01266902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153571|NCT01266902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153572|NCT01266902|Antiviral Agents|antiviral agents|mesh-ancestor
65153573|NCT01266902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65153574|NCT01266902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65153575|NCT01266902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65153576|NCT01266824|Proxymetacaine|proxymetacaine|mesh-list
65153577|NCT01266824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65153578|NCT01266824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65306741|NCT00844194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65306742|NCT00844194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65306743|NCT00844194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306744|NCT00844194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65306745|NCT00844194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306746|NCT00844194|Analgesics|analgesics|mesh-ancestor
65306747|NCT00844194|Sensory System Agents|sensory system agents|mesh-ancestor
65306748|NCT00844194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65306749|NCT00844194|Antidepressive Agents|antidepressive agents|mesh-ancestor
65306750|NCT00844194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65306751|NCT00844194|Dopamine Agents|dopamine agents|mesh-ancestor
65306752|NCT00660803|Fulvestrant|fulvestrant|mesh-list
65306753|NCT00660803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65306754|NCT00660803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306755|NCT00660803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65306756|NCT00660803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65306757|NCT00660803|Hormone Antagonists|hormone antagonists|mesh-ancestor
65306758|NCT00660803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65306759|NCT00660803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306760|NCT00661115|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65306761|NCT00661115|Vasodilator Agents|vasodilator agents|mesh-ancestor
65306762|NCT00661115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65306763|NCT00661115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65306764|NCT00661115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796153|NCT05037812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65153579|NCT01266824|Anesthetics, Local|anesthetics, local|mesh-ancestor
65153580|NCT01266824|Anesthetics|anesthetics|mesh-ancestor
65153581|NCT01266824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65153582|NCT01266824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153583|NCT01266824|Sensory System Agents|sensory system agents|mesh-ancestor
65153584|NCT01266824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65153585|NCT04253119|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65153586|NCT04253119|Antiviral Agents|antiviral agents|mesh-ancestor
65153587|NCT04253119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65153588|NCT01266590|Digoxin|digoxin|mesh-list
65153589|NCT01266590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65153590|NCT01266590|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65153591|NCT01266590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153601|NCT00607711|Alkylating Agents|alkylating agents|mesh-ancestor
65153602|NCT00607711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153603|NCT00607711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153604|NCT01263782|Bevacizumab|bevacizumab|mesh-list
65153605|NCT01263782|Carboplatin|carboplatin|mesh-list
65153606|NCT01263782|Pemetrexed|pemetrexed|mesh-list
65153607|NCT01263782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65153608|NCT01263782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153609|NCT01263782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65153610|NCT01263782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65153611|NCT01263782|Growth Substances|growth substances|mesh-ancestor
65306765|NCT00661115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306766|NCT00661115|Urological Agents|urological agents|mesh-ancestor
65306767|NCT04157699|Tenofovir|tenofovir|mesh-list
65306768|NCT04157699|Antiviral Agents|antiviral agents|mesh-ancestor
65306769|NCT04157699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65306770|NCT04157699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65306771|NCT04157699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65306772|NCT04157699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306773|NCT04157699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306774|NCT04157699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65306775|NCT04157699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65153612|NCT01263782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153613|NCT01263782|Growth Inhibitors|growth inhibitors|mesh-ancestor
65153614|NCT01263782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153615|NCT01263782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153616|NCT01263782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65153617|NCT01263782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65153618|NCT01263704|Cyclophosphamide|cyclophosphamide|mesh-list
65153619|NCT01263704|Rituximab|rituximab|mesh-list
65153620|NCT01263704|Fludarabine|fludarabine|mesh-list
65153621|NCT01263704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65153622|NCT01263704|Immunologic Factors|immunologic factors|mesh-ancestor
65153623|NCT01263704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153624|NCT01263704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65153625|NCT01263704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65153626|NCT01263704|Alkylating Agents|alkylating agents|mesh-ancestor
65153627|NCT01263704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153628|NCT01263704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153629|NCT01263704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65153630|NCT01263704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65153631|NCT01263470|Alogliptin|alogliptin|mesh-list
65153632|NCT01263470|Voglibose|voglibose|mesh-list
65153633|NCT01263470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65153634|NCT01263470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153635|NCT01263470|Incretins|incretins|mesh-ancestor
65153636|NCT01263470|Hormones|hormones|mesh-ancestor
65153637|NCT01263470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65153638|NCT01263470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65153639|NCT01263470|Protease Inhibitors|protease inhibitors|mesh-ancestor
65153640|NCT01263470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153641|NCT01263470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153642|NCT01263470|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65153643|NCT04322786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65153644|NCT04322786|Protease Inhibitors|protease inhibitors|mesh-ancestor
65153645|NCT04322786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153646|NCT04322786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153647|NCT04322240|Thioctic Acid|thioctic acid|mesh-list
65153648|NCT04322240|Antioxidants|antioxidants|mesh-ancestor
65153649|NCT04322240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153650|NCT04322240|Protective Agents|protective agents|mesh-ancestor
65153651|NCT04322240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153652|NCT04322240|Vitamin B Complex|vitamin b complex|mesh-ancestor
65153653|NCT04322240|Vitamins|vitamins|mesh-ancestor
65153654|NCT04322240|Micronutrients|micronutrients|mesh-ancestor
65153655|NCT01262456|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65153656|NCT01262456|Hemostatics|hemostatics|mesh-ancestor
65153672|NCT04321616|Antimalarials|antimalarials|mesh-ancestor
65153673|NCT04321616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65153674|NCT04321616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65153675|NCT04321616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65153676|NCT04321616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153677|NCT04321616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306776|NCT00665717|Raltegravir Potassium|raltegravir potassium|mesh-list
65306777|NCT00665717|Pravastatin|pravastatin|mesh-list
65306778|NCT00665717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65306779|NCT00665717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65306780|NCT00665717|Antiviral Agents|antiviral agents|mesh-ancestor
65306781|NCT00665717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65306782|NCT00665717|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65306783|NCT00665717|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65306784|NCT00665717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306785|NCT00665717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306786|NCT00665717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65306787|NCT00665717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65306788|NCT00665717|Antimetabolites|antimetabolites|mesh-ancestor
65306789|NCT00665717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65306790|NCT00665717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65306791|NCT02611596|Ranolazine|ranolazine|mesh-list
65306792|NCT02611596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65306793|NCT02611596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65306794|NCT02611596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306795|NCT00661349|Ritonavir|ritonavir|mesh-list
65306796|NCT00661349|Lopinavir|lopinavir|mesh-list
65306797|NCT00661349|Nevirapine|nevirapine|mesh-list
65306798|NCT00661349|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65306799|NCT00661349|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65153678|NCT04321616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65153679|NCT04321616|Antimetabolites|antimetabolites|mesh-ancestor
65153680|NCT04321616|Antiviral Agents|antiviral agents|mesh-ancestor
65153681|NCT00932893|Docetaxel|docetaxel|mesh-list
65153682|NCT00932893|Pemetrexed|pemetrexed|mesh-list
65153683|NCT00932893|Crizotinib|crizotinib|mesh-list
65153684|NCT00932893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153685|NCT00932893|Tubulin Modulators|tubulin modulators|mesh-ancestor
65153686|NCT00932893|Antimitotic Agents|antimitotic agents|mesh-ancestor
65153687|NCT00932893|Mitosis Modulators|mitosis modulators|mesh-ancestor
65153688|NCT00932893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153689|NCT00932893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153690|NCT00932893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65153691|NCT00932893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65153692|NCT00932893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65153693|NCT04321070|Clindamycin|clindamycin|mesh-list
65153694|NCT04321070|Clindamycin palmitate|clindamycin palmitate|mesh-list
65153695|NCT04321070|Clindamycin phosphate|clindamycin phosphate|mesh-list
65153696|NCT04321070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65153697|NCT04321070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65153698|NCT04321070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65153699|NCT04321070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153700|NCT04321070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153701|NCT02889224|Hydrocortisone|hydrocortisone|mesh-list
65153702|NCT02889224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65153703|NCT01260896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65153704|NCT01260896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65153705|NCT01260896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65306800|NCT00661349|Protease Inhibitors|protease inhibitors|mesh-ancestor
65306801|NCT00661349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306802|NCT00661349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306803|NCT00661349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65306804|NCT00661349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65306805|NCT00661349|Antiviral Agents|antiviral agents|mesh-ancestor
65306806|NCT00661349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65306807|NCT00661349|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65306808|NCT00661349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65306809|NCT00661349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65306810|NCT00661349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65306811|NCT00661349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65306812|NCT00661349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65306813|NCT00665873|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65306814|NCT00665873|Amoxicillin|amoxicillin|mesh-list
65306815|NCT00665873|Clavulanic Acids|clavulanic acids|mesh-list
65306816|NCT00665873|Clavulanic Acid|clavulanic acid|mesh-list
65306817|NCT00665873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65306818|NCT00665873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65306819|NCT00665873|Antitubercular Agents|antitubercular agents|mesh-ancestor
65306820|NCT00665873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306821|NCT00665873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153706|NCT01260896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65153707|NCT01260896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153708|NCT01260896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65153709|NCT01260896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153710|NCT01260896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65153711|NCT01260896|Antidepressive Agents|antidepressive agents|mesh-ancestor
65153712|NCT01260896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65153713|NCT00939523|Lapatinib|lapatinib|mesh-list
65153714|NCT00939523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153715|NCT00939523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65153716|NCT00939523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153717|NCT00939523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153718|NCT01260584|Clopidogrel|clopidogrel|mesh-list
65153719|NCT01260584|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65153725|NCT01260584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65153726|NCT01260584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153727|NCT01260584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153728|NCT00607945|Rosiglitazone|rosiglitazone|mesh-list
65153729|NCT00607945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65153730|NCT00607945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153731|NCT04262635|Capecitabine|capecitabine|mesh-list
65153732|NCT04262635|Cetuximab|cetuximab|mesh-list
65153733|NCT04262635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65153734|NCT04262635|Antimetabolites|antimetabolites|mesh-ancestor
65153735|NCT04262635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153736|NCT04262635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153737|NCT04262635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65153738|NCT00608101|Dexamethasone|dexamethasone|mesh-list
65306822|NCT00665873|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65306823|NCT00707850|Ribavirin|ribavirin|mesh-list
65306824|NCT00707850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65306825|NCT00707850|Interferon-alpha|interferon-alpha|mesh-list
65306826|NCT00707850|Antimetabolites|antimetabolites|mesh-ancestor
65306827|NCT00707850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306828|NCT00707850|Antiviral Agents|antiviral agents|mesh-ancestor
65306829|NCT00707850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65306830|NCT00707850|Immunologic Factors|immunologic factors|mesh-ancestor
65306831|NCT00707850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306832|NCT00665951|Ritonavir|ritonavir|mesh-list
65306833|NCT00665951|Lopinavir|lopinavir|mesh-list
65306834|NCT00665951|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65306835|NCT00665951|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65306836|NCT00665951|Protease Inhibitors|protease inhibitors|mesh-ancestor
65306837|NCT00665951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306838|NCT00665951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306839|NCT00665951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65153739|NCT00608101|Fludrocortisone|fludrocortisone|mesh-list
65153740|NCT00608101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65153741|NCT00608101|Antiemetics|antiemetics|mesh-ancestor
65153742|NCT00608101|Autonomic Agents|autonomic agents|mesh-ancestor
65153743|NCT00608101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65153744|NCT00608101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153745|NCT00608101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65153746|NCT00608101|Glucocorticoids|glucocorticoids|mesh-ancestor
65153747|NCT00608101|Hormones|hormones|mesh-ancestor
65153748|NCT00608101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65153749|NCT00608101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65153750|NCT00608101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153751|NCT04264039|Fludarabine|fludarabine|mesh-list
65153752|NCT04264039|Cyclophosphamide|cyclophosphamide|mesh-list
65153753|NCT04264039|Melphalan|melphalan|mesh-list
65153754|NCT04264039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153755|NCT04264039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153756|NCT04264039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65153757|NCT04264039|Immunologic Factors|immunologic factors|mesh-ancestor
65153758|NCT04264039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153759|NCT04264039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65153760|NCT04264039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65153761|NCT04264039|Alkylating Agents|alkylating agents|mesh-ancestor
65153762|NCT04264039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65153763|NCT00608179|Glimepiride|glimepiride|mesh-list
65153764|NCT00608179|Glyburide|glyburide|mesh-list
65153765|NCT00608179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65153766|NCT00608179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65153767|NCT00608179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153768|NCT00608179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65153769|NCT00608179|Immunologic Factors|immunologic factors|mesh-ancestor
65153770|NCT00608335|Micafungin|micafungin|mesh-list
65153771|NCT00608335|Antifungal Agents|antifungal agents|mesh-ancestor
65153772|NCT00608335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65153773|NCT00927589|Carboplatin|carboplatin|mesh-list
65153774|NCT00927589|Docetaxel|docetaxel|mesh-list
65153775|NCT00927589|Trastuzumab|trastuzumab|mesh-list
65153776|NCT00927589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153777|NCT00927589|Tubulin Modulators|tubulin modulators|mesh-ancestor
65153778|NCT00927589|Antimitotic Agents|antimitotic agents|mesh-ancestor
65153779|NCT00927589|Mitosis Modulators|mitosis modulators|mesh-ancestor
65306840|NCT00665951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65306841|NCT00665951|Antiviral Agents|antiviral agents|mesh-ancestor
65306842|NCT00665951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65306843|NCT00665951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65306844|NCT00665951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65306845|NCT00661739|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65306846|NCT00661739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65306847|NCT00661739|Alkylating Agents|alkylating agents|mesh-ancestor
65306848|NCT00661739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153780|NCT00927589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153781|NCT00927589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65153782|NCT00932113|Folic Acid|folic acid|mesh-list
65153783|NCT00932113|Adalimumab|adalimumab|mesh-list
65153784|NCT00932113|Methotrexate|methotrexate|mesh-list
65153785|NCT00932113|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65153786|NCT00932113|Abortifacient Agents|abortifacient agents|mesh-ancestor
65153787|NCT00932113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65153788|NCT00932113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153791|NCT00932113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153793|NCT00932113|Dermatologic Agents|dermatologic agents|mesh-ancestor
65153794|NCT00932113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153795|NCT00932113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65153796|NCT00932113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65153797|NCT00932113|Immunologic Factors|immunologic factors|mesh-ancestor
65153798|NCT00932113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65153799|NCT00932113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65153800|NCT00932113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65153801|NCT00932113|Hematinics|hematinics|mesh-ancestor
65153802|NCT00932113|Vitamin B Complex|vitamin b complex|mesh-ancestor
65153803|NCT00932113|Vitamins|vitamins|mesh-ancestor
65153804|NCT00932113|Micronutrients|micronutrients|mesh-ancestor
65153805|NCT00931801|Tenofovir|tenofovir|mesh-list
65153806|NCT00931801|Emtricitabine|emtricitabine|mesh-list
65153807|NCT00931801|Raltegravir Potassium|raltegravir potassium|mesh-list
65153808|NCT00931801|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65153809|NCT00931801|Antiviral Agents|antiviral agents|mesh-ancestor
65153810|NCT00931801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65153811|NCT00931801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65153812|NCT00931801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65153813|NCT00931801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153814|NCT00931801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153815|NCT00931801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65153816|NCT00931801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65153817|NCT00931801|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65153818|NCT00931801|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65153819|NCT00931801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65153820|NCT00931801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65153821|NCT00931801|Protease Inhibitors|protease inhibitors|mesh-ancestor
65153822|NCT00931723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65153823|NCT00931723|Antidepressive Agents|antidepressive agents|mesh-ancestor
65153824|NCT00931723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65153825|NCT00931723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65153826|NCT00931723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65153827|NCT00931723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65153828|NCT00931723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153830|NCT05025397|Sevoflurane|sevoflurane|mesh-list
65153831|NCT05025397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65153832|NCT05025397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65153833|NCT05025397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153834|NCT05025397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65153835|NCT05025397|Anesthetics, General|anesthetics, general|mesh-ancestor
65153836|NCT05025397|Anesthetics|anesthetics|mesh-ancestor
65153837|NCT05025397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65153838|NCT05025397|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65153839|NCT00608803|Doxorubicin|doxorubicin|mesh-list
65306849|NCT00661739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65306850|NCT00878969|Valsartan|valsartan|mesh-list
65306851|NCT00878969|Ramipril|ramipril|mesh-list
65306852|NCT00878969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65306853|NCT00878969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65306854|NCT00878969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65306855|NCT00878969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65306856|NCT00878969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306857|NCT00878969|Protease Inhibitors|protease inhibitors|mesh-ancestor
65306858|NCT00878969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306859|NCT00843492|PENTA|penta|mesh-list
65306860|NCT00843492|Nadroparin|nadroparin|mesh-list
65306861|NCT00843492|Fondaparinux|fondaparinux|mesh-list
65306862|NCT00843492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65306863|NCT00843492|Antithrombins|antithrombins|mesh-ancestor
65306864|NCT00843492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65306865|NCT00843492|Protease Inhibitors|protease inhibitors|mesh-ancestor
65306866|NCT00843492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306867|NCT00843492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306868|NCT00843492|Anticoagulants|anticoagulants|mesh-ancestor
65306869|NCT00843492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65306870|NCT00843492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65306871|NCT00666107|Vaccines|vaccines|mesh-list
65306872|NCT00666107|Immunologic Factors|immunologic factors|mesh-ancestor
65306873|NCT00666107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306874|NCT00666185|Fluconazole|fluconazole|mesh-list
65306875|NCT00666185|Micafungin|micafungin|mesh-list
65306876|NCT00666185|Antifungal Agents|antifungal agents|mesh-ancestor
65306877|NCT00666185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65306878|NCT00666185|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65306879|NCT00666185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65306880|NCT00666185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306881|NCT00666185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306882|NCT00666185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65153840|NCT00608803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65153841|NCT00608803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153842|NCT00608803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65153843|NCT00608803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65153844|NCT00608803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153845|NCT00608803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153846|NCT00931255|Sirolimus|sirolimus|mesh-list
65306883|NCT00666185|Hormone Antagonists|hormone antagonists|mesh-ancestor
65306884|NCT00666185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65306885|NCT00666185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306886|NCT00666185|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65306887|NCT00666185|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65306888|NCT00913224|Diclofenac|diclofenac|mesh-list
65306889|NCT00913224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65306890|NCT00913224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65306891|NCT00913224|Analgesics|analgesics|mesh-ancestor
65306892|NCT00913224|Sensory System Agents|sensory system agents|mesh-ancestor
65306893|NCT00913224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65306894|NCT00913224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306895|NCT00913224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65306896|NCT00913224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65306897|NCT00913224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65306898|NCT00913224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306899|NCT00913224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306900|NCT00666341|Immunologic Factors|immunologic factors|mesh-list
65306901|NCT00666341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306902|NCT00661973|Budesonide|budesonide|mesh-list
65153847|NCT00931255|Tacrolimus|tacrolimus|mesh-list
65153848|NCT00931255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65153849|NCT00931255|Immunologic Factors|immunologic factors|mesh-ancestor
65153850|NCT00931255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153851|NCT00931255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65153852|NCT00931255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153853|NCT00931255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153854|NCT00931255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65153855|NCT00931255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65153856|NCT00931255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65153857|NCT00931255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153858|NCT00931255|Antifungal Agents|antifungal agents|mesh-ancestor
65153859|NCT00609193|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65153860|NCT00609193|Antidepressive Agents|antidepressive agents|mesh-ancestor
65153861|NCT00609193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65153862|NCT00609193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65153868|NCT00930553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153869|NCT04262089|Pembrolizumab|pembrolizumab|mesh-list
65153870|NCT04262089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65153871|NCT04262089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153872|NCT00609817|Dexamethasone|dexamethasone|mesh-list
65153873|NCT00609817|Bortezomib|bortezomib|mesh-list
65153874|NCT00609817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65153875|NCT00609817|Antiemetics|antiemetics|mesh-ancestor
65153876|NCT00609817|Autonomic Agents|autonomic agents|mesh-ancestor
65153877|NCT00609817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65153878|NCT00609817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153879|NCT00609817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65153880|NCT00609817|Glucocorticoids|glucocorticoids|mesh-ancestor
65153881|NCT00609817|Hormones|hormones|mesh-ancestor
64796456|NCT04469959|Levodopa|levodopa|mesh-list
65153882|NCT00609817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65153883|NCT00609817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65306903|NCT00661973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65306904|NCT00661973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65306905|NCT00661973|Autonomic Agents|autonomic agents|mesh-ancestor
65306906|NCT00661973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65306907|NCT00661973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306908|NCT00661973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65306909|NCT00661973|Respiratory System Agents|respiratory system agents|mesh-ancestor
65306910|NCT00661973|Glucocorticoids|glucocorticoids|mesh-ancestor
65306911|NCT00661973|Hormones|hormones|mesh-ancestor
65306912|NCT00661973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65153884|NCT00609817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153886|NCT00929695|Methylprednisolone|methylprednisolone|mesh-list
65153887|NCT00929695|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65153888|NCT00929695|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65153889|NCT00929695|Prednisolone|prednisolone|mesh-list
65153890|NCT00929695|Prednisolone acetate|prednisolone acetate|mesh-list
65153891|NCT00929695|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65153892|NCT00929695|Prednisolone phosphate|prednisolone phosphate|mesh-list
65153893|NCT00929695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65153894|NCT00929695|Glucocorticoids|glucocorticoids|mesh-ancestor
65153895|NCT00929695|Hormones|hormones|mesh-ancestor
65153896|NCT00929695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65153897|NCT00929695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153898|NCT00929695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65153899|NCT00929695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153900|NCT00929695|Antiemetics|antiemetics|mesh-ancestor
65153901|NCT00929695|Autonomic Agents|autonomic agents|mesh-ancestor
65153902|NCT00929695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65153903|NCT00929695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65153904|NCT00929695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65153905|NCT00929695|Protective Agents|protective agents|mesh-ancestor
65153906|NCT00609895|Insulin Glargine|insulin glargine|mesh-list
65153907|NCT00609895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65153908|NCT00609895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153909|NCT04261465|Paclitaxel|paclitaxel|mesh-list
65153910|NCT04261465|Carboplatin|carboplatin|mesh-list
65153911|NCT04261465|Olaparib|olaparib|mesh-list
65153912|NCT04261465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65153913|NCT04261465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153914|NCT04261465|Tubulin Modulators|tubulin modulators|mesh-ancestor
65153915|NCT04261465|Antimitotic Agents|antimitotic agents|mesh-ancestor
65153916|NCT04261465|Mitosis Modulators|mitosis modulators|mesh-ancestor
65153917|NCT04261465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153918|NCT04261465|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65153919|NCT04261465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153920|NCT04260607|Ketamine|ketamine|mesh-list
65153921|NCT04260607|Analgesics|analgesics|mesh-ancestor
65153922|NCT04260607|Sensory System Agents|sensory system agents|mesh-ancestor
65153923|NCT04260607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65153924|NCT04260607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153925|NCT04260607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65153926|NCT04260607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65153927|NCT04260607|Anesthetics, General|anesthetics, general|mesh-ancestor
65153928|NCT04260607|Anesthetics|anesthetics|mesh-ancestor
65153929|NCT04260607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65153930|NCT04260607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65153931|NCT04260607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65153932|NCT04260607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64950621|NCT00398034|Testosterone|testosterone|mesh-list
65153936|NCT00927355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153937|NCT00923845|Sirolimus|sirolimus|mesh-list
65153938|NCT00923845|Cyclophosphamide|cyclophosphamide|mesh-list
65153939|NCT00923845|Pentostatin|pentostatin|mesh-list
65153940|NCT00923845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65153941|NCT00923845|Immunologic Factors|immunologic factors|mesh-ancestor
65306913|NCT00666575|Gabapentin|gabapentin|mesh-list
65306914|NCT00666575|Analgesics|analgesics|mesh-ancestor
65306915|NCT00666575|Sensory System Agents|sensory system agents|mesh-ancestor
65306916|NCT00666575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65306917|NCT00666575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306918|NCT00666575|Anticonvulsants|anticonvulsants|mesh-ancestor
65306919|NCT00666575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65306920|NCT00666575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65306921|NCT00666575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65153942|NCT00923845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153943|NCT00923845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65153944|NCT00923845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65153945|NCT00923845|Alkylating Agents|alkylating agents|mesh-ancestor
65153946|NCT00923845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153947|NCT00923845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153948|NCT00923845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65153949|NCT00923845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65153950|NCT00923845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65153951|NCT00923845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65153952|NCT00923845|Antifungal Agents|antifungal agents|mesh-ancestor
65153953|NCT00923845|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65153954|NCT00923845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153955|NCT05052541|Dronabinol|dronabinol|mesh-list
64796535|NCT04280601|Vitamin D|vitamin d|mesh-list
65153957|NCT05052541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153958|NCT05052541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65153959|NCT05052541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65153960|NCT05052541|Analgesics|analgesics|mesh-ancestor
65153961|NCT05052541|Sensory System Agents|sensory system agents|mesh-ancestor
65153962|NCT05052541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65153963|NCT05052541|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65153964|NCT05052541|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65153965|NCT05052541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65153966|NCT05052541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153967|NCT05052541|Hormones|hormones|mesh-ancestor
65153968|NCT05052541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65153969|NCT04260685|Lidocaine|lidocaine|mesh-list
65153970|NCT04260685|Esmolol|esmolol|mesh-list
65153971|NCT04260685|Anesthetics, Local|anesthetics, local|mesh-ancestor
65153972|NCT04260685|Anesthetics|anesthetics|mesh-ancestor
65153973|NCT04260685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65153974|NCT04260685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153975|NCT04260685|Sensory System Agents|sensory system agents|mesh-ancestor
65153976|NCT04260685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65153977|NCT04260685|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65153978|NCT04260685|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65153979|NCT04260685|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65153980|NCT04260685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65153981|NCT04260685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153982|NCT04260685|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65153983|NCT04260685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65153984|NCT04260685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65153985|NCT04260685|Adrenergic Agents|adrenergic agents|mesh-ancestor
65153986|NCT04260685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65153987|NCT05052151|Dialysis Solutions|dialysis solutions|mesh-list
65153988|NCT05052151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65153989|NCT05013463|Hydroxychloroquine|hydroxychloroquine|mesh-list
65153990|NCT05013463|Indapamide|indapamide|mesh-list
65153991|NCT05013463|Antimalarials|antimalarials|mesh-ancestor
65153992|NCT05013463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65153993|NCT05013463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65153994|NCT05013463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65153995|NCT05013463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153996|NCT05013463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153997|NCT05013463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65306922|NCT00666575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65306923|NCT00666575|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65306924|NCT00666575|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65306925|NCT00666575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65306926|NCT00666575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306927|NCT00666575|Antimanic Agents|antimanic agents|mesh-ancestor
65306928|NCT00666653|Pramipexole|pramipexole|mesh-list
65306929|NCT00666653|Antioxidants|antioxidants|mesh-ancestor
65306930|NCT00666653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306931|NCT00666653|Protective Agents|protective agents|mesh-ancestor
65306932|NCT00666653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306933|NCT00666653|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65306934|NCT00666653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65306935|NCT00666653|Dopamine Agonists|dopamine agonists|mesh-ancestor
65306936|NCT00666653|Dopamine Agents|dopamine agents|mesh-ancestor
65306937|NCT00666653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65306938|NCT00707928|Nitroglycerin|nitroglycerin|mesh-list
65306939|NCT00707928|Vasodilator Agents|vasodilator agents|mesh-ancestor
65306940|NCT00666809|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65306941|NCT00666809|Vasodilator Agents|vasodilator agents|mesh-ancestor
65306942|NCT00666809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65306943|NCT00666809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65306944|NCT00666809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306945|NCT00666809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306946|NCT00666809|Urological Agents|urological agents|mesh-ancestor
65306947|NCT00666887|Minocycline|minocycline|mesh-list
65306948|NCT00666887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65306949|NCT00666887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65306950|NCT00667043|Fentanyl|fentanyl|mesh-list
65306951|NCT00667043|Midazolam|midazolam|mesh-list
65306952|NCT00667043|Remifentanil|remifentanil|mesh-list
65306953|NCT00667043|Propofol|propofol|mesh-list
65153998|NCT05013463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65153999|NCT05013463|Diuretics|diuretics|mesh-ancestor
65154000|NCT05013463|Natriuretic Agents|natriuretic agents|mesh-ancestor
65154001|NCT05013463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154002|NCT05013463|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65154003|NCT05013463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65154024|NCT00610909|Serotonin Agents|serotonin agents|mesh-ancestor
65154025|NCT00610909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154026|NCT00610909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65154027|NCT00610909|Antidepressive Agents|antidepressive agents|mesh-ancestor
65154028|NCT00610909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65306954|NCT00667043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65306955|NCT00667043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65306956|NCT00667043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306957|NCT00667043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65306958|NCT00667043|Anesthetics, General|anesthetics, general|mesh-ancestor
65306959|NCT00667043|Anesthetics|anesthetics|mesh-ancestor
65306960|NCT00667043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65306961|NCT00667043|Narcotics|narcotics|mesh-ancestor
65306962|NCT00667043|Analgesics|analgesics|mesh-ancestor
65306963|NCT00667043|Sensory System Agents|sensory system agents|mesh-ancestor
65306964|NCT00667043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65306965|NCT00667043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65306966|NCT00667043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65306967|NCT00667043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65306968|NCT00667043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65306969|NCT00667043|GABA Modulators|gaba modulators|mesh-ancestor
65306970|NCT00667043|GABA Agents|gaba agents|mesh-ancestor
65306971|NCT00667043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65306972|NCT00667043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306973|NCT02631473|Ritonavir|ritonavir|mesh-list
65306974|NCT02631473|Lopinavir|lopinavir|mesh-list
65306975|NCT02631473|Efavirenz|efavirenz|mesh-list
65306976|NCT02631473|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65306977|NCT02631473|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65306978|NCT02631473|Protease Inhibitors|protease inhibitors|mesh-ancestor
65306979|NCT02631473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65306980|NCT02631473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65306981|NCT02631473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65154029|NCT00610909|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65154030|NCT00610909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65154031|NCT00610909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154032|NCT00927901|Maleic acid|maleic acid|mesh-list
65154033|NCT00927901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154034|NCT00927901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154035|NCT04255771|Gemcitabine|gemcitabine|mesh-list
65154036|NCT04255771|Cisplatin|cisplatin|mesh-list
65154037|NCT04255771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154038|NCT04255771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65154039|NCT04255771|Antimetabolites|antimetabolites|mesh-ancestor
65154040|NCT04255771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154041|NCT04255771|Antiviral Agents|antiviral agents|mesh-ancestor
65154042|NCT04255771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65154043|NCT04255771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154044|NCT04255771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65154045|NCT04255771|Immunologic Factors|immunologic factors|mesh-ancestor
65154046|NCT04255771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154047|NCT01218204|Atorvastatin|atorvastatin|mesh-list
65154048|NCT01218204|Ezetimibe|ezetimibe|mesh-list
65154049|NCT01218204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65306982|NCT02631473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65306983|NCT02631473|Antiviral Agents|antiviral agents|mesh-ancestor
65306984|NCT02631473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65306985|NCT02631473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65306986|NCT02631473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65306987|NCT02631473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65306988|NCT02631473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65154050|NCT01218204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65154051|NCT01218204|Antimetabolites|antimetabolites|mesh-ancestor
65154052|NCT01218204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154053|NCT01218204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65154054|NCT01218204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64950763|NCT00051987|Bortezomib|bortezomib|mesh-list
65154060|NCT00926575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65154062|NCT00926575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65154063|NCT00926575|Respiratory System Agents|respiratory system agents|mesh-ancestor
65154064|NCT05456412|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
65154065|NCT05456412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65154066|NCT05456412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154067|NCT05456412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154068|NCT01217892|Metformin|metformin|mesh-list
65154069|NCT01217892|Dapagliflozin|dapagliflozin|mesh-list
65154070|NCT01217892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65154071|NCT01217892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154072|NCT01217892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65154073|NCT01217892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154074|NCT01217814|Leucovorin|leucovorin|mesh-list
65154075|NCT01217814|Folic Acid|folic acid|mesh-list
65154076|NCT01217814|Golimumab|golimumab|mesh-list
65154077|NCT01217814|Methotrexate|methotrexate|mesh-list
65154078|NCT01217814|Levoleucovorin|levoleucovorin|mesh-list
65154079|NCT01217814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65154080|NCT01217814|Abortifacient Agents|abortifacient agents|mesh-ancestor
65154081|NCT01217814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65154082|NCT01217814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154083|NCT01217814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65154084|NCT01217814|Antimetabolites|antimetabolites|mesh-ancestor
65154085|NCT01217814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154086|NCT01217814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154087|NCT01217814|Dermatologic Agents|dermatologic agents|mesh-ancestor
65154088|NCT01217814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154089|NCT01217814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65154090|NCT01217814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65154091|NCT01217814|Immunologic Factors|immunologic factors|mesh-ancestor
65154092|NCT01217814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65154093|NCT01217814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65154094|NCT01217814|Antidotes|antidotes|mesh-ancestor
65154095|NCT01217814|Protective Agents|protective agents|mesh-ancestor
65154096|NCT01217814|Vitamin B Complex|vitamin b complex|mesh-ancestor
65154097|NCT01217814|Vitamins|vitamins|mesh-ancestor
65154098|NCT01217814|Micronutrients|micronutrients|mesh-ancestor
65154099|NCT01217814|Hematinics|hematinics|mesh-ancestor
65154100|NCT01217814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65154101|NCT01217814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65154102|NCT01217190|Ondansetron|ondansetron|mesh-list
65154103|NCT01217190|Antiemetics|antiemetics|mesh-ancestor
65154105|NCT01217190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65154106|NCT01217190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154107|NCT01217190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65154108|NCT01217190|Antipruritics|antipruritics|mesh-ancestor
65154109|NCT01217190|Dermatologic Agents|dermatologic agents|mesh-ancestor
65154110|NCT01217190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65154111|NCT01217190|Serotonin Agents|serotonin agents|mesh-ancestor
65154112|NCT01217190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65154113|NCT01217190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154114|NCT01217190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65306989|NCT02631473|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65306990|NCT02631473|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65306991|NCT02631473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65306992|NCT02631473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65306993|NCT02631473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65306994|NCT00825162|Vaccines|vaccines|mesh-list
65306995|NCT00825162|Immunologic Factors|immunologic factors|mesh-ancestor
65306996|NCT00825162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65306997|NCT00662441|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65154115|NCT01217190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65154116|NCT01217190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65154117|NCT01217190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65154118|NCT01217190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65154119|NCT01136733|Everolimus|everolimus|mesh-list
65154120|NCT01136733|Lenvatinib|lenvatinib|mesh-list
65154121|NCT01136733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154122|NCT01136733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65154123|NCT01136733|Immunologic Factors|immunologic factors|mesh-ancestor
65154124|NCT01136733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154125|NCT01136733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65154126|NCT01136733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154131|NCT01136655|Budesonide|budesonide|mesh-list
65154132|NCT01136655|Formoterol Fumarate|formoterol fumarate|mesh-list
65154133|NCT01136655|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65154134|NCT01136655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65154135|NCT01136655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65154136|NCT01136655|Autonomic Agents|autonomic agents|mesh-ancestor
65154137|NCT01136655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65154138|NCT01136655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154139|NCT01136655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65154140|NCT01136655|Respiratory System Agents|respiratory system agents|mesh-ancestor
65154141|NCT01136655|Glucocorticoids|glucocorticoids|mesh-ancestor
65154142|NCT01136655|Hormones|hormones|mesh-ancestor
65154143|NCT01136655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65154144|NCT01136655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65154145|NCT01136655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65154146|NCT01136655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65154147|NCT01136655|Adrenergic Agents|adrenergic agents|mesh-ancestor
65154148|NCT01136655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65154149|NCT01136655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154150|NCT01135017|Dronedarone|dronedarone|mesh-list
65154151|NCT01135017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65154152|NCT01134705|Beclomethasone|beclomethasone|mesh-list
65154153|NCT01134705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65154154|NCT01134705|Glucocorticoids|glucocorticoids|mesh-ancestor
65154155|NCT01134705|Hormones|hormones|mesh-ancestor
65154156|NCT01134705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65154157|NCT01134705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154158|NCT01134705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65154159|NCT01134705|Respiratory System Agents|respiratory system agents|mesh-ancestor
65154160|NCT01134627|Minocycline|minocycline|mesh-list
65154161|NCT01134627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65154162|NCT01134627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65154163|NCT01134393|Amlodipine|amlodipine|mesh-list
65154164|NCT01134393|Telmisartan|telmisartan|mesh-list
65154165|NCT01134393|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
65154166|NCT01134393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65154167|NCT01134393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65154168|NCT01134393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65154169|NCT01134393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154170|NCT01134393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65154171|NCT01134393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154172|NCT01134393|Vasodilator Agents|vasodilator agents|mesh-ancestor
65154173|NCT01134393|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65306998|NCT00662441|Vasodilator Agents|vasodilator agents|mesh-ancestor
65306999|NCT00662441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65307000|NCT00662441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65307001|NCT00662441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307002|NCT00662441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307003|NCT00662441|Urological Agents|urological agents|mesh-ancestor
65307004|NCT00911573|Vancomycin|vancomycin|mesh-list
65307005|NCT00911573|Clindamycin|clindamycin|mesh-list
65307006|NCT00911573|Clindamycin palmitate|clindamycin palmitate|mesh-list
65307007|NCT00911573|Clindamycin phosphate|clindamycin phosphate|mesh-list
65307008|NCT00911573|Tigecycline|tigecycline|mesh-list
65307009|NCT00911573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65307010|NCT00911573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65307011|NCT00911573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65307012|NCT00911573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307013|NCT00911573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307014|NCT00667433|Tenofovir|tenofovir|mesh-list
65307015|NCT00667433|Emtricitabine|emtricitabine|mesh-list
65307016|NCT00667433|Raltegravir Potassium|raltegravir potassium|mesh-list
65307017|NCT00667433|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65307018|NCT00667433|Antiviral Agents|antiviral agents|mesh-ancestor
65307019|NCT00667433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65307020|NCT00667433|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65154174|NCT01134393|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65154175|NCT05331469|Insulin|insulin|mesh-list
65154176|NCT05331469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65154177|NCT05331469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154179|NCT00922441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65154180|NCT00922441|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65154181|NCT00922441|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65154182|NCT00922441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154183|NCT01217112|Cannabidiol|cannabidiol|mesh-list
65154184|NCT01217112|Anticonvulsants|anticonvulsants|mesh-ancestor
65154185|NCT01216332|Vaccines|vaccines|mesh-list
65154186|NCT01216332|Immunologic Factors|immunologic factors|mesh-ancestor
65154187|NCT01216332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154188|NCT00922207|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65154189|NCT00922207|Entecavir|entecavir|mesh-list
65154190|NCT00922207|Adefovir|adefovir|mesh-list
65154191|NCT00922207|Antiviral Agents|antiviral agents|mesh-ancestor
65154192|NCT00922207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65154193|NCT00922207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65154194|NCT00922207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65154195|NCT00922207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154199|NCT01134315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154201|NCT01134315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65154202|NCT01134315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154203|NCT01134315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65154204|NCT01134315|Vitamins|vitamins|mesh-ancestor
65154205|NCT01134315|Micronutrients|micronutrients|mesh-ancestor
65154206|NCT01134315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65154207|NCT01216176|Anastrozole|anastrozole|mesh-list
65307021|NCT00667433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65307022|NCT00667433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307023|NCT00667433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307024|NCT00667433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65307025|NCT00667433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65307026|NCT00667433|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65307027|NCT00667433|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65307028|NCT00662519|Lenograstim|lenograstim|mesh-list
65307029|NCT00662519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65307030|NCT00662519|Immunologic Factors|immunologic factors|mesh-ancestor
65307031|NCT00662519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307032|NCT00667901|Riluzole|riluzole|mesh-list
65307033|NCT00667901|Anticonvulsants|anticonvulsants|mesh-ancestor
65307034|NCT00667901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65307035|NCT00667901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65307036|NCT00667901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65307037|NCT00667901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307038|NCT00667901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307039|NCT00667901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65154208|NCT01216176|Saracatinib|saracatinib|mesh-list
65154209|NCT01216176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65154210|NCT01216176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154211|NCT01216176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65154212|NCT01216176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65154213|NCT01216176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154214|NCT01216176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154215|NCT01216176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65154216|NCT01216176|Hormone Antagonists|hormone antagonists|mesh-ancestor
65154217|NCT01216176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65154218|NCT01216176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154219|NCT01133847|Guanfacine|guanfacine|mesh-list
65154220|NCT01133847|Methylphenidate|methylphenidate|mesh-list
65154221|NCT01133847|Amphetamine|amphetamine|mesh-list
65154222|NCT01133847|Adderall|adderall|mesh-list
65154223|NCT01133847|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65154224|NCT01133847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65154225|NCT01133847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154226|NCT01133847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65154227|NCT01133847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65154228|NCT01133847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65154229|NCT01133847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154230|NCT01133847|Dopamine Agents|dopamine agents|mesh-ancestor
65154231|NCT01133847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65154232|NCT01133847|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65154233|NCT01133847|Adrenergic Agents|adrenergic agents|mesh-ancestor
65154234|NCT01133847|Sympathomimetics|sympathomimetics|mesh-ancestor
65154235|NCT01133847|Autonomic Agents|autonomic agents|mesh-ancestor
65154236|NCT01133847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65154237|NCT01133847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65154238|NCT01133847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65154239|NCT01133847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65154240|NCT01133847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65154241|NCT05310253|Fludrocortisone|fludrocortisone|mesh-list
65154242|NCT05310253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65307040|NCT00667901|Protective Agents|protective agents|mesh-ancestor
65307041|NCT00667979|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65307042|NCT00667979|Vasodilator Agents|vasodilator agents|mesh-ancestor
65307043|NCT00667979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65307044|NCT00667979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65307045|NCT00667979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307046|NCT00667979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307047|NCT00667979|Urological Agents|urological agents|mesh-ancestor
65307048|NCT00668057|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65307049|NCT00668057|Vasodilator Agents|vasodilator agents|mesh-ancestor
65307050|NCT00668057|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65307051|NCT00668057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65307052|NCT00668057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056954|NCT04536922|Fludarabine|fludarabine|mesh-list
65307053|NCT00668057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307054|NCT00668057|Urological Agents|urological agents|mesh-ancestor
65307055|NCT00668135|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65307056|NCT00668135|Vasodilator Agents|vasodilator agents|mesh-ancestor
65307057|NCT00668135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65307058|NCT00668135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65307059|NCT00668135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307060|NCT00668135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307061|NCT00668135|Urological Agents|urological agents|mesh-ancestor
65307062|NCT02630303|Coal Tar|coal tar|mesh-list
65307063|NCT02630303|Keratolytic Agents|keratolytic agents|mesh-ancestor
65154243|NCT01133379|Fluorides|fluorides|mesh-list
65154244|NCT01133379|Cariostatic Agents|cariostatic agents|mesh-ancestor
65154245|NCT01133379|Protective Agents|protective agents|mesh-ancestor
65154246|NCT01133379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154247|NCT04253353|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65154248|NCT04253353|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65154249|NCT04253353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65154250|NCT04253353|Antimetabolites|antimetabolites|mesh-ancestor
65154251|NCT04253353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154252|NCT04253353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65154253|NCT04253353|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65154254|NCT04253353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154255|NCT05154669|Nicotine|nicotine|mesh-list
65154256|NCT05154669|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65154257|NCT05154669|Autonomic Agents|autonomic agents|mesh-ancestor
65154258|NCT05154669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65154259|NCT05154669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154260|NCT05154669|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65154261|NCT05154669|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65154262|NCT05154669|Cholinergic Agents|cholinergic agents|mesh-ancestor
65154263|NCT05154669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65154264|NCT05154669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307064|NCT02630303|Dermatologic Agents|dermatologic agents|mesh-ancestor
65307065|NCT04155983|Ropivacaine|ropivacaine|mesh-list
65307066|NCT04155983|Anesthetics, Local|anesthetics, local|mesh-ancestor
65307067|NCT04155983|Anesthetics|anesthetics|mesh-ancestor
65307068|NCT04155983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65307069|NCT04155983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307070|NCT04155983|Sensory System Agents|sensory system agents|mesh-ancestor
65307071|NCT04155983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65307072|NCT00668603|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65307073|NCT00668603|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65307074|NCT00668603|Estradiol|estradiol|mesh-list
65307075|NCT00668603|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65307076|NCT00668603|Estrogens|estrogens|mesh-ancestor
65307077|NCT00668603|Hormones|hormones|mesh-ancestor
65307078|NCT00668603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65307079|NCT00668603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307080|NCT00668603|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65307081|NCT00668603|Contraceptive Agents|contraceptive agents|mesh-ancestor
65307082|NCT00668603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65307083|NCT00668603|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65307084|NCT00662987|Amoxicillin|amoxicillin|mesh-list
65307085|NCT00662987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65307086|NCT00662987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65307087|NCT00668759|Amiodarone|amiodarone|mesh-list
65307088|NCT00668759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65307089|NCT00668759|Vasodilator Agents|vasodilator agents|mesh-ancestor
65307090|NCT00668759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65307091|NCT00668759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65154269|NCT00637455|Histamine Antagonists|histamine antagonists|mesh-ancestor
65154271|NCT00637455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65154272|NCT00637455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154273|NCT00637455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154274|NCT00919711|Denosumab|denosumab|mesh-list
65154275|NCT00919711|Risedronic Acid|risedronic acid|mesh-list
65154276|NCT00919711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65154277|NCT00919711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154278|NCT00919711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65154279|NCT00919711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65154280|NCT00919711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154281|NCT00919711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65154282|NCT01131585|Ranibizumab|ranibizumab|mesh-list
65154283|NCT01131585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65154284|NCT01131585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65154285|NCT01131585|Growth Substances|growth substances|mesh-ancestor
65154286|NCT01131585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154287|NCT01131585|Growth Inhibitors|growth inhibitors|mesh-ancestor
65307092|NCT00668759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307093|NCT00668759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65307094|NCT00668759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65307095|NCT00668759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65307096|NCT00668759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307097|NCT00668759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65307098|NCT00668759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65307099|NCT00668759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65307100|NCT00668837|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65307101|NCT00668837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65307102|NCT00668837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65307103|NCT00668837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65307104|NCT00668837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307105|NCT00668837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65307106|NCT00668837|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65154288|NCT01131585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154289|NCT01131507|Pancrelipase|pancrelipase|mesh-list
65154290|NCT01131507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65154291|NCT00919633|Interferons|interferons|mesh-list
65154292|NCT00919633|Ribavirin|ribavirin|mesh-list
65154293|NCT00919633|Interferon-alpha|interferon-alpha|mesh-list
65154294|NCT00919633|Interferon alpha-2|interferon alpha-2|mesh-list
65154295|NCT00919633|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65154296|NCT00919633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154297|NCT00919633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154298|NCT00919633|Antiviral Agents|antiviral agents|mesh-ancestor
65154299|NCT00919633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65154300|NCT00919633|Antimetabolites|antimetabolites|mesh-ancestor
65154301|NCT00919633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154302|NCT00919633|Immunologic Factors|immunologic factors|mesh-ancestor
65154303|NCT05139225|Daratumumab|daratumumab|mesh-list
65154304|NCT05139225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154305|NCT00926029|Listerine|listerine|mesh-list
65154306|NCT00926029|Triclosan|triclosan|mesh-list
65154307|NCT00926029|Fluorides|fluorides|mesh-list
65154308|NCT00926029|Sodium Fluoride|sodium fluoride|mesh-list
65154309|NCT00926029|Cariostatic Agents|cariostatic agents|mesh-ancestor
65154310|NCT00926029|Protective Agents|protective agents|mesh-ancestor
65154311|NCT00926029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154312|NCT00926029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65154313|NCT00926029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65154314|NCT00926029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65154315|NCT00926029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65154316|NCT00926029|Antimetabolites|antimetabolites|mesh-ancestor
65154317|NCT00926029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154318|NCT00926029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65154319|NCT04254835|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
65154320|NCT04254835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65154321|NCT04254835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65154322|NCT04254913|Edaravone|edaravone|mesh-list
65154323|NCT04254913|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65154324|NCT04254913|Antioxidants|antioxidants|mesh-ancestor
64796917|NCT02995252|Tenofovir|tenofovir|mesh-list
65154325|NCT04254913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154326|NCT04254913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65154327|NCT04254913|Protective Agents|protective agents|mesh-ancestor
65154328|NCT04254913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154329|NCT01130493|Levodopa|levodopa|mesh-list
65154330|NCT01130493|Carbidopa|carbidopa|mesh-list
65307107|NCT00668837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65307108|NCT00668837|Serotonin Agents|serotonin agents|mesh-ancestor
65307109|NCT00668837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65307110|NCT00668837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307111|NCT00668837|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65307112|NCT00668837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65307113|NCT00668837|Dopamine Agents|dopamine agents|mesh-ancestor
65307114|NCT00663221|Vitamin D|vitamin d|mesh-list
65307115|NCT00663221|Calcium|calcium|mesh-list
65307116|NCT00663221|Vitamins|vitamins|mesh-ancestor
65307117|NCT00663221|Micronutrients|micronutrients|mesh-ancestor
65307118|NCT00663221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307119|NCT00663221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65307120|NCT00663221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65307121|NCT00824850|Vaccines|vaccines|mesh-list
65307122|NCT00824850|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65307123|NCT00824850|Immunologic Factors|immunologic factors|mesh-ancestor
65307124|NCT00824850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307125|NCT00596687|Insulin|insulin|mesh-list
65307126|NCT00596687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65307128|NCT00596687|Insulin glulisine|insulin glulisine|mesh-list
65307129|NCT00596687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65307130|NCT00596687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307131|NCT02631239|Dexamethasone|dexamethasone|mesh-list
65307132|NCT02631239|Methotrexate|methotrexate|mesh-list
65307133|NCT02631239|Etoposide|etoposide|mesh-list
65307134|NCT02631239|Pegaspargase|pegaspargase|mesh-list
65307135|NCT02631239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65307136|NCT02631239|Antiemetics|antiemetics|mesh-ancestor
65307137|NCT02631239|Autonomic Agents|autonomic agents|mesh-ancestor
65307138|NCT02631239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65307139|NCT02631239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307140|NCT02631239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65307141|NCT02631239|Glucocorticoids|glucocorticoids|mesh-ancestor
65307142|NCT02631239|Hormones|hormones|mesh-ancestor
65307143|NCT02631239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65307147|NCT02631239|Abortifacient Agents|abortifacient agents|mesh-ancestor
65307148|NCT02631239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65307149|NCT02631239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65307150|NCT02631239|Antimetabolites|antimetabolites|mesh-ancestor
65307151|NCT02631239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307152|NCT02631239|Dermatologic Agents|dermatologic agents|mesh-ancestor
65307153|NCT02631239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307154|NCT02631239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65307155|NCT02631239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65307156|NCT02631239|Immunologic Factors|immunologic factors|mesh-ancestor
65307157|NCT02631239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65307158|NCT02631239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65307159|NCT02631239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65307160|NCT02631239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65307161|NCT02631239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65154331|NCT01130493|Entacapone|entacapone|mesh-list
65154332|NCT01130493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65154333|NCT01130493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65154334|NCT01130493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65154335|NCT01130493|Dopamine Agents|dopamine agents|mesh-ancestor
65154344|NCT01130493|Dopamine Agonists|dopamine agonists|mesh-ancestor
65154345|NCT01130337|Capecitabine|capecitabine|mesh-list
65154346|NCT01130337|Oxaliplatin|oxaliplatin|mesh-list
65154347|NCT01130337|Trastuzumab|trastuzumab|mesh-list
65154348|NCT01130337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65154349|NCT01130337|Antimetabolites|antimetabolites|mesh-ancestor
65154350|NCT01130337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154351|NCT01130337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154352|NCT01130337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65154353|NCT04901689|Leronlimab|leronlimab|mesh-list
65154354|NCT04901689|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65154355|NCT04901689|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65154356|NCT04901689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154357|NCT04901689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65154358|NCT04901689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65154359|NCT04901689|Antiviral Agents|antiviral agents|mesh-ancestor
65154360|NCT04901689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65154361|NCT04252963|Streptokinase|streptokinase|mesh-list
65154362|NCT04252963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65154363|NCT04252963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65154364|NCT04252963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154365|NCT04258657|Paclitaxel|paclitaxel|mesh-list
65154366|NCT04258657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65154367|NCT04258657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154368|NCT04258657|Tubulin Modulators|tubulin modulators|mesh-ancestor
65154369|NCT04258657|Antimitotic Agents|antimitotic agents|mesh-ancestor
65154370|NCT04258657|Mitosis Modulators|mitosis modulators|mesh-ancestor
65154371|NCT04258657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154372|NCT01130103|Paroxetine|paroxetine|mesh-list
65154373|NCT01130103|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65154374|NCT01130103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65154375|NCT01130103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65154376|NCT01130103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154377|NCT01130103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65154378|NCT01130103|Serotonin Agents|serotonin agents|mesh-ancestor
65154379|NCT01130103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154380|NCT01130103|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65154381|NCT01130103|Antidepressive Agents|antidepressive agents|mesh-ancestor
65154382|NCT01130103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65307162|NCT00663377|Losartan|losartan|mesh-list
65307163|NCT00663377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65307164|NCT00663377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65307165|NCT00663377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65307166|NCT00663377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65307167|NCT00663377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307168|NCT00669149|Aspirin|aspirin|mesh-list
65307169|NCT00669149|Heparin|heparin|mesh-list
65307170|NCT00669149|Enoxaparin|enoxaparin|mesh-list
65307171|NCT00669149|Bivalirudin|bivalirudin|mesh-list
65307172|NCT00669149|Clopidogrel|clopidogrel|mesh-list
65307173|NCT00669149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65307174|NCT00669149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65307175|NCT00669149|Analgesics|analgesics|mesh-ancestor
65307176|NCT00669149|Sensory System Agents|sensory system agents|mesh-ancestor
65307177|NCT00669149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64537053|NCT01573442|Hormones|hormones|mesh-ancestor
65154383|NCT01130103|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65154384|NCT01130103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65154385|NCT01130103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154386|NCT04254523|Morphine|morphine|mesh-list
65154387|NCT04254523|Bupivacaine|bupivacaine|mesh-list
65154388|NCT04254523|Anesthetics, Local|anesthetics, local|mesh-ancestor
65154389|NCT04254523|Anesthetics|anesthetics|mesh-ancestor
65154390|NCT04254523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65154391|NCT04254523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154392|NCT04254523|Sensory System Agents|sensory system agents|mesh-ancestor
65154393|NCT04254523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65154394|NCT04254523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65154395|NCT04254523|Narcotics|narcotics|mesh-ancestor
65154396|NCT04254523|Analgesics|analgesics|mesh-ancestor
65154397|NCT00625209|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
65154398|NCT00625209|Hydrocortisone|hydrocortisone|mesh-list
65154399|NCT00625209|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65154401|NCT00625209|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65154402|NCT00625209|Fludrocortisone|fludrocortisone|mesh-list
65154403|NCT00625209|Protein C|protein c|mesh-list
65154404|NCT00625209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65154405|NCT00625209|Anticoagulants|anticoagulants|mesh-ancestor
65154406|NCT00625209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65154407|NCT00625209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65154408|NCT00625209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154409|NCT00625209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65154410|NCT04254601|Erythromycin|erythromycin|mesh-list
65154411|NCT04254601|Erythromycin Estolate|erythromycin estolate|mesh-list
65154412|NCT04254601|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65154413|NCT04254601|Erythromycin stearate|erythromycin stearate|mesh-list
65154414|NCT04254601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65154415|NCT04254601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65154416|NCT04254601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65154417|NCT04254601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65154418|NCT04254601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154419|NCT04254601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154420|NCT01129557|Valsartan|valsartan|mesh-list
65154421|NCT01129557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65154422|NCT01129557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65154423|NCT01129557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65154424|NCT01129557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154425|NCT04254679|Analgesics, Opioid|analgesics, opioid|mesh-list
65307178|NCT00669149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307179|NCT00669149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65307180|NCT00669149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65307181|NCT00669149|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65307182|NCT00669149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65307183|NCT00669149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307184|NCT00669149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65307185|NCT00669149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65307186|NCT00669149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307187|NCT00669149|Antipyretics|antipyretics|mesh-ancestor
65307188|NCT00669149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65307189|NCT00669149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65307190|NCT00669149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65307191|NCT00669149|Purinergic Agents|purinergic agents|mesh-ancestor
65307192|NCT00669149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65154426|NCT04254679|Analgesics|analgesics|mesh-list
65154427|NCT04254679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
65154428|NCT04254679|Narcotics|narcotics|mesh-ancestor
65154429|NCT04254679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65154430|NCT04254679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154431|NCT04254679|Sensory System Agents|sensory system agents|mesh-ancestor
65154432|NCT04254679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65154433|NCT01129011|Naproxen|naproxen|mesh-list
65154434|NCT01129011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65154435|NCT01129011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65154436|NCT01129011|Analgesics|analgesics|mesh-ancestor
65154437|NCT01129011|Sensory System Agents|sensory system agents|mesh-ancestor
65154438|NCT01129011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65154439|NCT01129011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154440|NCT01129011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65154441|NCT01129011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65154442|NCT01129011|Gout Suppressants|gout suppressants|mesh-ancestor
65154443|NCT01129011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65154444|NCT01129011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154445|NCT01129011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154446|NCT04252885|Ritonavir|ritonavir|mesh-list
65154447|NCT04252885|Lopinavir|lopinavir|mesh-list
65154448|NCT04252885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65154449|NCT04252885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65154450|NCT04252885|Protease Inhibitors|protease inhibitors|mesh-ancestor
65154451|NCT04252885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154452|NCT04252885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154453|NCT04252885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65154454|NCT04252885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65154455|NCT04252885|Antiviral Agents|antiviral agents|mesh-ancestor
65154456|NCT04252885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65154457|NCT04252885|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65154458|NCT04252885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65154460|NCT04258423|Tacrolimus|tacrolimus|mesh-list
65154461|NCT04258423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65154462|NCT04258423|Immunologic Factors|immunologic factors|mesh-ancestor
65154463|NCT04258423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154464|NCT04258423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65154465|NCT04258423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154466|NCT04258423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154467|NCT04258423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154468|NCT04962841|Metformin|metformin|mesh-list
65154469|NCT04962841|Amlodipine|amlodipine|mesh-list
65307193|NCT00669149|Anticoagulants|anticoagulants|mesh-ancestor
65307194|NCT00669149|Antithrombins|antithrombins|mesh-ancestor
65307195|NCT00669149|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65307196|NCT00669149|Protease Inhibitors|protease inhibitors|mesh-ancestor
65307197|NCT00663455|Cyclosporine|cyclosporine|mesh-list
65307198|NCT00663455|Cyclosporins|cyclosporins|mesh-list
65307199|NCT00663455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307200|NCT00663455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154470|NCT04962841|Ramipril|ramipril|mesh-list
65154471|NCT04962841|Nebivolol|nebivolol|mesh-list
65154472|NCT04962841|Rivastigmine|rivastigmine|mesh-list
65154473|NCT04962841|Sertraline|sertraline|mesh-list
65154474|NCT04962841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65154475|NCT04962841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154489|NCT04962841|Protease Inhibitors|protease inhibitors|mesh-ancestor
65154490|NCT04962841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154491|NCT04962841|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65154492|NCT04962841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65154493|NCT04962841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65154494|NCT04962841|Adrenergic Agents|adrenergic agents|mesh-ancestor
65154495|NCT04962841|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65154496|NCT04962841|Cholinergic Agents|cholinergic agents|mesh-ancestor
65154497|NCT04962841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65154498|NCT04962841|Protective Agents|protective agents|mesh-ancestor
65154499|NCT00919867|Guanfacine|guanfacine|mesh-list
65154500|NCT00919867|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65154501|NCT00919867|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65154502|NCT00919867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154503|NCT00919867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65154504|NCT00919867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65154505|NCT00919867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65154506|NCT00919867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154507|NCT00919867|Dopamine Agents|dopamine agents|mesh-ancestor
65154508|NCT00919867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65154509|NCT00919867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65154510|NCT00919867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65154511|NCT00919867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65154512|NCT00919867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65154513|NCT00919867|Adrenergic Agents|adrenergic agents|mesh-ancestor
65154514|NCT04252261|Sulforaphane|sulforaphane|mesh-list
65154515|NCT04252261|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65154516|NCT04252261|Protective Agents|protective agents|mesh-ancestor
65154517|NCT04252261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154518|NCT04252261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154519|NCT05069935|Cyclophosphamide|cyclophosphamide|mesh-list
65154520|NCT05069935|Fludarabine|fludarabine|mesh-list
65154521|NCT05069935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65154522|NCT05069935|Antibodies|antibodies|mesh-list
65154523|NCT05069935|Immunoglobulins|immunoglobulins|mesh-list
65154524|NCT05069935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65154525|NCT05069935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65154526|NCT05069935|Immunologic Factors|immunologic factors|mesh-ancestor
65154527|NCT05069935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154528|NCT05069935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65154529|NCT05069935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65154530|NCT05069935|Alkylating Agents|alkylating agents|mesh-ancestor
65154531|NCT05069935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154532|NCT05069935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154533|NCT05069935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65154534|NCT04251871|Interferons|interferons|mesh-list
65154543|NCT04251871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65154545|NCT04251871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154546|NCT04251871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154547|NCT04251871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65154548|NCT04251871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65154549|NCT04251871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65154550|NCT04251871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65154552|NCT04251871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307201|NCT00663455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65307202|NCT00663455|Immunologic Factors|immunologic factors|mesh-ancestor
65307203|NCT00663455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307204|NCT00663455|Antifungal Agents|antifungal agents|mesh-ancestor
65307205|NCT00663455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65307206|NCT00663455|Dermatologic Agents|dermatologic agents|mesh-ancestor
65307207|NCT00663455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65307208|NCT00663455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65307209|NCT00669695|Atorvastatin|atorvastatin|mesh-list
65307210|NCT00669695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65307211|NCT00669695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65307212|NCT00669695|Antimetabolites|antimetabolites|mesh-ancestor
65307213|NCT00669695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307214|NCT00669695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65307215|NCT00669695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64537093|NCT01572740|Hormones|hormones|mesh-ancestor
65154553|NCT01128621|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65154554|NCT01128621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65154555|NCT01128621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154556|NCT01128621|Incretins|incretins|mesh-ancestor
65154557|NCT01128621|Hormones|hormones|mesh-ancestor
65154558|NCT01128621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65154559|NCT01128621|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65154560|NCT01128621|Protease Inhibitors|protease inhibitors|mesh-ancestor
65154561|NCT01128621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154562|NCT01128621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154563|NCT00918463|Dasatinib|dasatinib|mesh-list
65154564|NCT00918463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154565|NCT00918463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65154566|NCT00918463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154567|NCT00918463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154568|NCT05330065|Bevacizumab|bevacizumab|mesh-list
65154569|NCT05330065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65154570|NCT05330065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154571|NCT05330065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65154572|NCT05330065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65154573|NCT05330065|Growth Substances|growth substances|mesh-ancestor
65154574|NCT05330065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154575|NCT05330065|Growth Inhibitors|growth inhibitors|mesh-ancestor
65154576|NCT01128543|Vinorelbine|vinorelbine|mesh-list
65154577|NCT01128543|Lapatinib|lapatinib|mesh-list
65154578|NCT01128543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65154579|NCT01128543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154580|NCT01128543|Tubulin Modulators|tubulin modulators|mesh-ancestor
65154581|NCT01128543|Antimitotic Agents|antimitotic agents|mesh-ancestor
65154582|NCT01128543|Mitosis Modulators|mitosis modulators|mesh-ancestor
65154583|NCT01128543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154584|NCT01128543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65154585|NCT01128543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154586|NCT01128387|Panitumumab|panitumumab|mesh-list
65154587|NCT01128387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65154588|NCT01128387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154589|NCT01214850|Vaccines|vaccines|mesh-list
65154590|NCT01214850|Immunologic Factors|immunologic factors|mesh-ancestor
65154591|NCT01214850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154592|NCT01128153|Saxagliptin|saxagliptin|mesh-list
65154593|NCT01128153|Incretins|incretins|mesh-ancestor
65154594|NCT01128153|Hormones|hormones|mesh-ancestor
65154595|NCT01128153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65307216|NCT00669695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307217|NCT00663689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65307218|NCT00663689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307219|NCT00663689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65307220|NCT00663689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307221|NCT00663689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307222|NCT00669773|Docetaxel|docetaxel|mesh-list
65307223|NCT00669773|Doxorubicin|doxorubicin|mesh-list
65307224|NCT00669773|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65307225|NCT00669773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307226|NCT00669773|Tubulin Modulators|tubulin modulators|mesh-ancestor
65307227|NCT00669773|Antimitotic Agents|antimitotic agents|mesh-ancestor
65307228|NCT00669773|Mitosis Modulators|mitosis modulators|mesh-ancestor
65307229|NCT00669773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307230|NCT00669773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65307231|NCT00669773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65154596|NCT01128153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154597|NCT01128153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65154598|NCT01128153|Protease Inhibitors|protease inhibitors|mesh-ancestor
65154599|NCT01128153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154600|NCT01128153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154601|NCT01128153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65154603|NCT00925015|Cetuximab|cetuximab|mesh-list
65154606|NCT00925015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65154607|NCT00925015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154608|NCT00925015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154609|NCT00925015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154610|NCT00925015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65154611|NCT00925015|Immunologic Factors|immunologic factors|mesh-ancestor
65154612|NCT00925015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154613|NCT01127763|Carboplatin|carboplatin|mesh-list
65154615|NCT01127763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154616|NCT01127763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65154617|NCT01127763|Immunologic Factors|immunologic factors|mesh-ancestor
65154618|NCT01127763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154619|NCT01127607|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65154620|NCT01127607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65154621|NCT01127607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154622|NCT01127607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65154623|NCT01127607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65154624|NCT01127607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65154625|NCT01127607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154627|NCT01127607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65154628|NCT00924781|Epoetin Alfa|epoetin alfa|mesh-list
65154629|NCT00924781|Hematinics|hematinics|mesh-ancestor
65154630|NCT01127451|Denileukin diftitox|denileukin diftitox|mesh-list
65154631|NCT01127451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154632|NCT01214616|Vinorelbine|vinorelbine|mesh-list
65154633|NCT01214616|Afatinib|afatinib|mesh-list
65154634|NCT01214616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65154635|NCT01214616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154636|NCT01214616|Tubulin Modulators|tubulin modulators|mesh-ancestor
65154637|NCT01214616|Antimitotic Agents|antimitotic agents|mesh-ancestor
65154638|NCT01214616|Mitosis Modulators|mitosis modulators|mesh-ancestor
65154639|NCT01214616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154640|NCT01214616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65154641|NCT01214616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307232|NCT00669773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65307233|NCT00669773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307234|NCT00824616|Insulin|insulin|mesh-list
65307235|NCT00824616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65307236|NCT00824616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307237|NCT00663845|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65307238|NCT00663845|Vasodilator Agents|vasodilator agents|mesh-ancestor
65307239|NCT00663845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65307240|NCT00663845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65307241|NCT00663845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307242|NCT00663845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307243|NCT00663845|Urological Agents|urological agents|mesh-ancestor
65307244|NCT00708240|Citalopram|citalopram|mesh-list
65307245|NCT00708240|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65307246|NCT00708240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65307247|NCT00708240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65307248|NCT00708240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307249|NCT00708240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65307250|NCT00708240|Serotonin Agents|serotonin agents|mesh-ancestor
65307251|NCT00708240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307252|NCT00708240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65307253|NCT00708240|Antidepressive Agents|antidepressive agents|mesh-ancestor
65307254|NCT00708240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65307255|NCT04155515|Ribavirin|ribavirin|mesh-list
65307256|NCT04155515|Yimitasvir|yimitasvir|mesh-list
65307257|NCT04155515|Antimetabolites|antimetabolites|mesh-ancestor
65307258|NCT04155515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307259|NCT04155515|Antiviral Agents|antiviral agents|mesh-ancestor
65154642|NCT01213836|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65154643|NCT01213836|Antidepressive Agents|antidepressive agents|mesh-ancestor
65154644|NCT01213836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65154645|NCT01213836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65154646|NCT01213836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65154647|NCT01213836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65154648|NCT01213836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154649|NCT01213524|Nicotine|nicotine|mesh-list
65154650|NCT01213524|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65154651|NCT01213524|Autonomic Agents|autonomic agents|mesh-ancestor
65154652|NCT01213524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65154653|NCT01213524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154654|NCT01213524|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65154655|NCT01213524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65154656|NCT01213524|Cholinergic Agents|cholinergic agents|mesh-ancestor
65154657|NCT01213524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65154658|NCT01213524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154659|NCT01212588|Mifepristone|mifepristone|mesh-list
65307260|NCT04155515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65307261|NCT00664001|Antioxidants|antioxidants|mesh-list
65307262|NCT00664001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307263|NCT00664001|Protective Agents|protective agents|mesh-ancestor
65307264|NCT00664001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307265|NCT00824382|Olodaterol|olodaterol|mesh-list
65307266|NCT00824382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65307267|NCT00824382|Autonomic Agents|autonomic agents|mesh-ancestor
65307268|NCT00824382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65307269|NCT00824382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307270|NCT00824382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64537150|NCT01536704|Nicotine|nicotine|mesh-list
65154660|NCT01212588|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65154661|NCT01212588|Abortifacient Agents|abortifacient agents|mesh-ancestor
65154662|NCT01212588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65154663|NCT01212588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154664|NCT01212588|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65154665|NCT01212588|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65154666|NCT01212588|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65154667|NCT01212588|Contraceptive Agents|contraceptive agents|mesh-ancestor
65154668|NCT01212588|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65154669|NCT01212588|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65154670|NCT01212588|Hormone Antagonists|hormone antagonists|mesh-ancestor
65154671|NCT01212588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65154673|NCT01212588|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65154674|NCT01212588|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65154675|NCT00918385|Dasatinib|dasatinib|mesh-list
65154676|NCT00918385|Nilutamide|nilutamide|mesh-list
65154687|NCT00637819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154689|NCT00637819|Immunologic Factors|immunologic factors|mesh-ancestor
65154690|NCT00637819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154691|NCT00631501|Doxycycline|doxycycline|mesh-list
65154692|NCT00631501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65154693|NCT00631501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65154694|NCT00631501|Antimalarials|antimalarials|mesh-ancestor
65154695|NCT00631501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65154696|NCT00631501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65154697|NCT04746547|Dolutegravir|dolutegravir|mesh-list
65154698|NCT04746547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65154699|NCT04746547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65154700|NCT04746547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154701|NCT04746547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154702|NCT04746547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65154703|NCT04746547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65154704|NCT04746547|Antiviral Agents|antiviral agents|mesh-ancestor
65154705|NCT04746547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65154706|NCT04782037|Calcium|calcium|mesh-list
65154707|NCT04782037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65154708|NCT04782037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154709|NCT00924469|Prednisone|prednisone|mesh-list
65154710|NCT00924469|Leuprolide|leuprolide|mesh-list
65154711|NCT00924469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65154712|NCT00924469|Glucocorticoids|glucocorticoids|mesh-ancestor
65154713|NCT00924469|Hormones|hormones|mesh-ancestor
65154714|NCT00924469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65154715|NCT00924469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154716|NCT00924469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65154717|NCT00924469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154718|NCT00924469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65154719|NCT00924469|Fertility Agents|fertility agents|mesh-ancestor
65154720|NCT00924469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65154721|NCT00631579|Rasburicase|rasburicase|mesh-list
65154722|NCT00631579|Gout Suppressants|gout suppressants|mesh-ancestor
65307271|NCT00824382|Respiratory System Agents|respiratory system agents|mesh-ancestor
65307272|NCT00670319|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65307273|NCT00670319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65307274|NCT00670319|Hormone Antagonists|hormone antagonists|mesh-ancestor
65307275|NCT00670319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65307276|NCT00670319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307277|NCT00670319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65307278|NCT00670319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65307279|NCT00670319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65307280|NCT00708318|Fentanyl|fentanyl|mesh-list
65307281|NCT00708318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65307282|NCT00708318|Narcotics|narcotics|mesh-ancestor
65307283|NCT00708318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65307284|NCT00708318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307285|NCT00708318|Analgesics|analgesics|mesh-ancestor
65307286|NCT00708318|Sensory System Agents|sensory system agents|mesh-ancestor
65307287|NCT00708318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65307288|NCT00708318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65307289|NCT00708318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65307290|NCT00708318|Anesthetics, General|anesthetics, general|mesh-ancestor
65307291|NCT00708318|Anesthetics|anesthetics|mesh-ancestor
65307292|NCT00670475|Piroxicam|piroxicam|mesh-list
65307293|NCT00670475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65307294|NCT00670475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65307295|NCT00670475|Analgesics|analgesics|mesh-ancestor
65154723|NCT00631579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65154724|NCT04256473|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65154725|NCT04256473|Saruplase|saruplase|mesh-list
65154726|NCT04256473|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65154727|NCT04256473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65154728|NCT04256473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154729|NCT00916357|Insulin|insulin|mesh-list
65154730|NCT00916357|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65154731|NCT00916357|Insulin Lispro|insulin lispro|mesh-list
65154732|NCT00916357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65154733|NCT00916357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154734|NCT00916279|Paclitaxel|paclitaxel|mesh-list
65154735|NCT00916279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65154736|NCT00916279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154737|NCT00916279|Tubulin Modulators|tubulin modulators|mesh-ancestor
65154738|NCT00916279|Antimitotic Agents|antimitotic agents|mesh-ancestor
65154739|NCT00916279|Mitosis Modulators|mitosis modulators|mesh-ancestor
65154747|NCT04318158|Fentanyl|fentanyl|mesh-list
65154748|NCT04318158|Dexmedetomidine|dexmedetomidine|mesh-list
65154749|NCT04318158|Bupivacaine|bupivacaine|mesh-list
65154750|NCT04318158|Anesthetics, Local|anesthetics, local|mesh-ancestor
65154751|NCT04318158|Anesthetics|anesthetics|mesh-ancestor
65154752|NCT04318158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65154753|NCT04318158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154754|NCT04318158|Sensory System Agents|sensory system agents|mesh-ancestor
65154755|NCT04318158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65307296|NCT00670475|Sensory System Agents|sensory system agents|mesh-ancestor
65307297|NCT00670475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65307298|NCT00670475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307299|NCT00670475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65307300|NCT00670475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65307301|NCT00670475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65307302|NCT00670475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307303|NCT00670475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307304|NCT04154033|Naltrexone|naltrexone|mesh-list
65307305|NCT04154033|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65307306|NCT04154033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65307307|NCT04154033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307308|NCT04154033|Sensory System Agents|sensory system agents|mesh-ancestor
65307309|NCT04154033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65307310|NCT05530356|Dextrans|dextrans|mesh-list
65307311|NCT05530356|Anticoagulants|anticoagulants|mesh-ancestor
65154756|NCT04318158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65154757|NCT04318158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65154758|NCT04318158|Analgesics|analgesics|mesh-ancestor
65154759|NCT04318158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65154760|NCT04318158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65154761|NCT04318158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65154762|NCT04318158|Adrenergic Agents|adrenergic agents|mesh-ancestor
65154763|NCT04318158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65154764|NCT04318158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154765|NCT04318158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65154766|NCT04318158|Narcotics|narcotics|mesh-ancestor
65154767|NCT04318158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65154768|NCT04318158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65154769|NCT04318158|Anesthetics, General|anesthetics, general|mesh-ancestor
65154770|NCT01207596|Hydromorphone|hydromorphone|mesh-list
65154771|NCT01207596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65154772|NCT01207596|Narcotics|narcotics|mesh-ancestor
65154773|NCT01207596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65154774|NCT01207596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154775|NCT01207596|Analgesics|analgesics|mesh-ancestor
65154776|NCT01207596|Sensory System Agents|sensory system agents|mesh-ancestor
65154777|NCT01207596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65154778|NCT00915343|Hydrocortisone|hydrocortisone|mesh-list
65154779|NCT00915343|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65154780|NCT00915343|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65154781|NCT00915343|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65154782|NCT00915343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65154783|NCT04203043|Pycnogenols|pycnogenols|mesh-list
65154784|NCT04203043|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65154785|NCT04203043|Immunologic Factors|immunologic factors|mesh-ancestor
65154786|NCT04203043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154787|NCT04203043|Antioxidants|antioxidants|mesh-ancestor
65154788|NCT04203043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154789|NCT04203043|Protective Agents|protective agents|mesh-ancestor
65154790|NCT04203043|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65154791|NCT04435015|Camostat|camostat|mesh-list
65154792|NCT04435015|Protease Inhibitors|protease inhibitors|mesh-ancestor
65154793|NCT04435015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154794|NCT04435015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154795|NCT04435015|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65154796|NCT04435015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65154797|NCT00631813|Prucalopride|prucalopride|mesh-list
65154798|NCT00631813|Laxatives|laxatives|mesh-ancestor
65307312|NCT05530356|Plasma Substitutes|plasma substitutes|mesh-ancestor
65307313|NCT05530356|Blood Substitutes|blood substitutes|mesh-ancestor
65307314|NCT00664313|Linezolid|linezolid|mesh-list
65307315|NCT00664313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65307316|NCT00664313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65307317|NCT00664313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65307318|NCT00664313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307319|NCT00664313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307320|NCT00670553|Panobinostat|panobinostat|mesh-list
65307321|NCT00670553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307322|NCT00670553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65307323|NCT00670553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307324|NCT00670553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307325|NCT00833040|Sufentanil|sufentanil|mesh-list
65307326|NCT00833040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65307327|NCT00833040|Narcotics|narcotics|mesh-ancestor
65307328|NCT00833040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65307329|NCT00833040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307330|NCT00833040|Analgesics|analgesics|mesh-ancestor
65307331|NCT00833040|Sensory System Agents|sensory system agents|mesh-ancestor
65307332|NCT00833040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65307333|NCT00833040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65307334|NCT00833040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65307335|NCT00833040|Anesthetics, General|anesthetics, general|mesh-ancestor
65307336|NCT00833040|Anesthetics|anesthetics|mesh-ancestor
65307337|NCT02629835|Dexamethasone|dexamethasone|mesh-list
65307338|NCT02629835|Dexamethasone acetate|dexamethasone acetate|mesh-list
65154799|NCT00631813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65154800|NCT00631813|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65154801|NCT00631813|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65154802|NCT00631813|Serotonin Agents|serotonin agents|mesh-ancestor
65154803|NCT00631813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65154804|NCT00631813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154805|NCT00631813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154811|NCT04636255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65154812|NCT04636255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154813|NCT04911517|Capecitabine|capecitabine|mesh-list
65154814|NCT04911517|Antibodies|antibodies|mesh-list
65154815|NCT04911517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65154816|NCT04911517|Immunologic Factors|immunologic factors|mesh-ancestor
65154817|NCT04911517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154818|NCT04911517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65154819|NCT04911517|Antimetabolites|antimetabolites|mesh-ancestor
65154820|NCT04911517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154821|NCT04911517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154822|NCT03899857|Pembrolizumab|pembrolizumab|mesh-list
65154823|NCT03899857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65154824|NCT03899857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154825|NCT00637897|Paclitaxel|paclitaxel|mesh-list
65307339|NCT02629835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65307340|NCT02629835|BB 1101|bb 1101|mesh-list
65307341|NCT02629835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65307342|NCT02629835|Antiemetics|antiemetics|mesh-ancestor
65307343|NCT02629835|Autonomic Agents|autonomic agents|mesh-ancestor
65307344|NCT02629835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65307345|NCT02629835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307346|NCT02629835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65307347|NCT02629835|Glucocorticoids|glucocorticoids|mesh-ancestor
65307348|NCT02629835|Hormones|hormones|mesh-ancestor
65307349|NCT02629835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65154826|NCT00637897|Docetaxel|docetaxel|mesh-list
65154827|NCT00637897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65154828|NCT00637897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65154829|NCT00637897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154830|NCT00637897|Tubulin Modulators|tubulin modulators|mesh-ancestor
65154831|NCT00637897|Antimitotic Agents|antimitotic agents|mesh-ancestor
65154832|NCT00637897|Mitosis Modulators|mitosis modulators|mesh-ancestor
65154833|NCT00637897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154834|NCT03992443|Reteplase|reteplase|mesh-list
65154835|NCT03992443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65154836|NCT03992443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65154837|NCT03992443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154838|NCT04329949|Paclitaxel|paclitaxel|mesh-list
65154839|NCT04329949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65154840|NCT04329949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154841|NCT04329949|Tubulin Modulators|tubulin modulators|mesh-ancestor
65154842|NCT04329949|Antimitotic Agents|antimitotic agents|mesh-ancestor
65154843|NCT04329949|Mitosis Modulators|mitosis modulators|mesh-ancestor
65154844|NCT04329949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154845|NCT04597099|Flutamide|flutamide|mesh-list
65154846|NCT04597099|Estradiol|estradiol|mesh-list
65154847|NCT04597099|Progesterone|progesterone|mesh-list
65154848|NCT04597099|Estrogens|estrogens|mesh-ancestor
65154849|NCT04597099|Hormones|hormones|mesh-ancestor
65154850|NCT04597099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65154851|NCT04597099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154852|NCT04597099|Progestins|progestins|mesh-ancestor
65154853|NCT04597099|Androgen Antagonists|androgen antagonists|mesh-ancestor
65154854|NCT04597099|Hormone Antagonists|hormone antagonists|mesh-ancestor
65154855|NCT04597099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65154856|NCT04597099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154857|NCT04816513|Ustekinumab|ustekinumab|mesh-list
65154858|NCT04816513|Dermatologic Agents|dermatologic agents|mesh-ancestor
65154859|NCT04203511|Paclitaxel|paclitaxel|mesh-list
65154860|NCT04203511|Etoposide|etoposide|mesh-list
65154861|NCT04203511|Carboplatin|carboplatin|mesh-list
65154862|NCT04203511|Pemetrexed|pemetrexed|mesh-list
65154863|NCT04203511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65154864|NCT04203511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154865|NCT04203511|Tubulin Modulators|tubulin modulators|mesh-ancestor
65154866|NCT04203511|Antimitotic Agents|antimitotic agents|mesh-ancestor
65154867|NCT04203511|Mitosis Modulators|mitosis modulators|mesh-ancestor
65154868|NCT04203511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154869|NCT04203511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65154870|NCT04203511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65154871|NCT04203511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154872|NCT04203511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65154873|NCT04203511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65154874|NCT03690037|Tranexamic Acid|tranexamic acid|mesh-list
65154875|NCT03690037|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65154876|NCT03690037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65154877|NCT03690037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154878|NCT03690037|Hemostatics|hemostatics|mesh-ancestor
65154879|NCT03690037|Coagulants|coagulants|mesh-ancestor
65154881|NCT00910273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65307350|NCT02629835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65307351|NCT02629835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307353|NCT02629835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307354|NCT02629835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307355|NCT00664469|Atorvastatin|atorvastatin|mesh-list
65307356|NCT00664469|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65307357|NCT00664469|Simvastatin|simvastatin|mesh-list
65307358|NCT00664469|Ezetimibe|ezetimibe|mesh-list
65307359|NCT00664469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65307360|NCT00664469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65307361|NCT00664469|Antimetabolites|antimetabolites|mesh-ancestor
65307362|NCT00664469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307363|NCT00664469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65307364|NCT00664469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65307365|NCT00664469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307366|NCT00843024|Naproxen|naproxen|mesh-list
65307367|NCT00843024|Sumatriptan|sumatriptan|mesh-list
65307368|NCT00843024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65307369|NCT00843024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65307370|NCT00843024|Analgesics|analgesics|mesh-ancestor
65307371|NCT00843024|Sensory System Agents|sensory system agents|mesh-ancestor
65307372|NCT00843024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65307373|NCT00843024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307374|NCT00843024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65307375|NCT00843024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65307376|NCT00843024|Gout Suppressants|gout suppressants|mesh-ancestor
65307377|NCT00843024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65307378|NCT00843024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344937|NCT00864136|Levonorgestrel|levonorgestrel|mesh-list
65154883|NCT00910273|Analgesics|analgesics|mesh-ancestor
65154884|NCT00910273|Sensory System Agents|sensory system agents|mesh-ancestor
65154885|NCT00910273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65154886|NCT00910273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154887|NCT00910273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65154888|NCT00910273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65154889|NCT00910273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65154890|NCT00910273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65154891|NCT00910273|Immunologic Factors|immunologic factors|mesh-ancestor
65154892|NCT04156087|Gemcitabine|gemcitabine|mesh-list
65154893|NCT04156087|Durvalumab|durvalumab|mesh-list
65154894|NCT04156087|Tremelimumab|tremelimumab|mesh-list
65154895|NCT04156087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65154896|NCT04156087|Antimetabolites|antimetabolites|mesh-ancestor
65154897|NCT04156087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154898|NCT04156087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154899|NCT04156087|Antiviral Agents|antiviral agents|mesh-ancestor
65154900|NCT04156087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65307379|NCT00843024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307380|NCT00843024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65307381|NCT00843024|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65307382|NCT00843024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65307383|NCT00843024|Serotonin Agents|serotonin agents|mesh-ancestor
65154901|NCT04156087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154902|NCT04156087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65154903|NCT04156087|Immunologic Factors|immunologic factors|mesh-ancestor
65154904|NCT04156087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154905|NCT04156087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65154907|NCT00910039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154908|NCT00910039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65154909|NCT00910039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65154910|NCT00910039|Growth Substances|growth substances|mesh-ancestor
65154911|NCT00910039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154912|NCT00910039|Growth Inhibitors|growth inhibitors|mesh-ancestor
65154913|NCT00910039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65154914|NCT00910039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154915|NCT00910039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154916|NCT00909181|Mandelic Acids|mandelic acids|mesh-list
65154917|NCT00909181|Oxybutynin|oxybutynin|mesh-list
65154918|NCT00909181|Parasympatholytics|parasympatholytics|mesh-ancestor
65154919|NCT00909181|Autonomic Agents|autonomic agents|mesh-ancestor
65154920|NCT00909181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65154921|NCT00909181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154922|NCT00909181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65154923|NCT00909181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65154924|NCT00909181|Cholinergic Agents|cholinergic agents|mesh-ancestor
65154925|NCT00909181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65154926|NCT00909181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154927|NCT00909181|Urological Agents|urological agents|mesh-ancestor
65154928|NCT00909181|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65154929|NCT00909181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65154930|NCT00909181|Renal Agents|renal agents|mesh-ancestor
65154931|NCT05579665|Hyaluronic Acid|hyaluronic acid|mesh-list
65154932|NCT05579665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65154933|NCT05579665|Immunologic Factors|immunologic factors|mesh-ancestor
65154934|NCT05579665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154935|NCT05579665|Viscosupplements|viscosupplements|mesh-ancestor
65154936|NCT05579665|Protective Agents|protective agents|mesh-ancestor
65154937|NCT01286987|Talazoparib|talazoparib|mesh-list
65154938|NCT01286987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65154939|NCT01286987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154940|NCT01286987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154941|NCT01286987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154942|NCT01286753|Vemurafenib|vemurafenib|mesh-list
65154943|NCT01286753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154944|NCT01286753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65154945|NCT01286753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154946|NCT01286753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154947|NCT01284959|Risperidone|risperidone|mesh-list
65154948|NCT01284959|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65154949|NCT01284959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65154950|NCT01284959|Serotonin Agents|serotonin agents|mesh-ancestor
65154951|NCT01284959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65154952|NCT01284959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154953|NCT01284959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154960|NCT01284959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65154961|NCT01284959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65154962|NCT01283009|Methylprednisolone|methylprednisolone|mesh-list
65154963|NCT01283009|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65154964|NCT01283009|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65154965|NCT01283009|Prednisolone|prednisolone|mesh-list
65154966|NCT01283009|Prednisolone acetate|prednisolone acetate|mesh-list
65154967|NCT01283009|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65154968|NCT01283009|Prednisolone phosphate|prednisolone phosphate|mesh-list
65154969|NCT01283009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65154970|NCT01283009|Antiemetics|antiemetics|mesh-ancestor
65307384|NCT00843024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65307385|NCT04154813|Topiramate|topiramate|mesh-list
65307386|NCT04154813|Fluoxetine|fluoxetine|mesh-list
65307387|NCT04154813|Anticonvulsants|anticonvulsants|mesh-ancestor
65307388|NCT04154813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65307389|NCT04154813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307390|NCT04154813|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65307391|NCT04154813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65307392|NCT04154813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64301957|NCT03072290|Hormones|hormones|mesh-ancestor
65154971|NCT01283009|Autonomic Agents|autonomic agents|mesh-ancestor
64688351|NCT03123913|Hormones|hormones|mesh-ancestor
65154973|NCT01283009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154974|NCT01283009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65154975|NCT01283009|Glucocorticoids|glucocorticoids|mesh-ancestor
65154976|NCT01283009|Hormones|hormones|mesh-ancestor
65154977|NCT01283009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65154978|NCT01283009|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65154979|NCT01283009|Protective Agents|protective agents|mesh-ancestor
65154980|NCT01283009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65154981|NCT01283009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154982|NCT01282463|Docetaxel|docetaxel|mesh-list
65154983|NCT01282463|Ramucirumab|ramucirumab|mesh-list
65154984|NCT01282463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154985|NCT01282463|Tubulin Modulators|tubulin modulators|mesh-ancestor
65154986|NCT01282463|Antimitotic Agents|antimitotic agents|mesh-ancestor
65154987|NCT01282463|Mitosis Modulators|mitosis modulators|mesh-ancestor
65154988|NCT01282463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154989|NCT01281917|Sirolimus|sirolimus|mesh-list
65154990|NCT01281917|Bortezomib|bortezomib|mesh-list
65154991|NCT01281917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154992|NCT01281917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65154993|NCT01281917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65154994|NCT01281917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65154995|NCT01281917|Antifungal Agents|antifungal agents|mesh-ancestor
65154996|NCT01281917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65154997|NCT01281917|Immunologic Factors|immunologic factors|mesh-ancestor
65154998|NCT01281917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797597|NCT01386177|Doxazosin|doxazosin|mesh-list
65154999|NCT01281839|Ribavirin|ribavirin|mesh-list
65155000|NCT01281839|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65155001|NCT01281839|Simeprevir|simeprevir|mesh-list
65155002|NCT01281839|Antimetabolites|antimetabolites|mesh-ancestor
65155003|NCT01281839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155004|NCT01281839|Antiviral Agents|antiviral agents|mesh-ancestor
65155005|NCT01281839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65155006|NCT01281839|Protease Inhibitors|protease inhibitors|mesh-ancestor
65155007|NCT01281839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155008|NCT01280981|Tranexamic Acid|tranexamic acid|mesh-list
65155009|NCT01280981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65155010|NCT01280981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65155011|NCT01280981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155012|NCT01280981|Hemostatics|hemostatics|mesh-ancestor
65155013|NCT01280981|Coagulants|coagulants|mesh-ancestor
65155014|NCT02889653|Anticoagulants|anticoagulants|mesh-list
65155015|NCT01280591|Naproxen|naproxen|mesh-list
65155016|NCT01280591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65155017|NCT01280591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65155018|NCT01280591|Analgesics|analgesics|mesh-ancestor
65155019|NCT01280591|Sensory System Agents|sensory system agents|mesh-ancestor
65155020|NCT01280591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155021|NCT01280591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155022|NCT01280591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65155023|NCT01280591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64951723|NCT00055341|Ribavirin|ribavirin|mesh-list
65155029|NCT04323761|Antimetabolites|antimetabolites|mesh-ancestor
65155030|NCT04323761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155031|NCT04323761|Antiviral Agents|antiviral agents|mesh-ancestor
65307393|NCT04154813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307394|NCT04154813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65307395|NCT04154813|Serotonin Agents|serotonin agents|mesh-ancestor
65307396|NCT04154813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65307397|NCT04154813|Antidepressive Agents|antidepressive agents|mesh-ancestor
65307398|NCT04154813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65307399|NCT04154813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65307400|NCT04154813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65307401|NCT04154813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307402|NCT00664703|Methylphenidate|methylphenidate|mesh-list
65307403|NCT00664703|Lobeline|lobeline|mesh-list
65307404|NCT00664703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65307405|NCT00664703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307406|NCT00664703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65307407|NCT00664703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65307408|NCT00664703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65307409|NCT00664703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307410|NCT00664703|Dopamine Agents|dopamine agents|mesh-ancestor
65155032|NCT04323761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65155034|NCT05566223|Cyclophosphamide|cyclophosphamide|mesh-list
65155035|NCT05566223|Pembrolizumab|pembrolizumab|mesh-list
65155036|NCT05566223|Fludarabine|fludarabine|mesh-list
65155037|NCT05566223|Interleukin-2|interleukin-2|mesh-list
65155038|NCT05566223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65155039|NCT05566223|Immunologic Factors|immunologic factors|mesh-ancestor
65155040|NCT05566223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155041|NCT05566223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65155042|NCT05566223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65155043|NCT05566223|Alkylating Agents|alkylating agents|mesh-ancestor
65155044|NCT05566223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155045|NCT05566223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155046|NCT05566223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65155047|NCT05566223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65155048|NCT05566223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65155049|NCT05566223|Analgesics|analgesics|mesh-ancestor
65155050|NCT05566223|Sensory System Agents|sensory system agents|mesh-ancestor
65155051|NCT05566223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155052|NCT05566223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65155053|NCT05566223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65155054|NCT05566223|Antiviral Agents|antiviral agents|mesh-ancestor
65155055|NCT05566223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65155056|NCT01271933|Pregabalin|pregabalin|mesh-list
65155057|NCT01271933|Analgesics|analgesics|mesh-ancestor
65155058|NCT01271933|Sensory System Agents|sensory system agents|mesh-ancestor
65155059|NCT01271933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155060|NCT01271933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155061|NCT01271933|Anticonvulsants|anticonvulsants|mesh-ancestor
65155062|NCT01271933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65155063|NCT01271933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65155064|NCT01271933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155065|NCT01271933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65155066|NCT01271933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65155067|NCT01271933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65155068|NCT01271933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65307411|NCT00664703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65307412|NCT00664703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65307413|NCT00664703|Autonomic Agents|autonomic agents|mesh-ancestor
65307414|NCT00664703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65307415|NCT00664703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65307416|NCT00664703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65307417|NCT00664703|Cholinergic Agents|cholinergic agents|mesh-ancestor
65307418|NCT00664703|Respiratory System Agents|respiratory system agents|mesh-ancestor
65307419|NCT00670787|Losartan|losartan|mesh-list
65307420|NCT00670787|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65307421|NCT00670787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65307422|NCT00670787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65307423|NCT00670787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65307424|NCT00670787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65307425|NCT00670787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307426|NCT00670787|Diuretics|diuretics|mesh-ancestor
65307427|NCT00670787|Natriuretic Agents|natriuretic agents|mesh-ancestor
65307428|NCT00670787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307429|NCT00670787|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65307430|NCT00670787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65307431|NCT00664781|Rucaparib|rucaparib|mesh-list
65307432|NCT00664781|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65155069|NCT01271933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65155070|NCT01269125|Leuprolide|leuprolide|mesh-list
65155071|NCT01269125|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65155072|NCT01269125|Fertility Agents|fertility agents|mesh-ancestor
65155073|NCT01269125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65155074|NCT01269125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155075|NCT01269125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65155077|NCT01268891|Rasagiline|rasagiline|mesh-list
65155078|NCT01268891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65155079|NCT01268891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155080|NCT01268891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155081|NCT01268891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65155082|NCT01268891|Protective Agents|protective agents|mesh-ancestor
65155083|NCT01268891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155084|NCT04323527|Chloroquine|chloroquine|mesh-list
65155085|NCT04323527|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65155086|NCT04323527|Amebicides|amebicides|mesh-ancestor
65155087|NCT04323527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65155088|NCT04323527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65155089|NCT04323527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65155090|NCT04323527|Antimalarials|antimalarials|mesh-ancestor
65155091|NCT04323527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65155092|NCT04323527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65155093|NCT04323527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65155094|NCT04323527|Analgesics|analgesics|mesh-ancestor
65155102|NCT01267175|Insulin|insulin|mesh-list
65155103|NCT01267175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65155104|NCT01267175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155105|NCT02889497|Vaccines|vaccines|mesh-list
65155106|NCT02889497|Immunologic Factors|immunologic factors|mesh-ancestor
65155107|NCT02889497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307433|NCT00664781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307434|NCT00664781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307435|NCT00664781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307436|NCT00832650|Solifenacin Succinate|solifenacin succinate|mesh-list
65307437|NCT00832650|Fesoterodine|fesoterodine|mesh-list
65307438|NCT00832650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65307439|NCT00832650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65307440|NCT00832650|Cholinergic Agents|cholinergic agents|mesh-ancestor
65307441|NCT00832650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65307442|NCT00832650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307443|NCT00832650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307444|NCT00832650|Urological Agents|urological agents|mesh-ancestor
65307445|NCT04153487|Ascorbic Acid|ascorbic acid|mesh-list
65307446|NCT04153487|Vitamins|vitamins|mesh-ancestor
65307447|NCT04153487|Micronutrients|micronutrients|mesh-ancestor
65307448|NCT04153487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307449|NCT04153487|Antioxidants|antioxidants|mesh-ancestor
65307450|NCT04153487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307451|NCT04153487|Protective Agents|protective agents|mesh-ancestor
65307452|NCT00708396|Citalopram|citalopram|mesh-list
65307453|NCT00708396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64537310|NCT01440595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65155108|NCT01266317|Rituximab|rituximab|mesh-list
65155109|NCT01266317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65155110|NCT01266317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155111|NCT01266317|Immunologic Factors|immunologic factors|mesh-ancestor
65155112|NCT01266317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155113|NCT01266317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65155114|NCT01266161|Ibuprofen|ibuprofen|mesh-list
65155115|NCT01266161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65155116|NCT01266161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65155117|NCT01266161|Analgesics|analgesics|mesh-ancestor
65155118|NCT01266161|Sensory System Agents|sensory system agents|mesh-ancestor
65155119|NCT01266161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155120|NCT01266161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155121|NCT01266161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65155122|NCT01266161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65155123|NCT01266161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65155125|NCT01266161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155126|NCT01265849|Indomethacin|indomethacin|mesh-list
65155127|NCT01265849|Cyclophosphamide|cyclophosphamide|mesh-list
65155128|NCT01265849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65155129|NCT01265849|Immunologic Factors|immunologic factors|mesh-ancestor
65155130|NCT01265849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155131|NCT01265849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65155132|NCT01265849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65155133|NCT01265849|Alkylating Agents|alkylating agents|mesh-ancestor
65155134|NCT01265849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155135|NCT01265849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155136|NCT01265849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65155137|NCT01265849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65155138|NCT01265849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65307454|NCT00708396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65307455|NCT00708396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65307456|NCT00708396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307457|NCT00708396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65307458|NCT00708396|Serotonin Agents|serotonin agents|mesh-ancestor
65307459|NCT00708396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307460|NCT00708396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65307461|NCT00708396|Antidepressive Agents|antidepressive agents|mesh-ancestor
65307462|NCT00708396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65307463|NCT00665093|Insulin|insulin|mesh-list
65307464|NCT00665093|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65307465|NCT00665093|Insulin Aspart|insulin aspart|mesh-list
65307466|NCT00665093|Insulin Detemir|insulin detemir|mesh-list
65307467|NCT00665093|Biphasic Insulins|biphasic insulins|mesh-list
65307468|NCT00665093|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65307469|NCT00665093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65307470|NCT00665093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307471|NCT00595517|Esomeprazole|esomeprazole|mesh-list
64537331|NCT00497055|Dopamine Agents|dopamine agents|mesh-ancestor
65155139|NCT01265849|Analgesics|analgesics|mesh-ancestor
65155140|NCT01265849|Sensory System Agents|sensory system agents|mesh-ancestor
65155141|NCT01265849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155142|NCT01265849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65155143|NCT01265849|Gout Suppressants|gout suppressants|mesh-ancestor
65155144|NCT01265849|Tocolytic Agents|tocolytic agents|mesh-ancestor
65155145|NCT01265849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65155146|NCT01265849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64797763|NCT01386658|Icatibant|icatibant|mesh-list
65155147|NCT01265849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155148|NCT01265615|Cholecalciferol|cholecalciferol|mesh-list
65155149|NCT01265615|Vitamin D|vitamin d|mesh-list
65155150|NCT01265615|Calcitriol|calcitriol|mesh-list
65155151|NCT01265615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65155152|NCT01265615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155154|NCT01265615|Micronutrients|micronutrients|mesh-ancestor
65155155|NCT01265615|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65155156|NCT01265615|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65155157|NCT01265615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65155158|NCT01265615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155159|NCT01265615|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65155160|NCT01264679|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65155161|NCT01264679|Hematinics|hematinics|mesh-ancestor
65155162|NCT01264679|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65155163|NCT01264679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65155168|NCT05542667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155170|NCT01263509|Alogliptin|alogliptin|mesh-list
65155171|NCT01263509|Voglibose|voglibose|mesh-list
65155172|NCT01263509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65155173|NCT01263509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155174|NCT01263509|Incretins|incretins|mesh-ancestor
65155175|NCT01263509|Hormones|hormones|mesh-ancestor
65155176|NCT01263509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65155177|NCT01263509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65155178|NCT01263509|Protease Inhibitors|protease inhibitors|mesh-ancestor
65155179|NCT01263509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307472|NCT00595517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65307473|NCT00595517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65307474|NCT00595517|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65307475|NCT00595517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307476|NCT00595517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307477|NCT00911651|Bromides|bromides|mesh-list
65307478|NCT00911651|Albuterol|albuterol|mesh-list
65307479|NCT00911651|Ipratropium|ipratropium|mesh-list
65307480|NCT00911651|Anticonvulsants|anticonvulsants|mesh-ancestor
65307481|NCT00911651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65307482|NCT00911651|Autonomic Agents|autonomic agents|mesh-ancestor
65307483|NCT00911651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65307484|NCT00911651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307485|NCT00911651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65307486|NCT00911651|Respiratory System Agents|respiratory system agents|mesh-ancestor
65307487|NCT00911651|Tocolytic Agents|tocolytic agents|mesh-ancestor
65307488|NCT00911651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64537349|NCT00498615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155180|NCT01263509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155181|NCT01263509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65155182|NCT01263509|Vitamin B Complex|vitamin b complex|mesh-ancestor
65155183|NCT01263509|Vitamins|vitamins|mesh-ancestor
65155184|NCT01263509|Micronutrients|micronutrients|mesh-ancestor
65155185|NCT01263197|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
65155186|NCT01263197|Propranolol|propranolol|mesh-list
65155187|NCT01263197|Albuterol|albuterol|mesh-list
65155188|NCT01263197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65155189|NCT01263197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65155190|NCT01263197|Adrenergic Agents|adrenergic agents|mesh-ancestor
65155191|NCT01263197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65155192|NCT01263197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155193|NCT01263197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155194|NCT01263197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65155195|NCT01263197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65155196|NCT01263197|Vasodilator Agents|vasodilator agents|mesh-ancestor
65155197|NCT01263197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65155198|NCT01263197|Autonomic Agents|autonomic agents|mesh-ancestor
65155199|NCT01263197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155201|NCT01263197|Respiratory System Agents|respiratory system agents|mesh-ancestor
65155202|NCT01263197|Tocolytic Agents|tocolytic agents|mesh-ancestor
65155203|NCT01263197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65155204|NCT01263197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65155205|NCT01263197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65155206|NCT01263197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65155207|NCT01263197|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65155208|NCT01263197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65155209|NCT01263197|Disinfectants|disinfectants|mesh-ancestor
65155210|NCT01263119|Warfarin|warfarin|mesh-list
65155211|NCT01263119|Anticoagulants|anticoagulants|mesh-ancestor
65155212|NCT01262651|Nabiximols|nabiximols|mesh-list
65155213|NCT01262651|Analgesics|analgesics|mesh-ancestor
65155214|NCT01262651|Sensory System Agents|sensory system agents|mesh-ancestor
65155215|NCT01262651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155216|NCT01262651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155217|NCT05534087|Irinotecan|irinotecan|mesh-list
65155218|NCT05534087|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65155219|NCT05534087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65155220|NCT05534087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307489|NCT00911651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65307490|NCT00911651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65307491|NCT00911651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65307492|NCT00911651|Adrenergic Agents|adrenergic agents|mesh-ancestor
65307493|NCT00911651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65307494|NCT00911651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307495|NCT00911651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65307496|NCT00911651|Cholinergic Agents|cholinergic agents|mesh-ancestor
65307497|NCT00665327|Moxifloxacin|moxifloxacin|mesh-list
65307554|NCT00705042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65307555|NCT00705042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65307556|NCT00705042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65307557|NCT00705042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65307558|NCT00705042|Immunologic Factors|immunologic factors|mesh-ancestor
65307559|NCT00879437|Bevacizumab|bevacizumab|mesh-list
65307560|NCT00879437|Valproic Acid|valproic acid|mesh-list
65307561|NCT00879437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65307562|NCT00879437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307563|NCT00879437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65307564|NCT00879437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65307565|NCT00879437|Growth Substances|growth substances|mesh-ancestor
65307566|NCT00879437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307567|NCT00879437|Growth Inhibitors|growth inhibitors|mesh-ancestor
65307568|NCT00879437|Anticonvulsants|anticonvulsants|mesh-ancestor
65307569|NCT00879437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307570|NCT00879437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307571|NCT00879437|GABA Agents|gaba agents|mesh-ancestor
64537435|NCT00505635|Interferons|interferons|mesh-list
65155221|NCT05534087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155222|NCT05534087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155223|NCT01261793|Epratuzumab|epratuzumab|mesh-list
65155224|NCT01261793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65155225|NCT01261793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155226|NCT04321967|Nitroglycerin|nitroglycerin|mesh-list
65155227|NCT04321967|Vasodilator Agents|vasodilator agents|mesh-ancestor
65155228|NCT04321655|Ibuprofen|ibuprofen|mesh-list
65155229|NCT04321655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65155230|NCT04321655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65155231|NCT04321655|Analgesics|analgesics|mesh-ancestor
65155232|NCT04321655|Sensory System Agents|sensory system agents|mesh-ancestor
65155233|NCT04321655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155234|NCT04321655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155235|NCT04321655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65155236|NCT04321655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65155237|NCT04321655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65155243|NCT01261325|Anticonvulsants|anticonvulsants|mesh-list
65155244|NCT01260467|Memantine|memantine|mesh-list
65155245|NCT01260467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65155246|NCT01260467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65155247|NCT01260467|Dopamine Agents|dopamine agents|mesh-ancestor
65155248|NCT01260467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65155249|NCT01260467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155250|NCT01260467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155251|NCT01260467|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65155252|NCT01260467|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65155253|NCT01260311|Fesoterodine|fesoterodine|mesh-list
65155254|NCT01260311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65155255|NCT01260311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65155256|NCT01260311|Cholinergic Agents|cholinergic agents|mesh-ancestor
65155257|NCT01260311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65155258|NCT01260311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155259|NCT01260311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155260|NCT01260311|Urological Agents|urological agents|mesh-ancestor
65155261|NCT00623987|Warfarin|warfarin|mesh-list
65155262|NCT00623987|Anticoagulants|anticoagulants|mesh-ancestor
65307572|NCT00879437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65057476|NCT04531072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65307574|NCT00879437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65307575|NCT00879437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65307576|NCT00879437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65307577|NCT00665639|Caspofungin|caspofungin|mesh-list
65307578|NCT00665639|Micafungin|micafungin|mesh-list
65307579|NCT00665639|Antifungal Agents|antifungal agents|mesh-ancestor
65307580|NCT00665639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65307581|NCT00665639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307582|NCT00665639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307583|NCT04153253|Aflibercept|aflibercept|mesh-list
65307584|NCT04153253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65307585|NCT04153253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65307586|NCT04153253|Growth Substances|growth substances|mesh-ancestor
65307587|NCT04153253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307588|NCT04153253|Growth Inhibitors|growth inhibitors|mesh-ancestor
65307589|NCT04153253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307590|NCT00671645|Bevacizumab|bevacizumab|mesh-list
65307591|NCT00671645|Capecitabine|capecitabine|mesh-list
65307592|NCT00671645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65307593|NCT00671645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307594|NCT00671645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65307595|NCT00671645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65307596|NCT00671645|Growth Substances|growth substances|mesh-ancestor
65307597|NCT00671645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307598|NCT00671645|Growth Inhibitors|growth inhibitors|mesh-ancestor
65307599|NCT00671645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65307600|NCT00671645|Antimetabolites|antimetabolites|mesh-ancestor
65307601|NCT00671645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307602|NCT02629523|Afatinib|afatinib|mesh-list
65307603|NCT02629523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307604|NCT02629523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65307605|NCT02629523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307606|NCT02629523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307607|NCT00671801|Irinotecan|irinotecan|mesh-list
65307608|NCT00671801|Lenalidomide|lenalidomide|mesh-list
65155263|NCT01259375|Amrubicin|amrubicin|mesh-list
65155264|NCT01259375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307609|NCT00671801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65307610|NCT00671801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65307611|NCT00671801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307612|NCT00671801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307613|NCT00671801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307614|NCT00671801|Immunologic Factors|immunologic factors|mesh-ancestor
65307615|NCT00671801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307616|NCT00671801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65307617|NCT00671801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65307618|NCT00671801|Growth Substances|growth substances|mesh-ancestor
65307619|NCT00671801|Growth Inhibitors|growth inhibitors|mesh-ancestor
65307620|NCT04152161|BCG Vaccine|bcg vaccine|mesh-list
65307621|NCT04152161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65307622|NCT04152161|Immunologic Factors|immunologic factors|mesh-ancestor
65307623|NCT04152161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307624|NCT00676559|Ranibizumab|ranibizumab|mesh-list
65307625|NCT00676559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65307626|NCT00676559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65307627|NCT00676559|Growth Substances|growth substances|mesh-ancestor
65307628|NCT00676559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307629|NCT00676559|Growth Inhibitors|growth inhibitors|mesh-ancestor
65307630|NCT00676559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307631|NCT00672113|Nifedipine|nifedipine|mesh-list
65307632|NCT00672113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65307633|NCT00672113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65307634|NCT00672113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307635|NCT00672113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65307636|NCT00672113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307637|NCT00672113|Vasodilator Agents|vasodilator agents|mesh-ancestor
65307638|NCT00672113|Tocolytic Agents|tocolytic agents|mesh-ancestor
65307639|NCT00672113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65307640|NCT00676637|Timolol|timolol|mesh-list
65307641|NCT00676637|Travoprost|travoprost|mesh-list
65155265|NCT05536037|Metformin|metformin|mesh-list
65155266|NCT05536037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65155267|NCT05536037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155268|NCT00624143|Voriconazole|voriconazole|mesh-list
65155269|NCT00624143|Amphotericin B|amphotericin b|mesh-list
65155270|NCT00624143|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65155271|NCT00624143|Antifungal Agents|antifungal agents|mesh-ancestor
65155272|NCT00624143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65155273|NCT00624143|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65307642|NCT00676637|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65307643|NCT00676637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65307644|NCT00676637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65307645|NCT00676637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65307646|NCT00676637|Adrenergic Agents|adrenergic agents|mesh-ancestor
65057552|NCT02217631|Prednisolone|prednisolone|mesh-list
65307647|NCT00676637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65307648|NCT00676637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307649|NCT00676637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307650|NCT00676637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65307651|NCT00676637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65307652|NCT00672347|Clonidine|clonidine|mesh-list
65307653|NCT00672347|Morphine|morphine|mesh-list
65307654|NCT00672347|Bupivacaine|bupivacaine|mesh-list
65307655|NCT00672347|Anesthetics, Local|anesthetics, local|mesh-ancestor
65307656|NCT00672347|Anesthetics|anesthetics|mesh-ancestor
65307657|NCT00672347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65307658|NCT00672347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307659|NCT00672347|Sensory System Agents|sensory system agents|mesh-ancestor
65307660|NCT00672347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65307661|NCT00672347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65307662|NCT00672347|Narcotics|narcotics|mesh-ancestor
65307663|NCT00672347|Analgesics|analgesics|mesh-ancestor
65307664|NCT00672347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65307665|NCT00672347|Sympatholytics|sympatholytics|mesh-ancestor
65307666|NCT00672347|Autonomic Agents|autonomic agents|mesh-ancestor
65307667|NCT00672347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65307668|NCT00672347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65307669|NCT00672347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65307670|NCT00672347|Adrenergic Agents|adrenergic agents|mesh-ancestor
65307671|NCT00672347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65307672|NCT00672347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307673|NCT00676871|Blinatumomab|blinatumomab|mesh-list
65307674|NCT00676871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307675|NCT00677027|Lentinan|lentinan|mesh-list
65307676|NCT00677027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64688651|NCT03559049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65155274|NCT00624143|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65155275|NCT00624143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155276|NCT00624143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155277|NCT00624143|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65307677|NCT00677027|Immunologic Factors|immunologic factors|mesh-ancestor
65307678|NCT00677027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307679|NCT00677027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307680|NCT00595127|Cyclophosphamide|cyclophosphamide|mesh-list
65307681|NCT00595127|Fludarabine|fludarabine|mesh-list
65307682|NCT00595127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65307683|NCT00595127|Immunologic Factors|immunologic factors|mesh-ancestor
65307684|NCT00595127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307685|NCT00595127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65307686|NCT00595127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65307687|NCT00595127|Alkylating Agents|alkylating agents|mesh-ancestor
65307688|NCT00595127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307689|NCT00595127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307690|NCT00595127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65307691|NCT00672659|Dexetimide|dexetimide|mesh-list
65307692|NCT00672659|Pipamperone|pipamperone|mesh-list
65307693|NCT00672659|Citalopram|citalopram|mesh-list
65307694|NCT00672659|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65307695|NCT00672659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65307696|NCT00672659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65155278|NCT00624143|Hormone Antagonists|hormone antagonists|mesh-ancestor
65155279|NCT00624143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65155280|NCT00624143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155281|NCT00624143|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65155282|NCT00624143|Amebicides|amebicides|mesh-ancestor
65155283|NCT00624143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65155284|NCT00624143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65155285|NCT00624143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65155287|NCT05241275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65155288|NCT05241275|Anesthetics, General|anesthetics, general|mesh-ancestor
65155289|NCT05241275|Anesthetics|anesthetics|mesh-ancestor
65155290|NCT05241275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65155291|NCT05241275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155292|NCT05077709|Pembrolizumab|pembrolizumab|mesh-list
65155293|NCT05077709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65155294|NCT05077709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155295|NCT04650893|Dexamethasone|dexamethasone|mesh-list
65155296|NCT04650893|Ketorolac|ketorolac|mesh-list
65155297|NCT04650893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65155298|NCT04650893|Antiemetics|antiemetics|mesh-ancestor
65155299|NCT04650893|Autonomic Agents|autonomic agents|mesh-ancestor
65155300|NCT04650893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155301|NCT04650893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155302|NCT04650893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65155303|NCT04650893|Glucocorticoids|glucocorticoids|mesh-ancestor
65155304|NCT04650893|Hormones|hormones|mesh-ancestor
65155305|NCT04650893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65155306|NCT04650893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65155307|NCT04650893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155315|NCT04650893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155317|NCT04540835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65155318|NCT04540835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155319|NCT04005287|Pirenzepine|pirenzepine|mesh-list
65155320|NCT04005287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65307697|NCT00672659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307698|NCT00672659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65307699|NCT00672659|Serotonin Agents|serotonin agents|mesh-ancestor
65307700|NCT00672659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307701|NCT00672659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65307702|NCT00672659|Antidepressive Agents|antidepressive agents|mesh-ancestor
65307703|NCT00672659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65307704|NCT00672659|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65307705|NCT00672659|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65307706|NCT00672659|Parasympatholytics|parasympatholytics|mesh-ancestor
65307707|NCT00672659|Autonomic Agents|autonomic agents|mesh-ancestor
65307708|NCT00672659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65307709|NCT00672659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65307710|NCT00672659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65307711|NCT00672659|Cholinergic Agents|cholinergic agents|mesh-ancestor
65307712|NCT00672659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65307713|NCT00672659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65307714|NCT00672659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64537569|NCT03121677|Poly I-C|poly i-c|mesh-list
65155321|NCT04005287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65155322|NCT04005287|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65155323|NCT04005287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65155324|NCT04005287|Cholinergic Agents|cholinergic agents|mesh-ancestor
65155325|NCT04005287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65155326|NCT04005287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155327|NCT04005287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155329|NCT04320173|Anesthetics, Local|anesthetics, local|mesh-ancestor
65155330|NCT04320173|Anesthetics|anesthetics|mesh-ancestor
65155331|NCT04320173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65155332|NCT04320173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155333|NCT04320173|Sensory System Agents|sensory system agents|mesh-ancestor
65155334|NCT04320173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155335|NCT04320173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65155336|NCT04320173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65155337|NCT04320173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65155338|NCT04320173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65155339|NCT04320173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155340|NCT03192215|Aspirin|aspirin|mesh-list
65155341|NCT03192215|Apixaban|apixaban|mesh-list
65155342|NCT03192215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65155343|NCT03192215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65155344|NCT03192215|Analgesics|analgesics|mesh-ancestor
65155345|NCT03192215|Sensory System Agents|sensory system agents|mesh-ancestor
65155346|NCT03192215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155348|NCT03192215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65155349|NCT03192215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65155350|NCT03192215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65155351|NCT03192215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65155352|NCT03192215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155353|NCT03192215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65155354|NCT03192215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65155355|NCT03192215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155356|NCT03192215|Antipyretics|antipyretics|mesh-ancestor
65155357|NCT03192215|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65155358|NCT03192215|Antithrombins|antithrombins|mesh-ancestor
65307715|NCT00672659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65307716|NCT00877487|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65307717|NCT00877487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65307718|NCT00877487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307719|NCT00877487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65307720|NCT00877487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65307721|NCT00877487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65307722|NCT00877487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537595|NCT00525057|Dalteparin|dalteparin|mesh-list
65155359|NCT03192215|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65155360|NCT03192215|Protease Inhibitors|protease inhibitors|mesh-ancestor
65155361|NCT03192215|Anticoagulants|anticoagulants|mesh-ancestor
65155362|NCT04321733|Amoxicillin|amoxicillin|mesh-list
65155363|NCT04321733|Clavulanic Acid|clavulanic acid|mesh-list
65155364|NCT04321733|Clavulanic Acids|clavulanic acids|mesh-list
65155365|NCT04321733|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65155366|NCT04321733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65155367|NCT04321733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65155368|NCT04321733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65155369|NCT04321733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155370|NCT04321733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155371|NCT02029001|Everolimus|everolimus|mesh-list
65155372|NCT02029001|Sorafenib|sorafenib|mesh-list
65155373|NCT02029001|Durvalumab|durvalumab|mesh-list
65155374|NCT02029001|Olaparib|olaparib|mesh-list
65155375|NCT02029001|Lapatinib|lapatinib|mesh-list
65155377|NCT02029001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155378|NCT02029001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65155379|NCT02029001|Immunologic Factors|immunologic factors|mesh-ancestor
65155380|NCT02029001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155381|NCT02029001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65155382|NCT02029001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155383|NCT02029001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155384|NCT02029001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65155385|NCT02029001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65155387|NCT01613495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65155388|NCT01613495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65155389|NCT01613495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155390|NCT01321073|Treprostinil|treprostinil|mesh-list
65155391|NCT01321073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65155392|NCT00694733|Anastrozole|anastrozole|mesh-list
65155393|NCT00694733|Leuprolide|leuprolide|mesh-list
65155394|NCT00694733|Methyltestosterone|methyltestosterone|mesh-list
65155395|NCT00694733|Estradiol|estradiol|mesh-list
65155396|NCT00694733|Estrogens|estrogens|mesh-list
65155397|NCT00694733|Testosterone|testosterone|mesh-list
65155398|NCT00694733|Testosterone undecanoate|testosterone undecanoate|mesh-list
65155399|NCT00694733|Testosterone enanthate|testosterone enanthate|mesh-list
65155400|NCT00694733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65155401|NCT00694733|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65155402|NCT00694733|Hormones|hormones|mesh-ancestor
65155403|NCT00694733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65155404|NCT00694733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155405|NCT00694733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65155406|NCT00694733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65155407|NCT00694733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155408|NCT00694733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65155409|NCT00694733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155410|NCT00694733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155411|NCT00694733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65155412|NCT00694733|Hormone Antagonists|hormone antagonists|mesh-ancestor
65155413|NCT00694733|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65155414|NCT00694733|Fertility Agents|fertility agents|mesh-ancestor
65155415|NCT00694733|Androgens|androgens|mesh-ancestor
65155416|NCT00694733|Anabolic Agents|anabolic agents|mesh-ancestor
65307723|NCT00877487|Dopamine Agents|dopamine agents|mesh-ancestor
65307724|NCT00877487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65307725|NCT00677261|Anesthetics|anesthetics|mesh-list
65307726|NCT00677261|Anesthetics, Local|anesthetics, local|mesh-list
65307727|NCT00677261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65307728|NCT00677261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307729|NCT00677261|Sensory System Agents|sensory system agents|mesh-ancestor
65307730|NCT00677261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65307731|NCT00912119|Aminocaproic Acid|aminocaproic acid|mesh-list
65307732|NCT00912119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65307733|NCT00912119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65155417|NCT01259297|Amlodipine|amlodipine|mesh-list
65155418|NCT01259297|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65155419|NCT01259297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65155420|NCT01259297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65155421|NCT01259297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65155422|NCT01259297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155423|NCT01259297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65155424|NCT01259297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155425|NCT01259297|Vasodilator Agents|vasodilator agents|mesh-ancestor
65155426|NCT01259297|Diuretics|diuretics|mesh-ancestor
65155427|NCT01259297|Natriuretic Agents|natriuretic agents|mesh-ancestor
65155428|NCT01259297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65155429|NCT01126437|Tiotropium Bromide|tiotropium bromide|mesh-list
65155430|NCT01126437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65155431|NCT01126437|Autonomic Agents|autonomic agents|mesh-ancestor
65155432|NCT01126437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155433|NCT01126437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155434|NCT01126437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65155435|NCT01126437|Respiratory System Agents|respiratory system agents|mesh-ancestor
65155436|NCT01126437|Parasympatholytics|parasympatholytics|mesh-ancestor
65155437|NCT01126437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65155438|NCT01126437|Cholinergic Agents|cholinergic agents|mesh-ancestor
65155439|NCT01126437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65155440|NCT01126437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155442|NCT01258595|Immunologic Factors|immunologic factors|mesh-ancestor
65155443|NCT01258595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155444|NCT01257737|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
65155445|NCT01257737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155446|NCT01126359|Lidocaine|lidocaine|mesh-list
65155447|NCT01126359|Anesthetics, Local|anesthetics, local|mesh-ancestor
65155448|NCT01126359|Anesthetics|anesthetics|mesh-ancestor
65155449|NCT01126359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65155450|NCT01126359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155459|NCT00637533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65155460|NCT00637533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65155461|NCT00637533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65155462|NCT00637533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65155463|NCT00637533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155464|NCT00637533|Cholinergic Agents|cholinergic agents|mesh-ancestor
65155465|NCT00637533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65155466|NCT00637533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155467|NCT00637533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65155468|NCT00637533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155469|NCT01125813|Factor VIII|factor viii|mesh-list
65155470|NCT01125813|Coagulants|coagulants|mesh-ancestor
65155471|NCT04311645|Charcoal|charcoal|mesh-list
65155472|NCT04311645|Antidotes|antidotes|mesh-ancestor
65155473|NCT04311645|Protective Agents|protective agents|mesh-ancestor
65155474|NCT04311645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155475|NCT01257581|Tamoxifen|tamoxifen|mesh-list
65155476|NCT01257581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65155477|NCT01257581|Hormone Antagonists|hormone antagonists|mesh-ancestor
65155478|NCT01257581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65307734|NCT00912119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307735|NCT00912119|Hemostatics|hemostatics|mesh-ancestor
65307736|NCT00912119|Coagulants|coagulants|mesh-ancestor
65307737|NCT00677339|Vitamin D|vitamin d|mesh-list
65307738|NCT00677339|Ergocalciferols|ergocalciferols|mesh-list
65307739|NCT00677339|Cholecalciferol|cholecalciferol|mesh-list
65307740|NCT00677339|Vitamins|vitamins|mesh-list
65307741|NCT00677339|Micronutrients|micronutrients|mesh-ancestor
65307742|NCT00677339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307743|NCT00677339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65307744|NCT00677339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65307745|NCT00672971|Permethrin|permethrin|mesh-list
65307746|NCT00672971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155479|NCT01257581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155480|NCT01257581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65155481|NCT01257581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155482|NCT01257581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65155483|NCT01257581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65155484|NCT01257581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65155485|NCT00995566|Sitaxsentan|sitaxsentan|mesh-list
65155486|NCT00995566|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65155487|NCT00995566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155488|NCT01257425|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65155489|NCT01257425|Luteolytic Agents|luteolytic agents|mesh-ancestor
65155490|NCT01257425|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65155491|NCT01257425|Contraceptive Agents|contraceptive agents|mesh-ancestor
65155492|NCT01257425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65155493|NCT01257425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155494|NCT01257425|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65155495|NCT01257425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65155496|NCT01257425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155497|NCT00995488|Paclitaxel|paclitaxel|mesh-list
65155498|NCT00995488|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65155499|NCT00995488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65155500|NCT00995488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155501|NCT00995488|Tubulin Modulators|tubulin modulators|mesh-ancestor
65155502|NCT00995488|Antimitotic Agents|antimitotic agents|mesh-ancestor
65155503|NCT00995488|Mitosis Modulators|mitosis modulators|mesh-ancestor
65155504|NCT00995488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155505|NCT04293172|Ticagrelor|ticagrelor|mesh-list
65155506|NCT04293172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65155507|NCT04293172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65155508|NCT04293172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65155509|NCT04293172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65155510|NCT04293172|Purinergic Agents|purinergic agents|mesh-ancestor
65155511|NCT04293172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65155512|NCT04293172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155513|NCT04293172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155514|NCT01256879|Cimetidine|cimetidine|mesh-list
65155515|NCT01256879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65155527|NCT02869672|Immunologic Factors|immunologic factors|mesh-ancestor
65155528|NCT02869672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155529|NCT01125189|Interferons|interferons|mesh-list
65155530|NCT01125189|Ribavirin|ribavirin|mesh-list
65155531|NCT01125189|Interferon-alpha|interferon-alpha|mesh-list
65155532|NCT01125189|Interferon alpha-2|interferon alpha-2|mesh-list
65155533|NCT01125189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65155534|NCT01125189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155535|NCT01125189|Antiviral Agents|antiviral agents|mesh-ancestor
65155536|NCT01125189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65155537|NCT01125189|Antimetabolites|antimetabolites|mesh-ancestor
65155538|NCT01125189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307747|NCT00672971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307748|NCT00673205|Bicalutamide|bicalutamide|mesh-list
65307749|NCT00673205|Androgen Antagonists|androgen antagonists|mesh-ancestor
65307750|NCT00673205|Hormone Antagonists|hormone antagonists|mesh-ancestor
65307751|NCT00673205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65307752|NCT00673205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307753|NCT00673205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307754|NCT00677729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65307755|NCT00677729|Albuterol|albuterol|mesh-list
65307756|NCT00677729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65307757|NCT00677729|Autonomic Agents|autonomic agents|mesh-ancestor
65307758|NCT00677729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65307759|NCT00677729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307760|NCT00677729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65155539|NCT01125189|Immunologic Factors|immunologic factors|mesh-ancestor
65155540|NCT01125189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155541|NCT01256567|Docetaxel|docetaxel|mesh-list
65155542|NCT01256567|Ramucirumab|ramucirumab|mesh-list
65155543|NCT01256567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155544|NCT01256567|Tubulin Modulators|tubulin modulators|mesh-ancestor
65155545|NCT01256567|Antimitotic Agents|antimitotic agents|mesh-ancestor
65155546|NCT01256567|Mitosis Modulators|mitosis modulators|mesh-ancestor
65155547|NCT01256567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155548|NCT00996736|Voriconazole|voriconazole|mesh-list
65155549|NCT00996736|Natamycin|natamycin|mesh-list
65155550|NCT00996736|Antifungal Agents|antifungal agents|mesh-ancestor
65155551|NCT00996736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65155552|NCT00996736|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65155553|NCT00996736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65155554|NCT00996736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155555|NCT00996736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155556|NCT00996736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65155557|NCT00996736|Hormone Antagonists|hormone antagonists|mesh-ancestor
65155558|NCT00996736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65155559|NCT00996736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155560|NCT00996736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65155561|NCT00996736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65155562|NCT00996736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65155563|NCT00996658|Linagliptin|linagliptin|mesh-list
65155564|NCT00996658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65155565|NCT00996658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155566|NCT00996658|Incretins|incretins|mesh-ancestor
65155567|NCT00996658|Hormones|hormones|mesh-ancestor
65155568|NCT00996658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65155569|NCT00996658|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65155570|NCT00996658|Protease Inhibitors|protease inhibitors|mesh-ancestor
65155571|NCT00996658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155572|NCT00996658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155574|NCT04310631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65155575|NCT04310631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65155576|NCT04310631|Growth Substances|growth substances|mesh-ancestor
65155577|NCT04310631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155578|NCT04310631|Growth Inhibitors|growth inhibitors|mesh-ancestor
65155579|NCT04310631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155583|NCT01256411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65155584|NCT01256411|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65155585|NCT01256411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65307761|NCT00677729|Respiratory System Agents|respiratory system agents|mesh-ancestor
65307762|NCT00677729|Tocolytic Agents|tocolytic agents|mesh-ancestor
65307763|NCT00677729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65307764|NCT00677729|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65307765|NCT00677729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65307766|NCT00677729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65307767|NCT00677729|Adrenergic Agents|adrenergic agents|mesh-ancestor
65307768|NCT00677729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65307769|NCT00677729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307770|NCT02628197|Vitamin D|vitamin d|mesh-list
65307771|NCT02628197|Calcium|calcium|mesh-list
65307772|NCT02628197|Vitamins|vitamins|mesh-ancestor
65307773|NCT02628197|Micronutrients|micronutrients|mesh-ancestor
65307774|NCT02628197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307775|NCT02628197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65307776|NCT02628197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65307777|NCT00673829|Interleukin-2|interleukin-2|mesh-list
65307778|NCT00673829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307779|NCT00673829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65307780|NCT00673829|Analgesics|analgesics|mesh-ancestor
65307781|NCT00673829|Sensory System Agents|sensory system agents|mesh-ancestor
65307782|NCT00673829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65307783|NCT00673829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307784|NCT04152629|Methylphenidate|methylphenidate|mesh-list
64537636|NCT00525603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65155586|NCT01256411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155587|NCT01256411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65155588|NCT01256411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155589|NCT01256411|Vasodilator Agents|vasodilator agents|mesh-ancestor
65155590|NCT01256411|Diuretics|diuretics|mesh-ancestor
65155591|NCT01256411|Natriuretic Agents|natriuretic agents|mesh-ancestor
65155592|NCT01256411|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65155593|NCT01256411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65155594|NCT00996580|Levonorgestrel|levonorgestrel|mesh-list
65155595|NCT00996580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65155596|NCT00996580|Estradiol|estradiol|mesh-list
64798197|NCT01389427|Hormones|hormones|mesh-ancestor
65155597|NCT00996580|Estrogens|estrogens|mesh-ancestor
65155598|NCT00996580|Hormones|hormones|mesh-ancestor
65155599|NCT00996580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65155600|NCT00996580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155601|NCT00996580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65155602|NCT00996580|Contraceptive Agents|contraceptive agents|mesh-ancestor
65155603|NCT00996580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65155604|NCT00996580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65155605|NCT00996580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65155606|NCT00996580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65155607|NCT00996580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65155608|NCT01124175|Losartan|losartan|mesh-list
65155609|NCT01124175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65307785|NCT04152629|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65307786|NCT04152629|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65307787|NCT04152629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307788|NCT04152629|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65307789|NCT04152629|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65307790|NCT04152629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65307791|NCT04152629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307792|NCT04152629|Dopamine Agents|dopamine agents|mesh-ancestor
65307793|NCT04152629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65307794|NCT02535299|Metformin|metformin|mesh-list
65307795|NCT02535299|Liraglutide|liraglutide|mesh-list
65307796|NCT02535299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65307797|NCT02535299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307798|NCT02535299|Incretins|incretins|mesh-ancestor
65307799|NCT02535299|Hormones|hormones|mesh-ancestor
65307800|NCT02535299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65307801|NCT00674063|Alefacept|alefacept|mesh-list
65307802|NCT00674063|Dermatologic Agents|dermatologic agents|mesh-ancestor
65307803|NCT00674063|Immunologic Factors|immunologic factors|mesh-ancestor
65307804|NCT00674063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307805|NCT04151459|Metformin|metformin|mesh-list
65307806|NCT04151459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65307807|NCT04151459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307808|NCT00674141|Dexamethasone|dexamethasone|mesh-list
65307809|NCT00674141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65307810|NCT00674141|Antiemetics|antiemetics|mesh-ancestor
65307811|NCT00674141|Autonomic Agents|autonomic agents|mesh-ancestor
65307812|NCT00674141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65307813|NCT00674141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307814|NCT00674141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65307815|NCT00674141|Glucocorticoids|glucocorticoids|mesh-ancestor
65307816|NCT00674141|Hormones|hormones|mesh-ancestor
65307817|NCT00674141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65155610|NCT01124175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65155611|NCT01124175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65155612|NCT01124175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65155613|NCT01124175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155614|NCT01256177|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65155615|NCT01256177|Antidepressive Agents|antidepressive agents|mesh-ancestor
65155616|NCT01256177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65155617|NCT01256177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65307818|NCT00674141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65307819|NCT00674141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307820|NCT00678275|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65307821|NCT00678275|Immunologic Factors|immunologic factors|mesh-ancestor
65307822|NCT00678275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307823|NCT00678275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65307824|NCT02627807|Gemcitabine|gemcitabine|mesh-list
65307825|NCT02627807|Cisplatin|cisplatin|mesh-list
65307826|NCT02627807|Docetaxel|docetaxel|mesh-list
65307827|NCT02627807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307828|NCT02627807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65307829|NCT02627807|Antimetabolites|antimetabolites|mesh-ancestor
65307830|NCT02627807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155618|NCT01256177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65155619|NCT01256177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65155620|NCT01256177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155621|NCT02882451|Pinaverium|pinaverium|mesh-list
65155622|NCT02882451|Bromides|bromides|mesh-list
65155623|NCT02882451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155624|NCT02882451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155625|NCT02882451|Anticonvulsants|anticonvulsants|mesh-ancestor
65155626|NCT02882451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65155627|NCT02882451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65155628|NCT02882451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65155629|NCT02882451|Parasympatholytics|parasympatholytics|mesh-ancestor
65155630|NCT02882451|Autonomic Agents|autonomic agents|mesh-ancestor
65155631|NCT02882451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155632|NCT00999544|Oxycodone|oxycodone|mesh-list
65155633|NCT00999544|Aprepitant|aprepitant|mesh-list
65155634|NCT00999544|Fosaprepitant|fosaprepitant|mesh-list
65155635|NCT00999544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65155636|NCT00999544|Narcotics|narcotics|mesh-ancestor
65155637|NCT00999544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65155638|NCT00999544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155639|NCT00999544|Analgesics|analgesics|mesh-ancestor
65155640|NCT00999544|Sensory System Agents|sensory system agents|mesh-ancestor
65155641|NCT00999544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155642|NCT00999544|Antiemetics|antiemetics|mesh-ancestor
65155643|NCT00999544|Autonomic Agents|autonomic agents|mesh-ancestor
65155644|NCT00999544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65155645|NCT00999544|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65155646|NCT00999544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65155647|NCT00999544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155648|NCT02869984|Ramosetron|ramosetron|mesh-list
65155649|NCT02869984|Antiemetics|antiemetics|mesh-ancestor
65155653|NCT02869984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65155654|NCT02869984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65155655|NCT02869984|Serotonin Agents|serotonin agents|mesh-ancestor
65155656|NCT02869984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65155657|NCT02869984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155658|NCT01124097|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
65155659|NCT01124097|Anticonvulsants|anticonvulsants|mesh-ancestor
65155660|NCT01124097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65155661|NCT01124097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65155662|NCT01124097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65155663|NCT01124097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155664|NCT01123395|Colchicine|colchicine|mesh-list
65155665|NCT01123395|Gout Suppressants|gout suppressants|mesh-ancestor
65155666|NCT01123395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65155667|NCT01123395|Tubulin Modulators|tubulin modulators|mesh-ancestor
65155668|NCT01123395|Antimitotic Agents|antimitotic agents|mesh-ancestor
65155669|NCT01123395|Mitosis Modulators|mitosis modulators|mesh-ancestor
65307831|NCT02627807|Antiviral Agents|antiviral agents|mesh-ancestor
65307832|NCT02627807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65307833|NCT02627807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307834|NCT02627807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65307835|NCT02627807|Immunologic Factors|immunologic factors|mesh-ancestor
65307836|NCT02627807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307837|NCT02627807|Tubulin Modulators|tubulin modulators|mesh-ancestor
65307838|NCT02627807|Antimitotic Agents|antimitotic agents|mesh-ancestor
65307839|NCT02627807|Mitosis Modulators|mitosis modulators|mesh-ancestor
65307840|NCT00678431|Resveratrol|resveratrol|mesh-list
65307841|NCT00678431|Antioxidants|antioxidants|mesh-ancestor
65155670|NCT01123395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155671|NCT01123395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155672|NCT01255787|Vortioxetine|vortioxetine|mesh-list
65155673|NCT01255787|Antidepressive Agents|antidepressive agents|mesh-ancestor
65155674|NCT01255787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65155675|NCT01255787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65155676|NCT01255787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65155677|NCT01255787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65155678|NCT01255787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155679|NCT01255787|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65155680|NCT01255787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65155681|NCT01255787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65155682|NCT01255787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155683|NCT01255787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65155684|NCT01255787|Serotonin Agents|serotonin agents|mesh-ancestor
65155685|NCT01255787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65155686|NCT01255787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65155687|NCT01255787|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65155688|NCT01255787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65155689|NCT01255163|Exenatide|exenatide|mesh-list
65155690|NCT01255163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65155691|NCT01255163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155692|NCT01255163|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65155693|NCT01255163|Incretins|incretins|mesh-ancestor
65155694|NCT01255163|Hormones|hormones|mesh-ancestor
65155695|NCT01255163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65155696|NCT01123083|Muromonab-CD3|muromonab-cd3|mesh-list
65155697|NCT01123083|Immunologic Factors|immunologic factors|mesh-ancestor
65155698|NCT01123083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155699|NCT01123083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65155700|NCT05588609|Abiraterone Acetate|abiraterone acetate|mesh-list
65155701|NCT05588609|Afatinib|afatinib|mesh-list
65155702|NCT05588609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155703|NCT05588609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65155704|NCT05588609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155705|NCT05588609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155706|NCT05588609|Hormone Antagonists|hormone antagonists|mesh-ancestor
65155707|NCT05588609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65155708|NCT05588609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155709|NCT05588609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65155710|NCT05588609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65155711|NCT02870062|Chlorhexidine|chlorhexidine|mesh-list
65155712|NCT02870062|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65155713|NCT02870062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65155714|NCT02870062|Disinfectants|disinfectants|mesh-ancestor
65155715|NCT01254305|Milnacipran|milnacipran|mesh-list
65155716|NCT01254305|Sertraline|sertraline|mesh-list
65155717|NCT01254305|Fluoxetine|fluoxetine|mesh-list
65155718|NCT01254305|Paroxetine|paroxetine|mesh-list
65155719|NCT01254305|Citalopram|citalopram|mesh-list
65155720|NCT01254305|Levomilnacipran|levomilnacipran|mesh-list
65155725|NCT01254305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65155726|NCT01254305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307842|NCT00678431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307843|NCT00678431|Protective Agents|protective agents|mesh-ancestor
65307844|NCT00678431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307845|NCT00678431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307846|NCT00678431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65307847|NCT00678509|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65307848|NCT00678509|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65307849|NCT00678509|Immunologic Factors|immunologic factors|mesh-ancestor
65307850|NCT00678509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307851|NCT00674687|Gabapentin|gabapentin|mesh-list
65307852|NCT00674687|Analgesics|analgesics|mesh-ancestor
65307853|NCT00674687|Sensory System Agents|sensory system agents|mesh-ancestor
65307854|NCT00674687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65307855|NCT00674687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307856|NCT00674687|Anticonvulsants|anticonvulsants|mesh-ancestor
65307857|NCT00674687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65307858|NCT00674687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65307859|NCT00674687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65307860|NCT00674687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65307861|NCT00674687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65307862|NCT00674687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65307863|NCT00674687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65307864|NCT00674687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307865|NCT00674687|Antimanic Agents|antimanic agents|mesh-ancestor
65307866|NCT00656747|Amoxicillin|amoxicillin|mesh-list
65307867|NCT00656747|Moxifloxacin|moxifloxacin|mesh-list
65307868|NCT00656747|Clavulanic Acids|clavulanic acids|mesh-list
65307869|NCT00656747|Clavulanic Acid|clavulanic acid|mesh-list
65155727|NCT01254305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65155728|NCT01254305|Serotonin Agents|serotonin agents|mesh-ancestor
65155729|NCT01254305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155730|NCT01254305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65155731|NCT01254305|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65155732|NCT01254305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65155733|NCT01254305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155734|NCT01254305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155735|NCT01254305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65155736|NCT01254305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65155737|NCT01254305|Analgesics|analgesics|mesh-ancestor
65155738|NCT01254305|Sensory System Agents|sensory system agents|mesh-ancestor
65155739|NCT01122927|Aripiprazole|aripiprazole|mesh-list
65155740|NCT01122927|Antidepressive Agents|antidepressive agents|mesh-ancestor
65155741|NCT01122927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65155742|NCT01122927|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65155743|NCT01122927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65307870|NCT00656747|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65307871|NCT00656747|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65307872|NCT00656747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65307873|NCT00656747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65307874|NCT00656747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65307875|NCT00656747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65307876|NCT00656747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307877|NCT00656747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307878|NCT00656747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307879|NCT00656747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65307880|NCT00656747|Contraceptive Agents|contraceptive agents|mesh-ancestor
65307881|NCT00656747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65307882|NCT00656747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307883|NCT00656747|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65307884|NCT00656747|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65155744|NCT01122927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65155745|NCT01122927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155746|NCT01122927|Dopamine Agonists|dopamine agonists|mesh-ancestor
65155747|NCT01122927|Dopamine Agents|dopamine agents|mesh-ancestor
65155748|NCT01122927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65155749|NCT01122927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155750|NCT01122927|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65155751|NCT01122927|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65155752|NCT01122927|Serotonin Agents|serotonin agents|mesh-ancestor
65155753|NCT01122927|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65155754|NCT01122927|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65155755|NCT01122927|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65155756|NCT01122927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65155757|NCT01254227|Deferasirox|deferasirox|mesh-list
65155758|NCT01254227|Deferoxamine|deferoxamine|mesh-list
65155759|NCT01254227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65155760|NCT01254227|Chelating Agents|chelating agents|mesh-ancestor
65155761|NCT01254227|Sequestering Agents|sequestering agents|mesh-ancestor
65155762|NCT01254227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155763|NCT01254227|Siderophores|siderophores|mesh-ancestor
65155764|NCT04311255|Anesthetics|anesthetics|mesh-list
65155765|NCT04311255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65155766|NCT04311255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155767|NCT01122381|Ethosuximide|ethosuximide|mesh-list
65155768|NCT01122381|Anticonvulsants|anticonvulsants|mesh-ancestor
65155769|NCT00996034|Nicotine|nicotine|mesh-list
65155770|NCT00996034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155771|NCT00996034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65155772|NCT00996034|Autonomic Agents|autonomic agents|mesh-ancestor
65155773|NCT00996034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155774|NCT00996034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65155775|NCT00996034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65155776|NCT00996034|Cholinergic Agents|cholinergic agents|mesh-ancestor
65155777|NCT00996034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65155778|NCT00996034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155779|NCT01121991|Hormones|hormones|mesh-list
65155780|NCT01121991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65155781|NCT01121991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155782|NCT04292236|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
65155783|NCT04292236|Perilla seed oil|perilla seed oil|mesh-list
65307885|NCT00656747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65307886|NCT00656747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65307887|NCT00678743|Simvastatin|simvastatin|mesh-list
65307888|NCT00678743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65307889|NCT00678743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65307890|NCT00678743|Antimetabolites|antimetabolites|mesh-ancestor
65307891|NCT00678743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307892|NCT00678743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65307893|NCT00678743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65307894|NCT00678743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307895|NCT04152317|Misoprostol|misoprostol|mesh-list
65307896|NCT04152317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65307897|NCT04152317|Abortifacient Agents|abortifacient agents|mesh-ancestor
65307898|NCT04152317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65307899|NCT04152317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307900|NCT04152317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65307901|NCT04152317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65307902|NCT04152317|Oxytocics|oxytocics|mesh-ancestor
65307903|NCT02628665|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
65307904|NCT02628665|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
65307905|NCT02628665|Trioxsalen|trioxsalen|mesh-list
65307906|NCT02628665|Photosensitizing Agents|photosensitizing agents|mesh-list
65307907|NCT02628665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307908|NCT02628665|Dermatologic Agents|dermatologic agents|mesh-ancestor
65307909|NCT00678977|Gemcitabine|gemcitabine|mesh-list
65307910|NCT00678977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307911|NCT00678977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65307912|NCT00678977|Antimetabolites|antimetabolites|mesh-ancestor
65307913|NCT00678977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307914|NCT00678977|Antiviral Agents|antiviral agents|mesh-ancestor
65307915|NCT00678977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65307916|NCT00678977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307917|NCT00678977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65155784|NCT04292236|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65155785|NCT04292236|Protective Agents|protective agents|mesh-ancestor
65155786|NCT04292236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155787|NCT04292236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155789|NCT01121913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65155790|NCT01121913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65155793|NCT01121913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65155794|NCT01121913|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65155795|NCT01121913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65307918|NCT00678977|Immunologic Factors|immunologic factors|mesh-ancestor
65307919|NCT00678977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307920|NCT00674921|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65307921|NCT00674921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65307922|NCT00674921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65307923|NCT00674921|Renal Agents|renal agents|mesh-ancestor
65307924|NCT00674921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65307925|NCT00674921|Antimalarials|antimalarials|mesh-ancestor
65307926|NCT00674921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65307927|NCT00674921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65307928|NCT00674999|Bacitracin|bacitracin|mesh-list
65307929|NCT00674999|Nystatin|nystatin|mesh-list
65307930|NCT00674999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65307931|NCT00674999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65307932|NCT00674999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65307933|NCT00674999|Antifungal Agents|antifungal agents|mesh-ancestor
65307934|NCT00674999|Ionophores|ionophores|mesh-ancestor
65307935|NCT00674999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65307936|NCT00674999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307937|NCT00882713|Epoetin Alfa|epoetin alfa|mesh-list
65307938|NCT00882713|Hematinics|hematinics|mesh-ancestor
65307939|NCT04151381|Aminophylline|aminophylline|mesh-list
65307940|NCT04151381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65307941|NCT04151381|Autonomic Agents|autonomic agents|mesh-ancestor
65307942|NCT04151381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65307943|NCT04151381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307944|NCT04151381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65307945|NCT04151381|Respiratory System Agents|respiratory system agents|mesh-ancestor
65155796|NCT01121913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65155797|NCT01121913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155798|NCT01121913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65155799|NCT01121913|Serotonin Agents|serotonin agents|mesh-ancestor
65155800|NCT01121913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65155801|NCT01121913|Antidepressive Agents|antidepressive agents|mesh-ancestor
65155802|NCT04310943|Paclitaxel|paclitaxel|mesh-list
65155803|NCT04310943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65155804|NCT04310943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155805|NCT04310943|Tubulin Modulators|tubulin modulators|mesh-ancestor
65155806|NCT04310943|Antimitotic Agents|antimitotic agents|mesh-ancestor
65155807|NCT04310943|Mitosis Modulators|mitosis modulators|mesh-ancestor
65155808|NCT04310943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155809|NCT02868814|Pregabalin|pregabalin|mesh-list
65155810|NCT02868814|Analgesics|analgesics|mesh-ancestor
65155811|NCT02868814|Sensory System Agents|sensory system agents|mesh-ancestor
65155812|NCT02868814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155813|NCT02868814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155814|NCT02868814|Anticonvulsants|anticonvulsants|mesh-ancestor
65155815|NCT02868814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65307946|NCT04151381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65307947|NCT04151381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65307948|NCT04151381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307949|NCT04151381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307950|NCT04151381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65307951|NCT04151381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65307952|NCT04151381|Purinergic Agents|purinergic agents|mesh-ancestor
65307953|NCT04151381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64302523|NCT03246399|Lorecivivint|lorecivivint|mesh-list
65155816|NCT02868814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65155817|NCT02868814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798416|NCT01390662|Vitamin D|vitamin d|mesh-list
65155818|NCT02868814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65155819|NCT02868814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65155820|NCT02868814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65155821|NCT02868814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65155822|NCT02868814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65155823|NCT04292314|Hydroxyurea|hydroxyurea|mesh-list
65155824|NCT04292314|Deferoxamine|deferoxamine|mesh-list
65155825|NCT04292314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155826|NCT04292314|Antisickling Agents|antisickling agents|mesh-ancestor
65155827|NCT04292314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155828|NCT04292314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155829|NCT04292314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65155830|NCT04292314|Siderophores|siderophores|mesh-ancestor
65155831|NCT04292314|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65155832|NCT04292314|Chelating Agents|chelating agents|mesh-ancestor
65155833|NCT04292314|Sequestering Agents|sequestering agents|mesh-ancestor
65155834|NCT01121757|Lenalidomide|lenalidomide|mesh-list
65155835|NCT01121757|Azacitidine|azacitidine|mesh-list
65155836|NCT01121757|Immunologic Factors|immunologic factors|mesh-ancestor
65155837|NCT01121757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155838|NCT01121757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65155839|NCT01121757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65155840|NCT01121757|Growth Substances|growth substances|mesh-ancestor
65155841|NCT01121757|Growth Inhibitors|growth inhibitors|mesh-ancestor
65155842|NCT01121757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155843|NCT01121757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65155844|NCT01121757|Antimetabolites|antimetabolites|mesh-ancestor
65155845|NCT01121757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155846|NCT01121757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155847|NCT04319471|Capecitabine|capecitabine|mesh-list
65155848|NCT04319471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65155849|NCT04319471|Antimetabolites|antimetabolites|mesh-ancestor
65155850|NCT04319471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155851|NCT04319471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155852|NCT02882217|Histamine|histamine|mesh-list
65155853|NCT02882217|Glutarimide|glutarimide|mesh-list
65155854|NCT02882217|Histamine Agonists|histamine agonists|mesh-ancestor
65155855|NCT02882217|Histamine Agents|histamine agents|mesh-ancestor
65155856|NCT02882217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64514580|NCT05402020|Olodaterol|olodaterol|mesh-list
65155857|NCT02882217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155858|NCT02882217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155859|NCT02882217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65155860|NCT02882217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155877|NCT00991510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65155878|NCT00991510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155879|NCT00991510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65155880|NCT00991510|Antitubercular Agents|antitubercular agents|mesh-ancestor
65155881|NCT00991510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65155882|NCT00991510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65155883|NCT00991510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155884|NCT00991510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155885|NCT01119963|Castor Oil|castor oil|mesh-list
65307954|NCT04151381|Protective Agents|protective agents|mesh-ancestor
65307955|NCT00809133|Paclitaxel|paclitaxel|mesh-list
65307956|NCT00809133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65307957|NCT00809133|Bevacizumab|bevacizumab|mesh-list
65307958|NCT00809133|Carboplatin|carboplatin|mesh-list
65307959|NCT00809133|Afatinib|afatinib|mesh-list
65307960|NCT00809133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65307961|NCT00809133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307962|NCT00809133|Tubulin Modulators|tubulin modulators|mesh-ancestor
65307963|NCT00809133|Antimitotic Agents|antimitotic agents|mesh-ancestor
65307964|NCT00809133|Mitosis Modulators|mitosis modulators|mesh-ancestor
65307965|NCT00809133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307966|NCT00809133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65307967|NCT00809133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65155886|NCT01119963|Progesterone|progesterone|mesh-list
65155887|NCT01119963|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
65155888|NCT01119963|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
65155889|NCT01119963|Progestins|progestins|mesh-ancestor
65155890|NCT01119963|Hormones|hormones|mesh-ancestor
65155891|NCT01119963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65155892|NCT01119963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155893|NCT01119963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65155894|NCT01119963|Hormone Antagonists|hormone antagonists|mesh-ancestor
65155895|NCT01119963|Cathartics|cathartics|mesh-ancestor
65155896|NCT01119963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65155897|NCT01252667|Cyclosporine|cyclosporine|mesh-list
65155898|NCT01252667|Mycophenolic Acid|mycophenolic acid|mesh-list
65155899|NCT01252667|Clofarabine|clofarabine|mesh-list
65155900|NCT01252667|Cyclosporins|cyclosporins|mesh-list
65155901|NCT01252667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155902|NCT01252667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155903|NCT01252667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65155904|NCT01252667|Immunologic Factors|immunologic factors|mesh-ancestor
65155905|NCT01252667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155906|NCT01252667|Antifungal Agents|antifungal agents|mesh-ancestor
65155907|NCT01252667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65155908|NCT01252667|Dermatologic Agents|dermatologic agents|mesh-ancestor
65155909|NCT01252667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65155910|NCT01252667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65155911|NCT01252667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65155912|NCT01252667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155913|NCT01252667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65155914|NCT01252667|Antitubercular Agents|antitubercular agents|mesh-ancestor
65155915|NCT01252667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65155916|NCT01252667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65155917|NCT01252667|Antimetabolites|antimetabolites|mesh-ancestor
65155918|NCT02868580|Lamivudine|lamivudine|mesh-list
65155919|NCT02868580|Abacavir|abacavir|mesh-list
65155920|NCT02868580|Dolutegravir|dolutegravir|mesh-list
65155921|NCT02868580|Triumeq|triumeq|mesh-list
65155922|NCT02868580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65155925|NCT02868580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155927|NCT02868580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65155928|NCT02868580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65155929|NCT02868580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65155930|NCT02868580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65155931|NCT02868580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65155932|NCT02881749|Mechlorethamine|mechlorethamine|mesh-list
65155933|NCT02881749|Alkylating Agents|alkylating agents|mesh-ancestor
65155934|NCT02881749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155935|NCT02881749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65155936|NCT02881749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155937|NCT01119105|Vancomycin|vancomycin|mesh-list
65155938|NCT01119105|Lefamulin|lefamulin|mesh-list
65307968|NCT00809133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65307969|NCT00809133|Growth Substances|growth substances|mesh-ancestor
65307970|NCT00809133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307971|NCT00809133|Growth Inhibitors|growth inhibitors|mesh-ancestor
65307972|NCT00809133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65307973|NCT00809133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65307974|NCT00912275|Vinorelbine|vinorelbine|mesh-list
65307975|NCT00912275|Lapatinib|lapatinib|mesh-list
65307976|NCT00912275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65307977|NCT00912275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65307978|NCT00912275|Tubulin Modulators|tubulin modulators|mesh-ancestor
65307979|NCT00912275|Antimitotic Agents|antimitotic agents|mesh-ancestor
65307980|NCT00912275|Mitosis Modulators|mitosis modulators|mesh-ancestor
65307981|NCT00912275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65307982|NCT00912275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65307983|NCT00912275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155939|NCT01119105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65155940|NCT01119105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65155941|NCT01118949|Lacosamide|lacosamide|mesh-list
65155942|NCT01118949|Anticonvulsants|anticonvulsants|mesh-ancestor
65155943|NCT01118949|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65155944|NCT01118949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65155945|NCT01118949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65155946|NCT01118949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155947|NCT01252355|Interferons|interferons|mesh-list
65155948|NCT01252355|Interferon-beta|interferon-beta|mesh-list
65155949|NCT01252355|Teriflunomide|teriflunomide|mesh-list
65155950|NCT01252355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155951|NCT01252355|Antiviral Agents|antiviral agents|mesh-ancestor
65155952|NCT01252355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65155953|NCT01252355|Immunologic Factors|immunologic factors|mesh-ancestor
65155954|NCT01252355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155955|NCT01252355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65155956|NCT01252355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65155957|NCT01252355|Analgesics|analgesics|mesh-ancestor
65155958|NCT01252355|Sensory System Agents|sensory system agents|mesh-ancestor
65155959|NCT01252355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155960|NCT01252355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65155961|NCT01252355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65155962|NCT01252355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65155963|NCT01118325|Clopidogrel|clopidogrel|mesh-list
65155964|NCT01118325|Ticagrelor|ticagrelor|mesh-list
65155965|NCT01118325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65155966|NCT01118325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65155967|NCT01118325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65155968|NCT01118325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65155969|NCT01118325|Purinergic Agents|purinergic agents|mesh-ancestor
65155970|NCT01118325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65155971|NCT01118325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155972|NCT01118325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155973|NCT01117857|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65155974|NCT01117857|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65155975|NCT01117857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65155976|NCT01117857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65155977|NCT01117857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155978|NCT01117857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65155979|NCT01117857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307984|NCT00882557|Daptomycin|daptomycin|mesh-list
65307985|NCT00882557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65307986|NCT00882557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65307987|NCT02627573|Mycophenolic Acid|mycophenolic acid|mesh-list
65307988|NCT02627573|Cyclophosphamide|cyclophosphamide|mesh-list
65307989|NCT02627573|Busulfan|busulfan|mesh-list
65307990|NCT02627573|Fludarabine|fludarabine|mesh-list
65307991|NCT02627573|Fludarabine phosphate|fludarabine phosphate|mesh-list
65307992|NCT02627573|Tacrolimus|tacrolimus|mesh-list
65307993|NCT02627573|Thymoglobulin|thymoglobulin|mesh-list
65307994|NCT02627573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65307995|NCT02627573|Immunologic Factors|immunologic factors|mesh-ancestor
65307996|NCT02627573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65307997|NCT02627573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65307998|NCT02627573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65307999|NCT02627573|Alkylating Agents|alkylating agents|mesh-ancestor
65308000|NCT02627573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308001|NCT02627573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308002|NCT02627573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65308003|NCT02627573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65308004|NCT02627573|Antimetabolites|antimetabolites|mesh-ancestor
65308005|NCT02627573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65308006|NCT02627573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308007|NCT02627573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65308008|NCT02627573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65308009|NCT02627573|Antitubercular Agents|antitubercular agents|mesh-ancestor
65308010|NCT02627573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65308011|NCT02627573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65308012|NCT00675545|Carboplatin|carboplatin|mesh-list
65308013|NCT00675545|Docetaxel|docetaxel|mesh-list
65308014|NCT00675545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308015|NCT00675545|Tubulin Modulators|tubulin modulators|mesh-ancestor
65308016|NCT00675545|Antimitotic Agents|antimitotic agents|mesh-ancestor
65308017|NCT00675545|Mitosis Modulators|mitosis modulators|mesh-ancestor
65308018|NCT00675545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155980|NCT01117857|Analgesics|analgesics|mesh-ancestor
65155981|NCT01117857|Sensory System Agents|sensory system agents|mesh-ancestor
65155982|NCT01117857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155983|NCT01117857|Antidepressive Agents|antidepressive agents|mesh-ancestor
65155984|NCT01117857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65155985|NCT01117857|Dopamine Agents|dopamine agents|mesh-ancestor
65155986|NCT00991276|Pregabalin|pregabalin|mesh-list
65155987|NCT00991276|Pramipexole|pramipexole|mesh-list
65155988|NCT00991276|Analgesics|analgesics|mesh-ancestor
65308019|NCT00679523|Tavaborole|tavaborole|mesh-list
65308020|NCT00679523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65308021|NCT00679523|Antifungal Agents|antifungal agents|mesh-ancestor
65057923|NCT00239954|Citalopram|citalopram|mesh-list
65308022|NCT00679523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65308023|NCT00675701|Moxifloxacin|moxifloxacin|mesh-list
65308024|NCT00675701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64537873|NCT04387929|Antibodies|antibodies|mesh-list
65155989|NCT00991276|Sensory System Agents|sensory system agents|mesh-ancestor
65155990|NCT00991276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155991|NCT00991276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155992|NCT00991276|Anticonvulsants|anticonvulsants|mesh-ancestor
65155993|NCT00991276|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65155996|NCT00991276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65155998|NCT00991276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65155999|NCT00991276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65156000|NCT00991276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65156001|NCT00991276|Antioxidants|antioxidants|mesh-ancestor
65156002|NCT00991276|Protective Agents|protective agents|mesh-ancestor
65156003|NCT00991276|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65156004|NCT00991276|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65156005|NCT00991276|Dopamine Agonists|dopamine agonists|mesh-ancestor
65156006|NCT00991276|Dopamine Agents|dopamine agents|mesh-ancestor
65156007|NCT00991276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65156008|NCT02869126|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
65156009|NCT02869126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65156010|NCT02869126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156011|NCT00990652|Temozolomide|temozolomide|mesh-list
65156013|NCT00990652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65156014|NCT00990652|Alkylating Agents|alkylating agents|mesh-ancestor
65156015|NCT00990652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156016|NCT00990652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156017|NCT02867878|Adenosine|adenosine|mesh-list
65156018|NCT02867878|Analgesics|analgesics|mesh-ancestor
65156019|NCT02867878|Sensory System Agents|sensory system agents|mesh-ancestor
65156020|NCT02867878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65156021|NCT02867878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156022|NCT02867878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65156023|NCT02867878|Vasodilator Agents|vasodilator agents|mesh-ancestor
65156024|NCT02867878|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65156025|NCT02867878|Purinergic Agonists|purinergic agonists|mesh-ancestor
65156026|NCT02867878|Purinergic Agents|purinergic agents|mesh-ancestor
65156027|NCT02867878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65156028|NCT02867878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156029|NCT01207440|Ponatinib|ponatinib|mesh-list
65156030|NCT01207440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156031|NCT01207440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65156032|NCT01207440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156033|NCT01207440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156034|NCT00990184|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65156035|NCT00990184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65156036|NCT00990184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65156037|NCT00990184|Antimetabolites|antimetabolites|mesh-ancestor
65156038|NCT00990184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156039|NCT00990184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65156040|NCT00990106|Prazosin|prazosin|mesh-list
65156041|NCT00990106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65156042|NCT00990106|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64798637|NCT01392157|Copper|copper|mesh-list
65156043|NCT00990106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65156044|NCT00990106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65156045|NCT00990106|Adrenergic Agents|adrenergic agents|mesh-ancestor
65156046|NCT00990106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65156047|NCT00990106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156048|NCT00990106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156049|NCT02867566|Rituximab|rituximab|mesh-list
65156050|NCT02867566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65156051|NCT02867566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308025|NCT00675701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65308026|NCT00675701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65308027|NCT00675701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65308028|NCT00675701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308029|NCT00675701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308030|NCT00675701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308031|NCT00808899|Sirolimus|sirolimus|mesh-list
65308032|NCT00808899|Cyclophosphamide|cyclophosphamide|mesh-list
65308033|NCT00808899|Doxorubicin|doxorubicin|mesh-list
65308034|NCT00808899|Irinotecan|irinotecan|mesh-list
65308035|NCT00808899|Etoposide|etoposide|mesh-list
65308036|NCT00808899|Topotecan|topotecan|mesh-list
65308037|NCT00808899|Tretinoin|tretinoin|mesh-list
65308038|NCT00808899|Isotretinoin|isotretinoin|mesh-list
65308039|NCT00808899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64537879|NCT05361291|Antiemetics|antiemetics|mesh-ancestor
65156052|NCT02867566|Immunologic Factors|immunologic factors|mesh-ancestor
65156053|NCT02867566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156054|NCT02867566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65156055|NCT02867722|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65156056|NCT02867722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65156057|NCT02867722|Dermatologic Agents|dermatologic agents|mesh-ancestor
65156058|NCT02867800|Acetaminophen|acetaminophen|mesh-list
65156059|NCT02867800|Diphenhydramine|diphenhydramine|mesh-list
65156060|NCT02867800|Promethazine|promethazine|mesh-list
65156061|NCT02867800|Cyclosporine|cyclosporine|mesh-list
65156062|NCT02867800|Sirolimus|sirolimus|mesh-list
65156063|NCT02867800|Mycophenolic Acid|mycophenolic acid|mesh-list
65156064|NCT02867800|Methylprednisolone|methylprednisolone|mesh-list
65156065|NCT02867800|Methotrexate|methotrexate|mesh-list
64689466|NCT01970345|Mecasermin|mecasermin|mesh-list
65156081|NCT02867800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156082|NCT02867800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156083|NCT02867800|Dermatologic Agents|dermatologic agents|mesh-ancestor
65156084|NCT02867800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156085|NCT02867800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65156086|NCT02867800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65156087|NCT02867800|Immunologic Factors|immunologic factors|mesh-ancestor
65156088|NCT02867800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65156089|NCT02867800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65156090|NCT02867800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65156091|NCT02867800|Antifungal Agents|antifungal agents|mesh-ancestor
65156092|NCT02867800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65156093|NCT02867800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65156094|NCT02867800|Analgesics|analgesics|mesh-ancestor
65156095|NCT02867800|Sensory System Agents|sensory system agents|mesh-ancestor
65156096|NCT02867800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65156097|NCT02867800|Antipyretics|antipyretics|mesh-ancestor
65156098|NCT02867800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65156099|NCT02867800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65156100|NCT02867800|Antitubercular Agents|antitubercular agents|mesh-ancestor
65156101|NCT02867800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65156102|NCT02867800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65156103|NCT02867800|Antiemetics|antiemetics|mesh-ancestor
65156104|NCT02867800|Autonomic Agents|autonomic agents|mesh-ancestor
65156105|NCT02867800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65156106|NCT02867800|Glucocorticoids|glucocorticoids|mesh-ancestor
65156107|NCT02867800|Hormones|hormones|mesh-ancestor
65156108|NCT02867800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65156109|NCT02867800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65156110|NCT02867800|Protective Agents|protective agents|mesh-ancestor
65156111|NCT02867800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65156112|NCT02867800|Alkylating Agents|alkylating agents|mesh-ancestor
65156113|NCT02867800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65156114|NCT02867800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65308040|NCT00808899|Immunologic Factors|immunologic factors|mesh-ancestor
65308041|NCT00808899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308042|NCT00808899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65308043|NCT00808899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65308044|NCT00808899|Alkylating Agents|alkylating agents|mesh-ancestor
65308045|NCT00808899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308046|NCT00808899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308047|NCT00808899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65308048|NCT00808899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65308049|NCT00808899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65308050|NCT00808899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65308051|NCT00808899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308052|NCT00808899|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65308053|NCT00808899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65308054|NCT00808899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65308055|NCT00808899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64537898|NCT01445951|Insulin|insulin|mesh-list
65156115|NCT02867800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65156116|NCT02867800|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65156117|NCT02867800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65156118|NCT02867800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65156119|NCT02867800|Anesthetics, Local|anesthetics, local|mesh-ancestor
65156120|NCT02867800|Anesthetics|anesthetics|mesh-ancestor
65156121|NCT02867800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65156122|NCT02867800|Histamine Antagonists|histamine antagonists|mesh-ancestor
65156123|NCT02867800|Histamine Agents|histamine agents|mesh-ancestor
65156124|NCT02867800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65156125|NCT02867800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65156126|NCT02867800|Antipruritics|antipruritics|mesh-ancestor
65156127|NCT02867800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65156128|NCT02867800|Narcotics|narcotics|mesh-ancestor
65156129|NCT02867800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65156144|NCT02867176|Ketorolac|ketorolac|mesh-list
65156145|NCT02867176|Gabapentin|gabapentin|mesh-list
65156146|NCT02867176|Analgesics|analgesics|mesh-ancestor
65156147|NCT02867176|Sensory System Agents|sensory system agents|mesh-ancestor
65156148|NCT02867176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65156149|NCT02867176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156150|NCT02867176|Anticonvulsants|anticonvulsants|mesh-ancestor
65156151|NCT02867176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65156152|NCT02867176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65156153|NCT02867176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65156154|NCT02867176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65156155|NCT02867176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65156156|NCT02867176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65156157|NCT02867176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65156158|NCT02867176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156160|NCT02867176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65156161|NCT02867176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65156162|NCT02867176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65156163|NCT02867176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65156164|NCT02867176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65156165|NCT02867176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156166|NCT00982228|Insulin|insulin|mesh-list
65156167|NCT00982228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65156168|NCT00982228|Insulin Glargine|insulin glargine|mesh-list
65156169|NCT00982228|Insulin Aspart|insulin aspart|mesh-list
65156170|NCT00982228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65308056|NCT00808899|Antifungal Agents|antifungal agents|mesh-ancestor
65308057|NCT00808899|Keratolytic Agents|keratolytic agents|mesh-ancestor
65308058|NCT00808899|Dermatologic Agents|dermatologic agents|mesh-ancestor
65308059|NCT00808665|Dexmedetomidine|dexmedetomidine|mesh-list
65308060|NCT00808665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65308061|NCT00808665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65308062|NCT00808665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308063|NCT00808665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65308064|NCT00808665|Analgesics|analgesics|mesh-ancestor
65308065|NCT00808665|Sensory System Agents|sensory system agents|mesh-ancestor
65308066|NCT00808665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65308067|NCT00808665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65308068|NCT00808665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65308069|NCT00808665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65308070|NCT00808665|Adrenergic Agents|adrenergic agents|mesh-ancestor
65308071|NCT00808665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65308072|NCT00808665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308073|NCT00808509|Adalimumab|adalimumab|mesh-list
65308074|NCT00808509|Methotrexate|methotrexate|mesh-list
65308075|NCT00808509|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65308076|NCT00808509|Abortifacient Agents|abortifacient agents|mesh-ancestor
65308077|NCT00808509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65308078|NCT00808509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156171|NCT00982228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156172|NCT02867956|Etoposide|etoposide|mesh-list
65156173|NCT02867956|Apatinib|apatinib|mesh-list
65156174|NCT02867956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65156175|NCT02867956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156176|NCT02867956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65156177|NCT02867956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65156178|NCT02867956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156179|NCT02867956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156180|NCT02867956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65156181|NCT04291066|Acetylcysteine|acetylcysteine|mesh-list
65156182|NCT04291066|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65156183|NCT04291066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156184|NCT04291066|Antiviral Agents|antiviral agents|mesh-ancestor
65156185|NCT04291066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65156186|NCT04291066|Expectorants|expectorants|mesh-ancestor
65156187|NCT04291066|Respiratory System Agents|respiratory system agents|mesh-ancestor
65156188|NCT04291066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65156189|NCT04291066|Antioxidants|antioxidants|mesh-ancestor
65156190|NCT04291066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156191|NCT04291066|Protective Agents|protective agents|mesh-ancestor
65156192|NCT04291066|Antidotes|antidotes|mesh-ancestor
65156193|NCT01260350|Sofosbuvir|sofosbuvir|mesh-list
65156194|NCT01260350|Antiviral Agents|antiviral agents|mesh-ancestor
65156197|NCT01260194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65156198|NCT01260194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156199|NCT00629278|Tamoxifen|tamoxifen|mesh-list
65156200|NCT00629278|Docetaxel|docetaxel|mesh-list
65156201|NCT00629278|Cyclophosphamide|cyclophosphamide|mesh-list
65156202|NCT00629278|Doxorubicin|doxorubicin|mesh-list
65308079|NCT00808509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65308080|NCT00808509|Antimetabolites|antimetabolites|mesh-ancestor
65308081|NCT00808509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308082|NCT00808509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308083|NCT00808509|Dermatologic Agents|dermatologic agents|mesh-ancestor
65308084|NCT00808509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308085|NCT00808509|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65308086|NCT00808509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65156203|NCT00629278|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65156204|NCT00629278|Fluorouracil|fluorouracil|mesh-list
65156205|NCT00629278|Trastuzumab|trastuzumab|mesh-list
65156206|NCT00629278|Epirubicin|epirubicin|mesh-list
65156207|NCT00629278|Hormones|hormones|mesh-list
65156208|NCT00629278|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65156209|NCT00629278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156210|NCT00629278|Tubulin Modulators|tubulin modulators|mesh-ancestor
65156211|NCT00629278|Antimitotic Agents|antimitotic agents|mesh-ancestor
65156212|NCT00629278|Mitosis Modulators|mitosis modulators|mesh-ancestor
65156213|NCT00629278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156214|NCT00629278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65156215|NCT00629278|Immunologic Factors|immunologic factors|mesh-ancestor
65156216|NCT00629278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156217|NCT00629278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65156218|NCT00629278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65156219|NCT00629278|Alkylating Agents|alkylating agents|mesh-ancestor
65156220|NCT00629278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65156221|NCT00629278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65156222|NCT00629278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65156223|NCT00629278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65156224|NCT00629278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156225|NCT00629278|Antimetabolites|antimetabolites|mesh-ancestor
65156226|NCT00629278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65156227|NCT00629278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65156228|NCT00629278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65156229|NCT00629278|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65156230|NCT00629278|Hormone Antagonists|hormone antagonists|mesh-ancestor
65156231|NCT00629278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65156232|NCT00629278|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65156233|NCT00629278|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65156234|NCT00629278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65156236|NCT04207112|Moxifloxacin|moxifloxacin|mesh-list
65156237|NCT04207112|Linezolid|linezolid|mesh-list
65156238|NCT04207112|Bedaquiline|bedaquiline|mesh-list
65156239|NCT04207112|Clofazimine|clofazimine|mesh-list
65156240|NCT04207112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65156241|NCT04207112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65156242|NCT04207112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65156243|NCT04207112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65156244|NCT04207112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156245|NCT04207112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156246|NCT04207112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156247|NCT04207112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65156248|NCT04207112|Antitubercular Agents|antitubercular agents|mesh-ancestor
65156249|NCT04207112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65156250|NCT04207112|Leprostatic Agents|leprostatic agents|mesh-ancestor
65156251|NCT01259492|Methylphenidate|methylphenidate|mesh-list
65156252|NCT01259492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65156253|NCT01259492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156254|NCT01259492|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65156255|NCT01259492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65156256|NCT01259492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65156257|NCT01259492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156258|NCT01259492|Dopamine Agents|dopamine agents|mesh-ancestor
65156259|NCT01259492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65156260|NCT00624026|Memantine|memantine|mesh-list
65308087|NCT00808509|Immunologic Factors|immunologic factors|mesh-ancestor
65308088|NCT00808509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65308089|NCT00808509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65308090|NCT00808509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65308091|NCT04444869|Cisplatin|cisplatin|mesh-list
65308092|NCT04444869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308093|NCT04276857|Leucovorin|leucovorin|mesh-list
65308094|NCT04276857|Gemcitabine|gemcitabine|mesh-list
65308095|NCT04276857|Paclitaxel|paclitaxel|mesh-list
65308096|NCT04276857|Oxaliplatin|oxaliplatin|mesh-list
65057998|NCT00240032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65308097|NCT04276857|Irinotecan|irinotecan|mesh-list
65308098|NCT04276857|Folfirinox|folfirinox|mesh-list
65156261|NCT00624026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65156262|NCT00624026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65156263|NCT00624026|Dopamine Agents|dopamine agents|mesh-ancestor
65156264|NCT00624026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65156265|NCT00624026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156266|NCT00624026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156267|NCT00624026|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64952908|NCT02969265|Vasodilator Agents|vasodilator agents|mesh-ancestor
65156271|NCT05512910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65156272|NCT02888990|Dasatinib|dasatinib|mesh-list
65156273|NCT02888990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156274|NCT02888990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65156275|NCT02888990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156276|NCT02888990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156277|NCT05101928|Prednisone|prednisone|mesh-list
65156278|NCT05101928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65156279|NCT05101928|Glucocorticoids|glucocorticoids|mesh-ancestor
65156280|NCT05101928|Hormones|hormones|mesh-ancestor
65156281|NCT05101928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65156282|NCT05101928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156283|NCT05101928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65156284|NCT05101928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156285|NCT04952402|Vaccines|vaccines|mesh-list
65156286|NCT04952402|Immunologic Factors|immunologic factors|mesh-ancestor
65156287|NCT04952402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156288|NCT04654052|Clopidogrel|clopidogrel|mesh-list
65156289|NCT04654052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65156290|NCT04654052|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65156291|NCT04654052|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65156292|NCT04654052|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65156293|NCT04654052|Purinergic Agents|purinergic agents|mesh-ancestor
65156294|NCT04654052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65156295|NCT04654052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156296|NCT04654052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156297|NCT05625308|Folic Acid|folic acid|mesh-list
65156298|NCT05625308|Vitamin B 12|vitamin b 12|mesh-list
65156299|NCT05625308|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65156300|NCT05625308|Hyaluronic Acid|hyaluronic acid|mesh-list
65156301|NCT05625308|Vitamins|vitamins|mesh-ancestor
65156302|NCT05625308|Micronutrients|micronutrients|mesh-ancestor
65156303|NCT05625308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156304|NCT05625308|Hematinics|hematinics|mesh-ancestor
65156305|NCT05625308|Vitamin B Complex|vitamin b complex|mesh-ancestor
65156306|NCT05625308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65156307|NCT05625308|Immunologic Factors|immunologic factors|mesh-ancestor
65156309|NCT05625308|Protective Agents|protective agents|mesh-ancestor
65156310|NCT05625308|Antioxidants|antioxidants|mesh-ancestor
65156311|NCT05625308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156312|NCT05625308|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65156313|NCT05625308|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65156314|NCT05625308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156315|NCT05625308|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65156316|NCT04291664|Prednisone|prednisone|mesh-list
65308099|NCT04276857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65308100|NCT04276857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308101|NCT04276857|Tubulin Modulators|tubulin modulators|mesh-ancestor
65308102|NCT04276857|Antimitotic Agents|antimitotic agents|mesh-ancestor
65308103|NCT04276857|Mitosis Modulators|mitosis modulators|mesh-ancestor
65308104|NCT04276857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308105|NCT04276857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65308106|NCT04276857|Antimetabolites|antimetabolites|mesh-ancestor
65308107|NCT04276857|Antiviral Agents|antiviral agents|mesh-ancestor
65308108|NCT04276857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65308109|NCT04276857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308110|NCT04276857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65308111|NCT04276857|Immunologic Factors|immunologic factors|mesh-ancestor
65308112|NCT04276857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308113|NCT04276857|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65308114|NCT04276857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65156317|NCT04291664|Abiraterone Acetate|abiraterone acetate|mesh-list
65156318|NCT04291664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65156319|NCT04291664|Glucocorticoids|glucocorticoids|mesh-ancestor
65156320|NCT04291664|Hormones|hormones|mesh-ancestor
65156321|NCT04291664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65156322|NCT04291664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156323|NCT04291664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65156324|NCT04291664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156325|NCT04291664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65156326|NCT04291664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156327|NCT04291664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156328|NCT04291664|Hormone Antagonists|hormone antagonists|mesh-ancestor
65156329|NCT04291664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65156330|NCT04187469|Moxifloxacin|moxifloxacin|mesh-list
65156331|NCT04187469|Rifampin|rifampin|mesh-list
65156332|NCT04187469|Isoniazid|isoniazid|mesh-list
65156333|NCT04187469|Pyrazinamide|pyrazinamide|mesh-list
65156334|NCT04187469|Ethambutol|ethambutol|mesh-list
65156335|NCT04187469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65156336|NCT04187469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65156337|NCT04187469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65156338|NCT04187469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65156339|NCT04187469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156340|NCT04187469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156341|NCT04187469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156345|NCT04187469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65156346|NCT04187469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65156347|NCT04187469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65156348|NCT04187469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65156349|NCT04187469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65156350|NCT04187469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65156351|NCT04187469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65156352|NCT04187469|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65156354|NCT04187469|Antimetabolites|antimetabolites|mesh-ancestor
65156355|NCT04187469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65156357|NCT04187144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65156358|NCT04187144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65156359|NCT04187144|Renal Agents|renal agents|mesh-ancestor
65156360|NCT04187144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65156361|NCT01116687|R04929097|r04929097|mesh-list
65156362|NCT01116687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308115|NCT04276857|Antidotes|antidotes|mesh-ancestor
65308116|NCT04276857|Protective Agents|protective agents|mesh-ancestor
65308117|NCT04276857|Vitamin B Complex|vitamin b complex|mesh-ancestor
65308119|NCT04276857|Micronutrients|micronutrients|mesh-ancestor
65308120|NCT00807573|Paclitaxel|paclitaxel|mesh-list
65308121|NCT00807573|Bevacizumab|bevacizumab|mesh-list
65308122|NCT00807573|Pemetrexed|pemetrexed|mesh-list
65308123|NCT00807573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65308124|NCT00807573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308125|NCT00807573|Tubulin Modulators|tubulin modulators|mesh-ancestor
65308126|NCT00807573|Antimitotic Agents|antimitotic agents|mesh-ancestor
64971654|NCT00226447|Lamivudine|lamivudine|mesh-list
65156363|NCT01116687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156364|NCT02867020|Prednisone|prednisone|mesh-list
65156365|NCT02867020|Goserelin|goserelin|mesh-list
65156366|NCT02867020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65156367|NCT02867020|Glucocorticoids|glucocorticoids|mesh-ancestor
65156368|NCT02867020|Hormones|hormones|mesh-ancestor
65156369|NCT02867020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65156370|NCT02867020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156371|NCT02867020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65156372|NCT02867020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156373|NCT03918278|Gemcitabine|gemcitabine|mesh-list
65156374|NCT03918278|Paclitaxel|paclitaxel|mesh-list
65156375|NCT03918278|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65156376|NCT03918278|Carboplatin|carboplatin|mesh-list
65156377|NCT03918278|Pembrolizumab|pembrolizumab|mesh-list
65156378|NCT03918278|Pemetrexed|pemetrexed|mesh-list
65156379|NCT03918278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65156380|NCT03918278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156381|NCT03918278|Tubulin Modulators|tubulin modulators|mesh-ancestor
65156382|NCT03918278|Antimitotic Agents|antimitotic agents|mesh-ancestor
65156383|NCT03918278|Mitosis Modulators|mitosis modulators|mesh-ancestor
65156384|NCT03918278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156385|NCT03918278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65156387|NCT03918278|Antiviral Agents|antiviral agents|mesh-ancestor
65156388|NCT03918278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65156389|NCT03918278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156390|NCT03918278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65156391|NCT03918278|Immunologic Factors|immunologic factors|mesh-ancestor
65156392|NCT03918278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156393|NCT03918278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65156394|NCT03918278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65156395|NCT03918278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65156396|NCT03817502|Cariprazine|cariprazine|mesh-list
65156397|NCT03817502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65156398|NCT03817502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65156399|NCT03817502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65156400|NCT03817502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156401|NCT03817502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65156402|NCT04319978|Dexamethasone|dexamethasone|mesh-list
65156403|NCT04319978|Dexamethasone acetate|dexamethasone acetate|mesh-list
65156404|NCT04319978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65156405|NCT04319978|Antiemetics|antiemetics|mesh-ancestor
65156406|NCT04319978|Autonomic Agents|autonomic agents|mesh-ancestor
65156407|NCT04319978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65156408|NCT04319978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156409|NCT04319978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65156410|NCT04319978|Glucocorticoids|glucocorticoids|mesh-ancestor
65156411|NCT04319978|Hormones|hormones|mesh-ancestor
65156412|NCT04319978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65156413|NCT04319978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65156414|NCT04319978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156419|NCT01114737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156420|NCT01114737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65308127|NCT00807573|Mitosis Modulators|mitosis modulators|mesh-ancestor
65308128|NCT00807573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308129|NCT00807573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65308130|NCT00807573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65308131|NCT00807573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65308132|NCT00807573|Growth Substances|growth substances|mesh-ancestor
65308133|NCT00807573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308134|NCT00807573|Growth Inhibitors|growth inhibitors|mesh-ancestor
65308135|NCT00807573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308136|NCT00807573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65308137|NCT00807573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65308138|NCT00842712|Gemcitabine|gemcitabine|mesh-list
65308139|NCT00842712|Cisplatin|cisplatin|mesh-list
65308140|NCT00842712|Cetuximab|cetuximab|mesh-list
65308141|NCT00842712|Vinorelbine|vinorelbine|mesh-list
65308142|NCT00842712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308143|NCT00842712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65308144|NCT00842712|Antimetabolites|antimetabolites|mesh-ancestor
65308145|NCT00842712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308146|NCT00842712|Antiviral Agents|antiviral agents|mesh-ancestor
65308147|NCT00842712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65308148|NCT00842712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308149|NCT00842712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64537976|NCT05065671|Tolcapone|tolcapone|mesh-list
65156421|NCT01114737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156423|NCT00624182|Gemcitabine|gemcitabine|mesh-list
65156424|NCT00624182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65156425|NCT00624182|Antimetabolites|antimetabolites|mesh-ancestor
65156426|NCT00624182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156427|NCT00624182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156428|NCT00624182|Antiviral Agents|antiviral agents|mesh-ancestor
65156429|NCT00624182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65156430|NCT00624182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156431|NCT00624182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65156432|NCT00624182|Immunologic Factors|immunologic factors|mesh-ancestor
65156433|NCT00624182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156434|NCT03304418|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65156435|NCT03304418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156437|NCT00625677|Immunologic Factors|immunologic factors|mesh-ancestor
65156438|NCT00625677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156439|NCT00979576|Pemetrexed|pemetrexed|mesh-list
65156440|NCT00979576|Nintedanib|nintedanib|mesh-list
65156441|NCT00979576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156442|NCT00979576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156443|NCT00979576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156444|NCT00979576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65156445|NCT00979576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65156446|NCT00979576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65156447|NCT02867332|Cyclophosphamide|cyclophosphamide|mesh-list
65156449|NCT02867332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65156450|NCT02867332|Immunologic Factors|immunologic factors|mesh-ancestor
65308150|NCT00842712|Immunologic Factors|immunologic factors|mesh-ancestor
65308151|NCT00842712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308152|NCT00842712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65308153|NCT00842712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65308154|NCT00842712|Tubulin Modulators|tubulin modulators|mesh-ancestor
65308155|NCT00842712|Antimitotic Agents|antimitotic agents|mesh-ancestor
65308156|NCT00842712|Mitosis Modulators|mitosis modulators|mesh-ancestor
65308157|NCT00705120|Cyclosporine|cyclosporine|mesh-list
65308158|NCT00705120|Cyclophosphamide|cyclophosphamide|mesh-list
65308159|NCT00705120|Busulfan|busulfan|mesh-list
65308160|NCT00705120|Cyclosporins|cyclosporins|mesh-list
65308161|NCT00705120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65308162|NCT00705120|Immunologic Factors|immunologic factors|mesh-ancestor
65156451|NCT02867332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156452|NCT02867332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65156453|NCT02867332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65156454|NCT02867332|Alkylating Agents|alkylating agents|mesh-ancestor
65156455|NCT02867332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156456|NCT02867332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156457|NCT02867332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65156458|NCT02867332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65156459|NCT02867332|Analgesics|analgesics|mesh-ancestor
65156460|NCT02867332|Sensory System Agents|sensory system agents|mesh-ancestor
65156461|NCT02867332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65156462|NCT02702180|Molgramostim|molgramostim|mesh-list
65156463|NCT02702180|Sargramostim|sargramostim|mesh-list
65156464|NCT02702180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156465|NCT02702180|Immunologic Factors|immunologic factors|mesh-ancestor
65156466|NCT02702180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156467|NCT00980980|Chlorhexidine|chlorhexidine|mesh-list
65156468|NCT00980980|Mupirocin|mupirocin|mesh-list
65156469|NCT00980980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65156470|NCT00980980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65156471|NCT00980980|Disinfectants|disinfectants|mesh-ancestor
65156472|NCT00980980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65156473|NCT00980980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65156474|NCT00980980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156475|NCT00980980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156476|NCT04128748|Cytarabine|cytarabine|mesh-list
65156477|NCT04128748|Daunorubicin|daunorubicin|mesh-list
65156478|NCT04128748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65156479|NCT04128748|Antimetabolites|antimetabolites|mesh-ancestor
65156480|NCT04128748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156481|NCT04128748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156482|NCT04128748|Antiviral Agents|antiviral agents|mesh-ancestor
65156483|NCT04128748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65156484|NCT04128748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65156485|NCT04128748|Immunologic Factors|immunologic factors|mesh-ancestor
65156486|NCT04128748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156494|NCT04116502|Hydroxyurea|hydroxyurea|mesh-list
65156495|NCT04116502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156496|NCT04116502|Antiviral Agents|antiviral agents|mesh-ancestor
65156497|NCT04116502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65156498|NCT04116502|Immunologic Factors|immunologic factors|mesh-ancestor
65156499|NCT04116502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156500|NCT04116502|Antisickling Agents|antisickling agents|mesh-ancestor
65156501|NCT04116502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156502|NCT04116502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156503|NCT04116502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65156504|NCT04290442|Ropivacaine|ropivacaine|mesh-list
65156505|NCT04290442|Anesthetics, Local|anesthetics, local|mesh-ancestor
65156506|NCT04290442|Anesthetics|anesthetics|mesh-ancestor
65156507|NCT04290442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65308163|NCT00705120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308164|NCT00705120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65308165|NCT00705120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65308166|NCT00705120|Alkylating Agents|alkylating agents|mesh-ancestor
65308167|NCT00705120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308168|NCT00705120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308169|NCT00705120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65308170|NCT00705120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156508|NCT04290442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156509|NCT04290442|Sensory System Agents|sensory system agents|mesh-ancestor
65156510|NCT04290442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65156511|NCT02866786|Metformin|metformin|mesh-list
65156512|NCT02866786|Cyproterone Acetate|cyproterone acetate|mesh-list
65156513|NCT02866786|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65156514|NCT02866786|Estradiol|estradiol|mesh-list
65156515|NCT02866786|Cyproterone|cyproterone|mesh-list
65156516|NCT02866786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65156517|NCT02866786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156518|NCT02866786|Estrogens|estrogens|mesh-ancestor
65156519|NCT02866786|Hormones|hormones|mesh-ancestor
64689929|NCT01491815|Abatacept|abatacept|mesh-list
65156520|NCT02866786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65156521|NCT02866786|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65156522|NCT02866786|Contraceptive Agents|contraceptive agents|mesh-ancestor
65156523|NCT02866786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65156524|NCT02866786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65156525|NCT02866786|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65156526|NCT02866786|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65156527|NCT02866786|Androgen Antagonists|androgen antagonists|mesh-ancestor
65156528|NCT02866786|Hormone Antagonists|hormone antagonists|mesh-ancestor
65156529|NCT02866786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156530|NCT02866786|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65156531|NCT00979654|Sifalimumab|sifalimumab|mesh-list
65156532|NCT00979654|Immunologic Factors|immunologic factors|mesh-ancestor
65156533|NCT00979654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156534|NCT00978562|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65156535|NCT00978562|Hematinics|hematinics|mesh-ancestor
65156536|NCT00978562|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65156537|NCT00978562|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65156538|NCT04289974|Fulvestrant|fulvestrant|mesh-list
65156539|NCT04289974|Palbociclib|palbociclib|mesh-list
65156540|NCT04289974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65156541|NCT04289974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156542|NCT04289974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65156543|NCT04289974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65156544|NCT04289974|Hormone Antagonists|hormone antagonists|mesh-ancestor
65156545|NCT04289974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65156546|NCT04289974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156547|NCT04289974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65156548|NCT04289974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156549|NCT04289974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156550|NCT02865616|Vancomycin|vancomycin|mesh-list
65156551|NCT02865616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65156552|NCT02865616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65156553|NCT04084210|Nicotine|nicotine|mesh-list
65156554|NCT04084210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65156555|NCT04084210|Autonomic Agents|autonomic agents|mesh-ancestor
65156562|NCT04084210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156564|NCT02865460|Micronutrients|micronutrients|mesh-ancestor
65156565|NCT02865460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156566|NCT02865460|Vitamins|vitamins|mesh-ancestor
65156567|NCT00946712|Paclitaxel|paclitaxel|mesh-list
65156568|NCT00946712|Bevacizumab|bevacizumab|mesh-list
65156569|NCT00946712|Carboplatin|carboplatin|mesh-list
65156570|NCT00946712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65156571|NCT00946712|Cetuximab|cetuximab|mesh-list
65156572|NCT00946712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65308171|NCT00705120|Antifungal Agents|antifungal agents|mesh-ancestor
65308172|NCT00705120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65308173|NCT00705120|Dermatologic Agents|dermatologic agents|mesh-ancestor
65308174|NCT00705120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65308175|NCT00842244|Capecitabine|capecitabine|mesh-list
65308176|NCT00842244|Axitinib|axitinib|mesh-list
65308177|NCT00842244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308178|NCT00842244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65308179|NCT00842244|Antimetabolites|antimetabolites|mesh-ancestor
65308180|NCT00842244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308181|NCT00842244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65308182|NCT00842244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308183|NCT00832416|Tramadol|tramadol|mesh-list
65308184|NCT00832416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65308185|NCT00832416|Narcotics|narcotics|mesh-ancestor
65156573|NCT00946712|Endothelial Growth Factors|endothelial growth factors|mesh-list
65156574|NCT00946712|Antibodies|antibodies|mesh-list
65156575|NCT00946712|Immunoglobulins|immunoglobulins|mesh-list
65156576|NCT00946712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65156577|NCT00946712|Immunoglobulin G|immunoglobulin g|mesh-list
65156578|NCT00946712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65156579|NCT00946712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156580|NCT00946712|Tubulin Modulators|tubulin modulators|mesh-ancestor
65156581|NCT00946712|Antimitotic Agents|antimitotic agents|mesh-ancestor
65156582|NCT00946712|Mitosis Modulators|mitosis modulators|mesh-ancestor
65156583|NCT00946712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156584|NCT00946712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65156585|NCT00946712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65156586|NCT00946712|Growth Substances|growth substances|mesh-ancestor
65156587|NCT00946712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156588|NCT00946712|Growth Inhibitors|growth inhibitors|mesh-ancestor
65156589|NCT00946712|Immunologic Factors|immunologic factors|mesh-ancestor
65156590|NCT01206816|Afatinib|afatinib|mesh-list
65156591|NCT01206816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156592|NCT01206816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65156593|NCT01206816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156594|NCT01206816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156595|NCT01259102|Buprenorphine|buprenorphine|mesh-list
65156596|NCT01259102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65156597|NCT01259102|Narcotics|narcotics|mesh-ancestor
65156598|NCT01259102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65156599|NCT01259102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156600|NCT01259102|Analgesics|analgesics|mesh-ancestor
65156601|NCT01259102|Sensory System Agents|sensory system agents|mesh-ancestor
65156602|NCT01259102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65156603|NCT01259102|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65156604|NCT00978250|Tetrahydrouridine|tetrahydrouridine|mesh-list
65156605|NCT00978250|Antimetabolites|antimetabolites|mesh-ancestor
65156606|NCT00978250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156607|NCT01259024|Chlorotrianisene|chlorotrianisene|mesh-list
65156608|NCT01259024|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65156609|NCT01259024|Estrogens|estrogens|mesh-ancestor
65156610|NCT01259024|Hormones|hormones|mesh-ancestor
65156611|NCT01259024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65156612|NCT01259024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156613|NCT01259024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65156614|NCT01259024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156615|NCT04319900|Chloroquine|chloroquine|mesh-list
65156616|NCT04319900|Favipiravir|favipiravir|mesh-list
65156617|NCT04319900|Amebicides|amebicides|mesh-ancestor
65156618|NCT04319900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65156619|NCT04319900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65308186|NCT00832416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65308187|NCT00832416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308188|NCT00832416|Analgesics|analgesics|mesh-ancestor
65308189|NCT00832416|Sensory System Agents|sensory system agents|mesh-ancestor
65308190|NCT00832416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65308191|NCT00705198|Temozolomide|temozolomide|mesh-list
65308192|NCT00705198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65308193|NCT00705198|Alkylating Agents|alkylating agents|mesh-ancestor
65308194|NCT00705198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308195|NCT00705198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308196|NCT00702936|Telmisartan|telmisartan|mesh-list
65308197|NCT00702936|Ramipril|ramipril|mesh-list
65308198|NCT00702936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65308199|NCT00702936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65156620|NCT04319900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65156621|NCT04319900|Antimalarials|antimalarials|mesh-ancestor
65156622|NCT04319900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65156623|NCT04319900|Antiviral Agents|antiviral agents|mesh-ancestor
65156624|NCT01257698|Timolol|timolol|mesh-list
65156625|NCT01257698|Dorzolamide|dorzolamide|mesh-list
64953272|NCT00033098|Metyrapone|metyrapone|mesh-list
65156641|NCT01257542|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65156642|NCT01257542|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65156643|NCT01257542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65156644|NCT01257542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156645|NCT01257542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156646|NCT01257230|Tiotropium Bromide|tiotropium bromide|mesh-list
65156647|NCT01257230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65156648|NCT01257230|Autonomic Agents|autonomic agents|mesh-ancestor
65156649|NCT01257230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65156650|NCT01257230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156651|NCT01257230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65156652|NCT01257230|Respiratory System Agents|respiratory system agents|mesh-ancestor
65156653|NCT01257230|Parasympatholytics|parasympatholytics|mesh-ancestor
65156654|NCT01257230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65156655|NCT01257230|Cholinergic Agents|cholinergic agents|mesh-ancestor
65156656|NCT01257230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65156657|NCT01257230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156658|NCT01256684|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65156659|NCT01256684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65156660|NCT01256684|Immunologic Factors|immunologic factors|mesh-ancestor
65156661|NCT01256684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156663|NCT01204710|Mitoxantrone|mitoxantrone|mesh-list
65156664|NCT01204710|Olaratumab|olaratumab|mesh-list
65156665|NCT01204710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65156666|NCT01204710|Glucocorticoids|glucocorticoids|mesh-ancestor
65156667|NCT01204710|Hormones|hormones|mesh-ancestor
65156668|NCT01204710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65156669|NCT01204710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156670|NCT01204710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65156671|NCT01204710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156673|NCT01204710|Sensory System Agents|sensory system agents|mesh-ancestor
65156674|NCT01204710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65156675|NCT01204710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65156676|NCT01204710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65156677|NCT01204710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156678|NCT01204710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156679|NCT01256450|Buprenorphine|buprenorphine|mesh-list
65156680|NCT01256450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65156681|NCT01256450|Narcotics|narcotics|mesh-ancestor
65308200|NCT00702936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65308201|NCT00702936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308202|NCT00702936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65308203|NCT00702936|Protease Inhibitors|protease inhibitors|mesh-ancestor
65308204|NCT00702936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308205|NCT00683800|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65308206|NCT00683800|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65308207|NCT00683800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65308208|NCT00683800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65308209|NCT00683800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308210|NCT00683800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65308211|NCT00683800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308212|NCT00683800|Antidepressive Agents|antidepressive agents|mesh-ancestor
65308213|NCT00683800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65308214|NCT00683644|Zinc|zinc|mesh-list
65308215|NCT00683644|Zinc Sulfate|zinc sulfate|mesh-list
65308216|NCT00683644|Trace Elements|trace elements|mesh-ancestor
65308217|NCT00683644|Micronutrients|micronutrients|mesh-ancestor
65308218|NCT00683644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308219|NCT00683644|Astringents|astringents|mesh-ancestor
65308220|NCT00683644|Dermatologic Agents|dermatologic agents|mesh-ancestor
65156682|NCT01256450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65156683|NCT01256450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156684|NCT01256450|Analgesics|analgesics|mesh-ancestor
64953327|NCT00061074|Nicotine|nicotine|mesh-list
65156699|NCT01204398|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65156700|NCT01111851|Dexamethasone|dexamethasone|mesh-list
65156701|NCT01111851|Dexamethasone acetate|dexamethasone acetate|mesh-list
65156702|NCT01111851|Ondansetron|ondansetron|mesh-list
65156703|NCT01111851|Aprepitant|aprepitant|mesh-list
65156704|NCT01111851|Fosaprepitant|fosaprepitant|mesh-list
65156705|NCT01111851|BB 1101|bb 1101|mesh-list
65156706|NCT01111851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65156707|NCT01111851|Antiemetics|antiemetics|mesh-ancestor
65156708|NCT01111851|Autonomic Agents|autonomic agents|mesh-ancestor
65156709|NCT01111851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65156710|NCT01111851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156711|NCT01111851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65156712|NCT01111851|Glucocorticoids|glucocorticoids|mesh-ancestor
65156713|NCT01111851|Hormones|hormones|mesh-ancestor
65156714|NCT01111851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65156715|NCT01111851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65156716|NCT01111851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156717|NCT01111851|Protease Inhibitors|protease inhibitors|mesh-ancestor
65156718|NCT01111851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156719|NCT01111851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156720|NCT01111851|Antipruritics|antipruritics|mesh-ancestor
65156721|NCT01111851|Dermatologic Agents|dermatologic agents|mesh-ancestor
65156722|NCT01111851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65156723|NCT01111851|Serotonin Agents|serotonin agents|mesh-ancestor
65156724|NCT01111851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65156725|NCT01111851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65156726|NCT01111851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65308221|NCT00753064|Prazosin|prazosin|mesh-list
65308222|NCT00753064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65308223|NCT00753064|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65308224|NCT00753064|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65308225|NCT00753064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65308226|NCT00753064|Adrenergic Agents|adrenergic agents|mesh-ancestor
65308227|NCT00753064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65308228|NCT00753064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308229|NCT00753064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308230|NCT00751738|Azimilide|azimilide|mesh-list
65308231|NCT00751738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65308232|NCT00751738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65308233|NCT00751738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65308234|NCT00751738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308235|NCT00751738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65308236|NCT00751738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308237|NCT04060264|Eculizumab|eculizumab|mesh-list
65308238|NCT04060264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65308239|NCT04060264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65308240|NCT04060264|Immunologic Factors|immunologic factors|mesh-ancestor
65308241|NCT04060264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308242|NCT00684814|Zolpidem|zolpidem|mesh-list
65308243|NCT00684814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65308244|NCT00684814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65308245|NCT00684814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65308246|NCT00684814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308247|NCT00684814|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65156727|NCT01111851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65156728|NCT01111851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65156729|NCT01111851|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65156730|NCT01111851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65156732|NCT01256294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65156733|NCT01256294|Immunologic Factors|immunologic factors|mesh-ancestor
65156734|NCT01256294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156735|NCT01256294|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65156736|NCT01256294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156737|NCT01256294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156738|NCT01256060|Oxytocin|oxytocin|mesh-list
65156739|NCT01256060|Oxytocics|oxytocics|mesh-ancestor
65156740|NCT01256060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65156741|NCT01256060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156742|NCT01255904|Dexmedetomidine|dexmedetomidine|mesh-list
65156743|NCT01255904|Chloral Hydrate|chloral hydrate|mesh-list
65156744|NCT01255904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64690138|NCT00370565|Insulin|insulin|mesh-list
65308248|NCT00684814|GABA Agonists|gaba agonists|mesh-ancestor
65308249|NCT00684814|GABA Agents|gaba agents|mesh-ancestor
65308250|NCT00684814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65308251|NCT00684814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308252|NCT00576472|Methylphenidate|methylphenidate|mesh-list
65308253|NCT00576472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65308254|NCT00576472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308255|NCT00576472|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65308256|NCT00576472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65308257|NCT00576472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65308258|NCT00576472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308259|NCT00576472|Dopamine Agents|dopamine agents|mesh-ancestor
65308260|NCT00576472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65156747|NCT01255904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65156749|NCT01255904|Sensory System Agents|sensory system agents|mesh-ancestor
65156750|NCT01255904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65156751|NCT01255904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65156752|NCT01255904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65156753|NCT01255904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65156754|NCT01255904|Adrenergic Agents|adrenergic agents|mesh-ancestor
65156755|NCT01255904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65156756|NCT01255904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156757|NCT01255670|Metronidazole|metronidazole|mesh-list
65156758|NCT01255670|Penicillins|penicillins|mesh-list
65156759|NCT01255670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65156760|NCT01255670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65156761|NCT01255670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65156762|NCT01255670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65156763|NCT01203930|Rituximab|rituximab|mesh-list
65156764|NCT01203930|Idelalisib|idelalisib|mesh-list
65156765|NCT01203930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65156766|NCT01203930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156767|NCT01203930|Immunologic Factors|immunologic factors|mesh-ancestor
65156768|NCT01203930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156769|NCT01203930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65156770|NCT01203930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156771|NCT01203930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156772|NCT01254890|Azacitidine|azacitidine|mesh-list
65156773|NCT01254890|Sorafenib|sorafenib|mesh-list
65156774|NCT01254890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65156775|NCT01254890|Antimetabolites|antimetabolites|mesh-ancestor
65156776|NCT01254890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156777|NCT01254890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156778|NCT01254890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156779|NCT01254890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65156780|NCT01203852|Metoprolol|metoprolol|mesh-list
65156781|NCT01203852|Chlorthalidone|chlorthalidone|mesh-list
65156782|NCT01203852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65156783|NCT01203852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65156784|NCT01203852|Sympatholytics|sympatholytics|mesh-ancestor
65156785|NCT01203852|Autonomic Agents|autonomic agents|mesh-ancestor
65156786|NCT01203852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65156787|NCT01203852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156788|NCT01203852|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65156789|NCT01203852|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65156790|NCT01203852|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65156791|NCT01203852|Adrenergic Agents|adrenergic agents|mesh-ancestor
65156792|NCT01203852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65156793|NCT01203852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156794|NCT01203852|Diuretics|diuretics|mesh-ancestor
65308261|NCT00823212|Aspirin|aspirin|mesh-list
65308262|NCT00823212|Ticlopidine|ticlopidine|mesh-list
65308263|NCT00823212|Clopidogrel|clopidogrel|mesh-list
65308264|NCT00823212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65308265|NCT00823212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65308266|NCT00823212|Analgesics|analgesics|mesh-ancestor
65308267|NCT00823212|Sensory System Agents|sensory system agents|mesh-ancestor
65308268|NCT00823212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65308269|NCT00823212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308270|NCT00823212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65308271|NCT00823212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65308272|NCT00823212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65308273|NCT00823212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65308274|NCT00823212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308275|NCT00823212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65308276|NCT00823212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65308277|NCT00823212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308278|NCT00823212|Antipyretics|antipyretics|mesh-ancestor
65308279|NCT00823212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64538109|NCT00604461|Bevacizumab|bevacizumab|mesh-list
65156795|NCT01203852|Natriuretic Agents|natriuretic agents|mesh-ancestor
65156796|NCT01203852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65156797|NCT01203852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65156798|NCT01203072|Edoxaban|edoxaban|mesh-list
65156799|NCT01203072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65156800|NCT01203072|Antithrombins|antithrombins|mesh-ancestor
65156801|NCT01203072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65156803|NCT01203072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156804|NCT01203072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156805|NCT01203072|Anticoagulants|anticoagulants|mesh-ancestor
65156806|NCT01105377|Azacitidine|azacitidine|mesh-list
65156807|NCT01105377|Entinostat|entinostat|mesh-list
65156808|NCT01105377|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65156809|NCT01105377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65156810|NCT01105377|Antimetabolites|antimetabolites|mesh-ancestor
65156811|NCT01105377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156812|NCT01105377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156813|NCT01105377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156814|NCT01105065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65156815|NCT01105065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65156816|NCT01105065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64953443|NCT00033683|Abortifacient Agents|abortifacient agents|mesh-ancestor
65156821|NCT01105065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156822|NCT01105065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156824|NCT01111539|Citalopram|citalopram|mesh-list
65156825|NCT01111539|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65156826|NCT01111539|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65156827|NCT01111539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65156828|NCT01111539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156829|NCT01111539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65156830|NCT01111539|Serotonin Agents|serotonin agents|mesh-ancestor
65156831|NCT01111539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156832|NCT01111539|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65156833|NCT01111539|Antidepressive Agents|antidepressive agents|mesh-ancestor
65308280|NCT00823212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65308281|NCT00823212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65308282|NCT00823212|Purinergic Agents|purinergic agents|mesh-ancestor
65308283|NCT00823212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65308284|NCT00823212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65308285|NCT00823212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65308286|NCT02561494|Nefopam|nefopam|mesh-list
65308287|NCT02561494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65308288|NCT02561494|Analgesics|analgesics|mesh-ancestor
65308289|NCT02561494|Sensory System Agents|sensory system agents|mesh-ancestor
65308290|NCT02561494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65308291|NCT02561494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308292|NCT00576316|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65308293|NCT00576316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65308294|NCT00576316|Respiratory System Agents|respiratory system agents|mesh-ancestor
65308295|NCT00745810|Complement System Proteins|complement system proteins|mesh-list
65308296|NCT00745810|Immunologic Factors|immunologic factors|mesh-ancestor
65308297|NCT00745810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308298|NCT00755872|Risedronic Acid|risedronic acid|mesh-list
65308299|NCT00755872|Etidronic Acid|etidronic acid|mesh-list
65308300|NCT00755872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65308301|NCT00755872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65308302|NCT00755872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308303|NCT00755872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65308304|NCT00755872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308305|NCT00755872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65308306|NCT00755950|Silymarin|silymarin|mesh-list
65308307|NCT00755950|Antioxidants|antioxidants|mesh-ancestor
65308308|NCT00755950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308309|NCT00755950|Protective Agents|protective agents|mesh-ancestor
65308310|NCT00755950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308311|NCT00705354|Bacitracin|bacitracin|mesh-list
65308312|NCT00705354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65156834|NCT01111539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65156835|NCT01111539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65156836|NCT01111539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65156837|NCT01111539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65156838|NCT01111539|Dopamine Agonists|dopamine agonists|mesh-ancestor
65156839|NCT01111539|Dopamine Agents|dopamine agents|mesh-ancestor
65308313|NCT00705354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65308314|NCT00705354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65308315|NCT00575380|Azithromycin|azithromycin|mesh-list
65308316|NCT00575380|Moxifloxacin|moxifloxacin|mesh-list
65308317|NCT00575380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65308318|NCT00575380|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65308319|NCT00575380|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65308320|NCT00575380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65308321|NCT00575380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65308322|NCT00575380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65308323|NCT00575380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65308324|NCT00575380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308325|NCT00575380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308326|NCT00575380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308327|NCT00575380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65308328|NCT00575380|Contraceptive Agents|contraceptive agents|mesh-ancestor
65308329|NCT00575380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65308330|NCT00575380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308331|NCT00575380|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65308332|NCT00575380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65308333|NCT00575380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65308335|NCT00840996|Anesthetics, Local|anesthetics, local|mesh-ancestor
65308336|NCT00840996|Anesthetics|anesthetics|mesh-ancestor
64538159|NCT00578331|Histamine Agents|histamine agents|mesh-ancestor
65156840|NCT01111539|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65156841|NCT01111539|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65156842|NCT01111539|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65156843|NCT01111539|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65156844|NCT01111539|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65156845|NCT01111539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65156846|NCT02880345|Pembrolizumab|pembrolizumab|mesh-list
65156847|NCT02880345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65156848|NCT02880345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156849|NCT02879955|Acarbose|acarbose|mesh-list
65156850|NCT02879955|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65156851|NCT02879955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156852|NCT02879955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156853|NCT02879955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65156854|NCT02879955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156855|NCT02880033|Deferiprone|deferiprone|mesh-list
65156856|NCT02880033|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65156857|NCT02880033|Chelating Agents|chelating agents|mesh-ancestor
65156858|NCT02880033|Sequestering Agents|sequestering agents|mesh-ancestor
65156859|NCT02880033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156860|NCT01111461|Lenvatinib|lenvatinib|mesh-list
65156861|NCT01111461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156862|NCT01111461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65156863|NCT01111461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156864|NCT01111461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156865|NCT00625911|Ketamine|ketamine|mesh-list
65308337|NCT00840996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65308338|NCT00840996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308339|NCT00840996|Sensory System Agents|sensory system agents|mesh-ancestor
65308340|NCT00840996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65308341|NCT00840996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65308342|NCT00840996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65308343|NCT00840996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65308344|NCT00840996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65308345|NCT00840996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308346|NCT00756184|Travoprost|travoprost|mesh-list
65308347|NCT00756184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65308348|NCT00756340|Bevacizumab|bevacizumab|mesh-list
65156866|NCT00625911|Morphine|morphine|mesh-list
65156867|NCT00625911|Analgesics|analgesics|mesh-ancestor
65156868|NCT00625911|Sensory System Agents|sensory system agents|mesh-ancestor
65156869|NCT00625911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65156870|NCT00625911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156871|NCT00625911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65156872|NCT00625911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65156873|NCT00625911|Anesthetics, General|anesthetics, general|mesh-ancestor
65156874|NCT00625911|Anesthetics|anesthetics|mesh-ancestor
65156875|NCT00625911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65156876|NCT00625911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65156877|NCT00625911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65156878|NCT00625911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65156879|NCT00625911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156880|NCT00625911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65156881|NCT00625911|Narcotics|narcotics|mesh-ancestor
65156882|NCT01111149|Bupropion|bupropion|mesh-list
65156883|NCT01111149|Varenicline|varenicline|mesh-list
65156884|NCT01111149|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64953515|NCT00061542|Sympatholytics|sympatholytics|mesh-ancestor
65156893|NCT01111149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156894|NCT01111149|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65156895|NCT01111149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65156896|NCT01111149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156897|NCT01111149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65156898|NCT01111149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65156899|NCT01111149|Cholinergic Agents|cholinergic agents|mesh-ancestor
65156900|NCT01254656|Efavirenz|efavirenz|mesh-list
65156901|NCT01254656|Etravirine|etravirine|mesh-list
65156902|NCT01254656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65156903|NCT01254656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65156904|NCT01254656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156905|NCT01254656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156906|NCT01254656|Antiviral Agents|antiviral agents|mesh-ancestor
65156907|NCT01254656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65156908|NCT01254656|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65156909|NCT01254656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65156910|NCT01254656|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65156911|NCT01254656|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65156912|NCT01254656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65156913|NCT01254656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65156914|NCT01254344|Metronidazole|metronidazole|mesh-list
65156915|NCT01254344|Ceftriaxone|ceftriaxone|mesh-list
65156916|NCT01254344|Ertapenem|ertapenem|mesh-list
65156917|NCT01254344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65156918|NCT01254344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65156919|NCT01254344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65156920|NCT01254344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65156921|NCT05051007|Lidocaine|lidocaine|mesh-list
65308349|NCT00756340|Everolimus|everolimus|mesh-list
65308350|NCT00756340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65308351|NCT00756340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308352|NCT00756340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65308353|NCT00756340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65308354|NCT00756340|Growth Substances|growth substances|mesh-ancestor
65308355|NCT00756340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308356|NCT00756340|Growth Inhibitors|growth inhibitors|mesh-ancestor
65308357|NCT00756340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65308358|NCT00756340|Immunologic Factors|immunologic factors|mesh-ancestor
65156922|NCT05051007|Fentanyl|fentanyl|mesh-list
65156923|NCT05051007|Anesthetics, Local|anesthetics, local|mesh-ancestor
65156924|NCT05051007|Anesthetics|anesthetics|mesh-ancestor
65156925|NCT05051007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65156926|NCT05051007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156927|NCT05051007|Sensory System Agents|sensory system agents|mesh-ancestor
65156928|NCT05051007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65156929|NCT05051007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65156930|NCT05051007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65156931|NCT05051007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65156932|NCT05051007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65156933|NCT05051007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156934|NCT05051007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65156935|NCT05051007|Narcotics|narcotics|mesh-ancestor
65156936|NCT05051007|Analgesics|analgesics|mesh-ancestor
65156937|NCT05051007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65156938|NCT05051007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65156939|NCT05051007|Anesthetics, General|anesthetics, general|mesh-ancestor
65156940|NCT01102803|Cycloserine|cycloserine|mesh-list
65156941|NCT01102803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65156942|NCT01102803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65156943|NCT01102803|Renal Agents|renal agents|mesh-ancestor
65156944|NCT01102803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65156945|NCT01102803|Antitubercular Agents|antitubercular agents|mesh-ancestor
65156946|NCT01102803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65156947|NCT01102803|Antimetabolites|antimetabolites|mesh-ancestor
64799530|NCT01396733|Thioctic Acid|thioctic acid|mesh-list
65156948|NCT01102803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156953|NCT01109979|Medroxyprogesterone|medroxyprogesterone|mesh-list
65156954|NCT01109979|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65156956|NCT01109979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65156957|NCT01109979|Estrogens|estrogens|mesh-ancestor
65156958|NCT01109979|Hormones|hormones|mesh-ancestor
65156959|NCT01109979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65156960|NCT01109979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156961|NCT01109979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65156962|NCT01109979|Contraceptive Agents|contraceptive agents|mesh-ancestor
65156963|NCT01109979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65156964|NCT01109979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65156965|NCT01109979|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65156966|NCT01109979|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65156967|NCT01109979|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65156968|NCT01109979|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65156969|NCT01109979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65156970|NCT01109979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156971|NCT01109979|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65156972|NCT01109979|Hormone Antagonists|hormone antagonists|mesh-ancestor
65156973|NCT01109979|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65156975|NCT01109979|Natriuretic Agents|natriuretic agents|mesh-ancestor
65156976|NCT01102491|Ramosetron|ramosetron|mesh-list
65156977|NCT01102491|Antiemetics|antiemetics|mesh-ancestor
65156978|NCT01102491|Autonomic Agents|autonomic agents|mesh-ancestor
65156979|NCT01102491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65156980|NCT01102491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308359|NCT00705510|Cyclosporine|cyclosporine|mesh-list
65308360|NCT00705510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65308361|NCT00705510|Cyclosporins|cyclosporins|mesh-list
65308362|NCT00705510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308363|NCT00705510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308364|NCT00705510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65308365|NCT00705510|Immunologic Factors|immunologic factors|mesh-ancestor
65308366|NCT00705510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972545|NCT00231829|Celecoxib|celecoxib|mesh-list
65156981|NCT01102491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65156982|NCT01102491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65156983|NCT01102491|Serotonin Agents|serotonin agents|mesh-ancestor
65156984|NCT01102491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65156985|NCT01102491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156986|NCT01108809|Telmisartan|telmisartan|mesh-list
65156987|NCT01108809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65156988|NCT01108809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65156989|NCT01108809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65156990|NCT01108809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156991|NCT01253408|Dronabinol|dronabinol|mesh-list
65156992|NCT01253408|Hallucinogens|hallucinogens|mesh-ancestor
65156993|NCT01253408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156994|NCT01253408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65156995|NCT01253408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65156996|NCT01253408|Analgesics|analgesics|mesh-ancestor
65156997|NCT01253408|Sensory System Agents|sensory system agents|mesh-ancestor
65156998|NCT01253408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65156999|NCT01253408|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65157000|NCT01253408|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65157001|NCT01253408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65157002|NCT01253408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157003|NCT01253408|Hormones|hormones|mesh-ancestor
65157004|NCT01253408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65157005|NCT05506982|Psilocybin|psilocybin|mesh-list
65157006|NCT05506982|Hallucinogens|hallucinogens|mesh-ancestor
65157007|NCT05506982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157008|NCT05506982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65157009|NCT02879643|Vincristine|vincristine|mesh-list
65157010|NCT02879643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65157011|NCT02879643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65157012|NCT02879643|Tubulin Modulators|tubulin modulators|mesh-ancestor
65157013|NCT02879643|Antimitotic Agents|antimitotic agents|mesh-ancestor
65157014|NCT02879643|Mitosis Modulators|mitosis modulators|mesh-ancestor
65157015|NCT02879643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157016|NCT02879721|Candesartan|candesartan|mesh-list
65157017|NCT02879721|Enalapril|enalapril|mesh-list
65157018|NCT02879721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65157019|NCT02879721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65157021|NCT02879721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157022|NCT02879721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65157023|NCT02879721|Protease Inhibitors|protease inhibitors|mesh-ancestor
65157024|NCT02879721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157025|NCT01253174|Tetrahydrofolates|tetrahydrofolates|mesh-list
65157026|NCT01253174|Drospirenone|drospirenone|mesh-list
65157027|NCT01253174|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65157028|NCT01253174|Hormone Antagonists|hormone antagonists|mesh-ancestor
64514586|NCT05402020|Respiratory System Agents|respiratory system agents|mesh-ancestor
65157029|NCT01253174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65157030|NCT01253174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157031|NCT01253174|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65157032|NCT01253174|Diuretics|diuretics|mesh-ancestor
65157033|NCT01253174|Natriuretic Agents|natriuretic agents|mesh-ancestor
65157034|NCT01253174|Vitamin B Complex|vitamin b complex|mesh-ancestor
65157035|NCT01253174|Vitamins|vitamins|mesh-ancestor
65157036|NCT01253174|Micronutrients|micronutrients|mesh-ancestor
65308367|NCT00705510|Antifungal Agents|antifungal agents|mesh-ancestor
65308368|NCT00705510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65308369|NCT00705510|Dermatologic Agents|dermatologic agents|mesh-ancestor
65308370|NCT00705510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65308371|NCT00705510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65308372|NCT00705510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65308373|NCT00680914|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65308374|NCT00680914|Immunologic Factors|immunologic factors|mesh-ancestor
65308375|NCT00680914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308376|NCT00680836|Rifaximin|rifaximin|mesh-list
65308377|NCT00680836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65308378|NCT00680836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65308379|NCT00680836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65308380|NCT05434546|Pregnanolone|pregnanolone|mesh-list
65308381|NCT05434546|Anesthetics|anesthetics|mesh-ancestor
65308382|NCT05434546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65308383|NCT05434546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157037|NCT01108731|Milnacipran|milnacipran|mesh-list
65157038|NCT01108731|Levomilnacipran|levomilnacipran|mesh-list
65157039|NCT01108731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65157040|NCT01108731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65157041|NCT01108731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65157042|NCT01108731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157043|NCT01108731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65157044|NCT01108731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157045|NCT01108731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65157046|NCT01108731|Analgesics|analgesics|mesh-ancestor
65157047|NCT01108731|Sensory System Agents|sensory system agents|mesh-ancestor
65157048|NCT01108731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157049|NCT01108731|Antidepressive Agents|antidepressive agents|mesh-ancestor
65157050|NCT01108731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65157051|NCT04308525|Analgesics, Opioid|analgesics, opioid|mesh-list
65157052|NCT04308525|Narcotics|narcotics|mesh-ancestor
65157053|NCT04308525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65157054|NCT04308525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157055|NCT04308525|Analgesics|analgesics|mesh-ancestor
65157056|NCT04308525|Sensory System Agents|sensory system agents|mesh-ancestor
65157057|NCT04308525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157058|NCT01108341|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65157059|NCT01108341|Ofatumumab|ofatumumab|mesh-list
65157060|NCT01108341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65157061|NCT01108341|Alkylating Agents|alkylating agents|mesh-ancestor
65157062|NCT01108341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157063|NCT01108341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65157064|NCT01252940|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
65157065|NCT01252940|Antiviral Agents|antiviral agents|mesh-ancestor
65157066|NCT01252940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65157067|NCT01252940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65157068|NCT01252940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65157069|NCT01252940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157070|NCT01252940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157071|NCT01252940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65157072|NCT01252940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65157073|NCT01252238|Amlodipine|amlodipine|mesh-list
65157074|NCT01252238|Valsartan|valsartan|mesh-list
65157075|NCT01252238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65157076|NCT01252238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65308384|NCT05403580|Olanzapine|olanzapine|mesh-list
65308385|NCT05403580|Antiemetics|antiemetics|mesh-ancestor
65308386|NCT05403580|Autonomic Agents|autonomic agents|mesh-ancestor
65308387|NCT05403580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65308388|NCT05403580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308389|NCT05403580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65308390|NCT05403580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65308391|NCT05403580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65308392|NCT05403580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65308393|NCT05403580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65308394|NCT05403580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65308395|NCT05403580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65308396|NCT05403580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65308397|NCT05403580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308398|NCT05403580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65308399|NCT05403580|Serotonin Agents|serotonin agents|mesh-ancestor
65308400|NCT05428306|Acetaminophen|acetaminophen|mesh-list
65308401|NCT05428306|Ibuprofen|ibuprofen|mesh-list
65308402|NCT05428306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65308403|NCT05428306|Analgesics|analgesics|mesh-ancestor
65308404|NCT05428306|Sensory System Agents|sensory system agents|mesh-ancestor
65157077|NCT01252238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65157078|NCT01252238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157079|NCT01252238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65157080|NCT01252238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157081|NCT01252238|Vasodilator Agents|vasodilator agents|mesh-ancestor
65157082|NCT01252238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65157083|NCT01252238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65157084|NCT01101321|Oxycodone|oxycodone|mesh-list
65157085|NCT01101321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65157086|NCT01101321|Narcotics|narcotics|mesh-ancestor
65157087|NCT01101321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65157094|NCT04309929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157095|NCT04309929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157096|NCT01101165|Oxycodone|oxycodone|mesh-list
65157097|NCT01101165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65157098|NCT01101165|Narcotics|narcotics|mesh-ancestor
65157099|NCT01101165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65157100|NCT01101165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157101|NCT01101165|Analgesics|analgesics|mesh-ancestor
65157102|NCT01101165|Sensory System Agents|sensory system agents|mesh-ancestor
65157103|NCT01101165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157105|NCT01100853|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65157106|NCT01100853|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65157107|NCT01100853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157108|NCT01100853|Sensory System Agents|sensory system agents|mesh-ancestor
65157109|NCT01100853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157110|NCT02879097|Paclitaxel|paclitaxel|mesh-list
65157111|NCT02879097|Carboplatin|carboplatin|mesh-list
65157112|NCT02879097|Bevacizumab|bevacizumab|mesh-list
65157113|NCT02879097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65157114|NCT02879097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65157115|NCT02879097|Tubulin Modulators|tubulin modulators|mesh-ancestor
65157116|NCT02879097|Antimitotic Agents|antimitotic agents|mesh-ancestor
65308405|NCT05428306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65308406|NCT05428306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308407|NCT05428306|Antipyretics|antipyretics|mesh-ancestor
65308408|NCT05428306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65308409|NCT05428306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65308410|NCT05428306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65308411|NCT05428306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65308412|NCT05428306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308413|NCT05428306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308414|NCT05424796|Hemostatics|hemostatics|mesh-list
65308415|NCT05424796|Coagulants|coagulants|mesh-ancestor
65308416|NCT00757198|Remifentanil|remifentanil|mesh-list
65308417|NCT00757198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65308418|NCT00757198|Narcotics|narcotics|mesh-ancestor
65308419|NCT00757198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65308420|NCT00757198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308421|NCT00757198|Analgesics|analgesics|mesh-ancestor
65308422|NCT00757198|Sensory System Agents|sensory system agents|mesh-ancestor
65308423|NCT00757198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65308424|NCT00679432|Budesonide|budesonide|mesh-list
65308425|NCT00679432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65308426|NCT00679432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65308427|NCT00679432|Autonomic Agents|autonomic agents|mesh-ancestor
65308428|NCT00679432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65308429|NCT00679432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308430|NCT00679432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65308431|NCT00679432|Respiratory System Agents|respiratory system agents|mesh-ancestor
65308432|NCT00679432|Glucocorticoids|glucocorticoids|mesh-ancestor
65308433|NCT00679432|Hormones|hormones|mesh-ancestor
65308434|NCT00679432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65308435|NCT02560870|Chlorhexidine|chlorhexidine|mesh-list
65308436|NCT02560870|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65308437|NCT02560870|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65308446|NCT04050826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308447|NCT04050826|Sensory System Agents|sensory system agents|mesh-ancestor
65308448|NCT04050826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65308449|NCT04050826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65308450|NCT04050826|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65308451|NCT04050826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65308452|NCT04050826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65308453|NCT04050826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308454|NCT00757978|Memantine|memantine|mesh-list
65308455|NCT00757978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65308456|NCT00757978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65308457|NCT00757978|Dopamine Agents|dopamine agents|mesh-ancestor
65157117|NCT02879097|Mitosis Modulators|mitosis modulators|mesh-ancestor
65157118|NCT02879097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157119|NCT02879097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65157120|NCT02879097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65157121|NCT02879097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65157122|NCT02879097|Growth Substances|growth substances|mesh-ancestor
65157123|NCT02879097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157124|NCT02879097|Growth Inhibitors|growth inhibitors|mesh-ancestor
65157125|NCT02878863|Peoniflorin|peoniflorin|mesh-list
65157126|NCT02878863|Silymarin|silymarin|mesh-list
65157127|NCT02878863|Antioxidants|antioxidants|mesh-ancestor
65157128|NCT02878863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157129|NCT02878863|Protective Agents|protective agents|mesh-ancestor
65157130|NCT02878863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157131|NCT02878863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65157132|NCT02878863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65157133|NCT02878863|Analgesics|analgesics|mesh-ancestor
65157134|NCT02878863|Sensory System Agents|sensory system agents|mesh-ancestor
65157135|NCT02878863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157136|NCT02878863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65157137|NCT02878863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65157138|NCT02881125|Paclitaxel|paclitaxel|mesh-list
65157139|NCT02881125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65157140|NCT02881125|Nortriptyline|nortriptyline|mesh-list
65157141|NCT02881125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65157142|NCT02881125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65157143|NCT02881125|Tubulin Modulators|tubulin modulators|mesh-ancestor
65157144|NCT02881125|Antimitotic Agents|antimitotic agents|mesh-ancestor
65157145|NCT02881125|Mitosis Modulators|mitosis modulators|mesh-ancestor
65157146|NCT02881125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157147|NCT02881125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65157148|NCT02881125|Antidepressive Agents|antidepressive agents|mesh-ancestor
65157149|NCT02881125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65157150|NCT02881125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65157151|NCT02881125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65157152|NCT02881125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65157153|NCT02881125|Adrenergic Agents|adrenergic agents|mesh-ancestor
65157154|NCT02881125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65157155|NCT02881125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157156|NCT01107405|Loteprednol Etabonate|loteprednol etabonate|mesh-list
65157157|NCT01107405|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65157158|NCT01097577|Pregabalin|pregabalin|mesh-list
65157159|NCT01097577|Analgesics|analgesics|mesh-ancestor
65157164|NCT01097577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65157165|NCT01097577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65157166|NCT01097577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157167|NCT01097577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65157168|NCT01097577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65308458|NCT00757978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65308459|NCT00757978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308460|NCT00757978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308461|NCT00757978|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65308462|NCT00757978|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65308463|NCT00754702|Vinorelbine|vinorelbine|mesh-list
65308464|NCT00754702|Lapatinib|lapatinib|mesh-list
65308465|NCT00754702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65308466|NCT00754702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308467|NCT00754702|Tubulin Modulators|tubulin modulators|mesh-ancestor
65308468|NCT00754702|Antimitotic Agents|antimitotic agents|mesh-ancestor
65308469|NCT00754702|Mitosis Modulators|mitosis modulators|mesh-ancestor
65308470|NCT00754702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308471|NCT00754702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65308472|NCT00754702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157169|NCT01097577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65157170|NCT01097577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65157171|NCT01097577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65157172|NCT01097421|Pramipexole|pramipexole|mesh-list
65157173|NCT01097421|Antioxidants|antioxidants|mesh-ancestor
65157174|NCT01097421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157175|NCT01097421|Protective Agents|protective agents|mesh-ancestor
65157176|NCT01097421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157177|NCT01097421|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65157178|NCT01097421|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65157179|NCT01097421|Dopamine Agonists|dopamine agonists|mesh-ancestor
65157180|NCT01097421|Dopamine Agents|dopamine agents|mesh-ancestor
65157181|NCT01097421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65157183|NCT01251614|Methotrexate|methotrexate|mesh-list
65157184|NCT01251614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65157185|NCT01251614|Abortifacient Agents|abortifacient agents|mesh-ancestor
65157186|NCT01251614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65157187|NCT01251614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157188|NCT01251614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65157189|NCT01251614|Antimetabolites|antimetabolites|mesh-ancestor
65157190|NCT01251614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157191|NCT01251614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65157192|NCT01251614|Dermatologic Agents|dermatologic agents|mesh-ancestor
65157193|NCT01251614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157194|NCT01251614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65157195|NCT01251614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65157196|NCT01251614|Immunologic Factors|immunologic factors|mesh-ancestor
65157197|NCT01251614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65157198|NCT01251614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65157199|NCT01251614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65157200|NCT01106625|Metformin|metformin|mesh-list
65157201|NCT01106625|Canagliflozin|canagliflozin|mesh-list
65157202|NCT01106625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65157203|NCT01106625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157204|NCT01106625|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65157205|NCT01106625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157206|NCT01251380|Botulinum Toxins|botulinum toxins|mesh-list
65157207|NCT01251380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65157208|NCT01251380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65157209|NCT01251380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65157210|NCT01251380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65157211|NCT01251380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308473|NCT00754780|Pirfenidone|pirfenidone|mesh-list
65308474|NCT00754780|Analgesics|analgesics|mesh-ancestor
65308475|NCT00754780|Sensory System Agents|sensory system agents|mesh-ancestor
65308476|NCT00754780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65308477|NCT00754780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308478|NCT00754780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65308479|NCT00754780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65308480|NCT00754780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65308481|NCT00754780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65308482|NCT00754780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308483|NCT00822900|Progesterone|progesterone|mesh-list
65308484|NCT00822900|Progestins|progestins|mesh-ancestor
65308485|NCT00822900|Hormones|hormones|mesh-ancestor
65308486|NCT00822900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65308487|NCT00822900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308488|NCT00682786|Fluorouracil|fluorouracil|mesh-list
65308489|NCT00682786|Irinotecan|irinotecan|mesh-list
65308490|NCT00682786|Antimetabolites|antimetabolites|mesh-ancestor
65308491|NCT00682786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308492|NCT00682786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65308493|NCT00682786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308494|NCT00682786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65308495|NCT00682786|Immunologic Factors|immunologic factors|mesh-ancestor
65308496|NCT00682786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308497|NCT00682786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65308498|NCT00682786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64538308|NCT00611403|Cyclosporine|cyclosporine|mesh-list
65157212|NCT01251380|Cholinergic Agents|cholinergic agents|mesh-ancestor
65157213|NCT01251380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65157214|NCT01251380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157215|NCT01251380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65157216|NCT01251380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157217|NCT01251146|Atenolol|atenolol|mesh-list
65157218|NCT01251146|Bisoprolol|bisoprolol|mesh-list
65157219|NCT01251146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65157220|NCT01251146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65157221|NCT01251146|Sympatholytics|sympatholytics|mesh-ancestor
65157222|NCT01251146|Autonomic Agents|autonomic agents|mesh-ancestor
65157223|NCT01251146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157224|NCT01251146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157225|NCT01251146|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65157226|NCT01251146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65157227|NCT01251146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65157231|NCT02878707|Dexmedetomidine|dexmedetomidine|mesh-list
65157232|NCT02878707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65157233|NCT02878707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65157234|NCT02878707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308499|NCT00682786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308500|NCT00840450|Paclitaxel|paclitaxel|mesh-list
65308501|NCT00840450|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65308502|NCT00840450|Imatinib Mesylate|imatinib mesylate|mesh-list
65308503|NCT00840450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65308504|NCT00840450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308505|NCT00840450|Tubulin Modulators|tubulin modulators|mesh-ancestor
65308506|NCT00840450|Antimitotic Agents|antimitotic agents|mesh-ancestor
65308507|NCT00840450|Mitosis Modulators|mitosis modulators|mesh-ancestor
65308508|NCT00840450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308509|NCT00840450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65308510|NCT00840450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308511|NCT00754858|Belotecan|belotecan|mesh-list
65308512|NCT00754858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308513|NCT00754858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65308514|NCT00754858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65308515|NCT00754858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538334|NCT01534208|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65157235|NCT02878707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65157236|NCT02878707|Analgesics|analgesics|mesh-ancestor
65157237|NCT02878707|Sensory System Agents|sensory system agents|mesh-ancestor
65157238|NCT02878707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157239|NCT02878707|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65157240|NCT02878707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65157241|NCT02878707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65157242|NCT02878707|Adrenergic Agents|adrenergic agents|mesh-ancestor
65157243|NCT02878707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65157244|NCT02878707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157246|NCT04999215|Lipotropic Agents|lipotropic agents|mesh-ancestor
65157247|NCT04999215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65157248|NCT04999215|Antimetabolites|antimetabolites|mesh-ancestor
65157249|NCT04999215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157250|NCT04999215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65157251|NCT04999215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65157252|NCT04999215|Nootropic Agents|nootropic agents|mesh-ancestor
65157253|NCT01096017|Albuterol|albuterol|mesh-list
65157254|NCT01096017|Terbutaline|terbutaline|mesh-list
65157255|NCT01096017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65157256|NCT01096017|Autonomic Agents|autonomic agents|mesh-ancestor
65157257|NCT01096017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157258|NCT01096017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157259|NCT01096017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65157260|NCT01096017|Respiratory System Agents|respiratory system agents|mesh-ancestor
65157261|NCT01096017|Tocolytic Agents|tocolytic agents|mesh-ancestor
65157262|NCT01096017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65157263|NCT01096017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65157264|NCT01096017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65157265|NCT01096017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65157266|NCT01096017|Adrenergic Agents|adrenergic agents|mesh-ancestor
65157267|NCT01096017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65157268|NCT01096017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157269|NCT01096017|Sympathomimetics|sympathomimetics|mesh-ancestor
65157270|NCT00626223|Folic Acid|folic acid|mesh-list
65157271|NCT00626223|Hematinics|hematinics|mesh-ancestor
65157272|NCT00626223|Vitamin B Complex|vitamin b complex|mesh-ancestor
65157273|NCT00626223|Vitamins|vitamins|mesh-ancestor
65157274|NCT00626223|Micronutrients|micronutrients|mesh-ancestor
65308516|NCT00754858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308517|NCT00755014|Ethanol|ethanol|mesh-list
65308518|NCT00755014|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65308519|NCT00755014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65308520|NCT00755014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65308521|NCT00755014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308522|NCT00705588|Tadalafil|tadalafil|mesh-list
65308523|NCT00705588|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65308524|NCT00705588|Vasodilator Agents|vasodilator agents|mesh-ancestor
65308525|NCT00705588|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65308526|NCT00705588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65308527|NCT00705588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308528|NCT00705588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308529|NCT00705588|Urological Agents|urological agents|mesh-ancestor
65308530|NCT00755170|Bevacizumab|bevacizumab|mesh-list
65308531|NCT00755170|Vinorelbine|vinorelbine|mesh-list
65308532|NCT00755170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65308533|NCT00755170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308534|NCT00755170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65308535|NCT00755170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65308536|NCT00755170|Growth Substances|growth substances|mesh-ancestor
65308537|NCT00755170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308538|NCT00755170|Growth Inhibitors|growth inhibitors|mesh-ancestor
64538358|NCT02740179|Eplerenone|eplerenone|mesh-list
65157275|NCT00626223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157276|NCT01106157|Thymoglobulin|thymoglobulin|mesh-list
65157277|NCT01106157|Immunologic Factors|immunologic factors|mesh-ancestor
65157278|NCT01106157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157279|NCT01106157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65157280|NCT04828005|Naloxone|naloxone|mesh-list
65157281|NCT04828005|Nalmefene|nalmefene|mesh-list
65157282|NCT04828005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65157283|NCT04828005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157284|NCT04828005|Sensory System Agents|sensory system agents|mesh-ancestor
65157285|NCT04828005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157286|NCT02878161|Prednisone|prednisone|mesh-list
65157287|NCT02878161|Methylprednisolone|methylprednisolone|mesh-list
65157288|NCT02878161|Adalimumab|adalimumab|mesh-list
65157289|NCT02878161|Etanercept|etanercept|mesh-list
65157290|NCT02878161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65157291|NCT02878161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65157292|NCT02878161|Methotrexate|methotrexate|mesh-list
65157293|NCT02878161|Infliximab|infliximab|mesh-list
65157294|NCT02878161|Glucocorticoids|glucocorticoids|mesh-list
65157295|NCT02878161|Leflunomide|leflunomide|mesh-list
65157296|NCT02878161|Hormones|hormones|mesh-ancestor
65157297|NCT02878161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65157298|NCT02878161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157299|NCT02878161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65157300|NCT02878161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65157311|NCT02878161|Immunologic Factors|immunologic factors|mesh-ancestor
65157312|NCT02878161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65308539|NCT00755170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65308540|NCT00755170|Tubulin Modulators|tubulin modulators|mesh-ancestor
65308541|NCT00755170|Antimitotic Agents|antimitotic agents|mesh-ancestor
65308542|NCT00755170|Mitosis Modulators|mitosis modulators|mesh-ancestor
65308543|NCT00755170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308544|NCT00705822|Prednisone|prednisone|mesh-list
65308545|NCT00705822|Hydrocortisone|hydrocortisone|mesh-list
65308546|NCT00705822|Docetaxel|docetaxel|mesh-list
65308547|NCT00705822|Estramustine|estramustine|mesh-list
65308548|NCT00705822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308549|NCT00705822|Tubulin Modulators|tubulin modulators|mesh-ancestor
65308550|NCT00705822|Antimitotic Agents|antimitotic agents|mesh-ancestor
65308551|NCT00705822|Mitosis Modulators|mitosis modulators|mesh-ancestor
65308552|NCT00705822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308553|NCT00705822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65308554|NCT00705822|Glucocorticoids|glucocorticoids|mesh-ancestor
65308555|NCT00705822|Hormones|hormones|mesh-ancestor
65308556|NCT00705822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65308557|NCT00705822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308558|NCT00705822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65308559|NCT00705822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65308560|NCT00705822|Alkylating Agents|alkylating agents|mesh-ancestor
65308561|NCT00840294|Ciprofloxacin|ciprofloxacin|mesh-list
65308562|NCT00840294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65308563|NCT00840294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65308564|NCT00840294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65308565|NCT00840294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65308566|NCT00840294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308567|NCT00840294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308568|NCT00840294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308569|NCT00840294|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65308570|NCT00840294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65157313|NCT02878161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65157314|NCT02878161|Antiemetics|antiemetics|mesh-ancestor
65157315|NCT02878161|Autonomic Agents|autonomic agents|mesh-ancestor
65157316|NCT02878161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157317|NCT02878161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65157318|NCT02878161|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65157319|NCT02878161|Protective Agents|protective agents|mesh-ancestor
65157320|NCT02878161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65308571|NCT00755404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65308572|NCT00703170|Sirolimus|sirolimus|mesh-list
65308573|NCT00703170|Doxorubicin|doxorubicin|mesh-list
65308574|NCT00703170|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65308575|NCT00703170|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65308576|NCT00703170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308577|NCT00703170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65308578|NCT00703170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65308579|NCT00703170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308580|NCT00703170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308581|NCT00703170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65308582|NCT00703170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65308583|NCT00703170|Antifungal Agents|antifungal agents|mesh-ancestor
65308584|NCT00703170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65308585|NCT00703170|Immunologic Factors|immunologic factors|mesh-ancestor
65308586|NCT00703170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308587|NCT05370040|Vaccines|vaccines|mesh-list
65308588|NCT05370040|Immunologic Factors|immunologic factors|mesh-ancestor
65308589|NCT05370040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308590|NCT05354674|Bevacizumab|bevacizumab|mesh-list
65308591|NCT05354674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65308592|NCT05354674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308593|NCT05354674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65308594|NCT05354674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65308595|NCT05354674|Growth Substances|growth substances|mesh-ancestor
64538404|NCT01517984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157321|NCT02878161|Analgesics|analgesics|mesh-ancestor
65157322|NCT02878161|Sensory System Agents|sensory system agents|mesh-ancestor
65157323|NCT01093755|Omeprazole|omeprazole|mesh-list
65157324|NCT01093755|Dexlansoprazole|dexlansoprazole|mesh-list
65157325|NCT01093755|Lansoprazole|lansoprazole|mesh-list
65157326|NCT01093755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65157327|NCT01093755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65157328|NCT01093755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65157329|NCT01093755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157330|NCT01093755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157331|NCT01092663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65157332|NCT01092663|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65157333|NCT01092663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65157334|NCT01092663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157335|NCT01092663|Incretins|incretins|mesh-ancestor
65157336|NCT01092663|Hormones|hormones|mesh-ancestor
65157337|NCT01092663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65157338|NCT01092663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65157339|NCT01092663|Protease Inhibitors|protease inhibitors|mesh-ancestor
65157340|NCT01092663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157341|NCT01092663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157342|NCT01092663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65157343|NCT01092663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65308596|NCT05354674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308597|NCT05354674|Growth Inhibitors|growth inhibitors|mesh-ancestor
65308598|NCT00758134|Trastuzumab|trastuzumab|mesh-list
65308599|NCT00758134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65308600|NCT00758134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308601|NCT02560636|Pembrolizumab|pembrolizumab|mesh-list
65308602|NCT02560636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65308603|NCT02560636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308604|NCT00758212|Vaccines|vaccines|mesh-list
65308605|NCT00758212|Immunologic Factors|immunologic factors|mesh-ancestor
65308606|NCT00758212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308607|NCT00679042|Exenatide|exenatide|mesh-list
65308608|NCT00679042|Sirolimus|sirolimus|mesh-list
65308609|NCT00679042|Etanercept|etanercept|mesh-list
65308610|NCT00679042|Tacrolimus|tacrolimus|mesh-list
65308611|NCT00679042|Basiliximab|basiliximab|mesh-list
65308612|NCT00679042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65308613|NCT00679042|Immunologic Factors|immunologic factors|mesh-ancestor
65308614|NCT00679042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308615|NCT00679042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65308616|NCT00679042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157344|NCT01092663|Antimetabolites|antimetabolites|mesh-ancestor
65157345|NCT01092663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65157346|NCT01078623|Formoterol Fumarate|formoterol fumarate|mesh-list
65157347|NCT01078623|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65157348|NCT01078623|Autonomic Agents|autonomic agents|mesh-ancestor
65157349|NCT01078623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157350|NCT01078623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157351|NCT01078623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65157352|NCT01078623|Respiratory System Agents|respiratory system agents|mesh-ancestor
65157353|NCT01078623|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65157354|NCT01078623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65157355|NCT01078623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65157356|NCT01078623|Adrenergic Agents|adrenergic agents|mesh-ancestor
65157357|NCT01078623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65157358|NCT01078623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157359|NCT01092507|Vaccines|vaccines|mesh-list
65157360|NCT01092507|Immunologic Factors|immunologic factors|mesh-ancestor
65157361|NCT01092507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157362|NCT01078545|Leuprolide|leuprolide|mesh-list
65157363|NCT01078545|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65157364|NCT01078545|Fertility Agents|fertility agents|mesh-ancestor
65157368|NCT01078545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65157370|NCT01091259|Irinotecan|irinotecan|mesh-list
65157371|NCT01091259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65157372|NCT01091259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65157373|NCT01091259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65157374|NCT01091259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65157375|NCT01091259|Growth Substances|growth substances|mesh-ancestor
65157376|NCT01091259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157377|NCT01091259|Growth Inhibitors|growth inhibitors|mesh-ancestor
65157378|NCT01091259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65157379|NCT01091259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65157380|NCT01091259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157381|NCT01091259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157382|NCT01078389|Febuxostat|febuxostat|mesh-list
65157383|NCT01078389|Gout Suppressants|gout suppressants|mesh-ancestor
65308617|NCT00679042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308618|NCT00679042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65058523|NCT01689727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65308619|NCT00679042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65308620|NCT00679042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65308621|NCT00679042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308622|NCT00679042|Antifungal Agents|antifungal agents|mesh-ancestor
65308623|NCT00679042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65308624|NCT00679042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65308625|NCT00679042|Analgesics|analgesics|mesh-ancestor
65308626|NCT00679042|Sensory System Agents|sensory system agents|mesh-ancestor
65308627|NCT00679042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65308628|NCT00679042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65308629|NCT00679042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65308630|NCT00679042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65308631|NCT00679042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65157384|NCT01078389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65157385|NCT01090323|Deferasirox|deferasirox|mesh-list
65157386|NCT01090323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65157387|NCT01090323|Chelating Agents|chelating agents|mesh-ancestor
65157388|NCT01090323|Sequestering Agents|sequestering agents|mesh-ancestor
65157389|NCT01090323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799976|NCT05271448|Enalapril|enalapril|mesh-list
65157390|NCT02876991|Listerine|listerine|mesh-list
65157391|NCT02876991|Fluorides|fluorides|mesh-list
65157392|NCT02876991|Sodium Fluoride|sodium fluoride|mesh-list
65157393|NCT02876991|Cariostatic Agents|cariostatic agents|mesh-ancestor
65157394|NCT02876991|Protective Agents|protective agents|mesh-ancestor
65157395|NCT02876991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157396|NCT02876991|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65157397|NCT02876991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65157398|NCT01201356|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65157399|NCT01201356|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65157400|NCT01201356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157401|NCT01201356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65157402|NCT01201356|Immunologic Factors|immunologic factors|mesh-ancestor
65157403|NCT01201356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157404|NCT00637611|Fexofenadine|fexofenadine|mesh-list
65157405|NCT00637611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65157406|NCT00637611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65157407|NCT00637611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65157408|NCT00637611|Histamine Antagonists|histamine antagonists|mesh-ancestor
65157409|NCT00637611|Histamine Agents|histamine agents|mesh-ancestor
65157410|NCT00637611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65157411|NCT00637611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157412|NCT00637611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157413|NCT00626535|Esomeprazole|esomeprazole|mesh-list
65157414|NCT00626535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65157415|NCT00626535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65157416|NCT00626535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65157417|NCT00626535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157418|NCT00626535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157419|NCT01200810|Bicalutamide|bicalutamide|mesh-list
65157420|NCT01200810|R04929097|r04929097|mesh-list
65157421|NCT01200810|Androgen Antagonists|androgen antagonists|mesh-ancestor
65157422|NCT01200810|Hormone Antagonists|hormone antagonists|mesh-ancestor
65157423|NCT01200810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65157424|NCT01200810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308632|NCT00679042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65308633|NCT00679042|Incretins|incretins|mesh-ancestor
65308634|NCT00679042|Hormones|hormones|mesh-ancestor
65308635|NCT00679042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65308636|NCT05167864|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65308637|NCT05167864|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65308638|NCT05167864|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65308639|NCT05167864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65308640|NCT05167864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65308641|NCT05167864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308642|NCT05167864|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65308643|NCT05167864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65308644|NCT05167864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308645|NCT05167864|Cholinergic Agents|cholinergic agents|mesh-ancestor
65308646|NCT05167864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65308647|NCT00680056|Formoterol Fumarate|formoterol fumarate|mesh-list
65308648|NCT00680056|Tiotropium Bromide|tiotropium bromide|mesh-list
65308649|NCT00680056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65308650|NCT00680056|Autonomic Agents|autonomic agents|mesh-ancestor
65308651|NCT00680056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65308652|NCT00680056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308653|NCT00680056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65157425|NCT01200810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65157426|NCT01200810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157427|NCT01200810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157428|NCT01200342|Paclitaxel|paclitaxel|mesh-list
65157429|NCT01200342|Carboplatin|carboplatin|mesh-list
65157430|NCT01200342|Oblimersen|oblimersen|mesh-list
65157431|NCT01200342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65157432|NCT01200342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65157433|NCT01200342|Tubulin Modulators|tubulin modulators|mesh-ancestor
65157434|NCT01200342|Antimitotic Agents|antimitotic agents|mesh-ancestor
65157439|NCT05392452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157441|NCT01198548|Cholecalciferol|cholecalciferol|mesh-list
65157442|NCT01198548|Leucovorin|leucovorin|mesh-list
65157443|NCT01198548|Bevacizumab|bevacizumab|mesh-list
65157444|NCT01198548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65157445|NCT01198548|Fluorouracil|fluorouracil|mesh-list
65157446|NCT01198548|Oxaliplatin|oxaliplatin|mesh-list
65157447|NCT01198548|Antibodies|antibodies|mesh-list
65157448|NCT01198548|Immunoglobulins|immunoglobulins|mesh-list
65157449|NCT01198548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65157450|NCT01198548|Levoleucovorin|levoleucovorin|mesh-list
65157451|NCT01198548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65157452|NCT01198548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65157453|NCT01198548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65157454|NCT01198548|Growth Substances|growth substances|mesh-ancestor
65157455|NCT01198548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157456|NCT01198548|Growth Inhibitors|growth inhibitors|mesh-ancestor
65157457|NCT01198548|Vitamins|vitamins|mesh-ancestor
65157458|NCT01198548|Micronutrients|micronutrients|mesh-ancestor
65157459|NCT01198548|Immunologic Factors|immunologic factors|mesh-ancestor
65157460|NCT01198548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65157461|NCT01198548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65308654|NCT00680056|Respiratory System Agents|respiratory system agents|mesh-ancestor
65308655|NCT00680056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65308656|NCT00680056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65308657|NCT00680056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65308658|NCT00680056|Adrenergic Agents|adrenergic agents|mesh-ancestor
65308659|NCT00680056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65308660|NCT00680056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308661|NCT00680056|Parasympatholytics|parasympatholytics|mesh-ancestor
65308662|NCT00680056|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65308663|NCT00680056|Cholinergic Agents|cholinergic agents|mesh-ancestor
65308664|NCT00758368|Apomorphine|apomorphine|mesh-list
65308665|NCT00758368|Emetics|emetics|mesh-ancestor
65308666|NCT00758368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308667|NCT00758368|Autonomic Agents|autonomic agents|mesh-ancestor
65308668|NCT00758368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65308669|NCT00758368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65308670|NCT00758368|Dopamine Agonists|dopamine agonists|mesh-ancestor
65308671|NCT00758368|Dopamine Agents|dopamine agents|mesh-ancestor
65308672|NCT00758368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65308673|NCT00758368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308674|NCT05435560|Dexmedetomidine|dexmedetomidine|mesh-list
65308675|NCT05435560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65308676|NCT05435560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65308677|NCT05435560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308678|NCT05435560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65308679|NCT05435560|Analgesics|analgesics|mesh-ancestor
65308680|NCT05435560|Sensory System Agents|sensory system agents|mesh-ancestor
65308681|NCT05435560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65308682|NCT05435560|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65308683|NCT05435560|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65308684|NCT05435560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65308685|NCT05435560|Adrenergic Agents|adrenergic agents|mesh-ancestor
65308686|NCT05435560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65308687|NCT05435560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157462|NCT01198548|Antimetabolites|antimetabolites|mesh-ancestor
65157463|NCT01198548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157464|NCT01198548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65308688|NCT00680992|Denosumab|denosumab|mesh-list
65308689|NCT00680992|Immunoglobulins|immunoglobulins|mesh-list
65308690|NCT00680992|Immunoglobulin G|immunoglobulin g|mesh-list
65308691|NCT00680992|Immunologic Factors|immunologic factors|mesh-ancestor
65308692|NCT00680992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308693|NCT00680992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65058595|NCT00264615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65308694|NCT02559154|Thalidomide|thalidomide|mesh-list
65308695|NCT02559154|Dexamethasone|dexamethasone|mesh-list
65308696|NCT02559154|Cyclophosphamide|cyclophosphamide|mesh-list
65308697|NCT02559154|Doxorubicin|doxorubicin|mesh-list
65308698|NCT02559154|Bortezomib|bortezomib|mesh-list
65308699|NCT02559154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65308700|NCT02559154|Immunologic Factors|immunologic factors|mesh-ancestor
65308701|NCT02559154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308702|NCT02559154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65308703|NCT02559154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65308704|NCT02559154|Alkylating Agents|alkylating agents|mesh-ancestor
64538521|NCT01575899|Ofloxacin|ofloxacin|mesh-list
65157465|NCT01198548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65157466|NCT01198548|Antidotes|antidotes|mesh-ancestor
65157467|NCT01198548|Protective Agents|protective agents|mesh-ancestor
65157468|NCT01198548|Vitamin B Complex|vitamin b complex|mesh-ancestor
65157470|NCT00977938|Clopidogrel|clopidogrel|mesh-list
65157471|NCT00977938|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65157472|NCT00977938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65157473|NCT00977938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65157474|NCT00977938|Analgesics|analgesics|mesh-ancestor
65157475|NCT00977938|Sensory System Agents|sensory system agents|mesh-ancestor
65157476|NCT00977938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157477|NCT00977938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157479|NCT00977938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65157480|NCT00977938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65157481|NCT00977938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65157482|NCT00977938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157483|NCT00977938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65157484|NCT00977938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65157485|NCT00977938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157486|NCT00977938|Antipyretics|antipyretics|mesh-ancestor
65157487|NCT00977938|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65157488|NCT00977938|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65157489|NCT00977938|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65157490|NCT00977938|Purinergic Agents|purinergic agents|mesh-ancestor
65157491|NCT00977938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65157492|NCT00977548|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65157493|NCT00977548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65157494|NCT00977548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65157495|NCT00977548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157496|NCT00977548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157497|NCT04290208|Acetaminophen|acetaminophen|mesh-list
65157498|NCT04290208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65157499|NCT04290208|Analgesics|analgesics|mesh-ancestor
65157500|NCT04290208|Sensory System Agents|sensory system agents|mesh-ancestor
65157501|NCT04290208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157502|NCT04290208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157503|NCT04290208|Antipyretics|antipyretics|mesh-ancestor
65157504|NCT03223597|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65157505|NCT03223597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65157506|NCT01090011|Cetuximab|cetuximab|mesh-list
65157507|NCT01090011|Afatinib|afatinib|mesh-list
65308705|NCT02559154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308706|NCT02559154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308707|NCT02559154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65308708|NCT02559154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65308709|NCT02559154|Antiemetics|antiemetics|mesh-ancestor
65308710|NCT02559154|Autonomic Agents|autonomic agents|mesh-ancestor
65308711|NCT02559154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65308712|NCT02559154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65308713|NCT02559154|Glucocorticoids|glucocorticoids|mesh-ancestor
65308714|NCT02559154|Hormones|hormones|mesh-ancestor
65308715|NCT02559154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65308716|NCT02559154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65308717|NCT02559154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65308718|NCT02559154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65308719|NCT02559154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65308720|NCT02559154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308721|NCT02559154|Leprostatic Agents|leprostatic agents|mesh-ancestor
65308722|NCT02559154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65308723|NCT02559154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65308724|NCT02559154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65308725|NCT02559154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65308726|NCT02559154|Growth Substances|growth substances|mesh-ancestor
65308727|NCT02559154|Growth Inhibitors|growth inhibitors|mesh-ancestor
65308728|NCT00678886|Muromonab-CD3|muromonab-cd3|mesh-list
65308729|NCT00678886|Immunologic Factors|immunologic factors|mesh-ancestor
65308730|NCT00678886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308731|NCT00678886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65308732|NCT05747469|Lidocaine|lidocaine|mesh-list
65308733|NCT05747469|Anesthetics, Local|anesthetics, local|mesh-list
65308734|NCT05747469|Anesthetics|anesthetics|mesh-list
65308735|NCT05747469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65308736|NCT05747469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308737|NCT05747469|Sensory System Agents|sensory system agents|mesh-ancestor
65308744|NCT00804843|Niacin|niacin|mesh-list
65308745|NCT00804843|Atorvastatin|atorvastatin|mesh-list
65308746|NCT00804843|Simvastatin|simvastatin|mesh-list
65308747|NCT00804843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65308748|NCT00804843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65308749|NCT00804843|Antimetabolites|antimetabolites|mesh-ancestor
65308750|NCT00804843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308751|NCT00804843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65308752|NCT00804843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65308753|NCT00804843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308754|NCT00804843|Vasodilator Agents|vasodilator agents|mesh-ancestor
65308755|NCT00804843|Vitamin B Complex|vitamin b complex|mesh-ancestor
65308756|NCT00804843|Vitamins|vitamins|mesh-ancestor
65308757|NCT00804843|Micronutrients|micronutrients|mesh-ancestor
65308758|NCT00804843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308759|NCT00822120|Prednisone|prednisone|mesh-list
65308760|NCT00822120|Cyclophosphamide|cyclophosphamide|mesh-list
65308761|NCT00822120|Dacarbazine|dacarbazine|mesh-list
65308762|NCT00822120|Doxorubicin|doxorubicin|mesh-list
65308763|NCT00822120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65308764|NCT00822120|Etoposide|etoposide|mesh-list
65308765|NCT00822120|Vincristine|vincristine|mesh-list
65058673|NCT02218606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308766|NCT00822120|Bleomycin|bleomycin|mesh-list
65308767|NCT00822120|Vinblastine|vinblastine|mesh-list
64538576|NCT00587769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64954124|NCT00036764|Tubulin Modulators|tubulin modulators|mesh-ancestor
65157517|NCT02877615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65157518|NCT02877615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157519|NCT02877615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157520|NCT02437279|Nivolumab|nivolumab|mesh-list
65157521|NCT02437279|Ipilimumab|ipilimumab|mesh-list
65157522|NCT02437279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65157523|NCT02437279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65157524|NCT02437279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65157525|NCT02437279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157526|NCT01251653|Gemcitabine|gemcitabine|mesh-list
65157527|NCT01251653|Docetaxel|docetaxel|mesh-list
65157528|NCT01251653|Afatinib|afatinib|mesh-list
65157529|NCT01251653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65157530|NCT01251653|Antimetabolites|antimetabolites|mesh-ancestor
65157531|NCT01251653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157532|NCT01251653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65157533|NCT01251653|Antiviral Agents|antiviral agents|mesh-ancestor
65157534|NCT01251653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65157535|NCT01251653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157536|NCT01251653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65157537|NCT01251653|Immunologic Factors|immunologic factors|mesh-ancestor
65157538|NCT01251653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157539|NCT01251653|Tubulin Modulators|tubulin modulators|mesh-ancestor
65157540|NCT01251653|Antimitotic Agents|antimitotic agents|mesh-ancestor
65157541|NCT01251653|Mitosis Modulators|mitosis modulators|mesh-ancestor
65157542|NCT01251653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65157543|NCT00910663|Mycophenolic Acid|mycophenolic acid|mesh-list
65157544|NCT00910663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65308768|NCT00822120|Procarbazine|procarbazine|mesh-list
65308769|NCT00822120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65308770|NCT00822120|Immunologic Factors|immunologic factors|mesh-ancestor
65308771|NCT00822120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308772|NCT00822120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65308773|NCT00822120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65308774|NCT00822120|Alkylating Agents|alkylating agents|mesh-ancestor
65308775|NCT00822120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308776|NCT00822120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308777|NCT00822120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65308778|NCT00822120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65308779|NCT00822120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65308780|NCT00822120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65308781|NCT00822120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308782|NCT00822120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65308783|NCT00822120|Glucocorticoids|glucocorticoids|mesh-ancestor
65308784|NCT00822120|Hormones|hormones|mesh-ancestor
65308785|NCT00822120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65308786|NCT00822120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65308787|NCT00822120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65308788|NCT00822120|Tubulin Modulators|tubulin modulators|mesh-ancestor
65308789|NCT00822120|Antimitotic Agents|antimitotic agents|mesh-ancestor
65308790|NCT00822120|Mitosis Modulators|mitosis modulators|mesh-ancestor
65308791|NCT00804687|Pseudoephedrine|pseudoephedrine|mesh-list
65308792|NCT00804687|Ephedrine|ephedrine|mesh-list
65308793|NCT00804687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65308794|NCT00804687|Autonomic Agents|autonomic agents|mesh-ancestor
65308795|NCT00804687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65308796|NCT00804687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308797|NCT00804687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65308798|NCT00804687|Respiratory System Agents|respiratory system agents|mesh-ancestor
65308799|NCT00804687|Nasal Decongestants|nasal decongestants|mesh-ancestor
64538609|NCT03179163|Enalapril|enalapril|mesh-list
65157545|NCT00910663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65157546|NCT00910663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65157547|NCT00910663|Antitubercular Agents|antitubercular agents|mesh-ancestor
65157548|NCT00910663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65157549|NCT00910663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65157551|NCT00910663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157552|NCT01077375|Milnacipran|milnacipran|mesh-list
65157553|NCT01077375|Levomilnacipran|levomilnacipran|mesh-list
65308800|NCT00804687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65308801|NCT00804687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65308802|NCT00804687|Sympathomimetics|sympathomimetics|mesh-ancestor
65308803|NCT00804687|Adrenergic Agents|adrenergic agents|mesh-ancestor
65308804|NCT00804687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65308805|NCT00804687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308806|NCT00678652|Vaccines|vaccines|mesh-list
65308807|NCT00678652|Immunologic Factors|immunologic factors|mesh-ancestor
65308808|NCT00678652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308809|NCT02607657|Eplerenone|eplerenone|mesh-list
65308810|NCT02607657|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65308811|NCT02607657|Hormone Antagonists|hormone antagonists|mesh-ancestor
65308812|NCT02607657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65308813|NCT02607657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308814|NCT02607657|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65308815|NCT02607657|Diuretics|diuretics|mesh-ancestor
65308816|NCT02607657|Natriuretic Agents|natriuretic agents|mesh-ancestor
65308817|NCT02607657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65308818|NCT00574912|Insulin|insulin|mesh-list
65308819|NCT00574912|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65308820|NCT00574912|Insulin Glargine|insulin glargine|mesh-list
65308821|NCT00574912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65308822|NCT00574912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308823|NCT00922896|Gemcitabine|gemcitabine|mesh-list
65308824|NCT00922896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65308825|NCT00922896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308826|NCT00922896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64538628|NCT05247177|Sevoflurane|sevoflurane|mesh-list
65157554|NCT01077375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65157555|NCT01077375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65157556|NCT01077375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65157557|NCT01077375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157558|NCT01077375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65157559|NCT01077375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157560|NCT01077375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65157561|NCT01077375|Analgesics|analgesics|mesh-ancestor
65157562|NCT01077375|Sensory System Agents|sensory system agents|mesh-ancestor
65157563|NCT01077375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157564|NCT01077375|Antidepressive Agents|antidepressive agents|mesh-ancestor
65157565|NCT01077375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65157566|NCT02877771|Insulin|insulin|mesh-list
65157567|NCT02877771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65157568|NCT02877771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157569|NCT04306653|Betamethasone|betamethasone|mesh-list
65157570|NCT04306653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65157571|NCT04306653|Glucocorticoids|glucocorticoids|mesh-ancestor
65308827|NCT00922896|Antimetabolites|antimetabolites|mesh-ancestor
65308828|NCT00922896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308829|NCT00922896|Antiviral Agents|antiviral agents|mesh-ancestor
65308830|NCT00922896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65308831|NCT00922896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308832|NCT00922896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65308833|NCT00922896|Immunologic Factors|immunologic factors|mesh-ancestor
65308834|NCT00922896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308835|NCT00922896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65308836|NCT00761020|Mefloquine|mefloquine|mesh-list
65308837|NCT00761020|Antimalarials|antimalarials|mesh-ancestor
65308838|NCT00761020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65308839|NCT00761020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65308840|NCT00761020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65308841|NCT00804141|Bromides|bromides|mesh-list
65308842|NCT00804141|Methylnaltrexone|methylnaltrexone|mesh-list
65308843|NCT00804141|Anticonvulsants|anticonvulsants|mesh-ancestor
65308844|NCT00804141|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65308845|NCT00804141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308846|NCT00804141|Sensory System Agents|sensory system agents|mesh-ancestor
65308847|NCT00804141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65308848|NCT00677092|Imatinib Mesylate|imatinib mesylate|mesh-list
65308849|NCT00677092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308850|NCT00677092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65308851|NCT00677092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308852|NCT00677092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308853|NCT02607579|Ropivacaine|ropivacaine|mesh-list
65308854|NCT02607579|Anesthetics, Local|anesthetics, local|mesh-ancestor
65308855|NCT02607579|Anesthetics|anesthetics|mesh-ancestor
65308856|NCT02607579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65308857|NCT02607579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308858|NCT02607579|Sensory System Agents|sensory system agents|mesh-ancestor
65308859|NCT02607579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65308860|NCT03539367|Acetazolamide|acetazolamide|mesh-list
65308861|NCT03539367|Anticonvulsants|anticonvulsants|mesh-ancestor
65308862|NCT03539367|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65308863|NCT03539367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308864|NCT03539367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308865|NCT03539367|Diuretics|diuretics|mesh-ancestor
65308866|NCT03539367|Natriuretic Agents|natriuretic agents|mesh-ancestor
65308867|NCT03539367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308868|NCT02607423|Gemcitabine|gemcitabine|mesh-list
65308869|NCT02607423|Deoxyglucose|deoxyglucose|mesh-list
65308870|NCT02607423|Cisplatin|cisplatin|mesh-list
65308871|NCT02607423|Docetaxel|docetaxel|mesh-list
65308872|NCT02607423|Pemetrexed|pemetrexed|mesh-list
65308873|NCT02607423|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65308874|NCT02607423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308875|NCT02607423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65308876|NCT02607423|Antimetabolites|antimetabolites|mesh-ancestor
65308877|NCT02607423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308878|NCT02607423|Antiviral Agents|antiviral agents|mesh-ancestor
65308879|NCT02607423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65308880|NCT02607423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308881|NCT02607423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65308882|NCT02607423|Immunologic Factors|immunologic factors|mesh-ancestor
65308883|NCT02607423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308884|NCT02607423|Tubulin Modulators|tubulin modulators|mesh-ancestor
65308885|NCT02607423|Antimitotic Agents|antimitotic agents|mesh-ancestor
65308886|NCT02607423|Mitosis Modulators|mitosis modulators|mesh-ancestor
65308887|NCT02607423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65157572|NCT04306653|Hormones|hormones|mesh-ancestor
65157573|NCT04306653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65157578|NCT04306731|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65157579|NCT04306731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65157580|NCT04306731|Renal Agents|renal agents|mesh-ancestor
65157581|NCT04306731|Antimalarials|antimalarials|mesh-ancestor
65157582|NCT04306731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65157583|NCT04306731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65157584|NCT04306731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65157585|NCT04306731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157586|NCT04306731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157587|NCT04306731|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65157588|NCT04306731|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65157589|NCT04306731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65157591|NCT02877537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65157592|NCT02877537|Autonomic Agents|autonomic agents|mesh-ancestor
65157593|NCT02877537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157594|NCT02877537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157595|NCT02877537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65157596|NCT02877537|Respiratory System Agents|respiratory system agents|mesh-ancestor
65157597|NCT02877537|Tocolytic Agents|tocolytic agents|mesh-ancestor
65157598|NCT02877537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65157599|NCT02877537|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65157600|NCT02877537|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65157601|NCT02877537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65157602|NCT02877537|Adrenergic Agents|adrenergic agents|mesh-ancestor
65157603|NCT02877537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65157604|NCT02877537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157605|NCT01250873|Sertraline|sertraline|mesh-list
65157606|NCT01250873|Antidepressive Agents|antidepressive agents|mesh-ancestor
65308888|NCT02607423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65308889|NCT02607423|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65308890|NCT03416361|Vitamin D|vitamin d|mesh-list
65308891|NCT03416361|Cholecalciferol|cholecalciferol|mesh-list
65308892|NCT03416361|Vitamins|vitamins|mesh-ancestor
65308893|NCT03416361|Micronutrients|micronutrients|mesh-ancestor
65308894|NCT03416361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308895|NCT03416361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65308896|NCT03416361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65308897|NCT00761254|Domperidone|domperidone|mesh-list
65308898|NCT00761254|Antiemetics|antiemetics|mesh-ancestor
65308899|NCT00761254|Autonomic Agents|autonomic agents|mesh-ancestor
65308900|NCT00761254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65308901|NCT00761254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308902|NCT00761254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65308903|NCT00761254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65308904|NCT00761254|Dopamine Agents|dopamine agents|mesh-ancestor
65308905|NCT00761254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65308906|NCT00761254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308907|NCT00761332|Teriparatide|teriparatide|mesh-list
65308908|NCT00761332|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65308909|NCT00761332|Diphosphonates|diphosphonates|mesh-list
65308910|NCT00761332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65308911|NCT00761332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308912|NCT00761332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65308913|NCT00761332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65308914|NCT00761332|Hormone Antagonists|hormone antagonists|mesh-ancestor
65308915|NCT00761332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65308916|NCT00761332|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65308917|NCT00761332|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65308918|NCT04741438|Nivolumab|nivolumab|mesh-list
65058816|NCT00242372|Insulin|insulin|mesh-list
65308919|NCT04741438|Ipilimumab|ipilimumab|mesh-list
65308920|NCT04741438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65308921|NCT04741438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308922|NCT04741438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64538713|NCT02776605|Ponatinib|ponatinib|mesh-list
65308924|NCT03321201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65308925|NCT03321201|Hemostatics|hemostatics|mesh-ancestor
65308926|NCT03321201|Coagulants|coagulants|mesh-ancestor
65308927|NCT02612220|Hemostatics|hemostatics|mesh-list
65308928|NCT02612220|Coagulants|coagulants|mesh-ancestor
65308929|NCT04627246|Vaccines|vaccines|mesh-list
65308930|NCT04627246|Immunologic Factors|immunologic factors|mesh-ancestor
65308931|NCT04627246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308932|NCT00761644|Sirolimus|sirolimus|mesh-list
65308933|NCT00761644|Bevacizumab|bevacizumab|mesh-list
65308934|NCT00761644|Doxorubicin|doxorubicin|mesh-list
65308935|NCT00761644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65308936|NCT00761644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65308937|NCT00761644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308938|NCT00761644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65308939|NCT00761644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65308940|NCT00761644|Growth Substances|growth substances|mesh-ancestor
65308941|NCT00761644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308942|NCT00761644|Growth Inhibitors|growth inhibitors|mesh-ancestor
65308943|NCT00761644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65308944|NCT00761644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65308945|NCT00761644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65308946|NCT00761644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308947|NCT00761644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308948|NCT00761644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65308949|NCT00761644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65308950|NCT00761644|Antifungal Agents|antifungal agents|mesh-ancestor
65308951|NCT00761644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65308952|NCT00761644|Immunologic Factors|immunologic factors|mesh-ancestor
65308953|NCT02559388|Montelukast|montelukast|mesh-list
65157607|NCT01250873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65157608|NCT01250873|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65157609|NCT01250873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65157610|NCT01250873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65157611|NCT01250873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157612|NCT01250873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65157613|NCT01250873|Serotonin Agents|serotonin agents|mesh-ancestor
65157614|NCT01250873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157615|NCT02888327|Oseltamivir|oseltamivir|mesh-list
65157616|NCT02888327|Digoxin|digoxin|mesh-list
65157617|NCT02888327|Midazolam|midazolam|mesh-list
65157618|NCT02888327|Pitavastatin|pitavastatin|mesh-list
65157619|NCT02888327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65157620|NCT02888327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65157621|NCT02888327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64691039|NCT04757675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65157622|NCT02888327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157624|NCT02888327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65308954|NCT02559388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65308955|NCT02559388|Respiratory System Agents|respiratory system agents|mesh-ancestor
65308956|NCT02559388|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65308957|NCT02559388|Hormone Antagonists|hormone antagonists|mesh-ancestor
65308958|NCT02559388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65308959|NCT02559388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308960|NCT02559388|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65308961|NCT02559388|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65308962|NCT02559388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308963|NCT03168256|Apremilast|apremilast|mesh-list
65308964|NCT03168256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65308965|NCT03168256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65308966|NCT03168256|Analgesics|analgesics|mesh-ancestor
65308967|NCT03168256|Sensory System Agents|sensory system agents|mesh-ancestor
65308968|NCT03168256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65308969|NCT03168256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65308970|NCT03168256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65308971|NCT03168256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65308972|NCT03168256|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65308973|NCT03168256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65308974|NCT03168256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308975|NCT03168256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308976|NCT00761722|Azacitidine|azacitidine|mesh-list
65308977|NCT00761722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65308978|NCT00761722|Antimetabolites|antimetabolites|mesh-ancestor
65308979|NCT00761722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308980|NCT00761722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308981|NCT00761722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308982|NCT04507906|Nivolumab|nivolumab|mesh-list
65308983|NCT04507906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65308984|NCT04507906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65308985|NCT04507906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65308986|NCT04507906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157625|NCT02888327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65157626|NCT02888327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65157627|NCT02888327|Anesthetics, General|anesthetics, general|mesh-ancestor
65157628|NCT02888327|Anesthetics|anesthetics|mesh-ancestor
65308987|NCT03078010|Tazobactam|tazobactam|mesh-list
65308988|NCT03078010|Piperacillin|piperacillin|mesh-list
65308989|NCT03078010|Cefepime|cefepime|mesh-list
65308990|NCT03078010|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65308991|NCT03078010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65308992|NCT03078010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65308993|NCT03078010|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65308994|NCT03078010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65308995|NCT03078010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65308996|NCT00762190|Insulin|insulin|mesh-list
65308997|NCT00762190|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65308998|NCT00762190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65308999|NCT00762190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309000|NCT00762346|Zoledronic Acid|zoledronic acid|mesh-list
65309001|NCT00762346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65309002|NCT00762346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309003|NCT00762658|Betamethasone|betamethasone|mesh-list
65309004|NCT00762658|Tacrolimus|tacrolimus|mesh-list
65309005|NCT00762658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65309006|NCT00762658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65309007|NCT00762658|Immunologic Factors|immunologic factors|mesh-ancestor
65309008|NCT00762658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309009|NCT00762658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65309010|NCT00762658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309011|NCT00762658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309012|NCT00762658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65309013|NCT00762658|Glucocorticoids|glucocorticoids|mesh-ancestor
65309014|NCT00762658|Hormones|hormones|mesh-ancestor
65309015|NCT00762658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65309016|NCT00762658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65309017|NCT00762658|Respiratory System Agents|respiratory system agents|mesh-ancestor
65309018|NCT02558452|Tacrolimus|tacrolimus|mesh-list
65309025|NCT00762736|Pioglitazone|pioglitazone|mesh-list
65309029|NCT00762736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65309030|NCT00762736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65309031|NCT00762736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309032|NCT02915224|Obinutuzumab|obinutuzumab|mesh-list
65309033|NCT02915224|Chlorambucil|chlorambucil|mesh-list
65309034|NCT02915224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65309035|NCT02915224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65309036|NCT02915224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65309037|NCT02915224|Alkylating Agents|alkylating agents|mesh-ancestor
65309038|NCT02915224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309039|NCT02870920|Durvalumab|durvalumab|mesh-list
65309040|NCT02870920|Tremelimumab|tremelimumab|mesh-list
65309041|NCT02870920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65309042|NCT02870920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65309043|NCT02813824|Aspirin|aspirin|mesh-list
65309044|NCT02813824|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
65309045|NCT02813824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65309046|NCT02813824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65309047|NCT02813824|Analgesics|analgesics|mesh-ancestor
65309048|NCT02813824|Sensory System Agents|sensory system agents|mesh-ancestor
65309049|NCT02813824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65309050|NCT02813824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309051|NCT02813824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65309052|NCT02813824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65309053|NCT02813824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65309054|NCT02813824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65309058|NCT02813824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309074|NCT00763204|Hormones|hormones|mesh-ancestor
65309075|NCT00763204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65309076|NCT00763204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309077|NCT00763204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65309078|NCT00763204|Respiratory System Agents|respiratory system agents|mesh-ancestor
65309079|NCT02558218|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
65309080|NCT02558218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65309081|NCT02558218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65309082|NCT02558218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65309083|NCT02558218|Glucocorticoids|glucocorticoids|mesh-ancestor
65309084|NCT02558218|Hormones|hormones|mesh-ancestor
65309085|NCT02558218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65309086|NCT02558218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309087|NCT02558218|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65309088|NCT02558218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65309089|NCT00763438|Sertindole|sertindole|mesh-list
65309090|NCT00763438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65309091|NCT00763438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65309092|NCT00763438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65157629|NCT02888327|GABA Modulators|gaba modulators|mesh-ancestor
65157630|NCT02888327|GABA Agents|gaba agents|mesh-ancestor
65157631|NCT02888327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65157632|NCT02888327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157633|NCT02888327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65157634|NCT02888327|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65157635|NCT02888327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157636|NCT02888327|Protective Agents|protective agents|mesh-ancestor
65157637|NCT02888327|Antiviral Agents|antiviral agents|mesh-ancestor
65157638|NCT02888327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65157639|NCT02888327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65157640|NCT02888327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65157641|NCT02888327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65157642|NCT02888327|Antimetabolites|antimetabolites|mesh-ancestor
65157643|NCT02888327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65157644|NCT01248065|Vitamin D|vitamin d|mesh-list
65157647|NCT01248065|Vitamins|vitamins|mesh-ancestor
65157648|NCT01248065|Micronutrients|micronutrients|mesh-ancestor
65157649|NCT01248065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157650|NCT01248065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65157651|NCT01248065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65157652|NCT01248065|Glucocorticoids|glucocorticoids|mesh-ancestor
65157653|NCT01248065|Hormones|hormones|mesh-ancestor
65157654|NCT01248065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65157655|NCT01248065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65157656|NCT01250756|Vaccines|vaccines|mesh-list
65157657|NCT01250756|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65157658|NCT01250756|Immunologic Factors|immunologic factors|mesh-ancestor
65157659|NCT01250756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157660|NCT00977470|Hydroxychloroquine|hydroxychloroquine|mesh-list
65157661|NCT00977470|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65157662|NCT00977470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65157663|NCT00977470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65157664|NCT00977470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157665|NCT00977470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309093|NCT00763438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309094|NCT00763438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65309095|NCT01737502|Sirolimus|sirolimus|mesh-list
65309096|NCT01737502|Auranofin|auranofin|mesh-list
65309097|NCT01737502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65309098|NCT01737502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65309099|NCT01737502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65309100|NCT01737502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65309101|NCT01737502|Antifungal Agents|antifungal agents|mesh-ancestor
65309102|NCT01737502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65309103|NCT01737502|Immunologic Factors|immunologic factors|mesh-ancestor
65309104|NCT01737502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309105|NCT01737502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65309106|NCT02559232|Anticoagulants|anticoagulants|mesh-list
65309107|NCT00673816|Sunitinib|sunitinib|mesh-list
65309108|NCT00673816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65309109|NCT00673816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65157666|NCT00977470|Antimalarials|antimalarials|mesh-ancestor
65157667|NCT00977470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65157668|NCT00977470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65157669|NCT00977470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65157670|NCT00977470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65157671|NCT02865304|Endostar protein|endostar protein|mesh-list
65157672|NCT02865304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65157673|NCT02865304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65157674|NCT02865304|Growth Substances|growth substances|mesh-ancestor
65157675|NCT02865304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157676|NCT02865304|Growth Inhibitors|growth inhibitors|mesh-ancestor
65157677|NCT02865304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65157678|NCT04075474|Listerine|listerine|mesh-list
65157679|NCT04075474|Fluorides|fluorides|mesh-list
65157680|NCT04075474|Sodium Fluoride|sodium fluoride|mesh-list
65157681|NCT04075474|Cariostatic Agents|cariostatic agents|mesh-ancestor
65157682|NCT04075474|Protective Agents|protective agents|mesh-ancestor
65157683|NCT04075474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157684|NCT04075474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65157685|NCT04075474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65157686|NCT02866396|Pregabalin|pregabalin|mesh-list
65157687|NCT02866396|Analgesics|analgesics|mesh-ancestor
65157688|NCT02866396|Sensory System Agents|sensory system agents|mesh-ancestor
65157689|NCT02866396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800289|NCT05067439|Efavirenz|efavirenz|mesh-list
65157690|NCT02866396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157691|NCT02866396|Anticonvulsants|anticonvulsants|mesh-ancestor
65157692|NCT02866396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65157693|NCT02866396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65157694|NCT02866396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157695|NCT02866396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65157696|NCT02866396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65157698|NCT02866396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65157699|NCT02866396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65157701|NCT01087203|Analgesics|analgesics|mesh-ancestor
65157702|NCT01087203|Sensory System Agents|sensory system agents|mesh-ancestor
65157703|NCT01087203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157704|NCT01087203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157705|NCT01246583|Tofacitinib|tofacitinib|mesh-list
65157706|NCT01246583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65157707|NCT01246583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157708|NCT01246583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157709|NCT00626613|Risperidone|risperidone|mesh-list
65309110|NCT00673816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65309111|NCT00673816|Growth Substances|growth substances|mesh-ancestor
65309112|NCT00673816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309113|NCT00673816|Growth Inhibitors|growth inhibitors|mesh-ancestor
65309114|NCT00673816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65309115|NCT00673816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309116|NCT00673816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309117|NCT00763906|Norepinephrine|norepinephrine|mesh-list
65309118|NCT00763906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65309119|NCT00763906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65309120|NCT00763906|Adrenergic Agents|adrenergic agents|mesh-ancestor
65309121|NCT00763906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65309122|NCT00763906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309123|NCT00763906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309124|NCT00763906|Sympathomimetics|sympathomimetics|mesh-ancestor
65309125|NCT00763906|Autonomic Agents|autonomic agents|mesh-ancestor
65309126|NCT00763906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65309127|NCT00763906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65309128|NCT00764062|Amoxicillin|amoxicillin|mesh-list
65309129|NCT00764062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65309130|NCT00764062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65309131|NCT00758914|Vitamin E|vitamin e|mesh-list
65309132|NCT00758914|Vitamins|vitamins|mesh-ancestor
65309133|NCT00758914|Micronutrients|micronutrients|mesh-ancestor
65309134|NCT00758914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309135|NCT00758914|Antioxidants|antioxidants|mesh-ancestor
65309136|NCT00758914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309137|NCT00758914|Protective Agents|protective agents|mesh-ancestor
65309138|NCT00759070|Ritonavir|ritonavir|mesh-list
65309139|NCT00759070|Lopinavir|lopinavir|mesh-list
65309140|NCT00759070|Tenofovir|tenofovir|mesh-list
65309141|NCT00759070|Emtricitabine|emtricitabine|mesh-list
65309142|NCT00759070|Efavirenz|efavirenz|mesh-list
65309143|NCT00759070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65309144|NCT00759070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65309145|NCT00759070|Protease Inhibitors|protease inhibitors|mesh-ancestor
65157710|NCT00626613|Galantamine|galantamine|mesh-list
65157711|NCT00626613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65157712|NCT00626613|Serotonin Agents|serotonin agents|mesh-ancestor
65157713|NCT00626613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65157714|NCT00626613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157715|NCT00626613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309146|NCT00759070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309147|NCT00759070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309148|NCT00759070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65309149|NCT00759070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65309150|NCT00759070|Antiviral Agents|antiviral agents|mesh-ancestor
65309151|NCT00759070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65309152|NCT00759070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65309153|NCT00759070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65309154|NCT00759070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65309155|NCT00759070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65309156|NCT00759070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65309157|NCT00759070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65309158|NCT00759070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64538961|NCT00674115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65157716|NCT00626613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65157717|NCT00626613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65157718|NCT00626613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65157719|NCT00626613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65157738|NCT01079949|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65157739|NCT01079949|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65157740|NCT01079949|Fertility Agents|fertility agents|mesh-ancestor
65157741|NCT01079949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65157742|NCT01079949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157743|NCT01079949|Hormone Antagonists|hormone antagonists|mesh-ancestor
65157744|NCT01079949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65157745|NCT01079949|Hormones|hormones|mesh-ancestor
65157746|NCT00910429|Riociguat|riociguat|mesh-list
65157747|NCT00910429|Enzyme Activators|enzyme activators|mesh-ancestor
65157748|NCT00910429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157749|NCT03432949|Dexamethasone|dexamethasone|mesh-list
65157750|NCT03432949|Dexamethasone acetate|dexamethasone acetate|mesh-list
65157751|NCT03432949|BB 1101|bb 1101|mesh-list
65157752|NCT03432949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65157753|NCT03432949|Antiemetics|antiemetics|mesh-ancestor
65157754|NCT03432949|Autonomic Agents|autonomic agents|mesh-ancestor
65157755|NCT03432949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157756|NCT03432949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157757|NCT03432949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65157758|NCT03432949|Glucocorticoids|glucocorticoids|mesh-ancestor
65157759|NCT03432949|Hormones|hormones|mesh-ancestor
65157760|NCT03432949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65157761|NCT03432949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65157762|NCT03432949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65157763|NCT03432949|Protease Inhibitors|protease inhibitors|mesh-ancestor
65157764|NCT03432949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800359|NCT05051150|Mydriatics|mydriatics|mesh-ancestor
65157765|NCT03432949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157766|NCT00909727|Ivacaftor|ivacaftor|mesh-list
65157767|NCT00909727|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65157768|NCT00909727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65157769|NCT00909727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157770|NCT00977080|Cinacalcet|cinacalcet|mesh-list
65157772|NCT00977080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157773|NCT00977080|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65157774|NCT00977080|Hormone Antagonists|hormone antagonists|mesh-ancestor
65157775|NCT00977080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65157778|NCT04289194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65309159|NCT00759070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65309160|NCT00759070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65309161|NCT00764140|Mitogens|mitogens|mesh-list
65309162|NCT00764140|Mitosis Modulators|mitosis modulators|mesh-ancestor
65309163|NCT00764140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309164|NCT00672958|Vortioxetine|vortioxetine|mesh-list
65309165|NCT00672958|Antidepressive Agents|antidepressive agents|mesh-ancestor
65309166|NCT00672958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65309167|NCT00672958|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65309168|NCT00672958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65309169|NCT00672958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65309170|NCT00672958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309171|NCT00672958|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65309172|NCT00672958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65309173|NCT00672958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65309174|NCT00672958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309175|NCT00672958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65309176|NCT00672958|Serotonin Agents|serotonin agents|mesh-ancestor
65309177|NCT00672958|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65157779|NCT05234554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65157780|NCT05234554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65157781|NCT04083157|Imiquimod|imiquimod|mesh-list
65157782|NCT04083157|Vaccines|vaccines|mesh-list
65157783|NCT04083157|Immunologic Factors|immunologic factors|mesh-ancestor
65157784|NCT04083157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157785|NCT04083157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65157786|NCT04083157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65157787|NCT04083157|Interferon Inducers|interferon inducers|mesh-ancestor
65157788|NCT00975286|Metformin|metformin|mesh-list
65157789|NCT00975286|Insulin Glargine|insulin glargine|mesh-list
65157790|NCT00975286|Lixisenatide|lixisenatide|mesh-list
65157791|NCT00975286|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
65157792|NCT00975286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65157793|NCT00975286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157794|NCT00907777|Vaccines|vaccines|mesh-list
65157795|NCT00907777|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65157796|NCT00907777|Immunologic Factors|immunologic factors|mesh-ancestor
65157797|NCT00907777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157798|NCT03741517|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65157799|NCT03741517|Edotreotide|edotreotide|mesh-list
65157800|NCT03741517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65157801|NCT03741517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157802|NCT02864758|Vitamin K|vitamin k|mesh-list
65157803|NCT02864758|Rivaroxaban|rivaroxaban|mesh-list
65157804|NCT02864758|Dabigatran|dabigatran|mesh-list
65157805|NCT02864758|Vitamins|vitamins|mesh-ancestor
65157806|NCT02864758|Micronutrients|micronutrients|mesh-ancestor
65157807|NCT02864758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157808|NCT02864758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65157809|NCT02864758|Antithrombins|antithrombins|mesh-ancestor
65157810|NCT02864758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65157811|NCT02864758|Protease Inhibitors|protease inhibitors|mesh-ancestor
65157812|NCT02864758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157813|NCT02864758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157814|NCT02864758|Anticoagulants|anticoagulants|mesh-ancestor
65157815|NCT02864758|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65309178|NCT00672958|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65309179|NCT00672958|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65309180|NCT00672958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65309181|NCT00764374|Z 338|z 338|mesh-list
65309182|NCT00764374|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65309183|NCT00764374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309184|NCT00764374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309185|NCT00764374|Cholinergic Agents|cholinergic agents|mesh-ancestor
65309186|NCT00764374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65309187|NCT00764374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309188|NCT00764374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65309189|NCT00759226|Leucovorin|leucovorin|mesh-list
65309190|NCT00759226|Folic Acid|folic acid|mesh-list
65309191|NCT00759226|Gemcitabine|gemcitabine|mesh-list
65309192|NCT00759226|Cisplatin|cisplatin|mesh-list
65309193|NCT00759226|Levoleucovorin|levoleucovorin|mesh-list
65309194|NCT00759226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65309195|NCT00759226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65309196|NCT00759226|Antimetabolites|antimetabolites|mesh-ancestor
65309197|NCT00759226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309198|NCT00759226|Antiviral Agents|antiviral agents|mesh-ancestor
65309199|NCT00759226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65309200|NCT00759226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309201|NCT00759226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65309202|NCT00759226|Immunologic Factors|immunologic factors|mesh-ancestor
65309203|NCT00759226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309204|NCT00759226|Antidotes|antidotes|mesh-ancestor
65309205|NCT00759226|Protective Agents|protective agents|mesh-ancestor
65309206|NCT00759226|Vitamin B Complex|vitamin b complex|mesh-ancestor
65309207|NCT00759226|Vitamins|vitamins|mesh-ancestor
65309208|NCT00759226|Micronutrients|micronutrients|mesh-ancestor
65309209|NCT00759226|Hematinics|hematinics|mesh-ancestor
65309210|NCT00672646|Naproxen|naproxen|mesh-list
65309211|NCT00672646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64538995|NCT01439711|Hormone Antagonists|hormone antagonists|mesh-ancestor
65157816|NCT02864758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65157817|NCT02864758|Hemostatics|hemostatics|mesh-ancestor
65157818|NCT02864758|Coagulants|coagulants|mesh-ancestor
65157819|NCT04063579|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65157820|NCT04063579|Natriuretic Agents|natriuretic agents|mesh-ancestor
65157821|NCT04063579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157822|NCT04204798|Dexmedetomidine|dexmedetomidine|mesh-list
65157823|NCT04204798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65157824|NCT04204798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65309212|NCT00672646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65309213|NCT00672646|Analgesics|analgesics|mesh-ancestor
65309214|NCT00672646|Sensory System Agents|sensory system agents|mesh-ancestor
65309215|NCT00672646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65309216|NCT00672646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059115|NCT00244127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65309217|NCT00672646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65309219|NCT00672646|Gout Suppressants|gout suppressants|mesh-ancestor
65309220|NCT00672646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65309221|NCT00672646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309222|NCT00672646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309223|NCT00759460|Olanzapine|olanzapine|mesh-list
65309224|NCT00759460|Sertindole|sertindole|mesh-list
65309225|NCT00759460|Antiemetics|antiemetics|mesh-ancestor
65309226|NCT00759460|Autonomic Agents|autonomic agents|mesh-ancestor
65309227|NCT00759460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65309228|NCT00759460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309229|NCT00759460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65309230|NCT00759460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65309231|NCT00759460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65309232|NCT00759460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65309233|NCT00759460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65309234|NCT00759460|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65309235|NCT00759460|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65309236|NCT00759460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65309237|NCT00759460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309238|NCT00759460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65309239|NCT00759460|Serotonin Agents|serotonin agents|mesh-ancestor
65309240|NCT00765154|Ritonavir|ritonavir|mesh-list
65309241|NCT00765154|Darunavir|darunavir|mesh-list
65309242|NCT00765154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65309243|NCT00765154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65309244|NCT00765154|Protease Inhibitors|protease inhibitors|mesh-ancestor
65309245|NCT00765154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309246|NCT00765154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309247|NCT00765154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65309248|NCT00765154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65157825|NCT04204798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309249|NCT00765154|Antiviral Agents|antiviral agents|mesh-ancestor
65309250|NCT00765154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65309251|NCT00765154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65309252|NCT00765154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65309253|NCT00672490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65309254|NCT00672490|Antidepressive Agents|antidepressive agents|mesh-ancestor
65309255|NCT00672490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65309256|NCT00672490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65309257|NCT00672490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65309258|NCT00672490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65309259|NCT00672490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309260|NCT00770302|Saxagliptin|saxagliptin|mesh-list
65309261|NCT00770302|Incretins|incretins|mesh-ancestor
65309262|NCT00770302|Hormones|hormones|mesh-ancestor
65309263|NCT00770302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65309264|NCT00770302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309265|NCT00770302|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65309266|NCT00770302|Protease Inhibitors|protease inhibitors|mesh-ancestor
65309267|NCT00770302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309268|NCT00770302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309269|NCT00770302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65309270|NCT02557984|Naltrexone|naltrexone|mesh-list
65309271|NCT02557984|Amisulpride|amisulpride|mesh-list
65309272|NCT02557984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65309273|NCT02557984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65309274|NCT02557984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309275|NCT02557984|Sensory System Agents|sensory system agents|mesh-ancestor
65309276|NCT02557984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65309277|NCT02557984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65309278|NCT02557984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65309279|NCT02557984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65309280|NCT02557984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65309290|NCT00759928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65309291|NCT00759928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309292|NCT00759928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309294|NCT00670930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65309295|NCT00670930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65309296|NCT00670930|Respiratory System Agents|respiratory system agents|mesh-ancestor
65309297|NCT00770536|Doxorubicin|doxorubicin|mesh-list
65309298|NCT00770536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65309299|NCT00770536|Topotecan|topotecan|mesh-list
65309300|NCT00770536|Trebananib|trebananib|mesh-list
65309301|NCT00770536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65309302|NCT00770536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65309303|NCT00770536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65309304|NCT00770536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65309305|NCT00770536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309306|NCT00770536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309307|NCT00770536|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65309308|NCT00770536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65309309|NCT00770536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65309310|NCT00770536|Growth Substances|growth substances|mesh-ancestor
65309311|NCT00770536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309312|NCT00770536|Growth Inhibitors|growth inhibitors|mesh-ancestor
65309313|NCT00771004|Pioglitazone|pioglitazone|mesh-list
65309314|NCT00771004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65309315|NCT00771004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309316|NCT00674362|Certolizumab Pegol|certolizumab pegol|mesh-list
65309317|NCT00674362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65309318|NCT00674362|Immunologic Factors|immunologic factors|mesh-ancestor
65309319|NCT00674362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309320|NCT00674362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65309321|NCT00820950|Betamethasone|betamethasone|mesh-list
65309322|NCT00820950|Betamethasone Valerate|betamethasone valerate|mesh-list
65309323|NCT00820950|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65309324|NCT00820950|Betamethasone benzoate|betamethasone benzoate|mesh-list
65309325|NCT00820950|Calcipotriene|calcipotriene|mesh-list
65309326|NCT00820950|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65157826|NCT04204798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65157827|NCT04204798|Analgesics|analgesics|mesh-ancestor
65157828|NCT04204798|Sensory System Agents|sensory system agents|mesh-ancestor
65157829|NCT04204798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65309327|NCT00820950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65309328|NCT00820950|Glucocorticoids|glucocorticoids|mesh-ancestor
65309329|NCT00820950|Hormones|hormones|mesh-ancestor
65309330|NCT00820950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65309331|NCT00820950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309332|NCT00820950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65309333|NCT00820950|Respiratory System Agents|respiratory system agents|mesh-ancestor
65309334|NCT00820950|Dermatologic Agents|dermatologic agents|mesh-ancestor
65309335|NCT00765934|Lidocaine|lidocaine|mesh-list
65309336|NCT00765934|Tetracaine|tetracaine|mesh-list
65309337|NCT00765934|Anesthetics, Local|anesthetics, local|mesh-ancestor
65309338|NCT00765934|Anesthetics|anesthetics|mesh-ancestor
65309339|NCT00765934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65309340|NCT00765934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309341|NCT00765934|Sensory System Agents|sensory system agents|mesh-ancestor
65309342|NCT00765934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65309343|NCT00765934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65309344|NCT00765934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65309345|NCT00765934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65309346|NCT00765934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65309347|NCT00765934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309348|NCT04049344|Oxaliplatin|oxaliplatin|mesh-list
65309349|NCT04049344|Decitabine|decitabine|mesh-list
65309350|NCT04049344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65309351|NCT04049344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65309352|NCT04049344|Antimetabolites|antimetabolites|mesh-ancestor
65309353|NCT04049344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309354|NCT04049344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309355|NCT00670306|Cetrorelix|cetrorelix|mesh-list
65309356|NCT00670306|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65309369|NCT00709254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65309370|NCT00709254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65309371|NCT00709254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65309372|NCT00709254|Anesthetics, General|anesthetics, general|mesh-ancestor
65309373|NCT00709254|Anesthetics|anesthetics|mesh-ancestor
65309374|NCT00760318|Levetiracetam|levetiracetam|mesh-list
65309375|NCT00760318|Anticonvulsants|anticonvulsants|mesh-ancestor
65309376|NCT00760318|Nootropic Agents|nootropic agents|mesh-ancestor
65309377|NCT00591630|Cytarabine|cytarabine|mesh-list
65309378|NCT00591630|Rituximab|rituximab|mesh-list
65309379|NCT00591630|Etoposide|etoposide|mesh-list
65309380|NCT00591630|Melphalan|melphalan|mesh-list
65309381|NCT00591630|Carmustine|carmustine|mesh-list
65309382|NCT00591630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65157830|NCT04204798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65157831|NCT04204798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65157832|NCT04204798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65157833|NCT04204798|Adrenergic Agents|adrenergic agents|mesh-ancestor
65157834|NCT04204798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65157835|NCT04204798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157836|NCT00908011|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65157837|NCT00908011|Ezetimibe|ezetimibe|mesh-list
65157838|NCT00908011|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65157839|NCT00908011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64800432|NCT04801641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65157840|NCT00908011|Antimetabolites|antimetabolites|mesh-ancestor
65157841|NCT00908011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157842|NCT00908011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65157843|NCT00908011|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65157844|NCT00908011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157845|NCT05580523|Aspirin|aspirin|mesh-list
65157846|NCT05580523|Metformin|metformin|mesh-list
65157847|NCT05580523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65157848|NCT05580523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157849|NCT05580523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65157856|NCT05580523|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65157857|NCT05580523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65157858|NCT05580523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157859|NCT05580523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65157860|NCT05580523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65157861|NCT05580523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157862|NCT05580523|Antipyretics|antipyretics|mesh-ancestor
65157863|NCT00976456|Bevacizumab|bevacizumab|mesh-list
65157864|NCT00976456|Carboplatin|carboplatin|mesh-list
65157865|NCT00976456|Pemetrexed|pemetrexed|mesh-list
65157866|NCT00976456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65157867|NCT00976456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65157868|NCT00976456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65157869|NCT00976456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65157870|NCT00976456|Growth Substances|growth substances|mesh-ancestor
65157871|NCT00976456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157872|NCT00976456|Growth Inhibitors|growth inhibitors|mesh-ancestor
65157873|NCT00976456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157874|NCT00976456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157875|NCT00976456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65157876|NCT00976456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65157877|NCT01243151|Bococizumab|bococizumab|mesh-list
65157878|NCT01243151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65157879|NCT01243151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65157880|NCT01243151|Antimetabolites|antimetabolites|mesh-ancestor
65157881|NCT01243151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157882|NCT01243151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65157883|NCT00629512|Esomeprazole|esomeprazole|mesh-list
65157884|NCT00629512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65309383|NCT00591630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65309384|NCT00591630|Immunologic Factors|immunologic factors|mesh-ancestor
65309385|NCT00591630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309386|NCT00591630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65309387|NCT00591630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65309388|NCT00591630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65309389|NCT00591630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65309390|NCT00591630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309391|NCT00591630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309392|NCT00591630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65309393|NCT00591630|Antimetabolites|antimetabolites|mesh-ancestor
65309394|NCT00591630|Antiviral Agents|antiviral agents|mesh-ancestor
65309395|NCT00591630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65309396|NCT00591630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65309397|NCT00591630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65309398|NCT00591630|Alkylating Agents|alkylating agents|mesh-ancestor
65157885|NCT00629512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65157886|NCT00629512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65157887|NCT00629512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157888|NCT00629512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157889|NCT01711021|Amphetamine|amphetamine|mesh-list
65157890|NCT01711021|Dextroamphetamine|dextroamphetamine|mesh-list
65157891|NCT01711021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65157892|NCT01711021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157893|NCT01711021|Sympathomimetics|sympathomimetics|mesh-ancestor
65157894|NCT01711021|Autonomic Agents|autonomic agents|mesh-ancestor
65157895|NCT01711021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157896|NCT01711021|Dopamine Agents|dopamine agents|mesh-ancestor
65157897|NCT01711021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65157898|NCT01711021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157899|NCT01711021|Adrenergic Agents|adrenergic agents|mesh-ancestor
65157900|NCT01711021|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65157901|NCT01711021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65157902|NCT01711021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65157903|NCT01711021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65157904|NCT05517265|Acalabrutinib|acalabrutinib|mesh-list
65157905|NCT05517265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65157906|NCT02864602|Dexamethasone|dexamethasone|mesh-list
65157907|NCT02864602|Dexamethasone acetate|dexamethasone acetate|mesh-list
65157908|NCT02864602|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65157909|NCT02864602|BB 1101|bb 1101|mesh-list
65157910|NCT02864602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65157911|NCT02864602|Antiemetics|antiemetics|mesh-ancestor
65157912|NCT02864602|Autonomic Agents|autonomic agents|mesh-ancestor
65157913|NCT02864602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157914|NCT02864602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157915|NCT02864602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65157916|NCT02864602|Glucocorticoids|glucocorticoids|mesh-ancestor
65157917|NCT02864602|Hormones|hormones|mesh-ancestor
65157918|NCT02864602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65157926|NCT03667651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65157927|NCT00993148|Ritonavir|ritonavir|mesh-list
65157928|NCT00993148|Darunavir|darunavir|mesh-list
65157929|NCT00993148|Maraviroc|maraviroc|mesh-list
65157930|NCT00993148|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65157931|NCT00993148|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65157932|NCT00993148|Protease Inhibitors|protease inhibitors|mesh-ancestor
65157933|NCT00993148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309399|NCT00591630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65309400|NCT00771394|Tamsulosin|tamsulosin|mesh-list
65309401|NCT00771394|Solifenacin Succinate|solifenacin succinate|mesh-list
65309402|NCT00771394|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65309403|NCT00771394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65309404|NCT00771394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65309405|NCT00771394|Adrenergic Agents|adrenergic agents|mesh-ancestor
65309406|NCT00771394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65309407|NCT00771394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309408|NCT00771394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309409|NCT00771394|Urological Agents|urological agents|mesh-ancestor
65157934|NCT00993148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157935|NCT00993148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65157936|NCT00993148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65157937|NCT00993148|Antiviral Agents|antiviral agents|mesh-ancestor
65157938|NCT00993148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65157939|NCT00993148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65157940|NCT00993148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65157941|NCT00993148|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65157942|NCT00993148|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65157943|NCT00993148|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65157944|NCT03401047|Estradiol|estradiol|mesh-list
65157945|NCT03401047|Estrogens|estrogens|mesh-ancestor
65157946|NCT03401047|Hormones|hormones|mesh-ancestor
65157947|NCT03401047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65157948|NCT03401047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157949|NCT03384589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65157950|NCT03384589|Immunologic Factors|immunologic factors|mesh-ancestor
65157951|NCT03384589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157952|NCT03531073|Methotrexate|methotrexate|mesh-list
65157953|NCT03531073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65157954|NCT03531073|Abortifacient Agents|abortifacient agents|mesh-ancestor
65157955|NCT03531073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65157956|NCT03531073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157957|NCT03531073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65157958|NCT03531073|Antimetabolites|antimetabolites|mesh-ancestor
65157959|NCT03531073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157960|NCT03531073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65157961|NCT03531073|Dermatologic Agents|dermatologic agents|mesh-ancestor
65157962|NCT03531073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157963|NCT03531073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65157964|NCT03531073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65157965|NCT03531073|Immunologic Factors|immunologic factors|mesh-ancestor
65157966|NCT03531073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65157967|NCT03531073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65157968|NCT00907153|Vitamin D|vitamin d|mesh-list
65157969|NCT00907153|Vitamins|vitamins|mesh-ancestor
65157970|NCT00907153|Micronutrients|micronutrients|mesh-ancestor
65157971|NCT00907153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157972|NCT00907153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65157973|NCT00904033|Calcitriol|calcitriol|mesh-list
65157974|NCT00904033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65157975|NCT00904033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157976|NCT00904033|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65157977|NCT00904033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65157978|NCT00904033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157979|NCT00904033|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65157980|NCT00904033|Vitamins|vitamins|mesh-ancestor
65157981|NCT00904033|Micronutrients|micronutrients|mesh-ancestor
65157982|NCT00904033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65157983|NCT05175625|Myeloma Proteins|myeloma proteins|mesh-list
65157984|NCT05175625|Paraproteins|paraproteins|mesh-list
65309410|NCT00771394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65309411|NCT00771394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65309412|NCT00771394|Cholinergic Agents|cholinergic agents|mesh-ancestor
65309413|NCT00670228|Insulin|insulin|mesh-list
65309414|NCT00670228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65309415|NCT00670228|Insulin Glargine|insulin glargine|mesh-list
65309416|NCT00670228|Insulin glulisine|insulin glulisine|mesh-list
65309417|NCT00670228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65309418|NCT00670228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157985|NCT05175625|Immunologic Factors|immunologic factors|mesh-ancestor
65157986|NCT05175625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157987|NCT02555839|Thalidomide|thalidomide|mesh-list
65157988|NCT02555839|Dexamethasone|dexamethasone|mesh-list
65157991|NCT02555839|Pomalidomide|pomalidomide|mesh-list
65157992|NCT02555839|BB 1101|bb 1101|mesh-list
65157993|NCT02555839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65157994|NCT02555839|Antiemetics|antiemetics|mesh-ancestor
65157995|NCT02555839|Autonomic Agents|autonomic agents|mesh-ancestor
65157996|NCT02555839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157997|NCT02555839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157998|NCT02555839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65157999|NCT02555839|Glucocorticoids|glucocorticoids|mesh-ancestor
65158000|NCT02555839|Hormones|hormones|mesh-ancestor
65158001|NCT02555839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65158002|NCT02555839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65158003|NCT02555839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158004|NCT02555839|Protease Inhibitors|protease inhibitors|mesh-ancestor
65158005|NCT02555839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158006|NCT02555839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158007|NCT02555839|Immunologic Factors|immunologic factors|mesh-ancestor
65158008|NCT02555839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65158009|NCT02555839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65158010|NCT02555839|Growth Substances|growth substances|mesh-ancestor
65158011|NCT02555839|Growth Inhibitors|growth inhibitors|mesh-ancestor
65158012|NCT02555839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65158013|NCT02555839|Leprostatic Agents|leprostatic agents|mesh-ancestor
65158014|NCT02555839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65158015|NCT02555839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65158016|NCT01241591|Etanercept|etanercept|mesh-list
65158017|NCT01241591|Tofacitinib|tofacitinib|mesh-list
65158018|NCT01241591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65158019|NCT01241591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65158020|NCT01241591|Analgesics|analgesics|mesh-ancestor
65158021|NCT01241591|Sensory System Agents|sensory system agents|mesh-ancestor
65158022|NCT01241591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158023|NCT01241591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158024|NCT01241591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65158025|NCT01241591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65158026|NCT01241591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65158027|NCT01241591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65158028|NCT01241591|Immunologic Factors|immunologic factors|mesh-ancestor
65158029|NCT01241591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65158030|NCT01241591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158031|NCT01241591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158032|NCT03464461|Ketorolac|ketorolac|mesh-list
65158033|NCT03464461|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65158034|NCT03464461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65158035|NCT03464461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65158036|NCT03464461|Analgesics|analgesics|mesh-ancestor
65158037|NCT03464461|Sensory System Agents|sensory system agents|mesh-ancestor
65158038|NCT03464461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158039|NCT03464461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158040|NCT03464461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65158041|NCT03464461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65158042|NCT03464461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65158043|NCT03464461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158044|NCT03464461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309419|NCT00766246|Bevacizumab|bevacizumab|mesh-list
65309420|NCT00766246|Carboplatin|carboplatin|mesh-list
65309421|NCT00766246|Docetaxel|docetaxel|mesh-list
65309422|NCT00766246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65309423|NCT00766246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65309424|NCT00766246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65309425|NCT00766246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65309426|NCT00766246|Growth Substances|growth substances|mesh-ancestor
65309427|NCT00766246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309428|NCT00766246|Growth Inhibitors|growth inhibitors|mesh-ancestor
65309429|NCT00766246|Tubulin Modulators|tubulin modulators|mesh-ancestor
65309430|NCT00766246|Antimitotic Agents|antimitotic agents|mesh-ancestor
65309431|NCT00766246|Mitosis Modulators|mitosis modulators|mesh-ancestor
65309432|NCT00766246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309433|NCT00766402|Acetaminophen|acetaminophen|mesh-list
65309434|NCT00766402|Diclofenac|diclofenac|mesh-list
65309435|NCT00766402|Tramadol|tramadol|mesh-list
65309436|NCT00766402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65309437|NCT00766402|Analgesics|analgesics|mesh-ancestor
65309438|NCT00766402|Sensory System Agents|sensory system agents|mesh-ancestor
65309439|NCT00766402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65309440|NCT00766402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309441|NCT00766402|Antipyretics|antipyretics|mesh-ancestor
65309442|NCT00766402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65309443|NCT00766402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65309444|NCT00766402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65309468|NCT00760864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65309469|NCT00760864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65309470|NCT00766480|Fluorouracil|fluorouracil|mesh-list
65309471|NCT00766480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65309472|NCT00766480|Antimetabolites|antimetabolites|mesh-ancestor
65309473|NCT00766480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309474|NCT00766480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65309475|NCT00766480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65309476|NCT00766480|Immunologic Factors|immunologic factors|mesh-ancestor
65309477|NCT00766480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309479|NCT00772174|Pioglitazone|pioglitazone|mesh-list
65309480|NCT00772174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65309482|NCT00772564|Atorvastatin|atorvastatin|mesh-list
65309530|NCT00570778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65309531|NCT00570778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65309532|NCT00570778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65309533|NCT00570778|Cholinergic Agents|cholinergic agents|mesh-ancestor
65309534|NCT00570778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65309535|NCT00570778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309536|NCT00570778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309537|NCT00775372|Clarithromycin|clarithromycin|mesh-list
65309538|NCT00775372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65309539|NCT00775372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65309540|NCT00775372|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65309541|NCT00775372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309542|NCT00775372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309543|NCT00775372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65309589|NCT00773578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65309590|NCT00773578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309591|NCT00773578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65309592|NCT00773578|Respiratory System Agents|respiratory system agents|mesh-ancestor
65309593|NCT00773578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65309594|NCT00773578|Antioxidants|antioxidants|mesh-ancestor
65309595|NCT00773578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309596|NCT00773578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65309601|NCT00775762|Aspirin|aspirin|mesh-list
65309654|NCT00773812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65309655|NCT00773812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309656|NCT00767728|Mesalamine|mesalamine|mesh-list
65309657|NCT00767728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65309658|NCT00767728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65309659|NCT00767728|Analgesics|analgesics|mesh-ancestor
65309660|NCT00767728|Sensory System Agents|sensory system agents|mesh-ancestor
65309661|NCT00767728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65309719|NCT00774280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65309720|NCT00774280|Immunologic Factors|immunologic factors|mesh-ancestor
65309721|NCT00774280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309722|NCT00774280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65309723|NCT00774280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65309724|NCT00774280|Alkylating Agents|alkylating agents|mesh-ancestor
65309725|NCT00774280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309726|NCT00774280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65309727|NCT00774280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65309728|NCT04151147|Mitogens|mitogens|mesh-list
65309729|NCT04151147|Mitosis Modulators|mitosis modulators|mesh-ancestor
65309730|NCT04151147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309782|NCT00774904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65309783|NCT00774904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65309784|NCT00774904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309785|NCT00829296|Metoprolol|metoprolol|mesh-list
65309786|NCT00829296|Nebivolol|nebivolol|mesh-list
65309787|NCT00829296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65309788|NCT00829296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65309789|NCT00829296|Sympatholytics|sympatholytics|mesh-ancestor
65309790|NCT00829296|Autonomic Agents|autonomic agents|mesh-ancestor
65309791|NCT00829296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65309792|NCT00829296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309793|NCT00829296|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65309794|NCT00829296|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65309795|NCT00829296|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65309796|NCT00829296|Adrenergic Agents|adrenergic agents|mesh-ancestor
65309797|NCT00829296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65309798|NCT00829296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309799|NCT00829296|Vasodilator Agents|vasodilator agents|mesh-ancestor
65309800|NCT00829296|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65309801|NCT00829296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65309802|NCT00829296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65309803|NCT00774982|Mercaptopurine|mercaptopurine|mesh-list
65309804|NCT00774982|Antimetabolites|antimetabolites|mesh-ancestor
65309805|NCT00774982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309806|NCT00774982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65309807|NCT00774982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059713|NCT00246701|Antimetabolites|antimetabolites|mesh-ancestor
65309808|NCT00774982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65309809|NCT00774982|Immunologic Factors|immunologic factors|mesh-ancestor
65309810|NCT00774982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309811|NCT00774982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65309812|NCT00774982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309813|NCT00881621|Capecitabine|capecitabine|mesh-list
65309814|NCT00881621|Lapatinib|lapatinib|mesh-list
65309819|NCT00881621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65309820|NCT00881621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309821|NCT00779194|Sirolimus|sirolimus|mesh-list
65309822|NCT00779194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65309823|NCT00779194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65309824|NCT00779194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65309825|NCT00779194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65309826|NCT00779194|Antifungal Agents|antifungal agents|mesh-ancestor
65309827|NCT00779194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65309828|NCT00779194|Immunologic Factors|immunologic factors|mesh-ancestor
65309829|NCT00779194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309830|NCT02634281|Varenicline|varenicline|mesh-list
65309831|NCT02634281|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65309832|NCT02634281|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65309833|NCT02634281|Cholinergic Agents|cholinergic agents|mesh-ancestor
65309834|NCT02634281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64539631|NCT01414855|Cyclophosphamide|cyclophosphamide|mesh-list
65158045|NCT04319705|Azithromycin|azithromycin|mesh-list
65158046|NCT04319705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65158047|NCT04319705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65158048|NCT00906373|Sorafenib|sorafenib|mesh-list
65158049|NCT00906373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65158050|NCT00906373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158051|NCT00906373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65158052|NCT00906373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158053|NCT00906373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158054|NCT00906373|Immunologic Factors|immunologic factors|mesh-ancestor
65158055|NCT00906373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158056|NCT02850445|Olanzapine|olanzapine|mesh-list
65158057|NCT02850445|Antiemetics|antiemetics|mesh-ancestor
65158058|NCT02850445|Autonomic Agents|autonomic agents|mesh-ancestor
65158059|NCT02850445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158060|NCT02850445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158061|NCT02850445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65158062|NCT02850445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65158066|NCT02850445|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65158067|NCT02850445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65158068|NCT02850445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65158069|NCT02850445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158070|NCT02850445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65158071|NCT02850445|Serotonin Agents|serotonin agents|mesh-ancestor
65158072|NCT04220203|Capecitabine|capecitabine|mesh-list
65158073|NCT04220203|Trastuzumab|trastuzumab|mesh-list
65158074|NCT04220203|Tucatinib|tucatinib|mesh-list
65158075|NCT04220203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65158076|NCT04220203|Antimetabolites|antimetabolites|mesh-ancestor
65158077|NCT04220203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158078|NCT04220203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158079|NCT04220203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65158080|NCT04220203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65158081|NCT04220203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158082|NCT02850211|Ibuprofen|ibuprofen|mesh-list
65158083|NCT02850211|Celecoxib|celecoxib|mesh-list
65158084|NCT02850211|Tramadol|tramadol|mesh-list
65158085|NCT02850211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65158086|NCT02850211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65158087|NCT02850211|Analgesics|analgesics|mesh-ancestor
65158088|NCT02850211|Sensory System Agents|sensory system agents|mesh-ancestor
65158089|NCT02850211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158090|NCT02850211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309835|NCT02634281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309836|NCT02634281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309837|NCT00818766|Vancomycin|vancomycin|mesh-list
65309838|NCT00818766|Cefazolin|cefazolin|mesh-list
65309839|NCT00818766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65309840|NCT00818766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65309841|NCT00779350|Sertraline|sertraline|mesh-list
65309842|NCT00779350|Antidepressive Agents|antidepressive agents|mesh-ancestor
65309843|NCT00779350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65309844|NCT00779350|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65309845|NCT00779350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65309846|NCT00779350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65309847|NCT00779350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309848|NCT00779350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65309849|NCT00779350|Serotonin Agents|serotonin agents|mesh-ancestor
65309850|NCT00779350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309851|NCT00705978|Pancreatin|pancreatin|mesh-list
65309852|NCT00705978|Pancrelipase|pancrelipase|mesh-list
65309853|NCT00705978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65158091|NCT02850211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65158092|NCT02850211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65158093|NCT02850211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65158094|NCT02850211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158095|NCT02850211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158096|NCT02850211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65158097|NCT02850211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65158098|NCT02850211|Narcotics|narcotics|mesh-ancestor
65158099|NCT02850211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65158100|NCT03248167|Cannabidiol|cannabidiol|mesh-list
65158101|NCT03248167|Anticonvulsants|anticonvulsants|mesh-ancestor
65158102|NCT02850289|Interferons|interferons|mesh-list
65158103|NCT02850289|Ribavirin|ribavirin|mesh-list
65158104|NCT02850289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158105|NCT02850289|Antiviral Agents|antiviral agents|mesh-ancestor
65158106|NCT02850289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65158107|NCT02850289|Antimetabolites|antimetabolites|mesh-ancestor
65158108|NCT02850289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158109|NCT03217669|Sirolimus|sirolimus|mesh-list
65158110|NCT03217669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65158111|NCT03217669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65158112|NCT03217669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65158113|NCT03217669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158114|NCT03217669|Antifungal Agents|antifungal agents|mesh-ancestor
65158115|NCT03217669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65158116|NCT03217669|Immunologic Factors|immunologic factors|mesh-ancestor
65158117|NCT03217669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158118|NCT05331781|Morphine|morphine|mesh-list
65158119|NCT05331781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65158120|NCT05331781|Narcotics|narcotics|mesh-ancestor
65158121|NCT05331781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65158122|NCT05331781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158123|NCT05331781|Analgesics|analgesics|mesh-ancestor
65158124|NCT05331781|Sensory System Agents|sensory system agents|mesh-ancestor
65158125|NCT05331781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158126|NCT04202887|Fentanyl|fentanyl|mesh-list
65158127|NCT04202887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65158128|NCT04202887|Narcotics|narcotics|mesh-ancestor
65309854|NCT02556970|Acetaminophen|acetaminophen|mesh-list
65309855|NCT02556970|Diclofenac|diclofenac|mesh-list
65309856|NCT02556970|Levobupivacaine|levobupivacaine|mesh-list
65309857|NCT02556970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65309858|NCT02556970|Analgesics|analgesics|mesh-ancestor
65309859|NCT02556970|Sensory System Agents|sensory system agents|mesh-ancestor
65309860|NCT02556970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65309861|NCT02556970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309862|NCT02556970|Antipyretics|antipyretics|mesh-ancestor
65309863|NCT02556970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65309864|NCT02556970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65309865|NCT02556970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65309866|NCT02556970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65158129|NCT04202887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65158130|NCT04202887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158131|NCT04202887|Analgesics|analgesics|mesh-ancestor
65158132|NCT04202887|Sensory System Agents|sensory system agents|mesh-ancestor
65158133|NCT04202887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158134|NCT04202887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65158139|NCT05324215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65158140|NCT05324215|Narcotics|narcotics|mesh-ancestor
65158141|NCT05324215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65158142|NCT05324215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158143|NCT05324215|Analgesics|analgesics|mesh-ancestor
65158144|NCT05324215|Sensory System Agents|sensory system agents|mesh-ancestor
65158145|NCT05324215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158146|NCT05324215|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65158147|NCT05324215|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65158148|NCT05324215|Anesthetics, General|anesthetics, general|mesh-ancestor
65158149|NCT05324215|Anesthetics|anesthetics|mesh-ancestor
65158151|NCT02131753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158152|NCT02131753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65158153|NCT02131753|Immunologic Factors|immunologic factors|mesh-ancestor
65158154|NCT02131753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158155|NCT00905437|Pregabalin|pregabalin|mesh-list
65158156|NCT00905437|Analgesics|analgesics|mesh-ancestor
65158157|NCT00905437|Sensory System Agents|sensory system agents|mesh-ancestor
65158158|NCT00905437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158159|NCT00905437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158160|NCT00905437|Anticonvulsants|anticonvulsants|mesh-ancestor
65158161|NCT00905437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65158162|NCT00905437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65158163|NCT00905437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158164|NCT00905437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65158165|NCT00905437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65158166|NCT00905437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65158167|NCT00905437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65158168|NCT00905437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65158169|NCT05007691|Salicylic Acid|salicylic acid|mesh-list
65158170|NCT05007691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65158171|NCT05007691|Antifungal Agents|antifungal agents|mesh-ancestor
65158172|NCT05007691|Keratolytic Agents|keratolytic agents|mesh-ancestor
65158173|NCT05007691|Dermatologic Agents|dermatologic agents|mesh-ancestor
65158174|NCT01238861|Benralizumab|benralizumab|mesh-list
65158175|NCT01238861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65158176|NCT01238861|Respiratory System Agents|respiratory system agents|mesh-ancestor
65158177|NCT02888561|Dobutamine|dobutamine|mesh-list
65158178|NCT02888561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65158179|NCT02888561|Sympathomimetics|sympathomimetics|mesh-ancestor
65158180|NCT02888561|Autonomic Agents|autonomic agents|mesh-ancestor
65158181|NCT02888561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158182|NCT02888561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158183|NCT02888561|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65309867|NCT02556970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309868|NCT02556970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309869|NCT02556970|Anesthetics, Local|anesthetics, local|mesh-ancestor
65309870|NCT02556970|Anesthetics|anesthetics|mesh-ancestor
65309871|NCT02556970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65309872|NCT00594815|Leucovorin|leucovorin|mesh-list
65309873|NCT00594815|Cytarabine|cytarabine|mesh-list
65309874|NCT00594815|Rituximab|rituximab|mesh-list
65309875|NCT00594815|Methotrexate|methotrexate|mesh-list
65309876|NCT00594815|Vincristine|vincristine|mesh-list
65309877|NCT00594815|Procarbazine|procarbazine|mesh-list
65309878|NCT00594815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65309879|NCT00594815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65309880|NCT00594815|Immunologic Factors|immunologic factors|mesh-ancestor
65309881|NCT00594815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309882|NCT00594815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65309883|NCT00594815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65309884|NCT00594815|Abortifacient Agents|abortifacient agents|mesh-ancestor
65309885|NCT00594815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65158184|NCT02888561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65158185|NCT02888561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65158186|NCT02888561|Adrenergic Agents|adrenergic agents|mesh-ancestor
65158187|NCT02888561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65158188|NCT02888561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158189|NCT02888561|Protective Agents|protective agents|mesh-ancestor
65158190|NCT04319549|Sodium Hypochlorite|sodium hypochlorite|mesh-list
65158191|NCT04319549|Eusol|eusol|mesh-list
65158192|NCT04319549|Ketorolac|ketorolac|mesh-list
65158193|NCT04319549|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65158194|NCT04319549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65158195|NCT04319549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65158196|NCT04319549|Analgesics|analgesics|mesh-ancestor
65158197|NCT04319549|Sensory System Agents|sensory system agents|mesh-ancestor
65158198|NCT04319549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158199|NCT04319549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158200|NCT04319549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65158201|NCT04319549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65158202|NCT04319549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65158203|NCT04319549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158204|NCT04319549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158205|NCT04319549|Disinfectants|disinfectants|mesh-ancestor
65158206|NCT04319549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65158207|NCT00903409|Simvastatin|simvastatin|mesh-list
65158219|NCT01237223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158220|NCT01237223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65158221|NCT01237223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158222|NCT01237223|Vasodilator Agents|vasodilator agents|mesh-ancestor
65158223|NCT01236365|Atorvastatin|atorvastatin|mesh-list
65158224|NCT01236365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65158225|NCT01236365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65158226|NCT01236365|Antimetabolites|antimetabolites|mesh-ancestor
65158227|NCT01236365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158228|NCT01236365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65158229|NCT01236365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65158230|NCT01236365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158232|NCT00903331|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65309886|NCT00594815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65309887|NCT00594815|Antimetabolites|antimetabolites|mesh-ancestor
65309888|NCT00594815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309889|NCT00594815|Dermatologic Agents|dermatologic agents|mesh-ancestor
65309890|NCT00594815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309891|NCT00594815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64539694|NCT01514864|Dasatinib|dasatinib|mesh-list
65158233|NCT00903331|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65158234|NCT00903331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158235|NCT00903331|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65158236|NCT01235741|Pramlintide|pramlintide|mesh-list
65158237|NCT01235741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65158238|NCT01235741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158239|NCT01235507|Methotrexate|methotrexate|mesh-list
65158240|NCT01235507|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65158241|NCT01235507|Abortifacient Agents|abortifacient agents|mesh-ancestor
65158242|NCT01235507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65158243|NCT01235507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158244|NCT01235507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65158245|NCT01235507|Antimetabolites|antimetabolites|mesh-ancestor
65158246|NCT01235507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158247|NCT01235507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158248|NCT01235507|Dermatologic Agents|dermatologic agents|mesh-ancestor
65158249|NCT01235507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158250|NCT01235507|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65158251|NCT01235507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65158252|NCT01235507|Immunologic Factors|immunologic factors|mesh-ancestor
65158253|NCT01235507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65158254|NCT01235507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65158255|NCT01868269|Dexamethasone|dexamethasone|mesh-list
65158256|NCT01868269|Dexamethasone acetate|dexamethasone acetate|mesh-list
65158257|NCT01868269|Cyclophosphamide|cyclophosphamide|mesh-list
65158258|NCT01868269|Rituximab|rituximab|mesh-list
65158259|NCT01868269|BB 1101|bb 1101|mesh-list
65158260|NCT01868269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65158261|NCT01868269|Immunologic Factors|immunologic factors|mesh-ancestor
65158262|NCT01868269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158263|NCT01868269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65158264|NCT01868269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65158265|NCT01868269|Alkylating Agents|alkylating agents|mesh-ancestor
65158266|NCT01868269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158267|NCT01868269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158268|NCT01868269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64954890|NCT00066846|Calcium|calcium|mesh-list
65158272|NCT01868269|Autonomic Agents|autonomic agents|mesh-ancestor
65158273|NCT01868269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158274|NCT01868269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65158275|NCT01868269|Glucocorticoids|glucocorticoids|mesh-ancestor
65158277|NCT01868269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65158278|NCT01868269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65158279|NCT01868269|Protease Inhibitors|protease inhibitors|mesh-ancestor
65158280|NCT01868269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158281|NCT01235351|Clopidogrel|clopidogrel|mesh-list
65158282|NCT01235351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65158283|NCT01235351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65158284|NCT01235351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65158285|NCT01235351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65158286|NCT01235351|Purinergic Agents|purinergic agents|mesh-ancestor
65158287|NCT01235351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65158288|NCT01235351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158289|NCT01235351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158290|NCT01234883|Plasma-lyte 148|plasma-lyte 148|mesh-list
65158291|NCT01234883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65158292|NCT01234883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65158293|NCT01234649|Metformin|metformin|mesh-list
65158294|NCT01234649|Liraglutide|liraglutide|mesh-list
65158295|NCT01234649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65309892|NCT00594815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65309893|NCT00594815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65309894|NCT00594815|Antiviral Agents|antiviral agents|mesh-ancestor
65309895|NCT00594815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65309896|NCT00594815|Antidotes|antidotes|mesh-ancestor
65309897|NCT00594815|Protective Agents|protective agents|mesh-ancestor
65309898|NCT00594815|Vitamin B Complex|vitamin b complex|mesh-ancestor
65309899|NCT00594815|Vitamins|vitamins|mesh-ancestor
65309900|NCT00594815|Micronutrients|micronutrients|mesh-ancestor
65309901|NCT00594815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65309902|NCT00594815|Tubulin Modulators|tubulin modulators|mesh-ancestor
65309903|NCT00594815|Antimitotic Agents|antimitotic agents|mesh-ancestor
65309904|NCT00594815|Mitosis Modulators|mitosis modulators|mesh-ancestor
65309905|NCT00776542|Minocycline|minocycline|mesh-list
65309906|NCT00776542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65158296|NCT01234649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158297|NCT01234649|Incretins|incretins|mesh-ancestor
65158298|NCT01234649|Hormones|hormones|mesh-ancestor
65158299|NCT01234649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65158300|NCT02876679|Cyclosporine|cyclosporine|mesh-list
65158301|NCT02876679|Mycophenolic Acid|mycophenolic acid|mesh-list
65158302|NCT02876679|Cyclophosphamide|cyclophosphamide|mesh-list
65158303|NCT02876679|Cyclosporins|cyclosporins|mesh-list
65158304|NCT02876679|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65158305|NCT02876679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65158306|NCT02876679|Immunologic Factors|immunologic factors|mesh-ancestor
65158307|NCT02876679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158308|NCT02876679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65158309|NCT02876679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65158310|NCT02876679|Alkylating Agents|alkylating agents|mesh-ancestor
65158311|NCT02876679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158312|NCT02876679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158313|NCT02876679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65158314|NCT02876679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158315|NCT02876679|Antifungal Agents|antifungal agents|mesh-ancestor
65158316|NCT02876679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65158317|NCT02876679|Dermatologic Agents|dermatologic agents|mesh-ancestor
65158318|NCT02876679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65158319|NCT02876679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65158320|NCT02876679|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65158321|NCT02876679|Antitubercular Agents|antitubercular agents|mesh-ancestor
65158322|NCT02876679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65158323|NCT01075815|Hormones|hormones|mesh-list
65158324|NCT01075815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65158325|NCT01075815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65158326|NCT01075815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158327|NCT01072149|Fluticasone|fluticasone|mesh-list
65158328|NCT01072149|Xhance|xhance|mesh-list
65158329|NCT01072149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65158330|NCT01072149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65158331|NCT01072149|Autonomic Agents|autonomic agents|mesh-ancestor
65158332|NCT01072149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158333|NCT01072149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158334|NCT01072149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65158335|NCT01072149|Respiratory System Agents|respiratory system agents|mesh-ancestor
65158336|NCT01072149|Dermatologic Agents|dermatologic agents|mesh-ancestor
65158337|NCT01072149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65158338|NCT04413253|Dexamethasone|dexamethasone|mesh-list
65158339|NCT04413253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65158340|NCT04413253|Lifitegrast|lifitegrast|mesh-list
65158346|NCT04413253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158347|NCT04413253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65158348|NCT04413253|Glucocorticoids|glucocorticoids|mesh-ancestor
65309907|NCT00776542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65309908|NCT00776620|Glimepiride|glimepiride|mesh-list
65309909|NCT00776620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65309910|NCT00776620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65309911|NCT00776620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309912|NCT00776620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65309913|NCT00776620|Immunologic Factors|immunologic factors|mesh-ancestor
65309914|NCT00776698|Bevacizumab|bevacizumab|mesh-list
65309915|NCT00776698|Etoposide|etoposide|mesh-list
65309916|NCT00776698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65309917|NCT00776698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65309918|NCT00776698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65158349|NCT04413253|Hormones|hormones|mesh-ancestor
65158350|NCT04413253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65158351|NCT04413253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65158352|NCT04413253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158353|NCT01679119|Gemcitabine|gemcitabine|mesh-list
65158354|NCT01679119|Prednisolone|prednisolone|mesh-list
65158355|NCT01679119|Cyclophosphamide|cyclophosphamide|mesh-list
65158356|NCT01679119|Rituximab|rituximab|mesh-list
65158357|NCT01679119|Vincristine|vincristine|mesh-list
65158358|NCT01679119|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65158359|NCT01679119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65158360|NCT01679119|Immunologic Factors|immunologic factors|mesh-ancestor
65158361|NCT01679119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158362|NCT01679119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65158363|NCT01679119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64800964|NCT03191240|Coagulants|coagulants|mesh-ancestor
65158364|NCT01679119|Alkylating Agents|alkylating agents|mesh-ancestor
65158365|NCT01679119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158366|NCT01679119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158367|NCT01679119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65158368|NCT01679119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65158369|NCT01679119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65158371|NCT01679119|Antiviral Agents|antiviral agents|mesh-ancestor
65158372|NCT01679119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65158373|NCT01679119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158374|NCT01679119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65158375|NCT01679119|Tubulin Modulators|tubulin modulators|mesh-ancestor
65158376|NCT01679119|Antimitotic Agents|antimitotic agents|mesh-ancestor
65158377|NCT01679119|Mitosis Modulators|mitosis modulators|mesh-ancestor
65158378|NCT01679119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65158379|NCT01679119|Glucocorticoids|glucocorticoids|mesh-ancestor
65158380|NCT01679119|Hormones|hormones|mesh-ancestor
65158381|NCT01679119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65158382|NCT01679119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65158383|NCT01679119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65158384|NCT04778787|Dapagliflozin|dapagliflozin|mesh-list
65158385|NCT04778787|Digoxin|digoxin|mesh-list
65158386|NCT04778787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65158387|NCT04778787|Vasodilator Agents|vasodilator agents|mesh-list
65158388|NCT04778787|Diuretics|diuretics|mesh-list
65158389|NCT04778787|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
65158390|NCT04778787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65158391|NCT04778787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158392|NCT04778787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65158393|NCT04778787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158394|NCT04778787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65158395|NCT04778787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65158396|NCT04778787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158397|NCT04778787|Protective Agents|protective agents|mesh-ancestor
65158398|NCT04778787|Natriuretic Agents|natriuretic agents|mesh-ancestor
65158399|NCT04778787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65158400|NCT05263453|Vemurafenib|vemurafenib|mesh-list
65309919|NCT00776698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65309920|NCT00776698|Growth Substances|growth substances|mesh-ancestor
65309921|NCT00776698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309922|NCT00776698|Growth Inhibitors|growth inhibitors|mesh-ancestor
65309923|NCT00776698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65309924|NCT00776698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65309925|NCT00776698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65309926|NCT00776698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309927|NCT00776698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309928|NCT00820248|Panitumumab|panitumumab|mesh-list
65309929|NCT00820248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65309930|NCT00820248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65309931|NCT04150757|Ketamine|ketamine|mesh-list
65158401|NCT05263453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158402|NCT05263453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65158403|NCT05263453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158404|NCT05263453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158405|NCT04304157|Dexmedetomidine|dexmedetomidine|mesh-list
65158406|NCT04304157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65158407|NCT04304157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65158408|NCT04304157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158409|NCT04304157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65158410|NCT04304157|Analgesics|analgesics|mesh-ancestor
65158413|NCT04304157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65158414|NCT04304157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65158415|NCT04304157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65158416|NCT04304157|Adrenergic Agents|adrenergic agents|mesh-ancestor
65158417|NCT04304157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65158418|NCT04304157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158419|NCT04937413|Evolocumab|evolocumab|mesh-list
65158420|NCT04937413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65158421|NCT04937413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65158422|NCT04937413|Antimetabolites|antimetabolites|mesh-ancestor
65158423|NCT04937413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158424|NCT04937413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65158425|NCT02875587|Cabergoline|cabergoline|mesh-list
65158427|NCT02875587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65158428|NCT02875587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158429|NCT02875587|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65158430|NCT02875587|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65158431|NCT02875587|Dopamine Agonists|dopamine agonists|mesh-ancestor
65158432|NCT02875587|Dopamine Agents|dopamine agents|mesh-ancestor
65158433|NCT02875587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65158434|NCT02875587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158435|NCT01070979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65158436|NCT01070979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65158437|NCT01070979|Estradiol|estradiol|mesh-list
65158438|NCT01070979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65158439|NCT01070979|Estrogens|estrogens|mesh-list
65158440|NCT01070979|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65158441|NCT01070979|Hormones|hormones|mesh-ancestor
65158442|NCT01070979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65158443|NCT01070979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158444|NCT01070979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65158445|NCT01070979|Contraceptive Agents|contraceptive agents|mesh-ancestor
65158446|NCT01070979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65158447|NCT01070979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65158448|NCT01234337|Capecitabine|capecitabine|mesh-list
65158449|NCT01234337|Sorafenib|sorafenib|mesh-list
65158450|NCT01234337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65309932|NCT04150757|Analgesics|analgesics|mesh-ancestor
65309933|NCT04150757|Sensory System Agents|sensory system agents|mesh-ancestor
65309934|NCT04150757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65309935|NCT04150757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309936|NCT04150757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65309937|NCT04150757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65309938|NCT04150757|Anesthetics, General|anesthetics, general|mesh-ancestor
65309939|NCT04150757|Anesthetics|anesthetics|mesh-ancestor
65309940|NCT04150757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65309941|NCT04150757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65309942|NCT04150757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65309943|NCT04150757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65309944|NCT04150757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309945|NCT04150289|Panobinostat|panobinostat|mesh-list
65309946|NCT04150289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65309947|NCT04150289|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65309948|NCT04150289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309949|NCT04150289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309950|NCT04150367|Rifampin|rifampin|mesh-list
65309951|NCT04150367|Isoniazid|isoniazid|mesh-list
65158451|NCT01234337|Antimetabolites|antimetabolites|mesh-ancestor
65158452|NCT01234337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158453|NCT01234337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158454|NCT01234337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65158455|NCT01234337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158456|NCT02848963|Ketamine|ketamine|mesh-list
65158457|NCT02848963|Propofol|propofol|mesh-list
65158458|NCT02848963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65158459|NCT02848963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65158460|NCT02848963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158461|NCT02848963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65158462|NCT02848963|Anesthetics, General|anesthetics, general|mesh-ancestor
65158463|NCT02848963|Anesthetics|anesthetics|mesh-ancestor
65158464|NCT02848963|Analgesics|analgesics|mesh-ancestor
65158465|NCT02848963|Sensory System Agents|sensory system agents|mesh-ancestor
65158466|NCT02848963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158467|NCT02848963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65158468|NCT02848963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65158469|NCT02848963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65158470|NCT02848963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65158471|NCT02848963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158472|NCT01070043|Amlodipine|amlodipine|mesh-list
65158473|NCT01070043|Valsartan|valsartan|mesh-list
65158474|NCT01070043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65158475|NCT01070043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65158476|NCT01070043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65158477|NCT01070043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158478|NCT01070043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65158479|NCT01070043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158480|NCT01070043|Vasodilator Agents|vasodilator agents|mesh-ancestor
65158481|NCT01070043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65158482|NCT01070043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65309952|NCT04150367|Ethambutol|ethambutol|mesh-list
65309953|NCT04150367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65309954|NCT04150367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65309955|NCT04150367|Antitubercular Agents|antitubercular agents|mesh-ancestor
65309956|NCT04150367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65309957|NCT04150367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65309958|NCT04150367|Leprostatic Agents|leprostatic agents|mesh-ancestor
65309959|NCT04150367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65309960|NCT04150367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309961|NCT04150367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309962|NCT04150367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65309963|NCT04150367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65309964|NCT04150367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65309965|NCT04150367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65309966|NCT04150367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65309967|NCT04150367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65309968|NCT04150367|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65309969|NCT04150367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65309970|NCT04150367|Antimetabolites|antimetabolites|mesh-ancestor
65309971|NCT04150367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65309972|NCT02634203|Riociguat|riociguat|mesh-list
65309973|NCT02634203|Enzyme Activators|enzyme activators|mesh-ancestor
64539761|NCT01414075|Iron|iron|mesh-list
65158490|NCT01074255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65158491|NCT01074255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158492|NCT02962063|Paclitaxel|paclitaxel|mesh-list
65158493|NCT02962063|Carboplatin|carboplatin|mesh-list
65158494|NCT02962063|Durvalumab|durvalumab|mesh-list
65158495|NCT02962063|Tremelimumab|tremelimumab|mesh-list
65158496|NCT02962063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65158497|NCT02962063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158498|NCT02962063|Tubulin Modulators|tubulin modulators|mesh-ancestor
65158499|NCT02962063|Antimitotic Agents|antimitotic agents|mesh-ancestor
65158500|NCT02962063|Mitosis Modulators|mitosis modulators|mesh-ancestor
65158501|NCT02962063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158502|NCT02962063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65158503|NCT01073943|Bisacodyl|bisacodyl|mesh-list
65158504|NCT01073943|Picosulfate sodium|picosulfate sodium|mesh-list
65158505|NCT01073943|Cathartics|cathartics|mesh-ancestor
65158506|NCT01073943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65158507|NCT01073943|Laxatives|laxatives|mesh-ancestor
65158508|NCT01073865|Goserelin|goserelin|mesh-list
65158509|NCT01073865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65158510|NCT01073865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158511|NCT04899583|Sirolimus|sirolimus|mesh-list
65158512|NCT04899583|Paclitaxel|paclitaxel|mesh-list
65158513|NCT04899583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65158514|NCT04899583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158515|NCT04899583|Tubulin Modulators|tubulin modulators|mesh-ancestor
65158516|NCT04899583|Antimitotic Agents|antimitotic agents|mesh-ancestor
65158517|NCT04899583|Mitosis Modulators|mitosis modulators|mesh-ancestor
65158518|NCT04899583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309974|NCT02634203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309975|NCT00681005|Rabeprazole|rabeprazole|mesh-list
65309976|NCT00681005|Pantoprazole|pantoprazole|mesh-list
65309977|NCT00681005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65309978|NCT00681005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65309979|NCT00681005|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65309980|NCT00681005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309981|NCT00681005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309982|NCT02633969|Indomethacin|indomethacin|mesh-list
65309983|NCT02633969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65309984|NCT02633969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65309985|NCT02633969|Analgesics|analgesics|mesh-ancestor
65309986|NCT02633969|Sensory System Agents|sensory system agents|mesh-ancestor
65309987|NCT02633969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65309988|NCT02633969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309989|NCT02633969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65158519|NCT04899583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65158520|NCT04899583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65158521|NCT04899583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65158522|NCT04899583|Antifungal Agents|antifungal agents|mesh-ancestor
65158523|NCT04899583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65158524|NCT04899583|Immunologic Factors|immunologic factors|mesh-ancestor
65158525|NCT04899583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158526|NCT04862065|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
65158527|NCT04862065|Immunologic Factors|immunologic factors|mesh-ancestor
65158528|NCT04862065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158529|NCT01064635|Letrozole|letrozole|mesh-list
65158530|NCT01064635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158531|NCT01064635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65158532|NCT01064635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65158533|NCT01064635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158534|NCT01064635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158535|NCT01064635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65158536|NCT01064635|Hormone Antagonists|hormone antagonists|mesh-ancestor
65158537|NCT01064635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65158538|NCT01064635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158539|NCT04697485|Eplerenone|eplerenone|mesh-list
65158540|NCT04697485|Bumetanide|bumetanide|mesh-list
65158541|NCT04697485|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65158542|NCT04697485|Hormone Antagonists|hormone antagonists|mesh-ancestor
65158543|NCT04697485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65158544|NCT04697485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158545|NCT04697485|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65158546|NCT04697485|Diuretics|diuretics|mesh-ancestor
65158547|NCT04697485|Natriuretic Agents|natriuretic agents|mesh-ancestor
65158548|NCT04697485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65158549|NCT04697485|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64955168|NCT03338621|Antimetabolites|antimetabolites|mesh-ancestor
65158559|NCT01073631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65158560|NCT01073631|Hormone Antagonists|hormone antagonists|mesh-ancestor
65158561|NCT01073631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65158562|NCT01073631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158563|NCT01073631|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65158565|NCT00626769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65158566|NCT00626769|Protective Agents|protective agents|mesh-ancestor
65158567|NCT00626769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65309990|NCT02633969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65309991|NCT02633969|Gout Suppressants|gout suppressants|mesh-ancestor
65309992|NCT02633969|Tocolytic Agents|tocolytic agents|mesh-ancestor
65309993|NCT02633969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65309994|NCT02633969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65309995|NCT02633969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65309996|NCT02633969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65309997|NCT00684827|Albuterol|albuterol|mesh-list
65309998|NCT00684827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65309999|NCT00684827|Autonomic Agents|autonomic agents|mesh-ancestor
65310000|NCT00684827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65310001|NCT00684827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310002|NCT00684827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65310003|NCT00684827|Respiratory System Agents|respiratory system agents|mesh-ancestor
65310004|NCT00684827|Tocolytic Agents|tocolytic agents|mesh-ancestor
65158568|NCT00626769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158569|NCT00626769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65158570|NCT00626769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158571|NCT00626769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158572|NCT00626769|Phytoestrogens|phytoestrogens|mesh-ancestor
65158573|NCT00626769|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65158574|NCT00626769|Estrogens|estrogens|mesh-ancestor
65158575|NCT00626769|Hormones|hormones|mesh-ancestor
65158576|NCT00626769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65158577|NCT02875743|Posaconazole|posaconazole|mesh-list
65158578|NCT02875743|Antifungal Agents|antifungal agents|mesh-ancestor
65158579|NCT02875743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65158580|NCT02875743|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65158581|NCT02875743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65158582|NCT02875743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65158583|NCT02875743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65158584|NCT02875743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65158585|NCT02875743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801196|NCT02745535|Sofosbuvir|sofosbuvir|mesh-list
65158586|NCT02875743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158587|NCT02875743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65158588|NCT02875743|Hormone Antagonists|hormone antagonists|mesh-ancestor
65158589|NCT02875743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65158590|NCT02875743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158591|NCT01073163|Rituximab|rituximab|mesh-list
65158592|NCT01073163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65158593|NCT01073163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65158594|NCT01073163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158595|NCT01073163|Immunologic Factors|immunologic factors|mesh-ancestor
65158596|NCT01073163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158597|NCT01073163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65158598|NCT01073163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65158599|NCT01073163|Alkylating Agents|alkylating agents|mesh-ancestor
65158600|NCT01073163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158601|NCT02875821|Metformin|metformin|mesh-list
65158602|NCT02875821|Pioglitazone|pioglitazone|mesh-list
65158603|NCT02875821|Ipragliflozin|ipragliflozin|mesh-list
65158604|NCT02875821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65158605|NCT02875821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158606|NCT02875821|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65158607|NCT02875821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158608|NCT04304313|Sildenafil Citrate|sildenafil citrate|mesh-list
65158609|NCT04304313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310005|NCT00684827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65310006|NCT00684827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65310007|NCT00684827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65310008|NCT00684827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65310009|NCT00684827|Adrenergic Agents|adrenergic agents|mesh-ancestor
65310010|NCT00684827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65310011|NCT00684827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310012|NCT00820170|Paclitaxel|paclitaxel|mesh-list
65310013|NCT00820170|Dasatinib|dasatinib|mesh-list
65310014|NCT00820170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65310015|NCT00820170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310016|NCT00820170|Tubulin Modulators|tubulin modulators|mesh-ancestor
65310017|NCT00820170|Antimitotic Agents|antimitotic agents|mesh-ancestor
65310018|NCT00820170|Mitosis Modulators|mitosis modulators|mesh-ancestor
65310019|NCT00820170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310020|NCT00820170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65310021|NCT00820170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310022|NCT02627027|Metformin|metformin|mesh-list
65310023|NCT02627027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65310024|NCT02627027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310025|NCT00709332|Folic Acid|folic acid|mesh-list
65310026|NCT00709332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65310027|NCT00709332|Norgestimate|norgestimate|mesh-list
65310028|NCT00709332|Estradiol|estradiol|mesh-list
64539816|NCT01435577|Tapentadol|tapentadol|mesh-list
65158610|NCT04304313|Vasodilator Agents|vasodilator agents|mesh-ancestor
65158615|NCT01072929|Modafinil|modafinil|mesh-list
65158616|NCT01072929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65158617|NCT01072929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158618|NCT01072929|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65158619|NCT01072929|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65158620|NCT01072929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65158621|NCT01072929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158622|NCT04753749|Aspirin|aspirin|mesh-list
65158623|NCT04753749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65158624|NCT04753749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65158625|NCT04753749|Analgesics|analgesics|mesh-ancestor
65158626|NCT04753749|Sensory System Agents|sensory system agents|mesh-ancestor
64692083|NCT02059070|Bupivacaine|bupivacaine|mesh-list
65158627|NCT04753749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158628|NCT04753749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158629|NCT04753749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65158630|NCT04753749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65158631|NCT04753749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65158632|NCT04753749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65158633|NCT04753749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158634|NCT04753749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65158635|NCT04753749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65158636|NCT04753749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158638|NCT04305015|Analgesics, Opioid|analgesics, opioid|mesh-list
65158639|NCT04305015|Narcotics|narcotics|mesh-ancestor
65310029|NCT00709332|Estrogens|estrogens|mesh-ancestor
65310030|NCT00709332|Hormones|hormones|mesh-ancestor
65310031|NCT00709332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65310032|NCT00709332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310033|NCT00709332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65310034|NCT00709332|Contraceptive Agents|contraceptive agents|mesh-ancestor
65310035|NCT00709332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65310036|NCT00709332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65310037|NCT00709332|Hematinics|hematinics|mesh-ancestor
65310039|NCT00709332|Vitamins|vitamins|mesh-ancestor
65310040|NCT00709332|Micronutrients|micronutrients|mesh-ancestor
65310041|NCT00709332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65310042|NCT00709332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65310043|NCT00709332|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65310044|NCT00684905|Leuprolide|leuprolide|mesh-list
65158640|NCT04305015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65158641|NCT04305015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158642|NCT04305015|Analgesics|analgesics|mesh-ancestor
65158643|NCT04305015|Sensory System Agents|sensory system agents|mesh-ancestor
65158644|NCT04305015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158645|NCT01231607|Finasteride|finasteride|mesh-list
65158646|NCT01231607|Dutasteride|dutasteride|mesh-list
65158647|NCT01231607|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65158648|NCT01231607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65158649|NCT01231607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158650|NCT01231607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158651|NCT01231607|Hormone Antagonists|hormone antagonists|mesh-ancestor
65158652|NCT01231607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65158653|NCT01231607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158654|NCT01231607|Urological Agents|urological agents|mesh-ancestor
65158655|NCT01231373|Polidocanol|polidocanol|mesh-list
65158656|NCT01231373|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65158657|NCT01231373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65158658|NCT00975130|Golimumab|golimumab|mesh-list
65158659|NCT00975130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65158660|NCT00975130|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65158661|NCT00975130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65158662|NCT00975130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65158663|NCT00975130|Immunologic Factors|immunologic factors|mesh-ancestor
65158664|NCT00975130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158665|NCT01230827|Golimumab|golimumab|mesh-list
65158666|NCT01230827|Methotrexate|methotrexate|mesh-list
65158667|NCT01230827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65158668|NCT01230827|Abortifacient Agents|abortifacient agents|mesh-ancestor
65158669|NCT01230827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65158670|NCT01230827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158671|NCT01230827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65158672|NCT01230827|Antimetabolites|antimetabolites|mesh-ancestor
65158673|NCT01230827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158674|NCT01230827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158675|NCT01230827|Dermatologic Agents|dermatologic agents|mesh-ancestor
65158676|NCT01230827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158677|NCT01230827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65158678|NCT01230827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65158679|NCT01230827|Immunologic Factors|immunologic factors|mesh-ancestor
65158680|NCT01230827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65158685|NCT01230749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65158686|NCT01230749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158687|NCT00903175|Everolimus|everolimus|mesh-list
65158688|NCT00903175|Sunitinib|sunitinib|mesh-list
65310045|NCT00684905|Bicalutamide|bicalutamide|mesh-list
65310046|NCT00684905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65310047|NCT00684905|Fertility Agents|fertility agents|mesh-ancestor
65310048|NCT00684905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65310049|NCT00684905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310050|NCT00684905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65310051|NCT00684905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310052|NCT00684905|Androgen Antagonists|androgen antagonists|mesh-ancestor
65310053|NCT00684905|Hormone Antagonists|hormone antagonists|mesh-ancestor
65310054|NCT00684905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65310055|NCT00685061|Alemtuzumab|alemtuzumab|mesh-list
65310056|NCT00685061|Thymoglobulin|thymoglobulin|mesh-list
65310057|NCT00685061|Daclizumab|daclizumab|mesh-list
65310058|NCT00685061|Immunologic Factors|immunologic factors|mesh-ancestor
65310059|NCT00685061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310060|NCT00685061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64539840|NCT01411891|Disinfectants|disinfectants|mesh-ancestor
65158689|NCT00903175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158690|NCT00903175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65158691|NCT00903175|Immunologic Factors|immunologic factors|mesh-ancestor
65158692|NCT00903175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158693|NCT00903175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65158694|NCT00903175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65158695|NCT00903175|Growth Substances|growth substances|mesh-ancestor
65158696|NCT00903175|Growth Inhibitors|growth inhibitors|mesh-ancestor
65158697|NCT00903175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65158698|NCT00903175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158699|NCT00903175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158700|NCT01229735|Topiramate|topiramate|mesh-list
65158701|NCT01229735|Levetiracetam|levetiracetam|mesh-list
65158702|NCT01229735|Anticonvulsants|anticonvulsants|mesh-ancestor
65158703|NCT01229735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65158704|NCT01229735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158705|NCT01229735|Nootropic Agents|nootropic agents|mesh-ancestor
65158706|NCT03866200|Resveratrol|resveratrol|mesh-list
65158707|NCT03866200|Antioxidants|antioxidants|mesh-ancestor
65158708|NCT03866200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158709|NCT03866200|Protective Agents|protective agents|mesh-ancestor
65158710|NCT03866200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158711|NCT03866200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158712|NCT03866200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65158713|NCT02848183|Cytarabine|cytarabine|mesh-list
65158714|NCT02848183|Etoposide|etoposide|mesh-list
65158715|NCT02848183|Mitoxantrone|mitoxantrone|mesh-list
65158716|NCT02848183|Idarubicin|idarubicin|mesh-list
65158717|NCT02848183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65158718|NCT02848183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158719|NCT02848183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65158720|NCT02848183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65158721|NCT02848183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158722|NCT02848183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158723|NCT02848183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65158724|NCT02848183|Antimetabolites|antimetabolites|mesh-ancestor
65158725|NCT02848183|Antiviral Agents|antiviral agents|mesh-ancestor
65158726|NCT02848183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65158727|NCT02848183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65158728|NCT02848183|Immunologic Factors|immunologic factors|mesh-ancestor
65158729|NCT02848183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158730|NCT02848183|Analgesics|analgesics|mesh-ancestor
65158731|NCT02848183|Sensory System Agents|sensory system agents|mesh-ancestor
65310061|NCT00685061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65310062|NCT00685061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310063|NCT02633813|Naftifine|naftifine|mesh-list
65310064|NCT02633813|Antifungal Agents|antifungal agents|mesh-ancestor
65310065|NCT02633813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65310066|NCT00818454|Albuterol|albuterol|mesh-list
65310067|NCT00818454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65310068|NCT00818454|Autonomic Agents|autonomic agents|mesh-ancestor
65310069|NCT00818454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158732|NCT02848183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158733|NCT02848183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65158734|NCT00974974|Levodopa|levodopa|mesh-list
65158735|NCT00974974|Carbidopa|carbidopa|mesh-list
65158736|NCT00974974|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65158737|NCT00974974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65158738|NCT00974974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65158739|NCT00974974|Dopamine Agents|dopamine agents|mesh-ancestor
65158740|NCT00974974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65158741|NCT00974974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158742|NCT00974974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158743|NCT00974974|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65158744|NCT00974974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158745|NCT00974974|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65158746|NCT00974974|Immunologic Factors|immunologic factors|mesh-ancestor
65158747|NCT00974974|Dopamine Agonists|dopamine agonists|mesh-ancestor
65158748|NCT02848417|Curcumin|curcumin|mesh-list
65158749|NCT02848417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65158750|NCT02848417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65158751|NCT02848417|Analgesics|analgesics|mesh-ancestor
65158752|NCT02848417|Sensory System Agents|sensory system agents|mesh-ancestor
65158766|NCT02847403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65158767|NCT02848339|Aspirin|aspirin|mesh-list
65158768|NCT02848339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65158769|NCT02848339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65158770|NCT02848339|Analgesics|analgesics|mesh-ancestor
65158771|NCT02848339|Sensory System Agents|sensory system agents|mesh-ancestor
65158772|NCT02848339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158773|NCT02848339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158774|NCT02848339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65158775|NCT02848339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65158776|NCT02848339|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65158777|NCT02848339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65158778|NCT02848339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158779|NCT02848339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65158780|NCT02848339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65158781|NCT02848339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158782|NCT02848339|Antipyretics|antipyretics|mesh-ancestor
65158783|NCT02847481|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65158784|NCT02847481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65158785|NCT02847481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65158786|NCT02847481|Antitubercular Agents|antitubercular agents|mesh-ancestor
65158787|NCT04216303|Chrysarobin|chrysarobin|mesh-list
65158788|NCT04216303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65158789|NCT04216303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65158790|NCT04216303|Analgesics|analgesics|mesh-ancestor
65158791|NCT04216303|Sensory System Agents|sensory system agents|mesh-ancestor
65158792|NCT04216303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158793|NCT04216303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158794|NCT04216303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65158795|NCT04216303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65158796|NCT02847013|Bupivacaine|bupivacaine|mesh-list
65158797|NCT02847013|Anesthetics, Local|anesthetics, local|mesh-ancestor
65158798|NCT02847013|Anesthetics|anesthetics|mesh-ancestor
65158799|NCT02847013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65158800|NCT02847013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158801|NCT02847013|Sensory System Agents|sensory system agents|mesh-ancestor
65310070|NCT00818454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310071|NCT00818454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65310072|NCT00818454|Respiratory System Agents|respiratory system agents|mesh-ancestor
65310073|NCT00818454|Tocolytic Agents|tocolytic agents|mesh-ancestor
65310074|NCT00818454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65310075|NCT00818454|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65310076|NCT00818454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65310077|NCT00818454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65310078|NCT00818454|Adrenergic Agents|adrenergic agents|mesh-ancestor
65310079|NCT00818454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65310080|NCT00818454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158802|NCT02847013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158803|NCT02847091|Ipragliflozin|ipragliflozin|mesh-list
65158804|NCT02847091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65158805|NCT02847091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158806|NCT02847091|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65158807|NCT02847091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158808|NCT02846935|Decitabine|decitabine|mesh-list
65158809|NCT02846935|Tetrahydrouridine|tetrahydrouridine|mesh-list
65158810|NCT02846935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65158811|NCT02846935|Antimetabolites|antimetabolites|mesh-ancestor
65158812|NCT02846935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503520|NCT02378298|Antiemetics|antiemetics|mesh-ancestor
65158818|NCT02844673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158819|NCT02844673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158820|NCT02844673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65158821|NCT00992992|Tositumomab I-131|tositumomab i-131|mesh-list
65158822|NCT00992992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158823|NCT04201951|Tranexamic Acid|tranexamic acid|mesh-list
65158824|NCT04201951|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65158825|NCT04201951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65158826|NCT04201951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158827|NCT04201951|Hemostatics|hemostatics|mesh-ancestor
65158828|NCT04201951|Coagulants|coagulants|mesh-ancestor
65158829|NCT04753723|Gentamicins|gentamicins|mesh-list
65158830|NCT04753723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65158831|NCT04753723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65158832|NCT04753723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65158833|NCT04753723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158834|NCT04753723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158835|NCT04751851|Oxymetazoline|oxymetazoline|mesh-list
65158836|NCT04751851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65158837|NCT04751851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65158838|NCT04751851|Adrenergic Agents|adrenergic agents|mesh-ancestor
65158839|NCT04751851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65158840|NCT04751851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158841|NCT04751851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158842|NCT04751851|Sympathomimetics|sympathomimetics|mesh-ancestor
65158843|NCT04751851|Autonomic Agents|autonomic agents|mesh-ancestor
65158844|NCT04751851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158845|NCT04751851|Nasal Decongestants|nasal decongestants|mesh-ancestor
65158846|NCT04751851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65158847|NCT04751851|Respiratory System Agents|respiratory system agents|mesh-ancestor
65158848|NCT02844517|Pancrelipase|pancrelipase|mesh-list
65158849|NCT02844517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65158850|NCT03901729|Furosemide|furosemide|mesh-list
65158851|NCT03901729|Diuretics|diuretics|mesh-ancestor
65158852|NCT03901729|Natriuretic Agents|natriuretic agents|mesh-ancestor
65158853|NCT03901729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158854|NCT03901729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65158855|NCT03901729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65310081|NCT02626247|Vitamin A|vitamin a|mesh-list
65310082|NCT02626247|Vitamins|vitamins|mesh-ancestor
65310083|NCT02626247|Micronutrients|micronutrients|mesh-ancestor
65310084|NCT02626247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310085|NCT05758818|Moxifloxacin|moxifloxacin|mesh-list
65310086|NCT05758818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65310087|NCT05758818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65310088|NCT05758818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65310089|NCT05758818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65310090|NCT05758818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310091|NCT05758818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310092|NCT05758818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310093|NCT00828984|Laxatives|laxatives|mesh-list
65310094|NCT00828984|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65310095|NCT00828984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65310096|NCT00819390|Chloroquine|chloroquine|mesh-list
65310097|NCT00819390|Amebicides|amebicides|mesh-ancestor
65310098|NCT00819390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65310099|NCT00819390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65310100|NCT00819390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65310101|NCT00819390|Antimalarials|antimalarials|mesh-ancestor
65310102|NCT00819390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65310103|NCT00876395|Paclitaxel|paclitaxel|mesh-list
65158856|NCT03901729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158857|NCT02846857|Insulin|insulin|mesh-list
65158858|NCT02846857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65158859|NCT02846857|Glucagon|glucagon|mesh-list
65158860|NCT02846857|Hormones|hormones|mesh-list
65158861|NCT02846857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65158862|NCT02846857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158863|NCT02846857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65158864|NCT02846857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65158865|NCT04672525|Rifampin|rifampin|mesh-list
65158866|NCT04672525|Rifabutin|rifabutin|mesh-list
65158867|NCT04672525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65158868|NCT04672525|Antitubercular Agents|antitubercular agents|mesh-ancestor
65158869|NCT04672525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65158870|NCT04672525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65158871|NCT04672525|Leprostatic Agents|leprostatic agents|mesh-ancestor
65158872|NCT04672525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65158873|NCT04672525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158874|NCT04672525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158875|NCT04672525|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65158876|NCT04672525|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65158877|NCT04672525|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65158878|NCT04672525|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65158879|NCT04672525|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65158880|NCT04672525|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65158881|NCT00992446|Cytarabine|cytarabine|mesh-list
65158882|NCT00992446|Rituximab|rituximab|mesh-list
65158896|NCT00992446|Immunologic Factors|immunologic factors|mesh-ancestor
65158897|NCT00992446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158898|NCT00992446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158899|NCT00992446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65158900|NCT00992446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64539892|NCT01544114|Sensory System Agents|sensory system agents|mesh-ancestor
65310104|NCT00876395|Trastuzumab|trastuzumab|mesh-list
65310105|NCT00876395|Everolimus|everolimus|mesh-list
65310106|NCT00876395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65310107|NCT00876395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310108|NCT00876395|Tubulin Modulators|tubulin modulators|mesh-ancestor
65310109|NCT00876395|Antimitotic Agents|antimitotic agents|mesh-ancestor
65310110|NCT00876395|Mitosis Modulators|mitosis modulators|mesh-ancestor
65310111|NCT00876395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310112|NCT00876395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65310113|NCT00876395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65310114|NCT00876395|Immunologic Factors|immunologic factors|mesh-ancestor
65310115|NCT00876395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310117|NCT05758662|Fluorides|fluorides|mesh-list
65310118|NCT05758662|Sodium Fluoride|sodium fluoride|mesh-list
65310119|NCT05758662|Cariostatic Agents|cariostatic agents|mesh-ancestor
65310120|NCT05758662|Protective Agents|protective agents|mesh-ancestor
65310121|NCT05758662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539899|NCT01410799|Hormones|hormones|mesh-list
65158901|NCT00992446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65158902|NCT00992446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65158903|NCT00992446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158904|NCT00992446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158905|NCT00992446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65158906|NCT00992446|Antimetabolites|antimetabolites|mesh-ancestor
65158907|NCT00992446|Antiviral Agents|antiviral agents|mesh-ancestor
65158908|NCT00992446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65158909|NCT00992446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65158910|NCT00992446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65158911|NCT00992446|Alkylating Agents|alkylating agents|mesh-ancestor
65158912|NCT00992446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65158913|NCT00992446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65158914|NCT00992446|Keratolytic Agents|keratolytic agents|mesh-ancestor
65158915|NCT00992446|Dermatologic Agents|dermatologic agents|mesh-ancestor
65158916|NCT00992446|Tubulin Modulators|tubulin modulators|mesh-ancestor
65158917|NCT00992446|Antimitotic Agents|antimitotic agents|mesh-ancestor
65158918|NCT00992446|Mitosis Modulators|mitosis modulators|mesh-ancestor
65158919|NCT04452565|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65158920|NCT04452565|Dexamethasone|dexamethasone|mesh-list
65158921|NCT04452565|Dexamethasone acetate|dexamethasone acetate|mesh-list
65158922|NCT04452565|BB 1101|bb 1101|mesh-list
65158923|NCT04452565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65158924|NCT04452565|Antiemetics|antiemetics|mesh-ancestor
65158925|NCT04452565|Autonomic Agents|autonomic agents|mesh-ancestor
65158926|NCT04452565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158927|NCT04452565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158928|NCT04452565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65158929|NCT04452565|Glucocorticoids|glucocorticoids|mesh-ancestor
65158930|NCT04452565|Hormones|hormones|mesh-ancestor
65158931|NCT04452565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65158932|NCT04452565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65158933|NCT04452565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158934|NCT04452565|Protease Inhibitors|protease inhibitors|mesh-ancestor
65158935|NCT04452565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158936|NCT04452565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158937|NCT04452565|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65158938|NCT04452565|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65310122|NCT05758662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65310123|NCT05758662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65310124|NCT02633657|Gabapentin|gabapentin|mesh-list
65310125|NCT02633657|Analgesics|analgesics|mesh-ancestor
65310126|NCT02633657|Sensory System Agents|sensory system agents|mesh-ancestor
65310127|NCT02633657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65310128|NCT02633657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310129|NCT02633657|Anticonvulsants|anticonvulsants|mesh-ancestor
65310130|NCT02633657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65310131|NCT02633657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64539909|NCT04046263|Ferric Compounds|ferric compounds|mesh-list
65158939|NCT04452565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65158940|NCT04452565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65158941|NCT04452565|Antiviral Agents|antiviral agents|mesh-ancestor
65158942|NCT04452565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65158943|NCT02863120|Bupivacaine|bupivacaine|mesh-list
65158944|NCT02863120|Ropivacaine|ropivacaine|mesh-list
65158945|NCT02863120|Anesthetics, Local|anesthetics, local|mesh-ancestor
65158946|NCT02863120|Anesthetics|anesthetics|mesh-ancestor
65158947|NCT02863120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65158948|NCT02863120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503654|NCT01650298|Thrombin|thrombin|mesh-list
65158954|NCT03823534|Morphine|morphine|mesh-list
65158955|NCT03823534|Oxycodone|oxycodone|mesh-list
65158956|NCT03823534|Hydrocodone|hydrocodone|mesh-list
65158957|NCT03823534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64801578|NCT01729754|Etanercept|etanercept|mesh-list
65158958|NCT03823534|Narcotics|narcotics|mesh-ancestor
65158959|NCT03823534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65158960|NCT03823534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158961|NCT03823534|Analgesics|analgesics|mesh-ancestor
65158962|NCT03823534|Sensory System Agents|sensory system agents|mesh-ancestor
65158963|NCT03823534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158964|NCT03823534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65158965|NCT03823534|Antipyretics|antipyretics|mesh-ancestor
65158966|NCT03823534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65158967|NCT03823534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65158968|NCT03823534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65158969|NCT03823534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65158970|NCT03823534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158971|NCT03823534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158972|NCT03823534|Antitussive Agents|antitussive agents|mesh-ancestor
65158973|NCT03823534|Respiratory System Agents|respiratory system agents|mesh-ancestor
65158974|NCT02846701|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65158975|NCT02846701|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65158976|NCT02846701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65158977|NCT02846701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65158978|NCT02846701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158979|NCT02846701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65158980|NCT02846701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158981|NCT02846701|Analgesics|analgesics|mesh-ancestor
65158982|NCT02846701|Sensory System Agents|sensory system agents|mesh-ancestor
65158983|NCT02846701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158984|NCT02846701|Antidepressive Agents|antidepressive agents|mesh-ancestor
65158985|NCT02846701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65158986|NCT02846701|Dopamine Agents|dopamine agents|mesh-ancestor
65158987|NCT04327063|Ropivacaine|ropivacaine|mesh-list
65158988|NCT04327063|Anesthetics, Local|anesthetics, local|mesh-ancestor
65158989|NCT04327063|Anesthetics|anesthetics|mesh-ancestor
65158990|NCT04327063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65158991|NCT04327063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158992|NCT04327063|Sensory System Agents|sensory system agents|mesh-ancestor
65158993|NCT04327063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158994|NCT04565431|Natalizumab|natalizumab|mesh-list
65158995|NCT04565431|Immunologic Factors|immunologic factors|mesh-ancestor
65158996|NCT04565431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310132|NCT02633657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65310133|NCT02633657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65310134|NCT02633657|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65310135|NCT02633657|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65310136|NCT02633657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65310137|NCT02633657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310138|NCT02633657|Antimanic Agents|antimanic agents|mesh-ancestor
65310139|NCT02626169|Clopidogrel|clopidogrel|mesh-list
65310140|NCT02626169|Ticagrelor|ticagrelor|mesh-list
65310141|NCT02626169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65310142|NCT02626169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65310143|NCT02626169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65310144|NCT02626169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65310145|NCT02626169|Purinergic Agents|purinergic agents|mesh-ancestor
65158997|NCT04292704|Clotrimazole|clotrimazole|mesh-list
65158998|NCT04292704|Miconazole|miconazole|mesh-list
65158999|NCT04292704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65159000|NCT04292704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65159001|NCT04292704|Antifungal Agents|antifungal agents|mesh-ancestor
65159002|NCT04292704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65159003|NCT04292704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65159004|NCT04292704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159005|NCT04292704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159006|NCT04292704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65159007|NCT04292704|Hormone Antagonists|hormone antagonists|mesh-ancestor
65159008|NCT04292704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65159009|NCT04292704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159010|NCT04292704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65159011|NCT04292704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65159012|NCT05242783|Terlipressin|terlipressin|mesh-list
65159013|NCT05242783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65159014|NCT05242783|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65159015|NCT04191421|Spartalizumab|spartalizumab|mesh-list
65159016|NCT04191421|Siltuximab|siltuximab|mesh-list
65159019|NCT04191421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159020|NCT03987685|Topotecan|topotecan|mesh-list
65159021|NCT03987685|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65159022|NCT03987685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65159023|NCT03987685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159024|NCT03987685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159025|NCT03987685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159026|NCT00900757|Palonosetron|palonosetron|mesh-list
65159027|NCT00900757|Antiemetics|antiemetics|mesh-ancestor
65159028|NCT00900757|Autonomic Agents|autonomic agents|mesh-ancestor
65159029|NCT00900757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65159030|NCT00900757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159031|NCT00900757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65159032|NCT00900757|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64801658|NCT01360593|Gemcitabine|gemcitabine|mesh-list
65159033|NCT00900757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65159035|NCT00900757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65159036|NCT00900757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159037|NCT03733132|Metformin|metformin|mesh-list
65159038|NCT03733132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65159039|NCT03733132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159040|NCT04136743|Dexamethasone|dexamethasone|mesh-list
65159041|NCT04136743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65159042|NCT04136743|Antiemetics|antiemetics|mesh-ancestor
65159043|NCT04136743|Autonomic Agents|autonomic agents|mesh-ancestor
65310146|NCT02626169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65310147|NCT02626169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310148|NCT02626169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310149|NCT04139915|Dactolisib|dactolisib|mesh-list
65310150|NCT04139915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310151|NCT04148183|Metformin|metformin|mesh-list
65310152|NCT04148183|Rosiglitazone|rosiglitazone|mesh-list
65310153|NCT04148183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65310154|NCT04148183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310155|NCT00681395|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65310156|NCT00681395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65310157|NCT00681395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65310158|NCT00681395|Antimetabolites|antimetabolites|mesh-ancestor
65310159|NCT00681395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310160|NCT00681395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65310161|NCT00681395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65310162|NCT00681395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310163|NCT02633579|Erythromycin|erythromycin|mesh-list
65310164|NCT02633579|Erythromycin Estolate|erythromycin estolate|mesh-list
65310165|NCT02633579|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65310166|NCT02633579|Erythromycin stearate|erythromycin stearate|mesh-list
65310167|NCT02633579|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
65310168|NCT02633579|Atropine|atropine|mesh-list
65310169|NCT02633579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65310170|NCT02633579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65310171|NCT02633579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65310172|NCT02633579|Autonomic Agents|autonomic agents|mesh-ancestor
64975692|NCT00251017|Vancomycin|vancomycin|mesh-list
65159044|NCT04136743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65159045|NCT04136743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159046|NCT04136743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65159047|NCT04136743|Glucocorticoids|glucocorticoids|mesh-ancestor
65159048|NCT04136743|Hormones|hormones|mesh-ancestor
65159049|NCT04136743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65159050|NCT04136743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65159051|NCT04136743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159052|NCT03931057|Midazolam|midazolam|mesh-list
65159053|NCT03931057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65159054|NCT03931057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65159055|NCT03931057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65159056|NCT03931057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159057|NCT03931057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65159058|NCT03931057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65159059|NCT03931057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65159060|NCT03931057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65159061|NCT03931057|Anesthetics, General|anesthetics, general|mesh-ancestor
65159062|NCT03931057|Anesthetics|anesthetics|mesh-ancestor
65159063|NCT03931057|GABA Modulators|gaba modulators|mesh-ancestor
65310173|NCT02633579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65310174|NCT02633579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310175|NCT02633579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65310176|NCT02633579|Respiratory System Agents|respiratory system agents|mesh-ancestor
65310177|NCT02633579|Mydriatics|mydriatics|mesh-ancestor
65310178|NCT02633579|Parasympatholytics|parasympatholytics|mesh-ancestor
65310179|NCT02633579|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64975709|NCT00100074|Autonomic Agents|autonomic agents|mesh-ancestor
65159064|NCT03931057|GABA Agents|gaba agents|mesh-ancestor
65159065|NCT03931057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65159066|NCT03931057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159067|NCT02846155|Simethicone|simethicone|mesh-list
65159068|NCT02846155|Antifoaming Agents|antifoaming agents|mesh-ancestor
65159069|NCT02846155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159070|NCT02846155|Emollients|emollients|mesh-ancestor
65159071|NCT02846155|Dermatologic Agents|dermatologic agents|mesh-ancestor
65159072|NCT02845843|Interferons|interferons|mesh-list
65159073|NCT02845843|Ritonavir|ritonavir|mesh-list
65159075|NCT02845843|Interferon-beta|interferon-beta|mesh-list
65159076|NCT02845843|Interferon beta-1b|interferon beta-1b|mesh-list
65159077|NCT02845843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159078|NCT02845843|Antiviral Agents|antiviral agents|mesh-ancestor
65159079|NCT02845843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65159080|NCT02845843|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65159081|NCT02845843|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65159082|NCT02845843|Protease Inhibitors|protease inhibitors|mesh-ancestor
65159083|NCT02845843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159084|NCT02845843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159085|NCT02845843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65159086|NCT02845843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65159087|NCT02845843|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65159088|NCT02845843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65159089|NCT02845843|Immunologic Factors|immunologic factors|mesh-ancestor
65159090|NCT02845843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159093|NCT02845999|Fludarabine|fludarabine|mesh-list
65159094|NCT02845999|Cetuximab|cetuximab|mesh-list
65159095|NCT02845999|Interleukin-2|interleukin-2|mesh-list
65159096|NCT02845999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65159097|NCT02845999|Immunologic Factors|immunologic factors|mesh-ancestor
65159098|NCT02845999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159099|NCT02845999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65159100|NCT02845999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65159101|NCT02845999|Alkylating Agents|alkylating agents|mesh-ancestor
65159102|NCT02845999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159103|NCT02845999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159104|NCT02845999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65159105|NCT02845999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65159106|NCT02845999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65159107|NCT02845999|Analgesics|analgesics|mesh-ancestor
65159108|NCT02845999|Sensory System Agents|sensory system agents|mesh-ancestor
65159109|NCT02845999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65159110|NCT05337085|Midazolam|midazolam|mesh-list
65159111|NCT05337085|Dexmedetomidine|dexmedetomidine|mesh-list
65159112|NCT05337085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65159113|NCT05337085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65159114|NCT05337085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159115|NCT05337085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65159116|NCT05337085|Analgesics|analgesics|mesh-ancestor
65159117|NCT05337085|Sensory System Agents|sensory system agents|mesh-ancestor
65159118|NCT05337085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65159119|NCT05337085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65159120|NCT05337085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65159121|NCT05337085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65159122|NCT05337085|Adrenergic Agents|adrenergic agents|mesh-ancestor
65159123|NCT05337085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65159124|NCT05337085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159125|NCT05337085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65310180|NCT02633579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65310181|NCT02633579|Cholinergic Agents|cholinergic agents|mesh-ancestor
65310182|NCT02633579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65310183|NCT02633579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310184|NCT02633579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65310185|NCT02633579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65310186|NCT02633579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65310187|NCT02633579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65310188|NCT02633579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310189|NCT00685529|Formoterol Fumarate|formoterol fumarate|mesh-list
65310190|NCT00685529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65310191|NCT00685529|Autonomic Agents|autonomic agents|mesh-ancestor
65310192|NCT00685529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65310193|NCT00685529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310194|NCT00685529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65310195|NCT00685529|Respiratory System Agents|respiratory system agents|mesh-ancestor
65310196|NCT00685529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65310197|NCT00685529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65310198|NCT00685529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65310199|NCT00685529|Adrenergic Agents|adrenergic agents|mesh-ancestor
65310200|NCT00685529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65310201|NCT00685529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310202|NCT00685607|Simethicone|simethicone|mesh-list
65310203|NCT00685607|Loperamide|loperamide|mesh-list
65310204|NCT00685607|Antidiarrheals|antidiarrheals|mesh-list
65310205|NCT00685607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65310206|NCT00685607|Antifoaming Agents|antifoaming agents|mesh-ancestor
65159126|NCT05337085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65159127|NCT05337085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65159128|NCT05337085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65159129|NCT05337085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65159130|NCT05337085|Anesthetics, General|anesthetics, general|mesh-ancestor
65159131|NCT05337085|Anesthetics|anesthetics|mesh-ancestor
65159132|NCT05337085|GABA Modulators|gaba modulators|mesh-ancestor
65159133|NCT05337085|GABA Agents|gaba agents|mesh-ancestor
65159134|NCT02845765|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
65159135|NCT02845765|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65159136|NCT02845765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159137|NCT02845765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159138|NCT01723579|Estradiol|estradiol|mesh-list
65159139|NCT01723579|Estrogens|estrogens|mesh-ancestor
65159140|NCT01723579|Hormones|hormones|mesh-ancestor
65159141|NCT01723579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65159142|NCT01723579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159143|NCT00901927|Rituximab|rituximab|mesh-list
65159144|NCT00901927|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65159145|NCT00901927|Mitoxantrone|mitoxantrone|mesh-list
65159146|NCT00901927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65310207|NCT00685607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310208|NCT00685607|Emollients|emollients|mesh-ancestor
65310209|NCT00685607|Dermatologic Agents|dermatologic agents|mesh-ancestor
65310210|NCT00657059|Mycophenolic Acid|mycophenolic acid|mesh-list
65310211|NCT00657059|Prednisone|prednisone|mesh-list
65310212|NCT00657059|Methylprednisolone|methylprednisolone|mesh-list
65310213|NCT00657059|Irbesartan|irbesartan|mesh-list
65310214|NCT00657059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65310215|NCT00657059|Glucocorticoids|glucocorticoids|mesh-ancestor
65310216|NCT00657059|Hormones|hormones|mesh-ancestor
65310217|NCT00657059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65310218|NCT00657059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310219|NCT00657059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65310220|NCT00657059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310221|NCT00657059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65310222|NCT00657059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65310223|NCT00657059|Antitubercular Agents|antitubercular agents|mesh-ancestor
65310224|NCT00657059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65310225|NCT00657059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65159147|NCT00901927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159148|NCT00901927|Immunologic Factors|immunologic factors|mesh-ancestor
65159149|NCT00901927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159150|NCT00901927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65159151|NCT00901927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65159152|NCT00901927|Alkylating Agents|alkylating agents|mesh-ancestor
65159153|NCT00901927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159155|NCT00901927|Sensory System Agents|sensory system agents|mesh-ancestor
65159156|NCT00901927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65159157|NCT00901927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65159158|NCT00901927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65159159|NCT00901927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159160|NCT05335837|Anesthetics|anesthetics|mesh-list
65159161|NCT05335837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65159162|NCT05335837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159163|NCT00903721|Mometasone Furoate|mometasone furoate|mesh-list
65159164|NCT00903721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65159168|NCT02845219|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
65159169|NCT02845219|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65159170|NCT02845219|Contraceptive Agents|contraceptive agents|mesh-ancestor
65159171|NCT02845219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65159172|NCT02845219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159173|NCT02845219|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65159174|NCT02845219|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65159175|NCT02845219|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65159176|NCT02845219|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65159177|NCT02845219|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65159178|NCT02845219|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
65159179|NCT02845219|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65159180|NCT02845219|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65159181|NCT00968968|Trastuzumab|trastuzumab|mesh-list
65159182|NCT00968968|Lapatinib|lapatinib|mesh-list
65159183|NCT00968968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65159184|NCT00968968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310226|NCT00657059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310227|NCT00657059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310228|NCT00657059|Antiemetics|antiemetics|mesh-ancestor
65310229|NCT00657059|Autonomic Agents|autonomic agents|mesh-ancestor
65310230|NCT00657059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65310231|NCT00657059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65310232|NCT00657059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65310233|NCT00657059|Protective Agents|protective agents|mesh-ancestor
65310234|NCT00657059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65310235|NCT00657059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65310236|NCT00657059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65310237|NCT00667732|Exenatide|exenatide|mesh-list
65310238|NCT00667732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65310239|NCT00667732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310240|NCT00667732|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65310241|NCT00667732|Incretins|incretins|mesh-ancestor
65310242|NCT00667732|Hormones|hormones|mesh-ancestor
65310243|NCT00667732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65310244|NCT04161209|Citalopram|citalopram|mesh-list
65310245|NCT04161209|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65310246|NCT04161209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65310247|NCT04161209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65310248|NCT04161209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310249|NCT04161209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65310250|NCT04161209|Serotonin Agents|serotonin agents|mesh-ancestor
65310251|NCT04161209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310252|NCT04161209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65310253|NCT04161209|Antidepressive Agents|antidepressive agents|mesh-ancestor
65310254|NCT04161209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65159185|NCT00968968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65159186|NCT00968968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159187|NCT00968968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159188|NCT00973102|Estrogens|estrogens|mesh-list
65159189|NCT00973102|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65159190|NCT00973102|Hormones|hormones|mesh-ancestor
65159191|NCT00973102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65159192|NCT00973102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159193|NCT03691090|Paclitaxel|paclitaxel|mesh-list
65159194|NCT03691090|Cisplatin|cisplatin|mesh-list
65159195|NCT03691090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65159196|NCT03691090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159197|NCT03691090|Tubulin Modulators|tubulin modulators|mesh-ancestor
65159198|NCT03691090|Antimitotic Agents|antimitotic agents|mesh-ancestor
65159199|NCT03691090|Mitosis Modulators|mitosis modulators|mesh-ancestor
65310255|NCT04161053|Rifaximin|rifaximin|mesh-list
65310256|NCT04161053|Nitazoxanide|nitazoxanide|mesh-list
65310257|NCT04161053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65310258|NCT04161053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65310259|NCT04161053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65310260|NCT04161053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65310261|NCT00685841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65310262|NCT00685841|Formoterol Fumarate|formoterol fumarate|mesh-list
65310263|NCT00685841|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65159200|NCT03691090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159201|NCT00783211|Fexofenadine|fexofenadine|mesh-list
65159202|NCT00783211|Desloratadine|desloratadine|mesh-list
65159203|NCT00783211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65159204|NCT00783211|Cholinergic Agents|cholinergic agents|mesh-ancestor
65159205|NCT00783211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65159206|NCT00783211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159207|NCT00783211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159208|NCT00783211|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65159209|NCT00783211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65159210|NCT00783211|Histamine Antagonists|histamine antagonists|mesh-ancestor
65159211|NCT00783211|Histamine Agents|histamine agents|mesh-ancestor
65159212|NCT00783211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65159213|NCT03679546|Infliximab|infliximab|mesh-list
65159214|NCT03679546|Vedolizumab|vedolizumab|mesh-list
65159215|NCT03679546|Dermatologic Agents|dermatologic agents|mesh-ancestor
65159216|NCT03679546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65159217|NCT03679546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65159218|NCT00779545|Mometasone Furoate|mometasone furoate|mesh-list
65159219|NCT00779545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65159220|NCT00779545|Dermatologic Agents|dermatologic agents|mesh-ancestor
64692671|NCT01979276|Romidepsin|romidepsin|mesh-list
65159222|NCT03679312|Nitric Oxide|nitric oxide|mesh-list
65159223|NCT03679312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65159224|NCT03679312|Autonomic Agents|autonomic agents|mesh-ancestor
65159225|NCT03679312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65159226|NCT03679312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159227|NCT03679312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65159228|NCT03679312|Respiratory System Agents|respiratory system agents|mesh-ancestor
65159229|NCT03679312|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65159230|NCT03679312|Antioxidants|antioxidants|mesh-ancestor
65159231|NCT03679312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159232|NCT03679312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65159233|NCT03679312|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65159234|NCT03679312|Vasodilator Agents|vasodilator agents|mesh-ancestor
65159245|NCT02842567|Antioxidants|antioxidants|mesh-ancestor
65159246|NCT02842567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159247|NCT02842567|Protective Agents|protective agents|mesh-ancestor
65159248|NCT02842567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65159249|NCT02842567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65159250|NCT02842567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65159251|NCT02842567|Disinfectants|disinfectants|mesh-ancestor
65159252|NCT00705211|Ezetimibe|ezetimibe|mesh-list
65159253|NCT00705211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65159254|NCT00705211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65159255|NCT00705211|Antimetabolites|antimetabolites|mesh-ancestor
65159256|NCT00705211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159257|NCT00705211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65159258|NCT02839213|Scopolamine|scopolamine|mesh-list
65159259|NCT02839213|Bromides|bromides|mesh-list
65159260|NCT02839213|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65159261|NCT02839213|Anticonvulsants|anticonvulsants|mesh-ancestor
65159262|NCT02839213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65159263|NCT02839213|Antiemetics|antiemetics|mesh-ancestor
65159264|NCT02839213|Autonomic Agents|autonomic agents|mesh-ancestor
65159265|NCT02839213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65159266|NCT02839213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159267|NCT02839213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65159268|NCT02839213|Mydriatics|mydriatics|mesh-ancestor
65159269|NCT02839213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65310264|NCT00685841|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65310265|NCT00685841|Autonomic Agents|autonomic agents|mesh-ancestor
65310266|NCT00685841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65310267|NCT00685841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310268|NCT00685841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65310269|NCT00685841|Respiratory System Agents|respiratory system agents|mesh-ancestor
65310270|NCT00685841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65310271|NCT00685841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65310272|NCT00685841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65310273|NCT00685841|Adrenergic Agents|adrenergic agents|mesh-ancestor
65310274|NCT00685841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65344938|NCT00864136|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65159270|NCT02839213|Cholinergic Agents|cholinergic agents|mesh-ancestor
65159271|NCT02839213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65159272|NCT02839213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159273|NCT02839213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65159274|NCT02839213|Parasympatholytics|parasympatholytics|mesh-ancestor
65159275|NCT05334043|Curcumin|curcumin|mesh-list
65159276|NCT05334043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65159277|NCT05334043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65159278|NCT05334043|Analgesics|analgesics|mesh-ancestor
65159279|NCT05334043|Sensory System Agents|sensory system agents|mesh-ancestor
65159280|NCT05334043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65159281|NCT05334043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159282|NCT05334043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65159283|NCT05334043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65159284|NCT05334043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159285|NCT05334043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159286|NCT05334043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159287|NCT02839135|Scopolamine|scopolamine|mesh-list
65159288|NCT02839135|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65159289|NCT02839135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65159290|NCT02839135|Antiemetics|antiemetics|mesh-ancestor
65159291|NCT02839135|Autonomic Agents|autonomic agents|mesh-ancestor
65159292|NCT02839135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65159293|NCT02839135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159294|NCT02839135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65159295|NCT02839135|Mydriatics|mydriatics|mesh-ancestor
65159296|NCT02839135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65159298|NCT02839135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65159299|NCT02839135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159300|NCT02839135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65159301|NCT02839135|Parasympatholytics|parasympatholytics|mesh-ancestor
65159302|NCT02838823|Antibodies|antibodies|mesh-list
65159303|NCT02838823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65159314|NCT00156091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65159315|NCT00156091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65159316|NCT00156091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65159317|NCT00156091|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65159318|NCT00156091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65159319|NCT00156091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65159320|NCT00156091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159321|NCT00156091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65159322|NCT00156091|Serotonin Agents|serotonin agents|mesh-ancestor
65159324|NCT00140959|Atenolol|atenolol|mesh-list
65159325|NCT00140959|Amlodipine|amlodipine|mesh-list
65159326|NCT00140959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65159327|NCT00140959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65159328|NCT00140959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65159329|NCT00140959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159330|NCT00140959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64540061|NCT01390441|Glucocorticoids|glucocorticoids|mesh-ancestor
65310275|NCT00685841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310276|NCT00681785|Dalteparin|dalteparin|mesh-list
65310277|NCT00681785|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65310278|NCT00681785|Anticoagulants|anticoagulants|mesh-ancestor
65310279|NCT00681785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65310280|NCT00681785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65310281|NCT00681785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310282|NCT00671788|Dasatinib|dasatinib|mesh-list
65310283|NCT00671788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310284|NCT00671788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65310285|NCT00671788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310286|NCT00671788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159331|NCT00140959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159332|NCT00140959|Vasodilator Agents|vasodilator agents|mesh-ancestor
65159333|NCT00140959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65159334|NCT00140959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65159335|NCT00140959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65159336|NCT00140959|Adrenergic Agents|adrenergic agents|mesh-ancestor
65159337|NCT00140959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65159338|NCT00140959|Autonomic Agents|autonomic agents|mesh-ancestor
65159339|NCT00140959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65159340|NCT00140959|Sympatholytics|sympatholytics|mesh-ancestor
65159341|NCT00140959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65159342|NCT00140959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65159343|NCT00140959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65159344|NCT00095017|Etoricoxib|etoricoxib|mesh-list
65159345|NCT00095017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65159346|NCT00095017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65159347|NCT00095017|Analgesics|analgesics|mesh-ancestor
65159348|NCT00095017|Sensory System Agents|sensory system agents|mesh-ancestor
65159349|NCT00095017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65159350|NCT00095017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159351|NCT00095017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65159352|NCT00095017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65159353|NCT00095017|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65159354|NCT00095017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65159355|NCT00095017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159356|NCT00095017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159357|NCT00092755|Ibuprofen|ibuprofen|mesh-list
65159358|NCT00092755|Etoricoxib|etoricoxib|mesh-list
65159359|NCT00092755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65159360|NCT00092755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65159361|NCT00092755|Analgesics|analgesics|mesh-ancestor
65159362|NCT00092755|Sensory System Agents|sensory system agents|mesh-ancestor
65159363|NCT00092755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65159364|NCT00092755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159365|NCT00092755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65159366|NCT00092755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65159367|NCT00092755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65159370|NCT00092755|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65159371|NCT00899431|Rituximab|rituximab|mesh-list
65159372|NCT00899431|Fludarabine|fludarabine|mesh-list
65159373|NCT00899431|Fludarabine phosphate|fludarabine phosphate|mesh-list
65159374|NCT00899431|Lenalidomide|lenalidomide|mesh-list
65159375|NCT00899431|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65159376|NCT00899431|Allopurinol|allopurinol|mesh-list
65159377|NCT00899431|Thymoglobulin|thymoglobulin|mesh-list
65159378|NCT00899431|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65159379|NCT00899431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65159380|NCT00899431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310287|NCT02626481|Dexamethasone|dexamethasone|mesh-list
65310288|NCT02626481|Daratumumab|daratumumab|mesh-list
65310289|NCT02626481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65310290|NCT02626481|Antiemetics|antiemetics|mesh-ancestor
65310291|NCT02626481|Autonomic Agents|autonomic agents|mesh-ancestor
65310292|NCT02626481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65310293|NCT02626481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310294|NCT02626481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65310295|NCT02626481|Glucocorticoids|glucocorticoids|mesh-ancestor
65159381|NCT00899431|Immunologic Factors|immunologic factors|mesh-ancestor
65159382|NCT00899431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159383|NCT00899431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65159384|NCT00899431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65159385|NCT00899431|Antimetabolites|antimetabolites|mesh-ancestor
65159386|NCT00899431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159387|NCT00899431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65159388|NCT00899431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65159389|NCT00899431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65159390|NCT00899431|Growth Substances|growth substances|mesh-ancestor
65159391|NCT00899431|Growth Inhibitors|growth inhibitors|mesh-ancestor
65159392|NCT00899431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65159393|NCT00899431|Alkylating Agents|alkylating agents|mesh-ancestor
65159394|NCT00899431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159395|NCT00899431|Gout Suppressants|gout suppressants|mesh-ancestor
65159396|NCT00899431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65159397|NCT00899431|Antioxidants|antioxidants|mesh-ancestor
65159398|NCT00899431|Protective Agents|protective agents|mesh-ancestor
65159399|NCT00898807|Citalopram|citalopram|mesh-list
65159400|NCT00898807|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65159401|NCT00898807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65159402|NCT00898807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65159403|NCT00898807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159404|NCT00898807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65159405|NCT00898807|Serotonin Agents|serotonin agents|mesh-ancestor
65159406|NCT00898807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159407|NCT00898807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65159408|NCT00898807|Antidepressive Agents|antidepressive agents|mesh-ancestor
65159409|NCT00898807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65159410|NCT01229267|Vaccines|vaccines|mesh-list
65159411|NCT01229267|Immunologic Factors|immunologic factors|mesh-ancestor
65159412|NCT01229267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159413|NCT00897715|Rilonacept|rilonacept|mesh-list
65159414|NCT00897715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65159415|NCT01229111|Leucovorin|leucovorin|mesh-list
65159416|NCT01229111|Fluorouracil|fluorouracil|mesh-list
65159417|NCT01229111|Oxaliplatin|oxaliplatin|mesh-list
65159418|NCT01229111|Cediranib|cediranib|mesh-list
65159419|NCT01229111|Calcium|calcium|mesh-list
65159420|NCT01229111|Levoleucovorin|levoleucovorin|mesh-list
65159421|NCT01229111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65159422|NCT01229111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159423|NCT01229111|Antimetabolites|antimetabolites|mesh-ancestor
65159424|NCT01229111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159425|NCT01229111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65159426|NCT01229111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159427|NCT01229111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65159428|NCT01229111|Immunologic Factors|immunologic factors|mesh-ancestor
65159429|NCT01229111|Antidotes|antidotes|mesh-ancestor
65159430|NCT01229111|Protective Agents|protective agents|mesh-ancestor
65159431|NCT01229111|Vitamin B Complex|vitamin b complex|mesh-ancestor
65159432|NCT01229111|Vitamins|vitamins|mesh-ancestor
65159433|NCT01229111|Micronutrients|micronutrients|mesh-ancestor
65159434|NCT01229111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159435|NCT01229111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65159436|NCT01228175|Riboflavin|riboflavin|mesh-list
65159437|NCT01228175|Varenicline|varenicline|mesh-list
65159438|NCT01228175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65159439|NCT01228175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65159440|NCT01228175|Cholinergic Agents|cholinergic agents|mesh-ancestor
65310296|NCT02626481|Hormones|hormones|mesh-ancestor
65310297|NCT02626481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65310298|NCT02626481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65310299|NCT02626481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310300|NCT00777166|Oxytocin|oxytocin|mesh-list
65310301|NCT00777166|Oxytocics|oxytocics|mesh-ancestor
65310302|NCT00777166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65310303|NCT00777166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310304|NCT00681941|Sevelamer|sevelamer|mesh-list
65310305|NCT00681941|Chelating Agents|chelating agents|mesh-ancestor
65310306|NCT00681941|Sequestering Agents|sequestering agents|mesh-ancestor
65310307|NCT00681941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310308|NCT00657137|Capecitabine|capecitabine|mesh-list
65310309|NCT00657137|Lapatinib|lapatinib|mesh-list
65310310|NCT00657137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65310311|NCT00657137|Antimetabolites|antimetabolites|mesh-ancestor
65310312|NCT00657137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159441|NCT01228175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65159442|NCT01228175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159446|NCT01228175|Micronutrients|micronutrients|mesh-ancestor
65159447|NCT01228175|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65159448|NCT01228175|Dermatologic Agents|dermatologic agents|mesh-ancestor
65159449|NCT01228019|Niacin|niacin|mesh-list
65159450|NCT01228019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65159451|NCT01228019|Antimetabolites|antimetabolites|mesh-ancestor
65159452|NCT01228019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159453|NCT01228019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65159454|NCT01228019|Vasodilator Agents|vasodilator agents|mesh-ancestor
65159455|NCT01228019|Vitamin B Complex|vitamin b complex|mesh-ancestor
65159456|NCT01228019|Vitamins|vitamins|mesh-ancestor
65159457|NCT01228019|Micronutrients|micronutrients|mesh-ancestor
65159458|NCT01228019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159459|NCT01227707|Leucovorin|leucovorin|mesh-list
65159460|NCT01227707|Bevacizumab|bevacizumab|mesh-list
65159461|NCT01227707|Fluorouracil|fluorouracil|mesh-list
65159462|NCT01227707|Capecitabine|capecitabine|mesh-list
65159463|NCT01227707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65159464|NCT01227707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159465|NCT01227707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65159466|NCT01227707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65159467|NCT01227707|Growth Substances|growth substances|mesh-ancestor
65159468|NCT01227707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159469|NCT01227707|Growth Inhibitors|growth inhibitors|mesh-ancestor
65159470|NCT01227707|Antimetabolites|antimetabolites|mesh-ancestor
65159471|NCT01227707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159472|NCT01227707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65159473|NCT01227707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65159474|NCT01227707|Immunologic Factors|immunologic factors|mesh-ancestor
65159475|NCT01227707|Antidotes|antidotes|mesh-ancestor
65159476|NCT01227707|Protective Agents|protective agents|mesh-ancestor
65159477|NCT01227707|Vitamin B Complex|vitamin b complex|mesh-ancestor
65159478|NCT01227707|Vitamins|vitamins|mesh-ancestor
65159479|NCT01227707|Micronutrients|micronutrients|mesh-ancestor
65159480|NCT00633373|Cyclosporine|cyclosporine|mesh-list
65159481|NCT00633373|Cyclosporins|cyclosporins|mesh-list
65159482|NCT00633373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159483|NCT00633373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159484|NCT00633373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65159485|NCT00633373|Immunologic Factors|immunologic factors|mesh-ancestor
65310313|NCT00657137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310314|NCT00657137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65310315|NCT00657137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310316|NCT00777244|Mitotane|mitotane|mesh-list
65310317|NCT00777244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65310318|NCT00777244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310319|NCT04160897|Tenofovir|tenofovir|mesh-list
65310320|NCT04160897|Entecavir|entecavir|mesh-list
65310321|NCT04160897|Antiviral Agents|antiviral agents|mesh-ancestor
65310322|NCT04160897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65310323|NCT04160897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65159486|NCT00633373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159487|NCT00633373|Antifungal Agents|antifungal agents|mesh-ancestor
65159489|NCT00633373|Dermatologic Agents|dermatologic agents|mesh-ancestor
65159490|NCT00633373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65159491|NCT00633373|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65159492|NCT05334745|Hyaluronic Acid|hyaluronic acid|mesh-list
65159493|NCT05334745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65159494|NCT05334745|Immunologic Factors|immunologic factors|mesh-ancestor
65159495|NCT05334745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159496|NCT05334745|Viscosupplements|viscosupplements|mesh-ancestor
65159497|NCT05334745|Protective Agents|protective agents|mesh-ancestor
65159498|NCT02838589|Exenatide|exenatide|mesh-list
65159499|NCT02838589|Glucagon|glucagon|mesh-list
65159500|NCT02838589|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65159501|NCT02838589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65159502|NCT02838589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159503|NCT02838589|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65159504|NCT02838589|Incretins|incretins|mesh-ancestor
65159505|NCT02838589|Hormones|hormones|mesh-ancestor
65159506|NCT02838589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65159507|NCT02838589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65159508|NCT00895843|Ibuprofen|ibuprofen|mesh-list
65159509|NCT00895843|Epinephrine|epinephrine|mesh-list
65159510|NCT00895843|Bupivacaine|bupivacaine|mesh-list
65159511|NCT00895843|Anesthetics, Local|anesthetics, local|mesh-ancestor
65159512|NCT00895843|Anesthetics|anesthetics|mesh-ancestor
65159513|NCT00895843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65159514|NCT00895843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159515|NCT00895843|Sensory System Agents|sensory system agents|mesh-ancestor
65159516|NCT00895843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65159517|NCT00895843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65159518|NCT00895843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65159519|NCT00895843|Analgesics|analgesics|mesh-ancestor
65159523|NCT00895843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159524|NCT00895843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159525|NCT00895843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65159526|NCT00895843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65159527|NCT00895843|Adrenergic Agents|adrenergic agents|mesh-ancestor
65159528|NCT00895843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65159529|NCT00895843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65159530|NCT00895843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65159531|NCT00895843|Autonomic Agents|autonomic agents|mesh-ancestor
65159532|NCT00895843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65159533|NCT00895843|Respiratory System Agents|respiratory system agents|mesh-ancestor
65159535|NCT00895843|Sympathomimetics|sympathomimetics|mesh-ancestor
65159536|NCT00895843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65159537|NCT05333809|Pembrolizumab|pembrolizumab|mesh-list
65159538|NCT05333809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65159539|NCT05333809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159540|NCT05333731|Oxytocin|oxytocin|mesh-list
65159541|NCT05333731|Oxytocics|oxytocics|mesh-ancestor
65159542|NCT05333731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65159543|NCT05333731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159544|NCT04201561|Selenious Acid|selenious acid|mesh-list
65159545|NCT04201561|Sodium Selenite|sodium selenite|mesh-list
65159546|NCT04201561|Paclitaxel|paclitaxel|mesh-list
65159547|NCT04201561|Carboplatin|carboplatin|mesh-list
65310324|NCT04160897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65310325|NCT04160897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310326|NCT04160897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310327|NCT04160897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65310328|NCT04160897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65310329|NCT00777322|Riboflavin|riboflavin|mesh-list
65310330|NCT00777322|Dextrans|dextrans|mesh-list
65159548|NCT04201561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65159549|NCT04201561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159550|NCT04201561|Tubulin Modulators|tubulin modulators|mesh-ancestor
65159551|NCT04201561|Antimitotic Agents|antimitotic agents|mesh-ancestor
65159552|NCT04201561|Mitosis Modulators|mitosis modulators|mesh-ancestor
65159553|NCT04201561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159554|NCT04201561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159555|NCT04201561|Trace Elements|trace elements|mesh-ancestor
65159556|NCT04201561|Micronutrients|micronutrients|mesh-ancestor
65159557|NCT00895453|Iron|iron|mesh-list
65159558|NCT00895453|Itraconazole|itraconazole|mesh-list
65159559|NCT00895453|Antifungal Agents|antifungal agents|mesh-ancestor
65159560|NCT00895453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65159561|NCT00895453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65159562|NCT00895453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65159563|NCT00895453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159564|NCT00895453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159565|NCT00895453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65159566|NCT00895453|Hormone Antagonists|hormone antagonists|mesh-ancestor
65159567|NCT00895453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65159568|NCT00895453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159569|NCT00895453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65159570|NCT00895453|Trace Elements|trace elements|mesh-ancestor
65159571|NCT00895453|Micronutrients|micronutrients|mesh-ancestor
65159572|NCT00893737|Naproxen|naproxen|mesh-list
65159573|NCT00893737|Sumatriptan|sumatriptan|mesh-list
65159574|NCT00893737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65159575|NCT00893737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65159576|NCT00893737|Analgesics|analgesics|mesh-ancestor
65159577|NCT00893737|Sensory System Agents|sensory system agents|mesh-ancestor
65159578|NCT00893737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65159579|NCT00893737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159580|NCT00893737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65159581|NCT00893737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65159582|NCT00893737|Gout Suppressants|gout suppressants|mesh-ancestor
65159583|NCT00893737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65159584|NCT00893737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159585|NCT00893737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159586|NCT00893737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65159587|NCT00893737|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65159588|NCT00893737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65159589|NCT00893737|Serotonin Agents|serotonin agents|mesh-ancestor
65159590|NCT00893737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65159591|NCT00893113|Alfuzosin|alfuzosin|mesh-list
65159593|NCT00893113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65159594|NCT00893113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65159595|NCT00893113|Adrenergic Agents|adrenergic agents|mesh-ancestor
65159596|NCT00893113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65159597|NCT00893113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159598|NCT00893113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159599|NCT00893113|Urological Agents|urological agents|mesh-ancestor
65159600|NCT02840929|Esomeprazole|esomeprazole|mesh-list
65159601|NCT02840929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65159602|NCT02840929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65159603|NCT02840929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65159604|NCT02840929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159605|NCT02840929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159606|NCT02838121|Zoledronic Acid|zoledronic acid|mesh-list
65159607|NCT02838121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65310331|NCT00777322|Vitamin B Complex|vitamin b complex|mesh-ancestor
65310332|NCT00777322|Vitamins|vitamins|mesh-ancestor
65310333|NCT00777322|Micronutrients|micronutrients|mesh-ancestor
65310334|NCT00777322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310335|NCT00777322|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65310336|NCT00777322|Dermatologic Agents|dermatologic agents|mesh-ancestor
65310337|NCT00777322|Anticoagulants|anticoagulants|mesh-ancestor
65310338|NCT00777322|Plasma Substitutes|plasma substitutes|mesh-ancestor
65310339|NCT00777322|Blood Substitutes|blood substitutes|mesh-ancestor
65310340|NCT00682019|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65310341|NCT00682019|Vasodilator Agents|vasodilator agents|mesh-ancestor
65310343|NCT00682019|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65310344|NCT00682019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976578|NCT00256711|Gefitinib|gefitinib|mesh-list
65159608|NCT02838121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159609|NCT02837965|Doxycycline|doxycycline|mesh-list
65159610|NCT02837965|Prednisone|prednisone|mesh-list
65159611|NCT02837965|Methotrexate|methotrexate|mesh-list
65159612|NCT02837965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65159613|NCT02837965|Glucocorticoids|glucocorticoids|mesh-ancestor
65159614|NCT02837965|Hormones|hormones|mesh-ancestor
65159615|NCT02837965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65159616|NCT02837965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159617|NCT02837965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65159618|NCT02837965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159619|NCT02837965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65159620|NCT02837965|Abortifacient Agents|abortifacient agents|mesh-ancestor
65159621|NCT02837965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65159622|NCT02837965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65159623|NCT02837965|Antimetabolites|antimetabolites|mesh-ancestor
65159624|NCT02837965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159625|NCT02837965|Dermatologic Agents|dermatologic agents|mesh-ancestor
65159626|NCT02837965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159627|NCT02837965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65159628|NCT02837965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65159629|NCT02837965|Immunologic Factors|immunologic factors|mesh-ancestor
65159630|NCT02837965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65159631|NCT02837965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65159632|NCT02837965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65159633|NCT02837965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65159634|NCT02837965|Antimalarials|antimalarials|mesh-ancestor
65159635|NCT02837965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65159636|NCT02837965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65159637|NCT00892957|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65159638|NCT00892957|Thrombin|thrombin|mesh-list
65159639|NCT00892957|Aprotinin|aprotinin|mesh-list
65159640|NCT00892957|Hemostatics|hemostatics|mesh-ancestor
65159641|NCT00892957|Coagulants|coagulants|mesh-ancestor
65159642|NCT00892957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65159643|NCT00892957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65159644|NCT00892957|Protease Inhibitors|protease inhibitors|mesh-ancestor
65159645|NCT00892957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159646|NCT00892957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159647|NCT05322733|Cyclophosphamide|cyclophosphamide|mesh-list
65159648|NCT05322733|Fludarabine|fludarabine|mesh-list
65159649|NCT05322733|Obinutuzumab|obinutuzumab|mesh-list
65159650|NCT05322733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65159651|NCT05322733|Immunologic Factors|immunologic factors|mesh-ancestor
65159652|NCT05322733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159653|NCT05322733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65159654|NCT05322733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65159655|NCT05322733|Alkylating Agents|alkylating agents|mesh-ancestor
65159656|NCT05322733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159657|NCT05322733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310345|NCT00682019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310346|NCT00682019|Urological Agents|urological agents|mesh-ancestor
65310347|NCT00779896|Tazarotene|tazarotene|mesh-list
65310348|NCT00779896|Dermatologic Agents|dermatologic agents|mesh-ancestor
65310349|NCT00779896|Keratolytic Agents|keratolytic agents|mesh-ancestor
65159658|NCT05322733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65159659|NCT05322733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65159660|NCT00968812|Metformin|metformin|mesh-list
65159661|NCT00968812|Glimepiride|glimepiride|mesh-list
65159662|NCT00968812|Canagliflozin|canagliflozin|mesh-list
65159663|NCT00968812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65159664|NCT00968812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159665|NCT00968812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65159679|NCT05197192|Obinutuzumab|obinutuzumab|mesh-list
65159680|NCT05197192|Acalabrutinib|acalabrutinib|mesh-list
65159681|NCT05197192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159682|NCT05197192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65159684|NCT00992056|Nebivolol|nebivolol|mesh-list
65159685|NCT00992056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65159686|NCT00992056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65159687|NCT00992056|Sympatholytics|sympatholytics|mesh-ancestor
65159688|NCT00992056|Autonomic Agents|autonomic agents|mesh-ancestor
65159689|NCT00992056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65159690|NCT00992056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159691|NCT00992056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65159692|NCT00992056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65159693|NCT00992056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65159694|NCT00992056|Adrenergic Agents|adrenergic agents|mesh-ancestor
65159695|NCT00992056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65159696|NCT00992056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159697|NCT00992056|Vasodilator Agents|vasodilator agents|mesh-ancestor
65159698|NCT00992056|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65159699|NCT00992056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65159700|NCT00992056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65159701|NCT03677596|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65159702|NCT03677596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65159703|NCT03677596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159704|NCT03677596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65159705|NCT00967798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65159706|NCT00967798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65159707|NCT00967798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159708|NCT00967798|Incretins|incretins|mesh-ancestor
65159709|NCT00967798|Hormones|hormones|mesh-ancestor
64802328|NCT01401179|Cefazolin|cefazolin|mesh-list
65159710|NCT00967798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65159711|NCT00967798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65159712|NCT00967798|Protease Inhibitors|protease inhibitors|mesh-ancestor
65159713|NCT00967798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159714|NCT00967798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159715|NCT04248205|Ketamine|ketamine|mesh-list
65159716|NCT04248205|Analgesics|analgesics|mesh-ancestor
65159717|NCT04248205|Sensory System Agents|sensory system agents|mesh-ancestor
65159718|NCT04248205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65159719|NCT04248205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159720|NCT04248205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65159721|NCT04248205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65159722|NCT04248205|Anesthetics, General|anesthetics, general|mesh-ancestor
65159723|NCT04248205|Anesthetics|anesthetics|mesh-ancestor
65159724|NCT04248205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65159725|NCT04248205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65159726|NCT04248205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65159735|NCT02833831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159737|NCT02833987|Warfarin|warfarin|mesh-list
65159738|NCT02833987|Rivaroxaban|rivaroxaban|mesh-list
65159739|NCT02833987|Dabigatran|dabigatran|mesh-list
65159740|NCT02833987|Apixaban|apixaban|mesh-list
65159741|NCT02833987|Anticoagulants|anticoagulants|mesh-ancestor
65159742|NCT02833987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65159743|NCT02833987|Antithrombins|antithrombins|mesh-ancestor
65159744|NCT02833987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65159745|NCT02833987|Protease Inhibitors|protease inhibitors|mesh-ancestor
65310350|NCT02556268|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65310351|NCT02556268|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65310352|NCT02556268|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65310353|NCT02556268|Triumeq|triumeq|mesh-list
65310354|NCT02556268|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
65310355|NCT02556268|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
65310356|NCT02556268|Riociguat|riociguat|mesh-list
65310357|NCT02556268|Protease Inhibitors|protease inhibitors|mesh-list
65310358|NCT02556268|Antiviral Agents|antiviral agents|mesh-ancestor
65310359|NCT02556268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65159746|NCT02833987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159747|NCT02833987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159748|NCT02837185|Botulinum Toxins|botulinum toxins|mesh-list
65159749|NCT02837185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65159750|NCT02837185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65159751|NCT02837185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159752|NCT02837185|Cholinergic Agents|cholinergic agents|mesh-ancestor
65159753|NCT02837185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65159754|NCT02837185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159755|NCT00965458|Alefacept|alefacept|mesh-list
65159756|NCT00965458|Dermatologic Agents|dermatologic agents|mesh-ancestor
65159757|NCT00965458|Immunologic Factors|immunologic factors|mesh-ancestor
65159758|NCT00965458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159759|NCT04249531|Amikacin|amikacin|mesh-list
65159760|NCT04249531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65159761|NCT04249531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65159762|NCT02836639|Etoposide|etoposide|mesh-list
65159763|NCT02836639|Busulfan|busulfan|mesh-list
65159764|NCT02836639|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65159765|NCT02836639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65159766|NCT02836639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159767|NCT02836639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65159768|NCT02836639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65159769|NCT02836639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159770|NCT02836639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159771|NCT02836639|Alkylating Agents|alkylating agents|mesh-ancestor
65159772|NCT02836639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65159773|NCT02836639|Immunologic Factors|immunologic factors|mesh-ancestor
65159774|NCT02836639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159775|NCT02836639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65159776|NCT02836639|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65159777|NCT00972244|Dapagliflozin|dapagliflozin|mesh-list
65159778|NCT00972244|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65159779|NCT00972244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159780|NCT00972244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65159781|NCT00972244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159782|NCT05333419|Latanoprost|latanoprost|mesh-list
65159783|NCT05333419|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65159784|NCT05333419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65159785|NCT02836795|Antibodies|antibodies|mesh-list
65159786|NCT02836795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65159787|NCT02836795|Immunologic Factors|immunologic factors|mesh-ancestor
65159788|NCT02836795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159789|NCT02836483|Linezolid|linezolid|mesh-list
65159790|NCT02836483|Delpazolid|delpazolid|mesh-list
65159791|NCT02836483|Oxazolidinones|oxazolidinones|mesh-list
65159792|NCT02836483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65159793|NCT02836483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65159803|NCT02836171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159805|NCT02836171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65159806|NCT02836171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65310360|NCT02556268|Enzyme Activators|enzyme activators|mesh-ancestor
65310361|NCT02556268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310362|NCT02556268|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65310363|NCT02556268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65310364|NCT02556268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310365|NCT02556268|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65310366|NCT02556268|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65310367|NCT00875615|Carboplatin|carboplatin|mesh-list
65310368|NCT00875615|Sorafenib|sorafenib|mesh-list
65310369|NCT00875615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310370|NCT00875615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65310371|NCT00875615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310372|NCT00875615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310373|NCT02626559|Bupivacaine|bupivacaine|mesh-list
64976886|NCT00258388|Prednisone|prednisone|mesh-list
65159807|NCT02836171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65159808|NCT02836171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65159809|NCT02836171|Hormone Antagonists|hormone antagonists|mesh-ancestor
65159810|NCT02836171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65159811|NCT02836171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159812|NCT02836171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65159813|NCT00971932|Carboplatin|carboplatin|mesh-list
65159814|NCT00971932|Fluorouracil|fluorouracil|mesh-list
65159815|NCT00971932|Cetuximab|cetuximab|mesh-list
65159816|NCT00971932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159817|NCT00971932|Antimetabolites|antimetabolites|mesh-ancestor
65159818|NCT00971932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159819|NCT00971932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65159820|NCT00971932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65159821|NCT00971932|Immunologic Factors|immunologic factors|mesh-ancestor
65159822|NCT00971932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159823|NCT00971932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65159825|NCT04400929|Sargramostim|sargramostim|mesh-list
65159826|NCT04400929|Immunologic Factors|immunologic factors|mesh-ancestor
65159827|NCT04400929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159828|NCT04400929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159829|NCT05170672|Abatacept|abatacept|mesh-list
65159830|NCT05170672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65159831|NCT05170672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159832|NCT05170672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159833|NCT05170672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65159834|NCT05170672|Immunologic Factors|immunologic factors|mesh-ancestor
65159835|NCT05170672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159836|NCT05170672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65159837|NCT04249063|Lidocaine|lidocaine|mesh-list
65159838|NCT04249063|Anesthetics|anesthetics|mesh-list
65159839|NCT04249063|Anesthetics, Local|anesthetics, local|mesh-list
65159840|NCT04249063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65159841|NCT04249063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159842|NCT04249063|Sensory System Agents|sensory system agents|mesh-ancestor
65159843|NCT04249063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65159844|NCT04249063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65159845|NCT04249063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65159846|NCT04249063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65159847|NCT04249063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65159848|NCT04249063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159849|NCT00970684|Gemcitabine|gemcitabine|mesh-list
65159850|NCT00970684|Bevacizumab|bevacizumab|mesh-list
65159851|NCT00970684|Docetaxel|docetaxel|mesh-list
65310374|NCT02626559|Anesthetics, Local|anesthetics, local|mesh-ancestor
65310375|NCT02626559|Anesthetics|anesthetics|mesh-ancestor
65310376|NCT02626559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65310377|NCT02626559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310378|NCT02626559|Sensory System Agents|sensory system agents|mesh-ancestor
65310379|NCT02626559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65310380|NCT00768508|Naltrexone|naltrexone|mesh-list
65310381|NCT00768508|Ondansetron|ondansetron|mesh-list
65310382|NCT00768508|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65310383|NCT00768508|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65310384|NCT00768508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310385|NCT00768508|Sensory System Agents|sensory system agents|mesh-ancestor
65310386|NCT00768508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65310387|NCT00768508|Antiemetics|antiemetics|mesh-ancestor
65310388|NCT00768508|Autonomic Agents|autonomic agents|mesh-ancestor
65310389|NCT00768508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65310390|NCT00768508|Antipruritics|antipruritics|mesh-ancestor
65310391|NCT00768508|Dermatologic Agents|dermatologic agents|mesh-ancestor
65310392|NCT00768508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65310393|NCT00768508|Serotonin Agents|serotonin agents|mesh-ancestor
65310394|NCT00768508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65310395|NCT00768508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310396|NCT00768508|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65310397|NCT00768508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65159852|NCT00970684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65159853|NCT00970684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159854|NCT00970684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65159855|NCT00970684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65159856|NCT00970684|Growth Substances|growth substances|mesh-ancestor
65159857|NCT00970684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159863|NCT00970684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65159864|NCT00970684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159865|NCT00970684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65159866|NCT00970684|Immunologic Factors|immunologic factors|mesh-ancestor
65159867|NCT00970684|Tubulin Modulators|tubulin modulators|mesh-ancestor
65159868|NCT00970684|Antimitotic Agents|antimitotic agents|mesh-ancestor
65159869|NCT00970684|Mitosis Modulators|mitosis modulators|mesh-ancestor
65159870|NCT00967330|Bevacizumab|bevacizumab|mesh-list
65159871|NCT00967330|Irinotecan|irinotecan|mesh-list
65159872|NCT00967330|Temozolomide|temozolomide|mesh-list
65159873|NCT00967330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65159874|NCT00967330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159875|NCT00967330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65159876|NCT00967330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65159877|NCT00967330|Growth Substances|growth substances|mesh-ancestor
65159878|NCT00967330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159879|NCT00967330|Growth Inhibitors|growth inhibitors|mesh-ancestor
65159880|NCT00967330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65159881|NCT00967330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65159882|NCT00967330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159883|NCT00967330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310398|NCT00768508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65310399|NCT00768508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65310400|NCT00768508|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65310401|NCT00682487|Hydrocortisone|hydrocortisone|mesh-list
65310402|NCT00682487|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65310403|NCT00682487|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65310404|NCT00682487|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65310405|NCT00682487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65310406|NCT00777478|Sunitinib|sunitinib|mesh-list
65310407|NCT00777478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310408|NCT00777478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65310409|NCT00777478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64540173|NCT04529460|Immunologic Factors|immunologic factors|mesh-ancestor
64540174|NCT04529460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540175|NCT04032067|Finasteride|finasteride|mesh-list
64540178|NCT04032067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159884|NCT00967330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65159885|NCT00967330|Alkylating Agents|alkylating agents|mesh-ancestor
65159886|NCT02863276|Insulin|insulin|mesh-list
65159887|NCT02863276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65159888|NCT02863276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65159889|NCT02863276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159890|NCT04286152|Mirabegron|mirabegron|mesh-list
65159891|NCT04286152|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65159892|NCT04286152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65159893|NCT04286152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64693339|NCT03119831|Ethanol|ethanol|mesh-list
65159895|NCT04286152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65159896|NCT04286152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159897|NCT04286152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159898|NCT04286152|Urological Agents|urological agents|mesh-ancestor
65159899|NCT00966940|Travoprost|travoprost|mesh-list
65159900|NCT00966940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65159901|NCT00966940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65159902|NCT00966940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65159903|NCT00965848|Doripenem|doripenem|mesh-list
65159904|NCT00965848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65159905|NCT00965848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65159906|NCT03447574|Ethanol|ethanol|mesh-list
65159907|NCT03447574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65159908|NCT03447574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65159909|NCT03447574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65159910|NCT03447574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159911|NCT04284826|Mitomycins|mitomycins|mesh-list
65159912|NCT04284826|Mitomycin|mitomycin|mesh-list
65159913|NCT04284826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65159914|NCT04284826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159915|NCT04284826|Alkylating Agents|alkylating agents|mesh-ancestor
65159916|NCT04284826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159917|NCT04284826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65159918|NCT04284826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159919|NCT04285528|Lidocaine|lidocaine|mesh-list
65159920|NCT04285528|Fentanyl|fentanyl|mesh-list
65159921|NCT04285528|Ketamine|ketamine|mesh-list
65159922|NCT04285528|Propofol|propofol|mesh-list
65159923|NCT04285528|Anesthetics, Local|anesthetics, local|mesh-ancestor
65159924|NCT04285528|Anesthetics|anesthetics|mesh-ancestor
65159925|NCT04285528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65159926|NCT04285528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159927|NCT04285528|Sensory System Agents|sensory system agents|mesh-ancestor
65159940|NCT04285528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65310410|NCT00777478|Growth Substances|growth substances|mesh-ancestor
65310411|NCT00777478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310412|NCT00777478|Growth Inhibitors|growth inhibitors|mesh-ancestor
65310413|NCT00777478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65310414|NCT00777478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310415|NCT00777478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310477|NCT02556814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65310478|NCT02556814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310479|NCT02556814|Antioxidants|antioxidants|mesh-ancestor
65310480|NCT02556814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310481|NCT02556814|Protective Agents|protective agents|mesh-ancestor
65310482|NCT00682955|Zinc|zinc|mesh-list
65159941|NCT04285528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65159942|NCT04285528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65159943|NCT04285528|Narcotics|narcotics|mesh-ancestor
65159944|NCT04285528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65159945|NCT00629824|Interferons|interferons|mesh-list
65159946|NCT00629824|Ribavirin|ribavirin|mesh-list
65159947|NCT00629824|Interferon-alpha|interferon-alpha|mesh-list
65159948|NCT00629824|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65159949|NCT00629824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159950|NCT00629824|Antiviral Agents|antiviral agents|mesh-ancestor
65159951|NCT00629824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65159952|NCT00629824|Antimetabolites|antimetabolites|mesh-ancestor
65159953|NCT00629824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159954|NCT00629824|Immunologic Factors|immunologic factors|mesh-ancestor
65159955|NCT00629824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159956|NCT00961636|Niacin|niacin|mesh-list
65159957|NCT00961636|Niacinamide|niacinamide|mesh-list
65159958|NCT00961636|Nicotinic Acids|nicotinic acids|mesh-list
65159959|NCT00961636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65159960|NCT00961636|Antimetabolites|antimetabolites|mesh-ancestor
65159961|NCT00961636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159962|NCT00961636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65159963|NCT00961636|Vasodilator Agents|vasodilator agents|mesh-ancestor
65159964|NCT00961636|Vitamin B Complex|vitamin b complex|mesh-ancestor
65159965|NCT00961636|Vitamins|vitamins|mesh-ancestor
65159966|NCT00961636|Micronutrients|micronutrients|mesh-ancestor
65159967|NCT00961636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159968|NCT00964678|Carvedilol|carvedilol|mesh-list
65159969|NCT00964678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65159970|NCT00964678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65159971|NCT00964678|Adrenergic Agents|adrenergic agents|mesh-ancestor
65159972|NCT00964678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65159973|NCT00964678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159974|NCT00964678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159975|NCT00964678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65159977|NCT00964678|Protective Agents|protective agents|mesh-ancestor
65159978|NCT00964678|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65159979|NCT00964678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65159980|NCT00964678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65159981|NCT00964678|Vasodilator Agents|vasodilator agents|mesh-ancestor
65159982|NCT00964678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65159983|NCT00964678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65159984|NCT03263650|Prednisone|prednisone|mesh-list
65159985|NCT03263650|Carboplatin|carboplatin|mesh-list
65159986|NCT03263650|Olaparib|olaparib|mesh-list
65159987|NCT03263650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159988|NCT03263650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65159989|NCT03263650|Glucocorticoids|glucocorticoids|mesh-ancestor
65159992|NCT03263650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159993|NCT03263650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65159994|NCT03263650|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65159995|NCT03263650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159996|NCT03263650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159997|NCT00964366|Clindamycin|clindamycin|mesh-list
65159998|NCT00964366|Clindamycin palmitate|clindamycin palmitate|mesh-list
65159999|NCT00964366|Clindamycin phosphate|clindamycin phosphate|mesh-list
65160000|NCT00964366|Dapsone|dapsone|mesh-list
65160001|NCT00964366|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65160002|NCT00964366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65160003|NCT00964366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65160004|NCT00964366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65160005|NCT00964366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160006|NCT00964366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160007|NCT00964366|Dermatologic Agents|dermatologic agents|mesh-ancestor
65310483|NCT00682955|Zinc Sulfate|zinc sulfate|mesh-list
65310484|NCT00682955|Trace Elements|trace elements|mesh-ancestor
65310485|NCT00682955|Micronutrients|micronutrients|mesh-ancestor
65310486|NCT00682955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310487|NCT00682955|Astringents|astringents|mesh-ancestor
65310488|NCT00682955|Dermatologic Agents|dermatologic agents|mesh-ancestor
65310489|NCT00686621|Posaconazole|posaconazole|mesh-list
65310490|NCT00686621|Antifungal Agents|antifungal agents|mesh-ancestor
65310491|NCT00686621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65310492|NCT00686621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65310493|NCT00686621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65310494|NCT00686621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65160008|NCT00964366|Antimalarials|antimalarials|mesh-ancestor
65160009|NCT00964366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65160010|NCT00964366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65160011|NCT00964366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65160012|NCT00964366|Leprostatic Agents|leprostatic agents|mesh-ancestor
65160013|NCT03545464|Prednisone|prednisone|mesh-list
65160014|NCT03545464|Levocetirizine|levocetirizine|mesh-list
65160015|NCT03545464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65160016|NCT03545464|Glucocorticoids|glucocorticoids|mesh-ancestor
65160017|NCT03545464|Hormones|hormones|mesh-ancestor
65160018|NCT03545464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65160019|NCT03545464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160020|NCT03545464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65160021|NCT03545464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65160022|NCT03545464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65160023|NCT03545464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65160024|NCT03545464|Histamine Antagonists|histamine antagonists|mesh-ancestor
65160025|NCT03545464|Histamine Agents|histamine agents|mesh-ancestor
65160026|NCT03545464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65160027|NCT03545464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160028|NCT04284514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65160029|NCT04284514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65160030|NCT02860936|Lenvatinib|lenvatinib|mesh-list
65160031|NCT02860936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65160032|NCT02860936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65160033|NCT02860936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160034|NCT02860936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160035|NCT00630214|Calcium, Dietary|calcium, dietary|mesh-list
65160036|NCT00630214|Vitamin D|vitamin d|mesh-list
65160037|NCT00630214|Ergocalciferols|ergocalciferols|mesh-list
65160038|NCT00630214|Cholecalciferol|cholecalciferol|mesh-list
65160039|NCT00630214|Vitamins|vitamins|mesh-list
65160040|NCT00630214|Calcium Carbonate|calcium carbonate|mesh-list
65160041|NCT00630214|Calcium|calcium|mesh-list
65160042|NCT00630214|Micronutrients|micronutrients|mesh-ancestor
65160043|NCT00630214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160044|NCT00630214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65160045|NCT00630214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65160047|NCT00630214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160048|NCT00630214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65160049|NCT02860858|Aflibercept|aflibercept|mesh-list
65160050|NCT02860858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65160051|NCT02860858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65160052|NCT02860858|Growth Substances|growth substances|mesh-ancestor
65160053|NCT02860858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160054|NCT02860858|Growth Inhibitors|growth inhibitors|mesh-ancestor
65160055|NCT02860858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65160056|NCT00960076|Metformin|metformin|mesh-list
65160057|NCT00960076|Saxagliptin|saxagliptin|mesh-list
65160058|NCT00960076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65160059|NCT00960076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160060|NCT00960076|Incretins|incretins|mesh-ancestor
65160061|NCT00960076|Hormones|hormones|mesh-ancestor
65160062|NCT00960076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65310495|NCT00686621|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65310496|NCT00686621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65310497|NCT00686621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310498|NCT00686621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310499|NCT00686621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65310500|NCT00686621|Hormone Antagonists|hormone antagonists|mesh-ancestor
65310501|NCT00686621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65310502|NCT00686621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310503|NCT00683111|Esomeprazole|esomeprazole|mesh-list
65310504|NCT00683111|Famotidine|famotidine|mesh-list
65310505|NCT00683111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65310506|NCT00683111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65310507|NCT00683111|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65310508|NCT00683111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310509|NCT00683111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310510|NCT00683111|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65310511|NCT00683111|Histamine Antagonists|histamine antagonists|mesh-ancestor
65310512|NCT00683111|Histamine Agents|histamine agents|mesh-ancestor
65310513|NCT00683111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65310514|NCT00683111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310515|NCT04138901|Ropivacaine|ropivacaine|mesh-list
65310516|NCT04138901|Anesthetics, Local|anesthetics, local|mesh-ancestor
65310517|NCT04138901|Anesthetics|anesthetics|mesh-ancestor
65310518|NCT04138901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65310519|NCT04138901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310520|NCT04138901|Sensory System Agents|sensory system agents|mesh-ancestor
65310521|NCT04138901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65310522|NCT00922649|Insulin|insulin|mesh-list
65310523|NCT00922649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65310524|NCT00922649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310525|NCT04142411|Insulin|insulin|mesh-list
65310526|NCT04142411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65310527|NCT04142411|Hyaluronic Acid|hyaluronic acid|mesh-list
65310528|NCT04142411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65310529|NCT04142411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540275|NCT05174052|Dapagliflozin|dapagliflozin|mesh-list
65160063|NCT00960076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65310530|NCT04142411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65310531|NCT04142411|Immunologic Factors|immunologic factors|mesh-ancestor
65310532|NCT04142411|Viscosupplements|viscosupplements|mesh-ancestor
65310533|NCT04142411|Protective Agents|protective agents|mesh-ancestor
65310534|NCT00683189|Warfarin|warfarin|mesh-list
65310535|NCT00683189|Anticoagulants|anticoagulants|mesh-ancestor
65310536|NCT00667576|Maxacalcitol|maxacalcitol|mesh-list
65310537|NCT00667576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310538|NCT00667576|Dermatologic Agents|dermatologic agents|mesh-ancestor
65310539|NCT00667576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65310540|NCT00667576|Protective Agents|protective agents|mesh-ancestor
65160071|NCT04284202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65160072|NCT04284202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65160073|NCT04284202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160074|NCT04284202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160076|NCT01227629|Dabigatran|dabigatran|mesh-list
65160077|NCT01227629|Anticoagulants|anticoagulants|mesh-ancestor
65160078|NCT01227629|Antithrombins|antithrombins|mesh-ancestor
65160079|NCT01227629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65160080|NCT01227629|Protease Inhibitors|protease inhibitors|mesh-ancestor
65160081|NCT01227629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160082|NCT01227629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160083|NCT00963820|Ixazomib|ixazomib|mesh-list
65160084|NCT00963820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160085|NCT00963820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65160086|NCT00963820|Protease Inhibitors|protease inhibitors|mesh-ancestor
65160087|NCT00963820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160088|NCT03241186|Nivolumab|nivolumab|mesh-list
65160089|NCT03241186|Ipilimumab|ipilimumab|mesh-list
65160090|NCT03241186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65160091|NCT03241186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65160092|NCT03241186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65160093|NCT03241186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160094|NCT01227395|Azithromycin|azithromycin|mesh-list
65160095|NCT01227395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65160096|NCT01227395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65160097|NCT03237286|Ketamine|ketamine|mesh-list
65160098|NCT03237286|Analgesics|analgesics|mesh-ancestor
65160099|NCT03237286|Sensory System Agents|sensory system agents|mesh-ancestor
65160100|NCT03237286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65160101|NCT03237286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160102|NCT03237286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65160103|NCT03237286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65160104|NCT03237286|Anesthetics, General|anesthetics, general|mesh-ancestor
65160105|NCT03237286|Anesthetics|anesthetics|mesh-ancestor
65160106|NCT03237286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65160107|NCT03237286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65160108|NCT03237286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65160109|NCT03237286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65160110|NCT03237286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160111|NCT01226459|Minoxidil|minoxidil|mesh-list
65160112|NCT01226459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65160113|NCT01226459|Vasodilator Agents|vasodilator agents|mesh-ancestor
65160114|NCT01225991|Milnacipran|milnacipran|mesh-list
65160115|NCT01225991|Levomilnacipran|levomilnacipran|mesh-list
65160116|NCT01225991|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65160117|NCT01225991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65160118|NCT01225991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65160119|NCT01225991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160120|NCT01225991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65160121|NCT01225991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160122|NCT01225991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65160123|NCT01225991|Analgesics|analgesics|mesh-ancestor
65160124|NCT01225991|Sensory System Agents|sensory system agents|mesh-ancestor
65160125|NCT01225991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65310541|NCT00667576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310542|NCT04141787|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65310543|NCT04141787|Ceftriaxone|ceftriaxone|mesh-list
65310544|NCT04141787|Cefazolin|cefazolin|mesh-list
65310545|NCT04141787|Daptomycin|daptomycin|mesh-list
65310546|NCT04141787|Cloxacillin|cloxacillin|mesh-list
65310547|NCT04141787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65310548|NCT02557594|Tenofovir|tenofovir|mesh-list
65310549|NCT02557594|Antiviral Agents|antiviral agents|mesh-ancestor
65310550|NCT02557594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65310551|NCT02557594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65310552|NCT02557594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65310553|NCT02557594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310554|NCT02557594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310555|NCT02557594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65310556|NCT02557594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65310557|NCT00687011|Dexamethasone|dexamethasone|mesh-list
65310558|NCT00687011|Palonosetron|palonosetron|mesh-list
65310559|NCT00687011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65310560|NCT00687011|Antiemetics|antiemetics|mesh-ancestor
65310561|NCT00687011|Autonomic Agents|autonomic agents|mesh-ancestor
65310562|NCT00687011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65310563|NCT00687011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310564|NCT00687011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65310565|NCT00687011|Glucocorticoids|glucocorticoids|mesh-ancestor
65310566|NCT00687011|Hormones|hormones|mesh-ancestor
65310567|NCT00687011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65310568|NCT00687011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65160126|NCT01225991|Antidepressive Agents|antidepressive agents|mesh-ancestor
65160127|NCT01225991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65160128|NCT04283110|Midazolam|midazolam|mesh-list
65160129|NCT04283110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65160130|NCT04283110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65160137|NCT04283110|Anesthetics, General|anesthetics, general|mesh-ancestor
65160138|NCT04283110|Anesthetics|anesthetics|mesh-ancestor
65160139|NCT04283110|GABA Modulators|gaba modulators|mesh-ancestor
65160140|NCT04283110|GABA Agents|gaba agents|mesh-ancestor
65160141|NCT04283110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65160142|NCT04283110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160143|NCT01225835|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65160144|NCT01225835|Cetrorelix|cetrorelix|mesh-list
65160145|NCT01225835|Menotropins|menotropins|mesh-list
65160146|NCT01225835|Progesterone|progesterone|mesh-list
65160147|NCT01225835|Progestins|progestins|mesh-ancestor
65160148|NCT01225835|Hormones|hormones|mesh-ancestor
65160149|NCT01225835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65160150|NCT01225835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160151|NCT01225835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65160152|NCT01225835|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65310569|NCT00687011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310570|NCT00687011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65310571|NCT00687011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65310572|NCT00687011|Serotonin Agents|serotonin agents|mesh-ancestor
65310573|NCT00687011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65310574|NCT00687011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310575|NCT00683267|Capsaicin|capsaicin|mesh-list
65310576|NCT00683267|Antipruritics|antipruritics|mesh-ancestor
65310577|NCT00683267|Dermatologic Agents|dermatologic agents|mesh-ancestor
65310578|NCT00683267|Sensory System Agents|sensory system agents|mesh-ancestor
65310579|NCT00683267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65310580|NCT00683267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310581|NCT00683345|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65310582|NCT00683345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65160153|NCT01225835|Fertility Agents|fertility agents|mesh-ancestor
65160154|NCT01225835|Hormone Antagonists|hormone antagonists|mesh-ancestor
65160155|NCT04282096|Caseins|caseins|mesh-list
65160156|NCT04282096|Chelating Agents|chelating agents|mesh-ancestor
65160157|NCT04282096|Sequestering Agents|sequestering agents|mesh-ancestor
65160158|NCT04282096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160159|NCT02899000|Doxycycline|doxycycline|mesh-list
65160160|NCT02899000|Adapalene|adapalene|mesh-list
65160161|NCT02899000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65160162|NCT02899000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65160163|NCT02899000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65160164|NCT02899000|Antimalarials|antimalarials|mesh-ancestor
65160165|NCT02899000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65160166|NCT02899000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65160167|NCT02899000|Dermatologic Agents|dermatologic agents|mesh-ancestor
65160168|NCT02899000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65160169|NCT02899000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65160170|NCT02899000|Analgesics|analgesics|mesh-ancestor
65160171|NCT02899000|Sensory System Agents|sensory system agents|mesh-ancestor
65160172|NCT02899000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65160173|NCT02899000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160174|NCT02899000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65160175|NCT02899000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65160176|NCT04281862|Prednisolone|prednisolone|mesh-list
65160177|NCT04281862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65160178|NCT04281862|Glucocorticoids|glucocorticoids|mesh-ancestor
65160179|NCT04281862|Hormones|hormones|mesh-ancestor
65160180|NCT04281862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65160181|NCT04281862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160182|NCT04281862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65160183|NCT04281862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65160184|NCT03122002|Clopidogrel|clopidogrel|mesh-list
65160185|NCT03122002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160186|NCT03122002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160187|NCT03122002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65160188|NCT03122002|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65160189|NCT03122002|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65160190|NCT03122002|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65160191|NCT03122002|Purinergic Agents|purinergic agents|mesh-ancestor
65160192|NCT03122002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65160193|NCT02861482|Oxytocin|oxytocin|mesh-list
65160195|NCT02861482|Oxytocics|oxytocics|mesh-ancestor
65160196|NCT02861482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65160197|NCT02861482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160198|NCT02861716|Fentanyl|fentanyl|mesh-list
65160199|NCT02861716|Dexmedetomidine|dexmedetomidine|mesh-list
65160200|NCT02861716|Bupivacaine|bupivacaine|mesh-list
65310583|NCT00687245|Esomeprazole|esomeprazole|mesh-list
65310584|NCT00687245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65310585|NCT00687245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65310586|NCT00687245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65310587|NCT00687245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310588|NCT00687245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160201|NCT02861716|Anesthetics, Local|anesthetics, local|mesh-ancestor
65160202|NCT02861716|Anesthetics|anesthetics|mesh-ancestor
65160212|NCT02861716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65160213|NCT02861716|Adrenergic Agents|adrenergic agents|mesh-ancestor
65160214|NCT02861716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65160215|NCT02861716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160216|NCT02861716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65160217|NCT02861716|Narcotics|narcotics|mesh-ancestor
65160218|NCT02861716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65160219|NCT02861716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65160220|NCT02861716|Anesthetics, General|anesthetics, general|mesh-ancestor
65160221|NCT00960934|Vitamin D|vitamin d|mesh-list
65160222|NCT00960934|Cholecalciferol|cholecalciferol|mesh-list
65160223|NCT00960934|Calcium Carbonate|calcium carbonate|mesh-list
65160224|NCT00960934|Calcium|calcium|mesh-list
65160225|NCT00960934|Vitamins|vitamins|mesh-ancestor
65160226|NCT00960934|Micronutrients|micronutrients|mesh-ancestor
65160227|NCT00960934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160228|NCT00960934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65160229|NCT00960934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65160230|NCT00960934|Antacids|antacids|mesh-ancestor
65160231|NCT00960934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160232|NCT00960934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65160233|NCT00892177|Bevacizumab|bevacizumab|mesh-list
65160234|NCT00892177|Dasatinib|dasatinib|mesh-list
65160235|NCT00892177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65160236|NCT00892177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65160237|NCT00892177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65160238|NCT00892177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65160239|NCT00892177|Growth Substances|growth substances|mesh-ancestor
65160240|NCT00892177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802857|NCT01404377|Anesthetics|anesthetics|mesh-ancestor
65160241|NCT00892177|Growth Inhibitors|growth inhibitors|mesh-ancestor
65160242|NCT00892177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65160243|NCT00892177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160244|NCT00892177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160245|NCT00962104|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65160246|NCT00962104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65160247|NCT00962104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65160248|NCT00962104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65160249|NCT00962104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160250|NCT00962104|Adrenergic Agents|adrenergic agents|mesh-ancestor
65160251|NCT00962104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65160252|NCT00962104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160253|NCT02821000|Pembrolizumab|pembrolizumab|mesh-list
65160254|NCT02821000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65160255|NCT02821000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65160256|NCT02860624|Esomeprazole|esomeprazole|mesh-list
65160257|NCT02860624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65160258|NCT02860624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65160259|NCT02860624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65160260|NCT02860624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160261|NCT02860624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160263|NCT00892099|Ergocalciferols|ergocalciferols|mesh-list
65160264|NCT00892099|Cholecalciferol|cholecalciferol|mesh-list
65160265|NCT00892099|Vitamins|vitamins|mesh-list
65160266|NCT00892099|Micronutrients|micronutrients|mesh-ancestor
65160267|NCT00892099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160275|NCT00960856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160277|NCT00958438|Rilonacept|rilonacept|mesh-list
65160278|NCT00958438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65160279|NCT02835469|Menotropins|menotropins|mesh-list
65160280|NCT02835469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65160281|NCT02835469|Fertility Agents|fertility agents|mesh-ancestor
65310589|NCT00690521|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65310590|NCT00690521|Metolazone|metolazone|mesh-list
65310591|NCT00690521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65310592|NCT00690521|Diuretics|diuretics|mesh-ancestor
65310593|NCT00690521|Natriuretic Agents|natriuretic agents|mesh-ancestor
65310594|NCT00690521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310595|NCT00690521|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65310596|NCT00690521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65310597|NCT00690521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310598|NCT00666718|Insulin|insulin|mesh-list
65310599|NCT00666718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65310600|NCT00666718|Insulin Glargine|insulin glargine|mesh-list
65310601|NCT00666718|Insulin Lispro|insulin lispro|mesh-list
65310602|NCT00666718|Protamines|protamines|mesh-list
65310603|NCT00666718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65310604|NCT00666718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540366|NCT05083026|Antibodies|antibodies|mesh-list
65160282|NCT02835469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65160283|NCT02835469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160284|NCT05324059|Pregabalin|pregabalin|mesh-list
65160285|NCT05324059|Tramadol|tramadol|mesh-list
65160286|NCT05324059|Analgesics|analgesics|mesh-ancestor
65160287|NCT05324059|Sensory System Agents|sensory system agents|mesh-ancestor
65160288|NCT05324059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65160289|NCT05324059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160290|NCT05324059|Anticonvulsants|anticonvulsants|mesh-ancestor
65160291|NCT05324059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65160292|NCT05324059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65160293|NCT05324059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160294|NCT05324059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65160295|NCT05324059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65160296|NCT05324059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65160297|NCT05324059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65160298|NCT05324059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65160299|NCT05324059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65160300|NCT05324059|Narcotics|narcotics|mesh-ancestor
65160301|NCT02832973|Ramipril|ramipril|mesh-list
65160302|NCT02832973|Bisoprolol|bisoprolol|mesh-list
65160303|NCT02832973|Amiloride|amiloride|mesh-list
65160304|NCT02832973|Furosemide|furosemide|mesh-list
65160305|NCT02832973|Spironolactone|spironolactone|mesh-list
65160306|NCT02832973|Diuretics|diuretics|mesh-list
65160307|NCT02832973|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65160308|NCT02832973|Natriuretic Agents|natriuretic agents|mesh-ancestor
65160309|NCT02832973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160310|NCT02832973|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65160311|NCT02832973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65160312|NCT02832973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160313|NCT02832973|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65160314|NCT02832973|Hormone Antagonists|hormone antagonists|mesh-ancestor
65160315|NCT02832973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65160316|NCT02832973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65160317|NCT02832973|Protease Inhibitors|protease inhibitors|mesh-ancestor
65160318|NCT02832973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160319|NCT02832973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65160321|NCT02832973|Autonomic Agents|autonomic agents|mesh-ancestor
65160322|NCT02832973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65160323|NCT02832973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65310605|NCT00666718|Heparin Antagonists|heparin antagonists|mesh-ancestor
65310606|NCT00666718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310607|NCT00666718|Coagulants|coagulants|mesh-ancestor
65310608|NCT00683735|Metformin|metformin|mesh-list
65310609|NCT00683735|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65310610|NCT00683735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65310611|NCT00683735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310612|NCT00683735|Incretins|incretins|mesh-ancestor
65310613|NCT00683735|Hormones|hormones|mesh-ancestor
65310614|NCT00683735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65310615|NCT00683735|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65310616|NCT00683735|Protease Inhibitors|protease inhibitors|mesh-ancestor
65310617|NCT00683735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310618|NCT00683735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310619|NCT04139681|Menthol|menthol|mesh-list
65310620|NCT04139681|Antipruritics|antipruritics|mesh-ancestor
65310621|NCT04139681|Dermatologic Agents|dermatologic agents|mesh-ancestor
65310622|NCT04047394|Rasburicase|rasburicase|mesh-list
65310623|NCT04047394|Gout Suppressants|gout suppressants|mesh-ancestor
65310624|NCT04047394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65310625|NCT02625779|Valproic Acid|valproic acid|mesh-list
65310626|NCT02625779|Anticonvulsants|anticonvulsants|mesh-ancestor
65310627|NCT02625779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310628|NCT02625779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310629|NCT02625779|GABA Agents|gaba agents|mesh-ancestor
65310630|NCT02625779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65310631|NCT02625779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310632|NCT02625779|Antimanic Agents|antimanic agents|mesh-ancestor
65310633|NCT02625779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65310634|NCT02625779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65310635|NCT02625779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65310636|NCT00667420|Oxaliplatin|oxaliplatin|mesh-list
65310637|NCT00667420|Epirubicin|epirubicin|mesh-list
65310638|NCT00667420|Panitumumab|panitumumab|mesh-list
65310639|NCT00667420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540382|NCT01427803|Naproxen|naproxen|mesh-list
65310645|NCT00667420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65310646|NCT04141319|Ketorolac|ketorolac|mesh-list
65310647|NCT04141319|Epinephrine|epinephrine|mesh-list
65310648|NCT04141319|Ropivacaine|ropivacaine|mesh-list
65310649|NCT04141319|Anesthetics, Local|anesthetics, local|mesh-ancestor
65160324|NCT02832973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65160325|NCT02832973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65160326|NCT02832973|Adrenergic Agents|adrenergic agents|mesh-ancestor
65160327|NCT02832973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65160328|NCT02832973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65160329|NCT02832973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65160330|NCT02832973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65160331|NCT02831491|Docetaxel|docetaxel|mesh-list
65160332|NCT02831491|Ramucirumab|ramucirumab|mesh-list
65160333|NCT02831491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65160356|NCT04281706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65160357|NCT04281706|Anesthetics, General|anesthetics, general|mesh-ancestor
65160358|NCT04281706|Anesthetics|anesthetics|mesh-ancestor
65160359|NCT02835391|Surgiflo|surgiflo|mesh-list
65160360|NCT02835391|Hemostatics|hemostatics|mesh-ancestor
65160361|NCT02835391|Coagulants|coagulants|mesh-ancestor
65160362|NCT02831101|Sufentanil|sufentanil|mesh-list
65160363|NCT02831101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65160364|NCT02831101|Narcotics|narcotics|mesh-ancestor
65160365|NCT02831101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65160366|NCT02831101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160367|NCT02831101|Analgesics|analgesics|mesh-ancestor
65160368|NCT02831101|Sensory System Agents|sensory system agents|mesh-ancestor
65160369|NCT02831101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65160370|NCT02831101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65160371|NCT02831101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65160372|NCT02831101|Anesthetics, General|anesthetics, general|mesh-ancestor
65160373|NCT02831101|Anesthetics|anesthetics|mesh-ancestor
65160374|NCT04245787|Fluorides|fluorides|mesh-list
65160375|NCT04245787|Cariostatic Agents|cariostatic agents|mesh-ancestor
65160376|NCT04245787|Protective Agents|protective agents|mesh-ancestor
65160377|NCT04245787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160378|NCT02831179|Capecitabine|capecitabine|mesh-list
65160379|NCT02831179|Temozolomide|temozolomide|mesh-list
65160380|NCT02831179|Veliparib|veliparib|mesh-list
65160381|NCT02831179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65160382|NCT02831179|Antimetabolites|antimetabolites|mesh-ancestor
65160383|NCT02831179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160384|NCT02831179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65160385|NCT02831179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65160386|NCT02831179|Alkylating Agents|alkylating agents|mesh-ancestor
64505093|NCT02245672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65160395|NCT02830789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160398|NCT04243993|Calcium|calcium|mesh-list
65160399|NCT04243993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65160400|NCT04243993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160401|NCT04245319|Acitretin|acitretin|mesh-list
65160402|NCT04245319|Keratolytic Agents|keratolytic agents|mesh-ancestor
65160403|NCT04245319|Dermatologic Agents|dermatologic agents|mesh-ancestor
65160404|NCT02828059|Ropivacaine|ropivacaine|mesh-list
65160405|NCT02828059|Anesthetics, Local|anesthetics, local|mesh-ancestor
65160406|NCT02828059|Anesthetics|anesthetics|mesh-ancestor
65160407|NCT02828059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65160408|NCT02828059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160409|NCT02828059|Sensory System Agents|sensory system agents|mesh-ancestor
65160410|NCT02828059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65160411|NCT02827903|Metformin|metformin|mesh-list
65160412|NCT02827903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65160413|NCT02827903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65160414|NCT02827903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160415|NCT02827903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65160416|NCT02827903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65160417|NCT02827903|Antimetabolites|antimetabolites|mesh-ancestor
64693859|NCT03179345|Pregabalin|pregabalin|mesh-list
65160418|NCT02827903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160419|NCT02827903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65160420|NCT02827903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65160421|NCT02827903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160422|NCT01243424|Glimepiride|glimepiride|mesh-list
65310650|NCT04141319|Anesthetics|anesthetics|mesh-ancestor
65310651|NCT04141319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65310652|NCT04141319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310653|NCT04141319|Sensory System Agents|sensory system agents|mesh-ancestor
65310654|NCT04141319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65310655|NCT04141319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65310656|NCT04141319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65310657|NCT04141319|Adrenergic Agents|adrenergic agents|mesh-ancestor
65310658|NCT04141319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65310659|NCT04141319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310660|NCT04141319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65310661|NCT04141319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65310662|NCT04141319|Autonomic Agents|autonomic agents|mesh-ancestor
65310663|NCT04141319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65310664|NCT04141319|Respiratory System Agents|respiratory system agents|mesh-ancestor
65310665|NCT04141319|Mydriatics|mydriatics|mesh-ancestor
65310666|NCT04141319|Sympathomimetics|sympathomimetics|mesh-ancestor
65310667|NCT04141319|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64540429|NCT03821610|Melphalan|melphalan|mesh-list
65160423|NCT01243424|Linagliptin|linagliptin|mesh-list
65160424|NCT01243424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65160425|NCT01243424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65160426|NCT01243424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160427|NCT01243424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65160428|NCT01243424|Immunologic Factors|immunologic factors|mesh-ancestor
65160429|NCT01243424|Incretins|incretins|mesh-ancestor
65160430|NCT01243424|Hormones|hormones|mesh-ancestor
65160431|NCT01243424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65160432|NCT01243424|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65160433|NCT01243424|Protease Inhibitors|protease inhibitors|mesh-ancestor
65160434|NCT01243424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160435|NCT01243424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160436|NCT02831023|Pyrimethamine|pyrimethamine|mesh-list
65160437|NCT02831023|Piperaquine|piperaquine|mesh-list
65160438|NCT02831023|Primaquine|primaquine|mesh-list
65160439|NCT02831023|Sulfadoxine|sulfadoxine|mesh-list
65160440|NCT02831023|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65160441|NCT02831023|Amodiaquine|amodiaquine|mesh-list
65160442|NCT02831023|Artenimol|artenimol|mesh-list
65160443|NCT02831023|Methylene Blue|methylene blue|mesh-list
65160444|NCT02831023|Antimalarials|antimalarials|mesh-ancestor
65160445|NCT02831023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65160446|NCT02831023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65160447|NCT02831023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65160448|NCT02831023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65160449|NCT02831023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160450|NCT02831023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505143|NCT03340662|Hormone Antagonists|hormone antagonists|mesh-ancestor
65160455|NCT04244695|Antiemetics|antiemetics|mesh-ancestor
65160456|NCT04244695|Autonomic Agents|autonomic agents|mesh-ancestor
65160457|NCT04244695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65160458|NCT04244695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160459|NCT04244695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65160460|NCT04244695|Glucocorticoids|glucocorticoids|mesh-ancestor
65160461|NCT04244695|Hormones|hormones|mesh-ancestor
65160462|NCT04244695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65310668|NCT04141319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65310669|NCT04141319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65310670|NCT04141319|Analgesics|analgesics|mesh-ancestor
65310671|NCT04141319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65310672|NCT04141319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65310673|NCT04141319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65310674|NCT04141319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310675|NCT00683891|Clozapine|clozapine|mesh-list
65310676|NCT00683891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65310677|NCT00683891|Serotonin Agents|serotonin agents|mesh-ancestor
65310678|NCT00683891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65310679|NCT00683891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310680|NCT00683891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310681|NCT00683891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65310682|NCT00683891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65310683|NCT00683891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65310684|NCT00683891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65310685|NCT00683891|GABA Antagonists|gaba antagonists|mesh-ancestor
65310686|NCT00683891|GABA Agents|gaba agents|mesh-ancestor
65310687|NCT00683969|Mycophenolic Acid|mycophenolic acid|mesh-list
65310688|NCT00683969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65310689|NCT00683969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310690|NCT00683969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65310691|NCT00683969|Antitubercular Agents|antitubercular agents|mesh-ancestor
65310692|NCT00683969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65310693|NCT00683969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65310694|NCT00683969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344940|NCT00864136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65160463|NCT04244695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65160464|NCT04244695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65160465|NCT00887809|Gemcitabine|gemcitabine|mesh-list
65160466|NCT00887809|Bevacizumab|bevacizumab|mesh-list
65160467|NCT00887809|Docetaxel|docetaxel|mesh-list
65160468|NCT00887809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65160469|NCT00887809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65160470|NCT00887809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65160471|NCT00887809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65160472|NCT00887809|Growth Substances|growth substances|mesh-ancestor
65160473|NCT00887809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160474|NCT00887809|Growth Inhibitors|growth inhibitors|mesh-ancestor
65160475|NCT00887809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65160477|NCT00887809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160478|NCT00887809|Antiviral Agents|antiviral agents|mesh-ancestor
65160479|NCT00887809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65160480|NCT00887809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160481|NCT00887809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65310695|NCT00683969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310696|NCT00778024|Fluoxetine|fluoxetine|mesh-list
65310697|NCT00778024|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65310698|NCT00778024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65310699|NCT00778024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65310700|NCT00778024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310701|NCT00778024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65310702|NCT00778024|Serotonin Agents|serotonin agents|mesh-ancestor
65310703|NCT00778024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310704|NCT00778024|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65310705|NCT00778024|Antidepressive Agents|antidepressive agents|mesh-ancestor
65310706|NCT00778024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65310707|NCT00778024|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65310708|NCT00778024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65310709|NCT00778024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310710|NCT00853658|Enalapril|enalapril|mesh-list
65310711|NCT00853658|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65310712|NCT00853658|Protease Inhibitors|protease inhibitors|mesh-ancestor
65310713|NCT00853658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310714|NCT00853658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310715|NCT00853658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65310716|NCT00690677|Panobinostat|panobinostat|mesh-list
65310717|NCT00690677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310718|NCT00690677|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65310719|NCT00690677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310720|NCT00690677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310721|NCT00781300|Loteprednol Etabonate|loteprednol etabonate|mesh-list
65310722|NCT00781300|Dexamethasone|dexamethasone|mesh-list
65310723|NCT00781300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65310724|NCT00781300|Antiemetics|antiemetics|mesh-ancestor
64540483|NCT00684723|Lovastatin|lovastatin|mesh-list
65160482|NCT00887809|Immunologic Factors|immunologic factors|mesh-ancestor
65160483|NCT00887809|Tubulin Modulators|tubulin modulators|mesh-ancestor
65160484|NCT00887809|Antimitotic Agents|antimitotic agents|mesh-ancestor
65160485|NCT00887809|Mitosis Modulators|mitosis modulators|mesh-ancestor
65160486|NCT02827747|Vitamin A|vitamin a|mesh-list
65160487|NCT02827747|Antioxidants|antioxidants|mesh-list
65160488|NCT02827747|Vitamins|vitamins|mesh-ancestor
65160489|NCT02827747|Micronutrients|micronutrients|mesh-ancestor
65160490|NCT02827747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160491|NCT02827747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160492|NCT02827747|Protective Agents|protective agents|mesh-ancestor
65310725|NCT00781300|Autonomic Agents|autonomic agents|mesh-ancestor
65310726|NCT00781300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65310727|NCT00781300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310728|NCT00781300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65310729|NCT00781300|Glucocorticoids|glucocorticoids|mesh-ancestor
65310731|NCT00781300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65310732|NCT00781300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65310733|NCT00781300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310734|NCT00781300|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65310735|NCT00781378|Plasminogen|plasminogen|mesh-list
65310736|NCT00781378|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65310737|NCT00781378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65310738|NCT00781378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65310739|NCT00781378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310740|NCT02625389|Ethiodized Oil|ethiodized oil|mesh-list
65310741|NCT02625389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310742|NCT00666562|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65310743|NCT00666562|Antioxidants|antioxidants|mesh-ancestor
65310744|NCT00666562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310745|NCT00666562|Protective Agents|protective agents|mesh-ancestor
65310746|NCT00666562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310747|NCT00666562|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65310748|NCT00666562|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65310749|NCT00666562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310750|NCT00666562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65310751|NCT00769054|Ropivacaine|ropivacaine|mesh-list
65310752|NCT00769054|Anesthetics, Local|anesthetics, local|mesh-ancestor
65310753|NCT00769054|Anesthetics|anesthetics|mesh-ancestor
65310754|NCT00769054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65160493|NCT04281628|Ketamine|ketamine|mesh-list
65160494|NCT04281628|Analgesics|analgesics|mesh-ancestor
65160495|NCT04281628|Sensory System Agents|sensory system agents|mesh-ancestor
65160496|NCT04281628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65160497|NCT04281628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160498|NCT04281628|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65160500|NCT04281628|Anesthetics, General|anesthetics, general|mesh-ancestor
65160501|NCT04281628|Anesthetics|anesthetics|mesh-ancestor
65160502|NCT04281628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65160503|NCT04281628|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65160504|NCT04281628|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65160505|NCT04281628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65160506|NCT04281628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160507|NCT00886795|Abatacept|abatacept|mesh-list
65310755|NCT00769054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310756|NCT00769054|Sensory System Agents|sensory system agents|mesh-ancestor
65310757|NCT00769054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65310758|NCT04138979|Cyclophosphamide|cyclophosphamide|mesh-list
65310759|NCT04138979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65310760|NCT04138979|Immunologic Factors|immunologic factors|mesh-ancestor
65310761|NCT04138979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310762|NCT04138979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65310763|NCT04138979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65310764|NCT04138979|Alkylating Agents|alkylating agents|mesh-ancestor
65310765|NCT04138979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310766|NCT04138979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310767|NCT04138979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65310768|NCT00666328|Clevidipine|clevidipine|mesh-list
65310769|NCT00666328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65310770|NCT00666328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65310771|NCT00666328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310772|NCT00666328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65310773|NCT00666328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310774|NCT00694343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65310775|NCT00778180|Furosemide|furosemide|mesh-list
65310776|NCT00778180|Diuretics|diuretics|mesh-ancestor
65310777|NCT00778180|Natriuretic Agents|natriuretic agents|mesh-ancestor
65310778|NCT00778180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310779|NCT00778180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65310780|NCT00778180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65310781|NCT00778180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310782|NCT00769210|Simvastatin|simvastatin|mesh-list
65310783|NCT00769210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65310784|NCT00769210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65160508|NCT00886795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65160509|NCT00886795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160510|NCT00886795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65160511|NCT00886795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65160512|NCT00886795|Immunologic Factors|immunologic factors|mesh-ancestor
65160513|NCT00886795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160514|NCT00886795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65160515|NCT02783482|Immunoglobulins|immunoglobulins|mesh-list
65160516|NCT02783482|gamma-Globulins|gamma-globulins|mesh-list
65160517|NCT02783482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65160518|NCT02783482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65310785|NCT00769210|Antimetabolites|antimetabolites|mesh-ancestor
65310786|NCT00769210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310787|NCT00769210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65310788|NCT00769210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65060689|NCT01641289|Acetaminophen|acetaminophen|mesh-list
65310789|NCT00769210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310790|NCT00690911|Adalimumab|adalimumab|mesh-list
65310791|NCT00690911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65310792|NCT00690911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65310793|NCT00781846|Sirolimus|sirolimus|mesh-list
65310794|NCT00781846|Bevacizumab|bevacizumab|mesh-list
65310795|NCT00781846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65310796|NCT00781846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310797|NCT00781846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65310798|NCT00781846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65310799|NCT00781846|Growth Substances|growth substances|mesh-ancestor
65310800|NCT00781846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310801|NCT00781846|Growth Inhibitors|growth inhibitors|mesh-ancestor
65310802|NCT00781846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65310803|NCT00781846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65310804|NCT00781846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65310805|NCT00781846|Antifungal Agents|antifungal agents|mesh-ancestor
65310806|NCT00781846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65310807|NCT00781846|Immunologic Factors|immunologic factors|mesh-ancestor
65310808|NCT00853580|Lovastatin|lovastatin|mesh-list
65310809|NCT00853580|L 647318|l 647318|mesh-list
65310810|NCT00853580|Dihydromevinolin|dihydromevinolin|mesh-list
65310811|NCT00853580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65310812|NCT00853580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65310813|NCT00853580|Antimetabolites|antimetabolites|mesh-ancestor
65310814|NCT00853580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160519|NCT02783482|Immunologic Factors|immunologic factors|mesh-ancestor
65160520|NCT02783482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160521|NCT00953680|Losartan|losartan|mesh-list
65160522|NCT00953680|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65160523|NCT00953680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65160524|NCT00953680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65160537|NCT00890929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65160538|NCT00890929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65160539|NCT00890929|Growth Substances|growth substances|mesh-ancestor
65160540|NCT00890929|Growth Inhibitors|growth inhibitors|mesh-ancestor
65160541|NCT00890929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65160542|NCT00890929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65160543|NCT00890929|Antimetabolites|antimetabolites|mesh-ancestor
65160544|NCT00890929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310815|NCT00853580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65310816|NCT00853580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65310817|NCT00853580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310818|NCT00688493|Dapagliflozin|dapagliflozin|mesh-list
65310819|NCT00688493|Moxifloxacin|moxifloxacin|mesh-list
65310820|NCT00688493|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65310821|NCT00688493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65310822|NCT00688493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65310823|NCT00688493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65310824|NCT00688493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65310825|NCT00688493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310826|NCT00688493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310827|NCT00688493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310828|NCT00688493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65310829|NCT00688493|Contraceptive Agents|contraceptive agents|mesh-ancestor
65310830|NCT00688493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65310831|NCT00688493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310832|NCT00688493|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65310833|NCT00688493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65310834|NCT00688493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65310835|NCT00688493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65310836|NCT00688493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65310837|NCT00778414|Amoxicillin|amoxicillin|mesh-list
65310838|NCT00778414|Clavulanic Acids|clavulanic acids|mesh-list
65310839|NCT00778414|Clavulanic Acid|clavulanic acid|mesh-list
65310840|NCT00778414|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65310841|NCT00778414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65310842|NCT00778414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65310843|NCT00778414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540597|NCT02320695|Bacitracin|bacitracin|mesh-list
65310856|NCT00912938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65310857|NCT00912938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310858|NCT00688805|Propranolol|propranolol|mesh-list
65310859|NCT00688805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65310860|NCT00688805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65310861|NCT00688805|Adrenergic Agents|adrenergic agents|mesh-ancestor
65310862|NCT00688805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65060780|NCT04823065|Loperamide|loperamide|mesh-list
65310863|NCT00688805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310864|NCT00688805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310865|NCT00688805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65310866|NCT00688805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65310867|NCT00688805|Vasodilator Agents|vasodilator agents|mesh-ancestor
65310868|NCT04136639|Proanthocyanidin|proanthocyanidin|mesh-list
65310869|NCT04136639|Grape Seed Extract|grape seed extract|mesh-list
65310870|NCT04136639|Fluorides|fluorides|mesh-list
65310871|NCT04136639|Sodium Fluoride|sodium fluoride|mesh-list
65310872|NCT04136639|Cariostatic Agents|cariostatic agents|mesh-ancestor
65310873|NCT04136639|Protective Agents|protective agents|mesh-ancestor
65310874|NCT04136639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310875|NCT04136639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65310876|NCT04136639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65310877|NCT04136639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310878|NCT04136639|Antioxidants|antioxidants|mesh-ancestor
65310879|NCT04136639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310880|NCT04136639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65310881|NCT04136639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65310882|NCT02613026|Cyclophosphamide|cyclophosphamide|mesh-list
65310883|NCT02613026|Docetaxel|docetaxel|mesh-list
65310884|NCT02613026|Pirarubicin|pirarubicin|mesh-list
65310885|NCT02613026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65310886|NCT02613026|Immunologic Factors|immunologic factors|mesh-ancestor
65310887|NCT02613026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310888|NCT02613026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65310889|NCT02613026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65310890|NCT02613026|Alkylating Agents|alkylating agents|mesh-ancestor
65160545|NCT00890929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160546|NCT04246567|Fentanyl|fentanyl|mesh-list
65160547|NCT04246567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65160548|NCT04246567|Narcotics|narcotics|mesh-ancestor
65160549|NCT04246567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65310891|NCT02613026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310892|NCT02613026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310893|NCT02613026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65310894|NCT02613026|Tubulin Modulators|tubulin modulators|mesh-ancestor
65310895|NCT02613026|Antimitotic Agents|antimitotic agents|mesh-ancestor
65310896|NCT02613026|Mitosis Modulators|mitosis modulators|mesh-ancestor
65310897|NCT00778726|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65310898|NCT00778726|Benazepril|benazepril|mesh-list
65310899|NCT00778726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65310900|NCT00778726|Diuretics|diuretics|mesh-ancestor
65310901|NCT00778726|Natriuretic Agents|natriuretic agents|mesh-ancestor
65310902|NCT00778726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310903|NCT00778726|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65310904|NCT00778726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65310905|NCT00778726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310906|NCT00778726|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65310907|NCT00778726|Protease Inhibitors|protease inhibitors|mesh-ancestor
65310908|NCT00778726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310909|NCT00688883|Fludarabine|fludarabine|mesh-list
65310910|NCT00688883|Fludarabine phosphate|fludarabine phosphate|mesh-list
65310911|NCT00688883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310912|NCT00688883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65310913|NCT00688883|Antimetabolites|antimetabolites|mesh-ancestor
65310914|NCT00688883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310915|NCT00688883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65310916|NCT00688883|Immunologic Factors|immunologic factors|mesh-ancestor
65310917|NCT00688883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310918|NCT00769522|Cyclophosphamide|cyclophosphamide|mesh-list
65310919|NCT00769522|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65310920|NCT00769522|Rituximab|rituximab|mesh-list
65310921|NCT00769522|Fludarabine|fludarabine|mesh-list
65310922|NCT00769522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65310931|NCT00769522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65310932|NCT00688961|Aspirin|aspirin|mesh-list
65310933|NCT00688961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65310934|NCT00688961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65310935|NCT00688961|Analgesics|analgesics|mesh-ancestor
65310936|NCT00688961|Sensory System Agents|sensory system agents|mesh-ancestor
65310937|NCT00688961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65310938|NCT00688961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310939|NCT00688961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65310940|NCT00688961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65310941|NCT00688961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65310942|NCT00688961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65310943|NCT00688961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310944|NCT00688961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65310945|NCT00688961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65310946|NCT00688961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310947|NCT00688961|Antipyretics|antipyretics|mesh-ancestor
65310948|NCT00782470|Factor VIII|factor viii|mesh-list
65310949|NCT00782470|Coagulants|coagulants|mesh-ancestor
65310950|NCT00865280|Moxifloxacin|moxifloxacin|mesh-list
65310951|NCT00865280|Linezolid|linezolid|mesh-list
65310952|NCT00865280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65310953|NCT00865280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65310954|NCT00865280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65310955|NCT00865280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65310956|NCT00865280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310957|NCT00865280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310958|NCT00865280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310959|NCT00865280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65310960|NCT04136327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65310961|NCT00782548|Morphine|morphine|mesh-list
65310962|NCT00782548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65310963|NCT00782548|Narcotics|narcotics|mesh-ancestor
65310964|NCT00782548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65310965|NCT00782548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310970|NCT00689195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65310971|NCT00689195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65310972|NCT00689195|Analgesics|analgesics|mesh-ancestor
65310973|NCT00689195|Sensory System Agents|sensory system agents|mesh-ancestor
65310974|NCT00689195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65310975|NCT00689195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310976|NCT00689195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65310977|NCT00689195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65310978|NCT00689195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65310979|NCT00689195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65310980|NCT00689195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310981|NCT00865124|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65310982|NCT00865124|Spironolactone|spironolactone|mesh-list
65310983|NCT00865124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65310984|NCT00865124|Diuretics|diuretics|mesh-ancestor
65310985|NCT00865124|Natriuretic Agents|natriuretic agents|mesh-ancestor
65310986|NCT00865124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310987|NCT00865124|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65310988|NCT00865124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65310989|NCT00865124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65310990|NCT00865124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65310991|NCT00865124|Hormone Antagonists|hormone antagonists|mesh-ancestor
65310992|NCT00865124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65310993|NCT00865124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65310994|NCT00691067|Mifepristone|mifepristone|mesh-list
65310995|NCT00691067|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65310996|NCT00691067|Abortifacient Agents|abortifacient agents|mesh-ancestor
65310997|NCT00691067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65310998|NCT00691067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65310999|NCT00691067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65311000|NCT00691067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65311008|NCT00691067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65311009|NCT00691067|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65311010|NCT00691145|Tacrolimus|tacrolimus|mesh-list
65311011|NCT00691145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65311012|NCT00691145|Immunologic Factors|immunologic factors|mesh-ancestor
65311013|NCT00691145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311014|NCT00691145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65311015|NCT00691145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311016|NCT00691145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311017|NCT00694967|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
65311018|NCT00694967|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
65311019|NCT00694967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65311020|NCT00694967|Hormone Antagonists|hormone antagonists|mesh-ancestor
65311021|NCT00694967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65311022|NCT00694967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311024|NCT00694967|Hormones|hormones|mesh-ancestor
65311025|NCT00695045|Morphine|morphine|mesh-list
65311026|NCT00695045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65311027|NCT00695045|Narcotics|narcotics|mesh-ancestor
65311028|NCT00695045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65311029|NCT00695045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311030|NCT00695045|Analgesics|analgesics|mesh-ancestor
65311031|NCT00695045|Sensory System Agents|sensory system agents|mesh-ancestor
65311032|NCT00695045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65311033|NCT02624453|Fluconazole|fluconazole|mesh-list
65311034|NCT02624453|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65311035|NCT02624453|Antifungal Agents|antifungal agents|mesh-ancestor
65311036|NCT02624453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65311037|NCT02624453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65311038|NCT02624453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65311039|NCT02624453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311050|NCT00819234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311051|NCT00695201|Oxaliplatin|oxaliplatin|mesh-list
65311052|NCT00695201|Irinotecan|irinotecan|mesh-list
65311053|NCT00695201|Floxuridine|floxuridine|mesh-list
65311054|NCT00695201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311055|NCT00695201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65311056|NCT00695201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65311057|NCT00695201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311058|NCT00695201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311059|NCT00695201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65311060|NCT00695201|Antimetabolites|antimetabolites|mesh-ancestor
65311061|NCT00689585|Ethosuximide|ethosuximide|mesh-list
65311062|NCT00689585|Anticonvulsants|anticonvulsants|mesh-ancestor
65311063|NCT00667342|Bevacizumab|bevacizumab|mesh-list
65311064|NCT00667342|Doxorubicin|doxorubicin|mesh-list
65311065|NCT00667342|Methotrexate|methotrexate|mesh-list
65311066|NCT00667342|Etoposide|etoposide|mesh-list
65311067|NCT00667342|Ifosfamide|ifosfamide|mesh-list
65311068|NCT00667342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65311069|NCT00667342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311070|NCT00667342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65311071|NCT00667342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65311072|NCT00667342|Growth Substances|growth substances|mesh-ancestor
65311073|NCT00667342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311074|NCT00667342|Growth Inhibitors|growth inhibitors|mesh-ancestor
65311075|NCT00667342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65311076|NCT00667342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65311077|NCT00667342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65311078|NCT00667342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311079|NCT00667342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311080|NCT00667342|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65311081|NCT00667342|Abortifacient Agents|abortifacient agents|mesh-ancestor
65311092|NCT00667342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65311093|NCT00667342|Alkylating Agents|alkylating agents|mesh-ancestor
65311094|NCT00783016|Morphine|morphine|mesh-list
65311095|NCT00783016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65311096|NCT00783016|Narcotics|narcotics|mesh-ancestor
65311097|NCT00783016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65311098|NCT00783016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311099|NCT00783016|Analgesics|analgesics|mesh-ancestor
65311100|NCT00783016|Sensory System Agents|sensory system agents|mesh-ancestor
65311101|NCT00783016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65311102|NCT00769990|Genistein|genistein|mesh-list
65311103|NCT00769990|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65311104|NCT00769990|Protective Agents|protective agents|mesh-ancestor
65311105|NCT00769990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311106|NCT00769990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311107|NCT00769990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65311108|NCT00769990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311109|NCT00769990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311110|NCT00769990|Phytoestrogens|phytoestrogens|mesh-ancestor
65311111|NCT00769990|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65311112|NCT00769990|Estrogens|estrogens|mesh-ancestor
65311113|NCT00769990|Hormones|hormones|mesh-ancestor
65311114|NCT00769990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65311115|NCT00784420|Raltegravir Potassium|raltegravir potassium|mesh-list
65311116|NCT00784420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65311117|NCT00784420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65311118|NCT00784420|Antiviral Agents|antiviral agents|mesh-ancestor
65311119|NCT00784420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65311120|NCT00784420|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65311121|NCT00784420|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65311122|NCT00784420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311123|NCT00784420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311124|NCT02555800|Cidofovir|cidofovir|mesh-list
65311125|NCT02555800|Bevacizumab|bevacizumab|mesh-list
65311126|NCT02555800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65311127|NCT02555800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311130|NCT02555800|Growth Substances|growth substances|mesh-ancestor
65311131|NCT02555800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311132|NCT02555800|Growth Inhibitors|growth inhibitors|mesh-ancestor
65311133|NCT02555800|Antiviral Agents|antiviral agents|mesh-ancestor
65311134|NCT02555800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65311135|NCT02555800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311136|NCT02555800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311137|NCT00783172|Gemcitabine|gemcitabine|mesh-list
65311138|NCT00783172|Mitogens|mitogens|mesh-list
65311139|NCT00783172|Enkephalins|enkephalins|mesh-list
65311140|NCT00783172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65311141|NCT00783172|Antimetabolites|antimetabolites|mesh-ancestor
65311142|NCT00783172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311143|NCT00783172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311144|NCT00783172|Antiviral Agents|antiviral agents|mesh-ancestor
65311145|NCT00783172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65311146|NCT00783172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311147|NCT00783172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65311148|NCT00783172|Immunologic Factors|immunologic factors|mesh-ancestor
65311149|NCT00783172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311150|NCT00783172|Mitosis Modulators|mitosis modulators|mesh-ancestor
65311151|NCT00783172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65311152|NCT00783250|Albuterol|albuterol|mesh-list
65311153|NCT00783250|Tiotropium Bromide|tiotropium bromide|mesh-list
65311154|NCT00783250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65311155|NCT00783250|Autonomic Agents|autonomic agents|mesh-ancestor
65311156|NCT00783250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65311157|NCT00783250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311158|NCT00783250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65311159|NCT00783250|Respiratory System Agents|respiratory system agents|mesh-ancestor
65061061|NCT02757898|Biotin|biotin|mesh-list
65311175|NCT00871403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311176|NCT00871403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311177|NCT00871403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311178|NCT00871403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65311179|NCT00871403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65311180|NCT00691379|Paclitaxel|paclitaxel|mesh-list
65311181|NCT00691379|Bevacizumab|bevacizumab|mesh-list
65311182|NCT00691379|Carboplatin|carboplatin|mesh-list
65311183|NCT00691379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65311184|NCT00691379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311185|NCT00691379|Tubulin Modulators|tubulin modulators|mesh-ancestor
65311186|NCT00691379|Antimitotic Agents|antimitotic agents|mesh-ancestor
65311187|NCT00691379|Mitosis Modulators|mitosis modulators|mesh-ancestor
65311188|NCT00691379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311189|NCT00691379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65311190|NCT00691379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65311191|NCT00691379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65311192|NCT00691379|Growth Substances|growth substances|mesh-ancestor
65311193|NCT00691379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311194|NCT00691379|Growth Inhibitors|growth inhibitors|mesh-ancestor
65311195|NCT02624531|Cisplatin|cisplatin|mesh-list
65311196|NCT02624531|Taxane|taxane|mesh-list
65311197|NCT02624531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311198|NCT00691457|Contact Lens Solutions|contact lens solutions|mesh-list
65311199|NCT00691457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65311200|NCT00691457|Disinfectants|disinfectants|mesh-ancestor
65311201|NCT00691457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65311202|NCT04136015|Dasatinib|dasatinib|mesh-list
65311203|NCT04136015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311204|NCT04136015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65311205|NCT04136015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311206|NCT04136015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311207|NCT02624063|Sofosbuvir|sofosbuvir|mesh-list
65311208|NCT02624063|Simeprevir|simeprevir|mesh-list
65311209|NCT02624063|Antiviral Agents|antiviral agents|mesh-ancestor
65311210|NCT02624063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65311211|NCT02624063|Protease Inhibitors|protease inhibitors|mesh-ancestor
65160550|NCT04246567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160551|NCT04246567|Analgesics|analgesics|mesh-ancestor
65160552|NCT04246567|Sensory System Agents|sensory system agents|mesh-ancestor
65311212|NCT02624063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311213|NCT02624063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311214|NCT05298683|Acetaminophen|acetaminophen|mesh-list
65311215|NCT05298683|Diphenhydramine|diphenhydramine|mesh-list
65311216|NCT05298683|Promethazine|promethazine|mesh-list
65311217|NCT05298683|Dexamethasone|dexamethasone|mesh-list
65311218|NCT05298683|Pomalidomide|pomalidomide|mesh-list
65311219|NCT05298683|Ranitidine|ranitidine|mesh-list
65311220|NCT05298683|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65311221|NCT05298683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65311222|NCT05298683|Antiemetics|antiemetics|mesh-ancestor
65311223|NCT05298683|Autonomic Agents|autonomic agents|mesh-ancestor
65311224|NCT05298683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65311225|NCT05298683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311226|NCT05298683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65311227|NCT05298683|Glucocorticoids|glucocorticoids|mesh-ancestor
65311228|NCT05298683|Hormones|hormones|mesh-ancestor
65311229|NCT05298683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65311230|NCT05298683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65311231|NCT05298683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311232|NCT05298683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65311233|NCT05298683|Analgesics|analgesics|mesh-ancestor
65311234|NCT05298683|Sensory System Agents|sensory system agents|mesh-ancestor
65311235|NCT05298683|Antipyretics|antipyretics|mesh-ancestor
65311236|NCT05298683|Immunologic Factors|immunologic factors|mesh-ancestor
65311237|NCT05298683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65311238|NCT05298683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65311239|NCT05298683|Growth Substances|growth substances|mesh-ancestor
65311240|NCT05298683|Growth Inhibitors|growth inhibitors|mesh-ancestor
65311241|NCT05298683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65311242|NCT05298683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65311243|NCT05298683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65311244|NCT05298683|Anesthetics, Local|anesthetics, local|mesh-ancestor
65311246|NCT05298683|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65311247|NCT05298683|Histamine Antagonists|histamine antagonists|mesh-ancestor
65311248|NCT05298683|Histamine Agents|histamine agents|mesh-ancestor
65311253|NCT05298683|Dermatologic Agents|dermatologic agents|mesh-ancestor
65311254|NCT05298683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65311255|NCT05298683|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65311256|NCT00853112|Sildenafil Citrate|sildenafil citrate|mesh-list
65311257|NCT00853112|Vasodilator Agents|vasodilator agents|mesh-ancestor
65311258|NCT00853112|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65311259|NCT00853112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65311260|NCT00853112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311261|NCT00853112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311262|NCT00853112|Urological Agents|urological agents|mesh-ancestor
65311263|NCT02624141|Epoetin Alfa|epoetin alfa|mesh-list
65311264|NCT02624141|Hematinics|hematinics|mesh-ancestor
65311265|NCT00691613|Epoetin Alfa|epoetin alfa|mesh-list
65311266|NCT00691613|Hematinics|hematinics|mesh-ancestor
65311267|NCT00460603|Bevacizumab|bevacizumab|mesh-list
65311268|NCT00460603|Axitinib|axitinib|mesh-list
65311269|NCT00460603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65311270|NCT00460603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311271|NCT00460603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65311272|NCT00460603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65311273|NCT00460603|Growth Substances|growth substances|mesh-ancestor
65311274|NCT00460603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311275|NCT00460603|Growth Inhibitors|growth inhibitors|mesh-ancestor
65311276|NCT00460603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65311277|NCT00460603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311278|NCT00460603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311279|NCT00696059|Adalimumab|adalimumab|mesh-list
65311280|NCT00696059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65311281|NCT00696059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65311282|NCT00700466|Metoprolol|metoprolol|mesh-list
65311283|NCT00700466|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65311284|NCT00700466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65311285|NCT00700466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65311286|NCT00700466|Sympatholytics|sympatholytics|mesh-ancestor
65311287|NCT00700466|Autonomic Agents|autonomic agents|mesh-ancestor
65311288|NCT00700466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65311289|NCT00700466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541056|NCT03469050|Rifaximin|rifaximin|mesh-list
65311290|NCT00700466|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65311291|NCT00700466|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65311292|NCT00700466|Adrenergic Agents|adrenergic agents|mesh-ancestor
65311293|NCT00700466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65311294|NCT00700466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311295|NCT00700544|Norethandrolone|norethandrolone|mesh-list
65311296|NCT00700544|Anabolic Agents|anabolic agents|mesh-ancestor
65311297|NCT00700544|Hormones|hormones|mesh-ancestor
65311298|NCT00700544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65311299|NCT00700544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311300|NCT02612792|Atorvastatin|atorvastatin|mesh-list
65311301|NCT02612792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65311302|NCT02612792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65311303|NCT02612792|Antimetabolites|antimetabolites|mesh-ancestor
65311304|NCT02612792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311305|NCT02612792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65311306|NCT02612792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65311307|NCT02612792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311308|NCT00662038|Pirfenidone|pirfenidone|mesh-list
65311309|NCT00662038|Analgesics|analgesics|mesh-ancestor
65311310|NCT00662038|Sensory System Agents|sensory system agents|mesh-ancestor
65061211|NCT02271997|Trace Elements|trace elements|mesh-ancestor
65311311|NCT00662038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65311312|NCT00662038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311313|NCT00662038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65311314|NCT00662038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65311315|NCT00662038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65311316|NCT00662038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65311317|NCT00662038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311318|NCT00701792|Liver Extracts|liver extracts|mesh-list
65311319|NCT00701792|Hematinics|hematinics|mesh-ancestor
65311320|NCT00784498|Midazolam|midazolam|mesh-list
65311321|NCT00784498|Ketamine|ketamine|mesh-list
65160553|NCT04246567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65160554|NCT04246567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65160555|NCT04246567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65160556|NCT04246567|Anesthetics, General|anesthetics, general|mesh-ancestor
65160557|NCT04246567|Anesthetics|anesthetics|mesh-ancestor
65160558|NCT02830243|Sevoflurane|sevoflurane|mesh-list
65160559|NCT02830243|Desflurane|desflurane|mesh-list
65160560|NCT02830243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65160561|NCT02830243|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65160562|NCT02830243|Anesthetics, General|anesthetics, general|mesh-ancestor
65311322|NCT00784498|Propofol|propofol|mesh-list
65311323|NCT00784498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65311324|NCT00784498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65311325|NCT00784498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311326|NCT00784498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65311327|NCT00784498|Anesthetics, General|anesthetics, general|mesh-ancestor
65311328|NCT00784498|Anesthetics|anesthetics|mesh-ancestor
65311329|NCT00784498|Analgesics|analgesics|mesh-ancestor
65311330|NCT00784498|Sensory System Agents|sensory system agents|mesh-ancestor
65311331|NCT00784498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65311332|NCT00784498|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65311333|NCT00784498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65311334|NCT00784498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65311335|NCT00784498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65311336|NCT00784498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311337|NCT00784498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65311338|NCT00784498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65311339|NCT00784498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65311340|NCT00784498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65311341|NCT00784498|GABA Modulators|gaba modulators|mesh-ancestor
65311342|NCT00784498|GABA Agents|gaba agents|mesh-ancestor
65311343|NCT01022983|Simendan|simendan|mesh-list
65311344|NCT01022983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65311352|NCT00912860|Interferons|interferons|mesh-list
65311374|NCT02623673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65311375|NCT02623673|Glucocorticoids|glucocorticoids|mesh-ancestor
65311376|NCT02623673|Hormones|hormones|mesh-ancestor
65311377|NCT02623673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65311378|NCT02623673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65311379|NCT00784732|Mometasone Furoate|mometasone furoate|mesh-list
65311380|NCT00784732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65311381|NCT00784732|Dermatologic Agents|dermatologic agents|mesh-ancestor
65311382|NCT00784732|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65311383|NCT00459979|Sunitinib|sunitinib|mesh-list
65311384|NCT00459979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311385|NCT00459979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65061338|NCT00252863|Xhance|xhance|mesh-list
65311386|NCT00459979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65311387|NCT00459979|Growth Substances|growth substances|mesh-ancestor
65311388|NCT00459979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311389|NCT00459979|Growth Inhibitors|growth inhibitors|mesh-ancestor
65311390|NCT00459979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65311391|NCT00459979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311392|NCT00459979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311393|NCT00783484|Maraviroc|maraviroc|mesh-list
65311394|NCT00783484|Darunavir|darunavir|mesh-list
65311395|NCT00783484|Midazolam|midazolam|mesh-list
65311396|NCT00783484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65311397|NCT00783484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65311398|NCT00783484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65311399|NCT00783484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311400|NCT00783484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65311401|NCT00783484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65311402|NCT00783484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65311403|NCT00783484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65311404|NCT00783484|Anesthetics, General|anesthetics, general|mesh-ancestor
65311405|NCT00783484|Anesthetics|anesthetics|mesh-ancestor
65311416|NCT00783484|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65311417|NCT00783484|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65311418|NCT00783484|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65311419|NCT00783484|Protease Inhibitors|protease inhibitors|mesh-ancestor
65311420|NCT00783484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311421|NCT00828672|Bevacizumab|bevacizumab|mesh-list
65311422|NCT00828672|Capecitabine|capecitabine|mesh-list
65311423|NCT00828672|Oxaliplatin|oxaliplatin|mesh-list
65311424|NCT00828672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65311425|NCT00828672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311426|NCT00828672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65311427|NCT00828672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65311428|NCT00828672|Growth Substances|growth substances|mesh-ancestor
65311429|NCT00828672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311430|NCT00828672|Growth Inhibitors|growth inhibitors|mesh-ancestor
65311431|NCT00828672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65311432|NCT00828672|Antimetabolites|antimetabolites|mesh-ancestor
65311433|NCT00828672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311434|NCT00784888|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65311435|NCT00784888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65311436|NCT00784888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311437|NCT00784888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311438|NCT00784888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65311439|NCT00784888|Hormone Antagonists|hormone antagonists|mesh-ancestor
65311440|NCT00784888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65311441|NCT00784888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311442|NCT00873119|Paclitaxel|paclitaxel|mesh-list
65311443|NCT00873119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65311461|NCT00706680|Cyclosporine|cyclosporine|mesh-list
65311462|NCT00706680|Mycophenolic Acid|mycophenolic acid|mesh-list
65311463|NCT00706680|Prednisone|prednisone|mesh-list
65311464|NCT00706680|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65311465|NCT00706680|Cyclosporins|cyclosporins|mesh-list
65311466|NCT00706680|Thymoglobulin|thymoglobulin|mesh-list
65311467|NCT00706680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65311468|NCT00706680|Glucocorticoids|glucocorticoids|mesh-ancestor
65311469|NCT00706680|Hormones|hormones|mesh-ancestor
65311470|NCT00706680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65311471|NCT00706680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311472|NCT00706680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65311473|NCT00706680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311474|NCT00706680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311475|NCT00706680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311476|NCT00706680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65311477|NCT00706680|Immunologic Factors|immunologic factors|mesh-ancestor
65311478|NCT00706680|Antifungal Agents|antifungal agents|mesh-ancestor
65311479|NCT00706680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65311480|NCT00706680|Dermatologic Agents|dermatologic agents|mesh-ancestor
65311481|NCT00706680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65311482|NCT00706680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65311483|NCT00706680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65311484|NCT00706680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65311485|NCT00706680|Antitubercular Agents|antitubercular agents|mesh-ancestor
65311486|NCT00706680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65311487|NCT00706680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65311488|NCT00706680|Protective Agents|protective agents|mesh-ancestor
65311489|NCT02624999|Cisplatin|cisplatin|mesh-list
65311490|NCT02624999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311491|NCT02612480|Aspirin|aspirin|mesh-list
65311492|NCT02612480|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
65311493|NCT02612480|Clopidogrel|clopidogrel|mesh-list
65311494|NCT02612480|Ticagrelor|ticagrelor|mesh-list
65311495|NCT02612480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65311496|NCT02612480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65311497|NCT02612480|Analgesics|analgesics|mesh-ancestor
65311498|NCT02612480|Sensory System Agents|sensory system agents|mesh-ancestor
65311499|NCT02612480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65311500|NCT02612480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311501|NCT02612480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65311502|NCT02612480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65311503|NCT02612480|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65311504|NCT02612480|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65311505|NCT02612480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311506|NCT02612480|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65311507|NCT02612480|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65311508|NCT02612480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311509|NCT02612480|Antipyretics|antipyretics|mesh-ancestor
65311510|NCT02612480|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65311511|NCT02612480|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65311512|NCT02612480|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65311513|NCT02612480|Purinergic Agents|purinergic agents|mesh-ancestor
65311514|NCT02612480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65311515|NCT00784966|Etanercept|etanercept|mesh-list
65311516|NCT00784966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65311517|NCT00784966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65311518|NCT00784966|Analgesics|analgesics|mesh-ancestor
65311519|NCT00784966|Sensory System Agents|sensory system agents|mesh-ancestor
65311520|NCT00784966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65311521|NCT00784966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311522|NCT00784966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65311523|NCT00784966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65311524|NCT00784966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65311525|NCT00784966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65311526|NCT00784966|Immunologic Factors|immunologic factors|mesh-ancestor
65311527|NCT02623595|Molgramostim|molgramostim|mesh-list
65311528|NCT02623595|Sargramostim|sargramostim|mesh-list
65311529|NCT02623595|Immunologic Factors|immunologic factors|mesh-ancestor
65311530|NCT02623595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311531|NCT02623595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311532|NCT00665392|Docetaxel|docetaxel|mesh-list
65311533|NCT00665392|Fluorouracil|fluorouracil|mesh-list
65311534|NCT00665392|Cetuximab|cetuximab|mesh-list
65311535|NCT00665392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311536|NCT00665392|Tubulin Modulators|tubulin modulators|mesh-ancestor
65311537|NCT00665392|Antimitotic Agents|antimitotic agents|mesh-ancestor
65061440|NCT00281307|Antioxidants|antioxidants|mesh-ancestor
65311538|NCT00665392|Mitosis Modulators|mitosis modulators|mesh-ancestor
65311539|NCT00665392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311540|NCT00665392|Antimetabolites|antimetabolites|mesh-ancestor
65311541|NCT00665392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65311542|NCT00665392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65311543|NCT00665392|Immunologic Factors|immunologic factors|mesh-ancestor
65311544|NCT00665392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311545|NCT00665392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65311547|NCT00851630|Zidovudine|zidovudine|mesh-list
65311548|NCT00851630|Abacavir|abacavir|mesh-list
65311549|NCT00851630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65311550|NCT00851630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65311551|NCT00851630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311552|NCT00851630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311553|NCT00851630|Antiviral Agents|antiviral agents|mesh-ancestor
65311554|NCT00851630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65311555|NCT00851630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65311556|NCT00851630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65311557|NCT00851630|Antimetabolites|antimetabolites|mesh-ancestor
65311558|NCT05298761|Lidocaine|lidocaine|mesh-list
65311559|NCT05298761|Nalbuphine|nalbuphine|mesh-list
65311560|NCT05298761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65311561|NCT05298761|Narcotics|narcotics|mesh-ancestor
65311562|NCT05298761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65311563|NCT05298761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311564|NCT05298761|Analgesics|analgesics|mesh-ancestor
65311565|NCT05298761|Sensory System Agents|sensory system agents|mesh-ancestor
65311566|NCT05298761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65311567|NCT05298761|Anesthetics, Local|anesthetics, local|mesh-ancestor
65311568|NCT05298761|Anesthetics|anesthetics|mesh-ancestor
65311569|NCT05298761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65311570|NCT05298761|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65311571|NCT05298761|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65160563|NCT02830243|Anesthetics|anesthetics|mesh-ancestor
65160564|NCT02830243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65160565|NCT02830243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160566|NCT00889603|Donepezil|donepezil|mesh-list
65160567|NCT00889603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65311572|NCT05298761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65311573|NCT05298761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311574|NCT00459667|Interferons|interferons|mesh-list
65311575|NCT00459667|Interferon-beta|interferon-beta|mesh-list
65311576|NCT00459667|Interferon beta-1b|interferon beta-1b|mesh-list
65311577|NCT00459667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311578|NCT00459667|Antiviral Agents|antiviral agents|mesh-ancestor
65311579|NCT00459667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65311580|NCT00459667|Immunologic Factors|immunologic factors|mesh-ancestor
65311581|NCT00459667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311582|NCT00459667|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65311583|NCT02621255|Bupivacaine|bupivacaine|mesh-list
65311584|NCT02621255|Anesthetics|anesthetics|mesh-list
65311585|NCT02621255|Sevoflurane|sevoflurane|mesh-list
65311586|NCT02621255|Anesthetics, Local|anesthetics, local|mesh-ancestor
65311587|NCT02621255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65311588|NCT02621255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311589|NCT02621255|Sensory System Agents|sensory system agents|mesh-ancestor
65311590|NCT02621255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65311591|NCT02621255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65311592|NCT02621255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65311593|NCT02621255|Anesthetics, General|anesthetics, general|mesh-ancestor
65311594|NCT00828204|Interferons|interferons|mesh-list
65311595|NCT00828204|Interferon-beta|interferon-beta|mesh-list
65311596|NCT00828204|Interferon beta-1a|interferon beta-1a|mesh-list
65311597|NCT00828204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311598|NCT00828204|Antiviral Agents|antiviral agents|mesh-ancestor
65311599|NCT00828204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65311600|NCT00828204|Immunologic Factors|immunologic factors|mesh-ancestor
65311601|NCT00828204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311602|NCT00828204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65311616|NCT00784186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65311617|NCT00784186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65311618|NCT00784186|Oxytocics|oxytocics|mesh-ancestor
65311619|NCT00784186|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65311620|NCT00784186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65311621|NCT00784186|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65311622|NCT00784186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65311623|NCT00784186|Contraceptive Agents|contraceptive agents|mesh-ancestor
65311624|NCT00784186|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65311625|NCT00784186|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65311626|NCT00784186|Hormone Antagonists|hormone antagonists|mesh-ancestor
65311627|NCT00784186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65311628|NCT00784186|Luteolytic Agents|luteolytic agents|mesh-ancestor
65311629|NCT00784186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65311630|NCT00784186|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65311631|NCT00851552|Rituximab|rituximab|mesh-list
65311632|NCT00851552|Doxorubicin|doxorubicin|mesh-list
65311633|NCT00851552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65311634|NCT00851552|Bortezomib|bortezomib|mesh-list
65311635|NCT00851552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65311636|NCT00851552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311637|NCT00851552|Immunologic Factors|immunologic factors|mesh-ancestor
65311638|NCT00851552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311639|NCT00851552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65311640|NCT00851552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65311641|NCT00851552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65311642|NCT00851552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65311643|NCT00851552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311644|NCT00851552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311645|NCT00785122|Cyclophosphamide|cyclophosphamide|mesh-list
65311646|NCT00785122|Molgramostim|molgramostim|mesh-list
65311647|NCT00785122|Imiquimod|imiquimod|mesh-list
65311648|NCT00785122|Sargramostim|sargramostim|mesh-list
65311649|NCT00785122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65311655|NCT00785122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311656|NCT00785122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311657|NCT00785122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65311658|NCT00785122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65311659|NCT00785122|Interferon Inducers|interferon inducers|mesh-ancestor
65311660|NCT04116554|Bupivacaine|bupivacaine|mesh-list
65311661|NCT04116554|Anesthetics, Local|anesthetics, local|mesh-ancestor
65311662|NCT04116554|Anesthetics|anesthetics|mesh-ancestor
65311663|NCT04116554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65311664|NCT04116554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311665|NCT04116554|Sensory System Agents|sensory system agents|mesh-ancestor
65311666|NCT04116554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65311667|NCT00700856|Pioglitazone|pioglitazone|mesh-list
65311668|NCT00700856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65311669|NCT00700856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311670|NCT00790114|Midazolam|midazolam|mesh-list
65311671|NCT00790114|Caffeine|caffeine|mesh-list
65311672|NCT00790114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65311673|NCT00790114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65311674|NCT00790114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65311675|NCT00790114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311676|NCT00790114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65311677|NCT00790114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65311678|NCT00790114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65311679|NCT00790114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65311706|NCT00795262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311707|NCT00795262|Protective Agents|protective agents|mesh-ancestor
65311708|NCT00795262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311709|NCT00795262|Vitamin B Complex|vitamin b complex|mesh-ancestor
65311710|NCT00795262|Vitamins|vitamins|mesh-ancestor
65311711|NCT00795262|Micronutrients|micronutrients|mesh-ancestor
65311712|NCT00795262|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65311713|NCT00795262|Protease Inhibitors|protease inhibitors|mesh-ancestor
65311714|NCT00795262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311715|NCT00795262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65311716|NCT00785200|Chlorhexidine|chlorhexidine|mesh-list
65311717|NCT00785200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65311718|NCT00785200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65311719|NCT00785200|Disinfectants|disinfectants|mesh-ancestor
65311720|NCT00817206|Tacrolimus|tacrolimus|mesh-list
65311721|NCT00817206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65311722|NCT00817206|Immunologic Factors|immunologic factors|mesh-ancestor
65311723|NCT00817206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311724|NCT00817206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65311725|NCT00817206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311726|NCT00817206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311759|NCT04015908|Acetaminophen|acetaminophen|mesh-list
65311760|NCT04015908|Celecoxib|celecoxib|mesh-list
65311761|NCT04015908|Pregabalin|pregabalin|mesh-list
65311762|NCT04015908|Oxycodone|oxycodone|mesh-list
65311763|NCT04015908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65061671|NCT00287859|Topotecan|topotecan|mesh-list
65311764|NCT04015908|Analgesics|analgesics|mesh-ancestor
65311765|NCT04015908|Sensory System Agents|sensory system agents|mesh-ancestor
65311766|NCT04015908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65311767|NCT04015908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311768|NCT04015908|Antipyretics|antipyretics|mesh-ancestor
65311769|NCT04015908|Anticonvulsants|anticonvulsants|mesh-ancestor
65311770|NCT04015908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65311771|NCT04015908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65311772|NCT04015908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311773|NCT04015908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65311774|NCT04015908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65311775|NCT04015908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65311776|NCT04015908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65311777|NCT04015908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65311778|NCT04015908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65311779|NCT04015908|Narcotics|narcotics|mesh-ancestor
65311780|NCT04015908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65311781|NCT04015908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65311782|NCT04015908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65311783|NCT04015908|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65311784|NCT04015908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65311785|NCT04015908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311786|NCT00790816|Lapatinib|lapatinib|mesh-list
65311787|NCT00790816|Antineoplastic Agents|antineoplastic agents|mesh-list
65311788|NCT00790816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65311789|NCT00790816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311790|NCT00790816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311791|NCT00873041|Deferasirox|deferasirox|mesh-list
65311792|NCT00873041|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65160568|NCT00889603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160569|NCT00889603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160571|NCT00889603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65160572|NCT00889603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160573|NCT00889603|Nootropic Agents|nootropic agents|mesh-ancestor
65160574|NCT05660941|Insulin Lispro|insulin lispro|mesh-list
65311793|NCT00873041|Chelating Agents|chelating agents|mesh-ancestor
65311794|NCT00873041|Sequestering Agents|sequestering agents|mesh-ancestor
65311795|NCT00873041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311796|NCT00795496|Histamine|histamine|mesh-list
65311797|NCT00795496|Histamine Agonists|histamine agonists|mesh-ancestor
65311798|NCT00795496|Histamine Agents|histamine agents|mesh-ancestor
65311799|NCT00795496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65311800|NCT00795496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311801|NCT00795496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311802|NCT00795574|Infliximab|infliximab|mesh-list
65311803|NCT00795574|Dermatologic Agents|dermatologic agents|mesh-ancestor
65311804|NCT00795574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65311805|NCT00795574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65311806|NCT00785434|Citalopram|citalopram|mesh-list
65311807|NCT00785434|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65311808|NCT00785434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65311809|NCT00785434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65311810|NCT00785434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311811|NCT00785434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65311812|NCT00785434|Serotonin Agents|serotonin agents|mesh-ancestor
65311813|NCT00785434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311814|NCT00785434|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65311815|NCT00785434|Antidepressive Agents|antidepressive agents|mesh-ancestor
65311816|NCT00785434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65311817|NCT00790894|Epothilones|epothilones|mesh-list
65311818|NCT00790894|Tubulin Modulators|tubulin modulators|mesh-ancestor
65311819|NCT00790894|Antimitotic Agents|antimitotic agents|mesh-ancestor
65311820|NCT00790894|Mitosis Modulators|mitosis modulators|mesh-ancestor
65311821|NCT00790894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311822|NCT00790894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311823|NCT02623127|Sunitinib|sunitinib|mesh-list
65311824|NCT02623127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311825|NCT02623127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64541587|NCT04341090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160575|NCT05660941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65160576|NCT05660941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160577|NCT02829385|Apatinib|apatinib|mesh-list
65160578|NCT02829385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65160579|NCT02829385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65160580|NCT02829385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222833|NCT02700087|Histamine Antagonists|histamine antagonists|mesh-ancestor
65311826|NCT02623127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65311827|NCT02623127|Growth Substances|growth substances|mesh-ancestor
65311828|NCT02623127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311829|NCT02623127|Growth Inhibitors|growth inhibitors|mesh-ancestor
65311830|NCT02623127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65311831|NCT02623127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311832|NCT02623127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311833|NCT05263492|Pembrolizumab|pembrolizumab|mesh-list
65311834|NCT05263492|Lenvatinib|lenvatinib|mesh-list
65311835|NCT05263492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65311836|NCT05263492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311837|NCT05263492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65311838|NCT05263492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311839|NCT05263492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311840|NCT04134611|Hyaluronic Acid|hyaluronic acid|mesh-list
65311841|NCT04134611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65311843|NCT04134611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311844|NCT04134611|Viscosupplements|viscosupplements|mesh-ancestor
65311845|NCT04134611|Protective Agents|protective agents|mesh-ancestor
65311846|NCT02620631|Morphine|morphine|mesh-list
65311847|NCT02620631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65311848|NCT02620631|Narcotics|narcotics|mesh-ancestor
65311849|NCT02620631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65311850|NCT02620631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311851|NCT02620631|Analgesics|analgesics|mesh-ancestor
65311852|NCT02620631|Sensory System Agents|sensory system agents|mesh-ancestor
65311853|NCT02620631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65311854|NCT04030572|Clonidine|clonidine|mesh-list
65311855|NCT04030572|Analgesics|analgesics|mesh-ancestor
65160581|NCT02829385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160582|NCT02826343|Xenon|xenon|mesh-list
65160583|NCT02826343|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65160584|NCT02826343|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65160585|NCT02826343|Anesthetics, General|anesthetics, general|mesh-ancestor
65160586|NCT02826343|Anesthetics|anesthetics|mesh-ancestor
65160587|NCT02826343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65160603|NCT05660785|Immunologic Factors|immunologic factors|mesh-ancestor
65160604|NCT05660785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160605|NCT05660785|Antifungal Agents|antifungal agents|mesh-ancestor
65160606|NCT05660785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65160607|NCT05660785|Dermatologic Agents|dermatologic agents|mesh-ancestor
65160608|NCT05660785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65160609|NCT05660785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65160611|NCT04246255|Anesthetics, Local|anesthetics, local|mesh-ancestor
65160612|NCT04246255|Anesthetics|anesthetics|mesh-ancestor
65160613|NCT04246255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65311856|NCT04030572|Sensory System Agents|sensory system agents|mesh-ancestor
65311857|NCT04030572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65311858|NCT04030572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311859|NCT04030572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65311860|NCT04030572|Sympatholytics|sympatholytics|mesh-ancestor
65311861|NCT04030572|Autonomic Agents|autonomic agents|mesh-ancestor
65311862|NCT04030572|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65311863|NCT04030572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65311864|NCT04030572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65311865|NCT04030572|Adrenergic Agents|adrenergic agents|mesh-ancestor
65311866|NCT04030572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65311867|NCT04030572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311868|NCT00795808|Metformin|metformin|mesh-list
65311869|NCT00795808|Clomiphene|clomiphene|mesh-list
65311870|NCT00795808|Enclomiphene|enclomiphene|mesh-list
65311871|NCT00795808|Zuclomiphene|zuclomiphene|mesh-list
65311872|NCT00795808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65311873|NCT00795808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311874|NCT00795808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65311875|NCT00795808|Hormone Antagonists|hormone antagonists|mesh-ancestor
65311876|NCT00795808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65311877|NCT00795808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65311878|NCT00795808|Fertility Agents|fertility agents|mesh-ancestor
65311879|NCT00795808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65311880|NCT00795808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65311881|NCT00795808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65311882|NCT04135781|Paclitaxel|paclitaxel|mesh-list
65311883|NCT04135781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65311884|NCT04135781|Capecitabine|capecitabine|mesh-list
65311885|NCT04135781|Oxaliplatin|oxaliplatin|mesh-list
65311886|NCT04135781|Tegafur|tegafur|mesh-list
65311887|NCT04135781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65311888|NCT04135781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311889|NCT04135781|Tubulin Modulators|tubulin modulators|mesh-ancestor
65311897|NCT04135313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65311898|NCT04135313|Antimetabolites|antimetabolites|mesh-ancestor
65311899|NCT04135313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311900|NCT04135313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311901|NCT00692159|Pemetrexed|pemetrexed|mesh-list
65311902|NCT00692159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65311903|NCT00692159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311904|NCT00692159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311905|NCT00692159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65311906|NCT00692159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65311907|NCT00692315|Vitamin B 12|vitamin b 12|mesh-list
65311908|NCT00692315|Vitamins|vitamins|mesh-ancestor
65311909|NCT00692315|Micronutrients|micronutrients|mesh-ancestor
65311910|NCT00692315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311911|NCT00692315|Vitamin B Complex|vitamin b complex|mesh-ancestor
65311912|NCT02623049|Anticoagulants|anticoagulants|mesh-list
65311913|NCT02608944|Adenosine|adenosine|mesh-list
65311914|NCT02608944|Regadenoson|regadenoson|mesh-list
65311915|NCT02608944|Analgesics|analgesics|mesh-ancestor
65311916|NCT02608944|Sensory System Agents|sensory system agents|mesh-ancestor
65311917|NCT02608944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65311918|NCT02608944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311919|NCT02608944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65311920|NCT02608944|Vasodilator Agents|vasodilator agents|mesh-ancestor
65311921|NCT02608944|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65311922|NCT02608944|Purinergic Agonists|purinergic agonists|mesh-ancestor
65311923|NCT02608944|Purinergic Agents|purinergic agents|mesh-ancestor
65311924|NCT02608944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65311925|NCT02608944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160614|NCT04246255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160615|NCT04246255|Sensory System Agents|sensory system agents|mesh-ancestor
65160616|NCT04246255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65160617|NCT04246255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65160618|NCT04246255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65160619|NCT04246255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65160620|NCT04246255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65160621|NCT04246255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160622|NCT02825953|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65160623|NCT02825953|Respiratory System Agents|respiratory system agents|mesh-ancestor
65160624|NCT05217589|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65160625|NCT05217589|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
65160626|NCT05217589|beta-Endorphin|beta-endorphin|mesh-list
65160627|NCT05217589|Hormones|hormones|mesh-ancestor
65160628|NCT05217589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65160629|NCT05217589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311926|NCT02608944|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65311927|NCT00913614|SR 46349B|sr 46349b|mesh-list
65311928|NCT00913614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65311929|NCT00913614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65311930|NCT00913614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311931|NCT00913614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65311932|NCT00913614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65311933|NCT00913614|Serotonin Agents|serotonin agents|mesh-ancestor
65311934|NCT00913614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65311935|NCT00913614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311936|NCT00664534|Insulin|insulin|mesh-list
65311937|NCT00664534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65311938|NCT00664534|Insulin Glargine|insulin glargine|mesh-list
65311939|NCT00664534|Insulin Lispro|insulin lispro|mesh-list
65311940|NCT00664534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65311941|NCT00664534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311942|NCT00913848|Valproic Acid|valproic acid|mesh-list
65311943|NCT00913848|Anticonvulsants|anticonvulsants|mesh-ancestor
65311944|NCT00913848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65311945|NCT00913848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311946|NCT00913848|GABA Agents|gaba agents|mesh-ancestor
65311947|NCT00913848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65311948|NCT00913848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311949|NCT00913848|Antimanic Agents|antimanic agents|mesh-ancestor
65311950|NCT00913848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65311951|NCT00913848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65311952|NCT00913848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65311953|NCT02620163|Amlodipine|amlodipine|mesh-list
65311954|NCT02620163|Telmisartan|telmisartan|mesh-list
65311955|NCT02620163|Chlorthalidone|chlorthalidone|mesh-list
65311956|NCT02620163|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
65311957|NCT02620163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65311958|NCT02620163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65311959|NCT02620163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65311960|NCT02620163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541710|NCT01270191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65160630|NCT05217589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65160631|NCT05217589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160632|NCT05210725|Rivaroxaban|rivaroxaban|mesh-list
65160633|NCT05210725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65311961|NCT02620163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65311962|NCT02620163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311963|NCT02620163|Vasodilator Agents|vasodilator agents|mesh-ancestor
65311964|NCT02620163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65311965|NCT02620163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65311966|NCT02620163|Diuretics|diuretics|mesh-ancestor
65311967|NCT02620163|Natriuretic Agents|natriuretic agents|mesh-ancestor
65311968|NCT02620163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65311969|NCT00912821|Dialysis Solutions|dialysis solutions|mesh-list
65311970|NCT00912821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65311971|NCT00570310|Pregabalin|pregabalin|mesh-list
65311972|NCT00570310|Analgesics|analgesics|mesh-ancestor
65311973|NCT00570310|Sensory System Agents|sensory system agents|mesh-ancestor
65311974|NCT00570310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65311975|NCT00570310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311976|NCT00570310|Anticonvulsants|anticonvulsants|mesh-ancestor
65311977|NCT00570310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65311978|NCT00570310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65311979|NCT00570310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65311980|NCT00570310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65311981|NCT00570310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65311982|NCT00570310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65311983|NCT00570310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65311984|NCT00570310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65311985|NCT00696995|Insulin Aspart|insulin aspart|mesh-list
65311986|NCT00696995|Biphasic Insulins|biphasic insulins|mesh-list
65311987|NCT00696995|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65311988|NCT00696995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65311989|NCT00696995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65311990|NCT00664066|Epoetin Alfa|epoetin alfa|mesh-list
65061891|NCT02274571|Estrogens|estrogens|mesh-list
65311991|NCT00664066|Hematinics|hematinics|mesh-ancestor
65311992|NCT04676958|Vitamin K|vitamin k|mesh-list
65311993|NCT04676958|Vitamin K 2|vitamin k 2|mesh-list
65311994|NCT04676958|Vitamins|vitamins|mesh-ancestor
65311999|NCT04676958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312000|NCT04676958|Hemostatics|hemostatics|mesh-ancestor
65312001|NCT04676958|Coagulants|coagulants|mesh-ancestor
65312002|NCT02619929|Vinorelbine|vinorelbine|mesh-list
65312003|NCT02619929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65312004|NCT02619929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312005|NCT02619929|Tubulin Modulators|tubulin modulators|mesh-ancestor
65312006|NCT02619929|Antimitotic Agents|antimitotic agents|mesh-ancestor
65312007|NCT02619929|Mitosis Modulators|mitosis modulators|mesh-ancestor
65312008|NCT02619929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312009|NCT00796198|Latanoprost|latanoprost|mesh-list
65312010|NCT00796198|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65312011|NCT00796198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65312012|NCT02622503|Rituximab|rituximab|mesh-list
65312013|NCT02622503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65312014|NCT02622503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312015|NCT02622503|Immunologic Factors|immunologic factors|mesh-ancestor
65312016|NCT02622503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312017|NCT02622503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65312018|NCT00814710|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65312019|NCT00814710|Immunologic Factors|immunologic factors|mesh-ancestor
65312020|NCT00814710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312021|NCT00796276|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65312022|NCT00796276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65312023|NCT00796276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65312024|NCT00796276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65312025|NCT00796276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312026|NCT00796276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65312027|NCT00796276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65312028|NCT00796276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65312029|NCT00796276|Serotonin Agents|serotonin agents|mesh-ancestor
65312030|NCT00796276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65312031|NCT00796276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312032|NCT00796276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65312033|NCT00796276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65312034|NCT00796276|Dopamine Agents|dopamine agents|mesh-ancestor
65312035|NCT00796432|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65312036|NCT00796432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65312037|NCT00796432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65312038|NCT00796432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65312039|NCT00796432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312040|NCT00796432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65312041|NCT00796432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65312042|NCT00796432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65312043|NCT00796432|Serotonin Agents|serotonin agents|mesh-ancestor
65312044|NCT00796432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65312045|NCT00796432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312046|NCT00796432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65312047|NCT00796432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65312048|NCT00796432|Dopamine Agents|dopamine agents|mesh-ancestor
65312049|NCT00786058|Fluorouracil|fluorouracil|mesh-list
65312050|NCT00786058|Antimetabolites|antimetabolites|mesh-ancestor
65312051|NCT00786058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312052|NCT00786058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65312053|NCT00786058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312054|NCT00786058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65312055|NCT00786058|Immunologic Factors|immunologic factors|mesh-ancestor
65312086|NCT00814632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312087|NCT00814632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65312088|NCT00814632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65312089|NCT00814632|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65312090|NCT00814632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65312091|NCT00814632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312092|NCT00814632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312093|NCT00786136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65312094|NCT00786136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65312095|NCT00786136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65312096|NCT00786136|Antimetabolites|antimetabolites|mesh-ancestor
65312097|NCT00786136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312098|NCT00786136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65312099|NCT00786136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65312100|NCT00786136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312101|NCT02620007|Ciprofloxacin|ciprofloxacin|mesh-list
65312102|NCT02620007|Rifaximin|rifaximin|mesh-list
65312103|NCT02620007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65312104|NCT02620007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65312105|NCT02620007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65312106|NCT02620007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65312107|NCT02620007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312108|NCT02620007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312109|NCT02620007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312110|NCT02620007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65312111|NCT02620007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65312112|NCT02620007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65312113|NCT02554942|Epoetin Alfa|epoetin alfa|mesh-list
65312114|NCT02554942|Hematinics|hematinics|mesh-ancestor
65312115|NCT02619773|Mupirocin|mupirocin|mesh-list
65312116|NCT02619773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65312117|NCT02619773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65312118|NCT02619773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65312119|NCT02619773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344941|NCT00864136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160634|NCT05210725|Antithrombins|antithrombins|mesh-ancestor
65160635|NCT05210725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65312120|NCT02619773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312121|NCT02555488|Methylene Blue|methylene blue|mesh-list
65312122|NCT02555488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312123|NCT02555488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312124|NCT02554864|Lidocaine|lidocaine|mesh-list
65312125|NCT02554864|Ropivacaine|ropivacaine|mesh-list
65312126|NCT02554864|Anesthetics, Local|anesthetics, local|mesh-ancestor
65312127|NCT02554864|Anesthetics|anesthetics|mesh-ancestor
65312128|NCT02554864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65312129|NCT02554864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312130|NCT02554864|Sensory System Agents|sensory system agents|mesh-ancestor
65312131|NCT02554864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65312132|NCT02554864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65312133|NCT02554864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65312134|NCT02554864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65312135|NCT02554864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65312136|NCT02554864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312137|NCT00851318|Methotrexate|methotrexate|mesh-list
65312138|NCT00851318|Certolizumab Pegol|certolizumab pegol|mesh-list
65312139|NCT00851318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65312140|NCT00851318|Abortifacient Agents|abortifacient agents|mesh-ancestor
65312141|NCT00851318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65312142|NCT00851318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312143|NCT00851318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65312145|NCT00851318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312146|NCT00851318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312147|NCT00851318|Dermatologic Agents|dermatologic agents|mesh-ancestor
65312148|NCT00851318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312149|NCT00851318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65312150|NCT00851318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65312151|NCT00851318|Immunologic Factors|immunologic factors|mesh-ancestor
65160636|NCT05210725|Protease Inhibitors|protease inhibitors|mesh-ancestor
65160637|NCT05210725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160638|NCT05210725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160639|NCT05210725|Anticoagulants|anticoagulants|mesh-ancestor
65160640|NCT02826031|Hyaluronic Acid|hyaluronic acid|mesh-list
65160641|NCT02826031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65160643|NCT02826031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160644|NCT02826031|Viscosupplements|viscosupplements|mesh-ancestor
65160645|NCT02826031|Protective Agents|protective agents|mesh-ancestor
65160646|NCT02829697|Ropivacaine|ropivacaine|mesh-list
65160648|NCT02829697|Anesthetics|anesthetics|mesh-ancestor
65312152|NCT00851318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65312153|NCT00851318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65312154|NCT00786370|Dexmedetomidine|dexmedetomidine|mesh-list
65312155|NCT00786370|Propofol|propofol|mesh-list
65312156|NCT00786370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65312157|NCT00786370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65312158|NCT00786370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312159|NCT00786370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65312160|NCT00786370|Anesthetics, General|anesthetics, general|mesh-ancestor
65312161|NCT00786370|Anesthetics|anesthetics|mesh-ancestor
65312162|NCT00786370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65312163|NCT00786370|Analgesics|analgesics|mesh-ancestor
65312164|NCT00786370|Sensory System Agents|sensory system agents|mesh-ancestor
65312165|NCT00786370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65312166|NCT00786370|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65312167|NCT00786370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65312168|NCT00786370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65312169|NCT00786370|Adrenergic Agents|adrenergic agents|mesh-ancestor
65312170|NCT00786370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65312171|NCT00786370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312172|NCT00796900|Dantrolene|dantrolene|mesh-list
65312173|NCT00796900|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65312174|NCT00796900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312175|NCT00796900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65312176|NCT00796900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65312177|NCT00791830|Irbesartan|irbesartan|mesh-list
65312178|NCT00791830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65312179|NCT00791830|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65312180|NCT00791830|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65312181|NCT00791830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312182|NCT00786448|Darifenacin|darifenacin|mesh-list
65312183|NCT00786448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65312184|NCT00786448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65312185|NCT00786448|Cholinergic Agents|cholinergic agents|mesh-ancestor
65312186|NCT00786448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65344942|NCT00864136|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65312187|NCT00786448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312188|NCT00786448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312189|NCT00786448|Urological Agents|urological agents|mesh-ancestor
65312190|NCT04137653|Paclitaxel|paclitaxel|mesh-list
65312191|NCT04137653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65312192|NCT04137653|Carboplatin|carboplatin|mesh-list
65312193|NCT04137653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65312194|NCT04137653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312195|NCT04137653|Tubulin Modulators|tubulin modulators|mesh-ancestor
65312196|NCT04137653|Antimitotic Agents|antimitotic agents|mesh-ancestor
65312197|NCT04137653|Mitosis Modulators|mitosis modulators|mesh-ancestor
65312198|NCT04137653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312199|NCT00797056|Aspirin|aspirin|mesh-list
65312200|NCT00797056|Clopidogrel|clopidogrel|mesh-list
65312201|NCT00797056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65312202|NCT00797056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65312203|NCT00797056|Analgesics|analgesics|mesh-ancestor
65312204|NCT00797056|Sensory System Agents|sensory system agents|mesh-ancestor
65312205|NCT00797056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65312206|NCT00797056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312207|NCT00797056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65312208|NCT00797056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65312209|NCT00797056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65312210|NCT00797056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65312211|NCT00797056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312212|NCT00797056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65312213|NCT00797056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65312214|NCT00797056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312215|NCT00797056|Antipyretics|antipyretics|mesh-ancestor
65312216|NCT00797056|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65312217|NCT00797056|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65312218|NCT00797056|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65312227|NCT00593957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312228|NCT00593957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312229|NCT00697151|Aspirin|aspirin|mesh-list
65312230|NCT00697151|Warfarin|warfarin|mesh-list
65312231|NCT00697151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65312232|NCT00697151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65312233|NCT00697151|Analgesics|analgesics|mesh-ancestor
65312234|NCT00697151|Sensory System Agents|sensory system agents|mesh-ancestor
65312235|NCT00697151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65312236|NCT00697151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312237|NCT00697151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65312238|NCT00697151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65312239|NCT00697151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65312240|NCT00697151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65312241|NCT00697151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312242|NCT00697151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65312243|NCT00697151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65312244|NCT00697151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312245|NCT00697151|Antipyretics|antipyretics|mesh-ancestor
65312246|NCT00697151|Anticoagulants|anticoagulants|mesh-ancestor
65312247|NCT02621957|Pravastatin|pravastatin|mesh-list
65312248|NCT02621957|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65312249|NCT02621957|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65312250|NCT02621957|Antimetabolites|antimetabolites|mesh-ancestor
65312251|NCT02621957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312252|NCT02621957|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65312253|NCT02621957|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65312254|NCT02621957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312255|NCT00851084|Leucovorin|leucovorin|mesh-list
65312256|NCT00851084|Folic Acid|folic acid|mesh-list
65312257|NCT00851084|Oxaliplatin|oxaliplatin|mesh-list
65312258|NCT00851084|Aflibercept|aflibercept|mesh-list
65312259|NCT00851084|Levoleucovorin|levoleucovorin|mesh-list
65312260|NCT00851084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312261|NCT00851084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65312262|NCT00851084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65312265|NCT00851084|Growth Inhibitors|growth inhibitors|mesh-ancestor
65312266|NCT00851084|Antidotes|antidotes|mesh-ancestor
65312267|NCT00851084|Protective Agents|protective agents|mesh-ancestor
65312268|NCT00851084|Vitamin B Complex|vitamin b complex|mesh-ancestor
65312269|NCT00851084|Vitamins|vitamins|mesh-ancestor
65312270|NCT00851084|Micronutrients|micronutrients|mesh-ancestor
65312271|NCT00851084|Hematinics|hematinics|mesh-ancestor
65312272|NCT02617199|Fentanyl|fentanyl|mesh-list
65312273|NCT02617199|Analgesics|analgesics|mesh-list
65312274|NCT02617199|Ropivacaine|ropivacaine|mesh-list
65312275|NCT02617199|Anesthetics|anesthetics|mesh-ancestor
64978168|NCT00268489|Pemetrexed|pemetrexed|mesh-list
65160649|NCT02829697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65160650|NCT02829697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160651|NCT02829697|Sensory System Agents|sensory system agents|mesh-ancestor
65160652|NCT02829697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65160654|NCT02829151|Cilostazol|cilostazol|mesh-list
65160655|NCT02829151|Clopidogrel|clopidogrel|mesh-list
65160656|NCT02829151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65160657|NCT02829151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65160658|NCT02829151|Analgesics|analgesics|mesh-ancestor
65160659|NCT02829151|Sensory System Agents|sensory system agents|mesh-ancestor
65160660|NCT02829151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65160661|NCT02829151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160662|NCT02829151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65160663|NCT02829151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65160664|NCT02829151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65160665|NCT02829151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65160666|NCT02829151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160667|NCT02829151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65160668|NCT02829151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65160669|NCT02829151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160670|NCT02829151|Antipyretics|antipyretics|mesh-ancestor
65160671|NCT02829151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65160672|NCT02829151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65160673|NCT02829151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65160674|NCT02829151|Purinergic Agents|purinergic agents|mesh-ancestor
65160675|NCT02829151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65160676|NCT02829151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65160677|NCT02829151|Autonomic Agents|autonomic agents|mesh-ancestor
65160678|NCT02829151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65160679|NCT02829151|Respiratory System Agents|respiratory system agents|mesh-ancestor
65160680|NCT02829151|Vasodilator Agents|vasodilator agents|mesh-ancestor
65160681|NCT02829151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65160682|NCT02829151|Protective Agents|protective agents|mesh-ancestor
65160683|NCT02829151|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65160684|NCT02829151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65160685|NCT05660395|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
65160686|NCT05660395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65160687|NCT05660395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65160688|NCT02825719|Tranexamic Acid|tranexamic acid|mesh-list
65160689|NCT02825719|Ulipristal acetate|ulipristal acetate|mesh-list
65160690|NCT02825719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65160691|NCT02825719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65160692|NCT02825719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160694|NCT02825719|Coagulants|coagulants|mesh-ancestor
65160695|NCT02825719|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65160696|NCT02825719|Contraceptive Agents|contraceptive agents|mesh-ancestor
65160697|NCT02825719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65160698|NCT02825719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160699|NCT02825719|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65160700|NCT04241653|Sevoflurane|sevoflurane|mesh-list
65160701|NCT04241653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65160702|NCT04241653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65160703|NCT04241653|Anesthetics, General|anesthetics, general|mesh-ancestor
65160704|NCT04241653|Anesthetics|anesthetics|mesh-ancestor
65160705|NCT04241653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65312276|NCT02617199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65312277|NCT02617199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312278|NCT02617199|Anesthetics, Local|anesthetics, local|mesh-ancestor
65312279|NCT02617199|Sensory System Agents|sensory system agents|mesh-ancestor
65312280|NCT02617199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65312281|NCT02617199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65312282|NCT02617199|Narcotics|narcotics|mesh-ancestor
65312283|NCT02617199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65312284|NCT02617199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65062227|NCT00254618|Mesalamine|mesalamine|mesh-list
65312285|NCT02617199|Anesthetics, General|anesthetics, general|mesh-ancestor
65312286|NCT00845858|Metoclopramide|metoclopramide|mesh-list
65312287|NCT00845858|Antiemetics|antiemetics|mesh-ancestor
65312288|NCT00845858|Autonomic Agents|autonomic agents|mesh-ancestor
65312289|NCT00845858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65312290|NCT00845858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312291|NCT00845858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65312292|NCT00845858|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65312293|NCT00845858|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65312294|NCT00845858|Dopamine Agents|dopamine agents|mesh-ancestor
65312295|NCT00845858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65312296|NCT00845858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312297|NCT02619149|Tazobactam|tazobactam|mesh-list
65312298|NCT02619149|Piperacillin|piperacillin|mesh-list
65312299|NCT02619149|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65312300|NCT02619149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65312301|NCT02619149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65312302|NCT02619149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65312303|NCT02619149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312304|NCT02619149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312305|NCT04134065|Vitamin D|vitamin d|mesh-list
65312306|NCT04134065|Vitamins|vitamins|mesh-ancestor
65312307|NCT04134065|Micronutrients|micronutrients|mesh-ancestor
65312308|NCT04134065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160706|NCT04241653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160707|NCT04241731|Cetuximab|cetuximab|mesh-list
65160708|NCT04241731|Raltitrexed|raltitrexed|mesh-list
65160709|NCT04241731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65160710|NCT04241731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65160711|NCT04241731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65160712|NCT04241731|Antimetabolites|antimetabolites|mesh-ancestor
65312309|NCT04134065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65312310|NCT02616731|Tranexamic Acid|tranexamic acid|mesh-list
65312311|NCT02616731|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65312312|NCT02616731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65312313|NCT02616731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312314|NCT02616731|Hemostatics|hemostatics|mesh-ancestor
65312315|NCT02616731|Coagulants|coagulants|mesh-ancestor
65312316|NCT00850460|Atorvastatin|atorvastatin|mesh-list
65312317|NCT00850460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65312318|NCT00850460|Simvastatin|simvastatin|mesh-list
65312319|NCT00850460|Pravastatin|pravastatin|mesh-list
65312320|NCT00850460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65312321|NCT00850460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65312322|NCT00850460|Antimetabolites|antimetabolites|mesh-ancestor
65312323|NCT00850460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312324|NCT00850460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65312325|NCT00850460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65312326|NCT00850460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312327|NCT00661492|Cetuximab|cetuximab|mesh-list
65312328|NCT00661492|Mitoxantrone|mitoxantrone|mesh-list
65312329|NCT00661492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65312330|NCT00661492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312331|NCT00661492|Analgesics|analgesics|mesh-ancestor
65312332|NCT00661492|Sensory System Agents|sensory system agents|mesh-ancestor
65312333|NCT00661492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65312334|NCT00661492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312335|NCT00661492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65312336|NCT00661492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65312337|NCT00661492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312338|NCT00661492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312339|NCT00693251|Sirolimus|sirolimus|mesh-list
65312340|NCT00693251|Paclitaxel|paclitaxel|mesh-list
65312341|NCT00693251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65312351|NCT00693251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312352|NCT00693251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65312353|NCT00693251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65312354|NCT00693251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65312355|NCT00693251|Antifungal Agents|antifungal agents|mesh-ancestor
65312356|NCT00792376|Diclofenac|diclofenac|mesh-list
65312357|NCT00792376|Etoricoxib|etoricoxib|mesh-list
65312358|NCT00792376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65312359|NCT00792376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65312360|NCT00792376|Analgesics|analgesics|mesh-ancestor
65312361|NCT00792376|Sensory System Agents|sensory system agents|mesh-ancestor
65312362|NCT00792376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65062270|NCT01607671|Timolol|timolol|mesh-list
65312363|NCT00792376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312364|NCT00792376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65312365|NCT00792376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65312366|NCT00792376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65312367|NCT00792376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312368|NCT00792376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312369|NCT00792376|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65312370|NCT00592358|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65312371|NCT00592358|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65312372|NCT00592358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65312373|NCT00592358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65312374|NCT00592358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312375|NCT00592358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65312376|NCT00592358|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65312377|NCT00592358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65312378|NCT00592358|Serotonin Agents|serotonin agents|mesh-ancestor
65312379|NCT00592358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65312380|NCT00592358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160713|NCT04241731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160714|NCT04241731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65160715|NCT04241731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160716|NCT04241887|Anesthetics|anesthetics|mesh-list
65160717|NCT04241887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65160718|NCT04241887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160719|NCT02825797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65160720|NCT02825797|Antibodies|antibodies|mesh-list
65160732|NCT02824315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160734|NCT04242433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65160735|NCT02823925|Zoledronic Acid|zoledronic acid|mesh-list
65312381|NCT00592358|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65312382|NCT00592358|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65312383|NCT00592358|Dopamine Agents|dopamine agents|mesh-ancestor
65312384|NCT00814320|Immunoglobulins|immunoglobulins|mesh-list
65312385|NCT00814320|Antibodies|antibodies|mesh-list
65312386|NCT00814320|gamma-Globulins|gamma-globulins|mesh-list
65312387|NCT00814320|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65312388|NCT00814320|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65312389|NCT00814320|Immunoglobulin G|immunoglobulin g|mesh-list
65312390|NCT00814320|Immunologic Factors|immunologic factors|mesh-ancestor
65312391|NCT00814320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312392|NCT00869999|Rituximab|rituximab|mesh-list
65312393|NCT00869999|Everolimus|everolimus|mesh-list
65312394|NCT00869999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65312395|NCT00869999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312396|NCT00869999|Immunologic Factors|immunologic factors|mesh-ancestor
65312397|NCT00869999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312398|NCT00869999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65312399|NCT00869999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65312400|NCT04030988|Dexamethasone|dexamethasone|mesh-list
65312401|NCT04030988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65312402|NCT04030988|Antiemetics|antiemetics|mesh-ancestor
65312403|NCT04030988|Autonomic Agents|autonomic agents|mesh-ancestor
65312404|NCT04030988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65312405|NCT04030988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312406|NCT04030988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65312407|NCT04030988|Glucocorticoids|glucocorticoids|mesh-ancestor
65312408|NCT04030988|Hormones|hormones|mesh-ancestor
65312409|NCT04030988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65312410|NCT04030988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65312412|NCT00703352|Eplerenone|eplerenone|mesh-list
65312426|NCT00703430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312427|NCT00703430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312428|NCT00703430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65312429|NCT00703430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65312430|NCT00797836|Interferons|interferons|mesh-list
65312431|NCT00797836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312432|NCT00797836|Antiviral Agents|antiviral agents|mesh-ancestor
65312433|NCT00797836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65312434|NCT00693407|Capsaicin|capsaicin|mesh-list
65312435|NCT00693407|Antipruritics|antipruritics|mesh-ancestor
65312436|NCT00693407|Dermatologic Agents|dermatologic agents|mesh-ancestor
65312437|NCT00693407|Sensory System Agents|sensory system agents|mesh-ancestor
65312438|NCT00693407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65312439|NCT00693407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312440|NCT02618603|Triamcinolone|triamcinolone|mesh-list
65312441|NCT02618603|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65312442|NCT02618603|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65312443|NCT02618603|Botulinum Toxins|botulinum toxins|mesh-list
65312444|NCT02618603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65312445|NCT02618603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65312446|NCT02618603|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65312447|NCT02618603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65312448|NCT02618603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65312449|NCT02618603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312450|NCT02618603|Cholinergic Agents|cholinergic agents|mesh-ancestor
65312451|NCT02618603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65312452|NCT02618603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312453|NCT02618603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65312454|NCT02618603|Glucocorticoids|glucocorticoids|mesh-ancestor
65312455|NCT02618603|Hormones|hormones|mesh-ancestor
65312456|NCT02618603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65312457|NCT02618603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64542214|NCT04993560|Vaccines|vaccines|mesh-list
65160736|NCT02823925|Pamidronate|pamidronate|mesh-list
65160737|NCT02823925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65160738|NCT02823925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160739|NCT04201249|Piroxicam|piroxicam|mesh-list
65160740|NCT04201249|Lidocaine|lidocaine|mesh-list
65160741|NCT04201249|Anesthetics, Local|anesthetics, local|mesh-ancestor
65160742|NCT04201249|Anesthetics|anesthetics|mesh-ancestor
65160743|NCT04201249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65160744|NCT04201249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312458|NCT02618603|Immunologic Factors|immunologic factors|mesh-ancestor
65312459|NCT02618603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312460|NCT02618603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65312461|NCT02618603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65312462|NCT02616497|Aspirin|aspirin|mesh-list
65312463|NCT02616497|Triflusal|triflusal|mesh-list
65312464|NCT02616497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65312465|NCT02616497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65312466|NCT02616497|Analgesics|analgesics|mesh-ancestor
65312467|NCT02616497|Sensory System Agents|sensory system agents|mesh-ancestor
65312468|NCT02616497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65312469|NCT02616497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312470|NCT02616497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65312471|NCT02616497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65312472|NCT02616497|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65312473|NCT02616497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65312474|NCT02616497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312475|NCT02616497|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65312476|NCT02616497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65312477|NCT02616497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312478|NCT02616497|Antipyretics|antipyretics|mesh-ancestor
65312479|NCT00570232|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65312480|NCT00570232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312481|NCT00570232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65312482|NCT00570232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160745|NCT04201249|Sensory System Agents|sensory system agents|mesh-ancestor
65160746|NCT04201249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65160747|NCT04201249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65160748|NCT04201249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65160749|NCT04201249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65160750|NCT04201249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65160751|NCT04201249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160752|NCT04201249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65160753|NCT04201249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65160754|NCT04201249|Analgesics|analgesics|mesh-ancestor
65160755|NCT04201249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65160756|NCT04201249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65160757|NCT04201249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65160758|NCT04201249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160759|NCT00633685|Fluoxetine|fluoxetine|mesh-list
65160760|NCT00633685|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65160761|NCT00633685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65160762|NCT00633685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65160763|NCT00633685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160764|NCT00633685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65160765|NCT00633685|Serotonin Agents|serotonin agents|mesh-ancestor
65160766|NCT00633685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160767|NCT00633685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65312483|NCT00570232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312484|NCT05755854|Cyclophosphamide|cyclophosphamide|mesh-list
65312485|NCT05755854|Fludarabine|fludarabine|mesh-list
65312486|NCT05755854|Fludarabine phosphate|fludarabine phosphate|mesh-list
65312487|NCT05755854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65312488|NCT05755854|Immunologic Factors|immunologic factors|mesh-ancestor
65312489|NCT05755854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312490|NCT05755854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65312491|NCT05755854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65312492|NCT05755854|Alkylating Agents|alkylating agents|mesh-ancestor
65312493|NCT05755854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312494|NCT05755854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312495|NCT05755854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65312496|NCT05755854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65312497|NCT05755854|Antimetabolites|antimetabolites|mesh-ancestor
65312498|NCT00787384|Imatinib Mesylate|imatinib mesylate|mesh-list
65312499|NCT00787384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312500|NCT00787384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65312501|NCT00787384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312502|NCT00787384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312503|NCT04669002|Olaparib|olaparib|mesh-list
65312504|NCT04669002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65312505|NCT04669002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312506|NCT04669002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312507|NCT04669002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312508|NCT02616419|Lidocaine|lidocaine|mesh-list
65312509|NCT02616419|Anesthetics, Local|anesthetics, local|mesh-ancestor
65312510|NCT02616419|Anesthetics|anesthetics|mesh-ancestor
65312511|NCT02616419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65312512|NCT02616419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312513|NCT02616419|Sensory System Agents|sensory system agents|mesh-ancestor
65312514|NCT02616419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65312515|NCT02616419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65312516|NCT02616419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65160768|NCT00633685|Antidepressive Agents|antidepressive agents|mesh-ancestor
65160769|NCT00633685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65160770|NCT00633685|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65160771|NCT00633685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65312517|NCT02616419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65312518|NCT02616419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65312519|NCT02616419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312520|NCT04982848|Talazoparib|talazoparib|mesh-list
65312521|NCT04982848|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65312522|NCT04982848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312523|NCT04982848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312524|NCT04982848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312525|NCT00798070|Cyclophosphamide|cyclophosphamide|mesh-list
65312526|NCT00798070|Fluorouracil|fluorouracil|mesh-list
65312527|NCT00798070|Docetaxel|docetaxel|mesh-list
65312528|NCT00798070|Epirubicin|epirubicin|mesh-list
65312529|NCT00798070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65312530|NCT00798070|Immunologic Factors|immunologic factors|mesh-ancestor
65312531|NCT00798070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312532|NCT00798070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65312533|NCT00798070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65312534|NCT00798070|Alkylating Agents|alkylating agents|mesh-ancestor
65312535|NCT00798070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312536|NCT00798070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312537|NCT00798070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65312538|NCT00798070|Antimetabolites|antimetabolites|mesh-ancestor
65312539|NCT00798070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65312540|NCT00798070|Tubulin Modulators|tubulin modulators|mesh-ancestor
65312541|NCT00798070|Antimitotic Agents|antimitotic agents|mesh-ancestor
65312542|NCT00798070|Mitosis Modulators|mitosis modulators|mesh-ancestor
65312543|NCT00798070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65312544|NCT00798070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65312545|NCT00798070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65312546|NCT00798070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312547|NCT00809328|Azithromycin|azithromycin|mesh-list
65312550|NCT00798148|Carboplatin|carboplatin|mesh-list
65312559|NCT00798148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65312560|NCT00798148|Alkylating Agents|alkylating agents|mesh-ancestor
65312561|NCT00798148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65312562|NCT00798148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65312563|NCT00798148|Immunologic Factors|immunologic factors|mesh-ancestor
65312564|NCT00798148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312565|NCT00787462|Pregabalin|pregabalin|mesh-list
65312566|NCT00787462|Analgesics|analgesics|mesh-ancestor
65312567|NCT00787462|Sensory System Agents|sensory system agents|mesh-ancestor
65312568|NCT00787462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65312569|NCT00787462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312570|NCT00787462|Anticonvulsants|anticonvulsants|mesh-ancestor
65312571|NCT00787462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65312572|NCT00787462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65312573|NCT00787462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312574|NCT00787462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65312575|NCT00787462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65312576|NCT00787462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65312577|NCT00787462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65312578|NCT00787462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65312579|NCT00792766|Everolimus|everolimus|mesh-list
65312580|NCT00792766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312581|NCT00792766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65312582|NCT00792766|Immunologic Factors|immunologic factors|mesh-ancestor
65312583|NCT00792766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312584|NCT00798460|Lamivudine|lamivudine|mesh-list
65312585|NCT00798460|Adefovir|adefovir|mesh-list
65312586|NCT00798460|Clevudine|clevudine|mesh-list
65312587|NCT00798460|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65312588|NCT00798460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65312589|NCT00798460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312591|NCT00798460|Antiviral Agents|antiviral agents|mesh-ancestor
65312602|NCT02615873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312603|NCT02615873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312604|NCT02615873|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65312605|NCT02615873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312606|NCT02615873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65312607|NCT02615873|Immunologic Factors|immunologic factors|mesh-ancestor
65312608|NCT02615873|Dopamine Agonists|dopamine agonists|mesh-ancestor
65312609|NCT00814164|Daunorubicin|daunorubicin|mesh-list
65312610|NCT00814164|Clofarabine|clofarabine|mesh-list
65312611|NCT00814164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65312612|NCT00814164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312613|NCT00814164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65312614|NCT00814164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65312615|NCT00814164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312616|NCT00814164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312617|NCT00814164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65312618|NCT00814164|Antimetabolites|antimetabolites|mesh-ancestor
65312619|NCT02609334|Pemirolast|pemirolast|mesh-list
65312620|NCT02609334|Histamine Antagonists|histamine antagonists|mesh-ancestor
65312621|NCT02609334|Histamine Agents|histamine agents|mesh-ancestor
65312622|NCT02609334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65312623|NCT02609334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312624|NCT02609334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312625|NCT00659230|Dopamine|dopamine|mesh-list
65312626|NCT00659230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65312627|NCT00659230|Sympathomimetics|sympathomimetics|mesh-ancestor
65312628|NCT00659230|Autonomic Agents|autonomic agents|mesh-ancestor
65312629|NCT00659230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65312630|NCT00659230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312631|NCT00659230|Dopamine Agents|dopamine agents|mesh-ancestor
65312645|NCT00809094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312646|NCT00809094|Antidotes|antidotes|mesh-ancestor
65312647|NCT02615639|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65312648|NCT02615639|Interferon-alpha|interferon-alpha|mesh-list
65312649|NCT02615639|Entecavir|entecavir|mesh-list
65312650|NCT02615639|Telbivudine|telbivudine|mesh-list
65312651|NCT02615639|Interferon alpha-2|interferon alpha-2|mesh-list
65312652|NCT02615639|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65312653|NCT02615639|Vaccines|vaccines|mesh-list
65312654|NCT02615639|Immunologic Factors|immunologic factors|mesh-ancestor
65312655|NCT02615639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312656|NCT02615639|Antiviral Agents|antiviral agents|mesh-ancestor
65312657|NCT02615639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65312658|NCT02615639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65312659|NCT02615639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312660|NCT02615639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312661|NCT02615639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312662|NCT00798616|Methylprednisolone|methylprednisolone|mesh-list
65312663|NCT00798616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65312664|NCT00798616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65312665|NCT00798616|Prednisolone|prednisolone|mesh-list
65312666|NCT00798616|Prednisolone acetate|prednisolone acetate|mesh-list
65160772|NCT00633685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160773|NCT02823691|Metformin|metformin|mesh-list
65160774|NCT02823691|Lanreotide|lanreotide|mesh-list
65160775|NCT02823691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65160776|NCT02823691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160777|NCT02823691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65160778|NCT02825095|Lidocaine|lidocaine|mesh-list
65160779|NCT02825095|Anesthetics, Local|anesthetics, local|mesh-ancestor
65160780|NCT02825095|Anesthetics|anesthetics|mesh-ancestor
65160781|NCT02825095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65160782|NCT02825095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160783|NCT02825095|Sensory System Agents|sensory system agents|mesh-ancestor
65160784|NCT02825095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65160788|NCT02825095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65160789|NCT02825095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160790|NCT04195009|Anesthetics|anesthetics|mesh-list
65160791|NCT04195009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65160792|NCT04195009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160793|NCT05660083|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
65160794|NCT05660083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160795|NCT05660083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160797|NCT02822131|Chelating Agents|chelating agents|mesh-ancestor
65160798|NCT02822131|Sequestering Agents|sequestering agents|mesh-ancestor
65160799|NCT02822131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160800|NCT04239625|Vitamin A|vitamin a|mesh-list
65160801|NCT04239625|Retinol acetate|retinol acetate|mesh-list
65160802|NCT04239625|Vitamins|vitamins|mesh-ancestor
65160803|NCT04239625|Micronutrients|micronutrients|mesh-ancestor
65160804|NCT04239625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160805|NCT04239625|Protective Agents|protective agents|mesh-ancestor
65160806|NCT04239625|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65160807|NCT04239625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65160808|NCT04239625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65312667|NCT00798616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65312668|NCT00798616|Prednisolone phosphate|prednisolone phosphate|mesh-list
65312669|NCT00798616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65312670|NCT00798616|Antiemetics|antiemetics|mesh-ancestor
65312671|NCT00798616|Autonomic Agents|autonomic agents|mesh-ancestor
65312672|NCT00798616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65312673|NCT00798616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312674|NCT00798616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65312675|NCT00798616|Glucocorticoids|glucocorticoids|mesh-ancestor
65312676|NCT00798616|Hormones|hormones|mesh-ancestor
65312677|NCT00798616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65312678|NCT00798616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65312679|NCT00798616|Protective Agents|protective agents|mesh-ancestor
65312680|NCT00798616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65312681|NCT00798616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312682|NCT02618057|Levofloxacin|levofloxacin|mesh-list
65312683|NCT02618057|Ofloxacin|ofloxacin|mesh-list
65312684|NCT02618057|Prednisolone|prednisolone|mesh-list
65312685|NCT02618057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65312686|NCT02618057|Glucocorticoids|glucocorticoids|mesh-ancestor
65160809|NCT04239625|Immunologic Factors|immunologic factors|mesh-ancestor
65160810|NCT02821897|Anesthetics|anesthetics|mesh-list
65160811|NCT02821897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65160812|NCT02821897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160813|NCT02820493|Vedolizumab|vedolizumab|mesh-list
65160814|NCT02820493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65160815|NCT05659459|Pioglitazone|pioglitazone|mesh-list
65160816|NCT05659459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65160817|NCT05659459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160818|NCT02820259|Tacrolimus|tacrolimus|mesh-list
65160819|NCT02820259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65160820|NCT02820259|Immunologic Factors|immunologic factors|mesh-ancestor
65160821|NCT02820259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160822|NCT02820259|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65160823|NCT02820259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160824|NCT02820259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160825|NCT00633763|Fallypride|fallypride|mesh-list
65160826|NCT00633763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65160827|NCT00633763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65160828|NCT00633763|Dopamine Agents|dopamine agents|mesh-ancestor
65160829|NCT00633763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65160830|NCT00633763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160831|NCT00633763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160832|NCT02820025|Doxapram|doxapram|mesh-list
65160833|NCT02820025|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65160834|NCT02820025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160835|NCT02820025|Respiratory System Agents|respiratory system agents|mesh-ancestor
65160836|NCT02819869|Metformin|metformin|mesh-list
65160837|NCT02819869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65160838|NCT02819869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160839|NCT02820883|Vaccines|vaccines|mesh-list
65160840|NCT02820883|Immunologic Factors|immunologic factors|mesh-ancestor
65160841|NCT02820883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160842|NCT02819089|Dexmedetomidine|dexmedetomidine|mesh-list
65160843|NCT02819089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65160844|NCT02819089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65312687|NCT02618057|Hormones|hormones|mesh-ancestor
65312688|NCT02618057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65312689|NCT02618057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312690|NCT02618057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65312691|NCT02618057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312692|NCT02618057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65312693|NCT02618057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65312694|NCT02618057|Renal Agents|renal agents|mesh-ancestor
65312695|NCT02618057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65312696|NCT02618057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65312697|NCT02618057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65312698|NCT02618057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312699|NCT02618057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312700|NCT02618057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65312701|NCT02618057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65312702|NCT04137029|Bromides|bromides|mesh-list
65312703|NCT04137029|Formoterol Fumarate|formoterol fumarate|mesh-list
65312704|NCT04137029|Tiotropium Bromide|tiotropium bromide|mesh-list
65312705|NCT04137029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65312706|NCT04137029|Autonomic Agents|autonomic agents|mesh-ancestor
65312707|NCT04137029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65312708|NCT04137029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312709|NCT04137029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65312710|NCT04137029|Respiratory System Agents|respiratory system agents|mesh-ancestor
65312711|NCT04137029|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65312712|NCT04137029|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65312713|NCT04137029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65312714|NCT04137029|Adrenergic Agents|adrenergic agents|mesh-ancestor
65312715|NCT04137029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65344944|NCT00864136|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65160845|NCT02819089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160846|NCT02819089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65160847|NCT02819089|Analgesics|analgesics|mesh-ancestor
65160848|NCT02819089|Sensory System Agents|sensory system agents|mesh-ancestor
65160849|NCT02819089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65160850|NCT02819089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65160851|NCT02819089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65160852|NCT02819089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65160853|NCT02819089|Adrenergic Agents|adrenergic agents|mesh-ancestor
64514635|NCT02712801|Zidovudine|zidovudine|mesh-list
65160854|NCT02819089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65160855|NCT02819089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222834|NCT02700087|Histamine Agents|histamine agents|mesh-ancestor
65312716|NCT04137029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312717|NCT04137029|Parasympatholytics|parasympatholytics|mesh-ancestor
65312718|NCT04137029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65312719|NCT04137029|Cholinergic Agents|cholinergic agents|mesh-ancestor
65312720|NCT04137029|Anticonvulsants|anticonvulsants|mesh-ancestor
65312721|NCT00787774|Raltegravir Potassium|raltegravir potassium|mesh-list
65312722|NCT00787774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65312723|NCT00787774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65312724|NCT00787774|Antiviral Agents|antiviral agents|mesh-ancestor
65312725|NCT00787774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65312726|NCT00787774|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65312727|NCT00787774|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65312728|NCT00787774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312729|NCT00787774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312730|NCT00452413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65312731|NCT00452413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312732|NCT00452413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65312733|NCT00452413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312734|NCT00452413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312735|NCT00798772|Micronutrients|micronutrients|mesh-list
65312736|NCT00798772|Trace Elements|trace elements|mesh-list
65312737|NCT00798772|Antioxidants|antioxidants|mesh-list
65312738|NCT00798772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312739|NCT00798772|Protective Agents|protective agents|mesh-ancestor
65312740|NCT00798772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312741|NCT05073822|Mycophenolic Acid|mycophenolic acid|mesh-list
65312742|NCT05073822|Tacrolimus|tacrolimus|mesh-list
65312743|NCT05073822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65312744|NCT05073822|Immunologic Factors|immunologic factors|mesh-ancestor
65312745|NCT05073822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312746|NCT05073822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65312747|NCT05073822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344945|NCT00864214|Hormones|hormones|mesh-list
65160868|NCT02815657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65160869|NCT02815657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65160870|NCT02815657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160871|NCT04597333|Dinoprostone|dinoprostone|mesh-list
65160872|NCT04597333|Oxytocics|oxytocics|mesh-ancestor
65160873|NCT04597333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65160874|NCT04597333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160875|NCT00957580|Niacinamide|niacinamide|mesh-list
65160876|NCT00957580|Vitamin B Complex|vitamin b complex|mesh-ancestor
65160877|NCT00957580|Vitamins|vitamins|mesh-ancestor
65312748|NCT05073822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312749|NCT05073822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65312750|NCT05073822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312751|NCT05073822|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65312752|NCT05073822|Antitubercular Agents|antitubercular agents|mesh-ancestor
65312753|NCT05073822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65312754|NCT05073822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65312755|NCT00867503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65312756|NCT00867503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65312757|NCT00867503|Alkylating Agents|alkylating agents|mesh-ancestor
65312758|NCT00867503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312759|NCT00867503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312760|NCT00788164|Imiquimod|imiquimod|mesh-list
65312761|NCT00788164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65312762|NCT00788164|Immunologic Factors|immunologic factors|mesh-ancestor
65312763|NCT00788164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312764|NCT00788164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312765|NCT00788164|Interferon Inducers|interferon inducers|mesh-ancestor
65312766|NCT02615561|Pantothenic Acid|pantothenic acid|mesh-list
65312767|NCT02615561|Vitamin B Complex|vitamin b complex|mesh-ancestor
65312768|NCT02615561|Vitamins|vitamins|mesh-ancestor
65312769|NCT02615561|Micronutrients|micronutrients|mesh-ancestor
65312771|NCT00793234|Enoxaparin|enoxaparin|mesh-list
65312799|NCT04031027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65312800|NCT04031027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312801|NCT04031027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312802|NCT02609802|Sevoflurane|sevoflurane|mesh-list
65312803|NCT02609802|Desflurane|desflurane|mesh-list
65312804|NCT02609802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65312805|NCT02609802|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65312806|NCT02609802|Anesthetics, General|anesthetics, general|mesh-ancestor
65312807|NCT02609802|Anesthetics|anesthetics|mesh-ancestor
65312808|NCT02609802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65312809|NCT02609802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312810|NCT02609646|Vancomycin|vancomycin|mesh-list
65312811|NCT02609646|Meropenem|meropenem|mesh-list
65312812|NCT02609646|Tazobactam|tazobactam|mesh-list
65312813|NCT02609646|Linezolid|linezolid|mesh-list
65312814|NCT02609646|Piperacillin|piperacillin|mesh-list
65494086|NCT03701763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65312815|NCT02609646|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65312816|NCT02609646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65312817|NCT02609646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65312818|NCT02609646|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65312819|NCT02609646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312820|NCT02609646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312821|NCT02609646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65312822|NCT02610504|Hyaluronic Acid|hyaluronic acid|mesh-list
65312823|NCT02610504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65312824|NCT02610504|Immunologic Factors|immunologic factors|mesh-ancestor
65312825|NCT02610504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312826|NCT02610504|Viscosupplements|viscosupplements|mesh-ancestor
65312827|NCT02610504|Protective Agents|protective agents|mesh-ancestor
65312828|NCT04132583|Diclofenac|diclofenac|mesh-list
65312829|NCT04132583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65312830|NCT04132583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65312831|NCT04132583|Analgesics|analgesics|mesh-ancestor
65312832|NCT04132583|Sensory System Agents|sensory system agents|mesh-ancestor
65312833|NCT04132583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65160878|NCT00957580|Micronutrients|micronutrients|mesh-ancestor
65160879|NCT00957580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160880|NCT00957424|Nicotine|nicotine|mesh-list
65160881|NCT00957424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65160882|NCT00957424|Autonomic Agents|autonomic agents|mesh-ancestor
65312834|NCT04132583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312835|NCT04132583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65312836|NCT04132583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65312837|NCT04132583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65312838|NCT04132583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312839|NCT04132583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312840|NCT05754762|Remifentanil|remifentanil|mesh-list
65312841|NCT05754762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65312842|NCT05754762|Narcotics|narcotics|mesh-ancestor
65312843|NCT05754762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65312844|NCT05754762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312845|NCT05754762|Analgesics|analgesics|mesh-ancestor
65312846|NCT05754762|Sensory System Agents|sensory system agents|mesh-ancestor
65312847|NCT05754762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65312848|NCT05757648|Anesthetics|anesthetics|mesh-list
65312849|NCT05757648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65312850|NCT05757648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312851|NCT00914004|Desipramine|desipramine|mesh-list
65312852|NCT00914004|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65312853|NCT00914004|Antidepressive Agents|antidepressive agents|mesh-ancestor
65312854|NCT00914004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65312855|NCT00914004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312856|NCT00914004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312857|NCT00914004|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65312858|NCT00914004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65312859|NCT00914004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65312880|NCT00697385|Coagulants|coagulants|mesh-ancestor
65312881|NCT00451555|Fulvestrant|fulvestrant|mesh-list
65312882|NCT00451555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65312883|NCT00451555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312884|NCT00451555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65312885|NCT00451555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65312886|NCT00451555|Hormone Antagonists|hormone antagonists|mesh-ancestor
65312887|NCT00451555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65312888|NCT00451555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312890|NCT00867035|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65312891|NCT00867035|Chlorine dioxide|chlorine dioxide|mesh-list
65312892|NCT00867035|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65312893|NCT00867035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65312894|NCT00867035|Disinfectants|disinfectants|mesh-ancestor
65312895|NCT00867035|Dermatologic Agents|dermatologic agents|mesh-ancestor
65312896|NCT00867035|Dental Disinfectants|dental disinfectants|mesh-ancestor
65312897|NCT05754684|Aldesleukin|aldesleukin|mesh-list
65312898|NCT05754684|Interleukin-2|interleukin-2|mesh-list
65312899|NCT05754684|Molgramostim|molgramostim|mesh-list
65312900|NCT05754684|Dinutuximab|dinutuximab|mesh-list
65312901|NCT05754684|Spironolactone|spironolactone|mesh-list
65312902|NCT05754684|Sargramostim|sargramostim|mesh-list
65312903|NCT05754684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312904|NCT05754684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65312905|NCT05754684|Analgesics|analgesics|mesh-ancestor
65312906|NCT05754684|Sensory System Agents|sensory system agents|mesh-ancestor
65312907|NCT05754684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65312908|NCT05754684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312909|NCT05754684|Immunologic Factors|immunologic factors|mesh-ancestor
65312910|NCT05754684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65312911|NCT05754684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65312912|NCT05754684|Antiviral Agents|antiviral agents|mesh-ancestor
65312913|NCT05754684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65312914|NCT05754684|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65312915|NCT05754684|Hormone Antagonists|hormone antagonists|mesh-ancestor
65312917|NCT05754684|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65312922|NCT00694187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65312923|NCT00694187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65312924|NCT00694187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312925|NCT00694187|GABA Modulators|gaba modulators|mesh-ancestor
65312926|NCT00694187|GABA Agents|gaba agents|mesh-ancestor
65312927|NCT00694187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65312928|NCT00694187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312929|NCT02617121|Gabapentin|gabapentin|mesh-list
65312930|NCT02617121|Ramosetron|ramosetron|mesh-list
65312931|NCT02617121|Analgesics|analgesics|mesh-ancestor
65312932|NCT02617121|Sensory System Agents|sensory system agents|mesh-ancestor
65312933|NCT02617121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65312934|NCT02617121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312935|NCT02617121|Anticonvulsants|anticonvulsants|mesh-ancestor
65312936|NCT02617121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65312937|NCT02617121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65312938|NCT02617121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65312939|NCT02617121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65312940|NCT02617121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65312941|NCT02617121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65312942|NCT02617121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65312943|NCT02617121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312944|NCT02617121|Antimanic Agents|antimanic agents|mesh-ancestor
65312945|NCT02617121|Antiemetics|antiemetics|mesh-ancestor
65312946|NCT02617121|Autonomic Agents|autonomic agents|mesh-ancestor
65312947|NCT02617121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65312948|NCT02617121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65312949|NCT02617121|Serotonin Agents|serotonin agents|mesh-ancestor
65312950|NCT02609490|Olmesartan|olmesartan|mesh-list
65312951|NCT02609490|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65312952|NCT02609490|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65312953|NCT02609490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65312954|NCT02609490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65312955|NCT02609490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65312956|NCT02609490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312957|NCT02610348|Vaccines|vaccines|mesh-list
65160883|NCT00957424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65160884|NCT00957424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160885|NCT00957424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65312958|NCT02610348|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65312959|NCT02610348|Immunologic Factors|immunologic factors|mesh-ancestor
65312960|NCT02610348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312961|NCT05757336|Gemcitabine|gemcitabine|mesh-list
65312962|NCT05757336|Paclitaxel|paclitaxel|mesh-list
65312963|NCT05757336|Bevacizumab|bevacizumab|mesh-list
65312964|NCT05757336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65312965|NCT05757336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65312966|NCT05757336|Tubulin Modulators|tubulin modulators|mesh-ancestor
65312967|NCT05757336|Antimitotic Agents|antimitotic agents|mesh-ancestor
65312968|NCT05757336|Mitosis Modulators|mitosis modulators|mesh-ancestor
65312969|NCT05757336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65312970|NCT05757336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65312971|NCT05757336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65312972|NCT05757336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65312973|NCT05757336|Growth Substances|growth substances|mesh-ancestor
65312974|NCT05757336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65312975|NCT05757336|Growth Inhibitors|growth inhibitors|mesh-ancestor
65312976|NCT05757336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65312977|NCT05757336|Antimetabolites|antimetabolites|mesh-ancestor
65312978|NCT05757336|Antiviral Agents|antiviral agents|mesh-ancestor
65312979|NCT05757336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65312980|NCT05757336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65312981|NCT05757336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65312982|NCT05757336|Immunologic Factors|immunologic factors|mesh-ancestor
65312983|NCT00871871|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65312984|NCT00871871|Isosorbide|isosorbide|mesh-list
65312985|NCT00871871|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65312986|NCT00871871|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65312987|NCT00871871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65312988|NCT00871871|Diuretics|diuretics|mesh-ancestor
65312989|NCT00871871|Natriuretic Agents|natriuretic agents|mesh-ancestor
65312997|NCT02608788|Ketorolac|ketorolac|mesh-list
65313000|NCT02608788|Analgesics|analgesics|mesh-ancestor
65313001|NCT02608788|Sensory System Agents|sensory system agents|mesh-ancestor
65313002|NCT02608788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313003|NCT02608788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313004|NCT02608788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65313005|NCT02608788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65313006|NCT02608788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65313007|NCT02608788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313008|NCT02608788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313009|NCT04132349|Ulipristal acetate|ulipristal acetate|mesh-list
65313010|NCT04132349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65313011|NCT04132349|Contraceptive Agents|contraceptive agents|mesh-ancestor
65313012|NCT04132349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65313013|NCT04132349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313014|NCT04132349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65313015|NCT04961190|Paroxetine|paroxetine|mesh-list
65313016|NCT04961190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65313017|NCT04961190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65313018|NCT04961190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65313019|NCT04961190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65313020|NCT04961190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313021|NCT04961190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65313022|NCT04961190|Serotonin Agents|serotonin agents|mesh-ancestor
65313023|NCT04961190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313024|NCT04961190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65313025|NCT04961190|Antidepressive Agents|antidepressive agents|mesh-ancestor
65313026|NCT04961190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65313027|NCT04961190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65313028|NCT04961190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65313029|NCT04961190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313030|NCT04961190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65313031|NCT00849680|Vaccines|vaccines|mesh-list
65313032|NCT00849680|Immunologic Factors|immunologic factors|mesh-ancestor
65160886|NCT00957424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65160887|NCT00957424|Cholinergic Agents|cholinergic agents|mesh-ancestor
65160888|NCT00957424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65160889|NCT00957424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160890|NCT02818621|Dexmedetomidine|dexmedetomidine|mesh-list
65313033|NCT00849680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313034|NCT00866723|Bevacizumab|bevacizumab|mesh-list
65313035|NCT00866723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65313036|NCT00866723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313037|NCT00866723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65062954|NCT00290121|Serotonin Agents|serotonin agents|mesh-ancestor
65313038|NCT00866723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65313039|NCT00866723|Growth Substances|growth substances|mesh-ancestor
65313040|NCT00866723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313041|NCT00866723|Growth Inhibitors|growth inhibitors|mesh-ancestor
65313042|NCT02613455|Triamcinolone|triamcinolone|mesh-list
65313043|NCT02613455|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65313044|NCT02613455|Lidocaine|lidocaine|mesh-list
65313045|NCT02613455|Anesthetics, Local|anesthetics, local|mesh-ancestor
65313046|NCT02613455|Anesthetics|anesthetics|mesh-ancestor
65313047|NCT02613455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65313048|NCT02613455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313049|NCT02613455|Sensory System Agents|sensory system agents|mesh-ancestor
65313050|NCT02613455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313051|NCT02613455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65313052|NCT02613455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65313053|NCT02613455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65313054|NCT02613455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65313055|NCT02613455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313056|NCT02613455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65313057|NCT02613455|Glucocorticoids|glucocorticoids|mesh-ancestor
65313058|NCT02613455|Hormones|hormones|mesh-ancestor
65313059|NCT02613455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65313060|NCT02613455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65313061|NCT02613455|Immunologic Factors|immunologic factors|mesh-ancestor
65313062|NCT00703586|Maraviroc|maraviroc|mesh-list
65313063|NCT00703586|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65160891|NCT02818621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65160892|NCT02818621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65160893|NCT02818621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160894|NCT02818621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65160895|NCT02818621|Analgesics|analgesics|mesh-ancestor
65160896|NCT02818621|Sensory System Agents|sensory system agents|mesh-ancestor
65160897|NCT02818621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65160898|NCT02818621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65160899|NCT02818621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65160900|NCT02818621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65313064|NCT00703586|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65313065|NCT00703586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313066|NCT00703586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65313067|NCT00703586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65313068|NCT00703586|Antiviral Agents|antiviral agents|mesh-ancestor
65313069|NCT00703586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65313070|NCT00703586|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65313071|NCT04130399|Folfirinox|folfirinox|mesh-list
65313072|NCT04130399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313073|NCT00849056|rGLP-1 protein|rglp-1 protein|mesh-list
65313074|NCT00849056|Incretins|incretins|mesh-ancestor
65313075|NCT00849056|Hormones|hormones|mesh-ancestor
65313076|NCT00849056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65313077|NCT00849056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313078|NCT02612948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65313079|NCT02612948|Antidepressive Agents|antidepressive agents|mesh-ancestor
65313080|NCT02612948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65313081|NCT02612948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65313082|NCT02612948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65313083|NCT02612948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65313084|NCT02612948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313085|NCT00706862|Lactoferrin|lactoferrin|mesh-list
65313086|NCT00706862|Talactoferrin alfa|talactoferrin alfa|mesh-list
65313087|NCT00706862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313088|NCT00706862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65313089|NCT02612714|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65313090|NCT02612714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65313091|NCT02612714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65313092|NCT02612714|Antimetabolites|antimetabolites|mesh-ancestor
65313093|NCT02612714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313094|NCT02612714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65313095|NCT02612714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64542860|NCT04198129|Ampicillin|ampicillin|mesh-list
65160901|NCT02818621|Adrenergic Agents|adrenergic agents|mesh-ancestor
65160902|NCT02818621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65160903|NCT02818621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160904|NCT04642651|Dexmedetomidine|dexmedetomidine|mesh-list
65160905|NCT04642651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65160906|NCT04642651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65160907|NCT04642651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313096|NCT02612714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313097|NCT00837434|Adalimumab|adalimumab|mesh-list
65313098|NCT00837434|Etanercept|etanercept|mesh-list
65313099|NCT00837434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65313100|NCT00837434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65313101|NCT00837434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65313102|NCT00837434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65313103|NCT00837434|Analgesics|analgesics|mesh-ancestor
65313104|NCT00837434|Sensory System Agents|sensory system agents|mesh-ancestor
65313105|NCT00837434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313106|NCT00837434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313107|NCT00837434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65313108|NCT00837434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65313109|NCT00837434|Immunologic Factors|immunologic factors|mesh-ancestor
65313110|NCT00703742|Citalopram|citalopram|mesh-list
65313111|NCT00703742|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65313112|NCT00703742|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65313113|NCT00703742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65313114|NCT00703742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313115|NCT00703742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65313116|NCT00703742|Serotonin Agents|serotonin agents|mesh-ancestor
65313117|NCT00703742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313118|NCT00703742|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65313119|NCT00703742|Antidepressive Agents|antidepressive agents|mesh-ancestor
65313120|NCT00703742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65313121|NCT00702182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65313122|NCT00702182|Vinorelbine|vinorelbine|mesh-list
65313123|NCT00702182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313124|NCT00702182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65313125|NCT00702182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344946|NCT00864214|Estradiol|estradiol|mesh-list
65160908|NCT04642651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65160909|NCT04642651|Analgesics|analgesics|mesh-ancestor
65160910|NCT04642651|Sensory System Agents|sensory system agents|mesh-ancestor
65160911|NCT04642651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65160912|NCT04642651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65160913|NCT04642651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65160914|NCT04642651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65160915|NCT04642651|Adrenergic Agents|adrenergic agents|mesh-ancestor
65160916|NCT04642651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65160917|NCT04642651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160931|NCT01061151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160932|NCT01061151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65160933|NCT01061151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65313126|NCT00702182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313127|NCT00702182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65313128|NCT00702182|Tubulin Modulators|tubulin modulators|mesh-ancestor
65313129|NCT00702182|Antimitotic Agents|antimitotic agents|mesh-ancestor
65313130|NCT00702182|Mitosis Modulators|mitosis modulators|mesh-ancestor
65313131|NCT00702260|Ramipril|ramipril|mesh-list
65313132|NCT00702260|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65313133|NCT00702260|Protease Inhibitors|protease inhibitors|mesh-ancestor
65313134|NCT00702260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313135|NCT00702260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313136|NCT00702260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65313137|NCT00702416|Acetaminophen|acetaminophen|mesh-list
65313138|NCT00702416|Fentanyl|fentanyl|mesh-list
65313139|NCT00702416|Morphine|morphine|mesh-list
65313140|NCT00702416|Analgesics, Opioid|analgesics, opioid|mesh-list
65313141|NCT00702416|Narcotics|narcotics|mesh-list
65313142|NCT00702416|Analgesics|analgesics|mesh-list
65313143|NCT00702416|Anesthetics|anesthetics|mesh-list
65313144|NCT00702416|Ropivacaine|ropivacaine|mesh-list
65313145|NCT00702416|Anesthetics, Local|anesthetics, local|mesh-list
65313146|NCT00702416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65313147|NCT00702416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313148|NCT00702416|Sensory System Agents|sensory system agents|mesh-ancestor
65313149|NCT00702416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313150|NCT00702416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65313151|NCT00702416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65313152|NCT00702416|Anesthetics, General|anesthetics, general|mesh-ancestor
65313153|NCT00702416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65313154|NCT00702416|Antipyretics|antipyretics|mesh-ancestor
65313155|NCT00827918|Olanzapine|olanzapine|mesh-list
65313156|NCT00827918|Antiemetics|antiemetics|mesh-ancestor
65313157|NCT00827918|Autonomic Agents|autonomic agents|mesh-ancestor
65160934|NCT01061151|Antiviral Agents|antiviral agents|mesh-ancestor
65160935|NCT01061151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65160936|NCT01061151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65160937|NCT01061151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65160938|NCT01061151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65160939|NCT01061151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65160940|NCT01061151|Antimetabolites|antimetabolites|mesh-ancestor
65160941|NCT01061151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65160942|NCT01061151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65160944|NCT04472143|Antiemetics|antiemetics|mesh-ancestor
65160945|NCT04472143|Autonomic Agents|autonomic agents|mesh-ancestor
65160946|NCT04472143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65160947|NCT04472143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313158|NCT00827918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313159|NCT00827918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313160|NCT00827918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65313161|NCT00827918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65313162|NCT00827918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65313163|NCT00827918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65313164|NCT00827918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65313165|NCT00827918|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65313166|NCT00827918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65313167|NCT00827918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65313168|NCT00827918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313169|NCT00827918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65313170|NCT00827918|Serotonin Agents|serotonin agents|mesh-ancestor
65313171|NCT00813150|Dexamethasone|dexamethasone|mesh-list
65313172|NCT00813150|Cyclophosphamide|cyclophosphamide|mesh-list
65313173|NCT00813150|Bortezomib|bortezomib|mesh-list
65313174|NCT00813150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65313175|NCT00813150|Immunologic Factors|immunologic factors|mesh-ancestor
65313176|NCT00813150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313177|NCT00813150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65313178|NCT00813150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65313179|NCT00813150|Alkylating Agents|alkylating agents|mesh-ancestor
65313180|NCT00813150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313181|NCT00813150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313182|NCT00813150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65313183|NCT00813150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65313184|NCT00813150|Antiemetics|antiemetics|mesh-ancestor
65313185|NCT00813150|Autonomic Agents|autonomic agents|mesh-ancestor
65313186|NCT00813150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313187|NCT00813150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65313188|NCT00813150|Glucocorticoids|glucocorticoids|mesh-ancestor
65160948|NCT04472143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65160949|NCT04472143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65160950|NCT04472143|Serotonin Agents|serotonin agents|mesh-ancestor
65160951|NCT04472143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65160952|NCT04472143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160953|NCT01241552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65160954|NCT01241552|Immunologic Factors|immunologic factors|mesh-ancestor
65160955|NCT01241552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160956|NCT04748523|Mirtazapine|mirtazapine|mesh-list
65160957|NCT04748523|Antidepressive Agents|antidepressive agents|mesh-ancestor
65160958|NCT04748523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65160959|NCT04748523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65313189|NCT00813150|Hormones|hormones|mesh-ancestor
65313190|NCT00813150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65313191|NCT00813150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65313192|NCT00807846|Celecoxib|celecoxib|mesh-list
65313193|NCT00807846|Naproxen|naproxen|mesh-list
65313194|NCT00807846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65313195|NCT00807846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65313196|NCT00807846|Analgesics|analgesics|mesh-ancestor
65313197|NCT00807846|Sensory System Agents|sensory system agents|mesh-ancestor
65313198|NCT00807846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313199|NCT00807846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313200|NCT00807846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65313201|NCT00807846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65313202|NCT00807846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65313203|NCT00807846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65313204|NCT00807846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313205|NCT00807846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313206|NCT00807846|Gout Suppressants|gout suppressants|mesh-ancestor
65313207|NCT00810108|Ritonavir|ritonavir|mesh-list
65313208|NCT00810108|Lopinavir|lopinavir|mesh-list
65313209|NCT00810108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65313210|NCT00810108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65313211|NCT00810108|Protease Inhibitors|protease inhibitors|mesh-ancestor
65313212|NCT00810108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542966|NCT03973489|Autonomic Agents|autonomic agents|mesh-ancestor
65160960|NCT04748523|Histamine Antagonists|histamine antagonists|mesh-ancestor
65160961|NCT04748523|Histamine Agents|histamine agents|mesh-ancestor
65160962|NCT04748523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65160963|NCT04748523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160964|NCT04748523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160965|NCT04748523|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65160966|NCT04748523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65160967|NCT04748523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65160968|NCT04748523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65160969|NCT04748523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65160970|NCT04748523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65160971|NCT04748523|Adrenergic Agents|adrenergic agents|mesh-ancestor
65160972|NCT04748523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65160973|NCT04748523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65160974|NCT04748523|Serotonin Agents|serotonin agents|mesh-ancestor
65160975|NCT04748523|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65160976|NCT02817217|Valsartan|valsartan|mesh-list
65160977|NCT02817217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65160978|NCT02817217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64505656|NCT01726738|Trametinib|trametinib|mesh-list
65160987|NCT00948922|Immunologic Factors|immunologic factors|mesh-ancestor
65160988|NCT00948922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160989|NCT00948922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65160990|NCT00948922|Alkylating Agents|alkylating agents|mesh-ancestor
65313213|NCT00810108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313214|NCT00810108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65313215|NCT00810108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65313216|NCT00810108|Antiviral Agents|antiviral agents|mesh-ancestor
65313217|NCT00810108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65313218|NCT00810108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65313219|NCT00810108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65313220|NCT00827606|Atorvastatin|atorvastatin|mesh-list
65313221|NCT00827606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65313222|NCT00827606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65313223|NCT00827606|Antimetabolites|antimetabolites|mesh-ancestor
65313224|NCT00827606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313225|NCT00827606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65313226|NCT00827606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65313227|NCT00827606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313228|NCT04016220|Budesonide|budesonide|mesh-list
65313229|NCT04016220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65313230|NCT04016220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65313231|NCT04016220|Autonomic Agents|autonomic agents|mesh-ancestor
65313232|NCT04016220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313233|NCT04016220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313234|NCT04016220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65313235|NCT04016220|Respiratory System Agents|respiratory system agents|mesh-ancestor
65313236|NCT04016220|Glucocorticoids|glucocorticoids|mesh-ancestor
65313237|NCT04016220|Hormones|hormones|mesh-ancestor
65313238|NCT04016220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65313239|NCT00663052|Etanercept|etanercept|mesh-list
65313240|NCT00663052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65313241|NCT00663052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65313242|NCT00663052|Analgesics|analgesics|mesh-ancestor
65313243|NCT00663052|Sensory System Agents|sensory system agents|mesh-ancestor
65313254|NCT00707252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313255|NCT00707252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65313256|NCT00707252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313257|NCT00707252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313258|NCT00826748|Beclomethasone|beclomethasone|mesh-list
65313259|NCT00826748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65313260|NCT00826748|Glucocorticoids|glucocorticoids|mesh-ancestor
65313261|NCT00826748|Hormones|hormones|mesh-ancestor
65494087|NCT03701763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65063160|NCT01601509|Tramazoline|tramazoline|mesh-list
65313262|NCT00826748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65313263|NCT00826748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313264|NCT00826748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65313265|NCT00826748|Respiratory System Agents|respiratory system agents|mesh-ancestor
65313266|NCT00922844|Sevoflurane|sevoflurane|mesh-list
65313267|NCT00922844|Isoflurane|isoflurane|mesh-list
65313268|NCT00922844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65313269|NCT00922844|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65313270|NCT00922844|Anesthetics, General|anesthetics, general|mesh-ancestor
65313271|NCT00922844|Anesthetics|anesthetics|mesh-ancestor
65313272|NCT00922844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65313273|NCT00922844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313274|NCT00707330|Clarithromycin|clarithromycin|mesh-list
65313275|NCT00707330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65313276|NCT00707330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65313277|NCT00707330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65313278|NCT00707330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313279|NCT00707330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313280|NCT00707330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65313281|NCT00707330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65313282|NCT00707408|Imatinib Mesylate|imatinib mesylate|mesh-list
65313283|NCT00707408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313284|NCT00707408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65160991|NCT00948922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65160993|NCT00634309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65160994|NCT00634309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65160995|NCT00634309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65160996|NCT00634309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160997|NCT01239992|Niacin|niacin|mesh-list
65160998|NCT01239992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65160999|NCT01239992|Antimetabolites|antimetabolites|mesh-ancestor
65313285|NCT00707408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313286|NCT00707408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313287|NCT00788320|Vitamin D|vitamin d|mesh-list
65313288|NCT00788320|Cholecalciferol|cholecalciferol|mesh-list
65313289|NCT00788320|Vitamins|vitamins|mesh-ancestor
65313290|NCT00788320|Micronutrients|micronutrients|mesh-ancestor
65313291|NCT00788320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313292|NCT00788320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65313293|NCT00788320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65313294|NCT00807144|Tacrolimus|tacrolimus|mesh-list
65313295|NCT00807144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65313296|NCT00807144|Immunologic Factors|immunologic factors|mesh-ancestor
65313297|NCT00807144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313298|NCT00807144|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65313299|NCT00807144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313300|NCT00807144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313301|NCT00799240|Cisplatin|cisplatin|mesh-list
65313302|NCT00799240|Pemetrexed|pemetrexed|mesh-list
65313303|NCT00799240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65313304|NCT00799240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313305|NCT00799240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313306|NCT00799240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313307|NCT00799240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65313308|NCT00799240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65313309|NCT00799240|Immunologic Factors|immunologic factors|mesh-ancestor
65313310|NCT00799240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313311|NCT00591006|Hydrocortisone|hydrocortisone|mesh-list
65313312|NCT00591006|Phenytoin|phenytoin|mesh-list
65313313|NCT00591006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65313314|NCT00591006|Anticonvulsants|anticonvulsants|mesh-ancestor
65313315|NCT00591006|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65313316|NCT00591006|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65313317|NCT00591006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65313322|NCT00844844|Eculizumab|eculizumab|mesh-list
65313325|NCT00844844|Immunologic Factors|immunologic factors|mesh-ancestor
65313326|NCT00844844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313327|NCT05748054|Fluorides|fluorides|mesh-list
65313328|NCT05748054|Cariostatic Agents|cariostatic agents|mesh-ancestor
65313329|NCT05748054|Protective Agents|protective agents|mesh-ancestor
65313330|NCT05748054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313331|NCT00702572|Paclitaxel|paclitaxel|mesh-list
65313332|NCT00702572|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65313333|NCT00702572|Bevacizumab|bevacizumab|mesh-list
65313334|NCT00702572|Carboplatin|carboplatin|mesh-list
65313335|NCT00702572|Vorinostat|vorinostat|mesh-list
65063236|NCT00257621|Protease Inhibitors|protease inhibitors|mesh-ancestor
65313336|NCT00702572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65313338|NCT00702572|Tubulin Modulators|tubulin modulators|mesh-ancestor
65313339|NCT00702572|Antimitotic Agents|antimitotic agents|mesh-ancestor
65313340|NCT00702572|Mitosis Modulators|mitosis modulators|mesh-ancestor
65313341|NCT00702572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313342|NCT00702572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65313343|NCT00702572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65313344|NCT00702572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65313345|NCT00702572|Growth Substances|growth substances|mesh-ancestor
65313346|NCT00702572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313347|NCT00702572|Growth Inhibitors|growth inhibitors|mesh-ancestor
65313348|NCT00702572|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65313349|NCT00702572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313350|NCT00793468|Nicotine|nicotine|mesh-list
65313351|NCT00793468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65313352|NCT00793468|Autonomic Agents|autonomic agents|mesh-ancestor
65313353|NCT00793468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313354|NCT00793468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313355|NCT00793468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65313356|NCT00793468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65313357|NCT00793468|Cholinergic Agents|cholinergic agents|mesh-ancestor
65313358|NCT00793468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65313359|NCT00793468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313365|NCT00836810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65313366|NCT00836810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313367|NCT00836810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65313368|NCT00836810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313369|NCT00658684|Fesoterodine|fesoterodine|mesh-list
65313370|NCT00658684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65313371|NCT00658684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65313372|NCT00658684|Cholinergic Agents|cholinergic agents|mesh-ancestor
65313373|NCT00658684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65313374|NCT00658684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313375|NCT00658684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313376|NCT00658684|Urological Agents|urological agents|mesh-ancestor
65313377|NCT00660400|Azacitidine|azacitidine|mesh-list
65313378|NCT00660400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65313379|NCT00660400|Antimetabolites|antimetabolites|mesh-ancestor
65313380|NCT00660400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313381|NCT00660400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313382|NCT00660400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313383|NCT00826514|Tanezumab|tanezumab|mesh-list
65313384|NCT00826514|Analgesics|analgesics|mesh-ancestor
65313385|NCT00826514|Sensory System Agents|sensory system agents|mesh-ancestor
65313386|NCT00826514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313387|NCT00826514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313388|NCT00800566|Clofarabine|clofarabine|mesh-list
65313389|NCT00800566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65161000|NCT01239992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161001|NCT01239992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65161002|NCT01239992|Vasodilator Agents|vasodilator agents|mesh-ancestor
65161003|NCT01239992|Vitamin B Complex|vitamin b complex|mesh-ancestor
65161005|NCT01239992|Micronutrients|micronutrients|mesh-ancestor
65161006|NCT01239992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161007|NCT02816905|Fluorometholone|fluorometholone|mesh-list
65161008|NCT02816905|Dexamethasone|dexamethasone|mesh-list
65161009|NCT02816905|Rimexolone|rimexolone|mesh-list
65161010|NCT02816905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65161011|NCT02816905|Antiemetics|antiemetics|mesh-ancestor
65161012|NCT02816905|Autonomic Agents|autonomic agents|mesh-ancestor
65161013|NCT02816905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161014|NCT02816905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161015|NCT02816905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65161016|NCT02816905|Glucocorticoids|glucocorticoids|mesh-ancestor
65161017|NCT02816905|Hormones|hormones|mesh-ancestor
65161018|NCT02816905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65161019|NCT02816905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65161020|NCT02816905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161021|NCT02816905|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65161022|NCT01072539|Tigecycline|tigecycline|mesh-list
65161023|NCT01072539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65313390|NCT00800566|Antimetabolites|antimetabolites|mesh-ancestor
65313391|NCT00800566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313392|NCT00800566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313393|NCT00793858|Ciclesonide|ciclesonide|mesh-list
65313394|NCT00793858|Glucocorticoids|glucocorticoids|mesh-ancestor
65313395|NCT00793858|Hormones|hormones|mesh-ancestor
65313396|NCT00793858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65313397|NCT00793858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313398|NCT00793858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65313399|NCT00800722|Sirolimus|sirolimus|mesh-list
65313400|NCT00800722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65313401|NCT00800722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65313402|NCT00800722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65313403|NCT00800722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313404|NCT00800722|Antifungal Agents|antifungal agents|mesh-ancestor
65313405|NCT00800722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65313406|NCT00800722|Immunologic Factors|immunologic factors|mesh-ancestor
65313407|NCT00800722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313408|NCT00826280|Caffeine|caffeine|mesh-list
65313409|NCT00826280|Regadenoson|regadenoson|mesh-list
65313410|NCT00826280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65313411|NCT00826280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313412|NCT00826280|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65313413|NCT00826280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313414|NCT00826280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313415|NCT00826280|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65313416|NCT00826280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65313417|NCT00826280|Purinergic Agents|purinergic agents|mesh-ancestor
65313418|NCT00826280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65313419|NCT00826280|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65161024|NCT01072539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65161025|NCT01072539|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65161026|NCT01072539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65161027|NCT01072539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161028|NCT05517590|Tranexamic Acid|tranexamic acid|mesh-list
65161029|NCT05517590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65161030|NCT05517590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65161031|NCT05517590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161032|NCT05517590|Hemostatics|hemostatics|mesh-ancestor
65161033|NCT05517590|Coagulants|coagulants|mesh-ancestor
65161034|NCT05654077|Cyclophosphamide|cyclophosphamide|mesh-list
65161035|NCT05654077|Fludarabine|fludarabine|mesh-list
65161036|NCT05654077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65161037|NCT05654077|Immunologic Factors|immunologic factors|mesh-ancestor
65313420|NCT00826280|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65313421|NCT00826280|Purinergic Agonists|purinergic agonists|mesh-ancestor
65313422|NCT00800800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65313423|NCT00800800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65313424|NCT00800800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65313425|NCT00800800|Antimetabolites|antimetabolites|mesh-ancestor
65313426|NCT00800800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313427|NCT00800800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65313428|NCT00800800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65313429|NCT00800800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313430|NCT00703898|Nevirapine|nevirapine|mesh-list
65313431|NCT00703898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65313432|NCT00703898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65313433|NCT00703898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313434|NCT00703898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313435|NCT00703898|Antiviral Agents|antiviral agents|mesh-ancestor
65313436|NCT00703898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65313437|NCT00703898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65313438|NCT00703898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65313439|NCT00703898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65313440|NCT00703898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65313441|NCT04030442|Morphine|morphine|mesh-list
65313442|NCT04030442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65313443|NCT04030442|Narcotics|narcotics|mesh-ancestor
65313444|NCT04030442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65313445|NCT04030442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313446|NCT04030442|Analgesics|analgesics|mesh-ancestor
65313447|NCT04030442|Sensory System Agents|sensory system agents|mesh-ancestor
65313448|NCT04030442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313449|NCT00801034|Calcium|calcium|mesh-list
65313450|NCT00801034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65313451|NCT00801034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313452|NCT04130477|Nickel|nickel|mesh-list
65313461|NCT00702728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313462|NCT00702728|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65313463|NCT00702728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65313464|NCT00702728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313465|NCT04132115|Vancomycin|vancomycin|mesh-list
65313466|NCT04132115|Gentamicins|gentamicins|mesh-list
65313467|NCT04132115|Meropenem|meropenem|mesh-list
65313468|NCT04132115|Tazobactam|tazobactam|mesh-list
65313469|NCT04132115|Linezolid|linezolid|mesh-list
65313470|NCT04132115|Piperacillin|piperacillin|mesh-list
65313471|NCT04132115|Daptomycin|daptomycin|mesh-list
65313472|NCT04132115|Amikacin|amikacin|mesh-list
65313473|NCT04132115|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65313474|NCT04132115|Ceftobiprole|ceftobiprole|mesh-list
65313475|NCT04132115|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
65313476|NCT04132115|Acyclovir|acyclovir|mesh-list
65313477|NCT04132115|Ganciclovir|ganciclovir|mesh-list
65313478|NCT04132115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65313479|NCT04132115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65313480|NCT04132115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65313481|NCT04132115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313482|NCT04132115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313483|NCT04132115|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65313484|NCT04132115|Antiviral Agents|antiviral agents|mesh-ancestor
65313485|NCT00801268|Emodin|emodin|mesh-list
65313486|NCT00801268|Cathartics|cathartics|mesh-ancestor
65313487|NCT00801268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65313488|NCT00801268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65313489|NCT00801268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313490|NCT00801268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313491|NCT02614937|Squalamine|squalamine|mesh-list
65313492|NCT02614937|Ranibizumab|ranibizumab|mesh-list
65313493|NCT02614937|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65313494|NCT02614937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65313495|NCT02614937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65313496|NCT02614937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65313497|NCT02614937|Growth Substances|growth substances|mesh-ancestor
65313498|NCT02614937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161038|NCT05654077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313499|NCT02614937|Growth Inhibitors|growth inhibitors|mesh-ancestor
65313500|NCT02614937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313501|NCT02614937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65313502|NCT02614937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65313503|NCT02614937|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65313504|NCT02614937|Protective Agents|protective agents|mesh-ancestor
65313505|NCT00707642|Vaccines|vaccines|mesh-list
65313506|NCT00707642|Immunologic Factors|immunologic factors|mesh-ancestor
65313507|NCT00707642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313508|NCT00789568|Moxifloxacin|moxifloxacin|mesh-list
65313509|NCT00789568|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65313510|NCT00789568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65313511|NCT00789568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65313512|NCT00789568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65313513|NCT00789568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65313514|NCT00789568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313515|NCT00789568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313516|NCT00789568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313517|NCT00789568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65313518|NCT00789568|Contraceptive Agents|contraceptive agents|mesh-ancestor
65313519|NCT00789568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65313520|NCT00789568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313521|NCT00789568|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65313522|NCT00789568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65313523|NCT00789568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65313524|NCT00789646|Lidocaine|lidocaine|mesh-list
65313525|NCT00789646|Anesthetics, Local|anesthetics, local|mesh-ancestor
65313526|NCT00789646|Anesthetics|anesthetics|mesh-ancestor
64543279|NCT05096520|Sensory System Agents|sensory system agents|mesh-ancestor
65161039|NCT05654077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65161040|NCT05654077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65161041|NCT05654077|Alkylating Agents|alkylating agents|mesh-ancestor
65161042|NCT05654077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161043|NCT05654077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161044|NCT05654077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65161045|NCT04303767|Calcium|calcium|mesh-list
65161048|NCT04303767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161050|NCT04303767|Sequestering Agents|sequestering agents|mesh-ancestor
65161051|NCT04303767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161052|NCT02874963|Ethanol|ethanol|mesh-list
65161053|NCT02874963|Listerine|listerine|mesh-list
65161054|NCT02874963|Thymol|thymol|mesh-list
65161055|NCT02874963|Eucalyptol|eucalyptol|mesh-list
65161056|NCT02874963|Salicylates|salicylates|mesh-list
65161057|NCT02874963|Methyl salicylate|methyl salicylate|mesh-list
65161058|NCT02874963|Menthol|menthol|mesh-list
65161059|NCT02874963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65313527|NCT00789646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65313528|NCT00789646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313529|NCT00789646|Sensory System Agents|sensory system agents|mesh-ancestor
65313530|NCT00789646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313531|NCT00789646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65313532|NCT00789646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65313533|NCT00789646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65313534|NCT00789646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65313535|NCT00789646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313536|NCT00856973|Eszopiclone|eszopiclone|mesh-list
65313537|NCT00856973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65313538|NCT00856973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65313539|NCT00856973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313540|NCT00794638|Rituximab|rituximab|mesh-list
65313541|NCT00794638|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65313542|NCT00794638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65313543|NCT00794638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313544|NCT00794638|Immunologic Factors|immunologic factors|mesh-ancestor
65313545|NCT00794638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313546|NCT00794638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65313547|NCT00794638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65313548|NCT00794638|Alkylating Agents|alkylating agents|mesh-ancestor
65313575|NCT00707798|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65313576|NCT00707798|Immunologic Factors|immunologic factors|mesh-ancestor
65313577|NCT00707798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313578|NCT00801736|Paclitaxel|paclitaxel|mesh-list
65313579|NCT00801736|Cisplatin|cisplatin|mesh-list
65313580|NCT00801736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65313581|NCT00801736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313582|NCT00801736|Tubulin Modulators|tubulin modulators|mesh-ancestor
65313583|NCT00801736|Antimitotic Agents|antimitotic agents|mesh-ancestor
65313584|NCT00801736|Mitosis Modulators|mitosis modulators|mesh-ancestor
65313585|NCT00801736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313586|NCT00856661|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
65313587|NCT00856661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65313588|NCT00856661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65313589|NCT00856661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313590|NCT02606994|Diphenhydramine|diphenhydramine|mesh-list
65313591|NCT02606994|Lidocaine|lidocaine|mesh-list
65313592|NCT02606994|Anesthetics, Local|anesthetics, local|mesh-ancestor
65313593|NCT02606994|Anesthetics|anesthetics|mesh-ancestor
65313594|NCT02606994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65313595|NCT02606994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313596|NCT02606994|Sensory System Agents|sensory system agents|mesh-ancestor
65313597|NCT02606994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313598|NCT02606994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65313599|NCT02606994|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65313600|NCT02606994|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65313601|NCT02606994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65313602|NCT02606994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313603|NCT02606994|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65313604|NCT02606994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65313605|NCT02606994|Antiemetics|antiemetics|mesh-ancestor
65313606|NCT02606994|Autonomic Agents|autonomic agents|mesh-ancestor
65161060|NCT02874963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65161061|NCT02874963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65161062|NCT02874963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161063|NCT02874963|Antipruritics|antipruritics|mesh-ancestor
65161064|NCT02874963|Dermatologic Agents|dermatologic agents|mesh-ancestor
65161065|NCT02874963|Protective Agents|protective agents|mesh-ancestor
65161066|NCT02874963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65161067|NCT02874963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65313607|NCT02606994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65313608|NCT02606994|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65313609|NCT02606994|Histamine Antagonists|histamine antagonists|mesh-ancestor
65313610|NCT02606994|Histamine Agents|histamine agents|mesh-ancestor
65313611|NCT02606994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65313612|NCT02606994|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65313613|NCT00844376|Atorvastatin|atorvastatin|mesh-list
65313614|NCT00844376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65313615|NCT00844376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65313616|NCT00844376|Antimetabolites|antimetabolites|mesh-ancestor
65313617|NCT00844376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313618|NCT00844376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65313619|NCT00844376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65313620|NCT00844376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313621|NCT04046302|Dinoprostone|dinoprostone|mesh-list
65313622|NCT04046302|Oxytocics|oxytocics|mesh-ancestor
65313623|NCT04046302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65313624|NCT04046302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313625|NCT00914394|Phenylephrine|phenylephrine|mesh-list
65313626|NCT00914394|Oxymetazoline|oxymetazoline|mesh-list
65313627|NCT00914394|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
65313628|NCT00914394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65313629|NCT00914394|Mydriatics|mydriatics|mesh-ancestor
65313630|NCT00914394|Autonomic Agents|autonomic agents|mesh-ancestor
65313631|NCT00914394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313632|NCT00914394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313633|NCT00914394|Sympathomimetics|sympathomimetics|mesh-ancestor
65313634|NCT00914394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65313635|NCT00914394|Nasal Decongestants|nasal decongestants|mesh-ancestor
65313636|NCT00914394|Respiratory System Agents|respiratory system agents|mesh-ancestor
65313637|NCT00914394|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65313638|NCT00914394|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65313639|NCT00914394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65313640|NCT00914394|Adrenergic Agents|adrenergic agents|mesh-ancestor
65313641|NCT00914394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65161068|NCT02874963|Analgesics|analgesics|mesh-ancestor
65161069|NCT02874963|Sensory System Agents|sensory system agents|mesh-ancestor
65161070|NCT02874963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161071|NCT02874963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65161072|NCT02874963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65161073|NCT02874963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65161074|NCT02874963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313642|NCT00914394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313643|NCT00914394|Protective Agents|protective agents|mesh-ancestor
65313644|NCT00914394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313645|NCT04045678|Rotigotine|rotigotine|mesh-list
65313646|NCT04045678|Dopamine Agonists|dopamine agonists|mesh-ancestor
65313647|NCT04045678|Dopamine Agents|dopamine agents|mesh-ancestor
65313648|NCT04045678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65313649|NCT04045678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313650|NCT04045678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313651|NCT00658606|Alefacept|alefacept|mesh-list
65313652|NCT00658606|Dermatologic Agents|dermatologic agents|mesh-ancestor
65313653|NCT00658606|Immunologic Factors|immunologic factors|mesh-ancestor
65313654|NCT00658606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313655|NCT00795106|Capsaicin|capsaicin|mesh-list
65313656|NCT00795106|Antipruritics|antipruritics|mesh-ancestor
65313657|NCT00795106|Dermatologic Agents|dermatologic agents|mesh-ancestor
65313658|NCT00795106|Sensory System Agents|sensory system agents|mesh-ancestor
65313659|NCT00795106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313660|NCT00795106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313661|NCT00589290|Belinostat|belinostat|mesh-list
65313662|NCT00589290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313663|NCT00589290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65313664|NCT00589290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313665|NCT00589290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313666|NCT00802048|Ropivacaine|ropivacaine|mesh-list
65313667|NCT00802048|Anesthetics, Local|anesthetics, local|mesh-list
65313668|NCT00802048|Anesthetics|anesthetics|mesh-list
65313669|NCT00802048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65313670|NCT00802048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313671|NCT00802048|Sensory System Agents|sensory system agents|mesh-ancestor
64543474|NCT04022161|Nitric Oxide|nitric oxide|mesh-list
65161075|NCT02874963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161076|NCT02874963|Antifungal Agents|antifungal agents|mesh-ancestor
65161077|NCT02874963|Antitussive Agents|antitussive agents|mesh-ancestor
65161078|NCT02874963|Respiratory System Agents|respiratory system agents|mesh-ancestor
65161079|NCT02874963|Insect Repellents|insect repellents|mesh-ancestor
65161080|NCT02818309|Lesogaberan|lesogaberan|mesh-list
65161081|NCT02818309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65161082|NCT02818309|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65161083|NCT02818309|GABA Agonists|gaba agonists|mesh-ancestor
65161084|NCT02818309|GABA Agents|gaba agents|mesh-ancestor
65161085|NCT02818309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65161086|NCT02818309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313672|NCT00802048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313673|NCT00809536|Metformin|metformin|mesh-list
65313674|NCT00809536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65313675|NCT00809536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313676|NCT00809692|Histamine|histamine|mesh-list
65313677|NCT00809692|Histamine phosphate|histamine phosphate|mesh-list
65313678|NCT00809692|Histamine Agonists|histamine agonists|mesh-ancestor
65313679|NCT00809692|Histamine Agents|histamine agents|mesh-ancestor
65313680|NCT00809692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65313681|NCT00809692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313682|NCT00809692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313683|NCT00843284|Pregabalin|pregabalin|mesh-list
65313684|NCT00843284|Analgesics|analgesics|mesh-ancestor
65313685|NCT00843284|Sensory System Agents|sensory system agents|mesh-ancestor
65313686|NCT00843284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313687|NCT00843284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313688|NCT00843284|Anticonvulsants|anticonvulsants|mesh-ancestor
65313689|NCT00843284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65313690|NCT00843284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65313691|NCT00843284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313692|NCT00843284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65313693|NCT00843284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65313694|NCT00843284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65313695|NCT00843284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65313696|NCT00843284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65313697|NCT00802282|Psilocybin|psilocybin|mesh-list
65313698|NCT00802282|Hallucinogens|hallucinogens|mesh-ancestor
65313699|NCT00802282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313700|NCT00802282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65313717|NCT00825812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313718|NCT00825812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65313719|NCT00825812|Respiratory System Agents|respiratory system agents|mesh-ancestor
65313720|NCT00825812|Mydriatics|mydriatics|mesh-ancestor
65313721|NCT00825812|Parasympatholytics|parasympatholytics|mesh-ancestor
65313722|NCT00825812|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65313723|NCT00825812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65313724|NCT00825812|Cholinergic Agents|cholinergic agents|mesh-ancestor
65313725|NCT00825812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65313726|NCT00825812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313727|NCT00825812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65313728|NCT00825812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313729|NCT00825812|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65313730|NCT00802594|Pafuramidine|pafuramidine|mesh-list
65313731|NCT00802594|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65313732|NCT00802594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65313733|NCT00802594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65313734|NCT00802594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65313735|NCT00707876|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65313736|NCT00707876|Hematinics|hematinics|mesh-ancestor
65313737|NCT00707876|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65313738|NCT00707876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65313739|NCT02606448|Bupivacaine|bupivacaine|mesh-list
65313740|NCT02606448|Anesthetics, Local|anesthetics, local|mesh-ancestor
65313741|NCT02606448|Anesthetics|anesthetics|mesh-ancestor
65313742|NCT02606448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65313743|NCT02606448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313744|NCT02606448|Sensory System Agents|sensory system agents|mesh-ancestor
65313745|NCT02606448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313746|NCT05746572|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65313761|NCT00802828|Histamine Antagonists|histamine antagonists|mesh-ancestor
65313762|NCT00802828|Histamine Agents|histamine agents|mesh-ancestor
65313763|NCT00802828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65313764|NCT00802828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313765|NCT00802828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313766|NCT00802906|Bevacizumab|bevacizumab|mesh-list
65313767|NCT00802906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65313768|NCT00802906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313769|NCT00802906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65313770|NCT00802906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65313771|NCT00802906|Growth Substances|growth substances|mesh-ancestor
65313772|NCT00802906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313773|NCT00802906|Growth Inhibitors|growth inhibitors|mesh-ancestor
65313774|NCT00803218|Fluticasone|fluticasone|mesh-list
65313775|NCT00803218|Xhance|xhance|mesh-list
65313776|NCT00803218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65313777|NCT00803218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65313778|NCT00803218|Autonomic Agents|autonomic agents|mesh-ancestor
65313779|NCT00803218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313780|NCT00803218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313781|NCT00803218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65313782|NCT00803218|Respiratory System Agents|respiratory system agents|mesh-ancestor
65313783|NCT00803218|Dermatologic Agents|dermatologic agents|mesh-ancestor
65313784|NCT00803218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65313785|NCT00824564|Tranexamic Acid|tranexamic acid|mesh-list
65313786|NCT00824564|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65313787|NCT00824564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65313788|NCT00824564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313789|NCT00824564|Hemostatics|hemostatics|mesh-ancestor
65313790|NCT00824564|Coagulants|coagulants|mesh-ancestor
65313792|NCT00803374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65313799|NCT00803530|Ascorbic Acid|ascorbic acid|mesh-list
65313803|NCT00803530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313804|NCT00803530|Vitamins|vitamins|mesh-ancestor
65313805|NCT00803530|Micronutrients|micronutrients|mesh-ancestor
65313806|NCT00803764|Naproxen|naproxen|mesh-list
65313807|NCT00803764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65313808|NCT00803764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65313809|NCT00803764|Analgesics|analgesics|mesh-ancestor
65313810|NCT00803764|Sensory System Agents|sensory system agents|mesh-ancestor
65313811|NCT00803764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313812|NCT00803764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313813|NCT00803764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65313814|NCT00803764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65313815|NCT00803764|Gout Suppressants|gout suppressants|mesh-ancestor
65313816|NCT00803764|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65313817|NCT00803764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313818|NCT00803764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313819|NCT00704366|Saracatinib|saracatinib|mesh-list
65313820|NCT00704366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313821|NCT00704366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313822|NCT00704366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313823|NCT00708266|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65313824|NCT00708266|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65313825|NCT00708266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65313826|NCT00708266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65313827|NCT00803842|Doxycycline|doxycycline|mesh-list
65313828|NCT00803842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65313829|NCT00803842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65313830|NCT00803842|Antimalarials|antimalarials|mesh-ancestor
65313831|NCT00803842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65313832|NCT00803842|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65313833|NCT00658528|Esomeprazole|esomeprazole|mesh-list
65313834|NCT00658528|Rabeprazole|rabeprazole|mesh-list
65313835|NCT00658528|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65313836|NCT00658528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65161087|NCT02818309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161088|NCT01238822|Methylphenidate|methylphenidate|mesh-list
65161089|NCT01238822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65161090|NCT01238822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161091|NCT01238822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65161092|NCT01238822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65161093|NCT01238822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65313837|NCT00658528|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65313838|NCT00658528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313839|NCT00658528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313840|NCT02864394|Docetaxel|docetaxel|mesh-list
65313841|NCT02864394|Pembrolizumab|pembrolizumab|mesh-list
65313842|NCT02864394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313843|NCT02864394|Tubulin Modulators|tubulin modulators|mesh-ancestor
65313844|NCT02864394|Antimitotic Agents|antimitotic agents|mesh-ancestor
65313845|NCT02864394|Mitosis Modulators|mitosis modulators|mesh-ancestor
65313846|NCT02864394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313847|NCT02864394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65313848|NCT00856583|Risperidone|risperidone|mesh-list
65313849|NCT00856583|Sertindole|sertindole|mesh-list
65313850|NCT00856583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65313851|NCT00856583|Serotonin Agents|serotonin agents|mesh-ancestor
65313852|NCT00856583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65313853|NCT00856583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313854|NCT00856583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313855|NCT00856583|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65313856|NCT00856583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65313857|NCT00856583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65313858|NCT00856583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65313859|NCT00856583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65313860|NCT00856583|Dopamine Agents|dopamine agents|mesh-ancestor
65313862|NCT05753436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65313863|NCT05753436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65313864|NCT05753436|Analgesics|analgesics|mesh-ancestor
65313865|NCT05753436|Sensory System Agents|sensory system agents|mesh-ancestor
65313866|NCT05753436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313867|NCT05753436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313881|NCT05739942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313882|NCT05739942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313883|NCT00824408|Pemetrexed|pemetrexed|mesh-list
65313884|NCT00824408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313885|NCT00824408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313886|NCT00824408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313887|NCT00824408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65313888|NCT00824408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65313889|NCT02611700|Paclitaxel|paclitaxel|mesh-list
65313890|NCT02611700|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65313891|NCT02611700|Cisplatin|cisplatin|mesh-list
65313892|NCT02611700|Nimotuzumab|nimotuzumab|mesh-list
65313893|NCT02611700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65313894|NCT02611700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313895|NCT02611700|Tubulin Modulators|tubulin modulators|mesh-ancestor
65313896|NCT02611700|Antimitotic Agents|antimitotic agents|mesh-ancestor
65313897|NCT02611700|Mitosis Modulators|mitosis modulators|mesh-ancestor
65313898|NCT02611700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313899|NCT02611700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65313900|NCT00708344|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65313901|NCT00708344|Irbesartan|irbesartan|mesh-list
65313902|NCT00708344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65313903|NCT00708344|Diuretics|diuretics|mesh-ancestor
65313904|NCT00708344|Natriuretic Agents|natriuretic agents|mesh-ancestor
65313905|NCT00708344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313906|NCT00708344|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65313927|NCT04118699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65313928|NCT04118699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65313929|NCT04118699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65313930|NCT00856193|Glycopyrrolate|glycopyrrolate|mesh-list
65313931|NCT00856193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65313932|NCT00856193|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65313933|NCT00856193|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65313934|NCT00856193|Cholinergic Agents|cholinergic agents|mesh-ancestor
65313935|NCT00856193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65313936|NCT00856193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313937|NCT00856193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313938|NCT04130087|Selegiline|selegiline|mesh-list
65313939|NCT04130087|Antidepressive Agents|antidepressive agents|mesh-ancestor
65313940|NCT04130087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65313941|NCT04130087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65313942|NCT04130087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65313943|NCT04130087|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65313944|NCT04130087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313945|NCT04130087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313946|NCT04130087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65313947|NCT04130087|Protective Agents|protective agents|mesh-ancestor
65313948|NCT04130087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313949|NCT00652366|Gemcitabine|gemcitabine|mesh-list
65313950|NCT00652366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65313951|NCT00652366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65313952|NCT00652366|Antimetabolites|antimetabolites|mesh-ancestor
65313953|NCT00652366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313954|NCT00652366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65313955|NCT00652366|Antiviral Agents|antiviral agents|mesh-ancestor
65313956|NCT00652366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65313957|NCT00652366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313958|NCT00652366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65313959|NCT00652366|Immunologic Factors|immunologic factors|mesh-ancestor
65313960|NCT00652366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313965|NCT00841568|Natriuretic Agents|natriuretic agents|mesh-ancestor
65313966|NCT00841568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313967|NCT00855959|Budesonide|budesonide|mesh-list
65313968|NCT00855959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65313969|NCT00855959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65313970|NCT00855959|Autonomic Agents|autonomic agents|mesh-ancestor
65313971|NCT00855959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65313972|NCT00855959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65313973|NCT00855959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65313974|NCT00855959|Respiratory System Agents|respiratory system agents|mesh-ancestor
65313975|NCT00855959|Glucocorticoids|glucocorticoids|mesh-ancestor
65313976|NCT00855959|Hormones|hormones|mesh-ancestor
65313977|NCT00855959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65313978|NCT00704600|Nelfinavir|nelfinavir|mesh-list
65313979|NCT00704600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65313980|NCT00704600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65313981|NCT00704600|Protease Inhibitors|protease inhibitors|mesh-ancestor
65313982|NCT00704600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65313983|NCT00704600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65313984|NCT00704600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65313985|NCT00704600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65313986|NCT00704600|Antiviral Agents|antiviral agents|mesh-ancestor
65313987|NCT00704600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65313988|NCT00699881|Cetuximab|cetuximab|mesh-list
65313991|NCT00708578|Metformin|metformin|mesh-list
65314015|NCT00913328|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65314016|NCT00913328|Hormone Antagonists|hormone antagonists|mesh-ancestor
65314017|NCT00913328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65314018|NCT00913328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314019|NCT00913328|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65314020|NCT00913328|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65314021|NCT00913328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314022|NCT03307785|Paclitaxel|paclitaxel|mesh-list
65314023|NCT03307785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65314024|NCT03307785|Bevacizumab|bevacizumab|mesh-list
65314025|NCT03307785|Carboplatin|carboplatin|mesh-list
65314026|NCT03307785|Pemetrexed|pemetrexed|mesh-list
65314027|NCT03307785|Niraparib|niraparib|mesh-list
65314028|NCT03307785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65314029|NCT03307785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314030|NCT03307785|Tubulin Modulators|tubulin modulators|mesh-ancestor
65314031|NCT03307785|Antimitotic Agents|antimitotic agents|mesh-ancestor
65314032|NCT03307785|Mitosis Modulators|mitosis modulators|mesh-ancestor
65314033|NCT03307785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314034|NCT03307785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65314035|NCT03307785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65314036|NCT03307785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65314065|NCT00708812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314066|NCT00708812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65314067|NCT00708812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65314068|NCT00708812|Growth Substances|growth substances|mesh-ancestor
65314069|NCT00708812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314070|NCT00708812|Growth Inhibitors|growth inhibitors|mesh-ancestor
65314071|NCT04127747|Rituximab|rituximab|mesh-list
65314072|NCT04127747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65314073|NCT04127747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314074|NCT04127747|Immunologic Factors|immunologic factors|mesh-ancestor
65314075|NCT04127747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314076|NCT04127747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65314077|NCT00822926|Botulinum Toxins|botulinum toxins|mesh-list
65314078|NCT00822926|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65314079|NCT00822926|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65063987|NCT00272025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65314080|NCT00822926|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65314081|NCT00822926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65314082|NCT00822926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314083|NCT00822926|Cholinergic Agents|cholinergic agents|mesh-ancestor
65314084|NCT00822926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65314085|NCT00822926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314086|NCT00822926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65314087|NCT00822926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65314088|NCT00822770|Plerixafor|plerixafor|mesh-list
65314089|NCT00822770|Fludarabine|fludarabine|mesh-list
65314090|NCT00822770|Fludarabine phosphate|fludarabine phosphate|mesh-list
65314091|NCT00822770|Busulfan|busulfan|mesh-list
65314092|NCT00822770|Thymoglobulin|thymoglobulin|mesh-list
65314093|NCT00822770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65314094|NCT00822770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314096|NCT00822770|Antimetabolites|antimetabolites|mesh-ancestor
65314106|NCT00822770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65314107|NCT00822770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65314108|NCT02842086|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65314109|NCT02842086|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65314110|NCT02842086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65314111|NCT02842086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65314112|NCT02842086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314113|NCT02842086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314114|NCT02842086|Antiviral Agents|antiviral agents|mesh-ancestor
65314115|NCT02842086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65314116|NCT02842086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65314117|NCT02842086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65314118|NCT00822692|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65314119|NCT00822692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65314120|NCT00822692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65314121|NCT00822692|Renal Agents|renal agents|mesh-ancestor
65314122|NCT00822692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65314123|NCT00822692|Antimalarials|antimalarials|mesh-ancestor
65314124|NCT00822692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65314125|NCT00822692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65314126|NCT02607111|Dalteparin|dalteparin|mesh-list
65314159|NCT00704756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65314160|NCT00704756|Immunologic Factors|immunologic factors|mesh-ancestor
65314161|NCT00704756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314162|NCT00806442|Borage oil|borage oil|mesh-list
65314163|NCT00806442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65314164|NCT02608242|Amlodipine|amlodipine|mesh-list
65314165|NCT02608242|Telmisartan|telmisartan|mesh-list
65314166|NCT02608242|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
65314167|NCT02608242|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65314168|NCT02608242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65314169|NCT02608242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65314170|NCT02608242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65314171|NCT02608242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314172|NCT02608242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65314173|NCT02608242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314174|NCT02608242|Vasodilator Agents|vasodilator agents|mesh-ancestor
65314175|NCT02608242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65314176|NCT02608242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65314177|NCT02608242|Antimetabolites|antimetabolites|mesh-ancestor
65314178|NCT02608242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65314179|NCT02608242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65314180|NCT02608242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314181|NCT02608242|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65314182|NCT02608242|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65314183|NCT02607696|Zolpidem|zolpidem|mesh-list
65314184|NCT02607696|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65314185|NCT02607696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65161094|NCT01238822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161095|NCT01238822|Dopamine Agents|dopamine agents|mesh-ancestor
65161096|NCT01238822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65161097|NCT02818387|Midazolam|midazolam|mesh-list
65161098|NCT02818387|Remifentanil|remifentanil|mesh-list
65161099|NCT02818387|Propofol|propofol|mesh-list
65161100|NCT02818387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65161101|NCT02818387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65161102|NCT02818387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161103|NCT02818387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65161104|NCT02818387|Anesthetics, General|anesthetics, general|mesh-ancestor
65161105|NCT02818387|Anesthetics|anesthetics|mesh-ancestor
65161106|NCT02818387|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65161107|NCT02818387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65161108|NCT02818387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65161109|NCT02818387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65161110|NCT02818387|GABA Modulators|gaba modulators|mesh-ancestor
65161111|NCT02818387|GABA Agents|gaba agents|mesh-ancestor
65161112|NCT02818387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65161113|NCT02818387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161114|NCT02818387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65314186|NCT02607696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65314187|NCT02607696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314188|NCT02607696|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65314189|NCT02607696|GABA Agonists|gaba agonists|mesh-ancestor
65314190|NCT02607696|GABA Agents|gaba agents|mesh-ancestor
65314191|NCT02607696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65314192|NCT02607696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314193|NCT00839852|Cariprazine|cariprazine|mesh-list
65314194|NCT00839852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65314195|NCT00839852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65314196|NCT00839852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65314197|NCT00839852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314198|NCT00839852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65314199|NCT02604849|Gentamicins|gentamicins|mesh-list
65314200|NCT02604849|Neomycin|neomycin|mesh-list
65314201|NCT02604849|Streptomycin|streptomycin|mesh-list
65314202|NCT02604849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65314203|NCT02604849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65314204|NCT02604849|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65314205|NCT02604849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314206|NCT02604849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314207|NCT00709046|Pantoprazole|pantoprazole|mesh-list
65314208|NCT00709046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65314209|NCT00709046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65314210|NCT00709046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65314211|NCT00709046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314212|NCT00709046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161115|NCT02818387|Narcotics|narcotics|mesh-ancestor
65161116|NCT02818387|Analgesics|analgesics|mesh-ancestor
65161117|NCT02818387|Sensory System Agents|sensory system agents|mesh-ancestor
65161118|NCT02818387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161119|NCT05296629|Doxycycline|doxycycline|mesh-list
65161137|NCT04238221|Doxofylline|doxofylline|mesh-list
65161138|NCT04238221|Antitussive Agents|antitussive agents|mesh-ancestor
65161139|NCT04238221|Respiratory System Agents|respiratory system agents|mesh-ancestor
65161140|NCT04238221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64803757|NCT01409187|Interleukin-2|interleukin-2|mesh-list
65161142|NCT04238221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161143|NCT04238221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161144|NCT04238221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65161145|NCT04238221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65161146|NCT04238221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65161147|NCT04238221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161148|NCT01047501|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
65161149|NCT01047501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65161150|NCT01047501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65314213|NCT00820898|Gemcitabine|gemcitabine|mesh-list
65314214|NCT00820898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65314215|NCT00820898|Antimetabolites|antimetabolites|mesh-ancestor
65314216|NCT00820898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314217|NCT00820898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314218|NCT00820898|Antiviral Agents|antiviral agents|mesh-ancestor
65314219|NCT00820898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65314220|NCT00820898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314221|NCT00820898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65314222|NCT00820898|Immunologic Factors|immunologic factors|mesh-ancestor
65314223|NCT00820898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314224|NCT00865709|Leucovorin|leucovorin|mesh-list
65314225|NCT00865709|Oxaliplatin|oxaliplatin|mesh-list
65314226|NCT00865709|Fluorouracil|fluorouracil|mesh-list
65314227|NCT00865709|Sorafenib|sorafenib|mesh-list
65314228|NCT00865709|Levoleucovorin|levoleucovorin|mesh-list
65314229|NCT00865709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064133|NCT00259922|Alvimopan|alvimopan|mesh-list
65314230|NCT00865709|Antidotes|antidotes|mesh-ancestor
65314231|NCT00865709|Protective Agents|protective agents|mesh-ancestor
65314232|NCT00865709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314233|NCT00865709|Vitamin B Complex|vitamin b complex|mesh-ancestor
65314234|NCT00865709|Vitamins|vitamins|mesh-ancestor
65314235|NCT00865709|Micronutrients|micronutrients|mesh-ancestor
65314236|NCT00865709|Antimetabolites|antimetabolites|mesh-ancestor
65314237|NCT00865709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314238|NCT00865709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65314239|NCT00865709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65314240|NCT00865709|Immunologic Factors|immunologic factors|mesh-ancestor
65314241|NCT00865709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65314242|NCT00865709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314243|NCT00839306|Rabeprazole|rabeprazole|mesh-list
65314244|NCT00839306|Ranitidine|ranitidine|mesh-list
65314245|NCT00839306|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65314246|NCT00839306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65314255|NCT00839306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314256|NCT04131335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65314257|NCT04131335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65314258|NCT00839072|Trazodone|trazodone|mesh-list
65314259|NCT00839072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65314260|NCT00839072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65314261|NCT00839072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65314262|NCT00839072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314263|NCT00839072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65314264|NCT00839072|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65314265|NCT00839072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65314266|NCT00839072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65314267|NCT00839072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314268|NCT00839072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65314269|NCT00839072|Serotonin Agents|serotonin agents|mesh-ancestor
65314270|NCT00839072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65314271|NCT00839072|Antidepressive Agents|antidepressive agents|mesh-ancestor
65314272|NCT00704990|Vitamins|vitamins|mesh-list
65314273|NCT00704990|Ascorbic Acid|ascorbic acid|mesh-list
65314274|NCT00704990|Vitamin B 6|vitamin b 6|mesh-list
65314275|NCT00704990|Pyridoxal|pyridoxal|mesh-list
65314276|NCT00704990|Pyridoxine|pyridoxine|mesh-list
65314277|NCT00704990|Zinc|zinc|mesh-list
65314278|NCT00704990|Vitamin B Complex|vitamin b complex|mesh-list
65314279|NCT00704990|Micronutrients|micronutrients|mesh-ancestor
65314280|NCT00704990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314281|NCT00704990|Trace Elements|trace elements|mesh-ancestor
65314282|NCT00704990|Antioxidants|antioxidants|mesh-ancestor
65314283|NCT00704990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314284|NCT00704990|Protective Agents|protective agents|mesh-ancestor
65314285|NCT03553836|Pembrolizumab|pembrolizumab|mesh-list
65314286|NCT03553836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65314299|NCT02607774|GABA Modulators|gaba modulators|mesh-ancestor
65314300|NCT02607774|GABA Agents|gaba agents|mesh-ancestor
65314301|NCT02607774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65314302|NCT02607774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314303|NCT00838916|Insulin Glargine|insulin glargine|mesh-list
65314304|NCT00838916|rGLP-1 protein|rglp-1 protein|mesh-list
65314305|NCT00838916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65314306|NCT00838916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314307|NCT00838916|Incretins|incretins|mesh-ancestor
65314308|NCT00838916|Hormones|hormones|mesh-ancestor
65314309|NCT00838916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65314310|NCT00838682|Omeprazole|omeprazole|mesh-list
65314311|NCT00838682|Rabeprazole|rabeprazole|mesh-list
65314312|NCT00838682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65314313|NCT00838682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65314314|NCT00838682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65314315|NCT00838682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314316|NCT00838682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314317|NCT00913484|Disulfiram|disulfiram|mesh-list
65314318|NCT00913484|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65314319|NCT00913484|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65314320|NCT00913484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314321|NCT00913484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314322|NCT00803712|Vitamin D|vitamin d|mesh-list
65314323|NCT00803712|Ergocalciferols|ergocalciferols|mesh-list
65314324|NCT00803712|Cholecalciferol|cholecalciferol|mesh-list
65314325|NCT00803712|Vitamins|vitamins|mesh-list
65314326|NCT00803712|Cinacalcet|cinacalcet|mesh-list
65314327|NCT00803712|Micronutrients|micronutrients|mesh-ancestor
65314328|NCT00803712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314329|NCT00803712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65314335|NCT00803634|Diltiazem|diltiazem|mesh-list
65314344|NCT00803634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65314345|NCT00803634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314346|NCT00803634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65314347|NCT00803634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314348|NCT00803634|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65314349|NCT00803634|Diuretics|diuretics|mesh-ancestor
65314350|NCT00803634|Natriuretic Agents|natriuretic agents|mesh-ancestor
65314351|NCT00803634|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65314352|NCT00838526|Rabeprazole|rabeprazole|mesh-list
65314353|NCT00838526|Ranitidine|ranitidine|mesh-list
65314354|NCT00838526|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65314355|NCT00838526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65314356|NCT00838526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65314357|NCT00838526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65314358|NCT00838526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314359|NCT00838526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314360|NCT00838526|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65314361|NCT00838526|Histamine Antagonists|histamine antagonists|mesh-ancestor
65314362|NCT00838526|Histamine Agents|histamine agents|mesh-ancestor
65314363|NCT00838526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65314364|NCT00838526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314365|NCT00914472|Heparin|heparin|mesh-list
65314366|NCT00914472|Calcium heparin|calcium heparin|mesh-list
65314367|NCT00914472|Anticoagulants|anticoagulants|mesh-ancestor
65314368|NCT00914472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65314369|NCT00914472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65314370|NCT00914472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314371|NCT02611466|Naproxen|naproxen|mesh-list
65314372|NCT02611466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65314373|NCT02611466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65314386|NCT02610920|Iron|iron|mesh-list
65314387|NCT02610920|Trace Elements|trace elements|mesh-ancestor
65314388|NCT02610920|Micronutrients|micronutrients|mesh-ancestor
65314389|NCT02610920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314390|NCT00913562|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65314391|NCT00913562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65314392|NCT00913562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65314393|NCT00913562|Antimetabolites|antimetabolites|mesh-ancestor
65314394|NCT00913562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314395|NCT00913562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65314396|NCT00913562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65314397|NCT00913562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314398|NCT00818168|Infliximab|infliximab|mesh-list
65314399|NCT00818168|Dermatologic Agents|dermatologic agents|mesh-ancestor
65314400|NCT00818168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65314401|NCT00818168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65314402|NCT02607540|Cisplatin|cisplatin|mesh-list
65314403|NCT02607540|Fluorouracil|fluorouracil|mesh-list
65314404|NCT02607540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314405|NCT02607540|Antimetabolites|antimetabolites|mesh-ancestor
65314406|NCT02607540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314407|NCT02607540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65314408|NCT02607540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65314409|NCT02607540|Immunologic Factors|immunologic factors|mesh-ancestor
65314410|NCT02607540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314411|NCT00705692|Levamisole|levamisole|mesh-list
65314412|NCT00705692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65314413|NCT00705692|Immunologic Factors|immunologic factors|mesh-ancestor
65314414|NCT00705692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314415|NCT00705692|Antinematodal Agents|antinematodal agents|mesh-ancestor
65314416|NCT00705692|Anthelmintics|anthelmintics|mesh-ancestor
65314417|NCT00705692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65314418|NCT00705692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65314419|NCT00705692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65314420|NCT00705770|Hydrocortisone|hydrocortisone|mesh-list
65314421|NCT00705770|Anecortave|anecortave|mesh-list
65314422|NCT00705770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65161152|NCT01238120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65161153|NCT01238120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65161154|NCT01238120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65161155|NCT01238120|Analgesics|analgesics|mesh-ancestor
65161156|NCT01238120|Sensory System Agents|sensory system agents|mesh-ancestor
65314423|NCT00705770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65314424|NCT00705770|Growth Substances|growth substances|mesh-ancestor
65314425|NCT00705770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314426|NCT00705770|Growth Inhibitors|growth inhibitors|mesh-ancestor
65314427|NCT00705770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314428|NCT00705770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65314429|NCT00796653|Formoterol Fumarate|formoterol fumarate|mesh-list
65314430|NCT00796653|Olodaterol|olodaterol|mesh-list
65314431|NCT00796653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65314432|NCT00796653|Autonomic Agents|autonomic agents|mesh-ancestor
65314433|NCT00796653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65314434|NCT00796653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314435|NCT00796653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65314436|NCT00796653|Respiratory System Agents|respiratory system agents|mesh-ancestor
65314437|NCT00796653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65314438|NCT00796653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65314439|NCT00796653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65314440|NCT00796653|Adrenergic Agents|adrenergic agents|mesh-ancestor
65314441|NCT00796653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65314442|NCT00796653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314443|NCT00806286|Paclitaxel|paclitaxel|mesh-list
65314444|NCT00806286|Carboplatin|carboplatin|mesh-list
65314445|NCT00806286|Efatutazone|efatutazone|mesh-list
65314446|NCT00806286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65314447|NCT00806286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314448|NCT00806286|Tubulin Modulators|tubulin modulators|mesh-ancestor
65314471|NCT00590538|Estrogens|estrogens|mesh-ancestor
65314472|NCT00590538|Hormones|hormones|mesh-ancestor
65314473|NCT00590538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65314474|NCT02608320|Fentanyl|fentanyl|mesh-list
65314475|NCT02608320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65314476|NCT02608320|Narcotics|narcotics|mesh-ancestor
65314477|NCT02608320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65314478|NCT02608320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314479|NCT02608320|Analgesics|analgesics|mesh-ancestor
65314480|NCT02608320|Sensory System Agents|sensory system agents|mesh-ancestor
65314481|NCT02608320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65314482|NCT02608320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65314483|NCT02608320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65314484|NCT02608320|Anesthetics, General|anesthetics, general|mesh-ancestor
65314485|NCT02608320|Anesthetics|anesthetics|mesh-ancestor
65314486|NCT01731444|Phenylephrine|phenylephrine|mesh-list
65314487|NCT01731444|Oxymetazoline|oxymetazoline|mesh-list
65314488|NCT01731444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65314489|NCT01731444|Mydriatics|mydriatics|mesh-ancestor
65314490|NCT01731444|Autonomic Agents|autonomic agents|mesh-ancestor
65314491|NCT01731444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65314492|NCT01731444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314493|NCT01731444|Sympathomimetics|sympathomimetics|mesh-ancestor
65314494|NCT01731444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65314495|NCT01731444|Nasal Decongestants|nasal decongestants|mesh-ancestor
65314496|NCT01731444|Respiratory System Agents|respiratory system agents|mesh-ancestor
65314497|NCT01731444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65314498|NCT01731444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65314499|NCT01731444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65314500|NCT01731444|Adrenergic Agents|adrenergic agents|mesh-ancestor
65314501|NCT01731444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65314502|NCT01731444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314503|NCT01731444|Protective Agents|protective agents|mesh-ancestor
65314504|NCT05728944|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65161157|NCT01238120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161158|NCT01238120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161159|NCT01238120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65161160|NCT01238120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65161161|NCT01238120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65161162|NCT01238120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161163|NCT00634231|Valacyclovir|valacyclovir|mesh-list
65161164|NCT00634231|Antiviral Agents|antiviral agents|mesh-ancestor
65314505|NCT05728944|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65314506|NCT05728944|Aceclidine|aceclidine|mesh-list
65314507|NCT05728944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65314508|NCT05728944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65314509|NCT05728944|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65314510|NCT05728944|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65314511|NCT05728944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65314512|NCT05728944|Adrenergic Agents|adrenergic agents|mesh-ancestor
65314513|NCT05728944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65314514|NCT05728944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314515|NCT05728944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314516|NCT05728944|Miotics|miotics|mesh-ancestor
65314517|NCT05728944|Autonomic Agents|autonomic agents|mesh-ancestor
65314518|NCT05728944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65314519|NCT05728944|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65314520|NCT05728788|Antineoplastic Agents|antineoplastic agents|mesh-list
65314521|NCT02608164|Vitamin D|vitamin d|mesh-list
65314522|NCT02608164|Cholecalciferol|cholecalciferol|mesh-list
65314523|NCT02608164|Vitamins|vitamins|mesh-ancestor
65314524|NCT02608164|Micronutrients|micronutrients|mesh-ancestor
65314525|NCT02608164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314526|NCT02608164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65314527|NCT02608164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65314528|NCT00796419|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65314529|NCT00796419|Plasma Substitutes|plasma substitutes|mesh-ancestor
65314530|NCT00796419|Blood Substitutes|blood substitutes|mesh-ancestor
65314531|NCT04110873|Ubiquinone|ubiquinone|mesh-list
65314553|NCT00805740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65314554|NCT00805740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314555|NCT00805740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314556|NCT05613075|Hyaluronic Acid|hyaluronic acid|mesh-list
65314557|NCT05613075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65314558|NCT05613075|Immunologic Factors|immunologic factors|mesh-ancestor
65314559|NCT05613075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314560|NCT05613075|Viscosupplements|viscosupplements|mesh-ancestor
65314561|NCT05613075|Protective Agents|protective agents|mesh-ancestor
65314562|NCT01227876|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65314563|NCT01227876|Methylprednisolone|methylprednisolone|mesh-list
65314564|NCT01227876|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65314565|NCT01227876|Prednisolone|prednisolone|mesh-list
65314566|NCT01227876|Prednisolone acetate|prednisolone acetate|mesh-list
65314567|NCT01227876|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65314568|NCT01227876|Prednisolone phosphate|prednisolone phosphate|mesh-list
65314569|NCT01227876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65314570|NCT01227876|Antiemetics|antiemetics|mesh-ancestor
65314571|NCT01227876|Autonomic Agents|autonomic agents|mesh-ancestor
65314572|NCT01227876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65314573|NCT01227876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314574|NCT01227876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65314575|NCT01227876|Glucocorticoids|glucocorticoids|mesh-ancestor
65314576|NCT01227876|Hormones|hormones|mesh-ancestor
65314577|NCT01227876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65314578|NCT01227876|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65314579|NCT01227876|Protective Agents|protective agents|mesh-ancestor
65314580|NCT01227876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65314600|NCT02604459|Anesthetics, General|anesthetics, general|mesh-ancestor
65314601|NCT02604459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65314602|NCT02604459|Narcotics|narcotics|mesh-ancestor
65314603|NCT02604459|Analgesics|analgesics|mesh-ancestor
65314604|NCT02604459|Sensory System Agents|sensory system agents|mesh-ancestor
65314605|NCT02604459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65314606|NCT02604459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65314607|NCT02604459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65314608|NCT02604459|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65314609|NCT02604225|Methoxyflurane|methoxyflurane|mesh-list
65314610|NCT02604225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65064495|NCT00261521|Epoetin Alfa|epoetin alfa|mesh-list
65314611|NCT02604225|Anesthetics, General|anesthetics, general|mesh-ancestor
65314612|NCT02604225|Anesthetics|anesthetics|mesh-ancestor
65314613|NCT02604225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65314614|NCT02604225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314615|NCT02607072|Aspirin|aspirin|mesh-list
65314616|NCT02607072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65314617|NCT02607072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65314618|NCT02607072|Analgesics|analgesics|mesh-ancestor
65314619|NCT02607072|Sensory System Agents|sensory system agents|mesh-ancestor
65314620|NCT02607072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65314621|NCT02607072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314622|NCT02607072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65314623|NCT02607072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65314624|NCT02607072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65314625|NCT02607072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65314629|NCT02607072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314647|NCT03161652|Dopamine Agents|dopamine agents|mesh-ancestor
65314648|NCT03161652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65314649|NCT03161652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314650|NCT03161652|Protective Agents|protective agents|mesh-ancestor
65314651|NCT03161652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65314652|NCT03161652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65314653|NCT03161652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65314654|NCT03161652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65314655|NCT03161652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65314656|NCT03161652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65314657|NCT03161652|Antidepressive Agents|antidepressive agents|mesh-ancestor
65314658|NCT00588237|Paclitaxel|paclitaxel|mesh-list
65314659|NCT00588237|Bevacizumab|bevacizumab|mesh-list
65314660|NCT00588237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65314661|NCT00588237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314662|NCT00588237|Tubulin Modulators|tubulin modulators|mesh-ancestor
65314663|NCT00588237|Antimitotic Agents|antimitotic agents|mesh-ancestor
65314664|NCT00588237|Mitosis Modulators|mitosis modulators|mesh-ancestor
65314665|NCT00588237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314666|NCT00588237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65314667|NCT00588237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65314668|NCT00588237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65314669|NCT00588237|Growth Substances|growth substances|mesh-ancestor
65314670|NCT00588237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314671|NCT00588237|Growth Inhibitors|growth inhibitors|mesh-ancestor
65314672|NCT02605746|Ceritinib|ceritinib|mesh-list
65314673|NCT02605746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314674|NCT02605746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65314675|NCT02605746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314676|NCT02605746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314689|NCT00588822|Immunologic Factors|immunologic factors|mesh-ancestor
65314690|NCT00588822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314691|NCT00588822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65314692|NCT05563467|Pembrolizumab|pembrolizumab|mesh-list
65314693|NCT05563467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65314694|NCT05563467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314695|NCT00589914|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65314696|NCT00589914|Risperidone|risperidone|mesh-list
65314697|NCT00589914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65314698|NCT00589914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65314699|NCT00589914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65314700|NCT00589914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314701|NCT00589914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65314702|NCT00589914|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65314703|NCT00589914|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65314704|NCT00589914|Serotonin Agents|serotonin agents|mesh-ancestor
65314705|NCT00589914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65314706|NCT00589914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314707|NCT00589914|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65314708|NCT00589914|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65314709|NCT00589914|Dopamine Agents|dopamine agents|mesh-ancestor
65314710|NCT00789555|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
65314711|NCT00789555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65314712|NCT00789555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65314713|NCT00789555|Analgesics|analgesics|mesh-ancestor
65314714|NCT00789555|Sensory System Agents|sensory system agents|mesh-ancestor
65314715|NCT00789555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161165|NCT00634231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65161166|NCT02816593|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65161167|NCT02816593|Carbamide Peroxide|carbamide peroxide|mesh-list
65161168|NCT02816593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65161169|NCT02816593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65161170|NCT04237987|Cyclosporine|cyclosporine|mesh-list
65161171|NCT04237987|Aldesleukin|aldesleukin|mesh-list
65161172|NCT04237987|Interleukin-2|interleukin-2|mesh-list
65161173|NCT04237987|Cyclosporins|cyclosporins|mesh-list
65161174|NCT04237987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65161175|NCT04237987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161176|NCT04237987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65161177|NCT04237987|Immunologic Factors|immunologic factors|mesh-ancestor
65161192|NCT04551547|Vaccines|vaccines|mesh-list
65161193|NCT04551547|Immunologic Factors|immunologic factors|mesh-ancestor
65161194|NCT04551547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161195|NCT01045707|Insulin|insulin|mesh-list
65161196|NCT01045707|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65161197|NCT01045707|Insulin Glargine|insulin glargine|mesh-list
65161198|NCT01045707|Insulin Aspart|insulin aspart|mesh-list
65161199|NCT01045707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65314716|NCT00789555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314717|NCT00789555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65314718|NCT00789555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65314719|NCT00789555|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65314720|NCT00789555|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65314721|NCT00789555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65314722|NCT00789555|Histamine Antagonists|histamine antagonists|mesh-ancestor
65314723|NCT00789555|Histamine Agents|histamine agents|mesh-ancestor
65314724|NCT00789555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65314725|NCT00789555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314726|NCT03770455|Avelumab|avelumab|mesh-list
65314727|NCT03770455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65314728|NCT03770455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314729|NCT01026337|Sunitinib|sunitinib|mesh-list
65314730|NCT01026337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314731|NCT01026337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65314732|NCT01026337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65314733|NCT01026337|Growth Substances|growth substances|mesh-ancestor
65314734|NCT01026337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314735|NCT01026337|Growth Inhibitors|growth inhibitors|mesh-ancestor
65314736|NCT01026337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65314737|NCT01026337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314738|NCT01026337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314739|NCT03746275|Aspirin|aspirin|mesh-list
65314740|NCT03746275|Rivaroxaban|rivaroxaban|mesh-list
65314741|NCT03746275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65314765|NCT01026415|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65314766|NCT01026415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65314767|NCT01026415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65314768|NCT01026415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65314769|NCT01026415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314770|NCT01026415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65314771|NCT01026415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65314772|NCT01026415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65314773|NCT01026415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65314774|NCT01026415|Anesthetics, General|anesthetics, general|mesh-ancestor
65314775|NCT01026415|Anesthetics|anesthetics|mesh-ancestor
65314776|NCT01026415|GABA Modulators|gaba modulators|mesh-ancestor
65314777|NCT01026415|GABA Agents|gaba agents|mesh-ancestor
65314778|NCT01026415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65314779|NCT01026415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314780|NCT01026415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65314781|NCT01026415|Antitubercular Agents|antitubercular agents|mesh-ancestor
65314782|NCT01026415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65314783|NCT01026415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65314784|NCT01026415|Leprostatic Agents|leprostatic agents|mesh-ancestor
65314785|NCT01026415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65314786|NCT01026415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314806|NCT02604966|Artesunate|artesunate|mesh-list
65314816|NCT00914160|Diclofenac|diclofenac|mesh-list
65314817|NCT00914160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65314818|NCT00914160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65314819|NCT00914160|Analgesics|analgesics|mesh-ancestor
65314820|NCT00914160|Sensory System Agents|sensory system agents|mesh-ancestor
65314821|NCT00914160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65314822|NCT00914160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314823|NCT00914160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65314824|NCT00914160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65314825|NCT00914160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65314826|NCT00914160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314827|NCT00914160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314828|NCT00450619|Metronidazole|metronidazole|mesh-list
65314829|NCT00450619|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
65314830|NCT00450619|Vaccines|vaccines|mesh-list
65314831|NCT00450619|Sargramostim|sargramostim|mesh-list
65314832|NCT00450619|Immunologic Factors|immunologic factors|mesh-ancestor
65314833|NCT00450619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314834|NCT00450619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65314835|NCT00450619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65314836|NCT00450619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65314837|NCT00450619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65314838|NCT00450619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65314839|NCT00450619|Analgesics|analgesics|mesh-ancestor
65314840|NCT00450619|Sensory System Agents|sensory system agents|mesh-ancestor
65314841|NCT00450619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65314842|NCT00802074|Ritonavir|ritonavir|mesh-list
65314843|NCT00802074|Fosamprenavir|fosamprenavir|mesh-list
65314844|NCT00802074|Raltegravir Potassium|raltegravir potassium|mesh-list
65314845|NCT00802074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65314846|NCT00802074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65314847|NCT00802074|Protease Inhibitors|protease inhibitors|mesh-ancestor
65314860|NCT04112394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65314861|NCT04112394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314862|NCT04112394|Sensory System Agents|sensory system agents|mesh-ancestor
65314863|NCT04112394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65314864|NCT00450385|Prednisone|prednisone|mesh-list
65314865|NCT00450385|Cyclophosphamide|cyclophosphamide|mesh-list
65314866|NCT00450385|Rituximab|rituximab|mesh-list
65314867|NCT00450385|Doxorubicin|doxorubicin|mesh-list
65314868|NCT00450385|Vincristine|vincristine|mesh-list
65314869|NCT00450385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65314870|NCT00450385|Immunologic Factors|immunologic factors|mesh-ancestor
65314871|NCT00450385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314872|NCT00450385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65314873|NCT00450385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65314874|NCT00450385|Alkylating Agents|alkylating agents|mesh-ancestor
65314875|NCT00450385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314876|NCT00450385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314877|NCT00450385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65314878|NCT00450385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65314879|NCT00450385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65314880|NCT00450385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65314881|NCT00450385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65314882|NCT00450385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314883|NCT00450385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65314884|NCT00450385|Glucocorticoids|glucocorticoids|mesh-ancestor
65314885|NCT00450385|Hormones|hormones|mesh-ancestor
65314886|NCT00450385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65314887|NCT00450385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65314888|NCT00450385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65314889|NCT00450385|Tubulin Modulators|tubulin modulators|mesh-ancestor
65314890|NCT00450385|Antimitotic Agents|antimitotic agents|mesh-ancestor
65314891|NCT00450385|Mitosis Modulators|mitosis modulators|mesh-ancestor
65314892|NCT00588354|Triamcinolone|triamcinolone|mesh-list
65314893|NCT00588354|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65314894|NCT00588354|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65314895|NCT00588354|Lidocaine|lidocaine|mesh-list
65314896|NCT00588354|Clonidine|clonidine|mesh-list
65161200|NCT01045707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161201|NCT04533997|Furosemide|furosemide|mesh-list
65314897|NCT00588354|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65314898|NCT00588354|Anesthetics, Local|anesthetics, local|mesh-ancestor
65314899|NCT00588354|Anesthetics|anesthetics|mesh-ancestor
65314900|NCT00588354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65314901|NCT00588354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314902|NCT00588354|Sensory System Agents|sensory system agents|mesh-ancestor
65314903|NCT00588354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65314904|NCT00588354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65314905|NCT00588354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65314906|NCT00588354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65314907|NCT00588354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65494088|NCT03701763|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65064800|NCT00262808|Leucovorin|leucovorin|mesh-list
65314908|NCT00588354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314909|NCT00588354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65314910|NCT00588354|Glucocorticoids|glucocorticoids|mesh-ancestor
65314911|NCT00588354|Hormones|hormones|mesh-ancestor
65314912|NCT00588354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65314913|NCT00588354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65314914|NCT00588354|Immunologic Factors|immunologic factors|mesh-ancestor
65314915|NCT00588354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314916|NCT00588354|Analgesics|analgesics|mesh-ancestor
65314917|NCT00588354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65314918|NCT00588354|Sympatholytics|sympatholytics|mesh-ancestor
65314919|NCT00588354|Autonomic Agents|autonomic agents|mesh-ancestor
65314920|NCT00588354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65314921|NCT00588354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65314922|NCT00588354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65314923|NCT00588354|Adrenergic Agents|adrenergic agents|mesh-ancestor
65314924|NCT00588354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65314925|NCT00449761|Panobinostat|panobinostat|mesh-list
65314926|NCT00449761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65314927|NCT00449761|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65314928|NCT00449761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65314933|NCT00800982|Analgesics|analgesics|mesh-ancestor
65314934|NCT00800982|Sensory System Agents|sensory system agents|mesh-ancestor
65314935|NCT00800982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65314936|NCT00800982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314937|NCT00800982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65314938|NCT00800982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65314939|NCT00800982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65314940|NCT00800982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65314941|NCT00800982|Immunologic Factors|immunologic factors|mesh-ancestor
65314942|NCT01019395|Daptomycin|daptomycin|mesh-list
65314943|NCT01019395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65314944|NCT01019395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65314945|NCT00830960|Clopidogrel|clopidogrel|mesh-list
65314946|NCT00830960|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65314947|NCT00830960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65314948|NCT00830960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65314949|NCT00830960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65314950|NCT00830960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65314951|NCT00830960|Purinergic Agents|purinergic agents|mesh-ancestor
65314952|NCT00830960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65314953|NCT00830960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65314954|NCT00830960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314955|NCT01026961|Acetaminophen|acetaminophen|mesh-list
65314956|NCT01026961|Dimethindene|dimethindene|mesh-list
65314957|NCT01026961|Phenylephrine|phenylephrine|mesh-list
65314958|NCT01026961|Oxymetazoline|oxymetazoline|mesh-list
65314959|NCT01026961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65314960|NCT01026961|Analgesics|analgesics|mesh-ancestor
65314961|NCT01026961|Sensory System Agents|sensory system agents|mesh-ancestor
65314962|NCT01026961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65314978|NCT01026961|Protective Agents|protective agents|mesh-ancestor
65314979|NCT01026961|Antipruritics|antipruritics|mesh-ancestor
65314980|NCT01026961|Dermatologic Agents|dermatologic agents|mesh-ancestor
65314981|NCT01026961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65314982|NCT01026961|Histamine Antagonists|histamine antagonists|mesh-ancestor
65314983|NCT01026961|Histamine Agents|histamine agents|mesh-ancestor
65314985|NCT01566253|Acetaminophen|acetaminophen|mesh-list
65314986|NCT01566253|Ketoprofen|ketoprofen|mesh-list
65314987|NCT01566253|Morphine|morphine|mesh-list
65314988|NCT01566253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65314989|NCT01566253|Narcotics|narcotics|mesh-ancestor
65314990|NCT01566253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65314991|NCT01566253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65314992|NCT01566253|Analgesics|analgesics|mesh-ancestor
65314993|NCT01566253|Sensory System Agents|sensory system agents|mesh-ancestor
65314994|NCT01566253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65314995|NCT01566253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65314996|NCT01566253|Antipyretics|antipyretics|mesh-ancestor
65314997|NCT01566253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65314998|NCT01566253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65314999|NCT01566253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65315000|NCT01566253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65315001|NCT01566253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315002|NCT01566253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315003|NCT03849313|Adalimumab|adalimumab|mesh-list
65315004|NCT03849313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65315030|NCT00830804|Raltegravir Potassium|raltegravir potassium|mesh-list
65315031|NCT00830804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65315032|NCT00830804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65315033|NCT00830804|Protease Inhibitors|protease inhibitors|mesh-ancestor
65315034|NCT00830804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315035|NCT00830804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315036|NCT00830804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65315037|NCT00830804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65315038|NCT00830804|Antiviral Agents|antiviral agents|mesh-ancestor
65315039|NCT00830804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65315040|NCT00830804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65315041|NCT00830804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65315042|NCT00830804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65315043|NCT00830804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65315044|NCT00789477|Aflibercept|aflibercept|mesh-list
65315045|NCT00789477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65315046|NCT00789477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65315047|NCT00789477|Growth Substances|growth substances|mesh-ancestor
65315048|NCT00789477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315049|NCT00789477|Growth Inhibitors|growth inhibitors|mesh-ancestor
65315050|NCT00789477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315051|NCT01024075|Dexamethasone|dexamethasone|mesh-list
65315052|NCT01024075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65315053|NCT01024075|Antiemetics|antiemetics|mesh-ancestor
65315054|NCT01024075|Autonomic Agents|autonomic agents|mesh-ancestor
65315055|NCT01024075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65315056|NCT01024075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315057|NCT01024075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65315058|NCT01024075|Glucocorticoids|glucocorticoids|mesh-ancestor
65315059|NCT01024075|Hormones|hormones|mesh-ancestor
65315060|NCT01024075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65315061|NCT01024075|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65315062|NCT01024075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315071|NCT00913874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315072|NCT00913874|Antimanic Agents|antimanic agents|mesh-ancestor
65315073|NCT00913874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65315074|NCT00913874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65315075|NCT00913874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65315076|NCT00796614|Tamsulosin|tamsulosin|mesh-list
65315077|NCT00796614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65315078|NCT00796614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65315079|NCT00796614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65315080|NCT00796614|Adrenergic Agents|adrenergic agents|mesh-ancestor
65315081|NCT00796614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65315082|NCT00796614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315083|NCT00796614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315084|NCT00796614|Urological Agents|urological agents|mesh-ancestor
65315085|NCT02603445|Idelalisib|idelalisib|mesh-list
65315086|NCT02603445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315087|NCT02603445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315088|NCT02603445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315089|NCT02603679|Tamoxifen|tamoxifen|mesh-list
65315090|NCT02603679|Paclitaxel|paclitaxel|mesh-list
65315091|NCT02603679|Letrozole|letrozole|mesh-list
65315092|NCT02603679|Palbociclib|palbociclib|mesh-list
65315093|NCT02603679|Anastrozole|anastrozole|mesh-list
65315094|NCT02603679|Exemestane|exemestane|mesh-list
65315095|NCT02603679|Goserelin|goserelin|mesh-list
65315096|NCT02603679|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65315097|NCT02603679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65315098|NCT02603679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315099|NCT02603679|Tubulin Modulators|tubulin modulators|mesh-ancestor
65315100|NCT02603679|Antimitotic Agents|antimitotic agents|mesh-ancestor
65315101|NCT02603679|Mitosis Modulators|mitosis modulators|mesh-ancestor
65161202|NCT04533997|Diuretics|diuretics|mesh-ancestor
65161203|NCT04533997|Natriuretic Agents|natriuretic agents|mesh-ancestor
65161204|NCT04533997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161205|NCT04533997|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65161206|NCT04533997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65161207|NCT04533997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161208|NCT02874807|Empagliflozin|empagliflozin|mesh-list
65161209|NCT02874807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65161210|NCT02874807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161211|NCT02874807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65161212|NCT02874807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161213|NCT01054599|Memantine|memantine|mesh-list
65161214|NCT01054599|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64803834|NCT01409616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65161215|NCT01054599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65315102|NCT02603679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315103|NCT02603679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65315104|NCT02603679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315105|NCT02603679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65315106|NCT02603679|Hormone Antagonists|hormone antagonists|mesh-ancestor
65315107|NCT02603679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65315108|NCT02603679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315109|NCT02603679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65315110|NCT02603679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65315111|NCT02603679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65315112|NCT02603679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65315113|NCT02603679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65315114|NCT03995485|Sofosbuvir|sofosbuvir|mesh-list
65315115|NCT03995485|Antiviral Agents|antiviral agents|mesh-ancestor
65315116|NCT03995485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65315117|NCT02605434|Levodopa|levodopa|mesh-list
65315118|NCT02605434|Carbidopa|carbidopa|mesh-list
65315119|NCT02605434|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65315120|NCT02605434|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65315121|NCT02605434|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65315122|NCT02605434|Dopamine Agents|dopamine agents|mesh-ancestor
65315123|NCT02605434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65315131|NCT00863681|Riociguat|riociguat|mesh-list
65315151|NCT00789321|Vasodilator Agents|vasodilator agents|mesh-ancestor
65315152|NCT00811928|Fluconazole|fluconazole|mesh-list
65315153|NCT00811928|Posaconazole|posaconazole|mesh-list
65315154|NCT00811928|Antifungal Agents|antifungal agents|mesh-ancestor
65315155|NCT00811928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65315156|NCT00811928|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65315157|NCT00811928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65315158|NCT00811928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315159|NCT00811928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315160|NCT00811928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65315161|NCT00811928|Hormone Antagonists|hormone antagonists|mesh-ancestor
65315162|NCT00811928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65315163|NCT00811928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315164|NCT00811928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65315165|NCT00811928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65315166|NCT00811928|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65315167|NCT00811928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65315168|NCT00811928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65315169|NCT00448669|Tenofovir|tenofovir|mesh-list
65315170|NCT00448669|Emtricitabine|emtricitabine|mesh-list
65315171|NCT00448669|Antiviral Agents|antiviral agents|mesh-ancestor
65315172|NCT00448669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65315173|NCT00448669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65315174|NCT00448669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65315175|NCT00448669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315176|NCT00448669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315177|NCT00448669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65315178|NCT00448669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65315179|NCT00591734|Bevacizumab|bevacizumab|mesh-list
65315180|NCT00591734|Everolimus|everolimus|mesh-list
65315181|NCT00591734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65315182|NCT00591734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315192|NCT00848549|Anticonvulsants|anticonvulsants|mesh-ancestor
65315193|NCT00848549|Antimanic Agents|antimanic agents|mesh-ancestor
65315194|NCT00848549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65315195|NCT00848549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65315196|NCT00848549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315197|NCT00848549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65315198|NCT00848549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65315199|NCT00848549|Analgesics|analgesics|mesh-ancestor
65315200|NCT00848549|Sensory System Agents|sensory system agents|mesh-ancestor
65315201|NCT00848549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65315202|NCT00848549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65315203|NCT00848549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65315204|NCT00848549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315205|NCT00848549|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65315206|NCT00848549|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65315207|NCT00848549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65315208|NCT00848549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65315209|NCT00788151|Vaccines|vaccines|mesh-list
65315210|NCT00788151|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65315211|NCT00788151|Immunologic Factors|immunologic factors|mesh-ancestor
65315212|NCT00788151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315213|NCT04116359|Cisplatin|cisplatin|mesh-list
65315214|NCT04116359|Etoposide|etoposide|mesh-list
65315215|NCT04116359|Etoposide phosphate|etoposide phosphate|mesh-list
65315216|NCT04116359|Podophyllotoxin|podophyllotoxin|mesh-list
65315217|NCT04116359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315240|NCT00848393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65315241|NCT00848393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65315242|NCT00848393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315243|NCT00848393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65315244|NCT00848393|Analgesics|analgesics|mesh-ancestor
65315245|NCT00848393|Sensory System Agents|sensory system agents|mesh-ancestor
65315246|NCT00848393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65315247|NCT00848393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65315248|NCT00848393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65315249|NCT00848393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65315250|NCT00848393|Adrenergic Agents|adrenergic agents|mesh-ancestor
65315251|NCT00848393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65315252|NCT00848393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315253|NCT00848393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65315254|NCT00848393|Narcotics|narcotics|mesh-ancestor
65315255|NCT00848393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65315256|NCT00848393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65315257|NCT00848393|Anesthetics, General|anesthetics, general|mesh-ancestor
65315258|NCT00848393|Anesthetics|anesthetics|mesh-ancestor
65315259|NCT00848393|Anticoagulants|anticoagulants|mesh-ancestor
65315260|NCT00848393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65315261|NCT00848393|Chelating Agents|chelating agents|mesh-ancestor
65315262|NCT00848393|Sequestering Agents|sequestering agents|mesh-ancestor
65315263|NCT00815516|Amphotericin B|amphotericin b|mesh-list
65315264|NCT00815516|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65315265|NCT00815516|Micafungin|micafungin|mesh-list
65315266|NCT00815516|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
65315267|NCT00815516|Deoxycholic Acid|deoxycholic acid|mesh-list
65315268|NCT00815516|Amebicides|amebicides|mesh-ancestor
65315269|NCT00815516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65315270|NCT00815516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65315271|NCT00815516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65315284|NCT00787917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65315285|NCT00787917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315286|NCT00787917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315287|NCT00787917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65315288|NCT00787917|Hormone Antagonists|hormone antagonists|mesh-ancestor
65315289|NCT00787917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65315290|NCT00787917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315291|NCT00787917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65315292|NCT00787917|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65315293|NCT00787917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65315294|NCT00787917|Respiratory System Agents|respiratory system agents|mesh-ancestor
65315295|NCT05758064|Dydrogesterone|dydrogesterone|mesh-list
65315296|NCT05758064|Progestins|progestins|mesh-ancestor
65315297|NCT05758064|Hormones|hormones|mesh-ancestor
65315298|NCT05758064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65315299|NCT05758064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315300|NCT00829244|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65315301|NCT00829244|Hormones|hormones|mesh-ancestor
65315302|NCT00829244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65315303|NCT00829244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315304|NCT00787605|Amlodipine|amlodipine|mesh-list
65315305|NCT00787605|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65315306|NCT00787605|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65315307|NCT00787605|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65315308|NCT00787605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65315309|NCT00787605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315310|NCT00787605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65315311|NCT00787605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315312|NCT00787605|Vasodilator Agents|vasodilator agents|mesh-ancestor
65315313|NCT00787605|Diuretics|diuretics|mesh-ancestor
65315314|NCT00787605|Natriuretic Agents|natriuretic agents|mesh-ancestor
65315315|NCT00787605|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65315316|NCT00448591|Bevacizumab|bevacizumab|mesh-list
65315317|NCT00448591|Taxane|taxane|mesh-list
64545109|NCT03583489|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65315318|NCT00448591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65315319|NCT00448591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315320|NCT00448591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65315321|NCT00448591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65315322|NCT00448591|Growth Substances|growth substances|mesh-ancestor
65315323|NCT00448591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315324|NCT00448591|Growth Inhibitors|growth inhibitors|mesh-ancestor
65315325|NCT00787527|Prednisone|prednisone|mesh-list
65315326|NCT00787527|Cyclophosphamide|cyclophosphamide|mesh-list
65315327|NCT00787527|Doxorubicin|doxorubicin|mesh-list
65315328|NCT00787527|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65315329|NCT00787527|Vincristine|vincristine|mesh-list
65315330|NCT00787527|Vorinostat|vorinostat|mesh-list
65315331|NCT00787527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65315332|NCT00787527|Immunologic Factors|immunologic factors|mesh-ancestor
65315333|NCT00787527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315334|NCT00787527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65315335|NCT00787527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65315336|NCT00787527|Alkylating Agents|alkylating agents|mesh-ancestor
65315337|NCT00787527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315338|NCT00787527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315339|NCT00787527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65315340|NCT00787527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65315341|NCT00787527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65315342|NCT00787527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65315343|NCT00787527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315344|NCT00787527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65315345|NCT00787527|Glucocorticoids|glucocorticoids|mesh-ancestor
65315346|NCT00787527|Hormones|hormones|mesh-ancestor
65315347|NCT00787527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65315348|NCT00787527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65315361|NCT00806962|Vaccines|vaccines|mesh-list
65315362|NCT00806962|Immunologic Factors|immunologic factors|mesh-ancestor
65315363|NCT00806962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315364|NCT02553226|Oxytocin|oxytocin|mesh-list
65315365|NCT02553226|Oxytocics|oxytocics|mesh-ancestor
65315366|NCT02553226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65315367|NCT02553226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315368|NCT00810316|Clonazepam|clonazepam|mesh-list
65315369|NCT00810316|Alprazolam|alprazolam|mesh-list
65315370|NCT00810316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65315371|NCT00810316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65315372|NCT00810316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315373|NCT00810316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65315374|NCT00810316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65315375|NCT00810316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65315376|NCT00810316|GABA Modulators|gaba modulators|mesh-ancestor
65315377|NCT00810316|GABA Agents|gaba agents|mesh-ancestor
65315378|NCT00810316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65315379|NCT00810316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315380|NCT00810316|Anticonvulsants|anticonvulsants|mesh-ancestor
65315381|NCT00448435|Fluticasone|fluticasone|mesh-list
65315382|NCT00448435|Xhance|xhance|mesh-list
65315383|NCT00448435|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65315384|NCT00448435|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65315414|NCT02603055|Vaccines|vaccines|mesh-list
65315415|NCT02603055|Immunologic Factors|immunologic factors|mesh-ancestor
65315416|NCT02603055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315417|NCT02602743|Ketamine|ketamine|mesh-list
65315418|NCT02602743|Remifentanil|remifentanil|mesh-list
65315419|NCT02602743|Propofol|propofol|mesh-list
65315420|NCT02602743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65315421|NCT02602743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65315422|NCT02602743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315423|NCT02602743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65315424|NCT02602743|Anesthetics, General|anesthetics, general|mesh-ancestor
65315425|NCT02602743|Anesthetics|anesthetics|mesh-ancestor
65315426|NCT02602743|Analgesics|analgesics|mesh-ancestor
65315427|NCT02602743|Sensory System Agents|sensory system agents|mesh-ancestor
65315428|NCT02602743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65315429|NCT02602743|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65315430|NCT02602743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65315431|NCT02602743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65315432|NCT02602743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65315433|NCT02602743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315434|NCT02602743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65315435|NCT02602743|Narcotics|narcotics|mesh-ancestor
65315436|NCT00807118|Fesoterodine|fesoterodine|mesh-list
65315437|NCT00807118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65315438|NCT00807118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65315439|NCT00807118|Cholinergic Agents|cholinergic agents|mesh-ancestor
65315440|NCT00807118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65315441|NCT00807118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315442|NCT00807118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315443|NCT00807118|Urological Agents|urological agents|mesh-ancestor
65315444|NCT00448279|Trastuzumab|trastuzumab|mesh-list
65315445|NCT00448279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64310095|NCT04149470|Omeprazole|omeprazole|mesh-list
65161216|NCT01054599|Dopamine Agents|dopamine agents|mesh-ancestor
65161217|NCT01054599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65161218|NCT01054599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161219|NCT01054599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161220|NCT01054599|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65161221|NCT01054599|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65161222|NCT05635201|Anesthetics|anesthetics|mesh-list
65161223|NCT05635201|Propofol|propofol|mesh-list
65161224|NCT05635201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65315446|NCT00448279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315447|NCT00804856|Cytarabine|cytarabine|mesh-list
65315448|NCT00804856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65315449|NCT00804856|Antimetabolites|antimetabolites|mesh-ancestor
65315450|NCT00804856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315451|NCT00804856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315452|NCT00804856|Antiviral Agents|antiviral agents|mesh-ancestor
65315453|NCT00804856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65315454|NCT00804856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65315455|NCT00804856|Immunologic Factors|immunologic factors|mesh-ancestor
65315456|NCT00804856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315457|NCT00810706|Exemestane|exemestane|mesh-list
65315458|NCT00810706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315459|NCT00810706|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65315460|NCT00810706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65315461|NCT00810706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315462|NCT00810706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315463|NCT00810706|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65315464|NCT00810706|Hormone Antagonists|hormone antagonists|mesh-ancestor
65315465|NCT00810706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65315466|NCT00810706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315467|NCT00807196|Cyclophosphamide|cyclophosphamide|mesh-list
65315468|NCT00807196|Rituximab|rituximab|mesh-list
65315469|NCT00807196|Fludarabine|fludarabine|mesh-list
65315470|NCT00807196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65315471|NCT00807196|Immunologic Factors|immunologic factors|mesh-ancestor
65315472|NCT00807196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315473|NCT00807196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65315474|NCT00807196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65315475|NCT00807196|Alkylating Agents|alkylating agents|mesh-ancestor
65315480|NCT00448123|Tamsulosin|tamsulosin|mesh-list
65315487|NCT00448123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315488|NCT00448123|Urological Agents|urological agents|mesh-ancestor
65315489|NCT00804934|Ranibizumab|ranibizumab|mesh-list
65315490|NCT00804934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65315491|NCT00804934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65315492|NCT00804934|Growth Substances|growth substances|mesh-ancestor
65315493|NCT00804934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315494|NCT00804934|Growth Inhibitors|growth inhibitors|mesh-ancestor
65315495|NCT00804934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315496|NCT00805012|Docetaxel|docetaxel|mesh-list
65315497|NCT00805012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315498|NCT00805012|Tubulin Modulators|tubulin modulators|mesh-ancestor
65315499|NCT00805012|Antimitotic Agents|antimitotic agents|mesh-ancestor
65315500|NCT00805012|Mitosis Modulators|mitosis modulators|mesh-ancestor
65315501|NCT00805012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315502|NCT00447499|Lanreotide|lanreotide|mesh-list
65315503|NCT00447499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315504|NCT00805090|Itraconazole|itraconazole|mesh-list
65315505|NCT00805090|Diclofenac|diclofenac|mesh-list
65065400|NCT00295347|Citalopram|citalopram|mesh-list
65315506|NCT00805090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65315507|NCT00805090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65315508|NCT00805090|Analgesics|analgesics|mesh-ancestor
65315509|NCT00805090|Sensory System Agents|sensory system agents|mesh-ancestor
65315510|NCT00805090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65315537|NCT00810862|Dermatologic Agents|dermatologic agents|mesh-ancestor
65315538|NCT00810862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65315539|NCT00810862|Immunologic Factors|immunologic factors|mesh-ancestor
65315540|NCT00810862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65315541|NCT00810862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315542|NCT00810862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315543|NCT00800436|Trastuzumab|trastuzumab|mesh-list
65315544|NCT00800436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65315545|NCT00800436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315546|NCT00810940|Mannitol|mannitol|mesh-list
65315547|NCT00810940|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65315548|NCT00810940|Diuretics|diuretics|mesh-ancestor
65315549|NCT00810940|Natriuretic Agents|natriuretic agents|mesh-ancestor
65315550|NCT00810940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315551|NCT00655564|Alefacept|alefacept|mesh-list
65315552|NCT00655564|Dermatologic Agents|dermatologic agents|mesh-ancestor
65315553|NCT00655564|Immunologic Factors|immunologic factors|mesh-ancestor
65315554|NCT00655564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315555|NCT00447421|Pemetrexed|pemetrexed|mesh-list
65315556|NCT00447421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315557|NCT00447421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315558|NCT00447421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315559|NCT00447421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65315560|NCT00447421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65315561|NCT00651118|Fluticasone|fluticasone|mesh-list
65315562|NCT00651118|Xhance|xhance|mesh-list
65315563|NCT00651118|Azelastine|azelastine|mesh-list
65315564|NCT00651118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65315565|NCT00651118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65315566|NCT00651118|Autonomic Agents|autonomic agents|mesh-ancestor
65161225|NCT05635201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161226|NCT05635201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65161227|NCT05635201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65161228|NCT05635201|Anesthetics, General|anesthetics, general|mesh-ancestor
65161229|NCT02813863|Metformin|metformin|mesh-list
65161230|NCT02813863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65161231|NCT02813863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161232|NCT02874729|Dimercaprol|dimercaprol|mesh-list
65161233|NCT02874729|Chelating Agents|chelating agents|mesh-ancestor
65161234|NCT02874729|Sequestering Agents|sequestering agents|mesh-ancestor
65161235|NCT02874729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161236|NCT04275661|Magnesium Sulfate|magnesium sulfate|mesh-list
65161237|NCT04275661|Ketamine|ketamine|mesh-list
64505920|NCT03322488|Metronidazole|metronidazole|mesh-list
65161240|NCT04275661|Sensory System Agents|sensory system agents|mesh-ancestor
65161241|NCT04275661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161242|NCT04275661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161243|NCT04275661|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65315567|NCT00651118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65315568|NCT00651118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315569|NCT00651118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65315570|NCT00651118|Respiratory System Agents|respiratory system agents|mesh-ancestor
65315571|NCT00651118|Dermatologic Agents|dermatologic agents|mesh-ancestor
65315572|NCT00651118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65315573|NCT00651118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65315574|NCT00651118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315575|NCT00651118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315576|NCT00651118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65315577|NCT00651118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65315578|NCT00651118|Histamine Antagonists|histamine antagonists|mesh-ancestor
65315579|NCT00651118|Histamine Agents|histamine agents|mesh-ancestor
65315580|NCT00651118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65315581|NCT00447265|Etanercept|etanercept|mesh-list
65315582|NCT00447265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65065540|NCT00295542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065541|NCT00295542|Natriuretic Agents|natriuretic agents|mesh-ancestor
65065542|NCT00295542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65065543|NCT00295542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65065544|NCT00295542|Sympatholytics|sympatholytics|mesh-ancestor
65065545|NCT00295542|Autonomic Agents|autonomic agents|mesh-ancestor
65065546|NCT00295542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65065547|NCT00295542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65065548|NCT00295542|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65065549|NCT00295542|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65065550|NCT00295542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65065551|NCT00295542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65065552|NCT00295542|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65065553|NCT00266318|Interferons|interferons|mesh-list
65065554|NCT00266318|Ribavirin|ribavirin|mesh-list
65065555|NCT00266318|Interferon alfacon-1|interferon alfacon-1|mesh-list
65065556|NCT00266318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065557|NCT00266318|Antiviral Agents|antiviral agents|mesh-ancestor
65161244|NCT04275661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65161245|NCT04275661|Anesthetics, General|anesthetics, general|mesh-ancestor
65161246|NCT04275661|Anesthetics|anesthetics|mesh-ancestor
65161247|NCT04275661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65161248|NCT04275661|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65065558|NCT00266318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65065559|NCT00266318|Antimetabolites|antimetabolites|mesh-ancestor
65065560|NCT00266318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065561|NCT00266357|Gaboxadol|gaboxadol|mesh-list
65065562|NCT00266357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65065563|NCT00266357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065564|NCT00266357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065565|NCT00266357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65065566|NCT00266357|Analgesics|analgesics|mesh-ancestor
65065567|NCT00266357|Sensory System Agents|sensory system agents|mesh-ancestor
65065568|NCT00266357|Anticonvulsants|anticonvulsants|mesh-ancestor
65065569|NCT00266357|GABA Agonists|gaba agonists|mesh-ancestor
65065570|NCT00266357|GABA Agents|gaba agents|mesh-ancestor
65065571|NCT00301509|Ribavirin|ribavirin|mesh-list
65065572|NCT00301509|Antimetabolites|antimetabolites|mesh-ancestor
65065573|NCT00301509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065574|NCT00301509|Antiviral Agents|antiviral agents|mesh-ancestor
65065575|NCT00301509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65066802|NCT00272597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65066803|NCT00272597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65315584|NCT00447265|Analgesics|analgesics|mesh-ancestor
65315615|NCT00800202|Carboplatin|carboplatin|mesh-list
65315616|NCT00800202|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65315617|NCT00800202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65315618|NCT00800202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315619|NCT00800202|Tubulin Modulators|tubulin modulators|mesh-ancestor
65315620|NCT00800202|Antimitotic Agents|antimitotic agents|mesh-ancestor
65315621|NCT00800202|Mitosis Modulators|mitosis modulators|mesh-ancestor
65315622|NCT00800202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315623|NCT00800202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65315624|NCT00800202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65315625|NCT00800202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65315626|NCT00800202|Growth Substances|growth substances|mesh-ancestor
65315627|NCT00800202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315628|NCT00800202|Growth Inhibitors|growth inhibitors|mesh-ancestor
65315629|NCT00800202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65315630|NCT00800202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315631|NCT00811096|Chloroquine|chloroquine|mesh-list
65315632|NCT00811096|Tinidazole|tinidazole|mesh-list
65315633|NCT00811096|Amebicides|amebicides|mesh-ancestor
65315634|NCT00811096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65315635|NCT00811096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65315636|NCT00811096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65315637|NCT00811096|Antimalarials|antimalarials|mesh-ancestor
65315638|NCT00811096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65315639|NCT00811096|Alkylating Agents|alkylating agents|mesh-ancestor
65315640|NCT00811096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315664|NCT04111848|Sensory System Agents|sensory system agents|mesh-ancestor
65315665|NCT04111848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65315666|NCT04111848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315667|NCT04111848|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65315668|NCT04111848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65315669|NCT04111848|Anesthetics, General|anesthetics, general|mesh-ancestor
65315670|NCT04111848|Anesthetics|anesthetics|mesh-ancestor
65315671|NCT04111848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65315672|NCT04111848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65315673|NCT04111848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65315674|NCT04111848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65315675|NCT04111848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315676|NCT00457015|Ecallantide|ecallantide|mesh-list
65315677|NCT00457015|Analgesics|analgesics|mesh-ancestor
65315678|NCT00457015|Sensory System Agents|sensory system agents|mesh-ancestor
65315679|NCT00457015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65315680|NCT00457015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315681|NCT00457015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65315682|NCT00457015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65315683|NCT00457015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65315684|NCT00457015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65315685|NCT00654940|Pregabalin|pregabalin|mesh-list
65315686|NCT00654940|Analgesics|analgesics|mesh-ancestor
65315687|NCT00654940|Sensory System Agents|sensory system agents|mesh-ancestor
65315688|NCT00654940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64545527|NCT05633563|Trimetazidine|trimetazidine|mesh-list
65161249|NCT04275661|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65161250|NCT04275661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65161251|NCT04275661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161252|NCT04275661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65161253|NCT04275661|Anticonvulsants|anticonvulsants|mesh-ancestor
65161254|NCT04275661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65161255|NCT04275661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65161256|NCT04275661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65161257|NCT04275661|Tocolytic Agents|tocolytic agents|mesh-ancestor
65161258|NCT04275661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65161259|NCT04275661|Anesthetics, Local|anesthetics, local|mesh-ancestor
65161260|NCT01236560|Bevacizumab|bevacizumab|mesh-list
65161261|NCT01236560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65161262|NCT01236560|Temozolomide|temozolomide|mesh-list
65161263|NCT01236560|Vorinostat|vorinostat|mesh-list
65161264|NCT01236560|Endothelial Growth Factors|endothelial growth factors|mesh-list
65161265|NCT01236560|Antibodies|antibodies|mesh-list
65161266|NCT01236560|Immunoglobulins|immunoglobulins|mesh-list
65161267|NCT01236560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65161268|NCT01236560|Immunoglobulin G|immunoglobulin g|mesh-list
65161269|NCT01236560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161270|NCT01236560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64545554|NCT05220319|Glucocorticoids|glucocorticoids|mesh-ancestor
64545555|NCT05220319|Hormones|hormones|mesh-ancestor
64545556|NCT05220319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64545557|NCT05220319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64545566|NCT03155035|Vitamin D|vitamin d|mesh-list
65315689|NCT00654940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315690|NCT00654940|Anticonvulsants|anticonvulsants|mesh-ancestor
65315691|NCT00654940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65315692|NCT00654940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65315693|NCT00654940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315694|NCT00654940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65315696|NCT00654940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65315697|NCT00654940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65315698|NCT00654940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65315699|NCT00588666|Gemcitabine|gemcitabine|mesh-list
65315700|NCT00588666|Bevacizumab|bevacizumab|mesh-list
65315701|NCT00588666|Carboplatin|carboplatin|mesh-list
65315702|NCT00588666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65315703|NCT00588666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315704|NCT00588666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65315705|NCT00588666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65315706|NCT00588666|Growth Substances|growth substances|mesh-ancestor
65315707|NCT00588666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315708|NCT00588666|Growth Inhibitors|growth inhibitors|mesh-ancestor
65315709|NCT00588666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65315710|NCT00588666|Antimetabolites|antimetabolites|mesh-ancestor
65315711|NCT00588666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315712|NCT00588666|Antiviral Agents|antiviral agents|mesh-ancestor
65315713|NCT00588666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65315714|NCT00588666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315715|NCT00588666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65315716|NCT00588666|Immunologic Factors|immunologic factors|mesh-ancestor
65315717|NCT00805558|Moxifloxacin|moxifloxacin|mesh-list
65315718|NCT00805558|Metronidazole|metronidazole|mesh-list
65315719|NCT00805558|Ciprofloxacin|ciprofloxacin|mesh-list
65315723|NCT00805558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65315724|NCT00805558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65315725|NCT00805558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315726|NCT00805558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315727|NCT00805558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315728|NCT00805558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65315729|NCT00805558|Contraceptive Agents|contraceptive agents|mesh-ancestor
65315730|NCT00805558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65315731|NCT00805558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315732|NCT00805558|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65315733|NCT00805558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65315734|NCT00805558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65315735|NCT00805558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65315736|NCT00805558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65315737|NCT00805558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65315738|NCT00805558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65315739|NCT01019785|Ergocalciferols|ergocalciferols|mesh-list
65315740|NCT01019785|Vitamin D|vitamin d|mesh-list
65315741|NCT01019785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65315742|NCT01019785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315743|NCT01019785|Vitamins|vitamins|mesh-ancestor
65315744|NCT01019785|Micronutrients|micronutrients|mesh-ancestor
65315745|NCT01019785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65315746|NCT02604186|Botulinum Toxins|botulinum toxins|mesh-list
65315772|NCT01024543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315773|NCT01024543|Protective Agents|protective agents|mesh-ancestor
65315774|NCT01024543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65315775|NCT01024543|Protease Inhibitors|protease inhibitors|mesh-ancestor
65315776|NCT01024543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493888|NCT04002934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65493889|NCT04002934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493890|NCT04002934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65493892|NCT03991403|Bevacizumab|bevacizumab|mesh-list
65493893|NCT03991403|Carboplatin|carboplatin|mesh-list
65493894|NCT03991403|Pemetrexed|pemetrexed|mesh-list
65493895|NCT03991403|Atezolizumab|atezolizumab|mesh-list
65493896|NCT03991403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65493897|NCT03991403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493898|NCT03991403|Tubulin Modulators|tubulin modulators|mesh-ancestor
65493899|NCT03991403|Antimitotic Agents|antimitotic agents|mesh-ancestor
65493900|NCT03991403|Mitosis Modulators|mitosis modulators|mesh-ancestor
65493901|NCT03991403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493902|NCT03991403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65493903|NCT03991403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65493904|NCT03991403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65493905|NCT03991403|Growth Substances|growth substances|mesh-ancestor
65493906|NCT03991403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493907|NCT03991403|Growth Inhibitors|growth inhibitors|mesh-ancestor
65493908|NCT03991403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493909|NCT03991403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65493910|NCT03991403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65493911|NCT03930680|Dexrazoxane|dexrazoxane|mesh-list
65493912|NCT03930680|Razoxane|razoxane|mesh-list
65493913|NCT03930680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493914|NCT03930680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65493915|NCT03930680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65493916|NCT03930680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65493924|NCT03913559|Diphenhydramine|diphenhydramine|mesh-list
65493925|NCT03913559|Promethazine|promethazine|mesh-list
65493926|NCT03913559|Cytarabine|cytarabine|mesh-list
65493927|NCT03913559|Methylprednisolone|methylprednisolone|mesh-list
65493928|NCT03913559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65493929|NCT03913559|Hydrocortisone|hydrocortisone|mesh-list
65493930|NCT03913559|Methotrexate|methotrexate|mesh-list
65493931|NCT03913559|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65493932|NCT03913559|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65493933|NCT03913559|Abortifacient Agents|abortifacient agents|mesh-ancestor
65493934|NCT03913559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65493935|NCT03913559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493936|NCT03913559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65493937|NCT03913559|Antimetabolites|antimetabolites|mesh-ancestor
65493938|NCT03913559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493939|NCT03913559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493940|NCT03913559|Dermatologic Agents|dermatologic agents|mesh-ancestor
65493941|NCT03913559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493942|NCT03913559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65493943|NCT03913559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65493944|NCT03913559|Immunologic Factors|immunologic factors|mesh-ancestor
65493945|NCT03913559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65493946|NCT03913559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65493947|NCT03913559|Antiviral Agents|antiviral agents|mesh-ancestor
65493948|NCT03913559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65493949|NCT03913559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65493950|NCT03913559|Analgesics|analgesics|mesh-ancestor
65493951|NCT03913559|Sensory System Agents|sensory system agents|mesh-ancestor
65315778|NCT00811330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65315779|NCT00811330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65315780|NCT00811330|Antimetabolites|antimetabolites|mesh-ancestor
65315781|NCT00811330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315782|NCT00811330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65315783|NCT00811330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65315784|NCT00811330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315789|NCT00811408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65315790|NCT00811408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315791|NCT00811408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315792|NCT00446797|Celecoxib|celecoxib|mesh-list
65315793|NCT00446797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65315794|NCT00446797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65315795|NCT00446797|Analgesics|analgesics|mesh-ancestor
65315796|NCT00446797|Sensory System Agents|sensory system agents|mesh-ancestor
65315797|NCT00446797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65315798|NCT00446797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315799|NCT00446797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65315800|NCT00446797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65315801|NCT00446797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65315802|NCT00446797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65315803|NCT00446797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315804|NCT00446797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315805|NCT00855335|Ritonavir|ritonavir|mesh-list
65315806|NCT00855335|Darunavir|darunavir|mesh-list
65315807|NCT00855335|Cobicistat|cobicistat|mesh-list
65315808|NCT00855335|Rilpivirine|rilpivirine|mesh-list
65315809|NCT00855335|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
65315810|NCT00855335|Etravirine|etravirine|mesh-list
65315811|NCT00855335|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65315812|NCT00855335|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65315813|NCT00855335|Protease Inhibitors|protease inhibitors|mesh-ancestor
65315814|NCT00855335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315815|NCT00855335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315816|NCT00855335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65315834|NCT00811486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315835|NCT04114188|Prednisolone|prednisolone|mesh-list
65315836|NCT04114188|Infliximab|infliximab|mesh-list
65315837|NCT04114188|Tacrolimus|tacrolimus|mesh-list
65315838|NCT04114188|Thymoglobulin|thymoglobulin|mesh-list
65315839|NCT04114188|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65315840|NCT04114188|Immunoglobulins|immunoglobulins|mesh-list
65315841|NCT04114188|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65315842|NCT04114188|Antibodies|antibodies|mesh-list
65315843|NCT04114188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65315844|NCT04114188|Immunologic Factors|immunologic factors|mesh-ancestor
65315845|NCT04114188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315846|NCT04114188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65315847|NCT04114188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315848|NCT04114188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315849|NCT04114188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65315850|NCT04114188|Glucocorticoids|glucocorticoids|mesh-ancestor
65315851|NCT04114188|Hormones|hormones|mesh-ancestor
65315852|NCT04114188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65315853|NCT04114188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65315854|NCT04114188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315855|NCT04114188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65315856|NCT04114188|Dermatologic Agents|dermatologic agents|mesh-ancestor
65315857|NCT04114188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65315858|NCT00811876|Leuprolide|leuprolide|mesh-list
65161271|NCT01236560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65161272|NCT01236560|Growth Substances|growth substances|mesh-ancestor
65161273|NCT01236560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161274|NCT01236560|Growth Inhibitors|growth inhibitors|mesh-ancestor
65161275|NCT01236560|Immunologic Factors|immunologic factors|mesh-ancestor
65161276|NCT01236560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65161277|NCT01236560|Alkylating Agents|alkylating agents|mesh-ancestor
65161278|NCT01236560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161279|NCT01236560|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65161280|NCT01236560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65161281|NCT04303377|Evolocumab|evolocumab|mesh-list
65161282|NCT04303377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65161283|NCT04303377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65161284|NCT04303377|Antimetabolites|antimetabolites|mesh-ancestor
65161285|NCT04303377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161286|NCT04303377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65161287|NCT00948766|Rivastigmine|rivastigmine|mesh-list
65161288|NCT00948766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64803910|NCT01410201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161289|NCT00948766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65161290|NCT00948766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161291|NCT00948766|Cholinergic Agents|cholinergic agents|mesh-ancestor
65161292|NCT00948766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65161293|NCT00948766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161294|NCT00948766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65161295|NCT00948766|Protective Agents|protective agents|mesh-ancestor
65315859|NCT00811876|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65315860|NCT00811876|Fertility Agents|fertility agents|mesh-ancestor
65315861|NCT00811876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65315862|NCT00811876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315863|NCT00811876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65315864|NCT00811876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315865|NCT00915252|Cytarabine|cytarabine|mesh-list
65315866|NCT00915252|Azacitidine|azacitidine|mesh-list
65315867|NCT00915252|Daunorubicin|daunorubicin|mesh-list
65315868|NCT00915252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65315869|NCT00915252|Antimetabolites|antimetabolites|mesh-ancestor
65315870|NCT00915252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315871|NCT00915252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65315872|NCT00915252|Antiviral Agents|antiviral agents|mesh-ancestor
65315873|NCT00915252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65315874|NCT00915252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65315875|NCT00915252|Immunologic Factors|immunologic factors|mesh-ancestor
65315876|NCT00915252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315877|NCT00915252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315878|NCT00915252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65315879|NCT00915252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65315880|NCT00915252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65315881|NCT00593489|Insulin|insulin|mesh-list
65315882|NCT00593489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65315883|NCT00593489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315884|NCT00446641|Cilostazol|cilostazol|mesh-list
65315885|NCT00446641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65315886|NCT00446641|Autonomic Agents|autonomic agents|mesh-ancestor
65315887|NCT00446641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65315888|NCT00446641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315889|NCT00446641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65161296|NCT01053663|Oseltamivir|oseltamivir|mesh-list
65315902|NCT00646282|Vitamins|vitamins|mesh-ancestor
65315903|NCT00646282|Micronutrients|micronutrients|mesh-ancestor
65315904|NCT00646282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315905|NCT00646282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65315906|NCT00792636|Naproxen|naproxen|mesh-list
65315907|NCT00792636|Sumatriptan|sumatriptan|mesh-list
65315908|NCT00792636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65315909|NCT00792636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65315910|NCT00792636|Analgesics|analgesics|mesh-ancestor
65315911|NCT00792636|Sensory System Agents|sensory system agents|mesh-ancestor
65315912|NCT00792636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65315913|NCT00792636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315914|NCT00792636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65315915|NCT00792636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65315916|NCT00792636|Gout Suppressants|gout suppressants|mesh-ancestor
65315917|NCT00792636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65315918|NCT00792636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315919|NCT00792636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315920|NCT00792636|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65315921|NCT00792636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65315922|NCT00792636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65315923|NCT00792636|Serotonin Agents|serotonin agents|mesh-ancestor
65315924|NCT00792636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65315925|NCT00446563|Losartan|losartan|mesh-list
65315950|NCT00863057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65315951|NCT00863057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65315952|NCT00863057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65315953|NCT00863057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65315954|NCT00863057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315955|NCT00863057|Analgesics|analgesics|mesh-ancestor
65315956|NCT00863057|Sensory System Agents|sensory system agents|mesh-ancestor
65315957|NCT00863057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65315958|NCT00863057|Antidepressive Agents|antidepressive agents|mesh-ancestor
65315959|NCT00863057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65315960|NCT00863057|Dopamine Agents|dopamine agents|mesh-ancestor
65315961|NCT00863057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65315962|NCT00863057|Narcotics|narcotics|mesh-ancestor
65315963|NCT00863057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65315964|NCT00863057|Antitussive Agents|antitussive agents|mesh-ancestor
65315965|NCT00863057|Respiratory System Agents|respiratory system agents|mesh-ancestor
65315966|NCT00814216|Fluticasone|fluticasone|mesh-list
65315968|NCT00814216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65315969|NCT00814216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65315970|NCT00814216|Autonomic Agents|autonomic agents|mesh-ancestor
65315971|NCT00814216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65315972|NCT00814216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315973|NCT00814216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65315974|NCT00814216|Respiratory System Agents|respiratory system agents|mesh-ancestor
65315975|NCT00814216|Dermatologic Agents|dermatologic agents|mesh-ancestor
65315976|NCT00814216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65315977|NCT00829166|Capecitabine|capecitabine|mesh-list
65315978|NCT00829166|Trastuzumab|trastuzumab|mesh-list
65315979|NCT00829166|Lapatinib|lapatinib|mesh-list
65315980|NCT00829166|Maytansine|maytansine|mesh-list
65315981|NCT00829166|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65315982|NCT00829166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65315983|NCT00829166|Antimetabolites|antimetabolites|mesh-ancestor
65315988|NCT00829166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65315992|NCT00829166|Mitosis Modulators|mitosis modulators|mesh-ancestor
65315993|NCT00799266|Zoledronic Acid|zoledronic acid|mesh-list
65315994|NCT00799266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65315995|NCT00799266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65315996|NCT00650104|Ropinirole|ropinirole|mesh-list
65315997|NCT00650104|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65315998|NCT00650104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65315999|NCT00650104|Dopamine Agonists|dopamine agonists|mesh-ancestor
65316000|NCT00650104|Dopamine Agents|dopamine agents|mesh-ancestor
65316001|NCT00650104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65316002|NCT00650104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316003|NCT00650104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316005|NCT00808054|Prilocaine|prilocaine|mesh-list
65316006|NCT00808054|Anesthetics, Local|anesthetics, local|mesh-ancestor
65316007|NCT00808054|Anesthetics|anesthetics|mesh-ancestor
65316008|NCT00808054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65316009|NCT00808054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316010|NCT00808054|Sensory System Agents|sensory system agents|mesh-ancestor
65316011|NCT00808054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65316012|NCT00808054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65316013|NCT00808054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65316014|NCT00808054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65316015|NCT00808054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65316016|NCT00808054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316017|NCT05102734|Nitroglycerin|nitroglycerin|mesh-list
65316018|NCT05102734|Vasodilator Agents|vasodilator agents|mesh-ancestor
65316019|NCT00814528|Imiquimod|imiquimod|mesh-list
65316020|NCT00814528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65316021|NCT00814528|Immunologic Factors|immunologic factors|mesh-ancestor
65316025|NCT00814606|Ribavirin|ribavirin|mesh-list
64545972|NCT03855007|Abortifacient Agents|abortifacient agents|mesh-ancestor
65316038|NCT00654238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316039|NCT00862979|Cyclosporine|cyclosporine|mesh-list
65316040|NCT00862979|Mycophenolic Acid|mycophenolic acid|mesh-list
65316041|NCT00862979|Everolimus|everolimus|mesh-list
65316042|NCT00862979|Tacrolimus|tacrolimus|mesh-list
65316043|NCT00862979|Cyclosporins|cyclosporins|mesh-list
65316044|NCT00862979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65316045|NCT00862979|Immunologic Factors|immunologic factors|mesh-ancestor
65316046|NCT00862979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316047|NCT00862979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65316048|NCT00862979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316049|NCT00862979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316050|NCT00862979|Antifungal Agents|antifungal agents|mesh-ancestor
65316051|NCT00862979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65316052|NCT00862979|Dermatologic Agents|dermatologic agents|mesh-ancestor
65316053|NCT00862979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65316054|NCT00862979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316055|NCT00862979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65316056|NCT00862979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65316057|NCT00862979|Antitubercular Agents|antitubercular agents|mesh-ancestor
65316058|NCT00862979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65316059|NCT02605356|Dexamethasone|dexamethasone|mesh-list
65316060|NCT02605356|Bortezomib|bortezomib|mesh-list
65316061|NCT02605356|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65316062|NCT02605356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65316063|NCT02605356|Antiemetics|antiemetics|mesh-ancestor
65316064|NCT02605356|Autonomic Agents|autonomic agents|mesh-ancestor
65316065|NCT02605356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65316066|NCT02605356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316067|NCT02605356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65316068|NCT02605356|Glucocorticoids|glucocorticoids|mesh-ancestor
65316069|NCT02605356|Hormones|hormones|mesh-ancestor
65316070|NCT02605356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65316071|NCT02605356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65316072|NCT02605356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161297|NCT01053663|Antiviral Agents|antiviral agents|mesh-ancestor
65161298|NCT01053663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65161299|NCT01053663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514637|NCT02712801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65222835|NCT02700087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65316073|NCT00812266|Carboplatin|carboplatin|mesh-list
65316074|NCT00812266|Etoposide|etoposide|mesh-list
65316075|NCT00812266|Topotecan|topotecan|mesh-list
65066059|NCT00268814|Heroin|heroin|mesh-list
65316076|NCT00812266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316077|NCT00812266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65316078|NCT00812266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65316080|NCT00812266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316081|NCT00812266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316082|NCT00812266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65316083|NCT00814918|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65316084|NCT00814918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65316085|NCT00814918|Dermatologic Agents|dermatologic agents|mesh-ancestor
65316086|NCT04113954|Prilocaine|prilocaine|mesh-list
65316087|NCT04113954|Mepivacaine|mepivacaine|mesh-list
65316088|NCT04113954|Anesthetics, Local|anesthetics, local|mesh-ancestor
65316089|NCT04113954|Anesthetics|anesthetics|mesh-ancestor
65316090|NCT04113954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65316091|NCT04113954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316092|NCT04113954|Sensory System Agents|sensory system agents|mesh-ancestor
65316127|NCT00812422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65316128|NCT00812422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65316129|NCT00812422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65316130|NCT00812422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316131|NCT00812422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316132|NCT04110834|Itraconazole|itraconazole|mesh-list
65316133|NCT04110834|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
65316134|NCT04110834|Antifungal Agents|antifungal agents|mesh-ancestor
65316135|NCT04110834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65316136|NCT04110834|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65316137|NCT04110834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65316138|NCT04110834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316139|NCT04110834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316140|NCT04110834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65316141|NCT04110834|Hormone Antagonists|hormone antagonists|mesh-ancestor
65316142|NCT04110834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65316143|NCT04110834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316144|NCT04110834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65316145|NCT00812578|Cholecalciferol|cholecalciferol|mesh-list
65316146|NCT00812578|Vitamin D|vitamin d|mesh-list
65316147|NCT00812578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65316148|NCT00812578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316149|NCT00812578|Vitamins|vitamins|mesh-ancestor
65316150|NCT00812578|Micronutrients|micronutrients|mesh-ancestor
65316173|NCT04045522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65316174|NCT04045522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316175|NCT02551276|Albuterol|albuterol|mesh-list
65316176|NCT02551276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65316177|NCT02551276|Autonomic Agents|autonomic agents|mesh-ancestor
65316178|NCT02551276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65316179|NCT02551276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316180|NCT02551276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65316181|NCT02551276|Respiratory System Agents|respiratory system agents|mesh-ancestor
65316182|NCT02551276|Tocolytic Agents|tocolytic agents|mesh-ancestor
65316183|NCT02551276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65316184|NCT02551276|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65316185|NCT02551276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65316186|NCT02551276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65316187|NCT02551276|Adrenergic Agents|adrenergic agents|mesh-ancestor
65316188|NCT02551276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65316189|NCT02551276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316190|NCT00848081|Tadalafil|tadalafil|mesh-list
65316191|NCT00848081|Vasodilator Agents|vasodilator agents|mesh-ancestor
65316192|NCT00848081|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65316193|NCT00848081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65316194|NCT00848081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316195|NCT00848081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316196|NCT00848081|Urological Agents|urological agents|mesh-ancestor
65316197|NCT00815464|Antiviral Agents|antiviral agents|mesh-list
65316198|NCT00815464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65316199|NCT04111380|Paclitaxel|paclitaxel|mesh-list
65316200|NCT04111380|Cisplatin|cisplatin|mesh-list
65316201|NCT04111380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65316202|NCT04111380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316207|NCT04117919|Triamcinolone|triamcinolone|mesh-list
65316216|NCT04117919|Glucocorticoids|glucocorticoids|mesh-ancestor
65316217|NCT04117919|Hormones|hormones|mesh-ancestor
65316218|NCT04117919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65316219|NCT04117919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316220|NCT04117919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65316221|NCT04117919|Immunologic Factors|immunologic factors|mesh-ancestor
65316222|NCT04117919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316223|NCT04117919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316224|NCT00701285|Pravastatin|pravastatin|mesh-list
65316225|NCT00701285|Pitavastatin|pitavastatin|mesh-list
65316226|NCT00701285|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65316227|NCT00701285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65316228|NCT00701285|Antimetabolites|antimetabolites|mesh-ancestor
65316229|NCT00701285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316230|NCT00701285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65316231|NCT00701285|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65316232|NCT00701285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316233|NCT00700037|Atorvastatin|atorvastatin|mesh-list
65316234|NCT00700037|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65316235|NCT00700037|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65316236|NCT00700037|Antimetabolites|antimetabolites|mesh-ancestor
65316237|NCT00700037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316238|NCT00700037|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65316239|NCT00700037|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65316240|NCT00700037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316241|NCT00815542|Dinoprostone|dinoprostone|mesh-list
65316242|NCT00815542|Oxytocics|oxytocics|mesh-ancestor
65316243|NCT00815542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65316244|NCT00815542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316245|NCT00791778|Sorafenib|sorafenib|mesh-list
65316246|NCT00791778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316247|NCT00791778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65316248|NCT00791778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546158|NCT04904952|Antioxidants|antioxidants|mesh-ancestor
65161300|NCT01053663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161301|NCT01235546|Azithromycin|azithromycin|mesh-list
65161302|NCT01235546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65161303|NCT01235546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65161304|NCT01053429|Ziprasidone|ziprasidone|mesh-list
65316249|NCT00791778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316250|NCT02604576|Bromopride|bromopride|mesh-list
65316251|NCT02604576|Metoclopramide|metoclopramide|mesh-list
65316252|NCT02604576|Simethicone|simethicone|mesh-list
65316253|NCT02604576|Antifoaming Agents|antifoaming agents|mesh-ancestor
65316254|NCT02604576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316255|NCT02604576|Emollients|emollients|mesh-ancestor
65316256|NCT02604576|Dermatologic Agents|dermatologic agents|mesh-ancestor
65316257|NCT02604576|Antiemetics|antiemetics|mesh-ancestor
65316258|NCT02604576|Autonomic Agents|autonomic agents|mesh-ancestor
65316259|NCT02604576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65316260|NCT02604576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316261|NCT02604576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65316262|NCT02604576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65316263|NCT02604576|Dopamine Agents|dopamine agents|mesh-ancestor
65316264|NCT02604576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65316265|NCT02604576|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65316266|NCT04110132|Bupivacaine|bupivacaine|mesh-list
65316267|NCT04110132|Anesthetics, Local|anesthetics, local|mesh-ancestor
65316268|NCT04110132|Anesthetics|anesthetics|mesh-ancestor
65316269|NCT04110132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65316270|NCT04110132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316271|NCT04110132|Sensory System Agents|sensory system agents|mesh-ancestor
65316272|NCT04110132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65316273|NCT05645406|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65316274|NCT05645406|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65316275|NCT05645406|Estradiol|estradiol|mesh-list
65316276|NCT05645406|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65316277|NCT05645406|Estrogens|estrogens|mesh-ancestor
65316278|NCT05645406|Hormones|hormones|mesh-ancestor
65316279|NCT05645406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65316282|NCT05645406|Contraceptive Agents|contraceptive agents|mesh-ancestor
64546235|NCT03826693|Sensory System Agents|sensory system agents|mesh-ancestor
64546236|NCT03826693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64546253|NCT03660553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64546254|NCT03660553|Insulin Glargine|insulin glargine|mesh-list
64546255|NCT03660553|Insulin Aspart|insulin aspart|mesh-list
64546256|NCT03660553|Insulin Lispro|insulin lispro|mesh-list
64546257|NCT03660553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64546258|NCT03660553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546259|NCT04527744|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64546260|NCT04527744|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64546261|NCT04527744|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64546262|NCT04527744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64546263|NCT04527744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546264|NCT04527744|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64546265|NCT04527744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65316293|NCT00795132|Cyclosporine|cyclosporine|mesh-list
65316294|NCT00795132|Mycophenolic Acid|mycophenolic acid|mesh-list
65316295|NCT00795132|Fludarabine|fludarabine|mesh-list
65316296|NCT00795132|Busulfan|busulfan|mesh-list
65316297|NCT00795132|Cyclosporins|cyclosporins|mesh-list
65066245|NCT00269750|Oxybutynin|oxybutynin|mesh-list
65316298|NCT00795132|Thymoglobulin|thymoglobulin|mesh-list
65316299|NCT00795132|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65316300|NCT00795132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316301|NCT00795132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316302|NCT00795132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65316318|NCT02604420|Eculizumab|eculizumab|mesh-list
65316327|NCT04110210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316328|NCT04110210|Analgesics|analgesics|mesh-ancestor
65316329|NCT04110210|Sensory System Agents|sensory system agents|mesh-ancestor
65316330|NCT04110210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65316331|NCT00647296|Pramipexole|pramipexole|mesh-list
65316332|NCT00647296|Antioxidants|antioxidants|mesh-ancestor
65316333|NCT00647296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316334|NCT00647296|Protective Agents|protective agents|mesh-ancestor
65316335|NCT00647296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316336|NCT00647296|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65316337|NCT00647296|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65316338|NCT00647296|Dopamine Agonists|dopamine agonists|mesh-ancestor
65316339|NCT00647296|Dopamine Agents|dopamine agents|mesh-ancestor
65316340|NCT00647296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65316341|NCT00813202|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65316342|NCT00813202|Natriuretic Agents|natriuretic agents|mesh-ancestor
65316343|NCT00813202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316344|NCT00646906|Aspirin|aspirin|mesh-list
65316345|NCT00646906|Acetaminophen|acetaminophen|mesh-list
65316346|NCT00646906|Ibuprofen|ibuprofen|mesh-list
65316347|NCT00646906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65316348|NCT00646906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65316349|NCT00646906|Analgesics|analgesics|mesh-ancestor
65316350|NCT00646906|Sensory System Agents|sensory system agents|mesh-ancestor
65316351|NCT00646906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65316352|NCT00646906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316353|NCT00646906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65316354|NCT00646906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65316355|NCT00646906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65316356|NCT00646906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65316357|NCT00646906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316358|NCT00646906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65316359|NCT00646906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65316369|NCT00808678|Antimetabolites|antimetabolites|mesh-ancestor
65316370|NCT00808678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316371|NCT00808678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65493952|NCT03913559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066321|NCT00270101|Hematinics|hematinics|mesh-ancestor
65316372|NCT00808678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65316373|NCT00808678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316374|NCT00815854|Folic Acid|folic acid|mesh-list
65316375|NCT00815854|Hematinics|hematinics|mesh-ancestor
65316376|NCT00815854|Vitamin B Complex|vitamin b complex|mesh-ancestor
65316377|NCT00815854|Vitamins|vitamins|mesh-ancestor
65316378|NCT00815854|Micronutrients|micronutrients|mesh-ancestor
65316379|NCT00815854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316380|NCT00817648|Risperidone|risperidone|mesh-list
65316381|NCT00817648|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65316382|NCT00817648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65316383|NCT00817648|Serotonin Agents|serotonin agents|mesh-ancestor
65316384|NCT00817648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65316385|NCT00817648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316386|NCT00817648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316387|NCT00817648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65316388|NCT00817648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65316389|NCT00817648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65316390|NCT00817648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65316391|NCT00817648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65316392|NCT00817648|Dopamine Agents|dopamine agents|mesh-ancestor
65316393|NCT00817648|Antidepressive Agents|antidepressive agents|mesh-ancestor
65316394|NCT00829010|Vaccines|vaccines|mesh-list
65316395|NCT00829010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65316396|NCT00829010|Immunologic Factors|immunologic factors|mesh-ancestor
65316412|NCT00445939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65316413|NCT00445939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65316414|NCT00816244|Atorvastatin|atorvastatin|mesh-list
65316415|NCT00816244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65316416|NCT00816244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65316417|NCT00816244|Antimetabolites|antimetabolites|mesh-ancestor
65316418|NCT00816244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316419|NCT00816244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65316420|NCT00816244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65316421|NCT00816244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316422|NCT00817960|Methylphenidate|methylphenidate|mesh-list
65316423|NCT00817960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65316424|NCT00817960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316425|NCT00817960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65316426|NCT00817960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65316427|NCT00817960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65316428|NCT00817960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316429|NCT00817960|Dopamine Agents|dopamine agents|mesh-ancestor
65316430|NCT00817960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65316431|NCT00818038|Natalizumab|natalizumab|mesh-list
65316432|NCT00818038|Immunologic Factors|immunologic factors|mesh-ancestor
65316433|NCT00818038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316434|NCT00482053|Acetaminophen|acetaminophen|mesh-list
65316435|NCT00482053|Diphenhydramine|diphenhydramine|mesh-list
65316436|NCT00482053|Promethazine|promethazine|mesh-list
65316437|NCT00482053|Cyclosporine|cyclosporine|mesh-list
65316438|NCT00482053|Mycophenolic Acid|mycophenolic acid|mesh-list
65316439|NCT00482053|Methylprednisolone|methylprednisolone|mesh-list
64714171|NCT03065179|Ipilimumab|ipilimumab|mesh-list
65161305|NCT01053429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65161306|NCT01053429|Serotonin Agents|serotonin agents|mesh-ancestor
65161307|NCT01053429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65161308|NCT01053429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161313|NCT01053429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65161314|NCT01053429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65161315|NCT01053429|Dopamine Agents|dopamine agents|mesh-ancestor
65161317|NCT01233284|Tiotropium Bromide|tiotropium bromide|mesh-list
65161318|NCT01233284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65161319|NCT01233284|Autonomic Agents|autonomic agents|mesh-ancestor
65161320|NCT01233284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161321|NCT01233284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161322|NCT01233284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65161323|NCT01233284|Respiratory System Agents|respiratory system agents|mesh-ancestor
65161324|NCT01233284|Parasympatholytics|parasympatholytics|mesh-ancestor
65161325|NCT01233284|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65161326|NCT01233284|Cholinergic Agents|cholinergic agents|mesh-ancestor
65161327|NCT01233284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65316440|NCT00482053|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65316441|NCT00482053|Hydrocortisone|hydrocortisone|mesh-list
65316442|NCT00482053|Cyclophosphamide|cyclophosphamide|mesh-list
65316443|NCT00482053|Carmustine|carmustine|mesh-list
65316444|NCT00482053|Rituximab|rituximab|mesh-list
65316445|NCT00482053|Etoposide|etoposide|mesh-list
65316446|NCT00482053|Cyclosporins|cyclosporins|mesh-list
65316447|NCT00482053|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65316448|NCT00482053|Lenograstim|lenograstim|mesh-list
65493953|NCT03913559|Antipyretics|antipyretics|mesh-ancestor
65316449|NCT00482053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65316450|NCT00482053|Immunologic Factors|immunologic factors|mesh-ancestor
65316451|NCT00482053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316452|NCT00482053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65316453|NCT00482053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65316454|NCT00482053|Alkylating Agents|alkylating agents|mesh-ancestor
65316455|NCT00482053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316456|NCT00482053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316457|NCT00482053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65316458|NCT00482053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65316459|NCT00482053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65316460|NCT00482053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65316461|NCT00482053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65316462|NCT00482053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316463|NCT00482053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65316464|NCT00482053|Antifungal Agents|antifungal agents|mesh-ancestor
65316465|NCT00482053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65316466|NCT00482053|Dermatologic Agents|dermatologic agents|mesh-ancestor
65316467|NCT00482053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65316468|NCT00482053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65316469|NCT00482053|Analgesics|analgesics|mesh-ancestor
65316470|NCT00482053|Sensory System Agents|sensory system agents|mesh-ancestor
65161328|NCT01233284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161329|NCT01233284|Anticonvulsants|anticonvulsants|mesh-ancestor
65161330|NCT00948688|Vorinostat|vorinostat|mesh-list
65161331|NCT00948688|Fluorouracil|fluorouracil|mesh-list
65161332|NCT00948688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161333|NCT00948688|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65161334|NCT00948688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65161335|NCT00948688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161336|NCT00948688|Antimetabolites|antimetabolites|mesh-ancestor
65161337|NCT00948688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65161338|NCT00948688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65161339|NCT00948688|Immunologic Factors|immunologic factors|mesh-ancestor
65316471|NCT00482053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65316472|NCT00482053|Antipyretics|antipyretics|mesh-ancestor
65316473|NCT00482053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65316474|NCT00482053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65316475|NCT00482053|Antitubercular Agents|antitubercular agents|mesh-ancestor
65316476|NCT00482053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65316477|NCT00482053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65316478|NCT00482053|Antiemetics|antiemetics|mesh-ancestor
65316479|NCT00482053|Autonomic Agents|autonomic agents|mesh-ancestor
65316480|NCT00482053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65316481|NCT00482053|Glucocorticoids|glucocorticoids|mesh-ancestor
65316482|NCT00482053|Hormones|hormones|mesh-ancestor
65316483|NCT00482053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65316484|NCT00482053|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65316485|NCT00482053|Protective Agents|protective agents|mesh-ancestor
65316486|NCT00482053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65316487|NCT00482053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65316488|NCT00482053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65316489|NCT00482053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65316490|NCT00482053|Anesthetics, Local|anesthetics, local|mesh-ancestor
65316491|NCT00482053|Anesthetics|anesthetics|mesh-ancestor
65316492|NCT00482053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65316493|NCT00482053|Histamine Antagonists|histamine antagonists|mesh-ancestor
65316494|NCT00482053|Histamine Agents|histamine agents|mesh-ancestor
65316495|NCT00482053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65316496|NCT00482053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65316497|NCT00482053|Antipruritics|antipruritics|mesh-ancestor
65316498|NCT00455923|Fluticasone|fluticasone|mesh-list
65316499|NCT00455923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65316500|NCT00455923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65316501|NCT00455923|Autonomic Agents|autonomic agents|mesh-ancestor
65316502|NCT00455923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64546467|NCT00780403|Cetirizine|cetirizine|mesh-list
65316514|NCT00642616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65316515|NCT00642616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316516|NCT00809068|Tibolone|tibolone|mesh-list
65316517|NCT00809068|Fenofibrate|fenofibrate|mesh-list
65316518|NCT00809068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65316519|NCT00809068|Antimetabolites|antimetabolites|mesh-ancestor
65316520|NCT00809068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316521|NCT00809068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65316522|NCT00809068|Androgen Antagonists|androgen antagonists|mesh-ancestor
65316523|NCT00809068|Hormone Antagonists|hormone antagonists|mesh-ancestor
65066474|NCT00416390|Lycopene|lycopene|mesh-list
65316524|NCT00809068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65316525|NCT00809068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316526|NCT00809068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65316527|NCT00809068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65316528|NCT00809068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316529|NCT00809068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65316531|NCT00809068|Hormones|hormones|mesh-ancestor
65316532|NCT03844945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65316533|NCT03844945|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65316534|NCT01027117|Sildenafil Citrate|sildenafil citrate|mesh-list
65316535|NCT01027117|Vasodilator Agents|vasodilator agents|mesh-ancestor
65316536|NCT01027117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65316537|NCT01027117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65316538|NCT01027117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316539|NCT01027117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161340|NCT00948688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161341|NCT02188264|Cyclosporine|cyclosporine|mesh-list
65161342|NCT02188264|Cyclosporins|cyclosporins|mesh-list
65161343|NCT02188264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65161344|NCT02188264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161345|NCT02188264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65161346|NCT02188264|Immunologic Factors|immunologic factors|mesh-ancestor
65161347|NCT02188264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161348|NCT02188264|Antifungal Agents|antifungal agents|mesh-ancestor
65161349|NCT02188264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65161350|NCT02188264|Dermatologic Agents|dermatologic agents|mesh-ancestor
65161351|NCT02188264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65161352|NCT02188264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65161353|NCT01233050|Ethanol|ethanol|mesh-list
65161354|NCT01233050|Chlorhexidine|chlorhexidine|mesh-list
65161355|NCT01233050|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65161356|NCT01233050|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65161357|NCT01233050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65161358|NCT01233050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65161359|NCT01233050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316540|NCT01027117|Urological Agents|urological agents|mesh-ancestor
65316541|NCT03995563|Dexamethasone|dexamethasone|mesh-list
65316542|NCT03995563|Ropivacaine|ropivacaine|mesh-list
65316543|NCT03995563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65316544|NCT03995563|Antiemetics|antiemetics|mesh-ancestor
65316545|NCT03995563|Autonomic Agents|autonomic agents|mesh-ancestor
65316546|NCT03995563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65316547|NCT03995563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316548|NCT03995563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65316549|NCT03995563|Glucocorticoids|glucocorticoids|mesh-ancestor
65316550|NCT03995563|Hormones|hormones|mesh-ancestor
65316551|NCT03995563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65316552|NCT03995563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65316553|NCT03995563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316554|NCT03995563|Anesthetics, Local|anesthetics, local|mesh-ancestor
65316555|NCT03995563|Anesthetics|anesthetics|mesh-ancestor
65316556|NCT03995563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65316557|NCT03995563|Sensory System Agents|sensory system agents|mesh-ancestor
65316558|NCT04122625|Nivolumab|nivolumab|mesh-list
65316559|NCT04122625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65316560|NCT04122625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316561|NCT04122625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65316562|NCT04122625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316563|NCT00445003|Triamcinolone|triamcinolone|mesh-list
65316564|NCT00445003|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65316565|NCT00445003|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65316566|NCT00445003|Ranibizumab|ranibizumab|mesh-list
65316567|NCT00445003|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65316568|NCT00445003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65316569|NCT00445003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65316570|NCT00445003|Growth Substances|growth substances|mesh-ancestor
65316571|NCT00445003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316572|NCT00445003|Growth Inhibitors|growth inhibitors|mesh-ancestor
65316573|NCT00445003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316574|NCT00445003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65316575|NCT00445003|Glucocorticoids|glucocorticoids|mesh-ancestor
65316576|NCT00445003|Hormones|hormones|mesh-ancestor
65161360|NCT01233050|Disinfectants|disinfectants|mesh-ancestor
65316577|NCT00445003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65316578|NCT00445003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65316579|NCT00445003|Immunologic Factors|immunologic factors|mesh-ancestor
65316580|NCT00445003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316581|NCT00445003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316582|NCT00642460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65316583|NCT00642460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65316584|NCT00642460|Methotrexate|methotrexate|mesh-list
65316585|NCT00642460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65316586|NCT00642460|Abortifacient Agents|abortifacient agents|mesh-ancestor
65316587|NCT00642460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65316588|NCT00642460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316589|NCT00642460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65316590|NCT00642460|Antimetabolites|antimetabolites|mesh-ancestor
65316591|NCT00642460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316592|NCT00642460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316593|NCT00642460|Dermatologic Agents|dermatologic agents|mesh-ancestor
65316594|NCT00642460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316595|NCT00642460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65316596|NCT00642460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65316597|NCT00642460|Immunologic Factors|immunologic factors|mesh-ancestor
65316598|NCT00642460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65316599|NCT00642460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65316625|NCT00816634|Tubulin Modulators|tubulin modulators|mesh-ancestor
65316626|NCT00816634|Antimitotic Agents|antimitotic agents|mesh-ancestor
65316627|NCT00816634|Mitosis Modulators|mitosis modulators|mesh-ancestor
65316628|NCT00816634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316629|NCT00816634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65316630|NCT00816634|Antimetabolites|antimetabolites|mesh-ancestor
65316631|NCT00642304|Epoetin Alfa|epoetin alfa|mesh-list
65316632|NCT00642304|Hematinics|hematinics|mesh-ancestor
65316633|NCT00814580|Oxycodone|oxycodone|mesh-list
65316634|NCT00814580|Tapentadol|tapentadol|mesh-list
65316635|NCT00814580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65316636|NCT00814580|Narcotics|narcotics|mesh-ancestor
65316637|NCT00814580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65316638|NCT00814580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316639|NCT00814580|Analgesics|analgesics|mesh-ancestor
65316640|NCT00814580|Sensory System Agents|sensory system agents|mesh-ancestor
65316641|NCT00814580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65316642|NCT00814580|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65316643|NCT00814580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65316644|NCT00814580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65316645|NCT00814580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316646|NCT00814580|Adrenergic Agents|adrenergic agents|mesh-ancestor
65316647|NCT00814580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65316648|NCT00643162|Citalopram|citalopram|mesh-list
65316653|NCT00643162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65316674|NCT00653224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65316675|NCT00653224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316676|NCT00653224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316677|NCT00444925|Fesoterodine|fesoterodine|mesh-list
65316678|NCT00444925|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65316679|NCT00444925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65316680|NCT00444925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65316681|NCT00444925|Cholinergic Agents|cholinergic agents|mesh-ancestor
65316682|NCT00444925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65316683|NCT00444925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316684|NCT00444925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316685|NCT00444925|Urological Agents|urological agents|mesh-ancestor
65316686|NCT00641056|Insulin Glargine|insulin glargine|mesh-list
65316687|NCT00641056|Exenatide|exenatide|mesh-list
65316688|NCT00641056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65316689|NCT00641056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316690|NCT00641056|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65316691|NCT00641056|Incretins|incretins|mesh-ancestor
65316692|NCT00641056|Hormones|hormones|mesh-ancestor
65316693|NCT00641056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65316694|NCT00569374|Modafinil|modafinil|mesh-list
65316695|NCT00569374|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65316696|NCT00569374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316697|NCT00569374|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65316698|NCT00569374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65316699|NCT00569374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65316700|NCT00569374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316701|NCT00828464|Clobetasol|clobetasol|mesh-list
65316702|NCT00828464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65316703|NCT00828464|Glucocorticoids|glucocorticoids|mesh-ancestor
65316704|NCT00828464|Hormones|hormones|mesh-ancestor
65316705|NCT00828464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65316706|NCT00828464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316707|NCT00816712|Methyltestosterone|methyltestosterone|mesh-list
65316708|NCT00816712|Testosterone|testosterone|mesh-list
65161361|NCT01233050|Dermatologic Agents|dermatologic agents|mesh-ancestor
65161362|NCT01049217|Pregabalin|pregabalin|mesh-list
65161363|NCT01049217|Analgesics|analgesics|mesh-ancestor
65316709|NCT00816712|Testosterone undecanoate|testosterone undecanoate|mesh-list
65316710|NCT00816712|Testosterone enanthate|testosterone enanthate|mesh-list
65316711|NCT00816712|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65316712|NCT00816712|Androgens|androgens|mesh-ancestor
65316713|NCT00816712|Hormones|hormones|mesh-ancestor
65316714|NCT00816712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65316715|NCT00816712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316716|NCT00816712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65316717|NCT00816712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316718|NCT00816712|Anabolic Agents|anabolic agents|mesh-ancestor
65316719|NCT00818194|Cyclosporine|cyclosporine|mesh-list
65316720|NCT00818194|Tacrolimus|tacrolimus|mesh-list
65316721|NCT00818194|Cyclosporins|cyclosporins|mesh-list
65316722|NCT00818194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65316723|NCT00818194|Immunologic Factors|immunologic factors|mesh-ancestor
65316724|NCT00818194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316725|NCT00818194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65316726|NCT00818194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316727|NCT00818194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316728|NCT00818194|Antifungal Agents|antifungal agents|mesh-ancestor
65316729|NCT00818194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65161364|NCT01049217|Sensory System Agents|sensory system agents|mesh-ancestor
65161365|NCT01049217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161366|NCT01049217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161367|NCT01049217|Anticonvulsants|anticonvulsants|mesh-ancestor
65161368|NCT01049217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65161369|NCT01049217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65161370|NCT01049217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161371|NCT01049217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65161372|NCT01049217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65161373|NCT01049217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65161374|NCT01049217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65161375|NCT01049217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65161376|NCT01232738|Rasagiline|rasagiline|mesh-list
65161377|NCT01232738|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65161378|NCT01232738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506047|NCT03833362|Antiviral Agents|antiviral agents|mesh-ancestor
65161388|NCT00957268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65161389|NCT00957268|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65161391|NCT00957268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65161392|NCT00957268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161393|NCT02888444|Varenicline|varenicline|mesh-list
65161394|NCT02888444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65161395|NCT02888444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65161396|NCT02888444|Cholinergic Agents|cholinergic agents|mesh-ancestor
65161397|NCT02888444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65161398|NCT02888444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161399|NCT02888444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161400|NCT01230788|Rituximab|rituximab|mesh-list
65161401|NCT01230788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65161402|NCT01230788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161403|NCT01230788|Immunologic Factors|immunologic factors|mesh-ancestor
65316730|NCT00818194|Dermatologic Agents|dermatologic agents|mesh-ancestor
65316731|NCT00818194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65316732|NCT02610686|Chloroquine|chloroquine|mesh-list
65316733|NCT02610686|Amebicides|amebicides|mesh-ancestor
65316734|NCT02610686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65316735|NCT02610686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65316736|NCT02610686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65316737|NCT02610686|Antimalarials|antimalarials|mesh-ancestor
65316738|NCT02610686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65316739|NCT00816790|Tazobactam|tazobactam|mesh-list
65316740|NCT00816790|Piperacillin|piperacillin|mesh-list
65316741|NCT00816790|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65316742|NCT00816790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65316743|NCT00816790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65316744|NCT00816790|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65316745|NCT00816790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493954|NCT03913559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65316746|NCT00816790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316747|NCT00818350|Sunitinib|sunitinib|mesh-list
65316748|NCT00818350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316749|NCT00818350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65316750|NCT00818350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65316751|NCT00818350|Growth Substances|growth substances|mesh-ancestor
65316752|NCT00818350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316780|NCT00791700|Maraviroc|maraviroc|mesh-list
65316781|NCT00791700|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65316782|NCT00791700|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65316783|NCT00791700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316784|NCT00791700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65316785|NCT00791700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65316786|NCT00791700|Antiviral Agents|antiviral agents|mesh-ancestor
65316787|NCT00791700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65316788|NCT00791700|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65316789|NCT00628108|Levocetirizine|levocetirizine|mesh-list
65316790|NCT00628108|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65316791|NCT00628108|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65316792|NCT00628108|Histamine Antagonists|histamine antagonists|mesh-ancestor
65316793|NCT00628108|Histamine Agents|histamine agents|mesh-ancestor
65316794|NCT00628108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65316795|NCT00628108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316796|NCT00628108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316797|NCT00821392|Febuxostat|febuxostat|mesh-list
65316798|NCT00821392|Gout Suppressants|gout suppressants|mesh-ancestor
65316799|NCT00821392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65316800|NCT00591578|Valsartan|valsartan|mesh-list
65316801|NCT00591578|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65316802|NCT00591578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65316803|NCT00591578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65316804|NCT00591578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65316805|NCT00591578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316806|NCT00797862|Amlodipine|amlodipine|mesh-list
65316807|NCT00797862|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65316808|NCT00797862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65316809|NCT00797862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65316810|NCT00797862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65316811|NCT00797862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316812|NCT00797862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65316813|NCT00797862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316814|NCT00797862|Vasodilator Agents|vasodilator agents|mesh-ancestor
65316815|NCT00797862|Diuretics|diuretics|mesh-ancestor
65316816|NCT00797862|Natriuretic Agents|natriuretic agents|mesh-ancestor
65316817|NCT00797862|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65316818|NCT00817258|Cisplatin|cisplatin|mesh-list
65316819|NCT00817258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316820|NCT00794820|Cyclophosphamide|cyclophosphamide|mesh-list
65316821|NCT00794820|Rituximab|rituximab|mesh-list
65316822|NCT00794820|Fludarabine|fludarabine|mesh-list
65316823|NCT00794820|Fludarabine phosphate|fludarabine phosphate|mesh-list
65316824|NCT00794820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65316825|NCT00794820|Immunologic Factors|immunologic factors|mesh-ancestor
65316826|NCT00794820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316827|NCT00794820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65316828|NCT00794820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65316829|NCT00794820|Alkylating Agents|alkylating agents|mesh-ancestor
65316830|NCT00794820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316831|NCT00794820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316832|NCT00794820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65316833|NCT00794820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65316834|NCT00794820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65316835|NCT00794820|Antimetabolites|antimetabolites|mesh-ancestor
65316836|NCT00455533|Paclitaxel|paclitaxel|mesh-list
65316837|NCT00455533|Epothilones|epothilones|mesh-list
65316838|NCT00455533|Cyclophosphamide|cyclophosphamide|mesh-list
65316839|NCT00455533|Doxorubicin|doxorubicin|mesh-list
65316840|NCT00455533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65316841|NCT00455533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316842|NCT00455533|Tubulin Modulators|tubulin modulators|mesh-ancestor
65316843|NCT00455533|Antimitotic Agents|antimitotic agents|mesh-ancestor
65316864|NCT02610530|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65316865|NCT02610530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316866|NCT00923000|Morphine|morphine|mesh-list
65316867|NCT00923000|Nalbuphine|nalbuphine|mesh-list
65316868|NCT00923000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65316869|NCT00923000|Narcotics|narcotics|mesh-ancestor
65316870|NCT00923000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65316871|NCT00923000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316872|NCT00923000|Analgesics|analgesics|mesh-ancestor
65316873|NCT00923000|Sensory System Agents|sensory system agents|mesh-ancestor
65316874|NCT00923000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65316875|NCT01019863|Oxaliplatin|oxaliplatin|mesh-list
65316876|NCT01019863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316877|NCT00642850|Epoetin Alfa|epoetin alfa|mesh-list
65316878|NCT00642850|Hematinics|hematinics|mesh-ancestor
65316879|NCT00455455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65316880|NCT00913952|Clomipramine|clomipramine|mesh-list
65316881|NCT00913952|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65316882|NCT00913952|Antidepressive Agents|antidepressive agents|mesh-ancestor
65316883|NCT00913952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65316884|NCT00913952|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65316885|NCT00913952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65316886|NCT00913952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65316887|NCT00913952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316888|NCT00913952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65316889|NCT00913952|Serotonin Agents|serotonin agents|mesh-ancestor
65316890|NCT00913952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316891|NCT04581382|Pembrolizumab|pembrolizumab|mesh-list
65316892|NCT04581382|Nivolumab|nivolumab|mesh-list
65316893|NCT04581382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65316894|NCT04581382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316895|NCT04581382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65316909|NCT03840811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316910|NCT03840811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65316911|NCT03840811|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65316912|NCT03840811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65316913|NCT00640510|Olanzapine|olanzapine|mesh-list
65316914|NCT00640510|Antiemetics|antiemetics|mesh-ancestor
65316915|NCT00640510|Autonomic Agents|autonomic agents|mesh-ancestor
65316916|NCT00640510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65316917|NCT00640510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316918|NCT00640510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65316919|NCT00640510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65316920|NCT00640510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65316921|NCT00640510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65316922|NCT00640510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65316923|NCT00640510|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65316924|NCT00640510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65316925|NCT00640510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65316926|NCT00640510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316927|NCT00640510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65316928|NCT00640510|Serotonin Agents|serotonin agents|mesh-ancestor
65316929|NCT00913718|Fluoxetine|fluoxetine|mesh-list
65316930|NCT00913718|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65316931|NCT00913718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65316932|NCT00913718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65161404|NCT01230788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161405|NCT01230788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65161406|NCT01230710|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65161407|NCT01230710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161408|NCT01230710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65161409|NCT01230710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65161410|NCT01230710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161411|NCT00627081|Remifentanil|remifentanil|mesh-list
65161412|NCT00627081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65161413|NCT00627081|Narcotics|narcotics|mesh-ancestor
65161414|NCT00627081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65161415|NCT00627081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161416|NCT00627081|Analgesics|analgesics|mesh-ancestor
65161417|NCT00627081|Sensory System Agents|sensory system agents|mesh-ancestor
65161418|NCT00627081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161419|NCT02888054|Allopurinol|allopurinol|mesh-list
65161420|NCT02888054|Lesinurad|lesinurad|mesh-list
65161421|NCT02888054|Antimetabolites|antimetabolites|mesh-ancestor
65161422|NCT02888054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161423|NCT02888054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65161424|NCT02888054|Gout Suppressants|gout suppressants|mesh-ancestor
65161425|NCT02888054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65161426|NCT02888054|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65161427|NCT02888054|Antioxidants|antioxidants|mesh-ancestor
65161428|NCT02888054|Protective Agents|protective agents|mesh-ancestor
65316933|NCT00913718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316934|NCT00913718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65316935|NCT00913718|Serotonin Agents|serotonin agents|mesh-ancestor
65316936|NCT00913718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316937|NCT00913718|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65316938|NCT00913718|Antidepressive Agents|antidepressive agents|mesh-ancestor
65316939|NCT00913718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65316940|NCT00913718|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65316941|NCT00913718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65316942|NCT00913718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65316943|NCT00813800|Varenicline|varenicline|mesh-list
65316944|NCT00813800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65316945|NCT00813800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65316946|NCT00813800|Cholinergic Agents|cholinergic agents|mesh-ancestor
65316947|NCT00813800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65316948|NCT00813800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65316949|NCT00813800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316950|NCT00627016|Dexlansoprazole|dexlansoprazole|mesh-list
65316951|NCT00627016|Lansoprazole|lansoprazole|mesh-list
65316952|NCT00627016|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65316957|NCT00794664|Mipomersen|mipomersen|mesh-list
65316984|NCT00826306|Protective Agents|protective agents|mesh-ancestor
65316985|NCT00826306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65316986|NCT00826306|Dermatologic Agents|dermatologic agents|mesh-ancestor
65316987|NCT05753852|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
65316988|NCT05753852|Antiviral Agents|antiviral agents|mesh-ancestor
65316989|NCT05753852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65316990|NCT05753852|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65316991|NCT05753852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65316992|NCT00821782|Azithromycin|azithromycin|mesh-list
65316993|NCT00821782|Levofloxacin|levofloxacin|mesh-list
65316994|NCT00821782|Ofloxacin|ofloxacin|mesh-list
65316995|NCT00821782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65316996|NCT00821782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65316997|NCT00821782|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65316998|NCT00821782|Renal Agents|renal agents|mesh-ancestor
65316999|NCT00821782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65317000|NCT00821782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65317001|NCT00821782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317002|NCT00821782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317003|NCT00821782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317004|NCT00821782|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65317005|NCT00821782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65317006|NCT00847613|Tofacitinib|tofacitinib|mesh-list
65317007|NCT00847613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65317008|NCT00847613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317009|NCT00847613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317010|NCT00794196|Antidepressive Agents|antidepressive agents|mesh-list
65317011|NCT00794196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65317012|NCT00807092|Insulin|insulin|mesh-list
65317013|NCT00807092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65317014|NCT00807092|Metformin|metformin|mesh-list
65317015|NCT00807092|Insulin Aspart|insulin aspart|mesh-list
65317016|NCT00807092|Biphasic Insulins|biphasic insulins|mesh-list
65161429|NCT02888054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161430|NCT02888054|Uricosuric Agents|uricosuric agents|mesh-ancestor
65161431|NCT02888054|Renal Agents|renal agents|mesh-ancestor
65161432|NCT01040793|Olodaterol|olodaterol|mesh-list
65161433|NCT01040793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65161434|NCT01040793|Autonomic Agents|autonomic agents|mesh-ancestor
65161435|NCT01040793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161436|NCT01040793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161437|NCT01040793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65161438|NCT01040793|Respiratory System Agents|respiratory system agents|mesh-ancestor
65161439|NCT02811055|Aprepitant|aprepitant|mesh-list
65317017|NCT00807092|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65317018|NCT00807092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65317019|NCT00807092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317020|NCT04112550|Acetaminophen|acetaminophen|mesh-list
65317021|NCT04112550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65317022|NCT04112550|Oxycodone|oxycodone|mesh-list
65317023|NCT04112550|Methadone|methadone|mesh-list
65317024|NCT04112550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65317025|NCT04112550|Analgesics|analgesics|mesh-ancestor
65317026|NCT04112550|Sensory System Agents|sensory system agents|mesh-ancestor
65317027|NCT04112550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317028|NCT04112550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317029|NCT04112550|Antipyretics|antipyretics|mesh-ancestor
65317030|NCT04112550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65317031|NCT04112550|Narcotics|narcotics|mesh-ancestor
65317032|NCT04112550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65317033|NCT04112550|Antitussive Agents|antitussive agents|mesh-ancestor
65317034|NCT04112550|Respiratory System Agents|respiratory system agents|mesh-ancestor
65317035|NCT04112550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65317036|NCT04112550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65317037|NCT04112550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65317038|NCT00640042|Morphine|morphine|mesh-list
65317039|NCT00640042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65317040|NCT00640042|Narcotics|narcotics|mesh-ancestor
65317041|NCT00640042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65317042|NCT00640042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317043|NCT00640042|Analgesics|analgesics|mesh-ancestor
65317044|NCT00640042|Sensory System Agents|sensory system agents|mesh-ancestor
65317045|NCT00640042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317047|NCT00807014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65317048|NCT00807014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65317049|NCT00807014|Analgesics|analgesics|mesh-ancestor
65317050|NCT00807014|Sensory System Agents|sensory system agents|mesh-ancestor
65317051|NCT00807014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317052|NCT00807014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317053|NCT00807014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65317055|NCT00807014|Dermatologic Agents|dermatologic agents|mesh-ancestor
65317056|NCT00794040|Methylphenidate|methylphenidate|mesh-list
65317057|NCT00794040|Citalopram|citalopram|mesh-list
65317058|NCT00794040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65317059|NCT00794040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317060|NCT00794040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65317061|NCT00794040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65317062|NCT00794040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65317063|NCT00794040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317064|NCT00794040|Dopamine Agents|dopamine agents|mesh-ancestor
65317065|NCT00794040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65317066|NCT00794040|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65317067|NCT00794040|Serotonin Agents|serotonin agents|mesh-ancestor
65317068|NCT00794040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65317069|NCT00794040|Antidepressive Agents|antidepressive agents|mesh-ancestor
65317070|NCT00794040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65317071|NCT04109742|Curcumin|curcumin|mesh-list
65317072|NCT04109742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65317073|NCT04109742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65317074|NCT04109742|Analgesics|analgesics|mesh-ancestor
65317075|NCT04109742|Sensory System Agents|sensory system agents|mesh-ancestor
65317076|NCT04109742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317077|NCT04109742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317078|NCT04109742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65317079|NCT04109742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65317080|NCT04109742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317081|NCT04109742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317083|NCT00813488|Fentanyl|fentanyl|mesh-list
65317101|NCT00797316|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65317102|NCT00797316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65317103|NCT00797316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317104|NCT05640336|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65317105|NCT05640336|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65317106|NCT05640336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65317107|NCT05640336|Antitubercular Agents|antitubercular agents|mesh-ancestor
65317108|NCT05753696|Losartan|losartan|mesh-list
65317109|NCT05753696|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65317110|NCT05753696|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65317111|NCT05753696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65317112|NCT05753696|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65317113|NCT05753696|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65317114|NCT05753696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317115|NCT04107480|Dopamine|dopamine|mesh-list
65317116|NCT04107480|Dopamine Agonists|dopamine agonists|mesh-list
65317117|NCT04107480|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65317118|NCT04107480|Sympathomimetics|sympathomimetics|mesh-ancestor
65317119|NCT04107480|Autonomic Agents|autonomic agents|mesh-ancestor
65317120|NCT04107480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317121|NCT04107480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317122|NCT04107480|Dopamine Agents|dopamine agents|mesh-ancestor
65317123|NCT04107480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65317124|NCT04107480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317149|NCT00915408|Growth Substances|growth substances|mesh-ancestor
65317150|NCT00915408|Growth Inhibitors|growth inhibitors|mesh-ancestor
65317151|NCT05573724|Itraconazole|itraconazole|mesh-list
65317152|NCT05573724|Antifungal Agents|antifungal agents|mesh-ancestor
65317153|NCT05573724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65317154|NCT05573724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65317155|NCT05573724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65317156|NCT05573724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317157|NCT05573724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317158|NCT05573724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65317159|NCT05573724|Hormone Antagonists|hormone antagonists|mesh-ancestor
65317160|NCT05573724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65317161|NCT05573724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317162|NCT05573724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65317163|NCT04064840|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65317164|NCT04064840|Luteolytic Agents|luteolytic agents|mesh-ancestor
65317165|NCT04064840|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65317166|NCT04064840|Contraceptive Agents|contraceptive agents|mesh-ancestor
65317167|NCT04064840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65317168|NCT04064840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317169|NCT04064840|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65317170|NCT04064840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65161440|NCT02811055|Antiemetics|antiemetics|mesh-ancestor
65161441|NCT02811055|Autonomic Agents|autonomic agents|mesh-ancestor
65161442|NCT02811055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161443|NCT02811055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506112|NCT02727660|Hormones|hormones|mesh-ancestor
65161446|NCT02811055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64694904|NCT03220022|Antibodies|antibodies|mesh-list
65161447|NCT02811055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161448|NCT04192903|Cisplatin|cisplatin|mesh-list
65161449|NCT04192903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161450|NCT02810899|Dexmedetomidine|dexmedetomidine|mesh-list
65161451|NCT02810899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65161452|NCT02810899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65161453|NCT02810899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161454|NCT02810899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65161455|NCT02810899|Analgesics|analgesics|mesh-ancestor
65161456|NCT02810899|Sensory System Agents|sensory system agents|mesh-ancestor
65161457|NCT02810899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161458|NCT02810899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65161459|NCT02810899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65161460|NCT02810899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65161461|NCT02810899|Adrenergic Agents|adrenergic agents|mesh-ancestor
65161462|NCT02810899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65161463|NCT02810899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161464|NCT04237129|Insulin Aspart|insulin aspart|mesh-list
65161465|NCT04237129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65161466|NCT04237129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161467|NCT02810587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65317171|NCT04064840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317172|NCT00791076|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
65317173|NCT00791076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65317174|NCT00791076|Hormones|hormones|mesh-ancestor
65317175|NCT00791076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65317176|NCT00791076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317177|NCT05538312|Itraconazole|itraconazole|mesh-list
65317178|NCT05538312|Antifungal Agents|antifungal agents|mesh-ancestor
65317179|NCT05538312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65317180|NCT05538312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65317181|NCT05538312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65317182|NCT05538312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317183|NCT05538312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317184|NCT05538312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65317185|NCT05538312|Hormone Antagonists|hormone antagonists|mesh-ancestor
65317186|NCT05538312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65317187|NCT05538312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317188|NCT05538312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65317189|NCT00625378|Sorafenib|sorafenib|mesh-list
65493955|NCT03913559|Antiemetics|antiemetics|mesh-ancestor
65317190|NCT00625378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317191|NCT00625378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65317192|NCT00625378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317193|NCT00625378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317194|NCT00806624|Warfarin|warfarin|mesh-list
65317195|NCT00806624|Edoxaban|edoxaban|mesh-list
65317196|NCT00806624|Anticoagulants|anticoagulants|mesh-ancestor
65317197|NCT00806624|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65317198|NCT00806624|Antithrombins|antithrombins|mesh-ancestor
65317199|NCT00806624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65317200|NCT00806624|Protease Inhibitors|protease inhibitors|mesh-ancestor
65317212|NCT05753150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65317213|NCT00826852|Carboplatin|carboplatin|mesh-list
65317214|NCT00826852|Docetaxel|docetaxel|mesh-list
65317215|NCT00826852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317216|NCT00826852|Tubulin Modulators|tubulin modulators|mesh-ancestor
65317217|NCT00826852|Antimitotic Agents|antimitotic agents|mesh-ancestor
65317218|NCT00826852|Mitosis Modulators|mitosis modulators|mesh-ancestor
65317219|NCT00826852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317220|NCT00826930|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
65317221|NCT00826930|Antioxidants|antioxidants|mesh-ancestor
65317222|NCT00826930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317223|NCT00826930|Protective Agents|protective agents|mesh-ancestor
65317224|NCT00826930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317225|NCT00826930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65317226|NCT00826930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317227|NCT00913796|Potassium Citrate|potassium citrate|mesh-list
65317228|NCT00913796|Diuretics|diuretics|mesh-ancestor
65317229|NCT00913796|Natriuretic Agents|natriuretic agents|mesh-ancestor
65317230|NCT00913796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317231|NCT00913796|Expectorants|expectorants|mesh-ancestor
65317232|NCT00913796|Respiratory System Agents|respiratory system agents|mesh-ancestor
65317233|NCT00633880|Droxidopa|droxidopa|mesh-list
65317234|NCT00633880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65317235|NCT00633880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65317236|NCT04029428|Octreotide|octreotide|mesh-list
65317237|NCT04029428|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65317238|NCT04029428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65317243|NCT00819520|Ivermectin|ivermectin|mesh-list
65317261|NCT00631696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317262|NCT00631696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65317263|NCT00631696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65317264|NCT00631696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65317265|NCT00631696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65317266|NCT00631696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65317267|NCT02608112|Methotrexate|methotrexate|mesh-list
65317268|NCT02608112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65317269|NCT02608112|Abortifacient Agents|abortifacient agents|mesh-ancestor
65317270|NCT02608112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65317271|NCT02608112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317272|NCT02608112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65317273|NCT02608112|Antimetabolites|antimetabolites|mesh-ancestor
65317274|NCT02608112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317275|NCT02608112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317276|NCT02608112|Dermatologic Agents|dermatologic agents|mesh-ancestor
65317277|NCT02608112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317278|NCT02608112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65317279|NCT02608112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65317280|NCT02608112|Immunologic Factors|immunologic factors|mesh-ancestor
65317281|NCT02608112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65317282|NCT02608112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65317312|NCT00819754|Capecitabine|capecitabine|mesh-list
65317313|NCT00819754|Oxaliplatin|oxaliplatin|mesh-list
65317314|NCT00819754|Irinotecan|irinotecan|mesh-list
65317315|NCT00819754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65317316|NCT00819754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317317|NCT00819754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65317318|NCT00819754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65317319|NCT00819754|Growth Substances|growth substances|mesh-ancestor
65317320|NCT00819754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317321|NCT00819754|Growth Inhibitors|growth inhibitors|mesh-ancestor
65317322|NCT00819754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65317323|NCT00819754|Antimetabolites|antimetabolites|mesh-ancestor
65317324|NCT00819754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317325|NCT00819754|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65317326|NCT00819754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65317327|NCT00819754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317328|NCT00819988|Pregabalin|pregabalin|mesh-list
65317329|NCT00819988|Analgesics|analgesics|mesh-ancestor
65317330|NCT00819988|Sensory System Agents|sensory system agents|mesh-ancestor
65317331|NCT00819988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317332|NCT00819988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317333|NCT00819988|Anticonvulsants|anticonvulsants|mesh-ancestor
65317334|NCT00819988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65317335|NCT00819988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65317336|NCT00819988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317337|NCT00819988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65317338|NCT00819988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65317339|NCT00819988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65317340|NCT00819988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65066806|NCT00272636|Amiodarone|amiodarone|mesh-list
65317341|NCT00819988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65317342|NCT00827554|Nadroparin|nadroparin|mesh-list
65317343|NCT00827554|Anticoagulants|anticoagulants|mesh-ancestor
65317347|NCT00847145|Vaccines|vaccines|mesh-list
65317352|NCT00701597|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65317353|NCT00701597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317354|NCT00700193|Vaccines|vaccines|mesh-list
65317355|NCT00700193|Immunologic Factors|immunologic factors|mesh-ancestor
65317356|NCT00700193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317357|NCT00846521|Acarbose|acarbose|mesh-list
65317358|NCT00846521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65317359|NCT00846521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317360|NCT00846521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317361|NCT00846521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65317362|NCT00846521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317363|NCT00698945|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65317364|NCT00698945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65317365|NCT00698945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65317366|NCT00698945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65317367|NCT00698945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65317368|NCT00698945|Adrenergic Agents|adrenergic agents|mesh-ancestor
65317369|NCT00698945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65317370|NCT00698945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317371|NCT00698945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317372|NCT00862823|Tenofovir|tenofovir|mesh-list
65317373|NCT00862823|Emtricitabine|emtricitabine|mesh-list
65317374|NCT00862823|Efavirenz|efavirenz|mesh-list
65317389|NCT00790842|Dexamethasone|dexamethasone|mesh-list
65317402|NCT00790842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65317403|NCT00790842|Glucocorticoids|glucocorticoids|mesh-ancestor
65317404|NCT00790842|Hormones|hormones|mesh-ancestor
65317405|NCT00790842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65317406|NCT00790842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65317407|NCT00790842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317408|NCT00790842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65317409|NCT00790842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65317410|NCT00790842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317411|NCT00790842|Immunologic Factors|immunologic factors|mesh-ancestor
65317412|NCT00790842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65317413|NCT00790842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65317414|NCT00790842|Growth Substances|growth substances|mesh-ancestor
65317415|NCT00790842|Growth Inhibitors|growth inhibitors|mesh-ancestor
65317417|NCT04104204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65317418|NCT04104204|Narcotics|narcotics|mesh-ancestor
65317419|NCT04104204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65317420|NCT04104204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317421|NCT04104204|Analgesics|analgesics|mesh-ancestor
65317422|NCT04104204|Sensory System Agents|sensory system agents|mesh-ancestor
65317423|NCT04104204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317424|NCT05572476|Carboplatin|carboplatin|mesh-list
65317425|NCT05572476|Etoposide|etoposide|mesh-list
65317426|NCT05572476|Durvalumab|durvalumab|mesh-list
65317427|NCT05572476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317428|NCT05572476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65317429|NCT05572476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65317430|NCT05572476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65317431|NCT05572476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317432|NCT05572476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317433|NCT05572476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65317434|NCT00574288|Dexamethasone|dexamethasone|mesh-list
65317435|NCT00574288|Methylprednisolone|methylprednisolone|mesh-list
65317436|NCT00574288|Daratumumab|daratumumab|mesh-list
64547349|NCT03809793|Acipimox|acipimox|mesh-list
65161468|NCT02810587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65161469|NCT02810275|Leucovorin|leucovorin|mesh-list
65161470|NCT02810275|Folic Acid|folic acid|mesh-list
65161471|NCT02810275|Levoleucovorin|levoleucovorin|mesh-list
65161472|NCT02810275|Antidotes|antidotes|mesh-ancestor
65161473|NCT02810275|Protective Agents|protective agents|mesh-ancestor
65161474|NCT02810275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317437|NCT00574288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65317438|NCT00574288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65317439|NCT00574288|Antiemetics|antiemetics|mesh-ancestor
65317440|NCT00574288|Autonomic Agents|autonomic agents|mesh-ancestor
65317441|NCT00574288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317442|NCT00574288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317443|NCT00574288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65317444|NCT00574288|Glucocorticoids|glucocorticoids|mesh-ancestor
65317445|NCT00574288|Hormones|hormones|mesh-ancestor
65317446|NCT00574288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65317447|NCT00574288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65317448|NCT00574288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317449|NCT00574288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65317450|NCT00574288|Protective Agents|protective agents|mesh-ancestor
65317451|NCT00574288|Immunologic Factors|immunologic factors|mesh-ancestor
65317452|NCT00790452|Aspirin|aspirin|mesh-list
65317453|NCT00790452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65317454|NCT00790452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65317455|NCT00790452|Analgesics|analgesics|mesh-ancestor
65317456|NCT00790452|Sensory System Agents|sensory system agents|mesh-ancestor
65317457|NCT00790452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317458|NCT00790452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317459|NCT00790452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65317460|NCT00790452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65317461|NCT00790452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65317462|NCT00790452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65317463|NCT00790452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317464|NCT00790452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65317465|NCT00790452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65317466|NCT00790452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317479|NCT00823030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317480|NCT00823186|Paclitaxel|paclitaxel|mesh-list
65317481|NCT00823186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65317482|NCT00823186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317483|NCT00823186|Tubulin Modulators|tubulin modulators|mesh-ancestor
65317484|NCT00823186|Antimitotic Agents|antimitotic agents|mesh-ancestor
65317485|NCT00823186|Mitosis Modulators|mitosis modulators|mesh-ancestor
65317486|NCT00823186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317487|NCT00626392|Aspirin|aspirin|mesh-list
65317488|NCT00626392|Niacin|niacin|mesh-list
65317489|NCT00626392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65067451|NCT00277472|Diuretics|diuretics|mesh-ancestor
65317490|NCT00626392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65317491|NCT00626392|Analgesics|analgesics|mesh-ancestor
65317492|NCT00626392|Sensory System Agents|sensory system agents|mesh-ancestor
65317493|NCT00626392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317494|NCT00626392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317495|NCT00626392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65317496|NCT00626392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65317497|NCT00626392|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65317498|NCT00626392|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65317499|NCT00626392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317500|NCT00626392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65317501|NCT00626392|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65161475|NCT02810275|Vitamin B Complex|vitamin b complex|mesh-ancestor
65161476|NCT02810275|Vitamins|vitamins|mesh-ancestor
65161477|NCT02810275|Micronutrients|micronutrients|mesh-ancestor
65161478|NCT02810275|Hematinics|hematinics|mesh-ancestor
65161479|NCT00948064|Azacitidine|azacitidine|mesh-list
65161480|NCT00948064|Vorinostat|vorinostat|mesh-list
65161481|NCT00948064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65161482|NCT00948064|Antimetabolites|antimetabolites|mesh-ancestor
65161483|NCT00948064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161484|NCT00948064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161485|NCT00948064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65161486|NCT00948064|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65161487|NCT02813239|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65161488|NCT02813239|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65161489|NCT02813239|Luteolytic Agents|luteolytic agents|mesh-ancestor
65161490|NCT02813239|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65161491|NCT02813239|Contraceptive Agents|contraceptive agents|mesh-ancestor
65161492|NCT02813239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65161493|NCT02813239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161494|NCT02813239|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65161495|NCT02813239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65161496|NCT02813239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161497|NCT02858206|Paclitaxel|paclitaxel|mesh-list
65161498|NCT02858206|Nimotuzumab|nimotuzumab|mesh-list
65161499|NCT02858206|Nedaplatin|nedaplatin|mesh-list
65161500|NCT02858206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65161501|NCT02858206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317502|NCT00626392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317503|NCT00626392|Antipyretics|antipyretics|mesh-ancestor
65317504|NCT00626392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65317505|NCT00626392|Antimetabolites|antimetabolites|mesh-ancestor
65317506|NCT00626392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65317507|NCT00626392|Vasodilator Agents|vasodilator agents|mesh-ancestor
65317508|NCT00626392|Vitamin B Complex|vitamin b complex|mesh-ancestor
65317509|NCT00626392|Vitamins|vitamins|mesh-ancestor
65317510|NCT00626392|Micronutrients|micronutrients|mesh-ancestor
65317511|NCT00820690|Paclitaxel|paclitaxel|mesh-list
65317512|NCT00820690|Cyclophosphamide|cyclophosphamide|mesh-list
65317513|NCT00820690|Doxorubicin|doxorubicin|mesh-list
65317514|NCT00820690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65317515|NCT00820690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317516|NCT00820690|Tubulin Modulators|tubulin modulators|mesh-ancestor
65317517|NCT00820690|Antimitotic Agents|antimitotic agents|mesh-ancestor
65317518|NCT00820690|Mitosis Modulators|mitosis modulators|mesh-ancestor
65317519|NCT00820690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317520|NCT00820690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65317521|NCT00820690|Immunologic Factors|immunologic factors|mesh-ancestor
65317522|NCT00820690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317523|NCT00820690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65317524|NCT00820690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65317525|NCT00820690|Alkylating Agents|alkylating agents|mesh-ancestor
65317526|NCT00820690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65317527|NCT00820690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65317528|NCT00820690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65317529|NCT00820690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65317530|NCT00820690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317531|NCT00820768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65317532|NCT00820768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317533|NCT00624052|Amlodipine|amlodipine|mesh-list
65317545|NCT00821080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65317546|NCT00821080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65317547|NCT00821080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65317548|NCT00821080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317549|NCT00821080|Antifungal Agents|antifungal agents|mesh-ancestor
65317550|NCT00821080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65317551|NCT00821080|Immunologic Factors|immunologic factors|mesh-ancestor
65317552|NCT00821080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317553|NCT04044430|Nivolumab|nivolumab|mesh-list
65317554|NCT04044430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65317555|NCT04044430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317556|NCT04044430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65317557|NCT04044430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317558|NCT00821158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65317559|NCT00821158|Antioxidants|antioxidants|mesh-list
65317560|NCT00821158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317561|NCT00821158|Protective Agents|protective agents|mesh-ancestor
65317562|NCT00821158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067524|NCT00277862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317563|NCT02548936|Simvastatin|simvastatin|mesh-list
65317564|NCT02548936|Ezetimibe|ezetimibe|mesh-list
65317565|NCT02548936|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
65317566|NCT02548936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65317567|NCT02548936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65317568|NCT02548936|Antimetabolites|antimetabolites|mesh-ancestor
65317569|NCT02548936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317570|NCT02548936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65317589|NCT00785577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317590|NCT00785577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317591|NCT00785577|Anticonvulsants|anticonvulsants|mesh-ancestor
65317592|NCT00785577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65317593|NCT00785577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65317594|NCT00785577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317595|NCT00785577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65317596|NCT00785577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65317597|NCT00785577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65317598|NCT00785577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65317599|NCT00785577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65317600|NCT00830830|Hyaluronic Acid|hyaluronic acid|mesh-list
65317601|NCT00830830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65317602|NCT00830830|Immunologic Factors|immunologic factors|mesh-ancestor
65317603|NCT00830830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317604|NCT00830830|Viscosupplements|viscosupplements|mesh-ancestor
65317605|NCT00830830|Protective Agents|protective agents|mesh-ancestor
65317606|NCT00828958|Risperidone|risperidone|mesh-list
65317607|NCT00828958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65317608|NCT00828958|Serotonin Agents|serotonin agents|mesh-ancestor
65317609|NCT00828958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65317610|NCT00828958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317611|NCT00828958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317612|NCT00828958|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65317613|NCT00828958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65317614|NCT00828958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65317615|NCT00828958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65317616|NCT00828958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65317617|NCT00828958|Dopamine Agents|dopamine agents|mesh-ancestor
65317618|NCT02548780|Doxorubicin|doxorubicin|mesh-list
65317619|NCT02548780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64547577|NCT04846218|Progesterone|progesterone|mesh-list
65317630|NCT04105023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65317631|NCT04105023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317632|NCT04105023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317633|NCT04105023|Phytoestrogens|phytoestrogens|mesh-ancestor
65317634|NCT04105023|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65317635|NCT04105023|Estrogens|estrogens|mesh-ancestor
65317636|NCT04105023|Hormones|hormones|mesh-ancestor
65493956|NCT03913559|Autonomic Agents|autonomic agents|mesh-ancestor
65317637|NCT04105023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65317638|NCT04104867|Domperidone|domperidone|mesh-list
65317639|NCT04104867|Antiemetics|antiemetics|mesh-ancestor
65317640|NCT04104867|Autonomic Agents|autonomic agents|mesh-ancestor
65317641|NCT04104867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317642|NCT04104867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317643|NCT04104867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65317644|NCT04104867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65317645|NCT04104867|Dopamine Agents|dopamine agents|mesh-ancestor
65317646|NCT04104867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65317647|NCT04104867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317648|NCT00789828|Everolimus|everolimus|mesh-list
65317649|NCT00789828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317650|NCT00789828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65317651|NCT00789828|Immunologic Factors|immunologic factors|mesh-ancestor
65317652|NCT00789828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317653|NCT02550262|Fentanyl|fentanyl|mesh-list
65317654|NCT02550262|Bupivacaine|bupivacaine|mesh-list
65161502|NCT02858206|Tubulin Modulators|tubulin modulators|mesh-ancestor
65161503|NCT02858206|Antimitotic Agents|antimitotic agents|mesh-ancestor
65161504|NCT02858206|Mitosis Modulators|mitosis modulators|mesh-ancestor
65161505|NCT02858206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161506|NCT02858206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65161507|NCT02815189|Acetaminophen|acetaminophen|mesh-list
65161508|NCT02815189|Ibuprofen|ibuprofen|mesh-list
65161509|NCT02815189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65161510|NCT02815189|Analgesics|analgesics|mesh-ancestor
65161511|NCT02815189|Sensory System Agents|sensory system agents|mesh-ancestor
65161512|NCT02815189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161513|NCT02815189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161514|NCT02815189|Antipyretics|antipyretics|mesh-ancestor
65161515|NCT02815189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65161516|NCT02815189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65161521|NCT02809963|Eplerenone|eplerenone|mesh-list
65161522|NCT02809963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65161523|NCT02809963|Hormone Antagonists|hormone antagonists|mesh-ancestor
65161524|NCT02809963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65161525|NCT02809963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161526|NCT02809963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65317655|NCT02550262|Anesthetics, Local|anesthetics, local|mesh-ancestor
65317656|NCT02550262|Anesthetics|anesthetics|mesh-ancestor
65317657|NCT02550262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65317658|NCT02550262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317659|NCT02550262|Sensory System Agents|sensory system agents|mesh-ancestor
65317660|NCT02550262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317661|NCT02550262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65317662|NCT02550262|Narcotics|narcotics|mesh-ancestor
65317663|NCT02550262|Analgesics|analgesics|mesh-ancestor
65317664|NCT02550262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65317665|NCT02550262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65317666|NCT02550262|Anesthetics, General|anesthetics, general|mesh-ancestor
65317667|NCT02550418|Budesonide|budesonide|mesh-list
65317668|NCT02550418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65317669|NCT02550418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65317670|NCT02550418|Autonomic Agents|autonomic agents|mesh-ancestor
65317671|NCT02550418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317672|NCT02550418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317673|NCT02550418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65317674|NCT02550418|Respiratory System Agents|respiratory system agents|mesh-ancestor
65317675|NCT02550418|Glucocorticoids|glucocorticoids|mesh-ancestor
65317676|NCT02550418|Hormones|hormones|mesh-ancestor
65317677|NCT02550418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65317678|NCT00829114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65317679|NCT00829114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65317680|NCT00829114|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65317681|NCT00829114|Estradiol|estradiol|mesh-list
65317682|NCT00829114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65317683|NCT00829114|Estrogens|estrogens|mesh-ancestor
65317684|NCT00829114|Hormones|hormones|mesh-ancestor
64547591|NCT02512692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65161527|NCT02809963|Diuretics|diuretics|mesh-ancestor
65161528|NCT02809963|Natriuretic Agents|natriuretic agents|mesh-ancestor
65161529|NCT02809963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65161530|NCT02815111|Acetaminophen|acetaminophen|mesh-list
65161531|NCT02815111|Lidocaine|lidocaine|mesh-list
65161532|NCT02815111|Ketamine|ketamine|mesh-list
65161533|NCT02815111|Gabapentin|gabapentin|mesh-list
65161534|NCT02815111|Anesthetics, Local|anesthetics, local|mesh-ancestor
65161535|NCT02815111|Anesthetics|anesthetics|mesh-ancestor
65161536|NCT02815111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65161537|NCT02815111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161538|NCT02815111|Sensory System Agents|sensory system agents|mesh-ancestor
65161539|NCT02815111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161540|NCT02815111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65161541|NCT02815111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65317685|NCT00829114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65317686|NCT00829114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317687|NCT00829114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65317688|NCT00829114|Contraceptive Agents|contraceptive agents|mesh-ancestor
65317689|NCT00829114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65317690|NCT00829114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65317691|NCT00829114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65317692|NCT00829114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65317693|NCT00790296|Hormones|hormones|mesh-list
65317694|NCT00790296|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
65317695|NCT00790296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65317696|NCT00790296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317697|NCT00829192|Afamelanotide|afamelanotide|mesh-list
65317698|NCT00829192|Dermatologic Agents|dermatologic agents|mesh-ancestor
65317699|NCT00623194|Insulin|insulin|mesh-list
65161542|NCT02815111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65161543|NCT02815111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65161544|NCT02815111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161545|NCT02815111|Analgesics|analgesics|mesh-ancestor
65161546|NCT02815111|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65161547|NCT02815111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65161548|NCT02815111|Anesthetics, General|anesthetics, general|mesh-ancestor
65161549|NCT02815111|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65161550|NCT02815111|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65161551|NCT02815111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65161552|NCT02815111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65161553|NCT02815111|Antipyretics|antipyretics|mesh-ancestor
65161554|NCT02815111|Anticonvulsants|anticonvulsants|mesh-ancestor
65161555|NCT02815111|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65161556|NCT02815111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65161557|NCT02815111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65161558|NCT02815111|Antimanic Agents|antimanic agents|mesh-ancestor
65161559|NCT04236895|Insulin Glargine|insulin glargine|mesh-list
65161560|NCT04236895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65161561|NCT04236895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161562|NCT02809729|Cefazolin|cefazolin|mesh-list
65161563|NCT02809729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65161564|NCT02809729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65161565|NCT00953524|Vaccines|vaccines|mesh-list
65161566|NCT00953524|Immunologic Factors|immunologic factors|mesh-ancestor
65161567|NCT00953524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161568|NCT02809573|Prednisone|prednisone|mesh-list
65161569|NCT02809573|Cyclophosphamide|cyclophosphamide|mesh-list
65161570|NCT02809573|Vincristine|vincristine|mesh-list
65161571|NCT02809573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65161572|NCT02809573|Immunologic Factors|immunologic factors|mesh-ancestor
65161573|NCT02809573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161574|NCT02809573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65161575|NCT02809573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65161576|NCT02809573|Alkylating Agents|alkylating agents|mesh-ancestor
65161577|NCT02809573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161578|NCT02809573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161579|NCT02809573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65161580|NCT02809573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65161581|NCT02809573|Glucocorticoids|glucocorticoids|mesh-ancestor
65161582|NCT02809573|Hormones|hormones|mesh-ancestor
65161583|NCT02809573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65161584|NCT02809573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65317700|NCT00623194|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65317701|NCT00623194|Insulin Aspart|insulin aspart|mesh-list
65317702|NCT00623194|Insulin Detemir|insulin detemir|mesh-list
65317703|NCT00623194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65317704|NCT00623194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317705|NCT00784368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65317706|NCT02548468|Mycophenolic Acid|mycophenolic acid|mesh-list
65317707|NCT02548468|Cyclophosphamide|cyclophosphamide|mesh-list
65317708|NCT02548468|Fludarabine|fludarabine|mesh-list
65317709|NCT02548468|Fludarabine phosphate|fludarabine phosphate|mesh-list
65317710|NCT02548468|Tacrolimus|tacrolimus|mesh-list
65317711|NCT02548468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65317712|NCT02548468|Immunologic Factors|immunologic factors|mesh-ancestor
65317713|NCT02548468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317714|NCT02548468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65317715|NCT02548468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65317716|NCT02548468|Alkylating Agents|alkylating agents|mesh-ancestor
65317717|NCT02548468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317718|NCT02548468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317719|NCT02548468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65317720|NCT02548468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65317721|NCT02548468|Antimetabolites|antimetabolites|mesh-ancestor
65317722|NCT02548468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65317723|NCT02548468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65317724|NCT02548468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317725|NCT02548468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65161585|NCT02809573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65161586|NCT02809573|Tubulin Modulators|tubulin modulators|mesh-ancestor
65161587|NCT02809573|Antimitotic Agents|antimitotic agents|mesh-ancestor
65161595|NCT04388683|Respiratory System Agents|respiratory system agents|mesh-ancestor
65161596|NCT04388683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65161598|NCT04388683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161599|NCT04388683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65161600|NCT04388683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65161601|NCT04388683|Vasodilator Agents|vasodilator agents|mesh-ancestor
65161602|NCT04388683|Gasotransmitters|gasotransmitters|mesh-ancestor
65161603|NCT04388683|Protective Agents|protective agents|mesh-ancestor
65161604|NCT01040403|Bromides|bromides|mesh-list
65161605|NCT01040403|Tiotropium Bromide|tiotropium bromide|mesh-list
65161606|NCT01040403|Olodaterol|olodaterol|mesh-list
65161607|NCT01040403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65161608|NCT01040403|Autonomic Agents|autonomic agents|mesh-ancestor
65161609|NCT01040403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161610|NCT01040403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161611|NCT01040403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65161612|NCT01040403|Respiratory System Agents|respiratory system agents|mesh-ancestor
65161613|NCT01040403|Parasympatholytics|parasympatholytics|mesh-ancestor
65161614|NCT01040403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65161615|NCT01040403|Cholinergic Agents|cholinergic agents|mesh-ancestor
65161616|NCT01040403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65317726|NCT02548468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65317727|NCT02548468|Antitubercular Agents|antitubercular agents|mesh-ancestor
65317728|NCT02548468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65317729|NCT00829660|Acarbose|acarbose|mesh-list
65317730|NCT00829660|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65317731|NCT00829660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317732|NCT00829660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317733|NCT00829660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65317734|NCT00829660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317735|NCT00915564|Simeprevir|simeprevir|mesh-list
65317736|NCT00915564|Methadone|methadone|mesh-list
65317737|NCT00915564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65317738|NCT00915564|Narcotics|narcotics|mesh-ancestor
65317739|NCT00915564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65317740|NCT00915564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317741|NCT00915564|Analgesics|analgesics|mesh-ancestor
65317742|NCT00915564|Sensory System Agents|sensory system agents|mesh-ancestor
65317743|NCT00915564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547658|NCT05134194|Capecitabine|capecitabine|mesh-list
65161617|NCT01040403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161618|NCT01040403|Anticonvulsants|anticonvulsants|mesh-ancestor
65161619|NCT00957034|Testosterone|testosterone|mesh-list
65161620|NCT00957034|Androgens|androgens|mesh-ancestor
65161621|NCT00957034|Hormones|hormones|mesh-ancestor
65161622|NCT00957034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65161623|NCT00957034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161624|NCT02812693|Pembrolizumab|pembrolizumab|mesh-list
65161625|NCT02812693|Imatinib Mesylate|imatinib mesylate|mesh-list
65161626|NCT02812693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65161627|NCT02812693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161628|NCT02812693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65161629|NCT02812693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65161630|NCT02812693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161631|NCT04270552|Broncho-Vaxom|broncho-vaxom|mesh-list
65161632|NCT04270552|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65161633|NCT04270552|Immunologic Factors|immunologic factors|mesh-ancestor
65161634|NCT04270552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161635|NCT04237597|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
65161636|NCT04237597|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65161637|NCT04237597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161638|NCT04237597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65161639|NCT04237597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161640|NCT02090998|Lidocaine|lidocaine|mesh-list
65161641|NCT02090998|Amitriptyline|amitriptyline|mesh-list
65161642|NCT02090998|Anesthetics, Local|anesthetics, local|mesh-ancestor
65161643|NCT02090998|Anesthetics|anesthetics|mesh-ancestor
65161644|NCT02090998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65161645|NCT02090998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161646|NCT02090998|Sensory System Agents|sensory system agents|mesh-ancestor
65161647|NCT02090998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161648|NCT02090998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65161649|NCT02090998|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65161650|NCT02090998|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65317744|NCT00915564|Antitussive Agents|antitussive agents|mesh-ancestor
65317745|NCT00915564|Respiratory System Agents|respiratory system agents|mesh-ancestor
65317746|NCT00915564|Antiviral Agents|antiviral agents|mesh-ancestor
65317747|NCT00915564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65317748|NCT00915564|Protease Inhibitors|protease inhibitors|mesh-ancestor
65317749|NCT00915564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317750|NCT00915564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317751|NCT02603406|Epoetin Alfa|epoetin alfa|mesh-list
65317752|NCT02603406|Hematinics|hematinics|mesh-ancestor
65317753|NCT04106700|Apixaban|apixaban|mesh-list
65317754|NCT04106700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65317755|NCT04106700|Antithrombins|antithrombins|mesh-ancestor
65317756|NCT04106700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65317757|NCT04106700|Protease Inhibitors|protease inhibitors|mesh-ancestor
65317758|NCT04106700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317759|NCT04106700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317760|NCT04106700|Anticoagulants|anticoagulants|mesh-ancestor
65317761|NCT00831376|Albuterol|albuterol|mesh-list
65317762|NCT00831376|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65317763|NCT00831376|Autonomic Agents|autonomic agents|mesh-ancestor
65317764|NCT00831376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317765|NCT00831376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317766|NCT00831376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65161651|NCT02090998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64506313|NCT03320928|Abortifacient Agents|abortifacient agents|mesh-ancestor
65161656|NCT02090998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65161658|NCT02090998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65161659|NCT02090998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65161660|NCT02090998|Adrenergic Agents|adrenergic agents|mesh-ancestor
65161661|NCT02090998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65161662|NCT02689999|Rabeprazole|rabeprazole|mesh-list
64804284|NCT01413230|Vitamin D|vitamin d|mesh-list
65161663|NCT02689999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65161664|NCT02689999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65161665|NCT02689999|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65161666|NCT02689999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65161667|NCT02689999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161668|NCT02809105|Linaclotide|linaclotide|mesh-list
65161669|NCT02809105|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65161670|NCT02809105|Enzyme Activators|enzyme activators|mesh-ancestor
65161671|NCT02809105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161672|NCT02809105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65161673|NCT00953056|Vaccines|vaccines|mesh-list
65161674|NCT00953056|Immunologic Factors|immunologic factors|mesh-ancestor
65161675|NCT00953056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161676|NCT02811289|Mirabegron|mirabegron|mesh-list
65161677|NCT02811289|Glycerol|glycerol|mesh-list
65161678|NCT02811289|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65161679|NCT02811289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65161680|NCT02811289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65161681|NCT02811289|Adrenergic Agents|adrenergic agents|mesh-ancestor
65161682|NCT02811289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65161683|NCT02811289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317767|NCT00831376|Respiratory System Agents|respiratory system agents|mesh-ancestor
65317768|NCT00831376|Tocolytic Agents|tocolytic agents|mesh-ancestor
65317769|NCT00831376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65317770|NCT00831376|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65317771|NCT00831376|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65317772|NCT00831376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65317773|NCT00831376|Adrenergic Agents|adrenergic agents|mesh-ancestor
65317774|NCT00831376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65317775|NCT00831376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317776|NCT02602470|Metronidazole|metronidazole|mesh-list
65317777|NCT02602470|Azelaic acid|azelaic acid|mesh-list
65317778|NCT02602470|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64547700|NCT03806049|Paclitaxel|paclitaxel|mesh-list
65161684|NCT02811289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161685|NCT02811289|Urological Agents|urological agents|mesh-ancestor
65161686|NCT02811289|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65161687|NCT02811289|Protective Agents|protective agents|mesh-ancestor
65161688|NCT02808949|Dapivirine|dapivirine|mesh-list
65161689|NCT02808949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65161690|NCT02808949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65161691|NCT02808949|Antiviral Agents|antiviral agents|mesh-ancestor
65161692|NCT02808949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65161693|NCT04207177|Mycophenolic Acid|mycophenolic acid|mesh-list
65161694|NCT04207177|Tacrolimus|tacrolimus|mesh-list
65161695|NCT04207177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65161696|NCT04207177|Immunologic Factors|immunologic factors|mesh-ancestor
65161697|NCT04207177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161698|NCT04207177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65161699|NCT04207177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65161700|NCT04207177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161701|NCT04207177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65161702|NCT04207177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161703|NCT04207177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65161704|NCT04207177|Antitubercular Agents|antitubercular agents|mesh-ancestor
65161705|NCT04207177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65161706|NCT04207177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65161707|NCT02812147|Droxidopa|droxidopa|mesh-list
65161708|NCT02812147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65161709|NCT02812147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65161710|NCT04303065|Dexamethasone|dexamethasone|mesh-list
65161711|NCT04303065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65161712|NCT04303065|Antiemetics|antiemetics|mesh-ancestor
65161713|NCT04303065|Autonomic Agents|autonomic agents|mesh-ancestor
65161714|NCT04303065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161715|NCT04303065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161716|NCT04303065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65161717|NCT04303065|Glucocorticoids|glucocorticoids|mesh-ancestor
65161718|NCT04303065|Hormones|hormones|mesh-ancestor
65161719|NCT04303065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65161720|NCT04303065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64506384|NCT03315000|Xhance|xhance|mesh-list
65161727|NCT02854072|Capecitabine|capecitabine|mesh-list
65161728|NCT02854072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65161729|NCT02854072|Antimetabolites|antimetabolites|mesh-ancestor
65161730|NCT02854072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161731|NCT02854072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161732|NCT02854072|Antiviral Agents|antiviral agents|mesh-ancestor
65161733|NCT02854072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65161734|NCT02854072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65161735|NCT02854072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65161736|NCT02854072|Immunologic Factors|immunologic factors|mesh-ancestor
65161737|NCT02854072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161738|NCT02537314|Benzocaine|benzocaine|mesh-list
65161739|NCT02537314|Anesthetics, Local|anesthetics, local|mesh-ancestor
64547719|NCT00089479|Docetaxel|docetaxel|mesh-list
65317779|NCT02602470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65317780|NCT02602470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65317781|NCT02602470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65317782|NCT02602470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65317783|NCT02602470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65317784|NCT02602470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65317785|NCT02602470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65317786|NCT02602470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65317787|NCT02602470|Adrenergic Agents|adrenergic agents|mesh-ancestor
65317788|NCT02602470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65067751|NCT00316095|Telmisartan|telmisartan|mesh-list
65317789|NCT02602470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317790|NCT02602470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317791|NCT02602470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317792|NCT02602470|Dermatologic Agents|dermatologic agents|mesh-ancestor
65317793|NCT00824200|Tamsulosin|tamsulosin|mesh-list
65317794|NCT00824200|Adrenergic Agents|adrenergic agents|mesh-list
65317795|NCT00824200|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
65317796|NCT00824200|Adrenergic Antagonists|adrenergic antagonists|mesh-list
65161741|NCT02537314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65161742|NCT02537314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161743|NCT02537314|Sensory System Agents|sensory system agents|mesh-ancestor
65161744|NCT02537314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161745|NCT00631150|Levetiracetam|levetiracetam|mesh-list
65161746|NCT00631150|Anticonvulsants|anticonvulsants|mesh-ancestor
65161747|NCT00631150|Nootropic Agents|nootropic agents|mesh-ancestor
65161749|NCT04278040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65161750|NCT04278040|Alkylating Agents|alkylating agents|mesh-ancestor
65161751|NCT04278040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161752|NCT04278040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161753|NCT04278040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65161754|NCT04278040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65161755|NCT04278040|Immunologic Factors|immunologic factors|mesh-ancestor
65161756|NCT04278040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161757|NCT02856724|Dinoprostone|dinoprostone|mesh-list
65161758|NCT02856724|Oxytocics|oxytocics|mesh-ancestor
65161759|NCT02856724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65161760|NCT02856724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161761|NCT02808325|Polygeline|polygeline|mesh-list
65161762|NCT02808325|Plasma Substitutes|plasma substitutes|mesh-ancestor
65161763|NCT02808325|Blood Substitutes|blood substitutes|mesh-ancestor
65161764|NCT00955474|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65161765|NCT00955474|Citalopram|citalopram|mesh-list
65161766|NCT00955474|Sertraline|sertraline|mesh-list
65161767|NCT00955474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65161768|NCT00955474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65161769|NCT00955474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65161770|NCT00955474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161771|NCT00955474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65161772|NCT00955474|Serotonin Agents|serotonin agents|mesh-ancestor
65161773|NCT00955474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161774|NCT00955474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65161775|NCT00955474|Antidepressive Agents|antidepressive agents|mesh-ancestor
65161776|NCT00955474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65161777|NCT00955474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65317797|NCT00824200|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65317798|NCT00824200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65317799|NCT00824200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317800|NCT00824200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317801|NCT00824200|Urological Agents|urological agents|mesh-ancestor
65317802|NCT00829894|Risperidone|risperidone|mesh-list
65317803|NCT00829894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65317804|NCT00829894|Serotonin Agents|serotonin agents|mesh-ancestor
65317805|NCT00829894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65317806|NCT00829894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317807|NCT00829894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317808|NCT00829894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65317809|NCT00829894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65317810|NCT00829894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65317811|NCT00829894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65317812|NCT00829894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65317813|NCT00829894|Dopamine Agents|dopamine agents|mesh-ancestor
65161778|NCT00955474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65161779|NCT00955474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65161780|NCT02808247|Ifosfamide|ifosfamide|mesh-list
65161781|NCT02808247|Nintedanib|nintedanib|mesh-list
65161782|NCT02808247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65161783|NCT02808247|Alkylating Agents|alkylating agents|mesh-ancestor
65161784|NCT02808247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161785|NCT02808247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161786|NCT02808247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65161787|NCT02808247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65161788|NCT02808091|Bortezomib|bortezomib|mesh-list
65161789|NCT02808091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161790|NCT02811991|Acetaminophen|acetaminophen|mesh-list
65161791|NCT02811991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65161792|NCT02811991|Analgesics|analgesics|mesh-ancestor
64506451|NCT02486640|Interferon-beta|interferon-beta|mesh-list
65161823|NCT02804815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65161824|NCT02804815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65161825|NCT02804815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65161826|NCT02804815|Antipyretics|antipyretics|mesh-ancestor
65161827|NCT04017247|Oxytocin|oxytocin|mesh-list
65161828|NCT04017247|Oxytocics|oxytocics|mesh-ancestor
65161829|NCT04017247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65161830|NCT04017247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161831|NCT02814409|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65161832|NCT02814409|Plasminogen|plasminogen|mesh-list
65161833|NCT02814409|Tenecteplase|tenecteplase|mesh-list
65161839|NCT01227902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65161840|NCT01227902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161841|NCT00946192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65161842|NCT00946192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65161843|NCT00946192|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65161844|NCT00946192|Desogestrel|desogestrel|mesh-list
65161845|NCT00946192|Estradiol|estradiol|mesh-list
65161846|NCT00946192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65161847|NCT00946192|Progesterone|progesterone|mesh-list
65161848|NCT00946192|Estrogens|estrogens|mesh-ancestor
65161849|NCT00946192|Hormones|hormones|mesh-ancestor
65161850|NCT00946192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65161851|NCT00946192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161852|NCT00946192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65317814|NCT00622726|Bevacizumab|bevacizumab|mesh-list
65317815|NCT00622726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65317816|NCT00622726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317817|NCT00622726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65317818|NCT00622726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65317819|NCT00622726|Growth Substances|growth substances|mesh-ancestor
65317820|NCT00622726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317821|NCT00622726|Growth Inhibitors|growth inhibitors|mesh-ancestor
65317822|NCT00830050|Naproxen|naproxen|mesh-list
65317823|NCT00830050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65317824|NCT00830050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65317825|NCT00830050|Analgesics|analgesics|mesh-ancestor
65317826|NCT00830050|Sensory System Agents|sensory system agents|mesh-ancestor
65317827|NCT00830050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317828|NCT00830050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317829|NCT00830050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65317830|NCT00830050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65317831|NCT00830050|Gout Suppressants|gout suppressants|mesh-ancestor
65317832|NCT00830050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65317833|NCT00830050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547744|NCT00765375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65161853|NCT00946192|Contraceptive Agents|contraceptive agents|mesh-ancestor
65161854|NCT00946192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65161855|NCT00946192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65161856|NCT00946192|Progestins|progestins|mesh-ancestor
65161857|NCT00946192|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65161858|NCT00946192|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65161859|NCT00946192|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65161860|NCT01037127|Trametinib|trametinib|mesh-list
65161861|NCT01037127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161862|NCT01037127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65161863|NCT01037127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65161864|NCT01037127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161865|NCT02806999|Insulin|insulin|mesh-list
65161866|NCT02806999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65161867|NCT02806999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65161868|NCT02806999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161869|NCT00946114|Sildenafil Citrate|sildenafil citrate|mesh-list
65161870|NCT00946114|Vasodilator Agents|vasodilator agents|mesh-ancestor
65161871|NCT00946114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65161872|NCT00946114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65161873|NCT00946114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65161874|NCT00946114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161875|NCT00946114|Urological Agents|urological agents|mesh-ancestor
65161876|NCT00627471|Insulin|insulin|mesh-list
65161877|NCT00627471|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65161878|NCT00627471|Insulin Glargine|insulin glargine|mesh-list
65161879|NCT00627471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65161880|NCT00627471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161881|NCT04302441|Capecitabine|capecitabine|mesh-list
65161882|NCT04302441|Vinorelbine|vinorelbine|mesh-list
65161883|NCT04302441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65161884|NCT04302441|Antimetabolites|antimetabolites|mesh-ancestor
65317834|NCT00830050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317835|NCT00623428|Ribavirin|ribavirin|mesh-list
65317836|NCT00623428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65317837|NCT00623428|Antimetabolites|antimetabolites|mesh-ancestor
65317838|NCT00623428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317839|NCT00623428|Antiviral Agents|antiviral agents|mesh-ancestor
65317840|NCT00623428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65317841|NCT00824668|Insulin|insulin|mesh-list
65317842|NCT00824668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65317843|NCT00824668|Insulin Glargine|insulin glargine|mesh-list
65317844|NCT00824668|Insulin Aspart|insulin aspart|mesh-list
65317845|NCT00824668|Biphasic Insulins|biphasic insulins|mesh-list
65317846|NCT00824668|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65161885|NCT04302441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161886|NCT04302441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161887|NCT04302441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65161888|NCT04302441|Tubulin Modulators|tubulin modulators|mesh-ancestor
65161889|NCT04302441|Antimitotic Agents|antimitotic agents|mesh-ancestor
65161890|NCT04302441|Mitosis Modulators|mitosis modulators|mesh-ancestor
65161891|NCT02800447|Procarbazine|procarbazine|mesh-list
65161892|NCT02800447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161893|NCT05520619|Paclitaxel|paclitaxel|mesh-list
65161894|NCT05520619|Cisplatin|cisplatin|mesh-list
65161895|NCT05520619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65161896|NCT05520619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161897|NCT05520619|Tubulin Modulators|tubulin modulators|mesh-ancestor
65161898|NCT05520619|Antimitotic Agents|antimitotic agents|mesh-ancestor
65161899|NCT05520619|Mitosis Modulators|mitosis modulators|mesh-ancestor
65161900|NCT05520619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161901|NCT01038921|Melatonin|melatonin|mesh-list
65161902|NCT01038921|Antioxidants|antioxidants|mesh-ancestor
65161903|NCT01038921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161904|NCT01038921|Protective Agents|protective agents|mesh-ancestor
65161920|NCT02856568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65161922|NCT02856568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161923|NCT02856568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65161924|NCT04081831|Aspirin|aspirin|mesh-list
65161925|NCT04081831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65161926|NCT04081831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65161927|NCT04081831|Analgesics|analgesics|mesh-ancestor
65161928|NCT04081831|Sensory System Agents|sensory system agents|mesh-ancestor
65161929|NCT04081831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161930|NCT04081831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161931|NCT04081831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65161932|NCT04081831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65161933|NCT04081831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65161934|NCT04081831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65161935|NCT04081831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161936|NCT04081831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65161937|NCT04081831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65161938|NCT04081831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65161939|NCT04081831|Antipyretics|antipyretics|mesh-ancestor
65161940|NCT01081912|Hydrocodone|hydrocodone|mesh-list
65161941|NCT01081912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65161942|NCT01081912|Narcotics|narcotics|mesh-ancestor
65161943|NCT01081912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65161944|NCT01081912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161945|NCT01081912|Analgesics|analgesics|mesh-ancestor
65161946|NCT01081912|Sensory System Agents|sensory system agents|mesh-ancestor
65161947|NCT01081912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161948|NCT01081912|Antitussive Agents|antitussive agents|mesh-ancestor
65317847|NCT00824668|Insulin glulisine|insulin glulisine|mesh-list
65317848|NCT00824668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65317849|NCT00824668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317850|NCT00832234|Dexamethasone|dexamethasone|mesh-list
65317851|NCT00832234|Rituximab|rituximab|mesh-list
65317852|NCT00832234|Bortezomib|bortezomib|mesh-list
65317853|NCT00832234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65317854|NCT00832234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317855|NCT00832234|Immunologic Factors|immunologic factors|mesh-ancestor
65317856|NCT00832234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317857|NCT00832234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65317858|NCT00832234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65317859|NCT00832234|Antiemetics|antiemetics|mesh-ancestor
65317860|NCT00832234|Autonomic Agents|autonomic agents|mesh-ancestor
65317861|NCT00832234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317862|NCT00832234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65317863|NCT00832234|Glucocorticoids|glucocorticoids|mesh-ancestor
65317865|NCT00832234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65317866|NCT00832234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65317867|NCT05036980|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
65317868|NCT05036980|Antioxidants|antioxidants|mesh-ancestor
65317869|NCT05036980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317870|NCT05036980|Protective Agents|protective agents|mesh-ancestor
65317871|NCT05036980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547778|NCT05744115|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65161949|NCT01081912|Respiratory System Agents|respiratory system agents|mesh-ancestor
65161950|NCT01038609|Acetaminophen|acetaminophen|mesh-list
65161951|NCT01038609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65161952|NCT01038609|Morphine|morphine|mesh-list
65161953|NCT01038609|Hydrocodone|hydrocodone|mesh-list
65161954|NCT01038609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65161955|NCT01038609|Narcotics|narcotics|mesh-ancestor
65161956|NCT01038609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65161957|NCT01038609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161958|NCT01038609|Analgesics|analgesics|mesh-ancestor
65161959|NCT01038609|Sensory System Agents|sensory system agents|mesh-ancestor
65161960|NCT01038609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161961|NCT01038609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65161962|NCT01038609|Antipyretics|antipyretics|mesh-ancestor
64804587|NCT01415765|Immunologic Factors|immunologic factors|mesh-ancestor
64506626|NCT05713578|Docetaxel|docetaxel|mesh-list
65161983|NCT02853526|Warfarin|warfarin|mesh-list
65161984|NCT02853526|Anticoagulants|anticoagulants|mesh-ancestor
65161985|NCT02853526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65161986|NCT02853526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65161987|NCT02853526|Adrenergic Agents|adrenergic agents|mesh-ancestor
65161988|NCT02853526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65161989|NCT02853526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161990|NCT02853526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161991|NCT02853526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65161992|NCT02853526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65317872|NCT05036980|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65317873|NCT05036980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317874|NCT00837850|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
65317875|NCT00837850|Vasodilator Agents|vasodilator agents|mesh-ancestor
65317876|NCT00837850|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65317877|NCT00837850|Protective Agents|protective agents|mesh-ancestor
65317878|NCT00837850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317879|NCT00784134|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65317880|NCT00784134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65317881|NCT00784134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65317882|NCT00784134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317883|NCT00837928|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65317884|NCT00837928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65317885|NCT00837928|Alkylating Agents|alkylating agents|mesh-ancestor
65317886|NCT00837928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317887|NCT00837928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317888|NCT05565378|Pembrolizumab|pembrolizumab|mesh-list
65317889|NCT05565378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65317890|NCT05565378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317891|NCT04102566|Ibuprofen|ibuprofen|mesh-list
65317892|NCT04102566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65317893|NCT04102566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65317894|NCT04102566|Analgesics|analgesics|mesh-ancestor
65317895|NCT04102566|Sensory System Agents|sensory system agents|mesh-ancestor
65317896|NCT04102566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65317897|NCT04102566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317898|NCT04102566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65317899|NCT04102566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65317900|NCT04102566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65317901|NCT04102566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317902|NCT04102566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317903|NCT04102176|Tin Fluorides|tin fluorides|mesh-list
65317912|NCT00783432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65317913|NCT00783432|Respiratory System Agents|respiratory system agents|mesh-ancestor
65317914|NCT00783432|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65317915|NCT00783432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317916|NCT00783432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317917|NCT00783432|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65317918|NCT00783432|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65317919|NCT00783432|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65317920|NCT00783432|Histamine Antagonists|histamine antagonists|mesh-ancestor
65317921|NCT00783432|Histamine Agents|histamine agents|mesh-ancestor
65317922|NCT00783432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65317923|NCT00789360|Loxapine|loxapine|mesh-list
65317924|NCT00789360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65317925|NCT00789360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65317926|NCT00789360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65317927|NCT00789360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317928|NCT00789360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65317929|NCT00789360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65317930|NCT00789360|Dopamine Agents|dopamine agents|mesh-ancestor
65317931|NCT00789360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65161993|NCT02853526|Vasodilator Agents|vasodilator agents|mesh-ancestor
65161994|NCT00630682|Dextroamphetamine|dextroamphetamine|mesh-list
65161995|NCT00630682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65161996|NCT00630682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161997|NCT00630682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65161998|NCT00630682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65161999|NCT00630682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65162000|NCT00630682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162001|NCT00630682|Dopamine Agents|dopamine agents|mesh-ancestor
65162002|NCT00630682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65162003|NCT04269460|Bupivacaine|bupivacaine|mesh-list
65162004|NCT04269460|Anesthetics, Local|anesthetics, local|mesh-ancestor
65162005|NCT04269460|Anesthetics|anesthetics|mesh-ancestor
65162006|NCT04269460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65162007|NCT04269460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162008|NCT04269460|Sensory System Agents|sensory system agents|mesh-ancestor
65162009|NCT04269460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65162010|NCT04236115|Felypressin|felypressin|mesh-list
65162011|NCT04236115|Carticaine|carticaine|mesh-list
65162012|NCT04236115|Anesthetics, Local|anesthetics, local|mesh-ancestor
65162013|NCT04236115|Anesthetics|anesthetics|mesh-ancestor
65162014|NCT04236115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65162015|NCT04236115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162016|NCT04236115|Sensory System Agents|sensory system agents|mesh-ancestor
65162017|NCT04236115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64506682|NCT02480946|Antimetabolites|antimetabolites|mesh-ancestor
65162025|NCT02853370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65162026|NCT02853370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65162027|NCT02853370|Alkylating Agents|alkylating agents|mesh-ancestor
65162028|NCT02853370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162029|NCT02690155|Vitamin K|vitamin k|mesh-list
65162030|NCT02690155|Rivaroxaban|rivaroxaban|mesh-list
65162031|NCT02690155|Vitamins|vitamins|mesh-ancestor
65162032|NCT02690155|Micronutrients|micronutrients|mesh-ancestor
65162033|NCT02690155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317932|NCT00789360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317933|NCT05526924|Fluorouracil|fluorouracil|mesh-list
65317934|NCT05526924|Hydroxyurea|hydroxyurea|mesh-list
65317935|NCT05526924|Antimetabolites|antimetabolites|mesh-ancestor
65067901|NCT00316407|Tubulin Modulators|tubulin modulators|mesh-ancestor
65317936|NCT05526924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317937|NCT05526924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65317938|NCT05526924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317939|NCT05526924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65317940|NCT05526924|Immunologic Factors|immunologic factors|mesh-ancestor
65317941|NCT05526924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317942|NCT05526924|Antisickling Agents|antisickling agents|mesh-ancestor
65317943|NCT05526924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317944|NCT05526924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65317945|NCT00782418|Exenatide|exenatide|mesh-list
65317946|NCT00782418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65317947|NCT00782418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317948|NCT00782418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65317949|NCT00782418|Incretins|incretins|mesh-ancestor
65317950|NCT00782418|Hormones|hormones|mesh-ancestor
65317951|NCT00782418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65317952|NCT00782340|Droxidopa|droxidopa|mesh-list
65317953|NCT00782340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65317954|NCT00782340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65317955|NCT00774852|Prednisone|prednisone|mesh-list
65317956|NCT00774852|Cyclophosphamide|cyclophosphamide|mesh-list
65317957|NCT00774852|Abatacept|abatacept|mesh-list
65317958|NCT00774852|Azathioprine|azathioprine|mesh-list
65317959|NCT00774852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65317960|NCT00774852|Immunologic Factors|immunologic factors|mesh-ancestor
65317961|NCT00774852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317962|NCT00774852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65317963|NCT00774852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65317964|NCT00774852|Alkylating Agents|alkylating agents|mesh-ancestor
65317966|NCT00774852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65317971|NCT00774852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65317972|NCT00774852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65317973|NCT00774852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65317974|NCT00774852|Antimetabolites|antimetabolites|mesh-ancestor
65317975|NCT00774852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65317976|NCT00774306|Phenytoin|phenytoin|mesh-list
65317977|NCT00774306|Levetiracetam|levetiracetam|mesh-list
65317978|NCT00774306|Valproic Acid|valproic acid|mesh-list
65317979|NCT00774306|Anticonvulsants|anticonvulsants|mesh-ancestor
65317980|NCT00774306|Nootropic Agents|nootropic agents|mesh-ancestor
65317981|NCT00774306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65317982|NCT00774306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65317983|NCT00774306|GABA Agents|gaba agents|mesh-ancestor
65317984|NCT00774306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65317985|NCT00774306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317986|NCT00774306|Antimanic Agents|antimanic agents|mesh-ancestor
65317987|NCT00774306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65317988|NCT00774306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65317989|NCT00774306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65317990|NCT00774306|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65317991|NCT00774306|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65317992|NCT00774306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65317993|NCT00774306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65317994|NCT00774306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65317995|NCT04105920|Hyaluronic Acid|hyaluronic acid|mesh-list
65317996|NCT04105920|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65317997|NCT04105920|Immunologic Factors|immunologic factors|mesh-ancestor
65317998|NCT04105920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65317999|NCT04105920|Viscosupplements|viscosupplements|mesh-ancestor
65318000|NCT04105920|Protective Agents|protective agents|mesh-ancestor
65318001|NCT04105764|Bromides|bromides|mesh-list
65318013|NCT00781326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318014|NCT00781326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65318015|NCT00781326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318016|NCT00781326|Vasodilator Agents|vasodilator agents|mesh-ancestor
65318017|NCT00773838|Dexamethasone|dexamethasone|mesh-list
65318018|NCT00773838|Bortezomib|bortezomib|mesh-list
65318019|NCT00773838|Vorinostat|vorinostat|mesh-list
65318020|NCT00773838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65318021|NCT00773838|Antiemetics|antiemetics|mesh-ancestor
65318022|NCT00773838|Autonomic Agents|autonomic agents|mesh-ancestor
65318023|NCT00773838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65318024|NCT00773838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318025|NCT00773838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65318026|NCT00773838|Glucocorticoids|glucocorticoids|mesh-ancestor
65318027|NCT00773838|Hormones|hormones|mesh-ancestor
65318028|NCT00773838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65318029|NCT00773838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65318030|NCT00773838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318031|NCT00773838|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65318032|NCT00773838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318033|NCT00773838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318034|NCT00787644|Pioglitazone|pioglitazone|mesh-list
65318035|NCT00787644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65318036|NCT00787644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318037|NCT02602002|Remifentanil|remifentanil|mesh-list
65318038|NCT02602002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65318039|NCT02602002|Narcotics|narcotics|mesh-ancestor
65318040|NCT02602002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65318041|NCT02602002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318042|NCT02602002|Analgesics|analgesics|mesh-ancestor
65318043|NCT02602002|Sensory System Agents|sensory system agents|mesh-ancestor
65318044|NCT02602002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65318045|NCT00787566|Granisetron|granisetron|mesh-list
65318046|NCT00787566|Antiemetics|antiemetics|mesh-ancestor
65318047|NCT00787566|Autonomic Agents|autonomic agents|mesh-ancestor
65318048|NCT00787566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65318049|NCT00787566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162034|NCT02690155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65318050|NCT00787566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65318051|NCT00787566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65318052|NCT00787566|Serotonin Agents|serotonin agents|mesh-ancestor
65318053|NCT00787566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65318054|NCT00787566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318055|NCT02602938|Aspirin|aspirin|mesh-list
65318056|NCT02602938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65318057|NCT02602938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65318058|NCT02602938|Analgesics|analgesics|mesh-ancestor
65318059|NCT02602938|Sensory System Agents|sensory system agents|mesh-ancestor
65318060|NCT02602938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65318061|NCT02602938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318062|NCT02602938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65318063|NCT02602938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65318064|NCT02602938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65318065|NCT02602938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65318066|NCT02602938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318067|NCT02602938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65318068|NCT02602938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65318069|NCT02602938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318070|NCT02602938|Antipyretics|antipyretics|mesh-ancestor
65318071|NCT00787254|Lansoprazole|lansoprazole|mesh-list
65318072|NCT00787254|Dexlansoprazole|dexlansoprazole|mesh-list
65318073|NCT00787254|Gefarnate|gefarnate|mesh-list
65318074|NCT00787254|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65318075|NCT00787254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65318076|NCT00787254|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65318077|NCT00787254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318078|NCT00787254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318079|NCT00922402|Insulin|insulin|mesh-list
65162035|NCT02690155|Antithrombins|antithrombins|mesh-ancestor
65162036|NCT02690155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65162037|NCT02690155|Protease Inhibitors|protease inhibitors|mesh-ancestor
65162038|NCT02690155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162039|NCT02690155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162040|NCT02690155|Anticoagulants|anticoagulants|mesh-ancestor
65162041|NCT02690155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65162042|NCT02690155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65162043|NCT02690155|Hemostatics|hemostatics|mesh-ancestor
65162044|NCT02690155|Coagulants|coagulants|mesh-ancestor
65162045|NCT02806375|Cyclophosphamide|cyclophosphamide|mesh-list
65162046|NCT02806375|Busulfan|busulfan|mesh-list
65162047|NCT02806375|Fludarabine|fludarabine|mesh-list
65162048|NCT02806375|Fludarabine phosphate|fludarabine phosphate|mesh-list
65162049|NCT02806375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65162050|NCT02806375|Immunologic Factors|immunologic factors|mesh-ancestor
65318080|NCT00922402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65318081|NCT00922402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318082|NCT02550028|Levetiracetam|levetiracetam|mesh-list
65318083|NCT02550028|Phenobarbital|phenobarbital|mesh-list
65318084|NCT02550028|Anticonvulsants|anticonvulsants|mesh-ancestor
65318085|NCT02550028|Nootropic Agents|nootropic agents|mesh-ancestor
65318086|NCT02550028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65318087|NCT02550028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65318088|NCT02550028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318089|NCT02550028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65318090|NCT02550028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65318091|NCT02550028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65318092|NCT02550028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318093|NCT02550028|GABA Modulators|gaba modulators|mesh-ancestor
65318094|NCT02550028|GABA Agents|gaba agents|mesh-ancestor
65318095|NCT02550028|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65318096|NCT02550028|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65318097|NCT02550028|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65318098|NCT04105374|Flucytosine|flucytosine|mesh-list
65318099|NCT04105374|Temozolomide|temozolomide|mesh-list
65318100|NCT04105374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65318101|NCT04105374|Alkylating Agents|alkylating agents|mesh-ancestor
65318102|NCT04105374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318103|NCT04105374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318104|NCT04105374|Antifungal Agents|antifungal agents|mesh-ancestor
65318105|NCT04105374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65318106|NCT04105374|Antimetabolites|antimetabolites|mesh-ancestor
65318107|NCT00825058|Paroxetine|paroxetine|mesh-list
65318108|NCT00825058|Amibegron|amibegron|mesh-list
65318109|NCT00825058|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65318110|NCT00825058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65318111|NCT00825058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65318112|NCT00825058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318113|NCT00825058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65318114|NCT00825058|Serotonin Agents|serotonin agents|mesh-ancestor
65318117|NCT00825058|Antidepressive Agents|antidepressive agents|mesh-ancestor
65318118|NCT00825058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65318119|NCT00825058|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65318120|NCT00825058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65318121|NCT00825058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318122|NCT00825058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65318123|NCT00825058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65318124|NCT00825058|Adrenergic Agents|adrenergic agents|mesh-ancestor
65318125|NCT04102878|Anesthetics|anesthetics|mesh-list
65318126|NCT04102878|Anesthetics, Local|anesthetics, local|mesh-list
65318127|NCT04102878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65318128|NCT04102878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318129|NCT04102878|Sensory System Agents|sensory system agents|mesh-ancestor
65318130|NCT04102878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65318131|NCT00838240|Cytarabine|cytarabine|mesh-list
65318132|NCT00838240|Clofarabine|clofarabine|mesh-list
65318133|NCT00838240|Idarubicin|idarubicin|mesh-list
65318134|NCT00838240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65318135|NCT00838240|Antimetabolites|antimetabolites|mesh-ancestor
65318136|NCT00838240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318137|NCT00838240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318138|NCT00838240|Antiviral Agents|antiviral agents|mesh-ancestor
65318139|NCT00838240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65318140|NCT00838240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65318141|NCT00838240|Immunologic Factors|immunologic factors|mesh-ancestor
65318142|NCT00838240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318143|NCT00838240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65318144|NCT00838240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65318145|NCT00838240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65318146|NCT00838240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318147|NCT00773292|Cyclosporine|cyclosporine|mesh-list
65318148|NCT00773292|Cyclosporins|cyclosporins|mesh-list
65318149|NCT00773292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318150|NCT00773292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318151|NCT00773292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65318158|NCT00773292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65318159|NCT00838396|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
65318160|NCT00838396|Baclofen|baclofen|mesh-list
65318161|NCT00838396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65318162|NCT00838396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318163|NCT00838396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65318164|NCT00838396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65318165|NCT00838396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65318166|NCT00838396|GABA Agonists|gaba agonists|mesh-ancestor
65318167|NCT00838396|GABA Agents|gaba agents|mesh-ancestor
65318168|NCT00838396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65318169|NCT00838396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318170|NCT00838864|Ceftriaxone|ceftriaxone|mesh-list
65318171|NCT00838864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65318172|NCT00838864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65318173|NCT00833326|Docetaxel|docetaxel|mesh-list
65318174|NCT00833326|Antimitotic Agents|antimitotic agents|mesh-list
65318175|NCT00833326|Mitogens|mitogens|mesh-list
65318176|NCT00833326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318177|NCT00833326|Tubulin Modulators|tubulin modulators|mesh-ancestor
65318178|NCT00833326|Mitosis Modulators|mitosis modulators|mesh-ancestor
65318179|NCT00833326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318180|NCT00833404|Nicotine|nicotine|mesh-list
65318181|NCT00833404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65318182|NCT00833404|Autonomic Agents|autonomic agents|mesh-ancestor
65318183|NCT00833404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65318184|NCT00833404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318185|NCT00833404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65318186|NCT00833404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65318187|NCT00833404|Cholinergic Agents|cholinergic agents|mesh-ancestor
65318188|NCT00833404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65318190|NCT00621322|Vaccines|vaccines|mesh-list
65318202|NCT00839488|Histamine Agents|histamine agents|mesh-ancestor
65318203|NCT00839488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65318204|NCT00839488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318205|NCT00834184|Nikkomycin|nikkomycin|mesh-list
65318206|NCT00834184|Antifungal Agents|antifungal agents|mesh-ancestor
65318207|NCT00834184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65318208|NCT00834184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318209|NCT00834184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318210|NCT00834262|Insulin|insulin|mesh-list
65318211|NCT00834262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65318212|NCT00834262|Insulin Aspart|insulin aspart|mesh-list
65318213|NCT00834262|Insulin, Long-Acting|insulin, long-acting|mesh-list
65318214|NCT00834262|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65318215|NCT00834262|Biphasic Insulins|biphasic insulins|mesh-list
65318216|NCT00834262|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65318217|NCT00834262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65318218|NCT00834262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318219|NCT00853385|Adalimumab|adalimumab|mesh-list
65318220|NCT00853385|Tofacitinib|tofacitinib|mesh-list
65318221|NCT00853385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65318222|NCT00853385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65318223|NCT00853385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65318224|NCT00853385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318225|NCT00853385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318226|NCT00622336|Lenalidomide|lenalidomide|mesh-list
65318227|NCT00622336|Immunologic Factors|immunologic factors|mesh-ancestor
65162051|NCT02806375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162052|NCT02806375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65162053|NCT02806375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65162054|NCT02806375|Alkylating Agents|alkylating agents|mesh-ancestor
65162055|NCT02806375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162056|NCT02806375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162057|NCT02806375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65162058|NCT02806375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65162059|NCT02806375|Antimetabolites|antimetabolites|mesh-ancestor
65162060|NCT04273984|Misoprostol|misoprostol|mesh-list
65162061|NCT04273984|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65162062|NCT04273984|Abortifacient Agents|abortifacient agents|mesh-ancestor
65162063|NCT04273984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65162064|NCT04273984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162065|NCT04273984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65162066|NCT04273984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65162067|NCT04273984|Oxytocics|oxytocics|mesh-ancestor
65162068|NCT00943852|Losartan|losartan|mesh-list
65162069|NCT00943852|Isosorbide|isosorbide|mesh-list
65162070|NCT00943852|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65162071|NCT00943852|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65162072|NCT00943852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65318228|NCT00622336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318229|NCT00622336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65318230|NCT00622336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65318231|NCT00622336|Growth Substances|growth substances|mesh-ancestor
65318232|NCT00622336|Growth Inhibitors|growth inhibitors|mesh-ancestor
65318233|NCT00622336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318234|NCT00846365|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65318235|NCT00846365|Olmesartan|olmesartan|mesh-list
65318236|NCT00846365|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65318237|NCT00846365|Chlorthalidone|chlorthalidone|mesh-list
65318238|NCT00846365|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65318239|NCT00846365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65318240|NCT00846365|Diuretics|diuretics|mesh-ancestor
65318241|NCT00846365|Natriuretic Agents|natriuretic agents|mesh-ancestor
65318242|NCT00846365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318243|NCT00846365|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65318244|NCT00846365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65318245|NCT00846365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318246|NCT00846365|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65318247|NCT00846365|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65318248|NCT00834730|Ketamine|ketamine|mesh-list
65318249|NCT00834730|Analgesics|analgesics|mesh-ancestor
65318250|NCT00834730|Sensory System Agents|sensory system agents|mesh-ancestor
65318251|NCT00834730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65318252|NCT00834730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318253|NCT00834730|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65318254|NCT00834730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65318255|NCT00834730|Anesthetics, General|anesthetics, general|mesh-ancestor
65318256|NCT00834730|Anesthetics|anesthetics|mesh-ancestor
65318257|NCT00834730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65318258|NCT00834730|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65318259|NCT00834730|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65162073|NCT00943852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65162074|NCT00943852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65162075|NCT00943852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65162076|NCT00943852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162077|NCT00943852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65162078|NCT00943852|Diuretics|diuretics|mesh-ancestor
65162079|NCT00943852|Natriuretic Agents|natriuretic agents|mesh-ancestor
65162080|NCT00943852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162081|NCT00943852|Vasodilator Agents|vasodilator agents|mesh-ancestor
65318260|NCT00834730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65318261|NCT00834730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318262|NCT02601924|Anesthetics|anesthetics|mesh-list
65318263|NCT02601924|Anesthetics, Local|anesthetics, local|mesh-list
65318264|NCT02601924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65318265|NCT02601924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318266|NCT02601924|Sensory System Agents|sensory system agents|mesh-ancestor
65318267|NCT02601924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65318268|NCT00840112|Vitamin E|vitamin e|mesh-list
65318269|NCT00840112|Tocopherols|tocopherols|mesh-list
65318270|NCT00840112|alpha-Tocopherol|alpha-tocopherol|mesh-list
65318271|NCT00840112|Vitamins|vitamins|mesh-ancestor
65318272|NCT00840112|Micronutrients|micronutrients|mesh-ancestor
65318273|NCT00840112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318274|NCT00840112|Antioxidants|antioxidants|mesh-ancestor
65318275|NCT00840112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318276|NCT00840112|Protective Agents|protective agents|mesh-ancestor
65318277|NCT04101474|Ketamine|ketamine|mesh-list
65318278|NCT04101474|Analgesics|analgesics|mesh-ancestor
65318279|NCT04101474|Sensory System Agents|sensory system agents|mesh-ancestor
65318280|NCT04101474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65318281|NCT04101474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318282|NCT04101474|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65318283|NCT04101474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65318284|NCT04101474|Anesthetics, General|anesthetics, general|mesh-ancestor
65318285|NCT04101474|Anesthetics|anesthetics|mesh-ancestor
65318286|NCT04101474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65318287|NCT04101474|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65318288|NCT04101474|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65318289|NCT04101474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65318290|NCT04101474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318291|NCT04101708|Amoxicillin|amoxicillin|mesh-list
65318292|NCT04101708|Clarithromycin|clarithromycin|mesh-list
65318293|NCT04101708|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
65318294|NCT04101708|Lansoprazole|lansoprazole|mesh-list
65318295|NCT04101708|Dexlansoprazole|dexlansoprazole|mesh-list
65162082|NCT00943852|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65162083|NCT02853136|Fluvoxamine|fluvoxamine|mesh-list
65162084|NCT02853136|BI 409306|bi 409306|mesh-list
65162085|NCT02853136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65318296|NCT04101708|Bismuth|bismuth|mesh-list
65318297|NCT04101708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65318298|NCT04101708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65318299|NCT04101708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65318300|NCT04101708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318301|NCT04101708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318302|NCT04101708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65318303|NCT04101708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65318304|NCT04101708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65318305|NCT04101708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65318306|NCT04101708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65318307|NCT04101708|Antacids|antacids|mesh-ancestor
65318308|NCT00779142|Methotrexate|methotrexate|mesh-list
65318309|NCT00779142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65318310|NCT00779142|Abortifacient Agents|abortifacient agents|mesh-ancestor
65068284|NCT00417053|Melphalan|melphalan|mesh-list
65318311|NCT00779142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65318312|NCT00779142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318313|NCT00779142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65318314|NCT00779142|Antimetabolites|antimetabolites|mesh-ancestor
65318315|NCT00779142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318316|NCT00779142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318317|NCT00779142|Dermatologic Agents|dermatologic agents|mesh-ancestor
65318318|NCT00779142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318319|NCT00779142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65318320|NCT00779142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65318321|NCT00779142|Immunologic Factors|immunologic factors|mesh-ancestor
65318322|NCT00779142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65318323|NCT00779142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65318324|NCT00840346|Panobinostat|panobinostat|mesh-list
65318325|NCT00840346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318326|NCT00840346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65318327|NCT00840346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318336|NCT00840580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65318337|NCT00840580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65318338|NCT00840580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65318339|NCT00840580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65318340|NCT00840580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65318341|NCT00840580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65318342|NCT00840580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65318343|NCT00840580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318344|NCT00840580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318345|NCT00840580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318346|NCT00840580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65318347|NCT00840580|Contraceptive Agents|contraceptive agents|mesh-ancestor
65318348|NCT00840580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65318349|NCT00840580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318350|NCT00840580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65318351|NCT00840580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65318352|NCT00840580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65318353|NCT00840580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65318354|NCT00840580|Renal Agents|renal agents|mesh-ancestor
65318355|NCT00840580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65318356|NCT00840580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65318357|NCT00773136|Bimatoprost|bimatoprost|mesh-list
65162086|NCT02853136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64506737|NCT02480400|Dexetimide|dexetimide|mesh-list
65162089|NCT02853136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65162090|NCT02853136|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65162091|NCT02853136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65162092|NCT02853136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65162093|NCT02853136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162094|NCT02853136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65162096|NCT02853136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65162097|NCT02853136|Antidepressive Agents|antidepressive agents|mesh-ancestor
65162098|NCT02853136|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65162099|NCT02853136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65162100|NCT02853136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162101|NCT02853136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65162102|NCT02853136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65162103|NCT02806141|Colistin|colistin|mesh-list
65162104|NCT02806141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65162105|NCT02806141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65162106|NCT02802631|Minocycline|minocycline|mesh-list
65162107|NCT02802631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65162108|NCT02802631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65162109|NCT04235959|Tirzepatide|tirzepatide|mesh-list
65162110|NCT04235959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65162111|NCT04235959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162112|NCT04235959|Incretins|incretins|mesh-ancestor
65162113|NCT04235959|Hormones|hormones|mesh-ancestor
65162114|NCT04235959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65162115|NCT00952276|Vaccines|vaccines|mesh-list
65318358|NCT00773136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65318359|NCT02602860|Levetiracetam|levetiracetam|mesh-list
65318360|NCT02602860|Brivaracetam|brivaracetam|mesh-list
65318361|NCT02602860|Anticonvulsants|anticonvulsants|mesh-ancestor
65318362|NCT02602860|Nootropic Agents|nootropic agents|mesh-ancestor
65318363|NCT00701831|Insulin Glargine|insulin glargine|mesh-list
65318364|NCT00701831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65318365|NCT00701831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318366|NCT00835744|Clomiphene|clomiphene|mesh-list
65318367|NCT00835744|Enclomiphene|enclomiphene|mesh-list
65318368|NCT00835744|Zuclomiphene|zuclomiphene|mesh-list
65318369|NCT00835744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65318370|NCT00835744|Hormone Antagonists|hormone antagonists|mesh-ancestor
65318371|NCT00835744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65318372|NCT00835744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318373|NCT00835744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65318374|NCT00835744|Fertility Agents|fertility agents|mesh-ancestor
65318375|NCT00835744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65318376|NCT00835744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65318377|NCT00835744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65318378|NCT00778830|Cetuximab|cetuximab|mesh-list
65318379|NCT00778830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65318380|NCT00778830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318381|NCT00772668|Prednisone|prednisone|mesh-list
65318382|NCT00772668|Cyclophosphamide|cyclophosphamide|mesh-list
65318383|NCT00772668|Rituximab|rituximab|mesh-list
65318384|NCT00772668|Bortezomib|bortezomib|mesh-list
65318385|NCT00772668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65318386|NCT00772668|Immunologic Factors|immunologic factors|mesh-ancestor
65318387|NCT00772668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318389|NCT00772668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65318390|NCT00772668|Alkylating Agents|alkylating agents|mesh-ancestor
65318391|NCT00772668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318392|NCT00772668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318393|NCT00772668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65318394|NCT00772668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65318395|NCT00772668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64548243|NCT00086281|GABA Agents|gaba agents|mesh-ancestor
65318396|NCT00772668|Glucocorticoids|glucocorticoids|mesh-ancestor
65318397|NCT00772668|Hormones|hormones|mesh-ancestor
65318398|NCT00772668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65318399|NCT00772668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65318400|NCT00786474|Dalteparin|dalteparin|mesh-list
65318401|NCT00786474|Tinzaparin|tinzaparin|mesh-list
65318402|NCT00786474|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65318403|NCT00786474|Anticoagulants|anticoagulants|mesh-ancestor
65318404|NCT00786474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65318405|NCT00786474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65318406|NCT00786474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318407|NCT00784875|Zolpidem|zolpidem|mesh-list
65318408|NCT00784875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65318409|NCT00784875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65318410|NCT00784875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65318411|NCT00784875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318412|NCT00784875|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65318413|NCT00784875|GABA Agonists|gaba agonists|mesh-ancestor
65318414|NCT00784875|GABA Agents|gaba agents|mesh-ancestor
65318415|NCT00784875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65318416|NCT00784875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318417|NCT00701909|Ketamine|ketamine|mesh-list
65318418|NCT00701909|Morphine|morphine|mesh-list
65318419|NCT00701909|Analgesics|analgesics|mesh-ancestor
65318420|NCT00701909|Sensory System Agents|sensory system agents|mesh-ancestor
65318421|NCT00701909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65318422|NCT00701909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318423|NCT00701909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65318424|NCT00701909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65318425|NCT00701909|Anesthetics, General|anesthetics, general|mesh-ancestor
65318426|NCT00701909|Anesthetics|anesthetics|mesh-ancestor
65318427|NCT00701909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65318429|NCT00701909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65318437|NCT00699023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65318438|NCT00699023|Antimetabolites|antimetabolites|mesh-ancestor
65318439|NCT00699023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318440|NCT00699023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65318441|NCT00699023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65318442|NCT00699023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318443|NCT00853229|Pregabalin|pregabalin|mesh-list
65318444|NCT00853229|Analgesics|analgesics|mesh-ancestor
65318445|NCT00853229|Sensory System Agents|sensory system agents|mesh-ancestor
65318446|NCT00853229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65318447|NCT00853229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318448|NCT00853229|Anticonvulsants|anticonvulsants|mesh-ancestor
65318449|NCT00853229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65318450|NCT00853229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65318451|NCT00853229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318452|NCT00853229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65318453|NCT00853229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65318454|NCT00853229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65318455|NCT00853229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65318456|NCT00853229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65318457|NCT00853073|Bevacizumab|bevacizumab|mesh-list
65318458|NCT00853073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65162116|NCT00952276|Immunologic Factors|immunologic factors|mesh-ancestor
65162117|NCT00952276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162118|NCT02805829|Trastuzumab|trastuzumab|mesh-list
64514640|NCT02712801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162119|NCT02805829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65162121|NCT02856178|Caspofungin|caspofungin|mesh-list
65162122|NCT02856178|Olorofim|olorofim|mesh-list
65162123|NCT02856178|Antifungal Agents|antifungal agents|mesh-ancestor
65162124|NCT02856178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65162125|NCT02856178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162126|NCT02856178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162127|NCT02800135|Furosemide|furosemide|mesh-list
65162128|NCT02800135|Diuretics|diuretics|mesh-ancestor
65162129|NCT02800135|Natriuretic Agents|natriuretic agents|mesh-ancestor
65162130|NCT02800135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162131|NCT02800135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65162132|NCT02800135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65162133|NCT02800135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162134|NCT00494728|Nicotine|nicotine|mesh-list
65162135|NCT00494728|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65162136|NCT00494728|Autonomic Agents|autonomic agents|mesh-ancestor
65162137|NCT00494728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65162138|NCT00494728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162139|NCT00494728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65162140|NCT00494728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65162141|NCT00494728|Cholinergic Agents|cholinergic agents|mesh-ancestor
65162142|NCT00494728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65162143|NCT00494728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162144|NCT02799901|Nivolumab|nivolumab|mesh-list
65068427|NCT00317811|Alkylating Agents|alkylating agents|mesh-ancestor
65318459|NCT00853073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318460|NCT00853073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65318461|NCT00853073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65318462|NCT00853073|Growth Substances|growth substances|mesh-ancestor
65318463|NCT00853073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318464|NCT00853073|Growth Inhibitors|growth inhibitors|mesh-ancestor
65318465|NCT00845897|Botulinum Toxins|botulinum toxins|mesh-list
65318466|NCT00845897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65318467|NCT00845897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65318468|NCT00845897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318469|NCT00845897|Cholinergic Agents|cholinergic agents|mesh-ancestor
65318470|NCT00845897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65318471|NCT00845897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318473|NCT04120337|Anesthetics, Local|anesthetics, local|mesh-ancestor
65318474|NCT04120337|Anesthetics|anesthetics|mesh-ancestor
65318475|NCT04120337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65318476|NCT04120337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318477|NCT04120337|Sensory System Agents|sensory system agents|mesh-ancestor
65318478|NCT04120337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65318479|NCT04120337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65318480|NCT04120337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65318481|NCT04120337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65318482|NCT04120337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65318483|NCT04120337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318484|NCT00592319|Celecoxib|celecoxib|mesh-list
65318485|NCT00592319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65318486|NCT00592319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65318487|NCT00592319|Analgesics|analgesics|mesh-ancestor
65162145|NCT02799901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65162146|NCT02799901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162147|NCT02799901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65162148|NCT02799901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162149|NCT02802163|Dexamethasone|dexamethasone|mesh-list
65162150|NCT02802163|Lenalidomide|lenalidomide|mesh-list
65162151|NCT02802163|Panobinostat|panobinostat|mesh-list
65162152|NCT02802163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65162153|NCT02802163|Antiemetics|antiemetics|mesh-ancestor
65162154|NCT02802163|Autonomic Agents|autonomic agents|mesh-ancestor
65162155|NCT02802163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65162156|NCT02802163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162157|NCT02802163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65162171|NCT02805049|Caspofungin|caspofungin|mesh-list
65318488|NCT00592319|Sensory System Agents|sensory system agents|mesh-ancestor
65318489|NCT00592319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65318490|NCT00592319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318491|NCT00592319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65318492|NCT00592319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65318493|NCT00592319|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65318494|NCT00592319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65318495|NCT00592319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318496|NCT00592319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318497|NCT00862121|Mesalamine|mesalamine|mesh-list
65318498|NCT00862121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65318499|NCT00862121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65318500|NCT00862121|Analgesics|analgesics|mesh-ancestor
65318501|NCT00862121|Sensory System Agents|sensory system agents|mesh-ancestor
65318502|NCT00862121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65318503|NCT00862121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318504|NCT00862121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65318505|NCT00862121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65318506|NCT00784719|Cyclosporine|cyclosporine|mesh-list
65318507|NCT00784719|Cyclosporins|cyclosporins|mesh-list
65318508|NCT00784719|Tofacitinib|tofacitinib|mesh-list
65318509|NCT00784719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318510|NCT00784719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318511|NCT00784719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65318512|NCT00784719|Immunologic Factors|immunologic factors|mesh-ancestor
65318513|NCT00784719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318536|NCT00700583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318537|NCT00700583|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65318538|NCT00700583|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65318539|NCT00700583|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65318540|NCT00700583|Adrenergic Agents|adrenergic agents|mesh-ancestor
65318541|NCT00700583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65318542|NCT00700583|Urological Agents|urological agents|mesh-ancestor
65318543|NCT00913055|Octreotide|octreotide|mesh-list
65318544|NCT00913055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65318545|NCT00913055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65318546|NCT00913055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318547|NCT04117139|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65318548|NCT04117139|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65318549|NCT04117139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318550|NCT00845429|Vaccines|vaccines|mesh-list
65318551|NCT00845429|Immunologic Factors|immunologic factors|mesh-ancestor
65318552|NCT00845429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318553|NCT00844883|Sorafenib|sorafenib|mesh-list
65318554|NCT00844883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318555|NCT00844883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65318556|NCT00844883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318557|NCT00844883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318558|NCT00851903|Metformin|metformin|mesh-list
65318559|NCT00851903|Insulin Glargine|insulin glargine|mesh-list
65318560|NCT00851903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65318561|NCT00851903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65318562|NCT00851903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318563|NCT00851903|Incretins|incretins|mesh-ancestor
65318564|NCT00851903|Hormones|hormones|mesh-ancestor
65318565|NCT00851903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65318566|NCT00851903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65162172|NCT02805049|Micafungin|micafungin|mesh-list
65162173|NCT02805049|Echinocandins|echinocandins|mesh-list
65162174|NCT02805049|Antifungal Agents|antifungal agents|mesh-ancestor
65162175|NCT02805049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65162176|NCT02805049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162177|NCT02805049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162178|NCT02799589|Dexmedetomidine|dexmedetomidine|mesh-list
65162179|NCT02799589|Remifentanil|remifentanil|mesh-list
65162180|NCT02799589|Ropivacaine|ropivacaine|mesh-list
65162181|NCT02799589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65162182|NCT02799589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65162183|NCT02799589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318567|NCT00851903|Protease Inhibitors|protease inhibitors|mesh-ancestor
65318568|NCT00851903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318569|NCT00851903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318570|NCT00587457|Immunotoxin HA22|immunotoxin ha22|mesh-list
65318571|NCT00587457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318572|NCT00851747|Deoxycholic Acid|deoxycholic acid|mesh-list
65318573|NCT00851747|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65318574|NCT00851747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65318575|NCT04099563|Abrocitinib|abrocitinib|mesh-list
65318576|NCT04099563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65318577|NCT04099563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318578|NCT04099563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318579|NCT00767325|Methotrexate|methotrexate|mesh-list
65318580|NCT00767325|Abatacept|abatacept|mesh-list
65318581|NCT00767325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65318582|NCT00767325|Abortifacient Agents|abortifacient agents|mesh-ancestor
65318583|NCT00767325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65318584|NCT00767325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318585|NCT00767325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65318586|NCT00767325|Antimetabolites|antimetabolites|mesh-ancestor
65318587|NCT00767325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318588|NCT00767325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318589|NCT00767325|Dermatologic Agents|dermatologic agents|mesh-ancestor
65318590|NCT00767325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318591|NCT00767325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65318592|NCT00767325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65318593|NCT00767325|Immunologic Factors|immunologic factors|mesh-ancestor
65318594|NCT00767325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65318595|NCT00767325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65318596|NCT00767325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65318597|NCT00851591|Psyllium|psyllium|mesh-list
65318598|NCT00851591|Cathartics|cathartics|mesh-ancestor
65318599|NCT00851591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65318600|NCT02612363|Dexmedetomidine|dexmedetomidine|mesh-list
65318601|NCT02612363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65162184|NCT02799589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65162185|NCT02799589|Analgesics|analgesics|mesh-ancestor
65162186|NCT02799589|Sensory System Agents|sensory system agents|mesh-ancestor
65162187|NCT02799589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65162188|NCT02799589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65318602|NCT02612363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65318603|NCT02612363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318604|NCT02612363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65318605|NCT02612363|Analgesics|analgesics|mesh-ancestor
65318606|NCT02612363|Sensory System Agents|sensory system agents|mesh-ancestor
65318607|NCT02612363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65318608|NCT02612363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65318609|NCT02612363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65318610|NCT02612363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65318611|NCT02612363|Adrenergic Agents|adrenergic agents|mesh-ancestor
65318612|NCT02612363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65318613|NCT02612363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318614|NCT00702767|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65318615|NCT00702767|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65318616|NCT00702767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65318617|NCT00702767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65318618|NCT00912899|Noscapine|noscapine|mesh-list
65318619|NCT00912899|Antitussive Agents|antitussive agents|mesh-ancestor
65318620|NCT00912899|Respiratory System Agents|respiratory system agents|mesh-ancestor
65318621|NCT00700895|Warfarin|warfarin|mesh-list
65318622|NCT00700895|Anticoagulants|anticoagulants|mesh-ancestor
65318623|NCT00861341|Aspirin|aspirin|mesh-list
65318624|NCT00861341|Pioglitazone|pioglitazone|mesh-list
65318625|NCT00861341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65318626|NCT00861341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65318627|NCT00861341|Analgesics|analgesics|mesh-ancestor
65318628|NCT00861341|Sensory System Agents|sensory system agents|mesh-ancestor
65318629|NCT00861341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65318647|NCT00766467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318648|NCT00850499|Rituximab|rituximab|mesh-list
65318649|NCT00850499|Fludarabine|fludarabine|mesh-list
65318650|NCT00850499|Bortezomib|bortezomib|mesh-list
65318651|NCT00850499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65318652|NCT00850499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318653|NCT00850499|Immunologic Factors|immunologic factors|mesh-ancestor
65318654|NCT00850499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318655|NCT00850499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65318656|NCT00844805|Naproxen|naproxen|mesh-list
65318657|NCT00844805|Infliximab|infliximab|mesh-list
65318658|NCT00844805|Dermatologic Agents|dermatologic agents|mesh-ancestor
65318659|NCT00844805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65318660|NCT00844805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65318661|NCT00844805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65318662|NCT00844805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65318663|NCT00844805|Analgesics|analgesics|mesh-ancestor
65318664|NCT00844805|Sensory System Agents|sensory system agents|mesh-ancestor
65318665|NCT00844805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65318666|NCT00844805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162189|NCT02799589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65162190|NCT02799589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65162191|NCT02799589|Adrenergic Agents|adrenergic agents|mesh-ancestor
65162192|NCT02799589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65162193|NCT02799589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162195|NCT02799589|Anesthetics|anesthetics|mesh-ancestor
65162196|NCT02799589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65162197|NCT02799589|Narcotics|narcotics|mesh-ancestor
65162198|NCT02856100|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
65162199|NCT02856100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162200|NCT02801383|Interferons|interferons|mesh-list
65162201|NCT02801383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162202|NCT02801383|Antiviral Agents|antiviral agents|mesh-ancestor
65162203|NCT02801383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65162204|NCT02799355|Interferons|interferons|mesh-list
65162205|NCT02799355|Ribavirin|ribavirin|mesh-list
65162206|NCT02799355|Sofosbuvir|sofosbuvir|mesh-list
65162207|NCT02799355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162208|NCT02799355|Antiviral Agents|antiviral agents|mesh-ancestor
65162209|NCT02799355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65162210|NCT02799355|Antimetabolites|antimetabolites|mesh-ancestor
65162211|NCT02799355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162212|NCT02801305|Diltiazem|diltiazem|mesh-list
65162213|NCT02801305|Nitroglycerin|nitroglycerin|mesh-list
65162214|NCT02801305|Petrolatum|petrolatum|mesh-list
65162215|NCT02801305|Vasodilator Agents|vasodilator agents|mesh-ancestor
65162216|NCT02801305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65162217|NCT02801305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65162218|NCT02801305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65162219|NCT02801305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506870|NCT01780324|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65162251|NCT02795299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162252|NCT02795299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65162253|NCT02795299|Antimetabolites|antimetabolites|mesh-ancestor
65162254|NCT02795299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162255|NCT02795299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318667|NCT00844805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65318668|NCT00844805|Gout Suppressants|gout suppressants|mesh-ancestor
65318669|NCT00844805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65318670|NCT00844805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318671|NCT00844805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318672|NCT00765999|Linaclotide|linaclotide|mesh-list
65318673|NCT00765999|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65318674|NCT00765999|Enzyme Activators|enzyme activators|mesh-ancestor
65318675|NCT00765999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318676|NCT00765999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65318677|NCT04099407|Pirfenidone|pirfenidone|mesh-list
65318678|NCT04099407|Analgesics|analgesics|mesh-ancestor
65318679|NCT04099407|Sensory System Agents|sensory system agents|mesh-ancestor
65318680|NCT04099407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65068651|NCT00311961|Hormones|hormones|mesh-ancestor
65318681|NCT04099407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318682|NCT04099407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65318683|NCT04099407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65318684|NCT04099407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65318685|NCT04099407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65318686|NCT04099407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318687|NCT00765063|Dalteparin|dalteparin|mesh-list
65318688|NCT00765063|Anticoagulants|anticoagulants|mesh-ancestor
65318689|NCT00765063|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65318690|NCT00765063|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65318691|NCT00765063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318692|NCT00764751|Calcipotriene|calcipotriene|mesh-list
65318693|NCT00764751|Dermatologic Agents|dermatologic agents|mesh-ancestor
65318694|NCT00764517|Rituximab|rituximab|mesh-list
64548574|NCT03389022|Anesthetics|anesthetics|mesh-ancestor
65162256|NCT02795299|Dermatologic Agents|dermatologic agents|mesh-ancestor
65162257|NCT02795299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162258|NCT02795299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65162259|NCT02795299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65162260|NCT02795299|Immunologic Factors|immunologic factors|mesh-ancestor
65162261|NCT02795299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65162262|NCT02795299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65162263|NCT02795299|Hematinics|hematinics|mesh-ancestor
65162281|NCT01198002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162283|NCT01198002|Dermatologic Agents|dermatologic agents|mesh-ancestor
65162284|NCT01198002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162285|NCT01198002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65162286|NCT01198002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65162287|NCT01198002|Immunologic Factors|immunologic factors|mesh-ancestor
65162288|NCT01198002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65162289|NCT01198002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65318695|NCT00764517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65318696|NCT00764517|Vorinostat|vorinostat|mesh-list
65318697|NCT00764517|Cladribine|cladribine|mesh-list
65318698|NCT00764517|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
65318699|NCT00764517|Antibodies|antibodies|mesh-list
65318700|NCT00764517|Immunoglobulins|immunoglobulins|mesh-list
65318701|NCT00764517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65318702|NCT00764517|Immunologic Factors|immunologic factors|mesh-ancestor
65318703|NCT00764517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318704|NCT00764517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318705|NCT00764517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65318706|NCT00764517|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65318707|NCT00764517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318708|NCT00764517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318709|NCT00764517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65318710|NCT00764517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65318711|NCT00764517|Antimetabolites|antimetabolites|mesh-ancestor
65318712|NCT00764361|Doxycycline|doxycycline|mesh-list
65318713|NCT00764361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65318714|NCT00764361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65318715|NCT00764361|Antimalarials|antimalarials|mesh-ancestor
65318716|NCT00764361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65318717|NCT00764361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65318718|NCT00763971|Methylphenidate|methylphenidate|mesh-list
65318719|NCT00763971|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65318720|NCT00763971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65318721|NCT00763971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318722|NCT00763971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65318723|NCT00763971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65318724|NCT00763971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65318725|NCT00763971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318726|NCT00763971|Dopamine Agents|dopamine agents|mesh-ancestor
65318727|NCT00763971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65318728|NCT00763815|Metformin|metformin|mesh-list
65318729|NCT00763815|Pioglitazone|pioglitazone|mesh-list
65318730|NCT00763815|Lixisenatide|lixisenatide|mesh-list
65162290|NCT02795065|Enoxaparin|enoxaparin|mesh-list
65162291|NCT02795065|Bemiparin|bemiparin|mesh-list
65162292|NCT02795065|Anticoagulants|anticoagulants|mesh-ancestor
65162293|NCT02795065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65162294|NCT02795065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65318731|NCT00763815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65318732|NCT00763815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318733|NCT00763269|Silicon|silicon|mesh-list
65318734|NCT00763269|Triclosan|triclosan|mesh-list
65318735|NCT00763269|Fluorides|fluorides|mesh-list
65318736|NCT00763269|Cariostatic Agents|cariostatic agents|mesh-ancestor
65318737|NCT00763269|Protective Agents|protective agents|mesh-ancestor
65318738|NCT00763269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318739|NCT00763269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65318740|NCT00763269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65318741|NCT00763269|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65318742|NCT00763269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65318743|NCT00763269|Antimetabolites|antimetabolites|mesh-ancestor
65318744|NCT00763269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318745|NCT00763269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65318746|NCT00763269|Trace Elements|trace elements|mesh-ancestor
65318747|NCT00763269|Micronutrients|micronutrients|mesh-ancestor
65318748|NCT00763035|Dobutamine|dobutamine|mesh-list
65318749|NCT00763035|Regadenoson|regadenoson|mesh-list
65318750|NCT00763035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65318751|NCT00763035|Sympathomimetics|sympathomimetics|mesh-ancestor
65318752|NCT00763035|Autonomic Agents|autonomic agents|mesh-ancestor
65318753|NCT00763035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65318754|NCT00763035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318755|NCT00763035|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65318756|NCT00763035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65162295|NCT02795065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162296|NCT04233697|Romidepsin|romidepsin|mesh-list
65162297|NCT04233697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65162298|NCT04233697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162299|NCT05470699|Fluorides|fluorides|mesh-list
65162300|NCT05470699|Cariostatic Agents|cariostatic agents|mesh-ancestor
65162301|NCT05470699|Protective Agents|protective agents|mesh-ancestor
65162302|NCT05470699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162303|NCT03826303|Ethanol|ethanol|mesh-list
65162304|NCT03826303|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65162305|NCT03826303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65162306|NCT03826303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65162307|NCT03826303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162308|NCT02798653|Progesterone|progesterone|mesh-list
65162309|NCT02798653|Progestins|progestins|mesh-ancestor
65162310|NCT02798653|Hormones|hormones|mesh-ancestor
65162311|NCT02798653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65162312|NCT02798653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162313|NCT03863587|Ramucirumab|ramucirumab|mesh-list
65162314|NCT03863587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162315|NCT04233463|Budesonide|budesonide|mesh-list
65162316|NCT04233463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65162317|NCT04233463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65162318|NCT04233463|Autonomic Agents|autonomic agents|mesh-ancestor
65162319|NCT04233463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65318757|NCT00763035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65318758|NCT00763035|Adrenergic Agents|adrenergic agents|mesh-ancestor
65318759|NCT00763035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65318760|NCT00763035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318761|NCT00763035|Protective Agents|protective agents|mesh-ancestor
65318762|NCT00763035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65318763|NCT00763035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65318764|NCT00763035|Purinergic Agonists|purinergic agonists|mesh-ancestor
65318765|NCT00763035|Purinergic Agents|purinergic agents|mesh-ancestor
65318766|NCT00844649|Gemcitabine|gemcitabine|mesh-list
65318768|NCT00844649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65318769|NCT00844649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65318770|NCT00844649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318771|NCT00844649|Tubulin Modulators|tubulin modulators|mesh-ancestor
65318772|NCT00844649|Antimitotic Agents|antimitotic agents|mesh-ancestor
65318773|NCT00844649|Mitosis Modulators|mitosis modulators|mesh-ancestor
65318774|NCT00844649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318775|NCT00844649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65318776|NCT00844649|Antimetabolites|antimetabolites|mesh-ancestor
64548659|NCT02464878|Basiliximab|basiliximab|mesh-list
65162320|NCT04233463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162321|NCT04233463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65162322|NCT04233463|Respiratory System Agents|respiratory system agents|mesh-ancestor
65162358|NCT02797717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65162359|NCT02797717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65162360|NCT02797717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162361|NCT02797717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65162362|NCT02797717|Glucocorticoids|glucocorticoids|mesh-ancestor
65162363|NCT02797717|Hormones|hormones|mesh-ancestor
65162364|NCT02797717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65162365|NCT02797717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65162366|NCT02797717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65162381|NCT02792491|Cyclophosphamide|cyclophosphamide|mesh-list
65162382|NCT02792491|Rituximab|rituximab|mesh-list
65162383|NCT02792491|Doxorubicin|doxorubicin|mesh-list
65162384|NCT02792491|Vincristine|vincristine|mesh-list
65162385|NCT02792491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65162386|NCT02792491|Immunologic Factors|immunologic factors|mesh-ancestor
65162387|NCT02792491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162388|NCT02792491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65162389|NCT02792491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65162390|NCT02792491|Alkylating Agents|alkylating agents|mesh-ancestor
65162391|NCT02792491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162392|NCT02792491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162393|NCT02792491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65162394|NCT02792491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65162395|NCT02792491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65162396|NCT02792491|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65162397|NCT02792491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65162398|NCT02792491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162399|NCT02792491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65162400|NCT02792491|Glucocorticoids|glucocorticoids|mesh-ancestor
65162401|NCT02792491|Hormones|hormones|mesh-ancestor
65318777|NCT00844649|Antiviral Agents|antiviral agents|mesh-ancestor
65318778|NCT00844649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65318779|NCT00844649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318780|NCT00844649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65318781|NCT00844649|Immunologic Factors|immunologic factors|mesh-ancestor
65318782|NCT00844649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318783|NCT04098861|Timolol|timolol|mesh-list
65318784|NCT04098861|Latanoprost|latanoprost|mesh-list
65318785|NCT04098861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65318786|NCT04098861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65318787|NCT04098861|Adrenergic Agents|adrenergic agents|mesh-ancestor
65318788|NCT04098861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65318789|NCT04098861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318790|NCT04098861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318791|NCT04098861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65318792|NCT04098861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65318793|NCT04098861|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65318794|NCT04098861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65318795|NCT00850343|Certolizumab Pegol|certolizumab pegol|mesh-list
65318796|NCT00850343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65318797|NCT00850343|Immunologic Factors|immunologic factors|mesh-ancestor
65318798|NCT00850343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318799|NCT00850343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65318800|NCT00849875|Dacarbazine|dacarbazine|mesh-list
65318801|NCT00849875|Imidazole|imidazole|mesh-list
65318802|NCT00849875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65318803|NCT00849875|Alkylating Agents|alkylating agents|mesh-ancestor
64548678|NCT02010606|Bevacizumab|bevacizumab|mesh-list
65162402|NCT02792491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65162403|NCT02792491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65162404|NCT02792491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65162405|NCT02792491|Tubulin Modulators|tubulin modulators|mesh-ancestor
65162406|NCT02792491|Antimitotic Agents|antimitotic agents|mesh-ancestor
65162407|NCT02792491|Mitosis Modulators|mitosis modulators|mesh-ancestor
65162408|NCT02792803|Latanoprost|latanoprost|mesh-list
65162409|NCT02792803|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65162410|NCT02792803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65162411|NCT02797249|Aspirin|aspirin|mesh-list
65162412|NCT02797249|Salicylic Acid|salicylic acid|mesh-list
65162413|NCT02797249|Salicylates|salicylates|mesh-list
65162414|NCT02797249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65162415|NCT02797249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65162416|NCT02797249|Analgesics|analgesics|mesh-ancestor
64805038|NCT01418417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65162417|NCT02797249|Sensory System Agents|sensory system agents|mesh-ancestor
65162418|NCT02797249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65162419|NCT02797249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162420|NCT02797249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65162421|NCT02797249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65318804|NCT00849875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318805|NCT00849875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318806|NCT00849875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318807|NCT00844415|Dabigatran|dabigatran|mesh-list
65318808|NCT00844415|Antithrombins|antithrombins|mesh-ancestor
65318809|NCT00844415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65318810|NCT00844415|Protease Inhibitors|protease inhibitors|mesh-ancestor
65318811|NCT00844415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318812|NCT00844415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318813|NCT00844415|Anticoagulants|anticoagulants|mesh-ancestor
65318814|NCT00843635|Tadalafil|tadalafil|mesh-list
65318815|NCT00843635|Vasodilator Agents|vasodilator agents|mesh-ancestor
65318816|NCT00843635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65318817|NCT00843635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65318818|NCT00843635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318819|NCT00843635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318820|NCT00843635|Urological Agents|urological agents|mesh-ancestor
65318821|NCT00699179|Insulin Aspart|insulin aspart|mesh-list
65318822|NCT00699179|Biphasic Insulins|biphasic insulins|mesh-list
65318823|NCT00699179|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65318824|NCT00699179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65318825|NCT00699179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318826|NCT04116827|Tamoxifen|tamoxifen|mesh-list
65318827|NCT04116827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65318828|NCT04116827|Hormone Antagonists|hormone antagonists|mesh-ancestor
65318829|NCT04116827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65318830|NCT04116827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318831|NCT04116827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65318832|NCT04116827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318833|NCT04116827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65318834|NCT04116827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65318835|NCT04116827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65318836|NCT00849017|rGLP-1 protein|rglp-1 protein|mesh-list
65318842|NCT00842309|Cycloserine|cycloserine|mesh-list
65318843|NCT00842309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65318844|NCT00842309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65318845|NCT00842309|Renal Agents|renal agents|mesh-ancestor
65318846|NCT00842309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65318847|NCT00842309|Antitubercular Agents|antitubercular agents|mesh-ancestor
65318848|NCT00842309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65318849|NCT00842309|Antimetabolites|antimetabolites|mesh-ancestor
65318850|NCT00842309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318851|NCT00842153|Clobetasol|clobetasol|mesh-list
65318852|NCT00842153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65318853|NCT00842153|Glucocorticoids|glucocorticoids|mesh-ancestor
65318854|NCT00842153|Hormones|hormones|mesh-ancestor
65318855|NCT00842153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65318856|NCT00842153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318857|NCT00841763|Vaccines|vaccines|mesh-list
65318858|NCT00841763|Immunologic Factors|immunologic factors|mesh-ancestor
65318859|NCT00841763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318860|NCT05603429|Antioxidants|antioxidants|mesh-list
65318861|NCT05603429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318862|NCT05603429|Protective Agents|protective agents|mesh-ancestor
65318863|NCT05603429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318864|NCT00785538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65318865|NCT00785538|Immunologic Factors|immunologic factors|mesh-ancestor
65318866|NCT00785538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318867|NCT02602704|Bazedoxifene|bazedoxifene|mesh-list
65318868|NCT02602704|Calcium|calcium|mesh-list
65318869|NCT02602704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65318870|NCT02602704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318871|NCT02602704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65318872|NCT02602704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65318873|NCT02602704|Hormone Antagonists|hormone antagonists|mesh-ancestor
64548746|NCT01678495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65162422|NCT02797249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65162423|NCT02797249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65162424|NCT02797249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162425|NCT02797249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65162426|NCT02797249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65162427|NCT02797249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162428|NCT02797249|Antipyretics|antipyretics|mesh-ancestor
65162432|NCT02797249|Dermatologic Agents|dermatologic agents|mesh-ancestor
65318874|NCT02602704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65318875|NCT02602704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65318876|NCT00860405|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65318877|NCT00860405|Plasma Substitutes|plasma substitutes|mesh-ancestor
65318878|NCT00860405|Blood Substitutes|blood substitutes|mesh-ancestor
65318879|NCT00703313|Moxifloxacin|moxifloxacin|mesh-list
65318880|NCT00703313|Levofloxacin|levofloxacin|mesh-list
65318881|NCT00703313|Ofloxacin|ofloxacin|mesh-list
65318882|NCT00703313|Gatifloxacin|gatifloxacin|mesh-list
65318883|NCT00703313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65318884|NCT00703313|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65318885|NCT00703313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65318886|NCT00703313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65318887|NCT00703313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65318888|NCT00703313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65318889|NCT00703313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65318890|NCT00703313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318891|NCT00703313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162433|NCT02792335|Warfarin|warfarin|mesh-list
65162434|NCT02792335|Rivaroxaban|rivaroxaban|mesh-list
65162435|NCT02792335|Dabigatran|dabigatran|mesh-list
65162436|NCT02792335|Apixaban|apixaban|mesh-list
65162437|NCT02792335|Anticoagulants|anticoagulants|mesh-ancestor
65162438|NCT02792335|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65162439|NCT02792335|Antithrombins|antithrombins|mesh-ancestor
65162440|NCT02792335|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65162441|NCT02792335|Protease Inhibitors|protease inhibitors|mesh-ancestor
65162442|NCT02792335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162443|NCT02792335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162444|NCT01197300|Zoledronic Acid|zoledronic acid|mesh-list
65162445|NCT01197300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65162446|NCT01197300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162447|NCT04200235|Dexmedetomidine|dexmedetomidine|mesh-list
65162448|NCT04200235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65162449|NCT04200235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65162450|NCT04200235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162451|NCT04200235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65162452|NCT04200235|Analgesics|analgesics|mesh-ancestor
65162453|NCT04200235|Sensory System Agents|sensory system agents|mesh-ancestor
65162454|NCT04200235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65162455|NCT04200235|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65162456|NCT04200235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65162457|NCT04200235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65162458|NCT04200235|Adrenergic Agents|adrenergic agents|mesh-ancestor
65162459|NCT04200235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65162460|NCT04200235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162461|NCT02791243|Finasteride|finasteride|mesh-list
65162462|NCT02791243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65162463|NCT02791243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65162464|NCT02791243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162465|NCT02791243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162466|NCT02791243|Hormone Antagonists|hormone antagonists|mesh-ancestor
65162467|NCT02791243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65162468|NCT02791243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162469|NCT02791243|Urological Agents|urological agents|mesh-ancestor
65162470|NCT02797015|Ozanimod|ozanimod|mesh-list
65318892|NCT00703313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318893|NCT00703313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65318894|NCT00703313|Contraceptive Agents|contraceptive agents|mesh-ancestor
65318895|NCT00703313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65318896|NCT00703313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318897|NCT00703313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65318898|NCT00703313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65318899|NCT00703313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65318900|NCT00703313|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65318901|NCT00703313|Renal Agents|renal agents|mesh-ancestor
65318902|NCT00703313|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65318903|NCT00703313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65318904|NCT00703079|Octreotide|octreotide|mesh-list
65318906|NCT00703079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65318907|NCT00703079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65318908|NCT00703079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162471|NCT02797015|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65162472|NCT02797015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162473|NCT02797015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65162474|NCT02797015|Immunologic Factors|immunologic factors|mesh-ancestor
65162475|NCT02797015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162476|NCT03991819|Pembrolizumab|pembrolizumab|mesh-list
65162477|NCT03991819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65162478|NCT03991819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162479|NCT02796859|Siltuximab|siltuximab|mesh-list
65162480|NCT02796859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162481|NCT03803761|Fulvestrant|fulvestrant|mesh-list
65162482|NCT03803761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65162483|NCT03803761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162484|NCT03803761|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65162485|NCT03803761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65162486|NCT03803761|Hormone Antagonists|hormone antagonists|mesh-ancestor
65162487|NCT03803761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65162488|NCT03803761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162489|NCT02796547|Levobupivacaine|levobupivacaine|mesh-list
65162490|NCT02796547|Anesthetics, Local|anesthetics, local|mesh-ancestor
65162491|NCT02796547|Anesthetics|anesthetics|mesh-ancestor
65162492|NCT02796547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65162493|NCT02796547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162494|NCT02796547|Sensory System Agents|sensory system agents|mesh-ancestor
65162495|NCT02796547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65162496|NCT01196988|Vaccines|vaccines|mesh-list
65162497|NCT01196988|Immunologic Factors|immunologic factors|mesh-ancestor
65162498|NCT01196988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162499|NCT02796469|Pentoxifylline|pentoxifylline|mesh-list
65162511|NCT02796157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162512|NCT02796157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65162513|NCT02796157|Immunologic Factors|immunologic factors|mesh-ancestor
65162514|NCT02796157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162515|NCT01196052|Trastuzumab|trastuzumab|mesh-list
65162516|NCT01196052|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65162517|NCT01196052|Maytansine|maytansine|mesh-list
65162518|NCT01196052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65162519|NCT01196052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162520|NCT01196052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65162521|NCT01196052|Tubulin Modulators|tubulin modulators|mesh-ancestor
65162522|NCT01196052|Antimitotic Agents|antimitotic agents|mesh-ancestor
65318909|NCT00840827|Cyclosporine|cyclosporine|mesh-list
65318910|NCT00840827|Lenalidomide|lenalidomide|mesh-list
65318911|NCT00840827|Cyclosporins|cyclosporins|mesh-list
65318912|NCT00840827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318913|NCT00840827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318914|NCT00840827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65318915|NCT00840827|Immunologic Factors|immunologic factors|mesh-ancestor
65318916|NCT00840827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318917|NCT00840827|Antifungal Agents|antifungal agents|mesh-ancestor
65318918|NCT00840827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65318919|NCT00840827|Dermatologic Agents|dermatologic agents|mesh-ancestor
65318920|NCT00840827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65318921|NCT00840827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65318922|NCT00840827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65318923|NCT00840827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65318924|NCT00840827|Growth Substances|growth substances|mesh-ancestor
65318925|NCT00840827|Growth Inhibitors|growth inhibitors|mesh-ancestor
65318926|NCT00840827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318927|NCT00703469|Nivolumab|nivolumab|mesh-list
65318928|NCT00703469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65318929|NCT00703469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318930|NCT00703469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65318931|NCT00703469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318932|NCT02612207|Bilirubin|bilirubin|mesh-list
65318933|NCT02612207|Antioxidants|antioxidants|mesh-ancestor
65318934|NCT02612207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162523|NCT01196052|Mitosis Modulators|mitosis modulators|mesh-ancestor
65162524|NCT01196052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162525|NCT02689921|Trastuzumab|trastuzumab|mesh-list
65162526|NCT02689921|Pertuzumab|pertuzumab|mesh-list
65162527|NCT02689921|Letrozole|letrozole|mesh-list
65162528|NCT02689921|Anastrozole|anastrozole|mesh-list
65162529|NCT02689921|Leuprolide|leuprolide|mesh-list
65162530|NCT02689921|Exemestane|exemestane|mesh-list
65162531|NCT02689921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65162532|NCT02689921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162533|NCT02689921|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65162534|NCT02689921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65162535|NCT02689921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162536|NCT02689921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162537|NCT02689921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65162538|NCT02689921|Hormone Antagonists|hormone antagonists|mesh-ancestor
65162539|NCT02689921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65162540|NCT02689921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162541|NCT02689921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65162542|NCT02689921|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65162543|NCT02689921|Fertility Agents|fertility agents|mesh-ancestor
65162544|NCT02689921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65162545|NCT03116425|Pantothenic Acid|pantothenic acid|mesh-list
65162546|NCT03116425|Vitamin B Complex|vitamin b complex|mesh-ancestor
65318935|NCT02612207|Protective Agents|protective agents|mesh-ancestor
65318936|NCT02612207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318937|NCT00859937|Dasatinib|dasatinib|mesh-list
65318938|NCT00859937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318939|NCT00859937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65318940|NCT00859937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318941|NCT00859937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318942|NCT04030715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65318943|NCT04030715|Bismuth|bismuth|mesh-list
65318944|NCT04030715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65318945|NCT04030715|Antacids|antacids|mesh-ancestor
65318946|NCT04030715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318947|NCT04030715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65318948|NCT00592007|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65318949|NCT00592007|Fulvestrant|fulvestrant|mesh-list
65318950|NCT00592007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162547|NCT03116425|Vitamins|vitamins|mesh-ancestor
65162548|NCT03116425|Micronutrients|micronutrients|mesh-ancestor
65162549|NCT03116425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162550|NCT01195662|Dapagliflozin|dapagliflozin|mesh-list
65162551|NCT01195662|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65162552|NCT01195662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162553|NCT01195662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65162554|NCT01195662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162555|NCT02786407|Botulinum Toxins|botulinum toxins|mesh-list
65162556|NCT02786407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65162557|NCT02786407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65162558|NCT02786407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65162559|NCT02786407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65162560|NCT02786407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162561|NCT02786407|Cholinergic Agents|cholinergic agents|mesh-ancestor
65162562|NCT02786407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65162597|NCT02787967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65162598|NCT02788123|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
65162599|NCT02788123|Pantoprazole|pantoprazole|mesh-list
65162600|NCT02788123|Bismuth|bismuth|mesh-list
65162601|NCT02788123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65162602|NCT02788123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64507263|NCT01806545|Hemostatics|hemostatics|mesh-ancestor
65162636|NCT02785705|Vaccines|vaccines|mesh-list
65162637|NCT02785705|Immunologic Factors|immunologic factors|mesh-ancestor
65162638|NCT02785705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162639|NCT02821507|Sirolimus|sirolimus|mesh-list
65162640|NCT02821507|Cyclophosphamide|cyclophosphamide|mesh-list
65162641|NCT02821507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65162642|NCT02821507|Immunologic Factors|immunologic factors|mesh-ancestor
65162643|NCT02821507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162644|NCT02821507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65162645|NCT02821507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65162660|NCT02785393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65162661|NCT02785393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162662|NCT02785393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162663|NCT02787031|Anesthetics|anesthetics|mesh-list
65162664|NCT02787031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65162665|NCT02787031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162666|NCT03683251|Ranibizumab|ranibizumab|mesh-list
65162667|NCT03683251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65162668|NCT03683251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65318951|NCT00592007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65318952|NCT00592007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318953|NCT00592007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318954|NCT00592007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65318955|NCT00592007|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65318956|NCT00592007|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65318957|NCT00592007|Hormone Antagonists|hormone antagonists|mesh-ancestor
65318958|NCT00592007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65318959|NCT00592007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318960|NCT00591851|Paclitaxel|paclitaxel|mesh-list
65318961|NCT00591851|Cyclophosphamide|cyclophosphamide|mesh-list
65318962|NCT00591851|Doxorubicin|doxorubicin|mesh-list
65318963|NCT00591851|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65318964|NCT00591851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65318965|NCT00591851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65318966|NCT00591851|Tubulin Modulators|tubulin modulators|mesh-ancestor
65318967|NCT00591851|Antimitotic Agents|antimitotic agents|mesh-ancestor
65318968|NCT00591851|Mitosis Modulators|mitosis modulators|mesh-ancestor
65318969|NCT00591851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318970|NCT00591851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65318971|NCT00591851|Immunologic Factors|immunologic factors|mesh-ancestor
65318972|NCT00591851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318973|NCT00591851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65318974|NCT00591851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65318975|NCT00591851|Alkylating Agents|alkylating agents|mesh-ancestor
65318976|NCT00591851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65318977|NCT00591851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65068950|NCT00285428|Veltuzumab|veltuzumab|mesh-list
65162669|NCT03683251|Growth Substances|growth substances|mesh-ancestor
65162670|NCT03683251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162671|NCT03683251|Growth Inhibitors|growth inhibitors|mesh-ancestor
65162672|NCT03683251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162673|NCT02784223|Choline|choline|mesh-list
65162674|NCT02784223|Lipotropic Agents|lipotropic agents|mesh-ancestor
65162675|NCT02784223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65162676|NCT02784223|Antimetabolites|antimetabolites|mesh-ancestor
65162677|NCT02784223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162678|NCT02784223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65162679|NCT02784223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65162680|NCT02784223|Nootropic Agents|nootropic agents|mesh-ancestor
65162681|NCT05262751|Nintedanib|nintedanib|mesh-list
65162682|NCT05262751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162683|NCT05262751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65162684|NCT05262751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162685|NCT05262751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162686|NCT04231123|Anesthetics|anesthetics|mesh-list
65318978|NCT00591851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65318979|NCT00591851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65318980|NCT00591851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318981|NCT00839423|Vortioxetine|vortioxetine|mesh-list
65318982|NCT00839423|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65318983|NCT00839423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65318984|NCT00839423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65318985|NCT00839423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65318986|NCT00839423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65318987|NCT00839423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65318988|NCT00839423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65318989|NCT00839423|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65318990|NCT00839423|Antidepressive Agents|antidepressive agents|mesh-ancestor
65318991|NCT00839423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65318992|NCT00839423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65318993|NCT00839423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65318994|NCT00839423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65318995|NCT00839423|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65318996|NCT00839423|Serotonin Agents|serotonin agents|mesh-ancestor
65318997|NCT00839423|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64548882|NCT05135286|Miotics|miotics|mesh-ancestor
65162687|NCT04231123|Anesthetics, Local|anesthetics, local|mesh-list
65162688|NCT04231123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65162689|NCT04231123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162690|NCT04231123|Sensory System Agents|sensory system agents|mesh-ancestor
65162691|NCT04231123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65162692|NCT04231279|Secretin|secretin|mesh-list
65162693|NCT04231279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65162694|NCT04231279|Hormones|hormones|mesh-ancestor
65162695|NCT04231279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65162696|NCT04231279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162697|NCT02782273|Ketorolac|ketorolac|mesh-list
65162698|NCT02782273|Morphine|morphine|mesh-list
65162699|NCT02782273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65162700|NCT02782273|Narcotics|narcotics|mesh-ancestor
65162701|NCT02782273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65162702|NCT02782273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162703|NCT02782273|Analgesics|analgesics|mesh-ancestor
65162704|NCT02782273|Sensory System Agents|sensory system agents|mesh-ancestor
65162705|NCT02782273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507345|NCT01800838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65162724|NCT02268175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65162726|NCT02268175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65162727|NCT02268175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162728|NCT02268175|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65162729|NCT02268175|Fertility Agents|fertility agents|mesh-ancestor
65162730|NCT02268175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65162731|NCT02268175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65162732|NCT02268175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65318998|NCT00839423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65318999|NCT00839423|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65319000|NCT00839423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65319001|NCT00859469|Gemcitabine|gemcitabine|mesh-list
65319002|NCT00859469|Oxaliplatin|oxaliplatin|mesh-list
65319003|NCT00859469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65319004|NCT00859469|Antimetabolites|antimetabolites|mesh-ancestor
65319005|NCT00859469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319006|NCT00859469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319007|NCT00859469|Antiviral Agents|antiviral agents|mesh-ancestor
65319008|NCT00859469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319009|NCT00859469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319010|NCT00859469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65319011|NCT00859469|Immunologic Factors|immunologic factors|mesh-ancestor
65319012|NCT00859469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319013|NCT00703625|Sirolimus|sirolimus|mesh-list
65319014|NCT00703625|Docetaxel|docetaxel|mesh-list
65319015|NCT00703625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319016|NCT00703625|Tubulin Modulators|tubulin modulators|mesh-ancestor
65319017|NCT00703625|Antimitotic Agents|antimitotic agents|mesh-ancestor
65319018|NCT00703625|Mitosis Modulators|mitosis modulators|mesh-ancestor
65319053|NCT02611973|Sensory System Agents|sensory system agents|mesh-ancestor
65319054|NCT02611973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65319055|NCT02611973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319056|NCT02611973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65319057|NCT02611973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65319058|NCT02611973|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65319059|NCT02611973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65319060|NCT02611973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319061|NCT02611973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65319062|NCT02611973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65319063|NCT02611973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319064|NCT02611973|Antipyretics|antipyretics|mesh-ancestor
65319065|NCT02611973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548960|NCT04767035|Midazolam|midazolam|mesh-list
65162733|NCT02268175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162734|NCT02268175|Hormone Antagonists|hormone antagonists|mesh-ancestor
65162735|NCT02268175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65162736|NCT02783989|4-hydroxyphenylethanol|4-hydroxyphenylethanol|mesh-list
65162737|NCT02783989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65162738|NCT02783989|Antioxidants|antioxidants|mesh-ancestor
65162739|NCT02783989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162740|NCT02783989|Protective Agents|protective agents|mesh-ancestor
65162741|NCT02783989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162742|NCT02584309|Doxorubicin|doxorubicin|mesh-list
65162743|NCT02584309|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65162744|NCT02584309|Dexrazoxane|dexrazoxane|mesh-list
65162745|NCT02584309|Razoxane|razoxane|mesh-list
65162746|NCT02584309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65162747|NCT02584309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162748|NCT02584309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65162749|NCT02584309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65162750|NCT02584309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162751|NCT02584309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162752|NCT02584309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65162753|NCT02584309|Protective Agents|protective agents|mesh-ancestor
65162754|NCT02584309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162755|NCT02584309|Antimitotic Agents|antimitotic agents|mesh-ancestor
65162756|NCT02584309|Mitosis Modulators|mitosis modulators|mesh-ancestor
65162757|NCT02782429|Ketamine|ketamine|mesh-list
65162758|NCT02782429|Analgesics|analgesics|mesh-ancestor
65162759|NCT02782429|Sensory System Agents|sensory system agents|mesh-ancestor
65162760|NCT02782429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65162761|NCT02782429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162762|NCT02782429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65162784|NCT01855867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162786|NCT01855867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65162787|NCT02689843|Metformin|metformin|mesh-list
65162788|NCT02689843|Pioglitazone|pioglitazone|mesh-list
65162789|NCT02689843|Cyproterone Acetate|cyproterone acetate|mesh-list
65162790|NCT02689843|Spironolactone|spironolactone|mesh-list
65162791|NCT02689843|Cyproterone|cyproterone|mesh-list
65162792|NCT02689843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65162793|NCT02689843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162794|NCT02689843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65162795|NCT02689843|Hormone Antagonists|hormone antagonists|mesh-ancestor
65162796|NCT02689843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65162797|NCT02689843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65162798|NCT02689843|Diuretics|diuretics|mesh-ancestor
65162799|NCT02689843|Natriuretic Agents|natriuretic agents|mesh-ancestor
65162800|NCT02689843|Androgen Antagonists|androgen antagonists|mesh-ancestor
65319066|NCT02611973|Antisickling Agents|antisickling agents|mesh-ancestor
65319067|NCT02611973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65319068|NCT00771810|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
65319069|NCT00771810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65319070|NCT00771810|Vasodilator Agents|vasodilator agents|mesh-ancestor
65319071|NCT00836927|Sirolimus|sirolimus|mesh-list
65319072|NCT00836927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65319073|NCT00836927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319074|NCT00836927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65319075|NCT00836927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319076|NCT00836927|Antifungal Agents|antifungal agents|mesh-ancestor
65319077|NCT00836927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65319078|NCT00836927|Immunologic Factors|immunologic factors|mesh-ancestor
65319079|NCT00836927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319080|NCT00703235|Bevacizumab|bevacizumab|mesh-list
65319081|NCT00703235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65319082|NCT00703235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319083|NCT00703235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65319084|NCT00703235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65319085|NCT00703235|Growth Substances|growth substances|mesh-ancestor
65319086|NCT00703235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319087|NCT00703235|Growth Inhibitors|growth inhibitors|mesh-ancestor
65319088|NCT02612051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65319089|NCT00771030|Brodalumab|brodalumab|mesh-list
65319090|NCT00771030|Dermatologic Agents|dermatologic agents|mesh-ancestor
65319091|NCT00768300|Ambrisentan|ambrisentan|mesh-list
65319092|NCT00768300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65319093|NCT00768222|Triclosan|triclosan|mesh-list
64980989|NCT00289354|Biotin|biotin|mesh-list
65162801|NCT02689843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162802|NCT02689843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65162803|NCT02689843|Contraceptive Agents|contraceptive agents|mesh-ancestor
65162804|NCT02689843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65162805|NCT05166577|Valganciclovir|valganciclovir|mesh-list
65162806|NCT05166577|Pembrolizumab|pembrolizumab|mesh-list
65162807|NCT05166577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65162808|NCT05166577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162809|NCT05166577|Antiviral Agents|antiviral agents|mesh-ancestor
65162810|NCT05166577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65162811|NCT05341999|Ibuprofen|ibuprofen|mesh-list
65162812|NCT05341999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65162813|NCT05341999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65162814|NCT05341999|Analgesics|analgesics|mesh-ancestor
65162819|NCT05341999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65162820|NCT05341999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65162821|NCT05341999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162822|NCT05341999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162823|NCT02781805|Alendronate|alendronate|mesh-list
65319094|NCT00768222|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65319095|NCT00768222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319096|NCT00768222|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65319097|NCT00768222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65319098|NCT00768222|Antimetabolites|antimetabolites|mesh-ancestor
65319099|NCT00768222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319100|NCT00768222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65319101|NCT00768144|Sunitinib|sunitinib|mesh-list
65319102|NCT00768144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319103|NCT00768144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65319104|NCT00768144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65319105|NCT00768144|Growth Substances|growth substances|mesh-ancestor
65319106|NCT00768144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319107|NCT00768144|Growth Inhibitors|growth inhibitors|mesh-ancestor
65319108|NCT00768144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65319109|NCT00768144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319110|NCT00768144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319111|NCT00784836|Interferons|interferons|mesh-list
65319112|NCT00784836|Interferon-beta|interferon-beta|mesh-list
65319113|NCT00784836|Interferon beta-1a|interferon beta-1a|mesh-list
65319114|NCT00784836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319115|NCT00784836|Antiviral Agents|antiviral agents|mesh-ancestor
65319116|NCT00784836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319117|NCT00784836|Immunologic Factors|immunologic factors|mesh-ancestor
65319118|NCT00784836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319119|NCT00784836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65319142|NCT00858845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65319143|NCT00858845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319144|NCT00858845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65319145|NCT00858845|Sympatholytics|sympatholytics|mesh-ancestor
65319146|NCT00858845|Autonomic Agents|autonomic agents|mesh-ancestor
65319147|NCT00858845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65319148|NCT00858845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65319149|NCT00858845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65319150|NCT00858845|Adrenergic Agents|adrenergic agents|mesh-ancestor
65319151|NCT00858845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65319152|NCT00858845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319153|NCT05591339|BCG Vaccine|bcg vaccine|mesh-list
65319154|NCT05591339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65319155|NCT05591339|Immunologic Factors|immunologic factors|mesh-ancestor
65319156|NCT05591339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319157|NCT00770562|Dexamethasone|dexamethasone|mesh-list
65319158|NCT00770562|Rituximab|rituximab|mesh-list
65319159|NCT00770562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65319160|NCT00770562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319161|NCT00770562|Immunologic Factors|immunologic factors|mesh-ancestor
65319162|NCT00770562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319163|NCT00770562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65319164|NCT00770562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65319165|NCT00770562|Antiemetics|antiemetics|mesh-ancestor
65319166|NCT00770562|Autonomic Agents|autonomic agents|mesh-ancestor
65319167|NCT00770562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65162824|NCT02781805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65162825|NCT02781805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162826|NCT02781493|Prucalopride|prucalopride|mesh-list
65162827|NCT02781493|Laxatives|laxatives|mesh-ancestor
65162828|NCT02781493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65162829|NCT02781493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65162830|NCT02781493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65162831|NCT02781493|Serotonin Agents|serotonin agents|mesh-ancestor
65162832|NCT02781493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65162833|NCT02781493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162834|NCT02781493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162835|NCT02783053|Metformin|metformin|mesh-list
65162836|NCT02783053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65162837|NCT02783053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162838|NCT02782819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65162839|NCT02781415|Morphine|morphine|mesh-list
65162840|NCT02781415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65162841|NCT02781415|Narcotics|narcotics|mesh-ancestor
65162842|NCT02781415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65162843|NCT02781415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162844|NCT02781415|Analgesics|analgesics|mesh-ancestor
65162845|NCT02781415|Sensory System Agents|sensory system agents|mesh-ancestor
65162846|NCT02781415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65319168|NCT00770562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65319169|NCT00770562|Glucocorticoids|glucocorticoids|mesh-ancestor
65319170|NCT00770562|Hormones|hormones|mesh-ancestor
65319171|NCT00770562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65319172|NCT00770562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65319173|NCT00836693|Tadalafil|tadalafil|mesh-list
65319174|NCT00836693|Vasodilator Agents|vasodilator agents|mesh-ancestor
65319175|NCT00836693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65319176|NCT00836693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65319177|NCT00836693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319178|NCT00836693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319179|NCT00836693|Urological Agents|urological agents|mesh-ancestor
65319180|NCT00770484|Propranolol|propranolol|mesh-list
65319181|NCT00770484|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65319182|NCT00770484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65319183|NCT00770484|Adrenergic Agents|adrenergic agents|mesh-ancestor
65319184|NCT00770484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64549070|NCT01478048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65162847|NCT02785003|Acetaminophen|acetaminophen|mesh-list
65162848|NCT02785003|Ketamine|ketamine|mesh-list
65162849|NCT02785003|Morphine|morphine|mesh-list
65162850|NCT02785003|Narcotics|narcotics|mesh-list
65162851|NCT02785003|Alvimopan|alvimopan|mesh-list
65162852|NCT02785003|Analgesics|analgesics|mesh-ancestor
65162853|NCT02785003|Sensory System Agents|sensory system agents|mesh-ancestor
65162854|NCT02785003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65162855|NCT02785003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162856|NCT02785003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65162857|NCT02785003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65162858|NCT02785003|Anesthetics, General|anesthetics, general|mesh-ancestor
65162859|NCT02785003|Anesthetics|anesthetics|mesh-ancestor
65162860|NCT02785003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65162861|NCT02785003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65162862|NCT02785003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65162863|NCT02785003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65162864|NCT02785003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162865|NCT02785003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65162866|NCT02785003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65162867|NCT02785003|Antipyretics|antipyretics|mesh-ancestor
64805486|NCT01421368|Tenofovir|tenofovir|mesh-list
65162868|NCT02785003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65162869|NCT05297617|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65162870|NCT05297617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65162871|NCT05297617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162872|NCT05297617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162873|NCT05297617|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65162874|NCT05297617|Hormone Antagonists|hormone antagonists|mesh-ancestor
65162875|NCT05297617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65162876|NCT05297617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162877|NCT02782897|Immunoglobulins|immunoglobulins|mesh-list
65162878|NCT02782897|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65162880|NCT02782897|Immunologic Factors|immunologic factors|mesh-ancestor
65162881|NCT02782897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162882|NCT00638131|Bosentan|bosentan|mesh-list
65162883|NCT00638131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65162884|NCT00638131|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64507512|NCT00704964|Immunologic Factors|immunologic factors|mesh-ancestor
65319185|NCT00770484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319186|NCT00770484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319187|NCT00770484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65319188|NCT00770484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65319189|NCT00770484|Vasodilator Agents|vasodilator agents|mesh-ancestor
65319190|NCT00835679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65319191|NCT00835679|Cetuximab|cetuximab|mesh-list
65319192|NCT00835679|Dasatinib|dasatinib|mesh-list
65319193|NCT00835679|Antibodies|antibodies|mesh-list
65319194|NCT00835679|Immunoglobulins|immunoglobulins|mesh-list
65319195|NCT00835679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65319196|NCT00835679|Immunologic Factors|immunologic factors|mesh-ancestor
65319197|NCT00835679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319198|NCT00835679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319199|NCT00835679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65162918|NCT02780323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65162919|NCT02780323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65162920|NCT02780323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65162921|NCT02780323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65162922|NCT02780323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162923|NCT02780323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162924|NCT05331859|Insulin|insulin|mesh-list
65162925|NCT05331859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65162926|NCT05331859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162962|NCT05028829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64507636|NCT02047578|Busulfan|busulfan|mesh-list
65162982|NCT05322031|Dopamine Agonists|dopamine agonists|mesh-ancestor
65162983|NCT05322031|Dopamine Agents|dopamine agents|mesh-ancestor
65162984|NCT05322031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65162985|NCT05322031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162986|NCT05322031|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65162987|NCT05322031|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65162988|NCT05322031|Serotonin Agents|serotonin agents|mesh-ancestor
65162989|NCT05322031|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65162990|NCT05322031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65162991|NCT05322031|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65162992|NCT05322031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65162993|NCT02780011|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65162994|NCT02780011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65162995|NCT02780011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162996|NCT02780479|Dexamethasone|dexamethasone|mesh-list
65162997|NCT02780479|Prednisone|prednisone|mesh-list
65162998|NCT02780479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65162999|NCT02780479|Antiemetics|antiemetics|mesh-ancestor
65163000|NCT02780479|Autonomic Agents|autonomic agents|mesh-ancestor
65163001|NCT02780479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65163002|NCT02780479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163003|NCT02780479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65163004|NCT02780479|Glucocorticoids|glucocorticoids|mesh-ancestor
65163005|NCT02780479|Hormones|hormones|mesh-ancestor
65163006|NCT02780479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65163007|NCT02780479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65163008|NCT02780479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163009|NCT05252923|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
65163010|NCT05252923|Anticoagulants|anticoagulants|mesh-ancestor
64514645|NCT02712801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65163011|NCT05252923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65163012|NCT05252923|Antimetabolites|antimetabolites|mesh-ancestor
65163013|NCT05252923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319200|NCT00835679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319201|NCT00835679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319202|NCT00766506|Fentanyl|fentanyl|mesh-list
65319203|NCT00766506|Morphine|morphine|mesh-list
65319204|NCT00766506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65319205|NCT00766506|Narcotics|narcotics|mesh-ancestor
65319206|NCT00766506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65319207|NCT00766506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319208|NCT00766506|Analgesics|analgesics|mesh-ancestor
65319209|NCT00766506|Sensory System Agents|sensory system agents|mesh-ancestor
65319210|NCT00766506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65319211|NCT00766506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65319212|NCT00766506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65319213|NCT00766506|Anesthetics, General|anesthetics, general|mesh-ancestor
65319214|NCT00766506|Anesthetics|anesthetics|mesh-ancestor
65319215|NCT00770328|Pentoxifylline|pentoxifylline|mesh-list
65319216|NCT00770328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65319217|NCT00770328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319218|NCT00770328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319219|NCT00770328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65319220|NCT00770328|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65319221|NCT00770328|Protective Agents|protective agents|mesh-ancestor
65319222|NCT00770328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163014|NCT05252923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65163015|NCT05252923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65163016|NCT05252923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65163017|NCT05252923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65163046|NCT04228393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65163047|NCT04228393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163048|NCT02779777|Tipifarnib|tipifarnib|mesh-list
65163049|NCT02779777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163050|NCT05069545|Insulin|insulin|mesh-list
65163051|NCT05069545|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65163052|NCT05069545|Insulin Aspart|insulin aspart|mesh-list
65163053|NCT05069545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65163054|NCT05069545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163055|NCT05279833|Sotalol|sotalol|mesh-list
65163056|NCT05279833|Dronedarone|dronedarone|mesh-list
65163057|NCT05279833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65163058|NCT05279833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65163059|NCT05279833|Adrenergic Agents|adrenergic agents|mesh-ancestor
65163060|NCT05279833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65163061|NCT05279833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163062|NCT05279833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163063|NCT05279833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65163076|NCT05338723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163078|NCT05338723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65163079|NCT05338723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163081|NCT04975555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163082|NCT05338489|Itraconazole|itraconazole|mesh-list
65163083|NCT05338489|Rifampin|rifampin|mesh-list
65163084|NCT05338489|Antifungal Agents|antifungal agents|mesh-ancestor
65163085|NCT05338489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319223|NCT00770328|Vasodilator Agents|vasodilator agents|mesh-ancestor
65319224|NCT00770328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65319225|NCT00770328|Antioxidants|antioxidants|mesh-ancestor
65319226|NCT05500092|Gemcitabine|gemcitabine|mesh-list
65319227|NCT05500092|Cisplatin|cisplatin|mesh-list
65319228|NCT05500092|Docetaxel|docetaxel|mesh-list
65319229|NCT05500092|Nivolumab|nivolumab|mesh-list
65319230|NCT05500092|Pemetrexed|pemetrexed|mesh-list
65319231|NCT05500092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319232|NCT05500092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65319233|NCT05500092|Antimetabolites|antimetabolites|mesh-ancestor
65319234|NCT05500092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319235|NCT05500092|Antiviral Agents|antiviral agents|mesh-ancestor
65319236|NCT05500092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319237|NCT05500092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319238|NCT05500092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65319239|NCT05500092|Immunologic Factors|immunologic factors|mesh-ancestor
65319240|NCT05500092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319241|NCT05500092|Tubulin Modulators|tubulin modulators|mesh-ancestor
65319242|NCT05500092|Antimitotic Agents|antimitotic agents|mesh-ancestor
65319243|NCT05500092|Mitosis Modulators|mitosis modulators|mesh-ancestor
65319244|NCT05500092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64549138|NCT00801801|Docetaxel|docetaxel|mesh-list
65163086|NCT05338489|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65163087|NCT05338489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65163088|NCT05338489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163089|NCT05338489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163090|NCT05338489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65163091|NCT05338489|Hormone Antagonists|hormone antagonists|mesh-ancestor
65163092|NCT05338489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65163093|NCT05338489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163094|NCT05338489|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65163095|NCT05338489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65163096|NCT05338489|Antitubercular Agents|antitubercular agents|mesh-ancestor
65163097|NCT05338489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65163098|NCT05338489|Leprostatic Agents|leprostatic agents|mesh-ancestor
65163099|NCT05338489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65163100|NCT05338489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65163101|NCT05338489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65163102|NCT05338489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65163103|NCT05338489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65163104|NCT05338489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65163105|NCT05338489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65163106|NCT05266417|Insulin|insulin|mesh-list
65163107|NCT05266417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65163108|NCT05266417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163109|NCT02779465|Vitamin D|vitamin d|mesh-list
65163110|NCT02779465|Cholecalciferol|cholecalciferol|mesh-list
65163111|NCT02779465|Vitamins|vitamins|mesh-ancestor
65163112|NCT02779465|Micronutrients|micronutrients|mesh-ancestor
65163113|NCT02779465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163114|NCT02779465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65319245|NCT05500092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65319246|NCT05500092|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65319247|NCT05500092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65319248|NCT00916500|Cisplatin|cisplatin|mesh-list
65319249|NCT00916500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319250|NCT03110094|Adalimumab|adalimumab|mesh-list
65319251|NCT03110094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65319252|NCT03110094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65319253|NCT02600988|Vitamin D|vitamin d|mesh-list
65319254|NCT02600988|Ergocalciferols|ergocalciferols|mesh-list
65319255|NCT02600988|Cholecalciferol|cholecalciferol|mesh-list
65319256|NCT02600988|Vitamins|vitamins|mesh-list
65319257|NCT02600988|Micronutrients|micronutrients|mesh-ancestor
65319258|NCT02600988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319259|NCT02600988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65319260|NCT02600988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65319261|NCT04097574|Menthol|menthol|mesh-list
65319262|NCT04097574|Antipruritics|antipruritics|mesh-ancestor
65319263|NCT04097574|Dermatologic Agents|dermatologic agents|mesh-ancestor
65163115|NCT02779465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65163116|NCT02776189|Midazolam|midazolam|mesh-list
65163117|NCT02776189|Dexmedetomidine|dexmedetomidine|mesh-list
65163118|NCT02776189|Propofol|propofol|mesh-list
65163119|NCT02776189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65163120|NCT02776189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65163121|NCT02776189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163122|NCT02776189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65163123|NCT02776189|Anesthetics, General|anesthetics, general|mesh-ancestor
65163124|NCT02776189|Anesthetics|anesthetics|mesh-ancestor
65163125|NCT02776189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65163126|NCT02776189|Analgesics|analgesics|mesh-ancestor
65163152|NCT04883437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163153|NCT02775877|Letrozole|letrozole|mesh-list
65163154|NCT02775877|Clomiphene|clomiphene|mesh-list
65163155|NCT02775877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163156|NCT02775877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65163157|NCT02775877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65163158|NCT02775877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163159|NCT02775877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163160|NCT02775877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65163161|NCT02775877|Hormone Antagonists|hormone antagonists|mesh-ancestor
65163162|NCT02775877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65163163|NCT02775877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163164|NCT02775877|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64805790|NCT01423123|Paclitaxel|paclitaxel|mesh-list
65163165|NCT02775877|Fertility Agents|fertility agents|mesh-ancestor
65163166|NCT02775877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65163167|NCT02775877|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65163168|NCT02775877|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65163170|NCT02777671|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
65163171|NCT02777671|Anticonvulsants|anticonvulsants|mesh-ancestor
65163172|NCT02777671|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65163173|NCT02777671|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65163174|NCT02777671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65163175|NCT02777671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163176|NCT02777671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64507827|NCT05353192|Hormones|hormones|mesh-list
65163193|NCT04226443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65319264|NCT00766038|Hormones|hormones|mesh-list
65319265|NCT00766038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65319266|NCT00766038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319267|NCT00765882|Linaclotide|linaclotide|mesh-list
65319268|NCT00765882|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65319269|NCT00765882|Enzyme Activators|enzyme activators|mesh-ancestor
65319270|NCT00765882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319271|NCT00765882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65319272|NCT00913367|Insulin|insulin|mesh-list
65319273|NCT00913367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65319274|NCT00913367|Metformin|metformin|mesh-list
65319275|NCT00913367|Insulin Glargine|insulin glargine|mesh-list
65319276|NCT00913367|Glimepiride|glimepiride|mesh-list
65319277|NCT00913367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65319278|NCT00913367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163194|NCT04226443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163196|NCT04226443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65163197|NCT04226443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65163198|NCT04226443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65163199|NCT04226443|Anesthetics, General|anesthetics, general|mesh-ancestor
65163200|NCT04226443|Anesthetics|anesthetics|mesh-ancestor
65163201|NCT04226443|GABA Modulators|gaba modulators|mesh-ancestor
65163202|NCT04226443|GABA Agents|gaba agents|mesh-ancestor
65163203|NCT04226443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65163204|NCT04226443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163205|NCT04226443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65163206|NCT04226443|Narcotics|narcotics|mesh-ancestor
65163207|NCT04226443|Analgesics|analgesics|mesh-ancestor
65163208|NCT04226443|Sensory System Agents|sensory system agents|mesh-ancestor
65163209|NCT04226443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65163210|NCT02776891|Citric Acid|citric acid|mesh-list
65163211|NCT02776891|Sodium Citrate|sodium citrate|mesh-list
65163212|NCT02776891|Gallium citrate|gallium citrate|mesh-list
65163213|NCT02776891|Anticoagulants|anticoagulants|mesh-ancestor
65163214|NCT02776891|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65163215|NCT02776891|Chelating Agents|chelating agents|mesh-ancestor
65163216|NCT02776891|Sequestering Agents|sequestering agents|mesh-ancestor
65163217|NCT02776891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163218|NCT02776891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65163219|NCT02776813|Rituximab|rituximab|mesh-list
65163220|NCT02776813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65163221|NCT02776813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163222|NCT02776813|Immunologic Factors|immunologic factors|mesh-ancestor
65163223|NCT02776813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163224|NCT02776813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65163225|NCT05157997|Antibodies|antibodies|mesh-list
65163226|NCT05157997|Immunologic Factors|immunologic factors|mesh-ancestor
65163227|NCT05157997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163228|NCT02773147|Pyridoxine|pyridoxine|mesh-list
65163229|NCT02773147|Vitamin B 12|vitamin b 12|mesh-list
65163230|NCT02773147|Hydroxocobalamin|hydroxocobalamin|mesh-list
65163231|NCT02773147|Hematinics|hematinics|mesh-ancestor
65163232|NCT02773147|Vitamin B Complex|vitamin b complex|mesh-ancestor
65163233|NCT02773147|Vitamins|vitamins|mesh-ancestor
65163234|NCT02773147|Micronutrients|micronutrients|mesh-ancestor
65163235|NCT02773147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163236|NCT02773927|Metformin|metformin|mesh-list
64507872|NCT03303924|Sulbactam|sulbactam|mesh-list
65163261|NCT04771741|Ketorolac|ketorolac|mesh-list
65163262|NCT04771741|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65163263|NCT04771741|Meloxicam|meloxicam|mesh-list
65163264|NCT04771741|Pregabalin|pregabalin|mesh-list
65163265|NCT04771741|Cyclobenzaprine|cyclobenzaprine|mesh-list
65163266|NCT04771741|Analgesics|analgesics|mesh-ancestor
65163267|NCT04771741|Sensory System Agents|sensory system agents|mesh-ancestor
65319279|NCT00913367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65319280|NCT00913367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65319281|NCT00913367|Immunologic Factors|immunologic factors|mesh-ancestor
65319282|NCT00828113|Varenicline|varenicline|mesh-list
65319283|NCT00828113|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65319284|NCT00828113|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65319285|NCT00828113|Cholinergic Agents|cholinergic agents|mesh-ancestor
65319286|NCT00828113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65319287|NCT00828113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319288|NCT00828113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319289|NCT00707135|Sirolimus|sirolimus|mesh-list
65319290|NCT00707135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65319291|NCT00707135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64549175|NCT03084601|Calcium|calcium|mesh-list
65163268|NCT04771741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65163269|NCT04771741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163270|NCT04771741|Anticonvulsants|anticonvulsants|mesh-ancestor
65163271|NCT04771741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65163272|NCT04771741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65163273|NCT04771741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163274|NCT04771741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65163275|NCT04771741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65163276|NCT04771741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65163277|NCT04771741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65163278|NCT04771741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65163279|NCT04771741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65163280|NCT04771741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65163281|NCT04771741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65163282|NCT04771741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65163283|NCT04771741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65163284|NCT04771741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163303|NCT02772601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65163304|NCT02772601|Anesthetics, General|anesthetics, general|mesh-ancestor
65163306|NCT02772601|GABA Modulators|gaba modulators|mesh-ancestor
65163307|NCT02772601|GABA Agents|gaba agents|mesh-ancestor
65163308|NCT02772601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65163309|NCT02772601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163310|NCT02772601|Anticoagulants|anticoagulants|mesh-ancestor
65163311|NCT02772601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65163312|NCT02772601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65163313|NCT02772601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163314|NCT02772601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65163315|NCT02772601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65163316|NCT02772601|Purinergic Agents|purinergic agents|mesh-ancestor
65163317|NCT02772601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65163318|NCT02772601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65163319|NCT02772601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65163320|NCT02772601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65163321|NCT02772601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65163322|NCT02772601|Sympatholytics|sympatholytics|mesh-ancestor
65163323|NCT02772601|Autonomic Agents|autonomic agents|mesh-ancestor
65163324|NCT02772601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65163325|NCT02772601|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65163326|NCT02772601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65163327|NCT02772601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65163328|NCT02772601|Adrenergic Agents|adrenergic agents|mesh-ancestor
65163329|NCT02772211|Cycloserine|cycloserine|mesh-list
65163330|NCT02772211|Ketamine|ketamine|mesh-list
65163331|NCT02772211|Analgesics|analgesics|mesh-ancestor
65163332|NCT02772211|Sensory System Agents|sensory system agents|mesh-ancestor
65163333|NCT02772211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65319292|NCT00707135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65319293|NCT00707135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319294|NCT00707135|Antifungal Agents|antifungal agents|mesh-ancestor
65319295|NCT00707135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65319296|NCT00707135|Immunologic Factors|immunologic factors|mesh-ancestor
65319297|NCT00707135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319298|NCT00769704|Molgramostim|molgramostim|mesh-list
65319299|NCT00769704|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
65319300|NCT00769704|Sargramostim|sargramostim|mesh-list
65319301|NCT00769704|Immunologic Factors|immunologic factors|mesh-ancestor
65319302|NCT00769704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319303|NCT00769704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319304|NCT00769704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65319305|NCT00818753|Heparin|heparin|mesh-list
65319306|NCT00818753|Calcium heparin|calcium heparin|mesh-list
65319307|NCT00818753|Dabigatran|dabigatran|mesh-list
65319308|NCT00818753|Anticoagulants|anticoagulants|mesh-ancestor
65319309|NCT00818753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65319310|NCT00818753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65319311|NCT00818753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319312|NCT00818753|Antithrombins|antithrombins|mesh-ancestor
65319313|NCT00818753|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65319314|NCT00818753|Protease Inhibitors|protease inhibitors|mesh-ancestor
65163334|NCT02772211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163335|NCT02772211|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65163336|NCT02772211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65163337|NCT02772211|Anesthetics, General|anesthetics, general|mesh-ancestor
65163338|NCT02772211|Anesthetics|anesthetics|mesh-ancestor
65163339|NCT02772211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65163340|NCT02772211|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65163341|NCT02772211|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65163342|NCT02772211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65163343|NCT02772211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163344|NCT02772211|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65163380|NCT02767375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65163381|NCT02767375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163398|NCT02767219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65163399|NCT02767219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65163400|NCT02767219|Glucocorticoids|glucocorticoids|mesh-ancestor
65163401|NCT02767219|Hormones|hormones|mesh-ancestor
65163402|NCT02767219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65163403|NCT02767219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65163404|NCT02767219|Antimetabolites|antimetabolites|mesh-ancestor
65163405|NCT02767219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163406|NCT02767219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65163407|NCT02767219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65163408|NCT02767219|Immunologic Factors|immunologic factors|mesh-ancestor
65163409|NCT02771587|Ethanol|ethanol|mesh-list
65163410|NCT02771587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65163411|NCT02771587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65163412|NCT02771587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65319315|NCT00818753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319316|NCT00704249|Nevirapine|nevirapine|mesh-list
65319317|NCT00704249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65319318|NCT00704249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65319319|NCT00704249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319320|NCT00704249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319321|NCT00704249|Antiviral Agents|antiviral agents|mesh-ancestor
65319322|NCT00704249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319323|NCT00704249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65319324|NCT00704249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65319325|NCT00704249|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65319326|NCT00704249|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65319327|NCT00765726|Factor VIII|factor viii|mesh-list
65319328|NCT00765726|Coagulants|coagulants|mesh-ancestor
65319329|NCT04100226|Vitamin D|vitamin d|mesh-list
65319330|NCT04100226|Cholecalciferol|cholecalciferol|mesh-list
65319331|NCT04100226|Calcium Carbonate|calcium carbonate|mesh-list
65319332|NCT04100226|Vitamins|vitamins|mesh-ancestor
65319333|NCT04100226|Micronutrients|micronutrients|mesh-ancestor
65319334|NCT04100226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319335|NCT04100226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65319336|NCT04100226|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65319337|NCT04100226|Antacids|antacids|mesh-ancestor
65319338|NCT04100226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319339|NCT04100226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65319340|NCT00765336|Minocycline|minocycline|mesh-list
65319341|NCT00765336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65319342|NCT00765336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319343|NCT00818519|Drospirenone|drospirenone|mesh-list
65319344|NCT00818519|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65319345|NCT00818519|Hormone Antagonists|hormone antagonists|mesh-ancestor
65319346|NCT00818519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65319349|NCT00818519|Diuretics|diuretics|mesh-ancestor
65319357|NCT00765102|Romidepsin|romidepsin|mesh-list
65319358|NCT00765102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319359|NCT00765102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65319360|NCT00809354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65319361|NCT00809354|Tanezumab|tanezumab|mesh-list
65319362|NCT00809354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65319363|NCT00809354|Analgesics|analgesics|mesh-ancestor
65319364|NCT00809354|Sensory System Agents|sensory system agents|mesh-ancestor
65319365|NCT00809354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65319366|NCT00809354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319367|NCT00809354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65319368|NCT00809354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65319369|NCT00834899|Eptifibatide|eptifibatide|mesh-list
65319370|NCT00834899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65319371|NCT00764946|Raltegravir Potassium|raltegravir potassium|mesh-list
65319372|NCT00764946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65319373|NCT00764946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65319374|NCT00764946|Antiviral Agents|antiviral agents|mesh-ancestor
65319375|NCT00764946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319376|NCT00764946|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65319377|NCT00764946|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65319378|NCT00764946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319379|NCT00764946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319380|NCT00764868|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65319381|NCT00764868|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65319382|NCT00764868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319383|NCT00764868|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65319384|NCT00764868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65319385|NCT00764868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65319386|NCT00764868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319387|NCT00764868|Dopamine Agents|dopamine agents|mesh-ancestor
65319388|NCT00764868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65319389|NCT05752916|Clopidogrel|clopidogrel|mesh-list
65319390|NCT05752916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65319391|NCT05752916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163413|NCT02771587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163414|NCT02771743|Cyclophosphamide|cyclophosphamide|mesh-list
65163415|NCT02771743|Ifosfamide|ifosfamide|mesh-list
65163416|NCT02771743|Carboplatin|carboplatin|mesh-list
65319392|NCT05752916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319393|NCT05752916|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65319394|NCT05752916|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65319395|NCT05752916|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65319396|NCT05752916|Purinergic Agents|purinergic agents|mesh-ancestor
65319397|NCT05752916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65163417|NCT02771743|Doxorubicin|doxorubicin|mesh-list
65163418|NCT02771743|Etoposide|etoposide|mesh-list
65163419|NCT02771743|Interleukin-2|interleukin-2|mesh-list
65163420|NCT02771743|Isotretinoin|isotretinoin|mesh-list
65163421|NCT02771743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65163422|NCT02771743|Immunologic Factors|immunologic factors|mesh-ancestor
65163423|NCT02771743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163424|NCT02771743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65163425|NCT02771743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65163426|NCT02771743|Alkylating Agents|alkylating agents|mesh-ancestor
65163427|NCT02771743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163428|NCT02771743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163429|NCT02771743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65163430|NCT02771743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65163431|NCT02771743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65163432|NCT02771743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65163433|NCT02771743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163434|NCT02771743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65163435|NCT02771743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65163436|NCT02771743|Analgesics|analgesics|mesh-ancestor
65163437|NCT02771743|Sensory System Agents|sensory system agents|mesh-ancestor
65163438|NCT02771743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65163439|NCT02771743|Dermatologic Agents|dermatologic agents|mesh-ancestor
65163440|NCT02762851|Vaccines|vaccines|mesh-list
65163441|NCT02762851|Immunologic Factors|immunologic factors|mesh-ancestor
65163465|NCT02766439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65163466|NCT02766439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65163467|NCT02766439|Analgesics|analgesics|mesh-ancestor
65163468|NCT02766439|Sensory System Agents|sensory system agents|mesh-ancestor
65163469|NCT02766439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65163470|NCT02766439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163471|NCT02766439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65163472|NCT02766439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65163473|NCT02766439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65163474|NCT02766439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65163475|NCT02766439|Immunologic Factors|immunologic factors|mesh-ancestor
65163476|NCT04701307|Niraparib|niraparib|mesh-list
65163477|NCT04701307|Immunoglobulins|immunoglobulins|mesh-list
65163478|NCT04701307|Immunoglobulin G|immunoglobulin g|mesh-list
65163479|NCT04701307|Immunologic Factors|immunologic factors|mesh-ancestor
65163480|NCT04701307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163481|NCT04701307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65163482|NCT04701307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163483|NCT04701307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163484|NCT04701307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163485|NCT02765971|Picosulfate sodium|picosulfate sodium|mesh-list
65163486|NCT02765971|Cathartics|cathartics|mesh-ancestor
65163487|NCT02765971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65163488|NCT02765815|Ketorolac|ketorolac|mesh-list
65163489|NCT02765815|Epinephrine|epinephrine|mesh-list
65163490|NCT02765815|Racepinephrine|racepinephrine|mesh-list
65163491|NCT02765815|Morphine|morphine|mesh-list
65163492|NCT02765815|Bupivacaine|bupivacaine|mesh-list
65163493|NCT02765815|Epinephryl borate|epinephryl borate|mesh-list
65163494|NCT02765815|Anesthetics, Local|anesthetics, local|mesh-ancestor
65163495|NCT02765815|Anesthetics|anesthetics|mesh-ancestor
65163496|NCT02765815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65163515|NCT02765815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65163516|NCT02765815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65163517|NCT02765815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65163518|NCT02765815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65163519|NCT02765815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65163520|NCT02765815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65319398|NCT03990896|Talazoparib|talazoparib|mesh-list
65319399|NCT03990896|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65319400|NCT03990896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319401|NCT03990896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319402|NCT03990896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319403|NCT00756444|Panitumumab|panitumumab|mesh-list
65319404|NCT00756444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319405|NCT00756444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65319406|NCT00753012|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65319407|NCT00753012|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65319408|NCT00753012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319409|NCT00753012|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65319410|NCT00753012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65319411|NCT00753012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65319412|NCT00753012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319413|NCT00753012|Dopamine Agents|dopamine agents|mesh-ancestor
65319414|NCT00753012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65319415|NCT00806156|Etirinotecan pegol|etirinotecan pegol|mesh-list
65319416|NCT00806156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319417|NCT00806156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65319418|NCT00806156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65319419|NCT00806156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319420|NCT00806156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319421|NCT00764478|Asenapine|asenapine|mesh-list
65319422|NCT00764478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65319423|NCT00764478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64549289|NCT03703375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65163521|NCT02765815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163522|NCT02765347|Metformin|metformin|mesh-list
65163523|NCT02765347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64697011|NCT00360464|Azithromycin|azithromycin|mesh-list
65163524|NCT02765347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163526|NCT02770885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65163527|NCT02770885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163528|NCT02770651|Everolimus|everolimus|mesh-list
65163529|NCT02770651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163530|NCT02770651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65163531|NCT02770651|Immunologic Factors|immunologic factors|mesh-ancestor
65163532|NCT02770651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163533|NCT02770729|Moxifloxacin|moxifloxacin|mesh-list
65163534|NCT02770729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65163535|NCT02770729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65163536|NCT02770729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65163537|NCT02770729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65163538|NCT02770729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65319424|NCT00764478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65319425|NCT00764478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319426|NCT00764478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65319427|NCT00805766|Infliximab|infliximab|mesh-list
65319428|NCT00805766|Dermatologic Agents|dermatologic agents|mesh-ancestor
65319429|NCT00805766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65069407|NCT00287534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319430|NCT00805766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65319432|NCT00764322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65319433|NCT00764322|Hormone Antagonists|hormone antagonists|mesh-ancestor
65319434|NCT00764322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65319435|NCT00764322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319436|NCT00764322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65319437|NCT00764322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319438|NCT00764322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65319439|NCT00764322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65319440|NCT00764322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65319441|NCT03908060|Morphine|morphine|mesh-list
65319442|NCT03908060|Methadone|methadone|mesh-list
65319443|NCT03908060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65319444|NCT03908060|Narcotics|narcotics|mesh-ancestor
65319445|NCT03908060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65319446|NCT03908060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319447|NCT03908060|Analgesics|analgesics|mesh-ancestor
65319448|NCT03908060|Sensory System Agents|sensory system agents|mesh-ancestor
65319449|NCT03908060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65319450|NCT03908060|Antitussive Agents|antitussive agents|mesh-ancestor
65319451|NCT03908060|Respiratory System Agents|respiratory system agents|mesh-ancestor
65163539|NCT02770729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163540|NCT02770729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163541|NCT02770729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163542|NCT02770729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65163543|NCT02770729|Contraceptive Agents|contraceptive agents|mesh-ancestor
64806157|NCT01425073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65163544|NCT02770729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65163545|NCT02770729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163546|NCT02770729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65163547|NCT02770729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65163548|NCT02770729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65163549|NCT02770261|Candesartan|candesartan|mesh-list
65163550|NCT02770261|Candesartan cilexetil|candesartan cilexetil|mesh-list
65163551|NCT02770261|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65163552|NCT02770261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65163558|NCT02770261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163559|NCT02770261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65319452|NCT00752856|Ritonavir|ritonavir|mesh-list
65319453|NCT00752856|Lopinavir|lopinavir|mesh-list
65319454|NCT00752856|Tenofovir|tenofovir|mesh-list
65319455|NCT00752856|Emtricitabine|emtricitabine|mesh-list
65319456|NCT00752856|Raltegravir Potassium|raltegravir potassium|mesh-list
65319457|NCT00752856|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65319458|NCT00752856|Efavirenz|efavirenz|mesh-list
65319459|NCT00752856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65319460|NCT00752856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65319461|NCT00752856|Protease Inhibitors|protease inhibitors|mesh-ancestor
65319462|NCT00752856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319463|NCT00752856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319464|NCT00752856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65319465|NCT00752856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65319466|NCT00752856|Antiviral Agents|antiviral agents|mesh-ancestor
65319467|NCT00752856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319479|NCT00805142|Tapentadol|tapentadol|mesh-list
65319509|NCT03684980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319510|NCT03684980|Dermatologic Agents|dermatologic agents|mesh-ancestor
65319511|NCT03684980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319512|NCT03684980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65319513|NCT03684980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65319514|NCT03684980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65319515|NCT03684980|Antidotes|antidotes|mesh-ancestor
65319516|NCT03684980|Protective Agents|protective agents|mesh-ancestor
65319517|NCT03684980|Vitamin B Complex|vitamin b complex|mesh-ancestor
65319518|NCT03684980|Vitamins|vitamins|mesh-ancestor
65319519|NCT03684980|Micronutrients|micronutrients|mesh-ancestor
65319520|NCT00761319|Travoprost|travoprost|mesh-list
65319521|NCT00761319|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65319522|NCT00761319|Latanoprost|latanoprost|mesh-list
65319523|NCT00761319|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65319524|NCT00761319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65319525|NCT00704639|Carboplatin|carboplatin|mesh-list
65319526|NCT00704639|Cetuximab|cetuximab|mesh-list
65319527|NCT00704639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319528|NCT00704639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65319529|NCT00826943|Cetirizine|cetirizine|mesh-list
65319530|NCT00826943|Levocetirizine|levocetirizine|mesh-list
65319531|NCT00826943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65319532|NCT00826943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65319533|NCT00826943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65319534|NCT00826943|Histamine Antagonists|histamine antagonists|mesh-ancestor
65319535|NCT00826943|Histamine Agents|histamine agents|mesh-ancestor
65319536|NCT00826943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65319537|NCT00826943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319538|NCT00826943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319539|NCT00707369|Amoxicillin|amoxicillin|mesh-list
65319540|NCT00707369|Metronidazole|metronidazole|mesh-list
65319541|NCT00707369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65319542|NCT00707369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319543|NCT00707369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64549483|NCT00804609|Lidocaine|lidocaine|mesh-list
65163560|NCT02770261|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65163561|NCT02770261|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65163563|NCT02770105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65163564|NCT02770105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163565|NCT02770105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65163566|NCT02770105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319544|NCT00707369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65319545|NCT00760929|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65319546|NCT00760929|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65319547|NCT00760929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319548|NCT00760929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65319549|NCT00760929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319550|NCT00760929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319551|NCT00760929|Immunologic Factors|immunologic factors|mesh-ancestor
65319552|NCT00760929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319553|NCT00704951|Posaconazole|posaconazole|mesh-list
65319554|NCT00704951|Antifungal Agents|antifungal agents|mesh-ancestor
65319555|NCT00704951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319556|NCT00704951|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65319557|NCT00704951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65319558|NCT00704951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65163567|NCT02770105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163568|NCT02770105|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65163569|NCT02770105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65163570|NCT02770105|Purinergic Agents|purinergic agents|mesh-ancestor
65163571|NCT02770105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65163572|NCT02769793|Levodopa|levodopa|mesh-list
65163573|NCT02769793|Benserazide|benserazide|mesh-list
65163574|NCT02769793|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
65163575|NCT02769793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65163576|NCT02769793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65163577|NCT02769793|Dopamine Agents|dopamine agents|mesh-ancestor
65163578|NCT02769793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65163579|NCT02769793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163580|NCT02769793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163581|NCT02769793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163582|NCT02769325|Ketorolac|ketorolac|mesh-list
65163583|NCT02769325|Atropine|atropine|mesh-list
65163584|NCT02769325|Morphine|morphine|mesh-list
65163585|NCT02769325|Propofol|propofol|mesh-list
65163586|NCT02769325|Sevoflurane|sevoflurane|mesh-list
65163587|NCT02769325|Rocuronium|rocuronium|mesh-list
65163588|NCT02769325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65163589|NCT02769325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65163590|NCT02769325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163591|NCT02769325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65163592|NCT02769325|Anesthetics, General|anesthetics, general|mesh-ancestor
65163593|NCT02769325|Anesthetics|anesthetics|mesh-ancestor
65163594|NCT02769325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65163595|NCT02769325|Narcotics|narcotics|mesh-ancestor
65163596|NCT02769325|Analgesics|analgesics|mesh-ancestor
64697097|NCT01641822|Tobramycin|tobramycin|mesh-list
65163597|NCT02769325|Sensory System Agents|sensory system agents|mesh-ancestor
65163598|NCT02769325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65163599|NCT02769325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65163600|NCT02769325|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65163601|NCT02769325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65163602|NCT02769325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65163603|NCT02769325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65163604|NCT02769325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65163605|NCT02769325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65163606|NCT02769325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163607|NCT02769325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163608|NCT02769325|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65163609|NCT02769325|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65163610|NCT02769325|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65163611|NCT02769325|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65319559|NCT00704951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65319560|NCT00704951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65319561|NCT00704951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319562|NCT00704951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319563|NCT00704951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65319564|NCT00704951|Hormone Antagonists|hormone antagonists|mesh-ancestor
65319565|NCT00704951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65319566|NCT00704951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319567|NCT00759915|Morphine|morphine|mesh-list
65319568|NCT00759915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65319569|NCT00759915|Narcotics|narcotics|mesh-ancestor
65319570|NCT00759915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65319571|NCT00759915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319572|NCT00759915|Analgesics|analgesics|mesh-ancestor
65319573|NCT00759915|Sensory System Agents|sensory system agents|mesh-ancestor
65319574|NCT00759915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65319575|NCT00759759|Morphine|morphine|mesh-list
65319576|NCT00759759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65319577|NCT00759759|Narcotics|narcotics|mesh-ancestor
65319578|NCT00759759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65163612|NCT02769325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65163613|NCT02769325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65163614|NCT02769325|Autonomic Agents|autonomic agents|mesh-ancestor
65163615|NCT02769325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65163616|NCT02769325|Respiratory System Agents|respiratory system agents|mesh-ancestor
65163617|NCT02769325|Mydriatics|mydriatics|mesh-ancestor
65163618|NCT02769325|Parasympatholytics|parasympatholytics|mesh-ancestor
65163619|NCT02769325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64508246|NCT02485444|Oxytocin|oxytocin|mesh-list
65163627|NCT04224649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65163628|NCT04224649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163629|NCT04224649|Sensory System Agents|sensory system agents|mesh-ancestor
65163630|NCT04224649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65163631|NCT04224649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65163632|NCT04224649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65163633|NCT04224649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65163634|NCT04224649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65163635|NCT04224649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163636|NCT04224649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65163637|NCT04224649|Immunologic Factors|immunologic factors|mesh-ancestor
65163638|NCT04224649|Viscosupplements|viscosupplements|mesh-ancestor
65163639|NCT04224649|Protective Agents|protective agents|mesh-ancestor
65163640|NCT02769169|Ranibizumab|ranibizumab|mesh-list
65163641|NCT02769169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65163642|NCT02769169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65163643|NCT02769169|Growth Substances|growth substances|mesh-ancestor
65163644|NCT02769169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163645|NCT02769169|Growth Inhibitors|growth inhibitors|mesh-ancestor
65163646|NCT02769169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163647|NCT02769013|Praziquantel|praziquantel|mesh-list
65163648|NCT02769013|Anthelmintics|anthelmintics|mesh-ancestor
65163649|NCT02769013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65163650|NCT02769013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319579|NCT00759759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319580|NCT00759759|Analgesics|analgesics|mesh-ancestor
65319581|NCT00759759|Sensory System Agents|sensory system agents|mesh-ancestor
65319582|NCT00759759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65319584|NCT00759681|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
65319585|NCT00759681|Hemostatics|hemostatics|mesh-ancestor
65163651|NCT02768545|Ezetimibe|ezetimibe|mesh-list
65163652|NCT02768545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65163653|NCT02768545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65163654|NCT02768545|Antimetabolites|antimetabolites|mesh-ancestor
65163655|NCT02768545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163656|NCT02768545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65163657|NCT02764723|Bupivacaine|bupivacaine|mesh-list
65163658|NCT02764723|Ropivacaine|ropivacaine|mesh-list
65163659|NCT02764723|Anesthetics, Local|anesthetics, local|mesh-ancestor
65163660|NCT02764723|Anesthetics|anesthetics|mesh-ancestor
65163661|NCT02764723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65163662|NCT02764723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163663|NCT02764723|Sensory System Agents|sensory system agents|mesh-ancestor
65163664|NCT02764723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65163665|NCT04664959|Denosumab|denosumab|mesh-list
65163666|NCT04664959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65163667|NCT04664959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163668|NCT00951496|Paclitaxel|paclitaxel|mesh-list
65163669|NCT00951496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65163670|NCT00951496|Bevacizumab|bevacizumab|mesh-list
65163671|NCT00951496|Cisplatin|cisplatin|mesh-list
65163672|NCT00951496|Carboplatin|carboplatin|mesh-list
65163673|NCT00951496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65163674|NCT00951496|Endothelial Growth Factors|endothelial growth factors|mesh-list
65163675|NCT00951496|Antibodies|antibodies|mesh-list
65163676|NCT00951496|Immunoglobulins|immunoglobulins|mesh-list
65163677|NCT00951496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65163678|NCT00951496|Immunoglobulin G|immunoglobulin g|mesh-list
65163679|NCT00951496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65163680|NCT00951496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163681|NCT00951496|Tubulin Modulators|tubulin modulators|mesh-ancestor
65163682|NCT00951496|Antimitotic Agents|antimitotic agents|mesh-ancestor
65163683|NCT00951496|Mitosis Modulators|mitosis modulators|mesh-ancestor
65163684|NCT00951496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163685|NCT00951496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65163686|NCT00951496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65163687|NCT00951496|Growth Substances|growth substances|mesh-ancestor
65163688|NCT00951496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163689|NCT00951496|Growth Inhibitors|growth inhibitors|mesh-ancestor
65163700|NCT02768077|Melatonin|melatonin|mesh-list
65163701|NCT02768077|Antioxidants|antioxidants|mesh-ancestor
65163702|NCT02768077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163703|NCT02768077|Protective Agents|protective agents|mesh-ancestor
65163704|NCT02768077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163705|NCT02768077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65163706|NCT01193244|Prednisone|prednisone|mesh-list
65163707|NCT01193244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65163708|NCT01193244|Glucocorticoids|glucocorticoids|mesh-ancestor
65163709|NCT01193244|Hormones|hormones|mesh-ancestor
65163710|NCT01193244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65163711|NCT01193244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163712|NCT01193244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65163713|NCT01193244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163714|NCT02768389|Bevacizumab|bevacizumab|mesh-list
65163715|NCT02768389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65163716|NCT02768389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163717|NCT02768389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65163718|NCT02768389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65163719|NCT02768389|Growth Substances|growth substances|mesh-ancestor
65163720|NCT02768389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163721|NCT02768389|Growth Inhibitors|growth inhibitors|mesh-ancestor
65163722|NCT04224337|Doxorubicin|doxorubicin|mesh-list
65163723|NCT04224337|Durvalumab|durvalumab|mesh-list
65163724|NCT04224337|Ifosfamide|ifosfamide|mesh-list
65163725|NCT04224337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65319586|NCT00759681|Coagulants|coagulants|mesh-ancestor
65319587|NCT00826241|Temozolomide|temozolomide|mesh-list
65319588|NCT00826241|Lapatinib|lapatinib|mesh-list
65319589|NCT00826241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65319590|NCT00826241|Alkylating Agents|alkylating agents|mesh-ancestor
65319591|NCT00826241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319592|NCT00826241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319593|NCT00826241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65319594|NCT00826241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319595|NCT04097847|Clodronic Acid|clodronic acid|mesh-list
65319596|NCT04097847|Tocopherols|tocopherols|mesh-list
65319597|NCT04097847|Vitamin E|vitamin e|mesh-list
65319598|NCT04097847|Tocotrienols|tocotrienols|mesh-list
65319599|NCT04097847|alpha-Tocopherol|alpha-tocopherol|mesh-list
65319600|NCT04097847|Pentoxifylline|pentoxifylline|mesh-list
65163726|NCT04224337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163727|NCT04224337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65163728|NCT04224337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65163729|NCT04224337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163730|NCT04224337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163731|NCT04224337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65163732|NCT04224337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65163733|NCT04224337|Alkylating Agents|alkylating agents|mesh-ancestor
65163734|NCT02767999|Fluoxetine|fluoxetine|mesh-list
65163735|NCT02767999|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65163736|NCT02767999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65163737|NCT02767999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65163738|NCT02767999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163739|NCT02767999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65163740|NCT02767999|Serotonin Agents|serotonin agents|mesh-ancestor
65163741|NCT02767999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163742|NCT02767999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65163743|NCT02767999|Antidepressive Agents|antidepressive agents|mesh-ancestor
65163744|NCT02767999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65163745|NCT02767999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65163746|NCT02767999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65163747|NCT02767999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163748|NCT02764021|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65163749|NCT02764021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163763|NCT01192152|Incretins|incretins|mesh-ancestor
65163764|NCT01192152|Hormones|hormones|mesh-ancestor
65163765|NCT01192152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65163766|NCT01192152|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65163767|NCT01192152|Protease Inhibitors|protease inhibitors|mesh-ancestor
65163768|NCT01192152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163769|NCT01192152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163770|NCT04572451|Nivolumab|nivolumab|mesh-list
65163771|NCT04572451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65163772|NCT04572451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163773|NCT04572451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65163774|NCT04572451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163775|NCT02758249|Propofol|propofol|mesh-list
65163776|NCT02758249|Sevoflurane|sevoflurane|mesh-list
65163777|NCT02758249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65163778|NCT02758249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65163779|NCT02758249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163780|NCT02758249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65163781|NCT02758249|Anesthetics, General|anesthetics, general|mesh-ancestor
65163782|NCT02758249|Anesthetics|anesthetics|mesh-ancestor
65163783|NCT02758249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65319601|NCT04097847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65319602|NCT04097847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319603|NCT04097847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319604|NCT04097847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65319605|NCT04097847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65319606|NCT04097847|Protective Agents|protective agents|mesh-ancestor
65319607|NCT04097847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319608|NCT04097847|Vasodilator Agents|vasodilator agents|mesh-ancestor
65319609|NCT04097847|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65319610|NCT04097847|Antioxidants|antioxidants|mesh-ancestor
65319611|NCT04097847|Vitamins|vitamins|mesh-ancestor
65319612|NCT04097847|Micronutrients|micronutrients|mesh-ancestor
65319613|NCT04097847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65319614|NCT00762372|Nitrous Oxide|nitrous oxide|mesh-list
65319615|NCT00762372|Sevoflurane|sevoflurane|mesh-list
65319616|NCT00762372|Desflurane|desflurane|mesh-list
65319617|NCT00762372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65319618|NCT00762372|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65319619|NCT00762372|Anesthetics, General|anesthetics, general|mesh-ancestor
65319620|NCT00762372|Anesthetics|anesthetics|mesh-ancestor
65319621|NCT00762372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65319622|NCT00762372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319623|NCT00762372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65319624|NCT00762372|Analgesics|analgesics|mesh-ancestor
65163784|NCT02758249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65163785|NCT02758405|Fentanyl|fentanyl|mesh-list
65163786|NCT02758405|Bupivacaine|bupivacaine|mesh-list
65163787|NCT02758405|Anesthetics, Local|anesthetics, local|mesh-ancestor
65163788|NCT02758405|Anesthetics|anesthetics|mesh-ancestor
65163789|NCT02758405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65163790|NCT02758405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163791|NCT02758405|Sensory System Agents|sensory system agents|mesh-ancestor
65163792|NCT02758405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65163793|NCT02758405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65163794|NCT02758405|Narcotics|narcotics|mesh-ancestor
65163795|NCT02758405|Analgesics|analgesics|mesh-ancestor
65163796|NCT02758405|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65163797|NCT02758405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65163798|NCT02758405|Anesthetics, General|anesthetics, general|mesh-ancestor
65163799|NCT04549207|Denosumab|denosumab|mesh-list
65163800|NCT04549207|Zoledronic Acid|zoledronic acid|mesh-list
65163801|NCT04549207|Pamidronate|pamidronate|mesh-list
65163802|NCT04549207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65163803|NCT04549207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163804|NCT02758327|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65163805|NCT02758327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65163806|NCT02758327|Lubricant Eye Drops|lubricant eye drops|mesh-list
65163807|NCT02758327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65163808|NCT02758327|Laxatives|laxatives|mesh-ancestor
65163809|NCT02758327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65163810|NCT02763475|Cyclophosphamide|cyclophosphamide|mesh-list
65163811|NCT02763475|Fludarabine|fludarabine|mesh-list
65163812|NCT02763475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65163813|NCT02763475|Immunologic Factors|immunologic factors|mesh-ancestor
65319625|NCT00762372|Sensory System Agents|sensory system agents|mesh-ancestor
65319626|NCT00762372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65319627|NCT00833261|Paclitaxel|paclitaxel|mesh-list
65319628|NCT00833261|Cetuximab|cetuximab|mesh-list
65319629|NCT00833261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65319630|NCT00833261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319631|NCT00833261|Tubulin Modulators|tubulin modulators|mesh-ancestor
65319632|NCT00833261|Antimitotic Agents|antimitotic agents|mesh-ancestor
65319633|NCT00833261|Mitosis Modulators|mitosis modulators|mesh-ancestor
65319634|NCT00833261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319635|NCT00833261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65319636|NCT00833027|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65319637|NCT00833027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65319638|NCT00833027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319639|NCT00833027|Incretins|incretins|mesh-ancestor
65319640|NCT00833027|Hormones|hormones|mesh-ancestor
65319641|NCT00833027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65319642|NCT00833027|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65319643|NCT00833027|Protease Inhibitors|protease inhibitors|mesh-ancestor
65319644|NCT00833027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319645|NCT00833027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319646|NCT00752622|Infliximab|infliximab|mesh-list
65319647|NCT00752622|Dermatologic Agents|dermatologic agents|mesh-ancestor
65319675|NCT00754572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65319676|NCT00754572|Immunologic Factors|immunologic factors|mesh-ancestor
65319677|NCT00754572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65319678|NCT00754572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65319679|NCT00824993|Ibandronic Acid|ibandronic acid|mesh-list
65319680|NCT00824993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319681|NCT00824993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65319682|NCT04095312|Pancrelipase|pancrelipase|mesh-list
65319683|NCT04095312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65319684|NCT04095390|Capecitabine|capecitabine|mesh-list
65319685|NCT04095390|Letrozole|letrozole|mesh-list
65319686|NCT04095390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65319687|NCT04095390|Antimetabolites|antimetabolites|mesh-ancestor
65319688|NCT04095390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982072|NCT00119730|Rituximab|rituximab|mesh-list
65163820|NCT02763475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65163821|NCT02762383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65163822|NCT02762383|Antiviral Agents|antiviral agents|mesh-ancestor
65163823|NCT02762383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65163825|NCT02758015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65163826|NCT02758015|Lipotropic Agents|lipotropic agents|mesh-ancestor
65163827|NCT02758015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65163828|NCT02758015|Antimetabolites|antimetabolites|mesh-ancestor
65163829|NCT02758015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163830|NCT02758015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65163831|NCT02757703|Terlipressin|terlipressin|mesh-list
65163832|NCT02757703|Pantoprazole|pantoprazole|mesh-list
65163833|NCT02757703|Somatostatin|somatostatin|mesh-list
65163834|NCT02757703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65163835|NCT02757703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65163836|NCT02757703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65163837|NCT02757703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163838|NCT02757703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163839|NCT02757703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65163840|NCT02757703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65163841|NCT02757703|Hormones|hormones|mesh-ancestor
65163842|NCT02757703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65163843|NCT02757703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163844|NCT02763007|Pioglitazone|pioglitazone|mesh-list
65163845|NCT02763007|Alogliptin|alogliptin|mesh-list
65163846|NCT02763007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65163847|NCT02763007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163848|NCT02763007|Incretins|incretins|mesh-ancestor
65163849|NCT02763007|Hormones|hormones|mesh-ancestor
65163850|NCT02763007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65163851|NCT02763007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65163852|NCT02763007|Protease Inhibitors|protease inhibitors|mesh-ancestor
65163853|NCT02763007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163854|NCT02763007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163855|NCT00635323|Capecitabine|capecitabine|mesh-list
65163856|NCT00635323|Irinotecan|irinotecan|mesh-list
65163857|NCT00635323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65163858|NCT00635323|Antimetabolites|antimetabolites|mesh-ancestor
65163859|NCT00635323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163860|NCT00635323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163861|NCT00635323|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65163862|NCT00635323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65163863|NCT00635323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163864|NCT01191840|Vancomycin|vancomycin|mesh-list
65163865|NCT01191840|Cefazolin|cefazolin|mesh-list
65163866|NCT01191840|Daptomycin|daptomycin|mesh-list
65163867|NCT01191840|Cloxacillin|cloxacillin|mesh-list
65319689|NCT04095390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319690|NCT04095390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65319691|NCT04095390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65319692|NCT04095390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319693|NCT04095390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65319694|NCT04095390|Hormone Antagonists|hormone antagonists|mesh-ancestor
65319695|NCT04095390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65319696|NCT04095390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319697|NCT00754338|Dipivefrin|dipivefrin|mesh-list
65319698|NCT00754338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65319699|NCT00754338|Adrenergic Agents|adrenergic agents|mesh-ancestor
65319700|NCT00754338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65319701|NCT00754338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319702|NCT00754338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319703|NCT00708149|Lansoprazole|lansoprazole|mesh-list
65319704|NCT00708149|Dexlansoprazole|dexlansoprazole|mesh-list
65319705|NCT00708149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65319706|NCT00708149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65319707|NCT00708149|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65319708|NCT00708149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319709|NCT00708149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319710|NCT04016051|Clarithromycin|clarithromycin|mesh-list
65319711|NCT04016051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65319712|NCT04016051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319713|NCT04016051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65319714|NCT04016051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163868|NCT01191840|Oxacillin|oxacillin|mesh-list
65163869|NCT01191840|Nafcillin|nafcillin|mesh-list
65163870|NCT01191840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65163871|NCT01191840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65163872|NCT02752555|Antioxidants|antioxidants|mesh-list
65163873|NCT02752555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163874|NCT02752555|Protective Agents|protective agents|mesh-ancestor
65163875|NCT02752555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163876|NCT00624546|Lansoprazole|lansoprazole|mesh-list
65163877|NCT00624546|Dexlansoprazole|dexlansoprazole|mesh-list
65163878|NCT00624546|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65163879|NCT00624546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65163880|NCT00624546|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65163881|NCT00624546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163882|NCT00624546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163891|NCT02757469|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65163892|NCT02757469|Contraceptive Agents|contraceptive agents|mesh-ancestor
65163893|NCT02757469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65163894|NCT02757469|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65163895|NCT02757469|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65163896|NCT02757469|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65319715|NCT04016051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319716|NCT04016051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65319717|NCT04016051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65319718|NCT00761514|Adalimumab|adalimumab|mesh-list
65319719|NCT00761514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65319720|NCT00761514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65319721|NCT00831779|Dapagliflozin|dapagliflozin|mesh-list
65319722|NCT00831779|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65319723|NCT00831779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319724|NCT00831779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65319725|NCT00831779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319726|NCT00758043|Ribavirin|ribavirin|mesh-list
65319727|NCT00758043|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65319728|NCT00758043|Antimetabolites|antimetabolites|mesh-ancestor
65319729|NCT00758043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319731|NCT00758043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319732|NCT00831701|Tamsulosin|tamsulosin|mesh-list
65319733|NCT00831701|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65319734|NCT00831701|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65319735|NCT00831701|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65319736|NCT00831701|Adrenergic Agents|adrenergic agents|mesh-ancestor
65319737|NCT00831701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65319738|NCT00831701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163897|NCT02757469|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65163898|NCT02757469|Hormone Antagonists|hormone antagonists|mesh-ancestor
65163899|NCT02757469|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65163901|NCT02757469|Natriuretic Agents|natriuretic agents|mesh-ancestor
65163902|NCT02757391|Aldesleukin|aldesleukin|mesh-list
65163903|NCT02757391|Cyclophosphamide|cyclophosphamide|mesh-list
65163904|NCT02757391|Pembrolizumab|pembrolizumab|mesh-list
65163905|NCT02757391|Interleukin-2|interleukin-2|mesh-list
65163906|NCT02757391|Immunologic Factors|immunologic factors|mesh-list
65163907|NCT02757391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65163908|NCT02757391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163909|NCT02757391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65163910|NCT02757391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65163911|NCT02757391|Alkylating Agents|alkylating agents|mesh-ancestor
65163912|NCT02757391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163913|NCT02757391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163914|NCT02757391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65163915|NCT02757391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65163916|NCT02757391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65163917|NCT02757391|Analgesics|analgesics|mesh-ancestor
65163918|NCT02757391|Sensory System Agents|sensory system agents|mesh-ancestor
65163919|NCT02757391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65163920|NCT02757391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65163921|NCT02757391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65163922|NCT02757391|Antiviral Agents|antiviral agents|mesh-ancestor
65163923|NCT02757391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319739|NCT00831701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319740|NCT00831701|Urological Agents|urological agents|mesh-ancestor
65319741|NCT00705419|Tenofovir|tenofovir|mesh-list
65319742|NCT00705419|Emtricitabine|emtricitabine|mesh-list
65319743|NCT00705419|Maleic acid|maleic acid|mesh-list
65319744|NCT00705419|Antiviral Agents|antiviral agents|mesh-ancestor
65319745|NCT00705419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319746|NCT00705419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65319747|NCT00705419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65319748|NCT00705419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319749|NCT00705419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319750|NCT00705419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65319751|NCT00705419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65163924|NCT04564417|Pembrolizumab|pembrolizumab|mesh-list
65163925|NCT04564417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65163926|NCT04564417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163927|NCT05656170|Bupivacaine|bupivacaine|mesh-list
65163928|NCT05656170|Anesthetics, Local|anesthetics, local|mesh-ancestor
65163929|NCT05656170|Anesthetics|anesthetics|mesh-ancestor
65163930|NCT05656170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65163931|NCT05656170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163932|NCT05656170|Sensory System Agents|sensory system agents|mesh-ancestor
65163933|NCT05656170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65163934|NCT02757079|Melatonin|melatonin|mesh-list
65163935|NCT02757079|Antioxidants|antioxidants|mesh-ancestor
65163936|NCT02757079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163937|NCT02757079|Protective Agents|protective agents|mesh-ancestor
65163938|NCT02757079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163939|NCT02757079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65163940|NCT04529005|Angiotensin II|angiotensin ii|mesh-list
65163941|NCT04529005|Giapreza|giapreza|mesh-list
65163942|NCT04529005|Angiotensinogen|angiotensinogen|mesh-list
65163943|NCT04529005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65163944|NCT04529005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65163945|NCT04529005|Protease Inhibitors|protease inhibitors|mesh-ancestor
65163946|NCT04529005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163947|NCT04529005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163948|NCT05357040|Nitrous Oxide|nitrous oxide|mesh-list
65163949|NCT05357040|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65163960|NCT00943072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65163961|NCT00943072|Growth Substances|growth substances|mesh-ancestor
65163962|NCT00943072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163963|NCT00943072|Growth Inhibitors|growth inhibitors|mesh-ancestor
65163964|NCT00943072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163965|NCT05346588|Propofol|propofol|mesh-list
65163966|NCT05346588|Anesthetics|anesthetics|mesh-list
65163967|NCT05346588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65163968|NCT05346588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65163969|NCT05346588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163970|NCT05346588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65163971|NCT05346588|Anesthetics, General|anesthetics, general|mesh-ancestor
65163972|NCT04222855|Diltiazem|diltiazem|mesh-list
65163973|NCT04222855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65163974|NCT04222855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65163975|NCT04222855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65163976|NCT04222855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163977|NCT04222855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65163978|NCT04222855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163979|NCT04222855|Vasodilator Agents|vasodilator agents|mesh-ancestor
65163980|NCT00942994|Amlodipine|amlodipine|mesh-list
65163981|NCT00942994|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65163982|NCT00942994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65319752|NCT05425355|Acetaminophen|acetaminophen|mesh-list
65319753|NCT05425355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65319754|NCT05425355|Analgesics|analgesics|mesh-ancestor
65319755|NCT05425355|Sensory System Agents|sensory system agents|mesh-ancestor
65319756|NCT05425355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65319757|NCT05425355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319758|NCT05425355|Antipyretics|antipyretics|mesh-ancestor
65319759|NCT04093713|Nordefrin|nordefrin|mesh-list
65319760|NCT04093713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65319761|NCT00831311|Vaccines|vaccines|mesh-list
65319762|NCT00831311|Immunologic Factors|immunologic factors|mesh-ancestor
65319763|NCT00831311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319764|NCT00831233|Goserelin|goserelin|mesh-list
65163983|NCT00942994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65163984|NCT00942994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65163985|NCT00942994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163986|NCT00942994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65163987|NCT00942994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163988|NCT00942994|Vasodilator Agents|vasodilator agents|mesh-ancestor
65163989|NCT00942994|Diuretics|diuretics|mesh-ancestor
65163990|NCT00942994|Natriuretic Agents|natriuretic agents|mesh-ancestor
65163991|NCT00942994|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65163992|NCT04268602|Anesthetics|anesthetics|mesh-list
65163993|NCT04268602|Anesthetics, Local|anesthetics, local|mesh-list
65163994|NCT04268602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65163995|NCT04268602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163996|NCT04268602|Sensory System Agents|sensory system agents|mesh-ancestor
65163997|NCT04268602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65163998|NCT04314336|Coal Tar|coal tar|mesh-list
65163999|NCT04314336|Keratolytic Agents|keratolytic agents|mesh-ancestor
64806622|NCT04673162|Hormones|hormones|mesh-ancestor
65164000|NCT04314336|Dermatologic Agents|dermatologic agents|mesh-ancestor
65164001|NCT00624702|Maleic acid|maleic acid|mesh-list
65164002|NCT00624702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164003|NCT00624702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164004|NCT02756377|Chlorhexidine|chlorhexidine|mesh-list
65164005|NCT02756377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65164006|NCT02756377|Cetylpyridinium|cetylpyridinium|mesh-list
65164007|NCT02756377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65164008|NCT02756377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65164009|NCT02756377|Disinfectants|disinfectants|mesh-ancestor
65164010|NCT02756377|Dermatologic Agents|dermatologic agents|mesh-ancestor
65164011|NCT02199184|Prednisone|prednisone|mesh-list
65164012|NCT02199184|Cortisone|cortisone|mesh-list
65164013|NCT02199184|Cyclophosphamide|cyclophosphamide|mesh-list
65164014|NCT02199184|Rituximab|rituximab|mesh-list
65164032|NCT02199184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164033|NCT02199184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164034|NCT02199184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65164035|NCT02199184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65164036|NCT02199184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65164037|NCT02199184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65164038|NCT02199184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164039|NCT02199184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65164041|NCT02199184|Hormones|hormones|mesh-ancestor
65164042|NCT02199184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65164043|NCT02199184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65164044|NCT02199184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65164045|NCT02199184|Tubulin Modulators|tubulin modulators|mesh-ancestor
65164046|NCT02199184|Antimitotic Agents|antimitotic agents|mesh-ancestor
65164047|NCT02199184|Mitosis Modulators|mitosis modulators|mesh-ancestor
65164048|NCT02199184|Keratolytic Agents|keratolytic agents|mesh-ancestor
65164049|NCT02199184|Dermatologic Agents|dermatologic agents|mesh-ancestor
65164050|NCT05378100|Midazolam|midazolam|mesh-list
65164051|NCT05378100|Ketamine|ketamine|mesh-list
65319765|NCT00831233|Bicalutamide|bicalutamide|mesh-list
65319766|NCT00831233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65319767|NCT00831233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319768|NCT00831233|Androgen Antagonists|androgen antagonists|mesh-ancestor
65319769|NCT00831233|Hormone Antagonists|hormone antagonists|mesh-ancestor
65319770|NCT00831233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65319771|NCT00831233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319772|NCT05438277|Methylprednisolone|methylprednisolone|mesh-list
64549707|NCT04663347|Gemcitabine|gemcitabine|mesh-list
65164052|NCT05378100|Analgesics|analgesics|mesh-ancestor
65164053|NCT05378100|Sensory System Agents|sensory system agents|mesh-ancestor
65164054|NCT05378100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65164055|NCT05378100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164056|NCT05378100|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65164057|NCT05378100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65164058|NCT05378100|Anesthetics, General|anesthetics, general|mesh-ancestor
65164059|NCT05378100|Anesthetics|anesthetics|mesh-ancestor
65164060|NCT05378100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65164061|NCT05378100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65164062|NCT05378100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65164063|NCT05378100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65164064|NCT05378100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164065|NCT05378100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65164066|NCT05378100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65164067|NCT05378100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65164068|NCT05378100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65164069|NCT05378100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65164070|NCT05378100|GABA Modulators|gaba modulators|mesh-ancestor
65164071|NCT05378100|GABA Agents|gaba agents|mesh-ancestor
65164072|NCT02752477|Anesthetics|anesthetics|mesh-list
65164073|NCT02752477|Anesthetics, General|anesthetics, general|mesh-list
65164074|NCT02752477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65164107|NCT05657496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65164108|NCT05657496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164110|NCT05657496|Immunologic Factors|immunologic factors|mesh-ancestor
65164111|NCT05657496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164112|NCT05657496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164113|NCT04268524|Miltefosine|miltefosine|mesh-list
65164139|NCT02751619|Anesthetics|anesthetics|mesh-ancestor
65164140|NCT02751619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65164141|NCT02751619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164142|NCT02751619|Sensory System Agents|sensory system agents|mesh-ancestor
65164143|NCT02751619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65164144|NCT02751619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65164145|NCT02751619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65164146|NCT02751619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65164147|NCT02751619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65164148|NCT02751619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164149|NCT01734928|Thalidomide|thalidomide|mesh-list
65164150|NCT01734928|Dexamethasone|dexamethasone|mesh-list
65164151|NCT01734928|Bortezomib|bortezomib|mesh-list
64806756|NCT03882463|Insulin|insulin|mesh-list
65164152|NCT01734928|Pomalidomide|pomalidomide|mesh-list
65164153|NCT01734928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65164154|NCT01734928|Antiemetics|antiemetics|mesh-ancestor
65164155|NCT01734928|Autonomic Agents|autonomic agents|mesh-ancestor
65164156|NCT01734928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65164157|NCT01734928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164158|NCT01734928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65164159|NCT01734928|Glucocorticoids|glucocorticoids|mesh-ancestor
65164160|NCT01734928|Hormones|hormones|mesh-ancestor
65164161|NCT01734928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65164162|NCT01734928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65164163|NCT01734928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319773|NCT05438277|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65319774|NCT05438277|Triamcinolone|triamcinolone|mesh-list
65319775|NCT05438277|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65319776|NCT05438277|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65319777|NCT05438277|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65319778|NCT05438277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65319779|NCT05438277|Antiemetics|antiemetics|mesh-ancestor
65319780|NCT05438277|Autonomic Agents|autonomic agents|mesh-ancestor
65319781|NCT05438277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65319782|NCT05438277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319783|NCT05438277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65319784|NCT05438277|Glucocorticoids|glucocorticoids|mesh-ancestor
65319785|NCT05438277|Hormones|hormones|mesh-ancestor
65319786|NCT05438277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65319787|NCT05438277|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65319788|NCT05438277|Protective Agents|protective agents|mesh-ancestor
65319789|NCT05438277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65319790|NCT05438277|Immunologic Factors|immunologic factors|mesh-ancestor
65319791|NCT05438277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549714|NCT04663347|Carboplatin|carboplatin|mesh-list
65164164|NCT01734928|Immunologic Factors|immunologic factors|mesh-ancestor
65164165|NCT01734928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64508827|NCT03037437|Antimalarials|antimalarials|mesh-ancestor
65164170|NCT01734928|Leprostatic Agents|leprostatic agents|mesh-ancestor
65164171|NCT01734928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65164172|NCT01734928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65164173|NCT02751541|Sunscreening Agents|sunscreening agents|mesh-list
65164174|NCT02751541|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65164175|NCT02751541|Protective Agents|protective agents|mesh-ancestor
65164176|NCT02751541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164177|NCT02751541|Dermatologic Agents|dermatologic agents|mesh-ancestor
65164178|NCT02755753|Lansoprazole|lansoprazole|mesh-list
65164179|NCT02755753|Dexlansoprazole|dexlansoprazole|mesh-list
65164180|NCT02755753|Rebamipide|rebamipide|mesh-list
65164181|NCT02755753|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65164182|NCT02755753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65164183|NCT02755753|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65164184|NCT02755753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164185|NCT02755753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164186|NCT02755753|Antioxidants|antioxidants|mesh-ancestor
65164187|NCT02755753|Protective Agents|protective agents|mesh-ancestor
65164188|NCT02755753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164189|NCT02755909|Anesthetics|anesthetics|mesh-list
65164190|NCT02755909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65164191|NCT02755909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164192|NCT02761291|Gemcitabine|gemcitabine|mesh-list
65164193|NCT02761291|Valganciclovir|valganciclovir|mesh-list
65164194|NCT02761291|Valproic Acid|valproic acid|mesh-list
65164195|NCT02761291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65164196|NCT02761291|Antimetabolites|antimetabolites|mesh-ancestor
65164197|NCT02761291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164198|NCT02761291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164199|NCT02761291|Antiviral Agents|antiviral agents|mesh-ancestor
65164200|NCT02761291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65164201|NCT02761291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164202|NCT02761291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65164203|NCT02761291|Immunologic Factors|immunologic factors|mesh-ancestor
64549733|NCT04663347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65319792|NCT05438277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319793|NCT00761280|Temozolomide|temozolomide|mesh-list
65319794|NCT00761280|Carmustine|carmustine|mesh-list
65319795|NCT00761280|Lomustine|lomustine|mesh-list
65319796|NCT00761280|Trabedersen|trabedersen|mesh-list
65319797|NCT00761280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65319798|NCT00761280|Alkylating Agents|alkylating agents|mesh-ancestor
65319799|NCT00761280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319800|NCT00761280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319801|NCT00916890|Fentanyl|fentanyl|mesh-list
65319802|NCT00916890|Morphine|morphine|mesh-list
65164204|NCT02761291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164205|NCT02761291|Anticonvulsants|anticonvulsants|mesh-ancestor
65164206|NCT02761291|GABA Agents|gaba agents|mesh-ancestor
65164207|NCT02761291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65164208|NCT02761291|Antimanic Agents|antimanic agents|mesh-ancestor
65164209|NCT02761291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65164210|NCT02761291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65164211|NCT02761291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65164212|NCT01187550|Hormones|hormones|mesh-list
65164213|NCT01187550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65164214|NCT01187550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164215|NCT02855866|Acetaminophen|acetaminophen|mesh-list
65164216|NCT02855866|Dexamethasone|dexamethasone|mesh-list
65164217|NCT02855866|Cortisone|cortisone|mesh-list
65164218|NCT02855866|Dexamethasone acetate|dexamethasone acetate|mesh-list
65164219|NCT02855866|BB 1101|bb 1101|mesh-list
65164220|NCT02855866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65164221|NCT02855866|Antiemetics|antiemetics|mesh-ancestor
65164222|NCT02855866|Autonomic Agents|autonomic agents|mesh-ancestor
65164223|NCT02855866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65164224|NCT02855866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164225|NCT02855866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65164226|NCT02855866|Glucocorticoids|glucocorticoids|mesh-ancestor
65164227|NCT02855866|Hormones|hormones|mesh-ancestor
65164228|NCT02855866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65164229|NCT02855866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65164231|NCT02855866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65164232|NCT02855866|Analgesics|analgesics|mesh-ancestor
65164233|NCT02855866|Sensory System Agents|sensory system agents|mesh-ancestor
65164234|NCT02855866|Antipyretics|antipyretics|mesh-ancestor
65164235|NCT02855866|Protease Inhibitors|protease inhibitors|mesh-ancestor
65164236|NCT02855866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164237|NCT02855866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164238|NCT02751307|Metformin|metformin|mesh-list
65164239|NCT02751307|Clozapine|clozapine|mesh-list
65164240|NCT02751307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65164245|NCT02751307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164246|NCT02751307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65164247|NCT02751307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65164248|NCT02751307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65164249|NCT02751307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65164250|NCT02751307|GABA Antagonists|gaba antagonists|mesh-ancestor
65164251|NCT02751307|GABA Agents|gaba agents|mesh-ancestor
65164252|NCT00638209|Insulin|insulin|mesh-list
65164253|NCT00638209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65164254|NCT00638209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65164255|NCT00638209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164256|NCT05429671|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65164257|NCT05429671|Gentamicins|gentamicins|mesh-list
65164258|NCT05429671|Tobramycin|tobramycin|mesh-list
65164259|NCT05429671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65164260|NCT05429671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65164261|NCT05429671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164262|NCT05429671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319803|NCT00916890|Oxycodone|oxycodone|mesh-list
65319804|NCT00916890|Buprenorphine|buprenorphine|mesh-list
65319805|NCT00916890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65319806|NCT00916890|Narcotics|narcotics|mesh-ancestor
65319807|NCT00916890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65319808|NCT00916890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319809|NCT00916890|Analgesics|analgesics|mesh-ancestor
65319810|NCT00916890|Sensory System Agents|sensory system agents|mesh-ancestor
65319811|NCT00916890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65319812|NCT00916890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65319813|NCT00916890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65319814|NCT00916890|Anesthetics, General|anesthetics, general|mesh-ancestor
65319815|NCT00916890|Anesthetics|anesthetics|mesh-ancestor
65319816|NCT00916890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65319817|NCT02599701|Gabapentin|gabapentin|mesh-list
65319818|NCT02599701|Analgesics|analgesics|mesh-ancestor
65319819|NCT02599701|Sensory System Agents|sensory system agents|mesh-ancestor
65319820|NCT02599701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65319821|NCT02599701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319822|NCT02599701|Anticonvulsants|anticonvulsants|mesh-ancestor
65319823|NCT02599701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65319824|NCT02599701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65319825|NCT02599701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65319826|NCT02599701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65319827|NCT02599701|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65319828|NCT02599701|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65319829|NCT02599701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65319830|NCT02599701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319831|NCT02599701|Antimanic Agents|antimanic agents|mesh-ancestor
64549758|NCT05042466|Psilocybin|psilocybin|mesh-list
65164263|NCT01186770|Methylnaltrexone|methylnaltrexone|mesh-list
65164264|NCT01186770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65164265|NCT01186770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164266|NCT01186770|Sensory System Agents|sensory system agents|mesh-ancestor
65164267|NCT01186770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65164268|NCT02754817|Liraglutide|liraglutide|mesh-list
65164269|NCT02754817|Xultophy|xultophy|mesh-list
65164270|NCT02754817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65164271|NCT02754817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164272|NCT02754817|Incretins|incretins|mesh-ancestor
65164273|NCT02754817|Hormones|hormones|mesh-ancestor
64697751|NCT03703778|Hormones|hormones|mesh-ancestor
65164274|NCT02754817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65164276|NCT04230031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164277|NCT01186458|Rituximab|rituximab|mesh-list
65164278|NCT01186458|Fludarabine|fludarabine|mesh-list
65164279|NCT01186458|Bortezomib|bortezomib|mesh-list
65319832|NCT00824291|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65319833|NCT00824291|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65319834|NCT00824291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65319835|NCT00824291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65319836|NCT00824291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319837|NCT00824291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65319838|NCT00824291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319839|NCT00824291|Antidepressive Agents|antidepressive agents|mesh-ancestor
65319840|NCT00824291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65319841|NCT00752232|Saponin QA-21V1|saponin qa-21v1|mesh-list
65319842|NCT00752232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65319843|NCT00752232|Immunologic Factors|immunologic factors|mesh-ancestor
65319844|NCT00752232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164280|NCT01186458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65164281|NCT01186458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164282|NCT01186458|Immunologic Factors|immunologic factors|mesh-ancestor
65164283|NCT01186458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164284|NCT01186458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65164285|NCT01185366|Everolimus|everolimus|mesh-list
65164286|NCT01185366|Sunitinib|sunitinib|mesh-list
65164287|NCT01185366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164288|NCT01185366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65164289|NCT01185366|Immunologic Factors|immunologic factors|mesh-ancestor
65164290|NCT01185366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164291|NCT01185366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65164292|NCT01185366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65164293|NCT01185366|Growth Substances|growth substances|mesh-ancestor
65164294|NCT01185366|Growth Inhibitors|growth inhibitors|mesh-ancestor
65164295|NCT01185366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65164296|NCT01185366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164297|NCT01185366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164298|NCT01185288|Adalimumab|adalimumab|mesh-list
65164299|NCT01185288|Methotrexate|methotrexate|mesh-list
65164300|NCT01185288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65164301|NCT01185288|Abortifacient Agents|abortifacient agents|mesh-ancestor
65164302|NCT01185288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65164303|NCT01185288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164304|NCT01185288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65164305|NCT01185288|Antimetabolites|antimetabolites|mesh-ancestor
65164306|NCT01185288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164307|NCT01185288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164308|NCT01185288|Dermatologic Agents|dermatologic agents|mesh-ancestor
65164309|NCT01185288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164310|NCT01185288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65164311|NCT01185288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65164312|NCT01185288|Immunologic Factors|immunologic factors|mesh-ancestor
65164313|NCT01185288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65164318|NCT01184118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65164320|NCT01184118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65164321|NCT01184118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164322|NCT01184118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65164323|NCT01184118|Respiratory System Agents|respiratory system agents|mesh-ancestor
65164324|NCT01184118|Dermatologic Agents|dermatologic agents|mesh-ancestor
65164325|NCT01184118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65164326|NCT01183884|Tretinoin|tretinoin|mesh-list
65164327|NCT01183884|Isotretinoin|isotretinoin|mesh-list
65164328|NCT01183884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164329|NCT01183884|Keratolytic Agents|keratolytic agents|mesh-ancestor
65164330|NCT01183884|Dermatologic Agents|dermatologic agents|mesh-ancestor
65164331|NCT05344248|Antibodies|antibodies|mesh-list
65319845|NCT00760266|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65319846|NCT00760266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65319847|NCT00760266|Diuretics|diuretics|mesh-ancestor
65319848|NCT00760266|Natriuretic Agents|natriuretic agents|mesh-ancestor
65319849|NCT00760266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319850|NCT00760266|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65319851|NCT00760266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65319852|NCT00760266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319853|NCT00753714|Gemcitabine|gemcitabine|mesh-list
65319854|NCT00753714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65319855|NCT00753714|Antimetabolites|antimetabolites|mesh-ancestor
65319856|NCT00753714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319857|NCT00753714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319858|NCT00753714|Antiviral Agents|antiviral agents|mesh-ancestor
65319859|NCT00753714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319860|NCT00753714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319861|NCT00753714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65319862|NCT00753714|Immunologic Factors|immunologic factors|mesh-ancestor
65319863|NCT00753714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319864|NCT00759954|Morphine|morphine|mesh-list
65319865|NCT00759954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65319866|NCT00759954|Narcotics|narcotics|mesh-ancestor
65319867|NCT00759954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65319868|NCT00759954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319869|NCT00759954|Analgesics|analgesics|mesh-ancestor
64549785|NCT02900976|Rituximab|rituximab|mesh-list
65164332|NCT05344248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65164333|NCT05344248|Immunologic Factors|immunologic factors|mesh-ancestor
65164334|NCT05344248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164335|NCT01191762|Sevelamer|sevelamer|mesh-list
65164336|NCT01191762|Chelating Agents|chelating agents|mesh-ancestor
65164337|NCT01191762|Sequestering Agents|sequestering agents|mesh-ancestor
65164338|NCT01191762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164339|NCT04315974|Rivaroxaban|rivaroxaban|mesh-list
65164340|NCT04315974|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65164341|NCT04315974|Antithrombins|antithrombins|mesh-ancestor
65164342|NCT04315974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65164343|NCT04315974|Protease Inhibitors|protease inhibitors|mesh-ancestor
65164344|NCT04315974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164345|NCT04315974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164346|NCT04315974|Anticoagulants|anticoagulants|mesh-ancestor
65164347|NCT01723774|Anastrozole|anastrozole|mesh-list
65164348|NCT01723774|Goserelin|goserelin|mesh-list
65164349|NCT01723774|Palbociclib|palbociclib|mesh-list
65164350|NCT01723774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65164351|NCT01723774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164352|NCT01723774|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65164353|NCT01723774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65164354|NCT01723774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164355|NCT01723774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319870|NCT00759954|Sensory System Agents|sensory system agents|mesh-ancestor
65319871|NCT00759954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65319872|NCT00804908|Temozolomide|temozolomide|mesh-list
65319873|NCT00804908|Veliparib|veliparib|mesh-list
65319874|NCT00804908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65319875|NCT00804908|Alkylating Agents|alkylating agents|mesh-ancestor
65319876|NCT00804908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319877|NCT00804908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319878|NCT00804908|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65319879|NCT00804908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319881|NCT02608034|Rifampin|rifampin|mesh-list
65319882|NCT02608034|Vemurafenib|vemurafenib|mesh-list
65319883|NCT02608034|Antifungal Agents|antifungal agents|mesh-ancestor
65319884|NCT02608034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319885|NCT02608034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64549811|NCT05602597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65164356|NCT01723774|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65164357|NCT01723774|Hormone Antagonists|hormone antagonists|mesh-ancestor
65164358|NCT01723774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65164359|NCT01723774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164360|NCT01723774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65164361|NCT02855788|Leucovorin|leucovorin|mesh-list
65164362|NCT02855788|Paclitaxel|paclitaxel|mesh-list
65164363|NCT02855788|Oxaliplatin|oxaliplatin|mesh-list
65164364|NCT02855788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65164365|NCT02855788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164366|NCT02855788|Tubulin Modulators|tubulin modulators|mesh-ancestor
65164367|NCT02855788|Antimitotic Agents|antimitotic agents|mesh-ancestor
65164368|NCT02855788|Mitosis Modulators|mitosis modulators|mesh-ancestor
65164369|NCT02855788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164370|NCT02855788|Antidotes|antidotes|mesh-ancestor
65164371|NCT02855788|Protective Agents|protective agents|mesh-ancestor
65164372|NCT02855788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164373|NCT02855788|Vitamin B Complex|vitamin b complex|mesh-ancestor
65164374|NCT02855788|Vitamins|vitamins|mesh-ancestor
65164375|NCT02855788|Micronutrients|micronutrients|mesh-ancestor
65164376|NCT01190514|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65164377|NCT01190514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65164378|NCT01190514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65164379|NCT01190514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65164380|NCT01190514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164381|NCT01190514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65164382|NCT01190514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164383|NCT01190514|Antidepressive Agents|antidepressive agents|mesh-ancestor
65164384|NCT01190514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65164390|NCT01190436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164391|NCT01190436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65164393|NCT01190436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65164394|NCT01190436|Adrenergic Agents|adrenergic agents|mesh-ancestor
65164395|NCT01190436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65164396|NCT01190436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164397|NCT02852122|Choline|choline|mesh-list
65164398|NCT02852122|Lipotropic Agents|lipotropic agents|mesh-ancestor
65164399|NCT02852122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65164400|NCT02852122|Antimetabolites|antimetabolites|mesh-ancestor
65164401|NCT02852122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164402|NCT02852122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65319886|NCT02608034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65319887|NCT02608034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319888|NCT02608034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319889|NCT02608034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65319890|NCT02608034|Hormone Antagonists|hormone antagonists|mesh-ancestor
65319891|NCT02608034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65319892|NCT02608034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319893|NCT02608034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65319894|NCT02608034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65319895|NCT02608034|Antitubercular Agents|antitubercular agents|mesh-ancestor
65319896|NCT02608034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65164403|NCT02852122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65164404|NCT02852122|Nootropic Agents|nootropic agents|mesh-ancestor
65164405|NCT01035255|Enalapril|enalapril|mesh-list
65164406|NCT01035255|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65164407|NCT01035255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65164408|NCT01035255|Protease Inhibitors|protease inhibitors|mesh-ancestor
65164409|NCT01035255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164410|NCT01035255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164411|NCT01035255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65164412|NCT01035255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65164413|NCT00602524|Pilocarpine|pilocarpine|mesh-list
65164414|NCT00602524|Miotics|miotics|mesh-ancestor
65164415|NCT00602524|Autonomic Agents|autonomic agents|mesh-ancestor
65164416|NCT00602524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65164417|NCT00602524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164418|NCT00602524|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65164419|NCT00602524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65164420|NCT00602524|Cholinergic Agents|cholinergic agents|mesh-ancestor
65164421|NCT00602524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65164422|NCT00602524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164423|NCT01189890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65164425|NCT01189890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65164426|NCT01189890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164427|NCT01189890|Incretins|incretins|mesh-ancestor
65164428|NCT01189890|Hormones|hormones|mesh-ancestor
65164429|NCT01189890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65164430|NCT01189890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65164431|NCT01189890|Protease Inhibitors|protease inhibitors|mesh-ancestor
65164432|NCT01189890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164433|NCT01189890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164434|NCT01189890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65164435|NCT01189890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65164436|NCT01189890|Immunologic Factors|immunologic factors|mesh-ancestor
65164437|NCT01189812|Lithium Carbonate|lithium carbonate|mesh-list
65164438|NCT01189812|Citalopram|citalopram|mesh-list
65164439|NCT01189812|Antidepressive Agents|antidepressive agents|mesh-ancestor
65164440|NCT01189812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65164441|NCT01189812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164442|NCT01189812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164443|NCT01189812|Antimanic Agents|antimanic agents|mesh-ancestor
65164444|NCT01189812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65164445|NCT01189812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65164446|NCT01189812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164447|NCT01189812|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65164448|NCT01189812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65164449|NCT01189812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65164450|NCT01189812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65164451|NCT01189812|Serotonin Agents|serotonin agents|mesh-ancestor
65319897|NCT02608034|Leprostatic Agents|leprostatic agents|mesh-ancestor
65319898|NCT02608034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65319899|NCT02608034|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65319900|NCT02608034|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65319901|NCT02608034|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65319902|NCT02608034|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65319903|NCT02608034|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65319904|NCT02608034|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65319905|NCT02608034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319906|NCT02608034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65319907|NCT00589784|Sunitinib|sunitinib|mesh-list
65319908|NCT00589784|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
65319909|NCT00589784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164452|NCT01189812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65164453|NCT01189500|Tamoxifen|tamoxifen|mesh-list
65164466|NCT01189500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65164467|NCT01189500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164468|NCT01189500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65164469|NCT01189500|Antidepressive Agents|antidepressive agents|mesh-ancestor
65164470|NCT01189500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65164471|NCT00938860|Cyclosporine|cyclosporine|mesh-list
65164473|NCT00938860|Cyclosporins|cyclosporins|mesh-list
65164474|NCT00938860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65164475|NCT00938860|Immunologic Factors|immunologic factors|mesh-ancestor
65164476|NCT00938860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164477|NCT00938860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65164478|NCT00938860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164479|NCT00938860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164480|NCT00938860|Antifungal Agents|antifungal agents|mesh-ancestor
65164481|NCT00938860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65164482|NCT00938860|Dermatologic Agents|dermatologic agents|mesh-ancestor
65164483|NCT00938860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65164484|NCT00604396|Insulin|insulin|mesh-list
65164485|NCT00604396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65164486|NCT00604396|Insulin Detemir|insulin detemir|mesh-list
65164487|NCT00604396|Isophane Insulin, Human|isophane insulin, human|mesh-list
65164488|NCT00604396|Insulin, Isophane|insulin, isophane|mesh-list
65164489|NCT00604396|Isophane insulin, beef|isophane insulin, beef|mesh-list
65164490|NCT00604396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65164491|NCT00604396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164492|NCT00938470|Docetaxel|docetaxel|mesh-list
65164493|NCT00938470|Fluorouracil|fluorouracil|mesh-list
65164494|NCT00938470|Capecitabine|capecitabine|mesh-list
65164495|NCT00938470|Oxaliplatin|oxaliplatin|mesh-list
65164496|NCT00938470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164497|NCT00938470|Tubulin Modulators|tubulin modulators|mesh-ancestor
65164498|NCT00938470|Antimitotic Agents|antimitotic agents|mesh-ancestor
65164499|NCT00938470|Mitosis Modulators|mitosis modulators|mesh-ancestor
65164500|NCT00938470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164501|NCT00938470|Antimetabolites|antimetabolites|mesh-ancestor
65164502|NCT00938470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65164503|NCT00938470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65164504|NCT00938470|Immunologic Factors|immunologic factors|mesh-ancestor
65164505|NCT00938470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164506|NCT00602680|Donepezil|donepezil|mesh-list
65164507|NCT00602680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65164508|NCT00602680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164509|NCT00602680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164510|NCT00602680|Cholinergic Agents|cholinergic agents|mesh-ancestor
65164511|NCT00602680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65319910|NCT00589784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65319911|NCT00589784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65319912|NCT00589784|Growth Substances|growth substances|mesh-ancestor
65319913|NCT00589784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319914|NCT00589784|Growth Inhibitors|growth inhibitors|mesh-ancestor
65319915|NCT00589784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65319916|NCT00589784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319917|NCT00589784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319918|NCT00589784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65319919|NCT05750264|Ibuprofen|ibuprofen|mesh-list
65319920|NCT05750264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65319921|NCT05750264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65319922|NCT05750264|Analgesics|analgesics|mesh-ancestor
65319923|NCT05750264|Sensory System Agents|sensory system agents|mesh-ancestor
65319924|NCT05750264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65319925|NCT05750264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319926|NCT05750264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65319927|NCT05750264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65319928|NCT05750264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65319929|NCT05750264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319930|NCT05750264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319931|NCT05742854|Oxytocin|oxytocin|mesh-list
65319932|NCT05742854|Carbetocin|carbetocin|mesh-list
65319933|NCT05742854|Oxytocics|oxytocics|mesh-ancestor
65319934|NCT05742854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65319935|NCT05742854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319936|NCT00823979|Etravirine|etravirine|mesh-list
65319937|NCT00823979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65164512|NCT00602680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164513|NCT00602680|Nootropic Agents|nootropic agents|mesh-ancestor
65164514|NCT00938392|Vaccines|vaccines|mesh-list
65164515|NCT00938392|Immunologic Factors|immunologic factors|mesh-ancestor
65164529|NCT05381428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65164530|NCT05381428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164532|NCT05381428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65164533|NCT05381428|Gout Suppressants|gout suppressants|mesh-ancestor
65164534|NCT05381428|Tocolytic Agents|tocolytic agents|mesh-ancestor
65164535|NCT05381428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65164536|NCT05381428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65164537|NCT05381428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164538|NCT05381428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164539|NCT01022853|Nintedanib|nintedanib|mesh-list
65164540|NCT01022853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164541|NCT01022853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65164542|NCT01022853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319938|NCT00823979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65319939|NCT00823979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319940|NCT00823979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319941|NCT00823979|Antiviral Agents|antiviral agents|mesh-ancestor
65319942|NCT00823979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319943|NCT02606864|Nifurtimox|nifurtimox|mesh-list
65319944|NCT02606864|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65319945|NCT02606864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65319946|NCT02606864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65319947|NCT02606864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319948|NCT00823901|Clindamycin|clindamycin|mesh-list
65319949|NCT00823901|Clindamycin palmitate|clindamycin palmitate|mesh-list
65319950|NCT00823901|Clindamycin phosphate|clindamycin phosphate|mesh-list
65319951|NCT00823901|Tretinoin|tretinoin|mesh-list
65319952|NCT00823901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65319953|NCT00823901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319954|NCT00823901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65319955|NCT00823901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319956|NCT00823901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319957|NCT00823901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319958|NCT00823901|Keratolytic Agents|keratolytic agents|mesh-ancestor
65319959|NCT00823901|Dermatologic Agents|dermatologic agents|mesh-ancestor
65164543|NCT01022853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164544|NCT00937768|Leuprolide|leuprolide|mesh-list
65164545|NCT00937768|Goserelin|goserelin|mesh-list
65164546|NCT00937768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65164547|NCT00937768|Fertility Agents|fertility agents|mesh-ancestor
65164548|NCT00937768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65164549|NCT00937768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164550|NCT00937768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65164551|NCT00937768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164552|NCT00631228|Everolimus|everolimus|mesh-list
65164553|NCT00631228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164554|NCT00631228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65164555|NCT00631228|Immunologic Factors|immunologic factors|mesh-ancestor
65164556|NCT00631228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164557|NCT05381038|Paclitaxel|paclitaxel|mesh-list
65164558|NCT05381038|Docetaxel|docetaxel|mesh-list
65164559|NCT05381038|Irinotecan|irinotecan|mesh-list
65164560|NCT05381038|Azacitidine|azacitidine|mesh-list
65164561|NCT05381038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65164562|NCT05381038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164563|NCT05381038|Tubulin Modulators|tubulin modulators|mesh-ancestor
65164564|NCT05381038|Antimitotic Agents|antimitotic agents|mesh-ancestor
65164565|NCT05381038|Mitosis Modulators|mitosis modulators|mesh-ancestor
65164566|NCT05381038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164567|NCT05381038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65164568|NCT05381038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65164569|NCT05381038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164570|NCT05381038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65164572|NCT01473628|Rituximab|rituximab|mesh-list
65164573|NCT01473628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65164574|NCT01473628|Antibodies|antibodies|mesh-list
65164575|NCT01473628|Immunoglobulins|immunoglobulins|mesh-list
65164576|NCT01473628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65319960|NCT00823823|Calpastatin|calpastatin|mesh-list
65319961|NCT00823823|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65319962|NCT00823823|Protease Inhibitors|protease inhibitors|mesh-ancestor
65319963|NCT00823823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65319964|NCT00823823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319965|NCT02926898|Fenfluramine|fenfluramine|mesh-list
65319966|NCT02926898|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65319967|NCT02926898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65319968|NCT02926898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65319969|NCT02926898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65319970|NCT02926898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65319971|NCT02926898|Serotonin Agents|serotonin agents|mesh-ancestor
65319972|NCT02926898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319973|NCT00759564|Lactams|lactams|mesh-list
65319974|NCT00759564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65319975|NCT00759564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65319976|NCT00816023|Ecallantide|ecallantide|mesh-list
65319977|NCT00816023|Analgesics|analgesics|mesh-ancestor
65319978|NCT00816023|Sensory System Agents|sensory system agents|mesh-ancestor
65319979|NCT00816023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65319980|NCT00816023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319981|NCT00816023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65319982|NCT00816023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65319983|NCT00816023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65319984|NCT00816023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65319985|NCT00815633|Alefacept|alefacept|mesh-list
65319986|NCT00815633|Dermatologic Agents|dermatologic agents|mesh-ancestor
65319987|NCT00815633|Immunologic Factors|immunologic factors|mesh-ancestor
65319988|NCT00815633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65319989|NCT03631784|Paclitaxel|paclitaxel|mesh-list
65319990|NCT03631784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64549903|NCT04278859|Antibodies|antibodies|mesh-list
65164577|NCT01473628|Immunologic Factors|immunologic factors|mesh-ancestor
65164578|NCT01473628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164582|NCT05380960|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65164583|NCT05380960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65164584|NCT05380960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164586|NCT05380960|Coagulants|coagulants|mesh-ancestor
65164587|NCT00604630|Epoetin Alfa|epoetin alfa|mesh-list
65164588|NCT00604630|Hematinics|hematinics|mesh-ancestor
65164589|NCT01189266|Vorinostat|vorinostat|mesh-list
65164590|NCT01189266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164591|NCT01189266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65319991|NCT03631784|Carboplatin|carboplatin|mesh-list
65319992|NCT03631784|Pembrolizumab|pembrolizumab|mesh-list
65319993|NCT03631784|Pemetrexed|pemetrexed|mesh-list
65319994|NCT03631784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65319995|NCT03631784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65319996|NCT03631784|Tubulin Modulators|tubulin modulators|mesh-ancestor
65319997|NCT03631784|Antimitotic Agents|antimitotic agents|mesh-ancestor
65319998|NCT03631784|Mitosis Modulators|mitosis modulators|mesh-ancestor
65319999|NCT03631784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320000|NCT03631784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65320001|NCT03631784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320002|NCT03631784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65320003|NCT03631784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65320004|NCT02610881|Iron|iron|mesh-list
65320005|NCT02610881|Trace Elements|trace elements|mesh-list
65320006|NCT02610881|Folic Acid|folic acid|mesh-list
65320007|NCT02610881|Micronutrients|micronutrients|mesh-list
65320008|NCT02610881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164592|NCT01189266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164593|NCT01189266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164594|NCT01189032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65164595|NCT01189032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65164596|NCT01188798|Methotrexate|methotrexate|mesh-list
65164597|NCT01188798|Pentostatin|pentostatin|mesh-list
65164598|NCT01188798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65164599|NCT01188798|Abortifacient Agents|abortifacient agents|mesh-ancestor
64807206|NCT01426880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164600|NCT01188798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65164601|NCT01188798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164602|NCT01188798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65164603|NCT01188798|Antimetabolites|antimetabolites|mesh-ancestor
65164604|NCT01188798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164605|NCT01188798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164606|NCT01188798|Dermatologic Agents|dermatologic agents|mesh-ancestor
65164607|NCT01188798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164608|NCT01188798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65164609|NCT01188798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65164610|NCT01188798|Immunologic Factors|immunologic factors|mesh-ancestor
65164611|NCT01188798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65164612|NCT01188798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65164613|NCT01188798|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65164614|NCT01183104|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65164615|NCT01183104|Glimepiride|glimepiride|mesh-list
65164616|NCT01183104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65164617|NCT01183104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164618|NCT01183104|Incretins|incretins|mesh-ancestor
65164619|NCT01183104|Hormones|hormones|mesh-ancestor
65164620|NCT01183104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65164621|NCT01183104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65164622|NCT01183104|Protease Inhibitors|protease inhibitors|mesh-ancestor
65164623|NCT01183104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164624|NCT01183104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164625|NCT01183104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65164626|NCT01183104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65164627|NCT01183104|Immunologic Factors|immunologic factors|mesh-ancestor
65164628|NCT02885688|Insulin|insulin|mesh-list
65164629|NCT02885688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65320009|NCT02610881|Hematinics|hematinics|mesh-ancestor
65320010|NCT02610881|Vitamin B Complex|vitamin b complex|mesh-ancestor
65320011|NCT02610881|Vitamins|vitamins|mesh-ancestor
65320012|NCT00830765|Progesterone|progesterone|mesh-list
65320013|NCT00830765|Progestins|progestins|mesh-ancestor
65320014|NCT00830765|Hormones|hormones|mesh-ancestor
65320015|NCT00830765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65320016|NCT00830765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320017|NCT04093206|Vitamins|vitamins|mesh-list
65320018|NCT04093206|Ascorbic Acid|ascorbic acid|mesh-list
65320019|NCT04093206|Micronutrients|micronutrients|mesh-ancestor
65320020|NCT04093206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320021|NCT04093206|Antioxidants|antioxidants|mesh-ancestor
65164630|NCT02885688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164631|NCT00950248|Idebenone|idebenone|mesh-list
65164632|NCT00950248|Antioxidants|antioxidants|mesh-ancestor
65164633|NCT00950248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164634|NCT00950248|Protective Agents|protective agents|mesh-ancestor
65164635|NCT00950248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164636|NCT04269928|Epinephrine|epinephrine|mesh-list
65164637|NCT04269928|Racepinephrine|racepinephrine|mesh-list
65164638|NCT04269928|Epinephryl borate|epinephryl borate|mesh-list
65164639|NCT04269928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65164640|NCT04269928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65164641|NCT04269928|Adrenergic Agents|adrenergic agents|mesh-ancestor
65164642|NCT04269928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65164643|NCT04269928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164644|NCT04269928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164645|NCT04269928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65164646|NCT04269928|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65164647|NCT04269928|Autonomic Agents|autonomic agents|mesh-ancestor
65164648|NCT04269928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65164649|NCT04269928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65164657|NCT00604864|Antibodies|antibodies|mesh-list
65164658|NCT00604864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65164659|NCT00604864|Immunologic Factors|immunologic factors|mesh-ancestor
65164660|NCT00604864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164661|NCT00604864|Dermatologic Agents|dermatologic agents|mesh-ancestor
65164662|NCT00604864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65164663|NCT00604864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65164664|NCT01227824|Raltegravir Potassium|raltegravir potassium|mesh-list
65164665|NCT01227824|Dolutegravir|dolutegravir|mesh-list
65164666|NCT01227824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65164667|NCT01227824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65164668|NCT01227824|Antiviral Agents|antiviral agents|mesh-ancestor
65164669|NCT01227824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65164670|NCT01227824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65164671|NCT01227824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65164672|NCT01227824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164673|NCT01227824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164674|NCT00949702|Vemurafenib|vemurafenib|mesh-list
65164675|NCT00949702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164676|NCT00949702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65164677|NCT00949702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164678|NCT00949702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164679|NCT01034631|Everolimus|everolimus|mesh-list
65164680|NCT01034631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164681|NCT01034631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65164682|NCT01034631|Immunologic Factors|immunologic factors|mesh-ancestor
65164683|NCT01034631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164685|NCT01409200|Methyltestosterone|methyltestosterone|mesh-list
65164686|NCT01409200|Axitinib|axitinib|mesh-list
65164687|NCT01409200|Hormones|hormones|mesh-list
65164688|NCT01409200|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65164689|NCT01409200|Androgens|androgens|mesh-list
65164690|NCT01409200|Androgen Antagonists|androgen antagonists|mesh-list
65320022|NCT04093206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320023|NCT04093206|Protective Agents|protective agents|mesh-ancestor
65320024|NCT00830375|Memantine|memantine|mesh-list
65320025|NCT00830375|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65320026|NCT00830375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65320027|NCT00830375|Dopamine Agents|dopamine agents|mesh-ancestor
65320028|NCT00830375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65320029|NCT00830375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320030|NCT00830375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320031|NCT00830375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65320032|NCT00830375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65320033|NCT00708539|Progesterone|progesterone|mesh-list
65320034|NCT00708539|Progestins|progestins|mesh-ancestor
65320035|NCT00708539|Hormones|hormones|mesh-ancestor
65320036|NCT00708539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65320037|NCT00708539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320038|NCT00914420|Trapidil|trapidil|mesh-list
65320039|NCT00914420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65320040|NCT00914420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320041|NCT00914420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320042|NCT00914420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65320043|NCT00914420|Vasodilator Agents|vasodilator agents|mesh-ancestor
65164691|NCT01409200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65164692|NCT01409200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164693|NCT01409200|Antioxidants|antioxidants|mesh-ancestor
65164694|NCT01409200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164695|NCT01409200|Protective Agents|protective agents|mesh-ancestor
65164696|NCT01409200|Vitamins|vitamins|mesh-ancestor
65164697|NCT01409200|Micronutrients|micronutrients|mesh-ancestor
65164698|NCT01409200|Estrogens|estrogens|mesh-ancestor
65164699|NCT01409200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65164700|NCT01409200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164701|NCT01409200|Anabolic Agents|anabolic agents|mesh-ancestor
65164702|NCT01409200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65164703|NCT01409200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164704|NCT01409200|Hormone Antagonists|hormone antagonists|mesh-ancestor
65164705|NCT01227668|Aripiprazole|aripiprazole|mesh-list
65164706|NCT01227668|Antidepressive Agents|antidepressive agents|mesh-ancestor
65164707|NCT01227668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65164708|NCT01227668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65164709|NCT01227668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65164710|NCT01227668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65164711|NCT01227668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164712|NCT01227668|Dopamine Agonists|dopamine agonists|mesh-ancestor
65164713|NCT01227668|Dopamine Agents|dopamine agents|mesh-ancestor
65164714|NCT01227668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65164715|NCT01227668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164716|NCT01227668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65164717|NCT01227668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65164718|NCT01227668|Serotonin Agents|serotonin agents|mesh-ancestor
64549980|NCT05431764|Gemcitabine|gemcitabine|mesh-list
65320044|NCT04094532|Bupivacaine|bupivacaine|mesh-list
65320045|NCT04094532|Anesthetics, Local|anesthetics, local|mesh-ancestor
65320046|NCT04094532|Anesthetics|anesthetics|mesh-ancestor
65320047|NCT04094532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65320048|NCT04094532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320049|NCT04094532|Sensory System Agents|sensory system agents|mesh-ancestor
65320050|NCT04094532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65320051|NCT00708773|Irinotecan|irinotecan|mesh-list
65320052|NCT00708773|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65320053|NCT00708773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65320054|NCT00708773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320055|NCT00708773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320056|NCT00708773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65320057|NCT05758259|Vitamin D|vitamin d|mesh-list
65320058|NCT05758259|Ergocalciferols|ergocalciferols|mesh-list
65320059|NCT05758259|Cholecalciferol|cholecalciferol|mesh-list
65320060|NCT05758259|Vitamins|vitamins|mesh-list
65320061|NCT05758259|Micronutrients|micronutrients|mesh-ancestor
65320062|NCT05758259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320063|NCT05758259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65320064|NCT05758259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65320065|NCT00803738|Terconazole|terconazole|mesh-list
65320066|NCT00803738|Antifungal Agents|antifungal agents|mesh-ancestor
65164719|NCT01227668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65164720|NCT01227668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65164721|NCT01227668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65164738|NCT01034163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164739|NCT01034163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65164740|NCT01034163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164741|NCT01034163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164742|NCT01162122|Vaccines|vaccines|mesh-list
65164743|NCT01162122|Immunologic Factors|immunologic factors|mesh-ancestor
65164744|NCT01162122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164745|NCT01033071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65164746|NCT01033071|Olmesartan|olmesartan|mesh-list
65164747|NCT01033071|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65164748|NCT01033071|Chlorthalidone|chlorthalidone|mesh-list
65164749|NCT01033071|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65164750|NCT01033071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65164751|NCT01033071|Diuretics|diuretics|mesh-ancestor
65164752|NCT01033071|Natriuretic Agents|natriuretic agents|mesh-ancestor
65164753|NCT01033071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164754|NCT01033071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65164755|NCT01033071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65164756|NCT01033071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807358|NCT01427491|Laxatives|laxatives|mesh-ancestor
65164757|NCT01033071|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65164758|NCT01033071|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65164759|NCT01032915|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65164760|NCT01032915|Immunologic Factors|immunologic factors|mesh-ancestor
65164761|NCT01032915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320067|NCT00803738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65320068|NCT00591266|Amlodipine|amlodipine|mesh-list
65320069|NCT00591266|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65320070|NCT00591266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65320071|NCT00591266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65320072|NCT00591266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65320073|NCT00591266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320074|NCT00591266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65320075|NCT00591266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320076|NCT00591266|Vasodilator Agents|vasodilator agents|mesh-ancestor
65320077|NCT00591266|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65320078|NCT00591266|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65320079|NCT04093050|Vasopressins|vasopressins|mesh-list
65320080|NCT04093050|Hemostatics|hemostatics|mesh-ancestor
65320081|NCT04093050|Coagulants|coagulants|mesh-ancestor
65320082|NCT04093050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65320083|NCT04093050|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65320084|NCT04093050|Natriuretic Agents|natriuretic agents|mesh-ancestor
65320085|NCT04093050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320086|NCT00758394|Listerine|listerine|mesh-list
65320087|NCT00758394|Triclosan|triclosan|mesh-list
65320088|NCT00758394|Fluorides|fluorides|mesh-list
65320089|NCT00758394|Sodium Fluoride|sodium fluoride|mesh-list
65320090|NCT00758394|Fluorophosphate|fluorophosphate|mesh-list
65320091|NCT00758394|Cariostatic Agents|cariostatic agents|mesh-ancestor
65320092|NCT00758394|Protective Agents|protective agents|mesh-ancestor
65320093|NCT00758394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320094|NCT00758394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65320095|NCT00758394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64550000|NCT03382561|Carboplatin|carboplatin|mesh-list
65164762|NCT04589325|Ixekizumab|ixekizumab|mesh-list
65164763|NCT04589325|Dermatologic Agents|dermatologic agents|mesh-ancestor
65164764|NCT01161498|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
65164765|NCT01161498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164766|NCT01161498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65164767|NCT02873559|Testosterone|testosterone|mesh-list
65164768|NCT02873559|Androgens|androgens|mesh-ancestor
65164769|NCT02873559|Hormones|hormones|mesh-ancestor
65164770|NCT02873559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65164771|NCT02873559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164772|NCT01029795|Glyburide|glyburide|mesh-list
65164773|NCT01029795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65164774|NCT01029795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164775|NCT02885454|Simeprevir|simeprevir|mesh-list
65164776|NCT02885454|Odalasvir|odalasvir|mesh-list
65164777|NCT02885454|Drospirenone|drospirenone|mesh-list
65164778|NCT02885454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65164779|NCT02885454|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65320096|NCT00758394|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65320097|NCT00758394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65320098|NCT00758394|Antimetabolites|antimetabolites|mesh-ancestor
65320099|NCT00758394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320100|NCT00758394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65320101|NCT04450394|Insulin|insulin|mesh-list
65320102|NCT04450394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65320103|NCT04450394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320104|NCT00758160|Methylphenidate|methylphenidate|mesh-list
65320105|NCT00758160|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65320106|NCT00758160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320107|NCT00758160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65320108|NCT00758160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65320109|NCT00758160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65320110|NCT00758160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320111|NCT00758160|Dopamine Agents|dopamine agents|mesh-ancestor
65320112|NCT00758160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65320113|NCT02606552|Aspirin|aspirin|mesh-list
65320114|NCT02606552|Clopidogrel|clopidogrel|mesh-list
65320115|NCT02606552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65320116|NCT02606552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65320117|NCT02606552|Analgesics|analgesics|mesh-ancestor
65320118|NCT02606552|Sensory System Agents|sensory system agents|mesh-ancestor
65320119|NCT02606552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550030|NCT00813111|Epinephrine|epinephrine|mesh-list
65164792|NCT02885454|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65164793|NCT02885454|Diuretics|diuretics|mesh-ancestor
65164794|NCT02885454|Natriuretic Agents|natriuretic agents|mesh-ancestor
65164795|NCT02885454|Antiviral Agents|antiviral agents|mesh-ancestor
65164796|NCT02885454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65164797|NCT02885454|Protease Inhibitors|protease inhibitors|mesh-ancestor
65164798|NCT02885454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164799|NCT02885454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164800|NCT01032837|Oseltamivir|oseltamivir|mesh-list
65164801|NCT01032837|Antiviral Agents|antiviral agents|mesh-ancestor
65164802|NCT01032837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65164803|NCT01032837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164804|NCT01032837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164805|NCT01180296|Progesterone|progesterone|mesh-list
65164806|NCT01180296|Progestins|progestins|mesh-ancestor
65164807|NCT01180296|Hormones|hormones|mesh-ancestor
65164808|NCT01180296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65164809|NCT01180296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164810|NCT01160640|Metronidazole|metronidazole|mesh-list
65164811|NCT01160640|Doxycycline|doxycycline|mesh-list
65164812|NCT01160640|Ceftriaxone|ceftriaxone|mesh-list
65164813|NCT01160640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65164814|NCT01160640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65164815|NCT01160640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65320120|NCT02606552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320121|NCT02606552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65320122|NCT02606552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65320123|NCT02606552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65320124|NCT02606552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65320125|NCT02606552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320126|NCT02606552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65320127|NCT02606552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65320128|NCT02606552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320129|NCT02606552|Antipyretics|antipyretics|mesh-ancestor
65320130|NCT02606552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65320131|NCT02606552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65320132|NCT02606552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65320133|NCT02606552|Purinergic Agents|purinergic agents|mesh-ancestor
65320134|NCT02606552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65320135|NCT02852486|Pioglitazone|pioglitazone|mesh-list
65320136|NCT02852486|Imatinib Mesylate|imatinib mesylate|mesh-list
65320137|NCT02852486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65320138|NCT02852486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320139|NCT02852486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65320140|NCT02852486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65320141|NCT02852486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320142|NCT02852486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320143|NCT02608736|Valproic Acid|valproic acid|mesh-list
65320144|NCT02608736|Anticonvulsants|anticonvulsants|mesh-ancestor
65320145|NCT02608736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64550055|NCT00845481|Hormones|hormones|mesh-ancestor
65164816|NCT01160640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65164817|NCT01160640|Antimalarials|antimalarials|mesh-ancestor
65164818|NCT01160484|Lenalidomide|lenalidomide|mesh-list
65164819|NCT01160484|Immunologic Factors|immunologic factors|mesh-ancestor
65164820|NCT01160484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164821|NCT01160484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65164822|NCT01160484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65164823|NCT01160484|Growth Substances|growth substances|mesh-ancestor
65164824|NCT01160484|Growth Inhibitors|growth inhibitors|mesh-ancestor
65164825|NCT01160484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164826|NCT01032291|Lenalidomide|lenalidomide|mesh-list
65164827|NCT01032291|Cetuximab|cetuximab|mesh-list
65164828|NCT01032291|Immunologic Factors|immunologic factors|mesh-ancestor
65164829|NCT01032291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164830|NCT01032291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65164831|NCT01032291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65164832|NCT01032291|Growth Substances|growth substances|mesh-ancestor
65164833|NCT01032291|Growth Inhibitors|growth inhibitors|mesh-ancestor
65164834|NCT01032291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164835|NCT01032291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65164836|NCT01159938|Insulin Lispro|insulin lispro|mesh-list
65164837|NCT01159938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65320146|NCT02608736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320147|NCT02608736|GABA Agents|gaba agents|mesh-ancestor
65320148|NCT02608736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65320149|NCT02608736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320150|NCT02608736|Antimanic Agents|antimanic agents|mesh-ancestor
65320151|NCT02608736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65320152|NCT02608736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65320153|NCT02608736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65320154|NCT02607410|Insulin|insulin|mesh-list
65320155|NCT02607410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65320156|NCT02607410|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65320157|NCT02607410|Insulin, Isophane|insulin, isophane|mesh-list
65320158|NCT02607410|Isophane Insulin, Human|isophane insulin, human|mesh-list
65320159|NCT02607410|Isophane insulin, beef|isophane insulin, beef|mesh-list
65320160|NCT02607410|Insulin, Long-Acting|insulin, long-acting|mesh-list
65320161|NCT02607410|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65320162|NCT02607410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65320163|NCT02607410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320164|NCT02607410|Incretins|incretins|mesh-ancestor
65320165|NCT02607410|Hormones|hormones|mesh-ancestor
64550079|NCT01421069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65164838|NCT01159938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164839|NCT02873871|Hemostatics|hemostatics|mesh-list
65164840|NCT02873871|Coagulants|coagulants|mesh-ancestor
65164841|NCT04301739|Paclitaxel|paclitaxel|mesh-list
65164842|NCT04301739|Cyclophosphamide|cyclophosphamide|mesh-list
65164843|NCT04301739|Carboplatin|carboplatin|mesh-list
65164849|NCT04301739|Antimitotic Agents|antimitotic agents|mesh-ancestor
65164850|NCT04301739|Mitosis Modulators|mitosis modulators|mesh-ancestor
65164851|NCT04301739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164852|NCT04301739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65164853|NCT04301739|Immunologic Factors|immunologic factors|mesh-ancestor
65164854|NCT04301739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164855|NCT04301739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65164856|NCT04301739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65164857|NCT04301739|Alkylating Agents|alkylating agents|mesh-ancestor
65164858|NCT04301739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65164859|NCT04301739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65164860|NCT04301739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65164861|NCT04301739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65164862|NCT04301739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164863|NCT04301583|Proanthocyanidin|proanthocyanidin|mesh-list
65164864|NCT04301583|Procyanidin|procyanidin|mesh-list
65164865|NCT04301583|Antioxidants|antioxidants|mesh-ancestor
65164866|NCT04301583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164867|NCT04301583|Protective Agents|protective agents|mesh-ancestor
65164868|NCT04301583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164869|NCT04301583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65164870|NCT04301583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65164871|NCT04301583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65164872|NCT01021683|Itraconazole|itraconazole|mesh-list
65164873|NCT01021683|Antifungal Agents|antifungal agents|mesh-ancestor
65164874|NCT01021683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65164875|NCT01021683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65164876|NCT01021683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65164877|NCT01021683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320166|NCT02607410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65320167|NCT02607410|Protease Inhibitors|protease inhibitors|mesh-ancestor
65320168|NCT02607410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320169|NCT02607410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320170|NCT05694260|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
65320171|NCT05694260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65320172|NCT05694260|Antimetabolites|antimetabolites|mesh-ancestor
65320173|NCT05694260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320174|NCT05694260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65164878|NCT01021683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164879|NCT01021683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65164880|NCT01021683|Hormone Antagonists|hormone antagonists|mesh-ancestor
65164881|NCT01021683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65164882|NCT01021683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164883|NCT01021683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65164884|NCT01021215|Celecoxib|celecoxib|mesh-list
65164885|NCT01021215|Zileuton|zileuton|mesh-list
65164886|NCT01021215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65164887|NCT01021215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65164888|NCT01021215|Analgesics|analgesics|mesh-ancestor
65164889|NCT01021215|Sensory System Agents|sensory system agents|mesh-ancestor
65164890|NCT01021215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65164891|NCT01021215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164892|NCT01021215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65164893|NCT01021215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65164894|NCT01021215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65164895|NCT01021215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65164896|NCT01021215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164897|NCT01021215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164898|NCT01021215|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65164899|NCT01021215|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65164900|NCT01021215|Hormone Antagonists|hormone antagonists|mesh-ancestor
65164901|NCT01021215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65164902|NCT02760979|Denosumab|denosumab|mesh-list
65164903|NCT02760979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65164904|NCT02760979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164905|NCT02873325|Antiviral Agents|antiviral agents|mesh-list
65164906|NCT02873325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65164907|NCT02760901|Acetylcysteine|acetylcysteine|mesh-list
65164908|NCT02760901|Mannitol|mannitol|mesh-list
65164909|NCT02760901|Acetazolamide|acetazolamide|mesh-list
65164910|NCT02760901|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65164911|NCT02760901|Antiviral Agents|antiviral agents|mesh-ancestor
65164912|NCT02760901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65164913|NCT02760901|Expectorants|expectorants|mesh-ancestor
65164928|NCT00635713|Anastrozole|anastrozole|mesh-list
65164929|NCT00635713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65164930|NCT00635713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164931|NCT00635713|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65164932|NCT00635713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65164933|NCT00635713|Hormone Antagonists|hormone antagonists|mesh-ancestor
65164934|NCT00635713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65164935|NCT00635713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164936|NCT00635713|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65164937|NCT00635713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65164938|NCT00635713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164939|NCT00635713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164940|NCT02760823|Thioctic Acid|thioctic acid|mesh-list
65164941|NCT02760823|Antioxidants|antioxidants|mesh-ancestor
65164942|NCT02760823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320175|NCT05694260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320176|NCT05694260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65320177|NCT05694260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320178|NCT05693090|Osimertinib|osimertinib|mesh-list
65320179|NCT05693090|Tipifarnib|tipifarnib|mesh-list
65320180|NCT05693090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65320181|NCT05693090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65320182|NCT05693090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320183|NCT05693090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320184|NCT00751296|Lenalidomide|lenalidomide|mesh-list
65320185|NCT00751296|Immunologic Factors|immunologic factors|mesh-ancestor
65320186|NCT00751296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320187|NCT00751296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65320188|NCT00751296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65320189|NCT00751296|Growth Substances|growth substances|mesh-ancestor
65320190|NCT00751296|Growth Inhibitors|growth inhibitors|mesh-ancestor
65320191|NCT00751296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65320192|NCT04093518|Estradiol|estradiol|mesh-list
65320193|NCT04093518|Estrogens|estrogens|mesh-ancestor
65320194|NCT04093518|Hormones|hormones|mesh-ancestor
65320195|NCT04093518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65320196|NCT04093518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320197|NCT02606084|Esketamine|esketamine|mesh-list
65320198|NCT02606084|Antidepressive Agents|antidepressive agents|mesh-ancestor
65320199|NCT02606084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65320200|NCT02607488|Lidocaine|lidocaine|mesh-list
65320201|NCT02607488|Anesthetics, Local|anesthetics, local|mesh-ancestor
65320202|NCT02607488|Anesthetics|anesthetics|mesh-ancestor
65320203|NCT02607488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65164943|NCT02760823|Protective Agents|protective agents|mesh-ancestor
65164944|NCT02760823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164945|NCT02760823|Vitamin B Complex|vitamin b complex|mesh-ancestor
65164946|NCT02760823|Vitamins|vitamins|mesh-ancestor
65164947|NCT02760823|Micronutrients|micronutrients|mesh-ancestor
65164948|NCT01020747|Bevacizumab|bevacizumab|mesh-list
65164949|NCT01020747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65164950|NCT01020747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164951|NCT01020747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65164952|NCT01020747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65164953|NCT01020747|Growth Substances|growth substances|mesh-ancestor
65164954|NCT01020747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164955|NCT01020747|Growth Inhibitors|growth inhibitors|mesh-ancestor
65164956|NCT02754739|Pravastatin|pravastatin|mesh-list
65164957|NCT02754739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65164958|NCT02754739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65164959|NCT02754739|Antimetabolites|antimetabolites|mesh-ancestor
65164960|NCT02754739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164961|NCT02754739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65320204|NCT02607488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320205|NCT02607488|Sensory System Agents|sensory system agents|mesh-ancestor
65320206|NCT02607488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65320207|NCT02607488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65320208|NCT02607488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65320209|NCT02607488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65320210|NCT02607488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65320211|NCT02607488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320212|NCT00914498|Lidocaine|lidocaine|mesh-list
65320213|NCT00914498|Anesthetics, Local|anesthetics, local|mesh-ancestor
65320214|NCT00914498|Anesthetics|anesthetics|mesh-ancestor
65320215|NCT00914498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65320216|NCT00914498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320217|NCT00914498|Sensory System Agents|sensory system agents|mesh-ancestor
65320218|NCT00914498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65320219|NCT00914498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65320220|NCT00914498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65320221|NCT00914498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64550135|NCT05686993|Histamine Agents|histamine agents|mesh-ancestor
65164962|NCT02754739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65164963|NCT02754739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164964|NCT02754583|Azithromycin|azithromycin|mesh-list
65164965|NCT02754583|Tetracycline|tetracycline|mesh-list
65164966|NCT02754583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65164967|NCT02754583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65164968|NCT02754583|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65164969|NCT02754583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164970|NCT02754583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164971|NCT01031979|Yohimbine|yohimbine|mesh-list
65164972|NCT01031979|Mydriatics|mydriatics|mesh-ancestor
65164973|NCT01031979|Autonomic Agents|autonomic agents|mesh-ancestor
65164974|NCT01031979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65164981|NCT01031979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164983|NCT04624633|Acalabrutinib|acalabrutinib|mesh-list
65164984|NCT04624633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164985|NCT02753803|Pioglitazone|pioglitazone|mesh-list
65164986|NCT02753803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65164987|NCT02753803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164988|NCT04219579|Antithrombins|antithrombins|mesh-list
65164989|NCT04219579|Antithrombin III|antithrombin iii|mesh-list
65164990|NCT04219579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65164991|NCT04219579|Protease Inhibitors|protease inhibitors|mesh-ancestor
65164992|NCT04219579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164993|NCT04219579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164994|NCT04219579|Anticoagulants|anticoagulants|mesh-ancestor
65164995|NCT00635401|Varenicline|varenicline|mesh-list
65164996|NCT00635401|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65164997|NCT00635401|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65164998|NCT00635401|Cholinergic Agents|cholinergic agents|mesh-ancestor
65164999|NCT00635401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65165000|NCT00635401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165001|NCT00635401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165002|NCT02753725|Fentanyl|fentanyl|mesh-list
65165003|NCT02753725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65320222|NCT00914498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65320223|NCT00914498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320224|NCT00751881|Teriflunomide|teriflunomide|mesh-list
65320225|NCT00751881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65320226|NCT00751881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65320227|NCT00751881|Analgesics|analgesics|mesh-ancestor
65320228|NCT00751881|Sensory System Agents|sensory system agents|mesh-ancestor
65320229|NCT00751881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65320230|NCT00751881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320231|NCT00751881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65320232|NCT00751881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65320233|NCT00751881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65320234|NCT00751881|Immunologic Factors|immunologic factors|mesh-ancestor
65320235|NCT02386826|Bevacizumab|bevacizumab|mesh-list
65320236|NCT02386826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65320237|NCT02386826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65320238|NCT02386826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65320239|NCT02386826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65320240|NCT02386826|Growth Substances|growth substances|mesh-ancestor
65320241|NCT02386826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320242|NCT02386826|Growth Inhibitors|growth inhibitors|mesh-ancestor
65320243|NCT02599779|Pembrolizumab|pembrolizumab|mesh-list
65320244|NCT02599779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65320245|NCT02599779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165004|NCT02753725|Narcotics|narcotics|mesh-ancestor
65165005|NCT02753725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65165006|NCT02753725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165007|NCT02753725|Analgesics|analgesics|mesh-ancestor
65165008|NCT02753725|Sensory System Agents|sensory system agents|mesh-ancestor
65165009|NCT02753725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165010|NCT02753725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65165011|NCT02753725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65165012|NCT02753725|Anesthetics, General|anesthetics, general|mesh-ancestor
65165013|NCT02753725|Anesthetics|anesthetics|mesh-ancestor
65165014|NCT01020123|Glipizide|glipizide|mesh-list
65165015|NCT01020123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65165016|NCT01020123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165017|NCT04300959|Gemcitabine|gemcitabine|mesh-list
65165018|NCT04300959|Cisplatin|cisplatin|mesh-list
65165019|NCT04300959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165020|NCT04300959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65165021|NCT04300959|Antimetabolites|antimetabolites|mesh-ancestor
65165022|NCT04300959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165023|NCT04300959|Antiviral Agents|antiviral agents|mesh-ancestor
65165024|NCT04300959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65165025|NCT04300959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165026|NCT04300959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65165027|NCT04300959|Immunologic Factors|immunologic factors|mesh-ancestor
65165028|NCT04300959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165029|NCT02760355|Ribavirin|ribavirin|mesh-list
65165030|NCT02760355|Sofosbuvir|sofosbuvir|mesh-list
65320246|NCT05407662|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
65320247|NCT05407662|Mineralocorticoids|mineralocorticoids|mesh-list
65320248|NCT05407662|Hormone Antagonists|hormone antagonists|mesh-ancestor
65320249|NCT05407662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65320250|NCT05407662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320251|NCT05407662|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65070230|NCT00324480|Vorinostat|vorinostat|mesh-list
65320252|NCT05407662|Diuretics|diuretics|mesh-ancestor
65320253|NCT05407662|Natriuretic Agents|natriuretic agents|mesh-ancestor
65320254|NCT05407662|Hormones|hormones|mesh-ancestor
65320255|NCT02597556|Albendazole|albendazole|mesh-list
65320256|NCT02597556|Anthelmintics|anthelmintics|mesh-ancestor
65320257|NCT02597556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65320258|NCT02597556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65165031|NCT02760355|Ledipasvir|ledipasvir|mesh-list
65165032|NCT02760355|Antimetabolites|antimetabolites|mesh-ancestor
65165033|NCT02760355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165034|NCT02760355|Antiviral Agents|antiviral agents|mesh-ancestor
65165035|NCT02760355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65165036|NCT01028391|Metformin|metformin|mesh-list
65165037|NCT01028391|Pioglitazone|pioglitazone|mesh-list
65165038|NCT01028391|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65165039|NCT01028391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65165040|NCT01028391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165041|NCT01028391|Incretins|incretins|mesh-ancestor
65165042|NCT01028391|Hormones|hormones|mesh-ancestor
65165043|NCT01028391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64509708|NCT02916771|Hormones|hormones|mesh-ancestor
65165052|NCT01179672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165053|NCT01179672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65165054|NCT01179672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165055|NCT01179672|Analgesics|analgesics|mesh-ancestor
65165056|NCT01179672|Sensory System Agents|sensory system agents|mesh-ancestor
65165057|NCT01179672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165058|NCT01179672|Antidepressive Agents|antidepressive agents|mesh-ancestor
65165059|NCT01179672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65165060|NCT01179672|Dopamine Agents|dopamine agents|mesh-ancestor
65165061|NCT04301349|Misoprostol|misoprostol|mesh-list
65165062|NCT04301349|Dinoprostone|dinoprostone|mesh-list
65165063|NCT04301349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65165064|NCT04301349|Abortifacient Agents|abortifacient agents|mesh-ancestor
65165065|NCT04301349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65165066|NCT04301349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165067|NCT04301349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65165068|NCT04301349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65165069|NCT04301349|Oxytocics|oxytocics|mesh-ancestor
65165071|NCT02753647|Cyclophosphamide|cyclophosphamide|mesh-list
65165072|NCT02753647|Rituximab|rituximab|mesh-list
65165073|NCT02753647|Doxorubicin|doxorubicin|mesh-list
65165074|NCT02753647|Vincristine|vincristine|mesh-list
65165075|NCT02753647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65165076|NCT02753647|Immunologic Factors|immunologic factors|mesh-ancestor
65165077|NCT02753647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165078|NCT02753647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65165079|NCT02753647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65165080|NCT02753647|Alkylating Agents|alkylating agents|mesh-ancestor
65165081|NCT02753647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165082|NCT02753647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165083|NCT02753647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65165084|NCT02753647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65165085|NCT02753647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65165086|NCT02753647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65165087|NCT02753647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65320259|NCT02597556|Anticestodal Agents|anticestodal agents|mesh-ancestor
65320260|NCT02597556|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65320261|NCT02597556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65320262|NCT02597556|Tubulin Modulators|tubulin modulators|mesh-ancestor
65320263|NCT02597556|Antimitotic Agents|antimitotic agents|mesh-ancestor
65320264|NCT02597556|Mitosis Modulators|mitosis modulators|mesh-ancestor
65320265|NCT02597556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320266|NCT02597556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65320267|NCT02599857|Bisoprolol|bisoprolol|mesh-list
65320268|NCT02599857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65320269|NCT02599857|Sympatholytics|sympatholytics|mesh-ancestor
65320270|NCT02599857|Autonomic Agents|autonomic agents|mesh-ancestor
65320271|NCT02599857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65320272|NCT02599857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320273|NCT02599857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65320274|NCT02599857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65320275|NCT02599857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65320276|NCT02599857|Adrenergic Agents|adrenergic agents|mesh-ancestor
65320277|NCT02599857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65320278|NCT02599857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165088|NCT02753647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165089|NCT02753647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65165090|NCT02753647|Glucocorticoids|glucocorticoids|mesh-ancestor
65165092|NCT02753647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65165093|NCT02753647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65165094|NCT02753647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65165095|NCT02753647|Tubulin Modulators|tubulin modulators|mesh-ancestor
65165096|NCT02753647|Antimitotic Agents|antimitotic agents|mesh-ancestor
65165097|NCT02753647|Mitosis Modulators|mitosis modulators|mesh-ancestor
65165098|NCT02872389|Sevoflurane|sevoflurane|mesh-list
65165099|NCT02872389|Desflurane|desflurane|mesh-list
65165100|NCT02872389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65165101|NCT02872389|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65165102|NCT02872389|Anesthetics, General|anesthetics, general|mesh-ancestor
65165103|NCT02872389|Anesthetics|anesthetics|mesh-ancestor
65165104|NCT02872389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65165105|NCT02872389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165106|NCT01179516|Vortioxetine|vortioxetine|mesh-list
65165107|NCT01179516|Antidepressive Agents|antidepressive agents|mesh-ancestor
65165108|NCT01179516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65165109|NCT01179516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65165111|NCT01179516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65165112|NCT01179516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165113|NCT01179516|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65165114|NCT01179516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65165115|NCT01179516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65165116|NCT01179516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165117|NCT01179516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65165119|NCT01179516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65165120|NCT01179516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65165121|NCT01179516|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65165122|NCT01179516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65320279|NCT05406726|Palmidrol|palmidrol|mesh-list
65320280|NCT05406726|Analgesics|analgesics|mesh-ancestor
65320281|NCT05406726|Sensory System Agents|sensory system agents|mesh-ancestor
65320282|NCT05406726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65320283|NCT05406726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320284|NCT05406726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65320285|NCT05406726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65320286|NCT05406726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65320287|NCT05406726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65320288|NCT05406726|Antiviral Agents|antiviral agents|mesh-ancestor
65320289|NCT05406726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65320290|NCT05406726|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65320291|NCT05406726|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65320292|NCT05406726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65320293|NCT05406726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320294|NCT05406726|Hormones|hormones|mesh-ancestor
65320295|NCT05406726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65320296|NCT02599623|Anesthetics|anesthetics|mesh-list
65320297|NCT02599623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65320298|NCT02599623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320299|NCT02597400|Metformin|metformin|mesh-list
65320300|NCT02597400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65320301|NCT02597400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320302|NCT00830063|Naproxen|naproxen|mesh-list
65320303|NCT00830063|Tanezumab|tanezumab|mesh-list
65320304|NCT00830063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65320305|NCT00830063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65320306|NCT00830063|Analgesics|analgesics|mesh-ancestor
65320307|NCT00830063|Sensory System Agents|sensory system agents|mesh-ancestor
65320308|NCT00830063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65320309|NCT00830063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320310|NCT00830063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65320311|NCT00830063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65320312|NCT00830063|Gout Suppressants|gout suppressants|mesh-ancestor
65165123|NCT00635791|Sorafenib|sorafenib|mesh-list
65165124|NCT00635791|Vorinostat|vorinostat|mesh-list
65165125|NCT00635791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165126|NCT00635791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65165127|NCT00635791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165128|NCT00635791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320313|NCT00830063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65320314|NCT00830063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320315|NCT00830063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320316|NCT04092621|Amiodarone|amiodarone|mesh-list
65320317|NCT04092621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65320318|NCT04092621|Vasodilator Agents|vasodilator agents|mesh-ancestor
65320319|NCT04092621|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65320320|NCT04092621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65320321|NCT04092621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320322|NCT04092621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65320323|NCT04092621|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65320324|NCT04092621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65320325|NCT04092621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320326|NCT04092621|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65320327|NCT04092621|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65320328|NCT04092621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65320329|NCT04092387|Nicotine|nicotine|mesh-list
65320330|NCT04092387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65320331|NCT04092387|Autonomic Agents|autonomic agents|mesh-ancestor
65320332|NCT04092387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65320333|NCT04092387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320334|NCT04092387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65320335|NCT04092387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65320336|NCT04092387|Cholinergic Agents|cholinergic agents|mesh-ancestor
65320337|NCT04092387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65320338|NCT04092387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320339|NCT00751101|Nicotine|nicotine|mesh-list
65320340|NCT00751101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65320341|NCT00751101|Autonomic Agents|autonomic agents|mesh-ancestor
65320349|NCT04092309|Valsartan|valsartan|mesh-list
65320353|NCT04092309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65320354|NCT04092309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65320355|NCT04092309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320356|NCT04092309|Protease Inhibitors|protease inhibitors|mesh-ancestor
65320357|NCT04092309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320358|NCT02598414|Fluorophosphate|fluorophosphate|mesh-list
65320359|NCT02598414|Cariostatic Agents|cariostatic agents|mesh-ancestor
65320360|NCT02598414|Protective Agents|protective agents|mesh-ancestor
65320361|NCT02598414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320362|NCT04020003|Simendan|simendan|mesh-list
65320363|NCT04020003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65320364|NCT04020003|Vasodilator Agents|vasodilator agents|mesh-ancestor
65320365|NCT04020003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65320366|NCT04020003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65320367|NCT04020003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320368|NCT04020003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320369|NCT04020003|Protective Agents|protective agents|mesh-ancestor
65320370|NCT04020003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320371|NCT03977142|Chrysarobin|chrysarobin|mesh-list
65320372|NCT03977142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65320373|NCT03977142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65165129|NCT00635791|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65165130|NCT02760043|Dexamethasone|dexamethasone|mesh-list
65165131|NCT02760043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65165132|NCT02760043|Antiemetics|antiemetics|mesh-ancestor
65165133|NCT02760043|Autonomic Agents|autonomic agents|mesh-ancestor
65165134|NCT02760043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165135|NCT02760043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165136|NCT02760043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65165137|NCT02760043|Glucocorticoids|glucocorticoids|mesh-ancestor
65165138|NCT02760043|Hormones|hormones|mesh-ancestor
65165139|NCT02760043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65165140|NCT02760043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65165141|NCT02760043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165142|NCT02760121|Acetazolamide|acetazolamide|mesh-list
65165143|NCT02760121|Methazolamide|methazolamide|mesh-list
65165144|NCT02760121|Anticonvulsants|anticonvulsants|mesh-ancestor
65165145|NCT02760121|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65165146|NCT02760121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165147|NCT02760121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165148|NCT02760121|Diuretics|diuretics|mesh-ancestor
65165149|NCT02760121|Natriuretic Agents|natriuretic agents|mesh-ancestor
65165150|NCT02760121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165151|NCT05215873|Misoprostol|misoprostol|mesh-list
65165152|NCT05215873|Oxytocin|oxytocin|mesh-list
65165153|NCT05215873|Oxytocics|oxytocics|mesh-ancestor
65165154|NCT05215873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65165155|NCT05215873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165156|NCT05215873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65165157|NCT05215873|Abortifacient Agents|abortifacient agents|mesh-ancestor
65165158|NCT05215873|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65165159|NCT05215873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65165160|NCT02759887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65320374|NCT03977142|Analgesics|analgesics|mesh-ancestor
65320375|NCT03977142|Sensory System Agents|sensory system agents|mesh-ancestor
65320376|NCT03977142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65320377|NCT03977142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320378|NCT03977142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65320379|NCT03977142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65320380|NCT00751023|Modafinil|modafinil|mesh-list
65320381|NCT00751023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65320382|NCT00751023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320383|NCT00751023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65320384|NCT00751023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65320385|NCT00751023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65165161|NCT02759887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65165162|NCT02759887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165163|NCT02750917|Etoricoxib|etoricoxib|mesh-list
65165164|NCT02750917|Lornoxicam|lornoxicam|mesh-list
65165165|NCT02750917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65165166|NCT02750917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65165167|NCT02750917|Analgesics|analgesics|mesh-ancestor
65165168|NCT02750917|Sensory System Agents|sensory system agents|mesh-ancestor
65165169|NCT02750917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165170|NCT02750917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165171|NCT02750917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65165172|NCT02750917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65165173|NCT02750917|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65165174|NCT02750917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65165175|NCT02750917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165176|NCT02750917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165177|NCT02750995|Azacitidine|azacitidine|mesh-list
65165178|NCT02750995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65165179|NCT02750995|Antimetabolites|antimetabolites|mesh-ancestor
65165180|NCT02750995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165181|NCT02750995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165190|NCT04221919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165191|NCT04221919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165192|NCT04299633|Calcium|calcium|mesh-list
65165193|NCT04299633|Sevelamer|sevelamer|mesh-list
65165194|NCT04299633|Calcium acetate|calcium acetate|mesh-list
65165195|NCT04299633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65165196|NCT04299633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165197|NCT04299633|Chelating Agents|chelating agents|mesh-ancestor
65165198|NCT04299633|Sequestering Agents|sequestering agents|mesh-ancestor
65165199|NCT04299633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165200|NCT02695459|Everolimus|everolimus|mesh-list
65165201|NCT02695459|Cisplatin|cisplatin|mesh-list
65165202|NCT02695459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165203|NCT02695459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65165204|NCT02695459|Immunologic Factors|immunologic factors|mesh-ancestor
65165205|NCT02695459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165206|NCT04288713|Eculizumab|eculizumab|mesh-list
65165207|NCT04288713|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65165208|NCT04288713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65165209|NCT04288713|Immunologic Factors|immunologic factors|mesh-ancestor
65165210|NCT04288713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165211|NCT05112991|Lenvatinib|lenvatinib|mesh-list
65165212|NCT05112991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165213|NCT05112991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65165214|NCT05112991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165215|NCT05112991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165216|NCT01030341|Insulin|insulin|mesh-list
65165217|NCT01030341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65320386|NCT00751023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320387|NCT00917592|Amoxicillin|amoxicillin|mesh-list
65320388|NCT00917592|Clavulanic Acids|clavulanic acids|mesh-list
65320389|NCT00917592|Clavulanic Acid|clavulanic acid|mesh-list
65320390|NCT00917592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65320391|NCT00917592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65320392|NCT00917592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320393|NCT00917592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320394|NCT00917592|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65320395|NCT04091412|3-n-butylphthalide|3-n-butylphthalide|mesh-list
65320396|NCT04091412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65070394|NCT00324831|Glucocorticoids|glucocorticoids|mesh-ancestor
65320397|NCT04091412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65320398|NCT04091412|Protective Agents|protective agents|mesh-ancestor
65320399|NCT04091412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320400|NCT02599311|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65320401|NCT02599311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65320402|NCT02599311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65165218|NCT01030341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65165219|NCT01030341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165220|NCT02750293|Cholecalciferol|cholecalciferol|mesh-list
65165221|NCT02750293|Vitamin D|vitamin d|mesh-list
65165222|NCT02750293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65165223|NCT02750293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165224|NCT02750293|Vitamins|vitamins|mesh-ancestor
65165225|NCT02750293|Micronutrients|micronutrients|mesh-ancestor
65165226|NCT02750293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65165227|NCT04217785|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65165228|NCT04217785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65165229|NCT01026831|Timolol|timolol|mesh-list
65165230|NCT01026831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65165231|NCT01026831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65165232|NCT01026831|Adrenergic Agents|adrenergic agents|mesh-ancestor
65165233|NCT01026831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65165234|NCT01026831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165235|NCT01026831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165236|NCT01026831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65165237|NCT01026831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65165238|NCT02750137|Tetracaine|tetracaine|mesh-list
65165239|NCT02750137|Anesthetics, Local|anesthetics, local|mesh-ancestor
65165240|NCT02750137|Anesthetics|anesthetics|mesh-ancestor
65165241|NCT02750137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65165242|NCT02750137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165243|NCT02750137|Sensory System Agents|sensory system agents|mesh-ancestor
65165244|NCT02750137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165245|NCT02750059|Tenofovir|tenofovir|mesh-list
65165246|NCT02750059|Lamivudine|lamivudine|mesh-list
65165247|NCT02750059|Efavirenz|efavirenz|mesh-list
65165248|NCT02750059|Telmisartan|telmisartan|mesh-list
65165249|NCT02750059|Antiviral Agents|antiviral agents|mesh-ancestor
65165265|NCT02750059|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65165266|NCT03893617|Propranolol|propranolol|mesh-list
65165267|NCT03893617|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65165268|NCT03893617|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65165269|NCT03893617|Adrenergic Agents|adrenergic agents|mesh-ancestor
65165270|NCT03893617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65165271|NCT03893617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320403|NCT02599311|Cholinergic Agents|cholinergic agents|mesh-ancestor
65320404|NCT02599311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65320405|NCT02599311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320406|NCT02599311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320407|NCT02599311|Urological Agents|urological agents|mesh-ancestor
65320408|NCT00591773|Chlorthalidone|chlorthalidone|mesh-list
65320409|NCT00591773|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65320410|NCT00591773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65320411|NCT00591773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65320412|NCT00591773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320413|NCT00591773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65320414|NCT00591773|Diuretics|diuretics|mesh-ancestor
65320415|NCT00591773|Natriuretic Agents|natriuretic agents|mesh-ancestor
65320416|NCT00591773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320417|NCT00591773|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65320418|NCT00591773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65320419|NCT00750867|Immunoglobulins|immunoglobulins|mesh-list
65320420|NCT00750867|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65320421|NCT00750867|Antibodies|antibodies|mesh-list
65165272|NCT03893617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165273|NCT03893617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65165274|NCT03893617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65165275|NCT03893617|Vasodilator Agents|vasodilator agents|mesh-ancestor
65165276|NCT02749825|Goserelin|goserelin|mesh-list
65165277|NCT02749825|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65165278|NCT02749825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65165279|NCT02749825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165280|NCT02749825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65165281|NCT02749825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165282|NCT02749825|Luteolytic Agents|luteolytic agents|mesh-ancestor
65165283|NCT02749825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65165284|NCT02749825|Contraceptive Agents|contraceptive agents|mesh-ancestor
65165285|NCT02749825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65165286|NCT02759107|Dulaglutide|dulaglutide|mesh-list
65165287|NCT02759107|Tirzepatide|tirzepatide|mesh-list
65165288|NCT02759107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65165289|NCT02759107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165290|NCT02759107|Incretins|incretins|mesh-ancestor
65165291|NCT02759107|Hormones|hormones|mesh-ancestor
65165292|NCT02759107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65165293|NCT02758873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65165294|NCT02758873|Montelukast|montelukast|mesh-list
65165295|NCT02758873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65165296|NCT02758873|Autonomic Agents|autonomic agents|mesh-ancestor
65165297|NCT02758873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165298|NCT02758873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165299|NCT02758873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65165300|NCT02758873|Respiratory System Agents|respiratory system agents|mesh-ancestor
65165301|NCT02758873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65165302|NCT02758873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65165303|NCT02758873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65165304|NCT02758873|Adrenergic Agents|adrenergic agents|mesh-ancestor
65165311|NCT02758873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65165312|NCT02749747|Sulpiride|sulpiride|mesh-list
65320422|NCT00750867|gamma-Globulins|gamma-globulins|mesh-list
65320423|NCT00750867|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65320424|NCT00750867|Immunologic Factors|immunologic factors|mesh-ancestor
65320425|NCT00750867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320426|NCT00744042|Immunoglobulin G|immunoglobulin g|mesh-list
65320427|NCT00744042|Immunologic Factors|immunologic factors|mesh-ancestor
65320428|NCT00744042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320429|NCT04091763|Polidocanol|polidocanol|mesh-list
65320430|NCT04091763|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65320431|NCT04091763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65320432|NCT00829829|Rilonacept|rilonacept|mesh-list
65320433|NCT00829829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65320434|NCT05419089|Cisplatin|cisplatin|mesh-list
65320435|NCT05419089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65320436|NCT00829439|Levodopa|levodopa|mesh-list
65320437|NCT00829439|Carbidopa|carbidopa|mesh-list
65320438|NCT00829439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65320439|NCT00829439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65165313|NCT02749747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65165314|NCT02749747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65165315|NCT02749747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65165316|NCT02749747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165317|NCT02749747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65165318|NCT02749747|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65165319|NCT02749747|Dopamine Agents|dopamine agents|mesh-ancestor
65165320|NCT02749747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65165321|NCT02749747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165322|NCT02749747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65165323|NCT02749747|Antidepressive Agents|antidepressive agents|mesh-ancestor
65165324|NCT02749591|Botulinum Toxins|botulinum toxins|mesh-list
65165325|NCT02749591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65165326|NCT02749591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65165327|NCT02749591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65165328|NCT02749591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65165329|NCT02749591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165330|NCT02749591|Cholinergic Agents|cholinergic agents|mesh-ancestor
65165331|NCT02749591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65165332|NCT02749591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165333|NCT02749591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65165334|NCT02749591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165335|NCT04359979|Tamsulosin|tamsulosin|mesh-list
65165336|NCT04359979|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65165337|NCT04359979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65165338|NCT04359979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65165339|NCT04359979|Adrenergic Agents|adrenergic agents|mesh-ancestor
65165340|NCT04359979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65165341|NCT04359979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165342|NCT04359979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165343|NCT04359979|Urological Agents|urological agents|mesh-ancestor
65165344|NCT04180813|Linagliptin|linagliptin|mesh-list
65165345|NCT04180813|Acarbose|acarbose|mesh-list
65165346|NCT04180813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65165347|NCT04180813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165348|NCT04180813|Incretins|incretins|mesh-ancestor
65165349|NCT04180813|Hormones|hormones|mesh-ancestor
65165350|NCT04180813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65165351|NCT04180813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65165352|NCT04180813|Protease Inhibitors|protease inhibitors|mesh-ancestor
65165353|NCT04180813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320440|NCT00829439|Dopamine Agents|dopamine agents|mesh-ancestor
65320441|NCT00829439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65320442|NCT00829439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320443|NCT00829439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320444|NCT00829439|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65320445|NCT00829439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320446|NCT02599077|Dienogest|dienogest|mesh-list
65320447|NCT02599077|Levonorgestrel|levonorgestrel|mesh-list
65320448|NCT02599077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65320449|NCT02599077|Contraceptive Agents|contraceptive agents|mesh-ancestor
65320450|NCT02599077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65320451|NCT02599077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320452|NCT02599077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65320453|NCT02599077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65320454|NCT02599077|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65320455|NCT02599077|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65320456|NCT02599077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65320457|NCT02599077|Hormone Antagonists|hormone antagonists|mesh-ancestor
65320458|NCT02599077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65320459|NCT02599077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65320460|NCT02599077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65320461|NCT00829283|Orlistat|orlistat|mesh-list
65320462|NCT00829283|Sibutramine|sibutramine|mesh-list
65320463|NCT00829283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320464|NCT00829283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320465|NCT00829283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65320466|NCT00829283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65320467|NCT00829283|Antidepressive Agents|antidepressive agents|mesh-ancestor
65320468|NCT00829283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65320469|NCT00829283|Appetite Depressants|appetite depressants|mesh-ancestor
65165354|NCT04180813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165355|NCT04180813|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65165356|NCT04116775|Pembrolizumab|pembrolizumab|mesh-list
65165357|NCT04116775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65165359|NCT03913741|Tisotumab vedotin|tisotumab vedotin|mesh-list
65165360|NCT03913741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65165361|NCT03913741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165362|NCT02749123|Lidocaine|lidocaine|mesh-list
65165363|NCT02749123|Menthol|menthol|mesh-list
65165364|NCT02749123|Anesthetics, Local|anesthetics, local|mesh-ancestor
65165365|NCT02749123|Anesthetics|anesthetics|mesh-ancestor
65165366|NCT02749123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65165367|NCT02749123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320470|NCT05758025|Parathyroid Hormone|parathyroid hormone|mesh-list
65320471|NCT05758025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65320472|NCT05758025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320473|NCT00706277|Fentanyl|fentanyl|mesh-list
65320474|NCT00706277|Remifentanil|remifentanil|mesh-list
65320475|NCT00706277|Nitrous Oxide|nitrous oxide|mesh-list
65320476|NCT00706277|Propofol|propofol|mesh-list
65320477|NCT00706277|Sevoflurane|sevoflurane|mesh-list
65320478|NCT00706277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65320479|NCT00706277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65320480|NCT00706277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320481|NCT00706277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65320482|NCT00706277|Anesthetics, General|anesthetics, general|mesh-ancestor
65320483|NCT00706277|Anesthetics|anesthetics|mesh-ancestor
64550393|NCT03300427|Valsartan|valsartan|mesh-list
65165368|NCT02749123|Sensory System Agents|sensory system agents|mesh-ancestor
65165369|NCT02749123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165370|NCT02749123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65165378|NCT00635557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165379|NCT02748265|Epoprostenol|epoprostenol|mesh-list
65165380|NCT02748265|Phenylephrine|phenylephrine|mesh-list
65165381|NCT02748265|Oxymetazoline|oxymetazoline|mesh-list
65165382|NCT02748265|Tezosentan|tezosentan|mesh-list
65165383|NCT02748265|Propofol|propofol|mesh-list
65165384|NCT02748265|Sevoflurane|sevoflurane|mesh-list
65165385|NCT02748265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65165386|NCT02748265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65165387|NCT02748265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165388|NCT02748265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65165389|NCT02748265|Anesthetics, General|anesthetics, general|mesh-ancestor
65165390|NCT02748265|Anesthetics|anesthetics|mesh-ancestor
65165391|NCT02748265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65165392|NCT02748265|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65165393|NCT02748265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65165394|NCT02748265|Mydriatics|mydriatics|mesh-ancestor
65165395|NCT02748265|Autonomic Agents|autonomic agents|mesh-ancestor
65165396|NCT02748265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165397|NCT02748265|Sympathomimetics|sympathomimetics|mesh-ancestor
65165398|NCT02748265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65165399|NCT02748265|Nasal Decongestants|nasal decongestants|mesh-ancestor
65165400|NCT02748265|Respiratory System Agents|respiratory system agents|mesh-ancestor
65165401|NCT02748265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65165402|NCT02748265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65165403|NCT02748265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65165404|NCT02748265|Adrenergic Agents|adrenergic agents|mesh-ancestor
65165405|NCT02748265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65165406|NCT02748265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165407|NCT02748265|Protective Agents|protective agents|mesh-ancestor
65165408|NCT02748265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65165409|NCT02748265|Vasodilator Agents|vasodilator agents|mesh-ancestor
65165410|NCT01015833|Doxorubicin|doxorubicin|mesh-list
65165411|NCT01015833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65165412|NCT01015833|Sorafenib|sorafenib|mesh-list
65165413|NCT01015833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65165414|NCT01015833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165415|NCT01015833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65165416|NCT01015833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65165417|NCT01015833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165418|NCT01015833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165419|NCT01015833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65165420|NCT03523273|Liraglutide|liraglutide|mesh-list
65165421|NCT03523273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65165422|NCT03523273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165423|NCT03523273|Incretins|incretins|mesh-ancestor
65320484|NCT00706277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65320485|NCT00706277|Narcotics|narcotics|mesh-ancestor
65320486|NCT00706277|Analgesics|analgesics|mesh-ancestor
65320487|NCT00706277|Sensory System Agents|sensory system agents|mesh-ancestor
65320488|NCT00706277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65320489|NCT00706277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65320490|NCT00706277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65320491|NCT00706277|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65320492|NCT00706277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65320493|NCT00749463|Nicotine|nicotine|mesh-list
65320494|NCT00749463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65320495|NCT00749463|Autonomic Agents|autonomic agents|mesh-ancestor
65320496|NCT00749463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65320497|NCT00749463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320498|NCT00749463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65320499|NCT00749463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65320500|NCT00749463|Cholinergic Agents|cholinergic agents|mesh-ancestor
65320501|NCT00749463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65320502|NCT00749463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320503|NCT05413161|Omalizumab|omalizumab|mesh-list
65320504|NCT05413161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65320505|NCT05413161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65320506|NCT05413161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65165424|NCT03523273|Hormones|hormones|mesh-ancestor
65165425|NCT03523273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65165426|NCT02695381|Etodolac|etodolac|mesh-list
65165427|NCT02695381|Lidocaine|lidocaine|mesh-list
65165428|NCT02695381|Anesthetics, Local|anesthetics, local|mesh-ancestor
65165429|NCT02695381|Anesthetics|anesthetics|mesh-ancestor
65165430|NCT02695381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65165431|NCT02695381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165432|NCT02695381|Sensory System Agents|sensory system agents|mesh-ancestor
65165433|NCT02695381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165434|NCT02695381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65165435|NCT02695381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65165436|NCT02695381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65165437|NCT02695381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64510064|NCT04391361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65165441|NCT02695381|Analgesics|analgesics|mesh-ancestor
65165442|NCT02695381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65165443|NCT02695381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65165444|NCT02695381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65165445|NCT02695381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65165446|NCT02695381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165447|NCT02746783|Vaccines|vaccines|mesh-list
65165448|NCT02746783|Immunologic Factors|immunologic factors|mesh-ancestor
65165449|NCT02746783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165450|NCT02747953|Afatinib|afatinib|mesh-list
65165451|NCT02747953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165452|NCT02747953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65165453|NCT02747953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165454|NCT02747953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165455|NCT02735239|Leucovorin|leucovorin|mesh-list
65165456|NCT02735239|Paclitaxel|paclitaxel|mesh-list
65320507|NCT05413161|Respiratory System Agents|respiratory system agents|mesh-ancestor
65320508|NCT05413161|Immunologic Factors|immunologic factors|mesh-ancestor
65320509|NCT05413161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320510|NCT00821327|Gemcitabine|gemcitabine|mesh-list
65320511|NCT00821327|Sunitinib|sunitinib|mesh-list
65320512|NCT00821327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65320513|NCT00821327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65320514|NCT00821327|Antimetabolites|antimetabolites|mesh-ancestor
65320515|NCT00821327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320516|NCT00821327|Antiviral Agents|antiviral agents|mesh-ancestor
65320517|NCT00821327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65320518|NCT00821327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320519|NCT00821327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65320520|NCT00821327|Immunologic Factors|immunologic factors|mesh-ancestor
65320521|NCT00821327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320522|NCT00821327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65320523|NCT00821327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65320524|NCT00821327|Growth Substances|growth substances|mesh-ancestor
65320525|NCT00821327|Growth Inhibitors|growth inhibitors|mesh-ancestor
65320526|NCT00821327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65320527|NCT00709007|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65320528|NCT00709007|Antiviral Agents|antiviral agents|mesh-ancestor
65320529|NCT00709007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65320530|NCT00821093|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65320531|NCT00821093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65320532|NCT00821093|Autonomic Agents|autonomic agents|mesh-ancestor
65320533|NCT00821093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65320534|NCT00821093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320535|NCT00821093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65320536|NCT00821093|Respiratory System Agents|respiratory system agents|mesh-ancestor
65320537|NCT00821093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65165457|NCT02735239|Docetaxel|docetaxel|mesh-list
65165458|NCT02735239|Carboplatin|carboplatin|mesh-list
65165459|NCT02735239|Fluorouracil|fluorouracil|mesh-list
65165460|NCT02735239|Capecitabine|capecitabine|mesh-list
65165461|NCT02735239|Oxaliplatin|oxaliplatin|mesh-list
65165462|NCT02735239|Durvalumab|durvalumab|mesh-list
65165463|NCT02735239|Tremelimumab|tremelimumab|mesh-list
65165464|NCT02735239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65165465|NCT02735239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165466|NCT02735239|Tubulin Modulators|tubulin modulators|mesh-ancestor
65165467|NCT02735239|Antimitotic Agents|antimitotic agents|mesh-ancestor
65165468|NCT02735239|Mitosis Modulators|mitosis modulators|mesh-ancestor
65165469|NCT02735239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165470|NCT02735239|Antimetabolites|antimetabolites|mesh-ancestor
65320538|NCT00821093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65320539|NCT00821093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65320540|NCT00821093|Adrenergic Agents|adrenergic agents|mesh-ancestor
65320541|NCT00821093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65320542|NCT00821093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320543|NCT00709163|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65320544|NCT00709163|Natriuretic Agents|natriuretic agents|mesh-ancestor
65070554|NCT00304668|Dapivirine|dapivirine|mesh-list
65320545|NCT00709163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320546|NCT02611505|Esketamine|esketamine|mesh-list
65320547|NCT02611505|Antidepressive Agents|antidepressive agents|mesh-ancestor
65320548|NCT02611505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65320549|NCT00743652|Vaccines|vaccines|mesh-list
65320550|NCT00743652|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65320551|NCT00743652|Immunologic Factors|immunologic factors|mesh-ancestor
65320552|NCT00743652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320553|NCT00748215|Antidiarrheals|antidiarrheals|mesh-list
65320554|NCT00748215|Loperamide|loperamide|mesh-list
65320555|NCT00748215|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
65320556|NCT00748215|Calcium|calcium|mesh-list
65320557|NCT00748215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65320558|NCT00748215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320559|NCT00748215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65320560|NCT00917163|Sirolimus|sirolimus|mesh-list
65165471|NCT02735239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65165472|NCT02735239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65165473|NCT02735239|Immunologic Factors|immunologic factors|mesh-ancestor
65165474|NCT02735239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165475|NCT02735239|Antidotes|antidotes|mesh-ancestor
65165476|NCT02735239|Protective Agents|protective agents|mesh-ancestor
65165477|NCT02735239|Vitamin B Complex|vitamin b complex|mesh-ancestor
65165478|NCT02735239|Vitamins|vitamins|mesh-ancestor
65165479|NCT02735239|Micronutrients|micronutrients|mesh-ancestor
65165480|NCT02735239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65165481|NCT02655523|Dexamethasone|dexamethasone|mesh-list
65165482|NCT02655523|Triamcinolone|triamcinolone|mesh-list
65165483|NCT02655523|Bupivacaine|bupivacaine|mesh-list
65165484|NCT02655523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65165485|NCT02655523|Antiemetics|antiemetics|mesh-ancestor
65165486|NCT02655523|Autonomic Agents|autonomic agents|mesh-ancestor
65165487|NCT02655523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165488|NCT02655523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165489|NCT02655523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65165490|NCT02655523|Glucocorticoids|glucocorticoids|mesh-ancestor
65165491|NCT02655523|Hormones|hormones|mesh-ancestor
65165492|NCT02655523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65165493|NCT02655523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65165494|NCT02655523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165495|NCT02655523|Anesthetics, Local|anesthetics, local|mesh-ancestor
65165496|NCT02655523|Anesthetics|anesthetics|mesh-ancestor
65165497|NCT02655523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65165498|NCT02655523|Sensory System Agents|sensory system agents|mesh-ancestor
65165499|NCT02644291|Mebendazole|mebendazole|mesh-list
65320561|NCT00917163|Everolimus|everolimus|mesh-list
65320562|NCT00917163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65320563|NCT00917163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65320564|NCT00917163|Immunologic Factors|immunologic factors|mesh-ancestor
65320565|NCT00917163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320566|NCT00917163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65320567|NCT00917163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65320568|NCT00917163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65320569|NCT00917163|Antifungal Agents|antifungal agents|mesh-ancestor
65320570|NCT00749892|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65320571|NCT00749892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65320572|NCT00749892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65320573|NCT00749892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320574|NCT00749892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320575|NCT00749580|Raltegravir Potassium|raltegravir potassium|mesh-list
65320576|NCT00749580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65320577|NCT00749580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65320578|NCT00749580|Antiviral Agents|antiviral agents|mesh-ancestor
65165500|NCT02644291|Piperazine|piperazine|mesh-list
65165501|NCT02644291|Piperazine citrate|piperazine citrate|mesh-list
65165502|NCT02644291|DMP 777|dmp 777|mesh-list
65165503|NCT02644291|Antinematodal Agents|antinematodal agents|mesh-ancestor
65165504|NCT02644291|Anthelmintics|anthelmintics|mesh-ancestor
65165505|NCT02644291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65165506|NCT02644291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65165507|NCT02644291|Tubulin Modulators|tubulin modulators|mesh-ancestor
65165508|NCT02644291|Antimitotic Agents|antimitotic agents|mesh-ancestor
65165509|NCT02644291|Mitosis Modulators|mitosis modulators|mesh-ancestor
65165510|NCT02644291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165511|NCT02644291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64510136|NCT02085447|Serotonin Agents|serotonin agents|mesh-ancestor
65165514|NCT01015677|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65165515|NCT01015677|Estradiol|estradiol|mesh-list
65165516|NCT01015677|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65165517|NCT01015677|Estrogens|estrogens|mesh-ancestor
65165518|NCT01015677|Hormones|hormones|mesh-ancestor
65165519|NCT01015677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65165520|NCT01015677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165521|NCT01015677|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65165522|NCT01015677|Contraceptive Agents|contraceptive agents|mesh-ancestor
65165523|NCT01015677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65165524|NCT01015677|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65165525|NCT02281981|Curcumin|curcumin|mesh-list
65165526|NCT02281981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65165527|NCT02281981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65165528|NCT02281981|Analgesics|analgesics|mesh-ancestor
65165529|NCT02281981|Sensory System Agents|sensory system agents|mesh-ancestor
65165530|NCT02281981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165531|NCT02281981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165532|NCT02281981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65165533|NCT02281981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65165534|NCT02281981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165535|NCT02281981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165536|NCT02281981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165537|NCT04297839|Heparin|heparin|mesh-list
65165538|NCT04297839|Calcium heparin|calcium heparin|mesh-list
65165539|NCT04297839|Citric Acid|citric acid|mesh-list
65165540|NCT04297839|Sodium Citrate|sodium citrate|mesh-list
65320579|NCT00749580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65320580|NCT00749580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65320581|NCT00749580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65320582|NCT00749580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320583|NCT00749580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320584|NCT05377905|Doxorubicin|doxorubicin|mesh-list
65320585|NCT05377905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65320586|NCT05377905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65320587|NCT05377905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65320588|NCT05377905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65320589|NCT05377905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65320590|NCT05377905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320591|NCT05377905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320592|NCT00747006|Insulin Lispro|insulin lispro|mesh-list
65320593|NCT00747006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65320594|NCT00747006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320595|NCT04091178|Vitamin D|vitamin d|mesh-list
65320596|NCT04091178|Vitamins|vitamins|mesh-ancestor
65165541|NCT04297839|Anticoagulants|anticoagulants|mesh-ancestor
65165542|NCT04297839|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65165543|NCT04297839|Chelating Agents|chelating agents|mesh-ancestor
65165544|NCT04297839|Sequestering Agents|sequestering agents|mesh-ancestor
65165545|NCT04297839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165546|NCT04297839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65165547|NCT04297839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65165548|NCT02751151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65165549|NCT02751151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65165550|NCT02751151|Dermatologic Agents|dermatologic agents|mesh-ancestor
65165551|NCT04216459|Cholecalciferol|cholecalciferol|mesh-list
65165552|NCT04216459|Vitamin D|vitamin d|mesh-list
65165553|NCT04216459|Thiamine|thiamine|mesh-list
65165554|NCT04216459|Vitamins|vitamins|mesh-ancestor
65165555|NCT04216459|Micronutrients|micronutrients|mesh-ancestor
65165556|NCT04216459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165557|NCT04216459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65165558|NCT04216459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65165559|NCT04216459|Vitamin B Complex|vitamin b complex|mesh-ancestor
65165560|NCT04216771|Cytarabine|cytarabine|mesh-list
65165561|NCT04216771|Idarubicin|idarubicin|mesh-list
65165562|NCT04216771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65165563|NCT04216771|Antimetabolites|antimetabolites|mesh-ancestor
65165564|NCT04216771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165565|NCT04216771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165566|NCT04216771|Antiviral Agents|antiviral agents|mesh-ancestor
65165567|NCT04216771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65165568|NCT04216771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65165569|NCT04216771|Immunologic Factors|immunologic factors|mesh-ancestor
65165570|NCT04216771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165571|NCT04216771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65165572|NCT04216771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65165573|NCT04216771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65165574|NCT04216771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165575|NCT00636259|Bicalutamide|bicalutamide|mesh-list
65165576|NCT00636259|Androgen Antagonists|androgen antagonists|mesh-ancestor
65165577|NCT00636259|Hormone Antagonists|hormone antagonists|mesh-ancestor
65165578|NCT00636259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65165579|NCT00636259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320597|NCT04091178|Micronutrients|micronutrients|mesh-ancestor
65320598|NCT04091178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320599|NCT04091178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65320600|NCT00917358|Interferons|interferons|mesh-list
65320601|NCT00917358|Interferon-alpha|interferon-alpha|mesh-list
65320602|NCT00917358|Interferon alpha-2|interferon alpha-2|mesh-list
65320603|NCT00917358|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65320604|NCT00917358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65320605|NCT00917358|Antiviral Agents|antiviral agents|mesh-ancestor
65320606|NCT00917358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65320607|NCT00917358|Immunologic Factors|immunologic factors|mesh-ancestor
65320608|NCT00917358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320609|NCT00743340|Emtricitabine|emtricitabine|mesh-list
65320610|NCT00743340|Antiviral Agents|antiviral agents|mesh-ancestor
65320611|NCT00743340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65320612|NCT00743340|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65320613|NCT00743340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65320614|NCT00743340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64550508|NCT00857727|Dexmedetomidine|dexmedetomidine|mesh-list
65165580|NCT00636259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165581|NCT02736019|Celecoxib|celecoxib|mesh-list
65165582|NCT02736019|Tramadol|tramadol|mesh-list
65165583|NCT02736019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65165584|NCT02736019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65165585|NCT02736019|Analgesics|analgesics|mesh-ancestor
64510204|NCT02933697|Phenprocoumon|phenprocoumon|mesh-list
65165587|NCT02736019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165588|NCT02736019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165589|NCT02736019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65165591|NCT02736019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65165592|NCT02736019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65165593|NCT02736019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165594|NCT02736019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165595|NCT02736019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65165596|NCT02736019|Narcotics|narcotics|mesh-ancestor
65165597|NCT02736019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65165598|NCT04284397|Aspirin|aspirin|mesh-list
65165599|NCT04284397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65165600|NCT04284397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65165601|NCT04284397|Analgesics|analgesics|mesh-ancestor
65165602|NCT04284397|Sensory System Agents|sensory system agents|mesh-ancestor
65165603|NCT04284397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165604|NCT04284397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165605|NCT04284397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65165606|NCT04284397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65165607|NCT04284397|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65165608|NCT04284397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65165609|NCT04284397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165610|NCT04284397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65165611|NCT04284397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65165612|NCT04284397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165613|NCT04284397|Antipyretics|antipyretics|mesh-ancestor
65165614|NCT05595889|Irinotecan|irinotecan|mesh-list
65165615|NCT05595889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65165616|NCT05595889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65165617|NCT05595889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320615|NCT00743340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320616|NCT00743340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65320617|NCT00743340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65320618|NCT00749190|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65320619|NCT00749190|Empagliflozin|empagliflozin|mesh-list
65320620|NCT00749190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65320621|NCT00749190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320622|NCT00749190|Incretins|incretins|mesh-ancestor
65320623|NCT00749190|Hormones|hormones|mesh-ancestor
65320624|NCT00749190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65320625|NCT00749190|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65320626|NCT00749190|Protease Inhibitors|protease inhibitors|mesh-ancestor
65320627|NCT00749190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320628|NCT00749190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320629|NCT00749190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65320631|NCT00748566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65320632|NCT00748566|Serotonin Agents|serotonin agents|mesh-ancestor
65165618|NCT05595889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165619|NCT05595889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165620|NCT02735395|Amoxicillin|amoxicillin|mesh-list
65165621|NCT02735395|Metronidazole|metronidazole|mesh-list
65165622|NCT02735395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65165623|NCT02735395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65165624|NCT02735395|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65165625|NCT02735395|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65165626|NCT02741947|Levodopa|levodopa|mesh-list
65165627|NCT02741947|Benserazide|benserazide|mesh-list
65165628|NCT02741947|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
65165629|NCT02741947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65165630|NCT02741947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65165631|NCT02741947|Dopamine Agents|dopamine agents|mesh-ancestor
65165632|NCT02741947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65165633|NCT02741947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165634|NCT02741947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165635|NCT02741947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165636|NCT02740933|Demeclocycline|demeclocycline|mesh-list
65165637|NCT02740933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65165638|NCT02740933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65165639|NCT02739685|Everolimus|everolimus|mesh-list
65165640|NCT02739685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165641|NCT02739685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65165642|NCT02739685|Immunologic Factors|immunologic factors|mesh-ancestor
65165643|NCT02739685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165644|NCT02735317|Vitamin B 12|vitamin b 12|mesh-list
65165645|NCT02735317|Hydroxocobalamin|hydroxocobalamin|mesh-list
65165646|NCT02735317|Gentamicins|gentamicins|mesh-list
65165647|NCT02735317|Dexamethasone|dexamethasone|mesh-list
65165648|NCT02735317|Procaine|procaine|mesh-list
65165649|NCT02735317|Vitamins|vitamins|mesh-ancestor
65165650|NCT02735317|Micronutrients|micronutrients|mesh-ancestor
65165651|NCT02735317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165652|NCT02735317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65165653|NCT02735317|Antiemetics|antiemetics|mesh-ancestor
65165654|NCT02735317|Autonomic Agents|autonomic agents|mesh-ancestor
65165655|NCT02735317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165656|NCT02735317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65165657|NCT02735317|Glucocorticoids|glucocorticoids|mesh-ancestor
65165658|NCT02735317|Hormones|hormones|mesh-ancestor
65165659|NCT02735317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65320633|NCT00748566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65320634|NCT00748566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320635|NCT00748566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320636|NCT00748566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65320637|NCT00748566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65320638|NCT00748566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65320639|NCT00748566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65320640|NCT00748566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65320641|NCT00748566|Dopamine Agents|dopamine agents|mesh-ancestor
65320642|NCT02597166|Sofosbuvir|sofosbuvir|mesh-list
65320643|NCT02597166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
65320644|NCT02597166|Ledipasvir|ledipasvir|mesh-list
65320645|NCT02597166|Antiviral Agents|antiviral agents|mesh-ancestor
65320646|NCT02597166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65320647|NCT00743106|Fenoldopam|fenoldopam|mesh-list
65320648|NCT00743106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65320649|NCT00743106|Vasodilator Agents|vasodilator agents|mesh-ancestor
65320650|NCT00743106|Dopamine Agonists|dopamine agonists|mesh-ancestor
65320651|NCT00743106|Dopamine Agents|dopamine agents|mesh-ancestor
65320652|NCT00743106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65320653|NCT00743106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320654|NCT00743106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320655|NCT02597322|Axitinib|axitinib|mesh-list
65320656|NCT02597322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65320657|NCT02597322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65320658|NCT02597322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64714177|NCT02988050|Epinephrine|epinephrine|mesh-list
64510277|NCT04840641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65165681|NCT05544721|Sensory System Agents|sensory system agents|mesh-ancestor
65165682|NCT05544721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165683|NCT02738983|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65165684|NCT02738983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165685|NCT02738983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65165686|NCT02738983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165687|NCT02738983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165688|NCT02739061|Fluvoxamine|fluvoxamine|mesh-list
65165689|NCT02739061|Sertraline|sertraline|mesh-list
65165690|NCT02739061|Antidepressive Agents|antidepressive agents|mesh-ancestor
65165691|NCT02739061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65165692|NCT02739061|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65165693|NCT02739061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65165694|NCT02739061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65165695|NCT02739061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165696|NCT02739061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65165697|NCT02739061|Serotonin Agents|serotonin agents|mesh-ancestor
65165698|NCT02739061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165699|NCT02739061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65165700|NCT02739061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65320659|NCT02597322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320660|NCT00738699|Paclitaxel|paclitaxel|mesh-list
65320661|NCT00738699|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65320662|NCT00738699|Farletuzumab|farletuzumab|mesh-list
65320663|NCT00738699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65320664|NCT00738699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65320665|NCT00738699|Tubulin Modulators|tubulin modulators|mesh-ancestor
65320666|NCT00738699|Antimitotic Agents|antimitotic agents|mesh-ancestor
65320667|NCT00738699|Mitosis Modulators|mitosis modulators|mesh-ancestor
65320668|NCT00738699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320669|NCT00814307|Tofacitinib|tofacitinib|mesh-list
65320670|NCT00814307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65320671|NCT00814307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320672|NCT00814307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165701|NCT02739061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65165702|NCT02739061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65165703|NCT02739061|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65165704|NCT02739061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65165705|NCT02739061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165706|NCT02739061|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65165707|NCT02745925|Ibuprofen|ibuprofen|mesh-list
65165708|NCT02745925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65165709|NCT02745925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65165710|NCT02745925|Analgesics|analgesics|mesh-ancestor
65165733|NCT02745691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165734|NCT02745691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165735|NCT02745769|Ramucirumab|ramucirumab|mesh-list
65165736|NCT02745769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165737|NCT02734069|Carboplatin|carboplatin|mesh-list
65165738|NCT02734069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165740|NCT02737813|Anesthetics, Local|anesthetics, local|mesh-ancestor
65165741|NCT02737813|Anesthetics|anesthetics|mesh-ancestor
65165742|NCT02737813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65165743|NCT02737813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165744|NCT02737813|Sensory System Agents|sensory system agents|mesh-ancestor
65165745|NCT02737813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165747|NCT00636415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65165748|NCT00636415|Narcotics|narcotics|mesh-ancestor
65165749|NCT00636415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65165750|NCT00636415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165751|NCT00636415|Analgesics|analgesics|mesh-ancestor
65165752|NCT00636415|Sensory System Agents|sensory system agents|mesh-ancestor
65165753|NCT00636415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165754|NCT02733835|Remifentanil|remifentanil|mesh-list
65165755|NCT02733835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65165756|NCT02733835|Narcotics|narcotics|mesh-ancestor
65165757|NCT02733835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65165758|NCT02733835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165759|NCT02733835|Analgesics|analgesics|mesh-ancestor
65165760|NCT02733835|Sensory System Agents|sensory system agents|mesh-ancestor
65165761|NCT02733835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165762|NCT02737423|Vitamin D|vitamin d|mesh-list
65165763|NCT02737423|Cholecalciferol|cholecalciferol|mesh-list
65165764|NCT02737423|Vitamins|vitamins|mesh-ancestor
65165765|NCT02737423|Micronutrients|micronutrients|mesh-ancestor
65165781|NCT05473585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165782|NCT05473585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165783|NCT05473585|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65165784|NCT05473585|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65165785|NCT05473585|Cholinergic Agents|cholinergic agents|mesh-ancestor
65320673|NCT02596776|Deuterium Oxide|deuterium oxide|mesh-list
65320674|NCT02596776|Propranolol|propranolol|mesh-list
65320675|NCT02596776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65320676|NCT02596776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65320677|NCT02596776|Adrenergic Agents|adrenergic agents|mesh-ancestor
65320678|NCT02596776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65320679|NCT02596776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320680|NCT02596776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320681|NCT02596776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65320682|NCT02596776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65320683|NCT02596776|Vasodilator Agents|vasodilator agents|mesh-ancestor
65320684|NCT02596776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65320685|NCT02596776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65320686|NCT02596776|Protective Agents|protective agents|mesh-ancestor
65320687|NCT00748098|Gabapentin|gabapentin|mesh-list
65320688|NCT00748098|Analgesics|analgesics|mesh-ancestor
65320689|NCT00748098|Sensory System Agents|sensory system agents|mesh-ancestor
65320690|NCT00748098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65320691|NCT00748098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320692|NCT00748098|Anticonvulsants|anticonvulsants|mesh-ancestor
65320693|NCT00748098|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65320694|NCT00748098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65320695|NCT00748098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65320696|NCT00748098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65320697|NCT00748098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65320698|NCT00748098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65165786|NCT05473585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65165787|NCT05473585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165788|NCT05629429|Olaparib|olaparib|mesh-list
65165789|NCT05629429|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65165790|NCT05629429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165791|NCT05629429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165792|NCT05629429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165793|NCT02744131|Metformin|metformin|mesh-list
65165794|NCT02744131|Cyproterone Acetate|cyproterone acetate|mesh-list
65165795|NCT02744131|Contraceptive Agents|contraceptive agents|mesh-list
65165796|NCT02744131|Contraceptives, Oral|contraceptives, oral|mesh-list
65165797|NCT02744131|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65165798|NCT02744131|Estradiol|estradiol|mesh-list
65165799|NCT02744131|Cyproterone|cyproterone|mesh-list
65165800|NCT02744131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65165801|NCT02744131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165802|NCT02744131|Estrogens|estrogens|mesh-ancestor
65165803|NCT02744131|Hormones|hormones|mesh-ancestor
65165804|NCT02744131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65165805|NCT02744131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65165806|NCT02744131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65165807|NCT02744131|Androgen Antagonists|androgen antagonists|mesh-ancestor
65165808|NCT02744131|Hormone Antagonists|hormone antagonists|mesh-ancestor
65320699|NCT00748098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65320700|NCT00748098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320701|NCT00748098|Antimanic Agents|antimanic agents|mesh-ancestor
65320702|NCT00813995|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65320703|NCT00813995|Metformin|metformin|mesh-list
65320704|NCT00813995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65320705|NCT00813995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320706|NCT00813995|Incretins|incretins|mesh-ancestor
65320707|NCT00813995|Hormones|hormones|mesh-ancestor
65320708|NCT00813995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65320709|NCT00813995|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65320710|NCT00813995|Protease Inhibitors|protease inhibitors|mesh-ancestor
65320711|NCT00813995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320712|NCT00813995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320713|NCT00737529|Lenalidomide|lenalidomide|mesh-list
65165809|NCT02744131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165810|NCT02744131|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65165811|NCT03326791|Aspirin|aspirin|mesh-list
65165812|NCT03326791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65165813|NCT03326791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65165814|NCT03326791|Analgesics|analgesics|mesh-ancestor
65165815|NCT03326791|Sensory System Agents|sensory system agents|mesh-ancestor
65165816|NCT03326791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165817|NCT03326791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165818|NCT03326791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65165819|NCT03326791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65165820|NCT03326791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65165821|NCT03326791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65165822|NCT03326791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165823|NCT03326791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65165824|NCT03326791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65165825|NCT03326791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165827|NCT02743975|Bevacizumab|bevacizumab|mesh-list
65165833|NCT02743975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165834|NCT02743975|Growth Inhibitors|growth inhibitors|mesh-ancestor
65165835|NCT02743663|Albuterol|albuterol|mesh-list
65165836|NCT02743663|Bronchodilator Agents|bronchodilator agents|mesh-list
65165837|NCT02743663|Autonomic Agents|autonomic agents|mesh-ancestor
65165838|NCT02743663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165839|NCT02743663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165840|NCT02743663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65165841|NCT02743663|Respiratory System Agents|respiratory system agents|mesh-ancestor
65165842|NCT02743663|Tocolytic Agents|tocolytic agents|mesh-ancestor
65165843|NCT02743663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65165844|NCT02743663|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65165845|NCT02743663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65165846|NCT02743663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65165847|NCT02743663|Adrenergic Agents|adrenergic agents|mesh-ancestor
65165848|NCT02743663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65165849|NCT02743663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165850|NCT02733445|Dasatinib|dasatinib|mesh-list
65165851|NCT02733445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165852|NCT02733445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65165853|NCT02733445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165854|NCT02733445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165855|NCT02731105|Clindamycin|clindamycin|mesh-list
65165856|NCT02731105|Clindamycin palmitate|clindamycin palmitate|mesh-list
65165857|NCT02731105|Clindamycin phosphate|clindamycin phosphate|mesh-list
65320714|NCT00737529|Immunologic Factors|immunologic factors|mesh-ancestor
65320715|NCT00737529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320716|NCT00737529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65320717|NCT00737529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65320718|NCT00737529|Growth Substances|growth substances|mesh-ancestor
65320719|NCT00737529|Growth Inhibitors|growth inhibitors|mesh-ancestor
65320720|NCT00737529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65320721|NCT00813917|Varenicline|varenicline|mesh-list
65320722|NCT00813917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65320723|NCT00813917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65320724|NCT00813917|Cholinergic Agents|cholinergic agents|mesh-ancestor
65320725|NCT00813917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65320726|NCT00813917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320727|NCT00813917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320728|NCT02598102|Diclofenac|diclofenac|mesh-list
65320729|NCT02598102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65320730|NCT02598102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65320731|NCT02598102|Analgesics|analgesics|mesh-ancestor
65320732|NCT02598102|Sensory System Agents|sensory system agents|mesh-ancestor
65320733|NCT02598102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550628|NCT00827073|Lidocaine|lidocaine|mesh-list
65165858|NCT02731105|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
65165859|NCT02731105|Tretinoin|tretinoin|mesh-list
65165860|NCT02731105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65165861|NCT02731105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65165862|NCT02731105|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65165863|NCT02731105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165864|NCT02731105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165865|NCT02731105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165866|NCT02731105|Keratolytic Agents|keratolytic agents|mesh-ancestor
65165867|NCT02731105|Dermatologic Agents|dermatologic agents|mesh-ancestor
65165868|NCT02731105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65165869|NCT02731105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65165870|NCT02731105|Analgesics|analgesics|mesh-ancestor
65165871|NCT02731105|Sensory System Agents|sensory system agents|mesh-ancestor
65165872|NCT02731105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165873|NCT02731105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165874|NCT02731105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65165875|NCT02731105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65165876|NCT02743429|Dinutuximab|dinutuximab|mesh-list
65165877|NCT02743429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165878|NCT02730949|Folic Acid|folic acid|mesh-list
65165879|NCT02730949|Inositol|inositol|mesh-list
65165880|NCT02730949|Hematinics|hematinics|mesh-ancestor
65165881|NCT02730949|Vitamin B Complex|vitamin b complex|mesh-ancestor
65165882|NCT02730949|Vitamins|vitamins|mesh-ancestor
65165883|NCT02730949|Micronutrients|micronutrients|mesh-ancestor
65165884|NCT02730949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165885|NCT04205929|Curcumin|curcumin|mesh-list
65165886|NCT04205929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65165887|NCT04205929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65165888|NCT04205929|Analgesics|analgesics|mesh-ancestor
65165889|NCT04205929|Sensory System Agents|sensory system agents|mesh-ancestor
65165890|NCT04205929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65320734|NCT02598102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320735|NCT02598102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65320736|NCT02598102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65320737|NCT02598102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65320738|NCT02598102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320739|NCT02598102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320740|NCT02610647|Anesthetics|anesthetics|mesh-list
65320741|NCT02610647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65320742|NCT02610647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320743|NCT02595918|Nivolumab|nivolumab|mesh-list
65320744|NCT02595918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65320745|NCT02595918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65320746|NCT02595918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65320747|NCT02595918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320748|NCT02595840|Pemetrexed|pemetrexed|mesh-list
65320749|NCT02595840|Afatinib|afatinib|mesh-list
65320750|NCT02595840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65320751|NCT02595840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320752|NCT02595840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320753|NCT02595840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65320754|NCT02595840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64550641|NCT00860847|Ubiquinone|ubiquinone|mesh-list
65165891|NCT04205929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165892|NCT04205929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65165893|NCT04205929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65165894|NCT04205929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165895|NCT04205929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165896|NCT04205929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165897|NCT03259867|Nivolumab|nivolumab|mesh-list
65165898|NCT03259867|Tirapazamine|tirapazamine|mesh-list
65165907|NCT03854929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65165908|NCT03854929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65165909|NCT03854929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165910|NCT03854929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165911|NCT03854929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165912|NCT03854929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65165913|NCT03854929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65165914|NCT00636493|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
65165915|NCT00636493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65165916|NCT00636493|Glucocorticoids|glucocorticoids|mesh-ancestor
65165917|NCT00636493|Hormones|hormones|mesh-ancestor
65165918|NCT00636493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65165919|NCT00636493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165920|NCT02730481|Paclitaxel|paclitaxel|mesh-list
65165921|NCT02730481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65165922|NCT02730481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165923|NCT02730481|Tubulin Modulators|tubulin modulators|mesh-ancestor
65165924|NCT02730481|Antimitotic Agents|antimitotic agents|mesh-ancestor
65165925|NCT02730481|Mitosis Modulators|mitosis modulators|mesh-ancestor
65165926|NCT02730481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165927|NCT02730091|Letrozole|letrozole|mesh-list
65320755|NCT02595840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65320756|NCT02594241|Prednisolone|prednisolone|mesh-list
65320757|NCT02594241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65320758|NCT02594241|Methylprednisolone|methylprednisolone|mesh-list
65320759|NCT02594241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65320760|NCT02594241|Prednisolone acetate|prednisolone acetate|mesh-list
65320761|NCT02594241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65320762|NCT02594241|Prednisolone phosphate|prednisolone phosphate|mesh-list
65320763|NCT02594241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65320764|NCT02594241|Glucocorticoids|glucocorticoids|mesh-ancestor
65320765|NCT02594241|Hormones|hormones|mesh-ancestor
65320766|NCT02594241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65320767|NCT02594241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320768|NCT02594241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65320769|NCT02594241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65320770|NCT02594241|Antiemetics|antiemetics|mesh-ancestor
65320771|NCT02594241|Autonomic Agents|autonomic agents|mesh-ancestor
65320772|NCT02594241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65320773|NCT02594241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65165928|NCT02730091|Vinorelbine|vinorelbine|mesh-list
65165929|NCT02730091|Anastrozole|anastrozole|mesh-list
65165930|NCT02730091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165931|NCT02730091|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65165932|NCT02730091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65165933|NCT02730091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165934|NCT02730091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165935|NCT02730091|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65165936|NCT02730091|Hormone Antagonists|hormone antagonists|mesh-ancestor
65165937|NCT02730091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65165938|NCT02730091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165939|NCT02730091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65165940|NCT02730091|Tubulin Modulators|tubulin modulators|mesh-ancestor
65165941|NCT02730091|Antimitotic Agents|antimitotic agents|mesh-ancestor
65165942|NCT02730091|Mitosis Modulators|mitosis modulators|mesh-ancestor
65165943|NCT02730091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65165944|NCT02742805|Vitamin D|vitamin d|mesh-list
65165945|NCT02742805|Ergocalciferols|ergocalciferols|mesh-list
65165946|NCT02742805|Cholecalciferol|cholecalciferol|mesh-list
65165947|NCT02742805|Vitamins|vitamins|mesh-list
65165948|NCT02742805|Omalizumab|omalizumab|mesh-list
65165949|NCT02742805|Micronutrients|micronutrients|mesh-ancestor
65165950|NCT02742805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165951|NCT02742805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65165952|NCT02742805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65165953|NCT02742805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65165954|NCT02742805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65165955|NCT02742805|Respiratory System Agents|respiratory system agents|mesh-ancestor
65165956|NCT03208231|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65165957|NCT03208231|Antiviral Agents|antiviral agents|mesh-ancestor
65165958|NCT03208231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65165959|NCT02690389|Flumazenil|flumazenil|mesh-list
65165960|NCT02690389|Antidotes|antidotes|mesh-ancestor
65165961|NCT02690389|Protective Agents|protective agents|mesh-ancestor
65165962|NCT02690389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165963|NCT02690389|GABA Modulators|gaba modulators|mesh-ancestor
65165980|NCT02729935|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65165981|NCT02729935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65320774|NCT02594241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65320775|NCT02594241|Protective Agents|protective agents|mesh-ancestor
65320777|NCT00585975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65320778|NCT00585975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65320779|NCT00585975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64985168|NCT00297466|Nicotine|nicotine|mesh-list
65165982|NCT02729935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165983|NCT02729935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165984|NCT02729935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65165985|NCT02729935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65165986|NCT02729935|Analgesics|analgesics|mesh-ancestor
65165987|NCT02729935|Sensory System Agents|sensory system agents|mesh-ancestor
65165988|NCT02729935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165989|NCT02729935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165990|NCT02729935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65165991|NCT02729935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65165992|NCT02729467|Itraconazole|itraconazole|mesh-list
65165993|NCT02729467|Rifampin|rifampin|mesh-list
65165994|NCT02729467|Antifungal Agents|antifungal agents|mesh-ancestor
65165995|NCT02729467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65165996|NCT02729467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65165997|NCT02729467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65165998|NCT02729467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165999|NCT02729467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166000|NCT02729467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65166001|NCT02729467|Hormone Antagonists|hormone antagonists|mesh-ancestor
65166002|NCT02729467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65166003|NCT02729467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166004|NCT02729467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65166005|NCT02729467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65166006|NCT02729467|Antitubercular Agents|antitubercular agents|mesh-ancestor
65166007|NCT02729467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65166008|NCT02729467|Leprostatic Agents|leprostatic agents|mesh-ancestor
65166009|NCT02729467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65166010|NCT02729467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65166011|NCT02729467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65166012|NCT02729467|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65166013|NCT02729467|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65166014|NCT02729467|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65166015|NCT02729467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65166016|NCT02727205|Rotigotine|rotigotine|mesh-list
65166017|NCT02727205|Dopamine Agonists|dopamine agonists|mesh-ancestor
65166018|NCT02727205|Dopamine Agents|dopamine agents|mesh-ancestor
65166019|NCT02727205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65166020|NCT02727205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510725|NCT05825066|Tubulin Modulators|tubulin modulators|mesh-ancestor
65166025|NCT02721433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65166026|NCT02721433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166027|NCT02721043|Lenalidomide|lenalidomide|mesh-list
65166028|NCT02721043|Vaccines|vaccines|mesh-list
65166029|NCT02721043|Poly ICLC|poly iclc|mesh-list
65166030|NCT02721043|Immunologic Factors|immunologic factors|mesh-ancestor
65166031|NCT02721043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166032|NCT02721043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65166033|NCT02721043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65166034|NCT02721043|Growth Substances|growth substances|mesh-ancestor
65166035|NCT02721043|Growth Inhibitors|growth inhibitors|mesh-ancestor
65166036|NCT02721043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166037|NCT02721043|Interferon Inducers|interferon inducers|mesh-ancestor
65166038|NCT02728843|Deferiprone|deferiprone|mesh-list
65166039|NCT02728843|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65166040|NCT02728843|Chelating Agents|chelating agents|mesh-ancestor
65166041|NCT02728843|Sequestering Agents|sequestering agents|mesh-ancestor
65166042|NCT02728843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166043|NCT02726503|Lenvatinib|lenvatinib|mesh-list
65166044|NCT02726503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166045|NCT02726503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65320780|NCT00585975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65320781|NCT00585975|Analgesics|analgesics|mesh-ancestor
65320782|NCT00585975|Sensory System Agents|sensory system agents|mesh-ancestor
65320783|NCT00585975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65320784|NCT00585975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320785|NCT00585975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65320786|NCT00585975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65320787|NCT00918021|Olanzapine|olanzapine|mesh-list
65320788|NCT00918021|Antiemetics|antiemetics|mesh-ancestor
65320789|NCT00918021|Autonomic Agents|autonomic agents|mesh-ancestor
65320790|NCT00918021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65320791|NCT00918021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320792|NCT00918021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65320793|NCT00918021|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65320794|NCT00918021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65320795|NCT00918021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65320796|NCT00918021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65166046|NCT02726503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65166047|NCT02726503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166048|NCT02720965|Anesthetics|anesthetics|mesh-list
65166049|NCT02720965|Anesthetics, Local|anesthetics, local|mesh-list
65166050|NCT02720965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65166051|NCT02720965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166052|NCT02720965|Sensory System Agents|sensory system agents|mesh-ancestor
65166053|NCT02720965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166054|NCT02792413|Denosumab|denosumab|mesh-list
65166055|NCT02792413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65166056|NCT02792413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166057|NCT02726737|Lidocaine|lidocaine|mesh-list
65166058|NCT02726737|Anesthetics, Local|anesthetics, local|mesh-ancestor
65166059|NCT02726737|Anesthetics|anesthetics|mesh-ancestor
65166060|NCT02726737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65166061|NCT02726737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166062|NCT02726737|Sensory System Agents|sensory system agents|mesh-ancestor
65166063|NCT02726737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166064|NCT02726737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65166065|NCT02726737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65166066|NCT02726737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65166067|NCT02726737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65166068|NCT02726737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166069|NCT02720575|Vitamin D|vitamin d|mesh-list
65166070|NCT02720575|Vitamins|vitamins|mesh-ancestor
65166071|NCT02720575|Micronutrients|micronutrients|mesh-ancestor
65166072|NCT02720575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166073|NCT02720575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65166075|NCT02720341|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65166076|NCT02720341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65166077|NCT02720341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166078|NCT02720341|Cholinergic Agents|cholinergic agents|mesh-ancestor
65166079|NCT02720341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65166080|NCT02720341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166081|NCT02728453|Empagliflozin|empagliflozin|mesh-list
65166082|NCT02728453|Glimepiride|glimepiride|mesh-list
65166083|NCT02728453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65166084|NCT02728453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166085|NCT02728453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65166086|NCT02728453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320797|NCT00918021|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65320798|NCT00918021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65320799|NCT00918021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65320800|NCT00918021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320801|NCT00918021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65320802|NCT00918021|Serotonin Agents|serotonin agents|mesh-ancestor
65320803|NCT00585585|Betahistine|betahistine|mesh-list
65166087|NCT02728453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65166088|NCT02728453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65166089|NCT02728453|Immunologic Factors|immunologic factors|mesh-ancestor
65166090|NCT02728687|Mannitol|mannitol|mesh-list
65166091|NCT02728687|Menthol|menthol|mesh-list
65166092|NCT02728687|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65166093|NCT02728687|Diuretics|diuretics|mesh-ancestor
65166098|NCT02726269|Ofloxacin|ofloxacin|mesh-list
65166099|NCT02726269|Levofloxacin|levofloxacin|mesh-list
65166100|NCT02726269|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65166101|NCT02726269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65166102|NCT02726269|Renal Agents|renal agents|mesh-ancestor
65166103|NCT02726269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65166104|NCT02726269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65166105|NCT02726269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65166106|NCT02726269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65166107|NCT02726269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166108|NCT02726269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166109|NCT02726269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64808717|NCT01435343|Plerixafor|plerixafor|mesh-list
65166110|NCT02726269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65166111|NCT02694289|Metformin|metformin|mesh-list
65166112|NCT02694289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65166113|NCT02694289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166114|NCT02719795|Ropivacaine|ropivacaine|mesh-list
65166115|NCT02719795|Anesthetics, Local|anesthetics, local|mesh-ancestor
65166116|NCT02719795|Anesthetics|anesthetics|mesh-ancestor
65166117|NCT02719795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65166118|NCT02719795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166119|NCT02719795|Sensory System Agents|sensory system agents|mesh-ancestor
65166120|NCT02719795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166121|NCT02726347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65166122|NCT02726347|Immunologic Factors|immunologic factors|mesh-ancestor
65166123|NCT02726347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166124|NCT02726035|Naltrexone|naltrexone|mesh-list
65166125|NCT02726035|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65166126|NCT02726035|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65166127|NCT02726035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166128|NCT02726035|Sensory System Agents|sensory system agents|mesh-ancestor
65166129|NCT02726035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166130|NCT02719405|Caseins|caseins|mesh-list
65166131|NCT02719405|Chelating Agents|chelating agents|mesh-ancestor
65166132|NCT02719405|Sequestering Agents|sequestering agents|mesh-ancestor
65166133|NCT02719405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166134|NCT02725255|Albendazole|albendazole|mesh-list
65166135|NCT02725255|Anthelmintics|anthelmintics|mesh-ancestor
65166136|NCT02725255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65166137|NCT02725255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65166138|NCT02725255|Anticestodal Agents|anticestodal agents|mesh-ancestor
65166139|NCT02725255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65166140|NCT02725255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65166141|NCT02725255|Tubulin Modulators|tubulin modulators|mesh-ancestor
65166142|NCT02725255|Antimitotic Agents|antimitotic agents|mesh-ancestor
65166143|NCT02725255|Mitosis Modulators|mitosis modulators|mesh-ancestor
65166144|NCT02725255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166145|NCT02725255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166146|NCT02719015|Pembrolizumab|pembrolizumab|mesh-list
65166147|NCT02719015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65166148|NCT02719015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166149|NCT02725489|Durvalumab|durvalumab|mesh-list
65166150|NCT02725489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65320804|NCT00585585|Vasodilator Agents|vasodilator agents|mesh-ancestor
65320805|NCT00585585|Histamine Agonists|histamine agonists|mesh-ancestor
65320806|NCT00585585|Histamine Agents|histamine agents|mesh-ancestor
65320807|NCT00585585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65166151|NCT02725489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166152|NCT02718547|Timolol|timolol|mesh-list
65166153|NCT02718547|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65166154|NCT02718547|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65166155|NCT02718547|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
65166156|NCT02718547|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65166157|NCT02718547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166158|NCT02718547|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65166159|NCT02718547|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65166160|NCT02718547|Adrenergic Agents|adrenergic agents|mesh-ancestor
65166161|NCT02718547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65166162|NCT02718547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166163|NCT02718547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65166176|NCT02725099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166178|NCT01225211|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65166179|NCT01225211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65166180|NCT01225211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166181|NCT02685709|Octreotide|octreotide|mesh-list
65166182|NCT02685709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65166183|NCT02685709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65166184|NCT02685709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166185|NCT02265367|Milnacipran|milnacipran|mesh-list
64808793|NCT01435902|Xhance|xhance|mesh-list
65166186|NCT02265367|Levomilnacipran|levomilnacipran|mesh-list
65166187|NCT02265367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65166188|NCT02265367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65166189|NCT02265367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65166190|NCT02265367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166191|NCT02265367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65166192|NCT02265367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166193|NCT02265367|Antidepressive Agents|antidepressive agents|mesh-ancestor
65166194|NCT02265367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65166195|NCT02265367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65166196|NCT02265367|Analgesics|analgesics|mesh-ancestor
65166197|NCT02265367|Sensory System Agents|sensory system agents|mesh-ancestor
65166198|NCT02265367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166200|NCT02718469|Immunologic Factors|immunologic factors|mesh-ancestor
65166201|NCT02718469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166202|NCT02716285|Peppermint oil|peppermint oil|mesh-list
65166203|NCT02716285|Antiemetics|antiemetics|mesh-ancestor
65166204|NCT02716285|Autonomic Agents|autonomic agents|mesh-ancestor
65166205|NCT02716285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166206|NCT02716285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166207|NCT02716285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65166208|NCT02716285|Parasympatholytics|parasympatholytics|mesh-ancestor
65166209|NCT01224821|Tositumomab I-131|tositumomab i-131|mesh-list
65166210|NCT01224821|Antibodies|antibodies|mesh-list
65166211|NCT01224821|Immunologic Factors|immunologic factors|mesh-ancestor
65166212|NCT01224821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166213|NCT01224821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166214|NCT02684851|Fibrinolytic Agents|fibrinolytic agents|mesh-list
65166215|NCT02684851|Tranexamic Acid|tranexamic acid|mesh-list
65166216|NCT02684851|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
65166217|NCT02684851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65166218|NCT02684851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166219|NCT02684851|Hemostatics|hemostatics|mesh-ancestor
65166220|NCT02684851|Coagulants|coagulants|mesh-ancestor
65166221|NCT01224431|Lidocaine|lidocaine|mesh-list
65166222|NCT01224431|Anesthetics, Local|anesthetics, local|mesh-ancestor
65166223|NCT01224431|Anesthetics|anesthetics|mesh-ancestor
64511065|NCT05665088|Analgesics|analgesics|mesh-ancestor
65166232|NCT01224431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166234|NCT02716129|Nalbuphine|nalbuphine|mesh-list
65166235|NCT02716129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65166236|NCT02716129|Narcotics|narcotics|mesh-ancestor
65166237|NCT02716129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65166238|NCT02716129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166239|NCT02716129|Analgesics|analgesics|mesh-ancestor
65320808|NCT00585585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320809|NCT00585585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320810|NCT02593695|Fluoxetine|fluoxetine|mesh-list
65320811|NCT02593695|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65320812|NCT02593695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65320813|NCT02593695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65320814|NCT02593695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166240|NCT02716129|Sensory System Agents|sensory system agents|mesh-ancestor
65166241|NCT02716129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166242|NCT02718079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65166243|NCT02718079|Acetylcysteine|acetylcysteine|mesh-list
65166244|NCT02718079|Mannitol|mannitol|mesh-list
65166245|NCT02718079|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65166246|NCT02718079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65166247|NCT02718079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65166248|NCT02718079|Diuretics|diuretics|mesh-ancestor
65166249|NCT02718079|Natriuretic Agents|natriuretic agents|mesh-ancestor
65166250|NCT02718079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166251|NCT02718079|Antiviral Agents|antiviral agents|mesh-ancestor
65166252|NCT02718079|Expectorants|expectorants|mesh-ancestor
65166253|NCT02718079|Respiratory System Agents|respiratory system agents|mesh-ancestor
65166254|NCT02718079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65166255|NCT02718079|Antioxidants|antioxidants|mesh-ancestor
65166256|NCT02718079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166257|NCT02718079|Protective Agents|protective agents|mesh-ancestor
65166258|NCT02718079|Antidotes|antidotes|mesh-ancestor
65166259|NCT02717923|Capecitabine|capecitabine|mesh-list
65166260|NCT02717923|Cetuximab|cetuximab|mesh-list
65166261|NCT02717923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65166262|NCT02717923|Antimetabolites|antimetabolites|mesh-ancestor
65166263|NCT02717923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166264|NCT02717923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166265|NCT02717923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65166266|NCT02724163|Cytarabine|cytarabine|mesh-list
65166267|NCT02724163|Cyclophosphamide|cyclophosphamide|mesh-list
65166268|NCT02724163|Busulfan|busulfan|mesh-list
65166269|NCT02724163|Fludarabine|fludarabine|mesh-list
65166270|NCT02724163|Daunorubicin|daunorubicin|mesh-list
65166271|NCT02724163|Mitoxantrone|mitoxantrone|mesh-list
65166272|NCT02724163|Gemtuzumab|gemtuzumab|mesh-list
65166282|NCT02724163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65166283|NCT02724163|Antimetabolites|antimetabolites|mesh-ancestor
65166284|NCT02724163|Antiviral Agents|antiviral agents|mesh-ancestor
65166285|NCT02724163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65166286|NCT02724163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65166287|NCT02724163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65166288|NCT02724163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65166289|NCT02724163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65166290|NCT02724163|Analgesics|analgesics|mesh-ancestor
65166291|NCT02724163|Sensory System Agents|sensory system agents|mesh-ancestor
65166292|NCT02724163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166293|NCT02724163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65166304|NCT02723461|Oxytocin|oxytocin|mesh-list
65166305|NCT02723461|Oxytocics|oxytocics|mesh-ancestor
65166306|NCT02723461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65166307|NCT02723461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166308|NCT02715193|Volagidemab|volagidemab|mesh-list
65166309|NCT02715193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64511276|NCT05537740|Pembrolizumab|pembrolizumab|mesh-list
65166320|NCT02714959|Antiviral Agents|antiviral agents|mesh-ancestor
65166321|NCT02714959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65166322|NCT02714725|Dexmedetomidine|dexmedetomidine|mesh-list
65166323|NCT02714725|Propofol|propofol|mesh-list
65166324|NCT02714725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65166325|NCT02714725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65166326|NCT02714725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166327|NCT02714725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65166328|NCT02714725|Anesthetics, General|anesthetics, general|mesh-ancestor
65166329|NCT02714725|Anesthetics|anesthetics|mesh-ancestor
65166330|NCT02714725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65320815|NCT02593695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65320816|NCT02593695|Serotonin Agents|serotonin agents|mesh-ancestor
65320817|NCT02593695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320818|NCT02593695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65320819|NCT02593695|Antidepressive Agents|antidepressive agents|mesh-ancestor
65320820|NCT02593695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65320821|NCT02593695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65320822|NCT02593695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65320823|NCT02593695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320824|NCT00734097|Esomeprazole|esomeprazole|mesh-list
65320825|NCT00734097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65320826|NCT00734097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65320827|NCT00734097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65320828|NCT00734097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320829|NCT00734097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320830|NCT00819767|Valsartan|valsartan|mesh-list
65320831|NCT00819767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65320832|NCT00819767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65320833|NCT00819767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65320834|NCT00819767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320835|NCT04088175|Menthol|menthol|mesh-list
65320836|NCT04088175|Nicotine|nicotine|mesh-list
65320837|NCT04088175|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65320838|NCT04088175|Autonomic Agents|autonomic agents|mesh-ancestor
65320839|NCT04088175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65320840|NCT04088175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166331|NCT02714725|Analgesics|analgesics|mesh-ancestor
65166332|NCT02714725|Sensory System Agents|sensory system agents|mesh-ancestor
65166333|NCT02714725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166334|NCT02714725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65166335|NCT02714725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65166336|NCT02714725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65166337|NCT02714725|Adrenergic Agents|adrenergic agents|mesh-ancestor
65166338|NCT02714725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65166339|NCT02714725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166340|NCT01015287|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65166341|NCT01015287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65166342|NCT02714179|Acetaminophen|acetaminophen|mesh-list
65166343|NCT02714179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65166344|NCT02714179|Analgesics|analgesics|mesh-ancestor
65166345|NCT02714179|Sensory System Agents|sensory system agents|mesh-ancestor
65166346|NCT02714179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166347|NCT02714179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166348|NCT02714179|Antipyretics|antipyretics|mesh-ancestor
65166350|NCT01015131|Antiviral Agents|antiviral agents|mesh-ancestor
65166351|NCT01015131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65166352|NCT02723383|Baclofen|baclofen|mesh-list
65166353|NCT02723383|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65320841|NCT04088175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65320842|NCT04088175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65320843|NCT04088175|Cholinergic Agents|cholinergic agents|mesh-ancestor
65320844|NCT04088175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65320845|NCT04088175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320846|NCT04088175|Antipruritics|antipruritics|mesh-ancestor
65166354|NCT02723383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166355|NCT02723383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65166356|NCT02723383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166357|NCT02723383|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65166358|NCT02723383|GABA Agonists|gaba agonists|mesh-ancestor
65166359|NCT02723383|GABA Agents|gaba agents|mesh-ancestor
65166360|NCT02723383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65166361|NCT02723383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166362|NCT05269537|Ephedrine|ephedrine|mesh-list
65166363|NCT05269537|Fentanyl|fentanyl|mesh-list
65166364|NCT05269537|Bupivacaine|bupivacaine|mesh-list
65166365|NCT05269537|Oxytocin|oxytocin|mesh-list
65166366|NCT05269537|Anesthetics, Local|anesthetics, local|mesh-ancestor
65166367|NCT05269537|Anesthetics|anesthetics|mesh-ancestor
65166368|NCT05269537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65166369|NCT05269537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166370|NCT05269537|Sensory System Agents|sensory system agents|mesh-ancestor
65166371|NCT05269537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166372|NCT05269537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65166373|NCT05269537|Narcotics|narcotics|mesh-ancestor
65166374|NCT05269537|Analgesics|analgesics|mesh-ancestor
65166375|NCT05269537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65166376|NCT05269537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65166377|NCT05269537|Anesthetics, General|anesthetics, general|mesh-ancestor
65166395|NCT01222715|Immunoglobulin G|immunoglobulin g|mesh-list
65166396|NCT01222715|Endothelial Growth Factors|endothelial growth factors|mesh-list
65166397|NCT01222715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65166398|NCT01222715|Immunologic Factors|immunologic factors|mesh-ancestor
65166399|NCT01222715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166400|NCT01222715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65166401|NCT01222715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65166402|NCT01222715|Alkylating Agents|alkylating agents|mesh-ancestor
65166403|NCT01222715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166404|NCT01222715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166405|NCT01222715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65166406|NCT01222715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65166407|NCT01222715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65166408|NCT01222715|Growth Substances|growth substances|mesh-ancestor
65166409|NCT01222715|Growth Inhibitors|growth inhibitors|mesh-ancestor
65166410|NCT01222715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65166411|NCT01222715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65166412|NCT01222715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65166413|NCT01222715|Antifungal Agents|antifungal agents|mesh-ancestor
65166414|NCT01222715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65166415|NCT01222715|Tubulin Modulators|tubulin modulators|mesh-ancestor
65166416|NCT01222715|Antimitotic Agents|antimitotic agents|mesh-ancestor
65166417|NCT01222715|Mitosis Modulators|mitosis modulators|mesh-ancestor
65166418|NCT02723071|Ocrelizumab|ocrelizumab|mesh-list
65166419|NCT02723071|Immunologic Factors|immunologic factors|mesh-ancestor
65166420|NCT02723071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166421|NCT02722759|Chrysarobin|chrysarobin|mesh-list
65166422|NCT02722759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65166423|NCT02722759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65166424|NCT02722759|Analgesics|analgesics|mesh-ancestor
65166425|NCT02722759|Sensory System Agents|sensory system agents|mesh-ancestor
65166426|NCT02722759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166427|NCT02722759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166428|NCT02722759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65166429|NCT02722759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65166430|NCT02722603|Gabapentin|gabapentin|mesh-list
65166431|NCT02722603|Tramadol|tramadol|mesh-list
65166432|NCT02722603|Analgesics|analgesics|mesh-ancestor
65166433|NCT02722603|Sensory System Agents|sensory system agents|mesh-ancestor
65166434|NCT02722603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65320847|NCT04088175|Dermatologic Agents|dermatologic agents|mesh-ancestor
65320848|NCT00733005|Mometasone Furoate|mometasone furoate|mesh-list
65320849|NCT00733005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65320850|NCT00733005|Dermatologic Agents|dermatologic agents|mesh-ancestor
65320851|NCT00733005|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65320853|NCT05756621|Lacosamide|lacosamide|mesh-list
65320854|NCT05756621|Phenytoin|phenytoin|mesh-list
65320855|NCT05756621|Midazolam|midazolam|mesh-list
65166435|NCT02722603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166436|NCT02722603|Anticonvulsants|anticonvulsants|mesh-ancestor
65166437|NCT02722603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65166441|NCT02722603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65166443|NCT02722603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65166444|NCT02722603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166445|NCT02722603|Antimanic Agents|antimanic agents|mesh-ancestor
65166446|NCT02722603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65166447|NCT02722603|Narcotics|narcotics|mesh-ancestor
65166448|NCT02722447|Rivaroxaban|rivaroxaban|mesh-list
65166449|NCT02722447|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65166450|NCT02722447|Antithrombins|antithrombins|mesh-ancestor
65166451|NCT02722447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65166452|NCT02722447|Protease Inhibitors|protease inhibitors|mesh-ancestor
65166453|NCT02722447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65166454|NCT02722447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166455|NCT02722447|Anticoagulants|anticoagulants|mesh-ancestor
65166456|NCT01222403|Vaccines|vaccines|mesh-list
65166457|NCT01222403|MF59 oil emulsion|mf59 oil emulsion|mesh-list
65166458|NCT01222403|Immunologic Factors|immunologic factors|mesh-ancestor
65166459|NCT01222403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166460|NCT01222403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65166461|NCT02722369|Gemcitabine|gemcitabine|mesh-list
65166462|NCT02722369|Hydroxychloroquine|hydroxychloroquine|mesh-list
65166463|NCT02722369|Carboplatin|carboplatin|mesh-list
65166464|NCT02722369|Etoposide|etoposide|mesh-list
65166465|NCT02722369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166466|NCT02722369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65166467|NCT02722369|Antimetabolites|antimetabolites|mesh-ancestor
65166468|NCT02722369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166469|NCT02722369|Antiviral Agents|antiviral agents|mesh-ancestor
65166470|NCT02722369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65166471|NCT02722369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65166472|NCT02722369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65166473|NCT02722369|Immunologic Factors|immunologic factors|mesh-ancestor
65166474|NCT02722369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166475|NCT02722369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65166476|NCT02722369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65166477|NCT02722369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65166478|NCT02722369|Antimalarials|antimalarials|mesh-ancestor
65166479|NCT02722369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65166480|NCT02722369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65166481|NCT02722369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65166482|NCT01222247|Betamethasone|betamethasone|mesh-list
65166483|NCT01222247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65166484|NCT01222247|Glucocorticoids|glucocorticoids|mesh-ancestor
65166485|NCT01222247|Hormones|hormones|mesh-ancestor
65166486|NCT01222247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65166487|NCT01222247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166488|NCT01222247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65166489|NCT01222247|Respiratory System Agents|respiratory system agents|mesh-ancestor
65166490|NCT01014975|Fibrinolysin|fibrinolysin|mesh-list
65166491|NCT01014975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65166492|NCT01014975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65166493|NCT01014975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166495|NCT03982537|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65166496|NCT03982537|Antiviral Agents|antiviral agents|mesh-ancestor
65166497|NCT03982537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65166498|NCT03982537|Expectorants|expectorants|mesh-ancestor
65166499|NCT03982537|Respiratory System Agents|respiratory system agents|mesh-ancestor
65166500|NCT03982537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65166501|NCT03982537|Antioxidants|antioxidants|mesh-ancestor
65166502|NCT03982537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320856|NCT05756621|Ketamine|ketamine|mesh-list
65320857|NCT05756621|Levetiracetam|levetiracetam|mesh-list
65320858|NCT05756621|Thiopental|thiopental|mesh-list
65320859|NCT05756621|Anticonvulsants|anticonvulsants|mesh-list
65320860|NCT05756621|Propofol|propofol|mesh-list
65320861|NCT05756621|Anesthetics|anesthetics|mesh-list
65320862|NCT05756621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65320863|NCT05756621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65320864|NCT05756621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320865|NCT05756621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65320866|NCT05756621|Anesthetics, General|anesthetics, general|mesh-ancestor
65166503|NCT03982537|Protective Agents|protective agents|mesh-ancestor
65166504|NCT03982537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166505|NCT03982537|Antidotes|antidotes|mesh-ancestor
65166506|NCT05260593|Vitamins|vitamins|mesh-list
65166507|NCT05260593|Hydroxocobalamin|hydroxocobalamin|mesh-list
65166508|NCT05260593|Vitamin B 12|vitamin b 12|mesh-list
65166509|NCT05260593|Vitamin B Complex|vitamin b complex|mesh-list
65166510|NCT05260593|Micronutrients|micronutrients|mesh-ancestor
65166511|NCT05260593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166526|NCT01014585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166527|NCT01014585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65166529|NCT01014585|Sensory System Agents|sensory system agents|mesh-ancestor
65166530|NCT01014585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166531|NCT01014585|Antidepressive Agents|antidepressive agents|mesh-ancestor
65166532|NCT01014585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65166533|NCT00611143|Atorvastatin|atorvastatin|mesh-list
65166534|NCT00611143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65166535|NCT00611143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65166536|NCT00611143|Antimetabolites|antimetabolites|mesh-ancestor
65166537|NCT00611143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166538|NCT00611143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65166539|NCT00611143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65166540|NCT00611143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65166541|NCT02712619|Metformin|metformin|mesh-list
65166542|NCT02712619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65166543|NCT02712619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166544|NCT01220609|Epothilones|epothilones|mesh-list
65166545|NCT01220609|Tubulin Modulators|tubulin modulators|mesh-ancestor
65166546|NCT01220609|Antimitotic Agents|antimitotic agents|mesh-ancestor
65166547|NCT01220609|Mitosis Modulators|mitosis modulators|mesh-ancestor
65166548|NCT01220609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166549|NCT01220609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166550|NCT02713087|Phenylephrine|phenylephrine|mesh-list
65166551|NCT02713087|Oxymetazoline|oxymetazoline|mesh-list
65166552|NCT02713087|Ephedrine|ephedrine|mesh-list
65166553|NCT02713087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65166554|NCT02713087|Mydriatics|mydriatics|mesh-ancestor
65166555|NCT02713087|Autonomic Agents|autonomic agents|mesh-ancestor
65166556|NCT02713087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166557|NCT02713087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166558|NCT02713087|Sympathomimetics|sympathomimetics|mesh-ancestor
65166559|NCT02713087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65166560|NCT02713087|Nasal Decongestants|nasal decongestants|mesh-ancestor
65166561|NCT02713087|Respiratory System Agents|respiratory system agents|mesh-ancestor
65166562|NCT02713087|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65166563|NCT02713087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65166564|NCT02713087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65166565|NCT02713087|Adrenergic Agents|adrenergic agents|mesh-ancestor
65166566|NCT02713087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65166567|NCT02713087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166568|NCT02713087|Protective Agents|protective agents|mesh-ancestor
65166569|NCT02713087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65166570|NCT02712697|Prednisone|prednisone|mesh-list
65166571|NCT02712697|Hormones|hormones|mesh-list
65166572|NCT02712697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65166586|NCT01220297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550764|NCT04278547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65320867|NCT05756621|Analgesics|analgesics|mesh-ancestor
65320868|NCT05756621|Sensory System Agents|sensory system agents|mesh-ancestor
65320869|NCT05756621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65320870|NCT05756621|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65320871|NCT05756621|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65320872|NCT05756621|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65320873|NCT05756621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65320874|NCT05756621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320875|NCT05756621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65166587|NCT01220297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65166588|NCT01220297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65166589|NCT01220297|Alkylating Agents|alkylating agents|mesh-ancestor
65166590|NCT01220297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166591|NCT01220297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166592|NCT01220297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65166593|NCT01220297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65166594|NCT01220297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65166595|NCT01220297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65166596|NCT01220297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65166597|NCT01220297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65166598|NCT01220297|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65166599|NCT01220297|Antitubercular Agents|antitubercular agents|mesh-ancestor
65166600|NCT01220297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65166601|NCT01220297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65166602|NCT01220297|Antifungal Agents|antifungal agents|mesh-ancestor
65166603|NCT02712775|Minocycline|minocycline|mesh-list
65166604|NCT02712775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65166605|NCT02712775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65166606|NCT04318847|Ondansetron|ondansetron|mesh-list
65166607|NCT04318847|Antiemetics|antiemetics|mesh-ancestor
65166608|NCT04318847|Autonomic Agents|autonomic agents|mesh-ancestor
65166609|NCT04318847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166610|NCT04318847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166611|NCT04318847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65166612|NCT04318847|Antipruritics|antipruritics|mesh-ancestor
65166613|NCT04318847|Dermatologic Agents|dermatologic agents|mesh-ancestor
65166614|NCT04318847|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65166615|NCT04318847|Serotonin Agents|serotonin agents|mesh-ancestor
65166616|NCT04318847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65166617|NCT04318847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166618|NCT04318847|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65166619|NCT04318847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65166620|NCT04318847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65166621|NCT04318847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65166622|NCT04318847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65166623|NCT02721511|Furosemide|furosemide|mesh-list
65166624|NCT02721511|Diuretics|diuretics|mesh-ancestor
65166625|NCT02721511|Natriuretic Agents|natriuretic agents|mesh-ancestor
65166626|NCT02721511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166627|NCT02721511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65166628|NCT02721511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65166629|NCT02721511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166630|NCT02712307|Penicillins|penicillins|mesh-list
65166631|NCT02712307|Penicillin V|penicillin v|mesh-list
65166632|NCT02712307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65166633|NCT02712307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65166634|NCT02708251|Lidocaine|lidocaine|mesh-list
65166635|NCT02708251|Nitroglycerin|nitroglycerin|mesh-list
65166647|NCT02708251|Vasodilator Agents|vasodilator agents|mesh-ancestor
65166648|NCT02708173|Vaccines|vaccines|mesh-list
65166649|NCT02708173|Immunologic Factors|immunologic factors|mesh-ancestor
65166650|NCT02708173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166651|NCT00611611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65320876|NCT05756621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65320877|NCT05756621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65320878|NCT05756621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65320879|NCT05756621|GABA Modulators|gaba modulators|mesh-ancestor
65320880|NCT05756621|GABA Agents|gaba agents|mesh-ancestor
65320881|NCT05756621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65320882|NCT05756621|Nootropic Agents|nootropic agents|mesh-ancestor
65320883|NCT05756621|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65320884|NCT05756621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64315730|NCT05035862|Prednisone|prednisone|mesh-list
65166652|NCT00611611|Immunologic Factors|immunologic factors|mesh-ancestor
65166653|NCT00611611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166654|NCT00612625|Glucagon|glucagon|mesh-list
65166655|NCT00612625|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65166656|NCT00612625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65166657|NCT00612625|Hormones|hormones|mesh-ancestor
65166658|NCT00612625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65166659|NCT00612625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166660|NCT00612625|Incretins|incretins|mesh-ancestor
65166661|NCT03971071|Erenumab|erenumab|mesh-list
65166662|NCT03971071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65166663|NCT03971071|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65166664|NCT03971071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166665|NCT03971071|Analgesics|analgesics|mesh-ancestor
65166666|NCT03971071|Sensory System Agents|sensory system agents|mesh-ancestor
65166667|NCT03971071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166668|NCT03971071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166669|NCT03971071|Immunologic Factors|immunologic factors|mesh-ancestor
65166670|NCT02711917|Propofol|propofol|mesh-list
65166671|NCT02711917|Etomidate|etomidate|mesh-list
65166672|NCT02711917|Rocuronium|rocuronium|mesh-list
65166673|NCT02711917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65166674|NCT02711917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65166675|NCT02711917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166676|NCT02711917|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65166677|NCT02711917|Anesthetics, General|anesthetics, general|mesh-ancestor
65166678|NCT02711917|Anesthetics|anesthetics|mesh-ancestor
65166679|NCT02711917|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65166680|NCT02711917|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65166681|NCT02711917|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65166682|NCT02711917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166683|NCT02711449|Methylprednisolone|methylprednisolone|mesh-list
65166684|NCT02711449|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65166685|NCT02711449|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65166686|NCT02711449|Prednisolone|prednisolone|mesh-list
65166687|NCT02711449|Prednisolone acetate|prednisolone acetate|mesh-list
65166688|NCT02711449|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65166689|NCT02711449|Prednisolone phosphate|prednisolone phosphate|mesh-list
65166690|NCT02711449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65166691|NCT02711449|Antiemetics|antiemetics|mesh-ancestor
65166692|NCT02711449|Autonomic Agents|autonomic agents|mesh-ancestor
65166693|NCT02711449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166694|NCT02711449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166695|NCT02711449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65166696|NCT02711449|Glucocorticoids|glucocorticoids|mesh-ancestor
65166697|NCT02711449|Hormones|hormones|mesh-ancestor
65166708|NCT00612079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65166709|NCT00940498|Gedatolisib|gedatolisib|mesh-list
65166710|NCT00940498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65166711|NCT00940498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65166712|NCT00940498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166713|NCT03820531|Pancrelipase|pancrelipase|mesh-list
65166714|NCT03820531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65166715|NCT02850718|Sildenafil Citrate|sildenafil citrate|mesh-list
65166716|NCT02850718|Vasodilator Agents|vasodilator agents|mesh-ancestor
65166717|NCT02850718|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65166718|NCT02850718|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65320885|NCT05756621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65320886|NCT05756621|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65320887|NCT05756621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65320888|NCT05221229|Liraglutide|liraglutide|mesh-list
65320889|NCT05221229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65320890|NCT05221229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320891|NCT05221229|Incretins|incretins|mesh-ancestor
65320892|NCT05221229|Hormones|hormones|mesh-ancestor
65320893|NCT05221229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65320894|NCT00732381|Mometasone Furoate|mometasone furoate|mesh-list
65320895|NCT00732381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65320896|NCT00732381|Dermatologic Agents|dermatologic agents|mesh-ancestor
65320897|NCT00732381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65320898|NCT00732303|Pemetrexed|pemetrexed|mesh-list
65320899|NCT00732303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65320900|NCT00732303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320901|NCT00732303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320902|NCT00732303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65166719|NCT02850718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65166720|NCT02850718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166722|NCT02707393|Cyclosporine|cyclosporine|mesh-list
65166723|NCT02707393|Mycophenolic Acid|mycophenolic acid|mesh-list
65166724|NCT02707393|Fludarabine|fludarabine|mesh-list
65166725|NCT02707393|Melphalan|melphalan|mesh-list
65166726|NCT02707393|Thiotepa|thiotepa|mesh-list
65166727|NCT02707393|Cyclosporins|cyclosporins|mesh-list
65166728|NCT02707393|Thymoglobulin|thymoglobulin|mesh-list
65166729|NCT02707393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166730|NCT02707393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166731|NCT02707393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65166732|NCT02707393|Immunologic Factors|immunologic factors|mesh-ancestor
65166733|NCT02707393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166734|NCT02707393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65166735|NCT02707393|Antifungal Agents|antifungal agents|mesh-ancestor
65166736|NCT02707393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65166737|NCT02707393|Dermatologic Agents|dermatologic agents|mesh-ancestor
65166738|NCT02707393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65166739|NCT02707393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65166740|NCT02707393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65166741|NCT02707393|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65166742|NCT02707393|Antitubercular Agents|antitubercular agents|mesh-ancestor
65166743|NCT02707393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65166744|NCT02707393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65166745|NCT02707393|Alkylating Agents|alkylating agents|mesh-ancestor
65166746|NCT02707393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65166747|NCT00940342|Rituximab|rituximab|mesh-list
65166748|NCT00940342|Molgramostim|molgramostim|mesh-list
65166749|NCT00940342|Sargramostim|sargramostim|mesh-list
65166750|NCT00940342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65166751|NCT00940342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166752|NCT00940342|Immunologic Factors|immunologic factors|mesh-ancestor
65166753|NCT00940342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166754|NCT00940342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65166755|NCT00936910|Amphotericin B|amphotericin b|mesh-list
65166756|NCT00936910|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65166757|NCT00936910|Amebicides|amebicides|mesh-ancestor
65166758|NCT00936910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65166759|NCT00936910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65166760|NCT00936910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65320903|NCT00732303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65320904|NCT00813761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65320905|NCT00732069|Valsartan|valsartan|mesh-list
65320906|NCT00732069|Ramipril|ramipril|mesh-list
65320907|NCT00732069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65320908|NCT00732069|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65320909|NCT00732069|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65320910|NCT00732069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320911|NCT00732069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65320912|NCT00732069|Protease Inhibitors|protease inhibitors|mesh-ancestor
65320913|NCT00732069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320914|NCT02593383|Clindamycin|clindamycin|mesh-list
65166761|NCT00936910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65166762|NCT00936910|Antifungal Agents|antifungal agents|mesh-ancestor
65166763|NCT02707315|Gemcitabine|gemcitabine|mesh-list
65166764|NCT02707315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65166790|NCT02711683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65166791|NCT02711683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65166792|NCT02711683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166793|NCT02711683|Cholinergic Agents|cholinergic agents|mesh-ancestor
65166794|NCT02711683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65166795|NCT02711683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166796|NCT02711683|Nootropic Agents|nootropic agents|mesh-ancestor
65166797|NCT02711683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65166798|NCT02711683|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65166799|NCT02711683|Protective Agents|protective agents|mesh-ancestor
65166800|NCT05079061|Misoprostol|misoprostol|mesh-list
65166801|NCT05079061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65166802|NCT05079061|Abortifacient Agents|abortifacient agents|mesh-ancestor
65166803|NCT05079061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65166804|NCT05079061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166805|NCT05079061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65166806|NCT05079061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65166808|NCT00605020|Insulin|insulin|mesh-list
65166809|NCT00605020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65166810|NCT00605020|Insulin Aspart|insulin aspart|mesh-list
65166811|NCT00605020|Insulin, Long-Acting|insulin, long-acting|mesh-list
65166812|NCT00605020|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65166813|NCT00605020|Insulin Detemir|insulin detemir|mesh-list
65166814|NCT00605020|Biphasic Insulins|biphasic insulins|mesh-list
65166815|NCT00605020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65166816|NCT00605020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166827|NCT02707081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65166828|NCT02707081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166829|NCT00605098|Ritonavir|ritonavir|mesh-list
65166830|NCT00605098|Lopinavir|lopinavir|mesh-list
65166831|NCT00605098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65166832|NCT00605098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65166833|NCT00605098|Protease Inhibitors|protease inhibitors|mesh-ancestor
65166834|NCT00605098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65166835|NCT00605098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166836|NCT00605098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65166837|NCT00605098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65166838|NCT00605098|Antiviral Agents|antiviral agents|mesh-ancestor
65166839|NCT00605098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65166840|NCT00605098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65166841|NCT00605098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65166842|NCT02711215|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65166843|NCT02711215|Mirtazapine|mirtazapine|mesh-list
65166844|NCT02711215|Citalopram|citalopram|mesh-list
65166845|NCT02711215|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65166846|NCT02711215|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65320915|NCT02593383|Clindamycin palmitate|clindamycin palmitate|mesh-list
65320916|NCT02593383|Clindamycin phosphate|clindamycin phosphate|mesh-list
65320917|NCT02593383|Adapalene|adapalene|mesh-list
65320918|NCT02593383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65320919|NCT02593383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65320920|NCT02593383|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65320921|NCT02593383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65166847|NCT02711215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65166848|NCT02711215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65166849|NCT02711215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166850|NCT02711215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65166851|NCT02711215|Serotonin Agents|serotonin agents|mesh-ancestor
65166852|NCT02711215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166853|NCT02711215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65166854|NCT02711215|Antidepressive Agents|antidepressive agents|mesh-ancestor
65166855|NCT02711215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65166856|NCT02711215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166857|NCT02711215|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65166858|NCT02711215|Analgesics|analgesics|mesh-ancestor
65166859|NCT02711215|Sensory System Agents|sensory system agents|mesh-ancestor
65166860|NCT02711215|Dopamine Agents|dopamine agents|mesh-ancestor
65166861|NCT02711215|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65166862|NCT02711215|Histamine Antagonists|histamine antagonists|mesh-ancestor
65166863|NCT02711215|Histamine Agents|histamine agents|mesh-ancestor
65166864|NCT02711215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65166865|NCT02711215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65166866|NCT02711215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65166867|NCT02711215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65166868|NCT02711215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65166869|NCT02711215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65166870|NCT02711215|Adrenergic Agents|adrenergic agents|mesh-ancestor
65166871|NCT02711215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65166872|NCT02711215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65166873|NCT02711215|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65166874|NCT00603772|Tretinoin|tretinoin|mesh-list
65166875|NCT00603772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166876|NCT00603772|Keratolytic Agents|keratolytic agents|mesh-ancestor
65166877|NCT00603772|Dermatologic Agents|dermatologic agents|mesh-ancestor
65166878|NCT02706769|Acetaminophen|acetaminophen|mesh-list
65166879|NCT02706769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65166893|NCT03961165|Anticonvulsants|anticonvulsants|mesh-ancestor
65166894|NCT03961165|Parasympatholytics|parasympatholytics|mesh-ancestor
65166895|NCT03961165|Autonomic Agents|autonomic agents|mesh-ancestor
65166896|NCT03961165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166897|NCT03961165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166898|NCT03961165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65166899|NCT03961165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65166900|NCT03961165|Cholinergic Agents|cholinergic agents|mesh-ancestor
65166901|NCT03961165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65166902|NCT03961165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166903|NCT03961165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65166904|NCT03961165|Antiemetics|antiemetics|mesh-ancestor
65166905|NCT03961165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65166906|NCT03961165|Mydriatics|mydriatics|mesh-ancestor
65166907|NCT02706535|Itraconazole|itraconazole|mesh-list
65166908|NCT02706535|Rifampin|rifampin|mesh-list
65166909|NCT02706535|Antifungal Agents|antifungal agents|mesh-ancestor
65166910|NCT02706535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65166911|NCT02706535|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65166912|NCT02706535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65166913|NCT02706535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65166914|NCT02706535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166915|NCT02706535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65166916|NCT02706535|Hormone Antagonists|hormone antagonists|mesh-ancestor
65166917|NCT02706535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65166918|NCT02706535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166919|NCT02706535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65320922|NCT02593383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320923|NCT02593383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65320924|NCT02593383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65320925|NCT02593383|Analgesics|analgesics|mesh-ancestor
65320926|NCT02593383|Sensory System Agents|sensory system agents|mesh-ancestor
65320927|NCT02593383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65320928|NCT02593383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320929|NCT02593383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65166920|NCT02706535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65166921|NCT02706535|Antitubercular Agents|antitubercular agents|mesh-ancestor
65166922|NCT02706535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65166923|NCT02706535|Leprostatic Agents|leprostatic agents|mesh-ancestor
65166924|NCT02706535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65166925|NCT02706535|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65166926|NCT02706535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65166927|NCT02706535|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65166928|NCT02706535|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65166929|NCT02706535|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65166930|NCT02706535|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65166931|NCT02711059|Parathyroid Hormone|parathyroid hormone|mesh-list
65166932|NCT02711059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65166933|NCT02711059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166934|NCT04993027|Vancomycin|vancomycin|mesh-list
65166935|NCT04993027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65166936|NCT04993027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65166937|NCT03796273|Ketoconazole|ketoconazole|mesh-list
65166938|NCT03796273|Antifungal Agents|antifungal agents|mesh-ancestor
65166939|NCT03796273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64512091|NCT04775680|Antibodies|antibodies|mesh-list
65166947|NCT03796273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166948|NCT03796273|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65166949|NCT00612157|Eszopiclone|eszopiclone|mesh-list
65166950|NCT00612157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65166951|NCT00612157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65166952|NCT00612157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166953|NCT00936598|Zolpidem|zolpidem|mesh-list
65166954|NCT00936598|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65166955|NCT00936598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65166956|NCT00936598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65166957|NCT00936598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166958|NCT00936598|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65166959|NCT00936598|GABA Agonists|gaba agonists|mesh-ancestor
65166960|NCT00936598|GABA Agents|gaba agents|mesh-ancestor
65166961|NCT00936598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65166962|NCT00936598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166963|NCT01025817|Mycophenolic Acid|mycophenolic acid|mesh-list
65166964|NCT01025817|Everolimus|everolimus|mesh-list
65166965|NCT01025817|Tacrolimus|tacrolimus|mesh-list
65166966|NCT01025817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65166967|NCT01025817|Immunologic Factors|immunologic factors|mesh-ancestor
65166968|NCT01025817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166969|NCT01025817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65166970|NCT01025817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65166971|NCT01025817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166972|NCT01025817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166973|NCT01025817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65166974|NCT01025817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65166975|NCT01025817|Antitubercular Agents|antitubercular agents|mesh-ancestor
65166976|NCT01025817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65166977|NCT01025817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65166978|NCT00636883|Gemcitabine|gemcitabine|mesh-list
65166979|NCT00636883|Oxaliplatin|oxaliplatin|mesh-list
65166980|NCT00636883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65320930|NCT02593383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65320931|NCT02593383|Dermatologic Agents|dermatologic agents|mesh-ancestor
65320932|NCT00731679|Rifaximin|rifaximin|mesh-list
65320933|NCT00731679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65320934|NCT00731679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65320935|NCT00731679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65320936|NCT02609087|Propofol|propofol|mesh-list
65320937|NCT02609087|Sevoflurane|sevoflurane|mesh-list
65320938|NCT02609087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65320939|NCT02609087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65320940|NCT02609087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320941|NCT02609087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65320942|NCT02609087|Anesthetics, General|anesthetics, general|mesh-ancestor
65320943|NCT02609087|Anesthetics|anesthetics|mesh-ancestor
65320944|NCT02609087|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65320945|NCT02609087|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65320946|NCT00731133|Disulfiram|disulfiram|mesh-list
65320947|NCT00731133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65320948|NCT00731133|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
64550822|NCT05373186|Insulin Lispro|insulin lispro|mesh-list
65166981|NCT00636883|Antimetabolites|antimetabolites|mesh-ancestor
65166982|NCT00636883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166983|NCT00636883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166984|NCT00636883|Antiviral Agents|antiviral agents|mesh-ancestor
65166985|NCT00636883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65166986|NCT00636883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65166987|NCT00636883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65166988|NCT00636883|Immunologic Factors|immunologic factors|mesh-ancestor
65166989|NCT00636883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166990|NCT00605410|Bromides|bromides|mesh-list
65166991|NCT00605410|Ipratropium|ipratropium|mesh-list
65166992|NCT00605410|Anticonvulsants|anticonvulsants|mesh-ancestor
65166993|NCT00605410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65166994|NCT00605410|Autonomic Agents|autonomic agents|mesh-ancestor
65166995|NCT00605410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166996|NCT00605410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166997|NCT00605410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65166998|NCT00605410|Respiratory System Agents|respiratory system agents|mesh-ancestor
65166999|NCT00605410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65167000|NCT00605410|Cholinergic Agents|cholinergic agents|mesh-ancestor
65167001|NCT00605410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65167002|NCT00605410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167003|NCT04300881|Eplerenone|eplerenone|mesh-list
65167004|NCT04300881|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65167011|NCT04300881|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65167013|NCT03873493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167014|NCT04300309|Lumefantrine|lumefantrine|mesh-list
65167015|NCT04300309|Artemether|artemether|mesh-list
65167016|NCT04300309|Antimalarials|antimalarials|mesh-ancestor
65167017|NCT04300309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65167018|NCT04300309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65167019|NCT04300309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65167020|NCT00611689|Imatinib Mesylate|imatinib mesylate|mesh-list
65167022|NCT00611689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167023|NCT00611689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65167024|NCT00611689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167025|NCT00611689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167027|NCT05264077|Dexmedetomidine|dexmedetomidine|mesh-list
65320949|NCT00731133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320950|NCT00731133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320951|NCT00730275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65320952|NCT00730275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65320953|NCT00730275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320954|NCT00730275|Incretins|incretins|mesh-ancestor
65320955|NCT00730275|Hormones|hormones|mesh-ancestor
65320956|NCT00730275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65320957|NCT00730275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65320958|NCT00730275|Protease Inhibitors|protease inhibitors|mesh-ancestor
65320959|NCT00730275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167028|NCT05264077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65167029|NCT05264077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65167030|NCT05264077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167031|NCT05264077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65167032|NCT05264077|Analgesics|analgesics|mesh-ancestor
65167033|NCT05264077|Sensory System Agents|sensory system agents|mesh-ancestor
65167034|NCT05264077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65167035|NCT05264077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65167036|NCT05264077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65167037|NCT05264077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65167038|NCT05264077|Adrenergic Agents|adrenergic agents|mesh-ancestor
65167039|NCT05264077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65167040|NCT05264077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167041|NCT05264077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65167042|NCT05264077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65167043|NCT05264077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65167044|NCT05264077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65167045|NCT05264077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65167046|NCT05264077|Anesthetics, General|anesthetics, general|mesh-ancestor
65167047|NCT05264077|Anesthetics|anesthetics|mesh-ancestor
65167048|NCT05264077|GABA Modulators|gaba modulators|mesh-ancestor
65167049|NCT05264077|GABA Agents|gaba agents|mesh-ancestor
65167050|NCT00612859|Levetiracetam|levetiracetam|mesh-list
65167051|NCT00612859|Anticonvulsants|anticonvulsants|mesh-ancestor
65167052|NCT00612859|Nootropic Agents|nootropic agents|mesh-ancestor
65167053|NCT03872401|Evolocumab|evolocumab|mesh-list
65167054|NCT03872401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65167055|NCT03872401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65167056|NCT03872401|Antimetabolites|antimetabolites|mesh-ancestor
65167057|NCT03872401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167058|NCT03872401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65167059|NCT01010217|Mycophenolic Acid|mycophenolic acid|mesh-list
65167060|NCT01010217|Cyclophosphamide|cyclophosphamide|mesh-list
65167061|NCT01010217|Melphalan|melphalan|mesh-list
65167062|NCT01010217|Thiotepa|thiotepa|mesh-list
65167063|NCT01010217|Rituximab|rituximab|mesh-list
65167064|NCT01010217|Fludarabine|fludarabine|mesh-list
65167065|NCT01010217|Fludarabine phosphate|fludarabine phosphate|mesh-list
65167066|NCT01010217|Tacrolimus|tacrolimus|mesh-list
65167067|NCT01010217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65167068|NCT01010217|Immunologic Factors|immunologic factors|mesh-ancestor
65167069|NCT01010217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167070|NCT01010217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65167071|NCT01010217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65167072|NCT01010217|Alkylating Agents|alkylating agents|mesh-ancestor
65167073|NCT01010217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167074|NCT01010217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167075|NCT01010217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65167076|NCT01010217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65167087|NCT04558359|Giapreza|giapreza|mesh-list
65167088|NCT04558359|Angiotensinogen|angiotensinogen|mesh-list
65167089|NCT04558359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65167090|NCT04558359|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65167091|NCT04558359|Protease Inhibitors|protease inhibitors|mesh-ancestor
65320960|NCT00730275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320961|NCT04793711|Decanoic acid|decanoic acid|mesh-list
65320962|NCT04793711|Antifungal Agents|antifungal agents|mesh-ancestor
65320963|NCT04793711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65320964|NCT00729651|Cholecalciferol|cholecalciferol|mesh-list
65320965|NCT00729651|Vitamin D|vitamin d|mesh-list
65320966|NCT00729651|Alendronate|alendronate|mesh-list
65320967|NCT00729651|Calcium|calcium|mesh-list
65320968|NCT00729651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65320969|NCT00729651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320970|NCT00729651|Vitamins|vitamins|mesh-ancestor
65320971|NCT00729651|Micronutrients|micronutrients|mesh-ancestor
65320972|NCT00729651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65320973|NCT00729183|Calcium, Dietary|calcium, dietary|mesh-list
65320974|NCT00729183|Vitamin D|vitamin d|mesh-list
65320975|NCT00729183|Cholecalciferol|cholecalciferol|mesh-list
65320976|NCT00729183|Calcium Carbonate|calcium carbonate|mesh-list
65320977|NCT00729183|Calcium|calcium|mesh-list
65320978|NCT00729183|Vitamins|vitamins|mesh-ancestor
65320979|NCT00729183|Micronutrients|micronutrients|mesh-ancestor
65320980|NCT00729183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65320981|NCT00729183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65320982|NCT00729183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65320983|NCT00729183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320984|NCT00729183|Antacids|antacids|mesh-ancestor
65320985|NCT00729183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65320986|NCT00811733|Ofatumumab|ofatumumab|mesh-list
65320987|NCT00811733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65320988|NCT00728949|Tamoxifen|tamoxifen|mesh-list
65320989|NCT00728949|Letrozole|letrozole|mesh-list
65320990|NCT00728949|Fulvestrant|fulvestrant|mesh-list
65167092|NCT04558359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167093|NCT04558359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167094|NCT00604006|Spironolactone|spironolactone|mesh-list
65167095|NCT00604006|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65167096|NCT00604006|Hormone Antagonists|hormone antagonists|mesh-ancestor
65167097|NCT00604006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65167098|NCT00604006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167099|NCT00604006|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65167100|NCT00604006|Diuretics|diuretics|mesh-ancestor
65167101|NCT00604006|Natriuretic Agents|natriuretic agents|mesh-ancestor
65167103|NCT00604084|Permethrin|permethrin|mesh-list
65167104|NCT00604084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65167105|NCT00604084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65167106|NCT00604084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167107|NCT00604084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167108|NCT05379478|Antibodies|antibodies|mesh-list
65167109|NCT05379478|Immunologic Factors|immunologic factors|mesh-ancestor
65320991|NCT00728949|Anastrozole|anastrozole|mesh-list
65320992|NCT00728949|Exemestane|exemestane|mesh-list
65320993|NCT00728949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65320994|NCT00728949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65320995|NCT00728949|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65320996|NCT00728949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65320997|NCT00728949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65320998|NCT00728949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65320999|NCT00728949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65321000|NCT00728949|Hormone Antagonists|hormone antagonists|mesh-ancestor
65321001|NCT00728949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65167110|NCT05379478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167111|NCT04267042|Budesonide|budesonide|mesh-list
65167112|NCT04267042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65167113|NCT04267042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65167114|NCT04267042|Autonomic Agents|autonomic agents|mesh-ancestor
65167115|NCT04267042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65167116|NCT04267042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167117|NCT04267042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65167118|NCT04267042|Respiratory System Agents|respiratory system agents|mesh-ancestor
65167119|NCT04267042|Glucocorticoids|glucocorticoids|mesh-ancestor
65167120|NCT04267042|Hormones|hormones|mesh-ancestor
65167121|NCT04267042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65167122|NCT01013961|Rituximab|rituximab|mesh-list
65167123|NCT01013961|Alemtuzumab|alemtuzumab|mesh-list
65167124|NCT01013961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65167125|NCT01013961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167126|NCT01013961|Immunologic Factors|immunologic factors|mesh-ancestor
65167127|NCT01013961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167128|NCT01013961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65167129|NCT01217957|Dexamethasone|dexamethasone|mesh-list
65167130|NCT01217957|Lenalidomide|lenalidomide|mesh-list
65167131|NCT01217957|Ixazomib|ixazomib|mesh-list
65167132|NCT01217957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65167133|NCT01217957|Antiemetics|antiemetics|mesh-ancestor
65167134|NCT01217957|Autonomic Agents|autonomic agents|mesh-ancestor
65167135|NCT01217957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65167136|NCT01217957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167137|NCT01217957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65167138|NCT01217957|Glucocorticoids|glucocorticoids|mesh-ancestor
65167139|NCT01217957|Hormones|hormones|mesh-ancestor
65167140|NCT01217957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65167141|NCT01217957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65167142|NCT01217957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167143|NCT01217957|Immunologic Factors|immunologic factors|mesh-ancestor
65167145|NCT01217957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65167146|NCT01217957|Growth Substances|growth substances|mesh-ancestor
65167147|NCT01217957|Growth Inhibitors|growth inhibitors|mesh-ancestor
65167148|NCT01217957|Protease Inhibitors|protease inhibitors|mesh-ancestor
65167149|NCT01217957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167150|NCT01217957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167151|NCT01217801|Ondansetron|ondansetron|mesh-list
65167152|NCT01217801|Antiemetics|antiemetics|mesh-ancestor
65167153|NCT01217801|Autonomic Agents|autonomic agents|mesh-ancestor
65167154|NCT01217801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65167155|NCT01217801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167156|NCT01217801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65167157|NCT01217801|Antipruritics|antipruritics|mesh-ancestor
65167158|NCT01217801|Dermatologic Agents|dermatologic agents|mesh-ancestor
65167159|NCT01217801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65167160|NCT01217801|Serotonin Agents|serotonin agents|mesh-ancestor
65167161|NCT01217801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65167162|NCT01217801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167163|NCT01217801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65321002|NCT00728949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321003|NCT00728949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65321004|NCT00728949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65321005|NCT00728949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65321006|NCT00728949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65321007|NCT00728949|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65321008|NCT00728949|Immunologic Factors|immunologic factors|mesh-ancestor
65321009|NCT04773353|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65321010|NCT04773353|Hormones|hormones|mesh-ancestor
65321011|NCT04773353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65321012|NCT04773353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321013|NCT00918177|Levodopa|levodopa|mesh-list
65321014|NCT00918177|Carbidopa|carbidopa|mesh-list
65321015|NCT00918177|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65321016|NCT00918177|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65321017|NCT00918177|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65321018|NCT00918177|Dopamine Agents|dopamine agents|mesh-ancestor
65321019|NCT00918177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65321020|NCT00918177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321021|NCT00918177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321022|NCT00918177|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65321023|NCT00918177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65321024|NCT00918177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65321025|NCT00918177|Immunologic Factors|immunologic factors|mesh-ancestor
65321026|NCT00918177|Dopamine Agonists|dopamine agonists|mesh-ancestor
65321027|NCT00728481|Budesonide|budesonide|mesh-list
65321028|NCT00728481|Esomeprazole|esomeprazole|mesh-list
65321029|NCT00728481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64550885|NCT00835185|Folic Acid|folic acid|mesh-list
65167164|NCT01217801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65167165|NCT01217801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65167166|NCT01217801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65167167|NCT01217801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65167169|NCT00935818|Varenicline|varenicline|mesh-list
65167170|NCT00935818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65167171|NCT00935818|Antidepressive Agents|antidepressive agents|mesh-ancestor
65167173|NCT00935818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65167174|NCT00935818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65167175|NCT00935818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65167176|NCT00935818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167177|NCT00935818|Dopamine Agents|dopamine agents|mesh-ancestor
65167178|NCT00935818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65167179|NCT00935818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321030|NCT00728481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65321031|NCT00728481|Autonomic Agents|autonomic agents|mesh-ancestor
65321032|NCT00728481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65321033|NCT00728481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321034|NCT00728481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65321035|NCT00728481|Respiratory System Agents|respiratory system agents|mesh-ancestor
65321036|NCT00728481|Glucocorticoids|glucocorticoids|mesh-ancestor
65321037|NCT00728481|Hormones|hormones|mesh-ancestor
65321038|NCT00728481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65321039|NCT00728481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65321040|NCT00728481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65321041|NCT00728481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65321042|NCT00728481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65321043|NCT00728481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321044|NCT02593227|Cyclophosphamide|cyclophosphamide|mesh-list
65321045|NCT02593227|Vaccines|vaccines|mesh-list
65321046|NCT02593227|Immunologic Factors|immunologic factors|mesh-ancestor
65321047|NCT02593227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321048|NCT02593227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65321049|NCT02593227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65321050|NCT02593227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65167180|NCT00935818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65167181|NCT00935818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65167183|NCT00935818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65167184|NCT00935818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65167185|NCT00935818|Cholinergic Agents|cholinergic agents|mesh-ancestor
65167186|NCT02709265|Amikacin|amikacin|mesh-list
65167187|NCT02709265|Fosfomycin|fosfomycin|mesh-list
65167188|NCT02709265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65167189|NCT02709265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65167190|NCT00611845|Aprotinin|aprotinin|mesh-list
65167191|NCT00611845|Hemostatics|hemostatics|mesh-ancestor
65167192|NCT00611845|Coagulants|coagulants|mesh-ancestor
65167193|NCT00611845|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65167194|NCT00611845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65167195|NCT00611845|Protease Inhibitors|protease inhibitors|mesh-ancestor
65167196|NCT00611845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167197|NCT00611845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167198|NCT01216163|Acetaminophen|acetaminophen|mesh-list
65167199|NCT01216163|Ibuprofen|ibuprofen|mesh-list
65167200|NCT01216163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65167201|NCT01216163|Analgesics|analgesics|mesh-ancestor
65167202|NCT01216163|Sensory System Agents|sensory system agents|mesh-ancestor
65167203|NCT01216163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65167204|NCT01216163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167205|NCT01216163|Antipyretics|antipyretics|mesh-ancestor
65167206|NCT01216163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65167207|NCT01216163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65167208|NCT01216163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64512367|NCT04468984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167217|NCT05260255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65167218|NCT05260255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65167220|NCT00612469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65167221|NCT00612469|Listerine|listerine|mesh-list
65167222|NCT00612469|Vancomycin|vancomycin|mesh-list
65321051|NCT02593227|Alkylating Agents|alkylating agents|mesh-ancestor
65321052|NCT02593227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321053|NCT02593227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321054|NCT02593227|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65321055|NCT04030481|Anesthetics|anesthetics|mesh-list
65167223|NCT00612469|Fluorides|fluorides|mesh-list
65167224|NCT00612469|Sodium Fluoride|sodium fluoride|mesh-list
65167225|NCT00612469|Cariostatic Agents|cariostatic agents|mesh-ancestor
65167226|NCT00612469|Protective Agents|protective agents|mesh-ancestor
65167227|NCT00612469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167228|NCT00612469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65167229|NCT00612469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65167230|NCT00612469|Disinfectants|disinfectants|mesh-ancestor
65167231|NCT00612469|Dermatologic Agents|dermatologic agents|mesh-ancestor
65167232|NCT00612469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65167233|NCT00933244|Vitamin D|vitamin d|mesh-list
65167234|NCT00933244|Ergocalciferols|ergocalciferols|mesh-list
65167235|NCT00933244|Cholecalciferol|cholecalciferol|mesh-list
65167236|NCT00933244|Vitamins|vitamins|mesh-list
65167237|NCT00933244|Micronutrients|micronutrients|mesh-ancestor
65167238|NCT00933244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167239|NCT00933244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65167240|NCT00933244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65167241|NCT02709187|Candesartan|candesartan|mesh-list
65167242|NCT02709187|Candesartan cilexetil|candesartan cilexetil|mesh-list
65167243|NCT02709187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65167244|NCT02709187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65167245|NCT02709187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65167246|NCT02709187|Antimetabolites|antimetabolites|mesh-ancestor
65167247|NCT02709187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167248|NCT02709187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65167249|NCT02709187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65167250|NCT02709187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167251|NCT02709187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65167252|NCT02709187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65167253|NCT02709187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65167254|NCT00930046|Ropivacaine|ropivacaine|mesh-list
65167255|NCT00930046|Anesthetics, Local|anesthetics, local|mesh-ancestor
65167256|NCT00930046|Anesthetics|anesthetics|mesh-ancestor
65167257|NCT00930046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65167258|NCT00930046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167259|NCT00930046|Sensory System Agents|sensory system agents|mesh-ancestor
65167260|NCT00930046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65167261|NCT05244031|Analgesics, Opioid|analgesics, opioid|mesh-list
65167262|NCT05244031|Narcotics|narcotics|mesh-ancestor
65167263|NCT05244031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65167264|NCT05244031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167265|NCT05244031|Analgesics|analgesics|mesh-ancestor
65167266|NCT05244031|Sensory System Agents|sensory system agents|mesh-ancestor
65167267|NCT05244031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65167268|NCT04712071|Ketamine|ketamine|mesh-list
65167269|NCT04712071|Analgesics|analgesics|mesh-ancestor
65167270|NCT04712071|Sensory System Agents|sensory system agents|mesh-ancestor
65167271|NCT04712071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65167272|NCT04712071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167273|NCT04712071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65167274|NCT04712071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65167275|NCT04712071|Anesthetics, General|anesthetics, general|mesh-ancestor
65167276|NCT04712071|Anesthetics|anesthetics|mesh-ancestor
65167285|NCT05151328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167286|NCT05151328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65167288|NCT00609388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65167289|NCT00609388|Immunologic Factors|immunologic factors|mesh-ancestor
65167290|NCT00609388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167291|NCT00609388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65167292|NCT00609388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167293|NCT00609388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167294|NCT02709031|Cicletanine|cicletanine|mesh-list
65167295|NCT02709031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65167296|NCT02709031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65321056|NCT04030481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65321057|NCT04030481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321058|NCT02592915|Clonidine|clonidine|mesh-list
65321059|NCT02592915|Anesthetics|anesthetics|mesh-list
65321060|NCT02592915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65321061|NCT02592915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321062|NCT02592915|Analgesics|analgesics|mesh-ancestor
65321063|NCT02592915|Sensory System Agents|sensory system agents|mesh-ancestor
65321064|NCT02592915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64987327|NCT00324376|Sevelamer|sevelamer|mesh-list
65167297|NCT02709031|Diuretics|diuretics|mesh-ancestor
65167298|NCT02709031|Natriuretic Agents|natriuretic agents|mesh-ancestor
65167299|NCT02709031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167300|NCT05225545|Iron|iron|mesh-list
65167301|NCT05225545|Trace Elements|trace elements|mesh-ancestor
65167302|NCT05225545|Micronutrients|micronutrients|mesh-ancestor
65167303|NCT05225545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167304|NCT05378932|Melatonin|melatonin|mesh-list
65167305|NCT05378932|Antioxidants|antioxidants|mesh-ancestor
65167306|NCT05378932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167307|NCT05378932|Protective Agents|protective agents|mesh-ancestor
65167308|NCT05378932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167309|NCT05378932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65167310|NCT05222971|Durvalumab|durvalumab|mesh-list
65167311|NCT05222971|Olaparib|olaparib|mesh-list
65167312|NCT05222971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65167313|NCT05222971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167314|NCT05222971|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65167315|NCT05222971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167316|NCT05222971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167317|NCT00612547|Artesunate|artesunate|mesh-list
65167318|NCT00612547|Amodiaquine|amodiaquine|mesh-list
65167319|NCT00612547|Antimalarials|antimalarials|mesh-ancestor
65167320|NCT00612547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65167321|NCT00612547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65167322|NCT00612547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65167323|NCT00612547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167324|NCT00612547|Antiviral Agents|antiviral agents|mesh-ancestor
65167325|NCT00612547|Schistosomicides|schistosomicides|mesh-ancestor
65167326|NCT00612547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65167327|NCT00612547|Anthelmintics|anthelmintics|mesh-ancestor
65167328|NCT00606268|Micafungin|micafungin|mesh-list
65167329|NCT00606268|Antifungal Agents|antifungal agents|mesh-ancestor
65167330|NCT00606268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65167331|NCT05342857|Aflibercept|aflibercept|mesh-list
65167332|NCT05342857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65167333|NCT05342857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65167334|NCT05342857|Growth Substances|growth substances|mesh-ancestor
65167335|NCT05342857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167336|NCT05342857|Growth Inhibitors|growth inhibitors|mesh-ancestor
65167337|NCT05342857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167339|NCT04264624|Vasodilator Agents|vasodilator agents|mesh-ancestor
65167351|NCT01215851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167352|NCT01215851|Antitubercular Agents|antitubercular agents|mesh-ancestor
65167353|NCT00613093|Temozolomide|temozolomide|mesh-list
65167354|NCT00613093|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
65167355|NCT00613093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65167356|NCT00613093|Alkylating Agents|alkylating agents|mesh-ancestor
65167357|NCT00613093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167358|NCT00613093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167359|NCT00613093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167360|NCT00607750|Mecamylamine|mecamylamine|mesh-list
65167361|NCT00607750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65167362|NCT00607750|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
65167363|NCT00607750|Autonomic Agents|autonomic agents|mesh-ancestor
65167364|NCT00607750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65167365|NCT00607750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321065|NCT02592915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65321066|NCT02592915|Sympatholytics|sympatholytics|mesh-ancestor
65321067|NCT02592915|Autonomic Agents|autonomic agents|mesh-ancestor
65321068|NCT02592915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65321069|NCT02592915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65321070|NCT02592915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65321071|NCT02592915|Adrenergic Agents|adrenergic agents|mesh-ancestor
65321072|NCT02592915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65071062|NCT00295958|Freund's Adjuvant|freund's adjuvant|mesh-list
65321073|NCT02592915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321074|NCT00727311|Ribavirin|ribavirin|mesh-list
65321075|NCT00727311|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65321076|NCT00727311|Interferon-alpha|interferon-alpha|mesh-list
65321077|NCT00727311|Antimetabolites|antimetabolites|mesh-ancestor
65321078|NCT00727311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321079|NCT00727311|Antiviral Agents|antiviral agents|mesh-ancestor
65321080|NCT00727311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65321081|NCT00727311|Immunologic Factors|immunologic factors|mesh-ancestor
65321082|NCT00727311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321083|NCT00726999|Morphine|morphine|mesh-list
65321084|NCT00726999|Gabapentin|gabapentin|mesh-list
65167366|NCT00607750|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65167367|NCT00607750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65167368|NCT00607750|Cholinergic Agents|cholinergic agents|mesh-ancestor
65167369|NCT00607750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65167370|NCT00607750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167371|NCT00609544|Rilonacept|rilonacept|mesh-list
65167372|NCT00609544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65167373|NCT04908475|Apremilast|apremilast|mesh-list
65167374|NCT04908475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65167375|NCT04908475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65167376|NCT04908475|Analgesics|analgesics|mesh-ancestor
65167377|NCT04908475|Sensory System Agents|sensory system agents|mesh-ancestor
65167378|NCT04908475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65167379|NCT04908475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167380|NCT04908475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65167381|NCT04908475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65167382|NCT04908475|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65167383|NCT04908475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65167384|NCT04908475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167385|NCT04908475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167386|NCT03513211|Hydroxychloroquine|hydroxychloroquine|mesh-list
65167387|NCT03513211|Itraconazole|itraconazole|mesh-list
65167388|NCT03513211|Antimalarials|antimalarials|mesh-ancestor
65167389|NCT03513211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65167390|NCT03513211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65167391|NCT03513211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65167392|NCT03513211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167393|NCT03513211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167394|NCT03513211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65167395|NCT03513211|Antifungal Agents|antifungal agents|mesh-ancestor
65167396|NCT03513211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65167397|NCT03513211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65167398|NCT03513211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65167399|NCT03513211|Hormone Antagonists|hormone antagonists|mesh-ancestor
65321085|NCT00726999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65321086|NCT00726999|Narcotics|narcotics|mesh-ancestor
65321087|NCT00726999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65321088|NCT00726999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321089|NCT00726999|Analgesics|analgesics|mesh-ancestor
65321090|NCT00726999|Sensory System Agents|sensory system agents|mesh-ancestor
65321091|NCT00726999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65321092|NCT00726999|Anticonvulsants|anticonvulsants|mesh-ancestor
65321093|NCT00726999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65321094|NCT00726999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65321095|NCT00726999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65167400|NCT03513211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65167401|NCT03513211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512753|NCT04011345|Hematinics|hematinics|mesh-ancestor
65167411|NCT05198791|Hormone Antagonists|hormone antagonists|mesh-ancestor
65167412|NCT05198791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65167413|NCT05198791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167414|NCT05198791|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65167415|NCT05198791|Diuretics|diuretics|mesh-ancestor
65167416|NCT05198791|Natriuretic Agents|natriuretic agents|mesh-ancestor
65167417|NCT05198791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65167418|NCT01010061|Rituximab|rituximab|mesh-list
65167419|NCT01010061|Obinutuzumab|obinutuzumab|mesh-list
65167420|NCT01010061|Chlorambucil|chlorambucil|mesh-list
65167421|NCT01010061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65167422|NCT01010061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167423|NCT01010061|Immunologic Factors|immunologic factors|mesh-ancestor
65167424|NCT01010061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167425|NCT01010061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65167426|NCT01010061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65167427|NCT01010061|Alkylating Agents|alkylating agents|mesh-ancestor
65167428|NCT01010061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167429|NCT00607984|Melphalan|melphalan|mesh-list
65167430|NCT00607984|Thiotepa|thiotepa|mesh-list
65167431|NCT00607984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65167432|NCT00607984|Alkylating Agents|alkylating agents|mesh-ancestor
65167433|NCT00607984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167434|NCT00607984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167435|NCT00607984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65167436|NCT00607984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65167437|NCT00607984|Immunologic Factors|immunologic factors|mesh-ancestor
65167438|NCT00607984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167439|NCT00929734|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65167440|NCT00929734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65167441|NCT00929734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65167442|NCT00929734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65167443|NCT00929734|Antimetabolites|antimetabolites|mesh-ancestor
65167444|NCT00929734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167445|NCT00929734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65167446|NCT00929734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167447|NCT00609856|Insulin Glargine|insulin glargine|mesh-list
65167448|NCT00609856|Pioglitazone|pioglitazone|mesh-list
65167449|NCT00609856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65167450|NCT00609856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167451|NCT04527757|Anesthetics|anesthetics|mesh-list
65167452|NCT04527757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65167453|NCT04527757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167454|NCT00613249|Dapivirine|dapivirine|mesh-list
65167455|NCT00613249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65167456|NCT00613249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65167457|NCT00613249|Antiviral Agents|antiviral agents|mesh-ancestor
65167458|NCT00613249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65167459|NCT00613561|Fludarabine|fludarabine|mesh-list
65167460|NCT00613561|Busulfan|busulfan|mesh-list
65321096|NCT00726999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65321097|NCT00726999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65321098|NCT00726999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65321099|NCT00726999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321100|NCT00726999|Antimanic Agents|antimanic agents|mesh-ancestor
65321101|NCT00585351|Ranitidine|ranitidine|mesh-list
65321102|NCT00585351|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65321103|NCT00585351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65321104|NCT00585351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65321105|NCT00585351|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65321106|NCT00585351|Histamine Antagonists|histamine antagonists|mesh-ancestor
65321107|NCT00585351|Histamine Agents|histamine agents|mesh-ancestor
65321108|NCT00585351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65321109|NCT00585351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321110|NCT00585351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321111|NCT00813293|Sorafenib|sorafenib|mesh-list
65321112|NCT00813293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321113|NCT00813293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65321114|NCT00813293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65321115|NCT00813293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321116|NCT00726609|Posaconazole|posaconazole|mesh-list
65321117|NCT00726609|Antifungal Agents|antifungal agents|mesh-ancestor
65167461|NCT00613561|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65167462|NCT00613561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167463|NCT00613561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167464|NCT00613561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65167465|NCT00613561|Immunologic Factors|immunologic factors|mesh-ancestor
65167466|NCT00613561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167467|NCT00613561|Alkylating Agents|alkylating agents|mesh-ancestor
65167468|NCT00613561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65167472|NCT01009983|Panitumumab|panitumumab|mesh-list
65167473|NCT01009983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64810070|NCT01438944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65167474|NCT01009983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167475|NCT01009983|Tubulin Modulators|tubulin modulators|mesh-ancestor
65167476|NCT01009983|Antimitotic Agents|antimitotic agents|mesh-ancestor
65167477|NCT01009983|Mitosis Modulators|mitosis modulators|mesh-ancestor
65167478|NCT01009983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167479|NCT01009983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65167481|NCT04297215|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65167482|NCT04297215|Chitosan|chitosan|mesh-list
65167483|NCT04297215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65167484|NCT04297215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65167485|NCT04297215|Antimetabolites|antimetabolites|mesh-ancestor
65167486|NCT04297215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167487|NCT04297215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65167488|NCT04297215|Chelating Agents|chelating agents|mesh-ancestor
65167489|NCT04297215|Sequestering Agents|sequestering agents|mesh-ancestor
65167490|NCT04297215|Hemostatics|hemostatics|mesh-ancestor
65167491|NCT04297215|Coagulants|coagulants|mesh-ancestor
65167492|NCT02873091|Sufentanil|sufentanil|mesh-list
65167493|NCT02873091|Ropivacaine|ropivacaine|mesh-list
65167494|NCT02873091|Anesthetics, Local|anesthetics, local|mesh-ancestor
65321118|NCT00726609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65321119|NCT00726609|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65321120|NCT00726609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65321121|NCT00726609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65321122|NCT00726609|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65321123|NCT00726609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65321124|NCT00726609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65321125|NCT00726609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321126|NCT00726609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65321127|NCT00726609|Hormone Antagonists|hormone antagonists|mesh-ancestor
65167495|NCT02873091|Anesthetics|anesthetics|mesh-ancestor
65167496|NCT02873091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65167497|NCT02873091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167498|NCT02873091|Sensory System Agents|sensory system agents|mesh-ancestor
65167499|NCT02873091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65167500|NCT02873091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65167501|NCT02873091|Narcotics|narcotics|mesh-ancestor
65167502|NCT02873091|Analgesics|analgesics|mesh-ancestor
65167503|NCT02873091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65167504|NCT02873091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65167505|NCT02873091|Anesthetics, General|anesthetics, general|mesh-ancestor
65167506|NCT04298775|Morphine|morphine|mesh-list
65167507|NCT04298775|Anesthetics|anesthetics|mesh-list
65167508|NCT04298775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65167509|NCT04298775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167510|NCT04298775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65167511|NCT04298775|Narcotics|narcotics|mesh-ancestor
65167512|NCT04298775|Analgesics|analgesics|mesh-ancestor
65167513|NCT04298775|Sensory System Agents|sensory system agents|mesh-ancestor
65167514|NCT04298775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65167515|NCT01215227|Rasagiline|rasagiline|mesh-list
65167516|NCT01215227|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65167517|NCT01215227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167518|NCT01215227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167519|NCT01215227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65167520|NCT01215227|Protective Agents|protective agents|mesh-ancestor
65167521|NCT01215227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167522|NCT01009515|Paclitaxel|paclitaxel|mesh-list
65167523|NCT01009515|Carboplatin|carboplatin|mesh-list
65167524|NCT01009515|Temozolomide|temozolomide|mesh-list
65167525|NCT01009515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65167526|NCT01009515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167527|NCT01009515|Tubulin Modulators|tubulin modulators|mesh-ancestor
65167528|NCT01009515|Antimitotic Agents|antimitotic agents|mesh-ancestor
65167529|NCT01009515|Mitosis Modulators|mitosis modulators|mesh-ancestor
65167530|NCT01009515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167531|NCT01009515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65167532|NCT01009515|Alkylating Agents|alkylating agents|mesh-ancestor
65167533|NCT04550481|Lisinopril|lisinopril|mesh-list
65167534|NCT04550481|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65167535|NCT04550481|Protease Inhibitors|protease inhibitors|mesh-ancestor
65167536|NCT04550481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167537|NCT04550481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167538|NCT04550481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65167539|NCT04550481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65167540|NCT04550481|Protective Agents|protective agents|mesh-ancestor
65167541|NCT04550481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167542|NCT01214915|Anagrelide|anagrelide|mesh-list
65167543|NCT01214915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65167554|NCT01009203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65167555|NCT01009203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65167556|NCT01009203|Antifungal Agents|antifungal agents|mesh-ancestor
65167557|NCT01009203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65167558|NCT01009203|Immunologic Factors|immunologic factors|mesh-ancestor
65167559|NCT01009203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321128|NCT00726609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65321129|NCT00726609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321130|NCT00808028|Vaccines|vaccines|mesh-list
65321131|NCT00808028|Immunologic Factors|immunologic factors|mesh-ancestor
65321132|NCT00808028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321133|NCT03466346|Fluoxetine|fluoxetine|mesh-list
65321134|NCT03466346|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65321135|NCT03466346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65321136|NCT03466346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65321137|NCT03466346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321138|NCT03466346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65321139|NCT03466346|Serotonin Agents|serotonin agents|mesh-ancestor
65321140|NCT03466346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321141|NCT03466346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65321142|NCT03466346|Antidepressive Agents|antidepressive agents|mesh-ancestor
65321143|NCT03466346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65321144|NCT03466346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65321145|NCT03466346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65321146|NCT03466346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65321147|NCT05754242|Ascorbic Acid|ascorbic acid|mesh-list
65321149|NCT05754242|Micronutrients|micronutrients|mesh-ancestor
65321150|NCT05754242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321151|NCT05754242|Antioxidants|antioxidants|mesh-ancestor
65321152|NCT05754242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321153|NCT05754242|Protective Agents|protective agents|mesh-ancestor
65321154|NCT05728736|Lemborexant|lemborexant|mesh-list
65321155|NCT05728736|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65321156|NCT05728736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65321157|NCT05728736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321170|NCT05675462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65321171|NCT05675462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321172|NCT02608658|Immunoglobulins|immunoglobulins|mesh-list
65321173|NCT02608658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65321174|NCT02608658|Antibodies|antibodies|mesh-list
65321175|NCT02608658|Immunologic Factors|immunologic factors|mesh-ancestor
65321176|NCT02608658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321177|NCT00807248|Gaboxadol|gaboxadol|mesh-list
65321178|NCT00807248|Dexetimide|dexetimide|mesh-list
65321179|NCT00807248|Citalopram|citalopram|mesh-list
65321180|NCT00807248|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65167560|NCT01009047|Aripiprazole|aripiprazole|mesh-list
65167561|NCT01009047|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65167562|NCT01009047|Antidepressive Agents|antidepressive agents|mesh-ancestor
65167563|NCT01009047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65167564|NCT01009047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65167565|NCT01009047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65167566|NCT01009047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65167567|NCT01009047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167568|NCT01009047|Dopamine Agonists|dopamine agonists|mesh-ancestor
65167569|NCT01009047|Dopamine Agents|dopamine agents|mesh-ancestor
65167570|NCT01009047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65167571|NCT01009047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167572|NCT01009047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65167573|NCT01009047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65167574|NCT01009047|Serotonin Agents|serotonin agents|mesh-ancestor
65167575|NCT01009047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65167576|NCT01009047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65167577|NCT01009047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65167578|NCT01009047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65167579|NCT04205097|Neostigmine|neostigmine|mesh-list
65167580|NCT04205097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65167581|NCT04205097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167582|NCT04205097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167583|NCT04205097|Cholinergic Agents|cholinergic agents|mesh-ancestor
65167584|NCT04205097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65167585|NCT04205097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167586|NCT04205097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65167587|NCT04205097|Autonomic Agents|autonomic agents|mesh-ancestor
65167588|NCT04205097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65167590|NCT04205565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65167591|NCT04205565|Nootropic Agents|nootropic agents|mesh-ancestor
65167592|NCT01025193|Belimumab|belimumab|mesh-list
65167593|NCT01025193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65167594|NCT01025193|Immunologic Factors|immunologic factors|mesh-ancestor
65167595|NCT01025193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167596|NCT01008423|Budesonide|budesonide|mesh-list
65167597|NCT01008423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65167598|NCT01008423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65167599|NCT01008423|Autonomic Agents|autonomic agents|mesh-ancestor
65167600|NCT01008423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65167601|NCT01008423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167602|NCT01008423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65167603|NCT01008423|Respiratory System Agents|respiratory system agents|mesh-ancestor
65167604|NCT01008423|Glucocorticoids|glucocorticoids|mesh-ancestor
65167605|NCT01008423|Hormones|hormones|mesh-ancestor
65167606|NCT01008423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65167607|NCT04735861|Bevacizumab|bevacizumab|mesh-list
65167619|NCT03651271|Ipilimumab|ipilimumab|mesh-list
65167620|NCT03651271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65167621|NCT03651271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167622|NCT03651271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65167623|NCT03651271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167624|NCT03586687|Triamcinolone|triamcinolone|mesh-list
65167625|NCT03586687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65167627|NCT03586687|Hormones|hormones|mesh-ancestor
65321181|NCT00807248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65321182|NCT00807248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65321183|NCT00807248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321184|NCT00807248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65321185|NCT00807248|Serotonin Agents|serotonin agents|mesh-ancestor
64316026|NCT05557136|Ether|ether|mesh-list
65167628|NCT03586687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65167629|NCT03586687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167630|NCT01212185|Oxytocin|oxytocin|mesh-list
65167631|NCT01212185|Oxytocics|oxytocics|mesh-ancestor
65167632|NCT01212185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65167633|NCT01212185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167634|NCT00613717|Vitamin D|vitamin d|mesh-list
65167635|NCT00613717|Vitamins|vitamins|mesh-list
65167636|NCT00613717|Folic Acid|folic acid|mesh-list
65167637|NCT00613717|Vitamin A|vitamin a|mesh-list
65167638|NCT00613717|Iron|iron|mesh-list
65167639|NCT00613717|Vitamin B Complex|vitamin b complex|mesh-list
65167640|NCT00613717|Retinol palmitate|retinol palmitate|mesh-list
65167641|NCT00613717|Micronutrients|micronutrients|mesh-ancestor
65167642|NCT00613717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167643|NCT00613717|Trace Elements|trace elements|mesh-ancestor
65167644|NCT00613717|Hematinics|hematinics|mesh-ancestor
65167645|NCT00613717|Antioxidants|antioxidants|mesh-ancestor
65167646|NCT00613717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167647|NCT00613717|Protective Agents|protective agents|mesh-ancestor
65167648|NCT00613717|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65167649|NCT00613717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167650|NCT00613717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65167651|NCT03632941|Pembrolizumab|pembrolizumab|mesh-list
65167652|NCT03632941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65167653|NCT03632941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167654|NCT04477759|Atezolizumab|atezolizumab|mesh-list
65167655|NCT04477759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167656|NCT03369301|Immunoglobulins|immunoglobulins|mesh-list
65167657|NCT03369301|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65167658|NCT03369301|Antibodies|antibodies|mesh-list
65167659|NCT03369301|Immunologic Factors|immunologic factors|mesh-ancestor
65167660|NCT03369301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167661|NCT04865887|Pembrolizumab|pembrolizumab|mesh-list
65167662|NCT04865887|Lenvatinib|lenvatinib|mesh-list
65167663|NCT04865887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65167664|NCT04865887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167665|NCT04865887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65167666|NCT04865887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167667|NCT04865887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167668|NCT04177693|Letrozole|letrozole|mesh-list
65167669|NCT04177693|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65167670|NCT04177693|Clomiphene|clomiphene|mesh-list
65167671|NCT04177693|Enclomiphene|enclomiphene|mesh-list
65167672|NCT04177693|Zuclomiphene|zuclomiphene|mesh-list
65167673|NCT04177693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167674|NCT04177693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167675|NCT04177693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65167694|NCT05345119|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65167695|NCT05345119|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65167697|NCT05345119|Prednisolone acetate|prednisolone acetate|mesh-list
65167698|NCT05345119|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65167699|NCT05345119|Prednisolone phosphate|prednisolone phosphate|mesh-list
64810301|NCT01440725|Mitogens|mitogens|mesh-list
65167700|NCT05345119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65167701|NCT05345119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65167702|NCT05345119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65167703|NCT05345119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167704|NCT05345119|Antifungal Agents|antifungal agents|mesh-ancestor
65167706|NCT05345119|Immunologic Factors|immunologic factors|mesh-ancestor
65167707|NCT05345119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167708|NCT05345119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65167709|NCT05345119|Antiemetics|antiemetics|mesh-ancestor
65167710|NCT05345119|Autonomic Agents|autonomic agents|mesh-ancestor
65167711|NCT05345119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65167712|NCT05345119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65321186|NCT00807248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321187|NCT00807248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65321188|NCT00807248|Antidepressive Agents|antidepressive agents|mesh-ancestor
65321189|NCT00807248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65321190|NCT00807248|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65321191|NCT00807248|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65321192|NCT00807248|Parasympatholytics|parasympatholytics|mesh-ancestor
65321193|NCT00807248|Autonomic Agents|autonomic agents|mesh-ancestor
65321194|NCT00807248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65321195|NCT00807248|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65321196|NCT00807248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65321197|NCT00807248|Cholinergic Agents|cholinergic agents|mesh-ancestor
65321198|NCT00807248|Analgesics|analgesics|mesh-ancestor
65321199|NCT00807248|Sensory System Agents|sensory system agents|mesh-ancestor
65321200|NCT00807248|Anticonvulsants|anticonvulsants|mesh-ancestor
65167713|NCT05345119|Glucocorticoids|glucocorticoids|mesh-ancestor
65167714|NCT05345119|Hormones|hormones|mesh-ancestor
65167715|NCT05345119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65167716|NCT05345119|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65167717|NCT05345119|Protective Agents|protective agents|mesh-ancestor
65167718|NCT05345119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65167719|NCT03529123|Insulin|insulin|mesh-list
65167720|NCT03529123|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65167721|NCT03529123|Metformin|metformin|mesh-list
65167722|NCT03529123|Insulin Glargine|insulin glargine|mesh-list
65167723|NCT03529123|Insulin glulisine|insulin glulisine|mesh-list
65167724|NCT03529123|Lixisenatide|lixisenatide|mesh-list
65167725|NCT03529123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65167726|NCT03529123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167727|NCT04074187|Methylprednisolone|methylprednisolone|mesh-list
65167728|NCT04074187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65167729|NCT04074187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65167730|NCT04074187|Prednisolone|prednisolone|mesh-list
65167731|NCT04074187|Prednisolone acetate|prednisolone acetate|mesh-list
65167732|NCT04074187|Rituximab|rituximab|mesh-list
65167733|NCT04074187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65167738|NCT04074187|Immunologic Factors|immunologic factors|mesh-ancestor
65167739|NCT04074187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167740|NCT04074187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65167741|NCT04074187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65167742|NCT04074187|Antiemetics|antiemetics|mesh-ancestor
65167743|NCT04074187|Autonomic Agents|autonomic agents|mesh-ancestor
65167744|NCT04074187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65167745|NCT04074187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65167746|NCT04074187|Glucocorticoids|glucocorticoids|mesh-ancestor
65167747|NCT04074187|Hormones|hormones|mesh-ancestor
65167748|NCT04074187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65167749|NCT04074187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65167750|NCT04074187|Protective Agents|protective agents|mesh-ancestor
65167751|NCT04074187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65167752|NCT03128905|Prednisone|prednisone|mesh-list
65167753|NCT03128905|Colchicine|colchicine|mesh-list
65167754|NCT03128905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65167755|NCT03128905|Glucocorticoids|glucocorticoids|mesh-ancestor
65167756|NCT03128905|Hormones|hormones|mesh-ancestor
65167757|NCT03128905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65167758|NCT03128905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167759|NCT03128905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65167760|NCT03128905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167761|NCT03128905|Gout Suppressants|gout suppressants|mesh-ancestor
65167762|NCT03128905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65167763|NCT03128905|Tubulin Modulators|tubulin modulators|mesh-ancestor
65167764|NCT03128905|Antimitotic Agents|antimitotic agents|mesh-ancestor
65321201|NCT00807248|GABA Agonists|gaba agonists|mesh-ancestor
65321202|NCT00807248|GABA Agents|gaba agents|mesh-ancestor
65321203|NCT02607332|Paclitaxel|paclitaxel|mesh-list
65321204|NCT02607332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65321205|NCT02607332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321206|NCT02607332|Tubulin Modulators|tubulin modulators|mesh-ancestor
65321207|NCT02607332|Antimitotic Agents|antimitotic agents|mesh-ancestor
65321208|NCT02607332|Mitosis Modulators|mitosis modulators|mesh-ancestor
65321209|NCT02607332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321210|NCT03356756|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65321211|NCT03356756|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65321212|NCT03356756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321213|NCT05297669|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
65321214|NCT05297669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65321215|NCT05297669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65321216|NCT05297669|Analgesics|analgesics|mesh-ancestor
65321217|NCT05297669|Sensory System Agents|sensory system agents|mesh-ancestor
65321218|NCT05297669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65321219|NCT05297669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321220|NCT05297669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65321221|NCT05297669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65321222|NCT00589628|Infliximab|infliximab|mesh-list
65321223|NCT00589628|Dermatologic Agents|dermatologic agents|mesh-ancestor
64551073|NCT00870363|Efavirenz|efavirenz|mesh-list
65167765|NCT03128905|Mitosis Modulators|mitosis modulators|mesh-ancestor
65167766|NCT03128905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167767|NCT02430181|Interferons|interferons|mesh-list
65167768|NCT02430181|Ritonavir|ritonavir|mesh-list
65167769|NCT02430181|Interferon-alpha|interferon-alpha|mesh-list
65167770|NCT02430181|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65167771|NCT02430181|Lonafarnib|lonafarnib|mesh-list
65167772|NCT02430181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167773|NCT02430181|Antiviral Agents|antiviral agents|mesh-ancestor
65167774|NCT02430181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65167775|NCT02430181|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65167776|NCT02430181|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65167777|NCT02430181|Protease Inhibitors|protease inhibitors|mesh-ancestor
65167778|NCT02430181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167779|NCT02430181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167780|NCT02430181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65167781|NCT02430181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65167782|NCT02430181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65167783|NCT02430181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65167784|NCT02430181|Immunologic Factors|immunologic factors|mesh-ancestor
65167785|NCT02430181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167786|NCT00614653|Bevacizumab|bevacizumab|mesh-list
65167787|NCT00614653|Capecitabine|capecitabine|mesh-list
65167788|NCT00614653|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65167789|NCT00614653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65167790|NCT00614653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167791|NCT00614653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65321224|NCT00589628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65321225|NCT00589628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65321226|NCT00914576|Vitamins|vitamins|mesh-list
65321227|NCT00914576|Micronutrients|micronutrients|mesh-ancestor
65321228|NCT00914576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321229|NCT00914654|Formoterol Fumarate|formoterol fumarate|mesh-list
65321230|NCT00914654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65321231|NCT00914654|Autonomic Agents|autonomic agents|mesh-ancestor
65321232|NCT00914654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65321233|NCT00914654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321234|NCT00914654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65321235|NCT00914654|Respiratory System Agents|respiratory system agents|mesh-ancestor
65321236|NCT00914654|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65321237|NCT00914654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65321238|NCT00914654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65321239|NCT00914654|Adrenergic Agents|adrenergic agents|mesh-ancestor
65321240|NCT00914654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65321241|NCT00914654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321242|NCT02605772|Metformin|metformin|mesh-list
65321243|NCT02605772|Saxagliptin|saxagliptin|mesh-list
65167792|NCT00614653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65167793|NCT00614653|Growth Substances|growth substances|mesh-ancestor
65167794|NCT00614653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167795|NCT00614653|Growth Inhibitors|growth inhibitors|mesh-ancestor
65167796|NCT00614653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65167797|NCT00614653|Antimetabolites|antimetabolites|mesh-ancestor
65167798|NCT00614653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167799|NCT00614653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65167800|NCT00614653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167801|NCT03909451|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65167802|NCT03909451|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65167812|NCT03596125|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65167813|NCT03596125|Antioxidants|antioxidants|mesh-ancestor
65167814|NCT03596125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167815|NCT03596125|Protective Agents|protective agents|mesh-ancestor
65167816|NCT03596125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167817|NCT03596125|Antidotes|antidotes|mesh-ancestor
65167818|NCT02118727|Memantine|memantine|mesh-list
65167819|NCT02118727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65167820|NCT02118727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65167821|NCT02118727|Dopamine Agents|dopamine agents|mesh-ancestor
65167822|NCT02118727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65167823|NCT02118727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167824|NCT02118727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167825|NCT02118727|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65167826|NCT02118727|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65167827|NCT05343637|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65167828|NCT05343637|Vasodilator Agents|vasodilator agents|mesh-ancestor
65167829|NCT05343637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65167830|NCT05343637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65167831|NCT05343637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167832|NCT05343637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321244|NCT02605772|Acarbose|acarbose|mesh-list
65321245|NCT02605772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65321246|NCT02605772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321247|NCT02605772|Incretins|incretins|mesh-ancestor
65321248|NCT02605772|Hormones|hormones|mesh-ancestor
65321249|NCT02605772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65321250|NCT02605772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65321251|NCT02605772|Protease Inhibitors|protease inhibitors|mesh-ancestor
65321252|NCT02605772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65321253|NCT02605772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321254|NCT02605772|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65321255|NCT04115462|Morphine|morphine|mesh-list
65321256|NCT04115462|Histamine|histamine|mesh-list
65321257|NCT04115462|Histamine phosphate|histamine phosphate|mesh-list
65321258|NCT04115462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65321259|NCT04115462|Narcotics|narcotics|mesh-ancestor
65321260|NCT04115462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65321261|NCT04115462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321262|NCT04115462|Analgesics|analgesics|mesh-ancestor
64551110|NCT00871689|Aldesleukin|aldesleukin|mesh-list
65167833|NCT05343637|Urological Agents|urological agents|mesh-ancestor
65167834|NCT03776227|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65167835|NCT03776227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65167836|NCT03776227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167837|NCT03776227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65167838|NCT03776227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167839|NCT00614809|Gefitinib|gefitinib|mesh-list
65167840|NCT00614809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167841|NCT00614809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65167842|NCT00614809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167843|NCT00614809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167844|NCT02964013|Carboplatin|carboplatin|mesh-list
65167845|NCT02964013|Pembrolizumab|pembrolizumab|mesh-list
65167846|NCT02964013|Etoposide|etoposide|mesh-list
65167847|NCT02964013|Pemetrexed|pemetrexed|mesh-list
65167848|NCT02964013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167849|NCT02964013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64810439|NCT01441505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65167850|NCT02964013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65167854|NCT02964013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167855|NCT02964013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65167856|NCT02964013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65167857|NCT05343169|Naloxone|naloxone|mesh-list
65167858|NCT05343169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65167859|NCT05343169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167860|NCT05343169|Sensory System Agents|sensory system agents|mesh-ancestor
65167861|NCT05343169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65167862|NCT02480803|Levodopa|levodopa|mesh-list
65167863|NCT02480803|Carbidopa|carbidopa|mesh-list
65167864|NCT02480803|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65167865|NCT02480803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65167866|NCT02480803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65167867|NCT02480803|Dopamine Agents|dopamine agents|mesh-ancestor
65167875|NCT02480803|Dopamine Agonists|dopamine agonists|mesh-ancestor
65167876|NCT02699437|Antibodies|antibodies|mesh-list
65321263|NCT04115462|Sensory System Agents|sensory system agents|mesh-ancestor
65321264|NCT04115462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65321265|NCT04115462|Histamine Agonists|histamine agonists|mesh-ancestor
65321266|NCT04115462|Histamine Agents|histamine agents|mesh-ancestor
65321267|NCT04115462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65321268|NCT04115462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321269|NCT02605460|Plerixafor|plerixafor|mesh-list
65321270|NCT02605460|Cyclophosphamide|cyclophosphamide|mesh-list
65321271|NCT02605460|Busulfan|busulfan|mesh-list
65321272|NCT02605460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65321273|NCT02605460|Immunologic Factors|immunologic factors|mesh-ancestor
65321274|NCT02605460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321275|NCT02605460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65321276|NCT02605460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65321277|NCT02605460|Alkylating Agents|alkylating agents|mesh-ancestor
65321278|NCT02605460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551125|NCT00871689|Antimetabolites|antimetabolites|mesh-ancestor
65167877|NCT02699437|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
65167878|NCT02699437|Immunologic Factors|immunologic factors|mesh-ancestor
65167879|NCT02699437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167880|NCT01211483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65167881|NCT01211483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167882|NCT01211483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65167883|NCT01211483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167884|NCT01211483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167885|NCT00615823|Atorvastatin|atorvastatin|mesh-list
65167886|NCT00615823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65167887|NCT00615823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65167888|NCT00615823|Antimetabolites|antimetabolites|mesh-ancestor
65167889|NCT00615823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167890|NCT00615823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65167891|NCT00615823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65167892|NCT00615823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167893|NCT02699281|Palmidrol|palmidrol|mesh-list
65167894|NCT02699281|Analgesics|analgesics|mesh-ancestor
65167895|NCT02699281|Sensory System Agents|sensory system agents|mesh-ancestor
65167896|NCT02699281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65167897|NCT02699281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167898|NCT02699281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65167899|NCT02699281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65167900|NCT02699281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65167901|NCT02699281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65167902|NCT02699281|Antiviral Agents|antiviral agents|mesh-ancestor
65167903|NCT02699281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65167904|NCT02699281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65167905|NCT02699281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65167906|NCT02699281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65167907|NCT02699281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167908|NCT02699281|Hormones|hormones|mesh-ancestor
65167909|NCT02699281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65167913|NCT01140373|Cyclophosphamide|cyclophosphamide|mesh-list
65167914|NCT01140373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65167915|NCT01140373|Immunologic Factors|immunologic factors|mesh-ancestor
65167916|NCT01140373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167917|NCT01140373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65167918|NCT01140373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65321279|NCT02605460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321280|NCT02605460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65321281|NCT02605460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65321282|NCT02605460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65321283|NCT02605460|Antiviral Agents|antiviral agents|mesh-ancestor
65321284|NCT02605460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65321285|NCT00797108|Amoxicillin|amoxicillin|mesh-list
65321286|NCT00797108|Ceftriaxone|ceftriaxone|mesh-list
65321287|NCT00797108|Clavulanic Acid|clavulanic acid|mesh-list
65321288|NCT00797108|Clavulanic Acids|clavulanic acids|mesh-list
65321289|NCT00797108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65321290|NCT00797108|Lactams|lactams|mesh-list
64551143|NCT04174170|Serotonin Agents|serotonin agents|mesh-ancestor
65167919|NCT01140373|Alkylating Agents|alkylating agents|mesh-ancestor
65167920|NCT01140373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167921|NCT01140373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167922|NCT01140373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65167923|NCT02704507|Triamcinolone|triamcinolone|mesh-list
65167924|NCT02704507|Tretinoin|tretinoin|mesh-list
65167925|NCT02704507|Emollients|emollients|mesh-list
65167926|NCT02704507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65167927|NCT02704507|Glucocorticoids|glucocorticoids|mesh-ancestor
65167928|NCT02704507|Hormones|hormones|mesh-ancestor
65167929|NCT02704507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65167930|NCT02704507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167931|NCT02704507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167932|NCT02704507|Keratolytic Agents|keratolytic agents|mesh-ancestor
65167933|NCT02704507|Dermatologic Agents|dermatologic agents|mesh-ancestor
65167934|NCT01210001|Empagliflozin|empagliflozin|mesh-list
65167935|NCT01210001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65167942|NCT00624455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65167943|NCT00624455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167944|NCT00624455|Anticonvulsants|anticonvulsants|mesh-ancestor
65167945|NCT00624455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65167946|NCT00624455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65167947|NCT00624455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65167948|NCT00624455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65167949|NCT00624455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65167950|NCT00624455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65167951|NCT00624455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65167952|NCT00624455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167953|NCT00624455|Antimanic Agents|antimanic agents|mesh-ancestor
65167954|NCT01127659|Testosterone|testosterone|mesh-list
65167955|NCT01127659|Androgens|androgens|mesh-ancestor
65167957|NCT01127659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65167958|NCT01127659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167959|NCT02698969|Atropine|atropine|mesh-list
65167960|NCT02698969|Fentanyl|fentanyl|mesh-list
65167961|NCT02698969|Propofol|propofol|mesh-list
65167962|NCT02698969|Sevoflurane|sevoflurane|mesh-list
65167963|NCT02698969|Rocuronium|rocuronium|mesh-list
65167964|NCT02698969|Neostigmine|neostigmine|mesh-list
65167965|NCT02698969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65167966|NCT02698969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65167967|NCT02698969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167968|NCT02698969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65167969|NCT02698969|Anesthetics, General|anesthetics, general|mesh-ancestor
65167970|NCT02698969|Anesthetics|anesthetics|mesh-ancestor
65167971|NCT02698969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65167972|NCT02698969|Narcotics|narcotics|mesh-ancestor
65167973|NCT02698969|Analgesics|analgesics|mesh-ancestor
65167974|NCT02698969|Sensory System Agents|sensory system agents|mesh-ancestor
65167975|NCT02698969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65167976|NCT02698969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65167977|NCT02698969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65321291|NCT00797108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65321292|NCT00797108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65321293|NCT00797108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65071274|NCT00327132|Omeprazole|omeprazole|mesh-list
65321294|NCT00797108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65321295|NCT00797108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321296|NCT03236324|Epinephrine|epinephrine|mesh-list
65321298|NCT03236324|Anesthetics, Local|anesthetics, local|mesh-ancestor
65321299|NCT03236324|Anesthetics|anesthetics|mesh-ancestor
65321300|NCT03236324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65321301|NCT03236324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321302|NCT03236324|Sensory System Agents|sensory system agents|mesh-ancestor
65321303|NCT03236324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65321304|NCT03236324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65321305|NCT03236324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65321306|NCT03236324|Adrenergic Agents|adrenergic agents|mesh-ancestor
65321307|NCT03236324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65167978|NCT02698969|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65167979|NCT02698969|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65167980|NCT02698969|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65167981|NCT02698969|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65167982|NCT02698969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65167983|NCT02698969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65167984|NCT02698969|Autonomic Agents|autonomic agents|mesh-ancestor
65167985|NCT02698969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65167986|NCT02698969|Respiratory System Agents|respiratory system agents|mesh-ancestor
65167987|NCT02698969|Mydriatics|mydriatics|mesh-ancestor
65167988|NCT02698969|Parasympatholytics|parasympatholytics|mesh-ancestor
65167989|NCT02698969|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65167990|NCT02698969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65167991|NCT02698969|Cholinergic Agents|cholinergic agents|mesh-ancestor
65167992|NCT02698969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65167993|NCT02698969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167994|NCT02698969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65167995|NCT02698969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167996|NCT02698969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65167997|NCT00848731|Nitric Oxide|nitric oxide|mesh-list
64810591|NCT01442519|Mitomycins|mitomycins|mesh-list
65167998|NCT00848731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65167999|NCT00848731|Autonomic Agents|autonomic agents|mesh-ancestor
65168000|NCT00848731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65168001|NCT00848731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168003|NCT00848731|Respiratory System Agents|respiratory system agents|mesh-ancestor
65168004|NCT00848731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65168005|NCT00848731|Antioxidants|antioxidants|mesh-ancestor
65168012|NCT01209143|Rosiglitazone|rosiglitazone|mesh-list
65168013|NCT01209143|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65168014|NCT01209143|Norethindrone|norethindrone|mesh-list
65168015|NCT01209143|Norethindrone Acetate|norethindrone acetate|mesh-list
65168016|NCT01209143|Estradiol|estradiol|mesh-list
65168017|NCT01209143|Estrogens|estrogens|mesh-ancestor
65168018|NCT01209143|Hormones|hormones|mesh-ancestor
65168019|NCT01209143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65168020|NCT01209143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168021|NCT01209143|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65168022|NCT01209143|Contraceptive Agents|contraceptive agents|mesh-ancestor
65168023|NCT01209143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65168024|NCT01209143|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65168025|NCT01209143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65321308|NCT03236324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321309|NCT03236324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65321382|NCT00745368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65321383|NCT00745368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321384|NCT04025840|Dexamethasone|dexamethasone|mesh-list
65321385|NCT04025840|Glucocorticoids|glucocorticoids|mesh-list
65321386|NCT04025840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65321387|NCT04025840|Antiemetics|antiemetics|mesh-ancestor
65321388|NCT04025840|Autonomic Agents|autonomic agents|mesh-ancestor
65321389|NCT04025840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65321390|NCT04025840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321391|NCT04025840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65321392|NCT04025840|Hormones|hormones|mesh-ancestor
65321393|NCT04025840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65321394|NCT04025840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65321395|NCT04025840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321396|NCT00589472|Vorinostat|vorinostat|mesh-list
65321397|NCT00589472|Leuprolide|leuprolide|mesh-list
65321398|NCT00589472|Goserelin|goserelin|mesh-list
65321399|NCT00589472|Bicalutamide|bicalutamide|mesh-list
65321400|NCT00589472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321401|NCT00589472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64551242|NCT03216525|Alvimopan|alvimopan|mesh-list
65168026|NCT01209143|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65168027|NCT01209143|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65168028|NCT01209143|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65168029|NCT00454285|Amoxicillin|amoxicillin|mesh-list
65168030|NCT00454285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65168031|NCT00454285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65168032|NCT00614965|Irinotecan|irinotecan|mesh-list
65168033|NCT00614965|Pemetrexed|pemetrexed|mesh-list
65168034|NCT00614965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168035|NCT00614965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65168036|NCT00614965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65168037|NCT00614965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168038|NCT00614965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168039|NCT00614965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65168040|NCT00614965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65168041|NCT00390325|Sorafenib|sorafenib|mesh-list
65168042|NCT00390325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168043|NCT00390325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65168044|NCT00390325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168045|NCT00390325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168046|NCT00405613|Aspirin|aspirin|mesh-list
65168047|NCT00405613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65168048|NCT00405613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65168049|NCT00405613|Analgesics|analgesics|mesh-ancestor
65168050|NCT00405613|Sensory System Agents|sensory system agents|mesh-ancestor
65168051|NCT00405613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65168052|NCT00405613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168053|NCT00405613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65168054|NCT00405613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65168055|NCT00405613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65168056|NCT00405613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65168057|NCT00405613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168058|NCT00405613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65321402|NCT00589472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65321403|NCT00589472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321404|NCT00589472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65321405|NCT00589472|Fertility Agents|fertility agents|mesh-ancestor
65321406|NCT00589472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65321407|NCT00589472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321408|NCT00589472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65321409|NCT00589472|Androgen Antagonists|androgen antagonists|mesh-ancestor
65321410|NCT00589472|Hormone Antagonists|hormone antagonists|mesh-ancestor
65321411|NCT00589472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65321412|NCT02608931|Dronabinol|dronabinol|mesh-list
65168059|NCT00405613|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65168060|NCT00405613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168061|NCT00405613|Antipyretics|antipyretics|mesh-ancestor
65168062|NCT02703961|Cisplatin|cisplatin|mesh-list
65168063|NCT02703961|Docetaxel|docetaxel|mesh-list
65168064|NCT02703961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168065|NCT02703961|Tubulin Modulators|tubulin modulators|mesh-ancestor
65168066|NCT02703961|Antimitotic Agents|antimitotic agents|mesh-ancestor
65168067|NCT02703961|Mitosis Modulators|mitosis modulators|mesh-ancestor
65168068|NCT02703961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168069|NCT02703649|Letrozole|letrozole|mesh-list
65168070|NCT02703649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168071|NCT02703649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65168072|NCT02703649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65168073|NCT02703649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701585|NCT00003621|Carmustine|carmustine|mesh-list
65168081|NCT02703571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65168082|NCT02703571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168083|NCT02703571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168084|NCT02703415|Tramadol|tramadol|mesh-list
65168085|NCT02703415|Bupivacaine|bupivacaine|mesh-list
65168086|NCT02703415|Anesthetics, Local|anesthetics, local|mesh-ancestor
65168087|NCT02703415|Anesthetics|anesthetics|mesh-ancestor
65168088|NCT02703415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65168089|NCT02703415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168090|NCT02703415|Sensory System Agents|sensory system agents|mesh-ancestor
65168091|NCT02703415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65168092|NCT02703415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65168093|NCT02703415|Narcotics|narcotics|mesh-ancestor
65168094|NCT02703415|Analgesics|analgesics|mesh-ancestor
65168095|NCT02703181|Diketopiperazines|diketopiperazines|mesh-list
65168096|NCT02703181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65168097|NCT02703181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65168098|NCT04215835|Letrozole|letrozole|mesh-list
65168099|NCT04215835|Misoprostol|misoprostol|mesh-list
65168100|NCT04215835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168101|NCT04215835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65168102|NCT04215835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65168103|NCT04215835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168104|NCT04215835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168105|NCT04215835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65168106|NCT04215835|Hormone Antagonists|hormone antagonists|mesh-ancestor
65168107|NCT04215835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65168108|NCT04215835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168109|NCT04215835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65168110|NCT04215835|Abortifacient Agents|abortifacient agents|mesh-ancestor
65168111|NCT04215835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65168112|NCT04215835|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65168113|NCT04215835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65168114|NCT04215835|Oxytocics|oxytocics|mesh-ancestor
65168115|NCT01208207|Naproxen|naproxen|mesh-list
65168116|NCT01208207|Etoricoxib|etoricoxib|mesh-list
65168117|NCT01208207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65321413|NCT02608931|Hallucinogens|hallucinogens|mesh-ancestor
65321414|NCT02608931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321415|NCT02608931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65321416|NCT02608931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65321417|NCT02608931|Analgesics|analgesics|mesh-ancestor
65321418|NCT02608931|Sensory System Agents|sensory system agents|mesh-ancestor
65321419|NCT02608931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65321420|NCT02608931|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65321421|NCT02608931|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65321422|NCT02608931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65321423|NCT02608931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321424|NCT02608931|Hormones|hormones|mesh-ancestor
65321425|NCT02608931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65321426|NCT04618289|Vitamin D|vitamin d|mesh-list
65321427|NCT04618289|Cholecalciferol|cholecalciferol|mesh-list
65321428|NCT04618289|Vitamins|vitamins|mesh-ancestor
65321429|NCT04618289|Micronutrients|micronutrients|mesh-ancestor
65321430|NCT04618289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321431|NCT04618289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65321432|NCT04618289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65321433|NCT00744978|Varenicline|varenicline|mesh-list
65321434|NCT00744978|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65321435|NCT00744978|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65321436|NCT00744978|Cholinergic Agents|cholinergic agents|mesh-ancestor
65321437|NCT00744978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65321438|NCT00744978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321439|NCT00744978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168118|NCT01208207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65168119|NCT01208207|Analgesics|analgesics|mesh-ancestor
65168120|NCT01208207|Sensory System Agents|sensory system agents|mesh-ancestor
65168121|NCT01208207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65168122|NCT01208207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168123|NCT01208207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65168124|NCT01208207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65168125|NCT01208207|Gout Suppressants|gout suppressants|mesh-ancestor
65168126|NCT01208207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65168127|NCT01208207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168128|NCT01208207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168129|NCT01208207|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65168130|NCT05420285|Dapagliflozin|dapagliflozin|mesh-list
65168131|NCT05420285|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65168132|NCT05420285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168133|NCT05420285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65168134|NCT05420285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168135|NCT01012713|Calcitriol|calcitriol|mesh-list
65168136|NCT01012713|Clobetasol|clobetasol|mesh-list
65321440|NCT02595606|Hyaluronic Acid|hyaluronic acid|mesh-list
65321441|NCT02595606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65321442|NCT02595606|Immunologic Factors|immunologic factors|mesh-ancestor
65321443|NCT02595606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321444|NCT02595606|Viscosupplements|viscosupplements|mesh-ancestor
65321445|NCT02595606|Protective Agents|protective agents|mesh-ancestor
65321446|NCT05757167|Lumefantrine|lumefantrine|mesh-list
65321447|NCT05757167|Artemether|artemether|mesh-list
65321448|NCT05757167|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65321449|NCT05757167|Antimalarials|antimalarials|mesh-ancestor
65321450|NCT05757167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65321451|NCT05757167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65321452|NCT05757167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65321453|NCT02609945|Oxazolidinones|oxazolidinones|mesh-list
65321454|NCT02609945|Zolmitriptan|zolmitriptan|mesh-list
65321455|NCT02609945|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65321456|NCT02609945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65321457|NCT02609945|Serotonin Agents|serotonin agents|mesh-ancestor
65321458|NCT02609945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65321459|NCT02609945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321460|NCT02609945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321461|NCT02609945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65321462|NCT02609945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65168137|NCT01012713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65168138|NCT01012713|Glucocorticoids|glucocorticoids|mesh-ancestor
65168139|NCT01012713|Hormones|hormones|mesh-ancestor
65168140|NCT01012713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65168141|NCT01012713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168153|NCT02698813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168154|NCT02698813|Viscosupplements|viscosupplements|mesh-ancestor
65168155|NCT02698813|Protective Agents|protective agents|mesh-ancestor
65168156|NCT02702323|Apatinib|apatinib|mesh-list
65168157|NCT02702323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168158|NCT02702323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65168159|NCT02702323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168160|NCT02702323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168161|NCT01007253|Fluticasone|fluticasone|mesh-list
65168162|NCT01007253|Xhance|xhance|mesh-list
65168163|NCT01007253|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
65168164|NCT01007253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65168165|NCT01007253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65168166|NCT01007253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65168167|NCT01007253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65168168|NCT01007253|Autonomic Agents|autonomic agents|mesh-ancestor
65168169|NCT01007253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65168170|NCT01007253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168171|NCT01007253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65168172|NCT01007253|Respiratory System Agents|respiratory system agents|mesh-ancestor
65168173|NCT01007253|Dermatologic Agents|dermatologic agents|mesh-ancestor
65168174|NCT01007253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65168175|NCT01007253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65168176|NCT01007253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65168177|NCT01007253|Analgesics|analgesics|mesh-ancestor
65321463|NCT02609945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65321465|NCT04570475|Vitamins|vitamins|mesh-ancestor
65321466|NCT04570475|Micronutrients|micronutrients|mesh-ancestor
65321467|NCT04570475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321468|NCT04570475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65321469|NCT02609165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65321470|NCT02609165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65321471|NCT00739596|Amlodipine|amlodipine|mesh-list
65321472|NCT00739596|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65321473|NCT00739596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65321474|NCT00739596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65321475|NCT00739596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65321476|NCT00739596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321477|NCT00739596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65321478|NCT00739596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321479|NCT00739596|Vasodilator Agents|vasodilator agents|mesh-ancestor
65321480|NCT00739596|Diuretics|diuretics|mesh-ancestor
65321481|NCT00739596|Natriuretic Agents|natriuretic agents|mesh-ancestor
65321482|NCT00739596|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65321483|NCT00742326|Pioglitazone|pioglitazone|mesh-list
65321484|NCT00742326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65321485|NCT00742326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321486|NCT02597868|Capecitabine|capecitabine|mesh-list
65321487|NCT02597868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65321488|NCT02597868|Antimetabolites|antimetabolites|mesh-ancestor
65321489|NCT02597868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321490|NCT02597868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321491|NCT00811187|Lidocaine|lidocaine|mesh-list
65168178|NCT01007253|Sensory System Agents|sensory system agents|mesh-ancestor
65168179|NCT01007253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65168180|NCT01007253|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65168181|NCT01007253|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65168182|NCT01007253|Histamine Antagonists|histamine antagonists|mesh-ancestor
65168183|NCT01007253|Histamine Agents|histamine agents|mesh-ancestor
65168184|NCT01007253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65168185|NCT01007253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168186|NCT02691949|Mycophenolic Acid|mycophenolic acid|mesh-list
65168187|NCT02691949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65168188|NCT02691949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168189|NCT02691949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65168190|NCT02691949|Antitubercular Agents|antitubercular agents|mesh-ancestor
65168191|NCT02691949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65168192|NCT02691949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65168193|NCT02691949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168194|NCT02691949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168195|NCT04738123|Xanomeline|xanomeline|mesh-list
65168196|NCT04738123|Trospium chloride|trospium chloride|mesh-list
65321492|NCT00811187|Anesthetics, Local|anesthetics, local|mesh-ancestor
65321493|NCT00811187|Anesthetics|anesthetics|mesh-ancestor
65321494|NCT00811187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65321495|NCT00811187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321496|NCT00811187|Sensory System Agents|sensory system agents|mesh-ancestor
65321497|NCT00811187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65321498|NCT00811187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65321499|NCT00811187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65321500|NCT00811187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65321501|NCT00811187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65321502|NCT00811187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321503|NCT00917748|Docetaxel|docetaxel|mesh-list
65321504|NCT00917748|Modafinil|modafinil|mesh-list
65321505|NCT00917748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321506|NCT00917748|Tubulin Modulators|tubulin modulators|mesh-ancestor
65321507|NCT00917748|Antimitotic Agents|antimitotic agents|mesh-ancestor
65321508|NCT00917748|Mitosis Modulators|mitosis modulators|mesh-ancestor
65321509|NCT00917748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321510|NCT00917748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65321511|NCT00917748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321512|NCT00917748|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65321513|NCT00917748|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65321514|NCT00917748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65168197|NCT04738123|Parasympatholytics|parasympatholytics|mesh-ancestor
65168198|NCT04738123|Autonomic Agents|autonomic agents|mesh-ancestor
65168199|NCT04738123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65168200|NCT04738123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168201|NCT04738123|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65168202|NCT04738123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65168203|NCT04738123|Cholinergic Agents|cholinergic agents|mesh-ancestor
65168204|NCT04738123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65168219|NCT01006707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64810822|NCT01443325|Lidocaine|lidocaine|mesh-list
65168220|NCT01006707|Serotonin Agents|serotonin agents|mesh-ancestor
65168221|NCT01006707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64701734|NCT00003747|Carboplatin|carboplatin|mesh-list
65168222|NCT01006707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168223|NCT01006707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65168224|NCT01006707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65168225|NCT01006707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65168226|NCT01006707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65168227|NCT01006707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65168228|NCT01006629|Palivizumab|palivizumab|mesh-list
65168229|NCT01006629|Antiviral Agents|antiviral agents|mesh-ancestor
65168230|NCT01006629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65168231|NCT04214977|Anesthetics|anesthetics|mesh-list
65168232|NCT04214977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65168233|NCT04214977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168234|NCT02701933|Ketamine|ketamine|mesh-list
65168235|NCT02701933|Analgesics|analgesics|mesh-ancestor
65321515|NCT02595138|Zoledronic Acid|zoledronic acid|mesh-list
65321516|NCT02595138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65321517|NCT02595138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321518|NCT00591149|Docetaxel|docetaxel|mesh-list
65321519|NCT00591149|Oxaliplatin|oxaliplatin|mesh-list
65321520|NCT00591149|Cetuximab|cetuximab|mesh-list
65321521|NCT00591149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321522|NCT00591149|Tubulin Modulators|tubulin modulators|mesh-ancestor
65321523|NCT00591149|Antimitotic Agents|antimitotic agents|mesh-ancestor
65321524|NCT00591149|Mitosis Modulators|mitosis modulators|mesh-ancestor
65321525|NCT00591149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551353|NCT03750786|Leucovorin|leucovorin|mesh-list
65168236|NCT02701933|Sensory System Agents|sensory system agents|mesh-ancestor
65168237|NCT02701933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65168238|NCT02701933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168239|NCT02701933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65168240|NCT02701933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65168241|NCT02701933|Anesthetics, General|anesthetics, general|mesh-ancestor
65168242|NCT02701933|Anesthetics|anesthetics|mesh-ancestor
65168243|NCT02701933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65168244|NCT02701933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65168245|NCT02701933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65168246|NCT02701933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65168247|NCT02701933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168248|NCT04295967|Formaldehyde|formaldehyde|mesh-list
65168249|NCT04295967|Disinfectants|disinfectants|mesh-ancestor
65168250|NCT04295967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65168251|NCT01012323|Immunoglobulins|immunoglobulins|mesh-list
65168252|NCT01012323|Immunologic Factors|immunologic factors|mesh-ancestor
65168253|NCT01012323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168254|NCT02871765|Warfarin|warfarin|mesh-list
65168255|NCT02871765|Anticoagulants|anticoagulants|mesh-ancestor
65168256|NCT02549209|Paclitaxel|paclitaxel|mesh-list
65168257|NCT02549209|Carboplatin|carboplatin|mesh-list
65168258|NCT02549209|Pembrolizumab|pembrolizumab|mesh-list
65168259|NCT02549209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65168260|NCT02549209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168261|NCT02549209|Tubulin Modulators|tubulin modulators|mesh-ancestor
65168262|NCT02549209|Antimitotic Agents|antimitotic agents|mesh-ancestor
65168263|NCT02549209|Mitosis Modulators|mitosis modulators|mesh-ancestor
65168264|NCT02549209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168268|NCT02698267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65168269|NCT02698267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65168270|NCT02698267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65168271|NCT02698267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168272|NCT02698267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168273|NCT02698267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65168274|NCT02698267|Hormone Antagonists|hormone antagonists|mesh-ancestor
65168275|NCT02698267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65168276|NCT02698267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168277|NCT02698267|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65168278|NCT01011465|Oxytocin|oxytocin|mesh-list
65168279|NCT01011465|Oxytocics|oxytocics|mesh-ancestor
65168280|NCT01011465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65168281|NCT01011465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168282|NCT02494141|Curcumin|curcumin|mesh-list
65168283|NCT02494141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65168284|NCT02494141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65168285|NCT02494141|Analgesics|analgesics|mesh-ancestor
65168286|NCT02494141|Sensory System Agents|sensory system agents|mesh-ancestor
65168287|NCT02494141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65168288|NCT02494141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168289|NCT02494141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65321526|NCT00591149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65321527|NCT00735072|Maraviroc|maraviroc|mesh-list
65321528|NCT00735072|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65321529|NCT00735072|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65321530|NCT00735072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321531|NCT00735072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65321532|NCT00735072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65321533|NCT00735072|Antiviral Agents|antiviral agents|mesh-ancestor
65321534|NCT00735072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65321535|NCT00735072|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65321536|NCT00793598|Brincidofovir|brincidofovir|mesh-list
65321537|NCT00793598|Antiviral Agents|antiviral agents|mesh-ancestor
65321538|NCT00793598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65321539|NCT04115072|Praziquantel|praziquantel|mesh-list
65321540|NCT04115072|Anthelmintics|anthelmintics|mesh-ancestor
65321541|NCT04115072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65321542|NCT04115072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65321543|NCT00796562|Cyclophosphamide|cyclophosphamide|mesh-list
65321544|NCT00796562|Busulfan|busulfan|mesh-list
65321545|NCT00796562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65321546|NCT00796562|Immunologic Factors|immunologic factors|mesh-ancestor
65321547|NCT00796562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321548|NCT00796562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64551361|NCT04457245|Cariostatic Agents|cariostatic agents|mesh-ancestor
65168290|NCT02494141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65168291|NCT02494141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168292|NCT02494141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168293|NCT02494141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168294|NCT01011309|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
65168295|NCT01011309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65168296|NCT01011309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65168297|NCT01011309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65168298|NCT01011309|Schistosomicides|schistosomicides|mesh-ancestor
65168299|NCT01011309|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65168300|NCT01011309|Anthelmintics|anthelmintics|mesh-ancestor
65168303|NCT04214821|Ofloxacin|ofloxacin|mesh-list
65168304|NCT04214821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65168305|NCT04214821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65168306|NCT04214821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65168307|NCT04214821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65168308|NCT04214821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65168309|NCT04214821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65168310|NCT04214821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168311|NCT04214821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168312|NCT04214821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168313|NCT04214821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65168314|NCT04214821|Renal Agents|renal agents|mesh-ancestor
65168315|NCT04214821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65168316|NCT04214821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65168317|NCT00616213|Lenograstim|lenograstim|mesh-list
65168318|NCT00616213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65168319|NCT00616213|Immunologic Factors|immunologic factors|mesh-ancestor
65321549|NCT00796562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65321550|NCT00796562|Alkylating Agents|alkylating agents|mesh-ancestor
65321551|NCT00796562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321552|NCT00796562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321553|NCT00796562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65321554|NCT00801632|Prednisone|prednisone|mesh-list
65321555|NCT00801632|Methylprednisolone|methylprednisolone|mesh-list
65321556|NCT00801632|Cyclophosphamide|cyclophosphamide|mesh-list
65321557|NCT00801632|Rituximab|rituximab|mesh-list
65321558|NCT00801632|Tacrolimus|tacrolimus|mesh-list
65321559|NCT00801632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65321560|NCT00801632|Immunologic Factors|immunologic factors|mesh-ancestor
65321561|NCT00801632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321562|NCT00801632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65321563|NCT00801632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65321564|NCT00801632|Alkylating Agents|alkylating agents|mesh-ancestor
64551382|NCT03299088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168320|NCT00616213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168321|NCT00615667|Tacrolimus|tacrolimus|mesh-list
65168322|NCT00615667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65168323|NCT00615667|Immunologic Factors|immunologic factors|mesh-ancestor
65168324|NCT00615667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168325|NCT00615667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65168326|NCT00615667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168327|NCT00615667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168328|NCT02697955|Epinephrine|epinephrine|mesh-list
65168329|NCT02697955|Bupivacaine|bupivacaine|mesh-list
65168330|NCT02697955|Anesthetics, Local|anesthetics, local|mesh-ancestor
65168331|NCT02697955|Anesthetics|anesthetics|mesh-ancestor
65168332|NCT02697955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65168333|NCT02697955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168334|NCT02697955|Sensory System Agents|sensory system agents|mesh-ancestor
65168335|NCT02697955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65168336|NCT02697955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65168337|NCT02697955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65168343|NCT02697955|Autonomic Agents|autonomic agents|mesh-ancestor
65168344|NCT02697955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65168345|NCT02697955|Respiratory System Agents|respiratory system agents|mesh-ancestor
65168346|NCT02697955|Mydriatics|mydriatics|mesh-ancestor
65168347|NCT02697955|Sympathomimetics|sympathomimetics|mesh-ancestor
65168348|NCT02697955|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65168349|NCT04294329|Bupivacaine|bupivacaine|mesh-list
65168350|NCT04294329|Anesthetics, Local|anesthetics, local|mesh-ancestor
65168351|NCT04294329|Anesthetics|anesthetics|mesh-ancestor
65168352|NCT04294329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65168353|NCT04294329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168354|NCT04294329|Sensory System Agents|sensory system agents|mesh-ancestor
65168355|NCT04294329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65168356|NCT02701309|Iron|iron|mesh-list
65168357|NCT02701309|Protoporphyrin IX|protoporphyrin ix|mesh-list
65168358|NCT02701309|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
65168359|NCT02701309|Trace Elements|trace elements|mesh-ancestor
65168360|NCT02701309|Micronutrients|micronutrients|mesh-ancestor
65168361|NCT02701309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168362|NCT02701309|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65168363|NCT02701309|Dermatologic Agents|dermatologic agents|mesh-ancestor
65168364|NCT02701309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168365|NCT02701309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168366|NCT03250507|Bupivacaine|bupivacaine|mesh-list
65168367|NCT03250507|Anesthetics, Local|anesthetics, local|mesh-ancestor
65168368|NCT03250507|Anesthetics|anesthetics|mesh-ancestor
65321565|NCT00801632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321566|NCT00801632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321567|NCT00801632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65321568|NCT00801632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65321569|NCT00801632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65321570|NCT00801632|Glucocorticoids|glucocorticoids|mesh-ancestor
65321571|NCT00801632|Hormones|hormones|mesh-ancestor
65321572|NCT00801632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65321573|NCT00801632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65321574|NCT00801632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65321575|NCT00801632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65321576|NCT00801632|Antiemetics|antiemetics|mesh-ancestor
65321577|NCT00801632|Autonomic Agents|autonomic agents|mesh-ancestor
65168369|NCT03250507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65168370|NCT03250507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168371|NCT03250507|Sensory System Agents|sensory system agents|mesh-ancestor
64701883|NCT00003783|Leucovorin|leucovorin|mesh-list
65168372|NCT03250507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65168373|NCT00997893|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65168374|NCT00997893|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65168375|NCT00997893|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65168376|NCT00997893|Medroxyprogesterone|medroxyprogesterone|mesh-list
65168377|NCT00997893|Estradiol|estradiol|mesh-list
65168378|NCT00997893|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65168379|NCT00997893|Estrogens|estrogens|mesh-list
65168380|NCT00997893|Phytoestrogens|phytoestrogens|mesh-list
65168381|NCT00997893|Hormones|hormones|mesh-ancestor
65168382|NCT00997893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65168383|NCT00997893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168384|NCT00997893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65168385|NCT00997893|Contraceptive Agents|contraceptive agents|mesh-ancestor
65168386|NCT00997893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65168387|NCT00997893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65168388|NCT00997893|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65168389|NCT00997893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65168390|NCT00997893|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65168391|NCT00997893|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65168392|NCT00997893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65168393|NCT00997893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168394|NCT00997893|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65168395|NCT02697877|Regadenoson|regadenoson|mesh-list
65168396|NCT02697877|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65168397|NCT02697877|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65168398|NCT02697877|Purinergic Agonists|purinergic agonists|mesh-ancestor
65168399|NCT02697877|Purinergic Agents|purinergic agents|mesh-ancestor
65168400|NCT02697877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65168401|NCT02697877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168402|NCT02697877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168403|NCT04214665|Thioctic Acid|thioctic acid|mesh-list
65168404|NCT04214665|Antioxidants|antioxidants|mesh-ancestor
65168405|NCT04214665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168406|NCT04214665|Protective Agents|protective agents|mesh-ancestor
65168411|NCT02870673|Triamcinolone|triamcinolone|mesh-list
65168412|NCT02870673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65168413|NCT02870673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65168414|NCT02870673|Lidocaine|lidocaine|mesh-list
65168415|NCT02870673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65168416|NCT02870673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65168417|NCT02870673|Glucocorticoids|glucocorticoids|mesh-ancestor
65168418|NCT02870673|Hormones|hormones|mesh-ancestor
65222836|NCT02700087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321578|NCT00801632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65321579|NCT00801632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65321580|NCT00801632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65321581|NCT00801632|Protective Agents|protective agents|mesh-ancestor
65321582|NCT04111484|Adrenomedullin|adrenomedullin|mesh-list
65321583|NCT04111484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65321584|NCT04111484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65321585|NCT04111484|Autonomic Agents|autonomic agents|mesh-ancestor
65321586|NCT04111484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65321587|NCT04111484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321588|NCT04111484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65321589|NCT04111484|Respiratory System Agents|respiratory system agents|mesh-ancestor
65321590|NCT04111484|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65321591|NCT04111484|Vasodilator Agents|vasodilator agents|mesh-ancestor
65168419|NCT02870673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65168420|NCT02870673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168421|NCT02870673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65168422|NCT02870673|Immunologic Factors|immunologic factors|mesh-ancestor
65168423|NCT02870673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168424|NCT02870673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168425|NCT02870673|Anesthetics, Local|anesthetics, local|mesh-ancestor
65168426|NCT02870673|Anesthetics|anesthetics|mesh-ancestor
65168427|NCT02870673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65168428|NCT02870673|Sensory System Agents|sensory system agents|mesh-ancestor
65168429|NCT02870673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65168430|NCT02870673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65168431|NCT02870673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65168432|NCT02870673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65168433|NCT02870673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65168434|NCT00615745|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65168435|NCT00615745|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65168436|NCT00615745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65168437|NCT00615745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168438|NCT00615745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168439|NCT00615745|Antiviral Agents|antiviral agents|mesh-ancestor
65168440|NCT00615745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65168441|NCT00615745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65168442|NCT00615745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65168443|NCT05324839|Botulinum Toxins|botulinum toxins|mesh-list
65168444|NCT05324839|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65168445|NCT05324839|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65168446|NCT05324839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65168447|NCT05324839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65168448|NCT05324839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168449|NCT05324839|Cholinergic Agents|cholinergic agents|mesh-ancestor
65168450|NCT05324839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65168451|NCT05324839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168452|NCT05324839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65168453|NCT05324839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65168454|NCT02700685|Methylphenidate|methylphenidate|mesh-list
65168456|NCT02700685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65168457|NCT02700685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168458|NCT02700685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65168459|NCT02700685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65168460|NCT02700685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65168461|NCT02700685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321592|NCT04111484|Protective Agents|protective agents|mesh-ancestor
65321593|NCT04111328|Sufentanil|sufentanil|mesh-list
65321594|NCT04111328|Dexmedetomidine|dexmedetomidine|mesh-list
65321595|NCT04111328|Dsuvia|dsuvia|mesh-list
65321596|NCT04111328|Hydromorphone|hydromorphone|mesh-list
65321597|NCT04111328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65321598|NCT04111328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65321599|NCT04111328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321600|NCT04111328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65321601|NCT04111328|Analgesics|analgesics|mesh-ancestor
65321602|NCT04111328|Sensory System Agents|sensory system agents|mesh-ancestor
65321603|NCT04111328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65321604|NCT04111328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65321605|NCT04111328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65321606|NCT04111328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65321607|NCT04111328|Adrenergic Agents|adrenergic agents|mesh-ancestor
65321608|NCT04111328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65321609|NCT04111328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321610|NCT04111328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65321611|NCT04111328|Narcotics|narcotics|mesh-ancestor
65321612|NCT04111328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65321613|NCT04111328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65321614|NCT04111328|Anesthetics, General|anesthetics, general|mesh-ancestor
65321615|NCT04111328|Anesthetics|anesthetics|mesh-ancestor
65321616|NCT00806819|Folic Acid|folic acid|mesh-list
65168462|NCT02700685|Dopamine Agents|dopamine agents|mesh-ancestor
65168463|NCT02700685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65168464|NCT02700685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65168465|NCT02700685|Immunologic Factors|immunologic factors|mesh-ancestor
65168466|NCT02700685|Antioxidants|antioxidants|mesh-ancestor
65168467|NCT02700685|Protective Agents|protective agents|mesh-ancestor
65168468|NCT02700685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65168470|NCT02700763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168471|NCT02700763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65168472|NCT02700763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168473|NCT02700763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168474|NCT04215523|Dapagliflozin|dapagliflozin|mesh-list
65168475|NCT04215523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65168476|NCT04215523|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65168480|NCT04215523|Protease Inhibitors|protease inhibitors|mesh-ancestor
65168481|NCT04215523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168483|NCT03151681|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65168484|NCT03151681|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65168485|NCT03151681|Adrenergic Agents|adrenergic agents|mesh-ancestor
65168486|NCT03151681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65168487|NCT03151681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168488|NCT03151681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168489|NCT03151681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65168490|NCT03151681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65168491|NCT03151681|Vasodilator Agents|vasodilator agents|mesh-ancestor
65168492|NCT04215445|Empagliflozin|empagliflozin|mesh-list
65321617|NCT00806819|Vitamin B Complex|vitamin b complex|mesh-list
65321618|NCT00806819|Hydroxocobalamin|hydroxocobalamin|mesh-list
65321619|NCT00806819|Vitamin B 12|vitamin b 12|mesh-list
65321620|NCT00806819|Dexamethasone|dexamethasone|mesh-list
65321621|NCT00806819|Dexamethasone acetate|dexamethasone acetate|mesh-list
65321622|NCT00806819|Pemetrexed|pemetrexed|mesh-list
65321623|NCT00806819|Nintedanib|nintedanib|mesh-list
65321624|NCT00806819|BB 1101|bb 1101|mesh-list
65321625|NCT00806819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65321626|NCT00806819|Antiemetics|antiemetics|mesh-ancestor
65321627|NCT00806819|Autonomic Agents|autonomic agents|mesh-ancestor
65321628|NCT00806819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65321629|NCT00806819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321630|NCT00806819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65321631|NCT00806819|Glucocorticoids|glucocorticoids|mesh-ancestor
65321632|NCT00806819|Hormones|hormones|mesh-ancestor
65321633|NCT00806819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65321634|NCT00806819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65321635|NCT00806819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321636|NCT00806819|Protease Inhibitors|protease inhibitors|mesh-ancestor
65321637|NCT00806819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65321638|NCT00806819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168493|NCT04215445|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65168494|NCT04215445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168495|NCT04215445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65168496|NCT04215445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168497|NCT00951457|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65168498|NCT00951457|Alemtuzumab|alemtuzumab|mesh-list
65168499|NCT00951457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65168500|NCT00951457|Alkylating Agents|alkylating agents|mesh-ancestor
65168501|NCT00951457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168502|NCT00951457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168503|NCT00951457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65168504|NCT02691871|Docetaxel|docetaxel|mesh-list
65168505|NCT02691871|Apatinib|apatinib|mesh-list
65168506|NCT02691871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168507|NCT02691871|Tubulin Modulators|tubulin modulators|mesh-ancestor
65168508|NCT02691871|Antimitotic Agents|antimitotic agents|mesh-ancestor
65168509|NCT02691871|Mitosis Modulators|mitosis modulators|mesh-ancestor
65168510|NCT02691871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168511|NCT02691871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65168512|NCT02691871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168513|NCT02700217|Remifentanil|remifentanil|mesh-list
65168514|NCT02700217|Heroin|heroin|mesh-list
65168515|NCT02700217|Bupivacaine|bupivacaine|mesh-list
65168516|NCT02700217|Propofol|propofol|mesh-list
64811122|NCT01445340|Romidepsin|romidepsin|mesh-list
65168518|NCT02700217|Anesthetics|anesthetics|mesh-ancestor
65168519|NCT02700217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65168520|NCT02700217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168521|NCT02700217|Sensory System Agents|sensory system agents|mesh-ancestor
65168522|NCT02700217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65168523|NCT02700217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65168524|NCT02700217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65168525|NCT02700217|Anesthetics, General|anesthetics, general|mesh-ancestor
65321639|NCT00806819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65321640|NCT00806819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65321641|NCT00806819|Hematinics|hematinics|mesh-ancestor
65321642|NCT00806819|Vitamins|vitamins|mesh-ancestor
65321643|NCT00806819|Micronutrients|micronutrients|mesh-ancestor
65321644|NCT00806819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65321645|NCT04109534|Methacholine Chloride|methacholine chloride|mesh-list
65321646|NCT04109534|Miotics|miotics|mesh-ancestor
65321647|NCT04109534|Autonomic Agents|autonomic agents|mesh-ancestor
65321648|NCT04109534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65321649|NCT04109534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321650|NCT04109534|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65321651|NCT04109534|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
65321652|NCT04109534|Respiratory System Agents|respiratory system agents|mesh-ancestor
65321653|NCT04109534|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65321654|NCT04109534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65321655|NCT04109534|Cholinergic Agents|cholinergic agents|mesh-ancestor
65321656|NCT04109534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65321657|NCT04109534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321658|NCT05753735|Amoxicillin|amoxicillin|mesh-list
65321659|NCT05753735|Tazobactam|tazobactam|mesh-list
65168526|NCT02700217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65168527|NCT02700217|Narcotics|narcotics|mesh-ancestor
65168528|NCT02700217|Analgesics|analgesics|mesh-ancestor
65168529|NCT05323981|Pertuzumab|pertuzumab|mesh-list
65168530|NCT05323981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65168531|NCT05323981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168532|NCT02699827|Magnesium Sulfate|magnesium sulfate|mesh-list
65168533|NCT02699827|Levobupivacaine|levobupivacaine|mesh-list
65168534|NCT02699827|Analgesics|analgesics|mesh-ancestor
65168535|NCT02699827|Sensory System Agents|sensory system agents|mesh-ancestor
65168536|NCT02699827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65168537|NCT02699827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168538|NCT02699827|Anesthetics|anesthetics|mesh-ancestor
65168539|NCT02699827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65168540|NCT02699827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65168541|NCT02699827|Anticonvulsants|anticonvulsants|mesh-ancestor
65168542|NCT02699827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65168543|NCT02699827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65168544|NCT02699827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168545|NCT02699827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65168546|NCT02699827|Tocolytic Agents|tocolytic agents|mesh-ancestor
65168547|NCT02699827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65168550|NCT02705989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65168551|NCT02705989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168552|NCT02705989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168554|NCT02706067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168555|NCT02706067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168556|NCT02706067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65168557|NCT02706067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65168558|NCT02939287|Olanzapine|olanzapine|mesh-list
65168559|NCT02939287|Aprepitant|aprepitant|mesh-list
65168560|NCT02939287|Fosaprepitant|fosaprepitant|mesh-list
65168561|NCT02939287|Antiemetics|antiemetics|mesh-ancestor
65168562|NCT02939287|Autonomic Agents|autonomic agents|mesh-ancestor
65168563|NCT02939287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65321660|NCT05753735|Piperacillin|piperacillin|mesh-list
65321661|NCT05753735|Clavulanic Acids|clavulanic acids|mesh-list
65321662|NCT05753735|Clavulanic Acid|clavulanic acid|mesh-list
65321663|NCT05753735|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65321664|NCT05753735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65321665|NCT05753735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65321666|NCT05753735|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65321667|NCT05753735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65321668|NCT05753735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321669|NCT05326139|Tranexamic Acid|tranexamic acid|mesh-list
65321670|NCT05326139|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65321671|NCT05326139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65321672|NCT05326139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321673|NCT05326139|Hemostatics|hemostatics|mesh-ancestor
65321674|NCT05326139|Coagulants|coagulants|mesh-ancestor
65321675|NCT02605694|Prednisone|prednisone|mesh-list
65321676|NCT02605694|Rituximab|rituximab|mesh-list
65321677|NCT02605694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65321678|NCT02605694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321679|NCT02605694|Immunologic Factors|immunologic factors|mesh-ancestor
65321680|NCT02605694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321681|NCT02605694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65321682|NCT02605694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65321683|NCT02605694|Glucocorticoids|glucocorticoids|mesh-ancestor
65321684|NCT02605694|Hormones|hormones|mesh-ancestor
65321685|NCT02605694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65321686|NCT02605694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65321687|NCT02604134|Silver Nitrate|silver nitrate|mesh-list
65321688|NCT02604134|Fluorides|fluorides|mesh-list
65321689|NCT02604134|Fluorides, Topical|fluorides, topical|mesh-list
65321690|NCT02604134|Cariostatic Agents|cariostatic agents|mesh-ancestor
65168564|NCT02939287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168565|NCT02939287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65168566|NCT02939287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65168567|NCT02939287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65168568|NCT02939287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65168569|NCT02939287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65168570|NCT02939287|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65168571|NCT02939287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65168572|NCT02939287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65168573|NCT02939287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168574|NCT02939287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65168575|NCT02939287|Serotonin Agents|serotonin agents|mesh-ancestor
65168576|NCT02939287|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65168577|NCT05323201|Cyclophosphamide|cyclophosphamide|mesh-list
65321691|NCT02604134|Protective Agents|protective agents|mesh-ancestor
65321692|NCT02604134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321693|NCT02604134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65321694|NCT02604134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65321695|NCT00800540|Timolol|timolol|mesh-list
65321696|NCT00800540|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65321697|NCT00800540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65321698|NCT00800540|Brinzolamide|brinzolamide|mesh-list
65321699|NCT00800540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65321700|NCT00800540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65321701|NCT00800540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65321702|NCT00800540|Adrenergic Agents|adrenergic agents|mesh-ancestor
65321703|NCT00800540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65321704|NCT00800540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321705|NCT00800540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321706|NCT00800540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65321707|NCT00800540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65321708|NCT00800540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65321709|NCT00800540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65321710|NCT00800540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65321711|NCT00800540|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65321712|NCT00800540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65321713|NCT00796328|Phenylephrine|phenylephrine|mesh-list
65321714|NCT00796328|Oxymetazoline|oxymetazoline|mesh-list
65321715|NCT00796328|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65168578|NCT05323201|Fludarabine|fludarabine|mesh-list
65168579|NCT05323201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65168580|NCT05323201|Immunologic Factors|immunologic factors|mesh-ancestor
65168581|NCT05323201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168582|NCT05323201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65168583|NCT05323201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65168584|NCT05323201|Alkylating Agents|alkylating agents|mesh-ancestor
65168585|NCT05323201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168586|NCT05323201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168587|NCT05323201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65168589|NCT01208051|Lenalidomide|lenalidomide|mesh-list
65168590|NCT01208051|Cediranib|cediranib|mesh-list
65168591|NCT01208051|Maleic acid|maleic acid|mesh-list
65168592|NCT01208051|Immunologic Factors|immunologic factors|mesh-ancestor
65168593|NCT01208051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168594|NCT01208051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65168595|NCT01208051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65168596|NCT01208051|Growth Substances|growth substances|mesh-ancestor
65168597|NCT01208051|Growth Inhibitors|growth inhibitors|mesh-ancestor
65168598|NCT01208051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168599|NCT01208051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168600|NCT01208051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168601|NCT01208051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65168602|NCT05322889|Telmisartan|telmisartan|mesh-list
65168603|NCT05322889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65321716|NCT00796328|Mydriatics|mydriatics|mesh-ancestor
65321717|NCT00796328|Autonomic Agents|autonomic agents|mesh-ancestor
65321718|NCT00796328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65321719|NCT00796328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321720|NCT00796328|Sympathomimetics|sympathomimetics|mesh-ancestor
65321721|NCT00796328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65321722|NCT00796328|Nasal Decongestants|nasal decongestants|mesh-ancestor
65321723|NCT00796328|Respiratory System Agents|respiratory system agents|mesh-ancestor
65321724|NCT00796328|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65321725|NCT00796328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65321726|NCT00796328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65321727|NCT00796328|Adrenergic Agents|adrenergic agents|mesh-ancestor
65321728|NCT00796328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65321729|NCT00796328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321730|NCT00796328|Protective Agents|protective agents|mesh-ancestor
65321731|NCT02605382|Chlorhexidine|chlorhexidine|mesh-list
65321732|NCT02605382|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64551537|NCT00882687|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65168604|NCT05322889|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65168605|NCT05322889|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65168606|NCT05322889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168607|NCT00616915|Bupropion|bupropion|mesh-list
65168608|NCT00616915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65168609|NCT00616915|Antidepressive Agents|antidepressive agents|mesh-ancestor
65168610|NCT00616915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65168611|NCT00616915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65168612|NCT00616915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65168613|NCT00616915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65168614|NCT00616915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168615|NCT00616915|Dopamine Agents|dopamine agents|mesh-ancestor
65168616|NCT00616915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65168617|NCT00616915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168618|NCT00616915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65168619|NCT00616915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65168631|NCT05410223|Immunologic Factors|immunologic factors|mesh-ancestor
65168632|NCT05410223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168633|NCT05410223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65168634|NCT05410223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65168635|NCT05410223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65168636|NCT05410223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168637|NCT05410223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168638|NCT05410223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65168639|NCT05410223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65168640|NCT05410223|Antimalarials|antimalarials|mesh-ancestor
65168641|NCT05410223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65168642|NCT05410223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65168643|NCT05410223|Antacids|antacids|mesh-ancestor
65168644|NCT05410223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65168645|NCT05410223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65168646|NCT05410223|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65168647|NCT05410223|Renal Agents|renal agents|mesh-ancestor
65168648|NCT05410223|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65168649|NCT05410223|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65168650|NCT01206101|Liraglutide|liraglutide|mesh-list
65168651|NCT01206101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65321733|NCT02605382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65321734|NCT02605382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65321735|NCT02605382|Disinfectants|disinfectants|mesh-ancestor
65321736|NCT02605382|Dermatologic Agents|dermatologic agents|mesh-ancestor
65321737|NCT04110860|Voriconazole|voriconazole|mesh-list
65321738|NCT04110860|Antifungal Agents|antifungal agents|mesh-ancestor
65321739|NCT04110860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65321740|NCT04110860|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65321741|NCT04110860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65321742|NCT04110860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65321743|NCT04110860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321744|NCT04110860|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65321745|NCT04110860|Hormone Antagonists|hormone antagonists|mesh-ancestor
65168652|NCT01206101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168653|NCT01206101|Incretins|incretins|mesh-ancestor
65168654|NCT01206101|Hormones|hormones|mesh-ancestor
65168655|NCT01206101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65168656|NCT00997503|Aspirin|aspirin|mesh-list
65168657|NCT00997503|Paclitaxel|paclitaxel|mesh-list
65168658|NCT00997503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65168659|NCT00997503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65168660|NCT00997503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168661|NCT00997503|Tubulin Modulators|tubulin modulators|mesh-ancestor
65168662|NCT00997503|Antimitotic Agents|antimitotic agents|mesh-ancestor
65168663|NCT00997503|Mitosis Modulators|mitosis modulators|mesh-ancestor
65168664|NCT00997503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168665|NCT00997503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65168666|NCT00997503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65168667|NCT00997503|Analgesics|analgesics|mesh-ancestor
65168668|NCT00997503|Sensory System Agents|sensory system agents|mesh-ancestor
65168669|NCT00997503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65168670|NCT00997503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168671|NCT00997503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65168672|NCT00997503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65168673|NCT00997503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65168674|NCT00997503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65168675|NCT00997503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65168676|NCT00997503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65168677|NCT00997503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168678|NCT00997503|Antipyretics|antipyretics|mesh-ancestor
65168679|NCT02705053|Insulin|insulin|mesh-list
65168688|NCT01204775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65168689|NCT01204775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65168690|NCT01204775|Protease Inhibitors|protease inhibitors|mesh-ancestor
65168691|NCT01204775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168692|NCT01204775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168693|NCT02844907|Dexamethasone|dexamethasone|mesh-list
65168694|NCT02844907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65168695|NCT02844907|Antiemetics|antiemetics|mesh-ancestor
65168696|NCT02844907|Autonomic Agents|autonomic agents|mesh-ancestor
65168697|NCT02844907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65168698|NCT02844907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168699|NCT02844907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65168700|NCT02844907|Glucocorticoids|glucocorticoids|mesh-ancestor
65168701|NCT02844907|Hormones|hormones|mesh-ancestor
65168702|NCT02844907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65168703|NCT02844907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65168704|NCT02844907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168705|NCT00628719|Amphotericin B|amphotericin b|mesh-list
65168706|NCT00628719|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65321746|NCT04110860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65321747|NCT04110860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321748|NCT04110860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65321749|NCT02604836|Ibandronic Acid|ibandronic acid|mesh-list
65321750|NCT02604836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65321751|NCT02604836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321752|NCT04114526|Nicotine|nicotine|mesh-list
65321753|NCT04114526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65321754|NCT04114526|Autonomic Agents|autonomic agents|mesh-ancestor
65321755|NCT04114526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65321756|NCT04114526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321757|NCT04114526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65321758|NCT04114526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65321759|NCT04114526|Cholinergic Agents|cholinergic agents|mesh-ancestor
65321760|NCT04114526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65321761|NCT04114526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321762|NCT00915200|Acetylcysteine|acetylcysteine|mesh-list
65321763|NCT00915200|Silybin|silybin|mesh-list
65321764|NCT00915200|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65321765|NCT00915200|Antiviral Agents|antiviral agents|mesh-ancestor
65321766|NCT00915200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65321767|NCT00915200|Expectorants|expectorants|mesh-ancestor
65321768|NCT00915200|Respiratory System Agents|respiratory system agents|mesh-ancestor
65321769|NCT00915200|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65321770|NCT00915200|Antioxidants|antioxidants|mesh-ancestor
65321771|NCT00915200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321772|NCT00915200|Protective Agents|protective agents|mesh-ancestor
65321773|NCT00915200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321774|NCT00915200|Antidotes|antidotes|mesh-ancestor
65321775|NCT00915200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65321776|NCT00915200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321777|NCT00588146|Interferons|interferons|mesh-list
65321778|NCT00588146|Interferon-alpha|interferon-alpha|mesh-list
65321779|NCT00588146|Interferon alpha-2|interferon alpha-2|mesh-list
64551568|NCT02288377|Lanreotide|lanreotide|mesh-list
65168707|NCT00628719|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
65168708|NCT00628719|Deoxycholic Acid|deoxycholic acid|mesh-list
65168709|NCT00628719|Amebicides|amebicides|mesh-ancestor
65168710|NCT00628719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65168711|NCT00628719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65168712|NCT00628719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65321780|NCT00588146|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65321781|NCT00588146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321782|NCT00588146|Antiviral Agents|antiviral agents|mesh-ancestor
65321783|NCT00588146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65321784|NCT00588146|Immunologic Factors|immunologic factors|mesh-ancestor
65321785|NCT00588146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321786|NCT00444457|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65321787|NCT00444457|Immunologic Factors|immunologic factors|mesh-ancestor
65321788|NCT00444457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321789|NCT00799058|Dapivirine|dapivirine|mesh-list
65321790|NCT00799058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65321791|NCT00799058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65321792|NCT00799058|Antiviral Agents|antiviral agents|mesh-ancestor
65321793|NCT00799058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65321794|NCT00725985|Cladribine|cladribine|mesh-list
65321795|NCT00725985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321796|NCT00725985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65321797|NCT00725985|Immunologic Factors|immunologic factors|mesh-ancestor
65321798|NCT00725985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321799|NCT00793910|Gabapentin|gabapentin|mesh-list
65321800|NCT00793910|Analgesics|analgesics|mesh-ancestor
65321801|NCT00793910|Sensory System Agents|sensory system agents|mesh-ancestor
65321802|NCT00793910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64551594|NCT03176173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168713|NCT00628719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65168714|NCT00628719|Antifungal Agents|antifungal agents|mesh-ancestor
65168715|NCT00628719|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65168716|NCT00628719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65168717|NCT00616993|Difluprednate|difluprednate|mesh-list
65168718|NCT00616993|Glucocorticoids|glucocorticoids|mesh-ancestor
65168719|NCT00616993|Hormones|hormones|mesh-ancestor
65168720|NCT00616993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65168721|NCT00616993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168722|NCT02870361|Insulin|insulin|mesh-list
65168723|NCT02870361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65168724|NCT02870361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168725|NCT00616681|Oxcarbazepine|oxcarbazepine|mesh-list
65168726|NCT00616681|Anticonvulsants|anticonvulsants|mesh-ancestor
65168727|NCT00616681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65168728|NCT00616681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65168729|NCT00616681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65168730|NCT00616681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168731|NCT00616681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65168732|NCT00616681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65168733|NCT00997035|Voriconazole|voriconazole|mesh-list
65168734|NCT00997035|Antifungal Agents|antifungal agents|mesh-ancestor
65168735|NCT00997035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65168736|NCT00997035|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65168737|NCT00997035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65168738|NCT00997035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168739|NCT00997035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321803|NCT00793910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321804|NCT00793910|Anticonvulsants|anticonvulsants|mesh-ancestor
65321805|NCT00793910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65321806|NCT00793910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65321807|NCT00793910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65321808|NCT00793910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65321809|NCT00793910|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65321810|NCT00793910|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65321811|NCT00793910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65321812|NCT00793910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321813|NCT00793910|Antimanic Agents|antimanic agents|mesh-ancestor
65321814|NCT05589818|Pembrolizumab|pembrolizumab|mesh-list
65321815|NCT05589818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65321816|NCT05589818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321817|NCT01019941|Docetaxel|docetaxel|mesh-list
65321818|NCT01019941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321819|NCT01019941|Tubulin Modulators|tubulin modulators|mesh-ancestor
65321820|NCT01019941|Antimitotic Agents|antimitotic agents|mesh-ancestor
65321821|NCT01019941|Mitosis Modulators|mitosis modulators|mesh-ancestor
65321822|NCT01019941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321823|NCT04113668|Diflunisal|diflunisal|mesh-list
65321824|NCT04113668|BMS-986165|bms-986165|mesh-list
65321825|NCT04113668|Dermatologic Agents|dermatologic agents|mesh-ancestor
65321826|NCT04113668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65321827|NCT04113668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551615|NCT02220985|Antimetabolites|antimetabolites|mesh-ancestor
64551616|NCT02220985|Dermatologic Agents|dermatologic agents|mesh-ancestor
64551617|NCT02220985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551618|NCT02220985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64551619|NCT02220985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64551620|NCT02220985|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64551621|NCT02220985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65168740|NCT00997035|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65168741|NCT00997035|Hormone Antagonists|hormone antagonists|mesh-ancestor
65168742|NCT00997035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65168743|NCT00997035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168744|NCT00997035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65168745|NCT01204697|Docetaxel|docetaxel|mesh-list
65168748|NCT01204697|Tubulin Modulators|tubulin modulators|mesh-ancestor
65168749|NCT01204697|Antimitotic Agents|antimitotic agents|mesh-ancestor
65168750|NCT01204697|Mitosis Modulators|mitosis modulators|mesh-ancestor
65222837|NCT02700087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321828|NCT04113668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321829|NCT04113668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65321830|NCT04113668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65321831|NCT04113668|Analgesics|analgesics|mesh-ancestor
65321832|NCT04113668|Sensory System Agents|sensory system agents|mesh-ancestor
65321833|NCT04113668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65321834|NCT04113668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321835|NCT04113668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65321836|NCT04113668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65321837|NCT04113668|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65321838|NCT00444145|Lansoprazole|lansoprazole|mesh-list
65321839|NCT00444145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65321840|NCT00444145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65321841|NCT00444145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65321842|NCT00444145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65321843|NCT00444145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321844|NCT04107896|Tamsulosin|tamsulosin|mesh-list
65321845|NCT04107896|Silodosin|silodosin|mesh-list
65321846|NCT04107896|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65321847|NCT04107896|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65321848|NCT04107896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65321849|NCT04107896|Adrenergic Agents|adrenergic agents|mesh-ancestor
64551641|NCT03367533|Anesthetics|anesthetics|mesh-ancestor
65168751|NCT01204697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168752|NCT01204697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65168753|NCT01204697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168754|NCT01203917|Gefitinib|gefitinib|mesh-list
65168755|NCT01203917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168756|NCT01203917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65168757|NCT01203917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168758|NCT01203917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168759|NCT04213495|Anesthetics|anesthetics|mesh-list
65168760|NCT04213495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65168761|NCT04213495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168762|NCT04318223|Palbociclib|palbociclib|mesh-list
65168763|NCT04318223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168764|NCT04318223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65168765|NCT04318223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168766|NCT04318223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168767|NCT01202903|Omalizumab|omalizumab|mesh-list
65168768|NCT01202903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65168769|NCT01202903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65168770|NCT01202903|Respiratory System Agents|respiratory system agents|mesh-ancestor
65168771|NCT00618631|Carfentanil|carfentanil|mesh-list
65168772|NCT00618631|Nicotine|nicotine|mesh-list
65168773|NCT00618631|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65168774|NCT00618631|Autonomic Agents|autonomic agents|mesh-ancestor
65168775|NCT00618631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65168776|NCT00618631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168777|NCT00618631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65168778|NCT00618631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65321850|NCT04107896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65321851|NCT04107896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321852|NCT04107896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321853|NCT04107896|Urological Agents|urological agents|mesh-ancestor
65321854|NCT01024777|Vitamin D|vitamin d|mesh-list
65321855|NCT01024777|Ergocalciferols|ergocalciferols|mesh-list
65321856|NCT01024777|Cholecalciferol|cholecalciferol|mesh-list
65321857|NCT01024777|Vitamins|vitamins|mesh-list
65321858|NCT01024777|Micronutrients|micronutrients|mesh-ancestor
65321859|NCT01024777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321860|NCT01024777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64551662|NCT03213249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64551663|NCT03213249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64551664|NCT03213249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64551665|NCT03213249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551666|NCT03213249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551667|NCT03213249|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64551668|NCT03317067|Dexmedetomidine|dexmedetomidine|mesh-list
64551669|NCT03317067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64551670|NCT03317067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64989455|NCT05814523|Neurosteroids|neurosteroids|mesh-ancestor
65168779|NCT00618631|Cholinergic Agents|cholinergic agents|mesh-ancestor
65168780|NCT00618631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65168781|NCT00618631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168782|NCT00618631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65168783|NCT00618631|Narcotics|narcotics|mesh-ancestor
65168784|NCT00618631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65168785|NCT00618631|Analgesics|analgesics|mesh-ancestor
65168786|NCT00618631|Sensory System Agents|sensory system agents|mesh-ancestor
65168787|NCT04213573|Fluorides|fluorides|mesh-list
65168788|NCT04213573|Cariostatic Agents|cariostatic agents|mesh-ancestor
65168789|NCT04213573|Protective Agents|protective agents|mesh-ancestor
65168790|NCT04213573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168791|NCT00620269|Irinotecan|irinotecan|mesh-list
65168792|NCT00620269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65168793|NCT00620269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168794|NCT00620269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65168795|NCT00620269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65168796|NCT00620269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168797|NCT00620269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168798|NCT00620269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65168799|NCT04212403|Levofloxacin|levofloxacin|mesh-list
65168800|NCT04212403|Ofloxacin|ofloxacin|mesh-list
65168801|NCT04212403|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65168802|NCT04212403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65168803|NCT04212403|Renal Agents|renal agents|mesh-ancestor
65168804|NCT04212403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65168805|NCT04212403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65168806|NCT04212403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65168807|NCT04212403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168808|NCT04212403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168809|NCT04212403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168810|NCT04212403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65321861|NCT01024777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65321862|NCT00789854|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65321863|NCT00789854|Lithium Carbonate|lithium carbonate|mesh-list
65321864|NCT00789854|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65321865|NCT00789854|Antidepressive Agents|antidepressive agents|mesh-ancestor
65321866|NCT00789854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65321867|NCT00789854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65321868|NCT00789854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65321869|NCT00789854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65321870|NCT00789854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321871|NCT00789854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65321872|NCT00789854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321873|NCT00789854|Antimanic Agents|antimanic agents|mesh-ancestor
65168811|NCT04212403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65168812|NCT00637117|Interferons|interferons|mesh-list
65168813|NCT00637117|Interferon-alpha|interferon-alpha|mesh-list
65168814|NCT00637117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168815|NCT00637117|Antiviral Agents|antiviral agents|mesh-ancestor
65168816|NCT00637117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65168817|NCT00637117|Immunologic Factors|immunologic factors|mesh-ancestor
65168818|NCT00637117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168819|NCT02052193|Vemurafenib|vemurafenib|mesh-list
65168824|NCT02052193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168825|NCT00617695|Zolmitriptan|zolmitriptan|mesh-list
65168826|NCT00617695|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65168827|NCT00617695|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65168828|NCT00617695|Serotonin Agents|serotonin agents|mesh-ancestor
65168829|NCT00617695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65168830|NCT00617695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168831|NCT00617695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168832|NCT00619021|Gemcitabine|gemcitabine|mesh-list
65168833|NCT00619021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65168834|NCT00619021|Antimetabolites|antimetabolites|mesh-ancestor
65168835|NCT00619021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168836|NCT00619021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168837|NCT00619021|Antiviral Agents|antiviral agents|mesh-ancestor
65168838|NCT00619021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65168839|NCT00619021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168840|NCT00619021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65168841|NCT00619021|Immunologic Factors|immunologic factors|mesh-ancestor
65168842|NCT00619021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168843|NCT00620347|Sunitinib|sunitinib|mesh-list
65168844|NCT00620347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168845|NCT00620347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65168846|NCT00620347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65168847|NCT00620347|Growth Substances|growth substances|mesh-ancestor
65168848|NCT00620347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168849|NCT00620347|Growth Inhibitors|growth inhibitors|mesh-ancestor
65168850|NCT00620347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65168851|NCT00620347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168852|NCT00620347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168853|NCT04213105|Denosumab|denosumab|mesh-list
65168854|NCT04213105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65168855|NCT04213105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168856|NCT01887301|Nabiximols|nabiximols|mesh-list
65168857|NCT01887301|Analgesics|analgesics|mesh-ancestor
65168858|NCT01887301|Sensory System Agents|sensory system agents|mesh-ancestor
65168859|NCT01887301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65168860|NCT01887301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168861|NCT00996801|Vitamin D|vitamin d|mesh-list
65168862|NCT00996801|Cholecalciferol|cholecalciferol|mesh-list
65321874|NCT00789854|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65321875|NCT00789854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65321876|NCT00789854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65321877|NCT00789854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65321878|NCT00789854|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65321879|NCT00725205|Ribavirin|ribavirin|mesh-list
65321880|NCT00725205|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65321881|NCT00725205|Interferon-alpha|interferon-alpha|mesh-list
65321882|NCT00725205|Antimetabolites|antimetabolites|mesh-ancestor
65321883|NCT00725205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321884|NCT00725205|Antiviral Agents|antiviral agents|mesh-ancestor
65321885|NCT00725205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65321886|NCT00725205|Immunologic Factors|immunologic factors|mesh-ancestor
64551686|NCT00888459|Nicotine|nicotine|mesh-list
65168863|NCT00996801|Alendronate|alendronate|mesh-list
65168864|NCT00996801|Calcium Carbonate|calcium carbonate|mesh-list
65168865|NCT00996801|Calcium|calcium|mesh-list
65168866|NCT00996801|Vitamins|vitamins|mesh-ancestor
65168867|NCT00996801|Micronutrients|micronutrients|mesh-ancestor
65168868|NCT00996801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168869|NCT00996801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65168870|NCT00996801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65168871|NCT00996801|Antacids|antacids|mesh-ancestor
65168872|NCT00996801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168873|NCT00996801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65168874|NCT00619333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65168875|NCT00619333|Hormones|hormones|mesh-ancestor
65168876|NCT00619333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65168877|NCT00619333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168878|NCT04924621|Midazolam|midazolam|mesh-list
65168879|NCT04924621|Sufentanil|sufentanil|mesh-list
65168880|NCT04924621|Propofol|propofol|mesh-list
65168881|NCT04924621|Tetracaine|tetracaine|mesh-list
65168882|NCT04924621|Rocuronium|rocuronium|mesh-list
65168883|NCT04924621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65168884|NCT04924621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65168885|NCT04924621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168886|NCT04924621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65168887|NCT04924621|Anesthetics, General|anesthetics, general|mesh-ancestor
65168888|NCT04924621|Anesthetics|anesthetics|mesh-ancestor
65168889|NCT04924621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65168890|NCT04924621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65168891|NCT04924621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65168892|NCT04924621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65168893|NCT04924621|GABA Modulators|gaba modulators|mesh-ancestor
65168898|NCT04924621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65168899|NCT04924621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65168900|NCT04924621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65168901|NCT04924621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65168903|NCT04924621|Analgesics|analgesics|mesh-ancestor
65168904|NCT04924621|Sensory System Agents|sensory system agents|mesh-ancestor
65168905|NCT04924621|Anesthetics, Local|anesthetics, local|mesh-ancestor
65168907|NCT00516373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65168908|NCT00516373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168909|NCT00516373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168910|NCT00516373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168911|NCT02213497|Paclitaxel|paclitaxel|mesh-list
65168912|NCT02213497|Carboplatin|carboplatin|mesh-list
65168913|NCT02213497|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65168914|NCT02213497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65168915|NCT02213497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321887|NCT00725205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321888|NCT04071769|Xenon|xenon|mesh-list
65321889|NCT04071769|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65321890|NCT04071769|Anesthetics, General|anesthetics, general|mesh-ancestor
65321891|NCT04071769|Anesthetics|anesthetics|mesh-ancestor
65321892|NCT04071769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65321893|NCT04071769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321894|NCT00443755|Metformin|metformin|mesh-list
65321895|NCT00443755|Pioglitazone|pioglitazone|mesh-list
65321896|NCT00443755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65321897|NCT00443755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321898|NCT04107740|TA 0910|ta 0910|mesh-list
65321899|NCT04107740|Nootropic Agents|nootropic agents|mesh-ancestor
65321900|NCT00724971|Rituximab|rituximab|mesh-list
65321901|NCT00724971|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65321902|NCT00724971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65321903|NCT00724971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321904|NCT00724971|Immunologic Factors|immunologic factors|mesh-ancestor
65321905|NCT00724971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321906|NCT00724971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65321907|NCT00724971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65321908|NCT00443599|Insulin|insulin|mesh-list
65321909|NCT00443599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65321910|NCT00443599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65321911|NCT00443599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321912|NCT04107428|Somatostatin|somatostatin|mesh-list
65321913|NCT04107428|Hormones|hormones|mesh-ancestor
65321914|NCT04107428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65321915|NCT04107428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321916|NCT00455143|Dexmedetomidine|dexmedetomidine|mesh-list
65321917|NCT00455143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65168916|NCT02213497|Tubulin Modulators|tubulin modulators|mesh-ancestor
65168917|NCT02213497|Antimitotic Agents|antimitotic agents|mesh-ancestor
65168918|NCT02213497|Mitosis Modulators|mitosis modulators|mesh-ancestor
65168919|NCT02213497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168920|NCT02213497|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65168921|NCT02193841|Calcium|calcium|mesh-list
65168922|NCT02193841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65168923|NCT02193841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168924|NCT00618163|Meloxicam|meloxicam|mesh-list
65168925|NCT00618163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65168926|NCT00618163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65168927|NCT00618163|Analgesics|analgesics|mesh-ancestor
65168928|NCT00618163|Sensory System Agents|sensory system agents|mesh-ancestor
65168929|NCT00618163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65321918|NCT00455143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65321919|NCT00455143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321920|NCT00455143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65321921|NCT00455143|Analgesics|analgesics|mesh-ancestor
65321922|NCT00455143|Sensory System Agents|sensory system agents|mesh-ancestor
65321923|NCT00455143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65321924|NCT00455143|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65321925|NCT00455143|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65321926|NCT00455143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65321927|NCT00455143|Adrenergic Agents|adrenergic agents|mesh-ancestor
65321928|NCT00455143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65321929|NCT00455143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321930|NCT00724893|Interferons|interferons|mesh-list
65321931|NCT00724893|Ribavirin|ribavirin|mesh-list
65321932|NCT00724893|Interferon-alpha|interferon-alpha|mesh-list
65321933|NCT00724893|Interferon alpha-2|interferon alpha-2|mesh-list
65321934|NCT00724893|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65321935|NCT00724893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321936|NCT00724893|Antiviral Agents|antiviral agents|mesh-ancestor
65321937|NCT00724893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65321938|NCT00724893|Antimetabolites|antimetabolites|mesh-ancestor
65321939|NCT00724893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321940|NCT00724893|Immunologic Factors|immunologic factors|mesh-ancestor
65321941|NCT00724893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321942|NCT00789698|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65321943|NCT00789698|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65168930|NCT00618163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168931|NCT00618163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65168932|NCT00618163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65168933|NCT00618163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65168934|NCT00618163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65168935|NCT00618163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168936|NCT00618163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168937|NCT00618241|Raltegravir Potassium|raltegravir potassium|mesh-list
65168938|NCT00618241|Lamotrigine|lamotrigine|mesh-list
65168939|NCT00618241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65168940|NCT00618241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65168941|NCT00618241|Antiviral Agents|antiviral agents|mesh-ancestor
65168942|NCT00618241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65168943|NCT00618241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65168944|NCT00618241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65168945|NCT00618241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168946|NCT00618241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168947|NCT00618241|Anticonvulsants|anticonvulsants|mesh-ancestor
65168948|NCT00618241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65168949|NCT00618241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65168950|NCT00618241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65321944|NCT00789698|Antidepressive Agents|antidepressive agents|mesh-ancestor
65321945|NCT00789698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65321946|NCT00789698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65321947|NCT00789698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65321948|NCT00789698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65321949|NCT00789698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321950|NCT00789698|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65321951|NCT00789698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65321952|NCT00789698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65321953|NCT00789698|Adrenergic Agents|adrenergic agents|mesh-ancestor
65321954|NCT00789698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65321955|NCT00789698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321956|NCT00789698|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65321957|NCT00789698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65321958|NCT00789698|Serotonin Agents|serotonin agents|mesh-ancestor
65321959|NCT00789698|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65321960|NCT00789698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65321961|NCT00789698|Dopamine Agents|dopamine agents|mesh-ancestor
65321962|NCT00724815|Sumatriptan|sumatriptan|mesh-list
65321963|NCT00724815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65321964|NCT00724815|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65168951|NCT00618241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168952|NCT00618241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65168953|NCT00618241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65168954|NCT00618241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65168955|NCT00618241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65168956|NCT00618241|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65168957|NCT00618397|Ketamine|ketamine|mesh-list
65168958|NCT00618397|Analgesics|analgesics|mesh-ancestor
65168959|NCT00618397|Sensory System Agents|sensory system agents|mesh-ancestor
65168960|NCT00618397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65168961|NCT00618397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168962|NCT00618397|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65168963|NCT00618397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65168970|NCT00618397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168972|NCT04211545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65168973|NCT04211545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65168974|NCT04211545|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65168975|NCT04211545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168976|NCT04211545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168977|NCT00620581|Paroxetine|paroxetine|mesh-list
65168978|NCT00620581|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65168979|NCT00620581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65168980|NCT00620581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65168981|NCT00620581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168982|NCT00620581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65168983|NCT00620581|Serotonin Agents|serotonin agents|mesh-ancestor
65168984|NCT00620581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168985|NCT00620581|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65321965|NCT00724815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65321966|NCT00724815|Serotonin Agents|serotonin agents|mesh-ancestor
65321967|NCT00724815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65321968|NCT00724815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321969|NCT00724815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321970|NCT00798590|Glucagon|glucagon|mesh-list
65321971|NCT00798590|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65321972|NCT00798590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65321973|NCT00798590|Hormones|hormones|mesh-ancestor
65321974|NCT00798590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65321975|NCT00798590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071964|NCT00328029|Busulfan|busulfan|mesh-list
65321977|NCT00481195|Modafinil|modafinil|mesh-list
65321978|NCT00481195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65321979|NCT00481195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65321980|NCT00481195|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65321981|NCT00481195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65321982|NCT00481195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65321983|NCT00481195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321984|NCT03604549|Ethiodized Oil|ethiodized oil|mesh-list
65321985|NCT03604549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65321986|NCT01027429|Amoxicillin|amoxicillin|mesh-list
65321987|NCT01027429|Gentamicins|gentamicins|mesh-list
65321988|NCT01027429|Penicillins|penicillins|mesh-list
65321989|NCT01027429|Penicillin G Procaine|penicillin g procaine|mesh-list
65321990|NCT01027429|Penicillin G|penicillin g|mesh-list
65321991|NCT01027429|Penicillin G Benzathine|penicillin g benzathine|mesh-list
65321992|NCT01027429|Procaine|procaine|mesh-list
65321993|NCT01027429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65321994|NCT01027429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65321995|NCT01027429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65168986|NCT00620581|Antidepressive Agents|antidepressive agents|mesh-ancestor
65168987|NCT00620581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65168988|NCT00620581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65168989|NCT00620581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65168990|NCT00620581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168991|NCT01000311|Vaccines|vaccines|mesh-list
65168992|NCT01000311|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65168993|NCT01000311|Immunologic Factors|immunologic factors|mesh-ancestor
65168994|NCT01000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168995|NCT04209439|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65168996|NCT04209439|Bupivacaine|bupivacaine|mesh-list
65168997|NCT04209439|Anesthetics, Local|anesthetics, local|mesh-ancestor
65321996|NCT01027429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65321997|NCT01027429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65321998|NCT01027429|Anesthetics, Local|anesthetics, local|mesh-ancestor
65321999|NCT01027429|Anesthetics|anesthetics|mesh-ancestor
65322000|NCT01027429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65322001|NCT01027429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322002|NCT01027429|Sensory System Agents|sensory system agents|mesh-ancestor
65322003|NCT01027429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65322004|NCT01020253|Alendronate|alendronate|mesh-list
65322005|NCT01020253|Alfacalcidol|alfacalcidol|mesh-list
65322006|NCT01020253|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65322007|NCT01020253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65322008|NCT01020253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322009|NCT01020253|Vitamins|vitamins|mesh-ancestor
65322010|NCT01020253|Micronutrients|micronutrients|mesh-ancestor
65322011|NCT00454207|Sildenafil Citrate|sildenafil citrate|mesh-list
65322012|NCT00454207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322013|NCT00454207|Vasodilator Agents|vasodilator agents|mesh-ancestor
65322014|NCT00454207|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65322015|NCT00454207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65322016|NCT00454207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322017|NCT00454207|Urological Agents|urological agents|mesh-ancestor
65322018|NCT01020331|Memantine|memantine|mesh-list
65322019|NCT01020331|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65322020|NCT01020331|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65322021|NCT01020331|Dopamine Agents|dopamine agents|mesh-ancestor
65322022|NCT01020331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65322023|NCT01020331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322024|NCT01020331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322026|NCT01020331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65322038|NCT00738894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65322039|NCT00738894|Vasodilator Agents|vasodilator agents|mesh-ancestor
65322040|NCT00734994|Mitomycins|mitomycins|mesh-list
65322041|NCT00734994|Mitomycin|mitomycin|mesh-list
65322042|NCT00734994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65322043|NCT00734994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65322044|NCT00734994|Alkylating Agents|alkylating agents|mesh-ancestor
65322045|NCT00734994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322046|NCT00734994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65322047|NCT00734994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322048|NCT02593734|Olanzapine|olanzapine|mesh-list
65322049|NCT02593734|Risperidone|risperidone|mesh-list
65322050|NCT02593734|Fluoxetine|fluoxetine|mesh-list
65322051|NCT02593734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65322052|NCT02593734|Serotonin Agents|serotonin agents|mesh-ancestor
65322053|NCT02593734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65322054|NCT02593734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322055|NCT02593734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322056|NCT02593734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65322057|NCT02593734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65322058|NCT02593734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65322059|NCT02593734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65322060|NCT02593734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65322061|NCT02593734|Dopamine Agents|dopamine agents|mesh-ancestor
65322062|NCT02593734|Antiemetics|antiemetics|mesh-ancestor
65322063|NCT02593734|Autonomic Agents|autonomic agents|mesh-ancestor
65322064|NCT02593734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65322065|NCT02593734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65322066|NCT02593734|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64551844|NCT02641080|Aspirin|aspirin|mesh-list
65168998|NCT04209439|Anesthetics|anesthetics|mesh-ancestor
65168999|NCT04209439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65169000|NCT04209439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169001|NCT04209439|Sensory System Agents|sensory system agents|mesh-ancestor
65169002|NCT04209439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65169003|NCT04209439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65169004|NCT04209439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65169005|NCT04209439|Analgesics|analgesics|mesh-ancestor
65169006|NCT04209439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65169007|NCT04209439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65169008|NCT05228041|Benralizumab|benralizumab|mesh-list
65169009|NCT05228041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65169010|NCT05228041|Respiratory System Agents|respiratory system agents|mesh-ancestor
65169011|NCT01003899|Afatinib|afatinib|mesh-list
65169012|NCT01003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169013|NCT01003899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65169014|NCT01003899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322067|NCT02593734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65322068|NCT02593734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65322069|NCT02593734|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65322070|NCT02593734|Antidepressive Agents|antidepressive agents|mesh-ancestor
65322071|NCT02593734|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65322072|NCT02593734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65322073|NCT02593734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322074|NCT00798434|Fesoterodine|fesoterodine|mesh-list
65322075|NCT00798434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65322076|NCT00798434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65322077|NCT00798434|Cholinergic Agents|cholinergic agents|mesh-ancestor
65322078|NCT00798434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65322079|NCT00798434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322080|NCT00798434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322081|NCT00798434|Urological Agents|urological agents|mesh-ancestor
65322082|NCT04106804|Abatacept|abatacept|mesh-list
65322083|NCT04106804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65322084|NCT04106804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322085|NCT04106804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65322086|NCT04106804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65322087|NCT04106804|Immunologic Factors|immunologic factors|mesh-ancestor
65322088|NCT04106804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551875|NCT04015739|Durvalumab|durvalumab|mesh-list
65169015|NCT01003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169016|NCT04160377|Fluvoxamine|fluvoxamine|mesh-list
65169017|NCT04160377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169018|NCT04160377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169019|NCT04160377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65169020|NCT04160377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65169021|NCT04160377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65169022|NCT04160377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169023|NCT04160377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65169024|NCT04160377|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65169025|NCT04160377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65169026|NCT04160377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65169027|NCT04160377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65169028|NCT04160377|Serotonin Agents|serotonin agents|mesh-ancestor
65169035|NCT01000155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169036|NCT01000155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65169037|NCT01000155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169038|NCT01000155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169039|NCT00999921|Tamoxifen|tamoxifen|mesh-list
65169040|NCT00999921|Evening primrose oil|evening primrose oil|mesh-list
65169041|NCT00999921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65169042|NCT00999921|Hormone Antagonists|hormone antagonists|mesh-ancestor
65169043|NCT00999921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65169044|NCT00999921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169045|NCT00999921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65322089|NCT04106804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65322090|NCT00791648|Atorvastatin|atorvastatin|mesh-list
65322091|NCT00791648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65322092|NCT00791648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65322093|NCT00791648|Antimetabolites|antimetabolites|mesh-ancestor
65322094|NCT00791648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322095|NCT00791648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65322096|NCT00791648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65322097|NCT00791648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322098|NCT05366595|Zinc Sulfate|zinc sulfate|mesh-list
65322099|NCT05366595|Astringents|astringents|mesh-ancestor
65322100|NCT05366595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322101|NCT05366595|Dermatologic Agents|dermatologic agents|mesh-ancestor
65322102|NCT04087239|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65322103|NCT04087239|Antiviral Agents|antiviral agents|mesh-ancestor
65322104|NCT04087239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65322105|NCT04017338|Ezetimibe|ezetimibe|mesh-list
65322106|NCT04017338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65322107|NCT04017338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65322108|NCT04017338|Antimetabolites|antimetabolites|mesh-ancestor
64551896|NCT01876771|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65169046|NCT00999921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169047|NCT00999921|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65169048|NCT00999921|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65169049|NCT00999921|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65169050|NCT00999921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65169051|NCT00999921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65169052|NCT00999921|Analgesics|analgesics|mesh-ancestor
65169053|NCT00999921|Sensory System Agents|sensory system agents|mesh-ancestor
65169054|NCT00999921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65169055|NCT00999921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65169056|NCT00999921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65169057|NCT00999921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65169058|NCT00999921|Antimetabolites|antimetabolites|mesh-ancestor
65169059|NCT00999921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169060|NCT00999921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65169061|NCT00999921|Dermatologic Agents|dermatologic agents|mesh-ancestor
65169062|NCT02869347|Complement C1s|complement c1s|mesh-list
65169063|NCT02869347|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
65169064|NCT02869347|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
65169065|NCT02869347|Immunologic Factors|immunologic factors|mesh-ancestor
65169066|NCT02869347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169067|NCT02869347|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65169068|NCT02869347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65169069|NCT00621673|Factor VIII|factor viii|mesh-list
65169070|NCT00621673|Coagulants|coagulants|mesh-ancestor
65169071|NCT01002573|Acetaminophen|acetaminophen|mesh-list
65169072|NCT01002573|Ibuprofen|ibuprofen|mesh-list
65169073|NCT01002573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65169074|NCT01002573|Analgesics|analgesics|mesh-ancestor
65169075|NCT01002573|Sensory System Agents|sensory system agents|mesh-ancestor
65169076|NCT01002573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65169077|NCT01002573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169078|NCT01002573|Antipyretics|antipyretics|mesh-ancestor
65169079|NCT01002573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65322109|NCT04017338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322110|NCT04017338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65322111|NCT04106726|Ivermectin|ivermectin|mesh-list
65322112|NCT04106726|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65322113|NCT04106726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65322114|NCT03998774|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
65322115|NCT03998774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65322116|NCT03998774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65322117|NCT03998774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322118|NCT03998774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65322119|NCT00723957|Paclitaxel|paclitaxel|mesh-list
65322120|NCT00723957|Carboplatin|carboplatin|mesh-list
65322121|NCT00723957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65322122|NCT00723957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65322123|NCT00723957|Tubulin Modulators|tubulin modulators|mesh-ancestor
65322124|NCT00723957|Antimitotic Agents|antimitotic agents|mesh-ancestor
65072100|NCT00328458|Epothilones|epothilones|mesh-list
65322125|NCT00723957|Mitosis Modulators|mitosis modulators|mesh-ancestor
65322126|NCT00723957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322127|NCT02603822|Indomethacin|indomethacin|mesh-list
65322128|NCT02603822|Mannitol|mannitol|mesh-list
65322129|NCT02603822|Lactulose|lactulose|mesh-list
65322130|NCT02603822|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65322131|NCT02603822|Diuretics|diuretics|mesh-ancestor
65322132|NCT02603822|Natriuretic Agents|natriuretic agents|mesh-ancestor
65322133|NCT02603822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322134|NCT02603822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65322135|NCT02603822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65169080|NCT01002573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65169081|NCT01002573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65169082|NCT01002573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65169083|NCT01002573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169084|NCT01002573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169085|NCT00620893|Lubricant Eye Drops|lubricant eye drops|mesh-list
65169086|NCT00620893|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65169087|NCT00620893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65169088|NCT04293549|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65169089|NCT04293549|Mitogens|mitogens|mesh-list
65169090|NCT04293549|Mitosis Modulators|mitosis modulators|mesh-ancestor
65169091|NCT04293549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169092|NCT04293549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65169093|NCT00996333|Gemcitabine|gemcitabine|mesh-list
65169094|NCT00996333|Capecitabine|capecitabine|mesh-list
65169095|NCT00996333|Docetaxel|docetaxel|mesh-list
65169103|NCT00996333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65169104|NCT00996333|Immunologic Factors|immunologic factors|mesh-ancestor
65169105|NCT00996333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169106|NCT00996333|Tubulin Modulators|tubulin modulators|mesh-ancestor
65169107|NCT00996333|Antimitotic Agents|antimitotic agents|mesh-ancestor
65322136|NCT02603822|Analgesics|analgesics|mesh-ancestor
65322137|NCT02603822|Sensory System Agents|sensory system agents|mesh-ancestor
65322138|NCT02603822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65322139|NCT02603822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65322140|NCT02603822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65322141|NCT02603822|Gout Suppressants|gout suppressants|mesh-ancestor
65322142|NCT02603822|Tocolytic Agents|tocolytic agents|mesh-ancestor
65322143|NCT02603822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65322144|NCT02603822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65322145|NCT02603822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322146|NCT02603822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322147|NCT02603822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65322148|NCT02592057|Sofosbuvir|sofosbuvir|mesh-list
65322149|NCT02592057|Antiviral Agents|antiviral agents|mesh-ancestor
65322150|NCT02592057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65322151|NCT00723801|Losartan|losartan|mesh-list
65322152|NCT00723801|Atenolol|atenolol|mesh-list
65322153|NCT00723801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65322154|NCT00723801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65322155|NCT00723801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65169108|NCT00996333|Mitosis Modulators|mitosis modulators|mesh-ancestor
65169110|NCT00621907|Anesthetics, Local|anesthetics, local|mesh-ancestor
65169111|NCT00621907|Anesthetics|anesthetics|mesh-ancestor
65169112|NCT00621907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65169113|NCT00621907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169114|NCT00621907|Sensory System Agents|sensory system agents|mesh-ancestor
65169115|NCT00621907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65169116|NCT01349101|Mycophenolic Acid|mycophenolic acid|mesh-list
65169117|NCT01349101|Cyclophosphamide|cyclophosphamide|mesh-list
65169118|NCT01349101|Busulfan|busulfan|mesh-list
65169119|NCT01349101|Fludarabine|fludarabine|mesh-list
65169120|NCT01349101|Fludarabine phosphate|fludarabine phosphate|mesh-list
65169121|NCT01349101|Tacrolimus|tacrolimus|mesh-list
65169122|NCT01349101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65169123|NCT01349101|Immunologic Factors|immunologic factors|mesh-ancestor
65169124|NCT01349101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169125|NCT01349101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65169126|NCT01349101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65169127|NCT01349101|Alkylating Agents|alkylating agents|mesh-ancestor
65169128|NCT01349101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169129|NCT01349101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169130|NCT01349101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65169131|NCT01349101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65169132|NCT01349101|Antimetabolites|antimetabolites|mesh-ancestor
65169133|NCT01349101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65169134|NCT01349101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65169135|NCT01349101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169136|NCT01349101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65169137|NCT01349101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65169138|NCT01349101|Antitubercular Agents|antitubercular agents|mesh-ancestor
65169139|NCT01349101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65169140|NCT00620971|Gemcitabine|gemcitabine|mesh-list
65169141|NCT00620971|Bevacizumab|bevacizumab|mesh-list
65169142|NCT00620971|Cisplatin|cisplatin|mesh-list
65169143|NCT00620971|Docetaxel|docetaxel|mesh-list
65169144|NCT00620971|Vinorelbine|vinorelbine|mesh-list
65169145|NCT00620971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65169146|NCT00620971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65322156|NCT00723801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65322157|NCT00723801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322158|NCT00723801|Sympatholytics|sympatholytics|mesh-ancestor
65322159|NCT00723801|Autonomic Agents|autonomic agents|mesh-ancestor
65322160|NCT00723801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65322161|NCT00723801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322162|NCT00723801|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65322163|NCT00723801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65322164|NCT00723801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65322165|NCT00723801|Adrenergic Agents|adrenergic agents|mesh-ancestor
65322166|NCT00723801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65322167|NCT00797966|Citalopram|citalopram|mesh-list
65322168|NCT00797966|Fluoxetine|fluoxetine|mesh-list
65322169|NCT00797966|Paroxetine|paroxetine|mesh-list
65322170|NCT00797966|Sertraline|sertraline|mesh-list
65322171|NCT00797966|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65322172|NCT00797966|Brexpiprazole|brexpiprazole|mesh-list
65322173|NCT00797966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65322174|NCT00797966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64551959|NCT01389323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551960|NCT01389323|Antiviral Agents|antiviral agents|mesh-ancestor
64551961|NCT01389323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64551962|NCT01389323|Antimetabolites|antimetabolites|mesh-ancestor
64551963|NCT01389323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169147|NCT00620971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65169148|NCT00620971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65169149|NCT00620971|Growth Substances|growth substances|mesh-ancestor
65169150|NCT00620971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169151|NCT00620971|Growth Inhibitors|growth inhibitors|mesh-ancestor
65169152|NCT00620971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65169153|NCT00620971|Antimetabolites|antimetabolites|mesh-ancestor
65169154|NCT00620971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169155|NCT00620971|Antiviral Agents|antiviral agents|mesh-ancestor
65169156|NCT00620971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65169157|NCT00620971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169158|NCT00620971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65169159|NCT00620971|Immunologic Factors|immunologic factors|mesh-ancestor
65169160|NCT00620971|Tubulin Modulators|tubulin modulators|mesh-ancestor
65169161|NCT00620971|Antimitotic Agents|antimitotic agents|mesh-ancestor
65169162|NCT00620971|Mitosis Modulators|mitosis modulators|mesh-ancestor
65169163|NCT00620971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65169164|NCT04223661|Dexamethasone|dexamethasone|mesh-list
65169165|NCT04223661|Lenalidomide|lenalidomide|mesh-list
65169175|NCT04223661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65169176|NCT04223661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65169177|NCT04223661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169178|NCT04223661|Immunologic Factors|immunologic factors|mesh-ancestor
65169179|NCT04223661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65169180|NCT04223661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65169181|NCT04223661|Growth Substances|growth substances|mesh-ancestor
65322175|NCT00797966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65322176|NCT00797966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322177|NCT00797966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65322178|NCT00797966|Serotonin Agents|serotonin agents|mesh-ancestor
65322179|NCT00797966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322180|NCT00797966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65322181|NCT00797966|Antidepressive Agents|antidepressive agents|mesh-ancestor
65322182|NCT00797966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65322183|NCT00797966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65322184|NCT00797966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65322185|NCT00797966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322186|NCT00797966|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65169182|NCT04223661|Growth Inhibitors|growth inhibitors|mesh-ancestor
65169183|NCT04268277|Rituximab|rituximab|mesh-list
65169184|NCT04268277|Pembrolizumab|pembrolizumab|mesh-list
65169185|NCT04268277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65169186|NCT04268277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169187|NCT04268277|Immunologic Factors|immunologic factors|mesh-ancestor
65169188|NCT04268277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169189|NCT04268277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65169191|NCT00622141|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65169192|NCT00622141|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65169193|NCT00622141|Protease Inhibitors|protease inhibitors|mesh-ancestor
65169194|NCT00622141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169195|NCT00622141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169196|NCT00622141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65169197|NCT00622141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65169198|NCT00622141|Antiviral Agents|antiviral agents|mesh-ancestor
65169199|NCT00622141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65169200|NCT00622141|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65169201|NCT00622141|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65169202|NCT04210765|Clomiphene|clomiphene|mesh-list
65169203|NCT04210765|Enclomiphene|enclomiphene|mesh-list
65169204|NCT04210765|Zuclomiphene|zuclomiphene|mesh-list
65169205|NCT04210765|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65169206|NCT04210765|Hormone Antagonists|hormone antagonists|mesh-ancestor
65169207|NCT04210765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65169208|NCT04210765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169209|NCT04210765|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65169210|NCT04210765|Fertility Agents|fertility agents|mesh-ancestor
65169211|NCT04210765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65169212|NCT04210765|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65169213|NCT04210765|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65169214|NCT03735901|Levodopa|levodopa|mesh-list
65169215|NCT03735901|Carbidopa|carbidopa|mesh-list
65169216|NCT03735901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65169217|NCT03735901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65169218|NCT03735901|Dopamine Agents|dopamine agents|mesh-ancestor
65169219|NCT03735901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65169220|NCT03735901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169221|NCT03735901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169222|NCT03735901|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65169223|NCT03735901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169224|NCT00621283|Secretin|secretin|mesh-list
65169225|NCT00621283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65169226|NCT00621283|Hormones|hormones|mesh-ancestor
65169227|NCT00621283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65169228|NCT00621283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169229|NCT00995709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65322187|NCT00797966|Dopamine Agonists|dopamine agonists|mesh-ancestor
65322188|NCT00797966|Dopamine Agents|dopamine agents|mesh-ancestor
65322189|NCT05361837|Dexmedetomidine|dexmedetomidine|mesh-list
65322190|NCT05361837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65322191|NCT05361837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65322192|NCT05361837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322193|NCT05361837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65322194|NCT05361837|Analgesics|analgesics|mesh-ancestor
65322195|NCT05361837|Sensory System Agents|sensory system agents|mesh-ancestor
65322196|NCT05361837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65322197|NCT05361837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65322198|NCT05361837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65072182|NCT04998669|Rituximab|rituximab|mesh-list
65322199|NCT05361837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65322200|NCT05361837|Adrenergic Agents|adrenergic agents|mesh-ancestor
64551980|NCT05314569|Analgesics|analgesics|mesh-ancestor
64551981|NCT05314569|Sensory System Agents|sensory system agents|mesh-ancestor
64551982|NCT05314569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64551983|NCT05314569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64551984|NCT05314569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64551985|NCT05314569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64551986|NCT05314569|Adrenergic Agents|adrenergic agents|mesh-ancestor
64551987|NCT05314569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64551988|NCT05314569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551989|NCT05314569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64551990|NCT05314569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64551991|NCT05314569|Anesthetics, General|anesthetics, general|mesh-ancestor
64551992|NCT05314569|Anesthetics|anesthetics|mesh-ancestor
65169230|NCT00995709|Immunologic Factors|immunologic factors|mesh-ancestor
65169231|NCT00995709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169245|NCT00621361|Cediranib|cediranib|mesh-list
65169246|NCT00621361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169247|NCT00621361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65169248|NCT00621361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65169249|NCT00621361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65169250|NCT00621361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169251|NCT00621361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169252|NCT00621361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65169253|NCT05661643|Temozolomide|temozolomide|mesh-list
65169254|NCT05661643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65169255|NCT05661643|Alkylating Agents|alkylating agents|mesh-ancestor
65169256|NCT05661643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169257|NCT05661643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169258|NCT04208581|Fluticasone|fluticasone|mesh-list
65169259|NCT04208581|Xhance|xhance|mesh-list
65322201|NCT05361837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65322202|NCT05361837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322203|NCT00723255|Sirolimus|sirolimus|mesh-list
65322204|NCT00723255|Bevacizumab|bevacizumab|mesh-list
65322205|NCT00723255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65322206|NCT00723255|Antibodies|antibodies|mesh-list
65322207|NCT00723255|Immunoglobulins|immunoglobulins|mesh-list
65322208|NCT00723255|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65322209|NCT00723255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65322210|NCT00723255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65322211|NCT00723255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65322212|NCT00723255|Growth Substances|growth substances|mesh-ancestor
65322213|NCT00723255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322214|NCT00723255|Growth Inhibitors|growth inhibitors|mesh-ancestor
65322215|NCT00723255|Immunologic Factors|immunologic factors|mesh-ancestor
65322216|NCT00723255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65322217|NCT00723255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65169260|NCT04208581|Budesonide|budesonide|mesh-list
65169261|NCT04208581|Bromides|bromides|mesh-list
65169262|NCT04208581|Formoterol Fumarate|formoterol fumarate|mesh-list
65169263|NCT04208581|Tiotropium Bromide|tiotropium bromide|mesh-list
64811872|NCT01449617|Antipyretics|antipyretics|mesh-ancestor
65169264|NCT04208581|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65169265|NCT04208581|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65169266|NCT04208581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65169267|NCT04208581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65169268|NCT04208581|Autonomic Agents|autonomic agents|mesh-ancestor
65169269|NCT04208581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65169270|NCT04208581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169271|NCT04208581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65169272|NCT04208581|Respiratory System Agents|respiratory system agents|mesh-ancestor
65169273|NCT04208581|Dermatologic Agents|dermatologic agents|mesh-ancestor
65169274|NCT04208581|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65169275|NCT04208581|Glucocorticoids|glucocorticoids|mesh-ancestor
65169276|NCT04208581|Hormones|hormones|mesh-ancestor
65169277|NCT04208581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65169278|NCT04208581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65169279|NCT04208581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65169280|NCT04208581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65169281|NCT04208581|Adrenergic Agents|adrenergic agents|mesh-ancestor
65169282|NCT04208581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65169283|NCT04208581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169284|NCT04208581|Parasympatholytics|parasympatholytics|mesh-ancestor
65169285|NCT04208581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65169286|NCT04208581|Cholinergic Agents|cholinergic agents|mesh-ancestor
65169287|NCT04208581|Anticonvulsants|anticonvulsants|mesh-ancestor
65169288|NCT05368753|Lidocaine|lidocaine|mesh-list
65169289|NCT05368753|Ropivacaine|ropivacaine|mesh-list
65169290|NCT05368753|Anesthetics, Local|anesthetics, local|mesh-ancestor
65169291|NCT05368753|Anesthetics|anesthetics|mesh-ancestor
65169292|NCT05368753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65169293|NCT05368753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169304|NCT05368675|Naloxone|naloxone|mesh-list
65169305|NCT05368675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65169306|NCT05368675|Narcotics|narcotics|mesh-ancestor
65169307|NCT05368675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65169308|NCT05368675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169309|NCT05368675|Analgesics|analgesics|mesh-ancestor
65169310|NCT05368675|Sensory System Agents|sensory system agents|mesh-ancestor
65322218|NCT00723255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65322219|NCT00723255|Antifungal Agents|antifungal agents|mesh-ancestor
65322220|NCT00723255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65322221|NCT00791258|Amlodipine|amlodipine|mesh-list
65322222|NCT00791258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65322223|NCT00791258|Olmesartan|olmesartan|mesh-list
65322224|NCT00791258|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65322225|NCT00791258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65322226|NCT00791258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65322227|NCT00791258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65322228|NCT00791258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322229|NCT00791258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65322230|NCT00791258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552013|NCT03167905|Nitrous Oxide|nitrous oxide|mesh-list
64552014|NCT03167905|Ropivacaine|ropivacaine|mesh-list
64552015|NCT03167905|Entonox|entonox|mesh-list
64552016|NCT03167905|Anesthetics, Local|anesthetics, local|mesh-ancestor
64552017|NCT03167905|Anesthetics|anesthetics|mesh-ancestor
64552018|NCT03167905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64552019|NCT03167905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552020|NCT03167905|Sensory System Agents|sensory system agents|mesh-ancestor
64990603|NCT05126719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990604|NCT05126719|Tubulin Modulators|tubulin modulators|mesh-ancestor
64990605|NCT05126719|Antimitotic Agents|antimitotic agents|mesh-ancestor
64990606|NCT05126719|Mitosis Modulators|mitosis modulators|mesh-ancestor
64990607|NCT05126719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990608|NCT05126719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65169311|NCT05368675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65169312|NCT05368675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65169313|NCT05368675|Antitussive Agents|antitussive agents|mesh-ancestor
65169314|NCT05368675|Respiratory System Agents|respiratory system agents|mesh-ancestor
65169315|NCT05368207|Pembrolizumab|pembrolizumab|mesh-list
65169316|NCT05368207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65169317|NCT05368207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169318|NCT05368051|Capecitabine|capecitabine|mesh-list
65169319|NCT05368051|Antibodies|antibodies|mesh-list
65169320|NCT05368051|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65169321|NCT05368051|Immunologic Factors|immunologic factors|mesh-ancestor
65169322|NCT05368051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169323|NCT05368051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65169324|NCT05368051|Antimetabolites|antimetabolites|mesh-ancestor
65169325|NCT05368051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169326|NCT05368051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169327|NCT02641873|Leucovorin|leucovorin|mesh-list
65169328|NCT02641873|Bevacizumab|bevacizumab|mesh-list
65169329|NCT02641873|Irinotecan|irinotecan|mesh-list
65169330|NCT02641873|Levoleucovorin|levoleucovorin|mesh-list
65322231|NCT00791258|Vasodilator Agents|vasodilator agents|mesh-ancestor
65322232|NCT00791258|Diuretics|diuretics|mesh-ancestor
65322233|NCT00791258|Natriuretic Agents|natriuretic agents|mesh-ancestor
65322234|NCT00791258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65322235|NCT00791258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65322236|NCT00791258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65322237|NCT00808067|Dabigatran|dabigatran|mesh-list
65322238|NCT00808067|Antithrombins|antithrombins|mesh-ancestor
65322239|NCT00808067|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65322240|NCT00808067|Protease Inhibitors|protease inhibitors|mesh-ancestor
65322241|NCT00808067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322242|NCT00808067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322243|NCT00808067|Anticoagulants|anticoagulants|mesh-ancestor
65322244|NCT00723021|Zileuton|zileuton|mesh-list
65322245|NCT00723021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65322246|NCT00723021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65322247|NCT00723021|Analgesics|analgesics|mesh-ancestor
65322248|NCT00723021|Sensory System Agents|sensory system agents|mesh-ancestor
65322249|NCT00723021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65322250|NCT00723021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322251|NCT00723021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65322252|NCT00723021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65322253|NCT00723021|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65322254|NCT00723021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169331|NCT02641873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65169332|NCT02641873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169333|NCT02641873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65169334|NCT02641873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65169335|NCT02641873|Growth Substances|growth substances|mesh-ancestor
65169336|NCT02641873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169337|NCT02641873|Growth Inhibitors|growth inhibitors|mesh-ancestor
65169338|NCT02641873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65169339|NCT02641873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65169340|NCT02641873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169341|NCT02641873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169342|NCT02641873|Antidotes|antidotes|mesh-ancestor
65169343|NCT02641873|Protective Agents|protective agents|mesh-ancestor
65169344|NCT02641873|Vitamin B Complex|vitamin b complex|mesh-ancestor
65169345|NCT02641873|Vitamins|vitamins|mesh-ancestor
65169346|NCT02641873|Micronutrients|micronutrients|mesh-ancestor
65169347|NCT00998985|Grazoprevir|grazoprevir|mesh-list
65169348|NCT00998985|Antiviral Agents|antiviral agents|mesh-ancestor
65169349|NCT00998985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65169350|NCT05240391|Midodrine|midodrine|mesh-list
65169351|NCT05240391|Sympathomimetics|sympathomimetics|mesh-ancestor
65169352|NCT05240391|Autonomic Agents|autonomic agents|mesh-ancestor
65169353|NCT05240391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65169354|NCT05240391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169355|NCT05240391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65169356|NCT05240391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65169357|NCT05240391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65169358|NCT05240391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65322255|NCT00723021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322256|NCT00723021|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65322257|NCT00723021|Hormone Antagonists|hormone antagonists|mesh-ancestor
65322258|NCT00723021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65322259|NCT04087317|Acetaminophen|acetaminophen|mesh-list
65322260|NCT04087317|Ibuprofen|ibuprofen|mesh-list
65322261|NCT04087317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65322262|NCT04087317|Analgesics|analgesics|mesh-ancestor
65322263|NCT04087317|Sensory System Agents|sensory system agents|mesh-ancestor
65322264|NCT04087317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65322265|NCT04087317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322266|NCT04087317|Antipyretics|antipyretics|mesh-ancestor
65322267|NCT04087317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65322268|NCT04087317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65322269|NCT04087317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65322270|NCT04087317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65322271|NCT04087317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322272|NCT04087317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322273|NCT04309409|Nivolumab|nivolumab|mesh-list
64552042|NCT02638389|Sirolimus|sirolimus|mesh-list
65169369|NCT04294953|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65169370|NCT04294953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65169371|NCT04294953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65169372|NCT04294953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169373|NCT04294953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65169374|NCT04294953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169375|NCT04294953|Analgesics|analgesics|mesh-ancestor
65169376|NCT04294953|Sensory System Agents|sensory system agents|mesh-ancestor
65169377|NCT04294953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65169378|NCT04294953|Antidepressive Agents|antidepressive agents|mesh-ancestor
65169379|NCT04294953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65169380|NCT04294953|Dopamine Agents|dopamine agents|mesh-ancestor
65169381|NCT02869815|Methylene Blue|methylene blue|mesh-list
65169382|NCT02869815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169383|NCT02869815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169384|NCT04293081|Maleic acid|maleic acid|mesh-list
65169385|NCT04293081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169386|NCT04293081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169387|NCT04205643|Infliximab|infliximab|mesh-list
65169388|NCT04205643|Dermatologic Agents|dermatologic agents|mesh-ancestor
65169389|NCT04205643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65169390|NCT04205643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65169391|NCT02870907|Cyclophosphamide|cyclophosphamide|mesh-list
65169392|NCT02870907|Thiotepa|thiotepa|mesh-list
65169393|NCT02870907|Carboplatin|carboplatin|mesh-list
65169394|NCT02870907|Etoposide|etoposide|mesh-list
65169395|NCT02870907|Etoposide phosphate|etoposide phosphate|mesh-list
65169396|NCT02870907|Vincristine|vincristine|mesh-list
65169397|NCT02870907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65169398|NCT02870907|Immunologic Factors|immunologic factors|mesh-ancestor
65169399|NCT02870907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169400|NCT02870907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65169401|NCT02870907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65169402|NCT02870907|Alkylating Agents|alkylating agents|mesh-ancestor
65322274|NCT04309409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65322275|NCT04309409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65322276|NCT04309409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65322277|NCT04309409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322278|NCT04086537|Hepcidins|hepcidins|mesh-list
65322279|NCT04086537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65169403|NCT02870907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169404|NCT02870907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169405|NCT02870907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65169406|NCT02870907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65169407|NCT02870907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65169408|NCT02870907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65169409|NCT02870907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169410|NCT02870907|Tubulin Modulators|tubulin modulators|mesh-ancestor
65169411|NCT02870907|Antimitotic Agents|antimitotic agents|mesh-ancestor
65169412|NCT02870907|Mitosis Modulators|mitosis modulators|mesh-ancestor
65169413|NCT02868801|Pregabalin|pregabalin|mesh-list
64812020|NCT01453283|Alkylating Agents|alkylating agents|mesh-ancestor
65169414|NCT02868801|Analgesics|analgesics|mesh-ancestor
65169415|NCT02868801|Sensory System Agents|sensory system agents|mesh-ancestor
65169416|NCT02868801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65169417|NCT02868801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169418|NCT02868801|Anticonvulsants|anticonvulsants|mesh-ancestor
65169419|NCT02868801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65169420|NCT02868801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65169429|NCT01002339|Prednisone|prednisone|mesh-list
65169430|NCT01002339|Tacrolimus|tacrolimus|mesh-list
65169431|NCT01002339|Basiliximab|basiliximab|mesh-list
65169432|NCT01002339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65169433|NCT01002339|Immunologic Factors|immunologic factors|mesh-ancestor
65169434|NCT01002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169435|NCT01002339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65169436|NCT01002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169437|NCT01002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169438|NCT01002339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65169439|NCT01002339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169440|NCT01002339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65169441|NCT01002339|Antitubercular Agents|antitubercular agents|mesh-ancestor
65169442|NCT01002339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65169443|NCT01002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65169444|NCT01002339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65169445|NCT01002339|Glucocorticoids|glucocorticoids|mesh-ancestor
65169446|NCT01002339|Hormones|hormones|mesh-ancestor
65169447|NCT01002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65169448|NCT01002339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65169449|NCT01002339|Antifungal Agents|antifungal agents|mesh-ancestor
65169450|NCT01002339|Dermatologic Agents|dermatologic agents|mesh-ancestor
65169451|NCT01002339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65169452|NCT01002105|Baclofen|baclofen|mesh-list
65169453|NCT01002105|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65169454|NCT01002105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169455|NCT01002105|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65169456|NCT01002105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65169457|NCT01002105|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65169458|NCT01002105|GABA Agonists|gaba agonists|mesh-ancestor
65169459|NCT01002105|GABA Agents|gaba agents|mesh-ancestor
65169460|NCT01002105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65169461|NCT01002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169462|NCT02605993|Ravulizumab|ravulizumab|mesh-list
65169463|NCT02605993|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65169464|NCT02605993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65169465|NCT02605993|Immunologic Factors|immunologic factors|mesh-ancestor
65169466|NCT02605993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169467|NCT00995085|Pyridoxine|pyridoxine|mesh-list
65169468|NCT00995085|Metadoxine|metadoxine|mesh-list
65169469|NCT00995085|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65169470|NCT00995085|Vitamin B Complex|vitamin b complex|mesh-ancestor
65169471|NCT00995085|Vitamins|vitamins|mesh-ancestor
65169472|NCT00995085|Micronutrients|micronutrients|mesh-ancestor
65322280|NCT02608619|Choline|choline|mesh-list
65322281|NCT02608619|Lipotropic Agents|lipotropic agents|mesh-ancestor
65322282|NCT02608619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65322283|NCT02608619|Antimetabolites|antimetabolites|mesh-ancestor
65322284|NCT02608619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322285|NCT02608619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65322286|NCT02608619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65322287|NCT02608619|Nootropic Agents|nootropic agents|mesh-ancestor
65322288|NCT05754203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65322289|NCT05754203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322290|NCT05754203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65322291|NCT02591667|Bevacizumab|bevacizumab|mesh-list
65169473|NCT00995085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169474|NCT00603733|Mesalamine|mesalamine|mesh-list
65169475|NCT00603733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65169476|NCT00603733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65169477|NCT00603733|Analgesics|analgesics|mesh-ancestor
65169478|NCT00603733|Sensory System Agents|sensory system agents|mesh-ancestor
65169479|NCT00603733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65169480|NCT00603733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169481|NCT00603733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65169482|NCT00603733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65169483|NCT02471911|Dexamethasone|dexamethasone|mesh-list
65169484|NCT02471911|Rituximab|rituximab|mesh-list
65169485|NCT02471911|Carboplatin|carboplatin|mesh-list
65169486|NCT02471911|Etoposide|etoposide|mesh-list
65169487|NCT02471911|Ifosfamide|ifosfamide|mesh-list
64812095|NCT01457508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65169495|NCT02471911|Autonomic Agents|autonomic agents|mesh-ancestor
65169496|NCT02471911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65169497|NCT02471911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65169498|NCT02471911|Glucocorticoids|glucocorticoids|mesh-ancestor
65169499|NCT02471911|Hormones|hormones|mesh-ancestor
65169500|NCT02471911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65169501|NCT02471911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65169502|NCT02471911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65169503|NCT02471911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65169504|NCT02471911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65169505|NCT02471911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169506|NCT02471911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169507|NCT02471911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65169508|NCT02471911|Alkylating Agents|alkylating agents|mesh-ancestor
65169509|NCT00622375|Mesalamine|mesalamine|mesh-list
65169510|NCT00622375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65169511|NCT00622375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65169512|NCT00622375|Analgesics|analgesics|mesh-ancestor
65169513|NCT00622375|Sensory System Agents|sensory system agents|mesh-ancestor
65169514|NCT00622375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65169515|NCT00622375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169516|NCT00622375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65169517|NCT00622375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65169518|NCT02691325|Charcoal|charcoal|mesh-list
65169519|NCT02691325|Nemiralisib|nemiralisib|mesh-list
65169520|NCT02691325|Antidotes|antidotes|mesh-ancestor
65169521|NCT02691325|Protective Agents|protective agents|mesh-ancestor
65169522|NCT02691325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169523|NCT02691325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65169524|NCT02691325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169525|NCT02691325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169526|NCT01678027|Clarithromycin|clarithromycin|mesh-list
65169527|NCT01678027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65169528|NCT01678027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65169529|NCT01678027|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65169530|NCT01678027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322292|NCT02591667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65322293|NCT02591667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65322294|NCT02591667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65322295|NCT02591667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65322296|NCT02591667|Growth Substances|growth substances|mesh-ancestor
65322297|NCT02591667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322298|NCT02591667|Growth Inhibitors|growth inhibitors|mesh-ancestor
65322299|NCT00807599|Dexamethasone|dexamethasone|mesh-list
65322300|NCT00807599|Dexamethasone acetate|dexamethasone acetate|mesh-list
65322301|NCT00807599|Lenalidomide|lenalidomide|mesh-list
65322302|NCT00807599|Melphalan|melphalan|mesh-list
65322303|NCT00807599|BB 1101|bb 1101|mesh-list
65322304|NCT00807599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65322305|NCT00807599|Antiemetics|antiemetics|mesh-ancestor
65322306|NCT00807599|Autonomic Agents|autonomic agents|mesh-ancestor
65322307|NCT00807599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65322308|NCT00807599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169531|NCT01678027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169532|NCT01678027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65169533|NCT01678027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65169534|NCT04360681|Lofexidine|lofexidine|mesh-list
65169535|NCT04360681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65169536|NCT04360681|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65169537|NCT04360681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169538|NCT04360681|Sensory System Agents|sensory system agents|mesh-ancestor
65169539|NCT04360681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65169540|NCT04360681|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65169541|NCT04360681|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65169542|NCT04360681|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65169543|NCT04360681|Adrenergic Agents|adrenergic agents|mesh-ancestor
65169544|NCT04360681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65169545|NCT04360681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169546|NCT04340947|Nicotine|nicotine|mesh-list
65169547|NCT04340947|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65169548|NCT04340947|Autonomic Agents|autonomic agents|mesh-ancestor
65169549|NCT04340947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65169550|NCT04340947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169551|NCT04340947|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65169552|NCT04340947|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65169553|NCT04340947|Cholinergic Agents|cholinergic agents|mesh-ancestor
65169563|NCT04278625|Analgesics|analgesics|mesh-ancestor
65169564|NCT04278625|Sensory System Agents|sensory system agents|mesh-ancestor
65169565|NCT04278625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65169566|NCT04278625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169567|NCT04278625|Antipyretics|antipyretics|mesh-ancestor
65169568|NCT02689141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65169569|NCT02689141|Ofatumumab|ofatumumab|mesh-list
65169570|NCT02689141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65169571|NCT02689141|Alkylating Agents|alkylating agents|mesh-ancestor
65169572|NCT02689141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169573|NCT02689141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169574|NCT00622687|Iloprost|iloprost|mesh-list
65169575|NCT00622687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65169576|NCT00622687|Vasodilator Agents|vasodilator agents|mesh-ancestor
65169577|NCT02691403|Bupivacaine|bupivacaine|mesh-list
65169578|NCT02691403|Levobupivacaine|levobupivacaine|mesh-list
65169579|NCT02691403|Anesthetics, Local|anesthetics, local|mesh-ancestor
65169580|NCT02691403|Anesthetics|anesthetics|mesh-ancestor
65169581|NCT02691403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65322309|NCT00807599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65322310|NCT00807599|Glucocorticoids|glucocorticoids|mesh-ancestor
65322311|NCT00807599|Hormones|hormones|mesh-ancestor
65322312|NCT00807599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65322313|NCT00807599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65322314|NCT00807599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65322315|NCT00807599|Protease Inhibitors|protease inhibitors|mesh-ancestor
65322316|NCT00807599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322317|NCT00807599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322318|NCT00807599|Immunologic Factors|immunologic factors|mesh-ancestor
65322319|NCT00807599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65322320|NCT00807599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65322321|NCT00807599|Growth Substances|growth substances|mesh-ancestor
65322322|NCT00807599|Growth Inhibitors|growth inhibitors|mesh-ancestor
65322323|NCT00807599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65322324|NCT00807599|Alkylating Agents|alkylating agents|mesh-ancestor
65322325|NCT00807599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65322326|NCT00807599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65322327|NCT00788372|Fentanyl|fentanyl|mesh-list
65322328|NCT00788372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65322329|NCT00788372|Narcotics|narcotics|mesh-ancestor
65322330|NCT00788372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64552100|NCT00882895|Antiemetics|antiemetics|mesh-ancestor
65169582|NCT02691403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169583|NCT02691403|Sensory System Agents|sensory system agents|mesh-ancestor
65169584|NCT02691403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65169585|NCT00995007|Carboplatin|carboplatin|mesh-list
65169586|NCT00995007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169587|NCT00909883|Botulinum Toxins|botulinum toxins|mesh-list
65169588|NCT00909883|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65169589|NCT00909883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65169590|NCT00909883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169591|NCT00909883|Cholinergic Agents|cholinergic agents|mesh-ancestor
65169592|NCT00909883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65169593|NCT00909883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169594|NCT00639925|Gemcitabine|gemcitabine|mesh-list
65169595|NCT00639925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65169596|NCT00639925|Antimetabolites|antimetabolites|mesh-ancestor
65169597|NCT00639925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169598|NCT00639925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169599|NCT00639925|Antiviral Agents|antiviral agents|mesh-ancestor
65169600|NCT00639925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65169601|NCT00639925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169602|NCT00639925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65169603|NCT00639925|Immunologic Factors|immunologic factors|mesh-ancestor
65169604|NCT00639925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169605|NCT00994461|Celecoxib|celecoxib|mesh-list
65169606|NCT00994461|Loxoprofen|loxoprofen|mesh-list
65169607|NCT00994461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65169608|NCT00994461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65169609|NCT00994461|Analgesics|analgesics|mesh-ancestor
65169610|NCT00994461|Sensory System Agents|sensory system agents|mesh-ancestor
65322331|NCT00788372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322332|NCT00788372|Analgesics|analgesics|mesh-ancestor
65322333|NCT00788372|Sensory System Agents|sensory system agents|mesh-ancestor
65322334|NCT00788372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65322335|NCT00788372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65322336|NCT00788372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65322337|NCT00788372|Anesthetics, General|anesthetics, general|mesh-ancestor
65322338|NCT00788372|Anesthetics|anesthetics|mesh-ancestor
65322339|NCT00738582|Pemetrexed|pemetrexed|mesh-list
65322340|NCT00738582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65322341|NCT00738582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322342|NCT00738582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322343|NCT00738582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65322344|NCT00738582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65322345|NCT05753657|Pioglitazone|pioglitazone|mesh-list
65322346|NCT05753657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65322347|NCT05753657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072329|NCT00332319|Casopitant|casopitant|mesh-list
65322348|NCT00720759|Cycloserine|cycloserine|mesh-list
65322349|NCT00720759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65322350|NCT00720759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65322351|NCT00720759|Renal Agents|renal agents|mesh-ancestor
65322352|NCT00720759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65322353|NCT00720759|Antitubercular Agents|antitubercular agents|mesh-ancestor
64552118|NCT00900237|Anticonvulsants|anticonvulsants|mesh-ancestor
65169611|NCT00994461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65169612|NCT00994461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169613|NCT00994461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65169614|NCT00994461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65169615|NCT00994461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65169616|NCT00994461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65169617|NCT00994461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169618|NCT00994461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169631|NCT01202591|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65169632|NCT01202591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65169633|NCT01202591|Hormone Antagonists|hormone antagonists|mesh-ancestor
65169634|NCT01202591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65169635|NCT01202591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169636|NCT01202591|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65169637|NCT01202591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65169638|NCT01202591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169639|NCT01202591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169640|NCT01202279|Phenylpropanolamine|phenylpropanolamine|mesh-list
65169641|NCT01202279|Pseudoephedrine|pseudoephedrine|mesh-list
65169642|NCT01202279|Guaifenesin|guaifenesin|mesh-list
65169643|NCT01202279|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
65169644|NCT01202279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65169645|NCT01202279|Autonomic Agents|autonomic agents|mesh-ancestor
65169646|NCT01202279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65322354|NCT00720759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65322355|NCT00720759|Antimetabolites|antimetabolites|mesh-ancestor
65322356|NCT00720759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322357|NCT00918411|Ramosetron|ramosetron|mesh-list
65322358|NCT00918411|Antiemetics|antiemetics|mesh-ancestor
65322359|NCT00918411|Autonomic Agents|autonomic agents|mesh-ancestor
65322360|NCT00918411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65322361|NCT00918411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322362|NCT00918411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65322363|NCT00918411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65322364|NCT00918411|Serotonin Agents|serotonin agents|mesh-ancestor
65322365|NCT00918411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65322366|NCT00918411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322367|NCT00810407|Rifabutin|rifabutin|mesh-list
65322368|NCT00810407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64552138|NCT04337827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552139|NCT04337827|Immunologic Factors|immunologic factors|mesh-ancestor
64552140|NCT04337827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552141|NCT04337827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64552142|NCT01494506|Leucovorin|leucovorin|mesh-list
64552143|NCT01494506|Fluorouracil|fluorouracil|mesh-list
64552144|NCT01494506|Antimetabolites|antimetabolites|mesh-ancestor
64552145|NCT01494506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552146|NCT01494506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64552147|NCT01494506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552148|NCT01494506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64552149|NCT01494506|Immunologic Factors|immunologic factors|mesh-ancestor
64552150|NCT01494506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552151|NCT01494506|Antidotes|antidotes|mesh-ancestor
64317190|NCT02409147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991163|NCT04704661|Immunologic Factors|immunologic factors|mesh-ancestor
64991164|NCT04704661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991165|NCT04685135|Docetaxel|docetaxel|mesh-list
64991237|NCT04616560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991238|NCT04616560|Immunologic Factors|immunologic factors|mesh-ancestor
64991239|NCT04616560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322369|NCT00810407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65322370|NCT00810407|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65322371|NCT00810407|Antitubercular Agents|antitubercular agents|mesh-ancestor
65322372|NCT00720057|Naproxen|naproxen|mesh-list
65322373|NCT00720057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65322374|NCT00720057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65322375|NCT00720057|Analgesics|analgesics|mesh-ancestor
65322376|NCT00720057|Sensory System Agents|sensory system agents|mesh-ancestor
65322377|NCT00720057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65322378|NCT00720057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322379|NCT00720057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65322380|NCT00720057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65322381|NCT00720057|Gout Suppressants|gout suppressants|mesh-ancestor
65322382|NCT00720057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65322383|NCT00720057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322384|NCT00720057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322385|NCT00790868|Cycloserine|cycloserine|mesh-list
65322386|NCT00790868|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65322387|NCT00790868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65322388|NCT00790868|Renal Agents|renal agents|mesh-ancestor
65322389|NCT00790868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65322390|NCT00790868|Antitubercular Agents|antitubercular agents|mesh-ancestor
65322391|NCT00790868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65322392|NCT00790868|Antimetabolites|antimetabolites|mesh-ancestor
65322393|NCT00790868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322394|NCT00719901|Bortezomib|bortezomib|mesh-list
65169647|NCT01202279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169648|NCT01202279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65169649|NCT01202279|Respiratory System Agents|respiratory system agents|mesh-ancestor
65169650|NCT01202279|Nasal Decongestants|nasal decongestants|mesh-ancestor
65169651|NCT01202279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65169652|NCT01202279|Sympathomimetics|sympathomimetics|mesh-ancestor
65169653|NCT01202279|Adrenergic Agents|adrenergic agents|mesh-ancestor
65169654|NCT01202279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65169655|NCT01202279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169656|NCT01202279|Expectorants|expectorants|mesh-ancestor
65169657|NCT01202279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65169658|NCT01202279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65169659|NCT01202279|Appetite Depressants|appetite depressants|mesh-ancestor
65169660|NCT01202279|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65169661|NCT03877315|Cimetidine|cimetidine|mesh-list
65169662|NCT03877315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65169663|NCT03877315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65169664|NCT03877315|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65169665|NCT03877315|Histamine Antagonists|histamine antagonists|mesh-ancestor
65169666|NCT03877315|Histamine Agents|histamine agents|mesh-ancestor
65169667|NCT03877315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65169668|NCT03877315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169669|NCT03877315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322395|NCT00719901|Obatoclax|obatoclax|mesh-list
65322396|NCT00719901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65322397|NCT00719901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322398|NCT00719901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322399|NCT02603276|Red yeast rice|red yeast rice|mesh-list
65322400|NCT02603276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65322401|NCT02603276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65322402|NCT02603276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65322403|NCT02603276|Antimetabolites|antimetabolites|mesh-ancestor
64552177|NCT02643420|Mitosis Modulators|mitosis modulators|mesh-ancestor
65169670|NCT03877315|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65169671|NCT03877315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65169672|NCT03877315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169673|NCT02687347|Morphine|morphine|mesh-list
65169674|NCT02687347|Methadone|methadone|mesh-list
65169675|NCT02687347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65169676|NCT02687347|Narcotics|narcotics|mesh-ancestor
65169677|NCT02687347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65169678|NCT02687347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169679|NCT02687347|Analgesics|analgesics|mesh-ancestor
65169687|NCT02687425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169688|NCT02687425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169689|NCT02687425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65169690|NCT02687425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169691|NCT02687425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169692|NCT02687269|Ranolazine|ranolazine|mesh-list
65169693|NCT02687269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65169694|NCT02687269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65169695|NCT02687269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169696|NCT02689297|Chlorine dioxide|chlorine dioxide|mesh-list
65169697|NCT02689297|Dental Disinfectants|dental disinfectants|mesh-ancestor
65169698|NCT02689297|Disinfectants|disinfectants|mesh-ancestor
65169699|NCT02689297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65169700|NCT01201811|Azacitidine|azacitidine|mesh-list
65169701|NCT01201811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65169702|NCT01201811|Antimetabolites|antimetabolites|mesh-ancestor
65169703|NCT01201811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169704|NCT01201811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169705|NCT01201811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169706|NCT04186897|Salicylic Acid|salicylic acid|mesh-list
65169707|NCT04186897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65169708|NCT04186897|Antifungal Agents|antifungal agents|mesh-ancestor
65169709|NCT04186897|Keratolytic Agents|keratolytic agents|mesh-ancestor
65169710|NCT04186897|Dermatologic Agents|dermatologic agents|mesh-ancestor
65169711|NCT05392127|Vitamin K|vitamin k|mesh-list
65169712|NCT05392127|Vitamin K 1|vitamin k 1|mesh-list
65169713|NCT05392127|Repaglinide|repaglinide|mesh-list
64812324|NCT01461772|Carboplatin|carboplatin|mesh-list
65169715|NCT05392127|Omeprazole|omeprazole|mesh-list
65169716|NCT05392127|Warfarin|warfarin|mesh-list
65169717|NCT05392127|Vitamins|vitamins|mesh-ancestor
65169718|NCT05392127|Micronutrients|micronutrients|mesh-ancestor
65169719|NCT05392127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169720|NCT05392127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65169721|NCT05392127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65169722|NCT05392127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65169723|NCT05392127|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65169724|NCT05392127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65169725|NCT05392127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65169726|NCT05392127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65169727|NCT05392127|Anesthetics, General|anesthetics, general|mesh-ancestor
65169728|NCT05392127|Anesthetics|anesthetics|mesh-ancestor
65169729|NCT05392127|GABA Modulators|gaba modulators|mesh-ancestor
65169730|NCT05392127|GABA Agents|gaba agents|mesh-ancestor
65169731|NCT05392127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65169732|NCT05392127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169733|NCT05392127|Anticoagulants|anticoagulants|mesh-ancestor
65322404|NCT02603276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322405|NCT02603276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322406|NCT02603276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65322407|NCT02591277|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
65322408|NCT02591277|Antiviral Agents|antiviral agents|mesh-ancestor
65322409|NCT02591277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65322410|NCT00807365|Hormones|hormones|mesh-list
65322411|NCT00807365|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
65322412|NCT00807365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65322413|NCT00807365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322414|NCT02609711|Candesartan|candesartan|mesh-list
65322415|NCT02609711|Candesartan cilexetil|candesartan cilexetil|mesh-list
65322416|NCT02609711|Atorvastatin|atorvastatin|mesh-list
65322417|NCT02609711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65322418|NCT02609711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65169734|NCT05392127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65169735|NCT05392127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65169736|NCT05392127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65169737|NCT05392127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169738|NCT05392127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65169739|NCT05392127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65169740|NCT05392127|Hemostatics|hemostatics|mesh-ancestor
65169741|NCT05392127|Coagulants|coagulants|mesh-ancestor
65169742|NCT05392127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65169743|NCT05378399|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65169744|NCT05378399|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65169745|NCT05378399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65169746|NCT05378399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65169747|NCT05378399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169748|NCT05378399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169749|NCT05378399|Antiviral Agents|antiviral agents|mesh-ancestor
65169756|NCT02685163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169758|NCT02685163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169759|NCT00640003|Baclofen|baclofen|mesh-list
65169760|NCT00640003|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65169761|NCT00640003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169762|NCT00640003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65169763|NCT00640003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65169764|NCT00640003|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65169765|NCT00640003|GABA Agonists|gaba agonists|mesh-ancestor
65169766|NCT00640003|GABA Agents|gaba agents|mesh-ancestor
65169767|NCT00640003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65169768|NCT00640003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169769|NCT01201343|Interferons|interferons|mesh-list
65169770|NCT01201343|Interferon-beta|interferon-beta|mesh-list
65169771|NCT01201343|Interferon beta-1a|interferon beta-1a|mesh-list
65169772|NCT01201343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169773|NCT01201343|Antiviral Agents|antiviral agents|mesh-ancestor
65169774|NCT01201343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65169775|NCT01201343|Immunologic Factors|immunologic factors|mesh-ancestor
65169776|NCT01201343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169777|NCT01201343|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65169778|NCT04185649|Capecitabine|capecitabine|mesh-list
65169779|NCT04185649|Lapatinib|lapatinib|mesh-list
65169780|NCT04185649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65169781|NCT04185649|Antimetabolites|antimetabolites|mesh-ancestor
65169782|NCT04185649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169783|NCT04185649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65322419|NCT02609711|Antimetabolites|antimetabolites|mesh-ancestor
65072401|NCT00304616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65322420|NCT02609711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322421|NCT02609711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65322422|NCT02609711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65322423|NCT02609711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322424|NCT02609711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65322425|NCT02609711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65322426|NCT02609711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65322427|NCT05748665|Etomidate|etomidate|mesh-list
65169784|NCT04185649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65169785|NCT04185649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169786|NCT01201265|Gemcitabine|gemcitabine|mesh-list
64812401|NCT01463046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169787|NCT01201265|Bevacizumab|bevacizumab|mesh-list
65169788|NCT01201265|Carboplatin|carboplatin|mesh-list
65169789|NCT01201265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65169790|NCT01201265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169791|NCT01201265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65169792|NCT01201265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65169793|NCT01201265|Growth Substances|growth substances|mesh-ancestor
65169794|NCT01201265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169795|NCT01201265|Growth Inhibitors|growth inhibitors|mesh-ancestor
65169796|NCT01201265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65169797|NCT01201265|Antimetabolites|antimetabolites|mesh-ancestor
65169798|NCT01201265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169799|NCT01201265|Antiviral Agents|antiviral agents|mesh-ancestor
65169800|NCT01201265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65169801|NCT01201265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169802|NCT01201265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65169803|NCT01201265|Immunologic Factors|immunologic factors|mesh-ancestor
65169804|NCT04246801|Clobetasol|clobetasol|mesh-list
65169805|NCT04246801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65169806|NCT04246801|Glucocorticoids|glucocorticoids|mesh-ancestor
65169807|NCT04246801|Hormones|hormones|mesh-ancestor
65169808|NCT04246801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65169809|NCT04246801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169810|NCT00638677|Sorbitol|sorbitol|mesh-list
65169811|NCT00638677|Cathartics|cathartics|mesh-ancestor
65169812|NCT00638677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65169813|NCT01200485|Allopurinol|allopurinol|mesh-list
65169814|NCT01200485|Rasburicase|rasburicase|mesh-list
65169815|NCT01200485|Antimetabolites|antimetabolites|mesh-ancestor
65169816|NCT01200485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169817|NCT01200485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169818|NCT01200485|Gout Suppressants|gout suppressants|mesh-ancestor
65169819|NCT01200485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65169822|NCT01200485|Protective Agents|protective agents|mesh-ancestor
65169823|NCT01200485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169824|NCT02688907|Adavosertib|adavosertib|mesh-list
65169825|NCT02688907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169826|NCT02688907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169827|NCT02686645|Metronidazole|metronidazole|mesh-list
65169828|NCT02686645|Vancomycin|vancomycin|mesh-list
65169829|NCT02686645|Loperamide|loperamide|mesh-list
65169830|NCT02686645|Antidiarrheals|antidiarrheals|mesh-list
65169831|NCT02686645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65169832|NCT02686645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65169833|NCT02686645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65169834|NCT02686645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65169835|NCT02686645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65169836|NCT04318067|Melatonin|melatonin|mesh-list
65169837|NCT04318067|Antioxidants|antioxidants|mesh-ancestor
65169838|NCT04318067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169839|NCT04318067|Protective Agents|protective agents|mesh-ancestor
65169840|NCT04318067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322428|NCT05748665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65322429|NCT05748665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65322430|NCT05748665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322431|NCT05748665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65322432|NCT05748665|Anesthetics, General|anesthetics, general|mesh-ancestor
65322433|NCT05748665|Anesthetics|anesthetics|mesh-ancestor
65322434|NCT04016207|Guanfacine|guanfacine|mesh-list
65322435|NCT04016207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65322436|NCT04016207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65322437|NCT04016207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65322438|NCT04016207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65322439|NCT04016207|Adrenergic Agents|adrenergic agents|mesh-ancestor
65322440|NCT04016207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65169841|NCT04318067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65169842|NCT01200407|Amlodipine|amlodipine|mesh-list
65169843|NCT01200407|Olmesartan|olmesartan|mesh-list
65169844|NCT01200407|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65169845|NCT01200407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65169846|NCT01200407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65169847|NCT01200407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65169848|NCT01200407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169849|NCT01200407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65169850|NCT01200407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169851|NCT01200407|Vasodilator Agents|vasodilator agents|mesh-ancestor
65169852|NCT01200407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65169853|NCT01200407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65169854|NCT02685085|Misoprostol|misoprostol|mesh-list
65169855|NCT02685085|Dinoprostone|dinoprostone|mesh-list
65169856|NCT02685085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65169857|NCT02685085|Abortifacient Agents|abortifacient agents|mesh-ancestor
65169858|NCT02685085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65169859|NCT02685085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169860|NCT02685085|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65169861|NCT02685085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65169862|NCT02685085|Oxytocics|oxytocics|mesh-ancestor
65169863|NCT02688595|Anesthetics|anesthetics|mesh-list
65169864|NCT02688595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65169865|NCT02688595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169866|NCT01200329|Gemcitabine|gemcitabine|mesh-list
65169867|NCT01200329|Melphalan|melphalan|mesh-list
65169868|NCT01200329|Busulfan|busulfan|mesh-list
65169869|NCT01200329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65169870|NCT01200329|Antimetabolites|antimetabolites|mesh-ancestor
65169871|NCT01200329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169872|NCT01200329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169873|NCT01200329|Antiviral Agents|antiviral agents|mesh-ancestor
65169874|NCT01200329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65169875|NCT01200329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169876|NCT01200329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65169877|NCT01200329|Immunologic Factors|immunologic factors|mesh-ancestor
65169878|NCT01200329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169879|NCT01200329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65169880|NCT01200329|Alkylating Agents|alkylating agents|mesh-ancestor
65169881|NCT01200329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65169882|NCT01199939|Ritonavir|ritonavir|mesh-list
65169883|NCT01199939|Darunavir|darunavir|mesh-list
65169884|NCT01199939|Etravirine|etravirine|mesh-list
65169885|NCT01199939|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65169886|NCT01199939|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65169887|NCT01199939|Protease Inhibitors|protease inhibitors|mesh-ancestor
65169888|NCT01199939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169889|NCT01199939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169890|NCT01199939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65322441|NCT04016207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322442|NCT04016207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322443|NCT04030091|Insulin|insulin|mesh-list
65322444|NCT04030091|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65322445|NCT04030091|Insulin, Isophane|insulin, isophane|mesh-list
65322446|NCT04030091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65322447|NCT04030091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322448|NCT00734604|Sildenafil Citrate|sildenafil citrate|mesh-list
65322449|NCT00734604|Tadalafil|tadalafil|mesh-list
65322450|NCT00734604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322451|NCT00734604|Vasodilator Agents|vasodilator agents|mesh-ancestor
65322452|NCT00734604|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65322453|NCT00734604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65322454|NCT00734604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322455|NCT00734604|Urological Agents|urological agents|mesh-ancestor
65322456|NCT00590681|Bevacizumab|bevacizumab|mesh-list
65322457|NCT00590681|Temozolomide|temozolomide|mesh-list
65322458|NCT00590681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65322459|NCT00590681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65322460|NCT00590681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65322461|NCT00590681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65322462|NCT00590681|Growth Substances|growth substances|mesh-ancestor
65322463|NCT00590681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169891|NCT01199939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65169892|NCT01199939|Antiviral Agents|antiviral agents|mesh-ancestor
65169893|NCT01199939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65169894|NCT01199939|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65169902|NCT02688361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65169903|NCT02688361|Expectorants|expectorants|mesh-ancestor
65169904|NCT02688361|Respiratory System Agents|respiratory system agents|mesh-ancestor
65169905|NCT02688361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65169906|NCT02688361|Antioxidants|antioxidants|mesh-ancestor
65169907|NCT02688361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169908|NCT02688361|Protective Agents|protective agents|mesh-ancestor
65169909|NCT02688361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169910|NCT02688361|Antidotes|antidotes|mesh-ancestor
65169911|NCT01199861|Vaccines|vaccines|mesh-list
65169912|NCT01199861|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65169913|NCT01199861|Immunologic Factors|immunologic factors|mesh-ancestor
65169914|NCT01199861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169915|NCT01199861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65169916|NCT01199861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169917|NCT01199861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65169918|NCT03196219|Anti-Infective Agents|anti-infective agents|mesh-list
65169919|NCT03196219|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65169920|NCT00640081|Leucovorin|leucovorin|mesh-list
65169921|NCT00640081|Fluorouracil|fluorouracil|mesh-list
65169922|NCT00640081|Capecitabine|capecitabine|mesh-list
65169923|NCT00640081|Oxaliplatin|oxaliplatin|mesh-list
65169924|NCT00640081|Cetuximab|cetuximab|mesh-list
65169925|NCT00640081|Calcium|calcium|mesh-list
65169926|NCT00640081|Levoleucovorin|levoleucovorin|mesh-list
65169927|NCT00640081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65322464|NCT00590681|Growth Inhibitors|growth inhibitors|mesh-ancestor
65322465|NCT00590681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65322466|NCT00590681|Alkylating Agents|alkylating agents|mesh-ancestor
65322467|NCT00590681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322468|NCT05745701|Cyclosporine|cyclosporine|mesh-list
65322469|NCT05745701|Itraconazole|itraconazole|mesh-list
65322470|NCT05745701|Cyclosporins|cyclosporins|mesh-list
65322471|NCT05745701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322472|NCT05745701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322473|NCT05745701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65322474|NCT05745701|Immunologic Factors|immunologic factors|mesh-ancestor
65322475|NCT05745701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322476|NCT05745701|Antifungal Agents|antifungal agents|mesh-ancestor
65322477|NCT05745701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65322478|NCT05745701|Dermatologic Agents|dermatologic agents|mesh-ancestor
65322479|NCT05745701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65322480|NCT05745701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65322481|NCT05745701|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65322482|NCT05745701|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65322483|NCT05745701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65322484|NCT05745701|Hormone Antagonists|hormone antagonists|mesh-ancestor
65322485|NCT05745701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65322486|NCT05745701|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65322487|NCT00727272|Quinine|quinine|mesh-list
65322488|NCT00727272|Antimalarials|antimalarials|mesh-ancestor
65322489|NCT00727272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65322490|NCT00727272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65322491|NCT00727272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65322492|NCT00727272|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65322493|NCT00727272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322494|NCT00727272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65322495|NCT00727272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64552251|NCT01387607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65169928|NCT00640081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169929|NCT00640081|Antimetabolites|antimetabolites|mesh-ancestor
65169930|NCT00640081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169931|NCT00640081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65169932|NCT00640081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169933|NCT00640081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65169934|NCT00640081|Immunologic Factors|immunologic factors|mesh-ancestor
65322496|NCT00727272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65322497|NCT00727272|Analgesics|analgesics|mesh-ancestor
65322498|NCT00727272|Sensory System Agents|sensory system agents|mesh-ancestor
65322499|NCT02609477|Phentermine|phentermine|mesh-list
65322500|NCT02609477|Istradefylline|istradefylline|mesh-list
65322501|NCT02609477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65322502|NCT02609477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322503|NCT02609477|Appetite Depressants|appetite depressants|mesh-ancestor
65322504|NCT02609477|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65322505|NCT02609477|Sympathomimetics|sympathomimetics|mesh-ancestor
65322506|NCT02609477|Autonomic Agents|autonomic agents|mesh-ancestor
65322507|NCT02609477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65322508|NCT02609477|Adrenergic Agents|adrenergic agents|mesh-ancestor
65322509|NCT02609477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65322510|NCT02609477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322511|NCT02609477|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
65169935|NCT00640081|Antidotes|antidotes|mesh-ancestor
65169936|NCT00640081|Protective Agents|protective agents|mesh-ancestor
65169937|NCT00640081|Vitamin B Complex|vitamin b complex|mesh-ancestor
65169938|NCT00640081|Vitamins|vitamins|mesh-ancestor
65169939|NCT00640081|Micronutrients|micronutrients|mesh-ancestor
65169940|NCT00640081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65169941|NCT01199705|Immunoglobulins|immunoglobulins|mesh-list
65169942|NCT01199705|Antibodies|antibodies|mesh-list
65169943|NCT01199705|gamma-Globulins|gamma-globulins|mesh-list
65169944|NCT01199705|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65169945|NCT01199705|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65169946|NCT01199705|Immunologic Factors|immunologic factors|mesh-ancestor
65169947|NCT01199705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169948|NCT02688127|Tranexamic Acid|tranexamic acid|mesh-list
65169949|NCT02688127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65169950|NCT02688127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65169951|NCT02688127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169952|NCT02688127|Hemostatics|hemostatics|mesh-ancestor
65169953|NCT02688127|Coagulants|coagulants|mesh-ancestor
65169954|NCT04184947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65169955|NCT04184947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169956|NCT04184947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65169957|NCT04184947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169958|NCT00638833|Memantine|memantine|mesh-list
65169959|NCT00638833|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65169960|NCT00638833|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65169961|NCT00638833|Dopamine Agents|dopamine agents|mesh-ancestor
65169962|NCT00638833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65169963|NCT00638833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169972|NCT01198145|Sensory System Agents|sensory system agents|mesh-ancestor
65169973|NCT01198145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65169974|NCT01198145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169975|NCT01198145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65169976|NCT01198145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65169977|NCT01198145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65169978|NCT01179048|Liraglutide|liraglutide|mesh-list
65169979|NCT01179048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65169980|NCT01179048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169981|NCT01179048|Incretins|incretins|mesh-ancestor
65169983|NCT01179048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65169984|NCT00603265|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65169985|NCT00603265|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65222838|NCT02586181|Calcium, Dietary|calcium, dietary|mesh-list
65322512|NCT02609477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65322513|NCT02609477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65322514|NCT02609477|Purinergic Agents|purinergic agents|mesh-ancestor
65322515|NCT02592720|Tenecteplase|tenecteplase|mesh-list
65322516|NCT02592720|Tirofiban|tirofiban|mesh-list
65322517|NCT02592720|Bivalirudin|bivalirudin|mesh-list
65322518|NCT02592720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65322519|NCT02592720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65322520|NCT02592720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322521|NCT02592720|Antithrombins|antithrombins|mesh-ancestor
65322522|NCT02592720|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65322523|NCT02592720|Protease Inhibitors|protease inhibitors|mesh-ancestor
65322524|NCT02592720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322525|NCT02592720|Anticoagulants|anticoagulants|mesh-ancestor
65322526|NCT02592720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65322527|NCT02608073|Capecitabine|capecitabine|mesh-list
65322528|NCT02608073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65322529|NCT02608073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65322530|NCT02608073|Antimetabolites|antimetabolites|mesh-ancestor
65169986|NCT00603265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65169987|NCT00603265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65169988|NCT00603265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169989|NCT00603265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65169990|NCT00603265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169991|NCT00603265|Analgesics|analgesics|mesh-ancestor
65169992|NCT00603265|Sensory System Agents|sensory system agents|mesh-ancestor
65169993|NCT00603265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65169994|NCT00603265|Antidepressive Agents|antidepressive agents|mesh-ancestor
65169995|NCT00603265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65169996|NCT00603265|Dopamine Agents|dopamine agents|mesh-ancestor
65169997|NCT02686177|Metformin|metformin|mesh-list
65169998|NCT02686177|Liraglutide|liraglutide|mesh-list
65169999|NCT02686177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65170000|NCT02686177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170001|NCT02686177|Incretins|incretins|mesh-ancestor
65170002|NCT02686177|Hormones|hormones|mesh-ancestor
65170003|NCT02686177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65170004|NCT02686021|Dipyrone|dipyrone|mesh-list
65170005|NCT02686021|Ibuprofen|ibuprofen|mesh-list
65170006|NCT02686021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65170007|NCT02686021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65170008|NCT02686021|Analgesics|analgesics|mesh-ancestor
65170009|NCT02686021|Sensory System Agents|sensory system agents|mesh-ancestor
65170010|NCT02686021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170011|NCT02686021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170012|NCT02686021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65170013|NCT02686021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65170014|NCT02686021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65170015|NCT02686021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170016|NCT02686021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170017|NCT02686021|Antipyretics|antipyretics|mesh-ancestor
65170018|NCT01158534|Interferons|interferons|mesh-list
65170019|NCT01158534|Interferon-alpha|interferon-alpha|mesh-list
65170020|NCT01158534|Interferon alpha-2|interferon alpha-2|mesh-list
65170021|NCT01158534|Celecoxib|celecoxib|mesh-list
65170022|NCT01158534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170023|NCT01158534|Antiviral Agents|antiviral agents|mesh-ancestor
65170024|NCT01158534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65322531|NCT02608073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322532|NCT04041791|Amoxicillin|amoxicillin|mesh-list
65322533|NCT04041791|Gentamicins|gentamicins|mesh-list
65322534|NCT04041791|Ceftriaxone|ceftriaxone|mesh-list
65322535|NCT04041791|Clavulanic Acid|clavulanic acid|mesh-list
65322536|NCT04041791|Clavulanic Acids|clavulanic acids|mesh-list
65322537|NCT04041791|Penicillins|penicillins|mesh-list
65322538|NCT04041791|Ampicillin|ampicillin|mesh-list
65322539|NCT04041791|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65322540|NCT04041791|Penicillin G|penicillin g|mesh-list
65322541|NCT04041791|Penicillin G Benzathine|penicillin g benzathine|mesh-list
65322542|NCT04041791|Penicillin G Procaine|penicillin g procaine|mesh-list
65322543|NCT04041791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65322544|NCT04041791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65322545|NCT04041791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65322546|NCT04041791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322547|NCT04041791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322548|NCT04041791|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65322549|NCT02605226|Bicalutamide|bicalutamide|mesh-list
65322550|NCT02605226|Hormones|hormones|mesh-list
65322551|NCT02605226|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65322552|NCT02605226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65322553|NCT02605226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322554|NCT02605226|Androgen Antagonists|androgen antagonists|mesh-ancestor
65170025|NCT01158534|Immunologic Factors|immunologic factors|mesh-ancestor
65170026|NCT01158534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170027|NCT01158534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65170028|NCT01158534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65170029|NCT01158534|Analgesics|analgesics|mesh-ancestor
65170045|NCT05272878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65170046|NCT05272878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65170047|NCT05272878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65170048|NCT05272878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170049|NCT02683213|Fluoxetine|fluoxetine|mesh-list
65170050|NCT02683213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65170051|NCT02683213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65170052|NCT02683213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65170053|NCT02683213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170054|NCT02683213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65170055|NCT02683213|Serotonin Agents|serotonin agents|mesh-ancestor
65170056|NCT02683213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170057|NCT02683213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65170058|NCT02683213|Antidepressive Agents|antidepressive agents|mesh-ancestor
65170059|NCT02683213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65170060|NCT02683213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65170061|NCT02683213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65170062|NCT02683213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170063|NCT04185103|Valsartan|valsartan|mesh-list
65170064|NCT04185103|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65322555|NCT02605226|Hormone Antagonists|hormone antagonists|mesh-ancestor
65322556|NCT02605226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65322557|NCT05571878|Insulin Lispro|insulin lispro|mesh-list
65322558|NCT05571878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65322559|NCT05571878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322560|NCT05753189|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65322561|NCT05753189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65322562|NCT05753189|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65322563|NCT05753189|Aceclidine|aceclidine|mesh-list
65322564|NCT05753189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65322565|NCT05753189|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65322566|NCT05753189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65322567|NCT05753189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65322568|NCT05753189|Adrenergic Agents|adrenergic agents|mesh-ancestor
65072546|NCT00304850|Anesthetics|anesthetics|mesh-ancestor
65322569|NCT05753189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65322570|NCT05753189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322571|NCT05753189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322572|NCT05753189|Miotics|miotics|mesh-ancestor
65322573|NCT05753189|Autonomic Agents|autonomic agents|mesh-ancestor
65322574|NCT05753189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65322575|NCT05753189|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65322576|NCT04088448|Metformin|metformin|mesh-list
65322577|NCT04088448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65322578|NCT04088448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322579|NCT03648437|Acetaminophen|acetaminophen|mesh-list
65322580|NCT03648437|Ibuprofen|ibuprofen|mesh-list
65322581|NCT03648437|Indomethacin|indomethacin|mesh-list
64552335|NCT01831011|Analgesics|analgesics|mesh-ancestor
65170065|NCT04185103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65170066|NCT04185103|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65170067|NCT04185103|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65170068|NCT04185103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170069|NCT04033939|Propofol|propofol|mesh-list
65170070|NCT04033939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65170071|NCT04033939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65170072|NCT04033939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170073|NCT04033939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65170074|NCT04033939|Anesthetics, General|anesthetics, general|mesh-ancestor
65170075|NCT04033939|Anesthetics|anesthetics|mesh-ancestor
65170076|NCT00639691|Omalizumab|omalizumab|mesh-list
65170077|NCT00639691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65170078|NCT00639691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65170079|NCT00639691|Respiratory System Agents|respiratory system agents|mesh-ancestor
65170080|NCT02684071|Cyclophosphamide|cyclophosphamide|mesh-list
65170081|NCT02684071|Methotrexate|methotrexate|mesh-list
65170082|NCT02684071|Topotecan|topotecan|mesh-list
65170083|NCT02684071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65170084|NCT02684071|Immunologic Factors|immunologic factors|mesh-ancestor
65322582|NCT03648437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65322583|NCT03648437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65322584|NCT03648437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65322585|NCT03648437|Analgesics|analgesics|mesh-ancestor
65322586|NCT03648437|Sensory System Agents|sensory system agents|mesh-ancestor
65322587|NCT03648437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65322588|NCT03648437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322589|NCT03648437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65322590|NCT03648437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65322591|NCT03648437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65322592|NCT03648437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322593|NCT03648437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322594|NCT03648437|Antipyretics|antipyretics|mesh-ancestor
65322595|NCT03648437|Gout Suppressants|gout suppressants|mesh-ancestor
65322596|NCT03648437|Tocolytic Agents|tocolytic agents|mesh-ancestor
65322597|NCT03648437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65322598|NCT00806351|Caspofungin|caspofungin|mesh-list
65322599|NCT00806351|Anidulafungin|anidulafungin|mesh-list
65322600|NCT00806351|Antifungal Agents|antifungal agents|mesh-ancestor
65322601|NCT00806351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65322602|NCT00806351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322603|NCT00806351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322604|NCT03995251|Testosterone|testosterone|mesh-list
65170085|NCT02684071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170086|NCT02684071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65170087|NCT02684071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65170092|NCT02684071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65170093|NCT02684071|Abortifacient Agents|abortifacient agents|mesh-ancestor
65170094|NCT02684071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65170095|NCT02684071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65170096|NCT02684071|Antimetabolites|antimetabolites|mesh-ancestor
65170097|NCT02684071|Dermatologic Agents|dermatologic agents|mesh-ancestor
65170098|NCT02684071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170099|NCT02684071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65170100|NCT02684071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65170101|NCT02684071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65170102|NCT02684071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65170104|NCT00640159|Antidepressive Agents|antidepressive agents|mesh-ancestor
65170105|NCT00640159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65170106|NCT00640159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65170107|NCT00640159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65170108|NCT00640159|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65170109|NCT00640159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170110|NCT00640159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170111|NCT00640159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65170112|NCT00640159|Protective Agents|protective agents|mesh-ancestor
65170113|NCT00640159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170114|NCT00640861|Vaccines|vaccines|mesh-list
65170115|NCT00640861|Sargramostim|sargramostim|mesh-list
65170116|NCT00640861|Freund's Adjuvant|freund's adjuvant|mesh-list
65170117|NCT00640861|Immunologic Factors|immunologic factors|mesh-ancestor
65322605|NCT03995251|Androgens|androgens|mesh-ancestor
65322606|NCT03995251|Hormones|hormones|mesh-ancestor
65322607|NCT03995251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65322608|NCT03995251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322609|NCT01031017|Progesterone|progesterone|mesh-list
65322610|NCT01031017|Progestins|progestins|mesh-ancestor
65322611|NCT01031017|Hormones|hormones|mesh-ancestor
65322612|NCT01031017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65322613|NCT01031017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322614|NCT03742531|Oxytocin|oxytocin|mesh-list
65322615|NCT03742531|Oxytocics|oxytocics|mesh-ancestor
65322616|NCT03742531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65322617|NCT03742531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322618|NCT05738135|Aminophylline|aminophylline|mesh-list
65322619|NCT05738135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65322620|NCT05738135|Autonomic Agents|autonomic agents|mesh-ancestor
65322621|NCT05738135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65322622|NCT05738135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322623|NCT05738135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65322624|NCT05738135|Respiratory System Agents|respiratory system agents|mesh-ancestor
65322625|NCT05738135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65322626|NCT05738135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65322627|NCT05738135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322628|NCT05738135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322629|NCT05738135|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65322630|NCT05738135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65322631|NCT05738135|Purinergic Agents|purinergic agents|mesh-ancestor
65322632|NCT05738135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65170118|NCT00640861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170119|NCT00640861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65170120|NCT00602797|Paclitaxel|paclitaxel|mesh-list
65170121|NCT00602797|Vinorelbine|vinorelbine|mesh-list
65170122|NCT00602797|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65170123|NCT00602797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65170124|NCT00602797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170125|NCT00602797|Tubulin Modulators|tubulin modulators|mesh-ancestor
65170126|NCT00602797|Antimitotic Agents|antimitotic agents|mesh-ancestor
65170127|NCT00602797|Mitosis Modulators|mitosis modulators|mesh-ancestor
65170128|NCT00602797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170129|NCT01158222|Sunitinib|sunitinib|mesh-list
65170130|NCT01158222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170131|NCT01158222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65170132|NCT01158222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65170133|NCT01158222|Growth Substances|growth substances|mesh-ancestor
65170134|NCT01158222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322633|NCT05738135|Protective Agents|protective agents|mesh-ancestor
65322634|NCT00733902|Tanezumab|tanezumab|mesh-list
65322635|NCT00733902|Analgesics|analgesics|mesh-ancestor
65322636|NCT00733902|Sensory System Agents|sensory system agents|mesh-ancestor
65322637|NCT00733902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65322638|NCT00733902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322639|NCT05737355|Red yeast rice|red yeast rice|mesh-list
65322640|NCT05737355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65322641|NCT05737355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65322642|NCT05737355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65322643|NCT05737355|Antimetabolites|antimetabolites|mesh-ancestor
65322644|NCT05737355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322645|NCT05737355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072618|NCT00305396|Sirolimus|sirolimus|mesh-list
65322646|NCT05737355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65322648|NCT03540017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65322649|NCT02606981|Vitamins|vitamins|mesh-list
65322650|NCT02606981|Ascorbic Acid|ascorbic acid|mesh-list
65322651|NCT02606981|Micronutrients|micronutrients|mesh-ancestor
64552412|NCT03221400|Vitamins|vitamins|mesh-ancestor
65170135|NCT01158222|Growth Inhibitors|growth inhibitors|mesh-ancestor
65170136|NCT01158222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65170137|NCT01158222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170138|NCT01158222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170139|NCT02684305|Oxytocin|oxytocin|mesh-list
65170140|NCT02684305|Oxytocics|oxytocics|mesh-ancestor
65170141|NCT02684305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65170142|NCT02684305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170143|NCT02940769|Methamphetamine|methamphetamine|mesh-list
65170144|NCT02940769|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65170145|NCT02940769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170146|NCT02940769|Sympathomimetics|sympathomimetics|mesh-ancestor
65170147|NCT02940769|Autonomic Agents|autonomic agents|mesh-ancestor
65170148|NCT02940769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170149|NCT02940769|Dopamine Agents|dopamine agents|mesh-ancestor
65170150|NCT02940769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65170151|NCT02940769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170152|NCT02940769|Adrenergic Agents|adrenergic agents|mesh-ancestor
65170153|NCT02940769|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65170154|NCT02940769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65170155|NCT02940769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65170156|NCT02940769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65170159|NCT04315584|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
65170160|NCT04315584|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65170161|NCT04315584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170162|NCT04315584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170163|NCT04315584|Antimetabolites|antimetabolites|mesh-ancestor
65170164|NCT04315584|Antiviral Agents|antiviral agents|mesh-ancestor
65170165|NCT04315584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65170166|NCT04315584|Dopamine Agents|dopamine agents|mesh-ancestor
65170167|NCT04315584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65170168|NCT02683291|Mycophenolic Acid|mycophenolic acid|mesh-list
65170169|NCT02683291|Sirolimus|sirolimus|mesh-list
65170170|NCT02683291|Prednisone|prednisone|mesh-list
65170171|NCT02683291|Tacrolimus|tacrolimus|mesh-list
65170172|NCT02683291|Thymoglobulin|thymoglobulin|mesh-list
65170173|NCT02683291|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65322652|NCT02606981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322653|NCT02606981|Antioxidants|antioxidants|mesh-ancestor
65322654|NCT02606981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322655|NCT02606981|Protective Agents|protective agents|mesh-ancestor
65322656|NCT00914888|Metronidazole|metronidazole|mesh-list
65322657|NCT00914888|Clarithromycin|clarithromycin|mesh-list
65322658|NCT00914888|Ceftriaxone|ceftriaxone|mesh-list
65322659|NCT00914888|Tigecycline|tigecycline|mesh-list
65322660|NCT00914888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65322661|NCT00914888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65322662|NCT00914888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65322663|NCT00914888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65322664|NCT00914888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65322665|NCT00914888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322666|NCT00914888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322667|NCT00914888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65322668|NCT00914888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65322669|NCT02603198|Epinephrine|epinephrine|mesh-list
65322670|NCT02603198|Nordefrin|nordefrin|mesh-list
65322671|NCT02603198|Anesthetics|anesthetics|mesh-list
65322672|NCT02603198|Mepivacaine|mepivacaine|mesh-list
65322673|NCT02603198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65170174|NCT02683291|Basiliximab|basiliximab|mesh-list
65170175|NCT02683291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65170176|NCT02683291|Glucocorticoids|glucocorticoids|mesh-ancestor
65170177|NCT02683291|Hormones|hormones|mesh-ancestor
65170178|NCT02683291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65170179|NCT02683291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170180|NCT02683291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65170181|NCT02683291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170182|NCT02683291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65170183|NCT02683291|Immunologic Factors|immunologic factors|mesh-ancestor
65170184|NCT02683291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65170185|NCT02683291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170186|NCT02683291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170187|NCT02683291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65170188|NCT02683291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65170189|NCT02683291|Antitubercular Agents|antitubercular agents|mesh-ancestor
65170190|NCT02683291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65170191|NCT02683291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65170192|NCT02683291|Antifungal Agents|antifungal agents|mesh-ancestor
65170193|NCT02685397|Leuprolide|leuprolide|mesh-list
65170194|NCT02685397|Goserelin|goserelin|mesh-list
65170195|NCT02685397|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65170196|NCT02685397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65170197|NCT02685397|Fertility Agents|fertility agents|mesh-ancestor
65170198|NCT02685397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65170199|NCT02685397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170200|NCT02685397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65170201|NCT02685397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170202|NCT02685397|Luteolytic Agents|luteolytic agents|mesh-ancestor
65170203|NCT02685397|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65170204|NCT02685397|Contraceptive Agents|contraceptive agents|mesh-ancestor
65322674|NCT02603198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322675|NCT02603198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65322676|NCT02603198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65322677|NCT02603198|Adrenergic Agents|adrenergic agents|mesh-ancestor
65322678|NCT02603198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65322679|NCT02603198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322680|NCT02603198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65322681|NCT02603198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65322682|NCT02603198|Autonomic Agents|autonomic agents|mesh-ancestor
65322683|NCT02603198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65322684|NCT02603198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65322685|NCT02603198|Respiratory System Agents|respiratory system agents|mesh-ancestor
65322686|NCT02603198|Mydriatics|mydriatics|mesh-ancestor
65170205|NCT02685397|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65170206|NCT02683837|Remifentanil|remifentanil|mesh-list
65170207|NCT02683837|Sevoflurane|sevoflurane|mesh-list
65170208|NCT02683837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65170209|NCT02683837|Narcotics|narcotics|mesh-ancestor
65170210|NCT02683837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65170211|NCT02683837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170212|NCT02683837|Analgesics|analgesics|mesh-ancestor
65170213|NCT02683837|Sensory System Agents|sensory system agents|mesh-ancestor
65170214|NCT02683837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170215|NCT02683837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65170216|NCT02683837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65170217|NCT02683837|Anesthetics, General|anesthetics, general|mesh-ancestor
65170218|NCT02683837|Anesthetics|anesthetics|mesh-ancestor
65170219|NCT02680951|Cytarabine|cytarabine|mesh-list
65170220|NCT02680951|Fludarabine|fludarabine|mesh-list
65170221|NCT02680951|Dasatinib|dasatinib|mesh-list
65170222|NCT02680951|Idarubicin|idarubicin|mesh-list
65170223|NCT02680951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170224|NCT02680951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65170225|NCT02680951|Antimetabolites|antimetabolites|mesh-ancestor
65170226|NCT02680951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170227|NCT02680951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65170228|NCT02680951|Immunologic Factors|immunologic factors|mesh-ancestor
65170229|NCT02680951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170230|NCT02680951|Antiviral Agents|antiviral agents|mesh-ancestor
65170231|NCT02680951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65170240|NCT02680717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65170241|NCT02680717|Immunologic Factors|immunologic factors|mesh-ancestor
65170242|NCT02680717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170243|NCT02680717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65170244|NCT02680717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170245|NCT02680717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170246|NCT02680717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65170248|NCT02680717|Hormones|hormones|mesh-ancestor
65170249|NCT02680717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65170250|NCT02680717|Dermatologic Agents|dermatologic agents|mesh-ancestor
65170251|NCT02680795|Belinostat|belinostat|mesh-list
65170252|NCT02680795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170253|NCT02680795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65170254|NCT02680795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170255|NCT02680795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170256|NCT00640237|Calcifediol|calcifediol|mesh-list
65170257|NCT00640237|Vitamins|vitamins|mesh-ancestor
65170258|NCT00640237|Micronutrients|micronutrients|mesh-ancestor
65170259|NCT00640237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170260|NCT00640237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65170261|NCT02683759|Curcumin|curcumin|mesh-list
65170262|NCT02683759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64552462|NCT03025295|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65322687|NCT02603198|Sympathomimetics|sympathomimetics|mesh-ancestor
65322688|NCT02603198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65322689|NCT02603198|Anesthetics, Local|anesthetics, local|mesh-ancestor
65322690|NCT02603198|Sensory System Agents|sensory system agents|mesh-ancestor
65322691|NCT00719043|Vaccines|vaccines|mesh-list
65322692|NCT00719043|Immunologic Factors|immunologic factors|mesh-ancestor
65322693|NCT00719043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322694|NCT05545280|Glycopyrrolate|glycopyrrolate|mesh-list
65322695|NCT05545280|Neostigmine|neostigmine|mesh-list
65322696|NCT05545280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65322697|NCT05545280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322698|NCT05545280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552463|NCT03025295|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64552464|NCT03025295|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64552465|NCT03025295|Adrenergic Agents|adrenergic agents|mesh-ancestor
64552466|NCT03025295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64552467|NCT03025295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552468|NCT01471574|Interferons|interferons|mesh-list
64552469|NCT01471574|Ribavirin|ribavirin|mesh-list
64552470|NCT01471574|Interferon-alpha|interferon-alpha|mesh-list
64552471|NCT01471574|Interferon alpha-2|interferon alpha-2|mesh-list
64317504|NCT02164825|Ropivacaine|ropivacaine|mesh-list
64992392|NCT03803787|Budesonide|budesonide|mesh-list
64992393|NCT03803787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64992394|NCT03803787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64992395|NCT03803787|Autonomic Agents|autonomic agents|mesh-ancestor
64992396|NCT03803787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64992397|NCT03803787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170263|NCT02683759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65170264|NCT02683759|Analgesics|analgesics|mesh-ancestor
65170265|NCT02683759|Sensory System Agents|sensory system agents|mesh-ancestor
65170266|NCT02683759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170267|NCT02683759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170268|NCT02683759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65170269|NCT02683759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65170270|NCT02683759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170271|NCT02683759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170272|NCT02683759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170273|NCT04292691|Ropivacaine|ropivacaine|mesh-list
65170274|NCT04292691|Anesthetics, Local|anesthetics, local|mesh-ancestor
65170275|NCT04292691|Anesthetics|anesthetics|mesh-ancestor
65170276|NCT04292691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65170277|NCT04292691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170278|NCT04292691|Sensory System Agents|sensory system agents|mesh-ancestor
65170279|NCT04292691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170280|NCT00990249|Busulfan|busulfan|mesh-list
65322699|NCT05545280|Cholinergic Agents|cholinergic agents|mesh-ancestor
65322700|NCT05545280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65322701|NCT05545280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322702|NCT05545280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65322703|NCT05545280|Autonomic Agents|autonomic agents|mesh-ancestor
65322704|NCT05545280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65322705|NCT05545280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65322706|NCT05545280|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65322707|NCT05545280|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65322708|NCT00786422|Rivaroxaban|rivaroxaban|mesh-list
65322709|NCT00786422|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65170281|NCT00990249|Clofarabine|clofarabine|mesh-list
65170282|NCT00990249|Thymoglobulin|thymoglobulin|mesh-list
65170283|NCT00990249|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65170284|NCT00990249|Alkylating Agents|alkylating agents|mesh-ancestor
65170285|NCT00990249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170286|NCT00990249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65170287|NCT00990249|Immunologic Factors|immunologic factors|mesh-ancestor
65170288|NCT00990249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170289|NCT00990249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65170290|NCT00990249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170291|NCT00990249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65170292|NCT00990249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65170293|NCT00990249|Antimetabolites|antimetabolites|mesh-ancestor
65170294|NCT02846545|Golimumab|golimumab|mesh-list
65170295|NCT02846545|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65170296|NCT02846545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65170297|NCT02846545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65170298|NCT02846545|Immunologic Factors|immunologic factors|mesh-ancestor
65170299|NCT02846545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170300|NCT04291755|Pembrolizumab|pembrolizumab|mesh-list
65170301|NCT04291755|Nivolumab|nivolumab|mesh-list
65170314|NCT00640939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65170315|NCT00640939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65170316|NCT00640939|Analgesics|analgesics|mesh-ancestor
65170317|NCT00640939|Sensory System Agents|sensory system agents|mesh-ancestor
65170318|NCT00640939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170319|NCT00640939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170320|NCT00640939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65170321|NCT00640939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65170322|NCT00640939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65170323|NCT00640939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170324|NCT00640939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170325|NCT05663749|Metformin|metformin|mesh-list
65170326|NCT05663749|Topiramate|topiramate|mesh-list
65170327|NCT05663749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65170328|NCT05663749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170329|NCT05663749|Anticonvulsants|anticonvulsants|mesh-ancestor
65170330|NCT02867553|Rituximab|rituximab|mesh-list
65170331|NCT02867553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65170332|NCT02867553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170333|NCT02867553|Immunologic Factors|immunologic factors|mesh-ancestor
65170334|NCT02867553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170335|NCT02867553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65170336|NCT00909961|Zoledronic Acid|zoledronic acid|mesh-list
65170337|NCT00909961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65170338|NCT00909961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170339|NCT00642577|Leucovorin|leucovorin|mesh-list
65170340|NCT00642577|Bevacizumab|bevacizumab|mesh-list
65170341|NCT00642577|Fluorouracil|fluorouracil|mesh-list
65170342|NCT00642577|Irinotecan|irinotecan|mesh-list
65170343|NCT00642577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65170344|NCT00642577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170345|NCT00642577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65170346|NCT00642577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65322710|NCT00786422|Antithrombins|antithrombins|mesh-ancestor
65322711|NCT00786422|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65322712|NCT00786422|Protease Inhibitors|protease inhibitors|mesh-ancestor
65322713|NCT00786422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322714|NCT00786422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322715|NCT00786422|Anticoagulants|anticoagulants|mesh-ancestor
65322716|NCT00718887|Entecavir|entecavir|mesh-list
65322717|NCT00718887|Adefovir|adefovir|mesh-list
65322718|NCT00718887|Antiviral Agents|antiviral agents|mesh-ancestor
65322719|NCT00718887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65322720|NCT00718887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65322721|NCT00718887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65322722|NCT00718887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322723|NCT00718887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322725|NCT00786188|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65322726|NCT00786188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65322727|NCT00786188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65170347|NCT00642577|Growth Substances|growth substances|mesh-ancestor
65170348|NCT00642577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170349|NCT00642577|Growth Inhibitors|growth inhibitors|mesh-ancestor
65170350|NCT00642577|Antimetabolites|antimetabolites|mesh-ancestor
65170351|NCT00642577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170352|NCT00642577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65170353|NCT00642577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65170354|NCT00642577|Immunologic Factors|immunologic factors|mesh-ancestor
65170355|NCT00642577|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65170356|NCT00642577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65170357|NCT00642577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170358|NCT00642577|Antidotes|antidotes|mesh-ancestor
65170359|NCT00642577|Protective Agents|protective agents|mesh-ancestor
65170360|NCT00642577|Vitamin B Complex|vitamin b complex|mesh-ancestor
65170361|NCT00642577|Vitamins|vitamins|mesh-ancestor
65170362|NCT00642577|Micronutrients|micronutrients|mesh-ancestor
65170363|NCT04184401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65170364|NCT02682121|Metformin|metformin|mesh-list
65170369|NCT02683603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65170370|NCT02683603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65170371|NCT00641095|Cyclophosphamide|cyclophosphamide|mesh-list
65170372|NCT00641095|Rituximab|rituximab|mesh-list
65170373|NCT00641095|Fludarabine|fludarabine|mesh-list
65170374|NCT00641095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65170375|NCT00641095|Immunologic Factors|immunologic factors|mesh-ancestor
65170376|NCT00641095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170377|NCT00641095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65170378|NCT00641095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65170379|NCT00641095|Alkylating Agents|alkylating agents|mesh-ancestor
65170380|NCT00641095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170381|NCT00641095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170382|NCT00641095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65170383|NCT00641095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65170384|NCT01196975|Vaccines|vaccines|mesh-list
65170385|NCT01196975|Immunologic Factors|immunologic factors|mesh-ancestor
65170386|NCT01196975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170388|NCT00992589|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65170389|NCT00992589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65170390|NCT00992589|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65170391|NCT00992589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170392|NCT00992589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322728|NCT00786188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322729|NCT00786188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65322730|NCT00786188|Serotonin Agents|serotonin agents|mesh-ancestor
65322731|NCT00786188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322732|NCT00786188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65322733|NCT00786188|Antidepressive Agents|antidepressive agents|mesh-ancestor
65322734|NCT00786188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65322735|NCT00786188|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65322736|NCT00786188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65322737|NCT00786188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322738|NCT00733824|Plerixafor|plerixafor|mesh-list
65322739|NCT00733824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65322740|NCT00733824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65322741|NCT00733824|Antiviral Agents|antiviral agents|mesh-ancestor
65322742|NCT00733824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65322743|NCT00718809|Saracatinib|saracatinib|mesh-list
65322744|NCT00718809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65322745|NCT00718809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322746|NCT00718809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322747|NCT00585039|Albuterol|albuterol|mesh-list
65322748|NCT00585039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65322749|NCT00585039|Autonomic Agents|autonomic agents|mesh-ancestor
65322750|NCT00585039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170393|NCT01196741|Paclitaxel|paclitaxel|mesh-list
65170395|NCT01196741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65170396|NCT01196741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170397|NCT01196741|Tubulin Modulators|tubulin modulators|mesh-ancestor
65170398|NCT01196741|Antimitotic Agents|antimitotic agents|mesh-ancestor
65170399|NCT01196741|Mitosis Modulators|mitosis modulators|mesh-ancestor
65170400|NCT01196741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170401|NCT01196741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170402|NCT00629187|Temozolomide|temozolomide|mesh-list
65170403|NCT00629187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65170404|NCT00629187|Alkylating Agents|alkylating agents|mesh-ancestor
65170405|NCT00629187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170406|NCT00629187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170407|NCT04291287|Fibrinolytic Agents|fibrinolytic agents|mesh-list
65170408|NCT04291287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65170409|NCT04291287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170410|NCT00983385|Tapentadol|tapentadol|mesh-list
65170411|NCT00983385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65170412|NCT00983385|Narcotics|narcotics|mesh-ancestor
65170413|NCT00983385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65170414|NCT00983385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170415|NCT00983385|Analgesics|analgesics|mesh-ancestor
65170416|NCT00983385|Sensory System Agents|sensory system agents|mesh-ancestor
65170417|NCT00983385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170418|NCT00983385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65170419|NCT00983385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65170420|NCT00983385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65222839|NCT02586181|Vitamin D|vitamin d|mesh-list
65322751|NCT00585039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322752|NCT00585039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65322753|NCT00585039|Respiratory System Agents|respiratory system agents|mesh-ancestor
65322754|NCT00585039|Tocolytic Agents|tocolytic agents|mesh-ancestor
65322755|NCT00585039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65322756|NCT00585039|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65322757|NCT00585039|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65322758|NCT00585039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65322759|NCT00585039|Adrenergic Agents|adrenergic agents|mesh-ancestor
65322760|NCT00585039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65322761|NCT00585039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322762|NCT04085913|Lidocaine|lidocaine|mesh-list
65322763|NCT04085913|Epinephrine|epinephrine|mesh-list
65322764|NCT04085913|Racepinephrine|racepinephrine|mesh-list
65170421|NCT00983385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170422|NCT00983385|Adrenergic Agents|adrenergic agents|mesh-ancestor
65170423|NCT00983385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65170424|NCT00992511|Vaccines|vaccines|mesh-list
65170425|NCT00992511|Immunologic Factors|immunologic factors|mesh-ancestor
65170426|NCT00992511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170427|NCT02869035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65170428|NCT02869035|Citalopram|citalopram|mesh-list
65170429|NCT02869035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65170430|NCT02869035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65170431|NCT02869035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65170432|NCT02869035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170433|NCT02869035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65170434|NCT02869035|Serotonin Agents|serotonin agents|mesh-ancestor
65170435|NCT02869035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170436|NCT02869035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65170443|NCT02869035|Dopamine Agents|dopamine agents|mesh-ancestor
65170445|NCT04290819|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65170446|NCT04290819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170447|NCT04290819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65170448|NCT04290819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170449|NCT04290819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170450|NCT04290819|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65170451|NCT04290819|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65170452|NCT04290819|Purinergic Agents|purinergic agents|mesh-ancestor
65170453|NCT04290819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65170454|NCT04157517|Pembrolizumab|pembrolizumab|mesh-list
65170455|NCT04157517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65170456|NCT04157517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170457|NCT01196429|Sirolimus|sirolimus|mesh-list
65170458|NCT01196429|Paclitaxel|paclitaxel|mesh-list
65170459|NCT01196429|Docetaxel|docetaxel|mesh-list
65170460|NCT01196429|Carboplatin|carboplatin|mesh-list
65170461|NCT01196429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65170462|NCT01196429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65170463|NCT01196429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170465|NCT01196429|Antimitotic Agents|antimitotic agents|mesh-ancestor
65170466|NCT01196429|Mitosis Modulators|mitosis modulators|mesh-ancestor
65170467|NCT01196429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170468|NCT01196429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65170469|NCT01196429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65170470|NCT01196429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65170471|NCT01196429|Antifungal Agents|antifungal agents|mesh-ancestor
65170472|NCT01196429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65170473|NCT01196429|Immunologic Factors|immunologic factors|mesh-ancestor
65170474|NCT01196429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322765|NCT04085913|Bupivacaine|bupivacaine|mesh-list
65322766|NCT04085913|Epinephryl borate|epinephryl borate|mesh-list
65322767|NCT04085913|Anesthetics, Local|anesthetics, local|mesh-ancestor
65322768|NCT04085913|Anesthetics|anesthetics|mesh-ancestor
65322769|NCT04085913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65322770|NCT04085913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322771|NCT04085913|Sensory System Agents|sensory system agents|mesh-ancestor
65322772|NCT04085913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65322773|NCT04085913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65322774|NCT04085913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65322775|NCT04085913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65322776|NCT04085913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65322777|NCT04085913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322778|NCT04085913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65322779|NCT04085913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65322780|NCT04085913|Adrenergic Agents|adrenergic agents|mesh-ancestor
65322781|NCT04085913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65322782|NCT04085913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65322783|NCT04085913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65322784|NCT04085913|Autonomic Agents|autonomic agents|mesh-ancestor
65322785|NCT04085913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65322786|NCT04085913|Respiratory System Agents|respiratory system agents|mesh-ancestor
65322787|NCT04085913|Mydriatics|mydriatics|mesh-ancestor
65170475|NCT01157364|Bimatoprost|bimatoprost|mesh-list
65170476|NCT01157364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65170477|NCT01195415|Gemcitabine|gemcitabine|mesh-list
65170478|NCT01195415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65170479|NCT01195415|Antimetabolites|antimetabolites|mesh-ancestor
65170480|NCT01195415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170481|NCT01195415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170482|NCT01195415|Antiviral Agents|antiviral agents|mesh-ancestor
65170483|NCT01195415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65170484|NCT01195415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170485|NCT01195415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65170486|NCT01195415|Immunologic Factors|immunologic factors|mesh-ancestor
65170487|NCT01195415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170488|NCT01195103|Fentanyl|fentanyl|mesh-list
65170489|NCT01195103|Midazolam|midazolam|mesh-list
65170490|NCT01195103|Propofol|propofol|mesh-list
65170491|NCT01195103|Fospropofol|fospropofol|mesh-list
65170492|NCT01195103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65170493|NCT01195103|Narcotics|narcotics|mesh-ancestor
65170494|NCT01195103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65170495|NCT01195103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170496|NCT01195103|Analgesics|analgesics|mesh-ancestor
65170497|NCT01195103|Sensory System Agents|sensory system agents|mesh-ancestor
65170498|NCT01195103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170499|NCT01195103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65170500|NCT01195103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65170501|NCT01195103|Anesthetics, General|anesthetics, general|mesh-ancestor
65170502|NCT01195103|Anesthetics|anesthetics|mesh-ancestor
65170503|NCT01195103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65322788|NCT04085913|Sympathomimetics|sympathomimetics|mesh-ancestor
65322789|NCT04085913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65322790|NCT00806195|Vaccines|vaccines|mesh-list
65322791|NCT00806195|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65322792|NCT00806195|Immunologic Factors|immunologic factors|mesh-ancestor
65322793|NCT00806195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322794|NCT03462329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65322795|NCT03462329|Doxycycline|doxycycline|mesh-list
65322796|NCT03462329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65322797|NCT03462329|Antimalarials|antimalarials|mesh-ancestor
65322798|NCT03462329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65322799|NCT03462329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65322800|NCT05728151|Epinephrine|epinephrine|mesh-list
65322801|NCT05728151|Levobupivacaine|levobupivacaine|mesh-list
64552559|NCT00894699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170504|NCT01195103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65170505|NCT01195103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65170506|NCT01195103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65170507|NCT01195103|GABA Modulators|gaba modulators|mesh-ancestor
65170510|NCT01195103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170511|NCT01194869|Paclitaxel|paclitaxel|mesh-list
65170512|NCT01194869|Cisplatin|cisplatin|mesh-list
65170513|NCT01194869|Sorafenib|sorafenib|mesh-list
65170514|NCT01194869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65170515|NCT01194869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170516|NCT01194869|Tubulin Modulators|tubulin modulators|mesh-ancestor
65170517|NCT01194869|Antimitotic Agents|antimitotic agents|mesh-ancestor
65170518|NCT01194869|Mitosis Modulators|mitosis modulators|mesh-ancestor
65170519|NCT01194869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170520|NCT01194869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65170521|NCT01194869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170522|NCT01177800|Infliximab|infliximab|mesh-list
65170523|NCT01177800|Dermatologic Agents|dermatologic agents|mesh-ancestor
65170524|NCT01177800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65170525|NCT01177800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65170526|NCT01177722|Vaccines|vaccines|mesh-list
65170527|NCT01177722|Immunologic Factors|immunologic factors|mesh-ancestor
65170528|NCT01177722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170529|NCT02884986|Etoricoxib|etoricoxib|mesh-list
65170530|NCT02884986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65170531|NCT02884986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65170532|NCT02884986|Analgesics|analgesics|mesh-ancestor
65170533|NCT02884986|Sensory System Agents|sensory system agents|mesh-ancestor
65170534|NCT02884986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170535|NCT02884986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170536|NCT02884986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65170537|NCT02884986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65170538|NCT02884986|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65170539|NCT02884986|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65170540|NCT02884986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170541|NCT02884986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170542|NCT04124562|Nitrous Oxide|nitrous oxide|mesh-list
65170543|NCT04124562|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65170544|NCT04124562|Anesthetics, General|anesthetics, general|mesh-ancestor
65170545|NCT04124562|Anesthetics|anesthetics|mesh-ancestor
65170546|NCT04124562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65170547|NCT04124562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170548|NCT04124562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65170549|NCT04124562|Analgesics|analgesics|mesh-ancestor
65170550|NCT04124562|Sensory System Agents|sensory system agents|mesh-ancestor
65170551|NCT04124562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170552|NCT01177410|Mesalamine|mesalamine|mesh-list
65222840|NCT02586181|Ergocalciferols|ergocalciferols|mesh-list
65322802|NCT05728151|Mepivacaine|mepivacaine|mesh-list
65322803|NCT05728151|Carticaine|carticaine|mesh-list
65322804|NCT05728151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65322805|NCT05728151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65322806|NCT05728151|Adrenergic Agents|adrenergic agents|mesh-ancestor
65322807|NCT05728151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65322808|NCT05728151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322809|NCT05728151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322810|NCT05728151|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65322811|NCT05728151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65322812|NCT05728151|Autonomic Agents|autonomic agents|mesh-ancestor
65322813|NCT05728151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65322814|NCT05728151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65322815|NCT05728151|Respiratory System Agents|respiratory system agents|mesh-ancestor
65322816|NCT05728151|Mydriatics|mydriatics|mesh-ancestor
65322817|NCT05728151|Sympathomimetics|sympathomimetics|mesh-ancestor
65322818|NCT05728151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65170553|NCT01177410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65170554|NCT01177410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65170555|NCT01177410|Analgesics|analgesics|mesh-ancestor
65170556|NCT01177410|Sensory System Agents|sensory system agents|mesh-ancestor
65170557|NCT01177410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170558|NCT01177410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170559|NCT01177410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65170560|NCT01177410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65170561|NCT02884596|Serotonin|serotonin|mesh-list
65170562|NCT02884596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65170563|NCT02884596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65170564|NCT02884596|Serotonin Agents|serotonin agents|mesh-ancestor
65170565|NCT02884596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65170566|NCT02884596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170567|NCT02884596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170568|NCT02884596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65170569|NCT02884596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65170570|NCT04205916|Moxifloxacin|moxifloxacin|mesh-list
65170571|NCT04205916|Dexamethasone|dexamethasone|mesh-list
65170572|NCT04205916|Ketorolac|ketorolac|mesh-list
65170573|NCT04205916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65170574|NCT04205916|Antiemetics|antiemetics|mesh-ancestor
65170575|NCT04205916|Autonomic Agents|autonomic agents|mesh-ancestor
65170576|NCT04205916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170577|NCT04205916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170578|NCT04205916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65170579|NCT04205916|Glucocorticoids|glucocorticoids|mesh-ancestor
65170580|NCT04205916|Hormones|hormones|mesh-ancestor
65170581|NCT04205916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65170584|NCT04205916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65170585|NCT04205916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65170586|NCT04205916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65170587|NCT04205916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65170588|NCT04205916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170589|NCT04205916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170590|NCT04205916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65170591|NCT04205916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65170592|NCT04205916|Analgesics|analgesics|mesh-ancestor
65170593|NCT04205916|Sensory System Agents|sensory system agents|mesh-ancestor
65170594|NCT04205916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65170595|NCT04205916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65322819|NCT05728151|Anesthetics, Local|anesthetics, local|mesh-ancestor
65322820|NCT05728151|Anesthetics|anesthetics|mesh-ancestor
65322821|NCT05728151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65322822|NCT05728151|Sensory System Agents|sensory system agents|mesh-ancestor
65322823|NCT00733746|Gemcitabine|gemcitabine|mesh-list
65322824|NCT00733746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65322825|NCT00733746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65322826|NCT00733746|Antimetabolites|antimetabolites|mesh-ancestor
65322827|NCT00733746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322828|NCT00733746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65322829|NCT00733746|Antiviral Agents|antiviral agents|mesh-ancestor
65322830|NCT00733746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65322831|NCT00733746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170596|NCT01176240|Mannitol|mannitol|mesh-list
65170597|NCT01176240|Droxidopa|droxidopa|mesh-list
65170598|NCT01176240|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65170599|NCT01176240|Diuretics|diuretics|mesh-ancestor
65170600|NCT01176240|Natriuretic Agents|natriuretic agents|mesh-ancestor
65170601|NCT01176240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170602|NCT01176240|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65170603|NCT01176240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65170604|NCT01149096|Lenograstim|lenograstim|mesh-list
65170605|NCT01149096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65170606|NCT01149096|Immunologic Factors|immunologic factors|mesh-ancestor
65170607|NCT01149096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170608|NCT02867397|Oxaliplatin|oxaliplatin|mesh-list
65170609|NCT02867397|Epirubicin|epirubicin|mesh-list
65170610|NCT02867397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170611|NCT02867397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65170612|NCT02867397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65170613|NCT02867397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65170614|NCT02867397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170615|NCT02867397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170616|NCT01175382|Tamsulosin|tamsulosin|mesh-list
65170617|NCT01175382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65170618|NCT01175382|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65170619|NCT01175382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65170620|NCT01175382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65170621|NCT01175382|Adrenergic Agents|adrenergic agents|mesh-ancestor
65170622|NCT01175382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65170623|NCT01175382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170624|NCT01175382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170625|NCT01175382|Urological Agents|urological agents|mesh-ancestor
65170626|NCT01175382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65170627|NCT01175382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65170628|NCT01175382|Cholinergic Agents|cholinergic agents|mesh-ancestor
65170630|NCT01194245|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65170631|NCT01194245|Insulin Glargine|insulin glargine|mesh-list
65170632|NCT01194245|Insulin Aspart|insulin aspart|mesh-list
65170633|NCT01194245|Insulin Lispro|insulin lispro|mesh-list
65170634|NCT01194245|Insulin glulisine|insulin glulisine|mesh-list
65170635|NCT01194245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65170636|NCT01194245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170637|NCT00979407|Vaccines|vaccines|mesh-list
65170638|NCT00979407|Immunologic Factors|immunologic factors|mesh-ancestor
65170639|NCT00979407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170640|NCT04290429|Teduglutide|teduglutide|mesh-list
65170641|NCT04290429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65170642|NCT04290429|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65170643|NCT04290429|Protective Agents|protective agents|mesh-ancestor
65170644|NCT04290429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170645|NCT00975975|Basiliximab|basiliximab|mesh-list
65170646|NCT00975975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65170647|NCT00975975|Immunologic Factors|immunologic factors|mesh-ancestor
65322832|NCT00733746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65322833|NCT00733746|Immunologic Factors|immunologic factors|mesh-ancestor
65322834|NCT00733746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322835|NCT00733746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65322836|NCT03422705|Lisinopril|lisinopril|mesh-list
65322837|NCT03422705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65322838|NCT03422705|Protease Inhibitors|protease inhibitors|mesh-ancestor
65322839|NCT03422705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322840|NCT03422705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322841|NCT03422705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65322842|NCT03422705|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65322843|NCT03422705|Protective Agents|protective agents|mesh-ancestor
65322844|NCT03422705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322845|NCT02607293|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65322846|NCT02607293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65322847|NCT02607293|Hormones|hormones|mesh-ancestor
64552601|NCT01455194|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65170648|NCT00975975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170649|NCT01193153|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65170650|NCT01193153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65170651|NCT01193153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65170652|NCT01193153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65170653|NCT01193153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170654|NCT01193153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65170655|NCT01193153|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65170656|NCT01193153|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65170666|NCT04289883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65170667|NCT04289883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170669|NCT02865369|Protease Inhibitors|protease inhibitors|mesh-ancestor
65170670|NCT02865369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170671|NCT02865369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170672|NCT01192295|Oxycodone|oxycodone|mesh-list
65170673|NCT01192295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65170674|NCT01192295|Narcotics|narcotics|mesh-ancestor
65170675|NCT01192295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65170676|NCT01192295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170677|NCT01192295|Analgesics|analgesics|mesh-ancestor
65170678|NCT01192295|Sensory System Agents|sensory system agents|mesh-ancestor
65170679|NCT01192295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170680|NCT04289103|Inolimomab|inolimomab|mesh-list
65170681|NCT04289103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65170682|NCT04289103|Immunologic Factors|immunologic factors|mesh-ancestor
65170683|NCT04289103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170684|NCT01154166|Ropinirole|ropinirole|mesh-list
65170685|NCT01154166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65170686|NCT01154166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65170687|NCT01154166|Dopamine Agonists|dopamine agonists|mesh-ancestor
65170688|NCT01154166|Dopamine Agents|dopamine agents|mesh-ancestor
65170689|NCT01154166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65170690|NCT01154166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170691|NCT01154166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170692|NCT04290195|Aflibercept|aflibercept|mesh-list
65170693|NCT04290195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65170694|NCT04290195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65170695|NCT04290195|Growth Substances|growth substances|mesh-ancestor
65170696|NCT04290195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170697|NCT04290195|Growth Inhibitors|growth inhibitors|mesh-ancestor
65322848|NCT02607293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65322849|NCT02607293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322850|NCT02607371|Rivaroxaban|rivaroxaban|mesh-list
65322851|NCT02607371|Apixaban|apixaban|mesh-list
65322852|NCT02607371|Edoxaban|edoxaban|mesh-list
65322853|NCT02607371|Dabigatran|dabigatran|mesh-list
65322854|NCT02607371|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65322855|NCT02607371|Antithrombins|antithrombins|mesh-ancestor
65322856|NCT02607371|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65322857|NCT02607371|Protease Inhibitors|protease inhibitors|mesh-ancestor
65322858|NCT02607371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322859|NCT02607371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322860|NCT02607371|Anticoagulants|anticoagulants|mesh-ancestor
65322861|NCT04085757|Dinoprostone|dinoprostone|mesh-list
65322862|NCT04085757|Oxytocics|oxytocics|mesh-ancestor
65322863|NCT04085757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65322864|NCT04085757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322865|NCT00727194|Eculizumab|eculizumab|mesh-list
65322866|NCT00727194|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65322867|NCT00727194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65322868|NCT00727194|Immunologic Factors|immunologic factors|mesh-ancestor
65072844|NCT00329940|Letrozole|letrozole|mesh-list
65322869|NCT00727194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322870|NCT00717093|Varenicline|varenicline|mesh-list
65322871|NCT00717093|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65322872|NCT00717093|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65170698|NCT04290195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170699|NCT05656703|Anesthetics|anesthetics|mesh-list
65170700|NCT05656703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65170701|NCT05656703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170702|NCT05656079|Cyclophosphamide|cyclophosphamide|mesh-list
65170703|NCT05656079|Docetaxel|docetaxel|mesh-list
65170704|NCT05656079|Doxorubicin|doxorubicin|mesh-list
65170705|NCT05656079|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65170706|NCT05656079|Trastuzumab|trastuzumab|mesh-list
65170707|NCT05656079|Epirubicin|epirubicin|mesh-list
65170708|NCT05656079|Pertuzumab|pertuzumab|mesh-list
65170709|NCT05656079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65170710|NCT05656079|Immunologic Factors|immunologic factors|mesh-ancestor
65170711|NCT05656079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170712|NCT05656079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65170713|NCT05656079|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65170714|NCT05656079|Alkylating Agents|alkylating agents|mesh-ancestor
65170715|NCT05656079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170716|NCT05656079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170717|NCT05656079|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65170718|NCT05656079|Tubulin Modulators|tubulin modulators|mesh-ancestor
65170719|NCT05656079|Antimitotic Agents|antimitotic agents|mesh-ancestor
65170720|NCT05656079|Mitosis Modulators|mitosis modulators|mesh-ancestor
65170721|NCT05656079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65170722|NCT05656079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65170723|NCT05656079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65322873|NCT00717093|Cholinergic Agents|cholinergic agents|mesh-ancestor
65322874|NCT00717093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65322875|NCT00717093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322876|NCT00717093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322877|NCT00716859|Timolol|timolol|mesh-list
65322878|NCT00716859|Latanoprost|latanoprost|mesh-list
65322879|NCT00716859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65322880|NCT00716859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65322881|NCT00716859|Adrenergic Agents|adrenergic agents|mesh-ancestor
65322882|NCT00716859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65322883|NCT00716859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322884|NCT00716859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322885|NCT00716859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65322886|NCT00716859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65322887|NCT00716859|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65322888|NCT00716859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65322889|NCT00590135|Atorvastatin|atorvastatin|mesh-list
65322890|NCT00590135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65322891|NCT00590135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65322892|NCT00590135|Antimetabolites|antimetabolites|mesh-ancestor
65322893|NCT00590135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322894|NCT00590135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65322895|NCT00590135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65322896|NCT00590135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170729|NCT01181921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170730|NCT01181921|Cholinergic Agents|cholinergic agents|mesh-ancestor
65170731|NCT01181921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65170732|NCT01181921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170733|NCT01181921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65170734|NCT01181921|Autonomic Agents|autonomic agents|mesh-ancestor
65170735|NCT01181921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170736|NCT01181921|Nootropic Agents|nootropic agents|mesh-ancestor
65170737|NCT00932698|Ixazomib|ixazomib|mesh-list
65170738|NCT00932698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170739|NCT00932698|Protease Inhibitors|protease inhibitors|mesh-ancestor
65170740|NCT00932698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170741|NCT00932698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170742|NCT00978627|Insulin|insulin|mesh-list
65170743|NCT00978627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65170744|NCT00978627|Insulin Aspart|insulin aspart|mesh-list
65170745|NCT00978627|Insulin, Long-Acting|insulin, long-acting|mesh-list
65170746|NCT00978627|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65170747|NCT00978627|Insulin Detemir|insulin detemir|mesh-list
65170748|NCT00978627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65170749|NCT00978627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170750|NCT01181609|Bevacizumab|bevacizumab|mesh-list
65170751|NCT01181609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65170752|NCT01181609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170753|NCT01181609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65322897|NCT00589667|Gemcitabine|gemcitabine|mesh-list
65322898|NCT00589667|Pemetrexed|pemetrexed|mesh-list
65322899|NCT00589667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65322900|NCT00589667|Antimetabolites|antimetabolites|mesh-ancestor
65322901|NCT00589667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322902|NCT00589667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65322903|NCT00589667|Antiviral Agents|antiviral agents|mesh-ancestor
65322904|NCT00589667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65322905|NCT00589667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322906|NCT00589667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65322907|NCT00589667|Immunologic Factors|immunologic factors|mesh-ancestor
65322908|NCT00589667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322909|NCT00589667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65322910|NCT00589667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65322911|NCT00737568|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65322912|NCT00737568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65322913|NCT00737568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65322914|NCT00737568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552675|NCT04007393|Topiramate|topiramate|mesh-list
65170754|NCT01181609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65170755|NCT01181609|Growth Substances|growth substances|mesh-ancestor
65170756|NCT01181609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170757|NCT01181609|Growth Inhibitors|growth inhibitors|mesh-ancestor
65170758|NCT04261426|Immunoglobulins|immunoglobulins|mesh-list
65170759|NCT04261426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65170760|NCT04261426|Antibodies|antibodies|mesh-list
65170761|NCT04261426|gamma-Globulins|gamma-globulins|mesh-list
65170762|NCT04261426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65170763|NCT04261426|Immunologic Factors|immunologic factors|mesh-ancestor
65170764|NCT04261426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170765|NCT04264078|Fludarabine|fludarabine|mesh-list
65170766|NCT04264078|Cyclophosphamide|cyclophosphamide|mesh-list
65170767|NCT04264078|Melphalan|melphalan|mesh-list
65170768|NCT04264078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813375|NCT01471158|Brinzolamide|brinzolamide|mesh-list
65170769|NCT04264078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170770|NCT04264078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65170771|NCT04264078|Immunologic Factors|immunologic factors|mesh-ancestor
65170772|NCT04264078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170773|NCT04264078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65170774|NCT04264078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65170775|NCT04264078|Alkylating Agents|alkylating agents|mesh-ancestor
65170776|NCT04264078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65170777|NCT01153698|Dabigatran|dabigatran|mesh-list
65170778|NCT01153698|Antithrombins|antithrombins|mesh-ancestor
65170779|NCT01153698|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65170780|NCT01153698|Protease Inhibitors|protease inhibitors|mesh-ancestor
65170781|NCT01153698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170782|NCT01153698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170783|NCT01153698|Anticoagulants|anticoagulants|mesh-ancestor
65170784|NCT00608218|Ciclesonide|ciclesonide|mesh-list
65170785|NCT00608218|Glucocorticoids|glucocorticoids|mesh-ancestor
65170786|NCT00608218|Hormones|hormones|mesh-ancestor
65170787|NCT00608218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65170788|NCT00608218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170789|NCT00608218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65322915|NCT00737568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322916|NCT00737568|Antiviral Agents|antiviral agents|mesh-ancestor
65322917|NCT00737568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65322918|NCT00737568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65322919|NCT00737568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65322920|NCT05752799|Analgesics, Opioid|analgesics, opioid|mesh-list
65322921|NCT05752799|Anesthetics|anesthetics|mesh-list
65322922|NCT05752799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65322923|NCT05752799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322924|NCT05752799|Narcotics|narcotics|mesh-ancestor
65322925|NCT05752799|Analgesics|analgesics|mesh-ancestor
65322926|NCT05752799|Sensory System Agents|sensory system agents|mesh-ancestor
65322927|NCT05752799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65322928|NCT00737100|Bromides|bromides|mesh-list
65322929|NCT00737100|Tiotropium Bromide|tiotropium bromide|mesh-list
65322930|NCT00737100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65322931|NCT00737100|Autonomic Agents|autonomic agents|mesh-ancestor
65322932|NCT00737100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65322933|NCT00737100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552689|NCT05368805|Dabigatran|dabigatran|mesh-list
65170790|NCT02884050|Topiramate|topiramate|mesh-list
65170791|NCT02884050|Anticonvulsants|anticonvulsants|mesh-ancestor
65170792|NCT02884050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65170793|NCT02884050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170794|NCT02884440|Ropivacaine|ropivacaine|mesh-list
65170801|NCT00609934|Sorafenib|sorafenib|mesh-list
65170802|NCT00609934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170803|NCT00609934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65170804|NCT00609934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170805|NCT00609934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170806|NCT01147926|Prucalopride|prucalopride|mesh-list
65170807|NCT01147926|Laxatives|laxatives|mesh-ancestor
65170808|NCT01147926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65170809|NCT01147926|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65170810|NCT01147926|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65170811|NCT01147926|Serotonin Agents|serotonin agents|mesh-ancestor
65170812|NCT01147926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65170813|NCT01147926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170814|NCT01147926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170815|NCT05115136|Diphenhydramine|diphenhydramine|mesh-list
65170816|NCT05115136|Promethazine|promethazine|mesh-list
65170817|NCT05115136|Doxepin|doxepin|mesh-list
65170818|NCT05115136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65170819|NCT05115136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65170820|NCT05115136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65170821|NCT05115136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170822|NCT05115136|Anesthetics, Local|anesthetics, local|mesh-ancestor
65170823|NCT05115136|Anesthetics|anesthetics|mesh-ancestor
65170824|NCT05115136|Sensory System Agents|sensory system agents|mesh-ancestor
65170825|NCT05115136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170826|NCT05115136|Antiemetics|antiemetics|mesh-ancestor
65170827|NCT05115136|Autonomic Agents|autonomic agents|mesh-ancestor
65170828|NCT05115136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65170829|NCT05115136|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65170830|NCT05115136|Histamine Antagonists|histamine antagonists|mesh-ancestor
65170831|NCT05115136|Histamine Agents|histamine agents|mesh-ancestor
65170832|NCT05115136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65322934|NCT00737100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65322935|NCT00737100|Respiratory System Agents|respiratory system agents|mesh-ancestor
65322936|NCT00737100|Parasympatholytics|parasympatholytics|mesh-ancestor
65322937|NCT00737100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65322938|NCT00737100|Cholinergic Agents|cholinergic agents|mesh-ancestor
65322939|NCT00737100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65322940|NCT00737100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322941|NCT00737100|Anticonvulsants|anticonvulsants|mesh-ancestor
65322942|NCT00732498|Cytarabine|cytarabine|mesh-list
65322943|NCT00732498|Methylprednisolone|methylprednisolone|mesh-list
65322944|NCT00732498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65322945|NCT00732498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65322946|NCT00732498|Prednisolone|prednisolone|mesh-list
65322947|NCT00732498|Prednisolone acetate|prednisolone acetate|mesh-list
65322948|NCT00732498|Rituximab|rituximab|mesh-list
65322949|NCT00732498|Etoposide|etoposide|mesh-list
65322950|NCT00732498|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65322951|NCT00732498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65322952|NCT00732498|Prednisolone phosphate|prednisolone phosphate|mesh-list
65170833|NCT05115136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170834|NCT05115136|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65170835|NCT05115136|Antipruritics|antipruritics|mesh-ancestor
65170836|NCT05115136|Dermatologic Agents|dermatologic agents|mesh-ancestor
65170837|NCT05115136|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65170838|NCT05115136|Antidepressive Agents|antidepressive agents|mesh-ancestor
65170839|NCT05115136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65170840|NCT00608374|Fludarabine|fludarabine|mesh-list
65170841|NCT00608374|Fludarabine phosphate|fludarabine phosphate|mesh-list
65170842|NCT00608374|Chlorambucil|chlorambucil|mesh-list
65170843|NCT00608374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170844|NCT00608374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65170845|NCT00608374|Antimetabolites|antimetabolites|mesh-ancestor
65170846|NCT00608374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170847|NCT00608374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65170848|NCT00608374|Immunologic Factors|immunologic factors|mesh-ancestor
65170849|NCT00608374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170850|NCT00608374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65170851|NCT00608374|Alkylating Agents|alkylating agents|mesh-ancestor
65170852|NCT00625014|Haloperidol|haloperidol|mesh-list
65170853|NCT00625014|Haloperidol decanoate|haloperidol decanoate|mesh-list
65170854|NCT00625014|Antiemetics|antiemetics|mesh-ancestor
65170855|NCT00625014|Autonomic Agents|autonomic agents|mesh-ancestor
65170856|NCT00625014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170857|NCT00625014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170858|NCT00625014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65170859|NCT00625014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65170860|NCT00625014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65170861|NCT00625014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65170862|NCT00625014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65170863|NCT00625014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65170870|NCT01147848|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65170871|NCT01147848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65170872|NCT01147848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65170874|NCT01147848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170875|NCT01147848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170876|NCT01147848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65170877|NCT01147848|Respiratory System Agents|respiratory system agents|mesh-ancestor
65170878|NCT01147848|Dermatologic Agents|dermatologic agents|mesh-ancestor
65322953|NCT00732498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65322954|NCT00732498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65322955|NCT00732498|Immunologic Factors|immunologic factors|mesh-ancestor
65322956|NCT00732498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322957|NCT00732498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65322958|NCT00732498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65322959|NCT00732498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65322960|NCT00732498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65322961|NCT00732498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65322962|NCT00732498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322963|NCT00732498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65322964|NCT00732498|Antimetabolites|antimetabolites|mesh-ancestor
65322965|NCT00732498|Antiviral Agents|antiviral agents|mesh-ancestor
65322966|NCT00732498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65322967|NCT00732498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65322968|NCT00732498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65170879|NCT01147848|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65170880|NCT01147848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65170881|NCT01147848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65170882|NCT01147848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65170883|NCT01147848|Adrenergic Agents|adrenergic agents|mesh-ancestor
65170884|NCT01147848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65170885|NCT01147848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170886|NCT04261270|Ritonavir|ritonavir|mesh-list
65170887|NCT04261270|Oseltamivir|oseltamivir|mesh-list
65170888|NCT04261270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65170889|NCT04261270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65170890|NCT04261270|Protease Inhibitors|protease inhibitors|mesh-ancestor
65170891|NCT04261270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170892|NCT04261270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170893|NCT04261270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65170894|NCT04261270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65170895|NCT04261270|Antiviral Agents|antiviral agents|mesh-ancestor
65170896|NCT04261270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65170897|NCT04261270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65170898|NCT04261270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65170899|NCT01152996|Vortioxetine|vortioxetine|mesh-list
65170900|NCT01152996|Antidepressive Agents|antidepressive agents|mesh-ancestor
65170901|NCT01152996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65170902|NCT01152996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65170903|NCT01152996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65170904|NCT01152996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65170905|NCT01152996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170906|NCT01152996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65170907|NCT01152996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65170908|NCT01152996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65170909|NCT01152996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170910|NCT01152996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65170911|NCT01152996|Serotonin Agents|serotonin agents|mesh-ancestor
65170912|NCT01152996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65170913|NCT01152996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65170914|NCT01152996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65170915|NCT01152996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65170916|NCT00624936|Azacitidine|azacitidine|mesh-list
65170917|NCT00624936|Bortezomib|bortezomib|mesh-list
65170918|NCT00624936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65322969|NCT00732498|Antiemetics|antiemetics|mesh-ancestor
65322970|NCT00732498|Autonomic Agents|autonomic agents|mesh-ancestor
65322971|NCT00732498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65322972|NCT00732498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65322973|NCT00732498|Glucocorticoids|glucocorticoids|mesh-ancestor
65322974|NCT00732498|Hormones|hormones|mesh-ancestor
65322975|NCT00732498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65322976|NCT00732498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65322977|NCT00732498|Protective Agents|protective agents|mesh-ancestor
65322978|NCT00732498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65322979|NCT00790400|Everolimus|everolimus|mesh-list
65170919|NCT00624936|Antimetabolites|antimetabolites|mesh-ancestor
65170920|NCT00624936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813533|NCT01472016|Docetaxel|docetaxel|mesh-list
65170921|NCT00624936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170922|NCT00624936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170923|NCT00979953|Oxycodone|oxycodone|mesh-list
65170924|NCT00979953|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65170925|NCT00979953|Narcotics|narcotics|mesh-ancestor
65170926|NCT00979953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65170927|NCT00979953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170928|NCT00979953|Analgesics|analgesics|mesh-ancestor
65170929|NCT00979953|Sensory System Agents|sensory system agents|mesh-ancestor
65170930|NCT00979953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170931|NCT01181531|Vitamin D|vitamin d|mesh-list
65170932|NCT01181531|Cinacalcet|cinacalcet|mesh-list
65170937|NCT01181531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65170939|NCT01181531|Hormone Antagonists|hormone antagonists|mesh-ancestor
65170940|NCT01181531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65170941|NCT01152450|Tiotropium Bromide|tiotropium bromide|mesh-list
65170942|NCT01152450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65170943|NCT01152450|Autonomic Agents|autonomic agents|mesh-ancestor
65170944|NCT01152450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170945|NCT01152450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170946|NCT01152450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65170947|NCT01152450|Respiratory System Agents|respiratory system agents|mesh-ancestor
65170948|NCT01152450|Parasympatholytics|parasympatholytics|mesh-ancestor
65170949|NCT01152450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65170950|NCT01152450|Cholinergic Agents|cholinergic agents|mesh-ancestor
65170951|NCT01152450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65170952|NCT01152450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170953|NCT00610246|Sorafenib|sorafenib|mesh-list
65170954|NCT00610246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170955|NCT00610246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65170956|NCT00610246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170957|NCT00610246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170958|NCT01181141|Enoxaparin|enoxaparin|mesh-list
65170959|NCT01181141|Enoxaparin sodium|enoxaparin sodium|mesh-list
65170960|NCT01181141|Edoxaban|edoxaban|mesh-list
65170961|NCT01181141|Anticoagulants|anticoagulants|mesh-ancestor
65170962|NCT01181141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65170963|NCT01181141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65170964|NCT01181141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170965|NCT01181141|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65170966|NCT01181141|Antithrombins|antithrombins|mesh-ancestor
65170967|NCT01181141|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65170968|NCT01181141|Protease Inhibitors|protease inhibitors|mesh-ancestor
65170969|NCT01181141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170970|NCT00606814|Docetaxel|docetaxel|mesh-list
65170971|NCT00606814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170972|NCT00606814|Tubulin Modulators|tubulin modulators|mesh-ancestor
65170973|NCT00606814|Antimitotic Agents|antimitotic agents|mesh-ancestor
65170974|NCT00606814|Mitosis Modulators|mitosis modulators|mesh-ancestor
65170975|NCT00606814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170976|NCT01173120|Abatacept|abatacept|mesh-list
65222841|NCT02586181|Cholecalciferol|cholecalciferol|mesh-list
65322980|NCT00790400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65322981|NCT00790400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65322982|NCT00790400|Immunologic Factors|immunologic factors|mesh-ancestor
65322983|NCT00790400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322984|NCT00915512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65322985|NCT00915512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65322986|NCT00915512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65322987|NCT00915512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65322988|NCT00915512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65322989|NCT00915512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65322990|NCT00915512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65170977|NCT01173120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65170978|NCT01173120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170979|NCT01173120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170980|NCT01173120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65170981|NCT01173120|Immunologic Factors|immunologic factors|mesh-ancestor
65170982|NCT01173120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170983|NCT01173120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65170984|NCT00977379|Capecitabine|capecitabine|mesh-list
65170985|NCT00977379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65170986|NCT00977379|Antimetabolites|antimetabolites|mesh-ancestor
65170987|NCT00977379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170988|NCT00977379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170989|NCT04263844|Midazolam|midazolam|mesh-list
65170990|NCT04263844|Dexmedetomidine|dexmedetomidine|mesh-list
65170991|NCT04263844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65170992|NCT04263844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65170993|NCT04263844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170994|NCT04263844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65170995|NCT04263844|Analgesics|analgesics|mesh-ancestor
65170996|NCT04263844|Sensory System Agents|sensory system agents|mesh-ancestor
65170997|NCT04263844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170998|NCT04263844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65170999|NCT04263844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65171000|NCT04263844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65171001|NCT04263844|Adrenergic Agents|adrenergic agents|mesh-ancestor
65171002|NCT04263844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65171014|NCT00610324|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65171015|NCT00610324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65171016|NCT00610324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65171017|NCT00610324|Disinfectants|disinfectants|mesh-ancestor
65171018|NCT00610324|Dermatologic Agents|dermatologic agents|mesh-ancestor
65171020|NCT04261036|Antioxidants|antioxidants|mesh-ancestor
65171021|NCT04261036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171022|NCT04261036|Protective Agents|protective agents|mesh-ancestor
65171023|NCT04261036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171024|NCT04261036|Vitamins|vitamins|mesh-ancestor
65171025|NCT04261036|Micronutrients|micronutrients|mesh-ancestor
65171026|NCT04067115|Alovudine|alovudine|mesh-list
65171027|NCT04067115|Irinotecan|irinotecan|mesh-list
65171028|NCT04067115|Trabectedin|trabectedin|mesh-list
65171029|NCT04067115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65171030|NCT04067115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65171031|NCT04067115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171032|NCT04067115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171033|NCT04067115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171034|NCT04067115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65171035|NCT04067115|Alkylating Agents|alkylating agents|mesh-ancestor
65171036|NCT04067115|Antiviral Agents|antiviral agents|mesh-ancestor
65171037|NCT04067115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65171038|NCT02884128|Leucovorin|leucovorin|mesh-list
65171039|NCT02884128|Fluorouracil|fluorouracil|mesh-list
65171040|NCT02884128|Irinotecan|irinotecan|mesh-list
65171041|NCT02884128|Antimetabolites|antimetabolites|mesh-ancestor
65322991|NCT00915512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65322992|NCT00915512|Serotonin Agents|serotonin agents|mesh-ancestor
65322993|NCT00915512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65322994|NCT00915512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65322995|NCT00915512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65322996|NCT00915512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65322997|NCT00915512|Dopamine Agents|dopamine agents|mesh-ancestor
65322998|NCT02602652|Vaccines|vaccines|mesh-list
65322999|NCT02602652|Immunologic Factors|immunologic factors|mesh-ancestor
65323000|NCT02602652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323001|NCT02593500|Budesonide|budesonide|mesh-list
65323002|NCT02593500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65323003|NCT02593500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65323004|NCT02593500|Autonomic Agents|autonomic agents|mesh-ancestor
65323005|NCT02593500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323006|NCT02593500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323007|NCT02593500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65323008|NCT02593500|Respiratory System Agents|respiratory system agents|mesh-ancestor
65323009|NCT02593500|Glucocorticoids|glucocorticoids|mesh-ancestor
65323010|NCT02593500|Hormones|hormones|mesh-ancestor
64552752|NCT03258385|Micronutrients|micronutrients|mesh-ancestor
65171042|NCT02884128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171043|NCT02884128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65171044|NCT02884128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171045|NCT02884128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65171046|NCT02884128|Immunologic Factors|immunologic factors|mesh-ancestor
65171047|NCT02884128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171048|NCT02884128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65171049|NCT02884128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65171050|NCT02884128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171051|NCT02884128|Antidotes|antidotes|mesh-ancestor
65171052|NCT02884128|Protective Agents|protective agents|mesh-ancestor
65171053|NCT02884128|Vitamin B Complex|vitamin b complex|mesh-ancestor
65171054|NCT02884128|Vitamins|vitamins|mesh-ancestor
65171055|NCT02884128|Micronutrients|micronutrients|mesh-ancestor
65171056|NCT00629343|Azacitidine|azacitidine|mesh-list
65171057|NCT00629343|Temozolomide|temozolomide|mesh-list
65171058|NCT00629343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65171059|NCT00629343|Antimetabolites|antimetabolites|mesh-ancestor
65171060|NCT00629343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171061|NCT00629343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171062|NCT00629343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171063|NCT00629343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65171064|NCT00629343|Alkylating Agents|alkylating agents|mesh-ancestor
65171065|NCT01180049|Sirolimus|sirolimus|mesh-list
65171066|NCT01180049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65171067|NCT01180049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65171068|NCT01180049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65171069|NCT01180049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171076|NCT01147458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65171077|NCT01147458|Analgesics|analgesics|mesh-ancestor
65171078|NCT01147458|Sensory System Agents|sensory system agents|mesh-ancestor
65171079|NCT01147458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65171080|NCT01147458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171081|NCT01147458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65171082|NCT01147458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65323011|NCT02593500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65323012|NCT02594358|Caffeine|caffeine|mesh-list
65323013|NCT02594358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65323014|NCT02594358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323015|NCT02594358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65323016|NCT02594358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65323017|NCT02594358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323018|NCT02594358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65323019|NCT02594358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65323020|NCT02594358|Purinergic Agents|purinergic agents|mesh-ancestor
65171083|NCT01147458|Gout Suppressants|gout suppressants|mesh-ancestor
65171084|NCT01147458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65171085|NCT01147458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171086|NCT01147458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171087|NCT01172808|Tiotropium Bromide|tiotropium bromide|mesh-list
65171088|NCT01172808|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65171089|NCT01172808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65171090|NCT01172808|Autonomic Agents|autonomic agents|mesh-ancestor
65171091|NCT01172808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65171092|NCT01172808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171093|NCT01172808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65171094|NCT01172808|Respiratory System Agents|respiratory system agents|mesh-ancestor
65171095|NCT01172808|Parasympatholytics|parasympatholytics|mesh-ancestor
65171096|NCT01172808|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65171097|NCT01172808|Cholinergic Agents|cholinergic agents|mesh-ancestor
65171098|NCT01172808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65171099|NCT01172808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171100|NCT01172808|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65171101|NCT01172808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65171102|NCT01172808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65171103|NCT01172808|Adrenergic Agents|adrenergic agents|mesh-ancestor
65171104|NCT04315194|Clarithromycin|clarithromycin|mesh-list
65171105|NCT04315194|Oseltamivir|oseltamivir|mesh-list
65171106|NCT04315194|Naproxen|naproxen|mesh-list
65171107|NCT04315194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65171108|NCT04315194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65171109|NCT04315194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65171110|NCT04315194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171111|NCT04315194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171112|NCT04315194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65171113|NCT04315194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65171114|NCT04315194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65171115|NCT04315194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65171116|NCT04315194|Analgesics|analgesics|mesh-ancestor
65171117|NCT04315194|Sensory System Agents|sensory system agents|mesh-ancestor
65171118|NCT04315194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65171119|NCT04315194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171120|NCT04315194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65171121|NCT04315194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65171122|NCT04315194|Gout Suppressants|gout suppressants|mesh-ancestor
65171123|NCT04315194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65171124|NCT04315194|Antiviral Agents|antiviral agents|mesh-ancestor
65171125|NCT04066491|Gemcitabine|gemcitabine|mesh-list
65171126|NCT04066491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171127|NCT04066491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65171128|NCT04066491|Antimetabolites|antimetabolites|mesh-ancestor
65171129|NCT04066491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171130|NCT04066491|Antiviral Agents|antiviral agents|mesh-ancestor
65171131|NCT04066491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65171132|NCT04066491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171133|NCT04066491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65171134|NCT04066491|Immunologic Factors|immunologic factors|mesh-ancestor
65072991|NCT00451373|Daptomycin|daptomycin|mesh-list
65323021|NCT02594358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65323023|NCT00716625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323024|NCT00716625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65323025|NCT00716625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65323026|NCT00716625|Growth Substances|growth substances|mesh-ancestor
65323027|NCT00716625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323028|NCT00716625|Growth Inhibitors|growth inhibitors|mesh-ancestor
65323029|NCT00716625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65323030|NCT00716625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65323031|NCT00716625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323032|NCT00785486|Quinine|quinine|mesh-list
65323033|NCT00785486|Midazolam|midazolam|mesh-list
65323034|NCT00785486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65323035|NCT00785486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65323036|NCT00785486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65323037|NCT00785486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323038|NCT00785486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65323039|NCT00785486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65323040|NCT00785486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65323041|NCT00785486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65323042|NCT00785486|Anesthetics, General|anesthetics, general|mesh-ancestor
65323043|NCT00785486|Anesthetics|anesthetics|mesh-ancestor
65323044|NCT00785486|GABA Modulators|gaba modulators|mesh-ancestor
65323045|NCT00785486|GABA Agents|gaba agents|mesh-ancestor
65323046|NCT00785486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65323047|NCT00785486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323048|NCT00785486|Antimalarials|antimalarials|mesh-ancestor
65323049|NCT00785486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65323050|NCT00785486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65323051|NCT00785486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65171135|NCT04066491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171136|NCT01149486|Losartan|losartan|mesh-list
65171137|NCT01149486|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65171138|NCT01149486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65171139|NCT01149486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65171142|NCT01149486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171145|NCT01149486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171146|NCT01149486|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65171147|NCT01149486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65171148|NCT00640471|Cetuximab|cetuximab|mesh-list
65171149|NCT00640471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65171150|NCT00640471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171151|NCT00601705|Fluorouracil|fluorouracil|mesh-list
65323052|NCT00785486|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65323053|NCT00785486|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65323054|NCT00785486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323055|NCT00785486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65323056|NCT00785486|Analgesics|analgesics|mesh-ancestor
65323057|NCT00785486|Sensory System Agents|sensory system agents|mesh-ancestor
65323058|NCT00917904|Dapivirine|dapivirine|mesh-list
65323059|NCT00917904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65323060|NCT00917904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65323061|NCT00917904|Antiviral Agents|antiviral agents|mesh-ancestor
65323062|NCT00917904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65323063|NCT00589979|Lidocaine|lidocaine|mesh-list
65323064|NCT00589979|Anesthetics, Local|anesthetics, local|mesh-ancestor
65323065|NCT00589979|Anesthetics|anesthetics|mesh-ancestor
65323066|NCT00589979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65323067|NCT00589979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323068|NCT00589979|Sensory System Agents|sensory system agents|mesh-ancestor
65171152|NCT00601705|Oxaliplatin|oxaliplatin|mesh-list
65171153|NCT00601705|Epirubicin|epirubicin|mesh-list
65171154|NCT00601705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171155|NCT00601705|Antimetabolites|antimetabolites|mesh-ancestor
65171156|NCT00601705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171157|NCT00601705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65171158|NCT00601705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65171159|NCT00601705|Immunologic Factors|immunologic factors|mesh-ancestor
65171160|NCT00601705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171161|NCT00601705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65171162|NCT00601705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65171163|NCT00601705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65171164|NCT00601705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171165|NCT00641173|Paroxetine|paroxetine|mesh-list
65171166|NCT00641173|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65171167|NCT00641173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65171168|NCT00641173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65171169|NCT00641173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171170|NCT00641173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65171171|NCT00641173|Serotonin Agents|serotonin agents|mesh-ancestor
65171172|NCT00641173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171173|NCT00641173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65171174|NCT00641173|Antidepressive Agents|antidepressive agents|mesh-ancestor
65171175|NCT00641173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65171176|NCT00641173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65171177|NCT00641173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65171178|NCT00641173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171179|NCT00929110|Glycopyrrolate|glycopyrrolate|mesh-list
65171180|NCT00929110|Bromides|bromides|mesh-list
65171181|NCT00929110|Tiotropium Bromide|tiotropium bromide|mesh-list
65171182|NCT00929110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65171183|NCT00929110|Autonomic Agents|autonomic agents|mesh-ancestor
65171184|NCT00929110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65171185|NCT00929110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171186|NCT00929110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65171187|NCT00929110|Respiratory System Agents|respiratory system agents|mesh-ancestor
65171188|NCT00929110|Parasympatholytics|parasympatholytics|mesh-ancestor
65171189|NCT00929110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65171190|NCT00929110|Cholinergic Agents|cholinergic agents|mesh-ancestor
65171191|NCT00929110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65171192|NCT00929110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323069|NCT00589979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323070|NCT00589979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65323071|NCT00589979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65323072|NCT00589979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65323073|NCT00589979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65323074|NCT00589979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323075|NCT02590653|Atorvastatin|atorvastatin|mesh-list
65323076|NCT02590653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65323077|NCT02590653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65323078|NCT02590653|Antimetabolites|antimetabolites|mesh-ancestor
65323079|NCT02590653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323080|NCT02590653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65323081|NCT02590653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65323082|NCT02590653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65323083|NCT00915746|Ketoconazole|ketoconazole|mesh-list
65323084|NCT00915746|Antifungal Agents|antifungal agents|mesh-ancestor
65323085|NCT00915746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65323086|NCT00915746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65323087|NCT00915746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65171193|NCT00929110|Anticonvulsants|anticonvulsants|mesh-ancestor
65171194|NCT00929110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65171195|NCT00929110|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65171196|NCT00922519|Listerine|listerine|mesh-list
65171197|NCT00922519|Fluorides|fluorides|mesh-list
65171198|NCT00922519|Sodium Fluoride|sodium fluoride|mesh-list
65171199|NCT00922519|Cariostatic Agents|cariostatic agents|mesh-ancestor
65171200|NCT00922519|Protective Agents|protective agents|mesh-ancestor
65171201|NCT00922519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171202|NCT00922519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65171203|NCT00922519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65171204|NCT00640549|Atorvastatin|atorvastatin|mesh-list
65171205|NCT00640549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65171206|NCT00640549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65171207|NCT00640549|Antimetabolites|antimetabolites|mesh-ancestor
65171208|NCT00640549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171209|NCT00640549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65171210|NCT00640549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65171215|NCT02683369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171216|NCT01147068|Hemagglutinins|hemagglutinins|mesh-list
65171217|NCT01147068|Agglutinins|agglutinins|mesh-ancestor
65171218|NCT01147068|Immunologic Factors|immunologic factors|mesh-ancestor
65171219|NCT01147068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171220|NCT00640627|Celecoxib|celecoxib|mesh-list
65171221|NCT00640627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65171222|NCT00640627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65171223|NCT00640627|Analgesics|analgesics|mesh-ancestor
65171224|NCT00640627|Sensory System Agents|sensory system agents|mesh-ancestor
65171225|NCT00640627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65171226|NCT00640627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171227|NCT00640627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65171228|NCT00640627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65171229|NCT00640627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65171230|NCT00640627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65171231|NCT00640627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65323088|NCT00915746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65323089|NCT00915746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323090|NCT00915746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65323091|NCT00915746|Hormone Antagonists|hormone antagonists|mesh-ancestor
65323092|NCT00915746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65323093|NCT00915746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073069|NCT00451880|Famotidine|famotidine|mesh-list
65323094|NCT00915746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65323095|NCT03215927|Abatacept|abatacept|mesh-list
65323096|NCT03215927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65323097|NCT03215927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323098|NCT03215927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323099|NCT03215927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65323100|NCT03215927|Immunologic Factors|immunologic factors|mesh-ancestor
65323101|NCT03215927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552837|NCT03080545|Calcipotriene|calcipotriene|mesh-list
65171232|NCT00640627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171233|NCT02681887|Melatonin|melatonin|mesh-list
65171234|NCT02681887|Antioxidants|antioxidants|mesh-ancestor
65171235|NCT02681887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171236|NCT02681887|Protective Agents|protective agents|mesh-ancestor
65171237|NCT02681887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171238|NCT02681887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65171239|NCT01134042|Fluticasone|fluticasone|mesh-list
65171240|NCT01134042|Xhance|xhance|mesh-list
65171241|NCT01134042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65171242|NCT01134042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65171243|NCT01134042|Autonomic Agents|autonomic agents|mesh-ancestor
65171244|NCT01134042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65171245|NCT01134042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171246|NCT01134042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65171247|NCT01134042|Respiratory System Agents|respiratory system agents|mesh-ancestor
65171248|NCT01134042|Dermatologic Agents|dermatologic agents|mesh-ancestor
65171249|NCT01134042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65171250|NCT01179347|Tiotropium Bromide|tiotropium bromide|mesh-list
65171251|NCT01179347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65171252|NCT01179347|Autonomic Agents|autonomic agents|mesh-ancestor
65171253|NCT01179347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65171254|NCT01179347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171255|NCT01179347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65171256|NCT01179347|Respiratory System Agents|respiratory system agents|mesh-ancestor
65171257|NCT01179347|Parasympatholytics|parasympatholytics|mesh-ancestor
65171258|NCT01179347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65171259|NCT01179347|Cholinergic Agents|cholinergic agents|mesh-ancestor
65171260|NCT01179347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65171261|NCT01179347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171262|NCT01146288|Furosemide|furosemide|mesh-list
65171263|NCT01146288|Acetazolamide|acetazolamide|mesh-list
65171264|NCT01146288|Diuretics|diuretics|mesh-ancestor
65171265|NCT01146288|Natriuretic Agents|natriuretic agents|mesh-ancestor
65171266|NCT01146288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171267|NCT01146288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65171268|NCT01146288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65171269|NCT01146288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171270|NCT01146288|Anticonvulsants|anticonvulsants|mesh-ancestor
65171271|NCT01146288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65323102|NCT03215927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65323103|NCT00736944|Cisplatin|cisplatin|mesh-list
65323104|NCT00736944|Cetuximab|cetuximab|mesh-list
65323105|NCT00736944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65323106|NCT00736944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323107|NCT00736944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65323108|NCT02603510|Insulin Lispro|insulin lispro|mesh-list
65323109|NCT02603510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65323110|NCT02603510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323111|NCT04084977|Antibodies|antibodies|mesh-list
65323112|NCT04084977|Immunologic Factors|immunologic factors|mesh-ancestor
65323113|NCT04084977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323114|NCT04107194|Amoxicillin|amoxicillin|mesh-list
65323115|NCT04107194|Metronidazole|metronidazole|mesh-list
65323116|NCT04107194|Clarithromycin|clarithromycin|mesh-list
65323117|NCT04107194|Levofloxacin|levofloxacin|mesh-list
65323118|NCT04107194|Tetracycline|tetracycline|mesh-list
65323119|NCT04107194|Rifabutin|rifabutin|mesh-list
65323120|NCT04107194|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
65323121|NCT04107194|Pantoprazole|pantoprazole|mesh-list
65323122|NCT04107194|Bismuth|bismuth|mesh-list
65323123|NCT04107194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65171272|NCT01146288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171273|NCT01146054|Gemcitabine|gemcitabine|mesh-list
65171274|NCT01146054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65171275|NCT01146054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65171276|NCT01146054|Antimetabolites|antimetabolites|mesh-ancestor
65171277|NCT01146054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171278|NCT01146054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171279|NCT01146054|Antiviral Agents|antiviral agents|mesh-ancestor
65171280|NCT01146054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65171281|NCT01146054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171282|NCT01146054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65171287|NCT00640705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65171288|NCT00640705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65171289|NCT00640705|Analgesics|analgesics|mesh-ancestor
65171290|NCT00640705|Sensory System Agents|sensory system agents|mesh-ancestor
65171291|NCT00640705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65171292|NCT00640705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171294|NCT00640705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65171295|NCT00640705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65171296|NCT00640705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171297|NCT00640705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171298|NCT01145898|Timolol|timolol|mesh-list
65171299|NCT01145898|Dorzolamide|dorzolamide|mesh-list
65171300|NCT01145898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65171301|NCT01145898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65171302|NCT01145898|Adrenergic Agents|adrenergic agents|mesh-ancestor
65171303|NCT01145898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65171304|NCT01145898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171305|NCT01145898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171306|NCT01145898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65171307|NCT01145898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65171308|NCT01145898|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65171309|NCT01145898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171310|NCT02681653|Atorvastatin|atorvastatin|mesh-list
65171311|NCT02681653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65171312|NCT02681653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65323124|NCT04107194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65323125|NCT04107194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65323126|NCT04107194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65323127|NCT04107194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65323128|NCT04107194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65323129|NCT04107194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323130|NCT04107194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65323131|NCT04107194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65323132|NCT04107194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65323133|NCT04107194|Renal Agents|renal agents|mesh-ancestor
65323134|NCT04107194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65323135|NCT04107194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65323136|NCT04107194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323137|NCT04107194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65323138|NCT04107194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65323139|NCT04107194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65323140|NCT04107194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65323141|NCT04107194|Antacids|antacids|mesh-ancestor
65323142|NCT04107194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65171313|NCT02681653|Antimetabolites|antimetabolites|mesh-ancestor
65171314|NCT02681653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171315|NCT02681653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65171316|NCT02681653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65171317|NCT02681653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171318|NCT04315116|Loperamide|loperamide|mesh-list
65171319|NCT04315116|Antidiarrheals|antidiarrheals|mesh-list
65171320|NCT04315116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65171321|NCT02883114|Itraconazole|itraconazole|mesh-list
65171322|NCT02883114|Antifungal Agents|antifungal agents|mesh-ancestor
65171323|NCT02883114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65171324|NCT02883114|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65171325|NCT02883114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65171326|NCT02883114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171327|NCT02883114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171328|NCT02883114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65171329|NCT02883114|Hormone Antagonists|hormone antagonists|mesh-ancestor
65171330|NCT02883114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65171331|NCT02883114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171332|NCT02883114|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65171333|NCT04183387|Simvastatin|simvastatin|mesh-list
65171334|NCT04183387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65171335|NCT04183387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65171336|NCT04183387|Antimetabolites|antimetabolites|mesh-ancestor
65171337|NCT04183387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171338|NCT04183387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65171339|NCT04183387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65171340|NCT04183387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171341|NCT00625092|Leucovorin|leucovorin|mesh-list
65171342|NCT00625092|Fluorouracil|fluorouracil|mesh-list
65171343|NCT00625092|Oxaliplatin|oxaliplatin|mesh-list
65171344|NCT00625092|Calcium|calcium|mesh-list
65171345|NCT00625092|Levoleucovorin|levoleucovorin|mesh-list
65171346|NCT00625092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65171347|NCT00625092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323143|NCT04107194|Antitubercular Agents|antitubercular agents|mesh-ancestor
65323144|NCT02590263|Temozolomide|temozolomide|mesh-list
65323145|NCT02590263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65323146|NCT02590263|Alkylating Agents|alkylating agents|mesh-ancestor
65323147|NCT02590263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323148|NCT02590263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323149|NCT00736476|Vaccines|vaccines|mesh-list
65323150|NCT00736476|Immunologic Factors|immunologic factors|mesh-ancestor
65323151|NCT00736476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323152|NCT02606357|Insulin Glargine|insulin glargine|mesh-list
65323153|NCT02606357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65323154|NCT02606357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323155|NCT05642078|Vaccines|vaccines|mesh-list
65323156|NCT05642078|Immunologic Factors|immunologic factors|mesh-ancestor
65323157|NCT05642078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323158|NCT04019496|Calcitonin|calcitonin|mesh-list
65323159|NCT04019496|Salmon calcitonin|salmon calcitonin|mesh-list
65323160|NCT04019496|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
65171348|NCT00625092|Antimetabolites|antimetabolites|mesh-ancestor
65171349|NCT00625092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171350|NCT00625092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65171351|NCT00625092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171352|NCT00625092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65171353|NCT00625092|Immunologic Factors|immunologic factors|mesh-ancestor
65171359|NCT00931918|Prednisone|prednisone|mesh-list
65171360|NCT00931918|Cyclophosphamide|cyclophosphamide|mesh-list
65171361|NCT00931918|Rituximab|rituximab|mesh-list
65171362|NCT00931918|Doxorubicin|doxorubicin|mesh-list
65171363|NCT00931918|Vincristine|vincristine|mesh-list
65171364|NCT00931918|Bortezomib|bortezomib|mesh-list
65171365|NCT00931918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65171366|NCT00931918|Immunologic Factors|immunologic factors|mesh-ancestor
65171367|NCT00931918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171368|NCT00931918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65171369|NCT00931918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65171370|NCT00931918|Alkylating Agents|alkylating agents|mesh-ancestor
65171371|NCT00931918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171372|NCT00931918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171373|NCT00931918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65171374|NCT00931918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65171375|NCT00931918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65171376|NCT00931918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65171377|NCT00931918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65171378|NCT00931918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171379|NCT00931918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65171381|NCT00931918|Hormones|hormones|mesh-ancestor
65171382|NCT00931918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65171383|NCT00931918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65171384|NCT00931918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65171385|NCT00931918|Tubulin Modulators|tubulin modulators|mesh-ancestor
65171386|NCT00931918|Antimitotic Agents|antimitotic agents|mesh-ancestor
65171387|NCT00931918|Mitosis Modulators|mitosis modulators|mesh-ancestor
65171388|NCT04183075|Vitamins|vitamins|mesh-list
65171389|NCT04183075|Ascorbic Acid|ascorbic acid|mesh-list
65171390|NCT04183075|Micronutrients|micronutrients|mesh-ancestor
65171391|NCT04183075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171392|NCT04183075|Antioxidants|antioxidants|mesh-ancestor
65171393|NCT04183075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323161|NCT04019496|Antibodies|antibodies|mesh-list
65323162|NCT04019496|Katacalcin|katacalcin|mesh-list
65323163|NCT04019496|Immunologic Factors|immunologic factors|mesh-ancestor
65323164|NCT04019496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323165|NCT04019496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65323166|NCT04019496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65323167|NCT04019496|Vasodilator Agents|vasodilator agents|mesh-ancestor
65323168|NCT05717153|Eflornithine|eflornithine|mesh-list
65323169|NCT05717153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323170|NCT05717153|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65323171|NCT05717153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65323172|NCT05717153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65323173|NCT05717153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65323174|NCT05717153|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
65171394|NCT04183075|Protective Agents|protective agents|mesh-ancestor
65171395|NCT02679001|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
65171396|NCT02679001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65171397|NCT02678221|Aspirin|aspirin|mesh-list
65171398|NCT02678221|Sildenafil Citrate|sildenafil citrate|mesh-list
65171399|NCT02678221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65171400|NCT02678221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65171401|NCT02678221|Analgesics|analgesics|mesh-ancestor
65171402|NCT02678221|Sensory System Agents|sensory system agents|mesh-ancestor
65171403|NCT02678221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65171404|NCT02678221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171405|NCT02678221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65171406|NCT02678221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65171407|NCT02678221|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65171408|NCT02678221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65171409|NCT02678221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171410|NCT02678221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65171411|NCT02678221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65171412|NCT02678221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171413|NCT02678221|Antipyretics|antipyretics|mesh-ancestor
65171414|NCT02678221|Vasodilator Agents|vasodilator agents|mesh-ancestor
65171415|NCT02678221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65171416|NCT02678221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65171417|NCT02678221|Urological Agents|urological agents|mesh-ancestor
65171418|NCT00641329|Clonidine|clonidine|mesh-list
65171419|NCT00641329|Analgesics|analgesics|mesh-ancestor
65171420|NCT00641329|Sensory System Agents|sensory system agents|mesh-ancestor
65171421|NCT00641329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65171422|NCT00641329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171423|NCT00641329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65171424|NCT00641329|Sympatholytics|sympatholytics|mesh-ancestor
65171425|NCT00641329|Autonomic Agents|autonomic agents|mesh-ancestor
65171426|NCT00641329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65171429|NCT00641329|Adrenergic Agents|adrenergic agents|mesh-ancestor
65171430|NCT00641329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65171431|NCT00641329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171432|NCT01179191|Naltrexone|naltrexone|mesh-list
65171433|NCT01179191|Morphine|morphine|mesh-list
65171434|NCT01179191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65171435|NCT01179191|Narcotics|narcotics|mesh-ancestor
65171436|NCT01179191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65171437|NCT01179191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171438|NCT01179191|Analgesics|analgesics|mesh-ancestor
65171439|NCT01179191|Sensory System Agents|sensory system agents|mesh-ancestor
65171440|NCT01179191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65171441|NCT01179191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65171442|NCT01179191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65171443|NCT00642421|Octreotide|octreotide|mesh-list
65323175|NCT05717153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65323176|NCT05717153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323177|NCT00918489|Vorinostat|vorinostat|mesh-list
65323178|NCT00918489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323179|NCT00918489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65323180|NCT00918489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65323181|NCT00918489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323182|NCT05690087|Lidocaine|lidocaine|mesh-list
65323183|NCT05690087|Anesthetics, Local|anesthetics, local|mesh-ancestor
65323184|NCT05690087|Anesthetics|anesthetics|mesh-ancestor
65323185|NCT05690087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65323186|NCT05690087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323187|NCT05690087|Sensory System Agents|sensory system agents|mesh-ancestor
65323188|NCT05690087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323189|NCT05690087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65171444|NCT00642421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65171445|NCT00642421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65171446|NCT00642421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171447|NCT00642187|Budesonide|budesonide|mesh-list
65171448|NCT00642187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65171449|NCT00642187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65171451|NCT00642187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65171452|NCT00642187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171453|NCT00642187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65171454|NCT00642187|Respiratory System Agents|respiratory system agents|mesh-ancestor
65171455|NCT00642187|Glucocorticoids|glucocorticoids|mesh-ancestor
65171456|NCT00642187|Hormones|hormones|mesh-ancestor
65171457|NCT00642187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65171458|NCT05663125|Temozolomide|temozolomide|mesh-list
65171459|NCT05663125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65171460|NCT05663125|Alkylating Agents|alkylating agents|mesh-ancestor
65171461|NCT05663125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171462|NCT05663125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171463|NCT01132482|Sildenafil Citrate|sildenafil citrate|mesh-list
65171464|NCT01132482|Vasodilator Agents|vasodilator agents|mesh-ancestor
65171465|NCT01132482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65171466|NCT01132482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65171467|NCT01132482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171468|NCT01132482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171469|NCT01132482|Urological Agents|urological agents|mesh-ancestor
65171470|NCT02678767|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65171471|NCT02678767|Hematinics|hematinics|mesh-ancestor
65171472|NCT02678767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65171473|NCT02678767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65171474|NCT05362409|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65171475|NCT05362409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65171476|NCT05362409|Dermatologic Agents|dermatologic agents|mesh-ancestor
65171477|NCT00931762|Panobinostat|panobinostat|mesh-list
65171478|NCT00931762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171479|NCT00931762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65171480|NCT00931762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171481|NCT00931762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171482|NCT00641407|Insulin|insulin|mesh-list
65171483|NCT00641407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65171484|NCT00641407|Insulin Glargine|insulin glargine|mesh-list
65171485|NCT00641407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65171486|NCT00641407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171487|NCT02677597|Paclitaxel|paclitaxel|mesh-list
65171488|NCT02677597|Cisplatin|cisplatin|mesh-list
65323190|NCT05690087|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65323191|NCT05690087|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65323192|NCT05690087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65323193|NCT05690087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323194|NCT02604992|Dronabinol|dronabinol|mesh-list
65323195|NCT02604992|Hallucinogens|hallucinogens|mesh-ancestor
65323196|NCT02604992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323197|NCT02604992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65323198|NCT02604992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65323199|NCT02604992|Analgesics|analgesics|mesh-ancestor
65323200|NCT02604992|Sensory System Agents|sensory system agents|mesh-ancestor
65323201|NCT02604992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323202|NCT02604992|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65323203|NCT02604992|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65323204|NCT02604992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65323205|NCT02604992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323206|NCT02604992|Hormones|hormones|mesh-ancestor
64552935|NCT00218543|Adrenergic Agents|adrenergic agents|mesh-ancestor
65171489|NCT02677597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65171490|NCT02677597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171491|NCT02677597|Tubulin Modulators|tubulin modulators|mesh-ancestor
65171492|NCT02677597|Antimitotic Agents|antimitotic agents|mesh-ancestor
65171493|NCT02677597|Mitosis Modulators|mitosis modulators|mesh-ancestor
65171494|NCT02677597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171495|NCT01132326|Droxidopa|droxidopa|mesh-list
65171496|NCT01132326|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65171497|NCT01132326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65171498|NCT02681263|Temocillin|temocillin|mesh-list
65171499|NCT02681263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65171500|NCT02681263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65171501|NCT02677519|Methylphenidate|methylphenidate|mesh-list
65171505|NCT02677519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65171506|NCT02677519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65171507|NCT02677519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171509|NCT02677519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65171510|NCT01145508|Metronidazole|metronidazole|mesh-list
65171511|NCT01145508|Prednisone|prednisone|mesh-list
65171512|NCT01145508|Cortisone|cortisone|mesh-list
65171513|NCT01145508|Docetaxel|docetaxel|mesh-list
65171514|NCT01145508|Vaccines|vaccines|mesh-list
65171515|NCT01145508|Immunologic Factors|immunologic factors|mesh-ancestor
65171516|NCT01145508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171517|NCT01145508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171518|NCT01145508|Tubulin Modulators|tubulin modulators|mesh-ancestor
65171519|NCT01145508|Antimitotic Agents|antimitotic agents|mesh-ancestor
65171520|NCT01145508|Mitosis Modulators|mitosis modulators|mesh-ancestor
65171521|NCT01145508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171522|NCT01145508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65171523|NCT01145508|Glucocorticoids|glucocorticoids|mesh-ancestor
65171524|NCT01145508|Hormones|hormones|mesh-ancestor
65171525|NCT01145508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65171526|NCT01145508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65171527|NCT01145508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65171528|NCT01145508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65171529|NCT01145508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65171530|NCT01145508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65323207|NCT02604992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65323208|NCT03899597|Oxytocin|oxytocin|mesh-list
65323209|NCT03899597|Oxytocics|oxytocics|mesh-ancestor
65323210|NCT03899597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65323211|NCT03899597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323212|NCT00714285|Vaccines|vaccines|mesh-list
65323213|NCT00714285|Immunologic Factors|immunologic factors|mesh-ancestor
65323214|NCT00714285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323215|NCT02823665|Atropine|atropine|mesh-list
65323216|NCT02823665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65323217|NCT02823665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65323218|NCT02823665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65323219|NCT02823665|Autonomic Agents|autonomic agents|mesh-ancestor
65323220|NCT02823665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323221|NCT02823665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323222|NCT02823665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65323223|NCT02823665|Respiratory System Agents|respiratory system agents|mesh-ancestor
65323224|NCT02823665|Mydriatics|mydriatics|mesh-ancestor
65323225|NCT02823665|Parasympatholytics|parasympatholytics|mesh-ancestor
65171532|NCT00931528|Vasodilator Agents|vasodilator agents|mesh-ancestor
65171533|NCT00931528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65171534|NCT00931528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65171535|NCT00931528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171536|NCT00931528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171537|NCT00931528|Urological Agents|urological agents|mesh-ancestor
65171538|NCT04181749|Aspirin|aspirin|mesh-list
65171539|NCT04181749|Atorvastatin|atorvastatin|mesh-list
65171540|NCT04181749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65171541|NCT04181749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65171542|NCT04181749|Analgesics|analgesics|mesh-ancestor
65171543|NCT04181749|Sensory System Agents|sensory system agents|mesh-ancestor
65171544|NCT04181749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65171545|NCT04181749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171546|NCT04181749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65171547|NCT04181749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65171548|NCT04181749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65171549|NCT04181749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65171550|NCT04181749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171551|NCT04181749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65171552|NCT04181749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65171553|NCT04181749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171554|NCT04181749|Antipyretics|antipyretics|mesh-ancestor
65171555|NCT04181749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65171556|NCT04181749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65171557|NCT04181749|Antimetabolites|antimetabolites|mesh-ancestor
65171558|NCT04181749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65171559|NCT04181749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65171560|NCT04312152|Vitamins|vitamins|mesh-list
65171561|NCT04312152|Vitamin E|vitamin e|mesh-list
65171562|NCT04312152|Tocopherols|tocopherols|mesh-list
65171563|NCT04312152|Folic Acid|folic acid|mesh-list
65171564|NCT04312152|Vitamin B Complex|vitamin b complex|mesh-list
65171565|NCT04312152|Micronutrients|micronutrients|mesh-ancestor
65171566|NCT04312152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171567|NCT04312152|Antioxidants|antioxidants|mesh-ancestor
65171568|NCT04312152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323226|NCT02823665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65323227|NCT02823665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65323228|NCT02823665|Cholinergic Agents|cholinergic agents|mesh-ancestor
65323229|NCT02823665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65323230|NCT02823665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323231|NCT00776984|Tiotropium Bromide|tiotropium bromide|mesh-list
65323232|NCT00776984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65323233|NCT00776984|Autonomic Agents|autonomic agents|mesh-ancestor
65323234|NCT00776984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323235|NCT00776984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323236|NCT00776984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65323237|NCT00776984|Respiratory System Agents|respiratory system agents|mesh-ancestor
65323238|NCT00776984|Parasympatholytics|parasympatholytics|mesh-ancestor
65171569|NCT04312152|Protective Agents|protective agents|mesh-ancestor
65171570|NCT04312152|Hematinics|hematinics|mesh-ancestor
65171571|NCT00975195|Fluticasone|fluticasone|mesh-list
65171573|NCT00975195|Tiotropium Bromide|tiotropium bromide|mesh-list
65171574|NCT00975195|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65171575|NCT00975195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65171580|NCT00975195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65171581|NCT00975195|Respiratory System Agents|respiratory system agents|mesh-ancestor
65171582|NCT00975195|Dermatologic Agents|dermatologic agents|mesh-ancestor
65171583|NCT00975195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65171584|NCT00975195|Parasympatholytics|parasympatholytics|mesh-ancestor
65171585|NCT00975195|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65171586|NCT00975195|Cholinergic Agents|cholinergic agents|mesh-ancestor
65171587|NCT00975195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65171588|NCT00975195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171589|NCT00975195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65171590|NCT00975195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65171591|NCT00975195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65171592|NCT00975195|Adrenergic Agents|adrenergic agents|mesh-ancestor
65171593|NCT00642499|Dronabinol|dronabinol|mesh-list
65171594|NCT00642499|Hallucinogens|hallucinogens|mesh-ancestor
65171595|NCT00642499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171596|NCT00642499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65171597|NCT00642499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65171598|NCT00642499|Analgesics|analgesics|mesh-ancestor
65171599|NCT00642499|Sensory System Agents|sensory system agents|mesh-ancestor
65171600|NCT00642499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65171601|NCT00642499|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65171602|NCT00642499|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65171603|NCT00642499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65171604|NCT00642499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171606|NCT00642499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65171607|NCT00644215|Mitomycins|mitomycins|mesh-list
65171608|NCT00644215|Mitomycin|mitomycin|mesh-list
65171609|NCT00644215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65171610|NCT00644215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171611|NCT00644215|Alkylating Agents|alkylating agents|mesh-ancestor
65171612|NCT00644215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171613|NCT00644215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65171614|NCT00644215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171615|NCT01145352|Etanercept|etanercept|mesh-list
65171616|NCT01145352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65171617|NCT01145352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65171618|NCT01145352|Analgesics|analgesics|mesh-ancestor
65171619|NCT01145352|Sensory System Agents|sensory system agents|mesh-ancestor
65171620|NCT01145352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65171621|NCT01145352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171622|NCT01145352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65323239|NCT00776984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65323240|NCT00776984|Cholinergic Agents|cholinergic agents|mesh-ancestor
65323241|NCT00776984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65323242|NCT00776984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323243|NCT04015557|Acetaminophen|acetaminophen|mesh-list
65323244|NCT04015557|Acetylcysteine|acetylcysteine|mesh-list
65323245|NCT04015557|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65323246|NCT04015557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65323247|NCT04015557|Analgesics|analgesics|mesh-ancestor
65323248|NCT04015557|Sensory System Agents|sensory system agents|mesh-ancestor
65323249|NCT04015557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323250|NCT04015557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323251|NCT04015557|Antipyretics|antipyretics|mesh-ancestor
65323252|NCT04015557|Antiviral Agents|antiviral agents|mesh-ancestor
65323253|NCT04015557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65323254|NCT04015557|Expectorants|expectorants|mesh-ancestor
65323255|NCT04015557|Respiratory System Agents|respiratory system agents|mesh-ancestor
65323256|NCT04015557|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65323257|NCT04015557|Antioxidants|antioxidants|mesh-ancestor
64552980|NCT00216671|Risperidone|risperidone|mesh-list
65171623|NCT01145352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65171624|NCT01145352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65171625|NCT01145352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65171626|NCT01145352|Immunologic Factors|immunologic factors|mesh-ancestor
65171627|NCT01178099|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65171628|NCT01178099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65171629|NCT02673463|Spironolactone|spironolactone|mesh-list
65171630|NCT02673463|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65171631|NCT02673463|Hormone Antagonists|hormone antagonists|mesh-ancestor
65171632|NCT02673463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65171633|NCT02673463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171634|NCT02673463|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65171635|NCT02673463|Diuretics|diuretics|mesh-ancestor
65171636|NCT02673463|Natriuretic Agents|natriuretic agents|mesh-ancestor
65171637|NCT01169532|Vorinostat|vorinostat|mesh-list
65171638|NCT01169532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171639|NCT01169532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65171640|NCT01169532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171641|NCT01169532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171642|NCT02537353|Epinephrine|epinephrine|mesh-list
65171643|NCT02537353|Racepinephrine|racepinephrine|mesh-list
65171644|NCT02537353|Epinephryl borate|epinephryl borate|mesh-list
65171645|NCT02537353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65171650|NCT02537353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171651|NCT02537353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65171652|NCT02537353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65171653|NCT02537353|Autonomic Agents|autonomic agents|mesh-ancestor
65171654|NCT02537353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65171655|NCT02537353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65171656|NCT02537353|Respiratory System Agents|respiratory system agents|mesh-ancestor
65171657|NCT02537353|Mydriatics|mydriatics|mesh-ancestor
65171658|NCT02537353|Sympathomimetics|sympathomimetics|mesh-ancestor
65171659|NCT02537353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65171660|NCT00643357|Nitrous Oxide|nitrous oxide|mesh-list
65171661|NCT00643357|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65171662|NCT00643357|Anesthetics, General|anesthetics, general|mesh-ancestor
65171663|NCT00643357|Anesthetics|anesthetics|mesh-ancestor
65323258|NCT04015557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323259|NCT04015557|Protective Agents|protective agents|mesh-ancestor
65323260|NCT04015557|Antidotes|antidotes|mesh-ancestor
65323261|NCT00784784|Zanamivir|zanamivir|mesh-list
65323262|NCT00784784|Antiviral Agents|antiviral agents|mesh-ancestor
65323263|NCT00784784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65323264|NCT00784784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65323265|NCT00784784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323266|NCT00587288|Reslizumab|reslizumab|mesh-list
65323267|NCT00587288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65323268|NCT00587288|Respiratory System Agents|respiratory system agents|mesh-ancestor
65323269|NCT00800735|Interferons|interferons|mesh-list
65323270|NCT00800735|Ribavirin|ribavirin|mesh-list
65323271|NCT00800735|Interferon-alpha|interferon-alpha|mesh-list
65323272|NCT00800735|Interferon alpha-2|interferon alpha-2|mesh-list
65323273|NCT00800735|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65323274|NCT00800735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323275|NCT00800735|Antiviral Agents|antiviral agents|mesh-ancestor
65323276|NCT00800735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65323277|NCT00800735|Antimetabolites|antimetabolites|mesh-ancestor
65323278|NCT00800735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323279|NCT00800735|Immunologic Factors|immunologic factors|mesh-ancestor
64552998|NCT00783354|Cholinergic Agents|cholinergic agents|mesh-ancestor
65171664|NCT00643357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65171665|NCT00643357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171666|NCT00643357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65171667|NCT00643357|Analgesics|analgesics|mesh-ancestor
65171668|NCT00643357|Sensory System Agents|sensory system agents|mesh-ancestor
65171669|NCT00643357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65171670|NCT01177943|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65171671|NCT01177943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65171672|NCT01177943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65171673|NCT01177943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65171674|NCT01177943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171675|NCT01177943|Adrenergic Agents|adrenergic agents|mesh-ancestor
65171676|NCT01177943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65171677|NCT01177943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171678|NCT04178785|Remifentanil|remifentanil|mesh-list
65171679|NCT04178785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65171680|NCT04178785|Narcotics|narcotics|mesh-ancestor
65171681|NCT04178785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65171682|NCT04178785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171683|NCT04178785|Analgesics|analgesics|mesh-ancestor
65171684|NCT04178785|Sensory System Agents|sensory system agents|mesh-ancestor
65171685|NCT04178785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65171686|NCT00928486|Dexamethasone|dexamethasone|mesh-list
65171687|NCT00928486|Lenalidomide|lenalidomide|mesh-list
65171688|NCT00928486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65171689|NCT00928486|Antiemetics|antiemetics|mesh-ancestor
65171690|NCT00928486|Autonomic Agents|autonomic agents|mesh-ancestor
65171691|NCT00928486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65171692|NCT00928486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171693|NCT00928486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65323280|NCT00800735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323281|NCT05324163|Celecoxib|celecoxib|mesh-list
65323282|NCT05324163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65323283|NCT05324163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65323284|NCT05324163|Analgesics|analgesics|mesh-ancestor
65323285|NCT05324163|Sensory System Agents|sensory system agents|mesh-ancestor
65323286|NCT05324163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323287|NCT05324163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323288|NCT05324163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65323289|NCT05324163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65323290|NCT05324163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65323291|NCT05324163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65323292|NCT05324163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65323293|NCT05324163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323294|NCT00730158|Irinotecan|irinotecan|mesh-list
65171694|NCT00928486|Glucocorticoids|glucocorticoids|mesh-ancestor
65171695|NCT00928486|Hormones|hormones|mesh-ancestor
65171696|NCT00928486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65171697|NCT00928486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65171698|NCT00928486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171699|NCT00928486|Immunologic Factors|immunologic factors|mesh-ancestor
65171700|NCT00928486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65171701|NCT00928486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65171702|NCT00928486|Growth Substances|growth substances|mesh-ancestor
65171703|NCT00928486|Growth Inhibitors|growth inhibitors|mesh-ancestor
65171704|NCT03867357|Goserelin|goserelin|mesh-list
65171705|NCT03867357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65171706|NCT03867357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171707|NCT05655221|Mitogens|mitogens|mesh-list
65171708|NCT05655221|Mitosis Modulators|mitosis modulators|mesh-ancestor
65171709|NCT05655221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171710|NCT00610792|Doxorubicin|doxorubicin|mesh-list
65171711|NCT00610792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65171712|NCT00610792|Bortezomib|bortezomib|mesh-list
65171713|NCT00610792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65171714|NCT00610792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171715|NCT00610792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65171716|NCT00610792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65171730|NCT01168596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171732|NCT01168596|Protective Agents|protective agents|mesh-ancestor
65171733|NCT01168596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171734|NCT02675647|Heparin|heparin|mesh-list
65171735|NCT02675647|Protamines|protamines|mesh-list
65171736|NCT02675647|Anticoagulants|anticoagulants|mesh-ancestor
65171737|NCT02675647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65171738|NCT02675647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65171739|NCT02675647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171740|NCT02675647|Heparin Antagonists|heparin antagonists|mesh-ancestor
65171741|NCT02675647|Coagulants|coagulants|mesh-ancestor
65171742|NCT05370898|Calcium Carbonate|calcium carbonate|mesh-list
65171743|NCT05370898|Antacids|antacids|mesh-ancestor
65171744|NCT05370898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171745|NCT05370898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65171746|NCT00610948|Leucovorin|leucovorin|mesh-list
65171747|NCT00610948|Fluorouracil|fluorouracil|mesh-list
64814359|NCT01477840|Oxytocics|oxytocics|mesh-ancestor
65171748|NCT00610948|Oxaliplatin|oxaliplatin|mesh-list
65171749|NCT00610948|Everolimus|everolimus|mesh-list
65171750|NCT00610948|Panitumumab|panitumumab|mesh-list
65171751|NCT00610948|Calcium|calcium|mesh-list
65171752|NCT00610948|Levoleucovorin|levoleucovorin|mesh-list
65171753|NCT00610948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65323295|NCT00730158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65323296|NCT00730158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65323297|NCT00730158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65323298|NCT00730158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323299|NCT00730158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323300|NCT04114643|Thrombin|thrombin|mesh-list
65323301|NCT04114643|Hemostatics|hemostatics|mesh-ancestor
65323302|NCT04114643|Coagulants|coagulants|mesh-ancestor
65323303|NCT02989662|Mifepristone|mifepristone|mesh-list
65323304|NCT02989662|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65323305|NCT02989662|Abortifacient Agents|abortifacient agents|mesh-ancestor
65323306|NCT02989662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65323307|NCT02989662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323308|NCT02989662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65323309|NCT02989662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65323310|NCT02989662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65323311|NCT02989662|Contraceptive Agents|contraceptive agents|mesh-ancestor
65323312|NCT02989662|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65323313|NCT02989662|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65323314|NCT02989662|Hormone Antagonists|hormone antagonists|mesh-ancestor
64553037|NCT04277143|Daptomycin|daptomycin|mesh-list
65171754|NCT00610948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171755|NCT00610948|Antimetabolites|antimetabolites|mesh-ancestor
65171756|NCT00610948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171757|NCT00610948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65171758|NCT00610948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171759|NCT00610948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65171760|NCT00610948|Immunologic Factors|immunologic factors|mesh-ancestor
65171761|NCT00610948|Antidotes|antidotes|mesh-ancestor
65171762|NCT00610948|Protective Agents|protective agents|mesh-ancestor
65171763|NCT00610948|Vitamin B Complex|vitamin b complex|mesh-ancestor
65171764|NCT00610948|Vitamins|vitamins|mesh-ancestor
65171765|NCT00610948|Micronutrients|micronutrients|mesh-ancestor
65171766|NCT00610948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65171767|NCT02675413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65171768|NCT02675413|Dermatologic Agents|dermatologic agents|mesh-ancestor
65171769|NCT02675413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65171770|NCT02675413|Immunologic Factors|immunologic factors|mesh-ancestor
65171771|NCT02675413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171772|NCT00928408|Cinacalcet|cinacalcet|mesh-list
65171773|NCT00928408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65171774|NCT00928408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171775|NCT00928408|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65171776|NCT00928408|Hormone Antagonists|hormone antagonists|mesh-ancestor
65171793|NCT00930982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65171794|NCT00930982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171795|NCT00930982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171796|NCT00930982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171797|NCT00930982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65171798|NCT00930982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65171799|NCT01176773|Hyaluronic Acid|hyaluronic acid|mesh-list
65171800|NCT01176773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65171801|NCT01176773|Immunologic Factors|immunologic factors|mesh-ancestor
65171802|NCT01176773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323315|NCT02989662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65323316|NCT02989662|Luteolytic Agents|luteolytic agents|mesh-ancestor
65323317|NCT02989662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65323318|NCT02989662|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65323319|NCT00784550|Fluticasone|fluticasone|mesh-list
65323320|NCT00784550|Xhance|xhance|mesh-list
65323321|NCT00784550|Bromides|bromides|mesh-list
65323322|NCT00784550|Tiotropium Bromide|tiotropium bromide|mesh-list
65323323|NCT00784550|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65323324|NCT00784550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65323325|NCT00784550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65323326|NCT00784550|Autonomic Agents|autonomic agents|mesh-ancestor
65323327|NCT00784550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323328|NCT00784550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323329|NCT00784550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65323330|NCT00784550|Respiratory System Agents|respiratory system agents|mesh-ancestor
65323331|NCT00784550|Dermatologic Agents|dermatologic agents|mesh-ancestor
65323332|NCT00784550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65323333|NCT00784550|Parasympatholytics|parasympatholytics|mesh-ancestor
65323334|NCT00784550|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65323335|NCT00784550|Cholinergic Agents|cholinergic agents|mesh-ancestor
65323336|NCT00784550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65323337|NCT00784550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323338|NCT00784550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65323339|NCT00784550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65323340|NCT00784550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65323341|NCT00784550|Adrenergic Agents|adrenergic agents|mesh-ancestor
65171803|NCT01176773|Viscosupplements|viscosupplements|mesh-ancestor
65171804|NCT01176773|Protective Agents|protective agents|mesh-ancestor
65171805|NCT02887625|Insulin|insulin|mesh-list
65171806|NCT02887625|Insulin Glargine|insulin glargine|mesh-list
65171807|NCT02887625|Pioglitazone|pioglitazone|mesh-list
65171808|NCT02887625|Insulin Aspart|insulin aspart|mesh-list
65171809|NCT02887625|Exenatide|exenatide|mesh-list
65171810|NCT02887625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65171811|NCT02887625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171812|NCT02887625|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65171813|NCT02887625|Incretins|incretins|mesh-ancestor
65171814|NCT02887625|Hormones|hormones|mesh-ancestor
65171815|NCT02887625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65171816|NCT02886377|Antibodies|antibodies|mesh-list
65171817|NCT02886377|Immunologic Factors|immunologic factors|mesh-ancestor
65171818|NCT02886377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171819|NCT02675335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65171820|NCT02675335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65171821|NCT02675335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171822|NCT02675335|Incretins|incretins|mesh-ancestor
65171823|NCT02675335|Hormones|hormones|mesh-ancestor
65171824|NCT02675335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65222842|NCT02586181|Vitamins|vitamins|mesh-list
65323342|NCT00784550|Anticonvulsants|anticonvulsants|mesh-ancestor
65323343|NCT00729690|Pregabalin|pregabalin|mesh-list
65323344|NCT00729690|Analgesics|analgesics|mesh-ancestor
65323345|NCT00729690|Sensory System Agents|sensory system agents|mesh-ancestor
65323346|NCT00729690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323347|NCT00729690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323348|NCT00729690|Anticonvulsants|anticonvulsants|mesh-ancestor
65323349|NCT00729690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65323350|NCT00729690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65323351|NCT00729690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323352|NCT00729690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65323353|NCT00729690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65323354|NCT00729690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65323355|NCT00729690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65171825|NCT02675335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65171826|NCT02675335|Protease Inhibitors|protease inhibitors|mesh-ancestor
65171828|NCT02675335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171829|NCT02675101|Sucrose polyester|sucrose polyester|mesh-list
65171830|NCT02675101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65171831|NCT02675101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65171832|NCT02675101|Antimetabolites|antimetabolites|mesh-ancestor
65171833|NCT02675101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171834|NCT02675101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65171835|NCT00928018|Cyclosporine|cyclosporine|mesh-list
65171836|NCT00928018|Sirolimus|sirolimus|mesh-list
65171837|NCT00928018|Mycophenolic Acid|mycophenolic acid|mesh-list
65171844|NCT00928018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171845|NCT00928018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65171846|NCT00928018|Antimetabolites|antimetabolites|mesh-ancestor
65171847|NCT00928018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171848|NCT00928018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171849|NCT00928018|Dermatologic Agents|dermatologic agents|mesh-ancestor
65171850|NCT00928018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171851|NCT00928018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65171852|NCT00928018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65171853|NCT00928018|Immunologic Factors|immunologic factors|mesh-ancestor
65171854|NCT00928018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65171855|NCT00928018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65171856|NCT00928018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65171857|NCT00928018|Antifungal Agents|antifungal agents|mesh-ancestor
65171858|NCT00928018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65171859|NCT00928018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65171860|NCT00928018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65171861|NCT00928018|Antitubercular Agents|antitubercular agents|mesh-ancestor
65171862|NCT00928018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65171864|NCT02672839|Sequestering Agents|sequestering agents|mesh-ancestor
65171865|NCT02672839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171866|NCT02672995|Bevacizumab|bevacizumab|mesh-list
65171867|NCT02672995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65171868|NCT02672995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171869|NCT02672995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65171870|NCT02672995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65171871|NCT02672995|Growth Substances|growth substances|mesh-ancestor
65171872|NCT02672995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171873|NCT02672995|Growth Inhibitors|growth inhibitors|mesh-ancestor
65171874|NCT00609154|Glucagon|glucagon|mesh-list
65171875|NCT00609154|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65171876|NCT00609154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65171877|NCT00609154|Hormones|hormones|mesh-ancestor
65222843|NCT02586181|Folic Acid|folic acid|mesh-list
65323356|NCT00729690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65323357|NCT04027829|Dexmedetomidine|dexmedetomidine|mesh-list
65323358|NCT04027829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65323359|NCT04027829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65323360|NCT04027829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323361|NCT04027829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65323362|NCT04027829|Analgesics|analgesics|mesh-ancestor
65323363|NCT04027829|Sensory System Agents|sensory system agents|mesh-ancestor
65323364|NCT04027829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323365|NCT04027829|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65323366|NCT04027829|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65323367|NCT04027829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65323368|NCT04027829|Adrenergic Agents|adrenergic agents|mesh-ancestor
65323369|NCT04027829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65323370|NCT04027829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323371|NCT00784238|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65323372|NCT00784238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65323373|NCT00784238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65323374|NCT00784238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65323375|NCT00784238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323376|NCT00784238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65171878|NCT00609154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65171879|NCT00609154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171880|NCT00609154|Incretins|incretins|mesh-ancestor
65171881|NCT00910117|Nimotuzumab|nimotuzumab|mesh-list
65171882|NCT00910117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171883|NCT00910117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65171884|NCT00927862|Warfarin|warfarin|mesh-list
65171885|NCT00927862|Anticoagulants|anticoagulants|mesh-ancestor
65171886|NCT02672527|Dexamethasone|dexamethasone|mesh-list
65171887|NCT02672527|Trabectedin|trabectedin|mesh-list
65171888|NCT02672527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65171889|NCT02672527|Antiemetics|antiemetics|mesh-ancestor
65171890|NCT02672527|Autonomic Agents|autonomic agents|mesh-ancestor
65171891|NCT02672527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65171892|NCT02672527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171893|NCT02672527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65171894|NCT02672527|Glucocorticoids|glucocorticoids|mesh-ancestor
65171895|NCT02672527|Hormones|hormones|mesh-ancestor
65171896|NCT02672527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65171897|NCT02672527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65171898|NCT02672527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171899|NCT02672527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65171900|NCT02672527|Alkylating Agents|alkylating agents|mesh-ancestor
64814517|NCT01478607|Capsaicin|capsaicin|mesh-list
65171901|NCT02672527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171903|NCT00976989|Trastuzumab|trastuzumab|mesh-list
65171904|NCT00976989|Pertuzumab|pertuzumab|mesh-list
65171905|NCT00976989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171906|NCT00976989|Tubulin Modulators|tubulin modulators|mesh-ancestor
65171907|NCT00976989|Antimitotic Agents|antimitotic agents|mesh-ancestor
65171911|NCT05463133|Sirolimus|sirolimus|mesh-list
65171912|NCT05463133|Cyclophosphamide|cyclophosphamide|mesh-list
65171913|NCT05463133|Busulfan|busulfan|mesh-list
65323377|NCT00784238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65323378|NCT00784238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65323379|NCT00784238|Serotonin Agents|serotonin agents|mesh-ancestor
65323380|NCT00784238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65323381|NCT00784238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323382|NCT00784238|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65323383|NCT00784238|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65323384|NCT00784238|Dopamine Agents|dopamine agents|mesh-ancestor
65323385|NCT00729612|Paclitaxel|paclitaxel|mesh-list
65323386|NCT00729612|Carboplatin|carboplatin|mesh-list
65323387|NCT00729612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65323388|NCT00729612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65323389|NCT00729612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323390|NCT00729612|Tubulin Modulators|tubulin modulators|mesh-ancestor
65323391|NCT00729612|Antimitotic Agents|antimitotic agents|mesh-ancestor
65323392|NCT00729612|Mitosis Modulators|mitosis modulators|mesh-ancestor
65323393|NCT00729612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323394|NCT05684913|Hemostatics|hemostatics|mesh-list
65323395|NCT05684913|Coagulants|coagulants|mesh-ancestor
65323396|NCT00585546|Clenbuterol|clenbuterol|mesh-list
65323397|NCT00585546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65323398|NCT00585546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65323399|NCT00585546|Adrenergic Agents|adrenergic agents|mesh-ancestor
65323400|NCT00585546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64553116|NCT01833819|Sensory System Agents|sensory system agents|mesh-ancestor
65171914|NCT05463133|Alemtuzumab|alemtuzumab|mesh-list
65171915|NCT05463133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65171916|NCT05463133|Immunologic Factors|immunologic factors|mesh-ancestor
65171917|NCT05463133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171918|NCT05463133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65171919|NCT05463133|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65171920|NCT05463133|Alkylating Agents|alkylating agents|mesh-ancestor
65171921|NCT05463133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171922|NCT05463133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171923|NCT05463133|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65171924|NCT05463133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65171925|NCT05463133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65171926|NCT05463133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65171927|NCT05463133|Antifungal Agents|antifungal agents|mesh-ancestor
65171928|NCT05463133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65171929|NCT05449171|Vitamin D|vitamin d|mesh-list
65171930|NCT05449171|Vitamins|vitamins|mesh-list
65171931|NCT05449171|Thioctic Acid|thioctic acid|mesh-list
65171932|NCT05449171|Vitamin B 6|vitamin b 6|mesh-list
65171933|NCT05449171|Pyridoxal|pyridoxal|mesh-list
65171934|NCT05449171|Pyridoxine|pyridoxine|mesh-list
65171935|NCT05449171|Hyaluronic Acid|hyaluronic acid|mesh-list
65171936|NCT05449171|Micronutrients|micronutrients|mesh-ancestor
65171937|NCT05449171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171938|NCT05449171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65171939|NCT05449171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65323401|NCT00585546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323402|NCT00585546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323403|NCT00585546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65323404|NCT00585546|Autonomic Agents|autonomic agents|mesh-ancestor
65323405|NCT00585546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323406|NCT00585546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65323407|NCT00585546|Respiratory System Agents|respiratory system agents|mesh-ancestor
65323408|NCT00585546|Sympathomimetics|sympathomimetics|mesh-ancestor
65323409|NCT00768248|Ropivacaine|ropivacaine|mesh-list
65323410|NCT00768248|Anesthetics, Local|anesthetics, local|mesh-ancestor
65323411|NCT00768248|Anesthetics|anesthetics|mesh-ancestor
65323412|NCT00768248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65323413|NCT00768248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323414|NCT00768248|Sensory System Agents|sensory system agents|mesh-ancestor
65323415|NCT00768248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65171940|NCT05449171|Immunologic Factors|immunologic factors|mesh-ancestor
65171941|NCT05449171|Viscosupplements|viscosupplements|mesh-ancestor
65171942|NCT05449171|Protective Agents|protective agents|mesh-ancestor
65171943|NCT05449171|Vitamin B Complex|vitamin b complex|mesh-ancestor
65171944|NCT05449171|Antioxidants|antioxidants|mesh-ancestor
65171945|NCT05449171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171946|NCT02675023|Adalimumab|adalimumab|mesh-list
65171947|NCT02675023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65171948|NCT02675023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65171949|NCT00644371|Rituximab|rituximab|mesh-list
65171950|NCT00644371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65171951|NCT00644371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171952|NCT00644371|Immunologic Factors|immunologic factors|mesh-ancestor
65171953|NCT00644371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171954|NCT00644371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65171955|NCT02864199|Ribavirin|ribavirin|mesh-list
65171956|NCT02864199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65171957|NCT02864199|Antimetabolites|antimetabolites|mesh-ancestor
65171958|NCT02864199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171959|NCT02864199|Antiviral Agents|antiviral agents|mesh-ancestor
65171960|NCT02864199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65171961|NCT00607282|Udenafil|udenafil|mesh-list
65171962|NCT00607282|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65171963|NCT00607282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65171964|NCT00607282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171965|NCT00607282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171966|NCT05212311|Chitosan|chitosan|mesh-list
65171967|NCT05212311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65171968|NCT05212311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65171969|NCT05212311|Antimetabolites|antimetabolites|mesh-ancestor
65171970|NCT05212311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171971|NCT05212311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65171972|NCT05212311|Chelating Agents|chelating agents|mesh-ancestor
65171973|NCT05212311|Sequestering Agents|sequestering agents|mesh-ancestor
65171974|NCT05212311|Hemostatics|hemostatics|mesh-ancestor
65171975|NCT05212311|Coagulants|coagulants|mesh-ancestor
65171976|NCT00927472|Permethrin|permethrin|mesh-list
65171978|NCT00927472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171979|NCT00927472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171980|NCT00927472|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65171981|NCT00927472|Cholinergic Agents|cholinergic agents|mesh-ancestor
65171982|NCT00927472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65171989|NCT00642655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65171990|NCT00642733|Gemcitabine|gemcitabine|mesh-list
65171991|NCT00642733|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65222844|NCT02586181|Calcium|calcium|mesh-list
65323416|NCT02589717|Atezolizumab|atezolizumab|mesh-list
65323417|NCT02589717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323418|NCT02602028|Colchicine|colchicine|mesh-list
65323419|NCT02602028|Gout Suppressants|gout suppressants|mesh-ancestor
65323420|NCT02602028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65323421|NCT02602028|Tubulin Modulators|tubulin modulators|mesh-ancestor
65323422|NCT02602028|Antimitotic Agents|antimitotic agents|mesh-ancestor
65323423|NCT02602028|Mitosis Modulators|mitosis modulators|mesh-ancestor
65323424|NCT02602028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323425|NCT02602028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323426|NCT04103684|Dexamethasone|dexamethasone|mesh-list
65323427|NCT04103684|Methylprednisolone|methylprednisolone|mesh-list
65323428|NCT04103684|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65323429|NCT04103684|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65323430|NCT04103684|Prednisolone|prednisolone|mesh-list
65323431|NCT04103684|Prednisolone acetate|prednisolone acetate|mesh-list
65323432|NCT04103684|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65323433|NCT04103684|Prednisolone phosphate|prednisolone phosphate|mesh-list
65323434|NCT04103684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65323435|NCT04103684|Antiemetics|antiemetics|mesh-ancestor
65323436|NCT04103684|Autonomic Agents|autonomic agents|mesh-ancestor
65171992|NCT00642733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65171993|NCT00642733|Antimetabolites|antimetabolites|mesh-ancestor
65171994|NCT00642733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171995|NCT00642733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171996|NCT00642733|Antiviral Agents|antiviral agents|mesh-ancestor
65171997|NCT00642733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65171998|NCT00642733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171999|NCT00642733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65172000|NCT00642733|Immunologic Factors|immunologic factors|mesh-ancestor
65172001|NCT00642733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172002|NCT00642733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65172003|NCT00927394|Valsartan|valsartan|mesh-list
65172004|NCT00927394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65172005|NCT00927394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65172006|NCT00927394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65172007|NCT00927394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172008|NCT00643825|Temozolomide|temozolomide|mesh-list
65172009|NCT00643825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65172010|NCT00643825|Alkylating Agents|alkylating agents|mesh-ancestor
65172011|NCT00643825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172012|NCT00643825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172013|NCT04178863|Timolol|timolol|mesh-list
65172014|NCT04178863|Latanoprost|latanoprost|mesh-list
65172015|NCT04178863|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65172016|NCT04178863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65172017|NCT04178863|Adrenergic Agents|adrenergic agents|mesh-ancestor
65172018|NCT04178863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65172019|NCT04178863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172020|NCT04178863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172021|NCT04178863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65172022|NCT04178863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65172023|NCT04178863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65172024|NCT04178863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65172025|NCT04264858|Immunoglobulins|immunoglobulins|mesh-list
65323437|NCT04103684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323438|NCT04103684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323439|NCT04103684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65323440|NCT04103684|Glucocorticoids|glucocorticoids|mesh-ancestor
65323441|NCT04103684|Hormones|hormones|mesh-ancestor
65323442|NCT04103684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65323443|NCT04103684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65323444|NCT04103684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323445|NCT04103684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65323446|NCT04103684|Protective Agents|protective agents|mesh-ancestor
65323447|NCT00775268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65323448|NCT00775268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65323449|NCT00775268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323450|NCT05257629|Nicotine|nicotine|mesh-list
65323451|NCT05257629|Varenicline|varenicline|mesh-list
65172026|NCT04264858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65172027|NCT04264858|Antibodies|antibodies|mesh-list
65172028|NCT04264858|gamma-Globulins|gamma-globulins|mesh-list
65172029|NCT04264858|Immunologic Factors|immunologic factors|mesh-ancestor
65172030|NCT04264858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172031|NCT00976911|Paclitaxel|paclitaxel|mesh-list
65172032|NCT00976911|Bevacizumab|bevacizumab|mesh-list
65172033|NCT00976911|Doxorubicin|doxorubicin|mesh-list
65172034|NCT00976911|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65172035|NCT00976911|Topotecan|topotecan|mesh-list
65172036|NCT00976911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65172037|NCT00976911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172038|NCT00976911|Tubulin Modulators|tubulin modulators|mesh-ancestor
65172039|NCT00976911|Antimitotic Agents|antimitotic agents|mesh-ancestor
65172040|NCT00976911|Mitosis Modulators|mitosis modulators|mesh-ancestor
65172041|NCT00976911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172042|NCT00976911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65172043|NCT00976911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65172044|NCT00976911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65172045|NCT00976911|Growth Substances|growth substances|mesh-ancestor
65172046|NCT00976911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172047|NCT00976911|Growth Inhibitors|growth inhibitors|mesh-ancestor
65172048|NCT00976911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65172049|NCT00976911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65172050|NCT00976911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65172065|NCT05336968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65172067|NCT05336968|Hormones|hormones|mesh-ancestor
65172068|NCT05336968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65172069|NCT05336968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65172070|NCT05336968|Immunologic Factors|immunologic factors|mesh-ancestor
65172071|NCT05336968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172072|NCT05336968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172073|NCT05336968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65172074|NCT05336968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65172075|NCT05336968|Analgesics|analgesics|mesh-ancestor
65172076|NCT05336968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65172077|NCT05336968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65172078|NCT02674555|Naquotinib|naquotinib|mesh-list
65172079|NCT02674555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172080|NCT02674555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65172081|NCT02674555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172082|NCT02674555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172083|NCT00934648|Rituximab|rituximab|mesh-list
65172084|NCT00934648|Methotrexate|methotrexate|mesh-list
65222845|NCT02586181|Micronutrients|micronutrients|mesh-ancestor
65323452|NCT05257629|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65323453|NCT05257629|Autonomic Agents|autonomic agents|mesh-ancestor
65323454|NCT05257629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323455|NCT05257629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323456|NCT05257629|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65323457|NCT05257629|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65323458|NCT05257629|Cholinergic Agents|cholinergic agents|mesh-ancestor
65323459|NCT05257629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65323460|NCT05257629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323461|NCT00775190|Moxifloxacin|moxifloxacin|mesh-list
65323462|NCT00775190|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65323463|NCT00775190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65323464|NCT00775190|Contraceptive Agents|contraceptive agents|mesh-ancestor
65323465|NCT00775190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65323466|NCT00775190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323467|NCT00775190|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65323468|NCT00775190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65323469|NCT00775190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65323470|NCT00775190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65323471|NCT00775190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65323472|NCT00775190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65323473|NCT00775190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65323475|NCT00775190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323476|NCT00775190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323477|NCT00479557|Saponin QA-21V1|saponin qa-21v1|mesh-list
65323478|NCT00479557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65172085|NCT00934648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65172086|NCT00934648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172087|NCT00934648|Immunologic Factors|immunologic factors|mesh-ancestor
65172088|NCT00934648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172089|NCT00934648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65172090|NCT00934648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65172091|NCT00934648|Abortifacient Agents|abortifacient agents|mesh-ancestor
65172092|NCT00934648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65172093|NCT00934648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65172094|NCT00934648|Antimetabolites|antimetabolites|mesh-ancestor
65172095|NCT00934648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172096|NCT00934648|Dermatologic Agents|dermatologic agents|mesh-ancestor
65172097|NCT00934648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172098|NCT00934648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65172099|NCT00934648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65172100|NCT00934648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65172101|NCT01175213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65172102|NCT01175213|gamma-Globulins|gamma-globulins|mesh-list
65172103|NCT01175213|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65172104|NCT01175213|Immunologic Factors|immunologic factors|mesh-ancestor
65323479|NCT00479557|Immunologic Factors|immunologic factors|mesh-ancestor
65323480|NCT00479557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323481|NCT00774800|Insulin|insulin|mesh-list
65323482|NCT00774800|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65323483|NCT00774800|Insulin Lispro|insulin lispro|mesh-list
65323484|NCT00774800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65323485|NCT00774800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323486|NCT00439309|Thrombin|thrombin|mesh-list
65323487|NCT00439309|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
65323488|NCT00439309|Hemostatics|hemostatics|mesh-ancestor
65323489|NCT00439309|Coagulants|coagulants|mesh-ancestor
65323490|NCT00479167|Bortezomib|bortezomib|mesh-list
65323491|NCT00479167|Tositumomab I-131|tositumomab i-131|mesh-list
65323492|NCT00479167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323493|NCT00725322|Botulinum Toxins|botulinum toxins|mesh-list
65323494|NCT00725322|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65323495|NCT00725322|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65323496|NCT00725322|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65323497|NCT00725322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65172105|NCT01175213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172106|NCT00644449|Azithromycin|azithromycin|mesh-list
65172107|NCT00644449|Levofloxacin|levofloxacin|mesh-list
65172108|NCT00644449|Ofloxacin|ofloxacin|mesh-list
65172109|NCT00644449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65172110|NCT00644449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65172117|NCT00644449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172118|NCT00644449|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65172119|NCT00644449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65172120|NCT04287777|Mupirocin|mupirocin|mesh-list
65172121|NCT04287777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65172122|NCT04287777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65172123|NCT04287777|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65172124|NCT04287777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64401039|NCT02034331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65172125|NCT04287777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172126|NCT04180657|Protein C|protein c|mesh-list
65172127|NCT04180657|Anticoagulants|anticoagulants|mesh-ancestor
65172128|NCT04180657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65172129|NCT04180657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65172130|NCT04180657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172131|NCT05603065|Paclitaxel|paclitaxel|mesh-list
65172132|NCT05603065|Cisplatin|cisplatin|mesh-list
65172133|NCT05603065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65172134|NCT05603065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172135|NCT05603065|Tubulin Modulators|tubulin modulators|mesh-ancestor
65172136|NCT05603065|Antimitotic Agents|antimitotic agents|mesh-ancestor
65172137|NCT05603065|Mitosis Modulators|mitosis modulators|mesh-ancestor
65172138|NCT05603065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172139|NCT00927082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65172140|NCT00927082|Antiviral Agents|antiviral agents|mesh-ancestor
65172141|NCT00927082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65172142|NCT02674243|Povidone-Iodine|povidone-iodine|mesh-list
65172143|NCT02674243|Povidone|povidone|mesh-list
65172144|NCT02674243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65172145|NCT02674243|Plasma Substitutes|plasma substitutes|mesh-ancestor
65172146|NCT02674243|Blood Substitutes|blood substitutes|mesh-ancestor
65172147|NCT02674243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65172148|NCT02674243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65172149|NCT04256200|Dienogest|dienogest|mesh-list
65172150|NCT04256200|Contraceptive Agents|contraceptive agents|mesh-list
65323498|NCT00725322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323499|NCT00725322|Cholinergic Agents|cholinergic agents|mesh-ancestor
65323500|NCT00725322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65323501|NCT00725322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323502|NCT00725322|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65323503|NCT00725322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323504|NCT00725010|Temozolomide|temozolomide|mesh-list
65323505|NCT00725010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65323506|NCT00725010|Alkylating Agents|alkylating agents|mesh-ancestor
65323507|NCT00725010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323508|NCT00725010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323509|NCT05216055|Dexamethasone|dexamethasone|mesh-list
65323510|NCT05216055|Dexamethasone acetate|dexamethasone acetate|mesh-list
65323511|NCT05216055|Dexmedetomidine|dexmedetomidine|mesh-list
65323512|NCT05216055|Bupivacaine|bupivacaine|mesh-list
65323513|NCT05216055|Ropivacaine|ropivacaine|mesh-list
65323514|NCT05216055|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65323515|NCT05216055|BB 1101|bb 1101|mesh-list
65323516|NCT05216055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65323517|NCT05216055|Antiemetics|antiemetics|mesh-ancestor
65172151|NCT04256200|Contraceptives, Oral|contraceptives, oral|mesh-list
65172152|NCT04256200|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65172153|NCT04256200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65172154|NCT04256200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172155|NCT04256200|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65172156|NCT04256200|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65172157|NCT04256200|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65172158|NCT04256200|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65172159|NCT04256200|Hormone Antagonists|hormone antagonists|mesh-ancestor
65172160|NCT04256200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65172161|NCT04256200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65172162|NCT04256200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172163|NCT02676739|Adderall|adderall|mesh-list
65172164|NCT02676739|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65172165|NCT02676739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172166|NCT00976677|Paclitaxel|paclitaxel|mesh-list
65172167|NCT00976677|Bevacizumab|bevacizumab|mesh-list
65172168|NCT00976677|Carboplatin|carboplatin|mesh-list
65172169|NCT00976677|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65172170|NCT00976677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65172171|NCT00976677|Antibodies|antibodies|mesh-list
65172172|NCT00976677|Immunoglobulins|immunoglobulins|mesh-list
65172173|NCT00976677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65172174|NCT00976677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65172175|NCT00976677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172176|NCT00976677|Tubulin Modulators|tubulin modulators|mesh-ancestor
65172177|NCT00976677|Antimitotic Agents|antimitotic agents|mesh-ancestor
65172178|NCT00976677|Mitosis Modulators|mitosis modulators|mesh-ancestor
64814805|NCT01480531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65172198|NCT05332444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65172199|NCT05332444|Antitubercular Agents|antitubercular agents|mesh-ancestor
65172200|NCT05332444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65172201|NCT05332444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65172202|NCT05332444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65172203|NCT05332444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222846|NCT02586181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323518|NCT05216055|Autonomic Agents|autonomic agents|mesh-ancestor
65323519|NCT05216055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323520|NCT05216055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323521|NCT05216055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65323522|NCT05216055|Glucocorticoids|glucocorticoids|mesh-ancestor
65323523|NCT05216055|Hormones|hormones|mesh-ancestor
65323524|NCT05216055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65323525|NCT05216055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65323526|NCT05216055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323527|NCT05216055|Anesthetics, Local|anesthetics, local|mesh-ancestor
65323528|NCT05216055|Anesthetics|anesthetics|mesh-ancestor
65323529|NCT05216055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65323530|NCT05216055|Sensory System Agents|sensory system agents|mesh-ancestor
65323531|NCT05216055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65323532|NCT05216055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65323533|NCT05216055|Analgesics|analgesics|mesh-ancestor
65323534|NCT05216055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65323535|NCT05216055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64553251|NCT03100734|Etanercept|etanercept|mesh-list
65172204|NCT05332444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172205|NCT05332444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65172206|NCT05332444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65172207|NCT05332444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65172208|NCT05332444|Renal Agents|renal agents|mesh-ancestor
65172209|NCT05332444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65172210|NCT05332444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65172211|NCT05332444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172212|NCT05332444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65172213|NCT05332444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65172214|NCT05332444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65172216|NCT00642967|Epoetin Alfa|epoetin alfa|mesh-list
65172217|NCT00642967|Hematinics|hematinics|mesh-ancestor
65172218|NCT02865993|Povidone-Iodine|povidone-iodine|mesh-list
65172219|NCT02865993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65172220|NCT02865993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65172221|NCT04287543|Melatonin|melatonin|mesh-list
65172222|NCT04287543|Antioxidants|antioxidants|mesh-ancestor
65172223|NCT04287543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172224|NCT04287543|Protective Agents|protective agents|mesh-ancestor
65172225|NCT04287543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172226|NCT04287543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65172227|NCT04287387|Pioglitazone|pioglitazone|mesh-list
65172228|NCT04287387|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65172229|NCT04287387|Dapagliflozin|dapagliflozin|mesh-list
65172230|NCT04287387|Metformin|metformin|mesh-list
65172231|NCT04287387|Glimepiride|glimepiride|mesh-list
65172232|NCT04287387|Acarbose|acarbose|mesh-list
65172233|NCT04287387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65172234|NCT04287387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172235|NCT04287387|Incretins|incretins|mesh-ancestor
65172236|NCT04287387|Hormones|hormones|mesh-ancestor
65172250|NCT00644605|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65172251|NCT00644605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172252|NCT00644605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172253|NCT00644605|Urological Agents|urological agents|mesh-ancestor
65172254|NCT02865681|Letrozole|letrozole|mesh-list
65172255|NCT02865681|Clomiphene|clomiphene|mesh-list
65323536|NCT05216055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65323537|NCT05216055|Adrenergic Agents|adrenergic agents|mesh-ancestor
65323538|NCT05216055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65323539|NCT05216055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323540|NCT05216055|Protease Inhibitors|protease inhibitors|mesh-ancestor
65323541|NCT05216055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65323542|NCT00767000|Metformin|metformin|mesh-list
65323543|NCT00767000|Insulin Glargine|insulin glargine|mesh-list
65323544|NCT00767000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65323545|NCT00767000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323546|NCT05194449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65323547|NCT05194449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65323548|NCT05194449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323549|NCT00724932|Atropine|atropine|mesh-list
65323550|NCT00724932|Bromides|bromides|mesh-list
65323551|NCT00724932|Rocuronium|rocuronium|mesh-list
65323552|NCT00724932|Neostigmine|neostigmine|mesh-list
65323553|NCT00724932|Anticonvulsants|anticonvulsants|mesh-ancestor
65323554|NCT00724932|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65323555|NCT00724932|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65323556|NCT00724932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65172256|NCT02865681|Enclomiphene|enclomiphene|mesh-list
65172257|NCT02865681|Zuclomiphene|zuclomiphene|mesh-list
65172258|NCT02865681|Menotropins|menotropins|mesh-list
65172259|NCT02865681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172260|NCT02865681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172261|NCT02865681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65172262|NCT02865681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65172263|NCT02865681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172264|NCT02865681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65172265|NCT02865681|Hormone Antagonists|hormone antagonists|mesh-ancestor
65172266|NCT02865681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65172267|NCT02865681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172268|NCT02865681|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65172269|NCT02865681|Fertility Agents|fertility agents|mesh-ancestor
65172270|NCT02865681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65172271|NCT02865681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65172272|NCT02865681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65172273|NCT00644137|Pregabalin|pregabalin|mesh-list
65172274|NCT00644137|Analgesics|analgesics|mesh-ancestor
65172275|NCT00644137|Sensory System Agents|sensory system agents|mesh-ancestor
65172276|NCT00644137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65172277|NCT00644137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172278|NCT00644137|Anticonvulsants|anticonvulsants|mesh-ancestor
65172279|NCT00644137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65172280|NCT00644137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65172281|NCT00644137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172282|NCT00644137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65172283|NCT00644137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65172284|NCT00644137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65172285|NCT00644137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65172286|NCT00644137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65172288|NCT04982614|Immunologic Factors|immunologic factors|mesh-ancestor
65172289|NCT04982614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172290|NCT00910195|Acetaminophen|acetaminophen|mesh-list
65323557|NCT00724932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323558|NCT00724932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323559|NCT00724932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65323560|NCT00724932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65323561|NCT00724932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65323562|NCT00724932|Autonomic Agents|autonomic agents|mesh-ancestor
65323563|NCT00724932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65323564|NCT00724932|Respiratory System Agents|respiratory system agents|mesh-ancestor
65323565|NCT00724932|Mydriatics|mydriatics|mesh-ancestor
65323566|NCT00724932|Parasympatholytics|parasympatholytics|mesh-ancestor
65323567|NCT00724932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65323568|NCT00724932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65323569|NCT00724932|Cholinergic Agents|cholinergic agents|mesh-ancestor
65323570|NCT00724932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65323571|NCT00724932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323572|NCT00724932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65323573|NCT00724932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65323574|NCT00724932|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65323575|NCT00766532|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65323576|NCT00766532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65323577|NCT00766532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553299|NCT03179995|Octreotide|octreotide|mesh-list
65172291|NCT00910195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65172292|NCT00910195|Analgesics|analgesics|mesh-ancestor
65172293|NCT00910195|Sensory System Agents|sensory system agents|mesh-ancestor
65172294|NCT00910195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65172295|NCT00910195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172305|NCT04176367|Nootropic Agents|nootropic agents|mesh-ancestor
65172306|NCT04259476|Ketamine|ketamine|mesh-list
65172307|NCT04259476|Analgesics|analgesics|mesh-ancestor
65172308|NCT04259476|Sensory System Agents|sensory system agents|mesh-ancestor
65172309|NCT04259476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65172310|NCT04259476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172311|NCT04259476|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65172312|NCT04259476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65172313|NCT04259476|Anesthetics, General|anesthetics, general|mesh-ancestor
65172314|NCT04259476|Anesthetics|anesthetics|mesh-ancestor
65172315|NCT04259476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65172316|NCT04259476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65172317|NCT04259476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65172318|NCT04259476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65172319|NCT04259476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172320|NCT00970281|Olanzapine|olanzapine|mesh-list
65172321|NCT00970281|Antiemetics|antiemetics|mesh-ancestor
65172322|NCT00970281|Autonomic Agents|autonomic agents|mesh-ancestor
65172323|NCT00970281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65172324|NCT00970281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172325|NCT00970281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65172326|NCT00970281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65172327|NCT00970281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65172328|NCT00970281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65172329|NCT00970281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65323578|NCT00766532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323579|NCT00766532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65323580|NCT00766532|Hormone Antagonists|hormone antagonists|mesh-ancestor
65323581|NCT00766532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65323582|NCT00766532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323583|NCT04083807|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65323584|NCT04083807|Thrombin|thrombin|mesh-list
65323585|NCT04083807|Hemostatics|hemostatics|mesh-ancestor
65323586|NCT04083807|Coagulants|coagulants|mesh-ancestor
65323587|NCT05163483|Bevacizumab|bevacizumab|mesh-list
65323588|NCT05163483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65323589|NCT05163483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65323590|NCT05163483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323591|NCT05163483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65323592|NCT05163483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65323593|NCT05163483|Growth Substances|growth substances|mesh-ancestor
65323594|NCT05163483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323595|NCT05163483|Growth Inhibitors|growth inhibitors|mesh-ancestor
65323596|NCT05163483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323597|NCT05511038|Aflibercept|aflibercept|mesh-list
64553311|NCT03099408|Metronidazole|metronidazole|mesh-list
65172330|NCT00970281|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65172331|NCT00970281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65172332|NCT00970281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65172333|NCT00970281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172334|NCT00970281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65172335|NCT00970281|Serotonin Agents|serotonin agents|mesh-ancestor
65172336|NCT00607438|Paclitaxel|paclitaxel|mesh-list
65172337|NCT00607438|Sorafenib|sorafenib|mesh-list
65172338|NCT00607438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65172339|NCT00607438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65172340|NCT00607438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172341|NCT00607438|Tubulin Modulators|tubulin modulators|mesh-ancestor
65172342|NCT00607438|Antimitotic Agents|antimitotic agents|mesh-ancestor
65172343|NCT00607438|Mitosis Modulators|mitosis modulators|mesh-ancestor
65172344|NCT00607438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172345|NCT00607438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65172346|NCT00607438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172347|NCT00976209|Phenylephrine|phenylephrine|mesh-list
65172348|NCT00976209|Oxymetazoline|oxymetazoline|mesh-list
65172350|NCT00976209|Mydriatics|mydriatics|mesh-ancestor
65172351|NCT00976209|Autonomic Agents|autonomic agents|mesh-ancestor
65172352|NCT00976209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65172353|NCT00976209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172354|NCT00976209|Sympathomimetics|sympathomimetics|mesh-ancestor
65172355|NCT00976209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65172356|NCT00976209|Nasal Decongestants|nasal decongestants|mesh-ancestor
65172357|NCT00976209|Respiratory System Agents|respiratory system agents|mesh-ancestor
65172358|NCT00976209|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65172359|NCT00976209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65172360|NCT00976209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65172361|NCT00976209|Adrenergic Agents|adrenergic agents|mesh-ancestor
65172362|NCT00976209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65323598|NCT05511038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65323599|NCT05511038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65323600|NCT05511038|Growth Substances|growth substances|mesh-ancestor
65323601|NCT05511038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323602|NCT05511038|Growth Inhibitors|growth inhibitors|mesh-ancestor
65323603|NCT05511038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323604|NCT00766142|Leucovorin|leucovorin|mesh-list
65323605|NCT00766142|Fluorouracil|fluorouracil|mesh-list
65323606|NCT00766142|Oxaliplatin|oxaliplatin|mesh-list
65323607|NCT00766142|Cetuximab|cetuximab|mesh-list
65323608|NCT00766142|Calcium|calcium|mesh-list
65323609|NCT00766142|Levoleucovorin|levoleucovorin|mesh-list
65323610|NCT00766142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65323611|NCT00766142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323612|NCT00766142|Antimetabolites|antimetabolites|mesh-ancestor
65323613|NCT00766142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323614|NCT00766142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65323615|NCT00766142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323616|NCT00766142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65323617|NCT00766142|Immunologic Factors|immunologic factors|mesh-ancestor
65323618|NCT00766142|Antidotes|antidotes|mesh-ancestor
65323619|NCT00766142|Protective Agents|protective agents|mesh-ancestor
65323620|NCT00766142|Vitamin B Complex|vitamin b complex|mesh-ancestor
65323621|NCT00766142|Vitamins|vitamins|mesh-ancestor
65323622|NCT00766142|Micronutrients|micronutrients|mesh-ancestor
65323623|NCT00766142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65323624|NCT00916526|Mannitol|mannitol|mesh-list
65323625|NCT00916526|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65323626|NCT00916526|Diuretics|diuretics|mesh-ancestor
65323627|NCT00916526|Natriuretic Agents|natriuretic agents|mesh-ancestor
65323628|NCT00916526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323629|NCT00724854|Ribavirin|ribavirin|mesh-list
65323630|NCT00724854|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65323631|NCT00724854|Interferon-alpha|interferon-alpha|mesh-list
65172393|NCT01131078|Bevacizumab|bevacizumab|mesh-list
65172394|NCT01131078|Capecitabine|capecitabine|mesh-list
65172395|NCT01131078|Irinotecan|irinotecan|mesh-list
65172396|NCT01131078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65172397|NCT01131078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172398|NCT01131078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65172399|NCT01131078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65172400|NCT01131078|Growth Substances|growth substances|mesh-ancestor
65172401|NCT01131078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172402|NCT01131078|Growth Inhibitors|growth inhibitors|mesh-ancestor
65172403|NCT01131078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65323632|NCT00724854|Antimetabolites|antimetabolites|mesh-ancestor
65323633|NCT00724854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323634|NCT00724854|Antiviral Agents|antiviral agents|mesh-ancestor
65323635|NCT00724854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65323636|NCT00724854|Immunologic Factors|immunologic factors|mesh-ancestor
65323637|NCT00724854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323638|NCT04083651|Bromides|bromides|mesh-list
65323639|NCT04083651|Methylnaltrexone|methylnaltrexone|mesh-list
65323640|NCT04083651|Anticonvulsants|anticonvulsants|mesh-ancestor
65323641|NCT04083651|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65323642|NCT04083651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323643|NCT04083651|Sensory System Agents|sensory system agents|mesh-ancestor
65323644|NCT04083651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323645|NCT00728988|Atorvastatin|atorvastatin|mesh-list
65323646|NCT00728988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65323647|NCT00728988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65323648|NCT00728988|Antimetabolites|antimetabolites|mesh-ancestor
65323649|NCT00728988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553359|NCT05242081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65172404|NCT01131078|Antimetabolites|antimetabolites|mesh-ancestor
65172408|NCT01131078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172409|NCT03711279|Apatinib|apatinib|mesh-list
65172410|NCT03711279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172411|NCT03711279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65172412|NCT03711279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172413|NCT03711279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172414|NCT03709017|Ponatinib|ponatinib|mesh-list
65172415|NCT03709017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172416|NCT03709017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65172417|NCT03709017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172418|NCT03709017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172419|NCT03695445|Norepinephrine|norepinephrine|mesh-list
65172420|NCT03695445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65172421|NCT03695445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65172422|NCT03695445|Adrenergic Agents|adrenergic agents|mesh-ancestor
65172423|NCT03695445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65172424|NCT03695445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172425|NCT03695445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172426|NCT03695445|Sympathomimetics|sympathomimetics|mesh-ancestor
65172427|NCT03695445|Autonomic Agents|autonomic agents|mesh-ancestor
65172428|NCT03695445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65172429|NCT03695445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65172431|NCT04177303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65172432|NCT04177303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172433|NCT01167426|Glatiramer Acetate|glatiramer acetate|mesh-list
65172434|NCT01167426|(T,G)-A-L|(t,g)-a-l|mesh-list
65172435|NCT01167426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65172436|NCT01167426|Immunologic Factors|immunologic factors|mesh-ancestor
65172437|NCT01167426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172438|NCT01167426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65172439|NCT01167426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65172440|NCT02862873|Ondansetron|ondansetron|mesh-list
65172441|NCT02862873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65172442|NCT02862873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172443|NCT02862873|Antiemetics|antiemetics|mesh-ancestor
65172444|NCT02862873|Autonomic Agents|autonomic agents|mesh-ancestor
65323650|NCT00728988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65323651|NCT00728988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65323652|NCT00728988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65323653|NCT05133531|Ravulizumab|ravulizumab|mesh-list
65323654|NCT05133531|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65323655|NCT05133531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65323656|NCT05133531|Immunologic Factors|immunologic factors|mesh-ancestor
65323657|NCT05133531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323658|NCT04087746|Ranibizumab|ranibizumab|mesh-list
65323659|NCT04087746|Aflibercept|aflibercept|mesh-list
65323660|NCT04087746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65323661|NCT04087746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65323662|NCT04087746|Growth Substances|growth substances|mesh-ancestor
65323663|NCT04087746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323664|NCT04087746|Growth Inhibitors|growth inhibitors|mesh-ancestor
65323665|NCT04087746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323666|NCT04083417|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65323667|NCT04083417|Penicillins|penicillins|mesh-list
65172445|NCT02862873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65172446|NCT02862873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65172447|NCT02862873|Antipruritics|antipruritics|mesh-ancestor
65172448|NCT02862873|Dermatologic Agents|dermatologic agents|mesh-ancestor
65172449|NCT02862873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65172450|NCT02862873|Serotonin Agents|serotonin agents|mesh-ancestor
65172451|NCT02862873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65172452|NCT02862873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172453|NCT02862873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65172454|NCT02862873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65172455|NCT02862873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65172456|NCT02862873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65172457|NCT03814005|Paclitaxel|paclitaxel|mesh-list
65172458|NCT03814005|Docetaxel|docetaxel|mesh-list
65172459|NCT03814005|Carboplatin|carboplatin|mesh-list
65172460|NCT03814005|Azacitidine|azacitidine|mesh-list
65172461|NCT03814005|Pevonedistat|pevonedistat|mesh-list
65172462|NCT03814005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65172463|NCT03814005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172464|NCT03814005|Tubulin Modulators|tubulin modulators|mesh-ancestor
65172465|NCT03814005|Antimitotic Agents|antimitotic agents|mesh-ancestor
65172466|NCT03814005|Mitosis Modulators|mitosis modulators|mesh-ancestor
65172467|NCT03814005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172468|NCT03814005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65172469|NCT03814005|Antimetabolites|antimetabolites|mesh-ancestor
65172470|NCT03814005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172471|NCT03683433|Azacitidine|azacitidine|mesh-list
65172472|NCT03683433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65172473|NCT03683433|Antimetabolites|antimetabolites|mesh-ancestor
65172474|NCT03683433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172475|NCT03683433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172476|NCT03683433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172477|NCT03449901|Gemcitabine|gemcitabine|mesh-list
65172478|NCT03449901|Docetaxel|docetaxel|mesh-list
65172482|NCT03449901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172483|NCT03449901|Antiviral Agents|antiviral agents|mesh-ancestor
65172484|NCT03449901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65172485|NCT03449901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172486|NCT03449901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65172487|NCT03449901|Immunologic Factors|immunologic factors|mesh-ancestor
65172488|NCT03449901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323668|NCT04083417|Penicillin V|penicillin v|mesh-list
65323669|NCT04083417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65323670|NCT02588937|Entecavir|entecavir|mesh-list
65323671|NCT02588937|Antiviral Agents|antiviral agents|mesh-ancestor
65323672|NCT02588937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65323673|NCT04083105|Midazolam|midazolam|mesh-list
65323674|NCT04083105|Nitrous Oxide|nitrous oxide|mesh-list
65323675|NCT04083105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65323676|NCT04083105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65323677|NCT04083105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65323678|NCT04083105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323679|NCT04083105|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65323680|NCT04083105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65323681|NCT04083105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65323682|NCT04083105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65323683|NCT04083105|Anesthetics, General|anesthetics, general|mesh-ancestor
65323684|NCT04083105|Anesthetics|anesthetics|mesh-ancestor
65323685|NCT04083105|GABA Modulators|gaba modulators|mesh-ancestor
65323686|NCT04083105|GABA Agents|gaba agents|mesh-ancestor
65323687|NCT04083105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65323688|NCT04083105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323689|NCT04083105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65323690|NCT04083105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65323691|NCT04083105|Analgesics|analgesics|mesh-ancestor
65323692|NCT04083105|Sensory System Agents|sensory system agents|mesh-ancestor
65323693|NCT04083105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323694|NCT00735696|Paclitaxel|paclitaxel|mesh-list
65323695|NCT00735696|Carboplatin|carboplatin|mesh-list
65323696|NCT00735696|Ramucirumab|ramucirumab|mesh-list
64553391|NCT00915603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172489|NCT03449901|Tubulin Modulators|tubulin modulators|mesh-ancestor
65172490|NCT03449901|Antimitotic Agents|antimitotic agents|mesh-ancestor
65172491|NCT03449901|Mitosis Modulators|mitosis modulators|mesh-ancestor
65172493|NCT00968799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172494|NCT04016233|Tenofovir|tenofovir|mesh-list
65172495|NCT04016233|Antiviral Agents|antiviral agents|mesh-ancestor
65172496|NCT04016233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65172497|NCT04016233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65172498|NCT04016233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65172499|NCT04016233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172500|NCT04016233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172501|NCT04016233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65172502|NCT04016233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65172503|NCT04033471|Midazolam|midazolam|mesh-list
65172504|NCT04033471|Morphine|morphine|mesh-list
65172505|NCT04033471|Bupivacaine|bupivacaine|mesh-list
65172506|NCT04033471|Anesthetics, Local|anesthetics, local|mesh-ancestor
65172507|NCT04033471|Anesthetics|anesthetics|mesh-ancestor
65172508|NCT04033471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65323697|NCT00735696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65323698|NCT00735696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323699|NCT00735696|Tubulin Modulators|tubulin modulators|mesh-ancestor
65323700|NCT00735696|Antimitotic Agents|antimitotic agents|mesh-ancestor
65323701|NCT00735696|Mitosis Modulators|mitosis modulators|mesh-ancestor
65323702|NCT00735696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323703|NCT02593968|Interferons|interferons|mesh-list
65323704|NCT02593968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323705|NCT02593968|Antiviral Agents|antiviral agents|mesh-ancestor
65323706|NCT02593968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65323707|NCT02588547|Granisetron|granisetron|mesh-list
65323708|NCT02588547|Antiemetics|antiemetics|mesh-ancestor
65323709|NCT02588547|Autonomic Agents|autonomic agents|mesh-ancestor
65323710|NCT02588547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323711|NCT02588547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323712|NCT02588547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65323713|NCT02588547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65323714|NCT02588547|Serotonin Agents|serotonin agents|mesh-ancestor
64553417|NCT04474002|Cathartics|cathartics|mesh-ancestor
65172509|NCT04033471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172510|NCT04033471|Sensory System Agents|sensory system agents|mesh-ancestor
65172511|NCT04033471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65172512|NCT04033471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65172513|NCT04033471|Narcotics|narcotics|mesh-ancestor
65172514|NCT04033471|Analgesics|analgesics|mesh-ancestor
65172515|NCT04033471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65172516|NCT04033471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65172517|NCT04033471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65172518|NCT04033471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65172519|NCT04033471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65172520|NCT04033471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65172521|NCT04033471|Anesthetics, General|anesthetics, general|mesh-ancestor
65172522|NCT04033471|GABA Modulators|gaba modulators|mesh-ancestor
65172523|NCT04033471|GABA Agents|gaba agents|mesh-ancestor
65172524|NCT04033471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65172525|NCT04033471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172526|NCT00910351|Ciprofloxacin|ciprofloxacin|mesh-list
65172527|NCT00910351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65172528|NCT00910351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65172529|NCT00910351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65172530|NCT00910351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65172531|NCT00910351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172532|NCT00910351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172533|NCT00910351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172534|NCT00910351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65172535|NCT00910351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65172536|NCT04175587|Tretinoin|tretinoin|mesh-list
65172537|NCT04175587|Arsenic Trioxide|arsenic trioxide|mesh-list
65172538|NCT04175587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172539|NCT04175587|Keratolytic Agents|keratolytic agents|mesh-ancestor
65172540|NCT04175587|Dermatologic Agents|dermatologic agents|mesh-ancestor
65172541|NCT02668159|Vitamin D|vitamin d|mesh-list
65172542|NCT02668159|Ergocalciferols|ergocalciferols|mesh-list
65172543|NCT02668159|Cholecalciferol|cholecalciferol|mesh-list
65172544|NCT02668159|Vitamins|vitamins|mesh-list
65172545|NCT02668159|Micronutrients|micronutrients|mesh-ancestor
65172546|NCT02668159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172547|NCT02668159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65323715|NCT02588547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65323716|NCT02588547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323717|NCT00478231|Maraviroc|maraviroc|mesh-list
65323718|NCT00478231|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65323719|NCT00478231|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65323720|NCT00478231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323721|NCT00478231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65323722|NCT00478231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65323723|NCT00478231|Antiviral Agents|antiviral agents|mesh-ancestor
65323724|NCT00478231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65323725|NCT00478231|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65323726|NCT00474175|Benzocaine|benzocaine|mesh-list
65323727|NCT00474175|Anesthetics, Local|anesthetics, local|mesh-ancestor
65323728|NCT00474175|Anesthetics|anesthetics|mesh-ancestor
65323729|NCT00474175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65323730|NCT00474175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323731|NCT00474175|Sensory System Agents|sensory system agents|mesh-ancestor
65323732|NCT00474175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323733|NCT03002389|Fluticasone|fluticasone|mesh-list
65323734|NCT03002389|Xhance|xhance|mesh-list
65323735|NCT03002389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64553433|NCT02398825|Ponatinib|ponatinib|mesh-list
65172548|NCT02668159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65172549|NCT02670109|Cyclophosphamide|cyclophosphamide|mesh-list
65172550|NCT02670109|Busulfan|busulfan|mesh-list
65172551|NCT02670109|Carmustine|carmustine|mesh-list
65172552|NCT02670109|Carboplatin|carboplatin|mesh-list
65172557|NCT02670109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65172559|NCT02670109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172560|NCT02670109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172561|NCT02670109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65172562|NCT00922636|Methylphenidate|methylphenidate|mesh-list
65172563|NCT00922636|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65172564|NCT00922636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172565|NCT00922636|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65172566|NCT00922636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65172567|NCT00922636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65172568|NCT00922636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172569|NCT00922636|Dopamine Agents|dopamine agents|mesh-ancestor
65172570|NCT00922636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65172571|NCT02667925|Cisplatin|cisplatin|mesh-list
65172572|NCT02667925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172573|NCT02669719|Carboplatin|carboplatin|mesh-list
65172574|NCT02669719|Pemetrexed|pemetrexed|mesh-list
65172575|NCT02669719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172576|NCT02669719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172577|NCT02669719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172578|NCT02669719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65172579|NCT02669719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65172580|NCT00644761|Adefovir|adefovir|mesh-list
65172581|NCT00644761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65172582|NCT00644761|Antiviral Agents|antiviral agents|mesh-ancestor
65172583|NCT00644761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65323736|NCT03002389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65323737|NCT03002389|Autonomic Agents|autonomic agents|mesh-ancestor
65323738|NCT03002389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323739|NCT03002389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323740|NCT03002389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65323741|NCT03002389|Respiratory System Agents|respiratory system agents|mesh-ancestor
65323742|NCT03002389|Dermatologic Agents|dermatologic agents|mesh-ancestor
65323743|NCT03002389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65323744|NCT04082949|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65323745|NCT04082949|Hemostatics|hemostatics|mesh-ancestor
65323746|NCT04082949|Coagulants|coagulants|mesh-ancestor
65323747|NCT01020643|Propofol|propofol|mesh-list
65323748|NCT01020643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65323749|NCT01020643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65323750|NCT01020643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323751|NCT01020643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65323752|NCT01020643|Anesthetics, General|anesthetics, general|mesh-ancestor
65323753|NCT01020643|Anesthetics|anesthetics|mesh-ancestor
65323754|NCT03537391|Fluorides|fluorides|mesh-list
65323755|NCT03537391|Cariostatic Agents|cariostatic agents|mesh-ancestor
65323756|NCT03537391|Protective Agents|protective agents|mesh-ancestor
65323757|NCT03537391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323758|NCT04082715|Celecoxib|celecoxib|mesh-list
65323759|NCT04082715|Levodopa|levodopa|mesh-list
65323760|NCT04082715|Carbidopa|carbidopa|mesh-list
65323761|NCT04082715|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65323762|NCT04082715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65323763|NCT04082715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65323764|NCT04082715|Analgesics|analgesics|mesh-ancestor
65323765|NCT04082715|Sensory System Agents|sensory system agents|mesh-ancestor
65323766|NCT04082715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323767|NCT04082715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172584|NCT00644761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65172585|NCT00644761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65172586|NCT00644761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172587|NCT00644761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172589|NCT00645073|Ofloxacin|ofloxacin|mesh-list
65172590|NCT00645073|Cefdinir|cefdinir|mesh-list
65172591|NCT00645073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65172592|NCT00645073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65172593|NCT00645073|Renal Agents|renal agents|mesh-ancestor
65172594|NCT00645073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65172595|NCT00645073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65172596|NCT00645073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65323768|NCT04082715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65323769|NCT04082715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65323770|NCT04082715|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65323771|NCT04082715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65323772|NCT04082715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65323773|NCT04082715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323774|NCT04082715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65323775|NCT04082715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65323776|NCT04082715|Dopamine Agents|dopamine agents|mesh-ancestor
65323777|NCT04082715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65323778|NCT04082715|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65323779|NCT04082715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65323780|NCT04082715|Immunologic Factors|immunologic factors|mesh-ancestor
65323781|NCT04082715|Dopamine Agonists|dopamine agonists|mesh-ancestor
65323782|NCT00443209|Rizatriptan|rizatriptan|mesh-list
65323783|NCT00443209|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65323784|NCT00443209|Serotonin Agents|serotonin agents|mesh-ancestor
65323785|NCT00443209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64553485|NCT05061732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65172597|NCT00645073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172598|NCT00645073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172599|NCT00645073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172600|NCT00645073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65172601|NCT00645073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65172602|NCT04259008|Manganese|manganese|mesh-list
65172603|NCT04259008|Trace Elements|trace elements|mesh-ancestor
65172604|NCT04259008|Micronutrients|micronutrients|mesh-ancestor
65172605|NCT04259008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172606|NCT04258930|Calcium|calcium|mesh-list
65172607|NCT04258930|Calcium acetate|calcium acetate|mesh-list
65172608|NCT04258930|Aluminum sulfate|aluminum sulfate|mesh-list
65172609|NCT04258930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65172610|NCT04258930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172611|NCT04258930|Chelating Agents|chelating agents|mesh-ancestor
65172612|NCT04258930|Sequestering Agents|sequestering agents|mesh-ancestor
65172613|NCT04258930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172614|NCT04258930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65172615|NCT04258930|Immunologic Factors|immunologic factors|mesh-ancestor
65172616|NCT01175135|Risperidone|risperidone|mesh-list
65172617|NCT01175135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65172618|NCT01175135|Serotonin Agents|serotonin agents|mesh-ancestor
65172619|NCT01175135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65172620|NCT01175135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172621|NCT01175135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172622|NCT01175135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65172627|NCT01175135|Dopamine Agents|dopamine agents|mesh-ancestor
65172629|NCT02669641|Lipotropic Agents|lipotropic agents|mesh-ancestor
65172630|NCT02669641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65172631|NCT02669641|Antimetabolites|antimetabolites|mesh-ancestor
65172632|NCT02669641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172633|NCT02669641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65172634|NCT02669641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65172635|NCT02669641|Nootropic Agents|nootropic agents|mesh-ancestor
65172636|NCT00922480|Losartan|losartan|mesh-list
65172637|NCT00922480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65172638|NCT00922480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65323786|NCT00443209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323787|NCT00443209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323788|NCT02588235|Atorvastatin|atorvastatin|mesh-list
65323789|NCT02588235|Ezetimibe|ezetimibe|mesh-list
65323790|NCT02588235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65323791|NCT02588235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65323792|NCT02588235|Antimetabolites|antimetabolites|mesh-ancestor
65323793|NCT02588235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323794|NCT02588235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65323795|NCT02588235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65323796|NCT02588235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65323797|NCT01020955|Mecasermin|mecasermin|mesh-list
65323798|NCT01020955|Growth Substances|growth substances|mesh-ancestor
65323799|NCT01020955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323800|NCT03519997|Pembrolizumab|pembrolizumab|mesh-list
65323801|NCT03519997|Bavituximab|bavituximab|mesh-list
65172639|NCT00922480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65172640|NCT00922480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65172641|NCT00922480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172642|NCT04963036|Anesthetics|anesthetics|mesh-list
65172643|NCT04963036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65172644|NCT04963036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172645|NCT00973479|Golimumab|golimumab|mesh-list
65172646|NCT00973479|Methotrexate|methotrexate|mesh-list
65172647|NCT00973479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65172648|NCT00973479|Abortifacient Agents|abortifacient agents|mesh-ancestor
65172649|NCT00973479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65172650|NCT00973479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172651|NCT00973479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65172652|NCT00973479|Antimetabolites|antimetabolites|mesh-ancestor
65172653|NCT00973479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172654|NCT00973479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172655|NCT00973479|Dermatologic Agents|dermatologic agents|mesh-ancestor
65172656|NCT00973479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172657|NCT00973479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65172658|NCT00973479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65172659|NCT00973479|Immunologic Factors|immunologic factors|mesh-ancestor
65172660|NCT00973479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65172661|NCT00973479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65172662|NCT00973479|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65172663|NCT00973479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65172664|NCT01174043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65172665|NCT01174043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172666|NCT01174043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65172667|NCT01174043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172668|NCT01174043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172669|NCT04315493|Maleic acid|maleic acid|mesh-list
65172670|NCT04315493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172671|NCT04315493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172672|NCT04173871|Snake venom protein C activator|snake venom protein c activator|mesh-list
65172673|NCT04173871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65172674|NCT04173871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65172675|NCT04173871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172676|NCT02862483|Tadalafil|tadalafil|mesh-list
65172677|NCT02862483|Tamsulosin|tamsulosin|mesh-list
65172678|NCT02862483|Vasodilator Agents|vasodilator agents|mesh-ancestor
65323802|NCT03519997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65323803|NCT03519997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323804|NCT04082793|Diclofenac|diclofenac|mesh-list
65323805|NCT04082793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65323806|NCT04082793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65323807|NCT04082793|Analgesics|analgesics|mesh-ancestor
65323808|NCT04082793|Sensory System Agents|sensory system agents|mesh-ancestor
65323809|NCT04082793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323810|NCT04082793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323811|NCT04082793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65323812|NCT04082793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65323813|NCT04082793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65323814|NCT04082793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553522|NCT01728987|Vitamins|vitamins|mesh-ancestor
65172679|NCT02862483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65172680|NCT02862483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65172681|NCT02862483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172682|NCT02862483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172683|NCT02862483|Urological Agents|urological agents|mesh-ancestor
65172684|NCT02862483|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65172685|NCT02862483|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65172686|NCT02862483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65172687|NCT02862483|Adrenergic Agents|adrenergic agents|mesh-ancestor
65172688|NCT02862483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65172689|NCT02862483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172690|NCT02667535|Isosorbide|isosorbide|mesh-list
65172691|NCT02667535|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65172698|NCT02667535|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65172699|NCT02667535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172700|NCT00645151|Atorvastatin|atorvastatin|mesh-list
65172701|NCT00645151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65172702|NCT00645151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65172703|NCT00645151|Antimetabolites|antimetabolites|mesh-ancestor
65172704|NCT00645151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172705|NCT00645151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65172706|NCT00645151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65172707|NCT00645151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172708|NCT00645229|Ziprasidone|ziprasidone|mesh-list
65172709|NCT00645229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65172710|NCT00645229|Serotonin Agents|serotonin agents|mesh-ancestor
65172711|NCT00645229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65172712|NCT00645229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172713|NCT00645229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172714|NCT00645229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65172715|NCT00645229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65172716|NCT00645229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65172717|NCT00645229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65172718|NCT00645229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65172719|NCT00645229|Dopamine Agents|dopamine agents|mesh-ancestor
65172720|NCT01172873|Cycloserine|cycloserine|mesh-list
65172721|NCT01172873|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65172722|NCT01172873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65172723|NCT01172873|Renal Agents|renal agents|mesh-ancestor
65172724|NCT01172873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65172725|NCT01172873|Antitubercular Agents|antitubercular agents|mesh-ancestor
65172726|NCT01172873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65172727|NCT01172873|Antimetabolites|antimetabolites|mesh-ancestor
65172728|NCT01172873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172730|NCT02886299|Fenofibrate|fenofibrate|mesh-list
65172731|NCT02886299|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65323815|NCT04082793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323816|NCT00439231|Lenalidomide|lenalidomide|mesh-list
65323817|NCT00439231|Immunologic Factors|immunologic factors|mesh-ancestor
65323818|NCT00439231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323819|NCT00439231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65323820|NCT00439231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65323821|NCT00439231|Growth Substances|growth substances|mesh-ancestor
65323822|NCT00439231|Growth Inhibitors|growth inhibitors|mesh-ancestor
65323823|NCT00439231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323824|NCT00783692|Vedolizumab|vedolizumab|mesh-list
65323825|NCT00783692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65323826|NCT04973163|Midazolam|midazolam|mesh-list
65323827|NCT04973163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65323828|NCT04973163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65323829|NCT04973163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65323830|NCT04973163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323831|NCT04973163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65323832|NCT04973163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65323833|NCT04973163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65323834|NCT04973163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65323835|NCT04973163|Anesthetics, General|anesthetics, general|mesh-ancestor
65323836|NCT04973163|Anesthetics|anesthetics|mesh-ancestor
65323837|NCT04973163|GABA Modulators|gaba modulators|mesh-ancestor
65172732|NCT02886299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65172733|NCT02886299|Antimetabolites|antimetabolites|mesh-ancestor
65172734|NCT02886299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172735|NCT02886299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65172736|NCT02886299|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65172737|NCT02886299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172738|NCT00925600|Denosumab|denosumab|mesh-list
65172739|NCT00925600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65172740|NCT00925600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172741|NCT00645931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65172742|NCT00645931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65172743|NCT00645931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172744|NCT00645307|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65172745|NCT00645307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65172746|NCT00645307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65172747|NCT00645307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65172748|NCT00645307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172749|NCT00645307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65172750|NCT00645307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65172751|NCT00645307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65172752|NCT00645307|Serotonin Agents|serotonin agents|mesh-ancestor
65172753|NCT00645307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65172754|NCT00645307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172755|NCT00645307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65172756|NCT00645307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65172757|NCT00645307|Dopamine Agents|dopamine agents|mesh-ancestor
65172758|NCT02668861|Vitamin D|vitamin d|mesh-list
65172759|NCT02668861|Budesonide|budesonide|mesh-list
65172760|NCT02668861|Vitamins|vitamins|mesh-ancestor
65172761|NCT02668861|Micronutrients|micronutrients|mesh-ancestor
65323838|NCT04973163|GABA Agents|gaba agents|mesh-ancestor
65323839|NCT04973163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65323840|NCT04973163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323841|NCT00783224|Fluticasone|fluticasone|mesh-list
65323842|NCT00783224|Mometasone Furoate|mometasone furoate|mesh-list
65323843|NCT00783224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65323844|NCT00783224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65323845|NCT00783224|Autonomic Agents|autonomic agents|mesh-ancestor
65323846|NCT00783224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323847|NCT00783224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323848|NCT00783224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65323849|NCT00783224|Respiratory System Agents|respiratory system agents|mesh-ancestor
65323850|NCT00783224|Dermatologic Agents|dermatologic agents|mesh-ancestor
65323851|NCT00783224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65323852|NCT04082559|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65073817|NCT00307502|Efavirenz|efavirenz|mesh-list
65323853|NCT04082559|Metronidazole|metronidazole|mesh-list
65323854|NCT04082559|Doxycycline|doxycycline|mesh-list
65323855|NCT04082559|Ciprofloxacin|ciprofloxacin|mesh-list
65323857|NCT04082559|Complement Factor H|complement factor h|mesh-list
65323858|NCT04082559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65323859|NCT04082559|Antitubercular Agents|antitubercular agents|mesh-ancestor
65323860|NCT04082559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65323861|NCT04082559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65323862|NCT04082559|Antimalarials|antimalarials|mesh-ancestor
65323863|NCT04082559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65323864|NCT04082559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65323865|NCT04082559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65323866|NCT04082559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172763|NCT02668861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65172765|NCT02668861|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65172766|NCT02668861|Autonomic Agents|autonomic agents|mesh-ancestor
65172767|NCT02668861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65172768|NCT02668861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65172769|NCT02668861|Respiratory System Agents|respiratory system agents|mesh-ancestor
65172770|NCT02668861|Glucocorticoids|glucocorticoids|mesh-ancestor
65172771|NCT02668861|Hormones|hormones|mesh-ancestor
65172772|NCT02668861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65172773|NCT00968253|Cytarabine|cytarabine|mesh-list
65172774|NCT00968253|Dexamethasone|dexamethasone|mesh-list
65172775|NCT00968253|Methylprednisolone|methylprednisolone|mesh-list
65172776|NCT00968253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65172777|NCT00968253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65172778|NCT00968253|Prednisolone|prednisolone|mesh-list
65172779|NCT00968253|Prednisolone acetate|prednisolone acetate|mesh-list
65172780|NCT00968253|Cyclophosphamide|cyclophosphamide|mesh-list
65172781|NCT00968253|Doxorubicin|doxorubicin|mesh-list
65172782|NCT00968253|Methotrexate|methotrexate|mesh-list
65323867|NCT04082559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323868|NCT04082559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65323869|NCT04082559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65323870|NCT04082559|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65323871|NCT04082559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65323872|NCT04082559|Immunologic Factors|immunologic factors|mesh-ancestor
65323873|NCT04082559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323874|NCT02587845|Tranexamic Acid|tranexamic acid|mesh-list
65323875|NCT02587845|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65323876|NCT02587845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65323877|NCT02587845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323878|NCT02587845|Hemostatics|hemostatics|mesh-ancestor
64318675|NCT03538327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64318676|NCT03538327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318677|NCT03538327|Protective Agents|protective agents|mesh-ancestor
64318678|NCT03538327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318679|NCT02170597|Dabigatran|dabigatran|mesh-list
64318680|NCT02170597|Antithrombins|antithrombins|mesh-ancestor
64553589|NCT01723527|Buprenorphine|buprenorphine|mesh-list
65323879|NCT02587845|Coagulants|coagulants|mesh-ancestor
65323880|NCT00765674|Amlodipine|amlodipine|mesh-list
65323881|NCT00765674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65323882|NCT00765674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65323883|NCT00765674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65323884|NCT00765674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65323885|NCT00765674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323886|NCT00765674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65323887|NCT00765674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323888|NCT00765674|Vasodilator Agents|vasodilator agents|mesh-ancestor
65323889|NCT00765674|Diuretics|diuretics|mesh-ancestor
65323890|NCT00765674|Natriuretic Agents|natriuretic agents|mesh-ancestor
65323891|NCT00765674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65323892|NCT00586898|Ketoconazole|ketoconazole|mesh-list
65323893|NCT00586898|Bicalutamide|bicalutamide|mesh-list
65323894|NCT00586898|Testosterone|testosterone|mesh-list
65323895|NCT00586898|Estrogens|estrogens|mesh-list
65323896|NCT00586898|Androgens|androgens|mesh-ancestor
65172783|NCT00968253|Vincristine|vincristine|mesh-list
65172784|NCT00968253|Everolimus|everolimus|mesh-list
65323897|NCT00586898|Hormones|hormones|mesh-ancestor
65323898|NCT00586898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65323899|NCT00586898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323900|NCT00586898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323901|NCT00586898|Antifungal Agents|antifungal agents|mesh-ancestor
65323902|NCT00586898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65323903|NCT00586898|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65323904|NCT00586898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65323905|NCT00586898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65323906|NCT00586898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323907|NCT00586898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65323908|NCT00586898|Hormone Antagonists|hormone antagonists|mesh-ancestor
65323909|NCT00586898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65323910|NCT00586898|Androgen Antagonists|androgen antagonists|mesh-ancestor
65323911|NCT02587455|Pembrolizumab|pembrolizumab|mesh-list
65323912|NCT02587455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65323913|NCT02587455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172785|NCT00968253|Lenograstim|lenograstim|mesh-list
65172786|NCT00968253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65172787|NCT00968253|Prednisolone phosphate|prednisolone phosphate|mesh-list
65172788|NCT00968253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65172789|NCT00968253|Immunologic Factors|immunologic factors|mesh-ancestor
65172790|NCT00968253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172791|NCT00968253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65172792|NCT00968253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65172793|NCT00968253|Alkylating Agents|alkylating agents|mesh-ancestor
65172794|NCT00968253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172795|NCT00968253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172796|NCT00968253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65172797|NCT00968253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65172798|NCT00968253|Antiemetics|antiemetics|mesh-ancestor
65172799|NCT00968253|Autonomic Agents|autonomic agents|mesh-ancestor
65172800|NCT00968253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64514688|NCT01751087|Oxytocics|oxytocics|mesh-ancestor
65172801|NCT00968253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65172802|NCT00968253|Glucocorticoids|glucocorticoids|mesh-ancestor
65172803|NCT00968253|Hormones|hormones|mesh-ancestor
65172804|NCT00968253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65172805|NCT00968253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65172806|NCT00968253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65172807|NCT00968253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65172808|NCT00968253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65172810|NCT00968253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65172811|NCT00968253|Abortifacient Agents|abortifacient agents|mesh-ancestor
65172812|NCT00968253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65172813|NCT00968253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65172814|NCT00968253|Antimetabolites|antimetabolites|mesh-ancestor
65172815|NCT00968253|Dermatologic Agents|dermatologic agents|mesh-ancestor
65172816|NCT00968253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65172817|NCT00968253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65172818|NCT00968253|Antiviral Agents|antiviral agents|mesh-ancestor
65172819|NCT00968253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65172820|NCT00968253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65172821|NCT00968253|Tubulin Modulators|tubulin modulators|mesh-ancestor
65172822|NCT00968253|Antimitotic Agents|antimitotic agents|mesh-ancestor
65323914|NCT04099238|Warfarin|warfarin|mesh-list
65323915|NCT04099238|Rivaroxaban|rivaroxaban|mesh-list
65323916|NCT04099238|Dabigatran|dabigatran|mesh-list
65323917|NCT04099238|Apixaban|apixaban|mesh-list
65323918|NCT04099238|Anticoagulants|anticoagulants|mesh-list
65323919|NCT04099238|Edoxaban|edoxaban|mesh-list
65323920|NCT04099238|Acenocoumarol|acenocoumarol|mesh-list
65323921|NCT04099238|Phenindione|phenindione|mesh-list
65323922|NCT04099238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65323923|NCT04099238|Antithrombins|antithrombins|mesh-ancestor
65323924|NCT04099238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65323925|NCT04099238|Protease Inhibitors|protease inhibitors|mesh-ancestor
65323926|NCT04099238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65323927|NCT04099238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323928|NCT04932135|Hormones|hormones|mesh-list
65073891|NCT00308048|Interferon-alpha|interferon-alpha|mesh-list
65323929|NCT04932135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65323930|NCT04932135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323931|NCT04101812|Doxorubicin|doxorubicin|mesh-list
65323932|NCT04101812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65323933|NCT04101812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65323934|NCT04101812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553615|NCT03519984|Antimetabolites|antimetabolites|mesh-ancestor
65172823|NCT00968253|Mitosis Modulators|mitosis modulators|mesh-ancestor
65172824|NCT00968253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65172825|NCT00968253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65172826|NCT00968253|Protective Agents|protective agents|mesh-ancestor
65172827|NCT00646009|Fluticasone|fluticasone|mesh-list
65172828|NCT00646009|Budesonide|budesonide|mesh-list
65172829|NCT00646009|Albuterol|albuterol|mesh-list
65172830|NCT00646009|Formoterol Fumarate|formoterol fumarate|mesh-list
65172831|NCT00646009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65172832|NCT00646009|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65172833|NCT00646009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65172834|NCT00646009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65172835|NCT00646009|Autonomic Agents|autonomic agents|mesh-ancestor
65172836|NCT00646009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65172842|NCT00646009|Glucocorticoids|glucocorticoids|mesh-ancestor
65172843|NCT00646009|Hormones|hormones|mesh-ancestor
65172844|NCT00646009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65172845|NCT00646009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65172846|NCT00646009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65172847|NCT00646009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65172848|NCT00646009|Adrenergic Agents|adrenergic agents|mesh-ancestor
65172849|NCT00646009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65172850|NCT00646009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172851|NCT00646009|Tocolytic Agents|tocolytic agents|mesh-ancestor
65172852|NCT00646009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65172853|NCT00646009|Sympathomimetics|sympathomimetics|mesh-ancestor
65172854|NCT00646087|Ketamine|ketamine|mesh-list
65172855|NCT00646087|Analgesics|analgesics|mesh-ancestor
65172856|NCT00646087|Sensory System Agents|sensory system agents|mesh-ancestor
65172857|NCT00646087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65172858|NCT00646087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172859|NCT00646087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65172860|NCT00646087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65323935|NCT04101812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65323936|NCT04101812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65323937|NCT04101812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65323938|NCT04101812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323939|NCT04923867|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65323940|NCT04923867|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65323942|NCT04923867|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65323943|NCT04923867|Estrogens|estrogens|mesh-ancestor
65323944|NCT04923867|Hormones|hormones|mesh-ancestor
65323945|NCT04923867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65323946|NCT04923867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323947|NCT04923867|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65323948|NCT04923867|Contraceptive Agents|contraceptive agents|mesh-ancestor
65323949|NCT04923867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65323950|NCT04923867|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65323951|NCT02587533|Dopamine|dopamine|mesh-list
65323952|NCT02587533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65172861|NCT00646087|Anesthetics, General|anesthetics, general|mesh-ancestor
65172862|NCT00646087|Anesthetics|anesthetics|mesh-ancestor
65172863|NCT00646087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65172864|NCT00646087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65172865|NCT00646087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65172866|NCT00646087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65172867|NCT00646087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172868|NCT04255576|Vitamin D|vitamin d|mesh-list
65172869|NCT04255576|Calcium|calcium|mesh-list
65172870|NCT04255576|Vitamins|vitamins|mesh-ancestor
65172871|NCT04255576|Micronutrients|micronutrients|mesh-ancestor
65172872|NCT04255576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172873|NCT04255576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65172874|NCT04255576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65172875|NCT04255498|Etanercept|etanercept|mesh-list
65172876|NCT04255498|Mifepristone|mifepristone|mesh-list
65172877|NCT04255498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65172878|NCT04255498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65172880|NCT04255498|Sensory System Agents|sensory system agents|mesh-ancestor
65172881|NCT04255498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65172882|NCT04255498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172883|NCT04255498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65172884|NCT04255498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65172885|NCT04255498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65172886|NCT04255498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65172887|NCT04255498|Immunologic Factors|immunologic factors|mesh-ancestor
65172888|NCT04255498|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65172889|NCT04255498|Abortifacient Agents|abortifacient agents|mesh-ancestor
65172890|NCT04255498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65172891|NCT04255498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65172892|NCT04255498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65172893|NCT04255498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65172894|NCT04255498|Contraceptive Agents|contraceptive agents|mesh-ancestor
65172895|NCT04255498|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65172896|NCT04255498|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65172897|NCT04255498|Hormone Antagonists|hormone antagonists|mesh-ancestor
65172898|NCT04255498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65172899|NCT04255498|Luteolytic Agents|luteolytic agents|mesh-ancestor
65172900|NCT04255498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65323953|NCT02587533|Sympathomimetics|sympathomimetics|mesh-ancestor
65323954|NCT02587533|Autonomic Agents|autonomic agents|mesh-ancestor
65323955|NCT02587533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65323956|NCT02587533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323957|NCT02587533|Dopamine Agents|dopamine agents|mesh-ancestor
65323958|NCT02587533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65323959|NCT02587533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323960|NCT02587533|Protective Agents|protective agents|mesh-ancestor
65323961|NCT04875975|Rozanolixizumab|rozanolixizumab|mesh-list
65323962|NCT04875975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65323963|NCT04875975|Immunologic Factors|immunologic factors|mesh-ancestor
65323964|NCT04875975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323965|NCT04847661|Mefloquine|mefloquine|mesh-list
65323966|NCT04847661|Antimalarials|antimalarials|mesh-ancestor
65323967|NCT04847661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65172901|NCT04255498|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65172902|NCT02666209|Dexamethasone|dexamethasone|mesh-list
65172903|NCT02666209|Lenalidomide|lenalidomide|mesh-list
65172904|NCT02666209|Bortezomib|bortezomib|mesh-list
65172905|NCT02666209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65172906|NCT02666209|Antiemetics|antiemetics|mesh-ancestor
65172911|NCT02666209|Glucocorticoids|glucocorticoids|mesh-ancestor
65172912|NCT02666209|Hormones|hormones|mesh-ancestor
65172913|NCT02666209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65172914|NCT02666209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65172915|NCT02666209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172916|NCT02666209|Immunologic Factors|immunologic factors|mesh-ancestor
65172917|NCT02666209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65172918|NCT02666209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65172919|NCT02666209|Growth Substances|growth substances|mesh-ancestor
65172920|NCT02666209|Growth Inhibitors|growth inhibitors|mesh-ancestor
65172921|NCT00964743|Cytarabine|cytarabine|mesh-list
65172922|NCT00964743|Sorafenib|sorafenib|mesh-list
65172923|NCT00964743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65172924|NCT00964743|Antimetabolites|antimetabolites|mesh-ancestor
65172925|NCT00964743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172926|NCT00964743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172927|NCT00964743|Antiviral Agents|antiviral agents|mesh-ancestor
65172928|NCT00964743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65172929|NCT00964743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65172930|NCT00964743|Immunologic Factors|immunologic factors|mesh-ancestor
65172931|NCT00964743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172932|NCT00964743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65172933|NCT00964743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172934|NCT02862327|Dexamethasone|dexamethasone|mesh-list
65172935|NCT02862327|Dexamethasone acetate|dexamethasone acetate|mesh-list
65172936|NCT02862327|Ropivacaine|ropivacaine|mesh-list
65172937|NCT02862327|BB 1101|bb 1101|mesh-list
65172938|NCT02862327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65172939|NCT02862327|Antiemetics|antiemetics|mesh-ancestor
65172940|NCT02862327|Autonomic Agents|autonomic agents|mesh-ancestor
65172941|NCT02862327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65172942|NCT02862327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172943|NCT02862327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65172944|NCT02862327|Glucocorticoids|glucocorticoids|mesh-ancestor
65172945|NCT02862327|Hormones|hormones|mesh-ancestor
65172946|NCT02862327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65172947|NCT02862327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65172948|NCT02862327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172949|NCT02862327|Protease Inhibitors|protease inhibitors|mesh-ancestor
65172950|NCT02862327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706459|NCT02028806|Antidotes|antidotes|mesh-ancestor
65323968|NCT04847661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65323969|NCT04847661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65323970|NCT00919815|Cyclosporine|cyclosporine|mesh-list
65323971|NCT00919815|Prednisolone|prednisolone|mesh-list
65323972|NCT00919815|Cyclosporins|cyclosporins|mesh-list
65323973|NCT00919815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65323974|NCT00919815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323975|NCT00919815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65323976|NCT00919815|Immunologic Factors|immunologic factors|mesh-ancestor
65323977|NCT00919815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323978|NCT00919815|Antifungal Agents|antifungal agents|mesh-ancestor
65323979|NCT00919815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65323980|NCT00919815|Dermatologic Agents|dermatologic agents|mesh-ancestor
65323981|NCT00919815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65323982|NCT00919815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65323983|NCT00919815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65323984|NCT00919815|Glucocorticoids|glucocorticoids|mesh-ancestor
65323985|NCT00919815|Hormones|hormones|mesh-ancestor
65323986|NCT00919815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65323987|NCT00919815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65323988|NCT00919815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65323989|NCT00796991|Paclitaxel|paclitaxel|mesh-list
65323990|NCT00796991|Carboplatin|carboplatin|mesh-list
65323991|NCT00796991|Ipilimumab|ipilimumab|mesh-list
65323992|NCT00796991|Dacarbazine|dacarbazine|mesh-list
65323993|NCT00796991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65323994|NCT00796991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553671|NCT04377867|Abatacept|abatacept|mesh-list
65172951|NCT02862327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172952|NCT02862327|Anesthetics, Local|anesthetics, local|mesh-ancestor
65172954|NCT02862327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64815567|NCT01485718|Cathartics|cathartics|mesh-ancestor
65172955|NCT02862327|Sensory System Agents|sensory system agents|mesh-ancestor
65172956|NCT04945720|Durvalumab|durvalumab|mesh-list
65172957|NCT04945720|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65172958|NCT04945720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65172959|NCT04945720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172960|NCT04945720|Immunologic Factors|immunologic factors|mesh-ancestor
65172961|NCT04945720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172962|NCT02666365|Cefazolin|cefazolin|mesh-list
65172963|NCT02666365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65172964|NCT02666365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65172965|NCT02666443|Dexamethasone|dexamethasone|mesh-list
65172966|NCT02666443|Dexamethasone acetate|dexamethasone acetate|mesh-list
65172967|NCT02666443|BB 1101|bb 1101|mesh-list
65172968|NCT02666443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65172969|NCT02666443|Antiemetics|antiemetics|mesh-ancestor
65172970|NCT02666443|Autonomic Agents|autonomic agents|mesh-ancestor
65172971|NCT02666443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65172972|NCT02666443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65323995|NCT00796991|Tubulin Modulators|tubulin modulators|mesh-ancestor
65323996|NCT00796991|Antimitotic Agents|antimitotic agents|mesh-ancestor
65323997|NCT00796991|Mitosis Modulators|mitosis modulators|mesh-ancestor
65323998|NCT00796991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65323999|NCT00796991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65324000|NCT00796991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65324001|NCT00796991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65324002|NCT00796991|Alkylating Agents|alkylating agents|mesh-ancestor
65324003|NCT05678205|Cyclophosphamide|cyclophosphamide|mesh-list
65324004|NCT05678205|Fludarabine|fludarabine|mesh-list
65073971|NCT00308360|GABA Agents|gaba agents|mesh-ancestor
65324005|NCT05678205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65324006|NCT05678205|Immunologic Factors|immunologic factors|mesh-ancestor
65324007|NCT05678205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324008|NCT05678205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65324009|NCT05678205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65324010|NCT05678205|Alkylating Agents|alkylating agents|mesh-ancestor
65324011|NCT05678205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324012|NCT05678205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65324013|NCT05678205|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65324014|NCT04112147|Ubiquinone|ubiquinone|mesh-list
65324015|NCT04112147|Micronutrients|micronutrients|mesh-ancestor
65172973|NCT02666443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65172974|NCT02666443|Glucocorticoids|glucocorticoids|mesh-ancestor
65172975|NCT02666443|Hormones|hormones|mesh-ancestor
65172976|NCT02666443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65172977|NCT02666443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65172986|NCT01130532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172987|NCT01130532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172988|NCT01130532|Urological Agents|urological agents|mesh-ancestor
65172989|NCT04258306|Resveratrol|resveratrol|mesh-list
65172990|NCT04258306|Antioxidants|antioxidants|mesh-ancestor
65172991|NCT04258306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172992|NCT04258306|Protective Agents|protective agents|mesh-ancestor
65172993|NCT04258306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172994|NCT04258306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172995|NCT04258306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65172996|NCT00646711|Valproic Acid|valproic acid|mesh-list
65172997|NCT00646711|Anticonvulsants|anticonvulsants|mesh-ancestor
65172998|NCT00646711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172999|NCT00646711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173000|NCT00646711|GABA Agents|gaba agents|mesh-ancestor
65173001|NCT00646711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65173002|NCT00646711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173003|NCT00646711|Antimanic Agents|antimanic agents|mesh-ancestor
65173004|NCT00646711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65173005|NCT00646711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65173006|NCT00646711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65173007|NCT00972777|Besifloxacin|besifloxacin|mesh-list
65173008|NCT00972777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65173009|NCT00972777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65173010|NCT00972777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65324016|NCT04112147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324017|NCT00914771|Vaccines|vaccines|mesh-list
65324018|NCT00914771|Immunologic Factors|immunologic factors|mesh-ancestor
65324019|NCT00914771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324020|NCT02586987|Durvalumab|durvalumab|mesh-list
65324021|NCT02586987|Tremelimumab|tremelimumab|mesh-list
65324022|NCT02586987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65324023|NCT02586987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65324024|NCT02586753|Paclitaxel|paclitaxel|mesh-list
65324025|NCT02586753|Cisplatin|cisplatin|mesh-list
65324026|NCT02586753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65324027|NCT02586753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65324028|NCT02586753|Tubulin Modulators|tubulin modulators|mesh-ancestor
65324029|NCT02586753|Antimitotic Agents|antimitotic agents|mesh-ancestor
65324030|NCT02586753|Mitosis Modulators|mitosis modulators|mesh-ancestor
65324031|NCT02586753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324032|NCT00799487|Methylphenidate|methylphenidate|mesh-list
65324033|NCT00799487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65324034|NCT00799487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173011|NCT00972777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65173012|NCT00972777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173013|NCT00972777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173014|NCT00972777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173015|NCT04254874|Interferons|interferons|mesh-list
65173016|NCT04254874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173017|NCT04254874|Antiviral Agents|antiviral agents|mesh-ancestor
65173018|NCT04254874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65173019|NCT02667223|Bococizumab|bococizumab|mesh-list
65173020|NCT02667223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65173021|NCT02667223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65173022|NCT02667223|Antimetabolites|antimetabolites|mesh-ancestor
65173023|NCT02667223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173024|NCT02667223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65173026|NCT02863809|Dextrans|dextrans|mesh-list
64815640|NCT01485939|Lidocaine|lidocaine|mesh-list
65173027|NCT02863809|Vitamins|vitamins|mesh-ancestor
65173028|NCT02863809|Micronutrients|micronutrients|mesh-ancestor
65173029|NCT02863809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173030|NCT02863809|Vitamin B Complex|vitamin b complex|mesh-ancestor
65173031|NCT02863809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65173032|NCT02863809|Dermatologic Agents|dermatologic agents|mesh-ancestor
65173033|NCT02863809|Anticoagulants|anticoagulants|mesh-ancestor
65173034|NCT02863809|Plasma Substitutes|plasma substitutes|mesh-ancestor
65173035|NCT02863809|Blood Substitutes|blood substitutes|mesh-ancestor
65173036|NCT00918736|Hyaluronic Acid|hyaluronic acid|mesh-list
65173037|NCT00918736|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65173038|NCT00918736|Immunologic Factors|immunologic factors|mesh-ancestor
65173039|NCT00918736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173040|NCT00918736|Viscosupplements|viscosupplements|mesh-ancestor
65173041|NCT00918736|Protective Agents|protective agents|mesh-ancestor
65173042|NCT02666053|Fostemsavir|fostemsavir|mesh-list
65173043|NCT02666053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65173044|NCT02666053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65173045|NCT02666053|Antiviral Agents|antiviral agents|mesh-ancestor
65173046|NCT02666053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65173058|NCT04257838|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65173059|NCT04257838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65173060|NCT04257838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65173061|NCT04257838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65324035|NCT00799487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65324036|NCT00799487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65324037|NCT00799487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65324038|NCT00799487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324039|NCT00799487|Dopamine Agents|dopamine agents|mesh-ancestor
65324040|NCT00799487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65324041|NCT04713657|Propranolol|propranolol|mesh-list
65324042|NCT04713657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65324043|NCT04713657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65173062|NCT04257838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173063|NCT04257838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173064|NCT01172639|Sulfasalazine|sulfasalazine|mesh-list
65173065|NCT01172639|Prednisone|prednisone|mesh-list
65173066|NCT01172639|Methotrexate|methotrexate|mesh-list
65173067|NCT01172639|Leflunomide|leflunomide|mesh-list
65173068|NCT01172639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65173069|NCT01172639|Glucocorticoids|glucocorticoids|mesh-ancestor
65173070|NCT01172639|Hormones|hormones|mesh-ancestor
65173071|NCT01172639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65173072|NCT01172639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173073|NCT01172639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65173074|NCT01172639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173075|NCT01172639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65173076|NCT01172639|Abortifacient Agents|abortifacient agents|mesh-ancestor
65173077|NCT01172639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65173078|NCT01172639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65173079|NCT01172639|Antimetabolites|antimetabolites|mesh-ancestor
65173080|NCT01172639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173081|NCT01172639|Dermatologic Agents|dermatologic agents|mesh-ancestor
65173082|NCT01172639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173083|NCT01172639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65173084|NCT01172639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65173085|NCT01172639|Immunologic Factors|immunologic factors|mesh-ancestor
65173086|NCT01172639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65173087|NCT01172639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65173088|NCT01172639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65173089|NCT01172639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65173090|NCT01172639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65173091|NCT01172639|Analgesics|analgesics|mesh-ancestor
65173092|NCT01172639|Sensory System Agents|sensory system agents|mesh-ancestor
65173093|NCT01172639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65173094|NCT01172639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65173095|NCT01225562|Ticagrelor|ticagrelor|mesh-list
65173096|NCT01225562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65173097|NCT01225562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65173098|NCT01225562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65173099|NCT01225562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65173101|NCT01225562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65173102|NCT01225562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173103|NCT01225562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173104|NCT00925288|Vaccines|vaccines|mesh-list
64815709|NCT01486433|Antipyretics|antipyretics|mesh-ancestor
65173105|NCT00925288|Immunologic Factors|immunologic factors|mesh-ancestor
65173106|NCT00925288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173107|NCT01143714|Petrolatum|petrolatum|mesh-list
65173108|NCT01143714|Emollients|emollients|mesh-ancestor
65173115|NCT04920682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173116|NCT04174339|Apatinib|apatinib|mesh-list
65173117|NCT04174339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173118|NCT04174339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65173119|NCT04174339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173120|NCT04174339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173121|NCT00972543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65173122|NCT00972543|Immunologic Factors|immunologic factors|mesh-ancestor
65324044|NCT04713657|Adrenergic Agents|adrenergic agents|mesh-ancestor
65324045|NCT04713657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65324046|NCT04713657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324047|NCT04713657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324048|NCT04713657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65324049|NCT04713657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65324050|NCT04713657|Vasodilator Agents|vasodilator agents|mesh-ancestor
65324051|NCT00799409|Methylphenidate|methylphenidate|mesh-list
65324052|NCT00799409|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65324053|NCT00799409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324054|NCT00799409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65324055|NCT00799409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65324056|NCT00799409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65324057|NCT00799409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324058|NCT00799409|Dopamine Agents|dopamine agents|mesh-ancestor
65324059|NCT00799409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65173123|NCT00972543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173124|NCT00925132|Temozolomide|temozolomide|mesh-list
65173125|NCT00925132|Decitabine|decitabine|mesh-list
65173126|NCT00925132|Panobinostat|panobinostat|mesh-list
65173127|NCT00925132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65173128|NCT00925132|Alkylating Agents|alkylating agents|mesh-ancestor
65173129|NCT00925132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173130|NCT00925132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173131|NCT00925132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65173132|NCT00925132|Antimetabolites|antimetabolites|mesh-ancestor
65173133|NCT00925132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173134|NCT00925132|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65173135|NCT02862015|Gemcitabine|gemcitabine|mesh-list
65173136|NCT02862015|Folfirinox|folfirinox|mesh-list
65173137|NCT02862015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65173138|NCT02862015|Antimetabolites|antimetabolites|mesh-ancestor
65173139|NCT02862015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173140|NCT02862015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173141|NCT02862015|Antiviral Agents|antiviral agents|mesh-ancestor
65173142|NCT02862015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65173143|NCT02862015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173144|NCT02862015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65173145|NCT02862015|Immunologic Factors|immunologic factors|mesh-ancestor
65173146|NCT02862015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173147|NCT01143402|Temozolomide|temozolomide|mesh-list
65173148|NCT01143402|Dacarbazine|dacarbazine|mesh-list
65173149|NCT01143402|Imidazole|imidazole|mesh-list
65173150|NCT01143402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65173151|NCT01143402|Alkylating Agents|alkylating agents|mesh-ancestor
65173152|NCT01143402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173153|NCT01143402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173154|NCT01143402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173155|NCT00646945|Nitrous Oxide|nitrous oxide|mesh-list
65173156|NCT00646945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65173157|NCT00646945|Anesthetics, General|anesthetics, general|mesh-ancestor
65173158|NCT00646945|Anesthetics|anesthetics|mesh-ancestor
65173159|NCT00646945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65173160|NCT00646945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173161|NCT00646945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65173162|NCT00646945|Analgesics|analgesics|mesh-ancestor
65173163|NCT00646945|Sensory System Agents|sensory system agents|mesh-ancestor
65324060|NCT00782210|Olodaterol|olodaterol|mesh-list
65324061|NCT00782210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65324062|NCT00782210|Autonomic Agents|autonomic agents|mesh-ancestor
65324063|NCT00782210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324064|NCT00782210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324065|NCT00782210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65324066|NCT00782210|Respiratory System Agents|respiratory system agents|mesh-ancestor
65324067|NCT01558115|Denosumab|denosumab|mesh-list
65324068|NCT01558115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65324069|NCT01558115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324070|NCT02605265|Capecitabine|capecitabine|mesh-list
65324071|NCT02605265|Oxaliplatin|oxaliplatin|mesh-list
65324072|NCT02605265|Irinotecan|irinotecan|mesh-list
65324073|NCT02605265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65324074|NCT02605265|Antimetabolites|antimetabolites|mesh-ancestor
65324075|NCT02605265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324076|NCT02605265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65324077|NCT02605265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65074042|NCT00309218|Glucocorticoids|glucocorticoids|mesh-ancestor
65324078|NCT02605265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65324079|NCT02605265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65324080|NCT05561673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65324081|NCT05561673|Vaccines|vaccines|mesh-list
65324082|NCT05561673|Immunologic Factors|immunologic factors|mesh-ancestor
65324083|NCT05561673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324084|NCT05561673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65324085|NCT05561673|Antacids|antacids|mesh-ancestor
65324086|NCT05561673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324107|NCT04101500|Purinergic Agents|purinergic agents|mesh-ancestor
65324108|NCT04101500|Protective Agents|protective agents|mesh-ancestor
65324109|NCT02586441|Bromides|bromides|mesh-list
65324110|NCT02586441|Propofol|propofol|mesh-list
65324111|NCT02586441|Rocuronium|rocuronium|mesh-list
65324112|NCT02586441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65324113|NCT02586441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65324114|NCT02586441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324115|NCT02586441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65324116|NCT02586441|Anesthetics, General|anesthetics, general|mesh-ancestor
65324117|NCT02586441|Anesthetics|anesthetics|mesh-ancestor
65324118|NCT02586441|Anticonvulsants|anticonvulsants|mesh-ancestor
65324119|NCT02586441|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65324120|NCT02586441|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65324121|NCT02586441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65324122|NCT02586441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324123|NCT02586363|Entecavir|entecavir|mesh-list
65324124|NCT02586363|Antiviral Agents|antiviral agents|mesh-ancestor
65324125|NCT02586363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65324126|NCT02586129|Metformin|metformin|mesh-list
65324127|NCT02586129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65324128|NCT02586129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65324129|NCT02586129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324130|NCT02586129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65324131|NCT02586129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65324132|NCT02586129|Antimetabolites|antimetabolites|mesh-ancestor
65324133|NCT02586129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324134|NCT02586129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65324135|NCT02586129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65324136|NCT02586129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65324137|NCT04081077|Moxifloxacin|moxifloxacin|mesh-list
65324138|NCT04081077|Linezolid|linezolid|mesh-list
65324139|NCT04081077|Bedaquiline|bedaquiline|mesh-list
65324140|NCT04081077|Clofazimine|clofazimine|mesh-list
65324141|NCT04081077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65324142|NCT04081077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65324143|NCT04081077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65324147|NCT04081077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65324148|NCT04081077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65324149|NCT04081077|Antitubercular Agents|antitubercular agents|mesh-ancestor
65324150|NCT04081077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65324151|NCT04081077|Leprostatic Agents|leprostatic agents|mesh-ancestor
65324152|NCT04669665|Ketamine|ketamine|mesh-list
65074149|NCT00338754|Adalimumab|adalimumab|mesh-list
65324153|NCT04669665|Analgesics|analgesics|mesh-ancestor
65324154|NCT04669665|Sensory System Agents|sensory system agents|mesh-ancestor
65324155|NCT04669665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324156|NCT04669665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324157|NCT04669665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65324158|NCT04669665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65324159|NCT04669665|Anesthetics, General|anesthetics, general|mesh-ancestor
65324160|NCT04669665|Anesthetics|anesthetics|mesh-ancestor
65324161|NCT04669665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65324162|NCT04669665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65324163|NCT04669665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65324164|NCT04669665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65324165|NCT04669665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324166|NCT02586051|Obinutuzumab|obinutuzumab|mesh-list
65324167|NCT02586051|Immunoglobulins|immunoglobulins|mesh-list
65324168|NCT02586051|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65324169|NCT02586051|Antibodies|antibodies|mesh-list
65324170|NCT02586051|gamma-Globulins|gamma-globulins|mesh-list
65173164|NCT00646945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65173165|NCT00629889|Pregabalin|pregabalin|mesh-list
65173166|NCT00629889|Levetiracetam|levetiracetam|mesh-list
65173167|NCT00629889|Analgesics|analgesics|mesh-ancestor
65173168|NCT00629889|Sensory System Agents|sensory system agents|mesh-ancestor
65173169|NCT00629889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65173170|NCT00629889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173171|NCT00629889|Anticonvulsants|anticonvulsants|mesh-ancestor
65173172|NCT00629889|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65173173|NCT00629889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65173174|NCT00629889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173175|NCT00629889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65173177|NCT00629889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65173178|NCT00629889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65173179|NCT00629889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65173180|NCT00629889|Nootropic Agents|nootropic agents|mesh-ancestor
65173186|NCT03381261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65173187|NCT03381261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65173188|NCT03381261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65173189|NCT03381261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173190|NCT03381261|Cholinergic Agents|cholinergic agents|mesh-ancestor
65173191|NCT03381261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65173192|NCT03381261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173193|NCT03381261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65173194|NCT03381261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324171|NCT02586051|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65324172|NCT02586051|Immunologic Factors|immunologic factors|mesh-ancestor
65324173|NCT02586051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324174|NCT02586051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65324175|NCT02586051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65324176|NCT00763958|Buprenorphine|buprenorphine|mesh-list
65324177|NCT00763958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65324178|NCT00763958|Narcotics|narcotics|mesh-ancestor
65324179|NCT00763958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65324180|NCT00763958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324181|NCT00763958|Analgesics|analgesics|mesh-ancestor
65324182|NCT00763958|Sensory System Agents|sensory system agents|mesh-ancestor
65324183|NCT00763958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324184|NCT00763958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65324185|NCT04101578|Cyclosporine|cyclosporine|mesh-list
65324186|NCT04101578|Mycophenolic Acid|mycophenolic acid|mesh-list
65324187|NCT04101578|Prednisone|prednisone|mesh-list
65324188|NCT04101578|Methylprednisolone|methylprednisolone|mesh-list
65324189|NCT04101578|Cyclophosphamide|cyclophosphamide|mesh-list
65324190|NCT04101578|Methotrexate|methotrexate|mesh-list
65324191|NCT04101578|Azathioprine|azathioprine|mesh-list
65324192|NCT04101578|Bromides|bromides|mesh-list
65324193|NCT04101578|Tacrolimus|tacrolimus|mesh-list
65324194|NCT04101578|Cyclosporins|cyclosporins|mesh-list
65324195|NCT04101578|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65324196|NCT04101578|Immunoglobulins|immunoglobulins|mesh-list
65324197|NCT04101578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65324198|NCT04101578|gamma-Globulins|gamma-globulins|mesh-list
65324199|NCT04101578|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65324200|NCT04101578|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
65324201|NCT04101578|Immunologic Factors|immunologic factors|mesh-ancestor
65324202|NCT04101578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324203|NCT04101578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65324204|NCT04101578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65324205|NCT04101578|Alkylating Agents|alkylating agents|mesh-ancestor
65324206|NCT04101578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324207|NCT04101578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65324210|NCT04101578|Glucocorticoids|glucocorticoids|mesh-ancestor
65324212|NCT04101578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65324213|NCT04101578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65324214|NCT04101578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65324215|NCT04101578|Abortifacient Agents|abortifacient agents|mesh-ancestor
65324216|NCT04101578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65324217|NCT04101578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65324218|NCT04101578|Antimetabolites|antimetabolites|mesh-ancestor
65324219|NCT04101578|Dermatologic Agents|dermatologic agents|mesh-ancestor
65324220|NCT04101578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65324221|NCT04101578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65324222|NCT04101578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65173195|NCT00630045|Capecitabine|capecitabine|mesh-list
65173196|NCT00630045|Oxaliplatin|oxaliplatin|mesh-list
65173197|NCT00630045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65173198|NCT00630045|Antimetabolites|antimetabolites|mesh-ancestor
65173199|NCT00630045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173200|NCT00630045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173201|NCT02861859|Olanzapine|olanzapine|mesh-list
65173202|NCT02861859|Antiemetics|antiemetics|mesh-ancestor
65173203|NCT02861859|Autonomic Agents|autonomic agents|mesh-ancestor
65173204|NCT02861859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65173205|NCT02861859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173206|NCT02861859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65173207|NCT02861859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65173208|NCT02861859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65173209|NCT02861859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65173210|NCT02861859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65173211|NCT02861859|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65173212|NCT02861859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65173213|NCT02861859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65173214|NCT02861859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173215|NCT02861859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65173216|NCT02861859|Serotonin Agents|serotonin agents|mesh-ancestor
65173217|NCT00647023|Metformin|metformin|mesh-list
65173218|NCT00647023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65173219|NCT00647023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173220|NCT00924898|Tenofovir|tenofovir|mesh-list
65173221|NCT00924898|Emtricitabine|emtricitabine|mesh-list
65173222|NCT00924898|Efavirenz|efavirenz|mesh-list
65173223|NCT00924898|Antiviral Agents|antiviral agents|mesh-ancestor
65173224|NCT00924898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65173225|NCT00924898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65173226|NCT00924898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65173227|NCT00924898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173228|NCT00924898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173229|NCT00924898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65173230|NCT00924898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65173231|NCT00924898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65173232|NCT00924898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65173233|NCT00924898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65173234|NCT00924898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65173235|NCT00924898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65173236|NCT00924898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65173237|NCT01167192|Carboplatin|carboplatin|mesh-list
65173238|NCT01167192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173239|NCT00646321|Budesonide|budesonide|mesh-list
65173240|NCT00646321|Formoterol Fumarate|formoterol fumarate|mesh-list
65173241|NCT00646321|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65173242|NCT00646321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65173243|NCT00646321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65173244|NCT00646321|Autonomic Agents|autonomic agents|mesh-ancestor
65324223|NCT04101578|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65324224|NCT04101578|Antifungal Agents|antifungal agents|mesh-ancestor
65324225|NCT04101578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65324226|NCT04101578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65324227|NCT04101578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65324228|NCT04101578|Antitubercular Agents|antitubercular agents|mesh-ancestor
65324229|NCT04101578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65324230|NCT04101578|Antiemetics|antiemetics|mesh-ancestor
65324231|NCT04101578|Autonomic Agents|autonomic agents|mesh-ancestor
65324232|NCT04101578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324234|NCT04101578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65324235|NCT04101578|Protective Agents|protective agents|mesh-ancestor
65324236|NCT04101578|Anticonvulsants|anticonvulsants|mesh-ancestor
65324237|NCT04101578|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65324238|NCT04101578|Cholinergic Agents|cholinergic agents|mesh-ancestor
65324239|NCT04101578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65324240|NCT00763256|Triclosan|triclosan|mesh-list
65324241|NCT00763256|Fluorides|fluorides|mesh-list
65324242|NCT00763256|Cariostatic Agents|cariostatic agents|mesh-ancestor
65324243|NCT00763256|Protective Agents|protective agents|mesh-ancestor
65324244|NCT00763256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324245|NCT00763256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65324246|NCT00763256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65324247|NCT00763256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65173245|NCT00646321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65173246|NCT00646321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173247|NCT00646321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65173248|NCT00646321|Respiratory System Agents|respiratory system agents|mesh-ancestor
65173249|NCT00646321|Glucocorticoids|glucocorticoids|mesh-ancestor
65173257|NCT00646321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173259|NCT00647101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65173260|NCT00647101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65173261|NCT01166958|Teriparatide|teriparatide|mesh-list
65173262|NCT01166958|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65173263|NCT01166958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65173264|NCT01166958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173265|NCT01166958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65173266|NCT01166958|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65173267|NCT01166958|Hormone Antagonists|hormone antagonists|mesh-ancestor
65173268|NCT01166958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65173269|NCT01166958|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65173270|NCT01166958|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65173271|NCT01170221|Linezolid|linezolid|mesh-list
65173272|NCT01170221|Tedizolid|tedizolid|mesh-list
65173273|NCT01170221|Tedizolid phosphate|tedizolid phosphate|mesh-list
65173274|NCT01170221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65173275|NCT01170221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65173276|NCT01170221|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65173277|NCT01170221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173278|NCT01170221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173279|NCT04254640|Cytarabine|cytarabine|mesh-list
65173280|NCT04254640|Cladribine|cladribine|mesh-list
65324248|NCT00763256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65324249|NCT00763256|Antimetabolites|antimetabolites|mesh-ancestor
65324250|NCT00763256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324251|NCT00763256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65324252|NCT02585973|Cisplatin|cisplatin|mesh-list
65324253|NCT02585973|Adavosertib|adavosertib|mesh-list
65324254|NCT02585973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65324255|NCT02585973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65324256|NCT02585973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324257|NCT00920283|Cobalt|cobalt|mesh-list
65324258|NCT00920283|Trace Elements|trace elements|mesh-ancestor
65324259|NCT00920283|Micronutrients|micronutrients|mesh-ancestor
65324260|NCT00920283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324261|NCT00583947|Albuterol|albuterol|mesh-list
65324262|NCT00583947|Formoterol Fumarate|formoterol fumarate|mesh-list
65324263|NCT00583947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65324264|NCT00583947|Autonomic Agents|autonomic agents|mesh-ancestor
65324265|NCT00583947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324266|NCT00583947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324267|NCT00583947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65324268|NCT00583947|Respiratory System Agents|respiratory system agents|mesh-ancestor
65324269|NCT00583947|Tocolytic Agents|tocolytic agents|mesh-ancestor
65324270|NCT00583947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65324271|NCT00583947|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65324272|NCT00583947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65324273|NCT00583947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65324274|NCT00583947|Adrenergic Agents|adrenergic agents|mesh-ancestor
65324275|NCT00583947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65324276|NCT00583947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324277|NCT00772928|Vaccines|vaccines|mesh-list
65324278|NCT00772928|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65324279|NCT00772928|Immunologic Factors|immunologic factors|mesh-ancestor
64553938|NCT05054322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65173281|NCT04254640|Aclarubicin|aclarubicin|mesh-list
65173282|NCT04254640|Lenograstim|lenograstim|mesh-list
65173283|NCT04254640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65173284|NCT04254640|Antimetabolites|antimetabolites|mesh-ancestor
65173285|NCT04254640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173286|NCT04254640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173287|NCT04254640|Antiviral Agents|antiviral agents|mesh-ancestor
65173288|NCT04254640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65173289|NCT04254640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65173290|NCT04254640|Immunologic Factors|immunologic factors|mesh-ancestor
65324280|NCT00772928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324281|NCT00762164|Simvastatin|simvastatin|mesh-list
65324282|NCT00762164|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
65324283|NCT00762164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65324284|NCT00762164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65324285|NCT00762164|Antimetabolites|antimetabolites|mesh-ancestor
65324286|NCT00762164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324287|NCT00762164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65324288|NCT00762164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65324289|NCT00762164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65324290|NCT00761774|Brivaracetam|brivaracetam|mesh-list
65324291|NCT00761774|Anticonvulsants|anticonvulsants|mesh-ancestor
65324292|NCT04080375|Dinoprostone|dinoprostone|mesh-list
65324293|NCT04080375|Oxytocics|oxytocics|mesh-ancestor
65324294|NCT04080375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65324295|NCT04080375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324296|NCT00781274|Ribavirin|ribavirin|mesh-list
65324297|NCT00781274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65324298|NCT00781274|Antimetabolites|antimetabolites|mesh-ancestor
65324299|NCT00781274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324300|NCT00781274|Antiviral Agents|antiviral agents|mesh-ancestor
65324301|NCT00781274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65173291|NCT04254640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173292|NCT04254640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65173293|NCT04254640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65173294|NCT04254640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65173295|NCT04254640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65173296|NCT04254640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173297|NCT01166646|Clobetasol|clobetasol|mesh-list
65173298|NCT01166646|Halobetasol|halobetasol|mesh-list
65173299|NCT01166646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65173300|NCT01166646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65173301|NCT01166646|Glucocorticoids|glucocorticoids|mesh-ancestor
65173302|NCT01166646|Hormones|hormones|mesh-ancestor
65173303|NCT01166646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65173304|NCT01166646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173305|NCT01129284|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65173306|NCT01129284|Hormones|hormones|mesh-ancestor
65173307|NCT01129284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65173308|NCT01129284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173309|NCT00647257|Losartan|losartan|mesh-list
65173310|NCT00647257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65173311|NCT00647257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65173312|NCT00647257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65173313|NCT00647257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65173314|NCT00647257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173318|NCT04895761|Immunologic Factors|immunologic factors|mesh-ancestor
65173319|NCT04895761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173320|NCT04895761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65173321|NCT04895761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65173322|NCT04895761|Alkylating Agents|alkylating agents|mesh-ancestor
65324302|NCT05538663|Gemcitabine|gemcitabine|mesh-list
65324303|NCT05538663|Docetaxel|docetaxel|mesh-list
65324304|NCT05538663|BCG Vaccine|bcg vaccine|mesh-list
65074265|NCT00338910|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65324305|NCT05538663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65324306|NCT05538663|Antimetabolites|antimetabolites|mesh-ancestor
65324307|NCT05538663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324308|NCT05538663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65324309|NCT05538663|Antiviral Agents|antiviral agents|mesh-ancestor
65324310|NCT05538663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65324311|NCT05538663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65324312|NCT05538663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65324313|NCT05538663|Immunologic Factors|immunologic factors|mesh-ancestor
65324314|NCT05538663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324315|NCT05538663|Tubulin Modulators|tubulin modulators|mesh-ancestor
65324316|NCT05538663|Antimitotic Agents|antimitotic agents|mesh-ancestor
65173323|NCT04895761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173324|NCT04895761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173325|NCT04895761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65173326|NCT04895761|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65173327|NCT04895761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65173328|NCT04895761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173329|NCT04895761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65173330|NCT04895761|Hormone Antagonists|hormone antagonists|mesh-ancestor
65173331|NCT04895761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65173332|NCT01166178|Vitamin D|vitamin d|mesh-list
65173333|NCT01166178|Zoledronic Acid|zoledronic acid|mesh-list
65173334|NCT01166178|Calcium|calcium|mesh-list
65173335|NCT01166178|Vitamins|vitamins|mesh-ancestor
65173336|NCT01166178|Micronutrients|micronutrients|mesh-ancestor
65173337|NCT01166178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173338|NCT01166178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65173339|NCT01166178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65173340|NCT00924820|Bevacizumab|bevacizumab|mesh-list
65173341|NCT00924820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65173342|NCT00924820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173343|NCT00924820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65173344|NCT00924820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65173345|NCT00924820|Growth Substances|growth substances|mesh-ancestor
65173346|NCT00924820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173347|NCT00924820|Growth Inhibitors|growth inhibitors|mesh-ancestor
65173348|NCT01225172|Letrozole|letrozole|mesh-list
65173349|NCT01225172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173350|NCT01225172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65173351|NCT01225172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65173352|NCT01225172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173353|NCT01225172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173354|NCT01225172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65173355|NCT01225172|Hormone Antagonists|hormone antagonists|mesh-ancestor
65173356|NCT01225172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65173357|NCT01225172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173358|NCT02665039|Gemcitabine|gemcitabine|mesh-list
65173359|NCT02665039|Carboplatin|carboplatin|mesh-list
65173360|NCT02665039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173361|NCT02665039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65173362|NCT02665039|Antimetabolites|antimetabolites|mesh-ancestor
65173363|NCT02665039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173364|NCT02665039|Antiviral Agents|antiviral agents|mesh-ancestor
65173365|NCT02665039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65173366|NCT02665039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65324317|NCT05538663|Mitosis Modulators|mitosis modulators|mesh-ancestor
65324318|NCT05538663|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65324319|NCT05520177|Ranibizumab|ranibizumab|mesh-list
65324320|NCT05520177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65324321|NCT05520177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65324322|NCT05520177|Growth Substances|growth substances|mesh-ancestor
65324323|NCT05520177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324324|NCT05520177|Growth Inhibitors|growth inhibitors|mesh-ancestor
65324325|NCT05520177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65324326|NCT00780416|Ribavirin|ribavirin|mesh-list
65324327|NCT00780416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65324328|NCT00780416|Interferon-alpha|interferon-alpha|mesh-list
65324329|NCT00780416|Antimetabolites|antimetabolites|mesh-ancestor
65324330|NCT00780416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324331|NCT00780416|Antiviral Agents|antiviral agents|mesh-ancestor
65324332|NCT00780416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65324333|NCT00780416|Immunologic Factors|immunologic factors|mesh-ancestor
65324334|NCT00780416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324335|NCT02584881|Analgesics, Opioid|analgesics, opioid|mesh-list
65324336|NCT02584881|Narcotics|narcotics|mesh-ancestor
65324337|NCT02584881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65324338|NCT02584881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324339|NCT02584881|Analgesics|analgesics|mesh-ancestor
65324340|NCT02584881|Sensory System Agents|sensory system agents|mesh-ancestor
65324341|NCT02584881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65173367|NCT02665039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65173368|NCT02665039|Immunologic Factors|immunologic factors|mesh-ancestor
65173369|NCT02665039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173370|NCT00647491|Adalimumab|adalimumab|mesh-list
65173371|NCT00647491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65173372|NCT00647491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65173373|NCT04252456|Leucovorin|leucovorin|mesh-list
65173374|NCT04252456|Folic Acid|folic acid|mesh-list
65173375|NCT04252456|Fluorouracil|fluorouracil|mesh-list
65173376|NCT04252456|Aflibercept|aflibercept|mesh-list
65173377|NCT04252456|Levoleucovorin|levoleucovorin|mesh-list
65173378|NCT04252456|Antimetabolites|antimetabolites|mesh-ancestor
65173379|NCT04252456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173380|NCT04252456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65173381|NCT04252456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173382|NCT04252456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65173383|NCT04252456|Immunologic Factors|immunologic factors|mesh-ancestor
65173384|NCT04252456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173385|NCT04252456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65173386|NCT04252456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65173387|NCT04252456|Growth Substances|growth substances|mesh-ancestor
65173400|NCT01222520|Amlodipine|amlodipine|mesh-list
65173401|NCT01222520|Telmisartan|telmisartan|mesh-list
65173402|NCT01222520|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
65173403|NCT01222520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65173404|NCT01222520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65173405|NCT01222520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65324342|NCT00761462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65324343|NCT00761462|Ciprofloxacin|ciprofloxacin|mesh-list
65324344|NCT00761462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65324345|NCT00761462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65324346|NCT00761462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65324347|NCT00761462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65324348|NCT00761462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324349|NCT00761462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65324350|NCT00761462|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65324351|NCT00761462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65324352|NCT00761306|Vortioxetine|vortioxetine|mesh-list
65324353|NCT00761306|Antidepressive Agents|antidepressive agents|mesh-ancestor
65324354|NCT00761306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65324355|NCT00761306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65324356|NCT00761306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65324357|NCT00761306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65324358|NCT00761306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324359|NCT00761306|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65324360|NCT00761306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65324361|NCT00761306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65324362|NCT00761306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324363|NCT00761306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65324364|NCT00761306|Serotonin Agents|serotonin agents|mesh-ancestor
65324365|NCT00761306|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65324366|NCT00761306|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65324367|NCT00761306|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65173406|NCT01222520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173407|NCT01222520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65173408|NCT01222520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173409|NCT01222520|Vasodilator Agents|vasodilator agents|mesh-ancestor
65173410|NCT01222520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65173411|NCT01222520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65173412|NCT04172311|Levetiracetam|levetiracetam|mesh-list
65173413|NCT04172311|Anticonvulsants|anticonvulsants|mesh-ancestor
65173414|NCT04172311|Nootropic Agents|nootropic agents|mesh-ancestor
65173415|NCT01221350|Thioctic Acid|thioctic acid|mesh-list
65173416|NCT01221350|Antioxidants|antioxidants|mesh-ancestor
65173417|NCT01221350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173418|NCT01221350|Protective Agents|protective agents|mesh-ancestor
65173419|NCT01221350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173420|NCT01221350|Vitamin B Complex|vitamin b complex|mesh-ancestor
65173422|NCT01221350|Micronutrients|micronutrients|mesh-ancestor
65173423|NCT00647647|Terbinafine|terbinafine|mesh-list
65173424|NCT00647647|Antifungal Agents|antifungal agents|mesh-ancestor
65173425|NCT00647647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65324368|NCT00761306|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65324369|NCT00772538|Tiotropium Bromide|tiotropium bromide|mesh-list
65324370|NCT00772538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65324371|NCT00772538|Autonomic Agents|autonomic agents|mesh-ancestor
65324372|NCT00772538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324373|NCT00772538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324374|NCT00772538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65324375|NCT00772538|Respiratory System Agents|respiratory system agents|mesh-ancestor
65324376|NCT00772538|Parasympatholytics|parasympatholytics|mesh-ancestor
65324377|NCT00772538|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65324378|NCT00772538|Cholinergic Agents|cholinergic agents|mesh-ancestor
65324379|NCT00772538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65493957|NCT03913559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65324380|NCT00772538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324381|NCT04079517|Tamoxifen|tamoxifen|mesh-list
65324382|NCT04079517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65324383|NCT04079517|Hormone Antagonists|hormone antagonists|mesh-ancestor
65324384|NCT04079517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65324385|NCT04079517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324386|NCT04079517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65324387|NCT04079517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65324388|NCT04079517|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65324389|NCT04079517|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65324390|NCT04079517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65324391|NCT00761150|Acetaminophen|acetaminophen|mesh-list
65324414|NCT00760838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65324415|NCT00586664|Bepotastine besilate|bepotastine besilate|mesh-list
65324416|NCT00586664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65324417|NCT00586664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65324418|NCT00586664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65324419|NCT02584335|Lidocaine|lidocaine|mesh-list
65324420|NCT02584335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65324421|NCT02584335|Anesthetics, Local|anesthetics, local|mesh-ancestor
65324422|NCT02584335|Anesthetics|anesthetics|mesh-ancestor
65324423|NCT02584335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65324424|NCT02584335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324425|NCT02584335|Sensory System Agents|sensory system agents|mesh-ancestor
65324426|NCT02584335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324427|NCT02584335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65324428|NCT02584335|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65324429|NCT02584335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65324430|NCT02584335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65324431|NCT02584335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324432|NCT00437281|Pregabalin|pregabalin|mesh-list
65324433|NCT00437281|Analgesics|analgesics|mesh-ancestor
65324434|NCT00437281|Sensory System Agents|sensory system agents|mesh-ancestor
65324435|NCT00437281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324436|NCT00437281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324437|NCT00437281|Anticonvulsants|anticonvulsants|mesh-ancestor
65324438|NCT00437281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65324439|NCT00437281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65324440|NCT00437281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324441|NCT00437281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65324442|NCT00437281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65324443|NCT00437281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65324444|NCT00437281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65324445|NCT00437281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65324446|NCT04544007|Poly ICLC|poly iclc|mesh-list
65324447|NCT04544007|Interferon Inducers|interferon inducers|mesh-ancestor
65173426|NCT00647647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173427|NCT00647647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173428|NCT01221272|Ranolazine|ranolazine|mesh-list
65173429|NCT01221272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65173430|NCT01221272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65324448|NCT04544007|Immunologic Factors|immunologic factors|mesh-ancestor
65324449|NCT04544007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324450|NCT05468073|Aldesleukin|aldesleukin|mesh-list
65324451|NCT05468073|Interleukin-2|interleukin-2|mesh-list
65324452|NCT05468073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65324453|NCT05468073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65324454|NCT05468073|Analgesics|analgesics|mesh-ancestor
65324455|NCT05468073|Sensory System Agents|sensory system agents|mesh-ancestor
65324456|NCT05468073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324457|NCT05468073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324458|NCT05468073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65324459|NCT05468073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65324460|NCT05468073|Antiviral Agents|antiviral agents|mesh-ancestor
65324461|NCT05468073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65324462|NCT05674695|Omalizumab|omalizumab|mesh-list
65173431|NCT01221272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173432|NCT01220414|Naltrexone|naltrexone|mesh-list
65173433|NCT01220414|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65173434|NCT01220414|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65173435|NCT01220414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173436|NCT01220414|Sensory System Agents|sensory system agents|mesh-ancestor
65173437|NCT01220414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65173438|NCT01128894|Liraglutide|liraglutide|mesh-list
65173439|NCT01128894|rGLP-1 protein|rglp-1 protein|mesh-list
65173440|NCT01128894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65173441|NCT01128894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173442|NCT01128894|Incretins|incretins|mesh-ancestor
65173443|NCT01128894|Hormones|hormones|mesh-ancestor
65173444|NCT01128894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65173445|NCT01220180|Pregabalin|pregabalin|mesh-list
65173446|NCT01220180|Analgesics|analgesics|mesh-ancestor
65173447|NCT01220180|Sensory System Agents|sensory system agents|mesh-ancestor
65173448|NCT01220180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65173454|NCT01220180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65173455|NCT01220180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65173456|NCT01220180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65173457|NCT01220180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65173458|NCT01220180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65173459|NCT01220024|Bupivacaine|bupivacaine|mesh-list
65173460|NCT01220024|Anesthetics, Local|anesthetics, local|mesh-ancestor
65173461|NCT01220024|Anesthetics|anesthetics|mesh-ancestor
65173462|NCT01220024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65173463|NCT01220024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173464|NCT01220024|Sensory System Agents|sensory system agents|mesh-ancestor
65173465|NCT01220024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65173466|NCT00625248|Anticoagulants|anticoagulants|mesh-list
65173467|NCT00625248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65173468|NCT01143090|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65173469|NCT01143090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65173470|NCT01143090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65173471|NCT01143090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65173472|NCT01143090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173473|NCT01143090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65173474|NCT01143090|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65173475|NCT01143090|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65173476|NCT01143090|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65173477|NCT01143090|Adrenergic Agents|adrenergic agents|mesh-ancestor
65173478|NCT01143090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64816089|NCT01488552|Metformin|metformin|mesh-list
65173479|NCT01143090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173480|NCT01143090|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65324463|NCT05674695|Cyclosporine|cyclosporine|mesh-list
65324464|NCT05674695|Methotrexate|methotrexate|mesh-list
65324465|NCT05674695|Upadacitinib|upadacitinib|mesh-list
65324466|NCT05674695|Cyclosporins|cyclosporins|mesh-list
65324467|NCT05674695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65324468|NCT05674695|Abortifacient Agents|abortifacient agents|mesh-ancestor
65324469|NCT05674695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65324470|NCT05674695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324471|NCT05674695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65324472|NCT05674695|Antimetabolites|antimetabolites|mesh-ancestor
65324473|NCT05674695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324474|NCT05674695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65324475|NCT05674695|Dermatologic Agents|dermatologic agents|mesh-ancestor
65324476|NCT05674695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65324477|NCT05674695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65173481|NCT01143090|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65173482|NCT01143090|Serotonin Agents|serotonin agents|mesh-ancestor
65173483|NCT01143090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65173484|NCT01143090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65173485|NCT01143090|Dopamine Agents|dopamine agents|mesh-ancestor
65173487|NCT05125146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65173488|NCT05125146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65173489|NCT05125146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65173490|NCT05125146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173491|NCT05125146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65173492|NCT05125146|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65173493|NCT05125146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65173494|NCT05125146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65173495|NCT05125146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173496|NCT05125146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65173497|NCT05125146|Serotonin Agents|serotonin agents|mesh-ancestor
65173498|NCT05125146|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65173499|NCT05125146|Antidepressive Agents|antidepressive agents|mesh-ancestor
65173500|NCT01165554|Flutemetamol|flutemetamol|mesh-list
65173501|NCT01165554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65173502|NCT01165554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173503|NCT01218308|Vaccines|vaccines|mesh-list
65173504|NCT01218308|Immunologic Factors|immunologic factors|mesh-ancestor
65173505|NCT01218308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173506|NCT02887976|Methylprednisolone|methylprednisolone|mesh-list
65173507|NCT02887976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65173508|NCT02887976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65173509|NCT02887976|Prednisolone|prednisolone|mesh-list
65173510|NCT02887976|Prednisolone acetate|prednisolone acetate|mesh-list
65173511|NCT02887976|Abiraterone Acetate|abiraterone acetate|mesh-list
65173512|NCT02887976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65173513|NCT02887976|Prednisolone phosphate|prednisolone phosphate|mesh-list
65173514|NCT02887976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65173515|NCT02887976|Antiemetics|antiemetics|mesh-ancestor
65173516|NCT02887976|Autonomic Agents|autonomic agents|mesh-ancestor
65173524|NCT02887976|Protective Agents|protective agents|mesh-ancestor
65173525|NCT02887976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65173526|NCT02887976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173527|NCT02887976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65173528|NCT02887976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173529|NCT02887976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173530|NCT02887976|Hormone Antagonists|hormone antagonists|mesh-ancestor
65173531|NCT02887976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65173532|NCT01165320|Caspofungin|caspofungin|mesh-list
65173533|NCT01165320|Antifungal Agents|antifungal agents|mesh-ancestor
65324478|NCT05674695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65324479|NCT05674695|Immunologic Factors|immunologic factors|mesh-ancestor
65324480|NCT05674695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65324481|NCT05674695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65324482|NCT05674695|Antifungal Agents|antifungal agents|mesh-ancestor
65324483|NCT05674695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65324484|NCT05674695|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65324485|NCT05674695|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65324486|NCT05674695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65324487|NCT05674695|Respiratory System Agents|respiratory system agents|mesh-ancestor
65324488|NCT05674695|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65324489|NCT05674695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65324490|NCT02596269|Nefopam|nefopam|mesh-list
65324491|NCT02596269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65324492|NCT02596269|Analgesics|analgesics|mesh-ancestor
65324493|NCT02596269|Sensory System Agents|sensory system agents|mesh-ancestor
65324494|NCT02596269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324495|NCT02596269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324496|NCT00741039|Vaccines|vaccines|mesh-list
65324497|NCT00741039|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65324498|NCT00741039|Immunologic Factors|immunologic factors|mesh-ancestor
65324499|NCT00741039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324500|NCT02583321|Silver Sulfadiazine|silver sulfadiazine|mesh-list
65324501|NCT02583321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65324502|NCT02583321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65324503|NCT04454229|Penicillins|penicillins|mesh-list
65324504|NCT04454229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64554177|NCT04434378|Tamsulosin|tamsulosin|mesh-list
65173534|NCT01165320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65173535|NCT01165320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173536|NCT01165320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173537|NCT01217606|Timolol|timolol|mesh-list
65173538|NCT01217606|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65173539|NCT01217606|Bimatoprost|bimatoprost|mesh-list
65173540|NCT01217606|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65173541|NCT01217606|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65173542|NCT01217606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65173543|NCT01217606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65173544|NCT01217606|Adrenergic Agents|adrenergic agents|mesh-ancestor
65173545|NCT01217606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65173546|NCT01217606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173547|NCT01217606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173548|NCT01217606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65173549|NCT01217606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65173550|NCT01217606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65173551|NCT01217606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65173552|NCT01217606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65324505|NCT04454229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65324506|NCT04078659|Lidocaine|lidocaine|mesh-list
65324507|NCT04078659|Magnesium Sulfate|magnesium sulfate|mesh-list
65324508|NCT04078659|Fentanyl|fentanyl|mesh-list
65324509|NCT04078659|Propofol|propofol|mesh-list
65324510|NCT04078659|Atracurium|atracurium|mesh-list
65324511|NCT04078659|Anesthetics, Local|anesthetics, local|mesh-ancestor
65324512|NCT04078659|Anesthetics|anesthetics|mesh-ancestor
65324513|NCT04078659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65324514|NCT04078659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324515|NCT04078659|Sensory System Agents|sensory system agents|mesh-ancestor
65324516|NCT04078659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324517|NCT04078659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65324518|NCT04078659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65324519|NCT04078659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65173553|NCT01128114|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65173554|NCT01128114|Antidepressive Agents|antidepressive agents|mesh-ancestor
65173555|NCT01128114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65173556|NCT01128114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65173557|NCT01128114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65173558|NCT01128114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65173559|NCT01128114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173562|NCT01217060|Fluorouracil|fluorouracil|mesh-list
65173563|NCT01217060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65173564|NCT01217060|Antiemetics|antiemetics|mesh-ancestor
65173565|NCT01217060|Autonomic Agents|autonomic agents|mesh-ancestor
65173566|NCT01217060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65173567|NCT01217060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173568|NCT01217060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65173569|NCT01217060|Glucocorticoids|glucocorticoids|mesh-ancestor
65173570|NCT01217060|Hormones|hormones|mesh-ancestor
65173571|NCT01217060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65173572|NCT01217060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65173573|NCT01217060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173574|NCT01217060|Tubulin Modulators|tubulin modulators|mesh-ancestor
65173575|NCT01217060|Antimitotic Agents|antimitotic agents|mesh-ancestor
65173576|NCT01217060|Mitosis Modulators|mitosis modulators|mesh-ancestor
65173577|NCT01217060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173578|NCT01217060|Antimetabolites|antimetabolites|mesh-ancestor
65173579|NCT01217060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65173580|NCT01217060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65173581|NCT01217060|Immunologic Factors|immunologic factors|mesh-ancestor
65173582|NCT01170065|Nintedanib|nintedanib|mesh-list
65173583|NCT01170065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173584|NCT01170065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65173587|NCT02885922|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65173588|NCT02885922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173590|NCT00966693|Dexamethasone|dexamethasone|mesh-list
65173591|NCT00966693|Dexamethasone acetate|dexamethasone acetate|mesh-list
65173592|NCT00966693|Lenalidomide|lenalidomide|mesh-list
65173593|NCT00966693|Ichthammol|ichthammol|mesh-list
65173594|NCT00966693|BB 1101|bb 1101|mesh-list
65173595|NCT00966693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65173596|NCT00966693|Antiemetics|antiemetics|mesh-ancestor
65173597|NCT00966693|Autonomic Agents|autonomic agents|mesh-ancestor
65173598|NCT00966693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65173599|NCT00966693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173600|NCT00966693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65173601|NCT00966693|Glucocorticoids|glucocorticoids|mesh-ancestor
65173602|NCT00966693|Hormones|hormones|mesh-ancestor
65173603|NCT00966693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65173604|NCT00966693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65324520|NCT04078659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65324521|NCT04078659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324522|NCT04078659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65324523|NCT04078659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65324524|NCT04078659|Anesthetics, General|anesthetics, general|mesh-ancestor
65324525|NCT04078659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65324526|NCT04078659|Narcotics|narcotics|mesh-ancestor
65324527|NCT04078659|Analgesics|analgesics|mesh-ancestor
65324528|NCT04078659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65324529|NCT04078659|Anticonvulsants|anticonvulsants|mesh-ancestor
64319317|NCT05471648|Pertuzumab|pertuzumab|mesh-list
65173605|NCT00966693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173606|NCT00966693|Immunologic Factors|immunologic factors|mesh-ancestor
65173607|NCT00966693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65173608|NCT00966693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65173609|NCT00966693|Growth Substances|growth substances|mesh-ancestor
65173610|NCT00966693|Growth Inhibitors|growth inhibitors|mesh-ancestor
65173611|NCT00966693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65173612|NCT00966693|Leprostatic Agents|leprostatic agents|mesh-ancestor
65173613|NCT00966693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65173614|NCT00966693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65173615|NCT00966693|Protease Inhibitors|protease inhibitors|mesh-ancestor
65173616|NCT00966693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173617|NCT00966693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173618|NCT00966693|Dermatologic Agents|dermatologic agents|mesh-ancestor
65173619|NCT01215968|Dulaglutide|dulaglutide|mesh-list
65173620|NCT01215968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65173621|NCT01215968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173622|NCT02663713|Clopidogrel|clopidogrel|mesh-list
65173623|NCT02663713|Ticagrelor|ticagrelor|mesh-list
65173624|NCT02663713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65173625|NCT02663713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65173626|NCT02663713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65173627|NCT02663713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65173628|NCT02663713|Purinergic Agents|purinergic agents|mesh-ancestor
65173629|NCT02663713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65173630|NCT02663713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173631|NCT02663713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173633|NCT02664649|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
65173634|NCT02664649|Anticoagulants|anticoagulants|mesh-list
65173635|NCT02664649|Antithrombins|antithrombins|mesh-ancestor
65173636|NCT02664649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65173637|NCT02664649|Protease Inhibitors|protease inhibitors|mesh-ancestor
65173638|NCT02664649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173639|NCT02664649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173640|NCT02664493|Methylprednisolone|methylprednisolone|mesh-list
65173641|NCT02664493|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65173642|NCT02664493|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65173643|NCT02664493|Prednisolone|prednisolone|mesh-list
65173644|NCT02664493|Prednisolone acetate|prednisolone acetate|mesh-list
65173645|NCT02664493|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65173646|NCT02664493|Prednisolone phosphate|prednisolone phosphate|mesh-list
65173647|NCT02664493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65173648|NCT02664493|Antiemetics|antiemetics|mesh-ancestor
65173649|NCT02664493|Autonomic Agents|autonomic agents|mesh-ancestor
65173650|NCT02664493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65173651|NCT02664493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955759|NCT00410995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65173657|NCT02664493|Protective Agents|protective agents|mesh-ancestor
65173658|NCT02664493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65173659|NCT02664493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173660|NCT00963807|Deoxyglucose|deoxyglucose|mesh-list
65173661|NCT00963807|Alovudine|alovudine|mesh-list
65173662|NCT00963807|Dideoxynucleosides|dideoxynucleosides|mesh-list
65173663|NCT00963807|Cisplatin|cisplatin|mesh-list
65173664|NCT00963807|Docetaxel|docetaxel|mesh-list
65324530|NCT04078659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65324531|NCT04078659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65324532|NCT04078659|Tocolytic Agents|tocolytic agents|mesh-ancestor
65324533|NCT04078659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65324534|NCT04078659|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65324535|NCT04078659|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65324536|NCT04078659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65324537|NCT04078659|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65324538|NCT04078659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65324539|NCT04078659|Cholinergic Agents|cholinergic agents|mesh-ancestor
65324540|NCT04078659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65324541|NCT02583243|Buprenorphine|buprenorphine|mesh-list
64554222|NCT03095040|Vorolanib|vorolanib|mesh-list
65173665|NCT00963807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65173666|NCT00963807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173667|NCT00963807|Tubulin Modulators|tubulin modulators|mesh-ancestor
65173668|NCT00963807|Antimitotic Agents|antimitotic agents|mesh-ancestor
65173669|NCT00963807|Mitosis Modulators|mitosis modulators|mesh-ancestor
65173670|NCT00963807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173671|NCT00963807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65173672|NCT00963807|Antimetabolites|antimetabolites|mesh-ancestor
65173673|NCT00963807|Antiviral Agents|antiviral agents|mesh-ancestor
65173674|NCT00963807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65173675|NCT00963807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65173676|NCT00963807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65173677|NCT00963807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173678|NCT01142466|Interferons|interferons|mesh-list
65173679|NCT01142466|Interferon-beta|interferon-beta|mesh-list
65173680|NCT01142466|Interferon beta-1a|interferon beta-1a|mesh-list
65173681|NCT01142466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173682|NCT01142466|Antiviral Agents|antiviral agents|mesh-ancestor
65173683|NCT01142466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65173684|NCT01142466|Immunologic Factors|immunologic factors|mesh-ancestor
65173685|NCT01142466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173686|NCT01142466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65173687|NCT00648505|Metformin|metformin|mesh-list
65173688|NCT00648505|Glipizide|glipizide|mesh-list
65173689|NCT00648505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65173690|NCT00648505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173691|NCT01215734|Vaccines|vaccines|mesh-list
65173692|NCT01215734|Immunologic Factors|immunologic factors|mesh-ancestor
65173693|NCT01215734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173694|NCT02863185|Atorvastatin|atorvastatin|mesh-list
65173695|NCT02863185|Pitavastatin|pitavastatin|mesh-list
65173696|NCT02863185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65173697|NCT02863185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65173698|NCT02863185|Antimetabolites|antimetabolites|mesh-ancestor
65173699|NCT02863185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173700|NCT02863185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65173701|NCT02863185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65173702|NCT02863185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173703|NCT00647881|Paroxetine|paroxetine|mesh-list
65173704|NCT00647881|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65173705|NCT00647881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65173706|NCT00647881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65173707|NCT00647881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173708|NCT00647881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65173709|NCT00647881|Serotonin Agents|serotonin agents|mesh-ancestor
65173710|NCT00647881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173711|NCT00647881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65173712|NCT00647881|Antidepressive Agents|antidepressive agents|mesh-ancestor
65173713|NCT00647881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65324542|NCT02583243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65324543|NCT02583243|Narcotics|narcotics|mesh-ancestor
65324544|NCT02583243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65324545|NCT02583243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324546|NCT02583243|Analgesics|analgesics|mesh-ancestor
65324547|NCT02583243|Sensory System Agents|sensory system agents|mesh-ancestor
65324548|NCT02583243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324549|NCT02583243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65324550|NCT00798707|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65324551|NCT00798707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64554230|NCT03099499|TIC10 compound|tic10 compound|mesh-list
65173714|NCT00647881|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65173715|NCT00647881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65173716|NCT00647881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173717|NCT04174261|Clopidogrel|clopidogrel|mesh-list
65173718|NCT04174261|Ticagrelor|ticagrelor|mesh-list
65173719|NCT04174261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65173720|NCT04174261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65173721|NCT04174261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65173722|NCT04174261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65173729|NCT00971997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173731|NCT01142388|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65173732|NCT01142388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65173733|NCT01142388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65173734|NCT01142388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173735|NCT01142388|Tubulin Modulators|tubulin modulators|mesh-ancestor
65173736|NCT01142388|Antimitotic Agents|antimitotic agents|mesh-ancestor
65173737|NCT01142388|Mitosis Modulators|mitosis modulators|mesh-ancestor
65173738|NCT01142388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173739|NCT01142388|Immunologic Factors|immunologic factors|mesh-ancestor
65173740|NCT01142388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173741|NCT00910741|Gemcitabine|gemcitabine|mesh-list
65173742|NCT00910741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65173743|NCT00910741|Antimetabolites|antimetabolites|mesh-ancestor
65173744|NCT00910741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173745|NCT00910741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173746|NCT00910741|Antiviral Agents|antiviral agents|mesh-ancestor
65173747|NCT00910741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65173748|NCT00910741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173749|NCT00910741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65173750|NCT00910741|Immunologic Factors|immunologic factors|mesh-ancestor
65173751|NCT00910741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173752|NCT00647959|Doxycycline|doxycycline|mesh-list
65173753|NCT00647959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65173754|NCT00647959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65173755|NCT00647959|Antimalarials|antimalarials|mesh-ancestor
65173756|NCT00647959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65173757|NCT00647959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65173758|NCT03602235|Ascorbic Acid|ascorbic acid|mesh-list
65173759|NCT03602235|Melphalan|melphalan|mesh-list
65173760|NCT03602235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65173761|NCT03602235|Alkylating Agents|alkylating agents|mesh-ancestor
65173762|NCT03602235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173763|NCT03602235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173764|NCT03602235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65173765|NCT03602235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65173766|NCT03602235|Immunologic Factors|immunologic factors|mesh-ancestor
65173767|NCT03602235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173768|NCT03602235|Antioxidants|antioxidants|mesh-ancestor
65173769|NCT03602235|Protective Agents|protective agents|mesh-ancestor
65173770|NCT03602235|Vitamins|vitamins|mesh-ancestor
65173771|NCT03602235|Micronutrients|micronutrients|mesh-ancestor
65173772|NCT00648583|Ondansetron|ondansetron|mesh-list
65173773|NCT00648583|Antiemetics|antiemetics|mesh-ancestor
65324552|NCT00798707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65324553|NCT00798707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65324554|NCT00798707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324555|NCT00798707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65324556|NCT00798707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324557|NCT00798707|Antidepressive Agents|antidepressive agents|mesh-ancestor
65324558|NCT00798707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65324559|NCT00760214|Ramipril|ramipril|mesh-list
65324560|NCT00760214|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65324561|NCT00760214|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65324562|NCT00760214|Protease Inhibitors|protease inhibitors|mesh-ancestor
65173774|NCT00648583|Autonomic Agents|autonomic agents|mesh-ancestor
65173775|NCT00648583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65173776|NCT00648583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173777|NCT00648583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65173778|NCT00648583|Antipruritics|antipruritics|mesh-ancestor
65173779|NCT00648583|Dermatologic Agents|dermatologic agents|mesh-ancestor
65173780|NCT00648583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65173781|NCT00648583|Serotonin Agents|serotonin agents|mesh-ancestor
65173782|NCT00648583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65173783|NCT00648583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173784|NCT00648583|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65173785|NCT00648583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65173786|NCT00648583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65173787|NCT00648583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65173788|NCT00648583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65173790|NCT03809481|Argatroban|argatroban|mesh-list
65173791|NCT03809481|Antithrombins|antithrombins|mesh-ancestor
65173795|NCT03809481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173797|NCT03809481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65173798|NCT03809481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65173799|NCT03809481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65173800|NCT00649129|Oxybutynin|oxybutynin|mesh-list
65173801|NCT00649129|Parasympatholytics|parasympatholytics|mesh-ancestor
65173802|NCT00649129|Autonomic Agents|autonomic agents|mesh-ancestor
65173803|NCT00649129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65173804|NCT00649129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173805|NCT00649129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65173806|NCT00649129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65173807|NCT00649129|Cholinergic Agents|cholinergic agents|mesh-ancestor
65173808|NCT00649129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65173809|NCT00649129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173810|NCT00649129|Urological Agents|urological agents|mesh-ancestor
65173811|NCT01127646|Methylphenidate|methylphenidate|mesh-list
65173812|NCT01127646|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65173813|NCT01127646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65173814|NCT01127646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173815|NCT01127646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65173816|NCT01127646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65173817|NCT01127646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65173818|NCT01127646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173819|NCT01127646|Dopamine Agents|dopamine agents|mesh-ancestor
65173820|NCT01127646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65173821|NCT01127646|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65173822|NCT01127646|Adrenergic Agents|adrenergic agents|mesh-ancestor
65173823|NCT02660047|Liraglutide|liraglutide|mesh-list
65173824|NCT02660047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65173825|NCT02660047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173826|NCT02660047|Incretins|incretins|mesh-ancestor
65173827|NCT02660047|Hormones|hormones|mesh-ancestor
65173828|NCT02660047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65173829|NCT00648661|Dexetimide|dexetimide|mesh-list
65324563|NCT00760214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65324564|NCT00760214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324565|NCT00760214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65324566|NCT00760214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65324567|NCT00760214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65324568|NCT04401267|Antihypertensive Agents|antihypertensive agents|mesh-list
65324569|NCT04078425|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
65324570|NCT04078425|Hormone Antagonists|hormone antagonists|mesh-ancestor
65324571|NCT04078425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65324572|NCT04078425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324573|NCT04078425|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65324574|NCT04078425|Diuretics|diuretics|mesh-ancestor
65324575|NCT04078425|Natriuretic Agents|natriuretic agents|mesh-ancestor
65324576|NCT00638391|Anastrozole|anastrozole|mesh-list
65324577|NCT00638391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65324578|NCT00638391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65324579|NCT00638391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65324580|NCT00638391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65324581|NCT00638391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65324582|NCT00638391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173830|NCT00648661|Citalopram|citalopram|mesh-list
65173831|NCT00648661|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65173832|NCT00648661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65173833|NCT00648661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65173834|NCT00648661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173835|NCT00648661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65173836|NCT00648661|Serotonin Agents|serotonin agents|mesh-ancestor
65173837|NCT00648661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173838|NCT00648661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65173839|NCT00648661|Antidepressive Agents|antidepressive agents|mesh-ancestor
65173840|NCT00648661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65173841|NCT00648661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65173842|NCT00648661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65173843|NCT00648661|Parasympatholytics|parasympatholytics|mesh-ancestor
65173844|NCT00648661|Autonomic Agents|autonomic agents|mesh-ancestor
65173845|NCT00648661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65173846|NCT00648661|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65173847|NCT00648661|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65173848|NCT00648661|Cholinergic Agents|cholinergic agents|mesh-ancestor
65173849|NCT05367414|Tea Tree Oil|tea tree oil|mesh-list
65173850|NCT05367414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65173851|NCT05367414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65173852|NCT04171687|Clopidogrel|clopidogrel|mesh-list
65173853|NCT04171687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65173854|NCT04171687|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65173855|NCT04171687|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65173856|NCT04171687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65173857|NCT04171687|Purinergic Agents|purinergic agents|mesh-ancestor
65173858|NCT04171687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65324583|NCT00638391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65324584|NCT00638391|Hormone Antagonists|hormone antagonists|mesh-ancestor
65324585|NCT00638391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65324586|NCT00638391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324587|NCT02583633|Nifedipine|nifedipine|mesh-list
65324588|NCT02583633|Nitroglycerin|nitroglycerin|mesh-list
65324589|NCT02583633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65324590|NCT02583633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65324591|NCT02583633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324592|NCT02583633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65324593|NCT02583633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324594|NCT02583633|Vasodilator Agents|vasodilator agents|mesh-ancestor
65324595|NCT02583633|Tocolytic Agents|tocolytic agents|mesh-ancestor
65324596|NCT02583633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65324597|NCT04487067|Bevacizumab|bevacizumab|mesh-list
65324598|NCT04487067|Atezolizumab|atezolizumab|mesh-list
65324599|NCT04487067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65324600|NCT04487067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493958|NCT03913559|Glucocorticoids|glucocorticoids|mesh-ancestor
65173859|NCT04171687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173860|NCT04171687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173868|NCT00648817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65173869|NCT00648817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65173870|NCT03391869|Nivolumab|nivolumab|mesh-list
65173871|NCT03391869|Ipilimumab|ipilimumab|mesh-list
65173872|NCT03391869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65173873|NCT03391869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173874|NCT03391869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65173875|NCT03391869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173876|NCT02663323|Sirolimus|sirolimus|mesh-list
65173877|NCT02663323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65173878|NCT02663323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65173879|NCT02663323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65173880|NCT02663323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173881|NCT02663323|Antifungal Agents|antifungal agents|mesh-ancestor
65173882|NCT02663323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65173883|NCT02663323|Immunologic Factors|immunologic factors|mesh-ancestor
65173884|NCT02663323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173885|NCT01215188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65173886|NCT01215188|Immunologic Factors|immunologic factors|mesh-ancestor
65173887|NCT01215188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173888|NCT04285281|Gabapentin|gabapentin|mesh-list
65173889|NCT04285281|Analgesics|analgesics|mesh-ancestor
65173890|NCT04285281|Sensory System Agents|sensory system agents|mesh-ancestor
65173891|NCT04285281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65173892|NCT04285281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173893|NCT04285281|Anticonvulsants|anticonvulsants|mesh-ancestor
65173894|NCT04285281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65173895|NCT04285281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65173896|NCT04285281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65173897|NCT04285281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65173898|NCT04285281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65173899|NCT04285281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65074634|NCT00312533|Hylan|hylan|mesh-list
65324601|NCT04487067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65324602|NCT04487067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65324603|NCT04487067|Growth Substances|growth substances|mesh-ancestor
65324604|NCT04487067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324605|NCT04487067|Growth Inhibitors|growth inhibitors|mesh-ancestor
65324606|NCT05353257|Carboplatin|carboplatin|mesh-list
65324607|NCT05353257|Etoposide|etoposide|mesh-list
65324608|NCT05353257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65324609|NCT05353257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65324610|NCT05353257|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65324611|NCT05353257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65173900|NCT04285281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65173901|NCT04285281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173902|NCT04285281|Antimanic Agents|antimanic agents|mesh-ancestor
65173903|NCT02659657|Interleukin-2|interleukin-2|mesh-list
65173904|NCT02659657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173905|NCT02659657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65173906|NCT02659657|Analgesics|analgesics|mesh-ancestor
65173907|NCT02659657|Sensory System Agents|sensory system agents|mesh-ancestor
65173908|NCT02659657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65173909|NCT02659657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173910|NCT02659891|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65173911|NCT02659891|Immunologic Factors|immunologic factors|mesh-ancestor
65173912|NCT02659891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173913|NCT00648193|Paroxetine|paroxetine|mesh-list
65173914|NCT00648193|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65173915|NCT00648193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65173916|NCT00648193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65173917|NCT00648193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173918|NCT00648193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65173919|NCT00648193|Serotonin Agents|serotonin agents|mesh-ancestor
65173920|NCT00648193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173921|NCT00648193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65173922|NCT00648193|Antidepressive Agents|antidepressive agents|mesh-ancestor
65173923|NCT00648193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65173924|NCT00648193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65173925|NCT00648193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65173926|NCT00648193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173927|NCT01215032|Metformin|metformin|mesh-list
65173928|NCT01215032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65173951|NCT00648271|Autonomic Agents|autonomic agents|mesh-ancestor
65173952|NCT00648271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65173953|NCT00648271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173954|NCT00648271|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65173955|NCT00648271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65173956|NCT00648271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65173957|NCT00648271|Adrenergic Agents|adrenergic agents|mesh-ancestor
65173958|NCT00648271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65173959|NCT00648271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173960|NCT00648349|Rabeprazole|rabeprazole|mesh-list
65173961|NCT00648349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65173962|NCT00648349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65173963|NCT00648349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65173964|NCT00648349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173965|NCT00648349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173966|NCT00649207|Veliparib|veliparib|mesh-list
65173967|NCT00649207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65173968|NCT00649207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173969|NCT00649207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173970|NCT00649207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65324612|NCT05353257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65324613|NCT05353257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324614|NCT02582307|Acetaminophen|acetaminophen|mesh-list
65324615|NCT02582307|Scopolamine|scopolamine|mesh-list
65324616|NCT02582307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
65324617|NCT02582307|Analgesics|analgesics|mesh-list
65324618|NCT02582307|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65324619|NCT02582307|Sensory System Agents|sensory system agents|mesh-ancestor
65324620|NCT02582307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324621|NCT02582307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324622|NCT02582307|Antipyretics|antipyretics|mesh-ancestor
64554301|NCT00632827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64554302|NCT00632827|Methotrexate|methotrexate|mesh-list
64554303|NCT00632827|Etoposide|etoposide|mesh-list
64554304|NCT00632827|Vincristine|vincristine|mesh-list
64554305|NCT00632827|Vinorelbine|vinorelbine|mesh-list
64554306|NCT00632827|Denileukin diftitox|denileukin diftitox|mesh-list
64554307|NCT00632827|Lenograstim|lenograstim|mesh-list
64554308|NCT00632827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64554309|NCT00632827|Immunologic Factors|immunologic factors|mesh-ancestor
64554310|NCT00632827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554311|NCT00632827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64554312|NCT00632827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65173971|NCT00920686|Sumatriptan|sumatriptan|mesh-list
65173972|NCT00920686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65173973|NCT00920686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65173974|NCT00920686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65173975|NCT00920686|Serotonin Agents|serotonin agents|mesh-ancestor
65173976|NCT00920686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65173977|NCT00920686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173978|NCT00920686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173979|NCT00648427|Paroxetine|paroxetine|mesh-list
65173980|NCT00648427|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65173987|NCT00648427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65173988|NCT00648427|Antidepressive Agents|antidepressive agents|mesh-ancestor
65173989|NCT00648427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65173990|NCT00648427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65173991|NCT00648427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65173992|NCT00648427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173993|NCT04170751|Vasopressins|vasopressins|mesh-list
65173994|NCT04170751|Arginine Vasopressin|arginine vasopressin|mesh-list
65173995|NCT04170751|Norepinephrine|norepinephrine|mesh-list
65173996|NCT04170751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65173997|NCT04170751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65173998|NCT04170751|Adrenergic Agents|adrenergic agents|mesh-ancestor
65173999|NCT04170751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65174000|NCT04170751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174001|NCT04170751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174002|NCT04170751|Sympathomimetics|sympathomimetics|mesh-ancestor
65174003|NCT04170751|Autonomic Agents|autonomic agents|mesh-ancestor
65174004|NCT04170751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65174005|NCT04170751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65174006|NCT04170751|Hemostatics|hemostatics|mesh-ancestor
65324623|NCT02582307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65324624|NCT02582307|Antiemetics|antiemetics|mesh-ancestor
65324625|NCT02582307|Autonomic Agents|autonomic agents|mesh-ancestor
65324626|NCT02582307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65324627|NCT02582307|Mydriatics|mydriatics|mesh-ancestor
65324628|NCT02582307|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65324629|NCT02582307|Cholinergic Agents|cholinergic agents|mesh-ancestor
65324630|NCT02582307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65324631|NCT02582307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174007|NCT04170751|Coagulants|coagulants|mesh-ancestor
65174008|NCT04170751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65174009|NCT04170751|Natriuretic Agents|natriuretic agents|mesh-ancestor
65174010|NCT02659033|Ceftriaxone|ceftriaxone|mesh-list
65174011|NCT02659033|Cefotaxime|cefotaxime|mesh-list
65174012|NCT02659033|Cefoxitin|cefoxitin|mesh-list
65174013|NCT02659033|Cephalosporins|cephalosporins|mesh-list
65174014|NCT02659033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65174015|NCT02659033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65174016|NCT04170595|Trastuzumab|trastuzumab|mesh-list
65174017|NCT04170595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65174018|NCT04170595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174019|NCT00648973|Diphenhydramine|diphenhydramine|mesh-list
65174020|NCT00648973|Promethazine|promethazine|mesh-list
65174021|NCT00648973|Pseudoephedrine|pseudoephedrine|mesh-list
65174022|NCT00648973|Ephedrine|ephedrine|mesh-list
65174023|NCT00648973|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65174024|NCT00648973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65174025|NCT00648973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65174026|NCT00648973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174027|NCT00648973|Anesthetics, Local|anesthetics, local|mesh-ancestor
65174028|NCT00648973|Anesthetics|anesthetics|mesh-ancestor
65174029|NCT00648973|Sensory System Agents|sensory system agents|mesh-ancestor
65174030|NCT00648973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65174031|NCT00648973|Antiemetics|antiemetics|mesh-ancestor
65174032|NCT00648973|Autonomic Agents|autonomic agents|mesh-ancestor
65174033|NCT00648973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65174034|NCT00648973|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65174035|NCT00648973|Histamine Antagonists|histamine antagonists|mesh-ancestor
65174036|NCT00648973|Histamine Agents|histamine agents|mesh-ancestor
65174037|NCT00648973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65174038|NCT00648973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174039|NCT00648973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65174040|NCT00648973|Antipruritics|antipruritics|mesh-ancestor
65174041|NCT00648973|Dermatologic Agents|dermatologic agents|mesh-ancestor
65174042|NCT00648973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65174043|NCT00648973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65174044|NCT00648973|Respiratory System Agents|respiratory system agents|mesh-ancestor
65174045|NCT00648973|Nasal Decongestants|nasal decongestants|mesh-ancestor
65174046|NCT00648973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65174047|NCT00648973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65174048|NCT00648973|Sympathomimetics|sympathomimetics|mesh-ancestor
65174049|NCT00648973|Adrenergic Agents|adrenergic agents|mesh-ancestor
65174050|NCT02662309|Atezolizumab|atezolizumab|mesh-list
65174058|NCT04032691|Sympatholytics|sympatholytics|mesh-ancestor
65174059|NCT04032691|Autonomic Agents|autonomic agents|mesh-ancestor
65174060|NCT04032691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65174061|NCT04032691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65174062|NCT04032691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65174063|NCT04032691|Adrenergic Agents|adrenergic agents|mesh-ancestor
65174064|NCT04032691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65174065|NCT04032691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174066|NCT02658799|Diclofenac|diclofenac|mesh-list
65174067|NCT02658799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65174068|NCT02658799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65174069|NCT02658799|Analgesics|analgesics|mesh-ancestor
65174070|NCT02658799|Sensory System Agents|sensory system agents|mesh-ancestor
65174071|NCT02658799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65174072|NCT02658799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554321|NCT00632827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554322|NCT00632827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64319432|NCT02254577|Progesterone|progesterone|mesh-list
65324632|NCT02582307|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65324633|NCT02582307|Parasympatholytics|parasympatholytics|mesh-ancestor
65324634|NCT02689245|Tenofovir|tenofovir|mesh-list
65324635|NCT02689245|Antiviral Agents|antiviral agents|mesh-ancestor
65324636|NCT02689245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65324637|NCT02689245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65324638|NCT02689245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65324639|NCT02689245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65324640|NCT02689245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324641|NCT02689245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65324642|NCT02689245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65324643|NCT00802841|Imatinib Mesylate|imatinib mesylate|mesh-list
65324644|NCT00802841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65324645|NCT00802841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65324646|NCT00802841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65324647|NCT00802841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324648|NCT00772148|Tacrolimus|tacrolimus|mesh-list
65324649|NCT00772148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65324650|NCT00772148|Immunologic Factors|immunologic factors|mesh-ancestor
65324651|NCT00772148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324652|NCT00772148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65324653|NCT00772148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65324654|NCT00772148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324655|NCT02689089|Rifapentine|rifapentine|mesh-list
65324656|NCT02689089|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65174073|NCT02658799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65174074|NCT02658799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64816694|NCT01491256|Atorvastatin|atorvastatin|mesh-list
65174075|NCT02658799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65174076|NCT02658799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174077|NCT02658799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174078|NCT02655757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65174079|NCT02655757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65174080|NCT02655757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174081|NCT02655757|Incretins|incretins|mesh-ancestor
65174082|NCT02655757|Hormones|hormones|mesh-ancestor
65174083|NCT02655757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65174084|NCT02655757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65174085|NCT02655757|Protease Inhibitors|protease inhibitors|mesh-ancestor
65174086|NCT02655757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174087|NCT02655757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174088|NCT01214720|Bevacizumab|bevacizumab|mesh-list
65324657|NCT02689089|Antitubercular Agents|antitubercular agents|mesh-ancestor
65324658|NCT02689089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65324659|NCT02689089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65324660|NCT02689089|Leprostatic Agents|leprostatic agents|mesh-ancestor
65324661|NCT00759902|Morphine|morphine|mesh-list
65324662|NCT00759902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65324663|NCT00759902|Narcotics|narcotics|mesh-ancestor
65324664|NCT00759902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65324665|NCT00759902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324666|NCT00759902|Analgesics|analgesics|mesh-ancestor
65324667|NCT00759902|Sensory System Agents|sensory system agents|mesh-ancestor
65324668|NCT00759902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324669|NCT04077957|Hydroxychloroquine|hydroxychloroquine|mesh-list
65324670|NCT04077957|Sulfasalazine|sulfasalazine|mesh-list
65324671|NCT04077957|Etanercept|etanercept|mesh-list
65324672|NCT04077957|Methotrexate|methotrexate|mesh-list
65324673|NCT04077957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65324674|NCT04077957|Abortifacient Agents|abortifacient agents|mesh-ancestor
65324675|NCT04077957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65174089|NCT01214720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65174090|NCT01214720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174091|NCT01214720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65174092|NCT01214720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65174093|NCT01214720|Growth Substances|growth substances|mesh-ancestor
65174094|NCT01214720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174095|NCT01214720|Growth Inhibitors|growth inhibitors|mesh-ancestor
65174096|NCT02655913|Ascorbic Acid|ascorbic acid|mesh-list
65174097|NCT02655913|Vitamins|vitamins|mesh-ancestor
65174098|NCT02655913|Micronutrients|micronutrients|mesh-ancestor
65174099|NCT02655913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174100|NCT02655913|Antioxidants|antioxidants|mesh-ancestor
65174101|NCT02655913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174102|NCT02655913|Protective Agents|protective agents|mesh-ancestor
65174103|NCT00649285|Nitrofurantoin|nitrofurantoin|mesh-list
65174104|NCT00649285|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65174105|NCT00649285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65174106|NCT00649285|Renal Agents|renal agents|mesh-ancestor
65174107|NCT00649285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65174108|NCT04169269|Enoxaparin|enoxaparin|mesh-list
65174109|NCT04169269|Rivaroxaban|rivaroxaban|mesh-list
65174110|NCT04169269|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65174125|NCT02661373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65174126|NCT02661373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174127|NCT02661373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174128|NCT00649051|Metolazone|metolazone|mesh-list
65174129|NCT00649051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65174130|NCT00649051|Diuretics|diuretics|mesh-ancestor
65174131|NCT00649051|Natriuretic Agents|natriuretic agents|mesh-ancestor
65174132|NCT00649051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174133|NCT00649051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65174134|NCT00649051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65174135|NCT00649051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174136|NCT04168879|Bupivacaine|bupivacaine|mesh-list
65174137|NCT04168879|Anesthetics, Local|anesthetics, local|mesh-ancestor
65174138|NCT04168879|Anesthetics|anesthetics|mesh-ancestor
65174139|NCT04168879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65174140|NCT04168879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174141|NCT04168879|Sensory System Agents|sensory system agents|mesh-ancestor
65324676|NCT04077957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324677|NCT04077957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65324678|NCT04077957|Antimetabolites|antimetabolites|mesh-ancestor
65324679|NCT04077957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324680|NCT04077957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65324681|NCT04077957|Dermatologic Agents|dermatologic agents|mesh-ancestor
65324682|NCT04077957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65324683|NCT04077957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65324684|NCT04077957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65324685|NCT04077957|Immunologic Factors|immunologic factors|mesh-ancestor
65324686|NCT04077957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65324687|NCT04077957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65324688|NCT04077957|Antimalarials|antimalarials|mesh-ancestor
65324689|NCT04077957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65324690|NCT04077957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65324691|NCT04077957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65324692|NCT04077957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65324693|NCT04077957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65174142|NCT04168879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65174143|NCT00649987|Albuterol|albuterol|mesh-list
65174144|NCT00649987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65174145|NCT00649987|Autonomic Agents|autonomic agents|mesh-ancestor
65174146|NCT00649987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65174147|NCT00649987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174148|NCT00649987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65174149|NCT00649987|Respiratory System Agents|respiratory system agents|mesh-ancestor
65174150|NCT00649987|Tocolytic Agents|tocolytic agents|mesh-ancestor
64816770|NCT01492179|Lidocaine|lidocaine|mesh-list
65174151|NCT00649987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65174152|NCT00649987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65174153|NCT00649987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65174154|NCT00649987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65174155|NCT00649987|Adrenergic Agents|adrenergic agents|mesh-ancestor
65174156|NCT00649987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65174157|NCT00649987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174158|NCT01142232|Lenalidomide|lenalidomide|mesh-list
65174159|NCT01142232|Melphalan|melphalan|mesh-list
65174160|NCT01142232|Immunologic Factors|immunologic factors|mesh-ancestor
65174161|NCT01142232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174162|NCT01142232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65174163|NCT01142232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65174164|NCT01142232|Growth Substances|growth substances|mesh-ancestor
65174165|NCT01142232|Growth Inhibitors|growth inhibitors|mesh-ancestor
65174166|NCT01142232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174167|NCT01142232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65174168|NCT01142232|Alkylating Agents|alkylating agents|mesh-ancestor
65174169|NCT01142232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174179|NCT02536495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174181|NCT02536495|Antimitotic Agents|antimitotic agents|mesh-ancestor
65174182|NCT02536495|Mitosis Modulators|mitosis modulators|mesh-ancestor
65174183|NCT02536495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174184|NCT02536417|Melatonin|melatonin|mesh-list
65174185|NCT02536417|Antioxidants|antioxidants|mesh-ancestor
65174186|NCT02536417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174187|NCT02536417|Protective Agents|protective agents|mesh-ancestor
65324694|NCT04077957|Analgesics|analgesics|mesh-ancestor
65324695|NCT04077957|Sensory System Agents|sensory system agents|mesh-ancestor
65324696|NCT04077957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324697|NCT04077957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65324698|NCT04077957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65324699|NCT04102670|Hyaluronic Acid|hyaluronic acid|mesh-list
65324700|NCT04102670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324701|NCT04102670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65324702|NCT04102670|Immunologic Factors|immunologic factors|mesh-ancestor
65324703|NCT04102670|Viscosupplements|viscosupplements|mesh-ancestor
65324704|NCT04102670|Protective Agents|protective agents|mesh-ancestor
65324705|NCT04114097|Betamethasone|betamethasone|mesh-list
65324706|NCT04114097|Betamethasone Valerate|betamethasone valerate|mesh-list
65324707|NCT04114097|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65174188|NCT02536417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174189|NCT02536417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65174190|NCT01140906|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65174191|NCT01140906|Vortioxetine|vortioxetine|mesh-list
65174192|NCT01140906|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65174193|NCT01140906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65174194|NCT01140906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65174195|NCT01140906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174196|NCT01140906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65174197|NCT01140906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174198|NCT01140906|Analgesics|analgesics|mesh-ancestor
65174199|NCT01140906|Sensory System Agents|sensory system agents|mesh-ancestor
65174200|NCT01140906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65174201|NCT01140906|Antidepressive Agents|antidepressive agents|mesh-ancestor
65174202|NCT01140906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65174203|NCT01140906|Dopamine Agents|dopamine agents|mesh-ancestor
65174204|NCT01140906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65174205|NCT01140906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65174206|NCT01140906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65174207|NCT01140906|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65174208|NCT01140906|Serotonin Agents|serotonin agents|mesh-ancestor
65174209|NCT01140906|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65174210|NCT01140906|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65174211|NCT01140906|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65174212|NCT01140906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65174213|NCT00650065|Cetirizine|cetirizine|mesh-list
65174214|NCT00650065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65174215|NCT00650065|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65174216|NCT00650065|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65174217|NCT00650065|Histamine Antagonists|histamine antagonists|mesh-ancestor
65174218|NCT00650065|Histamine Agents|histamine agents|mesh-ancestor
65174219|NCT00650065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65174220|NCT00650065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174221|NCT00650065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174222|NCT04170439|Chromium|chromium|mesh-list
65174223|NCT04170439|Metformin|metformin|mesh-list
65174224|NCT04170439|Citric Acid|citric acid|mesh-list
65174225|NCT04170439|Sodium Citrate|sodium citrate|mesh-list
65174226|NCT04170439|Clomiphene|clomiphene|mesh-list
65174227|NCT04170439|Enclomiphene|enclomiphene|mesh-list
65174228|NCT04170439|Zuclomiphene|zuclomiphene|mesh-list
65174229|NCT04170439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65174230|NCT04170439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174231|NCT04170439|Anticoagulants|anticoagulants|mesh-ancestor
65174232|NCT04170439|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65174233|NCT04170439|Chelating Agents|chelating agents|mesh-ancestor
65174234|NCT04170439|Sequestering Agents|sequestering agents|mesh-ancestor
65174235|NCT04170439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324708|NCT04114097|Betamethasone benzoate|betamethasone benzoate|mesh-list
65324709|NCT04114097|Tacrolimus|tacrolimus|mesh-list
65324710|NCT04114097|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65324711|NCT04114097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65324712|NCT04114097|Immunologic Factors|immunologic factors|mesh-ancestor
65324713|NCT04114097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324714|NCT04114097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65324715|NCT04114097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65324716|NCT04114097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324717|NCT04114097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65174243|NCT04170439|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65174244|NCT04170439|Trace Elements|trace elements|mesh-ancestor
65174245|NCT04170439|Micronutrients|micronutrients|mesh-ancestor
65174247|NCT00649363|Antiemetics|antiemetics|mesh-ancestor
65174248|NCT00649363|Autonomic Agents|autonomic agents|mesh-ancestor
65174249|NCT00649363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65174250|NCT00649363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174251|NCT00649363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65174252|NCT00649363|Antipruritics|antipruritics|mesh-ancestor
65174253|NCT00649363|Dermatologic Agents|dermatologic agents|mesh-ancestor
65174254|NCT00649363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65174255|NCT00649363|Serotonin Agents|serotonin agents|mesh-ancestor
65174256|NCT00649363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65174257|NCT00649363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174258|NCT00649363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65174259|NCT00649363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65174260|NCT00649363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65174261|NCT00649363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65174262|NCT00649363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65174263|NCT03531645|Fulvestrant|fulvestrant|mesh-list
65174264|NCT03531645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65174265|NCT03531645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174266|NCT03531645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65174267|NCT03531645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65174268|NCT03531645|Hormone Antagonists|hormone antagonists|mesh-ancestor
65174269|NCT03531645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65174270|NCT03531645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174271|NCT02654743|Sulforaphane|sulforaphane|mesh-list
65174272|NCT02654743|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65174273|NCT02654743|Protective Agents|protective agents|mesh-ancestor
65174274|NCT02654743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174275|NCT02654743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174276|NCT04168723|Moxifloxacin|moxifloxacin|mesh-list
65174277|NCT04168723|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65174278|NCT04168723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65174279|NCT04168723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65174280|NCT04168723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65174281|NCT04168723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65174282|NCT04168723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174283|NCT04168723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174284|NCT04168723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174285|NCT04168723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65174286|NCT04168723|Contraceptive Agents|contraceptive agents|mesh-ancestor
65174287|NCT04168723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65174288|NCT04168723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174289|NCT04168723|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65174290|NCT04168723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65174291|NCT04168723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65174292|NCT03493425|Cisplatin|cisplatin|mesh-list
65174293|NCT03493425|Carboplatin|carboplatin|mesh-list
65174294|NCT03493425|Docetaxel|docetaxel|mesh-list
65174295|NCT03493425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174296|NCT03493425|Tubulin Modulators|tubulin modulators|mesh-ancestor
65174297|NCT03493425|Antimitotic Agents|antimitotic agents|mesh-ancestor
65324718|NCT04114097|Glucocorticoids|glucocorticoids|mesh-ancestor
65324719|NCT04114097|Hormones|hormones|mesh-ancestor
65324720|NCT04114097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65324721|NCT04114097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65324722|NCT04114097|Respiratory System Agents|respiratory system agents|mesh-ancestor
65324723|NCT04323189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65324724|NCT04323189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65324725|NCT04323189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324726|NCT04323189|Incretins|incretins|mesh-ancestor
65324727|NCT04323189|Hormones|hormones|mesh-ancestor
65324728|NCT04323189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65324729|NCT04323189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65324730|NCT04323189|Protease Inhibitors|protease inhibitors|mesh-ancestor
65324731|NCT04323189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174298|NCT03493425|Mitosis Modulators|mitosis modulators|mesh-ancestor
65174299|NCT03493425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174300|NCT00649441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65174301|NCT00649441|Quinapril|quinapril|mesh-list
65174308|NCT00649441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174309|NCT00649441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65174310|NCT00649441|Protease Inhibitors|protease inhibitors|mesh-ancestor
65174311|NCT00649441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174312|NCT02654665|Liraglutide|liraglutide|mesh-list
65174313|NCT02654665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65174314|NCT02654665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174315|NCT02654665|Incretins|incretins|mesh-ancestor
65174316|NCT02654665|Hormones|hormones|mesh-ancestor
65174317|NCT02654665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65174318|NCT02658721|Diclofenac|diclofenac|mesh-list
65174319|NCT02658721|Lidocaine|lidocaine|mesh-list
65174320|NCT02658721|Atropine|atropine|mesh-list
65174321|NCT02658721|Ephedrine|ephedrine|mesh-list
65174322|NCT02658721|Fentanyl|fentanyl|mesh-list
65174323|NCT02658721|Midazolam|midazolam|mesh-list
65174324|NCT02658721|Tramadol|tramadol|mesh-list
65174325|NCT02658721|Ondansetron|ondansetron|mesh-list
65174326|NCT02658721|Anesthetics, Local|anesthetics, local|mesh-ancestor
65174327|NCT02658721|Anesthetics|anesthetics|mesh-ancestor
65174328|NCT02658721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65174329|NCT02658721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174330|NCT02658721|Sensory System Agents|sensory system agents|mesh-ancestor
65174331|NCT02658721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65174332|NCT02658721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65174333|NCT02658721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65174334|NCT02658721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65174335|NCT02658721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65174336|NCT02658721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174337|NCT02658721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65174338|NCT02658721|Narcotics|narcotics|mesh-ancestor
65174339|NCT02658721|Analgesics|analgesics|mesh-ancestor
65174340|NCT02658721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65174341|NCT02658721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65174342|NCT02658721|Anesthetics, General|anesthetics, general|mesh-ancestor
65174343|NCT02658721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65174344|NCT02658721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65174345|NCT02658721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65174346|NCT02658721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65174347|NCT02658721|GABA Modulators|gaba modulators|mesh-ancestor
65174348|NCT02658721|GABA Agents|gaba agents|mesh-ancestor
65174349|NCT02658721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65174350|NCT02658721|Antiemetics|antiemetics|mesh-ancestor
65174351|NCT02658721|Autonomic Agents|autonomic agents|mesh-ancestor
65324732|NCT04323189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324733|NCT00772070|Vaccines|vaccines|mesh-list
65324734|NCT00772070|Immunologic Factors|immunologic factors|mesh-ancestor
65324735|NCT00772070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324736|NCT00796757|Interferons|interferons|mesh-list
65324737|NCT00796757|Interferon-alpha|interferon-alpha|mesh-list
65324738|NCT00796757|Interferon alpha-2|interferon alpha-2|mesh-list
65324739|NCT00796757|Bevacizumab|bevacizumab|mesh-list
65324740|NCT00796757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65324741|NCT00796757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65324742|NCT00796757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65324743|NCT00796757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65324744|NCT00796757|Growth Substances|growth substances|mesh-ancestor
65174352|NCT02658721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65174353|NCT02658721|Antipruritics|antipruritics|mesh-ancestor
65174354|NCT02658721|Dermatologic Agents|dermatologic agents|mesh-ancestor
65174355|NCT02658721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65174356|NCT02658721|Serotonin Agents|serotonin agents|mesh-ancestor
65174357|NCT02658721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65174358|NCT02658721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65174359|NCT02658721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65174360|NCT02658721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65174361|NCT02658721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65174362|NCT02658721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65174363|NCT02658721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174364|NCT02658721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65174365|NCT02658721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65174366|NCT02658721|Respiratory System Agents|respiratory system agents|mesh-ancestor
65174368|NCT02658721|Parasympatholytics|parasympatholytics|mesh-ancestor
65174369|NCT02658721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65174370|NCT02658721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65174371|NCT02658721|Cholinergic Agents|cholinergic agents|mesh-ancestor
65174372|NCT02658721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65174373|NCT02658721|Sympathomimetics|sympathomimetics|mesh-ancestor
65174377|NCT04283877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65174378|NCT04283877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174379|NCT04283877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65174380|NCT04283877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65174381|NCT04283877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65174382|NCT04283877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174383|NCT04283877|Dopamine Agents|dopamine agents|mesh-ancestor
65174384|NCT04283877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65174386|NCT00629967|Ribavirin|ribavirin|mesh-list
65174387|NCT00629967|Interferon-alpha|interferon-alpha|mesh-list
65174388|NCT00629967|Interferon alpha-2|interferon alpha-2|mesh-list
65174389|NCT00629967|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65174390|NCT00629967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174391|NCT00629967|Antiviral Agents|antiviral agents|mesh-ancestor
65174392|NCT00629967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65174393|NCT00629967|Antimetabolites|antimetabolites|mesh-ancestor
65174394|NCT00629967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174395|NCT00629967|Immunologic Factors|immunologic factors|mesh-ancestor
65174396|NCT00629967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174397|NCT02654587|Docetaxel|docetaxel|mesh-list
65174398|NCT02654587|Pemetrexed|pemetrexed|mesh-list
65174399|NCT02654587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174400|NCT02654587|Tubulin Modulators|tubulin modulators|mesh-ancestor
65174401|NCT02654587|Antimitotic Agents|antimitotic agents|mesh-ancestor
65174402|NCT02654587|Mitosis Modulators|mitosis modulators|mesh-ancestor
65174403|NCT02654587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174404|NCT02654587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174405|NCT02654587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65324745|NCT00796757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324746|NCT00796757|Growth Inhibitors|growth inhibitors|mesh-ancestor
65324747|NCT00796757|Antiviral Agents|antiviral agents|mesh-ancestor
65324748|NCT00796757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65324749|NCT00796757|Immunologic Factors|immunologic factors|mesh-ancestor
65324750|NCT00759356|Morphine|morphine|mesh-list
65324751|NCT00759356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65324752|NCT00759356|Narcotics|narcotics|mesh-ancestor
65324753|NCT00759356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65324754|NCT00759356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324755|NCT00759356|Analgesics|analgesics|mesh-ancestor
65324756|NCT00759356|Sensory System Agents|sensory system agents|mesh-ancestor
65324757|NCT00759356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324758|NCT05637515|Adalimumab|adalimumab|mesh-list
65324759|NCT05637515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65324760|NCT05637515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65324761|NCT04113941|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65324762|NCT04113941|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65324763|NCT04113941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324764|NCT04113941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324765|NCT04113941|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65324766|NCT04113941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64554404|NCT05040906|Rituximab|rituximab|mesh-list
65174406|NCT02654587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65174407|NCT01122264|Sildenafil Citrate|sildenafil citrate|mesh-list
65174408|NCT01122264|Tadalafil|tadalafil|mesh-list
65174409|NCT01122264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174410|NCT01122264|Vasodilator Agents|vasodilator agents|mesh-ancestor
65174411|NCT01122264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65174412|NCT01122264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65174413|NCT01122264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174414|NCT01122264|Urological Agents|urological agents|mesh-ancestor
65174415|NCT03288675|Serotonin|serotonin|mesh-list
65174416|NCT03288675|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65174417|NCT03288675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65174418|NCT03288675|Serotonin Agents|serotonin agents|mesh-ancestor
65174419|NCT03288675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65174420|NCT03288675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174421|NCT03288675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174422|NCT03288675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65174423|NCT03288675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65174424|NCT00920218|Vaccines|vaccines|mesh-list
65174425|NCT00920218|Immunologic Factors|immunologic factors|mesh-ancestor
65174426|NCT00920218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174427|NCT00649519|Amlodipine|amlodipine|mesh-list
65174428|NCT00649519|Benazepril|benazepril|mesh-list
65174429|NCT00649519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65174430|NCT00649519|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65174431|NCT00649519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65174432|NCT00649519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174433|NCT00649519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65324767|NCT04113941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324768|NCT04113941|Cholinergic Agents|cholinergic agents|mesh-ancestor
65324769|NCT04113941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65324770|NCT04102592|Permethrin|permethrin|mesh-list
65324771|NCT04102592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65324772|NCT04102592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324773|NCT04113551|Guanfacine|guanfacine|mesh-list
65324774|NCT04113551|Methylphenidate|methylphenidate|mesh-list
65324775|NCT04113551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65324776|NCT04113551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65324777|NCT04113551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65174434|NCT00649519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174435|NCT00649519|Vasodilator Agents|vasodilator agents|mesh-ancestor
65174436|NCT00649519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65174437|NCT00649519|Protease Inhibitors|protease inhibitors|mesh-ancestor
65174438|NCT00649519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174439|NCT00629811|Mitogens|mitogens|mesh-list
65174440|NCT00629811|Mitosis Modulators|mitosis modulators|mesh-ancestor
65174441|NCT00629811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174442|NCT02652091|Interferons|interferons|mesh-list
65174443|NCT02652091|Interferon-beta|interferon-beta|mesh-list
65174444|NCT02652091|Interferon beta-1b|interferon beta-1b|mesh-list
65174445|NCT02652091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174446|NCT02652091|Antiviral Agents|antiviral agents|mesh-ancestor
65174451|NCT00625560|Lamivudine|lamivudine|mesh-list
65174452|NCT00625560|Entecavir|entecavir|mesh-list
65174453|NCT00625560|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65174454|NCT00625560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65174455|NCT00625560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174456|NCT00625560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174457|NCT00625560|Antiviral Agents|antiviral agents|mesh-ancestor
65174458|NCT00625560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65174459|NCT00625560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65174460|NCT00625560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65174462|NCT00650455|Valdecoxib|valdecoxib|mesh-list
65174463|NCT00650455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65174464|NCT00650455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65174465|NCT00650455|Analgesics|analgesics|mesh-ancestor
65174466|NCT00650455|Sensory System Agents|sensory system agents|mesh-ancestor
65174467|NCT00650455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65174468|NCT00650455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174469|NCT00650455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65174470|NCT00650455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65174471|NCT00650455|Gout Suppressants|gout suppressants|mesh-ancestor
65174472|NCT00650455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65174473|NCT00650455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174474|NCT00650455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174475|NCT00650455|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65174476|NCT02654041|Methimazole|methimazole|mesh-list
65174477|NCT02654041|Antithyroid Agents|antithyroid agents|mesh-ancestor
65174478|NCT02654041|Hormone Antagonists|hormone antagonists|mesh-ancestor
65174479|NCT02654041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65174480|NCT02654041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174481|NCT02658409|Vaccines|vaccines|mesh-list
65174482|NCT02658409|Immunologic Factors|immunologic factors|mesh-ancestor
65174483|NCT02658409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174484|NCT01121562|Sunitinib|sunitinib|mesh-list
65174485|NCT01121562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174486|NCT01121562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65174487|NCT01121562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65174488|NCT01121562|Growth Substances|growth substances|mesh-ancestor
65174489|NCT01121562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174490|NCT01121562|Growth Inhibitors|growth inhibitors|mesh-ancestor
65174491|NCT01121562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65324778|NCT04113551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65324779|NCT04113551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324780|NCT04113551|Adrenergic Agents|adrenergic agents|mesh-ancestor
65324781|NCT04113551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65324782|NCT04113551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324783|NCT04113551|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65324784|NCT04113551|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65324785|NCT04113551|Dopamine Agents|dopamine agents|mesh-ancestor
65324786|NCT04113551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65324787|NCT04113551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64554430|NCT00983437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65174492|NCT01121562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174493|NCT01121562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174494|NCT02658253|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65174495|NCT02658253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65174496|NCT02658253|Immunologic Factors|immunologic factors|mesh-ancestor
65174497|NCT02658253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174498|NCT02658253|Antacids|antacids|mesh-ancestor
65174499|NCT02658253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174500|NCT02658253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65174501|NCT02651623|Moxifloxacin|moxifloxacin|mesh-list
65174502|NCT02651623|Sertraline|sertraline|mesh-list
65174503|NCT02651623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65174504|NCT02651623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65174505|NCT02651623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65174506|NCT02651623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65174507|NCT02651623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174508|NCT02651623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174509|NCT02651623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174510|NCT02651623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174511|NCT02651623|Antidepressive Agents|antidepressive agents|mesh-ancestor
65174512|NCT02651623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65174513|NCT02651623|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65174514|NCT02651623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65174515|NCT02651623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65174516|NCT02651623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65174517|NCT02651623|Serotonin Agents|serotonin agents|mesh-ancestor
65174524|NCT01121484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174526|NCT01121484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65174527|NCT00650221|Pravastatin|pravastatin|mesh-list
65174528|NCT00650221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65174529|NCT00650221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65174530|NCT00650221|Antimetabolites|antimetabolites|mesh-ancestor
65174531|NCT00650221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174532|NCT00650221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65174533|NCT00650221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65174534|NCT00650221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174535|NCT01169675|Pemetrexed|pemetrexed|mesh-list
65174536|NCT01169675|Afatinib|afatinib|mesh-list
65174537|NCT01169675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174538|NCT01169675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174539|NCT01169675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174540|NCT01169675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65174541|NCT01169675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65174542|NCT01169675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65174543|NCT00650533|Glimepiride|glimepiride|mesh-list
65174544|NCT00650533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65174545|NCT00650533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65174546|NCT00650533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174547|NCT00650533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65324788|NCT04113551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65324789|NCT04113551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65324790|NCT00798317|Plasminogen|plasminogen|mesh-list
65324791|NCT00798317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65324792|NCT00798317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65324793|NCT00798317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324794|NCT00077285|Cyclophosphamide|cyclophosphamide|mesh-list
65324795|NCT00077285|Ifosfamide|ifosfamide|mesh-list
65324796|NCT00077285|Carboplatin|carboplatin|mesh-list
65324797|NCT00077285|Doxorubicin|doxorubicin|mesh-list
65324798|NCT00077285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65324799|NCT00077285|Irinotecan|irinotecan|mesh-list
65324800|NCT00077285|Etoposide|etoposide|mesh-list
65324801|NCT00077285|Vincristine|vincristine|mesh-list
65324802|NCT00077285|Dexrazoxane|dexrazoxane|mesh-list
65324803|NCT00077285|Razoxane|razoxane|mesh-list
65324804|NCT00077285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65324805|NCT00077285|Immunologic Factors|immunologic factors|mesh-ancestor
64554440|NCT05031234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65174548|NCT00650533|Immunologic Factors|immunologic factors|mesh-ancestor
65174549|NCT02881866|Furosemide|furosemide|mesh-list
65174550|NCT02881866|Diuretics|diuretics|mesh-ancestor
65174551|NCT02881866|Natriuretic Agents|natriuretic agents|mesh-ancestor
65174552|NCT02881866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174553|NCT02881866|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65174554|NCT02881866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65174555|NCT02881866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174556|NCT00924664|Tanezumab|tanezumab|mesh-list
65174557|NCT00924664|Analgesics|analgesics|mesh-ancestor
65174558|NCT00924664|Sensory System Agents|sensory system agents|mesh-ancestor
65174559|NCT00924664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65174560|NCT00924664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174561|NCT02653651|Lidocaine|lidocaine|mesh-list
65174562|NCT02653651|Ketamine|ketamine|mesh-list
65174563|NCT02653651|Anesthetics, Local|anesthetics, local|mesh-ancestor
65174564|NCT02653651|Anesthetics|anesthetics|mesh-ancestor
65174565|NCT02653651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65174566|NCT02653651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174567|NCT02653651|Sensory System Agents|sensory system agents|mesh-ancestor
65174568|NCT02653651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65174569|NCT02653651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65174570|NCT02653651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65174571|NCT02653651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65174572|NCT02653651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65174573|NCT02653651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174574|NCT02653651|Analgesics|analgesics|mesh-ancestor
65174575|NCT02653651|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65174576|NCT02653651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65174577|NCT02653651|Anesthetics, General|anesthetics, general|mesh-ancestor
65174578|NCT02653651|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65174579|NCT02653651|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65174580|NCT02653651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65174581|NCT02651311|Ibuprofen|ibuprofen|mesh-list
65174582|NCT02651311|Fentanyl|fentanyl|mesh-list
65174589|NCT02651311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65174590|NCT02651311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65174591|NCT02651311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65174592|NCT02651311|Anesthetics, General|anesthetics, general|mesh-ancestor
65174593|NCT02651311|Anesthetics|anesthetics|mesh-ancestor
65174594|NCT02651311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65324806|NCT00077285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324807|NCT00077285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65324808|NCT00077285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65324809|NCT00077285|Alkylating Agents|alkylating agents|mesh-ancestor
65324810|NCT00077285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324811|NCT00077285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65324812|NCT00077285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65324813|NCT00077285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65324814|NCT00077285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65324815|NCT00077285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65324816|NCT00077285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65324817|NCT00077285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65324818|NCT00077285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65324819|NCT00077285|Tubulin Modulators|tubulin modulators|mesh-ancestor
65324820|NCT00077285|Antimitotic Agents|antimitotic agents|mesh-ancestor
65324821|NCT00077285|Mitosis Modulators|mitosis modulators|mesh-ancestor
65324822|NCT00077285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65324823|NCT00077285|Protective Agents|protective agents|mesh-ancestor
65324824|NCT00771914|Aspirin|aspirin|mesh-list
65324825|NCT00771914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65074789|NCT00343629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65324826|NCT00771914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65174595|NCT02651311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65174596|NCT02651311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65174597|NCT02651311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65174598|NCT02651311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65174599|NCT02651311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174600|NCT02651311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174601|NCT02653261|Tranexamic Acid|tranexamic acid|mesh-list
65174602|NCT02653261|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65174603|NCT02653261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65174604|NCT02653261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174606|NCT02653261|Coagulants|coagulants|mesh-ancestor
65174607|NCT02653339|Loratadine|loratadine|mesh-list
65174608|NCT02653339|Antipruritics|antipruritics|mesh-ancestor
65174609|NCT02653339|Dermatologic Agents|dermatologic agents|mesh-ancestor
65174610|NCT02653339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65174611|NCT02653339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65174612|NCT02653339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65174613|NCT02653339|Histamine Antagonists|histamine antagonists|mesh-ancestor
65174614|NCT02653339|Histamine Agents|histamine agents|mesh-ancestor
65174615|NCT02653339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65174616|NCT02653339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174617|NCT02653339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174618|NCT00649597|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65174619|NCT00649597|Benazepril|benazepril|mesh-list
65174620|NCT00649597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65174621|NCT00649597|Diuretics|diuretics|mesh-ancestor
65174622|NCT00649597|Natriuretic Agents|natriuretic agents|mesh-ancestor
65174623|NCT00649597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174624|NCT00649597|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65324827|NCT00771914|Analgesics|analgesics|mesh-ancestor
65324828|NCT00771914|Sensory System Agents|sensory system agents|mesh-ancestor
65324829|NCT00771914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324830|NCT00771914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324831|NCT00771914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65324832|NCT00771914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65324833|NCT00771914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65324834|NCT00771914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65324835|NCT00771914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324836|NCT00771914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65324837|NCT00771914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65324838|NCT00771914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65324839|NCT00771914|Antipyretics|antipyretics|mesh-ancestor
65324840|NCT04307511|Aspirin|aspirin|mesh-list
65324841|NCT04307511|Ticagrelor|ticagrelor|mesh-list
64554474|NCT03598673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65174625|NCT00649597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65174626|NCT00649597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174627|NCT00649597|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65174628|NCT00649597|Protease Inhibitors|protease inhibitors|mesh-ancestor
65174629|NCT00649597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174630|NCT02653027|Ivacaftor|ivacaftor|mesh-list
65174631|NCT02653027|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65174632|NCT02653027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65174633|NCT02653027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174634|NCT02652793|Lamivudine|lamivudine|mesh-list
65174635|NCT02652793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65174636|NCT02652793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65174637|NCT02652793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65174638|NCT02652793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174639|NCT02652793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174640|NCT02652793|Antiviral Agents|antiviral agents|mesh-ancestor
65174641|NCT02652793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65174642|NCT02652793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65174643|NCT02652793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65174644|NCT02652793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65174645|NCT02652793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65174646|NCT02652793|Protease Inhibitors|protease inhibitors|mesh-ancestor
65174647|NCT00650611|Ziprasidone|ziprasidone|mesh-list
65174648|NCT00650611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65174649|NCT00650611|Serotonin Agents|serotonin agents|mesh-ancestor
65174650|NCT00650611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65174651|NCT00650611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174656|NCT00650611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65174657|NCT00650611|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65174658|NCT00650611|Dopamine Agents|dopamine agents|mesh-ancestor
65174659|NCT00600067|Topiramate|topiramate|mesh-list
65174661|NCT00600067|Anticonvulsants|anticonvulsants|mesh-ancestor
65174662|NCT00600067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65174663|NCT00600067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174664|NCT00600067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65174665|NCT00600067|Appetite Depressants|appetite depressants|mesh-ancestor
65174666|NCT00600067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65174667|NCT00600067|Sympathomimetics|sympathomimetics|mesh-ancestor
65174668|NCT00600067|Autonomic Agents|autonomic agents|mesh-ancestor
65174669|NCT00600067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65174670|NCT00600067|Adrenergic Agents|adrenergic agents|mesh-ancestor
65174671|NCT00600067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65324842|NCT04307511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65324843|NCT04307511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65324844|NCT04307511|Analgesics|analgesics|mesh-ancestor
65324845|NCT04307511|Sensory System Agents|sensory system agents|mesh-ancestor
65324846|NCT04307511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324847|NCT04307511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324848|NCT04307511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65324849|NCT04307511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64554491|NCT05039580|Hormones|hormones|mesh-ancestor
65174672|NCT00600067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174673|NCT02650609|Methylprednisolone|methylprednisolone|mesh-list
65174674|NCT02650609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65174675|NCT02650609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65174677|NCT02650609|Prednisolone acetate|prednisolone acetate|mesh-list
65174678|NCT02650609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65174679|NCT02650609|Prednisolone phosphate|prednisolone phosphate|mesh-list
65174680|NCT02650609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65174681|NCT02650609|Antiemetics|antiemetics|mesh-ancestor
65174682|NCT02650609|Autonomic Agents|autonomic agents|mesh-ancestor
65174683|NCT02650609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65174684|NCT02650609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174685|NCT02650609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65174686|NCT02650609|Glucocorticoids|glucocorticoids|mesh-ancestor
65174687|NCT02650609|Hormones|hormones|mesh-ancestor
65174688|NCT02650609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65174689|NCT02650609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65174690|NCT02650609|Protective Agents|protective agents|mesh-ancestor
65174691|NCT02650609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65174692|NCT02650609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174693|NCT02652871|Cytarabine|cytarabine|mesh-list
65174694|NCT02652871|Idarubicin|idarubicin|mesh-list
65174695|NCT02652871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65174696|NCT02652871|Antimetabolites|antimetabolites|mesh-ancestor
65174697|NCT02652871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174698|NCT02652871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174699|NCT02652871|Antiviral Agents|antiviral agents|mesh-ancestor
65174700|NCT02652871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65174701|NCT02652871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65174702|NCT02652871|Immunologic Factors|immunologic factors|mesh-ancestor
65174703|NCT02652871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174704|NCT02652871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65174705|NCT02652871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65174706|NCT02652871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65174707|NCT02652871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174708|NCT00650299|Alprazolam|alprazolam|mesh-list
65174709|NCT00650299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65174710|NCT00650299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65174711|NCT00650299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174712|NCT00650299|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65174713|NCT00650299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65174714|NCT00650299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65174715|NCT00650299|GABA Modulators|gaba modulators|mesh-ancestor
65174716|NCT00650299|GABA Agents|gaba agents|mesh-ancestor
65174717|NCT00650299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65174718|NCT00650299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174719|NCT04168099|Cefotaxime|cefotaxime|mesh-list
65174720|NCT04168099|Cefoxitin|cefoxitin|mesh-list
65174721|NCT04168099|Gemifloxacin|gemifloxacin|mesh-list
65174722|NCT04168099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65174723|NCT04168099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65174724|NCT04168099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65174725|NCT04168099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65174730|NCT04283487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174731|NCT04283331|Proxymetacaine|proxymetacaine|mesh-list
65174732|NCT04283331|Propoxycaine|propoxycaine|mesh-list
65174733|NCT04283331|Anesthetics, Local|anesthetics, local|mesh-ancestor
65174734|NCT04283331|Anesthetics|anesthetics|mesh-ancestor
65324850|NCT04307511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65324851|NCT04307511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65324852|NCT04307511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324853|NCT04307511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65324854|NCT04307511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65324855|NCT04307511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65324856|NCT04307511|Antipyretics|antipyretics|mesh-ancestor
65324857|NCT04307511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65324858|NCT04307511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65324859|NCT04307511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65324860|NCT04307511|Purinergic Agents|purinergic agents|mesh-ancestor
65174735|NCT04283331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65174736|NCT04283331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174737|NCT04283331|Sensory System Agents|sensory system agents|mesh-ancestor
65174738|NCT04283331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65174740|NCT02657473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65174741|NCT02657473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65174742|NCT02657473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65174743|NCT02652637|Metronidazole|metronidazole|mesh-list
65174744|NCT02652637|Neomycin|neomycin|mesh-list
65174745|NCT02652637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65174746|NCT02652637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65174747|NCT02652637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65174748|NCT02652637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65174749|NCT02652637|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65174750|NCT02652637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174751|NCT02652637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174753|NCT00649675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65174754|NCT00649675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65174755|NCT00649675|Analgesics|analgesics|mesh-ancestor
65174756|NCT00649675|Sensory System Agents|sensory system agents|mesh-ancestor
65174757|NCT00649675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65174758|NCT00649675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174759|NCT00649675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65174760|NCT00649675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65174761|NCT00649675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65174762|NCT00649675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65174763|NCT00649675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174764|NCT00649675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174765|NCT02860923|Exenatide|exenatide|mesh-list
65174766|NCT02860923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65174767|NCT02860923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174768|NCT02860923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65174769|NCT02860923|Incretins|incretins|mesh-ancestor
65174770|NCT02860923|Hormones|hormones|mesh-ancestor
65174771|NCT02860923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65174772|NCT01121406|Gemcitabine|gemcitabine|mesh-list
65174773|NCT01121406|Paclitaxel|paclitaxel|mesh-list
65174774|NCT01121406|Doxorubicin|doxorubicin|mesh-list
65174775|NCT01121406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65174776|NCT01121406|Topotecan|topotecan|mesh-list
65174777|NCT01121406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65174778|NCT01121406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174779|NCT01121406|Tubulin Modulators|tubulin modulators|mesh-ancestor
65174780|NCT01121406|Antimitotic Agents|antimitotic agents|mesh-ancestor
65174781|NCT01121406|Mitosis Modulators|mitosis modulators|mesh-ancestor
65174782|NCT01121406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174783|NCT01121406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65174784|NCT01121406|Antimetabolites|antimetabolites|mesh-ancestor
65174785|NCT01121406|Antiviral Agents|antiviral agents|mesh-ancestor
65174786|NCT01121406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65174787|NCT01121406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174788|NCT01121406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65324861|NCT04307511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65324862|NCT00779324|Amantadine|amantadine|mesh-list
65324863|NCT00779324|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65324864|NCT00779324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65324865|NCT00779324|Antiviral Agents|antiviral agents|mesh-ancestor
65324866|NCT00779324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65324867|NCT00779324|Dopamine Agents|dopamine agents|mesh-ancestor
65324868|NCT00779324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65324869|NCT00779324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554510|NCT05024604|Hormones|hormones|mesh-ancestor
65174789|NCT01121406|Immunologic Factors|immunologic factors|mesh-ancestor
65174790|NCT01121406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174791|NCT01121406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65174792|NCT01121406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65174793|NCT01121406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65174794|NCT01121406|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65174796|NCT02652325|Cadexomer iodine|cadexomer iodine|mesh-list
65174797|NCT02652325|Povidone-Iodine|povidone-iodine|mesh-list
65174798|NCT02652325|Povidone|povidone|mesh-list
65174799|NCT02652325|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65174804|NCT02652325|Plasma Substitutes|plasma substitutes|mesh-ancestor
65174805|NCT02652325|Blood Substitutes|blood substitutes|mesh-ancestor
65174806|NCT00960687|Fenofibrate|fenofibrate|mesh-list
65174807|NCT00960687|Fenofibric acid|fenofibric acid|mesh-list
65174808|NCT00960687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65174809|NCT00960687|Antimetabolites|antimetabolites|mesh-ancestor
65174810|NCT00960687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174811|NCT00960687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65174812|NCT00960687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65174813|NCT00920140|Trametinib|trametinib|mesh-list
65174814|NCT00920140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174816|NCT00920140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174817|NCT00920140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174818|NCT04032847|Pembrolizumab|pembrolizumab|mesh-list
65174819|NCT04032847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65174820|NCT04032847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174821|NCT01120626|Donepezil|donepezil|mesh-list
64817378|NCT01495715|Idebenone|idebenone|mesh-list
65174822|NCT01120626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65174823|NCT01120626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174824|NCT01120626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174825|NCT01120626|Cholinergic Agents|cholinergic agents|mesh-ancestor
65174826|NCT01120626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65174827|NCT01120626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174828|NCT01120626|Nootropic Agents|nootropic agents|mesh-ancestor
65174829|NCT00650377|Finasteride|finasteride|mesh-list
65174830|NCT00650377|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65174831|NCT00650377|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65174832|NCT00650377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174833|NCT00650377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174834|NCT00650377|Hormone Antagonists|hormone antagonists|mesh-ancestor
65174835|NCT00650377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65174836|NCT00650377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174837|NCT00650377|Urological Agents|urological agents|mesh-ancestor
65174838|NCT02649751|Roscovitine|roscovitine|mesh-list
65174839|NCT02649751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174840|NCT02649751|Antiviral Agents|antiviral agents|mesh-ancestor
65174841|NCT02649751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65174842|NCT02649751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65174843|NCT02649751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174844|NCT02649751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174845|NCT04252300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65174846|NCT04252300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65174847|NCT04252300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65174848|NCT04252300|Antimetabolites|antimetabolites|mesh-ancestor
65174849|NCT04252300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324870|NCT00779324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324871|NCT00779324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65324872|NCT00779324|Analgesics|analgesics|mesh-ancestor
65324873|NCT00779324|Sensory System Agents|sensory system agents|mesh-ancestor
65324874|NCT00779324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324875|NCT00779246|Chlorhexidine|chlorhexidine|mesh-list
65324876|NCT00779246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64554518|NCT01041573|Immunologic Factors|immunologic factors|mesh-ancestor
65174850|NCT04252300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65174851|NCT04252300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65174852|NCT04252300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174853|NCT00924508|Triamcinolone|triamcinolone|mesh-list
65174854|NCT00924508|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65174855|NCT00924508|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65174856|NCT00924508|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65174857|NCT00924508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65174858|NCT00924508|Glucocorticoids|glucocorticoids|mesh-ancestor
65174859|NCT00924508|Hormones|hormones|mesh-ancestor
65174860|NCT00924508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65174861|NCT00924508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174862|NCT00924508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65174863|NCT00924508|Immunologic Factors|immunologic factors|mesh-ancestor
65174864|NCT00924508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174865|NCT00924508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174866|NCT00650923|Temozolomide|temozolomide|mesh-list
65174867|NCT00650923|Aflibercept|aflibercept|mesh-list
65174868|NCT00650923|Endothelial Growth Factors|endothelial growth factors|mesh-list
65174869|NCT00650923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65174878|NCT00637858|Lycopene|lycopene|mesh-list
65174879|NCT00637858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65174880|NCT00637858|Antioxidants|antioxidants|mesh-ancestor
65174881|NCT00637858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174882|NCT00637858|Protective Agents|protective agents|mesh-ancestor
65174883|NCT00637858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174884|NCT00637858|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65174885|NCT00637858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65174886|NCT00637858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174887|NCT02657161|Vaccines|vaccines|mesh-list
65174888|NCT02657161|Immunologic Factors|immunologic factors|mesh-ancestor
65174889|NCT02657161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174890|NCT01139580|Calcipotriene|calcipotriene|mesh-list
65174891|NCT01139580|Dermatologic Agents|dermatologic agents|mesh-ancestor
65174892|NCT04686760|Nitroglycerin|nitroglycerin|mesh-list
65174893|NCT04686760|Vasodilator Agents|vasodilator agents|mesh-ancestor
65174894|NCT04312698|Antihypertensive Agents|antihypertensive agents|mesh-list
65174895|NCT04312698|Hypolipidemic Agents|hypolipidemic agents|mesh-list
65174896|NCT04312698|Antimetabolites|antimetabolites|mesh-ancestor
65174897|NCT04312698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174898|NCT04312698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65174899|NCT04251832|Sodium thiosulfate|sodium thiosulfate|mesh-list
65174900|NCT04251832|Antidotes|antidotes|mesh-ancestor
65174901|NCT04251832|Protective Agents|protective agents|mesh-ancestor
65174902|NCT04251832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174903|NCT04251832|Antioxidants|antioxidants|mesh-ancestor
65174904|NCT04251832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174905|NCT04251832|Antitubercular Agents|antitubercular agents|mesh-ancestor
65174906|NCT04251832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65174907|NCT04251832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65174908|NCT04251832|Chelating Agents|chelating agents|mesh-ancestor
65174909|NCT04251832|Sequestering Agents|sequestering agents|mesh-ancestor
65174910|NCT02656771|Metronidazole|metronidazole|mesh-list
65174911|NCT02656771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65174912|NCT02656771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65174913|NCT02656771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65174914|NCT02656771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65174915|NCT00917644|Atorvastatin|atorvastatin|mesh-list
65174916|NCT00917644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65174917|NCT00917644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65174918|NCT00917644|Antimetabolites|antimetabolites|mesh-ancestor
65324877|NCT00779246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65324878|NCT00779246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65324879|NCT00779246|Disinfectants|disinfectants|mesh-ancestor
65324880|NCT00779246|Dermatologic Agents|dermatologic agents|mesh-ancestor
65324881|NCT02581761|Misoprostol|misoprostol|mesh-list
65324882|NCT02581761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65324883|NCT02581761|Abortifacient Agents|abortifacient agents|mesh-ancestor
65324884|NCT02581761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65324885|NCT02581761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174919|NCT00917644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174920|NCT00917644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65174921|NCT00917644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65174922|NCT00917644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174923|NCT00625170|Haloperidol|haloperidol|mesh-list
65174924|NCT00625170|Olanzapine|olanzapine|mesh-list
65174925|NCT00625170|Haloperidol decanoate|haloperidol decanoate|mesh-list
65174926|NCT00625170|Antiemetics|antiemetics|mesh-ancestor
65174927|NCT00625170|Autonomic Agents|autonomic agents|mesh-ancestor
65174928|NCT00625170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65174929|NCT00625170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174930|NCT00625170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65174931|NCT00625170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65174932|NCT00625170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65174933|NCT00625170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65174934|NCT00625170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65174935|NCT00625170|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65174936|NCT00625170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65174942|NCT00625170|Dopamine Agents|dopamine agents|mesh-ancestor
65174943|NCT00625170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65174945|NCT00599755|Carboplatin|carboplatin|mesh-list
65174946|NCT00599755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174947|NCT00599755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65174948|NCT00599755|Antimetabolites|antimetabolites|mesh-ancestor
65174949|NCT00599755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174950|NCT00599755|Antiviral Agents|antiviral agents|mesh-ancestor
65174951|NCT00599755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65174952|NCT00599755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174953|NCT00599755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65174954|NCT00599755|Immunologic Factors|immunologic factors|mesh-ancestor
65174955|NCT00599755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174956|NCT04251364|Acetazolamide|acetazolamide|mesh-list
65174957|NCT04251364|Atorvastatin|atorvastatin|mesh-list
65174958|NCT04251364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65174959|NCT04251364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65174960|NCT04251364|Antimetabolites|antimetabolites|mesh-ancestor
64708457|NCT05453929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174961|NCT04251364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174962|NCT04251364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65174963|NCT04251364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65174964|NCT04251364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174965|NCT04251364|Anticonvulsants|anticonvulsants|mesh-ancestor
65174966|NCT04251364|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65174967|NCT04251364|Diuretics|diuretics|mesh-ancestor
65174968|NCT04251364|Natriuretic Agents|natriuretic agents|mesh-ancestor
65174969|NCT04251364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174970|NCT04811014|Buprenorphine|buprenorphine|mesh-list
65174971|NCT04811014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65174972|NCT04811014|Naloxone|naloxone|mesh-list
65174973|NCT04811014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65174974|NCT04811014|Narcotics|narcotics|mesh-ancestor
65174975|NCT04811014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65174976|NCT04811014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174977|NCT04811014|Analgesics|analgesics|mesh-ancestor
65174978|NCT04811014|Sensory System Agents|sensory system agents|mesh-ancestor
65174979|NCT04811014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65174980|NCT04811014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65324886|NCT02581761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65324887|NCT02581761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65324888|NCT02581761|Oxytocics|oxytocics|mesh-ancestor
65324889|NCT00771758|Oxycodone|oxycodone|mesh-list
65324890|NCT00771758|Tapentadol|tapentadol|mesh-list
65324891|NCT00771758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65324892|NCT00771758|Narcotics|narcotics|mesh-ancestor
65324893|NCT00771758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65324894|NCT00771758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324895|NCT00771758|Analgesics|analgesics|mesh-ancestor
65324896|NCT00771758|Sensory System Agents|sensory system agents|mesh-ancestor
65324897|NCT00771758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324898|NCT00771758|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65324899|NCT00771758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65324900|NCT00771758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64554531|NCT03596957|Natriuretic Agents|natriuretic agents|mesh-ancestor
65174981|NCT02648425|Leucovorin|leucovorin|mesh-list
65174982|NCT02648425|Cisplatin|cisplatin|mesh-list
65174983|NCT02648425|Fluorouracil|fluorouracil|mesh-list
65174984|NCT02648425|Capecitabine|capecitabine|mesh-list
65174985|NCT02648425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174986|NCT02648425|Antimetabolites|antimetabolites|mesh-ancestor
65174987|NCT02648425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174988|NCT02648425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65174989|NCT02648425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65174990|NCT02648425|Immunologic Factors|immunologic factors|mesh-ancestor
65174991|NCT02648425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174992|NCT02648425|Antidotes|antidotes|mesh-ancestor
65174993|NCT02648425|Protective Agents|protective agents|mesh-ancestor
65174994|NCT02648425|Vitamin B Complex|vitamin b complex|mesh-ancestor
65174995|NCT02648425|Vitamins|vitamins|mesh-ancestor
65174996|NCT02648425|Micronutrients|micronutrients|mesh-ancestor
65174997|NCT02648503|Atropine|atropine|mesh-list
65174998|NCT02648503|Rocuronium|rocuronium|mesh-list
65174999|NCT02648503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65175000|NCT02648503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65175001|NCT02648503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65175002|NCT02648503|Autonomic Agents|autonomic agents|mesh-ancestor
65175003|NCT02648503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65175004|NCT02648503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175005|NCT02648503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65175006|NCT02648503|Respiratory System Agents|respiratory system agents|mesh-ancestor
65175011|NCT02648503|Cholinergic Agents|cholinergic agents|mesh-ancestor
65175012|NCT02648503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65175013|NCT02648503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175014|NCT02648503|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65175015|NCT02648503|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65175016|NCT02648503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65175017|NCT05253508|Lidocaine|lidocaine|mesh-list
65175018|NCT05253508|Anesthetics, Local|anesthetics, local|mesh-ancestor
65175019|NCT05253508|Anesthetics|anesthetics|mesh-ancestor
65175020|NCT05253508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65175021|NCT05253508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175022|NCT05253508|Sensory System Agents|sensory system agents|mesh-ancestor
65175023|NCT05253508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65175024|NCT05253508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65175025|NCT05253508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65175026|NCT05253508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65175027|NCT05253508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65175028|NCT05253508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175029|NCT04524130|Lidocaine|lidocaine|mesh-list
65324901|NCT00771758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324902|NCT00771758|Adrenergic Agents|adrenergic agents|mesh-ancestor
65324903|NCT00771758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65324904|NCT02581371|Cerebrolysin|cerebrolysin|mesh-list
65324905|NCT02581371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65324906|NCT02581371|Protective Agents|protective agents|mesh-ancestor
65324907|NCT02581371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324908|NCT02581371|Nootropic Agents|nootropic agents|mesh-ancestor
65324909|NCT02688465|Apomorphine|apomorphine|mesh-list
65324910|NCT02688465|Emetics|emetics|mesh-ancestor
65324911|NCT02688465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319661|NCT03536611|Warfarin|warfarin|mesh-list
65175030|NCT04524130|Ketamine|ketamine|mesh-list
65175031|NCT04524130|Anesthetics, Local|anesthetics, local|mesh-ancestor
65175032|NCT04524130|Anesthetics|anesthetics|mesh-ancestor
65175033|NCT04524130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65175034|NCT04524130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175035|NCT04524130|Sensory System Agents|sensory system agents|mesh-ancestor
65175036|NCT04524130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65175037|NCT04524130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65175038|NCT04524130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65175039|NCT04524130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65175040|NCT04524130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65175041|NCT04524130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175042|NCT04524130|Analgesics|analgesics|mesh-ancestor
65175043|NCT04524130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65175044|NCT04524130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65175045|NCT04524130|Anesthetics, General|anesthetics, general|mesh-ancestor
65175046|NCT04524130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65175047|NCT04524130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65175048|NCT04524130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65175049|NCT00649831|Amoxicillin|amoxicillin|mesh-list
65175050|NCT00649831|Azithromycin|azithromycin|mesh-list
65175051|NCT00649831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65175052|NCT00649831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65175054|NCT03969901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65175055|NCT03969901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175056|NCT03969901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175057|NCT03969901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65175058|NCT03969901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65175059|NCT02648659|Amoxicillin|amoxicillin|mesh-list
65175060|NCT02648659|Metronidazole|metronidazole|mesh-list
65175061|NCT02648659|Clarithromycin|clarithromycin|mesh-list
65175062|NCT02648659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65175063|NCT02648659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65175064|NCT02648659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65175065|NCT02648659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65175066|NCT02648659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65175067|NCT02648659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175068|NCT02648659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175069|NCT02648659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65175070|NCT02648659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65175071|NCT01125930|Tretinoin|tretinoin|mesh-list
65175072|NCT01125930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175073|NCT01125930|Keratolytic Agents|keratolytic agents|mesh-ancestor
65175074|NCT01125930|Dermatologic Agents|dermatologic agents|mesh-ancestor
65175075|NCT02656615|Abiraterone Acetate|abiraterone acetate|mesh-list
65175076|NCT02656615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175077|NCT02656615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65175079|NCT02656615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175081|NCT02656615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65175082|NCT02656615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324912|NCT02688465|Autonomic Agents|autonomic agents|mesh-ancestor
65324913|NCT02688465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324914|NCT02688465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65324915|NCT02688465|Dopamine Agonists|dopamine agonists|mesh-ancestor
65324916|NCT02688465|Dopamine Agents|dopamine agents|mesh-ancestor
65324917|NCT02688465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65324918|NCT02688465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324919|NCT00758498|Modafinil|modafinil|mesh-list
65175083|NCT02656615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65175084|NCT00651235|Losartan|losartan|mesh-list
65175085|NCT00651235|Propranolol|propranolol|mesh-list
65175086|NCT00651235|Atenolol|atenolol|mesh-list
65175087|NCT00651235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65175088|NCT00651235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65175089|NCT00651235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65175090|NCT00651235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65175091|NCT00651235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175092|NCT00651235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65175093|NCT00651235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65175094|NCT00651235|Adrenergic Agents|adrenergic agents|mesh-ancestor
65175095|NCT00651235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65175096|NCT00651235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175097|NCT00651235|Vasodilator Agents|vasodilator agents|mesh-ancestor
65175098|NCT00651235|Sympatholytics|sympatholytics|mesh-ancestor
65175099|NCT00651235|Autonomic Agents|autonomic agents|mesh-ancestor
65175100|NCT00651235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65175101|NCT00651235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65175102|NCT04806178|BCG Vaccine|bcg vaccine|mesh-list
65175103|NCT04806178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65175104|NCT04806178|Immunologic Factors|immunologic factors|mesh-ancestor
65175105|NCT04806178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175106|NCT04015219|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65175107|NCT04015219|Lifitegrast|lifitegrast|mesh-list
65175108|NCT04015219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65175109|NCT01137474|Dapagliflozin|dapagliflozin|mesh-list
65175110|NCT01137474|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65175111|NCT01137474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175112|NCT01137474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65175113|NCT01137474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175114|NCT04790188|Nootropic Agents|nootropic agents|mesh-list
65175116|NCT01168973|Ramucirumab|ramucirumab|mesh-list
65175117|NCT01168973|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65175118|NCT01168973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175119|NCT01168973|Tubulin Modulators|tubulin modulators|mesh-ancestor
65175120|NCT01168973|Antimitotic Agents|antimitotic agents|mesh-ancestor
65175121|NCT01168973|Mitosis Modulators|mitosis modulators|mesh-ancestor
65175122|NCT01168973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175123|NCT01168973|Immunologic Factors|immunologic factors|mesh-ancestor
65175124|NCT01168973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817686|NCT01497535|Insulin|insulin|mesh-list
65175126|NCT04747912|Dexamethasone acetate|dexamethasone acetate|mesh-list
65175127|NCT04747912|Methotrexate|methotrexate|mesh-list
65175128|NCT04747912|Vincristine|vincristine|mesh-list
65175129|NCT04747912|Dasatinib|dasatinib|mesh-list
65175130|NCT04747912|Ponatinib|ponatinib|mesh-list
65175131|NCT04747912|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65175132|NCT04747912|BB 1101|bb 1101|mesh-list
65175133|NCT04747912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65175134|NCT04747912|Antiemetics|antiemetics|mesh-ancestor
65175135|NCT04747912|Autonomic Agents|autonomic agents|mesh-ancestor
65175136|NCT04747912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65175137|NCT04747912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175138|NCT04747912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65175139|NCT04747912|Glucocorticoids|glucocorticoids|mesh-ancestor
65175140|NCT04747912|Hormones|hormones|mesh-ancestor
65175141|NCT04747912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65175142|NCT04747912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65175143|NCT04747912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65324920|NCT00758498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65324921|NCT00758498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324922|NCT00758498|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65324923|NCT00758498|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65324924|NCT00758498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65324925|NCT00758498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324926|NCT00798161|Metformin|metformin|mesh-list
65175144|NCT04747912|Protease Inhibitors|protease inhibitors|mesh-ancestor
65175145|NCT04747912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175146|NCT04747912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175147|NCT04747912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65175148|NCT04747912|Abortifacient Agents|abortifacient agents|mesh-ancestor
65175149|NCT04747912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65175150|NCT04747912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65175151|NCT04747912|Antimetabolites|antimetabolites|mesh-ancestor
65175162|NCT04747912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65175163|NCT04747912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65175164|NCT04747912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65175165|NCT00631618|Sunitinib|sunitinib|mesh-list
65175166|NCT00631618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175167|NCT00631618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65175168|NCT00631618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65175169|NCT00631618|Growth Substances|growth substances|mesh-ancestor
65175170|NCT00631618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175171|NCT00631618|Growth Inhibitors|growth inhibitors|mesh-ancestor
65175172|NCT00631618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65175173|NCT00631618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175174|NCT00631618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175175|NCT04431778|Ethosuximide|ethosuximide|mesh-list
65175176|NCT04431778|Anticonvulsants|anticonvulsants|mesh-ancestor
65175177|NCT04669132|Olanzapine|olanzapine|mesh-list
65175178|NCT04669132|Antiemetics|antiemetics|mesh-ancestor
65175179|NCT04669132|Autonomic Agents|autonomic agents|mesh-ancestor
65175180|NCT04669132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65175181|NCT04669132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175182|NCT04669132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65175183|NCT04669132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65175184|NCT04669132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64708681|NCT02227368|Ticagrelor|ticagrelor|mesh-list
65175185|NCT04669132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65175187|NCT04669132|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65175188|NCT04669132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65175189|NCT04669132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65175190|NCT04669132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175191|NCT04669132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65175192|NCT04669132|Serotonin Agents|serotonin agents|mesh-ancestor
65175193|NCT01168349|Epoetin Alfa|epoetin alfa|mesh-list
65175194|NCT01168349|Hematinics|hematinics|mesh-ancestor
65175195|NCT00915772|Metformin|metformin|mesh-list
65175196|NCT00915772|Linagliptin|linagliptin|mesh-list
65175197|NCT00915772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65175198|NCT00915772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175199|NCT00915772|Incretins|incretins|mesh-ancestor
65175200|NCT00915772|Hormones|hormones|mesh-ancestor
65175201|NCT00915772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65175202|NCT00915772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65175203|NCT00915772|Protease Inhibitors|protease inhibitors|mesh-ancestor
65175204|NCT00915772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175205|NCT00915772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175206|NCT00632086|Aspirin|aspirin|mesh-list
65175207|NCT00632086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65175208|NCT00632086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65175209|NCT00632086|Analgesics|analgesics|mesh-ancestor
65175210|NCT00632086|Sensory System Agents|sensory system agents|mesh-ancestor
65175211|NCT00632086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65175212|NCT00632086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324927|NCT00798161|Linagliptin|linagliptin|mesh-list
65324928|NCT00798161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65324929|NCT00798161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324930|NCT00798161|Incretins|incretins|mesh-ancestor
65324931|NCT00798161|Hormones|hormones|mesh-ancestor
65324932|NCT00798161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65324933|NCT00798161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65324934|NCT00798161|Protease Inhibitors|protease inhibitors|mesh-ancestor
65324935|NCT00798161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65324936|NCT00798161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324937|NCT02581683|Magnesium Sulfate|magnesium sulfate|mesh-list
65324938|NCT02581683|Ropivacaine|ropivacaine|mesh-list
65324939|NCT02581683|Anesthetics, Local|anesthetics, local|mesh-ancestor
65324940|NCT02581683|Anesthetics|anesthetics|mesh-ancestor
65175213|NCT00632086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65175214|NCT00632086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65175215|NCT00632086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65175216|NCT00632086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65175218|NCT00632086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65175219|NCT00632086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65175220|NCT00632086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175221|NCT00632086|Antipyretics|antipyretics|mesh-ancestor
65175222|NCT03848845|Pembrolizumab|pembrolizumab|mesh-list
65175223|NCT03848845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65175224|NCT03848845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175225|NCT00912964|Mirabegron|mirabegron|mesh-list
65175226|NCT00912964|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65175227|NCT00912964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65175228|NCT00912964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65175229|NCT00912964|Adrenergic Agents|adrenergic agents|mesh-ancestor
65175230|NCT00912964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65175231|NCT00912964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175232|NCT00912964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175233|NCT00912964|Urological Agents|urological agents|mesh-ancestor
65175234|NCT02641639|Fosbretabulin|fosbretabulin|mesh-list
65175235|NCT02641639|Combretastatin|combretastatin|mesh-list
65175236|NCT02641639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65175237|NCT02641639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175238|NCT02641639|Tubulin Modulators|tubulin modulators|mesh-ancestor
65175239|NCT02641639|Antimitotic Agents|antimitotic agents|mesh-ancestor
65175240|NCT02641639|Mitosis Modulators|mitosis modulators|mesh-ancestor
65175241|NCT02641639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175242|NCT02647567|Caffeine|caffeine|mesh-list
65175243|NCT02647567|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65175244|NCT02647567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175245|NCT02647567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65175246|NCT02647567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175247|NCT02647567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175248|NCT02647567|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65175249|NCT02647567|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65175250|NCT02647567|Purinergic Agents|purinergic agents|mesh-ancestor
65175251|NCT02647567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65175252|NCT02647489|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65175253|NCT02647489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65175254|NCT02647489|Immunologic Factors|immunologic factors|mesh-ancestor
65175255|NCT02647489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175256|NCT02647489|Antacids|antacids|mesh-ancestor
64708755|NCT05057689|Fentanyl|fentanyl|mesh-list
65175257|NCT02647489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175259|NCT04577716|Listerine|listerine|mesh-list
65175260|NCT04577716|Fluorides|fluorides|mesh-list
64554582|NCT03595397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65324941|NCT02581683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65324942|NCT02581683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324943|NCT02581683|Sensory System Agents|sensory system agents|mesh-ancestor
65324944|NCT02581683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324945|NCT02581683|Analgesics|analgesics|mesh-ancestor
65324946|NCT02581683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65324947|NCT02581683|Anticonvulsants|anticonvulsants|mesh-ancestor
65324948|NCT02581683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65324949|NCT02581683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65324950|NCT02581683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324951|NCT02581683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65175261|NCT04577716|Sodium Fluoride|sodium fluoride|mesh-list
65175262|NCT04577716|Cariostatic Agents|cariostatic agents|mesh-ancestor
65175263|NCT04577716|Protective Agents|protective agents|mesh-ancestor
65175264|NCT04577716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175265|NCT04577716|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65175266|NCT04577716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65175267|NCT00910897|Thalidomide|thalidomide|mesh-list
65175268|NCT00910897|Dexamethasone|dexamethasone|mesh-list
65175269|NCT00910897|Dexamethasone acetate|dexamethasone acetate|mesh-list
65175270|NCT00910897|Bortezomib|bortezomib|mesh-list
65175271|NCT00910897|BB 1101|bb 1101|mesh-list
65175272|NCT00910897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65175273|NCT00910897|Antiemetics|antiemetics|mesh-ancestor
65175274|NCT00910897|Autonomic Agents|autonomic agents|mesh-ancestor
65175275|NCT00910897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65175276|NCT00910897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175277|NCT00910897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65175278|NCT00910897|Glucocorticoids|glucocorticoids|mesh-ancestor
65175280|NCT00910897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65175281|NCT00910897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65175282|NCT00910897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175283|NCT00910897|Protease Inhibitors|protease inhibitors|mesh-ancestor
65175284|NCT00910897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175285|NCT00910897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175286|NCT00910897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65175287|NCT00910897|Immunologic Factors|immunologic factors|mesh-ancestor
65175288|NCT00910897|Leprostatic Agents|leprostatic agents|mesh-ancestor
65175289|NCT00910897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65175290|NCT00910897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65175291|NCT00910897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65175301|NCT00651547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175302|NCT00651547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65175303|NCT00651547|Respiratory System Agents|respiratory system agents|mesh-ancestor
65175304|NCT00651547|Glucocorticoids|glucocorticoids|mesh-ancestor
65175305|NCT00651547|Hormones|hormones|mesh-ancestor
65175306|NCT00651547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65175307|NCT00651547|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65175308|NCT00651547|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65175309|NCT00651547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65175310|NCT00651547|Adrenergic Agents|adrenergic agents|mesh-ancestor
65175311|NCT00651547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65175312|NCT00651547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175313|NCT00912808|Donepezil|donepezil|mesh-list
65175314|NCT00912808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65175315|NCT00912808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175316|NCT00912808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175317|NCT00912808|Cholinergic Agents|cholinergic agents|mesh-ancestor
65175318|NCT00912808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65324952|NCT02581683|Tocolytic Agents|tocolytic agents|mesh-ancestor
65324953|NCT02581683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65324954|NCT04170855|Furosemide|furosemide|mesh-list
65324955|NCT04170855|Diuretics|diuretics|mesh-ancestor
65324956|NCT04170855|Natriuretic Agents|natriuretic agents|mesh-ancestor
65324957|NCT04170855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324958|NCT04170855|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65324959|NCT04170855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65324960|NCT04170855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324961|NCT04076709|Anesthetics|anesthetics|mesh-list
65324962|NCT04076709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65324963|NCT04076709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324964|NCT00638781|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
65324965|NCT00638781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65324966|NCT00638781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65324967|NCT00638781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65324968|NCT04115423|Adalimumab|adalimumab|mesh-list
65324969|NCT04115423|Etanercept|etanercept|mesh-list
65324970|NCT04115423|Golimumab|golimumab|mesh-list
65324971|NCT04115423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
65324972|NCT04115423|Infliximab|infliximab|mesh-list
65175319|NCT00912808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175320|NCT00912808|Nootropic Agents|nootropic agents|mesh-ancestor
65175321|NCT02647255|Methylprednisolone|methylprednisolone|mesh-list
65175322|NCT02647255|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65175323|NCT02647255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65175324|NCT02647255|Prednisolone|prednisolone|mesh-list
65175325|NCT02647255|Prednisolone acetate|prednisolone acetate|mesh-list
65175326|NCT02647255|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65175327|NCT02647255|Prednisolone phosphate|prednisolone phosphate|mesh-list
65175328|NCT02647255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65175329|NCT02647255|Antiemetics|antiemetics|mesh-ancestor
65175330|NCT02647255|Autonomic Agents|autonomic agents|mesh-ancestor
65175331|NCT02647255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65175332|NCT02647255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175333|NCT02647255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65175334|NCT02647255|Glucocorticoids|glucocorticoids|mesh-ancestor
65175335|NCT02647255|Hormones|hormones|mesh-ancestor
65175336|NCT02647255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65175337|NCT02647255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65175338|NCT02647255|Protective Agents|protective agents|mesh-ancestor
65175339|NCT02647255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65175340|NCT02647255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175341|NCT04329442|Tenofovir|tenofovir|mesh-list
65175342|NCT04329442|Emtricitabine|emtricitabine|mesh-list
65175343|NCT04329442|Antiviral Agents|antiviral agents|mesh-ancestor
65175344|NCT04329442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65175345|NCT04329442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65175346|NCT04329442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65175347|NCT04329442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175348|NCT04329442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175349|NCT04329442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65324973|NCT04115423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65324974|NCT04115423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65324975|NCT04115423|Dermatologic Agents|dermatologic agents|mesh-ancestor
65324976|NCT04115423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65324977|NCT04115423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65324978|NCT04115423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65324979|NCT04115423|Analgesics|analgesics|mesh-ancestor
65324980|NCT04115423|Sensory System Agents|sensory system agents|mesh-ancestor
65324981|NCT04115423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65324982|NCT04115423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65324983|NCT04115423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65324984|NCT04115423|Immunologic Factors|immunologic factors|mesh-ancestor
65324985|NCT04266249|Paclitaxel|paclitaxel|mesh-list
65324986|NCT04266249|Maytansine|maytansine|mesh-list
65175350|NCT04329442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65175351|NCT04414228|Anesthetics|anesthetics|mesh-list
65175352|NCT04414228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65175353|NCT04414228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175354|NCT02641093|Pembrolizumab|pembrolizumab|mesh-list
65175355|NCT02641093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175356|NCT02641093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65175357|NCT00960531|Saponin QA-21V1|saponin qa-21v1|mesh-list
65175363|NCT04407754|Vitamins|vitamins|mesh-ancestor
65175364|NCT04407754|Micronutrients|micronutrients|mesh-ancestor
65175365|NCT04407754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175366|NCT03017833|Metformin|metformin|mesh-list
65175367|NCT03017833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65175368|NCT03017833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175369|NCT02859909|Immunoglobulins|immunoglobulins|mesh-list
65175370|NCT02859909|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65175371|NCT02859909|Immunologic Factors|immunologic factors|mesh-ancestor
65175372|NCT02859909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175373|NCT00652639|Clonazepam|clonazepam|mesh-list
65175374|NCT00652639|Anticonvulsants|anticonvulsants|mesh-ancestor
65175375|NCT00652639|GABA Modulators|gaba modulators|mesh-ancestor
65175376|NCT00652639|GABA Agents|gaba agents|mesh-ancestor
65175377|NCT00652639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65175378|NCT00652639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175379|NCT00652639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175380|NCT04117672|Antisecretory factor|antisecretory factor|mesh-list
65175381|NCT04117672|Antidiarrheals|antidiarrheals|mesh-ancestor
65175382|NCT04117672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65175383|NCT02644915|Edaravone|edaravone|mesh-list
65175384|NCT02644915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65175385|NCT02644915|Antioxidants|antioxidants|mesh-ancestor
65175386|NCT02644915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175387|NCT02644915|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65175388|NCT02644915|Protective Agents|protective agents|mesh-ancestor
65175389|NCT02644915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175390|NCT00651703|Imiquimod|imiquimod|mesh-list
65175391|NCT00651703|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65175392|NCT00651703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65175393|NCT00651703|Immunologic Factors|immunologic factors|mesh-ancestor
65175394|NCT00651703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175395|NCT00651703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175396|NCT00651703|Interferon Inducers|interferon inducers|mesh-ancestor
65175397|NCT02964585|Canagliflozin|canagliflozin|mesh-list
65175398|NCT02964585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65175399|NCT02964585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175400|NCT02964585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65175401|NCT02964585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175402|NCT02640703|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65175403|NCT02640703|Immunologic Factors|immunologic factors|mesh-ancestor
65324987|NCT04266249|Docetaxel|docetaxel|mesh-list
65324988|NCT04266249|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65324989|NCT04266249|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65324990|NCT04266249|Trastuzumab|trastuzumab|mesh-list
65324991|NCT04266249|Pertuzumab|pertuzumab|mesh-list
65324992|NCT04266249|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
65324993|NCT04266249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65324994|NCT04266249|Antibodies|antibodies|mesh-list
65324995|NCT04266249|Immunoglobulins|immunoglobulins|mesh-list
65324996|NCT04266249|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65324997|NCT04266249|Immunoconjugates|immunoconjugates|mesh-list
65324998|NCT04266249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65324999|NCT04266249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325000|NCT04266249|Tubulin Modulators|tubulin modulators|mesh-ancestor
65325001|NCT04266249|Antimitotic Agents|antimitotic agents|mesh-ancestor
65325002|NCT04266249|Mitosis Modulators|mitosis modulators|mesh-ancestor
65175404|NCT02640703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175405|NCT00651781|Bortezomib|bortezomib|mesh-list
65175406|NCT00651781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175407|NCT00957801|Methylprednisolone|methylprednisolone|mesh-list
65175408|NCT00957801|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65175409|NCT00957801|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65175410|NCT00957801|Prednisolone|prednisolone|mesh-list
65175411|NCT00957801|Prednisolone acetate|prednisolone acetate|mesh-list
65175412|NCT00957801|Methyltestosterone|methyltestosterone|mesh-list
65175413|NCT00957801|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65175414|NCT00957801|Prednisolone phosphate|prednisolone phosphate|mesh-list
65175415|NCT00957801|Testosterone|testosterone|mesh-list
65175416|NCT00957801|Testosterone undecanoate|testosterone undecanoate|mesh-list
65175417|NCT00957801|Testosterone enanthate|testosterone enanthate|mesh-list
65175418|NCT00957801|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65175419|NCT00957801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65175420|NCT00957801|Antiemetics|antiemetics|mesh-ancestor
65175421|NCT00957801|Autonomic Agents|autonomic agents|mesh-ancestor
65175422|NCT00957801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65175423|NCT00957801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175424|NCT00957801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65175425|NCT00957801|Glucocorticoids|glucocorticoids|mesh-ancestor
64817970|NCT01499485|Acetazolamide|acetazolamide|mesh-list
65175426|NCT00957801|Hormones|hormones|mesh-ancestor
65175427|NCT00957801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65175428|NCT00957801|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65175435|NCT02640469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65175436|NCT02640469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65175437|NCT02640469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65175438|NCT02640469|Disinfectants|disinfectants|mesh-ancestor
65175439|NCT02640469|Dermatologic Agents|dermatologic agents|mesh-ancestor
65175440|NCT02646709|Ketamine|ketamine|mesh-list
65175441|NCT02646709|Rocuronium|rocuronium|mesh-list
65175442|NCT02646709|Analgesics|analgesics|mesh-ancestor
65175443|NCT02646709|Sensory System Agents|sensory system agents|mesh-ancestor
65175444|NCT02646709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65175445|NCT02646709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175446|NCT02646709|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65175447|NCT02646709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65175448|NCT02646709|Anesthetics, General|anesthetics, general|mesh-ancestor
65175449|NCT02646709|Anesthetics|anesthetics|mesh-ancestor
65175450|NCT02646709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65175451|NCT02646709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65175452|NCT02646709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65175453|NCT02646709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65175454|NCT02646709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325003|NCT04266249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325004|NCT04266249|Immunologic Factors|immunologic factors|mesh-ancestor
65325005|NCT04266249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325006|NCT04113005|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65325007|NCT04113005|Hemostatics|hemostatics|mesh-ancestor
65325008|NCT04113005|Coagulants|coagulants|mesh-ancestor
65325009|NCT04113005|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65325010|NCT04113005|Natriuretic Agents|natriuretic agents|mesh-ancestor
65325011|NCT04113005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325012|NCT00588341|Temozolomide|temozolomide|mesh-list
65325013|NCT00588341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65325014|NCT00588341|Alkylating Agents|alkylating agents|mesh-ancestor
65325015|NCT00588341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325016|NCT00588341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325017|NCT00914693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65325018|NCT00914693|Gestodene|gestodene|mesh-list
65325019|NCT00914693|Femovan|femovan|mesh-list
65325020|NCT00914693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65325021|NCT00914693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65325022|NCT00914693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65325023|NCT00914693|Contraceptive Agents|contraceptive agents|mesh-ancestor
65175455|NCT02646709|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65175456|NCT02646709|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65175457|NCT02646709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65175458|NCT00651859|Bimatoprost|bimatoprost|mesh-list
65175459|NCT00651859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65175460|NCT00651859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65175461|NCT00651859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65175462|NCT02640313|Choline|choline|mesh-list
65175463|NCT02640313|Lipotropic Agents|lipotropic agents|mesh-ancestor
65175464|NCT02640313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65175465|NCT02640313|Antimetabolites|antimetabolites|mesh-ancestor
65175466|NCT02640313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175467|NCT02640313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65175468|NCT02640313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65175469|NCT02640313|Nootropic Agents|nootropic agents|mesh-ancestor
65175470|NCT02953509|Gemcitabine|gemcitabine|mesh-list
65175471|NCT02953509|Rituximab|rituximab|mesh-list
65175472|NCT02953509|Magrolimab|magrolimab|mesh-list
65175473|NCT02953509|Oxaliplatin|oxaliplatin|mesh-list
65175474|NCT02953509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65175475|NCT02953509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175476|NCT02953509|Immunologic Factors|immunologic factors|mesh-ancestor
65175477|NCT02953509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175478|NCT02953509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65175479|NCT02953509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65175480|NCT02953509|Antimetabolites|antimetabolites|mesh-ancestor
65175481|NCT02953509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175482|NCT02953509|Antiviral Agents|antiviral agents|mesh-ancestor
65175483|NCT02953509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65175484|NCT02953509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175485|NCT02953509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65175486|NCT02955823|Dexamethasone|dexamethasone|mesh-list
65175487|NCT02955823|Rituximab|rituximab|mesh-list
65175488|NCT02955823|Lenalidomide|lenalidomide|mesh-list
65175489|NCT02955823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64554662|NCT00916539|Protease Inhibitors|protease inhibitors|mesh-ancestor
65325024|NCT00914693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65325025|NCT00914693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325026|NCT00914693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65325027|NCT00914693|Estrogens|estrogens|mesh-ancestor
65325028|NCT00914693|Hormones|hormones|mesh-ancestor
65325029|NCT00914693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65325030|NCT00914693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65325031|NCT00914693|Progestins|progestins|mesh-ancestor
65325032|NCT00914693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65175490|NCT02955823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175491|NCT02955823|Immunologic Factors|immunologic factors|mesh-ancestor
65175492|NCT02955823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175493|NCT02955823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65175494|NCT02955823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65175495|NCT02955823|Antiemetics|antiemetics|mesh-ancestor
65175496|NCT02955823|Autonomic Agents|autonomic agents|mesh-ancestor
65175497|NCT02955823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65175498|NCT02955823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65175499|NCT02955823|Glucocorticoids|glucocorticoids|mesh-ancestor
65175500|NCT02955823|Hormones|hormones|mesh-ancestor
65175507|NCT02646397|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65175509|NCT02646397|Benidipine|benidipine|mesh-list
65175510|NCT02646397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65175511|NCT02646397|Diuretics|diuretics|mesh-ancestor
65175512|NCT02646397|Natriuretic Agents|natriuretic agents|mesh-ancestor
65175513|NCT02646397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175514|NCT02646397|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65175515|NCT02646397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65175516|NCT02646397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175517|NCT02646397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65175518|NCT02646397|Protease Inhibitors|protease inhibitors|mesh-ancestor
65175519|NCT02646397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175520|NCT02646397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65175521|NCT02646397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65175522|NCT02646397|Vasodilator Agents|vasodilator agents|mesh-ancestor
65175523|NCT00652795|Doxycycline|doxycycline|mesh-list
65175524|NCT00652795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65175525|NCT00652795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65175526|NCT00652795|Antimalarials|antimalarials|mesh-ancestor
65175527|NCT00652795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65175528|NCT00652795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65175529|NCT00911170|Bevacizumab|bevacizumab|mesh-list
65175530|NCT00911170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65175531|NCT00911170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175532|NCT00911170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65175533|NCT00911170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65175534|NCT00911170|Growth Substances|growth substances|mesh-ancestor
65175535|NCT00911170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175536|NCT00911170|Growth Inhibitors|growth inhibitors|mesh-ancestor
65175537|NCT00910975|Interferons|interferons|mesh-list
65175538|NCT00910975|Ribavirin|ribavirin|mesh-list
65175539|NCT00910975|Interferon-alpha|interferon-alpha|mesh-list
65175540|NCT00910975|Interferon alpha-2|interferon alpha-2|mesh-list
65175541|NCT00910975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65175542|NCT00910975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175543|NCT00910975|Antiviral Agents|antiviral agents|mesh-ancestor
65175544|NCT00910975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65175545|NCT00910975|Antimetabolites|antimetabolites|mesh-ancestor
65175546|NCT00910975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175547|NCT00910975|Immunologic Factors|immunologic factors|mesh-ancestor
65175548|NCT00910975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175549|NCT01167881|Glimepiride|glimepiride|mesh-list
65175550|NCT01167881|Empagliflozin|empagliflozin|mesh-list
65175551|NCT01167881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65175552|NCT01167881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65325033|NCT00915083|Amrubicin|amrubicin|mesh-list
65325034|NCT00915083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325035|NCT00802529|Gentamicins|gentamicins|mesh-list
65325036|NCT00802529|Methylprednisolone|methylprednisolone|mesh-list
65325037|NCT00802529|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65325038|NCT00802529|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65325039|NCT00802529|Prednisolone|prednisolone|mesh-list
65325040|NCT00802529|Prednisolone acetate|prednisolone acetate|mesh-list
65325041|NCT00802529|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65325042|NCT00802529|Prednisolone phosphate|prednisolone phosphate|mesh-list
65325043|NCT00802529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65325044|NCT00802529|Antiemetics|antiemetics|mesh-ancestor
65325045|NCT00802529|Autonomic Agents|autonomic agents|mesh-ancestor
65325046|NCT00802529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65325047|NCT00802529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325048|NCT00802529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65325049|NCT00802529|Glucocorticoids|glucocorticoids|mesh-ancestor
65325050|NCT00802529|Hormones|hormones|mesh-ancestor
65066807|NCT00272636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65325051|NCT00802529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65325052|NCT00802529|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65325053|NCT00802529|Protective Agents|protective agents|mesh-ancestor
65325054|NCT00802529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65175553|NCT01167881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175554|NCT01167881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65175555|NCT01167881|Immunologic Factors|immunologic factors|mesh-ancestor
65175556|NCT01167881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65175557|NCT01167881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175558|NCT02646085|Carbon-11 methionine|carbon-11 methionine|mesh-list
65175559|NCT02646085|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65175560|NCT02646085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175562|NCT02639767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175563|NCT02639767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175564|NCT02639767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175565|NCT02639767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65175566|NCT02639767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65175572|NCT04829344|Sensory System Agents|sensory system agents|mesh-ancestor
65175573|NCT04829344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65175574|NCT00960063|Cyclophosphamide|cyclophosphamide|mesh-list
65175575|NCT00960063|Temozolomide|temozolomide|mesh-list
65175576|NCT00960063|Ifosfamide|ifosfamide|mesh-list
65175577|NCT00960063|Doxorubicin|doxorubicin|mesh-list
65175578|NCT00960063|Irinotecan|irinotecan|mesh-list
65175579|NCT00960063|Etoposide|etoposide|mesh-list
65175580|NCT00960063|Vincristine|vincristine|mesh-list
65175581|NCT00960063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65175582|NCT00960063|Immunologic Factors|immunologic factors|mesh-ancestor
65175583|NCT00960063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175584|NCT00960063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65175585|NCT00960063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65175586|NCT00960063|Alkylating Agents|alkylating agents|mesh-ancestor
65175587|NCT00960063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325055|NCT00802529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325056|NCT00802529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65325057|NCT00802529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65325058|NCT00802529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65325059|NCT00802529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325060|NCT00802529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325061|NCT02605811|Temozolomide|temozolomide|mesh-list
65325062|NCT02605811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65325063|NCT02605811|Alkylating Agents|alkylating agents|mesh-ancestor
65325064|NCT02605811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325065|NCT02605811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325066|NCT00758264|Vaccines|vaccines|mesh-list
64554694|NCT03830385|Carboplatin|carboplatin|mesh-list
65175588|NCT00960063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175589|NCT00960063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65175590|NCT00960063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65175591|NCT00960063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65175592|NCT00960063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65175593|NCT00960063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175594|NCT00960063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65175595|NCT00960063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65175596|NCT00960063|Tubulin Modulators|tubulin modulators|mesh-ancestor
65175597|NCT00960063|Antimitotic Agents|antimitotic agents|mesh-ancestor
65175598|NCT00960063|Mitosis Modulators|mitosis modulators|mesh-ancestor
65175599|NCT02646319|Sirolimus|sirolimus|mesh-list
65175600|NCT02646319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65175601|NCT02646319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65175602|NCT02646319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65175603|NCT02646319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175604|NCT02646319|Antifungal Agents|antifungal agents|mesh-ancestor
65175605|NCT02646319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65175606|NCT02646319|Immunologic Factors|immunologic factors|mesh-ancestor
65175607|NCT02646319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175608|NCT00653965|Atorvastatin|atorvastatin|mesh-list
65175609|NCT00653965|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65175610|NCT00653965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65175611|NCT00653965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65175612|NCT00653965|Antimetabolites|antimetabolites|mesh-ancestor
65175613|NCT00653965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175614|NCT00653965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65175615|NCT00653965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65175616|NCT00653965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175617|NCT00959907|Botulinum Toxins|botulinum toxins|mesh-list
65175618|NCT00959907|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65175619|NCT00959907|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65175620|NCT00959907|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65175621|NCT00959907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65175622|NCT00959907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65175623|NCT00959907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175624|NCT00959907|Cholinergic Agents|cholinergic agents|mesh-ancestor
65175625|NCT00959907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65175626|NCT00959907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175627|NCT00959907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65175628|NCT00959907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65175629|NCT00912340|Trastuzumab|trastuzumab|mesh-list
65175630|NCT00912340|Everolimus|everolimus|mesh-list
65175631|NCT00912340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65175632|NCT00912340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175633|NCT00912340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65175634|NCT00912340|Immunologic Factors|immunologic factors|mesh-ancestor
65175635|NCT00912340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325067|NCT00758264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65325068|NCT00758264|Immunologic Factors|immunologic factors|mesh-ancestor
65325069|NCT00758264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325070|NCT05670743|Fluorides|fluorides|mesh-list
65325071|NCT05670743|Cariostatic Agents|cariostatic agents|mesh-ancestor
65325072|NCT05670743|Protective Agents|protective agents|mesh-ancestor
65325073|NCT05670743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325074|NCT04027517|Darbepoetin alfa|darbepoetin alfa|mesh-list
65325075|NCT04027517|Hematinics|hematinics|mesh-ancestor
65325076|NCT00588731|Cannabidiol|cannabidiol|mesh-list
65325077|NCT00588731|Anticonvulsants|anticonvulsants|mesh-ancestor
65325078|NCT04111367|Sofosbuvir|sofosbuvir|mesh-list
65325079|NCT04111367|Antiviral Agents|antiviral agents|mesh-ancestor
65325080|NCT04111367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65175636|NCT01167257|Botulinum Toxins|botulinum toxins|mesh-list
65175637|NCT01167257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65175645|NCT01167257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65175646|NCT01167257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65175647|NCT01119846|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65175648|NCT01119846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65175649|NCT01119846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175651|NCT01119846|Hormones|hormones|mesh-ancestor
65175652|NCT01119846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65175653|NCT01119846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65175654|NCT01119846|Protease Inhibitors|protease inhibitors|mesh-ancestor
65175655|NCT01119846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175656|NCT01119846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175657|NCT03775525|Capecitabine|capecitabine|mesh-list
65175658|NCT03775525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65175659|NCT03775525|Antimetabolites|antimetabolites|mesh-ancestor
65175660|NCT03775525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175661|NCT03775525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175663|NCT00654043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65175664|NCT00654043|Diuretics|diuretics|mesh-ancestor
65175665|NCT00654043|Natriuretic Agents|natriuretic agents|mesh-ancestor
65175666|NCT00654043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175667|NCT00654043|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65175668|NCT00654043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65175669|NCT00654043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175670|NCT04167007|Gemcitabine|gemcitabine|mesh-list
65175671|NCT04167007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65175672|NCT04167007|Antimetabolites|antimetabolites|mesh-ancestor
65175673|NCT04167007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175674|NCT04167007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175675|NCT04167007|Antiviral Agents|antiviral agents|mesh-ancestor
65175676|NCT04167007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65175677|NCT04167007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175678|NCT04167007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65175679|NCT04167007|Immunologic Factors|immunologic factors|mesh-ancestor
65175680|NCT04167007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175681|NCT03686332|Atezolizumab|atezolizumab|mesh-list
65175682|NCT03686332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65175683|NCT03686332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175684|NCT03686332|Immunologic Factors|immunologic factors|mesh-ancestor
65175685|NCT03686332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175686|NCT01167023|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65175687|NCT01167023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65175688|NCT00654121|Insulin|insulin|mesh-list
65175689|NCT00654121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65175690|NCT00654121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65175691|NCT00654121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175692|NCT03421288|Leucovorin|leucovorin|mesh-list
65325081|NCT05629949|Docetaxel|docetaxel|mesh-list
65325082|NCT05629949|Trastuzumab|trastuzumab|mesh-list
65325083|NCT05629949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325084|NCT05629949|Tubulin Modulators|tubulin modulators|mesh-ancestor
65325085|NCT05629949|Antimitotic Agents|antimitotic agents|mesh-ancestor
65325086|NCT05629949|Mitosis Modulators|mitosis modulators|mesh-ancestor
65325087|NCT05629949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554724|NCT03591575|Deferiprone|deferiprone|mesh-list
65175693|NCT03421288|Docetaxel|docetaxel|mesh-list
65175694|NCT03421288|Fluorouracil|fluorouracil|mesh-list
65175695|NCT03421288|Oxaliplatin|oxaliplatin|mesh-list
65175696|NCT03421288|Atezolizumab|atezolizumab|mesh-list
65175697|NCT03421288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175698|NCT03421288|Tubulin Modulators|tubulin modulators|mesh-ancestor
65175699|NCT03421288|Antimitotic Agents|antimitotic agents|mesh-ancestor
65175700|NCT03421288|Mitosis Modulators|mitosis modulators|mesh-ancestor
65175701|NCT03421288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175702|NCT03421288|Antimetabolites|antimetabolites|mesh-ancestor
65175703|NCT03421288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65175704|NCT03421288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65175705|NCT03421288|Immunologic Factors|immunologic factors|mesh-ancestor
65175710|NCT03421288|Vitamins|vitamins|mesh-ancestor
65175711|NCT03421288|Micronutrients|micronutrients|mesh-ancestor
65175712|NCT01166945|Amoxicillin|amoxicillin|mesh-list
65175713|NCT01166945|Clavulanic Acid|clavulanic acid|mesh-list
65175714|NCT01166945|Clavulanic Acids|clavulanic acids|mesh-list
65175715|NCT01166945|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65175716|NCT01166945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65175717|NCT01166945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65175718|NCT01166945|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65175719|NCT01166945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175720|NCT01166945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175721|NCT02639533|Pregabalin|pregabalin|mesh-list
65175722|NCT02639533|Analgesics|analgesics|mesh-ancestor
65175723|NCT02639533|Sensory System Agents|sensory system agents|mesh-ancestor
65175724|NCT02639533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65175725|NCT02639533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175726|NCT02639533|Anticonvulsants|anticonvulsants|mesh-ancestor
65175727|NCT02639533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64818302|NCT01501136|Mesna|mesna|mesh-list
65175728|NCT02639533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65175729|NCT02639533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175730|NCT02639533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65175731|NCT02639533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65175732|NCT02639533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65175733|NCT02639533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65175734|NCT02639533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65175735|NCT02639377|Chlorhexidine|chlorhexidine|mesh-list
65175736|NCT02639377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65175737|NCT02639377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65175738|NCT02639377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65175739|NCT02639377|Disinfectants|disinfectants|mesh-ancestor
65175740|NCT02639377|Dermatologic Agents|dermatologic agents|mesh-ancestor
65175741|NCT00910000|Gemcitabine|gemcitabine|mesh-list
65175742|NCT00910000|Carboplatin|carboplatin|mesh-list
65175743|NCT00910000|Vorinostat|vorinostat|mesh-list
65175744|NCT00910000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175745|NCT00910000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65175746|NCT00910000|Antimetabolites|antimetabolites|mesh-ancestor
65175747|NCT00910000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175748|NCT00910000|Antiviral Agents|antiviral agents|mesh-ancestor
65175749|NCT00910000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65175750|NCT00910000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175751|NCT00910000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65175752|NCT00910000|Immunologic Factors|immunologic factors|mesh-ancestor
65175753|NCT00910000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175754|NCT00910000|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65175755|NCT02885909|Insulin|insulin|mesh-list
65175756|NCT02885909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65175757|NCT02885909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325088|NCT05629949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65325089|NCT05628233|Azasetron|azasetron|mesh-list
65325090|NCT05628233|Antiemetics|antiemetics|mesh-ancestor
65325091|NCT05628233|Autonomic Agents|autonomic agents|mesh-ancestor
65325092|NCT05628233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65175758|NCT05657171|Cyproterone Acetate|cyproterone acetate|mesh-list
65175759|NCT05657171|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65175760|NCT05657171|Estradiol|estradiol|mesh-list
65175761|NCT05657171|Cyproterone|cyproterone|mesh-list
65175762|NCT05657171|Estrogens|estrogens|mesh-ancestor
65175763|NCT05657171|Hormones|hormones|mesh-ancestor
65175764|NCT05657171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65175765|NCT05657171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175766|NCT05657171|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65175767|NCT05657171|Contraceptive Agents|contraceptive agents|mesh-ancestor
65175768|NCT05657171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65175769|NCT05657171|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65175770|NCT05657171|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65175771|NCT05657171|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65175772|NCT05657171|Androgen Antagonists|androgen antagonists|mesh-ancestor
65175773|NCT05657171|Hormone Antagonists|hormone antagonists|mesh-ancestor
65175774|NCT05657171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175775|NCT05657171|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65175776|NCT00652873|Cabergoline|cabergoline|mesh-list
65175777|NCT00652873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65175782|NCT00652873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175783|NCT00652873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175785|NCT00652171|Anticonvulsants|anticonvulsants|mesh-ancestor
65175786|NCT00652171|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65175787|NCT00652171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65175788|NCT00652171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175789|NCT00652171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65175790|NCT00652171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175791|NCT00652171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65175792|NCT00652171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65175793|NCT00652171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65175794|NCT00652171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65175795|NCT00652171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65175796|NCT01119768|Esomeprazole|esomeprazole|mesh-list
65175797|NCT01119768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65175798|NCT01119768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65175799|NCT01119768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65175800|NCT01119768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175801|NCT01119768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175802|NCT01165307|Naproxen|naproxen|mesh-list
65175804|NCT01165307|Contraceptive Agents|contraceptive agents|mesh-list
65175805|NCT01165307|Contraceptives, Oral|contraceptives, oral|mesh-list
65175806|NCT01165307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65175807|NCT01165307|Estradiol|estradiol|mesh-list
65175808|NCT01165307|Estrogens|estrogens|mesh-ancestor
65175809|NCT01165307|Hormones|hormones|mesh-ancestor
65175810|NCT01165307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65175811|NCT01165307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175812|NCT01165307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65175813|NCT01165307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65175814|NCT01165307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65175815|NCT01165307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65175816|NCT01165307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65175817|NCT01165307|Analgesics|analgesics|mesh-ancestor
65175818|NCT01165307|Sensory System Agents|sensory system agents|mesh-ancestor
65175819|NCT01165307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65175820|NCT01165307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65175821|NCT01165307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65175822|NCT01165307|Gout Suppressants|gout suppressants|mesh-ancestor
65175823|NCT01165307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65175824|NCT01165307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175825|NCT01165307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175826|NCT01165307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65175827|NCT02639143|Clopidogrel|clopidogrel|mesh-list
65175828|NCT02639143|Ticagrelor|ticagrelor|mesh-list
65325093|NCT05628233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325094|NCT05628233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65325095|NCT05628233|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65325096|NCT05628233|Serotonin Agents|serotonin agents|mesh-ancestor
65325097|NCT05628233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65325098|NCT05628233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325099|NCT04109261|Palbociclib|palbociclib|mesh-list
65325100|NCT04109261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325101|NCT04109261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65325102|NCT04109261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325103|NCT04109261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325104|NCT04109339|Oxytocin|oxytocin|mesh-list
65175829|NCT02639143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65175830|NCT02639143|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65175831|NCT02639143|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65175832|NCT02639143|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65175833|NCT02639143|Purinergic Agents|purinergic agents|mesh-ancestor
65175834|NCT02639143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65175835|NCT02639143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175836|NCT02639143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175837|NCT02644057|Dobutamine|dobutamine|mesh-list
65175838|NCT02644057|Milrinone|milrinone|mesh-list
65175839|NCT02644057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65175840|NCT02644057|Sympathomimetics|sympathomimetics|mesh-ancestor
65175841|NCT02644057|Autonomic Agents|autonomic agents|mesh-ancestor
65175842|NCT02644057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65175843|NCT02644057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175844|NCT02644057|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65175845|NCT02644057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65175846|NCT02644057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65175847|NCT02644057|Adrenergic Agents|adrenergic agents|mesh-ancestor
65175852|NCT02644057|Vasodilator Agents|vasodilator agents|mesh-ancestor
65175853|NCT02644057|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65175854|NCT02644057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65175855|NCT02644057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175856|NCT00654277|Ondansetron|ondansetron|mesh-list
65175857|NCT00654277|Antiemetics|antiemetics|mesh-ancestor
65175858|NCT00654277|Autonomic Agents|autonomic agents|mesh-ancestor
65175859|NCT00654277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65175860|NCT00654277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175862|NCT00654277|Antipruritics|antipruritics|mesh-ancestor
65175863|NCT00654277|Dermatologic Agents|dermatologic agents|mesh-ancestor
65175864|NCT00654277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65175865|NCT00654277|Serotonin Agents|serotonin agents|mesh-ancestor
65175866|NCT00654277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65175867|NCT00654277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175868|NCT00654277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65175869|NCT00654277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65175870|NCT00654277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65175871|NCT00654277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65175872|NCT00654277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65175873|NCT01124838|Prednisone|prednisone|mesh-list
65175874|NCT01124838|Adalimumab|adalimumab|mesh-list
65175875|NCT01124838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65175876|NCT01124838|Glucocorticoids|glucocorticoids|mesh-ancestor
65175877|NCT01124838|Hormones|hormones|mesh-ancestor
65175878|NCT01124838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65175879|NCT01124838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175880|NCT01124838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65175881|NCT01124838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175882|NCT01124838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65175883|NCT00630435|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65325105|NCT04109339|Oxytocics|oxytocics|mesh-ancestor
65325106|NCT04109339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65325107|NCT04109339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325108|NCT00757172|Docetaxel|docetaxel|mesh-list
65325109|NCT00757172|Panitumumab|panitumumab|mesh-list
65325110|NCT00757172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325111|NCT00757172|Tubulin Modulators|tubulin modulators|mesh-ancestor
65325112|NCT00757172|Antimitotic Agents|antimitotic agents|mesh-ancestor
65325113|NCT00757172|Mitosis Modulators|mitosis modulators|mesh-ancestor
65175884|NCT00630435|Estrogens|estrogens|mesh-ancestor
65175885|NCT00630435|Hormones|hormones|mesh-ancestor
65175886|NCT00630435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65175887|NCT00630435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175888|NCT02858193|Carbocysteine|carbocysteine|mesh-list
65175889|NCT02858193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65175890|NCT02858193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65175891|NCT02858193|Expectorants|expectorants|mesh-ancestor
65175892|NCT02858193|Respiratory System Agents|respiratory system agents|mesh-ancestor
65175893|NCT02581215|Ramucirumab|ramucirumab|mesh-list
65175894|NCT02581215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175895|NCT04282941|Ibuprofen|ibuprofen|mesh-list
65175896|NCT04282941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65175897|NCT04282941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65175898|NCT04282941|Analgesics|analgesics|mesh-ancestor
65175899|NCT04282941|Sensory System Agents|sensory system agents|mesh-ancestor
65175900|NCT04282941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65175901|NCT04282941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175902|NCT04282941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65175903|NCT04282941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65175904|NCT04282941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65175905|NCT04282941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175906|NCT04282941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175907|NCT00910858|Lenalidomide|lenalidomide|mesh-list
65175908|NCT00910858|Epoetin Alfa|epoetin alfa|mesh-list
65175909|NCT00910858|Immunologic Factors|immunologic factors|mesh-ancestor
65175910|NCT00910858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175911|NCT00910858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65175912|NCT00910858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65175913|NCT00910858|Growth Substances|growth substances|mesh-ancestor
65175914|NCT00910858|Growth Inhibitors|growth inhibitors|mesh-ancestor
65175915|NCT00910858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175916|NCT00910858|Hematinics|hematinics|mesh-ancestor
65175917|NCT02567253|Cisplatin|cisplatin|mesh-list
65175918|NCT02567253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175919|NCT02859285|Estradiol|estradiol|mesh-list
65175920|NCT02859285|Estrogens|estrogens|mesh-ancestor
65175925|NCT04260412|Cathartics|cathartics|mesh-ancestor
65175926|NCT04260412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65175927|NCT03223155|Nivolumab|nivolumab|mesh-list
65175928|NCT03223155|Ipilimumab|ipilimumab|mesh-list
65175929|NCT03223155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65175930|NCT03223155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175931|NCT03223155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65175932|NCT03223155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175933|NCT04476550|Lenograstim|lenograstim|mesh-list
65175934|NCT04476550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65175935|NCT04476550|Immunologic Factors|immunologic factors|mesh-ancestor
65175936|NCT04476550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175938|NCT00598975|Cetuximab|cetuximab|mesh-list
65175939|NCT00598975|Etirinotecan pegol|etirinotecan pegol|mesh-list
65175940|NCT00598975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65175941|NCT00598975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65175942|NCT00598975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175943|NCT00598975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175944|NCT00598975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175945|NCT00598975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65175946|NCT00598975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65175947|NCT01124604|Tapentadol|tapentadol|mesh-list
65175948|NCT01124604|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65325114|NCT00757172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325115|NCT00757172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65325116|NCT00797225|Leuprolide|leuprolide|mesh-list
65325117|NCT00797225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65325118|NCT00797225|Fertility Agents|fertility agents|mesh-ancestor
65325119|NCT00797225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64554747|NCT03406533|Adrenergic Agents|adrenergic agents|mesh-ancestor
65175949|NCT01124604|Narcotics|narcotics|mesh-ancestor
65175950|NCT01124604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65175951|NCT01124604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175952|NCT01124604|Analgesics|analgesics|mesh-ancestor
65175953|NCT01124604|Sensory System Agents|sensory system agents|mesh-ancestor
65175954|NCT01124604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65175955|NCT01124604|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65175956|NCT01124604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65175957|NCT01124604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65175958|NCT01124604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175959|NCT01124604|Adrenergic Agents|adrenergic agents|mesh-ancestor
65175960|NCT01124604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65175961|NCT00909844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65175962|NCT00909844|Luteolytic Agents|luteolytic agents|mesh-ancestor
65175963|NCT00909844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65175964|NCT00909844|Contraceptive Agents|contraceptive agents|mesh-ancestor
65175965|NCT00909844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65175966|NCT00909844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175967|NCT00909844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65175968|NCT00909844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65175969|NCT00909844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175970|NCT01124448|TFF1 protein, human|tff1 protein, human|mesh-list
65175971|NCT01124448|Growth Inhibitors|growth inhibitors|mesh-ancestor
65175972|NCT01124448|Growth Substances|growth substances|mesh-ancestor
65175973|NCT01124448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175975|NCT02638909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175976|NCT02638909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65175977|NCT02638909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175978|NCT02638909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175979|NCT02643823|Methotrexate|methotrexate|mesh-list
65175980|NCT02643823|Antirheumatic Agents|antirheumatic agents|mesh-list
65175981|NCT02643823|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65175982|NCT02643823|Abortifacient Agents|abortifacient agents|mesh-ancestor
65175983|NCT02643823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65175984|NCT02643823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175985|NCT02643823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65175986|NCT02643823|Antimetabolites|antimetabolites|mesh-ancestor
65175987|NCT02643823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175988|NCT02643823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175989|NCT02643823|Dermatologic Agents|dermatologic agents|mesh-ancestor
65175990|NCT02643823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175991|NCT02643823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65175994|NCT02643823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65175996|NCT02638831|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65175997|NCT02638831|Ketoprofen|ketoprofen|mesh-list
65175998|NCT02638831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65175999|NCT02638831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65176000|NCT02638831|Analgesics|analgesics|mesh-ancestor
65176001|NCT02638831|Sensory System Agents|sensory system agents|mesh-ancestor
65176002|NCT02638831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65176003|NCT02638831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176004|NCT02638831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65176005|NCT02638831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65176006|NCT02638831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65176007|NCT02638831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176008|NCT02638831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176009|NCT01136772|Haloperidol|haloperidol|mesh-list
65176010|NCT01136772|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65325120|NCT00797225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325121|NCT00797225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65325122|NCT00797225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325123|NCT05277285|Sodium thiosulfate|sodium thiosulfate|mesh-list
65325124|NCT05277285|Antidotes|antidotes|mesh-ancestor
65325125|NCT05277285|Protective Agents|protective agents|mesh-ancestor
65325126|NCT05277285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325127|NCT05277285|Antioxidants|antioxidants|mesh-ancestor
65493959|NCT03913559|Hormones|hormones|mesh-ancestor
65325128|NCT05277285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554754|NCT03406533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64554755|NCT03406533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64554756|NCT03406533|GABA Modulators|gaba modulators|mesh-ancestor
65176011|NCT01136772|Haloperidol decanoate|haloperidol decanoate|mesh-list
65176012|NCT01136772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65176013|NCT01136772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65176014|NCT01136772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65176015|NCT01136772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176016|NCT01136772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65176017|NCT01136772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65176018|NCT01136772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65176019|NCT01136772|Serotonin Agents|serotonin agents|mesh-ancestor
65176020|NCT01136772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65176021|NCT01136772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176022|NCT01136772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65176023|NCT01136772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65176024|NCT01136772|Dopamine Agents|dopamine agents|mesh-ancestor
65176025|NCT01136772|Antiemetics|antiemetics|mesh-ancestor
65176026|NCT01136772|Autonomic Agents|autonomic agents|mesh-ancestor
65176027|NCT01136772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65176028|NCT01136772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65176029|NCT01136772|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65176031|NCT00909532|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65176032|NCT00909532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65176033|NCT00909532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176034|NCT02756845|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
65176035|NCT02756845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65176036|NCT02756845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176037|NCT01136382|Budesonide|budesonide|mesh-list
65176038|NCT01136382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65176039|NCT01136382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65176040|NCT01136382|Autonomic Agents|autonomic agents|mesh-ancestor
65176041|NCT01136382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65176042|NCT01136382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176043|NCT01136382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65176044|NCT01136382|Respiratory System Agents|respiratory system agents|mesh-ancestor
65176045|NCT01136382|Glucocorticoids|glucocorticoids|mesh-ancestor
65176046|NCT01136382|Hormones|hormones|mesh-ancestor
65176047|NCT01136382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65176048|NCT03513562|Venetoclax|venetoclax|mesh-list
65176049|NCT03513562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176050|NCT04257448|Gemcitabine|gemcitabine|mesh-list
65176051|NCT04257448|Paclitaxel|paclitaxel|mesh-list
65176052|NCT04257448|Lenalidomide|lenalidomide|mesh-list
65176053|NCT04257448|Azacitidine|azacitidine|mesh-list
65176054|NCT04257448|Durvalumab|durvalumab|mesh-list
65176055|NCT04257448|Romidepsin|romidepsin|mesh-list
65176056|NCT04257448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65176057|NCT04257448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176058|NCT04257448|Tubulin Modulators|tubulin modulators|mesh-ancestor
65176059|NCT04257448|Antimitotic Agents|antimitotic agents|mesh-ancestor
65176060|NCT04257448|Mitosis Modulators|mitosis modulators|mesh-ancestor
65325129|NCT05277285|Antitubercular Agents|antitubercular agents|mesh-ancestor
65325130|NCT05277285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65325131|NCT05277285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65325132|NCT05277285|Chelating Agents|chelating agents|mesh-ancestor
65325133|NCT05277285|Sequestering Agents|sequestering agents|mesh-ancestor
65325134|NCT04110665|Acetaminophen|acetaminophen|mesh-list
65325135|NCT04110665|Morphine|morphine|mesh-list
65325136|NCT04110665|Oxycodone|oxycodone|mesh-list
65176061|NCT04257448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176062|NCT04257448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65176063|NCT04257448|Antimetabolites|antimetabolites|mesh-ancestor
65176064|NCT04257448|Antiviral Agents|antiviral agents|mesh-ancestor
65176065|NCT04257448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65176071|NCT04257448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65176072|NCT04257448|Growth Substances|growth substances|mesh-ancestor
65176073|NCT04257448|Growth Inhibitors|growth inhibitors|mesh-ancestor
65176074|NCT04257448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65176075|NCT04257448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65176076|NCT02731729|Nivolumab|nivolumab|mesh-list
65176077|NCT02731729|Ipilimumab|ipilimumab|mesh-list
65176078|NCT02731729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65176079|NCT02731729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176080|NCT02731729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65176081|NCT02731729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176083|NCT02645461|Riluzole|riluzole|mesh-list
65176084|NCT02645461|Anticonvulsants|anticonvulsants|mesh-ancestor
65176085|NCT02645461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65176086|NCT02645461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65176087|NCT02645461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65176088|NCT02645461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176089|NCT02645461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176090|NCT02645461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65176091|NCT02645461|Protective Agents|protective agents|mesh-ancestor
65176092|NCT02645461|Analgesics|analgesics|mesh-ancestor
65176093|NCT02645461|Sensory System Agents|sensory system agents|mesh-ancestor
65176094|NCT02645461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65176095|NCT02645461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65176096|NCT02645461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65176097|NCT02645461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65176098|NCT02645461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65176099|NCT02645461|Antiviral Agents|antiviral agents|mesh-ancestor
65176100|NCT02645461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65176101|NCT02645461|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65176102|NCT02645461|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65176103|NCT02645461|Hormones|hormones|mesh-ancestor
65176104|NCT02645461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65176105|NCT00654589|Deferasirox|deferasirox|mesh-list
65176106|NCT00654589|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65176107|NCT00654589|Chelating Agents|chelating agents|mesh-ancestor
65176108|NCT00654589|Sequestering Agents|sequestering agents|mesh-ancestor
65176109|NCT00654589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176110|NCT02645227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65176111|NCT02645227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65176112|NCT02645227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65176113|NCT02645227|Antimetabolites|antimetabolites|mesh-ancestor
65176114|NCT02645227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176115|NCT02645227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65176116|NCT02645227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65176117|NCT02645227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176118|NCT00652483|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65176119|NCT00652483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65176120|NCT00652483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65176121|NCT00652483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65176122|NCT00652483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65176123|NCT00652483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65176124|NCT00652483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65176125|NCT00652483|Adrenergic Agents|adrenergic agents|mesh-ancestor
65325137|NCT04110665|Tramadol|tramadol|mesh-list
65325138|NCT04110665|Nefopam|nefopam|mesh-list
65325139|NCT04110665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65325140|NCT04110665|Narcotics|narcotics|mesh-ancestor
65325141|NCT04110665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65325142|NCT04110665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325143|NCT04110665|Analgesics|analgesics|mesh-ancestor
65325144|NCT04110665|Sensory System Agents|sensory system agents|mesh-ancestor
65325145|NCT04110665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65325146|NCT04110665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65325147|NCT04110665|Antipyretics|antipyretics|mesh-ancestor
64554770|NCT03400995|Antiviral Agents|antiviral agents|mesh-ancestor
65176126|NCT00652483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65176127|NCT00652483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176128|NCT00652483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176129|NCT01119066|Cyclophosphamide|cyclophosphamide|mesh-list
65176130|NCT01119066|Melphalan|melphalan|mesh-list
65176131|NCT01119066|Busulfan|busulfan|mesh-list
65176132|NCT01119066|Thiotepa|thiotepa|mesh-list
65176133|NCT01119066|Fludarabine|fludarabine|mesh-list
65176134|NCT01119066|Clofarabine|clofarabine|mesh-list
65176135|NCT01119066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65176140|NCT01119066|Alkylating Agents|alkylating agents|mesh-ancestor
65176141|NCT01119066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176142|NCT01119066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176143|NCT01119066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65176144|NCT01119066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65176145|NCT01119066|Antimetabolites|antimetabolites|mesh-ancestor
65176146|NCT00910624|Ribavirin|ribavirin|mesh-list
65176147|NCT00910624|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65176148|NCT00910624|Antimetabolites|antimetabolites|mesh-ancestor
65176149|NCT00910624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176150|NCT00910624|Antiviral Agents|antiviral agents|mesh-ancestor
65176151|NCT00910624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65176152|NCT00654667|Resveratrol|resveratrol|mesh-list
65176154|NCT00654667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176155|NCT00654667|Protective Agents|protective agents|mesh-ancestor
65176156|NCT00654667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176157|NCT00654667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176158|NCT00654667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65176159|NCT01123980|Insulin|insulin|mesh-list
65176160|NCT01123980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65176161|NCT01123980|Metformin|metformin|mesh-list
65176162|NCT01123980|Insulin Glargine|insulin glargine|mesh-list
65176163|NCT01123980|Insulin Aspart|insulin aspart|mesh-list
65176164|NCT01123980|Glimepiride|glimepiride|mesh-list
65176165|NCT01123980|Biphasic Insulins|biphasic insulins|mesh-list
65176166|NCT01123980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65176167|NCT01123980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65176168|NCT01123980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176169|NCT01123980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65176170|NCT01123980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65176171|NCT01123980|Immunologic Factors|immunologic factors|mesh-ancestor
65176172|NCT02859129|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
65176173|NCT02859129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65176174|NCT02859129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65176175|NCT02859129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64818727|NCT01502904|Antimetabolites|antimetabolites|mesh-ancestor
65176176|NCT02859129|Antimetabolites|antimetabolites|mesh-ancestor
65176177|NCT02859129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176178|NCT02859129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65176179|NCT02859129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65176180|NCT02859129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176181|NCT02859129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65176182|NCT04164823|Analgesics|analgesics|mesh-list
65325148|NCT04077333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65325149|NCT04077333|Respiratory System Agents|respiratory system agents|mesh-ancestor
65325150|NCT00638859|Telithromycin|telithromycin|mesh-list
65325151|NCT00638859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65325152|NCT00638859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65176183|NCT04164823|Sensory System Agents|sensory system agents|mesh-ancestor
65176184|NCT04164823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65176185|NCT04164823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176186|NCT02857959|Penicillins|penicillins|mesh-list
65176187|NCT02857959|Penicillin G|penicillin g|mesh-list
65176188|NCT02857959|Penicillin G Benzathine|penicillin g benzathine|mesh-list
65176189|NCT02857959|Penicillin G Procaine|penicillin g procaine|mesh-list
65176190|NCT02857959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65176191|NCT02857959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65176192|NCT02643433|Vaccines|vaccines|mesh-list
65176193|NCT02643433|Immunologic Factors|immunologic factors|mesh-ancestor
65176194|NCT02643433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176195|NCT00632476|Ascorbic Acid|ascorbic acid|mesh-list
65176196|NCT00632476|Vitamins|vitamins|mesh-ancestor
65176197|NCT00632476|Micronutrients|micronutrients|mesh-ancestor
65176198|NCT00632476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176199|NCT00632476|Antioxidants|antioxidants|mesh-ancestor
65176200|NCT00632476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176201|NCT00632476|Protective Agents|protective agents|mesh-ancestor
65176202|NCT04164745|Pembrolizumab|pembrolizumab|mesh-list
65176203|NCT04164745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65176204|NCT04164745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176205|NCT03770338|Teriparatide|teriparatide|mesh-list
65176206|NCT03770338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65176211|NCT01198522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65176212|NCT01198522|Immunologic Factors|immunologic factors|mesh-ancestor
65176213|NCT01198522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176214|NCT01198522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65176215|NCT01198522|Antimetabolites|antimetabolites|mesh-ancestor
65176216|NCT01198522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176217|NCT01198522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176218|NCT01198522|Antiviral Agents|antiviral agents|mesh-ancestor
65176219|NCT01198522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65176220|NCT01198522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176221|NCT01198522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65176222|NCT02638285|Clomiphene|clomiphene|mesh-list
65176223|NCT02638285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65176224|NCT02638285|Hormone Antagonists|hormone antagonists|mesh-ancestor
65176225|NCT02638285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65176226|NCT02638285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176227|NCT02638285|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65176228|NCT02638285|Fertility Agents|fertility agents|mesh-ancestor
65176229|NCT02638285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65176230|NCT02638285|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65176231|NCT02638285|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65176232|NCT01134250|Paclitaxel|paclitaxel|mesh-list
65176233|NCT01134250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65176234|NCT01134250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176235|NCT01134250|Tubulin Modulators|tubulin modulators|mesh-ancestor
65176236|NCT01134250|Antimitotic Agents|antimitotic agents|mesh-ancestor
65176237|NCT01134250|Mitosis Modulators|mitosis modulators|mesh-ancestor
65176238|NCT01134250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176239|NCT01118520|Amlodipine|amlodipine|mesh-list
65176240|NCT01118520|Perindopril|perindopril|mesh-list
65176241|NCT01118520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65176242|NCT01118520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65176243|NCT01118520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65176244|NCT01118520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176245|NCT01118520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65176246|NCT01118520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176247|NCT01118520|Vasodilator Agents|vasodilator agents|mesh-ancestor
65176248|NCT01118520|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65176249|NCT01118520|Protease Inhibitors|protease inhibitors|mesh-ancestor
65176250|NCT01118520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176251|NCT01135992|Insulin|insulin|mesh-list
65325153|NCT04042701|Pembrolizumab|pembrolizumab|mesh-list
65325154|NCT04042701|Trastuzumab|trastuzumab|mesh-list
65325155|NCT04042701|Camptothecin|camptothecin|mesh-list
65325156|NCT04042701|Immunoconjugates|immunoconjugates|mesh-list
65325157|NCT04042701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65325158|NCT04042701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325159|NCT04042701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65325160|NCT04042701|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65176252|NCT01135992|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65176253|NCT01135992|Insulin Glargine|insulin glargine|mesh-list
65176254|NCT01135992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65176255|NCT01135992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176256|NCT03734770|Progesterone|progesterone|mesh-list
65176257|NCT03734770|Progestins|progestins|mesh-ancestor
65176258|NCT03734770|Hormones|hormones|mesh-ancestor
65176259|NCT03734770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65176260|NCT03734770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176261|NCT00959049|Vaccines|vaccines|mesh-list
65176262|NCT00959049|Immunologic Factors|immunologic factors|mesh-ancestor
65176263|NCT00959049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176264|NCT00956943|Nicotine|nicotine|mesh-list
65176265|NCT00956943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65176266|NCT00956943|Autonomic Agents|autonomic agents|mesh-ancestor
65176267|NCT00956943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65176268|NCT00956943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176269|NCT00956943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65176270|NCT00956943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65176271|NCT00956943|Cholinergic Agents|cholinergic agents|mesh-ancestor
65176272|NCT00956943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65176273|NCT00956943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176274|NCT01135914|Ranibizumab|ranibizumab|mesh-list
65176275|NCT01135914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65176276|NCT01135914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65176277|NCT01135914|Growth Substances|growth substances|mesh-ancestor
65176282|NCT00907738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176283|NCT00907738|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65176284|NCT00907738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176285|NCT00907738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176286|NCT02829723|Spartalizumab|spartalizumab|mesh-list
65176287|NCT02829723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65176288|NCT02829723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176289|NCT02829723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176290|NCT01123356|Lenalidomide|lenalidomide|mesh-list
65176292|NCT01123356|Immunologic Factors|immunologic factors|mesh-ancestor
65176293|NCT01123356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176294|NCT01123356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65176295|NCT01123356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65176296|NCT01123356|Growth Substances|growth substances|mesh-ancestor
65176297|NCT01123356|Growth Inhibitors|growth inhibitors|mesh-ancestor
65176298|NCT01123356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176299|NCT00630357|Levetiracetam|levetiracetam|mesh-list
65176300|NCT00630357|Anticonvulsants|anticonvulsants|mesh-ancestor
65176301|NCT00630357|Nootropic Agents|nootropic agents|mesh-ancestor
65176302|NCT02858817|Atovaquone|atovaquone|mesh-list
65176303|NCT02858817|Proguanil|proguanil|mesh-list
65176304|NCT02858817|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
65176305|NCT02858817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65176306|NCT02858817|Antimalarials|antimalarials|mesh-ancestor
65176307|NCT02858817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65176308|NCT02858817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65176309|NCT02858817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176310|NCT02858817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176311|NCT02858817|Antimetabolites|antimetabolites|mesh-ancestor
65176312|NCT02883192|Ondansetron|ondansetron|mesh-list
65176313|NCT02883192|Antiemetics|antiemetics|mesh-ancestor
65176314|NCT02883192|Autonomic Agents|autonomic agents|mesh-ancestor
65176315|NCT02883192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65176316|NCT02883192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325161|NCT04042701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65325162|NCT04042701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325163|NCT04042701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325164|NCT04042701|Immunologic Factors|immunologic factors|mesh-ancestor
64554794|NCT03597035|Spironolactone|spironolactone|mesh-list
65176317|NCT02883192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65176318|NCT02883192|Antipruritics|antipruritics|mesh-ancestor
65176319|NCT02883192|Dermatologic Agents|dermatologic agents|mesh-ancestor
65176320|NCT02883192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65176321|NCT02883192|Serotonin Agents|serotonin agents|mesh-ancestor
65176322|NCT02883192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65176323|NCT02883192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176324|NCT02883192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65176325|NCT02883192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65176326|NCT02883192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65176327|NCT02883192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65176328|NCT02883192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65176329|NCT03922048|Bupivacaine|bupivacaine|mesh-list
65176330|NCT03922048|Anesthetics, Local|anesthetics, local|mesh-ancestor
65176331|NCT03922048|Anesthetics|anesthetics|mesh-ancestor
65176332|NCT03922048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65176333|NCT03922048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176334|NCT03922048|Sensory System Agents|sensory system agents|mesh-ancestor
65176335|NCT03922048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65176336|NCT00632554|Prednisolone|prednisolone|mesh-list
65176337|NCT00632554|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65176338|NCT00632554|Methylprednisolone|methylprednisolone|mesh-list
65176339|NCT00632554|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65176340|NCT00632554|Prednisolone acetate|prednisolone acetate|mesh-list
65176341|NCT00632554|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65176342|NCT00632554|Prednisolone phosphate|prednisolone phosphate|mesh-list
65176343|NCT00632554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65176344|NCT00632554|Glucocorticoids|glucocorticoids|mesh-ancestor
65176345|NCT00632554|Hormones|hormones|mesh-ancestor
65176346|NCT00632554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65176347|NCT00632554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176348|NCT00632554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65176349|NCT00632554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176354|NCT00632554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65176355|NCT00632554|Protective Agents|protective agents|mesh-ancestor
65176357|NCT03082209|Venetoclax|venetoclax|mesh-list
65176358|NCT03082209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65176359|NCT03082209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176360|NCT03082209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65176361|NCT03082209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65176362|NCT03082209|Growth Substances|growth substances|mesh-ancestor
65176363|NCT03082209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176364|NCT03082209|Growth Inhibitors|growth inhibitors|mesh-ancestor
65176365|NCT02224144|Vitamin D|vitamin d|mesh-list
65176366|NCT02224144|Cholecalciferol|cholecalciferol|mesh-list
65176367|NCT02224144|Calcitriol|calcitriol|mesh-list
65176368|NCT02224144|Vitamins|vitamins|mesh-ancestor
65176369|NCT02224144|Micronutrients|micronutrients|mesh-ancestor
65176370|NCT02224144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176371|NCT02224144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65176372|NCT02224144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65176373|NCT02224144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65176374|NCT02224144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65176375|NCT02224144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176376|NCT02224144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65176377|NCT05419180|Stiripentol|stiripentol|mesh-list
65176378|NCT05419180|Anticonvulsants|anticonvulsants|mesh-ancestor
65176379|NCT04280289|Cannabidiol|cannabidiol|mesh-list
65176380|NCT04280289|Anticonvulsants|anticonvulsants|mesh-ancestor
65176382|NCT03302728|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65176383|NCT03302728|Immunologic Factors|immunologic factors|mesh-ancestor
65176384|NCT03302728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176385|NCT03302728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65176386|NCT03302728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65176387|NCT03302728|Growth Substances|growth substances|mesh-ancestor
65176388|NCT03302728|Growth Inhibitors|growth inhibitors|mesh-ancestor
65325165|NCT04042701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325166|NCT02537847|Ertapenem|ertapenem|mesh-list
65325167|NCT02537847|Fluoroquinolones|fluoroquinolones|mesh-list
65325168|NCT02537847|Sitafloxacin|sitafloxacin|mesh-list
65325169|NCT02537847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65325170|NCT02537847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65325171|NCT02537847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65325172|NCT02537847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325173|NCT02537847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325174|NCT02537847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65325175|NCT02537847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65325176|NCT02537847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325177|NCT04033029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64554802|NCT03400683|Letrozole|letrozole|mesh-list
65176389|NCT03302728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176390|NCT03302728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65176391|NCT03839914|Vancomycin|vancomycin|mesh-list
65176392|NCT03839914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65176393|NCT03839914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65176394|NCT03832972|Estrogens|estrogens|mesh-list
65176395|NCT03832972|Hormones|hormones|mesh-ancestor
65176396|NCT03832972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65176397|NCT03832972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176398|NCT02860299|Heparin|heparin|mesh-list
65176399|NCT02860299|Calcium heparin|calcium heparin|mesh-list
65176400|NCT02860299|Anticoagulants|anticoagulants|mesh-ancestor
65176401|NCT02860299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176402|NCT02860299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65176403|NCT02860299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64818951|NCT01503788|Anesthetics|anesthetics|mesh-ancestor
65176405|NCT05374564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65176406|NCT05374564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176407|NCT02858505|Iron|iron|mesh-list
65176408|NCT02858505|Trace Elements|trace elements|mesh-ancestor
65176409|NCT02858505|Micronutrients|micronutrients|mesh-ancestor
65176410|NCT02858505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176411|NCT01518556|Idarubicin|idarubicin|mesh-list
65176412|NCT01518556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65176413|NCT01518556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176414|NCT01518556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65176415|NCT01518556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65176416|NCT01518556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176417|NCT01518556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176418|NCT02994069|Cisplatin|cisplatin|mesh-list
65176419|NCT02994069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176420|NCT02860221|Epinephrine|epinephrine|mesh-list
65176421|NCT02860221|Tranexamic Acid|tranexamic acid|mesh-list
65176422|NCT02860221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65176423|NCT02860221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65176430|NCT02860221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65176431|NCT02860221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176432|NCT02860221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65176433|NCT02860221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65176434|NCT02860221|Autonomic Agents|autonomic agents|mesh-ancestor
65176435|NCT02860221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65176436|NCT02860221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65176437|NCT02860221|Respiratory System Agents|respiratory system agents|mesh-ancestor
65176438|NCT02860221|Mydriatics|mydriatics|mesh-ancestor
65176439|NCT02860221|Sympathomimetics|sympathomimetics|mesh-ancestor
65176440|NCT02860221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65176441|NCT01874353|Olaparib|olaparib|mesh-list
65176442|NCT01874353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65325178|NCT04033029|Tazobactam|tazobactam|mesh-list
65325179|NCT04033029|Piperacillin|piperacillin|mesh-list
65325180|NCT04033029|Daptomycin|daptomycin|mesh-list
65325181|NCT04033029|Ceftazidime|ceftazidime|mesh-list
65325182|NCT04033029|Cefepime|cefepime|mesh-list
65325183|NCT04033029|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65325184|NCT04033029|Ceftolozane|ceftolozane|mesh-list
65325185|NCT04033029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65325186|NCT04033029|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65325187|NCT04033029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325188|NCT04033029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325189|NCT02687841|Pentoxifylline|pentoxifylline|mesh-list
65325190|NCT02687841|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65325191|NCT02687841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176443|NCT01874353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176444|NCT01874353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176445|NCT01874353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176446|NCT02857569|Nivolumab|nivolumab|mesh-list
65176447|NCT02857569|Ipilimumab|ipilimumab|mesh-list
65176448|NCT02857569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65176449|NCT02857569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176450|NCT02857569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65176451|NCT02857569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176452|NCT04164355|Tadalafil|tadalafil|mesh-list
65176453|NCT04164355|Vasodilator Agents|vasodilator agents|mesh-ancestor
65176454|NCT04164355|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65176455|NCT04164355|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65176456|NCT04164355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176457|NCT04164355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176458|NCT04164355|Urological Agents|urological agents|mesh-ancestor
65176460|NCT01605253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65176461|NCT01605253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65176462|NCT01605253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176463|NCT00655135|Vedolizumab|vedolizumab|mesh-list
65176464|NCT00655135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65176465|NCT02637973|Empagliflozin|empagliflozin|mesh-list
65176466|NCT02637973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65176467|NCT02637973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176468|NCT02637973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65176469|NCT02637973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176470|NCT02635867|Calcium, Dietary|calcium, dietary|mesh-list
65176471|NCT02635867|Calcium|calcium|mesh-list
65176472|NCT02635867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65176473|NCT02635867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176474|NCT02635867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65176475|NCT00955305|Paclitaxel|paclitaxel|mesh-list
65176476|NCT00955305|Bevacizumab|bevacizumab|mesh-list
65176477|NCT00955305|Carboplatin|carboplatin|mesh-list
65176478|NCT00955305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65176479|NCT00955305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176480|NCT00955305|Tubulin Modulators|tubulin modulators|mesh-ancestor
65176481|NCT00955305|Antimitotic Agents|antimitotic agents|mesh-ancestor
65176482|NCT00955305|Mitosis Modulators|mitosis modulators|mesh-ancestor
65176483|NCT00955305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176484|NCT00955305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65176485|NCT00955305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65176486|NCT00955305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65176487|NCT00955305|Growth Substances|growth substances|mesh-ancestor
65176488|NCT00955305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176489|NCT00955305|Growth Inhibitors|growth inhibitors|mesh-ancestor
65176490|NCT00656695|Cyclosporine|cyclosporine|mesh-list
65176491|NCT00656695|Cyclosporins|cyclosporins|mesh-list
65325192|NCT02687841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325193|NCT02687841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65325194|NCT02687841|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65325195|NCT02687841|Protective Agents|protective agents|mesh-ancestor
65325196|NCT02687841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325197|NCT02687841|Vasodilator Agents|vasodilator agents|mesh-ancestor
65176492|NCT00656695|Antifungal Agents|antifungal agents|mesh-ancestor
65176497|NCT00656695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65176498|NCT00656695|Immunologic Factors|immunologic factors|mesh-ancestor
65176499|NCT00656695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176500|NCT00656695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65176501|NCT00656695|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65176502|NCT04204083|Hyaluronic Acid|hyaluronic acid|mesh-list
65176503|NCT04204083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65176504|NCT04204083|Immunologic Factors|immunologic factors|mesh-ancestor
65176505|NCT04204083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176506|NCT04204083|Viscosupplements|viscosupplements|mesh-ancestor
65176507|NCT04204083|Protective Agents|protective agents|mesh-ancestor
65176508|NCT00598585|Sildenafil Citrate|sildenafil citrate|mesh-list
65176509|NCT00598585|Vasodilator Agents|vasodilator agents|mesh-ancestor
65176510|NCT00598585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65176511|NCT00598585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65176512|NCT00598585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176513|NCT00598585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176514|NCT00598585|Urological Agents|urological agents|mesh-ancestor
65176515|NCT02815995|Durvalumab|durvalumab|mesh-list
65176516|NCT02815995|Tremelimumab|tremelimumab|mesh-list
65176517|NCT02815995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65176518|NCT02815995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176519|NCT02635243|Glucagon|glucagon|mesh-list
65176520|NCT02635243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176521|NCT02635243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65176522|NCT02635243|Hormones|hormones|mesh-ancestor
65176523|NCT02635243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65176525|NCT00953667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65176526|NCT00953667|Antimetabolites|antimetabolites|mesh-ancestor
65176527|NCT00953667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176528|NCT00953667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65176529|NCT00953667|Vasodilator Agents|vasodilator agents|mesh-ancestor
65176530|NCT00953667|Vitamin B Complex|vitamin b complex|mesh-ancestor
65176532|NCT00953667|Micronutrients|micronutrients|mesh-ancestor
65176533|NCT00953667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176534|NCT02857491|Ranibizumab|ranibizumab|mesh-list
65176535|NCT02857491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65176536|NCT02857491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65176537|NCT02857491|Growth Substances|growth substances|mesh-ancestor
65176538|NCT02857491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176539|NCT02857491|Growth Inhibitors|growth inhibitors|mesh-ancestor
65176540|NCT02857491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176541|NCT00883129|Mycophenolic Acid|mycophenolic acid|mesh-list
65176542|NCT00883129|Cyclophosphamide|cyclophosphamide|mesh-list
65176543|NCT00883129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65176544|NCT00883129|Immunologic Factors|immunologic factors|mesh-ancestor
65176545|NCT00883129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176546|NCT00883129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65176547|NCT00883129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65176548|NCT00883129|Alkylating Agents|alkylating agents|mesh-ancestor
65176549|NCT00883129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176550|NCT00883129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176551|NCT00883129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65176552|NCT00883129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65176553|NCT00883129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65176554|NCT00883129|Antitubercular Agents|antitubercular agents|mesh-ancestor
65176555|NCT00883129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65176556|NCT00883129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65176557|NCT00883129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176558|NCT02856867|Leucovorin|leucovorin|mesh-list
65176559|NCT02856867|Fluorouracil|fluorouracil|mesh-list
65325198|NCT02687841|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65325199|NCT02687841|Antioxidants|antioxidants|mesh-ancestor
65325200|NCT00778622|Metformin|metformin|mesh-list
65325201|NCT00778622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65325202|NCT00778622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325203|NCT00777920|Ambrisentan|ambrisentan|mesh-list
65325204|NCT00777920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65325205|NCT04236141|Rituximab|rituximab|mesh-list
65325206|NCT04236141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65325207|NCT04236141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65325208|NCT04236141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325209|NCT04236141|Immunologic Factors|immunologic factors|mesh-ancestor
65325210|NCT04236141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325211|NCT04236141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65325212|NCT04236141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65325213|NCT04236141|Alkylating Agents|alkylating agents|mesh-ancestor
65325214|NCT04236141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325215|NCT04097444|Leucovorin|leucovorin|mesh-list
65325216|NCT04097444|Bevacizumab|bevacizumab|mesh-list
65325217|NCT04097444|Fluorouracil|fluorouracil|mesh-list
64554831|NCT05037006|Anesthetics, General|anesthetics, general|mesh-ancestor
65176560|NCT02856867|Oxaliplatin|oxaliplatin|mesh-list
65176561|NCT02856867|Nintedanib|nintedanib|mesh-list
65176562|NCT02856867|Antimetabolites|antimetabolites|mesh-ancestor
65176563|NCT02856867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176564|NCT02856867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65176565|NCT02856867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176570|NCT02856867|Protective Agents|protective agents|mesh-ancestor
65176571|NCT02856867|Vitamin B Complex|vitamin b complex|mesh-ancestor
65176572|NCT02856867|Vitamins|vitamins|mesh-ancestor
65176573|NCT02856867|Micronutrients|micronutrients|mesh-ancestor
65176574|NCT02856867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65176575|NCT02856867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176576|NCT00630513|Ampicillin|ampicillin|mesh-list
65176577|NCT00630513|Ertapenem|ertapenem|mesh-list
65176578|NCT00630513|Sulbactam|sulbactam|mesh-list
65176579|NCT00630513|Sultamicillin|sultamicillin|mesh-list
65176580|NCT00630513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65176581|NCT00630513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65176582|NCT00630513|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65176583|NCT00630513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176584|NCT00630513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176585|NCT02157051|Vaccines|vaccines|mesh-list
65176586|NCT02157051|Immunologic Factors|immunologic factors|mesh-ancestor
65176587|NCT02157051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176588|NCT05287360|Apatinib|apatinib|mesh-list
65176589|NCT05287360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176590|NCT05287360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65176591|NCT05287360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176592|NCT05287360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176593|NCT00954447|Linagliptin|linagliptin|mesh-list
65176594|NCT00954447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65176595|NCT00954447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176596|NCT00954447|Incretins|incretins|mesh-ancestor
65176597|NCT00954447|Hormones|hormones|mesh-ancestor
65176598|NCT00954447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65176599|NCT00954447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65325218|NCT04097444|Capecitabine|capecitabine|mesh-list
65325219|NCT04097444|Oxaliplatin|oxaliplatin|mesh-list
65325220|NCT04097444|Irinotecan|irinotecan|mesh-list
65325221|NCT04097444|Calcium|calcium|mesh-list
65325222|NCT04097444|Levoleucovorin|levoleucovorin|mesh-list
65325223|NCT04097444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65325224|NCT04097444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325225|NCT04097444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65325226|NCT04097444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65325227|NCT04097444|Growth Substances|growth substances|mesh-ancestor
65325228|NCT04097444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325229|NCT04097444|Growth Inhibitors|growth inhibitors|mesh-ancestor
65176600|NCT00954447|Protease Inhibitors|protease inhibitors|mesh-ancestor
65176601|NCT00954447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176602|NCT00954447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176603|NCT00903760|Decitabine|decitabine|mesh-list
65176604|NCT00903760|Clofarabine|clofarabine|mesh-list
65176605|NCT00903760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65176606|NCT00903760|Antimetabolites|antimetabolites|mesh-ancestor
64710102|NCT02806544|Tamoxifen|tamoxifen|mesh-list
65176607|NCT00903760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176609|NCT00903760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176610|NCT05273554|Pembrolizumab|pembrolizumab|mesh-list
65176611|NCT05273554|Lenvatinib|lenvatinib|mesh-list
65176612|NCT05273554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65176613|NCT05273554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176614|NCT05273554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65176615|NCT05273554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176616|NCT05273554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176617|NCT05177614|Micronutrients|micronutrients|mesh-list
65176618|NCT05177614|Trace Elements|trace elements|mesh-list
65176619|NCT05177614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176620|NCT02823028|Nicotine|nicotine|mesh-list
65176621|NCT02823028|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65176622|NCT02823028|Autonomic Agents|autonomic agents|mesh-ancestor
65176623|NCT02823028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65176624|NCT02823028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176625|NCT02823028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65176626|NCT02823028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65176627|NCT02823028|Cholinergic Agents|cholinergic agents|mesh-ancestor
65176628|NCT02823028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65176629|NCT02823028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176630|NCT04202536|Tenofovir|tenofovir|mesh-list
65176631|NCT04202536|Antiviral Agents|antiviral agents|mesh-ancestor
65176632|NCT04202536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65176633|NCT04202536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65176634|NCT04202536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65176635|NCT04202536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176636|NCT04202536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176637|NCT04202536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65176638|NCT04202536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65176643|NCT02794402|Incretins|incretins|mesh-ancestor
65176644|NCT02794402|Hormones|hormones|mesh-ancestor
65176645|NCT02794402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65176646|NCT00883051|Lasmiditan|lasmiditan|mesh-list
65176647|NCT00883051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65176648|NCT00883051|Serotonin Agents|serotonin agents|mesh-ancestor
65176649|NCT00883051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65176650|NCT00883051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176651|NCT00883051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176652|NCT02783092|Cannabidiol|cannabidiol|mesh-list
65176653|NCT02783092|Anticonvulsants|anticonvulsants|mesh-ancestor
65176654|NCT03395587|Temozolomide|temozolomide|mesh-list
65176655|NCT03395587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65176656|NCT03395587|Alkylating Agents|alkylating agents|mesh-ancestor
65325230|NCT04097444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65325231|NCT04097444|Antimetabolites|antimetabolites|mesh-ancestor
65325232|NCT04097444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325233|NCT04097444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65325234|NCT04097444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65325235|NCT04097444|Immunologic Factors|immunologic factors|mesh-ancestor
65325236|NCT04097444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65176657|NCT03395587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176658|NCT03395587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176659|NCT00903682|Efavirenz|efavirenz|mesh-list
65176660|NCT00903682|Etravirine|etravirine|mesh-list
65176661|NCT00903682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65176662|NCT00903682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65176663|NCT00903682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176664|NCT00903682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176665|NCT00903682|Antiviral Agents|antiviral agents|mesh-ancestor
65176666|NCT00903682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65176667|NCT00903682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65176668|NCT00903682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65176669|NCT00903682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65176670|NCT00903682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65176671|NCT00903682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65176672|NCT00903682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65176673|NCT00655603|Pancrelipase|pancrelipase|mesh-list
65176674|NCT00655603|Hormones|hormones|mesh-list
65176675|NCT00655603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65176676|NCT00655603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176677|NCT00655603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65176678|NCT02715466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65176679|NCT00655681|Pamidronate|pamidronate|mesh-list
65176680|NCT00655681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65176681|NCT00655681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176683|NCT04221568|Bupivacaine|bupivacaine|mesh-list
65176684|NCT04221568|Levobupivacaine|levobupivacaine|mesh-list
65176685|NCT04221568|Anesthetics, Local|anesthetics, local|mesh-ancestor
65176686|NCT04221568|Anesthetics|anesthetics|mesh-ancestor
65176687|NCT04221568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65176688|NCT04221568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176689|NCT04221568|Sensory System Agents|sensory system agents|mesh-ancestor
65176690|NCT04221568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65176691|NCT04221568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65176692|NCT04221568|Narcotics|narcotics|mesh-ancestor
65176693|NCT04221568|Analgesics|analgesics|mesh-ancestor
65176694|NCT04221568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65176695|NCT04221568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65176696|NCT04221568|Anesthetics, General|anesthetics, general|mesh-ancestor
65176697|NCT01135524|Buprenorphine|buprenorphine|mesh-list
65176698|NCT01135524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65176699|NCT01135524|Narcotics|narcotics|mesh-ancestor
65176700|NCT01135524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65176701|NCT01135524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176702|NCT01135524|Analgesics|analgesics|mesh-ancestor
65176703|NCT01135524|Sensory System Agents|sensory system agents|mesh-ancestor
65176704|NCT01135524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65176705|NCT01135524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64819259|NCT01505127|Amoxicillin|amoxicillin|mesh-list
65176706|NCT00948675|Paclitaxel|paclitaxel|mesh-list
65176707|NCT00948675|Bevacizumab|bevacizumab|mesh-list
65176708|NCT00948675|Carboplatin|carboplatin|mesh-list
65176709|NCT00948675|Pemetrexed|pemetrexed|mesh-list
65176710|NCT00948675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65176715|NCT00948675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176717|NCT00948675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65176718|NCT00948675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65176719|NCT00948675|Growth Substances|growth substances|mesh-ancestor
65176720|NCT00948675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325237|NCT04097444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65325238|NCT04097444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325239|NCT04097444|Antidotes|antidotes|mesh-ancestor
65325240|NCT04097444|Protective Agents|protective agents|mesh-ancestor
65325241|NCT04097444|Vitamin B Complex|vitamin b complex|mesh-ancestor
65325242|NCT04097444|Vitamins|vitamins|mesh-ancestor
65325243|NCT04097444|Micronutrients|micronutrients|mesh-ancestor
65325244|NCT04097288|Dexetimide|dexetimide|mesh-list
65176721|NCT00948675|Growth Inhibitors|growth inhibitors|mesh-ancestor
65176722|NCT00948675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176723|NCT00948675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65176724|NCT00948675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65176725|NCT02642497|Ketamine|ketamine|mesh-list
65176726|NCT02642497|Analgesics|analgesics|mesh-ancestor
65176727|NCT02642497|Sensory System Agents|sensory system agents|mesh-ancestor
65176728|NCT02642497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65176729|NCT02642497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176730|NCT02642497|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65176731|NCT02642497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65176732|NCT02642497|Anesthetics, General|anesthetics, general|mesh-ancestor
65176733|NCT02642497|Anesthetics|anesthetics|mesh-ancestor
65176734|NCT02642497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65176735|NCT02642497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65176736|NCT02642497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65176737|NCT02642497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65176738|NCT02642497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176739|NCT04273581|Thalidomide|thalidomide|mesh-list
65176740|NCT04273581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65176741|NCT04273581|Immunologic Factors|immunologic factors|mesh-ancestor
65176742|NCT04273581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176743|NCT04273581|Leprostatic Agents|leprostatic agents|mesh-ancestor
65176744|NCT04273581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65176745|NCT04273581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65176746|NCT04273581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65176747|NCT04273581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65176748|NCT04273581|Growth Substances|growth substances|mesh-ancestor
65176749|NCT04273581|Growth Inhibitors|growth inhibitors|mesh-ancestor
65176750|NCT04273581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176751|NCT01110408|Amoxicillin|amoxicillin|mesh-list
65176752|NCT01110408|Clavulanic Acid|clavulanic acid|mesh-list
65176753|NCT01110408|Clavulanic Acids|clavulanic acids|mesh-list
65176754|NCT01110408|Cefepime|cefepime|mesh-list
65176755|NCT01110408|Doripenem|doripenem|mesh-list
65176756|NCT01110408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65176757|NCT01110408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65176758|NCT01110408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65176759|NCT01110408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65176760|NCT01110408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176761|NCT01110408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176762|NCT00953043|Lubiprostone|lubiprostone|mesh-list
65176763|NCT00953043|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65176764|NCT00953043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65176765|NCT00953043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176766|NCT02850484|Budesonide|budesonide|mesh-list
65176767|NCT02850484|Formoterol Fumarate|formoterol fumarate|mesh-list
65176768|NCT02850484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65176769|NCT02850484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65176770|NCT02850484|Autonomic Agents|autonomic agents|mesh-ancestor
65176771|NCT02850484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65176772|NCT02850484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176773|NCT02850484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65176774|NCT02850484|Respiratory System Agents|respiratory system agents|mesh-ancestor
65176775|NCT02850484|Glucocorticoids|glucocorticoids|mesh-ancestor
65176776|NCT02850484|Hormones|hormones|mesh-ancestor
65176777|NCT02850484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65176778|NCT02850484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65176779|NCT02850484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65176784|NCT01135134|Mometasone Furoate|mometasone furoate|mesh-list
65176785|NCT01135134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65325245|NCT04097288|Citalopram|citalopram|mesh-list
65325246|NCT04097288|Reboxetine|reboxetine|mesh-list
65325247|NCT04097288|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65325248|NCT04097288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65325249|NCT04097288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65325250|NCT04097288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325251|NCT04097288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65325252|NCT04097288|Serotonin Agents|serotonin agents|mesh-ancestor
65325253|NCT04097288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325254|NCT04097288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65325255|NCT04097288|Antidepressive Agents|antidepressive agents|mesh-ancestor
65325256|NCT04097288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64554869|NCT03593213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65176786|NCT01135134|Dermatologic Agents|dermatologic agents|mesh-ancestor
65176787|NCT01135134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65176788|NCT00948441|Ethanol|ethanol|mesh-list
65176789|NCT00948441|Heparin|heparin|mesh-list
65176790|NCT00948441|Anticoagulants|anticoagulants|mesh-ancestor
65176791|NCT00948441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65176792|NCT00948441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65176793|NCT00948441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176794|NCT00948441|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65176795|NCT00948441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65176796|NCT00948441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65176797|NCT00948441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176798|NCT02849782|4-Aminopyridine|4-aminopyridine|mesh-list
65176799|NCT02849782|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65176800|NCT02849782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65176801|NCT02849782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176802|NCT00630903|Methoxsalen|methoxsalen|mesh-list
65176803|NCT00630903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65176804|NCT00630903|Dermatologic Agents|dermatologic agents|mesh-ancestor
65176805|NCT02883426|Vaccines|vaccines|mesh-list
65176806|NCT02883426|Immunologic Factors|immunologic factors|mesh-ancestor
65176807|NCT02883426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176808|NCT02849548|Suvorexant|suvorexant|mesh-list
65176809|NCT02849548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65176810|NCT02849548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65176811|NCT02849548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65176812|NCT02849548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176813|NCT02849548|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65176814|NCT02849548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65176815|NCT02849548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176816|NCT02849236|Ropivacaine|ropivacaine|mesh-list
65176817|NCT02849236|Anesthetics, Local|anesthetics, local|mesh-ancestor
65176818|NCT02849236|Anesthetics|anesthetics|mesh-ancestor
65176819|NCT02849236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65176820|NCT02849236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176821|NCT02849236|Sensory System Agents|sensory system agents|mesh-ancestor
65176822|NCT02849236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65176823|NCT02856789|Hemostatics|hemostatics|mesh-list
65176824|NCT02856789|Coagulants|coagulants|mesh-ancestor
65176825|NCT01117350|Metformin|metformin|mesh-list
65176826|NCT01117350|Insulin Glargine|insulin glargine|mesh-list
65176827|NCT01117350|Liraglutide|liraglutide|mesh-list
65176828|NCT01117350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65176829|NCT01117350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176830|NCT01117350|Incretins|incretins|mesh-ancestor
65176831|NCT01117350|Hormones|hormones|mesh-ancestor
65176832|NCT01117350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65176833|NCT00952731|Tamoxifen|tamoxifen|mesh-list
65176834|NCT00952731|Afimoxifene|afimoxifene|mesh-list
65325257|NCT04097288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65325258|NCT04097288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65325259|NCT04097288|Parasympatholytics|parasympatholytics|mesh-ancestor
65325260|NCT04097288|Autonomic Agents|autonomic agents|mesh-ancestor
65325261|NCT04097288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65325262|NCT04097288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65325263|NCT04097288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65325264|NCT04097288|Cholinergic Agents|cholinergic agents|mesh-ancestor
65325265|NCT04097288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65325266|NCT04097288|Adrenergic Agents|adrenergic agents|mesh-ancestor
65325267|NCT04231539|Nicotine|nicotine|mesh-list
64554880|NCT03595163|Folic Acid|folic acid|mesh-list
65176835|NCT00952731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65176836|NCT00952731|Hormone Antagonists|hormone antagonists|mesh-ancestor
65176837|NCT00952731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65176838|NCT00952731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176839|NCT00952731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65176840|NCT00952731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176841|NCT00952731|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65176842|NCT00952731|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65176843|NCT00952731|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65176844|NCT04202224|Acetaminophen|acetaminophen|mesh-list
65176845|NCT04202224|Ibuprofen|ibuprofen|mesh-list
65176846|NCT04202224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65176847|NCT04202224|Analgesics|analgesics|mesh-ancestor
65176848|NCT04202224|Sensory System Agents|sensory system agents|mesh-ancestor
65176849|NCT04202224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65176850|NCT04202224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176853|NCT04202224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65176854|NCT04202224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65176855|NCT04202224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65176856|NCT04202224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176857|NCT04202224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176858|NCT00947427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65176859|NCT00947427|Immunologic Factors|immunologic factors|mesh-ancestor
65176860|NCT00947427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176862|NCT02848612|Calcium heparin|calcium heparin|mesh-list
65176863|NCT02848612|Anticoagulants|anticoagulants|mesh-ancestor
65176864|NCT02848612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65176865|NCT02848612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65176866|NCT02848612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176867|NCT04811404|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
65176868|NCT04811404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65176869|NCT04811404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65176870|NCT04235062|Furosemide|furosemide|mesh-list
65176871|NCT04235062|Calcium|calcium|mesh-list
65176872|NCT04235062|Diuretics|diuretics|mesh-list
65176873|NCT04235062|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
65176874|NCT04235062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65176875|NCT04235062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176876|NCT04235062|Natriuretic Agents|natriuretic agents|mesh-ancestor
65176877|NCT04235062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65176878|NCT04235062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176879|NCT02848768|Sunitinib|sunitinib|mesh-list
65176880|NCT02848768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176881|NCT02848768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65176882|NCT02848768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65176883|NCT02848768|Growth Substances|growth substances|mesh-ancestor
65176884|NCT02848768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176885|NCT02848768|Growth Inhibitors|growth inhibitors|mesh-ancestor
65176886|NCT02848768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65176887|NCT02848768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325268|NCT04231539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65325269|NCT04231539|Autonomic Agents|autonomic agents|mesh-ancestor
65325270|NCT04231539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65325271|NCT04231539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325272|NCT04231539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65325273|NCT04231539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65325274|NCT04231539|Cholinergic Agents|cholinergic agents|mesh-ancestor
65325275|NCT04231539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65325276|NCT04231539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325277|NCT04219449|Protein C|protein c|mesh-list
65325278|NCT04219449|Anticoagulants|anticoagulants|mesh-ancestor
65325279|NCT04219449|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65325280|NCT04219449|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65325281|NCT04219449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325282|NCT04209855|Paclitaxel|paclitaxel|mesh-list
65325283|NCT04209855|Maytansine|maytansine|mesh-list
65325284|NCT04209855|Doxorubicin|doxorubicin|mesh-list
65325285|NCT04209855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65325286|NCT04209855|Topotecan|topotecan|mesh-list
65325287|NCT04209855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65325288|NCT04209855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325289|NCT04209855|Tubulin Modulators|tubulin modulators|mesh-ancestor
65325290|NCT04209855|Antimitotic Agents|antimitotic agents|mesh-ancestor
65325291|NCT04209855|Mitosis Modulators|mitosis modulators|mesh-ancestor
65325292|NCT04209855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325293|NCT04209855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65325294|NCT04209855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65325295|NCT04209855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65325296|NCT04209855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325297|NCT04209855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65325298|NCT00756938|Losartan|losartan|mesh-list
65325299|NCT00756938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65176888|NCT02848768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176889|NCT02848300|Bimatoprost|bimatoprost|mesh-list
65176890|NCT02848300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65176891|NCT00953745|Aripiprazole|aripiprazole|mesh-list
65176892|NCT00953745|Citalopram|citalopram|mesh-list
65176893|NCT00953745|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65176894|NCT00953745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65176895|NCT00953745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65176896|NCT00953745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176897|NCT00953745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65325300|NCT00756938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65325301|NCT00756938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65325302|NCT00756938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65325303|NCT00756938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325304|NCT04076865|Lidocaine|lidocaine|mesh-list
65325305|NCT04076865|Histamine|histamine|mesh-list
65325306|NCT04076865|Anesthetics, Local|anesthetics, local|mesh-ancestor
65325307|NCT04076865|Anesthetics|anesthetics|mesh-ancestor
65325308|NCT04076865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65325309|NCT04076865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325310|NCT04076865|Sensory System Agents|sensory system agents|mesh-ancestor
64554927|NCT00919035|Sirolimus|sirolimus|mesh-list
65176898|NCT00953745|Serotonin Agents|serotonin agents|mesh-ancestor
65176899|NCT00953745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176900|NCT00953745|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65176901|NCT00953745|Antidepressive Agents|antidepressive agents|mesh-ancestor
65176902|NCT00953745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65176903|NCT00953745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65176904|NCT00953745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65176905|NCT00953745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65176906|NCT00953745|Dopamine Agonists|dopamine agonists|mesh-ancestor
65176907|NCT00953745|Dopamine Agents|dopamine agents|mesh-ancestor
65176908|NCT00953745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65176909|NCT00953745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65176910|NCT00953745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65176911|NCT00953745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65176912|NCT00953745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65176913|NCT00953745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65176914|NCT04202380|Azithromycin|azithromycin|mesh-list
65176915|NCT04202380|Ampicillin|ampicillin|mesh-list
65176916|NCT04202380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65176917|NCT04202380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65176918|NCT02847442|Levodopa|levodopa|mesh-list
65176919|NCT02847442|Opicapone|opicapone|mesh-list
65176920|NCT02847442|Dopa Decarboxylase|dopa decarboxylase|mesh-list
65176921|NCT02847442|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
65176922|NCT02847442|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65176923|NCT02847442|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65176927|NCT02847442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176928|NCT02847442|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65176929|NCT02847442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176930|NCT04736602|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65176931|NCT04736602|Luteolytic Agents|luteolytic agents|mesh-ancestor
65176932|NCT04736602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65176933|NCT04736602|Contraceptive Agents|contraceptive agents|mesh-ancestor
65176934|NCT04736602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65176935|NCT04736602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176936|NCT04736602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65176937|NCT04736602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65176938|NCT04736602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176939|NCT04716712|Azithromycin|azithromycin|mesh-list
65176940|NCT04716712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65176941|NCT04716712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65176942|NCT01478698|Plasminogen|plasminogen|mesh-list
65176943|NCT01478698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65176944|NCT01478698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65176945|NCT01478698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65176946|NCT01478698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176947|NCT01199380|Nicotine|nicotine|mesh-list
65176948|NCT01199380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65176949|NCT01199380|Autonomic Agents|autonomic agents|mesh-ancestor
65176950|NCT01199380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65325311|NCT04076865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65325312|NCT04076865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65325313|NCT04076865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65325314|NCT04076865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65325315|NCT04076865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65325316|NCT04076865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325317|NCT04076865|Histamine Agonists|histamine agonists|mesh-ancestor
65325318|NCT04076865|Histamine Agents|histamine agents|mesh-ancestor
65325319|NCT04076865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65325320|NCT00770588|Gefitinib|gefitinib|mesh-list
65325321|NCT00770588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65325322|NCT00770588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65176951|NCT01199380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176952|NCT01199380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65176953|NCT01199380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65176954|NCT01199380|Cholinergic Agents|cholinergic agents|mesh-ancestor
65176955|NCT01199380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65176956|NCT01199380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176957|NCT02847286|Dapivirine|dapivirine|mesh-list
65176958|NCT02847286|Clotrimazole|clotrimazole|mesh-list
65176959|NCT02847286|Miconazole|miconazole|mesh-list
65176960|NCT02847286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65176961|NCT02847286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65176962|NCT02847286|Antiviral Agents|antiviral agents|mesh-ancestor
65176963|NCT02847286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65176964|NCT02847286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65176965|NCT02847286|Antifungal Agents|antifungal agents|mesh-ancestor
65176966|NCT02847286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65176967|NCT02847286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65176968|NCT02847286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176969|NCT02847286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176970|NCT02847286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65176971|NCT02847286|Hormone Antagonists|hormone antagonists|mesh-ancestor
65176972|NCT02847286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65176973|NCT02847286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176974|NCT02847286|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65176975|NCT02847286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65176976|NCT00902668|Lovastatin|lovastatin|mesh-list
65176977|NCT00902668|L 647318|l 647318|mesh-list
65176978|NCT00902668|Dihydromevinolin|dihydromevinolin|mesh-list
65176979|NCT00902668|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65176980|NCT00902668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65176981|NCT00902668|Antimetabolites|antimetabolites|mesh-ancestor
65176982|NCT00902668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176983|NCT00902668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65176984|NCT00902668|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65176985|NCT00902668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176986|NCT00433420|Paclitaxel|paclitaxel|mesh-list
65176987|NCT00433420|Cyclophosphamide|cyclophosphamide|mesh-list
65176988|NCT00433420|Fluorouracil|fluorouracil|mesh-list
65176989|NCT00433420|Epirubicin|epirubicin|mesh-list
65176990|NCT00433420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65176991|NCT00433420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176992|NCT00433420|Tubulin Modulators|tubulin modulators|mesh-ancestor
65176993|NCT00433420|Antimitotic Agents|antimitotic agents|mesh-ancestor
65176994|NCT00433420|Mitosis Modulators|mitosis modulators|mesh-ancestor
65176998|NCT00433420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176999|NCT00433420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65177000|NCT00433420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64819547|NCT01506505|Natriuretic Agents|natriuretic agents|mesh-ancestor
65177001|NCT00433420|Alkylating Agents|alkylating agents|mesh-ancestor
65325323|NCT00770588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65325324|NCT00770588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325325|NCT02604719|Tranexamic Acid|tranexamic acid|mesh-list
65325326|NCT02604719|Ethamsylate|ethamsylate|mesh-list
65325327|NCT02604719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64554948|NCT04374981|Analgesics|analgesics|mesh-ancestor
65177002|NCT00433420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65177003|NCT00433420|Antimetabolites|antimetabolites|mesh-ancestor
65177004|NCT00433420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65177005|NCT00433420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65177006|NCT00433420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65177007|NCT00433420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65177008|NCT00433420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177009|NCT05014828|Lenvatinib|lenvatinib|mesh-list
65177010|NCT05014828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177011|NCT05014828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65177012|NCT05014828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177013|NCT05014828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177014|NCT04202068|Ceftriaxone|ceftriaxone|mesh-list
65177015|NCT04202068|Sulbactam|sulbactam|mesh-list
65177016|NCT04202068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65177017|NCT04202068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65177018|NCT04202068|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65177019|NCT04202068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177020|NCT04202068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177021|NCT02850250|Cefuroxime|cefuroxime|mesh-list
65177022|NCT02850250|Cefuroxime axetil|cefuroxime axetil|mesh-list
65177023|NCT02850250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65177024|NCT02850250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65177025|NCT05012644|Palbociclib|palbociclib|mesh-list
65177026|NCT05012644|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65177027|NCT05012644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177028|NCT05012644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65177029|NCT05012644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177030|NCT05012644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177031|NCT05012644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65177032|NCT05012644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65177033|NCT05012644|Hormone Antagonists|hormone antagonists|mesh-ancestor
65177034|NCT05012644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65177035|NCT05012644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177036|NCT02846506|Metformin|metformin|mesh-list
65177037|NCT02846506|Canagliflozin|canagliflozin|mesh-list
65177038|NCT02846506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65177039|NCT02846506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177040|NCT02846506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65177041|NCT02846506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177042|NCT02846428|Cyclophosphamide|cyclophosphamide|mesh-list
65177043|NCT02846428|Docetaxel|docetaxel|mesh-list
65177044|NCT02846428|Fluorouracil|fluorouracil|mesh-list
65177045|NCT02846428|Capecitabine|capecitabine|mesh-list
65177046|NCT02846428|Epirubicin|epirubicin|mesh-list
65177047|NCT02846428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65177048|NCT02846428|Immunologic Factors|immunologic factors|mesh-ancestor
65177049|NCT02846428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177050|NCT02846428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65177051|NCT02846428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65177052|NCT02846428|Alkylating Agents|alkylating agents|mesh-ancestor
65177053|NCT02846428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177054|NCT02846428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177055|NCT02846428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65177056|NCT02846428|Tubulin Modulators|tubulin modulators|mesh-ancestor
65177057|NCT02846428|Antimitotic Agents|antimitotic agents|mesh-ancestor
65177058|NCT02846428|Mitosis Modulators|mitosis modulators|mesh-ancestor
65177059|NCT02846428|Antimetabolites|antimetabolites|mesh-ancestor
65177060|NCT02846428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65177061|NCT02846428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65177062|NCT02846428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65177063|NCT02846428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65177064|NCT02846428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177066|NCT03561376|Zinc Oxide|zinc oxide|mesh-list
65325328|NCT02604719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65325329|NCT02604719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325330|NCT02604719|Hemostatics|hemostatics|mesh-ancestor
65325331|NCT02604719|Coagulants|coagulants|mesh-ancestor
65325332|NCT02604797|Flurbiprofen|flurbiprofen|mesh-list
65325333|NCT02604797|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
65325334|NCT02604797|Sufentanil|sufentanil|mesh-list
65325335|NCT02604797|Dsuvia|dsuvia|mesh-list
65325336|NCT02604797|Nalbuphine|nalbuphine|mesh-list
65325337|NCT02604797|Ramosetron|ramosetron|mesh-list
65325338|NCT02604797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65325339|NCT02604797|Narcotics|narcotics|mesh-ancestor
65325340|NCT02604797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65325341|NCT02604797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65325342|NCT02604797|Analgesics|analgesics|mesh-ancestor
65325343|NCT02604797|Sensory System Agents|sensory system agents|mesh-ancestor
65325344|NCT02604797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65325345|NCT02604797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65325346|NCT02604797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65325347|NCT02604797|Anesthetics, General|anesthetics, general|mesh-ancestor
65325348|NCT02604797|Anesthetics|anesthetics|mesh-ancestor
65325349|NCT02604797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65325350|NCT02604797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65177067|NCT03561376|Emollients|emollients|mesh-ancestor
65177068|NCT03561376|Dermatologic Agents|dermatologic agents|mesh-ancestor
65177069|NCT03561376|Sunscreening Agents|sunscreening agents|mesh-ancestor
65177070|NCT03561376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65177071|NCT03561376|Protective Agents|protective agents|mesh-ancestor
65177072|NCT03561376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177073|NCT02844712|beta-Lactams|beta-lactams|mesh-list
65177074|NCT02844712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65177075|NCT02844712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65177076|NCT00947349|Interferons|interferons|mesh-list
65177077|NCT00947349|Ribavirin|ribavirin|mesh-list
64819623|NCT01506752|Donepezil|donepezil|mesh-list
65177078|NCT00947349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177079|NCT00947349|Antiviral Agents|antiviral agents|mesh-ancestor
65177080|NCT00947349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65177081|NCT00947349|Antimetabolites|antimetabolites|mesh-ancestor
65177082|NCT00947349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177083|NCT03425812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65177084|NCT03425812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65177085|NCT03425812|Analgesics|analgesics|mesh-ancestor
65177086|NCT03425812|Sensory System Agents|sensory system agents|mesh-ancestor
65177087|NCT03425812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65177088|NCT03425812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177089|NCT03425812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65177090|NCT03425812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65177091|NCT02845804|Everolimus|everolimus|mesh-list
65177092|NCT02845804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177093|NCT02845804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65177094|NCT02845804|Immunologic Factors|immunologic factors|mesh-ancestor
65177095|NCT02845804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177096|NCT02844634|Tenofovir|tenofovir|mesh-list
65177097|NCT02844634|Emtricitabine|emtricitabine|mesh-list
65177098|NCT02844634|Doxycycline|doxycycline|mesh-list
65325351|NCT02604797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65325352|NCT02604797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65325353|NCT02604797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65325354|NCT02604797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075321|NCT00316160|Dopamine Agents|dopamine agents|mesh-ancestor
65325355|NCT02604797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65325356|NCT02604797|Antiemetics|antiemetics|mesh-ancestor
65325357|NCT02604797|Autonomic Agents|autonomic agents|mesh-ancestor
65325358|NCT02604797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65325359|NCT02604797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65325361|NCT02604797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65325362|NCT00777608|Donepezil|donepezil|mesh-list
65325363|NCT00777608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65325364|NCT00777608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554977|NCT03090516|Nootropic Agents|nootropic agents|mesh-ancestor
65177099|NCT02844634|Antiviral Agents|antiviral agents|mesh-ancestor
65177100|NCT02844634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65177101|NCT02844634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65177102|NCT02844634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65177103|NCT02844634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177104|NCT02844634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177105|NCT02844634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65177106|NCT02844634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65177107|NCT02844634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65177108|NCT02844634|Antimalarials|antimalarials|mesh-ancestor
65177109|NCT02844634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65177110|NCT02844634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65177111|NCT02845648|Cholinergic Antagonists|cholinergic antagonists|mesh-list
65177112|NCT02845648|Cholinergic Agents|cholinergic agents|mesh-ancestor
65177113|NCT02845648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65177114|NCT02845648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177115|NCT02845648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177116|NCT00952419|Vaccines|vaccines|mesh-list
65177117|NCT00952419|Immunologic Factors|immunologic factors|mesh-ancestor
65177118|NCT00952419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177119|NCT02844322|Rituximab|rituximab|mesh-list
65177120|NCT02844322|Bortezomib|bortezomib|mesh-list
65177121|NCT02844322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65177122|NCT02844322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65177123|NCT02844322|Immunologic Factors|immunologic factors|mesh-ancestor
65177124|NCT02844322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177125|NCT02844322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65177126|NCT02845570|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65177127|NCT02845570|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65177128|NCT02845570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177130|NCT01996605|Oxytocics|oxytocics|mesh-ancestor
65177131|NCT01996605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65177132|NCT01996605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177133|NCT00630981|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65177134|NCT00630981|Citalopram|citalopram|mesh-list
65177135|NCT00630981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65177136|NCT00630981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65177137|NCT00630981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65177138|NCT00630981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177139|NCT00630981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65177140|NCT00630981|Serotonin Agents|serotonin agents|mesh-ancestor
65177142|NCT00630981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65177143|NCT00630981|Antidepressive Agents|antidepressive agents|mesh-ancestor
65177144|NCT00630981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65177145|NCT00630981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65382103|NCT00841256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382104|NCT00989703|Methotrexate|methotrexate|mesh-list
65382105|NCT00989703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65382106|NCT00989703|Abortifacient Agents|abortifacient agents|mesh-ancestor
65382107|NCT00989703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65382108|NCT00989703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382109|NCT00989703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65382110|NCT00989703|Antimetabolites|antimetabolites|mesh-ancestor
65382111|NCT00989703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382112|NCT00989703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382113|NCT00989703|Dermatologic Agents|dermatologic agents|mesh-ancestor
65382114|NCT00989703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382115|NCT00989703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65382116|NCT00989703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65382117|NCT00989703|Immunologic Factors|immunologic factors|mesh-ancestor
65382118|NCT00989703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65382119|NCT00989703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65382120|NCT01012960|Methylnaltrexone|methylnaltrexone|mesh-list
65382121|NCT01012960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65382122|NCT01012960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382123|NCT01012960|Sensory System Agents|sensory system agents|mesh-ancestor
65382124|NCT01012960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65382125|NCT00625586|Gemcitabine|gemcitabine|mesh-list
65382126|NCT00625586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65382127|NCT00625586|Antimetabolites|antimetabolites|mesh-ancestor
65382128|NCT00625586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328700|NCT00563563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64328701|NCT00563563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328702|NCT00563563|Dopamine Agents|dopamine agents|mesh-ancestor
64328703|NCT00563563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64328704|NCT00563563|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64328705|NCT00563563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64328706|NCT00563563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328707|NCT05149365|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64328708|NCT05149365|Cyclosporine|cyclosporine|mesh-list
64328709|NCT05149365|Methotrexate|methotrexate|mesh-list
64328710|NCT05149365|Cyclosporins|cyclosporins|mesh-list
64328711|NCT05149365|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64328712|NCT05149365|Abortifacient Agents|abortifacient agents|mesh-ancestor
64328713|NCT05149365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64328714|NCT05149365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328715|NCT05149365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64328716|NCT05149365|Antimetabolites|antimetabolites|mesh-ancestor
64328717|NCT05149365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328718|NCT05149365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556515|NCT04361643|Growth Substances|growth substances|mesh-ancestor
65382129|NCT00625586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382130|NCT00625586|Antiviral Agents|antiviral agents|mesh-ancestor
65382131|NCT00625586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65382132|NCT00625586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382133|NCT00625586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65382134|NCT00625586|Immunologic Factors|immunologic factors|mesh-ancestor
65382135|NCT00625586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382136|NCT02547116|Rifampin|rifampin|mesh-list
65382137|NCT02547116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65382138|NCT02547116|Antitubercular Agents|antitubercular agents|mesh-ancestor
65382139|NCT02547116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65382140|NCT02547116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65382141|NCT02547116|Leprostatic Agents|leprostatic agents|mesh-ancestor
65382142|NCT02547116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65382143|NCT02547116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382144|NCT02547116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382145|NCT02547116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65382146|NCT02547116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65382147|NCT02547116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65382148|NCT02547116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65382149|NCT02547116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65382150|NCT02547116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65382151|NCT02549690|Testosterone|testosterone|mesh-list
65382152|NCT02549690|Androgens|androgens|mesh-ancestor
65382153|NCT02549690|Hormones|hormones|mesh-ancestor
64774764|NCT01728636|Hemostatics|hemostatics|mesh-ancestor
64556516|NCT04361643|Growth Inhibitors|growth inhibitors|mesh-ancestor
64556517|NCT04361643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556518|NCT04406051|Norepinephrine|norepinephrine|mesh-list
64556519|NCT04406051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64556520|NCT04406051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64556521|NCT04406051|Adrenergic Agents|adrenergic agents|mesh-ancestor
64556522|NCT04406051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64321593|NCT02205151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328719|NCT05149365|Dermatologic Agents|dermatologic agents|mesh-ancestor
64328720|NCT05149365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328721|NCT05149365|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64328722|NCT05149365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64328723|NCT05149365|Immunologic Factors|immunologic factors|mesh-ancestor
64328724|NCT05149365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64328725|NCT05149365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64328726|NCT05149365|Antifungal Agents|antifungal agents|mesh-ancestor
64328727|NCT05149365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64328728|NCT05149365|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64328729|NCT05149365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64328730|NCT05149365|Incretins|incretins|mesh-ancestor
64328898|NCT02177825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328900|NCT02390817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64328901|NCT02390817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382154|NCT02549690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65382155|NCT02549690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382156|NCT02549768|Dexmedetomidine|dexmedetomidine|mesh-list
65382157|NCT02549768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65382158|NCT02549768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65382159|NCT02549768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382160|NCT02549768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65382161|NCT02549768|Analgesics|analgesics|mesh-ancestor
65382162|NCT02549768|Sensory System Agents|sensory system agents|mesh-ancestor
65382163|NCT02549768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65382164|NCT02549768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65382165|NCT02549768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65382166|NCT02549768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65382167|NCT02549768|Adrenergic Agents|adrenergic agents|mesh-ancestor
65382168|NCT02549768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65382169|NCT02549768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382170|NCT00841724|Fludarabine|fludarabine|mesh-list
65382171|NCT00841724|Busulfan|busulfan|mesh-list
65382172|NCT00841724|Thymoglobulin|thymoglobulin|mesh-list
65382173|NCT00841724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382174|NCT00841724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382175|NCT00841724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65382176|NCT00841724|Immunologic Factors|immunologic factors|mesh-ancestor
65382177|NCT00841724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382178|NCT00841724|Alkylating Agents|alkylating agents|mesh-ancestor
65382179|NCT00841724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65382180|NCT00841724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65382181|NCT00843362|Dinoprostone|dinoprostone|mesh-list
65382182|NCT00843362|Oxytocics|oxytocics|mesh-ancestor
65382183|NCT00843362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65382184|NCT00843362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382194|NCT00621140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65382195|NCT00621140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382196|NCT00621140|Incretins|incretins|mesh-ancestor
65382197|NCT00621140|Hormones|hormones|mesh-ancestor
65382198|NCT00621140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65382199|NCT00621140|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65382200|NCT00621140|Protease Inhibitors|protease inhibitors|mesh-ancestor
65382201|NCT00621140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382202|NCT00621140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382203|NCT00207727|Ustekinumab|ustekinumab|mesh-list
65382204|NCT00207727|Dermatologic Agents|dermatologic agents|mesh-ancestor
65382205|NCT00841880|Felodipine|felodipine|mesh-list
65382206|NCT00841880|Ramipril|ramipril|mesh-list
65382207|NCT00841880|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65382208|NCT00841880|Protease Inhibitors|protease inhibitors|mesh-ancestor
65382209|NCT00841880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382210|NCT00841880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382211|NCT00841880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65382212|NCT00841880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65382213|NCT00841880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65382214|NCT00841880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65382215|NCT00841880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65382216|NCT00841880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382217|NCT00841880|Vasodilator Agents|vasodilator agents|mesh-ancestor
65382218|NCT00843440|Bevacizumab|bevacizumab|mesh-list
65382219|NCT00843440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64328902|NCT02390817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328903|NCT02390817|Cholinergic Agents|cholinergic agents|mesh-ancestor
64328904|NCT02390817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64328905|NCT02390817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328906|NCT02390817|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64328907|NCT02390817|Autonomic Agents|autonomic agents|mesh-ancestor
64328908|NCT02390817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64328909|NCT00537043|Carvedilol|carvedilol|mesh-list
64328910|NCT00537043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64328911|NCT00537043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64328912|NCT00537043|Adrenergic Agents|adrenergic agents|mesh-ancestor
64328913|NCT00537043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64328914|NCT00537043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328934|NCT02180789|Tamsulosin|tamsulosin|mesh-list
64328935|NCT02180789|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64328936|NCT02180789|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64328937|NCT02180789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64328938|NCT02180789|Adrenergic Agents|adrenergic agents|mesh-ancestor
64328939|NCT02180789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65382220|NCT00843440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382221|NCT00843440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65382222|NCT00843440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65382223|NCT00843440|Growth Substances|growth substances|mesh-ancestor
65382224|NCT00843440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382225|NCT00843440|Growth Inhibitors|growth inhibitors|mesh-ancestor
65382226|NCT00504556|Warfarin|warfarin|mesh-list
65382227|NCT00504556|Edoxaban|edoxaban|mesh-list
65382228|NCT00504556|Anticoagulants|anticoagulants|mesh-ancestor
65382229|NCT00504556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65382230|NCT00504556|Antithrombins|antithrombins|mesh-ancestor
65382231|NCT00504556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65382232|NCT00504556|Protease Inhibitors|protease inhibitors|mesh-ancestor
65382233|NCT00504556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382234|NCT00504556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382235|NCT00206323|Topiramate|topiramate|mesh-list
65382236|NCT00206323|Anticonvulsants|anticonvulsants|mesh-ancestor
65382237|NCT00206323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65382238|NCT00206323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382239|NCT02546804|Chlorhexidine|chlorhexidine|mesh-list
65382240|NCT02546804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65382241|NCT02546804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65382242|NCT02546804|Disinfectants|disinfectants|mesh-ancestor
65382243|NCT00842114|Interferons|interferons|mesh-list
65382244|NCT00842114|Prednisone|prednisone|mesh-list
65382245|NCT00842114|Cyclophosphamide|cyclophosphamide|mesh-list
65382246|NCT00842114|Vincristine|vincristine|mesh-list
65382247|NCT00842114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65382248|NCT00842114|Immunologic Factors|immunologic factors|mesh-ancestor
65382249|NCT00842114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382250|NCT00842114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65382251|NCT00842114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65382252|NCT00842114|Alkylating Agents|alkylating agents|mesh-ancestor
65382253|NCT00842114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382254|NCT00842114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382255|NCT00842114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65382256|NCT00842114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65382257|NCT00842114|Glucocorticoids|glucocorticoids|mesh-ancestor
65382258|NCT00842114|Hormones|hormones|mesh-ancestor
65382259|NCT00842114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65382260|NCT00842114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65382261|NCT00842114|Antiviral Agents|antiviral agents|mesh-ancestor
65382262|NCT00842114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65382263|NCT00842114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65382264|NCT00842114|Tubulin Modulators|tubulin modulators|mesh-ancestor
65382265|NCT00842114|Antimitotic Agents|antimitotic agents|mesh-ancestor
65382266|NCT00842114|Mitosis Modulators|mitosis modulators|mesh-ancestor
65382267|NCT00842192|Insulin Detemir|insulin detemir|mesh-list
65382268|NCT00842192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65382269|NCT00842192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382270|NCT00536991|Calcitriol|calcitriol|mesh-list
65382271|NCT00536991|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
65382272|NCT00536991|Ketoconazole|ketoconazole|mesh-list
65382273|NCT00536991|Hydrocortisone|hydrocortisone|mesh-list
65382274|NCT00536991|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65382276|NCT00536991|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65382277|NCT00536991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65382278|NCT00536991|Antifungal Agents|antifungal agents|mesh-ancestor
65382279|NCT00536991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65382280|NCT00536991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64774896|NCT03162510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64328940|NCT02180789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328941|NCT02180789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328942|NCT02180789|Urological Agents|urological agents|mesh-ancestor
64328943|NCT02282683|Prednisone|prednisone|mesh-list
64328944|NCT02282683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64328945|NCT02282683|Glucocorticoids|glucocorticoids|mesh-ancestor
64328946|NCT02282683|Hormones|hormones|mesh-ancestor
64328947|NCT02282683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64328948|NCT02282683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328949|NCT02282683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64329350|NCT02256605|Vitamin D|vitamin d|mesh-list
64329351|NCT02256605|Cholecalciferol|cholecalciferol|mesh-list
64329352|NCT02256605|Vitamins|vitamins|mesh-ancestor
64329353|NCT02256605|Micronutrients|micronutrients|mesh-ancestor
64329354|NCT02256605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329355|NCT02256605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64329356|NCT02256605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64329357|NCT00393991|Fluticasone|fluticasone|mesh-list
64329359|NCT00393991|Formoterol Fumarate|formoterol fumarate|mesh-list
64556523|NCT04406051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556524|NCT04406051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556525|NCT04406051|Sympathomimetics|sympathomimetics|mesh-ancestor
64556526|NCT04406051|Autonomic Agents|autonomic agents|mesh-ancestor
64556527|NCT04406051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556528|NCT04406051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64556529|NCT04991298|Fentanyl|fentanyl|mesh-list
64556530|NCT04991298|Midazolam|midazolam|mesh-list
64556531|NCT04991298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64556532|NCT04991298|Narcotics|narcotics|mesh-ancestor
65382281|NCT00536991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65382282|NCT00536991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382283|NCT00536991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382284|NCT00536991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65382285|NCT00536991|Hormone Antagonists|hormone antagonists|mesh-ancestor
65382286|NCT00536991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65382287|NCT00536991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382288|NCT00536991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65382289|NCT00536991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65382290|NCT00536991|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65382291|NCT00536991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65382292|NCT00536991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65382293|NCT00536991|Vitamins|vitamins|mesh-ancestor
65382294|NCT00536991|Micronutrients|micronutrients|mesh-ancestor
65382295|NCT00536991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65382296|NCT04348916|Pembrolizumab|pembrolizumab|mesh-list
65382297|NCT04348916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65382298|NCT04348916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382299|NCT03902613|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65382300|NCT03902613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65382301|NCT03902613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65382302|NCT03902613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65382303|NCT03902613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382304|NCT03902613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65382305|NCT03902613|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65382306|NCT03902613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65382307|NCT03902613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65382308|NCT03902613|Adrenergic Agents|adrenergic agents|mesh-ancestor
64556533|NCT04991298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64321599|NCT05504720|Trastuzumab|trastuzumab|mesh-list
64329360|NCT00393991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64329361|NCT00393991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64329362|NCT00393991|Autonomic Agents|autonomic agents|mesh-ancestor
64329363|NCT00393991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64329364|NCT00393991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329365|NCT00393991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64329366|NCT00393991|Respiratory System Agents|respiratory system agents|mesh-ancestor
64329367|NCT00393991|Dermatologic Agents|dermatologic agents|mesh-ancestor
64329396|NCT02191007|Dermatologic Agents|dermatologic agents|mesh-ancestor
64329397|NCT02191007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64329398|NCT02191007|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65382309|NCT03902613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65382310|NCT03902613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382311|NCT03902613|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65382312|NCT03902613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65382313|NCT03902613|Serotonin Agents|serotonin agents|mesh-ancestor
65382314|NCT03902613|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65382315|NCT03902613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65382316|NCT03902613|Dopamine Agents|dopamine agents|mesh-ancestor
65382317|NCT00504166|Alendronate|alendronate|mesh-list
65382318|NCT00504166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65382319|NCT00504166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382320|NCT02546648|Tranexamic Acid|tranexamic acid|mesh-list
65382321|NCT02546648|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65382322|NCT02546648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65382323|NCT02546648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65382324|NCT02546648|Antimetabolites|antimetabolites|mesh-ancestor
65382325|NCT02546648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382326|NCT02546648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65382327|NCT02546648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65382328|NCT02546648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382329|NCT02546648|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64774952|NCT01740258|Growth Substances|growth substances|mesh-ancestor
64329399|NCT02191007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64329400|NCT02191007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329401|NCT02191007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64329403|NCT02191007|Micronutrients|micronutrients|mesh-ancestor
64329872|NCT02380053|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64329873|NCT02380053|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64329874|NCT02380053|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64329875|NCT02380053|Adrenergic Agents|adrenergic agents|mesh-ancestor
64329952|NCT02379663|Protease Inhibitors|protease inhibitors|mesh-ancestor
64329953|NCT02379663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329954|NCT02379663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329955|NCT02379663|Anticoagulants|anticoagulants|mesh-ancestor
64668537|NCT02283827|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64668538|NCT02283827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64668539|NCT05735717|Rituximab|rituximab|mesh-list
64668540|NCT05735717|Fludarabine|fludarabine|mesh-list
64668541|NCT05735717|Melphalan|melphalan|mesh-list
64668542|NCT05735717|Busulfan|busulfan|mesh-list
64668543|NCT05735717|Levetiracetam|levetiracetam|mesh-list
64668544|NCT05735717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64668545|NCT05735717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64668546|NCT05735717|Immunologic Factors|immunologic factors|mesh-ancestor
64668547|NCT05735717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668548|NCT05735717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64668549|NCT05735717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668550|NCT05735717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64668551|NCT05735717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64668552|NCT05735717|Alkylating Agents|alkylating agents|mesh-ancestor
65382330|NCT02546648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65382331|NCT02546648|Hemostatics|hemostatics|mesh-ancestor
65382332|NCT02546648|Coagulants|coagulants|mesh-ancestor
65382333|NCT00842504|Micafungin|micafungin|mesh-list
65382334|NCT00842504|Antifungal Agents|antifungal agents|mesh-ancestor
65382335|NCT00842504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65382336|NCT00842582|Azacitidine|azacitidine|mesh-list
65382337|NCT00842582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65382338|NCT00842582|Antimetabolites|antimetabolites|mesh-ancestor
65382339|NCT00842582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382340|NCT00842582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382341|NCT00842582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382342|NCT00843908|Imidacloprid|imidacloprid|mesh-list
65382343|NCT00843908|Cholinergic Agents|cholinergic agents|mesh-ancestor
65382344|NCT00843908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65131935|NCT00479765|Mitosis Modulators|mitosis modulators|mesh-ancestor
65382345|NCT00843908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382346|NCT00843908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382348|NCT00842660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65382349|NCT00842660|Antimetabolites|antimetabolites|mesh-ancestor
65382350|NCT00842660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382351|NCT00842660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382352|NCT00842660|Antiviral Agents|antiviral agents|mesh-ancestor
65382353|NCT00842660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65382354|NCT00842660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382355|NCT00842660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65382356|NCT00842660|Immunologic Factors|immunologic factors|mesh-ancestor
64668559|NCT01626092|Alemtuzumab|alemtuzumab|mesh-list
64668560|NCT01626092|Clofarabine|clofarabine|mesh-list
64668561|NCT01626092|Cyclosporins|cyclosporins|mesh-list
64668562|NCT01626092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64668563|NCT01626092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668564|NCT01626092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64668565|NCT01626092|Immunologic Factors|immunologic factors|mesh-ancestor
64668566|NCT01626092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668567|NCT01626092|Antifungal Agents|antifungal agents|mesh-ancestor
64668568|NCT01626092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64668569|NCT01626092|Dermatologic Agents|dermatologic agents|mesh-ancestor
64556534|NCT04991298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556536|NCT04991298|Sensory System Agents|sensory system agents|mesh-ancestor
64556537|NCT04991298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556538|NCT04991298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64556539|NCT04991298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64556540|NCT04991298|Anesthetics, General|anesthetics, general|mesh-ancestor
64556541|NCT04991298|Anesthetics|anesthetics|mesh-ancestor
64556542|NCT04991298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64556543|NCT04991298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64556544|NCT04991298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64668570|NCT01626092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65382357|NCT00842660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382358|NCT00509236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65382359|NCT00509236|Glipizide|glipizide|mesh-list
65382360|NCT00509236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65382361|NCT00509236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382362|NCT00509236|Incretins|incretins|mesh-ancestor
65382363|NCT00509236|Hormones|hormones|mesh-ancestor
65382364|NCT00509236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65382365|NCT00509236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65382366|NCT00509236|Protease Inhibitors|protease inhibitors|mesh-ancestor
65382367|NCT00509236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382368|NCT00509236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382369|NCT00842894|Insulin|insulin|mesh-list
65382370|NCT00842894|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65382371|NCT00842894|Insulin Aspart|insulin aspart|mesh-list
65382372|NCT00842894|Insulin Detemir|insulin detemir|mesh-list
65382373|NCT00842894|Biphasic Insulins|biphasic insulins|mesh-list
65382374|NCT00842894|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65382375|NCT00842894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65382376|NCT00842894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382377|NCT00508924|Heparin|heparin|mesh-list
65382378|NCT00508924|Argatroban|argatroban|mesh-list
65382379|NCT00508924|Anticoagulants|anticoagulants|mesh-ancestor
65382380|NCT00508924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65382381|NCT00508924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65382382|NCT00508924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382383|NCT00508924|Antithrombins|antithrombins|mesh-ancestor
65382384|NCT00508924|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65382385|NCT00508924|Protease Inhibitors|protease inhibitors|mesh-ancestor
65382386|NCT00508924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382387|NCT00508924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65382388|NCT00836576|Benazepril|benazepril|mesh-list
65382389|NCT00836576|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65382390|NCT00836576|Protease Inhibitors|protease inhibitors|mesh-ancestor
65382391|NCT00836576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64774992|NCT01746264|Vitamin D|vitamin d|mesh-list
64668571|NCT01626092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64668572|NCT01626092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64668573|NCT01626092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382392|NCT00836576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382393|NCT00836576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65382394|NCT00836654|Catumaxomab|catumaxomab|mesh-list
65382395|NCT00836654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65382396|NCT00844064|Trabedersen|trabedersen|mesh-list
65382397|NCT00844064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382398|NCT04688788|Fexofenadine|fexofenadine|mesh-list
65382399|NCT04688788|Methylprednisolone|methylprednisolone|mesh-list
65382400|NCT04688788|Rituximab|rituximab|mesh-list
65382401|NCT04688788|Ocrelizumab|ocrelizumab|mesh-list
65382402|NCT04688788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65382403|NCT04688788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382404|NCT04688788|Immunologic Factors|immunologic factors|mesh-ancestor
65382405|NCT04688788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382406|NCT04688788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65382407|NCT04688788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65382408|NCT04688788|Antiemetics|antiemetics|mesh-ancestor
65382409|NCT04688788|Autonomic Agents|autonomic agents|mesh-ancestor
65382410|NCT04688788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65382411|NCT04688788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64775028|NCT01750398|Hormones|hormones|mesh-ancestor
64668574|NCT01626092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64668575|NCT01626092|Antitubercular Agents|antitubercular agents|mesh-ancestor
64668576|NCT01626092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64668577|NCT01626092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64668578|NCT01626092|Alkylating Agents|alkylating agents|mesh-ancestor
64668579|NCT01626092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64668580|NCT01626092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64668581|NCT01626092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64668582|NCT01626092|Antimetabolites|antimetabolites|mesh-ancestor
64668584|NCT01694966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64668585|NCT01694966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668586|NCT01937975|Grazoprevir|grazoprevir|mesh-list
64668587|NCT01937975|Antiviral Agents|antiviral agents|mesh-ancestor
64668588|NCT01937975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64668589|NCT01628588|Bimatoprost|bimatoprost|mesh-list
64668590|NCT01628588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64668592|NCT00374985|Oxaliplatin|oxaliplatin|mesh-list
64668593|NCT00374985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64668594|NCT00374985|Tubulin Modulators|tubulin modulators|mesh-ancestor
64668595|NCT00374985|Antimitotic Agents|antimitotic agents|mesh-ancestor
64668596|NCT00374985|Mitosis Modulators|mitosis modulators|mesh-ancestor
64668597|NCT00374985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668598|NCT01695668|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64668599|NCT01695668|Cyclosporine|cyclosporine|mesh-list
64668603|NCT01695668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64668605|NCT01695668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668606|NCT01695668|Antifungal Agents|antifungal agents|mesh-ancestor
64668607|NCT01695668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64668608|NCT01695668|Dermatologic Agents|dermatologic agents|mesh-ancestor
64668609|NCT01695668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64668610|NCT01695668|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64668611|NCT01695668|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64668612|NCT03270020|Denosumab|denosumab|mesh-list
64668613|NCT03270020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64668641|NCT01629134|Protective Agents|protective agents|mesh-ancestor
65382412|NCT04688788|Glucocorticoids|glucocorticoids|mesh-ancestor
65382413|NCT04688788|Hormones|hormones|mesh-ancestor
65382414|NCT04688788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65382415|NCT04688788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65382416|NCT04688788|Protective Agents|protective agents|mesh-ancestor
65382417|NCT04688788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65382418|NCT04688788|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65382419|NCT04688788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65382420|NCT04688788|Histamine Antagonists|histamine antagonists|mesh-ancestor
65382422|NCT04688788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65382423|NCT04688788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382424|NCT05221593|Lithium Carbonate|lithium carbonate|mesh-list
65382425|NCT05221593|Antidepressive Agents|antidepressive agents|mesh-ancestor
65382426|NCT05221593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65382427|NCT05221593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382428|NCT05221593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382429|NCT05221593|Antimanic Agents|antimanic agents|mesh-ancestor
65382430|NCT05221593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65382431|NCT05221593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64668642|NCT01629290|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
64668643|NCT01629290|Cariostatic Agents|cariostatic agents|mesh-ancestor
64668644|NCT01629290|Protective Agents|protective agents|mesh-ancestor
64668645|NCT01629290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668646|NCT01696760|Aspirin|aspirin|mesh-list
64668647|NCT01696760|Enoxaparin|enoxaparin|mesh-list
64668648|NCT01696760|Enoxaparin sodium|enoxaparin sodium|mesh-list
64668649|NCT01696760|Anticoagulants|anticoagulants|mesh-ancestor
64668650|NCT01696760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64668651|NCT01696760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64556545|NCT04991298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64556546|NCT04991298|GABA Modulators|gaba modulators|mesh-ancestor
64556547|NCT04991298|GABA Agents|gaba agents|mesh-ancestor
64556548|NCT04991298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64556549|NCT04991298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556550|NCT04361175|Letrozole|letrozole|mesh-list
64556551|NCT04361175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321620|NCT02220673|Protective Agents|protective agents|mesh-ancestor
64668652|NCT01696760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668653|NCT01696760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64668654|NCT01696760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64668655|NCT01696760|Analgesics|analgesics|mesh-ancestor
64668656|NCT01696760|Sensory System Agents|sensory system agents|mesh-ancestor
64668676|NCT02958969|Antithrombins|antithrombins|mesh-ancestor
64668677|NCT02958969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64668678|NCT02958969|Protease Inhibitors|protease inhibitors|mesh-ancestor
64668680|NCT02958969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668681|NCT02958969|Anticoagulants|anticoagulants|mesh-ancestor
64668682|NCT01924871|Remifentanil|remifentanil|mesh-list
64668683|NCT01924871|Desflurane|desflurane|mesh-list
64668684|NCT01924871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64668685|NCT01924871|Narcotics|narcotics|mesh-ancestor
64668686|NCT01924871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64668687|NCT01924871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668688|NCT01924871|Analgesics|analgesics|mesh-ancestor
65382432|NCT05221593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382433|NCT00844142|Sulfasalazine|sulfasalazine|mesh-list
65382434|NCT00844142|Etanercept|etanercept|mesh-list
65382435|NCT00844142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65382436|NCT00844142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65382437|NCT00844142|Analgesics|analgesics|mesh-ancestor
65382438|NCT00844142|Sensory System Agents|sensory system agents|mesh-ancestor
65382439|NCT00844142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65382440|NCT00844142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382441|NCT00844142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65382442|NCT00844142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65382443|NCT00844142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65382444|NCT00844142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65382445|NCT00844142|Immunologic Factors|immunologic factors|mesh-ancestor
65382446|NCT00844142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65382447|NCT00837044|Naproxen|naproxen|mesh-list
65382448|NCT00837044|Sumatriptan|sumatriptan|mesh-list
65382449|NCT00837044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65382450|NCT00837044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65382451|NCT00837044|Analgesics|analgesics|mesh-ancestor
65382452|NCT00837044|Sensory System Agents|sensory system agents|mesh-ancestor
65382453|NCT00837044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65382454|NCT00837044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382455|NCT00837044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65382456|NCT00837044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65382457|NCT00837044|Gout Suppressants|gout suppressants|mesh-ancestor
65382458|NCT00837044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65382459|NCT00837044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382460|NCT00837044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382461|NCT00837044|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65382462|NCT00837044|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65382463|NCT00837044|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65382464|NCT00837044|Serotonin Agents|serotonin agents|mesh-ancestor
65382465|NCT00837044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65382466|NCT01013272|Lamivudine|lamivudine|mesh-list
65382467|NCT01013272|Entecavir|entecavir|mesh-list
65382468|NCT01013272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64668689|NCT01924871|Sensory System Agents|sensory system agents|mesh-ancestor
64668690|NCT01924871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65382469|NCT01013272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65382470|NCT01013272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382471|NCT01013272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382472|NCT01013272|Antiviral Agents|antiviral agents|mesh-ancestor
65382473|NCT01013272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65382474|NCT01013272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65382475|NCT01013272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65382476|NCT04232085|Mycophenolic Acid|mycophenolic acid|mesh-list
65382477|NCT04232085|Cyclophosphamide|cyclophosphamide|mesh-list
65382478|NCT04232085|Melphalan|melphalan|mesh-list
65382479|NCT04232085|Fludarabine|fludarabine|mesh-list
65382480|NCT04232085|Alemtuzumab|alemtuzumab|mesh-list
65382481|NCT04232085|Tacrolimus|tacrolimus|mesh-list
65382482|NCT04232085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65382483|NCT04232085|Immunologic Factors|immunologic factors|mesh-ancestor
65382484|NCT04232085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382485|NCT04232085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65382486|NCT04232085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65382487|NCT04232085|Alkylating Agents|alkylating agents|mesh-ancestor
65382488|NCT04232085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382489|NCT04232085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382490|NCT04232085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65382491|NCT04232085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65382492|NCT04232085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382493|NCT04232085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65382494|NCT04232085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65382495|NCT04232085|Antitubercular Agents|antitubercular agents|mesh-ancestor
65382496|NCT04232085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65382497|NCT04232085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65382498|NCT04232085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65382499|NCT02546024|Antidepressive Agents|antidepressive agents|mesh-list
64775101|NCT01766466|Cangrelor|cangrelor|mesh-list
64668691|NCT01924871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64668692|NCT01924871|Anesthetics, General|anesthetics, general|mesh-ancestor
64668693|NCT01924871|Anesthetics|anesthetics|mesh-ancestor
64668694|NCT01698710|Paclitaxel|paclitaxel|mesh-list
64668695|NCT01698710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64668696|NCT01698710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64668697|NCT01698710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64668698|NCT01698710|Tubulin Modulators|tubulin modulators|mesh-ancestor
64668699|NCT01698710|Antimitotic Agents|antimitotic agents|mesh-ancestor
64668700|NCT01698710|Mitosis Modulators|mitosis modulators|mesh-ancestor
64668701|NCT01698710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668702|NCT01924949|Sofosbuvir|sofosbuvir|mesh-list
65382500|NCT02546024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65382501|NCT01010698|Acyclovir|acyclovir|mesh-list
65382502|NCT01010698|Cimetidine|cimetidine|mesh-list
65382503|NCT01010698|Antiviral Agents|antiviral agents|mesh-ancestor
65382504|NCT01010698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65382505|NCT01010698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65382506|NCT01010698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65382507|NCT01010698|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65382508|NCT01010698|Histamine Antagonists|histamine antagonists|mesh-ancestor
65382509|NCT01010698|Histamine Agents|histamine agents|mesh-ancestor
65382510|NCT01010698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65382511|NCT01010698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382512|NCT01010698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382513|NCT01010698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65382514|NCT01010698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65382515|NCT01010698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382516|NCT03541486|Gemcitabine|gemcitabine|mesh-list
65382517|NCT03541486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382518|NCT03541486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65382519|NCT03541486|Antimetabolites|antimetabolites|mesh-ancestor
65382520|NCT03541486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382521|NCT03541486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382522|NCT03541486|Antiviral Agents|antiviral agents|mesh-ancestor
65382523|NCT03541486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65382524|NCT03541486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382525|NCT03541486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65382526|NCT03541486|Immunologic Factors|immunologic factors|mesh-ancestor
65382527|NCT04893291|Sirolimus|sirolimus|mesh-list
65382528|NCT04893291|Everolimus|everolimus|mesh-list
65382529|NCT04893291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382546|NCT04867707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382547|NCT04867707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382548|NCT02547896|Diclofenac|diclofenac|mesh-list
65382549|NCT02547896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65382550|NCT02547896|Codeine|codeine|mesh-list
65382551|NCT02547896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65382552|NCT02547896|Analgesics|analgesics|mesh-ancestor
65382553|NCT02547896|Sensory System Agents|sensory system agents|mesh-ancestor
65382554|NCT02547896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65382555|NCT02547896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382556|NCT02547896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65382557|NCT02547896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65382558|NCT02547896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65382559|NCT02547896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382560|NCT02547896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382561|NCT02547896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65382562|NCT02547896|Narcotics|narcotics|mesh-ancestor
65382563|NCT02547896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65382564|NCT02547896|Antitussive Agents|antitussive agents|mesh-ancestor
65382565|NCT02547896|Respiratory System Agents|respiratory system agents|mesh-ancestor
65382566|NCT01564251|Gemcitabine|gemcitabine|mesh-list
65382567|NCT01564251|GDC-0575|gdc-0575|mesh-list
65382568|NCT01564251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65382569|NCT01564251|Antimetabolites|antimetabolites|mesh-ancestor
65382570|NCT01564251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382571|NCT01564251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382572|NCT01564251|Antiviral Agents|antiviral agents|mesh-ancestor
65382573|NCT01564251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65382574|NCT01564251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382590|NCT05357547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65382591|NCT05357547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65382592|NCT05357547|Serotonin Agents|serotonin agents|mesh-ancestor
65382593|NCT05357547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65382594|NCT05357547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382595|NCT00844454|Ethanol|ethanol|mesh-list
65382596|NCT00844454|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65382597|NCT00844454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65382598|NCT00844454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65382599|NCT00844454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382600|NCT02545712|Ethanol|ethanol|mesh-list
65382601|NCT02545712|Benzyl Alcohol|benzyl alcohol|mesh-list
65382602|NCT02545712|Sorbitol|sorbitol|mesh-list
65382603|NCT02545712|Glycerol|glycerol|mesh-list
65382604|NCT02545712|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65382605|NCT02545712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65382606|NCT02545712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65382607|NCT02545712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382608|NCT02545712|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65382609|NCT02545712|Protective Agents|protective agents|mesh-ancestor
65382610|NCT02545712|Cathartics|cathartics|mesh-ancestor
65382611|NCT02545712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65382612|NCT02545712|Anesthetics, Local|anesthetics, local|mesh-ancestor
65382613|NCT02545712|Anesthetics|anesthetics|mesh-ancestor
64775224|NCT01786902|Hormones|hormones|mesh-list
64668706|NCT01924949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64668707|NCT01938989|Methamphetamine|methamphetamine|mesh-list
64668708|NCT01938989|beta-Endorphin|beta-endorphin|mesh-list
64668709|NCT01938989|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64668710|NCT01938989|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64668711|NCT01938989|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64668712|NCT01938989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668715|NCT01938989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668716|NCT01938989|Dopamine Agents|dopamine agents|mesh-ancestor
64668717|NCT01938989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64668718|NCT01938989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668719|NCT01938989|Adrenergic Agents|adrenergic agents|mesh-ancestor
64668720|NCT01938989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64668721|NCT01938989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64668722|NCT01938989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64668723|NCT01938989|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64668724|NCT01938989|Hormones|hormones|mesh-ancestor
64668725|NCT01938989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64668726|NCT01939301|Nitric Oxide|nitric oxide|mesh-list
64668727|NCT01939301|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64668728|NCT01939301|Autonomic Agents|autonomic agents|mesh-ancestor
64668729|NCT01939301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668730|NCT01939301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668731|NCT01939301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64668732|NCT01939301|Respiratory System Agents|respiratory system agents|mesh-ancestor
65382614|NCT02545712|Sensory System Agents|sensory system agents|mesh-ancestor
65382615|NCT02545712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65382616|NCT01011010|Doxorubicin|doxorubicin|mesh-list
65382617|NCT01011010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65382618|NCT01011010|Mitomycins|mitomycins|mesh-list
65382619|NCT01011010|Mitomycin|mitomycin|mesh-list
65382620|NCT01011010|Sorafenib|sorafenib|mesh-list
65382621|NCT01011010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65382622|NCT01011010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382623|NCT01011010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65382624|NCT01011010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65382625|NCT01011010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382626|NCT01011010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382627|NCT01011010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65382628|NCT01011010|Alkylating Agents|alkylating agents|mesh-ancestor
65382629|NCT01011010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65382630|NCT00851708|Acetylcysteine|acetylcysteine|mesh-list
65382631|NCT00851708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65382632|NCT00851708|Antiviral Agents|antiviral agents|mesh-ancestor
65382633|NCT00851708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65382634|NCT00851708|Expectorants|expectorants|mesh-ancestor
65382635|NCT00851708|Respiratory System Agents|respiratory system agents|mesh-ancestor
65382636|NCT00851708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65382637|NCT00851708|Antioxidants|antioxidants|mesh-ancestor
65382638|NCT00851708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382639|NCT00851708|Protective Agents|protective agents|mesh-ancestor
65382640|NCT00851708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382641|NCT00851708|Antidotes|antidotes|mesh-ancestor
65382642|NCT05018481|Hyaluronic Acid|hyaluronic acid|mesh-list
65382643|NCT05018481|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65382644|NCT05018481|Immunologic Factors|immunologic factors|mesh-ancestor
65382645|NCT05018481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382646|NCT05018481|Viscosupplements|viscosupplements|mesh-ancestor
65382657|NCT00621842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65382658|NCT00621842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382659|NCT00621842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65382660|NCT00621842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382661|NCT00621842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65382662|NCT00621842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65382663|NCT00621842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65382664|NCT00621842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65382665|NCT00621842|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65382666|NCT04849455|Morphine|morphine|mesh-list
65382667|NCT04849455|Ropivacaine|ropivacaine|mesh-list
65382668|NCT04849455|Anesthetics, Local|anesthetics, local|mesh-list
65382669|NCT04849455|Anesthetics|anesthetics|mesh-list
65382670|NCT04849455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65382671|NCT04849455|Narcotics|narcotics|mesh-ancestor
65382672|NCT04849455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65382673|NCT04849455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382674|NCT04849455|Analgesics|analgesics|mesh-ancestor
65382675|NCT04849455|Sensory System Agents|sensory system agents|mesh-ancestor
65382676|NCT04849455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65382677|NCT02545010|Paclitaxel|paclitaxel|mesh-list
65382678|NCT02545010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65382679|NCT02545010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382680|NCT02545010|Tubulin Modulators|tubulin modulators|mesh-ancestor
65382681|NCT02545010|Antimitotic Agents|antimitotic agents|mesh-ancestor
65382682|NCT02545010|Mitosis Modulators|mitosis modulators|mesh-ancestor
65382683|NCT02545010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382684|NCT01013506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65382685|NCT01013506|Letrozole|letrozole|mesh-list
65382686|NCT01013506|Goserelin|goserelin|mesh-list
65382687|NCT01013506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556554|NCT04361175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64556555|NCT04361175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556556|NCT04361175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64556557|NCT04361175|Hormone Antagonists|hormone antagonists|mesh-ancestor
64556558|NCT04361175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64556559|NCT04361175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556560|NCT04368819|Allopurinol|allopurinol|mesh-list
64556561|NCT04368819|Antimetabolites|antimetabolites|mesh-ancestor
64556562|NCT04368819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321631|NCT02205541|Eculizumab|eculizumab|mesh-list
64668733|NCT01939301|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64668734|NCT01939301|Antioxidants|antioxidants|mesh-ancestor
64668735|NCT01939301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382688|NCT01013506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65382689|NCT01013506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382690|NCT01013506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382691|NCT01013506|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65382692|NCT01013506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65382693|NCT01013506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65382694|NCT01013506|Hormone Antagonists|hormone antagonists|mesh-ancestor
65382695|NCT01013506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65382696|NCT01013506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382697|NCT01013506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65382698|NCT00844688|Gemcitabine|gemcitabine|mesh-list
65382699|NCT00844688|Sorafenib|sorafenib|mesh-list
65382700|NCT00844688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65382701|NCT00844688|Antimetabolites|antimetabolites|mesh-ancestor
65382702|NCT00844688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382703|NCT00844688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382704|NCT00844688|Antiviral Agents|antiviral agents|mesh-ancestor
65382705|NCT00844688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65382706|NCT00844688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382707|NCT00844688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65382708|NCT00844688|Immunologic Factors|immunologic factors|mesh-ancestor
65382709|NCT00844688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382711|NCT04541680|Nintedanib|nintedanib|mesh-list
65382738|NCT00503776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65382739|NCT00503776|Protective Agents|protective agents|mesh-ancestor
65382740|NCT00503776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382741|NCT02545634|Sulfalene|sulfalene|mesh-list
65382742|NCT02545634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65382743|NCT02545634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65382744|NCT02545634|Renal Agents|renal agents|mesh-ancestor
65382745|NCT02545634|Antimalarials|antimalarials|mesh-ancestor
65382746|NCT02545634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65382747|NCT02545634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65382748|NCT05260671|Cetuximab|cetuximab|mesh-list
65382749|NCT05260671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65382750|NCT05260671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382751|NCT00855686|Memantine|memantine|mesh-list
65382752|NCT00855686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65382753|NCT00855686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65382754|NCT00855686|Dopamine Agents|dopamine agents|mesh-ancestor
65382755|NCT00855686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65382756|NCT00855686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382757|NCT00855686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382758|NCT00855686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65382759|NCT00855686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65382760|NCT00619112|Temozolomide|temozolomide|mesh-list
65382761|NCT00619112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65382762|NCT00619112|Alkylating Agents|alkylating agents|mesh-ancestor
65382763|NCT00619112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382764|NCT00619112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382765|NCT03457701|Iron|iron|mesh-list
65382766|NCT03457701|Trace Elements|trace elements|mesh-ancestor
65382767|NCT03457701|Micronutrients|micronutrients|mesh-ancestor
65382768|NCT03457701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382769|NCT00845156|Thioctic Acid|thioctic acid|mesh-list
65382770|NCT00845156|Antioxidants|antioxidants|mesh-ancestor
65382771|NCT00845156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382780|NCT03262935|Lapatinib|lapatinib|mesh-list
65382781|NCT03262935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65382782|NCT03262935|Antimetabolites|antimetabolites|mesh-ancestor
65382783|NCT03262935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382784|NCT03262935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382785|NCT03262935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65382786|NCT03262935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65382787|NCT03262935|Tubulin Modulators|tubulin modulators|mesh-ancestor
65382788|NCT03262935|Antimitotic Agents|antimitotic agents|mesh-ancestor
65382789|NCT03262935|Mitosis Modulators|mitosis modulators|mesh-ancestor
65382790|NCT03262935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65382791|NCT03262935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382792|NCT00852332|Curcumin|curcumin|mesh-list
65382793|NCT00852332|Docetaxel|docetaxel|mesh-list
65382794|NCT00852332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382795|NCT00852332|Tubulin Modulators|tubulin modulators|mesh-ancestor
65382796|NCT00852332|Antimitotic Agents|antimitotic agents|mesh-ancestor
65132386|NCT04553328|Bupivacaine|bupivacaine|mesh-list
65382797|NCT00852332|Mitosis Modulators|mitosis modulators|mesh-ancestor
65382798|NCT00852332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382799|NCT00852332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65382800|NCT00852332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65382801|NCT00852332|Analgesics|analgesics|mesh-ancestor
65382802|NCT00852332|Sensory System Agents|sensory system agents|mesh-ancestor
65382803|NCT00852332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65382804|NCT00852332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668736|NCT01939301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64668737|NCT01939301|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64668738|NCT01939301|Vasodilator Agents|vasodilator agents|mesh-ancestor
64668739|NCT01939301|Gasotransmitters|gasotransmitters|mesh-ancestor
64668740|NCT01939301|Protective Agents|protective agents|mesh-ancestor
64668741|NCT03078075|Naltrexone|naltrexone|mesh-list
64668742|NCT03078075|Bupropion|bupropion|mesh-list
64668743|NCT03078075|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64668744|NCT03078075|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64668745|NCT03078075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668746|NCT03078075|Sensory System Agents|sensory system agents|mesh-ancestor
64668747|NCT03078075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668748|NCT03078075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64668749|NCT03078075|Antidepressive Agents|antidepressive agents|mesh-ancestor
64668750|NCT03078075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64668751|NCT03078075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64668752|NCT03078075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64668753|NCT03078075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64668754|NCT03078075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668755|NCT03078075|Dopamine Agents|dopamine agents|mesh-ancestor
64668784|NCT01928693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668785|NCT01928693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65382805|NCT00852332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65382806|NCT00852332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65382807|NCT00852332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382808|NCT00852410|Lidocaine|lidocaine|mesh-list
65382809|NCT00852410|Epinephrine|epinephrine|mesh-list
65382810|NCT00852410|Racepinephrine|racepinephrine|mesh-list
65382811|NCT00852410|Epinephryl borate|epinephryl borate|mesh-list
65382812|NCT00852410|Anesthetics, Local|anesthetics, local|mesh-ancestor
65382813|NCT00852410|Anesthetics|anesthetics|mesh-ancestor
65382814|NCT00852410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65382815|NCT00852410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382816|NCT00852410|Sensory System Agents|sensory system agents|mesh-ancestor
65382817|NCT00852410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65382818|NCT00852410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65382819|NCT00852410|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65382820|NCT00852410|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65382821|NCT00852410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65382822|NCT00852410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382823|NCT00852410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65382824|NCT00852410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65382825|NCT00852410|Adrenergic Agents|adrenergic agents|mesh-ancestor
65382826|NCT00852410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65382827|NCT00852410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65382828|NCT00852410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65382829|NCT00852410|Autonomic Agents|autonomic agents|mesh-ancestor
65382830|NCT00852410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65382831|NCT00852410|Respiratory System Agents|respiratory system agents|mesh-ancestor
65382832|NCT00852410|Mydriatics|mydriatics|mesh-ancestor
65382833|NCT00852410|Sympathomimetics|sympathomimetics|mesh-ancestor
65382834|NCT00852410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65382835|NCT00992121|Bevacizumab|bevacizumab|mesh-list
65382836|NCT00992121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65382837|NCT00992121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382838|NCT00992121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65382839|NCT00992121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65382840|NCT00992121|Growth Substances|growth substances|mesh-ancestor
64775434|NCT01828476|Antimalarials|antimalarials|mesh-ancestor
65382842|NCT00992121|Growth Inhibitors|growth inhibitors|mesh-ancestor
65382843|NCT04420299|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65382844|NCT04420299|Bemiparin|bemiparin|mesh-list
65382845|NCT04420299|Anticoagulants|anticoagulants|mesh-ancestor
65382846|NCT04420299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65382847|NCT04420299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65382848|NCT04420299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382849|NCT00992199|Fluorouracil|fluorouracil|mesh-list
65382850|NCT00992199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382851|NCT00992199|Antimetabolites|antimetabolites|mesh-ancestor
65382852|NCT00992199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382853|NCT00992199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65382854|NCT00992199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65382855|NCT00992199|Immunologic Factors|immunologic factors|mesh-ancestor
65382856|NCT00992199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382857|NCT00856310|Fasinumab|fasinumab|mesh-list
65382858|NCT00856310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65382859|NCT00856310|Analgesics|analgesics|mesh-ancestor
65382860|NCT00856310|Sensory System Agents|sensory system agents|mesh-ancestor
65382861|NCT00856310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65382862|NCT00856310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382863|NCT02773485|Gemcitabine|gemcitabine|mesh-list
65382864|NCT02773485|Cisplatin|cisplatin|mesh-list
65382865|NCT02773485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382866|NCT02773485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65382867|NCT02773485|Antimetabolites|antimetabolites|mesh-ancestor
65382868|NCT02773485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382869|NCT02773485|Antiviral Agents|antiviral agents|mesh-ancestor
65382870|NCT02773485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65382871|NCT02773485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382872|NCT02773485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65382873|NCT02773485|Immunologic Factors|immunologic factors|mesh-ancestor
65382885|NCT00992355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65382886|NCT00992355|Antiemetics|antiemetics|mesh-ancestor
65382887|NCT00992355|Autonomic Agents|autonomic agents|mesh-ancestor
65382888|NCT00992355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65382889|NCT00992355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382890|NCT00992355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65382891|NCT00992355|Glucocorticoids|glucocorticoids|mesh-ancestor
65382892|NCT00992355|Hormones|hormones|mesh-ancestor
65382893|NCT00992355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65382894|NCT00992355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65382895|NCT00992355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382896|NCT00992355|Protease Inhibitors|protease inhibitors|mesh-ancestor
65382897|NCT00992355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382898|NCT00992355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382899|NCT00992355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65382900|NCT00992355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65382901|NCT00992355|Analgesics|analgesics|mesh-ancestor
65382902|NCT00992355|Sensory System Agents|sensory system agents|mesh-ancestor
65382903|NCT00992355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65382904|NCT00992355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65382905|NCT00992355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65382906|NCT00992355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65382907|NCT02465307|Hydrocortisone|hydrocortisone|mesh-list
65382908|NCT02465307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65382909|NCT00852566|Imatinib Mesylate|imatinib mesylate|mesh-list
65382910|NCT00852566|Dasatinib|dasatinib|mesh-list
65382911|NCT00852566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382912|NCT00852566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64668786|NCT01928693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64668787|NCT01928693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64668789|NCT01928849|Anticonvulsants|anticonvulsants|mesh-ancestor
64668790|NCT01928849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64668791|NCT01928849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668792|NCT01928849|GABA Agents|gaba agents|mesh-ancestor
64668793|NCT01928849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64668817|NCT01944293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64668818|NCT01944293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64668819|NCT01944293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64668820|NCT01944293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64668821|NCT01944293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64668823|NCT01944293|GABA Agents|gaba agents|mesh-ancestor
64668824|NCT01944371|Disulfiram|disulfiram|mesh-list
64668825|NCT01944371|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64668826|NCT01944371|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
64394176|NCT02402491|Antipyretics|antipyretics|mesh-ancestor
64668827|NCT01944371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64668828|NCT01944371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382913|NCT00852566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382914|NCT00852566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382915|NCT00856622|Timolol|timolol|mesh-list
65382916|NCT00856622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65382917|NCT00856622|Latanoprost|latanoprost|mesh-list
65382918|NCT00856622|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65382919|NCT00856622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65382920|NCT00856622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65382921|NCT00856622|Adrenergic Agents|adrenergic agents|mesh-ancestor
65382922|NCT00856622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65382923|NCT00856622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382924|NCT00856622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382925|NCT00856622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65382926|NCT00856622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65382927|NCT00856700|Incretins|incretins|mesh-list
65382928|NCT00856700|Hormones|hormones|mesh-ancestor
65382929|NCT00856700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65382930|NCT00856700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382931|NCT00618956|Milnacipran|milnacipran|mesh-list
65382932|NCT00618956|Levomilnacipran|levomilnacipran|mesh-list
65382933|NCT00618956|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65382934|NCT00618956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65382935|NCT00618956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65382936|NCT00618956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382937|NCT00618956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64668830|NCT02343120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64668831|NCT02343120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64668832|NCT02343120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556563|NCT04368819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556564|NCT04368819|Gout Suppressants|gout suppressants|mesh-ancestor
64556565|NCT04368819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64556566|NCT04368819|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64556567|NCT04368819|Antioxidants|antioxidants|mesh-ancestor
64556568|NCT04368819|Protective Agents|protective agents|mesh-ancestor
64556569|NCT04368819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556570|NCT04368585|Simethicone|simethicone|mesh-list
64556571|NCT04368585|Omeprazole|omeprazole|mesh-list
64556572|NCT04368585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64556573|NCT04368585|Magnesium Hydroxide|magnesium hydroxide|mesh-list
64556574|NCT04368585|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
64556575|NCT04368585|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
64556577|NCT04368585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64556578|NCT04368585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64668833|NCT02343120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668834|NCT01631630|Pioglitazone|pioglitazone|mesh-list
64668835|NCT01631630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65382938|NCT00618956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382939|NCT00618956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65382940|NCT00618956|Analgesics|analgesics|mesh-ancestor
65382941|NCT00618956|Sensory System Agents|sensory system agents|mesh-ancestor
65382942|NCT00618956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65382943|NCT00618956|Antidepressive Agents|antidepressive agents|mesh-ancestor
65382944|NCT00618956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65382945|NCT00852800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65382946|NCT00845546|Loratadine|loratadine|mesh-list
65382948|NCT00845546|Ephedrine|ephedrine|mesh-list
65382949|NCT00845546|Antipruritics|antipruritics|mesh-ancestor
65382950|NCT00845546|Dermatologic Agents|dermatologic agents|mesh-ancestor
65382951|NCT00845546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65382952|NCT00845546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65382953|NCT00845546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65382954|NCT00845546|Histamine Antagonists|histamine antagonists|mesh-ancestor
65382955|NCT00845546|Histamine Agents|histamine agents|mesh-ancestor
65382956|NCT00845546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65382957|NCT00845546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382958|NCT00845546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382959|NCT00845546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65382960|NCT00845546|Autonomic Agents|autonomic agents|mesh-ancestor
65382961|NCT00845546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65382962|NCT00845546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65382963|NCT00845546|Respiratory System Agents|respiratory system agents|mesh-ancestor
65382964|NCT00845546|Nasal Decongestants|nasal decongestants|mesh-ancestor
65382965|NCT00845546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65382966|NCT00845546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65382967|NCT00845546|Sympathomimetics|sympathomimetics|mesh-ancestor
65382968|NCT00845546|Adrenergic Agents|adrenergic agents|mesh-ancestor
65382969|NCT00852956|Betahistine|betahistine|mesh-list
65382970|NCT00852956|Vasodilator Agents|vasodilator agents|mesh-ancestor
65382971|NCT00852956|Histamine Agonists|histamine agonists|mesh-ancestor
64668836|NCT01631630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668838|NCT03837860|Risperidone|risperidone|mesh-list
64668839|NCT03837860|Ziprasidone|ziprasidone|mesh-list
64668840|NCT03837860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64668841|NCT03837860|Narcotics|narcotics|mesh-ancestor
64668842|NCT03837860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64668843|NCT03837860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668844|NCT03837860|Analgesics|analgesics|mesh-ancestor
64668845|NCT03837860|Sensory System Agents|sensory system agents|mesh-ancestor
64668846|NCT03837860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668855|NCT03837860|Dopamine Agents|dopamine agents|mesh-ancestor
65382972|NCT00852956|Histamine Agents|histamine agents|mesh-ancestor
65382973|NCT00852956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65382974|NCT00852956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382975|NCT00852956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382976|NCT00716417|Afatinib|afatinib|mesh-list
65382977|NCT00716417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382978|NCT00716417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65382979|NCT00716417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382980|NCT00716417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382981|NCT02592863|Pentoxifylline|pentoxifylline|mesh-list
65382982|NCT02592863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65382983|NCT02592863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382984|NCT02592863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382985|NCT02592863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65382986|NCT02592863|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65382987|NCT02592863|Protective Agents|protective agents|mesh-ancestor
65382988|NCT02592863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382989|NCT02592863|Vasodilator Agents|vasodilator agents|mesh-ancestor
65382990|NCT02592863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65382991|NCT02592863|Antioxidants|antioxidants|mesh-ancestor
64668856|NCT02289989|Hydrocortisone|hydrocortisone|mesh-list
64668857|NCT02289989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64668858|NCT03076112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64668859|NCT03076112|Ipragliflozin|ipragliflozin|mesh-list
64668860|NCT03076112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64668861|NCT03076112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668862|NCT03076112|Incretins|incretins|mesh-ancestor
64668863|NCT03076112|Hormones|hormones|mesh-ancestor
64668864|NCT03076112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64668865|NCT03076112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64668866|NCT03076112|Protease Inhibitors|protease inhibitors|mesh-ancestor
64668867|NCT03076112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64668868|NCT03076112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668869|NCT03076112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64668870|NCT03129945|Indomethacin|indomethacin|mesh-list
64668871|NCT03129945|Nifedipine|nifedipine|mesh-list
64668872|NCT03129945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64668873|NCT03129945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64668874|NCT03129945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668875|NCT03129945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64668876|NCT03129945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668877|NCT03129945|Vasodilator Agents|vasodilator agents|mesh-ancestor
64668878|NCT03129945|Tocolytic Agents|tocolytic agents|mesh-ancestor
64668879|NCT03129945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64668880|NCT03129945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64668881|NCT03129945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64668882|NCT03129945|Analgesics|analgesics|mesh-ancestor
64668883|NCT03129945|Sensory System Agents|sensory system agents|mesh-ancestor
64556580|NCT04368585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556581|NCT04368585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556582|NCT04368585|Antifoaming Agents|antifoaming agents|mesh-ancestor
64556583|NCT04368585|Emollients|emollients|mesh-ancestor
65382992|NCT00719537|Aspirin|aspirin|mesh-list
65382993|NCT00719537|Progesterone|progesterone|mesh-list
65382994|NCT00719537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65382995|NCT00719537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65382996|NCT00719537|Analgesics|analgesics|mesh-ancestor
65382997|NCT00719537|Sensory System Agents|sensory system agents|mesh-ancestor
65382998|NCT00719537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65382999|NCT00719537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383000|NCT00719537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65383001|NCT00719537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65383002|NCT00719537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65383003|NCT00719537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65383004|NCT00719537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383005|NCT00719537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65383006|NCT00719537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65383007|NCT00719537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383008|NCT00719537|Antipyretics|antipyretics|mesh-ancestor
65383009|NCT00719537|Progestins|progestins|mesh-ancestor
65383010|NCT00719537|Hormones|hormones|mesh-ancestor
65383011|NCT00719537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65383012|NCT00853190|Chlorpheniramine|chlorpheniramine|mesh-list
64775626|NCT01852344|Dopamine Agents|dopamine agents|mesh-ancestor
64556584|NCT04368585|Dermatologic Agents|dermatologic agents|mesh-ancestor
64556585|NCT04368585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64556586|NCT04368585|Immunologic Factors|immunologic factors|mesh-ancestor
64321658|NCT05504330|Antipyretics|antipyretics|mesh-ancestor
64668884|NCT03129945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668885|NCT03129945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64668886|NCT03129945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64668889|NCT03129945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64668890|NCT01700036|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64668891|NCT01700036|Protein C Inhibitor|protein c inhibitor|mesh-list
64668892|NCT01700036|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64668893|NCT01700036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64668894|NCT01700036|Protease Inhibitors|protease inhibitors|mesh-ancestor
64668895|NCT01700036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64668896|NCT01700036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668897|NCT02971748|Pembrolizumab|pembrolizumab|mesh-list
64668898|NCT02971748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64668899|NCT02971748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64668900|NCT01950299|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64668912|NCT03093207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64668913|NCT03093207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668914|NCT03093207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64668915|NCT03093207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64668916|NCT03093207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64668917|NCT03093207|Antipyretics|antipyretics|mesh-ancestor
64668919|NCT05482451|Tretinoin|tretinoin|mesh-list
64668920|NCT05482451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64668921|NCT05482451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64668922|NCT05482451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64668923|NCT05482451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668924|NCT05482451|Keratolytic Agents|keratolytic agents|mesh-ancestor
65383013|NCT00853190|Hydrocodone|hydrocodone|mesh-list
65383014|NCT00853190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383015|NCT00853190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65383016|NCT00853190|Narcotics|narcotics|mesh-ancestor
65383017|NCT00853190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65383018|NCT00853190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383019|NCT00853190|Analgesics|analgesics|mesh-ancestor
65383020|NCT00853190|Sensory System Agents|sensory system agents|mesh-ancestor
65383021|NCT00853190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65383022|NCT00853190|Antitussive Agents|antitussive agents|mesh-ancestor
65383023|NCT00853190|Respiratory System Agents|respiratory system agents|mesh-ancestor
65383024|NCT00853190|Antipruritics|antipruritics|mesh-ancestor
65383025|NCT00853190|Dermatologic Agents|dermatologic agents|mesh-ancestor
65383026|NCT00853190|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65383027|NCT00853190|Histamine Antagonists|histamine antagonists|mesh-ancestor
65383028|NCT00853190|Histamine Agents|histamine agents|mesh-ancestor
65383029|NCT00853190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65383030|NCT00853190|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65383031|NCT02591225|Phenprocoumon|phenprocoumon|mesh-list
65383032|NCT02591225|Anticoagulants|anticoagulants|mesh-ancestor
65383034|NCT00573794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65383035|NCT00573794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65383036|NCT00715793|Temozolomide|temozolomide|mesh-list
65383037|NCT00715793|Decitabine|decitabine|mesh-list
64668925|NCT05482451|Dermatologic Agents|dermatologic agents|mesh-ancestor
64668926|NCT02228408|Hydralazine|hydralazine|mesh-list
64668927|NCT02228408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64668928|NCT02228408|Vasodilator Agents|vasodilator agents|mesh-ancestor
64668929|NCT03134703|Morphine|morphine|mesh-list
64668930|NCT03134703|Methadone|methadone|mesh-list
64668931|NCT03134703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64668932|NCT03134703|Narcotics|narcotics|mesh-ancestor
64668933|NCT03134703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64668934|NCT03134703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668935|NCT03134703|Analgesics|analgesics|mesh-ancestor
64668936|NCT03134703|Sensory System Agents|sensory system agents|mesh-ancestor
64668937|NCT03134703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668938|NCT03134703|Antitussive Agents|antitussive agents|mesh-ancestor
64668939|NCT03134703|Respiratory System Agents|respiratory system agents|mesh-ancestor
64668940|NCT01951391|Benzalkonium Compounds|benzalkonium compounds|mesh-list
64668941|NCT01951391|Triclocarban|triclocarban|mesh-list
64668942|NCT01951391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64668943|NCT01951391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64668944|NCT02342886|Moxifloxacin|moxifloxacin|mesh-list
64668945|NCT02342886|Rifampin|rifampin|mesh-list
64668946|NCT02342886|Isoniazid|isoniazid|mesh-list
64668947|NCT02342886|Pyrazinamide|pyrazinamide|mesh-list
64668948|NCT02342886|Ethambutol|ethambutol|mesh-list
64668949|NCT02342886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64668950|NCT02342886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64668951|NCT02342886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64668952|NCT02342886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64556587|NCT04368585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556589|NCT04368585|Antioxidants|antioxidants|mesh-ancestor
64556590|NCT04368585|Protective Agents|protective agents|mesh-ancestor
64556591|NCT04361331|Lenvatinib|lenvatinib|mesh-list
65383038|NCT00715793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65383039|NCT00715793|Alkylating Agents|alkylating agents|mesh-ancestor
65383040|NCT00715793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383041|NCT00715793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383042|NCT00715793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65383043|NCT00715793|Antimetabolites|antimetabolites|mesh-ancestor
65383044|NCT00715793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383045|NCT00924014|Furosemide|furosemide|mesh-list
65383046|NCT00924014|Conivaptan|conivaptan|mesh-list
65383047|NCT00924014|Diuretics|diuretics|mesh-ancestor
65383048|NCT00924014|Natriuretic Agents|natriuretic agents|mesh-ancestor
65383049|NCT00924014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383050|NCT00924014|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65383051|NCT00924014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65383052|NCT00924014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383053|NCT00924014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65383054|NCT00853268|Oxycodone|oxycodone|mesh-list
65383055|NCT00853268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65383056|NCT00853268|Narcotics|narcotics|mesh-ancestor
65383057|NCT00853268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65383058|NCT00853268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383059|NCT00853268|Analgesics|analgesics|mesh-ancestor
65383060|NCT00853268|Sensory System Agents|sensory system agents|mesh-ancestor
65383061|NCT00853268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65383062|NCT00845780|Amiodarone|amiodarone|mesh-list
65383063|NCT00845780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65383064|NCT00845780|Vasodilator Agents|vasodilator agents|mesh-ancestor
65383065|NCT00845780|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65383082|NCT00853502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65383083|NCT00853502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383084|NCT00853502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65383085|NCT00853502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383086|NCT00853502|Anabolic Agents|anabolic agents|mesh-ancestor
65383087|NCT00853736|Oxycodone|oxycodone|mesh-list
65383088|NCT00853736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65383089|NCT00853736|Narcotics|narcotics|mesh-ancestor
65383090|NCT00853736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65383091|NCT00853736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383092|NCT00853736|Analgesics|analgesics|mesh-ancestor
65383093|NCT00853736|Sensory System Agents|sensory system agents|mesh-ancestor
65383094|NCT00853736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65132696|NCT04551768|Ribavirin|ribavirin|mesh-list
65383095|NCT00857168|Testosterone|testosterone|mesh-list
65383096|NCT00857168|Androgens|androgens|mesh-ancestor
65383097|NCT00857168|Hormones|hormones|mesh-ancestor
65383098|NCT00857168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65383099|NCT00857168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383100|NCT00857324|Vorinostat|vorinostat|mesh-list
65383101|NCT00857324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383102|NCT00857324|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65383103|NCT00857324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383104|NCT00857324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383105|NCT00853892|Oxycodone|oxycodone|mesh-list
64775711|NCT05328102|Lenalidomide|lenalidomide|mesh-list
64556592|NCT04361331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556593|NCT04361331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64556594|NCT04361331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556595|NCT04361331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556596|NCT04990830|Heparin|heparin|mesh-list
64556597|NCT04990830|Enoxaparin|enoxaparin|mesh-list
64556598|NCT04990830|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64556599|NCT04990830|Tinzaparin|tinzaparin|mesh-list
64556600|NCT04990830|Dalteparin|dalteparin|mesh-list
64556601|NCT04990830|Enoxaparin sodium|enoxaparin sodium|mesh-list
64556602|NCT04990830|Anticoagulants|anticoagulants|mesh-ancestor
64556603|NCT04990830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64556604|NCT04990830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64556605|NCT04990830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556606|NCT04361409|Gemcitabine|gemcitabine|mesh-list
64556607|NCT04361409|Rituximab|rituximab|mesh-list
64668955|NCT02342886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64668957|NCT02342886|Antitubercular Agents|antitubercular agents|mesh-ancestor
64668958|NCT02342886|Leprostatic Agents|leprostatic agents|mesh-ancestor
64668959|NCT02342886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64668960|NCT02342886|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64668961|NCT02342886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64668962|NCT02342886|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64668963|NCT02342886|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65383106|NCT00853892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65383107|NCT00853892|Narcotics|narcotics|mesh-ancestor
65383108|NCT00853892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65383109|NCT00853892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383110|NCT00853892|Analgesics|analgesics|mesh-ancestor
65383111|NCT00853892|Sensory System Agents|sensory system agents|mesh-ancestor
65383112|NCT00853892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65383113|NCT04164212|Vaccines|vaccines|mesh-list
65383114|NCT04164212|Immunologic Factors|immunologic factors|mesh-ancestor
65383115|NCT04164212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383116|NCT00857558|Saxagliptin|saxagliptin|mesh-list
65383117|NCT00857558|Incretins|incretins|mesh-ancestor
65383118|NCT00857558|Hormones|hormones|mesh-ancestor
65383119|NCT00857558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65383120|NCT00857558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383121|NCT00857558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65383122|NCT00857558|Protease Inhibitors|protease inhibitors|mesh-ancestor
65383123|NCT00857558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383124|NCT00857558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383125|NCT00857558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65383126|NCT00718523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65383127|NCT00718523|Immunologic Factors|immunologic factors|mesh-ancestor
65383128|NCT00718523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383129|NCT00715559|Cysteamine|cysteamine|mesh-list
65383130|NCT00715559|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
65383131|NCT00715559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383132|NCT05289869|Oxytocin|oxytocin|mesh-list
65383133|NCT05289869|Oxytocics|oxytocics|mesh-ancestor
65383134|NCT05289869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65383135|NCT05289869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668964|NCT02342886|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64668965|NCT02342886|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64668966|NCT02342886|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64668967|NCT02342886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64668969|NCT02342886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64668970|NCT04350281|Interferons|interferons|mesh-list
64668971|NCT04350281|Interferon-beta|interferon-beta|mesh-list
64668972|NCT04350281|Hydroxychloroquine|hydroxychloroquine|mesh-list
64668973|NCT04350281|Interferon beta-1b|interferon beta-1b|mesh-list
64668974|NCT04350281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64668975|NCT04350281|Antiviral Agents|antiviral agents|mesh-ancestor
64668976|NCT04350281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64668977|NCT04350281|Antimalarials|antimalarials|mesh-ancestor
64668978|NCT04350281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64668979|NCT04350281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64668980|NCT04350281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383136|NCT00620282|Liraglutide|liraglutide|mesh-list
65383137|NCT00620282|Glimepiride|glimepiride|mesh-list
65383138|NCT00620282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65383139|NCT00620282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383140|NCT00620282|Incretins|incretins|mesh-ancestor
65383141|NCT00620282|Hormones|hormones|mesh-ancestor
65383142|NCT00620282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65383143|NCT00620282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65383144|NCT00620282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65383145|NCT00620282|Immunologic Factors|immunologic factors|mesh-ancestor
65383146|NCT05684861|Isotretinoin|isotretinoin|mesh-list
65383147|NCT05684861|Dermatologic Agents|dermatologic agents|mesh-ancestor
65383148|NCT04042688|Tranexamic Acid|tranexamic acid|mesh-list
65383149|NCT04042688|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65383150|NCT04042688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65383151|NCT04042688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383152|NCT04042688|Hemostatics|hemostatics|mesh-ancestor
65383153|NCT04042688|Coagulants|coagulants|mesh-ancestor
65383154|NCT02590133|Fluorouracil|fluorouracil|mesh-list
65383155|NCT02590133|Endostar protein|endostar protein|mesh-list
65383156|NCT02590133|Endostatins|endostatins|mesh-list
65383157|NCT02590133|Nedaplatin|nedaplatin|mesh-list
65383158|NCT02590133|Antimetabolites|antimetabolites|mesh-ancestor
65383159|NCT02590133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383160|NCT02590133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65383161|NCT02590133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383162|NCT02590133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65383163|NCT02590133|Immunologic Factors|immunologic factors|mesh-ancestor
65383164|NCT02590133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383165|NCT02590133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65383166|NCT02590133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65383167|NCT02590133|Growth Substances|growth substances|mesh-ancestor
65383180|NCT00857870|Insulin Glargine|insulin glargine|mesh-list
65383181|NCT00857870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65383182|NCT00857870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383183|NCT00848432|Risperidone|risperidone|mesh-list
65383184|NCT00848432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65383185|NCT00848432|Serotonin Agents|serotonin agents|mesh-ancestor
65383186|NCT00848432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65383187|NCT00848432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383188|NCT00848432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383189|NCT00848432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65383190|NCT00848432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65383191|NCT00848432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65383192|NCT00848432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65383193|NCT00848432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65383194|NCT00848432|Dopamine Agents|dopamine agents|mesh-ancestor
65383195|NCT00854750|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65383196|NCT00854750|Hormones|hormones|mesh-ancestor
65383197|NCT00854750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65383198|NCT00854750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383199|NCT00858182|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65383200|NCT02545244|Chlorhexidine|chlorhexidine|mesh-list
65383201|NCT02545244|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65383202|NCT02545244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65383203|NCT02545244|Disinfectants|disinfectants|mesh-ancestor
65383204|NCT00858338|Floxuridine|floxuridine|mesh-list
65383205|NCT00858338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65383206|NCT00858338|Antimetabolites|antimetabolites|mesh-ancestor
65383207|NCT00858338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383208|NCT00858338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383209|NCT00515086|Everolimus|everolimus|mesh-list
65383210|NCT00515086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383211|NCT00515086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65383212|NCT00515086|Immunologic Factors|immunologic factors|mesh-ancestor
65383213|NCT00515086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383214|NCT00858806|Imatinib Mesylate|imatinib mesylate|mesh-list
64775806|NCT00954876|Cetuximab|cetuximab|mesh-list
64668981|NCT04350281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668982|NCT04350281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64668983|NCT04350281|Immunologic Factors|immunologic factors|mesh-ancestor
65383215|NCT00858806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383216|NCT00858806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65383217|NCT00858806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383218|NCT00858806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383219|NCT01011478|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65383220|NCT01011478|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65383221|NCT01011478|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65383222|NCT01011478|Antimetabolites|antimetabolites|mesh-ancestor
65383223|NCT01011478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383224|NCT01011478|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65383225|NCT01011478|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65383226|NCT01011478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383227|NCT00849368|Azathioprine|azathioprine|mesh-list
65383228|NCT00849368|Allopurinol|allopurinol|mesh-list
65383229|NCT00849368|Antimetabolites|antimetabolites|mesh-ancestor
65383230|NCT00849368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383231|NCT00849368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383232|NCT00849368|Gout Suppressants|gout suppressants|mesh-ancestor
65383233|NCT00849368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65383234|NCT00849368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65383235|NCT00849368|Antioxidants|antioxidants|mesh-ancestor
65383236|NCT00849368|Protective Agents|protective agents|mesh-ancestor
65383237|NCT00849368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383238|NCT00849368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65383239|NCT00849368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383240|NCT00849368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65383241|NCT00849368|Immunologic Factors|immunologic factors|mesh-ancestor
65383242|NCT02544932|Warfarin|warfarin|mesh-list
65383243|NCT02544932|Dabigatran|dabigatran|mesh-list
65383244|NCT02544932|Anticoagulants|anticoagulants|mesh-ancestor
65383245|NCT02544932|Antithrombins|antithrombins|mesh-ancestor
65383246|NCT02544932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65383247|NCT02544932|Protease Inhibitors|protease inhibitors|mesh-ancestor
64668984|NCT04350281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668985|NCT04350281|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64668986|NCT02389998|Hyoscyamine|hyoscyamine|mesh-list
64668987|NCT02389998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64668988|NCT02389998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64668989|NCT02389998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64668990|NCT02389998|Autonomic Agents|autonomic agents|mesh-ancestor
64556608|NCT04361409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64556609|NCT04361409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556610|NCT04361409|Immunologic Factors|immunologic factors|mesh-ancestor
65383248|NCT02544932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383249|NCT02544932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383251|NCT02544854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65383252|NCT02544854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65383253|NCT02544854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383254|NCT02544854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65383255|NCT02544854|Anesthetics, General|anesthetics, general|mesh-ancestor
65383256|NCT02544854|Anesthetics|anesthetics|mesh-ancestor
65383257|NCT00861536|Thymoglobulin|thymoglobulin|mesh-list
65383258|NCT00861536|Immunologic Factors|immunologic factors|mesh-ancestor
65383259|NCT00861536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383260|NCT00861536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65383261|NCT02544776|Amlodipine|amlodipine|mesh-list
65383262|NCT02544776|Clomiphene|clomiphene|mesh-list
65383263|NCT02544776|Enclomiphene|enclomiphene|mesh-list
65383264|NCT02544776|Zuclomiphene|zuclomiphene|mesh-list
65383265|NCT02544776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383266|NCT02544776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65383267|NCT02544776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65383268|NCT02544776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65383269|NCT02544776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65383270|NCT02544776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556611|NCT04361409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556612|NCT04361409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64556613|NCT04361409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64556614|NCT04361409|Antimetabolites|antimetabolites|mesh-ancestor
64668991|NCT02389998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668992|NCT02389998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668993|NCT02389998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64668994|NCT02389998|Respiratory System Agents|respiratory system agents|mesh-ancestor
64669017|NCT01647932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64669018|NCT01647932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669019|NCT04903002|Oxytocin|oxytocin|mesh-list
64669020|NCT04903002|Oxytocics|oxytocics|mesh-ancestor
64669021|NCT04903002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64669022|NCT04903002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669023|NCT02366130|Denosumab|denosumab|mesh-list
64669024|NCT02366130|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64669025|NCT02366130|Hormones|hormones|mesh-list
64669026|NCT02366130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64669027|NCT02366130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669028|NCT02366130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64669029|NCT02366130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669030|NCT01635062|Calcitriol|calcitriol|mesh-list
64669031|NCT01635062|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
64669032|NCT01635062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64669033|NCT01635062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669034|NCT01635062|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64669035|NCT01635062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64669036|NCT01635062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383271|NCT02544776|Vasodilator Agents|vasodilator agents|mesh-ancestor
65383272|NCT02544776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65383273|NCT02544776|Hormone Antagonists|hormone antagonists|mesh-ancestor
65383274|NCT02544776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65383275|NCT02544776|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65383276|NCT02544776|Fertility Agents|fertility agents|mesh-ancestor
65383277|NCT02544776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65383278|NCT02544776|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65383279|NCT02544776|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65383280|NCT00859118|Axitinib|axitinib|mesh-list
65383281|NCT00859118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383282|NCT00859118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65383283|NCT00859118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383284|NCT00859118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383285|NCT00849602|Chloroquine|chloroquine|mesh-list
65383286|NCT00849602|Amebicides|amebicides|mesh-ancestor
65383287|NCT00849602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65383288|NCT00849602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65383289|NCT00849602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65383290|NCT00849602|Antimalarials|antimalarials|mesh-ancestor
65383291|NCT00849602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65383292|NCT00859274|Budesonide|budesonide|mesh-list
65383293|NCT00859274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65383294|NCT00859274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65383295|NCT00859274|Autonomic Agents|autonomic agents|mesh-ancestor
65383296|NCT00859274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65383297|NCT00859274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383298|NCT00859274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65383299|NCT00859274|Respiratory System Agents|respiratory system agents|mesh-ancestor
65383300|NCT00859274|Glucocorticoids|glucocorticoids|mesh-ancestor
65383301|NCT00859274|Hormones|hormones|mesh-ancestor
65383302|NCT00859274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65383303|NCT00859352|Midazolam|midazolam|mesh-list
64775911|NCT05151588|Docetaxel|docetaxel|mesh-list
64669037|NCT01635062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64669038|NCT01635062|Vitamins|vitamins|mesh-ancestor
64669039|NCT01635062|Micronutrients|micronutrients|mesh-ancestor
64669055|NCT02342418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64669057|NCT04902378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64669058|NCT04902378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669062|NCT03102645|Imipramine|imipramine|mesh-list
65383304|NCT00859352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65383305|NCT00859352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65383306|NCT00859352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65383307|NCT00859352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383308|NCT00859352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65383309|NCT00859352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65383310|NCT00859352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65383311|NCT00859352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65383312|NCT00859352|Anesthetics, General|anesthetics, general|mesh-ancestor
65383313|NCT00859352|Anesthetics|anesthetics|mesh-ancestor
65383314|NCT00859352|GABA Modulators|gaba modulators|mesh-ancestor
65383315|NCT00859352|GABA Agents|gaba agents|mesh-ancestor
65383316|NCT00859352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65383317|NCT00859352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383318|NCT00861926|Beclomethasone|beclomethasone|mesh-list
65383319|NCT00861926|Albuterol|albuterol|mesh-list
65383320|NCT00861926|Formoterol Fumarate|formoterol fumarate|mesh-list
65383321|NCT00861926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65383322|NCT00861926|Autonomic Agents|autonomic agents|mesh-ancestor
65383323|NCT00861926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65383324|NCT00861926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383325|NCT00861926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65383326|NCT00861926|Respiratory System Agents|respiratory system agents|mesh-ancestor
65383327|NCT00861926|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65383328|NCT00861926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65383329|NCT00861926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65383330|NCT00861926|Adrenergic Agents|adrenergic agents|mesh-ancestor
65383331|NCT00861926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65383332|NCT00861926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383334|NCT00861926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65383335|NCT00861926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65383336|NCT00861926|Glucocorticoids|glucocorticoids|mesh-ancestor
65383337|NCT00861926|Hormones|hormones|mesh-ancestor
65383338|NCT00861926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65383339|NCT00849992|Imiquimod|imiquimod|mesh-list
64669063|NCT03102645|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64669064|NCT03102645|Antidepressive Agents|antidepressive agents|mesh-ancestor
64669065|NCT03102645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64669066|NCT03102645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64669067|NCT03102645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65383340|NCT00849992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65383341|NCT00849992|Immunologic Factors|immunologic factors|mesh-ancestor
65383342|NCT00849992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383343|NCT00849992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383344|NCT00849992|Interferon Inducers|interferon inducers|mesh-ancestor
65383345|NCT00618722|Deoxycholic Acid|deoxycholic acid|mesh-list
65383346|NCT00618722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65383347|NCT00618722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65383348|NCT02544698|Vaccines|vaccines|mesh-list
65383349|NCT02544698|Immunologic Factors|immunologic factors|mesh-ancestor
65383350|NCT02544698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383351|NCT00862394|Formoterol Fumarate|formoterol fumarate|mesh-list
65383352|NCT00862394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65383353|NCT00862394|Autonomic Agents|autonomic agents|mesh-ancestor
65383354|NCT00862394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65383355|NCT00862394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383356|NCT00862394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65383357|NCT00862394|Respiratory System Agents|respiratory system agents|mesh-ancestor
65383358|NCT00862394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65383359|NCT00862394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65383360|NCT00862394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65383361|NCT00862394|Adrenergic Agents|adrenergic agents|mesh-ancestor
65383362|NCT00862394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65383363|NCT00862394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383364|NCT00862472|Timolol|timolol|mesh-list
65383365|NCT00862472|Cloprostenol|cloprostenol|mesh-list
65383366|NCT00862472|Luteolytic Agents|luteolytic agents|mesh-ancestor
65383367|NCT00862472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65383368|NCT00862472|Contraceptive Agents|contraceptive agents|mesh-ancestor
65383369|NCT00862472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65383370|NCT00862472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775965|NCT04418466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64669068|NCT03102645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64669069|NCT03102645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669070|NCT03102645|Adrenergic Agents|adrenergic agents|mesh-ancestor
64669071|NCT03102645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64669072|NCT03102645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669073|NCT01639352|Pasireotide|pasireotide|mesh-list
64669074|NCT01639352|Hormones|hormones|mesh-ancestor
64669075|NCT01639352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64669076|NCT01639352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383371|NCT00862472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65383372|NCT00862472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65383373|NCT00862472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65383374|NCT00862472|Adrenergic Agents|adrenergic agents|mesh-ancestor
65383375|NCT00862472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65383376|NCT00862472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383377|NCT00862472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65383378|NCT00862472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65383379|NCT04007744|Pembrolizumab|pembrolizumab|mesh-list
65383380|NCT04007744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65383381|NCT04007744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383382|NCT00850304|Arsenic Trioxide|arsenic trioxide|mesh-list
65383383|NCT00850304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383384|NCT00850382|Cytarabine|cytarabine|mesh-list
65383385|NCT00850382|Daunorubicin|daunorubicin|mesh-list
65383386|NCT00850382|Dasatinib|dasatinib|mesh-list
65383387|NCT00850382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65383388|NCT00850382|Antimetabolites|antimetabolites|mesh-ancestor
65383389|NCT00850382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383390|NCT00850382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383391|NCT00850382|Antiviral Agents|antiviral agents|mesh-ancestor
65383392|NCT00850382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65383393|NCT00850382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65383394|NCT00850382|Immunologic Factors|immunologic factors|mesh-ancestor
65383395|NCT00850382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383396|NCT00850382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65383398|NCT00850382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65383399|NCT00850382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383400|NCT00850382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65383401|NCT00860366|Uric Acid|uric acid|mesh-list
65383402|NCT00860366|Antioxidants|antioxidants|mesh-ancestor
65383403|NCT00860366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383404|NCT00860366|Protective Agents|protective agents|mesh-ancestor
65383405|NCT00860366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383412|NCT00862628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383413|NCT00862628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383414|NCT00507442|Dexamethasone|dexamethasone|mesh-list
65383415|NCT00507442|Cyclophosphamide|cyclophosphamide|mesh-list
65383416|NCT00507442|Lenalidomide|lenalidomide|mesh-list
65383417|NCT00507442|Bortezomib|bortezomib|mesh-list
65383418|NCT00507442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65383419|NCT00507442|Immunologic Factors|immunologic factors|mesh-ancestor
65383420|NCT00507442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383421|NCT00507442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65383422|NCT00507442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65383423|NCT00507442|Alkylating Agents|alkylating agents|mesh-ancestor
65383424|NCT00507442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383425|NCT00507442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383426|NCT00507442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65383427|NCT00507442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65383428|NCT00507442|Antiemetics|antiemetics|mesh-ancestor
65383429|NCT00507442|Autonomic Agents|autonomic agents|mesh-ancestor
65383430|NCT00507442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65383431|NCT00507442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65383432|NCT00507442|Glucocorticoids|glucocorticoids|mesh-ancestor
65383433|NCT00507442|Hormones|hormones|mesh-ancestor
65383434|NCT00507442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65383435|NCT00507442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65383436|NCT00507442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65383437|NCT00507442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65383438|NCT00507442|Growth Substances|growth substances|mesh-ancestor
65383439|NCT00507442|Growth Inhibitors|growth inhibitors|mesh-ancestor
65383440|NCT00862706|Telbivudine|telbivudine|mesh-list
65383441|NCT00862706|Antiviral Agents|antiviral agents|mesh-ancestor
65383442|NCT00862706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65383443|NCT00862706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65383444|NCT00862706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383445|NCT00862706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383452|NCT00850850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383453|NCT00850850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383454|NCT00850850|Cholinergic Agents|cholinergic agents|mesh-ancestor
65383455|NCT00850850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65383456|NCT00850850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383457|NCT00850850|Miotics|miotics|mesh-ancestor
65383458|NCT00850850|Autonomic Agents|autonomic agents|mesh-ancestor
65383459|NCT00850850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65383460|NCT00619892|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65383461|NCT00619892|Antidepressive Agents|antidepressive agents|mesh-ancestor
65383462|NCT00619892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65383463|NCT00619892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65383464|NCT00619892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65383465|NCT00619892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65383466|NCT00619892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383467|NCT00861068|Lacosamide|lacosamide|mesh-list
65383468|NCT00861068|Anticonvulsants|anticonvulsants|mesh-ancestor
65383469|NCT00861068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65383470|NCT00861068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65383471|NCT00861068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65383472|NCT00861068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383473|NCT00863096|Vaccines|vaccines|mesh-list
65383474|NCT00863096|Immunologic Factors|immunologic factors|mesh-ancestor
65383475|NCT00863096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776088|NCT01420926|Bortezomib|bortezomib|mesh-list
64669077|NCT01705496|Fialuridine|fialuridine|mesh-list
64669078|NCT01705496|Antiviral Agents|antiviral agents|mesh-ancestor
64669079|NCT01705496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64669080|NCT01705496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64669081|NCT01705496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669082|NCT01705496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669083|NCT02287415|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64669084|NCT02287415|Warfarin|warfarin|mesh-list
64669085|NCT02287415|Anticoagulants|anticoagulants|mesh-ancestor
64669086|NCT02287415|Anticonvulsants|anticonvulsants|mesh-ancestor
64669087|NCT02287415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64556615|NCT04361409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556617|NCT04361409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64556618|NCT04361409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556619|NCT04361409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64556621|NCT04368273|Immunologic Factors|immunologic factors|mesh-ancestor
64556622|NCT04368273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556623|NCT04995354|Mitogens|mitogens|mesh-list
64556624|NCT04995354|Mitosis Modulators|mitosis modulators|mesh-ancestor
64556625|NCT04995354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556626|NCT04368351|Azithromycin|azithromycin|mesh-list
64556627|NCT04368351|Hydroxychloroquine|hydroxychloroquine|mesh-list
64556628|NCT04368351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64556629|NCT04368351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65383476|NCT00870272|Misoprostol|misoprostol|mesh-list
65383477|NCT00870272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65383478|NCT00870272|Abortifacient Agents|abortifacient agents|mesh-ancestor
65383479|NCT00870272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65383480|NCT00870272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383481|NCT00870272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65383482|NCT00870272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65383483|NCT00870272|Oxytocics|oxytocics|mesh-ancestor
65383484|NCT00863252|Mycophenolic Acid|mycophenolic acid|mesh-list
65383485|NCT00863252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65383486|NCT00863252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383487|NCT00863252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65383488|NCT00863252|Antitubercular Agents|antitubercular agents|mesh-ancestor
65383489|NCT00863252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65383490|NCT00863252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65383491|NCT00863252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383492|NCT00863252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383493|NCT00502996|Rituximab|rituximab|mesh-list
65383494|NCT00502996|Methotrexate|methotrexate|mesh-list
65383495|NCT00502996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65383496|NCT00502996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383497|NCT00502996|Immunologic Factors|immunologic factors|mesh-ancestor
65383498|NCT00502996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383499|NCT00502996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65383500|NCT00502996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65383501|NCT00502996|Abortifacient Agents|abortifacient agents|mesh-ancestor
65383523|NCT01013584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383524|NCT01013584|Vitamins|vitamins|mesh-ancestor
65383525|NCT01013584|Micronutrients|micronutrients|mesh-ancestor
65383526|NCT01013584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65383527|NCT00864110|Deoxyglucose|deoxyglucose|mesh-list
65383528|NCT00864110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65383529|NCT00864110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65383530|NCT00864110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383531|NCT00864110|Antimetabolites|antimetabolites|mesh-ancestor
65383532|NCT00864110|Antiviral Agents|antiviral agents|mesh-ancestor
65383533|NCT00864110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65383534|NCT00864188|Beta Carotene|beta carotene|mesh-list
65383535|NCT00864188|Carotenoids|carotenoids|mesh-list
65383536|NCT00864188|Antioxidants|antioxidants|mesh-ancestor
65383537|NCT00864188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383538|NCT00864188|Protective Agents|protective agents|mesh-ancestor
65383539|NCT00864188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383540|NCT00864188|Provitamins|provitamins|mesh-ancestor
65383541|NCT00864188|Vitamins|vitamins|mesh-ancestor
65383542|NCT00864188|Micronutrients|micronutrients|mesh-ancestor
65383543|NCT00865670|Azithromycin|azithromycin|mesh-list
65383544|NCT00865670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65383545|NCT00865670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65383546|NCT00864344|Sertraline|sertraline|mesh-list
65383547|NCT00864344|Antidepressive Agents|antidepressive agents|mesh-ancestor
65383548|NCT00864344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65383549|NCT00864344|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65383550|NCT00864344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65383551|NCT00864344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65383552|NCT00864344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383553|NCT00864344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65383554|NCT00864344|Serotonin Agents|serotonin agents|mesh-ancestor
64556630|NCT04368351|Antimalarials|antimalarials|mesh-ancestor
64556631|NCT04368351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64556632|NCT04368351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64321688|NCT02215213|Micronutrients|micronutrients|mesh-ancestor
64669088|NCT02287415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64669089|NCT02287415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64669090|NCT02287415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669091|NCT02312934|Nicotine|nicotine|mesh-list
64669092|NCT02312934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64669093|NCT02312934|Autonomic Agents|autonomic agents|mesh-ancestor
64669094|NCT02312934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64669095|NCT02312934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669096|NCT02312934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65383555|NCT00864344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383556|NCT00864500|Clobetasol|clobetasol|mesh-list
65383557|NCT00864500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65383558|NCT00864500|Glucocorticoids|glucocorticoids|mesh-ancestor
65383559|NCT00864500|Hormones|hormones|mesh-ancestor
65383560|NCT00864500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65383561|NCT00864500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383562|NCT00864734|Metformin|metformin|mesh-list
65383563|NCT00864734|Glyburide|glyburide|mesh-list
65383564|NCT00864734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65383565|NCT00864734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383566|NCT00864812|Fluticasone|fluticasone|mesh-list
65383567|NCT00864812|Xhance|xhance|mesh-list
65383568|NCT00864812|Tiotropium Bromide|tiotropium bromide|mesh-list
65383569|NCT00864812|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65383570|NCT00864812|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65383571|NCT00864812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65383572|NCT00864812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65383573|NCT00864812|Autonomic Agents|autonomic agents|mesh-ancestor
65383574|NCT00864812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65383575|NCT00864812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383576|NCT00864812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65383577|NCT00864812|Respiratory System Agents|respiratory system agents|mesh-ancestor
65383578|NCT00864812|Dermatologic Agents|dermatologic agents|mesh-ancestor
65383579|NCT00864812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65383580|NCT00864812|Parasympatholytics|parasympatholytics|mesh-ancestor
65383581|NCT00864812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65383582|NCT00864812|Cholinergic Agents|cholinergic agents|mesh-ancestor
65383583|NCT00864812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65383584|NCT00864812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776175|NCT01907334|Tocolytic Agents|tocolytic agents|mesh-ancestor
64669097|NCT02312934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64669098|NCT02312934|Cholinergic Agents|cholinergic agents|mesh-ancestor
64669099|NCT02312934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64669100|NCT02312934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669138|NCT02978157|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64669139|NCT02978157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669140|NCT02978157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669141|NCT02978157|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64669142|NCT02978157|Renal Agents|renal agents|mesh-ancestor
64669146|NCT02978157|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64669147|NCT02978157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64669149|NCT02978157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64669150|NCT01705964|Epinephrine|epinephrine|mesh-list
65383585|NCT00864812|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65383586|NCT00864812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65383587|NCT00864812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65383588|NCT00864812|Adrenergic Agents|adrenergic agents|mesh-ancestor
65383589|NCT00864812|Glucocorticoids|glucocorticoids|mesh-ancestor
65383590|NCT00864812|Hormones|hormones|mesh-ancestor
65383591|NCT00864812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65383592|NCT00864812|Sympathomimetics|sympathomimetics|mesh-ancestor
65383593|NCT02590055|Gemcitabine|gemcitabine|mesh-list
65383594|NCT02590055|Docetaxel|docetaxel|mesh-list
65383595|NCT02590055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65383596|NCT02590055|Antimetabolites|antimetabolites|mesh-ancestor
65383597|NCT02590055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383598|NCT02590055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383599|NCT02590055|Antiviral Agents|antiviral agents|mesh-ancestor
65383600|NCT02590055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65383601|NCT02590055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383602|NCT02590055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65383603|NCT02590055|Immunologic Factors|immunologic factors|mesh-ancestor
65383604|NCT02590055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383605|NCT02590055|Tubulin Modulators|tubulin modulators|mesh-ancestor
65383606|NCT02590055|Antimitotic Agents|antimitotic agents|mesh-ancestor
65383607|NCT02590055|Mitosis Modulators|mitosis modulators|mesh-ancestor
65383608|NCT00864890|Dexetimide|dexetimide|mesh-list
65383609|NCT00864890|Citalopram|citalopram|mesh-list
65383610|NCT00864890|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65383611|NCT00864890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65383612|NCT00864890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65383613|NCT00864890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383614|NCT00864890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65383615|NCT00864890|Serotonin Agents|serotonin agents|mesh-ancestor
65383616|NCT00864890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383627|NCT00864890|Cholinergic Agents|cholinergic agents|mesh-ancestor
65383628|NCT00919295|Mirtazapine|mirtazapine|mesh-list
65383629|NCT00919295|Antidepressive Agents|antidepressive agents|mesh-ancestor
65383630|NCT00919295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65383631|NCT00919295|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65383632|NCT00919295|Histamine Antagonists|histamine antagonists|mesh-ancestor
65383633|NCT00919295|Histamine Agents|histamine agents|mesh-ancestor
65383634|NCT00919295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65383635|NCT00919295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383636|NCT00919295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383637|NCT00919295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65383638|NCT00919295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65383639|NCT00919295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65383640|NCT00919295|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65383641|NCT00919295|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65383642|NCT00919295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65383643|NCT00919295|Adrenergic Agents|adrenergic agents|mesh-ancestor
65383644|NCT00919295|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65383645|NCT00919295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65383646|NCT00919295|Serotonin Agents|serotonin agents|mesh-ancestor
65383647|NCT00919295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65383648|NCT00865748|Metformin|metformin|mesh-list
65383649|NCT00865748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65383650|NCT00865748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669151|NCT01705964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64669152|NCT01705964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64669153|NCT01705964|Adrenergic Agents|adrenergic agents|mesh-ancestor
64669154|NCT01705964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64669158|NCT01705964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64669159|NCT01705964|Autonomic Agents|autonomic agents|mesh-ancestor
64669160|NCT01705964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64669161|NCT01705964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64669162|NCT01705964|Respiratory System Agents|respiratory system agents|mesh-ancestor
64669163|NCT01705964|Mydriatics|mydriatics|mesh-ancestor
64669164|NCT01705964|Sympathomimetics|sympathomimetics|mesh-ancestor
64669165|NCT01705964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64669166|NCT02341482|Itraconazole|itraconazole|mesh-list
64556633|NCT04368351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556634|NCT04368351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556635|NCT04368351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64556636|NCT05620641|Gabapentin|gabapentin|mesh-list
64556637|NCT05620641|Ondansetron|ondansetron|mesh-list
64556638|NCT05620641|Analgesics|analgesics|mesh-ancestor
64556639|NCT05620641|Sensory System Agents|sensory system agents|mesh-ancestor
64556640|NCT05620641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556641|NCT05620641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556642|NCT05620641|Anticonvulsants|anticonvulsants|mesh-ancestor
64556643|NCT05620641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64556644|NCT05620641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64321704|NCT05564546|Vasodilator Agents|vasodilator agents|mesh-ancestor
65383651|NCT00865982|Docetaxel|docetaxel|mesh-list
65383652|NCT00865982|Capecitabine|capecitabine|mesh-list
65383653|NCT00865982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383654|NCT00865982|Tubulin Modulators|tubulin modulators|mesh-ancestor
65383655|NCT00865982|Antimitotic Agents|antimitotic agents|mesh-ancestor
65383656|NCT00865982|Mitosis Modulators|mitosis modulators|mesh-ancestor
65383657|NCT00865982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383658|NCT00865982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65383659|NCT00865982|Antimetabolites|antimetabolites|mesh-ancestor
65383660|NCT00866060|Memantine|memantine|mesh-list
65383661|NCT00866060|Donepezil|donepezil|mesh-list
65383662|NCT00866060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65383663|NCT00866060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383664|NCT00866060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383665|NCT00866060|Cholinergic Agents|cholinergic agents|mesh-ancestor
65383666|NCT00866060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65383667|NCT00866060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383668|NCT00866060|Nootropic Agents|nootropic agents|mesh-ancestor
65383669|NCT00866060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65383670|NCT00866060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65383671|NCT00866060|Dopamine Agents|dopamine agents|mesh-ancestor
65383672|NCT00866060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65383673|NCT00866060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65383674|NCT00871052|Vitamin D|vitamin d|mesh-list
65383675|NCT00871052|Calcipotriene|calcipotriene|mesh-list
65383676|NCT00871052|Vitamins|vitamins|mesh-ancestor
65383677|NCT00871052|Micronutrients|micronutrients|mesh-ancestor
65383700|NCT00506662|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65383702|NCT00506662|Isophane Insulin, Human|isophane insulin, human|mesh-list
65383703|NCT00506662|Insulin, Isophane|insulin, isophane|mesh-list
65383704|NCT00506662|Isophane insulin, beef|isophane insulin, beef|mesh-list
65383705|NCT00506662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65383706|NCT00506662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383707|NCT03121534|Dexamethasone|dexamethasone|mesh-list
65383708|NCT03121534|Nivolumab|nivolumab|mesh-list
65383709|NCT03121534|Blinatumomab|blinatumomab|mesh-list
65383710|NCT03121534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65383711|NCT03121534|Antiemetics|antiemetics|mesh-ancestor
65383712|NCT03121534|Autonomic Agents|autonomic agents|mesh-ancestor
65383713|NCT03121534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65383714|NCT03121534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383715|NCT03121534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65383716|NCT03121534|Glucocorticoids|glucocorticoids|mesh-ancestor
65383717|NCT03121534|Hormones|hormones|mesh-ancestor
65383718|NCT03121534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65383719|NCT03121534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65383720|NCT03121534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383721|NCT03121534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65383722|NCT03121534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65383723|NCT03121534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383724|NCT01012102|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65383725|NCT01012102|Freund's Adjuvant|freund's adjuvant|mesh-list
65383726|NCT01012102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65383727|NCT01012102|Immunologic Factors|immunologic factors|mesh-ancestor
65383728|NCT01012102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383729|NCT04615624|Furosemide|furosemide|mesh-list
65383730|NCT04615624|Diuretics|diuretics|mesh-ancestor
65383731|NCT04615624|Natriuretic Agents|natriuretic agents|mesh-ancestor
65383732|NCT04615624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383744|NCT00713609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383745|NCT00713609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383746|NCT00713609|Dermatologic Agents|dermatologic agents|mesh-ancestor
65383747|NCT00713609|Keratolytic Agents|keratolytic agents|mesh-ancestor
65383748|NCT00513682|Pancrelipase|pancrelipase|mesh-list
65383749|NCT00513682|Pancreatin|pancreatin|mesh-list
65383750|NCT00513682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65383751|NCT00493012|Vitamin D|vitamin d|mesh-list
65383752|NCT00493012|Vitamins|vitamins|mesh-ancestor
65383753|NCT00493012|Micronutrients|micronutrients|mesh-ancestor
65383754|NCT00493012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383755|NCT00493012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65383756|NCT00918593|Bleomycin|bleomycin|mesh-list
65383757|NCT00918593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65383758|NCT00918593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383759|NCT04083833|Tetrodotoxin|tetrodotoxin|mesh-list
65383760|NCT04083833|Anesthetics, Local|anesthetics, local|mesh-ancestor
65383761|NCT04083833|Anesthetics|anesthetics|mesh-ancestor
65383762|NCT04083833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65383763|NCT04083833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383764|NCT04083833|Sensory System Agents|sensory system agents|mesh-ancestor
65383765|NCT04083833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65383766|NCT04083833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65383767|NCT04083833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65383768|NCT04083833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383769|NCT05330429|Leucovorin|leucovorin|mesh-list
65383770|NCT05330429|Bevacizumab|bevacizumab|mesh-list
65383771|NCT05330429|Magrolimab|magrolimab|mesh-list
65383772|NCT05330429|Fluorouracil|fluorouracil|mesh-list
65383773|NCT05330429|Irinotecan|irinotecan|mesh-list
65133361|NCT04547088|Apatinib|apatinib|mesh-list
65383774|NCT05330429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65383775|NCT05330429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383776|NCT05330429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65383777|NCT05330429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65383778|NCT05330429|Growth Substances|growth substances|mesh-ancestor
65383779|NCT05330429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383782|NCT05330429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383783|NCT05330429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65383784|NCT05330429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65383785|NCT05330429|Immunologic Factors|immunologic factors|mesh-ancestor
65383786|NCT05330429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65383787|NCT05330429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65383788|NCT05330429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383789|NCT05330429|Antidotes|antidotes|mesh-ancestor
65383790|NCT05330429|Protective Agents|protective agents|mesh-ancestor
65383791|NCT05330429|Vitamin B Complex|vitamin b complex|mesh-ancestor
65383792|NCT05330429|Vitamins|vitamins|mesh-ancestor
65383793|NCT05330429|Micronutrients|micronutrients|mesh-ancestor
65383794|NCT05684705|Rifabutin|rifabutin|mesh-list
65383795|NCT05684705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65383796|NCT05684705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65383797|NCT05684705|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65383798|NCT05684705|Antitubercular Agents|antitubercular agents|mesh-ancestor
65383799|NCT05238233|Proxymetacaine|proxymetacaine|mesh-list
65383800|NCT05238233|Pilocarpine|pilocarpine|mesh-list
65383801|NCT05238233|Tropicamide|tropicamide|mesh-list
65383802|NCT05238233|Miotics|miotics|mesh-ancestor
65383803|NCT05238233|Autonomic Agents|autonomic agents|mesh-ancestor
65383804|NCT05238233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65383805|NCT05238233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383806|NCT05238233|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65383807|NCT05238233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65383808|NCT05238233|Cholinergic Agents|cholinergic agents|mesh-ancestor
65383819|NCT05232851|Vaccines|vaccines|mesh-list
65383832|NCT05311475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383833|NCT05311475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65383834|NCT05311475|Respiratory System Agents|respiratory system agents|mesh-ancestor
65383835|NCT05311475|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65383836|NCT05311475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383837|NCT05311475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383838|NCT05311475|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65383839|NCT05311475|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65383840|NCT05311475|Histamine Antagonists|histamine antagonists|mesh-ancestor
65383841|NCT05311475|Histamine Agents|histamine agents|mesh-ancestor
65383842|NCT05311475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65383843|NCT00617708|Gemcitabine|gemcitabine|mesh-list
65383844|NCT00617708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65383845|NCT00617708|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65383846|NCT00617708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65383847|NCT00617708|Antimetabolites|antimetabolites|mesh-ancestor
65383848|NCT00617708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383849|NCT00617708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383850|NCT00617708|Antiviral Agents|antiviral agents|mesh-ancestor
65383851|NCT00617708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65383852|NCT00617708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383853|NCT00617708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65383854|NCT00617708|Immunologic Factors|immunologic factors|mesh-ancestor
65383855|NCT00617708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383856|NCT00617708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65383857|NCT04083209|Analgesics, Opioid|analgesics, opioid|mesh-list
65383858|NCT04083209|Narcotics|narcotics|mesh-ancestor
65383859|NCT04083209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65383876|NCT00864968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383877|NCT00876044|Aflibercept|aflibercept|mesh-list
65383878|NCT00876044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65383879|NCT00876044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65383880|NCT00876044|Growth Substances|growth substances|mesh-ancestor
65383881|NCT00876044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383882|NCT00876044|Growth Inhibitors|growth inhibitors|mesh-ancestor
65383883|NCT00876044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383884|NCT00866216|Azithromycin|azithromycin|mesh-list
65383885|NCT00866216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65383886|NCT00866216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65383887|NCT00871208|Retapamulin|retapamulin|mesh-list
65383888|NCT00871208|Hydrocortisone|hydrocortisone|mesh-list
65383889|NCT00871208|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65383890|NCT00871208|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65383891|NCT00871208|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65383892|NCT00871208|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
65383893|NCT00871208|Dermatologic Agents|dermatologic agents|mesh-ancestor
65383894|NCT00871208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65383895|NCT00871208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65383896|NCT00871208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65383897|NCT00871364|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65383898|NCT00871364|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65383899|NCT00871364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65383900|NCT00871364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65383901|NCT00871364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383902|NCT00871364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65383903|NCT00871364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383904|NCT00871364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65383905|NCT00871364|Antidepressive Agents|antidepressive agents|mesh-ancestor
65383906|NCT00871364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65383915|NCT05113745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65383916|NCT05113745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383917|NCT00866450|Calcium, Dietary|calcium, dietary|mesh-list
65383918|NCT00866450|Calcium|calcium|mesh-list
65383919|NCT00866450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65383920|NCT00866450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383921|NCT00866450|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65383922|NCT03894969|Vaccines|vaccines|mesh-list
65383923|NCT03894969|Immunologic Factors|immunologic factors|mesh-ancestor
65383924|NCT03894969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133508|NCT01128595|Xhance|xhance|mesh-list
65383925|NCT00876434|Sirolimus|sirolimus|mesh-list
65383926|NCT00876434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65383927|NCT00876434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65383928|NCT00876434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65383929|NCT00876434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383930|NCT00876434|Antifungal Agents|antifungal agents|mesh-ancestor
65383931|NCT00876434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65383932|NCT00876434|Immunologic Factors|immunologic factors|mesh-ancestor
65383933|NCT00876434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383934|NCT00871442|Fentanyl|fentanyl|mesh-list
65383935|NCT00871442|Bupivacaine|bupivacaine|mesh-list
65383936|NCT00871442|Anesthetics|anesthetics|mesh-list
65383937|NCT00871442|Anesthetics, Local|anesthetics, local|mesh-ancestor
65383938|NCT00871442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65383939|NCT00871442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383940|NCT00871442|Sensory System Agents|sensory system agents|mesh-ancestor
65383941|NCT00871442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65383942|NCT00871442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65383943|NCT00871442|Narcotics|narcotics|mesh-ancestor
65383944|NCT00871442|Analgesics|analgesics|mesh-ancestor
65383945|NCT00871442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65383946|NCT00871442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65383947|NCT00871442|Anesthetics, General|anesthetics, general|mesh-ancestor
65383948|NCT05355597|Clonidine|clonidine|mesh-list
65383949|NCT05355597|Epinephrine|epinephrine|mesh-list
65383950|NCT05355597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65383954|NCT05355597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383955|NCT05355597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383956|NCT05355597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65383957|NCT05355597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65383958|NCT05355597|Autonomic Agents|autonomic agents|mesh-ancestor
65383959|NCT05355597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65383960|NCT05355597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65383961|NCT05355597|Respiratory System Agents|respiratory system agents|mesh-ancestor
65383962|NCT05355597|Mydriatics|mydriatics|mesh-ancestor
65383963|NCT05355597|Sympathomimetics|sympathomimetics|mesh-ancestor
65383964|NCT05355597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65383965|NCT05355597|Analgesics|analgesics|mesh-ancestor
65383966|NCT05355597|Sensory System Agents|sensory system agents|mesh-ancestor
65383967|NCT05355597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65383968|NCT05355597|Sympatholytics|sympatholytics|mesh-ancestor
65383969|NCT05355597|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65383970|NCT00866528|Paclitaxel|paclitaxel|mesh-list
65383971|NCT00866528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65383972|NCT00866528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383973|NCT00866528|Tubulin Modulators|tubulin modulators|mesh-ancestor
65383974|NCT00866528|Antimitotic Agents|antimitotic agents|mesh-ancestor
65383975|NCT00866528|Mitosis Modulators|mitosis modulators|mesh-ancestor
65383976|NCT00866528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383977|NCT00871598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65383978|NCT00871598|Immunologic Factors|immunologic factors|mesh-ancestor
65383979|NCT00871598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383980|NCT00992667|Acetovanillone|acetovanillone|mesh-list
65383981|NCT00992667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65383982|NCT00992667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65383983|NCT00992667|Analgesics|analgesics|mesh-ancestor
65383984|NCT00992667|Sensory System Agents|sensory system agents|mesh-ancestor
65383985|NCT00992667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65383986|NCT00992667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776572|NCT05567952|Protease Inhibitors|protease inhibitors|mesh-ancestor
64321705|NCT05564546|Gasotransmitters|gasotransmitters|mesh-ancestor
64669167|NCT02341482|Antifungal Agents|antifungal agents|mesh-ancestor
64669168|NCT02341482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64669169|NCT02341482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64669170|NCT02341482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64669171|NCT02341482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383987|NCT00992667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65383988|NCT00992667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65383989|NCT00992667|Antioxidants|antioxidants|mesh-ancestor
65383990|NCT00992667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65383991|NCT00992667|Protective Agents|protective agents|mesh-ancestor
65383992|NCT00992667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65383993|NCT05171972|Ofatumumab|ofatumumab|mesh-list
65383994|NCT05171972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65383995|NCT00992823|Iron|iron|mesh-list
65383996|NCT00992823|Trace Elements|trace elements|mesh-ancestor
65383997|NCT00992823|Micronutrients|micronutrients|mesh-ancestor
65383998|NCT00992823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65383999|NCT03894813|Metronidazole|metronidazole|mesh-list
65133588|NCT02882308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384000|NCT03894813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65384001|NCT03894813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65384002|NCT03894813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65384003|NCT03894813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65384004|NCT00615992|Tiotropium Bromide|tiotropium bromide|mesh-list
65384005|NCT00615992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65384006|NCT00615992|Autonomic Agents|autonomic agents|mesh-ancestor
65384007|NCT00615992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65384008|NCT00615992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384009|NCT00615992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65384010|NCT00615992|Respiratory System Agents|respiratory system agents|mesh-ancestor
65384011|NCT00615992|Parasympatholytics|parasympatholytics|mesh-ancestor
65384012|NCT00615992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65384013|NCT00615992|Cholinergic Agents|cholinergic agents|mesh-ancestor
65384014|NCT00615992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65384015|NCT00615992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384016|NCT00876824|Amphotericin B|amphotericin b|mesh-list
65384017|NCT00876824|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65384032|NCT00866684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65384033|NCT00866684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384034|NCT00866684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384035|NCT00866684|Antifungal Agents|antifungal agents|mesh-ancestor
65384036|NCT00866684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65384037|NCT00866684|Dermatologic Agents|dermatologic agents|mesh-ancestor
65384038|NCT00866684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65384039|NCT00866684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65384040|NCT00866684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384041|NCT00866684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65384042|NCT00866684|Antimetabolites|antimetabolites|mesh-ancestor
65384043|NCT00866684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65384044|NCT00993057|Insulin|insulin|mesh-list
65384045|NCT00993057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65384046|NCT00993057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384047|NCT00866762|Vorinostat|vorinostat|mesh-list
65384048|NCT00866762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65384049|NCT00866762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384050|NCT00866762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384051|NCT00866762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384052|NCT00876902|polysaccharide-K|polysaccharide-k|mesh-list
65384053|NCT00876902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65384054|NCT00876902|Immunologic Factors|immunologic factors|mesh-ancestor
65384055|NCT00876902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384056|NCT00876902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65384057|NCT00876902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384058|NCT00876902|Antiviral Agents|antiviral agents|mesh-ancestor
65384059|NCT00876902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65384060|NCT00876902|Interferon Inducers|interferon inducers|mesh-ancestor
65384061|NCT00876902|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65384062|NCT00876902|Protective Agents|protective agents|mesh-ancestor
65384063|NCT00993135|Methotrexate|methotrexate|mesh-list
64669172|NCT02341482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669173|NCT02341482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64669174|NCT02341482|Hormone Antagonists|hormone antagonists|mesh-ancestor
64669175|NCT02341482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64669176|NCT02341482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669177|NCT02341482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64669178|NCT03140631|Protamines|protamines|mesh-list
64669179|NCT03140631|Heparin Antagonists|heparin antagonists|mesh-ancestor
64669180|NCT03140631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384064|NCT00993135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65384065|NCT00993135|Abortifacient Agents|abortifacient agents|mesh-ancestor
65384066|NCT00993135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65384067|NCT00993135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384068|NCT00993135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65384069|NCT00993135|Antimetabolites|antimetabolites|mesh-ancestor
65384070|NCT00993135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384071|NCT00993135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384072|NCT00993135|Dermatologic Agents|dermatologic agents|mesh-ancestor
65384073|NCT00993135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384074|NCT00993135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65384075|NCT00993135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65384076|NCT00993135|Immunologic Factors|immunologic factors|mesh-ancestor
65384077|NCT00993135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65133661|NCT04558268|Folic Acid|folic acid|mesh-list
65384078|NCT00993135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65384079|NCT00866996|Methylphenidate|methylphenidate|mesh-list
65384080|NCT00866996|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65384081|NCT00866996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65384082|NCT00866996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384083|NCT00866996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65384084|NCT00866996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65384085|NCT00866996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65384086|NCT00866996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384087|NCT00866996|Dopamine Agents|dopamine agents|mesh-ancestor
64669181|NCT03140631|Coagulants|coagulants|mesh-ancestor
64669182|NCT04420260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
64669183|NCT04420260|Immunologic Factors|immunologic factors|mesh-ancestor
64669184|NCT04420260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669185|NCT00422643|Hyaluronic Acid|hyaluronic acid|mesh-list
64669186|NCT00422643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64669187|NCT00422643|Immunologic Factors|immunologic factors|mesh-ancestor
64669188|NCT00422643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669189|NCT00422643|Viscosupplements|viscosupplements|mesh-ancestor
64669190|NCT00422643|Protective Agents|protective agents|mesh-ancestor
64669191|NCT05405907|Hemostatics|hemostatics|mesh-list
64669192|NCT05405907|Coagulants|coagulants|mesh-ancestor
64669193|NCT01706588|Diclofenac|diclofenac|mesh-list
64669194|NCT01706588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64669195|NCT01706588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64669196|NCT01706588|Analgesics|analgesics|mesh-ancestor
64669197|NCT01706588|Sensory System Agents|sensory system agents|mesh-ancestor
64669198|NCT01706588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64669210|NCT01602692|Anesthetics, Local|anesthetics, local|mesh-ancestor
64669211|NCT01602692|Anesthetics|anesthetics|mesh-ancestor
64669212|NCT01602692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64669213|NCT01602692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669214|NCT01602692|Sensory System Agents|sensory system agents|mesh-ancestor
65384088|NCT00866996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65384089|NCT00866996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65384090|NCT00866996|Adrenergic Agents|adrenergic agents|mesh-ancestor
65384091|NCT00871910|Dexamethasone|dexamethasone|mesh-list
65384092|NCT00871910|Ondansetron|ondansetron|mesh-list
65384093|NCT00871910|Aprepitant|aprepitant|mesh-list
65384094|NCT00871910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65384095|NCT00871910|Antiemetics|antiemetics|mesh-ancestor
65384096|NCT00871910|Autonomic Agents|autonomic agents|mesh-ancestor
65384097|NCT00871910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65384098|NCT00871910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384099|NCT00871910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65384100|NCT00871910|Glucocorticoids|glucocorticoids|mesh-ancestor
65384101|NCT00871910|Hormones|hormones|mesh-ancestor
65384102|NCT00871910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65384103|NCT00871910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65384104|NCT00871910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384105|NCT00871910|Antipruritics|antipruritics|mesh-ancestor
65384106|NCT00871910|Dermatologic Agents|dermatologic agents|mesh-ancestor
65384107|NCT00871910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65384108|NCT00871910|Serotonin Agents|serotonin agents|mesh-ancestor
65384109|NCT00871910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65384110|NCT00871910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384111|NCT00871910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65384112|NCT00871910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65384113|NCT00871910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65384114|NCT00871910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65384115|NCT00871910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65384116|NCT00871910|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65384117|NCT05355441|Analgesics|analgesics|mesh-list
65384118|NCT05355441|Sensory System Agents|sensory system agents|mesh-ancestor
65384119|NCT05355441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65384121|NCT05155436|Amlodipine|amlodipine|mesh-list
65384130|NCT05155436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65384131|NCT05155436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65384132|NCT01564329|Endostar protein|endostar protein|mesh-list
65384133|NCT01564329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65384134|NCT01564329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65384135|NCT01564329|Growth Substances|growth substances|mesh-ancestor
65384136|NCT01564329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384137|NCT01564329|Growth Inhibitors|growth inhibitors|mesh-ancestor
65384138|NCT01564329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384139|NCT05213481|Tepotinib|tepotinib|mesh-list
65384140|NCT05213481|Carbamazepine|carbamazepine|mesh-list
65384141|NCT05213481|Anticonvulsants|anticonvulsants|mesh-ancestor
65384142|NCT05213481|Antimanic Agents|antimanic agents|mesh-ancestor
65384143|NCT05213481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65384144|NCT05213481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65384145|NCT05213481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384146|NCT05213481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65384147|NCT05213481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65384148|NCT05213481|Analgesics|analgesics|mesh-ancestor
65384149|NCT05213481|Sensory System Agents|sensory system agents|mesh-ancestor
65384150|NCT05213481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65384151|NCT05213481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64776750|NCT04346394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64669215|NCT01602692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64669216|NCT01602692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64669217|NCT01602692|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64669218|NCT01602692|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64669219|NCT01602692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64669220|NCT01602692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669221|NCT01602692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64669222|NCT01602692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64669223|NCT01602692|Adrenergic Agents|adrenergic agents|mesh-ancestor
64556647|NCT05620641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64556648|NCT05620641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64556649|NCT05620641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64556650|NCT05620641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556651|NCT05620641|Antimanic Agents|antimanic agents|mesh-ancestor
64556652|NCT05620641|Antiemetics|antiemetics|mesh-ancestor
64556653|NCT05620641|Autonomic Agents|autonomic agents|mesh-ancestor
64321716|NCT02205775|Atorvastatin|atorvastatin|mesh-list
64669224|NCT01602692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64669225|NCT01602692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64669226|NCT01602692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64669227|NCT01602692|Autonomic Agents|autonomic agents|mesh-ancestor
64669228|NCT01602692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64669229|NCT01602692|Respiratory System Agents|respiratory system agents|mesh-ancestor
64669230|NCT01602692|Mydriatics|mydriatics|mesh-ancestor
64669231|NCT01602692|Sympathomimetics|sympathomimetics|mesh-ancestor
64669232|NCT01602692|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64669233|NCT01603940|Losartan|losartan|mesh-list
64669234|NCT01603940|Benazepril|benazepril|mesh-list
64669235|NCT01603940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65384152|NCT05213481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65384153|NCT05213481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384154|NCT05213481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65384155|NCT05213481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65384157|NCT00993525|Ranibizumab|ranibizumab|mesh-list
65384158|NCT00993525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65384159|NCT00993525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65384160|NCT00993525|Growth Substances|growth substances|mesh-ancestor
65384161|NCT00993525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669236|NCT01603940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64669237|NCT01603940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64669238|NCT01603940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64669239|NCT01603940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669240|NCT01603940|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64669241|NCT01603940|Protease Inhibitors|protease inhibitors|mesh-ancestor
64669242|NCT01603940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669243|NCT01605032|Bortezomib|bortezomib|mesh-list
64669244|NCT01605032|Melphalan|melphalan|mesh-list
64669245|NCT01605032|Busulfan|busulfan|mesh-list
64669246|NCT01605032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669247|NCT01605032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64669248|NCT01605032|Alkylating Agents|alkylating agents|mesh-ancestor
64669266|NCT01706666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64669267|NCT01706666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64669269|NCT01706666|Autonomic Agents|autonomic agents|mesh-ancestor
64669270|NCT01706666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64669271|NCT01706666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64669272|NCT01706666|Glucocorticoids|glucocorticoids|mesh-ancestor
64669273|NCT01706666|Hormones|hormones|mesh-ancestor
64669274|NCT01706666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64394650|NCT03805841|Bromides|bromides|mesh-list
64669275|NCT01706666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64669276|NCT01706666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64669277|NCT01706666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64669278|NCT01706666|Growth Substances|growth substances|mesh-ancestor
64669279|NCT01706666|Growth Inhibitors|growth inhibitors|mesh-ancestor
64669281|NCT03149991|Brexpiprazole|brexpiprazole|mesh-list
64669282|NCT03149991|Analgesics|analgesics|mesh-ancestor
64669283|NCT03149991|Sensory System Agents|sensory system agents|mesh-ancestor
64669284|NCT03149991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64669285|NCT03149991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669308|NCT05400993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669309|NCT05400993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669310|NCT05400993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64669312|NCT05400993|Antimitotic Agents|antimitotic agents|mesh-ancestor
64669313|NCT05400993|Mitosis Modulators|mitosis modulators|mesh-ancestor
64669314|NCT05400993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64669315|NCT05400993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64669316|NCT05400993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64669317|NCT05400993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556654|NCT05620641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64556655|NCT05620641|Antipruritics|antipruritics|mesh-ancestor
64556656|NCT05620641|Dermatologic Agents|dermatologic agents|mesh-ancestor
64556657|NCT05620641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64556658|NCT05620641|Serotonin Agents|serotonin agents|mesh-ancestor
64556659|NCT05620641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64556660|NCT04360785|Methotrexate|methotrexate|mesh-list
64556661|NCT04360785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64556662|NCT04360785|Abortifacient Agents|abortifacient agents|mesh-ancestor
64556663|NCT04360785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64321725|NCT02205775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669318|NCT01605890|Tenofovir|tenofovir|mesh-list
64669319|NCT01605890|Emtricitabine|emtricitabine|mesh-list
64669320|NCT01605890|Raltegravir Potassium|raltegravir potassium|mesh-list
65384162|NCT00993525|Growth Inhibitors|growth inhibitors|mesh-ancestor
65384163|NCT00993525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384164|NCT00993681|Vaccines|vaccines|mesh-list
65384165|NCT00993681|Immunologic Factors|immunologic factors|mesh-ancestor
65384166|NCT00993681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384167|NCT03892707|Folic Acid|folic acid|mesh-list
65384168|NCT03892707|Vitamin B Complex|vitamin b complex|mesh-list
65384169|NCT03892707|Celecoxib|celecoxib|mesh-list
65384170|NCT03892707|Etoricoxib|etoricoxib|mesh-list
65384171|NCT03892707|Meloxicam|meloxicam|mesh-list
65384172|NCT03892707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65384173|NCT03892707|Nimesulide|nimesulide|mesh-list
64669321|NCT01605890|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64669322|NCT01605890|Antiviral Agents|antiviral agents|mesh-ancestor
64669323|NCT01605890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64669324|NCT01605890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64669325|NCT01605890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64669326|NCT01605890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669327|NCT01605890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669328|NCT01605890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64669349|NCT01607450|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64669351|NCT01607450|Hormones|hormones|mesh-ancestor
64669352|NCT01607450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64669353|NCT01607450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669354|NCT01607450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64669355|NCT05738993|Pertuzumab|pertuzumab|mesh-list
64669356|NCT05738993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64669357|NCT05738993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669358|NCT01709474|Vitamin D|vitamin d|mesh-list
64669359|NCT01709474|Ergocalciferols|ergocalciferols|mesh-list
64669360|NCT01709474|Cholecalciferol|cholecalciferol|mesh-list
64669361|NCT01709474|Vitamins|vitamins|mesh-list
64669362|NCT01709474|Micronutrients|micronutrients|mesh-ancestor
64669363|NCT01709474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669364|NCT01709474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64669365|NCT01709474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64669366|NCT02992808|Menotropins|menotropins|mesh-list
64669367|NCT02992808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64669368|NCT02992808|Fertility Agents|fertility agents|mesh-ancestor
64669369|NCT02992808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64669370|NCT02992808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669371|NCT02992886|Raltitrexed|raltitrexed|mesh-list
64669372|NCT02992886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64669373|NCT02992886|Antimetabolites|antimetabolites|mesh-ancestor
64669374|NCT02992886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669375|NCT02992886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669376|NCT02992886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64669377|NCT02992886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669378|NCT02331095|Warfarin|warfarin|mesh-list
64669379|NCT02331095|Rivaroxaban|rivaroxaban|mesh-list
64669380|NCT02331095|Atorvastatin|atorvastatin|mesh-list
64669381|NCT02331095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64669382|NCT02331095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64669383|NCT02331095|Antimetabolites|antimetabolites|mesh-ancestor
64669384|NCT02331095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669385|NCT02331095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64669410|NCT05316935|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64669411|NCT05316935|Cyproterone|cyproterone|mesh-list
64669412|NCT05316935|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
64669413|NCT05316935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669414|NCT05316935|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64669415|NCT05316935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64669416|NCT05316935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556664|NCT04360785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556665|NCT04360785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65384174|NCT03892707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65384175|NCT03892707|Benphothiamine|benphothiamine|mesh-list
65384176|NCT03892707|Vitamins|vitamins|mesh-ancestor
65384177|NCT03892707|Micronutrients|micronutrients|mesh-ancestor
65384178|NCT03892707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384179|NCT03892707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65384180|NCT03892707|Analgesics|analgesics|mesh-ancestor
65384181|NCT03892707|Sensory System Agents|sensory system agents|mesh-ancestor
65384182|NCT03892707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65384183|NCT03892707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65384184|NCT03892707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65384185|NCT03892707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64556666|NCT04360785|Antimetabolites|antimetabolites|mesh-ancestor
64556667|NCT04360785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556668|NCT04360785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556669|NCT04360785|Dermatologic Agents|dermatologic agents|mesh-ancestor
64556670|NCT04360785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556671|NCT04360785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64556672|NCT04360785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64556673|NCT04360785|Immunologic Factors|immunologic factors|mesh-ancestor
64556674|NCT04360785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64556675|NCT04360785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64556676|NCT04360317|Docetaxel|docetaxel|mesh-list
64321735|NCT02205931|Carbamazepine|carbamazepine|mesh-list
64321736|NCT02205931|Phenytoin|phenytoin|mesh-list
64669417|NCT05316935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669418|NCT05316935|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64669419|NCT05316935|Hormone Antagonists|hormone antagonists|mesh-ancestor
64669420|NCT05316935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64669421|NCT05316935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669422|NCT05316935|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64484317|NCT05640778|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64669423|NCT05316935|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64669425|NCT05316935|Contraceptive Agents|contraceptive agents|mesh-ancestor
64669426|NCT05316935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64669427|NCT05316935|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64669428|NCT05316935|Estrogens|estrogens|mesh-ancestor
64669454|NCT02288819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669456|NCT01642238|Hirudins|hirudins|mesh-list
64669457|NCT01642238|Bivalirudin|bivalirudin|mesh-list
64669458|NCT01642238|Clopidogrel|clopidogrel|mesh-list
64669459|NCT01642238|Ticagrelor|ticagrelor|mesh-list
64669460|NCT01642238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64669461|NCT01642238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64669462|NCT01642238|Analgesics|analgesics|mesh-ancestor
64669463|NCT01642238|Sensory System Agents|sensory system agents|mesh-ancestor
64669464|NCT01642238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64669465|NCT01642238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669466|NCT01642238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64669467|NCT01642238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64669468|NCT01642238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64669469|NCT01642238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64669470|NCT01642238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669471|NCT01642238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64669472|NCT01642238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64669473|NCT01642238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669474|NCT01642238|Antipyretics|antipyretics|mesh-ancestor
64669475|NCT01642238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64669476|NCT01642238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64669492|NCT05259995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64669493|NCT05259995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669494|NCT05259995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384186|NCT03892707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384187|NCT03892707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384188|NCT03892707|Hematinics|hematinics|mesh-ancestor
65384189|NCT03892707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65384190|NCT03892707|Immunologic Factors|immunologic factors|mesh-ancestor
65384191|NCT03892707|Chelating Agents|chelating agents|mesh-ancestor
65384192|NCT03892707|Sequestering Agents|sequestering agents|mesh-ancestor
65384193|NCT00513604|Aldesleukin|aldesleukin|mesh-list
65384194|NCT00513604|Cyclophosphamide|cyclophosphamide|mesh-list
65384195|NCT00513604|Fludarabine|fludarabine|mesh-list
65384196|NCT00513604|Fludarabine phosphate|fludarabine phosphate|mesh-list
65384197|NCT00513604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65384198|NCT00513604|Immunologic Factors|immunologic factors|mesh-ancestor
65384199|NCT00513604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384200|NCT00513604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65384201|NCT00513604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65384202|NCT00513604|Alkylating Agents|alkylating agents|mesh-ancestor
65384203|NCT00513604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384204|NCT00513604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384205|NCT00513604|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65384206|NCT00513604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65384207|NCT00513604|Antimetabolites|antimetabolites|mesh-ancestor
65384208|NCT00513604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65384209|NCT00513604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65384210|NCT00513604|Antiviral Agents|antiviral agents|mesh-ancestor
64776803|NCT03616236|Naloxone|naloxone|mesh-list
64669495|NCT05259995|Sympathomimetics|sympathomimetics|mesh-ancestor
64669496|NCT05259995|Autonomic Agents|autonomic agents|mesh-ancestor
64669497|NCT05259995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64669498|NCT05259995|Nasal Decongestants|nasal decongestants|mesh-ancestor
64556677|NCT04360317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556678|NCT04360317|Tubulin Modulators|tubulin modulators|mesh-ancestor
64556679|NCT04360317|Antimitotic Agents|antimitotic agents|mesh-ancestor
64556680|NCT04360317|Mitosis Modulators|mitosis modulators|mesh-ancestor
64556681|NCT04360317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556682|NCT03074136|Sodium Hypochlorite|sodium hypochlorite|mesh-list
64556683|NCT03074136|Eusol|eusol|mesh-list
64556684|NCT03074136|Disinfectants|disinfectants|mesh-ancestor
64556685|NCT03074136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64556686|NCT04146155|Liraglutide|liraglutide|mesh-list
64556687|NCT04146155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64556688|NCT04146155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669499|NCT05259995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64669500|NCT05259995|Respiratory System Agents|respiratory system agents|mesh-ancestor
64669502|NCT05737199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64669503|NCT05737199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669504|NCT03028883|Buprenorphine|buprenorphine|mesh-list
64669505|NCT03028883|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64669506|NCT03028883|Narcotics|narcotics|mesh-ancestor
64669507|NCT03028883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64669508|NCT03028883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776813|NCT03551730|Enoxaparin sodium|enoxaparin sodium|mesh-list
64776814|NCT03551730|Anticoagulants|anticoagulants|mesh-ancestor
64776815|NCT03551730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64776816|NCT03551730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64776817|NCT03551730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776818|NCT03522246|Nivolumab|nivolumab|mesh-list
64776819|NCT03522246|Rucaparib|rucaparib|mesh-list
64776820|NCT03522246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64388300|NCT02354261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64388301|NCT02354261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388302|NCT02354261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65384211|NCT00513604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65384212|NCT03971409|Doxorubicin|doxorubicin|mesh-list
65384213|NCT03971409|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65384214|NCT03971409|Avelumab|avelumab|mesh-list
65384215|NCT03971409|Camptothecin|camptothecin|mesh-list
65384216|NCT03971409|Antibodies|antibodies|mesh-list
65384217|NCT03971409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65384218|NCT03971409|Immunoconjugates|immunoconjugates|mesh-list
65384219|NCT03971409|Immunoglobulin G|immunoglobulin g|mesh-list
65384220|NCT03971409|Immunologic Factors|immunologic factors|mesh-ancestor
65384221|NCT03971409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384222|NCT03971409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65384223|NCT03971409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384224|NCT03971409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65384225|NCT03971409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65384226|NCT03971409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384227|NCT03971409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384228|NCT03971409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65384229|NCT03971409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65384230|NCT03971409|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65384231|NCT00872144|Nabiximols|nabiximols|mesh-list
65384232|NCT00872144|Analgesics|analgesics|mesh-ancestor
65384233|NCT00872144|Sensory System Agents|sensory system agents|mesh-ancestor
65384234|NCT00872144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776821|NCT03522246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776822|NCT03522246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64776823|NCT03522246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776824|NCT03522246|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64776825|NCT03522246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776826|NCT03464292|Capsaicin|capsaicin|mesh-list
64776827|NCT03464292|Antipruritics|antipruritics|mesh-ancestor
64776828|NCT03464292|Dermatologic Agents|dermatologic agents|mesh-ancestor
64388307|NCT02350439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388308|NCT02350439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64388309|NCT02350439|Vasodilator Agents|vasodilator agents|mesh-ancestor
64388310|NCT02350439|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65384240|NCT05018585|Immunologic Factors|immunologic factors|mesh-ancestor
65384241|NCT05018585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384242|NCT05018585|Antacids|antacids|mesh-ancestor
65384243|NCT05018585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384244|NCT05018585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65384245|NCT05018585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65384246|NCT05018585|Vitamins|vitamins|mesh-ancestor
65384247|NCT05018585|Micronutrients|micronutrients|mesh-ancestor
65384248|NCT05018585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65384249|NCT00867152|Ritonavir|ritonavir|mesh-list
65384250|NCT00867152|Lopinavir|lopinavir|mesh-list
65384251|NCT00867152|Darunavir|darunavir|mesh-list
65384252|NCT00867152|Dolutegravir|dolutegravir|mesh-list
65384253|NCT00867152|Etravirine|etravirine|mesh-list
65384254|NCT00867152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65384255|NCT00867152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65384256|NCT00867152|Protease Inhibitors|protease inhibitors|mesh-ancestor
65384257|NCT00867152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384258|NCT00867152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384259|NCT00867152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65384260|NCT00867152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65384261|NCT00867152|Antiviral Agents|antiviral agents|mesh-ancestor
64776829|NCT03464292|Sensory System Agents|sensory system agents|mesh-ancestor
64776830|NCT03464292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776831|NCT03464292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776832|NCT03462342|Olaparib|olaparib|mesh-list
64776833|NCT03462342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64776834|NCT03462342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776835|NCT03462342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384269|NCT04039958|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
65384270|NCT04039958|Antiviral Agents|antiviral agents|mesh-ancestor
65384271|NCT04039958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65384272|NCT00872378|Exenatide|exenatide|mesh-list
65384273|NCT00872378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65384274|NCT00872378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384275|NCT00872378|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65384276|NCT00872378|Incretins|incretins|mesh-ancestor
65384277|NCT00872378|Hormones|hormones|mesh-ancestor
65384278|NCT00872378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65384279|NCT00994071|Temozolomide|temozolomide|mesh-list
65384280|NCT00994071|Veliparib|veliparib|mesh-list
65384281|NCT00994071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65384282|NCT00994071|Alkylating Agents|alkylating agents|mesh-ancestor
65384283|NCT00994071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384284|NCT00994071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384285|NCT00994071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65384286|NCT00994071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384287|NCT00994149|Diazoxide|diazoxide|mesh-list
65384288|NCT00994149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65384289|NCT00994149|Vasodilator Agents|vasodilator agents|mesh-ancestor
65384290|NCT00573248|Nicotine|nicotine|mesh-list
65384291|NCT00573248|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65384292|NCT00573248|Autonomic Agents|autonomic agents|mesh-ancestor
65384293|NCT00573248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65384294|NCT00573248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384295|NCT00573248|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65384296|NCT00573248|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65384297|NCT00573248|Cholinergic Agents|cholinergic agents|mesh-ancestor
64669509|NCT03028883|Analgesics|analgesics|mesh-ancestor
64669510|NCT03028883|Sensory System Agents|sensory system agents|mesh-ancestor
64776839|NCT03366480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64776840|NCT03366480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776841|NCT03366480|Tubulin Modulators|tubulin modulators|mesh-ancestor
64776842|NCT03366480|Antimitotic Agents|antimitotic agents|mesh-ancestor
64776843|NCT03366480|Mitosis Modulators|mitosis modulators|mesh-ancestor
64776844|NCT03366480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776845|NCT03024996|Atezolizumab|atezolizumab|mesh-list
64388324|NCT02353949|Flutemetamol|flutemetamol|mesh-list
64388325|NCT02353949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64388326|NCT02353949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388327|NCT02354027|Metformin|metformin|mesh-list
65384298|NCT00573248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65384299|NCT00573248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384300|NCT04039880|Olorofim|olorofim|mesh-list
65384301|NCT04039880|Antifungal Agents|antifungal agents|mesh-ancestor
65384302|NCT04039880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65384303|NCT00994305|Acetylcysteine|acetylcysteine|mesh-list
65384304|NCT00994305|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65384305|NCT00994305|Antiviral Agents|antiviral agents|mesh-ancestor
65384306|NCT00994305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65384307|NCT00994305|Expectorants|expectorants|mesh-ancestor
65384308|NCT00994305|Respiratory System Agents|respiratory system agents|mesh-ancestor
65384309|NCT00994305|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65384310|NCT00994305|Antioxidants|antioxidants|mesh-ancestor
65384311|NCT00994305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384312|NCT00994305|Protective Agents|protective agents|mesh-ancestor
65384313|NCT00994305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384314|NCT00994305|Antidotes|antidotes|mesh-ancestor
65384315|NCT00877760|Interferons|interferons|mesh-list
65384316|NCT00877760|Entecavir|entecavir|mesh-list
65384317|NCT00877760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384318|NCT00877760|Antiviral Agents|antiviral agents|mesh-ancestor
65384319|NCT00877760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65384320|NCT04083911|Cytarabine|cytarabine|mesh-list
65384321|NCT04083911|Decitabine|decitabine|mesh-list
65384322|NCT04083911|Homoharringtonine|homoharringtonine|mesh-list
65384323|NCT04083911|Aclarubicin|aclarubicin|mesh-list
64776846|NCT03024996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776847|NCT02867124|Naltrexone|naltrexone|mesh-list
64776848|NCT02867124|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64776849|NCT02867124|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64776850|NCT02867124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776851|NCT02867124|Sensory System Agents|sensory system agents|mesh-ancestor
64776852|NCT02867124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776853|NCT02723994|Leucovorin|leucovorin|mesh-list
64776854|NCT02723994|Cytarabine|cytarabine|mesh-list
64776855|NCT02723994|Dexamethasone|dexamethasone|mesh-list
64776856|NCT02723994|Prednisone|prednisone|mesh-list
64776857|NCT02723994|Cyclophosphamide|cyclophosphamide|mesh-list
65384327|NCT04083911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384328|NCT04083911|Antiviral Agents|antiviral agents|mesh-ancestor
65384329|NCT04083911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65384330|NCT04083911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65384331|NCT04083911|Immunologic Factors|immunologic factors|mesh-ancestor
65384332|NCT04083911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384333|NCT04083911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384334|NCT04083911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65384335|NCT04083911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65384336|NCT04083911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65384337|NCT04083911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64776859|NCT02723994|Methotrexate|methotrexate|mesh-list
64776860|NCT02723994|Vincristine|vincristine|mesh-list
64776861|NCT02723994|Asparaginase|asparaginase|mesh-list
64776862|NCT02723994|Mercaptopurine|mercaptopurine|mesh-list
64776863|NCT02723994|Pegaspargase|pegaspargase|mesh-list
64776864|NCT02723994|Thioguanine|thioguanine|mesh-list
64776865|NCT02723994|Levoleucovorin|levoleucovorin|mesh-list
64776866|NCT02723994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64776867|NCT02723994|Immunologic Factors|immunologic factors|mesh-ancestor
64776868|NCT02723994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776869|NCT02723994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65384368|NCT02588417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384369|NCT02588417|Anesthetics, Local|anesthetics, local|mesh-ancestor
65384370|NCT02588417|Anesthetics|anesthetics|mesh-ancestor
65384371|NCT02588417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65384372|NCT02588417|Sensory System Agents|sensory system agents|mesh-ancestor
65384373|NCT00532935|Metformin|metformin|mesh-list
65384374|NCT00532935|Pioglitazone|pioglitazone|mesh-list
65384375|NCT00532935|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65384376|NCT00532935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65384377|NCT00532935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133976|NCT00577694|Clofarabine|clofarabine|mesh-list
65384378|NCT00532935|Incretins|incretins|mesh-ancestor
65384379|NCT00532935|Hormones|hormones|mesh-ancestor
65384380|NCT00532935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65384381|NCT00532935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65384382|NCT00532935|Protease Inhibitors|protease inhibitors|mesh-ancestor
65384383|NCT00532935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384384|NCT00532935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384386|NCT00994539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65384387|NCT00994539|Narcotics|narcotics|mesh-ancestor
65384388|NCT00994539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65384389|NCT00994539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384390|NCT00994539|Analgesics|analgesics|mesh-ancestor
65384391|NCT00994539|Sensory System Agents|sensory system agents|mesh-ancestor
65384392|NCT00994539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65384393|NCT00878306|Ritonavir|ritonavir|mesh-list
65384394|NCT00878306|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65384395|NCT00878306|Efavirenz|efavirenz|mesh-list
65384396|NCT00878306|Disulfiram|disulfiram|mesh-list
65384397|NCT00878306|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65384398|NCT00878306|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65384399|NCT00878306|Protease Inhibitors|protease inhibitors|mesh-ancestor
65384400|NCT00878306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384401|NCT00878306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384402|NCT00878306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65384403|NCT00878306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65384404|NCT00878306|Antiviral Agents|antiviral agents|mesh-ancestor
65384405|NCT00878306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65384406|NCT00878306|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65384407|NCT00878306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65384408|NCT00878306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65384409|NCT00878306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65384410|NCT00878306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65384411|NCT00878306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65384412|NCT00878306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65384413|NCT00878306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65384414|NCT00878306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65384415|NCT00878306|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65384416|NCT00878306|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65384417|NCT00994617|Losartan|losartan|mesh-list
65384418|NCT00994617|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65384419|NCT00994617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65384420|NCT00994617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65384421|NCT00994617|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65384422|NCT00994617|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65384423|NCT00994617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384424|NCT00994617|Diuretics|diuretics|mesh-ancestor
65384425|NCT00994617|Natriuretic Agents|natriuretic agents|mesh-ancestor
65384426|NCT00994617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776891|NCT02723994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64776892|NCT02723994|Antimetabolites|antimetabolites|mesh-ancestor
64776893|NCT02723994|Dermatologic Agents|dermatologic agents|mesh-ancestor
64776894|NCT02723994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64776895|NCT02723994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64776896|NCT02723994|Antiviral Agents|antiviral agents|mesh-ancestor
64776897|NCT02723994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64776898|NCT02723994|Antidotes|antidotes|mesh-ancestor
64776899|NCT02723994|Protective Agents|protective agents|mesh-ancestor
64776900|NCT02723994|Vitamin B Complex|vitamin b complex|mesh-ancestor
64776901|NCT02723994|Vitamins|vitamins|mesh-ancestor
64776902|NCT02723994|Micronutrients|micronutrients|mesh-ancestor
64388371|NCT03149159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65384434|NCT00995397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65384435|NCT00995397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384436|NCT00995397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384437|NCT00995397|Antipruritics|antipruritics|mesh-ancestor
65384438|NCT00995397|Dermatologic Agents|dermatologic agents|mesh-ancestor
65384439|NCT00995397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65384440|NCT00919451|Cyclosporine|cyclosporine|mesh-list
65384441|NCT00919451|Cyclosporins|cyclosporins|mesh-list
65384475|NCT01014052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64776903|NCT02723994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64776904|NCT02723994|Tubulin Modulators|tubulin modulators|mesh-ancestor
64776905|NCT02723994|Antimitotic Agents|antimitotic agents|mesh-ancestor
64776906|NCT02723994|Mitosis Modulators|mitosis modulators|mesh-ancestor
64776907|NCT02534376|Simvastatin|simvastatin|mesh-list
64776909|NCT02534376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64776910|NCT02534376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64776911|NCT02534376|Antimetabolites|antimetabolites|mesh-ancestor
64776912|NCT02534376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776913|NCT02534376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64388380|NCT02349581|Bupivacaine|bupivacaine|mesh-list
64388381|NCT02349581|Anesthetics, Local|anesthetics, local|mesh-ancestor
64388382|NCT02349581|Anesthetics|anesthetics|mesh-ancestor
65384476|NCT01014052|Protective Agents|protective agents|mesh-ancestor
65384477|NCT01014052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384478|NCT00512902|Imatinib Mesylate|imatinib mesylate|mesh-list
65384479|NCT00512902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384480|NCT00512902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65384481|NCT00512902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384482|NCT00512902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384483|NCT01014364|Hydrocortisone|hydrocortisone|mesh-list
65384484|NCT01014364|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65384485|NCT01014364|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65384486|NCT01014364|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65384487|NCT01014364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65384508|NCT01015456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65384509|NCT01015456|Antitubercular Agents|antitubercular agents|mesh-ancestor
65384510|NCT01015456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65384511|NCT01015456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65384512|NCT01015456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384513|NCT02589041|Ropivacaine|ropivacaine|mesh-list
65384514|NCT02589041|Anesthetics, Local|anesthetics, local|mesh-ancestor
65384515|NCT02589041|Anesthetics|anesthetics|mesh-ancestor
65384516|NCT02589041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65384517|NCT02589041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384518|NCT02589041|Sensory System Agents|sensory system agents|mesh-ancestor
65384519|NCT02589041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65384520|NCT00492232|Zolpidem|zolpidem|mesh-list
65384521|NCT00492232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65384522|NCT00492232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65384523|NCT00492232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65384524|NCT00492232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384525|NCT00492232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64669511|NCT03028883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64669512|NCT03028883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64669513|NCT05238467|Antibodies|antibodies|mesh-list
64669514|NCT05238467|Immunologic Factors|immunologic factors|mesh-ancestor
64669515|NCT05238467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669516|NCT02290613|Ambrisentan|ambrisentan|mesh-list
64669517|NCT02290613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64669518|NCT05736419|Mycophenolic Acid|mycophenolic acid|mesh-list
64669519|NCT05736419|Dexamethasone|dexamethasone|mesh-list
64669520|NCT05736419|Cyclophosphamide|cyclophosphamide|mesh-list
64669521|NCT05736419|Rituximab|rituximab|mesh-list
64669522|NCT05736419|Fludarabine|fludarabine|mesh-list
64669523|NCT05736419|Bortezomib|bortezomib|mesh-list
64669524|NCT05736419|Tacrolimus|tacrolimus|mesh-list
64669525|NCT05736419|Thymoglobulin|thymoglobulin|mesh-list
64669526|NCT05736419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64669527|NCT05736419|Immunologic Factors|immunologic factors|mesh-ancestor
64669528|NCT05736419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669535|NCT05736419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64669537|NCT05736419|Antiemetics|antiemetics|mesh-ancestor
64669538|NCT05736419|Autonomic Agents|autonomic agents|mesh-ancestor
64669539|NCT05736419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64669540|NCT05736419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64669541|NCT05736419|Glucocorticoids|glucocorticoids|mesh-ancestor
64669542|NCT05736419|Hormones|hormones|mesh-ancestor
64669573|NCT01610570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669574|NCT01610570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64669575|NCT01610570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669576|NCT01610570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669577|NCT01610570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64669578|NCT05736341|Midazolam|midazolam|mesh-list
64669579|NCT05736341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64669580|NCT05736341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64669581|NCT05736341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64669582|NCT05736341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556689|NCT04146155|Incretins|incretins|mesh-ancestor
64556690|NCT04146155|Hormones|hormones|mesh-ancestor
64556691|NCT04146155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64556692|NCT04990752|Urinastatin|urinastatin|mesh-list
64556693|NCT04990752|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64321764|NCT02205931|Analgesics|analgesics|mesh-ancestor
65384526|NCT00492232|GABA Agonists|gaba agonists|mesh-ancestor
65384527|NCT00492232|GABA Agents|gaba agents|mesh-ancestor
65384528|NCT00492232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65384529|NCT00492232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384531|NCT02587871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65384532|NCT02587871|Antimetabolites|antimetabolites|mesh-ancestor
65384533|NCT02587871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384534|NCT02587871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384535|NCT02587871|Antiviral Agents|antiviral agents|mesh-ancestor
65384536|NCT02587871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65384537|NCT02587871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64669583|NCT05736341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64669616|NCT01646762|Paclitaxel|paclitaxel|mesh-list
64669617|NCT01646762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64669618|NCT01646762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64669619|NCT01646762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669620|NCT01646762|Tubulin Modulators|tubulin modulators|mesh-ancestor
64669621|NCT01646762|Antimitotic Agents|antimitotic agents|mesh-ancestor
64669622|NCT01646762|Mitosis Modulators|mitosis modulators|mesh-ancestor
64669623|NCT01646762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669624|NCT04997525|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64669625|NCT04997525|Estradiol|estradiol|mesh-list
64669632|NCT04997525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64669633|NCT04997525|Progestins|progestins|mesh-ancestor
64669634|NCT01649180|Axitinib|axitinib|mesh-list
64669635|NCT01649180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669636|NCT01649180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64669637|NCT01649180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669638|NCT01649180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669639|NCT04408313|Naltrexone|naltrexone|mesh-list
64669640|NCT04408313|Buprenorphine|buprenorphine|mesh-list
64669641|NCT04408313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64669642|NCT04408313|Narcotics|narcotics|mesh-ancestor
64669643|NCT04408313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64669644|NCT04408313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669645|NCT04408313|Analgesics|analgesics|mesh-ancestor
64669646|NCT04408313|Sensory System Agents|sensory system agents|mesh-ancestor
64669647|NCT04408313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64669648|NCT04408313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64669649|NCT04408313|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64669650|NCT01619774|Trametinib|trametinib|mesh-list
64669651|NCT01619774|Dabrafenib|dabrafenib|mesh-list
64669652|NCT01619774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669653|NCT01619774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64669654|NCT01619774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669655|NCT01619774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669656|NCT01651442|Zolpidem|zolpidem|mesh-list
64669657|NCT01651442|Trazodone|trazodone|mesh-list
64669658|NCT01651442|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64669659|NCT01651442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64669662|NCT01651442|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64669663|NCT01651442|GABA Agonists|gaba agonists|mesh-ancestor
64669664|NCT01651442|GABA Agents|gaba agents|mesh-ancestor
64669665|NCT01651442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64669666|NCT01651442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669667|NCT01651442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64669668|NCT01651442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64669669|NCT01651442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64669670|NCT01651442|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64669671|NCT01651442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64669672|NCT01651442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64669673|NCT01651442|Serotonin Agents|serotonin agents|mesh-ancestor
64669674|NCT01651442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64669675|NCT01651442|Antidepressive Agents|antidepressive agents|mesh-ancestor
64669676|NCT05710406|Cetuximab|cetuximab|mesh-list
64776941|NCT02058420|Protective Agents|protective agents|mesh-ancestor
64776942|NCT02058420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776943|NCT02058420|Vitamins|vitamins|mesh-ancestor
64776944|NCT02058420|Micronutrients|micronutrients|mesh-ancestor
64776945|NCT01976286|Salicylic Acid|salicylic acid|mesh-list
64776946|NCT01976286|Salicylates|salicylates|mesh-list
64776947|NCT01976286|Glycolic acid|glycolic acid|mesh-list
64776948|NCT01976286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64776949|NCT01976286|Antifungal Agents|antifungal agents|mesh-ancestor
64388419|NCT03147599|Mebeverine|mebeverine|mesh-list
64388420|NCT03147599|Anticonvulsants|anticonvulsants|mesh-ancestor
64388421|NCT03147599|Parasympatholytics|parasympatholytics|mesh-ancestor
64388422|NCT03147599|Autonomic Agents|autonomic agents|mesh-ancestor
64388423|NCT03147599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64388424|NCT03147599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388425|NCT02349113|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64388426|NCT02349113|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65384538|NCT02587871|Immunologic Factors|immunologic factors|mesh-ancestor
65384539|NCT02587871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384540|NCT00919919|Progesterone|progesterone|mesh-list
65384541|NCT00919919|Progestins|progestins|mesh-ancestor
65384542|NCT00919919|Hormones|hormones|mesh-ancestor
65384543|NCT00919919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65384544|NCT00919919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384545|NCT00491764|Posaconazole|posaconazole|mesh-list
64776950|NCT01976286|Keratolytic Agents|keratolytic agents|mesh-ancestor
64776951|NCT01976286|Dermatologic Agents|dermatologic agents|mesh-ancestor
64388428|NCT02349113|Estradiol|estradiol|mesh-list
65384570|NCT05557721|Anesthetics|anesthetics|mesh-ancestor
65384571|NCT05557721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65384572|NCT05557721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384573|NCT05557721|Sensory System Agents|sensory system agents|mesh-ancestor
65384574|NCT05557721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65384575|NCT05557721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65384576|NCT05557721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65384577|NCT05557721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65384578|NCT05557721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65384579|NCT05557721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384580|NCT00615836|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65384581|NCT00615836|Hemostatics|hemostatics|mesh-ancestor
65384582|NCT00615836|Coagulants|coagulants|mesh-ancestor
65384583|NCT00615836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65384584|NCT00615836|Natriuretic Agents|natriuretic agents|mesh-ancestor
65384585|NCT00615836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384586|NCT05139212|Dexmedetomidine|dexmedetomidine|mesh-list
65384587|NCT05139212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65384588|NCT05139212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64669677|NCT05710406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64669678|NCT05710406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669679|NCT05710328|Deoxyglucose|deoxyglucose|mesh-list
64669680|NCT05710328|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64669681|NCT05710328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64669682|NCT05710328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669692|NCT04901975|Diuretics|diuretics|mesh-ancestor
64556695|NCT04990752|Protease Inhibitors|protease inhibitors|mesh-ancestor
64556696|NCT04990752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556697|NCT04990752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556698|NCT02245191|Phenylephrine|phenylephrine|mesh-list
64556699|NCT02245191|Oxymetazoline|oxymetazoline|mesh-list
64556700|NCT02245191|Ephedrine|ephedrine|mesh-list
64556701|NCT02245191|Metaraminol|metaraminol|mesh-list
64556702|NCT02245191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64669693|NCT04901975|Natriuretic Agents|natriuretic agents|mesh-ancestor
64669694|NCT05421416|Loratadine|loratadine|mesh-list
64669695|NCT05421416|Antipruritics|antipruritics|mesh-ancestor
64669696|NCT05421416|Dermatologic Agents|dermatologic agents|mesh-ancestor
64669697|NCT05421416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64669698|NCT05421416|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64669699|NCT05421416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64669700|NCT05421416|Histamine Antagonists|histamine antagonists|mesh-ancestor
64669701|NCT05421416|Histamine Agents|histamine agents|mesh-ancestor
64669702|NCT05421416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64669703|NCT05421416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669704|NCT05421416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669705|NCT04868045|Hormones|hormones|mesh-list
64669706|NCT04868045|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
64669707|NCT04868045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65384589|NCT05139212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384590|NCT05139212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65384591|NCT05139212|Analgesics|analgesics|mesh-ancestor
65384592|NCT05139212|Sensory System Agents|sensory system agents|mesh-ancestor
65384593|NCT05139212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65384594|NCT05139212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65384595|NCT05139212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65384596|NCT05139212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65384597|NCT05139212|Adrenergic Agents|adrenergic agents|mesh-ancestor
65384598|NCT05139212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64669708|NCT04868045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669709|NCT04803539|Capecitabine|capecitabine|mesh-list
64669710|NCT04803539|Apatinib|apatinib|mesh-list
64669711|NCT04803539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64669712|NCT04803539|Antimetabolites|antimetabolites|mesh-ancestor
64669713|NCT04803539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669714|NCT04803539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669715|NCT04803539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64669716|NCT04803539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669717|NCT04799015|Dexamethasone|dexamethasone|mesh-list
64669718|NCT04799015|Metoclopramide|metoclopramide|mesh-list
64669719|NCT04799015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64669720|NCT04799015|Antiemetics|antiemetics|mesh-ancestor
64669721|NCT04799015|Autonomic Agents|autonomic agents|mesh-ancestor
64669722|NCT04799015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64669723|NCT04799015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669724|NCT04799015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64669725|NCT04799015|Glucocorticoids|glucocorticoids|mesh-ancestor
64669726|NCT04799015|Hormones|hormones|mesh-ancestor
64669727|NCT04799015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64669728|NCT04799015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64669729|NCT04799015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669730|NCT04799015|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64669731|NCT04799015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64669732|NCT04799015|Dopamine Agents|dopamine agents|mesh-ancestor
64669733|NCT04799015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64669735|NCT03141359|Paclitaxel|paclitaxel|mesh-list
64669736|NCT03141359|Etoposide|etoposide|mesh-list
64669737|NCT03141359|Carboplatin|carboplatin|mesh-list
64669738|NCT03141359|Durvalumab|durvalumab|mesh-list
64669758|NCT01658228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669759|NCT01658228|Nootropic Agents|nootropic agents|mesh-ancestor
64669760|NCT01658228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64669761|NCT01658228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64669762|NCT01658228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64669763|NCT01658228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64669764|NCT01658228|Antidepressive Agents|antidepressive agents|mesh-ancestor
64669765|NCT01658228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64669766|NCT01658228|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64669767|NCT01658228|Serotonin Agents|serotonin agents|mesh-ancestor
64669768|NCT05709938|Insulin|insulin|mesh-list
64556703|NCT02245191|Mydriatics|mydriatics|mesh-ancestor
64556704|NCT02245191|Autonomic Agents|autonomic agents|mesh-ancestor
64556705|NCT02245191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556706|NCT02245191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556707|NCT02245191|Sympathomimetics|sympathomimetics|mesh-ancestor
64556708|NCT02245191|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64556709|NCT02245191|Nasal Decongestants|nasal decongestants|mesh-ancestor
64556710|NCT02245191|Respiratory System Agents|respiratory system agents|mesh-ancestor
64556711|NCT02245191|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64556712|NCT02245191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64321780|NCT04528004|Vitamins|vitamins|mesh-ancestor
64669769|NCT05709938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64669770|NCT05709938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64669771|NCT05709938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669772|NCT01659866|Ciprofloxacin|ciprofloxacin|mesh-list
64776969|NCT01858740|Abortifacient Agents|abortifacient agents|mesh-ancestor
64776970|NCT01858740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64776971|NCT01858740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776972|NCT01858740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64776973|NCT01858740|Antimetabolites|antimetabolites|mesh-ancestor
64776974|NCT01858740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776975|NCT01858740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776976|NCT01858740|Dermatologic Agents|dermatologic agents|mesh-ancestor
65384599|NCT05139212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384600|NCT00872924|Sumatriptan|sumatriptan|mesh-list
65384601|NCT00872924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65384602|NCT00872924|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65384603|NCT00872924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65384604|NCT00872924|Serotonin Agents|serotonin agents|mesh-ancestor
65384605|NCT00872924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65384606|NCT00872924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384607|NCT00872924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384608|NCT00878540|Mirtazapine|mirtazapine|mesh-list
65384609|NCT00878540|Antidepressive Agents|antidepressive agents|mesh-ancestor
65384610|NCT00878540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65384611|NCT00878540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65384612|NCT00878540|Histamine Antagonists|histamine antagonists|mesh-ancestor
65384613|NCT00878540|Histamine Agents|histamine agents|mesh-ancestor
65384614|NCT00878540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65384615|NCT00878540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384616|NCT00878540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384617|NCT00878540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65384618|NCT00878540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65384619|NCT00878540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65384633|NCT04018274|Estrogens|estrogens|mesh-ancestor
65384634|NCT04018274|Hormones|hormones|mesh-ancestor
65384635|NCT04018274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65384636|NCT04018274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384637|NCT04018274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65384638|NCT04018274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65384639|NCT04018274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65384640|NCT04018274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65384641|NCT04018274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64669773|NCT01659866|Gentamicins|gentamicins|mesh-list
64669774|NCT01659866|Ceftriaxone|ceftriaxone|mesh-list
64669775|NCT01659866|Imipenem|imipenem|mesh-list
64669776|NCT01659866|Amikacin|amikacin|mesh-list
64669777|NCT01659866|Cefuroxime|cefuroxime|mesh-list
64669778|NCT01659866|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64669779|NCT01659866|Aztreonam|aztreonam|mesh-list
64669780|NCT01659866|Trimethoprim|trimethoprim|mesh-list
64669781|NCT01659866|Sulfamethoxazole|sulfamethoxazole|mesh-list
64669782|NCT01659866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64669783|NCT01659866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64669784|NCT01659866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64669785|NCT01659866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64669786|NCT01659866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669787|NCT01659866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669788|NCT01659866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669789|NCT01659866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64669790|NCT01659866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64669791|NCT01659866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64669792|NCT01659866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64669793|NCT01659866|Renal Agents|renal agents|mesh-ancestor
64669794|NCT01659866|Antimalarials|antimalarials|mesh-ancestor
64669821|NCT02947529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669823|NCT02947529|Coagulants|coagulants|mesh-ancestor
64669824|NCT01660802|Dexamethasone|dexamethasone|mesh-list
64669825|NCT01660802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64669826|NCT01660802|Antiemetics|antiemetics|mesh-ancestor
64669827|NCT01660802|Autonomic Agents|autonomic agents|mesh-ancestor
64669828|NCT01660802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64669829|NCT01660802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669830|NCT01660802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64669831|NCT01660802|Glucocorticoids|glucocorticoids|mesh-ancestor
64669832|NCT01660802|Hormones|hormones|mesh-ancestor
64669833|NCT01660802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64669834|NCT01660802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64669835|NCT01660802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669836|NCT02899325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64669837|NCT02899325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64669838|NCT02899325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669839|NCT01661114|Gemcitabine|gemcitabine|mesh-list
64669840|NCT01661114|Fluorouracil|fluorouracil|mesh-list
64669841|NCT01661114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669842|NCT01661114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64669843|NCT01661114|Antimetabolites|antimetabolites|mesh-ancestor
64669870|NCT02988843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64669871|NCT02988843|Growth Substances|growth substances|mesh-ancestor
64669872|NCT02988843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669873|NCT02988843|Growth Inhibitors|growth inhibitors|mesh-ancestor
64556713|NCT02245191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64556714|NCT02245191|Adrenergic Agents|adrenergic agents|mesh-ancestor
64556715|NCT02245191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64556716|NCT02245191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556717|NCT02245191|Protective Agents|protective agents|mesh-ancestor
64556718|NCT02245191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64556719|NCT04145921|Tacrine|tacrine|mesh-list
64556720|NCT04145921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64776990|NCT01688076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64776991|NCT01688076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64776992|NCT01688076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776993|NCT01688076|Cholinergic Agents|cholinergic agents|mesh-ancestor
64776994|NCT01688076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64776995|NCT01688076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776996|NCT01688076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64776997|NCT01688076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776998|NCT01239030|Methylphenidate|methylphenidate|mesh-list
64776999|NCT01239030|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64777000|NCT01239030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384642|NCT00873002|Sorafenib|sorafenib|mesh-list
65384643|NCT00873002|Panobinostat|panobinostat|mesh-list
65384644|NCT00873002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384645|NCT00873002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65384646|NCT00873002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384647|NCT00873002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384648|NCT00873002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65384649|NCT00491530|Calcium, Dietary|calcium, dietary|mesh-list
65384650|NCT00491530|Atorvastatin|atorvastatin|mesh-list
65384651|NCT00491530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65384652|NCT00491530|Simvastatin|simvastatin|mesh-list
65384653|NCT00491530|Fenofibric acid|fenofibric acid|mesh-list
65384654|NCT00491530|Calcium|calcium|mesh-list
65384655|NCT00491530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65384656|NCT00491530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384657|NCT00491530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65384658|NCT00491530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65384660|NCT00491530|Antimetabolites|antimetabolites|mesh-ancestor
64777002|NCT01239030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64777003|NCT01239030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64777004|NCT01239030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777005|NCT01239030|Dopamine Agents|dopamine agents|mesh-ancestor
64777006|NCT01239030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64777007|NCT01086540|Acetaminophen|acetaminophen|mesh-list
65384675|NCT02587169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65384676|NCT02587169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384677|NCT02587169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65384678|NCT02587169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65384679|NCT02587169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384680|NCT02587169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384682|NCT00873236|Interferon-alpha|interferon-alpha|mesh-list
65384683|NCT00873236|Interferon alpha-2|interferon alpha-2|mesh-list
65384684|NCT00873236|Bevacizumab|bevacizumab|mesh-list
65384685|NCT00873236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65384686|NCT00873236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384687|NCT00873236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65384688|NCT00873236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65384689|NCT00873236|Growth Substances|growth substances|mesh-ancestor
65384690|NCT00873236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384691|NCT00873236|Growth Inhibitors|growth inhibitors|mesh-ancestor
65384692|NCT00873236|Antiviral Agents|antiviral agents|mesh-ancestor
65384693|NCT00873236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65384694|NCT00873236|Immunologic Factors|immunologic factors|mesh-ancestor
65384695|NCT00868010|Donepezil|donepezil|mesh-list
65384696|NCT00868010|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65384697|NCT00868010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556721|NCT04145921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556722|NCT04145921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556723|NCT04145921|Cholinergic Agents|cholinergic agents|mesh-ancestor
64556724|NCT04145921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64556725|NCT04145921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556726|NCT04145921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64556727|NCT04145921|Autonomic Agents|autonomic agents|mesh-ancestor
64556728|NCT04145921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556729|NCT04145921|Nootropic Agents|nootropic agents|mesh-ancestor
64556730|NCT04145687|Metformin|metformin|mesh-list
64556731|NCT04145687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64556732|NCT04145687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556733|NCT04359615|Hydroxychloroquine|hydroxychloroquine|mesh-list
64556734|NCT04359615|Favipiravir|favipiravir|mesh-list
64556735|NCT04359615|Antimalarials|antimalarials|mesh-ancestor
64321790|NCT02221063|Vitamins|vitamins|mesh-ancestor
64669875|NCT01661270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64669876|NCT01661270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64777012|NCT01086540|Rituximab|rituximab|mesh-list
64777013|NCT01086540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64777014|NCT01086540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64777015|NCT01086540|Immunologic Factors|immunologic factors|mesh-ancestor
64777016|NCT01086540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777017|NCT01086540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64777018|NCT01086540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64777019|NCT01086540|Glucocorticoids|glucocorticoids|mesh-ancestor
64777020|NCT01086540|Hormones|hormones|mesh-ancestor
65384698|NCT00868010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777021|NCT01086540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64777022|NCT01086540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64777023|NCT01086540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64388477|NCT02348333|Uricosuric Agents|uricosuric agents|mesh-ancestor
64388478|NCT02348333|Gout Suppressants|gout suppressants|mesh-ancestor
64388479|NCT02348333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64388480|NCT02348333|Renal Agents|renal agents|mesh-ancestor
64388481|NCT02343419|Methacholine Chloride|methacholine chloride|mesh-list
64777024|NCT01086540|Analgesics|analgesics|mesh-ancestor
64777025|NCT01086540|Sensory System Agents|sensory system agents|mesh-ancestor
65384736|NCT05653661|Mitosis Modulators|mitosis modulators|mesh-ancestor
65384737|NCT05653661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384738|NCT00873392|Nicotine|nicotine|mesh-list
65384739|NCT00873392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65384740|NCT00873392|Autonomic Agents|autonomic agents|mesh-ancestor
65384741|NCT00873392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65384742|NCT00873392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384743|NCT00873392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65384744|NCT00873392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65384745|NCT00873392|Cholinergic Agents|cholinergic agents|mesh-ancestor
65384746|NCT00873392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65384747|NCT00873392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384748|NCT00879008|Moxifloxacin|moxifloxacin|mesh-list
65134348|NCT04578158|Quercetin|quercetin|mesh-list
65384749|NCT00879008|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65384750|NCT00879008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65384751|NCT00879008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65384752|NCT00879008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65384753|NCT00879008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65384755|NCT00879008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384756|NCT00879008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384757|NCT00879008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65384758|NCT00879008|Contraceptive Agents|contraceptive agents|mesh-ancestor
65384759|NCT00879008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65384760|NCT00879008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384761|NCT00879008|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64388495|NCT02342717|BI 425809|bi 425809|mesh-list
64669877|NCT01661270|Growth Substances|growth substances|mesh-ancestor
64669878|NCT01661270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669879|NCT01661270|Growth Inhibitors|growth inhibitors|mesh-ancestor
64669880|NCT01661270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669901|NCT02249780|Parathyroid Hormone|parathyroid hormone|mesh-list
64669902|NCT02249780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64669903|NCT02249780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669905|NCT03170661|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64669906|NCT03170661|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64669907|NCT03170661|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64669908|NCT03170661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64669909|NCT03170661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669910|NCT03175731|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64669911|NCT03175731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64777037|NCT01086540|Anesthetics|anesthetics|mesh-ancestor
65384762|NCT00879008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65384763|NCT00879008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65384764|NCT04658147|Nivolumab|nivolumab|mesh-list
65384765|NCT04658147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65384766|NCT04658147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384767|NCT04658147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65384768|NCT04658147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384769|NCT00879164|Bupivacaine|bupivacaine|mesh-list
65384770|NCT00879164|Anesthetics, Local|anesthetics, local|mesh-ancestor
65384771|NCT00879164|Anesthetics|anesthetics|mesh-ancestor
65384772|NCT00879164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65384773|NCT00879164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384774|NCT00879164|Sensory System Agents|sensory system agents|mesh-ancestor
65384775|NCT00879164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65384776|NCT05487599|Sirolimus|sirolimus|mesh-list
65384777|NCT05487599|Prednisone|prednisone|mesh-list
65384778|NCT05487599|Methylprednisolone|methylprednisolone|mesh-list
65384779|NCT05487599|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65384780|NCT05487599|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65384781|NCT05487599|Prednisolone|prednisolone|mesh-list
65384782|NCT05487599|Prednisolone acetate|prednisolone acetate|mesh-list
64777040|NCT01086540|Histamine Agents|histamine agents|mesh-ancestor
64669912|NCT03175731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669913|NCT01662908|Heparin|heparin|mesh-list
64669914|NCT01662908|Enoxaparin|enoxaparin|mesh-list
64669915|NCT01662908|Calcium heparin|calcium heparin|mesh-list
64669916|NCT01662908|Warfarin|warfarin|mesh-list
64669917|NCT01662908|Edoxaban|edoxaban|mesh-list
64669918|NCT01662908|Anticoagulants|anticoagulants|mesh-ancestor
64669919|NCT01662908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64669920|NCT01662908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64669921|NCT01662908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669922|NCT01662908|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64556736|NCT04359615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64556737|NCT04359615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64556738|NCT04359615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64556739|NCT04359615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556740|NCT04359615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556741|NCT04359615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64556742|NCT04359615|Antiviral Agents|antiviral agents|mesh-ancestor
64556743|NCT02635386|Metformin|metformin|mesh-list
64556744|NCT02635386|Dapagliflozin|dapagliflozin|mesh-list
64556745|NCT02635386|Exenatide|exenatide|mesh-list
64556746|NCT02635386|Topiramate|topiramate|mesh-list
64556747|NCT02635386|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64556748|NCT02635386|Phentermine|phentermine|mesh-list
64556749|NCT02635386|Glucagon|glucagon|mesh-list
64556750|NCT02635386|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64556751|NCT02635386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64556752|NCT02635386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556753|NCT02635386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669946|NCT02240030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64669947|NCT02240030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777048|NCT01962870|Hemostatics|hemostatics|mesh-ancestor
64777049|NCT01962870|Coagulants|coagulants|mesh-ancestor
64777050|NCT01962870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64777051|NCT01962870|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64777052|NCT01962870|Natriuretic Agents|natriuretic agents|mesh-ancestor
64545776|NCT02467153|Vitamin D|vitamin d|mesh-list
64777053|NCT01962870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384783|NCT05487599|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65384784|NCT05487599|Prednisolone phosphate|prednisolone phosphate|mesh-list
65384785|NCT05487599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65384786|NCT05487599|Glucocorticoids|glucocorticoids|mesh-ancestor
65384787|NCT05487599|Hormones|hormones|mesh-ancestor
65384788|NCT05487599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65384789|NCT05487599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384790|NCT05487599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65384791|NCT05487599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384792|NCT05487599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65384793|NCT05487599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65384794|NCT05487599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65384795|NCT05487599|Antifungal Agents|antifungal agents|mesh-ancestor
65384796|NCT05487599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65384797|NCT05487599|Immunologic Factors|immunologic factors|mesh-ancestor
65384798|NCT05487599|Antiemetics|antiemetics|mesh-ancestor
65384799|NCT05487599|Autonomic Agents|autonomic agents|mesh-ancestor
65384800|NCT05487599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65384801|NCT05487599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65384802|NCT05487599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65384803|NCT05487599|Protective Agents|protective agents|mesh-ancestor
65384804|NCT04729049|Morphine|morphine|mesh-list
65384805|NCT04729049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65384806|NCT04729049|Narcotics|narcotics|mesh-ancestor
65384807|NCT04729049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65384808|NCT04729049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669948|NCT02240030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669950|NCT05183828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669952|NCT05183828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64669953|NCT05183828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669954|NCT05183828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669955|NCT05183828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64669956|NCT05183828|Hormone Antagonists|hormone antagonists|mesh-ancestor
64669957|NCT05183828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64669958|NCT05183828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384809|NCT04729049|Analgesics|analgesics|mesh-ancestor
65384810|NCT04729049|Sensory System Agents|sensory system agents|mesh-ancestor
65384811|NCT04729049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65384812|NCT02585765|Pioglitazone|pioglitazone|mesh-list
65384813|NCT02585765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65384814|NCT02585765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384815|NCT04634669|Dextromethorphan|dextromethorphan|mesh-list
65384816|NCT04634669|Bupropion|bupropion|mesh-list
65384817|NCT04634669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65384818|NCT04634669|Antidepressive Agents|antidepressive agents|mesh-ancestor
65384819|NCT04634669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65384820|NCT04634669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65384821|NCT04634669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65384822|NCT04634669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65384823|NCT04634669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384824|NCT04634669|Dopamine Agents|dopamine agents|mesh-ancestor
64669959|NCT03180489|Dapagliflozin|dapagliflozin|mesh-list
64669960|NCT03180489|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64669961|NCT03180489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669962|NCT03180489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64669963|NCT03180489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669964|NCT03471663|Palbociclib|palbociclib|mesh-list
64669965|NCT03471663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669966|NCT03471663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64669967|NCT03471663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669968|NCT03471663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669969|NCT01664858|Calcium|calcium|mesh-list
64669970|NCT01664858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64669971|NCT01664858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669972|NCT04348695|Simvastatin|simvastatin|mesh-list
64669973|NCT04348695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64669974|NCT04348695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64669996|NCT00375765|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64669997|NCT00375765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64669998|NCT00375765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414788|NCT02419755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64669999|NCT00375765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670000|NCT00375765|Hormone Antagonists|hormone antagonists|mesh-ancestor
64670001|NCT00375765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64670002|NCT00375765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556754|NCT02635386|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64556755|NCT02635386|Incretins|incretins|mesh-ancestor
64556756|NCT02635386|Hormones|hormones|mesh-ancestor
64556757|NCT02635386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64556758|NCT02635386|Anticonvulsants|anticonvulsants|mesh-ancestor
64556759|NCT02635386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64556760|NCT02635386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64556761|NCT02635386|Appetite Depressants|appetite depressants|mesh-ancestor
64556762|NCT02635386|Sympathomimetics|sympathomimetics|mesh-ancestor
64556763|NCT02635386|Autonomic Agents|autonomic agents|mesh-ancestor
64556764|NCT02635386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670003|NCT03325647|Methyltestosterone|methyltestosterone|mesh-list
64670004|NCT03325647|Testosterone|testosterone|mesh-list
64670005|NCT03325647|Testosterone undecanoate|testosterone undecanoate|mesh-list
64670006|NCT03325647|Testosterone enanthate|testosterone enanthate|mesh-list
64670007|NCT03325647|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64670008|NCT03325647|Androgens|androgens|mesh-ancestor
65384825|NCT04634669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65384826|NCT04634669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384827|NCT04634669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65384828|NCT04634669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65384829|NCT04634669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384830|NCT04634669|Antitussive Agents|antitussive agents|mesh-ancestor
65384831|NCT04634669|Respiratory System Agents|respiratory system agents|mesh-ancestor
65384832|NCT04634669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65384833|NCT04634669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65384834|NCT02585531|Dexamethasone|dexamethasone|mesh-list
65384835|NCT02585531|Epinephrine|epinephrine|mesh-list
65384836|NCT02585531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65384837|NCT02585531|Antiemetics|antiemetics|mesh-ancestor
65384838|NCT02585531|Autonomic Agents|autonomic agents|mesh-ancestor
65384839|NCT02585531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65384840|NCT02585531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384841|NCT02585531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64777074|NCT01967862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777075|NCT01967862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64777076|NCT01967862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64777077|NCT01976988|Heparin|heparin|mesh-list
64777078|NCT01976988|Anticoagulants|anticoagulants|mesh-ancestor
64777079|NCT01976988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64777080|NCT01976988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64777081|NCT01976988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777082|NCT01980654|Rituximab|rituximab|mesh-list
64777083|NCT01980654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64670009|NCT03325647|Hormones|hormones|mesh-ancestor
64670010|NCT03325647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64670011|NCT03325647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670012|NCT03325647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64670013|NCT03325647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670014|NCT03325647|Anabolic Agents|anabolic agents|mesh-ancestor
64670015|NCT01665950|Simvastatin|simvastatin|mesh-list
64670016|NCT01665950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64670017|NCT01665950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64670018|NCT01665950|Antimetabolites|antimetabolites|mesh-ancestor
64670019|NCT01665950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670020|NCT01665950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64670021|NCT01665950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64670022|NCT01665950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670023|NCT01667978|Ritonavir|ritonavir|mesh-list
64670024|NCT01667978|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64670025|NCT01667978|Norethindrone|norethindrone|mesh-list
64670061|NCT00375843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64670062|NCT00375843|Serotonin Agents|serotonin agents|mesh-ancestor
64777084|NCT01980654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64777085|NCT01980654|Immunologic Factors|immunologic factors|mesh-ancestor
64777086|NCT01980654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777087|NCT01980654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64777088|NCT01984398|Citric Acid|citric acid|mesh-list
64777089|NCT01984398|Sodium Citrate|sodium citrate|mesh-list
64777090|NCT01984398|Enclomiphene|enclomiphene|mesh-list
64777091|NCT01984398|Clomiphene|clomiphene|mesh-list
64777092|NCT01984398|Zuclomiphene|zuclomiphene|mesh-list
65384842|NCT02585531|Glucocorticoids|glucocorticoids|mesh-ancestor
65384843|NCT02585531|Hormones|hormones|mesh-ancestor
65384844|NCT02585531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65384845|NCT02585531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65384846|NCT02585531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384847|NCT02585531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65384848|NCT02585531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65384849|NCT02585531|Adrenergic Agents|adrenergic agents|mesh-ancestor
65384850|NCT02585531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65384851|NCT02585531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384852|NCT02585531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65384853|NCT02585531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65384854|NCT02585531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65384855|NCT02585531|Respiratory System Agents|respiratory system agents|mesh-ancestor
65384856|NCT02585531|Mydriatics|mydriatics|mesh-ancestor
65384857|NCT02585531|Sympathomimetics|sympathomimetics|mesh-ancestor
65384858|NCT02585531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65384859|NCT00920153|Gemcitabine|gemcitabine|mesh-list
65384860|NCT00920153|Cytarabine|cytarabine|mesh-list
65384861|NCT00920153|Dexamethasone|dexamethasone|mesh-list
65384862|NCT00920153|Methylprednisolone|methylprednisolone|mesh-list
65384863|NCT00920153|Doxorubicin|doxorubicin|mesh-list
65384864|NCT00920153|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65384865|NCT00920153|Etoposide|etoposide|mesh-list
65384866|NCT00920153|Vincristine|vincristine|mesh-list
65384867|NCT00920153|Melphalan|melphalan|mesh-list
65384868|NCT00920153|Vinorelbine|vinorelbine|mesh-list
64777096|NCT01984398|Sequestering Agents|sequestering agents|mesh-ancestor
64777097|NCT01984398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777098|NCT01984398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64777099|NCT01984398|Hormone Antagonists|hormone antagonists|mesh-ancestor
64777101|NCT01984398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384877|NCT00920153|Autonomic Agents|autonomic agents|mesh-ancestor
65384878|NCT00920153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65384879|NCT00920153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384880|NCT00920153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65384881|NCT00920153|Glucocorticoids|glucocorticoids|mesh-ancestor
65384882|NCT00920153|Hormones|hormones|mesh-ancestor
65384883|NCT00920153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65384884|NCT00920153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65384885|NCT00920153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384886|NCT00920153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65384887|NCT00920153|Antimetabolites|antimetabolites|mesh-ancestor
65384888|NCT00920153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384889|NCT00920153|Antiviral Agents|antiviral agents|mesh-ancestor
65384890|NCT00920153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65384891|NCT00920153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384892|NCT00920153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65384893|NCT00920153|Immunologic Factors|immunologic factors|mesh-ancestor
65384894|NCT00920153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65384895|NCT00920153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65384896|NCT00920153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65384897|NCT00920153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65384898|NCT00920153|Tubulin Modulators|tubulin modulators|mesh-ancestor
64670063|NCT00375843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670064|NCT00375843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64670065|NCT00375843|Antidepressive Agents|antidepressive agents|mesh-ancestor
64670066|NCT00375843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64670069|NCT03247569|Antithrombins|antithrombins|mesh-ancestor
64670070|NCT03247569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64670071|NCT03247569|Protease Inhibitors|protease inhibitors|mesh-ancestor
64670072|NCT03247569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670073|NCT03247569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670074|NCT03247569|Anticoagulants|anticoagulants|mesh-ancestor
64670075|NCT01668836|Resveratrol|resveratrol|mesh-list
64670076|NCT01668836|Antioxidants|antioxidants|mesh-ancestor
64670077|NCT01668836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670078|NCT01668836|Protective Agents|protective agents|mesh-ancestor
64670079|NCT01668836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670080|NCT01668836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670081|NCT01668836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65384899|NCT00920153|Antimitotic Agents|antimitotic agents|mesh-ancestor
65384900|NCT00920153|Mitosis Modulators|mitosis modulators|mesh-ancestor
65384901|NCT00920153|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65384902|NCT00920153|Protective Agents|protective agents|mesh-ancestor
65384903|NCT00920153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65384904|NCT00920153|Alkylating Agents|alkylating agents|mesh-ancestor
65384905|NCT00920153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65384906|NCT04080713|Budesonide|budesonide|mesh-list
65384907|NCT04080713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65384908|NCT04080713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65384909|NCT04080713|Autonomic Agents|autonomic agents|mesh-ancestor
65384910|NCT04080713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65384911|NCT04080713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384912|NCT04080713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65384913|NCT04080713|Respiratory System Agents|respiratory system agents|mesh-ancestor
65384914|NCT04080713|Glucocorticoids|glucocorticoids|mesh-ancestor
65384915|NCT04080713|Hormones|hormones|mesh-ancestor
65384916|NCT04080713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65384917|NCT04081805|Estradiol|estradiol|mesh-list
65384918|NCT04081805|Estrogens|estrogens|mesh-ancestor
65384919|NCT04081805|Hormones|hormones|mesh-ancestor
65384920|NCT04081805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65384921|NCT04081805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670082|NCT02849457|Vigabatrin|vigabatrin|mesh-list
64670083|NCT02849457|Anticonvulsants|anticonvulsants|mesh-ancestor
64670084|NCT02849457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670085|NCT02849457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670086|NCT02849457|GABA Agents|gaba agents|mesh-ancestor
64670087|NCT02849457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64670088|NCT02849457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670089|NCT03744663|Buprenorphine|buprenorphine|mesh-list
64670090|NCT03744663|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64670091|NCT03744663|Naloxone|naloxone|mesh-list
64556765|NCT02635386|Adrenergic Agents|adrenergic agents|mesh-ancestor
64556766|NCT02635386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64556767|NCT03924947|Pancrelipase|pancrelipase|mesh-list
64556768|NCT03924947|Pancreatin|pancreatin|mesh-list
64321845|NCT05503706|Protective Agents|protective agents|mesh-ancestor
64670092|NCT03744663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64670093|NCT03744663|Narcotics|narcotics|mesh-ancestor
64670094|NCT03744663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64670095|NCT03744663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395445|NCT01674647|Anticoagulants|anticoagulants|mesh-ancestor
64670096|NCT03744663|Analgesics|analgesics|mesh-ancestor
64670097|NCT03744663|Sensory System Agents|sensory system agents|mesh-ancestor
64670098|NCT03744663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670099|NCT03744663|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64670100|NCT01669538|Galantamine|galantamine|mesh-list
64670101|NCT01669538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64670102|NCT01669538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670103|NCT01669538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670104|NCT01669538|Cholinergic Agents|cholinergic agents|mesh-ancestor
64670105|NCT01669538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65384922|NCT05519189|Ropivacaine|ropivacaine|mesh-list
65384923|NCT05519189|Anesthetics, Local|anesthetics, local|mesh-ancestor
65384924|NCT05519189|Anesthetics|anesthetics|mesh-ancestor
65384925|NCT05519189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65384926|NCT05519189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384927|NCT05519189|Sensory System Agents|sensory system agents|mesh-ancestor
65384928|NCT05519189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65384929|NCT04080323|Dinoprostone|dinoprostone|mesh-list
65384930|NCT04080323|Oxytocics|oxytocics|mesh-ancestor
65384931|NCT04080323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65384932|NCT04080323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384933|NCT03930017|Vaccines|vaccines|mesh-list
65384934|NCT03930017|Immunologic Factors|immunologic factors|mesh-ancestor
65384935|NCT03930017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384936|NCT00533949|Paclitaxel|paclitaxel|mesh-list
64777123|NCT01988922|Ketamine|ketamine|mesh-list
64670106|NCT01669538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670107|NCT01669538|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64670108|NCT01669538|Autonomic Agents|autonomic agents|mesh-ancestor
64670109|NCT01669538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670110|NCT01669538|Nootropic Agents|nootropic agents|mesh-ancestor
64670111|NCT00375375|Lactulose|lactulose|mesh-list
64670112|NCT00375375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64670117|NCT04333095|Bupivacaine|bupivacaine|mesh-list
64670118|NCT04333095|Anesthetics, Local|anesthetics, local|mesh-ancestor
64670119|NCT04333095|Anesthetics|anesthetics|mesh-ancestor
64670120|NCT04333095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64670121|NCT04333095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670122|NCT04333095|Sensory System Agents|sensory system agents|mesh-ancestor
64670123|NCT04333095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670124|NCT05045144|Vaccines|vaccines|mesh-list
64670125|NCT05045144|Immunologic Factors|immunologic factors|mesh-ancestor
64670126|NCT05045144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670129|NCT05357079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64670130|NCT05357079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670131|NCT05357079|Hemostatics|hemostatics|mesh-ancestor
64670132|NCT05357079|Coagulants|coagulants|mesh-ancestor
64670133|NCT00375687|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64670134|NCT00375687|Luteolytic Agents|luteolytic agents|mesh-ancestor
64670135|NCT00375687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64670136|NCT00375687|Contraceptive Agents|contraceptive agents|mesh-ancestor
64670137|NCT00375687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64670140|NCT00375687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64670141|NCT00375687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670142|NCT01658241|Panobinostat|panobinostat|mesh-list
64670143|NCT01658241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670144|NCT01658241|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64670145|NCT01658241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670146|NCT01658241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670147|NCT01455051|Ofatumumab|ofatumumab|mesh-list
64670148|NCT01455051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670149|NCT01673828|Pregnanolone|pregnanolone|mesh-list
64670150|NCT01673828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64670151|NCT01673828|Anesthetics|anesthetics|mesh-ancestor
64670152|NCT01673828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64670153|NCT01673828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670154|NCT05325099|Azacitidine|azacitidine|mesh-list
64670155|NCT05325099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64670156|NCT05325099|Antimetabolites|antimetabolites|mesh-ancestor
64670157|NCT05325099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670158|NCT05325099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64777130|NCT01988922|Anesthetics, General|anesthetics, general|mesh-ancestor
64777131|NCT01988922|Anesthetics|anesthetics|mesh-ancestor
64777132|NCT01988922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64777133|NCT01988922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64777134|NCT01988922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64777135|NCT01988922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64777136|NCT01988922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777137|NCT01994538|Oxymetazoline|oxymetazoline|mesh-list
65384937|NCT00533949|Carboplatin|carboplatin|mesh-list
65384938|NCT00533949|Cetuximab|cetuximab|mesh-list
65384939|NCT00533949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65384940|NCT00533949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384941|NCT00533949|Tubulin Modulators|tubulin modulators|mesh-ancestor
65384942|NCT00533949|Antimitotic Agents|antimitotic agents|mesh-ancestor
65384943|NCT00533949|Mitosis Modulators|mitosis modulators|mesh-ancestor
65384944|NCT00533949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384945|NCT00533949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65384946|NCT00485134|Vaccines|vaccines|mesh-list
65384947|NCT00485134|Immunologic Factors|immunologic factors|mesh-ancestor
65384948|NCT00485134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384949|NCT02585141|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65384950|NCT02585141|Clindamycin|clindamycin|mesh-list
65384951|NCT02585141|Clindamycin palmitate|clindamycin palmitate|mesh-list
65384952|NCT02585141|Clindamycin phosphate|clindamycin phosphate|mesh-list
65384953|NCT02585141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65384954|NCT02585141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65384955|NCT02585141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384956|NCT02585141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384957|NCT04079231|Aflibercept|aflibercept|mesh-list
65384958|NCT04079231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65384959|NCT04079231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65384960|NCT04079231|Growth Substances|growth substances|mesh-ancestor
65384961|NCT04079231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384962|NCT04079231|Growth Inhibitors|growth inhibitors|mesh-ancestor
65384963|NCT04079231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65384964|NCT00994695|Vaccines|vaccines|mesh-list
65384965|NCT00994695|Immunologic Factors|immunologic factors|mesh-ancestor
64777143|NCT01994538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384966|NCT00994695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384967|NCT04521803|Rifampin|rifampin|mesh-list
65384968|NCT04521803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65384969|NCT04521803|Antitubercular Agents|antitubercular agents|mesh-ancestor
65384970|NCT04521803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65384971|NCT04521803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65384972|NCT04521803|Leprostatic Agents|leprostatic agents|mesh-ancestor
65384973|NCT04521803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65384974|NCT04521803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65384975|NCT04521803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65384976|NCT04521803|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65384977|NCT04521803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65384978|NCT04521803|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65384979|NCT04521803|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65384980|NCT04521803|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65384981|NCT04521803|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65384982|NCT00920465|Misoprostol|misoprostol|mesh-list
65384983|NCT00920465|Mifepristone|mifepristone|mesh-list
65384984|NCT00920465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65384985|NCT00920465|Abortifacient Agents|abortifacient agents|mesh-ancestor
65384986|NCT00920465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65384987|NCT00920465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65384988|NCT00920465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64670159|NCT05325099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556769|NCT03924947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64556770|NCT00934635|Risperidone|risperidone|mesh-list
64556771|NCT00934635|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64556772|NCT00934635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64512961|NCT03845114|Insulin|insulin|mesh-list
64556773|NCT00934635|Serotonin Agents|serotonin agents|mesh-ancestor
64556774|NCT00934635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64556775|NCT00934635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556776|NCT00934635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556777|NCT00934635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64556778|NCT00934635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64670160|NCT05293509|Cyclosporine|cyclosporine|mesh-list
64670161|NCT05293509|Mycophenolic Acid|mycophenolic acid|mesh-list
64670162|NCT05293509|Dexamethasone|dexamethasone|mesh-list
64670163|NCT05293509|Cyclophosphamide|cyclophosphamide|mesh-list
64670164|NCT05293509|Busulfan|busulfan|mesh-list
64670165|NCT05293509|Rituximab|rituximab|mesh-list
64670166|NCT05293509|Fludarabine|fludarabine|mesh-list
64670167|NCT05293509|Bortezomib|bortezomib|mesh-list
64670168|NCT05293509|Tacrolimus|tacrolimus|mesh-list
64670169|NCT05293509|Cyclosporins|cyclosporins|mesh-list
64670170|NCT05293509|Thymoglobulin|thymoglobulin|mesh-list
64670171|NCT05293509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64670172|NCT05293509|Immunologic Factors|immunologic factors|mesh-ancestor
64670173|NCT05293509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670174|NCT05293509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65384989|NCT00920465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65384990|NCT00920465|Oxytocics|oxytocics|mesh-ancestor
65384991|NCT00920465|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65384992|NCT00920465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65384993|NCT00920465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65384994|NCT00920465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65384995|NCT00920465|Contraceptive Agents|contraceptive agents|mesh-ancestor
65384996|NCT00920465|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65384997|NCT00920465|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65384998|NCT00920465|Hormone Antagonists|hormone antagonists|mesh-ancestor
65384999|NCT00920465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65385000|NCT00920465|Luteolytic Agents|luteolytic agents|mesh-ancestor
65385001|NCT00920465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65385002|NCT00920465|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65385003|NCT03890367|Vaccines|vaccines|mesh-list
65385004|NCT03890367|Immunologic Factors|immunologic factors|mesh-ancestor
65385005|NCT03890367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385006|NCT00994773|Tenofovir|tenofovir|mesh-list
65385007|NCT00994773|Entecavir|entecavir|mesh-list
65385008|NCT00994773|Simvastatin|simvastatin|mesh-list
65385009|NCT00994773|Antiviral Agents|antiviral agents|mesh-ancestor
65385010|NCT00994773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65385011|NCT00994773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65385012|NCT00994773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65385013|NCT00994773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385014|NCT00994773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385015|NCT00994773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65385016|NCT00994773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65385017|NCT00994773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65385018|NCT00994773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65385019|NCT00994773|Antimetabolites|antimetabolites|mesh-ancestor
65385020|NCT00994773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64670175|NCT05293509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64670176|NCT05293509|Alkylating Agents|alkylating agents|mesh-ancestor
64670177|NCT05293509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670178|NCT05293509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670179|NCT05293509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64670180|NCT05293509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64670181|NCT05293509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64670183|NCT05293509|Autonomic Agents|autonomic agents|mesh-ancestor
64670184|NCT05293509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777171|NCT01999920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777172|NCT01999920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64777173|NCT01999920|Serotonin Agents|serotonin agents|mesh-ancestor
64777174|NCT01999920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777175|NCT01999920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64777176|NCT01999920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64777177|NCT02002650|Indomethacin|indomethacin|mesh-list
64777178|NCT02002650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64777179|NCT02002650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64777180|NCT02002650|Analgesics|analgesics|mesh-ancestor
64388615|NCT02345993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64388616|NCT02345993|Respiratory System Agents|respiratory system agents|mesh-ancestor
65385021|NCT00994773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65385022|NCT02583191|Rivaroxaban|rivaroxaban|mesh-list
65385023|NCT02583191|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65385024|NCT02583191|Antithrombins|antithrombins|mesh-ancestor
65385025|NCT02583191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65385026|NCT02583191|Protease Inhibitors|protease inhibitors|mesh-ancestor
65385027|NCT02583191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385028|NCT02583191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385029|NCT02583191|Anticoagulants|anticoagulants|mesh-ancestor
65385030|NCT03084237|Docetaxel|docetaxel|mesh-list
65385031|NCT03084237|Trastuzumab|trastuzumab|mesh-list
65385032|NCT03084237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385033|NCT03084237|Tubulin Modulators|tubulin modulators|mesh-ancestor
65385034|NCT03084237|Antimitotic Agents|antimitotic agents|mesh-ancestor
65385035|NCT03084237|Mitosis Modulators|mitosis modulators|mesh-ancestor
65385036|NCT03084237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385052|NCT00996021|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65385053|NCT00996021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65385054|NCT00996021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65385055|NCT00996021|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65385056|NCT00996021|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65385057|NCT00996021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65385058|NCT00996021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65385059|NCT00996021|Antiviral Agents|antiviral agents|mesh-ancestor
65385060|NCT00996099|Insulin|insulin|mesh-list
65385061|NCT00996099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65385062|NCT00996099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65385063|NCT00996099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385064|NCT04515329|Cyclosporine|cyclosporine|mesh-list
65385065|NCT04515329|Lubricant Eye Drops|lubricant eye drops|mesh-list
64670185|NCT05293509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64670186|NCT05293509|Glucocorticoids|glucocorticoids|mesh-ancestor
64670187|NCT05293509|Hormones|hormones|mesh-ancestor
64670188|NCT05293509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64670189|NCT05293509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64670199|NCT04736433|Valsartan|valsartan|mesh-list
64670200|NCT04736433|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64670201|NCT04736433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64670202|NCT04736433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64670203|NCT04736433|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64670204|NCT04736433|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64670205|NCT04736433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670206|NCT04736433|Protease Inhibitors|protease inhibitors|mesh-ancestor
64670207|NCT04736433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670208|NCT02296775|Rituximab|rituximab|mesh-list
64670209|NCT02296775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64670214|NCT01675778|Hydromorphone|hydromorphone|mesh-list
64670215|NCT01675778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64670216|NCT01675778|Narcotics|narcotics|mesh-ancestor
64670217|NCT01675778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64670218|NCT01675778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670219|NCT01675778|Analgesics|analgesics|mesh-ancestor
64670220|NCT01675778|Sensory System Agents|sensory system agents|mesh-ancestor
64670221|NCT01675778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670222|NCT04736589|Sirolimus|sirolimus|mesh-list
64670223|NCT04736589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64556780|NCT00934635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64556781|NCT00934635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64556782|NCT00934635|Dopamine Agents|dopamine agents|mesh-ancestor
64556783|NCT00934635|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64556784|NCT00934635|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64556785|NCT04359537|Hydroxychloroquine|hydroxychloroquine|mesh-list
64556786|NCT04359537|Antimalarials|antimalarials|mesh-ancestor
64556787|NCT04359537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64556788|NCT04359537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64321859|NCT05503706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64670224|NCT04736589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64670225|NCT04736589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64670226|NCT04736589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670227|NCT04736589|Antifungal Agents|antifungal agents|mesh-ancestor
64670228|NCT04736589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64670229|NCT04736589|Immunologic Factors|immunologic factors|mesh-ancestor
64670230|NCT04736589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670231|NCT05201859|Capecitabine|capecitabine|mesh-list
64670232|NCT05201859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64670233|NCT05201859|Antimetabolites|antimetabolites|mesh-ancestor
64670234|NCT05201859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385066|NCT04515329|Cyclosporins|cyclosporins|mesh-list
65385067|NCT04515329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385068|NCT04515329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385069|NCT04515329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65385070|NCT04515329|Immunologic Factors|immunologic factors|mesh-ancestor
65385071|NCT04515329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385072|NCT04515329|Antifungal Agents|antifungal agents|mesh-ancestor
65385073|NCT04515329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65385074|NCT04515329|Dermatologic Agents|dermatologic agents|mesh-ancestor
65385075|NCT04515329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65385076|NCT04515329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65385077|NCT04515329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65385078|NCT04515329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65385079|NCT02584751|Nitric Oxide|nitric oxide|mesh-list
65385080|NCT02584751|Omeprazole|omeprazole|mesh-list
64670235|NCT05201859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670236|NCT02594111|Colchicine|colchicine|mesh-list
64670237|NCT02594111|Gout Suppressants|gout suppressants|mesh-ancestor
64670238|NCT02594111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64670239|NCT02594111|Tubulin Modulators|tubulin modulators|mesh-ancestor
64670240|NCT02594111|Antimitotic Agents|antimitotic agents|mesh-ancestor
64670241|NCT02594111|Mitosis Modulators|mitosis modulators|mesh-ancestor
64670256|NCT02589353|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64670257|NCT02589353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670258|NCT02589353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670259|NCT02589353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64670260|NCT02589353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670271|NCT02986607|Parathyroid Hormone|parathyroid hormone|mesh-list
64670272|NCT02986607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64670273|NCT02986607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670274|NCT01678976|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64670275|NCT01678976|Oxcarbazepine|oxcarbazepine|mesh-list
64670276|NCT01678976|Anticonvulsants|anticonvulsants|mesh-ancestor
64670277|NCT01678976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64670278|NCT01678976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64670279|NCT01678976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64670280|NCT01678976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670281|NCT01678976|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64670282|NCT01678976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64670283|NCT04645667|Tacrolimus|tacrolimus|mesh-list
64670284|NCT04645667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64670285|NCT04645667|Immunologic Factors|immunologic factors|mesh-ancestor
64670286|NCT04645667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670287|NCT04645667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64670288|NCT04645667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670289|NCT04645667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670290|NCT02249936|Omeprazole|omeprazole|mesh-list
64670291|NCT02249936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64670292|NCT02249936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64670293|NCT02249936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64670294|NCT02249936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670296|NCT03190005|Clopidogrel|clopidogrel|mesh-list
64670297|NCT03190005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64670298|NCT03190005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64556789|NCT04359537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64556790|NCT04359537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556791|NCT04359537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556792|NCT04359537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64556793|NCT03923699|Anesthetics|anesthetics|mesh-list
65385081|NCT02584751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65385082|NCT02584751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65385083|NCT02584751|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65385084|NCT02584751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385085|NCT02584751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385086|NCT02584751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65385087|NCT02584751|Autonomic Agents|autonomic agents|mesh-ancestor
65385088|NCT02584751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385089|NCT02584751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385090|NCT02584751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65385091|NCT02584751|Respiratory System Agents|respiratory system agents|mesh-ancestor
65385092|NCT02584751|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65385093|NCT02584751|Antioxidants|antioxidants|mesh-ancestor
65385094|NCT02584751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65385095|NCT02584751|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65385096|NCT02584751|Vasodilator Agents|vasodilator agents|mesh-ancestor
65385097|NCT02584751|Gasotransmitters|gasotransmitters|mesh-ancestor
64556794|NCT03923699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64556795|NCT03923699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556796|NCT03922997|Atezolizumab|atezolizumab|mesh-list
64556797|NCT03922997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556798|NCT04356417|Antimalarials|antimalarials|mesh-list
64556799|NCT04356417|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64556800|NCT04356417|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64556801|NCT04356417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556802|NCT04356417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64556803|NCT04356417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64556804|NCT04356417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64556805|NCT04355949|Vitamin D|vitamin d|mesh-list
64556806|NCT04355949|Ergocalciferols|ergocalciferols|mesh-list
64556807|NCT04355949|Cholecalciferol|cholecalciferol|mesh-list
64556808|NCT04355949|Vitamins|vitamins|mesh-list
64670299|NCT03190005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64670300|NCT03190005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64670301|NCT03190005|Purinergic Agents|purinergic agents|mesh-ancestor
64670304|NCT03190005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670305|NCT04816214|Carboplatin|carboplatin|mesh-list
64670306|NCT04816214|Pemetrexed|pemetrexed|mesh-list
64670307|NCT04816214|Osimertinib|osimertinib|mesh-list
64670308|NCT04816214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670309|NCT04816214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670310|NCT04816214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670311|NCT04816214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64670312|NCT04816214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64670313|NCT04816214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64670314|NCT01461915|Gemcitabine|gemcitabine|mesh-list
64670315|NCT01461915|Paclitaxel|paclitaxel|mesh-list
64670316|NCT01461915|Heparin|heparin|mesh-list
64670317|NCT01461915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64670318|NCT01461915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670319|NCT01461915|Tubulin Modulators|tubulin modulators|mesh-ancestor
64670320|NCT01461915|Antimitotic Agents|antimitotic agents|mesh-ancestor
64670321|NCT01461915|Mitosis Modulators|mitosis modulators|mesh-ancestor
64670322|NCT01461915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670323|NCT01461915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64670324|NCT01461915|Antimetabolites|antimetabolites|mesh-ancestor
64670325|NCT01461915|Antiviral Agents|antiviral agents|mesh-ancestor
64670326|NCT01461915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65385098|NCT02584751|Protective Agents|protective agents|mesh-ancestor
65385099|NCT00999219|Zolpidem|zolpidem|mesh-list
65385100|NCT00999219|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65385101|NCT00999219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65385102|NCT00999219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65385103|NCT00999219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385104|NCT00999219|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65385105|NCT00999219|GABA Agonists|gaba agonists|mesh-ancestor
65385106|NCT00999219|GABA Agents|gaba agents|mesh-ancestor
65385107|NCT00999219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65385108|NCT00999219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385109|NCT00996177|Fentanyl|fentanyl|mesh-list
65385110|NCT00996177|Morphine|morphine|mesh-list
64777225|NCT02020278|Tolvaptan|tolvaptan|mesh-list
64670327|NCT01461915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670328|NCT01461915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64670329|NCT01461915|Immunologic Factors|immunologic factors|mesh-ancestor
64670330|NCT01461915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670331|NCT01461915|Anticoagulants|anticoagulants|mesh-ancestor
64670332|NCT01461915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64670333|NCT01461915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64670335|NCT01682642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64670336|NCT01682642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670337|NCT01683422|Gemcitabine|gemcitabine|mesh-list
64556812|NCT04355949|Vitamin B Complex|vitamin b complex|mesh-list
64556813|NCT04355949|Micronutrients|micronutrients|mesh-ancestor
64556814|NCT04355949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556815|NCT04355949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64556816|NCT04355949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64556817|NCT04355949|Hematinics|hematinics|mesh-ancestor
64556818|NCT05580887|Paclitaxel|paclitaxel|mesh-list
64556819|NCT05580887|Cyclophosphamide|cyclophosphamide|mesh-list
64556820|NCT05580887|Carboplatin|carboplatin|mesh-list
64556821|NCT05580887|Doxorubicin|doxorubicin|mesh-list
64321885|NCT02220361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64670338|NCT01683422|Capecitabine|capecitabine|mesh-list
64670339|NCT01683422|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64670340|NCT01683422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64670341|NCT01683422|Antimetabolites|antimetabolites|mesh-ancestor
64670363|NCT05066061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64670364|NCT05066061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64670365|NCT04781673|Lidocaine|lidocaine|mesh-list
64670366|NCT04781673|Ketamine|ketamine|mesh-list
64670367|NCT04781673|Anesthetics, Local|anesthetics, local|mesh-ancestor
64670368|NCT04781673|Anesthetics|anesthetics|mesh-ancestor
64670369|NCT04781673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64670370|NCT04781673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670371|NCT04781673|Sensory System Agents|sensory system agents|mesh-ancestor
64670372|NCT04781673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670373|NCT04781673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64670374|NCT04781673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64670375|NCT04781673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64670376|NCT04781673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64670377|NCT04781673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670378|NCT04781673|Analgesics|analgesics|mesh-ancestor
64670379|NCT04781673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64670380|NCT04781673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64670381|NCT04781673|Anesthetics, General|anesthetics, general|mesh-ancestor
64670382|NCT04781673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64670383|NCT04781673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64670384|NCT04781673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64670385|NCT03197025|Aldesleukin|aldesleukin|mesh-list
64670386|NCT03197025|Interleukin-2|interleukin-2|mesh-list
65385111|NCT00996177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65385112|NCT00996177|Narcotics|narcotics|mesh-ancestor
65385113|NCT00996177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65385114|NCT00996177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385115|NCT00996177|Analgesics|analgesics|mesh-ancestor
65385116|NCT00996177|Sensory System Agents|sensory system agents|mesh-ancestor
65385117|NCT00996177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385118|NCT00996177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65385119|NCT00996177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65385120|NCT00996177|Anesthetics, General|anesthetics, general|mesh-ancestor
65385121|NCT00996177|Anesthetics|anesthetics|mesh-ancestor
65385122|NCT04079933|Nicotine|nicotine|mesh-list
65134706|NCT01120093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65385123|NCT04079933|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65385124|NCT04079933|Autonomic Agents|autonomic agents|mesh-ancestor
65385125|NCT04079933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385126|NCT04079933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385127|NCT04079933|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65385128|NCT04079933|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65385129|NCT04079933|Cholinergic Agents|cholinergic agents|mesh-ancestor
65385130|NCT04079933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64670387|NCT03197025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670388|NCT03197025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64670389|NCT03197025|Analgesics|analgesics|mesh-ancestor
64670390|NCT03197025|Sensory System Agents|sensory system agents|mesh-ancestor
64670391|NCT03197025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670392|NCT03197025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670393|NCT03197025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64670394|NCT03197025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64670395|NCT03197025|Antiviral Agents|antiviral agents|mesh-ancestor
64556822|NCT05580887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64556824|NCT05580887|Tubulin Modulators|tubulin modulators|mesh-ancestor
64556825|NCT05580887|Antimitotic Agents|antimitotic agents|mesh-ancestor
64556826|NCT05580887|Mitosis Modulators|mitosis modulators|mesh-ancestor
64556827|NCT05580887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670396|NCT03197025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64670397|NCT02249546|Amoxicillin|amoxicillin|mesh-list
64670398|NCT02249546|Clarithromycin|clarithromycin|mesh-list
64670400|NCT02249546|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64670401|NCT02249546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64670402|NCT02249546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64670403|NCT02249546|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64670404|NCT02249546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670405|NCT02249546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670406|NCT02249546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64670407|NCT02249546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64670408|NCT02249546|Antiviral Agents|antiviral agents|mesh-ancestor
64670409|NCT02249546|Expectorants|expectorants|mesh-ancestor
64670410|NCT02249546|Respiratory System Agents|respiratory system agents|mesh-ancestor
64670411|NCT02249546|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64670412|NCT02249546|Antioxidants|antioxidants|mesh-ancestor
64670432|NCT02333045|Antiviral Agents|antiviral agents|mesh-ancestor
64670433|NCT02333045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64670434|NCT02333045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64670435|NCT02333045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65385131|NCT04079933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385132|NCT00999297|Capsaicin|capsaicin|mesh-list
65385133|NCT00999297|Antipruritics|antipruritics|mesh-ancestor
65385134|NCT00999297|Dermatologic Agents|dermatologic agents|mesh-ancestor
65385135|NCT00999297|Sensory System Agents|sensory system agents|mesh-ancestor
65385136|NCT00999297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385137|NCT00999297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385138|NCT00583115|Imatinib Mesylate|imatinib mesylate|mesh-list
65385139|NCT00583115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385140|NCT00583115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65385141|NCT00583115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385142|NCT00583115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385143|NCT05371223|Gemcitabine|gemcitabine|mesh-list
65385144|NCT05371223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65385145|NCT05371223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65385146|NCT05371223|Antimetabolites|antimetabolites|mesh-ancestor
65385147|NCT05371223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385148|NCT05371223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385149|NCT05371223|Antiviral Agents|antiviral agents|mesh-ancestor
65385150|NCT05371223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65385151|NCT05371223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385152|NCT05371223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64670436|NCT02333045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64670437|NCT02333045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64670438|NCT02333045|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64670440|NCT01684748|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64670441|NCT01684748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64670442|NCT01684748|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64670443|NCT01684748|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64670444|NCT01684748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670445|NCT04028063|Doxorubicin|doxorubicin|mesh-list
64670446|NCT04028063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64670447|NCT04028063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670448|NCT04028063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64670449|NCT04028063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64670450|NCT04028063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670451|NCT04028063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670452|NCT03998735|Lobeline|lobeline|mesh-list
64670453|NCT03998735|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64670454|NCT03998735|Autonomic Agents|autonomic agents|mesh-ancestor
64670455|NCT03998735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670456|NCT03998735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670457|NCT03998735|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64670458|NCT03998735|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64670459|NCT03998735|Cholinergic Agents|cholinergic agents|mesh-ancestor
64670460|NCT03998735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64670461|NCT03998735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670462|NCT03998735|Respiratory System Agents|respiratory system agents|mesh-ancestor
64670469|NCT01685684|Oxycodone|oxycodone|mesh-list
64670470|NCT01685684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65385153|NCT05371223|Immunologic Factors|immunologic factors|mesh-ancestor
65385154|NCT05371223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385155|NCT00532779|Naltrexone|naltrexone|mesh-list
65385156|NCT00532779|Bupropion|bupropion|mesh-list
64777266|NCT02025426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64777267|NCT02025426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64777268|NCT02025426|Adrenergic Agents|adrenergic agents|mesh-ancestor
64777269|NCT02025426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64777270|NCT02025426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777271|NCT02025426|Protective Agents|protective agents|mesh-ancestor
64777272|NCT02025426|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64777273|NCT02028780|Dabigatran|dabigatran|mesh-list
64777274|NCT02028780|Antithrombins|antithrombins|mesh-ancestor
64777275|NCT02028780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65385157|NCT00532779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65385158|NCT00532779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65385159|NCT00532779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385160|NCT00532779|Sensory System Agents|sensory system agents|mesh-ancestor
65385161|NCT00532779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385162|NCT00532779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65385163|NCT00532779|Antidepressive Agents|antidepressive agents|mesh-ancestor
65385164|NCT00532779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65385165|NCT00532779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65385166|NCT00532779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65385193|NCT00500110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385194|NCT00500110|Tubulin Modulators|tubulin modulators|mesh-ancestor
65385195|NCT00500110|Antimitotic Agents|antimitotic agents|mesh-ancestor
65385196|NCT00500110|Mitosis Modulators|mitosis modulators|mesh-ancestor
65385197|NCT00500110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385198|NCT00500110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65385199|NCT00500110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385200|NCT00500110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65385201|NCT00500110|Fertility Agents|fertility agents|mesh-ancestor
65385202|NCT00500110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65385203|NCT00500110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385204|NCT00500110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65385205|NCT04358237|Pembrolizumab|pembrolizumab|mesh-list
65385206|NCT04358237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65385207|NCT04358237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385208|NCT05304533|Itraconazole|itraconazole|mesh-list
65385210|NCT05304533|Antifungal Agents|antifungal agents|mesh-ancestor
65385211|NCT05304533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65385212|NCT05304533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65385213|NCT05304533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65385214|NCT05304533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385215|NCT05304533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385216|NCT05304533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65385217|NCT05304533|Hormone Antagonists|hormone antagonists|mesh-ancestor
65385218|NCT05304533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65385219|NCT05304533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385220|NCT05304533|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65385221|NCT05304533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65385222|NCT05304533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64670471|NCT01685684|Narcotics|narcotics|mesh-ancestor
64670472|NCT01685684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64670473|NCT01685684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670474|NCT01685684|Analgesics|analgesics|mesh-ancestor
64670475|NCT01685684|Sensory System Agents|sensory system agents|mesh-ancestor
64670476|NCT01685684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670477|NCT03978767|Acetaminophen|acetaminophen|mesh-list
64670478|NCT03978767|Ibuprofen|ibuprofen|mesh-list
64670479|NCT03978767|Ketorolac|ketorolac|mesh-list
64556828|NCT05580887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64556829|NCT05580887|Immunologic Factors|immunologic factors|mesh-ancestor
64670483|NCT03978767|Sensory System Agents|sensory system agents|mesh-ancestor
64670484|NCT03978767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670485|NCT03978767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385223|NCT05304533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65385224|NCT05304533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65385225|NCT05304533|Vasodilator Agents|vasodilator agents|mesh-ancestor
65385226|NCT04338269|Atezolizumab|atezolizumab|mesh-list
65385227|NCT04338269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385228|NCT00534495|Rilonacept|rilonacept|mesh-list
65385229|NCT00534495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65385230|NCT04077827|Propofol|propofol|mesh-list
65385231|NCT04077827|Desflurane|desflurane|mesh-list
65385232|NCT04077827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65385233|NCT04077827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65385234|NCT04077827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385235|NCT04077827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65385236|NCT04077827|Anesthetics, General|anesthetics, general|mesh-ancestor
65385237|NCT04077827|Anesthetics|anesthetics|mesh-ancestor
65385238|NCT04077827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65385239|NCT00996723|Dasatinib|dasatinib|mesh-list
65385240|NCT00996723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385241|NCT00996723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65385242|NCT00996723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385243|NCT00996723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385244|NCT05332587|Rituximab|rituximab|mesh-list
65385245|NCT05332587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65385246|NCT05332587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670486|NCT03978767|Antipyretics|antipyretics|mesh-ancestor
64670487|NCT03978767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64670488|NCT03978767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64670489|NCT03978767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64670490|NCT03978767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64670491|NCT03978767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670492|NCT03978767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670493|NCT03978767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64670494|NCT03978767|Narcotics|narcotics|mesh-ancestor
64670495|NCT03978767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64670496|NCT04436133|Vaccines|vaccines|mesh-list
64670497|NCT04436133|Immunologic Factors|immunologic factors|mesh-ancestor
64670498|NCT04436133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670499|NCT01685996|Zonisamide|zonisamide|mesh-list
64670500|NCT01685996|Anticonvulsants|anticonvulsants|mesh-ancestor
64670501|NCT01685996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64670502|NCT01685996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64670503|NCT01685996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670506|NCT03207399|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64670507|NCT03207399|Antiviral Agents|antiviral agents|mesh-ancestor
64670508|NCT03207399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64670509|NCT04633148|Cyclophosphamide|cyclophosphamide|mesh-list
64670510|NCT04633148|Fludarabine|fludarabine|mesh-list
64670511|NCT04633148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64670512|NCT04633148|Immunologic Factors|immunologic factors|mesh-ancestor
64670513|NCT04633148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670514|NCT04633148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64777326|NCT02036424|Bevacizumab|bevacizumab|mesh-list
64777327|NCT02036424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64777328|NCT02036424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64777329|NCT02036424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64777330|NCT02036424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64777331|NCT02036424|Growth Substances|growth substances|mesh-ancestor
64777332|NCT02036424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385247|NCT05332587|Immunologic Factors|immunologic factors|mesh-ancestor
65385248|NCT05332587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385249|NCT05332587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65385250|NCT00996879|Midazolam|midazolam|mesh-list
65385251|NCT00996879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65385252|NCT00996879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65385253|NCT00996879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65385254|NCT00996879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385255|NCT00996879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65385256|NCT00996879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65385257|NCT00996879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65385258|NCT00996879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65385259|NCT00996879|Anesthetics, General|anesthetics, general|mesh-ancestor
65385260|NCT00996879|Anesthetics|anesthetics|mesh-ancestor
65385261|NCT00996879|GABA Modulators|gaba modulators|mesh-ancestor
65385262|NCT00996879|GABA Agents|gaba agents|mesh-ancestor
65385263|NCT00996879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65385264|NCT00996879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385265|NCT02582177|Ketoconazole|ketoconazole|mesh-list
65385266|NCT02582177|Clotrimazole|clotrimazole|mesh-list
65385267|NCT02582177|Miconazole|miconazole|mesh-list
65385268|NCT02582177|Dexamethasone|dexamethasone|mesh-list
65385269|NCT02582177|Dexamethasone acetate|dexamethasone acetate|mesh-list
65385270|NCT02582177|Betamethasone|betamethasone|mesh-list
65385271|NCT02582177|Betamethasone Valerate|betamethasone valerate|mesh-list
65385272|NCT02582177|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65385273|NCT02582177|Betamethasone benzoate|betamethasone benzoate|mesh-list
65385274|NCT02582177|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65385275|NCT02582177|BB 1101|bb 1101|mesh-list
64777338|NCT02036424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64777339|NCT02036424|Glucocorticoids|glucocorticoids|mesh-ancestor
64777340|NCT02036424|Hormones|hormones|mesh-ancestor
64777341|NCT02036424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64777342|NCT02036424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64777343|NCT02044380|Afatinib|afatinib|mesh-list
65385282|NCT02582177|Glucocorticoids|glucocorticoids|mesh-ancestor
65385283|NCT02582177|Hormones|hormones|mesh-ancestor
65385284|NCT02582177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65385285|NCT02582177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65385286|NCT02582177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385287|NCT02582177|Protease Inhibitors|protease inhibitors|mesh-ancestor
65385288|NCT02582177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385289|NCT02582177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385290|NCT02582177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65385291|NCT02582177|Respiratory System Agents|respiratory system agents|mesh-ancestor
65385292|NCT02582177|Antifungal Agents|antifungal agents|mesh-ancestor
65385293|NCT02582177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65385294|NCT02582177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65385295|NCT02582177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65385296|NCT02582177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65385297|NCT02582177|Hormone Antagonists|hormone antagonists|mesh-ancestor
65385298|NCT02582177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65385299|NCT02582177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65385300|NCT02582177|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65385301|NCT02626715|Vidarabine|vidarabine|mesh-list
65385302|NCT02626715|Fludarabine phosphate|fludarabine phosphate|mesh-list
65385303|NCT02626715|Fludarabine|fludarabine|mesh-list
65385304|NCT02626715|Alemtuzumab|alemtuzumab|mesh-list
65385305|NCT02626715|Thiotepa|thiotepa|mesh-list
65385306|NCT02626715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65385307|NCT02626715|Antimetabolites|antimetabolites|mesh-ancestor
65385308|NCT02626715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385309|NCT02626715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385310|NCT02626715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64546024|NCT04404751|Vitamin B 12|vitamin b 12|mesh-list
64777352|NCT02047032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64777353|NCT02047032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777354|NCT02047032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385313|NCT02626715|Antiviral Agents|antiviral agents|mesh-ancestor
65385314|NCT02626715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65385315|NCT02626715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65385316|NCT02626715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65385317|NCT02626715|Alkylating Agents|alkylating agents|mesh-ancestor
65385318|NCT02626715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65385319|NCT05325177|Ibuprofen|ibuprofen|mesh-list
65385320|NCT05325177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65385321|NCT05325177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65385322|NCT05325177|Analgesics|analgesics|mesh-ancestor
65385323|NCT05325177|Sensory System Agents|sensory system agents|mesh-ancestor
65385324|NCT05325177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385325|NCT05325177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385326|NCT05325177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65385327|NCT05325177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65385328|NCT05325177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65385329|NCT05325177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385330|NCT05325177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385331|NCT04099667|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
65385332|NCT04099667|Botulinum Toxins|botulinum toxins|mesh-list
65385333|NCT04099667|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65385334|NCT04099667|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65385335|NCT04099667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65385336|NCT04099667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65385337|NCT04099667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777355|NCT02047032|Urological Agents|urological agents|mesh-ancestor
64670515|NCT04633148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64670516|NCT04633148|Alkylating Agents|alkylating agents|mesh-ancestor
64670517|NCT04633148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670518|NCT04633148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670519|NCT04633148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64670520|NCT04543409|Benralizumab|benralizumab|mesh-list
64670521|NCT04543409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64670522|NCT04543409|Respiratory System Agents|respiratory system agents|mesh-ancestor
64670524|NCT02196155|Botulinum Toxins|botulinum toxins|mesh-list
64670525|NCT02196155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64670526|NCT02196155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65385338|NCT04099667|Cholinergic Agents|cholinergic agents|mesh-ancestor
65385339|NCT04099667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65385340|NCT04099667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385341|NCT04099667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65385342|NCT04099667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385343|NCT04099667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65385344|NCT00997191|Triamcinolone|triamcinolone|mesh-list
65385345|NCT00997191|Bevacizumab|bevacizumab|mesh-list
65385346|NCT00997191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65385347|NCT00997191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385348|NCT00997191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65134929|NCT04577378|Isotretinoin|isotretinoin|mesh-list
65385349|NCT00997191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65385350|NCT00997191|Growth Substances|growth substances|mesh-ancestor
65385351|NCT00997191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385352|NCT00997191|Growth Inhibitors|growth inhibitors|mesh-ancestor
65385353|NCT00997191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65385354|NCT00997191|Glucocorticoids|glucocorticoids|mesh-ancestor
65385355|NCT00997191|Hormones|hormones|mesh-ancestor
65385356|NCT00997191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65385357|NCT00997269|Ubiquinone|ubiquinone|mesh-list
65385358|NCT00997269|Coenzyme Q10|coenzyme q10|mesh-list
65385359|NCT00997269|Micronutrients|micronutrients|mesh-ancestor
65385360|NCT00997269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385361|NCT00997269|Vitamins|vitamins|mesh-ancestor
65385362|NCT02582099|Gentamicins|gentamicins|mesh-list
65385363|NCT02582099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65385364|NCT02582099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65385365|NCT02582099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65385366|NCT02582099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385367|NCT02582099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777379|NCT02054754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64777380|NCT02054754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64777381|NCT02054754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64777382|NCT02054754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64777383|NCT02054754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777384|NCT02054754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65385380|NCT00997347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65385381|NCT00997347|Contraceptive Agents|contraceptive agents|mesh-ancestor
65385382|NCT00997347|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65385383|NCT00997347|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65385384|NCT00997347|Hormone Antagonists|hormone antagonists|mesh-ancestor
65385385|NCT00997347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65385386|NCT00997347|Luteolytic Agents|luteolytic agents|mesh-ancestor
65385387|NCT00997347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65385388|NCT00997347|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65385389|NCT00997581|Apremilast|apremilast|mesh-list
65385390|NCT00997581|Indomethacin|indomethacin|mesh-list
65385391|NCT00997581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65385392|NCT00997581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65385393|NCT00997581|Analgesics|analgesics|mesh-ancestor
65385394|NCT00997581|Sensory System Agents|sensory system agents|mesh-ancestor
65385395|NCT00997581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385396|NCT00997581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385397|NCT00997581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65385398|NCT00997581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65385399|NCT00997581|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65385400|NCT00997581|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65385401|NCT00997581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385402|NCT00997581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385403|NCT00997581|Gout Suppressants|gout suppressants|mesh-ancestor
65385404|NCT00997581|Tocolytic Agents|tocolytic agents|mesh-ancestor
65385405|NCT00997581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65385406|NCT00997581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64670527|NCT02196155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64670528|NCT02196155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64670529|NCT02196155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777390|NCT02054754|Sensory System Agents|sensory system agents|mesh-ancestor
64777391|NCT02054754|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64777392|NCT02054754|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64777393|NCT02054754|Hormones|hormones|mesh-ancestor
64777394|NCT02054754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64777395|NCT02057640|Dexamethasone|dexamethasone|mesh-list
64777396|NCT02057640|Ixazomib|ixazomib|mesh-list
65385407|NCT02044497|Oxycodone|oxycodone|mesh-list
65385408|NCT02044497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65385409|NCT02044497|Narcotics|narcotics|mesh-ancestor
65385410|NCT02044497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65385411|NCT02044497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385412|NCT02044497|Analgesics|analgesics|mesh-ancestor
65385413|NCT02044497|Sensory System Agents|sensory system agents|mesh-ancestor
65385414|NCT02044497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385415|NCT05183139|Dexamethasone|dexamethasone|mesh-list
65385416|NCT05183139|Lenalidomide|lenalidomide|mesh-list
65385417|NCT05183139|Pomalidomide|pomalidomide|mesh-list
65385418|NCT05183139|Ixazomib|ixazomib|mesh-list
65385419|NCT05183139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65385420|NCT05183139|Antiemetics|antiemetics|mesh-ancestor
65385421|NCT05183139|Autonomic Agents|autonomic agents|mesh-ancestor
65385422|NCT05183139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385423|NCT05183139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385424|NCT05183139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65385425|NCT05183139|Glucocorticoids|glucocorticoids|mesh-ancestor
65385426|NCT05183139|Hormones|hormones|mesh-ancestor
65385427|NCT05183139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65385428|NCT05183139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65385429|NCT05183139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385430|NCT05183139|Immunologic Factors|immunologic factors|mesh-ancestor
65385431|NCT05183139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65385432|NCT05183139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65385433|NCT05183139|Growth Substances|growth substances|mesh-ancestor
65385434|NCT05183139|Growth Inhibitors|growth inhibitors|mesh-ancestor
65385435|NCT05183139|Protease Inhibitors|protease inhibitors|mesh-ancestor
65385436|NCT05183139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670544|NCT02124941|Antiviral Agents|antiviral agents|mesh-ancestor
64670545|NCT02124941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64670546|NCT02124941|Expectorants|expectorants|mesh-ancestor
64777401|NCT02057640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777402|NCT02057640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777403|NCT02057640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64777404|NCT02057640|Glucocorticoids|glucocorticoids|mesh-ancestor
64777405|NCT02057640|Hormones|hormones|mesh-ancestor
64777406|NCT02057640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65385437|NCT05183139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385438|NCT00999843|Sorafenib|sorafenib|mesh-list
65385439|NCT00999843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385440|NCT00999843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65385441|NCT00999843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385442|NCT00999843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385443|NCT00997659|Chromium|chromium|mesh-list
65385444|NCT00997659|Picolinic acid|picolinic acid|mesh-list
65385445|NCT00997659|Trace Elements|trace elements|mesh-ancestor
65385446|NCT00997659|Micronutrients|micronutrients|mesh-ancestor
65385447|NCT00997659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385448|NCT00997659|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65385449|NCT00997659|Chelating Agents|chelating agents|mesh-ancestor
65385450|NCT00997659|Sequestering Agents|sequestering agents|mesh-ancestor
65385451|NCT00997659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385452|NCT03828227|Bevacizumab|bevacizumab|mesh-list
65385453|NCT03828227|Capecitabine|capecitabine|mesh-list
65385454|NCT03828227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65385455|NCT03828227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385456|NCT03828227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65385457|NCT03828227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65385458|NCT03828227|Growth Substances|growth substances|mesh-ancestor
65385459|NCT03828227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385460|NCT03828227|Growth Inhibitors|growth inhibitors|mesh-ancestor
65385461|NCT03828227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65385462|NCT03828227|Antimetabolites|antimetabolites|mesh-ancestor
65385463|NCT03828227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385464|NCT03827213|Bupivacaine|bupivacaine|mesh-list
65385465|NCT03827213|Anesthetics, Local|anesthetics, local|mesh-ancestor
65385466|NCT03827213|Anesthetics|anesthetics|mesh-ancestor
64395899|NCT02592707|Antipruritics|antipruritics|mesh-ancestor
64777412|NCT02057640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64777413|NCT02059902|Lidocaine|lidocaine|mesh-list
64777414|NCT02059902|Anesthetics, Local|anesthetics, local|mesh-ancestor
64777415|NCT02059902|Anesthetics|anesthetics|mesh-ancestor
64777416|NCT02059902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65385467|NCT03827213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65385468|NCT03827213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385469|NCT03827213|Sensory System Agents|sensory system agents|mesh-ancestor
65385470|NCT03827213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385471|NCT00997815|Botulinum Toxins|botulinum toxins|mesh-list
65385472|NCT00997815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65385473|NCT00997815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65385474|NCT00997815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65385475|NCT00997815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65385476|NCT00997815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385477|NCT00997815|Cholinergic Agents|cholinergic agents|mesh-ancestor
65385478|NCT00997815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65385479|NCT00997815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385480|NCT00997815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65385481|NCT00997815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385482|NCT04077983|Gemcitabine|gemcitabine|mesh-list
65385483|NCT04077983|Paclitaxel|paclitaxel|mesh-list
65385484|NCT04077983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65385485|NCT04077983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385486|NCT04077983|Tubulin Modulators|tubulin modulators|mesh-ancestor
65385487|NCT04077983|Antimitotic Agents|antimitotic agents|mesh-ancestor
65385488|NCT04077983|Mitosis Modulators|mitosis modulators|mesh-ancestor
64777417|NCT02059902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670547|NCT02124941|Respiratory System Agents|respiratory system agents|mesh-ancestor
64670548|NCT02124941|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64670549|NCT02124941|Antioxidants|antioxidants|mesh-ancestor
64670550|NCT02124941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670551|NCT02124941|Protective Agents|protective agents|mesh-ancestor
64670552|NCT02124941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670553|NCT02124941|Antidotes|antidotes|mesh-ancestor
64670554|NCT04121403|Rituximab|rituximab|mesh-list
64670555|NCT04121403|Cladribine|cladribine|mesh-list
64670556|NCT04121403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64670557|NCT04121403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670558|NCT04121403|Immunologic Factors|immunologic factors|mesh-ancestor
64670559|NCT04121403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670560|NCT04121403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64670561|NCT04121403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64670562|NCT02049515|Ofatumumab|ofatumumab|mesh-list
64670563|NCT02049515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670564|NCT03224403|Acetaminophen|acetaminophen|mesh-list
64777421|NCT02059902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64777422|NCT02059902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64777423|NCT02059902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64546101|NCT04747171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64777424|NCT02059902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777425|NCT02061384|Calcitriol|calcitriol|mesh-list
64777426|NCT02061384|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
64777427|NCT02061384|Tretinoin|tretinoin|mesh-list
64777428|NCT02061384|Isotretinoin|isotretinoin|mesh-list
65385489|NCT04077983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385490|NCT04077983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65385491|NCT04077983|Antimetabolites|antimetabolites|mesh-ancestor
65385492|NCT04077983|Antiviral Agents|antiviral agents|mesh-ancestor
65385493|NCT04077983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65385494|NCT04077983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385495|NCT04077983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65385496|NCT04077983|Immunologic Factors|immunologic factors|mesh-ancestor
65385497|NCT04077983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385498|NCT03822845|Edetic Acid|edetic acid|mesh-list
65385499|NCT03822845|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65385500|NCT03822845|Chelating Agents|chelating agents|mesh-ancestor
65385501|NCT03822845|Sequestering Agents|sequestering agents|mesh-ancestor
65385502|NCT03822845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385503|NCT03822845|Anticoagulants|anticoagulants|mesh-ancestor
65385504|NCT03822845|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65385505|NCT03822845|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65385506|NCT01000233|Inositol|inositol|mesh-list
65385507|NCT01000233|Vitamin B Complex|vitamin b complex|mesh-ancestor
65385508|NCT01000233|Vitamins|vitamins|mesh-ancestor
65385509|NCT01000233|Micronutrients|micronutrients|mesh-ancestor
65385510|NCT01000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385511|NCT04075955|Olanzapine|olanzapine|mesh-list
65385512|NCT04075955|Aprepitant|aprepitant|mesh-list
65385513|NCT04075955|Antiemetics|antiemetics|mesh-ancestor
65385514|NCT04075955|Autonomic Agents|autonomic agents|mesh-ancestor
65385515|NCT04075955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385516|NCT04075955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670565|NCT03224403|Ibuprofen|ibuprofen|mesh-list
64670566|NCT03224403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64670567|NCT03224403|Analgesics|analgesics|mesh-ancestor
65385517|NCT04075955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65385518|NCT04075955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65385519|NCT04075955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65385520|NCT04075955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65385521|NCT04075955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65385522|NCT04075955|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65385523|NCT04075955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65385524|NCT04075955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65385525|NCT04075955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385526|NCT04075955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65385527|NCT04075955|Serotonin Agents|serotonin agents|mesh-ancestor
65385528|NCT04075955|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65385529|NCT00484198|Pioglitazone|pioglitazone|mesh-list
65385530|NCT00484198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65385531|NCT00484198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385532|NCT04077905|Methylprednisolone|methylprednisolone|mesh-list
65385533|NCT04077905|Doxorubicin|doxorubicin|mesh-list
65385534|NCT04077905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64556830|NCT05580887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556832|NCT05580887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64556833|NCT05580887|Alkylating Agents|alkylating agents|mesh-ancestor
64556834|NCT05580887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64670568|NCT03224403|Sensory System Agents|sensory system agents|mesh-ancestor
64670569|NCT03224403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670570|NCT03224403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670571|NCT03224403|Antipyretics|antipyretics|mesh-ancestor
64670572|NCT03224403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64670573|NCT03224403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64670574|NCT03224403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64670575|NCT03224403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64670576|NCT03224403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670577|NCT03224403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670578|NCT02334059|Ketamine|ketamine|mesh-list
64670579|NCT02334059|Analgesics|analgesics|mesh-ancestor
64670580|NCT02334059|Sensory System Agents|sensory system agents|mesh-ancestor
64670581|NCT02334059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670582|NCT02334059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670583|NCT02334059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64670598|NCT04499573|Dexamethasone|dexamethasone|mesh-list
64670599|NCT04499573|Cyclophosphamide|cyclophosphamide|mesh-list
64670600|NCT04499573|Fludarabine|fludarabine|mesh-list
64670603|NCT04499573|Immunologic Factors|immunologic factors|mesh-ancestor
64670604|NCT04499573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670605|NCT04499573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64670606|NCT04499573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64670607|NCT04499573|Alkylating Agents|alkylating agents|mesh-ancestor
64670608|NCT04499573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670609|NCT04499573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670610|NCT04499573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64670611|NCT04499573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64670612|NCT04499573|Antiemetics|antiemetics|mesh-ancestor
64670613|NCT04499573|Autonomic Agents|autonomic agents|mesh-ancestor
64670614|NCT04499573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670615|NCT04499573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64670616|NCT04499573|Glucocorticoids|glucocorticoids|mesh-ancestor
64670617|NCT04499573|Hormones|hormones|mesh-ancestor
64777437|NCT02061384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64777438|NCT02061384|Vitamins|vitamins|mesh-ancestor
64777439|NCT02061384|Micronutrients|micronutrients|mesh-ancestor
64777440|NCT02061384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64777441|NCT02061774|Acetaminophen|acetaminophen|mesh-list
64777442|NCT02061774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65385535|NCT04077905|Etoposide|etoposide|mesh-list
65385536|NCT04077905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65385537|NCT04077905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385538|NCT04077905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65385539|NCT04077905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65385540|NCT04077905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385541|NCT04077905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385542|NCT04077905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65385543|NCT04077905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65385544|NCT04077905|Antiemetics|antiemetics|mesh-ancestor
65385545|NCT04077905|Autonomic Agents|autonomic agents|mesh-ancestor
65385546|NCT04077905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385547|NCT04077905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385548|NCT04077905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65385549|NCT04077905|Glucocorticoids|glucocorticoids|mesh-ancestor
65385550|NCT04077905|Hormones|hormones|mesh-ancestor
65385551|NCT04077905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65385552|NCT04077905|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65385553|NCT04077905|Protective Agents|protective agents|mesh-ancestor
65385554|NCT04282187|Azacitidine|azacitidine|mesh-list
65385555|NCT04282187|Decitabine|decitabine|mesh-list
65385556|NCT04282187|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
65385557|NCT04282187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65385558|NCT04282187|Antimetabolites|antimetabolites|mesh-ancestor
65385559|NCT04282187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385560|NCT04282187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385561|NCT04282187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385562|NCT04282187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65385563|NCT04471246|Cephalexin|cephalexin|mesh-list
64670618|NCT04499573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64670619|NCT04499573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64670620|NCT04499573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670621|NCT04499573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64777450|NCT02062710|Phenylephrine|phenylephrine|mesh-list
64777451|NCT02062710|Oxymetazoline|oxymetazoline|mesh-list
64777452|NCT02062710|Dextromethorphan|dextromethorphan|mesh-list
64777453|NCT02062710|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64777454|NCT02062710|Mydriatics|mydriatics|mesh-ancestor
64777455|NCT02062710|Autonomic Agents|autonomic agents|mesh-ancestor
64777456|NCT02062710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777457|NCT02062710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777458|NCT02062710|Sympathomimetics|sympathomimetics|mesh-ancestor
64777459|NCT02062710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64777460|NCT02062710|Nasal Decongestants|nasal decongestants|mesh-ancestor
64777461|NCT02062710|Respiratory System Agents|respiratory system agents|mesh-ancestor
64388890|NCT02709889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65385564|NCT04471246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65385565|NCT04471246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65385566|NCT04166110|Oxymetazoline|oxymetazoline|mesh-list
65385567|NCT04166110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65385568|NCT04166110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65385569|NCT04166110|Adrenergic Agents|adrenergic agents|mesh-ancestor
65385570|NCT04166110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65385571|NCT04166110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385572|NCT04166110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385573|NCT04166110|Sympathomimetics|sympathomimetics|mesh-ancestor
65385579|NCT04276259|Naltrexone|naltrexone|mesh-list
65385603|NCT05057117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65385604|NCT05057117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385605|NCT05057117|Cholinergic Agents|cholinergic agents|mesh-ancestor
65385606|NCT05057117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65385607|NCT05057117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385608|NCT05057117|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65385609|NCT05057117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385610|NCT01019278|Cisplatin|cisplatin|mesh-list
65385611|NCT01019278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385612|NCT01014520|Gabapentin|gabapentin|mesh-list
65385613|NCT01014520|Amitriptyline|amitriptyline|mesh-list
65385614|NCT01014520|Analgesics|analgesics|mesh-ancestor
65385615|NCT01014520|Sensory System Agents|sensory system agents|mesh-ancestor
65385616|NCT01014520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385617|NCT01014520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385618|NCT01014520|Anticonvulsants|anticonvulsants|mesh-ancestor
65385619|NCT01014520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65385620|NCT01014520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65385621|NCT01014520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65385622|NCT01014520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65385623|NCT01014520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65385624|NCT01014520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65385625|NCT01014520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65385626|NCT01014520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385627|NCT01014520|Antimanic Agents|antimanic agents|mesh-ancestor
65385628|NCT01014520|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65385629|NCT01014520|Antidepressive Agents|antidepressive agents|mesh-ancestor
65385630|NCT01014520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65385631|NCT01014520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65385632|NCT01014520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65385635|NCT01016002|Temoporfin|temoporfin|mesh-list
65385645|NCT01019434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65385646|NCT01019434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65385647|NCT01019434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65385648|NCT01019434|Antifungal Agents|antifungal agents|mesh-ancestor
65385649|NCT01019434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65385650|NCT01019434|Immunologic Factors|immunologic factors|mesh-ancestor
65385651|NCT01019434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385652|NCT01016158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65385653|NCT01016158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65385654|NCT00499252|Paclitaxel|paclitaxel|mesh-list
65385655|NCT00499252|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65385656|NCT00499252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65385657|NCT00499252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385658|NCT00499252|Tubulin Modulators|tubulin modulators|mesh-ancestor
65385659|NCT00499252|Antimitotic Agents|antimitotic agents|mesh-ancestor
65385660|NCT00499252|Mitosis Modulators|mitosis modulators|mesh-ancestor
65385661|NCT00499252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385662|NCT01019590|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65385663|NCT01019590|Olmesartan|olmesartan|mesh-list
65385664|NCT01019590|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65385665|NCT01019590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65385666|NCT01019590|Diuretics|diuretics|mesh-ancestor
65385667|NCT01019590|Natriuretic Agents|natriuretic agents|mesh-ancestor
65385668|NCT01019590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385669|NCT01019590|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65385670|NCT01019590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65385671|NCT01019590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385674|NCT03775421|Macitentan|macitentan|mesh-list
64777501|NCT02134314|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64777502|NCT02134314|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
64777503|NCT02134314|Immunologic Factors|immunologic factors|mesh-ancestor
64777504|NCT02134314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777505|NCT02134314|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64777506|NCT02134314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64777507|NCT02135016|Lidocaine|lidocaine|mesh-list
64777508|NCT02135016|Anesthetics, Local|anesthetics, local|mesh-ancestor
64777509|NCT02135016|Anesthetics|anesthetics|mesh-ancestor
64388944|NCT02442739|Anesthetics, General|anesthetics, general|mesh-ancestor
65385690|NCT00532155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65385691|NCT00532155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65385692|NCT00532155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385693|NCT00532155|Tubulin Modulators|tubulin modulators|mesh-ancestor
65385694|NCT00532155|Antimitotic Agents|antimitotic agents|mesh-ancestor
65385695|NCT00532155|Mitosis Modulators|mitosis modulators|mesh-ancestor
65385696|NCT00532155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385697|NCT00532155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65385698|NCT00532155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65385699|NCT00532155|Growth Substances|growth substances|mesh-ancestor
65385700|NCT00532155|Growth Inhibitors|growth inhibitors|mesh-ancestor
65385701|NCT01019668|Verteporfin|verteporfin|mesh-list
65385702|NCT01019668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65385703|NCT01019668|Dermatologic Agents|dermatologic agents|mesh-ancestor
65385704|NCT01019746|Propofol|propofol|mesh-list
65385705|NCT01019746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65385706|NCT01019746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65385707|NCT01019746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385708|NCT01019746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65385709|NCT01019746|Anesthetics, General|anesthetics, general|mesh-ancestor
65385710|NCT01019746|Anesthetics|anesthetics|mesh-ancestor
65385711|NCT00205777|Bazedoxifene|bazedoxifene|mesh-list
65385712|NCT00205777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64777511|NCT02135016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777512|NCT02135016|Sensory System Agents|sensory system agents|mesh-ancestor
64777513|NCT02135016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777514|NCT02135016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64777515|NCT02135016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64777516|NCT02135016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64777517|NCT02135016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64777518|NCT02135016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777519|NCT02135094|Oxymetazoline|oxymetazoline|mesh-list
64777520|NCT02135094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64777521|NCT02135094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64388951|NCT02437045|Meropenem|meropenem|mesh-list
65385720|NCT01004055|Anti-Infective Agents|anti-infective agents|mesh-list
65385721|NCT01004055|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65385722|NCT00483652|4-Aminopyridine|4-aminopyridine|mesh-list
65385723|NCT00483652|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65385724|NCT00483652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65385725|NCT00483652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385726|NCT00998283|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
65385727|NCT00998283|Immunologic Factors|immunologic factors|mesh-ancestor
65385728|NCT00998283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777522|NCT02135094|Adrenergic Agents|adrenergic agents|mesh-ancestor
64777523|NCT02135094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64777524|NCT02135094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777525|NCT02135094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777526|NCT02135094|Sympathomimetics|sympathomimetics|mesh-ancestor
64777527|NCT02135094|Autonomic Agents|autonomic agents|mesh-ancestor
64777528|NCT02135094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777529|NCT02135094|Nasal Decongestants|nasal decongestants|mesh-ancestor
64777530|NCT02135094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64777531|NCT02135094|Respiratory System Agents|respiratory system agents|mesh-ancestor
64777532|NCT02139540|Nitrous Oxide|nitrous oxide|mesh-list
65385757|NCT01000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388962|NCT03022903|Dermatologic Agents|dermatologic agents|mesh-ancestor
64388963|NCT02442427|Palivizumab|palivizumab|mesh-list
64388964|NCT02442427|Antiviral Agents|antiviral agents|mesh-ancestor
65385758|NCT01000623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65385759|NCT01000623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385760|NCT01000623|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65385761|NCT01000623|Antidepressive Agents|antidepressive agents|mesh-ancestor
65385762|NCT01000623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65385763|NCT00998439|Paclitaxel|paclitaxel|mesh-list
65385764|NCT00998439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64777533|NCT02139540|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64777534|NCT02139540|Anesthetics, General|anesthetics, general|mesh-ancestor
64777535|NCT02139540|Anesthetics|anesthetics|mesh-ancestor
64777536|NCT02139540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64777537|NCT02139540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777538|NCT02139540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64777539|NCT02139540|Analgesics|analgesics|mesh-ancestor
64777540|NCT02139540|Sensory System Agents|sensory system agents|mesh-ancestor
64777541|NCT02139540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385794|NCT01000857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65385795|NCT01000857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385796|NCT01000857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65385797|NCT01000857|Serotonin Agents|serotonin agents|mesh-ancestor
65385798|NCT01000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385799|NCT01000857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65385800|NCT01000857|Antidepressive Agents|antidepressive agents|mesh-ancestor
65385801|NCT01000857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65385802|NCT01000857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65385803|NCT01000857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65385804|NCT01000857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385805|NCT01004445|Amikacin|amikacin|mesh-list
65385806|NCT01004445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65385807|NCT01004445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65385808|NCT03739931|Durvalumab|durvalumab|mesh-list
65385809|NCT03739931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65385810|NCT03739931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385811|NCT02580695|Hyaluronic Acid|hyaluronic acid|mesh-list
65385812|NCT02580695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65385813|NCT02580695|Immunologic Factors|immunologic factors|mesh-ancestor
65385814|NCT02580695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385815|NCT02580695|Viscosupplements|viscosupplements|mesh-ancestor
65385816|NCT02580695|Protective Agents|protective agents|mesh-ancestor
65385817|NCT02581553|Allopurinol|allopurinol|mesh-list
65385818|NCT02581553|Lesinurad|lesinurad|mesh-list
65385819|NCT02581553|Antimetabolites|antimetabolites|mesh-ancestor
64670622|NCT04499573|Antimetabolites|antimetabolites|mesh-ancestor
64670623|NCT04499573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64670624|NCT04499573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64670625|NCT04499573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64777545|NCT02148588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65385820|NCT02581553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385821|NCT02581553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385822|NCT02581553|Gout Suppressants|gout suppressants|mesh-ancestor
65385823|NCT02581553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65385824|NCT02581553|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65385825|NCT02581553|Antioxidants|antioxidants|mesh-ancestor
65385826|NCT02581553|Protective Agents|protective agents|mesh-ancestor
65385827|NCT02581553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385828|NCT02581553|Uricosuric Agents|uricosuric agents|mesh-ancestor
65385829|NCT02581553|Renal Agents|renal agents|mesh-ancestor
65385830|NCT03666065|Insulin|insulin|mesh-list
65385831|NCT03666065|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65385832|NCT03666065|Insulin Aspart|insulin aspart|mesh-list
65385833|NCT03666065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65385834|NCT03666065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385835|NCT03944915|Paclitaxel|paclitaxel|mesh-list
65385836|NCT03944915|Carboplatin|carboplatin|mesh-list
65385837|NCT03944915|Fluorouracil|fluorouracil|mesh-list
65385838|NCT03944915|Nivolumab|nivolumab|mesh-list
65385839|NCT03944915|Hydroxyurea|hydroxyurea|mesh-list
65385840|NCT03944915|Lenograstim|lenograstim|mesh-list
65385841|NCT03944915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65385842|NCT03944915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385843|NCT03944915|Tubulin Modulators|tubulin modulators|mesh-ancestor
65385844|NCT03944915|Antimitotic Agents|antimitotic agents|mesh-ancestor
65385845|NCT03944915|Mitosis Modulators|mitosis modulators|mesh-ancestor
65385846|NCT03944915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385847|NCT03944915|Antimetabolites|antimetabolites|mesh-ancestor
65385848|NCT03944915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65385849|NCT03944915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65385850|NCT03944915|Immunologic Factors|immunologic factors|mesh-ancestor
65385851|NCT03944915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385852|NCT03944915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65385853|NCT03944915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65385854|NCT03944915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65385855|NCT03944915|Antisickling Agents|antisickling agents|mesh-ancestor
65385858|NCT00482170|Etanercept|etanercept|mesh-list
65385859|NCT00482170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65385860|NCT00482170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65385861|NCT00482170|Analgesics|analgesics|mesh-ancestor
65385862|NCT00482170|Sensory System Agents|sensory system agents|mesh-ancestor
65385863|NCT00482170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385864|NCT00482170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385865|NCT00482170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65385866|NCT00482170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65385867|NCT00482170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65385868|NCT00482170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65385869|NCT00482170|Immunologic Factors|immunologic factors|mesh-ancestor
65385870|NCT05228249|Cytarabine|cytarabine|mesh-list
65385871|NCT05228249|Etoposide|etoposide|mesh-list
65385872|NCT05228249|Podophyllotoxin|podophyllotoxin|mesh-list
65385873|NCT05228249|Etoposide phosphate|etoposide phosphate|mesh-list
65385874|NCT05228249|Melphalan|melphalan|mesh-list
65385875|NCT05228249|Mechlorethamine|mechlorethamine|mesh-list
65385876|NCT05228249|Carmustine|carmustine|mesh-list
65385877|NCT05228249|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65385878|NCT05228249|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
65385879|NCT05228249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65385880|NCT05228249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385881|NCT05228249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65385882|NCT05228249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65385883|NCT05228249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385884|NCT05228249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777583|NCT02158572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777584|NCT02159976|Amoxicillin|amoxicillin|mesh-list
64777585|NCT02159976|Metronidazole|metronidazole|mesh-list
64777586|NCT02159976|Clarithromycin|clarithromycin|mesh-list
65385908|NCT04218695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65385909|NCT04218695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65385910|NCT01001013|Pioglitazone|pioglitazone|mesh-list
65385911|NCT01001013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65385912|NCT01001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385913|NCT01004601|Docetaxel|docetaxel|mesh-list
65385914|NCT01004601|Pemetrexed|pemetrexed|mesh-list
65385915|NCT01004601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385916|NCT01004601|Tubulin Modulators|tubulin modulators|mesh-ancestor
65385917|NCT01004601|Antimitotic Agents|antimitotic agents|mesh-ancestor
65385918|NCT01004601|Mitosis Modulators|mitosis modulators|mesh-ancestor
65385919|NCT01004601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385920|NCT01004601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385921|NCT01004601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65385922|NCT01004601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65385923|NCT01001247|Rilpivirine|rilpivirine|mesh-list
65385924|NCT01001247|Omeprazole|omeprazole|mesh-list
65385925|NCT01001247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65385926|NCT01001247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65385927|NCT01001247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65385928|NCT01001247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385929|NCT01001247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385930|NCT01001247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65385931|NCT01001247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65385932|NCT01001247|Antiviral Agents|antiviral agents|mesh-ancestor
65385933|NCT01001247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65385934|NCT01001247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65385935|NCT01001247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64777587|NCT02159976|Tetracycline|tetracycline|mesh-list
64670626|NCT04499573|Antiviral Agents|antiviral agents|mesh-ancestor
64670627|NCT04499573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64670628|NCT03425097|Fexofenadine|fexofenadine|mesh-list
64670629|NCT03425097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64670630|NCT03425097|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64670631|NCT03425097|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64670632|NCT03425097|Histamine Antagonists|histamine antagonists|mesh-ancestor
64670633|NCT03425097|Histamine Agents|histamine agents|mesh-ancestor
64670634|NCT03425097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64670635|NCT03425097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777596|NCT02159976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385936|NCT04205357|Sulfasalazine|sulfasalazine|mesh-list
65385937|NCT04205357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65385938|NCT04205357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65385939|NCT04205357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65385940|NCT04205357|Analgesics|analgesics|mesh-ancestor
65385941|NCT04205357|Sensory System Agents|sensory system agents|mesh-ancestor
65385942|NCT04205357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385943|NCT04205357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385944|NCT04205357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65385945|NCT04205357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65385946|NCT04205357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65385947|NCT02580773|Tinzaparin|tinzaparin|mesh-list
65385948|NCT02580773|Anticoagulants|anticoagulants|mesh-ancestor
65385949|NCT02580773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65385950|NCT02580773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65385951|NCT02580773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385952|NCT01008813|Vaccines|vaccines|mesh-list
65385953|NCT01008813|Immunologic Factors|immunologic factors|mesh-ancestor
65385954|NCT01008813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385955|NCT05674565|Magnesium Sulfate|magnesium sulfate|mesh-list
65385957|NCT05674565|Sensory System Agents|sensory system agents|mesh-ancestor
65385958|NCT05674565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385959|NCT05674565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385960|NCT05674565|Anesthetics|anesthetics|mesh-ancestor
65385961|NCT05674565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65385962|NCT05674565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65385963|NCT05674565|Anticonvulsants|anticonvulsants|mesh-ancestor
65385964|NCT05674565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65385965|NCT05674565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64777599|NCT02159976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64670636|NCT03425097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670637|NCT01926041|Varenicline|varenicline|mesh-list
64670638|NCT01926041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64670639|NCT01926041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64670640|NCT01926041|Cholinergic Agents|cholinergic agents|mesh-ancestor
64670641|NCT01926041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64670667|NCT04706949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556835|NCT05580887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64556836|NCT05580887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64556837|NCT05580887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64556838|NCT05580887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556839|NCT04994262|Menthol|menthol|mesh-list
65385966|NCT05674565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777610|NCT02160288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64777611|NCT02160288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777612|NCT02160288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64777613|NCT02160288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777614|NCT02160990|Exenatide|exenatide|mesh-list
64777615|NCT02160990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64777616|NCT02160990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777617|NCT02160990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64777618|NCT02160990|Incretins|incretins|mesh-ancestor
65385967|NCT05674565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65385968|NCT05674565|Tocolytic Agents|tocolytic agents|mesh-ancestor
65385969|NCT05674565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65385970|NCT01001637|Curcumin|curcumin|mesh-list
65385971|NCT01001637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65385972|NCT01001637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65385973|NCT01001637|Analgesics|analgesics|mesh-ancestor
65385974|NCT01001637|Sensory System Agents|sensory system agents|mesh-ancestor
65385975|NCT01001637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65385976|NCT01001637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65385977|NCT01001637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65385978|NCT01001637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65385979|NCT01001637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65385980|NCT01001637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65385981|NCT01001637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65385982|NCT01005147|Tranexamic Acid|tranexamic acid|mesh-list
65385983|NCT01005147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65385984|NCT01005147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65385986|NCT01005147|Hemostatics|hemostatics|mesh-ancestor
65386001|NCT01005303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386002|NCT01005303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65386003|NCT01005303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65386004|NCT01005381|Calcium, Dietary|calcium, dietary|mesh-list
65386005|NCT01005381|Vitamin D|vitamin d|mesh-list
65386006|NCT01005381|Calcium Carbonate|calcium carbonate|mesh-list
65386007|NCT01005381|Calcium|calcium|mesh-list
65386008|NCT01005381|Vitamins|vitamins|mesh-ancestor
65386009|NCT01005381|Micronutrients|micronutrients|mesh-ancestor
65386010|NCT01005381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386011|NCT01005381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65386012|NCT01005381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65386013|NCT01005381|Antacids|antacids|mesh-ancestor
65386014|NCT01005381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386015|NCT01005381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65386016|NCT01002183|Fosmidomycin|fosmidomycin|mesh-list
65386017|NCT01002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65386018|NCT01002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65386019|NCT05154279|Terlipressin|terlipressin|mesh-list
65386020|NCT05154279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65386021|NCT05154279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65386022|NCT01005537|Aldesleukin|aldesleukin|mesh-list
65386023|NCT01005537|Cyclophosphamide|cyclophosphamide|mesh-list
65386024|NCT01005537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65386025|NCT01005537|Immunologic Factors|immunologic factors|mesh-ancestor
65386026|NCT01005537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386027|NCT01005537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65386028|NCT01005537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65386030|NCT01005537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386031|NCT01005537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386032|NCT01005537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65386033|NCT01005537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65386034|NCT01005537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65386035|NCT01005537|Antiviral Agents|antiviral agents|mesh-ancestor
65386036|NCT01005537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64546331|NCT03644485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546332|NCT03644485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64777643|NCT02178696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777644|NCT02178696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64777645|NCT02178696|Serotonin Agents|serotonin agents|mesh-ancestor
65386042|NCT05733741|Viscosupplements|viscosupplements|mesh-ancestor
65386043|NCT05733741|Protective Agents|protective agents|mesh-ancestor
65386044|NCT05733741|Anesthetics, Local|anesthetics, local|mesh-ancestor
65386045|NCT05733741|Anesthetics|anesthetics|mesh-ancestor
65386046|NCT05733741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65386047|NCT05733741|Sensory System Agents|sensory system agents|mesh-ancestor
65386048|NCT05733741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65386049|NCT01005927|Calcium|calcium|mesh-list
65386050|NCT01005927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65386051|NCT01005927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386052|NCT03742713|Docetaxel|docetaxel|mesh-list
65386053|NCT03742713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386054|NCT03742713|Tubulin Modulators|tubulin modulators|mesh-ancestor
65386055|NCT03742713|Antimitotic Agents|antimitotic agents|mesh-ancestor
65386056|NCT03742713|Mitosis Modulators|mitosis modulators|mesh-ancestor
65386057|NCT03742713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386058|NCT01002729|Oseltamivir|oseltamivir|mesh-list
65386059|NCT01002729|Antiviral Agents|antiviral agents|mesh-ancestor
65386060|NCT01002729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65386061|NCT01002729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386062|NCT01002729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386063|NCT01002807|Metformin|metformin|mesh-list
65386064|NCT01002807|Dapagliflozin|dapagliflozin|mesh-list
65386065|NCT01002807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65386066|NCT01002807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386067|NCT01002807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65386068|NCT01002807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386069|NCT05733351|Docetaxel|docetaxel|mesh-list
65386070|NCT05733351|Antibodies|antibodies|mesh-list
64670668|NCT04706949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670669|NCT04706949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670670|NCT04706949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64670671|NCT04706949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64670672|NCT02299349|Epinephrine|epinephrine|mesh-list
64777651|NCT02180100|Fluconazole|fluconazole|mesh-list
64777652|NCT02180100|Terconazole|terconazole|mesh-list
64777653|NCT02180100|Antifungal Agents|antifungal agents|mesh-ancestor
64777654|NCT02180100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64777655|NCT02180100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64777656|NCT02180100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64777657|NCT02180100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386071|NCT05733351|Immunoglobulins|immunoglobulins|mesh-list
65386072|NCT05733351|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65386073|NCT05733351|Immunologic Factors|immunologic factors|mesh-ancestor
65386074|NCT05733351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386075|NCT05733351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386076|NCT05733351|Tubulin Modulators|tubulin modulators|mesh-ancestor
65386077|NCT05733351|Antimitotic Agents|antimitotic agents|mesh-ancestor
65386078|NCT05733351|Mitosis Modulators|mitosis modulators|mesh-ancestor
65386079|NCT05733351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386080|NCT05733117|Vitamin D|vitamin d|mesh-list
65386081|NCT05733117|Vitamins|vitamins|mesh-ancestor
65386082|NCT05733117|Micronutrients|micronutrients|mesh-ancestor
65386083|NCT05733117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386084|NCT05733117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65386085|NCT05732961|Luspatercept|luspatercept|mesh-list
65386086|NCT05732961|Hematinics|hematinics|mesh-ancestor
65386087|NCT01006395|Zoledronic Acid|zoledronic acid|mesh-list
65386088|NCT01006395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65386089|NCT01006395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386090|NCT00615056|Leucovorin|leucovorin|mesh-list
65386091|NCT00615056|Bevacizumab|bevacizumab|mesh-list
65386092|NCT00615056|Fluorouracil|fluorouracil|mesh-list
65386093|NCT00615056|Oxaliplatin|oxaliplatin|mesh-list
65386094|NCT00615056|Irinotecan|irinotecan|mesh-list
65386095|NCT00615056|Axitinib|axitinib|mesh-list
65386096|NCT00615056|Levoleucovorin|levoleucovorin|mesh-list
65386097|NCT00615056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65386098|NCT00615056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386099|NCT00615056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64670673|NCT02299349|Racepinephrine|racepinephrine|mesh-list
64670674|NCT02299349|Morphine|morphine|mesh-list
64670675|NCT02299349|Bupivacaine|bupivacaine|mesh-list
64670676|NCT02299349|Epinephryl borate|epinephryl borate|mesh-list
64670677|NCT02299349|Anesthetics, Local|anesthetics, local|mesh-ancestor
64670678|NCT02299349|Anesthetics|anesthetics|mesh-ancestor
64670679|NCT02299349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64777660|NCT02180100|Hormone Antagonists|hormone antagonists|mesh-ancestor
64777661|NCT02180100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64777662|NCT02180100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777663|NCT02180100|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64777664|NCT02180100|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64777665|NCT02181426|Ketorolac|ketorolac|mesh-list
65386100|NCT00615056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65386101|NCT00615056|Growth Substances|growth substances|mesh-ancestor
65386102|NCT00615056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386103|NCT00615056|Growth Inhibitors|growth inhibitors|mesh-ancestor
65386104|NCT00615056|Antimetabolites|antimetabolites|mesh-ancestor
65386105|NCT00615056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386106|NCT00615056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65386107|NCT00615056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65386108|NCT00615056|Immunologic Factors|immunologic factors|mesh-ancestor
65386109|NCT00615056|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65386110|NCT00615056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65386111|NCT00615056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386112|NCT00615056|Antidotes|antidotes|mesh-ancestor
65386113|NCT00615056|Protective Agents|protective agents|mesh-ancestor
65386114|NCT00615056|Vitamin B Complex|vitamin b complex|mesh-ancestor
65386115|NCT00615056|Vitamins|vitamins|mesh-ancestor
65386116|NCT00615056|Micronutrients|micronutrients|mesh-ancestor
65386117|NCT00615056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65386118|NCT01006551|Ziprasidone|ziprasidone|mesh-list
65386119|NCT01006551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65386120|NCT01006551|Serotonin Agents|serotonin agents|mesh-ancestor
65386121|NCT01006551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65386122|NCT01006551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386123|NCT01006551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386124|NCT01006551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65386125|NCT01006551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64670680|NCT02299349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670681|NCT02299349|Sensory System Agents|sensory system agents|mesh-ancestor
64670682|NCT02299349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670683|NCT02299349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64670684|NCT02299349|Narcotics|narcotics|mesh-ancestor
64670685|NCT02299349|Analgesics|analgesics|mesh-ancestor
64670686|NCT02299349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64670687|NCT02299349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64670688|NCT02299349|Adrenergic Agents|adrenergic agents|mesh-ancestor
64777669|NCT02181426|Sensory System Agents|sensory system agents|mesh-ancestor
64777670|NCT02181426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777677|NCT02192814|Lacosamide|lacosamide|mesh-list
65386126|NCT01006551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65386127|NCT01006551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65386128|NCT01006551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65386129|NCT01006551|Dopamine Agents|dopamine agents|mesh-ancestor
65386130|NCT05732727|Antihypertensive Agents|antihypertensive agents|mesh-list
65386131|NCT00873626|Ciprofloxacin|ciprofloxacin|mesh-list
65386132|NCT00873626|Levofloxacin|levofloxacin|mesh-list
65386133|NCT00873626|Ofloxacin|ofloxacin|mesh-list
65386134|NCT00873626|Fluoroquinolones|fluoroquinolones|mesh-list
65386135|NCT00873626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65386136|NCT00873626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65386137|NCT00873626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65386138|NCT00873626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65386139|NCT00873626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386140|NCT00873626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386141|NCT00873626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386142|NCT00873626|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65386143|NCT00873626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65386144|NCT00873626|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65386145|NCT00873626|Renal Agents|renal agents|mesh-ancestor
65386146|NCT00873626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65386147|NCT00879242|Deferasirox|deferasirox|mesh-list
65386148|NCT00879242|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65386149|NCT00879242|Chelating Agents|chelating agents|mesh-ancestor
65386150|NCT00879242|Sequestering Agents|sequestering agents|mesh-ancestor
65386151|NCT00879242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386152|NCT05732493|Capecitabine|capecitabine|mesh-list
65386153|NCT05732493|Oxaliplatin|oxaliplatin|mesh-list
65386154|NCT05732493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65386155|NCT05732493|Antimetabolites|antimetabolites|mesh-ancestor
65386156|NCT05732493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386157|NCT05732493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386158|NCT00868634|Bevacizumab|bevacizumab|mesh-list
65386159|NCT00868634|Capecitabine|capecitabine|mesh-list
64777684|NCT02195232|Antioxidants|antioxidants|mesh-ancestor
64777685|NCT02195232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777686|NCT02195232|Protective Agents|protective agents|mesh-ancestor
64777687|NCT02195232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777688|NCT02196168|Cisplatin|cisplatin|mesh-list
64777689|NCT02196168|Adavosertib|adavosertib|mesh-list
64777690|NCT02196168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64777691|NCT02196168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64777692|NCT02196168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777693|NCT02201394|Aspirin|aspirin|mesh-list
64777694|NCT02201394|Ticagrelor|ticagrelor|mesh-list
65386161|NCT00868634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65386162|NCT00868634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386163|NCT00868634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65386164|NCT00868634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65386165|NCT00868634|Growth Substances|growth substances|mesh-ancestor
65386166|NCT00868634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386167|NCT00868634|Growth Inhibitors|growth inhibitors|mesh-ancestor
65386168|NCT00868634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65386169|NCT00868634|Antimetabolites|antimetabolites|mesh-ancestor
65386170|NCT00868634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386171|NCT00868634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65386172|NCT00868634|Tubulin Modulators|tubulin modulators|mesh-ancestor
65386173|NCT00868634|Antimitotic Agents|antimitotic agents|mesh-ancestor
65386174|NCT00868634|Mitosis Modulators|mitosis modulators|mesh-ancestor
65386175|NCT05232357|Sodium thiosulfate|sodium thiosulfate|mesh-list
65386176|NCT05232357|Methylene Blue|methylene blue|mesh-list
65386177|NCT05232357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386178|NCT05232357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386179|NCT05232357|Antidotes|antidotes|mesh-ancestor
64777695|NCT02201394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64777696|NCT02201394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64777697|NCT02201394|Analgesics|analgesics|mesh-ancestor
64777698|NCT02201394|Sensory System Agents|sensory system agents|mesh-ancestor
64777699|NCT02201394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777700|NCT02201394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777701|NCT02201394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64777702|NCT02201394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64777703|NCT02201394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65386193|NCT00879476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65386194|NCT00868946|Ribavirin|ribavirin|mesh-list
65386195|NCT00868946|Antimetabolites|antimetabolites|mesh-ancestor
65386196|NCT00868946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386197|NCT00868946|Antiviral Agents|antiviral agents|mesh-ancestor
65386198|NCT00868946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65386199|NCT00482014|Carboplatin|carboplatin|mesh-list
65386200|NCT00482014|Pemetrexed|pemetrexed|mesh-list
65386201|NCT00482014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386202|NCT00482014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386203|NCT00482014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386204|NCT00482014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65386205|NCT00482014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65386206|NCT00879788|Ramipril|ramipril|mesh-list
65386207|NCT00879788|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65386208|NCT00879788|Protease Inhibitors|protease inhibitors|mesh-ancestor
65386209|NCT00879788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386210|NCT00879788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386211|NCT00879788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65386212|NCT03595553|Vancomycin|vancomycin|mesh-list
65386213|NCT03595553|Benzimidazole|benzimidazole|mesh-list
64777707|NCT02201394|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64777708|NCT02201394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64777709|NCT02201394|Antipyretics|antipyretics|mesh-ancestor
64777710|NCT02201394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64777711|NCT02201394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64777712|NCT02201394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64777713|NCT02201394|Purinergic Agents|purinergic agents|mesh-ancestor
64777714|NCT02201394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65386229|NCT00614822|Growth Substances|growth substances|mesh-ancestor
65386230|NCT00614822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386231|NCT00614822|Growth Inhibitors|growth inhibitors|mesh-ancestor
65386232|NCT00614822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386233|NCT00614822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386234|NCT00614822|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65386235|NCT00614822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65386236|NCT04861298|Quercetin|quercetin|mesh-list
65386237|NCT04861298|Antioxidants|antioxidants|mesh-ancestor
65386238|NCT04861298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386239|NCT04861298|Protective Agents|protective agents|mesh-ancestor
65386240|NCT04861298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386241|NCT03582917|Alfacalcidol|alfacalcidol|mesh-list
65386242|NCT03582917|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65386243|NCT03582917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65386244|NCT03582917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386245|NCT03582917|Vitamins|vitamins|mesh-ancestor
65386246|NCT03582917|Micronutrients|micronutrients|mesh-ancestor
65386247|NCT05226728|Pembrolizumab|pembrolizumab|mesh-list
65386248|NCT05226728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65386249|NCT05226728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386250|NCT00869180|Diclofenac|diclofenac|mesh-list
65386251|NCT00869180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65386252|NCT00869180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65386253|NCT00869180|Analgesics|analgesics|mesh-ancestor
65386254|NCT00869180|Sensory System Agents|sensory system agents|mesh-ancestor
65386258|NCT00869180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65386260|NCT00869180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386261|NCT00869180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386262|NCT00874328|Irinotecan|irinotecan|mesh-list
65386263|NCT00874328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386264|NCT00874328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65386265|NCT00874328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65386266|NCT00874328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386267|NCT00874328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386268|NCT00874406|Leucovorin|leucovorin|mesh-list
65386269|NCT00874406|Fluorouracil|fluorouracil|mesh-list
65386270|NCT00874406|Oxaliplatin|oxaliplatin|mesh-list
65386271|NCT00874406|Antimetabolites|antimetabolites|mesh-ancestor
65386272|NCT00874406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386273|NCT00874406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65386274|NCT00874406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386275|NCT00874406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65386276|NCT00874406|Immunologic Factors|immunologic factors|mesh-ancestor
65386277|NCT00874406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386278|NCT00874406|Antidotes|antidotes|mesh-ancestor
65386279|NCT00874406|Protective Agents|protective agents|mesh-ancestor
65386280|NCT00874406|Vitamin B Complex|vitamin b complex|mesh-ancestor
65386281|NCT00874406|Vitamins|vitamins|mesh-ancestor
65386282|NCT00874406|Micronutrients|micronutrients|mesh-ancestor
65386283|NCT04840628|Respiratory System Agents|respiratory system agents|mesh-list
65386284|NCT00880178|Niacin|niacin|mesh-list
65386285|NCT00880178|Niacinamide|niacinamide|mesh-list
65386286|NCT00880178|Nicotinic Acids|nicotinic acids|mesh-list
65386287|NCT00880178|Simvastatin|simvastatin|mesh-list
65386288|NCT00880178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65386289|NCT00880178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65386290|NCT00880178|Antimetabolites|antimetabolites|mesh-ancestor
65386291|NCT00880178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386292|NCT00880178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65386293|NCT00880178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65386294|NCT00880178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386295|NCT00880178|Vasodilator Agents|vasodilator agents|mesh-ancestor
64777740|NCT02209272|Lidocaine|lidocaine|mesh-list
64777741|NCT02209272|Benzyl Alcohol|benzyl alcohol|mesh-list
64777742|NCT02209272|Anesthetics, Local|anesthetics, local|mesh-ancestor
64777743|NCT02209272|Anesthetics|anesthetics|mesh-ancestor
64777744|NCT02209272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64777745|NCT02209272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777746|NCT02209272|Sensory System Agents|sensory system agents|mesh-ancestor
64777747|NCT02209272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777748|NCT02209272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64777749|NCT02209272|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65386300|NCT04077125|Rifaximin|rifaximin|mesh-list
65386301|NCT04077125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65386302|NCT04077125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65386303|NCT04077125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65386304|NCT04194203|Paclitaxel|paclitaxel|mesh-list
65386305|NCT04194203|Bevacizumab|bevacizumab|mesh-list
65386306|NCT04194203|Carboplatin|carboplatin|mesh-list
65386307|NCT04194203|Pemetrexed|pemetrexed|mesh-list
65386308|NCT04194203|Atezolizumab|atezolizumab|mesh-list
65386309|NCT04194203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65386310|NCT04194203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386311|NCT04194203|Tubulin Modulators|tubulin modulators|mesh-ancestor
65386312|NCT04194203|Antimitotic Agents|antimitotic agents|mesh-ancestor
65386313|NCT04194203|Mitosis Modulators|mitosis modulators|mesh-ancestor
65386314|NCT04194203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386315|NCT04194203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65386316|NCT04194203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65386317|NCT04194203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65386318|NCT04194203|Growth Substances|growth substances|mesh-ancestor
65386319|NCT04194203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386330|NCT05172401|Hormones|hormones|mesh-ancestor
65386335|NCT05172401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386336|NCT05172401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386338|NCT00143455|Irinotecan|irinotecan|mesh-list
65386339|NCT00143455|Etoposide|etoposide|mesh-list
65386340|NCT00143455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64777751|NCT02209272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64777752|NCT02209272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777753|NCT02214420|Ribavirin|ribavirin|mesh-list
64777754|NCT02214420|Sofosbuvir|sofosbuvir|mesh-list
64777755|NCT02214420|Simeprevir|simeprevir|mesh-list
64777756|NCT02214420|Antimetabolites|antimetabolites|mesh-ancestor
65386341|NCT00143455|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65386342|NCT00143455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65386343|NCT00143455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386344|NCT00143455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386345|NCT00143455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65386346|NCT00143455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65386347|NCT01006863|Phenylephrine|phenylephrine|mesh-list
65386348|NCT01006863|Oxymetazoline|oxymetazoline|mesh-list
65386349|NCT01006863|Ephedrine|ephedrine|mesh-list
65386350|NCT01006863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65386351|NCT01006863|Mydriatics|mydriatics|mesh-ancestor
65386352|NCT01006863|Autonomic Agents|autonomic agents|mesh-ancestor
65386353|NCT01006863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65386354|NCT01006863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386355|NCT01006863|Sympathomimetics|sympathomimetics|mesh-ancestor
65386356|NCT01006863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65386357|NCT01006863|Nasal Decongestants|nasal decongestants|mesh-ancestor
65386361|NCT01006863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65386377|NCT03535727|Mitosis Modulators|mitosis modulators|mesh-ancestor
65386378|NCT03535727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386379|NCT03535727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65386380|NCT03535727|Antimetabolites|antimetabolites|mesh-ancestor
65386381|NCT03535727|Antiviral Agents|antiviral agents|mesh-ancestor
65386382|NCT03535727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65386383|NCT03535727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386384|NCT03535727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65386385|NCT03535727|Immunologic Factors|immunologic factors|mesh-ancestor
65386386|NCT03535727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386387|NCT03535727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65386388|NCT03535727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65386389|NCT03529955|Apremilast|apremilast|mesh-list
65386390|NCT03529955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65386391|NCT03529955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65386392|NCT03529955|Analgesics|analgesics|mesh-ancestor
65386393|NCT03529955|Sensory System Agents|sensory system agents|mesh-ancestor
65386394|NCT03529955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65386395|NCT03529955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386396|NCT03529955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65386397|NCT03529955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65386398|NCT03529955|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65386399|NCT03529955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65386400|NCT03529955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386401|NCT03529955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386402|NCT00142909|Lofexidine|lofexidine|mesh-list
65386403|NCT00142909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65386414|NCT01007019|Esomeprazole|esomeprazole|mesh-list
64777785|NCT02222610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64777786|NCT02223702|Amoxicillin|amoxicillin|mesh-list
64777787|NCT02223702|Moxifloxacin|moxifloxacin|mesh-list
65386421|NCT05633979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64777788|NCT02223702|Metronidazole|metronidazole|mesh-list
64777789|NCT02223702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64777790|NCT02223702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64777791|NCT02223702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64777792|NCT02223702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64777793|NCT02223702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386422|NCT05633979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386423|NCT03508739|Valsartan|valsartan|mesh-list
65386424|NCT03508739|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65386425|NCT03508739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65386426|NCT03508739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65386427|NCT03508739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65386428|NCT03508739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386429|NCT00205699|Olanzapine|olanzapine|mesh-list
65386430|NCT00205699|Risperidone|risperidone|mesh-list
65386431|NCT00205699|Aripiprazole|aripiprazole|mesh-list
65386432|NCT00205699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65386433|NCT00205699|Serotonin Agents|serotonin agents|mesh-ancestor
65386434|NCT00205699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65386435|NCT00205699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386436|NCT00205699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386437|NCT00205699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65386438|NCT00205699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65386439|NCT00205699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64777799|NCT02225106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64777800|NCT02225106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777801|NCT02225106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64777802|NCT02225106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64777803|NCT02225106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64777804|NCT02225106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777805|NCT02225106|Dopamine Agents|dopamine agents|mesh-ancestor
64777806|NCT02225106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64777807|NCT02233296|Lasmiditan|lasmiditan|mesh-list
64777808|NCT02233296|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64777809|NCT02233296|Serotonin Agents|serotonin agents|mesh-ancestor
64389241|NCT03187093|Vortioxetine|vortioxetine|mesh-list
64389242|NCT03187093|Citalopram|citalopram|mesh-list
64389243|NCT03187093|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65386456|NCT03503513|Gentamicins|gentamicins|mesh-list
65386457|NCT03503513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65386458|NCT03503513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65386459|NCT03503513|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65386460|NCT03503513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386461|NCT03503513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386462|NCT03498521|Gemcitabine|gemcitabine|mesh-list
65386463|NCT03498521|Bevacizumab|bevacizumab|mesh-list
65386464|NCT03498521|Carboplatin|carboplatin|mesh-list
65386465|NCT03498521|Trastuzumab|trastuzumab|mesh-list
65386494|NCT03850691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65386495|NCT03850691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386496|NCT03850691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65386497|NCT03850691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65386498|NCT03850691|Antiviral Agents|antiviral agents|mesh-ancestor
65386499|NCT03850691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65386500|NCT02580149|Clopidogrel|clopidogrel|mesh-list
65386501|NCT02580149|Ticagrelor|ticagrelor|mesh-list
65386502|NCT02580149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65386503|NCT02580149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65386504|NCT02580149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65386505|NCT02580149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65386506|NCT02580149|Purinergic Agents|purinergic agents|mesh-ancestor
65386507|NCT02580149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65386508|NCT02580149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386509|NCT02580149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386510|NCT05618925|Cyclophosphamide|cyclophosphamide|mesh-list
65386511|NCT05618925|Rituximab|rituximab|mesh-list
65386512|NCT05618925|Fludarabine|fludarabine|mesh-list
65386513|NCT05618925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65386514|NCT05618925|Immunologic Factors|immunologic factors|mesh-ancestor
65386515|NCT05618925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386516|NCT05618925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65386517|NCT05618925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65386518|NCT05618925|Alkylating Agents|alkylating agents|mesh-ancestor
65386519|NCT05618925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386520|NCT05618925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386521|NCT05618925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65386522|NCT05618925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65386523|NCT04996017|Atezolizumab|atezolizumab|mesh-list
65386524|NCT04996017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386525|NCT04994223|Rivaroxaban|rivaroxaban|mesh-list
65386526|NCT04994223|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65386527|NCT04994223|Antithrombins|antithrombins|mesh-ancestor
65386528|NCT04994223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64777829|NCT02239380|Autonomic Agents|autonomic agents|mesh-ancestor
64777830|NCT02239380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777831|NCT02239380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777832|NCT02239380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64777833|NCT02239380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65386532|NCT04994223|Anticoagulants|anticoagulants|mesh-ancestor
65386533|NCT04126031|Ceftazidime|ceftazidime|mesh-list
65386534|NCT04126031|Avibactam|avibactam|mesh-list
65386535|NCT04126031|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
65386536|NCT04126031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65386537|NCT04126031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65386538|NCT04126031|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65386539|NCT04126031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386540|NCT04126031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386541|NCT01007565|Anesthetics|anesthetics|mesh-list
65386542|NCT01007565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65386543|NCT01007565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386544|NCT05229003|Irinotecan|irinotecan|mesh-list
65386545|NCT05229003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65386546|NCT05229003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65386547|NCT05229003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386548|NCT05229003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386549|NCT05229003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386550|NCT01016626|Mycophenolic Acid|mycophenolic acid|mesh-list
65386551|NCT01016626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65386552|NCT01016626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670689|NCT02299349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64670690|NCT02299349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670717|NCT00376155|Antimalarials|antimalarials|mesh-ancestor
64670718|NCT00376155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64670719|NCT00376155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64670720|NCT00376155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64670722|NCT00376155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670723|NCT00376155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670724|NCT00376155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64670725|NCT00376155|Renal Agents|renal agents|mesh-ancestor
64670726|NCT01989221|Granisetron|granisetron|mesh-list
64670727|NCT01989221|Antiemetics|antiemetics|mesh-ancestor
64670728|NCT01989221|Autonomic Agents|autonomic agents|mesh-ancestor
64670729|NCT01989221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670730|NCT01989221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670731|NCT01989221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64670732|NCT01989221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64670733|NCT01989221|Serotonin Agents|serotonin agents|mesh-ancestor
64670734|NCT01989221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64670735|NCT01989221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670736|NCT03226899|Colchicine|colchicine|mesh-list
65386553|NCT01016626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65386554|NCT01016626|Antitubercular Agents|antitubercular agents|mesh-ancestor
65386555|NCT01016626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65386556|NCT01016626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65386557|NCT01016626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386558|NCT01016626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386559|NCT04436926|Analgesics, Opioid|analgesics, opioid|mesh-list
65386560|NCT04436926|Narcotics|narcotics|mesh-ancestor
65386561|NCT04436926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65386562|NCT04436926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386563|NCT04436926|Analgesics|analgesics|mesh-ancestor
65386564|NCT04436926|Sensory System Agents|sensory system agents|mesh-ancestor
65386565|NCT04436926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65386566|NCT02798471|Heparin|heparin|mesh-list
65386567|NCT02798471|Enoxaparin|enoxaparin|mesh-list
65386568|NCT02798471|Warfarin|warfarin|mesh-list
65386569|NCT02798471|Edoxaban|edoxaban|mesh-list
65386570|NCT02798471|Fondaparinux|fondaparinux|mesh-list
65386571|NCT02798471|Anticoagulants|anticoagulants|mesh-ancestor
65386572|NCT02798471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65386573|NCT02798471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65386574|NCT02798471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386575|NCT02798471|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65386576|NCT02798471|Antithrombins|antithrombins|mesh-ancestor
65386577|NCT02798471|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65386578|NCT02798471|Protease Inhibitors|protease inhibitors|mesh-ancestor
65386579|NCT02798471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386580|NCT03443765|Vitamin D|vitamin d|mesh-list
65386581|NCT03443765|Immunoglobulins|immunoglobulins|mesh-list
65386582|NCT03443765|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64777855|NCT02241486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64777856|NCT02241486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386601|NCT03440177|Ramipril|ramipril|mesh-list
65386602|NCT03440177|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65386603|NCT03440177|Protease Inhibitors|protease inhibitors|mesh-ancestor
65386604|NCT03440177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386605|NCT03440177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386606|NCT03440177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65386607|NCT00489736|Amiodarone|amiodarone|mesh-list
65386608|NCT00489736|Dronedarone|dronedarone|mesh-list
65386609|NCT00489736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65386610|NCT00489736|Vasodilator Agents|vasodilator agents|mesh-ancestor
65386611|NCT00489736|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65386612|NCT00489736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65386613|NCT00489736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386614|NCT00489736|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65386615|NCT00489736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65386616|NCT00489736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65386617|NCT00489736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386618|NCT00489736|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65386619|NCT00489736|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65386620|NCT00489736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65386621|NCT00617084|Everolimus|everolimus|mesh-list
65386622|NCT00617084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386623|NCT00617084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65386624|NCT00617084|Immunologic Factors|immunologic factors|mesh-ancestor
65386625|NCT00617084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386626|NCT02758847|Paclitaxel|paclitaxel|mesh-list
65386627|NCT02758847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65386629|NCT02758847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386639|NCT01016860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386640|NCT00874484|Enoxaparin|enoxaparin|mesh-list
65386641|NCT00874484|Anticoagulants|anticoagulants|mesh-ancestor
65386642|NCT00874484|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65386643|NCT00874484|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65386644|NCT00874484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386645|NCT00869492|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65386646|NCT00869492|Dermatologic Agents|dermatologic agents|mesh-ancestor
65386647|NCT00489424|Acetaminophen|acetaminophen|mesh-list
65386648|NCT00489424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65386649|NCT00489424|Analgesics|analgesics|mesh-ancestor
65386650|NCT00489424|Sensory System Agents|sensory system agents|mesh-ancestor
65386651|NCT00489424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65386652|NCT00489424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386653|NCT00489424|Antipyretics|antipyretics|mesh-ancestor
65386654|NCT00869570|Capecitabine|capecitabine|mesh-list
65386655|NCT00869570|Sorafenib|sorafenib|mesh-list
65386656|NCT00869570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65386657|NCT00869570|Antimetabolites|antimetabolites|mesh-ancestor
65386658|NCT00869570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386659|NCT00869570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386660|NCT00869570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65386661|NCT00869570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386662|NCT05127304|Bromides|bromides|mesh-list
65386663|NCT05127304|Tiotropium Bromide|tiotropium bromide|mesh-list
65386664|NCT05127304|Olodaterol|olodaterol|mesh-list
65386665|NCT05127304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65386666|NCT05127304|Autonomic Agents|autonomic agents|mesh-ancestor
65386667|NCT05127304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65386669|NCT05127304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64777888|NCT02251236|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65386686|NCT01020136|Axitinib|axitinib|mesh-list
65386687|NCT01020136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386688|NCT01020136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65386689|NCT01020136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386690|NCT01020136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386691|NCT03412643|Paclitaxel|paclitaxel|mesh-list
65386692|NCT03412643|Cyclophosphamide|cyclophosphamide|mesh-list
65386693|NCT03412643|Doxorubicin|doxorubicin|mesh-list
65386694|NCT03412643|Trastuzumab|trastuzumab|mesh-list
65386695|NCT03412643|Pertuzumab|pertuzumab|mesh-list
65386696|NCT03412643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65386697|NCT03412643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386698|NCT03412643|Tubulin Modulators|tubulin modulators|mesh-ancestor
65386699|NCT03412643|Antimitotic Agents|antimitotic agents|mesh-ancestor
65386700|NCT03412643|Mitosis Modulators|mitosis modulators|mesh-ancestor
65386701|NCT03412643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386702|NCT03412643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65386703|NCT03412643|Immunologic Factors|immunologic factors|mesh-ancestor
65386704|NCT03412643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386705|NCT03412643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65386706|NCT03412643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65386707|NCT03412643|Alkylating Agents|alkylating agents|mesh-ancestor
65386708|NCT03412643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64670737|NCT03226899|Allopurinol|allopurinol|mesh-list
64670738|NCT03226899|Febuxostat|febuxostat|mesh-list
64670739|NCT03226899|Lesinurad|lesinurad|mesh-list
64670740|NCT03226899|Gout Suppressants|gout suppressants|mesh-ancestor
64670741|NCT03226899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64670742|NCT03226899|Tubulin Modulators|tubulin modulators|mesh-ancestor
64670751|NCT03226899|Protective Agents|protective agents|mesh-ancestor
64670752|NCT03226899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670753|NCT03226899|Uricosuric Agents|uricosuric agents|mesh-ancestor
64670754|NCT03226899|Renal Agents|renal agents|mesh-ancestor
64670755|NCT01990703|Levonorgestrel|levonorgestrel|mesh-list
64670756|NCT01990703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64670757|NCT01990703|Contraceptive Agents|contraceptive agents|mesh-ancestor
64670758|NCT01990703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64670759|NCT01990703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670760|NCT01990703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64670761|NCT01990703|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64670762|NCT01990703|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64670763|NCT03230175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64670764|NCT03230175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64670765|NCT01992185|Sunscreening Agents|sunscreening agents|mesh-list
64670766|NCT01992185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64556841|NCT04994262|Dermatologic Agents|dermatologic agents|mesh-ancestor
64556842|NCT00939159|Panobinostat|panobinostat|mesh-list
64556843|NCT00939159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556844|NCT00939159|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64777897|NCT02251236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64777898|NCT02251236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64777899|NCT02251236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64777900|NCT02251236|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64777901|NCT02251938|Sirolimus|sirolimus|mesh-list
64777902|NCT02251938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64777903|NCT02251938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64777904|NCT02251938|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64777905|NCT02251938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64777906|NCT02251938|Antifungal Agents|antifungal agents|mesh-ancestor
65386709|NCT03412643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65386710|NCT03412643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65386711|NCT03412643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65386712|NCT03412643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386713|NCT03412643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65386714|NCT01017094|Silver Sulfadiazine|silver sulfadiazine|mesh-list
65386715|NCT01017094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65386716|NCT01017094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65386717|NCT01020214|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65386718|NCT01020214|Olmesartan|olmesartan|mesh-list
65386719|NCT01020214|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65386720|NCT01020214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65386721|NCT01020214|Diuretics|diuretics|mesh-ancestor
65386722|NCT01020214|Natriuretic Agents|natriuretic agents|mesh-ancestor
65386723|NCT01020214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386724|NCT01020214|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65386729|NCT03970824|Adalimumab|adalimumab|mesh-list
64777909|NCT02251938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777910|NCT02258412|Ethanol|ethanol|mesh-list
64777911|NCT02258412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
64777912|NCT02258412|Hand Sanitizers|hand sanitizers|mesh-list
64777913|NCT02258412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64777914|NCT02258412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64777915|NCT02258412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777916|NCT02258412|Disinfectants|disinfectants|mesh-ancestor
64777917|NCT02260440|Pembrolizumab|pembrolizumab|mesh-list
64777918|NCT02260440|Azacitidine|azacitidine|mesh-list
65386744|NCT00564486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65386745|NCT00564486|Analgesics|analgesics|mesh-ancestor
65386746|NCT00564486|Sensory System Agents|sensory system agents|mesh-ancestor
65386747|NCT00564486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65386748|NCT00564486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386749|NCT00564486|Antipyretics|antipyretics|mesh-ancestor
65386750|NCT00481078|Paclitaxel|paclitaxel|mesh-list
65386751|NCT00481078|Carboplatin|carboplatin|mesh-list
65386752|NCT00481078|Vorinostat|vorinostat|mesh-list
65386753|NCT00481078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65386754|NCT00481078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386755|NCT00481078|Tubulin Modulators|tubulin modulators|mesh-ancestor
65386756|NCT00481078|Antimitotic Agents|antimitotic agents|mesh-ancestor
65386757|NCT00481078|Mitosis Modulators|mitosis modulators|mesh-ancestor
65386758|NCT00481078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386759|NCT00481078|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65386760|NCT00481078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386761|NCT00480532|Doxycycline|doxycycline|mesh-list
65386762|NCT00480532|Levonorgestrel|levonorgestrel|mesh-list
65386763|NCT00480532|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65386764|NCT00480532|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65386765|NCT00480532|Estradiol|estradiol|mesh-list
65386778|NCT00480532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65386779|NCT00480532|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65386780|NCT00480532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65386781|NCT00480532|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65386782|NCT00480532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65386783|NCT04013880|Decitabine|decitabine|mesh-list
65386784|NCT04013880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65136357|NCT01201798|Difluprednate|difluprednate|mesh-list
65386785|NCT04013880|Antimetabolites|antimetabolites|mesh-ancestor
65386786|NCT04013880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386787|NCT04013880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386788|NCT04013880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386789|NCT00934518|Cetuximab|cetuximab|mesh-list
65386790|NCT00934518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65386791|NCT00934518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386792|NCT00496366|Capecitabine|capecitabine|mesh-list
65386793|NCT00496366|Lapatinib|lapatinib|mesh-list
65386794|NCT00496366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65386795|NCT00496366|Antimetabolites|antimetabolites|mesh-ancestor
65386796|NCT00496366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386797|NCT00496366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386798|NCT00496366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65386799|NCT00496366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386800|NCT00934752|Paclitaxel|paclitaxel|mesh-list
65386801|NCT00934752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65386802|NCT00934752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386803|NCT00934752|Tubulin Modulators|tubulin modulators|mesh-ancestor
65386804|NCT00934752|Antimitotic Agents|antimitotic agents|mesh-ancestor
65386805|NCT00934752|Mitosis Modulators|mitosis modulators|mesh-ancestor
65386806|NCT00934752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386807|NCT01020292|Nelfinavir|nelfinavir|mesh-list
65386808|NCT01020292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65386809|NCT01020292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65386810|NCT01020292|Protease Inhibitors|protease inhibitors|mesh-ancestor
65386811|NCT01020292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386812|NCT01020292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777941|NCT02267772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64777942|NCT02267772|Narcotics|narcotics|mesh-ancestor
64777943|NCT02267772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64777944|NCT02267772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777945|NCT02267772|Analgesics|analgesics|mesh-ancestor
64777946|NCT02267772|Sensory System Agents|sensory system agents|mesh-ancestor
64777947|NCT02267772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777948|NCT02267772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64777949|NCT02267772|Antipyretics|antipyretics|mesh-ancestor
64777950|NCT02271906|Afatinib|afatinib|mesh-list
65386815|NCT01020292|Antiviral Agents|antiviral agents|mesh-ancestor
65386816|NCT01020292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65386817|NCT00934830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65386818|NCT00934830|Amoxicillin|amoxicillin|mesh-list
65386819|NCT00934830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65386820|NCT02575404|Pembrolizumab|pembrolizumab|mesh-list
65386821|NCT02575404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65386822|NCT02575404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386823|NCT00564018|Insulin Detemir|insulin detemir|mesh-list
65386824|NCT00564018|Protamines|protamines|mesh-list
65386825|NCT00564018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65386826|NCT00564018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386827|NCT00564018|Heparin Antagonists|heparin antagonists|mesh-ancestor
65386828|NCT00564018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386829|NCT00564018|Coagulants|coagulants|mesh-ancestor
65386830|NCT00935298|Tacrolimus|tacrolimus|mesh-list
65386831|NCT00935298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65386832|NCT00935298|Immunologic Factors|immunologic factors|mesh-ancestor
65386833|NCT00935298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386834|NCT00935298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65386835|NCT00935298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386836|NCT00935298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386837|NCT04014192|Dapagliflozin|dapagliflozin|mesh-list
65386838|NCT04014192|Empagliflozin|empagliflozin|mesh-list
65386839|NCT04014192|Canagliflozin|canagliflozin|mesh-list
65386840|NCT04014192|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64777951|NCT02271906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64777952|NCT02271906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64777953|NCT02271906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64777954|NCT02271906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777955|NCT02274870|Bupivacaine|bupivacaine|mesh-list
64777956|NCT02274870|Anesthetics, Local|anesthetics, local|mesh-ancestor
64777957|NCT02274870|Anesthetics|anesthetics|mesh-ancestor
64777958|NCT02274870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64777959|NCT02274870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777960|NCT02274870|Sensory System Agents|sensory system agents|mesh-ancestor
64389392|NCT02328443|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64389393|NCT02328443|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64389394|NCT02328443|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65386845|NCT00935610|Chelating Agents|chelating agents|mesh-ancestor
65386846|NCT00935610|Sequestering Agents|sequestering agents|mesh-ancestor
65386847|NCT00935610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386848|NCT04013646|Epoetin Alfa|epoetin alfa|mesh-list
65386849|NCT04013646|Hematinics|hematinics|mesh-ancestor
65386850|NCT04074473|Propranolol|propranolol|mesh-list
65386851|NCT04074473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65386852|NCT04074473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65386853|NCT04074473|Adrenergic Agents|adrenergic agents|mesh-ancestor
65386854|NCT04074473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65136429|NCT01683552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65386860|NCT03356483|Niacin|niacin|mesh-list
64777961|NCT02274870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777962|NCT02276274|Alogliptin|alogliptin|mesh-list
64777963|NCT02276274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64777964|NCT02276274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777965|NCT02276274|Incretins|incretins|mesh-ancestor
64777966|NCT02276274|Hormones|hormones|mesh-ancestor
65386881|NCT00563784|Paclitaxel|paclitaxel|mesh-list
65386882|NCT00563784|Carboplatin|carboplatin|mesh-list
65386883|NCT00563784|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65386884|NCT00563784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65386885|NCT00563784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386886|NCT00563784|Tubulin Modulators|tubulin modulators|mesh-ancestor
65386887|NCT00563784|Antimitotic Agents|antimitotic agents|mesh-ancestor
65386888|NCT00563784|Mitosis Modulators|mitosis modulators|mesh-ancestor
65386889|NCT00563784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386890|NCT00563784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65386891|NCT00563784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386892|NCT00203047|Prednisone|prednisone|mesh-list
65386893|NCT00203047|Glatiramer Acetate|glatiramer acetate|mesh-list
65386894|NCT00203047|(T,G)-A-L|(t,g)-a-l|mesh-list
65386895|NCT00203047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65386896|NCT00203047|Glucocorticoids|glucocorticoids|mesh-ancestor
65386897|NCT00203047|Hormones|hormones|mesh-ancestor
65386898|NCT00203047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65386899|NCT00203047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386900|NCT00203047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65386901|NCT00203047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386902|NCT00203047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65386923|NCT04074551|Vasodilator Agents|vasodilator agents|mesh-ancestor
65386924|NCT04074551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65386925|NCT04074551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65386926|NCT04074551|Antimetabolites|antimetabolites|mesh-ancestor
65386927|NCT04074551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65386928|NCT04074551|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65386929|NCT04074551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386930|NCT04074551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65386931|NCT04074551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65386932|NCT04074551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65386933|NCT02608385|Pembrolizumab|pembrolizumab|mesh-list
65386934|NCT02608385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65386935|NCT02608385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65386936|NCT00142519|Morphine|morphine|mesh-list
65386938|NCT00142519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65386939|NCT00142519|Narcotics|narcotics|mesh-ancestor
65386940|NCT00142519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65386941|NCT00142519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386942|NCT00142519|Analgesics|analgesics|mesh-ancestor
65386943|NCT00142519|Sensory System Agents|sensory system agents|mesh-ancestor
65386944|NCT00142519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65386945|NCT00142519|Antitussive Agents|antitussive agents|mesh-ancestor
65386946|NCT00142519|Respiratory System Agents|respiratory system agents|mesh-ancestor
65386947|NCT03713294|Dexamethasone|dexamethasone|mesh-list
65386948|NCT03713294|Dexamethasone acetate|dexamethasone acetate|mesh-list
65386949|NCT03713294|Pomalidomide|pomalidomide|mesh-list
65386950|NCT03713294|Elotuzumab|elotuzumab|mesh-list
65386973|NCT00141817|Pantoprazole|pantoprazole|mesh-list
65386974|NCT00141817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65386975|NCT00141817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65386976|NCT00141817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65386977|NCT00141817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65386978|NCT00141817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65386979|NCT03967171|Oxytocin|oxytocin|mesh-list
65386980|NCT03967171|Oxytocics|oxytocics|mesh-ancestor
65386981|NCT03967171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65386982|NCT03967171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386983|NCT03967327|Morphine|morphine|mesh-list
65386984|NCT03967327|Buprenorphine|buprenorphine|mesh-list
65386985|NCT03967327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65386986|NCT03967327|Narcotics|narcotics|mesh-ancestor
65386987|NCT03967327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65386988|NCT03967327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65386989|NCT03967327|Analgesics|analgesics|mesh-ancestor
65386990|NCT03967327|Sensory System Agents|sensory system agents|mesh-ancestor
65386991|NCT03967327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65386992|NCT03967327|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65386993|NCT01075945|Lumefantrine|lumefantrine|mesh-list
65386994|NCT01075945|Artemether|artemether|mesh-list
65386995|NCT01075945|Piperaquine|piperaquine|mesh-list
65386996|NCT01075945|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65386997|NCT01075945|Artenimol|artenimol|mesh-list
65386998|NCT01075945|Antimalarials|antimalarials|mesh-ancestor
65386999|NCT01075945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65387000|NCT01075945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65387001|NCT01075945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387002|NCT00874562|Sirolimus|sirolimus|mesh-list
65387003|NCT00874562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65387011|NCT00201643|Dexamethasone|dexamethasone|mesh-list
65387021|NCT00201643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65387022|NCT00201643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65387023|NCT00201643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387024|NCT00201643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65387025|NCT00201643|Respiratory System Agents|respiratory system agents|mesh-ancestor
65387026|NCT03798314|Nivolumab|nivolumab|mesh-list
65387027|NCT03798314|Pomalidomide|pomalidomide|mesh-list
65387028|NCT03798314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65387029|NCT03798314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387030|NCT03798314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65387031|NCT03798314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387032|NCT03798314|Immunologic Factors|immunologic factors|mesh-ancestor
65387033|NCT03798314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387034|NCT03798314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65387035|NCT03798314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65387036|NCT03798314|Growth Substances|growth substances|mesh-ancestor
65387037|NCT03798314|Growth Inhibitors|growth inhibitors|mesh-ancestor
65387038|NCT01077427|Gemcitabine|gemcitabine|mesh-list
65387039|NCT01077427|Capecitabine|capecitabine|mesh-list
65387040|NCT01077427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387041|NCT01077427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65387042|NCT01077427|Antimetabolites|antimetabolites|mesh-ancestor
65387043|NCT01077427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387044|NCT01077427|Antiviral Agents|antiviral agents|mesh-ancestor
65387045|NCT01077427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387046|NCT01077427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387047|NCT01077427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65387048|NCT01077427|Immunologic Factors|immunologic factors|mesh-ancestor
65387049|NCT01077427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387050|NCT00883064|Lisinopril|lisinopril|mesh-list
65387051|NCT00883064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65387052|NCT00883064|Protease Inhibitors|protease inhibitors|mesh-ancestor
65387053|NCT00883064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64778033|NCT02284386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778034|NCT02284464|Prednisone|prednisone|mesh-list
64778035|NCT02284464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64778036|NCT02284464|Glucocorticoids|glucocorticoids|mesh-ancestor
64778037|NCT02284464|Hormones|hormones|mesh-ancestor
65387060|NCT01077505|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
65387061|NCT01077505|Contraceptives, Oral|contraceptives, oral|mesh-list
65387062|NCT01077505|rGLP-1 protein|rglp-1 protein|mesh-list
65387063|NCT01077505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65387064|NCT01077505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387065|NCT01077505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65387066|NCT01077505|Incretins|incretins|mesh-ancestor
65387067|NCT01077505|Hormones|hormones|mesh-ancestor
65387068|NCT01077505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65387069|NCT01077505|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65387070|NCT01077505|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65387071|NCT01077505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65387072|NCT01077505|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
65387073|NCT01077505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65387074|NCT01073995|Triamcinolone|triamcinolone|mesh-list
65387075|NCT01073995|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65387076|NCT01073995|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65387077|NCT01073995|Bupivacaine|bupivacaine|mesh-list
65387078|NCT01073995|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65387079|NCT01073995|Anesthetics, Local|anesthetics, local|mesh-ancestor
65387080|NCT01073995|Anesthetics|anesthetics|mesh-ancestor
65387081|NCT01073995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65387082|NCT01073995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387083|NCT01073995|Sensory System Agents|sensory system agents|mesh-ancestor
65387084|NCT01073995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65387085|NCT01073995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65387086|NCT01073995|Glucocorticoids|glucocorticoids|mesh-ancestor
65387087|NCT01073995|Hormones|hormones|mesh-ancestor
64778038|NCT02284464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64778041|NCT02284464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556845|NCT00939159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387088|NCT01073995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65387089|NCT01073995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65387090|NCT01073995|Immunologic Factors|immunologic factors|mesh-ancestor
65387091|NCT01073995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387092|NCT01073995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387093|NCT01074073|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65387094|NCT01074073|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65387095|NCT01074073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65387096|NCT01074073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65387097|NCT01074073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387098|NCT01074073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65387099|NCT01074073|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65387100|NCT01074073|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65387101|NCT01074073|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65387102|NCT01074073|Adrenergic Agents|adrenergic agents|mesh-ancestor
65387103|NCT01074073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65387104|NCT01074073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387105|NCT01074073|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65387106|NCT01074073|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65387107|NCT01074073|Serotonin Agents|serotonin agents|mesh-ancestor
65387108|NCT01074073|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65387109|NCT01074073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65387110|NCT01074073|Dopamine Agents|dopamine agents|mesh-ancestor
65387111|NCT00874874|Sorafenib|sorafenib|mesh-list
65387112|NCT00874874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387113|NCT00874874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65387114|NCT00874874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387115|NCT00874874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778059|NCT02284854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64778060|NCT02285634|Lidocaine|lidocaine|mesh-list
64778061|NCT02285634|Phenylephrine|phenylephrine|mesh-list
64778062|NCT02285634|Epinephrine|epinephrine|mesh-list
64778063|NCT02285634|Oxymetazoline|oxymetazoline|mesh-list
64778064|NCT02285634|Anesthetics, Local|anesthetics, local|mesh-ancestor
64778065|NCT02285634|Anesthetics|anesthetics|mesh-ancestor
64778066|NCT02285634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64778067|NCT02285634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778068|NCT02285634|Sensory System Agents|sensory system agents|mesh-ancestor
64389502|NCT03144713|Adrenergic Agents|adrenergic agents|mesh-ancestor
64389503|NCT03144713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64389504|NCT03144713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387129|NCT00130039|Purinergic Agents|purinergic agents|mesh-ancestor
65387130|NCT00130039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65387131|NCT00130039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387132|NCT00130039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387133|NCT00130039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65387134|NCT00130039|Autonomic Agents|autonomic agents|mesh-ancestor
65387135|NCT00130039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65387136|NCT00130039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65387137|NCT00130039|Respiratory System Agents|respiratory system agents|mesh-ancestor
65387138|NCT00130039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65387139|NCT00130039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65387140|NCT00130039|Vasodilator Agents|vasodilator agents|mesh-ancestor
65387141|NCT00130039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65387142|NCT00130039|Protective Agents|protective agents|mesh-ancestor
65387143|NCT00130039|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64778069|NCT02285634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778070|NCT02285634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64778071|NCT02285634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64778072|NCT02285634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64778073|NCT02285634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64778075|NCT02285634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65387163|NCT00883298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387164|NCT00883298|Growth Inhibitors|growth inhibitors|mesh-ancestor
65387165|NCT00883298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65387166|NCT00883298|Alkylating Agents|alkylating agents|mesh-ancestor
65387167|NCT00883298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387168|NCT00881114|Cetuximab|cetuximab|mesh-list
65387169|NCT00881114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387170|NCT00881114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65387171|NCT00475852|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65387172|NCT00475852|Natriuretic Agents|natriuretic agents|mesh-ancestor
65387173|NCT00475852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387174|NCT00141271|Ziprasidone|ziprasidone|mesh-list
65387175|NCT00141271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65387176|NCT00141271|Serotonin Agents|serotonin agents|mesh-ancestor
65387177|NCT00141271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65387178|NCT00141271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387179|NCT00141271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387180|NCT00141271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65387181|NCT00141271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65387182|NCT00141271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65387183|NCT00141271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65387184|NCT00141271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65387185|NCT00141271|Dopamine Agents|dopamine agents|mesh-ancestor
65387186|NCT01017640|Mitomycins|mitomycins|mesh-list
65387187|NCT01017640|Mitomycin|mitomycin|mesh-list
65387188|NCT01017640|Veliparib|veliparib|mesh-list
64778082|NCT02285634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64778083|NCT02285634|Respiratory System Agents|respiratory system agents|mesh-ancestor
64778084|NCT02285634|Mydriatics|mydriatics|mesh-ancestor
64778085|NCT02285634|Sympathomimetics|sympathomimetics|mesh-ancestor
64778086|NCT02285634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64778087|NCT02285634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64778088|NCT02285634|Nasal Decongestants|nasal decongestants|mesh-ancestor
64778089|NCT02285634|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64778090|NCT02285634|Protective Agents|protective agents|mesh-ancestor
64778091|NCT02287350|Diclofenac|diclofenac|mesh-list
64389526|NCT02075632|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
64389527|NCT02075632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64389528|NCT02075632|Glucocorticoids|glucocorticoids|mesh-ancestor
64389529|NCT02075632|Hormones|hormones|mesh-ancestor
64389530|NCT02075632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65387198|NCT00614120|Glimepiride|glimepiride|mesh-list
65387199|NCT00614120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65387200|NCT00614120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387201|NCT00614120|Incretins|incretins|mesh-ancestor
65387202|NCT00614120|Hormones|hormones|mesh-ancestor
65387203|NCT00614120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65387204|NCT00614120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65387205|NCT00614120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65387206|NCT00614120|Immunologic Factors|immunologic factors|mesh-ancestor
65387207|NCT00496054|Vaccines|vaccines|mesh-list
65387208|NCT00496054|Immunologic Factors|immunologic factors|mesh-ancestor
65387232|NCT04387240|Artemisinin|artemisinin|mesh-list
65387233|NCT04387240|Antimalarials|antimalarials|mesh-ancestor
65387234|NCT04387240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65387235|NCT04387240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65387237|NCT04387240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387238|NCT04387240|Antiviral Agents|antiviral agents|mesh-ancestor
65387239|NCT04387240|Schistosomicides|schistosomicides|mesh-ancestor
65387240|NCT04387240|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65387241|NCT04387240|Anthelmintics|anthelmintics|mesh-ancestor
65387242|NCT00495586|Amoxicillin|amoxicillin|mesh-list
65387243|NCT00495586|Clavulanic Acids|clavulanic acids|mesh-list
65387244|NCT00495586|Clavulanic Acid|clavulanic acid|mesh-list
65387245|NCT00495586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65387246|NCT00495586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387247|NCT00495586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387248|NCT00495586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387249|NCT00495586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65387250|NCT00613730|Gemcitabine|gemcitabine|mesh-list
65387251|NCT00613730|Panitumumab|panitumumab|mesh-list
65387252|NCT00613730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65387253|NCT00613730|Antimetabolites|antimetabolites|mesh-ancestor
65387254|NCT00613730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387255|NCT00613730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387256|NCT00613730|Antiviral Agents|antiviral agents|mesh-ancestor
65387257|NCT00613730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387258|NCT00613730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387259|NCT00613730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65387260|NCT00613730|Immunologic Factors|immunologic factors|mesh-ancestor
65387261|NCT00613730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387262|NCT00613730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65387263|NCT00613574|Bromides|bromides|mesh-list
65387264|NCT00613574|Tiotropium Bromide|tiotropium bromide|mesh-list
65387266|NCT00613574|Autonomic Agents|autonomic agents|mesh-ancestor
65387276|NCT00613574|Anticonvulsants|anticonvulsants|mesh-ancestor
65387277|NCT00881426|Cefprozil|cefprozil|mesh-list
65387278|NCT00881426|Cephalosporins|cephalosporins|mesh-list
65387279|NCT00881426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65387280|NCT00881426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387281|NCT00883532|Budesonide|budesonide|mesh-list
65387282|NCT00883532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65387283|NCT00883532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65387284|NCT00883532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65387285|NCT00883532|Autonomic Agents|autonomic agents|mesh-ancestor
65387286|NCT00883532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65387287|NCT00883532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387288|NCT00883532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65387289|NCT00883532|Respiratory System Agents|respiratory system agents|mesh-ancestor
65387290|NCT00883532|Glucocorticoids|glucocorticoids|mesh-ancestor
65387291|NCT00883532|Hormones|hormones|mesh-ancestor
65387292|NCT00883532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65387293|NCT00881582|Interferons|interferons|mesh-list
65387294|NCT00881582|Interferon-alpha|interferon-alpha|mesh-list
65387295|NCT00881582|Interferon alpha-2|interferon alpha-2|mesh-list
65387296|NCT00881582|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65387297|NCT00881582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387298|NCT00881582|Antiviral Agents|antiviral agents|mesh-ancestor
65387299|NCT00881582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387300|NCT00881582|Immunologic Factors|immunologic factors|mesh-ancestor
65387301|NCT00881582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387302|NCT00881738|Clarithromycin|clarithromycin|mesh-list
65387303|NCT00881738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65387304|NCT00881738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387305|NCT00881738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65387306|NCT00881738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387307|NCT00881738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387308|NCT00881738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65387310|NCT00613106|Ibuprofen|ibuprofen|mesh-list
65387317|NCT00613106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65387318|NCT00613106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65387319|NCT00613106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65387320|NCT00613106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387321|NCT00613106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387322|NCT00881816|Paclitaxel|paclitaxel|mesh-list
65387323|NCT00881816|Capecitabine|capecitabine|mesh-list
65387324|NCT00881816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65387325|NCT00881816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387326|NCT00881816|Tubulin Modulators|tubulin modulators|mesh-ancestor
65387327|NCT00881816|Antimitotic Agents|antimitotic agents|mesh-ancestor
65387328|NCT00881816|Mitosis Modulators|mitosis modulators|mesh-ancestor
65387329|NCT00881816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387330|NCT00881816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65387331|NCT00881816|Antimetabolites|antimetabolites|mesh-ancestor
65387332|NCT03712904|Aflibercept|aflibercept|mesh-list
65387333|NCT03712904|Endothelial Growth Factors|endothelial growth factors|mesh-list
65387334|NCT03712904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65387335|NCT03712904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65387336|NCT03712904|Growth Substances|growth substances|mesh-ancestor
65387337|NCT03712904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387338|NCT03712904|Growth Inhibitors|growth inhibitors|mesh-ancestor
65387339|NCT03712904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387340|NCT04634162|Cangrelor|cangrelor|mesh-list
64389575|NCT02326727|Fentanyl|fentanyl|mesh-list
64556846|NCT00939159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556847|NCT04144439|Butyric Acid|butyric acid|mesh-list
64714195|NCT02988050|Anesthetics, General|anesthetics, general|mesh-ancestor
64556849|NCT04144439|Histamine Agents|histamine agents|mesh-ancestor
64321905|NCT05175001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670767|NCT01992185|Protective Agents|protective agents|mesh-ancestor
64670768|NCT01992185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670769|NCT01992185|Dermatologic Agents|dermatologic agents|mesh-ancestor
64670770|NCT04332627|Neostigmine|neostigmine|mesh-list
64670771|NCT04332627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64670772|NCT04332627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670773|NCT04332627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670774|NCT04332627|Cholinergic Agents|cholinergic agents|mesh-ancestor
64670775|NCT04332627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64670776|NCT04332627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670777|NCT04332627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64670778|NCT04332627|Autonomic Agents|autonomic agents|mesh-ancestor
64670779|NCT04332627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670780|NCT03440229|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64670781|NCT03440229|Laxatives|laxatives|mesh-ancestor
64670782|NCT03440229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64670783|NCT01963091|Oxytocin|oxytocin|mesh-list
64670784|NCT01963091|Oxytocics|oxytocics|mesh-ancestor
64670785|NCT01963091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64670786|NCT01963091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778140|NCT02291016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64778141|NCT02291016|Respiratory System Agents|respiratory system agents|mesh-ancestor
64778142|NCT02291016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64778143|NCT02291016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64778144|NCT02291016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65387341|NCT04634162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65387342|NCT04634162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65387343|NCT04634162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65387344|NCT04634162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65387345|NCT04634162|Purinergic Agents|purinergic agents|mesh-ancestor
65387346|NCT04634162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65387347|NCT04634162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387348|NCT04634162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387349|NCT00875966|Azithromycin|azithromycin|mesh-list
65387350|NCT00875966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65387351|NCT00875966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387352|NCT00141037|Mycophenolic Acid|mycophenolic acid|mesh-list
65387353|NCT00141037|Trimethoprim|trimethoprim|mesh-list
65387354|NCT00141037|Sulfamethoxazole|sulfamethoxazole|mesh-list
65387355|NCT00141037|Valganciclovir|valganciclovir|mesh-list
65387356|NCT00141037|Ganciclovir|ganciclovir|mesh-list
65387357|NCT00141037|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65387358|NCT00141037|Prednisone|prednisone|mesh-list
65387359|NCT00141037|Tacrolimus|tacrolimus|mesh-list
65387360|NCT00141037|Daclizumab|daclizumab|mesh-list
65387361|NCT00141037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65387362|NCT00141037|Glucocorticoids|glucocorticoids|mesh-ancestor
65387363|NCT00141037|Hormones|hormones|mesh-ancestor
65387364|NCT00141037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65387365|NCT00141037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387366|NCT00141037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65387367|NCT00141037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778148|NCT02296164|Mechlorethamine|mechlorethamine|mesh-list
64670787|NCT02306759|Ketamine|ketamine|mesh-list
64670788|NCT02306759|Analgesics|analgesics|mesh-ancestor
64670789|NCT02306759|Sensory System Agents|sensory system agents|mesh-ancestor
64670790|NCT02306759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670791|NCT02306759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670792|NCT02306759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64670793|NCT02306759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64670794|NCT02306759|Anesthetics, General|anesthetics, general|mesh-ancestor
64670796|NCT02306759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65387368|NCT00141037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65387369|NCT00141037|Immunologic Factors|immunologic factors|mesh-ancestor
65387370|NCT00141037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65387371|NCT00141037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387372|NCT00141037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387373|NCT00141037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65387374|NCT00141037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65387375|NCT00141037|Antitubercular Agents|antitubercular agents|mesh-ancestor
65387376|NCT00141037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65387377|NCT00141037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387378|NCT00141037|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65387379|NCT00141037|Renal Agents|renal agents|mesh-ancestor
65387380|NCT00141037|Antimalarials|antimalarials|mesh-ancestor
65387381|NCT00141037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65387382|NCT00141037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65387383|NCT00141037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65387384|NCT00141037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65387385|NCT00141037|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65387386|NCT00141037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65387387|NCT00141037|Antiviral Agents|antiviral agents|mesh-ancestor
65387388|NCT00141037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65387390|NCT01582555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65387391|NCT01582555|Antidotes|antidotes|mesh-ancestor
64670797|NCT02306759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64670799|NCT02306759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64670800|NCT02306759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670801|NCT03298113|Protective Agents|protective agents|mesh-list
64670815|NCT03232749|Protective Agents|protective agents|mesh-ancestor
64670816|NCT03441633|Rivaroxaban|rivaroxaban|mesh-list
64670817|NCT03441633|Apixaban|apixaban|mesh-list
64670818|NCT03441633|Dabigatran|dabigatran|mesh-list
64670819|NCT03441633|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64670820|NCT03441633|Antithrombins|antithrombins|mesh-ancestor
64670821|NCT03441633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64670822|NCT03441633|Protease Inhibitors|protease inhibitors|mesh-ancestor
64670823|NCT03441633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670824|NCT03441633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670825|NCT03441633|Anticoagulants|anticoagulants|mesh-ancestor
64670827|NCT01687400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64670828|NCT01687400|Antimetabolites|antimetabolites|mesh-ancestor
64670829|NCT01687400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670830|NCT01687400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670831|NCT01687400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670832|NCT01688102|Vitamin D|vitamin d|mesh-list
64670833|NCT01688102|Cholecalciferol|cholecalciferol|mesh-list
64670834|NCT01688102|Vitamins|vitamins|mesh-ancestor
64670835|NCT01688102|Micronutrients|micronutrients|mesh-ancestor
64556850|NCT04144439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64556851|NCT04144439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556852|NCT04144439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387392|NCT01582555|Protective Agents|protective agents|mesh-ancestor
65387393|NCT01582555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387394|NCT01582555|Antioxidants|antioxidants|mesh-ancestor
65387395|NCT01582555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387396|NCT01582555|Antiviral Agents|antiviral agents|mesh-ancestor
65387397|NCT01582555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387398|NCT01582555|Expectorants|expectorants|mesh-ancestor
65387399|NCT01582555|Respiratory System Agents|respiratory system agents|mesh-ancestor
65387400|NCT01582555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65387401|NCT04115774|Diphosphonates|diphosphonates|mesh-list
65387402|NCT04115774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65387403|NCT04115774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387404|NCT00923390|Aldesleukin|aldesleukin|mesh-list
65387405|NCT00923390|Cyclophosphamide|cyclophosphamide|mesh-list
65387406|NCT00923390|Fludarabine|fludarabine|mesh-list
65387407|NCT00923390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65387408|NCT00923390|Immunologic Factors|immunologic factors|mesh-ancestor
65387409|NCT00923390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387410|NCT00923390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65387411|NCT00923390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65387412|NCT00923390|Alkylating Agents|alkylating agents|mesh-ancestor
65387413|NCT00923390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387414|NCT00923390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387415|NCT00923390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65387416|NCT00923390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65387417|NCT00923390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65387418|NCT00923390|Antiviral Agents|antiviral agents|mesh-ancestor
64778181|NCT02303184|Growth Inhibitors|growth inhibitors|mesh-ancestor
65387440|NCT00888758|Sirolimus|sirolimus|mesh-list
65387441|NCT00888758|Umirolimus|umirolimus|mesh-list
65387442|NCT00888758|Everolimus|everolimus|mesh-list
65387443|NCT00888758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387444|NCT00888758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65387445|NCT00888758|Immunologic Factors|immunologic factors|mesh-ancestor
65387446|NCT00888758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387447|NCT00888758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65387448|NCT00888758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65387449|NCT00888758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387450|NCT00888758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65387451|NCT00888758|Antifungal Agents|antifungal agents|mesh-ancestor
65387452|NCT00888836|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65387453|NCT00888836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387454|NCT04038320|Sofosbuvir|sofosbuvir|mesh-list
65387455|NCT04038320|Ledipasvir|ledipasvir|mesh-list
65387456|NCT04038320|Antiviral Agents|antiviral agents|mesh-ancestor
65387457|NCT04038320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387458|NCT00563706|Risperidone|risperidone|mesh-list
65387459|NCT00563706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65387460|NCT00563706|Serotonin Agents|serotonin agents|mesh-ancestor
65387461|NCT00563706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65387462|NCT00563706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387463|NCT00563706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387464|NCT00563706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65387465|NCT00563706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65387466|NCT00563706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65387467|NCT00563706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65387468|NCT00563706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65387469|NCT00563706|Dopamine Agents|dopamine agents|mesh-ancestor
65387470|NCT02543606|Esomeprazole|esomeprazole|mesh-list
65387471|NCT02543606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65387472|NCT02543606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65387473|NCT02543606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64556853|NCT04994574|Tiotropium Bromide|tiotropium bromide|mesh-list
64556854|NCT04994574|Olodaterol|olodaterol|mesh-list
64556855|NCT04994574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64556856|NCT04994574|Autonomic Agents|autonomic agents|mesh-ancestor
64556857|NCT04994574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556858|NCT04994574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556859|NCT04994574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64556860|NCT04994574|Respiratory System Agents|respiratory system agents|mesh-ancestor
64778198|NCT02312622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64778199|NCT02312622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778200|NCT02312622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778201|NCT02312622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64778202|NCT02314104|Ropivacaine|ropivacaine|mesh-list
65387474|NCT02543606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387475|NCT02543606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387477|NCT00939588|Telmisartan|telmisartan|mesh-list
65387478|NCT00939588|Ramipril|ramipril|mesh-list
65387479|NCT00939588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65387480|NCT00939588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65387481|NCT00939588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65387482|NCT00939588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387483|NCT00939588|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65387484|NCT00939588|Protease Inhibitors|protease inhibitors|mesh-ancestor
65387485|NCT00939588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387486|NCT00889148|Gabapentin|gabapentin|mesh-list
65387487|NCT00889148|Analgesics|analgesics|mesh-ancestor
65387488|NCT00889148|Sensory System Agents|sensory system agents|mesh-ancestor
65387489|NCT00889148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65387490|NCT00889148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387491|NCT00889148|Anticonvulsants|anticonvulsants|mesh-ancestor
65387492|NCT00889148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65387520|NCT00129961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65387521|NCT00129961|Immunologic Factors|immunologic factors|mesh-ancestor
65387522|NCT00129961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387523|NCT00129961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65387524|NCT00129961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387525|NCT00129961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387526|NCT00129961|Antifungal Agents|antifungal agents|mesh-ancestor
65387527|NCT00129961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387528|NCT00129961|Dermatologic Agents|dermatologic agents|mesh-ancestor
65387529|NCT00129961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65387530|NCT00129961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65387531|NCT00129961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65387532|NCT00129961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387533|NCT00528567|Bevacizumab|bevacizumab|mesh-list
65387534|NCT00528567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65387535|NCT00528567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387536|NCT00528567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65387537|NCT00528567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65387538|NCT00528567|Growth Substances|growth substances|mesh-ancestor
65387539|NCT00528567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387540|NCT00528567|Growth Inhibitors|growth inhibitors|mesh-ancestor
65387541|NCT00936234|Vildagliptin|vildagliptin|mesh-list
65387542|NCT00936234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65387543|NCT00936234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387544|NCT00936234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65387545|NCT00936234|Protease Inhibitors|protease inhibitors|mesh-ancestor
65387567|NCT00936624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64778241|NCT02330172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64778242|NCT02330172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778243|NCT02330172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64778244|NCT02330172|Autonomic Agents|autonomic agents|mesh-ancestor
64778245|NCT02330172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778246|NCT02331108|Propofol|propofol|mesh-list
64778247|NCT02331108|Anesthetics|anesthetics|mesh-list
64778248|NCT02331108|Sevoflurane|sevoflurane|mesh-list
64778249|NCT02331108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64778250|NCT02331108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64778251|NCT02331108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387568|NCT00936624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387569|NCT00936624|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65387570|NCT00936624|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65387571|NCT00936624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387572|NCT00138151|Interferons|interferons|mesh-list
65387573|NCT00138151|Interferon-alpha|interferon-alpha|mesh-list
65387574|NCT00138151|Interferon alpha-2|interferon alpha-2|mesh-list
65387575|NCT00138151|Paclitaxel|paclitaxel|mesh-list
65387576|NCT00138151|Isotretinoin|isotretinoin|mesh-list
65387577|NCT00138151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65387578|NCT00138151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387579|NCT00138151|Tubulin Modulators|tubulin modulators|mesh-ancestor
65387605|NCT02581631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387606|NCT00884546|Dexamethasone|dexamethasone|mesh-list
65387607|NCT00884546|Lenalidomide|lenalidomide|mesh-list
65387608|NCT00884546|Bortezomib|bortezomib|mesh-list
65387609|NCT00884546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65387610|NCT00884546|Antiemetics|antiemetics|mesh-ancestor
65387611|NCT00884546|Autonomic Agents|autonomic agents|mesh-ancestor
65387612|NCT00884546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65387613|NCT00884546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387614|NCT00884546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65387615|NCT00884546|Glucocorticoids|glucocorticoids|mesh-ancestor
65387617|NCT00884546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65387618|NCT00884546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65387619|NCT00884546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387620|NCT00884546|Immunologic Factors|immunologic factors|mesh-ancestor
65387621|NCT00884546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65387622|NCT00884546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65387623|NCT00884546|Growth Substances|growth substances|mesh-ancestor
65387624|NCT00884546|Growth Inhibitors|growth inhibitors|mesh-ancestor
65387625|NCT00886106|Midazolam|midazolam|mesh-list
65387626|NCT00886106|Remifentanil|remifentanil|mesh-list
65387627|NCT00886106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65387628|NCT00886106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65387629|NCT00886106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65387630|NCT00886106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387631|NCT00886106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65387632|NCT00886106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65387633|NCT00886106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65387634|NCT00886106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65387635|NCT00886106|Anesthetics, General|anesthetics, general|mesh-ancestor
65387636|NCT00886106|Anesthetics|anesthetics|mesh-ancestor
65387637|NCT00886106|GABA Modulators|gaba modulators|mesh-ancestor
65387638|NCT00886106|GABA Agents|gaba agents|mesh-ancestor
65387649|NCT00889694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65387650|NCT00889694|Analgesics|analgesics|mesh-ancestor
65387651|NCT00889694|Sensory System Agents|sensory system agents|mesh-ancestor
65387652|NCT00889694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65387653|NCT00889694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387654|NCT00889694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65387655|NCT00889694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65387656|NCT00889694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65387657|NCT00529035|Interleukin-2|interleukin-2|mesh-list
65387658|NCT00529035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387659|NCT00529035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65387660|NCT00529035|Analgesics|analgesics|mesh-ancestor
65387661|NCT00529035|Sensory System Agents|sensory system agents|mesh-ancestor
65387662|NCT00529035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65387663|NCT00529035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387664|NCT04421664|Hydroxychloroquine|hydroxychloroquine|mesh-list
65387665|NCT04421664|Antimalarials|antimalarials|mesh-ancestor
65387666|NCT04421664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65387667|NCT04421664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65387668|NCT04421664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387669|NCT04421664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387670|NCT04421664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387671|NCT04421664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65387672|NCT02578043|Clindamycin|clindamycin|mesh-list
65387673|NCT02578043|Clindamycin palmitate|clindamycin palmitate|mesh-list
65387674|NCT02578043|Clindamycin phosphate|clindamycin phosphate|mesh-list
65387675|NCT02578043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65387676|NCT02578043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65387677|NCT02578043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387678|NCT02578043|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65387679|NCT02578043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387680|NCT02578043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387692|NCT04074317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387693|NCT00941148|Insulin|insulin|mesh-list
65387694|NCT00941148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65387695|NCT00941148|Metformin|metformin|mesh-list
65387696|NCT00941148|Insulin Detemir|insulin detemir|mesh-list
65387697|NCT00941148|Insulin, Isophane|insulin, isophane|mesh-list
65387698|NCT00941148|Isophane Insulin, Human|isophane insulin, human|mesh-list
65387699|NCT00941148|Isophane insulin, beef|isophane insulin, beef|mesh-list
65387700|NCT00941148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65387701|NCT00941148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387702|NCT02541500|Minocycline|minocycline|mesh-list
65066820|NCT00281970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066821|NCT00281970|Tubulin Modulators|tubulin modulators|mesh-ancestor
65066822|NCT00281970|Antimitotic Agents|antimitotic agents|mesh-ancestor
65066823|NCT00281970|Mitosis Modulators|mitosis modulators|mesh-ancestor
65066824|NCT00281970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066825|NCT00272675|Chlorhexidine|chlorhexidine|mesh-list
65066826|NCT00272675|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65066827|NCT00272675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65066828|NCT00272675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65066829|NCT00272675|Disinfectants|disinfectants|mesh-ancestor
65066830|NCT00272675|Dermatologic Agents|dermatologic agents|mesh-ancestor
65066831|NCT00307827|Visilizumab|visilizumab|mesh-list
65066832|NCT00307827|Immunologic Factors|immunologic factors|mesh-ancestor
65066833|NCT00307827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066834|NCT00272714|Afimoxifene|afimoxifene|mesh-list
65066835|NCT00272714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066836|NCT00272714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65066837|NCT00272714|Hormone Antagonists|hormone antagonists|mesh-ancestor
65066842|NCT00272753|Budesonide|budesonide|mesh-list
65066855|NCT00272753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65066856|NCT00272753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65066857|NCT00272753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65066858|NCT00272753|Adrenergic Agents|adrenergic agents|mesh-ancestor
65066859|NCT00272753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65066860|NCT00272753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066861|NCT00272753|Tocolytic Agents|tocolytic agents|mesh-ancestor
65066862|NCT00272753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65066863|NCT00272831|Cilostazol|cilostazol|mesh-list
65066864|NCT00272831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65066865|NCT00272831|Autonomic Agents|autonomic agents|mesh-ancestor
65066866|NCT00272831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066867|NCT00272831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066868|NCT00272831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65066869|NCT00272831|Respiratory System Agents|respiratory system agents|mesh-ancestor
65066870|NCT00272831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65066871|NCT00272831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65066872|NCT00272831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066873|NCT00272831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65066874|NCT00272831|Vasodilator Agents|vasodilator agents|mesh-ancestor
65066875|NCT00272831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65066876|NCT00272831|Protective Agents|protective agents|mesh-ancestor
65066877|NCT00272831|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65066878|NCT00272831|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65387703|NCT02541500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65387704|NCT02541500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387705|NCT04073849|Epoetin Alfa|epoetin alfa|mesh-list
65387706|NCT04073849|Hematinics|hematinics|mesh-ancestor
65387707|NCT03263429|Irinotecan|irinotecan|mesh-list
65387708|NCT03263429|Panitumumab|panitumumab|mesh-list
64778340|NCT02369172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778341|NCT02369172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64778342|NCT02369172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64778343|NCT02369172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64778344|NCT02374164|Febuxostat|febuxostat|mesh-list
64778345|NCT02374164|Gout Suppressants|gout suppressants|mesh-ancestor
65387723|NCT00609674|Respiratory System Agents|respiratory system agents|mesh-ancestor
64778346|NCT02374164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64778347|NCT02374398|Tranexamic Acid|tranexamic acid|mesh-list
64389774|NCT03185143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64389775|NCT03185143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389776|NCT05076773|Morphine|morphine|mesh-list
65387724|NCT00609674|Dermatologic Agents|dermatologic agents|mesh-ancestor
65387725|NCT00609674|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65387726|NCT00941382|Metformin|metformin|mesh-list
65387727|NCT00941382|Sibutramine|sibutramine|mesh-list
65387728|NCT00941382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65387729|NCT00941382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387730|NCT00941382|Antidepressive Agents|antidepressive agents|mesh-ancestor
65387731|NCT00941382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65387732|NCT00941382|Appetite Depressants|appetite depressants|mesh-ancestor
65387733|NCT00941382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65387734|NCT03253679|Adavosertib|adavosertib|mesh-list
65387735|NCT03253679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387736|NCT03253679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387737|NCT00137839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65387738|NCT00137839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387739|NCT00137839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65387740|NCT00137839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387741|NCT00137839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387742|NCT00941460|Temozolomide|temozolomide|mesh-list
65387743|NCT00941460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65387744|NCT00941460|Alkylating Agents|alkylating agents|mesh-ancestor
65387745|NCT00941460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387746|NCT00941460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387751|NCT00890318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65387752|NCT00890318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387753|NCT00890318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387754|NCT00890318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65387755|NCT00890318|Hormone Antagonists|hormone antagonists|mesh-ancestor
65387756|NCT00890318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65387757|NCT00890318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387758|NCT00890318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65387759|NCT00563316|Irinotecan|irinotecan|mesh-list
65387760|NCT00563316|Panitumumab|panitumumab|mesh-list
65387761|NCT00563316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65387762|NCT00563316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65387763|NCT00563316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387764|NCT00563316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387765|NCT00563316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387766|NCT00563316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65387767|NCT04037774|Dexmedetomidine|dexmedetomidine|mesh-list
65387768|NCT04037774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65387769|NCT04037774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65387770|NCT04037774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387771|NCT04037774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65387772|NCT04037774|Analgesics|analgesics|mesh-ancestor
65387773|NCT04037774|Sensory System Agents|sensory system agents|mesh-ancestor
65387774|NCT04037774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65387775|NCT04037774|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65387776|NCT04037774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65387777|NCT04037774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65387778|NCT04037774|Adrenergic Agents|adrenergic agents|mesh-ancestor
65387779|NCT04037774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65387780|NCT04037774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387782|NCT02542748|Ephedrine|ephedrine|mesh-list
65387783|NCT02542748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64778373|NCT02384070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64778374|NCT02384070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64778375|NCT02384070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64778376|NCT02384070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778377|NCT02384070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64778378|NCT02384070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64778379|NCT02384070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547085|NCT00245037|Antifungal Agents|antifungal agents|mesh-ancestor
64778380|NCT02384070|Antipyretics|antipyretics|mesh-ancestor
64389808|NCT02432365|Paclitaxel|paclitaxel|mesh-list
64389809|NCT02432365|Cisplatin|cisplatin|mesh-list
64389810|NCT02432365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65387788|NCT02542748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387789|NCT02542748|Sympathomimetics|sympathomimetics|mesh-ancestor
65387790|NCT02542748|Autonomic Agents|autonomic agents|mesh-ancestor
65387791|NCT02542748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65387792|NCT02542748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65387793|NCT02542748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65387794|NCT00941616|Factor VIII|factor viii|mesh-list
65387795|NCT00941616|Coagulants|coagulants|mesh-ancestor
65387796|NCT02542592|Methylprednisolone|methylprednisolone|mesh-list
65387797|NCT02542592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65387798|NCT02542592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65387799|NCT02542592|Prednisolone|prednisolone|mesh-list
65387800|NCT02542592|Prednisolone acetate|prednisolone acetate|mesh-list
65387801|NCT02542592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65387802|NCT02542592|Prednisolone phosphate|prednisolone phosphate|mesh-list
65387803|NCT02542592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65387804|NCT02542592|Antiemetics|antiemetics|mesh-ancestor
65387805|NCT02542592|Autonomic Agents|autonomic agents|mesh-ancestor
65387806|NCT02542592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65387807|NCT02542592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778381|NCT02384070|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65387819|NCT03178487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387820|NCT03178487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387821|NCT03178487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65387822|NCT04430036|Gemcitabine|gemcitabine|mesh-list
65387823|NCT04430036|Cisplatin|cisplatin|mesh-list
65387824|NCT04430036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387825|NCT04430036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65387826|NCT04430036|Antimetabolites|antimetabolites|mesh-ancestor
65387827|NCT04430036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387828|NCT04430036|Antiviral Agents|antiviral agents|mesh-ancestor
65387829|NCT04430036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387830|NCT04430036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387831|NCT04430036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65387832|NCT04430036|Immunologic Factors|immunologic factors|mesh-ancestor
65387833|NCT04430036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493960|NCT03913559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65493961|NCT03913559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65493962|NCT03913559|Protective Agents|protective agents|mesh-ancestor
65493963|NCT03913559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65493964|NCT03913559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65493965|NCT03913559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65493966|NCT03913559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65493967|NCT03913559|Anesthetics, Local|anesthetics, local|mesh-ancestor
65493968|NCT03913559|Anesthetics|anesthetics|mesh-ancestor
65493969|NCT03913559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65493970|NCT03913559|Histamine Antagonists|histamine antagonists|mesh-ancestor
65493977|NCT03900754|Oxytocin|oxytocin|mesh-list
65387844|NCT00528957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65387845|NCT00528957|Antimetabolites|antimetabolites|mesh-ancestor
65387846|NCT00890630|Oxytocin|oxytocin|mesh-list
65387847|NCT00890630|Oxytocics|oxytocics|mesh-ancestor
65387848|NCT00890630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65387849|NCT00890630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387850|NCT00890708|Voriconazole|voriconazole|mesh-list
65387851|NCT00890708|Antifungal Agents|antifungal agents|mesh-ancestor
65387852|NCT00890708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387853|NCT00890708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65387854|NCT00890708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65387855|NCT00890708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387856|NCT00890708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387857|NCT00890708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65387858|NCT00890708|Hormone Antagonists|hormone antagonists|mesh-ancestor
65387859|NCT00890708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65387860|NCT00890708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387861|NCT00890708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65387862|NCT00890786|Bevacizumab|bevacizumab|mesh-list
65387863|NCT00890786|Irinotecan|irinotecan|mesh-list
65387864|NCT00890786|Temozolomide|temozolomide|mesh-list
65387865|NCT00890786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65387866|NCT00890786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387867|NCT00890786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65387868|NCT00890786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65387891|NCT00890942|Sensory System Agents|sensory system agents|mesh-ancestor
65387892|NCT00890942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65387893|NCT00942006|Doxycycline|doxycycline|mesh-list
65387894|NCT00942006|Ceftriaxone|ceftriaxone|mesh-list
65387895|NCT00942006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65387896|NCT00942006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387897|NCT00942006|Antimalarials|antimalarials|mesh-ancestor
65387898|NCT00942006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65387899|NCT00942006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65387900|NCT02542124|Interleukin-12|interleukin-12|mesh-list
65387901|NCT02542124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65387902|NCT02542124|Immunologic Factors|immunologic factors|mesh-ancestor
65387903|NCT02542124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387904|NCT02542124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65387905|NCT02542124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65137501|NCT01177384|Acarbose|acarbose|mesh-list
65387906|NCT02542124|Growth Substances|growth substances|mesh-ancestor
65387907|NCT02542124|Growth Inhibitors|growth inhibitors|mesh-ancestor
65387908|NCT02542124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387909|NCT00942318|Insulin|insulin|mesh-list
65387910|NCT00942318|Metformin|metformin|mesh-list
65387911|NCT00942318|Insulin Aspart|insulin aspart|mesh-list
65387912|NCT00942318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65387913|NCT00942318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387914|NCT04819269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65387915|NCT04819269|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65387916|NCT05280054|Probenecid|probenecid|mesh-list
65387917|NCT05280054|Uricosuric Agents|uricosuric agents|mesh-ancestor
65387918|NCT05280054|Gout Suppressants|gout suppressants|mesh-ancestor
65387919|NCT05280054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65387920|NCT05280054|Renal Agents|renal agents|mesh-ancestor
65387921|NCT03999099|Suvorexant|suvorexant|mesh-list
65387922|NCT03999099|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65387923|NCT03999099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65387924|NCT03999099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64778433|NCT02401542|Docetaxel|docetaxel|mesh-list
64556861|NCT04994574|Parasympatholytics|parasympatholytics|mesh-ancestor
64556862|NCT04994574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64556863|NCT04994574|Cholinergic Agents|cholinergic agents|mesh-ancestor
64556864|NCT04994574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64556865|NCT04994574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556866|NCT04355637|Budesonide|budesonide|mesh-list
64556867|NCT04355637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64556868|NCT04355637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65387925|NCT03999099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387926|NCT03999099|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65387927|NCT03999099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65387928|NCT03999099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387929|NCT01007799|Vitamin D|vitamin d|mesh-list
65387930|NCT01007799|Ergocalciferols|ergocalciferols|mesh-list
65387931|NCT01007799|Cholecalciferol|cholecalciferol|mesh-list
65387932|NCT01007799|Vitamins|vitamins|mesh-list
65387933|NCT01007799|Micronutrients|micronutrients|mesh-ancestor
65387934|NCT01007799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387935|NCT01007799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65387936|NCT01007799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65387937|NCT00609518|Folic Acid|folic acid|mesh-list
65387938|NCT00609518|Vitamin B 12|vitamin b 12|mesh-list
65387939|NCT00609518|Vitamin B Complex|vitamin b complex|mesh-list
65387940|NCT00609518|Dexamethasone|dexamethasone|mesh-list
65387941|NCT00609518|Dexamethasone acetate|dexamethasone acetate|mesh-list
65387942|NCT00609518|Pemetrexed|pemetrexed|mesh-list
65387943|NCT00609518|BB 1101|bb 1101|mesh-list
65387944|NCT00609518|Vitamins|vitamins|mesh-ancestor
65387945|NCT00609518|Micronutrients|micronutrients|mesh-ancestor
65387946|NCT00609518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387947|NCT00609518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65387948|NCT00609518|Antiemetics|antiemetics|mesh-ancestor
65387949|NCT00609518|Autonomic Agents|autonomic agents|mesh-ancestor
65387950|NCT00609518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65387951|NCT00609518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65387952|NCT00609518|Glucocorticoids|glucocorticoids|mesh-ancestor
65387953|NCT00609518|Hormones|hormones|mesh-ancestor
65387954|NCT00609518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65387955|NCT00609518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65387956|NCT00609518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65387957|NCT00609518|Protease Inhibitors|protease inhibitors|mesh-ancestor
65387958|NCT00609518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387959|NCT00609518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387967|NCT00886496|Agglutinins|agglutinins|mesh-ancestor
65387968|NCT00886496|Immunologic Factors|immunologic factors|mesh-ancestor
65387969|NCT00886496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387970|NCT00886496|Coagulants|coagulants|mesh-ancestor
65387971|NCT00884858|Maraviroc|maraviroc|mesh-list
65387972|NCT00884858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65387973|NCT00884858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65387974|NCT00884858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387975|NCT00884858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65387976|NCT00884858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65387977|NCT00884858|Antiviral Agents|antiviral agents|mesh-ancestor
65387978|NCT00884858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387979|NCT00884858|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65387980|NCT00891332|Leucovorin|leucovorin|mesh-list
65387981|NCT00891332|Antidotes|antidotes|mesh-ancestor
65387982|NCT00891332|Protective Agents|protective agents|mesh-ancestor
65387983|NCT00891332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387984|NCT00891332|Vitamin B Complex|vitamin b complex|mesh-ancestor
65387985|NCT00891332|Vitamins|vitamins|mesh-ancestor
65387986|NCT00891332|Micronutrients|micronutrients|mesh-ancestor
65387987|NCT00609362|Rosiglitazone|rosiglitazone|mesh-list
65387988|NCT00609362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65387989|NCT00609362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65387990|NCT04038008|Fluconazole|fluconazole|mesh-list
65387991|NCT04038008|Antifungal Agents|antifungal agents|mesh-ancestor
65387992|NCT04038008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65387993|NCT04038008|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65387994|NCT04038008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65387995|NCT04038008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65387996|NCT04038008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65387997|NCT04038008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65387998|NCT04038008|Hormone Antagonists|hormone antagonists|mesh-ancestor
65387999|NCT04038008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65388000|NCT04038008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388001|NCT04038008|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64556869|NCT04355637|Autonomic Agents|autonomic agents|mesh-ancestor
64321915|NCT00140855|Immunoglobulins|immunoglobulins|mesh-list
64670836|NCT01688102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670837|NCT01688102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64778504|NCT05718024|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64778505|NCT05718024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64778506|NCT05718024|Adrenergic Agents|adrenergic agents|mesh-ancestor
64778507|NCT05718024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64778508|NCT05718024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778509|NCT05718024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64778510|NCT05718024|Narcotics|narcotics|mesh-ancestor
64778511|NCT05718024|Antidepressive Agents|antidepressive agents|mesh-ancestor
64778512|NCT05718024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64778513|NCT05717790|Gemcitabine|gemcitabine|mesh-list
64389939|NCT02431975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389940|NCT02431975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65388002|NCT04038008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65388003|NCT00886574|Aspirin|aspirin|mesh-list
65388004|NCT00886574|Cilostazol|cilostazol|mesh-list
65388005|NCT00886574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65388006|NCT00886574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65388007|NCT00886574|Analgesics|analgesics|mesh-ancestor
65388008|NCT00886574|Sensory System Agents|sensory system agents|mesh-ancestor
65388042|NCT00137449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65388043|NCT00137449|Growth Substances|growth substances|mesh-ancestor
65388044|NCT00137449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388045|NCT00137449|Growth Inhibitors|growth inhibitors|mesh-ancestor
65388046|NCT00137449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65388047|NCT00137449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388048|NCT00137449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388049|NCT00886886|Reboxetine|reboxetine|mesh-list
65388050|NCT00886886|Antidepressive Agents|antidepressive agents|mesh-ancestor
65388051|NCT00886886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65388052|NCT00886886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65388053|NCT00886886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65388054|NCT00886886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65388055|NCT00886886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388056|NCT00886886|Adrenergic Agents|adrenergic agents|mesh-ancestor
65388057|NCT00886886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65388058|NCT00886886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388059|NCT00887042|Fludarabine|fludarabine|mesh-list
65388060|NCT00887042|Busulfan|busulfan|mesh-list
65388061|NCT00887042|Thymoglobulin|thymoglobulin|mesh-list
65388062|NCT00887042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388063|NCT00887042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388064|NCT00887042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65388065|NCT00887042|Immunologic Factors|immunologic factors|mesh-ancestor
65388066|NCT00887042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388067|NCT00887042|Alkylating Agents|alkylating agents|mesh-ancestor
65388068|NCT00887042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65388069|NCT00887042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65388070|NCT00892112|Plasma Substitutes|plasma substitutes|mesh-list
65388071|NCT00892112|Immunoglobulins|immunoglobulins|mesh-list
65388072|NCT00892112|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65388073|NCT00892112|Antibodies|antibodies|mesh-list
65388074|NCT00892112|gamma-Globulins|gamma-globulins|mesh-list
65388075|NCT00892112|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64778554|NCT05359068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64778555|NCT05359068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64778556|NCT05359068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388082|NCT00887120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65388083|NCT00887120|Protease Inhibitors|protease inhibitors|mesh-ancestor
65388084|NCT00887120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388085|NCT00887120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388086|NCT00887120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65388087|NCT00887120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65388088|NCT00887120|Antiviral Agents|antiviral agents|mesh-ancestor
65388089|NCT00887120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65388090|NCT00887120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65388091|NCT00887120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65388092|NCT00892190|Dasatinib|dasatinib|mesh-list
65388093|NCT00892190|Tretinoin|tretinoin|mesh-list
65388094|NCT00892190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388095|NCT00892190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65388096|NCT00892190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388097|NCT00892190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388098|NCT00892190|Keratolytic Agents|keratolytic agents|mesh-ancestor
65388099|NCT00892190|Dermatologic Agents|dermatologic agents|mesh-ancestor
65388100|NCT00887276|Amoxicillin|amoxicillin|mesh-list
65388101|NCT00887276|Moxifloxacin|moxifloxacin|mesh-list
65388102|NCT00887276|Ampicillin|ampicillin|mesh-list
65388103|NCT00887276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65388104|NCT00887276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65388105|NCT00887276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64670838|NCT01688102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64670839|NCT01994993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64670840|NCT01994993|Metronidazole|metronidazole|mesh-list
64670841|NCT01994993|Clindamycin|clindamycin|mesh-list
64670842|NCT01994993|Clindamycin palmitate|clindamycin palmitate|mesh-list
64670843|NCT01994993|Clindamycin phosphate|clindamycin phosphate|mesh-list
64670844|NCT01994993|Gentamicins|gentamicins|mesh-list
64670845|NCT01994993|Tazobactam|tazobactam|mesh-list
64670846|NCT01994993|Piperacillin|piperacillin|mesh-list
64670847|NCT01994993|Ampicillin|ampicillin|mesh-list
64670848|NCT01994993|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64670849|NCT01994993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64670850|NCT01994993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64670851|NCT01994993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64670852|NCT01994993|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64670854|NCT01994993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670855|NCT01994993|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64670856|NCT01688336|Leucovorin|leucovorin|mesh-list
64670857|NCT01688336|Oxaliplatin|oxaliplatin|mesh-list
64670858|NCT01688336|Irinotecan|irinotecan|mesh-list
64670859|NCT01688336|Folfirinox|folfirinox|mesh-list
65388106|NCT00887276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65388107|NCT00887276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388108|NCT00887276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388109|NCT00887276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388110|NCT00528879|Metformin|metformin|mesh-list
65388111|NCT00528879|Dapagliflozin|dapagliflozin|mesh-list
65388112|NCT00528879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65388113|NCT00528879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388114|NCT00528879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65388115|NCT00528879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388116|NCT00608894|Prednisone|prednisone|mesh-list
65388117|NCT00608894|Azathioprine|azathioprine|mesh-list
65388118|NCT00608894|Tacrolimus|tacrolimus|mesh-list
65388119|NCT00608894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65388120|NCT00608894|Glucocorticoids|glucocorticoids|mesh-ancestor
65388121|NCT00608894|Hormones|hormones|mesh-ancestor
65388122|NCT00608894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65388123|NCT00608894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388124|NCT00608894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65388125|NCT00608894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388126|NCT00608894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65388127|NCT00608894|Immunologic Factors|immunologic factors|mesh-ancestor
65388128|NCT00608894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65388129|NCT00608894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388130|NCT00608894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388154|NCT00892424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388155|NCT00892424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388156|NCT02541032|Minocycline|minocycline|mesh-list
65388157|NCT02541032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65388158|NCT02541032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65388159|NCT00892502|Bismuth|bismuth|mesh-list
65388160|NCT00892502|Antacids|antacids|mesh-ancestor
65388161|NCT00892502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388162|NCT00892502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65388163|NCT00885404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65388164|NCT00885404|Plasma-lyte 148|plasma-lyte 148|mesh-list
65388165|NCT00885404|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65388166|NCT00191113|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65388167|NCT00191113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65388168|NCT00191113|Medroxyprogesterone|medroxyprogesterone|mesh-list
65388169|NCT00191113|Estradiol|estradiol|mesh-list
65388170|NCT00191113|Hormones|hormones|mesh-ancestor
65388171|NCT00191113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65388172|NCT00191113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388173|NCT00191113|Estrogens|estrogens|mesh-ancestor
65388174|NCT00191113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65388175|NCT00191113|Contraceptive Agents|contraceptive agents|mesh-ancestor
65388176|NCT00191113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65388177|NCT00191113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65388178|NCT00191113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65388179|NCT00191113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65388180|NCT00191113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65388181|NCT00191113|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65388200|NCT03966235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388201|NCT03966235|Protective Agents|protective agents|mesh-ancestor
65388202|NCT03966235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388203|NCT03966235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65388204|NCT01077661|Nebivolol|nebivolol|mesh-list
65388205|NCT01077661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65388206|NCT01077661|Vasodilator Agents|vasodilator agents|mesh-ancestor
65388207|NCT01077661|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65388208|NCT01077661|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65388209|NCT01077661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65388210|NCT01077661|Adrenergic Agents|adrenergic agents|mesh-ancestor
65388211|NCT01077661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65137792|NCT04488237|Vitamin D|vitamin d|mesh-list
65388212|NCT01077661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388213|NCT01077661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388214|NCT00606320|Aripiprazole|aripiprazole|mesh-list
65388215|NCT00606320|Antidepressive Agents|antidepressive agents|mesh-ancestor
65388216|NCT00606320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65388217|NCT00606320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65388218|NCT00606320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65388219|NCT00606320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65388220|NCT00606320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388221|NCT00606320|Dopamine Agonists|dopamine agonists|mesh-ancestor
65388222|NCT00606320|Dopamine Agents|dopamine agents|mesh-ancestor
65388223|NCT00606320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65388224|NCT00606320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388245|NCT03966859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388246|NCT03966859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65388247|NCT03966859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65388248|NCT03966859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388249|NCT00528411|Aspirin|aspirin|mesh-list
65388250|NCT00528411|Clopidogrel|clopidogrel|mesh-list
65388251|NCT00528411|Ticagrelor|ticagrelor|mesh-list
65388252|NCT00528411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65388253|NCT00528411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65388254|NCT00528411|Analgesics|analgesics|mesh-ancestor
65388255|NCT00528411|Sensory System Agents|sensory system agents|mesh-ancestor
65388256|NCT00528411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65388257|NCT00528411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388258|NCT00528411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65388259|NCT00528411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65388260|NCT00528411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65388261|NCT00528411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65388262|NCT00528411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388263|NCT00528411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65388264|NCT00528411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65388265|NCT00528411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388266|NCT00528411|Antipyretics|antipyretics|mesh-ancestor
65388267|NCT00528411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65388268|NCT00528411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65388269|NCT00528411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65388270|NCT00528411|Purinergic Agents|purinergic agents|mesh-ancestor
65388271|NCT00528411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65388272|NCT00895544|Vaccines|vaccines|mesh-list
65388273|NCT00895544|Immunologic Factors|immunologic factors|mesh-ancestor
65388274|NCT00895544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388275|NCT00895778|Rocuronium|rocuronium|mesh-list
65388278|NCT00895778|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65388286|NCT00187135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65388287|NCT00187135|Anesthetics, General|anesthetics, general|mesh-ancestor
65388288|NCT00187135|Anesthetics|anesthetics|mesh-ancestor
65388289|NCT00187135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65388290|NCT00187135|Narcotics|narcotics|mesh-ancestor
65388291|NCT00187135|Analgesics|analgesics|mesh-ancestor
65388292|NCT00187135|Sensory System Agents|sensory system agents|mesh-ancestor
65388293|NCT00187135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65388294|NCT00187135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65388295|NCT00896402|Iodine|iodine|mesh-list
65388296|NCT00896402|Chlorhexidine|chlorhexidine|mesh-list
65388297|NCT00896402|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65388298|NCT00896402|Povidone-Iodine|povidone-iodine|mesh-list
65388299|NCT00896402|Povidone|povidone|mesh-list
65388300|NCT00896402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65388301|NCT00896402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65388302|NCT00896402|Disinfectants|disinfectants|mesh-ancestor
65388303|NCT00896402|Dermatologic Agents|dermatologic agents|mesh-ancestor
65388304|NCT00896402|Trace Elements|trace elements|mesh-ancestor
65388305|NCT00896402|Micronutrients|micronutrients|mesh-ancestor
65388306|NCT00896402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388307|NCT00896402|Plasma Substitutes|plasma substitutes|mesh-ancestor
65388308|NCT00896402|Blood Substitutes|blood substitutes|mesh-ancestor
65388309|NCT00560352|Dexamethasone|dexamethasone|mesh-list
65388310|NCT00560352|Bortezomib|bortezomib|mesh-list
65388311|NCT00560352|Dasatinib|dasatinib|mesh-list
65388312|NCT00560352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65388313|NCT00560352|Antiemetics|antiemetics|mesh-ancestor
65388314|NCT00560352|Autonomic Agents|autonomic agents|mesh-ancestor
65388315|NCT00560352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65388319|NCT00560352|Hormones|hormones|mesh-ancestor
65388335|NCT00892892|Sympatholytics|sympatholytics|mesh-ancestor
65388336|NCT00892892|Autonomic Agents|autonomic agents|mesh-ancestor
65388337|NCT00892892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65388338|NCT00892892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65388339|NCT00892892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65388340|NCT00892892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65388341|NCT00892892|Adrenergic Agents|adrenergic agents|mesh-ancestor
65388342|NCT00892892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65388343|NCT00944814|Zinc|zinc|mesh-list
65388344|NCT00944814|Trace Elements|trace elements|mesh-ancestor
65388345|NCT00944814|Micronutrients|micronutrients|mesh-ancestor
65388346|NCT00944814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388347|NCT00527787|Naproxen|naproxen|mesh-list
65388348|NCT00527787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65388349|NCT00527787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65388350|NCT00527787|Analgesics|analgesics|mesh-ancestor
65388351|NCT00527787|Sensory System Agents|sensory system agents|mesh-ancestor
65388352|NCT00527787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65388353|NCT00527787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388354|NCT00527787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65388355|NCT00527787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65388356|NCT00527787|Gout Suppressants|gout suppressants|mesh-ancestor
65388357|NCT00527787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65388358|NCT00527787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388359|NCT00527787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388360|NCT00893048|Prednisone|prednisone|mesh-list
65388361|NCT00893048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65388362|NCT00893048|Glucocorticoids|glucocorticoids|mesh-ancestor
65388363|NCT00893048|Hormones|hormones|mesh-ancestor
65388364|NCT00893048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64670860|NCT01688336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670881|NCT01963481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64670882|NCT01963481|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64670883|NCT01963481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64670884|NCT01963481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670887|NCT01963481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64670889|NCT04436744|Anastrozole|anastrozole|mesh-list
64670890|NCT04436744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556870|NCT04355637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556871|NCT04355637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556872|NCT04355637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64556873|NCT04355637|Respiratory System Agents|respiratory system agents|mesh-ancestor
64556874|NCT04355637|Glucocorticoids|glucocorticoids|mesh-ancestor
64556875|NCT04355637|Hormones|hormones|mesh-ancestor
64778718|NCT03179436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64778719|NCT03179436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388365|NCT00893048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388366|NCT00893048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65388367|NCT00893048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388368|NCT00942864|Ranibizumab|ranibizumab|mesh-list
65388369|NCT00942864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64778720|NCT03149874|Vaccines|vaccines|mesh-list
64778721|NCT03149874|Immunologic Factors|immunologic factors|mesh-ancestor
64778722|NCT03149874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778723|NCT02834052|Poly I-C|poly i-c|mesh-list
64778724|NCT02834052|Pembrolizumab|pembrolizumab|mesh-list
65388370|NCT00942864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65388371|NCT00942864|Growth Substances|growth substances|mesh-ancestor
65388372|NCT00942864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388373|NCT00942864|Growth Inhibitors|growth inhibitors|mesh-ancestor
65388374|NCT00942864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388375|NCT04036448|Lenalidomide|lenalidomide|mesh-list
65388376|NCT04036448|Immunologic Factors|immunologic factors|mesh-ancestor
65388377|NCT04036448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388378|NCT04036448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65388379|NCT04036448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65388380|NCT04036448|Growth Substances|growth substances|mesh-ancestor
65388381|NCT04036448|Growth Inhibitors|growth inhibitors|mesh-ancestor
65388382|NCT04036448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388383|NCT00896558|Midazolam|midazolam|mesh-list
65388384|NCT00896558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65388385|NCT00896558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64778733|NCT02834052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64778734|NCT02834052|Antiviral Agents|antiviral agents|mesh-ancestor
64778735|NCT02834052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64778736|NCT02828358|Calcium, Dietary|calcium, dietary|mesh-list
64778737|NCT02828358|Leucovorin|leucovorin|mesh-list
64778738|NCT02828358|Folic Acid|folic acid|mesh-list
64778739|NCT02828358|Cytarabine|cytarabine|mesh-list
64778740|NCT02828358|Dexamethasone|dexamethasone|mesh-list
65388404|NCT00943176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388406|NCT00129259|Trace Elements|trace elements|mesh-ancestor
65388407|NCT00129259|Micronutrients|micronutrients|mesh-ancestor
65388408|NCT00129259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388409|NCT00896714|Anesthetics|anesthetics|mesh-list
65388410|NCT00896714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65388411|NCT00896714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388412|NCT00940524|Cytarabine|cytarabine|mesh-list
65388413|NCT00940524|Cyclophosphamide|cyclophosphamide|mesh-list
65388414|NCT00940524|Methotrexate|methotrexate|mesh-list
65388415|NCT00940524|Etoposide|etoposide|mesh-list
65388416|NCT00940524|Asparaginase|asparaginase|mesh-list
65388417|NCT00940524|Dasatinib|dasatinib|mesh-list
65388418|NCT00940524|Mitoxantrone|mitoxantrone|mesh-list
65388419|NCT00940524|Pegaspargase|pegaspargase|mesh-list
65388420|NCT00940524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65388421|NCT00940524|Immunologic Factors|immunologic factors|mesh-ancestor
65388422|NCT00940524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388423|NCT00940524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65388424|NCT00940524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65388425|NCT00940524|Alkylating Agents|alkylating agents|mesh-ancestor
65388426|NCT00940524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388427|NCT00940524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388428|NCT00940524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65388429|NCT00940524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65388430|NCT00940524|Abortifacient Agents|abortifacient agents|mesh-ancestor
65388431|NCT00940524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65388433|NCT00940524|Antimetabolites|antimetabolites|mesh-ancestor
64778746|NCT02828358|Prednisolone acetate|prednisolone acetate|mesh-list
64778747|NCT02828358|Hydrocortisone|hydrocortisone|mesh-list
64778748|NCT02828358|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64778749|NCT02828358|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64778750|NCT02828358|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64778751|NCT02828358|Cortisone|cortisone|mesh-list
64778752|NCT02828358|Cyclophosphamide|cyclophosphamide|mesh-list
65388437|NCT00940524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65388438|NCT00940524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65388439|NCT00940524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65388440|NCT00940524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65388441|NCT00940524|Antiviral Agents|antiviral agents|mesh-ancestor
65388442|NCT00940524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65388443|NCT00940524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65388444|NCT00940524|Analgesics|analgesics|mesh-ancestor
65388445|NCT00940524|Sensory System Agents|sensory system agents|mesh-ancestor
65388446|NCT00940524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65388447|NCT00186901|Vitamin D|vitamin d|mesh-list
65388448|NCT00186901|Calcium Carbonate|calcium carbonate|mesh-list
65388449|NCT00186901|Calcium|calcium|mesh-list
65388450|NCT00186901|Vitamins|vitamins|mesh-ancestor
65388451|NCT00186901|Micronutrients|micronutrients|mesh-ancestor
65388452|NCT00186901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388453|NCT00186901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65388454|NCT00186901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65388455|NCT00186901|Antacids|antacids|mesh-ancestor
65388456|NCT00186901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388457|NCT00186901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65388458|NCT00943410|Trastuzumab|trastuzumab|mesh-list
65388459|NCT00943410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65388461|NCT00896948|Antibodies|antibodies|mesh-list
65388474|NCT00186121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65388475|NCT00186121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388476|NCT00897026|Paclitaxel|paclitaxel|mesh-list
65388477|NCT00897026|Cyclophosphamide|cyclophosphamide|mesh-list
65388478|NCT00897026|Doxorubicin|doxorubicin|mesh-list
65388479|NCT00897026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65388480|NCT00897026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65388481|NCT00897026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388482|NCT00897026|Tubulin Modulators|tubulin modulators|mesh-ancestor
65388483|NCT00897026|Antimitotic Agents|antimitotic agents|mesh-ancestor
65388484|NCT00897026|Mitosis Modulators|mitosis modulators|mesh-ancestor
65388485|NCT00897026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388486|NCT00897026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65388487|NCT00897026|Immunologic Factors|immunologic factors|mesh-ancestor
65388488|NCT00897026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388489|NCT00897026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65388490|NCT00897026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65388491|NCT00897026|Alkylating Agents|alkylating agents|mesh-ancestor
65388492|NCT00897026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65388493|NCT00897026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65388494|NCT00897026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65388495|NCT00897026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65388496|NCT00897026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388497|NCT00186043|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65388498|NCT00186043|Antidepressive Agents|antidepressive agents|mesh-ancestor
65388499|NCT00186043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65388520|NCT03875313|Talazoparib|talazoparib|mesh-list
65388521|NCT03875313|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65388522|NCT03875313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388523|NCT03875313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388524|NCT03875313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388525|NCT01008345|Ezetimibe|ezetimibe|mesh-list
65388526|NCT01008345|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65388527|NCT01008345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65388528|NCT01008345|Antimetabolites|antimetabolites|mesh-ancestor
65388529|NCT01008345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388530|NCT01008345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65388531|NCT05239533|Nivolumab|nivolumab|mesh-list
65388532|NCT05239533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65388533|NCT05239533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65388534|NCT05239533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388535|NCT05239533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65388536|NCT05239533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388537|NCT05239533|Immunologic Factors|immunologic factors|mesh-ancestor
65388538|NCT05239533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388539|NCT04828083|Lidocaine|lidocaine|mesh-list
65388540|NCT04828083|Anesthetics, Local|anesthetics, local|mesh-ancestor
65388541|NCT04828083|Anesthetics|anesthetics|mesh-ancestor
65388542|NCT04828083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65388543|NCT04828083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388544|NCT04828083|Sensory System Agents|sensory system agents|mesh-ancestor
65388545|NCT04828083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65388546|NCT04828083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65388547|NCT04828083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65388548|NCT04828083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65388549|NCT04828083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65388550|NCT04828083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388551|NCT05225961|Aspirin|aspirin|mesh-list
65388552|NCT05225961|Tirofiban|tirofiban|mesh-list
65388553|NCT05225961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65388554|NCT05225961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65388557|NCT05225961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65388558|NCT05225961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388559|NCT05225961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65388560|NCT05225961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65388561|NCT05225961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65388562|NCT05225961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65388563|NCT05225961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388564|NCT05225961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65388565|NCT05225961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65388566|NCT05225961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388567|NCT05225961|Antipyretics|antipyretics|mesh-ancestor
65388568|NCT00556998|Voriconazole|voriconazole|mesh-list
65388569|NCT00556998|Antifungal Agents|antifungal agents|mesh-ancestor
65388570|NCT00556998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65388571|NCT00556998|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65388572|NCT00556998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65388573|NCT00556998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388574|NCT00556998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388575|NCT00556998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65388576|NCT00556998|Hormone Antagonists|hormone antagonists|mesh-ancestor
65388577|NCT00556998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65388578|NCT00556998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388579|NCT00556998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65388580|NCT00945360|Letrozole|letrozole|mesh-list
65388581|NCT00945360|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65388582|NCT00945360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388583|NCT00945360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65388584|NCT00945360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388585|NCT00945360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388586|NCT00945360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65388587|NCT00945360|Hormone Antagonists|hormone antagonists|mesh-ancestor
65388591|NCT00943566|Morphine|morphine|mesh-list
65388596|NCT00943566|Analgesics|analgesics|mesh-ancestor
65388597|NCT00943566|Sensory System Agents|sensory system agents|mesh-ancestor
65388598|NCT00943566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65388599|NCT00943566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65388600|NCT00943566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65388601|NCT00943566|Anesthetics, General|anesthetics, general|mesh-ancestor
65388602|NCT00943566|Anesthetics|anesthetics|mesh-ancestor
65388603|NCT00940680|Losartan|losartan|mesh-list
65388604|NCT00940680|Amlodipine|amlodipine|mesh-list
65388605|NCT00940680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65388606|NCT00940680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65388607|NCT00940680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65388608|NCT00940680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388609|NCT00940680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65388610|NCT00940680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388611|NCT00940680|Vasodilator Agents|vasodilator agents|mesh-ancestor
65388612|NCT00940680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65388613|NCT00940680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65388614|NCT00940680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65388615|NCT00945438|Vaccines|vaccines|mesh-list
65388616|NCT00945438|Immunologic Factors|immunologic factors|mesh-ancestor
65388617|NCT00945438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388618|NCT00527397|Insulin|insulin|mesh-list
65388619|NCT00527397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65388620|NCT00527397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388621|NCT00943956|Everolimus|everolimus|mesh-list
64778914|NCT05722548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64778915|NCT05722548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778917|NCT05722002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64778918|NCT05722002|Analgesics|analgesics|mesh-ancestor
64778919|NCT05722002|Sensory System Agents|sensory system agents|mesh-ancestor
64778920|NCT05722002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65388645|NCT00134719|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65388646|NCT00134719|Immunologic Factors|immunologic factors|mesh-ancestor
65388647|NCT00134719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388648|NCT00940836|Acetaminophen|acetaminophen|mesh-list
65388649|NCT00940836|Chlorpheniramine|chlorpheniramine|mesh-list
65388650|NCT00940836|Phenylephrine|phenylephrine|mesh-list
65388651|NCT00940836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65388652|NCT00940836|Analgesics|analgesics|mesh-ancestor
65388653|NCT00940836|Sensory System Agents|sensory system agents|mesh-ancestor
65388654|NCT00940836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65388655|NCT00940836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388656|NCT00940836|Antipyretics|antipyretics|mesh-ancestor
65388657|NCT00940836|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65388658|NCT00940836|Mydriatics|mydriatics|mesh-ancestor
65388659|NCT00940836|Autonomic Agents|autonomic agents|mesh-ancestor
65388660|NCT00940836|Sympathomimetics|sympathomimetics|mesh-ancestor
65388661|NCT00940836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65388662|NCT00940836|Nasal Decongestants|nasal decongestants|mesh-ancestor
65388663|NCT00940836|Respiratory System Agents|respiratory system agents|mesh-ancestor
65388664|NCT00940836|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65388666|NCT00940836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65388687|NCT00944424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388688|NCT00944424|Tubulin Modulators|tubulin modulators|mesh-ancestor
65388689|NCT00944424|Antimitotic Agents|antimitotic agents|mesh-ancestor
65388690|NCT00944424|Mitosis Modulators|mitosis modulators|mesh-ancestor
65388691|NCT00944424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388692|NCT00944424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65388693|NCT00944424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65388694|NCT04591353|Lidocaine|lidocaine|mesh-list
65388695|NCT04591353|Anesthetics, Local|anesthetics, local|mesh-ancestor
65388696|NCT04591353|Anesthetics|anesthetics|mesh-ancestor
65388697|NCT04591353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65388698|NCT04591353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388699|NCT04591353|Sensory System Agents|sensory system agents|mesh-ancestor
65388700|NCT04591353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65388701|NCT04591353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65388702|NCT04591353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65388703|NCT04591353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65388704|NCT04591353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65388705|NCT04591353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388706|NCT00944502|Dexamethasone|dexamethasone|mesh-list
65388707|NCT00944502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65388708|NCT00944502|Antiemetics|antiemetics|mesh-ancestor
65388709|NCT00944502|Autonomic Agents|autonomic agents|mesh-ancestor
64778952|NCT05719818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64778953|NCT05719818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778954|NCT05719506|Dexmedetomidine|dexmedetomidine|mesh-list
65388735|NCT00946374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388736|NCT00946374|Immunologic Factors|immunologic factors|mesh-ancestor
65388737|NCT00946374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388738|NCT00946374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65388739|NCT00946374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65388740|NCT00946374|Antifungal Agents|antifungal agents|mesh-ancestor
65388741|NCT00946374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65388742|NCT00946374|Dermatologic Agents|dermatologic agents|mesh-ancestor
65388743|NCT00946374|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65388744|NCT05068791|Dextromethorphan|dextromethorphan|mesh-list
65388745|NCT05068791|Psilocybin|psilocybin|mesh-list
65388746|NCT05068791|Antitussive Agents|antitussive agents|mesh-ancestor
65388747|NCT05068791|Respiratory System Agents|respiratory system agents|mesh-ancestor
65388748|NCT05068791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65388749|NCT05068791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65388750|NCT05068791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65388751|NCT05068791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388752|NCT05068791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388753|NCT05068791|Hallucinogens|hallucinogens|mesh-ancestor
65388754|NCT05068791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65388755|NCT00950196|Amantadine|amantadine|mesh-list
65388756|NCT00950196|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65388757|NCT00950196|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65388758|NCT00950196|Antiviral Agents|antiviral agents|mesh-ancestor
65388759|NCT00950196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65388760|NCT00950196|Dopamine Agents|dopamine agents|mesh-ancestor
65388761|NCT00950196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65388763|NCT00950196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388774|NCT00525915|Fluorouracil|fluorouracil|mesh-list
65388775|NCT00525915|Oxaliplatin|oxaliplatin|mesh-list
65388776|NCT00525915|Antimetabolites|antimetabolites|mesh-ancestor
65388777|NCT00525915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388778|NCT00525915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65388779|NCT00525915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388780|NCT00525915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65388781|NCT00525915|Immunologic Factors|immunologic factors|mesh-ancestor
65388782|NCT00525915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388783|NCT03143153|Fluorouracil|fluorouracil|mesh-list
65388784|NCT03143153|Nivolumab|nivolumab|mesh-list
65388785|NCT03143153|Ipilimumab|ipilimumab|mesh-list
65388786|NCT03143153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388787|NCT03143153|Antimetabolites|antimetabolites|mesh-ancestor
65388788|NCT03143153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388789|NCT03143153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65388790|NCT03143153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65388791|NCT03143153|Immunologic Factors|immunologic factors|mesh-ancestor
65388792|NCT03143153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388793|NCT03143153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65388794|NCT03143153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65388795|NCT00521001|Everolimus|everolimus|mesh-list
65388796|NCT00521001|Temozolomide|temozolomide|mesh-list
65388797|NCT00521001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388798|NCT00521001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65388799|NCT00521001|Immunologic Factors|immunologic factors|mesh-ancestor
65388800|NCT00521001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388801|NCT00521001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65388802|NCT00521001|Alkylating Agents|alkylating agents|mesh-ancestor
65388819|NCT03966547|Sensory System Agents|sensory system agents|mesh-ancestor
65388820|NCT03966547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65388821|NCT01326325|Ketamine|ketamine|mesh-list
65388822|NCT01326325|Analgesics|analgesics|mesh-ancestor
65388823|NCT01326325|Sensory System Agents|sensory system agents|mesh-ancestor
65388824|NCT01326325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65388825|NCT01326325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388826|NCT01326325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65388827|NCT01326325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65388828|NCT01326325|Anesthetics, General|anesthetics, general|mesh-ancestor
65388829|NCT01326325|Anesthetics|anesthetics|mesh-ancestor
65388830|NCT01326325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65388831|NCT01326325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65388832|NCT01326325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65388833|NCT01326325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65388834|NCT01326325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388835|NCT01326403|Tranexamic Acid|tranexamic acid|mesh-list
65388836|NCT01326403|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65388837|NCT01326403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65388838|NCT01326403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388839|NCT01326403|Hemostatics|hemostatics|mesh-ancestor
65388840|NCT01326403|Coagulants|coagulants|mesh-ancestor
65388841|NCT00520845|Celecoxib|celecoxib|mesh-list
65388842|NCT00520845|Docetaxel|docetaxel|mesh-list
65388843|NCT00520845|Pemetrexed|pemetrexed|mesh-list
65388844|NCT00520845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388845|NCT00520845|Tubulin Modulators|tubulin modulators|mesh-ancestor
65388846|NCT00520845|Antimitotic Agents|antimitotic agents|mesh-ancestor
65388847|NCT00520845|Mitosis Modulators|mitosis modulators|mesh-ancestor
65388848|NCT00520845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388849|NCT00520845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388850|NCT00520845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65388851|NCT00520845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65388853|NCT00520845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65388859|NCT00520845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65388860|NCT00520845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65388861|NCT00520845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65388862|NCT00185731|Atorvastatin|atorvastatin|mesh-list
65388863|NCT00185731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65388864|NCT00185731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65388865|NCT00185731|Antimetabolites|antimetabolites|mesh-ancestor
65388866|NCT00185731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388867|NCT00185731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65388868|NCT00185731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65388869|NCT00185731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388870|NCT00582491|Modafinil|modafinil|mesh-list
65388871|NCT00582491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65388872|NCT00582491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388873|NCT00582491|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65388874|NCT00582491|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65388875|NCT00582491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65388876|NCT00582491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388877|NCT00520767|Dexamethasone|dexamethasone|mesh-list
65388878|NCT00520767|Dexamethasone acetate|dexamethasone acetate|mesh-list
65388879|NCT00520767|Bortezomib|bortezomib|mesh-list
65388880|NCT00520767|Melphalan|melphalan|mesh-list
65388881|NCT00520767|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65388882|NCT00520767|BB 1101|bb 1101|mesh-list
65388883|NCT00520767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65388884|NCT00520767|Antiemetics|antiemetics|mesh-ancestor
65388885|NCT00520767|Autonomic Agents|autonomic agents|mesh-ancestor
65388886|NCT00520767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65388887|NCT00520767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388888|NCT00520767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65388889|NCT00520767|Glucocorticoids|glucocorticoids|mesh-ancestor
65388890|NCT00520767|Hormones|hormones|mesh-ancestor
65388893|NCT00520767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388899|NCT00520767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65388900|NCT00520767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65388901|NCT00520767|Immunologic Factors|immunologic factors|mesh-ancestor
65388902|NCT03873987|Oritavancin|oritavancin|mesh-list
65388903|NCT03873987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65388904|NCT03873987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65388905|NCT02579681|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65388906|NCT02579681|Dermatologic Agents|dermatologic agents|mesh-ancestor
65388907|NCT02579681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65388908|NCT02579681|Immunologic Factors|immunologic factors|mesh-ancestor
65388909|NCT02579681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388910|NCT00528645|Saracatinib|saracatinib|mesh-list
65388911|NCT00528645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388912|NCT00528645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388913|NCT00528645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388914|NCT01017796|Ascorbic Acid|ascorbic acid|mesh-list
65388915|NCT01017796|Acetylcysteine|acetylcysteine|mesh-list
65388916|NCT01017796|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65388917|NCT01017796|Antiviral Agents|antiviral agents|mesh-ancestor
65388918|NCT01017796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65388919|NCT01017796|Expectorants|expectorants|mesh-ancestor
65388920|NCT01017796|Respiratory System Agents|respiratory system agents|mesh-ancestor
65388921|NCT01017796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65388922|NCT01017796|Antioxidants|antioxidants|mesh-ancestor
65388923|NCT01017796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388924|NCT01017796|Protective Agents|protective agents|mesh-ancestor
65388926|NCT01017796|Antidotes|antidotes|mesh-ancestor
65388950|NCT01783535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65388951|NCT01783535|Tubulin Modulators|tubulin modulators|mesh-ancestor
65388952|NCT01783535|Antimitotic Agents|antimitotic agents|mesh-ancestor
65388953|NCT01783535|Mitosis Modulators|mitosis modulators|mesh-ancestor
65388954|NCT01783535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65388955|NCT04073537|Paclitaxel|paclitaxel|mesh-list
65388956|NCT04073537|Carboplatin|carboplatin|mesh-list
65388957|NCT04073537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65388958|NCT04073537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388959|NCT04073537|Tubulin Modulators|tubulin modulators|mesh-ancestor
65388960|NCT04073537|Antimitotic Agents|antimitotic agents|mesh-ancestor
65388961|NCT04073537|Mitosis Modulators|mitosis modulators|mesh-ancestor
65388962|NCT04073537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388963|NCT01020994|Octenidine|octenidine|mesh-list
65388964|NCT01020994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65388965|NCT01020994|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65388966|NCT00494026|Carboplatin|carboplatin|mesh-list
65388967|NCT00494026|Pemetrexed|pemetrexed|mesh-list
65388968|NCT00494026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388969|NCT00494026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65388970|NCT00494026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388971|NCT00494026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65388972|NCT00494026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65388973|NCT00524589|Calcitriol|calcitriol|mesh-list
65388974|NCT00524589|Dexamethasone|dexamethasone|mesh-list
65388975|NCT00524589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65388976|NCT00524589|Antiemetics|antiemetics|mesh-ancestor
65388977|NCT00524589|Autonomic Agents|autonomic agents|mesh-ancestor
65388978|NCT00524589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65388979|NCT00524589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65388980|NCT00524589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65388981|NCT00524589|Glucocorticoids|glucocorticoids|mesh-ancestor
65388982|NCT00524589|Hormones|hormones|mesh-ancestor
65388983|NCT00524589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65388984|NCT00524589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65388985|NCT00524589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65388989|NCT00524589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65388990|NCT00524589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65388991|NCT00524589|Vitamins|vitamins|mesh-ancestor
65388992|NCT00524589|Micronutrients|micronutrients|mesh-ancestor
65388993|NCT00524589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65388994|NCT01015066|Naltrexone|naltrexone|mesh-list
65388995|NCT01015066|Buprenorphine|buprenorphine|mesh-list
65388996|NCT01015066|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65388997|NCT01015066|Naloxone|naloxone|mesh-list
65388998|NCT01015066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65388999|NCT01015066|Narcotics|narcotics|mesh-ancestor
65389000|NCT01015066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65389001|NCT01015066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389002|NCT01015066|Analgesics|analgesics|mesh-ancestor
65389003|NCT01015066|Sensory System Agents|sensory system agents|mesh-ancestor
65389004|NCT01015066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389005|NCT01015066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65389006|NCT01015066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65389007|NCT00472030|Omalizumab|omalizumab|mesh-list
65389008|NCT00472030|Prednisone|prednisone|mesh-list
65389009|NCT00472030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65389010|NCT00472030|Glucocorticoids|glucocorticoids|mesh-ancestor
65389011|NCT00472030|Hormones|hormones|mesh-ancestor
65389012|NCT00472030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65389013|NCT00472030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389014|NCT00472030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65389015|NCT00472030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389016|NCT00472030|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65389017|NCT00472030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65389018|NCT00472030|Respiratory System Agents|respiratory system agents|mesh-ancestor
65389019|NCT00127855|Vaccines|vaccines|mesh-list
65389020|NCT00127855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65389021|NCT00127855|Immunologic Factors|immunologic factors|mesh-ancestor
65389032|NCT00493636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389033|NCT00493636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65389034|NCT00493636|Immunologic Factors|immunologic factors|mesh-ancestor
65389035|NCT00493636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389036|NCT00493636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65389037|NCT00524121|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65389038|NCT00524121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389039|NCT00524121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65389040|NCT00524121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389041|NCT00524121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389042|NCT04207060|Indomethacin|indomethacin|mesh-list
65389043|NCT04207060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65389044|NCT04207060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65389045|NCT04207060|Analgesics|analgesics|mesh-ancestor
65389046|NCT04207060|Sensory System Agents|sensory system agents|mesh-ancestor
65389047|NCT04207060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389048|NCT04207060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389049|NCT04207060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65389050|NCT04207060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65389051|NCT04207060|Gout Suppressants|gout suppressants|mesh-ancestor
65389052|NCT04207060|Tocolytic Agents|tocolytic agents|mesh-ancestor
65389053|NCT04207060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65389054|NCT04207060|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65389055|NCT04207060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389056|NCT04207060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389057|NCT01018342|Nitrofurantoin|nitrofurantoin|mesh-list
65389058|NCT01018342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65389059|NCT01018342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65389060|NCT01018342|Renal Agents|renal agents|mesh-ancestor
65389061|NCT01018342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65389062|NCT03965767|Tranexamic Acid|tranexamic acid|mesh-list
65389063|NCT03965767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64670891|NCT04436744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64670892|NCT04436744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670893|NCT04436744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670894|NCT04436744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64670895|NCT04436744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64670896|NCT04436744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64670897|NCT04436744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64670898|NCT04436744|Hormone Antagonists|hormone antagonists|mesh-ancestor
65389064|NCT03965767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65389065|NCT03965767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389066|NCT03965767|Hemostatics|hemostatics|mesh-ancestor
65389067|NCT03965767|Coagulants|coagulants|mesh-ancestor
65389068|NCT00133705|Mifepristone|mifepristone|mesh-list
65389069|NCT00133705|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65389070|NCT00133705|Abortifacient Agents|abortifacient agents|mesh-ancestor
65389071|NCT00133705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65389072|NCT00133705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389073|NCT00133705|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65389074|NCT00133705|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65389075|NCT00133705|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65389076|NCT00133705|Contraceptive Agents|contraceptive agents|mesh-ancestor
65389077|NCT00133705|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65389078|NCT00133705|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65389079|NCT00133705|Hormone Antagonists|hormone antagonists|mesh-ancestor
65389080|NCT00133705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65389122|NCT00132691|Dermatologic Agents|dermatologic agents|mesh-ancestor
65389123|NCT00132691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389124|NCT00132691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65389125|NCT00132691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65389126|NCT00132691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65389127|NCT00132691|Antifungal Agents|antifungal agents|mesh-ancestor
65389128|NCT00132691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65389129|NCT00132691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65389130|NCT00132691|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65389131|NCT00132691|Antitubercular Agents|antitubercular agents|mesh-ancestor
65389132|NCT00132691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65389133|NCT00132691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65389134|NCT00132691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65389135|NCT00132691|Glucocorticoids|glucocorticoids|mesh-ancestor
65389136|NCT00132691|Hormones|hormones|mesh-ancestor
65389137|NCT00132691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65389138|NCT02390427|Paclitaxel|paclitaxel|mesh-list
65389139|NCT02390427|Maytansine|maytansine|mesh-list
65389140|NCT02390427|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65389141|NCT02390427|Trastuzumab|trastuzumab|mesh-list
65389142|NCT02390427|Pertuzumab|pertuzumab|mesh-list
65389143|NCT02390427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65389144|NCT02390427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389145|NCT02390427|Tubulin Modulators|tubulin modulators|mesh-ancestor
65389146|NCT02390427|Antimitotic Agents|antimitotic agents|mesh-ancestor
65389147|NCT02390427|Mitosis Modulators|mitosis modulators|mesh-ancestor
65389148|NCT02390427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389149|NCT02390427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65389150|NCT00125359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65389151|NCT00125359|Bexarotene|bexarotene|mesh-list
65389152|NCT00125359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389153|NCT00125359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64779231|NCT05312892|Vasodilator Agents|vasodilator agents|mesh-ancestor
64779232|NCT05309616|Ixekizumab|ixekizumab|mesh-list
64779233|NCT05309616|Dermatologic Agents|dermatologic agents|mesh-ancestor
64779234|NCT05307198|Capecitabine|capecitabine|mesh-list
64779235|NCT05307198|Oxaliplatin|oxaliplatin|mesh-list
64779236|NCT05307198|Antibodies|antibodies|mesh-list
64779237|NCT05307198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64779238|NCT05307198|Immunologic Factors|immunologic factors|mesh-ancestor
64779239|NCT05307198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779240|NCT05307198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64779241|NCT05307198|Antimetabolites|antimetabolites|mesh-ancestor
64779242|NCT05307198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779243|NCT05307198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389164|NCT00524043|Serotonin Agents|serotonin agents|mesh-ancestor
65389165|NCT00524043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65389166|NCT00524043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389167|NCT00524043|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65389168|NCT00524043|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65389169|NCT00524043|Dopamine Agents|dopamine agents|mesh-ancestor
65389170|NCT01076803|Lanreotide|lanreotide|mesh-list
65389171|NCT01076803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389172|NCT00523419|Pemetrexed|pemetrexed|mesh-list
65389204|NCT03865407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389205|NCT00487942|Modafinil|modafinil|mesh-list
65389206|NCT00487942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65389207|NCT00487942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389208|NCT00487942|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65389209|NCT00487942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65389210|NCT00487942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65389211|NCT00487942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389212|NCT00132301|Prednisone|prednisone|mesh-list
65389213|NCT00132301|Docetaxel|docetaxel|mesh-list
65389214|NCT00132301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389215|NCT00132301|Tubulin Modulators|tubulin modulators|mesh-ancestor
65389216|NCT00132301|Antimitotic Agents|antimitotic agents|mesh-ancestor
65389217|NCT00132301|Mitosis Modulators|mitosis modulators|mesh-ancestor
65389218|NCT00132301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389219|NCT00132301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65389220|NCT00132301|Glucocorticoids|glucocorticoids|mesh-ancestor
65389221|NCT00132301|Hormones|hormones|mesh-ancestor
65389222|NCT00132301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65389223|NCT00132301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389224|NCT00132301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65389225|NCT00519831|Cetuximab|cetuximab|mesh-list
65389226|NCT00519831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65389227|NCT00519831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389228|NCT04303845|Erenumab|erenumab|mesh-list
65389229|NCT04303845|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65389230|NCT04303845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389231|NCT04303845|Analgesics|analgesics|mesh-ancestor
65389232|NCT04303845|Sensory System Agents|sensory system agents|mesh-ancestor
65389233|NCT04303845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389234|NCT04303845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389235|NCT04187703|Azacitidine|azacitidine|mesh-list
65389236|NCT04187703|Decitabine|decitabine|mesh-list
64779265|NCT05251038|Leucovorin|leucovorin|mesh-list
64670899|NCT04436744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64670900|NCT04436744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670901|NCT01963793|Aprepitant|aprepitant|mesh-list
64670902|NCT01963793|Fosaprepitant|fosaprepitant|mesh-list
65389237|NCT04187703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65389238|NCT04187703|Antimetabolites|antimetabolites|mesh-ancestor
65389239|NCT04187703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389240|NCT04187703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389241|NCT04187703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389242|NCT00131911|Sorafenib|sorafenib|mesh-list
65389243|NCT00131911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389244|NCT00131911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65389245|NCT00131911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389246|NCT00131911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389247|NCT00184093|Gemcitabine|gemcitabine|mesh-list
65389248|NCT00184093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65389249|NCT00184093|Antimetabolites|antimetabolites|mesh-ancestor
65389250|NCT00184093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389251|NCT00184093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389252|NCT00184093|Antiviral Agents|antiviral agents|mesh-ancestor
65389253|NCT00184093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65389254|NCT00184093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389255|NCT00184093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65389256|NCT00184093|Immunologic Factors|immunologic factors|mesh-ancestor
65389257|NCT00184093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389258|NCT01074619|Memantine|memantine|mesh-list
65389259|NCT01074619|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65389260|NCT01074619|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65389261|NCT01074619|Dopamine Agents|dopamine agents|mesh-ancestor
65389262|NCT01074619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65389267|NCT00183625|Olanzapine|olanzapine|mesh-list
65389285|NCT00183625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65389286|NCT00183625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65389287|NCT00511875|Doxycycline|doxycycline|mesh-list
65389288|NCT00511875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65389289|NCT00511875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65389290|NCT00511875|Antimalarials|antimalarials|mesh-ancestor
65389291|NCT00511875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65389292|NCT00511875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65389293|NCT02576327|Dexamethasone|dexamethasone|mesh-list
65389294|NCT02576327|Dexamethasone acetate|dexamethasone acetate|mesh-list
65389295|NCT02576327|Aprepitant|aprepitant|mesh-list
65389296|NCT02576327|Tropisetron|tropisetron|mesh-list
65389297|NCT02576327|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65389298|NCT02576327|BB 1101|bb 1101|mesh-list
65389299|NCT02576327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65389300|NCT02576327|Antiemetics|antiemetics|mesh-ancestor
65389301|NCT02576327|Autonomic Agents|autonomic agents|mesh-ancestor
65389302|NCT02576327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389303|NCT02576327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389304|NCT02576327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65389305|NCT02576327|Glucocorticoids|glucocorticoids|mesh-ancestor
65389306|NCT02576327|Hormones|hormones|mesh-ancestor
65389307|NCT02576327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65389308|NCT02576327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65389309|NCT02576327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389310|NCT02576327|Protease Inhibitors|protease inhibitors|mesh-ancestor
65389311|NCT02576327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389312|NCT02576327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389313|NCT02576327|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65389314|NCT02576327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65389329|NCT00183391|Adrenergic Agents|adrenergic agents|mesh-ancestor
65389330|NCT00493246|Acetaminophen|acetaminophen|mesh-list
65389331|NCT00493246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65389332|NCT00493246|Analgesics|analgesics|mesh-ancestor
65389333|NCT00493246|Sensory System Agents|sensory system agents|mesh-ancestor
65138914|NCT05140655|Fulvestrant|fulvestrant|mesh-list
65389334|NCT00493246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389335|NCT00493246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389336|NCT00493246|Antipyretics|antipyretics|mesh-ancestor
65389337|NCT01021150|Cisplatin|cisplatin|mesh-list
65389338|NCT01021150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389339|NCT03997006|Atropine|atropine|mesh-list
65389340|NCT03997006|Aminophylline|aminophylline|mesh-list
65389341|NCT03997006|Neostigmine|neostigmine|mesh-list
65389342|NCT03997006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65389343|NCT03997006|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65389344|NCT03997006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65389345|NCT03997006|Autonomic Agents|autonomic agents|mesh-ancestor
65389346|NCT03997006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389347|NCT03997006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389348|NCT03997006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65389349|NCT03997006|Respiratory System Agents|respiratory system agents|mesh-ancestor
65389350|NCT03997006|Mydriatics|mydriatics|mesh-ancestor
65389351|NCT03997006|Parasympatholytics|parasympatholytics|mesh-ancestor
65389352|NCT03997006|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65389353|NCT03997006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65389354|NCT03997006|Cholinergic Agents|cholinergic agents|mesh-ancestor
65389355|NCT03997006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65389356|NCT03997006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389357|NCT03997006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65389358|NCT03997006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389359|NCT03997006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65389360|NCT03997006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65389361|NCT03997006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65389362|NCT03997006|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65389363|NCT03997006|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65389364|NCT03997006|Purinergic Agents|purinergic agents|mesh-ancestor
65389368|NCT02272049|Xenon|xenon|mesh-list
65389369|NCT02272049|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65389370|NCT02272049|Anesthetics, General|anesthetics, general|mesh-ancestor
65389371|NCT02272049|Anesthetics|anesthetics|mesh-ancestor
65389372|NCT02272049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65389373|NCT02272049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389374|NCT03996538|Metformin|metformin|mesh-list
65389375|NCT03996538|Vaccines|vaccines|mesh-list
65389376|NCT03996538|Immunologic Factors|immunologic factors|mesh-ancestor
65389377|NCT03996538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389378|NCT03996538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65389379|NCT02576015|Lidocaine|lidocaine|mesh-list
65389380|NCT02576015|Ropivacaine|ropivacaine|mesh-list
65389381|NCT02576015|Anesthetics, Local|anesthetics, local|mesh-ancestor
65389382|NCT02576015|Anesthetics|anesthetics|mesh-ancestor
65389383|NCT02576015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65389384|NCT02576015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389385|NCT02576015|Sensory System Agents|sensory system agents|mesh-ancestor
65389386|NCT02576015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389387|NCT02576015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65389388|NCT02576015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65389389|NCT02576015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65389390|NCT02576015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65389391|NCT02576015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389392|NCT02577965|Everolimus|everolimus|mesh-list
65389393|NCT02577965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389394|NCT02577965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65389395|NCT02577965|Immunologic Factors|immunologic factors|mesh-ancestor
65389396|NCT02577965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389397|NCT00182689|Sorafenib|sorafenib|mesh-list
65389398|NCT00182689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389400|NCT00182689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779425|NCT04534218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64779426|NCT04534218|Alkylating Agents|alkylating agents|mesh-ancestor
64779427|NCT04534218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779428|NCT04534218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389413|NCT02578121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65389414|NCT02578121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65389415|NCT02578121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389416|NCT02578121|Immunologic Factors|immunologic factors|mesh-ancestor
65389417|NCT02578121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65389418|NCT02578121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65389419|NCT02578121|Growth Substances|growth substances|mesh-ancestor
65389420|NCT02578121|Growth Inhibitors|growth inhibitors|mesh-ancestor
65389421|NCT02578121|Protease Inhibitors|protease inhibitors|mesh-ancestor
65389422|NCT02578121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389423|NCT02578121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389424|NCT00487240|Insulin|insulin|mesh-list
65389425|NCT00487240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65389426|NCT00487240|Insulin Lispro|insulin lispro|mesh-list
65389427|NCT00487240|Insulin Detemir|insulin detemir|mesh-list
65389428|NCT00487240|Protamines|protamines|mesh-list
65389429|NCT00487240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65389430|NCT00487240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389431|NCT00487240|Heparin Antagonists|heparin antagonists|mesh-ancestor
64779455|NCT04509414|Midazolam|midazolam|mesh-list
64779456|NCT04509414|Dexmedetomidine|dexmedetomidine|mesh-list
64779457|NCT04509414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64779458|NCT04509414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65389460|NCT02224391|Nicotine|nicotine|mesh-list
65389461|NCT02224391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65389462|NCT02224391|Autonomic Agents|autonomic agents|mesh-ancestor
65389463|NCT02224391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389464|NCT02224391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389465|NCT02224391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65389466|NCT02224391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65389467|NCT02224391|Cholinergic Agents|cholinergic agents|mesh-ancestor
65389468|NCT02224391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65389469|NCT02224391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389470|NCT00487162|Insulin|insulin|mesh-list
65389471|NCT00487162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65389472|NCT00487162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389473|NCT03871959|Pembrolizumab|pembrolizumab|mesh-list
65389474|NCT03871959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65389475|NCT03871959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389476|NCT00487084|Lidocaine|lidocaine|mesh-list
65389477|NCT00487084|Morphine|morphine|mesh-list
65389478|NCT00487084|Anesthetics, Local|anesthetics, local|mesh-ancestor
65389509|NCT01721291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389510|NCT01021540|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65389511|NCT01021540|Hormones|hormones|mesh-ancestor
65389512|NCT01021540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65389513|NCT01021540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389514|NCT04840511|Lidocaine|lidocaine|mesh-list
65389515|NCT04840511|Anesthetics, Local|anesthetics, local|mesh-ancestor
65389516|NCT04840511|Anesthetics|anesthetics|mesh-ancestor
65389517|NCT04840511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65389518|NCT04840511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389519|NCT04840511|Sensory System Agents|sensory system agents|mesh-ancestor
65389520|NCT04840511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389521|NCT04840511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65389522|NCT04840511|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65389523|NCT04840511|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65389524|NCT04840511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65389525|NCT04840511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389526|NCT02199665|Dexamethasone|dexamethasone|mesh-list
65389527|NCT02199665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65389528|NCT02199665|Antiemetics|antiemetics|mesh-ancestor
65389529|NCT02199665|Autonomic Agents|autonomic agents|mesh-ancestor
65389530|NCT02199665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389531|NCT02199665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389532|NCT02199665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65389533|NCT02199665|Glucocorticoids|glucocorticoids|mesh-ancestor
65389534|NCT02199665|Hormones|hormones|mesh-ancestor
65389535|NCT02199665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65389536|NCT02199665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65389538|NCT01021696|Acetaminophen|acetaminophen|mesh-list
65389552|NCT01021696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389553|NCT01021696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65389554|NCT01021696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65389555|NCT01021696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65389556|NCT01021696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65389557|NCT01021696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65389558|NCT01021696|Antipyretics|antipyretics|mesh-ancestor
65389559|NCT01021696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65389560|NCT02577575|Oxytocin|oxytocin|mesh-list
65389561|NCT02577575|Oxytocics|oxytocics|mesh-ancestor
65139133|NCT01687439|Tubulin Modulators|tubulin modulators|mesh-ancestor
65389562|NCT02577575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65389563|NCT02577575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389565|NCT00485758|Niacinamide|niacinamide|mesh-list
65389566|NCT00485758|Nicotinic Acids|nicotinic acids|mesh-list
65389567|NCT00485758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65389568|NCT00485758|Antimetabolites|antimetabolites|mesh-ancestor
65389569|NCT00485758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389570|NCT00485758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65389571|NCT00485758|Vasodilator Agents|vasodilator agents|mesh-ancestor
65389572|NCT00485758|Vitamin B Complex|vitamin b complex|mesh-ancestor
65389573|NCT00485758|Vitamins|vitamins|mesh-ancestor
65389574|NCT00485758|Micronutrients|micronutrients|mesh-ancestor
65389575|NCT00485758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389576|NCT02577341|Docetaxel|docetaxel|mesh-list
65389577|NCT02577341|Nimotuzumab|nimotuzumab|mesh-list
65389578|NCT02577341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389579|NCT02577341|Tubulin Modulators|tubulin modulators|mesh-ancestor
65389580|NCT02577341|Antimitotic Agents|antimitotic agents|mesh-ancestor
65389581|NCT02577341|Mitosis Modulators|mitosis modulators|mesh-ancestor
65389582|NCT02577341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389583|NCT02577341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65389584|NCT02577497|Fluticasone|fluticasone|mesh-list
65389585|NCT02577497|Beclomethasone|beclomethasone|mesh-list
65389586|NCT02577497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64779533|NCT04320342|Hormones|hormones|mesh-ancestor
64670903|NCT01963793|Antiemetics|antiemetics|mesh-ancestor
64670904|NCT01963793|Autonomic Agents|autonomic agents|mesh-ancestor
64670905|NCT01963793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670906|NCT01963793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670907|NCT01963793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65389587|NCT02577497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65389588|NCT02577497|Autonomic Agents|autonomic agents|mesh-ancestor
65389589|NCT02577497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389590|NCT02577497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389591|NCT02577497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65389592|NCT02577497|Respiratory System Agents|respiratory system agents|mesh-ancestor
65389593|NCT02577497|Dermatologic Agents|dermatologic agents|mesh-ancestor
65389594|NCT02577497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65389595|NCT02577497|Glucocorticoids|glucocorticoids|mesh-ancestor
65389596|NCT02577497|Hormones|hormones|mesh-ancestor
65389597|NCT02577497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65389598|NCT02575859|Cisplatin|cisplatin|mesh-list
65389599|NCT02575859|Mitomycins|mitomycins|mesh-list
65389600|NCT02575859|Mitomycin|mitomycin|mesh-list
65389601|NCT02575859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389602|NCT02575859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65389603|NCT02575859|Alkylating Agents|alkylating agents|mesh-ancestor
65389604|NCT02575859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389605|NCT02575859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65389606|NCT02575859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389607|NCT03850444|Paclitaxel|paclitaxel|mesh-list
65389608|NCT03850444|Carboplatin|carboplatin|mesh-list
65389609|NCT03850444|Pembrolizumab|pembrolizumab|mesh-list
65389610|NCT03850444|Pemetrexed|pemetrexed|mesh-list
65389611|NCT03850444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65389612|NCT03850444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389613|NCT03850444|Tubulin Modulators|tubulin modulators|mesh-ancestor
65389614|NCT03850444|Antimitotic Agents|antimitotic agents|mesh-ancestor
65389615|NCT03850444|Mitosis Modulators|mitosis modulators|mesh-ancestor
65389616|NCT03850444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389617|NCT03850444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65389618|NCT03850444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389619|NCT03850444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65389630|NCT00581555|Etanercept|etanercept|mesh-list
65389631|NCT00581555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65389632|NCT00581555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65389633|NCT00581555|Analgesics|analgesics|mesh-ancestor
65389634|NCT00581555|Sensory System Agents|sensory system agents|mesh-ancestor
65389635|NCT00581555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389636|NCT00581555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389637|NCT00581555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65389638|NCT00581555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65389639|NCT00581555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65389640|NCT00581555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65389641|NCT00581555|Immunologic Factors|immunologic factors|mesh-ancestor
65389642|NCT00469144|Fludarabine|fludarabine|mesh-list
65389643|NCT00469144|Busulfan|busulfan|mesh-list
65389644|NCT00469144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389645|NCT00469144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389646|NCT00469144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65389647|NCT00469144|Immunologic Factors|immunologic factors|mesh-ancestor
65389648|NCT00469144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389649|NCT00469144|Alkylating Agents|alkylating agents|mesh-ancestor
65389650|NCT00469144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65389651|NCT00469144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65389652|NCT03987022|Acetaminophen|acetaminophen|mesh-list
65389653|NCT03987022|Ketorolac|ketorolac|mesh-list
65389654|NCT03987022|Oxycodone|oxycodone|mesh-list
65389655|NCT03987022|Hydromorphone|hydromorphone|mesh-list
65389656|NCT03987022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65389657|NCT03987022|Narcotics|narcotics|mesh-ancestor
65389658|NCT03987022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65389659|NCT03987022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389660|NCT03987022|Analgesics|analgesics|mesh-ancestor
65389661|NCT03987022|Sensory System Agents|sensory system agents|mesh-ancestor
65389662|NCT03987022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389664|NCT03987022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65389672|NCT01025128|Vitamins|vitamins|mesh-ancestor
65389673|NCT01025128|Micronutrients|micronutrients|mesh-ancestor
65389674|NCT01025128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389675|NCT01025128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65389676|NCT00468910|Aspirin|aspirin|mesh-list
65389677|NCT00468910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65389678|NCT00468910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65389679|NCT00468910|Analgesics|analgesics|mesh-ancestor
65389680|NCT00468910|Sensory System Agents|sensory system agents|mesh-ancestor
65389681|NCT00468910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389682|NCT00468910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389683|NCT00468910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65389684|NCT00468910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65389685|NCT00468910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65389686|NCT00468910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65389687|NCT00468910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389688|NCT00468910|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65389689|NCT00468910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65389690|NCT00468910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389691|NCT00468910|Antipyretics|antipyretics|mesh-ancestor
65389692|NCT01412333|Interferons|interferons|mesh-list
65389693|NCT01412333|Interferon-beta|interferon-beta|mesh-list
65389694|NCT01412333|Interferon beta-1a|interferon beta-1a|mesh-list
65389695|NCT01412333|Ocrelizumab|ocrelizumab|mesh-list
65389696|NCT01412333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389697|NCT01412333|Antiviral Agents|antiviral agents|mesh-ancestor
65389698|NCT01412333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65389699|NCT01412333|Immunologic Factors|immunologic factors|mesh-ancestor
65389700|NCT01412333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389719|NCT00519285|Antimitotic Agents|antimitotic agents|mesh-ancestor
65389720|NCT00519285|Mitosis Modulators|mitosis modulators|mesh-ancestor
65389721|NCT00519285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389722|NCT00519285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65389723|NCT00519285|Glucocorticoids|glucocorticoids|mesh-ancestor
65389725|NCT00519285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65389726|NCT00519285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389727|NCT00519285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65389728|NCT00519285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65389729|NCT00519285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65389730|NCT00519285|Growth Substances|growth substances|mesh-ancestor
65389731|NCT00519285|Growth Inhibitors|growth inhibitors|mesh-ancestor
65389732|NCT00464620|Dasatinib|dasatinib|mesh-list
65389733|NCT00464620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389734|NCT00464620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65389735|NCT00464620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389736|NCT00464620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389737|NCT05212857|Leuprolide|leuprolide|mesh-list
65389738|NCT05212857|Goserelin|goserelin|mesh-list
65389739|NCT05212857|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65389740|NCT05212857|Abiraterone Acetate|abiraterone acetate|mesh-list
65389741|NCT05212857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65389742|NCT05212857|Fertility Agents|fertility agents|mesh-ancestor
65389743|NCT05212857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65389744|NCT05212857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389745|NCT05212857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65389746|NCT05212857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389747|NCT05212857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65389748|NCT05212857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389749|NCT05212857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389750|NCT05212857|Hormone Antagonists|hormone antagonists|mesh-ancestor
65389751|NCT05212857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65389757|NCT02099123|Atorvastatin|atorvastatin|mesh-list
65389759|NCT02099123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65389760|NCT02099123|Antimetabolites|antimetabolites|mesh-ancestor
65389761|NCT02099123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389762|NCT02099123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65389763|NCT02099123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65389764|NCT02099123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389765|NCT00464542|Metronidazole|metronidazole|mesh-list
65389766|NCT00464542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65389767|NCT00464542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65389768|NCT00464542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65389769|NCT00464542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65389770|NCT02578823|Antipyretics|antipyretics|mesh-list
65389771|NCT02578823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389772|NCT01969643|Trastuzumab|trastuzumab|mesh-list
65389773|NCT01969643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65389774|NCT01969643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389775|NCT00464308|Esomeprazole|esomeprazole|mesh-list
65389776|NCT00464308|Rabeprazole|rabeprazole|mesh-list
65389777|NCT00464308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65389778|NCT00464308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65389779|NCT00464308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65389780|NCT00464308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389781|NCT00464308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389782|NCT00463840|Fluorouracil|fluorouracil|mesh-list
65389783|NCT00463840|Oxaliplatin|oxaliplatin|mesh-list
65389784|NCT00463840|Antimetabolites|antimetabolites|mesh-ancestor
65389785|NCT00463840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389786|NCT00463840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65389787|NCT00463840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389788|NCT00463840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65139356|NCT01680965|Ofatumumab|ofatumumab|mesh-list
65389789|NCT00463840|Immunologic Factors|immunologic factors|mesh-ancestor
65389791|NCT00129389|Paclitaxel|paclitaxel|mesh-list
65389800|NCT00129389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389801|NCT00129389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65389802|NCT00129389|Immunologic Factors|immunologic factors|mesh-ancestor
65389803|NCT00129389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389804|NCT00129389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65389805|NCT00129389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65389806|NCT00129389|Alkylating Agents|alkylating agents|mesh-ancestor
65389807|NCT00129389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65389808|NCT00129389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65389809|NCT00129389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65389810|NCT00129389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65389811|NCT00129389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389812|NCT00129389|Antimetabolites|antimetabolites|mesh-ancestor
65389813|NCT00129389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65389814|NCT00468052|Fentanyl|fentanyl|mesh-list
65389815|NCT00468052|Dexmedetomidine|dexmedetomidine|mesh-list
65389816|NCT00468052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65389817|NCT00468052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65389818|NCT00468052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389819|NCT00468052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65389820|NCT00468052|Analgesics|analgesics|mesh-ancestor
65389821|NCT00468052|Sensory System Agents|sensory system agents|mesh-ancestor
65389822|NCT00468052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389823|NCT00468052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65389824|NCT00468052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65389825|NCT00468052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65389826|NCT00468052|Adrenergic Agents|adrenergic agents|mesh-ancestor
65389846|NCT04711343|Immunologic Factors|immunologic factors|mesh-ancestor
65389847|NCT04711343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389848|NCT00128843|Anastrozole|anastrozole|mesh-list
65389849|NCT00128843|Exemestane|exemestane|mesh-list
65389850|NCT00128843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65389851|NCT00128843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389852|NCT00128843|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65389853|NCT00128843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65389854|NCT00128843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389855|NCT00128843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389856|NCT00128843|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65389857|NCT00128843|Hormone Antagonists|hormone antagonists|mesh-ancestor
65389858|NCT00128843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65389859|NCT00128843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389860|NCT04073927|Butyric Acid|butyric acid|mesh-list
65389861|NCT04073927|Histamine Antagonists|histamine antagonists|mesh-ancestor
65389862|NCT04073927|Histamine Agents|histamine agents|mesh-ancestor
65389863|NCT04073927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65389864|NCT04073927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389865|NCT04073927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389866|NCT00124657|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65389867|NCT00124657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389868|NCT00124657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65389869|NCT00124657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389870|NCT00124657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389871|NCT02578277|BMS-955176|bms-955176|mesh-list
65389872|NCT02578277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65389873|NCT02578277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65389874|NCT02578277|Antiviral Agents|antiviral agents|mesh-ancestor
65389889|NCT00555906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389890|NCT00555906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65389891|NCT00555906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389892|NCT00555906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389893|NCT04071353|Interferons|interferons|mesh-list
65389894|NCT04071353|Ribavirin|ribavirin|mesh-list
65389895|NCT04071353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389896|NCT04071353|Antiviral Agents|antiviral agents|mesh-ancestor
65389897|NCT04071353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65389898|NCT04071353|Antimetabolites|antimetabolites|mesh-ancestor
65389899|NCT04071353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389900|NCT00709475|Insulin Detemir|insulin detemir|mesh-list
65389901|NCT00709475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65389902|NCT00709475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389903|NCT00555672|Fluorouracil|fluorouracil|mesh-list
65389904|NCT00555672|Sunitinib|sunitinib|mesh-list
65389905|NCT00555672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389906|NCT00555672|Antimetabolites|antimetabolites|mesh-ancestor
65389907|NCT00555672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389908|NCT00555672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65389909|NCT00555672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65389910|NCT00555672|Immunologic Factors|immunologic factors|mesh-ancestor
65389911|NCT00555672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389912|NCT00555672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65389913|NCT00555672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65389914|NCT00555672|Growth Substances|growth substances|mesh-ancestor
65389915|NCT00555672|Growth Inhibitors|growth inhibitors|mesh-ancestor
65389916|NCT00555672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65389917|NCT00555672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389918|NCT02575547|Docetaxel|docetaxel|mesh-list
65389919|NCT02575547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389920|NCT02575547|Tubulin Modulators|tubulin modulators|mesh-ancestor
64670908|NCT01963793|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64670927|NCT04313504|Niraparib|niraparib|mesh-list
64670928|NCT04313504|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64670929|NCT04313504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670930|NCT04313504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670931|NCT04313504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670933|NCT01996943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64670934|NCT01996943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64670935|NCT01996943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64670936|NCT01996943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670937|NCT04812626|Triamcinolone|triamcinolone|mesh-list
65389921|NCT02575547|Antimitotic Agents|antimitotic agents|mesh-ancestor
65389922|NCT02575547|Mitosis Modulators|mitosis modulators|mesh-ancestor
65389923|NCT02575547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389924|NCT01037387|Bronchodilator Agents|bronchodilator agents|mesh-list
65389925|NCT01037387|Autonomic Agents|autonomic agents|mesh-ancestor
65389926|NCT01037387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389927|NCT01037387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389928|NCT01037387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65389929|NCT01037387|Respiratory System Agents|respiratory system agents|mesh-ancestor
65389930|NCT02574533|Pembrolizumab|pembrolizumab|mesh-list
65389931|NCT02574533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65389932|NCT02574533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65389933|NCT02574533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389934|NCT02574533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389935|NCT04652375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65389936|NCT00709553|Midazolam|midazolam|mesh-list
65389937|NCT00709553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65389938|NCT00709553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65389939|NCT00709553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65389940|NCT00709553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389941|NCT00709553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65389942|NCT00709553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65389943|NCT00709553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65389944|NCT00709553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65389945|NCT00709553|Anesthetics, General|anesthetics, general|mesh-ancestor
65389946|NCT00709553|Anesthetics|anesthetics|mesh-ancestor
65389947|NCT00709553|GABA Modulators|gaba modulators|mesh-ancestor
65389948|NCT00709553|GABA Agents|gaba agents|mesh-ancestor
65389949|NCT00709553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65389950|NCT00709553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389965|NCT00561912|Decitabine|decitabine|mesh-list
65389966|NCT00561912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65389967|NCT00561912|Antiviral Agents|antiviral agents|mesh-ancestor
65389968|NCT00561912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65389969|NCT00561912|Immunologic Factors|immunologic factors|mesh-ancestor
65389970|NCT00561912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389971|NCT00561912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65389972|NCT00561912|Antimetabolites|antimetabolites|mesh-ancestor
65389973|NCT00561912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389974|NCT00561912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65389975|NCT00561678|Dexmedetomidine|dexmedetomidine|mesh-list
65389976|NCT00561678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65389977|NCT00561678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65389978|NCT00561678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65389979|NCT00561678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65389980|NCT00561678|Analgesics|analgesics|mesh-ancestor
65389981|NCT00561678|Sensory System Agents|sensory system agents|mesh-ancestor
65389982|NCT00561678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65389983|NCT00561678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65389984|NCT00561678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65389985|NCT00561678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65389986|NCT00561678|Adrenergic Agents|adrenergic agents|mesh-ancestor
65389987|NCT00561678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65389988|NCT00561678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65389989|NCT00946608|Loratadine|loratadine|mesh-list
65389990|NCT00946608|Antipruritics|antipruritics|mesh-ancestor
65389991|NCT00946608|Dermatologic Agents|dermatologic agents|mesh-ancestor
65389992|NCT00946608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65389993|NCT00946608|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65389994|NCT00946608|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65389995|NCT00946608|Histamine Antagonists|histamine antagonists|mesh-ancestor
65389996|NCT00946608|Histamine Agents|histamine agents|mesh-ancestor
65390006|NCT00463606|Calcium|calcium|mesh-list
65390007|NCT00463606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65390008|NCT00463606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390009|NCT00463606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65390010|NCT00463606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65390011|NCT00463606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65390012|NCT00463606|Antimetabolites|antimetabolites|mesh-ancestor
65390013|NCT00463606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390014|NCT00463606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65390015|NCT00463606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65390016|NCT00463606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390017|NCT03961308|Vedolizumab|vedolizumab|mesh-list
65390018|NCT03961308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65390019|NCT00956436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65390021|NCT00956436|Liver Extracts|liver extracts|mesh-list
65390022|NCT00956436|Antibodies|antibodies|mesh-list
65390023|NCT00956436|Immunoglobulins|immunoglobulins|mesh-list
65390024|NCT00956436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65390025|NCT00956436|Immunologic Factors|immunologic factors|mesh-ancestor
65390026|NCT00956436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390027|NCT00956436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390028|NCT00956436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65390029|NCT00956436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390030|NCT00956436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390031|NCT00956436|Hematinics|hematinics|mesh-ancestor
65390032|NCT00950586|Dextromethorphan|dextromethorphan|mesh-list
65390033|NCT00950586|Antitussive Agents|antitussive agents|mesh-ancestor
65390040|NCT00467896|Iloprost|iloprost|mesh-list
65390054|NCT02531737|Mitosis Modulators|mitosis modulators|mesh-ancestor
65390055|NCT02531737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390056|NCT02531737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65390057|NCT02531737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390058|NCT01326559|Docetaxel|docetaxel|mesh-list
65390059|NCT01326559|Cetuximab|cetuximab|mesh-list
65390060|NCT01326559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390061|NCT01326559|Tubulin Modulators|tubulin modulators|mesh-ancestor
65390062|NCT01326559|Antimitotic Agents|antimitotic agents|mesh-ancestor
65390063|NCT01326559|Mitosis Modulators|mitosis modulators|mesh-ancestor
65390064|NCT01326559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390065|NCT01326559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65390066|NCT04069949|Sorafenib|sorafenib|mesh-list
65390067|NCT04069949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390068|NCT04069949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65390069|NCT04069949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390070|NCT04069949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390071|NCT02575235|Cetylpyridinium|cetylpyridinium|mesh-list
65390072|NCT02575235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65390073|NCT02575235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65390109|NCT01022476|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65390110|NCT01022476|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65390111|NCT01022476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390112|NCT01022476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390113|NCT02575001|Hydrocortisone|hydrocortisone|mesh-list
65390114|NCT02575001|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65390115|NCT02575001|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65390116|NCT02575001|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65390117|NCT02575001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65390118|NCT01021930|Sirolimus|sirolimus|mesh-list
65390119|NCT01021930|Paclitaxel|paclitaxel|mesh-list
65390120|NCT01021930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65390121|NCT01021930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390122|NCT01021930|Tubulin Modulators|tubulin modulators|mesh-ancestor
65390123|NCT01021930|Antimitotic Agents|antimitotic agents|mesh-ancestor
65390124|NCT01021930|Mitosis Modulators|mitosis modulators|mesh-ancestor
65390125|NCT01021930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390126|NCT01021930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65390127|NCT01021930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65390128|NCT01021930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65390129|NCT01021930|Antifungal Agents|antifungal agents|mesh-ancestor
65390130|NCT01021930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65390131|NCT01021930|Immunologic Factors|immunologic factors|mesh-ancestor
65390132|NCT01021930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390133|NCT00946764|Imipramine|imipramine|mesh-list
65390134|NCT00946764|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65390135|NCT00946764|Antidepressive Agents|antidepressive agents|mesh-ancestor
65390136|NCT00946764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65390137|NCT00946764|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65390138|NCT00946764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65390141|NCT00946764|Adrenergic Agents|adrenergic agents|mesh-ancestor
65390151|NCT00950820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65390152|NCT00950898|Caffeine|caffeine|mesh-list
65390153|NCT00950898|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65390154|NCT00950898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390155|NCT00950898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65390156|NCT00950898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390157|NCT00950898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390158|NCT00950898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65390159|NCT00950898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65390160|NCT00950898|Purinergic Agents|purinergic agents|mesh-ancestor
65390161|NCT00950898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65390162|NCT00168805|Enoxaparin|enoxaparin|mesh-list
65390163|NCT00168805|Dabigatran|dabigatran|mesh-list
65390165|NCT00168805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65390166|NCT00168805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65390167|NCT00168805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390168|NCT00168805|Antithrombins|antithrombins|mesh-ancestor
65390169|NCT00168805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65390170|NCT00168805|Protease Inhibitors|protease inhibitors|mesh-ancestor
65390171|NCT00168805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390172|NCT00467584|Aspirin|aspirin|mesh-list
65390173|NCT00467584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65390174|NCT00467584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65390175|NCT00467584|Analgesics|analgesics|mesh-ancestor
65390176|NCT00467584|Sensory System Agents|sensory system agents|mesh-ancestor
65390177|NCT00467584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65390178|NCT00467584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390179|NCT00467584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65390180|NCT00467584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65390181|NCT00467584|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65390182|NCT00467584|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65390183|NCT00467584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390184|NCT00467584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65390185|NCT00467584|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65390186|NCT00467584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390189|NCT02574611|Neostigmine|neostigmine|mesh-list
65390190|NCT02574611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65390191|NCT02574611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390192|NCT02574611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390193|NCT02574611|Cholinergic Agents|cholinergic agents|mesh-ancestor
65390194|NCT02574611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65390195|NCT02574611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390196|NCT02574611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65390197|NCT02574611|Autonomic Agents|autonomic agents|mesh-ancestor
65390198|NCT02574611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65390199|NCT02574611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65390200|NCT02574611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65390201|NCT02574611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65390202|NCT00714779|Fluoxetine|fluoxetine|mesh-list
65390203|NCT00714779|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65390204|NCT00714779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65390205|NCT00714779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65390206|NCT00714779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390207|NCT00714779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65390208|NCT00714779|Serotonin Agents|serotonin agents|mesh-ancestor
65390209|NCT00714779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390210|NCT00714779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65390211|NCT00714779|Antidepressive Agents|antidepressive agents|mesh-ancestor
65390212|NCT00714779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65390213|NCT00714779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65390214|NCT00714779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65390215|NCT00714779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390216|NCT00168103|Complement C1s|complement c1s|mesh-list
65390217|NCT00168103|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
65390218|NCT00168103|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
65390231|NCT00463060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390232|NCT00463060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390233|NCT03964753|Paclitaxel|paclitaxel|mesh-list
65390234|NCT03964753|Cisplatin|cisplatin|mesh-list
65390235|NCT03964753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65139809|NCT02893371|Lamotrigine|lamotrigine|mesh-list
65390236|NCT03964753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390237|NCT03964753|Tubulin Modulators|tubulin modulators|mesh-ancestor
65390238|NCT03964753|Antimitotic Agents|antimitotic agents|mesh-ancestor
65390239|NCT03964753|Mitosis Modulators|mitosis modulators|mesh-ancestor
65390240|NCT03964753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390242|NCT00956748|Ciprofloxacin|ciprofloxacin|mesh-list
65390243|NCT00956748|Dexamethasone|dexamethasone|mesh-list
65390244|NCT00956748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65390245|NCT00956748|Antiemetics|antiemetics|mesh-ancestor
65390246|NCT00956748|Autonomic Agents|autonomic agents|mesh-ancestor
65390247|NCT00956748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65390248|NCT00956748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390249|NCT00956748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65390250|NCT00956748|Glucocorticoids|glucocorticoids|mesh-ancestor
65390251|NCT00956748|Hormones|hormones|mesh-ancestor
65390252|NCT00956748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65390253|NCT00956748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65390254|NCT00956748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390255|NCT00956748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390256|NCT00956748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390257|NCT00956748|Antiviral Agents|antiviral agents|mesh-ancestor
65390258|NCT00956748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65390259|NCT00956748|Expectorants|expectorants|mesh-ancestor
65390260|NCT00956748|Respiratory System Agents|respiratory system agents|mesh-ancestor
65390261|NCT00956748|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65390262|NCT00956748|Antioxidants|antioxidants|mesh-ancestor
65390263|NCT00956748|Protective Agents|protective agents|mesh-ancestor
65390264|NCT00956748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65390265|NCT00956748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64670938|NCT04812626|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64670939|NCT04812626|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64670940|NCT04812626|Fluorouracil|fluorouracil|mesh-list
64670941|NCT04812626|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64670942|NCT04812626|Antimetabolites|antimetabolites|mesh-ancestor
65390266|NCT00956748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65390267|NCT00956748|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65390268|NCT00956748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65390269|NCT01079923|Vitamin D|vitamin d|mesh-list
65390270|NCT01079923|Ergocalciferols|ergocalciferols|mesh-list
65390271|NCT01079923|Cholecalciferol|cholecalciferol|mesh-list
65390272|NCT01079923|Vitamins|vitamins|mesh-list
65390273|NCT01079923|Micronutrients|micronutrients|mesh-ancestor
65390274|NCT01079923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390275|NCT01079923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65390276|NCT01079923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65390277|NCT00947076|Fluoxetine|fluoxetine|mesh-list
65390278|NCT00947076|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65390279|NCT00947076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65390280|NCT00947076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65390281|NCT00947076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390282|NCT00947076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65390283|NCT00947076|Serotonin Agents|serotonin agents|mesh-ancestor
65390284|NCT00947076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390285|NCT00947076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65390286|NCT00947076|Antidepressive Agents|antidepressive agents|mesh-ancestor
65390287|NCT00947076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65390288|NCT00947076|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65390289|NCT00947076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65390291|NCT00462982|Sunitinib|sunitinib|mesh-list
65390312|NCT02573597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65390313|NCT02573597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65390314|NCT02573597|Anesthetics, General|anesthetics, general|mesh-ancestor
65390315|NCT05300958|Deferoxamine|deferoxamine|mesh-list
65390316|NCT05300958|Siderophores|siderophores|mesh-ancestor
65390317|NCT05300958|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65390318|NCT05300958|Chelating Agents|chelating agents|mesh-ancestor
65390319|NCT05300958|Sequestering Agents|sequestering agents|mesh-ancestor
65390320|NCT05300958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390321|NCT04070729|Hyaluronic Acid|hyaluronic acid|mesh-list
65390322|NCT04070729|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65390323|NCT04070729|Immunologic Factors|immunologic factors|mesh-ancestor
65390324|NCT04070729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390325|NCT04070729|Viscosupplements|viscosupplements|mesh-ancestor
65390326|NCT04070729|Protective Agents|protective agents|mesh-ancestor
65390327|NCT00467272|Daptomycin|daptomycin|mesh-list
65390328|NCT00467272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65390329|NCT00467272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65390330|NCT00956982|Interferons|interferons|mesh-list
65390331|NCT00956982|Ribavirin|ribavirin|mesh-list
65390332|NCT00956982|Interferon-alpha|interferon-alpha|mesh-list
65390333|NCT00956982|Interferon alpha-2|interferon alpha-2|mesh-list
65390334|NCT00956982|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65390335|NCT00956982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390336|NCT00956982|Antiviral Agents|antiviral agents|mesh-ancestor
65390337|NCT00956982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65390338|NCT00956982|Antimetabolites|antimetabolites|mesh-ancestor
65390339|NCT00956982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390340|NCT00956982|Immunologic Factors|immunologic factors|mesh-ancestor
65390341|NCT00956982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390342|NCT00714857|Dexmedetomidine|dexmedetomidine|mesh-list
65390343|NCT00714857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65390346|NCT00714857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64780091|NCT02462148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390356|NCT00957060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65390357|NCT00957060|Glimepiride|glimepiride|mesh-list
65390358|NCT00957060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65390359|NCT00957060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390360|NCT00957060|Incretins|incretins|mesh-ancestor
65390361|NCT00957060|Hormones|hormones|mesh-ancestor
65390362|NCT00957060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65390363|NCT00957060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65390364|NCT00957060|Protease Inhibitors|protease inhibitors|mesh-ancestor
65390365|NCT00957060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390366|NCT00957060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390367|NCT00957060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65390368|NCT00957060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65390369|NCT00957060|Immunologic Factors|immunologic factors|mesh-ancestor
65390370|NCT02573519|Acetylcholine|acetylcholine|mesh-list
65390371|NCT02573519|Donepezil|donepezil|mesh-list
65390372|NCT02573519|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
65390373|NCT02573519|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65390374|NCT02573519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390375|NCT02573519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390376|NCT02573519|Cholinergic Agents|cholinergic agents|mesh-ancestor
65390377|NCT02573519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65390378|NCT02573519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390379|NCT02573519|Nootropic Agents|nootropic agents|mesh-ancestor
65390380|NCT02573519|Vasodilator Agents|vasodilator agents|mesh-ancestor
65390381|NCT02573519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65390382|NCT02572583|Oseltamivir|oseltamivir|mesh-list
65390383|NCT02572583|Antiviral Agents|antiviral agents|mesh-ancestor
65390384|NCT02572583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65390385|NCT02572583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390386|NCT02572583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390387|NCT00951444|Gemcitabine|gemcitabine|mesh-list
65390388|NCT00951444|Carboplatin|carboplatin|mesh-list
65390389|NCT00951444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390390|NCT00951444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64670943|NCT04812626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670944|NCT04812626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65390391|NCT00951444|Antimetabolites|antimetabolites|mesh-ancestor
65390392|NCT00951444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390393|NCT00951444|Antiviral Agents|antiviral agents|mesh-ancestor
65390394|NCT00951444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65390395|NCT00951444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390396|NCT00951444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65390397|NCT00951444|Immunologic Factors|immunologic factors|mesh-ancestor
65390398|NCT00951444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390399|NCT00462826|Aflibercept|aflibercept|mesh-list
65390400|NCT00462826|Endothelial Growth Factors|endothelial growth factors|mesh-list
65390401|NCT00462826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65390402|NCT00462826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65390403|NCT00462826|Growth Substances|growth substances|mesh-ancestor
65390404|NCT00462826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390405|NCT00462826|Growth Inhibitors|growth inhibitors|mesh-ancestor
65390406|NCT00462826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390407|NCT00718601|Imetelstat|imetelstat|mesh-list
65390408|NCT00718601|Motesanib diphosphate|motesanib diphosphate|mesh-list
65390409|NCT00718601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390410|NCT00718601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390411|NCT00718601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65390412|NCT00947388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65390413|NCT00947388|Alemtuzumab|alemtuzumab|mesh-list
65390414|NCT00947388|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65390415|NCT00947388|Antibodies|antibodies|mesh-list
65390416|NCT00947388|Immunoglobulins|immunoglobulins|mesh-list
65390417|NCT00947388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65390418|NCT00947388|Immunologic Factors|immunologic factors|mesh-ancestor
65390419|NCT00947388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390434|NCT03910985|Autonomic Agents|autonomic agents|mesh-ancestor
65390435|NCT03910985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65390436|NCT03910985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390437|NCT03910985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65390438|NCT03910985|Respiratory System Agents|respiratory system agents|mesh-ancestor
65390439|NCT00957216|Ubiquinone|ubiquinone|mesh-list
65390440|NCT00957216|Coenzyme Q10|coenzyme q10|mesh-list
65390441|NCT00957216|Micronutrients|micronutrients|mesh-ancestor
65390442|NCT00957216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390443|NCT00957216|Vitamins|vitamins|mesh-ancestor
65390444|NCT00718757|Dexamethasone|dexamethasone|mesh-list
65390445|NCT00718757|Irinotecan|irinotecan|mesh-list
65390446|NCT00718757|Vincristine|vincristine|mesh-list
65390447|NCT00718757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65390448|NCT00718757|Antiemetics|antiemetics|mesh-ancestor
65390449|NCT00718757|Autonomic Agents|autonomic agents|mesh-ancestor
65390450|NCT00718757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65390451|NCT00718757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390452|NCT00718757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65390453|NCT00718757|Glucocorticoids|glucocorticoids|mesh-ancestor
65390454|NCT00718757|Hormones|hormones|mesh-ancestor
65390455|NCT00718757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65390456|NCT00718757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65390457|NCT00718757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390458|NCT00718757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65390459|NCT00718757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65390460|NCT00718757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390461|NCT00718757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390481|NCT00951834|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65390482|NCT00951834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390483|NCT00951834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65390484|NCT00715013|Epothilone B|epothilone b|mesh-list
65390485|NCT00715013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390486|NCT00715013|Tubulin Modulators|tubulin modulators|mesh-ancestor
65390487|NCT00715013|Antimitotic Agents|antimitotic agents|mesh-ancestor
65390488|NCT00715013|Mitosis Modulators|mitosis modulators|mesh-ancestor
65390489|NCT00715013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390490|NCT00715091|Diclofenac|diclofenac|mesh-list
65390491|NCT00715091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65390492|NCT00715091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65390493|NCT00715091|Analgesics|analgesics|mesh-ancestor
65390494|NCT00715091|Sensory System Agents|sensory system agents|mesh-ancestor
65390495|NCT00715091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65390496|NCT00715091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390497|NCT00715091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65390498|NCT00715091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65390499|NCT00715091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65390500|NCT00715091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390501|NCT00715091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390502|NCT00718913|Docetaxel|docetaxel|mesh-list
65390503|NCT00718913|Capecitabine|capecitabine|mesh-list
65390504|NCT00718913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390505|NCT00718913|Tubulin Modulators|tubulin modulators|mesh-ancestor
65390506|NCT00718913|Antimitotic Agents|antimitotic agents|mesh-ancestor
65390507|NCT00718913|Mitosis Modulators|mitosis modulators|mesh-ancestor
65390508|NCT00718913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390509|NCT00718913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65390510|NCT00718913|Antimetabolites|antimetabolites|mesh-ancestor
65390511|NCT04011930|Vitamin D|vitamin d|mesh-list
65390512|NCT04011930|Cholecalciferol|cholecalciferol|mesh-list
65390523|NCT00551616|Levonorgestrel|levonorgestrel|mesh-list
65390524|NCT00551616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65390525|NCT00551616|Contraceptive Agents|contraceptive agents|mesh-ancestor
65390526|NCT00551616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65390527|NCT00551616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390528|NCT00551616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65390529|NCT00551616|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65390530|NCT00551616|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65390531|NCT02574221|Fluorides|fluorides|mesh-list
65390532|NCT02574221|Tin Fluorides|tin fluorides|mesh-list
65390533|NCT02574221|Cariostatic Agents|cariostatic agents|mesh-ancestor
65390534|NCT02574221|Protective Agents|protective agents|mesh-ancestor
65066882|NCT00416468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65390535|NCT02574221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390536|NCT00452530|Enoxaparin|enoxaparin|mesh-list
65390537|NCT00452530|Enoxaparin sodium|enoxaparin sodium|mesh-list
65390538|NCT00452530|Apixaban|apixaban|mesh-list
65390539|NCT00452530|Anticoagulants|anticoagulants|mesh-ancestor
65390540|NCT00452530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65390541|NCT00452530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65390542|NCT00452530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390543|NCT00452530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65390544|NCT00452530|Antithrombins|antithrombins|mesh-ancestor
65390545|NCT00452530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65390546|NCT00452530|Protease Inhibitors|protease inhibitors|mesh-ancestor
65390547|NCT00452530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390548|NCT00549198|Tenofovir|tenofovir|mesh-list
65390549|NCT00549198|Lamivudine|lamivudine|mesh-list
65390550|NCT00549198|Emtricitabine|emtricitabine|mesh-list
65390570|NCT00506415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390571|NCT00506415|Cholinergic Agents|cholinergic agents|mesh-ancestor
65390572|NCT00506415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65390573|NCT00506415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390574|NCT00506415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65390575|NCT00506415|Protective Agents|protective agents|mesh-ancestor
65390576|NCT04036526|Vaccines|vaccines|mesh-list
65390577|NCT04036526|Immunologic Factors|immunologic factors|mesh-ancestor
65390578|NCT04036526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390579|NCT00452452|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65390580|NCT00452452|Immunologic Factors|immunologic factors|mesh-ancestor
65390581|NCT00452452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390582|NCT01009437|Ritonavir|ritonavir|mesh-list
65390583|NCT01009437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65390584|NCT01009437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65390585|NCT01009437|Protease Inhibitors|protease inhibitors|mesh-ancestor
65390586|NCT01009437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390587|NCT01009437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390588|NCT01009437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65390589|NCT01009437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65390590|NCT01009437|Antiviral Agents|antiviral agents|mesh-ancestor
65390591|NCT01009437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65390592|NCT01009437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65390593|NCT01009437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65390594|NCT00719381|Pioglitazone|pioglitazone|mesh-list
65390595|NCT00719381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65390596|NCT00719381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390597|NCT00510783|Phenytoin|phenytoin|mesh-list
65390598|NCT00510783|Fosphenytoin|fosphenytoin|mesh-list
65390615|NCT00518973|Antidepressive Agents|antidepressive agents|mesh-ancestor
65390616|NCT00518973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65390617|NCT00518973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65390618|NCT00518973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65390619|NCT00518973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65390620|NCT00518973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390621|NCT05300334|Adenosine|adenosine|mesh-list
65390622|NCT05300334|Analgesics|analgesics|mesh-ancestor
65390623|NCT05300334|Sensory System Agents|sensory system agents|mesh-ancestor
65390624|NCT05300334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65390625|NCT05300334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390626|NCT05300334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65390627|NCT05300334|Vasodilator Agents|vasodilator agents|mesh-ancestor
65390628|NCT05300334|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65390629|NCT05300334|Purinergic Agonists|purinergic agonists|mesh-ancestor
65390630|NCT05300334|Purinergic Agents|purinergic agents|mesh-ancestor
65390631|NCT05300334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65390632|NCT05300334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390633|NCT00897884|Metformin|metformin|mesh-list
65390634|NCT00897884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65390635|NCT00897884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390636|NCT01022164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65390637|NCT01022164|Hemostatics|hemostatics|mesh-ancestor
65390638|NCT01022164|Coagulants|coagulants|mesh-ancestor
65390639|NCT01012479|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65390640|NCT01012479|Candesartan|candesartan|mesh-list
65390641|NCT01012479|Candesartan cilexetil|candesartan cilexetil|mesh-list
65390643|NCT01012479|Diuretics|diuretics|mesh-ancestor
65390663|NCT00462670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390664|NCT00462670|Natriuretic Agents|natriuretic agents|mesh-ancestor
65390665|NCT00462670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390666|NCT01009593|Sorafenib|sorafenib|mesh-list
65390667|NCT01009593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390668|NCT01009593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65390669|NCT01009593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390670|NCT01009593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390671|NCT00719459|Iron|iron|mesh-list
65390672|NCT00719459|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65390673|NCT00719459|Trace Elements|trace elements|mesh-ancestor
65390674|NCT00719459|Micronutrients|micronutrients|mesh-ancestor
65390675|NCT00719459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390676|NCT00719459|Hematinics|hematinics|mesh-ancestor
65390677|NCT00711503|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65390678|NCT00711503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65390679|NCT00948168|Exenatide|exenatide|mesh-list
65390680|NCT00948168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65390681|NCT00948168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390682|NCT00948168|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65390683|NCT00948168|Incretins|incretins|mesh-ancestor
65390684|NCT00948168|Hormones|hormones|mesh-ancestor
65390685|NCT00948168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65390686|NCT00958386|Irinotecan|irinotecan|mesh-list
65390687|NCT00958386|Panitumumab|panitumumab|mesh-list
65390688|NCT00958386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65390689|NCT00958386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65390690|NCT00958386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390691|NCT00958386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390692|NCT00958386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390693|NCT00958386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65390694|NCT00719693|Calcium, Dietary|calcium, dietary|mesh-list
65390695|NCT00719693|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65390696|NCT00719693|Fenofibric acid|fenofibric acid|mesh-list
65390697|NCT00719693|Fenofibrate|fenofibrate|mesh-list
65390698|NCT00719693|Calcium|calcium|mesh-list
65390699|NCT00719693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64670945|NCT04812626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390700|NCT00719693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390701|NCT00719693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65390702|NCT00719693|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65390703|NCT00719693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65390704|NCT00719693|Antimetabolites|antimetabolites|mesh-ancestor
65390705|NCT00719693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390706|NCT00719693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65390707|NCT00719693|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65390708|NCT00719693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390709|NCT00948402|Metformin|metformin|mesh-list
65390710|NCT00948402|Biguanides|biguanides|mesh-list
65390711|NCT00948402|Contraceptive Agents|contraceptive agents|mesh-list
65390712|NCT00948402|Contraceptives, Oral|contraceptives, oral|mesh-list
65390713|NCT00948402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65390714|NCT00948402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390715|NCT00948402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65390716|NCT00948402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65390717|NCT05352126|Disinfectants|disinfectants|mesh-list
65390718|NCT05352126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65390719|NCT00948480|Sargramostim|sargramostim|mesh-list
65390720|NCT00948480|Immunologic Factors|immunologic factors|mesh-ancestor
65390721|NCT00948480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390722|NCT03753555|Calcium, Dietary|calcium, dietary|mesh-list
65390723|NCT03753555|Atorvastatin|atorvastatin|mesh-list
65390724|NCT03753555|Probucol|probucol|mesh-list
65390725|NCT03753555|Calcium|calcium|mesh-list
65390726|NCT03753555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65390727|NCT03753555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390728|NCT03753555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65390729|NCT03753555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65390730|NCT03753555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65390731|NCT03753555|Antimetabolites|antimetabolites|mesh-ancestor
65390736|NCT03753555|Antioxidants|antioxidants|mesh-ancestor
65390743|NCT00606086|Antiviral Agents|antiviral agents|mesh-ancestor
65390744|NCT00606086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65390745|NCT00606086|Antimetabolites|antimetabolites|mesh-ancestor
65390746|NCT00606086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390747|NCT00606086|Immunologic Factors|immunologic factors|mesh-ancestor
65390748|NCT00606086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390749|NCT02573363|Cytarabine|cytarabine|mesh-list
65390750|NCT02573363|Mitoxantrone|mitoxantrone|mesh-list
65390751|NCT02573363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65390752|NCT02573363|Antimetabolites|antimetabolites|mesh-ancestor
65390753|NCT02573363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390754|NCT02573363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390755|NCT02573363|Antiviral Agents|antiviral agents|mesh-ancestor
65390756|NCT02573363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65390757|NCT02573363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65390758|NCT02573363|Immunologic Factors|immunologic factors|mesh-ancestor
65390759|NCT02573363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390760|NCT02573363|Analgesics|analgesics|mesh-ancestor
65390761|NCT02573363|Sensory System Agents|sensory system agents|mesh-ancestor
65390762|NCT02573363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65390763|NCT02573363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65390764|NCT02573363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65390765|NCT02573363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390766|NCT00715637|Cytarabine|cytarabine|mesh-list
65390767|NCT00715637|Amonafide|amonafide|mesh-list
65390768|NCT00715637|Daunorubicin|daunorubicin|mesh-list
65390769|NCT00715637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65390792|NCT00893594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65390793|NCT00893594|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65390794|NCT00893594|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65390795|NCT00893594|Serotonin Agents|serotonin agents|mesh-ancestor
65390796|NCT00893594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65390797|NCT00893594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390798|NCT00893594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390799|NCT00893594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65390800|NCT00893594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65390801|NCT00893594|Analgesics|analgesics|mesh-ancestor
65390802|NCT00893594|Sensory System Agents|sensory system agents|mesh-ancestor
65390803|NCT00893594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65390804|NCT00893594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65390805|NCT00893594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65390806|NCT00893594|Gout Suppressants|gout suppressants|mesh-ancestor
65390807|NCT00893594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65390808|NCT00893594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390809|NCT00715715|Prednisone|prednisone|mesh-list
65390810|NCT00715715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65390811|NCT00715715|Glucocorticoids|glucocorticoids|mesh-ancestor
65390812|NCT00715715|Hormones|hormones|mesh-ancestor
65390813|NCT00715715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65390814|NCT00715715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390815|NCT00715715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65390816|NCT00715715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390817|NCT00953394|Octreotide|octreotide|mesh-list
65390818|NCT00953394|Fluorouracil|fluorouracil|mesh-list
65390819|NCT00953394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65390820|NCT00953394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65390821|NCT00953394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390822|NCT00953394|Antimetabolites|antimetabolites|mesh-ancestor
65390824|NCT00953394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65390833|NCT00898508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390834|NCT00609986|Insulin|insulin|mesh-list
65390835|NCT00609986|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65390836|NCT00609986|Insulin Glargine|insulin glargine|mesh-list
65390837|NCT00609986|Insulin, Isophane|insulin, isophane|mesh-list
65390838|NCT00609986|Isophane Insulin, Human|isophane insulin, human|mesh-list
65390839|NCT00609986|Isophane insulin, beef|isophane insulin, beef|mesh-list
65390840|NCT00609986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65390841|NCT00609986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390843|NCT00715871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65390844|NCT00715871|Autonomic Agents|autonomic agents|mesh-ancestor
65390845|NCT00715871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65390846|NCT00715871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390847|NCT00715871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65390848|NCT00715871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65390849|NCT00715871|Cholinergic Agents|cholinergic agents|mesh-ancestor
65390850|NCT00715871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65390851|NCT00715871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390852|NCT00712049|Nicotinic Acids|nicotinic acids|mesh-list
65390853|NCT00712049|Niacin|niacin|mesh-list
65390854|NCT00712049|Niacinamide|niacinamide|mesh-list
65390855|NCT00712049|Simvastatin|simvastatin|mesh-list
65390856|NCT00712049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65390857|NCT00712049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65390858|NCT00712049|Antimetabolites|antimetabolites|mesh-ancestor
65390859|NCT00712049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390860|NCT00712049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65390861|NCT00712049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65390862|NCT00712049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390863|NCT00712049|Vitamin B Complex|vitamin b complex|mesh-ancestor
65390864|NCT00712049|Vitamins|vitamins|mesh-ancestor
65390865|NCT00712049|Micronutrients|micronutrients|mesh-ancestor
65390866|NCT00712049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390867|NCT00712049|Vasodilator Agents|vasodilator agents|mesh-ancestor
65390868|NCT00712205|Calcitriol|calcitriol|mesh-list
65390869|NCT00712205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65390870|NCT00712205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780394|NCT02530476|Sorafenib|sorafenib|mesh-list
65390871|NCT00712205|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65390872|NCT00712205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65390873|NCT00712205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390874|NCT00712205|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65390875|NCT00712205|Vitamins|vitamins|mesh-ancestor
65390876|NCT00712205|Micronutrients|micronutrients|mesh-ancestor
65390877|NCT00712205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65390878|NCT00451906|Bevacizumab|bevacizumab|mesh-list
65390879|NCT00451906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65390880|NCT00451906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390881|NCT00451906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65390882|NCT00451906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65390883|NCT00451906|Growth Substances|growth substances|mesh-ancestor
65390884|NCT00451906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390885|NCT00451906|Growth Inhibitors|growth inhibitors|mesh-ancestor
65390886|NCT04070495|Clarithromycin|clarithromycin|mesh-list
65390887|NCT04070495|Rifampin|rifampin|mesh-list
65390888|NCT04070495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65390889|NCT04070495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65390890|NCT04070495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65390891|NCT04070495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390892|NCT04070495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390893|NCT04070495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65390894|NCT04070495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65390895|NCT04070495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65390896|NCT04070495|Antitubercular Agents|antitubercular agents|mesh-ancestor
65390905|NCT00712439|Gabapentin|gabapentin|mesh-list
65390916|NCT00712439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65390917|NCT00712439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65390918|NCT00712439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390919|NCT00712439|Antimanic Agents|antimanic agents|mesh-ancestor
65390920|NCT00716183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65390921|NCT00716183|Amoxicillin|amoxicillin|mesh-list
65390922|NCT00716183|Clavulanic Acids|clavulanic acids|mesh-list
65390923|NCT00716183|Clavulanic Acid|clavulanic acid|mesh-list
65390924|NCT00716183|Lactams|lactams|mesh-list
65390925|NCT00716183|beta-Lactams|beta-lactams|mesh-list
65390926|NCT00716183|Cloxacillin|cloxacillin|mesh-list
65390927|NCT00716183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65390928|NCT00716183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390929|NCT00716183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390930|NCT00716183|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65390931|NCT00712517|Propofol|propofol|mesh-list
65390932|NCT00712517|Sevoflurane|sevoflurane|mesh-list
65390933|NCT00712517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65390934|NCT00712517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65390935|NCT00712517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390936|NCT00712517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65390937|NCT00712517|Anesthetics, General|anesthetics, general|mesh-ancestor
65390938|NCT00712517|Anesthetics|anesthetics|mesh-ancestor
65390939|NCT00712517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65390940|NCT00712517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65390941|NCT00712595|Mifepristone|mifepristone|mesh-list
65390942|NCT00712595|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65390943|NCT00712595|Abortifacient Agents|abortifacient agents|mesh-ancestor
65390944|NCT00712595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65390945|NCT00712595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780438|NCT02541864|Amoxicillin|amoxicillin|mesh-list
64670946|NCT04812626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64670947|NCT04812626|Immunologic Factors|immunologic factors|mesh-ancestor
64670948|NCT04812626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670949|NCT04812626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64670950|NCT04812626|Glucocorticoids|glucocorticoids|mesh-ancestor
64670951|NCT04812626|Hormones|hormones|mesh-ancestor
64670952|NCT04812626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64670953|NCT04812626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670954|NCT04197986|Infigratinib|infigratinib|mesh-list
64670955|NCT04197986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670956|NCT01997411|Glucagon|glucagon|mesh-list
64670957|NCT01997411|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64670958|NCT01997411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64670959|NCT01997411|Hormones|hormones|mesh-ancestor
65390946|NCT00712595|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65390947|NCT00712595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65390948|NCT00712595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65390949|NCT00712595|Contraceptive Agents|contraceptive agents|mesh-ancestor
65390950|NCT00712595|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65390951|NCT00712595|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65390952|NCT00712595|Hormone Antagonists|hormone antagonists|mesh-ancestor
65390953|NCT00712595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65390954|NCT00712595|Luteolytic Agents|luteolytic agents|mesh-ancestor
65390955|NCT00712595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65390956|NCT00712595|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65390957|NCT00115765|Bevacizumab|bevacizumab|mesh-list
65390958|NCT00115765|Panitumumab|panitumumab|mesh-list
65390959|NCT00115765|Oxaliplatin|oxaliplatin|mesh-list
65390960|NCT00115765|Irinotecan|irinotecan|mesh-list
65390961|NCT00115765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65390962|NCT00115765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390963|NCT00115765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65390964|NCT00115765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65390965|NCT00115765|Growth Substances|growth substances|mesh-ancestor
65390966|NCT00115765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65390967|NCT00115765|Growth Inhibitors|growth inhibitors|mesh-ancestor
65390968|NCT00115765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65390969|NCT00115765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65390970|NCT00115765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65390971|NCT00115765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390972|NCT00606008|Sunitinib|sunitinib|mesh-list
65390973|NCT00606008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65390990|NCT00721331|Dermatologic Agents|dermatologic agents|mesh-ancestor
65390991|NCT00721331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65390992|NCT00721331|Antipruritics|antipruritics|mesh-ancestor
65390993|NCT00721331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65390994|NCT00721331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65390995|NCT00721331|Histamine Antagonists|histamine antagonists|mesh-ancestor
65390996|NCT00721331|Histamine Agents|histamine agents|mesh-ancestor
65390997|NCT00721331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65390998|NCT00721331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65390999|NCT00721331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391000|NCT00721331|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65391001|NCT00721331|Antidepressive Agents|antidepressive agents|mesh-ancestor
65391002|NCT00721331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65391003|NCT00721331|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65391004|NCT00721331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65391005|NCT00721331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65391006|NCT00721331|Adrenergic Agents|adrenergic agents|mesh-ancestor
65391007|NCT00123955|Spironolactone|spironolactone|mesh-list
65391008|NCT00123955|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65391009|NCT00123955|Hormone Antagonists|hormone antagonists|mesh-ancestor
65391010|NCT00123955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65391011|NCT00123955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391012|NCT00123955|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65391013|NCT00123955|Diuretics|diuretics|mesh-ancestor
65391014|NCT00123955|Natriuretic Agents|natriuretic agents|mesh-ancestor
65391015|NCT01027546|Tranexamic Acid|tranexamic acid|mesh-list
65391016|NCT01027546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65391017|NCT01027546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65391018|NCT01027546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391019|NCT01027546|Hemostatics|hemostatics|mesh-ancestor
65391032|NCT01026064|Cantharidin|cantharidin|mesh-list
65391033|NCT01026064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65391034|NCT01026064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65391035|NCT01026064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391036|NCT01026064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391037|NCT02571959|Amoxicillin|amoxicillin|mesh-list
65391038|NCT02571959|Clavulanic Acids|clavulanic acids|mesh-list
65391039|NCT02571959|Clavulanic Acid|clavulanic acid|mesh-list
65391040|NCT02571959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65391041|NCT02571959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65391042|NCT02571959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391043|NCT02571959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391044|NCT02571959|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65391045|NCT00461500|Fluticasone|fluticasone|mesh-list
65391046|NCT00461500|Xhance|xhance|mesh-list
65391047|NCT00461500|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65391048|NCT00461500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65391049|NCT00461500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65391050|NCT00461500|Autonomic Agents|autonomic agents|mesh-ancestor
65391051|NCT00461500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391052|NCT00461500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391053|NCT00461500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65391054|NCT00461500|Respiratory System Agents|respiratory system agents|mesh-ancestor
65391055|NCT00461500|Dermatologic Agents|dermatologic agents|mesh-ancestor
65391056|NCT00461500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65391057|NCT00461500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65391058|NCT00461500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65391059|NCT00461500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65391060|NCT00461500|Adrenergic Agents|adrenergic agents|mesh-ancestor
65391061|NCT00461500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65391063|NCT00893906|Vaccines|vaccines|mesh-list
65391075|NCT00721487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65391076|NCT00721487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391077|NCT00721487|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65391078|NCT00721487|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65391079|NCT00167245|Topiramate|topiramate|mesh-list
65391080|NCT00167245|Anticonvulsants|anticonvulsants|mesh-ancestor
65391081|NCT00167245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65391082|NCT00167245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391083|NCT00894062|Everolimus|everolimus|mesh-list
65391084|NCT00894062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391085|NCT00894062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65391086|NCT00894062|Immunologic Factors|immunologic factors|mesh-ancestor
65391087|NCT00894062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391088|NCT00443560|Fentanyl|fentanyl|mesh-list
65391089|NCT00443560|Bupivacaine|bupivacaine|mesh-list
65391090|NCT00443560|Anesthetics, Local|anesthetics, local|mesh-ancestor
65391091|NCT00443560|Anesthetics|anesthetics|mesh-ancestor
65391092|NCT00443560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65391093|NCT00443560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391094|NCT00443560|Sensory System Agents|sensory system agents|mesh-ancestor
65391095|NCT00443560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391096|NCT00443560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65391097|NCT00443560|Narcotics|narcotics|mesh-ancestor
65391098|NCT00443560|Analgesics|analgesics|mesh-ancestor
65391099|NCT00443560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65391100|NCT00443560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65391101|NCT00443560|Anesthetics, General|anesthetics, general|mesh-ancestor
65391102|NCT01022632|Curcumin|curcumin|mesh-list
65391103|NCT01022632|Fluoxetine|fluoxetine|mesh-list
65391104|NCT01022632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65391119|NCT01022632|Analgesics|analgesics|mesh-ancestor
65391120|NCT01022632|Sensory System Agents|sensory system agents|mesh-ancestor
65391121|NCT01022632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391122|NCT01022632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65391123|NCT01022632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65391124|NCT01022632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391125|NCT01026376|Decitabine|decitabine|mesh-list
65391126|NCT01026376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65391127|NCT01026376|Antimetabolites|antimetabolites|mesh-ancestor
65391128|NCT01026376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391129|NCT01026376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391130|NCT01026376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391131|NCT00716573|Everolimus|everolimus|mesh-list
65391132|NCT00716573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391133|NCT00716573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65391134|NCT00716573|Immunologic Factors|immunologic factors|mesh-ancestor
65066883|NCT00416468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65391135|NCT00716573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391137|NCT02539706|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65391138|NCT02539706|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65391139|NCT02539706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65391140|NCT02539706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391141|NCT02539706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391142|NCT00451204|Glatiramer Acetate|glatiramer acetate|mesh-list
65391143|NCT00451204|Estrogens|estrogens|mesh-list
65391169|NCT03537586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391170|NCT03537586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65391171|NCT03537586|Vasodilator Agents|vasodilator agents|mesh-ancestor
65391172|NCT03537586|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65391173|NCT03537586|Purinergic Agonists|purinergic agonists|mesh-ancestor
65391174|NCT03537586|Purinergic Agents|purinergic agents|mesh-ancestor
65391175|NCT03537586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65391176|NCT03537586|Antithrombins|antithrombins|mesh-ancestor
65391177|NCT03537586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65391178|NCT03537586|Protease Inhibitors|protease inhibitors|mesh-ancestor
65391179|NCT03537586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391180|NCT00722033|Indomethacin|indomethacin|mesh-list
65391181|NCT00722033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65391182|NCT00722033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65391183|NCT00722033|Analgesics|analgesics|mesh-ancestor
65391184|NCT00722033|Sensory System Agents|sensory system agents|mesh-ancestor
65391185|NCT00722033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391186|NCT00722033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391187|NCT00722033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65391188|NCT00722033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65391189|NCT00722033|Gout Suppressants|gout suppressants|mesh-ancestor
65391190|NCT00722033|Tocolytic Agents|tocolytic agents|mesh-ancestor
65391191|NCT00722033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65391192|NCT00722033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65391193|NCT00722033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391194|NCT00722033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391195|NCT00894374|Artesunate|artesunate|mesh-list
65391196|NCT00894374|Antimalarials|antimalarials|mesh-ancestor
65391197|NCT00894374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65391198|NCT00894374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65391199|NCT00894374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65391200|NCT00894374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391201|NCT00894374|Antiviral Agents|antiviral agents|mesh-ancestor
65391202|NCT00894374|Schistosomicides|schistosomicides|mesh-ancestor
65391203|NCT00894374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65391204|NCT00894374|Anthelmintics|anthelmintics|mesh-ancestor
65391205|NCT04920149|Mesalamine|mesalamine|mesh-list
65391208|NCT04920149|Analgesics|analgesics|mesh-ancestor
65391209|NCT04920149|Sensory System Agents|sensory system agents|mesh-ancestor
65391210|NCT04920149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391211|NCT04920149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391212|NCT04920149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65391213|NCT04920149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65391214|NCT01026610|Entecavir|entecavir|mesh-list
65391215|NCT01026610|Antiviral Agents|antiviral agents|mesh-ancestor
65391216|NCT01026610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65391217|NCT00901550|Methotrexate|methotrexate|mesh-list
65391218|NCT00901550|Infliximab|infliximab|mesh-list
65391219|NCT00901550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65391220|NCT00901550|Abortifacient Agents|abortifacient agents|mesh-ancestor
65391221|NCT00901550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65391222|NCT00901550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391223|NCT00901550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65391224|NCT00901550|Antimetabolites|antimetabolites|mesh-ancestor
65391225|NCT00901550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391226|NCT00901550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391227|NCT00901550|Dermatologic Agents|dermatologic agents|mesh-ancestor
65391228|NCT00901550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391229|NCT00901550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65391230|NCT00901550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65391231|NCT00901550|Immunologic Factors|immunologic factors|mesh-ancestor
65391232|NCT00901550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65391233|NCT00901550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65391234|NCT00901550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65391235|NCT02573051|Isosorbide|isosorbide|mesh-list
65391236|NCT02573051|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65391237|NCT02573051|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65391238|NCT02573051|Misoprostol|misoprostol|mesh-list
65391239|NCT02573051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65391240|NCT02573051|Abortifacient Agents|abortifacient agents|mesh-ancestor
65391251|NCT02573051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391252|NCT02539940|Paclitaxel|paclitaxel|mesh-list
65391253|NCT02539940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65391254|NCT02539940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391255|NCT02539940|Tubulin Modulators|tubulin modulators|mesh-ancestor
65391256|NCT02539940|Antimitotic Agents|antimitotic agents|mesh-ancestor
65391257|NCT02539940|Mitosis Modulators|mitosis modulators|mesh-ancestor
65391258|NCT02539940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391259|NCT01028092|Cyclosporine|cyclosporine|mesh-list
65391260|NCT01028092|Everolimus|everolimus|mesh-list
65391261|NCT01028092|Interleukin-2|interleukin-2|mesh-list
65391262|NCT01028092|Cyclosporins|cyclosporins|mesh-list
65391263|NCT01028092|Thymoglobulin|thymoglobulin|mesh-list
65391264|NCT01028092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391265|NCT01028092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391266|NCT01028092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65391267|NCT01028092|Immunologic Factors|immunologic factors|mesh-ancestor
65391268|NCT01028092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391269|NCT01028092|Antifungal Agents|antifungal agents|mesh-ancestor
65391270|NCT01028092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65391271|NCT01028092|Dermatologic Agents|dermatologic agents|mesh-ancestor
65391272|NCT01028092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65391273|NCT01028092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65391274|NCT01028092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391275|NCT01028092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65391276|NCT01028092|Analgesics|analgesics|mesh-ancestor
65391277|NCT01028092|Sensory System Agents|sensory system agents|mesh-ancestor
65391278|NCT01028092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391298|NCT00894608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391299|NCT00894608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65391300|NCT00894608|Hormone Antagonists|hormone antagonists|mesh-ancestor
65391301|NCT00894608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65391302|NCT00894608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391303|NCT00901784|Topiramate|topiramate|mesh-list
65391304|NCT00901784|Anticonvulsants|anticonvulsants|mesh-ancestor
65391305|NCT00901784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65391306|NCT00901784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391307|NCT00905996|Propranolol|propranolol|mesh-list
65391308|NCT00905996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65391309|NCT00905996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65391310|NCT00905996|Adrenergic Agents|adrenergic agents|mesh-ancestor
65391311|NCT00905996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65391312|NCT00905996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391313|NCT00905996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391314|NCT00905996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65391315|NCT00905996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65391316|NCT00905996|Vasodilator Agents|vasodilator agents|mesh-ancestor
65391317|NCT02539628|Ropivacaine|ropivacaine|mesh-list
65391318|NCT02539628|Anesthetics, Local|anesthetics, local|mesh-ancestor
65391319|NCT02539628|Anesthetics|anesthetics|mesh-ancestor
65391320|NCT02539628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65391321|NCT02539628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391322|NCT02539628|Sensory System Agents|sensory system agents|mesh-ancestor
65391323|NCT02539628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391324|NCT02573987|Lidocaine|lidocaine|mesh-list
65391325|NCT02573987|Nitrous Oxide|nitrous oxide|mesh-list
65391326|NCT02573987|Anesthetics, Local|anesthetics, local|mesh-ancestor
65391327|NCT02573987|Anesthetics|anesthetics|mesh-ancestor
65391328|NCT02573987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65391339|NCT02573987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65391340|NCT02573987|Analgesics|analgesics|mesh-ancestor
65391341|NCT00906386|Varenicline|varenicline|mesh-list
65391342|NCT00906386|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65391343|NCT00906386|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65391344|NCT00906386|Cholinergic Agents|cholinergic agents|mesh-ancestor
65391345|NCT00906386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65391346|NCT00906386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391347|NCT00906386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391348|NCT00722579|Cobalt|cobalt|mesh-list
65391349|NCT00722579|Chromium|chromium|mesh-list
65391350|NCT00722579|Trace Elements|trace elements|mesh-ancestor
65391351|NCT00722579|Micronutrients|micronutrients|mesh-ancestor
65391352|NCT00722579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391353|NCT04069169|Lidocaine|lidocaine|mesh-list
65391354|NCT04069169|Anesthetics, Local|anesthetics, local|mesh-ancestor
65391355|NCT04069169|Anesthetics|anesthetics|mesh-ancestor
65391356|NCT04069169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65391357|NCT04069169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391358|NCT04069169|Sensory System Agents|sensory system agents|mesh-ancestor
65391359|NCT04069169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391360|NCT04069169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65391361|NCT04069169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65391362|NCT04069169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65391363|NCT04069169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65391364|NCT04069169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391365|NCT00713687|Gemcitabine|gemcitabine|mesh-list
65391366|NCT00713687|Oxaliplatin|oxaliplatin|mesh-list
65391367|NCT00713687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65391368|NCT00713687|Antimetabolites|antimetabolites|mesh-ancestor
65391369|NCT00713687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391370|NCT00713687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391371|NCT00713687|Antiviral Agents|antiviral agents|mesh-ancestor
65391372|NCT00713687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65391380|NCT02540876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391381|NCT02540876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391382|NCT00894920|Biotin|biotin|mesh-list
65391383|NCT00894920|Vitamin B Complex|vitamin b complex|mesh-ancestor
65391384|NCT00894920|Vitamins|vitamins|mesh-ancestor
65391385|NCT00894920|Micronutrients|micronutrients|mesh-ancestor
65391386|NCT00894920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391387|NCT00722735|Ciprofloxacin|ciprofloxacin|mesh-list
65391388|NCT00722735|Finafloxacin|finafloxacin|mesh-list
65391389|NCT00722735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65391390|NCT00722735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65391391|NCT00722735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65391392|NCT00722735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65391393|NCT00722735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391394|NCT00722735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391395|NCT00722735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391396|NCT00722735|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65391397|NCT00722735|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65391398|NCT00722735|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65391399|NCT00722735|Renal Agents|renal agents|mesh-ancestor
65391400|NCT04067531|Clindamycin|clindamycin|mesh-list
65391401|NCT04067531|Clindamycin palmitate|clindamycin palmitate|mesh-list
65391402|NCT04067531|Clindamycin phosphate|clindamycin phosphate|mesh-list
65391403|NCT04067531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65391404|NCT04067531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65391405|NCT04067531|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65391406|NCT04067531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391407|NCT04067531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391408|NCT00713765|Donepezil|donepezil|mesh-list
65391409|NCT00713765|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65391410|NCT00713765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780698|NCT03907176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64670960|NCT01997411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64670961|NCT01997411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670962|NCT01997411|Incretins|incretins|mesh-ancestor
64670963|NCT03534635|Pembrolizumab|pembrolizumab|mesh-list
64670964|NCT03534635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64670965|NCT03534635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670972|NCT04153760|Sensory System Agents|sensory system agents|mesh-ancestor
64670973|NCT04153760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670974|NCT04153760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391411|NCT00713765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391412|NCT00713765|Cholinergic Agents|cholinergic agents|mesh-ancestor
65391413|NCT00713765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65391414|NCT00713765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391415|NCT00713765|Nootropic Agents|nootropic agents|mesh-ancestor
65391416|NCT00717587|Sunitinib|sunitinib|mesh-list
65391417|NCT00717587|Motexafin gadolinium|motexafin gadolinium|mesh-list
65391418|NCT00717587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391419|NCT00717587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65391420|NCT00717587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65391421|NCT00717587|Growth Substances|growth substances|mesh-ancestor
65391422|NCT00717587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391423|NCT00717587|Growth Inhibitors|growth inhibitors|mesh-ancestor
65391424|NCT00717587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65391425|NCT00717587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391426|NCT00717587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391427|NCT00717587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65391428|NCT00717587|Dermatologic Agents|dermatologic agents|mesh-ancestor
65391429|NCT00894998|Heparin|heparin|mesh-list
65391430|NCT00894998|Calcium heparin|calcium heparin|mesh-list
65391431|NCT00894998|Anticoagulants|anticoagulants|mesh-ancestor
65391432|NCT00894998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65391435|NCT00713921|Fesoterodine|fesoterodine|mesh-list
65391463|NCT03476369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391464|NCT03476369|Analgesics|analgesics|mesh-ancestor
65391465|NCT03476369|Sensory System Agents|sensory system agents|mesh-ancestor
65391466|NCT03476369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391467|NCT03476369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65391468|NCT03476369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65391469|NCT03476369|Anesthetics, General|anesthetics, general|mesh-ancestor
65391470|NCT03476369|Anesthetics|anesthetics|mesh-ancestor
65391471|NCT03476369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65391472|NCT03476369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65391473|NCT03476369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65391474|NCT03476369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65391475|NCT03476369|Purinergic Agents|purinergic agents|mesh-ancestor
65391476|NCT03476369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65391477|NCT03476369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391478|NCT00722969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65391479|NCT00722969|Sorafenib|sorafenib|mesh-list
65391480|NCT00722969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391481|NCT00722969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65391482|NCT00722969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391483|NCT00722969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391484|NCT04069325|Febuxostat|febuxostat|mesh-list
65391485|NCT04069325|Gout Suppressants|gout suppressants|mesh-ancestor
65391486|NCT04069325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65391487|NCT00723047|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65391488|NCT00723047|Hemostatics|hemostatics|mesh-ancestor
65391489|NCT00723047|Coagulants|coagulants|mesh-ancestor
65391490|NCT03451799|Temozolomide|temozolomide|mesh-list
65391491|NCT03451799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65391492|NCT03451799|Alkylating Agents|alkylating agents|mesh-ancestor
65391493|NCT03451799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391494|NCT03451799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391495|NCT00450814|Cyclophosphamide|cyclophosphamide|mesh-list
65391496|NCT00450814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65391502|NCT00450814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391503|NCT00450814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391504|NCT00450814|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65391505|NCT02571491|Ketamine|ketamine|mesh-list
65391506|NCT02571491|Morphine|morphine|mesh-list
65391507|NCT02571491|Remifentanil|remifentanil|mesh-list
65391508|NCT02571491|Analgesics|analgesics|mesh-ancestor
65391509|NCT02571491|Sensory System Agents|sensory system agents|mesh-ancestor
65391510|NCT02571491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391511|NCT02571491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391512|NCT02571491|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65391513|NCT02571491|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65391514|NCT02571491|Anesthetics, General|anesthetics, general|mesh-ancestor
65391515|NCT02571491|Anesthetics|anesthetics|mesh-ancestor
65391516|NCT02571491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65391517|NCT02571491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65391518|NCT02571491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65391519|NCT02571491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65391520|NCT02571491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391521|NCT02571491|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65391522|NCT02571491|Narcotics|narcotics|mesh-ancestor
65391523|NCT00723437|Acitretin|acitretin|mesh-list
65391524|NCT00723437|Keratolytic Agents|keratolytic agents|mesh-ancestor
65391525|NCT00723437|Dermatologic Agents|dermatologic agents|mesh-ancestor
65391526|NCT00723515|Listerine|listerine|mesh-list
65391527|NCT00723515|Calcium|calcium|mesh-list
65391528|NCT00723515|Fluorides|fluorides|mesh-list
65391529|NCT00723515|Sodium Fluoride|sodium fluoride|mesh-list
65391530|NCT00723515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65391531|NCT00723515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391532|NCT00723515|Cariostatic Agents|cariostatic agents|mesh-ancestor
65391533|NCT00723515|Protective Agents|protective agents|mesh-ancestor
65391534|NCT00723515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65391535|NCT00723515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65391536|NCT01028170|Furosemide|furosemide|mesh-list
64556876|NCT04355637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64556878|NCT04367025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556879|NCT03076710|Bupivacaine|bupivacaine|mesh-list
64556880|NCT03076710|Anesthetics, Local|anesthetics, local|mesh-ancestor
64556881|NCT03076710|Anesthetics|anesthetics|mesh-ancestor
64556882|NCT03076710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65391537|NCT01028170|Diuretics|diuretics|mesh-ancestor
65391538|NCT01028170|Natriuretic Agents|natriuretic agents|mesh-ancestor
65391539|NCT01028170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391540|NCT01028170|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65391541|NCT01028170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65391542|NCT01028170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391543|NCT00518115|Exenatide|exenatide|mesh-list
65391544|NCT00518115|rGLP-1 protein|rglp-1 protein|mesh-list
65391545|NCT00518115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65391546|NCT00518115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391547|NCT00518115|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65391548|NCT00518115|Incretins|incretins|mesh-ancestor
65391549|NCT00518115|Hormones|hormones|mesh-ancestor
65391550|NCT00518115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65391551|NCT00723983|Sumatriptan|sumatriptan|mesh-list
65391552|NCT00723983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65391553|NCT00723983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65391554|NCT00723983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65391555|NCT00723983|Serotonin Agents|serotonin agents|mesh-ancestor
65391556|NCT00723983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65391557|NCT00723983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391558|NCT00723983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391559|NCT00450658|Ibuprofen|ibuprofen|mesh-list
65391560|NCT00450658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65391561|NCT00450658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65391562|NCT00450658|Analgesics|analgesics|mesh-ancestor
65391563|NCT00450658|Sensory System Agents|sensory system agents|mesh-ancestor
65391581|NCT02572505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65391582|NCT00517881|Epoetin Alfa|epoetin alfa|mesh-list
65391583|NCT00517881|Hematinics|hematinics|mesh-ancestor
65391584|NCT01010139|Codeine|codeine|mesh-list
65391585|NCT01010139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65391586|NCT01010139|Narcotics|narcotics|mesh-ancestor
65391587|NCT01010139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65391588|NCT01010139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391589|NCT01010139|Analgesics|analgesics|mesh-ancestor
65391590|NCT01010139|Sensory System Agents|sensory system agents|mesh-ancestor
65391591|NCT01010139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391592|NCT01010139|Antitussive Agents|antitussive agents|mesh-ancestor
65391593|NCT01010139|Respiratory System Agents|respiratory system agents|mesh-ancestor
65391594|NCT00724295|Ribavirin|ribavirin|mesh-list
65391595|NCT00724295|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65391596|NCT00724295|Antimetabolites|antimetabolites|mesh-ancestor
65391597|NCT00724295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391598|NCT00724295|Antiviral Agents|antiviral agents|mesh-ancestor
65391599|NCT00724295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65391600|NCT00718289|Dialysis Solutions|dialysis solutions|mesh-list
65391601|NCT00718289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65391602|NCT00517413|Epoetin Alfa|epoetin alfa|mesh-list
65391603|NCT00517413|Hematinics|hematinics|mesh-ancestor
65391604|NCT00724529|Infliximab|infliximab|mesh-list
65391605|NCT00724529|Dermatologic Agents|dermatologic agents|mesh-ancestor
65391606|NCT00724529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65391607|NCT00724529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65391608|NCT01012869|Everolimus|everolimus|mesh-list
65391609|NCT01012869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391610|NCT01012869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65391611|NCT01012869|Immunologic Factors|immunologic factors|mesh-ancestor
65391612|NCT01012869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391613|NCT01010295|Doxycycline|doxycycline|mesh-list
65391614|NCT01010295|Tetracycline|tetracycline|mesh-list
65391615|NCT01010295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65391616|NCT01010295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65391617|NCT01010295|Antimalarials|antimalarials|mesh-ancestor
65391618|NCT01010295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65391619|NCT01010295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65391622|NCT01010295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391623|NCT01010373|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
65391624|NCT01010373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65391625|NCT01010373|Immunologic Factors|immunologic factors|mesh-ancestor
65391626|NCT01010373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391627|NCT01010373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391628|NCT01010373|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65391629|NCT01010373|Protective Agents|protective agents|mesh-ancestor
65391630|NCT01010373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65391631|NCT01010373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65391632|NCT01010373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391633|NCT01010373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391634|NCT01010373|Antiviral Agents|antiviral agents|mesh-ancestor
65391635|NCT01010373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65391636|NCT01010451|Anti-Infective Agents|anti-infective agents|mesh-list
65391637|NCT01010451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65391638|NCT01010451|Calcium|calcium|mesh-list
65391639|NCT01010451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65391640|NCT01010451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391641|NCT02570789|Sunitinib|sunitinib|mesh-list
65391642|NCT02570789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391643|NCT02570789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65391644|NCT02570789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65391645|NCT02570789|Growth Substances|growth substances|mesh-ancestor
65391646|NCT02570789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391647|NCT02570789|Growth Inhibitors|growth inhibitors|mesh-ancestor
65391648|NCT02570789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65391666|NCT00724685|Ropivacaine|ropivacaine|mesh-list
65391667|NCT00724685|Anesthetics, Local|anesthetics, local|mesh-ancestor
65391668|NCT00724685|Anesthetics|anesthetics|mesh-ancestor
65391669|NCT00724685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65391670|NCT00724685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391671|NCT00724685|Sensory System Agents|sensory system agents|mesh-ancestor
65391672|NCT00724685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391673|NCT00123487|Dasatinib|dasatinib|mesh-list
65391674|NCT00123487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391675|NCT00123487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65391676|NCT00123487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391677|NCT00123487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391678|NCT00509925|Insulin|insulin|mesh-list
65391679|NCT00509925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65391680|NCT00509925|Insulin Aspart|insulin aspart|mesh-list
65391681|NCT00509925|Insulin Detemir|insulin detemir|mesh-list
65391682|NCT00509925|Isophane Insulin, Human|isophane insulin, human|mesh-list
65391683|NCT00509925|Insulin, Isophane|insulin, isophane|mesh-list
65391684|NCT00509925|Isophane insulin, beef|isophane insulin, beef|mesh-list
65391685|NCT00509925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65391686|NCT00509925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391687|NCT05277974|Dexamethasone|dexamethasone|mesh-list
65391688|NCT05277974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65391689|NCT05277974|Antiemetics|antiemetics|mesh-ancestor
65391690|NCT05277974|Autonomic Agents|autonomic agents|mesh-ancestor
65391691|NCT05277974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391692|NCT05277974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391693|NCT05277974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65391694|NCT05277974|Glucocorticoids|glucocorticoids|mesh-ancestor
65391695|NCT05277974|Hormones|hormones|mesh-ancestor
65391696|NCT05277974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65391698|NCT05277974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391710|NCT00504777|Antimetabolites|antimetabolites|mesh-ancestor
65391711|NCT00504777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391712|NCT00504777|Dermatologic Agents|dermatologic agents|mesh-ancestor
65391713|NCT00504777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391714|NCT00504777|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65391715|NCT00504777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65391716|NCT00504777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65391717|NCT03968263|Hydrocodone|hydrocodone|mesh-list
65391718|NCT03968263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65391719|NCT03968263|Narcotics|narcotics|mesh-ancestor
65391720|NCT03968263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65391721|NCT03968263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391722|NCT03968263|Analgesics|analgesics|mesh-ancestor
65391723|NCT03968263|Sensory System Agents|sensory system agents|mesh-ancestor
65391724|NCT03968263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391725|NCT03968263|Antitussive Agents|antitussive agents|mesh-ancestor
65391726|NCT03968263|Respiratory System Agents|respiratory system agents|mesh-ancestor
65391727|NCT00895076|Dexamethasone|dexamethasone|mesh-list
65391728|NCT00895076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65391729|NCT00895076|Antiemetics|antiemetics|mesh-ancestor
65391730|NCT00895076|Autonomic Agents|autonomic agents|mesh-ancestor
65391731|NCT00895076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391732|NCT00895076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391733|NCT00895076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65391734|NCT00895076|Glucocorticoids|glucocorticoids|mesh-ancestor
65391735|NCT00895076|Hormones|hormones|mesh-ancestor
65391736|NCT00895076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65391737|NCT00895076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65391738|NCT00895076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391739|NCT01078519|Anesthetics|anesthetics|mesh-list
65391740|NCT01078519|Anesthetics, Local|anesthetics, local|mesh-list
65391741|NCT01078519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65391752|NCT03968185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391753|NCT00509769|Trastuzumab|trastuzumab|mesh-list
65391754|NCT00509769|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65391755|NCT00509769|Maytansine|maytansine|mesh-list
65391756|NCT00509769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65391757|NCT00509769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391758|NCT00509769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65391759|NCT00509769|Tubulin Modulators|tubulin modulators|mesh-ancestor
65391760|NCT00509769|Antimitotic Agents|antimitotic agents|mesh-ancestor
65391761|NCT00509769|Mitosis Modulators|mitosis modulators|mesh-ancestor
65391762|NCT00509769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391763|NCT05206877|Insulin|insulin|mesh-list
65391764|NCT05206877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65391765|NCT05206877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65391766|NCT05206877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391767|NCT01074697|Dexamethasone|dexamethasone|mesh-list
65391768|NCT01074697|Palonosetron|palonosetron|mesh-list
65391769|NCT01074697|Fosaprepitant|fosaprepitant|mesh-list
65391770|NCT01074697|Aprepitant|aprepitant|mesh-list
65391771|NCT01074697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65391772|NCT01074697|Antiemetics|antiemetics|mesh-ancestor
65391773|NCT01074697|Autonomic Agents|autonomic agents|mesh-ancestor
65391774|NCT01074697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391775|NCT01074697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391776|NCT01074697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65391777|NCT01074697|Glucocorticoids|glucocorticoids|mesh-ancestor
65391778|NCT01074697|Hormones|hormones|mesh-ancestor
65391779|NCT01074697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65391780|NCT01074697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65391781|NCT01074697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391782|NCT01074697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391783|NCT01074697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65391785|NCT01074697|Serotonin Agents|serotonin agents|mesh-ancestor
65391794|NCT05124275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65391795|NCT05124275|Cholinergic Agents|cholinergic agents|mesh-ancestor
65391796|NCT05124275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65391797|NCT05124275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391798|NCT01080079|Terbinafine|terbinafine|mesh-list
65391799|NCT01080079|Antifungal Agents|antifungal agents|mesh-ancestor
65391800|NCT01080079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65391801|NCT01080079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391802|NCT01080079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391803|NCT00725231|Alemtuzumab|alemtuzumab|mesh-list
65391804|NCT00725231|Doxorubicin|doxorubicin|mesh-list
65391805|NCT00725231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65391806|NCT00725231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65391807|NCT00725231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391808|NCT00725231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65391809|NCT00725231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65391810|NCT00725231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65391811|NCT00725231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65391812|NCT00725231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391813|NCT00114127|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65391814|NCT00114127|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65391815|NCT00114127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65391816|NCT00114127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65391817|NCT00114127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391818|NCT00114127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65391819|NCT00114127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391821|NCT00114127|Sensory System Agents|sensory system agents|mesh-ancestor
65391838|NCT00902954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65391839|NCT02540720|Dexamethasone|dexamethasone|mesh-list
65391840|NCT02540720|gamma-Globulins|gamma-globulins|mesh-list
65391841|NCT02540720|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65391842|NCT02540720|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65391843|NCT02540720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65391844|NCT02540720|Antiemetics|antiemetics|mesh-ancestor
65391845|NCT02540720|Autonomic Agents|autonomic agents|mesh-ancestor
65391846|NCT02540720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391847|NCT02540720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391848|NCT02540720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65391849|NCT02540720|Glucocorticoids|glucocorticoids|mesh-ancestor
65391850|NCT02540720|Hormones|hormones|mesh-ancestor
65391851|NCT02540720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65391852|NCT02540720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65391853|NCT02540720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391854|NCT02540720|Immunologic Factors|immunologic factors|mesh-ancestor
65391855|NCT02540642|Vitamin B 12|vitamin b 12|mesh-list
65391856|NCT02540642|Vitamins|vitamins|mesh-ancestor
65391857|NCT02540642|Micronutrients|micronutrients|mesh-ancestor
65391858|NCT02540642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391859|NCT02540642|Vitamin B Complex|vitamin b complex|mesh-ancestor
65391860|NCT00122317|Eculizumab|eculizumab|mesh-list
65391861|NCT00122317|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65391862|NCT00122317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65391863|NCT00122317|Immunologic Factors|immunologic factors|mesh-ancestor
65391864|NCT00122317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391865|NCT00908336|Docetaxel|docetaxel|mesh-list
65391866|NCT00908336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65391867|NCT00908336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391868|NCT00908336|Tubulin Modulators|tubulin modulators|mesh-ancestor
65391869|NCT00908336|Antimitotic Agents|antimitotic agents|mesh-ancestor
65391870|NCT00908336|Mitosis Modulators|mitosis modulators|mesh-ancestor
65391871|NCT00908336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391872|NCT00908336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65391879|NCT01074853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65391880|NCT01074853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65391881|NCT01074853|Adrenergic Agents|adrenergic agents|mesh-ancestor
65391882|NCT01074853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65391883|NCT01074853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391884|NCT01074853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391885|NCT01074853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65391886|NCT01074853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65391887|NCT01074853|Vasodilator Agents|vasodilator agents|mesh-ancestor
65391888|NCT00725777|Lumefantrine|lumefantrine|mesh-list
65391889|NCT00725777|Artemether|artemether|mesh-list
65391890|NCT00725777|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65391891|NCT00725777|Antimalarials|antimalarials|mesh-ancestor
65391892|NCT00725777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65391893|NCT00725777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65391895|NCT00165841|Rabeprazole|rabeprazole|mesh-list
65391938|NCT00726869|Elotuzumab|elotuzumab|mesh-list
65391939|NCT00726869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391940|NCT01028248|Ranibizumab|ranibizumab|mesh-list
65391941|NCT01028248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65391942|NCT01028248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65391943|NCT01028248|Growth Substances|growth substances|mesh-ancestor
65391944|NCT01028248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391945|NCT01028248|Growth Inhibitors|growth inhibitors|mesh-ancestor
65391946|NCT01028248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65391947|NCT00726011|Tetrodotoxin|tetrodotoxin|mesh-list
65391948|NCT00726011|Anesthetics, Local|anesthetics, local|mesh-ancestor
65391949|NCT00726011|Anesthetics|anesthetics|mesh-ancestor
65391950|NCT00726011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65391951|NCT00726011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391952|NCT00726011|Sensory System Agents|sensory system agents|mesh-ancestor
65391953|NCT00726011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65391954|NCT00726011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65391955|NCT00726011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65391956|NCT00726011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391957|NCT00603980|Alprazolam|alprazolam|mesh-list
65391958|NCT00603980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65391959|NCT00603980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65391960|NCT00603980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391961|NCT00603980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65391962|NCT00603980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65391963|NCT00603980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65141552|NCT01332968|Prednisone|prednisone|mesh-list
65391985|NCT01028482|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65391986|NCT01028482|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65391987|NCT01028482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65391988|NCT01028482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65391989|NCT01028482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65391990|NCT01028482|Serotonin Agents|serotonin agents|mesh-ancestor
65391991|NCT01028482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65391992|NCT00903188|Cyclosporine|cyclosporine|mesh-list
65391993|NCT00903188|Mycophenolic Acid|mycophenolic acid|mesh-list
65391994|NCT00903188|Methylprednisolone|methylprednisolone|mesh-list
65391995|NCT00903188|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65391996|NCT00903188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65391997|NCT00903188|Prednisolone|prednisolone|mesh-list
65391998|NCT00903188|Prednisolone acetate|prednisolone acetate|mesh-list
65391999|NCT00903188|Everolimus|everolimus|mesh-list
65392000|NCT00903188|Cyclosporins|cyclosporins|mesh-list
65392001|NCT00903188|Basiliximab|basiliximab|mesh-list
65392002|NCT00903188|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65392003|NCT00903188|Prednisolone phosphate|prednisolone phosphate|mesh-list
65392004|NCT00903188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392005|NCT00903188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392006|NCT00903188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65392007|NCT00903188|Immunologic Factors|immunologic factors|mesh-ancestor
65392008|NCT00903188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392009|NCT00903188|Antifungal Agents|antifungal agents|mesh-ancestor
65392010|NCT00903188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65392011|NCT00903188|Dermatologic Agents|dermatologic agents|mesh-ancestor
65392012|NCT00903188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65392013|NCT00903188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65392014|NCT00903188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392015|NCT00903188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65392016|NCT00903188|Antiemetics|antiemetics|mesh-ancestor
65392017|NCT00903188|Autonomic Agents|autonomic agents|mesh-ancestor
65392018|NCT00903188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65392019|NCT00903188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65392020|NCT00903188|Glucocorticoids|glucocorticoids|mesh-ancestor
65392021|NCT00903188|Hormones|hormones|mesh-ancestor
65392023|NCT00903188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65392024|NCT00903188|Protective Agents|protective agents|mesh-ancestor
65392025|NCT00903188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65392026|NCT00903188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65392027|NCT00903188|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65392028|NCT00903188|Antitubercular Agents|antitubercular agents|mesh-ancestor
65392029|NCT00903188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65392030|NCT00908726|Propofol|propofol|mesh-list
65392031|NCT00908726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65392032|NCT00908726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65392033|NCT00908726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392034|NCT00908726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65392035|NCT00908726|Anesthetics, General|anesthetics, general|mesh-ancestor
65392036|NCT00908726|Anesthetics|anesthetics|mesh-ancestor
65066884|NCT00416468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392037|NCT02948309|Viscum album peptide|viscum album peptide|mesh-list
65392038|NCT02948309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392039|NCT02948309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65392040|NCT02948309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65392041|NCT02948309|Antiviral Agents|antiviral agents|mesh-ancestor
65392042|NCT02948309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65392044|NCT00449956|Dorzolamide|dorzolamide|mesh-list
65392045|NCT00449956|Maleic acid|maleic acid|mesh-list
65392046|NCT00449956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392047|NCT00449956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392048|NCT00449956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65392049|NCT00449956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65392050|NCT00449956|Adrenergic Agents|adrenergic agents|mesh-ancestor
65392051|NCT00449956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65392052|NCT00449956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392053|NCT00449956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65392054|NCT00449956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65392055|NCT00449956|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65392056|NCT00907400|Naproxen|naproxen|mesh-list
65392058|NCT00907400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65392063|NCT00907400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65392064|NCT00907400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65392065|NCT00907400|Gout Suppressants|gout suppressants|mesh-ancestor
65392066|NCT00907400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65392067|NCT00907400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392068|NCT00907400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392069|NCT00727493|Alendronate|alendronate|mesh-list
65392070|NCT00727493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65392071|NCT00727493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392072|NCT00727727|Piribedil|piribedil|mesh-list
65392073|NCT00727727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65392074|NCT00727727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65392075|NCT00727727|Dopamine Agonists|dopamine agonists|mesh-ancestor
65392076|NCT00727727|Dopamine Agents|dopamine agents|mesh-ancestor
65392077|NCT00727727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65392078|NCT00727727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392079|NCT00727727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392080|NCT00903656|Lapatinib|lapatinib|mesh-list
65392081|NCT00903656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392082|NCT00903656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65392083|NCT00903656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392084|NCT00903656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392085|NCT00730067|Sildenafil Citrate|sildenafil citrate|mesh-list
65392114|NCT02538302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65392115|NCT02538302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392116|NCT02538302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65392117|NCT02538302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65392118|NCT02538302|Cholinergic Agents|cholinergic agents|mesh-ancestor
65392119|NCT02538302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65392120|NCT02538302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392121|NCT02538302|Urological Agents|urological agents|mesh-ancestor
65392122|NCT02538302|Hemostatics|hemostatics|mesh-ancestor
65392123|NCT02538302|Coagulants|coagulants|mesh-ancestor
65392124|NCT02538302|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65392125|NCT02538302|Natriuretic Agents|natriuretic agents|mesh-ancestor
65392126|NCT00903734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65392127|NCT00903734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392128|NCT00903734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65392129|NCT00903734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392130|NCT00903734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392131|NCT00509067|Olanzapine|olanzapine|mesh-list
65392132|NCT00509067|Risperidone|risperidone|mesh-list
65392133|NCT00509067|Aripiprazole|aripiprazole|mesh-list
65392134|NCT00509067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65392135|NCT00509067|Ziprasidone|ziprasidone|mesh-list
65392136|NCT00509067|Choline|choline|mesh-list
65392137|NCT00509067|Galantamine|galantamine|mesh-list
65392138|NCT00509067|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
65392139|NCT00509067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65392140|NCT00509067|Serotonin Agents|serotonin agents|mesh-ancestor
65392141|NCT00509067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65392142|NCT00509067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392143|NCT00509067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392144|NCT00509067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65392145|NCT00509067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65392146|NCT00509067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65392147|NCT00509067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65392148|NCT00509067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65392155|NCT00509067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65392156|NCT00509067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65392157|NCT00509067|Antidepressive Agents|antidepressive agents|mesh-ancestor
65392158|NCT00509067|Dopamine Agonists|dopamine agonists|mesh-ancestor
65392159|NCT00509067|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65392160|NCT00509067|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65392161|NCT00509067|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65392162|NCT00509067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65392163|NCT00509067|Lipotropic Agents|lipotropic agents|mesh-ancestor
65392164|NCT00509067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65392165|NCT00509067|Antimetabolites|antimetabolites|mesh-ancestor
65392166|NCT00509067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65392167|NCT00509067|Nootropic Agents|nootropic agents|mesh-ancestor
65392168|NCT00509067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65392169|NCT00509067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392170|NCT00509067|Cholinergic Agents|cholinergic agents|mesh-ancestor
65392171|NCT00509067|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65392172|NCT02538146|Acetylcarnitine|acetylcarnitine|mesh-list
65392173|NCT02538146|Vitamin B Complex|vitamin b complex|mesh-ancestor
65392174|NCT02538146|Vitamins|vitamins|mesh-ancestor
65392175|NCT02538146|Micronutrients|micronutrients|mesh-ancestor
65392176|NCT02538146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392177|NCT02538146|Nootropic Agents|nootropic agents|mesh-ancestor
65392178|NCT00908024|Cetuximab|cetuximab|mesh-list
65392179|NCT00908024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65392180|NCT00908024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392181|NCT00730223|Efavirenz|efavirenz|mesh-list
65392182|NCT00730223|Nevirapine|nevirapine|mesh-list
65392183|NCT00730223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65392184|NCT00730223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65392185|NCT00730223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392186|NCT00730223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392196|NCT00730223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65392197|NCT02539394|Methylprednisolone|methylprednisolone|mesh-list
65392198|NCT02539394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65392199|NCT02539394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65392200|NCT02539394|Prednisolone|prednisolone|mesh-list
65392201|NCT02539394|Prednisolone acetate|prednisolone acetate|mesh-list
65392202|NCT02539394|Hemostatics|hemostatics|mesh-list
65392203|NCT02539394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65392204|NCT02539394|Prednisolone phosphate|prednisolone phosphate|mesh-list
65392205|NCT02539394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65392206|NCT02539394|Antiemetics|antiemetics|mesh-ancestor
65392207|NCT02539394|Autonomic Agents|autonomic agents|mesh-ancestor
65392208|NCT02539394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65392209|NCT02539394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392210|NCT02539394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65392211|NCT02539394|Glucocorticoids|glucocorticoids|mesh-ancestor
65392212|NCT02539394|Hormones|hormones|mesh-ancestor
65392213|NCT02539394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65392214|NCT02539394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65392215|NCT02539394|Protective Agents|protective agents|mesh-ancestor
65392216|NCT02539394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65392217|NCT02539394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392218|NCT02539394|Coagulants|coagulants|mesh-ancestor
65392219|NCT00908180|Cytarabine|cytarabine|mesh-list
65392220|NCT00908180|Cyclosporine|cyclosporine|mesh-list
65392221|NCT00908180|Etoposide|etoposide|mesh-list
65392222|NCT00908180|Melphalan|melphalan|mesh-list
65392223|NCT00908180|Alemtuzumab|alemtuzumab|mesh-list
65392224|NCT00908180|Carmustine|carmustine|mesh-list
65392225|NCT00908180|Cyclosporins|cyclosporins|mesh-list
65392226|NCT00908180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65392227|NCT00908180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392228|NCT00908180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65392229|NCT00908180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65392230|NCT00908180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392231|NCT00908180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392232|NCT00908180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65392233|NCT00908180|Antimetabolites|antimetabolites|mesh-ancestor
65392234|NCT00908180|Antiviral Agents|antiviral agents|mesh-ancestor
65392235|NCT00908180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65392236|NCT00908180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65392237|NCT00908180|Immunologic Factors|immunologic factors|mesh-ancestor
65392238|NCT00908180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392239|NCT00908180|Antifungal Agents|antifungal agents|mesh-ancestor
65392240|NCT00908180|Dermatologic Agents|dermatologic agents|mesh-ancestor
65392241|NCT00908180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65392242|NCT00908180|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65392243|NCT00908180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65392244|NCT00908180|Alkylating Agents|alkylating agents|mesh-ancestor
65392245|NCT00908180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65392246|NCT00908180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65392247|NCT04480463|Aflibercept|aflibercept|mesh-list
65392248|NCT04480463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65392249|NCT04480463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65392250|NCT04480463|Growth Substances|growth substances|mesh-ancestor
65392251|NCT04480463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392252|NCT04480463|Growth Inhibitors|growth inhibitors|mesh-ancestor
65392253|NCT04480463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392254|NCT00909506|Metformin|metformin|mesh-list
65392255|NCT00909506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65392256|NCT00909506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392257|NCT03997539|Vinorelbine|vinorelbine|mesh-list
65392258|NCT03997539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65392259|NCT03997539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392260|NCT03997539|Tubulin Modulators|tubulin modulators|mesh-ancestor
65392261|NCT03997539|Antimitotic Agents|antimitotic agents|mesh-ancestor
65141839|NCT01342484|Hormones|hormones|mesh-ancestor
65392262|NCT03997539|Mitosis Modulators|mitosis modulators|mesh-ancestor
65392263|NCT03997539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392264|NCT02570243|Heparin|heparin|mesh-list
65392265|NCT02570243|Calcium heparin|calcium heparin|mesh-list
65392266|NCT02570243|Anticoagulants|anticoagulants|mesh-ancestor
65392267|NCT02570243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65392272|NCT00927212|Immunologic Factors|immunologic factors|mesh-ancestor
65392274|NCT00927212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392275|NCT00927212|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65392276|NCT00927212|Protective Agents|protective agents|mesh-ancestor
65392277|NCT00927212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65392278|NCT00927212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65392279|NCT00927212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392280|NCT00927212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392281|NCT00927212|Antiviral Agents|antiviral agents|mesh-ancestor
65392282|NCT00927212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65392284|NCT00927290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65392285|NCT00927290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392286|NCT00728195|Olanzapine|olanzapine|mesh-list
65392287|NCT00728195|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
65392288|NCT00728195|Antiemetics|antiemetics|mesh-ancestor
65392289|NCT00728195|Autonomic Agents|autonomic agents|mesh-ancestor
65392290|NCT00728195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65392291|NCT00728195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392292|NCT00728195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65392293|NCT00728195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65392294|NCT00728195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65392295|NCT00728195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65392296|NCT00728195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65392297|NCT00728195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65392298|NCT00728195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65392299|NCT00728195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65392300|NCT00728195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392301|NCT00728195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65392302|NCT00728195|Serotonin Agents|serotonin agents|mesh-ancestor
65392319|NCT00728273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392320|NCT00927602|PENTA|penta|mesh-list
65392321|NCT00927602|Fondaparinux|fondaparinux|mesh-list
65392322|NCT00927602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65392323|NCT00927602|Antithrombins|antithrombins|mesh-ancestor
65392324|NCT00927602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65392325|NCT00927602|Protease Inhibitors|protease inhibitors|mesh-ancestor
65392326|NCT00927602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392327|NCT00927602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392328|NCT00927602|Anticoagulants|anticoagulants|mesh-ancestor
65392329|NCT00927602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65392330|NCT00927602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65392331|NCT04286867|Ethanol|ethanol|mesh-list
65392332|NCT04286867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65392333|NCT04286867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65392334|NCT04286867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65392335|NCT04286867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392336|NCT00730535|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65392337|NCT00730535|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65392375|NCT00904280|Analgesics|analgesics|mesh-ancestor
65392376|NCT00904280|Sensory System Agents|sensory system agents|mesh-ancestor
65392377|NCT00904280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65392378|NCT00904280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65392379|NCT04237103|Methotrexate|methotrexate|mesh-list
65392380|NCT04237103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65392381|NCT04237103|Abortifacient Agents|abortifacient agents|mesh-ancestor
65392382|NCT04237103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65392383|NCT04237103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392384|NCT04237103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65392385|NCT04237103|Antimetabolites|antimetabolites|mesh-ancestor
65392386|NCT04237103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392387|NCT04237103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392388|NCT04237103|Dermatologic Agents|dermatologic agents|mesh-ancestor
65392389|NCT04237103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392390|NCT04237103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65392391|NCT04237103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65392392|NCT04237103|Immunologic Factors|immunologic factors|mesh-ancestor
65392393|NCT04237103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65392394|NCT04237103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65392395|NCT00928148|Amphetamine|amphetamine|mesh-list
65392398|NCT00928148|Sympathomimetics|sympathomimetics|mesh-ancestor
65392425|NCT00728585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392426|NCT00730769|Valganciclovir|valganciclovir|mesh-list
65392427|NCT00730769|Ganciclovir|ganciclovir|mesh-list
65392428|NCT00730769|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65392429|NCT00730769|Antiviral Agents|antiviral agents|mesh-ancestor
65392430|NCT00730769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65392431|NCT00730769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65392432|NCT00730769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392433|NCT00730769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392434|NCT00728663|Docetaxel|docetaxel|mesh-list
65392435|NCT00728663|Cetuximab|cetuximab|mesh-list
65392436|NCT00728663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392437|NCT00728663|Tubulin Modulators|tubulin modulators|mesh-ancestor
65392438|NCT00728663|Antimitotic Agents|antimitotic agents|mesh-ancestor
65392439|NCT00728663|Mitosis Modulators|mitosis modulators|mesh-ancestor
65392440|NCT00728663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392441|NCT00728663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65392442|NCT00731003|Tryptophan|tryptophan|mesh-list
65392443|NCT00731003|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
65392444|NCT00731003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65392445|NCT00731003|Antidepressive Agents|antidepressive agents|mesh-ancestor
65392446|NCT00731003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65392447|NCT00729131|Etanercept|etanercept|mesh-list
65392448|NCT00729131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65392449|NCT00729131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65392450|NCT00729131|Analgesics|analgesics|mesh-ancestor
65392451|NCT00729131|Sensory System Agents|sensory system agents|mesh-ancestor
65392452|NCT00729131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65392453|NCT00729131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392454|NCT00729131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65392455|NCT00729131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65392456|NCT00729131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65392457|NCT00729131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65392458|NCT00729131|Immunologic Factors|immunologic factors|mesh-ancestor
65392459|NCT00729287|Selenium|selenium|mesh-list
65392464|NCT00729287|Trace Elements|trace elements|mesh-ancestor
65392465|NCT00729287|Micronutrients|micronutrients|mesh-ancestor
65392466|NCT00731393|Vaccines|vaccines|mesh-list
65392467|NCT00731393|Immunologic Factors|immunologic factors|mesh-ancestor
65392468|NCT00731393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392469|NCT02569463|Aldesleukin|aldesleukin|mesh-list
65392470|NCT02569463|Interleukin-2|interleukin-2|mesh-list
65392471|NCT02569463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392472|NCT02569463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65392473|NCT02569463|Analgesics|analgesics|mesh-ancestor
65392474|NCT02569463|Sensory System Agents|sensory system agents|mesh-ancestor
65392475|NCT02569463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65392476|NCT02569463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392477|NCT02569463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65392478|NCT02569463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65392479|NCT02569463|Antiviral Agents|antiviral agents|mesh-ancestor
65392480|NCT02569463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65392481|NCT00731627|Simvastatin|simvastatin|mesh-list
65392482|NCT00731627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65392483|NCT00731627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65392484|NCT00731627|Antimetabolites|antimetabolites|mesh-ancestor
65392485|NCT00731627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392486|NCT00731627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65142053|NCT00602004|Losartan|losartan|mesh-list
65392487|NCT00731627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65392488|NCT00731627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392490|NCT00568178|Amlodipine|amlodipine|mesh-list
65392491|NCT00568178|Enalapril|enalapril|mesh-list
65392492|NCT00568178|Enalaprilat|enalaprilat|mesh-list
65392493|NCT00568178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65392494|NCT00568178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65392495|NCT00568178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65392496|NCT00568178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392499|NCT00568178|Vasodilator Agents|vasodilator agents|mesh-ancestor
65392506|NCT00577889|Gemcitabine|gemcitabine|mesh-list
65392507|NCT00577889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65392508|NCT00577889|Antimetabolites|antimetabolites|mesh-ancestor
65392509|NCT00577889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392510|NCT00577889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392511|NCT00577889|Antiviral Agents|antiviral agents|mesh-ancestor
65392512|NCT00577889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65392513|NCT00577889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392514|NCT00577889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65392515|NCT00577889|Immunologic Factors|immunologic factors|mesh-ancestor
65392516|NCT00577889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392517|NCT00729599|Cetylpyridinium|cetylpyridinium|mesh-list
65392518|NCT00729599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65392519|NCT00729599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65392520|NCT02538926|Prednisone|prednisone|mesh-list
65392521|NCT02538926|Cortisone|cortisone|mesh-list
65392522|NCT02538926|Cyclophosphamide|cyclophosphamide|mesh-list
65392523|NCT02538926|Rituximab|rituximab|mesh-list
65392524|NCT02538926|Doxorubicin|doxorubicin|mesh-list
65392525|NCT02538926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65392526|NCT02538926|Etoposide|etoposide|mesh-list
65392527|NCT02538926|Vincristine|vincristine|mesh-list
65392528|NCT02538926|Etoposide phosphate|etoposide phosphate|mesh-list
65392529|NCT02538926|Imatinib Mesylate|imatinib mesylate|mesh-list
65392530|NCT02538926|Asparaginase|asparaginase|mesh-list
65392531|NCT02538926|Podophyllotoxin|podophyllotoxin|mesh-list
65392532|NCT02538926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65392533|NCT02538926|Antibodies|antibodies|mesh-list
65392534|NCT02538926|Immunoglobulins|immunoglobulins|mesh-list
65392535|NCT02538926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65392536|NCT02538926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65392537|NCT02538926|Immunologic Factors|immunologic factors|mesh-ancestor
65392538|NCT02538926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392551|NCT02538926|Hormones|hormones|mesh-ancestor
65392552|NCT02538926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65392553|NCT02538926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65392554|NCT02538926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65392555|NCT02538926|Tubulin Modulators|tubulin modulators|mesh-ancestor
65392556|NCT02538926|Antimitotic Agents|antimitotic agents|mesh-ancestor
65392557|NCT02538926|Mitosis Modulators|mitosis modulators|mesh-ancestor
65392558|NCT02538926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65392559|NCT02538926|Keratolytic Agents|keratolytic agents|mesh-ancestor
65392560|NCT02538926|Dermatologic Agents|dermatologic agents|mesh-ancestor
65392561|NCT00904904|Ketorolac|ketorolac|mesh-list
65392562|NCT00904904|Indomethacin|indomethacin|mesh-list
65392563|NCT00904904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65392564|NCT00904904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65392565|NCT00904904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65392566|NCT00904904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65392567|NCT00904904|Analgesics|analgesics|mesh-ancestor
65392568|NCT00904904|Sensory System Agents|sensory system agents|mesh-ancestor
65392569|NCT00904904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65392570|NCT00904904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392571|NCT00904904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65392572|NCT00904904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65392573|NCT00904904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65392574|NCT00904904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392575|NCT00904904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392576|NCT00904904|Gout Suppressants|gout suppressants|mesh-ancestor
65392577|NCT00904904|Tocolytic Agents|tocolytic agents|mesh-ancestor
65392580|NCT00731861|Vatalanib|vatalanib|mesh-list
65392599|NCT00567476|Tocolytic Agents|tocolytic agents|mesh-ancestor
65392600|NCT00567476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65392601|NCT00567476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65392602|NCT00567476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65392603|NCT00567476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65392604|NCT00567476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392605|NCT00567476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65392606|NCT00567476|Sympathomimetics|sympathomimetics|mesh-ancestor
65392607|NCT00729911|Amiodarone|amiodarone|mesh-list
65392608|NCT00729911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65392609|NCT00729911|Vasodilator Agents|vasodilator agents|mesh-ancestor
65392610|NCT00729911|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65392611|NCT00729911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65392612|NCT00729911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392613|NCT00729911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65392614|NCT00729911|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65392615|NCT00729911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65392616|NCT00729911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392617|NCT00729911|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65392618|NCT00729911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65392619|NCT00729911|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65392620|NCT04018703|Midazolam|midazolam|mesh-list
65392621|NCT04018703|Dexmedetomidine|dexmedetomidine|mesh-list
65392622|NCT04018703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65392623|NCT04018703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65392624|NCT04018703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392625|NCT04018703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65392626|NCT04018703|Analgesics|analgesics|mesh-ancestor
65392627|NCT04018703|Sensory System Agents|sensory system agents|mesh-ancestor
65392641|NCT04018703|Anesthetics|anesthetics|mesh-ancestor
65392642|NCT04018703|GABA Modulators|gaba modulators|mesh-ancestor
65392643|NCT04018703|GABA Agents|gaba agents|mesh-ancestor
65392644|NCT04629872|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65392645|NCT04629872|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65392646|NCT04629872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392647|NCT04629872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65392648|NCT04629872|Immunologic Factors|immunologic factors|mesh-ancestor
65392649|NCT04629872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392650|NCT04065581|Metformin|metformin|mesh-list
65392651|NCT04065581|Acarbose|acarbose|mesh-list
65392652|NCT04065581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65392653|NCT04065581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392654|NCT04065581|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65392655|NCT04065581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392656|NCT04065581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392657|NCT00733889|Docetaxel|docetaxel|mesh-list
65392658|NCT00733889|Fluorouracil|fluorouracil|mesh-list
65392659|NCT00733889|Cetuximab|cetuximab|mesh-list
65392660|NCT00733889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392661|NCT00733889|Tubulin Modulators|tubulin modulators|mesh-ancestor
65392662|NCT00733889|Antimitotic Agents|antimitotic agents|mesh-ancestor
65392663|NCT00733889|Mitosis Modulators|mitosis modulators|mesh-ancestor
65392664|NCT00733889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392665|NCT00733889|Antimetabolites|antimetabolites|mesh-ancestor
65392667|NCT00733889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65392690|NCT04644627|Gentamicins|gentamicins|mesh-list
65392691|NCT04644627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65392692|NCT04644627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65392693|NCT04644627|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65392694|NCT04644627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392695|NCT04644627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392696|NCT00732407|Losartan|losartan|mesh-list
65392697|NCT00732407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65392698|NCT00732407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65392699|NCT00732407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65392700|NCT00732407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65392701|NCT00732407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392702|NCT00507819|Sildenafil Citrate|sildenafil citrate|mesh-list
65392703|NCT00507819|Vasodilator Agents|vasodilator agents|mesh-ancestor
65392704|NCT00507819|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65392705|NCT00507819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65392706|NCT00507819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392707|NCT00507819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392708|NCT00507819|Urological Agents|urological agents|mesh-ancestor
65392709|NCT02569307|Minocycline|minocycline|mesh-list
65392710|NCT02569307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65392711|NCT02569307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65392712|NCT01013103|Atorvastatin|atorvastatin|mesh-list
65392713|NCT01013103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65392714|NCT01013103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65392716|NCT01013103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392717|NCT01013103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65392718|NCT01013103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65392719|NCT01013103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392720|NCT00732485|Fenofibrate|fenofibrate|mesh-list
65392733|NCT02569073|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65392734|NCT02569073|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65392735|NCT02569073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65392736|NCT02569073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392737|NCT02569073|Hormones|hormones|mesh-ancestor
65392738|NCT02569073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65392739|NCT00732563|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65392740|NCT00732563|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65392741|NCT00732563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392742|NCT00734123|Aspirin|aspirin|mesh-list
65392743|NCT00734123|Rimonabant|rimonabant|mesh-list
65392744|NCT00734123|Enalapril|enalapril|mesh-list
65392745|NCT00734123|Clopidogrel|clopidogrel|mesh-list
65392746|NCT00734123|Atorvastatin|atorvastatin|mesh-list
65392747|NCT00734123|Simvastatin|simvastatin|mesh-list
65392748|NCT00734123|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65392749|NCT00734123|Diuretics|diuretics|mesh-list
65392750|NCT00734123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65392751|NCT00734123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65392752|NCT00734123|Analgesics|analgesics|mesh-ancestor
65392753|NCT00734123|Sensory System Agents|sensory system agents|mesh-ancestor
65392754|NCT00734123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65392755|NCT00734123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392756|NCT00734123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65392757|NCT00734123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65392758|NCT00734123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65392759|NCT00734123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65392760|NCT00734123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392778|NCT00734123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65392779|NCT00734123|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65392780|NCT00734123|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65392781|NCT00734123|Hormones|hormones|mesh-ancestor
65392782|NCT00734123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65392783|NCT00734279|Leuprolide|leuprolide|mesh-list
65392784|NCT00734279|Ganirelix|ganirelix|mesh-list
65392785|NCT00734279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65392786|NCT00734279|Fertility Agents|fertility agents|mesh-ancestor
65392787|NCT00734279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65392788|NCT00734279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392789|NCT00734279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65392790|NCT00734279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392791|NCT00734279|Hormone Antagonists|hormone antagonists|mesh-ancestor
65392792|NCT00734279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65392793|NCT00442936|Oxazolidinones|oxazolidinones|mesh-list
65392794|NCT00442936|Zolmitriptan|zolmitriptan|mesh-list
65392795|NCT00442936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65392796|NCT00442936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65392797|NCT00442936|Serotonin Agents|serotonin agents|mesh-ancestor
65392798|NCT00442936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65392799|NCT00442936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392800|NCT00442936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392801|NCT00442936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65392802|NCT00442936|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65392803|NCT00442936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392804|NCT03410043|Osimertinib|osimertinib|mesh-list
65392805|NCT03410043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392806|NCT03410043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65392807|NCT03410043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392808|NCT03410043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392809|NCT00732953|Paclitaxel|paclitaxel|mesh-list
65392810|NCT00732953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65392811|NCT00732953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392812|NCT00732953|Tubulin Modulators|tubulin modulators|mesh-ancestor
64781624|NCT05444088|Bevacizumab|bevacizumab|mesh-list
64670977|NCT04153760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64670978|NCT04153760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65392813|NCT00732953|Antimitotic Agents|antimitotic agents|mesh-ancestor
65392814|NCT00732953|Mitosis Modulators|mitosis modulators|mesh-ancestor
65392815|NCT00732953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392816|NCT00577655|Albuterol|albuterol|mesh-list
65392817|NCT00577655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65392818|NCT00577655|Autonomic Agents|autonomic agents|mesh-ancestor
65392819|NCT00577655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65392820|NCT00577655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392821|NCT00577655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65392822|NCT00577655|Respiratory System Agents|respiratory system agents|mesh-ancestor
65392823|NCT00577655|Tocolytic Agents|tocolytic agents|mesh-ancestor
65392824|NCT00577655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65392825|NCT00577655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65392826|NCT00577655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65392827|NCT00577655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65392828|NCT00577655|Adrenergic Agents|adrenergic agents|mesh-ancestor
65392829|NCT00577655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65392830|NCT00577655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392831|NCT00733031|Gemcitabine|gemcitabine|mesh-list
65392832|NCT00733031|Pemetrexed|pemetrexed|mesh-list
65392833|NCT00733031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65392834|NCT00733031|Antimetabolites|antimetabolites|mesh-ancestor
65392835|NCT00733031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392836|NCT00733031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392837|NCT00733031|Antiviral Agents|antiviral agents|mesh-ancestor
65392838|NCT00733031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65392839|NCT00733031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392840|NCT00733031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65392841|NCT00733031|Immunologic Factors|immunologic factors|mesh-ancestor
65392842|NCT00733031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392843|NCT00733031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65392844|NCT00733031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65392845|NCT01327781|Tamoxifen|tamoxifen|mesh-list
65392852|NCT01327781|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65392853|NCT01327781|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65392854|NCT01327781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65392855|NCT00734669|Glyburide|glyburide|mesh-list
65392856|NCT00734669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65392857|NCT00734669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392858|NCT00113269|Mycophenolic Acid|mycophenolic acid|mesh-list
65142429|NCT00595322|Bevacizumab|bevacizumab|mesh-list
65392860|NCT00113269|Tacrolimus|tacrolimus|mesh-list
65392861|NCT00113269|Thymoglobulin|thymoglobulin|mesh-list
65392862|NCT00113269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65392863|NCT00113269|Basiliximab|basiliximab|mesh-list
65392864|NCT00113269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65392865|NCT00113269|Immunologic Factors|immunologic factors|mesh-ancestor
65392866|NCT00113269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392867|NCT00113269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65392868|NCT00113269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392869|NCT00113269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392870|NCT00113269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65392871|NCT00113269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392872|NCT00113269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65392873|NCT00113269|Antitubercular Agents|antitubercular agents|mesh-ancestor
65392874|NCT00113269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65392875|NCT00113269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65392876|NCT00113269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65392877|NCT04065269|Olaparib|olaparib|mesh-list
65392878|NCT04065269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65392879|NCT04065269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392880|NCT04065269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392881|NCT04065269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392882|NCT00515619|Lacosamide|lacosamide|mesh-list
65392883|NCT00515619|Anticonvulsants|anticonvulsants|mesh-ancestor
65392884|NCT00515619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65392885|NCT00515619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65392886|NCT00515619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64781700|NCT05122494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64781701|NCT05122494|Antimetabolites|antimetabolites|mesh-ancestor
64781702|NCT05122494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781703|NCT05122494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781704|NCT05122494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64781705|NCT05122494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781706|NCT05063604|Citalopram|citalopram|mesh-list
65392891|NCT01815359|Antidotes|antidotes|mesh-ancestor
65392892|NCT01815359|Protective Agents|protective agents|mesh-ancestor
65392893|NCT01815359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392894|NCT01815359|Vitamin B Complex|vitamin b complex|mesh-ancestor
65392895|NCT01815359|Vitamins|vitamins|mesh-ancestor
65392896|NCT01815359|Micronutrients|micronutrients|mesh-ancestor
65392897|NCT01815359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65392898|NCT01815359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392899|NCT01815359|Alkylating Agents|alkylating agents|mesh-ancestor
65392900|NCT01815359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392901|NCT01815359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65392902|NCT01815359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392903|NCT00449644|Bedaquiline|bedaquiline|mesh-list
65392904|NCT00449644|Antitubercular Agents|antitubercular agents|mesh-ancestor
65392905|NCT00449644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65392906|NCT00449644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65392907|NCT00733265|Ticagrelor|ticagrelor|mesh-list
65392908|NCT00733265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65392909|NCT00733265|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65392910|NCT00733265|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65392911|NCT00733265|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65392912|NCT00733265|Purinergic Agents|purinergic agents|mesh-ancestor
65392913|NCT00733265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65392916|NCT00112489|Paclitaxel|paclitaxel|mesh-list
65392927|NCT01023100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392928|NCT00515463|Denosumab|denosumab|mesh-list
65392929|NCT00515463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65392930|NCT00515463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392931|NCT01082731|Artesunate|artesunate|mesh-list
65392932|NCT01082731|Lumefantrine|lumefantrine|mesh-list
65392933|NCT01082731|Artemether|artemether|mesh-list
65392934|NCT01082731|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65392935|NCT01082731|Mefloquine|mefloquine|mesh-list
65392936|NCT01082731|Antimalarials|antimalarials|mesh-ancestor
65392937|NCT01082731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65392938|NCT01082731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65392939|NCT01082731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65392940|NCT01082731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392941|NCT01082731|Antiviral Agents|antiviral agents|mesh-ancestor
65392942|NCT01082731|Schistosomicides|schistosomicides|mesh-ancestor
65392943|NCT01082731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65392944|NCT01082731|Anthelmintics|anthelmintics|mesh-ancestor
65392945|NCT00739193|Amiodarone|amiodarone|mesh-list
65392946|NCT00739193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65392947|NCT00739193|Vasodilator Agents|vasodilator agents|mesh-ancestor
65392948|NCT00739193|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65392949|NCT00739193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65392950|NCT00739193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392951|NCT00739193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65392952|NCT00739193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65392953|NCT00739193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65392954|NCT00739193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392955|NCT00739193|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65392956|NCT00739193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65392957|NCT00739193|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65392958|NCT01011543|Dimercaprol|dimercaprol|mesh-list
65392959|NCT01011543|Chelating Agents|chelating agents|mesh-ancestor
65392960|NCT01011543|Sequestering Agents|sequestering agents|mesh-ancestor
64670979|NCT04153760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670980|NCT04153760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64670981|NCT04153760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64670982|NCT04153760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670984|NCT02657486|Infigratinib|infigratinib|mesh-list
64670985|NCT02657486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65392961|NCT01011543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392962|NCT00733811|Deferiprone|deferiprone|mesh-list
65392963|NCT00733811|Deferoxamine|deferoxamine|mesh-list
65392964|NCT00733811|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65392965|NCT00733811|Chelating Agents|chelating agents|mesh-ancestor
65392966|NCT00733811|Sequestering Agents|sequestering agents|mesh-ancestor
65392967|NCT00733811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392968|NCT00733811|Siderophores|siderophores|mesh-ancestor
65392969|NCT00739505|Immunoglobulin G|immunoglobulin g|mesh-list
65392970|NCT00739505|Immunologic Factors|immunologic factors|mesh-ancestor
65392971|NCT00739505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392972|NCT00507507|Tenofovir|tenofovir|mesh-list
65392973|NCT00507507|Antiviral Agents|antiviral agents|mesh-ancestor
65392974|NCT00507507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65392975|NCT00507507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65392976|NCT00507507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65392977|NCT00507507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65392978|NCT00507507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65392979|NCT00507507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65392980|NCT00507507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65392981|NCT00459706|Etanercept|etanercept|mesh-list
65392982|NCT00459706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65392983|NCT00459706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65392984|NCT00459706|Analgesics|analgesics|mesh-ancestor
65392985|NCT00459706|Sensory System Agents|sensory system agents|mesh-ancestor
65392986|NCT00459706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65392987|NCT00459706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65392988|NCT00459706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65392989|NCT00459706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65392990|NCT00459706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65392991|NCT00459706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65392992|NCT00459706|Immunologic Factors|immunologic factors|mesh-ancestor
65392993|NCT00735527|Lorazepam|lorazepam|mesh-list
65392994|NCT00735527|Anticonvulsants|anticonvulsants|mesh-ancestor
65393001|NCT00735527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65393002|NCT00735527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65393003|NCT00735527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65393004|NCT00735527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65393005|NCT00735527|GABA Modulators|gaba modulators|mesh-ancestor
65393006|NCT00735527|GABA Agents|gaba agents|mesh-ancestor
65393007|NCT00735527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65393008|NCT00735527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393009|NCT00735761|Acyclovir|acyclovir|mesh-list
65393011|NCT00735761|Antiviral Agents|antiviral agents|mesh-ancestor
65393012|NCT00735761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65393013|NCT00735761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65393014|NCT00740285|Lidocaine|lidocaine|mesh-list
65393015|NCT00740285|Anesthetics, Local|anesthetics, local|mesh-ancestor
65393016|NCT00740285|Anesthetics|anesthetics|mesh-ancestor
65393017|NCT00740285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65393018|NCT00740285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393019|NCT00740285|Sensory System Agents|sensory system agents|mesh-ancestor
65393020|NCT00740285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65393021|NCT00740285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65393022|NCT00740285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65393023|NCT00740285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65393024|NCT00740285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65393025|NCT00740285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393026|NCT00507429|Paclitaxel|paclitaxel|mesh-list
65393027|NCT00507429|Fosbretabulin|fosbretabulin|mesh-list
65393028|NCT00507429|Combretastatin|combretastatin|mesh-list
65393029|NCT00507429|Carboplatin|carboplatin|mesh-list
65393030|NCT00507429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65393048|NCT01011621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65393049|NCT01011621|Glucocorticoids|glucocorticoids|mesh-ancestor
65393050|NCT01011621|Hormones|hormones|mesh-ancestor
65393051|NCT01011621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65393052|NCT01011621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393053|NCT01011621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65393054|NCT01011621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393055|NCT01011621|Antiemetics|antiemetics|mesh-ancestor
65393056|NCT01011621|Autonomic Agents|autonomic agents|mesh-ancestor
65393057|NCT01011621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65393058|NCT01011621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65393059|NCT01011621|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65393060|NCT01011621|Protective Agents|protective agents|mesh-ancestor
65393061|NCT01011621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65393062|NCT01011621|Respiratory System Agents|respiratory system agents|mesh-ancestor
65393063|NCT00449176|Oxycodone|oxycodone|mesh-list
65393064|NCT00449176|Tapentadol|tapentadol|mesh-list
65393065|NCT00449176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65393066|NCT00449176|Narcotics|narcotics|mesh-ancestor
65393067|NCT00449176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65393068|NCT00449176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393069|NCT00449176|Analgesics|analgesics|mesh-ancestor
65393070|NCT00449176|Sensory System Agents|sensory system agents|mesh-ancestor
65393071|NCT00449176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65393072|NCT00449176|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65393073|NCT00449176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65393074|NCT00449176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65393075|NCT00449176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393076|NCT00449176|Adrenergic Agents|adrenergic agents|mesh-ancestor
65393077|NCT00449176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64670986|NCT02385110|Dexamethasone|dexamethasone|mesh-list
64670987|NCT02385110|Methotrexate|methotrexate|mesh-list
64670988|NCT02385110|Etoposide|etoposide|mesh-list
64670989|NCT02385110|Alemtuzumab|alemtuzumab|mesh-list
64670990|NCT02385110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64670991|NCT02385110|Antiemetics|antiemetics|mesh-ancestor
64670992|NCT02385110|Autonomic Agents|autonomic agents|mesh-ancestor
64670993|NCT02385110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670994|NCT02385110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670995|NCT02385110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64670996|NCT02385110|Glucocorticoids|glucocorticoids|mesh-ancestor
64670997|NCT02385110|Hormones|hormones|mesh-ancestor
64670998|NCT02385110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64670999|NCT02385110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65393078|NCT00515073|Diphenhydramine|diphenhydramine|mesh-list
65393079|NCT00515073|Promethazine|promethazine|mesh-list
65393080|NCT00515073|Dexamethasone|dexamethasone|mesh-list
65393081|NCT00515073|Paclitaxel|paclitaxel|mesh-list
65393082|NCT00515073|Cimetidine|cimetidine|mesh-list
65393083|NCT00515073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65393084|NCT00515073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393085|NCT00515073|Tubulin Modulators|tubulin modulators|mesh-ancestor
65393087|NCT00515073|Mitosis Modulators|mitosis modulators|mesh-ancestor
65393088|NCT00515073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393089|NCT00515073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65393090|NCT00515073|Antiemetics|antiemetics|mesh-ancestor
65393091|NCT00515073|Autonomic Agents|autonomic agents|mesh-ancestor
65393092|NCT00515073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65393093|NCT00515073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393094|NCT00515073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65393095|NCT00515073|Glucocorticoids|glucocorticoids|mesh-ancestor
65393096|NCT00515073|Hormones|hormones|mesh-ancestor
65393097|NCT00515073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65393098|NCT00515073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65393099|NCT00515073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65393100|NCT00515073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65393101|NCT00515073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65393102|NCT00515073|Anesthetics, Local|anesthetics, local|mesh-ancestor
65393103|NCT00515073|Anesthetics|anesthetics|mesh-ancestor
65393104|NCT00515073|Sensory System Agents|sensory system agents|mesh-ancestor
65393105|NCT00515073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65393106|NCT00515073|Histamine Antagonists|histamine antagonists|mesh-ancestor
65393107|NCT00515073|Histamine Agents|histamine agents|mesh-ancestor
65393108|NCT00515073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65393109|NCT00515073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65393110|NCT00515073|Antipruritics|antipruritics|mesh-ancestor
65393111|NCT00515073|Dermatologic Agents|dermatologic agents|mesh-ancestor
65393112|NCT00515073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65393113|NCT00515073|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65393114|NCT00515073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65393117|NCT00710021|Vitamin D|vitamin d|mesh-list
65393118|NCT00710021|Ergocalciferols|ergocalciferols|mesh-list
65393119|NCT00710021|Cholecalciferol|cholecalciferol|mesh-list
65393120|NCT00710021|Vitamins|vitamins|mesh-list
65393121|NCT00710021|Micronutrients|micronutrients|mesh-ancestor
65393122|NCT00710021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393123|NCT00710021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65393124|NCT00710021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65393125|NCT00504153|Dasatinib|dasatinib|mesh-list
65393126|NCT00504153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393127|NCT00504153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65393128|NCT00504153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393129|NCT00504153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393130|NCT00740363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65393131|NCT00740363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65393132|NCT00740363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393133|NCT00740363|Incretins|incretins|mesh-ancestor
65393134|NCT00740363|Hormones|hormones|mesh-ancestor
65393135|NCT00740363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65393136|NCT00740363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65393137|NCT00740363|Protease Inhibitors|protease inhibitors|mesh-ancestor
65393138|NCT00740363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393139|NCT00740363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393140|NCT04065035|Sunscreening Agents|sunscreening agents|mesh-list
65393141|NCT04065035|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65393142|NCT04065035|Protective Agents|protective agents|mesh-ancestor
65393143|NCT04065035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393144|NCT04065035|Dermatologic Agents|dermatologic agents|mesh-ancestor
65393145|NCT00442702|Darbepoetin alfa|darbepoetin alfa|mesh-list
65393146|NCT00442702|Hematinics|hematinics|mesh-ancestor
65393147|NCT00740519|Insulin Detemir|insulin detemir|mesh-list
65393150|NCT00514917|Docetaxel|docetaxel|mesh-list
65393162|NCT00514917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65393163|NCT00514917|Androgen Antagonists|androgen antagonists|mesh-ancestor
65393164|NCT00514917|Hormone Antagonists|hormone antagonists|mesh-ancestor
65393165|NCT00514917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65393166|NCT01011699|Niacinamide|niacinamide|mesh-list
65393167|NCT01011699|Niacin|niacin|mesh-list
65393168|NCT01011699|Nicotinic Acids|nicotinic acids|mesh-list
65393169|NCT01011699|Sevelamer|sevelamer|mesh-list
65393170|NCT01011699|Cinacalcet|cinacalcet|mesh-list
65393171|NCT01011699|Vitamin B Complex|vitamin b complex|mesh-ancestor
65393172|NCT01011699|Vitamins|vitamins|mesh-ancestor
65393173|NCT01011699|Micronutrients|micronutrients|mesh-ancestor
65393174|NCT01011699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393175|NCT01011699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65393176|NCT01011699|Antimetabolites|antimetabolites|mesh-ancestor
65393177|NCT01011699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393178|NCT01011699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65393179|NCT01011699|Vasodilator Agents|vasodilator agents|mesh-ancestor
65393180|NCT01011699|Chelating Agents|chelating agents|mesh-ancestor
65393181|NCT01011699|Sequestering Agents|sequestering agents|mesh-ancestor
65393182|NCT01011699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65393183|NCT01011699|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65393184|NCT01011699|Hormone Antagonists|hormone antagonists|mesh-ancestor
65393185|NCT01011699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65393186|NCT00504075|Immunoglobulins|immunoglobulins|mesh-list
65393187|NCT00504075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65393188|NCT00504075|Antibodies|antibodies|mesh-list
65393189|NCT00504075|gamma-Globulins|gamma-globulins|mesh-list
65393190|NCT00504075|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65393191|NCT00504075|Immunologic Factors|immunologic factors|mesh-ancestor
65393192|NCT00504075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393193|NCT00503997|Oxaliplatin|oxaliplatin|mesh-list
65393194|NCT00503997|Pemetrexed|pemetrexed|mesh-list
65393195|NCT00503997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671000|NCT02385110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671001|NCT02385110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64671002|NCT02385110|Abortifacient Agents|abortifacient agents|mesh-ancestor
64671003|NCT02385110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64671004|NCT02385110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64671005|NCT02385110|Antimetabolites|antimetabolites|mesh-ancestor
64671006|NCT02385110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671007|NCT02385110|Dermatologic Agents|dermatologic agents|mesh-ancestor
65393196|NCT00503997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393197|NCT00503997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393198|NCT00503997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65393199|NCT00503997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65393200|NCT00741143|Fe(III)-EDTA|fe(iii)-edta|mesh-list
65393201|NCT00741143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65393202|NCT00741143|Chelating Agents|chelating agents|mesh-ancestor
65393203|NCT00741143|Sequestering Agents|sequestering agents|mesh-ancestor
65393204|NCT00741143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393205|NCT00736463|Atorvastatin|atorvastatin|mesh-list
65393206|NCT00736463|Simvastatin|simvastatin|mesh-list
65393207|NCT00736463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65393208|NCT00736463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65393209|NCT00736463|Antimetabolites|antimetabolites|mesh-ancestor
65393210|NCT00736463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393211|NCT00736463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65393212|NCT00736463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65393213|NCT00736463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393214|NCT00736541|Acetylcysteine|acetylcysteine|mesh-list
65393215|NCT00736541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65393216|NCT00736541|Cystatins|cystatins|mesh-list
65393217|NCT00736541|Antiviral Agents|antiviral agents|mesh-ancestor
65393218|NCT00736541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65393219|NCT00736541|Expectorants|expectorants|mesh-ancestor
65393220|NCT00736541|Respiratory System Agents|respiratory system agents|mesh-ancestor
65393221|NCT00736541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65393222|NCT00736541|Antioxidants|antioxidants|mesh-ancestor
65393223|NCT00736541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393224|NCT00736541|Protective Agents|protective agents|mesh-ancestor
65393225|NCT00736541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393238|NCT01082809|Sunitinib|sunitinib|mesh-list
65393239|NCT01082809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393240|NCT01082809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65393241|NCT01082809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65393242|NCT01082809|Growth Substances|growth substances|mesh-ancestor
65393243|NCT01082809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393244|NCT01082809|Growth Inhibitors|growth inhibitors|mesh-ancestor
65393245|NCT01082809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65393246|NCT01082809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393247|NCT01082809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393248|NCT01080469|Tacrolimus|tacrolimus|mesh-list
65393249|NCT01080469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65393250|NCT01080469|Immunologic Factors|immunologic factors|mesh-ancestor
65393251|NCT01080469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393252|NCT01080469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65393253|NCT01080469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393254|NCT01080469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393255|NCT01079065|Famotidine|famotidine|mesh-list
65393256|NCT01079065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65393257|NCT01079065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65393258|NCT01079065|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65393259|NCT01079065|Histamine Antagonists|histamine antagonists|mesh-ancestor
65393260|NCT01079065|Histamine Agents|histamine agents|mesh-ancestor
65393261|NCT01079065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65393262|NCT01079065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393263|NCT01079065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393264|NCT00711191|Antibodies|antibodies|mesh-list
65393265|NCT00711191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65393266|NCT00711191|Immunologic Factors|immunologic factors|mesh-ancestor
65393267|NCT00711191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393268|NCT00741221|Bevacizumab|bevacizumab|mesh-list
65393269|NCT00741221|Pemetrexed|pemetrexed|mesh-list
65393270|NCT00741221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65393271|NCT00741221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393278|NCT00741221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393279|NCT00741221|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65393280|NCT00741221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65393281|NCT00736619|Paclitaxel|paclitaxel|mesh-list
65393282|NCT00736619|Cetuximab|cetuximab|mesh-list
65393283|NCT00736619|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65393284|NCT00736619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65393285|NCT00736619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393286|NCT00736619|Tubulin Modulators|tubulin modulators|mesh-ancestor
65393287|NCT00736619|Antimitotic Agents|antimitotic agents|mesh-ancestor
65393288|NCT00736619|Mitosis Modulators|mitosis modulators|mesh-ancestor
65393289|NCT00736619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393290|NCT00736619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65393291|NCT00741377|Zoledronic Acid|zoledronic acid|mesh-list
65393292|NCT00741377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65393293|NCT00741377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393294|NCT05742269|Atezolizumab|atezolizumab|mesh-list
65393295|NCT05742269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393296|NCT00448864|Ecallantide|ecallantide|mesh-list
65393297|NCT00448864|Analgesics|analgesics|mesh-ancestor
65393298|NCT00448864|Sensory System Agents|sensory system agents|mesh-ancestor
65393299|NCT00448864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65393300|NCT00448864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393301|NCT00448864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65393302|NCT00448864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65393303|NCT00448864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65393304|NCT00448864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65393325|NCT00929630|Hemostatics|hemostatics|mesh-ancestor
65393326|NCT00929630|Coagulants|coagulants|mesh-ancestor
65393327|NCT00925106|Celecoxib|celecoxib|mesh-list
65393328|NCT00925106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65393329|NCT00925106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65393330|NCT00925106|Analgesics|analgesics|mesh-ancestor
65393331|NCT00925106|Sensory System Agents|sensory system agents|mesh-ancestor
65393332|NCT00925106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65393333|NCT00925106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393334|NCT00925106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65393335|NCT00925106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65393336|NCT00925106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65393337|NCT00925106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65393338|NCT00925106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393339|NCT00925106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393340|NCT00905528|Telmisartan|telmisartan|mesh-list
65393341|NCT00905528|Ramipril|ramipril|mesh-list
65393342|NCT00905528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65393343|NCT00905528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65393344|NCT00905528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65393345|NCT00905528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393346|NCT00905528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65393347|NCT00905528|Protease Inhibitors|protease inhibitors|mesh-ancestor
65393348|NCT00905528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393349|NCT00736697|Moxidectin|moxidectin|mesh-list
65393350|NCT00736697|Anthelmintics|anthelmintics|mesh-ancestor
65393351|NCT00736697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65393352|NCT00736697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65393353|NCT00736697|Antinematodal Agents|antinematodal agents|mesh-ancestor
65393354|NCT02568995|Ketorolac|ketorolac|mesh-list
65393355|NCT02568995|Epinephrine|epinephrine|mesh-list
65393356|NCT02568995|Racepinephrine|racepinephrine|mesh-list
65393357|NCT02568995|Ropivacaine|ropivacaine|mesh-list
65393358|NCT02568995|Epinephryl borate|epinephryl borate|mesh-list
65393359|NCT02568995|Anesthetics, Local|anesthetics, local|mesh-ancestor
65393360|NCT02568995|Anesthetics|anesthetics|mesh-ancestor
65393365|NCT02568995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65393366|NCT02568995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65393367|NCT02568995|Analgesics|analgesics|mesh-ancestor
65393368|NCT02568995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65393369|NCT02568995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65393370|NCT02568995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65393371|NCT02568995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393372|NCT02568995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393373|NCT02568995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65393374|NCT02568995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65393375|NCT02568995|Adrenergic Agents|adrenergic agents|mesh-ancestor
65393376|NCT02568995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65393377|NCT02568995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65393378|NCT02568995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65393379|NCT02568995|Autonomic Agents|autonomic agents|mesh-ancestor
65393380|NCT02568995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65393381|NCT02568995|Respiratory System Agents|respiratory system agents|mesh-ancestor
65393382|NCT02568995|Mydriatics|mydriatics|mesh-ancestor
65393383|NCT02568995|Sympathomimetics|sympathomimetics|mesh-ancestor
65393384|NCT02568995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65393385|NCT00930020|Minocycline|minocycline|mesh-list
65393386|NCT00930020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65393387|NCT00930020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65393388|NCT00930098|Clofarabine|clofarabine|mesh-list
65393389|NCT00930098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65393390|NCT00930098|Antimetabolites|antimetabolites|mesh-ancestor
65393392|NCT00930098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393412|NCT00930332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393413|NCT00930332|Analgesics|analgesics|mesh-ancestor
65393414|NCT00930332|Sensory System Agents|sensory system agents|mesh-ancestor
65393415|NCT00930332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65393416|NCT00930332|Antitussive Agents|antitussive agents|mesh-ancestor
65393417|NCT00930332|Respiratory System Agents|respiratory system agents|mesh-ancestor
65393418|NCT05704985|Paclitaxel|paclitaxel|mesh-list
65393419|NCT05704985|Carboplatin|carboplatin|mesh-list
65393420|NCT05704985|Pembrolizumab|pembrolizumab|mesh-list
65393421|NCT05704985|Fluorouracil|fluorouracil|mesh-list
65393422|NCT05704985|Capecitabine|capecitabine|mesh-list
65393423|NCT05704985|Oxaliplatin|oxaliplatin|mesh-list
65393424|NCT05704985|Nivolumab|nivolumab|mesh-list
65393425|NCT05704985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65393426|NCT05704985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65393427|NCT05704985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393428|NCT05704985|Tubulin Modulators|tubulin modulators|mesh-ancestor
65393429|NCT05704985|Antimitotic Agents|antimitotic agents|mesh-ancestor
65393430|NCT05704985|Mitosis Modulators|mitosis modulators|mesh-ancestor
65393431|NCT05704985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393432|NCT05704985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65393433|NCT05704985|Antimetabolites|antimetabolites|mesh-ancestor
65393434|NCT05704985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65393435|NCT05704985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65393436|NCT05704985|Immunologic Factors|immunologic factors|mesh-ancestor
65393437|NCT05704985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393438|NCT02568839|Docetaxel|docetaxel|mesh-list
65393439|NCT02568839|Trastuzumab|trastuzumab|mesh-list
65393440|NCT02568839|Pertuzumab|pertuzumab|mesh-list
65393441|NCT02568839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393442|NCT02568839|Tubulin Modulators|tubulin modulators|mesh-ancestor
65393457|NCT00930488|Contraceptive Agents|contraceptive agents|mesh-ancestor
65393458|NCT00930488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65393459|NCT00930488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393460|NCT00930488|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65393461|NCT00930488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65393462|NCT00930488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65393463|NCT00736931|Levetiracetam|levetiracetam|mesh-list
65393464|NCT00736931|Lorazepam|lorazepam|mesh-list
65393465|NCT00736931|Brivaracetam|brivaracetam|mesh-list
65393466|NCT00736931|Anticonvulsants|anticonvulsants|mesh-ancestor
65393467|NCT00736931|Nootropic Agents|nootropic agents|mesh-ancestor
65393468|NCT00736931|Antiemetics|antiemetics|mesh-ancestor
65393469|NCT00736931|Autonomic Agents|autonomic agents|mesh-ancestor
65393470|NCT00736931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65393471|NCT00736931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393472|NCT00736931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65393473|NCT00736931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65393474|NCT00736931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65393475|NCT00736931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65393476|NCT00736931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65393477|NCT00736931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65393478|NCT00736931|GABA Modulators|gaba modulators|mesh-ancestor
65393479|NCT00736931|GABA Agents|gaba agents|mesh-ancestor
65393480|NCT00736931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65393481|NCT00736931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393482|NCT05669339|Irinotecan|irinotecan|mesh-list
65393483|NCT05669339|Sorafenib|sorafenib|mesh-list
65393484|NCT05669339|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65393485|NCT05669339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65393486|NCT05669339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393487|NCT05669339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393488|NCT05669339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393489|NCT05669339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65393490|NCT00567164|Drospirenone|drospirenone|mesh-list
65393491|NCT00567164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65393497|NCT00567164|Natriuretic Agents|natriuretic agents|mesh-ancestor
65393498|NCT00920933|Prednisolone|prednisolone|mesh-list
65393499|NCT00920933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65393500|NCT00920933|Glucocorticoids|glucocorticoids|mesh-ancestor
65393501|NCT00920933|Hormones|hormones|mesh-ancestor
65393502|NCT00920933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65393503|NCT00920933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393504|NCT00920933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65393505|NCT00920933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393506|NCT00930566|Methoxsalen|methoxsalen|mesh-list
65393507|NCT00930566|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65393508|NCT00930566|Dermatologic Agents|dermatologic agents|mesh-ancestor
65393509|NCT00925730|Pimecrolimus|pimecrolimus|mesh-list
65393510|NCT00925730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65393511|NCT00925730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65393512|NCT00925730|Analgesics|analgesics|mesh-ancestor
65393513|NCT00925730|Sensory System Agents|sensory system agents|mesh-ancestor
65393514|NCT00925730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65393515|NCT00925730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393516|NCT00925730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65393517|NCT00925730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65393518|NCT00925730|Dermatologic Agents|dermatologic agents|mesh-ancestor
65393519|NCT00925730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65393520|NCT00925730|Immunologic Factors|immunologic factors|mesh-ancestor
65393521|NCT00925730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65393522|NCT00925730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393523|NCT00925730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393524|NCT04063865|Everolimus|everolimus|mesh-list
65393525|NCT04063865|Tacrolimus|tacrolimus|mesh-list
65393526|NCT04063865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65393527|NCT04063865|Immunologic Factors|immunologic factors|mesh-ancestor
65393528|NCT04063865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782085|NCT04104438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782086|NCT03745950|Olaparib|olaparib|mesh-list
64782087|NCT03745950|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64782088|NCT03745950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782089|NCT03745950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782090|NCT03745950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782091|NCT03737604|Bupivacaine|bupivacaine|mesh-list
65393540|NCT00713219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65393542|NCT00931580|Cholecalciferol|cholecalciferol|mesh-list
65393543|NCT00931580|Vitamins|vitamins|mesh-ancestor
65393544|NCT00931580|Micronutrients|micronutrients|mesh-ancestor
65393545|NCT00931580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393546|NCT00931580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65393547|NCT00931580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65393548|NCT05661461|Sirolimus|sirolimus|mesh-list
64782092|NCT03737604|Ropivacaine|ropivacaine|mesh-list
64782093|NCT03737604|Anesthetics, Local|anesthetics, local|mesh-ancestor
64782094|NCT03737604|Anesthetics|anesthetics|mesh-ancestor
65393584|NCT00737555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393585|NCT00932048|Atorvastatin|atorvastatin|mesh-list
65393586|NCT00932048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65393587|NCT00932048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65393588|NCT00932048|Antimetabolites|antimetabolites|mesh-ancestor
65393589|NCT00932048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393590|NCT00932048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65393591|NCT00932048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65393592|NCT00932048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393593|NCT04015778|Paclitaxel|paclitaxel|mesh-list
65393594|NCT04015778|Carboplatin|carboplatin|mesh-list
65393595|NCT04015778|Nivolumab|nivolumab|mesh-list
65393596|NCT04015778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65393597|NCT04015778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393598|NCT04015778|Tubulin Modulators|tubulin modulators|mesh-ancestor
65393599|NCT04015778|Antimitotic Agents|antimitotic agents|mesh-ancestor
65393600|NCT04015778|Mitosis Modulators|mitosis modulators|mesh-ancestor
65393601|NCT04015778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393602|NCT04015778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65393603|NCT04015778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65393604|NCT00926354|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
65393605|NCT00926354|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65393606|NCT00926354|Immunologic Factors|immunologic factors|mesh-ancestor
65393607|NCT00926354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393608|NCT00926354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393609|NCT00926354|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65393610|NCT00926354|Protective Agents|protective agents|mesh-ancestor
65393611|NCT00926354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65393612|NCT00926354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65393613|NCT00926354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782116|NCT03260712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65393624|NCT05518877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393625|NCT05518877|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65393626|NCT05518877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65393627|NCT05518877|Anesthetics, General|anesthetics, general|mesh-ancestor
65393628|NCT05518877|Anesthetics|anesthetics|mesh-ancestor
65393629|NCT05518877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65393630|NCT05518877|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64782117|NCT03260712|Antimetabolites|antimetabolites|mesh-ancestor
64782118|NCT03260712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782119|NCT03260712|Antiviral Agents|antiviral agents|mesh-ancestor
64782120|NCT03260712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64782121|NCT03260712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393631|NCT05518877|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65393632|NCT05518877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65393633|NCT05518877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393634|NCT00737789|Mesalamine|mesalamine|mesh-list
65393635|NCT00737789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65393636|NCT00737789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65393637|NCT00737789|Analgesics|analgesics|mesh-ancestor
65393638|NCT00737789|Sensory System Agents|sensory system agents|mesh-ancestor
65393639|NCT00737789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65393640|NCT00737789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393641|NCT00737789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65393642|NCT00737789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65393643|NCT00700115|Ritonavir|ritonavir|mesh-list
65393644|NCT00700115|Lopinavir|lopinavir|mesh-list
65393664|NCT05097599|Talazoparib|talazoparib|mesh-list
64782130|NCT03086616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782131|NCT03086616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782132|NCT03040596|Fluticasone|fluticasone|mesh-list
64782133|NCT03040596|Xhance|xhance|mesh-list
64782134|NCT03040596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64782135|NCT03040596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64782136|NCT03040596|Autonomic Agents|autonomic agents|mesh-ancestor
64782137|NCT03040596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65393665|NCT05097599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65393666|NCT05097599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393667|NCT05097599|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65393668|NCT05097599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393669|NCT05097599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393670|NCT05095259|Insulin|insulin|mesh-list
65393671|NCT05095259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65393672|NCT05095259|Epinephrine|epinephrine|mesh-list
65393673|NCT05095259|Glucagon|glucagon|mesh-list
65393674|NCT05095259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65393675|NCT05095259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393676|NCT05095259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65393677|NCT05095259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65393678|NCT05095259|Adrenergic Agents|adrenergic agents|mesh-ancestor
65393679|NCT05095259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65393680|NCT05095259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393681|NCT05095259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65393682|NCT05095259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65393683|NCT05095259|Autonomic Agents|autonomic agents|mesh-ancestor
65393701|NCT00566852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65393702|NCT00936650|Cinacalcet|cinacalcet|mesh-list
65393703|NCT00936650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65393704|NCT00936650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393705|NCT00936650|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65393706|NCT00936650|Hormone Antagonists|hormone antagonists|mesh-ancestor
65393707|NCT00936650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65393708|NCT00442546|Pregabalin|pregabalin|mesh-list
65393709|NCT00442546|Analgesics|analgesics|mesh-ancestor
65393710|NCT00442546|Sensory System Agents|sensory system agents|mesh-ancestor
65393711|NCT00442546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65393712|NCT00442546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393713|NCT00442546|Anticonvulsants|anticonvulsants|mesh-ancestor
65393714|NCT00442546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65393715|NCT00442546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65393716|NCT00442546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393717|NCT00442546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65393718|NCT00442546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65393719|NCT00442546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65393720|NCT00442546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65393721|NCT00442546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65393722|NCT00936962|Vaccines|vaccines|mesh-list
65393753|NCT00566696|Antitubercular Agents|antitubercular agents|mesh-ancestor
65393754|NCT00566696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65393755|NCT00566696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65393756|NCT00566696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393757|NCT00926666|Levobupivacaine|levobupivacaine|mesh-list
65393758|NCT00926666|Anesthetics, Local|anesthetics, local|mesh-ancestor
65393759|NCT00926666|Anesthetics|anesthetics|mesh-ancestor
65393760|NCT00926666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65393761|NCT00926666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393762|NCT00926666|Sensory System Agents|sensory system agents|mesh-ancestor
65393763|NCT00926666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65393765|NCT00926900|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65393766|NCT00926900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65393767|NCT00926900|Renal Agents|renal agents|mesh-ancestor
65393768|NCT00926900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65393769|NCT00926900|Antitubercular Agents|antitubercular agents|mesh-ancestor
65393770|NCT00926900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65393771|NCT00926900|Antimetabolites|antimetabolites|mesh-ancestor
65393772|NCT00926900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393773|NCT00503841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65393774|NCT00503841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393775|NCT00503841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65393776|NCT00503841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393777|NCT00503841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393778|NCT00937508|Varenicline|varenicline|mesh-list
65393779|NCT00937508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65393780|NCT00937508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65393781|NCT00937508|Cholinergic Agents|cholinergic agents|mesh-ancestor
65393782|NCT00937508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65393783|NCT00937508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393784|NCT00937508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393785|NCT00937664|Gemcitabine|gemcitabine|mesh-list
65393787|NCT00937664|Antimetabolites|antimetabolites|mesh-ancestor
65393793|NCT00937664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65393794|NCT00937664|Immunologic Factors|immunologic factors|mesh-ancestor
65393795|NCT00937664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393796|NCT00937820|Darexaban|darexaban|mesh-list
65393797|NCT00937820|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65393798|NCT00937820|Antithrombins|antithrombins|mesh-ancestor
65393799|NCT00937820|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65393800|NCT00937820|Protease Inhibitors|protease inhibitors|mesh-ancestor
65393801|NCT00937820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393802|NCT00937820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393803|NCT00937820|Anticoagulants|anticoagulants|mesh-ancestor
65393804|NCT00506883|Colchicine|colchicine|mesh-list
65393805|NCT00506883|Gout Suppressants|gout suppressants|mesh-ancestor
65393806|NCT00506883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65393807|NCT00506883|Tubulin Modulators|tubulin modulators|mesh-ancestor
65393808|NCT00506883|Antimitotic Agents|antimitotic agents|mesh-ancestor
65393809|NCT00506883|Mitosis Modulators|mitosis modulators|mesh-ancestor
65393810|NCT00506883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393811|NCT00506883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393812|NCT01028638|Bevacizumab|bevacizumab|mesh-list
65393813|NCT01028638|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
65393814|NCT01028638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65393815|NCT01028638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393816|NCT01028638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65393817|NCT01028638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65393818|NCT01028638|Growth Substances|growth substances|mesh-ancestor
65393819|NCT01028638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393820|NCT01028638|Growth Inhibitors|growth inhibitors|mesh-ancestor
65393821|NCT01028638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65393822|NCT01028638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393823|NCT00938132|Warfarin|warfarin|mesh-list
65393824|NCT00938132|Anticoagulants|anticoagulants|mesh-ancestor
65393825|NCT01023334|Lidocaine|lidocaine|mesh-list
65393826|NCT01023334|Anesthetics|anesthetics|mesh-list
65393827|NCT01023334|Anesthetics, Local|anesthetics, local|mesh-ancestor
64782254|NCT04978584|Hormones|hormones|mesh-ancestor
64782255|NCT04978584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64782256|NCT04978584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64782257|NCT04978584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64782258|NCT04978584|Tubulin Modulators|tubulin modulators|mesh-ancestor
64782259|NCT04978584|Antimitotic Agents|antimitotic agents|mesh-ancestor
64782260|NCT04978584|Mitosis Modulators|mitosis modulators|mesh-ancestor
64782261|NCT04978584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64782262|NCT04978584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64782263|NCT04978584|Growth Substances|growth substances|mesh-ancestor
64782264|NCT04978584|Growth Inhibitors|growth inhibitors|mesh-ancestor
65393833|NCT01023334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65393834|NCT01023334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65393835|NCT01023334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65393836|NCT01023334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393837|NCT00938522|Cilostazol|cilostazol|mesh-list
65393838|NCT00938522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65393839|NCT00938522|Autonomic Agents|autonomic agents|mesh-ancestor
65393840|NCT00938522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65393841|NCT00938522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393873|NCT01562990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65393874|NCT01562990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393875|NCT01562990|Immunologic Factors|immunologic factors|mesh-ancestor
65393876|NCT01562990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393877|NCT01562990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65393878|NCT01562990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65393879|NCT01562990|Antimetabolites|antimetabolites|mesh-ancestor
65393880|NCT01562990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393881|NCT01562990|Antiviral Agents|antiviral agents|mesh-ancestor
65393882|NCT01562990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65393883|NCT01562990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393884|NCT01562990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65393885|NCT01562990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65393886|NCT00737867|Gemcitabine|gemcitabine|mesh-list
65393887|NCT00737867|Carboplatin|carboplatin|mesh-list
65393888|NCT00737867|Vinorelbine|vinorelbine|mesh-list
65393889|NCT00737867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393890|NCT00737867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65393891|NCT00737867|Antimetabolites|antimetabolites|mesh-ancestor
65393892|NCT00737867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393893|NCT00737867|Antiviral Agents|antiviral agents|mesh-ancestor
65393894|NCT00737867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65393895|NCT00737867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393896|NCT00737867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65393897|NCT00737867|Immunologic Factors|immunologic factors|mesh-ancestor
65393898|NCT00737867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393899|NCT00737867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65393900|NCT00737867|Tubulin Modulators|tubulin modulators|mesh-ancestor
65393901|NCT00737867|Antimitotic Agents|antimitotic agents|mesh-ancestor
64671008|NCT02385110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671009|NCT02385110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64671010|NCT02385110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64671011|NCT02385110|Immunologic Factors|immunologic factors|mesh-ancestor
64671044|NCT01971593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671045|NCT01971593|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64671047|NCT01971593|Natriuretic Agents|natriuretic agents|mesh-ancestor
64671048|NCT01971593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64671049|NCT02986451|Clarithromycin|clarithromycin|mesh-list
64671050|NCT02986451|Dexamethasone|dexamethasone|mesh-list
64671051|NCT02986451|Lenalidomide|lenalidomide|mesh-list
64671072|NCT02986451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671073|NCT02986451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64671074|NCT02986451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64671075|NCT03245463|Hyaluronic Acid|hyaluronic acid|mesh-list
65393902|NCT00737867|Mitosis Modulators|mitosis modulators|mesh-ancestor
65393903|NCT03976466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65393904|NCT03976466|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65393905|NCT03976466|Calcium|calcium|mesh-list
65393906|NCT03976466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65393907|NCT03976466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393908|NCT03976466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65393909|NCT03976466|Antitubercular Agents|antitubercular agents|mesh-ancestor
65393910|NCT02536755|Eliglustat|eliglustat|mesh-list
65393911|NCT02536755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393912|NCT02536755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393913|NCT02567279|Denosumab|denosumab|mesh-list
65393914|NCT02567279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65393915|NCT02567279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393916|NCT00933374|Paclitaxel|paclitaxel|mesh-list
65393917|NCT00933374|Everolimus|everolimus|mesh-list
65393918|NCT00933374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65393919|NCT00933374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65393920|NCT00933374|Tubulin Modulators|tubulin modulators|mesh-ancestor
65393921|NCT00933374|Antimitotic Agents|antimitotic agents|mesh-ancestor
65393922|NCT00933374|Mitosis Modulators|mitosis modulators|mesh-ancestor
65393923|NCT00933374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393924|NCT00933374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65393925|NCT00933374|Immunologic Factors|immunologic factors|mesh-ancestor
65393926|NCT00933374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393927|NCT03303105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65393928|NCT03303105|Immunologic Factors|immunologic factors|mesh-ancestor
65393929|NCT03303105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393930|NCT00933452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65393937|NCT00933452|Analgesics|analgesics|mesh-ancestor
65393945|NCT00447694|Chelating Agents|chelating agents|mesh-ancestor
65393946|NCT00447694|Sequestering Agents|sequestering agents|mesh-ancestor
65393947|NCT00447694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393948|NCT00564278|Antidepressive Agents|antidepressive agents|mesh-list
65393949|NCT00564278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65393950|NCT00447382|Insulin|insulin|mesh-list
65393951|NCT00447382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65393952|NCT00447382|Insulin Aspart|insulin aspart|mesh-list
65393953|NCT00447382|Insulin Detemir|insulin detemir|mesh-list
65393954|NCT00447382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65393955|NCT00447382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393956|NCT00938990|Midazolam|midazolam|mesh-list
65393957|NCT00938990|Etomidate|etomidate|mesh-list
65393958|NCT00938990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65393959|NCT00938990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65393960|NCT00938990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65393961|NCT00938990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393962|NCT00938990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65393963|NCT00938990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65393964|NCT00938990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65393965|NCT00938990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65393966|NCT00938990|Anesthetics, General|anesthetics, general|mesh-ancestor
65393967|NCT00938990|Anesthetics|anesthetics|mesh-ancestor
65393968|NCT00938990|GABA Modulators|gaba modulators|mesh-ancestor
65393969|NCT00938990|GABA Agents|gaba agents|mesh-ancestor
65393970|NCT00938990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65393971|NCT00938990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65393972|NCT00933998|Vitamin B 12|vitamin b 12|mesh-list
65393973|NCT00933998|Pyridoxal|pyridoxal|mesh-list
65393974|NCT00933998|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
65393975|NCT00933998|Vitamin B Complex|vitamin b complex|mesh-ancestor
65393976|NCT00933998|Vitamins|vitamins|mesh-ancestor
65393991|NCT03360916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65393993|NCT00446992|Antiemetics|antiemetics|mesh-ancestor
65393994|NCT00446992|Autonomic Agents|autonomic agents|mesh-ancestor
65393995|NCT00446992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65393996|NCT00446992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65393997|NCT00446992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65393998|NCT00446992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65393999|NCT00446992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65394000|NCT00446992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65394001|NCT00446992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65394002|NCT00446992|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65394003|NCT00446992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65394004|NCT00446992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65394005|NCT00446992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394006|NCT00446992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65394007|NCT00446992|Serotonin Agents|serotonin agents|mesh-ancestor
65394008|NCT00503139|Etanercept|etanercept|mesh-list
65394009|NCT00503139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65394010|NCT00503139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65394011|NCT00503139|Analgesics|analgesics|mesh-ancestor
65394012|NCT00503139|Sensory System Agents|sensory system agents|mesh-ancestor
65394013|NCT00503139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65394014|NCT00503139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394015|NCT00503139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65394016|NCT00503139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65394017|NCT00503139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65394018|NCT00503139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65394019|NCT00503139|Immunologic Factors|immunologic factors|mesh-ancestor
65394020|NCT00577031|Bevacizumab|bevacizumab|mesh-list
65394021|NCT00577031|Oxaliplatin|oxaliplatin|mesh-list
65394022|NCT00577031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65394023|NCT00577031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394034|NCT00565448|Mitosis Modulators|mitosis modulators|mesh-ancestor
65394035|NCT00565448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394036|NCT00565448|Antimetabolites|antimetabolites|mesh-ancestor
65394037|NCT00565448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65394038|NCT00565448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65394039|NCT00565448|Immunologic Factors|immunologic factors|mesh-ancestor
65394040|NCT00565448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394041|NCT01012011|Sorafenib|sorafenib|mesh-list
65394042|NCT01012011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394043|NCT01012011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65394044|NCT01012011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394045|NCT01012011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394046|NCT00934076|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65394047|NCT00934076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394048|NCT00934076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65394049|NCT00934076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394050|NCT00934076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394051|NCT00934154|Thalidomide|thalidomide|mesh-list
65394052|NCT00934154|Prednisolone|prednisolone|mesh-list
65394053|NCT00934154|Melphalan|melphalan|mesh-list
65394054|NCT00934154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65394055|NCT00934154|Alkylating Agents|alkylating agents|mesh-ancestor
65394056|NCT00934154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394057|NCT00934154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394058|NCT00934154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65394059|NCT00934154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65394060|NCT00934154|Immunologic Factors|immunologic factors|mesh-ancestor
65394061|NCT00934154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394076|NCT00446446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394077|NCT05078255|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
65394078|NCT05078255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65394079|NCT05078255|Incretins|incretins|mesh-ancestor
65394080|NCT05078255|Hormones|hormones|mesh-ancestor
65394081|NCT05078255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65394082|NCT05078255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394083|NCT00939458|Lamotrigine|lamotrigine|mesh-list
65394084|NCT00939458|Anticonvulsants|anticonvulsants|mesh-ancestor
65394085|NCT00939458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65394086|NCT00939458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65394087|NCT00939458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394088|NCT00939458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65394089|NCT00939458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394090|NCT00939458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65394091|NCT00939458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65394092|NCT00939458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65394093|NCT00939458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65394094|NCT00939458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65394095|NCT02566967|Tofacitinib|tofacitinib|mesh-list
65394096|NCT02566967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65394097|NCT02566967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394098|NCT02566967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394099|NCT00939068|Telbivudine|telbivudine|mesh-list
65394100|NCT00939068|Antiviral Agents|antiviral agents|mesh-ancestor
65394101|NCT00939068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65394102|NCT00939068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65394103|NCT00939068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394104|NCT00939068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394105|NCT00934232|Busulfan|busulfan|mesh-list
65394106|NCT00934232|Alkylating Agents|alkylating agents|mesh-ancestor
65394108|NCT00934232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65394117|NCT01013571|Insulin glulisine|insulin glulisine|mesh-list
65394118|NCT01013571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65394119|NCT01013571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394120|NCT00514449|Valacyclovir|valacyclovir|mesh-list
65394121|NCT00514449|Antiviral Agents|antiviral agents|mesh-ancestor
65394122|NCT00514449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65394123|NCT00492921|Cyclophosphamide|cyclophosphamide|mesh-list
65394124|NCT00492921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65394125|NCT00492921|Immunologic Factors|immunologic factors|mesh-ancestor
65394126|NCT00492921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394127|NCT00492921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65394128|NCT00492921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65394129|NCT00492921|Alkylating Agents|alkylating agents|mesh-ancestor
65394130|NCT00492921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394131|NCT00492921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394132|NCT00492921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65394133|NCT00738257|Pamidronate|pamidronate|mesh-list
65394134|NCT00738257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65394135|NCT00738257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143699|NCT02875873|Adrenergic Agents|adrenergic agents|mesh-ancestor
65394136|NCT00738335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65394137|NCT00738335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394138|NCT00738335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65394139|NCT00738335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394140|NCT00738335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394142|NCT00502671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64671076|NCT03245463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64671078|NCT03245463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671079|NCT03245463|Viscosupplements|viscosupplements|mesh-ancestor
64671080|NCT03245463|Protective Agents|protective agents|mesh-ancestor
64671081|NCT01974245|Cholecalciferol|cholecalciferol|mesh-list
64671082|NCT01974245|Vitamin D|vitamin d|mesh-list
64671083|NCT01974245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64671084|NCT01974245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671085|NCT01974245|Vitamins|vitamins|mesh-ancestor
64671086|NCT01974245|Micronutrients|micronutrients|mesh-ancestor
64671087|NCT01974245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64671088|NCT03307005|Zolpidem|zolpidem|mesh-list
64671089|NCT03307005|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64671090|NCT03307005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64671091|NCT03307005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64671092|NCT03307005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556883|NCT03076710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556885|NCT03076710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556887|NCT04143581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64556888|NCT04143581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394143|NCT00502671|Antimetabolites|antimetabolites|mesh-ancestor
65394144|NCT00502671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394145|NCT00502671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394146|NCT00738413|Deferasirox|deferasirox|mesh-list
65394147|NCT00738413|Deferoxamine|deferoxamine|mesh-list
65394148|NCT00738413|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65394149|NCT00738413|Chelating Agents|chelating agents|mesh-ancestor
65394150|NCT00738413|Sequestering Agents|sequestering agents|mesh-ancestor
65394151|NCT00738413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394152|NCT00738413|Siderophores|siderophores|mesh-ancestor
65394153|NCT00697463|Teriparatide|teriparatide|mesh-list
65394154|NCT00697463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65394155|NCT00697463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394156|NCT00697463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65394157|NCT04409795|Metformin|metformin|mesh-list
65394158|NCT04409795|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65394159|NCT04409795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65394160|NCT04409795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394161|NCT04409795|Incretins|incretins|mesh-ancestor
65394162|NCT04409795|Hormones|hormones|mesh-ancestor
65394163|NCT04409795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65394164|NCT04409795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65394165|NCT04409795|Protease Inhibitors|protease inhibitors|mesh-ancestor
65394166|NCT04409795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394167|NCT04409795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394168|NCT00492531|Sildenafil Citrate|sildenafil citrate|mesh-list
65394169|NCT00492531|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
65394170|NCT00492531|Vasodilator Agents|vasodilator agents|mesh-ancestor
65394171|NCT00492531|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65394172|NCT00492531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556890|NCT04143581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556891|NCT03071172|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64556892|NCT03071172|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64556893|NCT03071172|Progesterone|progesterone|mesh-list
64556894|NCT03071172|Hormones|hormones|mesh-ancestor
64556895|NCT03071172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64556896|NCT03071172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556897|NCT03071172|Progestins|progestins|mesh-ancestor
64556898|NCT03071172|Luteolytic Agents|luteolytic agents|mesh-ancestor
64556899|NCT03071172|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64556900|NCT03071172|Contraceptive Agents|contraceptive agents|mesh-ancestor
64556901|NCT03071172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64556902|NCT03071172|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64321954|NCT02221453|Hormones|hormones|mesh-ancestor
64782494|NCT02777268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65394173|NCT00492531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394174|NCT00492531|Urological Agents|urological agents|mesh-ancestor
65394175|NCT01015209|Acetylcysteine|acetylcysteine|mesh-list
65394176|NCT01015209|Chitosan|chitosan|mesh-list
65394177|NCT01015209|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65394178|NCT01015209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65394179|NCT01015209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65394180|NCT01015209|Antiviral Agents|antiviral agents|mesh-ancestor
65394181|NCT01015209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65394182|NCT01015209|Expectorants|expectorants|mesh-ancestor
65394183|NCT01015209|Respiratory System Agents|respiratory system agents|mesh-ancestor
65394184|NCT01015209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65394185|NCT01015209|Antioxidants|antioxidants|mesh-ancestor
65394186|NCT01015209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394187|NCT01015209|Protective Agents|protective agents|mesh-ancestor
65394188|NCT01015209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394189|NCT01015209|Antidotes|antidotes|mesh-ancestor
65394190|NCT01015209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65394191|NCT01015209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65394192|NCT01015209|Antimetabolites|antimetabolites|mesh-ancestor
65394193|NCT01015209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65394194|NCT01015209|Chelating Agents|chelating agents|mesh-ancestor
65394195|NCT01015209|Sequestering Agents|sequestering agents|mesh-ancestor
65394196|NCT01015209|Hemostatics|hemostatics|mesh-ancestor
65394197|NCT01015209|Coagulants|coagulants|mesh-ancestor
65394198|NCT04948463|Vancomycin|vancomycin|mesh-list
65394199|NCT04948463|Ciprofloxacin|ciprofloxacin|mesh-list
65394200|NCT04948463|Tazobactam|tazobactam|mesh-list
65394201|NCT04948463|Piperacillin|piperacillin|mesh-list
65394202|NCT04948463|Amikacin|amikacin|mesh-list
65394203|NCT04948463|Ceftazidime|ceftazidime|mesh-list
65394204|NCT04948463|Cefepime|cefepime|mesh-list
65394205|NCT04948463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65394206|NCT04948463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65394207|NCT04948463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65143779|NCT01102972|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65394208|NCT04948463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65394213|NCT04948463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65394214|NCT04948463|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65394215|NCT01080547|Capecitabine|capecitabine|mesh-list
65394216|NCT01080547|Oxaliplatin|oxaliplatin|mesh-list
65394217|NCT01080547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65394218|NCT01080547|Antimetabolites|antimetabolites|mesh-ancestor
65394219|NCT01080547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394220|NCT01080547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394221|NCT04930991|Omeprazole|omeprazole|mesh-list
65394222|NCT04930991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65394223|NCT04930991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65394224|NCT04930991|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65394225|NCT04930991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394226|NCT04930991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394227|NCT00111241|Letrozole|letrozole|mesh-list
65394228|NCT00111241|Anastrozole|anastrozole|mesh-list
65394229|NCT00111241|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65394230|NCT00111241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394231|NCT00111241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65394232|NCT00111241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394233|NCT00111241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394234|NCT00111241|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65394235|NCT00111241|Hormone Antagonists|hormone antagonists|mesh-ancestor
65394236|NCT00111241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65394237|NCT00111241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394238|NCT00111241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65394239|NCT00492297|Sorafenib|sorafenib|mesh-list
65394240|NCT00492297|Dacarbazine|dacarbazine|mesh-list
65394241|NCT00492297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394242|NCT00492297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65394243|NCT00492297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394244|NCT00492297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394245|NCT00492297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65394252|NCT04835129|Dexamethasone|dexamethasone|mesh-list
65394253|NCT04835129|Pomalidomide|pomalidomide|mesh-list
65394254|NCT04835129|Elotuzumab|elotuzumab|mesh-list
65394255|NCT04835129|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65394256|NCT04835129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65394257|NCT04835129|Antiemetics|antiemetics|mesh-ancestor
65394258|NCT04835129|Autonomic Agents|autonomic agents|mesh-ancestor
65394259|NCT04835129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65394260|NCT04835129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394261|NCT04835129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65394262|NCT04835129|Glucocorticoids|glucocorticoids|mesh-ancestor
65394263|NCT04835129|Hormones|hormones|mesh-ancestor
65394264|NCT04835129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65394265|NCT04835129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65394266|NCT04835129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394267|NCT04835129|Immunologic Factors|immunologic factors|mesh-ancestor
65394268|NCT04835129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65394269|NCT04835129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65394270|NCT04835129|Growth Substances|growth substances|mesh-ancestor
65394271|NCT04835129|Growth Inhibitors|growth inhibitors|mesh-ancestor
65394272|NCT04816643|Vaccines|vaccines|mesh-list
65394273|NCT04816643|Immunologic Factors|immunologic factors|mesh-ancestor
65394274|NCT04816643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394275|NCT00446134|Ribavirin|ribavirin|mesh-list
65394276|NCT00446134|Taribavirin|taribavirin|mesh-list
65394277|NCT00446134|Antimetabolites|antimetabolites|mesh-ancestor
65394278|NCT00446134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394279|NCT00446134|Antiviral Agents|antiviral agents|mesh-ancestor
65394280|NCT00446134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65394281|NCT00934466|Dextromethorphan|dextromethorphan|mesh-list
65394282|NCT00934466|Antitussive Agents|antitussive agents|mesh-ancestor
65394283|NCT00934466|Respiratory System Agents|respiratory system agents|mesh-ancestor
65394295|NCT00921245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394296|NCT00921245|Urological Agents|urological agents|mesh-ancestor
65394297|NCT03459092|Botulinum Toxins|botulinum toxins|mesh-list
65394298|NCT03459092|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65394299|NCT03459092|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65394300|NCT03459092|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65394301|NCT03459092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65394302|NCT03459092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394303|NCT03459092|Cholinergic Agents|cholinergic agents|mesh-ancestor
65394304|NCT03459092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65394305|NCT03459092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394306|NCT03459092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65394307|NCT03459092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65394308|NCT00940238|Dexetimide|dexetimide|mesh-list
65394309|NCT00940238|Citalopram|citalopram|mesh-list
65394310|NCT00940238|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65394311|NCT00940238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65394312|NCT00940238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65394313|NCT00940238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394314|NCT00940238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65394315|NCT00940238|Serotonin Agents|serotonin agents|mesh-ancestor
65394316|NCT00940238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394317|NCT00940238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65394318|NCT00940238|Antidepressive Agents|antidepressive agents|mesh-ancestor
65394319|NCT00940238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65394320|NCT00940238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65394321|NCT00940238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65394322|NCT00940238|Parasympatholytics|parasympatholytics|mesh-ancestor
65394323|NCT00940238|Autonomic Agents|autonomic agents|mesh-ancestor
65394324|NCT00940238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65394325|NCT00940238|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65394326|NCT00940238|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65394335|NCT04013438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65394336|NCT04013438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394337|NCT04013438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65394338|NCT04013438|Contraceptive Agents|contraceptive agents|mesh-ancestor
65394339|NCT04013438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65394340|NCT04013438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65394341|NCT04013438|Urological Agents|urological agents|mesh-ancestor
65394342|NCT02565719|Interferons|interferons|mesh-list
65394343|NCT02565719|Tenofovir|tenofovir|mesh-list
65394344|NCT02565719|Interferon-alpha|interferon-alpha|mesh-list
65394345|NCT02565719|Interferon alpha-2|interferon alpha-2|mesh-list
65394346|NCT02565719|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65394347|NCT02565719|REP 2139|rep 2139|mesh-list
65394348|NCT02565719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394349|NCT02565719|Antiviral Agents|antiviral agents|mesh-ancestor
65394350|NCT02565719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65394351|NCT02565719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65394352|NCT02565719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65394353|NCT02565719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394354|NCT02565719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394355|NCT02565719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65394356|NCT02565719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65394357|NCT02565719|Immunologic Factors|immunologic factors|mesh-ancestor
65394358|NCT02565719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394359|NCT00111007|Paclitaxel|paclitaxel|mesh-list
65394360|NCT00111007|Carboplatin|carboplatin|mesh-list
65394361|NCT00111007|Sorafenib|sorafenib|mesh-list
65394362|NCT00111007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65394363|NCT00111007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394364|NCT00111007|Tubulin Modulators|tubulin modulators|mesh-ancestor
65394365|NCT00111007|Antimitotic Agents|antimitotic agents|mesh-ancestor
65394366|NCT00111007|Mitosis Modulators|mitosis modulators|mesh-ancestor
65394367|NCT00111007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394368|NCT00111007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65394372|NCT00699335|Narcotics|narcotics|mesh-ancestor
65394376|NCT00699335|Sensory System Agents|sensory system agents|mesh-ancestor
65394377|NCT00699335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65394378|NCT00699335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65394379|NCT00699335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65394380|NCT00699335|Anesthetics, General|anesthetics, general|mesh-ancestor
65394381|NCT00699335|Anesthetics|anesthetics|mesh-ancestor
65394382|NCT00939614|Lamotrigine|lamotrigine|mesh-list
65394383|NCT00939614|Anticonvulsants|anticonvulsants|mesh-ancestor
65394384|NCT00939614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65394385|NCT00939614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65394386|NCT00939614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394387|NCT00939614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65394388|NCT00939614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394389|NCT00939614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65394390|NCT00939614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65394391|NCT00939614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65394392|NCT00939614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65394393|NCT00939614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65394394|NCT03962881|Vaccines|vaccines|mesh-list
65394395|NCT03962881|Immunologic Factors|immunologic factors|mesh-ancestor
65394396|NCT03962881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394397|NCT00935246|Dexetimide|dexetimide|mesh-list
65394398|NCT00935246|Citalopram|citalopram|mesh-list
65394399|NCT00935246|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65394400|NCT00935246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65394401|NCT00935246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65394402|NCT00935246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394403|NCT00935246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65394404|NCT00935246|Serotonin Agents|serotonin agents|mesh-ancestor
64671093|NCT03307005|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64671094|NCT03307005|GABA Agonists|gaba agonists|mesh-ancestor
64671095|NCT03307005|GABA Agents|gaba agents|mesh-ancestor
64671096|NCT03307005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671097|NCT03307005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671098|NCT02005601|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64671099|NCT02005601|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64671100|NCT02005601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64671101|NCT02005601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64671102|NCT02005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671103|NCT02005601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671104|NCT02005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671125|NCT02305277|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64671126|NCT02305277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394405|NCT00935246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394406|NCT00935246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65394407|NCT00935246|Antidepressive Agents|antidepressive agents|mesh-ancestor
65394408|NCT00935246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65394409|NCT00935246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65394410|NCT00935246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65394411|NCT00935246|Parasympatholytics|parasympatholytics|mesh-ancestor
65394412|NCT00935246|Autonomic Agents|autonomic agents|mesh-ancestor
65394413|NCT00935246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65394414|NCT00935246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65394415|NCT00935246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65394416|NCT00935246|Cholinergic Agents|cholinergic agents|mesh-ancestor
65394417|NCT00935480|Raltegravir Potassium|raltegravir potassium|mesh-list
65394418|NCT00935480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65394419|NCT00935480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65394420|NCT00935480|Antiviral Agents|antiviral agents|mesh-ancestor
65394421|NCT00935480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65394422|NCT00935480|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65394423|NCT00935480|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65394424|NCT00935480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394425|NCT00935480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394426|NCT00939848|Gemcitabine|gemcitabine|mesh-list
65394427|NCT00939848|Cisplatin|cisplatin|mesh-list
65394428|NCT00939848|Cediranib|cediranib|mesh-list
65394429|NCT00939848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394430|NCT00939848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65394431|NCT00939848|Antimetabolites|antimetabolites|mesh-ancestor
65394432|NCT00939848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394433|NCT00939848|Antiviral Agents|antiviral agents|mesh-ancestor
65394434|NCT00939848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65394435|NCT00939848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394436|NCT00939848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65394437|NCT00939848|Immunologic Factors|immunologic factors|mesh-ancestor
65394441|NCT00935558|Exemestane|exemestane|mesh-list
65394448|NCT00935558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394449|NCT00935558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394450|NCT00935558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65394451|NCT00935558|Analgesics|analgesics|mesh-ancestor
65394452|NCT00935558|Sensory System Agents|sensory system agents|mesh-ancestor
65394453|NCT00935558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65394454|NCT00935558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65394455|NCT00935558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394456|NCT00935558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394457|NCT00935558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65394458|NCT00935558|Hormone Antagonists|hormone antagonists|mesh-ancestor
65394459|NCT00935558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65394460|NCT00935558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65394461|NCT00935558|Cathartics|cathartics|mesh-ancestor
65394462|NCT00935558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65394463|NCT05280236|Propofol|propofol|mesh-list
65394464|NCT05280236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65394465|NCT05280236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65394466|NCT05280236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394467|NCT05280236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65394468|NCT05280236|Anesthetics, General|anesthetics, general|mesh-ancestor
65394469|NCT05280236|Anesthetics|anesthetics|mesh-ancestor
65394470|NCT00940472|Metformin|metformin|mesh-list
65394471|NCT00940472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65394472|NCT00940472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394473|NCT00939926|Risperidone|risperidone|mesh-list
65394474|NCT00939926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65394475|NCT00939926|Serotonin Agents|serotonin agents|mesh-ancestor
65394476|NCT00939926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671127|NCT02305277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671128|NCT02305277|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64671129|NCT02305277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64671130|NCT03309657|Tazobactam|tazobactam|mesh-list
64671131|NCT03309657|Ceftolozane|ceftolozane|mesh-list
64671132|NCT03309657|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
64671133|NCT03309657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64671134|NCT03309657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64671135|NCT03309657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64671136|NCT03309657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671137|NCT03309657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671138|NCT03309657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64671139|NCT03309657|Renal Agents|renal agents|mesh-ancestor
64671140|NCT03463161|Pembrolizumab|pembrolizumab|mesh-list
64671141|NCT03463161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65394477|NCT00939926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394478|NCT00939926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394479|NCT00939926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65394480|NCT00939926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65394481|NCT00939926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65394482|NCT00939926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65394483|NCT00939926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65394484|NCT00939926|Dopamine Agents|dopamine agents|mesh-ancestor
65394485|NCT00940550|Melatonin|melatonin|mesh-list
65394486|NCT00940550|Zolpidem|zolpidem|mesh-list
65394487|NCT00940550|Temazepam|temazepam|mesh-list
65394488|NCT00940550|Antioxidants|antioxidants|mesh-ancestor
65394489|NCT00940550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394490|NCT00940550|Protective Agents|protective agents|mesh-ancestor
65394491|NCT00940550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394492|NCT00940550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65394493|NCT00940550|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65394494|NCT00940550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65394495|NCT00940550|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65394496|NCT00940550|GABA Agonists|gaba agonists|mesh-ancestor
65394497|NCT00940550|GABA Agents|gaba agents|mesh-ancestor
65394498|NCT00940550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65394499|NCT00940550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65394500|NCT00940550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65394501|NCT00940550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65394502|NCT00940550|GABA Modulators|gaba modulators|mesh-ancestor
65394503|NCT00940628|Orlistat|orlistat|mesh-list
65394504|NCT00940628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394505|NCT00940628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394506|NCT00940628|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65394507|NCT00940628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65394508|NCT00936182|Fluconazole|fluconazole|mesh-list
65394509|NCT00936182|Antifungal Agents|antifungal agents|mesh-ancestor
65394510|NCT00936182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65394511|NCT00936182|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65394517|NCT00936182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65394518|NCT00936182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394519|NCT00936182|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65394520|NCT00936182|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65394522|NCT00936260|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65394523|NCT00936260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394524|NCT00445978|Verapamil|verapamil|mesh-list
65394525|NCT00445978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65394526|NCT00445978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65394527|NCT00445978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65394528|NCT00445978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394529|NCT00445978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65394530|NCT00445978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394531|NCT00445978|Vasodilator Agents|vasodilator agents|mesh-ancestor
65394532|NCT02566733|Remifentanil|remifentanil|mesh-list
65394533|NCT02566733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65394534|NCT02566733|Narcotics|narcotics|mesh-ancestor
65394535|NCT02566733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65394536|NCT02566733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394537|NCT02566733|Analgesics|analgesics|mesh-ancestor
65394538|NCT02566733|Sensory System Agents|sensory system agents|mesh-ancestor
65394539|NCT02566733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65394540|NCT01028950|Darexaban|darexaban|mesh-list
65394541|NCT01028950|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65394542|NCT01028950|Antithrombins|antithrombins|mesh-ancestor
65394543|NCT01028950|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65394544|NCT01028950|Protease Inhibitors|protease inhibitors|mesh-ancestor
65394545|NCT01028950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394546|NCT01028950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394547|NCT01028950|Anticoagulants|anticoagulants|mesh-ancestor
65394548|NCT00940784|Aspirin|aspirin|mesh-list
65394549|NCT00940784|Clopidogrel|clopidogrel|mesh-list
65394550|NCT00940784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65394551|NCT00940784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65394552|NCT00940784|Analgesics|analgesics|mesh-ancestor
65394553|NCT00940784|Sensory System Agents|sensory system agents|mesh-ancestor
65394554|NCT00940784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65394555|NCT00940784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394556|NCT00940784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65394557|NCT00940784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65394558|NCT00940784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65394559|NCT00940784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65394560|NCT00940784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394561|NCT00940784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65394562|NCT00940784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65394563|NCT00940784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394564|NCT00940784|Antipyretics|antipyretics|mesh-ancestor
65394565|NCT00940784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65394566|NCT00940784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65394567|NCT00940784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65394568|NCT00940784|Purinergic Agents|purinergic agents|mesh-ancestor
65394569|NCT00940784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65394570|NCT01023490|Vitamin D|vitamin d|mesh-list
65394571|NCT01023490|Vitamins|vitamins|mesh-ancestor
65394572|NCT01023490|Micronutrients|micronutrients|mesh-ancestor
65394573|NCT01023490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394574|NCT01023490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65394575|NCT00698009|Cyclophosphamide|cyclophosphamide|mesh-list
65394576|NCT00698009|Fludarabine|fludarabine|mesh-list
65394577|NCT00698009|Fludarabine phosphate|fludarabine phosphate|mesh-list
65394578|NCT00698009|Interleukin-2|interleukin-2|mesh-list
65394579|NCT00698009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65394580|NCT00698009|Immunologic Factors|immunologic factors|mesh-ancestor
65394581|NCT00698009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394582|NCT00698009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65394583|NCT00698009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65394584|NCT00698009|Alkylating Agents|alkylating agents|mesh-ancestor
64556903|NCT03071172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64556904|NCT03071172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671142|NCT03463161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671143|NCT03467685|Anesthetics|anesthetics|mesh-list
64671144|NCT03467685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64671145|NCT03467685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671146|NCT03468075|Ascorbic Acid|ascorbic acid|mesh-list
64671147|NCT03468075|Gemcitabine|gemcitabine|mesh-list
64671148|NCT03468075|Vitamins|vitamins|mesh-ancestor
64671149|NCT03468075|Micronutrients|micronutrients|mesh-ancestor
64671150|NCT03468075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671151|NCT03468075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64671152|NCT03468075|Antimetabolites|antimetabolites|mesh-ancestor
65394585|NCT00698009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394586|NCT00698009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394587|NCT00698009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65394588|NCT00698009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65394589|NCT00698009|Antimetabolites|antimetabolites|mesh-ancestor
65394590|NCT00698009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65394591|NCT00698009|Analgesics|analgesics|mesh-ancestor
65394592|NCT00698009|Sensory System Agents|sensory system agents|mesh-ancestor
65394593|NCT00698009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65394594|NCT04648631|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65394595|NCT04648631|Respiratory System Agents|respiratory system agents|mesh-ancestor
65394596|NCT00944606|Vitamin D|vitamin d|mesh-list
65394597|NCT00944606|Vitamins|vitamins|mesh-ancestor
65394598|NCT00944606|Micronutrients|micronutrients|mesh-ancestor
65394599|NCT00944606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394600|NCT00944606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65394601|NCT05257655|Analgesics, Opioid|analgesics, opioid|mesh-list
65394602|NCT05257655|Narcotics|narcotics|mesh-ancestor
65394603|NCT05257655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65394604|NCT05257655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394605|NCT05257655|Analgesics|analgesics|mesh-ancestor
65394606|NCT05257655|Sensory System Agents|sensory system agents|mesh-ancestor
65394607|NCT05257655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65394608|NCT00944684|Ribavirin|ribavirin|mesh-list
65394609|NCT00944684|Antimetabolites|antimetabolites|mesh-ancestor
65394610|NCT00944684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394611|NCT00944684|Antiviral Agents|antiviral agents|mesh-ancestor
65394612|NCT00944684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65394613|NCT04061057|Lidocaine|lidocaine|mesh-list
65394614|NCT04061057|Anesthetics, Local|anesthetics, local|mesh-ancestor
65394630|NCT00921167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65394631|NCT00921167|Growth Substances|growth substances|mesh-ancestor
65394632|NCT00921167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394633|NCT00921167|Growth Inhibitors|growth inhibitors|mesh-ancestor
65394634|NCT00921167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65394635|NCT00921167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65394636|NCT00921167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394637|NCT00921167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394638|NCT04061447|Clarithromycin|clarithromycin|mesh-list
65394639|NCT04061447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65394640|NCT04061447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65394641|NCT04061447|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65394642|NCT04061447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394643|NCT04061447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394644|NCT04061447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65394645|NCT04061447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65394646|NCT03968978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65394647|NCT03968978|Immunologic Factors|immunologic factors|mesh-ancestor
65394648|NCT03968978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394649|NCT05472779|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65394650|NCT05472779|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65394651|NCT05472779|Estradiol|estradiol|mesh-list
65394652|NCT05472779|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65394653|NCT05472779|Estrogens|estrogens|mesh-ancestor
65394654|NCT05472779|Hormones|hormones|mesh-ancestor
65394655|NCT05472779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65394656|NCT05472779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394661|NCT02565953|Paclitaxel|paclitaxel|mesh-list
65394673|NCT05222165|Infigratinib|infigratinib|mesh-list
65394674|NCT05222165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394675|NCT04555811|Rituximab|rituximab|mesh-list
65394676|NCT04555811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65394677|NCT04555811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394678|NCT04555811|Immunologic Factors|immunologic factors|mesh-ancestor
65394679|NCT04555811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394680|NCT04555811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65394681|NCT00697619|Zoledronic Acid|zoledronic acid|mesh-list
65394682|NCT00697619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65394683|NCT00697619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394684|NCT02566187|Atorvastatin|atorvastatin|mesh-list
65394685|NCT02566187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65394686|NCT02566187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65394687|NCT02566187|Antimetabolites|antimetabolites|mesh-ancestor
65394688|NCT02566187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394689|NCT02566187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65394690|NCT02566187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65394691|NCT02566187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394692|NCT05324891|Fentanyl|fentanyl|mesh-list
65394693|NCT05324891|Dexmedetomidine|dexmedetomidine|mesh-list
65394694|NCT05324891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65394695|NCT05324891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65394696|NCT05324891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394697|NCT05324891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65394698|NCT05324891|Analgesics|analgesics|mesh-ancestor
65394699|NCT05324891|Sensory System Agents|sensory system agents|mesh-ancestor
65394700|NCT05324891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65394701|NCT05324891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64671162|NCT03468933|Plasminogen|plasminogen|mesh-list
64671163|NCT03468933|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64671164|NCT03468933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64671165|NCT03468933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64671166|NCT03468933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671167|NCT03472287|Diacetylrhein|diacetylrhein|mesh-list
64671168|NCT03472287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64671169|NCT02219984|Anticoagulants|anticoagulants|mesh-list
64671170|NCT02067416|Paclitaxel|paclitaxel|mesh-list
64671171|NCT02067416|Docetaxel|docetaxel|mesh-list
64671172|NCT02067416|Epirubicin|epirubicin|mesh-list
64671173|NCT02067416|Taxane|taxane|mesh-list
64671174|NCT02067416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64671177|NCT02067416|Antimitotic Agents|antimitotic agents|mesh-ancestor
64671178|NCT02067416|Mitosis Modulators|mitosis modulators|mesh-ancestor
64671179|NCT02067416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671180|NCT02067416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65394702|NCT05324891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65394703|NCT05324891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65394704|NCT05324891|Adrenergic Agents|adrenergic agents|mesh-ancestor
65394705|NCT05324891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65394706|NCT05324891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394707|NCT05324891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65394708|NCT05324891|Narcotics|narcotics|mesh-ancestor
65394709|NCT05324891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65394710|NCT05324891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65394711|NCT05324891|Anesthetics, General|anesthetics, general|mesh-ancestor
65394712|NCT05324891|Anesthetics|anesthetics|mesh-ancestor
65394713|NCT04482803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65394714|NCT04482803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
65394715|NCT04482803|beta-Endorphin|beta-endorphin|mesh-list
65394716|NCT04482803|Hormones|hormones|mesh-ancestor
65394717|NCT04482803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65394718|NCT04482803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394719|NCT04482803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65394720|NCT04482803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394721|NCT05451329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65394722|NCT05451329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65394723|NCT00445432|Adalimumab|adalimumab|mesh-list
65394724|NCT00445432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65394725|NCT00445432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65394726|NCT03370133|Ustekinumab|ustekinumab|mesh-list
65394727|NCT03370133|Dermatologic Agents|dermatologic agents|mesh-ancestor
65394728|NCT00696137|Fentanyl|fentanyl|mesh-list
65394729|NCT00696137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65394730|NCT00696137|Narcotics|narcotics|mesh-ancestor
65394731|NCT00696137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65394732|NCT00696137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394733|NCT00696137|Analgesics|analgesics|mesh-ancestor
65394734|NCT00696137|Sensory System Agents|sensory system agents|mesh-ancestor
65394735|NCT00696137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65394736|NCT00696137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65394737|NCT00696137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65394738|NCT00696137|Anesthetics, General|anesthetics, general|mesh-ancestor
64671181|NCT02067416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65394740|NCT02565641|Gemcitabine|gemcitabine|mesh-list
65394741|NCT02565641|Capecitabine|capecitabine|mesh-list
65394742|NCT02565641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65394743|NCT02565641|Antimetabolites|antimetabolites|mesh-ancestor
65394744|NCT02565641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394745|NCT02565641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394746|NCT02565641|Antiviral Agents|antiviral agents|mesh-ancestor
65394747|NCT02565641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65394748|NCT02565641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394749|NCT02565641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65394750|NCT02565641|Immunologic Factors|immunologic factors|mesh-ancestor
65394751|NCT02565641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394752|NCT04036721|Prednisone|prednisone|mesh-list
65394753|NCT04036721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65394754|NCT04036721|Glucocorticoids|glucocorticoids|mesh-ancestor
65394755|NCT04036721|Hormones|hormones|mesh-ancestor
65394756|NCT04036721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65394757|NCT04036721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394758|NCT04036721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65394759|NCT04036721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394760|NCT00441142|Temozolomide|temozolomide|mesh-list
65394761|NCT00441142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65394762|NCT00441142|Alkylating Agents|alkylating agents|mesh-ancestor
65394763|NCT00441142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394764|NCT00441142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394765|NCT03848416|Ixekizumab|ixekizumab|mesh-list
65394766|NCT03848416|Dermatologic Agents|dermatologic agents|mesh-ancestor
65394767|NCT01029418|Sorafenib|sorafenib|mesh-list
65394768|NCT01029418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394769|NCT01029418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65394770|NCT01029418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394784|NCT04060979|Vasodilator Agents|vasodilator agents|mesh-ancestor
65394785|NCT04060979|Gasotransmitters|gasotransmitters|mesh-ancestor
65394786|NCT04060979|Protective Agents|protective agents|mesh-ancestor
65394787|NCT00458302|Darunavir|darunavir|mesh-list
65394788|NCT00458302|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65394789|NCT00458302|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65394790|NCT00458302|Protease Inhibitors|protease inhibitors|mesh-ancestor
65394791|NCT00458302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394792|NCT00458302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394793|NCT00458302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65394794|NCT00458302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65394795|NCT00458302|Antiviral Agents|antiviral agents|mesh-ancestor
65394796|NCT00458302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65394797|NCT00444106|Artesunate|artesunate|mesh-list
65394798|NCT00444106|Lumefantrine|lumefantrine|mesh-list
65394799|NCT00444106|Artemether|artemether|mesh-list
65394800|NCT00444106|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65394801|NCT00444106|Mefloquine|mefloquine|mesh-list
65394802|NCT00444106|Atovaquone|atovaquone|mesh-list
65394803|NCT00444106|Proguanil|proguanil|mesh-list
65394804|NCT00444106|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
65394805|NCT00444106|Antimalarials|antimalarials|mesh-ancestor
65394806|NCT00444106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65394807|NCT00444106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65394808|NCT00444106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65394809|NCT00444106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394810|NCT00444106|Antiviral Agents|antiviral agents|mesh-ancestor
65394811|NCT00444106|Schistosomicides|schistosomicides|mesh-ancestor
65144377|NCT01048099|Pertuzumab|pertuzumab|mesh-list
65394812|NCT00444106|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65394813|NCT00444106|Anthelmintics|anthelmintics|mesh-ancestor
65394814|NCT00444106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394815|NCT00444106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394816|NCT00444106|Antimetabolites|antimetabolites|mesh-ancestor
65394817|NCT00561470|Leucovorin|leucovorin|mesh-list
65394818|NCT00561470|Fluorouracil|fluorouracil|mesh-list
65394819|NCT00561470|Irinotecan|irinotecan|mesh-list
65394820|NCT00561470|Aflibercept|aflibercept|mesh-list
65394821|NCT00561470|Levoleucovorin|levoleucovorin|mesh-list
65394822|NCT00561470|Antimetabolites|antimetabolites|mesh-ancestor
64783020|NCT02908620|Anesthetics|anesthetics|mesh-list
65394824|NCT00561470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65394825|NCT00561470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394826|NCT00561470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65394827|NCT00561470|Immunologic Factors|immunologic factors|mesh-ancestor
65394828|NCT00561470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394829|NCT00561470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65394830|NCT00561470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65394831|NCT00561470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394832|NCT00561470|Antidotes|antidotes|mesh-ancestor
65394833|NCT00561470|Protective Agents|protective agents|mesh-ancestor
65394834|NCT00561470|Vitamin B Complex|vitamin b complex|mesh-ancestor
65394835|NCT00561470|Vitamins|vitamins|mesh-ancestor
65394836|NCT00561470|Micronutrients|micronutrients|mesh-ancestor
65394837|NCT00561470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65394838|NCT00561470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65394839|NCT00561470|Growth Substances|growth substances|mesh-ancestor
65394840|NCT00561470|Growth Inhibitors|growth inhibitors|mesh-ancestor
65394841|NCT00443872|Selegiline|selegiline|mesh-list
65394842|NCT00443872|Antidepressive Agents|antidepressive agents|mesh-ancestor
65394843|NCT00443872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65394844|NCT00443872|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65394845|NCT00443872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65394846|NCT00443872|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65394847|NCT00443872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394848|NCT00443872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394849|NCT00443872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65394850|NCT00443872|Protective Agents|protective agents|mesh-ancestor
65394851|NCT00443872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394852|NCT01323244|Simeprevir|simeprevir|mesh-list
65394853|NCT01323244|Antiviral Agents|antiviral agents|mesh-ancestor
65394854|NCT01323244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65394855|NCT01323244|Protease Inhibitors|protease inhibitors|mesh-ancestor
65394856|NCT01323244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64783021|NCT02908620|Tetracaine|tetracaine|mesh-list
64671182|NCT02067416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64671183|NCT02067416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671185|NCT03258645|Antithrombins|antithrombins|mesh-ancestor
64671186|NCT03258645|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64671187|NCT03258645|Protease Inhibitors|protease inhibitors|mesh-ancestor
64671188|NCT03258645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671189|NCT03258645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783043|NCT02911818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783044|NCT02912364|Carbamazepine|carbamazepine|mesh-list
64783045|NCT02912364|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
65394857|NCT01323244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394858|NCT03034642|Dimercaprol|dimercaprol|mesh-list
65394859|NCT03034642|Chelating Agents|chelating agents|mesh-ancestor
65394860|NCT03034642|Sequestering Agents|sequestering agents|mesh-ancestor
65394861|NCT03034642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394862|NCT03840226|Magnesium Oxide|magnesium oxide|mesh-list
65394863|NCT03840226|Antacids|antacids|mesh-ancestor
65394864|NCT03840226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394865|NCT03840226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65394866|NCT03962738|Lasmiditan|lasmiditan|mesh-list
65394867|NCT03962738|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65394868|NCT03962738|Serotonin Agents|serotonin agents|mesh-ancestor
65394869|NCT03962738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65394870|NCT03962738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394871|NCT03962738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394872|NCT00561392|Rivastigmine|rivastigmine|mesh-list
65394873|NCT00561392|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65394874|NCT00561392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394875|NCT00561392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394876|NCT00561392|Cholinergic Agents|cholinergic agents|mesh-ancestor
65394877|NCT00561392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65394878|NCT00561392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394879|NCT00561392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65394880|NCT00561392|Protective Agents|protective agents|mesh-ancestor
65394881|NCT00694109|Mipomersen|mipomersen|mesh-list
65394882|NCT00694109|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65394883|NCT00694109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65394896|NCT03068741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65394897|NCT03068741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65394898|NCT00561080|Vaccines|vaccines|mesh-list
65394899|NCT00561080|Immunologic Factors|immunologic factors|mesh-ancestor
65394900|NCT00561080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394901|NCT01307306|Metformin|metformin|mesh-list
65394902|NCT01307306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65394903|NCT01307306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394904|NCT00941096|Timolol|timolol|mesh-list
65394905|NCT00941096|Bimatoprost|bimatoprost|mesh-list
65394906|NCT00941096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65394907|NCT00941096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65394908|NCT00941096|Adrenergic Agents|adrenergic agents|mesh-ancestor
65394909|NCT00941096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65394910|NCT00941096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394911|NCT00941096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394912|NCT00941096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65394913|NCT00941096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65394914|NCT04012424|Curcumin|curcumin|mesh-list
65394915|NCT04012424|Analgesics|analgesics|mesh-list
65394916|NCT04012424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65394917|NCT04012424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65394918|NCT04012424|Sensory System Agents|sensory system agents|mesh-ancestor
65394919|NCT04012424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65394920|NCT04012424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394921|NCT04012424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65394922|NCT04012424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65394923|NCT04012424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394924|NCT04012424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394925|NCT04012424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394926|NCT00562094|Pantoprazole|pantoprazole|mesh-list
65394927|NCT00562094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65394928|NCT00562094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65394929|NCT00562094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65394930|NCT00562094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394931|NCT00562094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394932|NCT03817853|Prednisone|prednisone|mesh-list
64671190|NCT03258645|Anticoagulants|anticoagulants|mesh-ancestor
65394933|NCT03817853|Methylprednisolone|methylprednisolone|mesh-list
65394934|NCT03817853|Prednisolone|prednisolone|mesh-list
65394935|NCT03817853|Cyclophosphamide|cyclophosphamide|mesh-list
65394936|NCT03817853|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65394937|NCT03817853|Doxorubicin|doxorubicin|mesh-list
65394938|NCT03817853|Vincristine|vincristine|mesh-list
65394939|NCT03817853|Obinutuzumab|obinutuzumab|mesh-list
65394940|NCT03817853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65394941|NCT03817853|Immunologic Factors|immunologic factors|mesh-ancestor
65394942|NCT03817853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394943|NCT03817853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65394944|NCT03817853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65394945|NCT03817853|Alkylating Agents|alkylating agents|mesh-ancestor
65394946|NCT03817853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394947|NCT03817853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394948|NCT03817853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65394949|NCT03817853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65394950|NCT03817853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65394951|NCT03817853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65394952|NCT03817853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394953|NCT03817853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65394954|NCT03817853|Glucocorticoids|glucocorticoids|mesh-ancestor
65394955|NCT03817853|Hormones|hormones|mesh-ancestor
65394956|NCT03817853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65394957|NCT03817853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65394958|NCT03817853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65394959|NCT03817853|Tubulin Modulators|tubulin modulators|mesh-ancestor
65394960|NCT03817853|Antimitotic Agents|antimitotic agents|mesh-ancestor
65394961|NCT03817853|Mitosis Modulators|mitosis modulators|mesh-ancestor
65394962|NCT03817853|Antiemetics|antiemetics|mesh-ancestor
65394963|NCT03817853|Autonomic Agents|autonomic agents|mesh-ancestor
65394964|NCT03817853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65144526|NCT05643651|Aspirin|aspirin|mesh-list
65394965|NCT03817853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65394974|NCT00439270|Docetaxel|docetaxel|mesh-list
65394975|NCT00439270|Dasatinib|dasatinib|mesh-list
65394976|NCT00439270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394977|NCT00439270|Tubulin Modulators|tubulin modulators|mesh-ancestor
65394978|NCT00439270|Antimitotic Agents|antimitotic agents|mesh-ancestor
65394979|NCT00439270|Mitosis Modulators|mitosis modulators|mesh-ancestor
65394980|NCT00439270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394981|NCT00439270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65394982|NCT00439270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394983|NCT00944918|Fulvestrant|fulvestrant|mesh-list
65394984|NCT00944918|Anastrozole|anastrozole|mesh-list
65394985|NCT00944918|Exemestane|exemestane|mesh-list
65394986|NCT00944918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65394987|NCT00944918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65394988|NCT00944918|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65394989|NCT00944918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65394990|NCT00944918|Hormone Antagonists|hormone antagonists|mesh-ancestor
65394991|NCT00944918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65394992|NCT00944918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65394993|NCT00944918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65394994|NCT00944918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65394995|NCT00944918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65394996|NCT00944918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65394997|NCT04012268|Aspirin|aspirin|mesh-list
65394998|NCT04012268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65394999|NCT04012268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65395000|NCT04012268|Analgesics|analgesics|mesh-ancestor
65395001|NCT04012268|Sensory System Agents|sensory system agents|mesh-ancestor
65395002|NCT04012268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65395003|NCT04012268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395004|NCT04012268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65395005|NCT04012268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65395006|NCT04012268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65395007|NCT04012268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65395012|NCT04012268|Antipyretics|antipyretics|mesh-ancestor
65395013|NCT03995134|Remifentanil|remifentanil|mesh-list
65395014|NCT03995134|Propofol|propofol|mesh-list
65395015|NCT03995134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65395016|NCT03995134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65395017|NCT03995134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395018|NCT03995134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65395019|NCT03995134|Anesthetics, General|anesthetics, general|mesh-ancestor
65395020|NCT03995134|Anesthetics|anesthetics|mesh-ancestor
65395021|NCT03995134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65395022|NCT03995134|Narcotics|narcotics|mesh-ancestor
65395023|NCT03995134|Analgesics|analgesics|mesh-ancestor
65395024|NCT03995134|Sensory System Agents|sensory system agents|mesh-ancestor
65395025|NCT03995134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65395026|NCT00553280|Pregabalin|pregabalin|mesh-list
65395027|NCT00553280|Analgesics|analgesics|mesh-ancestor
65395028|NCT00553280|Sensory System Agents|sensory system agents|mesh-ancestor
65395029|NCT00553280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65395030|NCT00553280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395031|NCT00553280|Anticonvulsants|anticonvulsants|mesh-ancestor
65395032|NCT00553280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65395033|NCT00553280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65395034|NCT00553280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395035|NCT00553280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65395036|NCT00553280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65395037|NCT00553280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65395038|NCT00553280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65395039|NCT00553280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65395040|NCT01024192|Zolpidem|zolpidem|mesh-list
65395042|NCT01024192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65395060|NCT00944996|Paroxetine|paroxetine|mesh-list
65395061|NCT00944996|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65395062|NCT00944996|Sertraline|sertraline|mesh-list
65395063|NCT00944996|Clomipramine|clomipramine|mesh-list
65395064|NCT00944996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65395065|NCT00944996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65395066|NCT00944996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65395067|NCT00944996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395068|NCT00944996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65395069|NCT00944996|Serotonin Agents|serotonin agents|mesh-ancestor
65395070|NCT00944996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395071|NCT00944996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65395072|NCT00944996|Antidepressive Agents|antidepressive agents|mesh-ancestor
65395073|NCT00944996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65395074|NCT00944996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65395075|NCT00944996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65395076|NCT00944996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395077|NCT00944996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65395078|NCT00944996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65395079|NCT00950066|Amlodipine|amlodipine|mesh-list
65395080|NCT00950066|Irbesartan|irbesartan|mesh-list
65395081|NCT00950066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65395082|NCT00950066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65395083|NCT00950066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65395084|NCT00950066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395085|NCT00950066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65395086|NCT00950066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395087|NCT00950066|Vasodilator Agents|vasodilator agents|mesh-ancestor
65395088|NCT00950066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65395089|NCT00950066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65395090|NCT01031212|Acetic Acid|acetic acid|mesh-list
65395091|NCT01031212|Paclitaxel|paclitaxel|mesh-list
65395092|NCT01031212|Carboplatin|carboplatin|mesh-list
65395093|NCT01031212|Cetuximab|cetuximab|mesh-list
65395094|NCT01031212|Vadimezan|vadimezan|mesh-list
65395097|NCT01031212|Tubulin Modulators|tubulin modulators|mesh-ancestor
65395098|NCT01031212|Antimitotic Agents|antimitotic agents|mesh-ancestor
65395099|NCT01031212|Mitosis Modulators|mitosis modulators|mesh-ancestor
65395100|NCT01031212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395101|NCT01031212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65395102|NCT01031212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65395103|NCT01031212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65395104|NCT01024348|Acetaminophen|acetaminophen|mesh-list
65395105|NCT01024348|Tramadol|tramadol|mesh-list
65395106|NCT01024348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65395107|NCT01024348|Analgesics|analgesics|mesh-ancestor
65395108|NCT01024348|Sensory System Agents|sensory system agents|mesh-ancestor
65395109|NCT01024348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65395110|NCT01024348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395111|NCT01024348|Antipyretics|antipyretics|mesh-ancestor
65395112|NCT01024348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65395113|NCT01024348|Narcotics|narcotics|mesh-ancestor
65395114|NCT01024348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65395115|NCT03994744|Metformin|metformin|mesh-list
65395116|NCT03994744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65395117|NCT03994744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65395118|NCT03994744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395119|NCT03994744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395120|NCT03994744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395121|NCT00950222|Imipenem|imipenem|mesh-list
65395122|NCT00950222|Amikacin|amikacin|mesh-list
65395123|NCT00950222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65395124|NCT00950222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65395125|NCT05301530|Docetaxel|docetaxel|mesh-list
65395126|NCT05301530|Trastuzumab|trastuzumab|mesh-list
65395127|NCT05301530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395128|NCT05301530|Tubulin Modulators|tubulin modulators|mesh-ancestor
65395129|NCT05301530|Antimitotic Agents|antimitotic agents|mesh-ancestor
65395130|NCT05301530|Mitosis Modulators|mitosis modulators|mesh-ancestor
65395131|NCT05301530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395132|NCT05301530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65395133|NCT00941174|Leucovorin|leucovorin|mesh-list
65395134|NCT00941174|Calcium|calcium|mesh-list
64671191|NCT03482583|Nicotine|nicotine|mesh-list
65395137|NCT00941174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395138|NCT00941174|Antidotes|antidotes|mesh-ancestor
65395139|NCT00941174|Protective Agents|protective agents|mesh-ancestor
65395140|NCT00941174|Vitamin B Complex|vitamin b complex|mesh-ancestor
65395141|NCT00941174|Vitamins|vitamins|mesh-ancestor
65395142|NCT00941174|Micronutrients|micronutrients|mesh-ancestor
65395143|NCT00440518|Lacosamide|lacosamide|mesh-list
65395144|NCT00440518|Anticonvulsants|anticonvulsants|mesh-ancestor
65395145|NCT00440518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65395146|NCT00440518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65395147|NCT00440518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65395148|NCT00440518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395149|NCT00950534|Insulin Glargine|insulin glargine|mesh-list
65395150|NCT00950534|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65395151|NCT00950534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395152|NCT00941252|Imiquimod|imiquimod|mesh-list
65395153|NCT00941252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65395154|NCT00941252|Immunologic Factors|immunologic factors|mesh-ancestor
65395155|NCT00941252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395156|NCT00941252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395157|NCT00941252|Interferon Inducers|interferon inducers|mesh-ancestor
65395158|NCT01031368|Cytarabine|cytarabine|mesh-list
65395159|NCT01031368|Clofarabine|clofarabine|mesh-list
65395160|NCT01031368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65395161|NCT01031368|Antimetabolites|antimetabolites|mesh-ancestor
65395162|NCT01031368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395163|NCT01031368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395164|NCT01031368|Antiviral Agents|antiviral agents|mesh-ancestor
65395165|NCT01031368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65395166|NCT01031368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65395167|NCT01031368|Immunologic Factors|immunologic factors|mesh-ancestor
65395168|NCT01031368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395169|NCT00945308|Eptifibatide|eptifibatide|mesh-list
65395170|NCT00945308|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65395171|NCT03172936|Spartalizumab|spartalizumab|mesh-list
65395175|NCT01030042|Leucovorin|leucovorin|mesh-list
65395178|NCT01030042|Cetuximab|cetuximab|mesh-list
65395179|NCT01030042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395180|NCT01030042|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65395181|NCT01030042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65395182|NCT01030042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395183|NCT01030042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395184|NCT01030042|Antidotes|antidotes|mesh-ancestor
65395185|NCT01030042|Protective Agents|protective agents|mesh-ancestor
65395186|NCT01030042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395187|NCT01030042|Vitamin B Complex|vitamin b complex|mesh-ancestor
65395188|NCT01030042|Vitamins|vitamins|mesh-ancestor
65395189|NCT01030042|Micronutrients|micronutrients|mesh-ancestor
65395190|NCT01030042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65395191|NCT01024504|Bevacizumab|bevacizumab|mesh-list
65395192|NCT01024504|Capecitabine|capecitabine|mesh-list
65395193|NCT01024504|Oxaliplatin|oxaliplatin|mesh-list
65395194|NCT01024504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65395195|NCT01024504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395196|NCT01024504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65395197|NCT01024504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65395198|NCT01024504|Growth Substances|growth substances|mesh-ancestor
65395199|NCT01024504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395200|NCT01024504|Growth Inhibitors|growth inhibitors|mesh-ancestor
65395201|NCT01024504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65395202|NCT01024504|Antimetabolites|antimetabolites|mesh-ancestor
65395203|NCT01024504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395205|NCT01030120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65395206|NCT01030120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65395207|NCT01030120|Analgesics|analgesics|mesh-ancestor
65395208|NCT01030120|Sensory System Agents|sensory system agents|mesh-ancestor
65395209|NCT01030120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65395210|NCT01030120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395211|NCT01030120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64783280|NCT03020004|Antimetabolites|antimetabolites|mesh-ancestor
64671192|NCT03482583|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64671193|NCT03482583|Autonomic Agents|autonomic agents|mesh-ancestor
64671219|NCT01602380|Fulvestrant|fulvestrant|mesh-list
64671220|NCT01602380|Anastrozole|anastrozole|mesh-list
64671221|NCT01602380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64671222|NCT01602380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395212|NCT01030120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65395213|NCT01030120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65395214|NCT01030120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65395215|NCT01030120|Immunologic Factors|immunologic factors|mesh-ancestor
65395216|NCT00951236|Cortisone|cortisone|mesh-list
65395217|NCT00951236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65395218|NCT00945542|Hemostatics|hemostatics|mesh-list
65395219|NCT00945542|Coagulants|coagulants|mesh-ancestor
65395220|NCT00438256|Capecitabine|capecitabine|mesh-list
65395221|NCT00438256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65395222|NCT00438256|Antimetabolites|antimetabolites|mesh-ancestor
65395223|NCT00438256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395224|NCT00438256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395225|NCT01031524|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65395226|NCT01031524|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65395227|NCT01031524|Immunologic Factors|immunologic factors|mesh-ancestor
65395228|NCT01031524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395229|NCT00945620|Ropivacaine|ropivacaine|mesh-list
65395230|NCT00945620|Anesthetics, Local|anesthetics, local|mesh-ancestor
65395231|NCT00945620|Anesthetics|anesthetics|mesh-ancestor
65395232|NCT00945620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65395233|NCT00945620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395234|NCT00945620|Sensory System Agents|sensory system agents|mesh-ancestor
65395235|NCT00945620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65395236|NCT01565746|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65395237|NCT01565746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395238|NCT01030510|Rocuronium|rocuronium|mesh-list
64783337|NCT03044418|Anesthetics|anesthetics|mesh-ancestor
65395259|NCT04813822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65395260|NCT04813822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65395261|NCT02917564|Triamcinolone|triamcinolone|mesh-list
65395262|NCT02917564|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65395263|NCT02917564|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65395264|NCT02917564|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65395265|NCT02917564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65395266|NCT02917564|Glucocorticoids|glucocorticoids|mesh-ancestor
65395267|NCT02917564|Hormones|hormones|mesh-ancestor
65395268|NCT02917564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65395269|NCT02917564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395270|NCT02917564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65395271|NCT02917564|Immunologic Factors|immunologic factors|mesh-ancestor
65395272|NCT02917564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395273|NCT02917564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395274|NCT00952016|Methotrexate|methotrexate|mesh-list
65395275|NCT00952016|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65395276|NCT00952016|Abortifacient Agents|abortifacient agents|mesh-ancestor
65395277|NCT00952016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65395278|NCT00952016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395279|NCT00952016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65395280|NCT00952016|Antimetabolites|antimetabolites|mesh-ancestor
65395281|NCT00952016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395282|NCT00952016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395283|NCT00952016|Dermatologic Agents|dermatologic agents|mesh-ancestor
65395284|NCT00952016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395285|NCT00952016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65395286|NCT00952016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65395287|NCT00952016|Immunologic Factors|immunologic factors|mesh-ancestor
65395288|NCT00952016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65395300|NCT00942344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65395301|NCT00942344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395302|NCT00942344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65395303|NCT00942344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395304|NCT00942344|Vasodilator Agents|vasodilator agents|mesh-ancestor
65395305|NCT00942344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65395306|NCT00942344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65395307|NCT00942344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65395308|NCT00946166|Simvastatin|simvastatin|mesh-list
65395309|NCT00946166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65395310|NCT00946166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65395311|NCT00946166|Antimetabolites|antimetabolites|mesh-ancestor
65395312|NCT00946166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395313|NCT00946166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65395314|NCT00946166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65395315|NCT00946166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395316|NCT00952562|Cholecalciferol|cholecalciferol|mesh-list
65395317|NCT00952562|Vitamin D|vitamin d|mesh-list
65395318|NCT00952562|Vitamins|vitamins|mesh-ancestor
65395319|NCT00952562|Micronutrients|micronutrients|mesh-ancestor
65395320|NCT00952562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395321|NCT00952562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65395322|NCT00952562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65395323|NCT00952640|Vitamin A|vitamin a|mesh-list
65395324|NCT00952640|Vitamins|vitamins|mesh-ancestor
65395325|NCT00952640|Micronutrients|micronutrients|mesh-ancestor
65395326|NCT00952640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395327|NCT00952796|Moxifloxacin|moxifloxacin|mesh-list
65395328|NCT00952796|Ampicillin|ampicillin|mesh-list
65395329|NCT00952796|Sulbactam|sulbactam|mesh-list
65395330|NCT00952796|Sultamicillin|sultamicillin|mesh-list
65395343|NCT00952952|Sensory System Agents|sensory system agents|mesh-ancestor
65395344|NCT00952952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65395345|NCT00952952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395346|NCT00952952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65395347|NCT00952952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65395348|NCT00953108|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65395349|NCT00953108|Citalopram|citalopram|mesh-list
65395350|NCT00953108|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65395351|NCT00953108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65395352|NCT00953108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65395353|NCT00953108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395354|NCT00953108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65395355|NCT00953108|Serotonin Agents|serotonin agents|mesh-ancestor
65395356|NCT00953108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395357|NCT00953108|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65395358|NCT00953108|Antidepressive Agents|antidepressive agents|mesh-ancestor
65395359|NCT00953108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65395360|NCT00953108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65395361|NCT00953108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65395362|NCT00953108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65395363|NCT00953498|Pioglitazone|pioglitazone|mesh-list
65395364|NCT00953498|Rosiglitazone|rosiglitazone|mesh-list
65395365|NCT00953498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65395366|NCT00953498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395367|NCT00943358|Vaccines|vaccines|mesh-list
65395368|NCT00943358|Immunologic Factors|immunologic factors|mesh-ancestor
65395369|NCT00943358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395370|NCT00120289|Niacin|niacin|mesh-list
65395371|NCT00120289|Simvastatin|simvastatin|mesh-list
65395372|NCT00120289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65395373|NCT00120289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65395374|NCT00120289|Antimetabolites|antimetabolites|mesh-ancestor
65395375|NCT00120289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395376|NCT00120289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65395383|NCT00120289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395384|NCT00946556|Valacyclovir|valacyclovir|mesh-list
65395385|NCT00946556|Antiviral Agents|antiviral agents|mesh-ancestor
65395386|NCT00946556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65395387|NCT00943748|Deferiprone|deferiprone|mesh-list
65395388|NCT00943748|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65395389|NCT00943748|Chelating Agents|chelating agents|mesh-ancestor
65395390|NCT00943748|Sequestering Agents|sequestering agents|mesh-ancestor
65395391|NCT00943748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395392|NCT00946790|Hydroxychloroquine|hydroxychloroquine|mesh-list
65395393|NCT00946790|Antimalarials|antimalarials|mesh-ancestor
65395394|NCT00946790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65395395|NCT00946790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65395396|NCT00946790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65395397|NCT00946790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395398|NCT00946790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395399|NCT00946790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65395400|NCT00954200|Ibuprofen|ibuprofen|mesh-list
65395401|NCT00954200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65395402|NCT00954200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65395403|NCT00954200|Analgesics|analgesics|mesh-ancestor
65395404|NCT00954200|Sensory System Agents|sensory system agents|mesh-ancestor
65395405|NCT00954200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65395406|NCT00954200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395407|NCT00954200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65395408|NCT00954200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65395409|NCT00954200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65395410|NCT00954200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395411|NCT00954200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395412|NCT00954278|Sorafenib|sorafenib|mesh-list
65395413|NCT00954278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395414|NCT00954278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65395415|NCT00954278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493980|NCT03900754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395417|NCT00550446|Adalimumab|adalimumab|mesh-list
65395423|NCT00550446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395424|NCT00953472|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65395425|NCT00953472|Natriuretic Agents|natriuretic agents|mesh-ancestor
65395426|NCT00953472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395427|NCT00953550|Rocuronium|rocuronium|mesh-list
65395428|NCT00953550|Succinylcholine|succinylcholine|mesh-list
65395429|NCT00953550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65395430|NCT00953550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65395431|NCT00953550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65395432|NCT00953550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65395433|NCT00953550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395434|NCT00953550|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
65395435|NCT00953628|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65395436|NCT00953628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65395437|NCT00953628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395438|NCT00949026|Sirolimus|sirolimus|mesh-list
65395439|NCT00949026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65395440|NCT00949026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65395441|NCT00949026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65395442|NCT00949026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395443|NCT00949026|Antifungal Agents|antifungal agents|mesh-ancestor
65395444|NCT00949026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65395445|NCT00949026|Immunologic Factors|immunologic factors|mesh-ancestor
65395446|NCT00949026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395447|NCT00949182|Doxorubicin|doxorubicin|mesh-list
65395448|NCT00949182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65395449|NCT00949182|Mitomycins|mitomycins|mesh-list
65395450|NCT00949182|Mitomycin|mitomycin|mesh-list
65395451|NCT00949182|Sorafenib|sorafenib|mesh-list
65395452|NCT00949182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65395453|NCT00949182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395454|NCT00949182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65395455|NCT00949182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65395456|NCT00949182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395457|NCT00949182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395458|NCT00949182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65395462|NCT00436618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395463|NCT00436618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65395464|NCT00436618|Immunologic Factors|immunologic factors|mesh-ancestor
65395465|NCT00436618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395466|NCT01024660|Donepezil|donepezil|mesh-list
65395467|NCT01024660|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65395468|NCT01024660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395469|NCT01024660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395470|NCT01024660|Cholinergic Agents|cholinergic agents|mesh-ancestor
65395471|NCT01024660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65395472|NCT01024660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395473|NCT01024660|Nootropic Agents|nootropic agents|mesh-ancestor
65395474|NCT01751126|Cyclosporine|cyclosporine|mesh-list
65395475|NCT01751126|Cyclosporins|cyclosporins|mesh-list
65395476|NCT01751126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395477|NCT01751126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395478|NCT01751126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65395479|NCT01751126|Immunologic Factors|immunologic factors|mesh-ancestor
65395480|NCT01751126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395481|NCT01751126|Antifungal Agents|antifungal agents|mesh-ancestor
65395482|NCT01751126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65395483|NCT01751126|Dermatologic Agents|dermatologic agents|mesh-ancestor
65395484|NCT01751126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65395485|NCT01751126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65395486|NCT00943982|Interferons|interferons|mesh-list
65395487|NCT00943982|Interferon-gamma|interferon-gamma|mesh-list
65395488|NCT00943982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395489|NCT00943982|Antiviral Agents|antiviral agents|mesh-ancestor
65395490|NCT00943982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65395491|NCT00548808|Insulin|insulin|mesh-list
65395492|NCT00548808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65395493|NCT00548808|Insulin Glargine|insulin glargine|mesh-list
65395494|NCT00548808|Insulin Lispro|insulin lispro|mesh-list
65395495|NCT00548808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65395496|NCT00548808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395497|NCT04011878|Mitomycins|mitomycins|mesh-list
65395503|NCT04011878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65395504|NCT04011878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395505|NCT00954096|Nicotine|nicotine|mesh-list
65395506|NCT00954096|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65395507|NCT00954096|Autonomic Agents|autonomic agents|mesh-ancestor
65395508|NCT00954096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65395509|NCT00954096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395510|NCT00954096|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65395511|NCT00954096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65395512|NCT00954096|Cholinergic Agents|cholinergic agents|mesh-ancestor
65395513|NCT00954096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65395514|NCT00954096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395515|NCT00954252|Flurbiprofen|flurbiprofen|mesh-list
65395516|NCT00954252|Analgesics|analgesics|mesh-ancestor
65395517|NCT00954252|Sensory System Agents|sensory system agents|mesh-ancestor
65395518|NCT00954252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65395519|NCT00954252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395520|NCT00954252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65395521|NCT00954252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65395522|NCT00954252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65395523|NCT00954252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65395524|NCT00954252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65395525|NCT00954252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395526|NCT00954252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395527|NCT00110617|Deferasirox|deferasirox|mesh-list
65395528|NCT00110617|Deferoxamine|deferoxamine|mesh-list
65395529|NCT00110617|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65395530|NCT00110617|Chelating Agents|chelating agents|mesh-ancestor
65395531|NCT00110617|Sequestering Agents|sequestering agents|mesh-ancestor
65395532|NCT00110617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783515|NCT05093790|Aspirin|aspirin|mesh-list
64671223|NCT01602380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64671224|NCT01602380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64671225|NCT01602380|Hormone Antagonists|hormone antagonists|mesh-ancestor
64671226|NCT01602380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64671227|NCT01602380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671228|NCT01602380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64671229|NCT01602380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64671230|NCT01602380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671231|NCT01602380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671232|NCT03483675|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64671233|NCT03483675|Immunologic Factors|immunologic factors|mesh-ancestor
65395533|NCT00110617|Siderophores|siderophores|mesh-ancestor
65395534|NCT00949494|Hylan|hylan|mesh-list
65395535|NCT00949494|Hyaluronic Acid|hyaluronic acid|mesh-list
65395536|NCT00949494|Viscosupplements|viscosupplements|mesh-ancestor
65395537|NCT00949494|Protective Agents|protective agents|mesh-ancestor
65395538|NCT00949494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395539|NCT00949494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65395540|NCT00949494|Immunologic Factors|immunologic factors|mesh-ancestor
65395541|NCT00954486|Epoetin Alfa|epoetin alfa|mesh-list
65395542|NCT00954486|Hematinics|hematinics|mesh-ancestor
65395543|NCT00550238|Pimavanserin|pimavanserin|mesh-list
65395544|NCT00550238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65395545|NCT00550238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65395546|NCT00550238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65395547|NCT00550238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65395548|NCT00550238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65395549|NCT00550238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395550|NCT00550238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65395551|NCT00550238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65395552|NCT00550238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65395553|NCT00550238|Serotonin Agents|serotonin agents|mesh-ancestor
65395554|NCT00550238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65395555|NCT00550238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395556|NCT02903680|Dexamethasone|dexamethasone|mesh-list
65395557|NCT02903680|Dexamethasone acetate|dexamethasone acetate|mesh-list
65395558|NCT02903680|BB 1101|bb 1101|mesh-list
65395559|NCT02903680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64783534|NCT05093790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64671234|NCT03483675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671236|NCT03327051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64671237|NCT03327051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64671238|NCT03327051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64671239|NCT03327051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671240|NCT03327051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671241|NCT02057939|Leuprolide|leuprolide|mesh-list
64671242|NCT02057939|Androgens|androgens|mesh-list
64671243|NCT02057939|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64671244|NCT02057939|Fertility Agents|fertility agents|mesh-ancestor
64671272|NCT02058251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64671273|NCT02058251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671274|NCT03329937|Niraparib|niraparib|mesh-list
64671275|NCT03329937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64556905|NCT03070938|Anti-Infective Agents|anti-infective agents|mesh-list
64556906|NCT03070938|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64556907|NCT04143815|Botulinum Toxins|botulinum toxins|mesh-list
64556908|NCT04143815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64556909|NCT04143815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64556910|NCT04143815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64556911|NCT04143815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65395560|NCT02903680|Antiemetics|antiemetics|mesh-ancestor
65395561|NCT02903680|Autonomic Agents|autonomic agents|mesh-ancestor
65395562|NCT02903680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65395563|NCT02903680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395564|NCT02903680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65395565|NCT02903680|Glucocorticoids|glucocorticoids|mesh-ancestor
65395566|NCT02903680|Hormones|hormones|mesh-ancestor
65395567|NCT02903680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65493981|NCT03897439|Bupropion|bupropion|mesh-list
65395568|NCT02903680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65395569|NCT02903680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395570|NCT02903680|Protease Inhibitors|protease inhibitors|mesh-ancestor
65395571|NCT02903680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395572|NCT02903680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395573|NCT00946946|Mesalamine|mesalamine|mesh-list
65395574|NCT00946946|Azathioprine|azathioprine|mesh-list
65395575|NCT00946946|Antimetabolites|antimetabolites|mesh-ancestor
65395576|NCT00946946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395577|NCT00946946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65395578|NCT00946946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395579|NCT00946946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65395580|NCT00946946|Immunologic Factors|immunologic factors|mesh-ancestor
65395581|NCT00946946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395582|NCT00946946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65395583|NCT00946946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65395584|NCT00946946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65395585|NCT00946946|Analgesics|analgesics|mesh-ancestor
65395586|NCT00946946|Sensory System Agents|sensory system agents|mesh-ancestor
64324312|NCT02261779|Tretinoin|tretinoin|mesh-list
64556912|NCT04143815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671276|NCT03329937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671277|NCT03329937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671278|NCT03329937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671279|NCT01710254|Regadenoson|regadenoson|mesh-list
64671280|NCT01710254|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64671281|NCT01710254|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64671282|NCT01710254|Purinergic Agonists|purinergic agonists|mesh-ancestor
64671283|NCT01710254|Purinergic Agents|purinergic agents|mesh-ancestor
64671284|NCT01710254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671285|NCT01710254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671286|NCT01710254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671287|NCT03496545|Acetaminophen|acetaminophen|mesh-list
64671288|NCT03496545|Bromocriptine|bromocriptine|mesh-list
64671289|NCT03496545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65395587|NCT00946946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65395588|NCT00946946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65395589|NCT00947024|Glipizide|glipizide|mesh-list
65395590|NCT00947024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65395591|NCT00947024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395592|NCT00949572|Vaccines|vaccines|mesh-list
65395593|NCT00949572|Aluminum sulfate|aluminum sulfate|mesh-list
65395594|NCT00949572|Immunologic Factors|immunologic factors|mesh-ancestor
65395595|NCT00949572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395596|NCT00949572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65395597|NCT01031992|Tranexamic Acid|tranexamic acid|mesh-list
65395598|NCT01031992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65395599|NCT01031992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65395600|NCT01031992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395601|NCT01031992|Hemostatics|hemostatics|mesh-ancestor
65395602|NCT01031992|Coagulants|coagulants|mesh-ancestor
65395603|NCT00954564|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65395604|NCT00954564|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65395605|NCT00954564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395606|NCT00954564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395607|NCT00954564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65395608|NCT00954564|Hormone Antagonists|hormone antagonists|mesh-ancestor
65395609|NCT00954564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65395610|NCT00954564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395611|NCT00949728|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65395612|NCT00949728|Hemostatics|hemostatics|mesh-ancestor
65395613|NCT00949728|Coagulants|coagulants|mesh-ancestor
65395614|NCT00954902|Antioxidants|antioxidants|mesh-list
64671290|NCT03496545|Analgesics|analgesics|mesh-ancestor
64671296|NCT03496545|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64671299|NCT03496545|Dopamine Agonists|dopamine agonists|mesh-ancestor
64671300|NCT03496545|Dopamine Agents|dopamine agents|mesh-ancestor
64671301|NCT03496545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671302|NCT03496545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671303|NCT01710332|Aflibercept|aflibercept|mesh-list
64671304|NCT01710332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64671305|NCT01710332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64671306|NCT01710332|Growth Substances|growth substances|mesh-ancestor
64671307|NCT01710332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671308|NCT01710332|Growth Inhibitors|growth inhibitors|mesh-ancestor
64671309|NCT01710332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671310|NCT02311907|Paclitaxel|paclitaxel|mesh-list
64671311|NCT02311907|Carboplatin|carboplatin|mesh-list
64671312|NCT02311907|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64671313|NCT02311907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64671314|NCT02311907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671315|NCT02311907|Tubulin Modulators|tubulin modulators|mesh-ancestor
65395615|NCT00954902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395616|NCT00954902|Protective Agents|protective agents|mesh-ancestor
65395617|NCT00954902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395618|NCT01034020|Nicotine|nicotine|mesh-list
65395619|NCT01034020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65395620|NCT01034020|Autonomic Agents|autonomic agents|mesh-ancestor
65395621|NCT01034020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65395622|NCT01034020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395623|NCT01034020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65395624|NCT01034020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65395625|NCT01034020|Cholinergic Agents|cholinergic agents|mesh-ancestor
65395626|NCT01034020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65395627|NCT01034020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395628|NCT01032148|Panobinostat|panobinostat|mesh-list
65395629|NCT01032148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395630|NCT01032148|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65395631|NCT01032148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395632|NCT01032148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395633|NCT01032304|Erdosteine|erdosteine|mesh-list
65395634|NCT01032304|Expectorants|expectorants|mesh-ancestor
65395635|NCT01032304|Respiratory System Agents|respiratory system agents|mesh-ancestor
65395636|NCT00954642|Paclitaxel|paclitaxel|mesh-list
65395637|NCT00954642|Bevacizumab|bevacizumab|mesh-list
65395638|NCT00954642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65395639|NCT00954642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395640|NCT00954642|Tubulin Modulators|tubulin modulators|mesh-ancestor
65395641|NCT00954642|Antimitotic Agents|antimitotic agents|mesh-ancestor
65395642|NCT00954642|Mitosis Modulators|mitosis modulators|mesh-ancestor
65395643|NCT00954642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395644|NCT00954642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64671316|NCT02311907|Antimitotic Agents|antimitotic agents|mesh-ancestor
64671317|NCT02311907|Mitosis Modulators|mitosis modulators|mesh-ancestor
64671318|NCT02311907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671319|NCT02013245|Vaccines|vaccines|mesh-list
64671320|NCT02013245|Immunologic Factors|immunologic factors|mesh-ancestor
64671321|NCT02013245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671322|NCT01980485|Carbon Monoxide|carbon monoxide|mesh-list
64671323|NCT01980485|Antimetabolites|antimetabolites|mesh-ancestor
64671324|NCT01980485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671325|NCT01980485|Gasotransmitters|gasotransmitters|mesh-ancestor
64671326|NCT01980485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671327|NCT01980485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671328|NCT01981967|Vaccines|vaccines|mesh-list
65395645|NCT00954642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65395646|NCT00954642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65395647|NCT00954642|Growth Substances|growth substances|mesh-ancestor
65395648|NCT00954642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395649|NCT00954642|Growth Inhibitors|growth inhibitors|mesh-ancestor
65395650|NCT00954798|Vaccines|vaccines|mesh-list
65395651|NCT00954798|Immunologic Factors|immunologic factors|mesh-ancestor
65395652|NCT00954798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395653|NCT00110305|Efavirenz|efavirenz|mesh-list
65395654|NCT00110305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
65395655|NCT00110305|Rilpivirine|rilpivirine|mesh-list
65395656|NCT00110305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65395657|NCT00110305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395658|NCT00110305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395659|NCT00110305|Antiviral Agents|antiviral agents|mesh-ancestor
65395660|NCT00110305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65395661|NCT00110305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65395662|NCT00110305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65395663|NCT00110305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65395664|NCT00110305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65395665|NCT00110305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65395666|NCT00110305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65395667|NCT00110305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65395668|NCT00110305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65395669|NCT00560066|Vaccines|vaccines|mesh-list
65395670|NCT00560066|Immunologic Factors|immunologic factors|mesh-ancestor
65395671|NCT00560066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395672|NCT00549900|Vaccines|vaccines|mesh-list
65395690|NCT00435994|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65395691|NCT01563120|Metformin|metformin|mesh-list
65395692|NCT01563120|Glyburide|glyburide|mesh-list
65395693|NCT01563120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65395694|NCT01563120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395695|NCT00435370|Tropisetron|tropisetron|mesh-list
65395696|NCT00435370|Risperidone|risperidone|mesh-list
65395697|NCT00435370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65395698|NCT00435370|Serotonin Agents|serotonin agents|mesh-ancestor
65395699|NCT00435370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65395700|NCT00435370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395701|NCT00435370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395702|NCT00435370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65395703|NCT00435370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65395704|NCT00435370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65395705|NCT00435370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65395706|NCT00435370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65395707|NCT00435370|Dopamine Agents|dopamine agents|mesh-ancestor
65395708|NCT00435370|Antiemetics|antiemetics|mesh-ancestor
65395709|NCT00435370|Autonomic Agents|autonomic agents|mesh-ancestor
65395710|NCT00435370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65395711|NCT00435370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65395712|NCT00435370|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65395713|NCT05100654|Doxycycline|doxycycline|mesh-list
65395714|NCT05100654|Ciprofloxacin|ciprofloxacin|mesh-list
65395715|NCT05100654|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65395716|NCT05100654|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65145275|NCT01096186|Carbidopa|carbidopa|mesh-list
65395732|NCT00096031|Cetuximab|cetuximab|mesh-list
65395736|NCT00118417|Sertraline|sertraline|mesh-list
65395737|NCT00118417|Antidepressive Agents|antidepressive agents|mesh-ancestor
65395738|NCT00118417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65395739|NCT00118417|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65395740|NCT00118417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65395741|NCT00118417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65395742|NCT00118417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395743|NCT00118417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65395744|NCT00118417|Serotonin Agents|serotonin agents|mesh-ancestor
65395745|NCT00118417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395746|NCT00118417|Anticonvulsants|anticonvulsants|mesh-ancestor
65395747|NCT00118417|GABA Modulators|gaba modulators|mesh-ancestor
65395748|NCT00118417|GABA Agents|gaba agents|mesh-ancestor
65395749|NCT04293744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65395750|NCT01079455|Corticosterone|corticosterone|mesh-list
65395751|NCT01079455|Bupivacaine|bupivacaine|mesh-list
65395752|NCT01079455|Hyaluronic Acid|hyaluronic acid|mesh-list
65395753|NCT01079455|Anesthetics, Local|anesthetics, local|mesh-ancestor
65395754|NCT01079455|Anesthetics|anesthetics|mesh-ancestor
65395755|NCT01079455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65395756|NCT01079455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395757|NCT01079455|Sensory System Agents|sensory system agents|mesh-ancestor
65395758|NCT01079455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65395759|NCT01079455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65395760|NCT01079455|Immunologic Factors|immunologic factors|mesh-ancestor
65395761|NCT01079455|Viscosupplements|viscosupplements|mesh-ancestor
65395762|NCT01079455|Protective Agents|protective agents|mesh-ancestor
65395763|NCT01079455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65395764|NCT00549848|Cytarabine|cytarabine|mesh-list
65395765|NCT00549848|Dexamethasone|dexamethasone|mesh-list
65395766|NCT00549848|Dexamethasone acetate|dexamethasone acetate|mesh-list
65395767|NCT00549848|Prednisone|prednisone|mesh-list
65395768|NCT00549848|Prednisolone|prednisolone|mesh-list
65395769|NCT00549848|Cyclophosphamide|cyclophosphamide|mesh-list
65395770|NCT00549848|Doxorubicin|doxorubicin|mesh-list
65395771|NCT00549848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65395772|NCT00549848|Methotrexate|methotrexate|mesh-list
65395773|NCT00549848|Etoposide|etoposide|mesh-list
64671329|NCT01981967|Immunologic Factors|immunologic factors|mesh-ancestor
64671330|NCT01981967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671331|NCT01982123|Edetic Acid|edetic acid|mesh-list
64671332|NCT01982123|Pentetic Acid|pentetic acid|mesh-list
65395774|NCT00549848|Etoposide phosphate|etoposide phosphate|mesh-list
65395775|NCT00549848|Vincristine|vincristine|mesh-list
65395776|NCT00549848|Daunorubicin|daunorubicin|mesh-list
65395777|NCT00549848|Asparaginase|asparaginase|mesh-list
65395778|NCT00549848|Dasatinib|dasatinib|mesh-list
65395779|NCT00549848|Mercaptopurine|mercaptopurine|mesh-list
65395780|NCT00549848|Clofarabine|clofarabine|mesh-list
65395781|NCT00549848|Pegaspargase|pegaspargase|mesh-list
65395782|NCT00549848|Thioguanine|thioguanine|mesh-list
65395783|NCT00549848|BB 1101|bb 1101|mesh-list
65395784|NCT00549848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65395785|NCT00549848|Immunologic Factors|immunologic factors|mesh-ancestor
65395786|NCT00549848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395787|NCT00549848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65395788|NCT00549848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65395789|NCT00549848|Alkylating Agents|alkylating agents|mesh-ancestor
65395790|NCT00549848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395791|NCT00549848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395792|NCT00549848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65395793|NCT00549848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65395794|NCT00549848|Antiemetics|antiemetics|mesh-ancestor
65395795|NCT00549848|Autonomic Agents|autonomic agents|mesh-ancestor
65395796|NCT00549848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65395797|NCT00549848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65395798|NCT00549848|Glucocorticoids|glucocorticoids|mesh-ancestor
65395799|NCT00549848|Hormones|hormones|mesh-ancestor
65395800|NCT00549848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65395801|NCT00549848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65395802|NCT00549848|Protease Inhibitors|protease inhibitors|mesh-ancestor
65395803|NCT00549848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395804|NCT00549848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65395805|NCT00549848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65395806|NCT00549848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65395807|NCT00549848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65395808|NCT00549848|Abortifacient Agents|abortifacient agents|mesh-ancestor
65395815|NCT00549848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65395816|NCT00549848|Antiviral Agents|antiviral agents|mesh-ancestor
65395817|NCT00549848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65395818|NCT00549848|Tubulin Modulators|tubulin modulators|mesh-ancestor
65395819|NCT00549848|Antimitotic Agents|antimitotic agents|mesh-ancestor
65395820|NCT00549848|Mitosis Modulators|mitosis modulators|mesh-ancestor
65395821|NCT00549848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65395822|NCT01083589|Docetaxel|docetaxel|mesh-list
65395823|NCT01083589|Imatinib Mesylate|imatinib mesylate|mesh-list
65395824|NCT01083589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395825|NCT01083589|Tubulin Modulators|tubulin modulators|mesh-ancestor
65395826|NCT01083589|Antimitotic Agents|antimitotic agents|mesh-ancestor
65395827|NCT01083589|Mitosis Modulators|mitosis modulators|mesh-ancestor
65395828|NCT01083589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395829|NCT01083589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65395830|NCT01083589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395831|NCT00549770|Valsartan|valsartan|mesh-list
65395832|NCT00549770|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65395833|NCT00549770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65395834|NCT00549770|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65395835|NCT00549770|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65395836|NCT00549770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395837|NCT00548184|Trastuzumab|trastuzumab|mesh-list
65395838|NCT00548184|Lapatinib|lapatinib|mesh-list
65395839|NCT00548184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65395840|NCT00548184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395841|NCT00548184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65395842|NCT00548184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395843|NCT00548184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395844|NCT00454636|Cisplatin|cisplatin|mesh-list
65395845|NCT00454636|Docetaxel|docetaxel|mesh-list
65395846|NCT00454636|Capecitabine|capecitabine|mesh-list
65395857|NCT00454636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65395858|NCT00454636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65395859|NCT00454636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395860|NCT00427960|Atorvastatin|atorvastatin|mesh-list
65395861|NCT00427960|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65395862|NCT00427960|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65395863|NCT00427960|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65395864|NCT00427960|Antimetabolites|antimetabolites|mesh-ancestor
65395865|NCT00427960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395866|NCT00427960|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65395867|NCT00427960|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65395868|NCT00427960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395869|NCT04768686|Pembrolizumab|pembrolizumab|mesh-list
65395870|NCT04768686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65395871|NCT04768686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395872|NCT00955890|Dexrazoxane|dexrazoxane|mesh-list
65395873|NCT00955890|Razoxane|razoxane|mesh-list
65395874|NCT00955890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395875|NCT00955890|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65395876|NCT00955890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65395877|NCT00955890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65395878|NCT00955890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395879|NCT00955890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395880|NCT00955890|Protective Agents|protective agents|mesh-ancestor
65395881|NCT00955890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395882|NCT00955890|Antimitotic Agents|antimitotic agents|mesh-ancestor
65395883|NCT00955890|Mitosis Modulators|mitosis modulators|mesh-ancestor
65395884|NCT00956046|Vaccines|vaccines|mesh-list
65395885|NCT00956046|Immunologic Factors|immunologic factors|mesh-ancestor
65395899|NCT00956202|Vaccines|vaccines|mesh-list
64552347|NCT01831011|Antipyretics|antipyretics|mesh-ancestor
64783753|NCT03219294|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64783754|NCT03219294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64783755|NCT03219294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783756|NCT03219294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783757|NCT03219294|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64783758|NCT03219294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64783759|NCT03219294|Cholinergic Agents|cholinergic agents|mesh-ancestor
64783760|NCT03219294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65395903|NCT00695903|Daptomycin|daptomycin|mesh-list
65395904|NCT00695903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65395905|NCT00695903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65395906|NCT02768363|Valacyclovir|valacyclovir|mesh-list
65395907|NCT02768363|Antiviral Agents|antiviral agents|mesh-ancestor
65395908|NCT02768363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65395909|NCT02759861|Sofosbuvir|sofosbuvir|mesh-list
65395910|NCT02759861|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
65395911|NCT02759861|Ledipasvir|ledipasvir|mesh-list
65395912|NCT02759861|Antiviral Agents|antiviral agents|mesh-ancestor
65395913|NCT02759861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65395914|NCT00548262|Voriconazole|voriconazole|mesh-list
65395915|NCT00548262|Anidulafungin|anidulafungin|mesh-list
65395916|NCT00548262|Antifungal Agents|antifungal agents|mesh-ancestor
65395917|NCT00548262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65395918|NCT00548262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65395919|NCT00548262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65395920|NCT00548262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395921|NCT00548262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395922|NCT00548262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65395923|NCT00548262|Hormone Antagonists|hormone antagonists|mesh-ancestor
65395924|NCT00548262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64783766|NCT03223272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64783767|NCT03223272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64783768|NCT03223272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65395937|NCT02565173|Analgesics|analgesics|mesh-ancestor
65395938|NCT02565173|Sensory System Agents|sensory system agents|mesh-ancestor
65395939|NCT02565173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65395940|NCT02565173|Vasodilator Agents|vasodilator agents|mesh-ancestor
65395941|NCT02565173|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65395942|NCT02565173|Purinergic Agonists|purinergic agonists|mesh-ancestor
65395943|NCT02565173|Purinergic Agents|purinergic agents|mesh-ancestor
65395944|NCT02730923|Anastrozole|anastrozole|mesh-list
65395945|NCT02730923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65145503|NCT01025635|Azelaic acid|azelaic acid|mesh-list
65395946|NCT02730923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65395947|NCT02730923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65395948|NCT02730923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65395949|NCT02730923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395950|NCT02730923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395951|NCT02730923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65395952|NCT02730923|Hormone Antagonists|hormone antagonists|mesh-ancestor
65395953|NCT02730923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65395954|NCT02730923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395956|NCT04619082|Antiviral Agents|antiviral agents|mesh-ancestor
65395957|NCT04619082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65395958|NCT04619082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65395959|NCT04619082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65395960|NCT04619082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395961|NCT04619082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395962|NCT04619082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65395963|NCT04619082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65395964|NCT03717623|Posaconazole|posaconazole|mesh-list
65395965|NCT03717623|Antifungal Agents|antifungal agents|mesh-ancestor
65395966|NCT03717623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64671333|NCT01982123|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
64671334|NCT01982123|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
64671335|NCT01982123|Antidotes|antidotes|mesh-ancestor
64671336|NCT01982123|Protective Agents|protective agents|mesh-ancestor
64671337|NCT01982123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671338|NCT01982123|Chelating Agents|chelating agents|mesh-ancestor
64556913|NCT04143815|Cholinergic Agents|cholinergic agents|mesh-ancestor
64783780|NCT03239106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64783781|NCT03239106|Analgesics|analgesics|mesh-ancestor
64783782|NCT03239106|Sensory System Agents|sensory system agents|mesh-ancestor
64783783|NCT03239106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783784|NCT03239106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783785|NCT03239106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64783786|NCT03239106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64783787|NCT03239106|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64783788|NCT03239106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64783789|NCT03239106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64783790|NCT03239106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395194|NCT01674569|Growth Substances|growth substances|mesh-ancestor
65395967|NCT03717623|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65395968|NCT03717623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65395969|NCT03717623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65395970|NCT03717623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65395971|NCT03717623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65395972|NCT03717623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65395973|NCT03717623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65395974|NCT03717623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65395975|NCT03717623|Hormone Antagonists|hormone antagonists|mesh-ancestor
65395976|NCT03717623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65395977|NCT03717623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65395978|NCT00095173|Abatacept|abatacept|mesh-list
65395979|NCT00095173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65396000|NCT00690443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396001|NCT03954834|Tirzepatide|tirzepatide|mesh-list
65396002|NCT03954834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65396003|NCT03954834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396004|NCT03954834|Incretins|incretins|mesh-ancestor
65396005|NCT03954834|Hormones|hormones|mesh-ancestor
65396006|NCT03954834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65396007|NCT00693017|Zonisamide|zonisamide|mesh-list
65396008|NCT00693017|Anticonvulsants|anticonvulsants|mesh-ancestor
65396009|NCT00693017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65396010|NCT00693017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65396011|NCT00693017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396012|NCT00693017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65396013|NCT00693017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396014|NCT05299554|Hydrocortisone|hydrocortisone|mesh-list
65396015|NCT05299554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65396016|NCT00692237|Sildenafil Citrate|sildenafil citrate|mesh-list
65396017|NCT00692237|Vasodilator Agents|vasodilator agents|mesh-ancestor
65396018|NCT00692237|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65396019|NCT00692237|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65396020|NCT00692237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396021|NCT00692237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396022|NCT00692237|Urological Agents|urological agents|mesh-ancestor
65396024|NCT00110149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65396025|NCT00110149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396026|NCT00110149|Immunologic Factors|immunologic factors|mesh-ancestor
65396027|NCT00110149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396028|NCT00110149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65396029|NCT01084057|Vorinostat|vorinostat|mesh-list
65396030|NCT01084057|Epothilone B|epothilone b|mesh-list
65396031|NCT01084057|Epothilones|epothilones|mesh-list
65396032|NCT01084057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396033|NCT01084057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65396034|NCT01084057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396036|NCT01084057|Tubulin Modulators|tubulin modulators|mesh-ancestor
65396040|NCT03954444|Oxymetazoline|oxymetazoline|mesh-list
65396041|NCT03954444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65396042|NCT03954444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65396043|NCT03954444|Adrenergic Agents|adrenergic agents|mesh-ancestor
65396044|NCT03954444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65396045|NCT03954444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396046|NCT03954444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396047|NCT03954444|Sympathomimetics|sympathomimetics|mesh-ancestor
65396048|NCT03954444|Autonomic Agents|autonomic agents|mesh-ancestor
65396049|NCT03954444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65396050|NCT03954444|Nasal Decongestants|nasal decongestants|mesh-ancestor
65396051|NCT03954444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65396052|NCT03954444|Respiratory System Agents|respiratory system agents|mesh-ancestor
65396053|NCT03954444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65396054|NCT03954444|Mydriatics|mydriatics|mesh-ancestor
65396055|NCT03954444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65396056|NCT03954444|Protective Agents|protective agents|mesh-ancestor
65396057|NCT03953820|Diazepam|diazepam|mesh-list
65396058|NCT03953820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65396059|NCT03953820|Anticonvulsants|anticonvulsants|mesh-ancestor
65396060|NCT03953820|Antiemetics|antiemetics|mesh-ancestor
65396061|NCT03953820|Autonomic Agents|autonomic agents|mesh-ancestor
65396062|NCT03953820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65396063|NCT03953820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396064|NCT03953820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65396065|NCT03953820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65396066|NCT03953820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65396067|NCT03953820|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65396068|NCT03953820|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65396069|NCT03953820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65396070|NCT03953820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65396071|NCT03953820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65396073|NCT03953820|Anesthetics, General|anesthetics, general|mesh-ancestor
64783852|NCT03334734|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64783853|NCT03334734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64783854|NCT03334734|Antimetabolites|antimetabolites|mesh-ancestor
64783855|NCT03334734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783856|NCT03334734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64783857|NCT03336450|Midazolam|midazolam|mesh-list
64783858|NCT03336450|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64783859|NCT03336450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64783860|NCT03336450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64783861|NCT03336450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395267|NCT01374217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64395268|NCT01374217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395269|NCT01374217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64395270|NCT01374217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64395271|NCT01374217|Vasodilator Agents|vasodilator agents|mesh-ancestor
65396083|NCT02611037|Antimetabolites|antimetabolites|mesh-ancestor
65396084|NCT02611037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396085|NCT02611037|Antiviral Agents|antiviral agents|mesh-ancestor
65396086|NCT02611037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65396087|NCT02611037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396100|NCT04492956|Ecopipam|ecopipam|mesh-list
64783862|NCT03336450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64783863|NCT03336450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64783864|NCT03336450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64783865|NCT03336450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64783866|NCT03336450|Anesthetics, General|anesthetics, general|mesh-ancestor
64783867|NCT03336450|Anesthetics|anesthetics|mesh-ancestor
64783868|NCT03336450|GABA Modulators|gaba modulators|mesh-ancestor
64783869|NCT03336450|GABA Agents|gaba agents|mesh-ancestor
64783870|NCT03336450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65396119|NCT00692003|Zonisamide|zonisamide|mesh-list
65396120|NCT00692003|Anticonvulsants|anticonvulsants|mesh-ancestor
65396121|NCT00692003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65396122|NCT00692003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65396123|NCT00692003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396124|NCT00692003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65396125|NCT00692003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396126|NCT02564315|Nicotine|nicotine|mesh-list
65396127|NCT02564315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65396128|NCT02564315|Autonomic Agents|autonomic agents|mesh-ancestor
65396129|NCT02564315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65396130|NCT02564315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396131|NCT02564315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65396132|NCT02564315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65396133|NCT02564315|Cholinergic Agents|cholinergic agents|mesh-ancestor
65396134|NCT02564315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65396135|NCT02564315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396136|NCT02564237|Vaccines|vaccines|mesh-list
65396137|NCT02564237|Immunologic Factors|immunologic factors|mesh-ancestor
65396138|NCT02564237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396139|NCT00427648|Lidocaine|lidocaine|mesh-list
65396140|NCT00427648|Anesthetics, Local|anesthetics, local|mesh-ancestor
65396141|NCT00427648|Anesthetics|anesthetics|mesh-ancestor
65396142|NCT00427648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65396143|NCT00427648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396144|NCT00427648|Sensory System Agents|sensory system agents|mesh-ancestor
64783874|NCT03340350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64783875|NCT03341910|Nicotinic Acids|nicotinic acids|mesh-list
64783876|NCT03341910|Tazarotene|tazarotene|mesh-list
64783877|NCT03341910|Dermatologic Agents|dermatologic agents|mesh-ancestor
64783878|NCT03341910|Keratolytic Agents|keratolytic agents|mesh-ancestor
64783879|NCT03341910|Vitamin B Complex|vitamin b complex|mesh-ancestor
64783880|NCT03341910|Vitamins|vitamins|mesh-ancestor
64783881|NCT03341910|Micronutrients|micronutrients|mesh-ancestor
65396149|NCT00427648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65396150|NCT00427648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396151|NCT02153177|Acetaminophen|acetaminophen|mesh-list
65396152|NCT02153177|Ibuprofen|ibuprofen|mesh-list
65396153|NCT02153177|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65396154|NCT02153177|Hydrocodone|hydrocodone|mesh-list
65396155|NCT02153177|Oxycodone|oxycodone|mesh-list
65396156|NCT02153177|Omeprazole|omeprazole|mesh-list
65396157|NCT02153177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65396158|NCT02153177|Analgesics|analgesics|mesh-ancestor
65396159|NCT02153177|Sensory System Agents|sensory system agents|mesh-ancestor
65396160|NCT02153177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65396161|NCT02153177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396162|NCT02153177|Antipyretics|antipyretics|mesh-ancestor
65396163|NCT02153177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65396164|NCT02153177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65396165|NCT02153177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65396166|NCT02153177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65396167|NCT02153177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396168|NCT02153177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396169|NCT02153177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65396170|NCT02153177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65396171|NCT02153177|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65396172|NCT02153177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65396173|NCT02153177|Narcotics|narcotics|mesh-ancestor
65396174|NCT02153177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65396182|NCT02564861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65396183|NCT02564861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65396184|NCT02564861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396185|NCT00416884|Fludarabine|fludarabine|mesh-list
65396186|NCT00416884|Alemtuzumab|alemtuzumab|mesh-list
65396187|NCT00416884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396188|NCT00416884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65396189|NCT03507257|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65396190|NCT03507257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65396191|NCT03507257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396192|NCT00555620|Capecitabine|capecitabine|mesh-list
65396193|NCT00555620|Oxaliplatin|oxaliplatin|mesh-list
65396194|NCT00555620|Sunitinib|sunitinib|mesh-list
65396195|NCT00555620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396196|NCT00555620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65396197|NCT00555620|Antimetabolites|antimetabolites|mesh-ancestor
65396198|NCT00555620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396199|NCT00555620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64556914|NCT04143815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64556915|NCT04143815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556916|NCT04143815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64556917|NCT04143815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321979|NCT02396433|Carboplatin|carboplatin|mesh-list
64671339|NCT01982123|Sequestering Agents|sequestering agents|mesh-ancestor
64671340|NCT01982123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671341|NCT01982123|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64671342|NCT01982123|Anticoagulants|anticoagulants|mesh-ancestor
64671343|NCT01982123|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64671344|NCT01982123|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64671345|NCT02061683|Bimatoprost|bimatoprost|mesh-list
64671346|NCT02061683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64671347|NCT01711658|Lapatinib|lapatinib|mesh-list
64671348|NCT01711658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671349|NCT01711658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64671350|NCT01711658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671351|NCT01711658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671352|NCT01712360|Naftifine|naftifine|mesh-list
64671353|NCT01712360|Antifungal Agents|antifungal agents|mesh-ancestor
64671354|NCT01712360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64671388|NCT04413344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64671389|NCT04413344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671390|NCT04413344|Dopamine Agonists|dopamine agonists|mesh-ancestor
64671391|NCT04413344|Dopamine Agents|dopamine agents|mesh-ancestor
64671392|NCT04413344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671393|NCT04413344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671394|NCT01717742|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64671412|NCT01717898|Hormone Antagonists|hormone antagonists|mesh-ancestor
64671415|NCT01737944|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64671416|NCT01737944|Abortifacient Agents|abortifacient agents|mesh-ancestor
64671417|NCT01737944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64671418|NCT01737944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671419|NCT01737944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64671420|NCT01737944|Antimetabolites|antimetabolites|mesh-ancestor
64671421|NCT01737944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783897|NCT03375294|Anesthetics, General|anesthetics, general|mesh-ancestor
64783898|NCT03375294|Anesthetics|anesthetics|mesh-ancestor
64783899|NCT03375294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64783900|NCT03375294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783901|NCT03375294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64783902|NCT03375294|Analgesics|analgesics|mesh-ancestor
64783903|NCT03375294|Sensory System Agents|sensory system agents|mesh-ancestor
64783904|NCT03375294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783905|NCT03379506|Grazoprevir|grazoprevir|mesh-list
64783906|NCT03379506|Antiviral Agents|antiviral agents|mesh-ancestor
64395308|NCT02959619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64395309|NCT02959619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395310|NCT04935931|Naltrexone|naltrexone|mesh-list
64395311|NCT04935931|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64395312|NCT04935931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65396200|NCT00555620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65396201|NCT00555620|Growth Substances|growth substances|mesh-ancestor
65396202|NCT00555620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396203|NCT00555620|Growth Inhibitors|growth inhibitors|mesh-ancestor
65396204|NCT00555620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65396205|NCT00555620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396206|NCT00433966|Paclitaxel|paclitaxel|mesh-list
65396207|NCT00433966|Heparin|heparin|mesh-list
65396208|NCT00433966|Calcium heparin|calcium heparin|mesh-list
65396209|NCT00433966|Bivalirudin|bivalirudin|mesh-list
65396210|NCT00433966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64783907|NCT03379506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64783908|NCT03395808|Tramadol|tramadol|mesh-list
64783909|NCT03395808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64783910|NCT03395808|Narcotics|narcotics|mesh-ancestor
65396236|NCT03463265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396237|NCT03463265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65396238|NCT03463265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65396239|NCT03463265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65396240|NCT03463265|Antifungal Agents|antifungal agents|mesh-ancestor
65396241|NCT03463265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65396242|NCT03463265|Immunologic Factors|immunologic factors|mesh-ancestor
65396243|NCT00947336|Norfloxacin|norfloxacin|mesh-list
65396244|NCT00947336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65396245|NCT00947336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65396246|NCT00947336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65396247|NCT00947336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65396248|NCT00947336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396249|NCT00947336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396250|NCT00947336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396251|NCT00947336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65396252|NCT00947336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65396253|NCT00955214|Paclitaxel|paclitaxel|mesh-list
65396254|NCT00955214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65396255|NCT00955214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396256|NCT00955214|Tubulin Modulators|tubulin modulators|mesh-ancestor
65396257|NCT00955214|Antimitotic Agents|antimitotic agents|mesh-ancestor
65396258|NCT00955214|Mitosis Modulators|mitosis modulators|mesh-ancestor
64671422|NCT01737944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671423|NCT01737944|Dermatologic Agents|dermatologic agents|mesh-ancestor
64671424|NCT01737944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671425|NCT01737944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64671426|NCT01737944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64671427|NCT01737944|Immunologic Factors|immunologic factors|mesh-ancestor
64671428|NCT01737944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64671429|NCT01737944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64671430|NCT01740206|Methylphenidate|methylphenidate|mesh-list
64671431|NCT01740206|Amphetamine|amphetamine|mesh-list
64671432|NCT01740206|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64671433|NCT01740206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671434|NCT01740206|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64671435|NCT01740206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64671436|NCT01740206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64671437|NCT01740206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671438|NCT01740206|Dopamine Agents|dopamine agents|mesh-ancestor
64671439|NCT01740206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671440|NCT01740206|Sympathomimetics|sympathomimetics|mesh-ancestor
64671441|NCT01740206|Autonomic Agents|autonomic agents|mesh-ancestor
64783922|NCT03395886|Analgesics|analgesics|mesh-ancestor
64783923|NCT03395886|Sensory System Agents|sensory system agents|mesh-ancestor
64783924|NCT03395886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783925|NCT03395886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64783926|NCT03395886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65396259|NCT00955214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396260|NCT00956462|Dexamethasone|dexamethasone|mesh-list
65396261|NCT00956462|Ketorolac|ketorolac|mesh-list
65396262|NCT00956462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65396263|NCT00956462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65396264|NCT00956462|Antiemetics|antiemetics|mesh-ancestor
65396265|NCT00956462|Autonomic Agents|autonomic agents|mesh-ancestor
65396266|NCT00956462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65396267|NCT00956462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396268|NCT00956462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65396269|NCT00956462|Glucocorticoids|glucocorticoids|mesh-ancestor
65396270|NCT00956462|Hormones|hormones|mesh-ancestor
65396271|NCT00956462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65396272|NCT00956462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65396273|NCT00956462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396274|NCT00956462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65396275|NCT00956462|Analgesics|analgesics|mesh-ancestor
65396276|NCT00956462|Sensory System Agents|sensory system agents|mesh-ancestor
65396277|NCT00956462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65396278|NCT00956462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65396279|NCT00956462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396280|NCT00956462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396281|NCT05300360|Adenosine|adenosine|mesh-list
65396282|NCT05300360|Analgesics|analgesics|mesh-ancestor
65396283|NCT05300360|Sensory System Agents|sensory system agents|mesh-ancestor
65396284|NCT05300360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65396285|NCT05300360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396286|NCT05300360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65396287|NCT05300360|Vasodilator Agents|vasodilator agents|mesh-ancestor
65396288|NCT05300360|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65396289|NCT05300360|Purinergic Agonists|purinergic agonists|mesh-ancestor
64783950|NCT03440424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64783951|NCT03440424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783952|NCT03448068|Ketamine|ketamine|mesh-list
64783953|NCT03448068|Analgesics|analgesics|mesh-ancestor
64783954|NCT03448068|Sensory System Agents|sensory system agents|mesh-ancestor
64783955|NCT03448068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783956|NCT03448068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783957|NCT03448068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64395345|NCT04877275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64395346|NCT04877275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396291|NCT05300360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65396292|NCT05300360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396293|NCT00956696|Topiramate|topiramate|mesh-list
65396294|NCT00956696|Anticonvulsants|anticonvulsants|mesh-ancestor
65396295|NCT00956696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65396296|NCT00956696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396297|NCT03952650|Chloroquine|chloroquine|mesh-list
65396298|NCT03952650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65396299|NCT03952650|Pyrimethamine|pyrimethamine|mesh-list
65396300|NCT03952650|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65396301|NCT03952650|Ibuprofen|ibuprofen|mesh-list
65396302|NCT03952650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65396303|NCT03952650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65396304|NCT03952650|Analgesics|analgesics|mesh-ancestor
65396305|NCT03952650|Sensory System Agents|sensory system agents|mesh-ancestor
65396306|NCT03952650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65396307|NCT03952650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396308|NCT03952650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65396309|NCT03952650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65396310|NCT03952650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65396311|NCT03952650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396312|NCT03952650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396313|NCT03952650|Amebicides|amebicides|mesh-ancestor
65396314|NCT03952650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65396315|NCT03952650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65396316|NCT03952650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64395347|NCT04955249|Dexmedetomidine|dexmedetomidine|mesh-list
64783958|NCT03448068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64783959|NCT03448068|Anesthetics, General|anesthetics, general|mesh-ancestor
64783960|NCT03448068|Anesthetics|anesthetics|mesh-ancestor
64783961|NCT03448068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64783962|NCT03448068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64783963|NCT03448068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64783964|NCT03448068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65396317|NCT03952650|Antimalarials|antimalarials|mesh-ancestor
65396318|NCT03952650|Filaricides|filaricides|mesh-ancestor
64395352|NCT04955249|Analgesics|analgesics|mesh-ancestor
64395353|NCT04955249|Sensory System Agents|sensory system agents|mesh-ancestor
64395354|NCT04955249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395355|NCT04955249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64395356|NCT04955249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64395357|NCT04955249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64395358|NCT04955249|Adrenergic Agents|adrenergic agents|mesh-ancestor
65396319|NCT03952650|Antinematodal Agents|antinematodal agents|mesh-ancestor
65396320|NCT03952650|Anthelmintics|anthelmintics|mesh-ancestor
65396321|NCT03952650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65396322|NCT00955526|Istradefylline|istradefylline|mesh-list
65396323|NCT00955526|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
65396324|NCT00955526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65396354|NCT05277480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65396355|NCT05277480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396356|NCT05277480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396357|NCT00956072|Imatinib Mesylate|imatinib mesylate|mesh-list
65396358|NCT00956072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396359|NCT00956072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65396360|NCT00956072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396361|NCT00956072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396362|NCT02564003|Oxycodone|oxycodone|mesh-list
65396363|NCT02564003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65396364|NCT02564003|Narcotics|narcotics|mesh-ancestor
65396365|NCT02564003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65396366|NCT02564003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396367|NCT02564003|Analgesics|analgesics|mesh-ancestor
65396368|NCT02564003|Sensory System Agents|sensory system agents|mesh-ancestor
65396369|NCT02564003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65396370|NCT00956150|Rifaximin|rifaximin|mesh-list
65396371|NCT00956150|Lactulose|lactulose|mesh-list
65396372|NCT00956150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65396373|NCT00956150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65396374|NCT00956150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65396375|NCT00923663|Lenalidomide|lenalidomide|mesh-list
65396376|NCT00923663|Immunologic Factors|immunologic factors|mesh-ancestor
64783966|NCT03453060|Thrombin|thrombin|mesh-list
64671442|NCT01740206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64671443|NCT01740206|Adrenergic Agents|adrenergic agents|mesh-ancestor
64671444|NCT01740206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64671445|NCT01740362|Tofacitinib|tofacitinib|mesh-list
64671446|NCT01740362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64671447|NCT01740362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671465|NCT01741454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64556919|NCT04355247|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64556920|NCT04355247|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64556921|NCT04355247|Prednisolone|prednisolone|mesh-list
64556922|NCT04355247|Prednisolone acetate|prednisolone acetate|mesh-list
64556923|NCT04355247|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64556924|NCT04355247|Prednisolone phosphate|prednisolone phosphate|mesh-list
64556925|NCT04355247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64671466|NCT01741454|Cholinergic Agents|cholinergic agents|mesh-ancestor
64671467|NCT01720316|Glycine|glycine|mesh-list
64671468|NCT01720316|Glycine Agents|glycine agents|mesh-ancestor
64671469|NCT01720316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671470|NCT01720316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671471|NCT01720316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671472|NCT02399345|Ritonavir|ritonavir|mesh-list
64671473|NCT02399345|Ribavirin|ribavirin|mesh-list
64671474|NCT02399345|Sofosbuvir|sofosbuvir|mesh-list
64671475|NCT02399345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64671476|NCT02399345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64671477|NCT02399345|Protease Inhibitors|protease inhibitors|mesh-ancestor
64671478|NCT02399345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671479|NCT02399345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671480|NCT02399345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65396377|NCT00923663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396378|NCT00923663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65396379|NCT00923663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65396380|NCT00923663|Growth Substances|growth substances|mesh-ancestor
65396381|NCT00923663|Growth Inhibitors|growth inhibitors|mesh-ancestor
65396382|NCT00923663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396383|NCT03284502|Cetuximab|cetuximab|mesh-list
65396384|NCT03284502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65396385|NCT03284502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396386|NCT00743873|Mitogens|mitogens|mesh-list
65396387|NCT00743873|Mitosis Modulators|mitosis modulators|mesh-ancestor
65396388|NCT00743873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396389|NCT04011098|Fentanyl|fentanyl|mesh-list
65396390|NCT04011098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65396391|NCT04011098|Narcotics|narcotics|mesh-ancestor
65396392|NCT04011098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65396393|NCT04011098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396394|NCT04011098|Analgesics|analgesics|mesh-ancestor
65493982|NCT03897439|Nicotine|nicotine|mesh-list
65396395|NCT04011098|Sensory System Agents|sensory system agents|mesh-ancestor
65396396|NCT04011098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65396397|NCT04011098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65396398|NCT04011098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65396399|NCT04011098|Anesthetics, General|anesthetics, general|mesh-ancestor
65396400|NCT04011098|Anesthetics|anesthetics|mesh-ancestor
65396401|NCT00927563|Tolcapone|tolcapone|mesh-list
65396402|NCT00927563|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65396403|NCT00927563|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65396404|NCT00927563|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65396405|NCT00927563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396406|NCT00927563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396407|NCT00956306|Udenafil|udenafil|mesh-list
65396408|NCT00956306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65396409|NCT00956306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65396410|NCT00956306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396411|NCT00956306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396414|NCT00775229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65396415|NCT00775229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396416|NCT00775229|Sensory System Agents|sensory system agents|mesh-ancestor
65396417|NCT00775229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65396418|NCT00962442|Acetylcysteine|acetylcysteine|mesh-list
65396419|NCT00962442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65396420|NCT00962442|Antiviral Agents|antiviral agents|mesh-ancestor
65396421|NCT00962442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65396422|NCT00962442|Expectorants|expectorants|mesh-ancestor
65396423|NCT00962442|Respiratory System Agents|respiratory system agents|mesh-ancestor
65396424|NCT00962442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65396425|NCT00962442|Antioxidants|antioxidants|mesh-ancestor
65396426|NCT00962442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396427|NCT00962442|Protective Agents|protective agents|mesh-ancestor
65396428|NCT00962442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396429|NCT00962442|Antidotes|antidotes|mesh-ancestor
65396430|NCT00957320|Sirolimus|sirolimus|mesh-list
65396431|NCT00957320|Asparaginase|asparaginase|mesh-list
65396432|NCT00957320|Pegaspargase|pegaspargase|mesh-list
65396433|NCT00957320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65396434|NCT00957320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65396435|NCT00957320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65396436|NCT00957320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396437|NCT00957320|Antifungal Agents|antifungal agents|mesh-ancestor
65396438|NCT00957320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65396439|NCT00957320|Immunologic Factors|immunologic factors|mesh-ancestor
65396440|NCT00957320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396441|NCT00653159|Copper|copper|mesh-list
64671481|NCT02399345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64671482|NCT02399345|Antiviral Agents|antiviral agents|mesh-ancestor
64671483|NCT02399345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64671484|NCT02399345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64671485|NCT02399345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64671486|NCT02399345|Antimetabolites|antimetabolites|mesh-ancestor
64671487|NCT02400437|Dexamethasone|dexamethasone|mesh-list
64671488|NCT02400437|Rituximab|rituximab|mesh-list
64671489|NCT02400437|Ixazomib|ixazomib|mesh-list
64671490|NCT02400437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64671491|NCT02400437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671492|NCT02400437|Immunologic Factors|immunologic factors|mesh-ancestor
64671493|NCT02400437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671494|NCT02400437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64671495|NCT02400437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64671496|NCT02400437|Antiemetics|antiemetics|mesh-ancestor
64671497|NCT02400437|Autonomic Agents|autonomic agents|mesh-ancestor
64671499|NCT02400437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64671500|NCT02400437|Glucocorticoids|glucocorticoids|mesh-ancestor
64671502|NCT02400437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64671503|NCT02400437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64784025|NCT03503292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64784026|NCT03503292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64784027|NCT03503292|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64784028|NCT03506724|Labetalol|labetalol|mesh-list
64784029|NCT03506724|Nifedipine|nifedipine|mesh-list
64784030|NCT03506724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64784031|NCT03506724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64784032|NCT03506724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784033|NCT03506724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64784034|NCT03506724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784035|NCT03506724|Vasodilator Agents|vasodilator agents|mesh-ancestor
64395417|NCT02388373|Formoterol Fumarate|formoterol fumarate|mesh-list
64395418|NCT02388373|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65396442|NCT00653159|Levonorgestrel|levonorgestrel|mesh-list
65396443|NCT00653159|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65396444|NCT00653159|Contraceptive Agents|contraceptive agents|mesh-ancestor
65396445|NCT00653159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65396446|NCT00653159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396447|NCT00653159|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65396448|NCT00653159|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65396481|NCT03024684|Antimetabolites|antimetabolites|mesh-ancestor
65396482|NCT03024684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396483|NCT03024684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65396484|NCT03024684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65396485|NCT03024684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396486|NCT00744107|Cobalt|cobalt|mesh-list
65396487|NCT00744107|Trace Elements|trace elements|mesh-ancestor
65396488|NCT00744107|Micronutrients|micronutrients|mesh-ancestor
65396489|NCT00744107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784036|NCT03506724|Tocolytic Agents|tocolytic agents|mesh-ancestor
64784037|NCT03506724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64784038|NCT03506724|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65396490|NCT00117637|Interferons|interferons|mesh-list
65396491|NCT00117637|Sorafenib|sorafenib|mesh-list
65396492|NCT00117637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396493|NCT00117637|Antiviral Agents|antiviral agents|mesh-ancestor
65396494|NCT00117637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65396495|NCT00117637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65396496|NCT00117637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396497|NCT00117637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396498|NCT00744185|Propranolol|propranolol|mesh-list
65396499|NCT00744185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65396500|NCT00744185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65396501|NCT00744185|Adrenergic Agents|adrenergic agents|mesh-ancestor
65396502|NCT00744185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65396503|NCT00744185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396504|NCT00744185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396505|NCT00744185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65396508|NCT02897778|Entinostat|entinostat|mesh-list
65396523|NCT00741767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395441|NCT01674647|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64784051|NCT03509766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64784052|NCT03509766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784053|NCT03509766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784055|NCT03532776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64784056|NCT03532776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784057|NCT03532776|Keratolytic Agents|keratolytic agents|mesh-ancestor
64784058|NCT03532776|Dermatologic Agents|dermatologic agents|mesh-ancestor
64784059|NCT03532776|Tubulin Modulators|tubulin modulators|mesh-ancestor
64784060|NCT03532776|Antimitotic Agents|antimitotic agents|mesh-ancestor
64784061|NCT03532776|Mitosis Modulators|mitosis modulators|mesh-ancestor
64395442|NCT01674647|Protease Inhibitors|protease inhibitors|mesh-ancestor
64395443|NCT01674647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396524|NCT00741767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65396525|NCT00741767|Respiratory System Agents|respiratory system agents|mesh-ancestor
65396526|NCT00741767|Dermatologic Agents|dermatologic agents|mesh-ancestor
65396527|NCT00741767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65396528|NCT00741767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65396529|NCT00741767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65396530|NCT00741767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65396531|NCT00741767|Adrenergic Agents|adrenergic agents|mesh-ancestor
65396532|NCT00741767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65396534|NCT00741767|Glucocorticoids|glucocorticoids|mesh-ancestor
65396555|NCT00741845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64395444|NCT01674647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784062|NCT03532776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784063|NCT03533244|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64784064|NCT03533244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64784065|NCT03541356|Carbidopa|carbidopa|mesh-list
64784066|NCT03541356|Levodopa|levodopa|mesh-list
64784067|NCT03541356|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
64784068|NCT03541356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64784069|NCT03541356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64784070|NCT03541356|Dopamine Agents|dopamine agents|mesh-ancestor
64784071|NCT03541356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65396556|NCT00741845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64395446|NCT01674647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64395447|NCT01674647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64395448|NCT01674647|Hemostatics|hemostatics|mesh-ancestor
64395449|NCT01674647|Coagulants|coagulants|mesh-ancestor
64395450|NCT02669407|Lidocaine|lidocaine|mesh-list
64395451|NCT02669407|Anesthetics, Local|anesthetics, local|mesh-list
65396557|NCT00741845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64784072|NCT03541356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784073|NCT03541356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784074|NCT03541356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64784075|NCT03541356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784076|NCT03557658|Bexagliflozin|bexagliflozin|mesh-list
64784077|NCT03557658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65396593|NCT00957866|Antiviral Agents|antiviral agents|mesh-ancestor
65396594|NCT00957866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65396595|NCT00957866|Antimetabolites|antimetabolites|mesh-ancestor
65396596|NCT00957866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396597|NCT00958022|Carboplatin|carboplatin|mesh-list
65396598|NCT00958022|Etoposide|etoposide|mesh-list
65396599|NCT00958022|Etoposide phosphate|etoposide phosphate|mesh-list
65396600|NCT00958022|Panobinostat|panobinostat|mesh-list
65396601|NCT00958022|Podophyllotoxin|podophyllotoxin|mesh-list
65396602|NCT00958022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396603|NCT00958022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65396604|NCT00958022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65396605|NCT00958022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65396606|NCT00958022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396607|NCT00958022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396608|NCT00958022|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65396609|NCT00958022|Keratolytic Agents|keratolytic agents|mesh-ancestor
65396610|NCT00958022|Dermatologic Agents|dermatologic agents|mesh-ancestor
65396611|NCT00958022|Tubulin Modulators|tubulin modulators|mesh-ancestor
65396612|NCT00958022|Antimitotic Agents|antimitotic agents|mesh-ancestor
65396613|NCT00958022|Mitosis Modulators|mitosis modulators|mesh-ancestor
65396614|NCT00958100|Tenofovir|tenofovir|mesh-list
65396615|NCT00958100|Lamivudine|lamivudine|mesh-list
65396616|NCT00958100|Emtricitabine|emtricitabine|mesh-list
65396617|NCT00958100|Raltegravir Potassium|raltegravir potassium|mesh-list
65396618|NCT00958100|Abacavir|abacavir|mesh-list
65396619|NCT00958100|Dideoxynucleosides|dideoxynucleosides|mesh-list
65396620|NCT00958100|Antiviral Agents|antiviral agents|mesh-ancestor
65396621|NCT00958100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65396628|NCT00958100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65396629|NCT00958100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65396630|NCT00958100|Antimetabolites|antimetabolites|mesh-ancestor
65396631|NCT00948584|Insulin|insulin|mesh-list
65396632|NCT00948584|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65396633|NCT00948584|Insulin Glargine|insulin glargine|mesh-list
65396634|NCT00948584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65396635|NCT00948584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396636|NCT00948662|Ketoconazole|ketoconazole|mesh-list
65396637|NCT00948662|Antifungal Agents|antifungal agents|mesh-ancestor
65396638|NCT00948662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65396639|NCT00948662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65396640|NCT00948662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65396641|NCT00948662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396642|NCT00948662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396643|NCT00948662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65396644|NCT00948662|Hormone Antagonists|hormone antagonists|mesh-ancestor
65396645|NCT00948662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65396646|NCT00948662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396647|NCT00948662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65396648|NCT00948740|Vitamin D|vitamin d|mesh-list
65396649|NCT00948740|Ergocalciferols|ergocalciferols|mesh-list
64671504|NCT02400437|Protease Inhibitors|protease inhibitors|mesh-ancestor
64671505|NCT02400437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671534|NCT02406443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64671535|NCT02406443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671536|NCT02406443|Incretins|incretins|mesh-ancestor
64671537|NCT02406443|Hormones|hormones|mesh-ancestor
64671538|NCT02406443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64671539|NCT02406443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64671540|NCT02406443|Protease Inhibitors|protease inhibitors|mesh-ancestor
64671541|NCT02406443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671542|NCT02406443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671543|NCT02032433|Naltrexone|naltrexone|mesh-list
64671544|NCT02032433|Buprenorphine|buprenorphine|mesh-list
64671545|NCT02032433|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64671546|NCT02032433|Naloxone|naloxone|mesh-list
64671547|NCT02032433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64671548|NCT02032433|Narcotics|narcotics|mesh-ancestor
64671549|NCT02032433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64671550|NCT02032433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671555|NCT02032433|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64671556|NCT02342015|Atorvastatin|atorvastatin|mesh-list
64671557|NCT02342015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64671558|NCT02342015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64671559|NCT02342015|Antimetabolites|antimetabolites|mesh-ancestor
64556926|NCT04355247|Antiemetics|antiemetics|mesh-ancestor
64556927|NCT04355247|Autonomic Agents|autonomic agents|mesh-ancestor
64671560|NCT02342015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671561|NCT02342015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64671562|NCT02342015|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64671563|NCT02342015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784102|NCT03593538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784103|NCT03610464|Amphetamine|amphetamine|mesh-list
64784104|NCT03610464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64784105|NCT03610464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784106|NCT03610464|Sympathomimetics|sympathomimetics|mesh-ancestor
64784107|NCT03610464|Autonomic Agents|autonomic agents|mesh-ancestor
64784108|NCT03610464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64784109|NCT03610464|Dopamine Agents|dopamine agents|mesh-ancestor
64784110|NCT03610464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64395469|NCT04909853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65396650|NCT00948740|Vitamins|vitamins|mesh-ancestor
65396651|NCT00948740|Micronutrients|micronutrients|mesh-ancestor
65396652|NCT00948740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396653|NCT00948740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65396654|NCT00948740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65396655|NCT00108433|Vancomycin|vancomycin|mesh-list
65396656|NCT00108433|Cefazolin|cefazolin|mesh-list
65396657|NCT00108433|Linezolid|linezolid|mesh-list
65396658|NCT00108433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65396659|NCT00108433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65396660|NCT00108433|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65396661|NCT00108433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396662|NCT00108433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396663|NCT01084369|Methyltestosterone|methyltestosterone|mesh-list
65396664|NCT01084369|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65396665|NCT01084369|Testosterone|testosterone|mesh-list
65396666|NCT01084369|Testosterone undecanoate|testosterone undecanoate|mesh-list
65396667|NCT01084369|Testosterone enanthate|testosterone enanthate|mesh-list
65396668|NCT01084369|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65396669|NCT01084369|Androgens|androgens|mesh-ancestor
65396670|NCT01084369|Hormones|hormones|mesh-ancestor
65396671|NCT01084369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65396672|NCT01084369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396673|NCT01084369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65396674|NCT01084369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396675|NCT01084369|Anabolic Agents|anabolic agents|mesh-ancestor
65396676|NCT01084369|Vasodilator Agents|vasodilator agents|mesh-ancestor
64395470|NCT04909853|Antiviral Agents|antiviral agents|mesh-ancestor
65396677|NCT01084369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65396678|NCT01084369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65396679|NCT01084369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396680|NCT01084369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396681|NCT01084369|Urological Agents|urological agents|mesh-ancestor
65396682|NCT03040778|Vitamin E|vitamin e|mesh-list
65396683|NCT03040778|Tocopherols|tocopherols|mesh-list
65396684|NCT03040778|Tocotrienols|tocotrienols|mesh-list
65396685|NCT03040778|alpha-Tocopherol|alpha-tocopherol|mesh-list
65396686|NCT03040778|Pentoxifylline|pentoxifylline|mesh-list
65396687|NCT03040778|Vitamins|vitamins|mesh-ancestor
65396688|NCT03040778|Micronutrients|micronutrients|mesh-ancestor
64671564|NCT02342327|Menthol|menthol|mesh-list
64671565|NCT02342327|Antipruritics|antipruritics|mesh-ancestor
64671566|NCT02342327|Dermatologic Agents|dermatologic agents|mesh-ancestor
64671567|NCT01721564|Bosentan|bosentan|mesh-list
64671568|NCT01721564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64671569|NCT01721564|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64671570|NCT01721564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671571|NCT02342561|Anti-Infective Agents|anti-infective agents|mesh-list
64671572|NCT02342561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64671573|NCT02343575|Valproic Acid|valproic acid|mesh-list
64671574|NCT02343575|Haloperidol|haloperidol|mesh-list
64671575|NCT02343575|Haloperidol decanoate|haloperidol decanoate|mesh-list
64671576|NCT02343575|Antiemetics|antiemetics|mesh-ancestor
64671577|NCT02343575|Autonomic Agents|autonomic agents|mesh-ancestor
64671578|NCT02343575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64671579|NCT02343575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671580|NCT02343575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64671581|NCT02343575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64671582|NCT02343575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64671583|NCT02343575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64671584|NCT02343575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64671585|NCT02343575|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64671586|NCT02343575|Dopamine Agents|dopamine agents|mesh-ancestor
64671587|NCT02343575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671588|NCT02343575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671589|NCT02343575|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64671590|NCT02343575|Anticonvulsants|anticonvulsants|mesh-ancestor
64671591|NCT02343575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671592|NCT02343575|GABA Agents|gaba agents|mesh-ancestor
64671593|NCT02343575|Antimanic Agents|antimanic agents|mesh-ancestor
64671594|NCT01744574|Progesterone|progesterone|mesh-list
64671595|NCT01744574|Progestins|progestins|mesh-ancestor
64671596|NCT01744574|Hormones|hormones|mesh-ancestor
64671597|NCT01744574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64671598|NCT01744574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671599|NCT01744730|Clindamycin|clindamycin|mesh-list
64671600|NCT01744730|Clindamycin palmitate|clindamycin palmitate|mesh-list
64671601|NCT01744730|Clindamycin phosphate|clindamycin phosphate|mesh-list
64671602|NCT01744730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64671605|NCT01744730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671606|NCT01744730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671608|NCT02033993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64671609|NCT02033993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64671610|NCT02033993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671611|NCT02033993|Tubulin Modulators|tubulin modulators|mesh-ancestor
64671612|NCT02033993|Antimitotic Agents|antimitotic agents|mesh-ancestor
64671614|NCT02033993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671615|NCT00354965|Amoxicillin|amoxicillin|mesh-list
64671616|NCT00354965|Clavulanic Acid|clavulanic acid|mesh-list
64671617|NCT00354965|Clavulanic Acids|clavulanic acids|mesh-list
64671618|NCT00354965|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64671619|NCT00354965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64671620|NCT00354965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64671621|NCT00354965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65396689|NCT03040778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396690|NCT03040778|Antioxidants|antioxidants|mesh-ancestor
65396691|NCT03040778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396692|NCT03040778|Protective Agents|protective agents|mesh-ancestor
65396693|NCT03040778|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65396694|NCT03040778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396695|NCT03040778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65493983|NCT03897439|Varenicline|varenicline|mesh-list
65146270|NCT04295551|Ritonavir|ritonavir|mesh-list
65396696|NCT03040778|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65396698|NCT03040778|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65396699|NCT00949130|Linezolid|linezolid|mesh-list
65396700|NCT00949130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65396701|NCT00949130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65396702|NCT00949130|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65396703|NCT00949130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784122|NCT03615534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64671622|NCT00354965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671623|NCT00354965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671624|NCT02037425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64671625|NCT02037425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64671626|NCT02037425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64671627|NCT02037425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64671628|NCT02037425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671629|NCT02037425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64671630|NCT02037425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64556928|NCT04355247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556929|NCT04355247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556930|NCT04355247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64556931|NCT04355247|Glucocorticoids|glucocorticoids|mesh-ancestor
64556933|NCT04355247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64321989|NCT02231203|Vitamins|vitamins|mesh-ancestor
64671631|NCT02037425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671632|NCT02037425|Cholinergic Agents|cholinergic agents|mesh-ancestor
64671633|NCT02037425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671634|NCT00355043|Zinc Sulfate|zinc sulfate|mesh-list
64671635|NCT00355043|Astringents|astringents|mesh-ancestor
64671636|NCT00355043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671637|NCT00355043|Dermatologic Agents|dermatologic agents|mesh-ancestor
64671638|NCT02037893|Antipyrine|antipyrine|mesh-list
64671639|NCT02037893|Benzocaine|benzocaine|mesh-list
64671640|NCT02037893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64671641|NCT02037893|Anesthetics, Local|anesthetics, local|mesh-ancestor
64671642|NCT02037893|Anesthetics|anesthetics|mesh-ancestor
64671643|NCT02037893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64671644|NCT02037893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671645|NCT02037893|Sensory System Agents|sensory system agents|mesh-ancestor
64671646|NCT02037893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64671647|NCT02037893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64671648|NCT02037893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64671649|NCT02037893|Analgesics|analgesics|mesh-ancestor
64671650|NCT02037893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64671651|NCT02037893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64671652|NCT02040623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64671653|NCT02040623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64671654|NCT02041325|Lenalidomide|lenalidomide|mesh-list
64671655|NCT02041325|Immunologic Factors|immunologic factors|mesh-ancestor
64784131|NCT03630198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64784132|NCT03630198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784133|NCT03630198|Sensory System Agents|sensory system agents|mesh-ancestor
64784134|NCT03630198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64784135|NCT03630198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64784136|NCT03630198|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64784137|NCT03630198|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64784138|NCT03630198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64395495|NCT04556357|Sympathomimetics|sympathomimetics|mesh-ancestor
64395496|NCT04556357|Nasal Decongestants|nasal decongestants|mesh-ancestor
64395497|NCT04556357|Respiratory System Agents|respiratory system agents|mesh-ancestor
64395498|NCT04556357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64395499|NCT04556357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64395500|NCT04556357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64395501|NCT04556357|Adrenergic Agents|adrenergic agents|mesh-ancestor
64395502|NCT04556357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64324408|NCT05480072|Sensory System Agents|sensory system agents|mesh-ancestor
64324409|NCT05480072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64784139|NCT03630198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784140|NCT03638622|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65396739|NCT05351606|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65396740|NCT05351606|Cholinergic Agents|cholinergic agents|mesh-ancestor
65396741|NCT05351606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65396742|NCT05351606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396743|NCT05351606|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65396744|NCT05351606|Antidepressive Agents|antidepressive agents|mesh-ancestor
65396745|NCT05351606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65396746|NCT05351606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65396747|NCT05351606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65396748|NCT05351606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65396749|NCT05351606|Dopamine Agents|dopamine agents|mesh-ancestor
65396750|NCT05351606|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65396751|NCT05351606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65396752|NCT05351606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396753|NCT00963222|Vitamin A|vitamin a|mesh-list
65396754|NCT00963222|Vitamins|vitamins|mesh-ancestor
65396755|NCT00963222|Micronutrients|micronutrients|mesh-ancestor
65396756|NCT00963222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396757|NCT02703584|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65396758|NCT02703584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65396759|NCT02703584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396760|NCT00968682|Trastuzumab|trastuzumab|mesh-list
65396761|NCT00968682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65396762|NCT00968682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396763|NCT00968760|Cytarabine|cytarabine|mesh-list
65396764|NCT00968760|Etoposide|etoposide|mesh-list
65396765|NCT00968760|Melphalan|melphalan|mesh-list
65396766|NCT00968760|Interleukin-2|interleukin-2|mesh-list
65396767|NCT00968760|Carmustine|carmustine|mesh-list
65396768|NCT00968760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65396769|NCT00968760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396770|NCT00968760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65396771|NCT00968760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65396772|NCT00968760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671656|NCT02041325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671657|NCT02041325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65396773|NCT00968760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396774|NCT00968760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65396775|NCT00968760|Antimetabolites|antimetabolites|mesh-ancestor
65396776|NCT00968760|Antiviral Agents|antiviral agents|mesh-ancestor
65396777|NCT00968760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65396778|NCT00968760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65396779|NCT00968760|Immunologic Factors|immunologic factors|mesh-ancestor
65396780|NCT00968760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396781|NCT00968760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65396782|NCT00968760|Alkylating Agents|alkylating agents|mesh-ancestor
65396783|NCT00968760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65396784|NCT00968760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65396785|NCT00968760|Analgesics|analgesics|mesh-ancestor
65396786|NCT00968760|Sensory System Agents|sensory system agents|mesh-ancestor
64784156|NCT03674970|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64671658|NCT02041325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64671659|NCT02041325|Growth Substances|growth substances|mesh-ancestor
64671660|NCT02041325|Growth Inhibitors|growth inhibitors|mesh-ancestor
64671661|NCT02041325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671662|NCT01723514|Erenumab|erenumab|mesh-list
64671663|NCT01723514|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64671664|NCT01723514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671665|NCT01723514|Analgesics|analgesics|mesh-ancestor
64671666|NCT01723514|Sensory System Agents|sensory system agents|mesh-ancestor
64671667|NCT01723514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64671668|NCT01723514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671687|NCT05718869|Immunologic Factors|immunologic factors|mesh-ancestor
64671690|NCT05718869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64671691|NCT05718869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671692|NCT05718869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671693|NCT02354339|Magnesium Oxide|magnesium oxide|mesh-list
64671694|NCT02354339|Antacids|antacids|mesh-ancestor
64671695|NCT02354339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671696|NCT02354339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64671697|NCT01747850|Ethanol|ethanol|mesh-list
64671698|NCT01747850|Nabiximols|nabiximols|mesh-list
64671699|NCT01747850|Dronabinol|dronabinol|mesh-list
64671700|NCT01747850|Cannabidiol|cannabidiol|mesh-list
64671701|NCT01747850|Peppermint oil|peppermint oil|mesh-list
64671702|NCT01747850|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64671703|NCT01747850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64671704|NCT01747850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64671705|NCT01747850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671706|NCT01747850|Anticonvulsants|anticonvulsants|mesh-ancestor
64671707|NCT01747850|Analgesics|analgesics|mesh-ancestor
64671708|NCT01747850|Sensory System Agents|sensory system agents|mesh-ancestor
64671709|NCT01747850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64671710|NCT01747850|Hallucinogens|hallucinogens|mesh-ancestor
64671711|NCT01747850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64556934|NCT04355247|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64556935|NCT04355247|Protective Agents|protective agents|mesh-ancestor
64556936|NCT04355247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64556937|NCT04355247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671712|NCT01747850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64671713|NCT01747850|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64671714|NCT01747850|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64671715|NCT01747850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671716|NCT01747850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671717|NCT01747850|Hormones|hormones|mesh-ancestor
64784166|NCT03704376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784167|NCT03704376|Sensory System Agents|sensory system agents|mesh-ancestor
64784168|NCT03704376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64784169|NCT03704376|Analgesics|analgesics|mesh-ancestor
64784170|NCT03704376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64784171|NCT03704376|Sympatholytics|sympatholytics|mesh-ancestor
64784172|NCT03704376|Autonomic Agents|autonomic agents|mesh-ancestor
65396787|NCT00968760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65396788|NCT02573324|Temozolomide|temozolomide|mesh-list
65396789|NCT02573324|Immunoconjugates|immunoconjugates|mesh-list
65396790|NCT02573324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65396791|NCT02573324|Alkylating Agents|alkylating agents|mesh-ancestor
65396792|NCT02573324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396793|NCT02573324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396794|NCT02573324|Immunologic Factors|immunologic factors|mesh-ancestor
65396795|NCT02573324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396796|NCT02465138|Ketorolac|ketorolac|mesh-list
65396797|NCT02465138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65396798|NCT02465138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65396799|NCT02465138|Analgesics|analgesics|mesh-ancestor
65396800|NCT02465138|Sensory System Agents|sensory system agents|mesh-ancestor
65396801|NCT02465138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65396802|NCT02465138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396803|NCT02465138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65396804|NCT02465138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65396805|NCT02465138|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65396806|NCT02465138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396808|NCT00968994|Petrolatum|petrolatum|mesh-list
65396825|NCT00094861|Mitosis Modulators|mitosis modulators|mesh-ancestor
64784180|NCT03716076|Oxytocics|oxytocics|mesh-ancestor
64784181|NCT03716076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64784182|NCT03716076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784183|NCT03835728|Ocrelizumab|ocrelizumab|mesh-list
64784184|NCT03835728|Immunologic Factors|immunologic factors|mesh-ancestor
64784185|NCT03835728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784186|NCT03889158|Ascorbic Acid|ascorbic acid|mesh-list
64784187|NCT03889158|Vaccines|vaccines|mesh-list
64784188|NCT03889158|Immunologic Factors|immunologic factors|mesh-ancestor
64784189|NCT03889158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784190|NCT03889158|Antioxidants|antioxidants|mesh-ancestor
64784191|NCT03889158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784192|NCT03889158|Protective Agents|protective agents|mesh-ancestor
65396826|NCT00094861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396827|NCT00963534|Rituximab|rituximab|mesh-list
65396828|NCT00963534|Lenalidomide|lenalidomide|mesh-list
65396829|NCT00963534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65396830|NCT00963534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65396831|NCT00963534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396832|NCT00963534|Immunologic Factors|immunologic factors|mesh-ancestor
65396833|NCT00963534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396834|NCT00963534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65396835|NCT00963534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65396861|NCT00963768|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65396862|NCT00963768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396863|NCT00963768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65396864|NCT00963768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396865|NCT00969462|Doxorubicin|doxorubicin|mesh-list
65396866|NCT00969462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65396867|NCT00969462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396868|NCT00969462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65396869|NCT00969462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65396870|NCT00969462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396871|NCT00969462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784195|NCT04138758|Bromides|bromides|mesh-list
64784196|NCT04138758|Tiotropium Bromide|tiotropium bromide|mesh-list
64784197|NCT04138758|Olodaterol|olodaterol|mesh-list
64784198|NCT04138758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64784199|NCT04138758|Autonomic Agents|autonomic agents|mesh-ancestor
64784200|NCT04138758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65396872|NCT00963846|Huperzine A|huperzine a|mesh-list
65396873|NCT00963846|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65396874|NCT00963846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65396875|NCT00963846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396876|NCT00963846|Cholinergic Agents|cholinergic agents|mesh-ancestor
65396877|NCT00963846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65396878|NCT00963846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552778|NCT03083821|Entecavir|entecavir|mesh-list
65396902|NCT00958854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396903|NCT00958854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396904|NCT00958854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65396905|NCT00958854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65396906|NCT00958854|Antimetabolites|antimetabolites|mesh-ancestor
65396907|NCT00958854|Leprostatic Agents|leprostatic agents|mesh-ancestor
65396908|NCT00958854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65396909|NCT00958854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65396910|NCT00958854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65396911|NCT00958854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65396912|NCT00958854|Growth Substances|growth substances|mesh-ancestor
65396913|NCT00958854|Growth Inhibitors|growth inhibitors|mesh-ancestor
65396914|NCT00964080|Leucovorin|leucovorin|mesh-list
65396915|NCT00964080|Fluorouracil|fluorouracil|mesh-list
65396916|NCT00964080|Oxaliplatin|oxaliplatin|mesh-list
65396917|NCT00964080|Antimetabolites|antimetabolites|mesh-ancestor
65396918|NCT00964080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396919|NCT00964080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65396920|NCT00964080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65396921|NCT00964080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65396922|NCT00964080|Immunologic Factors|immunologic factors|mesh-ancestor
64671718|NCT01747850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64671719|NCT01747850|Antiemetics|antiemetics|mesh-ancestor
64671720|NCT01747850|Autonomic Agents|autonomic agents|mesh-ancestor
64671721|NCT01747850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64671722|NCT01747850|Parasympatholytics|parasympatholytics|mesh-ancestor
64671723|NCT01727414|Methylphenidate|methylphenidate|mesh-list
64671731|NCT01727414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671732|NCT02048891|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64671733|NCT02048891|Progesterone|progesterone|mesh-list
64671734|NCT02048891|Progestins|progestins|mesh-ancestor
64671735|NCT02048891|Hormones|hormones|mesh-ancestor
64671736|NCT02048891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64671737|NCT02048891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671738|NCT02048891|Luteolytic Agents|luteolytic agents|mesh-ancestor
64671739|NCT02048891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64671740|NCT02048891|Contraceptive Agents|contraceptive agents|mesh-ancestor
64671741|NCT02048891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64671742|NCT02048891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64671743|NCT02048891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64671744|NCT02048891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671745|NCT01727726|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64671746|NCT01727726|Brexpiprazole|brexpiprazole|mesh-list
64671747|NCT01727726|Antidepressive Agents|antidepressive agents|mesh-ancestor
64671748|NCT01727726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64671749|NCT01727726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64484319|NCT05640778|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64671751|NCT01727726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64671752|NCT01727726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671753|NCT01727726|Serotonin Agents|serotonin agents|mesh-ancestor
64671754|NCT01727726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671755|NCT01727726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671756|NCT01727726|Dopamine Agonists|dopamine agonists|mesh-ancestor
64784221|NCT04420572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64784222|NCT04420572|Respiratory System Agents|respiratory system agents|mesh-ancestor
64784223|NCT03541980|Acetaminophen|acetaminophen|mesh-list
64784224|NCT03541980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64784225|NCT03541980|Analgesics|analgesics|mesh-ancestor
64784226|NCT03541980|Sensory System Agents|sensory system agents|mesh-ancestor
64784227|NCT03541980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64784228|NCT03541980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784229|NCT03541980|Antipyretics|antipyretics|mesh-ancestor
65396923|NCT00964080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396924|NCT00964080|Antidotes|antidotes|mesh-ancestor
65396925|NCT00964080|Protective Agents|protective agents|mesh-ancestor
65396926|NCT00964080|Vitamin B Complex|vitamin b complex|mesh-ancestor
65396927|NCT00964080|Vitamins|vitamins|mesh-ancestor
65396928|NCT00964080|Micronutrients|micronutrients|mesh-ancestor
65396929|NCT00969852|Sertraline|sertraline|mesh-list
65396930|NCT00969852|Antidepressive Agents|antidepressive agents|mesh-ancestor
65396931|NCT00969852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65396932|NCT00969852|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65396933|NCT00969852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65396934|NCT00969852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65396935|NCT00969852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65396966|NCT00970008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65396967|NCT00970008|Immunologic Factors|immunologic factors|mesh-ancestor
65396968|NCT00970008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396969|NCT00970086|Bupivacaine|bupivacaine|mesh-list
65396970|NCT00970086|Levobupivacaine|levobupivacaine|mesh-list
65396971|NCT00970086|Anesthetics, Local|anesthetics, local|mesh-ancestor
65396972|NCT00970086|Anesthetics|anesthetics|mesh-ancestor
65396973|NCT00970086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65396974|NCT00970086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396975|NCT00970086|Sensory System Agents|sensory system agents|mesh-ancestor
65396976|NCT00970086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65396977|NCT00689351|Vaccines|vaccines|mesh-list
65396978|NCT00689351|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65396979|NCT00689351|Immunologic Factors|immunologic factors|mesh-ancestor
65396980|NCT00689351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396981|NCT03950622|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65396982|NCT03950622|Immunologic Factors|immunologic factors|mesh-ancestor
65396983|NCT03950622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396984|NCT02563847|Erythritol|erythritol|mesh-list
65396985|NCT02563847|Tryptophan|tryptophan|mesh-list
65396986|NCT02563847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65396987|NCT02563847|Antidepressive Agents|antidepressive agents|mesh-ancestor
65396988|NCT02563847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65396989|NCT02563847|Vasodilator Agents|vasodilator agents|mesh-ancestor
65396990|NCT00746681|Pregabalin|pregabalin|mesh-list
65396991|NCT00746681|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65396992|NCT00746681|Analgesics|analgesics|mesh-ancestor
65396993|NCT00746681|Sensory System Agents|sensory system agents|mesh-ancestor
65396994|NCT00746681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65396995|NCT00746681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65396996|NCT00746681|Anticonvulsants|anticonvulsants|mesh-ancestor
65396997|NCT00746681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65396998|NCT00746681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65396999|NCT00746681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395586|NCT04564625|Vitamin D|vitamin d|mesh-list
64671757|NCT01727726|Dopamine Agents|dopamine agents|mesh-ancestor
64671758|NCT02355821|Bisoprolol|bisoprolol|mesh-list
64671759|NCT02355821|Moxonidine|moxonidine|mesh-list
64671760|NCT02355821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64671761|NCT02355821|Sympatholytics|sympatholytics|mesh-ancestor
64784252|NCT04284930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64784253|NCT04267770|Insulin|insulin|mesh-list
64784254|NCT04267770|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64784255|NCT04267770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64784256|NCT04267770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784257|NCT04204200|Vitamins|vitamins|mesh-list
64784258|NCT04204200|Ascorbic Acid|ascorbic acid|mesh-list
64784259|NCT04204200|Micronutrients|micronutrients|mesh-ancestor
64784260|NCT04204200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395602|NCT04422743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64395603|NCT04422743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395604|NCT04422743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395605|NCT02535221|Epirubicin|epirubicin|mesh-list
64395606|NCT02535221|Goserelin|goserelin|mesh-list
64395607|NCT02535221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64395608|NCT02535221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397000|NCT00746681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65397001|NCT00746681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65397002|NCT00746681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65397003|NCT00746681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65397004|NCT00746681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65397005|NCT00746681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65397006|NCT00746681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65397007|NCT00746681|Cholinergic Agents|cholinergic agents|mesh-ancestor
65397009|NCT00746681|Urological Agents|urological agents|mesh-ancestor
64784261|NCT04204200|Antioxidants|antioxidants|mesh-ancestor
64784262|NCT04204200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784263|NCT04204200|Protective Agents|protective agents|mesh-ancestor
64784264|NCT04179474|Erenumab|erenumab|mesh-list
64784265|NCT04179474|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64784266|NCT04179474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784267|NCT04179474|Analgesics|analgesics|mesh-ancestor
64784268|NCT04179474|Sensory System Agents|sensory system agents|mesh-ancestor
64784271|NCT04175262|Sunitinib|sunitinib|mesh-list
65397031|NCT00959400|Anesthetics|anesthetics|mesh-ancestor
65397032|NCT02563769|Clavulanic Acids|clavulanic acids|mesh-list
65397033|NCT02563769|Clavulanic Acid|clavulanic acid|mesh-list
65397034|NCT02563769|Cocaine|cocaine|mesh-list
65397035|NCT02563769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65397036|NCT02563769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65397037|NCT02563769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397038|NCT02563769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397039|NCT02563769|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65397040|NCT02563769|Anesthetics, Local|anesthetics, local|mesh-ancestor
65397041|NCT02563769|Anesthetics|anesthetics|mesh-ancestor
65397042|NCT02563769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65397043|NCT02563769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397044|NCT02563769|Sensory System Agents|sensory system agents|mesh-ancestor
65397045|NCT02563769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65397046|NCT02563769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65397047|NCT02563769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65397048|NCT02563769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65397049|NCT02563769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65397050|NCT02563769|Dopamine Agents|dopamine agents|mesh-ancestor
65397051|NCT02563769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65397052|NCT00959478|Carbon Monoxide|carbon monoxide|mesh-list
65397053|NCT00959478|Antimetabolites|antimetabolites|mesh-ancestor
64784273|NCT04175262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64784274|NCT04175262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64784275|NCT04175262|Growth Substances|growth substances|mesh-ancestor
64784276|NCT04175262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784277|NCT04175262|Growth Inhibitors|growth inhibitors|mesh-ancestor
64784278|NCT04175262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64784279|NCT04175262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784280|NCT04175262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784281|NCT04150224|Macozinone|macozinone|mesh-list
65397064|NCT00964626|Mitosis Modulators|mitosis modulators|mesh-ancestor
65397065|NCT00964626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397066|NCT02562287|Olanzapine|olanzapine|mesh-list
65397067|NCT02562287|Risperidone|risperidone|mesh-list
65146643|NCT04479267|Hormones|hormones|mesh-ancestor
65397068|NCT02562287|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65397069|NCT02562287|Clozapine|clozapine|mesh-list
65397070|NCT02562287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65397071|NCT02562287|Serotonin Agents|serotonin agents|mesh-ancestor
65397072|NCT02562287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65397073|NCT02562287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397074|NCT02562287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397075|NCT02562287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65397076|NCT02562287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65397077|NCT02562287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65397078|NCT02562287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65397079|NCT02562287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65397080|NCT02562287|Dopamine Agents|dopamine agents|mesh-ancestor
65397081|NCT02562287|Antiemetics|antiemetics|mesh-ancestor
65397082|NCT02562287|Autonomic Agents|autonomic agents|mesh-ancestor
65397083|NCT02562287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65397084|NCT02562287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65397085|NCT02562287|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65397086|NCT02562287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65397087|NCT02562287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65397088|NCT02562287|Antidepressive Agents|antidepressive agents|mesh-ancestor
65397089|NCT02562287|GABA Antagonists|gaba antagonists|mesh-ancestor
64395621|NCT05137145|Linaclotide|linaclotide|mesh-list
64671762|NCT02355821|Autonomic Agents|autonomic agents|mesh-ancestor
64784282|NCT04150224|Antitubercular Agents|antitubercular agents|mesh-ancestor
64784283|NCT04150224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64784284|NCT04150224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64784285|NCT04112160|Ketorolac|ketorolac|mesh-list
64784286|NCT04112160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64784287|NCT04112160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64784288|NCT04112160|Analgesics|analgesics|mesh-ancestor
64784289|NCT04112160|Sensory System Agents|sensory system agents|mesh-ancestor
64784290|NCT04112160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64784291|NCT04112160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397090|NCT02562287|GABA Agents|gaba agents|mesh-ancestor
65397091|NCT02562053|Fluoxetine|fluoxetine|mesh-list
65397092|NCT02562053|Contraceptive Agents|contraceptive agents|mesh-list
65397093|NCT02562053|Contraceptives, Oral|contraceptives, oral|mesh-list
65397094|NCT02562053|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65397095|NCT02562053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65397096|NCT02562053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65397097|NCT02562053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65397098|NCT02562053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397099|NCT02562053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65397100|NCT02562053|Serotonin Agents|serotonin agents|mesh-ancestor
65397101|NCT02562053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397102|NCT02562053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65397103|NCT02562053|Antidepressive Agents|antidepressive agents|mesh-ancestor
65397104|NCT02562053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65397105|NCT02562053|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65397106|NCT02562053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65397107|NCT02562053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397108|NCT02562053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64784300|NCT04102956|Fertility Agents|fertility agents|mesh-ancestor
64784301|NCT04102956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64784302|NCT04102956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784303|NCT04053270|Afamelanotide|afamelanotide|mesh-list
65397124|NCT00553358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784304|NCT04053270|Dermatologic Agents|dermatologic agents|mesh-ancestor
64784305|NCT03976752|Tenofovir|tenofovir|mesh-list
64784306|NCT03976752|Emtricitabine|emtricitabine|mesh-list
64784307|NCT03976752|Cobicistat|cobicistat|mesh-list
64784308|NCT03976752|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64784309|NCT03976752|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64784310|NCT03976752|Elvitegravir|elvitegravir|mesh-list
64784311|NCT03976752|Antiviral Agents|antiviral agents|mesh-ancestor
64395633|NCT04419389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64395634|NCT05304845|Aspirin|aspirin|mesh-list
65397125|NCT00553358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65397126|NCT00553358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65397127|NCT00553358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397128|NCT00744809|Moxifloxacin|moxifloxacin|mesh-list
65397129|NCT00744809|Efavirenz|efavirenz|mesh-list
65397130|NCT00744809|Rilpivirine|rilpivirine|mesh-list
65397131|NCT00744809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65397160|NCT02286830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64395643|NCT05304845|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64784312|NCT03976752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64784313|NCT03976752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64784314|NCT03976752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64784315|NCT03976752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784316|NCT03976752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784317|NCT03976752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64784318|NCT03976752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64784319|NCT03976752|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64784320|NCT03976752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64395644|NCT05304845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64395645|NCT05304845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395646|NCT05304845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64395647|NCT05304845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64395648|NCT05304845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397161|NCT02286830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397162|NCT00749567|Bevacizumab|bevacizumab|mesh-list
65397163|NCT00749567|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65397164|NCT00749567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65397168|NCT00749567|Growth Substances|growth substances|mesh-ancestor
64784321|NCT03976752|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65397194|NCT00689117|Clindamycin|clindamycin|mesh-list
65397195|NCT00689117|Clindamycin palmitate|clindamycin palmitate|mesh-list
65397196|NCT00689117|Clindamycin phosphate|clindamycin phosphate|mesh-list
64784322|NCT03962634|Oxymetazoline|oxymetazoline|mesh-list
64784323|NCT03962634|Tetracaine|tetracaine|mesh-list
64784324|NCT03962634|Carticaine|carticaine|mesh-list
64784325|NCT03962634|Anesthetics, Local|anesthetics, local|mesh-ancestor
64784326|NCT03962634|Anesthetics|anesthetics|mesh-ancestor
64784327|NCT03962634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64784328|NCT03962634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784329|NCT03962634|Sensory System Agents|sensory system agents|mesh-ancestor
64784330|NCT03962634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64784331|NCT03962634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64395651|NCT05303597|Anesthetics, Local|anesthetics, local|mesh-ancestor
64395652|NCT05303597|Anesthetics|anesthetics|mesh-ancestor
64395653|NCT05303597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64395654|NCT05303597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397197|NCT00689117|Tretinoin|tretinoin|mesh-list
65397198|NCT00689117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65397199|NCT00689117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65397206|NCT00949442|Insulin|insulin|mesh-list
65397235|NCT00547248|Vaccines|vaccines|mesh-list
65397236|NCT00547248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65397237|NCT00547248|Immunologic Factors|immunologic factors|mesh-ancestor
65397238|NCT00547248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397239|NCT00688103|Etanercept|etanercept|mesh-list
65397240|NCT00688103|Methotrexate|methotrexate|mesh-list
65397241|NCT00688103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65397242|NCT00688103|Abortifacient Agents|abortifacient agents|mesh-ancestor
65397243|NCT00688103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64784332|NCT03962634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64784333|NCT03962634|Adrenergic Agents|adrenergic agents|mesh-ancestor
64784334|NCT03962634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64784335|NCT03962634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784336|NCT03962634|Sympathomimetics|sympathomimetics|mesh-ancestor
64784337|NCT03962634|Autonomic Agents|autonomic agents|mesh-ancestor
64784338|NCT03962634|Nasal Decongestants|nasal decongestants|mesh-ancestor
64784339|NCT03962634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64784340|NCT03962634|Respiratory System Agents|respiratory system agents|mesh-ancestor
65397244|NCT00688103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397245|NCT00688103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65397246|NCT00688103|Antimetabolites|antimetabolites|mesh-ancestor
65397247|NCT00688103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397248|NCT00688103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784344|NCT03933774|Dermatologic Agents|dermatologic agents|mesh-ancestor
64784345|NCT03933618|Anastrozole|anastrozole|mesh-list
64784346|NCT03933618|Clomiphene|clomiphene|mesh-list
64784347|NCT03933618|Enclomiphene|enclomiphene|mesh-list
64784348|NCT03933618|Zuclomiphene|zuclomiphene|mesh-list
64784349|NCT03933618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784350|NCT03933618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64784351|NCT03933618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784352|NCT03933618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64395671|NCT04280939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64395672|NCT04280939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395673|NCT05302817|Xenon|xenon|mesh-list
64395674|NCT05302817|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64395675|NCT05302817|Anesthetics, General|anesthetics, general|mesh-ancestor
64395676|NCT05302817|Anesthetics|anesthetics|mesh-ancestor
64395677|NCT05302817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64395678|NCT05302817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397275|NCT00949598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65397276|NCT00949598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65397277|NCT00949598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64784353|NCT03933618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64784354|NCT03933618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784355|NCT03933618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64784356|NCT03933618|Hormone Antagonists|hormone antagonists|mesh-ancestor
64784357|NCT03933618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64784358|NCT03933618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784359|NCT03933618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64784360|NCT03933618|Fertility Agents|fertility agents|mesh-ancestor
64395679|NCT04489589|Midodrine|midodrine|mesh-list
64395680|NCT04489589|Sympathomimetics|sympathomimetics|mesh-ancestor
64395681|NCT04489589|Autonomic Agents|autonomic agents|mesh-ancestor
64395682|NCT04489589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395683|NCT04489589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395684|NCT04489589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64324437|NCT03922880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65397313|NCT00745043|Bronchodilator Agents|bronchodilator agents|mesh-list
65397314|NCT00745043|Autonomic Agents|autonomic agents|mesh-ancestor
65397315|NCT00745043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65397316|NCT00745043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397317|NCT00745043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65397318|NCT00745043|Respiratory System Agents|respiratory system agents|mesh-ancestor
65397319|NCT00949832|Calcium, Dietary|calcium, dietary|mesh-list
65397320|NCT00949832|Vitamin D|vitamin d|mesh-list
65397321|NCT00949832|Ergocalciferols|ergocalciferols|mesh-list
65397322|NCT00949832|Cholecalciferol|cholecalciferol|mesh-list
65397323|NCT00949832|Vitamins|vitamins|mesh-list
65397324|NCT00949832|Calcium|calcium|mesh-list
65397325|NCT00949832|Micronutrients|micronutrients|mesh-ancestor
65397326|NCT00949832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397327|NCT00949832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64784361|NCT03933618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64784362|NCT03933618|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64784363|NCT03933618|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64784365|NCT03930264|Antimetabolites|antimetabolites|mesh-ancestor
64784366|NCT03930264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784367|NCT03930264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64784368|NCT03930264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784369|NCT03930264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64784370|NCT03930264|Immunologic Factors|immunologic factors|mesh-ancestor
64784371|NCT03930264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395685|NCT04489589|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65397342|NCT00961844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397343|NCT00961844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397344|NCT00686777|Interferons|interferons|mesh-list
65397345|NCT00686777|Ribavirin|ribavirin|mesh-list
65397346|NCT00686777|Interferon-alpha|interferon-alpha|mesh-list
65397347|NCT00686777|Interferon alpha-2|interferon alpha-2|mesh-list
65397348|NCT00686777|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65397349|NCT00686777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397350|NCT00686777|Antiviral Agents|antiviral agents|mesh-ancestor
65397351|NCT00686777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65397352|NCT00686777|Antimetabolites|antimetabolites|mesh-ancestor
65397353|NCT00686777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397354|NCT00686777|Immunologic Factors|immunologic factors|mesh-ancestor
65397355|NCT00686777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397356|NCT04009772|Metronidazole|metronidazole|mesh-list
65397357|NCT04009772|Cefuroxime|cefuroxime|mesh-list
65397358|NCT04009772|Cefuroxime axetil|cefuroxime axetil|mesh-list
65397359|NCT04009772|Cefepime|cefepime|mesh-list
65397360|NCT04009772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65397362|NCT04009772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64784372|NCT03930264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64784373|NCT03858894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64784374|NCT03858894|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64784375|NCT03856164|Tranexamic Acid|tranexamic acid|mesh-list
64784376|NCT03856164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64784377|NCT03856164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64784378|NCT03856164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784379|NCT03856164|Hemostatics|hemostatics|mesh-ancestor
64784380|NCT03856164|Coagulants|coagulants|mesh-ancestor
65397374|NCT00747305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65397375|NCT00747305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65397376|NCT00747305|Growth Substances|growth substances|mesh-ancestor
65397377|NCT00747305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397378|NCT00747305|Growth Inhibitors|growth inhibitors|mesh-ancestor
65397379|NCT00747305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65397380|NCT00747305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397381|NCT00747305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397382|NCT05254106|Paclitaxel|paclitaxel|mesh-list
65397383|NCT05254106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65397384|NCT05254106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397385|NCT05254106|Tubulin Modulators|tubulin modulators|mesh-ancestor
65397386|NCT05254106|Antimitotic Agents|antimitotic agents|mesh-ancestor
65397387|NCT05254106|Mitosis Modulators|mitosis modulators|mesh-ancestor
65397388|NCT05254106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397389|NCT00747383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65397390|NCT00747383|Glimepiride|glimepiride|mesh-list
65397391|NCT00747383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65397392|NCT00747383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397393|NCT00747383|Incretins|incretins|mesh-ancestor
65397409|NCT00106639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397410|NCT00106639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397411|NCT00106639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65397412|NCT00747539|Interferons|interferons|mesh-list
65397413|NCT00747539|Ribavirin|ribavirin|mesh-list
65397414|NCT00747539|Interferon-alpha|interferon-alpha|mesh-list
65397415|NCT00747539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397416|NCT00747539|Antiviral Agents|antiviral agents|mesh-ancestor
65397417|NCT00747539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65397418|NCT00747539|Antimetabolites|antimetabolites|mesh-ancestor
65397419|NCT00747539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397420|NCT00747539|Immunologic Factors|immunologic factors|mesh-ancestor
65397421|NCT00747539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397422|NCT00745433|Metformin|metformin|mesh-list
65397423|NCT00745433|Repaglinide|repaglinide|mesh-list
65397424|NCT00745433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65397425|NCT00745433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397426|NCT00962234|Deuterium Oxide|deuterium oxide|mesh-list
65397427|NCT00962234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397428|NCT00962234|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65397429|NCT00962234|Protective Agents|protective agents|mesh-ancestor
65397430|NCT00962234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397431|NCT00747695|Rabeprazole|rabeprazole|mesh-list
65397432|NCT00747695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65397433|NCT00747695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65397434|NCT00747695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65397435|NCT00747695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397436|NCT00747695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397437|NCT00959972|Nicotine|nicotine|mesh-list
65397438|NCT00959972|Varenicline|varenicline|mesh-list
65397439|NCT00959972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65397440|NCT00959972|Autonomic Agents|autonomic agents|mesh-ancestor
65397441|NCT00959972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64671763|NCT02355821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64671764|NCT02355821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671765|NCT02355821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64671766|NCT02355821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64671767|NCT02355821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64671768|NCT02355821|Adrenergic Agents|adrenergic agents|mesh-ancestor
64671769|NCT02355821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671770|NCT02355821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784407|NCT03805386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65397442|NCT00959972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397443|NCT00959972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65397444|NCT00959972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65397445|NCT00959972|Cholinergic Agents|cholinergic agents|mesh-ancestor
65397446|NCT00959972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65397447|NCT00959972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397448|NCT04009616|Chlorhexidine|chlorhexidine|mesh-list
65397449|NCT04009616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65397450|NCT04009616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65397451|NCT04009616|Disinfectants|disinfectants|mesh-ancestor
65397452|NCT00960284|Gemcitabine|gemcitabine|mesh-list
65397453|NCT00960284|Fluorouracil|fluorouracil|mesh-list
65397454|NCT00960284|Capecitabine|capecitabine|mesh-list
65397456|NCT00960284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397457|NCT00960284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65397458|NCT00960284|Antimetabolites|antimetabolites|mesh-ancestor
65397459|NCT00960284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397460|NCT00960284|Antiviral Agents|antiviral agents|mesh-ancestor
65397461|NCT00960284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65397462|NCT00960284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397463|NCT00960284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65397464|NCT00960284|Immunologic Factors|immunologic factors|mesh-ancestor
65397465|NCT00960284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397466|NCT00960284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65397467|NCT00960284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65397468|NCT00960284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65397469|NCT00105469|Tobramycin|tobramycin|mesh-list
65397470|NCT00105469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65397471|NCT00105469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65397472|NCT00962312|Capecitabine|capecitabine|mesh-list
65397473|NCT00962312|Lapatinib|lapatinib|mesh-list
64784423|NCT03730116|Autonomic Agents|autonomic agents|mesh-ancestor
64784424|NCT03730116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64784425|NCT03730116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784426|NCT03730116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64784427|NCT03730116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64784428|NCT03730116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64784429|NCT03730116|Adrenergic Agents|adrenergic agents|mesh-ancestor
64784430|NCT03730116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64784431|NCT03730116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784432|NCT03730116|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65397485|NCT00960518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397486|NCT00960518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397487|NCT00960830|Mirtazapine|mirtazapine|mesh-list
65397488|NCT00960830|Antidepressive Agents|antidepressive agents|mesh-ancestor
65397489|NCT00960830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65397490|NCT00960830|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65397491|NCT00960830|Histamine Antagonists|histamine antagonists|mesh-ancestor
65397492|NCT00960830|Histamine Agents|histamine agents|mesh-ancestor
65397493|NCT00960830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65397494|NCT00960830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397495|NCT00960830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397496|NCT00960830|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65397497|NCT00960830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64784434|NCT03730116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784435|NCT03370536|Ibutilide|ibutilide|mesh-list
64784436|NCT03370536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64784437|NCT03161964|Propranolol|propranolol|mesh-list
64784438|NCT03161964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64784439|NCT03161964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64784440|NCT03161964|Adrenergic Agents|adrenergic agents|mesh-ancestor
65397523|NCT00105235|Dermatologic Agents|dermatologic agents|mesh-ancestor
65397524|NCT00105235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65397525|NCT00105235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65397526|NCT00105235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397527|NCT00105235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65397528|NCT00105235|Antitubercular Agents|antitubercular agents|mesh-ancestor
65397529|NCT00105235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65397530|NCT00105235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65397532|NCT03962803|Immunologic Factors|immunologic factors|mesh-ancestor
65397533|NCT03962803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397534|NCT00547118|Rimonabant|rimonabant|mesh-list
65397535|NCT00547118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65397536|NCT00547118|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65397537|NCT00547118|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65397538|NCT00547118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65397539|NCT00547118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397540|NCT00547118|Hormones|hormones|mesh-ancestor
65397541|NCT00547118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65397542|NCT00547118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397543|NCT00962936|Pidilizumab|pidilizumab|mesh-list
65397544|NCT00962936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65397545|NCT00962936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397546|NCT01087099|Albendazole|albendazole|mesh-list
65397547|NCT01087099|Anthelmintics|anthelmintics|mesh-ancestor
65397548|NCT01087099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65397549|NCT01087099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65397550|NCT01087099|Anticestodal Agents|anticestodal agents|mesh-ancestor
65397551|NCT01087099|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65397552|NCT01087099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64671772|NCT05718323|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64671773|NCT05718323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784449|NCT03078270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64784450|NCT03078270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64784451|NCT03078270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64784452|NCT03078270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784453|NCT03078270|Cholinergic Agents|cholinergic agents|mesh-ancestor
64784454|NCT03078270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64784455|NCT03078270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784456|NCT03078270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64784457|NCT03078270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64784458|NCT03042780|Folfirinox|folfirinox|mesh-list
64784459|NCT03042780|Lenograstim|lenograstim|mesh-list
64395766|NCT01228331|Immunologic Factors|immunologic factors|mesh-ancestor
64395767|NCT01228331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395768|NCT01228331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64395769|NCT01228331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64395770|NCT01228331|Alkylating Agents|alkylating agents|mesh-ancestor
64395771|NCT01228331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397553|NCT01087099|Tubulin Modulators|tubulin modulators|mesh-ancestor
65397558|NCT03946124|Fesoterodine|fesoterodine|mesh-list
64784460|NCT03042780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64784461|NCT03042780|Immunologic Factors|immunologic factors|mesh-ancestor
64784462|NCT03042780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784463|NCT03042780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784464|NCT02985840|Dexamethasone|dexamethasone|mesh-list
64784465|NCT02985840|Ondansetron|ondansetron|mesh-list
64784466|NCT02985840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64784467|NCT02985840|Antiemetics|antiemetics|mesh-ancestor
64784468|NCT02985840|Autonomic Agents|autonomic agents|mesh-ancestor
64395773|NCT01228331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64395774|NCT01228331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64395775|NCT01228331|Antiemetics|antiemetics|mesh-ancestor
64395776|NCT01228331|Autonomic Agents|autonomic agents|mesh-ancestor
64395777|NCT01228331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395778|NCT01228331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64395779|NCT01228331|Glucocorticoids|glucocorticoids|mesh-ancestor
64395780|NCT01228331|Hormones|hormones|mesh-ancestor
65397588|NCT00750113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65397589|NCT00750113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397590|NCT00750113|Vasodilator Agents|vasodilator agents|mesh-ancestor
65397591|NCT00750113|Tocolytic Agents|tocolytic agents|mesh-ancestor
65397592|NCT00750113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64784469|NCT02985840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64784470|NCT02985840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784471|NCT02985840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64784472|NCT02985840|Glucocorticoids|glucocorticoids|mesh-ancestor
64784473|NCT02985840|Hormones|hormones|mesh-ancestor
64784474|NCT02985840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64784475|NCT02985840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64784476|NCT02985840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784477|NCT02985840|Antipruritics|antipruritics|mesh-ancestor
65397626|NCT00967772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397627|NCT00967772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397628|NCT00967772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65397629|NCT00967772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65397630|NCT00967772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65397631|NCT00967772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65397632|NCT00967772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65397633|NCT00967850|Verteporfin|verteporfin|mesh-list
65397634|NCT00967850|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65397635|NCT00967850|Dermatologic Agents|dermatologic agents|mesh-ancestor
65397636|NCT00967928|Everolimus|everolimus|mesh-list
65397637|NCT00967928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397638|NCT00967928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65397639|NCT00967928|Immunologic Factors|immunologic factors|mesh-ancestor
65397640|NCT00967928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397641|NCT00546000|Fluticasone|fluticasone|mesh-list
65397642|NCT00546000|Xhance|xhance|mesh-list
65397643|NCT00546000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65397644|NCT00546000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65397645|NCT00546000|Autonomic Agents|autonomic agents|mesh-ancestor
65397646|NCT00546000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65397647|NCT00546000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397648|NCT00546000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65397649|NCT00546000|Respiratory System Agents|respiratory system agents|mesh-ancestor
65397650|NCT00546000|Dermatologic Agents|dermatologic agents|mesh-ancestor
64671789|NCT01748942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64671790|NCT01748942|Antiemetics|antiemetics|mesh-ancestor
64671791|NCT01748942|Autonomic Agents|autonomic agents|mesh-ancestor
64671792|NCT01748942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64671793|NCT01748942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784480|NCT02985840|Serotonin Agents|serotonin agents|mesh-ancestor
64784481|NCT02985840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64784482|NCT02985840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784483|NCT02985840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64784484|NCT02985840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64784485|NCT02985840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64784486|NCT02985840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64784487|NCT02985840|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64395785|NCT01228331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64395786|NCT01228331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64395787|NCT01228331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65397651|NCT00546000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65397652|NCT00968006|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65397653|NCT00968006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65397654|NCT00968006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397655|NCT00968006|Incretins|incretins|mesh-ancestor
65397656|NCT00968006|Hormones|hormones|mesh-ancestor
65397657|NCT00968006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65397658|NCT00968006|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65397659|NCT00968006|Protease Inhibitors|protease inhibitors|mesh-ancestor
65397660|NCT00968006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397661|NCT00968006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397662|NCT00968162|Fludarabine|fludarabine|mesh-list
65397663|NCT00968162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397664|NCT00968240|Bevacizumab|bevacizumab|mesh-list
65397665|NCT00968240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65397666|NCT00968240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397667|NCT00968240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65397668|NCT00968240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65397669|NCT00968240|Growth Substances|growth substances|mesh-ancestor
65397670|NCT00968240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784488|NCT02974686|Mycophenolic Acid|mycophenolic acid|mesh-list
64784489|NCT02974686|Everolimus|everolimus|mesh-list
64784490|NCT02974686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784491|NCT02974686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64784492|NCT02974686|Immunologic Factors|immunologic factors|mesh-ancestor
64784493|NCT02974686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784494|NCT02974686|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64784495|NCT02974686|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64784496|NCT02974686|Antitubercular Agents|antitubercular agents|mesh-ancestor
64395793|NCT01228331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64395794|NCT01228331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64395795|NCT01228331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64395796|NCT01228331|Antiviral Agents|antiviral agents|mesh-ancestor
64395797|NCT01228331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64395798|NCT01228331|Tubulin Modulators|tubulin modulators|mesh-ancestor
64395799|NCT01228331|Antimitotic Agents|antimitotic agents|mesh-ancestor
64395800|NCT01228331|Mitosis Modulators|mitosis modulators|mesh-ancestor
65397680|NCT00968396|Melphalan|melphalan|mesh-list
65397681|NCT00968396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65397689|NCT04008732|Nitroglycerin|nitroglycerin|mesh-list
64784497|NCT02974686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64784498|NCT02974686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64784499|NCT02974686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784500|NCT02974686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784501|NCT02966184|Albuterol|albuterol|mesh-list
64784502|NCT02966184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65397716|NCT01013805|Immunologic Factors|immunologic factors|mesh-ancestor
65397717|NCT01013805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397718|NCT01013805|Antidotes|antidotes|mesh-ancestor
65397719|NCT01013805|Protective Agents|protective agents|mesh-ancestor
65397720|NCT01013805|Vitamin B Complex|vitamin b complex|mesh-ancestor
65397721|NCT01013805|Vitamins|vitamins|mesh-ancestor
65397722|NCT01013805|Micronutrients|micronutrients|mesh-ancestor
64784503|NCT02966184|Autonomic Agents|autonomic agents|mesh-ancestor
64784504|NCT02966184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64784505|NCT02966184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397723|NCT00104299|Prednisone|prednisone|mesh-list
65397724|NCT00104299|Methylprednisolone|methylprednisolone|mesh-list
65397725|NCT00104299|Cyclophosphamide|cyclophosphamide|mesh-list
65397726|NCT00104299|Rituximab|rituximab|mesh-list
65397727|NCT00104299|Azathioprine|azathioprine|mesh-list
65397728|NCT00104299|Glucocorticoids|glucocorticoids|mesh-list
65397729|NCT00104299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65397730|NCT00104299|Immunologic Factors|immunologic factors|mesh-ancestor
65397731|NCT00104299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397732|NCT00104299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65397756|NCT05196308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64395813|NCT01171937|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64784509|NCT02966184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64784510|NCT02966184|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64784511|NCT02966184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64784512|NCT02966184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64784513|NCT02966184|Adrenergic Agents|adrenergic agents|mesh-ancestor
64784514|NCT02966184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64784515|NCT02966184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784516|NCT02774148|Acetaminophen|acetaminophen|mesh-list
64784517|NCT02774148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64784518|NCT02774148|Analgesics|analgesics|mesh-ancestor
64784519|NCT02774148|Sensory System Agents|sensory system agents|mesh-ancestor
64395814|NCT01171937|Dopamine Agents|dopamine agents|mesh-ancestor
64395815|NCT03136445|Tranexamic Acid|tranexamic acid|mesh-list
64395816|NCT03136445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65397757|NCT05196308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397758|NCT05196308|Cholinergic Agents|cholinergic agents|mesh-ancestor
65397759|NCT05196308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65397760|NCT00082381|Insulin Glargine|insulin glargine|mesh-list
65397761|NCT00082381|Exenatide|exenatide|mesh-list
65397792|NCT00964106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65397793|NCT00964106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65397794|NCT00964106|Antimetabolites|antimetabolites|mesh-ancestor
65397795|NCT00964106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65397796|NCT00964106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65397797|NCT00964106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397798|NCT00964106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65397799|NCT00964106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65397800|NCT00964106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65397801|NCT00964106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64784520|NCT02774148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64784521|NCT02774148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784522|NCT02774148|Antipyretics|antipyretics|mesh-ancestor
64784523|NCT02744352|Ropivacaine|ropivacaine|mesh-list
65397802|NCT00964106|Purinergic Agents|purinergic agents|mesh-ancestor
65397803|NCT00964106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65397804|NCT00964106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65397805|NCT00964106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65397806|NCT00964106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65397807|NCT00964106|Antitubercular Agents|antitubercular agents|mesh-ancestor
65397808|NCT00964106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65397809|NCT00964106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65397810|NCT00964106|Leprostatic Agents|leprostatic agents|mesh-ancestor
65397811|NCT00964106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65397812|NCT00964106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65147382|NCT01037218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784535|NCT02587650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784536|NCT02514252|Fentanyl|fentanyl|mesh-list
64784537|NCT02514252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64784538|NCT02514252|Narcotics|narcotics|mesh-ancestor
64784539|NCT02514252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64784540|NCT02514252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784541|NCT02514252|Analgesics|analgesics|mesh-ancestor
64784542|NCT02514252|Sensory System Agents|sensory system agents|mesh-ancestor
64784543|NCT02514252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65397830|NCT00964106|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65397831|NCT00964106|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65397832|NCT00964106|Analgesics|analgesics|mesh-ancestor
65397833|NCT00964106|Sensory System Agents|sensory system agents|mesh-ancestor
65397834|NCT00964106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65397835|NCT00964106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65397836|NCT00964106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65397837|NCT00964106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65397838|NCT00964106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65397839|NCT00964106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65397840|NCT00960336|Doxorubicin|doxorubicin|mesh-list
65397841|NCT00960336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65397842|NCT00960336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65397843|NCT00960336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397844|NCT00960336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65397845|NCT00960336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65397846|NCT00960336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397847|NCT00960336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397848|NCT00965172|Calcium|calcium|mesh-list
65397849|NCT00965172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65397850|NCT00965172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397851|NCT01084837|Bortezomib|bortezomib|mesh-list
65397852|NCT01084837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397853|NCT00545844|Montelukast|montelukast|mesh-list
65397854|NCT00545844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65397855|NCT00545844|Respiratory System Agents|respiratory system agents|mesh-ancestor
64784546|NCT02514252|Anesthetics, General|anesthetics, general|mesh-ancestor
64784547|NCT02514252|Anesthetics|anesthetics|mesh-ancestor
64784548|NCT02434146|Phenylephrine|phenylephrine|mesh-list
64784549|NCT02434146|Oxymetazoline|oxymetazoline|mesh-list
65397858|NCT00545844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65397859|NCT00545844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397860|NCT00545844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65397861|NCT00545844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65397862|NCT00545844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397863|NCT01084993|Heparin|heparin|mesh-list
65397864|NCT01084993|Bivalirudin|bivalirudin|mesh-list
65397865|NCT01084993|Anticoagulants|anticoagulants|mesh-ancestor
65397866|NCT01084993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65397867|NCT01084993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65397868|NCT01084993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397869|NCT01084993|Antithrombins|antithrombins|mesh-ancestor
65397870|NCT01084993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65397871|NCT01084993|Protease Inhibitors|protease inhibitors|mesh-ancestor
65397872|NCT01084993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397873|NCT00492063|Vaccines|vaccines|mesh-list
65397874|NCT00492063|Immunologic Factors|immunologic factors|mesh-ancestor
65397875|NCT00492063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397876|NCT00960492|Temozolomide|temozolomide|mesh-list
65397877|NCT00960492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65397878|NCT00960492|Alkylating Agents|alkylating agents|mesh-ancestor
64671794|NCT01748942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64671795|NCT01748942|Glucocorticoids|glucocorticoids|mesh-ancestor
64671796|NCT01748942|Hormones|hormones|mesh-ancestor
64671797|NCT01748942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64322000|NCT02231281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322001|NCT02231281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64322002|NCT02231281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64322003|NCT02231281|Antiviral Agents|antiviral agents|mesh-ancestor
64322004|NCT02231281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64556938|NCT03903809|Epoetin Alfa|epoetin alfa|mesh-list
64556939|NCT03903809|Hematinics|hematinics|mesh-ancestor
64556940|NCT04987554|Immunoferon|immunoferon|mesh-list
64556941|NCT04987554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64556942|NCT04987554|Immunologic Factors|immunologic factors|mesh-ancestor
64556943|NCT04987554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556944|NCT04358367|Dexmedetomidine|dexmedetomidine|mesh-list
64556945|NCT04358367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64556946|NCT04358367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64556947|NCT04358367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556948|NCT04358367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64556949|NCT04358367|Analgesics|analgesics|mesh-ancestor
64556950|NCT04358367|Sensory System Agents|sensory system agents|mesh-ancestor
64556951|NCT04358367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556952|NCT04358367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64784559|NCT02434146|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65397879|NCT00960492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397880|NCT00960492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397881|NCT00971724|Prednisolone|prednisolone|mesh-list
65397882|NCT00971724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65397883|NCT00971724|Glucocorticoids|glucocorticoids|mesh-ancestor
65397884|NCT00971724|Hormones|hormones|mesh-ancestor
65397885|NCT00971724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65397886|NCT00971724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397887|NCT00971724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65397888|NCT00971724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397889|NCT02976909|Paclitaxel|paclitaxel|mesh-list
64556953|NCT04358367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64556954|NCT04358367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64556955|NCT04358367|Adrenergic Agents|adrenergic agents|mesh-ancestor
64556956|NCT04358367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671798|NCT01748942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64671799|NCT01748942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671800|NCT01748942|Protease Inhibitors|protease inhibitors|mesh-ancestor
64671801|NCT01748942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671802|NCT01748942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671803|NCT01748942|Dermatologic Agents|dermatologic agents|mesh-ancestor
64671804|NCT02355977|Minocycline|minocycline|mesh-list
64671805|NCT02355977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64671806|NCT02355977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64671807|NCT01749410|Botulinum Toxins|botulinum toxins|mesh-list
64671808|NCT01749410|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64671809|NCT01749410|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64671810|NCT01749410|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64671811|NCT01749410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64671812|NCT01749410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671813|NCT01749410|Cholinergic Agents|cholinergic agents|mesh-ancestor
64671814|NCT01749410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671815|NCT01749410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671816|NCT01749410|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64671817|NCT01749410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64671818|NCT01729598|Valproic Acid|valproic acid|mesh-list
64671819|NCT01729598|Anticonvulsants|anticonvulsants|mesh-ancestor
64671820|NCT01729598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671821|NCT01729598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322012|NCT02231359|Autonomic Agents|autonomic agents|mesh-ancestor
64556957|NCT04358367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556958|NCT04987242|Rasburicase|rasburicase|mesh-list
64556959|NCT04987242|Gout Suppressants|gout suppressants|mesh-ancestor
64556960|NCT04987242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64556961|NCT04358523|Sofosbuvir|sofosbuvir|mesh-list
64556962|NCT04358523|Antiviral Agents|antiviral agents|mesh-ancestor
64556963|NCT04358523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64556966|NCT00936663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556967|NCT00936663|Incretins|incretins|mesh-ancestor
64556968|NCT00936663|Hormones|hormones|mesh-ancestor
64556969|NCT00936663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64556970|NCT00936663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64556971|NCT00936663|Protease Inhibitors|protease inhibitors|mesh-ancestor
64556972|NCT00936663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556973|NCT00936663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556974|NCT03903185|Sofosbuvir|sofosbuvir|mesh-list
64556975|NCT03903185|Ledipasvir|ledipasvir|mesh-list
64556976|NCT03903185|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64556977|NCT03903185|Antiviral Agents|antiviral agents|mesh-ancestor
64556978|NCT03903185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64784569|NCT02345460|Leucovorin|leucovorin|mesh-list
64784570|NCT02345460|Fluorouracil|fluorouracil|mesh-list
64784571|NCT02345460|Oxaliplatin|oxaliplatin|mesh-list
64784572|NCT02345460|Irinotecan|irinotecan|mesh-list
64784573|NCT02345460|Calcium|calcium|mesh-list
64784574|NCT02345460|Levoleucovorin|levoleucovorin|mesh-list
64784575|NCT02345460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64784576|NCT02345460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784577|NCT02345460|Antimetabolites|antimetabolites|mesh-ancestor
64395852|NCT03189641|Vasodilator Agents|vasodilator agents|mesh-ancestor
64395853|NCT03189641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64395854|NCT03189641|Protective Agents|protective agents|mesh-ancestor
64395855|NCT03189641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64395856|NCT03189641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64395857|NCT03189641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397890|NCT02976909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65397891|NCT02976909|Cisplatin|cisplatin|mesh-list
65397892|NCT02976909|Fluorouracil|fluorouracil|mesh-list
65397893|NCT02976909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65397894|NCT02976909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395858|NCT00416351|Clofarabine|clofarabine|mesh-list
65397930|NCT05181735|Hematinics|hematinics|mesh-ancestor
65397931|NCT00960960|Paclitaxel|paclitaxel|mesh-list
65397932|NCT00960960|Bevacizumab|bevacizumab|mesh-list
65397933|NCT00960960|Trastuzumab|trastuzumab|mesh-list
65397934|NCT00960960|Letrozole|letrozole|mesh-list
65397935|NCT00960960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65397936|NCT00960960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65397937|NCT00960960|Tubulin Modulators|tubulin modulators|mesh-ancestor
65397938|NCT00960960|Antimitotic Agents|antimitotic agents|mesh-ancestor
65397939|NCT00960960|Mitosis Modulators|mitosis modulators|mesh-ancestor
65397940|NCT00960960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397941|NCT00960960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65397942|NCT00960960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65397943|NCT00960960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65397944|NCT00960960|Growth Substances|growth substances|mesh-ancestor
65397945|NCT00960960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397946|NCT00960960|Growth Inhibitors|growth inhibitors|mesh-ancestor
65397947|NCT00960960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65397948|NCT00960960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65397949|NCT00960960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65397950|NCT00960960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65397951|NCT00960960|Hormone Antagonists|hormone antagonists|mesh-ancestor
65397952|NCT00960960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65397953|NCT00965640|Botulinum Toxins|botulinum toxins|mesh-list
65397954|NCT00965640|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65397955|NCT00965640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65397956|NCT00965640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397957|NCT00965640|Cholinergic Agents|cholinergic agents|mesh-ancestor
65397958|NCT00965640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65397959|NCT00965640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397960|NCT00961038|Ciprofloxacin|ciprofloxacin|mesh-list
65397961|NCT00961038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65397970|NCT00961194|Ketamine|ketamine|mesh-list
65397971|NCT00961194|Analgesics|analgesics|mesh-ancestor
65397972|NCT00961194|Sensory System Agents|sensory system agents|mesh-ancestor
65397973|NCT00961194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65397974|NCT00961194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397975|NCT00961194|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65397976|NCT00961194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65397977|NCT00961194|Anesthetics, General|anesthetics, general|mesh-ancestor
65397978|NCT00961194|Anesthetics|anesthetics|mesh-ancestor
65397979|NCT00961194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65397980|NCT00961194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65397981|NCT00961194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65397982|NCT00961194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65397983|NCT00961194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65397984|NCT05279586|Colistin|colistin|mesh-list
65397985|NCT05279586|Lactulose|lactulose|mesh-list
65397986|NCT05279586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65397987|NCT05279586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65397988|NCT05279586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65397989|NCT00965796|Lidocaine|lidocaine|mesh-list
65397990|NCT00965796|Anesthetics, Local|anesthetics, local|mesh-ancestor
65397991|NCT00965796|Anesthetics|anesthetics|mesh-ancestor
65397992|NCT00965796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65397993|NCT00965796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65397994|NCT00965796|Sensory System Agents|sensory system agents|mesh-ancestor
65397995|NCT00965796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65397996|NCT00965796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65397997|NCT00965796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65397998|NCT00965796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65397999|NCT00965796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65398000|NCT00965796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398001|NCT00415636|Pemetrexed|pemetrexed|mesh-list
65398002|NCT00415636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398003|NCT00415636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784625|NCT02015910|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64784626|NCT02015910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64784627|NCT02015910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784628|NCT02015910|Incretins|incretins|mesh-ancestor
64784629|NCT02015910|Hormones|hormones|mesh-ancestor
64784630|NCT02015910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64784631|NCT02015910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64784632|NCT02015910|Protease Inhibitors|protease inhibitors|mesh-ancestor
64395906|NCT02592707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64395907|NCT02592707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64395908|NCT02592707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64395909|NCT02592707|Chelating Agents|chelating agents|mesh-ancestor
64395910|NCT02592707|Sequestering Agents|sequestering agents|mesh-ancestor
64395911|NCT03855917|Sofosbuvir|sofosbuvir|mesh-list
64395912|NCT03855917|Antiviral Agents|antiviral agents|mesh-ancestor
64395913|NCT03855917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65398009|NCT00965874|Sensory System Agents|sensory system agents|mesh-ancestor
65398010|NCT00965874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65398011|NCT00965874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398012|NCT00965874|Anesthetics|anesthetics|mesh-ancestor
65398013|NCT00965874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65398014|NCT00965874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65398015|NCT00965874|Anticonvulsants|anticonvulsants|mesh-ancestor
65398016|NCT00965874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65398017|NCT00965874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64784633|NCT02015910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784634|NCT02015910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784635|NCT01980342|Efavirenz|efavirenz|mesh-list
64784636|NCT01980342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64784637|NCT01980342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64784638|NCT01980342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784639|NCT01980342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784640|NCT01980342|Antiviral Agents|antiviral agents|mesh-ancestor
64784641|NCT01980342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64395914|NCT03104855|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
64395915|NCT03104855|Calcifediol|calcifediol|mesh-list
64395916|NCT03104855|Vitamins|vitamins|mesh-ancestor
64395917|NCT03104855|Micronutrients|micronutrients|mesh-ancestor
64395918|NCT03104855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398042|NCT00972660|Tacrolimus|tacrolimus|mesh-list
65398043|NCT00972660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65398044|NCT00972660|Glucocorticoids|glucocorticoids|mesh-ancestor
65398045|NCT00972660|Hormones|hormones|mesh-ancestor
65398046|NCT00972660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65398047|NCT00972660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398048|NCT00972660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65398049|NCT00972660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398050|NCT00972660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398051|NCT00972660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398052|NCT00972660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65398065|NCT04008966|Cetrorelix|cetrorelix|mesh-list
65398075|NCT04008966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65398076|NCT04008966|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65398077|NCT04008966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65398078|NCT04008966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398079|NCT04008966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65398080|NCT04008966|Fertility Agents|fertility agents|mesh-ancestor
65398081|NCT04008966|Hormone Antagonists|hormone antagonists|mesh-ancestor
65398082|NCT00425854|Afatinib|afatinib|mesh-list
65398083|NCT00425854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398084|NCT00425854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65398085|NCT00425854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398086|NCT00425854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322013|NCT02231359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64671822|NCT01729598|GABA Agents|gaba agents|mesh-ancestor
64671823|NCT01729598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671824|NCT01729598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671825|NCT01729598|Antimanic Agents|antimanic agents|mesh-ancestor
64671826|NCT01729598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64671827|NCT01729598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64671828|NCT01729598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64671829|NCT05718011|Dexmedetomidine|dexmedetomidine|mesh-list
64671830|NCT05718011|Ketamine|ketamine|mesh-list
64671831|NCT05718011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64671832|NCT05718011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64671833|NCT05718011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671865|NCT02314403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671866|NCT02314403|Immunologic Factors|immunologic factors|mesh-ancestor
64671867|NCT02314403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671868|NCT02314403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64671869|NCT02314403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64671870|NCT02314403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671871|NCT02314403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64671872|NCT02052557|Bupivacaine|bupivacaine|mesh-list
64671873|NCT02052557|Anesthetics, Local|anesthetics, local|mesh-ancestor
64671887|NCT02052635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671889|NCT01732718|Atorvastatin|atorvastatin|mesh-list
64671890|NCT01732718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64671891|NCT01732718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64671892|NCT01732718|Antimetabolites|antimetabolites|mesh-ancestor
64556979|NCT03917303|Adalimumab|adalimumab|mesh-list
64556980|NCT03917303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64556981|NCT03917303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64556982|NCT03070860|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64556983|NCT03070860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64556984|NCT03070860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322035|NCT02398929|Bisoprolol|bisoprolol|mesh-list
64671893|NCT01732718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671894|NCT01732718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64397291|NCT05063513|Rituximab|rituximab|mesh-list
64671895|NCT01732718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64671896|NCT01732718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671897|NCT02362373|Levonorgestrel|levonorgestrel|mesh-list
64671898|NCT02362373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64671899|NCT02362373|Contraceptive Agents|contraceptive agents|mesh-ancestor
64671900|NCT02362373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64671901|NCT02362373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671902|NCT02362373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64671903|NCT02362373|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64671904|NCT02362373|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64671905|NCT02363621|Ranibizumab|ranibizumab|mesh-list
64671906|NCT02363621|Aflibercept|aflibercept|mesh-list
64671907|NCT02363621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65398087|NCT00425698|Epoetin Alfa|epoetin alfa|mesh-list
65398088|NCT00425698|Hematinics|hematinics|mesh-ancestor
65398089|NCT01037530|Ramipril|ramipril|mesh-list
65398090|NCT01037530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65398091|NCT01037530|Protease Inhibitors|protease inhibitors|mesh-ancestor
65398092|NCT01037530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398093|NCT01037530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398094|NCT01037530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65398095|NCT00973050|Bicalutamide|bicalutamide|mesh-list
65398096|NCT00973050|Androgen Antagonists|androgen antagonists|mesh-ancestor
65398097|NCT00973050|Hormone Antagonists|hormone antagonists|mesh-ancestor
65398098|NCT00973050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65398099|NCT00973050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398100|NCT00973050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398101|NCT00973128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
65398102|NCT00973128|Sargramostim|sargramostim|mesh-list
65398103|NCT00973128|Immunologic Factors|immunologic factors|mesh-ancestor
65398104|NCT00973128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398105|NCT00973128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65398106|NCT00973128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65398107|NCT00973128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65398108|NCT00973986|Atorvastatin|atorvastatin|mesh-list
65398109|NCT00973986|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65398110|NCT00973986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65398111|NCT00973986|Antimetabolites|antimetabolites|mesh-ancestor
65147681|NCT01237899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65398112|NCT00973986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398113|NCT00973986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65398114|NCT00973986|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65398115|NCT00973986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398117|NCT00966576|Brinzolamide|brinzolamide|mesh-list
65398118|NCT00966576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398119|NCT00966576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398120|NCT00966576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65398121|NCT00966576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65398122|NCT00966576|Adrenergic Agents|adrenergic agents|mesh-ancestor
64784674|NCT01851174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784675|NCT01851174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64784676|NCT01851174|Antimetabolites|antimetabolites|mesh-ancestor
64784677|NCT01851174|Antiviral Agents|antiviral agents|mesh-ancestor
64784678|NCT01851174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64784679|NCT01851174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784680|NCT01851174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64784681|NCT01851174|Immunologic Factors|immunologic factors|mesh-ancestor
64784682|NCT01851174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784683|NCT01846182|Pregabalin|pregabalin|mesh-list
64784684|NCT01846182|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64784685|NCT01846182|Analgesics|analgesics|mesh-ancestor
65398124|NCT00966576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398125|NCT00966576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65398126|NCT00966576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65398127|NCT00966576|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65398128|NCT00425308|Cyclosporine|cyclosporine|mesh-list
65398129|NCT00425308|Mycophenolic Acid|mycophenolic acid|mesh-list
65398130|NCT00425308|Everolimus|everolimus|mesh-list
65398131|NCT00425308|Cyclosporins|cyclosporins|mesh-list
65398132|NCT00425308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398133|NCT00425308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398134|NCT00425308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65398135|NCT00425308|Immunologic Factors|immunologic factors|mesh-ancestor
65398136|NCT00425308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398137|NCT00425308|Antifungal Agents|antifungal agents|mesh-ancestor
65398147|NCT04008888|Dexamethasone|dexamethasone|mesh-list
64784686|NCT01846182|Sensory System Agents|sensory system agents|mesh-ancestor
64784687|NCT01846182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64784688|NCT01846182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784689|NCT01846182|Anticonvulsants|anticonvulsants|mesh-ancestor
64784690|NCT01846182|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64784691|NCT01846182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64395965|NCT03748433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395966|NCT00540995|Etoposide|etoposide|mesh-list
64395967|NCT00540995|Podophyllotoxin|podophyllotoxin|mesh-list
64395968|NCT00540995|Etoposide phosphate|etoposide phosphate|mesh-list
64395969|NCT00540995|Busulfan|busulfan|mesh-list
64395970|NCT00540995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65398160|NCT04008888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65398161|NCT04008888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65398162|NCT04008888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398163|NCT04008888|Protease Inhibitors|protease inhibitors|mesh-ancestor
65398164|NCT04008888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398165|NCT04008888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398166|NCT04008888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65398167|NCT04008888|Immunologic Factors|immunologic factors|mesh-ancestor
65398168|NCT04008888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64784692|NCT01846182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784693|NCT01846182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64784694|NCT01846182|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64784695|NCT01846182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64784696|NCT01846182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64784697|NCT01846182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64784698|NCT01846182|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64784699|NCT01846182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64395971|NCT00540995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395972|NCT00540995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64395973|NCT00540995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64395974|NCT00540995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64395975|NCT00540995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395976|NCT00540995|Alkylating Agents|alkylating agents|mesh-ancestor
64395977|NCT00540995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64395978|NCT00540995|Immunologic Factors|immunologic factors|mesh-ancestor
65398192|NCT00545064|Dorzolamide|dorzolamide|mesh-list
65398193|NCT00545064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784700|NCT01846182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64784701|NCT01846182|Antidepressive Agents|antidepressive agents|mesh-ancestor
64784702|NCT01846182|Dopamine Agents|dopamine agents|mesh-ancestor
64784703|NCT01800162|Methotrexate|methotrexate|mesh-list
64784704|NCT01800162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64784705|NCT01800162|Abortifacient Agents|abortifacient agents|mesh-ancestor
64784706|NCT01800162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64784707|NCT01800162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784708|NCT01800162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64395980|NCT00540995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64395981|NCT00540995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64395982|NCT00540995|Keratolytic Agents|keratolytic agents|mesh-ancestor
64395983|NCT00540995|Dermatologic Agents|dermatologic agents|mesh-ancestor
64395984|NCT00540995|Tubulin Modulators|tubulin modulators|mesh-ancestor
64395985|NCT00540995|Antimitotic Agents|antimitotic agents|mesh-ancestor
64395986|NCT00540995|Mitosis Modulators|mitosis modulators|mesh-ancestor
65398231|NCT01589068|Progestins|progestins|mesh-ancestor
64784709|NCT01800162|Antimetabolites|antimetabolites|mesh-ancestor
64784710|NCT01800162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784711|NCT01800162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784712|NCT01800162|Dermatologic Agents|dermatologic agents|mesh-ancestor
64784713|NCT01800162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784714|NCT01800162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64784715|NCT01800162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64784716|NCT01800162|Immunologic Factors|immunologic factors|mesh-ancestor
64784717|NCT01800162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64395988|NCT03103451|Immunologic Factors|immunologic factors|mesh-ancestor
64395989|NCT03103451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395990|NCT05103215|Lidocaine|lidocaine|mesh-list
64395991|NCT05103215|Anesthetics, Local|anesthetics, local|mesh-ancestor
64395992|NCT05103215|Anesthetics|anesthetics|mesh-ancestor
64395993|NCT05103215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64395994|NCT05103215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395995|NCT05103215|Sensory System Agents|sensory system agents|mesh-ancestor
65398270|NCT00432172|Antimitotic Agents|antimitotic agents|mesh-ancestor
65398271|NCT00432172|Mitosis Modulators|mitosis modulators|mesh-ancestor
65398272|NCT00432172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65398282|NCT01034410|Cytarabine|cytarabine|mesh-list
64784718|NCT01800162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64784719|NCT01756560|Bupivacaine|bupivacaine|mesh-list
64784720|NCT01756560|Anesthetics, Local|anesthetics, local|mesh-ancestor
64784721|NCT01756560|Anesthetics|anesthetics|mesh-ancestor
64784722|NCT01756560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64784723|NCT01756560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784724|NCT01756560|Sensory System Agents|sensory system agents|mesh-ancestor
64784725|NCT01756560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64784726|NCT01738698|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64395997|NCT05103215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65398306|NCT00980304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65398307|NCT00424528|Tiotropium Bromide|tiotropium bromide|mesh-list
65398308|NCT00424528|Formoterol Fumarate|formoterol fumarate|mesh-list
65398309|NCT00424528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65398310|NCT00424528|Autonomic Agents|autonomic agents|mesh-ancestor
65398311|NCT00424528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65398312|NCT00424528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398313|NCT00424528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65398314|NCT00424528|Respiratory System Agents|respiratory system agents|mesh-ancestor
65398315|NCT00424528|Parasympatholytics|parasympatholytics|mesh-ancestor
65398316|NCT00424528|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65398317|NCT00424528|Cholinergic Agents|cholinergic agents|mesh-ancestor
65398318|NCT00424528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65398319|NCT00424528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398320|NCT00424528|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65398321|NCT00424528|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65398322|NCT00424528|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65398323|NCT00424528|Adrenergic Agents|adrenergic agents|mesh-ancestor
65398324|NCT00974766|Glucocorticoids|glucocorticoids|mesh-list
65398325|NCT00974766|Hormones|hormones|mesh-ancestor
65398326|NCT00974766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65398327|NCT00974766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398328|NCT00980382|Docetaxel|docetaxel|mesh-list
65398329|NCT00980382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398330|NCT00980382|Tubulin Modulators|tubulin modulators|mesh-ancestor
65398331|NCT00980382|Antimitotic Agents|antimitotic agents|mesh-ancestor
65398332|NCT00980382|Mitosis Modulators|mitosis modulators|mesh-ancestor
64784727|NCT01738698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64784728|NCT01738698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784729|NCT01738698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64784730|NCT01738698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64784731|NCT01738698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64784732|NCT01738698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784733|NCT01738698|Dopamine Agents|dopamine agents|mesh-ancestor
64396003|NCT05001815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64396004|NCT05001815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64396005|NCT05001815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396006|NCT02644967|Ipilimumab|ipilimumab|mesh-list
64396007|NCT02644967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64396008|NCT02644967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396009|NCT02644967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64396010|NCT02644967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324489|NCT01484119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398333|NCT00980382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398334|NCT00967434|Atorvastatin|atorvastatin|mesh-list
65398335|NCT00967434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65398336|NCT00967434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65398337|NCT00967434|Antimetabolites|antimetabolites|mesh-ancestor
64784734|NCT01738698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64784735|NCT01717482|Metformin|metformin|mesh-list
64784736|NCT01717482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64784737|NCT01717482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784738|NCT01702896|Interleukin-2|interleukin-2|mesh-list
64784739|NCT01702896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784740|NCT01702896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64784741|NCT01702896|Analgesics|analgesics|mesh-ancestor
64784742|NCT01702896|Sensory System Agents|sensory system agents|mesh-ancestor
64784743|NCT01702896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64784744|NCT01702896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784745|NCT01683864|Cisplatin|cisplatin|mesh-list
65398366|NCT04082910|Sensory System Agents|sensory system agents|mesh-ancestor
65398367|NCT04082910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65398368|NCT04082910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398369|NCT04082910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65398370|NCT04082910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65398371|NCT04082910|Immunologic Factors|immunologic factors|mesh-ancestor
65398372|NCT04082910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65398373|NCT04082910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65398374|NCT04082910|Sympatholytics|sympatholytics|mesh-ancestor
65398375|NCT04082910|Autonomic Agents|autonomic agents|mesh-ancestor
65398376|NCT04082910|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65398377|NCT04082910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65398378|NCT04082910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65398379|NCT04082910|Adrenergic Agents|adrenergic agents|mesh-ancestor
65398380|NCT04082910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65398381|NCT04082910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398382|NCT00975078|Prednisone|prednisone|mesh-list
65398398|NCT00980850|Immunologic Factors|immunologic factors|mesh-ancestor
65398399|NCT00980850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398400|NCT00414466|Gabapentin|gabapentin|mesh-list
65398401|NCT00414466|Analgesics|analgesics|mesh-ancestor
65398402|NCT00414466|Sensory System Agents|sensory system agents|mesh-ancestor
65398403|NCT00414466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65398404|NCT00414466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398405|NCT00414466|Anticonvulsants|anticonvulsants|mesh-ancestor
65398406|NCT00414466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65398407|NCT00414466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65398408|NCT00414466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65398409|NCT00414466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65398410|NCT00414466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65398411|NCT00414466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65398412|NCT00414466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65398413|NCT00414466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398414|NCT00414466|Antimanic Agents|antimanic agents|mesh-ancestor
65398415|NCT00984750|Acetylcarnitine|acetylcarnitine|mesh-list
65398416|NCT00984750|Simvastatin|simvastatin|mesh-list
65398417|NCT00984750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65398418|NCT00984750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65398419|NCT00984750|Antimetabolites|antimetabolites|mesh-ancestor
65398420|NCT00984750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398421|NCT00984750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65398422|NCT00984750|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65398423|NCT00984750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398424|NCT00984750|Vitamin B Complex|vitamin b complex|mesh-ancestor
65398425|NCT00984750|Vitamins|vitamins|mesh-ancestor
65398426|NCT00984750|Micronutrients|micronutrients|mesh-ancestor
65398427|NCT00984750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398428|NCT00984750|Nootropic Agents|nootropic agents|mesh-ancestor
65398429|NCT00975312|Tretinoin|tretinoin|mesh-list
65398433|NCT04974996|Prednisone|prednisone|mesh-list
65398441|NCT04974996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398442|NCT04974996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65398443|NCT04974996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65398444|NCT04974996|Alkylating Agents|alkylating agents|mesh-ancestor
65398445|NCT04974996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398446|NCT04974996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398447|NCT04974996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65398448|NCT04974996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65398449|NCT04974996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65398450|NCT04974996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65398451|NCT04974996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65398452|NCT04974996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398453|NCT04974996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65398454|NCT04974996|Glucocorticoids|glucocorticoids|mesh-ancestor
65398455|NCT04974996|Hormones|hormones|mesh-ancestor
65398456|NCT04974996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65398457|NCT04974996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65398458|NCT04974996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65398459|NCT04974996|Tubulin Modulators|tubulin modulators|mesh-ancestor
65398460|NCT04974996|Antimitotic Agents|antimitotic agents|mesh-ancestor
65398461|NCT04974996|Mitosis Modulators|mitosis modulators|mesh-ancestor
65398462|NCT00981006|Mitogens|mitogens|mesh-list
64784771|NCT01527942|Antipyretics|antipyretics|mesh-ancestor
64671908|NCT02363621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64671909|NCT02363621|Growth Substances|growth substances|mesh-ancestor
64671910|NCT02363621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671911|NCT02363621|Growth Inhibitors|growth inhibitors|mesh-ancestor
64671912|NCT02363621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671913|NCT01749956|Leucovorin|leucovorin|mesh-list
64671914|NCT01749956|Fluorouracil|fluorouracil|mesh-list
64671915|NCT01749956|Oxaliplatin|oxaliplatin|mesh-list
64671916|NCT01749956|Aflibercept|aflibercept|mesh-list
64671919|NCT01749956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64671920|NCT01749956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671921|NCT01749956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64671933|NCT02365961|Clonidine|clonidine|mesh-list
64671934|NCT02365961|Epinephrine|epinephrine|mesh-list
64671935|NCT02365961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64671936|NCT02365961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64671937|NCT02365961|Adrenergic Agents|adrenergic agents|mesh-ancestor
64671938|NCT02365961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671939|NCT02365961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671940|NCT02365961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671941|NCT02365961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64671942|NCT02365961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64671943|NCT02365961|Autonomic Agents|autonomic agents|mesh-ancestor
64671944|NCT02365961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64671945|NCT02365961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64671946|NCT02365961|Respiratory System Agents|respiratory system agents|mesh-ancestor
64671947|NCT02365961|Mydriatics|mydriatics|mesh-ancestor
64671948|NCT02365961|Sympathomimetics|sympathomimetics|mesh-ancestor
64784782|NCT01483872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784783|NCT01483872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64784784|NCT01483872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64784785|NCT01483872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64784786|NCT01483872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64784787|NCT01483872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64784788|NCT01483872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784789|NCT01385280|Exemestane|exemestane|mesh-list
64784790|NCT01385280|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64784791|NCT01385280|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64784792|NCT01385280|Estradiol|estradiol|mesh-list
64784793|NCT01385280|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64784794|NCT01385280|Estrogens|estrogens|mesh-ancestor
65398463|NCT00981006|Mitosis Modulators|mitosis modulators|mesh-ancestor
65398464|NCT00981006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398465|NCT00975390|Caffeine|caffeine|mesh-list
65398466|NCT00975390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65398467|NCT00975390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398468|NCT00975390|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65398469|NCT00975390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398470|NCT00975390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398471|NCT00975390|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65398472|NCT00975390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65398473|NCT00975390|Purinergic Agents|purinergic agents|mesh-ancestor
65398474|NCT00975390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65398497|NCT00984984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65398498|NCT00984984|Prednisolone phosphate|prednisolone phosphate|mesh-list
65398499|NCT00984984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65398500|NCT00984984|Antiemetics|antiemetics|mesh-ancestor
65398501|NCT00984984|Autonomic Agents|autonomic agents|mesh-ancestor
64784795|NCT01385280|Hormones|hormones|mesh-ancestor
64784796|NCT01385280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64784797|NCT01385280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784798|NCT01385280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64784799|NCT01385280|Contraceptive Agents|contraceptive agents|mesh-ancestor
64784800|NCT01385280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64784801|NCT01385280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64784802|NCT01385280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784803|NCT01385280|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64784804|NCT01385280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64396051|NCT04552847|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64396052|NCT04552847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396053|NCT05167331|Nitrous Oxide|nitrous oxide|mesh-list
65398502|NCT00984984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65398503|NCT00984984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398537|NCT00981708|Immunologic Factors|immunologic factors|mesh-ancestor
65398538|NCT00981708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398539|NCT00981708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65398540|NCT00981708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65398541|NCT00981708|Alkylating Agents|alkylating agents|mesh-ancestor
65398542|NCT00981708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398543|NCT00981708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398544|NCT00981708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65398545|NCT00981708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65398546|NCT00981708|Antiemetics|antiemetics|mesh-ancestor
65398547|NCT00981708|Autonomic Agents|autonomic agents|mesh-ancestor
65398548|NCT00981708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65398549|NCT00981708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65398550|NCT00981708|Glucocorticoids|glucocorticoids|mesh-ancestor
65398551|NCT00981708|Hormones|hormones|mesh-ancestor
65398552|NCT00981708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65398553|NCT00981708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65398554|NCT00981708|Protease Inhibitors|protease inhibitors|mesh-ancestor
65398555|NCT00981708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398556|NCT00981708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65398557|NCT00981708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65398558|NCT00981708|Growth Substances|growth substances|mesh-ancestor
65398559|NCT00981708|Growth Inhibitors|growth inhibitors|mesh-ancestor
65398560|NCT00981786|Timolol|timolol|mesh-list
65148131|NCT01259856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398561|NCT00981786|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65398562|NCT00981786|Travoprost|travoprost|mesh-list
65398563|NCT00981786|Brinzolamide|brinzolamide|mesh-list
65398564|NCT00981786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65398565|NCT00981786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65398566|NCT00981786|Adrenergic Agents|adrenergic agents|mesh-ancestor
65398567|NCT00981786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65398568|NCT00981786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398569|NCT00981786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398570|NCT00981786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65398571|NCT00981786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64671949|NCT02365961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64671950|NCT02365961|Analgesics|analgesics|mesh-ancestor
64784829|NCT01302444|Urological Agents|urological agents|mesh-ancestor
65398572|NCT00981786|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65398573|NCT00981786|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65398574|NCT00981786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65398575|NCT00981786|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65398576|NCT00981786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398577|NCT04007562|Hydroxychloroquine|hydroxychloroquine|mesh-list
65398578|NCT04007562|Antimalarials|antimalarials|mesh-ancestor
65398579|NCT04007562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65398580|NCT04007562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65398581|NCT04007562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65398582|NCT04007562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398583|NCT04007562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398584|NCT04007562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65398585|NCT00985374|Everolimus|everolimus|mesh-list
65398586|NCT00985374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398587|NCT00985374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65398588|NCT00985374|Immunologic Factors|immunologic factors|mesh-ancestor
65398589|NCT00985374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398590|NCT00975936|Ketoconazole|ketoconazole|mesh-list
65398591|NCT00975936|Antifungal Agents|antifungal agents|mesh-ancestor
65398592|NCT00975936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65398593|NCT00975936|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65398594|NCT00975936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65398595|NCT00975936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398596|NCT00975936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398597|NCT00975936|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65398598|NCT00975936|Hormone Antagonists|hormone antagonists|mesh-ancestor
65398599|NCT00975936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65398600|NCT00975936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398601|NCT00975936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65398602|NCT00976092|Heparin|heparin|mesh-list
65398603|NCT00976092|Calcium heparin|calcium heparin|mesh-list
65398604|NCT00976092|Bivalirudin|bivalirudin|mesh-list
65398605|NCT00976092|Clopidogrel|clopidogrel|mesh-list
65398609|NCT00976092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64784846|NCT01284504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64784847|NCT01284504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784848|NCT01284504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784849|NCT01183416|Tretinoin|tretinoin|mesh-list
64784850|NCT01183416|Isotretinoin|isotretinoin|mesh-list
64784851|NCT01183416|Antibodies|antibodies|mesh-list
64784852|NCT01183416|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64784853|NCT01183416|Immunologic Factors|immunologic factors|mesh-ancestor
64784854|NCT01183416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784855|NCT01183416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396103|NCT04268849|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64396104|NCT04268849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64396105|NCT02642159|Nicotinic Acids|nicotinic acids|mesh-list
64396106|NCT02642159|Niacin|niacin|mesh-list
64396107|NCT02642159|Niacinamide|niacinamide|mesh-list
64396108|NCT02642159|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65398610|NCT00976092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64784856|NCT01183416|Keratolytic Agents|keratolytic agents|mesh-ancestor
64784857|NCT01183416|Dermatologic Agents|dermatologic agents|mesh-ancestor
65398648|NCT00976170|Sorafenib|sorafenib|mesh-list
65398649|NCT00976170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398650|NCT00976170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65398651|NCT00976170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398652|NCT00976170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398653|NCT00982254|Insulin|insulin|mesh-list
65398654|NCT00982254|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65398655|NCT00982254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65398656|NCT00982254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398657|NCT00985608|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65398658|NCT00985608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65398659|NCT00985608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64784858|NCT01169610|Varenicline|varenicline|mesh-list
64784859|NCT01169610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65398660|NCT00985608|Antitubercular Agents|antitubercular agents|mesh-ancestor
65398661|NCT00976326|Insulin|insulin|mesh-list
65398662|NCT00976326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65398663|NCT00976326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398664|NCT00982332|Betamethasone|betamethasone|mesh-list
65398665|NCT00982332|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
65398666|NCT00982332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65398667|NCT00982332|Glucocorticoids|glucocorticoids|mesh-ancestor
65398668|NCT00982332|Hormones|hormones|mesh-ancestor
65398669|NCT00982332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65398687|NCT04007328|Hormones|hormones|mesh-ancestor
64784875|NCT01166724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64784876|NCT01166724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784877|NCT01166724|Antifungal Agents|antifungal agents|mesh-ancestor
64784878|NCT01151904|Timolol|timolol|mesh-list
64784879|NCT01151904|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64784880|NCT01151904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64784881|NCT01151904|Latanoprost|latanoprost|mesh-list
64784882|NCT01151904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64784883|NCT01151904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64396120|NCT02642159|Vasodilator Agents|vasodilator agents|mesh-ancestor
64396121|NCT05072873|Tranexamic Acid|tranexamic acid|mesh-list
64396122|NCT05072873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64396123|NCT05072873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64396124|NCT05072873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396125|NCT05072873|Hemostatics|hemostatics|mesh-ancestor
64396126|NCT05072873|Coagulants|coagulants|mesh-ancestor
64396127|NCT05072405|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64324503|NCT02268409|Hematinics|hematinics|mesh-ancestor
64324504|NCT02268487|Sertraline|sertraline|mesh-list
65398691|NCT04007328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65398692|NCT04007328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398693|NCT00985920|Tranexamic Acid|tranexamic acid|mesh-list
64784884|NCT01151904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64784885|NCT01151904|Adrenergic Agents|adrenergic agents|mesh-ancestor
64784886|NCT01151904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64784887|NCT01151904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784888|NCT01151904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784889|NCT01151904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64784890|NCT01151904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64784891|NCT01151904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64784892|NCT01151904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64396128|NCT05072405|Simvastatin|simvastatin|mesh-list
64396129|NCT05072405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64396130|NCT05072405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64396131|NCT05072405|Antimetabolites|antimetabolites|mesh-ancestor
64396132|NCT05072405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396133|NCT05072405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65398727|NCT04008186|Digoxin|digoxin|mesh-list
65398728|NCT04008186|Verapamil|verapamil|mesh-list
65398729|NCT04008186|Midazolam|midazolam|mesh-list
65398767|NCT04008186|Vasodilator Agents|vasodilator agents|mesh-ancestor
65398768|NCT04008186|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65398769|NCT00982566|Navitoclax|navitoclax|mesh-list
65398770|NCT00982566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398771|NCT00977028|Lidocaine|lidocaine|mesh-list
65398772|NCT00977028|Epinephrine|epinephrine|mesh-list
65398773|NCT00977028|Racepinephrine|racepinephrine|mesh-list
65398774|NCT00977028|Anesthetics|anesthetics|mesh-list
65398775|NCT00977028|Epinephryl borate|epinephryl borate|mesh-list
65398776|NCT00977028|Anesthetics, Local|anesthetics, local|mesh-ancestor
65398777|NCT00977028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65398778|NCT00977028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398779|NCT00977028|Sensory System Agents|sensory system agents|mesh-ancestor
65398780|NCT00977028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65398781|NCT00977028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65398782|NCT00977028|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65398783|NCT00977028|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65398784|NCT00977028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65398785|NCT00977028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398786|NCT00977028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65398788|NCT00977028|Adrenergic Agents|adrenergic agents|mesh-ancestor
65398789|NCT00977028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65398790|NCT00977028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65398791|NCT00977028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65398792|NCT00977028|Autonomic Agents|autonomic agents|mesh-ancestor
65398793|NCT00977028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65398794|NCT00977028|Respiratory System Agents|respiratory system agents|mesh-ancestor
65398795|NCT00977028|Mydriatics|mydriatics|mesh-ancestor
65398796|NCT00977028|Sympathomimetics|sympathomimetics|mesh-ancestor
65398797|NCT00977028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65398798|NCT00982722|Calcium, Dietary|calcium, dietary|mesh-list
65398799|NCT00982722|Cholecalciferol|cholecalciferol|mesh-list
65398800|NCT00982722|Vitamin D|vitamin d|mesh-list
65398801|NCT00982722|Calcium Carbonate|calcium carbonate|mesh-list
65398810|NCT00982722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65398811|NCT00982800|Gabapentin|gabapentin|mesh-list
65398812|NCT00982800|Analgesics|analgesics|mesh-ancestor
65398813|NCT00982800|Sensory System Agents|sensory system agents|mesh-ancestor
65398814|NCT00982800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65398815|NCT00982800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398816|NCT00982800|Anticonvulsants|anticonvulsants|mesh-ancestor
65398817|NCT00982800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65398818|NCT00982800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65398819|NCT00982800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65398820|NCT00982800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65398821|NCT00982800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65398822|NCT00982800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65398823|NCT00982800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65398824|NCT00982800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398825|NCT00982800|Antimanic Agents|antimanic agents|mesh-ancestor
65398826|NCT00986076|Enoxaparin|enoxaparin|mesh-list
65398827|NCT00986076|Anticoagulants|anticoagulants|mesh-ancestor
65398828|NCT00986076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65398829|NCT00986076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65398830|NCT00986076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398831|NCT00984828|Bortezomib|bortezomib|mesh-list
65398832|NCT00984828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398833|NCT00983034|Amoxicillin|amoxicillin|mesh-list
65398834|NCT00983034|Clarithromycin|clarithromycin|mesh-list
65398835|NCT00983034|Lansoprazole|lansoprazole|mesh-list
65398836|NCT00983034|Dexlansoprazole|dexlansoprazole|mesh-list
65398837|NCT00983034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65398838|NCT00983034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65398839|NCT00983034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65398840|NCT00983034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398841|NCT00983034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398842|NCT00983034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65398843|NCT00983034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65398844|NCT00983034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65398845|NCT00983034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64671951|NCT02365961|Sensory System Agents|sensory system agents|mesh-ancestor
64671952|NCT02365961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64784939|NCT00903396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64784940|NCT00903396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64784941|NCT00903396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64784942|NCT00903396|Serotonin Agents|serotonin agents|mesh-ancestor
64784943|NCT00903396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64784944|NCT00903396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784945|NCT00875394|Metformin|metformin|mesh-list
64784946|NCT00875394|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64784947|NCT00875394|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64784948|NCT00875394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396180|NCT04479865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396181|NCT04479865|Nootropic Agents|nootropic agents|mesh-ancestor
64396182|NCT03491059|Nicotine|nicotine|mesh-list
64396183|NCT03491059|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64396184|NCT03491059|Autonomic Agents|autonomic agents|mesh-ancestor
64396185|NCT03491059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64396186|NCT03491059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398846|NCT00983034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65398847|NCT00983112|Thrombin|thrombin|mesh-list
65398848|NCT00983112|Hemostatics|hemostatics|mesh-ancestor
65398849|NCT00983112|Coagulants|coagulants|mesh-ancestor
65398884|NCT00977964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398885|NCT00983424|Cyclosporine|cyclosporine|mesh-list
65398886|NCT00983424|Paclitaxel|paclitaxel|mesh-list
65398887|NCT00983424|Cyclosporins|cyclosporins|mesh-list
65398888|NCT00983424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65398889|NCT00983424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398890|NCT00983424|Tubulin Modulators|tubulin modulators|mesh-ancestor
65398891|NCT00983424|Antimitotic Agents|antimitotic agents|mesh-ancestor
65398892|NCT00983424|Mitosis Modulators|mitosis modulators|mesh-ancestor
65398893|NCT00983424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398894|NCT00983424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398895|NCT00983424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65398896|NCT00983424|Immunologic Factors|immunologic factors|mesh-ancestor
65398897|NCT00983424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398898|NCT00983424|Antifungal Agents|antifungal agents|mesh-ancestor
65398899|NCT00983424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65398900|NCT00983424|Dermatologic Agents|dermatologic agents|mesh-ancestor
65398901|NCT00983424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65398902|NCT00983424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65398903|NCT00983736|Tramadol|tramadol|mesh-list
65398904|NCT00983736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65398905|NCT00983736|Narcotics|narcotics|mesh-ancestor
65398906|NCT00983736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65398907|NCT00983736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398908|NCT00983736|Analgesics|analgesics|mesh-ancestor
65398909|NCT00983736|Sensory System Agents|sensory system agents|mesh-ancestor
65398910|NCT00983736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65398911|NCT00986778|Lamivudine|lamivudine|mesh-list
65398912|NCT00986778|Adefovir|adefovir|mesh-list
65398913|NCT00986778|Entecavir|entecavir|mesh-list
65398914|NCT00986778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65398915|NCT00986778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64553540|NCT03100422|Armin|armin|mesh-list
64671953|NCT02365961|Sympatholytics|sympatholytics|mesh-ancestor
64671954|NCT02365961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64671955|NCT05532059|Gemcitabine|gemcitabine|mesh-list
64671956|NCT05532059|Cisplatin|cisplatin|mesh-list
64671957|NCT05532059|Lenvatinib|lenvatinib|mesh-list
64671958|NCT05532059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671959|NCT05532059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64671960|NCT05532059|Antimetabolites|antimetabolites|mesh-ancestor
64671961|NCT05532059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671962|NCT05532059|Antiviral Agents|antiviral agents|mesh-ancestor
64671963|NCT05532059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64784968|NCT00749658|Antidepressive Agents|antidepressive agents|mesh-ancestor
64784969|NCT00749658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64784970|NCT00749658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64784971|NCT00749658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64784972|NCT00749658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64784973|NCT00749658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784974|NCT00749658|Dopamine Agents|dopamine agents|mesh-ancestor
64784975|NCT00749658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64784976|NCT00749658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784977|NCT00749658|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64784978|NCT00749658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64396207|NCT05251129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64396208|NCT05251129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396209|NCT01797523|Metformin|metformin|mesh-list
64396210|NCT01797523|Everolimus|everolimus|mesh-list
64396211|NCT01797523|Letrozole|letrozole|mesh-list
64396212|NCT01797523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65398916|NCT00986778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398952|NCT00414388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398953|NCT00414388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65398954|NCT00414388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398955|NCT00414388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398956|NCT00978588|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65398957|NCT00978588|Plasma Substitutes|plasma substitutes|mesh-ancestor
65398958|NCT00978588|Blood Substitutes|blood substitutes|mesh-ancestor
65398959|NCT01037608|Nabiximols|nabiximols|mesh-list
65398960|NCT01037608|Analgesics|analgesics|mesh-ancestor
65398961|NCT01037608|Sensory System Agents|sensory system agents|mesh-ancestor
65398962|NCT01037608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65398963|NCT01037608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398964|NCT04006080|Vedolizumab|vedolizumab|mesh-list
65398965|NCT04006080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65398966|NCT00984438|Bevacizumab|bevacizumab|mesh-list
65398967|NCT00984438|Irinotecan|irinotecan|mesh-list
65398968|NCT00984438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65398969|NCT00984438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398970|NCT00984438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65398971|NCT00984438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65398972|NCT00984438|Growth Substances|growth substances|mesh-ancestor
65398973|NCT00984438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65398974|NCT00984438|Growth Inhibitors|growth inhibitors|mesh-ancestor
65398975|NCT00984438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65398976|NCT00984438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65398977|NCT00984438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65398978|NCT00984438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65398979|NCT00424372|Pregabalin|pregabalin|mesh-list
65398980|NCT00424372|Analgesics|analgesics|mesh-ancestor
65398981|NCT00424372|Sensory System Agents|sensory system agents|mesh-ancestor
64785000|NCT00704496|Pseudoephedrine|pseudoephedrine|mesh-list
64785001|NCT00704496|Ephedrine|ephedrine|mesh-list
64785002|NCT00704496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64785003|NCT00704496|Autonomic Agents|autonomic agents|mesh-ancestor
64785004|NCT00704496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785005|NCT00704496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785006|NCT00704496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64785007|NCT00704496|Respiratory System Agents|respiratory system agents|mesh-ancestor
64785008|NCT00704496|Nasal Decongestants|nasal decongestants|mesh-ancestor
64785009|NCT00704496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64785010|NCT00704496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65398995|NCT00987168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65398996|NCT00987168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65398997|NCT00978978|Fentanyl|fentanyl|mesh-list
65398998|NCT00978978|Midazolam|midazolam|mesh-list
65398999|NCT00978978|Propofol|propofol|mesh-list
65399000|NCT00978978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65399001|NCT00978978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65399002|NCT00978978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399003|NCT00978978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65399004|NCT00978978|Anesthetics, General|anesthetics, general|mesh-ancestor
65399005|NCT00978978|Anesthetics|anesthetics|mesh-ancestor
65399006|NCT00978978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64785012|NCT00704496|Adrenergic Agents|adrenergic agents|mesh-ancestor
64785013|NCT00704496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64785014|NCT00704496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785015|NCT00692094|Melatonin|melatonin|mesh-list
64785016|NCT00692094|Antioxidants|antioxidants|mesh-ancestor
64785017|NCT00692094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785018|NCT00692094|Protective Agents|protective agents|mesh-ancestor
64785019|NCT00692094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785020|NCT00692094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64396244|NCT02382757|Insulin|insulin|mesh-list
64396245|NCT02382757|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64396246|NCT02382757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64396247|NCT02382757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399037|NCT00542880|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64396248|NCT02382679|Vitamins|vitamins|mesh-list
64396252|NCT00916747|Pravastatin|pravastatin|mesh-list
65399038|NCT00542880|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65399039|NCT00542880|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65399040|NCT00542880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65399041|NCT00542880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65399042|NCT00542880|Autonomic Agents|autonomic agents|mesh-ancestor
65399043|NCT00542880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65399044|NCT00542880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399045|NCT00542880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65399070|NCT01033318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65399071|NCT01033318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65399072|NCT01033318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65399073|NCT01033318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65399074|NCT01033318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399075|NCT01033396|Fexofenadine|fexofenadine|mesh-list
65399076|NCT01033396|Terfenadine|terfenadine|mesh-list
65399077|NCT01033396|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65399078|NCT01033396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65399079|NCT01033396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65399080|NCT01033396|Histamine Antagonists|histamine antagonists|mesh-ancestor
65399081|NCT01033396|Histamine Agents|histamine agents|mesh-ancestor
65399082|NCT01033396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65399083|NCT01033396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399084|NCT01033396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399085|NCT00979056|Rifaximin|rifaximin|mesh-list
65399086|NCT00979056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65399087|NCT00979056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65399088|NCT00979056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65399089|NCT00988494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65399090|NCT00988494|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65399092|NCT00092677|Ezetimibe|ezetimibe|mesh-list
65399093|NCT00092677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65399094|NCT00092677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65399095|NCT00092677|Antimetabolites|antimetabolites|mesh-ancestor
65399096|NCT00092677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399097|NCT00092677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65399098|NCT00092677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65399099|NCT00092677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399100|NCT00542178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65399101|NCT00542178|Simvastatin|simvastatin|mesh-list
65399112|NCT00987636|Diphosphonates|diphosphonates|mesh-list
65399113|NCT00987636|Busulfan|busulfan|mesh-list
65399114|NCT00987636|Treosulfan|treosulfan|mesh-list
65399115|NCT00987636|Alkylating Agents|alkylating agents|mesh-ancestor
65399116|NCT00987636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399117|NCT00987636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65399118|NCT00987636|Immunologic Factors|immunologic factors|mesh-ancestor
65399119|NCT00987636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399120|NCT00987636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65399121|NCT00987636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399122|NCT00987636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65399123|NCT00987636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65399124|NCT00424294|Celecoxib|celecoxib|mesh-list
65399125|NCT00424294|Methotrexate|methotrexate|mesh-list
65399126|NCT00424294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65399127|NCT00424294|Abortifacient Agents|abortifacient agents|mesh-ancestor
65399128|NCT00424294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65399129|NCT00424294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399130|NCT00424294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65399131|NCT00424294|Antimetabolites|antimetabolites|mesh-ancestor
65399132|NCT00424294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399133|NCT00424294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399134|NCT00424294|Dermatologic Agents|dermatologic agents|mesh-ancestor
65399135|NCT00424294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399136|NCT00424294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65399137|NCT00424294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65399138|NCT00424294|Immunologic Factors|immunologic factors|mesh-ancestor
65399139|NCT00424294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65399140|NCT00424294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65399141|NCT00424294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65399142|NCT00424294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65399143|NCT00424294|Analgesics|analgesics|mesh-ancestor
65399144|NCT00424294|Sensory System Agents|sensory system agents|mesh-ancestor
65399152|NCT05587998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65399153|NCT05587998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399154|NCT05587998|Analgesics|analgesics|mesh-ancestor
65399155|NCT05587998|Sensory System Agents|sensory system agents|mesh-ancestor
65399156|NCT05587998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65399157|NCT00988728|Olanzapine|olanzapine|mesh-list
65399158|NCT00988728|Antiemetics|antiemetics|mesh-ancestor
65399159|NCT00988728|Autonomic Agents|autonomic agents|mesh-ancestor
65399160|NCT00988728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65399161|NCT00988728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399162|NCT00988728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65399163|NCT00988728|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65399164|NCT00988728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65399165|NCT00988728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65399166|NCT00988728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65399167|NCT00988728|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65399168|NCT00988728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65399169|NCT00988728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65399170|NCT00988728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399171|NCT00988728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65399172|NCT00988728|Serotonin Agents|serotonin agents|mesh-ancestor
65399173|NCT00988806|Simendan|simendan|mesh-list
65399174|NCT00988806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65399175|NCT00988806|Vasodilator Agents|vasodilator agents|mesh-ancestor
65399176|NCT00988806|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65399177|NCT00988806|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65399178|NCT00988806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399179|NCT00988806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399180|NCT00988806|Protective Agents|protective agents|mesh-ancestor
65399181|NCT00988806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399182|NCT04005768|Hydroxychloroquine|hydroxychloroquine|mesh-list
65399183|NCT04005768|Antimalarials|antimalarials|mesh-ancestor
65399184|NCT04005768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65399185|NCT04005768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65399191|NCT00987792|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65399192|NCT00987792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65399193|NCT00987792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65399194|NCT00987792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65399195|NCT00987792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65399196|NCT00987792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399197|NCT00987792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399198|NCT00987792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399199|NCT00987792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65399200|NCT00987792|Contraceptive Agents|contraceptive agents|mesh-ancestor
65399201|NCT00987792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65399202|NCT00987792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399203|NCT00987792|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65399204|NCT00987792|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65399205|NCT00987792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65399206|NCT00987870|Betamethasone|betamethasone|mesh-list
65399207|NCT00987870|Calcipotriene|calcipotriene|mesh-list
65399208|NCT00987870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65399209|NCT00987870|Glucocorticoids|glucocorticoids|mesh-ancestor
65399210|NCT00987870|Hormones|hormones|mesh-ancestor
65399211|NCT00987870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65399212|NCT00987870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399213|NCT00987870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65399214|NCT00987870|Respiratory System Agents|respiratory system agents|mesh-ancestor
65399215|NCT00987870|Dermatologic Agents|dermatologic agents|mesh-ancestor
65399216|NCT00988026|Minocycline|minocycline|mesh-list
65399217|NCT00988026|Lymecycline|lymecycline|mesh-list
65399218|NCT00988026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65399219|NCT00988026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65399220|NCT05578170|Pembrolizumab|pembrolizumab|mesh-list
65399221|NCT05578170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65399223|NCT00989274|Vaccines|vaccines|mesh-list
65399231|NCT05712642|Bevacizumab|bevacizumab|mesh-list
65399232|NCT05712642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65399233|NCT05712642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399234|NCT05712642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65399235|NCT05712642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65399236|NCT05712642|Growth Substances|growth substances|mesh-ancestor
65399237|NCT05712642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399238|NCT05712642|Growth Inhibitors|growth inhibitors|mesh-ancestor
65399239|NCT05492682|Cyclophosphamide|cyclophosphamide|mesh-list
65399240|NCT05492682|Pembrolizumab|pembrolizumab|mesh-list
65399241|NCT05492682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65399242|NCT05492682|Immunologic Factors|immunologic factors|mesh-ancestor
65399243|NCT05492682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399244|NCT05492682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65399245|NCT05492682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65399246|NCT05492682|Alkylating Agents|alkylating agents|mesh-ancestor
65399247|NCT05492682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399248|NCT05492682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399249|NCT05492682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65399250|NCT05492682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65399251|NCT01085149|Simvastatin|simvastatin|mesh-list
65399252|NCT01085149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65399253|NCT01085149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65399254|NCT01085149|Antimetabolites|antimetabolites|mesh-ancestor
65399255|NCT01085149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399256|NCT01085149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65399257|NCT01085149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65399258|NCT01085149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399259|NCT04005612|Vitamin D|vitamin d|mesh-list
65399260|NCT04005612|Ergocalciferols|ergocalciferols|mesh-list
65399261|NCT04005612|Cholecalciferol|cholecalciferol|mesh-list
65399262|NCT04005612|Vitamins|vitamins|mesh-list
65399263|NCT04005612|Micronutrients|micronutrients|mesh-ancestor
65399264|NCT04005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671964|NCT05532059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671965|NCT05532059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64556985|NCT05583149|Cyclophosphamide|cyclophosphamide|mesh-list
64556986|NCT05583149|Fludarabine|fludarabine|mesh-list
64556987|NCT05583149|Acalabrutinib|acalabrutinib|mesh-list
64556988|NCT05583149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64785177|NCT04043520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64785178|NCT04043520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785180|NCT03582930|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
64785181|NCT03582930|Respiratory System Agents|respiratory system agents|mesh-ancestor
64785182|NCT03472872|Acetaminophen|acetaminophen|mesh-list
65399265|NCT04005612|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65399266|NCT04005612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65399267|NCT00413920|Mycophenolic Acid|mycophenolic acid|mesh-list
65399268|NCT00413920|Prednisone|prednisone|mesh-list
65399269|NCT00413920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65399270|NCT00413920|Glucocorticoids|glucocorticoids|mesh-ancestor
65399271|NCT00413920|Hormones|hormones|mesh-ancestor
65399272|NCT00413920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65399273|NCT00413920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399274|NCT00413920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65399275|NCT00413920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399276|NCT00413920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65399277|NCT00413920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65399278|NCT00413920|Antitubercular Agents|antitubercular agents|mesh-ancestor
65399279|NCT00413920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65399280|NCT00413920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65399281|NCT00413920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399282|NCT00413920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399283|NCT00091819|Vancomycin|vancomycin|mesh-list
65399284|NCT00091819|Telavancin|telavancin|mesh-list
65399285|NCT00091819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65399286|NCT00091819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65399287|NCT01326871|Gemcitabine|gemcitabine|mesh-list
65399288|NCT01326871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399289|NCT01326871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65399290|NCT01326871|Antimetabolites|antimetabolites|mesh-ancestor
65399292|NCT01326871|Antiviral Agents|antiviral agents|mesh-ancestor
64785193|NCT03472872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64785194|NCT03472872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785195|NCT03472872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785196|NCT03301038|Rifampin|rifampin|mesh-list
65399301|NCT01081561|Micronutrients|micronutrients|mesh-ancestor
65399302|NCT01081561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399303|NCT01081561|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65399304|NCT01081561|Dermatologic Agents|dermatologic agents|mesh-ancestor
65399305|NCT04004754|Miltefosine|miltefosine|mesh-list
65399306|NCT04004754|Antifungal Agents|antifungal agents|mesh-ancestor
65399307|NCT04004754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65399308|NCT04004754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399309|NCT04004754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65399310|NCT04004754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65399311|NCT00539994|Retapamulin|retapamulin|mesh-list
65399312|NCT00539994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65399313|NCT00539994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65399314|NCT04508790|Dexamethasone|dexamethasone|mesh-list
65399315|NCT04508790|Dexamethasone acetate|dexamethasone acetate|mesh-list
65399316|NCT04508790|Pomalidomide|pomalidomide|mesh-list
65399317|NCT04508790|Ichthammol|ichthammol|mesh-list
65399318|NCT04508790|BB 1101|bb 1101|mesh-list
65399319|NCT04508790|Leflunomide|leflunomide|mesh-list
65399320|NCT04508790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65399321|NCT04508790|Antiemetics|antiemetics|mesh-ancestor
65399322|NCT04508790|Autonomic Agents|autonomic agents|mesh-ancestor
65399323|NCT04508790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65399324|NCT04508790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399325|NCT04508790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65399326|NCT04508790|Glucocorticoids|glucocorticoids|mesh-ancestor
65399327|NCT04508790|Hormones|hormones|mesh-ancestor
65399328|NCT04508790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64556989|NCT05583149|Immunologic Factors|immunologic factors|mesh-ancestor
64556990|NCT05583149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556991|NCT05583149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64556992|NCT05583149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64556993|NCT05583149|Alkylating Agents|alkylating agents|mesh-ancestor
64556994|NCT05583149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322043|NCT02398929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64671966|NCT05532059|Immunologic Factors|immunologic factors|mesh-ancestor
64671967|NCT05532059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671968|NCT05532059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64671969|NCT03809234|Ondansetron|ondansetron|mesh-list
64671970|NCT03809234|Antiemetics|antiemetics|mesh-ancestor
64671971|NCT03809234|Autonomic Agents|autonomic agents|mesh-ancestor
64671972|NCT03809234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65399329|NCT04508790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64396432|NCT04439773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785204|NCT03301038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785205|NCT03301038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64785206|NCT03301038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64785207|NCT03301038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64785208|NCT03301038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64785209|NCT03301038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64396433|NCT04439773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64396434|NCT04439773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64396435|NCT04439773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64396436|NCT04439773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65399330|NCT04508790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399331|NCT04508790|Protease Inhibitors|protease inhibitors|mesh-ancestor
65399332|NCT04508790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399333|NCT04508790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399334|NCT04508790|Immunologic Factors|immunologic factors|mesh-ancestor
65399335|NCT04508790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65399336|NCT04508790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65399337|NCT04508790|Growth Substances|growth substances|mesh-ancestor
65399338|NCT04508790|Growth Inhibitors|growth inhibitors|mesh-ancestor
65399339|NCT04508790|Dermatologic Agents|dermatologic agents|mesh-ancestor
65399340|NCT04508790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65399341|NCT04005222|Selenium|selenium|mesh-list
65399342|NCT04005222|Melatonin|melatonin|mesh-list
65399343|NCT04005222|Antioxidants|antioxidants|mesh-ancestor
65399352|NCT00098839|Leucovorin|leucovorin|mesh-list
64785210|NCT03301038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64785211|NCT02411526|Risperidone|risperidone|mesh-list
64785212|NCT02411526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64785213|NCT02411526|Serotonin Agents|serotonin agents|mesh-ancestor
64785214|NCT02411526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64785215|NCT02411526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785216|NCT02411526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785217|NCT02411526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64785218|NCT02411526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64785219|NCT02411526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64396437|NCT04439773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396438|NCT02389231|Interleukin-2|interleukin-2|mesh-list
65399360|NCT00098839|Doxorubicin|doxorubicin|mesh-list
65399361|NCT00098839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65399362|NCT00098839|Methotrexate|methotrexate|mesh-list
65399363|NCT00098839|Etoposide|etoposide|mesh-list
65399364|NCT00098839|Vincristine|vincristine|mesh-list
65399365|NCT00098839|Etoposide phosphate|etoposide phosphate|mesh-list
65399366|NCT00098839|Asparaginase|asparaginase|mesh-list
65399367|NCT00098839|Pegaspargase|pegaspargase|mesh-list
65399368|NCT00098839|Epratuzumab|epratuzumab|mesh-list
65399369|NCT00098839|Dexrazoxane|dexrazoxane|mesh-list
65399370|NCT00098839|Razoxane|razoxane|mesh-list
65399371|NCT00098839|Levoleucovorin|levoleucovorin|mesh-list
65399372|NCT00098839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65399373|NCT00098839|Immunologic Factors|immunologic factors|mesh-ancestor
65399374|NCT00098839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399375|NCT00098839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65399376|NCT00098839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65399377|NCT00098839|Alkylating Agents|alkylating agents|mesh-ancestor
65399379|NCT00098839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64785220|NCT02411526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64785221|NCT02411526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64785222|NCT02411526|Dopamine Agents|dopamine agents|mesh-ancestor
64785223|NCT00564876|Dasatinib|dasatinib|mesh-list
64785224|NCT00564876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64785225|NCT00564876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64785226|NCT00564876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785227|NCT00564876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785228|NCT00558870|Morphine|morphine|mesh-list
64785229|NCT00558870|Methadone|methadone|mesh-list
64785230|NCT00558870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64785231|NCT00558870|Narcotics|narcotics|mesh-ancestor
64396444|NCT02389231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396445|NCT02383927|Tipifarnib|tipifarnib|mesh-list
64396446|NCT02383927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396447|NCT02383771|Aspirin|aspirin|mesh-list
65399393|NCT00098839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65399394|NCT00098839|Antimetabolites|antimetabolites|mesh-ancestor
65399395|NCT00098839|Dermatologic Agents|dermatologic agents|mesh-ancestor
65399396|NCT00098839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65399397|NCT00098839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65399398|NCT00098839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64785232|NCT00558870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64785233|NCT00558870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785234|NCT00558870|Analgesics|analgesics|mesh-ancestor
64785235|NCT00558870|Sensory System Agents|sensory system agents|mesh-ancestor
64785236|NCT00558870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785237|NCT00558870|Antitussive Agents|antitussive agents|mesh-ancestor
64785238|NCT00558870|Respiratory System Agents|respiratory system agents|mesh-ancestor
65399431|NCT01085383|Antidepressive Agents|antidepressive agents|mesh-ancestor
65399432|NCT01085383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65399433|NCT01085383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65399434|NCT01085383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65399435|NCT01085383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65399436|NCT01085383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399437|NCT01085383|Dopamine Agonists|dopamine agonists|mesh-ancestor
65399438|NCT01085383|Dopamine Agents|dopamine agents|mesh-ancestor
65399439|NCT01085383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65399440|NCT01085383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399441|NCT01085383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65399442|NCT01085383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65399443|NCT01085383|Serotonin Agents|serotonin agents|mesh-ancestor
65399444|NCT01085383|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65399445|NCT01085383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65399446|NCT01085383|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65399447|NCT01085383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65399448|NCT00485589|Methotrexate|methotrexate|mesh-list
65399449|NCT00485589|Ocrelizumab|ocrelizumab|mesh-list
65399450|NCT00485589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65399451|NCT00485589|Abortifacient Agents|abortifacient agents|mesh-ancestor
65399452|NCT00485589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65399453|NCT00485589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399454|NCT00485589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65399455|NCT00485589|Antimetabolites|antimetabolites|mesh-ancestor
65399456|NCT00485589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671973|NCT03809234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671974|NCT03809234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64671975|NCT03809234|Antipruritics|antipruritics|mesh-ancestor
64671976|NCT03809234|Dermatologic Agents|dermatologic agents|mesh-ancestor
64671977|NCT03809234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64785241|NCT00548886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64785242|NCT00548886|Adrenergic Agents|adrenergic agents|mesh-ancestor
64785243|NCT00548886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64785244|NCT00548886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785245|NCT00548886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785246|NCT00548886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64785247|NCT00548886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64785248|NCT00548886|Autonomic Agents|autonomic agents|mesh-ancestor
64396463|NCT02383771|Antipyretics|antipyretics|mesh-ancestor
64396464|NCT02383771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64396465|NCT02383771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64396466|NCT02383771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64396467|NCT02383771|Purinergic Agents|purinergic agents|mesh-ancestor
64396468|NCT02383771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64396469|NCT02378623|Apixaban|apixaban|mesh-list
64396470|NCT02378623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65399457|NCT00485589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399458|NCT00485589|Dermatologic Agents|dermatologic agents|mesh-ancestor
65399459|NCT00485589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399460|NCT00485589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65399461|NCT00485589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64553830|NCT01720485|Cholinergic Agents|cholinergic agents|mesh-ancestor
64785249|NCT00548886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785250|NCT00548886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64785251|NCT00548886|Respiratory System Agents|respiratory system agents|mesh-ancestor
64785252|NCT00548886|Mydriatics|mydriatics|mesh-ancestor
64785253|NCT00548886|Sympathomimetics|sympathomimetics|mesh-ancestor
64785254|NCT00548886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64785255|NCT00538980|Dasatinib|dasatinib|mesh-list
64785256|NCT00538980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396471|NCT02378623|Antithrombins|antithrombins|mesh-ancestor
64396472|NCT02378623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64396473|NCT02378623|Protease Inhibitors|protease inhibitors|mesh-ancestor
65399494|NCT04286295|Cholinergic Agents|cholinergic agents|mesh-ancestor
65399495|NCT04286295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65399496|NCT04286295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399497|NCT00750347|Acetaminophen|acetaminophen|mesh-list
65399498|NCT00750347|Rimonabant|rimonabant|mesh-list
65399499|NCT00750347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65399500|NCT00750347|Analgesics|analgesics|mesh-ancestor
65399501|NCT00750347|Sensory System Agents|sensory system agents|mesh-ancestor
65399502|NCT00750347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65399503|NCT00750347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399504|NCT00750347|Antipyretics|antipyretics|mesh-ancestor
65399505|NCT00750347|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65399506|NCT00750347|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65399507|NCT00750347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65399508|NCT00750347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65399509|NCT00750347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399510|NCT00750347|Hormones|hormones|mesh-ancestor
65399511|NCT00750347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65399512|NCT00750425|Cediranib|cediranib|mesh-list
65399513|NCT00750425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399514|NCT00750425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65399515|NCT00750425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399516|NCT00750425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399517|NCT00745589|Sevelamer|sevelamer|mesh-list
65399520|NCT00745589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785257|NCT00538980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64785258|NCT00538980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785259|NCT00538980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785260|NCT00519090|Imatinib Mesylate|imatinib mesylate|mesh-list
64785261|NCT00519090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64785262|NCT00519090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64785263|NCT00519090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785264|NCT00519090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785265|NCT00506064|Melatonin|melatonin|mesh-list
64785266|NCT00506064|Antioxidants|antioxidants|mesh-ancestor
64396479|NCT02372149|Antibodies|antibodies|mesh-list
65399521|NCT00750581|Indomethacin|indomethacin|mesh-list
65399522|NCT00750581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65399523|NCT00750581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65399524|NCT00750581|Analgesics|analgesics|mesh-ancestor
65399525|NCT00750581|Sensory System Agents|sensory system agents|mesh-ancestor
65399526|NCT00750581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65399527|NCT00750581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399528|NCT00750581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65399529|NCT00750581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65399530|NCT00750581|Gout Suppressants|gout suppressants|mesh-ancestor
65399531|NCT00750581|Tocolytic Agents|tocolytic agents|mesh-ancestor
65399532|NCT00750581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65399533|NCT00750581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65399534|NCT00750581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399535|NCT00750581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149107|NCT02867917|Cathartics|cathartics|mesh-ancestor
65399537|NCT00685763|Capecitabine|capecitabine|mesh-list
65399538|NCT00685763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65399539|NCT00685763|Antimetabolites|antimetabolites|mesh-ancestor
65399540|NCT00685763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785267|NCT00506064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785268|NCT00506064|Protective Agents|protective agents|mesh-ancestor
64785269|NCT00506064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785270|NCT00506064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64785271|NCT00503880|Cytarabine|cytarabine|mesh-list
64785272|NCT00503880|Clofarabine|clofarabine|mesh-list
64785273|NCT00503880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64785274|NCT00503880|Antimetabolites|antimetabolites|mesh-ancestor
64785275|NCT00503880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785276|NCT00503880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396489|NCT02661061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396490|NCT02661061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65399550|NCT00098293|Efavirenz|efavirenz|mesh-list
65399551|NCT00098293|Maraviroc|maraviroc|mesh-list
65399552|NCT00098293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65399553|NCT00098293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65399554|NCT00098293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399555|NCT00098293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399556|NCT00098293|Antiviral Agents|antiviral agents|mesh-ancestor
65399557|NCT00098293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65399558|NCT00098293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65399559|NCT00098293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65399560|NCT00098293|Antimetabolites|antimetabolites|mesh-ancestor
65399561|NCT00098293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65399562|NCT00098293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65399563|NCT00098293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64785277|NCT00503880|Antiviral Agents|antiviral agents|mesh-ancestor
65399583|NCT01087567|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65399584|NCT01087567|Metformin|metformin|mesh-list
65399585|NCT01087567|Pioglitazone|pioglitazone|mesh-list
65399586|NCT01087567|Glimepiride|glimepiride|mesh-list
65399587|NCT01087567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65399588|NCT01087567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399589|NCT01087567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65399590|NCT01087567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65399591|NCT01087567|Immunologic Factors|immunologic factors|mesh-ancestor
65399592|NCT00751049|Timolol|timolol|mesh-list
65399593|NCT00751049|Latanoprost|latanoprost|mesh-list
65399594|NCT00751049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65399595|NCT00751049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65399596|NCT00751049|Adrenergic Agents|adrenergic agents|mesh-ancestor
65399597|NCT00751049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65399598|NCT00751049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399599|NCT00751049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399600|NCT00751049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65399601|NCT00751049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65399602|NCT00751049|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65399603|NCT00751049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65399604|NCT00500331|Pioglitazone|pioglitazone|mesh-list
65399605|NCT00500331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65399606|NCT00500331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399607|NCT01019109|Cobalt|cobalt|mesh-list
65399608|NCT01019109|Trace Elements|trace elements|mesh-ancestor
64671978|NCT03809234|Serotonin Agents|serotonin agents|mesh-ancestor
64671979|NCT03809234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671980|NCT03809234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671981|NCT03809234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64671982|NCT03809234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64671983|NCT03809234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64671984|NCT03809234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64671985|NCT03809234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64671986|NCT03711188|Nivolumab|nivolumab|mesh-list
64671987|NCT03711188|Ipilimumab|ipilimumab|mesh-list
64671988|NCT03711188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64671991|NCT03711188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671993|NCT02366663|Rituximab|rituximab|mesh-list
64671997|NCT02366663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64671998|NCT02366663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671999|NCT02366663|Immunologic Factors|immunologic factors|mesh-ancestor
64672000|NCT02366663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672001|NCT02366663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64672002|NCT02366663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64672003|NCT02366663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64672004|NCT02366663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64672005|NCT02366663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64672006|NCT02366663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785289|NCT00442260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64785290|NCT00145704|Vitamin D|vitamin d|mesh-list
64785291|NCT00145704|Ergocalciferols|ergocalciferols|mesh-list
64785292|NCT00145704|Cholecalciferol|cholecalciferol|mesh-list
64785293|NCT00145704|Risedronic Acid|risedronic acid|mesh-list
65399609|NCT01019109|Micronutrients|micronutrients|mesh-ancestor
65399610|NCT01019109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399611|NCT00499863|Methylphenidate|methylphenidate|mesh-list
65149187|NCT00986245|Ropinirole|ropinirole|mesh-list
65399612|NCT00499863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65399613|NCT00499863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399614|NCT00499863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65399615|NCT00499863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65399616|NCT00499863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65399617|NCT00499863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399618|NCT00499863|Dopamine Agents|dopamine agents|mesh-ancestor
65399619|NCT00499863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65399620|NCT04475835|Heparin|heparin|mesh-list
65399621|NCT04475835|Bivalirudin|bivalirudin|mesh-list
65399622|NCT04475835|Anticoagulants|anticoagulants|mesh-ancestor
65399623|NCT04475835|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65399624|NCT04475835|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65399625|NCT04475835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399626|NCT04475835|Antithrombins|antithrombins|mesh-ancestor
65399627|NCT04475835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65399628|NCT04475835|Protease Inhibitors|protease inhibitors|mesh-ancestor
65399629|NCT04475835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399630|NCT01014507|Goserelin|goserelin|mesh-list
65399631|NCT01014507|Contraceptive Agents|contraceptive agents|mesh-list
64785295|NCT00145704|Vitamins|vitamins|mesh-list
64672007|NCT02366663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64672008|NCT02366663|Antimetabolites|antimetabolites|mesh-ancestor
64672009|NCT02366663|Antiviral Agents|antiviral agents|mesh-ancestor
64672010|NCT02366663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64672011|NCT02366663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64672012|NCT02366663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64672013|NCT02366663|Alkylating Agents|alkylating agents|mesh-ancestor
64672014|NCT02366663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64672015|NCT01754480|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64672016|NCT01754480|Hemostatics|hemostatics|mesh-ancestor
64672017|NCT01754480|Coagulants|coagulants|mesh-ancestor
64672018|NCT02367599|Vitamin D|vitamin d|mesh-list
64672019|NCT02367599|Vitamins|vitamins|mesh-ancestor
64672020|NCT02367599|Micronutrients|micronutrients|mesh-ancestor
64556995|NCT05583149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556996|NCT05583149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64556998|NCT04366869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64556999|NCT04366869|Antifungal Agents|antifungal agents|mesh-ancestor
65399632|NCT01014507|Contraceptives, Oral|contraceptives, oral|mesh-list
65399633|NCT01014507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65399634|NCT01014507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399635|NCT01014507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65399636|NCT01014507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399637|NCT01014507|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65399638|NCT00097981|Thalidomide|thalidomide|mesh-list
65399639|NCT00097981|Dexamethasone|dexamethasone|mesh-list
65399640|NCT00097981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65399641|NCT00097981|Antiemetics|antiemetics|mesh-ancestor
65399642|NCT00097981|Autonomic Agents|autonomic agents|mesh-ancestor
65399643|NCT00097981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65399644|NCT00097981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399645|NCT00097981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65399646|NCT00097981|Glucocorticoids|glucocorticoids|mesh-ancestor
65399647|NCT00097981|Hormones|hormones|mesh-ancestor
65399648|NCT00097981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65399649|NCT00097981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65399650|NCT00097981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399651|NCT00097981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65399652|NCT00097981|Immunologic Factors|immunologic factors|mesh-ancestor
65399653|NCT00097981|Leprostatic Agents|leprostatic agents|mesh-ancestor
65399654|NCT00097981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65399655|NCT00097981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65399656|NCT00097981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65399657|NCT00097981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65399658|NCT00097981|Growth Substances|growth substances|mesh-ancestor
65399659|NCT00097981|Growth Inhibitors|growth inhibitors|mesh-ancestor
65399660|NCT01016145|Antipsychotic Agents|antipsychotic agents|mesh-list
65399661|NCT01016145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65399662|NCT01016145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64557000|NCT04366869|Keratolytic Agents|keratolytic agents|mesh-ancestor
64557001|NCT04366869|Dermatologic Agents|dermatologic agents|mesh-ancestor
64557003|NCT04989270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64557004|NCT04989270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557006|NCT05583071|Methotrexate|methotrexate|mesh-list
64557007|NCT05583071|Lenalidomide|lenalidomide|mesh-list
64557008|NCT05583071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64557009|NCT05583071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557010|NCT05583071|Immunologic Factors|immunologic factors|mesh-ancestor
64557011|NCT05583071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557012|NCT05583071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64557013|NCT05583071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64785316|NCT00090870|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64785317|NCT00090870|Thalidomide|thalidomide|mesh-list
64785318|NCT00090870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64785319|NCT00090870|Antiviral Agents|antiviral agents|mesh-ancestor
64785320|NCT00090870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64785321|NCT00090870|Immunologic Factors|immunologic factors|mesh-ancestor
64785322|NCT00090870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785323|NCT00090870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64785324|NCT00090870|Leprostatic Agents|leprostatic agents|mesh-ancestor
65399663|NCT01016145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65399664|NCT01016145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396534|NCT02371603|Antimalarials|antimalarials|mesh-ancestor
64396535|NCT02371603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64396536|NCT02371603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64396537|NCT02371603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64396538|NCT02371603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64396539|NCT02371603|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64396540|NCT02371603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64396541|NCT04230109|Pembrolizumab|pembrolizumab|mesh-list
65399704|NCT01085617|Alkylating Agents|alkylating agents|mesh-ancestor
65399705|NCT01085617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399706|NCT01085617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399707|NCT01085617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65399708|NCT01085617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65399709|NCT01085617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65399710|NCT01085617|Abortifacient Agents|abortifacient agents|mesh-ancestor
65399711|NCT01085617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65399712|NCT01085617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65399713|NCT01085617|Antimetabolites|antimetabolites|mesh-ancestor
65399714|NCT01085617|Dermatologic Agents|dermatologic agents|mesh-ancestor
65399715|NCT01085617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399716|NCT01085617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65399717|NCT01085617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65399718|NCT01085617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65399719|NCT01085617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64672021|NCT02367599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672022|NCT02367599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64672023|NCT02368457|Tocopherols|tocopherols|mesh-list
64672024|NCT02368457|Vitamin E|vitamin e|mesh-list
64672025|NCT02368457|Tocotrienols|tocotrienols|mesh-list
64672026|NCT02368457|alpha-Tocopherol|alpha-tocopherol|mesh-list
64672027|NCT02368457|Pentoxifylline|pentoxifylline|mesh-list
64672028|NCT02368457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64672029|NCT02368457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64672030|NCT02368457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672031|NCT02368457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64672032|NCT02368457|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64672033|NCT02368457|Protective Agents|protective agents|mesh-ancestor
64672034|NCT02368457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672035|NCT02368457|Vasodilator Agents|vasodilator agents|mesh-ancestor
64672036|NCT02368457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64672037|NCT02368457|Antioxidants|antioxidants|mesh-ancestor
64672038|NCT02368457|Vitamins|vitamins|mesh-ancestor
64672039|NCT02368457|Micronutrients|micronutrients|mesh-ancestor
64672040|NCT02371187|Dapagliflozin|dapagliflozin|mesh-list
64672041|NCT02371187|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64672042|NCT02371187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672043|NCT02371187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64672044|NCT02371187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672045|NCT02373137|Ofloxacin|ofloxacin|mesh-list
64672046|NCT02373137|Prednisolone|prednisolone|mesh-list
64672047|NCT02373137|Phenylephrine|phenylephrine|mesh-list
64672048|NCT02373137|Oxymetazoline|oxymetazoline|mesh-list
64672049|NCT02373137|Tropicamide|tropicamide|mesh-list
64672050|NCT02373137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64672051|NCT02373137|Glucocorticoids|glucocorticoids|mesh-ancestor
64672052|NCT02373137|Hormones|hormones|mesh-ancestor
64672073|NCT02373137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64672075|NCT02373137|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64672076|NCT02373137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64672077|NCT02373137|Renal Agents|renal agents|mesh-ancestor
64672078|NCT02373137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64672079|NCT02373137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64672080|NCT02373137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64672081|NCT02373137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64672082|NCT02373137|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64557014|NCT05583071|Abortifacient Agents|abortifacient agents|mesh-ancestor
64785336|NCT00074724|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64785337|NCT00074724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64785338|NCT00074724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64785339|NCT00074724|Adrenergic Agents|adrenergic agents|mesh-ancestor
64785340|NCT00074724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64785341|NCT00074724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785342|NCT00074724|Protective Agents|protective agents|mesh-ancestor
64785343|NCT00058188|Cholecalciferol|cholecalciferol|mesh-list
64785344|NCT00058188|Vitamin D|vitamin d|mesh-list
64785345|NCT00058188|Zoledronic Acid|zoledronic acid|mesh-list
64785346|NCT00058188|Calcium|calcium|mesh-list
64785347|NCT00058188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65399720|NCT01085617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65399721|NCT01085617|Antiviral Agents|antiviral agents|mesh-ancestor
65399722|NCT01085617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65399723|NCT01085617|Tubulin Modulators|tubulin modulators|mesh-ancestor
65399724|NCT01085617|Antimitotic Agents|antimitotic agents|mesh-ancestor
65399725|NCT01085617|Mitosis Modulators|mitosis modulators|mesh-ancestor
65399726|NCT01085617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65399727|NCT01085617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65399728|NCT00499083|Tamoxifen|tamoxifen|mesh-list
65399729|NCT00499083|Paclitaxel|paclitaxel|mesh-list
65399730|NCT00499083|Cyclophosphamide|cyclophosphamide|mesh-list
65399731|NCT00499083|Doxorubicin|doxorubicin|mesh-list
64785349|NCT00058188|Vitamins|vitamins|mesh-ancestor
65399759|NCT01087879|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65399760|NCT01087879|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65399761|NCT01087879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65399762|NCT01087879|Etonogestrel|etonogestrel|mesh-list
65399763|NCT01087879|Desogestrel|desogestrel|mesh-list
65399764|NCT01087879|NuvaRing|nuvaring|mesh-list
65399765|NCT01087879|Norelgestromin|norelgestromin|mesh-list
65399766|NCT01087879|Contraceptive Agents|contraceptive agents|mesh-list
65399767|NCT01087879|Estradiol|estradiol|mesh-list
65399768|NCT01087879|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65399769|NCT01087879|Estrogens|estrogens|mesh-ancestor
65399770|NCT01087879|Hormones|hormones|mesh-ancestor
65399771|NCT01087879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65399772|NCT01087879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399773|NCT01087879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65399774|NCT01087879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65399775|NCT01087879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65399776|NCT01087879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65399777|NCT01087879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65399778|NCT01087879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65399779|NCT01087879|Progestins|progestins|mesh-ancestor
65399780|NCT01085695|Rabeprazole|rabeprazole|mesh-list
65399781|NCT01085695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65399782|NCT01085695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65399783|NCT01085695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64557015|NCT05583071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64557016|NCT05583071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64557017|NCT05583071|Antimetabolites|antimetabolites|mesh-ancestor
64557018|NCT05583071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557019|NCT05583071|Dermatologic Agents|dermatologic agents|mesh-ancestor
64557020|NCT05583071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557021|NCT05583071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64557022|NCT05583071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64557023|NCT05583071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64557024|NCT05583071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64557025|NCT05583071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64557026|NCT05583071|Growth Substances|growth substances|mesh-ancestor
64557027|NCT05583071|Growth Inhibitors|growth inhibitors|mesh-ancestor
64557028|NCT04989348|Hormones|hormones|mesh-list
64557029|NCT04989348|Progestins|progestins|mesh-list
64557030|NCT04989348|Hormone Antagonists|hormone antagonists|mesh-list
64557031|NCT04989348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64322067|NCT02396043|Immunologic Factors|immunologic factors|mesh-ancestor
64672083|NCT02373137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64672084|NCT05488067|Atorvastatin|atorvastatin|mesh-list
64672085|NCT05488067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64672086|NCT05488067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64672087|NCT05488067|Antimetabolites|antimetabolites|mesh-ancestor
64672088|NCT05488067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672089|NCT05488067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64785360|NCT00003726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64785361|NCT02595996|Propranolol|propranolol|mesh-list
65399784|NCT01085695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785362|NCT02595996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64785363|NCT02595996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64785364|NCT02595996|Adrenergic Agents|adrenergic agents|mesh-ancestor
64785365|NCT02595996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64785366|NCT02595996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785367|NCT02595996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785368|NCT02595996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64785369|NCT02595996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64396574|NCT02376049|Clobetasol|clobetasol|mesh-list
64396575|NCT02376049|Pimecrolimus|pimecrolimus|mesh-list
64396576|NCT02376049|Emollients|emollients|mesh-list
64396577|NCT02376049|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64396578|NCT02376049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64396579|NCT02376049|Glucocorticoids|glucocorticoids|mesh-ancestor
64396580|NCT02376049|Hormones|hormones|mesh-ancestor
64396581|NCT02376049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65399786|NCT01088035|Carboplatin|carboplatin|mesh-list
65399822|NCT00751205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65399823|NCT00751205|Glucocorticoids|glucocorticoids|mesh-ancestor
65399824|NCT00751205|Hormones|hormones|mesh-ancestor
65399825|NCT00751205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65399826|NCT00751205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399827|NCT00751205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65399828|NCT00751205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399829|NCT00751205|Antiemetics|antiemetics|mesh-ancestor
65399830|NCT00751205|Autonomic Agents|autonomic agents|mesh-ancestor
65399831|NCT00751205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65399832|NCT00751205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65399833|NCT00751205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65399834|NCT00751205|Protective Agents|protective agents|mesh-ancestor
65399835|NCT00751205|Vitamin B Complex|vitamin b complex|mesh-ancestor
65399836|NCT00751205|Vitamins|vitamins|mesh-ancestor
65399837|NCT00751205|Micronutrients|micronutrients|mesh-ancestor
65399838|NCT00751205|Nootropic Agents|nootropic agents|mesh-ancestor
65399839|NCT00751205|Tubulin Modulators|tubulin modulators|mesh-ancestor
64672090|NCT05488067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64672091|NCT05488067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64672092|NCT02373371|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
64672093|NCT02373371|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64672094|NCT02373371|Dermatologic Agents|dermatologic agents|mesh-ancestor
64672095|NCT00354653|Lamivudine|lamivudine|mesh-list
64672096|NCT00354653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64672097|NCT00354653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64672098|NCT00354653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64672099|NCT00354653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672100|NCT00354653|Antiviral Agents|antiviral agents|mesh-ancestor
64672101|NCT00354653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64672102|NCT00354653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64672103|NCT00354653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64672104|NCT00354731|Pentoxifylline|pentoxifylline|mesh-list
64672118|NCT00354809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64672119|NCT00354809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672120|NCT00354809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64672121|NCT00354809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64672122|NCT00354809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64672123|NCT00354809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672124|NCT04769258|Vaccines|vaccines|mesh-list
64672125|NCT04769258|Immunologic Factors|immunologic factors|mesh-ancestor
64672126|NCT04769258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672127|NCT01762904|Ethanol|ethanol|mesh-list
64672128|NCT01762904|Chlorhexidine|chlorhexidine|mesh-list
64672129|NCT01762904|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64672130|NCT01762904|Triclosan|triclosan|mesh-list
64557032|NCT04989348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557033|NCT05582993|Factor VIII|factor viii|mesh-list
64557034|NCT05582993|Coagulants|coagulants|mesh-ancestor
64557035|NCT04346823|Sevoflurane|sevoflurane|mesh-list
64557036|NCT04346823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64557037|NCT04346823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64557038|NCT04346823|Anesthetics, General|anesthetics, general|mesh-ancestor
64557039|NCT04346823|Anesthetics|anesthetics|mesh-ancestor
64557040|NCT04346823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64557041|NCT04346823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557042|NCT05582837|Topiramate|topiramate|mesh-list
64672131|NCT01762904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
64785384|NCT00000132|Autonomic Agents|autonomic agents|mesh-ancestor
64785385|NCT00000132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785386|NCT00000132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785387|NCT00000132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64785388|NCT00000132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64785389|NCT00000132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65399840|NCT00751205|Antimitotic Agents|antimitotic agents|mesh-ancestor
65399841|NCT00751205|Mitosis Modulators|mitosis modulators|mesh-ancestor
65399842|NCT00751205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399843|NCT00752063|Capecitabine|capecitabine|mesh-list
65399844|NCT00752063|Oxaliplatin|oxaliplatin|mesh-list
65399845|NCT00752063|Sorafenib|sorafenib|mesh-list
65399846|NCT00752063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65399847|NCT00752063|Antimetabolites|antimetabolites|mesh-ancestor
65399848|NCT00752063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399849|NCT00752063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399850|NCT00752063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65399851|NCT00752063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399852|NCT00752141|Mandelic Acids|mandelic acids|mesh-list
65399853|NCT00752141|Oxybutynin|oxybutynin|mesh-list
65399854|NCT00752141|Parasympatholytics|parasympatholytics|mesh-ancestor
65399855|NCT00752141|Autonomic Agents|autonomic agents|mesh-ancestor
65399856|NCT00752141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65399857|NCT00752141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399858|NCT00752141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65399859|NCT00752141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65399860|NCT00752141|Cholinergic Agents|cholinergic agents|mesh-ancestor
65399861|NCT00752141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65399862|NCT00752141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399863|NCT00752141|Urological Agents|urological agents|mesh-ancestor
65399864|NCT00752141|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65399865|NCT00752141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65399866|NCT00752141|Renal Agents|renal agents|mesh-ancestor
65399867|NCT00752375|Trimethoprim|trimethoprim|mesh-list
65399868|NCT00752375|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65399869|NCT00752375|Sulfamethoxazole|sulfamethoxazole|mesh-list
64785397|NCT00000138|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64785398|NCT00000138|Prednisolone acetate|prednisolone acetate|mesh-list
64785399|NCT00000138|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64785400|NCT00000138|Prednisolone phosphate|prednisolone phosphate|mesh-list
64785401|NCT00000138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65399871|NCT00752375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65399872|NCT00752375|Renal Agents|renal agents|mesh-ancestor
65399873|NCT00752375|Antimalarials|antimalarials|mesh-ancestor
65399874|NCT00752375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65399875|NCT00752375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65399876|NCT00752375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65399877|NCT00752375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399878|NCT00752375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399879|NCT00752375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65399880|NCT00752375|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65399881|NCT00752375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65399882|NCT00752375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65399883|NCT00751517|Cyclophosphamide|cyclophosphamide|mesh-list
65399884|NCT00751517|Methotrexate|methotrexate|mesh-list
65399885|NCT00751517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65399886|NCT00751517|Immunologic Factors|immunologic factors|mesh-ancestor
65399887|NCT00751517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399888|NCT00751517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65399889|NCT00751517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65399890|NCT00751517|Alkylating Agents|alkylating agents|mesh-ancestor
65399891|NCT00751517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399892|NCT00751517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399893|NCT00751517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65399894|NCT00751517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65399895|NCT00751517|Abortifacient Agents|abortifacient agents|mesh-ancestor
65399896|NCT00751517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65399897|NCT00751517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65399898|NCT00751517|Antimetabolites|antimetabolites|mesh-ancestor
65399899|NCT00751517|Dermatologic Agents|dermatologic agents|mesh-ancestor
65399900|NCT00751517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399901|NCT00751517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65399902|NCT00751517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65399903|NCT02561117|Metronidazole|metronidazole|mesh-list
65399904|NCT02561117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65399905|NCT02561117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65399906|NCT02561117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65399907|NCT02561117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65399908|NCT00684515|Aspirin|aspirin|mesh-list
65399909|NCT00684515|Vorapaxar|vorapaxar|mesh-list
65399910|NCT00684515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65399911|NCT00684515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65399912|NCT00684515|Analgesics|analgesics|mesh-ancestor
65399913|NCT00684515|Sensory System Agents|sensory system agents|mesh-ancestor
65399914|NCT00684515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65399915|NCT00684515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399916|NCT00684515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65399917|NCT00684515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65399918|NCT00684515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65399919|NCT00684515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65399920|NCT00684515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399921|NCT00684515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65399922|NCT00684515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65399923|NCT00684515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399924|NCT00684515|Antipyretics|antipyretics|mesh-ancestor
65399925|NCT00751751|Losartan|losartan|mesh-list
65399926|NCT00751751|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65399927|NCT00751751|Olmesartan|olmesartan|mesh-list
65399928|NCT00751751|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65399929|NCT00751751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65399930|NCT00751751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64672132|NCT01762904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64672133|NCT01762904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64672134|NCT01762904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672135|NCT01762904|Disinfectants|disinfectants|mesh-ancestor
64672136|NCT01762904|Dermatologic Agents|dermatologic agents|mesh-ancestor
64672137|NCT01762904|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64672138|NCT01762904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64672139|NCT01762904|Antimetabolites|antimetabolites|mesh-ancestor
64672140|NCT01762904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672141|NCT01762904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64672142|NCT02376257|Cycloserine|cycloserine|mesh-list
64672143|NCT02376257|Modafinil|modafinil|mesh-list
64672144|NCT02376257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64672145|NCT02376257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672146|NCT02376257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64672147|NCT02376257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64672148|NCT02376257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65399931|NCT00751751|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65399932|NCT00751751|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65399933|NCT00751751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399934|NCT00751751|Diuretics|diuretics|mesh-ancestor
65399935|NCT00751751|Natriuretic Agents|natriuretic agents|mesh-ancestor
65399936|NCT00751751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399937|NCT00751751|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65399938|NCT00751751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65399939|NCT00490815|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
65399940|NCT00490815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65399941|NCT00490815|Glucocorticoids|glucocorticoids|mesh-ancestor
65399942|NCT00490815|Hormones|hormones|mesh-ancestor
65399943|NCT00490815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65399944|NCT00490815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399945|NCT04453137|Adalimumab|adalimumab|mesh-list
65399946|NCT04453137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65399947|NCT04453137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65399948|NCT03855189|Mometasone Furoate|mometasone furoate|mesh-list
65399949|NCT03855189|Beclomethasone|beclomethasone|mesh-list
65399950|NCT03855189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65399951|NCT03855189|Dermatologic Agents|dermatologic agents|mesh-ancestor
65399952|NCT03855189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65399953|NCT03855189|Glucocorticoids|glucocorticoids|mesh-ancestor
65399954|NCT03855189|Hormones|hormones|mesh-ancestor
65399955|NCT03855189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65399956|NCT03855189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399957|NCT03855189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65399958|NCT03855189|Respiratory System Agents|respiratory system agents|mesh-ancestor
65399959|NCT03853551|Osimertinib|osimertinib|mesh-list
64785432|NCT00000192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64672149|NCT02376257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672150|NCT02376257|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64672151|NCT02376257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64672152|NCT02376257|Renal Agents|renal agents|mesh-ancestor
64672153|NCT02376257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64672154|NCT02376257|Antitubercular Agents|antitubercular agents|mesh-ancestor
64672155|NCT02376257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64672156|NCT02376257|Antimetabolites|antimetabolites|mesh-ancestor
64672157|NCT01762982|Benzalkonium Compounds|benzalkonium compounds|mesh-list
64672158|NCT01762982|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64672159|NCT01762982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64672160|NCT03211286|Tranexamic Acid|tranexamic acid|mesh-list
64672162|NCT03211286|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65399960|NCT03853551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65399961|NCT03853551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65399962|NCT03853551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65399963|NCT03853551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399964|NCT00423670|Ribavirin|ribavirin|mesh-list
65399965|NCT00423670|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65399966|NCT00423670|Antimetabolites|antimetabolites|mesh-ancestor
65399967|NCT00423670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65399968|NCT00423670|Antiviral Agents|antiviral agents|mesh-ancestor
65399969|NCT00423670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64785448|NCT00000204|Sensory System Agents|sensory system agents|mesh-ancestor
64785449|NCT00000204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785450|NCT00000204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64785451|NCT00000210|Buprenorphine|buprenorphine|mesh-list
64785452|NCT00000210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64785453|NCT00000210|Narcotics|narcotics|mesh-ancestor
64785454|NCT00000210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64785455|NCT00000210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785456|NCT00000210|Analgesics|analgesics|mesh-ancestor
64785458|NCT00000210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785459|NCT00000210|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64785460|NCT00000222|Buprenorphine|buprenorphine|mesh-list
64785461|NCT00000222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64785462|NCT00000222|Narcotics|narcotics|mesh-ancestor
64785463|NCT00000222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64785464|NCT00000222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785465|NCT00000222|Analgesics|analgesics|mesh-ancestor
65399998|NCT00406354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65399999|NCT01037842|Mitiglinide|mitiglinide|mesh-list
65400000|NCT01037842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65400001|NCT01037842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400002|NCT00483405|Capecitabine|capecitabine|mesh-list
65400003|NCT00483405|Oxaliplatin|oxaliplatin|mesh-list
65400004|NCT00483405|Cetuximab|cetuximab|mesh-list
65400005|NCT00483405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65400006|NCT00483405|Antimetabolites|antimetabolites|mesh-ancestor
65400007|NCT00483405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400008|NCT00483405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400009|NCT00483405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65400010|NCT00483327|Megestrol|megestrol|mesh-list
65400011|NCT00483327|Megestrol Acetate|megestrol acetate|mesh-list
65400012|NCT00483327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65400013|NCT00483327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65400014|NCT00483327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65400015|NCT00483327|Contraceptive Agents|contraceptive agents|mesh-ancestor
65400016|NCT00483327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65400017|NCT00483327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400018|NCT00483327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65400019|NCT00483327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65400020|NCT00483327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65400021|NCT00483327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400022|NCT00483327|Appetite Stimulants|appetite stimulants|mesh-ancestor
64785471|NCT00000228|Narcotics|narcotics|mesh-ancestor
64785472|NCT00000228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64785473|NCT00000228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785474|NCT00000228|Analgesics|analgesics|mesh-ancestor
64785475|NCT00000228|Sensory System Agents|sensory system agents|mesh-ancestor
64785476|NCT00000228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400031|NCT00684203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400032|NCT00684203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400033|NCT00684203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65400034|NCT00684203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65400035|NCT00684203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65400036|NCT00684203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65400037|NCT00684203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400038|NCT00684203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65400039|NCT00684203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65400040|NCT00684203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400041|NCT00684203|Antipyretics|antipyretics|mesh-ancestor
65400042|NCT00684203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65400043|NCT00684203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65400044|NCT00684203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65400045|NCT00684203|Purinergic Agents|purinergic agents|mesh-ancestor
65400046|NCT00684203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65400047|NCT00751829|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65400048|NCT00751829|Olmesartan|olmesartan|mesh-list
65400049|NCT00751829|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65400050|NCT00751829|Nitrendipine|nitrendipine|mesh-list
65400051|NCT00751829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65400052|NCT00751829|Diuretics|diuretics|mesh-ancestor
65400053|NCT00751829|Natriuretic Agents|natriuretic agents|mesh-ancestor
65400054|NCT00751829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400055|NCT00751829|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65400056|NCT00751829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65400057|NCT00751829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400058|NCT00751829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64785478|NCT00000234|Buprenorphine|buprenorphine|mesh-list
64785484|NCT00000234|Sensory System Agents|sensory system agents|mesh-ancestor
64785485|NCT00000234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785486|NCT00000234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64785487|NCT00000240|Buprenorphine|buprenorphine|mesh-list
64785488|NCT00000240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64785489|NCT00000240|Narcotics|narcotics|mesh-ancestor
64785490|NCT00000240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64785491|NCT00000240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785492|NCT00000240|Analgesics|analgesics|mesh-ancestor
64785493|NCT00000240|Sensory System Agents|sensory system agents|mesh-ancestor
64785494|NCT00000240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785495|NCT00000240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64785497|NCT00000246|Antidotes|antidotes|mesh-ancestor
65400061|NCT00751829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65149637|NCT04290013|Hemostatics|hemostatics|mesh-ancestor
65400062|NCT00751829|Vasodilator Agents|vasodilator agents|mesh-ancestor
65400063|NCT00423592|Ambrisentan|ambrisentan|mesh-list
65400064|NCT00423592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65400065|NCT01037998|Gefitinib|gefitinib|mesh-list
65400066|NCT01037998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400067|NCT01037998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65400068|NCT01037998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400069|NCT01037998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400070|NCT00751907|Atorvastatin|atorvastatin|mesh-list
65400071|NCT00751907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65400072|NCT00751907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65400095|NCT00752921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65400096|NCT00752921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65400097|NCT00752921|Analgesics|analgesics|mesh-ancestor
65400098|NCT00752921|Sensory System Agents|sensory system agents|mesh-ancestor
65400099|NCT00752921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400100|NCT00752921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400101|NCT00752921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65400102|NCT00752921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65400103|NCT00752921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65400104|NCT00752921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65400105|NCT00752921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400106|NCT00752921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400107|NCT00683657|Saxagliptin|saxagliptin|mesh-list
65400108|NCT00683657|Incretins|incretins|mesh-ancestor
65400109|NCT00683657|Hormones|hormones|mesh-ancestor
65400110|NCT00683657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65400111|NCT00683657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400112|NCT00683657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65400113|NCT00683657|Protease Inhibitors|protease inhibitors|mesh-ancestor
65400114|NCT00683657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400115|NCT00683657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400116|NCT00683657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65400117|NCT00755885|Abiraterone Acetate|abiraterone acetate|mesh-list
65400118|NCT00755885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400119|NCT00755885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64672163|NCT03211286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64672164|NCT03211286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672165|NCT03211286|Hemostatics|hemostatics|mesh-ancestor
64672189|NCT05309564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64672190|NCT05309564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672191|NCT05309564|Cholinergic Agents|cholinergic agents|mesh-ancestor
64672192|NCT05309564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64672193|NCT05309564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672194|NCT05309564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64672195|NCT05309564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64397567|NCT05057351|Glycerol|glycerol|mesh-list
64672196|NCT03161756|Denosumab|denosumab|mesh-list
64672197|NCT03161756|Nivolumab|nivolumab|mesh-list
64672198|NCT03161756|Ipilimumab|ipilimumab|mesh-list
64672199|NCT03161756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64672200|NCT03161756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672201|NCT03161756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64557045|NCT05582837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64557046|NCT05582837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557047|NCT05582837|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64672202|NCT03161756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785512|NCT00000264|Anesthetics|anesthetics|mesh-ancestor
64785513|NCT00000264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64785514|NCT00000264|Analgesics|analgesics|mesh-ancestor
64785515|NCT00000264|Sensory System Agents|sensory system agents|mesh-ancestor
64785516|NCT00000264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785517|NCT00000270|Cocaine|cocaine|mesh-list
64785518|NCT00000270|Anesthetics, Local|anesthetics, local|mesh-ancestor
64785519|NCT00000270|Anesthetics|anesthetics|mesh-ancestor
64785520|NCT00000270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65400120|NCT00755885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400121|NCT00755885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400122|NCT00755885|Hormone Antagonists|hormone antagonists|mesh-ancestor
65400123|NCT00755885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65400124|NCT00755885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400125|NCT00755885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65400126|NCT00755963|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65400127|NCT00755963|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65400128|NCT00755963|Estradiol|estradiol|mesh-list
65400129|NCT00755963|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65400130|NCT00755963|Progesterone|progesterone|mesh-list
65400131|NCT00755963|Estrogens|estrogens|mesh-ancestor
65400132|NCT00755963|Hormones|hormones|mesh-ancestor
65400133|NCT00755963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65400134|NCT00755963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400135|NCT00755963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65400136|NCT00755963|Contraceptive Agents|contraceptive agents|mesh-ancestor
65400137|NCT00755963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65400138|NCT00755963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65400139|NCT00755963|Progestins|progestins|mesh-ancestor
65400140|NCT00753311|Rizatriptan|rizatriptan|mesh-list
65400141|NCT00753311|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65400142|NCT00753311|Serotonin Agents|serotonin agents|mesh-ancestor
65400143|NCT00753311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65400144|NCT00753311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400145|NCT00753311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400148|NCT00753389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400149|NCT00753467|Interferons|interferons|mesh-list
65400150|NCT00753467|Adefovir|adefovir|mesh-list
65400151|NCT00753467|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65400152|NCT00753467|Interferon-gamma|interferon-gamma|mesh-list
65400153|NCT00753467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400154|NCT00753467|Antiviral Agents|antiviral agents|mesh-ancestor
65400155|NCT00753467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65400156|NCT00753467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65400157|NCT00753467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65400158|NCT00753467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400159|NCT00753467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400160|NCT00482703|Dasatinib|dasatinib|mesh-list
65400161|NCT00482703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400162|NCT00482703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64672203|NCT03161756|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64672204|NCT03161756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672205|NCT01766024|Interferons|interferons|mesh-list
64672206|NCT01766024|Interferon-beta|interferon-beta|mesh-list
64672207|NCT01766024|Interferon beta-1a|interferon beta-1a|mesh-list
64672208|NCT01766024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672209|NCT01766024|Antiviral Agents|antiviral agents|mesh-ancestor
64672210|NCT01766024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64672211|NCT01766024|Immunologic Factors|immunologic factors|mesh-ancestor
64672212|NCT01766024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672213|NCT01766024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64672214|NCT01767506|Azithromycin|azithromycin|mesh-list
64672215|NCT01767506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64672216|NCT01767506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64672217|NCT02383043|Cocaine|cocaine|mesh-list
64672232|NCT02383043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64672233|NCT02383043|Anesthetics, Local|anesthetics, local|mesh-ancestor
64672241|NCT01768520|Analgesics|analgesics|mesh-ancestor
64672242|NCT01768520|Sensory System Agents|sensory system agents|mesh-ancestor
64672243|NCT01768520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64672244|NCT01768520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672245|NCT01768520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64672246|NCT01768520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64672247|NCT01768520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64672248|NCT01768520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64672249|NCT01768520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64672250|NCT01768520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672251|NCT00355589|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64672252|NCT00355589|Ramipril|ramipril|mesh-list
64672253|NCT00355589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64672254|NCT00355589|Diuretics|diuretics|mesh-ancestor
64672255|NCT00355589|Natriuretic Agents|natriuretic agents|mesh-ancestor
64672256|NCT00355589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672257|NCT00355589|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64672258|NCT00355589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64672259|NCT00355589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672260|NCT00355589|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64672261|NCT00355589|Protease Inhibitors|protease inhibitors|mesh-ancestor
64672262|NCT00355589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64672263|NCT01769222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64672264|NCT01769222|Ipilimumab|ipilimumab|mesh-list
64672265|NCT01769222|Antibodies|antibodies|mesh-list
64672266|NCT01769222|Immunoglobulins|immunoglobulins|mesh-list
64672267|NCT01769222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64672268|NCT01769222|Immunologic Factors|immunologic factors|mesh-ancestor
64672281|NCT02240888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400163|NCT00482703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400164|NCT00482703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400165|NCT04052867|Lidocaine|lidocaine|mesh-list
65400166|NCT04052867|Anesthetics, Local|anesthetics, local|mesh-ancestor
65400167|NCT04052867|Anesthetics|anesthetics|mesh-ancestor
65400168|NCT04052867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65400169|NCT04052867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400170|NCT04052867|Sensory System Agents|sensory system agents|mesh-ancestor
65400171|NCT04052867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400172|NCT04052867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65400173|NCT04052867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65400174|NCT04052867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65400175|NCT04052867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65400176|NCT04052867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400177|NCT00482391|Paclitaxel|paclitaxel|mesh-list
65400178|NCT00482391|Cyclophosphamide|cyclophosphamide|mesh-list
65400179|NCT00482391|Doxorubicin|doxorubicin|mesh-list
65400180|NCT00482391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65400181|NCT00482391|Trastuzumab|trastuzumab|mesh-list
65400182|NCT00482391|Lapatinib|lapatinib|mesh-list
65400183|NCT00482391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65400184|NCT00482391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400185|NCT00482391|Tubulin Modulators|tubulin modulators|mesh-ancestor
65400186|NCT00482391|Antimitotic Agents|antimitotic agents|mesh-ancestor
64672283|NCT02387801|Dermatologic Agents|dermatologic agents|mesh-ancestor
64672284|NCT02259608|BCG Vaccine|bcg vaccine|mesh-list
64672285|NCT02259608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64672286|NCT02259608|Immunologic Factors|immunologic factors|mesh-ancestor
64672287|NCT02259608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672288|NCT02326844|Talazoparib|talazoparib|mesh-list
64672289|NCT02326844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64672290|NCT02326844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64672291|NCT02326844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672292|NCT02326844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672293|NCT02239874|Vitamin D|vitamin d|mesh-list
64672294|NCT02239874|Ergocalciferols|ergocalciferols|mesh-list
64672295|NCT02239874|Cholecalciferol|cholecalciferol|mesh-list
64672296|NCT02239874|Vitamins|vitamins|mesh-list
64672297|NCT02239874|Micronutrients|micronutrients|mesh-ancestor
64672298|NCT02239874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557048|NCT05582837|Antidepressive Agents|antidepressive agents|mesh-ancestor
64557049|NCT05582837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64557050|NCT05582837|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64557051|NCT05582837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64557052|NCT05582837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64557053|NCT05582837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557054|NCT05582837|Adrenergic Agents|adrenergic agents|mesh-ancestor
64672299|NCT02239874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64672300|NCT02239874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64672301|NCT05274269|Ivacaftor|ivacaftor|mesh-list
65400187|NCT00482391|Mitosis Modulators|mitosis modulators|mesh-ancestor
65400188|NCT00482391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400189|NCT00482391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65400190|NCT00482391|Immunologic Factors|immunologic factors|mesh-ancestor
65400191|NCT00482391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400192|NCT00482391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65400193|NCT00482391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65400194|NCT00482391|Alkylating Agents|alkylating agents|mesh-ancestor
65400195|NCT00482391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65400196|NCT00482391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65400197|NCT00482391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65400198|NCT00482391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65400199|NCT00482391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400200|NCT00482391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65400201|NCT00482391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65400202|NCT00753779|Simvastatin|simvastatin|mesh-list
65400203|NCT00753779|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65400204|NCT00753779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65400205|NCT00753779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65400206|NCT00753779|Antimetabolites|antimetabolites|mesh-ancestor
65400207|NCT00753779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400208|NCT00753779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65400209|NCT00753779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64785548|NCT00000294|Carvedilol|carvedilol|mesh-list
64672302|NCT05274269|Elexacaftor|elexacaftor|mesh-list
64672303|NCT05274269|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64672304|NCT05274269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64672305|NCT05274269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672306|NCT01771952|Hyaluronic Acid|hyaluronic acid|mesh-list
64672307|NCT01771952|Hylan|hylan|mesh-list
64672308|NCT01771952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64672309|NCT01771952|Immunologic Factors|immunologic factors|mesh-ancestor
64672322|NCT02389361|Narcotics|narcotics|mesh-ancestor
64672323|NCT02389361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64672324|NCT02252354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64672325|NCT02252354|Relugolix|relugolix|mesh-list
64672326|NCT02252354|Androgen Antagonists|androgen antagonists|mesh-ancestor
64672327|NCT02252354|Hormone Antagonists|hormone antagonists|mesh-ancestor
64672328|NCT02252354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64672329|NCT02252354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672330|NCT02393339|Acetaminophen|acetaminophen|mesh-list
64672331|NCT02393339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64672334|NCT02393339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64672335|NCT02393339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672336|NCT02393339|Antipyretics|antipyretics|mesh-ancestor
64672338|NCT05235191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64672339|NCT05235191|Narcotics|narcotics|mesh-ancestor
64672340|NCT05235191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65400210|NCT00753779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400211|NCT00757523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
65400212|NCT00757523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65400213|NCT00757523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65400214|NCT00757523|Analgesics|analgesics|mesh-ancestor
65400215|NCT00757523|Sensory System Agents|sensory system agents|mesh-ancestor
65400216|NCT00757523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400217|NCT00757523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400218|NCT00757523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65400219|NCT00757523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65400220|NCT00757523|Dermatologic Agents|dermatologic agents|mesh-ancestor
65400221|NCT00757679|Milnacipran|milnacipran|mesh-list
65400222|NCT00757679|Levomilnacipran|levomilnacipran|mesh-list
65400223|NCT00757679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65400224|NCT00757679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65400225|NCT00757679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65400226|NCT00757679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400227|NCT00757679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65400228|NCT00757679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400229|NCT00757679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65400230|NCT00757679|Analgesics|analgesics|mesh-ancestor
65400231|NCT00757679|Sensory System Agents|sensory system agents|mesh-ancestor
65400232|NCT00757679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400233|NCT00757679|Antidepressive Agents|antidepressive agents|mesh-ancestor
65400234|NCT00757679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65400235|NCT00496587|Gemcitabine|gemcitabine|mesh-list
65400236|NCT00496587|Bevacizumab|bevacizumab|mesh-list
65400237|NCT00496587|Capecitabine|capecitabine|mesh-list
65400238|NCT00496587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65400239|NCT00496587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400240|NCT00496587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65400241|NCT00496587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65400242|NCT00496587|Growth Substances|growth substances|mesh-ancestor
65400243|NCT00496587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400244|NCT00496587|Growth Inhibitors|growth inhibitors|mesh-ancestor
64785599|NCT00000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785600|NCT00000342|Risperidone|risperidone|mesh-list
64785601|NCT00000342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64785602|NCT00000342|Serotonin Agents|serotonin agents|mesh-ancestor
64785603|NCT00000342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64785604|NCT00000342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400247|NCT00496587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400248|NCT00496587|Antiviral Agents|antiviral agents|mesh-ancestor
65400249|NCT00496587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65400250|NCT00496587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400251|NCT00496587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65400252|NCT00496587|Immunologic Factors|immunologic factors|mesh-ancestor
65400253|NCT00757835|Timolol|timolol|mesh-list
65400254|NCT00757835|Latanoprost|latanoprost|mesh-list
65400255|NCT00757835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65400256|NCT00757835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65400257|NCT00757835|Adrenergic Agents|adrenergic agents|mesh-ancestor
65400258|NCT00757835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65400259|NCT00757835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400260|NCT00757835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400261|NCT00757835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65400262|NCT00757835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65400263|NCT00757835|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65400264|NCT00757835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65400265|NCT01038154|Pravastatin|pravastatin|mesh-list
65400266|NCT01038154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65400267|NCT01038154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65400268|NCT01038154|Antimetabolites|antimetabolites|mesh-ancestor
65400269|NCT01038154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400270|NCT01038154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64672341|NCT05235191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672342|NCT05235191|Analgesics|analgesics|mesh-ancestor
64672343|NCT05235191|Sensory System Agents|sensory system agents|mesh-ancestor
64672344|NCT05235191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64672345|NCT05235191|Antitussive Agents|antitussive agents|mesh-ancestor
64672346|NCT05235191|Respiratory System Agents|respiratory system agents|mesh-ancestor
64672347|NCT01774604|Indomethacin|indomethacin|mesh-list
64672348|NCT01774604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64672349|NCT01774604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64672351|NCT01774604|Sensory System Agents|sensory system agents|mesh-ancestor
64672352|NCT01774604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64672353|NCT01774604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672354|NCT01774604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64785607|NCT00000342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64785608|NCT00000342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64785609|NCT00000342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64785610|NCT00000342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64785611|NCT00000342|Dopamine Agents|dopamine agents|mesh-ancestor
64785612|NCT00000348|Dihydrexidine|dihydrexidine|mesh-list
64785613|NCT00000348|Dopamine Agonists|dopamine agonists|mesh-ancestor
64785614|NCT00000348|Dopamine Agents|dopamine agents|mesh-ancestor
64785615|NCT00000348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64785616|NCT00000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396780|NCT02369965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64396781|NCT02640755|Paclitaxel|paclitaxel|mesh-list
64396782|NCT02640755|Fulvestrant|fulvestrant|mesh-list
64396783|NCT02640755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64396784|NCT02640755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396785|NCT02640755|Tubulin Modulators|tubulin modulators|mesh-ancestor
65400271|NCT01038154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65400272|NCT01038154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400273|NCT00405652|Mycophenolic Acid|mycophenolic acid|mesh-list
65400311|NCT02560649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65400312|NCT02560649|Interferon-alpha|interferon-alpha|mesh-list
65400313|NCT02560649|Entecavir|entecavir|mesh-list
65400314|NCT02560649|Adefovir|adefovir|mesh-list
65400315|NCT02560649|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65400316|NCT02560649|Antiviral Agents|antiviral agents|mesh-ancestor
65400317|NCT02560649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65400318|NCT02560649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65400319|NCT02560649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65400320|NCT02560649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400321|NCT02560649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400322|NCT02560649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65400323|NCT02560649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65400324|NCT02560649|Immunologic Factors|immunologic factors|mesh-ancestor
65400325|NCT02560649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400326|NCT00754403|Metformin|metformin|mesh-list
65400327|NCT00754403|Pioglitazone|pioglitazone|mesh-list
65400328|NCT00754403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65400329|NCT00754403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400330|NCT00758225|Idebenone|idebenone|mesh-list
65400331|NCT00758225|Antioxidants|antioxidants|mesh-ancestor
65400332|NCT00758225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785618|NCT00000354|Lofexidine|lofexidine|mesh-list
64672355|NCT01774604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64672356|NCT01774604|Gout Suppressants|gout suppressants|mesh-ancestor
64672357|NCT01774604|Tocolytic Agents|tocolytic agents|mesh-ancestor
64672358|NCT01774604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64672359|NCT01774604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64672360|NCT01774604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64672361|NCT01774604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672372|NCT01777412|Bevacizumab|bevacizumab|mesh-list
64557055|NCT05582837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64557056|NCT04728633|Carmustine|carmustine|mesh-list
64557057|NCT04728633|Ethiodized Oil|ethiodized oil|mesh-list
64557058|NCT04728633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64557059|NCT04728633|Alkylating Agents|alkylating agents|mesh-ancestor
64322107|NCT03544073|Fertility Agents|fertility agents|mesh-ancestor
64672373|NCT01777412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64672374|NCT01777412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672375|NCT01777412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64672376|NCT01777412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64672377|NCT01777412|Growth Substances|growth substances|mesh-ancestor
64672378|NCT01777412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672379|NCT01777412|Growth Inhibitors|growth inhibitors|mesh-ancestor
64672380|NCT02236910|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
64672381|NCT02236910|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64672389|NCT01780454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672390|NCT01780454|Immunologic Factors|immunologic factors|mesh-ancestor
64672391|NCT01780454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672392|NCT01780454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64672394|NCT04869449|Antifungal Agents|antifungal agents|mesh-ancestor
64672395|NCT04869449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64672396|NCT04869449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64672397|NCT04869449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65400333|NCT00758225|Protective Agents|protective agents|mesh-ancestor
65400334|NCT00758225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785629|NCT00000354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785630|NCT00000372|Cycloserine|cycloserine|mesh-list
64785631|NCT00000372|Clozapine|clozapine|mesh-list
64785632|NCT00000372|Glycine|glycine|mesh-list
64785633|NCT00000372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64785634|NCT00000372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64785635|NCT00000372|Renal Agents|renal agents|mesh-ancestor
64785636|NCT00000372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64785637|NCT00000372|Antitubercular Agents|antitubercular agents|mesh-ancestor
64396799|NCT04400539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396800|NCT03099785|Rifamycins|rifamycins|mesh-list
64396801|NCT03099785|Rifamycin SV|rifamycin sv|mesh-list
64396802|NCT03099785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64396803|NCT03099785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64396804|NCT03099785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64396805|NCT02375503|Vitamin D|vitamin d|mesh-list
64396806|NCT02375503|Calcium|calcium|mesh-list
65400335|NCT02561039|Ibandronic Acid|ibandronic acid|mesh-list
65400338|NCT00422734|Tadalafil|tadalafil|mesh-list
64785638|NCT00000372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64785639|NCT00000372|Antimetabolites|antimetabolites|mesh-ancestor
64785641|NCT00000372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65400373|NCT00754871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65400374|NCT00754871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400375|NCT00754871|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65400376|NCT00754871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65400377|NCT00754871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65400378|NCT00754871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65400379|NCT00754871|Hormone Antagonists|hormone antagonists|mesh-ancestor
65400380|NCT00754871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65400381|NCT00754871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65400382|NCT00754871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400383|NCT00754871|Androgens|androgens|mesh-ancestor
65400384|NCT00754871|Hormones|hormones|mesh-ancestor
65400385|NCT00754871|Anabolic Agents|anabolic agents|mesh-ancestor
65400386|NCT00755027|Rasagiline|rasagiline|mesh-list
65400387|NCT00755027|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65400388|NCT00755027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400389|NCT00755027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400390|NCT00755027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65400391|NCT00755027|Protective Agents|protective agents|mesh-ancestor
65400392|NCT00755027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672398|NCT04869449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64672399|NCT04869449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672400|NCT04869449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64672401|NCT04869449|Hormone Antagonists|hormone antagonists|mesh-ancestor
64672402|NCT04869449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64672403|NCT04869449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672404|NCT04869449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64672419|NCT01420874|Micronutrients|micronutrients|mesh-ancestor
64672420|NCT00355901|Visilizumab|visilizumab|mesh-list
64397798|NCT02362711|Hormones|hormones|mesh-ancestor
64672421|NCT00355901|Immunologic Factors|immunologic factors|mesh-ancestor
64672422|NCT00355901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672424|NCT00355667|Azosemide|azosemide|mesh-list
64672425|NCT00355667|Diuretics|diuretics|mesh-ancestor
64672426|NCT00355667|Natriuretic Agents|natriuretic agents|mesh-ancestor
64672427|NCT00355667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672428|NCT00355667|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64672429|NCT00355667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64672430|NCT00355667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672431|NCT02364336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64672432|NCT02364336|Antiviral Agents|antiviral agents|mesh-ancestor
64672433|NCT02364336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64672434|NCT04419948|Ibuprofen|ibuprofen|mesh-list
64672435|NCT04419948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64672436|NCT04419948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64672437|NCT04419948|Analgesics|analgesics|mesh-ancestor
64785647|NCT00000372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64785648|NCT00000372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64785649|NCT00000372|GABA Antagonists|gaba antagonists|mesh-ancestor
64785650|NCT00000372|GABA Agents|gaba agents|mesh-ancestor
64785651|NCT00000372|Glycine Agents|glycine agents|mesh-ancestor
64785652|NCT00000384|Sertraline|sertraline|mesh-list
64785653|NCT00000384|Antidepressive Agents|antidepressive agents|mesh-ancestor
64785654|NCT00000384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64785655|NCT00000384|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64396816|NCT00867191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396817|NCT00867191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396818|NCT00867191|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64396819|NCT00867191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64396820|NCT00867191|Histamine Antagonists|histamine antagonists|mesh-ancestor
64396821|NCT00867191|Histamine Agents|histamine agents|mesh-ancestor
65400393|NCT05435729|Levodopa|levodopa|mesh-list
65400394|NCT05435729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65400395|NCT05435729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65400396|NCT05435729|Dopamine Agents|dopamine agents|mesh-ancestor
64785656|NCT00000384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64785657|NCT00000384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64785658|NCT00000384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785659|NCT00000384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64785660|NCT00000384|Serotonin Agents|serotonin agents|mesh-ancestor
64785661|NCT00000384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785662|NCT00000390|Imipramine|imipramine|mesh-list
64785663|NCT00000390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64785664|NCT00000390|Antidepressive Agents|antidepressive agents|mesh-ancestor
64785665|NCT00000390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64396825|NCT00834119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64396826|NCT02299141|Nintedanib|nintedanib|mesh-list
64396827|NCT02299141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400432|NCT04050059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65400433|NCT04050059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65400434|NCT04050059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65400435|NCT04050059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400436|NCT04050059|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65400437|NCT02150967|Infigratinib|infigratinib|mesh-list
65400438|NCT02150967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400439|NCT00482001|Donepezil|donepezil|mesh-list
65400440|NCT00482001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65400441|NCT00482001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400442|NCT00482001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400443|NCT00482001|Cholinergic Agents|cholinergic agents|mesh-ancestor
65400466|NCT00421174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65400467|NCT00421174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64785666|NCT00000390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64785667|NCT00000390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64785668|NCT00000390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64785669|NCT00000390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785670|NCT00000390|Adrenergic Agents|adrenergic agents|mesh-ancestor
64785671|NCT00000390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64785672|NCT00000390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396835|NCT02643251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396836|NCT02643251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64396837|NCT02643251|Sympatholytics|sympatholytics|mesh-ancestor
64396838|NCT02643251|Autonomic Agents|autonomic agents|mesh-ancestor
64396839|NCT02643251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64396840|NCT02643251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64396841|NCT02643251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64396842|NCT02643251|Adrenergic Agents|adrenergic agents|mesh-ancestor
65400468|NCT00421174|Immunologic Factors|immunologic factors|mesh-ancestor
64945407|NCT05663580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400504|NCT00481767|Immunologic Factors|immunologic factors|mesh-ancestor
64945408|NCT05663580|Antiviral Agents|antiviral agents|mesh-ancestor
64945409|NCT05663580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64945410|NCT05663580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64945411|NCT05663580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64945412|NCT05663580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64945413|NCT05663580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64945414|NCT05663411|Cinacalcet|cinacalcet|mesh-list
64945415|NCT05663411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64396843|NCT02643251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64396844|NCT02643251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396845|NCT02375191|Fentanyl|fentanyl|mesh-list
64396846|NCT02375191|Dexmedetomidine|dexmedetomidine|mesh-list
64396847|NCT02375191|Ropivacaine|ropivacaine|mesh-list
64396848|NCT02375191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64396849|NCT02375191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64945416|NCT05663411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945417|NCT05663411|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64945418|NCT05663411|Hormone Antagonists|hormone antagonists|mesh-ancestor
64945419|NCT05663411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64945420|NCT05657860|Guanfacine|guanfacine|mesh-list
64945421|NCT05657860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64945422|NCT05657860|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64945423|NCT05657860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64396851|NCT02375191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64396852|NCT02375191|Analgesics|analgesics|mesh-ancestor
64396853|NCT02375191|Sensory System Agents|sensory system agents|mesh-ancestor
64396854|NCT02375191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64396855|NCT02375191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64396856|NCT02375191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64396857|NCT02375191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64396858|NCT02375191|Adrenergic Agents|adrenergic agents|mesh-ancestor
65400544|NCT00420784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65400545|NCT00420784|Antimetabolites|antimetabolites|mesh-ancestor
65400546|NCT00420784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400547|NCT00420784|Immunologic Factors|immunologic factors|mesh-ancestor
65400548|NCT00420784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400578|NCT00420238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65400579|NCT00420238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65400580|NCT00420238|Analgesics|analgesics|mesh-ancestor
65400581|NCT00420238|Sensory System Agents|sensory system agents|mesh-ancestor
64945424|NCT05657860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64945425|NCT05657860|Adrenergic Agents|adrenergic agents|mesh-ancestor
64945426|NCT05657860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64945427|NCT05657860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945428|NCT05657860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945429|NCT05642962|Pancrelipase|pancrelipase|mesh-list
64945430|NCT05642962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64945431|NCT05633615|Cyclophosphamide|cyclophosphamide|mesh-list
64785673|NCT00000402|Calcium|calcium|mesh-list
64785674|NCT00000402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64396859|NCT02375191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64396860|NCT02375191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396861|NCT02375191|Anesthetics, Local|anesthetics, local|mesh-ancestor
64396862|NCT02375191|Anesthetics|anesthetics|mesh-ancestor
64396863|NCT02375191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65400590|NCT04081545|Analgesics|analgesics|mesh-list
64785675|NCT00000402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785676|NCT00000438|Naltrexone|naltrexone|mesh-list
64785677|NCT00000438|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64785678|NCT00000438|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64785679|NCT00000438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785680|NCT00000438|Sensory System Agents|sensory system agents|mesh-ancestor
64785681|NCT00000438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785682|NCT00000444|Nicotine|nicotine|mesh-list
64785683|NCT00000444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64785684|NCT00000444|Autonomic Agents|autonomic agents|mesh-ancestor
64396869|NCT03100877|Melphalan|melphalan|mesh-list
64396870|NCT03100877|Mechlorethamine|mechlorethamine|mesh-list
64396871|NCT03100877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64396872|NCT03100877|Lenalidomide|lenalidomide|mesh-list
64396873|NCT03100877|Lenograstim|lenograstim|mesh-list
64396874|NCT03100877|Mitogens|mitogens|mesh-list
64396875|NCT03100877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64396876|NCT03100877|Immunologic Factors|immunologic factors|mesh-ancestor
65400616|NCT00097591|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65400617|NCT00097591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65400618|NCT00097591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65400652|NCT00419926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65400653|NCT00419926|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65400654|NCT00419926|Antitubercular Agents|antitubercular agents|mesh-ancestor
65400655|NCT00419926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65400656|NCT00419770|Amphotericin B|amphotericin b|mesh-list
65400657|NCT00419770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65400658|NCT00419770|Deferasirox|deferasirox|mesh-list
65400659|NCT00419770|Amebicides|amebicides|mesh-ancestor
65400660|NCT00419770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65400661|NCT00419770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65400662|NCT00419770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65400663|NCT00419770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64785685|NCT00000444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400664|NCT00419770|Antifungal Agents|antifungal agents|mesh-ancestor
65400665|NCT00419770|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65400666|NCT00419770|Chelating Agents|chelating agents|mesh-ancestor
65400667|NCT00419770|Sequestering Agents|sequestering agents|mesh-ancestor
65400668|NCT00419770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400669|NCT00080119|Isoniazid|isoniazid|mesh-list
65400670|NCT00080119|Trimethoprim|trimethoprim|mesh-list
65400671|NCT00080119|Sulfamethoxazole|sulfamethoxazole|mesh-list
65400672|NCT00080119|Antitubercular Agents|antitubercular agents|mesh-ancestor
65400673|NCT00080119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65400674|NCT00080119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65400675|NCT00080119|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65400676|NCT00080119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65400677|NCT00080119|Antimetabolites|antimetabolites|mesh-ancestor
65400678|NCT00080119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400679|NCT00080119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65400681|NCT00080119|Renal Agents|renal agents|mesh-ancestor
64785700|NCT00000510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64785701|NCT00000510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64785702|NCT00000510|Analgesics|analgesics|mesh-ancestor
64785703|NCT00000510|Sensory System Agents|sensory system agents|mesh-ancestor
64785704|NCT00000510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785705|NCT00000510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785706|NCT00000510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64785707|NCT00000510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64785708|NCT00000510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65400696|NCT01034878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65400697|NCT01034878|Growth Substances|growth substances|mesh-ancestor
65400698|NCT01034878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400699|NCT01034878|Growth Inhibitors|growth inhibitors|mesh-ancestor
65400700|NCT01034878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65400701|NCT01034878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400702|NCT01034878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400703|NCT01082263|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65400704|NCT01082263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65400705|NCT01082263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65400706|NCT01082263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65400707|NCT01082263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400708|NCT01082263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65400709|NCT01082263|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65400710|NCT01082263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65400711|NCT01082263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65400712|NCT01082263|Adrenergic Agents|adrenergic agents|mesh-ancestor
65400713|NCT01082263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65400714|NCT01082263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400715|NCT01082263|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64785716|NCT00000510|Vasodilator Agents|vasodilator agents|mesh-ancestor
64785717|NCT00000570|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64785718|NCT00000570|Respiratory System Agents|respiratory system agents|mesh-ancestor
64785719|NCT00000600|Vitamins|vitamins|mesh-list
64785720|NCT00000600|Vitamin E|vitamin e|mesh-list
64785721|NCT00000600|Micronutrients|micronutrients|mesh-ancestor
64785722|NCT00000600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785723|NCT00000600|Antioxidants|antioxidants|mesh-ancestor
64785724|NCT00000600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785725|NCT00000600|Protective Agents|protective agents|mesh-ancestor
64785726|NCT00000636|Pyridoxine|pyridoxine|mesh-list
64785727|NCT00000636|Vitamin B 6|vitamin b 6|mesh-list
64396898|NCT00794495|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64396899|NCT00794495|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65400728|NCT00494091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400729|NCT00494091|Antifungal Agents|antifungal agents|mesh-ancestor
65400730|NCT00494091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65400731|NCT00494091|Immunologic Factors|immunologic factors|mesh-ancestor
65493985|NCT03897439|Autonomic Agents|autonomic agents|mesh-ancestor
65150305|NCT01306643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65400732|NCT00494091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400733|NCT01017159|Immunoglobulins|immunoglobulins|mesh-list
65400734|NCT01017159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65400735|NCT01017159|Antibodies|antibodies|mesh-list
65400736|NCT01017159|Immunologic Factors|immunologic factors|mesh-ancestor
65400737|NCT01017159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400738|NCT00494013|Insulin Lispro|insulin lispro|mesh-list
65400739|NCT00494013|Protamines|protamines|mesh-list
65400740|NCT00494013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65400741|NCT00494013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400744|NCT00494013|Coagulants|coagulants|mesh-ancestor
64785728|NCT00000636|Rifampin|rifampin|mesh-list
64785729|NCT00000636|Isoniazid|isoniazid|mesh-list
64785730|NCT00000636|Pyrazinamide|pyrazinamide|mesh-list
64785731|NCT00000636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64785732|NCT00000636|Antitubercular Agents|antitubercular agents|mesh-ancestor
64785733|NCT00000636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64785734|NCT00000636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64785735|NCT00000636|Leprostatic Agents|leprostatic agents|mesh-ancestor
64785736|NCT00000636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64785737|NCT00000636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396903|NCT00794495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396904|NCT00794495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396905|NCT00794495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65400759|NCT00541866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400760|NCT00541866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400761|NCT00541866|Antiviral Agents|antiviral agents|mesh-ancestor
65400762|NCT00541866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65400763|NCT00541866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65400764|NCT00541866|Immunologic Factors|immunologic factors|mesh-ancestor
64785738|NCT00000636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785739|NCT00000636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64785740|NCT00000636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64785741|NCT00000636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64785742|NCT00000636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64785743|NCT00000636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64785744|NCT00000636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64785745|NCT00000636|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64785746|NCT00000636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64785747|NCT00000636|Antimetabolites|antimetabolites|mesh-ancestor
64396912|NCT04157075|Sensory System Agents|sensory system agents|mesh-ancestor
64396913|NCT04157075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64396914|NCT00763529|Fluticasone|fluticasone|mesh-list
64396915|NCT00763529|Mometasone Furoate|mometasone furoate|mesh-list
65400799|NCT04221828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400800|NCT04221828|Tubulin Modulators|tubulin modulators|mesh-ancestor
65400801|NCT04221828|Antimitotic Agents|antimitotic agents|mesh-ancestor
65400802|NCT04221828|Mitosis Modulators|mitosis modulators|mesh-ancestor
65400803|NCT04221828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400804|NCT04221750|Metformin|metformin|mesh-list
65400805|NCT04221750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65400806|NCT04221750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945432|NCT05633615|Fludarabine|fludarabine|mesh-list
64785748|NCT00000636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64785749|NCT00000636|Vitamin B Complex|vitamin b complex|mesh-ancestor
64785750|NCT00000636|Vitamins|vitamins|mesh-ancestor
64785751|NCT00000636|Micronutrients|micronutrients|mesh-ancestor
64785752|NCT00000636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785753|NCT00000648|Ceftriaxone|ceftriaxone|mesh-list
64785754|NCT00000648|Penicillins|penicillins|mesh-list
64785755|NCT00000648|Penicillin G|penicillin g|mesh-list
65400837|NCT00481065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65400838|NCT00481065|Immunologic Factors|immunologic factors|mesh-ancestor
65400839|NCT00481065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400840|NCT01017393|Ketamine|ketamine|mesh-list
65400841|NCT01017393|Analgesics|analgesics|mesh-ancestor
65400842|NCT01017393|Sensory System Agents|sensory system agents|mesh-ancestor
65400843|NCT01017393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400844|NCT01017393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400845|NCT01017393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65400846|NCT01017393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65400847|NCT01017393|Anesthetics, General|anesthetics, general|mesh-ancestor
65400848|NCT01017393|Anesthetics|anesthetics|mesh-ancestor
65400849|NCT01017393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65400850|NCT01017393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65400851|NCT01017393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65400852|NCT01017393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65400853|NCT01017393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400854|NCT00493311|Acetaminophen|acetaminophen|mesh-list
65400855|NCT00493311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65400856|NCT00493311|Analgesics|analgesics|mesh-ancestor
65400857|NCT00493311|Sensory System Agents|sensory system agents|mesh-ancestor
65400858|NCT00493311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400859|NCT00493311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400860|NCT00493311|Antipyretics|antipyretics|mesh-ancestor
65400861|NCT00571649|Enoxaparin|enoxaparin|mesh-list
65400862|NCT00571649|Rivaroxaban|rivaroxaban|mesh-list
64785756|NCT00000648|Penicillin G Benzathine|penicillin g benzathine|mesh-list
64672438|NCT04419948|Sensory System Agents|sensory system agents|mesh-ancestor
64672439|NCT04419948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64672440|NCT04419948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672441|NCT04419948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64672442|NCT04419948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64785757|NCT00000648|Penicillin G Procaine|penicillin g procaine|mesh-list
64785758|NCT00000648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64785759|NCT00000648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64785760|NCT00000654|Fialuridine|fialuridine|mesh-list
64785761|NCT00000654|Antiviral Agents|antiviral agents|mesh-ancestor
64785762|NCT00000654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64785763|NCT00000654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64785764|NCT00000654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396930|NCT03105505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396931|NCT03105505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64396932|NCT03105505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64396933|NCT03105505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64396934|NCT03105193|Lidocaine|lidocaine|mesh-list
64396935|NCT03105193|Anesthetics, Local|anesthetics, local|mesh-ancestor
64396936|NCT03105193|Anesthetics|anesthetics|mesh-ancestor
65400863|NCT00571649|Enoxaparin sodium|enoxaparin sodium|mesh-list
65400864|NCT00571649|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65400865|NCT00571649|Antithrombins|antithrombins|mesh-ancestor
65400866|NCT00571649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65400867|NCT00571649|Protease Inhibitors|protease inhibitors|mesh-ancestor
65400868|NCT00571649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785766|NCT00000660|Etoposide|etoposide|mesh-list
65400899|NCT05677620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400900|NCT05677620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65400901|NCT05677620|Anesthetics, General|anesthetics, general|mesh-ancestor
65400902|NCT05677620|Anesthetics|anesthetics|mesh-ancestor
65400903|NCT00681629|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65400904|NCT00681629|Antidepressive Agents|antidepressive agents|mesh-ancestor
65400905|NCT00681629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65400906|NCT00681629|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65400907|NCT00681629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65400908|NCT00681629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65400909|NCT00681629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400910|NCT00969176|Acetaminophen|acetaminophen|mesh-list
65400911|NCT00969176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65400912|NCT00969176|Analgesics|analgesics|mesh-ancestor
65400913|NCT00969176|Sensory System Agents|sensory system agents|mesh-ancestor
65400914|NCT00969176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400915|NCT00969176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400916|NCT00969176|Antipyretics|antipyretics|mesh-ancestor
65400917|NCT04503252|Cefazolin|cefazolin|mesh-list
65400918|NCT04503252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65400919|NCT04503252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65400920|NCT00679367|Dexamethasone|dexamethasone|mesh-list
65400921|NCT00679367|Lenalidomide|lenalidomide|mesh-list
65400922|NCT00679367|Melphalan|melphalan|mesh-list
65400923|NCT00679367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65400924|NCT00679367|Antiemetics|antiemetics|mesh-ancestor
65400925|NCT00679367|Autonomic Agents|autonomic agents|mesh-ancestor
65400926|NCT00679367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400927|NCT00679367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400928|NCT00679367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65400929|NCT00679367|Glucocorticoids|glucocorticoids|mesh-ancestor
65400930|NCT00679367|Hormones|hormones|mesh-ancestor
65400931|NCT00679367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65400932|NCT00679367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64672443|NCT04419948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64672444|NCT04419948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64672445|NCT04419948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672446|NCT01312922|Dexetimide|dexetimide|mesh-list
64672447|NCT01312922|Pipamperone|pipamperone|mesh-list
64672448|NCT01312922|Citalopram|citalopram|mesh-list
64672449|NCT01312922|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65400933|NCT00679367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400934|NCT00679367|Immunologic Factors|immunologic factors|mesh-ancestor
64785779|NCT00000702|Antiviral Agents|antiviral agents|mesh-ancestor
64785780|NCT00000702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64785781|NCT00000702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64785782|NCT00000702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64785783|NCT00000714|Leucovorin|leucovorin|mesh-list
64785784|NCT00000714|Trimetrexate|trimetrexate|mesh-list
64785785|NCT00000714|Calcium|calcium|mesh-list
64785786|NCT00000714|Levoleucovorin|levoleucovorin|mesh-list
65400935|NCT00679367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65400936|NCT00679367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65400937|NCT00679367|Growth Substances|growth substances|mesh-ancestor
65400938|NCT00679367|Growth Inhibitors|growth inhibitors|mesh-ancestor
65400939|NCT00679367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65400940|NCT00679367|Alkylating Agents|alkylating agents|mesh-ancestor
65400941|NCT00679367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400942|NCT00679367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65400943|NCT00679367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65400944|NCT00969566|Metformin|metformin|mesh-list
65400945|NCT00969566|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65400946|NCT00969566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65400947|NCT00969566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400948|NCT00969566|Incretins|incretins|mesh-ancestor
65400949|NCT00969566|Hormones|hormones|mesh-ancestor
65400955|NCT00755495|Doxepin|doxepin|mesh-list
65400975|NCT00964262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65400976|NCT00964262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785792|NCT00000714|Vitamins|vitamins|mesh-ancestor
65400977|NCT00964262|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65400978|NCT00964262|Incretins|incretins|mesh-ancestor
64785793|NCT00000714|Micronutrients|micronutrients|mesh-ancestor
64785794|NCT00000714|Antifungal Agents|antifungal agents|mesh-ancestor
65400979|NCT00964262|Hormones|hormones|mesh-ancestor
65400980|NCT00964262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65400981|NCT00973778|Capecitabine|capecitabine|mesh-list
65400982|NCT00973778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65400983|NCT00973778|Antimetabolites|antimetabolites|mesh-ancestor
65400984|NCT00973778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400985|NCT00973778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65400986|NCT05623410|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65400987|NCT05623410|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65400988|NCT05623410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65400989|NCT05623410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65400990|NCT05623410|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65400991|NCT05623410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65400992|NCT05623410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65400993|NCT05623410|Cholinergic Agents|cholinergic agents|mesh-ancestor
65400994|NCT05623410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65400995|NCT00964418|Insulin|insulin|mesh-list
65400996|NCT00964418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65400997|NCT00964418|Insulin Glargine|insulin glargine|mesh-list
65400998|NCT00964418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65400999|NCT00964418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401000|NCT00974012|Valproic Acid|valproic acid|mesh-list
65401001|NCT00974012|Anticonvulsants|anticonvulsants|mesh-ancestor
64557060|NCT04728633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557061|NCT04728633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557062|NCT05003700|Lenvatinib|lenvatinib|mesh-list
64557063|NCT05003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557064|NCT05003700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64322114|NCT03168087|Plasma-lyte 148|plasma-lyte 148|mesh-list
64672469|NCT01312922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64672470|NCT01312922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64672471|NCT03785405|Valsartan|valsartan|mesh-list
64672472|NCT03785405|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64672473|NCT03785405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64672474|NCT03785405|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64672477|NCT03763643|Rituximab|rituximab|mesh-list
64672478|NCT03763643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65401002|NCT00974012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401003|NCT00974012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401004|NCT00974012|GABA Agents|gaba agents|mesh-ancestor
65401005|NCT00974012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65401006|NCT00974012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401007|NCT00974012|Antimanic Agents|antimanic agents|mesh-ancestor
65401008|NCT00974012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65401009|NCT00974012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65401010|NCT00974012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65401011|NCT00964574|Insulin|insulin|mesh-list
65401012|NCT00964574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65401013|NCT00964574|Insulin Glargine|insulin glargine|mesh-list
65401014|NCT00964574|Insulin glulisine|insulin glulisine|mesh-list
65401015|NCT00964574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65401016|NCT00964574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401017|NCT00970580|Paclitaxel|paclitaxel|mesh-list
65401018|NCT00970580|Carboplatin|carboplatin|mesh-list
65401019|NCT00970580|Alkylating Agents|alkylating agents|mesh-list
65401020|NCT00970580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65401021|NCT00970580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672479|NCT03763643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672480|NCT03763643|Immunologic Factors|immunologic factors|mesh-ancestor
64672481|NCT03763643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672482|NCT03763643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64672483|NCT01783574|Methyltestosterone|methyltestosterone|mesh-list
64672484|NCT01783574|Testosterone|testosterone|mesh-list
64672485|NCT01783574|Testosterone undecanoate|testosterone undecanoate|mesh-list
64672486|NCT01783574|Testosterone enanthate|testosterone enanthate|mesh-list
64672487|NCT01783574|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64672488|NCT01783574|Androgens|androgens|mesh-ancestor
64672489|NCT01783574|Hormones|hormones|mesh-ancestor
64672490|NCT01783574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64672491|NCT01783574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672492|NCT01783574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64672493|NCT01783574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672494|NCT01783574|Anabolic Agents|anabolic agents|mesh-ancestor
64672495|NCT03656783|Tenofovir|tenofovir|mesh-list
64672496|NCT03656783|Emtricitabine|emtricitabine|mesh-list
64672497|NCT03656783|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64672498|NCT03656783|Antiviral Agents|antiviral agents|mesh-ancestor
64672499|NCT03656783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64672500|NCT03656783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64672501|NCT03656783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64672502|NCT03656783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64672511|NCT01784666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64672513|NCT01784666|Vasodilator Agents|vasodilator agents|mesh-ancestor
64672514|NCT04362293|Sirolimus|sirolimus|mesh-list
64672515|NCT04362293|Plerixafor|plerixafor|mesh-list
64672516|NCT04362293|Cyclophosphamide|cyclophosphamide|mesh-list
64672517|NCT04362293|Thiotepa|thiotepa|mesh-list
64672518|NCT04362293|Alemtuzumab|alemtuzumab|mesh-list
64672519|NCT04362293|Hydroxyurea|hydroxyurea|mesh-list
64672520|NCT04362293|Azathioprine|azathioprine|mesh-list
64672521|NCT04362293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64672522|NCT04362293|Immunologic Factors|immunologic factors|mesh-ancestor
64672523|NCT04362293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672524|NCT04362293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64672525|NCT04362293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65401022|NCT00970580|Tubulin Modulators|tubulin modulators|mesh-ancestor
65401023|NCT00970580|Antimitotic Agents|antimitotic agents|mesh-ancestor
65401024|NCT00970580|Mitosis Modulators|mitosis modulators|mesh-ancestor
65401025|NCT00970580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401026|NCT00974324|Endostar protein|endostar protein|mesh-list
65401027|NCT00974324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65401028|NCT00974324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65401029|NCT00974324|Growth Substances|growth substances|mesh-ancestor
65401030|NCT00974324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401031|NCT00974324|Growth Inhibitors|growth inhibitors|mesh-ancestor
65401032|NCT00974324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672526|NCT04362293|Alkylating Agents|alkylating agents|mesh-ancestor
64672527|NCT04362293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672528|NCT04362293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672529|NCT04362293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64672530|NCT04362293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64672531|NCT04362293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64672532|NCT04362293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64672533|NCT04362293|Antifungal Agents|antifungal agents|mesh-ancestor
64672534|NCT04362293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64672535|NCT04362293|Antisickling Agents|antisickling agents|mesh-ancestor
64672536|NCT04362293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64672537|NCT04362293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64672538|NCT04362293|Antimetabolites|antimetabolites|mesh-ancestor
64672539|NCT04362293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64557065|NCT05003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557066|NCT05003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557068|NCT04143191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557069|NCT04143191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64672540|NCT04362293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64672541|NCT04362293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64672542|NCT04362293|Antiviral Agents|antiviral agents|mesh-ancestor
64672543|NCT04296695|Tenofovir|tenofovir|mesh-list
64672544|NCT04296695|Efavirenz|efavirenz|mesh-list
64672545|NCT04296695|Antiviral Agents|antiviral agents|mesh-ancestor
64672546|NCT04296695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64672547|NCT04296695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64672548|NCT04296695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64672549|NCT04296695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64672550|NCT04296695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672551|NCT04296695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64672552|NCT04296695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64672555|NCT04296695|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64672556|NCT04296695|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64672557|NCT04296695|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64672558|NCT04296695|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64672559|NCT03310541|Fulvestrant|fulvestrant|mesh-list
64672560|NCT03310541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64672561|NCT03310541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672562|NCT03310541|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64672563|NCT03310541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64672564|NCT03310541|Hormone Antagonists|hormone antagonists|mesh-ancestor
64672565|NCT03310541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64672566|NCT03310541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672583|NCT01787006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64672584|NCT02260622|Aspirin|aspirin|mesh-list
64672585|NCT02260622|Rivaroxaban|rivaroxaban|mesh-list
64672586|NCT02260622|Clopidogrel|clopidogrel|mesh-list
64672587|NCT02260622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64672588|NCT02260622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64672589|NCT02260622|Analgesics|analgesics|mesh-ancestor
64672590|NCT02260622|Sensory System Agents|sensory system agents|mesh-ancestor
65401033|NCT00545714|Cyclophosphamide|cyclophosphamide|mesh-list
65401034|NCT00545714|Rituximab|rituximab|mesh-list
65401035|NCT00545714|Fludarabine|fludarabine|mesh-list
65401036|NCT00545714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65401037|NCT00545714|Immunologic Factors|immunologic factors|mesh-ancestor
65401038|NCT00545714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401039|NCT00545714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65401040|NCT00545714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65401041|NCT00545714|Alkylating Agents|alkylating agents|mesh-ancestor
65401042|NCT00545714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401043|NCT00545714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401044|NCT00545714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65401045|NCT00545714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65401046|NCT00964730|Moxifloxacin|moxifloxacin|mesh-list
64672591|NCT02260622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64672592|NCT02260622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672593|NCT02260622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64672594|NCT02260622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64672595|NCT02260622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64672596|NCT02260622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64672597|NCT02260622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672598|NCT02260622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64672599|NCT02260622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64672600|NCT02260622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64672601|NCT02260622|Antipyretics|antipyretics|mesh-ancestor
64672602|NCT02260622|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64672603|NCT02260622|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64672604|NCT02260622|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64672605|NCT02260622|Purinergic Agents|purinergic agents|mesh-ancestor
64672606|NCT02260622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64672607|NCT02260622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64672608|NCT02260622|Antithrombins|antithrombins|mesh-ancestor
64672609|NCT02260622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64672610|NCT02260622|Protease Inhibitors|protease inhibitors|mesh-ancestor
64672611|NCT02260622|Anticoagulants|anticoagulants|mesh-ancestor
64672612|NCT03186209|Benralizumab|benralizumab|mesh-list
64672613|NCT03186209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64672614|NCT03186209|Respiratory System Agents|respiratory system agents|mesh-ancestor
64672615|NCT02261948|Simendan|simendan|mesh-list
64672616|NCT02261948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64672617|NCT02261948|Vasodilator Agents|vasodilator agents|mesh-ancestor
64557070|NCT04143191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557071|NCT04143191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557073|NCT04661007|Immunologic Factors|immunologic factors|mesh-ancestor
64672618|NCT02261948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64672619|NCT02261948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64672620|NCT02261948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64672621|NCT02261948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672622|NCT02261948|Protective Agents|protective agents|mesh-ancestor
64672623|NCT02261948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672624|NCT01787240|Citalopram|citalopram|mesh-list
64672625|NCT01787240|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64672649|NCT04903652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64672650|NCT04903652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672651|NCT04903652|Tubulin Modulators|tubulin modulators|mesh-ancestor
64672652|NCT04903652|Antimitotic Agents|antimitotic agents|mesh-ancestor
64672653|NCT04903652|Mitosis Modulators|mitosis modulators|mesh-ancestor
64672654|NCT04903652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672656|NCT04071821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64672657|NCT04071821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65401047|NCT00964730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65401048|NCT00964730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65401049|NCT00964730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65401050|NCT00964730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65401051|NCT00964730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401052|NCT00964730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401053|NCT00964730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401054|NCT00539838|Mycophenolic Acid|mycophenolic acid|mesh-list
65401055|NCT00539838|Prednisone|prednisone|mesh-list
65401056|NCT00539838|Methylprednisolone|methylprednisolone|mesh-list
65401057|NCT00539838|Methotrexate|methotrexate|mesh-list
65401058|NCT00539838|Azathioprine|azathioprine|mesh-list
65401059|NCT00539838|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65401060|NCT00539838|Ocrelizumab|ocrelizumab|mesh-list
65401061|NCT00539838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65401062|NCT00539838|Glucocorticoids|glucocorticoids|mesh-ancestor
65401063|NCT00539838|Hormones|hormones|mesh-ancestor
65401064|NCT00539838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65401065|NCT00539838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401066|NCT00539838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65401067|NCT00539838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401068|NCT00539838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65401069|NCT00539838|Abortifacient Agents|abortifacient agents|mesh-ancestor
65401070|NCT00539838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65401071|NCT00539838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65401072|NCT00539838|Antimetabolites|antimetabolites|mesh-ancestor
64785855|NCT00000804|Protease Inhibitors|protease inhibitors|mesh-ancestor
64672658|NCT04071821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64672659|NCT04071821|Histamine Antagonists|histamine antagonists|mesh-ancestor
64672661|NCT04071821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64672662|NCT04071821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672663|NCT04071821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672665|NCT03064295|Regadenoson|regadenoson|mesh-list
64672666|NCT03064295|Analgesics|analgesics|mesh-ancestor
64672667|NCT03064295|Sensory System Agents|sensory system agents|mesh-ancestor
64672668|NCT03064295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64672669|NCT03064295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672670|NCT03064295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64672671|NCT03064295|Vasodilator Agents|vasodilator agents|mesh-ancestor
64672672|NCT03064295|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64672673|NCT03064295|Purinergic Agonists|purinergic agonists|mesh-ancestor
64672674|NCT03064295|Purinergic Agents|purinergic agents|mesh-ancestor
64672675|NCT03064295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64672700|NCT01810952|Insulin, Isophane|insulin, isophane|mesh-list
64672701|NCT01810952|Isophane Insulin, Human|isophane insulin, human|mesh-list
64672702|NCT01810952|Isophane insulin, beef|isophane insulin, beef|mesh-list
64672703|NCT01810952|Insulin Lispro|insulin lispro|mesh-list
64672704|NCT01810952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65401073|NCT00539838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401074|NCT00539838|Dermatologic Agents|dermatologic agents|mesh-ancestor
65401075|NCT00539838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401076|NCT00539838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65401077|NCT00539838|Immunologic Factors|immunologic factors|mesh-ancestor
65401078|NCT00539838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65401079|NCT00539838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65401080|NCT00539838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65401081|NCT00539838|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65401082|NCT00539838|Antitubercular Agents|antitubercular agents|mesh-ancestor
65401083|NCT00539838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65401084|NCT00539838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64672705|NCT01810952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672706|NCT04059887|Atezolizumab|atezolizumab|mesh-list
64672707|NCT04059887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672708|NCT01877642|Lorazepam|lorazepam|mesh-list
64672709|NCT01877642|Loxapine|loxapine|mesh-list
64672710|NCT01877642|Anticonvulsants|anticonvulsants|mesh-ancestor
64672711|NCT01877642|Antiemetics|antiemetics|mesh-ancestor
64672712|NCT01877642|Autonomic Agents|autonomic agents|mesh-ancestor
64672713|NCT01877642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64672714|NCT01877642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672715|NCT01877642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64672716|NCT01877642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64672717|NCT01877642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64672718|NCT01877642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64672719|NCT01877642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64672720|NCT01877642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64672721|NCT01877642|GABA Modulators|gaba modulators|mesh-ancestor
64672722|NCT01877642|GABA Agents|gaba agents|mesh-ancestor
64672723|NCT01877642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64672724|NCT01877642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672725|NCT01877642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64672726|NCT01877642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64672727|NCT01877642|Dopamine Agents|dopamine agents|mesh-ancestor
64672740|NCT01811654|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64672741|NCT01811654|Immunologic Factors|immunologic factors|mesh-ancestor
64672742|NCT01811654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672743|NCT01811654|Viscosupplements|viscosupplements|mesh-ancestor
64672744|NCT01811654|Protective Agents|protective agents|mesh-ancestor
64672745|NCT02266472|Metformin|metformin|mesh-list
64672746|NCT02266472|Empagliflozin|empagliflozin|mesh-list
64557074|NCT04661007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557075|NCT04661007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64557076|NCT04661007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64557077|NCT04661007|Growth Substances|growth substances|mesh-ancestor
64557078|NCT04661007|Growth Inhibitors|growth inhibitors|mesh-ancestor
64557079|NCT04661007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557080|NCT03647657|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64557081|NCT03647657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64557082|NCT03647657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557084|NCT04461288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64557085|NCT04461288|Autonomic Agents|autonomic agents|mesh-ancestor
64557086|NCT04461288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64557087|NCT04461288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557088|NCT04461288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64557089|NCT04461288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64322126|NCT02144441|Insulin Glargine|insulin glargine|mesh-list
64672747|NCT02266472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64672748|NCT02266472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672749|NCT02266472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65401085|NCT00539838|Antiemetics|antiemetics|mesh-ancestor
65401086|NCT00539838|Autonomic Agents|autonomic agents|mesh-ancestor
65401087|NCT00539838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65401088|NCT00539838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65401089|NCT00539838|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65401090|NCT00539838|Protective Agents|protective agents|mesh-ancestor
65401091|NCT00970892|Warfarin|warfarin|mesh-list
65401092|NCT00970892|Anticoagulants|anticoagulants|mesh-ancestor
65401093|NCT00964808|Oxycodone|oxycodone|mesh-list
65401094|NCT00964808|Buprenorphine|buprenorphine|mesh-list
65401095|NCT00964808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65401096|NCT00964808|Narcotics|narcotics|mesh-ancestor
65401097|NCT00964808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64785896|NCT00000834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64672750|NCT02266472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672751|NCT03500289|Midazolam|midazolam|mesh-list
64672752|NCT03500289|Ketamine|ketamine|mesh-list
64672753|NCT03500289|Analgesics|analgesics|mesh-ancestor
64672754|NCT03500289|Sensory System Agents|sensory system agents|mesh-ancestor
64672756|NCT03500289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672757|NCT03500289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64672758|NCT03500289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64672759|NCT03500289|Anesthetics, General|anesthetics, general|mesh-ancestor
64672760|NCT03500289|Anesthetics|anesthetics|mesh-ancestor
64672761|NCT03500289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64672762|NCT03500289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64672763|NCT03500289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64672764|NCT03500289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64672765|NCT03500289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672766|NCT03500289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64672767|NCT03500289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64672768|NCT03500289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64672769|NCT03500289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64672770|NCT03500289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64672771|NCT03500289|GABA Modulators|gaba modulators|mesh-ancestor
64672772|NCT03500289|GABA Agents|gaba agents|mesh-ancestor
64672773|NCT01812044|Lidocaine|lidocaine|mesh-list
64672774|NCT01812044|Bupivacaine|bupivacaine|mesh-list
64672775|NCT01812044|Anesthetics, Local|anesthetics, local|mesh-list
64672776|NCT01812044|Anesthetics|anesthetics|mesh-list
64672777|NCT01812044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64672796|NCT03974789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64672797|NCT03974789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672798|NCT01812668|Fluorides|fluorides|mesh-list
64672799|NCT01812668|Cariostatic Agents|cariostatic agents|mesh-ancestor
64672800|NCT01812668|Protective Agents|protective agents|mesh-ancestor
64672801|NCT01812668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672802|NCT02570477|Vancomycin|vancomycin|mesh-list
64672803|NCT02570477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64557090|NCT04461288|Cholinergic Agents|cholinergic agents|mesh-ancestor
64557091|NCT04461288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64557092|NCT04461288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557093|NCT05582135|Morphine|morphine|mesh-list
64557094|NCT05582135|Esketamine|esketamine|mesh-list
64557095|NCT05582135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64557096|NCT05582135|Narcotics|narcotics|mesh-ancestor
64557097|NCT05582135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64557098|NCT05582135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557099|NCT05582135|Analgesics|analgesics|mesh-ancestor
64557100|NCT05582135|Sensory System Agents|sensory system agents|mesh-ancestor
64557101|NCT05582135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64557102|NCT05582135|Antidepressive Agents|antidepressive agents|mesh-ancestor
64557103|NCT05582135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64557104|NCT03070704|Liraglutide|liraglutide|mesh-list
64557105|NCT03070704|Xultophy|xultophy|mesh-list
64557106|NCT03070704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65401098|NCT00964808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401099|NCT00964808|Analgesics|analgesics|mesh-ancestor
65401100|NCT00964808|Sensory System Agents|sensory system agents|mesh-ancestor
65401101|NCT00964808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65401102|NCT00964808|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65401103|NCT00970970|Bevacizumab|bevacizumab|mesh-list
65401104|NCT00970970|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
65401105|NCT00970970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65401106|NCT00970970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401107|NCT00970970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65401108|NCT00970970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65401109|NCT00970970|Growth Substances|growth substances|mesh-ancestor
64557107|NCT03070704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557108|NCT03070704|Incretins|incretins|mesh-ancestor
64557109|NCT03070704|Hormones|hormones|mesh-ancestor
64557110|NCT03070704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64557111|NCT03069768|Varenicline|varenicline|mesh-list
64557112|NCT03069768|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64557113|NCT03069768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64557114|NCT03069768|Cholinergic Agents|cholinergic agents|mesh-ancestor
64557115|NCT03069768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64557116|NCT03069768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672804|NCT02570477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64672805|NCT04344821|Calcium|calcium|mesh-list
64672806|NCT04344821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64672807|NCT04344821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672808|NCT04351100|Diacetylrhein|diacetylrhein|mesh-list
64672809|NCT04351100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64672810|NCT05328674|Mitogens|mitogens|mesh-list
64672811|NCT05328674|Mitosis Modulators|mitosis modulators|mesh-ancestor
64672812|NCT05328674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672813|NCT01798316|Acetaminophen|acetaminophen|mesh-list
64672814|NCT01798316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64672815|NCT01798316|Analgesics|analgesics|mesh-ancestor
64672816|NCT01798316|Sensory System Agents|sensory system agents|mesh-ancestor
64672817|NCT01798316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64672818|NCT01798316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672819|NCT01798316|Antipyretics|antipyretics|mesh-ancestor
64672830|NCT01798394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64672834|NCT01798550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64672835|NCT01798550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64557117|NCT03069768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557119|NCT04141553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64557120|NCT04141553|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64557121|NCT04141553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64557122|NCT04141553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557123|NCT04141553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64557124|NCT04141553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557125|NCT04141553|Vasodilator Agents|vasodilator agents|mesh-ancestor
64557126|NCT04141163|Metformin|metformin|mesh-list
64557127|NCT04141163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64557128|NCT04141163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557129|NCT00942825|Cisplatin|cisplatin|mesh-list
64557130|NCT00942825|Pemetrexed|pemetrexed|mesh-list
64322171|NCT02231905|Antioxidants|antioxidants|mesh-ancestor
64322172|NCT02231905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672836|NCT01798550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672837|NCT00357305|Cytarabine|cytarabine|mesh-list
64672838|NCT00357305|Etoposide|etoposide|mesh-list
64672839|NCT00357305|Etoposide phosphate|etoposide phosphate|mesh-list
64672840|NCT00357305|Vorinostat|vorinostat|mesh-list
64672841|NCT00357305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65401110|NCT00970970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401111|NCT00970970|Growth Inhibitors|growth inhibitors|mesh-ancestor
65150677|NCT01182285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65401112|NCT00970970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65401113|NCT00970970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401114|NCT03765450|Infliximab|infliximab|mesh-list
65401115|NCT03765450|Dermatologic Agents|dermatologic agents|mesh-ancestor
65401116|NCT03765450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65401117|NCT03765450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65401118|NCT00971126|Thalidomide|thalidomide|mesh-list
65401119|NCT00971126|Sorafenib|sorafenib|mesh-list
65401120|NCT00971126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672842|NCT00357305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672843|NCT00357305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64672844|NCT00357305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64672845|NCT00357305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64672846|NCT00357305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672847|NCT00357305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64672848|NCT00357305|Antimetabolites|antimetabolites|mesh-ancestor
64672849|NCT00357305|Antiviral Agents|antiviral agents|mesh-ancestor
64672850|NCT00357305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64672851|NCT00357305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64672852|NCT00357305|Immunologic Factors|immunologic factors|mesh-ancestor
64672853|NCT00357305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672854|NCT00357305|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64672855|NCT02340000|Amoxicillin|amoxicillin|mesh-list
64672856|NCT02340000|Clavulanic Acid|clavulanic acid|mesh-list
64672857|NCT02340000|Clavulanic Acids|clavulanic acids|mesh-list
64672858|NCT02340000|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64672859|NCT02340000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64672860|NCT02340000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64672861|NCT02340000|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64672862|NCT02340000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64672863|NCT02340000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672864|NCT01813214|Vemurafenib|vemurafenib|mesh-list
64672865|NCT01813214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672866|NCT01813214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64672867|NCT01813214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64672868|NCT01813214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672869|NCT01815008|Aspirin|aspirin|mesh-list
64672870|NCT01815008|Clopidogrel|clopidogrel|mesh-list
64672871|NCT01815008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64672872|NCT01815008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64672873|NCT01815008|Analgesics|analgesics|mesh-ancestor
64672874|NCT01815008|Sensory System Agents|sensory system agents|mesh-ancestor
64672875|NCT01815008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64672876|NCT01815008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557131|NCT00942825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557132|NCT00942825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557133|NCT00942825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557134|NCT00942825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64557135|NCT00942825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64672877|NCT01815008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64672878|NCT01815008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64672879|NCT01815008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64672880|NCT01815008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64672881|NCT01815008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672882|NCT01815008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64672897|NCT01801124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64672899|NCT00357461|Vaccines|vaccines|mesh-list
64672900|NCT00357461|Freund's Adjuvant|freund's adjuvant|mesh-list
64672901|NCT00357461|Immunologic Factors|immunologic factors|mesh-ancestor
65401121|NCT00971126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65401122|NCT00971126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401123|NCT00971126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401124|NCT00971126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65401125|NCT00971126|Immunologic Factors|immunologic factors|mesh-ancestor
65401126|NCT00971126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401127|NCT00971126|Leprostatic Agents|leprostatic agents|mesh-ancestor
65401128|NCT00971126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65401129|NCT00971126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64672902|NCT00357461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672903|NCT00357461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64672904|NCT00357461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672905|NCT00357461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64672906|NCT00357461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672907|NCT00357461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64672908|NCT00357539|Azithromycin|azithromycin|mesh-list
64672909|NCT00357539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64672910|NCT00357539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64672911|NCT03331965|Metoclopramide|metoclopramide|mesh-list
64672912|NCT03331965|Antiemetics|antiemetics|mesh-ancestor
64672913|NCT03331965|Autonomic Agents|autonomic agents|mesh-ancestor
64672914|NCT03331965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64672915|NCT03331965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672916|NCT03331965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64672917|NCT03331965|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64672918|NCT03331965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64672919|NCT03331965|Dopamine Agents|dopamine agents|mesh-ancestor
64672920|NCT03331965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64672921|NCT03331965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672922|NCT03278223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64672923|NCT03279237|Leucovorin|leucovorin|mesh-list
64672924|NCT03279237|Paclitaxel|paclitaxel|mesh-list
64672925|NCT03279237|Carboplatin|carboplatin|mesh-list
64672926|NCT03279237|Fluorouracil|fluorouracil|mesh-list
64672927|NCT03279237|Oxaliplatin|oxaliplatin|mesh-list
64672928|NCT03279237|Irinotecan|irinotecan|mesh-list
64672929|NCT03279237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64672938|NCT03279237|Immunologic Factors|immunologic factors|mesh-ancestor
64672939|NCT03279237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672940|NCT03279237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64672941|NCT03279237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64672942|NCT03279237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64672943|NCT03279237|Antidotes|antidotes|mesh-ancestor
64672944|NCT03279237|Protective Agents|protective agents|mesh-ancestor
64672945|NCT03279237|Vitamin B Complex|vitamin b complex|mesh-ancestor
64672946|NCT03279237|Vitamins|vitamins|mesh-ancestor
64672947|NCT03279237|Micronutrients|micronutrients|mesh-ancestor
64672948|NCT03282591|Serlopitant|serlopitant|mesh-list
64672949|NCT03282591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64672950|NCT03282591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64672951|NCT03282591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672952|NCT03282591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672953|NCT03509883|Apixaban|apixaban|mesh-list
64672954|NCT03509883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64672955|NCT03509883|Antithrombins|antithrombins|mesh-ancestor
64672956|NCT03509883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64672957|NCT03509883|Protease Inhibitors|protease inhibitors|mesh-ancestor
64672958|NCT03509883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557136|NCT04544943|Gentamicins|gentamicins|mesh-list
64557137|NCT04544943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64557138|NCT04544943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64557139|NCT04544943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64557140|NCT04544943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322192|NCT02698293|Cholecalciferol|cholecalciferol|mesh-list
64672959|NCT03509883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672960|NCT03509883|Anticoagulants|anticoagulants|mesh-ancestor
64672961|NCT03336645|Midazolam|midazolam|mesh-list
65401130|NCT00971126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65401131|NCT00971126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65401132|NCT00971126|Growth Substances|growth substances|mesh-ancestor
65401133|NCT00971126|Growth Inhibitors|growth inhibitors|mesh-ancestor
65401134|NCT00964964|Insulin|insulin|mesh-list
65401135|NCT00964964|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65401136|NCT00964964|Insulin, Long-Acting|insulin, long-acting|mesh-list
65401137|NCT00964964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65401138|NCT00964964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401139|NCT00965042|Ceftobiprole|ceftobiprole|mesh-list
65401140|NCT00965042|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
65401141|NCT00965042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65401142|NCT00965042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65401143|NCT03676764|Azithromycin|azithromycin|mesh-list
64672962|NCT03336645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64672963|NCT03336645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64672964|NCT03336645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64672965|NCT03336645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672966|NCT03336645|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64672967|NCT03336645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64672970|NCT03336645|Anesthetics, General|anesthetics, general|mesh-ancestor
64672971|NCT03336645|Anesthetics|anesthetics|mesh-ancestor
64672972|NCT03336645|GABA Modulators|gaba modulators|mesh-ancestor
64672973|NCT03336645|GABA Agents|gaba agents|mesh-ancestor
64672974|NCT03336645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64672975|NCT03336645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672976|NCT00376311|Calcitonin|calcitonin|mesh-list
64672977|NCT00376311|Salmon calcitonin|salmon calcitonin|mesh-list
64672978|NCT00376311|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
64672979|NCT00376311|Katacalcin|katacalcin|mesh-list
64672980|NCT00376311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64672981|NCT00376311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672982|NCT00376311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64672983|NCT00376311|Vasodilator Agents|vasodilator agents|mesh-ancestor
64672985|NCT03511521|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64672986|NCT03511521|Insulin Aspart|insulin aspart|mesh-list
64672987|NCT03511521|Insulin, Isophane|insulin, isophane|mesh-list
64672988|NCT03511521|Isophane Insulin, Human|isophane insulin, human|mesh-list
64672989|NCT03511521|Isophane insulin, beef|isophane insulin, beef|mesh-list
64672990|NCT03511521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64672991|NCT03511521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672992|NCT00376077|Methylprednisolone|methylprednisolone|mesh-list
64672993|NCT00376077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64672994|NCT00376077|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64672995|NCT00376077|gamma-Globulins|gamma-globulins|mesh-list
64672996|NCT00376077|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64673005|NCT00376077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64673007|NCT00376077|Protective Agents|protective agents|mesh-ancestor
64673008|NCT00376077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64673009|NCT00376077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673010|NCT00376077|Immunologic Factors|immunologic factors|mesh-ancestor
64673011|NCT03519243|Darbepoetin alfa|darbepoetin alfa|mesh-list
64673012|NCT03519243|Hematinics|hematinics|mesh-ancestor
64673013|NCT03577275|Moxifloxacin|moxifloxacin|mesh-list
64673014|NCT03577275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64673015|NCT03577275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64673016|NCT03577275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64673017|NCT03577275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64673018|NCT03577275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673019|NCT03577275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673020|NCT03577275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673021|NCT03521505|Dexmedetomidine|dexmedetomidine|mesh-list
64673022|NCT03521505|Propofol|propofol|mesh-list
64673023|NCT03521505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65401144|NCT03676764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65401145|NCT03676764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65401146|NCT00974792|Leucovorin|leucovorin|mesh-list
65401147|NCT00974792|Cytarabine|cytarabine|mesh-list
65401148|NCT00974792|Cyclophosphamide|cyclophosphamide|mesh-list
65401149|NCT00974792|Ifosfamide|ifosfamide|mesh-list
65401150|NCT00974792|Rituximab|rituximab|mesh-list
65401151|NCT00974792|Doxorubicin|doxorubicin|mesh-list
65401152|NCT00974792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64673024|NCT03521505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64673025|NCT03521505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673026|NCT03521505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64673027|NCT03521505|Anesthetics, General|anesthetics, general|mesh-ancestor
64673028|NCT03521505|Anesthetics|anesthetics|mesh-ancestor
64673029|NCT03521505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64673030|NCT03521505|Analgesics|analgesics|mesh-ancestor
64673031|NCT03521505|Sensory System Agents|sensory system agents|mesh-ancestor
64673032|NCT03521505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64557141|NCT04544943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557143|NCT04140461|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64557144|NCT04140461|Flucytosine|flucytosine|mesh-list
64557145|NCT04140461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64557146|NCT04140461|Amebicides|amebicides|mesh-ancestor
64557147|NCT04140461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64673033|NCT03521505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64673034|NCT03521505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64673035|NCT03521505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64673036|NCT03521505|Adrenergic Agents|adrenergic agents|mesh-ancestor
64673037|NCT03521505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64673038|NCT03521505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673039|NCT03522441|Clindamycin|clindamycin|mesh-list
64673040|NCT03522441|Clindamycin palmitate|clindamycin palmitate|mesh-list
64673041|NCT03522441|Clindamycin phosphate|clindamycin phosphate|mesh-list
64673042|NCT03522441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64673043|NCT03522441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64673044|NCT03522441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64673045|NCT03522441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673048|NCT03530631|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64673049|NCT03530631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673050|NCT03350217|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
64673051|NCT03350217|Plasma Substitutes|plasma substitutes|mesh-ancestor
64673052|NCT03350217|Blood Substitutes|blood substitutes|mesh-ancestor
64673053|NCT03351933|Immunoglobulins|immunoglobulins|mesh-list
64673054|NCT03351933|Antibodies|antibodies|mesh-list
64673055|NCT03351933|gamma-Globulins|gamma-globulins|mesh-list
64673056|NCT03351933|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64673057|NCT03351933|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64673058|NCT03351933|Immunologic Factors|immunologic factors|mesh-ancestor
64673059|NCT03351933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673061|NCT03594045|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64673062|NCT03594045|Antithrombins|antithrombins|mesh-ancestor
64673063|NCT03594045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64673064|NCT03594045|Protease Inhibitors|protease inhibitors|mesh-ancestor
64673072|NCT03595449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673073|NCT03595449|Sensory System Agents|sensory system agents|mesh-ancestor
64673074|NCT03595449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64673075|NCT03595449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64673076|NCT03595449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64673077|NCT03595449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64673078|NCT03595449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64673079|NCT03595449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673080|NCT03597009|Nivolumab|nivolumab|mesh-list
64673081|NCT03597009|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
64673082|NCT03597009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64673083|NCT03597009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673084|NCT03597009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64673085|NCT03597009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673086|NCT03352323|Phenylephrine|phenylephrine|mesh-list
65401153|NCT00974792|Methotrexate|methotrexate|mesh-list
65401154|NCT00974792|Etoposide|etoposide|mesh-list
65401155|NCT00974792|Vincristine|vincristine|mesh-list
65401156|NCT00974792|Etoposide phosphate|etoposide phosphate|mesh-list
65401157|NCT00974792|Levoleucovorin|levoleucovorin|mesh-list
65401158|NCT00974792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65401159|NCT00974792|Immunologic Factors|immunologic factors|mesh-ancestor
65401160|NCT00974792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401161|NCT00974792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65401162|NCT00974792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65401163|NCT00974792|Alkylating Agents|alkylating agents|mesh-ancestor
65401164|NCT00974792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401165|NCT00974792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401166|NCT00974792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64785962|NCT00000918|Efavirenz|efavirenz|mesh-list
64673087|NCT03352323|Oxymetazoline|oxymetazoline|mesh-list
64673088|NCT03352323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64673089|NCT03352323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64673090|NCT03352323|Adrenergic Agents|adrenergic agents|mesh-ancestor
64673091|NCT03352323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64673092|NCT03352323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673093|NCT03352323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673094|NCT03352323|Sympathomimetics|sympathomimetics|mesh-ancestor
64673095|NCT03352323|Autonomic Agents|autonomic agents|mesh-ancestor
64673096|NCT03352323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64673097|NCT03352323|Nasal Decongestants|nasal decongestants|mesh-ancestor
64673098|NCT03352323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64673099|NCT03352323|Respiratory System Agents|respiratory system agents|mesh-ancestor
64673100|NCT03352323|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64557150|NCT04140461|Antifungal Agents|antifungal agents|mesh-ancestor
64557151|NCT04140461|Antimetabolites|antimetabolites|mesh-ancestor
64557152|NCT04140461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557153|NCT03021629|Vitamin D|vitamin d|mesh-list
64557154|NCT03021629|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
64557155|NCT03021629|Vitamins|vitamins|mesh-ancestor
64557156|NCT03021629|Micronutrients|micronutrients|mesh-ancestor
64557157|NCT03021629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557158|NCT03021629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64557159|NCT03021395|Decitabine|decitabine|mesh-list
64557160|NCT03021395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64557161|NCT03021395|Antimetabolites|antimetabolites|mesh-ancestor
64673101|NCT03352323|Mydriatics|mydriatics|mesh-ancestor
64673102|NCT03352323|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64673103|NCT03352323|Protective Agents|protective agents|mesh-ancestor
64673104|NCT04734639|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
64673105|NCT04734639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673106|NCT04734639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673108|NCT03357393|Glycopyrrolate|glycopyrrolate|mesh-list
64673109|NCT03357393|Scopolamine|scopolamine|mesh-list
64673110|NCT03357393|Morphine|morphine|mesh-list
64673111|NCT03357393|Propofol|propofol|mesh-list
64673112|NCT03357393|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64673113|NCT03357393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64673114|NCT03357393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64673115|NCT03357393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673121|NCT03357393|Analgesics|analgesics|mesh-ancestor
64673122|NCT03357393|Sensory System Agents|sensory system agents|mesh-ancestor
64673123|NCT03357393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64673124|NCT03357393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64673125|NCT03357393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64673126|NCT03357393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64673127|NCT03357393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64673128|NCT03357393|GABA Modulators|gaba modulators|mesh-ancestor
65401167|NCT00974792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65401168|NCT00974792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65401169|NCT00974792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65401170|NCT00974792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65401171|NCT00974792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401172|NCT00974792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65401173|NCT00974792|Abortifacient Agents|abortifacient agents|mesh-ancestor
65401174|NCT00974792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65401175|NCT00974792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65401176|NCT00974792|Antimetabolites|antimetabolites|mesh-ancestor
65401177|NCT00974792|Dermatologic Agents|dermatologic agents|mesh-ancestor
65401178|NCT00974792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65401179|NCT00974792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65401180|NCT00974792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65401181|NCT00974792|Antiviral Agents|antiviral agents|mesh-ancestor
64673129|NCT03357393|GABA Agents|gaba agents|mesh-ancestor
64673130|NCT03357393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64673131|NCT03357393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673132|NCT03357393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64673169|NCT03366207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64673170|NCT03366207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64673183|NCT03368235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673184|NCT02310750|PF-06700841|pf-06700841|mesh-list
64673185|NCT02310750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64673186|NCT02310750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673187|NCT02310750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673188|NCT03615807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64673189|NCT03615807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64673190|NCT02310672|Macitentan|macitentan|mesh-list
64673191|NCT02310672|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64673192|NCT02310672|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64673193|NCT02310672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673194|NCT02310672|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64673195|NCT03626415|Abrocitinib|abrocitinib|mesh-list
64673196|NCT03626415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64557162|NCT03021395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557163|NCT03021395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557164|NCT03021395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557165|NCT03021317|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64557166|NCT03021317|Hormones|hormones|mesh-ancestor
64557167|NCT03021317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64557168|NCT03021317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557169|NCT04987632|Letrozole|letrozole|mesh-list
64557170|NCT04987632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557171|NCT04987632|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64557172|NCT04987632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64557173|NCT04987632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557174|NCT04987632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557175|NCT04987632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64557176|NCT04987632|Hormone Antagonists|hormone antagonists|mesh-ancestor
64557177|NCT04987632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64557178|NCT04987632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557179|NCT03032367|Bedaquiline|bedaquiline|mesh-list
64557180|NCT03032367|Antitubercular Agents|antitubercular agents|mesh-ancestor
64557181|NCT03032367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64557182|NCT03032367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65401182|NCT00974792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65401183|NCT00974792|Antidotes|antidotes|mesh-ancestor
65401184|NCT00974792|Protective Agents|protective agents|mesh-ancestor
65401185|NCT00974792|Vitamin B Complex|vitamin b complex|mesh-ancestor
65401186|NCT00974792|Vitamins|vitamins|mesh-ancestor
65401187|NCT00974792|Micronutrients|micronutrients|mesh-ancestor
65401188|NCT00974792|Tubulin Modulators|tubulin modulators|mesh-ancestor
65401189|NCT00974792|Antimitotic Agents|antimitotic agents|mesh-ancestor
65401190|NCT00974792|Mitosis Modulators|mitosis modulators|mesh-ancestor
65401191|NCT00965120|Bradykinin|bradykinin|mesh-list
64557183|NCT02634606|Tocotrienols|tocotrienols|mesh-list
64557184|NCT02634606|Vitamin E|vitamin e|mesh-list
64557185|NCT02634606|Tocopherols|tocopherols|mesh-list
64557186|NCT02634606|Antioxidants|antioxidants|mesh-ancestor
64557187|NCT02634606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557188|NCT02634606|Protective Agents|protective agents|mesh-ancestor
64557189|NCT02634606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557190|NCT02634606|Vitamins|vitamins|mesh-ancestor
64557191|NCT02634606|Micronutrients|micronutrients|mesh-ancestor
64557192|NCT05002686|Paclitaxel|paclitaxel|mesh-list
64557193|NCT05002686|Capecitabine|capecitabine|mesh-list
64557194|NCT05002686|Oxaliplatin|oxaliplatin|mesh-list
64557195|NCT05002686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64557196|NCT05002686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557197|NCT05002686|Tubulin Modulators|tubulin modulators|mesh-ancestor
64557198|NCT05002686|Antimitotic Agents|antimitotic agents|mesh-ancestor
64557199|NCT05002686|Mitosis Modulators|mitosis modulators|mesh-ancestor
64557208|NCT03588689|Sensory System Agents|sensory system agents|mesh-ancestor
64557209|NCT03588689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64557210|NCT04985526|Octenidine|octenidine|mesh-list
64557211|NCT04985526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64557212|NCT04985526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64557213|NCT03588611|Hirudins|hirudins|mesh-list
64557214|NCT03588611|Bivalirudin|bivalirudin|mesh-list
64557215|NCT03588611|Antithrombins|antithrombins|mesh-ancestor
64557216|NCT03588611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64557217|NCT03588611|Protease Inhibitors|protease inhibitors|mesh-ancestor
64557218|NCT03588611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557219|NCT03588611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557220|NCT03588611|Anticoagulants|anticoagulants|mesh-ancestor
64557221|NCT03588611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64673197|NCT03626415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673198|NCT03626415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673199|NCT04373421|Chlorhexidine|chlorhexidine|mesh-list
64673200|NCT04373421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64673201|NCT04373421|Benzydamine|benzydamine|mesh-list
64673202|NCT04373421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64673203|NCT04373421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64673204|NCT04373421|Disinfectants|disinfectants|mesh-ancestor
64673205|NCT04373421|Dermatologic Agents|dermatologic agents|mesh-ancestor
64673206|NCT04373421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64673207|NCT03632109|Gentamicins|gentamicins|mesh-list
64673208|NCT03632109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64673228|NCT02363946|Histamine Agents|histamine agents|mesh-ancestor
64673229|NCT02363946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64673230|NCT02363946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673231|NCT02363946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64673232|NCT02363946|Antipruritics|antipruritics|mesh-ancestor
64673233|NCT02363946|Dermatologic Agents|dermatologic agents|mesh-ancestor
64673235|NCT02363478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64673236|NCT02363478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64673237|NCT02363478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64673238|NCT02363478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673239|NCT02363478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64673240|NCT02363478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64673241|NCT02363478|Serotonin Agents|serotonin agents|mesh-ancestor
64673242|NCT02363478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64673243|NCT02363478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673244|NCT02338362|Fluticasone|fluticasone|mesh-list
64673245|NCT02338362|Xhance|xhance|mesh-list
64673246|NCT02338362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65401192|NCT00965120|Kininogens|kininogens|mesh-list
65401193|NCT00965120|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
65401194|NCT00965120|Vasodilator Agents|vasodilator agents|mesh-ancestor
65401195|NCT00965120|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65401196|NCT00965120|Protease Inhibitors|protease inhibitors|mesh-ancestor
65401197|NCT00965120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401198|NCT00965120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401199|NCT00679289|Interferons|interferons|mesh-list
65401200|NCT00679289|Ecromeximab|ecromeximab|mesh-list
65401201|NCT00679289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401202|NCT00679289|Antiviral Agents|antiviral agents|mesh-ancestor
64484461|NCT01727713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64557222|NCT03588611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64557223|NCT03588533|Capecitabine|capecitabine|mesh-list
64557224|NCT03588533|Trastuzumab|trastuzumab|mesh-list
64557225|NCT03588533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557226|NCT03588533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64557227|NCT03588533|Antimetabolites|antimetabolites|mesh-ancestor
64557228|NCT03588533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557229|NCT03588533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64557230|NCT03068442|Flutemetamol|flutemetamol|mesh-list
64557231|NCT03068442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64557232|NCT03068442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557233|NCT00939705|Topiramate|topiramate|mesh-list
64557234|NCT00939705|Anticonvulsants|anticonvulsants|mesh-ancestor
64322280|NCT02397603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64322282|NCT02145065|Paclitaxel|paclitaxel|mesh-list
64673254|NCT02338362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64673256|NCT02360280|Ketamine|ketamine|mesh-list
64673257|NCT02360280|Analgesics|analgesics|mesh-ancestor
64673258|NCT02360280|Sensory System Agents|sensory system agents|mesh-ancestor
64673259|NCT02360280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64673260|NCT02360280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673261|NCT02360280|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64673262|NCT02360280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64673263|NCT02360280|Anesthetics, General|anesthetics, general|mesh-ancestor
64673264|NCT02360280|Anesthetics|anesthetics|mesh-ancestor
64673265|NCT02360280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64673281|NCT01803074|BMS-955176|bms-955176|mesh-list
64673282|NCT01803074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64673283|NCT01803074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64673284|NCT01803074|Protease Inhibitors|protease inhibitors|mesh-ancestor
64673285|NCT01803074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673286|NCT01803074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673288|NCT01803074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64673289|NCT01803074|Antiviral Agents|antiviral agents|mesh-ancestor
64673290|NCT01803074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64673291|NCT01803074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64673292|NCT01803074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64673293|NCT01803074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64673294|NCT01803074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64673295|NCT05327894|Blinatumomab|blinatumomab|mesh-list
64673296|NCT05327894|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64673297|NCT05327894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673298|NCT05327894|Immunologic Factors|immunologic factors|mesh-ancestor
64673299|NCT05327894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673300|NCT05327660|Carbon Monoxide|carbon monoxide|mesh-list
64673301|NCT05327660|Antimetabolites|antimetabolites|mesh-ancestor
64673302|NCT05327660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673303|NCT05327660|Gasotransmitters|gasotransmitters|mesh-ancestor
64673304|NCT05327660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64673305|NCT05327660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557235|NCT00939705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64557236|NCT00939705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557237|NCT05001672|Tenofovir|tenofovir|mesh-list
65401203|NCT00679289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65401204|NCT00679289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65401205|NCT00679211|Trastuzumab|trastuzumab|mesh-list
65401206|NCT00679211|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65401207|NCT00679211|Maytansine|maytansine|mesh-list
65401208|NCT00679211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65401209|NCT00679211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401210|NCT00679211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65401211|NCT00679211|Tubulin Modulators|tubulin modulators|mesh-ancestor
65401212|NCT00679211|Antimitotic Agents|antimitotic agents|mesh-ancestor
65401213|NCT00679211|Mitosis Modulators|mitosis modulators|mesh-ancestor
65401214|NCT00679211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401215|NCT00545948|Cisplatin|cisplatin|mesh-list
65401216|NCT00545948|Pemetrexed|pemetrexed|mesh-list
65401217|NCT00545948|Vinorelbine|vinorelbine|mesh-list
65401218|NCT00545948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401219|NCT00545948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401220|NCT00545948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557238|NCT05001672|Antiviral Agents|antiviral agents|mesh-ancestor
64557239|NCT05001672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64557240|NCT05001672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64557241|NCT05001672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64557242|NCT05001672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557243|NCT05001672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557244|NCT05001672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64557245|NCT05001672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64557246|NCT04354545|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64557247|NCT04354545|Lifitegrast|lifitegrast|mesh-list
64557248|NCT04354545|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64557249|NCT03587285|Goserelin|goserelin|mesh-list
64557250|NCT03587285|Abiraterone Acetate|abiraterone acetate|mesh-list
64557251|NCT03587285|Bicalutamide|bicalutamide|mesh-list
64557252|NCT03587285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64557253|NCT03587285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557254|NCT03587285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64557255|NCT03587285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557256|NCT03587285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557257|NCT03587285|Hormone Antagonists|hormone antagonists|mesh-ancestor
64322294|NCT02226757|Mitosis Modulators|mitosis modulators|mesh-ancestor
64673306|NCT01822886|Gemcitabine|gemcitabine|mesh-list
64673309|NCT01822886|Antimetabolites|antimetabolites|mesh-ancestor
64673310|NCT01822886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673311|NCT01822886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673312|NCT01822886|Antiviral Agents|antiviral agents|mesh-ancestor
64673313|NCT01822886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64673314|NCT01822886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673315|NCT01822886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64673316|NCT01822886|Immunologic Factors|immunologic factors|mesh-ancestor
64673317|NCT01822886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673318|NCT01822886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64673319|NCT01823510|Aspirin|aspirin|mesh-list
64673320|NCT01823510|Clopidogrel|clopidogrel|mesh-list
64673321|NCT01823510|Ticagrelor|ticagrelor|mesh-list
64673322|NCT01823510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64673323|NCT01823510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64673324|NCT01823510|Analgesics|analgesics|mesh-ancestor
64673325|NCT01823510|Sensory System Agents|sensory system agents|mesh-ancestor
65401221|NCT00545948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65401222|NCT00545948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65401223|NCT00545948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65401224|NCT00545948|Tubulin Modulators|tubulin modulators|mesh-ancestor
65401225|NCT00545948|Antimitotic Agents|antimitotic agents|mesh-ancestor
65401226|NCT00545948|Mitosis Modulators|mitosis modulators|mesh-ancestor
65401227|NCT00755573|Pregabalin|pregabalin|mesh-list
65401228|NCT00755573|Analgesics|analgesics|mesh-ancestor
65401229|NCT00755573|Sensory System Agents|sensory system agents|mesh-ancestor
65401230|NCT00755573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65401231|NCT00755573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786029|NCT00000948|Aldesleukin|aldesleukin|mesh-list
64673326|NCT01823510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64673333|NCT01823510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64673334|NCT01823510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64673335|NCT01823510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673336|NCT01823510|Antipyretics|antipyretics|mesh-ancestor
64673337|NCT01823510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64673338|NCT01823510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64557258|NCT03587285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64557259|NCT03587285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557260|NCT03587285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64557261|NCT03587285|Androgen Antagonists|androgen antagonists|mesh-ancestor
64557262|NCT03587129|Apatinib|apatinib|mesh-list
64557263|NCT03587129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557264|NCT03587129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64557265|NCT03587129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557266|NCT03587129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557267|NCT02245503|Tamsulosin|tamsulosin|mesh-list
64557268|NCT02245503|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64557269|NCT02245503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64557270|NCT02245503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64557271|NCT02245503|Adrenergic Agents|adrenergic agents|mesh-ancestor
64557272|NCT02245503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64557273|NCT02245503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557274|NCT02245503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557275|NCT02245503|Urological Agents|urological agents|mesh-ancestor
64557276|NCT03586817|Palonosetron|palonosetron|mesh-list
64557277|NCT03586817|Fosaprepitant|fosaprepitant|mesh-list
64557278|NCT03586817|Aprepitant|aprepitant|mesh-list
64557279|NCT03586817|Antiemetics|antiemetics|mesh-ancestor
64557280|NCT03586817|Autonomic Agents|autonomic agents|mesh-ancestor
64557281|NCT03586817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64557282|NCT03586817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557283|NCT03586817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64557284|NCT03586817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64557285|NCT03586817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64557286|NCT03586817|Serotonin Agents|serotonin agents|mesh-ancestor
64557287|NCT03586817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64557288|NCT03586817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557289|NCT03586817|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64557290|NCT03891173|Vinorelbine|vinorelbine|mesh-list
64557291|NCT03891173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557292|NCT03891173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64714196|NCT02988050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64557294|NCT03891173|Antimitotic Agents|antimitotic agents|mesh-ancestor
64557295|NCT03891173|Mitosis Modulators|mitosis modulators|mesh-ancestor
64557296|NCT03891173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557297|NCT03585725|Ribavirin|ribavirin|mesh-list
64557298|NCT03585725|Antimetabolites|antimetabolites|mesh-ancestor
64557299|NCT03585725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401232|NCT00755573|Anticonvulsants|anticonvulsants|mesh-ancestor
65401233|NCT00755573|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65401234|NCT00755573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65401235|NCT00755573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401236|NCT00755573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65401237|NCT00755573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65401238|NCT00755573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65401239|NCT00755573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65401240|NCT00755573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64557300|NCT03585725|Antiviral Agents|antiviral agents|mesh-ancestor
64557301|NCT03585725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64557302|NCT03585569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64557303|NCT03585569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64557306|NCT03585569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557307|NCT03585569|Cholinergic Agents|cholinergic agents|mesh-ancestor
64557308|NCT03585569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64557309|NCT03585569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557310|NCT03585569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64557311|NCT03585569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64557312|NCT03585179|Tranexamic Acid|tranexamic acid|mesh-list
64557313|NCT03585179|Hydroquinone|hydroquinone|mesh-list
64557314|NCT03585179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64557315|NCT03585179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64557316|NCT03585179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557317|NCT03585179|Hemostatics|hemostatics|mesh-ancestor
64557318|NCT03585179|Coagulants|coagulants|mesh-ancestor
64557319|NCT03585179|Antioxidants|antioxidants|mesh-ancestor
64557320|NCT03585179|Protective Agents|protective agents|mesh-ancestor
64673339|NCT01823510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64673340|NCT01823510|Purinergic Agents|purinergic agents|mesh-ancestor
64673341|NCT01823510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64673342|NCT05327582|Paclitaxel|paclitaxel|mesh-list
64673343|NCT05327582|Durvalumab|durvalumab|mesh-list
64673344|NCT05327582|Lenvatinib|lenvatinib|mesh-list
64673345|NCT05327582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64673346|NCT05327582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673347|NCT05327582|Tubulin Modulators|tubulin modulators|mesh-ancestor
64673348|NCT05327582|Antimitotic Agents|antimitotic agents|mesh-ancestor
64673349|NCT05327582|Mitosis Modulators|mitosis modulators|mesh-ancestor
64673350|NCT05327582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673351|NCT05327582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64673352|NCT05327582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64673353|NCT05327582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673354|NCT02271698|Dexamethasone|dexamethasone|mesh-list
64673355|NCT02271698|Dexamethasone acetate|dexamethasone acetate|mesh-list
64673356|NCT02271698|BB 1101|bb 1101|mesh-list
64322383|NCT00705783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64557321|NCT03585179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557322|NCT03585179|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64557323|NCT03585101|Grazoprevir|grazoprevir|mesh-list
64557324|NCT03585101|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
64557325|NCT03585101|Antiviral Agents|antiviral agents|mesh-ancestor
64557326|NCT03585101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64557327|NCT03584087|Terlipressin|terlipressin|mesh-list
64557328|NCT03584087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64557329|NCT03584087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64557330|NCT03834363|Fentanyl|fentanyl|mesh-list
64557331|NCT03834363|Morphine|morphine|mesh-list
64673357|NCT02271698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64673359|NCT02271698|Autonomic Agents|autonomic agents|mesh-ancestor
64673360|NCT02271698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64673361|NCT02271698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673362|NCT02271698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64673363|NCT02271698|Glucocorticoids|glucocorticoids|mesh-ancestor
64673364|NCT02271698|Hormones|hormones|mesh-ancestor
64673365|NCT02271698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65401241|NCT00975104|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
65401242|NCT00975104|Immunologic Factors|immunologic factors|mesh-ancestor
65401243|NCT00975104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401244|NCT04008290|Liraglutide|liraglutide|mesh-list
65401245|NCT04008290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65401246|NCT04008290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401247|NCT04008290|Incretins|incretins|mesh-ancestor
65401248|NCT04008290|Hormones|hormones|mesh-ancestor
64786046|NCT00000954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673366|NCT02271698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64673367|NCT02271698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673368|NCT02271698|Protease Inhibitors|protease inhibitors|mesh-ancestor
64673369|NCT02271698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673370|NCT02271698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673371|NCT02328404|Vitamin D|vitamin d|mesh-list
64673372|NCT02328404|Cholecalciferol|cholecalciferol|mesh-list
64673373|NCT02328404|Vitamins|vitamins|mesh-ancestor
64673374|NCT02328404|Micronutrients|micronutrients|mesh-ancestor
64673375|NCT02328404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673376|NCT02328404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64673377|NCT02328404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64673378|NCT05748236|Lamotrigine|lamotrigine|mesh-list
64673379|NCT05748236|Carbamazepine|carbamazepine|mesh-list
64673380|NCT05748236|Anticonvulsants|anticonvulsants|mesh-ancestor
64673381|NCT05748236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64673382|NCT05748236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64673383|NCT05748236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673384|NCT05748236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64673387|NCT05748236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64673388|NCT05748236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64673389|NCT05748236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64673390|NCT05748236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64673392|NCT05748236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64673394|NCT05748236|Sensory System Agents|sensory system agents|mesh-ancestor
64673395|NCT05748236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64673396|NCT05748236|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64673397|NCT05748236|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64673398|NCT01829516|Oxytocin|oxytocin|mesh-list
64673399|NCT01829516|Oxytocics|oxytocics|mesh-ancestor
64673400|NCT01829516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64673401|NCT01829516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673402|NCT01830140|Bimatoprost|bimatoprost|mesh-list
64673403|NCT01830140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64673404|NCT01830842|Nicotine|nicotine|mesh-list
64673405|NCT01830842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64673406|NCT01830842|Autonomic Agents|autonomic agents|mesh-ancestor
64673407|NCT01830842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64673408|NCT01830842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673409|NCT01830842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64673410|NCT01830842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64673411|NCT01830842|Cholinergic Agents|cholinergic agents|mesh-ancestor
64557333|NCT03834363|Narcotics|narcotics|mesh-ancestor
64557334|NCT03834363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64557335|NCT03834363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557336|NCT03834363|Analgesics|analgesics|mesh-ancestor
64557337|NCT03834363|Sensory System Agents|sensory system agents|mesh-ancestor
64557338|NCT03834363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64557339|NCT03834363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64322392|NCT00705783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64322398|NCT03719768|Avelumab|avelumab|mesh-list
64673412|NCT01830842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64673413|NCT01830842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673414|NCT01831232|Cytarabine|cytarabine|mesh-list
64673415|NCT01831232|Idarubicin|idarubicin|mesh-list
64673416|NCT01831232|Pravastatin|pravastatin|mesh-list
64673417|NCT01831232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64673418|NCT01831232|Antimetabolites|antimetabolites|mesh-ancestor
65401249|NCT04008290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65401250|NCT02559167|Cannabidiol|cannabidiol|mesh-list
65401251|NCT02559167|Anticonvulsants|anticonvulsants|mesh-ancestor
65401252|NCT00975182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65401253|NCT00975182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401254|NCT00975182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65401255|NCT00975182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401256|NCT00975182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401257|NCT05271071|Lidocaine|lidocaine|mesh-list
65401258|NCT05271071|Anesthetics, Local|anesthetics, local|mesh-ancestor
65401259|NCT05271071|Anesthetics|anesthetics|mesh-ancestor
65401260|NCT05271071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65401261|NCT05271071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401262|NCT05271071|Sensory System Agents|sensory system agents|mesh-ancestor
65401263|NCT05271071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65401264|NCT05271071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65401265|NCT05271071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65401267|NCT05271071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65401268|NCT05271071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401269|NCT00972140|Formoterol Fumarate|formoterol fumarate|mesh-list
65401270|NCT00972140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65401271|NCT00972140|Autonomic Agents|autonomic agents|mesh-ancestor
64786068|NCT00000990|Zidovudine|zidovudine|mesh-list
64673419|NCT01831232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673420|NCT01831232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673421|NCT01831232|Antiviral Agents|antiviral agents|mesh-ancestor
64673422|NCT01831232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64673423|NCT01831232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64673424|NCT01831232|Immunologic Factors|immunologic factors|mesh-ancestor
64673425|NCT01831232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673426|NCT01831232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64673427|NCT01831232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64673428|NCT01831232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64673429|NCT01831232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673430|NCT01831232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64673431|NCT01831232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64673433|NCT01831232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64673434|NCT01831934|Vaccines|vaccines|mesh-list
64673435|NCT01831934|Immunologic Factors|immunologic factors|mesh-ancestor
64673436|NCT01831934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673437|NCT01833026|Albuterol|albuterol|mesh-list
64673438|NCT01833026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64673439|NCT01833026|Autonomic Agents|autonomic agents|mesh-ancestor
64673440|NCT01833026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64673441|NCT01833026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673442|NCT01833026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64673443|NCT01833026|Respiratory System Agents|respiratory system agents|mesh-ancestor
64673444|NCT01833026|Tocolytic Agents|tocolytic agents|mesh-ancestor
64673445|NCT01833026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64673446|NCT01833026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65401272|NCT00972140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65401273|NCT00972140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401274|NCT00972140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65401275|NCT00972140|Respiratory System Agents|respiratory system agents|mesh-ancestor
65401276|NCT00972140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65401277|NCT00972140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65401278|NCT00972140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65401279|NCT00972140|Adrenergic Agents|adrenergic agents|mesh-ancestor
65401280|NCT00972140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65401281|NCT00972140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401282|NCT00972218|Adalimumab|adalimumab|mesh-list
65401283|NCT00972218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65401284|NCT00972218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64786078|NCT00000996|Doxorubicin|doxorubicin|mesh-list
64673447|NCT01833026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64673448|NCT01833026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64673449|NCT01833026|Adrenergic Agents|adrenergic agents|mesh-ancestor
64673450|NCT01833026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64673451|NCT01833026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673454|NCT03383523|Toltrazuril|toltrazuril|mesh-list
64673455|NCT03383523|Anthelmintics|anthelmintics|mesh-ancestor
64673481|NCT05747768|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64673482|NCT05747768|Pitavastatin|pitavastatin|mesh-list
64673483|NCT05747768|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64673484|NCT05747768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64673485|NCT05747768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64673486|NCT05747768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673487|NCT05747768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64673488|NCT05747768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64673489|NCT05747768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64673490|NCT05747768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64673491|NCT05747768|Anesthetics, General|anesthetics, general|mesh-ancestor
64673492|NCT05747768|Anesthetics|anesthetics|mesh-ancestor
64557340|NCT03834363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64557341|NCT03834363|Anesthetics, General|anesthetics, general|mesh-ancestor
64557342|NCT03834363|Anesthetics|anesthetics|mesh-ancestor
64557343|NCT03031353|Misoprostol|misoprostol|mesh-list
64557344|NCT03031353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64557345|NCT03031353|Abortifacient Agents|abortifacient agents|mesh-ancestor
64557346|NCT03031353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64673493|NCT05747768|GABA Modulators|gaba modulators|mesh-ancestor
64673494|NCT05747768|GABA Agents|gaba agents|mesh-ancestor
64673495|NCT05747768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64673496|NCT05747768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673497|NCT05747768|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64673498|NCT05747768|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64673520|NCT04410159|Blood Substitutes|blood substitutes|mesh-ancestor
64673521|NCT04410159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64673522|NCT04410159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64673523|NCT03398421|Itraconazole|itraconazole|mesh-list
64673524|NCT03398421|Nemiralisib|nemiralisib|mesh-list
64673525|NCT03398421|Antifungal Agents|antifungal agents|mesh-ancestor
64673526|NCT03398421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64673527|NCT03398421|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64673528|NCT03398421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64673529|NCT03398421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673530|NCT03398421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673531|NCT03398421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64673532|NCT03398421|Hormone Antagonists|hormone antagonists|mesh-ancestor
64673533|NCT03398421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65401285|NCT05230901|Dihydralazine|dihydralazine|mesh-list
65401286|NCT05230901|Spironolactone|spironolactone|mesh-list
65401287|NCT05230901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65401288|NCT05230901|Hormone Antagonists|hormone antagonists|mesh-ancestor
65401289|NCT05230901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65401290|NCT05230901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401291|NCT05230901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65401292|NCT05230901|Diuretics|diuretics|mesh-ancestor
65401293|NCT05230901|Natriuretic Agents|natriuretic agents|mesh-ancestor
65401294|NCT05230901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65401295|NCT00972296|Carbon Fiber|carbon fiber|mesh-list
65401296|NCT00972296|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65401297|NCT00972296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65401298|NCT03927950|Citalopram|citalopram|mesh-list
65401299|NCT03927950|Bupropion|bupropion|mesh-list
64786092|NCT00001044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64673534|NCT03398421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673535|NCT03398421|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64673536|NCT03398421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64673537|NCT01839110|Ranolazine|ranolazine|mesh-list
64673538|NCT01839110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64673539|NCT01839110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64673540|NCT01839110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673541|NCT04885712|Metformin|metformin|mesh-list
64673542|NCT04885712|Pioglitazone|pioglitazone|mesh-list
64673543|NCT04885712|Dapagliflozin|dapagliflozin|mesh-list
64673544|NCT04885712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64673545|NCT04885712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673546|NCT04885712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64673547|NCT04885712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673548|NCT00559754|Bevacizumab|bevacizumab|mesh-list
64673549|NCT00559754|Docetaxel|docetaxel|mesh-list
64673550|NCT00559754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64673551|NCT00559754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673552|NCT00559754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64673553|NCT00559754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64673554|NCT00559754|Growth Substances|growth substances|mesh-ancestor
64673555|NCT00559754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673578|NCT01841606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64673580|NCT01841606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64673581|NCT04392141|Colchicine|colchicine|mesh-list
64673582|NCT04392141|Gout Suppressants|gout suppressants|mesh-ancestor
64673583|NCT04392141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64673584|NCT04392141|Tubulin Modulators|tubulin modulators|mesh-ancestor
64673585|NCT04392141|Antimitotic Agents|antimitotic agents|mesh-ancestor
64673586|NCT04392141|Mitosis Modulators|mitosis modulators|mesh-ancestor
64673587|NCT04392141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673589|NCT04838054|Chlorine dioxide|chlorine dioxide|mesh-list
64673590|NCT04838054|Dental Disinfectants|dental disinfectants|mesh-ancestor
64673591|NCT04838054|Disinfectants|disinfectants|mesh-ancestor
64673592|NCT04838054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64673594|NCT00559364|Pancrelipase|pancrelipase|mesh-list
64673595|NCT00559364|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64673596|NCT00559364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64673597|NCT00559364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64557347|NCT03031353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557348|NCT03031353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64557349|NCT03031353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64557350|NCT03031353|Oxytocics|oxytocics|mesh-ancestor
64557351|NCT05702957|Letrozole|letrozole|mesh-list
65401300|NCT03927950|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65401301|NCT03927950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65401302|NCT03927950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65401303|NCT03927950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401304|NCT03927950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65401305|NCT03927950|Serotonin Agents|serotonin agents|mesh-ancestor
65401306|NCT03927950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401307|NCT03927950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65401308|NCT03927950|Antidepressive Agents|antidepressive agents|mesh-ancestor
65401309|NCT03927950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65401310|NCT03927950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65401311|NCT03927950|Dopamine Agents|dopamine agents|mesh-ancestor
65401312|NCT03927950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65401313|NCT03927950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64557352|NCT05702957|Clomiphene|clomiphene|mesh-list
64557353|NCT05702957|Enclomiphene|enclomiphene|mesh-list
64557354|NCT05702957|Zuclomiphene|zuclomiphene|mesh-list
64557355|NCT05702957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557356|NCT05702957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557357|NCT05702957|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64557358|NCT05702957|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64673598|NCT00559364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673599|NCT00559364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673600|NCT05746676|Hyaluronic Acid|hyaluronic acid|mesh-list
64673601|NCT05746676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673602|NCT05746676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64673603|NCT05746676|Immunologic Factors|immunologic factors|mesh-ancestor
64673604|NCT05746676|Viscosupplements|viscosupplements|mesh-ancestor
64673605|NCT05746676|Protective Agents|protective agents|mesh-ancestor
64673606|NCT05746598|Cisplatin|cisplatin|mesh-list
64673607|NCT05746598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673608|NCT05745974|Fibrin fragment D|fibrin fragment d|mesh-list
64673609|NCT05745974|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64673610|NCT05745974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64673620|NCT05745038|GABA Agents|gaba agents|mesh-ancestor
64673621|NCT05745038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64673622|NCT05745038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673623|NCT02306850|Pembrolizumab|pembrolizumab|mesh-list
64673624|NCT02306850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64673625|NCT02306850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673626|NCT02306694|Factor VIII|factor viii|mesh-list
64673627|NCT02306694|Coagulants|coagulants|mesh-ancestor
64673628|NCT01648140|Interferons|interferons|mesh-list
64673629|NCT01648140|Ribavirin|ribavirin|mesh-list
64673630|NCT01648140|Interferon-alpha|interferon-alpha|mesh-list
64673631|NCT01648140|Interferon alpha-2|interferon alpha-2|mesh-list
64673632|NCT01648140|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64673633|NCT01648140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673634|NCT01648140|Antiviral Agents|antiviral agents|mesh-ancestor
64673635|NCT01648140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64673636|NCT01648140|Antimetabolites|antimetabolites|mesh-ancestor
64673637|NCT01648140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673638|NCT01648140|Immunologic Factors|immunologic factors|mesh-ancestor
64673639|NCT01648140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673640|NCT02335242|Sildenafil Citrate|sildenafil citrate|mesh-list
64673641|NCT02335242|Vasodilator Agents|vasodilator agents|mesh-ancestor
64673642|NCT02335242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64673643|NCT02335242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64673644|NCT02335242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401314|NCT03927950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401315|NCT00972842|Lenalidomide|lenalidomide|mesh-list
65401316|NCT00972842|Vorinostat|vorinostat|mesh-list
65401317|NCT00972842|Immunologic Factors|immunologic factors|mesh-ancestor
65401318|NCT00972842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401319|NCT00972842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65401320|NCT00972842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65401321|NCT00972842|Growth Substances|growth substances|mesh-ancestor
65401322|NCT00972842|Growth Inhibitors|growth inhibitors|mesh-ancestor
65401323|NCT00972842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401324|NCT00972842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65401325|NCT00972842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786120|NCT00001080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64673645|NCT02335242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673646|NCT02335242|Urological Agents|urological agents|mesh-ancestor
64673647|NCT04883892|Hyaluronic Acid|hyaluronic acid|mesh-list
64673648|NCT04883892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64673649|NCT04883892|Immunologic Factors|immunologic factors|mesh-ancestor
64673650|NCT04883892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673651|NCT04883892|Viscosupplements|viscosupplements|mesh-ancestor
64484320|NCT05640778|Hormone Antagonists|hormone antagonists|mesh-ancestor
64484321|NCT05640778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64484322|NCT01743560|Everolimus|everolimus|mesh-list
64484323|NCT01743560|Exemestane|exemestane|mesh-list
64484324|NCT01743560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64484325|NCT01743560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64484326|NCT01743560|Immunologic Factors|immunologic factors|mesh-ancestor
64484327|NCT01743560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484328|NCT01743560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64557360|NCT05702957|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64557361|NCT05702957|Hormone Antagonists|hormone antagonists|mesh-ancestor
64557362|NCT05702957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64557363|NCT05702957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557364|NCT05702957|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64484329|NCT01743560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64484331|NCT01743560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484332|NCT01743560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64484333|NCT01743560|Hormone Antagonists|hormone antagonists|mesh-ancestor
64484334|NCT01743560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64484335|NCT00796744|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
64484336|NCT00796744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64484337|NCT00796744|Vasodilator Agents|vasodilator agents|mesh-ancestor
64484338|NCT00792922|Azithromycin|azithromycin|mesh-list
64484339|NCT00792922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64484340|NCT00792922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64484341|NCT01780831|Raltegravir Potassium|raltegravir potassium|mesh-list
64484342|NCT01780831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64484343|NCT01780831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64484344|NCT01780831|Antiviral Agents|antiviral agents|mesh-ancestor
64484345|NCT01780831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64484346|NCT01780831|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64484355|NCT04382170|Analgesics|analgesics|mesh-ancestor
64484356|NCT04382170|Sensory System Agents|sensory system agents|mesh-ancestor
64484357|NCT04382170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484358|NCT04382170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64484359|NCT04382170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64484360|NCT04382170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64484361|NCT04382170|Adrenergic Agents|adrenergic agents|mesh-ancestor
64484362|NCT04382170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64484363|NCT04382170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484364|NCT04718350|Simendan|simendan|mesh-list
64484365|NCT04718350|Milrinone|milrinone|mesh-list
65401326|NCT00972842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401327|NCT00975494|Sildenafil Citrate|sildenafil citrate|mesh-list
65401328|NCT00975494|Vasodilator Agents|vasodilator agents|mesh-ancestor
65401329|NCT00975494|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65401330|NCT00975494|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65401331|NCT00975494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401332|NCT00975494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401333|NCT00975494|Urological Agents|urological agents|mesh-ancestor
65401334|NCT00975572|Vaccines|vaccines|mesh-list
65401335|NCT00975572|Immunologic Factors|immunologic factors|mesh-ancestor
65401336|NCT00975572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401337|NCT00965666|Etanercept|etanercept|mesh-list
65150908|NCT00629863|Fluorouracil|fluorouracil|mesh-list
65401338|NCT00965666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65401339|NCT00965666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64484366|NCT04718350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64484367|NCT04718350|Vasodilator Agents|vasodilator agents|mesh-ancestor
64484368|NCT04718350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64484369|NCT04718350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64484370|NCT04718350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484371|NCT04718350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484372|NCT04718350|Protective Agents|protective agents|mesh-ancestor
64484373|NCT04718350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399063|NCT05007587|Micronutrients|micronutrients|mesh-ancestor
64673652|NCT04883892|Protective Agents|protective agents|mesh-ancestor
64673653|NCT02334384|Anti-Infective Agents|anti-infective agents|mesh-list
64673654|NCT02334384|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64673655|NCT02305758|Bevacizumab|bevacizumab|mesh-list
64673656|NCT02305758|Fluorouracil|fluorouracil|mesh-list
64673657|NCT02305758|Veliparib|veliparib|mesh-list
64673658|NCT02305758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64673659|NCT02305758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673660|NCT02305758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64673661|NCT02305758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64673662|NCT02305758|Growth Substances|growth substances|mesh-ancestor
64673663|NCT02305758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673664|NCT02305758|Growth Inhibitors|growth inhibitors|mesh-ancestor
64673665|NCT02305758|Antimetabolites|antimetabolites|mesh-ancestor
64673666|NCT02305758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673667|NCT02305758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64673668|NCT02305758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64673669|NCT02305758|Immunologic Factors|immunologic factors|mesh-ancestor
64673670|NCT02305758|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64673671|NCT02305758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673672|NCT04365153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64673673|NCT04365153|Immunologic Factors|immunologic factors|mesh-ancestor
64557367|NCT05702957|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64557368|NCT05702957|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64557369|NCT04405505|Paclitaxel|paclitaxel|mesh-list
64484462|NCT01727713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484463|NCT01727713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64484464|NCT01727713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64484465|NCT01727713|Serotonin Agents|serotonin agents|mesh-ancestor
64484466|NCT01727713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64484467|NCT01727713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64673674|NCT04365153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673675|NCT03654417|Lidocaine|lidocaine|mesh-list
64673676|NCT03654417|Anesthetics, Local|anesthetics, local|mesh-ancestor
65401340|NCT00965666|Analgesics|analgesics|mesh-ancestor
65401341|NCT00965666|Sensory System Agents|sensory system agents|mesh-ancestor
65401342|NCT00965666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65401343|NCT00965666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401344|NCT00965666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65401345|NCT00965666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65401346|NCT00965666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65401347|NCT00965666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65401348|NCT00965666|Immunologic Factors|immunologic factors|mesh-ancestor
65401349|NCT00975728|Antioxidants|antioxidants|mesh-list
65401350|NCT00975728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401351|NCT00975728|Protective Agents|protective agents|mesh-ancestor
65401352|NCT00975728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401353|NCT04049747|Bicalutamide|bicalutamide|mesh-list
65401354|NCT04049747|Finasteride|finasteride|mesh-list
65401355|NCT04049747|Androgen Antagonists|androgen antagonists|mesh-ancestor
65401356|NCT04049747|Hormone Antagonists|hormone antagonists|mesh-ancestor
65401357|NCT04049747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65401358|NCT04049747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786148|NCT00001122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64786158|NCT00001128|Azithromycin|azithromycin|mesh-list
64673677|NCT03654417|Anesthetics|anesthetics|mesh-ancestor
64673678|NCT03654417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64673680|NCT03654417|Sensory System Agents|sensory system agents|mesh-ancestor
64673681|NCT03654417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64673682|NCT03654417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64673683|NCT03654417|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64673684|NCT03654417|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64673685|NCT03654417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64673686|NCT03654417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673687|NCT00376701|Bevacizumab|bevacizumab|mesh-list
64673688|NCT00376701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64673695|NCT04358991|Ceftazidime|ceftazidime|mesh-list
64673696|NCT04358991|Avibactam|avibactam|mesh-list
64673697|NCT04358991|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
64673698|NCT04358991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64673699|NCT04358991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64673700|NCT04358991|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64673701|NCT04358991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673702|NCT04358991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673703|NCT04338009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64673704|NCT04338009|Protease Inhibitors|protease inhibitors|mesh-ancestor
64673705|NCT04338009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673706|NCT04338009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673707|NCT02303574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64673708|NCT02354976|Fenofibrate|fenofibrate|mesh-list
64673709|NCT02354976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64673710|NCT02354976|Antimetabolites|antimetabolites|mesh-ancestor
64673711|NCT02354976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673712|NCT02354976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64673713|NCT02303262|Gemcitabine|gemcitabine|mesh-list
65401359|NCT04049747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401360|NCT04049747|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65401361|NCT04049747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65401362|NCT04049747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401363|NCT04049747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401364|NCT04049747|Urological Agents|urological agents|mesh-ancestor
65401365|NCT00973154|Prednisone|prednisone|mesh-list
65401366|NCT00973154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65401367|NCT00973154|Glucocorticoids|glucocorticoids|mesh-ancestor
65401368|NCT00973154|Hormones|hormones|mesh-ancestor
64786167|NCT00001128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64786173|NCT00001296|Interferons|interferons|mesh-list
64673714|NCT02303262|Mocetinostat|mocetinostat|mesh-list
64673715|NCT02303262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64673716|NCT02303262|Antimetabolites|antimetabolites|mesh-ancestor
64484475|NCT04658927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484476|NCT04658927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557370|NCT04405505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64557371|NCT04405505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557372|NCT04405505|Tubulin Modulators|tubulin modulators|mesh-ancestor
64557373|NCT04405505|Antimitotic Agents|antimitotic agents|mesh-ancestor
64557374|NCT04405505|Mitosis Modulators|mitosis modulators|mesh-ancestor
64557375|NCT04405505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557376|NCT03580733|Caspofungin|caspofungin|mesh-list
64557377|NCT03580733|Antifungal Agents|antifungal agents|mesh-list
64557378|NCT03580733|Clotrimazole|clotrimazole|mesh-list
64557379|NCT03580733|Miconazole|miconazole|mesh-list
64557380|NCT03580733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64557381|NCT03580733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557382|NCT03580733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557383|NCT03580733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64557384|NCT03580733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64557385|NCT03580733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64557386|NCT03580733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64557387|NCT03580733|Hormone Antagonists|hormone antagonists|mesh-ancestor
64557388|NCT03580733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64557389|NCT03580733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322442|NCT02396979|Methadone|methadone|mesh-list
64673718|NCT02303262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673719|NCT02303262|Antiviral Agents|antiviral agents|mesh-ancestor
64673720|NCT02303262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64673721|NCT02303262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673722|NCT02303262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64673723|NCT02303262|Immunologic Factors|immunologic factors|mesh-ancestor
64673724|NCT02303262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673725|NCT02303262|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64673726|NCT04889664|Ketamine|ketamine|mesh-list
64673727|NCT04889664|Analgesics|analgesics|mesh-ancestor
64673728|NCT04889664|Sensory System Agents|sensory system agents|mesh-ancestor
64673729|NCT04889664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64673730|NCT04889664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673731|NCT04889664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64673732|NCT04889664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64673733|NCT04889664|Anesthetics, General|anesthetics, general|mesh-ancestor
64673734|NCT04889664|Anesthetics|anesthetics|mesh-ancestor
64673735|NCT04889664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64673736|NCT04889664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64673737|NCT04889664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64673738|NCT04889664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64673739|NCT04889664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673740|NCT00558896|Dexamethasone|dexamethasone|mesh-list
64673741|NCT00558896|Pomalidomide|pomalidomide|mesh-list
64557390|NCT03580733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65401369|NCT00973154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65401370|NCT00973154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401371|NCT00973154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65401372|NCT00973154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401373|NCT00965900|Propranolol|propranolol|mesh-list
64557391|NCT03580733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64557393|NCT03461445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64557394|NCT03461445|Immunologic Factors|immunologic factors|mesh-ancestor
64557395|NCT03461445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557396|NCT03461445|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64557397|NCT03461445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557398|NCT03461445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557399|NCT04939662|Bevacizumab|bevacizumab|mesh-list
64557400|NCT04939662|Olaparib|olaparib|mesh-list
64557401|NCT04939662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64557402|NCT04939662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557403|NCT04939662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64557404|NCT04939662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64557405|NCT04939662|Growth Substances|growth substances|mesh-ancestor
64557406|NCT04939662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557407|NCT04939662|Growth Inhibitors|growth inhibitors|mesh-ancestor
64557408|NCT04939662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64557409|NCT04939662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557410|NCT04939662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557411|NCT05581979|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64714197|NCT02988050|Analgesics|analgesics|mesh-ancestor
64714198|NCT02988050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64714199|NCT02988050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64714200|NCT02988050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64673742|NCT00558896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64673743|NCT00558896|Antiemetics|antiemetics|mesh-ancestor
64673744|NCT00558896|Autonomic Agents|autonomic agents|mesh-ancestor
64673745|NCT00558896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64673746|NCT00558896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673763|NCT02265224|Antiviral Agents|antiviral agents|mesh-ancestor
64673764|NCT02265224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64673765|NCT02265224|Expectorants|expectorants|mesh-ancestor
64673766|NCT02265224|Respiratory System Agents|respiratory system agents|mesh-ancestor
64673767|NCT02265224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64673768|NCT02265224|Antioxidants|antioxidants|mesh-ancestor
64673769|NCT02265224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673770|NCT02265224|Protective Agents|protective agents|mesh-ancestor
64673771|NCT02265224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673772|NCT02265224|Antidotes|antidotes|mesh-ancestor
64673774|NCT01859078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64673775|NCT01859078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64673776|NCT01859078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673777|NCT01859078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673778|NCT01859078|Protective Agents|protective agents|mesh-ancestor
64714201|NCT02988050|Adrenergic Agents|adrenergic agents|mesh-ancestor
64714202|NCT02988050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64714205|NCT02988050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64714206|NCT02988050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64714207|NCT02988050|Autonomic Agents|autonomic agents|mesh-ancestor
64714208|NCT02988050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64714209|NCT02988050|Respiratory System Agents|respiratory system agents|mesh-ancestor
64714210|NCT02988050|Mydriatics|mydriatics|mesh-ancestor
64714211|NCT02988050|Sympathomimetics|sympathomimetics|mesh-ancestor
64714212|NCT02988050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64714213|NCT02988986|Tamoxifen|tamoxifen|mesh-list
64714214|NCT02988986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64714215|NCT02988986|Hormone Antagonists|hormone antagonists|mesh-ancestor
64714216|NCT02988986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64714217|NCT02988986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714218|NCT02988986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64714219|NCT02988986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64714220|NCT02988986|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65401374|NCT00965900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65401375|NCT00965900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65401376|NCT00965900|Adrenergic Agents|adrenergic agents|mesh-ancestor
65401377|NCT00965900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65401378|NCT00965900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401379|NCT00965900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401380|NCT00965900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65401381|NCT00965900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65401382|NCT00965900|Vasodilator Agents|vasodilator agents|mesh-ancestor
65401383|NCT03486197|Pembrolizumab|pembrolizumab|mesh-list
65401384|NCT03486197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65401385|NCT03486197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322489|NCT02258815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673779|NCT01859078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673780|NCT00558428|Amlodipine|amlodipine|mesh-list
64673781|NCT00558428|Telmisartan|telmisartan|mesh-list
64673782|NCT00558428|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
64673783|NCT00558428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64673784|NCT00558428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64673785|NCT00558428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64673786|NCT00558428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673787|NCT00558428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64673788|NCT00558428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673789|NCT00558428|Vasodilator Agents|vasodilator agents|mesh-ancestor
64673790|NCT00558428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64673791|NCT00558428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64673792|NCT05314725|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64673793|NCT05314725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673794|NCT05314725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64673795|NCT05314725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673796|NCT04310085|Lumefantrine|lumefantrine|mesh-list
64673797|NCT04310085|Artemether|artemether|mesh-list
64673798|NCT04310085|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64673799|NCT04310085|Antimalarials|antimalarials|mesh-ancestor
64673800|NCT04310085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64673801|NCT04310085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64673813|NCT03407625|Misoprostol|misoprostol|mesh-list
64673814|NCT03407625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64673815|NCT03407625|Abortifacient Agents|abortifacient agents|mesh-ancestor
64673816|NCT03407625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64673817|NCT03407625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673818|NCT03407625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64673819|NCT03407625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64673820|NCT03407625|Oxytocics|oxytocics|mesh-ancestor
64714221|NCT02988986|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64714222|NCT02988986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64714223|NCT02832115|Lidocaine|lidocaine|mesh-list
64714224|NCT02832115|Nitroglycerin|nitroglycerin|mesh-list
64714225|NCT02832115|Anesthetics, Local|anesthetics, local|mesh-list
64714226|NCT02832115|Anesthetics|anesthetics|mesh-list
64714227|NCT02832115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64714228|NCT02832115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714229|NCT02832115|Sensory System Agents|sensory system agents|mesh-ancestor
64714230|NCT02832115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714231|NCT02832115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64714232|NCT02832115|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64714233|NCT02832115|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64714234|NCT02832115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64714235|NCT02832115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714236|NCT02832115|Vasodilator Agents|vasodilator agents|mesh-ancestor
65401386|NCT00973232|Acetaminophen|acetaminophen|mesh-list
65401387|NCT00973232|Tramadol|tramadol|mesh-list
65401388|NCT00973232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65401389|NCT00973232|Analgesics|analgesics|mesh-ancestor
65401390|NCT00973232|Sensory System Agents|sensory system agents|mesh-ancestor
65401391|NCT00973232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65401392|NCT00973232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401393|NCT00973232|Antipyretics|antipyretics|mesh-ancestor
65401394|NCT00973232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65401395|NCT00973232|Narcotics|narcotics|mesh-ancestor
65401396|NCT00973232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64714237|NCT03054506|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64714238|NCT03054506|Laxatives|laxatives|mesh-ancestor
64714239|NCT03054506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64714240|NCT02935699|Diphenhydramine|diphenhydramine|mesh-list
64714241|NCT02935699|Promethazine|promethazine|mesh-list
64714242|NCT02935699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64714244|NCT02935699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64714245|NCT02935699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714246|NCT02935699|Anesthetics, Local|anesthetics, local|mesh-ancestor
64714247|NCT02935699|Anesthetics|anesthetics|mesh-ancestor
64714248|NCT02935699|Sensory System Agents|sensory system agents|mesh-ancestor
64714249|NCT02935699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64673822|NCT03666663|Bupivacaine|bupivacaine|mesh-list
64673823|NCT03666663|Ropivacaine|ropivacaine|mesh-list
64673824|NCT03666663|Anesthetics, Local|anesthetics, local|mesh-ancestor
64673825|NCT03666663|Anesthetics|anesthetics|mesh-ancestor
64673826|NCT03666663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64673827|NCT03666663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673828|NCT03666663|Sensory System Agents|sensory system agents|mesh-ancestor
64673829|NCT03666663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64673830|NCT03666663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64673831|NCT03666663|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64673832|NCT03666663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64673833|NCT03666663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64673834|NCT03666663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673835|NCT05692154|Fexofenadine|fexofenadine|mesh-list
64673836|NCT05692154|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64714250|NCT02935699|Antiemetics|antiemetics|mesh-ancestor
64714251|NCT02935699|Autonomic Agents|autonomic agents|mesh-ancestor
64714252|NCT02935699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64714253|NCT02935699|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64714254|NCT02935699|Histamine Antagonists|histamine antagonists|mesh-ancestor
64714255|NCT02935699|Histamine Agents|histamine agents|mesh-ancestor
64714256|NCT02935699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64714257|NCT02935699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714258|NCT02935699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64714259|NCT02935699|Antipruritics|antipruritics|mesh-ancestor
64714260|NCT02935699|Dermatologic Agents|dermatologic agents|mesh-ancestor
64714261|NCT02936479|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
64714262|NCT02936479|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64714263|NCT02936479|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64714264|NCT02936479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64714265|NCT02936479|Immunologic Factors|immunologic factors|mesh-ancestor
64714266|NCT02936479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714267|NCT02841241|Esmolol|esmolol|mesh-list
64714268|NCT02841241|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64714269|NCT02841241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64714270|NCT02841241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64322542|NCT02228239|Mirtazapine|mirtazapine|mesh-list
64673837|NCT05692154|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64673838|NCT05692154|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64673839|NCT05692154|Histamine Antagonists|histamine antagonists|mesh-ancestor
64673840|NCT05692154|Histamine Agents|histamine agents|mesh-ancestor
65401397|NCT00973310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65401398|NCT00973310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401399|NCT00973310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65401400|NCT00973310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401401|NCT00973310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401402|NCT00973388|Moxifloxacin|moxifloxacin|mesh-list
65401403|NCT00973388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65401404|NCT00973388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65401405|NCT00973388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64673841|NCT05692154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64673842|NCT05692154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673843|NCT05692154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673844|NCT04290039|Atropine|atropine|mesh-list
64673845|NCT04290039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64673846|NCT04290039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64673847|NCT04290039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64673848|NCT04290039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64673849|NCT04290039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64673850|NCT04290039|Autonomic Agents|autonomic agents|mesh-ancestor
64673851|NCT04290039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64673852|NCT04290039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673853|NCT04290039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64673854|NCT04290039|Respiratory System Agents|respiratory system agents|mesh-ancestor
64673855|NCT04290039|Mydriatics|mydriatics|mesh-ancestor
64673856|NCT04290039|Parasympatholytics|parasympatholytics|mesh-ancestor
64673857|NCT04290039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64673858|NCT04290039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64673859|NCT04290039|Cholinergic Agents|cholinergic agents|mesh-ancestor
64673860|NCT04290039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64673861|NCT04290039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673862|NCT01863134|Eptifibatide|eptifibatide|mesh-list
64673863|NCT01863134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64673864|NCT03415581|Oxycodone|oxycodone|mesh-list
64673880|NCT00557492|Growth Inhibitors|growth inhibitors|mesh-ancestor
64331754|NCT04887467|Apomorphine|apomorphine|mesh-list
64714272|NCT02841241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64714273|NCT02841241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714274|NCT02841241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714275|NCT00374881|Phenylephrine|phenylephrine|mesh-list
64714276|NCT00374881|Oxymetazoline|oxymetazoline|mesh-list
64714277|NCT00374881|Morphine|morphine|mesh-list
64714278|NCT00374881|Sorbitol|sorbitol|mesh-list
64714279|NCT00374881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64714280|NCT00374881|Narcotics|narcotics|mesh-ancestor
64714281|NCT00374881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64714282|NCT00374881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714283|NCT00374881|Analgesics|analgesics|mesh-ancestor
64714284|NCT00374881|Sensory System Agents|sensory system agents|mesh-ancestor
64714285|NCT00374881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714286|NCT00374881|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64714287|NCT00374881|Mydriatics|mydriatics|mesh-ancestor
64453673|NCT02020031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64714288|NCT00374881|Autonomic Agents|autonomic agents|mesh-ancestor
64714289|NCT00374881|Sympathomimetics|sympathomimetics|mesh-ancestor
64714290|NCT00374881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64714291|NCT00374881|Nasal Decongestants|nasal decongestants|mesh-ancestor
64714292|NCT00374881|Respiratory System Agents|respiratory system agents|mesh-ancestor
64714293|NCT00374881|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64714294|NCT00374881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64714295|NCT00374881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64714296|NCT00374881|Adrenergic Agents|adrenergic agents|mesh-ancestor
64714297|NCT00374881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64714298|NCT00374881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714299|NCT00374881|Protective Agents|protective agents|mesh-ancestor
64714300|NCT00374881|Cathartics|cathartics|mesh-ancestor
64714301|NCT00374881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65401406|NCT00973388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65401407|NCT00973388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401408|NCT00973388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401409|NCT00973388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401410|NCT00975962|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65150977|NCT01177293|Amlodipine|amlodipine|mesh-list
65401411|NCT00975962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65401412|NCT00975962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65401413|NCT00975962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401414|NCT00966056|Mitomycins|mitomycins|mesh-list
65401415|NCT00966056|Mitomycin|mitomycin|mesh-list
65401416|NCT00966056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64673882|NCT00557492|Antimetabolites|antimetabolites|mesh-ancestor
64673883|NCT00557492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673884|NCT00557492|Antiviral Agents|antiviral agents|mesh-ancestor
64673885|NCT00557492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64673886|NCT00557492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673887|NCT00557492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64673888|NCT00557492|Immunologic Factors|immunologic factors|mesh-ancestor
64673890|NCT01865708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64673891|NCT01865708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64673892|NCT01865708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64673893|NCT01865708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714303|NCT00374959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64714304|NCT00374959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64714305|NCT02846233|Metformin|metformin|mesh-list
64714306|NCT02846233|Empagliflozin|empagliflozin|mesh-list
64714307|NCT02846233|Dulaglutide|dulaglutide|mesh-list
64714308|NCT02846233|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64714309|NCT02846233|rGLP-1 protein|rglp-1 protein|mesh-list
64714310|NCT02846233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64714311|NCT02846233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714312|NCT02846233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714313|NCT02846233|Incretins|incretins|mesh-ancestor
64714314|NCT02846233|Hormones|hormones|mesh-ancestor
64673894|NCT04203225|Lidocaine|lidocaine|mesh-list
64673895|NCT04203225|Epinephrine|epinephrine|mesh-list
64673896|NCT04203225|Tetracaine|tetracaine|mesh-list
64673897|NCT04203225|Anesthetics, Local|anesthetics, local|mesh-ancestor
64673898|NCT04203225|Anesthetics|anesthetics|mesh-ancestor
64673899|NCT04203225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64673900|NCT04203225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673901|NCT04203225|Sensory System Agents|sensory system agents|mesh-ancestor
64673902|NCT04203225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64673903|NCT04203225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64673904|NCT04203225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64673905|NCT04203225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64673906|NCT04203225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64673907|NCT04203225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673908|NCT04203225|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64673909|NCT04203225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64673910|NCT04203225|Adrenergic Agents|adrenergic agents|mesh-ancestor
64673911|NCT04203225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64673913|NCT04203225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64673915|NCT04203225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64673916|NCT04203225|Respiratory System Agents|respiratory system agents|mesh-ancestor
64673917|NCT04203225|Mydriatics|mydriatics|mesh-ancestor
64673918|NCT04203225|Sympathomimetics|sympathomimetics|mesh-ancestor
64673919|NCT04203225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64673920|NCT05314257|Granisetron|granisetron|mesh-list
64673921|NCT05314257|Antiemetics|antiemetics|mesh-ancestor
64673922|NCT05314257|Autonomic Agents|autonomic agents|mesh-ancestor
64673937|NCT01866410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64673938|NCT01866410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401417|NCT00966056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401418|NCT00966056|Alkylating Agents|alkylating agents|mesh-ancestor
65401419|NCT00966056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401420|NCT00966056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65401421|NCT00966056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401422|NCT00976040|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65401423|NCT00976040|Antiviral Agents|antiviral agents|mesh-ancestor
64673939|NCT01866410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673940|NCT00377325|Cyclosporine|cyclosporine|mesh-list
64673941|NCT00377325|Cyclosporins|cyclosporins|mesh-list
64673942|NCT00377325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673943|NCT00377325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673944|NCT00377325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64673945|NCT00377325|Immunologic Factors|immunologic factors|mesh-ancestor
64673946|NCT00377325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673947|NCT00377325|Antifungal Agents|antifungal agents|mesh-ancestor
64673948|NCT00377325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64673949|NCT00377325|Dermatologic Agents|dermatologic agents|mesh-ancestor
64673950|NCT00377325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64673951|NCT00377325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64673952|NCT03440450|Gemcitabine|gemcitabine|mesh-list
64673953|NCT03440450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64673954|NCT03440450|Antimetabolites|antimetabolites|mesh-ancestor
64673955|NCT03440450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673956|NCT03440450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673957|NCT03440450|Antiviral Agents|antiviral agents|mesh-ancestor
64673958|NCT03440450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64714315|NCT02846233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64714316|NCT02865590|Cimetidine|cimetidine|mesh-list
64714317|NCT02865590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64714318|NCT02865590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64714319|NCT02865590|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64714320|NCT02865590|Histamine Antagonists|histamine antagonists|mesh-ancestor
64714321|NCT02865590|Histamine Agents|histamine agents|mesh-ancestor
64714322|NCT02865590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64714323|NCT02865590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714324|NCT02865590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714325|NCT02865590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64714326|NCT02865590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64714327|NCT02865590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64714328|NCT02868242|Sofosbuvir|sofosbuvir|mesh-list
64714329|NCT02868242|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64714330|NCT02868242|Ledipasvir|ledipasvir|mesh-list
64714331|NCT02868242|Antiviral Agents|antiviral agents|mesh-ancestor
64714332|NCT02868242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64714333|NCT03075553|Nivolumab|nivolumab|mesh-list
64714334|NCT03075553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64714335|NCT03075553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64714336|NCT03075553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64714337|NCT03075553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714338|NCT03054740|Ethyl Chloride|ethyl chloride|mesh-list
64714339|NCT03054740|Anesthetics, Local|anesthetics, local|mesh-ancestor
64714340|NCT03054740|Anesthetics|anesthetics|mesh-ancestor
64322612|NCT02394093|Aspirin|aspirin|mesh-list
64673959|NCT03440450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673960|NCT03440450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64673961|NCT03440450|Immunologic Factors|immunologic factors|mesh-ancestor
64673962|NCT03440450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673963|NCT02332824|Candesartan|candesartan|mesh-list
64673964|NCT02332824|Candesartan cilexetil|candesartan cilexetil|mesh-list
64673965|NCT02332824|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
64673966|NCT02332824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64673967|NCT02332824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64673968|NCT02332824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64673969|NCT02332824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673970|NCT02332824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673971|NCT03701061|Vaccines|vaccines|mesh-list
65401424|NCT00976040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65401425|NCT00979706|Cyclosporine|cyclosporine|mesh-list
65401426|NCT00979706|Interleukin-2|interleukin-2|mesh-list
65401427|NCT00979706|Cyclosporins|cyclosporins|mesh-list
65401428|NCT00979706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401429|NCT00979706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401430|NCT00979706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65401431|NCT00979706|Immunologic Factors|immunologic factors|mesh-ancestor
65401432|NCT00979706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401433|NCT00979706|Antifungal Agents|antifungal agents|mesh-ancestor
65401434|NCT00979706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65401435|NCT00979706|Dermatologic Agents|dermatologic agents|mesh-ancestor
65401436|NCT00979706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65401437|NCT00979706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65401438|NCT00979706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673972|NCT03701061|Immunologic Factors|immunologic factors|mesh-ancestor
64673974|NCT03420014|Doxorubicin|doxorubicin|mesh-list
64673975|NCT03420014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64673976|NCT03420014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64673977|NCT03420014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673978|NCT03420014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64714341|NCT03054740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64714342|NCT03054740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714343|NCT03054740|Sensory System Agents|sensory system agents|mesh-ancestor
64714344|NCT03054740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714346|NCT02997722|Analgesics|analgesics|mesh-ancestor
64714347|NCT02997722|Sensory System Agents|sensory system agents|mesh-ancestor
64714348|NCT02997722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714349|NCT02997722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714350|NCT02997722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64322634|NCT02146391|Fertility Agents|fertility agents|mesh-ancestor
64673979|NCT03420014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64673980|NCT03420014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673981|NCT03420014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673991|NCT03705273|Glucocorticoids|glucocorticoids|mesh-ancestor
64673992|NCT03705273|Hormones|hormones|mesh-ancestor
64673993|NCT03705273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64673994|NCT03705273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64673995|NCT03705273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673996|NCT03705273|Protease Inhibitors|protease inhibitors|mesh-ancestor
64673997|NCT03705273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673998|NCT03705273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673999|NCT04184271|Fluorides|fluorides|mesh-list
64674000|NCT04184271|Cariostatic Agents|cariostatic agents|mesh-ancestor
64674001|NCT04184271|Protective Agents|protective agents|mesh-ancestor
64674002|NCT04184271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674003|NCT03936387|Ropivacaine|ropivacaine|mesh-list
64674004|NCT03936387|Anesthetics, Local|anesthetics, local|mesh-ancestor
64674005|NCT03936387|Anesthetics|anesthetics|mesh-ancestor
64674006|NCT03936387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64674007|NCT03936387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674008|NCT03936387|Sensory System Agents|sensory system agents|mesh-ancestor
64674009|NCT03936387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64674010|NCT04173429|Nadroparin|nadroparin|mesh-list
64674011|NCT04173429|Warfarin|warfarin|mesh-list
64674012|NCT04173429|Calcium|calcium|mesh-list
64674013|NCT04173429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64674014|NCT04173429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674015|NCT04173429|Anticoagulants|anticoagulants|mesh-ancestor
65401439|NCT00979706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65401440|NCT00979706|Analgesics|analgesics|mesh-ancestor
65401441|NCT00979706|Sensory System Agents|sensory system agents|mesh-ancestor
65401442|NCT00979706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65401443|NCT00979862|Cediranib|cediranib|mesh-list
65401444|NCT00979862|Maleic acid|maleic acid|mesh-list
65401445|NCT00979862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401446|NCT00979862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401447|NCT00979862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401448|NCT00979862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65401449|NCT00966290|Warfarin|warfarin|mesh-list
65401450|NCT00966290|Anticoagulants|anticoagulants|mesh-list
65401451|NCT00966290|Acenocoumarol|acenocoumarol|mesh-list
64786249|NCT00001698|Ketorolac|ketorolac|mesh-list
64674016|NCT04173429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64674017|NCT04173429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64674018|NCT04173429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674019|NCT03710187|Hydrocortisone|hydrocortisone|mesh-list
64674020|NCT03710187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64674021|NCT04167189|Lidocaine|lidocaine|mesh-list
64674022|NCT04167189|Anesthetics, Local|anesthetics, local|mesh-ancestor
64674023|NCT04167189|Anesthetics|anesthetics|mesh-ancestor
64399376|NCT02039479|Antimanic Agents|antimanic agents|mesh-ancestor
64674024|NCT04167189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64674025|NCT04167189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674026|NCT04167189|Sensory System Agents|sensory system agents|mesh-ancestor
64674027|NCT04167189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64674028|NCT04167189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64674029|NCT04167189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64674030|NCT04167189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64674031|NCT04167189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64674032|NCT04167189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674033|NCT03929367|Oxytocin|oxytocin|mesh-list
64674034|NCT03929367|Oxytocics|oxytocics|mesh-ancestor
64674035|NCT03929367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64674036|NCT03929367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714351|NCT02997722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64714352|NCT02997722|Anesthetics, General|anesthetics, general|mesh-ancestor
64714353|NCT02997722|Anesthetics|anesthetics|mesh-ancestor
64714354|NCT02997722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64714355|NCT02997722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64674037|NCT04149405|Diphosphonates|diphosphonates|mesh-list
64674038|NCT04149405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64674040|NCT00556712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64674041|NCT00556712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674042|NCT00556712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64674043|NCT00556712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674044|NCT00556712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674046|NCT03717051|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64674047|NCT03717051|Autonomic Agents|autonomic agents|mesh-ancestor
64674054|NCT03717051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674056|NCT04350320|Gout Suppressants|gout suppressants|mesh-ancestor
64674057|NCT04350320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64674058|NCT04350320|Tubulin Modulators|tubulin modulators|mesh-ancestor
64674059|NCT04350320|Antimitotic Agents|antimitotic agents|mesh-ancestor
64674060|NCT04350320|Mitosis Modulators|mitosis modulators|mesh-ancestor
64674061|NCT04350320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674062|NCT04350320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674063|NCT03920865|Risdiplam|risdiplam|mesh-list
64674064|NCT03920865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64674065|NCT03920865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64674066|NCT03920865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401452|NCT00966290|Fluindione|fluindione|mesh-list
65401453|NCT00966290|Phenindione|phenindione|mesh-list
65401454|NCT00966368|Insulin|insulin|mesh-list
65401455|NCT00966368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65401456|NCT00966368|Insulin, Long-Acting|insulin, long-acting|mesh-list
65401457|NCT00966368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65401458|NCT00966368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401459|NCT00980408|Cycloserine|cycloserine|mesh-list
65401460|NCT00980408|Memantine|memantine|mesh-list
65401461|NCT00980408|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65401462|NCT00980408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65401463|NCT00980408|Dopamine Agents|dopamine agents|mesh-ancestor
65401464|NCT00980408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65401465|NCT00980408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401466|NCT00980408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401467|NCT00980408|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65401468|NCT00980408|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65401469|NCT00980408|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65401470|NCT00980408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64674067|NCT00556322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64674068|NCT00556322|Docetaxel|docetaxel|mesh-list
64674069|NCT00556322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674070|NCT00556322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64674071|NCT00556322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674072|NCT00556322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674073|NCT00556322|Tubulin Modulators|tubulin modulators|mesh-ancestor
64674074|NCT00556322|Antimitotic Agents|antimitotic agents|mesh-ancestor
64674075|NCT00556322|Mitosis Modulators|mitosis modulators|mesh-ancestor
64674076|NCT04137627|Melatonin|melatonin|mesh-list
64674077|NCT04137627|Antioxidants|antioxidants|mesh-ancestor
64674078|NCT04137627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674079|NCT04137627|Protective Agents|protective agents|mesh-ancestor
64674080|NCT04137627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674081|NCT04137627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64674082|NCT04136145|Belimumab|belimumab|mesh-list
64674083|NCT04136145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64674084|NCT04136145|Immunologic Factors|immunologic factors|mesh-ancestor
64674085|NCT04136145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674086|NCT01869686|Denosumab|denosumab|mesh-list
64674087|NCT01869686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64674088|NCT01869686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674089|NCT03360890|Docetaxel|docetaxel|mesh-list
64674090|NCT03360890|Pembrolizumab|pembrolizumab|mesh-list
64674091|NCT03360890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674092|NCT03360890|Tubulin Modulators|tubulin modulators|mesh-ancestor
64674093|NCT03360890|Antimitotic Agents|antimitotic agents|mesh-ancestor
64674094|NCT03360890|Mitosis Modulators|mitosis modulators|mesh-ancestor
64674095|NCT03360890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674096|NCT03360890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64674097|NCT03862755|Heparin|heparin|mesh-list
64674098|NCT03862755|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64674099|NCT03862755|Tinzaparin|tinzaparin|mesh-list
64674100|NCT03862755|Dalteparin|dalteparin|mesh-list
64674101|NCT03862755|Anticoagulants|anticoagulants|mesh-ancestor
64674102|NCT03862755|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64674103|NCT03862755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64674104|NCT03862755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674105|NCT02332590|Adalimumab|adalimumab|mesh-list
65401471|NCT00980408|Renal Agents|renal agents|mesh-ancestor
65401472|NCT00980408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65401473|NCT00980408|Antitubercular Agents|antitubercular agents|mesh-ancestor
65401474|NCT00980408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65401475|NCT00980408|Antimetabolites|antimetabolites|mesh-ancestor
65401476|NCT00980876|Ciprofloxacin|ciprofloxacin|mesh-list
65401477|NCT00980876|Hydrocortisone|hydrocortisone|mesh-list
65401478|NCT00980876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65401479|NCT00980876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65401480|NCT00980876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65401481|NCT00980876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65401482|NCT00980876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65401483|NCT00980876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401484|NCT00980876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401485|NCT00980876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674106|NCT02332590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64674107|NCT02332590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64674108|NCT04076787|Sunitinib|sunitinib|mesh-list
64674109|NCT04076787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64714356|NCT02997722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64714357|NCT02997722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64714358|NCT02997722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714359|NCT03108482|Celecoxib|celecoxib|mesh-list
64714360|NCT03108482|Tramadol|tramadol|mesh-list
64714361|NCT03108482|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64714362|NCT03108482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64714364|NCT03108482|Sensory System Agents|sensory system agents|mesh-ancestor
64714365|NCT03108482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714366|NCT03108482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714368|NCT03108482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64714369|NCT03108482|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64322650|NCT02146547|Aripiprazole|aripiprazole|mesh-list
64674110|NCT04076787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64674111|NCT04076787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64674112|NCT04076787|Growth Substances|growth substances|mesh-ancestor
64674113|NCT04076787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674114|NCT04076787|Growth Inhibitors|growth inhibitors|mesh-ancestor
64674115|NCT04076787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64674116|NCT04076787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674123|NCT00554840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674124|NCT00554840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674127|NCT04069221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64674128|NCT04069221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64674129|NCT04069221|Antiviral Agents|antiviral agents|mesh-ancestor
64674130|NCT04069221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64674131|NCT04069221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64674132|NCT04069221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64674133|NCT04069221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674134|NCT04069221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674135|NCT04069221|Antimalarials|antimalarials|mesh-ancestor
64674136|NCT04069221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64674137|NCT04069221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64674139|NCT03054038|Necitumumab|necitumumab|mesh-list
64674140|NCT03054038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674141|NCT03054038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64674142|NCT03054038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674143|NCT03054038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674144|NCT03054038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64674145|NCT02302716|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65401486|NCT00980876|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65401487|NCT00980876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65401488|NCT05279040|Ivacaftor|ivacaftor|mesh-list
65401489|NCT05279040|Elexacaftor|elexacaftor|mesh-list
65401490|NCT05279040|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65401491|NCT05279040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65401492|NCT05279040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401493|NCT04930536|Acalabrutinib|acalabrutinib|mesh-list
65401494|NCT04930536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401495|NCT00989898|Insulin|insulin|mesh-list
65401496|NCT00989898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65401497|NCT00989898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401498|NCT00990054|Plerixafor|plerixafor|mesh-list
65401499|NCT00990054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65401500|NCT00990054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65401501|NCT00990054|Antiviral Agents|antiviral agents|mesh-ancestor
65401502|NCT00990054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65401503|NCT03388632|Nivolumab|nivolumab|mesh-list
65401504|NCT03388632|Ipilimumab|ipilimumab|mesh-list
65401505|NCT03388632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65401506|NCT03388632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401507|NCT03388632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64786293|NCT00001842|Hormones|hormones|mesh-ancestor
64674146|NCT02302716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674147|NCT03958071|Pirfenidone|pirfenidone|mesh-list
64674148|NCT03958071|Nintedanib|nintedanib|mesh-list
64674149|NCT03958071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674150|NCT03958071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64674151|NCT03958071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674152|NCT03958071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674153|NCT03958071|Analgesics|analgesics|mesh-ancestor
64674154|NCT03958071|Sensory System Agents|sensory system agents|mesh-ancestor
64674155|NCT03958071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64674156|NCT03958071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674157|NCT03958071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64674158|NCT03958071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64674159|NCT03958071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64674160|NCT03958071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64674161|NCT04066647|Dexamethasone|dexamethasone|mesh-list
64674162|NCT04066647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64714370|NCT03108482|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64714371|NCT03108482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64714372|NCT03108482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714373|NCT03108482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64714374|NCT03108482|Narcotics|narcotics|mesh-ancestor
64714375|NCT03108482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64714376|NCT02850601|Dexamethasone|dexamethasone|mesh-list
64714377|NCT02850601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64714378|NCT02850601|Antiemetics|antiemetics|mesh-ancestor
64714379|NCT02850601|Autonomic Agents|autonomic agents|mesh-ancestor
64714380|NCT02850601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322664|NCT02146547|Serotonin Agents|serotonin agents|mesh-ancestor
64674163|NCT04066647|Antiemetics|antiemetics|mesh-ancestor
64674164|NCT04066647|Autonomic Agents|autonomic agents|mesh-ancestor
65401508|NCT03388632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401509|NCT05361408|Zoledronic Acid|zoledronic acid|mesh-list
65401510|NCT05361408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65401511|NCT05361408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401512|NCT05590572|Etoposide|etoposide|mesh-list
65401513|NCT05590572|Ifosfamide|ifosfamide|mesh-list
65401514|NCT05590572|Isophosphamide mustard|isophosphamide mustard|mesh-list
65401515|NCT05590572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65401516|NCT05590572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401517|NCT05590572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64786316|NCT00001890|Estrogens|estrogens|mesh-list
64674165|NCT04066647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64674166|NCT04066647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674167|NCT04066647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64674168|NCT04066647|Glucocorticoids|glucocorticoids|mesh-ancestor
64674169|NCT04066647|Hormones|hormones|mesh-ancestor
64674170|NCT04066647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64674171|NCT04066647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64674178|NCT04041453|Anticestodal Agents|anticestodal agents|mesh-ancestor
64674179|NCT04041453|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64674180|NCT04041453|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64674183|NCT04041453|Mitosis Modulators|mitosis modulators|mesh-ancestor
64674184|NCT04041453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674185|NCT04041453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674187|NCT02354508|Hormones|hormones|mesh-ancestor
64674188|NCT02354508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64674189|NCT02354508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674190|NCT00554216|Topiramate|topiramate|mesh-list
64674191|NCT00554216|Phentermine|phentermine|mesh-list
64674192|NCT00554216|Anticonvulsants|anticonvulsants|mesh-ancestor
64674193|NCT00554216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64674194|NCT00554216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674195|NCT00554216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64674196|NCT00554216|Appetite Depressants|appetite depressants|mesh-ancestor
64674197|NCT00554216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64674198|NCT00554216|Sympathomimetics|sympathomimetics|mesh-ancestor
64674199|NCT00554216|Autonomic Agents|autonomic agents|mesh-ancestor
64674200|NCT00554216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64674201|NCT00554216|Adrenergic Agents|adrenergic agents|mesh-ancestor
64674202|NCT00554216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64674203|NCT00554216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674204|NCT02353572|Dexamethasone|dexamethasone|mesh-list
64674205|NCT02353572|Bortezomib|bortezomib|mesh-list
64674206|NCT02353572|Melphalan|melphalan|mesh-list
64674207|NCT02353572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64674208|NCT02353572|Antiemetics|antiemetics|mesh-ancestor
64674209|NCT02353572|Autonomic Agents|autonomic agents|mesh-ancestor
64674210|NCT02353572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64674211|NCT02353572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674212|NCT02353572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64674213|NCT02353572|Glucocorticoids|glucocorticoids|mesh-ancestor
64674214|NCT02353572|Hormones|hormones|mesh-ancestor
64674215|NCT02353572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64674216|NCT02353572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64674217|NCT02353572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674218|NCT02353572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64674219|NCT02353572|Alkylating Agents|alkylating agents|mesh-ancestor
64674220|NCT02353572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714381|NCT02850601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714382|NCT02850601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64714383|NCT02850601|Glucocorticoids|glucocorticoids|mesh-ancestor
64714384|NCT02850601|Hormones|hormones|mesh-ancestor
64714385|NCT02850601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65401518|NCT05590572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65401519|NCT05590572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401520|NCT05590572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401521|NCT05590572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65401522|NCT05590572|Alkylating Agents|alkylating agents|mesh-ancestor
65401523|NCT03069378|Pembrolizumab|pembrolizumab|mesh-list
65401524|NCT03069378|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
65401525|NCT03069378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65401526|NCT03069378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401527|NCT05590416|Adalimumab|adalimumab|mesh-list
65401528|NCT05590416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65401529|NCT05590416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65401530|NCT00990444|Insulin|insulin|mesh-list
65401531|NCT00990444|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65401532|NCT00990444|Dextrans|dextrans|mesh-list
65401533|NCT00990444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65401534|NCT00990444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714386|NCT02850601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64714387|NCT02850601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64714388|NCT03056456|Insulin Lispro|insulin lispro|mesh-list
64714389|NCT03056456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64714390|NCT03056456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714391|NCT03057704|Lidocaine|lidocaine|mesh-list
64714392|NCT03057704|Anesthetics, Local|anesthetics, local|mesh-ancestor
64714393|NCT03057704|Anesthetics|anesthetics|mesh-ancestor
64714394|NCT03057704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64714395|NCT03057704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714396|NCT03057704|Sensory System Agents|sensory system agents|mesh-ancestor
64714397|NCT03057704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714398|NCT03057704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64714399|NCT03057704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64714400|NCT03057704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64714401|NCT03057704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64714402|NCT03057704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714403|NCT02874092|Ticagrelor|ticagrelor|mesh-list
64714404|NCT02874092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64714405|NCT02874092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64714406|NCT02874092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64714407|NCT02874092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64714408|NCT02874092|Purinergic Agents|purinergic agents|mesh-ancestor
64714409|NCT02874092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64714410|NCT02874092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714411|NCT02874092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714412|NCT02876900|Asenapine|asenapine|mesh-list
64714413|NCT02876900|Maleic acid|maleic acid|mesh-list
64714419|NCT02876900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714420|NCT02876900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64714421|NCT02878382|Calcipotriene|calcipotriene|mesh-list
64714422|NCT02878382|Dermatologic Agents|dermatologic agents|mesh-ancestor
64714423|NCT03117140|Dexamethasone|dexamethasone|mesh-list
64714425|NCT03117140|Buprenorphine|buprenorphine|mesh-list
64714426|NCT03117140|Ropivacaine|ropivacaine|mesh-list
64714427|NCT03117140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64714428|NCT03117140|Antiemetics|antiemetics|mesh-ancestor
64714429|NCT03117140|Autonomic Agents|autonomic agents|mesh-ancestor
64714430|NCT03117140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322720|NCT04163185|Serotonin Agents|serotonin agents|mesh-ancestor
64674221|NCT02353572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64674222|NCT02353572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65401535|NCT00990444|Anticoagulants|anticoagulants|mesh-ancestor
65401536|NCT00990444|Plasma Substitutes|plasma substitutes|mesh-ancestor
65401537|NCT00990444|Blood Substitutes|blood substitutes|mesh-ancestor
65401538|NCT00990600|Tenofovir|tenofovir|mesh-list
65401539|NCT00990600|Emtricitabine|emtricitabine|mesh-list
65401540|NCT00990600|Efavirenz|efavirenz|mesh-list
65401541|NCT00990600|Antiviral Agents|antiviral agents|mesh-ancestor
65401542|NCT00990600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65401543|NCT00990600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65401544|NCT00990600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65401545|NCT00990600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401546|NCT00990600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401547|NCT00990600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65401548|NCT00990600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65401549|NCT00990600|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65401550|NCT00990600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65401551|NCT00990600|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65401552|NCT00990600|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65401553|NCT00990600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65401554|NCT00990600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65401555|NCT02897076|Betamethasone|betamethasone|mesh-list
65401556|NCT02897076|Betamethasone Valerate|betamethasone valerate|mesh-list
65401557|NCT02897076|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65401558|NCT02897076|Betamethasone benzoate|betamethasone benzoate|mesh-list
65401559|NCT02897076|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65151128|NCT00965263|Cocaine|cocaine|mesh-list
65401581|NCT02797548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401582|NCT02797548|Antipyretics|antipyretics|mesh-ancestor
65401583|NCT00990678|Vitamin D|vitamin d|mesh-list
65401584|NCT00990678|Calcitriol|calcitriol|mesh-list
65401585|NCT00990678|Calcium|calcium|mesh-list
65401586|NCT00990678|Vitamins|vitamins|mesh-ancestor
65401587|NCT00990678|Micronutrients|micronutrients|mesh-ancestor
65401588|NCT00990678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401589|NCT00990678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65401590|NCT00990678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65401591|NCT00990678|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65401592|NCT00990678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65401593|NCT00990678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401594|NCT00990678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65401595|NCT00538590|Mitomycins|mitomycins|mesh-list
65401596|NCT00538590|Mitomycin|mitomycin|mesh-list
65401597|NCT00538590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65401598|NCT00538590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401599|NCT00538590|Alkylating Agents|alkylating agents|mesh-ancestor
65401600|NCT00538590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401601|NCT00538590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65401634|NCT00537810|Sibutramine|sibutramine|mesh-list
65151199|NCT02862145|Glucocorticoids|glucocorticoids|mesh-ancestor
65401635|NCT00537810|Antidepressive Agents|antidepressive agents|mesh-ancestor
65401636|NCT00537810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65401637|NCT00537810|Appetite Depressants|appetite depressants|mesh-ancestor
65401638|NCT00537810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65401639|NCT01829568|Rituximab|rituximab|mesh-list
65401640|NCT01829568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65401641|NCT01829568|Lenalidomide|lenalidomide|mesh-list
65401642|NCT01829568|Antibodies|antibodies|mesh-list
65401643|NCT01829568|Immunoglobulins|immunoglobulins|mesh-list
65401644|NCT01829568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65401645|NCT01829568|Immunologic Factors|immunologic factors|mesh-ancestor
65401646|NCT01829568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401647|NCT01829568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401648|NCT01829568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65401649|NCT01829568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65401650|NCT01829568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65401651|NCT01829568|Growth Substances|growth substances|mesh-ancestor
65401652|NCT01829568|Growth Inhibitors|growth inhibitors|mesh-ancestor
65401653|NCT00848328|Rituximab|rituximab|mesh-list
65401654|NCT00848328|Lenalidomide|lenalidomide|mesh-list
65401689|NCT05566626|Tropicamide|tropicamide|mesh-list
65401690|NCT05566626|Mydriatics|mydriatics|mesh-ancestor
65401691|NCT05566626|Autonomic Agents|autonomic agents|mesh-ancestor
65401692|NCT05566626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65401693|NCT05566626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401694|NCT05566626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65401695|NCT05566626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65401696|NCT05566626|Cholinergic Agents|cholinergic agents|mesh-ancestor
65401697|NCT05566626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65401698|NCT05566626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401699|NCT00989508|Perhexiline|perhexiline|mesh-list
65401700|NCT00989508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65401701|NCT00989508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65401702|NCT00989508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401703|NCT00989508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65401704|NCT00989508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401746|NCT01589419|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65401747|NCT01589419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401748|NCT00676403|Pregabalin|pregabalin|mesh-list
65401749|NCT00676403|Analgesics|analgesics|mesh-ancestor
65401750|NCT00676403|Sensory System Agents|sensory system agents|mesh-ancestor
65401751|NCT00676403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65401752|NCT00676403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401753|NCT00676403|Anticonvulsants|anticonvulsants|mesh-ancestor
65401754|NCT00676403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65401763|NCT00078949|Cytarabine|cytarabine|mesh-list
65401810|NCT03961867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401811|NCT00077857|Docetaxel|docetaxel|mesh-list
65401812|NCT00077857|Capecitabine|capecitabine|mesh-list
65401813|NCT00077857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401814|NCT00077857|Tubulin Modulators|tubulin modulators|mesh-ancestor
65401815|NCT00077857|Antimitotic Agents|antimitotic agents|mesh-ancestor
65401816|NCT00077857|Mitosis Modulators|mitosis modulators|mesh-ancestor
65401817|NCT00077857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401818|NCT00077857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65401819|NCT00077857|Antimetabolites|antimetabolites|mesh-ancestor
65401820|NCT00545402|Mycophenolic Acid|mycophenolic acid|mesh-list
65401821|NCT00545402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65401822|NCT00545402|Tacrolimus|tacrolimus|mesh-list
65401823|NCT00545402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65401824|NCT00545402|Immunologic Factors|immunologic factors|mesh-ancestor
65401868|NCT01583023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65401869|NCT01583023|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65401870|NCT01583023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65401871|NCT01583023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65401872|NCT00976976|Cisplatin|cisplatin|mesh-list
65401873|NCT00976976|Docetaxel|docetaxel|mesh-list
65401874|NCT00976976|Capecitabine|capecitabine|mesh-list
65401875|NCT00976976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65401876|NCT00976976|Tubulin Modulators|tubulin modulators|mesh-ancestor
65401877|NCT00976976|Antimitotic Agents|antimitotic agents|mesh-ancestor
65401878|NCT00976976|Mitosis Modulators|mitosis modulators|mesh-ancestor
65401879|NCT00976976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65401931|NCT00977444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65401932|NCT00977444|Prednisolone phosphate|prednisolone phosphate|mesh-list
65401933|NCT00977444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65402004|NCT00967148|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65402005|NCT00967148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402006|NCT04007588|Nivolumab|nivolumab|mesh-list
65402007|NCT04007588|Ipilimumab|ipilimumab|mesh-list
65402008|NCT04007588|Linrodostat|linrodostat|mesh-list
65402009|NCT04007588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65402010|NCT04007588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402011|NCT04007588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65402012|NCT04007588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402013|NCT04007588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402014|NCT00978146|Hydroxyurea|hydroxyurea|mesh-list
65402015|NCT00978146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402016|NCT00978146|Antisickling Agents|antisickling agents|mesh-ancestor
65402017|NCT00978146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402018|NCT00978146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402019|NCT00978146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65402020|NCT00981968|Sitaxsentan|sitaxsentan|mesh-list
65402021|NCT00981968|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65402059|NCT00982436|Mitosis Modulators|mitosis modulators|mesh-ancestor
65402060|NCT00982436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402061|NCT00545168|Permethrin|permethrin|mesh-list
65402062|NCT00545168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402063|NCT00545168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402064|NCT00984932|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65402065|NCT00984932|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65402066|NCT00984932|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65402123|NCT00984152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402124|NCT00984152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402125|NCT00984152|Antiviral Agents|antiviral agents|mesh-ancestor
65402126|NCT00984152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65402127|NCT00984152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65402128|NCT00984152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65402129|NCT00984152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65402130|NCT00984152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65402188|NCT00541346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65402189|NCT00541346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65402190|NCT00541346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402191|NCT00541346|Dopamine Agents|dopamine agents|mesh-ancestor
65402192|NCT00541346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65402193|NCT00988520|Bromides|bromides|mesh-list
65402194|NCT00988520|Propofol|propofol|mesh-list
65402195|NCT00988520|Sevoflurane|sevoflurane|mesh-list
65402196|NCT00988520|Rocuronium|rocuronium|mesh-list
65402197|NCT00988520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65402254|NCT05470400|Immunologic Factors|immunologic factors|mesh-ancestor
65402255|NCT05470400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402256|NCT05450900|Biotin|biotin|mesh-list
65402257|NCT05450900|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65402258|NCT05450900|Vitamins|vitamins|mesh-ancestor
65402259|NCT05450900|Micronutrients|micronutrients|mesh-ancestor
65402260|NCT05450900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402261|NCT05450900|Vitamin B Complex|vitamin b complex|mesh-ancestor
65402262|NCT05450900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65402263|NCT00988910|Contraceptive Agents|contraceptive agents|mesh-list
65402264|NCT00988910|Contraceptives, Oral|contraceptives, oral|mesh-list
65402265|NCT00988910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65402266|NCT00988910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65402267|NCT00988910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402268|NCT00988910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65402269|NCT00986336|Topiramate|topiramate|mesh-list
65402270|NCT00986336|Risperidone|risperidone|mesh-list
65402314|NCT00543062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65402315|NCT00543062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65402316|NCT00543062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65402317|NCT00543062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402318|NCT00543062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402319|NCT00543062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402320|NCT00543062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402321|NCT00543062|Antiemetics|antiemetics|mesh-ancestor
65402380|NCT04003350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402381|NCT04003350|Analgesics|analgesics|mesh-ancestor
65402382|NCT04003350|Sensory System Agents|sensory system agents|mesh-ancestor
65402383|NCT04003350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65402384|NCT04003350|Anticonvulsants|anticonvulsants|mesh-ancestor
65402385|NCT04003350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65402386|NCT04003350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65402387|NCT04003350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65402388|NCT04003350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65402389|NCT04003350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65402390|NCT04003350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65402391|NCT04003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402392|NCT04003350|Antimanic Agents|antimanic agents|mesh-ancestor
65402393|NCT04003350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65402394|NCT04003350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65402395|NCT04003350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65402396|NCT04003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402414|NCT00748163|Paclitaxel|paclitaxel|mesh-list
65402438|NCT00485693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65402439|NCT00485693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402440|NCT00485693|Sensory System Agents|sensory system agents|mesh-ancestor
65402441|NCT00485693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65402442|NCT00485693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65402443|NCT00485693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65402505|NCT00989820|Dermatologic Agents|dermatologic agents|mesh-ancestor
65402506|NCT05357820|Itraconazole|itraconazole|mesh-list
65402507|NCT05357820|Rifampin|rifampin|mesh-list
65402508|NCT05357820|Antifungal Agents|antifungal agents|mesh-ancestor
65402509|NCT05357820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65402510|NCT05357820|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65402511|NCT05357820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65402512|NCT05357820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402513|NCT05357820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402514|NCT05357820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65402532|NCT00748787|Cathartics|cathartics|mesh-ancestor
65402569|NCT04360070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65402570|NCT04360070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65402571|NCT04360070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65402642|NCT05711810|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65402643|NCT05711810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65402644|NCT05711810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65402645|NCT05711810|Vasodilator Agents|vasodilator agents|mesh-ancestor
65402646|NCT05711810|Tocolytic Agents|tocolytic agents|mesh-ancestor
65402647|NCT05711810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65402712|NCT01004874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65402713|NCT01004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65402714|NCT01004874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65402715|NCT01004874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65402716|NCT01004874|Growth Substances|growth substances|mesh-ancestor
65402779|NCT00090103|Dutasteride|dutasteride|mesh-list
65402780|NCT00090103|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65402781|NCT00090103|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65402782|NCT00090103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65402783|NCT00090103|Adrenergic Agents|adrenergic agents|mesh-ancestor
65402850|NCT00086515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402851|NCT00541658|Risedronic Acid|risedronic acid|mesh-list
65402852|NCT00541658|Etidronic Acid|etidronic acid|mesh-list
65402853|NCT00541658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65402854|NCT00541658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65402919|NCT04004234|Mitosis Modulators|mitosis modulators|mesh-ancestor
65402920|NCT04004234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402921|NCT04004234|Immunologic Factors|immunologic factors|mesh-ancestor
65402922|NCT04004234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65402923|NCT04004234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65402924|NCT04004234|Antimetabolites|antimetabolites|mesh-ancestor
65402925|NCT04004234|Antiviral Agents|antiviral agents|mesh-ancestor
65402926|NCT04004234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65402927|NCT04004234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65402928|NCT04004234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65402929|NCT04004234|Trace Elements|trace elements|mesh-ancestor
65402984|NCT04003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65402985|NCT04086212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65402986|NCT04086212|Icodextrin|icodextrin|mesh-list
65402987|NCT04086212|Dialysis Solutions|dialysis solutions|mesh-list
65402988|NCT05404490|Bupivacaine|bupivacaine|mesh-list
65402989|NCT05404490|Anesthetics, Local|anesthetics, local|mesh-ancestor
65402990|NCT05404490|Anesthetics|anesthetics|mesh-ancestor
65402993|NCT05404490|Sensory System Agents|sensory system agents|mesh-ancestor
65403053|NCT05589974|Dermatologic Agents|dermatologic agents|mesh-ancestor
65403054|NCT05589896|Mycophenolic Acid|mycophenolic acid|mesh-list
65152627|NCT01153425|Zoledronic Acid|zoledronic acid|mesh-list
65403055|NCT05589896|Cyclophosphamide|cyclophosphamide|mesh-list
65403056|NCT05589896|Busulfan|busulfan|mesh-list
65403057|NCT05589896|Fludarabine|fludarabine|mesh-list
65403058|NCT05589896|Tacrolimus|tacrolimus|mesh-list
65403060|NCT05589896|Immunologic Factors|immunologic factors|mesh-ancestor
65403122|NCT05361278|Sodium Hypochlorite|sodium hypochlorite|mesh-list
65403123|NCT05361278|Eusol|eusol|mesh-list
65403124|NCT05361278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65403125|NCT05361278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65403126|NCT05361278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65403127|NCT05361278|Disinfectants|disinfectants|mesh-ancestor
65403128|NCT05361278|Dermatologic Agents|dermatologic agents|mesh-ancestor
65403129|NCT00764855|Propofol|propofol|mesh-list
65403130|NCT00764855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65403133|NCT00764855|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65403188|NCT00412360|Cyclosporine|cyclosporine|mesh-list
65403189|NCT00412360|Mycophenolic Acid|mycophenolic acid|mesh-list
65403190|NCT00412360|Cyclophosphamide|cyclophosphamide|mesh-list
65403191|NCT00412360|Fludarabine|fludarabine|mesh-list
65403192|NCT00412360|Cyclosporins|cyclosporins|mesh-list
65403193|NCT00412360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65403194|NCT00412360|Immunologic Factors|immunologic factors|mesh-ancestor
65403195|NCT00412360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403196|NCT00412360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65403197|NCT00412360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65403198|NCT00412360|Alkylating Agents|alkylating agents|mesh-ancestor
65403199|NCT00412360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403200|NCT00412360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403249|NCT01035190|Autonomic Agents|autonomic agents|mesh-ancestor
65403250|NCT01035190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65403251|NCT01035190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403252|NCT01035190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65403253|NCT01035190|Respiratory System Agents|respiratory system agents|mesh-ancestor
65403255|NCT01035190|Hormones|hormones|mesh-ancestor
65403318|NCT00766025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65403319|NCT00766025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403320|NCT00766181|Lidocaine|lidocaine|mesh-list
65403321|NCT00766181|Anesthetics, Local|anesthetics, local|mesh-ancestor
65403322|NCT00766181|Anesthetics|anesthetics|mesh-ancestor
65403323|NCT00766181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65403324|NCT00766181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403325|NCT00766181|Sensory System Agents|sensory system agents|mesh-ancestor
65403383|NCT00762671|Antioxidants|antioxidants|mesh-ancestor
65403384|NCT00762671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403385|NCT00762671|Protective Agents|protective agents|mesh-ancestor
65403386|NCT00762671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65403387|NCT00762671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403388|NCT00762671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65403389|NCT02558387|Nintedanib|nintedanib|mesh-list
65403390|NCT02558387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403391|NCT02558387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65403392|NCT02558387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403393|NCT02558387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403394|NCT00766805|Propranolol|propranolol|mesh-list
65403448|NCT00767117|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65403449|NCT00767117|Protease Inhibitors|protease inhibitors|mesh-ancestor
65403450|NCT00767117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403451|NCT00767117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403452|NCT00767117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65403453|NCT00767117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65403454|NCT00767117|Antiviral Agents|antiviral agents|mesh-ancestor
65403455|NCT00767117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65403456|NCT00767117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65403457|NCT00767117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65403458|NCT00767117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65403460|NCT00762983|Loratadine|loratadine|mesh-list
65403511|NCT00767663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403512|NCT00767663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403513|NCT00767663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65403514|NCT00767663|Vasodilator Agents|vasodilator agents|mesh-ancestor
65403515|NCT00402688|Levofloxacin|levofloxacin|mesh-list
65403516|NCT00402688|Ofloxacin|ofloxacin|mesh-list
65403577|NCT00767975|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65403578|NCT00767975|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65403579|NCT00767975|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65403580|NCT00767975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65403581|NCT00767975|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65403646|NCT00770471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403647|NCT00770471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65403648|NCT00770471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403649|NCT00539240|Antidepressive Agents|antidepressive agents|mesh-list
65403650|NCT00539240|Nortriptyline|nortriptyline|mesh-list
65403651|NCT00539240|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
65403652|NCT00539240|Rabeprazole|rabeprazole|mesh-list
65403653|NCT00539240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65403654|NCT00539240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65403655|NCT00539240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65403656|NCT00539240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65403709|NCT00673673|Antimetabolites|antimetabolites|mesh-ancestor
65403710|NCT00673673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65403711|NCT00673673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65403712|NCT00673673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65403713|NCT00673673|Immunologic Factors|immunologic factors|mesh-ancestor
65403714|NCT05357768|Formaldehyde|formaldehyde|mesh-list
65403715|NCT05357768|Disinfectants|disinfectants|mesh-ancestor
65403716|NCT05357768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65403717|NCT00763685|Etoricoxib|etoricoxib|mesh-list
65403718|NCT00763685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65403719|NCT00763685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65403720|NCT00763685|Analgesics|analgesics|mesh-ancestor
65403721|NCT00763685|Sensory System Agents|sensory system agents|mesh-ancestor
65403722|NCT00763685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65403769|NCT00763763|Autonomic Agents|autonomic agents|mesh-ancestor
65403770|NCT00763763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65403771|NCT00763763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403772|NCT00763763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65403773|NCT00763763|Glucocorticoids|glucocorticoids|mesh-ancestor
65403840|NCT00771017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403841|NCT00771017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65403842|NCT00771017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403843|NCT00771017|Androgen Antagonists|androgen antagonists|mesh-ancestor
65403844|NCT00771017|Hormone Antagonists|hormone antagonists|mesh-ancestor
65403845|NCT00771017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65403846|NCT00769145|Ranibizumab|ranibizumab|mesh-list
65403847|NCT00769145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65403848|NCT00769145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65403849|NCT00769145|Growth Substances|growth substances|mesh-ancestor
65403850|NCT00769145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403851|NCT00769145|Growth Inhibitors|growth inhibitors|mesh-ancestor
65403852|NCT00769145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403853|NCT00763997|Acetaminophen|acetaminophen|mesh-list
65403854|NCT00763997|Dipyrone|dipyrone|mesh-list
65403855|NCT00763997|Ibuprofen|ibuprofen|mesh-list
65403856|NCT00763997|Parecoxib|parecoxib|mesh-list
65403857|NCT00763997|Valdecoxib|valdecoxib|mesh-list
65403858|NCT00763997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65403898|NCT05088356|Tacrolimus|tacrolimus|mesh-list
65403899|NCT05088356|Alkylating Agents|alkylating agents|mesh-list
65403900|NCT05088356|Lenograstim|lenograstim|mesh-list
65403901|NCT05088356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65403902|NCT05088356|Immunologic Factors|immunologic factors|mesh-ancestor
65403903|NCT05088356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65403904|NCT05088356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65403905|NCT05088356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65403907|NCT05088356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65403967|NCT01415882|Glucocorticoids|glucocorticoids|mesh-ancestor
65403968|NCT01415882|Hormones|hormones|mesh-ancestor
65404042|NCT00398866|Glucocorticoids|glucocorticoids|mesh-ancestor
65404043|NCT00398866|Hormones|hormones|mesh-ancestor
65404044|NCT00398866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65404045|NCT00398866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65404114|NCT04694300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65404115|NCT04694300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65404116|NCT04694300|Gout Suppressants|gout suppressants|mesh-ancestor
65404117|NCT04694300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65404118|NCT04694300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65404119|NCT04694300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404184|NCT00398320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65404185|NCT00398320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65404186|NCT00398320|Growth Substances|growth substances|mesh-ancestor
65404187|NCT00398320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404188|NCT00398320|Growth Inhibitors|growth inhibitors|mesh-ancestor
65404189|NCT00398320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65404190|NCT00398320|Antimetabolites|antimetabolites|mesh-ancestor
65493987|NCT03897439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404192|NCT00670007|Protease Inhibitors|protease inhibitors|mesh-list
65404248|NCT00779441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65404249|NCT00779441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404250|NCT00779441|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65404251|NCT00779441|GABA Agonists|gaba agonists|mesh-ancestor
65404252|NCT00779441|GABA Agents|gaba agents|mesh-ancestor
65404253|NCT00779441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65404254|NCT00779441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404255|NCT02556437|Immunoglobulins|immunoglobulins|mesh-list
65404256|NCT02556437|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65404257|NCT02556437|Antibodies|antibodies|mesh-list
65404258|NCT02556437|Immunologic Factors|immunologic factors|mesh-ancestor
65404310|NCT02556905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65404311|NCT02556905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65404312|NCT02556905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404313|NCT02556905|Immunologic Factors|immunologic factors|mesh-ancestor
65404314|NCT02556905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65404315|NCT02556905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65404316|NCT02556905|Growth Substances|growth substances|mesh-ancestor
65404317|NCT02556905|Growth Inhibitors|growth inhibitors|mesh-ancestor
65404318|NCT00539006|Fluticasone|fluticasone|mesh-list
65404319|NCT00539006|Xhance|xhance|mesh-list
65404320|NCT00539006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65404321|NCT00539006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65404322|NCT00539006|Autonomic Agents|autonomic agents|mesh-ancestor
65404323|NCT00539006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65404329|NCT04047329|Anesthetics|anesthetics|mesh-list
65404369|NCT00535262|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65404370|NCT00535262|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65404371|NCT00535262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65404372|NCT00535262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404373|NCT00535262|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65404374|NCT00535262|Protective Agents|protective agents|mesh-ancestor
65404375|NCT00535262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404376|NCT00772499|Atenolol|atenolol|mesh-list
65404377|NCT00772499|Amlodipine|amlodipine|mesh-list
65404378|NCT00772499|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65404379|NCT00772499|Olmesartan|olmesartan|mesh-list
65404380|NCT00772499|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65404381|NCT00772499|Hydralazine|hydralazine|mesh-list
65404382|NCT00772499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65404383|NCT00772499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65404403|NCT00989690|Docetaxel|docetaxel|mesh-list
65404430|NCT00074581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404431|NCT00074581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65404432|NCT00074581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65404433|NCT00074581|Antiviral Agents|antiviral agents|mesh-ancestor
65404434|NCT00074581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65404435|NCT00074581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65404436|NCT00074581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65404437|NCT00074581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65404438|NCT00074581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65404439|NCT00074581|Antimetabolites|antimetabolites|mesh-ancestor
65404440|NCT00074581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65404441|NCT00074581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65404442|NCT00074581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65404445|NCT00776477|Aspirin|aspirin|mesh-list
65404487|NCT00776633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404488|NCT00776633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65404489|NCT00776633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65404490|NCT00776633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65404491|NCT00776633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65404492|NCT00776633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404493|NCT00776633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65404494|NCT00776633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65404495|NCT00776633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65404496|NCT00776633|Antipyretics|antipyretics|mesh-ancestor
65404497|NCT00776633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65404498|NCT00776633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65404499|NCT00776633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65404500|NCT00776633|Purinergic Agents|purinergic agents|mesh-ancestor
65404501|NCT00776633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65404502|NCT01093963|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65404503|NCT01093963|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65404544|NCT00536978|Etoposide|etoposide|mesh-list
65404545|NCT00536978|Alemtuzumab|alemtuzumab|mesh-list
65404546|NCT00536978|Tacrolimus|tacrolimus|mesh-list
65404547|NCT00536978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65404548|NCT00536978|Immunologic Factors|immunologic factors|mesh-ancestor
65404549|NCT00536978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404550|NCT00536978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65404551|NCT00536978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65404552|NCT00536978|Alkylating Agents|alkylating agents|mesh-ancestor
65404553|NCT00536978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404554|NCT00536978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404555|NCT00536978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65404556|NCT00536978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65404557|NCT00536978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65404558|NCT00536978|Abortifacient Agents|abortifacient agents|mesh-ancestor
65404559|NCT00536978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65404560|NCT00536978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65404600|NCT04026230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65404601|NCT04026230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65404602|NCT04026230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65404603|NCT00536510|Niacin|niacin|mesh-list
65404604|NCT00536510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65404605|NCT00536510|Antimetabolites|antimetabolites|mesh-ancestor
65404606|NCT00536510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404607|NCT00536510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65404608|NCT00536510|Vasodilator Agents|vasodilator agents|mesh-ancestor
65404609|NCT00536510|Vitamin B Complex|vitamin b complex|mesh-ancestor
65404610|NCT00536510|Vitamins|vitamins|mesh-ancestor
65404662|NCT00398086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65404663|NCT00398086|Immunologic Factors|immunologic factors|mesh-ancestor
65404664|NCT00398086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404665|NCT04364360|Sulforaphane|sulforaphane|mesh-list
65404666|NCT04364360|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65404667|NCT04364360|Protective Agents|protective agents|mesh-ancestor
65404668|NCT04364360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404669|NCT04364360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404670|NCT00536198|Sertraline|sertraline|mesh-list
65404671|NCT00536198|Antidepressive Agents|antidepressive agents|mesh-ancestor
65404672|NCT00536198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65404673|NCT00536198|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65404674|NCT00536198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65404675|NCT00536198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65404676|NCT00536198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404677|NCT00536198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65404678|NCT00536198|Serotonin Agents|serotonin agents|mesh-ancestor
65404721|NCT00057811|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65404722|NCT00057811|Prednisolone phosphate|prednisolone phosphate|mesh-list
65404723|NCT00057811|Levoleucovorin|levoleucovorin|mesh-list
65404724|NCT00057811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65404725|NCT00057811|Immunologic Factors|immunologic factors|mesh-ancestor
65404726|NCT00057811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404727|NCT00057811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65404728|NCT00057811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65404729|NCT00057811|Alkylating Agents|alkylating agents|mesh-ancestor
65404730|NCT00057811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404731|NCT00057811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65404732|NCT00057811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65404733|NCT00057811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65404734|NCT00057811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65404735|NCT00057811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65404736|NCT00057811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65404737|NCT00057811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65404738|NCT00057811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65404740|NCT00057811|Hormones|hormones|mesh-ancestor
65404776|NCT02530801|Growth Substances|growth substances|mesh-ancestor
65404777|NCT02530801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404778|NCT02530801|Growth Inhibitors|growth inhibitors|mesh-ancestor
65404779|NCT02530801|Antimetabolites|antimetabolites|mesh-ancestor
65404780|NCT02530801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404845|NCT00992030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65404846|NCT00992030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65404847|NCT00992030|Alkylating Agents|alkylating agents|mesh-ancestor
65404848|NCT00992030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65404914|NCT03979352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65404915|NCT03979352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404916|NCT03979352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65404917|NCT00773201|Sotalol|sotalol|mesh-list
65404918|NCT00773201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65404983|NCT00773591|Cholinergic Agents|cholinergic agents|mesh-ancestor
65404984|NCT00773591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65404985|NCT00995306|Capsaicin|capsaicin|mesh-list
65404986|NCT00995306|Antipruritics|antipruritics|mesh-ancestor
65404987|NCT00995306|Dermatologic Agents|dermatologic agents|mesh-ancestor
65404988|NCT00995306|Sensory System Agents|sensory system agents|mesh-ancestor
65404989|NCT00995306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65404990|NCT00995306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65404991|NCT00666965|Rotigotine|rotigotine|mesh-list
65404992|NCT00666965|Dopamine Agonists|dopamine agonists|mesh-ancestor
65404993|NCT00666965|Dopamine Agents|dopamine agents|mesh-ancestor
65405047|NCT00778193|Aspirin|aspirin|mesh-list
65405048|NCT00778193|Celecoxib|celecoxib|mesh-list
65405049|NCT00778193|Naproxen|naproxen|mesh-list
65405050|NCT00778193|Clopidogrel|clopidogrel|mesh-list
65405051|NCT00778193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65405052|NCT00778193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65405053|NCT00778193|Analgesics|analgesics|mesh-ancestor
65405054|NCT00778193|Sensory System Agents|sensory system agents|mesh-ancestor
65405055|NCT00778193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65405056|NCT00778193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405057|NCT00778193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65405058|NCT00778193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65405059|NCT00778193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65405065|NCT00778193|Antipyretics|antipyretics|mesh-ancestor
65405108|NCT00995618|Histamine Agents|histamine agents|mesh-ancestor
65405109|NCT00995618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65405110|NCT00995618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65405111|NCT00995618|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65405112|NCT00778427|Metformin|metformin|mesh-list
65405113|NCT00778427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65405114|NCT00778427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405180|NCT00667277|Bevacizumab|bevacizumab|mesh-list
65405181|NCT00667277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65405182|NCT00667277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405188|NCT00774527|Cyclophosphamide|cyclophosphamide|mesh-list
65405251|NCT00784589|Rituximab|rituximab|mesh-list
65405252|NCT00784589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65405253|NCT00784589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405254|NCT00784589|Immunologic Factors|immunologic factors|mesh-ancestor
65405255|NCT00784589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405256|NCT00784589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65405320|NCT00789971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65405321|NCT00789971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65405322|NCT00789971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65405323|NCT00789971|Glucocorticoids|glucocorticoids|mesh-ancestor
65405324|NCT00789971|Hormones|hormones|mesh-ancestor
65405325|NCT00789971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65405326|NCT00789971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405327|NCT00789971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65405328|NCT00789971|Immunologic Factors|immunologic factors|mesh-ancestor
65405385|NCT00996788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405386|NCT00996788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405387|NCT01564550|Insulin|insulin|mesh-list
65405388|NCT01564550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65405389|NCT01564550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65405390|NCT01564550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405391|NCT00996866|Vitamin D|vitamin d|mesh-list
65405392|NCT00996866|Cholecalciferol|cholecalciferol|mesh-list
65405393|NCT00996866|Vitamins|vitamins|mesh-ancestor
65405394|NCT00996866|Micronutrients|micronutrients|mesh-ancestor
65405395|NCT00996866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405396|NCT00996866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65405397|NCT00996866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65405398|NCT00790439|Cyclosporine|cyclosporine|mesh-list
65405399|NCT00790439|Sirolimus|sirolimus|mesh-list
65405400|NCT00790439|Mycophenolic Acid|mycophenolic acid|mesh-list
65405401|NCT00790439|Heparin|heparin|mesh-list
65405446|NCT00785603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65405447|NCT00785603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65405448|NCT00785603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405449|NCT00570401|Dasatinib|dasatinib|mesh-list
65405516|NCT00783107|Cyclosporine|cyclosporine|mesh-list
65405517|NCT00783107|Cyclosporins|cyclosporins|mesh-list
65405518|NCT00783107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405520|NCT00783107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65405587|NCT00783731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65405588|NCT00783731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405589|NCT00783731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65405590|NCT00783731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65405658|NCT00391846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65405659|NCT00391846|Sympatholytics|sympatholytics|mesh-ancestor
65405660|NCT00391846|Autonomic Agents|autonomic agents|mesh-ancestor
65405661|NCT00391846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65405662|NCT00391846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405663|NCT00391846|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65405664|NCT00391846|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65405665|NCT00391846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65405666|NCT00391846|Adrenergic Agents|adrenergic agents|mesh-ancestor
65405667|NCT00391846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65405668|NCT00391846|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65405669|NCT00391846|Hormone Antagonists|hormone antagonists|mesh-ancestor
65405670|NCT00391846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65405671|NCT00391846|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65405672|NCT00391846|Natriuretic Agents|natriuretic agents|mesh-ancestor
65405673|NCT00391846|Antioxidants|antioxidants|mesh-ancestor
65405674|NCT00391846|Protective Agents|protective agents|mesh-ancestor
65405713|NCT00409006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405714|NCT00409006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405715|NCT00409006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65405716|NCT00409006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65405717|NCT00409006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65405718|NCT00997880|Calcium, Dietary|calcium, dietary|mesh-list
65405719|NCT00997880|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65405720|NCT00997880|Calcium|calcium|mesh-list
65405721|NCT00997880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65405722|NCT00997880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405723|NCT00997880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65405724|NCT00997880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65405725|NCT00997880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65405726|NCT00997880|Antimetabolites|antimetabolites|mesh-ancestor
65405727|NCT00997880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405728|NCT00997880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65405730|NCT00997880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65405768|NCT00998192|Carboplatin|carboplatin|mesh-list
65405769|NCT00998192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65405770|NCT00998192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405771|NCT00998192|Tubulin Modulators|tubulin modulators|mesh-ancestor
65405772|NCT00998192|Antimitotic Agents|antimitotic agents|mesh-ancestor
65405773|NCT00998192|Mitosis Modulators|mitosis modulators|mesh-ancestor
65405774|NCT00998192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405775|NCT00994526|Vitamin E|vitamin e|mesh-list
65405776|NCT00994526|Calcium|calcium|mesh-list
65405777|NCT00994526|Vitamins|vitamins|mesh-ancestor
65405778|NCT00994526|Micronutrients|micronutrients|mesh-ancestor
65405779|NCT00994526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405780|NCT00994526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65405781|NCT00994526|Antioxidants|antioxidants|mesh-ancestor
65405782|NCT00994526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405783|NCT00994526|Protective Agents|protective agents|mesh-ancestor
65405784|NCT00998504|Resveratrol|resveratrol|mesh-list
65405826|NCT00998816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65405827|NCT00533702|Dacarbazine|dacarbazine|mesh-list
65405828|NCT00533702|Ramucirumab|ramucirumab|mesh-list
65405829|NCT00533702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65405830|NCT00533702|Imidazole|imidazole|mesh-list
65405831|NCT00533702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65405832|NCT00533702|Alkylating Agents|alkylating agents|mesh-ancestor
65405896|NCT01044394|Laxatives|laxatives|mesh-ancestor
65405897|NCT03474094|Atezolizumab|atezolizumab|mesh-list
65405898|NCT03474094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65405899|NCT03474094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65405900|NCT03474094|Immunologic Factors|immunologic factors|mesh-ancestor
65405901|NCT03474094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65405902|NCT01043536|Temozolomide|temozolomide|mesh-list
65405903|NCT01043536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65405904|NCT01043536|Alkylating Agents|alkylating agents|mesh-ancestor
65405905|NCT01043536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65405908|NCT00056407|Dutasteride|dutasteride|mesh-list
65405960|NCT00395746|Incretins|incretins|mesh-ancestor
65405961|NCT00395746|Hormones|hormones|mesh-ancestor
65405962|NCT00395746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65405963|NCT01004900|Timolol|timolol|mesh-list
65405965|NCT01004900|Travoprost|travoprost|mesh-list
65406031|NCT00999440|Respiratory System Agents|respiratory system agents|mesh-ancestor
65406032|NCT00054691|Gefitinib|gefitinib|mesh-list
65406033|NCT00054691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406034|NCT00054691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65406035|NCT00054691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406036|NCT00054691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406037|NCT02530879|Esomeprazole|esomeprazole|mesh-list
65406038|NCT02530879|Omeprazole|omeprazole|mesh-list
65406098|NCT00066703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406099|NCT00066703|Luteolytic Agents|luteolytic agents|mesh-ancestor
65406100|NCT00066703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65406101|NCT00066703|Contraceptive Agents|contraceptive agents|mesh-ancestor
65406169|NCT01094977|Coagulants|coagulants|mesh-ancestor
65406170|NCT01095133|Amiloride|amiloride|mesh-list
65406171|NCT01095133|Diuretics|diuretics|mesh-ancestor
65406172|NCT01095133|Natriuretic Agents|natriuretic agents|mesh-ancestor
65406173|NCT01095133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406174|NCT01095133|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65406175|NCT01095133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65406176|NCT01095133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65406180|NCT00387088|Tiotropium Bromide|tiotropium bromide|mesh-list
65406236|NCT00386308|Hemostatics|hemostatics|mesh-ancestor
65406237|NCT00386308|Coagulants|coagulants|mesh-ancestor
65406238|NCT00064987|Hormones|hormones|mesh-list
65406239|NCT00064987|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65406240|NCT00064987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65406242|NCT00374140|Everolimus|everolimus|mesh-list
65406309|NCT00791297|Contraceptive Agents|contraceptive agents|mesh-ancestor
65406310|NCT00791297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65406311|NCT00791297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406312|NCT00791297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65406313|NCT01045876|Dexamethasone|dexamethasone|mesh-list
65406314|NCT01045876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65406315|NCT01045876|Antiemetics|antiemetics|mesh-ancestor
65406316|NCT01045876|Autonomic Agents|autonomic agents|mesh-ancestor
65406317|NCT01045876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65406318|NCT01045876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406319|NCT01045876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65406320|NCT01045876|Glucocorticoids|glucocorticoids|mesh-ancestor
65406321|NCT01045876|Hormones|hormones|mesh-ancestor
65406322|NCT01045876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65406325|NCT00385762|Paroxetine|paroxetine|mesh-list
65406368|NCT00038467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65406369|NCT00038467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406370|NCT00038467|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65406371|NCT00038467|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65406372|NCT00038467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65406373|NCT00038467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65406374|NCT00038467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65406375|NCT00038467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406435|NCT00570323|Hormone Antagonists|hormone antagonists|mesh-ancestor
65406436|NCT00570323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65406437|NCT00570323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406438|NCT00570323|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65406442|NCT00791531|Methotrexate|methotrexate|mesh-list
65406505|NCT00796211|Nortriptyline|nortriptyline|mesh-list
65406506|NCT00796211|Calcipotriene|calcipotriene|mesh-list
65406507|NCT00796211|Dermatologic Agents|dermatologic agents|mesh-ancestor
65406508|NCT00796211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65406509|NCT00796211|Antidepressive Agents|antidepressive agents|mesh-ancestor
65406510|NCT00796211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65406511|NCT00796211|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65406512|NCT00796211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65406513|NCT00796211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65406514|NCT00796211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406515|NCT00796211|Adrenergic Agents|adrenergic agents|mesh-ancestor
65406516|NCT00796211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65406565|NCT04080427|Sensory System Agents|sensory system agents|mesh-ancestor
65406566|NCT04080427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65406567|NCT04080427|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65406568|NCT04080427|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65406569|NCT04080427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65406570|NCT04080427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406571|NCT04080427|Hormones|hormones|mesh-ancestor
65406631|NCT00789503|Vitamin D|vitamin d|mesh-list
65406632|NCT00789503|Cholecalciferol|cholecalciferol|mesh-list
65406633|NCT00789503|Calcium|calcium|mesh-list
65406634|NCT00789503|Vitamins|vitamins|mesh-ancestor
65406635|NCT00789503|Micronutrients|micronutrients|mesh-ancestor
65406636|NCT00789503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406637|NCT00789503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65406638|NCT00789503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65406639|NCT00797303|Bevacizumab|bevacizumab|mesh-list
65406640|NCT00797303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65406641|NCT00797303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406697|NCT00801281|Tubulin Modulators|tubulin modulators|mesh-ancestor
65406698|NCT00801281|Antimitotic Agents|antimitotic agents|mesh-ancestor
65406699|NCT00801281|Mitosis Modulators|mitosis modulators|mesh-ancestor
65406700|NCT00801359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65406701|NCT00801515|Maraviroc|maraviroc|mesh-list
65406702|NCT00801515|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65406703|NCT00801515|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65406704|NCT00801515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406705|NCT00801515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65406706|NCT00801515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65406707|NCT00801515|Antiviral Agents|antiviral agents|mesh-ancestor
65406708|NCT00801515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65406709|NCT00801515|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65406710|NCT00797693|Misoprostol|misoprostol|mesh-list
65406711|NCT00797693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65406712|NCT00797693|Abortifacient Agents|abortifacient agents|mesh-ancestor
65406713|NCT00797693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65406714|NCT00797693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406715|NCT00797693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65406716|NCT00797693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65406717|NCT00797693|Oxytocics|oxytocics|mesh-ancestor
65406718|NCT00797771|Insulin|insulin|mesh-list
65406719|NCT00797771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65406720|NCT00797771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406721|NCT00793559|Terlipressin|terlipressin|mesh-list
65406722|NCT00793559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65406723|NCT00793559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65406724|NCT00797927|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65406725|NCT00797927|Antipsychotic Agents|antipsychotic agents|mesh-list
65406726|NCT00797927|Antidepressive Agents|antidepressive agents|mesh-ancestor
65406727|NCT00797927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65406728|NCT00797927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65406729|NCT00797927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65406739|NCT00798083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65406740|NCT00798083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65406741|NCT00798083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65406742|NCT00798083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65406743|NCT00798083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65406744|NCT00798083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406746|NCT00798083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65406747|NCT00798083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65406748|NCT00798083|Anesthetics, General|anesthetics, general|mesh-ancestor
65406749|NCT00798083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65406750|NCT00798083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65406751|NCT00798083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65406752|NCT00798083|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65406753|NCT00798083|Antidepressive Agents|antidepressive agents|mesh-ancestor
65406754|NCT00798083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65406755|NCT00798083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65406756|NCT00798083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65406757|NCT00798083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65406758|NCT00798083|Adrenergic Agents|adrenergic agents|mesh-ancestor
65406759|NCT00798395|Zopiclone|zopiclone|mesh-list
65406760|NCT00798395|Mirtazapine|mirtazapine|mesh-list
65406790|NCT00658541|Zolpidem|zolpidem|mesh-list
65406791|NCT00658541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65406792|NCT00658541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65406793|NCT00658541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65406794|NCT00658541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406795|NCT00658541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65406796|NCT00658541|GABA Agonists|gaba agonists|mesh-ancestor
65406797|NCT00658541|GABA Agents|gaba agents|mesh-ancestor
65406798|NCT00658541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65406799|NCT00658541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406800|NCT00048061|Vitamin D|vitamin d|mesh-list
65406801|NCT00048061|Ibandronic Acid|ibandronic acid|mesh-list
65406853|NCT04045769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65406854|NCT04045769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406855|NCT04045769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65406856|NCT04045769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406857|NCT01097317|Carboplatin|carboplatin|mesh-list
65406858|NCT01097317|Vinorelbine|vinorelbine|mesh-list
65406859|NCT01097317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65406860|NCT01097317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65406865|NCT01095679|Baclofen|baclofen|mesh-list
65406920|NCT03953209|Spironolactone|spironolactone|mesh-list
65406921|NCT03953209|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65406922|NCT03953209|Hormone Antagonists|hormone antagonists|mesh-ancestor
65406923|NCT03953209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65406924|NCT03953209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406925|NCT03953209|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65406926|NCT03953209|Diuretics|diuretics|mesh-ancestor
65406927|NCT03953209|Natriuretic Agents|natriuretic agents|mesh-ancestor
65406928|NCT01583959|Folic Acid|folic acid|mesh-list
65406929|NCT01583959|Hematinics|hematinics|mesh-ancestor
65406930|NCT01583959|Vitamin B Complex|vitamin b complex|mesh-ancestor
65406931|NCT01583959|Vitamins|vitamins|mesh-ancestor
65406932|NCT01583959|Micronutrients|micronutrients|mesh-ancestor
65406933|NCT01583959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406934|NCT00803387|Travoprost|travoprost|mesh-list
65406935|NCT00803387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65406936|NCT02553551|Vitamins|vitamins|mesh-list
65406937|NCT02553551|Micronutrients|micronutrients|mesh-ancestor
65406938|NCT02553551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406939|NCT00803465|Fluticasone|fluticasone|mesh-list
65406941|NCT00803465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65406976|NCT00794807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406977|NCT00794885|Folic Acid|folic acid|mesh-list
65406978|NCT00794885|Vitamin B Complex|vitamin b complex|mesh-list
65406979|NCT00794885|Enalapril|enalapril|mesh-list
65406980|NCT00794885|Enalaprilat|enalaprilat|mesh-list
65406981|NCT00794885|Maleic acid|maleic acid|mesh-list
65406982|NCT00794885|Hematinics|hematinics|mesh-ancestor
65406983|NCT00794885|Vitamins|vitamins|mesh-ancestor
65406984|NCT00794885|Micronutrients|micronutrients|mesh-ancestor
65406985|NCT00794885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65406986|NCT00794885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65406987|NCT00794885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407042|NCT00799175|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65407043|NCT00799175|Autonomic Agents|autonomic agents|mesh-ancestor
65407044|NCT00799175|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65407045|NCT00799175|Respiratory System Agents|respiratory system agents|mesh-ancestor
65407046|NCT00799175|Mydriatics|mydriatics|mesh-ancestor
65407047|NCT00799175|Sympathomimetics|sympathomimetics|mesh-ancestor
65407048|NCT00799175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65407049|NCT00799175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65407050|NCT00799175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65407051|NCT00799175|Analgesics|analgesics|mesh-ancestor
65407052|NCT00799175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65407053|NCT00799175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65407054|NCT00799175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65407055|NCT00799175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407056|NCT00656513|Pilocarpine|pilocarpine|mesh-list
65407057|NCT00656513|Miotics|miotics|mesh-ancestor
65407103|NCT02553083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65407104|NCT02553083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65407105|NCT02553083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65407106|NCT02553083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65407107|NCT02553083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407108|NCT02553083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407109|NCT00804947|Melphalan|melphalan|mesh-list
65407110|NCT00804947|Busulfan|busulfan|mesh-list
65407111|NCT00804947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65407112|NCT00804947|Alkylating Agents|alkylating agents|mesh-ancestor
65407169|NCT00805649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65407170|NCT00805649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65407171|NCT00805649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65407172|NCT00805649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65407173|NCT00805649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65407174|NCT00805649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65407175|NCT00805649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65407176|NCT00805649|GABA Modulators|gaba modulators|mesh-ancestor
65407177|NCT00805649|GABA Agents|gaba agents|mesh-ancestor
65407178|NCT00805649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65407179|NCT00805649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407230|NCT00655499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407231|NCT00655499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407232|NCT00655499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65407233|NCT00800267|Timolol|timolol|mesh-list
65407234|NCT00800267|Latanoprost|latanoprost|mesh-list
65407235|NCT00800267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65407236|NCT00800267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65407237|NCT00800267|Adrenergic Agents|adrenergic agents|mesh-ancestor
65407238|NCT00800267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65407239|NCT00800267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407240|NCT00800267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407241|NCT00800267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65407242|NCT00800267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65407243|NCT00800267|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65407289|NCT00651755|Cyclophosphamide|cyclophosphamide|mesh-list
65407290|NCT00651755|Rituximab|rituximab|mesh-list
65407291|NCT00651755|Doxorubicin|doxorubicin|mesh-list
65407292|NCT00651755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65407293|NCT00651755|Vincristine|vincristine|mesh-list
65407294|NCT00651755|Ondansetron|ondansetron|mesh-list
65407295|NCT00651755|Aprepitant|aprepitant|mesh-list
65407296|NCT00651755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65407297|NCT00651755|Immunologic Factors|immunologic factors|mesh-ancestor
65407358|NCT00808145|Gemcitabine|gemcitabine|mesh-list
65407359|NCT00808145|Cisplatin|cisplatin|mesh-list
65407360|NCT00808145|Sorafenib|sorafenib|mesh-list
65407361|NCT00808145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407362|NCT00808145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65407363|NCT00808145|Antimetabolites|antimetabolites|mesh-ancestor
65407430|NCT00811421|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65407431|NCT00811421|Mefloquine|mefloquine|mesh-list
65407432|NCT00811421|Antimalarials|antimalarials|mesh-ancestor
65407433|NCT00811421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65407434|NCT00811421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65407435|NCT00811421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65407436|NCT00811421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65407437|NCT00811421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407438|NCT00811421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407439|NCT00811421|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65407440|NCT00811421|Renal Agents|renal agents|mesh-ancestor
65407441|NCT00569777|Ketotifen|ketotifen|mesh-list
65407442|NCT00569777|Antipruritics|antipruritics|mesh-ancestor
65407443|NCT00569777|Dermatologic Agents|dermatologic agents|mesh-ancestor
65407444|NCT00569777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65407445|NCT00569777|Histamine Antagonists|histamine antagonists|mesh-ancestor
65407446|NCT00569777|Histamine Agents|histamine agents|mesh-ancestor
65407447|NCT00569777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65407448|NCT00569777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407449|NCT00569777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407450|NCT00569777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65407451|NCT00654095|Atorvastatin|atorvastatin|mesh-list
65407452|NCT00654095|Ezetimibe|ezetimibe|mesh-list
65407453|NCT00654095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65407454|NCT00654095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65407455|NCT00654095|Antimetabolites|antimetabolites|mesh-ancestor
65407456|NCT00654095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407457|NCT00654095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65407458|NCT00654095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65407459|NCT00654095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407460|NCT00811967|Ribavirin|ribavirin|mesh-list
65407461|NCT00811967|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65407469|NCT04046159|Tamoxifen|tamoxifen|mesh-list
65407472|NCT04046159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65407473|NCT04046159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407474|NCT04046159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65407475|NCT04046159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407476|NCT04046159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65407477|NCT04046159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65407478|NCT04046159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65407479|NCT00653939|Paclitaxel|paclitaxel|mesh-list
65407480|NCT00653939|Fosbretabulin|fosbretabulin|mesh-list
65407481|NCT00653939|Combretastatin|combretastatin|mesh-list
65407482|NCT00653939|Bevacizumab|bevacizumab|mesh-list
65407483|NCT00653939|Carboplatin|carboplatin|mesh-list
65407484|NCT00653939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65407485|NCT00653939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407532|NCT00646451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65407533|NCT00646451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65407534|NCT00646451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65407535|NCT00809237|Hydroxychloroquine|hydroxychloroquine|mesh-list
65407536|NCT00809237|Gefitinib|gefitinib|mesh-list
65407537|NCT00809237|Antimalarials|antimalarials|mesh-ancestor
65407538|NCT00809237|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65407539|NCT00809237|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65407540|NCT00809237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65407541|NCT00809237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407599|NCT00817895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65407600|NCT00817895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65407601|NCT00817895|Immunologic Factors|immunologic factors|mesh-ancestor
65407602|NCT00817895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407603|NCT00814229|Vaccines|vaccines|mesh-list
65407604|NCT00814229|Aluminum sulfate|aluminum sulfate|mesh-list
65407605|NCT00814229|Immunologic Factors|immunologic factors|mesh-ancestor
65407606|NCT00814229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407607|NCT00814229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65407608|NCT00568685|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65407609|NCT00568685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65407663|NCT00061945|Protective Agents|protective agents|mesh-ancestor
65407664|NCT00061945|Vitamin B Complex|vitamin b complex|mesh-ancestor
65407665|NCT00061945|Vitamins|vitamins|mesh-ancestor
65407666|NCT00061945|Micronutrients|micronutrients|mesh-ancestor
65407667|NCT00061945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65407668|NCT00061945|Tubulin Modulators|tubulin modulators|mesh-ancestor
65407669|NCT00061945|Antimitotic Agents|antimitotic agents|mesh-ancestor
65407670|NCT00061945|Mitosis Modulators|mitosis modulators|mesh-ancestor
65407733|NCT01046032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65407734|NCT01046032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407735|NCT00061633|Vancomycin|vancomycin|mesh-list
65407736|NCT00061633|Penicillins|penicillins|mesh-list
65407737|NCT00061633|Telavancin|telavancin|mesh-list
65407738|NCT00061633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65407739|NCT00061633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65407740|NCT00645593|Gemcitabine|gemcitabine|mesh-list
65407741|NCT00645593|Cetuximab|cetuximab|mesh-list
65407742|NCT00645593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65407799|NCT00365794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407800|NCT01098019|Botulinum Toxins|botulinum toxins|mesh-list
65407801|NCT01098019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65407802|NCT01098019|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65407803|NCT01098019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65407804|NCT01098019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65407805|NCT01098019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407807|NCT01098019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65407808|NCT01098019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407865|NCT00059215|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65407866|NCT00059215|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65407867|NCT00059215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65407868|NCT00059215|Purinergic Agents|purinergic agents|mesh-ancestor
65407869|NCT00059215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65407870|NCT00059215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65407871|NCT00059215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65407932|NCT00372424|Growth Inhibitors|growth inhibitors|mesh-ancestor
65407933|NCT00372424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65407934|NCT00372424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65407935|NCT02530411|Fulvestrant|fulvestrant|mesh-list
65407936|NCT02530411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65408003|NCT00488475|Sensory System Agents|sensory system agents|mesh-ancestor
65408004|NCT00488475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65408005|NCT00488475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408006|NCT00488475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65408007|NCT00488475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65408008|NCT00488475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65408009|NCT00488475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65408010|NCT00488475|Immunologic Factors|immunologic factors|mesh-ancestor
65408011|NCT01020279|Celecoxib|celecoxib|mesh-list
65408012|NCT01020279|Ketoprofen|ketoprofen|mesh-list
65408013|NCT01020279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65408067|NCT01017939|Antitussive Agents|antitussive agents|mesh-ancestor
65408068|NCT01017939|Respiratory System Agents|respiratory system agents|mesh-ancestor
65408069|NCT01017939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65408070|NCT01017939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65408071|NCT01017939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65408072|NCT01017939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65408073|NCT01017939|Autonomic Agents|autonomic agents|mesh-ancestor
65408074|NCT01017939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65408075|NCT01017939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65408076|NCT01017939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65408077|NCT01017939|Vasodilator Agents|vasodilator agents|mesh-ancestor
65408078|NCT01017939|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65408129|NCT00463047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65408130|NCT00463047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408131|NCT00463047|Analgesics|analgesics|mesh-ancestor
65408132|NCT00463047|Sensory System Agents|sensory system agents|mesh-ancestor
65408133|NCT00463047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65408134|NCT00463047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65408135|NCT00463047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65408197|NCT00462501|Leucovorin|leucovorin|mesh-list
65408198|NCT00462501|Bevacizumab|bevacizumab|mesh-list
65408199|NCT00462501|Fluorouracil|fluorouracil|mesh-list
65408200|NCT00462501|Oxaliplatin|oxaliplatin|mesh-list
65408201|NCT00462501|Calcium|calcium|mesh-list
65408202|NCT00462501|Levoleucovorin|levoleucovorin|mesh-list
65408203|NCT00462501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65408204|NCT00462501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408205|NCT00462501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65408206|NCT00462501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65408207|NCT00462501|Growth Substances|growth substances|mesh-ancestor
65408208|NCT00462501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408209|NCT00462501|Growth Inhibitors|growth inhibitors|mesh-ancestor
65408211|NCT00462501|Antimetabolites|antimetabolites|mesh-ancestor
65408260|NCT01049854|Vidarabine|vidarabine|mesh-list
65408261|NCT01049854|Cyclophosphamide|cyclophosphamide|mesh-list
65408262|NCT01049854|Thiotepa|thiotepa|mesh-list
65408263|NCT01049854|Busulfan|busulfan|mesh-list
65408264|NCT01049854|Fludarabine phosphate|fludarabine phosphate|mesh-list
65408265|NCT01049854|Fludarabine|fludarabine|mesh-list
65408266|NCT01049854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65408267|NCT01049854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65408268|NCT01049854|Immunologic Factors|immunologic factors|mesh-ancestor
65408269|NCT01049854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408270|NCT01049854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65408326|NCT00453063|Mometasone Furoate|mometasone furoate|mesh-list
65408327|NCT00453063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65408328|NCT00453063|Dermatologic Agents|dermatologic agents|mesh-ancestor
65408329|NCT00453063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65408330|NCT00371566|Lapatinib|lapatinib|mesh-list
65408331|NCT00371566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408396|NCT00814619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65408397|NCT00641147|Curcumin|curcumin|mesh-list
65408398|NCT00641147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65408399|NCT00641147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65408400|NCT00641147|Analgesics|analgesics|mesh-ancestor
65408467|NCT00452439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65408468|NCT00452439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65408469|NCT00452439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65408470|NCT00452439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408539|NCT03877809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65408540|NCT03877809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65408541|NCT03877809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65408542|NCT03877809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408543|NCT03877809|Antifungal Agents|antifungal agents|mesh-ancestor
65408544|NCT03877809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65408545|NCT03877809|Immunologic Factors|immunologic factors|mesh-ancestor
65408546|NCT03877809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408547|NCT01049932|Rilpivirine|rilpivirine|mesh-list
65408548|NCT01049932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65408549|NCT01049932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65408550|NCT01049932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408551|NCT01049932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408601|NCT00819377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408602|NCT00819377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408603|NCT00819377|Protective Agents|protective agents|mesh-ancestor
65408604|NCT00819377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408605|NCT01023165|Insulin Lispro|insulin lispro|mesh-list
65408606|NCT01023165|Insulin Aspart|insulin aspart|mesh-list
65408607|NCT01023165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65408608|NCT01023165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408609|NCT01023243|Aspirin|aspirin|mesh-list
65408668|NCT01026129|Remifentanil|remifentanil|mesh-list
65408669|NCT01026129|Anesthetics, Local|anesthetics, local|mesh-ancestor
65408670|NCT01026129|Anesthetics|anesthetics|mesh-ancestor
65408671|NCT01026129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65408672|NCT01026129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408673|NCT01026129|Sensory System Agents|sensory system agents|mesh-ancestor
65408674|NCT01026129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65408675|NCT01026129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65408676|NCT01026129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65408677|NCT01026129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65408678|NCT01026129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65408679|NCT01026129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408680|NCT01026129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65408681|NCT01026129|Narcotics|narcotics|mesh-ancestor
65408729|NCT00451191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65408730|NCT00451035|Panobinostat|panobinostat|mesh-list
65408731|NCT00451035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408732|NCT00451035|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65408733|NCT00451035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408801|NCT00450801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65408802|NCT00450801|Serotonin Agents|serotonin agents|mesh-ancestor
65408803|NCT00450801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65408804|NCT01023633|Oxaliplatin|oxaliplatin|mesh-list
65408805|NCT01023633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408806|NCT00458211|Ziprasidone|ziprasidone|mesh-list
65408807|NCT00458211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65408808|NCT00458211|Serotonin Agents|serotonin agents|mesh-ancestor
65408809|NCT00458211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65408810|NCT00458211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408811|NCT00458211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65408812|NCT00458211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65408813|NCT00458211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65408814|NCT00458211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65408815|NCT00458211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65408816|NCT00458211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65408817|NCT00458211|Dopamine Agents|dopamine agents|mesh-ancestor
65408818|NCT00450723|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
65408819|NCT00450723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65408820|NCT00450723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408854|NCT00819845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65408855|NCT00819845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65408856|NCT00819845|Vasodilator Agents|vasodilator agents|mesh-ancestor
65408857|NCT00819845|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65158370|NCT01679119|Antimetabolites|antimetabolites|mesh-ancestor
65408858|NCT00819845|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65408859|NCT00819845|Protease Inhibitors|protease inhibitors|mesh-ancestor
65408860|NCT00819845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65408861|NCT00457743|Sunitinib|sunitinib|mesh-list
65408862|NCT00457743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408863|NCT00457743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65408865|NCT00457743|Growth Substances|growth substances|mesh-ancestor
65408917|NCT00820547|Alkylating Agents|alkylating agents|mesh-ancestor
65408918|NCT00820547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65408919|NCT00820547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65408920|NCT00820547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65408921|NCT00820547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65408922|NCT00820547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65408923|NCT00820547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65408984|NCT00467649|Insulin Glargine|insulin glargine|mesh-list
65408985|NCT00467649|Insulin Aspart|insulin aspart|mesh-list
65408986|NCT00467649|Insulin Lispro|insulin lispro|mesh-list
65408987|NCT00467649|Insulin Detemir|insulin detemir|mesh-list
65408988|NCT00467649|Insulin glulisine|insulin glulisine|mesh-list
65409047|NCT01024179|Sirolimus|sirolimus|mesh-list
65409056|NCT00821483|Frovatriptan|frovatriptan|mesh-list
65409057|NCT00821483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65409058|NCT00821483|Serotonin Agents|serotonin agents|mesh-ancestor
65409059|NCT00821483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65409060|NCT00821483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409061|NCT00821483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409062|NCT02551367|Letrozole|letrozole|mesh-list
65409063|NCT02551367|Clomiphene|clomiphene|mesh-list
65409064|NCT02551367|Enclomiphene|enclomiphene|mesh-list
65409121|NCT01022229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409122|NCT01022229|Vitamin B Complex|vitamin b complex|mesh-ancestor
65409123|NCT00449787|Naproxen|naproxen|mesh-list
65409124|NCT00449787|Sumatriptan|sumatriptan|mesh-list
65409125|NCT00449787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65409193|NCT00457665|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65409194|NCT00457665|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65409195|NCT00457665|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65409196|NCT00457665|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65409197|NCT00457665|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65409198|NCT00457665|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65409259|NCT01024491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409260|NCT01024491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65409261|NCT01024491|Antidepressive Agents|antidepressive agents|mesh-ancestor
65409262|NCT01024491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65409263|NCT01024491|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65409264|NCT01024491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65409265|NCT01024491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409266|NCT00446199|Drospirenone|drospirenone|mesh-list
65409267|NCT00446199|Estradiol|estradiol|mesh-list
65409325|NCT01027065|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65409326|NCT01027065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409327|NCT01027065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409328|NCT01027065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65409329|NCT01027065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65409330|NCT00456495|Ranibizumab|ranibizumab|mesh-list
65409331|NCT00456495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65409332|NCT00456495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65409392|NCT01028079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65409393|NCT01028079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65409394|NCT01028079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65409395|NCT01028079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409396|NCT01028079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65409397|NCT01028079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65409464|NCT00370552|Mitosis Modulators|mitosis modulators|mesh-ancestor
65409465|NCT00370552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409466|NCT00370552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65409467|NCT00370552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65409468|NCT00370552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65409469|NCT00370552|Growth Substances|growth substances|mesh-ancestor
65409470|NCT00370552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409491|NCT04429152|Tenofovir|tenofovir|mesh-list
65409532|NCT01047982|Micronutrients|micronutrients|mesh-ancestor
65409533|NCT01047982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409534|NCT00536874|Gemcitabine|gemcitabine|mesh-list
65409535|NCT00536874|Oxaliplatin|oxaliplatin|mesh-list
65409536|NCT00536874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65159034|NCT00900757|Serotonin Agents|serotonin agents|mesh-ancestor
65409537|NCT00536874|Antimetabolites|antimetabolites|mesh-ancestor
65409538|NCT00536874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409539|NCT00536874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409596|NCT03862716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409597|NCT03862716|Incretins|incretins|mesh-ancestor
65409598|NCT03862716|Hormones|hormones|mesh-ancestor
65409599|NCT03862716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65409600|NCT00992082|Ketorolac|ketorolac|mesh-list
65409601|NCT00992082|Epinephrine|epinephrine|mesh-list
65409602|NCT00992082|Morphine|morphine|mesh-list
65409603|NCT00992082|Ropivacaine|ropivacaine|mesh-list
65409604|NCT00992082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65409605|NCT00992082|Narcotics|narcotics|mesh-ancestor
65409607|NCT00992082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409663|NCT00363298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65409664|NCT00363298|Sympathomimetics|sympathomimetics|mesh-ancestor
65409665|NCT00363298|Autonomic Agents|autonomic agents|mesh-ancestor
65409666|NCT00363298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65409667|NCT00363298|Dopamine Agents|dopamine agents|mesh-ancestor
65409668|NCT00363298|Adrenergic Agents|adrenergic agents|mesh-ancestor
65409733|NCT04002024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65409734|NCT04002024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65409735|NCT04002024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65409736|NCT04002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409738|NCT01028313|Methylprednisolone|methylprednisolone|mesh-list
65409803|NCT00379834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65409804|NCT00379834|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65409805|NCT00379834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409806|NCT02292706|Sofosbuvir|sofosbuvir|mesh-list
65409807|NCT02292706|Antiviral Agents|antiviral agents|mesh-ancestor
65409808|NCT02292706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65409872|NCT00454779|Docetaxel|docetaxel|mesh-list
65409873|NCT00454779|Panitumumab|panitumumab|mesh-list
65409874|NCT00454779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65409875|NCT00454779|Tubulin Modulators|tubulin modulators|mesh-ancestor
65409876|NCT00454779|Antimitotic Agents|antimitotic agents|mesh-ancestor
65409877|NCT00454779|Mitosis Modulators|mitosis modulators|mesh-ancestor
65409880|NCT00992862|Moexipril|moexipril|mesh-list
65409941|NCT00993642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65409942|NCT00993642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65409943|NCT00993642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65409944|NCT01028547|Dexamethasone|dexamethasone|mesh-list
65409945|NCT01028547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65409946|NCT01028547|Antiemetics|antiemetics|mesh-ancestor
65409947|NCT01028547|Autonomic Agents|autonomic agents|mesh-ancestor
65409948|NCT01028547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65409949|NCT01028547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65409950|NCT01028547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65410004|NCT00425373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65410005|NCT00425373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410006|NCT00425373|Vasodilator Agents|vasodilator agents|mesh-ancestor
65410007|NCT00425373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65410008|NCT00425373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65410009|NCT01031589|Rilpivirine|rilpivirine|mesh-list
65410012|NCT01031589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410070|NCT00994344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410071|NCT00994344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410072|NCT00994344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65410073|NCT00994344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65410074|NCT00994344|Antiviral Agents|antiviral agents|mesh-ancestor
65410075|NCT00994344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65410076|NCT00994344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65410078|NCT00994500|Bortezomib|bortezomib|mesh-list
65410136|NCT00995826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65410137|NCT00994812|Metformin|metformin|mesh-list
65410138|NCT00994812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65410139|NCT00994812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410140|NCT00994968|Cyclophosphamide|cyclophosphamide|mesh-list
65410141|NCT00994968|Docetaxel|docetaxel|mesh-list
65410142|NCT00994968|Doxorubicin|doxorubicin|mesh-list
65410144|NCT00994968|Tegafur|tegafur|mesh-list
65410205|NCT00996684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410206|NCT00996762|Lapatinib|lapatinib|mesh-list
65410207|NCT00996762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410208|NCT00996762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65410209|NCT00996762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410210|NCT00996762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410212|NCT05162196|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65410213|NCT05162196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410271|NCT00424827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65410272|NCT00424827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410273|NCT00424827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65410274|NCT00424827|Immunologic Factors|immunologic factors|mesh-ancestor
65410275|NCT00424827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410276|NCT00424827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65410277|NCT01001364|Budesonide|budesonide|mesh-list
65410278|NCT01001364|Formoterol Fumarate|formoterol fumarate|mesh-list
65410281|NCT01001364|Autonomic Agents|autonomic agents|mesh-ancestor
65410340|NCT00377962|Immunologic Factors|immunologic factors|mesh-ancestor
65410341|NCT00377962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410342|NCT00377962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410343|NCT00377962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410344|NCT00377962|Antimetabolites|antimetabolites|mesh-ancestor
65410345|NCT00377962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65410409|NCT00377260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65410410|NCT00377260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65410411|NCT00377260|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65410412|NCT00377260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410413|NCT00377260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410479|NCT00368992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65410480|NCT00368992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410481|NCT00368992|Tubulin Modulators|tubulin modulators|mesh-ancestor
65410482|NCT00368992|Antimitotic Agents|antimitotic agents|mesh-ancestor
65410483|NCT00368992|Mitosis Modulators|mitosis modulators|mesh-ancestor
65410484|NCT00368992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410485|NCT00368992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65410486|NCT00368992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65410487|NCT00368992|Growth Substances|growth substances|mesh-ancestor
65410488|NCT00368992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410489|NCT00368992|Growth Inhibitors|growth inhibitors|mesh-ancestor
65410490|NCT00368992|Immunologic Factors|immunologic factors|mesh-ancestor
65410491|NCT00376246|Ezetimibe|ezetimibe|mesh-list
65410492|NCT00376246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65410493|NCT00376246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65410539|NCT01050322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65410540|NCT01050322|Tubulin Modulators|tubulin modulators|mesh-ancestor
65410541|NCT01050322|Antimitotic Agents|antimitotic agents|mesh-ancestor
65410542|NCT01050322|Mitosis Modulators|mitosis modulators|mesh-ancestor
65410543|NCT01050322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65410544|NCT00531960|Bevacizumab|bevacizumab|mesh-list
65410545|NCT00531960|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65410546|NCT00531960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65410547|NCT00531960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410604|NCT00361504|Adrenergic Agents|adrenergic agents|mesh-ancestor
65410605|NCT00361504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65410606|NCT00361270|Complement Factor H|complement factor h|mesh-list
65410607|NCT00361270|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65410608|NCT00361270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65410609|NCT00361270|Immunologic Factors|immunologic factors|mesh-ancestor
65410674|NCT00998322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410675|NCT00998322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410676|NCT00998322|Antiviral Agents|antiviral agents|mesh-ancestor
65410677|NCT00998322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65410682|NCT00367744|Rosiglitazone|rosiglitazone|mesh-list
65410743|NCT01002690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65410744|NCT01002690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65410745|NCT01002690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65410746|NCT01002690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65410747|NCT01002690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65410749|NCT01048684|Mannitol|mannitol|mesh-list
65410811|NCT01003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
65410812|NCT01003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410813|NCT03883386|Loratadine|loratadine|mesh-list
65410814|NCT03883386|Antipruritics|antipruritics|mesh-ancestor
65410815|NCT03883386|Dermatologic Agents|dermatologic agents|mesh-ancestor
65410880|NCT01032057|Immunologic Factors|immunologic factors|mesh-ancestor
65410881|NCT01032057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160396|NCT02830789|Antacids|antacids|mesh-ancestor
65410882|NCT01003314|Vaccines|vaccines|mesh-list
65410883|NCT01003314|Immunologic Factors|immunologic factors|mesh-ancestor
65410884|NCT01003314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410885|NCT00530088|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
65410886|NCT00530088|Trioxsalen|trioxsalen|mesh-list
65410887|NCT00530088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65410888|NCT00530088|Dermatologic Agents|dermatologic agents|mesh-ancestor
65410889|NCT00530088|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65410890|NCT01006668|Propofol|propofol|mesh-list
65410891|NCT01006668|Sevoflurane|sevoflurane|mesh-list
65410892|NCT01006668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65410893|NCT01006668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65410894|NCT01006668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410895|NCT01006668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65410896|NCT01006668|Anesthetics, General|anesthetics, general|mesh-ancestor
65410897|NCT01006668|Anesthetics|anesthetics|mesh-ancestor
65410898|NCT01006668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65410936|NCT00441363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65410937|NCT00441363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65410938|NCT00441363|Dopamine Agonists|dopamine agonists|mesh-ancestor
65410939|NCT00441363|Dopamine Agents|dopamine agents|mesh-ancestor
65410940|NCT00441363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65410941|NCT00441363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65410942|NCT00626795|Mupirocin|mupirocin|mesh-list
65410943|NCT00626795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65411002|NCT03880266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411003|NCT00423891|Entecavir|entecavir|mesh-list
65411004|NCT00423891|Antiviral Agents|antiviral agents|mesh-ancestor
65411005|NCT00423891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65411006|NCT00830609|Ribavirin|ribavirin|mesh-list
65411007|NCT00830609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65411008|NCT00830609|Interferon-alpha|interferon-alpha|mesh-list
65411009|NCT00830609|Antimetabolites|antimetabolites|mesh-ancestor
65411010|NCT00830609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411011|NCT00830609|Antiviral Agents|antiviral agents|mesh-ancestor
65411012|NCT00830609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65411013|NCT00830609|Immunologic Factors|immunologic factors|mesh-ancestor
65411014|NCT00830609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411068|NCT00626405|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65411069|NCT00626405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65411070|NCT00626405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411071|NCT00626405|Tubulin Modulators|tubulin modulators|mesh-ancestor
65411072|NCT00626405|Antimitotic Agents|antimitotic agents|mesh-ancestor
65411073|NCT00626405|Mitosis Modulators|mitosis modulators|mesh-ancestor
65411074|NCT00626405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411136|NCT00357994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411137|NCT00357994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411138|NCT00357994|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65411139|NCT00357994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65411140|NCT00357994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65411141|NCT00357994|Immunologic Factors|immunologic factors|mesh-ancestor
65411142|NCT00357994|Dopamine Agonists|dopamine agonists|mesh-ancestor
65411143|NCT00823433|Penicillins|penicillins|mesh-list
65411144|NCT00823433|Penicillin V|penicillin v|mesh-list
65411145|NCT00823433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65411146|NCT00823433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65411147|NCT00423657|Vancomycin|vancomycin|mesh-list
65411148|NCT00423657|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
65411149|NCT00423657|Aztreonam|aztreonam|mesh-list
65411152|NCT00831155|Nicotine|nicotine|mesh-list
65411198|NCT02550119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411199|NCT02550119|Protease Inhibitors|protease inhibitors|mesh-ancestor
65411200|NCT02550119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65411201|NCT02550119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411202|NCT02550119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65411203|NCT02550119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65411204|NCT02550119|Dermatologic Agents|dermatologic agents|mesh-ancestor
65411205|NCT02550119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65411206|NCT02550119|Serotonin Agents|serotonin agents|mesh-ancestor
65411262|NCT04396535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411263|NCT04396535|Tubulin Modulators|tubulin modulators|mesh-ancestor
65411264|NCT04396535|Antimitotic Agents|antimitotic agents|mesh-ancestor
65411265|NCT04396535|Mitosis Modulators|mitosis modulators|mesh-ancestor
65411266|NCT04396535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411267|NCT00622739|Ziprasidone|ziprasidone|mesh-list
65411268|NCT00622739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65411269|NCT00622739|Serotonin Agents|serotonin agents|mesh-ancestor
65411270|NCT00622739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65411291|NCT00824057|Midazolam|midazolam|mesh-list
65411328|NCT01053208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65411329|NCT01053208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65411330|NCT01053208|Anesthetics, Local|anesthetics, local|mesh-ancestor
65411331|NCT01053208|Anesthetics|anesthetics|mesh-ancestor
65411332|NCT01053208|Antiemetics|antiemetics|mesh-ancestor
65411333|NCT01053208|Autonomic Agents|autonomic agents|mesh-ancestor
65411334|NCT01053208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65411335|NCT01053208|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65411336|NCT01053208|Histamine Antagonists|histamine antagonists|mesh-ancestor
65411337|NCT01053208|Histamine Agents|histamine agents|mesh-ancestor
65411338|NCT01053208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65411339|NCT01053208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65411340|NCT01053208|Antipruritics|antipruritics|mesh-ancestor
65411341|NCT01053208|Dermatologic Agents|dermatologic agents|mesh-ancestor
65411342|NCT00423189|Ranibizumab|ranibizumab|mesh-list
65411343|NCT00423189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65411390|NCT00827411|Analgesics|analgesics|mesh-ancestor
65411391|NCT00827411|Sensory System Agents|sensory system agents|mesh-ancestor
65411392|NCT00827411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65411393|NCT00827411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411394|NCT00827411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65411395|NCT00827411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65411396|NCT00827411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65411397|NCT00827411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65411456|NCT00350272|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65411457|NCT00350272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65411458|NCT00350272|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65411526|NCT00825149|Alkylating Agents|alkylating agents|mesh-ancestor
65411527|NCT00825149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411528|NCT00825149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411529|NCT00825149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65411530|NCT00825149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65411531|NCT00825149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65411532|NCT00825149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65411536|NCT00825149|Hormones|hormones|mesh-ancestor
65411590|NCT02549963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65411591|NCT02549963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411593|NCT00624065|Lisinopril|lisinopril|mesh-list
65411594|NCT00624065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65411595|NCT00624065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65411596|NCT00624065|Adrenergic Agents|adrenergic agents|mesh-ancestor
65411597|NCT00624065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65411598|NCT00624065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411599|NCT00624065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411600|NCT00624065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65411601|NCT00624065|Antioxidants|antioxidants|mesh-ancestor
65411602|NCT00624065|Protective Agents|protective agents|mesh-ancestor
65411603|NCT00624065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65411604|NCT00624065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65411605|NCT00624065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65411606|NCT00624065|Vasodilator Agents|vasodilator agents|mesh-ancestor
65411607|NCT00624065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65411608|NCT00624065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65411609|NCT00624065|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65411610|NCT00624065|Protease Inhibitors|protease inhibitors|mesh-ancestor
65411611|NCT00624065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65411612|NCT00624065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65411613|NCT00833339|Mifepristone|mifepristone|mesh-list
65411629|NCT00825617|Hormones|hormones|mesh-list
65411639|NCT00360334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65411640|NCT00422097|Epothilones|epothilones|mesh-list
65411641|NCT00422097|Famotidine|famotidine|mesh-list
65411642|NCT00422097|Tubulin Modulators|tubulin modulators|mesh-ancestor
65411643|NCT00422097|Antimitotic Agents|antimitotic agents|mesh-ancestor
65411644|NCT00422097|Mitosis Modulators|mitosis modulators|mesh-ancestor
65411645|NCT00422097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411646|NCT00422097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411647|NCT00422097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65411648|NCT00422097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65411649|NCT00422097|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65411701|NCT00833807|Paclitaxel|paclitaxel|mesh-list
65411702|NCT00833807|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65411703|NCT00833807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65411704|NCT00833807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65411705|NCT00833807|Tubulin Modulators|tubulin modulators|mesh-ancestor
65411706|NCT00833807|Antimitotic Agents|antimitotic agents|mesh-ancestor
65411707|NCT00833807|Mitosis Modulators|mitosis modulators|mesh-ancestor
65411708|NCT00833807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65411709|NCT00833963|Trastuzumab|trastuzumab|mesh-list
65411711|NCT00833963|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65411712|NCT00833963|Maytansine|maytansine|mesh-list
65411767|NCT00837707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65411768|NCT00837707|Serotonin Agents|serotonin agents|mesh-ancestor
65411769|NCT00837707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65411773|NCT01055938|Valproic Acid|valproic acid|mesh-list
65411839|NCT00837941|Histamine Agents|histamine agents|mesh-ancestor
65411840|NCT00837941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65411841|NCT00837941|Antipruritics|antipruritics|mesh-ancestor
65411842|NCT00837941|Dermatologic Agents|dermatologic agents|mesh-ancestor
65411843|NCT01053442|Fe(III)-EDTA|fe(iii)-edta|mesh-list
65411845|NCT01053442|Chelating Agents|chelating agents|mesh-ancestor
65411909|NCT00528996|Tiotropium Bromide|tiotropium bromide|mesh-list
65411910|NCT00528996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65411911|NCT00528996|Autonomic Agents|autonomic agents|mesh-ancestor
65411912|NCT00528996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65411913|NCT00528996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411922|NCT00359788|Albuterol|albuterol|mesh-list
65411980|NCT00838955|Antifungal Agents|antifungal agents|mesh-ancestor
65411981|NCT00838955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65411982|NCT00838955|Immunologic Factors|immunologic factors|mesh-ancestor
65411983|NCT00838955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65411984|NCT00347776|Azithromycin|azithromycin|mesh-list
65411985|NCT00347776|Tetracycline|tetracycline|mesh-list
65411986|NCT00347776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65411987|NCT00347776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65411988|NCT00347776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65411989|NCT00347776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65411991|NCT04452136|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65412044|NCT01053910|Ramipril|ramipril|mesh-list
65412045|NCT01053910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65412046|NCT01053910|Protease Inhibitors|protease inhibitors|mesh-ancestor
65412047|NCT01053910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412048|NCT01053910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412049|NCT01053910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65412050|NCT00829595|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65412110|NCT05262270|Naltrexone|naltrexone|mesh-list
65412111|NCT05262270|Buprenorphine|buprenorphine|mesh-list
65412112|NCT05262270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65412113|NCT05262270|Narcotics|narcotics|mesh-ancestor
65412114|NCT05262270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65412115|NCT05262270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412116|NCT05262270|Analgesics|analgesics|mesh-ancestor
65412117|NCT05262270|Sensory System Agents|sensory system agents|mesh-ancestor
65412118|NCT05262270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412119|NCT05262270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65412120|NCT05262270|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65412121|NCT05259696|Cemiplimab|cemiplimab|mesh-list
65412122|NCT05259696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65412123|NCT05259696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412124|NCT00830297|Isophane Insulin, Human|isophane insulin, human|mesh-list
65412125|NCT00830297|Insulin, Isophane|insulin, isophane|mesh-list
65412126|NCT00830297|Isophane insulin, beef|isophane insulin, beef|mesh-list
65412127|NCT00830297|Insulin, Long-Acting|insulin, long-acting|mesh-list
65412128|NCT00830297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65412129|NCT00830297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412166|NCT00621257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65412167|NCT00621257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65412168|NCT00840671|Cerebrolysin|cerebrolysin|mesh-list
65412169|NCT00840671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65412170|NCT00840671|Protective Agents|protective agents|mesh-ancestor
65412171|NCT00840671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412172|NCT00840671|Nootropic Agents|nootropic agents|mesh-ancestor
65412173|NCT02546531|Gemcitabine|gemcitabine|mesh-list
65412174|NCT02546531|Pembrolizumab|pembrolizumab|mesh-list
65412175|NCT02546531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65412176|NCT02546531|Antimetabolites|antimetabolites|mesh-ancestor
65412177|NCT02546531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412178|NCT02546531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412179|NCT02546531|Antiviral Agents|antiviral agents|mesh-ancestor
65412180|NCT02546531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65412181|NCT02546531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412182|NCT02546531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65412183|NCT02546531|Immunologic Factors|immunologic factors|mesh-ancestor
65412184|NCT02546531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412185|NCT02546531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65412186|NCT05205720|Ropivacaine|ropivacaine|mesh-list
65412187|NCT05205720|Anesthetics, Local|anesthetics, local|mesh-ancestor
65412188|NCT05205720|Anesthetics|anesthetics|mesh-ancestor
65412189|NCT05205720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65412190|NCT05205720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412191|NCT05205720|Sensory System Agents|sensory system agents|mesh-ancestor
65412192|NCT05205720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412193|NCT04043195|Oxaliplatin|oxaliplatin|mesh-list
65412194|NCT04043195|Nivolumab|nivolumab|mesh-list
65412195|NCT04043195|Ipilimumab|ipilimumab|mesh-list
65412210|NCT05643846|Anesthetics, Local|anesthetics, local|mesh-list
65412211|NCT05643846|Anesthetics|anesthetics|mesh-list
65412212|NCT05643846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65412213|NCT05643846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412214|NCT05643846|Sensory System Agents|sensory system agents|mesh-ancestor
65412215|NCT05643846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412216|NCT00841139|Perhexiline|perhexiline|mesh-list
65412217|NCT00841139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65412218|NCT00841139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65412219|NCT00841139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412220|NCT00841139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65412221|NCT00841139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412222|NCT00841139|Vasodilator Agents|vasodilator agents|mesh-ancestor
65412223|NCT00844337|Amoxicillin|amoxicillin|mesh-list
65412224|NCT00844337|Gentamicins|gentamicins|mesh-list
65412225|NCT00844337|Penicillins|penicillins|mesh-list
65412226|NCT00844337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65412227|NCT00844337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65412228|NCT00844337|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65412229|NCT00844337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412230|NCT00844337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412231|NCT00841373|Ranibizumab|ranibizumab|mesh-list
65161740|NCT02537314|Anesthetics|anesthetics|mesh-ancestor
65412232|NCT00841373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65412233|NCT00841373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65412234|NCT00841373|Growth Substances|growth substances|mesh-ancestor
65412235|NCT00841373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412238|NCT00851513|Lidocaine|lidocaine|mesh-list
65412255|NCT00841841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412256|NCT00841841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412257|NCT00841841|Antipyretics|antipyretics|mesh-ancestor
65412258|NCT00841841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65412259|NCT00841841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65412260|NCT00841841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65412261|NCT02545751|Thymalfasin|thymalfasin|mesh-list
65412262|NCT02545751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65412263|NCT02545751|Immunologic Factors|immunologic factors|mesh-ancestor
65412264|NCT02545751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412320|NCT00620555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65412321|NCT00620555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65412322|NCT00620555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412323|NCT00620555|Antimanic Agents|antimanic agents|mesh-ancestor
65412324|NCT00845351|Bexarotene|bexarotene|mesh-list
65412325|NCT00845351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412326|NCT02546141|Caseins|caseins|mesh-list
65412327|NCT02546141|Chelating Agents|chelating agents|mesh-ancestor
65412328|NCT02546141|Sequestering Agents|sequestering agents|mesh-ancestor
65412388|NCT00620321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65412389|NCT00620321|Antimetabolites|antimetabolites|mesh-ancestor
65412390|NCT00620321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412391|NCT00620321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412392|NCT00620321|Antiviral Agents|antiviral agents|mesh-ancestor
65412393|NCT00620321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65412394|NCT00620321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65412395|NCT00620321|Immunologic Factors|immunologic factors|mesh-ancestor
65412396|NCT00620321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412397|NCT00620321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65412398|NCT00620321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65412399|NCT00620321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65412400|NCT00620321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412401|NCT00621023|Ascorbic Acid|ascorbic acid|mesh-list
65412402|NCT00621023|Decitabine|decitabine|mesh-list
65412403|NCT00621023|Arsenic Trioxide|arsenic trioxide|mesh-list
65412404|NCT00621023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65412448|NCT00852371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412449|NCT00852371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65412450|NCT00852371|Renal Agents|renal agents|mesh-ancestor
65412451|NCT00528372|Metformin|metformin|mesh-list
65412452|NCT00528372|Dapagliflozin|dapagliflozin|mesh-list
65412453|NCT00528372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65412454|NCT00528372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412455|NCT00528372|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65412456|NCT00528372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412457|NCT01564680|Acetaminophen|acetaminophen|mesh-list
65412458|NCT01564680|Lornoxicam|lornoxicam|mesh-list
65412460|NCT01564680|Analgesics|analgesics|mesh-ancestor
65412509|NCT00619619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412510|NCT00619619|Antidepressive Agents|antidepressive agents|mesh-ancestor
65412511|NCT00619619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65412512|NCT00848939|Treprostinil|treprostinil|mesh-list
65412513|NCT00848939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65412514|NCT00842933|Prednisone|prednisone|mesh-list
65412515|NCT00842933|Methylprednisolone|methylprednisolone|mesh-list
65412516|NCT00842933|Hydrocortisone|hydrocortisone|mesh-list
65412517|NCT00842933|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65412518|NCT00842933|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65412519|NCT00842933|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65412520|NCT00842933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65412521|NCT00842933|Glucocorticoids|glucocorticoids|mesh-ancestor
64797395|NCT01384448|Dobutamine|dobutamine|mesh-list
64797396|NCT01384448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65412572|NCT00527826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65412573|NCT00527826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412574|NCT00849329|Lapatinib|lapatinib|mesh-list
65412575|NCT00849329|Esomeprazole|esomeprazole|mesh-list
65412576|NCT00849329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65412577|NCT00849329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65412578|NCT00849329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65412579|NCT00849329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412580|NCT00849329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412581|NCT00849329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412582|NCT00849329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65412583|NCT03998670|Methamphetamine|methamphetamine|mesh-list
65412586|NCT03998670|Sympathomimetics|sympathomimetics|mesh-ancestor
65412628|NCT00619307|Immunologic Factors|immunologic factors|mesh-ancestor
65412629|NCT00619307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412630|NCT00619307|Antiviral Agents|antiviral agents|mesh-ancestor
65412631|NCT00619307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65412632|NCT00855881|Tegafur|tegafur|mesh-list
65412633|NCT00855881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65412634|NCT00855881|Antimetabolites|antimetabolites|mesh-ancestor
65412635|NCT00855881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412636|NCT00855881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412637|NCT00619229|Alprostadil|alprostadil|mesh-list
65412638|NCT00619229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65412639|NCT00619229|Vasodilator Agents|vasodilator agents|mesh-ancestor
65412640|NCT00619229|Urological Agents|urological agents|mesh-ancestor
65412641|NCT02546297|Budesonide|budesonide|mesh-list
65412642|NCT02546297|Bromides|bromides|mesh-list
65412643|NCT02546297|Formoterol Fumarate|formoterol fumarate|mesh-list
65412644|NCT02546297|Tiotropium Bromide|tiotropium bromide|mesh-list
65412645|NCT02546297|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65412646|NCT02546297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65412647|NCT02546297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65412648|NCT02546297|Autonomic Agents|autonomic agents|mesh-ancestor
65412649|NCT02546297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412650|NCT02546297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412651|NCT02546297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65412652|NCT02546297|Respiratory System Agents|respiratory system agents|mesh-ancestor
65412653|NCT02546297|Glucocorticoids|glucocorticoids|mesh-ancestor
65412654|NCT02546297|Hormones|hormones|mesh-ancestor
65412655|NCT02546297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65412656|NCT02546297|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65412657|NCT02546297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65412658|NCT02546297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65412666|NCT00618995|Niacin|niacin|mesh-list
65412671|NCT00618995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412672|NCT00618995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65412673|NCT00618995|Vasodilator Agents|vasodilator agents|mesh-ancestor
65412674|NCT00618995|Vitamin B Complex|vitamin b complex|mesh-ancestor
65412675|NCT00618995|Vitamins|vitamins|mesh-ancestor
65412676|NCT00618995|Micronutrients|micronutrients|mesh-ancestor
65412677|NCT00618995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412678|NCT03685344|Durvalumab|durvalumab|mesh-list
65412679|NCT03685344|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
65412680|NCT03685344|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65412681|NCT03685344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65412682|NCT03685344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412683|NCT03685344|Immunologic Factors|immunologic factors|mesh-ancestor
65412684|NCT03685344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412686|NCT00856037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65412687|NCT00856037|Topotecan|topotecan|mesh-list
65412688|NCT00856037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65412689|NCT00856037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65412690|NCT00856037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65412691|NCT00856037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65412692|NCT00856037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412726|NCT02544893|Anesthetics|anesthetics|mesh-ancestor
65412727|NCT02544893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65412728|NCT02544893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412729|NCT02544893|Sensory System Agents|sensory system agents|mesh-ancestor
65412730|NCT02544893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412731|NCT02544893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65412732|NCT02544893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65412733|NCT02544893|Analgesics|analgesics|mesh-ancestor
65412734|NCT02544893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65412735|NCT02544893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65412792|NCT00527514|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65412793|NCT00527514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65412794|NCT00527514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65412795|NCT00527514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65412796|NCT00527514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412797|NCT00527514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65412802|NCT03998826|Piroxicam|piroxicam|mesh-list
65412857|NCT00857519|Immunologic Factors|immunologic factors|mesh-ancestor
65412858|NCT00857519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412859|NCT00618449|Azithromycin|azithromycin|mesh-list
65412860|NCT00618449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65412861|NCT00618449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65412862|NCT00857597|Esomeprazole|esomeprazole|mesh-list
65412863|NCT00857597|Omeprazole|omeprazole|mesh-list
65412864|NCT00857597|Rabeprazole|rabeprazole|mesh-list
65412865|NCT00857597|Pantoprazole|pantoprazole|mesh-list
65412866|NCT00857597|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65412867|NCT00857597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65412868|NCT00857597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65412869|NCT00857597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65412870|NCT00857597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412871|NCT00857753|Fentanyl|fentanyl|mesh-list
65412872|NCT00857753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65412873|NCT00857753|Narcotics|narcotics|mesh-ancestor
65412918|NCT00519636|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65412919|NCT00857909|Amiloride|amiloride|mesh-list
65412920|NCT00857909|Spironolactone|spironolactone|mesh-list
65412921|NCT00857909|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65412922|NCT00857909|Hormone Antagonists|hormone antagonists|mesh-ancestor
65412923|NCT00857909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65412924|NCT00857909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412925|NCT00857909|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65412926|NCT00857909|Diuretics|diuretics|mesh-ancestor
65412927|NCT00857909|Natriuretic Agents|natriuretic agents|mesh-ancestor
65412933|NCT00857987|Expectorants|expectorants|mesh-list
65412982|NCT00858377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65412983|NCT00858377|Immunologic Factors|immunologic factors|mesh-ancestor
65412984|NCT00858377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412985|NCT00854711|Nitric Oxide|nitric oxide|mesh-list
65412986|NCT00854711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65412988|NCT00854711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65412989|NCT00854711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65412990|NCT00854711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65412991|NCT00854711|Respiratory System Agents|respiratory system agents|mesh-ancestor
65412992|NCT00854711|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65412993|NCT00854711|Antioxidants|antioxidants|mesh-ancestor
65412994|NCT00854711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65412995|NCT00854711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65412996|NCT00854711|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65412997|NCT00854711|Vasodilator Agents|vasodilator agents|mesh-ancestor
65412998|NCT00854711|Gasotransmitters|gasotransmitters|mesh-ancestor
65412999|NCT00854711|Protective Agents|protective agents|mesh-ancestor
65413000|NCT00858455|Dolutegravir|dolutegravir|mesh-list
65413001|NCT00858455|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65413009|NCT02544737|Apatinib|apatinib|mesh-list
65413039|NCT00617903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413040|NCT00617903|Dermatologic Agents|dermatologic agents|mesh-ancestor
65413041|NCT00526110|Docetaxel|docetaxel|mesh-list
65413042|NCT00526110|Fluorouracil|fluorouracil|mesh-list
65413043|NCT00526110|Oxaliplatin|oxaliplatin|mesh-list
65413044|NCT00526110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413045|NCT00526110|Tubulin Modulators|tubulin modulators|mesh-ancestor
65413046|NCT00526110|Antimitotic Agents|antimitotic agents|mesh-ancestor
65413047|NCT00526110|Mitosis Modulators|mitosis modulators|mesh-ancestor
65413048|NCT00526110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413049|NCT00526110|Antimetabolites|antimetabolites|mesh-ancestor
65413050|NCT00526110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65413051|NCT00526110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65413052|NCT00526110|Immunologic Factors|immunologic factors|mesh-ancestor
65413101|NCT04523688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413102|NCT04523688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413103|NCT00511836|Naltrexone|naltrexone|mesh-list
65413104|NCT00511836|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65413105|NCT00511836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65413106|NCT00511836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413107|NCT00511836|Sensory System Agents|sensory system agents|mesh-ancestor
65413108|NCT00511836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65413109|NCT00859703|Risedronic Acid|risedronic acid|mesh-list
65413110|NCT00859703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65413116|NCT03998436|Esmolol|esmolol|mesh-list
65413161|NCT00524316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413162|NCT00524316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413163|NCT00524316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65413164|NCT00524316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65413165|NCT00524316|Growth Substances|growth substances|mesh-ancestor
65413166|NCT00524316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413167|NCT00524316|Growth Inhibitors|growth inhibitors|mesh-ancestor
65413169|NCT03861936|Botulinum Toxins|botulinum toxins|mesh-list
65413227|NCT00796068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65413228|NCT00796068|Dermatologic Agents|dermatologic agents|mesh-ancestor
65413229|NCT00796068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65413230|NCT00796068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65413231|NCT00796068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65413232|NCT00796068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65413233|NCT00796068|Antitubercular Agents|antitubercular agents|mesh-ancestor
65413234|NCT00796068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65413235|NCT00796068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65413236|NCT00796068|Alkylating Agents|alkylating agents|mesh-ancestor
65413237|NCT00796068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65413238|NCT04732182|Donepezil|donepezil|mesh-list
65413239|NCT04732182|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65413240|NCT04732182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413290|NCT00523848|Leprostatic Agents|leprostatic agents|mesh-ancestor
65413291|NCT00523848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65413292|NCT00523848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65413293|NCT00523848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65413294|NCT00523848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65413295|NCT00523848|Growth Substances|growth substances|mesh-ancestor
65413296|NCT00523848|Growth Inhibitors|growth inhibitors|mesh-ancestor
65413359|NCT03639714|Ipilimumab|ipilimumab|mesh-list
65413360|NCT03639714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65413361|NCT03639714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413362|NCT03639714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65162879|NCT02782897|Antibodies|antibodies|mesh-list
65413363|NCT03639714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413364|NCT00861029|Moxifloxacin|moxifloxacin|mesh-list
65413365|NCT00861029|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65413366|NCT00861029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65413367|NCT00861029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65413368|NCT00861029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65413369|NCT00861029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65413420|NCT00865631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65413421|NCT00865631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65413422|NCT00865631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65413490|NCT00864149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65413491|NCT00864149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65413492|NCT01010100|Acarbose|acarbose|mesh-list
65413493|NCT01010100|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65413494|NCT01010100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413495|NCT01010100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413496|NCT01010100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65413497|NCT01010100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413498|NCT00870779|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65413499|NCT00870779|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65413500|NCT00870779|Dermatologic Agents|dermatologic agents|mesh-ancestor
65413501|NCT01010178|Theophylline|theophylline|mesh-list
65413502|NCT01010178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65413550|NCT00864305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65413551|NCT00864305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65413552|NCT00864305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65413553|NCT00864305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413554|NCT00864305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413555|NCT00864305|Antimanic Agents|antimanic agents|mesh-ancestor
65413556|NCT00510276|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65413557|NCT00510276|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65413615|NCT04545762|Fludarabine phosphate|fludarabine phosphate|mesh-list
65413616|NCT04545762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65413617|NCT04545762|Immunologic Factors|immunologic factors|mesh-ancestor
65413618|NCT04545762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413619|NCT04545762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65413620|NCT04545762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65413621|NCT04545762|Alkylating Agents|alkylating agents|mesh-ancestor
65413622|NCT04545762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413623|NCT04545762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413624|NCT04545762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65413625|NCT04545762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65413626|NCT04545762|Antimetabolites|antimetabolites|mesh-ancestor
65413627|NCT00871247|Finasteride|finasteride|mesh-list
65413628|NCT00871247|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65413629|NCT00871247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65413672|NCT00871949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413673|NCT00871949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413674|NCT00865007|Ritonavir|ritonavir|mesh-list
65413675|NCT00865007|Lopinavir|lopinavir|mesh-list
65413676|NCT00865007|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65413677|NCT00865007|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65413678|NCT00865007|Protease Inhibitors|protease inhibitors|mesh-ancestor
65413679|NCT00865007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413680|NCT00865007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413681|NCT00865007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65413682|NCT00865007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65413683|NCT00865007|Antiviral Agents|antiviral agents|mesh-ancestor
65413684|NCT00865007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65413685|NCT00865007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65413686|NCT00865007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65413731|NCT00872651|Latanoprost|latanoprost|mesh-list
65413732|NCT00872651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65413734|NCT00872651|Adrenergic Agents|adrenergic agents|mesh-ancestor
65413735|NCT00872651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413736|NCT00872651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413737|NCT00872651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413738|NCT00872651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65413739|NCT00872651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65413740|NCT00872651|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65413798|NCT00877175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65413799|NCT00877175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65413800|NCT00877175|Cholinergic Agents|cholinergic agents|mesh-ancestor
65413801|NCT00420927|Adalimumab|adalimumab|mesh-list
65413802|NCT00420927|Methotrexate|methotrexate|mesh-list
65413803|NCT00420927|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65413804|NCT00420927|Abortifacient Agents|abortifacient agents|mesh-ancestor
65413805|NCT00420927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65413819|NCT00573443|Quinidine|quinidine|mesh-list
65413863|NCT00873509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65413864|NCT00873509|Serotonin Agents|serotonin agents|mesh-ancestor
65413865|NCT00873509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413866|NCT00873509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413867|NCT00877253|Carboplatin|carboplatin|mesh-list
65413868|NCT00877253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65413869|NCT05225753|Chrysarobin|chrysarobin|mesh-list
65413870|NCT05225753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65413871|NCT05225753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65413872|NCT05225753|Analgesics|analgesics|mesh-ancestor
65413873|NCT05225753|Sensory System Agents|sensory system agents|mesh-ancestor
65413874|NCT05225753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65413875|NCT05225753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413876|NCT05225753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65413877|NCT05225753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65413880|NCT00874133|Domperidone|domperidone|mesh-list
65413922|NCT04040465|Sensory System Agents|sensory system agents|mesh-ancestor
65413923|NCT04040465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65413924|NCT04040465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413925|NCT04040465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65413926|NCT04040465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65413927|NCT04040465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65413928|NCT04040465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65413929|NCT04040465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413930|NCT04040465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65413931|NCT04040465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65413932|NCT04040465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65413933|NCT04040465|Antipyretics|antipyretics|mesh-ancestor
65413934|NCT00420849|Dexamethasone|dexamethasone|mesh-list
65413935|NCT00420849|Lenalidomide|lenalidomide|mesh-list
65413936|NCT00420849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65413937|NCT00420849|Antiemetics|antiemetics|mesh-ancestor
65413938|NCT00420849|Autonomic Agents|autonomic agents|mesh-ancestor
65413941|NCT00420849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65413978|NCT00617201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65413979|NCT00617201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65413980|NCT00617201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65413981|NCT00617201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65413982|NCT00617201|Adrenergic Agents|adrenergic agents|mesh-ancestor
65413983|NCT00617201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65413984|NCT00617201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65413985|NCT00420303|Etanercept|etanercept|mesh-list
65413988|NCT00420303|Analgesics|analgesics|mesh-ancestor
65414042|NCT00875069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65414043|NCT00875069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414044|NCT01029639|Insulin|insulin|mesh-list
65414045|NCT01029639|Insulin Aspart|insulin aspart|mesh-list
65414046|NCT01029639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65414047|NCT01029639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65414048|NCT01029639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414049|NCT00875147|Bevacizumab|bevacizumab|mesh-list
65414050|NCT00875147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65414051|NCT00875147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414052|NCT00875147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65414106|NCT03726671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65414107|NCT03726671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65414108|NCT03726671|Nootropic Agents|nootropic agents|mesh-ancestor
65414109|NCT00868283|Cerebrolysin|cerebrolysin|mesh-list
65414110|NCT00868283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65414111|NCT00868283|Protective Agents|protective agents|mesh-ancestor
65414112|NCT00868283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414113|NCT00868283|Nootropic Agents|nootropic agents|mesh-ancestor
65414114|NCT04039373|Mycophenolic Acid|mycophenolic acid|mesh-list
65414115|NCT04039373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65414116|NCT04039373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414117|NCT04039373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65414118|NCT04039373|Antitubercular Agents|antitubercular agents|mesh-ancestor
65414119|NCT04039373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65414120|NCT04039373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65414121|NCT04039373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414122|NCT04039373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414123|NCT00875537|Capsaicin|capsaicin|mesh-list
65414124|NCT00875537|Antipruritics|antipruritics|mesh-ancestor
65414125|NCT00875537|Dermatologic Agents|dermatologic agents|mesh-ancestor
65414163|NCT00878657|Immunologic Factors|immunologic factors|mesh-ancestor
65414164|NCT00878657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414165|NCT00868829|Chromium|chromium|mesh-list
65414166|NCT00868829|Sirolimus|sirolimus|mesh-list
65414167|NCT00868829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65414168|NCT00868829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65414169|NCT00868829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65414170|NCT00868829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414171|NCT00868829|Antifungal Agents|antifungal agents|mesh-ancestor
65414172|NCT00868829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65414173|NCT00868829|Immunologic Factors|immunologic factors|mesh-ancestor
65414174|NCT00868829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414175|NCT00868829|Trace Elements|trace elements|mesh-ancestor
65414225|NCT00531284|Autonomic Agents|autonomic agents|mesh-ancestor
65414226|NCT00531284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414227|NCT00531284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414228|NCT00531284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65414229|NCT00531284|Glucocorticoids|glucocorticoids|mesh-ancestor
65414230|NCT00531284|Hormones|hormones|mesh-ancestor
65414231|NCT00531284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65414295|NCT01005758|Etoposide phosphate|etoposide phosphate|mesh-list
65414296|NCT01005758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65414297|NCT01005758|Immunologic Factors|immunologic factors|mesh-ancestor
65414298|NCT01005758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414299|NCT01005758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65414300|NCT01005758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65414301|NCT01005758|Alkylating Agents|alkylating agents|mesh-ancestor
65414303|NCT01005758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414361|NCT01000220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414362|NCT05147558|Pembrolizumab|pembrolizumab|mesh-list
65414363|NCT05147558|Lenvatinib|lenvatinib|mesh-list
65414364|NCT05147558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65414365|NCT05147558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414366|NCT05147558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65414367|NCT05147558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414368|NCT05147558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414369|NCT01006694|Antidepressive Agents|antidepressive agents|mesh-list
65414370|NCT01006694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65414371|NCT01000298|Amoxicillin|amoxicillin|mesh-list
65414372|NCT01000298|Cefdinir|cefdinir|mesh-list
65414373|NCT01000298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65414374|NCT01000298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65414375|NCT00614939|Saxagliptin|saxagliptin|mesh-list
65414376|NCT00614939|Incretins|incretins|mesh-ancestor
65414377|NCT00614939|Hormones|hormones|mesh-ancestor
65414378|NCT00614939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65414379|NCT00614939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414380|NCT00614939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65414381|NCT00614939|Protease Inhibitors|protease inhibitors|mesh-ancestor
65414414|NCT04040309|Anesthetics|anesthetics|mesh-ancestor
65414415|NCT04040309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65414416|NCT04040309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414417|NCT04040309|Sensory System Agents|sensory system agents|mesh-ancestor
65414418|NCT04040309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414419|NCT04040309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65414420|NCT04040309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65414421|NCT04040309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65414422|NCT04040309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65414477|NCT00880373|Heroin|heroin|mesh-list
65414480|NCT00880373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65414481|NCT00880373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414483|NCT00880373|Sensory System Agents|sensory system agents|mesh-ancestor
65414484|NCT00880373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414485|NCT00880373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65414486|NCT00880373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65414487|NCT00880373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65414488|NCT00880373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65414489|NCT00880373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65414545|NCT01007864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414546|NCT01007864|Protective Agents|protective agents|mesh-ancestor
65414547|NCT01007864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414548|NCT01007864|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65414549|NCT01007864|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65414550|NCT01007864|Dopamine Agonists|dopamine agonists|mesh-ancestor
65414551|NCT01007864|Dopamine Agents|dopamine agents|mesh-ancestor
65414552|NCT01007864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65414554|NCT01008020|Antioxidants|antioxidants|mesh-ancestor
65414610|NCT01008566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414611|NCT01008566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65414612|NCT01008566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414613|NCT01008566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414614|NCT01008566|Immunologic Factors|immunologic factors|mesh-ancestor
65414615|NCT01008566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414616|NCT03885596|Acetaminophen|acetaminophen|mesh-list
65414679|NCT05732948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414680|NCT05732948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414681|NCT05732948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65414682|NCT00529802|Everolimus|everolimus|mesh-list
65414683|NCT00529802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414684|NCT00529802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65414685|NCT00529802|Immunologic Factors|immunologic factors|mesh-ancestor
65414686|NCT00529802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414687|NCT05021900|Tenalisib|tenalisib|mesh-list
65414688|NCT05021900|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
65414743|NCT04932746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65414744|NCT04932746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414745|NCT04932746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65414746|NCT04932746|Analgesics|analgesics|mesh-ancestor
65414747|NCT04932746|Sensory System Agents|sensory system agents|mesh-ancestor
65414748|NCT04932746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414749|NCT04932746|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65414750|NCT04932746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65414751|NCT04932746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65414752|NCT04932746|Adrenergic Agents|adrenergic agents|mesh-ancestor
65414753|NCT04932746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65414755|NCT00614393|Irinotecan|irinotecan|mesh-list
65414808|NCT04366115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65414809|NCT04366115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65414810|NCT04366115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414811|NCT04366115|Protease Inhibitors|protease inhibitors|mesh-ancestor
65414812|NCT04366115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414813|NCT04366115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414814|NCT04038125|Dexamethasone|dexamethasone|mesh-list
65414873|NCT00881231|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65414874|NCT00881231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65414875|NCT00881231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414876|NCT00883727|Plasma-lyte 148|plasma-lyte 148|mesh-list
65414877|NCT00883727|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65414878|NCT00883727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65414879|NCT00881387|Gemcitabine|gemcitabine|mesh-list
65414880|NCT00881387|Rituximab|rituximab|mesh-list
65414881|NCT00881387|Vinorelbine|vinorelbine|mesh-list
65414882|NCT00881387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65414883|NCT00881387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65414884|NCT00881387|Immunologic Factors|immunologic factors|mesh-ancestor
65414885|NCT00881387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65414886|NCT00881387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65414887|NCT00881387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65414888|NCT00881387|Antimetabolites|antimetabolites|mesh-ancestor
65414889|NCT00881387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65414890|NCT00881387|Antiviral Agents|antiviral agents|mesh-ancestor
65414891|NCT00881387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65414892|NCT00881387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65414929|NCT02543411|Sensory System Agents|sensory system agents|mesh-ancestor
65414930|NCT02543411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65414931|NCT02543411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65164456|NCT01189500|Hormone Antagonists|hormone antagonists|mesh-ancestor
65414932|NCT02543411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65414933|NCT02543411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65414934|NCT02543411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65414936|NCT00882323|Cyclophosphamide|cyclophosphamide|mesh-list
65414996|NCT00609869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65414997|NCT00609869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65414998|NCT00609869|Growth Substances|growth substances|mesh-ancestor
65414999|NCT00609869|Growth Inhibitors|growth inhibitors|mesh-ancestor
65415000|NCT00888797|Etodolac|etodolac|mesh-list
65415001|NCT00888797|Propranolol|propranolol|mesh-list
65415002|NCT00888797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65415003|NCT00888797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65415004|NCT00888797|Adrenergic Agents|adrenergic agents|mesh-ancestor
65415005|NCT00888797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65415006|NCT00888797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415007|NCT00888797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415008|NCT00888797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65415009|NCT00888797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65415053|NCT00887003|Hormones|hormones|mesh-ancestor
65415057|NCT00887003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65415058|NCT00887003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415059|NCT00887081|Ribavirin|ribavirin|mesh-list
65415060|NCT00887081|Interferon-alpha|interferon-alpha|mesh-list
65415061|NCT00887081|Interferon alpha-2|interferon alpha-2|mesh-list
65415062|NCT00887081|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65415063|NCT00887081|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65415064|NCT00887081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65415065|NCT00887081|Antimetabolites|antimetabolites|mesh-ancestor
65415066|NCT00887081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415067|NCT00887081|Antiviral Agents|antiviral agents|mesh-ancestor
65415122|NCT04895306|Anabolic Agents|anabolic agents|mesh-ancestor
65415123|NCT02542241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65415124|NCT00889343|Leucovorin|leucovorin|mesh-list
65415125|NCT00889343|Fluorouracil|fluorouracil|mesh-list
65415126|NCT00889343|Oxaliplatin|oxaliplatin|mesh-list
65415127|NCT00889343|Irinotecan|irinotecan|mesh-list
65415128|NCT00889343|Sorafenib|sorafenib|mesh-list
65415129|NCT00889343|Antimetabolites|antimetabolites|mesh-ancestor
65415130|NCT00889343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415131|NCT00889343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65415132|NCT00889343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415133|NCT00889343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65415134|NCT00889343|Immunologic Factors|immunologic factors|mesh-ancestor
65415135|NCT00889343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415136|NCT00889343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65415137|NCT00889343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65415138|NCT00889343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415139|NCT00889343|Antidotes|antidotes|mesh-ancestor
65415181|NCT01565096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65415182|NCT01565096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65415183|NCT01565096|Immunologic Factors|immunologic factors|mesh-ancestor
65415184|NCT01565096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65415185|NCT01565096|Protease Inhibitors|protease inhibitors|mesh-ancestor
65415186|NCT01565096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415187|NCT01565096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415188|NCT00889499|Tropisetron|tropisetron|mesh-list
65415189|NCT00889499|Antiemetics|antiemetics|mesh-ancestor
65415190|NCT00889499|Autonomic Agents|autonomic agents|mesh-ancestor
65415191|NCT00889499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65415192|NCT00889499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415193|NCT00889499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65415243|NCT00521144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415244|NCT00521144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415245|NCT00520676|Carboplatin|carboplatin|mesh-list
65415246|NCT00520676|Docetaxel|docetaxel|mesh-list
65415247|NCT00520676|Pemetrexed|pemetrexed|mesh-list
65415248|NCT00520676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415249|NCT00520676|Tubulin Modulators|tubulin modulators|mesh-ancestor
65415250|NCT00520676|Antimitotic Agents|antimitotic agents|mesh-ancestor
65415251|NCT00520676|Mitosis Modulators|mitosis modulators|mesh-ancestor
65415252|NCT00520676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415253|NCT00520676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415254|NCT00520676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65415255|NCT00520676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65415256|NCT00889733|Cisplatin|cisplatin|mesh-list
65415257|NCT00889733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415258|NCT00887627|Conivaptan|conivaptan|mesh-list
65415261|NCT00887627|Natriuretic Agents|natriuretic agents|mesh-ancestor
65415300|NCT00890279|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65415301|NCT00890279|Protease Inhibitors|protease inhibitors|mesh-ancestor
65415302|NCT00890279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415303|NCT00890279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65415304|NCT00608543|Aripiprazole|aripiprazole|mesh-list
65415305|NCT00608543|Antidepressive Agents|antidepressive agents|mesh-ancestor
65415306|NCT00608543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65415370|NCT04037657|Anesthetics, General|anesthetics, general|mesh-ancestor
65415371|NCT04037657|Anesthetics|anesthetics|mesh-ancestor
65415372|NCT00893009|Theophylline|theophylline|mesh-list
65415373|NCT00893009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65415374|NCT00893009|Autonomic Agents|autonomic agents|mesh-ancestor
65415375|NCT00893009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65415376|NCT00893009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415377|NCT00893009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65415378|NCT00893009|Respiratory System Agents|respiratory system agents|mesh-ancestor
65415379|NCT00893009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65415380|NCT00893009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415435|NCT00520130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65415436|NCT00520130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65415437|NCT00520130|Antimetabolites|antimetabolites|mesh-ancestor
65415438|NCT00520130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415439|NCT00520130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65415440|NCT00520130|Antiviral Agents|antiviral agents|mesh-ancestor
65415441|NCT00520130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65415442|NCT00520130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415443|NCT00520130|Antifungal Agents|antifungal agents|mesh-ancestor
65415501|NCT00430989|Anesthetics|anesthetics|mesh-ancestor
65415502|NCT00430989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65415503|NCT00430989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415504|NCT00430989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65415505|NCT00430989|Analgesics|analgesics|mesh-ancestor
65415506|NCT00430989|Sensory System Agents|sensory system agents|mesh-ancestor
65415507|NCT00430989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65415508|NCT00518882|Liraglutide|liraglutide|mesh-list
65415509|NCT00518882|Exenatide|exenatide|mesh-list
65415510|NCT00518882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65415511|NCT00518882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415512|NCT00518882|Incretins|incretins|mesh-ancestor
65415513|NCT00518882|Hormones|hormones|mesh-ancestor
65415514|NCT00518882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65415515|NCT00518882|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65415561|NCT00430677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65415562|NCT02631759|Levetiracetam|levetiracetam|mesh-list
65415563|NCT02631759|Anticonvulsants|anticonvulsants|mesh-ancestor
65415564|NCT02631759|Nootropic Agents|nootropic agents|mesh-ancestor
65415565|NCT01035801|Insulin Lispro|insulin lispro|mesh-list
65415566|NCT01035801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65415567|NCT01035801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415568|NCT00525512|Tiotropium Bromide|tiotropium bromide|mesh-list
65415569|NCT00525512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65415570|NCT00525512|Autonomic Agents|autonomic agents|mesh-ancestor
65415580|NCT05199662|Tenecteplase|tenecteplase|mesh-list
65415627|NCT01036035|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65415628|NCT01036659|Ecallantide|ecallantide|mesh-list
65415629|NCT01036659|Bradykinin|bradykinin|mesh-list
65415630|NCT01036659|Kallikreins|kallikreins|mesh-list
65415631|NCT01036659|Kininogens|kininogens|mesh-list
65415632|NCT01036659|Vasodilator Agents|vasodilator agents|mesh-ancestor
65415698|NCT00346216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65415699|NCT00346216|Gout Suppressants|gout suppressants|mesh-ancestor
65415700|NCT01051648|Triamcinolone|triamcinolone|mesh-list
65415701|NCT01051648|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65415702|NCT01051648|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65415703|NCT01051648|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65415704|NCT01051648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65415705|NCT01051648|Glucocorticoids|glucocorticoids|mesh-ancestor
65415706|NCT01051648|Hormones|hormones|mesh-ancestor
65415707|NCT01051648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65415708|NCT01051648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415709|NCT01051648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65415710|NCT01051648|Immunologic Factors|immunologic factors|mesh-ancestor
65415711|NCT01051648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415712|NCT01051648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415713|NCT00429273|Guanfacine|guanfacine|mesh-list
65415756|NCT00417885|Growth Substances|growth substances|mesh-ancestor
65415757|NCT00417885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415758|NCT00417885|Growth Inhibitors|growth inhibitors|mesh-ancestor
65415759|NCT00417885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65415760|NCT00417885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415761|NCT00417885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415762|NCT00417885|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65415763|NCT00417885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65415764|NCT00417885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65415765|NCT00417885|Hormone Antagonists|hormone antagonists|mesh-ancestor
65415766|NCT00417885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65415767|NCT01036893|Prucalopride|prucalopride|mesh-list
65415768|NCT01036893|Laxatives|laxatives|mesh-ancestor
65415769|NCT01036893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65415770|NCT01036893|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65415771|NCT01036893|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65415772|NCT01036893|Serotonin Agents|serotonin agents|mesh-ancestor
65415773|NCT01036893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65415775|NCT01036893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415810|NCT03989830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65415811|NCT03989830|Growth Substances|growth substances|mesh-ancestor
65415812|NCT03989830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415813|NCT03989830|Growth Inhibitors|growth inhibitors|mesh-ancestor
65415814|NCT03989830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65415825|NCT02533492|Triclosan|triclosan|mesh-list
65415880|NCT01057264|Growth Inhibitors|growth inhibitors|mesh-ancestor
65415881|NCT01057264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65415882|NCT01057264|Antimetabolites|antimetabolites|mesh-ancestor
65415883|NCT01057264|Antiviral Agents|antiviral agents|mesh-ancestor
65415884|NCT01057264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65415885|NCT01057264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415886|NCT01057264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65415887|NCT01057264|Immunologic Factors|immunologic factors|mesh-ancestor
65415888|NCT03991312|Itraconazole|itraconazole|mesh-list
65415889|NCT03991312|Rifampin|rifampin|mesh-list
65415890|NCT03991312|Antifungal Agents|antifungal agents|mesh-ancestor
65415891|NCT03991312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65415892|NCT03991312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65415893|NCT03991312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65415894|NCT03991312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415895|NCT03991312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65415896|NCT03991312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65415897|NCT03991312|Hormone Antagonists|hormone antagonists|mesh-ancestor
65415898|NCT03991312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65415899|NCT03991312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415900|NCT03991312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65415901|NCT03991312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65415930|NCT01057498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65415931|NCT03742258|Prednisone|prednisone|mesh-list
65415932|NCT03742258|Cortisone|cortisone|mesh-list
65415933|NCT03742258|Cyclophosphamide|cyclophosphamide|mesh-list
65415934|NCT03742258|Rituximab|rituximab|mesh-list
65415935|NCT03742258|Doxorubicin|doxorubicin|mesh-list
65415936|NCT03742258|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65415937|NCT03742258|Vincristine|vincristine|mesh-list
65415938|NCT03742258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65415939|NCT03742258|Antibodies|antibodies|mesh-list
65415940|NCT03742258|Immunoglobulins|immunoglobulins|mesh-list
65415941|NCT03742258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65415942|NCT03742258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65415943|NCT03742258|Immunologic Factors|immunologic factors|mesh-ancestor
65415944|NCT03742258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65415945|NCT03742258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65415946|NCT03742258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65415947|NCT03742258|Alkylating Agents|alkylating agents|mesh-ancestor
65415991|NCT00354172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65415992|NCT00354172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65415993|NCT00354172|Antifungal Agents|antifungal agents|mesh-ancestor
65415994|NCT00354172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65415995|NCT00354172|Dermatologic Agents|dermatologic agents|mesh-ancestor
65415996|NCT00354172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65416061|NCT00512252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65416062|NCT00512252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65416063|NCT00512252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416064|NCT00512252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416065|NCT00512252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65416131|NCT00523640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65416132|NCT00523640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416133|NCT00523640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65416134|NCT00523640|Immunologic Factors|immunologic factors|mesh-ancestor
65416135|NCT03457142|Dexamethasone|dexamethasone|mesh-list
65416136|NCT03457142|Dexamethasone acetate|dexamethasone acetate|mesh-list
65416137|NCT03457142|Abatacept|abatacept|mesh-list
65416138|NCT03457142|Ixazomib|ixazomib|mesh-list
65416139|NCT03457142|Ichthammol|ichthammol|mesh-list
65416140|NCT03457142|BB 1101|bb 1101|mesh-list
65416141|NCT03457142|Glycine|glycine|mesh-list
65416197|NCT00515294|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65416198|NCT00515294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65416199|NCT00515294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65416200|NCT00515294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65416270|NCT01033305|Cyclosporins|cyclosporins|mesh-list
65416271|NCT01033305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416272|NCT01033305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416273|NCT01033305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65416274|NCT01033305|Immunologic Factors|immunologic factors|mesh-ancestor
65416275|NCT01033305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416276|NCT01033305|Antifungal Agents|antifungal agents|mesh-ancestor
65416277|NCT01033305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65416278|NCT01033305|Dermatologic Agents|dermatologic agents|mesh-ancestor
65416279|NCT01033305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65416280|NCT01033305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65416281|NCT00514904|Vaccines|vaccines|mesh-list
65416284|NCT00440115|Bupropion|bupropion|mesh-list
65416333|NCT00416715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416334|NCT00416715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65416335|NCT00416715|Hormone Antagonists|hormone antagonists|mesh-ancestor
65416336|NCT00416715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65416337|NCT00416715|Antacids|antacids|mesh-ancestor
65416338|NCT00416715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65416339|NCT01037517|Plerixafor|plerixafor|mesh-list
65416340|NCT01037517|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65416341|NCT01037517|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65416342|NCT01037517|Antiviral Agents|antiviral agents|mesh-ancestor
65416343|NCT01037517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65416399|NCT03336216|Gemcitabine|gemcitabine|mesh-list
65416400|NCT03336216|Paclitaxel|paclitaxel|mesh-list
65416401|NCT03336216|Fluorouracil|fluorouracil|mesh-list
65416402|NCT03336216|Oxaliplatin|oxaliplatin|mesh-list
65416403|NCT03336216|Nivolumab|nivolumab|mesh-list
65416404|NCT03336216|Irinotecan|irinotecan|mesh-list
65416405|NCT03336216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65416406|NCT03336216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416407|NCT03336216|Tubulin Modulators|tubulin modulators|mesh-ancestor
65416408|NCT03336216|Antimitotic Agents|antimitotic agents|mesh-ancestor
65416409|NCT03336216|Mitosis Modulators|mitosis modulators|mesh-ancestor
65416410|NCT03336216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416411|NCT03336216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65416412|NCT03336216|Antimetabolites|antimetabolites|mesh-ancestor
65416413|NCT03336216|Antiviral Agents|antiviral agents|mesh-ancestor
65416414|NCT03336216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65416415|NCT03336216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416416|NCT03336216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65416417|NCT03336216|Immunologic Factors|immunologic factors|mesh-ancestor
65416418|NCT03336216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416457|NCT03742557|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65416458|NCT03742557|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65416459|NCT03742557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65416460|NCT03742557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416461|NCT01324089|Resveratrol|resveratrol|mesh-list
65416462|NCT01324089|Piperine|piperine|mesh-list
65416463|NCT01324089|Antioxidants|antioxidants|mesh-ancestor
65416464|NCT01324089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416523|NCT00344968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65416524|NCT00344968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416525|NCT00509028|Budesonide|budesonide|mesh-list
65416526|NCT00509028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65416527|NCT00509028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65166074|NCT02720341|Armin|armin|mesh-list
65416528|NCT00509028|Autonomic Agents|autonomic agents|mesh-ancestor
65416529|NCT00509028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65416530|NCT00509028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416531|NCT00509028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65416532|NCT00509028|Respiratory System Agents|respiratory system agents|mesh-ancestor
65416587|NCT00352690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65416588|NCT00352690|Tubulin Modulators|tubulin modulators|mesh-ancestor
65416589|NCT00352690|Antimitotic Agents|antimitotic agents|mesh-ancestor
65416590|NCT00352690|Mitosis Modulators|mitosis modulators|mesh-ancestor
65416592|NCT00895505|Warfarin|warfarin|mesh-list
65416660|NCT04036253|Hematinics|hematinics|mesh-ancestor
65416661|NCT00893555|Voriconazole|voriconazole|mesh-list
65416662|NCT00893555|Antifungal Agents|antifungal agents|mesh-ancestor
65416663|NCT00893555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65416664|NCT00893555|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65416665|NCT00893555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65416666|NCT00893555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416667|NCT00893555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416725|NCT01058902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416726|NCT01058902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65416727|NCT01058902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65416728|NCT01058902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416729|NCT01058902|Antipyretics|antipyretics|mesh-ancestor
65416730|NCT00609167|Dexamethasone|dexamethasone|mesh-list
65416792|NCT00891605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416793|NCT00893711|Vitamin D|vitamin d|mesh-list
65416794|NCT00893711|Vitamins|vitamins|mesh-ancestor
65416795|NCT00893711|Micronutrients|micronutrients|mesh-ancestor
65416796|NCT00893711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416797|NCT00893711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65416798|NCT00514020|Leucovorin|leucovorin|mesh-list
65416799|NCT00514020|Fluorouracil|fluorouracil|mesh-list
65416800|NCT00514020|Oxaliplatin|oxaliplatin|mesh-list
65416801|NCT00514020|Calcium|calcium|mesh-list
65416802|NCT00514020|Levoleucovorin|levoleucovorin|mesh-list
65416803|NCT00514020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65416804|NCT00514020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416805|NCT00514020|Antimetabolites|antimetabolites|mesh-ancestor
65416806|NCT00514020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416807|NCT00514020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65416814|NCT00514020|Vitamins|vitamins|mesh-ancestor
65416852|NCT03067272|Contraceptive Agents|contraceptive agents|mesh-list
65416853|NCT03067272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65416854|NCT03067272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416855|NCT00891761|Dexamethasone|dexamethasone|mesh-list
65416856|NCT00891761|Dexamethasone acetate|dexamethasone acetate|mesh-list
65416857|NCT00891761|Ondansetron|ondansetron|mesh-list
65416858|NCT00891761|Casopitant|casopitant|mesh-list
65416859|NCT00891761|BB 1101|bb 1101|mesh-list
65416860|NCT00891761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65416861|NCT00891761|Antiemetics|antiemetics|mesh-ancestor
65416862|NCT00891761|Autonomic Agents|autonomic agents|mesh-ancestor
65416863|NCT00891761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65416866|NCT00891761|Glucocorticoids|glucocorticoids|mesh-ancestor
65416917|NCT00513474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65416918|NCT00513474|Antimetabolites|antimetabolites|mesh-ancestor
65416919|NCT00513474|Dermatologic Agents|dermatologic agents|mesh-ancestor
65416920|NCT00513474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65416921|NCT00513474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65416924|NCT00513474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65416987|NCT01011036|Cholinergic Agents|cholinergic agents|mesh-ancestor
65416988|NCT01011036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65416989|NCT01011036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65416990|NCT01011036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65416991|NCT01011036|Urological Agents|urological agents|mesh-ancestor
65416992|NCT01011036|Anticonvulsants|anticonvulsants|mesh-ancestor
65416993|NCT01011036|GABA Modulators|gaba modulators|mesh-ancestor
65417055|NCT00343252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65417056|NCT00343252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417057|NCT00892229|Misoprostol|misoprostol|mesh-list
65417058|NCT00892229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65417059|NCT00892229|Abortifacient Agents|abortifacient agents|mesh-ancestor
65417060|NCT00892229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65417061|NCT00892229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417062|NCT00892229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65417063|NCT00892229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65417071|NCT00892307|Adenosine|adenosine|mesh-list
65417119|NCT00892463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65417120|NCT00892463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65417121|NCT00892463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65417122|NCT00892463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65417123|NCT00892463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417124|NCT01011114|Cinacalcet|cinacalcet|mesh-list
65417125|NCT01011114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65417126|NCT01011114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417185|NCT04035707|Rocuronium|rocuronium|mesh-list
65417186|NCT04035707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417187|NCT04035707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65417188|NCT04035707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65417189|NCT04035707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65417190|NCT04035707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417256|NCT00902057|Coagulants|coagulants|mesh-ancestor
65417257|NCT00902057|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65417258|NCT00902057|Natriuretic Agents|natriuretic agents|mesh-ancestor
65417259|NCT00902057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417260|NCT00902135|Interferons|interferons|mesh-list
65417261|NCT00902135|Interferon-beta|interferon-beta|mesh-list
65417262|NCT00902135|Interferon beta-1b|interferon beta-1b|mesh-list
65417263|NCT00902135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417324|NCT00902837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65417325|NCT00605813|Sertraline|sertraline|mesh-list
65417326|NCT00605813|Antidepressive Agents|antidepressive agents|mesh-ancestor
65417327|NCT00605813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65417328|NCT00605813|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65417395|NCT00605657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417396|NCT00605657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417397|NCT00605657|GABA Agents|gaba agents|mesh-ancestor
65417398|NCT00605657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65417399|NCT00605657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417400|NCT00605657|Antimanic Agents|antimanic agents|mesh-ancestor
65417401|NCT00605657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65417402|NCT00605657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65417403|NCT00605657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65417404|NCT00899951|Fentanyl|fentanyl|mesh-list
65417405|NCT00899951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65417406|NCT00899951|Narcotics|narcotics|mesh-ancestor
65417459|NCT00904085|Analgesics|analgesics|mesh-ancestor
65417460|NCT00904085|Sensory System Agents|sensory system agents|mesh-ancestor
65417461|NCT00904085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417462|NCT00904085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65417463|NCT00908453|Fosphenytoin|fosphenytoin|mesh-list
65417464|NCT00908453|Anticonvulsants|anticonvulsants|mesh-ancestor
65417465|NCT00908453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65417466|NCT00908453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65417467|NCT00908453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417468|NCT00908531|Letrozole|letrozole|mesh-list
65417469|NCT00908531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417470|NCT00908531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65417471|NCT00908531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65417472|NCT00908531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417473|NCT00908531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417474|NCT00908531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65417514|NCT00908921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417515|NCT00908921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65417516|NCT00908921|Immunologic Factors|immunologic factors|mesh-ancestor
65417517|NCT00904631|Salicylic Acid|salicylic acid|mesh-list
65417518|NCT00904631|Salicylates|salicylates|mesh-list
65417519|NCT00904631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65417520|NCT00904631|Antifungal Agents|antifungal agents|mesh-ancestor
65417521|NCT00904631|Keratolytic Agents|keratolytic agents|mesh-ancestor
65417522|NCT00904631|Dermatologic Agents|dermatologic agents|mesh-ancestor
65417523|NCT00904631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65417524|NCT00904631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65417525|NCT00904631|Analgesics|analgesics|mesh-ancestor
65417526|NCT00904631|Sensory System Agents|sensory system agents|mesh-ancestor
65417527|NCT00904631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417576|NCT01057966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417577|NCT00603941|Paclitaxel|paclitaxel|mesh-list
65417578|NCT00603941|Efatutazone|efatutazone|mesh-list
65417579|NCT00603941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65417580|NCT00603941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417581|NCT00603941|Tubulin Modulators|tubulin modulators|mesh-ancestor
65417582|NCT00603941|Antimitotic Agents|antimitotic agents|mesh-ancestor
65417583|NCT00603941|Mitosis Modulators|mitosis modulators|mesh-ancestor
65417584|NCT00603941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167102|NCT00604084|Ivermectin|ivermectin|mesh-list
65417585|NCT00340678|Losartan|losartan|mesh-list
65417586|NCT00340678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65417587|NCT00340678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65417588|NCT00340678|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65417589|NCT00340678|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65417590|NCT00340678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417591|NCT01055470|Diclofenac|diclofenac|mesh-list
65417592|NCT01055470|Lornoxicam|lornoxicam|mesh-list
65417593|NCT01055470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65417594|NCT01055470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65417595|NCT01055470|Analgesics|analgesics|mesh-ancestor
65417596|NCT01055470|Sensory System Agents|sensory system agents|mesh-ancestor
65417627|NCT00909311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65417628|NCT00909311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65417629|NCT00907751|Rituximab|rituximab|mesh-list
65417630|NCT00907751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65417631|NCT00907751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417632|NCT00907751|Immunologic Factors|immunologic factors|mesh-ancestor
65417633|NCT00907751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417634|NCT00907751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65417635|NCT00336856|Irinotecan|irinotecan|mesh-list
65417636|NCT00336856|Cetuximab|cetuximab|mesh-list
65417637|NCT00336856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65417638|NCT00336856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65417639|NCT00336856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417640|NCT00336856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417641|NCT00336856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417683|NCT00605033|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65417684|NCT00605033|Naloxone|naloxone|mesh-list
65417685|NCT00605033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65417686|NCT00605033|Narcotics|narcotics|mesh-ancestor
65417687|NCT00605033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65417688|NCT00605033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417689|NCT00605033|Analgesics|analgesics|mesh-ancestor
65417690|NCT00605033|Sensory System Agents|sensory system agents|mesh-ancestor
65417691|NCT00605033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65417692|NCT00605033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65417693|NCT03988114|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65417694|NCT03988114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65417695|NCT03988114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417696|NCT03988114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417697|NCT03988114|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65417698|NCT03988114|Hormone Antagonists|hormone antagonists|mesh-ancestor
65417699|NCT03988114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65417700|NCT03988114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417701|NCT00905723|Estradiol|estradiol|mesh-list
65417702|NCT00905723|Estrogens|estrogens|mesh-ancestor
65417703|NCT00905723|Hormones|hormones|mesh-ancestor
65417704|NCT00905723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65417706|NCT00907985|Lamotrigine|lamotrigine|mesh-list
65417732|NCT01325194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65417733|NCT01325194|Immunologic Factors|immunologic factors|mesh-ancestor
65417734|NCT01325194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417735|NCT00908219|Bevacizumab|bevacizumab|mesh-list
65417736|NCT00908219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65417743|NCT00908297|Ubiquinone|ubiquinone|mesh-list
65417801|NCT00931775|Adrenergic Agents|adrenergic agents|mesh-ancestor
65417802|NCT00931775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65417803|NCT00931775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417804|NCT00931775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65417805|NCT00931775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65417871|NCT00338728|Letrozole|letrozole|mesh-list
65417872|NCT00338728|Imatinib Mesylate|imatinib mesylate|mesh-list
65417873|NCT00338728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65417874|NCT00338728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65417875|NCT00338728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65417876|NCT00338728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65417877|NCT00338728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65417878|NCT00338728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65417879|NCT00338728|Hormone Antagonists|hormone antagonists|mesh-ancestor
65417880|NCT00338728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65417935|NCT00504582|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65417936|NCT00504582|Hemostatics|hemostatics|mesh-ancestor
65417937|NCT00504582|Coagulants|coagulants|mesh-ancestor
65417938|NCT01011426|Bisacodyl|bisacodyl|mesh-list
65417939|NCT01011426|Cathartics|cathartics|mesh-ancestor
65417940|NCT01011426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65417941|NCT01011426|Laxatives|laxatives|mesh-ancestor
65418005|NCT00929045|Hormones|hormones|mesh-list
65418006|NCT00929045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65418007|NCT00929045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418008|NCT00925457|Domperidone|domperidone|mesh-list
65418009|NCT00925457|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65418010|NCT00925457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418011|NCT00925457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418012|NCT00925457|Antiemetics|antiemetics|mesh-ancestor
65418072|NCT00492726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65418073|NCT00492726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418074|NCT00492726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418075|NCT00492726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418076|NCT00492726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65418077|NCT00492726|Contraceptive Agents|contraceptive agents|mesh-ancestor
65418078|NCT00492726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65418079|NCT00492726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418081|NCT00492726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65418135|NCT01011660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418136|NCT01011660|Vasodilator Agents|vasodilator agents|mesh-ancestor
65418137|NCT01011660|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65418138|NCT01011660|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65418139|NCT01011660|Antimetabolites|antimetabolites|mesh-ancestor
65418140|NCT01011660|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65418141|NCT01011660|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65418142|NCT01011660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418143|NCT01011660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65418144|NCT01011660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65418145|NCT01011660|Diuretics|diuretics|mesh-ancestor
65418146|NCT01011660|Natriuretic Agents|natriuretic agents|mesh-ancestor
65418196|NCT00492024|Moxifloxacin|moxifloxacin|mesh-list
65418197|NCT00492024|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65418198|NCT00492024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65418267|NCT00934739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65418268|NCT00934739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65418269|NCT00934739|Analgesics|analgesics|mesh-ancestor
65418270|NCT00934739|Sensory System Agents|sensory system agents|mesh-ancestor
65418271|NCT00934739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65418272|NCT00934739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65418273|NCT00934739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418274|NCT01015482|Midazolam|midazolam|mesh-list
65418336|NCT01013532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65418337|NCT01013532|Antioxidants|antioxidants|mesh-ancestor
65418338|NCT00934895|Paclitaxel|paclitaxel|mesh-list
65418339|NCT00934895|Everolimus|everolimus|mesh-list
65418340|NCT00934895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65418341|NCT00934895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65418342|NCT00934895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418343|NCT00934895|Tubulin Modulators|tubulin modulators|mesh-ancestor
65418344|NCT00934895|Antimitotic Agents|antimitotic agents|mesh-ancestor
65418345|NCT00934895|Mitosis Modulators|mitosis modulators|mesh-ancestor
65418346|NCT00934895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418347|NCT00934895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65418348|NCT00934895|Immunologic Factors|immunologic factors|mesh-ancestor
65418349|NCT00934895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418350|NCT00926705|Fentanyl|fentanyl|mesh-list
65418375|NCT00934973|Mebeverine|mebeverine|mesh-list
65418396|NCT01018836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418397|NCT01018836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418398|NCT01018836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65418399|NCT01018836|Protective Agents|protective agents|mesh-ancestor
65418400|NCT04015661|Paclitaxel|paclitaxel|mesh-list
65418401|NCT04015661|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65418403|NCT04015661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418464|NCT00930839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65418465|NCT00930839|Vasodilator Agents|vasodilator agents|mesh-ancestor
65418466|NCT00930839|Vitamin B Complex|vitamin b complex|mesh-ancestor
65418467|NCT00930839|Vitamins|vitamins|mesh-ancestor
65418468|NCT00930839|Micronutrients|micronutrients|mesh-ancestor
65418469|NCT01015794|Ephedrine|ephedrine|mesh-list
65418470|NCT01015794|Pseudoephedrine|pseudoephedrine|mesh-list
65418471|NCT01015794|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65418472|NCT01015794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418473|NCT01015794|Sympathomimetics|sympathomimetics|mesh-ancestor
65418474|NCT01015794|Autonomic Agents|autonomic agents|mesh-ancestor
65418475|NCT01015794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65418477|NCT01015794|Adrenergic Agents|adrenergic agents|mesh-ancestor
65418525|NCT00931073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65418526|NCT00931073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65418527|NCT00931073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65418528|NCT00931073|Hormone Antagonists|hormone antagonists|mesh-ancestor
65418530|NCT00931073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418594|NCT01019382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65418595|NCT01019382|Antimetabolites|antimetabolites|mesh-ancestor
65418596|NCT01019382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418597|NCT01019382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418598|NCT01019382|Antiviral Agents|antiviral agents|mesh-ancestor
65418599|NCT01019382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65418600|NCT01019382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418601|NCT01019382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65418602|NCT01019382|Immunologic Factors|immunologic factors|mesh-ancestor
65418660|NCT00937079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418661|NCT00937079|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65418662|NCT00937079|Incretins|incretins|mesh-ancestor
65418663|NCT00937079|Hormones|hormones|mesh-ancestor
65418664|NCT00937079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65418665|NCT00566111|Ceftriaxone|ceftriaxone|mesh-list
65418666|NCT00566111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65418667|NCT00566111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65418668|NCT00937625|Cyclophosphamide|cyclophosphamide|mesh-list
65418669|NCT00937625|Fludarabine|fludarabine|mesh-list
65418670|NCT00937625|Fludarabine phosphate|fludarabine phosphate|mesh-list
65418725|NCT04013243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65418726|NCT04013243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418727|NCT04013243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65418728|NCT04013243|Tocolytic Agents|tocolytic agents|mesh-ancestor
65418730|NCT00938171|Anesthetics|anesthetics|mesh-list
65418792|NCT03972137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65418793|NCT03972137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418794|NCT03972137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65418795|NCT03972137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65418796|NCT03972137|Cholinergic Agents|cholinergic agents|mesh-ancestor
65418797|NCT03972137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65418798|NCT03972137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418799|NCT00490698|Zoledronic Acid|zoledronic acid|mesh-list
65418858|NCT00511004|Albendazole|albendazole|mesh-list
65418859|NCT00511004|Diethylcarbamazine|diethylcarbamazine|mesh-list
65418860|NCT00511004|Anthelmintics|anthelmintics|mesh-ancestor
65418861|NCT00511004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65418862|NCT00511004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65418863|NCT00511004|Anticestodal Agents|anticestodal agents|mesh-ancestor
65418864|NCT00511004|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65418865|NCT00511004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65418866|NCT00511004|Tubulin Modulators|tubulin modulators|mesh-ancestor
65418867|NCT00511004|Antimitotic Agents|antimitotic agents|mesh-ancestor
65418868|NCT00511004|Mitosis Modulators|mitosis modulators|mesh-ancestor
65418869|NCT00511004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418870|NCT00511004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418871|NCT00511004|Filaricides|filaricides|mesh-ancestor
65418920|NCT04012619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418921|NCT04012619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65418922|NCT04012619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418923|NCT04012619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65418924|NCT04012619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65418926|NCT00941057|Tetrahydrofolates|tetrahydrofolates|mesh-list
65418927|NCT00941057|Dienogest|dienogest|mesh-list
65418988|NCT00335452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65418989|NCT00335452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65418990|NCT00335452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65418991|NCT00522548|Mycophenolic Acid|mycophenolic acid|mesh-list
65418992|NCT00522548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65418993|NCT00522548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65418995|NCT00522548|Antitubercular Agents|antitubercular agents|mesh-ancestor
65419057|NCT00335140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65419058|NCT00335140|Antidotes|antidotes|mesh-ancestor
65419059|NCT00335140|Protective Agents|protective agents|mesh-ancestor
65419060|NCT00335140|Vitamin B Complex|vitamin b complex|mesh-ancestor
65419061|NCT00335140|Vitamins|vitamins|mesh-ancestor
65419062|NCT00335140|Micronutrients|micronutrients|mesh-ancestor
65419063|NCT00335140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65419064|NCT00335140|Tubulin Modulators|tubulin modulators|mesh-ancestor
65419065|NCT00335140|Antimitotic Agents|antimitotic agents|mesh-ancestor
65419066|NCT00335140|Mitosis Modulators|mitosis modulators|mesh-ancestor
65419067|NCT01061320|Tocopherols|tocopherols|mesh-list
65419125|NCT00309166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419126|NCT01063816|Gemcitabine|gemcitabine|mesh-list
65419127|NCT01063816|Carboplatin|carboplatin|mesh-list
65419128|NCT01063816|Veliparib|veliparib|mesh-list
65419129|NCT01063816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419130|NCT01063816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65419131|NCT01063816|Antimetabolites|antimetabolites|mesh-ancestor
65419132|NCT01063816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419133|NCT01063816|Antiviral Agents|antiviral agents|mesh-ancestor
65419134|NCT01063816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65419135|NCT01063816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419136|NCT01063816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65419137|NCT01063816|Immunologic Factors|immunologic factors|mesh-ancestor
65419138|NCT01063816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419139|NCT01063816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65419140|NCT00501852|Glycopyrrolate|glycopyrrolate|mesh-list
65419141|NCT00501852|Tiotropium Bromide|tiotropium bromide|mesh-list
65419142|NCT00501852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65419143|NCT00501852|Autonomic Agents|autonomic agents|mesh-ancestor
65419144|NCT00501852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65419145|NCT00501852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419146|NCT00501852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65419179|NCT01059604|Sensory System Agents|sensory system agents|mesh-ancestor
65419180|NCT01059604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65419181|NCT01059604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419182|NCT01059604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65419183|NCT01059604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65419184|NCT01059604|Gout Suppressants|gout suppressants|mesh-ancestor
65419185|NCT01059604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65419186|NCT01059604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419187|NCT01059604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419188|NCT01059604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65419189|NCT01059604|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65419190|NCT01059604|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65419191|NCT01059604|Serotonin Agents|serotonin agents|mesh-ancestor
65419192|NCT01059604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65419193|NCT02532634|Dexamethasone|dexamethasone|mesh-list
65419194|NCT02532634|Dexamethasone acetate|dexamethasone acetate|mesh-list
65419195|NCT02532634|Aprepitant|aprepitant|mesh-list
65419196|NCT02532634|Fosaprepitant|fosaprepitant|mesh-list
65419197|NCT02532634|Palonosetron|palonosetron|mesh-list
65419198|NCT02532634|Ramosetron|ramosetron|mesh-list
65419199|NCT02532634|BB 1101|bb 1101|mesh-list
65419200|NCT02532634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65419201|NCT02532634|Antiemetics|antiemetics|mesh-ancestor
65419231|NCT01014156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65419232|NCT01014156|Vasodilator Agents|vasodilator agents|mesh-ancestor
65419233|NCT00322348|Goserelin|goserelin|mesh-list
65419234|NCT00322348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65419235|NCT00322348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419237|NCT01014234|Sirolimus|sirolimus|mesh-list
65419303|NCT00308074|Antidepressive Agents|antidepressive agents|mesh-ancestor
65419304|NCT00308074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65419305|NCT00308074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65419306|NCT00308074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65419307|NCT00308074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65419308|NCT00308074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419309|NCT00308074|Dopamine Agonists|dopamine agonists|mesh-ancestor
65419310|NCT00308074|Dopamine Agents|dopamine agents|mesh-ancestor
65419311|NCT00308074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65419312|NCT00308074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419313|NCT00308074|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65419314|NCT00308074|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65419315|NCT00308074|Serotonin Agents|serotonin agents|mesh-ancestor
65419316|NCT00308074|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65419317|NCT00308074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65419318|NCT00308074|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65419319|NCT00308074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65419320|NCT03997058|Estazolam|estazolam|mesh-list
65419357|NCT01015196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65419358|NCT01015196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419359|NCT01015196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419360|NCT01009892|Codeine|codeine|mesh-list
65419361|NCT01009892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65419362|NCT01009892|Narcotics|narcotics|mesh-ancestor
65419363|NCT01009892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65419383|NCT01061788|Everolimus|everolimus|mesh-list
65419424|NCT04410965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65419425|NCT04410965|Analgesics|analgesics|mesh-ancestor
65419426|NCT04410965|Sensory System Agents|sensory system agents|mesh-ancestor
65419427|NCT04410965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65419428|NCT04410965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419429|NCT04410965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65419430|NCT04410965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65419431|NCT04410965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65419432|NCT04410965|Immunologic Factors|immunologic factors|mesh-ancestor
65419433|NCT04012775|Insulin|insulin|mesh-list
65419491|NCT00321646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419492|NCT00321646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65419493|NCT00321646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65419494|NCT00321646|Growth Substances|growth substances|mesh-ancestor
65419495|NCT00321646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419496|NCT00321646|Growth Inhibitors|growth inhibitors|mesh-ancestor
65419497|NCT00321646|Tubulin Modulators|tubulin modulators|mesh-ancestor
65419498|NCT00321646|Antimitotic Agents|antimitotic agents|mesh-ancestor
65419499|NCT00321646|Mitosis Modulators|mitosis modulators|mesh-ancestor
65419500|NCT00321646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419501|NCT00403767|Warfarin|warfarin|mesh-list
65419502|NCT00403767|Rivaroxaban|rivaroxaban|mesh-list
65419503|NCT00403767|Anticoagulants|anticoagulants|mesh-ancestor
65419504|NCT00403767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65419505|NCT00403767|Antithrombins|antithrombins|mesh-ancestor
65419506|NCT00403767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65419507|NCT00403767|Protease Inhibitors|protease inhibitors|mesh-ancestor
65419508|NCT00403767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419509|NCT00403767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419510|NCT00492284|Dexamethasone|dexamethasone|mesh-list
65419511|NCT00492284|Ranibizumab|ranibizumab|mesh-list
65419512|NCT00492284|Verteporfin|verteporfin|mesh-list
65419513|NCT00492284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65419514|NCT00492284|Antiemetics|antiemetics|mesh-ancestor
65419515|NCT00492284|Autonomic Agents|autonomic agents|mesh-ancestor
65419516|NCT00492284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65419517|NCT00492284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419518|NCT00492284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65419519|NCT00492284|Glucocorticoids|glucocorticoids|mesh-ancestor
65419520|NCT00492284|Hormones|hormones|mesh-ancestor
65419521|NCT00492284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65419522|NCT00492284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65419536|NCT01013012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419537|NCT01013012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65419538|NCT01013012|Glucocorticoids|glucocorticoids|mesh-ancestor
65419539|NCT01013012|Hormones|hormones|mesh-ancestor
65419540|NCT01013012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65419541|NCT01013012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65419542|NCT01013012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419543|NCT01013012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65419544|NCT01013012|Serotonin Agents|serotonin agents|mesh-ancestor
65419545|NCT01013012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65419546|NCT01013012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419547|NCT01009970|Prednisone|prednisone|mesh-list
65419548|NCT01009970|Cyclophosphamide|cyclophosphamide|mesh-list
65419549|NCT01009970|Rituximab|rituximab|mesh-list
65419550|NCT01009970|Doxorubicin|doxorubicin|mesh-list
65419551|NCT01009970|Vincristine|vincristine|mesh-list
65419552|NCT01009970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65419595|NCT03563157|Cyclophosphamide|cyclophosphamide|mesh-list
65419596|NCT03563157|Fluorouracil|fluorouracil|mesh-list
65419597|NCT03563157|Capecitabine|capecitabine|mesh-list
65419598|NCT03563157|Oxaliplatin|oxaliplatin|mesh-list
65419599|NCT03563157|Cetuximab|cetuximab|mesh-list
65419600|NCT03563157|Avelumab|avelumab|mesh-list
65419601|NCT03563157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65419602|NCT03563157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419603|NCT03563157|Tubulin Modulators|tubulin modulators|mesh-ancestor
65419604|NCT03563157|Antimitotic Agents|antimitotic agents|mesh-ancestor
65419605|NCT03563157|Mitosis Modulators|mitosis modulators|mesh-ancestor
65419606|NCT03563157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419607|NCT03563157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65419608|NCT03563157|Immunologic Factors|immunologic factors|mesh-ancestor
65419609|NCT03563157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419610|NCT03563157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65419611|NCT03563157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65419619|NCT03563157|Vitamins|vitamins|mesh-ancestor
65419655|NCT01589055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65419656|NCT01589055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65419657|NCT01589055|Cholinergic Agents|cholinergic agents|mesh-ancestor
65419658|NCT01589055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65419659|NCT01589055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419660|NCT00414765|Aldesleukin|aldesleukin|mesh-list
65419661|NCT00414765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419662|NCT00414765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65419663|NCT00414765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65419664|NCT00414765|Antiviral Agents|antiviral agents|mesh-ancestor
65419665|NCT00414765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65419666|NCT03997292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65419667|NCT03997292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65419668|NCT03997292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65419670|NCT01013402|Insulin|insulin|mesh-list
65419674|NCT01013480|Baclofen|baclofen|mesh-list
65419715|NCT01014468|Bevacizumab|bevacizumab|mesh-list
65419716|NCT01014468|Ranibizumab|ranibizumab|mesh-list
65419717|NCT01014468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65419718|NCT01014468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419719|NCT01014468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65419720|NCT01014468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65419721|NCT01014468|Growth Substances|growth substances|mesh-ancestor
65419786|NCT00565409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65419787|NCT00565409|Antimetabolites|antimetabolites|mesh-ancestor
65419788|NCT00565409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419790|NCT00565409|Dermatologic Agents|dermatologic agents|mesh-ancestor
65419857|NCT00503906|Antiviral Agents|antiviral agents|mesh-ancestor
65419858|NCT00503906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65419859|NCT00503906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65419860|NCT00503906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65419861|NCT00503906|Immunologic Factors|immunologic factors|mesh-ancestor
65419862|NCT00305110|Hydromorphone|hydromorphone|mesh-list
65419863|NCT00305110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65419864|NCT00305110|Narcotics|narcotics|mesh-ancestor
65419927|NCT00499746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65419928|NCT00499746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65419929|NCT00499746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65419930|NCT00499746|Dopamine Agents|dopamine agents|mesh-ancestor
65419931|NCT00499746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65419932|NCT00499746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65419933|NCT00499746|Narcotics|narcotics|mesh-ancestor
65419934|NCT00499746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65419993|NCT00499590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65419994|NCT00499590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65419995|NCT00499590|Growth Substances|growth substances|mesh-ancestor
65419996|NCT00499590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65419997|NCT00499590|Growth Inhibitors|growth inhibitors|mesh-ancestor
65419998|NCT00499590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65419999|NCT00510146|Olanzapine|olanzapine|mesh-list
65420000|NCT00510146|Antiemetics|antiemetics|mesh-ancestor
65420001|NCT00510146|Autonomic Agents|autonomic agents|mesh-ancestor
65420015|NCT04250064|Bevacizumab|bevacizumab|mesh-list
65420059|NCT00393939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65420060|NCT00393939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65420061|NCT00393939|Growth Substances|growth substances|mesh-ancestor
65420062|NCT00393939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420063|NCT00393939|Growth Inhibitors|growth inhibitors|mesh-ancestor
65420064|NCT00393939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65420065|NCT00393939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420067|NCT00488982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420068|NCT00488982|Tubulin Modulators|tubulin modulators|mesh-ancestor
65420069|NCT00488982|Antimitotic Agents|antimitotic agents|mesh-ancestor
65420070|NCT00488982|Mitosis Modulators|mitosis modulators|mesh-ancestor
65420071|NCT00488982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420072|NCT00488826|Vaccines|vaccines|mesh-list
65420073|NCT00488826|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65420074|NCT00488826|Immunologic Factors|immunologic factors|mesh-ancestor
65420075|NCT00488826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420076|NCT01017354|Calcifediol|calcifediol|mesh-list
65420077|NCT01017354|Vitamins|vitamins|mesh-ancestor
65420078|NCT01017354|Micronutrients|micronutrients|mesh-ancestor
65420079|NCT01017354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420080|NCT01017354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65420081|NCT00393861|Bevacizumab|bevacizumab|mesh-list
65420082|NCT00393861|Oxaliplatin|oxaliplatin|mesh-list
65420083|NCT00393861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65420084|NCT00393861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420085|NCT00393861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65420086|NCT00393861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65420087|NCT00393861|Growth Substances|growth substances|mesh-ancestor
65420088|NCT00393861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420089|NCT00393861|Growth Inhibitors|growth inhibitors|mesh-ancestor
65420090|NCT01040559|Idarubicin|idarubicin|mesh-list
65420091|NCT01040559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65420092|NCT01040559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420093|NCT01040559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65420094|NCT01040559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65420095|NCT01040559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674223|NCT02353572|Immunologic Factors|immunologic factors|mesh-ancestor
64674224|NCT03886701|Isoniazid|isoniazid|mesh-list
64674225|NCT03886701|Rifapentine|rifapentine|mesh-list
64674234|NCT03886701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65420096|NCT01040559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420097|NCT01020396|Metronidazole|metronidazole|mesh-list
65420098|NCT01020396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65420099|NCT01020396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65420100|NCT01020396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65420101|NCT01020396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65420102|NCT00488592|Molgramostim|molgramostim|mesh-list
65420103|NCT00488592|Sargramostim|sargramostim|mesh-list
65420104|NCT00488592|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65420105|NCT00488592|Immunologic Factors|immunologic factors|mesh-ancestor
65420106|NCT00488592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420109|NCT00488514|Naproxen|naproxen|mesh-list
65420161|NCT03984526|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65420162|NCT03984526|Cholinergic Agents|cholinergic agents|mesh-ancestor
65420163|NCT03984526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65420164|NCT03984526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420165|NCT03984526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65420166|NCT03984526|Sympathomimetics|sympathomimetics|mesh-ancestor
65420167|NCT03984526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65420168|NCT03984526|Adrenergic Agents|adrenergic agents|mesh-ancestor
65420169|NCT01017666|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
65420170|NCT01017666|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
65420223|NCT00303628|Growth Substances|growth substances|mesh-ancestor
65420224|NCT00303628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420225|NCT00303628|Growth Inhibitors|growth inhibitors|mesh-ancestor
65420226|NCT00303628|Immunologic Factors|immunologic factors|mesh-ancestor
65420227|NCT00303628|Antimetabolites|antimetabolites|mesh-ancestor
65420228|NCT00303628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420229|NCT00303628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65420292|NCT00474786|Sorafenib|sorafenib|mesh-list
65420293|NCT00474786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420294|NCT00474786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65420295|NCT00474786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420296|NCT00474786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420297|NCT00474786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65420298|NCT00474786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65420299|NCT00474786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65420300|NCT00474786|Antifungal Agents|antifungal agents|mesh-ancestor
65420301|NCT00474786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65420302|NCT00474786|Immunologic Factors|immunologic factors|mesh-ancestor
65420303|NCT00474786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420304|NCT00392769|Cetuximab|cetuximab|mesh-list
65420305|NCT00392769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65420306|NCT00392769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420307|NCT01041183|Ramosetron|ramosetron|mesh-list
65420308|NCT01041183|Antiemetics|antiemetics|mesh-ancestor
65420309|NCT01041183|Autonomic Agents|autonomic agents|mesh-ancestor
65420310|NCT01041183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65420317|NCT00319696|Bosentan|bosentan|mesh-list
65420347|NCT00392379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420348|NCT00392379|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65420349|NCT00392379|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65420350|NCT00392379|Cholinergic Agents|cholinergic agents|mesh-ancestor
65420351|NCT00392379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65420352|NCT00392379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420353|NCT01038063|Lumefantrine|lumefantrine|mesh-list
65420354|NCT01038063|Artemether|artemether|mesh-list
65420415|NCT01014104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65420416|NCT01014104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420417|NCT01014104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65420418|NCT01014104|Glucocorticoids|glucocorticoids|mesh-ancestor
65420419|NCT01014104|Hormones|hormones|mesh-ancestor
65420420|NCT01014104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65420421|NCT01014104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65420482|NCT01014416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420483|NCT01014416|Natriuretic Agents|natriuretic agents|mesh-ancestor
65420484|NCT01014416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420485|NCT00497796|Ganciclovir|ganciclovir|mesh-list
65420486|NCT00497796|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65420487|NCT00497796|Maribavir|maribavir|mesh-list
65420552|NCT04428372|Natriuretic Agents|natriuretic agents|mesh-ancestor
65420553|NCT04428372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420554|NCT04056624|Carotenoids|carotenoids|mesh-list
65420555|NCT04056624|Antioxidants|antioxidants|mesh-ancestor
65420556|NCT04056624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420557|NCT04056624|Protective Agents|protective agents|mesh-ancestor
65420558|NCT04056624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420559|NCT01014858|Donepezil|donepezil|mesh-list
65420560|NCT01014858|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65420561|NCT01014858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420562|NCT01014858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420563|NCT01014858|Cholinergic Agents|cholinergic agents|mesh-ancestor
65420564|NCT01014858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65420565|NCT01014858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420566|NCT01014858|Nootropic Agents|nootropic agents|mesh-ancestor
65420567|NCT00471276|Sunitinib|sunitinib|mesh-list
65420568|NCT00471276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420569|NCT00471276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65420571|NCT00471276|Growth Substances|growth substances|mesh-ancestor
65420608|NCT00496470|Respiratory System Agents|respiratory system agents|mesh-ancestor
65420609|NCT00496470|Glucocorticoids|glucocorticoids|mesh-ancestor
65420610|NCT00496470|Hormones|hormones|mesh-ancestor
65420611|NCT00496470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65420612|NCT00496470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65420613|NCT00496470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65420614|NCT00496470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65420615|NCT00496470|Adrenergic Agents|adrenergic agents|mesh-ancestor
65420616|NCT00496470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65420617|NCT00496470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420618|NCT00496470|Parasympatholytics|parasympatholytics|mesh-ancestor
65420619|NCT00496470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65420620|NCT00496470|Cholinergic Agents|cholinergic agents|mesh-ancestor
65420621|NCT00496470|Anticonvulsants|anticonvulsants|mesh-ancestor
65420622|NCT01021176|Diltiazem|diltiazem|mesh-list
65420623|NCT01021176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65420624|NCT01021176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65420662|NCT01021488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420663|NCT01021488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65420664|NCT01021488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65420665|NCT01021488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420666|NCT01021488|Anticoagulants|anticoagulants|mesh-ancestor
65420667|NCT01021488|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65420668|NCT01021488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65420669|NCT00487188|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65420670|NCT00487188|Enfuvirtide|enfuvirtide|mesh-list
65420671|NCT00487188|Antiviral Agents|antiviral agents|mesh-ancestor
65420672|NCT00487188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65420673|NCT00487188|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65420674|NCT00487188|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65420675|NCT00487188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420676|NCT00487188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65420677|NCT00509366|Gemcitabine|gemcitabine|mesh-list
65420678|NCT00509366|Cisplatin|cisplatin|mesh-list
65420679|NCT00509366|Docetaxel|docetaxel|mesh-list
65420720|NCT00499694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65420721|NCT00499694|Growth Substances|growth substances|mesh-ancestor
65420722|NCT00499694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420723|NCT00499694|Growth Inhibitors|growth inhibitors|mesh-ancestor
65420724|NCT00486954|Paclitaxel|paclitaxel|mesh-list
65420725|NCT00486954|Lapatinib|lapatinib|mesh-list
65420726|NCT00486954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65420727|NCT00486954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420728|NCT00486954|Tubulin Modulators|tubulin modulators|mesh-ancestor
65420729|NCT00486954|Antimitotic Agents|antimitotic agents|mesh-ancestor
65420730|NCT00486954|Mitosis Modulators|mitosis modulators|mesh-ancestor
65420731|NCT00486954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420732|NCT00486954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65420733|NCT00486954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420734|NCT00494676|Methamphetamine|methamphetamine|mesh-list
65420735|NCT00494676|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65420736|NCT00494676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420737|NCT00494676|Sympathomimetics|sympathomimetics|mesh-ancestor
65420738|NCT00494676|Autonomic Agents|autonomic agents|mesh-ancestor
65420739|NCT00494676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65420740|NCT00494676|Dopamine Agents|dopamine agents|mesh-ancestor
65420741|NCT00494676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65420742|NCT00494676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420743|NCT00494676|Adrenergic Agents|adrenergic agents|mesh-ancestor
65420769|NCT00486330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65420770|NCT00486330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420771|NCT00486330|Analgesics|analgesics|mesh-ancestor
65420772|NCT00486330|Sensory System Agents|sensory system agents|mesh-ancestor
65420773|NCT00486330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65420774|NCT00486330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65420775|NCT01021566|Methadone|methadone|mesh-list
65420776|NCT01021566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65420777|NCT01021566|Narcotics|narcotics|mesh-ancestor
65420834|NCT00469092|Metformin|metformin|mesh-list
65420835|NCT00469092|Insulin Glargine|insulin glargine|mesh-list
65420836|NCT00469092|Insulin Aspart|insulin aspart|mesh-list
65420837|NCT00469092|Glimepiride|glimepiride|mesh-list
65420838|NCT00469092|Biphasic Insulins|biphasic insulins|mesh-list
65420839|NCT00469092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65420840|NCT00469092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420841|NCT00469092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65420842|NCT00469092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65420843|NCT00469092|Immunologic Factors|immunologic factors|mesh-ancestor
65420844|NCT00499616|Cyclophosphamide|cyclophosphamide|mesh-list
65420901|NCT00493038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65420902|NCT00493038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65420903|NCT00493038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65420904|NCT00493038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65420905|NCT00493038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420906|NCT00493038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420907|NCT00493038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420908|NCT00493038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65420909|NCT00493038|Contraceptive Agents|contraceptive agents|mesh-ancestor
65420910|NCT00493038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65420911|NCT00493038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420912|NCT00493038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65420913|NCT00493038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65420914|NCT00493038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65420915|NCT00493038|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65420916|NCT00392223|Azithromycin|azithromycin|mesh-list
65420917|NCT00392223|Minocycline|minocycline|mesh-list
65420918|NCT00392223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65420919|NCT00392223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65420920|NCT00402285|Lycopene|lycopene|mesh-list
65420921|NCT00402285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65420922|NCT00402285|Antioxidants|antioxidants|mesh-ancestor
65420923|NCT00402285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420924|NCT00402285|Protective Agents|protective agents|mesh-ancestor
65420925|NCT00402285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420926|NCT00402285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65420927|NCT00402285|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65420928|NCT00402285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420929|NCT03747159|Belimumab|belimumab|mesh-list
65420930|NCT03747159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65420931|NCT03747159|Immunologic Factors|immunologic factors|mesh-ancestor
65420933|NCT00413283|Gemcitabine|gemcitabine|mesh-list
65420943|NCT00413283|Immunologic Factors|immunologic factors|mesh-ancestor
65420944|NCT00413283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420945|NCT00402051|Carboplatin|carboplatin|mesh-list
65420946|NCT00402051|Pemetrexed|pemetrexed|mesh-list
65420947|NCT00402051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420948|NCT00402051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65420949|NCT00402051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420950|NCT00402051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65420951|NCT00402051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65420952|NCT00401973|Metformin|metformin|mesh-list
65420953|NCT00401973|Amantadine|amantadine|mesh-list
65420954|NCT00401973|Zonisamide|zonisamide|mesh-list
65420955|NCT00401973|Olanzapine|olanzapine|mesh-list
65420956|NCT00401973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65420957|NCT00401973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65420958|NCT00401973|Antiemetics|antiemetics|mesh-ancestor
65420959|NCT00401973|Autonomic Agents|autonomic agents|mesh-ancestor
65420960|NCT00401973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65420961|NCT00401973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65420962|NCT00401973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65420963|NCT00401973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65420964|NCT00401973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65420965|NCT00401973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65420966|NCT00401973|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65420967|NCT00401973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65420968|NCT00401973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65420993|NCT00401193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65420994|NCT00401193|Hemostatics|hemostatics|mesh-ancestor
65420995|NCT00401193|Coagulants|coagulants|mesh-ancestor
65420996|NCT00400569|Sunitinib|sunitinib|mesh-list
65420997|NCT00400569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65420998|NCT00400569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65420999|NCT00400569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65421000|NCT00400569|Growth Substances|growth substances|mesh-ancestor
65421001|NCT00400569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421002|NCT00400569|Growth Inhibitors|growth inhibitors|mesh-ancestor
65421003|NCT00400569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65421004|NCT00400569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421005|NCT00400569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421006|NCT00413049|Amlodipine|amlodipine|mesh-list
65421007|NCT00413049|Valsartan|valsartan|mesh-list
65421008|NCT00413049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65421009|NCT00413049|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65421010|NCT00413049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65421011|NCT00413049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421012|NCT00413049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65421013|NCT00413049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421014|NCT00413049|Vasodilator Agents|vasodilator agents|mesh-ancestor
65421015|NCT00413049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65421016|NCT00413049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65421017|NCT03732495|Denosumab|denosumab|mesh-list
65421018|NCT03732495|Lenvatinib|lenvatinib|mesh-list
65421019|NCT03732495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421020|NCT03732495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65421038|NCT01324245|Dopamine Agents|dopamine agents|mesh-ancestor
65421039|NCT01324245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65421040|NCT01324245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421041|NCT01324245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421042|NCT01324245|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65421043|NCT01324245|Protease Inhibitors|protease inhibitors|mesh-ancestor
65421044|NCT01324245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421045|NCT00454194|Pemetrexed|pemetrexed|mesh-list
65421046|NCT00454194|Sorafenib|sorafenib|mesh-list
65421047|NCT00454194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421048|NCT00454194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421049|NCT00454194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421050|NCT00454194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65421051|NCT00454194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65421052|NCT00454194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65421053|NCT00468546|Methotrexate|methotrexate|mesh-list
65421054|NCT00468546|Rituximab|rituximab|mesh-list
65421055|NCT00468546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65421056|NCT00468546|Abortifacient Agents|abortifacient agents|mesh-ancestor
65421057|NCT00468546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65421058|NCT00468546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421059|NCT00468546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65421060|NCT00468546|Antimetabolites|antimetabolites|mesh-ancestor
64674236|NCT00552578|Buprenorphine|buprenorphine|mesh-list
64674237|NCT00552578|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64674238|NCT00552578|Naloxone|naloxone|mesh-list
64674239|NCT00552578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64674240|NCT00552578|Narcotics|narcotics|mesh-ancestor
64674241|NCT00552578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64674242|NCT00552578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674243|NCT00552578|Analgesics|analgesics|mesh-ancestor
64674244|NCT00552578|Sensory System Agents|sensory system agents|mesh-ancestor
64674245|NCT00552578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64674246|NCT00552578|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64674247|NCT02301936|Sofosbuvir|sofosbuvir|mesh-list
64674248|NCT02301936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64674249|NCT02301936|Ledipasvir|ledipasvir|mesh-list
64674251|NCT02301936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64674252|NCT03881163|Acetylcysteine|acetylcysteine|mesh-list
64674253|NCT03881163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64674254|NCT03881163|Antiviral Agents|antiviral agents|mesh-ancestor
64674255|NCT03881163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64674256|NCT03881163|Expectorants|expectorants|mesh-ancestor
64674257|NCT03881163|Respiratory System Agents|respiratory system agents|mesh-ancestor
64674258|NCT03881163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64674259|NCT03881163|Antioxidants|antioxidants|mesh-ancestor
64674260|NCT03881163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674261|NCT03881163|Protective Agents|protective agents|mesh-ancestor
64674262|NCT03881163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674263|NCT03881163|Antidotes|antidotes|mesh-ancestor
64674264|NCT02352090|Dienogest|dienogest|mesh-list
64674265|NCT02352090|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64674266|NCT02352090|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65421061|NCT00468546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421062|NCT00468546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421063|NCT00468546|Dermatologic Agents|dermatologic agents|mesh-ancestor
65421064|NCT00468546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421065|NCT00468546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65421066|NCT00468546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65421067|NCT00468546|Immunologic Factors|immunologic factors|mesh-ancestor
65421068|NCT00468546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65421069|NCT00468546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65421070|NCT00468546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65421071|NCT00303316|Vaccines|vaccines|mesh-list
65421072|NCT00303316|Immunologic Factors|immunologic factors|mesh-ancestor
65421073|NCT00303316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421074|NCT01064986|Hydrocortisone|hydrocortisone|mesh-list
65421075|NCT01064986|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65421076|NCT01064986|Epinephrine|epinephrine|mesh-list
65421077|NCT01064986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65421078|NCT01064986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65421079|NCT01064986|Adrenergic Agents|adrenergic agents|mesh-ancestor
65421080|NCT01064986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65421081|NCT01064986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421082|NCT01064986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421083|NCT01064986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65421084|NCT01064986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65421085|NCT01064986|Autonomic Agents|autonomic agents|mesh-ancestor
65421086|NCT01064986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65421087|NCT01064986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65421088|NCT01064986|Respiratory System Agents|respiratory system agents|mesh-ancestor
65421089|NCT01064986|Mydriatics|mydriatics|mesh-ancestor
65421090|NCT01064986|Sympathomimetics|sympathomimetics|mesh-ancestor
65421091|NCT01064986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65421092|NCT01064986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65421102|NCT03980002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65421103|NCT03980002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65421104|NCT03980002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65421105|NCT03980002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65421106|NCT03980002|Growth Substances|growth substances|mesh-ancestor
65421107|NCT03980002|Growth Inhibitors|growth inhibitors|mesh-ancestor
65421108|NCT03980002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421109|NCT00331864|Ranibizumab|ranibizumab|mesh-list
65421110|NCT00331864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65421111|NCT00331864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65421112|NCT00331864|Growth Substances|growth substances|mesh-ancestor
65421113|NCT00331864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421114|NCT00331864|Growth Inhibitors|growth inhibitors|mesh-ancestor
65421115|NCT00331864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170629|NCT01194245|Insulin|insulin|mesh-list
65421116|NCT00331630|Paclitaxel|paclitaxel|mesh-list
65421117|NCT00331630|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65421118|NCT00331630|Lapatinib|lapatinib|mesh-list
65421119|NCT00331630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65421120|NCT00331630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421121|NCT00331630|Tubulin Modulators|tubulin modulators|mesh-ancestor
65421122|NCT00331630|Antimitotic Agents|antimitotic agents|mesh-ancestor
65421123|NCT00331630|Mitosis Modulators|mitosis modulators|mesh-ancestor
65421124|NCT00331630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421125|NCT00331630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65421126|NCT00331630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421127|NCT00331552|Cyclophosphamide|cyclophosphamide|mesh-list
65421128|NCT00331552|Doxorubicin|doxorubicin|mesh-list
65421129|NCT00331552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65421130|NCT00331552|Trastuzumab|trastuzumab|mesh-list
65421147|NCT00331552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421148|NCT04320628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
65421149|NCT04320628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65421150|NCT00331006|Rituximab|rituximab|mesh-list
65421151|NCT00331006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65421152|NCT00331006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421153|NCT00331006|Immunologic Factors|immunologic factors|mesh-ancestor
65421154|NCT00331006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421155|NCT00331006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65421156|NCT00302458|Methylphenidate|methylphenidate|mesh-list
65421157|NCT00302458|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65421158|NCT00302458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421159|NCT00302458|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65421160|NCT00302458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65421161|NCT00302458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65421162|NCT00302458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421163|NCT00302458|Dopamine Agents|dopamine agents|mesh-ancestor
65421204|NCT00301834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65421205|NCT00301834|Glucocorticoids|glucocorticoids|mesh-ancestor
65421206|NCT00301834|Hormones|hormones|mesh-ancestor
65421207|NCT00301834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65421208|NCT00301834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65421209|NCT00301834|Protective Agents|protective agents|mesh-ancestor
65421210|NCT00301834|Alkylating Agents|alkylating agents|mesh-ancestor
65421211|NCT00301834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65421212|NCT00301834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65421213|NCT00301834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65421214|NCT00301366|Protease Inhibitors|protease inhibitors|mesh-list
65421215|NCT00301366|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65421216|NCT00301366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421217|NCT00301366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421218|NCT00301366|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65421219|NCT00301366|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65421220|NCT00466440|Prednisone|prednisone|mesh-list
65421221|NCT00466440|Docetaxel|docetaxel|mesh-list
65421222|NCT00466440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421223|NCT00466440|Tubulin Modulators|tubulin modulators|mesh-ancestor
65421224|NCT00466440|Antimitotic Agents|antimitotic agents|mesh-ancestor
65421225|NCT00466440|Mitosis Modulators|mitosis modulators|mesh-ancestor
65421226|NCT00466440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421227|NCT00466440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65421228|NCT00466440|Glucocorticoids|glucocorticoids|mesh-ancestor
65421252|NCT03926754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65421253|NCT03926754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65421254|NCT03926754|Adrenergic Agents|adrenergic agents|mesh-ancestor
65421255|NCT03926754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65421256|NCT03926754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421257|NCT03926754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421258|NCT03926754|Urological Agents|urological agents|mesh-ancestor
65421259|NCT00465894|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65421260|NCT00465894|Estradiol|estradiol|mesh-list
65421261|NCT00465894|Estrogens|estrogens|mesh-ancestor
65421262|NCT00465894|Hormones|hormones|mesh-ancestor
65421314|NCT00412893|Isavuconazole|isavuconazole|mesh-list
65421315|NCT00412893|Antifungal Agents|antifungal agents|mesh-ancestor
65421316|NCT00412893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65421317|NCT00412893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65421318|NCT00412893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65421319|NCT00412893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421320|NCT00412893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421321|NCT00412893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65421322|NCT00412893|Hormone Antagonists|hormone antagonists|mesh-ancestor
65421323|NCT00412893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65421324|NCT00412893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421325|NCT00412893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65421326|NCT00412737|Oseltamivir|oseltamivir|mesh-list
65421327|NCT00412737|Antiviral Agents|antiviral agents|mesh-ancestor
65421328|NCT00412737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65421329|NCT00412737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421330|NCT00412737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421331|NCT00508742|Vaccines|vaccines|mesh-list
65421332|NCT00508742|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65421333|NCT00508742|Immunologic Factors|immunologic factors|mesh-ancestor
65421334|NCT00508742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421335|NCT01041963|Losartan|losartan|mesh-list
65421364|NCT01042041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65421365|NCT01042041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65421366|NCT01042041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421367|NCT01042041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421368|NCT01042041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65421369|NCT01042041|Alkylating Agents|alkylating agents|mesh-ancestor
65421370|NCT01042041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65421371|NCT00499460|Oxycodone|oxycodone|mesh-list
65421372|NCT00499460|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65421373|NCT00499460|Narcotics|narcotics|mesh-ancestor
65421374|NCT00499460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65421375|NCT00499460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421376|NCT00499460|Analgesics|analgesics|mesh-ancestor
65421377|NCT00499460|Sensory System Agents|sensory system agents|mesh-ancestor
65421378|NCT00499460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65421379|NCT00412113|Calcium, Dietary|calcium, dietary|mesh-list
65421380|NCT00412113|Amlodipine|amlodipine|mesh-list
65421381|NCT00412113|Atorvastatin|atorvastatin|mesh-list
65421382|NCT00412113|Calcium|calcium|mesh-list
65421383|NCT00412113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65421384|NCT00412113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421385|NCT00412113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65421386|NCT00412113|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65421387|NCT00412113|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65421388|NCT00412113|Antimetabolites|antimetabolites|mesh-ancestor
65421389|NCT00412113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421390|NCT00412113|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65421391|NCT00412113|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65421392|NCT00412113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421393|NCT00412113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65421394|NCT00412113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65421406|NCT00411645|Antiviral Agents|antiviral agents|mesh-ancestor
65421407|NCT00411645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65421408|NCT00490724|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65421409|NCT00490724|Natriuretic Agents|natriuretic agents|mesh-ancestor
65421410|NCT00490724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421411|NCT01039155|Oxaliplatin|oxaliplatin|mesh-list
65421412|NCT01039155|Azacitidine|azacitidine|mesh-list
65421413|NCT01039155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421414|NCT01039155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65421416|NCT01039155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421417|NCT01039155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421418|NCT01039233|Bicalutamide|bicalutamide|mesh-list
65421419|NCT01039233|Androgen Antagonists|androgen antagonists|mesh-ancestor
65421420|NCT01039233|Hormone Antagonists|hormone antagonists|mesh-ancestor
65421421|NCT01039233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65421422|NCT01039233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421423|NCT01039233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421424|NCT00490646|Docetaxel|docetaxel|mesh-list
65421425|NCT00490646|Trastuzumab|trastuzumab|mesh-list
65421426|NCT00490646|Epothilones|epothilones|mesh-list
65421427|NCT00490646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421428|NCT00490646|Tubulin Modulators|tubulin modulators|mesh-ancestor
65421429|NCT00490646|Antimitotic Agents|antimitotic agents|mesh-ancestor
65421430|NCT00490646|Mitosis Modulators|mitosis modulators|mesh-ancestor
65421457|NCT01039545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421458|NCT01039545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65421459|NCT01039545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65421460|NCT01039545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65421461|NCT01039545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65421462|NCT01039545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421463|NCT01039545|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65421464|NCT01039545|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65421465|NCT00490568|Rosiglitazone|rosiglitazone|mesh-list
65421466|NCT00490568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65421467|NCT00490568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421468|NCT00561353|Ribavirin|ribavirin|mesh-list
65421469|NCT00561353|Simeprevir|simeprevir|mesh-list
65421470|NCT00561353|Antimetabolites|antimetabolites|mesh-ancestor
65421471|NCT00561353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421472|NCT00561353|Antiviral Agents|antiviral agents|mesh-ancestor
65421473|NCT00561353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65421474|NCT00561353|Protease Inhibitors|protease inhibitors|mesh-ancestor
65421475|NCT00561353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421476|NCT00859781|Ketoconazole|ketoconazole|mesh-list
65421477|NCT00859781|Hydrocortisone|hydrocortisone|mesh-list
65421478|NCT00859781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65421479|NCT00859781|Antifungal Agents|antifungal agents|mesh-ancestor
65421480|NCT00859781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65421481|NCT00859781|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65421482|NCT00859781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65421483|NCT00859781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421484|NCT00859781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421485|NCT00859781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65421486|NCT00859781|Hormone Antagonists|hormone antagonists|mesh-ancestor
65421498|NCT00944957|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65421499|NCT00944957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65421500|NCT00944957|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65421501|NCT00944957|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65421502|NCT00944957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65421503|NCT00944957|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65421565|NCT00941369|Insulin, Isophane|insulin, isophane|mesh-list
65421566|NCT00941369|Isophane Insulin, Human|isophane insulin, human|mesh-list
65421567|NCT00941369|Isophane insulin, beef|isophane insulin, beef|mesh-list
65421568|NCT00941369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65421569|NCT00941369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421570|NCT00950027|Povidone-Iodine|povidone-iodine|mesh-list
65421571|NCT00950027|Povidone|povidone|mesh-list
65421572|NCT00950027|Plasma Substitutes|plasma substitutes|mesh-ancestor
65421573|NCT00950027|Blood Substitutes|blood substitutes|mesh-ancestor
65421574|NCT00950027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65421575|NCT00950027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65421576|NCT00941525|Latanoprost|latanoprost|mesh-list
65421577|NCT00941525|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65421578|NCT00941525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65421579|NCT00456261|Gemcitabine|gemcitabine|mesh-list
65421580|NCT00456261|Bevacizumab|bevacizumab|mesh-list
65421581|NCT00456261|Carboplatin|carboplatin|mesh-list
65421582|NCT00456261|Pemetrexed|pemetrexed|mesh-list
65421583|NCT00456261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65421584|NCT00456261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421585|NCT00456261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65421586|NCT00456261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65421587|NCT00456261|Growth Substances|growth substances|mesh-ancestor
65421588|NCT00456261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421617|NCT00410163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421618|NCT00410163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65421619|NCT00410163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65421620|NCT00410163|Alkylating Agents|alkylating agents|mesh-ancestor
65421621|NCT00410163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421622|NCT00410163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421623|NCT00410163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65421624|NCT03617523|Vaccines|vaccines|mesh-list
65421625|NCT03617523|Immunologic Factors|immunologic factors|mesh-ancestor
65421626|NCT03617523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421627|NCT00409617|Adalimumab|adalimumab|mesh-list
65421628|NCT00409617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65421629|NCT00409617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65421630|NCT00300274|Cyclosporine|cyclosporine|mesh-list
65421631|NCT00300274|Mycophenolic Acid|mycophenolic acid|mesh-list
65421632|NCT00300274|Everolimus|everolimus|mesh-list
65421633|NCT00300274|Cyclosporins|cyclosporins|mesh-list
65421649|NCT01043211|Lidocaine|lidocaine|mesh-list
65421675|NCT01043445|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65421676|NCT01043445|Protective Agents|protective agents|mesh-ancestor
65421677|NCT01043445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421678|NCT00396591|Aflibercept|aflibercept|mesh-list
65421679|NCT00396591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65421680|NCT00396591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65421681|NCT00396591|Growth Substances|growth substances|mesh-ancestor
65421682|NCT00396591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421683|NCT00396591|Growth Inhibitors|growth inhibitors|mesh-ancestor
65421684|NCT00396591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421685|NCT00316264|Palivizumab|palivizumab|mesh-list
65421686|NCT00316264|Antiviral Agents|antiviral agents|mesh-ancestor
65421687|NCT00316264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65421688|NCT00385827|Prednisone|prednisone|mesh-list
65421689|NCT00385827|Mitoxantrone|mitoxantrone|mesh-list
65421690|NCT00385827|Siltuximab|siltuximab|mesh-list
65421691|NCT00385827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65421692|NCT00385827|Glucocorticoids|glucocorticoids|mesh-ancestor
65421693|NCT00385827|Hormones|hormones|mesh-ancestor
65421694|NCT00385827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65421695|NCT00385827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421696|NCT00385827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65421697|NCT00385827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421698|NCT00385827|Analgesics|analgesics|mesh-ancestor
65421699|NCT00385827|Sensory System Agents|sensory system agents|mesh-ancestor
65421726|NCT00507728|Cholinergic Agents|cholinergic agents|mesh-ancestor
65421727|NCT00498368|Rituximab|rituximab|mesh-list
65421728|NCT00498368|Angiotensin II|angiotensin ii|mesh-list
65421729|NCT00498368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65421730|NCT00498368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421731|NCT00498368|Immunologic Factors|immunologic factors|mesh-ancestor
65421732|NCT00498368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421733|NCT00498368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65421734|NCT00498368|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65421735|NCT04460066|Paclitaxel|paclitaxel|mesh-list
65421736|NCT04460066|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65421737|NCT04460066|Antibodies|antibodies|mesh-list
65421738|NCT04460066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65421739|NCT04460066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421740|NCT04460066|Tubulin Modulators|tubulin modulators|mesh-ancestor
65421741|NCT04460066|Antimitotic Agents|antimitotic agents|mesh-ancestor
65421742|NCT04460066|Mitosis Modulators|mitosis modulators|mesh-ancestor
65421743|NCT04460066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421744|NCT04460066|Immunologic Factors|immunologic factors|mesh-ancestor
65421745|NCT04460066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421746|NCT00385671|Pregabalin|pregabalin|mesh-list
65421747|NCT00385671|Gabapentin|gabapentin|mesh-list
65421748|NCT00385671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65421749|NCT00385671|Analgesics|analgesics|mesh-ancestor
65421750|NCT00385671|Sensory System Agents|sensory system agents|mesh-ancestor
65421776|NCT00496964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65421777|NCT00496964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421778|NCT00496964|Cholinergic Agents|cholinergic agents|mesh-ancestor
65421779|NCT00496964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65421780|NCT00496964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421781|NCT00496964|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65421782|NCT00496964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65421783|NCT01011062|Losartan|losartan|mesh-list
65421784|NCT01011062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65421785|NCT01011062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65421786|NCT01011062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65421787|NCT01011062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65421788|NCT01011062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421790|NCT00490490|Lugol's solution|lugol's solution|mesh-list
65421791|NCT00490490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65421792|NCT00490490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65421793|NCT00490490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65421794|NCT00490490|Trace Elements|trace elements|mesh-ancestor
65421815|NCT05176418|Nicotine|nicotine|mesh-list
65421830|NCT00385593|Autonomic Agents|autonomic agents|mesh-ancestor
65421831|NCT00385593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65421832|NCT00385593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421833|NCT00385593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65421834|NCT00385593|Respiratory System Agents|respiratory system agents|mesh-ancestor
65421835|NCT00385593|Glucocorticoids|glucocorticoids|mesh-ancestor
65421836|NCT00385593|Hormones|hormones|mesh-ancestor
65421837|NCT00385593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65421838|NCT00385593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65421839|NCT00385593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65421840|NCT00385593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65421841|NCT00385593|Adrenergic Agents|adrenergic agents|mesh-ancestor
65421842|NCT00385593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65421843|NCT00385593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421844|NCT01015040|Solifenacin Succinate|solifenacin succinate|mesh-list
65421845|NCT01015040|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65421846|NCT01015040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65421847|NCT01015040|Cholinergic Agents|cholinergic agents|mesh-ancestor
65421848|NCT01015040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65421849|NCT01015040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421852|NCT00495170|Paclitaxel|paclitaxel|mesh-list
65421881|NCT01043601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65421882|NCT01043601|Adrenergic Agents|adrenergic agents|mesh-ancestor
65421883|NCT01043601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65421884|NCT01043601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421885|NCT01043679|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65421886|NCT01043679|Antidepressive Agents|antidepressive agents|mesh-ancestor
65421887|NCT01043679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65421888|NCT01043679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65421889|NCT01043679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65421890|NCT01043679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65421891|NCT01043679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421892|NCT00408993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65421893|NCT00408993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65421894|NCT00408993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65421895|NCT00408993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65421896|NCT00408993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421897|NCT00408993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65421898|NCT00408993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421899|NCT00408993|Analgesics|analgesics|mesh-ancestor
65421900|NCT00408993|Sensory System Agents|sensory system agents|mesh-ancestor
65421901|NCT00408993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65421902|NCT00408993|Antidepressive Agents|antidepressive agents|mesh-ancestor
65421903|NCT00408993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65421904|NCT00408993|Dopamine Agents|dopamine agents|mesh-ancestor
65421905|NCT00395967|Plerixafor|plerixafor|mesh-list
65421928|NCT00560573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65421929|NCT00560573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65421930|NCT00560573|Immunologic Factors|immunologic factors|mesh-ancestor
65171450|NCT00642187|Autonomic Agents|autonomic agents|mesh-ancestor
65421931|NCT00560573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421932|NCT00560573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65421933|NCT00560573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65421935|NCT00950105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65421936|NCT00950105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65421937|NCT00950105|Analgesics|analgesics|mesh-ancestor
65421938|NCT00950105|Sensory System Agents|sensory system agents|mesh-ancestor
65421939|NCT00950105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65421940|NCT00950105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421941|NCT00950105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65421942|NCT00950105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65421943|NCT00950105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65421944|NCT00950105|Immunologic Factors|immunologic factors|mesh-ancestor
65421945|NCT00950261|Cisplatin|cisplatin|mesh-list
65421946|NCT00950261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65421947|NCT05280197|Bupivacaine|bupivacaine|mesh-list
65421948|NCT05280197|Anesthetics, Local|anesthetics, local|mesh-ancestor
65421949|NCT05280197|Anesthetics|anesthetics|mesh-ancestor
65421950|NCT05280197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65421951|NCT05280197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421952|NCT05280197|Sensory System Agents|sensory system agents|mesh-ancestor
65421953|NCT05280197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65421954|NCT00946595|Ritonavir|ritonavir|mesh-list
65421955|NCT00946595|Lopinavir|lopinavir|mesh-list
65421956|NCT00946595|Tenofovir|tenofovir|mesh-list
65421957|NCT00946595|Efavirenz|efavirenz|mesh-list
65421958|NCT00946595|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65421959|NCT00946595|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65421960|NCT00946595|Protease Inhibitors|protease inhibitors|mesh-ancestor
65421961|NCT00946595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806745|NCT03996265|Dopamine Agents|dopamine agents|mesh-ancestor
64674267|NCT02352090|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64674268|NCT02352090|Estradiol|estradiol|mesh-list
64674269|NCT02352090|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64674270|NCT02352090|Nandrolone|nandrolone|mesh-list
64674271|NCT02352090|Estrogens|estrogens|mesh-ancestor
64674272|NCT02352090|Hormones|hormones|mesh-ancestor
64674273|NCT02352090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64674274|NCT02352090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65421962|NCT00946595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65421963|NCT00946595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65421964|NCT00946595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65421965|NCT00946595|Antiviral Agents|antiviral agents|mesh-ancestor
65421966|NCT00946595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65421967|NCT00946595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65421968|NCT00946595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65421969|NCT00946595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65421970|NCT00946595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65421971|NCT00946595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65421972|NCT00946595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65421973|NCT00946595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65421974|NCT00946595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65421975|NCT00946595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65421976|NCT00494780|Prednisone|prednisone|mesh-list
65421977|NCT00494780|Prednisolone|prednisolone|mesh-list
65421978|NCT00494780|Cyclophosphamide|cyclophosphamide|mesh-list
65421979|NCT00494780|Doxorubicin|doxorubicin|mesh-list
65421980|NCT00494780|Vincristine|vincristine|mesh-list
65422013|NCT01011452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422014|NCT00490022|Dihydrotestosterone|dihydrotestosterone|mesh-list
65422015|NCT00490022|Androgens|androgens|mesh-ancestor
65422016|NCT00490022|Hormones|hormones|mesh-ancestor
65422017|NCT00490022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65422018|NCT00490022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422019|NCT01011530|Pevonedistat|pevonedistat|mesh-list
65422020|NCT01011530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422021|NCT01011530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422022|NCT00493454|Rituximab|rituximab|mesh-list
65422023|NCT00493454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65422024|NCT00493454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65422025|NCT00493454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422026|NCT00493454|Immunologic Factors|immunologic factors|mesh-ancestor
65422027|NCT00493454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422028|NCT00493454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65422029|NCT00493220|Ceftriaxone|ceftriaxone|mesh-list
65422030|NCT00493220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65422031|NCT00493220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65422032|NCT00950339|Omeprazole|omeprazole|mesh-list
65422068|NCT00489554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422069|NCT00408681|Lithium Carbonate|lithium carbonate|mesh-list
65422070|NCT00408681|Antidepressive Agents|antidepressive agents|mesh-ancestor
65422071|NCT00408681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65422072|NCT00408681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422073|NCT00408681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422074|NCT00408681|Antimanic Agents|antimanic agents|mesh-ancestor
65422075|NCT00408681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65422076|NCT00408681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65422077|NCT00408681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171605|NCT00642499|Hormones|hormones|mesh-ancestor
65422078|NCT00560417|Insulin|insulin|mesh-list
65422079|NCT00560417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65422080|NCT00560417|Insulin Glargine|insulin glargine|mesh-list
65422081|NCT00560417|Insulin Lispro|insulin lispro|mesh-list
65422082|NCT00560417|Protamines|protamines|mesh-list
65422126|NCT00942539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422127|NCT00942539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65422128|NCT00942539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65422129|NCT00942539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65422130|NCT00942539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65422131|NCT00942539|Anesthetics, General|anesthetics, general|mesh-ancestor
65422132|NCT00942539|Anesthetics|anesthetics|mesh-ancestor
65422133|NCT00942539|GABA Modulators|gaba modulators|mesh-ancestor
65422134|NCT00942539|GABA Agents|gaba agents|mesh-ancestor
65422135|NCT00942539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65422136|NCT00942539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422137|NCT00947063|Promethazine|promethazine|mesh-list
65422138|NCT00947063|Diphenhydramine|diphenhydramine|mesh-list
65422189|NCT03968159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422190|NCT00947141|Valganciclovir|valganciclovir|mesh-list
65422191|NCT00947141|Ganciclovir|ganciclovir|mesh-list
65422192|NCT00947141|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65422193|NCT00947141|Foscarnet|foscarnet|mesh-list
65422194|NCT00947141|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
65422195|NCT00947141|Antiviral Agents|antiviral agents|mesh-ancestor
65422196|NCT00947141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65422197|NCT00947141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65422198|NCT00947141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422199|NCT00947141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422200|NCT00947141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65422201|NCT03966365|Timolol|timolol|mesh-list
65422202|NCT03966365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65422203|NCT03966365|Dorzolamide|dorzolamide|mesh-list
65422204|NCT03966365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65422205|NCT03966365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65422206|NCT03966365|Adrenergic Agents|adrenergic agents|mesh-ancestor
65422207|NCT03966365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65422208|NCT03966365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422209|NCT03966365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422210|NCT03966365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65422214|NCT03966365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65422241|NCT00947375|Dopamine Agents|dopamine agents|mesh-ancestor
65422242|NCT00947375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65422243|NCT00947375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422244|NCT00947375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65422245|NCT00947375|Anticonvulsants|anticonvulsants|mesh-ancestor
65422246|NCT00947375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65422247|NCT00947375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65422248|NCT00947375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65422249|NCT00947375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65422250|NCT00947453|Montelukast|montelukast|mesh-list
65422251|NCT00947453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65422252|NCT00947453|Respiratory System Agents|respiratory system agents|mesh-ancestor
65422253|NCT00947453|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65422254|NCT00947453|Hormone Antagonists|hormone antagonists|mesh-ancestor
65422255|NCT00947453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65422256|NCT00947453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422257|NCT00947453|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65422258|NCT00947453|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65422259|NCT00947453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422260|NCT00942773|Voriconazole|voriconazole|mesh-list
65422291|NCT01045083|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65422292|NCT01045083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65422293|NCT01045083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65422294|NCT01045083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422295|NCT01045083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65422296|NCT01045083|Serotonin Agents|serotonin agents|mesh-ancestor
65422297|NCT01045083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422298|NCT01045083|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65171827|NCT02675335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422299|NCT01045083|Antidepressive Agents|antidepressive agents|mesh-ancestor
65422300|NCT01045083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65422301|NCT01045083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65422302|NCT01045083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65422303|NCT01045083|Dopamine Agents|dopamine agents|mesh-ancestor
65422304|NCT01040325|Vaccines|vaccines|mesh-list
65422305|NCT01040325|Immunologic Factors|immunologic factors|mesh-ancestor
65422306|NCT01040325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422307|NCT00947843|Aspirin|aspirin|mesh-list
65422308|NCT00947843|Clopidogrel|clopidogrel|mesh-list
65422309|NCT00947843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65422310|NCT00947843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65422311|NCT00947843|Analgesics|analgesics|mesh-ancestor
65422312|NCT00947843|Sensory System Agents|sensory system agents|mesh-ancestor
65422313|NCT00947843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65422314|NCT00947843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422315|NCT00947843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65422336|NCT00407745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65422337|NCT00407745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422338|NCT00407745|Anticonvulsants|anticonvulsants|mesh-ancestor
65422339|NCT00407745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65422340|NCT00407745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65422341|NCT00407745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422342|NCT00407745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65422343|NCT00407745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65422344|NCT00407745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65422345|NCT00407745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65422346|NCT00407745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65422347|NCT00951431|Esomeprazole|esomeprazole|mesh-list
65422348|NCT00951431|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65422349|NCT00951431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65422350|NCT00951431|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65422351|NCT00951431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422353|NCT00299494|Rituximab|rituximab|mesh-list
65422393|NCT01065220|Cyproterone Acetate|cyproterone acetate|mesh-list
65422394|NCT01065220|Testolactone|testolactone|mesh-list
65422395|NCT01065220|Lynestrenol|lynestrenol|mesh-list
65422396|NCT01065220|Estradiol|estradiol|mesh-list
65422397|NCT01065220|Cyproterone|cyproterone|mesh-list
65422398|NCT01065220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
65422399|NCT01065220|Estrogens|estrogens|mesh-ancestor
65422400|NCT01065220|Hormones|hormones|mesh-ancestor
65422401|NCT01065220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65422402|NCT01065220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422403|NCT01065220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65422404|NCT01065220|Contraceptive Agents|contraceptive agents|mesh-ancestor
65422405|NCT01065220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65422406|NCT01065220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65422407|NCT01065220|Androgen Antagonists|androgen antagonists|mesh-ancestor
65422408|NCT01065220|Hormone Antagonists|hormone antagonists|mesh-ancestor
65422409|NCT01065220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422410|NCT01065220|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65422411|NCT01065220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65422412|NCT01065220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422413|NCT01065220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422415|NCT01065220|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65422448|NCT00299182|Vincristine|vincristine|mesh-list
65422449|NCT00299182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65422450|NCT00299182|Immunologic Factors|immunologic factors|mesh-ancestor
65422451|NCT00299182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422452|NCT00299182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65422453|NCT00299182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65422454|NCT00299182|Alkylating Agents|alkylating agents|mesh-ancestor
65422455|NCT00299182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422515|NCT01065376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65422516|NCT01065376|Dopamine Agonists|dopamine agonists|mesh-ancestor
65422517|NCT01065376|Dopamine Agents|dopamine agents|mesh-ancestor
65422518|NCT01065376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65422519|NCT01065376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422520|NCT01065376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422521|NCT00944177|Metformin|metformin|mesh-list
65422522|NCT00944177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65422523|NCT00944177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422524|NCT00553475|Pregabalin|pregabalin|mesh-list
65422525|NCT00553475|Analgesics|analgesics|mesh-ancestor
65422526|NCT00553475|Sensory System Agents|sensory system agents|mesh-ancestor
65422527|NCT00553475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65422528|NCT00553475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422529|NCT00553475|Anticonvulsants|anticonvulsants|mesh-ancestor
65422530|NCT00553475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65422531|NCT00553475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65422532|NCT00553475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422533|NCT00553475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65422534|NCT00553475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65422535|NCT00553475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65422536|NCT00553475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65422537|NCT00553475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65422538|NCT00329602|Ropinirole|ropinirole|mesh-list
65422539|NCT00329602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65422540|NCT00329602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65422541|NCT00329602|Dopamine Agonists|dopamine agonists|mesh-ancestor
65422542|NCT00329602|Dopamine Agents|dopamine agents|mesh-ancestor
65422561|NCT01060696|Parasympatholytics|parasympatholytics|mesh-ancestor
65422562|NCT01060696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65422563|NCT01060696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65422564|NCT01060696|Analgesics|analgesics|mesh-ancestor
65422565|NCT01060696|Sensory System Agents|sensory system agents|mesh-ancestor
65422566|NCT01060696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65422567|NCT01060696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65422568|NCT01060696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65422569|NCT01060696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422570|NCT01065610|Oxytocin|oxytocin|mesh-list
65422571|NCT01065610|Oxytocics|oxytocics|mesh-ancestor
65422572|NCT01065610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65422573|NCT01065610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422574|NCT00463866|Budesonide|budesonide|mesh-list
65422575|NCT00463866|Formoterol Fumarate|formoterol fumarate|mesh-list
65422576|NCT00463866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65422577|NCT00463866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65422578|NCT00463866|Autonomic Agents|autonomic agents|mesh-ancestor
65422579|NCT00463866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65422580|NCT00463866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422581|NCT00463866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65422582|NCT00463866|Respiratory System Agents|respiratory system agents|mesh-ancestor
65422583|NCT00463866|Glucocorticoids|glucocorticoids|mesh-ancestor
65422584|NCT00463866|Hormones|hormones|mesh-ancestor
65422586|NCT00463866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65422613|NCT00949247|Antimitotic Agents|antimitotic agents|mesh-ancestor
65422614|NCT00949247|Mitosis Modulators|mitosis modulators|mesh-ancestor
65422615|NCT00949247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422616|NCT00551135|Pregabalin|pregabalin|mesh-list
65422617|NCT00551135|Analgesics|analgesics|mesh-ancestor
65422618|NCT00551135|Sensory System Agents|sensory system agents|mesh-ancestor
65422619|NCT00551135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65422620|NCT00551135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422621|NCT00551135|Anticonvulsants|anticonvulsants|mesh-ancestor
65422622|NCT00551135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65422623|NCT00551135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65422624|NCT00551135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422625|NCT00551135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65422626|NCT00551135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65422627|NCT00551135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65422628|NCT00551135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65422629|NCT00551135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65422630|NCT00944333|Clopidogrel|clopidogrel|mesh-list
65422631|NCT00944333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65422632|NCT00944333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65422633|NCT00944333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65422634|NCT00944333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65422635|NCT00944333|Purinergic Agents|purinergic agents|mesh-ancestor
65422636|NCT00944333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65422637|NCT00944333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422638|NCT00944333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422639|NCT00299104|Methylprednisolone|methylprednisolone|mesh-list
65422640|NCT00299104|Rituximab|rituximab|mesh-list
65422641|NCT00299104|Methotrexate|methotrexate|mesh-list
65422642|NCT00299104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65422654|NCT00299104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422655|NCT00299104|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65422656|NCT00299104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65422657|NCT00299104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65422658|NCT00299104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65422659|NCT00299104|Antiemetics|antiemetics|mesh-ancestor
65422660|NCT00299104|Autonomic Agents|autonomic agents|mesh-ancestor
65422661|NCT00299104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65422662|NCT00299104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65422663|NCT00299104|Glucocorticoids|glucocorticoids|mesh-ancestor
65422664|NCT00299104|Hormones|hormones|mesh-ancestor
65422668|NCT03979456|Rituximab|rituximab|mesh-list
65422719|NCT00489476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422720|NCT04216043|Caseins|caseins|mesh-list
65422721|NCT04216043|Chelating Agents|chelating agents|mesh-ancestor
65422722|NCT04216043|Sequestering Agents|sequestering agents|mesh-ancestor
65422723|NCT04216043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422724|NCT00957125|Bevacizumab|bevacizumab|mesh-list
65422725|NCT00957125|Docetaxel|docetaxel|mesh-list
65422726|NCT00957125|Epirubicin|epirubicin|mesh-list
65422727|NCT00957125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65422728|NCT00957125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422729|NCT00957125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65422730|NCT00957125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65422731|NCT00957125|Growth Substances|growth substances|mesh-ancestor
65422732|NCT00957125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422733|NCT00957125|Growth Inhibitors|growth inhibitors|mesh-ancestor
65422734|NCT00957125|Tubulin Modulators|tubulin modulators|mesh-ancestor
65422735|NCT00957125|Antimitotic Agents|antimitotic agents|mesh-ancestor
65422736|NCT00957125|Mitosis Modulators|mitosis modulators|mesh-ancestor
65422737|NCT00957125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422738|NCT00957125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65422739|NCT00957125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65422740|NCT00957125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65422741|NCT00957125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422742|NCT00957203|Istradefylline|istradefylline|mesh-list
65422743|NCT00957203|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
65422744|NCT00957203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65422745|NCT00957203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65422746|NCT00957203|Purinergic Agents|purinergic agents|mesh-ancestor
65422747|NCT00957203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65422748|NCT00957203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422749|NCT00957203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422750|NCT00952913|Lansoprazole|lansoprazole|mesh-list
65422751|NCT00952913|Dexlansoprazole|dexlansoprazole|mesh-list
65422752|NCT00952913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65422753|NCT00952913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65422756|NCT00952913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422757|NCT00952991|Vildagliptin|vildagliptin|mesh-list
65422758|NCT00952991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65422759|NCT00952991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422760|NCT00952991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65422761|NCT00952991|Protease Inhibitors|protease inhibitors|mesh-ancestor
65422762|NCT00952991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422763|NCT00952991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422764|NCT00953303|Dexamethasone|dexamethasone|mesh-list
65422765|NCT00953303|Dexamethasone acetate|dexamethasone acetate|mesh-list
65422767|NCT00953303|Torsemide|torsemide|mesh-list
65422768|NCT00953303|Dobutamine|dobutamine|mesh-list
65422769|NCT00953303|Dopamine|dopamine|mesh-list
65422770|NCT00953303|Furosemide|furosemide|mesh-list
65422771|NCT00953303|Nitroglycerin|nitroglycerin|mesh-list
65422772|NCT00953303|Glucocorticoids|glucocorticoids|mesh-list
65422773|NCT00953303|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65422774|NCT00953303|BB 1101|bb 1101|mesh-list
65422775|NCT00953303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65422776|NCT00953303|Antiemetics|antiemetics|mesh-ancestor
65422777|NCT00953303|Autonomic Agents|autonomic agents|mesh-ancestor
65422778|NCT00953303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65422779|NCT00953303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422780|NCT00953303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65422781|NCT00953303|Hormones|hormones|mesh-ancestor
65422782|NCT00953303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65422808|NCT05300555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65422809|NCT05300555|Protease Inhibitors|protease inhibitors|mesh-ancestor
65422810|NCT05300555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422811|NCT05300555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422812|NCT04010669|Somatostatin|somatostatin|mesh-list
65422813|NCT04010669|Hormones|hormones|mesh-ancestor
65422814|NCT04010669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65422815|NCT04010669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422816|NCT00452790|Vaccines|vaccines|mesh-list
65422817|NCT00452790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65422818|NCT00452790|Immunologic Factors|immunologic factors|mesh-ancestor
65422819|NCT00452790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422820|NCT00953381|Omeprazole|omeprazole|mesh-list
65422821|NCT00953381|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65422822|NCT00953381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65422823|NCT00953381|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65422824|NCT00953381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422825|NCT00953381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422826|NCT05300477|Acetazolamide|acetazolamide|mesh-list
65422827|NCT05300477|Epoetin Alfa|epoetin alfa|mesh-list
65422828|NCT05300477|Hematinics|hematinics|mesh-ancestor
65422829|NCT05300477|Anticonvulsants|anticonvulsants|mesh-ancestor
65422830|NCT05300477|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65422831|NCT05300477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422832|NCT05300477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422833|NCT05300477|Diuretics|diuretics|mesh-ancestor
65422834|NCT05300477|Natriuretic Agents|natriuretic agents|mesh-ancestor
65422835|NCT05300477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422836|NCT00953459|Sunitinib|sunitinib|mesh-list
65422837|NCT00953459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65422838|NCT00953459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422839|NCT00953459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65422840|NCT00953459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65422841|NCT00953459|Growth Substances|growth substances|mesh-ancestor
64807651|NCT01429545|Nifedipine|nifedipine|mesh-list
64674275|NCT02352090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64674276|NCT02352090|Contraceptive Agents|contraceptive agents|mesh-ancestor
64674277|NCT02352090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64674278|NCT02352090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64674279|NCT02352090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64674280|NCT02352090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65422842|NCT00953459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422843|NCT00953459|Growth Inhibitors|growth inhibitors|mesh-ancestor
65422844|NCT00953459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65422845|NCT00953459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422846|NCT00953459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422847|NCT00953459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65422848|NCT00953537|Capecitabine|capecitabine|mesh-list
65422849|NCT00953537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65422850|NCT00953537|Antimetabolites|antimetabolites|mesh-ancestor
65422851|NCT00953537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422852|NCT00953537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422853|NCT00463788|Cisplatin|cisplatin|mesh-list
65422854|NCT00463788|Cetuximab|cetuximab|mesh-list
65422855|NCT00463788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422856|NCT00463788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65422858|NCT00548249|Trace Elements|trace elements|mesh-ancestor
65422859|NCT00548249|Micronutrients|micronutrients|mesh-ancestor
65422860|NCT00548249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422861|NCT01025466|Memantine|memantine|mesh-list
65422862|NCT01025466|Rivastigmine|rivastigmine|mesh-list
65422863|NCT01025466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65422864|NCT01025466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65422865|NCT01025466|Dopamine Agents|dopamine agents|mesh-ancestor
65422866|NCT01025466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65422867|NCT01025466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422868|NCT01025466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422869|NCT01025466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65422870|NCT01025466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65422871|NCT01025466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65422872|NCT01025466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65422873|NCT01025466|Cholinergic Agents|cholinergic agents|mesh-ancestor
65422874|NCT01025466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65422885|NCT03839940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422886|NCT03839940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65422887|NCT03839940|Glucocorticoids|glucocorticoids|mesh-ancestor
65422888|NCT03839940|Hormones|hormones|mesh-ancestor
65422889|NCT03839940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65422890|NCT03839940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65422891|NCT03839940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65422892|NCT03839940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65422893|NCT03839940|Immunologic Factors|immunologic factors|mesh-ancestor
65422894|NCT03905928|Nicotine|nicotine|mesh-list
65422895|NCT03905928|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65422896|NCT03905928|Autonomic Agents|autonomic agents|mesh-ancestor
65422897|NCT03905928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65422898|NCT03905928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422899|NCT03905928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65422900|NCT03905928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65422901|NCT03905928|Cholinergic Agents|cholinergic agents|mesh-ancestor
65422902|NCT03905928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65422903|NCT03905928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65422904|NCT01027494|Ciprofloxacin|ciprofloxacin|mesh-list
65422905|NCT01027494|Dexamethasone|dexamethasone|mesh-list
65422906|NCT01027494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65422907|NCT01027494|Antiemetics|antiemetics|mesh-ancestor
65422908|NCT01027494|Autonomic Agents|autonomic agents|mesh-ancestor
65422909|NCT01027494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65422910|NCT01027494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422911|NCT01027494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65422912|NCT01027494|Glucocorticoids|glucocorticoids|mesh-ancestor
65422913|NCT01027494|Hormones|hormones|mesh-ancestor
65422915|NCT01027494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65422928|NCT01025700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65422929|NCT01025700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422930|NCT01025700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65422931|NCT01025700|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65422932|NCT01025700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65422933|NCT01025700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65422934|NCT01025700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65422935|NCT00462462|Ethanol|ethanol|mesh-list
65422936|NCT00462462|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65422937|NCT00462462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65422938|NCT00462462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65422939|NCT00462462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65422940|NCT00462384|Epoetin Alfa|epoetin alfa|mesh-list
65422941|NCT00462384|Hematinics|hematinics|mesh-ancestor
65422942|NCT00452400|Olodaterol|olodaterol|mesh-list
65422943|NCT00452400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65422944|NCT00452400|Autonomic Agents|autonomic agents|mesh-ancestor
65422988|NCT00443430|Methylprednisolone|methylprednisolone|mesh-list
65422989|NCT00443430|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65422990|NCT00443430|Prednisolone acetate|prednisolone acetate|mesh-list
65422991|NCT00443430|Etanercept|etanercept|mesh-list
65422992|NCT00443430|Methotrexate|methotrexate|mesh-list
65422993|NCT00443430|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65423057|NCT01025934|Growth Inhibitors|growth inhibitors|mesh-ancestor
65423058|NCT01026090|Dronedarone|dronedarone|mesh-list
65423059|NCT01026090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65423060|NCT00460746|Ritonavir|ritonavir|mesh-list
65423061|NCT00460746|Darunavir|darunavir|mesh-list
65423062|NCT00460746|Etravirine|etravirine|mesh-list
65423063|NCT00460746|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65423064|NCT00460746|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65423065|NCT00460746|Protease Inhibitors|protease inhibitors|mesh-ancestor
65423066|NCT00460746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423067|NCT00460746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423068|NCT00460746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65423069|NCT00460746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65423085|NCT00459342|Dasatinib|dasatinib|mesh-list
65423116|NCT01028508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65423117|NCT01028508|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65423118|NCT01026636|Ceftobiprole|ceftobiprole|mesh-list
65423119|NCT01026636|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
65423120|NCT01026636|Cephalosporins|cephalosporins|mesh-list
65423121|NCT01026636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65423122|NCT01026636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65423123|NCT00313300|Apixaban|apixaban|mesh-list
65423124|NCT00313300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65423125|NCT00313300|Antithrombins|antithrombins|mesh-ancestor
65423126|NCT00313300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65423127|NCT00313300|Protease Inhibitors|protease inhibitors|mesh-ancestor
65423128|NCT00313300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423129|NCT00313300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423130|NCT00313300|Anticoagulants|anticoagulants|mesh-ancestor
65423131|NCT00459186|Prednisone|prednisone|mesh-list
65423132|NCT00459186|Docetaxel|docetaxel|mesh-list
65423133|NCT00459186|Everolimus|everolimus|mesh-list
65423134|NCT00459186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423135|NCT00459186|Tubulin Modulators|tubulin modulators|mesh-ancestor
65423136|NCT00459186|Antimitotic Agents|antimitotic agents|mesh-ancestor
65423170|NCT01026714|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65423171|NCT01026714|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65423172|NCT01026714|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65423173|NCT01026714|Analgesics|analgesics|mesh-ancestor
65423174|NCT01026714|Sensory System Agents|sensory system agents|mesh-ancestor
65423175|NCT01026714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65423176|NCT01026714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65423177|NCT01026714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65423178|NCT01026714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65423179|NCT01026714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65423180|NCT01026714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65423181|NCT03996252|Calcitriol|calcitriol|mesh-list
65423182|NCT03996252|Fluorouracil|fluorouracil|mesh-list
65423183|NCT03996252|Calcipotriene|calcipotriene|mesh-list
65423184|NCT03996252|Antimetabolites|antimetabolites|mesh-ancestor
65423185|NCT03996252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423186|NCT03996252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65423187|NCT03996252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423188|NCT03996252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65423189|NCT03996252|Immunologic Factors|immunologic factors|mesh-ancestor
65423190|NCT03996252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423191|NCT03996252|Dermatologic Agents|dermatologic agents|mesh-ancestor
65423192|NCT03996252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65423193|NCT03996252|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65423194|NCT03996252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65423195|NCT03996252|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65423196|NCT03996252|Vitamins|vitamins|mesh-ancestor
65423197|NCT03996252|Micronutrients|micronutrients|mesh-ancestor
65423198|NCT03996252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65423199|NCT00313144|Protease Inhibitors|protease inhibitors|mesh-list
65423212|NCT00328198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423213|NCT00450450|Lenograstim|lenograstim|mesh-list
65423214|NCT00450450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65423215|NCT00450450|Immunologic Factors|immunologic factors|mesh-ancestor
65423216|NCT00450450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423217|NCT03440892|Sulfasalazine|sulfasalazine|mesh-list
65423218|NCT03440892|Methotrexate|methotrexate|mesh-list
65423219|NCT03440892|Abatacept|abatacept|mesh-list
65423220|NCT03440892|Tofacitinib|tofacitinib|mesh-list
65423221|NCT03440892|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65423222|NCT03440892|Abortifacient Agents|abortifacient agents|mesh-ancestor
65423226|NCT03440892|Antimetabolites|antimetabolites|mesh-ancestor
65423276|NCT00441792|Etomidate|etomidate|mesh-list
65423277|NCT00441792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65423278|NCT00441792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65423279|NCT00441792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65423280|NCT00441792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423281|NCT00441792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65423282|NCT00441792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65423283|NCT00441792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65423284|NCT00441792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65423285|NCT00441792|Anesthetics, General|anesthetics, general|mesh-ancestor
65423286|NCT00441792|Anesthetics|anesthetics|mesh-ancestor
65423287|NCT00441792|GABA Modulators|gaba modulators|mesh-ancestor
65423288|NCT00441792|GABA Agents|gaba agents|mesh-ancestor
65423289|NCT00441792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65423290|NCT00441792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423291|NCT00312208|Cyclophosphamide|cyclophosphamide|mesh-list
65423292|NCT00312208|Docetaxel|docetaxel|mesh-list
65423293|NCT00312208|Doxorubicin|doxorubicin|mesh-list
65423294|NCT00312208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65423295|NCT00312208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65423296|NCT00312208|Immunologic Factors|immunologic factors|mesh-ancestor
65423297|NCT00312208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423298|NCT00312208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65423299|NCT00312208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65423300|NCT00312208|Alkylating Agents|alkylating agents|mesh-ancestor
65423301|NCT00312208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423302|NCT00312208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423304|NCT00312208|Tubulin Modulators|tubulin modulators|mesh-ancestor
65423325|NCT00327340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423326|NCT00327340|Tubulin Modulators|tubulin modulators|mesh-ancestor
65423327|NCT00327340|Antimitotic Agents|antimitotic agents|mesh-ancestor
65423328|NCT00327340|Mitosis Modulators|mitosis modulators|mesh-ancestor
65423329|NCT00327340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423330|NCT00327340|Analgesics|analgesics|mesh-ancestor
65423331|NCT00327340|Sensory System Agents|sensory system agents|mesh-ancestor
65423332|NCT00327340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65423333|NCT00327340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423334|NCT00327340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65423335|NCT00327340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65423336|NCT00327340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423337|NCT03824704|Nivolumab|nivolumab|mesh-list
65423338|NCT03824704|Rucaparib|rucaparib|mesh-list
65423339|NCT03824704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65423340|NCT03824704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423341|NCT03824704|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65423342|NCT03824704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423343|NCT03824704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65423344|NCT03824704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423345|NCT00958139|Permethrin|permethrin|mesh-list
65423346|NCT00958139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423347|NCT00958139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423348|NCT00450216|Ibuprofen|ibuprofen|mesh-list
65423349|NCT00450216|Famotidine|famotidine|mesh-list
65423350|NCT00450216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65423351|NCT00450216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65423352|NCT00450216|Analgesics|analgesics|mesh-ancestor
65423353|NCT00450216|Sensory System Agents|sensory system agents|mesh-ancestor
65423354|NCT00450216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65423355|NCT00450216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423366|NCT00450216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65423367|NCT00953771|Danazol|danazol|mesh-list
65423368|NCT00953771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65423369|NCT00953771|Hormone Antagonists|hormone antagonists|mesh-ancestor
65423370|NCT00953771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65423371|NCT00953771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423372|NCT01566006|Mycophenolic Acid|mycophenolic acid|mesh-list
65423373|NCT01566006|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
65423374|NCT01566006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65423375|NCT01566006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423376|NCT01566006|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65423377|NCT01566006|Antitubercular Agents|antitubercular agents|mesh-ancestor
65423378|NCT01566006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65423379|NCT01566006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65423380|NCT01566006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423381|NCT01566006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423382|NCT01566006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65423383|NCT00958451|Ergocalciferols|ergocalciferols|mesh-list
65423384|NCT00958451|Vitamin D|vitamin d|mesh-list
65423385|NCT00958451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65423386|NCT00958451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423387|NCT00958451|Vitamins|vitamins|mesh-ancestor
65423388|NCT00958451|Micronutrients|micronutrients|mesh-ancestor
65423389|NCT00958451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65423416|NCT01023750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423417|NCT01023750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65423418|NCT05300009|Methotrexate|methotrexate|mesh-list
65423419|NCT05300009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65423420|NCT05300009|Abortifacient Agents|abortifacient agents|mesh-ancestor
65423421|NCT05300009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65423422|NCT05300009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423423|NCT05300009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65423424|NCT05300009|Antimetabolites|antimetabolites|mesh-ancestor
65423425|NCT05300009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423426|NCT05300009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423427|NCT05300009|Dermatologic Agents|dermatologic agents|mesh-ancestor
65423428|NCT05300009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423429|NCT05300009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65423430|NCT05300009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65423431|NCT05300009|Immunologic Factors|immunologic factors|mesh-ancestor
65423432|NCT05300009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65423433|NCT05300009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65423469|NCT00954395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423470|NCT00954395|Hemostatics|hemostatics|mesh-ancestor
65423471|NCT00954395|Coagulants|coagulants|mesh-ancestor
65423472|NCT00954395|Anticoagulants|anticoagulants|mesh-ancestor
65423473|NCT03741101|Trametinib|trametinib|mesh-list
65423474|NCT03741101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423475|NCT03741101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65423476|NCT03741101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423477|NCT03741101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423478|NCT00449670|Vaccines|vaccines|mesh-list
65423479|NCT00449670|Immunologic Factors|immunologic factors|mesh-ancestor
65423480|NCT00449670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423481|NCT04010903|Insulin|insulin|mesh-list
65423482|NCT04010903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65423483|NCT04010903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423484|NCT05299931|Ustekinumab|ustekinumab|mesh-list
65423485|NCT05299931|Dermatologic Agents|dermatologic agents|mesh-ancestor
65423486|NCT00296374|Atorvastatin|atorvastatin|mesh-list
65423487|NCT00296374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65423488|NCT00296374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65423489|NCT00296374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65423490|NCT00296374|Antimetabolites|antimetabolites|mesh-ancestor
65423491|NCT00296374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423492|NCT00296374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65423493|NCT00296374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65423494|NCT00296374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423495|NCT03387761|Nivolumab|nivolumab|mesh-list
65423496|NCT03387761|Ipilimumab|ipilimumab|mesh-list
65423497|NCT03387761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65423498|NCT03387761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423499|NCT03387761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65423500|NCT03387761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423501|NCT01060774|Lidocaine|lidocaine|mesh-list
65423502|NCT01060774|Bupivacaine|bupivacaine|mesh-list
65423503|NCT01060774|Anesthetics, Local|anesthetics, local|mesh-ancestor
65423504|NCT01060774|Anesthetics|anesthetics|mesh-ancestor
65423505|NCT01060774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65423506|NCT01060774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423507|NCT01060774|Sensory System Agents|sensory system agents|mesh-ancestor
65423508|NCT01060774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65423509|NCT01060774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65423510|NCT01060774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65423511|NCT01060774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65423512|NCT01060774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65423513|NCT01060774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423514|NCT00954785|Diclofenac|diclofenac|mesh-list
65423515|NCT00954785|Etoricoxib|etoricoxib|mesh-list
65423516|NCT00954785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65423571|NCT01062958|Hydroxocobalamin|hydroxocobalamin|mesh-list
65423572|NCT01062958|Micronutrients|micronutrients|mesh-ancestor
65423573|NCT01062958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423574|NCT01062958|Hematinics|hematinics|mesh-ancestor
65423575|NCT01062958|Vitamin B Complex|vitamin b complex|mesh-ancestor
65423576|NCT01028976|Ascorbic Acid|ascorbic acid|mesh-list
65423577|NCT01028976|Vitamins|vitamins|mesh-ancestor
65423578|NCT01028976|Micronutrients|micronutrients|mesh-ancestor
65423579|NCT01028976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423580|NCT01028976|Antioxidants|antioxidants|mesh-ancestor
65423581|NCT01028976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423582|NCT01028976|Protective Agents|protective agents|mesh-ancestor
65423583|NCT01024140|Citalopram|citalopram|mesh-list
65423584|NCT01024140|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65423585|NCT01024140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65423586|NCT01024140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65423587|NCT01024140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423588|NCT01024140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65423589|NCT01024140|Serotonin Agents|serotonin agents|mesh-ancestor
65423590|NCT01024140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423591|NCT01024140|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65423592|NCT01024140|Antidepressive Agents|antidepressive agents|mesh-ancestor
65423593|NCT01024140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65423594|NCT00457626|Valsartan|valsartan|mesh-list
65423595|NCT00457626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65423596|NCT00457626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65423599|NCT02748707|Celecoxib|celecoxib|mesh-list
65423618|NCT05014061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65423619|NCT05014061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423620|NCT05014061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65423621|NCT05014061|Vasodilator Agents|vasodilator agents|mesh-ancestor
65423622|NCT05014061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65423623|NCT05014061|Purinergic Agonists|purinergic agonists|mesh-ancestor
65423624|NCT05014061|Purinergic Agents|purinergic agents|mesh-ancestor
65423625|NCT05014061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65423626|NCT05014061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423627|NCT00373113|Capecitabine|capecitabine|mesh-list
65423628|NCT00373113|Sunitinib|sunitinib|mesh-list
65423629|NCT00373113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65423630|NCT00373113|Antimetabolites|antimetabolites|mesh-ancestor
65423631|NCT00373113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423635|NCT00373113|Growth Substances|growth substances|mesh-ancestor
65423677|NCT00384189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65423678|NCT00384189|Adrenergic Agents|adrenergic agents|mesh-ancestor
65423679|NCT00384189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65423680|NCT00384189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423681|NCT00384189|Glucocorticoids|glucocorticoids|mesh-ancestor
65423682|NCT00384189|Hormones|hormones|mesh-ancestor
65423683|NCT00384189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65423684|NCT00384189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65423685|NCT00326716|Ritonavir|ritonavir|mesh-list
65423686|NCT00326716|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65423687|NCT00326716|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
65423701|NCT01063192|Leucovorin|leucovorin|mesh-list
65423741|NCT01063426|Antimetabolites|antimetabolites|mesh-ancestor
65423742|NCT01063426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423743|NCT01063426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65423744|NCT01063426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65423745|NCT01063426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423746|NCT01063426|Anticoagulants|anticoagulants|mesh-ancestor
65423747|NCT01063426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65423748|NCT01063426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65423749|NCT00548405|Interferons|interferons|mesh-list
65423750|NCT00548405|Interferon-beta|interferon-beta|mesh-list
65423751|NCT00548405|Interferon beta-1a|interferon beta-1a|mesh-list
65423752|NCT00548405|Alemtuzumab|alemtuzumab|mesh-list
65423753|NCT00548405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423754|NCT00548405|Antiviral Agents|antiviral agents|mesh-ancestor
65423755|NCT00548405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65423756|NCT00548405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65423757|NCT00548405|Immunologic Factors|immunologic factors|mesh-ancestor
65423758|NCT00548405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423759|NCT00548405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65423760|NCT04919369|Vitamins|vitamins|mesh-list
65423761|NCT04919369|Vitamin A|vitamin a|mesh-list
65423762|NCT04919369|Atezolizumab|atezolizumab|mesh-list
65423763|NCT04919369|Tretinoin|tretinoin|mesh-list
65423764|NCT04919369|Retinol palmitate|retinol palmitate|mesh-list
65423765|NCT04919369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65423766|NCT04919369|Micronutrients|micronutrients|mesh-ancestor
65423767|NCT04919369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423768|NCT04919369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423769|NCT04919369|Immunologic Factors|immunologic factors|mesh-ancestor
65423770|NCT04919369|Keratolytic Agents|keratolytic agents|mesh-ancestor
65423771|NCT04919369|Dermatologic Agents|dermatologic agents|mesh-ancestor
65423772|NCT04919369|Antioxidants|antioxidants|mesh-ancestor
65423773|NCT04919369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423774|NCT04919369|Protective Agents|protective agents|mesh-ancestor
65423775|NCT04919369|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65423776|NCT00959075|Thiamine|thiamine|mesh-list
65423777|NCT00959075|Vitamins|vitamins|mesh-ancestor
65423783|NCT00295750|Fertility Agents|fertility agents|mesh-ancestor
65423784|NCT00295750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65423785|NCT00295750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423786|NCT00295750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65423787|NCT00295750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423788|NCT00959231|Cyclosporine|cyclosporine|mesh-list
65423789|NCT00959231|Mycophenolic Acid|mycophenolic acid|mesh-list
65423790|NCT00959231|Cyclophosphamide|cyclophosphamide|mesh-list
65423791|NCT00959231|Fludarabine|fludarabine|mesh-list
65423792|NCT00959231|Fludarabine phosphate|fludarabine phosphate|mesh-list
65423793|NCT00959231|Cyclosporins|cyclosporins|mesh-list
65423794|NCT00959231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65423795|NCT00959231|Immunologic Factors|immunologic factors|mesh-ancestor
65423796|NCT00959231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423797|NCT00959231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65423798|NCT00959231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65423799|NCT00959231|Alkylating Agents|alkylating agents|mesh-ancestor
65423800|NCT00959231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423801|NCT00959231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423802|NCT00959231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65423803|NCT00959231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65423804|NCT00959231|Antimetabolites|antimetabolites|mesh-ancestor
65423805|NCT00959231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423806|NCT00959231|Antifungal Agents|antifungal agents|mesh-ancestor
65423834|NCT00959387|Paclitaxel|paclitaxel|mesh-list
65423835|NCT00959387|Cisplatin|cisplatin|mesh-list
65423836|NCT00959387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65423837|NCT00959387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423838|NCT00959387|Tubulin Modulators|tubulin modulators|mesh-ancestor
65423839|NCT00959387|Antimitotic Agents|antimitotic agents|mesh-ancestor
65423840|NCT00959387|Mitosis Modulators|mitosis modulators|mesh-ancestor
65423841|NCT00959387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423842|NCT04718285|Favipiravir|favipiravir|mesh-list
65423843|NCT04718285|Montelukast|montelukast|mesh-list
65423844|NCT04718285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65423845|NCT04718285|Respiratory System Agents|respiratory system agents|mesh-ancestor
65423846|NCT04718285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65423847|NCT04718285|Hormone Antagonists|hormone antagonists|mesh-ancestor
65423848|NCT04718285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65423849|NCT04718285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423850|NCT04718285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65423851|NCT04718285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65423852|NCT04718285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423853|NCT04718285|Antiviral Agents|antiviral agents|mesh-ancestor
65423854|NCT04718285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65423855|NCT00959621|Aspirin|aspirin|mesh-list
65423856|NCT00959621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65423857|NCT00959621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65423858|NCT00959621|Analgesics|analgesics|mesh-ancestor
65423863|NCT00959621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65423881|NCT00960245|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65423882|NCT00960245|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65423883|NCT00960245|Adrenergic Agents|adrenergic agents|mesh-ancestor
65423884|NCT00960245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65423885|NCT00960245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423886|NCT00960245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423887|NCT00960245|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65423888|NCT00960245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65423889|NCT00960245|Sympatholytics|sympatholytics|mesh-ancestor
65423890|NCT00960245|Autonomic Agents|autonomic agents|mesh-ancestor
65423891|NCT00960245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65423892|NCT00406653|Abatacept|abatacept|mesh-list
65423893|NCT00406653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65423894|NCT00406653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423895|NCT00406653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423896|NCT00406653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65423897|NCT00406653|Immunologic Factors|immunologic factors|mesh-ancestor
65423898|NCT00406653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423899|NCT00406653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65423900|NCT00547157|Cisplatin|cisplatin|mesh-list
65423901|NCT00547157|Panitumumab|panitumumab|mesh-list
65423902|NCT00547157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423903|NCT00547157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65423904|NCT00960479|Ribavirin|ribavirin|mesh-list
65423930|NCT00960713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65423931|NCT00960713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423932|NCT00960713|Immunologic Factors|immunologic factors|mesh-ancestor
65423933|NCT00960713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423934|NCT00960713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65423935|NCT04009889|Silicon|silicon|mesh-list
65423936|NCT04009889|Trace Elements|trace elements|mesh-ancestor
65423937|NCT04009889|Micronutrients|micronutrients|mesh-ancestor
65423938|NCT04009889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423939|NCT00962507|Everolimus|everolimus|mesh-list
65423940|NCT00962507|Panobinostat|panobinostat|mesh-list
65423941|NCT00962507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423942|NCT00962507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65423943|NCT00962507|Immunologic Factors|immunologic factors|mesh-ancestor
65423944|NCT00962507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65423945|NCT00962507|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65423946|NCT00962507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173486|NCT05125146|Trazodone|trazodone|mesh-list
65423987|NCT00075387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65423988|NCT00075387|Alkylating Agents|alkylating agents|mesh-ancestor
65423989|NCT00075387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65423990|NCT00075387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65423991|NCT00075387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65423992|NCT00075387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65423993|NCT00075387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65423994|NCT00075387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65423995|NCT00075387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65423996|NCT00075387|Protective Agents|protective agents|mesh-ancestor
65423997|NCT00075387|Antioxidants|antioxidants|mesh-ancestor
65423998|NCT00075387|Antitubercular Agents|antitubercular agents|mesh-ancestor
65423999|NCT00075387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65424000|NCT00075387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65424045|NCT00963833|Interferons|interferons|mesh-list
65424046|NCT00963833|Interferon-beta|interferon-beta|mesh-list
65424047|NCT00963833|Interferon beta-1b|interferon beta-1b|mesh-list
65424048|NCT00963833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424049|NCT00963833|Antiviral Agents|antiviral agents|mesh-ancestor
65424050|NCT00963833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65424051|NCT00963833|Immunologic Factors|immunologic factors|mesh-ancestor
65424052|NCT00963833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424053|NCT00963833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65424054|NCT00967655|Capecitabine|capecitabine|mesh-list
65424055|NCT00967655|Irinotecan|irinotecan|mesh-list
65424056|NCT00967655|Panitumumab|panitumumab|mesh-list
65424057|NCT00967655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65424058|NCT00967655|Antimetabolites|antimetabolites|mesh-ancestor
65424059|NCT00967655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424060|NCT00967655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424061|NCT00967655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65424062|NCT00967655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65424063|NCT00967655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424064|NCT00967655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65424065|NCT00546377|Cyclophosphamide|cyclophosphamide|mesh-list
65424066|NCT00546377|Rituximab|rituximab|mesh-list
65424067|NCT00546377|Mitoxantrone|mitoxantrone|mesh-list
65424068|NCT00546377|Pentostatin|pentostatin|mesh-list
65424069|NCT00546377|Sargramostim|sargramostim|mesh-list
65424070|NCT00546377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65424071|NCT00546377|Immunologic Factors|immunologic factors|mesh-ancestor
65424072|NCT00546377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424073|NCT00546377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65424074|NCT00546377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65424075|NCT00546377|Alkylating Agents|alkylating agents|mesh-ancestor
65424076|NCT00546377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424090|NCT00967967|Dermatologic Agents|dermatologic agents|mesh-ancestor
65424091|NCT00967967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65424092|NCT00967967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65424093|NCT00967967|Cholinergic Agents|cholinergic agents|mesh-ancestor
65424094|NCT00967967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65424095|NCT00967967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424096|NCT00967967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424097|NCT00967967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65424098|NCT00967967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65424099|NCT00967967|Histamine Antagonists|histamine antagonists|mesh-ancestor
65424100|NCT00967967|Histamine Agents|histamine agents|mesh-ancestor
65424101|NCT00964457|Cetuximab|cetuximab|mesh-list
65424102|NCT00964457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65424150|NCT05253287|Hormones|hormones|mesh-list
65424151|NCT05253287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65424152|NCT05253287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424153|NCT00968591|Everolimus|everolimus|mesh-list
65424154|NCT00968591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424155|NCT00968591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65424156|NCT00968591|Immunologic Factors|immunologic factors|mesh-ancestor
65424157|NCT00968591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424158|NCT00968903|Methylprednisolone|methylprednisolone|mesh-list
65424159|NCT00968903|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65424160|NCT00968903|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65424161|NCT00968903|Prednisolone|prednisolone|mesh-list
65424162|NCT00968903|Prednisolone acetate|prednisolone acetate|mesh-list
65424163|NCT00968903|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65424164|NCT00968903|Prednisolone phosphate|prednisolone phosphate|mesh-list
65424165|NCT00968903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65424166|NCT00968903|Antiemetics|antiemetics|mesh-ancestor
65424167|NCT00968903|Autonomic Agents|autonomic agents|mesh-ancestor
65424168|NCT00968903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65424169|NCT00968903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424170|NCT00968903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65424171|NCT00968903|Glucocorticoids|glucocorticoids|mesh-ancestor
65424172|NCT00968903|Hormones|hormones|mesh-ancestor
65424173|NCT00968903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65424174|NCT00968903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65424175|NCT00968903|Protective Agents|protective agents|mesh-ancestor
65424176|NCT00968903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65424177|NCT00968903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424178|NCT00969137|Nicotine|nicotine|mesh-list
65424179|NCT00969137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65424180|NCT00969137|Autonomic Agents|autonomic agents|mesh-ancestor
65424181|NCT00969137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65424182|NCT00969137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424183|NCT00969137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65424184|NCT00969137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65424189|NCT00965315|Fenofibrate|fenofibrate|mesh-list
65424190|NCT00965315|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65424191|NCT00965315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65424192|NCT00965315|Antimetabolites|antimetabolites|mesh-ancestor
65424193|NCT00965315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424194|NCT00965315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65424195|NCT00965315|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65424196|NCT00965315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424197|NCT00969293|Ecallantide|ecallantide|mesh-list
65424198|NCT00969293|Analgesics|analgesics|mesh-ancestor
65424199|NCT00969293|Sensory System Agents|sensory system agents|mesh-ancestor
65424200|NCT00969293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65424201|NCT00969293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424202|NCT00969293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65424203|NCT00969293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65424204|NCT00969293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65424205|NCT00969293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65424206|NCT00969449|Naproxen|naproxen|mesh-list
65424207|NCT00969449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65424208|NCT00969449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65424209|NCT00969449|Analgesics|analgesics|mesh-ancestor
65424210|NCT00969449|Sensory System Agents|sensory system agents|mesh-ancestor
65424211|NCT00969449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65424212|NCT00969449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424213|NCT00969449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65424214|NCT00969449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65424215|NCT00969449|Gout Suppressants|gout suppressants|mesh-ancestor
65424216|NCT00969449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65424217|NCT00969449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424218|NCT00969449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424219|NCT00965393|Bradykinin|bradykinin|mesh-list
65424231|NCT00965549|Insulin glulisine|insulin glulisine|mesh-list
65424232|NCT00965549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65424233|NCT00965549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424234|NCT00966251|Pidilizumab|pidilizumab|mesh-list
65424235|NCT00966251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65424236|NCT00966251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424237|NCT00966329|Maraviroc|maraviroc|mesh-list
65424238|NCT00966329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65424239|NCT00966329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65424240|NCT00966329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424241|NCT00966329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65424242|NCT00966329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65424243|NCT00966329|Antiviral Agents|antiviral agents|mesh-ancestor
65424244|NCT00966329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65424245|NCT00966329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65424246|NCT00970697|Becaplermin|becaplermin|mesh-list
65424247|NCT00970697|Anticoagulants|anticoagulants|mesh-ancestor
65424248|NCT00970697|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
65424249|NCT00970697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65173789|NCT03809481|Danaparoid|danaparoid|mesh-list
65424250|NCT00970697|Growth Substances|growth substances|mesh-ancestor
65424251|NCT00970697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424253|NCT00967031|Lapatinib|lapatinib|mesh-list
65424254|NCT00967031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65424255|NCT00967031|Antimetabolites|antimetabolites|mesh-ancestor
65424256|NCT00967031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424257|NCT00967031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424258|NCT00967031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65424259|NCT00967031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424260|NCT00967109|Chrysarobin|chrysarobin|mesh-list
65424261|NCT00967109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65424262|NCT00967109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65424263|NCT00967109|Analgesics|analgesics|mesh-ancestor
65424264|NCT00967109|Sensory System Agents|sensory system agents|mesh-ancestor
65424265|NCT00967109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65424270|NCT00545753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424271|NCT00545753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424272|NCT00970931|Chlorthalidone|chlorthalidone|mesh-list
65424273|NCT00970931|Amiloride|amiloride|mesh-list
65424274|NCT00970931|Diuretics|diuretics|mesh-list
65424275|NCT00970931|Natriuretic Agents|natriuretic agents|mesh-ancestor
65424276|NCT00970931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424277|NCT00970931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65424278|NCT00970931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65424279|NCT00970931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65424280|NCT00970931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424281|NCT00970931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65424282|NCT00970931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65424283|NCT00970931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65424284|NCT00970931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65424285|NCT00406419|Methotrexate|methotrexate|mesh-list
65424286|NCT00406419|Ocrelizumab|ocrelizumab|mesh-list
65424287|NCT00406419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65424288|NCT00406419|Abortifacient Agents|abortifacient agents|mesh-ancestor
65424289|NCT00406419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65424290|NCT00406419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424291|NCT00406419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65424292|NCT00406419|Antimetabolites|antimetabolites|mesh-ancestor
65424293|NCT00406419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424294|NCT00406419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424295|NCT00406419|Dermatologic Agents|dermatologic agents|mesh-ancestor
65424296|NCT00406419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424297|NCT00406419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65424298|NCT00406419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65424299|NCT00406419|Immunologic Factors|immunologic factors|mesh-ancestor
65424300|NCT00406419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65424301|NCT00406419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65424302|NCT00967421|Ethanol|ethanol|mesh-list
65424303|NCT00967421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64674281|NCT02352090|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64674282|NCT02352090|Hormone Antagonists|hormone antagonists|mesh-ancestor
64714431|NCT03117140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714432|NCT03117140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65424304|NCT00967421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65424305|NCT00967421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65424306|NCT00967421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424307|NCT00971165|Losartan|losartan|mesh-list
65424308|NCT00971165|Chlorthalidone|chlorthalidone|mesh-list
65424309|NCT00971165|Amiloride|amiloride|mesh-list
65424310|NCT00971165|Diuretics|diuretics|mesh-list
65424311|NCT00971165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65424312|NCT00971165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65424313|NCT00971165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65424314|NCT00971165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65424315|NCT00971165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424368|NCT00972101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424369|NCT00972101|Immunologic Factors|immunologic factors|mesh-ancestor
65424370|NCT00972101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424371|NCT00972101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65424372|NCT00972101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65424373|NCT00972101|Antimetabolites|antimetabolites|mesh-ancestor
65424374|NCT00972101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424375|NCT00972101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65424376|NCT00972101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65424377|NCT00972101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65424378|NCT00972101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65424379|NCT00972101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65424429|NCT00383331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65424430|NCT00383331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65424431|NCT03934541|Vaccines|vaccines|mesh-list
65424432|NCT03934541|Immunologic Factors|immunologic factors|mesh-ancestor
65424433|NCT03934541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424434|NCT00325234|Gemcitabine|gemcitabine|mesh-list
65424435|NCT00325234|Carboplatin|carboplatin|mesh-list
65424436|NCT00325234|Pemetrexed|pemetrexed|mesh-list
65424437|NCT00325234|Vinorelbine|vinorelbine|mesh-list
65424438|NCT00325234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424439|NCT00325234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65424440|NCT00325234|Antimetabolites|antimetabolites|mesh-ancestor
65424441|NCT00325234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424442|NCT00325234|Antiviral Agents|antiviral agents|mesh-ancestor
65424443|NCT00325234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65424444|NCT00325234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424445|NCT00325234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65424446|NCT00325234|Immunologic Factors|immunologic factors|mesh-ancestor
65424447|NCT00325234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424448|NCT00325234|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65424449|NCT00325234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65424450|NCT00325234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65424483|NCT03978364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424484|NCT03978364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424485|NCT03978364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424486|NCT01046487|Cyclophosphamide|cyclophosphamide|mesh-list
65424487|NCT01046487|Imatinib Mesylate|imatinib mesylate|mesh-list
65424488|NCT01046487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65424489|NCT01046487|Immunologic Factors|immunologic factors|mesh-ancestor
65424490|NCT01046487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424491|NCT01046487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65424492|NCT01046487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65424493|NCT01046487|Alkylating Agents|alkylating agents|mesh-ancestor
65424494|NCT01046487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424495|NCT01046487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424496|NCT01046487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65424497|NCT01046487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65424498|NCT01046487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424499|NCT03978286|Vortioxetine|vortioxetine|mesh-list
65424500|NCT03978286|Sertraline|sertraline|mesh-list
65424501|NCT03978286|Antidepressive Agents|antidepressive agents|mesh-ancestor
65424502|NCT03978286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65424503|NCT03978286|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65424504|NCT03978286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65424505|NCT03978286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65424506|NCT03978286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424507|NCT03978286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65424508|NCT03978286|Serotonin Agents|serotonin agents|mesh-ancestor
65424509|NCT03978286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424510|NCT03978286|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65424511|NCT03978286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65424526|NCT03933449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424527|NCT03933449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65424528|NCT03933449|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65424529|NCT03933449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65424530|NCT03933449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424531|NCT00974441|Valproic Acid|valproic acid|mesh-list
65424532|NCT00974441|Anticonvulsants|anticonvulsants|mesh-ancestor
65424533|NCT00974441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424534|NCT00974441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424535|NCT00974441|GABA Agents|gaba agents|mesh-ancestor
65424536|NCT00974441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65424538|NCT00974441|Antimanic Agents|antimanic agents|mesh-ancestor
65424588|NCT00974987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424589|NCT00974987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424590|NCT00975065|Metformin|metformin|mesh-list
65424591|NCT00975065|Vildagliptin|vildagliptin|mesh-list
65424592|NCT00975065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65424593|NCT00975065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424594|NCT00975065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65424595|NCT00975065|Protease Inhibitors|protease inhibitors|mesh-ancestor
65424596|NCT00975065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424597|NCT00975065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424598|NCT00972881|Capecitabine|capecitabine|mesh-list
65424599|NCT00972881|Irinotecan|irinotecan|mesh-list
65424600|NCT00972881|Cetuximab|cetuximab|mesh-list
65424601|NCT00972881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65424602|NCT00972881|Antimetabolites|antimetabolites|mesh-ancestor
65424603|NCT00972881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424604|NCT00972881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424605|NCT00972881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65424606|NCT00972881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65424607|NCT00972881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424608|NCT00972881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65424609|NCT00290758|Genistein|genistein|mesh-list
65424610|NCT00290758|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65424611|NCT00290758|Protective Agents|protective agents|mesh-ancestor
65424612|NCT00290758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424613|NCT00290758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424614|NCT00290758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65424620|NCT00290758|Hormones|hormones|mesh-ancestor
65424634|NCT01060930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424635|NCT01060930|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65424636|NCT01060930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65424637|NCT01060930|Autonomic Agents|autonomic agents|mesh-ancestor
65424638|NCT01060930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65424639|NCT01060930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65424640|NCT01060930|Respiratory System Agents|respiratory system agents|mesh-ancestor
65424641|NCT01060930|Mydriatics|mydriatics|mesh-ancestor
65424642|NCT01060930|Sympathomimetics|sympathomimetics|mesh-ancestor
65424643|NCT01060930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65424697|NCT00975767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65424698|NCT00975767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424699|NCT00365547|Bevacizumab|bevacizumab|mesh-list
65424700|NCT00365547|Topotecan|topotecan|mesh-list
65424701|NCT00365547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65424702|NCT00365547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424703|NCT00365547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65424704|NCT00365547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65424705|NCT00365547|Growth Substances|growth substances|mesh-ancestor
65424706|NCT00365547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424707|NCT00365547|Growth Inhibitors|growth inhibitors|mesh-ancestor
65424708|NCT00365547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65424709|NCT00365547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65424710|NCT00365547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424711|NCT00365547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424712|NCT00979589|Aspirin|aspirin|mesh-list
65424713|NCT00979589|Clopidogrel|clopidogrel|mesh-list
65424714|NCT00979589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65424715|NCT00979589|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65424716|NCT00979589|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65424717|NCT00979589|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65424718|NCT00979589|Purinergic Agents|purinergic agents|mesh-ancestor
65424719|NCT00979589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65424720|NCT00979589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424721|NCT00979589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424734|NCT00294658|Prednisone|prednisone|mesh-list
65424745|NCT00979667|Antiviral Agents|antiviral agents|mesh-ancestor
65424746|NCT00979667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65424747|NCT00979667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424748|NCT00979667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424749|NCT03978052|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65424750|NCT03978052|Antioxidants|antioxidants|mesh-ancestor
65424751|NCT03978052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424812|NCT00977249|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65424813|NCT00977249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65424814|NCT00977249|Cholinergic Agents|cholinergic agents|mesh-ancestor
65424815|NCT00977249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65424816|NCT00977249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424817|NCT00977249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424818|NCT01069822|Midazolam|midazolam|mesh-list
65424819|NCT01069822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65424820|NCT01069822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65424821|NCT01069822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65424822|NCT01069822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424823|NCT01069822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65424824|NCT01069822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65424825|NCT01069822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65424826|NCT01069822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65424827|NCT01069822|Anesthetics, General|anesthetics, general|mesh-ancestor
65424828|NCT01069822|Anesthetics|anesthetics|mesh-ancestor
65424829|NCT01069822|GABA Modulators|gaba modulators|mesh-ancestor
65424830|NCT01069822|GABA Agents|gaba agents|mesh-ancestor
65424831|NCT01069822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65424832|NCT01069822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424833|NCT00364923|10-deazaaminopterin|10-deazaaminopterin|mesh-list
65424834|NCT00364923|Aminopterin|aminopterin|mesh-list
65424835|NCT00364923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65424836|NCT00364923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424837|NCT00364923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424838|NCT00364923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424839|NCT00273052|Metoprolol|metoprolol|mesh-list
65424840|NCT00273052|Carvedilol|carvedilol|mesh-list
65424841|NCT00273052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65424842|NCT00273052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65424843|NCT00273052|Sympatholytics|sympatholytics|mesh-ancestor
64809645|NCT03979365|Tacrolimus|tacrolimus|mesh-list
64714433|NCT03117140|Glucocorticoids|glucocorticoids|mesh-ancestor
64714434|NCT03117140|Hormones|hormones|mesh-ancestor
64714435|NCT03117140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64714436|NCT03117140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64714437|NCT03117140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322725|NCT02149901|Autonomic Agents|autonomic agents|mesh-ancestor
64674283|NCT02352090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64674284|NCT02352090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674285|NCT02352090|Androgens|androgens|mesh-ancestor
64674286|NCT02352090|Anabolic Agents|anabolic agents|mesh-ancestor
65424844|NCT00273052|Autonomic Agents|autonomic agents|mesh-ancestor
65424845|NCT00273052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65424846|NCT00273052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174385|NCT00629967|Interferons|interferons|mesh-list
65424847|NCT00273052|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65424848|NCT00273052|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65424849|NCT00273052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65424850|NCT00273052|Adrenergic Agents|adrenergic agents|mesh-ancestor
65424851|NCT00273052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65424852|NCT00273052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424853|NCT00273052|Antioxidants|antioxidants|mesh-ancestor
65424854|NCT00273052|Protective Agents|protective agents|mesh-ancestor
65424855|NCT00273052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65424856|NCT00273052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65424857|NCT00273052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65424858|NCT00273052|Vasodilator Agents|vasodilator agents|mesh-ancestor
65424903|NCT00272038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424904|NCT00272038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424905|NCT00271024|Naltrexone|naltrexone|mesh-list
65424906|NCT00271024|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65424907|NCT00271024|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65424908|NCT00271024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424909|NCT00271024|Sensory System Agents|sensory system agents|mesh-ancestor
65424910|NCT00271024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65424911|NCT00381693|Azacitidine|azacitidine|mesh-list
65424912|NCT00381693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65424913|NCT00381693|Antimetabolites|antimetabolites|mesh-ancestor
65424914|NCT00381693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424915|NCT00381693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65424963|NCT01029132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65424964|NCT01029132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424965|NCT01029132|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65424966|NCT01029132|Autonomic Agents|autonomic agents|mesh-ancestor
65424967|NCT01029132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65424968|NCT01029132|Nootropic Agents|nootropic agents|mesh-ancestor
65424969|NCT04008017|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
65424970|NCT04008017|Immunologic Factors|immunologic factors|mesh-ancestor
65424971|NCT04008017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65424972|NCT01049763|Oseltamivir|oseltamivir|mesh-list
65424973|NCT01049763|Antiviral Agents|antiviral agents|mesh-ancestor
65424974|NCT01049763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65424975|NCT01049763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65424976|NCT01049763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424977|NCT00981773|Maraviroc|maraviroc|mesh-list
65424978|NCT00981773|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65424979|NCT00981773|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65424980|NCT00981773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65424981|NCT00981773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65424982|NCT00981773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65424983|NCT00981773|Antiviral Agents|antiviral agents|mesh-ancestor
65424984|NCT00981773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65424985|NCT00981773|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65424986|NCT01049841|Sirolimus|sirolimus|mesh-list
65424987|NCT01049841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65424988|NCT01049841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65424989|NCT01049841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65424990|NCT01049841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425010|NCT00981851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425011|NCT00981851|Tocolytic Agents|tocolytic agents|mesh-ancestor
65425012|NCT00981851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65425013|NCT00981851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65425014|NCT00981851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65425015|NCT00981851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65425016|NCT00981851|Adrenergic Agents|adrenergic agents|mesh-ancestor
65425017|NCT00981929|Losartan|losartan|mesh-list
65425018|NCT00981929|Tramadol|tramadol|mesh-list
65425076|NCT00381303|Antiviral Agents|antiviral agents|mesh-ancestor
65425077|NCT00381303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65425078|NCT00381303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65425079|NCT00381303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65425080|NCT00364689|Rifaximin|rifaximin|mesh-list
65425081|NCT00364689|Lactulose|lactulose|mesh-list
65425082|NCT00364689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65425083|NCT00364689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65425084|NCT00364689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65425085|NCT00545129|Tanezumab|tanezumab|mesh-list
65425086|NCT00545129|Analgesics|analgesics|mesh-ancestor
65425087|NCT00545129|Sensory System Agents|sensory system agents|mesh-ancestor
65425088|NCT00545129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65425089|NCT00545129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425090|NCT00956111|Vaccines|vaccines|mesh-list
65425091|NCT00956111|Immunologic Factors|immunologic factors|mesh-ancestor
65425092|NCT00956111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425093|NCT00982631|Sirolimus|sirolimus|mesh-list
65425094|NCT00982631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65425095|NCT00982631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65425096|NCT00982631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65425097|NCT00982631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425098|NCT00982631|Antifungal Agents|antifungal agents|mesh-ancestor
65425099|NCT00982631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65425100|NCT00982631|Immunologic Factors|immunologic factors|mesh-ancestor
65425101|NCT00982631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425102|NCT00364611|Bevacizumab|bevacizumab|mesh-list
65425103|NCT00364611|Trastuzumab|trastuzumab|mesh-list
65425104|NCT00364611|Docetaxel|docetaxel|mesh-list
65425116|NCT00956189|Aripiprazole|aripiprazole|mesh-list
65425124|NCT00956189|Dopamine Agonists|dopamine agonists|mesh-ancestor
65425125|NCT00956189|Dopamine Agents|dopamine agents|mesh-ancestor
65425126|NCT00956189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65425127|NCT00956189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425193|NCT00983021|Insulin|insulin|mesh-list
65425194|NCT00983021|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65425195|NCT00983021|Liraglutide|liraglutide|mesh-list
65425196|NCT00983021|Insulin, Long-Acting|insulin, long-acting|mesh-list
65425197|NCT00983021|Xultophy|xultophy|mesh-list
65425198|NCT00983021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65425199|NCT00983021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425200|NCT00983021|Incretins|incretins|mesh-ancestor
65425201|NCT00983021|Hormones|hormones|mesh-ancestor
65425202|NCT00983021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65425203|NCT00984971|Tenofovir|tenofovir|mesh-list
65425204|NCT00984971|Antiviral Agents|antiviral agents|mesh-ancestor
65425205|NCT00984971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65425206|NCT00984971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65425207|NCT00984971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65425208|NCT00984971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425209|NCT00984971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425210|NCT00984971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65425211|NCT00984971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65425212|NCT00544817|Temozolomide|temozolomide|mesh-list
65425213|NCT00544817|Sorafenib|sorafenib|mesh-list
65425214|NCT00544817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65425215|NCT00544817|Alkylating Agents|alkylating agents|mesh-ancestor
65425246|NCT00988481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65425247|NCT00988481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425248|NCT00289900|Atorvastatin|atorvastatin|mesh-list
65425249|NCT00289900|Simvastatin|simvastatin|mesh-list
65425250|NCT00289900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65425251|NCT00289900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65425252|NCT00289900|Antimetabolites|antimetabolites|mesh-ancestor
65425253|NCT00289900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425254|NCT00289900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65425255|NCT00289900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65425256|NCT00289900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425257|NCT00543725|Efavirenz|efavirenz|mesh-list
65425258|NCT00543725|Rilpivirine|rilpivirine|mesh-list
65425259|NCT00543725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65425260|NCT00543725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65425305|NCT00988715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65425306|NCT00988715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65425307|NCT00988715|Antitubercular Agents|antitubercular agents|mesh-ancestor
65425308|NCT00988715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65425309|NCT03975166|Fluticasone|fluticasone|mesh-list
65425310|NCT03975166|Xhance|xhance|mesh-list
65425311|NCT03975166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65425312|NCT03975166|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65425313|NCT03975166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65425314|NCT03975166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65425315|NCT03975166|Autonomic Agents|autonomic agents|mesh-ancestor
65425316|NCT03975166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65425368|NCT02535039|Protective Agents|protective agents|mesh-ancestor
65425369|NCT02535039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65425370|NCT02535039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425371|NCT00363129|Vitamin E|vitamin e|mesh-list
65425372|NCT00363129|Vitamins|vitamins|mesh-ancestor
65425373|NCT00363129|Micronutrients|micronutrients|mesh-ancestor
65425374|NCT00363129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425375|NCT00363129|Antioxidants|antioxidants|mesh-ancestor
65425376|NCT00363129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425377|NCT00363129|Protective Agents|protective agents|mesh-ancestor
65425378|NCT00379587|Rituximab|rituximab|mesh-list
65425379|NCT00379587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65425380|NCT00379587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425432|NCT00378573|Antimitotic Agents|antimitotic agents|mesh-ancestor
65425433|NCT00378573|Mitosis Modulators|mitosis modulators|mesh-ancestor
65425434|NCT02346747|Immunologic Factors|immunologic factors|mesh-list
65425435|NCT02346747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425436|NCT01047891|Sorafenib|sorafenib|mesh-list
65425437|NCT01047891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425438|NCT01047891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65425439|NCT01047891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425441|NCT02534571|Epinephrine|epinephrine|mesh-list
65425500|NCT03975010|Analgesics|analgesics|mesh-ancestor
65425501|NCT03975010|Sensory System Agents|sensory system agents|mesh-ancestor
65425502|NCT03975010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65425503|NCT03975010|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65425504|NCT03975010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65425505|NCT01016990|Valproic Acid|valproic acid|mesh-list
65425506|NCT01016990|Anticonvulsants|anticonvulsants|mesh-ancestor
65425507|NCT01016990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425508|NCT01016990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425509|NCT01016990|GABA Agents|gaba agents|mesh-ancestor
65425510|NCT01016990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65425511|NCT01016990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425512|NCT01016990|Antimanic Agents|antimanic agents|mesh-ancestor
65425513|NCT01016990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65425514|NCT01016990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65425515|NCT01016990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65425516|NCT01048047|Amlodipine|amlodipine|mesh-list
65425517|NCT01048047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65425518|NCT01048047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65425519|NCT01048047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65425520|NCT01048047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175053|NCT03969901|Relebactam|relebactam|mesh-list
65425521|NCT01048047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65425522|NCT01048047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425549|NCT01029288|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65425550|NCT01029288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425551|NCT01029444|Insulin Aspart|insulin aspart|mesh-list
65425552|NCT01029444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65425553|NCT01029444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425554|NCT01029522|Atorvastatin|atorvastatin|mesh-list
65425555|NCT01029522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65425556|NCT01029522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65425557|NCT01029522|Antimetabolites|antimetabolites|mesh-ancestor
65425558|NCT01029522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425559|NCT01029522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65425560|NCT01029522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65425561|NCT01029522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425562|NCT00447876|Botulinum Toxins|botulinum toxins|mesh-list
65425563|NCT00447876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65425564|NCT00447876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65425565|NCT00447876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65425566|NCT00447876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65425567|NCT00447876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425568|NCT00447876|Cholinergic Agents|cholinergic agents|mesh-ancestor
65425569|NCT00447876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65425570|NCT00447876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425571|NCT00447876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65425572|NCT00447876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65425573|NCT03654066|Botulinum Toxins|botulinum toxins|mesh-list
65425574|NCT03654066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65425575|NCT03654066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65425576|NCT03654066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65425577|NCT03654066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65425578|NCT03654066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425579|NCT03654066|Cholinergic Agents|cholinergic agents|mesh-ancestor
65425580|NCT03654066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65425584|NCT01565772|Etoposide|etoposide|mesh-list
65425588|NCT01565772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65425589|NCT01565772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425590|NCT01565772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425591|NCT00456300|Exenatide|exenatide|mesh-list
65425592|NCT00456300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65425593|NCT00456300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425594|NCT00456300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65425595|NCT00456300|Incretins|incretins|mesh-ancestor
65175125|NCT04747912|Dexamethasone|dexamethasone|mesh-list
65425596|NCT00456300|Hormones|hormones|mesh-ancestor
65425597|NCT00456300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65425598|NCT00267748|Sunitinib|sunitinib|mesh-list
65425599|NCT00267748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425600|NCT00267748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65425601|NCT00267748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65425602|NCT00267748|Growth Substances|growth substances|mesh-ancestor
65425603|NCT00267748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425604|NCT00267748|Growth Inhibitors|growth inhibitors|mesh-ancestor
65425605|NCT00267748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65425606|NCT00267748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425607|NCT00267748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425608|NCT00267202|Omalizumab|omalizumab|mesh-list
65425609|NCT00267202|Immunologic Factors|immunologic factors|mesh-list
65425610|NCT00267202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425611|NCT00267202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65425612|NCT00267202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65425613|NCT00267202|Respiratory System Agents|respiratory system agents|mesh-ancestor
65425614|NCT01067638|Tranexamic Acid|tranexamic acid|mesh-list
65425615|NCT01067638|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65425618|NCT01067638|Hemostatics|hemostatics|mesh-ancestor
65425632|NCT00267046|Antimitotic Agents|antimitotic agents|mesh-ancestor
65425633|NCT00267046|Mitosis Modulators|mitosis modulators|mesh-ancestor
65425634|NCT00267046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65425635|NCT00267046|Alkylating Agents|alkylating agents|mesh-ancestor
65425636|NCT01029678|Vinorelbine|vinorelbine|mesh-list
65425637|NCT01029678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425638|NCT01029678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65425639|NCT01029678|Tubulin Modulators|tubulin modulators|mesh-ancestor
65425640|NCT01029678|Antimitotic Agents|antimitotic agents|mesh-ancestor
65425641|NCT01029678|Mitosis Modulators|mitosis modulators|mesh-ancestor
65425642|NCT01029678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425643|NCT00286468|Alogliptin|alogliptin|mesh-list
65425644|NCT00286468|Glyburide|glyburide|mesh-list
65425645|NCT00286468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65425646|NCT00286468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425647|NCT00286468|Incretins|incretins|mesh-ancestor
65425648|NCT00286468|Hormones|hormones|mesh-ancestor
65425649|NCT00286468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65425650|NCT00286468|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65425651|NCT00286468|Protease Inhibitors|protease inhibitors|mesh-ancestor
65425652|NCT00286468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425653|NCT00286468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425654|NCT00507026|Diclofenac|diclofenac|mesh-list
65425655|NCT00507026|Ketorolac|ketorolac|mesh-list
65425656|NCT00507026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65425657|NCT00507026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65425658|NCT00507026|Analgesics|analgesics|mesh-ancestor
65425659|NCT00507026|Sensory System Agents|sensory system agents|mesh-ancestor
65425660|NCT00507026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65425661|NCT00507026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425662|NCT00507026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65425663|NCT00507026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65425664|NCT00507026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65425665|NCT00507026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425671|NCT01019174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425672|NCT01019174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65425673|NCT01019174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65425686|NCT01011920|Rituximab|rituximab|mesh-list
65425743|NCT00286234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425744|NCT01019408|Chloroquine|chloroquine|mesh-list
65175279|NCT00910897|Hormones|hormones|mesh-ancestor
65425745|NCT01019408|Amebicides|amebicides|mesh-ancestor
65425746|NCT01019408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65425747|NCT01019408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65425748|NCT01019408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65425749|NCT01019408|Antimalarials|antimalarials|mesh-ancestor
65425750|NCT01019408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65425752|NCT01067950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65425753|NCT00445848|Bevacizumab|bevacizumab|mesh-list
65425754|NCT00445848|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65425755|NCT00445848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65425756|NCT00445848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425757|NCT00445848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65425758|NCT00445848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65425759|NCT00445848|Growth Substances|growth substances|mesh-ancestor
65425760|NCT00445848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425761|NCT00445848|Growth Inhibitors|growth inhibitors|mesh-ancestor
65425800|NCT00293020|Analgesics|analgesics|mesh-ancestor
65425801|NCT00293020|Sensory System Agents|sensory system agents|mesh-ancestor
65425802|NCT00293020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65425803|NCT00293020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65425804|NCT00293020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65425805|NCT00293020|Anesthetics, General|anesthetics, general|mesh-ancestor
65425806|NCT00293020|Anesthetics|anesthetics|mesh-ancestor
65425807|NCT00377637|Mycophenolic Acid|mycophenolic acid|mesh-list
65425808|NCT00377637|Cyclophosphamide|cyclophosphamide|mesh-list
65425809|NCT00377637|Azathioprine|azathioprine|mesh-list
65425810|NCT00377637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65425811|NCT00377637|Immunologic Factors|immunologic factors|mesh-ancestor
65425812|NCT00377637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425813|NCT00377637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65425814|NCT00377637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65425815|NCT00377637|Alkylating Agents|alkylating agents|mesh-ancestor
65425816|NCT00377637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425817|NCT00377637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425818|NCT00377637|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65425819|NCT00377637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65425820|NCT00377637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65425821|NCT00377637|Antitubercular Agents|antitubercular agents|mesh-ancestor
65425822|NCT00377637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65425823|NCT00377637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65425824|NCT00377637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425850|NCT00377403|Autonomic Agents|autonomic agents|mesh-ancestor
65425851|NCT00377403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65425852|NCT00377403|Nasal Decongestants|nasal decongestants|mesh-ancestor
65425853|NCT00377403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65425854|NCT00377403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65425855|NCT00377403|Sympathomimetics|sympathomimetics|mesh-ancestor
65425856|NCT00377403|Adrenergic Agents|adrenergic agents|mesh-ancestor
65425857|NCT00377403|Expectorants|expectorants|mesh-ancestor
65425858|NCT00377403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65425859|NCT00377403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65425860|NCT00377403|Appetite Depressants|appetite depressants|mesh-ancestor
65425861|NCT00377403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65425862|NCT00370149|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65425863|NCT00370149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65425915|NCT03991845|Levocetirizine|levocetirizine|mesh-list
65425916|NCT03991845|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65425917|NCT03991845|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65425918|NCT03991845|Histamine Antagonists|histamine antagonists|mesh-ancestor
65425919|NCT03991845|Histamine Agents|histamine agents|mesh-ancestor
65425920|NCT03991845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65425921|NCT03991845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425922|NCT03991845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425923|NCT01017380|Celecoxib|celecoxib|mesh-list
65425924|NCT01017380|Etoricoxib|etoricoxib|mesh-list
65425925|NCT01017380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65425926|NCT01017380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65425927|NCT01017380|Analgesics|analgesics|mesh-ancestor
65425928|NCT01017380|Sensory System Agents|sensory system agents|mesh-ancestor
65425929|NCT01017380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65425930|NCT01017380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65425931|NCT01017380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65425932|NCT01017380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65425933|NCT01017380|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65425934|NCT01017380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65425935|NCT01017380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65425936|NCT01017380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425937|NCT00369681|Rituximab|rituximab|mesh-list
65425938|NCT00369681|Doxorubicin|doxorubicin|mesh-list
65425939|NCT00369681|Dacarbazine|dacarbazine|mesh-list
65425940|NCT00369681|Bleomycin|bleomycin|mesh-list
65425941|NCT00369681|Vinblastine|vinblastine|mesh-list
65425942|NCT00369681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65425943|NCT00369681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425944|NCT00369681|Immunologic Factors|immunologic factors|mesh-ancestor
65425959|NCT00266812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65425960|NCT00266812|Alkylating Agents|alkylating agents|mesh-ancestor
65425961|NCT00266812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425962|NCT00266812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65425963|NCT04249544|Pramipexole|pramipexole|mesh-list
65425964|NCT04249544|Antioxidants|antioxidants|mesh-ancestor
65425965|NCT04249544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65425966|NCT04249544|Protective Agents|protective agents|mesh-ancestor
65425967|NCT04249544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426026|NCT01019642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65426027|NCT01019642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426028|NCT01019642|Vitamins|vitamins|mesh-ancestor
65426029|NCT01019642|Micronutrients|micronutrients|mesh-ancestor
65426030|NCT01019642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65426031|NCT00266656|Hormones|hormones|mesh-list
65426032|NCT00266656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65426033|NCT00266656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426034|NCT00483548|Ziprasidone|ziprasidone|mesh-list
65426035|NCT00483548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65426036|NCT00483548|Serotonin Agents|serotonin agents|mesh-ancestor
65426037|NCT00483548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65426038|NCT00483548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426039|NCT00483548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426040|NCT00483548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65426041|NCT00483548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65426042|NCT00483548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65426043|NCT00483548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65426044|NCT00483548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65426045|NCT00483548|Dopamine Agents|dopamine agents|mesh-ancestor
65426046|NCT00445770|Etanercept|etanercept|mesh-list
65426047|NCT00445770|Methotrexate|methotrexate|mesh-list
65426048|NCT00445770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65426049|NCT00445770|Abortifacient Agents|abortifacient agents|mesh-ancestor
65426065|NCT00445770|Analgesics|analgesics|mesh-ancestor
65426075|NCT00266032|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65426076|NCT00266032|Diuretics|diuretics|mesh-ancestor
65426077|NCT00266032|Natriuretic Agents|natriuretic agents|mesh-ancestor
65426078|NCT01019798|Docetaxel|docetaxel|mesh-list
65426079|NCT01019798|Sunitinib|sunitinib|mesh-list
65426080|NCT01019798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426081|NCT01019798|Tubulin Modulators|tubulin modulators|mesh-ancestor
65426082|NCT01019798|Antimitotic Agents|antimitotic agents|mesh-ancestor
65426083|NCT01019798|Mitosis Modulators|mitosis modulators|mesh-ancestor
65426084|NCT01019798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426085|NCT01019798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65426086|NCT01019798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65426087|NCT01019798|Growth Substances|growth substances|mesh-ancestor
65426088|NCT01019798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426089|NCT01019798|Growth Inhibitors|growth inhibitors|mesh-ancestor
65426090|NCT01019798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65426091|NCT01019798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426092|NCT00483002|Varenicline|varenicline|mesh-list
65426093|NCT00483002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65426094|NCT00483002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65426095|NCT00483002|Cholinergic Agents|cholinergic agents|mesh-ancestor
65426096|NCT00483002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65426097|NCT00483002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426098|NCT00483002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426099|NCT00482612|Mirtazapine|mirtazapine|mesh-list
65426100|NCT00482612|Antidepressive Agents|antidepressive agents|mesh-ancestor
65426101|NCT00482612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65426122|NCT00282568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426123|NCT00282568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65426124|NCT00282568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426125|NCT00282568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426126|NCT02532322|Acetaminophen|acetaminophen|mesh-list
65426127|NCT02532322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65426128|NCT02532322|Analgesics|analgesics|mesh-ancestor
65426129|NCT02532322|Sensory System Agents|sensory system agents|mesh-ancestor
65426130|NCT02532322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65426131|NCT02532322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426132|NCT02532322|Antipyretics|antipyretics|mesh-ancestor
65426133|NCT00445692|Clarithromycin|clarithromycin|mesh-list
65426134|NCT00445692|Dexamethasone|dexamethasone|mesh-list
65426135|NCT00445692|Dexamethasone acetate|dexamethasone acetate|mesh-list
65426136|NCT00445692|Lenalidomide|lenalidomide|mesh-list
65426137|NCT00445692|Ichthammol|ichthammol|mesh-list
65426138|NCT00445692|BB 1101|bb 1101|mesh-list
65426139|NCT00445692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65426140|NCT00445692|Antiemetics|antiemetics|mesh-ancestor
65426141|NCT00445692|Autonomic Agents|autonomic agents|mesh-ancestor
65426142|NCT00445692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65426178|NCT00282412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65426179|NCT00282412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426180|NCT00282412|Antifungal Agents|antifungal agents|mesh-ancestor
65426181|NCT00282412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65426182|NCT00282412|Dermatologic Agents|dermatologic agents|mesh-ancestor
65426183|NCT00282412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65426184|NCT00282412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65426185|NCT00282412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65426186|NCT00282412|Antitubercular Agents|antitubercular agents|mesh-ancestor
65426187|NCT00282412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65426188|NCT00282412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65426242|NCT00543569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65426243|NCT00543569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65426244|NCT00543569|Dermatologic Agents|dermatologic agents|mesh-ancestor
65426245|NCT00984347|Oxytocin|oxytocin|mesh-list
65426246|NCT00984347|Oxytocics|oxytocics|mesh-ancestor
65426316|NCT00265096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65426317|NCT00265096|Immunologic Factors|immunologic factors|mesh-ancestor
65426318|NCT00265096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426319|NCT02201108|Teriflunomide|teriflunomide|mesh-list
65426320|NCT02201108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65426321|NCT02201108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65426322|NCT02201108|Analgesics|analgesics|mesh-ancestor
65426323|NCT02201108|Sensory System Agents|sensory system agents|mesh-ancestor
65426324|NCT02201108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65426325|NCT02201108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426326|NCT02201108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65426327|NCT02201108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65426328|NCT02201108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65426329|NCT02201108|Immunologic Factors|immunologic factors|mesh-ancestor
65426330|NCT00986609|Poly I-C|poly i-c|mesh-list
65426331|NCT00986609|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65426332|NCT00986609|Vaccines|vaccines|mesh-list
65426333|NCT00986609|Poly ICLC|poly iclc|mesh-list
65426334|NCT00986609|Immunologic Factors|immunologic factors|mesh-ancestor
65426335|NCT00986609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426374|NCT01012232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65426375|NCT01012232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426376|NCT01012232|Sensory System Agents|sensory system agents|mesh-ancestor
65426377|NCT01012232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65426378|NCT00541229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65426379|NCT00541229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65426380|NCT00541229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426381|NCT00541229|Incretins|incretins|mesh-ancestor
65426382|NCT00541229|Hormones|hormones|mesh-ancestor
65426383|NCT00541229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65426384|NCT00541229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65426385|NCT00541229|Protease Inhibitors|protease inhibitors|mesh-ancestor
65426386|NCT00541229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426387|NCT00541229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426388|NCT04006691|Mitomycins|mitomycins|mesh-list
65426389|NCT04006691|Mitomycin|mitomycin|mesh-list
65426390|NCT04006691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65426429|NCT01019876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426430|NCT01019876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65426431|NCT05463419|Vaccines|vaccines|mesh-list
65426432|NCT05463419|Immunologic Factors|immunologic factors|mesh-ancestor
65426433|NCT05463419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426434|NCT01017770|Artesunate|artesunate|mesh-list
65426435|NCT01017770|Lumefantrine|lumefantrine|mesh-list
65426436|NCT01017770|Artemether|artemether|mesh-list
65426437|NCT01017770|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65426438|NCT01017770|Amodiaquine|amodiaquine|mesh-list
65426439|NCT01017770|Antimalarials|antimalarials|mesh-ancestor
65426440|NCT01017770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65426496|NCT00481832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65426497|NCT00481832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65426498|NCT00481832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65426499|NCT00481832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65426500|NCT00481832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426501|NCT00481832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65426502|NCT00481832|Antifungal Agents|antifungal agents|mesh-ancestor
65176030|NCT00909532|Ivacaftor|ivacaftor|mesh-list
65426503|NCT00481832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65426504|NCT00481832|Dermatologic Agents|dermatologic agents|mesh-ancestor
65426505|NCT00481832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65426558|NCT04377503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65426559|NCT04377503|Antiemetics|antiemetics|mesh-ancestor
65426560|NCT04377503|Autonomic Agents|autonomic agents|mesh-ancestor
65426561|NCT04377503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65426562|NCT04377503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426563|NCT04377503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65426564|NCT04377503|Glucocorticoids|glucocorticoids|mesh-ancestor
65426565|NCT04377503|Hormones|hormones|mesh-ancestor
65426566|NCT04377503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65426567|NCT04377503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65426568|NCT04377503|Protective Agents|protective agents|mesh-ancestor
65426569|NCT04377503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65426570|NCT04377503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426571|NCT00542789|Esomeprazole|esomeprazole|mesh-list
65426572|NCT00542789|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65426573|NCT00542789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65426574|NCT00542789|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65426575|NCT00542789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426576|NCT00542789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426577|NCT00464672|Vaccines|vaccines|mesh-list
65426578|NCT00464672|Immunologic Factors|immunologic factors|mesh-ancestor
65426579|NCT00464672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426610|NCT00473876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426611|NCT00463580|Infliximab|infliximab|mesh-list
65426612|NCT00463580|Dermatologic Agents|dermatologic agents|mesh-ancestor
65426613|NCT00463580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65426614|NCT00463580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65426615|NCT01020734|Cyclosporine|cyclosporine|mesh-list
65426616|NCT01020734|Cyclophosphamide|cyclophosphamide|mesh-list
65426617|NCT01020734|Busulfan|busulfan|mesh-list
65426618|NCT01020734|Methotrexate|methotrexate|mesh-list
65426619|NCT01020734|Fludarabine|fludarabine|mesh-list
65426677|NCT04891289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426678|NCT04891289|Antiviral Agents|antiviral agents|mesh-ancestor
65426679|NCT04891289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65426680|NCT04891289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426681|NCT04891289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65426682|NCT04891289|Immunologic Factors|immunologic factors|mesh-ancestor
65426683|NCT03911843|Vitamin D|vitamin d|mesh-list
65426684|NCT03911843|Vitamins|vitamins|mesh-ancestor
65426685|NCT03911843|Micronutrients|micronutrients|mesh-ancestor
65426686|NCT03911843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426687|NCT03911843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65426688|NCT00361335|Golimumab|golimumab|mesh-list
65426689|NCT00361335|Methotrexate|methotrexate|mesh-list
65426690|NCT00361335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65426691|NCT00361335|Abortifacient Agents|abortifacient agents|mesh-ancestor
65426692|NCT00361335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65426693|NCT00361335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426694|NCT00361335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65426733|NCT04004507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65426734|NCT04004507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426735|NCT04004507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426736|NCT04004507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65426737|NCT01070290|Capecitabine|capecitabine|mesh-list
65426738|NCT01070290|Oxaliplatin|oxaliplatin|mesh-list
65426739|NCT01070290|Irinotecan|irinotecan|mesh-list
65426740|NCT01070290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65426741|NCT01070290|Antimetabolites|antimetabolites|mesh-ancestor
65426743|NCT01070290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426798|NCT00368979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426799|NCT00368979|Hormone Antagonists|hormone antagonists|mesh-ancestor
65426800|NCT00368979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65426801|NCT00368979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426802|NCT00264238|Memantine|memantine|mesh-list
65426803|NCT00264238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65426804|NCT00264238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65426805|NCT00264238|Dopamine Agents|dopamine agents|mesh-ancestor
65426806|NCT00264238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65426807|NCT00264238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426808|NCT00264238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426857|NCT00368745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65426858|NCT00368745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65426859|NCT00368745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65426860|NCT00368745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65426861|NCT03235739|Naloxegol|naloxegol|mesh-list
65426862|NCT03235739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65426863|NCT03235739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426864|NCT03235739|Sensory System Agents|sensory system agents|mesh-ancestor
65426865|NCT03235739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65426866|NCT04573673|Emodin|emodin|mesh-list
65426867|NCT04573673|Cathartics|cathartics|mesh-ancestor
65426868|NCT04573673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65426869|NCT04573673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65426870|NCT04573673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426871|NCT04573673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426872|NCT01050699|Fentanyl|fentanyl|mesh-list
65426873|NCT01050699|Midazolam|midazolam|mesh-list
65426874|NCT01050699|Dexmedetomidine|dexmedetomidine|mesh-list
65426875|NCT01050699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65426876|NCT01050699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65426877|NCT01050699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426878|NCT01050699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65426879|NCT01050699|Analgesics|analgesics|mesh-ancestor
65176404|NCT05374564|Flutemetamol|flutemetamol|mesh-list
65426880|NCT01050699|Sensory System Agents|sensory system agents|mesh-ancestor
65426881|NCT01050699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65426882|NCT01050699|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65426883|NCT01050699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65426884|NCT01050699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65426885|NCT01050699|Adrenergic Agents|adrenergic agents|mesh-ancestor
65426886|NCT01050699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65426887|NCT01050699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426888|NCT01050699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65426890|NCT01050699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65426893|NCT01050699|Anesthetics|anesthetics|mesh-ancestor
65426897|NCT01050699|GABA Modulators|gaba modulators|mesh-ancestor
65426898|NCT01050699|GABA Agents|gaba agents|mesh-ancestor
65426899|NCT02408315|Misoprostol|misoprostol|mesh-list
65426900|NCT02408315|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65426901|NCT02408315|Abortifacient Agents|abortifacient agents|mesh-ancestor
65426902|NCT02408315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65426903|NCT02408315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426904|NCT02408315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65426905|NCT02408315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65426906|NCT02408315|Oxytocics|oxytocics|mesh-ancestor
65426907|NCT05711693|Bepridil|bepridil|mesh-list
65426908|NCT05711693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65426909|NCT05711693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65426910|NCT05711693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65426911|NCT05711693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65426912|NCT05711693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426913|NCT05711693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65426914|NCT05711693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426915|NCT05711693|Vasodilator Agents|vasodilator agents|mesh-ancestor
65426916|NCT04005365|Propranolol|propranolol|mesh-list
65426917|NCT04005365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65426918|NCT04005365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65426919|NCT04005365|Adrenergic Agents|adrenergic agents|mesh-ancestor
65426920|NCT04005365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65426921|NCT04005365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426922|NCT04005365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426923|NCT04005365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65426924|NCT04005365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65426925|NCT04005365|Vasodilator Agents|vasodilator agents|mesh-ancestor
65426926|NCT05711615|Doxorubicin|doxorubicin|mesh-list
65426941|NCT01027182|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65426942|NCT01027182|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65426943|NCT01027182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426944|NCT01027182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426945|NCT00358917|Ritonavir|ritonavir|mesh-list
65426946|NCT00358917|Lopinavir|lopinavir|mesh-list
65426947|NCT00358917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
65426948|NCT00358917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65426949|NCT00358917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65426950|NCT00358917|Protease Inhibitors|protease inhibitors|mesh-ancestor
65426951|NCT00358917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426952|NCT00358917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426953|NCT00358917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65176524|NCT00953667|Niacin|niacin|mesh-list
65426954|NCT00358917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65426955|NCT00358917|Antiviral Agents|antiviral agents|mesh-ancestor
65426956|NCT00358917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65426957|NCT00358917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65426958|NCT00358917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65426959|NCT00358917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65426960|NCT01048515|Caffeine|caffeine|mesh-list
65426961|NCT01048515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65426962|NCT01048515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426963|NCT01048515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65426964|NCT01048515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426965|NCT01048515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674289|NCT03848871|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64674290|NCT03848871|Betamethasone benzoate|betamethasone benzoate|mesh-list
64674292|NCT03848871|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64674293|NCT03848871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64674294|NCT03848871|Glucocorticoids|glucocorticoids|mesh-ancestor
64674299|NCT03848871|Respiratory System Agents|respiratory system agents|mesh-ancestor
64674300|NCT03848871|Dermatologic Agents|dermatologic agents|mesh-ancestor
64674301|NCT04032327|Bupivacaine|bupivacaine|mesh-list
64674302|NCT04032327|Anesthetics, Local|anesthetics, local|mesh-ancestor
64674303|NCT04032327|Anesthetics|anesthetics|mesh-ancestor
64674304|NCT04032327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64674305|NCT04032327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674306|NCT04032327|Sensory System Agents|sensory system agents|mesh-ancestor
64674307|NCT04032327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64674308|NCT04041219|Tacrolimus|tacrolimus|mesh-list
64674309|NCT04041219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64674310|NCT04041219|Immunologic Factors|immunologic factors|mesh-ancestor
64674311|NCT04041219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674312|NCT04041219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64674313|NCT04041219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426966|NCT01048515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65426967|NCT01048515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65426968|NCT01048515|Purinergic Agents|purinergic agents|mesh-ancestor
65426969|NCT01048515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65426970|NCT01050777|Paromomycin|paromomycin|mesh-list
65426971|NCT01050777|Meglumine Antimoniate|meglumine antimoniate|mesh-list
65426972|NCT01050777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65426973|NCT01050777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65426974|NCT01050777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65426975|NCT01050777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65426976|NCT00264004|Cediranib|cediranib|mesh-list
65426977|NCT00264004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426978|NCT00264004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65426979|NCT00264004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65426980|NCT00264004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426981|NCT01069198|Vitamin A|vitamin a|mesh-list
65426982|NCT01069198|Albendazole|albendazole|mesh-list
65426983|NCT01069198|Vitamins|vitamins|mesh-ancestor
65426984|NCT01069198|Micronutrients|micronutrients|mesh-ancestor
65426985|NCT01069198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65426986|NCT01069198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65426987|NCT01069198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65426988|NCT01069198|Anthelmintics|anthelmintics|mesh-ancestor
65426989|NCT01069198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65426990|NCT01069198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65426991|NCT01069198|Anticestodal Agents|anticestodal agents|mesh-ancestor
65426992|NCT01069198|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65426993|NCT01069198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65426994|NCT01069198|Tubulin Modulators|tubulin modulators|mesh-ancestor
65426995|NCT01069198|Antimitotic Agents|antimitotic agents|mesh-ancestor
65426996|NCT01069198|Mitosis Modulators|mitosis modulators|mesh-ancestor
65426997|NCT00368355|Cytarabine|cytarabine|mesh-list
65426998|NCT00368355|Cyclophosphamide|cyclophosphamide|mesh-list
65426999|NCT00368355|Alemtuzumab|alemtuzumab|mesh-list
65427000|NCT00368355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65427001|NCT00368355|Immunologic Factors|immunologic factors|mesh-ancestor
65427002|NCT00368355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811790|NCT01449344|Glucocorticoids|glucocorticoids|mesh-ancestor
64674314|NCT04041219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674315|NCT00552344|Certolizumab Pegol|certolizumab pegol|mesh-list
65427003|NCT00368355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65427004|NCT00368355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65427005|NCT00368355|Alkylating Agents|alkylating agents|mesh-ancestor
65427006|NCT00368355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427007|NCT00368355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427008|NCT00368355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65427009|NCT00368355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65427010|NCT00368355|Antimetabolites|antimetabolites|mesh-ancestor
65427011|NCT00368355|Antiviral Agents|antiviral agents|mesh-ancestor
65427012|NCT00368355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65427013|NCT00368355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65427014|NCT01070680|Dexmedetomidine|dexmedetomidine|mesh-list
65427015|NCT01070680|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65427016|NCT01070680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65427017|NCT01070680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427018|NCT01070680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65427019|NCT01070680|Analgesics|analgesics|mesh-ancestor
65427020|NCT01070680|Sensory System Agents|sensory system agents|mesh-ancestor
65427021|NCT01070680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65427022|NCT01070680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65427023|NCT01070680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65427024|NCT01070680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65427025|NCT01070680|Adrenergic Agents|adrenergic agents|mesh-ancestor
65427026|NCT01070680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65427027|NCT01070680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427028|NCT00445146|Elvitegravir|elvitegravir|mesh-list
65427029|NCT00445146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65427030|NCT00445146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65427031|NCT00445146|Antiviral Agents|antiviral agents|mesh-ancestor
65427032|NCT00445146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64674316|NCT00552344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64674317|NCT00552344|Immunologic Factors|immunologic factors|mesh-ancestor
64674318|NCT00552344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674319|NCT00552344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64674320|NCT02814968|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64674321|NCT02814968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64674322|NCT02814968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674323|NCT03879603|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64674324|NCT03879603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64674325|NCT03879603|Immunologic Factors|immunologic factors|mesh-ancestor
64674326|NCT03879603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674327|NCT03879603|Antacids|antacids|mesh-ancestor
64674328|NCT03879603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427033|NCT00445146|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65427034|NCT00445146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427035|NCT00445146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427036|NCT01581736|Insulin|insulin|mesh-list
65427037|NCT01581736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65427038|NCT01581736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65427039|NCT01581736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427040|NCT01030302|Bortezomib|bortezomib|mesh-list
65427041|NCT01030302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427042|NCT00368277|Amlodipine|amlodipine|mesh-list
65427043|NCT00368277|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65427044|NCT00368277|Ramipril|ramipril|mesh-list
65427045|NCT00368277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65427052|NCT00368277|Diuretics|diuretics|mesh-ancestor
65427095|NCT02534337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427096|NCT02534337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427097|NCT02534337|Antiviral Agents|antiviral agents|mesh-ancestor
65427098|NCT02534337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65427166|NCT04004117|Fentanyl|fentanyl|mesh-list
65427167|NCT04004117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65427168|NCT04004117|Narcotics|narcotics|mesh-ancestor
65427169|NCT04004117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65427170|NCT04004117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427171|NCT04004117|Analgesics|analgesics|mesh-ancestor
65427172|NCT04004117|Sensory System Agents|sensory system agents|mesh-ancestor
65427173|NCT04004117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65427174|NCT04004117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65427175|NCT04004117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65427176|NCT04004117|Anesthetics, General|anesthetics, general|mesh-ancestor
65427177|NCT04004117|Anesthetics|anesthetics|mesh-ancestor
65427178|NCT00539513|Acetylcysteine|acetylcysteine|mesh-list
65427179|NCT00539513|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65427180|NCT00539513|Antiviral Agents|antiviral agents|mesh-ancestor
65427181|NCT00539513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65427182|NCT00539513|Expectorants|expectorants|mesh-ancestor
65427183|NCT00539513|Respiratory System Agents|respiratory system agents|mesh-ancestor
65427226|NCT02583893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65427227|NCT02583893|Antimetabolites|antimetabolites|mesh-ancestor
65427228|NCT02583893|Antiviral Agents|antiviral agents|mesh-ancestor
65427229|NCT02583893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65427230|NCT02583893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65427231|NCT02583893|Immunologic Factors|immunologic factors|mesh-ancestor
65427232|NCT02583893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427233|NCT02583893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65427234|NCT02583893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65427235|NCT02583893|Antifungal Agents|antifungal agents|mesh-ancestor
65427236|NCT02583893|Analgesics|analgesics|mesh-ancestor
65427237|NCT02583893|Sensory System Agents|sensory system agents|mesh-ancestor
65427238|NCT02583893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65427239|NCT04221191|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65427240|NCT04221191|Dermatologic Agents|dermatologic agents|mesh-ancestor
65427241|NCT04221191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65427242|NCT04221191|Immunologic Factors|immunologic factors|mesh-ancestor
65427243|NCT04221191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427284|NCT05360147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65427285|NCT00444912|Plerixafor|plerixafor|mesh-list
65427286|NCT00444912|Rituximab|rituximab|mesh-list
65427287|NCT00444912|Lenograstim|lenograstim|mesh-list
65427288|NCT00444912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65427289|NCT00444912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427290|NCT00444912|Immunologic Factors|immunologic factors|mesh-ancestor
65427291|NCT00444912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427292|NCT00444912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65427293|NCT00444912|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65427294|NCT00444912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65427295|NCT00444912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65427296|NCT00444912|Antiviral Agents|antiviral agents|mesh-ancestor
65427297|NCT00444912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65427298|NCT00538733|Clarithromycin|clarithromycin|mesh-list
65427299|NCT00538733|Thalidomide|thalidomide|mesh-list
65427300|NCT00538733|Dexamethasone|dexamethasone|mesh-list
65427342|NCT00990197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65427343|NCT00990197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427344|NCT00990197|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65427345|NCT00990197|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65427346|NCT00990197|Cholinergic Agents|cholinergic agents|mesh-ancestor
65427347|NCT00990197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65427348|NCT00990197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427408|NCT01048983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65427409|NCT01048983|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65427410|NCT01048983|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65427411|NCT01048983|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65427412|NCT00990275|Ethanol|ethanol|mesh-list
65427413|NCT00990275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65427414|NCT00990275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65427415|NCT00990275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65427416|NCT00990275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427417|NCT01340417|Melatonin|melatonin|mesh-list
65427418|NCT01340417|Antioxidants|antioxidants|mesh-ancestor
65427419|NCT01340417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427420|NCT01340417|Protective Agents|protective agents|mesh-ancestor
65427421|NCT01340417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427422|NCT01340417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65427423|NCT01049061|Farletuzumab|farletuzumab|mesh-list
65427424|NCT01049061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427425|NCT00367341|Citalopram|citalopram|mesh-list
65427426|NCT00367341|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65427427|NCT00367341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65427461|NCT00616967|Mitosis Modulators|mitosis modulators|mesh-ancestor
65427462|NCT00616967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427463|NCT00616967|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65427464|NCT00616967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427465|NCT05360537|Insulin Glargine|insulin glargine|mesh-list
65427466|NCT05360537|Liraglutide|liraglutide|mesh-list
65427467|NCT05360537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65427530|NCT00989729|Methylprednisolone|methylprednisolone|mesh-list
65427531|NCT00989729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65427532|NCT00989729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65427533|NCT00989729|Prednisolone|prednisolone|mesh-list
65427534|NCT00989729|Prednisolone acetate|prednisolone acetate|mesh-list
65427535|NCT00989729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65427536|NCT00989729|Prednisolone phosphate|prednisolone phosphate|mesh-list
65427537|NCT00989729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65427538|NCT00989729|Antiemetics|antiemetics|mesh-ancestor
65427539|NCT00989729|Autonomic Agents|autonomic agents|mesh-ancestor
65427540|NCT00989729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65427541|NCT00989729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427542|NCT00989729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65427543|NCT00989729|Glucocorticoids|glucocorticoids|mesh-ancestor
65427544|NCT00989729|Hormones|hormones|mesh-ancestor
65427545|NCT00989729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65427546|NCT00989729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65427589|NCT00991211|Antimitotic Agents|antimitotic agents|mesh-ancestor
65427590|NCT00991211|Mitosis Modulators|mitosis modulators|mesh-ancestor
65427591|NCT00357903|Etanercept|etanercept|mesh-list
65427592|NCT00357903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65427593|NCT00357903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65427594|NCT00357903|Analgesics|analgesics|mesh-ancestor
65427595|NCT00357903|Sensory System Agents|sensory system agents|mesh-ancestor
65427596|NCT00357903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65427597|NCT00357903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427598|NCT00357903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65427656|NCT00444600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65427657|NCT00444600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65427658|NCT00444600|Growth Substances|growth substances|mesh-ancestor
65427659|NCT00444600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427660|NCT00444600|Growth Inhibitors|growth inhibitors|mesh-ancestor
65427661|NCT00444600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427662|NCT00444600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65427663|NCT00444600|Glucocorticoids|glucocorticoids|mesh-ancestor
65427664|NCT00444600|Hormones|hormones|mesh-ancestor
65427665|NCT00444600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65427666|NCT00444600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65427667|NCT00444600|Immunologic Factors|immunologic factors|mesh-ancestor
65427718|NCT04403165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65427719|NCT05440487|Chelating Agents|chelating agents|mesh-list
65427720|NCT05440487|Sequestering Agents|sequestering agents|mesh-ancestor
65427721|NCT05440487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427722|NCT00440310|Talaporfin|talaporfin|mesh-list
65427723|NCT00440310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427724|NCT00440310|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65427725|NCT00440310|Dermatologic Agents|dermatologic agents|mesh-ancestor
65427726|NCT01055847|Aztreonam|aztreonam|mesh-list
65427727|NCT01055847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65427728|NCT01055847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65427783|NCT05379959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427784|NCT05379959|Adrenergic Agents|adrenergic agents|mesh-ancestor
65177307|NCT03936790|Analgesics|analgesics|mesh-ancestor
65427785|NCT05379959|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65427786|NCT05379959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65427787|NCT05379959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65427788|NCT05379959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65427789|NCT03158064|Durvalumab|durvalumab|mesh-list
65427790|NCT03158064|Tremelimumab|tremelimumab|mesh-list
65427791|NCT03158064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65427792|NCT03158064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427793|NCT04791228|Doxorubicin|doxorubicin|mesh-list
65427794|NCT04791228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65427795|NCT04791228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65427796|NCT04791228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427797|NCT04791228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65427798|NCT04791228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65427799|NCT04791228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427800|NCT04791228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427801|NCT05357885|Antibodies|antibodies|mesh-list
65427802|NCT05357885|Immunologic Factors|immunologic factors|mesh-ancestor
65427835|NCT05186363|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65427836|NCT05186363|Renal Agents|renal agents|mesh-ancestor
65427837|NCT03742323|Idelalisib|idelalisib|mesh-list
65427838|NCT03742323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427839|NCT03742323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427840|NCT03742323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427841|NCT04715022|Ascorbic Acid|ascorbic acid|mesh-list
65427842|NCT04715022|Antioxidants|antioxidants|mesh-ancestor
65427843|NCT04715022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427844|NCT04715022|Protective Agents|protective agents|mesh-ancestor
65427845|NCT04715022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427846|NCT04715022|Vitamins|vitamins|mesh-ancestor
65427847|NCT04715022|Micronutrients|micronutrients|mesh-ancestor
65427848|NCT00356811|Paclitaxel|paclitaxel|mesh-list
65427849|NCT00356811|Lapatinib|lapatinib|mesh-list
65427896|NCT04994561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65427897|NCT04994561|Antioxidants|antioxidants|mesh-ancestor
65427898|NCT04994561|Protective Agents|protective agents|mesh-ancestor
65427899|NCT04994561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65427900|NCT04994561|Vitamin B Complex|vitamin b complex|mesh-ancestor
65427901|NCT04994561|Vitamins|vitamins|mesh-ancestor
65427902|NCT04994561|Micronutrients|micronutrients|mesh-ancestor
65427903|NCT01030770|Ranibizumab|ranibizumab|mesh-list
65427904|NCT01030770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65427905|NCT01030770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65427962|NCT00536939|Growth Inhibitors|growth inhibitors|mesh-ancestor
65427963|NCT04597697|Insulin|insulin|mesh-list
65427964|NCT04597697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65427965|NCT04597697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65427966|NCT00347919|Lapatinib|lapatinib|mesh-list
65427967|NCT00347919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65427968|NCT00347919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65427969|NCT00347919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65427971|NCT00439140|Botulinum Toxins|botulinum toxins|mesh-list
65428029|NCT00443820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65428030|NCT00443820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428031|NCT00443820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428032|NCT00438672|Dexamethasone|dexamethasone|mesh-list
65428033|NCT00438672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65428097|NCT04002635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65428098|NCT04002635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65428099|NCT04002635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428100|NCT04002635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428101|NCT04002635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65428167|NCT00356265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65428168|NCT00356265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65428169|NCT00356265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65428170|NCT00356265|Adrenergic Agents|adrenergic agents|mesh-ancestor
65428171|NCT00356265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65428172|NCT00356265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428173|NCT00356265|Protective Agents|protective agents|mesh-ancestor
65428175|NCT01052259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65428176|NCT01052259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428177|NCT01052259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65428178|NCT01052259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428183|NCT01056549|Exenatide|exenatide|mesh-list
65428230|NCT01564355|Triamcinolone|triamcinolone|mesh-list
65428231|NCT01564355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65428232|NCT01564355|Glucocorticoids|glucocorticoids|mesh-ancestor
65428233|NCT01564355|Hormones|hormones|mesh-ancestor
65428234|NCT01564355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65428235|NCT01564355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428236|NCT01056705|Vaccines|vaccines|mesh-list
65428237|NCT01056705|Immunologic Factors|immunologic factors|mesh-ancestor
65428238|NCT01056705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428239|NCT00437268|Irinotecan|irinotecan|mesh-list
65428240|NCT00437268|Cetuximab|cetuximab|mesh-list
65428241|NCT00437268|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65428242|NCT00437268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65428243|NCT00437268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428244|NCT00437268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428245|NCT00437268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428246|NCT00437268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65428247|NCT04002089|Bupivacaine|bupivacaine|mesh-list
65428248|NCT04002089|Anesthetics, Local|anesthetics, local|mesh-ancestor
65428249|NCT04002089|Anesthetics|anesthetics|mesh-ancestor
65428250|NCT04002089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65428251|NCT04002089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428252|NCT04002089|Sensory System Agents|sensory system agents|mesh-ancestor
65428253|NCT04002089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65428254|NCT04002245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
65428255|NCT04002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65428256|NCT01056861|Botulinum Toxins|botulinum toxins|mesh-list
65428277|NCT04139525|Calcium heparin|calcium heparin|mesh-list
65428278|NCT04139525|Citric Acid|citric acid|mesh-list
65428279|NCT04139525|Sodium Citrate|sodium citrate|mesh-list
65428280|NCT04139525|Anticoagulants|anticoagulants|mesh-ancestor
65428281|NCT04139525|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65428282|NCT04139525|Chelating Agents|chelating agents|mesh-ancestor
65428283|NCT04139525|Sequestering Agents|sequestering agents|mesh-ancestor
65428284|NCT04139525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428285|NCT04139525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65428286|NCT04139525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65428287|NCT00437034|Aflibercept|aflibercept|mesh-list
65428288|NCT00437034|Endothelial Growth Factors|endothelial growth factors|mesh-list
65428289|NCT00437034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65428290|NCT00437034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65428291|NCT00437034|Growth Substances|growth substances|mesh-ancestor
65428292|NCT00437034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428293|NCT00437034|Growth Inhibitors|growth inhibitors|mesh-ancestor
65428294|NCT00437034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428295|NCT00337467|Ritonavir|ritonavir|mesh-list
65428296|NCT00337467|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65428297|NCT00337467|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65428298|NCT00337467|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65428299|NCT00337467|Protease Inhibitors|protease inhibitors|mesh-ancestor
65428300|NCT00337467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428301|NCT00337467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428302|NCT00337467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65428303|NCT00337467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65428304|NCT00337467|Antiviral Agents|antiviral agents|mesh-ancestor
64674329|NCT03879603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64674330|NCT00553514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64674331|NCT00553514|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64674332|NCT00553514|Hormones|hormones|mesh-ancestor
64674333|NCT00553514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64674334|NCT00553514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674335|NCT00553514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64674337|NCT02813642|Mitosis Modulators|mitosis modulators|mesh-ancestor
64674338|NCT02813642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674339|NCT03852537|Methylprednisolone|methylprednisolone|mesh-list
64674340|NCT03852537|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64674341|NCT03852537|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64674342|NCT03852537|Prednisolone|prednisolone|mesh-list
64674343|NCT03852537|Prednisolone acetate|prednisolone acetate|mesh-list
64674344|NCT03852537|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64674345|NCT03852537|Prednisolone phosphate|prednisolone phosphate|mesh-list
64714438|NCT03117140|Anesthetics, Local|anesthetics, local|mesh-ancestor
64714439|NCT03117140|Anesthetics|anesthetics|mesh-ancestor
64714440|NCT03117140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64714441|NCT03117140|Sensory System Agents|sensory system agents|mesh-ancestor
65428305|NCT00337467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65428306|NCT00337467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65428307|NCT00337467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65428308|NCT00428220|Sunitinib|sunitinib|mesh-list
65428309|NCT00428220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428310|NCT00428220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65428311|NCT00428220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65428312|NCT00428220|Growth Substances|growth substances|mesh-ancestor
65428313|NCT00428220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428314|NCT00428220|Growth Inhibitors|growth inhibitors|mesh-ancestor
65428315|NCT00428220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65428316|NCT00428220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428317|NCT00428220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428318|NCT01057329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65428319|NCT01057329|Olanzapine|olanzapine|mesh-list
65428320|NCT01057329|Aripiprazole|aripiprazole|mesh-list
65428321|NCT01057329|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65428322|NCT01057329|Antiemetics|antiemetics|mesh-ancestor
65428323|NCT01057329|Autonomic Agents|autonomic agents|mesh-ancestor
65428324|NCT01057329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65428325|NCT01057329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428326|NCT01057329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65428327|NCT01057329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65428328|NCT01057329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65428347|NCT01057329|Analgesics|analgesics|mesh-ancestor
65428354|NCT01057407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428355|NCT01057563|Paclitaxel|paclitaxel|mesh-list
65428356|NCT01057563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65428357|NCT01057563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65428358|NCT01057563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428359|NCT01057563|Tubulin Modulators|tubulin modulators|mesh-ancestor
65428360|NCT01057563|Antimitotic Agents|antimitotic agents|mesh-ancestor
65428361|NCT01057563|Mitosis Modulators|mitosis modulators|mesh-ancestor
65428362|NCT01057563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428363|NCT00345579|PENTA|penta|mesh-list
65428368|NCT04002323|Lamivudine|lamivudine|mesh-list
65428419|NCT03986385|Oxaliplatin|oxaliplatin|mesh-list
65428420|NCT03986385|Apatinib|apatinib|mesh-list
65428421|NCT03986385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65428422|NCT03986385|Antimetabolites|antimetabolites|mesh-ancestor
65428423|NCT03986385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428424|NCT03986385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428425|NCT03986385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65428426|NCT03986385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428427|NCT00344019|Atorvastatin|atorvastatin|mesh-list
65428428|NCT00344019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65428429|NCT00344019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65428430|NCT00344019|Antimetabolites|antimetabolites|mesh-ancestor
65428431|NCT00344019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428432|NCT00344019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65428433|NCT00344019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65428434|NCT00344019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428435|NCT00535847|Interferons|interferons|mesh-list
65428436|NCT00535847|Ribavirin|ribavirin|mesh-list
65428437|NCT00535847|Interferon-alpha|interferon-alpha|mesh-list
65428438|NCT00535847|Interferon alpha-2|interferon alpha-2|mesh-list
65428439|NCT00535847|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65428440|NCT00535847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428441|NCT00535847|Antiviral Agents|antiviral agents|mesh-ancestor
65428474|NCT01057875|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65428475|NCT01057875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428476|NCT01057875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65428477|NCT01057875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428478|NCT01057875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428479|NCT01057875|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65428480|NCT01057875|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65428539|NCT00992069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65428540|NCT00992069|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65428541|NCT00992069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65428542|NCT00992069|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65428543|NCT00992069|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65428544|NCT00992069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65428545|NCT00992069|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65428546|NCT01060293|Dopamine|dopamine|mesh-list
65428547|NCT01060293|Furosemide|furosemide|mesh-list
65428548|NCT01060293|Diuretics|diuretics|mesh-ancestor
65428549|NCT01060293|Natriuretic Agents|natriuretic agents|mesh-ancestor
65428550|NCT01060293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428551|NCT01060293|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65428552|NCT01060293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65428553|NCT01060293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428554|NCT01060293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65428555|NCT01060293|Sympathomimetics|sympathomimetics|mesh-ancestor
65428556|NCT01060293|Autonomic Agents|autonomic agents|mesh-ancestor
65428561|NCT05343767|Metformin|metformin|mesh-list
65428595|NCT00416598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428596|NCT00416598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65428597|NCT00416598|Alkylating Agents|alkylating agents|mesh-ancestor
65428598|NCT00416598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65428599|NCT00416598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65428600|NCT00416598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65428601|NCT00416598|Keratolytic Agents|keratolytic agents|mesh-ancestor
65428602|NCT00416598|Dermatologic Agents|dermatologic agents|mesh-ancestor
65428603|NCT00416598|Tubulin Modulators|tubulin modulators|mesh-ancestor
65428604|NCT00416598|Antimitotic Agents|antimitotic agents|mesh-ancestor
65428605|NCT00416598|Mitosis Modulators|mitosis modulators|mesh-ancestor
65428614|NCT04001465|Miotics|miotics|mesh-ancestor
65428659|NCT00992849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65428660|NCT00992849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428661|NCT00992849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65428662|NCT00992849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65428663|NCT00992849|Growth Substances|growth substances|mesh-ancestor
65428664|NCT00992849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428665|NCT00992849|Growth Inhibitors|growth inhibitors|mesh-ancestor
65428666|NCT04001231|Exenatide|exenatide|mesh-list
65428667|NCT04001231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65428668|NCT04001231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428669|NCT04001231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65428671|NCT04001231|Hormones|hormones|mesh-ancestor
65428723|NCT01034124|Midazolam|midazolam|mesh-list
65428724|NCT01034124|Warfarin|warfarin|mesh-list
65428725|NCT01034124|Vitamins|vitamins|mesh-ancestor
65428726|NCT01034124|Micronutrients|micronutrients|mesh-ancestor
65428727|NCT01034124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428728|NCT01034124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65428729|NCT01034124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65428730|NCT01034124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65428731|NCT01034124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65428732|NCT01034124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65428733|NCT01034124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65428734|NCT01034124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65428735|NCT01034124|Anesthetics, General|anesthetics, general|mesh-ancestor
65428736|NCT01034124|Anesthetics|anesthetics|mesh-ancestor
65428786|NCT00995657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65428787|NCT00995657|Autonomic Agents|autonomic agents|mesh-ancestor
65428788|NCT00995657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65428789|NCT00995657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428790|NCT00995657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65428791|NCT00995657|Respiratory System Agents|respiratory system agents|mesh-ancestor
65428792|NCT00995657|Dermatologic Agents|dermatologic agents|mesh-ancestor
65428793|NCT00995657|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65428794|NCT00994097|Gemcitabine|gemcitabine|mesh-list
65428795|NCT00994097|Pemetrexed|pemetrexed|mesh-list
65428796|NCT00994097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428797|NCT00994097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65428798|NCT00994097|Antimetabolites|antimetabolites|mesh-ancestor
65428799|NCT00994097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428800|NCT00994097|Antiviral Agents|antiviral agents|mesh-ancestor
65428801|NCT00994097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65428802|NCT00994097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428804|NCT00994097|Immunologic Factors|immunologic factors|mesh-ancestor
65428842|NCT00338949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65428843|NCT00338949|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65428844|NCT00338949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65428845|NCT00338949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65428846|NCT01325259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65428847|NCT01325259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65428849|NCT00332709|Zoledronic Acid|zoledronic acid|mesh-list
65428909|NCT03983889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65428910|NCT03983889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428911|NCT03983889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65428912|NCT03983889|Narcotics|narcotics|mesh-ancestor
65428913|NCT03983889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65428914|NCT03983889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65428915|NCT03983889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65428916|NCT03983889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65428917|NCT03983889|GABA Modulators|gaba modulators|mesh-ancestor
65428918|NCT03983889|GABA Agents|gaba agents|mesh-ancestor
65428919|NCT00337935|Epoetin Alfa|epoetin alfa|mesh-list
65428920|NCT00337935|Hematinics|hematinics|mesh-ancestor
65428976|NCT00436956|Glucocorticoids|glucocorticoids|mesh-ancestor
65428977|NCT00436956|Hormones|hormones|mesh-ancestor
65428978|NCT00436956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65428979|NCT00436956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65428980|NCT00436956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65428981|NCT00436956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65428982|NCT00436956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65428983|NCT00436956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65428984|NCT00436956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65428985|NCT00436644|Topotecan|topotecan|mesh-list
65429040|NCT00436566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65429041|NCT00436566|Immunologic Factors|immunologic factors|mesh-ancestor
65429042|NCT00436566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429043|NCT00436566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65429044|NCT00436566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65429045|NCT00436566|Alkylating Agents|alkylating agents|mesh-ancestor
65429046|NCT00436566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65429047|NCT00436566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65429048|NCT00436566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65429049|NCT00436566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65429050|NCT00436566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429051|NCT00436566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65429052|NCT00436566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65429053|NCT01060683|Chrysarobin|chrysarobin|mesh-list
65429055|NCT01060683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65429100|NCT01055301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65429101|NCT01055379|Rasagiline|rasagiline|mesh-list
65429102|NCT01055379|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65429103|NCT01055379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429105|NCT01055379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65429169|NCT00352053|Tenofovir|tenofovir|mesh-list
65429170|NCT00352053|Antiviral Agents|antiviral agents|mesh-ancestor
65429171|NCT00352053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65429172|NCT00352053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65429173|NCT00352053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65429174|NCT00352053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429175|NCT00352053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429176|NCT00352053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65429177|NCT00352053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65429178|NCT00995033|Varenicline|varenicline|mesh-list
65429179|NCT00995033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65429180|NCT00995033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65429181|NCT00995033|Cholinergic Agents|cholinergic agents|mesh-ancestor
65429182|NCT00995033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65429183|NCT00995033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429184|NCT00995033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429185|NCT00997061|Topotecan|topotecan|mesh-list
65429225|NCT00436332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65429226|NCT00436332|Growth Substances|growth substances|mesh-ancestor
65429227|NCT00436332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429228|NCT00436332|Growth Inhibitors|growth inhibitors|mesh-ancestor
65429229|NCT00436332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65429230|NCT00436332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429232|NCT00532259|Pidilizumab|pidilizumab|mesh-list
65429291|NCT01003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429292|NCT01003847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65429293|NCT00530855|Lacosamide|lacosamide|mesh-list
65178806|NCT00670345|Coagulants|coagulants|mesh-ancestor
65429294|NCT00530855|Anticonvulsants|anticonvulsants|mesh-ancestor
65429295|NCT00530855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65429296|NCT00530855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65429297|NCT00530855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65429298|NCT00530855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429299|NCT01004237|Valsartan|valsartan|mesh-list
65429300|NCT01004237|Pravastatin|pravastatin|mesh-list
65429301|NCT01004237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65429302|NCT01004237|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65429303|NCT01004237|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65429305|NCT01004237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65429348|NCT01005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429349|NCT01005641|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65429350|NCT01005641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65429351|NCT01005641|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65429352|NCT01005641|Hormone Antagonists|hormone antagonists|mesh-ancestor
65429353|NCT01005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65429354|NCT01005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429355|NCT01005797|Sorafenib|sorafenib|mesh-list
65429356|NCT01005797|Panobinostat|panobinostat|mesh-list
65429357|NCT01005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429358|NCT01005797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65429359|NCT01005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429360|NCT01005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429361|NCT01005797|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65429362|NCT01006031|Interferons|interferons|mesh-list
65429363|NCT01006031|Ribavirin|ribavirin|mesh-list
65429364|NCT01006031|Interferon-alpha|interferon-alpha|mesh-list
65429365|NCT01006031|Interferon alpha-2|interferon alpha-2|mesh-list
65429366|NCT01006031|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65429367|NCT01006031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429376|NCT01006187|Anesthetics|anesthetics|mesh-ancestor
65429402|NCT03882047|Mometasone Furoate|mometasone furoate|mesh-list
65429403|NCT03882047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65429404|NCT03882047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65429405|NCT03882047|Autonomic Agents|autonomic agents|mesh-ancestor
65429406|NCT03882047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65429407|NCT03882047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429410|NCT03882047|Dermatologic Agents|dermatologic agents|mesh-ancestor
65429469|NCT00999791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65429470|NCT00999791|Growth Substances|growth substances|mesh-ancestor
65429471|NCT00999791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429472|NCT00999791|Growth Inhibitors|growth inhibitors|mesh-ancestor
65429473|NCT00999791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65429474|NCT00999791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65429475|NCT00999791|Analgesics|analgesics|mesh-ancestor
65429476|NCT00999791|Sensory System Agents|sensory system agents|mesh-ancestor
65429477|NCT00999791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65429478|NCT00999791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65429534|NCT01009073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429535|NCT01009073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429536|NCT01009073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429537|NCT01009073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65429538|NCT00530075|Gusperimus|gusperimus|mesh-list
65429539|NCT00530075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65429540|NCT00530075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429541|NCT00530075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65429542|NCT00530075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429543|NCT00530075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65429544|NCT00530075|Immunologic Factors|immunologic factors|mesh-ancestor
65429545|NCT00530075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65429546|NCT00530075|Protective Agents|protective agents|mesh-ancestor
65429547|NCT01001585|Sevoflurane|sevoflurane|mesh-list
65429548|NCT01001585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65429549|NCT01001585|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65429550|NCT01001585|Anesthetics, General|anesthetics, general|mesh-ancestor
65429551|NCT01001585|Anesthetics|anesthetics|mesh-ancestor
65429593|NCT04000295|Tubulin Modulators|tubulin modulators|mesh-ancestor
65429594|NCT04000295|Antimitotic Agents|antimitotic agents|mesh-ancestor
65429595|NCT04000295|Mitosis Modulators|mitosis modulators|mesh-ancestor
65429596|NCT04000295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429597|NCT04000295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65429598|NCT04000295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65429599|NCT04000295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429600|NCT04000295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65429602|NCT01003613|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65429603|NCT01003613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65429604|NCT01003613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65429605|NCT01003613|Analgesics|analgesics|mesh-ancestor
65429606|NCT01003613|Sensory System Agents|sensory system agents|mesh-ancestor
65429654|NCT00469898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65429655|NCT00469898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429656|NCT00469898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429657|NCT01021436|Amikacin|amikacin|mesh-list
65429658|NCT01021436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65429659|NCT01021436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65429660|NCT00529763|Dasatinib|dasatinib|mesh-list
65429661|NCT00529763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429662|NCT00529763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65429720|NCT00486434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429721|NCT00486434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65429722|NCT00486434|Vasodilator Agents|vasodilator agents|mesh-ancestor
65429723|NCT00529451|Ramipril|ramipril|mesh-list
65429724|NCT00529451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65429725|NCT00529451|Protease Inhibitors|protease inhibitors|mesh-ancestor
65429726|NCT00529451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429727|NCT00529451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429728|NCT00529451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65429729|NCT05641259|Azacitidine|azacitidine|mesh-list
65429730|NCT05641259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65429731|NCT05641259|Antimetabolites|antimetabolites|mesh-ancestor
65429732|NCT05641259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429733|NCT05641259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429734|NCT05641259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429735|NCT05405387|Budesonide|budesonide|mesh-list
65429736|NCT05405387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65429737|NCT05405387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65429738|NCT05405387|Autonomic Agents|autonomic agents|mesh-ancestor
65429739|NCT05405387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65429744|NCT05405387|Hormones|hormones|mesh-ancestor
65429774|NCT05637281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429775|NCT05637281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429776|NCT00321711|Azacitidine|azacitidine|mesh-list
65429777|NCT00321711|Decitabine|decitabine|mesh-list
65429778|NCT00321711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65429779|NCT00321711|Antimetabolites|antimetabolites|mesh-ancestor
65429780|NCT00321711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429781|NCT00321711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429782|NCT00321711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429839|NCT01025102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65429840|NCT01025102|Narcotics|narcotics|mesh-ancestor
65429841|NCT01025102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65429842|NCT01025102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429843|NCT01025102|Analgesics|analgesics|mesh-ancestor
65429844|NCT01025102|Sensory System Agents|sensory system agents|mesh-ancestor
65429845|NCT01025102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65429846|NCT01025102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65429847|NCT01025102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65429848|NCT01025102|Anesthetics, General|anesthetics, general|mesh-ancestor
65429849|NCT01025102|Anesthetics|anesthetics|mesh-ancestor
65429850|NCT01025102|Anesthetics, Local|anesthetics, local|mesh-ancestor
65429851|NCT00424476|Belimumab|belimumab|mesh-list
65429852|NCT00424476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65429853|NCT00424476|Immunologic Factors|immunologic factors|mesh-ancestor
65429854|NCT00424476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429855|NCT01037634|Oseltamivir|oseltamivir|mesh-list
65429856|NCT01037634|Antiviral Agents|antiviral agents|mesh-ancestor
65429857|NCT01037634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65429858|NCT01037634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429860|NCT01037712|Valacyclovir|valacyclovir|mesh-list
65429893|NCT03836664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65429894|NCT00350727|Lapatinib|lapatinib|mesh-list
65429895|NCT00350727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429896|NCT00350727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65429897|NCT00350727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429898|NCT00350727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429899|NCT01032486|Rasagiline|rasagiline|mesh-list
65429900|NCT01032486|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65429901|NCT01032486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429902|NCT01032486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429903|NCT01032486|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65429904|NCT01032486|Protective Agents|protective agents|mesh-ancestor
65429905|NCT01032486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429906|NCT01061697|Pregabalin|pregabalin|mesh-list
65429907|NCT01061697|Analgesics|analgesics|mesh-ancestor
65429920|NCT00434304|Ropinirole|ropinirole|mesh-list
65429951|NCT00424008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65429952|NCT00424008|Sympathomimetics|sympathomimetics|mesh-ancestor
65429953|NCT00423930|Bevacizumab|bevacizumab|mesh-list
65429954|NCT00423930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65429955|NCT00423930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429956|NCT00423930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65429957|NCT00423930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65429958|NCT00423930|Growth Substances|growth substances|mesh-ancestor
65429959|NCT00423930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429960|NCT00423930|Growth Inhibitors|growth inhibitors|mesh-ancestor
65429961|NCT00423852|Paclitaxel|paclitaxel|mesh-list
65429962|NCT00423852|Carboplatin|carboplatin|mesh-list
65429963|NCT00423852|Ifosfamide|ifosfamide|mesh-list
65429964|NCT00423852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65429965|NCT00423852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429966|NCT00423852|Tubulin Modulators|tubulin modulators|mesh-ancestor
65429967|NCT00423852|Antimitotic Agents|antimitotic agents|mesh-ancestor
65429968|NCT00423852|Mitosis Modulators|mitosis modulators|mesh-ancestor
65429969|NCT00423852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429970|NCT00423852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65429971|NCT00423852|Alkylating Agents|alkylating agents|mesh-ancestor
65429972|NCT00461708|Gemcitabine|gemcitabine|mesh-list
65429973|NCT00461708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65429974|NCT00461708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65429975|NCT00461708|Antimetabolites|antimetabolites|mesh-ancestor
65429976|NCT00461708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429977|NCT00461708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429978|NCT00461708|Antiviral Agents|antiviral agents|mesh-ancestor
65429979|NCT00461708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65429980|NCT00461708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65429981|NCT00461708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64714442|NCT03117140|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64714443|NCT03117140|Narcotics|narcotics|mesh-ancestor
64714444|NCT03117140|Analgesics|analgesics|mesh-ancestor
64714445|NCT03117140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64714446|NCT03117140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64714447|NCT03117140|Sympatholytics|sympatholytics|mesh-ancestor
64714448|NCT03117140|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64714449|NCT03117140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64714450|NCT03117140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64714451|NCT03117140|Adrenergic Agents|adrenergic agents|mesh-ancestor
64714452|NCT03117140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64714453|NCT03117140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714454|NCT03118466|Cytarabine|cytarabine|mesh-list
65429982|NCT00461708|Immunologic Factors|immunologic factors|mesh-ancestor
65429983|NCT00461708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429984|NCT00461708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65429985|NCT00327171|Aflibercept|aflibercept|mesh-list
65429986|NCT00327171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65429987|NCT00327171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65429988|NCT00327171|Growth Substances|growth substances|mesh-ancestor
65429989|NCT00327171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429990|NCT00327171|Growth Inhibitors|growth inhibitors|mesh-ancestor
65429991|NCT00327171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65429992|NCT01038024|Antioxidants|antioxidants|mesh-list
65429993|NCT01038024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65429994|NCT01038024|Protective Agents|protective agents|mesh-ancestor
65429995|NCT01038024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65429996|NCT00461630|Niacin|niacin|mesh-list
65429997|NCT00461630|Simvastatin|simvastatin|mesh-list
65429998|NCT00461630|Ezetimibe|ezetimibe|mesh-list
65429999|NCT00461630|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
65430000|NCT00461630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65430001|NCT00461630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65430002|NCT00461630|Antimetabolites|antimetabolites|mesh-ancestor
65430036|NCT01325415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430037|NCT01325415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430038|NCT01325415|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65430039|NCT01325415|Sensory System Agents|sensory system agents|mesh-ancestor
65430040|NCT01325415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65430041|NCT01022840|Ketamine|ketamine|mesh-list
65430042|NCT01022840|Esketamine|esketamine|mesh-list
65430043|NCT01022840|Analgesics|analgesics|mesh-ancestor
65430044|NCT01022840|Sensory System Agents|sensory system agents|mesh-ancestor
65430045|NCT01022840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65430046|NCT01022840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430047|NCT01022840|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65430048|NCT01022840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65430098|NCT01063647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430099|NCT01063647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65430100|NCT01063647|Immunologic Factors|immunologic factors|mesh-ancestor
65430101|NCT01063647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430102|NCT01063647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65430103|NCT00468728|Vancomycin|vancomycin|mesh-list
65430164|NCT00433290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430165|NCT00433290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65430166|NCT00433290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430167|NCT00433290|Analgesics|analgesics|mesh-ancestor
65430168|NCT00433290|Sensory System Agents|sensory system agents|mesh-ancestor
65430234|NCT00320541|Growth Inhibitors|growth inhibitors|mesh-ancestor
65430235|NCT00320541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65430236|NCT00320541|Antimetabolites|antimetabolites|mesh-ancestor
65430237|NCT00320541|Antiviral Agents|antiviral agents|mesh-ancestor
65430238|NCT00320541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65430239|NCT00320541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430240|NCT00320541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65430241|NCT00320541|Immunologic Factors|immunologic factors|mesh-ancestor
65430242|NCT00320385|Trastuzumab|trastuzumab|mesh-list
65430243|NCT00320385|Lapatinib|lapatinib|mesh-list
65430244|NCT00320385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65430245|NCT00320385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430246|NCT00320385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65430247|NCT00320385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430249|NCT00309777|Simvastatin|simvastatin|mesh-list
65430295|NCT00319449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65430296|NCT00319449|Antimetabolites|antimetabolites|mesh-ancestor
65430297|NCT00319449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430298|NCT00319449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65430299|NCT00319449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65430300|NCT00319449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430301|NCT00308685|Albuterol|albuterol|mesh-list
65430302|NCT00308685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65430361|NCT01064115|Histamine Antagonists|histamine antagonists|mesh-ancestor
65430362|NCT01064115|Histamine Agents|histamine agents|mesh-ancestor
65430363|NCT01064115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65430364|NCT01064115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430365|NCT01064115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430366|NCT00422058|Liraglutide|liraglutide|mesh-list
65430367|NCT00422058|Orlistat|orlistat|mesh-list
65430368|NCT00422058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65430369|NCT00422058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430370|NCT00422058|Incretins|incretins|mesh-ancestor
65430371|NCT00422058|Hormones|hormones|mesh-ancestor
65430372|NCT00422058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65430373|NCT00422058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430423|NCT01038648|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65430424|NCT01038648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65430425|NCT01038648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430426|NCT01038648|Incretins|incretins|mesh-ancestor
65430427|NCT01038648|Hormones|hormones|mesh-ancestor
65430428|NCT01038648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65430429|NCT01038648|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65430430|NCT01038648|Protease Inhibitors|protease inhibitors|mesh-ancestor
65430431|NCT01038648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430432|NCT01038648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430433|NCT00432666|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65430434|NCT00432666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65430435|NCT00432666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65430436|NCT00432666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430437|NCT00432666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65430438|NCT00432666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65430439|NCT00432666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430440|NCT00432666|Cholinergic Agents|cholinergic agents|mesh-ancestor
65430441|NCT00432666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65430442|NCT00451958|Leuprolide|leuprolide|mesh-list
65430443|NCT00451958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65430444|NCT00451958|Fertility Agents|fertility agents|mesh-ancestor
65430445|NCT00451958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65430472|NCT01026116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65430473|NCT01026116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65430474|NCT01026116|Alkylating Agents|alkylating agents|mesh-ancestor
65430475|NCT01026116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65430476|NCT01026116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65430477|NCT01026116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65430478|NCT01026116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65430540|NCT00459290|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65430541|NCT00459290|Hormone Antagonists|hormone antagonists|mesh-ancestor
65430542|NCT00459290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65430543|NCT00459290|Luteolytic Agents|luteolytic agents|mesh-ancestor
65430544|NCT00459290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65430545|NCT00459290|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65430546|NCT00443534|Sunitinib|sunitinib|mesh-list
65430547|NCT00443534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430556|NCT00419952|Budesonide|budesonide|mesh-list
65430604|NCT00308139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65430605|NCT00308139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430606|NCT00308139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65430607|NCT00308139|Incretins|incretins|mesh-ancestor
65430608|NCT00308139|Hormones|hormones|mesh-ancestor
65430609|NCT00308139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65430610|NCT00459056|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65430611|NCT00459056|Carvedilol|carvedilol|mesh-list
65430612|NCT00459056|Lisinopril|lisinopril|mesh-list
65430613|NCT00459056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65430614|NCT00459056|Diuretics|diuretics|mesh-ancestor
65430615|NCT00459056|Natriuretic Agents|natriuretic agents|mesh-ancestor
65430616|NCT00459056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430617|NCT00459056|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65430618|NCT00459056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65430619|NCT00459056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430620|NCT00459056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65430621|NCT00459056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65430622|NCT00459056|Adrenergic Agents|adrenergic agents|mesh-ancestor
65430623|NCT00459056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65430624|NCT00459056|Antioxidants|antioxidants|mesh-ancestor
65430656|NCT00431496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65430657|NCT00316173|Carboplatin|carboplatin|mesh-list
65430658|NCT00316173|Topotecan|topotecan|mesh-list
65430659|NCT00316173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430660|NCT00316173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65430661|NCT00316173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65430662|NCT00316173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430663|NCT00316173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430664|NCT00412542|Thalidomide|thalidomide|mesh-list
65430665|NCT00412542|Irinotecan|irinotecan|mesh-list
65430666|NCT00412542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65430667|NCT00412542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65430668|NCT00412542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430669|NCT00412542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430670|NCT00412542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430671|NCT00412542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65430672|NCT00412542|Immunologic Factors|immunologic factors|mesh-ancestor
65430673|NCT00412542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430674|NCT00412542|Leprostatic Agents|leprostatic agents|mesh-ancestor
65430675|NCT00412542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65430676|NCT00412542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65430677|NCT00412542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65430678|NCT00412542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65430679|NCT00412542|Growth Substances|growth substances|mesh-ancestor
65430680|NCT00412542|Growth Inhibitors|growth inhibitors|mesh-ancestor
65430681|NCT00316017|Dextrans|dextrans|mesh-list
65430682|NCT00316017|Anticoagulants|anticoagulants|mesh-ancestor
65430683|NCT00316017|Plasma Substitutes|plasma substitutes|mesh-ancestor
65430684|NCT00316017|Blood Substitutes|blood substitutes|mesh-ancestor
65430685|NCT00451178|Prednisone|prednisone|mesh-list
65430686|NCT00451178|Cyclophosphamide|cyclophosphamide|mesh-list
65430687|NCT00451178|Rituximab|rituximab|mesh-list
65430688|NCT00451178|Doxorubicin|doxorubicin|mesh-list
64815487|NCT01485367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64714455|NCT03118466|Etoposide|etoposide|mesh-list
64714456|NCT03118466|Mitoxantrone|mitoxantrone|mesh-list
64714457|NCT03118466|Lenalidomide|lenalidomide|mesh-list
64674347|NCT03852537|Antiemetics|antiemetics|mesh-ancestor
64674348|NCT03852537|Autonomic Agents|autonomic agents|mesh-ancestor
64674349|NCT03852537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64674350|NCT03852537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674351|NCT03852537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64674352|NCT03852537|Glucocorticoids|glucocorticoids|mesh-ancestor
64674353|NCT03852537|Hormones|hormones|mesh-ancestor
65430689|NCT00451178|Vincristine|vincristine|mesh-list
65430690|NCT00451178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65430691|NCT00451178|Immunologic Factors|immunologic factors|mesh-ancestor
65430692|NCT00451178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430693|NCT00451178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65430694|NCT00451178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65430695|NCT00451178|Alkylating Agents|alkylating agents|mesh-ancestor
65430696|NCT00451178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430697|NCT00451178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430698|NCT00451178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65430699|NCT00451178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65430700|NCT00451178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65430701|NCT00451178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65430702|NCT00451178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65430703|NCT00451178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430704|NCT00451178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65430705|NCT00451178|Glucocorticoids|glucocorticoids|mesh-ancestor
65430706|NCT00451178|Hormones|hormones|mesh-ancestor
65430707|NCT00451178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65430708|NCT00451178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65430709|NCT00451178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65430710|NCT00451178|Tubulin Modulators|tubulin modulators|mesh-ancestor
65430711|NCT00451178|Antimitotic Agents|antimitotic agents|mesh-ancestor
65430712|NCT00451178|Mitosis Modulators|mitosis modulators|mesh-ancestor
65430713|NCT00450866|Epothilones|epothilones|mesh-list
65430736|NCT01026584|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65430737|NCT01026584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65430738|NCT01023464|Emollients|emollients|mesh-list
65430739|NCT01023464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65430740|NCT01023464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65430741|NCT01023464|Dermatologic Agents|dermatologic agents|mesh-ancestor
65430742|NCT01023542|Everolimus|everolimus|mesh-list
65430743|NCT01023542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430745|NCT01023542|Immunologic Factors|immunologic factors|mesh-ancestor
65430804|NCT01566552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65430805|NCT01566552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65430806|NCT01028924|Teduglutide|teduglutide|mesh-list
65430807|NCT01028924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65430808|NCT01028924|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65430809|NCT01028924|Protective Agents|protective agents|mesh-ancestor
65430810|NCT01028924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430811|NCT01029002|Vitamin D|vitamin d|mesh-list
65430812|NCT01029002|Vitamins|vitamins|mesh-ancestor
65430871|NCT00441116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430872|NCT00441116|Hormone Antagonists|hormone antagonists|mesh-ancestor
65430873|NCT00441116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65430874|NCT00441116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430875|NCT01024322|Diclofenac|diclofenac|mesh-list
65430876|NCT01024322|Prednisolone acetate|prednisolone acetate|mesh-list
65430877|NCT01024322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65430878|NCT01024322|Methylprednisolone|methylprednisolone|mesh-list
65430879|NCT01024322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65430880|NCT01024322|Prednisolone|prednisolone|mesh-list
65430881|NCT01024322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65430882|NCT01024322|Prednisolone phosphate|prednisolone phosphate|mesh-list
65430883|NCT01024322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65430884|NCT01024322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65430885|NCT01024322|Analgesics|analgesics|mesh-ancestor
65430886|NCT01024322|Sensory System Agents|sensory system agents|mesh-ancestor
65430887|NCT01024322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65430888|NCT01024322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430889|NCT01024322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65430890|NCT01024322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65430891|NCT01024322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65430892|NCT01024322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430893|NCT01024322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430894|NCT01024322|Antiemetics|antiemetics|mesh-ancestor
65430895|NCT01024322|Autonomic Agents|autonomic agents|mesh-ancestor
65430896|NCT01024322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65430897|NCT01024322|Glucocorticoids|glucocorticoids|mesh-ancestor
65430898|NCT01024322|Hormones|hormones|mesh-ancestor
65430899|NCT01024322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65430900|NCT01024322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65430901|NCT01024322|Protective Agents|protective agents|mesh-ancestor
65430902|NCT01024322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65430903|NCT01024322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65430910|NCT00430248|Allopurinol|allopurinol|mesh-list
65430911|NCT00430248|Febuxostat|febuxostat|mesh-list
65430912|NCT00430248|Antimetabolites|antimetabolites|mesh-ancestor
65430913|NCT00430248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430914|NCT00430248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65430915|NCT00430248|Gout Suppressants|gout suppressants|mesh-ancestor
65430981|NCT00449072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430982|NCT00419094|Levetiracetam|levetiracetam|mesh-list
65430983|NCT00419094|Anticonvulsants|anticonvulsants|mesh-ancestor
65430984|NCT00419094|Nootropic Agents|nootropic agents|mesh-ancestor
65430985|NCT00448916|Pregabalin|pregabalin|mesh-list
65430986|NCT00448916|Analgesics|analgesics|mesh-ancestor
65430987|NCT00448916|Sensory System Agents|sensory system agents|mesh-ancestor
65430988|NCT00448916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65430989|NCT00448916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65430990|NCT00448916|Anticonvulsants|anticonvulsants|mesh-ancestor
65430991|NCT00448916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65430992|NCT00448916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65430993|NCT00448916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65430994|NCT00448916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65430995|NCT00448916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65430996|NCT00448916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65430999|NCT00418938|Leucovorin|leucovorin|mesh-list
65431042|NCT01039350|Hematinics|hematinics|mesh-ancestor
65431043|NCT01039506|Irinotecan|irinotecan|mesh-list
65431044|NCT01039506|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65431045|NCT01039506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65431046|NCT01039506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431047|NCT01039506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431048|NCT01039506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431049|NCT01033500|Abatacept|abatacept|mesh-list
65431050|NCT01033500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65431051|NCT01033500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431052|NCT01033500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431053|NCT01033500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65431054|NCT01033500|Immunologic Factors|immunologic factors|mesh-ancestor
65431055|NCT01033500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431056|NCT01033500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65431102|NCT01039740|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65431103|NCT01039740|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65431104|NCT01039740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65431105|NCT01039740|Adrenergic Agents|adrenergic agents|mesh-ancestor
65431106|NCT01039740|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65431107|NCT01039740|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65431108|NCT01039740|Serotonin Agents|serotonin agents|mesh-ancestor
65431109|NCT01039740|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65431110|NCT00448136|Bevacizumab|bevacizumab|mesh-list
65431111|NCT00448136|Streptozocin|streptozocin|mesh-list
65431112|NCT00448136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65431113|NCT00448136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431114|NCT00448136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65431164|NCT00440726|Dermatologic Agents|dermatologic agents|mesh-ancestor
65431165|NCT00440726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65431166|NCT00440726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65431167|NCT00440726|Immunologic Factors|immunologic factors|mesh-ancestor
65431168|NCT00440726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65431169|NCT00440726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65431170|NCT00440726|Antiviral Agents|antiviral agents|mesh-ancestor
65431171|NCT00440726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65431172|NCT00440726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65431173|NCT00440726|Tubulin Modulators|tubulin modulators|mesh-ancestor
65431174|NCT00440726|Antimitotic Agents|antimitotic agents|mesh-ancestor
65431175|NCT00440726|Mitosis Modulators|mitosis modulators|mesh-ancestor
65431176|NCT01030016|Atenolol|atenolol|mesh-list
65431177|NCT01030016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65431178|NCT01030016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65431179|NCT01030016|Adrenergic Agents|adrenergic agents|mesh-ancestor
65431180|NCT01030016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65431181|NCT01030016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431220|NCT01030094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65431221|NCT01030094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65431222|NCT01030094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65431223|NCT01565798|Copper|copper|mesh-list
65431224|NCT01565798|Trace Elements|trace elements|mesh-ancestor
65431225|NCT01565798|Micronutrients|micronutrients|mesh-ancestor
65431226|NCT01565798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431227|NCT01030328|Fenofibrate|fenofibrate|mesh-list
65431228|NCT01030328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65431229|NCT01030328|Antimetabolites|antimetabolites|mesh-ancestor
65431230|NCT01030328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431231|NCT01030328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65431283|NCT00411450|Panitumumab|panitumumab|mesh-list
65431284|NCT00411450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65431285|NCT00411450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431286|NCT00404820|Vitamin D|vitamin d|mesh-list
65431287|NCT00404820|Zoledronic Acid|zoledronic acid|mesh-list
65431288|NCT00404820|Alendronate|alendronate|mesh-list
65431289|NCT00404820|Calcium|calcium|mesh-list
65431290|NCT00404820|Vitamins|vitamins|mesh-ancestor
65431291|NCT00404820|Micronutrients|micronutrients|mesh-ancestor
65431292|NCT00404820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431293|NCT00404820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65431294|NCT00404820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65431295|NCT00446030|Cyclophosphamide|cyclophosphamide|mesh-list
65431296|NCT00446030|Bevacizumab|bevacizumab|mesh-list
65431297|NCT00446030|Carboplatin|carboplatin|mesh-list
65431298|NCT00446030|Docetaxel|docetaxel|mesh-list
65431299|NCT00446030|Doxorubicin|doxorubicin|mesh-list
65431300|NCT00446030|Trastuzumab|trastuzumab|mesh-list
65431301|NCT00446030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65431302|NCT00446030|Immunologic Factors|immunologic factors|mesh-ancestor
65431303|NCT00446030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431304|NCT00446030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65431305|NCT00446030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65431306|NCT00446030|Alkylating Agents|alkylating agents|mesh-ancestor
65431307|NCT00446030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431308|NCT00446030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431335|NCT01036854|Ondansetron|ondansetron|mesh-list
65431336|NCT01036854|Antiemetics|antiemetics|mesh-ancestor
65431337|NCT01036854|Autonomic Agents|autonomic agents|mesh-ancestor
65431338|NCT01036854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65431339|NCT01036854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431340|NCT01036854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65431341|NCT01036854|Antipruritics|antipruritics|mesh-ancestor
65431342|NCT01036854|Dermatologic Agents|dermatologic agents|mesh-ancestor
65431343|NCT01036854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65431344|NCT01036854|Serotonin Agents|serotonin agents|mesh-ancestor
65431345|NCT01036854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65431346|NCT01036854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431347|NCT01036854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65431348|NCT01036854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65431349|NCT01036854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65431350|NCT01036854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65431351|NCT01036854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65431352|NCT01030796|Caffeine|caffeine|mesh-list
65431353|NCT01030796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65431354|NCT01030796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431355|NCT01030796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65431356|NCT01030796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431357|NCT01030796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431358|NCT01030796|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65431359|NCT01030796|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65431360|NCT01030796|Purinergic Agents|purinergic agents|mesh-ancestor
65431361|NCT01030796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65431362|NCT00455858|Insulin Detemir|insulin detemir|mesh-list
65431363|NCT00455858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65431364|NCT00455858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431382|NCT00439556|Thymoglobulin|thymoglobulin|mesh-list
65431383|NCT00439556|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65431384|NCT00439556|Immunologic Factors|immunologic factors|mesh-ancestor
65431385|NCT00439556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431386|NCT00439556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431387|NCT00439556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65431388|NCT00439556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65431389|NCT00439556|Abortifacient Agents|abortifacient agents|mesh-ancestor
65431390|NCT00439556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65431391|NCT00439556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65431392|NCT00439556|Antimetabolites|antimetabolites|mesh-ancestor
65431393|NCT00439556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431444|NCT03802058|Tubulin Modulators|tubulin modulators|mesh-ancestor
65431445|NCT03802058|Antimitotic Agents|antimitotic agents|mesh-ancestor
65431446|NCT03802058|Mitosis Modulators|mitosis modulators|mesh-ancestor
65431447|NCT03802058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431448|NCT00445328|Heparin|heparin|mesh-list
65431449|NCT00445328|Calcium heparin|calcium heparin|mesh-list
65431450|NCT00445328|Dalteparin|dalteparin|mesh-list
65431451|NCT00445328|Tinzaparin|tinzaparin|mesh-list
65431452|NCT00445328|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65431453|NCT00445328|Anticoagulants|anticoagulants|mesh-ancestor
65431454|NCT00445328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65431455|NCT00445328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65431456|NCT00445328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431457|NCT00455312|Methylprednisolone|methylprednisolone|mesh-list
65431458|NCT00455312|Cyclophosphamide|cyclophosphamide|mesh-list
65431459|NCT00455312|Fludarabine|fludarabine|mesh-list
65431460|NCT00455312|Alemtuzumab|alemtuzumab|mesh-list
65431461|NCT00455312|Thymoglobulin|thymoglobulin|mesh-list
65431462|NCT00455312|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65431463|NCT00455312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65431464|NCT00455312|Immunologic Factors|immunologic factors|mesh-ancestor
65431465|NCT00455312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431466|NCT00455312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65431467|NCT00455312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65431468|NCT00455312|Alkylating Agents|alkylating agents|mesh-ancestor
65431470|NCT00455312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431495|NCT01031030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65431496|NCT01031030|Antimetabolites|antimetabolites|mesh-ancestor
65431497|NCT01031030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65431498|NCT01031030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65431499|NCT01031030|Abortifacient Agents|abortifacient agents|mesh-ancestor
65431500|NCT01031030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65431501|NCT01031030|Dermatologic Agents|dermatologic agents|mesh-ancestor
65431502|NCT01031030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431503|NCT01031030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65431504|NCT01031030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65431505|NCT01031030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65431506|NCT01031030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65431507|NCT01031030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65431508|NCT01024712|Paclitaxel|paclitaxel|mesh-list
65431509|NCT01024712|Carboplatin|carboplatin|mesh-list
65431510|NCT01024712|Gefitinib|gefitinib|mesh-list
65431511|NCT01024712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65431512|NCT01024712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431513|NCT01024712|Tubulin Modulators|tubulin modulators|mesh-ancestor
65431514|NCT01024712|Antimitotic Agents|antimitotic agents|mesh-ancestor
65431515|NCT01024712|Mitosis Modulators|mitosis modulators|mesh-ancestor
65431516|NCT01024712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431517|NCT01024712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65431518|NCT01024712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431519|NCT01323452|Entecavir|entecavir|mesh-list
65431520|NCT01323452|Antiviral Agents|antiviral agents|mesh-ancestor
65431544|NCT01024868|Anesthetics|anesthetics|mesh-ancestor
65431545|NCT01024868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65431546|NCT01024868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431547|NCT01024868|Sensory System Agents|sensory system agents|mesh-ancestor
65431548|NCT01024868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65431550|NCT03795194|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65431551|NCT03795194|Clavulanic Acids|clavulanic acids|mesh-list
65431552|NCT03795194|Ampicillin|ampicillin|mesh-list
65431553|NCT03795194|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65431554|NCT03795194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431555|NCT03795194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431556|NCT03795194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65431557|NCT03795194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65431558|NCT00404352|Interferon beta-1a|interferon beta-1a|mesh-list
65431559|NCT00404352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65431560|NCT00404352|Immunologic Factors|immunologic factors|mesh-ancestor
65431561|NCT00404352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431562|NCT00404352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431563|NCT00404352|Antiviral Agents|antiviral agents|mesh-ancestor
65431564|NCT00404352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65431565|NCT00439244|Zoledronic Acid|zoledronic acid|mesh-list
65431566|NCT00439244|Teriparatide|teriparatide|mesh-list
65431570|NCT04844762|Menthol|menthol|mesh-list
65431596|NCT01033760|Ritonavir|ritonavir|mesh-list
65431597|NCT01033760|Darunavir|darunavir|mesh-list
65431598|NCT01033760|Tenofovir|tenofovir|mesh-list
65431599|NCT01033760|Emtricitabine|emtricitabine|mesh-list
65431600|NCT01033760|Raltegravir Potassium|raltegravir potassium|mesh-list
65431601|NCT01033760|Maraviroc|maraviroc|mesh-list
65431602|NCT01033760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65431603|NCT01033760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65431665|NCT00410046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65431666|NCT00410046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65431667|NCT00410046|Immunologic Factors|immunologic factors|mesh-ancestor
65431668|NCT00416624|Epoetin Alfa|epoetin alfa|mesh-list
65431669|NCT00416624|Darbepoetin alfa|darbepoetin alfa|mesh-list
65431670|NCT00416624|Hematinics|hematinics|mesh-ancestor
65431671|NCT02501954|Paclitaxel|paclitaxel|mesh-list
65431672|NCT02501954|Carboplatin|carboplatin|mesh-list
65431673|NCT02501954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65431674|NCT02501954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431675|NCT02501954|Tubulin Modulators|tubulin modulators|mesh-ancestor
65431676|NCT02501954|Antimitotic Agents|antimitotic agents|mesh-ancestor
65431677|NCT02501954|Mitosis Modulators|mitosis modulators|mesh-ancestor
65431678|NCT02501954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431679|NCT00262600|Warfarin|warfarin|mesh-list
65431680|NCT00262600|Dabigatran|dabigatran|mesh-list
65431681|NCT00262600|Anticoagulants|anticoagulants|mesh-ancestor
65431682|NCT00262600|Antithrombins|antithrombins|mesh-ancestor
65431683|NCT00262600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65431684|NCT00262600|Protease Inhibitors|protease inhibitors|mesh-ancestor
65431685|NCT00262600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431686|NCT00262600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431687|NCT00409578|Valsartan|valsartan|mesh-list
65431688|NCT00409578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65431689|NCT00409578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65431690|NCT00409578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65431691|NCT00409578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431715|NCT00262522|Protease Inhibitors|protease inhibitors|mesh-ancestor
65431716|NCT00262522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431717|NCT00262522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431718|NCT00262522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65431719|NCT00262522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65431720|NCT00262522|Antiviral Agents|antiviral agents|mesh-ancestor
65431721|NCT00262522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65431722|NCT00262522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65431723|NCT00262522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65431778|NCT00409344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65431779|NCT00409344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65431780|NCT00409344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431781|NCT00409344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65431782|NCT00409344|Analgesics|analgesics|mesh-ancestor
65431783|NCT00409344|Sensory System Agents|sensory system agents|mesh-ancestor
65431784|NCT00409344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65431785|NCT00409344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65431786|NCT00409344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65431787|NCT00409344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65431788|NCT00409344|Adrenergic Agents|adrenergic agents|mesh-ancestor
65431789|NCT00409344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65431790|NCT00409344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431791|NCT00415610|Nicardipine|nicardipine|mesh-list
65431792|NCT00415610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65431793|NCT00415610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65431794|NCT00415610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65431795|NCT00415610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431832|NCT00249808|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65431833|NCT00249808|Immunologic Factors|immunologic factors|mesh-ancestor
65431834|NCT00249808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431835|NCT00278512|Cyclophosphamide|cyclophosphamide|mesh-list
65431836|NCT00278512|Fludarabine|fludarabine|mesh-list
65431837|NCT00278512|Alemtuzumab|alemtuzumab|mesh-list
65431838|NCT00278512|Tacrolimus|tacrolimus|mesh-list
65431839|NCT00278512|Thymoglobulin|thymoglobulin|mesh-list
65431840|NCT00278512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65431841|NCT00278512|Immunologic Factors|immunologic factors|mesh-ancestor
65431842|NCT00278512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431843|NCT00278512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65431844|NCT00278512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65431845|NCT00278512|Alkylating Agents|alkylating agents|mesh-ancestor
65431846|NCT00278512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431847|NCT00278512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431848|NCT00278512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65431849|NCT00278512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65431850|NCT00278512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431851|NCT00278512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65431852|NCT01072240|Rituximab|rituximab|mesh-list
65431887|NCT01324076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431888|NCT01324076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431889|NCT01324076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65431890|NCT00409188|Cyclophosphamide|cyclophosphamide|mesh-list
65431891|NCT00409188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65431892|NCT00409188|Immunologic Factors|immunologic factors|mesh-ancestor
65431893|NCT00409188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431894|NCT00409188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65431895|NCT00409188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65431896|NCT00409188|Alkylating Agents|alkylating agents|mesh-ancestor
65431897|NCT00409188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431898|NCT00409188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431899|NCT00409188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65431900|NCT00434954|Insulin Aspart|insulin aspart|mesh-list
65431901|NCT00434954|Exenatide|exenatide|mesh-list
65431902|NCT00434954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65431903|NCT00434954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431904|NCT00434954|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65431905|NCT00434954|Incretins|incretins|mesh-ancestor
65431906|NCT00434954|Hormones|hormones|mesh-ancestor
65431907|NCT00434954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65431908|NCT00276484|Atorvastatin|atorvastatin|mesh-list
65431909|NCT00276484|Ezetimibe|ezetimibe|mesh-list
65431910|NCT00276484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65431911|NCT00276484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65431912|NCT00276484|Antimetabolites|antimetabolites|mesh-ancestor
65431913|NCT00276484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431914|NCT00276484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65431915|NCT00276484|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65431931|NCT00434876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65431932|NCT00434876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65431933|NCT00434876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65431934|NCT00434876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65431935|NCT00434876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431936|NCT01072318|Letrozole|letrozole|mesh-list
65431937|NCT01072318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65431938|NCT01072318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65431939|NCT01072318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65431940|NCT01072318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65431941|NCT01072318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65431942|NCT01072318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65431992|NCT00434642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65431993|NCT00434642|Growth Substances|growth substances|mesh-ancestor
65431994|NCT00434642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65431995|NCT00434642|Growth Inhibitors|growth inhibitors|mesh-ancestor
65431997|NCT00434642|Antimetabolites|antimetabolites|mesh-ancestor
65432061|NCT00408876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65432062|NCT00408876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65432063|NCT00408876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65432131|NCT00425438|Cyclophosphamide|cyclophosphamide|mesh-list
65432132|NCT00425438|Azathioprine|azathioprine|mesh-list
65432133|NCT00425438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65432134|NCT00425438|Immunologic Factors|immunologic factors|mesh-ancestor
65432135|NCT00425438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432136|NCT00425438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65432137|NCT00425438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65432138|NCT00425438|Alkylating Agents|alkylating agents|mesh-ancestor
65432139|NCT00425438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432140|NCT00425438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432141|NCT00425438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65432142|NCT00425438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65432143|NCT00425438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65432144|NCT00425438|Antitubercular Agents|antitubercular agents|mesh-ancestor
65432145|NCT00425438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65432146|NCT00425438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65432150|NCT00425438|Hormones|hormones|mesh-ancestor
65432188|NCT00433004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65432189|NCT00433004|Contraceptive Agents|contraceptive agents|mesh-ancestor
65432190|NCT00433004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65432191|NCT00433004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432192|NCT00433004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65432193|NCT00433004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65432194|NCT00433004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65432195|NCT02732288|Melatonin|melatonin|mesh-list
65432196|NCT02732288|Antioxidants|antioxidants|mesh-ancestor
65432197|NCT02732288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432198|NCT02732288|Protective Agents|protective agents|mesh-ancestor
65432199|NCT02732288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432200|NCT02732288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65432201|NCT00393042|Amphetamine|amphetamine|mesh-list
65432202|NCT00393042|Adderall|adderall|mesh-list
65432247|NCT03546192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432248|NCT01043952|Remifentanil|remifentanil|mesh-list
65432249|NCT01043952|Propofol|propofol|mesh-list
65432250|NCT01043952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65432251|NCT01043952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65432252|NCT01043952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432253|NCT01043952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65432254|NCT01043952|Anesthetics, General|anesthetics, general|mesh-ancestor
65432255|NCT01043952|Anesthetics|anesthetics|mesh-ancestor
65432256|NCT01043952|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65432257|NCT01043952|Narcotics|narcotics|mesh-ancestor
65432258|NCT01043952|Analgesics|analgesics|mesh-ancestor
65432259|NCT01043952|Sensory System Agents|sensory system agents|mesh-ancestor
65432260|NCT01043952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65432261|NCT00274924|Prednisone|prednisone|mesh-list
65432262|NCT00274924|Cyclophosphamide|cyclophosphamide|mesh-list
65432263|NCT00274924|Ifosfamide|ifosfamide|mesh-list
65432264|NCT00274924|Rituximab|rituximab|mesh-list
65432265|NCT00274924|Carboplatin|carboplatin|mesh-list
65432266|NCT00274924|Doxorubicin|doxorubicin|mesh-list
65432267|NCT00274924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65432268|NCT00274924|Etoposide|etoposide|mesh-list
65432304|NCT00274846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432305|NCT00274846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65432306|NCT00274846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65432307|NCT00274846|Alkylating Agents|alkylating agents|mesh-ancestor
65432308|NCT00274846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432309|NCT00274846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432310|NCT00274846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65432311|NCT00274846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65432370|NCT00236080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432371|NCT00236080|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65432372|NCT00236080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65432373|NCT00236080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65432439|NCT00408408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432440|NCT00408408|Tubulin Modulators|tubulin modulators|mesh-ancestor
65432441|NCT00408408|Antimitotic Agents|antimitotic agents|mesh-ancestor
65432442|NCT00408408|Mitosis Modulators|mitosis modulators|mesh-ancestor
65432443|NCT00408408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65432444|NCT00408408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65432445|NCT00408408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65181957|NCT02803918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65432446|NCT00414050|Vaccines|vaccines|mesh-list
65432447|NCT00414050|Immunologic Factors|immunologic factors|mesh-ancestor
65432448|NCT00414050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432449|NCT03973840|Methyltestosterone|methyltestosterone|mesh-list
65432450|NCT03973840|Testosterone|testosterone|mesh-list
65432454|NCT03973840|Androgens|androgens|mesh-ancestor
65432500|NCT01071694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432501|NCT01071694|Antiviral Agents|antiviral agents|mesh-ancestor
65432502|NCT01071694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65432503|NCT01071694|Immunologic Factors|immunologic factors|mesh-ancestor
65432504|NCT01071694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432505|NCT01071694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65432506|NCT00413894|Epoetin Alfa|epoetin alfa|mesh-list
65432507|NCT00413894|Hematinics|hematinics|mesh-ancestor
65432508|NCT03972748|Itraconazole|itraconazole|mesh-list
65432509|NCT03972748|Antifungal Agents|antifungal agents|mesh-ancestor
65432510|NCT03972748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65432511|NCT03972748|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65432512|NCT03972748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65432513|NCT03972748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432514|NCT03972748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432515|NCT03972748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65432516|NCT03972748|Hormone Antagonists|hormone antagonists|mesh-ancestor
65432517|NCT03972748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65432518|NCT03972748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432519|NCT03972748|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65432520|NCT01581814|Metformin|metformin|mesh-list
65432521|NCT01581814|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65432522|NCT01581814|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65432523|NCT01581814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65432524|NCT01581814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432525|NCT01581814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65432526|NCT01581814|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65432527|NCT01581814|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65432528|NCT01581814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65432529|NCT01581814|Contraceptive Agents|contraceptive agents|mesh-ancestor
65432530|NCT01581814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65432531|NCT01581814|Estrogens|estrogens|mesh-ancestor
65432532|NCT01581814|Hormones|hormones|mesh-ancestor
65432533|NCT01581814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65432538|NCT00407550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432539|NCT00407550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432540|NCT00407550|Antiviral Agents|antiviral agents|mesh-ancestor
65432541|NCT00407550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65432542|NCT00407550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432543|NCT00407550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65432544|NCT00407550|Immunologic Factors|immunologic factors|mesh-ancestor
65432605|NCT00004494|Protective Agents|protective agents|mesh-ancestor
65432606|NCT00004494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432607|NCT00315705|Cyclophosphamide|cyclophosphamide|mesh-list
65432608|NCT00315705|Etoposide|etoposide|mesh-list
65432609|NCT00315705|Clofarabine|clofarabine|mesh-list
65432610|NCT00315705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65432611|NCT00315705|Immunologic Factors|immunologic factors|mesh-ancestor
65432612|NCT00315705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432613|NCT00315705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65432614|NCT00315705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65432615|NCT00315705|Alkylating Agents|alkylating agents|mesh-ancestor
65432616|NCT00315705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432670|NCT03980847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182187|NCT02624401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65432671|NCT00391872|Clopidogrel|clopidogrel|mesh-list
65432672|NCT00391872|Ticagrelor|ticagrelor|mesh-list
65432673|NCT00391872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65432674|NCT00391872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65432675|NCT00391872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65432676|NCT00391872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65432677|NCT00391872|Purinergic Agents|purinergic agents|mesh-ancestor
65432736|NCT00305877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65432737|NCT00305877|Cetuximab|cetuximab|mesh-list
65432738|NCT00305877|Capecitabine|capecitabine|mesh-list
65432739|NCT00305877|Antibodies|antibodies|mesh-list
65432740|NCT00305877|Immunoglobulins|immunoglobulins|mesh-list
65432741|NCT00305877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65432742|NCT00305877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65432743|NCT00305877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65432744|NCT00305877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65182258|NCT00695929|Simendan|simendan|mesh-list
65432745|NCT00305877|Growth Substances|growth substances|mesh-ancestor
65432802|NCT01062945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65432803|NCT01062945|Adrenergic Agents|adrenergic agents|mesh-ancestor
65432804|NCT01062945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65432805|NCT01062945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432806|NCT01062945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432807|NCT01063023|Moxifloxacin|moxifloxacin|mesh-list
65432808|NCT01063023|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65432809|NCT01063023|Asunaprevir|asunaprevir|mesh-list
65432810|NCT01063023|Protease Inhibitors|protease inhibitors|mesh-ancestor
65432811|NCT01063023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432812|NCT01063023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432813|NCT01063023|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65432814|NCT01063023|Contraceptive Agents|contraceptive agents|mesh-ancestor
65432815|NCT01063023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65432816|NCT01063023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432817|NCT01063023|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65432818|NCT01063023|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65432819|NCT01063023|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65182331|NCT02624089|Ropivacaine|ropivacaine|mesh-list
65432856|NCT01063179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432857|NCT01063179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65432858|NCT01063179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65432859|NCT01063179|Immunologic Factors|immunologic factors|mesh-ancestor
65432860|NCT01063179|Leprostatic Agents|leprostatic agents|mesh-ancestor
65432861|NCT01063179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65432862|NCT01063179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65432863|NCT01063179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65432864|NCT01063179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65432865|NCT01063179|Growth Substances|growth substances|mesh-ancestor
65432866|NCT01063179|Growth Inhibitors|growth inhibitors|mesh-ancestor
65432867|NCT00293709|Etanercept|etanercept|mesh-list
65432868|NCT00293709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65432869|NCT00293709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65432870|NCT00293709|Analgesics|analgesics|mesh-ancestor
65432871|NCT00293709|Sensory System Agents|sensory system agents|mesh-ancestor
65432872|NCT00293709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65432873|NCT00293709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432874|NCT00293709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65432875|NCT00293709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65432876|NCT00293709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65432877|NCT00293709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65432878|NCT00293709|Immunologic Factors|immunologic factors|mesh-ancestor
65432907|NCT01064271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65432908|NCT01064271|Serotonin Agents|serotonin agents|mesh-ancestor
65432909|NCT01064271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65432910|NCT01064271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432911|NCT01064271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65432912|NCT01064271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65432913|NCT01064271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65432914|NCT01064271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65432915|NCT01064271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65432971|NCT03980223|Antimalarials|antimalarials|mesh-ancestor
65432972|NCT03980223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65432973|NCT03980223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65432974|NCT01067391|Tadalafil|tadalafil|mesh-list
65432975|NCT01067391|Vasodilator Agents|vasodilator agents|mesh-ancestor
65432976|NCT01067391|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65432977|NCT01067391|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65432978|NCT01067391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65432979|NCT01067391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65432982|NCT00402168|Abatacept|abatacept|mesh-list
65433040|NCT00290511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65433041|NCT00290511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65433042|NCT00290511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65433043|NCT00290511|Antimetabolites|antimetabolites|mesh-ancestor
65433044|NCT00290511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433045|NCT00290511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65433046|NCT00290511|Analgesics|analgesics|mesh-ancestor
65433047|NCT00290511|Sensory System Agents|sensory system agents|mesh-ancestor
65433048|NCT00290511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65433049|NCT00290511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65433050|NCT00290511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433051|NCT00290433|Cytarabine|cytarabine|mesh-list
65433052|NCT00290433|Dexamethasone|dexamethasone|mesh-list
65433053|NCT00290433|Cyclophosphamide|cyclophosphamide|mesh-list
65433054|NCT00290433|Doxorubicin|doxorubicin|mesh-list
65433099|NCT00304083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433100|NCT00304083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65433101|NCT00304083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65433102|NCT00304083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433103|NCT00304083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433104|NCT00304083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65433105|NCT00304083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65433106|NCT00304083|Alkylating Agents|alkylating agents|mesh-ancestor
65433164|NCT00289887|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65433165|NCT00289887|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65433166|NCT00289887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433167|NCT01068093|Ezetimibe|ezetimibe|mesh-list
65433168|NCT01068093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65433169|NCT01068093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65433170|NCT01068093|Antimetabolites|antimetabolites|mesh-ancestor
65433172|NCT01068093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65433229|NCT00390546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65433230|NCT00390546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65433231|NCT00390546|Adrenergic Agents|adrenergic agents|mesh-ancestor
65433232|NCT00390546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65433233|NCT00390546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433234|NCT00390546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433235|NCT00390546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65433236|NCT00390546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65433237|NCT00390546|Vasodilator Agents|vasodilator agents|mesh-ancestor
65433238|NCT00390546|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65433239|NCT00390546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433240|NCT00390546|Protective Agents|protective agents|mesh-ancestor
65433241|NCT00400764|Rituximab|rituximab|mesh-list
65433242|NCT00400764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65433243|NCT00400764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433244|NCT00400764|Immunologic Factors|immunologic factors|mesh-ancestor
65433245|NCT00400764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433246|NCT00400764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65433247|NCT00302211|Bosentan|bosentan|mesh-list
65433248|NCT00302211|Sildenafil Citrate|sildenafil citrate|mesh-list
65433249|NCT00302211|Iloprost|iloprost|mesh-list
65433250|NCT00302211|Vasodilator Agents|vasodilator agents|mesh-ancestor
65433251|NCT00302211|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65433252|NCT00302211|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65433253|NCT00302211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433254|NCT00302211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433255|NCT00302211|Urological Agents|urological agents|mesh-ancestor
65433256|NCT00302211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65433257|NCT00302211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65433258|NCT00302211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65433259|NCT01045902|Moxifloxacin|moxifloxacin|mesh-list
65433273|NCT01045902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433274|NCT01045902|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65433275|NCT01045902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65433276|NCT01045902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65433277|NCT01045902|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65433278|NCT01041690|Bevacizumab|bevacizumab|mesh-list
65433279|NCT01041690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65433280|NCT01041690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433281|NCT01041690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65433282|NCT01041690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65433340|NCT00388362|Prednisone|prednisone|mesh-list
65433341|NCT00388362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65182864|NCT02788552|Vitamins|vitamins|mesh-list
65433342|NCT00388362|Glucocorticoids|glucocorticoids|mesh-ancestor
65433343|NCT00388362|Hormones|hormones|mesh-ancestor
65433344|NCT00388362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65433345|NCT00388362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433346|NCT00388362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65433347|NCT00388362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433348|NCT00388362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65433349|NCT00388362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65433350|NCT00388362|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65433351|NCT00388362|Antifungal Agents|antifungal agents|mesh-ancestor
65433352|NCT00388362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65433353|NCT00388362|Immunologic Factors|immunologic factors|mesh-ancestor
65433354|NCT01046058|Simeprevir|simeprevir|mesh-list
65433355|NCT01046058|Antiviral Agents|antiviral agents|mesh-ancestor
65433356|NCT01046058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65433357|NCT01046058|Protease Inhibitors|protease inhibitors|mesh-ancestor
65433393|NCT00387348|Dexetimide|dexetimide|mesh-list
65433394|NCT00387348|Citalopram|citalopram|mesh-list
65433395|NCT00387348|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65433396|NCT00387348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65433397|NCT00387348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65433398|NCT00387348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433399|NCT00387348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65433400|NCT00387348|Serotonin Agents|serotonin agents|mesh-ancestor
65433401|NCT00387348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433402|NCT00387348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65433403|NCT00387348|Antidepressive Agents|antidepressive agents|mesh-ancestor
65433404|NCT00387348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65433405|NCT00387348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65433406|NCT00387348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65433407|NCT00387348|Parasympatholytics|parasympatholytics|mesh-ancestor
65433408|NCT00387348|Autonomic Agents|autonomic agents|mesh-ancestor
65433409|NCT00387348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65433410|NCT00387348|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65433411|NCT00387348|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65433412|NCT00387348|Cholinergic Agents|cholinergic agents|mesh-ancestor
65433415|NCT03992820|Anesthetics|anesthetics|mesh-ancestor
65433444|NCT00431444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65433445|NCT00431444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65433446|NCT00431444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65433447|NCT02594384|Rituximab|rituximab|mesh-list
65433448|NCT02594384|Atezolizumab|atezolizumab|mesh-list
65433449|NCT02594384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65433450|NCT02594384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433512|NCT00429416|Antiviral Agents|antiviral agents|mesh-ancestor
65433513|NCT00429416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65433514|NCT00429416|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65433515|NCT00429416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433516|NCT00429416|Protective Agents|protective agents|mesh-ancestor
65433517|NCT00429182|Cyclophosphamide|cyclophosphamide|mesh-list
65433518|NCT00429182|Thiotepa|thiotepa|mesh-list
65433519|NCT00429182|Carboplatin|carboplatin|mesh-list
65433520|NCT00429182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65433521|NCT00429182|Immunologic Factors|immunologic factors|mesh-ancestor
65433522|NCT00429182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433523|NCT00429182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65433524|NCT00429182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65433525|NCT00429182|Alkylating Agents|alkylating agents|mesh-ancestor
65433575|NCT00301821|Antimitotic Agents|antimitotic agents|mesh-ancestor
65433576|NCT00301821|Mitosis Modulators|mitosis modulators|mesh-ancestor
65433577|NCT03976713|Bromides|bromides|mesh-list
65433578|NCT03976713|Tiotropium Bromide|tiotropium bromide|mesh-list
65433579|NCT03976713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65433580|NCT03976713|Autonomic Agents|autonomic agents|mesh-ancestor
65433581|NCT03976713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65433582|NCT03976713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433583|NCT03976713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65433584|NCT03976713|Respiratory System Agents|respiratory system agents|mesh-ancestor
65433585|NCT03976713|Parasympatholytics|parasympatholytics|mesh-ancestor
65433586|NCT03976713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65433587|NCT03976713|Cholinergic Agents|cholinergic agents|mesh-ancestor
65433588|NCT03976713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65433589|NCT03976713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433590|NCT03976713|Anticonvulsants|anticonvulsants|mesh-ancestor
65433591|NCT00372996|Fulvestrant|fulvestrant|mesh-list
65433592|NCT00372996|Exemestane|exemestane|mesh-list
65433593|NCT00372996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65433594|NCT00372996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433595|NCT00372996|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65433596|NCT00372996|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65433597|NCT00372996|Hormone Antagonists|hormone antagonists|mesh-ancestor
65433598|NCT00372996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65433599|NCT00372996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433600|NCT00372996|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65433601|NCT00372996|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65433602|NCT00372996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433604|NCT00399360|Metformin|metformin|mesh-list
65433618|NCT00428792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433619|NCT00428792|Dopamine Agents|dopamine agents|mesh-ancestor
65433620|NCT00428792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65433621|NCT00300885|Paclitaxel|paclitaxel|mesh-list
65433622|NCT00300885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65433623|NCT00300885|Carboplatin|carboplatin|mesh-list
65433624|NCT00300885|Sorafenib|sorafenib|mesh-list
65433625|NCT00300885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65433626|NCT00300885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433627|NCT00300885|Tubulin Modulators|tubulin modulators|mesh-ancestor
65433628|NCT00300885|Antimitotic Agents|antimitotic agents|mesh-ancestor
65433629|NCT00300885|Mitosis Modulators|mitosis modulators|mesh-ancestor
65433630|NCT00300885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433631|NCT00300885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65433633|NCT00386334|Eszopiclone|eszopiclone|mesh-list
65433678|NCT03979989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65433679|NCT03979989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433680|NCT03979989|Analgesics|analgesics|mesh-ancestor
65433681|NCT03979989|Sensory System Agents|sensory system agents|mesh-ancestor
65433682|NCT03979989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65433683|NCT03979989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65433684|NCT03979989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65433685|NCT03979989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65433686|NCT03979989|Adrenergic Agents|adrenergic agents|mesh-ancestor
65433687|NCT03979989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65433688|NCT01325571|Tacrolimus|tacrolimus|mesh-list
65433689|NCT01325571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65433690|NCT01325571|Immunologic Factors|immunologic factors|mesh-ancestor
65433691|NCT01325571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433692|NCT01325571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65433693|NCT01325571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433694|NCT01325571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433695|NCT00386022|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65433696|NCT00386022|Estrogens|estrogens|mesh-list
65433697|NCT00386022|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
65433698|NCT00386022|Hormones|hormones|mesh-ancestor
65433699|NCT00386022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65433700|NCT00386022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433701|NCT00386022|Hormone Antagonists|hormone antagonists|mesh-ancestor
65433702|NCT01068795|Enoxaparin|enoxaparin|mesh-list
65433703|NCT01068795|Anticoagulants|anticoagulants|mesh-ancestor
65433704|NCT01068795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65433705|NCT01068795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65433721|NCT00385944|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65433722|NCT00385944|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65433723|NCT00385944|Purinergic Agents|purinergic agents|mesh-ancestor
65433724|NCT00385944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65433725|NCT00385944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433726|NCT00385944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433727|NCT00286221|Fentanyl|fentanyl|mesh-list
65433728|NCT00286221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65433729|NCT00286221|Narcotics|narcotics|mesh-ancestor
65433730|NCT00286221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65433731|NCT00286221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433732|NCT00286221|Analgesics|analgesics|mesh-ancestor
65433733|NCT00286221|Sensory System Agents|sensory system agents|mesh-ancestor
65433734|NCT00286221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65433735|NCT00286221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65433736|NCT00286221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65433737|NCT00286221|Anesthetics, General|anesthetics, general|mesh-ancestor
65433738|NCT00286221|Anesthetics|anesthetics|mesh-ancestor
65433739|NCT00398112|Sunitinib|sunitinib|mesh-list
65433740|NCT00398112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433741|NCT00398112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65433774|NCT00372528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65433775|NCT00372528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65433776|NCT00372528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433777|NCT00372528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65433778|NCT00372528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65433779|NCT00372528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65433780|NCT00372528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65433781|NCT00372528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65433782|NCT00283803|Sulindac sulfone|sulindac sulfone|mesh-list
65433783|NCT00283803|Hormones|hormones|mesh-list
65183309|NCT02786446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433832|NCT03742466|Prednisolone phosphate|prednisolone phosphate|mesh-list
65433833|NCT03742466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65433834|NCT03742466|Antiemetics|antiemetics|mesh-ancestor
65433835|NCT03742466|Autonomic Agents|autonomic agents|mesh-ancestor
65433836|NCT03742466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65433837|NCT03742466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433838|NCT03742466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65433839|NCT03742466|Glucocorticoids|glucocorticoids|mesh-ancestor
65433840|NCT03742466|Hormones|hormones|mesh-ancestor
65433841|NCT03742466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65433842|NCT03742466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65433843|NCT03742466|Protective Agents|protective agents|mesh-ancestor
65433844|NCT03742466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65433845|NCT03742466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433846|NCT01065285|Vaccines|vaccines|mesh-list
65433847|NCT01065285|Immunologic Factors|immunologic factors|mesh-ancestor
65433848|NCT01065285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433849|NCT01033526|Aspirin|aspirin|mesh-list
65433850|NCT01033526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65433851|NCT01033526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65433852|NCT01033526|Analgesics|analgesics|mesh-ancestor
65433853|NCT01033526|Sensory System Agents|sensory system agents|mesh-ancestor
65433854|NCT01033526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65433855|NCT01033526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433856|NCT01033526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65433857|NCT01033526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65433858|NCT01033526|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65433859|NCT01033526|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65433860|NCT01033526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433861|NCT01033526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65433862|NCT01033526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65433863|NCT01033526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433864|NCT01033526|Antipyretics|antipyretics|mesh-ancestor
65433872|NCT00397488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65433873|NCT00397488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433874|NCT00397488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433875|NCT01581411|Plasminogen|plasminogen|mesh-list
65433876|NCT01581411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65433877|NCT01581411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65433878|NCT01581411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65433879|NCT01581411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433880|NCT02900664|Trametinib|trametinib|mesh-list
65433881|NCT02900664|Spartalizumab|spartalizumab|mesh-list
65433882|NCT02900664|Nazartinib|nazartinib|mesh-list
65433883|NCT02900664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433884|NCT02900664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65433885|NCT02900664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433886|NCT02900664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433887|NCT02900664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65433888|NCT01324596|Prednisolone|prednisolone|mesh-list
65433889|NCT01324596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65433929|NCT01324596|Protective Agents|protective agents|mesh-ancestor
65183459|NCT02784340|Protease Inhibitors|protease inhibitors|mesh-ancestor
65433930|NCT00424190|Vancomycin|vancomycin|mesh-list
65433931|NCT00424190|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
65433932|NCT00424190|Aztreonam|aztreonam|mesh-list
65433933|NCT00424190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65433934|NCT00424190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65433935|NCT02859012|Axitinib|axitinib|mesh-list
65433936|NCT02859012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433937|NCT02859012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65433938|NCT02859012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65433939|NCT02859012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433940|NCT00274287|Sargramostim|sargramostim|mesh-list
65433941|NCT00274287|Immunologic Factors|immunologic factors|mesh-ancestor
65433942|NCT00274287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65433943|NCT01045278|Interferons|interferons|mesh-list
65433944|NCT01045278|Ribavirin|ribavirin|mesh-list
65433945|NCT01045278|Interferon-alpha|interferon-alpha|mesh-list
65433946|NCT01045278|Interferon alpha-2|interferon alpha-2|mesh-list
65433947|NCT01045278|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65433949|NCT01045278|Antiviral Agents|antiviral agents|mesh-ancestor
65433983|NCT00272961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433984|NCT00282087|Gemcitabine|gemcitabine|mesh-list
65433985|NCT00282087|Docetaxel|docetaxel|mesh-list
65433986|NCT00282087|Doxorubicin|doxorubicin|mesh-list
65433987|NCT00282087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65433988|NCT00282087|Antimetabolites|antimetabolites|mesh-ancestor
65433989|NCT00282087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65433990|NCT00282087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65433991|NCT00282087|Antiviral Agents|antiviral agents|mesh-ancestor
65433992|NCT00282087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65434048|NCT02532309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65434049|NCT02532309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434050|NCT00258856|Vaccines|vaccines|mesh-list
65434051|NCT00258856|Immunologic Factors|immunologic factors|mesh-ancestor
65434052|NCT00258856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434053|NCT00269919|Risperidone|risperidone|mesh-list
65434054|NCT00269919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65434055|NCT00269919|Serotonin Agents|serotonin agents|mesh-ancestor
65434056|NCT00269919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65434057|NCT00269919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434067|NCT00257920|Vitamins|vitamins|mesh-ancestor
65434113|NCT00231478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434114|NCT00207142|Ritonavir|ritonavir|mesh-list
65434115|NCT00207142|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65434116|NCT00207142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65434117|NCT00207142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65434118|NCT00207142|Protease Inhibitors|protease inhibitors|mesh-ancestor
65434119|NCT00207142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434120|NCT00207142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434121|NCT00207142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65434122|NCT00207142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65434123|NCT00207142|Antiviral Agents|antiviral agents|mesh-ancestor
65434124|NCT00207142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65434125|NCT00207142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65434126|NCT00207142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65434127|NCT00268905|Carboplatin|carboplatin|mesh-list
65434128|NCT00268905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434129|NCT00206518|Docetaxel|docetaxel|mesh-list
65434130|NCT00206518|Doxorubicin|doxorubicin|mesh-list
65434169|NCT00423488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65434170|NCT00423488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434171|NCT03972592|Sirolimus|sirolimus|mesh-list
65434172|NCT03972592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65434173|NCT03972592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65434174|NCT03972592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65434175|NCT03972592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434176|NCT03972592|Antifungal Agents|antifungal agents|mesh-ancestor
65434177|NCT03972592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65434178|NCT03972592|Immunologic Factors|immunologic factors|mesh-ancestor
65434179|NCT03972592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434180|NCT00404066|Dexamethasone|dexamethasone|mesh-list
65434182|NCT00404066|Docetaxel|docetaxel|mesh-list
65434232|NCT00412958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434233|NCT00423176|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65434234|NCT00423176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65434235|NCT00423176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65434236|NCT00423176|Antitubercular Agents|antitubercular agents|mesh-ancestor
65434238|NCT01040702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65434300|NCT01042704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65434301|NCT01042704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65434302|NCT01042704|Analgesics|analgesics|mesh-ancestor
65434303|NCT01042704|Sensory System Agents|sensory system agents|mesh-ancestor
65434304|NCT01042704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65434305|NCT01042704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65434306|NCT01042704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65434307|NCT01042704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434308|NCT01042704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65434309|NCT01042704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65434310|NCT01042704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434311|NCT01042704|Antipyretics|antipyretics|mesh-ancestor
65434312|NCT01042704|Immunologic Factors|immunologic factors|mesh-ancestor
65434313|NCT01042704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65434314|NCT01042704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65434315|NCT01042704|Growth Substances|growth substances|mesh-ancestor
65434357|NCT01046994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434358|NCT01040936|Atorvastatin|atorvastatin|mesh-list
65434359|NCT01040936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65434360|NCT01040936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65434361|NCT01040936|Antimetabolites|antimetabolites|mesh-ancestor
65434362|NCT01040936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434363|NCT01040936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65434364|NCT01040936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65434365|NCT01040936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434366|NCT01041092|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65434367|NCT01041092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65434368|NCT01041092|Hormone Antagonists|hormone antagonists|mesh-ancestor
65434369|NCT01041092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65434370|NCT01041092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434371|NCT01041092|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65434372|NCT01041092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65434373|NCT01041092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65434374|NCT01041170|Rimonabant|rimonabant|mesh-list
65434375|NCT01041170|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65434376|NCT01041170|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65434406|NCT01039142|Acitretin|acitretin|mesh-list
65434407|NCT01039142|Keratolytic Agents|keratolytic agents|mesh-ancestor
65434408|NCT01039142|Dermatologic Agents|dermatologic agents|mesh-ancestor
65434409|NCT00422162|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65434410|NCT00422162|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65434476|NCT01047072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434477|NCT01047072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65434478|NCT01047072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65434479|NCT01047072|Antitubercular Agents|antitubercular agents|mesh-ancestor
65434480|NCT01047072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65434481|NCT01047072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65434482|NCT00372060|Pioglitazone|pioglitazone|mesh-list
65434483|NCT00372060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65434484|NCT00372060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65434485|NCT00372060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434487|NCT00372060|Hormones|hormones|mesh-ancestor
65434541|NCT00280293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65434542|NCT00280293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65434543|NCT00280293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434544|NCT00280293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65434545|NCT00280293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434546|NCT00280293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65434547|NCT00280293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65434606|NCT00403130|Antiviral Agents|antiviral agents|mesh-ancestor
65434607|NCT00403130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65434608|NCT00403130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434609|NCT00403130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65434610|NCT00403130|Immunologic Factors|immunologic factors|mesh-ancestor
65434611|NCT01039610|Moxifloxacin|moxifloxacin|mesh-list
65434612|NCT01039610|Linezolid|linezolid|mesh-list
65434613|NCT01039610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65434614|NCT01039610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65434615|NCT01039610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65434616|NCT01039610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65434617|NCT01039610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434618|NCT01039610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434619|NCT01039610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434620|NCT01039610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65434667|NCT00371826|Hormones|hormones|mesh-ancestor
65434668|NCT00371826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65434669|NCT00371826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434670|NCT00371826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65434671|NCT00371826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65434672|NCT00371826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434673|NCT00371826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434674|NCT00371826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65434675|NCT00371826|Immunologic Factors|immunologic factors|mesh-ancestor
65434676|NCT00371826|Antifungal Agents|antifungal agents|mesh-ancestor
65434677|NCT00371826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65434678|NCT00371826|Dermatologic Agents|dermatologic agents|mesh-ancestor
65434679|NCT00371826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65434680|NCT00371826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65434688|NCT02457702|Glycerol|glycerol|mesh-list
65434727|NCT00401258|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65434728|NCT00401258|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65434729|NCT00401258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65434730|NCT00401258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65434796|NCT00395694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65434797|NCT00395694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65434798|NCT00395694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434799|NCT00395694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65434800|NCT00395694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434801|NCT00395694|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65434802|NCT00395694|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65434803|NCT00395694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65434804|NCT00395694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65434805|NCT00395694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65434806|NCT00419744|Budesonide|budesonide|mesh-list
65434807|NCT00419744|Formoterol Fumarate|formoterol fumarate|mesh-list
65434808|NCT00419744|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65434809|NCT00419744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65434852|NCT00395304|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65434853|NCT00395304|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65434854|NCT00395304|Glucocorticoids|glucocorticoids|mesh-ancestor
65434855|NCT00395304|Hormones|hormones|mesh-ancestor
65434856|NCT00395304|Sympathomimetics|sympathomimetics|mesh-ancestor
65434857|NCT00395226|Zinc Sulfate|zinc sulfate|mesh-list
65434858|NCT00395226|Astringents|astringents|mesh-ancestor
65434859|NCT00395226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434860|NCT00395226|Dermatologic Agents|dermatologic agents|mesh-ancestor
65434861|NCT00394914|Pleconaril|pleconaril|mesh-list
65434862|NCT00394914|Antiviral Agents|antiviral agents|mesh-ancestor
65434863|NCT00394914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65434864|NCT00366444|Diclofenac|diclofenac|mesh-list
65434865|NCT00366444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65434866|NCT00366444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65434867|NCT00366444|Analgesics|analgesics|mesh-ancestor
65434868|NCT00366444|Sensory System Agents|sensory system agents|mesh-ancestor
65434869|NCT00366444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65434870|NCT00366444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434910|NCT00377520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434911|NCT00377520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434912|NCT00377520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65434913|NCT00377520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65434914|NCT00377364|Acetaminophen|acetaminophen|mesh-list
65434915|NCT00377364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65434916|NCT00377364|Analgesics|analgesics|mesh-ancestor
65434917|NCT00377364|Sensory System Agents|sensory system agents|mesh-ancestor
65434918|NCT00377364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65434919|NCT00377364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434920|NCT00377364|Antipyretics|antipyretics|mesh-ancestor
65434921|NCT00365508|Nicotine|nicotine|mesh-list
65434922|NCT00365508|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65434923|NCT00365508|Autonomic Agents|autonomic agents|mesh-ancestor
65434924|NCT00365508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65434925|NCT00365508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434926|NCT00365508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65434927|NCT00365508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65434928|NCT00365508|Cholinergic Agents|cholinergic agents|mesh-ancestor
65434929|NCT00365508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65434930|NCT00365508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434931|NCT00365352|Gabapentin|gabapentin|mesh-list
65434932|NCT00365352|Analgesics|analgesics|mesh-ancestor
65434933|NCT00365352|Sensory System Agents|sensory system agents|mesh-ancestor
65434934|NCT00365352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65434935|NCT00365352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65434936|NCT00365352|Anticonvulsants|anticonvulsants|mesh-ancestor
65434957|NCT00410072|Tenofovir|tenofovir|mesh-list
65434958|NCT00410072|Entecavir|entecavir|mesh-list
65434959|NCT00410072|Antiviral Agents|antiviral agents|mesh-ancestor
65434960|NCT00410072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65434961|NCT00410072|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65434962|NCT00410072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65434963|NCT00410072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65434964|NCT00410072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65434965|NCT00410072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65434966|NCT00410072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65434967|NCT00409838|Methotrexate|methotrexate|mesh-list
65434968|NCT00409838|Abatacept|abatacept|mesh-list
65434969|NCT00409838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65434970|NCT00409838|Abortifacient Agents|abortifacient agents|mesh-ancestor
65434971|NCT00409838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65434972|NCT00409838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184509|NCT01192178|Autonomic Agents|autonomic agents|mesh-ancestor
65435014|NCT01039844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435015|NCT01039844|Tubulin Modulators|tubulin modulators|mesh-ancestor
65435016|NCT01039844|Antimitotic Agents|antimitotic agents|mesh-ancestor
65435017|NCT01039844|Mitosis Modulators|mitosis modulators|mesh-ancestor
65435018|NCT01039844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435019|NCT01042028|Capecitabine|capecitabine|mesh-list
65435020|NCT01042028|Irinotecan|irinotecan|mesh-list
65435021|NCT01042028|Cetuximab|cetuximab|mesh-list
65435022|NCT01042028|Everolimus|everolimus|mesh-list
65435023|NCT01042028|Oxaliplatin|oxaliplatin|mesh-list
65435024|NCT01042028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65435025|NCT01042028|Antimetabolites|antimetabolites|mesh-ancestor
65435026|NCT01042028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435030|NCT01042028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435075|NCT02095184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65435076|NCT02095184|Hormone Antagonists|hormone antagonists|mesh-ancestor
65435077|NCT02095184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65435078|NCT02095184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435079|NCT02095184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65435080|NCT00397982|Sirolimus|sirolimus|mesh-list
65435081|NCT00397982|Bevacizumab|bevacizumab|mesh-list
65435082|NCT00397982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65435083|NCT00397982|Endothelial Growth Factors|endothelial growth factors|mesh-list
65435084|NCT00397982|Antibodies|antibodies|mesh-list
65435085|NCT00397982|Immunoglobulins|immunoglobulins|mesh-list
65435086|NCT00397982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65435087|NCT00397982|Immunoglobulin G|immunoglobulin g|mesh-list
65435088|NCT00397982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435089|NCT00397982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65435090|NCT00397982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65435091|NCT00397982|Growth Substances|growth substances|mesh-ancestor
65435092|NCT00397982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435093|NCT00397982|Growth Inhibitors|growth inhibitors|mesh-ancestor
65435094|NCT00397982|Immunologic Factors|immunologic factors|mesh-ancestor
65435095|NCT00397982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65435096|NCT00397982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65435097|NCT00397982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65435098|NCT00397982|Antifungal Agents|antifungal agents|mesh-ancestor
65435125|NCT01035320|Simvastatin|simvastatin|mesh-list
65435126|NCT01035320|Ezetimibe|ezetimibe|mesh-list
65435127|NCT01035320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65435128|NCT01035320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65435129|NCT01035320|Antimetabolites|antimetabolites|mesh-ancestor
65435130|NCT01035320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435131|NCT01035320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65435132|NCT01035320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65435134|NCT01042730|Pitavastatin|pitavastatin|mesh-list
65435191|NCT00407030|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65435192|NCT00407030|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65435193|NCT00407030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65435194|NCT00407030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65435195|NCT00407030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184732|NCT02877888|Fluorides|fluorides|mesh-list
65435196|NCT00407030|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65435197|NCT00407030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65435199|NCT00407030|Cholinergic Agents|cholinergic agents|mesh-ancestor
65435254|NCT01043744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65435255|NCT01043744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65435256|NCT00395018|Entecavir|entecavir|mesh-list
65435257|NCT00395018|Antiviral Agents|antiviral agents|mesh-ancestor
65435258|NCT00395018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65435259|NCT01036412|Chlorhexidine|chlorhexidine|mesh-list
65435260|NCT01036412|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65435261|NCT01036412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65435262|NCT01036412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65435263|NCT01036412|Disinfectants|disinfectants|mesh-ancestor
65435324|NCT00203476|Sequestering Agents|sequestering agents|mesh-ancestor
65435325|NCT00203242|Valproic Acid|valproic acid|mesh-list
65435326|NCT00203242|Anticonvulsants|anticonvulsants|mesh-ancestor
65435327|NCT00203242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435328|NCT00203242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435329|NCT00203242|GABA Agents|gaba agents|mesh-ancestor
65435330|NCT00203242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65435331|NCT00203242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435332|NCT00203242|Antimanic Agents|antimanic agents|mesh-ancestor
65435333|NCT00203242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65435334|NCT00203242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65435335|NCT00203242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65435336|NCT00200356|Ozagrel|ozagrel|mesh-list
65435337|NCT00200356|Edaravone|edaravone|mesh-list
65435338|NCT00200356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65435339|NCT00200356|Antioxidants|antioxidants|mesh-ancestor
65435340|NCT00200356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435341|NCT00200356|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65435342|NCT00200356|Protective Agents|protective agents|mesh-ancestor
65435343|NCT00200356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435344|NCT00200356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435345|NCT00200356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65435346|NCT00200356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65435347|NCT00200356|Histamine Antagonists|histamine antagonists|mesh-ancestor
65435348|NCT00200356|Histamine Agents|histamine agents|mesh-ancestor
65435349|NCT00200356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65435350|NCT00227344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
65435374|NCT00256204|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65435375|NCT00256204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435376|NCT00256204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435377|NCT00256204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65435378|NCT00256204|Protective Agents|protective agents|mesh-ancestor
65435379|NCT00256204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435380|NCT03972358|Misoprostol|misoprostol|mesh-list
65435381|NCT03972358|Mifepristone|mifepristone|mesh-list
65435382|NCT03972358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65435383|NCT03972358|Abortifacient Agents|abortifacient agents|mesh-ancestor
65435439|NCT00278889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65435440|NCT00278889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65435441|NCT00278889|Immunologic Factors|immunologic factors|mesh-ancestor
65435442|NCT00278889|Antidotes|antidotes|mesh-ancestor
65435443|NCT00278889|Protective Agents|protective agents|mesh-ancestor
65435444|NCT00278889|Vitamin B Complex|vitamin b complex|mesh-ancestor
65435445|NCT00278889|Vitamins|vitamins|mesh-ancestor
65435446|NCT00278889|Micronutrients|micronutrients|mesh-ancestor
65435447|NCT00278889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65435448|NCT00278889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435449|NCT01070745|Ibuprofen|ibuprofen|mesh-list
65435503|NCT00296517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435504|NCT00224770|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65435505|NCT00224770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65435506|NCT00224770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65435507|NCT00224770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435508|NCT00266409|Alprazolam|alprazolam|mesh-list
65435509|NCT00266409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65435510|NCT00266409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65435511|NCT00266409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435512|NCT00266409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65435513|NCT00266409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65435514|NCT00266409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65435515|NCT00266409|GABA Modulators|gaba modulators|mesh-ancestor
65435564|NCT01071135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435565|NCT00275301|Olanzapine|olanzapine|mesh-list
65435566|NCT00275301|Antiemetics|antiemetics|mesh-ancestor
65435567|NCT00275301|Autonomic Agents|autonomic agents|mesh-ancestor
65435568|NCT00275301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65435569|NCT00275301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435570|NCT00275301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65435585|NCT00251745|Lansoprazole|lansoprazole|mesh-list
65435634|NCT00255034|Antimetabolites|antimetabolites|mesh-ancestor
65435635|NCT00255034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435636|NCT00255034|Antiviral Agents|antiviral agents|mesh-ancestor
65435637|NCT00255034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65435638|NCT00255034|Immunologic Factors|immunologic factors|mesh-ancestor
65435639|NCT00255034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435640|NCT03991104|Oxaliplatin|oxaliplatin|mesh-list
65435641|NCT03991104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435701|NCT00358644|Decitabine|decitabine|mesh-list
65435702|NCT00358644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65435703|NCT00358644|Antimetabolites|antimetabolites|mesh-ancestor
65435704|NCT00358644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435705|NCT00358644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435706|NCT00358644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435707|NCT01048320|Gemcitabine|gemcitabine|mesh-list
65435708|NCT01048320|Oxaliplatin|oxaliplatin|mesh-list
65435709|NCT01048320|Imatinib Mesylate|imatinib mesylate|mesh-list
65435710|NCT01048320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65435711|NCT01048320|Antimetabolites|antimetabolites|mesh-ancestor
65435712|NCT01048320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435713|NCT01048320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435714|NCT01048320|Antiviral Agents|antiviral agents|mesh-ancestor
65435715|NCT01048320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65435716|NCT01048320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435717|NCT01048320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65435718|NCT01048320|Immunologic Factors|immunologic factors|mesh-ancestor
65435719|NCT01048320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435720|NCT01048320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65435755|NCT00363480|Dermatologic Agents|dermatologic agents|mesh-ancestor
65435756|NCT00363480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65435757|NCT00363480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65435758|NCT00363480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65435759|NCT00363480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65435760|NCT00363480|Adrenergic Agents|adrenergic agents|mesh-ancestor
65435761|NCT00363480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65435762|NCT00363480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435763|NCT00363480|Tocolytic Agents|tocolytic agents|mesh-ancestor
65435764|NCT00363480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65435765|NCT03990636|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65435766|NCT03990636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65435767|NCT03990636|Dermatologic Agents|dermatologic agents|mesh-ancestor
65435768|NCT01048398|Acetaminophen|acetaminophen|mesh-list
65435769|NCT01048398|Remifentanil|remifentanil|mesh-list
65435770|NCT01048398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65435771|NCT01048398|Analgesics|analgesics|mesh-ancestor
65435772|NCT01048398|Sensory System Agents|sensory system agents|mesh-ancestor
65435773|NCT01048398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65435774|NCT01048398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435775|NCT01048398|Antipyretics|antipyretics|mesh-ancestor
65435776|NCT01048398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65435777|NCT01048398|Narcotics|narcotics|mesh-ancestor
65435778|NCT01048398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65435779|NCT01073644|Sunitinib|sunitinib|mesh-list
65435780|NCT01073644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435804|NCT00221104|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65435805|NCT00221104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65435806|NCT00221104|Antimetabolites|antimetabolites|mesh-ancestor
65435807|NCT00221104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435808|NCT00221104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65435809|NCT00221104|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65435810|NCT00221104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435811|NCT00189202|Sirolimus|sirolimus|mesh-list
65435812|NCT00189202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65435813|NCT00189202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65435814|NCT00189202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65435815|NCT00189202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435816|NCT00189202|Antifungal Agents|antifungal agents|mesh-ancestor
65435817|NCT00189202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65435818|NCT00189202|Immunologic Factors|immunologic factors|mesh-ancestor
65435819|NCT00189202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435862|NCT00362232|Anticoagulants|anticoagulants|mesh-ancestor
65435863|NCT00362232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65435864|NCT00362232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65435865|NCT01048554|Bevacizumab|bevacizumab|mesh-list
65435866|NCT01048554|Temozolomide|temozolomide|mesh-list
65435867|NCT01048554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65435868|NCT01048554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435869|NCT01048554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65435870|NCT01048554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65435871|NCT01048554|Growth Substances|growth substances|mesh-ancestor
65435872|NCT01048554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65435873|NCT01048554|Growth Inhibitors|growth inhibitors|mesh-ancestor
65435874|NCT01048554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65435875|NCT01048554|Alkylating Agents|alkylating agents|mesh-ancestor
65435876|NCT01048554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435877|NCT00219544|Pregabalin|pregabalin|mesh-list
65435878|NCT00219544|Analgesics|analgesics|mesh-ancestor
65435891|NCT00357552|Ritonavir|ritonavir|mesh-list
65435919|NCT00187096|Alkylating Agents|alkylating agents|mesh-ancestor
65435920|NCT00187096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65435921|NCT00187096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435922|NCT00187096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65435923|NCT00187096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65435924|NCT00187096|Antimetabolites|antimetabolites|mesh-ancestor
65435925|NCT00187096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65435926|NCT00187096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65435927|NCT00187096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65435928|NCT00187096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65435929|NCT00187096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65435930|NCT00187096|Analgesics|analgesics|mesh-ancestor
65435931|NCT00187096|Sensory System Agents|sensory system agents|mesh-ancestor
65435932|NCT00187096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65435933|NCT00357396|Melphalan|melphalan|mesh-list
65435934|NCT00357396|Busulfan|busulfan|mesh-list
65435935|NCT00357396|Thiotepa|thiotepa|mesh-list
65435936|NCT00357396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65435937|NCT00357396|Alkylating Agents|alkylating agents|mesh-ancestor
65435939|NCT00357396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65435975|NCT00186628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65435976|NCT00186628|Analgesics|analgesics|mesh-ancestor
65435977|NCT00186628|Sensory System Agents|sensory system agents|mesh-ancestor
65435978|NCT00186628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65435979|NCT00186628|Antipyretics|antipyretics|mesh-ancestor
65435980|NCT00186628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65435981|NCT00186628|Antiemetics|antiemetics|mesh-ancestor
65435982|NCT00186628|Autonomic Agents|autonomic agents|mesh-ancestor
65435983|NCT00186628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65435984|NCT00186628|Glucocorticoids|glucocorticoids|mesh-ancestor
65435985|NCT00186628|Hormones|hormones|mesh-ancestor
65435986|NCT00186628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65435987|NCT00186628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65435988|NCT00186628|Protective Agents|protective agents|mesh-ancestor
65435989|NCT00186628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65435990|NCT00186628|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65435991|NCT00186628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65435992|NCT00186628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65435993|NCT00186628|Anesthetics, Local|anesthetics, local|mesh-ancestor
65436030|NCT00357006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65436031|NCT00357006|Contraceptive Agents|contraceptive agents|mesh-ancestor
65436032|NCT00357006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65436033|NCT00357006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65436035|NCT01050114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65436036|NCT01050114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65436037|NCT01050114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65436038|NCT01050114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436039|NCT01050114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65436040|NCT01050114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65436041|NCT01050114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436042|NCT01050114|Cholinergic Agents|cholinergic agents|mesh-ancestor
65436043|NCT01050114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65436044|NCT01050114|Parasympatholytics|parasympatholytics|mesh-ancestor
65436045|NCT01050114|Autonomic Agents|autonomic agents|mesh-ancestor
65436046|NCT01050114|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65436047|NCT01050114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65436048|NCT01050114|Urological Agents|urological agents|mesh-ancestor
65436049|NCT01048632|Oxandrolone|oxandrolone|mesh-list
65436050|NCT01048632|Androgens|androgens|mesh-ancestor
65436051|NCT01048632|Hormones|hormones|mesh-ancestor
65436052|NCT01048632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65436053|NCT01048632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436054|NCT01048632|Anabolic Agents|anabolic agents|mesh-ancestor
65436055|NCT00165646|Rabeprazole|rabeprazole|mesh-list
65436056|NCT00165646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65436057|NCT00165646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65436058|NCT00165646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65436059|NCT00165646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436076|NCT01050270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65436077|NCT01050270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65436078|NCT01050270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65436079|NCT01050270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65436080|NCT01050270|Antiviral Agents|antiviral agents|mesh-ancestor
65436081|NCT01050270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65436082|NCT01050270|Expectorants|expectorants|mesh-ancestor
65436083|NCT01050270|Respiratory System Agents|respiratory system agents|mesh-ancestor
65436084|NCT01050270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65436143|NCT01050348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436144|NCT01050348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65436145|NCT01050348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65436146|NCT01050348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436147|NCT01053390|Leucovorin|leucovorin|mesh-list
65436148|NCT01053390|Fluorouracil|fluorouracil|mesh-list
65436149|NCT01053390|Epirubicin|epirubicin|mesh-list
65436150|NCT01053390|Somatostatin|somatostatin|mesh-list
65436151|NCT01053390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436152|NCT01053390|Antimetabolites|antimetabolites|mesh-ancestor
65436153|NCT01053390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436154|NCT01053390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65436155|NCT01053390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65436156|NCT01053390|Immunologic Factors|immunologic factors|mesh-ancestor
65436157|NCT01053390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436158|NCT01053390|Antidotes|antidotes|mesh-ancestor
65436159|NCT01053390|Protective Agents|protective agents|mesh-ancestor
65436160|NCT01053390|Vitamin B Complex|vitamin b complex|mesh-ancestor
65436161|NCT01053390|Vitamins|vitamins|mesh-ancestor
65436162|NCT01053390|Micronutrients|micronutrients|mesh-ancestor
65436163|NCT01053390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65436164|NCT01053390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65436167|NCT01053390|Hormones|hormones|mesh-ancestor
65436195|NCT01049022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65436196|NCT01049022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436197|NCT01049022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436198|NCT01049022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436199|NCT01049022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65436200|NCT01049022|Contraceptive Agents|contraceptive agents|mesh-ancestor
65436201|NCT01049022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65436202|NCT01049022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436203|NCT01049022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65436204|NCT01049022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65436205|NCT01049022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65436206|NCT02534610|Etoricoxib|etoricoxib|mesh-list
65436207|NCT02534610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65436208|NCT02534610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65436209|NCT02534610|Analgesics|analgesics|mesh-ancestor
65436210|NCT02534610|Sensory System Agents|sensory system agents|mesh-ancestor
65436211|NCT02534610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65436212|NCT02534610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436213|NCT02534610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65436214|NCT02534610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65436215|NCT02534610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65436246|NCT00185380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65436247|NCT00185380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436248|NCT00185380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65436249|NCT00185380|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65436250|NCT00185380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65436251|NCT01077466|Natalizumab|natalizumab|mesh-list
65436252|NCT01077466|Immunologic Factors|immunologic factors|mesh-ancestor
65436253|NCT01077466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436254|NCT00160654|Levetiracetam|levetiracetam|mesh-list
65436255|NCT00160654|Anticonvulsants|anticonvulsants|mesh-ancestor
65436256|NCT00160654|Nootropic Agents|nootropic agents|mesh-ancestor
65436257|NCT01582672|Sunitinib|sunitinib|mesh-list
65436258|NCT01582672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436259|NCT01582672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65436260|NCT01582672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65436261|NCT01582672|Growth Substances|growth substances|mesh-ancestor
65436262|NCT01582672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436263|NCT01582672|Growth Inhibitors|growth inhibitors|mesh-ancestor
65436264|NCT01582672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65436265|NCT01582672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436266|NCT01582672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436267|NCT00366678|Vaccines|vaccines|mesh-list
65436298|NCT01054092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436299|NCT00360282|Rizatriptan|rizatriptan|mesh-list
65436300|NCT00360282|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65436301|NCT00360282|Serotonin Agents|serotonin agents|mesh-ancestor
65436302|NCT00360282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65436303|NCT00360282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436304|NCT00360282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436305|NCT00373958|Vaccines|vaccines|mesh-list
65436306|NCT00373958|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65436307|NCT00373958|Immunologic Factors|immunologic factors|mesh-ancestor
65436308|NCT00373958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436309|NCT00373880|Cocaine|cocaine|mesh-list
65436310|NCT00373880|Aripiprazole|aripiprazole|mesh-list
65436311|NCT00373880|Antidepressive Agents|antidepressive agents|mesh-ancestor
65436312|NCT00373880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65436313|NCT00373880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65436314|NCT00373880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65436315|NCT00373880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65436316|NCT00373880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436317|NCT00373880|Dopamine Agonists|dopamine agonists|mesh-ancestor
65436318|NCT00373880|Dopamine Agents|dopamine agents|mesh-ancestor
65436319|NCT00373880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65436320|NCT00373880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436321|NCT00373880|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65436322|NCT00373880|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65436323|NCT00373880|Serotonin Agents|serotonin agents|mesh-ancestor
65436324|NCT00373880|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65436325|NCT00373880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65436326|NCT00373880|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65436341|NCT00184600|Insulin Detemir|insulin detemir|mesh-list
65436342|NCT00184600|Biphasic Insulins|biphasic insulins|mesh-list
65436343|NCT00184600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65436344|NCT00184600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436345|NCT00265317|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65436346|NCT00265317|Sunitinib|sunitinib|mesh-list
65436347|NCT00265317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436348|NCT00265317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65436349|NCT00265317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436350|NCT00265317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436351|NCT00265317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65436352|NCT00265317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65436353|NCT00265317|Growth Substances|growth substances|mesh-ancestor
65436354|NCT00265317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436355|NCT00265317|Growth Inhibitors|growth inhibitors|mesh-ancestor
65436356|NCT00373490|Vorinostat|vorinostat|mesh-list
65436357|NCT00373490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436358|NCT00373490|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65436359|NCT00373490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436360|NCT00373490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436361|NCT00251589|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65436362|NCT00251589|Vorinostat|vorinostat|mesh-list
65436363|NCT00251589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436364|NCT00251589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65436365|NCT00251589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436366|NCT00251589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436367|NCT00251589|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65436368|NCT00265239|Edaravone|edaravone|mesh-list
65436369|NCT00265239|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65436370|NCT00265239|Antioxidants|antioxidants|mesh-ancestor
65436371|NCT00265239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436375|NCT00159874|Sildenafil Citrate|sildenafil citrate|mesh-list
65436383|NCT00159874|Vasodilator Agents|vasodilator agents|mesh-ancestor
65436384|NCT00159874|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65436385|NCT00159874|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65436386|NCT00159874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436387|NCT00159874|Urological Agents|urological agents|mesh-ancestor
65436388|NCT03989778|Vitamin D|vitamin d|mesh-list
65436389|NCT03989778|Vitamins|vitamins|mesh-ancestor
65436390|NCT03989778|Micronutrients|micronutrients|mesh-ancestor
65436391|NCT03989778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436392|NCT03989778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65436393|NCT00184054|Ascorbic Acid|ascorbic acid|mesh-list
65436394|NCT00184054|Arsenic Trioxide|arsenic trioxide|mesh-list
65436395|NCT00184054|Vitamins|vitamins|mesh-ancestor
65436396|NCT00184054|Micronutrients|micronutrients|mesh-ancestor
65436397|NCT00184054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436398|NCT00184054|Antioxidants|antioxidants|mesh-ancestor
65436399|NCT00184054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436400|NCT00184054|Protective Agents|protective agents|mesh-ancestor
65436401|NCT00184054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436402|NCT02533908|Fentanyl|fentanyl|mesh-list
65436403|NCT02533908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65436404|NCT02533908|Narcotics|narcotics|mesh-ancestor
65436405|NCT02533908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65436406|NCT02533908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436407|NCT02533908|Analgesics|analgesics|mesh-ancestor
65436408|NCT02533908|Sensory System Agents|sensory system agents|mesh-ancestor
65436409|NCT02533908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65436410|NCT02533908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65436411|NCT02533908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65436412|NCT02533908|Anesthetics, General|anesthetics, general|mesh-ancestor
65436413|NCT02533908|Anesthetics|anesthetics|mesh-ancestor
65436429|NCT00183274|Adrenergic Agents|adrenergic agents|mesh-ancestor
65436430|NCT00183274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65436431|NCT00183274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436432|NCT00183274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436433|NCT00183274|Sympathomimetics|sympathomimetics|mesh-ancestor
65436434|NCT00183274|Autonomic Agents|autonomic agents|mesh-ancestor
65436435|NCT00183274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65436436|NCT00183274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65436437|NCT00183274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65436438|NCT00183274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65436439|NCT00183274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65436440|NCT00183274|Antidepressive Agents|antidepressive agents|mesh-ancestor
65436441|NCT00183274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65436442|NCT00183274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65436443|NCT00183274|Serotonin Agents|serotonin agents|mesh-ancestor
65436487|NCT03989310|Paclitaxel|paclitaxel|mesh-list
65436488|NCT03989310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65436489|NCT03989310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65436490|NCT03989310|Antibodies|antibodies|mesh-list
65436491|NCT03989310|Immunoglobulins|immunoglobulins|mesh-list
65436492|NCT03989310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65436493|NCT03989310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436494|NCT03989310|Tubulin Modulators|tubulin modulators|mesh-ancestor
65436495|NCT03989310|Antimitotic Agents|antimitotic agents|mesh-ancestor
65436496|NCT03989310|Mitosis Modulators|mitosis modulators|mesh-ancestor
65436497|NCT03989310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436498|NCT03989310|Immunologic Factors|immunologic factors|mesh-ancestor
65436499|NCT03989310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436500|NCT03989310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65436501|NCT03989310|Antimetabolites|antimetabolites|mesh-ancestor
65436502|NCT03989310|Antiviral Agents|antiviral agents|mesh-ancestor
65436503|NCT03989310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65436504|NCT03989310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436505|NCT03989310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65436506|NCT03989310|Trace Elements|trace elements|mesh-ancestor
65436507|NCT03989310|Micronutrients|micronutrients|mesh-ancestor
65436508|NCT03966898|Letrozole|letrozole|mesh-list
65436509|NCT03966898|Anastrozole|anastrozole|mesh-list
65436510|NCT03966898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436511|NCT03966898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65436512|NCT03966898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65436513|NCT03966898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436514|NCT03966898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436515|NCT03966898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65436534|NCT01051284|Immunologic Factors|immunologic factors|mesh-ancestor
65436535|NCT01051284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436536|NCT01051362|Carboplatin|carboplatin|mesh-list
65436537|NCT01051362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436538|NCT01055808|Insulin|insulin|mesh-list
65436539|NCT01055808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65436540|NCT01055808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436541|NCT00265083|Golimumab|golimumab|mesh-list
65436542|NCT00265083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65436543|NCT00265083|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65436544|NCT00265083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65436545|NCT00265083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65436546|NCT00265083|Immunologic Factors|immunologic factors|mesh-ancestor
65436547|NCT00265083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436548|NCT00264849|Omalizumab|omalizumab|mesh-list
65436549|NCT00264849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65436550|NCT00264849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65436551|NCT00264849|Respiratory System Agents|respiratory system agents|mesh-ancestor
65436552|NCT01073709|Acetaminophen|acetaminophen|mesh-list
65436553|NCT01073709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65436554|NCT01073709|Analgesics|analgesics|mesh-ancestor
65436555|NCT01073709|Sensory System Agents|sensory system agents|mesh-ancestor
65436556|NCT01073709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65436557|NCT01073709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436558|NCT01073709|Antipyretics|antipyretics|mesh-ancestor
65436559|NCT00211809|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65436560|NCT00211809|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65436561|NCT00211809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65436562|NCT00211809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65436563|NCT00211809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436564|NCT00211809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65436565|NCT00211809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436567|NCT00211809|Antidepressive Agents|antidepressive agents|mesh-ancestor
65436575|NCT01071291|Vasodilator Agents|vasodilator agents|mesh-ancestor
65436576|NCT01071291|Vitamin B Complex|vitamin b complex|mesh-ancestor
65436577|NCT01071291|Vitamins|vitamins|mesh-ancestor
65436578|NCT01071291|Micronutrients|micronutrients|mesh-ancestor
65436579|NCT01071291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436580|NCT00129766|Palivizumab|palivizumab|mesh-list
65436581|NCT00129766|Antiviral Agents|antiviral agents|mesh-ancestor
65436582|NCT00129766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65436583|NCT00150592|Guanfacine|guanfacine|mesh-list
65436584|NCT00150592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65436585|NCT00150592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65436586|NCT00150592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65436587|NCT00150592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65436588|NCT00150592|Adrenergic Agents|adrenergic agents|mesh-ancestor
65436589|NCT00150592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65436590|NCT00150592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436591|NCT00150592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436592|NCT00149890|Cyclosporine|cyclosporine|mesh-list
65436593|NCT00149890|Cyclosporins|cyclosporins|mesh-list
65436594|NCT00149890|Basiliximab|basiliximab|mesh-list
65436595|NCT00149890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436596|NCT00149890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436597|NCT00149890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65436598|NCT00149890|Immunologic Factors|immunologic factors|mesh-ancestor
65436599|NCT00149890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436600|NCT00149890|Antifungal Agents|antifungal agents|mesh-ancestor
65436624|NCT00348348|Besifloxacin|besifloxacin|mesh-list
65436625|NCT00348348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65436626|NCT00348348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65436627|NCT00348348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65436628|NCT00348348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65436629|NCT00348348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436630|NCT00348348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436631|NCT00348348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436632|NCT00354744|Dactinomycin|dactinomycin|mesh-list
65436633|NCT00354744|Cyclophosphamide|cyclophosphamide|mesh-list
65436635|NCT00354744|Isophosphamide mustard|isophosphamide mustard|mesh-list
65436636|NCT00354744|Doxorubicin|doxorubicin|mesh-list
65436637|NCT00354744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65436638|NCT00354744|Irinotecan|irinotecan|mesh-list
65436639|NCT00354744|Etoposide|etoposide|mesh-list
65436640|NCT00354744|Vincristine|vincristine|mesh-list
65436641|NCT00354744|Camptothecin|camptothecin|mesh-list
65436642|NCT00354744|Lenograstim|lenograstim|mesh-list
65436643|NCT00354744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65436644|NCT00354744|Immunologic Factors|immunologic factors|mesh-ancestor
65436645|NCT00354744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436646|NCT00354744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65436647|NCT00354744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65436648|NCT00354744|Alkylating Agents|alkylating agents|mesh-ancestor
65436649|NCT00354744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436650|NCT00354744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436651|NCT00354744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65436652|NCT00354744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65436653|NCT00354744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64674354|NCT03852537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64674355|NCT03852537|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64674356|NCT03852537|Protective Agents|protective agents|mesh-ancestor
64674357|NCT03852537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64674358|NCT03852537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674359|NCT03875859|Benzoic Acid|benzoic acid|mesh-list
64674360|NCT03875859|Antifungal Agents|antifungal agents|mesh-ancestor
64674361|NCT03875859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64674362|NCT00553202|Cyclosporine|cyclosporine|mesh-list
64674363|NCT00553202|Methylprednisolone|methylprednisolone|mesh-list
64674364|NCT00553202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64674365|NCT00553202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64674381|NCT00553202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64674383|NCT00553202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674384|NCT00553202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674385|NCT00553202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64674386|NCT00553202|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64674387|NCT00553202|Abortifacient Agents|abortifacient agents|mesh-ancestor
65436654|NCT00354744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65436655|NCT00354744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436656|NCT00354744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65436657|NCT00354744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65436658|NCT00354744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65436659|NCT00354744|Tubulin Modulators|tubulin modulators|mesh-ancestor
65436660|NCT00354744|Antimitotic Agents|antimitotic agents|mesh-ancestor
65436661|NCT00354744|Mitosis Modulators|mitosis modulators|mesh-ancestor
65436662|NCT00354744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65436663|NCT00354744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65436664|NCT00354744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65436665|NCT00354744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65436666|NCT01055964|Tacrolimus|tacrolimus|mesh-list
65436717|NCT01324544|Sensory System Agents|sensory system agents|mesh-ancestor
65436718|NCT01324544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65436719|NCT01324544|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65436720|NCT00394082|Paclitaxel|paclitaxel|mesh-list
65436721|NCT00394082|Bevacizumab|bevacizumab|mesh-list
65436722|NCT00394082|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65436723|NCT00394082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65436724|NCT00394082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436725|NCT00394082|Tubulin Modulators|tubulin modulators|mesh-ancestor
65436726|NCT00394082|Antimitotic Agents|antimitotic agents|mesh-ancestor
65436727|NCT00394082|Mitosis Modulators|mitosis modulators|mesh-ancestor
65436728|NCT00394082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436729|NCT00394082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65436730|NCT00394082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65436731|NCT00394082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65436732|NCT00394082|Growth Substances|growth substances|mesh-ancestor
65436733|NCT00394082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436734|NCT00394082|Growth Inhibitors|growth inhibitors|mesh-ancestor
65436735|NCT00393848|Ketoconazole|ketoconazole|mesh-list
65436749|NCT00393458|Autonomic Agents|autonomic agents|mesh-ancestor
65436771|NCT00392990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65436772|NCT00392990|Immunologic Factors|immunologic factors|mesh-ancestor
65436773|NCT00392990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436774|NCT00392990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65436775|NCT00392990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65436776|NCT00392990|Alkylating Agents|alkylating agents|mesh-ancestor
65436777|NCT00392990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436778|NCT00392990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65436779|NCT00392990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65436780|NCT00392990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65436781|NCT00392990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65436782|NCT00392990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65436783|NCT00392990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65436784|NCT00392990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436785|NCT00392990|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65436786|NCT00392990|Abortifacient Agents|abortifacient agents|mesh-ancestor
65436787|NCT00392990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65436788|NCT00392990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65436789|NCT00392990|Antimetabolites|antimetabolites|mesh-ancestor
65436790|NCT00392990|Dermatologic Agents|dermatologic agents|mesh-ancestor
65436791|NCT00392990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65436824|NCT01046162|GABA Modulators|gaba modulators|mesh-ancestor
65436825|NCT01046162|GABA Agents|gaba agents|mesh-ancestor
65436826|NCT01046162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65436827|NCT01046162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436828|NCT00417482|Risperidone|risperidone|mesh-list
65436829|NCT00417482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65436830|NCT00417482|Serotonin Agents|serotonin agents|mesh-ancestor
65436831|NCT00417482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65436832|NCT00417482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436833|NCT00417482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436886|NCT00249873|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65436887|NCT00249873|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65436888|NCT00249873|Purinergic Agents|purinergic agents|mesh-ancestor
65436889|NCT00249873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65436890|NCT00249873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436891|NCT00249873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436892|NCT01037348|Ranibizumab|ranibizumab|mesh-list
65436899|NCT03490292|Paclitaxel|paclitaxel|mesh-list
65436952|NCT00762554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65436953|NCT00762554|Narcotics|narcotics|mesh-ancestor
65436954|NCT00762554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65436955|NCT00762554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436956|NCT00762554|Analgesics|analgesics|mesh-ancestor
65436957|NCT00762554|Sensory System Agents|sensory system agents|mesh-ancestor
65436958|NCT00762554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65436959|NCT00762554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65436960|NCT00762554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65436961|NCT00762554|Anesthetics, General|anesthetics, general|mesh-ancestor
65436962|NCT00762554|Anesthetics|anesthetics|mesh-ancestor
65436963|NCT00391898|Levodopa|levodopa|mesh-list
65436964|NCT00391898|Carbidopa|carbidopa|mesh-list
65436965|NCT00391898|Entacapone|entacapone|mesh-list
65436966|NCT00391898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65436967|NCT00391898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65436968|NCT00391898|Dopamine Agents|dopamine agents|mesh-ancestor
65436969|NCT00391898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65436970|NCT00391898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436971|NCT00391898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65436972|NCT00391898|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65436973|NCT00391898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65436974|NCT00391898|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65436975|NCT01046864|Leucovorin|leucovorin|mesh-list
65436976|NCT01046864|Fluorouracil|fluorouracil|mesh-list
65436977|NCT01046864|Irinotecan|irinotecan|mesh-list
65436978|NCT01046864|Antimetabolites|antimetabolites|mesh-ancestor
65436979|NCT01046864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65436988|NCT01046864|Antidotes|antidotes|mesh-ancestor
65186530|NCT05382351|Tenofovir|tenofovir|mesh-list
65437000|NCT01046942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437001|NCT01046942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65437002|NCT01046942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65437003|NCT01046942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65437004|NCT01046942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65437005|NCT01046942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437006|NCT01046942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65437007|NCT01046942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65437008|NCT01046942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437009|NCT01046942|Antipyretics|antipyretics|mesh-ancestor
65437010|NCT01046942|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65437011|NCT01046942|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65437012|NCT01046942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65437013|NCT01046942|Purinergic Agents|purinergic agents|mesh-ancestor
65437014|NCT01046942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65437015|NCT01049438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65437016|NCT01049438|Doxycycline|doxycycline|mesh-list
65437017|NCT01049438|Minocycline|minocycline|mesh-list
65437018|NCT01049438|Mupirocin|mupirocin|mesh-list
65437020|NCT01049438|Trimethoprim|trimethoprim|mesh-list
65437055|NCT00391586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65437056|NCT00391586|Antimetabolites|antimetabolites|mesh-ancestor
65437057|NCT00391586|Antiviral Agents|antiviral agents|mesh-ancestor
65437058|NCT00391586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65437059|NCT00391586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437060|NCT00391586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65437061|NCT00391586|Immunologic Factors|immunologic factors|mesh-ancestor
65437062|NCT00391586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437063|NCT00391586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65437064|NCT00391586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65437065|NCT00391586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65437066|NCT00391586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65437067|NCT00391586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65437068|NCT00391586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65437069|NCT00391430|Sertraline|sertraline|mesh-list
65437070|NCT00391430|Antidepressive Agents|antidepressive agents|mesh-ancestor
65437071|NCT00391430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65437079|NCT00391274|Docetaxel|docetaxel|mesh-list
65437111|NCT01047488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65437112|NCT01047488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65437113|NCT01047488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65437114|NCT01047488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65437115|NCT01047488|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65437116|NCT01047488|Antidepressive Agents|antidepressive agents|mesh-ancestor
65437117|NCT01047488|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65437118|NCT01047488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65437119|NCT01047488|Adrenergic Agents|adrenergic agents|mesh-ancestor
65437120|NCT01047488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65437121|NCT01047566|Digoxin|digoxin|mesh-list
65437122|NCT01047566|Dronedarone|dronedarone|mesh-list
65437123|NCT01047566|Calcium Channel Blockers|calcium channel blockers|mesh-list
65437124|NCT01047566|Calcium|calcium|mesh-list
65437125|NCT01047566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65437126|NCT01047566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65437127|NCT01047566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437128|NCT01047566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65437129|NCT01047566|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65437130|NCT01047566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437131|NCT01047566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437132|NCT01047566|Protective Agents|protective agents|mesh-ancestor
65437133|NCT01047566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65437162|NCT00371150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65437163|NCT00264303|Levocetirizine|levocetirizine|mesh-list
65437164|NCT00264303|Desloratadine|desloratadine|mesh-list
65437165|NCT00264303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65437166|NCT00264303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65437167|NCT00264303|Histamine Antagonists|histamine antagonists|mesh-ancestor
65437168|NCT00264303|Histamine Agents|histamine agents|mesh-ancestor
65437169|NCT00264303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65437170|NCT00264303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437171|NCT00264303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437172|NCT00264303|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65437173|NCT00264303|Cholinergic Agents|cholinergic agents|mesh-ancestor
65437174|NCT01071369|Betamethasone|betamethasone|mesh-list
65437175|NCT01071369|Betamethasone Valerate|betamethasone valerate|mesh-list
65437176|NCT01071369|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65437177|NCT01071369|Betamethasone benzoate|betamethasone benzoate|mesh-list
65437178|NCT01071369|Lidocaine|lidocaine|mesh-list
65437179|NCT01071369|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65437180|NCT01071369|Anesthetics, Local|anesthetics, local|mesh-ancestor
65437181|NCT01071369|Anesthetics|anesthetics|mesh-ancestor
65437182|NCT01071369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65437214|NCT01044446|Dialysis Solutions|dialysis solutions|mesh-list
65437215|NCT01044446|Icodextrin|icodextrin|mesh-list
65437216|NCT01044446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65437217|NCT03971019|Calcium, Dietary|calcium, dietary|mesh-list
65437218|NCT03971019|Atorvastatin|atorvastatin|mesh-list
65437219|NCT03971019|Simvastatin|simvastatin|mesh-list
65437220|NCT03971019|Calcium|calcium|mesh-list
65437221|NCT03971019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65437222|NCT03971019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437223|NCT03971019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65437224|NCT03971019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65437280|NCT00262821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437281|NCT01326117|Tadalafil|tadalafil|mesh-list
65437282|NCT01326117|Vasodilator Agents|vasodilator agents|mesh-ancestor
65437283|NCT01326117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65437284|NCT01326117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65437285|NCT01326117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437286|NCT01326117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437287|NCT01326117|Urological Agents|urological agents|mesh-ancestor
65437288|NCT03970239|Ketanserin|ketanserin|mesh-list
65437289|NCT03970239|Fluorides|fluorides|mesh-list
65437290|NCT03970239|Altanserin|altanserin|mesh-list
65437291|NCT03970239|Cariostatic Agents|cariostatic agents|mesh-ancestor
65437292|NCT03970239|Protective Agents|protective agents|mesh-ancestor
65437293|NCT03970239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437294|NCT03970239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65437295|NCT03970239|Serotonin Agents|serotonin agents|mesh-ancestor
65437296|NCT03970239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65437297|NCT03970239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437298|NCT03970239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65437299|NCT03970239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65437300|NCT00170950|Amlodipine|amlodipine|mesh-list
65437301|NCT00170950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65437302|NCT00170950|Benazepril|benazepril|mesh-list
65437303|NCT00170950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65437304|NCT00170950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65437305|NCT00170950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65437306|NCT00170950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437308|NCT00170950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437327|NCT02531529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65437328|NCT02531529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437329|NCT02531529|Analgesics|analgesics|mesh-ancestor
65437330|NCT02531529|Sensory System Agents|sensory system agents|mesh-ancestor
65437331|NCT02531529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65437332|NCT02531529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65437333|NCT02531529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65437334|NCT02531529|Anesthetics, General|anesthetics, general|mesh-ancestor
65437335|NCT02531529|Anesthetics|anesthetics|mesh-ancestor
65437336|NCT01071525|Niacin|niacin|mesh-list
65437337|NCT01071525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65437338|NCT01071525|Antimetabolites|antimetabolites|mesh-ancestor
65437339|NCT01071525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437390|NCT00390416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437391|NCT00390416|Antimetabolites|antimetabolites|mesh-ancestor
65437392|NCT00390416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65437393|NCT00390416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65437394|NCT00390416|Immunologic Factors|immunologic factors|mesh-ancestor
65437395|NCT00390416|Antidotes|antidotes|mesh-ancestor
65437396|NCT00390416|Protective Agents|protective agents|mesh-ancestor
65437397|NCT00390416|Vitamin B Complex|vitamin b complex|mesh-ancestor
65437398|NCT00390416|Vitamins|vitamins|mesh-ancestor
65437399|NCT00390416|Micronutrients|micronutrients|mesh-ancestor
65437400|NCT00261495|Oxycodone|oxycodone|mesh-list
65437401|NCT00261495|Hydromorphone|hydromorphone|mesh-list
65437402|NCT00261495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65437403|NCT00261495|Narcotics|narcotics|mesh-ancestor
65437404|NCT00261495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65437405|NCT00261495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437406|NCT00261495|Analgesics|analgesics|mesh-ancestor
65437407|NCT00261495|Sensory System Agents|sensory system agents|mesh-ancestor
65437408|NCT00261495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65437409|NCT00168844|Tiotropium Bromide|tiotropium bromide|mesh-list
65437410|NCT00168844|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65437411|NCT00168844|Autonomic Agents|autonomic agents|mesh-ancestor
65437412|NCT00168844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65437413|NCT00168844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437414|NCT00168844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65437415|NCT00168844|Respiratory System Agents|respiratory system agents|mesh-ancestor
65437416|NCT00168844|Parasympatholytics|parasympatholytics|mesh-ancestor
65437417|NCT00168844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65437418|NCT00168844|Cholinergic Agents|cholinergic agents|mesh-ancestor
65437419|NCT00168844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65437420|NCT00168844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437421|NCT00365456|Risedronic Acid|risedronic acid|mesh-list
65437422|NCT00365456|Hormones|hormones|mesh-list
65437432|NCT01047956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65437433|NCT01047956|Narcotics|narcotics|mesh-ancestor
65437434|NCT01047956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65437435|NCT01047956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437436|NCT01047956|Analgesics|analgesics|mesh-ancestor
65437437|NCT01047956|Sensory System Agents|sensory system agents|mesh-ancestor
65437438|NCT01047956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65437439|NCT01047956|Antitussive Agents|antitussive agents|mesh-ancestor
65437440|NCT01047956|Respiratory System Agents|respiratory system agents|mesh-ancestor
65437441|NCT03480698|Cerebrolysin|cerebrolysin|mesh-list
65437442|NCT03480698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65437443|NCT03480698|Protective Agents|protective agents|mesh-ancestor
65437444|NCT03480698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437445|NCT03480698|Nootropic Agents|nootropic agents|mesh-ancestor
65437446|NCT00206427|Lapatinib|lapatinib|mesh-list
65437447|NCT00206427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437448|NCT00206427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65437449|NCT00206427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437450|NCT00206427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437451|NCT00389324|Immunoglobulins|immunoglobulins|mesh-list
65186982|NCT00857389|Dermatologic Agents|dermatologic agents|mesh-ancestor
65437452|NCT00389324|Antibodies|antibodies|mesh-list
65437453|NCT00389324|gamma-Globulins|gamma-globulins|mesh-list
65437485|NCT01049672|Analgesics|analgesics|mesh-ancestor
65437486|NCT01049672|Sensory System Agents|sensory system agents|mesh-ancestor
65437487|NCT01049672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65437488|NCT01049672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65437489|NCT01049672|Anesthetics, General|anesthetics, general|mesh-ancestor
65437490|NCT01049672|Anesthetics|anesthetics|mesh-ancestor
65437491|NCT01048190|Vaccines|vaccines|mesh-list
65437492|NCT01048190|Immunologic Factors|immunologic factors|mesh-ancestor
65437493|NCT01048190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437494|NCT01048268|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
65437495|NCT01048268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65437496|NCT01048268|Incretins|incretins|mesh-ancestor
65437497|NCT01048268|Hormones|hormones|mesh-ancestor
65437498|NCT01048268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65437499|NCT01048268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437500|NCT03993236|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65437501|NCT03993236|Ezetimibe|ezetimibe|mesh-list
65437502|NCT03993236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65437503|NCT03993236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65437540|NCT00369278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437541|NCT00369278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437542|NCT00529373|Calcium, Dietary|calcium, dietary|mesh-list
65437614|NCT05173493|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65437615|NCT05173493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65437616|NCT05173493|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65437617|NCT05173493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65437618|NCT05173493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65437619|NCT05173493|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65437620|NCT03872843|Ibuprofen|ibuprofen|mesh-list
65437621|NCT03872843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65437622|NCT03872843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65437623|NCT03872843|Analgesics|analgesics|mesh-ancestor
65437624|NCT03872843|Sensory System Agents|sensory system agents|mesh-ancestor
65437625|NCT03872843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65437626|NCT03872843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437627|NCT03872843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65437628|NCT03872843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65437629|NCT03872843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65437630|NCT03872843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437631|NCT03872843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437632|NCT03966040|Vaccines|vaccines|mesh-list
65437633|NCT03966040|Immunologic Factors|immunologic factors|mesh-ancestor
65437634|NCT03966040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437635|NCT03999125|Dexamethasone|dexamethasone|mesh-list
65437636|NCT03999125|Dexamethasone acetate|dexamethasone acetate|mesh-list
65437637|NCT03999125|Ranibizumab|ranibizumab|mesh-list
65437638|NCT03999125|Aflibercept|aflibercept|mesh-list
65437639|NCT03999125|BB 1101|bb 1101|mesh-list
65437640|NCT03999125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65437641|NCT03999125|Antiemetics|antiemetics|mesh-ancestor
65437642|NCT03999125|Autonomic Agents|autonomic agents|mesh-ancestor
65437643|NCT03999125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65437644|NCT03999125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437645|NCT03999125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65437646|NCT03999125|Glucocorticoids|glucocorticoids|mesh-ancestor
65437647|NCT03999125|Hormones|hormones|mesh-ancestor
65437650|NCT03999125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437655|NCT03999125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65437656|NCT03999125|Growth Substances|growth substances|mesh-ancestor
65437657|NCT03999125|Growth Inhibitors|growth inhibitors|mesh-ancestor
65437658|NCT00168064|Mechlorethamine|mechlorethamine|mesh-list
65437659|NCT00168064|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65437660|NCT00168064|Alkylating Agents|alkylating agents|mesh-ancestor
65437661|NCT00168064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437662|NCT00168064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65437663|NCT00168064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437664|NCT00166114|Citalopram|citalopram|mesh-list
65437665|NCT00166114|Desipramine|desipramine|mesh-list
65437666|NCT00166114|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65437667|NCT00166114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65437668|NCT00166114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65437671|NCT00166114|Serotonin Agents|serotonin agents|mesh-ancestor
65437714|NCT03998969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65437715|NCT03998969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437716|NCT03998969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437717|NCT00129220|Haloperidol|haloperidol|mesh-list
65437718|NCT00129220|Olanzapine|olanzapine|mesh-list
65437719|NCT00129220|Haloperidol decanoate|haloperidol decanoate|mesh-list
65437720|NCT00129220|Antiemetics|antiemetics|mesh-ancestor
65437721|NCT00129220|Autonomic Agents|autonomic agents|mesh-ancestor
65437722|NCT00129220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65437723|NCT00129220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437724|NCT00129220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65437725|NCT00129220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65437726|NCT00129220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65437727|NCT00129220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65437728|NCT00129220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65437729|NCT00129220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65437730|NCT00129220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65437772|NCT04754945|Dermatologic Agents|dermatologic agents|mesh-ancestor
65437773|NCT00128830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
65437774|NCT00128830|Etravirine|etravirine|mesh-list
65437775|NCT00128830|Enfuvirtide|enfuvirtide|mesh-list
65437776|NCT00128830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
65437777|NCT00128830|Protease Inhibitors|protease inhibitors|mesh-list
65437778|NCT00128830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65437779|NCT00128830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437780|NCT00128830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437781|NCT00128830|Antiviral Agents|antiviral agents|mesh-ancestor
65437782|NCT00128830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65437783|NCT00128830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65437784|NCT00128830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65437785|NCT00128830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65437786|NCT00128830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65437787|NCT00128830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65437788|NCT01074892|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65437789|NCT01074892|Levonorgestrel|levonorgestrel|mesh-list
65437827|NCT01075828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437828|NCT01074970|Cisplatin|cisplatin|mesh-list
65437829|NCT01074970|Rucaparib|rucaparib|mesh-list
65437830|NCT01074970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65437831|NCT01074970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65437832|NCT01074970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65437833|NCT01074970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437834|NCT03968146|Acetaminophen|acetaminophen|mesh-list
65437835|NCT03968146|Ketorolac|ketorolac|mesh-list
65437836|NCT03968146|Fentanyl|fentanyl|mesh-list
65437837|NCT03968146|Meperidine|meperidine|mesh-list
65437838|NCT03968146|Morphine|morphine|mesh-list
65437893|NCT00141778|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
65437894|NCT00141778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65437895|NCT00141778|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65437896|NCT00141778|Mineralocorticoids|mineralocorticoids|mesh-list
65437897|NCT00141778|Hormone Antagonists|hormone antagonists|mesh-ancestor
65437898|NCT00141778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65437899|NCT00141778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437900|NCT00141778|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65437901|NCT00141778|Diuretics|diuretics|mesh-ancestor
65187428|NCT00625469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65437902|NCT00141778|Natriuretic Agents|natriuretic agents|mesh-ancestor
65437903|NCT00141778|Protease Inhibitors|protease inhibitors|mesh-ancestor
65437904|NCT00141778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65437905|NCT00141778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65437906|NCT00141778|Hormones|hormones|mesh-ancestor
65437907|NCT01079884|Esomeprazole|esomeprazole|mesh-list
65437950|NCT01076140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65437951|NCT01076140|Protective Agents|protective agents|mesh-ancestor
65437952|NCT01076140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437953|NCT01076140|Vasodilator Agents|vasodilator agents|mesh-ancestor
65437954|NCT01076140|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65437955|NCT01076140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65437956|NCT01076140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65437957|NCT01076140|Adrenergic Agents|adrenergic agents|mesh-ancestor
65437958|NCT01076140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65437959|NCT00205803|Vaccines|vaccines|mesh-list
65437960|NCT00205803|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65437961|NCT00205803|Immunologic Factors|immunologic factors|mesh-ancestor
65437962|NCT00205803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437963|NCT00127192|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65437964|NCT00127192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65437965|NCT00127192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65437966|NCT00127192|Incretins|incretins|mesh-ancestor
65437967|NCT00127192|Hormones|hormones|mesh-ancestor
65437968|NCT00127192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65437969|NCT00127192|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65437970|NCT00127192|Protease Inhibitors|protease inhibitors|mesh-ancestor
65438003|NCT00203307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65438004|NCT00203307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65438005|NCT00203307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65438006|NCT00203307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65438007|NCT00203307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65438008|NCT00203307|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65438009|NCT00203307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65438010|NCT00203307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65438011|NCT00203307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438012|NCT00203307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65438013|NCT00203307|Serotonin Agents|serotonin agents|mesh-ancestor
65438014|NCT00126568|Sorafenib|sorafenib|mesh-list
65438015|NCT00126568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438065|NCT00200967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438066|NCT00200967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65438067|NCT00200967|Glucocorticoids|glucocorticoids|mesh-ancestor
65438068|NCT00200967|Hormones|hormones|mesh-ancestor
65438069|NCT00200967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65438070|NCT02533440|Anesthetics|anesthetics|mesh-list
65438071|NCT02533440|Anesthetics, Local|anesthetics, local|mesh-list
65438072|NCT02533440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65438073|NCT02533440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438074|NCT02533440|Sensory System Agents|sensory system agents|mesh-ancestor
65438075|NCT02533440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65438076|NCT00354432|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65438077|NCT00354432|Caseins|caseins|mesh-list
65438078|NCT00354432|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65438079|NCT00354432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65438080|NCT00354432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65438081|NCT00354432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438082|NCT00354432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65438083|NCT00354432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438084|NCT00354432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65438085|NCT00354432|Antidepressive Agents|antidepressive agents|mesh-ancestor
65438086|NCT00354432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65438087|NCT00354432|Chelating Agents|chelating agents|mesh-ancestor
65438088|NCT00354432|Sequestering Agents|sequestering agents|mesh-ancestor
65438089|NCT00140140|Paclitaxel|paclitaxel|mesh-list
65438090|NCT00140140|Vinorelbine|vinorelbine|mesh-list
65438091|NCT00140140|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65438109|NCT00346164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65438110|NCT00346164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65438111|NCT00346164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438112|NCT00346164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438113|NCT00346164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65438114|NCT00346164|Alkylating Agents|alkylating agents|mesh-ancestor
65438115|NCT01052298|Ciprofloxacin|ciprofloxacin|mesh-list
65438116|NCT01052298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65438117|NCT01052298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65438118|NCT01052298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65438119|NCT01052298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65438120|NCT01052298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438121|NCT01052298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438122|NCT01052298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438168|NCT00368966|Immunologic Factors|immunologic factors|mesh-ancestor
65438169|NCT00368966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438170|NCT00114166|Topotecan|topotecan|mesh-list
65438171|NCT00114166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65438172|NCT00114166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65438173|NCT00114166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438174|NCT00114166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438175|NCT00114166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438235|NCT00136318|Citalopram|citalopram|mesh-list
65438236|NCT00136318|Antimetabolites|antimetabolites|mesh-ancestor
65438237|NCT00136318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438238|NCT00136318|Antiviral Agents|antiviral agents|mesh-ancestor
65438239|NCT00136318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65438240|NCT00136318|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65438241|NCT00136318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65438242|NCT00136318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65438243|NCT00136318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65438244|NCT00136318|Serotonin Agents|serotonin agents|mesh-ancestor
65438245|NCT00136318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438246|NCT00136318|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65438298|NCT00136084|Antimitotic Agents|antimitotic agents|mesh-ancestor
65438299|NCT00136084|Mitosis Modulators|mitosis modulators|mesh-ancestor
65438300|NCT00136084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65438301|NCT00136084|Analgesics|analgesics|mesh-ancestor
65438302|NCT00136084|Sensory System Agents|sensory system agents|mesh-ancestor
65438303|NCT00136084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65438370|NCT03988452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65438371|NCT03988452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65438372|NCT03988452|Protease Inhibitors|protease inhibitors|mesh-ancestor
65438373|NCT03988452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438374|NCT03988452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438440|NCT00527423|Growth Inhibitors|growth inhibitors|mesh-ancestor
65438441|NCT00527423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438442|NCT00527111|Fluorouracil|fluorouracil|mesh-list
65438443|NCT00527111|Cetuximab|cetuximab|mesh-list
65438444|NCT00527111|Antimetabolites|antimetabolites|mesh-ancestor
65438445|NCT00527111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438446|NCT00527111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65438447|NCT00527111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438448|NCT00527111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65438449|NCT00527111|Immunologic Factors|immunologic factors|mesh-ancestor
65438450|NCT00527111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438451|NCT00527111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65438452|NCT00336024|Leucovorin|leucovorin|mesh-list
65438453|NCT00336024|Cyclophosphamide|cyclophosphamide|mesh-list
65438454|NCT00336024|Thiotepa|thiotepa|mesh-list
65438455|NCT00336024|Carboplatin|carboplatin|mesh-list
65438456|NCT00336024|Methotrexate|methotrexate|mesh-list
65438457|NCT00336024|Etoposide|etoposide|mesh-list
65438500|NCT04090697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438501|NCT04090697|Anabolic Agents|anabolic agents|mesh-ancestor
65438502|NCT00367640|Immunologic Factors|immunologic factors|mesh-list
65438503|NCT00367640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438504|NCT01325220|Baclofen|baclofen|mesh-list
65438505|NCT01325220|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65438506|NCT01325220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438507|NCT01325220|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65438508|NCT01325220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65438509|NCT01325220|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65438510|NCT01325220|GABA Agonists|gaba agonists|mesh-ancestor
65438511|NCT01325220|GABA Agents|gaba agents|mesh-ancestor
65438512|NCT01325220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65438513|NCT01325220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438514|NCT00367484|Interferons|interferons|mesh-list
65438515|NCT00367484|Interferon-beta|interferon-beta|mesh-list
65438516|NCT00367484|Interferon beta-1a|interferon beta-1a|mesh-list
65438517|NCT00367484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438518|NCT00367484|Antiviral Agents|antiviral agents|mesh-ancestor
65438519|NCT00367484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65438520|NCT00367484|Immunologic Factors|immunologic factors|mesh-ancestor
65438521|NCT00367484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438522|NCT00367484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65438523|NCT00526799|Sorafenib|sorafenib|mesh-list
65438524|NCT00526799|Topotecan|topotecan|mesh-list
65438525|NCT00526799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438526|NCT00526799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65438527|NCT00526799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438528|NCT00526799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438529|NCT00526799|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65438530|NCT00526799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65438531|NCT01059084|Valacyclovir|valacyclovir|mesh-list
65438532|NCT01059084|Antiviral Agents|antiviral agents|mesh-ancestor
65438533|NCT01059084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65438543|NCT02534870|Protease Inhibitors|protease inhibitors|mesh-ancestor
65438544|NCT02534870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438545|NCT02534870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438546|NCT02534870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65438547|NCT02534870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65438548|NCT02534870|Antiviral Agents|antiviral agents|mesh-ancestor
65438549|NCT02534870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65438550|NCT02534870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65438551|NCT02534870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65438552|NCT03992066|Epoetin Alfa|epoetin alfa|mesh-list
65438553|NCT03992066|Darbepoetin alfa|darbepoetin alfa|mesh-list
65438554|NCT03992066|Hematinics|hematinics|mesh-ancestor
65438555|NCT03986268|Vitamin D|vitamin d|mesh-list
65438556|NCT03986268|Cholecalciferol|cholecalciferol|mesh-list
65438557|NCT03986268|Vitamins|vitamins|mesh-ancestor
65438558|NCT03986268|Micronutrients|micronutrients|mesh-ancestor
65438559|NCT03986268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438560|NCT03986268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65438561|NCT03986268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65438562|NCT01048892|Cyclophosphamide|cyclophosphamide|mesh-list
65438563|NCT01048892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65438564|NCT01048892|Immunologic Factors|immunologic factors|mesh-ancestor
65438565|NCT01048892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438595|NCT01044992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438596|NCT01044992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438597|NCT00520403|Interferons|interferons|mesh-list
65438598|NCT00520403|Interferon-alpha|interferon-alpha|mesh-list
65438599|NCT00520403|Interferon alpha-2|interferon alpha-2|mesh-list
65438600|NCT00520403|Bevacizumab|bevacizumab|mesh-list
65438601|NCT00520403|Vinblastine|vinblastine|mesh-list
65438602|NCT00520403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65438603|NCT00520403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438617|NCT00520013|Paclitaxel|paclitaxel|mesh-list
65438663|NCT00135694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
65438664|NCT00135694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65438665|NCT00135694|Glucocorticoids|glucocorticoids|mesh-ancestor
65438666|NCT00135694|Hormones|hormones|mesh-ancestor
65438667|NCT00135694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65438668|NCT00135694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438669|NCT00135694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65438670|NCT00135694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438671|NCT00135694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438672|NCT00135694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438673|NCT00524459|Docetaxel|docetaxel|mesh-list
65438674|NCT00524459|Doxorubicin|doxorubicin|mesh-list
65438675|NCT00524459|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65438676|NCT00524459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438677|NCT00524459|Tubulin Modulators|tubulin modulators|mesh-ancestor
65438678|NCT00524459|Antimitotic Agents|antimitotic agents|mesh-ancestor
65438679|NCT00524459|Mitosis Modulators|mitosis modulators|mesh-ancestor
65438680|NCT00524459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438681|NCT00524459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65438682|NCT00524459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65438683|NCT00524459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65438684|NCT00524459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438685|NCT00519623|Insulin|insulin|mesh-list
65438686|NCT00519623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65438687|NCT00519623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438688|NCT01076530|Temozolomide|temozolomide|mesh-list
65438689|NCT01076530|Vorinostat|vorinostat|mesh-list
65438690|NCT01076530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65438691|NCT01076530|Alkylating Agents|alkylating agents|mesh-ancestor
65438692|NCT01076530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438693|NCT01076530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438694|NCT01076530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65438695|NCT01076530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438702|NCT00124618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65438703|NCT00124618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438704|NCT00124072|Folic Acid|folic acid|mesh-list
65438705|NCT00124072|Vitamin B 12|vitamin b 12|mesh-list
65438706|NCT00124072|Hydroxocobalamin|hydroxocobalamin|mesh-list
65438707|NCT00124072|Simvastatin|simvastatin|mesh-list
65438708|NCT00124072|Vitamins|vitamins|mesh-ancestor
65438709|NCT00124072|Micronutrients|micronutrients|mesh-ancestor
65438710|NCT00124072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438711|NCT00124072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65438712|NCT00124072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65438718|NCT00124072|Hematinics|hematinics|mesh-ancestor
65438768|NCT00335556|Antimitotic Agents|antimitotic agents|mesh-ancestor
65438769|NCT00335556|Mitosis Modulators|mitosis modulators|mesh-ancestor
65438770|NCT00335556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65438771|NCT00335556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65438772|NCT00335556|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65438773|NCT00335556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65438774|NCT00518687|Vaccines|vaccines|mesh-list
65438775|NCT00518687|Immunologic Factors|immunologic factors|mesh-ancestor
65438776|NCT00518687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65438777|NCT00134056|Prednisone|prednisone|mesh-list
65438778|NCT00134056|Docetaxel|docetaxel|mesh-list
65438779|NCT00134056|Atrasentan|atrasentan|mesh-list
65438780|NCT00134056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438781|NCT00134056|Tubulin Modulators|tubulin modulators|mesh-ancestor
65438831|NCT00335322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65438832|NCT00335322|Protease Inhibitors|protease inhibitors|mesh-ancestor
65438833|NCT00335322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65438834|NCT00335322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438835|NCT00335322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65438836|NCT00335322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65438837|NCT00335322|Antiviral Agents|antiviral agents|mesh-ancestor
65438838|NCT00335322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65438839|NCT00335322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65438840|NCT00335322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65438841|NCT00335322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65438842|NCT00335322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65438843|NCT00335322|Antimetabolites|antimetabolites|mesh-ancestor
65438844|NCT00335322|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65438845|NCT00335322|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65438846|NCT00335322|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65438847|NCT00335322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65438884|NCT03755765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65438885|NCT01061112|Tolbutamide|tolbutamide|mesh-list
65438886|NCT01061112|Fluconazole|fluconazole|mesh-list
65438887|NCT01061112|Ketoprofen|ketoprofen|mesh-list
65438888|NCT01061112|Flurbiprofen|flurbiprofen|mesh-list
65438889|NCT01061112|Antifungal Agents|antifungal agents|mesh-ancestor
65438890|NCT01061112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65438891|NCT01061112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65438951|NCT00112294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65438952|NCT00112294|Tubulin Modulators|tubulin modulators|mesh-ancestor
65438953|NCT00112294|Antimitotic Agents|antimitotic agents|mesh-ancestor
65438954|NCT00112294|Mitosis Modulators|mitosis modulators|mesh-ancestor
65439024|NCT00323622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65439025|NCT00323622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439026|NCT00323622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439027|NCT00323622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65439028|NCT00323622|Renal Agents|renal agents|mesh-ancestor
65439029|NCT01326039|Bupivacaine|bupivacaine|mesh-list
65439030|NCT01326039|Anesthetics, Local|anesthetics, local|mesh-ancestor
65439031|NCT01326039|Anesthetics|anesthetics|mesh-ancestor
65439036|NCT01057758|Simvastatin|simvastatin|mesh-list
65439091|NCT01060176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439092|NCT01060176|Hemostatics|hemostatics|mesh-ancestor
65439093|NCT01060176|Coagulants|coagulants|mesh-ancestor
65439094|NCT00132808|Zoledronic Acid|zoledronic acid|mesh-list
65439095|NCT00132808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65439096|NCT00132808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439097|NCT03982992|Blinatumomab|blinatumomab|mesh-list
65439098|NCT03982992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439099|NCT03695471|Pembrolizumab|pembrolizumab|mesh-list
65439100|NCT03695471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65439101|NCT03695471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439102|NCT01061268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65439103|NCT01061268|Lubricant Eye Drops|lubricant eye drops|mesh-list
65439104|NCT01061268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65439155|NCT03649841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65439156|NCT03649841|Glucocorticoids|glucocorticoids|mesh-ancestor
65439157|NCT03649841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65439158|NCT03649841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439159|NCT03649841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65439160|NCT03649841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439161|NCT03649841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65439162|NCT03649841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439163|NCT03649841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439164|NCT03649841|Hormone Antagonists|hormone antagonists|mesh-ancestor
65439165|NCT03649841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65439166|NCT03649841|Antioxidants|antioxidants|mesh-ancestor
65439167|NCT03649841|Protective Agents|protective agents|mesh-ancestor
65439168|NCT03649841|Vitamins|vitamins|mesh-ancestor
65439169|NCT03649841|Micronutrients|micronutrients|mesh-ancestor
65439170|NCT03649841|Estrogens|estrogens|mesh-ancestor
65439171|NCT03649841|Anabolic Agents|anabolic agents|mesh-ancestor
65439172|NCT00522431|Testosterone|testosterone|mesh-list
65439173|NCT00522431|Androgens|androgens|mesh-ancestor
65439174|NCT00522431|Hormones|hormones|mesh-ancestor
65439175|NCT00522431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65439209|NCT02531841|Thiotepa|thiotepa|mesh-list
65439210|NCT02531841|Carmustine|carmustine|mesh-list
65439211|NCT02531841|Busulfan|busulfan|mesh-list
65439212|NCT02531841|BB 1101|bb 1101|mesh-list
65439213|NCT02531841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65439214|NCT02531841|Antiemetics|antiemetics|mesh-ancestor
65439215|NCT02531841|Autonomic Agents|autonomic agents|mesh-ancestor
65439216|NCT02531841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65439217|NCT02531841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439218|NCT02531841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65439219|NCT02531841|Glucocorticoids|glucocorticoids|mesh-ancestor
65439220|NCT02531841|Hormones|hormones|mesh-ancestor
65439221|NCT02531841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65439222|NCT02531841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65439272|NCT03519971|Cisplatin|cisplatin|mesh-list
65439273|NCT03519971|Carboplatin|carboplatin|mesh-list
65439274|NCT03519971|Pemetrexed|pemetrexed|mesh-list
65439275|NCT03519971|Durvalumab|durvalumab|mesh-list
65439276|NCT03519971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65439277|NCT03519971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439342|NCT01076842|Exenatide|exenatide|mesh-list
65439343|NCT01076842|Insulin Detemir|insulin detemir|mesh-list
65188852|NCT02724202|Analgesics|analgesics|mesh-ancestor
65439344|NCT01076842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65439345|NCT01076842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439346|NCT01076842|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65439347|NCT01076842|Incretins|incretins|mesh-ancestor
65439348|NCT01076842|Hormones|hormones|mesh-ancestor
65439349|NCT01076842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65439350|NCT01060410|Cyclophosphamide|cyclophosphamide|mesh-list
65439351|NCT01060410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65439352|NCT01060410|Immunologic Factors|immunologic factors|mesh-ancestor
65439353|NCT01060410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439354|NCT01060410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65439355|NCT01060410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65439356|NCT01060410|Alkylating Agents|alkylating agents|mesh-ancestor
65439357|NCT01060410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439358|NCT01060410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439359|NCT01060410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65439360|NCT00231465|Docetaxel|docetaxel|mesh-list
65439361|NCT00231465|Gefitinib|gefitinib|mesh-list
65439362|NCT00231465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439363|NCT00231465|Tubulin Modulators|tubulin modulators|mesh-ancestor
65439364|NCT00231465|Antimitotic Agents|antimitotic agents|mesh-ancestor
65439365|NCT00231465|Mitosis Modulators|mitosis modulators|mesh-ancestor
65439392|NCT00110890|Cinacalcet|cinacalcet|mesh-list
65439393|NCT00110890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65439394|NCT00110890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439395|NCT00110890|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65439396|NCT00110890|Hormone Antagonists|hormone antagonists|mesh-ancestor
65439397|NCT00110890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65439398|NCT00182637|Bortezomib|bortezomib|mesh-list
65439399|NCT00182637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439400|NCT01076998|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65439401|NCT01076998|Lubricant Eye Drops|lubricant eye drops|mesh-list
65439402|NCT01076998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65439403|NCT00122278|Dexamethasone|dexamethasone|mesh-list
65439404|NCT00122278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65439405|NCT00122278|Antiemetics|antiemetics|mesh-ancestor
65439406|NCT00122278|Autonomic Agents|autonomic agents|mesh-ancestor
65439451|NCT00110812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65439452|NCT00110812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65439453|NCT00110812|Antiviral Agents|antiviral agents|mesh-ancestor
65439454|NCT00110812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65439455|NCT00516269|Methylphenidate|methylphenidate|mesh-list
65439456|NCT00516269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65439457|NCT00516269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439458|NCT00516269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65439459|NCT00516269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65439462|NCT00516269|Dopamine Agents|dopamine agents|mesh-ancestor
65439515|NCT01060488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
65439517|NCT01060488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65439518|NCT01060488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439519|NCT01060566|Ivacaftor|ivacaftor|mesh-list
65439520|NCT01060566|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65439521|NCT01060566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65439522|NCT01060566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439523|NCT02533284|Magnesium Sulfate|magnesium sulfate|mesh-list
65439524|NCT02533284|Analgesics|analgesics|mesh-ancestor
65439525|NCT02533284|Sensory System Agents|sensory system agents|mesh-ancestor
65439579|NCT01045304|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65439580|NCT01080742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65439581|NCT01080742|Bisoprolol|bisoprolol|mesh-list
65439582|NCT01080742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65439583|NCT01080742|Diuretics|diuretics|mesh-ancestor
65439584|NCT01080742|Natriuretic Agents|natriuretic agents|mesh-ancestor
65439585|NCT01080742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439586|NCT01080742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65439589|NCT01080742|Sympatholytics|sympatholytics|mesh-ancestor
65439644|NCT00096382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65439645|NCT00096382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65439646|NCT00096382|Antimetabolites|antimetabolites|mesh-ancestor
65439647|NCT00096382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65439648|NCT00096382|Analgesics|analgesics|mesh-ancestor
65439649|NCT00096382|Sensory System Agents|sensory system agents|mesh-ancestor
65439650|NCT00096382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65439651|NCT00096382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65439652|NCT00096382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65439653|NCT00096382|Antiviral Agents|antiviral agents|mesh-ancestor
65439654|NCT00096382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65439655|NCT00384332|Olanzapine|olanzapine|mesh-list
65439656|NCT00384332|Antiemetics|antiemetics|mesh-ancestor
65439671|NCT00096226|Paclitaxel|paclitaxel|mesh-list
65439706|NCT01082848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65439707|NCT01082848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65439708|NCT01082848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439709|NCT01082848|Dopamine Agonists|dopamine agonists|mesh-ancestor
65439710|NCT01082848|Dopamine Agents|dopamine agents|mesh-ancestor
65439775|NCT00104572|Calcium|calcium|mesh-list
65439776|NCT00104572|Testosterone|testosterone|mesh-list
65439777|NCT00104572|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65439778|NCT00104572|Vitamins|vitamins|mesh-ancestor
65439779|NCT00104572|Micronutrients|micronutrients|mesh-ancestor
65439780|NCT00104572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439781|NCT00104572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65439782|NCT00104572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65439783|NCT00104572|Androgens|androgens|mesh-ancestor
65439784|NCT00104572|Hormones|hormones|mesh-ancestor
65439785|NCT00104572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65439786|NCT00104572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65439787|NCT00104572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439788|NCT00104572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65439789|NCT00104572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439790|NCT00104572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439791|NCT00104572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65439792|NCT00104572|Hormone Antagonists|hormone antagonists|mesh-ancestor
65439794|NCT00514943|Afatinib|afatinib|mesh-list
65439795|NCT00514943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65439796|NCT00514943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439800|NCT00103402|Alfuzosin|alfuzosin|mesh-list
65439828|NCT03330821|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65439829|NCT03330821|Pevonedistat|pevonedistat|mesh-list
65439830|NCT03330821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65439831|NCT03330821|Antimetabolites|antimetabolites|mesh-ancestor
65439832|NCT03330821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439833|NCT03330821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439834|NCT03330821|Antiviral Agents|antiviral agents|mesh-ancestor
65439835|NCT03330821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65439894|NCT00228423|Clopidogrel|clopidogrel|mesh-list
65439895|NCT00228423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65439896|NCT00228423|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65439897|NCT00228423|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65439898|NCT00228423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65439899|NCT00228423|Purinergic Agents|purinergic agents|mesh-ancestor
65439900|NCT00228423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65439901|NCT00228423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439902|NCT00228423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439903|NCT00513695|Paclitaxel|paclitaxel|mesh-list
65439904|NCT00513695|Cyclophosphamide|cyclophosphamide|mesh-list
65439905|NCT00513695|Doxorubicin|doxorubicin|mesh-list
65439906|NCT00513695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65439907|NCT00513695|Sunitinib|sunitinib|mesh-list
65439908|NCT00513695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65439909|NCT00513695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65439910|NCT00513695|Tubulin Modulators|tubulin modulators|mesh-ancestor
65439911|NCT00513695|Antimitotic Agents|antimitotic agents|mesh-ancestor
65439912|NCT00513695|Mitosis Modulators|mitosis modulators|mesh-ancestor
65439913|NCT00513695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439949|NCT00099268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65439950|NCT00099268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65439951|NCT00099268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65439952|NCT00099268|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65439953|NCT00099268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65439954|NCT00099268|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65439955|NCT00099268|Immunologic Factors|immunologic factors|mesh-ancestor
65439956|NCT00099268|Dopamine Agonists|dopamine agonists|mesh-ancestor
65439957|NCT00099268|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65439958|NCT00511355|Levonorgestrel|levonorgestrel|mesh-list
65439959|NCT00511355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65440011|NCT00120250|Eszopiclone|eszopiclone|mesh-list
65440012|NCT00120250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65440013|NCT00120250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65440014|NCT00120250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440015|NCT01081600|Trastuzumab|trastuzumab|mesh-list
65440016|NCT01081600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65440017|NCT01081600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440018|NCT01079338|Caffeine|caffeine|mesh-list
65440019|NCT01079338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65440020|NCT01079338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440021|NCT01079338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65440022|NCT01079338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440023|NCT01079338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440024|NCT01079338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65440025|NCT01079338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65440026|NCT01079338|Purinergic Agents|purinergic agents|mesh-ancestor
65440070|NCT00510887|Bortezomib|bortezomib|mesh-list
65440071|NCT00510887|Mitoxantrone|mitoxantrone|mesh-list
65440072|NCT00510887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65440073|NCT00510887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440074|NCT00510887|Immunologic Factors|immunologic factors|mesh-ancestor
65440075|NCT00510887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440076|NCT00510887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65440077|NCT00510887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65440078|NCT00510887|Antiemetics|antiemetics|mesh-ancestor
65440079|NCT00510887|Autonomic Agents|autonomic agents|mesh-ancestor
65440080|NCT00510887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65440081|NCT00510887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65440082|NCT00510887|Glucocorticoids|glucocorticoids|mesh-ancestor
65440083|NCT00510887|Hormones|hormones|mesh-ancestor
65440084|NCT00510887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65440085|NCT00510887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65440086|NCT00510887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440087|NCT00510887|Analgesics|analgesics|mesh-ancestor
65440088|NCT00510887|Sensory System Agents|sensory system agents|mesh-ancestor
65440090|NCT00510887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65440091|NCT00510887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440092|NCT01012349|Aspirin|aspirin|mesh-list
65440093|NCT01012349|Citric Acid|citric acid|mesh-list
65440094|NCT01012349|Sodium Citrate|sodium citrate|mesh-list
65440097|NCT01012349|Analgesics|analgesics|mesh-ancestor
65440122|NCT01009541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440123|NCT01009541|Anticonvulsants|anticonvulsants|mesh-ancestor
65440124|NCT01009541|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65440125|NCT01009541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65440126|NCT01009541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440127|NCT01009541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65440128|NCT01009541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65440129|NCT01009541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65440130|NCT01009541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65440131|NCT01009541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65440132|NCT00510653|Imatinib Mesylate|imatinib mesylate|mesh-list
65440133|NCT00510653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440134|NCT00510653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65440135|NCT00510653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440136|NCT00510653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440137|NCT01009697|Codeine|codeine|mesh-list
65440138|NCT01009697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65440139|NCT01009697|Narcotics|narcotics|mesh-ancestor
65440140|NCT01009697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65440141|NCT01009697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440142|NCT01009697|Analgesics|analgesics|mesh-ancestor
65440143|NCT01009697|Sensory System Agents|sensory system agents|mesh-ancestor
65440144|NCT01009697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65440145|NCT01009697|Antitussive Agents|antitussive agents|mesh-ancestor
65440146|NCT01009697|Respiratory System Agents|respiratory system agents|mesh-ancestor
65440147|NCT01009853|Codeine|codeine|mesh-list
65440148|NCT01009853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65440149|NCT01009853|Narcotics|narcotics|mesh-ancestor
65440150|NCT01009853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65440164|NCT00506285|Dopamine Agents|dopamine agents|mesh-ancestor
65440165|NCT00506285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65440166|NCT00506129|Fludarabine|fludarabine|mesh-list
65440167|NCT00506129|Fludarabine phosphate|fludarabine phosphate|mesh-list
65440168|NCT00506129|Melphalan|melphalan|mesh-list
65440169|NCT00506129|Thymoglobulin|thymoglobulin|mesh-list
65440170|NCT00506129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65440171|NCT00506129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440172|NCT00506129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65440173|NCT00506129|Antimetabolites|antimetabolites|mesh-ancestor
65440174|NCT00506129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440175|NCT00506129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65440229|NCT01010243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65440230|NCT01010243|Growth Substances|growth substances|mesh-ancestor
65440231|NCT01010243|Growth Inhibitors|growth inhibitors|mesh-ancestor
65440232|NCT01010243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65440233|NCT01010243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65440234|NCT01010243|Alkylating Agents|alkylating agents|mesh-ancestor
65440235|NCT01010243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440236|NCT00383708|Lanreotide|lanreotide|mesh-list
65440237|NCT00383708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440238|NCT00504881|Brivaracetam|brivaracetam|mesh-list
65440239|NCT00504881|Anticonvulsants|anticonvulsants|mesh-ancestor
65440240|NCT00504725|Ketamine|ketamine|mesh-list
65440241|NCT00504725|Analgesics|analgesics|mesh-ancestor
65440242|NCT00504725|Sensory System Agents|sensory system agents|mesh-ancestor
65440248|NCT00504725|Anesthetics|anesthetics|mesh-ancestor
65440289|NCT00383162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65440290|NCT00383162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65440291|NCT00383162|Analgesics|analgesics|mesh-ancestor
65440292|NCT00383162|Sensory System Agents|sensory system agents|mesh-ancestor
65440293|NCT00383162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65440294|NCT00383162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440295|NCT00383162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65440296|NCT00383162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65440297|NCT00383162|Gout Suppressants|gout suppressants|mesh-ancestor
65440298|NCT00383162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65440299|NCT00383162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440300|NCT00383162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440301|NCT00383162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65440302|NCT00383162|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65440303|NCT00383162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65440304|NCT00383162|Serotonin Agents|serotonin agents|mesh-ancestor
65440305|NCT00383162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65440306|NCT01052792|Naproxen|naproxen|mesh-list
65440307|NCT01052792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65440342|NCT01045538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440343|NCT00361634|Etanercept|etanercept|mesh-list
65440344|NCT00361634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65440345|NCT00361634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65440346|NCT00361634|Analgesics|analgesics|mesh-ancestor
65440347|NCT00361634|Sensory System Agents|sensory system agents|mesh-ancestor
65440411|NCT00357110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440412|NCT00357110|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65440413|NCT00357110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65440414|NCT00357110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440415|NCT00357110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440416|NCT03337646|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65440417|NCT03337646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65440418|NCT03337646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440419|NCT03337646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65440420|NCT03337646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65440421|NCT03337646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65440422|NCT03337646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440423|NCT03337646|Dopamine Agents|dopamine agents|mesh-ancestor
65440472|NCT00381680|Vincristine|vincristine|mesh-list
65440473|NCT00381680|Etoposide phosphate|etoposide phosphate|mesh-list
65440474|NCT00381680|Asparaginase|asparaginase|mesh-list
65440475|NCT00381680|Mercaptopurine|mercaptopurine|mesh-list
65440476|NCT00381680|Pegaspargase|pegaspargase|mesh-list
65440477|NCT00381680|Levoleucovorin|levoleucovorin|mesh-list
65440478|NCT00381680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65440479|NCT00381680|Immunologic Factors|immunologic factors|mesh-ancestor
65440480|NCT00381680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440481|NCT00381680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65440482|NCT00381680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65440483|NCT00381680|Alkylating Agents|alkylating agents|mesh-ancestor
65440484|NCT00381680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440485|NCT00381680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440486|NCT00381680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65440487|NCT00381680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65440488|NCT00381680|Antiemetics|antiemetics|mesh-ancestor
65440489|NCT00381680|Autonomic Agents|autonomic agents|mesh-ancestor
65440490|NCT00381680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65440491|NCT00381680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65440492|NCT00381680|Glucocorticoids|glucocorticoids|mesh-ancestor
65440493|NCT00381680|Hormones|hormones|mesh-ancestor
65440494|NCT00381680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65440495|NCT00381680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65440496|NCT00381680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65440523|NCT03292250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440524|NCT03292250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65440525|NCT03292250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440526|NCT03292250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440527|NCT01053338|Diphenhydramine|diphenhydramine|mesh-list
65440528|NCT01053338|Promethazine|promethazine|mesh-list
65440529|NCT01053338|Ibuprofen|ibuprofen|mesh-list
65440530|NCT01053338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440531|NCT01053338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65440532|NCT01053338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65440533|NCT01053338|Analgesics|analgesics|mesh-ancestor
65440534|NCT01053338|Sensory System Agents|sensory system agents|mesh-ancestor
65440535|NCT01053338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65440536|NCT01053338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440537|NCT01053338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65440538|NCT01053338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65440539|NCT01053338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65440540|NCT01053338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440541|NCT01053338|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65440542|NCT01053338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65440543|NCT01053338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65440544|NCT01053338|Anesthetics, Local|anesthetics, local|mesh-ancestor
65440545|NCT01053338|Anesthetics|anesthetics|mesh-ancestor
65440546|NCT01053338|Antiemetics|antiemetics|mesh-ancestor
65440547|NCT01053338|Autonomic Agents|autonomic agents|mesh-ancestor
65440548|NCT01053338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65440549|NCT01053338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65440550|NCT01053338|Histamine Antagonists|histamine antagonists|mesh-ancestor
65440551|NCT01053338|Histamine Agents|histamine agents|mesh-ancestor
65440552|NCT01053338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65440553|NCT01053338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65440554|NCT01053338|Antipruritics|antipruritics|mesh-ancestor
65440555|NCT01053338|Dermatologic Agents|dermatologic agents|mesh-ancestor
65440556|NCT01050374|Albendazole|albendazole|mesh-list
65440557|NCT01050374|Praziquantel|praziquantel|mesh-list
65440558|NCT01050374|Mebendazole|mebendazole|mesh-list
65440564|NCT01050374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65440565|NCT01050374|Anticestodal Agents|anticestodal agents|mesh-ancestor
65440566|NCT01050374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65440567|NCT01050374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65440568|NCT01050374|Tubulin Modulators|tubulin modulators|mesh-ancestor
65440569|NCT01050374|Antimitotic Agents|antimitotic agents|mesh-ancestor
65440570|NCT01050374|Mitosis Modulators|mitosis modulators|mesh-ancestor
65440571|NCT01050374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440572|NCT01050374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440573|NCT01050374|Antinematodal Agents|antinematodal agents|mesh-ancestor
65440574|NCT01050374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440575|NCT00360698|Insulin|insulin|mesh-list
65440576|NCT00360698|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65440577|NCT00360698|Metformin|metformin|mesh-list
65440578|NCT00360698|Insulin Glargine|insulin glargine|mesh-list
65440626|NCT01074801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65440627|NCT01074801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440628|NCT01074879|Caseins|caseins|mesh-list
65440629|NCT01074879|Chelating Agents|chelating agents|mesh-ancestor
65440630|NCT01074879|Sequestering Agents|sequestering agents|mesh-ancestor
65440631|NCT01074879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440632|NCT00226941|Diphenhydramine|diphenhydramine|mesh-list
65440633|NCT00226941|Promethazine|promethazine|mesh-list
65440634|NCT00226941|Capecitabine|capecitabine|mesh-list
65440635|NCT00226941|Oxaliplatin|oxaliplatin|mesh-list
65440636|NCT00226941|Cetuximab|cetuximab|mesh-list
65440637|NCT00226941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65440638|NCT00226941|Antimetabolites|antimetabolites|mesh-ancestor
65440639|NCT00226941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440640|NCT00226941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440641|NCT00226941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65440642|NCT00226941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65440643|NCT00226941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65440644|NCT00226941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65440645|NCT00226941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440646|NCT00226941|Anesthetics, Local|anesthetics, local|mesh-ancestor
65440647|NCT00226941|Anesthetics|anesthetics|mesh-ancestor
65440648|NCT00226941|Sensory System Agents|sensory system agents|mesh-ancestor
65440649|NCT00226941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65440650|NCT00226941|Antiemetics|antiemetics|mesh-ancestor
65440651|NCT00226941|Autonomic Agents|autonomic agents|mesh-ancestor
65440652|NCT00226941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65440675|NCT01075581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440676|NCT01075581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65440677|NCT01075581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65440678|NCT01075581|Autonomic Agents|autonomic agents|mesh-ancestor
65440679|NCT01075581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65440680|NCT01075581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65440681|NCT01075581|Respiratory System Agents|respiratory system agents|mesh-ancestor
65440682|NCT01075581|Mydriatics|mydriatics|mesh-ancestor
65440683|NCT01075581|Sympathomimetics|sympathomimetics|mesh-ancestor
65440684|NCT01075581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65440685|NCT00356408|Certolizumab Pegol|certolizumab pegol|mesh-list
65440686|NCT00356408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65440687|NCT00356408|Immunologic Factors|immunologic factors|mesh-ancestor
65440688|NCT00356408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440689|NCT00356408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65440690|NCT00509795|Ranibizumab|ranibizumab|mesh-list
65440691|NCT00509795|Aflibercept|aflibercept|mesh-list
65440692|NCT00509795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65440693|NCT00509795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65440694|NCT00509795|Growth Substances|growth substances|mesh-ancestor
65440695|NCT00509795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440696|NCT00509795|Growth Inhibitors|growth inhibitors|mesh-ancestor
65440697|NCT00509795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440698|NCT00504257|Bevacizumab|bevacizumab|mesh-list
65440699|NCT00504257|Docetaxel|docetaxel|mesh-list
65440700|NCT00504257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65440701|NCT00504257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440702|NCT00504257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65440703|NCT00504257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65440704|NCT00504257|Growth Substances|growth substances|mesh-ancestor
65440706|NCT00504257|Growth Inhibitors|growth inhibitors|mesh-ancestor
65440720|NCT00160641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65440721|NCT00160641|Immunologic Factors|immunologic factors|mesh-ancestor
65440722|NCT00160641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440723|NCT00160641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65440724|NCT00493025|Paclitaxel|paclitaxel|mesh-list
65440725|NCT00493025|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65440726|NCT00493025|Cisplatin|cisplatin|mesh-list
65440727|NCT00493025|Gefitinib|gefitinib|mesh-list
65440728|NCT00493025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65440729|NCT00493025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440786|NCT00380588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440787|NCT00380588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65440788|NCT00380588|Immunologic Factors|immunologic factors|mesh-ancestor
65440789|NCT00380588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440790|NCT00379808|Montelukast|montelukast|mesh-list
65440791|NCT00379808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65440792|NCT00379808|Respiratory System Agents|respiratory system agents|mesh-ancestor
65440793|NCT00379808|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65440794|NCT00379808|Hormone Antagonists|hormone antagonists|mesh-ancestor
65440795|NCT00379808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65440796|NCT00379808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440807|NCT00355784|Hormones|hormones|mesh-list
65440849|NCT01053806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65440850|NCT01053806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65440851|NCT01053806|Growth Substances|growth substances|mesh-ancestor
65440852|NCT01053806|Growth Inhibitors|growth inhibitors|mesh-ancestor
65440853|NCT01053806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440854|NCT01053806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65440855|NCT01053806|Antimetabolites|antimetabolites|mesh-ancestor
65440856|NCT01053806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440857|NCT01053806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440858|NCT00355472|Mogamulizumab|mogamulizumab|mesh-list
65440859|NCT00355472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440860|NCT01053884|Anidulafungin|anidulafungin|mesh-list
65440861|NCT01053884|Antifungal Agents|antifungal agents|mesh-ancestor
65440862|NCT01053884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65440863|NCT00492557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65440864|NCT00492557|Immunologic Factors|immunologic factors|mesh-ancestor
65440865|NCT00492557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440906|NCT00508157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65440907|NCT00508157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65440908|NCT00508157|Antidepressive Agents|antidepressive agents|mesh-ancestor
65440909|NCT00508157|Dopamine Agonists|dopamine agonists|mesh-ancestor
65440976|NCT01015547|Methotrexate|methotrexate|mesh-list
65440977|NCT01015547|Infliximab|infliximab|mesh-list
65440978|NCT01015547|Naltrexone|naltrexone|mesh-list
65440979|NCT01015547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65440980|NCT01015547|Abortifacient Agents|abortifacient agents|mesh-ancestor
65440981|NCT01015547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65440982|NCT01015547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65440983|NCT01015547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65440984|NCT01015547|Antimetabolites|antimetabolites|mesh-ancestor
65440985|NCT01015547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65440986|NCT01015547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65440987|NCT01015547|Dermatologic Agents|dermatologic agents|mesh-ancestor
65440988|NCT01015547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65440989|NCT01015547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65440990|NCT01015547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65190488|NCT02697838|Paclitaxel|paclitaxel|mesh-list
65440991|NCT01015547|Immunologic Factors|immunologic factors|mesh-ancestor
65440992|NCT01015547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65440993|NCT01015547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65440994|NCT01015547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65440995|NCT01015547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65440996|NCT01015547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65440997|NCT01015547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65440999|NCT01015547|Sensory System Agents|sensory system agents|mesh-ancestor
65441000|NCT01015547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65441001|NCT01015547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65441024|NCT00507455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65441025|NCT00507455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441026|NCT00507455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441027|NCT00507455|Urological Agents|urological agents|mesh-ancestor
65441028|NCT00507455|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65441029|NCT00507455|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65441030|NCT00507455|Cholinergic Agents|cholinergic agents|mesh-ancestor
65441031|NCT04275713|Metformin|metformin|mesh-list
65441032|NCT04275713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65441033|NCT04275713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441034|NCT00506831|Imatinib Mesylate|imatinib mesylate|mesh-list
65441035|NCT00506831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441036|NCT00506831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65441037|NCT00506831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441038|NCT00506831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441039|NCT00490919|Buprenorphine|buprenorphine|mesh-list
65441041|NCT00490919|Narcotics|narcotics|mesh-ancestor
65441082|NCT01012193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441083|NCT01012193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441084|NCT01012193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65441085|NCT01012193|Autonomic Agents|autonomic agents|mesh-ancestor
65441086|NCT01012193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65441087|NCT01012193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65441088|NCT01012193|Respiratory System Agents|respiratory system agents|mesh-ancestor
65441149|NCT00378014|Immunologic Factors|immunologic factors|mesh-ancestor
65441150|NCT00378014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441151|NCT00485303|Prednisone|prednisone|mesh-list
65441152|NCT00485303|Abiraterone Acetate|abiraterone acetate|mesh-list
65441153|NCT00485303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65441154|NCT00485303|Glucocorticoids|glucocorticoids|mesh-ancestor
65441155|NCT00485303|Hormones|hormones|mesh-ancestor
65441156|NCT00485303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65441157|NCT00485303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441158|NCT00485303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65441159|NCT00485303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441160|NCT00485303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65441161|NCT00485303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441162|NCT00485303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441163|NCT00485303|Hormone Antagonists|hormone antagonists|mesh-ancestor
65441164|NCT00485303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65441165|NCT01018823|Ertugliflozin|ertugliflozin|mesh-list
65441166|NCT01018823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65441167|NCT01018823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441168|NCT01018823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65441169|NCT01018823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441170|NCT01016249|Epinephrine|epinephrine|mesh-list
65441171|NCT01016249|Racepinephrine|racepinephrine|mesh-list
65441172|NCT01016249|Epinephryl borate|epinephryl borate|mesh-list
65441173|NCT01016249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65441174|NCT01016249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65441175|NCT01016249|Adrenergic Agents|adrenergic agents|mesh-ancestor
65441176|NCT01016249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65441194|NCT00502775|Fluticasone|fluticasone|mesh-list
65441195|NCT00502775|Xhance|xhance|mesh-list
65441196|NCT00502775|Fexofenadine|fexofenadine|mesh-list
65441197|NCT00502775|Terfenadine|terfenadine|mesh-list
65441198|NCT00502775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65441199|NCT00502775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65441200|NCT00502775|Autonomic Agents|autonomic agents|mesh-ancestor
65441201|NCT00502775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65441202|NCT00502775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441203|NCT00502775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65441204|NCT00502775|Respiratory System Agents|respiratory system agents|mesh-ancestor
65441205|NCT00502775|Dermatologic Agents|dermatologic agents|mesh-ancestor
65441258|NCT00355082|Anticonvulsants|anticonvulsants|mesh-list
65441259|NCT00355082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65441260|NCT00355082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65441261|NCT00355082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441263|NCT00355082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441325|NCT00484289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441326|NCT00484289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441327|NCT00484289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65441328|NCT00484289|Immunologic Factors|immunologic factors|mesh-ancestor
65441329|NCT00484289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441330|NCT00484289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65441331|NCT01013831|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65441332|NCT01013831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441337|NCT01013909|Bifonazole|bifonazole|mesh-list
65441392|NCT00333840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441393|NCT00333840|Antiviral Agents|antiviral agents|mesh-ancestor
65441394|NCT00333840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65441395|NCT00333840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65441396|NCT00333840|Antimetabolites|antimetabolites|mesh-ancestor
65441397|NCT00333840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441398|NCT00333840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65441399|NCT00333840|Immunologic Factors|immunologic factors|mesh-ancestor
65441400|NCT00333840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441401|NCT00333840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65441402|NCT00333840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441403|NCT01019603|Nicotinic Acids|nicotinic acids|mesh-list
65441455|NCT00333138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65441456|NCT00333138|Immunologic Factors|immunologic factors|mesh-ancestor
65441457|NCT00333138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441458|NCT01061658|Vaccines|vaccines|mesh-list
65441459|NCT01061658|Immunologic Factors|immunologic factors|mesh-ancestor
65441460|NCT01061658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441461|NCT01058382|Progesterone|progesterone|mesh-list
65441462|NCT01058382|Progestins|progestins|mesh-ancestor
65441463|NCT01058382|Hormones|hormones|mesh-ancestor
65441464|NCT01058382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65441465|NCT01058382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441466|NCT01061814|Mipomersen|mipomersen|mesh-list
65441467|NCT01061814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65441468|NCT01061814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65441518|NCT00320424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65441519|NCT00320424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65441520|NCT00338286|Epoetin Alfa|epoetin alfa|mesh-list
65441521|NCT00338286|Hematinics|hematinics|mesh-ancestor
65441522|NCT00329550|Certolizumab Pegol|certolizumab pegol|mesh-list
65441523|NCT00329550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65441524|NCT00329550|Immunologic Factors|immunologic factors|mesh-ancestor
65441525|NCT00329550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441526|NCT00329550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65441527|NCT00375674|Sunitinib|sunitinib|mesh-list
65441528|NCT00375674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441529|NCT00375674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65441530|NCT00375674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65441531|NCT00375674|Growth Substances|growth substances|mesh-ancestor
65441532|NCT00375674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441533|NCT00375674|Growth Inhibitors|growth inhibitors|mesh-ancestor
65441534|NCT00375674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65441535|NCT00375674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441536|NCT00375674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441537|NCT03991910|Ramipril|ramipril|mesh-list
65441538|NCT03991910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65441571|NCT00349622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65441572|NCT00349622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65441573|NCT03987698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65441574|NCT03987698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441575|NCT03987698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441576|NCT01054508|Nicotinic Acids|nicotinic acids|mesh-list
65441577|NCT01054508|Niacin|niacin|mesh-list
65441578|NCT01054508|Niacinamide|niacinamide|mesh-list
65441579|NCT01054508|Vitamin B Complex|vitamin b complex|mesh-ancestor
65441580|NCT01054508|Vitamins|vitamins|mesh-ancestor
65441581|NCT01054508|Micronutrients|micronutrients|mesh-ancestor
65441582|NCT01054508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441583|NCT01054508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65441584|NCT01054508|Antimetabolites|antimetabolites|mesh-ancestor
65441585|NCT01054508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441586|NCT01054508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65441587|NCT01054508|Vasodilator Agents|vasodilator agents|mesh-ancestor
65441588|NCT00348686|Felodipine|felodipine|mesh-list
65441589|NCT00348686|Candesartan|candesartan|mesh-list
65441590|NCT00348686|Candesartan cilexetil|candesartan cilexetil|mesh-list
65191092|NCT01097057|Plerixafor|plerixafor|mesh-list
65441624|NCT03989024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65441625|NCT03989024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65441626|NCT03989024|Hormones|hormones|mesh-ancestor
65441627|NCT03987308|Insulin Aspart|insulin aspart|mesh-list
65441628|NCT03987308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65441629|NCT03987308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441630|NCT00348374|Insulin Lispro|insulin lispro|mesh-list
65441631|NCT00348374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65441632|NCT00348374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441633|NCT03742232|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65441634|NCT03742232|Laxatives|laxatives|mesh-ancestor
65441635|NCT03742232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65441636|NCT03988478|Psychotropic Drugs|psychotropic drugs|mesh-list
65441637|NCT00352664|Donepezil|donepezil|mesh-list
65441638|NCT00352664|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65441639|NCT00352664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65441684|NCT00483119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65441685|NCT00483119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65441686|NCT00483119|Alkylating Agents|alkylating agents|mesh-ancestor
65441687|NCT00483119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441688|NCT00483119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441689|NCT00483119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65441690|NCT01016639|Capecitabine|capecitabine|mesh-list
65441691|NCT01016639|Oxaliplatin|oxaliplatin|mesh-list
65441692|NCT01016639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65441693|NCT01016639|Antimetabolites|antimetabolites|mesh-ancestor
65441694|NCT01016639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441695|NCT01016639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441696|NCT00501293|Methylphenidate|methylphenidate|mesh-list
65441697|NCT00501293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65441698|NCT00501293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441699|NCT00501293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65441700|NCT00501293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65441701|NCT00501293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65441702|NCT00501293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441703|NCT00501293|Dopamine Agents|dopamine agents|mesh-ancestor
65441704|NCT00501293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65441705|NCT01014221|Prednisolone|prednisolone|mesh-list
65441733|NCT00359762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65441734|NCT00359762|Immunologic Factors|immunologic factors|mesh-ancestor
65441735|NCT03988010|Amantadine|amantadine|mesh-list
65441736|NCT03988010|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65441737|NCT03988010|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65441738|NCT03988010|Antiviral Agents|antiviral agents|mesh-ancestor
65441739|NCT03988010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65441740|NCT03988010|Dopamine Agents|dopamine agents|mesh-ancestor
65441741|NCT03988010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65441742|NCT03988010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441743|NCT03988010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441744|NCT03988010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65441745|NCT03988010|Analgesics|analgesics|mesh-ancestor
65441746|NCT03988010|Sensory System Agents|sensory system agents|mesh-ancestor
65441747|NCT03988010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65441748|NCT01055522|Interleukin-2|interleukin-2|mesh-list
65441749|NCT01055522|Dacarbazine|dacarbazine|mesh-list
65441750|NCT01055522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441752|NCT01055522|Analgesics|analgesics|mesh-ancestor
65441790|NCT00328926|Hormones|hormones|mesh-list
65441791|NCT00328926|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65441792|NCT00328926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65441793|NCT00328926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441794|NCT00328926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65441795|NCT00347360|Carvedilol|carvedilol|mesh-list
65441796|NCT00347360|Lisinopril|lisinopril|mesh-list
65441797|NCT00347360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65441798|NCT00347360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65441799|NCT00347360|Adrenergic Agents|adrenergic agents|mesh-ancestor
65441800|NCT00347360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65441801|NCT00347360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441802|NCT00347360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441804|NCT00347360|Antioxidants|antioxidants|mesh-ancestor
65441849|NCT00352118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65441850|NCT00352118|Immunologic Factors|immunologic factors|mesh-ancestor
65441851|NCT00352118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441852|NCT00352118|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65441853|NCT00318474|Mycophenolic Acid|mycophenolic acid|mesh-list
65441854|NCT00318474|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65441855|NCT00318474|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65441856|NCT00318474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65441857|NCT00318474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65441858|NCT00318474|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65441859|NCT00318474|Antitubercular Agents|antitubercular agents|mesh-ancestor
65441860|NCT00318474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65441861|NCT00318474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65441862|NCT00318474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65441863|NCT00318474|Protease Inhibitors|protease inhibitors|mesh-ancestor
65441864|NCT00350870|Disulfiram|disulfiram|mesh-list
65441869|NCT00350792|Carboplatin|carboplatin|mesh-list
65441908|NCT01058720|Vitamin D|vitamin d|mesh-list
65441909|NCT01058720|Cholecalciferol|cholecalciferol|mesh-list
65441910|NCT01058720|Vitamins|vitamins|mesh-ancestor
65441911|NCT01058720|Micronutrients|micronutrients|mesh-ancestor
65441912|NCT01058720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441913|NCT01058720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65441914|NCT01058720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65441915|NCT00346268|Parecoxib|parecoxib|mesh-list
65441916|NCT00346268|Morphine|morphine|mesh-list
65441917|NCT00346268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65441918|NCT00346268|Narcotics|narcotics|mesh-ancestor
65441919|NCT00346268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65441920|NCT00346268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441921|NCT00346268|Analgesics|analgesics|mesh-ancestor
65441970|NCT03985280|Sensory System Agents|sensory system agents|mesh-ancestor
65441971|NCT03985280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65441972|NCT01058876|Nicotine|nicotine|mesh-list
65441973|NCT01058876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65441974|NCT01058876|Autonomic Agents|autonomic agents|mesh-ancestor
65441975|NCT01058876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65441976|NCT01058876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65441977|NCT01058876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65441978|NCT01058876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65441979|NCT01058876|Cholinergic Agents|cholinergic agents|mesh-ancestor
65441980|NCT01058876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65442033|NCT00335972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65442034|NCT00335972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65442035|NCT00335972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65191600|NCT00705445|Zinc|zinc|mesh-list
65442036|NCT00335972|Adrenergic Agents|adrenergic agents|mesh-ancestor
65442037|NCT00335972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65442038|NCT00335972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442039|NCT00335972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65442040|NCT00335972|Narcotics|narcotics|mesh-ancestor
65442041|NCT03983460|Betamethasone|betamethasone|mesh-list
65442042|NCT03983460|Betamethasone Valerate|betamethasone valerate|mesh-list
65442043|NCT03983460|Clobetasol|clobetasol|mesh-list
65442044|NCT03983460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65442045|NCT03983460|Glucocorticoids|glucocorticoids|mesh-ancestor
65442046|NCT03983460|Hormones|hormones|mesh-ancestor
65442049|NCT03983460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65442093|NCT00345878|Immunologic Factors|immunologic factors|mesh-ancestor
65442094|NCT00345878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442095|NCT01059110|Salicylates|salicylates|mesh-list
65442096|NCT01059110|Imiquimod|imiquimod|mesh-list
65442097|NCT01059110|Fluorouracil|fluorouracil|mesh-list
65442098|NCT01059110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65442099|NCT01059110|Immunologic Factors|immunologic factors|mesh-ancestor
65442100|NCT01059110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442101|NCT01059110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442102|NCT01059110|Interferon Inducers|interferon inducers|mesh-ancestor
65442103|NCT01059110|Antimetabolites|antimetabolites|mesh-ancestor
65442104|NCT01059110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442105|NCT01059110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65442155|NCT01056926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442156|NCT01056926|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65442157|NCT01056926|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65442158|NCT01056926|Cholinergic Agents|cholinergic agents|mesh-ancestor
65442159|NCT01056926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65442160|NCT01056926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442161|NCT01059422|Lamivudine|lamivudine|mesh-list
65442223|NCT01062360|Nasal Decongestants|nasal decongestants|mesh-ancestor
65442224|NCT01062360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65442225|NCT01062360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65442226|NCT01062360|Sympathomimetics|sympathomimetics|mesh-ancestor
65442227|NCT01062360|Adrenergic Agents|adrenergic agents|mesh-ancestor
65442228|NCT01062360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65442229|NCT01063842|Acetaminophen|acetaminophen|mesh-list
65442230|NCT01063842|Tramadol|tramadol|mesh-list
65442231|NCT01063842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65442232|NCT01063842|Analgesics|analgesics|mesh-ancestor
65442233|NCT01063842|Sensory System Agents|sensory system agents|mesh-ancestor
65442234|NCT01063842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442235|NCT01063842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442236|NCT01063842|Antipyretics|antipyretics|mesh-ancestor
65442237|NCT01063842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65442238|NCT01063842|Narcotics|narcotics|mesh-ancestor
65442239|NCT01063842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65442240|NCT01063920|Naproxen|naproxen|mesh-list
65442241|NCT01063920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65442243|NCT01063920|Analgesics|analgesics|mesh-ancestor
65442279|NCT00334802|Immunologic Factors|immunologic factors|mesh-ancestor
65442280|NCT00334802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442281|NCT03985358|Analgesics, Opioid|analgesics, opioid|mesh-list
65442282|NCT03985358|Narcotics|narcotics|mesh-ancestor
65442283|NCT03985358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65442284|NCT03985358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442285|NCT03985358|Analgesics|analgesics|mesh-ancestor
65442286|NCT03985358|Sensory System Agents|sensory system agents|mesh-ancestor
65442287|NCT03985358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442288|NCT01052324|Remifentanil|remifentanil|mesh-list
65442289|NCT01052324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65442290|NCT01052324|Narcotics|narcotics|mesh-ancestor
65442291|NCT01052324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65442292|NCT01052324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442293|NCT01052324|Analgesics|analgesics|mesh-ancestor
65442294|NCT01052324|Sensory System Agents|sensory system agents|mesh-ancestor
65442295|NCT01052324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442296|NCT01059890|Metronidazole|metronidazole|mesh-list
65442297|NCT01059890|Ciprofloxacin|ciprofloxacin|mesh-list
65442298|NCT01059890|Cefotaxime|cefotaxime|mesh-list
65442299|NCT01059890|Cefoxitin|cefoxitin|mesh-list
65442300|NCT01059890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65442301|NCT01059890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65442302|NCT01059890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65442303|NCT01059890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65442304|NCT01059890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65442305|NCT01059890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65442306|NCT01059890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442307|NCT01059890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442308|NCT01059890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442309|NCT01059890|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65442310|NCT01059890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65442311|NCT01057160|Rizatriptan|rizatriptan|mesh-list
65442322|NCT00307086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65442323|NCT00307086|Alkylating Agents|alkylating agents|mesh-ancestor
65442324|NCT00307086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442325|NCT00307086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65442326|NCT00307086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65442327|NCT00307086|Immunologic Factors|immunologic factors|mesh-ancestor
65442328|NCT00307086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442329|NCT02533544|Tenofovir|tenofovir|mesh-list
65442330|NCT02533544|Antiviral Agents|antiviral agents|mesh-ancestor
65442331|NCT02533544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65442332|NCT02533544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65442333|NCT02533544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65442334|NCT02533544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442335|NCT02533544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442336|NCT02533544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65442338|NCT03991208|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
65442339|NCT03991208|Antimalarials|antimalarials|mesh-ancestor
65442340|NCT03991208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65442341|NCT03991208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65442342|NCT03991208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65442343|NCT00325416|Melphalan|melphalan|mesh-list
65442344|NCT00325416|Topotecan|topotecan|mesh-list
65442345|NCT00325416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65442346|NCT00325416|Alkylating Agents|alkylating agents|mesh-ancestor
65442348|NCT00325416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442371|NCT01060514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65442372|NCT01060514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442373|NCT01060514|Tubulin Modulators|tubulin modulators|mesh-ancestor
65442374|NCT01060514|Antimitotic Agents|antimitotic agents|mesh-ancestor
65442375|NCT01060514|Mitosis Modulators|mitosis modulators|mesh-ancestor
65442376|NCT01060514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442377|NCT01061216|Insulin|insulin|mesh-list
65442378|NCT01061216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65442379|NCT01061216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65442380|NCT01061216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442381|NCT00314574|Omalizumab|omalizumab|mesh-list
65442382|NCT00314574|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65442385|NCT01064154|Carvedilol|carvedilol|mesh-list
65442434|NCT00314340|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65442435|NCT00314340|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65442436|NCT00314340|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65442437|NCT00306852|Mitomycins|mitomycins|mesh-list
65442438|NCT00306852|Mitomycin|mitomycin|mesh-list
65442439|NCT00306852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65442440|NCT00306852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442441|NCT00306852|Alkylating Agents|alkylating agents|mesh-ancestor
65442442|NCT00306852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442443|NCT00306852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65442497|NCT00332696|Autonomic Agents|autonomic agents|mesh-ancestor
65442498|NCT00332696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442499|NCT00332696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442501|NCT00332696|Glucocorticoids|glucocorticoids|mesh-ancestor
65442570|NCT01057628|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65442571|NCT01057628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442572|NCT01057628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65442573|NCT01057628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442574|NCT00331760|Cisplatin|cisplatin|mesh-list
65442575|NCT00331760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442576|NCT00225147|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
65442577|NCT00225147|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65442578|NCT00225147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65442579|NCT00225147|Immunologic Factors|immunologic factors|mesh-ancestor
65442580|NCT00225147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442581|NCT00313014|Oxycodone|oxycodone|mesh-list
65442582|NCT00313014|Buprenorphine|buprenorphine|mesh-list
65442583|NCT00313014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65442584|NCT00313014|Narcotics|narcotics|mesh-ancestor
65442629|NCT00156819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65442630|NCT00156819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65442631|NCT00156819|Autonomic Agents|autonomic agents|mesh-ancestor
65442632|NCT00156819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442633|NCT00156819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442634|NCT00156819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65192140|NCT00631527|Sunitinib|sunitinib|mesh-list
65442635|NCT00156819|Respiratory System Agents|respiratory system agents|mesh-ancestor
65442636|NCT00156819|Dermatologic Agents|dermatologic agents|mesh-ancestor
65442637|NCT00156819|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65442638|NCT00156819|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65442639|NCT00156819|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65442640|NCT00156819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65442641|NCT00156819|Adrenergic Agents|adrenergic agents|mesh-ancestor
65442642|NCT00156819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65442643|NCT00156819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442644|NCT00156819|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65442645|NCT00156819|Hormone Antagonists|hormone antagonists|mesh-ancestor
65442682|NCT01582737|Rivaroxaban|rivaroxaban|mesh-list
65442683|NCT01582737|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65442684|NCT01582737|Antithrombins|antithrombins|mesh-ancestor
65442685|NCT01582737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65442686|NCT01582737|Protease Inhibitors|protease inhibitors|mesh-ancestor
65442687|NCT01582737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442688|NCT01582737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442689|NCT01582737|Anticoagulants|anticoagulants|mesh-ancestor
65442690|NCT01077609|Fluticasone|fluticasone|mesh-list
65442691|NCT01077609|Xhance|xhance|mesh-list
65442692|NCT01077609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65442693|NCT01077609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65442694|NCT01077609|Autonomic Agents|autonomic agents|mesh-ancestor
65442695|NCT01077609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442696|NCT01077609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442697|NCT01077609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65442698|NCT01077609|Respiratory System Agents|respiratory system agents|mesh-ancestor
65442703|NCT00223977|Hematinics|hematinics|mesh-ancestor
65442741|NCT00331682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442742|NCT00331682|Growth Inhibitors|growth inhibitors|mesh-ancestor
65442743|NCT00331682|Growth Substances|growth substances|mesh-ancestor
65442744|NCT00331682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442745|NCT00331682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65442810|NCT01064232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65442811|NCT01064232|Serotonin Agents|serotonin agents|mesh-ancestor
65442812|NCT01064232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65442813|NCT01064232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442814|NCT01064232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442815|NCT01064232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65442816|NCT01064232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65442817|NCT01064232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65442818|NCT01064232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65442819|NCT01064232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65442820|NCT01064232|Dopamine Agents|dopamine agents|mesh-ancestor
65442821|NCT00501059|Aspirin|aspirin|mesh-list
65442822|NCT00501059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65442823|NCT00501059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65442824|NCT00501059|Analgesics|analgesics|mesh-ancestor
65442825|NCT00501059|Sensory System Agents|sensory system agents|mesh-ancestor
65442826|NCT00501059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442827|NCT00501059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442828|NCT00501059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65442829|NCT00501059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65442830|NCT00501059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65442831|NCT00501059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65442832|NCT00501059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442833|NCT00501059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65442834|NCT00501059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65442835|NCT00501059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442836|NCT00501059|Antipyretics|antipyretics|mesh-ancestor
65442837|NCT00344318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65442838|NCT00344318|Immunologic Factors|immunologic factors|mesh-ancestor
65442839|NCT00344318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442840|NCT00322868|Pioglitazone|pioglitazone|mesh-list
65442841|NCT00322868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65442842|NCT00322868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442843|NCT01016717|Omeprazole|omeprazole|mesh-list
65442844|NCT01016717|Pantoprazole|pantoprazole|mesh-list
65442849|NCT01016717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442850|NCT01016795|Lenograstim|lenograstim|mesh-list
65442851|NCT01016795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65442852|NCT01016795|Immunologic Factors|immunologic factors|mesh-ancestor
65442853|NCT01016795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442854|NCT00343382|Pilocarpine|pilocarpine|mesh-list
65442855|NCT00343382|Miotics|miotics|mesh-ancestor
65442856|NCT00343382|Autonomic Agents|autonomic agents|mesh-ancestor
65442857|NCT00343382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442858|NCT00343382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442915|NCT00329030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65442916|NCT00328562|Gefitinib|gefitinib|mesh-list
65442917|NCT00328562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65442918|NCT00328562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65442919|NCT00328562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442920|NCT00328562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442921|NCT00328172|Metformin|metformin|mesh-list
65442922|NCT00328172|Linagliptin|linagliptin|mesh-list
65442923|NCT00328172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65442924|NCT00328172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442925|NCT00328172|Incretins|incretins|mesh-ancestor
65442926|NCT00328172|Hormones|hormones|mesh-ancestor
65442927|NCT00328172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65442928|NCT00328172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65442932|NCT01061372|Pregabalin|pregabalin|mesh-list
65442975|NCT00305448|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65442976|NCT00305448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65442977|NCT00305448|Hormone Antagonists|hormone antagonists|mesh-ancestor
65442978|NCT00305448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65442979|NCT00305448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442980|NCT01063218|Emollients|emollients|mesh-list
65442981|NCT01063218|Dermatologic Agents|dermatologic agents|mesh-ancestor
65442982|NCT00305058|Morphine|morphine|mesh-list
65442983|NCT00305058|Hydromorphone|hydromorphone|mesh-list
65442984|NCT00305058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65442985|NCT00305058|Narcotics|narcotics|mesh-ancestor
65442986|NCT00305058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65442987|NCT00305058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65442988|NCT00305058|Analgesics|analgesics|mesh-ancestor
65442989|NCT00305058|Sensory System Agents|sensory system agents|mesh-ancestor
65442990|NCT00305058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65442991|NCT01061450|Simvastatin|simvastatin|mesh-list
65442992|NCT01061450|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65442993|NCT01061450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65442994|NCT01061450|Antimetabolites|antimetabolites|mesh-ancestor
65442995|NCT01061450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65442996|NCT01061450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65442997|NCT01061450|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65442998|NCT01061450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65442999|NCT03986294|Leucovorin|leucovorin|mesh-list
65443000|NCT03986294|Antidotes|antidotes|mesh-ancestor
65443001|NCT03986294|Protective Agents|protective agents|mesh-ancestor
65443002|NCT03986294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443003|NCT03986294|Vitamin B Complex|vitamin b complex|mesh-ancestor
65443004|NCT03986294|Vitamins|vitamins|mesh-ancestor
65443005|NCT03986294|Micronutrients|micronutrients|mesh-ancestor
65443020|NCT00321932|Vitamins|vitamins|mesh-ancestor
65443021|NCT00321932|Micronutrients|micronutrients|mesh-ancestor
65443022|NCT00321932|Antacids|antacids|mesh-ancestor
65443023|NCT00321932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65443024|NCT00326612|Midazolam|midazolam|mesh-list
65443025|NCT00326612|Diazepam|diazepam|mesh-list
65443026|NCT00326612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65443027|NCT00326612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65443030|NCT00326612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65443090|NCT01060904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65443091|NCT01060904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65443092|NCT01060904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443093|NCT01060904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65443094|NCT01060904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65443095|NCT01060904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443158|NCT01061060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65443159|NCT01061060|Vasodilator Agents|vasodilator agents|mesh-ancestor
65443160|NCT01061060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65443161|NCT00310388|Ezogabine|ezogabine|mesh-list
65443162|NCT00310388|Anticonvulsants|anticonvulsants|mesh-ancestor
65443163|NCT00310388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65443164|NCT00310388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443166|NCT03981770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65443167|NCT03981770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443168|NCT00500357|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65443169|NCT00500357|Immunologic Factors|immunologic factors|mesh-ancestor
65443170|NCT00500357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443171|NCT01063556|Donepezil|donepezil|mesh-list
65443219|NCT03985982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443220|NCT03985982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65443221|NCT03985982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65443222|NCT00499889|Vidarabine|vidarabine|mesh-list
65443223|NCT00499889|Methotrexate|methotrexate|mesh-list
65443224|NCT00499889|Fludarabine phosphate|fludarabine phosphate|mesh-list
65443225|NCT00499889|Fludarabine|fludarabine|mesh-list
65443226|NCT00499889|Busulfan|busulfan|mesh-list
65443227|NCT00499889|Imatinib Mesylate|imatinib mesylate|mesh-list
65443228|NCT00499889|Tacrolimus|tacrolimus|mesh-list
65443229|NCT00499889|Thymoglobulin|thymoglobulin|mesh-list
65443230|NCT00499889|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65443231|NCT00499889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65443232|NCT00499889|Abortifacient Agents|abortifacient agents|mesh-ancestor
65443233|NCT00499889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65443234|NCT00499889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443235|NCT00499889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65443236|NCT00499889|Antimetabolites|antimetabolites|mesh-ancestor
65443237|NCT00499889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443238|NCT00499889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443276|NCT00308750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65443277|NCT00308750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65443278|NCT00489359|Carboplatin|carboplatin|mesh-list
65443279|NCT00489359|Pemetrexed|pemetrexed|mesh-list
65443280|NCT00489359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443281|NCT00489359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443282|NCT00489359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443283|NCT00489359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65443284|NCT00489359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65443285|NCT00481247|Imatinib Mesylate|imatinib mesylate|mesh-list
65443286|NCT00481247|Dasatinib|dasatinib|mesh-list
65443287|NCT00481247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443288|NCT00481247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65443289|NCT00481247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443290|NCT00481247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443291|NCT04101461|Iron|iron|mesh-list
65443292|NCT04101461|Hepcidins|hepcidins|mesh-list
65443293|NCT04101461|Trace Elements|trace elements|mesh-ancestor
65443294|NCT04101461|Micronutrients|micronutrients|mesh-ancestor
65443295|NCT04101461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443296|NCT04101461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65443297|NCT01017107|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
65443298|NCT01017107|Protein C|protein c|mesh-list
65443299|NCT01017107|Anticoagulants|anticoagulants|mesh-ancestor
65443300|NCT01017107|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65443301|NCT01017107|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65443302|NCT01017107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443304|NCT03997019|Analgesics, Opioid|analgesics, opioid|mesh-list
65443324|NCT00498797|Antimitotic Agents|antimitotic agents|mesh-ancestor
65443325|NCT00498797|Mitosis Modulators|mitosis modulators|mesh-ancestor
65443326|NCT00498797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443327|NCT00498797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65443328|NCT00498797|Glucocorticoids|glucocorticoids|mesh-ancestor
65443329|NCT00498797|Hormones|hormones|mesh-ancestor
65443330|NCT00498797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65443331|NCT00498797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443332|NCT00498797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65443333|NCT00498485|Sodium Oxybate|sodium oxybate|mesh-list
65443334|NCT00498485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65443335|NCT00498485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65443336|NCT00498485|Anesthetics, General|anesthetics, general|mesh-ancestor
65443337|NCT00498485|Anesthetics|anesthetics|mesh-ancestor
65443338|NCT00498485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65443380|NCT01069302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443381|NCT00321620|Zoledronic Acid|zoledronic acid|mesh-list
65443382|NCT00321620|Denosumab|denosumab|mesh-list
65443383|NCT00321620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65443384|NCT00321620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443385|NCT00304278|Cisplatin|cisplatin|mesh-list
65443386|NCT00304278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65443387|NCT00304278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443388|NCT00304278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65443389|NCT00304278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443390|NCT00304278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443392|NCT03981068|Cisplatin|cisplatin|mesh-list
65443398|NCT01064102|Cetirizine|cetirizine|mesh-list
65443442|NCT03979586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443443|NCT03979586|Viscosupplements|viscosupplements|mesh-ancestor
65443444|NCT03979586|Protective Agents|protective agents|mesh-ancestor
65443445|NCT00294762|Paclitaxel|paclitaxel|mesh-list
65443446|NCT00294762|Carboplatin|carboplatin|mesh-list
65443447|NCT00294762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65443448|NCT00294762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65443449|NCT00294762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443450|NCT00294762|Tubulin Modulators|tubulin modulators|mesh-ancestor
65443451|NCT00294762|Antimitotic Agents|antimitotic agents|mesh-ancestor
65443452|NCT00294762|Mitosis Modulators|mitosis modulators|mesh-ancestor
65443453|NCT00294762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443504|NCT01069536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443505|NCT00320216|Ustekinumab|ustekinumab|mesh-list
65443506|NCT00320216|Dermatologic Agents|dermatologic agents|mesh-ancestor
65443507|NCT00290706|Gemcitabine|gemcitabine|mesh-list
65443575|NCT00303108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65443576|NCT00302952|Lovastatin|lovastatin|mesh-list
65443577|NCT00302952|L 647318|l 647318|mesh-list
65443578|NCT00302952|Dihydromevinolin|dihydromevinolin|mesh-list
65443579|NCT00302952|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65443580|NCT00302952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65443581|NCT00302952|Antimetabolites|antimetabolites|mesh-ancestor
65443582|NCT00302952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443583|NCT00302952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65443584|NCT00302952|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65443585|NCT00302952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443586|NCT01066572|Lisinopril|lisinopril|mesh-list
65443587|NCT01066572|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65443588|NCT01066572|Protease Inhibitors|protease inhibitors|mesh-ancestor
65443589|NCT01066572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443590|NCT01066572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443591|NCT01066572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65443631|NCT01066806|Calcium|calcium|mesh-list
65443632|NCT01066806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65443633|NCT01066806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443634|NCT03977610|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65443635|NCT03977610|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65443636|NCT03977610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443637|NCT01066884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65443638|NCT01066884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443639|NCT01066884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65443640|NCT01066884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443641|NCT01066884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443642|NCT02532270|Phenylephrine|phenylephrine|mesh-list
65443643|NCT02532270|Oxymetazoline|oxymetazoline|mesh-list
65443644|NCT02532270|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65443645|NCT02532270|Mydriatics|mydriatics|mesh-ancestor
65443646|NCT02532270|Autonomic Agents|autonomic agents|mesh-ancestor
65443647|NCT02532270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65443674|NCT00289848|Hormones|hormones|mesh-ancestor
65443687|NCT01066962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65443688|NCT01066962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65443689|NCT01066962|Protease Inhibitors|protease inhibitors|mesh-ancestor
65443690|NCT01066962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65443691|NCT01066962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443692|NCT01066962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65443693|NCT01066962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65443694|NCT01066962|Antiviral Agents|antiviral agents|mesh-ancestor
65443754|NCT03982784|Analgesics|analgesics|mesh-ancestor
65443755|NCT03982784|Sensory System Agents|sensory system agents|mesh-ancestor
65443756|NCT03982784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65443757|NCT03978884|Losartan|losartan|mesh-list
65443758|NCT03978884|Amlodipine|amlodipine|mesh-list
65443759|NCT03978884|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65443760|NCT03978884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65443823|NCT00303602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65443824|NCT00303602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65443825|NCT00303602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65443826|NCT00303602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65443827|NCT00303602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65443828|NCT00303602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65443832|NCT00303602|Serotonin Agents|serotonin agents|mesh-ancestor
65443890|NCT03977298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65443891|NCT03977298|Disinfectants|disinfectants|mesh-ancestor
65443892|NCT03977220|Paclitaxel|paclitaxel|mesh-list
65443893|NCT03977220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65443894|NCT03977220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443895|NCT03977220|Tubulin Modulators|tubulin modulators|mesh-ancestor
65443896|NCT03977220|Antimitotic Agents|antimitotic agents|mesh-ancestor
65443897|NCT03977220|Mitosis Modulators|mitosis modulators|mesh-ancestor
65443898|NCT03977220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65443899|NCT00293202|Etanercept|etanercept|mesh-list
65443900|NCT00293202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65443902|NCT00293202|Analgesics|analgesics|mesh-ancestor
65443954|NCT00284934|Prednisone|prednisone|mesh-list
65443955|NCT00284934|Tacrolimus|tacrolimus|mesh-list
65443956|NCT00284934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65443957|NCT00284934|Glucocorticoids|glucocorticoids|mesh-ancestor
65443958|NCT00284934|Hormones|hormones|mesh-ancestor
65443959|NCT00284934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65443960|NCT00284934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65443961|NCT00284934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65443962|NCT00284934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65443963|NCT00284934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65444019|NCT00298272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65444020|NCT00298272|Protective Agents|protective agents|mesh-ancestor
65444021|NCT00298272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65444022|NCT00298272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65444023|NCT00298272|Analgesics|analgesics|mesh-ancestor
65444024|NCT00298272|Sensory System Agents|sensory system agents|mesh-ancestor
65444091|NCT01068132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444092|NCT00297492|Nicotine|nicotine|mesh-list
65444093|NCT00297492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65444094|NCT00297492|Autonomic Agents|autonomic agents|mesh-ancestor
65444095|NCT00297492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65444096|NCT00297492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444097|NCT00297492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65444098|NCT00297492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65444099|NCT00297492|Cholinergic Agents|cholinergic agents|mesh-ancestor
65444100|NCT00297492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65444101|NCT00297492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444102|NCT00496769|Aspirin|aspirin|mesh-list
65444103|NCT00496769|Apixaban|apixaban|mesh-list
65444104|NCT00496769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65444105|NCT00496769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65444106|NCT00496769|Analgesics|analgesics|mesh-ancestor
65444107|NCT00496769|Sensory System Agents|sensory system agents|mesh-ancestor
65444108|NCT00496769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65444109|NCT00496769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444110|NCT00496769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65444111|NCT00496769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65444112|NCT00496769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65444113|NCT00496769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65444114|NCT00496769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444115|NCT00496769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65444116|NCT00496769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65444117|NCT00496769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444118|NCT00496769|Antipyretics|antipyretics|mesh-ancestor
65444119|NCT00496769|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65444120|NCT00496769|Antithrombins|antithrombins|mesh-ancestor
65444121|NCT00496769|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65444135|NCT00283062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444136|NCT00283062|Tubulin Modulators|tubulin modulators|mesh-ancestor
65444137|NCT00283062|Antimitotic Agents|antimitotic agents|mesh-ancestor
65444138|NCT00283062|Mitosis Modulators|mitosis modulators|mesh-ancestor
65444139|NCT00283062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444140|NCT00283062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65444141|NCT00283062|Fertility Agents|fertility agents|mesh-ancestor
65444142|NCT00283062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65444143|NCT00283062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444144|NCT00283062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65444145|NCT00282984|Varenicline|varenicline|mesh-list
65444146|NCT00282984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65444147|NCT00282984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65444148|NCT00282984|Cholinergic Agents|cholinergic agents|mesh-ancestor
65444149|NCT00282984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65444150|NCT00282984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444151|NCT00282984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444152|NCT00296400|Atorvastatin|atorvastatin|mesh-list
65444153|NCT00296400|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65444154|NCT00296400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65444155|NCT00296400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65444156|NCT00296400|Antimetabolites|antimetabolites|mesh-ancestor
65444157|NCT00296400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444158|NCT00296400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65444159|NCT00296400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65444160|NCT00296400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444161|NCT00296244|Mycophenolic Acid|mycophenolic acid|mesh-list
65444162|NCT00296244|Prednisone|prednisone|mesh-list
65444163|NCT00296244|Methylprednisolone|methylprednisolone|mesh-list
65444164|NCT00296244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65444165|NCT00296244|Tacrolimus|tacrolimus|mesh-list
65444166|NCT00296244|Basiliximab|basiliximab|mesh-list
65444167|NCT00296244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65444168|NCT00296244|Glucocorticoids|glucocorticoids|mesh-ancestor
65444169|NCT00296244|Hormones|hormones|mesh-ancestor
65444174|NCT00296244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65444175|NCT00296244|Immunologic Factors|immunologic factors|mesh-ancestor
65444176|NCT00296244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65444177|NCT00296244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444178|NCT00296244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444179|NCT00296244|Antiemetics|antiemetics|mesh-ancestor
65444180|NCT00296244|Autonomic Agents|autonomic agents|mesh-ancestor
65444181|NCT00296244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65444182|NCT00296244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65444183|NCT00296244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65444184|NCT00296244|Protective Agents|protective agents|mesh-ancestor
65444185|NCT00296244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65444186|NCT00296244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65444234|NCT00281580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444235|NCT00281580|Vasodilator Agents|vasodilator agents|mesh-ancestor
65444236|NCT00281580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65444238|NCT00495755|Alemtuzumab|alemtuzumab|mesh-list
65444305|NCT00292188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65444306|NCT00292188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65444307|NCT00292188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444308|NCT00292188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65444309|NCT00292188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65444310|NCT00292188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65444311|NCT00292188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65444312|NCT00292188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65444313|NCT00271596|Citalopram|citalopram|mesh-list
65444314|NCT00271596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65444315|NCT00271596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65444316|NCT00271596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65444317|NCT00271596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444318|NCT00271596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65444319|NCT00271596|Serotonin Agents|serotonin agents|mesh-ancestor
65444320|NCT00271596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444359|NCT01070472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65444360|NCT01070472|Oxytocics|oxytocics|mesh-ancestor
65444361|NCT00280566|Ziprasidone|ziprasidone|mesh-list
65444362|NCT00280566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65444363|NCT00280566|Serotonin Agents|serotonin agents|mesh-ancestor
65444364|NCT00280566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65444430|NCT01064726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65444431|NCT01064726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444432|NCT01064726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65444433|NCT01064726|Respiratory System Agents|respiratory system agents|mesh-ancestor
65444434|NCT01064726|Dermatologic Agents|dermatologic agents|mesh-ancestor
65444435|NCT01064726|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65444436|NCT01064726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65444495|NCT00301964|Bevacizumab|bevacizumab|mesh-list
65444496|NCT00301964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65444497|NCT00301964|Antibodies|antibodies|mesh-list
65444498|NCT00301964|Immunoglobulins|immunoglobulins|mesh-list
65444499|NCT00301964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65444500|NCT00301964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444501|NCT00301964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65444502|NCT00301964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65444503|NCT00301964|Growth Substances|growth substances|mesh-ancestor
65444504|NCT00301964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444505|NCT00301964|Growth Inhibitors|growth inhibitors|mesh-ancestor
65444506|NCT00301964|Immunologic Factors|immunologic factors|mesh-ancestor
65444507|NCT00301808|Docetaxel|docetaxel|mesh-list
65444508|NCT00301808|Pemetrexed|pemetrexed|mesh-list
65444509|NCT00301808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65444510|NCT00301808|Tubulin Modulators|tubulin modulators|mesh-ancestor
65444511|NCT00301808|Antimitotic Agents|antimitotic agents|mesh-ancestor
65444555|NCT00268242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65444556|NCT00294554|Memantine|memantine|mesh-list
65444557|NCT00294554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65444558|NCT00294554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65444559|NCT00294554|Dopamine Agents|dopamine agents|mesh-ancestor
65444560|NCT00294554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65444561|NCT00294554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444562|NCT00294554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444563|NCT00294554|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65444564|NCT00294554|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65444565|NCT00294398|Fluticasone|fluticasone|mesh-list
65444566|NCT00294398|Xhance|xhance|mesh-list
65444567|NCT00294398|Budesonide|budesonide|mesh-list
65444568|NCT00294398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65444569|NCT00294398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65444570|NCT00294398|Autonomic Agents|autonomic agents|mesh-ancestor
65444571|NCT00294398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65444572|NCT00294398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444573|NCT00294398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65444574|NCT00294398|Respiratory System Agents|respiratory system agents|mesh-ancestor
65444609|NCT00291330|Warfarin|warfarin|mesh-list
65444610|NCT00291330|Dabigatran|dabigatran|mesh-list
65444611|NCT00291330|Anticoagulants|anticoagulants|mesh-ancestor
65444612|NCT00291330|Antithrombins|antithrombins|mesh-ancestor
65444613|NCT00291330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65444614|NCT00291330|Protease Inhibitors|protease inhibitors|mesh-ancestor
65444615|NCT00291330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444616|NCT00291330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444617|NCT03975036|Antibodies|antibodies|mesh-list
65444618|NCT03975036|Immunologic Factors|immunologic factors|mesh-ancestor
65444629|NCT01582230|Vildagliptin|vildagliptin|mesh-list
65444675|NCT01066676|Ibuprofen|ibuprofen|mesh-list
65444676|NCT01066676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65444677|NCT01066676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65444678|NCT01066676|Analgesics|analgesics|mesh-ancestor
65444679|NCT01066676|Sensory System Agents|sensory system agents|mesh-ancestor
65444680|NCT01066676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65444681|NCT01066676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444741|NCT01066754|Histamine Antagonists|histamine antagonists|mesh-ancestor
65444742|NCT01066754|Histamine Agents|histamine agents|mesh-ancestor
65444743|NCT01066754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65444744|NCT01066754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65444814|NCT02532192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65444815|NCT02532192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65444816|NCT02532192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444817|NCT02532192|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65444818|NCT02532192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65444819|NCT02532192|Antifungal Agents|antifungal agents|mesh-ancestor
65444820|NCT02532192|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65444821|NCT02532192|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65444822|NCT02532192|Hormone Antagonists|hormone antagonists|mesh-ancestor
65444823|NCT02532192|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65444824|NCT02532192|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65444825|NCT02532192|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65444826|NCT00293462|Sargramostim|sargramostim|mesh-list
65444827|NCT00293462|Immunologic Factors|immunologic factors|mesh-ancestor
65444828|NCT00293462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444829|NCT00316082|Metformin|metformin|mesh-list
65444830|NCT00316082|Saxagliptin|saxagliptin|mesh-list
65444871|NCT01325558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65444872|NCT01325558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444873|NCT01325558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65444874|NCT01325558|Immunologic Factors|immunologic factors|mesh-ancestor
65444875|NCT01325558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444876|NCT00315458|Buprenorphine|buprenorphine|mesh-list
65444877|NCT00315458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65444878|NCT00315458|Narcotics|narcotics|mesh-ancestor
65444879|NCT00315458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65444880|NCT00315458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65444881|NCT00315458|Analgesics|analgesics|mesh-ancestor
65444882|NCT00315458|Sensory System Agents|sensory system agents|mesh-ancestor
65444883|NCT00315458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65444884|NCT00315458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65444885|NCT01065662|Sirolimus|sirolimus|mesh-list
65444886|NCT01065662|Cediranib|cediranib|mesh-list
65444887|NCT01065662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65444931|NCT00293384|Autonomic Agents|autonomic agents|mesh-ancestor
65444932|NCT00293384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65444933|NCT00293384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65444934|NCT00293384|Glucocorticoids|glucocorticoids|mesh-ancestor
65444935|NCT00293384|Hormones|hormones|mesh-ancestor
65444936|NCT00293384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65444937|NCT00293384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65444938|NCT00293384|Protease Inhibitors|protease inhibitors|mesh-ancestor
65444939|NCT00293384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65444940|NCT00293384|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65444941|NCT00293384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65444942|NCT00293384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65444943|NCT00293384|Serotonin Agents|serotonin agents|mesh-ancestor
65444944|NCT00297830|Zoledronic Acid|zoledronic acid|mesh-list
65444945|NCT00297830|Alendronate|alendronate|mesh-list
65444948|NCT00296816|Bevacizumab|bevacizumab|mesh-list
65444990|NCT01082146|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65444991|NCT01082146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65444992|NCT01082146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65444993|NCT01082146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65444994|NCT01082146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445060|NCT00275262|Leuprolide|leuprolide|mesh-list
65445061|NCT00275262|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65445062|NCT00275262|Fertility Agents|fertility agents|mesh-ancestor
65445063|NCT00275262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65445064|NCT00275262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445065|NCT00275262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65445066|NCT00275262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445067|NCT00275028|Cediranib|cediranib|mesh-list
65445068|NCT00275028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445072|NCT00471497|Imatinib Mesylate|imatinib mesylate|mesh-list
65445127|NCT01082458|Sensory System Agents|sensory system agents|mesh-ancestor
65445128|NCT01082458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65445129|NCT01082458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65445130|NCT01082458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65445131|NCT01082458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65445132|NCT01082458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65445133|NCT01082458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445134|NCT01082458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65445135|NCT01082458|Narcotics|narcotics|mesh-ancestor
65445136|NCT01082458|Analgesics|analgesics|mesh-ancestor
65445137|NCT00469859|Cytarabine|cytarabine|mesh-list
65445138|NCT00469859|Idarubicin|idarubicin|mesh-list
65445139|NCT00469859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65445140|NCT00469859|Antimetabolites|antimetabolites|mesh-ancestor
65445141|NCT00469859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445142|NCT00469859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445143|NCT00469859|Antiviral Agents|antiviral agents|mesh-ancestor
65445144|NCT00469859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65445145|NCT00469859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65445146|NCT00469859|Immunologic Factors|immunologic factors|mesh-ancestor
65445147|NCT00469859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445148|NCT00469859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65445178|NCT01021787|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65445179|NCT00093808|Capecitabine|capecitabine|mesh-list
65445180|NCT00093808|Trastuzumab|trastuzumab|mesh-list
65445181|NCT00093808|Vinorelbine|vinorelbine|mesh-list
65445182|NCT00093808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65445183|NCT00093808|Antimetabolites|antimetabolites|mesh-ancestor
65445184|NCT00093808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445185|NCT00093808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445186|NCT00093808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65445187|NCT00093808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65445188|NCT00093808|Tubulin Modulators|tubulin modulators|mesh-ancestor
65445189|NCT00093808|Antimitotic Agents|antimitotic agents|mesh-ancestor
65445190|NCT00093808|Mitosis Modulators|mitosis modulators|mesh-ancestor
65445191|NCT00469079|Nicotine|nicotine|mesh-list
65445192|NCT00469079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65445193|NCT00469079|Autonomic Agents|autonomic agents|mesh-ancestor
65445194|NCT00469079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65445195|NCT00469079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445196|NCT00469079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65445197|NCT00469079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65445198|NCT00469079|Cholinergic Agents|cholinergic agents|mesh-ancestor
65445234|NCT00116428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
65445235|NCT03971214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65445236|NCT03971214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445237|NCT03971214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445238|NCT01073748|Acetaminophen|acetaminophen|mesh-list
65445239|NCT01073748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65445240|NCT01073748|Analgesics|analgesics|mesh-ancestor
65445241|NCT01073748|Sensory System Agents|sensory system agents|mesh-ancestor
65445242|NCT01073748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65445243|NCT01073748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445244|NCT01073748|Antipyretics|antipyretics|mesh-ancestor
65445296|NCT00468143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445297|NCT00467831|Acetylcysteine|acetylcysteine|mesh-list
65445298|NCT00467831|Erythromycin|erythromycin|mesh-list
65445299|NCT00467831|Erythromycin Estolate|erythromycin estolate|mesh-list
65445300|NCT00467831|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65445301|NCT00467831|Erythromycin stearate|erythromycin stearate|mesh-list
65445302|NCT00467831|Zileuton|zileuton|mesh-list
65445303|NCT00467831|Losartan|losartan|mesh-list
65445304|NCT00467831|Pravastatin|pravastatin|mesh-list
65445305|NCT00467831|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65445311|NCT00467831|Antiviral Agents|antiviral agents|mesh-ancestor
65445360|NCT00116272|Sensory System Agents|sensory system agents|mesh-ancestor
65445361|NCT00116272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65445362|NCT00116272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445363|NCT00116272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65445364|NCT00116272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65445365|NCT00116272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65445366|NCT00116272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65445367|NCT00116272|Immunologic Factors|immunologic factors|mesh-ancestor
65445368|NCT01022021|Rituximab|rituximab|mesh-list
65445369|NCT01022021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65445370|NCT01022021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65445371|NCT01022021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445372|NCT01022021|Immunologic Factors|immunologic factors|mesh-ancestor
65445374|NCT01022021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65445419|NCT00467363|Micronutrients|micronutrients|mesh-ancestor
65445420|NCT01071174|Dapivirine|dapivirine|mesh-list
65445421|NCT01071174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65445422|NCT01071174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65445423|NCT01071174|Antiviral Agents|antiviral agents|mesh-ancestor
65445424|NCT01071174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65445425|NCT00466505|Celecoxib|celecoxib|mesh-list
65445426|NCT00466505|Cetuximab|cetuximab|mesh-list
65445427|NCT00466505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65445488|NCT01072578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445489|NCT01072734|Vaccines|vaccines|mesh-list
65445490|NCT01072734|Immunologic Factors|immunologic factors|mesh-ancestor
65445491|NCT01072734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445492|NCT03970668|Insulin|insulin|mesh-list
65445493|NCT03970668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65445494|NCT03970668|Linagliptin|linagliptin|mesh-list
65445495|NCT03970668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65445496|NCT03970668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445554|NCT03961828|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
65445555|NCT03961828|Ledipasvir|ledipasvir|mesh-list
65445556|NCT03961828|Antiviral Agents|antiviral agents|mesh-ancestor
65445557|NCT03961828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65445558|NCT00465179|Sunitinib|sunitinib|mesh-list
65445559|NCT00465179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445624|NCT00464087|Anticoagulants|anticoagulants|mesh-ancestor
65445625|NCT00464087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65445626|NCT00464087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65445627|NCT00464087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445628|NCT00464087|Antithrombins|antithrombins|mesh-ancestor
65445629|NCT00464087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65445630|NCT00464087|Protease Inhibitors|protease inhibitors|mesh-ancestor
65445631|NCT00464087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445632|NCT00464087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65445633|NCT00452699|Fluticasone|fluticasone|mesh-list
65445634|NCT00452699|Xhance|xhance|mesh-list
65445635|NCT00452699|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65445636|NCT00452699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65445637|NCT00452699|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65445638|NCT00452699|Autonomic Agents|autonomic agents|mesh-ancestor
65445639|NCT00452699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65445640|NCT00452699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445641|NCT00452699|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65445642|NCT00452699|Respiratory System Agents|respiratory system agents|mesh-ancestor
65445643|NCT00452699|Dermatologic Agents|dermatologic agents|mesh-ancestor
65445644|NCT00452699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65445645|NCT00452699|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65445646|NCT00452699|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65445647|NCT00452699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65445677|NCT01086046|Anticoagulants|anticoagulants|mesh-ancestor
65445678|NCT01086046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65445679|NCT01086046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65445680|NCT01086046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445681|NCT01090648|Etravirine|etravirine|mesh-list
65445682|NCT01090648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65445683|NCT01090648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65445684|NCT01090648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445685|NCT01090648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445686|NCT01090648|Antiviral Agents|antiviral agents|mesh-ancestor
65445687|NCT01090648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65445688|NCT03741244|Temozolomide|temozolomide|mesh-list
65445689|NCT03741244|Apatinib|apatinib|mesh-list
65445690|NCT03741244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65445691|NCT03741244|Alkylating Agents|alkylating agents|mesh-ancestor
65445693|NCT03741244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445736|NCT00068692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445737|NCT00068692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65445738|NCT00068692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445807|NCT00296504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65445808|NCT00296504|Antiviral Agents|antiviral agents|mesh-ancestor
65445809|NCT00296504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65445810|NCT00296504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65445811|NCT00296504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65445812|NCT00313820|Pregabalin|pregabalin|mesh-list
65445813|NCT00313820|Analgesics|analgesics|mesh-ancestor
65445814|NCT00313820|Sensory System Agents|sensory system agents|mesh-ancestor
65445815|NCT00313820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65445816|NCT00313820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445817|NCT00313820|Anticonvulsants|anticonvulsants|mesh-ancestor
65445818|NCT00313820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65445819|NCT00313820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65445820|NCT00313820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445821|NCT00313820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65445822|NCT00313820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65445823|NCT00313820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65445864|NCT00313586|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65445865|NCT00313586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65445866|NCT00313586|Antimetabolites|antimetabolites|mesh-ancestor
65445867|NCT00313586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445868|NCT00313586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445869|NCT00313586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445870|NCT01069328|Paclitaxel|paclitaxel|mesh-list
65445871|NCT01069328|Bevacizumab|bevacizumab|mesh-list
65445872|NCT01069328|Carboplatin|carboplatin|mesh-list
65445873|NCT01069328|Sorafenib|sorafenib|mesh-list
65445874|NCT01069328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65445875|NCT01069328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445876|NCT01069328|Tubulin Modulators|tubulin modulators|mesh-ancestor
65445877|NCT01069328|Antimitotic Agents|antimitotic agents|mesh-ancestor
65445878|NCT01069328|Mitosis Modulators|mitosis modulators|mesh-ancestor
65445879|NCT01069328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445880|NCT01069328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65445881|NCT01069328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65445882|NCT01069328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65445883|NCT01069328|Growth Substances|growth substances|mesh-ancestor
65445884|NCT01069328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445885|NCT01069328|Growth Inhibitors|growth inhibitors|mesh-ancestor
65445886|NCT01069328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65445887|NCT01069328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445888|NCT01067222|Modafinil|modafinil|mesh-list
65445889|NCT01067222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65445895|NCT00312572|Buprenorphine|buprenorphine|mesh-list
65445911|NCT00290732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445912|NCT00312494|Ziprasidone|ziprasidone|mesh-list
65445913|NCT00312494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65445914|NCT00312494|Serotonin Agents|serotonin agents|mesh-ancestor
65445915|NCT00312494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65445916|NCT00312494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445917|NCT00312494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65445918|NCT00312494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65445919|NCT00312494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65445920|NCT00312494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65445921|NCT00312494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65445922|NCT00312494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65445923|NCT00312494|Dopamine Agents|dopamine agents|mesh-ancestor
65445924|NCT00312338|Moxifloxacin|moxifloxacin|mesh-list
65445925|NCT00312338|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65445926|NCT00312338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65445927|NCT00312338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65445928|NCT00312338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65445929|NCT00312338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65445930|NCT00312338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445931|NCT00312338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65445932|NCT00312338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65445962|NCT00290498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65445963|NCT00290498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65445964|NCT00290498|Glucocorticoids|glucocorticoids|mesh-ancestor
65445965|NCT00290498|Hormones|hormones|mesh-ancestor
65445966|NCT00290498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65445967|NCT00290498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65445968|NCT00290498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65445969|NCT00290498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65445970|NCT00290498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65445971|NCT00290498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65445972|NCT00290498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65445973|NCT00290498|Abortifacient Agents|abortifacient agents|mesh-ancestor
65445976|NCT00290498|Antimetabolites|antimetabolites|mesh-ancestor
65446022|NCT00451451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65446023|NCT00451451|Immunologic Factors|immunologic factors|mesh-ancestor
65446024|NCT00451451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446025|NCT00451451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65446026|NCT00451451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65446027|NCT01062698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65446028|NCT01062698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65446029|NCT01062698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65446030|NCT01062698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446031|NCT03977324|Chlorhexidine|chlorhexidine|mesh-list
65446032|NCT03977324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65446033|NCT03977324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65446034|NCT03977324|Disinfectants|disinfectants|mesh-ancestor
65446035|NCT01069874|Vitamin D|vitamin d|mesh-list
65446036|NCT01069874|Cholecalciferol|cholecalciferol|mesh-list
65446037|NCT01069874|Vitamins|vitamins|mesh-ancestor
65446042|NCT01022645|Copper|copper|mesh-list
65446080|NCT01062776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446081|NCT01025921|Colistin|colistin|mesh-list
65446082|NCT01025921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65446083|NCT01025921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65446084|NCT01070030|Amlodipine|amlodipine|mesh-list
65446085|NCT01070030|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65446093|NCT01070030|Diuretics|diuretics|mesh-ancestor
65446149|NCT03982004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446150|NCT03982004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65446151|NCT03982004|Immunologic Factors|immunologic factors|mesh-ancestor
65446152|NCT03982004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446153|NCT03982004|Interferon Inducers|interferon inducers|mesh-ancestor
65446154|NCT01026233|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65446155|NCT01026233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65446156|NCT01026233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446157|NCT01062932|Cycloserine|cycloserine|mesh-list
65446158|NCT01062932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65446159|NCT01062932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65446160|NCT01062932|Renal Agents|renal agents|mesh-ancestor
65446161|NCT01062932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65446162|NCT01062932|Antitubercular Agents|antitubercular agents|mesh-ancestor
65446163|NCT01062932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65446165|NCT01062932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446166|NCT01026311|Ubiquinone|ubiquinone|mesh-list
65446167|NCT01026311|Coenzyme Q10|coenzyme q10|mesh-list
65446168|NCT01026311|Micronutrients|micronutrients|mesh-ancestor
65446169|NCT01026311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446170|NCT01026311|Vitamins|vitamins|mesh-ancestor
65446171|NCT01063010|Bevacizumab|bevacizumab|mesh-list
65446205|NCT01581320|Micronutrients|micronutrients|mesh-ancestor
65446206|NCT01581320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446207|NCT01581320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65446208|NCT01581320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65446209|NCT00289016|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
65446210|NCT00289016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65446211|NCT00289016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446212|NCT00288704|Rilonacept|rilonacept|mesh-list
65446213|NCT00288704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65446214|NCT00288626|Cytarabine|cytarabine|mesh-list
65446215|NCT00288626|Prednisone|prednisone|mesh-list
65446216|NCT00288626|Etoposide|etoposide|mesh-list
65446217|NCT00288626|Melphalan|melphalan|mesh-list
65446218|NCT00288626|Carmustine|carmustine|mesh-list
65446219|NCT00288626|Lenograstim|lenograstim|mesh-list
65446220|NCT00288626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65446221|NCT00288626|Glucocorticoids|glucocorticoids|mesh-ancestor
65446222|NCT00288626|Hormones|hormones|mesh-ancestor
65446223|NCT00288626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65446224|NCT00288626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446225|NCT00288626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65446226|NCT00288626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446227|NCT00288626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65446228|NCT00288626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65446229|NCT00288626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65446230|NCT00288626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446231|NCT00288626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446232|NCT00288626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65446252|NCT00087178|Fluorouracil|fluorouracil|mesh-list
65446253|NCT00087178|Epirubicin|epirubicin|mesh-list
65446254|NCT00087178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65446255|NCT00087178|Immunologic Factors|immunologic factors|mesh-ancestor
65446256|NCT00087178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446257|NCT00087178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65446258|NCT00087178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65446259|NCT00087178|Alkylating Agents|alkylating agents|mesh-ancestor
65446260|NCT00087178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446261|NCT00087178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446262|NCT00087178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65446270|NCT00288080|Prednisone|prednisone|mesh-list
65446316|NCT00287690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446317|NCT00287690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446318|NCT00287690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65446319|NCT00287690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446320|NCT00287690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446386|NCT01091896|Bevacizumab|bevacizumab|mesh-list
65446387|NCT01091896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65446388|NCT01091896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446389|NCT01091896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65446390|NCT01091896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65446391|NCT01091896|Growth Substances|growth substances|mesh-ancestor
65446392|NCT01091896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446393|NCT01091896|Growth Inhibitors|growth inhibitors|mesh-ancestor
65446394|NCT00065260|Cyclosporine|cyclosporine|mesh-list
65446395|NCT00065260|Alemtuzumab|alemtuzumab|mesh-list
65446396|NCT00065260|Cyclosporins|cyclosporins|mesh-list
65446397|NCT00065260|Thymoglobulin|thymoglobulin|mesh-list
65446398|NCT00065260|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65446399|NCT00065260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446400|NCT00065260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446401|NCT00065260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65446402|NCT00065260|Immunologic Factors|immunologic factors|mesh-ancestor
65446444|NCT00460031|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65446445|NCT00460031|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65446446|NCT00460031|Lenalidomide|lenalidomide|mesh-list
65446447|NCT00460031|Immunologic Factors|immunologic factors|mesh-ancestor
65446448|NCT00460031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446449|NCT00460031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65446450|NCT00460031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65446451|NCT00460031|Growth Substances|growth substances|mesh-ancestor
65446452|NCT00460031|Growth Inhibitors|growth inhibitors|mesh-ancestor
65446453|NCT00460031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446454|NCT00460031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65446455|NCT00460031|Antifungal Agents|antifungal agents|mesh-ancestor
65446456|NCT00460031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65446457|NCT00460031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65446458|NCT00460031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65446459|NCT00460031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446461|NCT00460031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65446500|NCT00311402|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
65446501|NCT00311402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65446502|NCT00311402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65446503|NCT00311402|Analgesics|analgesics|mesh-ancestor
65446504|NCT00311402|Sensory System Agents|sensory system agents|mesh-ancestor
65446505|NCT00311402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65446506|NCT00311402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446507|NCT00311402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65446508|NCT00311402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65446509|NCT00311402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65446510|NCT00311402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65446511|NCT00311402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446512|NCT00311402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65446513|NCT00311402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65446558|NCT01092130|Vitamin D|vitamin d|mesh-list
65446559|NCT01092130|Vitamins|vitamins|mesh-ancestor
65446560|NCT01092130|Micronutrients|micronutrients|mesh-ancestor
65446561|NCT01092130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446562|NCT01092130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65446563|NCT00064792|Simvastatin|simvastatin|mesh-list
65446564|NCT00064792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65446565|NCT00064792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65446566|NCT00064792|Antimetabolites|antimetabolites|mesh-ancestor
65446567|NCT00064792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446568|NCT00064792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65446569|NCT00064792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65446570|NCT00064792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446571|NCT01095016|Fenoterol|fenoterol|mesh-list
65446573|NCT01095016|Autonomic Agents|autonomic agents|mesh-ancestor
65446619|NCT00286442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65446620|NCT00286442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446621|NCT00286442|Incretins|incretins|mesh-ancestor
65446622|NCT00286442|Hormones|hormones|mesh-ancestor
65446623|NCT00286442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65446624|NCT00286442|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65446625|NCT00286442|Protease Inhibitors|protease inhibitors|mesh-ancestor
65446626|NCT00286442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446627|NCT00286442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446628|NCT00063934|Docetaxel|docetaxel|mesh-list
65446629|NCT00063934|Doxorubicin|doxorubicin|mesh-list
65446630|NCT00063934|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65446631|NCT00063934|Oblimersen|oblimersen|mesh-list
65446632|NCT00063934|Lenograstim|lenograstim|mesh-list
65446633|NCT00063934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446634|NCT00063934|Tubulin Modulators|tubulin modulators|mesh-ancestor
65446635|NCT00063934|Antimitotic Agents|antimitotic agents|mesh-ancestor
65446677|NCT00458705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65446678|NCT00458705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446679|NCT00458705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65446680|NCT00458705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65446681|NCT00458705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65446682|NCT00458705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446683|NCT00458705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446684|NCT00458705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65446685|NCT00458705|Immunologic Factors|immunologic factors|mesh-ancestor
65446686|NCT00458705|Leprostatic Agents|leprostatic agents|mesh-ancestor
65446694|NCT00062374|Alovudine|alovudine|mesh-list
65446740|NCT01023425|Nootropic Agents|nootropic agents|mesh-ancestor
65446741|NCT00285584|Bupropion|bupropion|mesh-list
65446742|NCT00285584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65446743|NCT00285584|Antidepressive Agents|antidepressive agents|mesh-ancestor
65446744|NCT00285584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65446745|NCT00285584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65446746|NCT00285584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65446747|NCT00285584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65446748|NCT00285584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446749|NCT00285584|Dopamine Agents|dopamine agents|mesh-ancestor
65446750|NCT00285584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65446751|NCT00285584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446752|NCT00285584|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65446753|NCT00285584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65446754|NCT00285584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446755|NCT01583842|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65446756|NCT01583842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446757|NCT01583842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446758|NCT01583842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446759|NCT01583842|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65446760|NCT00291668|Certolizumab Pegol|certolizumab pegol|mesh-list
65446761|NCT00291668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65446762|NCT00291668|Immunologic Factors|immunologic factors|mesh-ancestor
65446763|NCT00291668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446786|NCT01063478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446787|NCT01063478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65446788|NCT01063478|Immunologic Factors|immunologic factors|mesh-ancestor
65446789|NCT01063478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446790|NCT01327144|Acyclovir|acyclovir|mesh-list
65446791|NCT01327144|Famciclovir|famciclovir|mesh-list
65446792|NCT01327144|Antiviral Agents|antiviral agents|mesh-ancestor
65446857|NCT00448019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65446858|NCT00448019|Immunologic Factors|immunologic factors|mesh-ancestor
65446859|NCT00448019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446860|NCT00448019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65446861|NCT00448019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65446862|NCT00448019|Alkylating Agents|alkylating agents|mesh-ancestor
65446863|NCT00448019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446864|NCT00448019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446865|NCT00448019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65446866|NCT00448019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65446867|NCT00448019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65446868|NCT00448019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65446869|NCT00448019|Growth Substances|growth substances|mesh-ancestor
65446870|NCT00448019|Growth Inhibitors|growth inhibitors|mesh-ancestor
65446871|NCT00448019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65446872|NCT00448019|Antimetabolites|antimetabolites|mesh-ancestor
65446873|NCT00457691|Leucovorin|leucovorin|mesh-list
65446874|NCT00457691|Fluorouracil|fluorouracil|mesh-list
65446875|NCT00457691|Irinotecan|irinotecan|mesh-list
65446876|NCT00457691|Sunitinib|sunitinib|mesh-list
65446877|NCT00457691|Levoleucovorin|levoleucovorin|mesh-list
65446888|NCT00457691|Antidotes|antidotes|mesh-ancestor
65446911|NCT01565759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446912|NCT00446849|Mesalamine|mesalamine|mesh-list
65446913|NCT00446849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65446914|NCT00446849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65446916|NCT00446849|Sensory System Agents|sensory system agents|mesh-ancestor
65446917|NCT00446849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65446918|NCT00446849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65446919|NCT00446849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65446920|NCT00446849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65446921|NCT01565837|Ipilimumab|ipilimumab|mesh-list
65446922|NCT01565837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65446923|NCT01565837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446924|NCT01565837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65446925|NCT01565837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446926|NCT00446459|Mycophenolic Acid|mycophenolic acid|mesh-list
65446927|NCT00446459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65446928|NCT00446459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65446929|NCT00446459|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65446930|NCT00446459|Antitubercular Agents|antitubercular agents|mesh-ancestor
65446931|NCT00446459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65446932|NCT00446459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65446933|NCT00446459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446934|NCT00446459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446960|NCT00456521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446961|NCT00456521|Dopamine Agents|dopamine agents|mesh-ancestor
65446962|NCT00456521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65446963|NCT00456521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65446964|NCT00456521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65446965|NCT00456521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65446966|NCT00456365|Pravastatin|pravastatin|mesh-list
65446967|NCT00456365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65446968|NCT00456365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65446969|NCT00456365|Antimetabolites|antimetabolites|mesh-ancestor
65446970|NCT00456365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65446971|NCT00456365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65446972|NCT00456365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65447018|NCT00444587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447019|NCT03841331|Serlopitant|serlopitant|mesh-list
65447020|NCT03841331|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65447021|NCT03841331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65447022|NCT03841331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447023|NCT03841331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447024|NCT00235716|Vitamins|vitamins|mesh-list
65447025|NCT00235716|Vitamin E|vitamin e|mesh-list
65447026|NCT00235716|Tocopherols|tocopherols|mesh-list
65447027|NCT00235716|Tocotrienols|tocotrienols|mesh-list
65447028|NCT00235716|alpha-Tocopherol|alpha-tocopherol|mesh-list
65447082|NCT00283244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447083|NCT00283244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65447084|NCT00283244|Immunologic Factors|immunologic factors|mesh-ancestor
65447085|NCT00283244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447086|NCT00283244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65447087|NCT00282464|Ziprasidone|ziprasidone|mesh-list
65447088|NCT00282464|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65447089|NCT00282464|Serotonin Agents|serotonin agents|mesh-ancestor
65447090|NCT00282464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65447091|NCT00282464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447092|NCT00282464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447093|NCT00282464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65447143|NCT00281840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447144|NCT00281840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65447145|NCT00281840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65447146|NCT00281840|Growth Substances|growth substances|mesh-ancestor
65447147|NCT00281840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447148|NCT00281840|Growth Inhibitors|growth inhibitors|mesh-ancestor
65447149|NCT00281840|Tubulin Modulators|tubulin modulators|mesh-ancestor
65447150|NCT00281840|Antimitotic Agents|antimitotic agents|mesh-ancestor
65447151|NCT00281840|Mitosis Modulators|mitosis modulators|mesh-ancestor
65447152|NCT00281840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447153|NCT00272792|Verapamil|verapamil|mesh-list
65447154|NCT00272792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65447155|NCT00272792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65447156|NCT00272792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65447157|NCT00272792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447158|NCT00272792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65447200|NCT03954964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447201|NCT03954964|Analgesics|analgesics|mesh-ancestor
65447202|NCT03954964|Sensory System Agents|sensory system agents|mesh-ancestor
65447273|NCT03976544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65447274|NCT03976544|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65447275|NCT03976544|Progestins|progestins|mesh-ancestor
65447276|NCT03741686|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
65447277|NCT03741686|Cathartics|cathartics|mesh-ancestor
65447278|NCT03741686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65447279|NCT00279812|Selenium|selenium|mesh-list
65447280|NCT00279812|Antioxidants|antioxidants|mesh-ancestor
65447281|NCT00279812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447339|NCT00047320|Etoposide|etoposide|mesh-list
65447340|NCT00047320|Ifosfamide|ifosfamide|mesh-list
65447341|NCT00047320|Isophosphamide mustard|isophosphamide mustard|mesh-list
65447342|NCT00047320|Thiotepa|thiotepa|mesh-list
65447412|NCT01071564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447413|NCT01071564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447414|NCT00268346|Gefitinib|gefitinib|mesh-list
65447415|NCT00268346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447416|NCT00268346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65447417|NCT00268346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447418|NCT00268346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447419|NCT00250718|Levofloxacin|levofloxacin|mesh-list
65447420|NCT00250718|Ofloxacin|ofloxacin|mesh-list
65447421|NCT00250718|Dexamethasone|dexamethasone|mesh-list
65447422|NCT00250718|Rituximab|rituximab|mesh-list
65447423|NCT00250718|Etoposide|etoposide|mesh-list
65447424|NCT00250718|Vincristine|vincristine|mesh-list
65447425|NCT00250718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65447426|NCT00250718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447427|NCT00250718|Immunologic Factors|immunologic factors|mesh-ancestor
65447428|NCT00250718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447429|NCT00250718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65447430|NCT00250718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65447431|NCT00250718|Antiemetics|antiemetics|mesh-ancestor
65447432|NCT00250718|Autonomic Agents|autonomic agents|mesh-ancestor
65447433|NCT00250718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65447434|NCT00250718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65447435|NCT00250718|Glucocorticoids|glucocorticoids|mesh-ancestor
65196956|NCT00654160|Vitamins|vitamins|mesh-ancestor
65447440|NCT00250718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65447462|NCT00276458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65447463|NCT00276458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447464|NCT00276380|Aspirin|aspirin|mesh-list
65447465|NCT00276380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65447466|NCT00276380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65447467|NCT00276380|Analgesics|analgesics|mesh-ancestor
65447468|NCT00276380|Sensory System Agents|sensory system agents|mesh-ancestor
65447469|NCT00276380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65447470|NCT00276380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447471|NCT00276380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65447472|NCT00276380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65447473|NCT00276380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65447474|NCT00276380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65447475|NCT00276380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447476|NCT00276380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65447477|NCT00276380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65447478|NCT00276380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447479|NCT00276380|Antipyretics|antipyretics|mesh-ancestor
65447480|NCT02531984|Azithromycin|azithromycin|mesh-list
65447481|NCT02531984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65447482|NCT02531984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65447483|NCT00267956|Ustekinumab|ustekinumab|mesh-list
65447484|NCT00267956|Dermatologic Agents|dermatologic agents|mesh-ancestor
65447485|NCT00267488|Topotecan|topotecan|mesh-list
65447486|NCT00267488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65447510|NCT00046930|Antiviral Agents|antiviral agents|mesh-ancestor
65447511|NCT00046930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65447512|NCT00046930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65447513|NCT00046930|Immunologic Factors|immunologic factors|mesh-ancestor
65447514|NCT00046930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447515|NCT00046930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65447516|NCT00046930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65447517|NCT00046930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65447518|NCT00046930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65447519|NCT00046930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447520|NCT00058552|Pertuzumab|pertuzumab|mesh-list
65447521|NCT00058552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65447522|NCT00058552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447523|NCT01093768|Vasopressins|vasopressins|mesh-list
65447524|NCT01093768|Arginine Vasopressin|arginine vasopressin|mesh-list
65447525|NCT01093768|Oxytocin|oxytocin|mesh-list
65447526|NCT01093768|Oxytocics|oxytocics|mesh-ancestor
65447527|NCT01093768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65447528|NCT01093768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447529|NCT01093768|Hemostatics|hemostatics|mesh-ancestor
65447530|NCT01093768|Coagulants|coagulants|mesh-ancestor
65447531|NCT01093768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65447532|NCT01093768|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65447533|NCT01093768|Natriuretic Agents|natriuretic agents|mesh-ancestor
65447534|NCT00044512|Sorafenib|sorafenib|mesh-list
65447535|NCT00044512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447536|NCT00044512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65447560|NCT03953716|Hormones|hormones|mesh-ancestor
65447561|NCT03953716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65447562|NCT01096498|Levonorgestrel|levonorgestrel|mesh-list
65447563|NCT01096498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65447564|NCT01096498|Contraceptive Agents|contraceptive agents|mesh-ancestor
65447565|NCT01096498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65447566|NCT01096498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447567|NCT01096498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65447568|NCT01096498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65447569|NCT01096498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65447570|NCT00147537|Paclitaxel|paclitaxel|mesh-list
65447571|NCT00147537|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65447572|NCT00147537|Carboplatin|carboplatin|mesh-list
65447573|NCT00147537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65447574|NCT00147537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65447575|NCT00147537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65447576|NCT00147537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447577|NCT00147537|Tubulin Modulators|tubulin modulators|mesh-ancestor
65447578|NCT00147537|Antimitotic Agents|antimitotic agents|mesh-ancestor
65447579|NCT00147537|Mitosis Modulators|mitosis modulators|mesh-ancestor
65447581|NCT00147537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65447613|NCT00222105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65447614|NCT00222105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65447615|NCT00222105|Antiemetics|antiemetics|mesh-ancestor
65447616|NCT00222105|Autonomic Agents|autonomic agents|mesh-ancestor
65447617|NCT00222105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65447618|NCT00222105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447619|NCT00222105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65447620|NCT00222105|Glucocorticoids|glucocorticoids|mesh-ancestor
65447621|NCT00222105|Hormones|hormones|mesh-ancestor
65447622|NCT00222105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65447623|NCT00222105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65447624|NCT00222105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447625|NCT00222105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65447626|NCT00222105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65447627|NCT00222105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65447628|NCT00222105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447629|NCT00222105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447630|NCT00222105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65447631|NCT00222105|Immunologic Factors|immunologic factors|mesh-ancestor
65447632|NCT00222105|Leprostatic Agents|leprostatic agents|mesh-ancestor
65447633|NCT00222105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65447634|NCT00222105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65447635|NCT00222105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65447636|NCT00222105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65447637|NCT00222105|Growth Substances|growth substances|mesh-ancestor
65447638|NCT00222105|Growth Inhibitors|growth inhibitors|mesh-ancestor
65447639|NCT00247676|Sunitinib|sunitinib|mesh-list
65447640|NCT00247676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447641|NCT00247676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65447642|NCT00247676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65447643|NCT00247676|Growth Substances|growth substances|mesh-ancestor
65447644|NCT00247676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447649|NCT00267020|Gemcitabine|gemcitabine|mesh-list
65447653|NCT00267020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447654|NCT00267020|Antiviral Agents|antiviral agents|mesh-ancestor
65447655|NCT00267020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65447656|NCT00267020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447657|NCT00267020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65447658|NCT00267020|Immunologic Factors|immunologic factors|mesh-ancestor
65447659|NCT00267020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447660|NCT03975062|Dabigatran|dabigatran|mesh-list
65447661|NCT03975062|Antithrombins|antithrombins|mesh-ancestor
65447662|NCT03975062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65447663|NCT03975062|Protease Inhibitors|protease inhibitors|mesh-ancestor
65447664|NCT03975062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447665|NCT03975062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447666|NCT03975062|Anticoagulants|anticoagulants|mesh-ancestor
65447667|NCT03970772|Glucagon|glucagon|mesh-list
65447668|NCT03970772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65447669|NCT03970772|Hormones|hormones|mesh-ancestor
65447670|NCT03970772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65447712|NCT00266864|Hormones|hormones|mesh-ancestor
65447713|NCT00266864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65447714|NCT00266864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447715|NCT00266864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65447716|NCT00266864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447717|NCT00266864|Anabolic Agents|anabolic agents|mesh-ancestor
65447718|NCT00266708|Risedronic Acid|risedronic acid|mesh-list
65447719|NCT00266708|Etidronic Acid|etidronic acid|mesh-list
65447720|NCT00266708|Diphosphonates|diphosphonates|mesh-list
65447721|NCT00266708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65447722|NCT00266708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65447723|NCT00266708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447724|NCT00266708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65447773|NCT00221403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447774|NCT00221403|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65447775|NCT00221403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65447776|NCT00221403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65447777|NCT00221403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65447778|NCT00221403|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65447779|NCT00221403|Dopamine Agents|dopamine agents|mesh-ancestor
65447780|NCT00221403|Anticonvulsants|anticonvulsants|mesh-ancestor
65447781|NCT00221403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447782|NCT00221403|GABA Agents|gaba agents|mesh-ancestor
65447783|NCT00221403|Antimanic Agents|antimanic agents|mesh-ancestor
65447784|NCT00145977|Vitamin D|vitamin d|mesh-list
65447785|NCT00145977|Alendronate|alendronate|mesh-list
65447786|NCT00145977|Calcium|calcium|mesh-list
65447787|NCT00145977|Vitamins|vitamins|mesh-ancestor
65447788|NCT00145977|Micronutrients|micronutrients|mesh-ancestor
65447789|NCT00145977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447790|NCT00145977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65447791|NCT00145977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65447792|NCT00238238|Rituximab|rituximab|mesh-list
65447793|NCT00238238|Lenalidomide|lenalidomide|mesh-list
65447794|NCT00238238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65447795|NCT00238238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65447796|NCT00238238|Immunologic Factors|immunologic factors|mesh-ancestor
65447826|NCT01072604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65447827|NCT01072604|Analgesics|analgesics|mesh-ancestor
65447828|NCT01072604|Sensory System Agents|sensory system agents|mesh-ancestor
65447829|NCT01072604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65447830|NCT01072604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65447831|NCT01072604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65447832|NCT01072604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65447833|NCT01072604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65447834|NCT01072604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65447835|NCT01072604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65447836|NCT01072604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65447837|NCT01072604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65447838|NCT01072604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65447888|NCT00237458|Lacosamide|lacosamide|mesh-list
65447889|NCT00237458|Anticonvulsants|anticonvulsants|mesh-ancestor
65447890|NCT00237458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65447891|NCT00237458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65447892|NCT00237458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65447959|NCT00041080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65447960|NCT00041080|Hormone Antagonists|hormone antagonists|mesh-ancestor
65447961|NCT00041080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65197507|NCT00708565|Iloprost|iloprost|mesh-list
65448028|NCT00203294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65448029|NCT00203294|Glucocorticoids|glucocorticoids|mesh-ancestor
65448030|NCT00203294|Hormones|hormones|mesh-ancestor
65448031|NCT00203294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65448032|NCT01074086|Everolimus|everolimus|mesh-list
65448033|NCT01074086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448034|NCT01074086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65448035|NCT01074086|Immunologic Factors|immunologic factors|mesh-ancestor
65448036|NCT01074086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448037|NCT00264290|Valganciclovir|valganciclovir|mesh-list
65448038|NCT00264290|Antiviral Agents|antiviral agents|mesh-ancestor
65448039|NCT00264290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65448040|NCT00234494|Gemcitabine|gemcitabine|mesh-list
65448041|NCT00234494|Bevacizumab|bevacizumab|mesh-list
65448093|NCT00039130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65448094|NCT00039130|Immunologic Factors|immunologic factors|mesh-ancestor
65448095|NCT00039130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448096|NCT00039130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65448097|NCT00039130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65448098|NCT00039130|Alkylating Agents|alkylating agents|mesh-ancestor
65448099|NCT00039130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448100|NCT00039130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448101|NCT00039130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65448102|NCT00039130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65448103|NCT00039130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65448104|NCT00039130|Antiemetics|antiemetics|mesh-ancestor
65448105|NCT00039130|Autonomic Agents|autonomic agents|mesh-ancestor
65448106|NCT00039130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65448107|NCT00039130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65448108|NCT00039130|Glucocorticoids|glucocorticoids|mesh-ancestor
65448109|NCT00039130|Hormones|hormones|mesh-ancestor
65448110|NCT00039130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65448111|NCT00039130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65448112|NCT00039130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65448113|NCT00039130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65448114|NCT00039130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65448115|NCT00039130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448116|NCT00039130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65448117|NCT00039130|Abortifacient Agents|abortifacient agents|mesh-ancestor
65448118|NCT00039130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65448119|NCT00039130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64674388|NCT00553202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64674389|NCT00553202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64674390|NCT00553202|Antimetabolites|antimetabolites|mesh-ancestor
64674391|NCT00553202|Dermatologic Agents|dermatologic agents|mesh-ancestor
64674392|NCT00553202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674393|NCT00553202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64674394|NCT00553202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64674395|NCT00553202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64714459|NCT03118466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64714460|NCT03118466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64714461|NCT03118466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64714462|NCT03118466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64714463|NCT03118466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714464|NCT03118466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64714465|NCT03118466|Antimetabolites|antimetabolites|mesh-ancestor
64714466|NCT03118466|Antiviral Agents|antiviral agents|mesh-ancestor
64714467|NCT03118466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64714468|NCT03118466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65448120|NCT00039130|Antimetabolites|antimetabolites|mesh-ancestor
65448121|NCT00039130|Dermatologic Agents|dermatologic agents|mesh-ancestor
65448122|NCT00039130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65448123|NCT00039130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65448124|NCT00039130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65448125|NCT00039130|Antiviral Agents|antiviral agents|mesh-ancestor
65448126|NCT00039130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65448127|NCT00039130|Antidotes|antidotes|mesh-ancestor
65448128|NCT00039130|Protective Agents|protective agents|mesh-ancestor
65448129|NCT00039130|Vitamin B Complex|vitamin b complex|mesh-ancestor
65448130|NCT00039130|Vitamins|vitamins|mesh-ancestor
65448131|NCT00039130|Micronutrients|micronutrients|mesh-ancestor
65448132|NCT00039130|Tubulin Modulators|tubulin modulators|mesh-ancestor
65448133|NCT00039130|Antimitotic Agents|antimitotic agents|mesh-ancestor
65448134|NCT00039130|Mitosis Modulators|mitosis modulators|mesh-ancestor
65448135|NCT00039130|Gout Suppressants|gout suppressants|mesh-ancestor
65448136|NCT00039130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65448137|NCT00039130|Antioxidants|antioxidants|mesh-ancestor
65448138|NCT01096654|Epinephrine|epinephrine|mesh-list
65448139|NCT01096654|Racepinephrine|racepinephrine|mesh-list
65448140|NCT01096654|Epinephryl borate|epinephryl borate|mesh-list
65448141|NCT01096654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65448142|NCT01096654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65448143|NCT01096654|Adrenergic Agents|adrenergic agents|mesh-ancestor
65448144|NCT01096654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65448145|NCT01096654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448146|NCT01096654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448147|NCT01096654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65448148|NCT01096654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65448149|NCT01096654|Autonomic Agents|autonomic agents|mesh-ancestor
65448150|NCT01096654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65448151|NCT01096654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65448152|NCT01096654|Respiratory System Agents|respiratory system agents|mesh-ancestor
65448153|NCT01096654|Mydriatics|mydriatics|mesh-ancestor
65448156|NCT00035932|Ritonavir|ritonavir|mesh-list
65448164|NCT00035932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448165|NCT00035932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448166|NCT00035932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65448167|NCT00035932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65448168|NCT00035932|Antiviral Agents|antiviral agents|mesh-ancestor
65448169|NCT00035932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65448170|NCT00035932|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65448171|NCT00035932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65448172|NCT00035932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65448173|NCT00035932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65448174|NCT03953326|Nitroprusside|nitroprusside|mesh-list
65448175|NCT03953326|Acetylcholine|acetylcholine|mesh-list
65448176|NCT03953326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65448177|NCT03953326|Vasodilator Agents|vasodilator agents|mesh-ancestor
65448178|NCT03953326|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65448179|NCT03953326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448180|NCT03953326|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65448181|NCT03953326|Cholinergic Agents|cholinergic agents|mesh-ancestor
65448182|NCT03953326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65448183|NCT03953326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448184|NCT01097278|Cholecalciferol|cholecalciferol|mesh-list
65448185|NCT01097278|Vitamin D|vitamin d|mesh-list
65448186|NCT01097278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65448187|NCT01097278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448188|NCT01097278|Vitamins|vitamins|mesh-ancestor
65448189|NCT01097278|Micronutrients|micronutrients|mesh-ancestor
65448190|NCT01097278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64714469|NCT03118466|Immunologic Factors|immunologic factors|mesh-ancestor
64714470|NCT03118466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714471|NCT03118466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64714472|NCT03118466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64714473|NCT03118466|Growth Substances|growth substances|mesh-ancestor
64714474|NCT03118466|Growth Inhibitors|growth inhibitors|mesh-ancestor
64714475|NCT03118466|Analgesics|analgesics|mesh-ancestor
64714476|NCT03118466|Sensory System Agents|sensory system agents|mesh-ancestor
64714477|NCT03118466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714478|NCT03068312|Ivacaftor|ivacaftor|mesh-list
64714479|NCT03068312|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64714480|NCT03068312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64714481|NCT03068312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714482|NCT03119168|Simethicone|simethicone|mesh-list
64714483|NCT03119168|Antifoaming Agents|antifoaming agents|mesh-ancestor
64714484|NCT03119168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714485|NCT03119168|Emollients|emollients|mesh-ancestor
64714486|NCT03119168|Dermatologic Agents|dermatologic agents|mesh-ancestor
64714487|NCT03070730|Atenolol|atenolol|mesh-list
64714488|NCT03070730|Droxidopa|droxidopa|mesh-list
64714489|NCT03070730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65448191|NCT00022516|Cyclophosphamide|cyclophosphamide|mesh-list
65448192|NCT00022516|Methotrexate|methotrexate|mesh-list
65448193|NCT00022516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65448194|NCT00022516|Immunologic Factors|immunologic factors|mesh-ancestor
65448195|NCT00022516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448196|NCT00022516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65448197|NCT00022516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65448198|NCT00022516|Alkylating Agents|alkylating agents|mesh-ancestor
65448199|NCT00022516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448200|NCT00022516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448201|NCT00022516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65448202|NCT00022516|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65448203|NCT00022516|Abortifacient Agents|abortifacient agents|mesh-ancestor
65448204|NCT00022516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65448205|NCT00022516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65448206|NCT00022516|Antimetabolites|antimetabolites|mesh-ancestor
65448207|NCT00022516|Dermatologic Agents|dermatologic agents|mesh-ancestor
65448208|NCT00022516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448209|NCT00022516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65448210|NCT00022516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65448211|NCT01097512|Gemcitabine|gemcitabine|mesh-list
65448212|NCT01097512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65448213|NCT01097512|Antimetabolites|antimetabolites|mesh-ancestor
65448214|NCT01097512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832950|NCT01596998|Epinephrine|epinephrine|mesh-list
64322755|NCT04440267|Antiemetics|antiemetics|mesh-ancestor
64674396|NCT00553202|Antifungal Agents|antifungal agents|mesh-ancestor
64674397|NCT00553202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64674398|NCT00553202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64674399|NCT00553202|Antiemetics|antiemetics|mesh-ancestor
64674400|NCT00553202|Autonomic Agents|autonomic agents|mesh-ancestor
64674401|NCT00553202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399762|NCT02039791|Paclitaxel|paclitaxel|mesh-list
64674402|NCT00553202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64674403|NCT00553202|Glucocorticoids|glucocorticoids|mesh-ancestor
64674404|NCT00553202|Hormones|hormones|mesh-ancestor
64674405|NCT00553202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64714490|NCT03070730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64714491|NCT03070730|Sympatholytics|sympatholytics|mesh-ancestor
64714492|NCT03070730|Autonomic Agents|autonomic agents|mesh-ancestor
64714493|NCT03070730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714494|NCT03070730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674406|NCT00553202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64674407|NCT00553202|Protective Agents|protective agents|mesh-ancestor
64674408|NCT00553202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64674409|NCT00552188|Atreleuton|atreleuton|mesh-list
64674410|NCT00552188|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64674411|NCT00552188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674412|NCT00552188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832968|NCT01596998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65448215|NCT01097512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448216|NCT01097512|Antiviral Agents|antiviral agents|mesh-ancestor
65448217|NCT01097512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65448218|NCT01097512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448219|NCT01097512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65448220|NCT01097512|Immunologic Factors|immunologic factors|mesh-ancestor
65448221|NCT01097512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448222|NCT00033514|Trastuzumab|trastuzumab|mesh-list
65448223|NCT00033514|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65448224|NCT00033514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65448225|NCT00033514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448226|NCT00033514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65448227|NCT00033514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448228|NCT00033514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448230|NCT00006916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65448231|NCT00006916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448232|NCT02529982|Curcumin|curcumin|mesh-list
65448233|NCT02529982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65448234|NCT02529982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65448235|NCT02529982|Analgesics|analgesics|mesh-ancestor
65448236|NCT02529982|Sensory System Agents|sensory system agents|mesh-ancestor
64674413|NCT00377793|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
64674414|NCT00377793|Vasodilator Agents|vasodilator agents|mesh-ancestor
64674415|NCT00377793|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64674416|NCT00377793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64674417|NCT00377793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674418|NCT00377793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674419|NCT00377793|Urological Agents|urological agents|mesh-ancestor
64674439|NCT04027803|Eculizumab|eculizumab|mesh-list
64674440|NCT04027803|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64674441|NCT04027803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64674442|NCT04027803|Immunologic Factors|immunologic factors|mesh-ancestor
64674443|NCT04027803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674444|NCT00552110|Mometasone Furoate|mometasone furoate|mesh-list
64674445|NCT00552110|Phenylephrine|phenylephrine|mesh-list
64674446|NCT00552110|Oxymetazoline|oxymetazoline|mesh-list
64674447|NCT00552110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64674448|NCT00552110|Dermatologic Agents|dermatologic agents|mesh-ancestor
64674449|NCT00552110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64674450|NCT00552110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64674451|NCT00552110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64674452|NCT00552110|Adrenergic Agents|adrenergic agents|mesh-ancestor
64674453|NCT00552110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64674454|NCT00552110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674455|NCT00552110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674456|NCT00552110|Sympathomimetics|sympathomimetics|mesh-ancestor
64674457|NCT00552110|Autonomic Agents|autonomic agents|mesh-ancestor
64674458|NCT00552110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64674459|NCT00552110|Nasal Decongestants|nasal decongestants|mesh-ancestor
64674460|NCT00552110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64674461|NCT00552110|Respiratory System Agents|respiratory system agents|mesh-ancestor
65448237|NCT02529982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65448238|NCT02529982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448239|NCT02529982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65448240|NCT02529982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65448241|NCT02529982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448242|NCT02529982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448243|NCT02529982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448244|NCT00454649|Gemcitabine|gemcitabine|mesh-list
65448245|NCT00454649|Paclitaxel|paclitaxel|mesh-list
65448246|NCT00454649|Docetaxel|docetaxel|mesh-list
65448247|NCT00454649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65448248|NCT00454649|Cisplatin|cisplatin|mesh-list
65448249|NCT00454649|Carboplatin|carboplatin|mesh-list
65448250|NCT00454649|Capecitabine|capecitabine|mesh-list
65448251|NCT00454649|Pemetrexed|pemetrexed|mesh-list
65448252|NCT00454649|Axitinib|axitinib|mesh-list
65448253|NCT00454649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65448254|NCT00454649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448255|NCT00454649|Tubulin Modulators|tubulin modulators|mesh-ancestor
65448256|NCT00454649|Antimitotic Agents|antimitotic agents|mesh-ancestor
64674462|NCT00552110|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64674463|NCT00552110|Mydriatics|mydriatics|mesh-ancestor
64674464|NCT00552110|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64674465|NCT00552110|Protective Agents|protective agents|mesh-ancestor
64674466|NCT02301624|Eculizumab|eculizumab|mesh-list
64674467|NCT02301624|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64674468|NCT02301624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64674469|NCT02301624|Immunologic Factors|immunologic factors|mesh-ancestor
64674470|NCT02301624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674471|NCT02007122|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64674472|NCT02007122|Cephalosporins|cephalosporins|mesh-list
64674473|NCT02007122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64674474|NCT02007122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64674475|NCT03250520|Titanium dioxide|titanium dioxide|mesh-list
64674476|NCT03250520|Sunscreening Agents|sunscreening agents|mesh-ancestor
64399838|NCT02332603|Prednisolone|prednisolone|mesh-list
64674477|NCT03250520|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64674478|NCT03250520|Protective Agents|protective agents|mesh-ancestor
64674479|NCT03250520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714495|NCT03070730|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64714497|NCT03070730|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64714498|NCT03070730|Adrenergic Agents|adrenergic agents|mesh-ancestor
64714499|NCT03070730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64714500|NCT03070730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714501|NCT03070730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64714502|NCT03070730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64714503|NCT05405270|Imiquimod|imiquimod|mesh-list
64714504|NCT05405270|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64714505|NCT05405270|Immunologic Factors|immunologic factors|mesh-ancestor
64714508|NCT05405270|Interferon Inducers|interferon inducers|mesh-ancestor
64714509|NCT03121820|Memantine|memantine|mesh-list
64714510|NCT03121820|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64714511|NCT03121820|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64714512|NCT03121820|Dopamine Agents|dopamine agents|mesh-ancestor
64714513|NCT03121820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64322791|NCT02146937|Finasteride|finasteride|mesh-list
64674480|NCT03250520|Dermatologic Agents|dermatologic agents|mesh-ancestor
64674482|NCT03847389|Clobetasol|clobetasol|mesh-list
64674483|NCT03847389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65448257|NCT00454649|Mitosis Modulators|mitosis modulators|mesh-ancestor
65448258|NCT00454649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448259|NCT00454649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65448260|NCT00454649|Antimetabolites|antimetabolites|mesh-ancestor
65448261|NCT00454649|Antiviral Agents|antiviral agents|mesh-ancestor
65448262|NCT00454649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65448263|NCT00454649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448264|NCT00454649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65448265|NCT00454649|Immunologic Factors|immunologic factors|mesh-ancestor
65448266|NCT00454649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448267|NCT00454649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65448268|NCT00454649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65448269|NCT00454649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65448270|NCT00454571|Leuprolide|leuprolide|mesh-list
65448271|NCT00454571|Goserelin|goserelin|mesh-list
65448272|NCT00454571|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65448273|NCT00454571|Fertility Agents|fertility agents|mesh-ancestor
65448274|NCT00454571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65448275|NCT00454571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448276|NCT00454571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65448277|NCT00454571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448278|NCT01323257|Ritonavir|ritonavir|mesh-list
64674484|NCT03847389|Glucocorticoids|glucocorticoids|mesh-ancestor
64674485|NCT03847389|Hormones|hormones|mesh-ancestor
64674486|NCT03847389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64674487|NCT03847389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674488|NCT02351934|Celecoxib|celecoxib|mesh-list
64674489|NCT02351934|Furosemide|furosemide|mesh-list
64674490|NCT02351934|Gabapentin|gabapentin|mesh-list
64674491|NCT02351934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64674492|NCT02351934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64674493|NCT02351934|Analgesics|analgesics|mesh-ancestor
64674494|NCT02351934|Sensory System Agents|sensory system agents|mesh-ancestor
64674502|NCT02351934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674503|NCT02351934|Anticonvulsants|anticonvulsants|mesh-ancestor
64674504|NCT02351934|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64674505|NCT02351934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64674506|NCT02351934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64674507|NCT02351934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64674508|NCT02351934|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64674509|NCT02351934|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64674510|NCT02351934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64674511|NCT02351934|Antimanic Agents|antimanic agents|mesh-ancestor
64674512|NCT02351934|Diuretics|diuretics|mesh-ancestor
64674513|NCT02351934|Natriuretic Agents|natriuretic agents|mesh-ancestor
64674514|NCT02351934|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64674515|NCT02351934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64674516|NCT03193190|Leucovorin|leucovorin|mesh-list
64674517|NCT03193190|Gemcitabine|gemcitabine|mesh-list
64674518|NCT03193190|Paclitaxel|paclitaxel|mesh-list
64674519|NCT03193190|Bevacizumab|bevacizumab|mesh-list
64674520|NCT03193190|Fluorouracil|fluorouracil|mesh-list
64674521|NCT03193190|Oxaliplatin|oxaliplatin|mesh-list
64674522|NCT03193190|Atezolizumab|atezolizumab|mesh-list
65448279|NCT01323257|Darunavir|darunavir|mesh-list
65448280|NCT01323257|Erythromycin|erythromycin|mesh-list
65448281|NCT01323257|Erythromycin Estolate|erythromycin estolate|mesh-list
65448282|NCT01323257|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65448283|NCT01323257|Erythromycin stearate|erythromycin stearate|mesh-list
65448284|NCT01323257|Simeprevir|simeprevir|mesh-list
65448285|NCT01323257|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65448286|NCT01323257|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65448287|NCT01323257|Protease Inhibitors|protease inhibitors|mesh-ancestor
65448288|NCT01323257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448289|NCT01323257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448290|NCT01323257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65448291|NCT01323257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65448292|NCT01323257|Antiviral Agents|antiviral agents|mesh-ancestor
65448293|NCT01323257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65448294|NCT01323257|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65448295|NCT01323257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65448296|NCT01323257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65448297|NCT01323257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65448298|NCT01323257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65448299|NCT03837743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65448300|NCT01323335|Rasburicase|rasburicase|mesh-list
64674523|NCT03193190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64674524|NCT03193190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64714514|NCT03121820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714515|NCT03121820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714516|NCT03121820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64714517|NCT03121820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64714518|NCT03123614|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64714519|NCT03123614|Prednisolone|prednisolone|mesh-list
64714520|NCT03123614|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64714521|NCT03123614|Methylprednisolone|methylprednisolone|mesh-list
64714522|NCT03123614|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64714523|NCT03123614|Prednisolone acetate|prednisolone acetate|mesh-list
64714524|NCT03123614|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64714525|NCT03123614|Prednisolone phosphate|prednisolone phosphate|mesh-list
64714526|NCT03123614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64322814|NCT02147015|Hormones|hormones|mesh-ancestor
64674525|NCT03193190|Tubulin Modulators|tubulin modulators|mesh-ancestor
64674526|NCT03193190|Antimitotic Agents|antimitotic agents|mesh-ancestor
64674527|NCT03193190|Mitosis Modulators|mitosis modulators|mesh-ancestor
64674528|NCT03193190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674529|NCT03193190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64674530|NCT03193190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64674531|NCT03193190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64674532|NCT03193190|Growth Substances|growth substances|mesh-ancestor
64674533|NCT03193190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674534|NCT03193190|Growth Inhibitors|growth inhibitors|mesh-ancestor
64674535|NCT03193190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64674536|NCT03193190|Antimetabolites|antimetabolites|mesh-ancestor
64674537|NCT03193190|Antiviral Agents|antiviral agents|mesh-ancestor
64674538|NCT03193190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64674539|NCT03193190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448301|NCT01323335|Uric Acid|uric acid|mesh-list
65448302|NCT01323335|Gout Suppressants|gout suppressants|mesh-ancestor
65448303|NCT01323335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65448304|NCT01323335|Antioxidants|antioxidants|mesh-ancestor
65448305|NCT01323335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448306|NCT01323335|Protective Agents|protective agents|mesh-ancestor
65448307|NCT01323335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448308|NCT03836729|Tenofovir|tenofovir|mesh-list
65448309|NCT03836729|Emtricitabine|emtricitabine|mesh-list
64674541|NCT03193190|Immunologic Factors|immunologic factors|mesh-ancestor
64674542|NCT03193190|Antidotes|antidotes|mesh-ancestor
64674543|NCT03193190|Protective Agents|protective agents|mesh-ancestor
64674544|NCT03193190|Vitamin B Complex|vitamin b complex|mesh-ancestor
64674546|NCT03193190|Micronutrients|micronutrients|mesh-ancestor
64674547|NCT00377481|Darbepoetin alfa|darbepoetin alfa|mesh-list
64674548|NCT00377481|Hematinics|hematinics|mesh-ancestor
64674549|NCT00377559|Docetaxel|docetaxel|mesh-list
64674550|NCT00377559|Doxorubicin|doxorubicin|mesh-list
64674551|NCT00377559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64674552|NCT00377559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674553|NCT00377559|Tubulin Modulators|tubulin modulators|mesh-ancestor
64674554|NCT00377559|Antimitotic Agents|antimitotic agents|mesh-ancestor
64674555|NCT00377559|Mitosis Modulators|mitosis modulators|mesh-ancestor
64674556|NCT00377559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674557|NCT00377559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64674573|NCT02301390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64674575|NCT03026348|Vaccines|vaccines|mesh-list
64674576|NCT03026348|Immunologic Factors|immunologic factors|mesh-ancestor
64674577|NCT03026348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674578|NCT03026348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64674579|NCT03026348|Antacids|antacids|mesh-ancestor
64674580|NCT03026348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674581|NCT03026348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64674582|NCT04763408|Sorafenib|sorafenib|mesh-list
64674583|NCT04763408|Lenvatinib|lenvatinib|mesh-list
64674584|NCT04763408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674585|NCT04763408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64674586|NCT04763408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674587|NCT04763408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674588|NCT03825939|Tranexamic Acid|tranexamic acid|mesh-list
64714527|NCT03123614|Glucocorticoids|glucocorticoids|mesh-ancestor
64714528|NCT03123614|Hormones|hormones|mesh-ancestor
64714529|NCT03123614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64714530|NCT03123614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714531|NCT03123614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64714532|NCT03123614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64714533|NCT03123614|Antiemetics|antiemetics|mesh-ancestor
64714534|NCT03123614|Autonomic Agents|autonomic agents|mesh-ancestor
64714535|NCT03123614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714536|NCT03123614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64714537|NCT03123614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64714538|NCT03123614|Protective Agents|protective agents|mesh-ancestor
64714539|NCT03123614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64714540|NCT03123848|Darunavir|darunavir|mesh-list
64714541|NCT03123848|Cobicistat|cobicistat|mesh-list
64714542|NCT03123848|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
64714543|NCT03123848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64714544|NCT03123848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64714545|NCT03123848|Protease Inhibitors|protease inhibitors|mesh-ancestor
64714546|NCT03123848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64714547|NCT03123848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714548|NCT03123848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64714549|NCT03123848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64714550|NCT03123848|Antiviral Agents|antiviral agents|mesh-ancestor
64714551|NCT03123848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64714552|NCT03123848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64714553|NCT03123848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64714554|NCT02946073|Buprenorphine|buprenorphine|mesh-list
64674589|NCT03825939|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65448310|NCT03836729|Antiviral Agents|antiviral agents|mesh-ancestor
65448311|NCT03836729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65448312|NCT03836729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65448313|NCT03836729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65448314|NCT03836729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448315|NCT03836729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448316|NCT03836729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65448317|NCT03836729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65448318|NCT01027481|Ranibizumab|ranibizumab|mesh-list
65448319|NCT01027481|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65448320|NCT01027481|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65448321|NCT01027481|Growth Substances|growth substances|mesh-ancestor
65448322|NCT01027481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448323|NCT01027481|Growth Inhibitors|growth inhibitors|mesh-ancestor
65448324|NCT01027481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448325|NCT00443729|Ritonavir|ritonavir|mesh-list
65448326|NCT00443729|Lopinavir|lopinavir|mesh-list
64674590|NCT03825939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64674591|NCT03825939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674592|NCT03825939|Hemostatics|hemostatics|mesh-ancestor
64674593|NCT03825939|Coagulants|coagulants|mesh-ancestor
64674594|NCT03988647|Pembrolizumab|pembrolizumab|mesh-list
64674595|NCT03988647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64674596|NCT03988647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674597|NCT00551642|Nitric Oxide|nitric oxide|mesh-list
64674598|NCT00551642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64674599|NCT00551642|Autonomic Agents|autonomic agents|mesh-ancestor
64674625|NCT02648282|Immunologic Factors|immunologic factors|mesh-ancestor
64674626|NCT02648282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674627|NCT02648282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64674628|NCT02648282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64674630|NCT02648282|Alkylating Agents|alkylating agents|mesh-ancestor
64674631|NCT02648282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714555|NCT02946073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64714557|NCT02946073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64714558|NCT02946073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714559|NCT02946073|Analgesics|analgesics|mesh-ancestor
64714560|NCT02946073|Sensory System Agents|sensory system agents|mesh-ancestor
64674632|NCT02648282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674633|NCT02648282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64674634|NCT02648282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64674636|NCT04004481|Tramadol|tramadol|mesh-list
64674637|NCT04004481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64674638|NCT04004481|Narcotics|narcotics|mesh-ancestor
64674639|NCT04004481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64674640|NCT04004481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674641|NCT04004481|Analgesics|analgesics|mesh-ancestor
64674642|NCT04004481|Sensory System Agents|sensory system agents|mesh-ancestor
64674663|NCT02985801|Pancreatin|pancreatin|mesh-list
64674664|NCT02985801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64674665|NCT02988362|Amlodipine|amlodipine|mesh-list
64674666|NCT02988362|Candesartan|candesartan|mesh-list
64674667|NCT02988362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64674668|NCT02988362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64674669|NCT02988362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64674670|NCT02988362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674671|NCT02988362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64674672|NCT02988362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448327|NCT00443729|Raltegravir Potassium|raltegravir potassium|mesh-list
65448328|NCT00443729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65448329|NCT00443729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65448330|NCT00443729|Protease Inhibitors|protease inhibitors|mesh-ancestor
65448331|NCT00443729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448332|NCT00443729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448333|NCT00443729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65448334|NCT00443729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65448335|NCT00443729|Antiviral Agents|antiviral agents|mesh-ancestor
65448336|NCT00443729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65448337|NCT00443729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65448338|NCT00443729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65448339|NCT00443729|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65448340|NCT00443729|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65448341|NCT00443651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64833071|NCT01597648|Antiviral Agents|antiviral agents|mesh-ancestor
64674673|NCT02988362|Vasodilator Agents|vasodilator agents|mesh-ancestor
64674674|NCT02988362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64674675|NCT02988362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64674676|NCT02988440|Sorafenib|sorafenib|mesh-list
64674677|NCT02988440|Spartalizumab|spartalizumab|mesh-list
64674678|NCT02988440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674679|NCT02988440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64674680|NCT02988440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674681|NCT02988440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674682|NCT02988440|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64674683|NCT00550550|Fluticasone|fluticasone|mesh-list
64674684|NCT00550550|Mometasone Furoate|mometasone furoate|mesh-list
64674685|NCT00550550|Loratadine|loratadine|mesh-list
64674686|NCT00550550|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64674687|NCT00550550|Prednisone|prednisone|mesh-list
64674688|NCT00550550|Albuterol|albuterol|mesh-list
64674689|NCT00550550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64674690|NCT00550550|Glucocorticoids|glucocorticoids|mesh-ancestor
64674691|NCT00550550|Hormones|hormones|mesh-ancestor
64674692|NCT00550550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64674693|NCT00550550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674694|NCT00550550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64674695|NCT00550550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674708|NCT00550550|Adrenergic Agents|adrenergic agents|mesh-ancestor
64674709|NCT00550550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64674710|NCT00550550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674711|NCT00550550|Antipruritics|antipruritics|mesh-ancestor
64674712|NCT00550550|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64674713|NCT00550550|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64674714|NCT00550550|Histamine Antagonists|histamine antagonists|mesh-ancestor
64674715|NCT00550550|Histamine Agents|histamine agents|mesh-ancestor
64674716|NCT00550550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64674717|NCT00550550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64674718|NCT00550550|Analgesics|analgesics|mesh-ancestor
64674719|NCT00550550|Sensory System Agents|sensory system agents|mesh-ancestor
64674720|NCT00550550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64674721|NCT01590680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64674722|NCT01590680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674723|NCT01590680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674724|NCT01590680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674725|NCT01590680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64674726|NCT02971839|Ivacaftor|ivacaftor|mesh-list
65448342|NCT00443651|Rituximab|rituximab|mesh-list
65448343|NCT00443651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65448344|NCT00443651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448345|NCT00443651|Immunologic Factors|immunologic factors|mesh-ancestor
65448346|NCT00443651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448347|NCT00443651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65448348|NCT01027715|Anticonvulsants|anticonvulsants|mesh-list
65448349|NCT03567473|Dexamethasone|dexamethasone|mesh-list
65448350|NCT03567473|Dexamethasone acetate|dexamethasone acetate|mesh-list
65448351|NCT03567473|Epinephrine|epinephrine|mesh-list
65448352|NCT03567473|Racepinephrine|racepinephrine|mesh-list
65448353|NCT03567473|Epinephryl borate|epinephryl borate|mesh-list
65448354|NCT03567473|BB 1101|bb 1101|mesh-list
65448355|NCT03567473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64674727|NCT02971839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64714561|NCT02946073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714565|NCT03071744|Narcotics|narcotics|mesh-ancestor
64714566|NCT03071744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64714567|NCT03071744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714568|NCT03071744|Analgesics|analgesics|mesh-ancestor
64714569|NCT03071744|Sensory System Agents|sensory system agents|mesh-ancestor
64714570|NCT03071744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714571|NCT03071744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64714572|NCT03071744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64714573|NCT03071744|Anesthetics, General|anesthetics, general|mesh-ancestor
64674728|NCT02971839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64674729|NCT02971839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674730|NCT02974803|Trametinib|trametinib|mesh-list
64674731|NCT02974803|Dabrafenib|dabrafenib|mesh-list
64674732|NCT02974803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674733|NCT02974803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64674734|NCT02974803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674735|NCT02974803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674736|NCT02281136|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64674737|NCT02281136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64674738|NCT02281136|Dermatologic Agents|dermatologic agents|mesh-ancestor
64674739|NCT00558038|Lactulose|lactulose|mesh-list
64674740|NCT00558038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64674741|NCT01507233|Morphine|morphine|mesh-list
64674742|NCT01507233|Bupivacaine|bupivacaine|mesh-list
64674743|NCT01507233|Anesthetics, Local|anesthetics, local|mesh-ancestor
64674744|NCT01507233|Anesthetics|anesthetics|mesh-ancestor
64674745|NCT01507233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64674746|NCT01507233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674747|NCT01507233|Sensory System Agents|sensory system agents|mesh-ancestor
64674748|NCT01507233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64674749|NCT01507233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64674750|NCT01507233|Narcotics|narcotics|mesh-ancestor
64674751|NCT01507233|Analgesics|analgesics|mesh-ancestor
64674752|NCT02278562|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64674753|NCT02278562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64674754|NCT00378417|Vaccines|vaccines|mesh-list
64674755|NCT00378417|Immunologic Factors|immunologic factors|mesh-ancestor
64674756|NCT00378417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674757|NCT01487499|Cisplatin|cisplatin|mesh-list
64674758|NCT01487499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674759|NCT01483209|Botulinum Toxins|botulinum toxins|mesh-list
64674760|NCT01483209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64674761|NCT01483209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64674770|NCT02281448|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64674771|NCT02281448|Contraceptive Agents|contraceptive agents|mesh-list
64674772|NCT02281448|Contraceptives, Oral|contraceptives, oral|mesh-list
64674773|NCT02281448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64674774|NCT02281448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64674775|NCT02281448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448356|NCT03567473|Antiemetics|antiemetics|mesh-ancestor
65448357|NCT03567473|Autonomic Agents|autonomic agents|mesh-ancestor
65448358|NCT03567473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65448359|NCT03567473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448360|NCT03567473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65448361|NCT03567473|Glucocorticoids|glucocorticoids|mesh-ancestor
65448362|NCT03567473|Hormones|hormones|mesh-ancestor
65448363|NCT03567473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65448364|NCT03567473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65448365|NCT03567473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448366|NCT03567473|Protease Inhibitors|protease inhibitors|mesh-ancestor
65448367|NCT03567473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448368|NCT03567473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448369|NCT03567473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64833100|NCT01597726|Misoprostol|misoprostol|mesh-list
64674776|NCT02281448|Anticonvulsants|anticonvulsants|mesh-ancestor
64674777|NCT02281448|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64674778|NCT02281448|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64674779|NCT02281448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64400132|NCT04998071|Sensory System Agents|sensory system agents|mesh-ancestor
64674780|NCT02281448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674781|NCT02281448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64674782|NCT00378729|Metformin|metformin|mesh-list
64674783|NCT00378729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64674784|NCT00378729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714575|NCT03074630|Dapagliflozin|dapagliflozin|mesh-list
64714576|NCT03074630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64714577|NCT03074630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64714578|NCT03074630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64714579|NCT03074630|Antimetabolites|antimetabolites|mesh-ancestor
64714580|NCT03074630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714581|NCT03074630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64714582|NCT03074630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64714583|NCT03074630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453905|NCT04659044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64714584|NCT03074630|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64714589|NCT05404334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64322868|NCT02392845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674786|NCT00378495|Antifungal Agents|antifungal agents|mesh-ancestor
64674787|NCT00378495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64674788|NCT00378495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674789|NCT00378495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64674790|NCT00378495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64674791|NCT02281526|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64674792|NCT02281526|Anticonvulsants|anticonvulsants|mesh-ancestor
64674793|NCT02281526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64674794|NCT02281526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64674795|NCT02281526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64674796|NCT02281526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674797|NCT03802227|Oxycodone|oxycodone|mesh-list
64674798|NCT03802227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64674799|NCT03802227|Narcotics|narcotics|mesh-ancestor
64674800|NCT03802227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64674801|NCT03802227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674802|NCT03802227|Analgesics|analgesics|mesh-ancestor
64674803|NCT03802227|Sensory System Agents|sensory system agents|mesh-ancestor
64674834|NCT01394211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448370|NCT03567473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65448371|NCT03567473|Adrenergic Agents|adrenergic agents|mesh-ancestor
65448372|NCT03567473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65448373|NCT03567473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65448374|NCT03567473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65448375|NCT03567473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65448376|NCT03567473|Respiratory System Agents|respiratory system agents|mesh-ancestor
65448377|NCT03567473|Mydriatics|mydriatics|mesh-ancestor
65448378|NCT03567473|Sympathomimetics|sympathomimetics|mesh-ancestor
65448379|NCT03567473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65448380|NCT00443261|Azacitidine|azacitidine|mesh-list
65448381|NCT00443261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448382|NCT00443261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65448383|NCT00443261|Antimetabolites|antimetabolites|mesh-ancestor
65448384|NCT00443261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448385|NCT00443261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448386|NCT00439517|Cetuximab|cetuximab|mesh-list
65448387|NCT00439517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65448388|NCT00439517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448389|NCT01028261|CKD732|ckd732|mesh-list
65448390|NCT01028261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65448391|NCT01028261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65448392|NCT01028261|Growth Substances|growth substances|mesh-ancestor
65448393|NCT01028261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448394|NCT01028261|Growth Inhibitors|growth inhibitors|mesh-ancestor
65448395|NCT01028261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448396|NCT01028339|Mannitol|mannitol|mesh-list
64674836|NCT01394211|Hormone Antagonists|hormone antagonists|mesh-ancestor
64674837|NCT01394211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64674838|NCT01394211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674839|NCT02717949|Ribavirin|ribavirin|mesh-list
64674840|NCT02717949|Sofosbuvir|sofosbuvir|mesh-list
64674841|NCT02717949|Ledipasvir|ledipasvir|mesh-list
64674842|NCT02717949|Antimetabolites|antimetabolites|mesh-ancestor
64674843|NCT02717949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674844|NCT02717949|Antiviral Agents|antiviral agents|mesh-ancestor
64674845|NCT02717949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64674846|NCT02300610|Gemcitabine|gemcitabine|mesh-list
64674847|NCT02300610|Cisplatin|cisplatin|mesh-list
64674848|NCT02300610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674856|NCT02300610|Immunologic Factors|immunologic factors|mesh-ancestor
64674857|NCT02300610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674859|NCT01880840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64674860|NCT01880840|Autonomic Agents|autonomic agents|mesh-ancestor
64674861|NCT01880840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64674862|NCT01880840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674863|NCT01880840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64714591|NCT00374894|Succimer|succimer|mesh-list
64714592|NCT00374894|Antidotes|antidotes|mesh-ancestor
64714593|NCT00374894|Protective Agents|protective agents|mesh-ancestor
65448397|NCT01028339|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65448398|NCT01028339|Diuretics|diuretics|mesh-ancestor
65448399|NCT01028339|Natriuretic Agents|natriuretic agents|mesh-ancestor
65448400|NCT01028339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448401|NCT01031459|Interferons|interferons|mesh-list
65448402|NCT01031459|Interferon-beta|interferon-beta|mesh-list
65448403|NCT01031459|Interferon beta-1b|interferon beta-1b|mesh-list
65448404|NCT01031459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448405|NCT01031459|Antiviral Agents|antiviral agents|mesh-ancestor
65448406|NCT01031459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65448407|NCT01031459|Immunologic Factors|immunologic factors|mesh-ancestor
65448408|NCT01031459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448409|NCT01031459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65448410|NCT00438815|Complement C1s|complement c1s|mesh-list
65448411|NCT00438815|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
65448412|NCT00438815|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
65448413|NCT00438815|Immunologic Factors|immunologic factors|mesh-ancestor
65448414|NCT00438815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448415|NCT00438815|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65448416|NCT00438815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65448417|NCT00438659|Mometasone Furoate|mometasone furoate|mesh-list
64833140|NCT01597895|Maraviroc|maraviroc|mesh-list
64714594|NCT00374894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714595|NCT00374894|Chelating Agents|chelating agents|mesh-ancestor
64714596|NCT00374894|Sequestering Agents|sequestering agents|mesh-ancestor
64714597|NCT00374894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714598|NCT03088267|Amphetamine|amphetamine|mesh-list
64714599|NCT03088267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64714600|NCT03088267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714601|NCT03088267|Sympathomimetics|sympathomimetics|mesh-ancestor
64714602|NCT03088267|Autonomic Agents|autonomic agents|mesh-ancestor
64714603|NCT03088267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714604|NCT03088267|Dopamine Agents|dopamine agents|mesh-ancestor
64714605|NCT03088267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64714606|NCT03088267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714607|NCT03088267|Adrenergic Agents|adrenergic agents|mesh-ancestor
64714608|NCT03088267|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64714609|NCT03088267|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64714610|NCT03088267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64714611|NCT03088267|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64714612|NCT03088345|Vasopressins|vasopressins|mesh-list
64714613|NCT03088345|Arginine Vasopressin|arginine vasopressin|mesh-list
64714614|NCT03088345|Hemostatics|hemostatics|mesh-ancestor
64714615|NCT03088345|Coagulants|coagulants|mesh-ancestor
64714616|NCT03088345|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64714617|NCT03088345|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64714618|NCT03088345|Natriuretic Agents|natriuretic agents|mesh-ancestor
64714621|NCT03127514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64714622|NCT02858713|Betamethasone|betamethasone|mesh-list
64714623|NCT02858713|Betamethasone Valerate|betamethasone valerate|mesh-list
64322886|NCT03166527|Immunoglobulins|immunoglobulins|mesh-list
64674864|NCT01880840|Respiratory System Agents|respiratory system agents|mesh-ancestor
64674865|NCT01880840|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64674866|NCT01880840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448418|NCT00438659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65197940|NCT00656110|Antiemetics|antiemetics|mesh-ancestor
65448419|NCT00438659|Dermatologic Agents|dermatologic agents|mesh-ancestor
65448420|NCT00438659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65448421|NCT01028495|Gemcitabine|gemcitabine|mesh-list
65448422|NCT01028495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65448423|NCT01028495|Antimetabolites|antimetabolites|mesh-ancestor
65448424|NCT01028495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448425|NCT01028495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448426|NCT01028495|Antiviral Agents|antiviral agents|mesh-ancestor
65448427|NCT01028495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65448428|NCT01028495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448429|NCT01028495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65448430|NCT01028495|Immunologic Factors|immunologic factors|mesh-ancestor
64833162|NCT01597934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64674867|NCT01880840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714624|NCT02858713|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64714626|NCT02858713|Calcipotriene|calcipotriene|mesh-list
64714627|NCT02858713|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64714628|NCT02858713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64714629|NCT02858713|Glucocorticoids|glucocorticoids|mesh-ancestor
64714630|NCT02858713|Hormones|hormones|mesh-ancestor
64714631|NCT02858713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64714632|NCT02858713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714633|NCT02858713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64714634|NCT02858713|Respiratory System Agents|respiratory system agents|mesh-ancestor
64714635|NCT02858713|Dermatologic Agents|dermatologic agents|mesh-ancestor
64714636|NCT00375050|Riluzole|riluzole|mesh-list
64714637|NCT00375050|Anticonvulsants|anticonvulsants|mesh-ancestor
64714638|NCT00375050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64714639|NCT00375050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64714640|NCT00375050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64714641|NCT00375050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714642|NCT00375050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714643|NCT00375050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64714644|NCT00375050|Protective Agents|protective agents|mesh-ancestor
64714645|NCT02860507|Glycopyrrolate|glycopyrrolate|mesh-list
64714646|NCT02860507|Neostigmine|neostigmine|mesh-list
64714647|NCT02860507|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64714648|NCT02860507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64714649|NCT02860507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714650|NCT02860507|Cholinergic Agents|cholinergic agents|mesh-ancestor
64714651|NCT02860507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64714652|NCT02860507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714653|NCT02860507|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64714654|NCT02860507|Autonomic Agents|autonomic agents|mesh-ancestor
64714655|NCT02860507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714656|NCT02860507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64714657|NCT02860507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64714659|NCT03082196|Fluorides|fluorides|mesh-list
64714664|NCT03082196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714665|NCT02861131|Neostigmine|neostigmine|mesh-list
64714666|NCT02861131|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64714667|NCT02861131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64714668|NCT02861131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674868|NCT01880840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64674869|NCT01880840|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64674870|NCT01880840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64674871|NCT01880840|Histamine Antagonists|histamine antagonists|mesh-ancestor
65448431|NCT01028495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448432|NCT00437645|Amlodipine|amlodipine|mesh-list
65448433|NCT00437645|Valsartan|valsartan|mesh-list
65448434|NCT00437645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65448435|NCT00437645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65448436|NCT00437645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65448437|NCT00437645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448438|NCT00437645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65448439|NCT00437645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448440|NCT00437645|Vasodilator Agents|vasodilator agents|mesh-ancestor
65448441|NCT00437645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65448442|NCT00437645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65448443|NCT03995147|Prednisone|prednisone|mesh-list
65448444|NCT03995147|Cyclophosphamide|cyclophosphamide|mesh-list
65448445|NCT03995147|Doxorubicin|doxorubicin|mesh-list
65448446|NCT03995147|Pembrolizumab|pembrolizumab|mesh-list
65448447|NCT03995147|Vincristine|vincristine|mesh-list
65448448|NCT03995147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65448449|NCT03995147|Immunologic Factors|immunologic factors|mesh-ancestor
64674872|NCT01880840|Histamine Agents|histamine agents|mesh-ancestor
64674873|NCT01880840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64674874|NCT01377441|Ibuprofen|ibuprofen|mesh-list
64674875|NCT01377441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64674876|NCT01377441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64674877|NCT01377441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64674878|NCT01377441|Analgesics|analgesics|mesh-ancestor
64674879|NCT01377441|Sensory System Agents|sensory system agents|mesh-ancestor
64674880|NCT01377441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64674881|NCT01377441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674882|NCT01377441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64674883|NCT01377441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64674884|NCT01377441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674885|NCT01377441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674886|NCT01882868|Leucovorin|leucovorin|mesh-list
64674887|NCT01882868|Irinotecan|irinotecan|mesh-list
64674888|NCT01882868|Aflibercept|aflibercept|mesh-list
64674889|NCT01882868|Levoleucovorin|levoleucovorin|mesh-list
64674890|NCT01882868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64674891|NCT01882868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64674895|NCT01882868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64674917|NCT02300298|Mitosis Modulators|mitosis modulators|mesh-ancestor
64674918|NCT02300298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674919|NCT02300298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64674920|NCT02300298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674921|NCT02300220|Ciprofloxacin|ciprofloxacin|mesh-list
64674922|NCT02300220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64674923|NCT02300220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64674924|NCT02300220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64674925|NCT02300220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64674926|NCT02300220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674927|NCT02300220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674928|NCT02300220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674929|NCT02300220|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64674930|NCT02300220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64674931|NCT01379469|Carbamazepine|carbamazepine|mesh-list
64674932|NCT01379469|Anticonvulsants|anticonvulsants|mesh-ancestor
65448450|NCT03995147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448451|NCT03995147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65448452|NCT03995147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65448453|NCT03995147|Alkylating Agents|alkylating agents|mesh-ancestor
65448454|NCT03995147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448455|NCT03995147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448456|NCT03995147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65448457|NCT03995147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65448458|NCT03995147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65448459|NCT03995147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65448460|NCT03995147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65448461|NCT03995147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448462|NCT03995147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65448463|NCT03995147|Glucocorticoids|glucocorticoids|mesh-ancestor
65448464|NCT03995147|Hormones|hormones|mesh-ancestor
65448465|NCT03995147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65448466|NCT03995147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65448467|NCT03995147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65448468|NCT03995147|Tubulin Modulators|tubulin modulators|mesh-ancestor
65448469|NCT03995147|Antimitotic Agents|antimitotic agents|mesh-ancestor
65448470|NCT03995147|Mitosis Modulators|mitosis modulators|mesh-ancestor
65448471|NCT00437489|Insulin|insulin|mesh-list
64674933|NCT01379469|Antimanic Agents|antimanic agents|mesh-ancestor
64674934|NCT01379469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64674935|NCT01379469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64674937|NCT01379469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64674964|NCT05289050|Analgesics|analgesics|mesh-ancestor
64674965|NCT05289050|Sensory System Agents|sensory system agents|mesh-ancestor
64674966|NCT05289050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64674967|NCT05289050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674968|NCT05289050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64674969|NCT05289050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64674970|NCT05289050|Anesthetics, General|anesthetics, general|mesh-ancestor
64674971|NCT05289050|Anesthetics|anesthetics|mesh-ancestor
64674972|NCT05289050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64674973|NCT05289050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64674974|NCT05289050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64674975|NCT05289050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64674976|NCT05289050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674977|NCT05289050|Antidepressive Agents|antidepressive agents|mesh-ancestor
64675001|NCT02658357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64714669|NCT02861131|Cholinergic Agents|cholinergic agents|mesh-ancestor
64714670|NCT02861131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64714671|NCT02861131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714672|NCT02861131|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64714673|NCT02861131|Autonomic Agents|autonomic agents|mesh-ancestor
64714674|NCT02861131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714675|NCT03136328|Edotreotide|edotreotide|mesh-list
64714676|NCT03136328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64714677|NCT03136328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448472|NCT00437489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65448473|NCT00437489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65448474|NCT00437489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448475|NCT01028573|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65448476|NCT01028573|Laxatives|laxatives|mesh-ancestor
65448477|NCT01028573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65448478|NCT04683575|Selenium|selenium|mesh-list
65448479|NCT04683575|Antioxidants|antioxidants|mesh-ancestor
65448480|NCT04683575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448481|NCT04683575|Protective Agents|protective agents|mesh-ancestor
65448482|NCT04683575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448483|NCT04683575|Trace Elements|trace elements|mesh-ancestor
65448484|NCT04683575|Micronutrients|micronutrients|mesh-ancestor
65448485|NCT00442559|Montelukast|montelukast|mesh-list
65448486|NCT00442559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65448487|NCT00442559|Respiratory System Agents|respiratory system agents|mesh-ancestor
65448488|NCT00442559|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65448489|NCT00442559|Hormone Antagonists|hormone antagonists|mesh-ancestor
65448490|NCT00442559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65448491|NCT00442559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448492|NCT00442559|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65448493|NCT00442559|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65448494|NCT00442559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448495|NCT01323491|Nicotine|nicotine|mesh-list
65448496|NCT01323491|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65448497|NCT01323491|Autonomic Agents|autonomic agents|mesh-ancestor
65448498|NCT01323491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65448499|NCT01323491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448500|NCT01323491|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64714678|NCT05057858|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64675002|NCT02658357|Serotonin Agents|serotonin agents|mesh-ancestor
64675003|NCT02658357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64675004|NCT02658357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675005|NCT02658357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675006|NCT02658357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64675007|NCT02658357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64675008|NCT02658357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64675010|NCT02658357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64675011|NCT02658357|Dopamine Agents|dopamine agents|mesh-ancestor
64675013|NCT02988908|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64675014|NCT02988908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675015|NCT02988908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675016|NCT02988908|Cholinergic Agents|cholinergic agents|mesh-ancestor
64675017|NCT02988908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65448501|NCT01323491|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65448502|NCT01323491|Cholinergic Agents|cholinergic agents|mesh-ancestor
65448503|NCT01323491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65448504|NCT01323491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448505|NCT00441545|Sevelamer|sevelamer|mesh-list
65448506|NCT00441545|Chelating Agents|chelating agents|mesh-ancestor
65448507|NCT00441545|Sequestering Agents|sequestering agents|mesh-ancestor
65448508|NCT00441545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448509|NCT00436553|Ranibizumab|ranibizumab|mesh-list
65448510|NCT00436553|Verteporfin|verteporfin|mesh-list
65448511|NCT00436553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65448512|NCT00436553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65448513|NCT00436553|Growth Substances|growth substances|mesh-ancestor
65448514|NCT00436553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448515|NCT00436553|Growth Inhibitors|growth inhibitors|mesh-ancestor
65448516|NCT00436553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448517|NCT00436553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65448518|NCT00436553|Dermatologic Agents|dermatologic agents|mesh-ancestor
65448519|NCT01028729|Gemcitabine|gemcitabine|mesh-list
65448520|NCT01028729|Endostar protein|endostar protein|mesh-list
65448521|NCT01028729|Endostatins|endostatins|mesh-list
64675018|NCT02988908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675019|NCT02988908|Nootropic Agents|nootropic agents|mesh-ancestor
64675020|NCT02326272|Certolizumab Pegol|certolizumab pegol|mesh-list
64675021|NCT02326272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64675022|NCT02326272|Immunologic Factors|immunologic factors|mesh-ancestor
64331910|NCT04495296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675026|NCT02325414|Diphosphonates|diphosphonates|mesh-list
64675027|NCT02325414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64675028|NCT02325414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675029|NCT02349048|Sofosbuvir|sofosbuvir|mesh-list
64675050|NCT01280643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64675051|NCT01280643|Growth Substances|growth substances|mesh-ancestor
64675052|NCT01280643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675053|NCT01280643|Growth Inhibitors|growth inhibitors|mesh-ancestor
64675054|NCT01280643|Immunologic Factors|immunologic factors|mesh-ancestor
64675055|NCT01280643|Antimetabolites|antimetabolites|mesh-ancestor
64675056|NCT01280643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675057|NCT01280643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64675058|NCT01280643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64675059|NCT01280643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64675060|NCT01280643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64675061|NCT01280643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675062|NCT01280643|Antidotes|antidotes|mesh-ancestor
64675063|NCT01280643|Protective Agents|protective agents|mesh-ancestor
64675064|NCT01280643|Vitamin B Complex|vitamin b complex|mesh-ancestor
64675065|NCT01280643|Vitamins|vitamins|mesh-ancestor
64675066|NCT01280643|Micronutrients|micronutrients|mesh-ancestor
64675067|NCT01888952|Prednisone|prednisone|mesh-list
64675068|NCT01888952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64675069|NCT01888952|Glucocorticoids|glucocorticoids|mesh-ancestor
64675070|NCT01888952|Hormones|hormones|mesh-ancestor
64675071|NCT01888952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64675072|NCT01888952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675073|NCT01888952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64675074|NCT01888952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448522|NCT01028729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448523|NCT01028729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65448524|NCT01028729|Antimetabolites|antimetabolites|mesh-ancestor
65448525|NCT01028729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448526|NCT01028729|Antiviral Agents|antiviral agents|mesh-ancestor
65448527|NCT01028729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65448528|NCT01028729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448529|NCT01028729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65448530|NCT01028729|Immunologic Factors|immunologic factors|mesh-ancestor
65448531|NCT01028729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448532|NCT01028729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64714679|NCT05057858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64714680|NCT05057858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64714681|NCT05057858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64714682|NCT05057858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714683|NCT05057858|Antiviral Agents|antiviral agents|mesh-ancestor
64714684|NCT05057858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64714685|NCT05057858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64714686|NCT05057858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64714687|NCT04707092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64714688|NCT04707092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64714689|NCT02953561|Azacitidine|azacitidine|mesh-list
64714690|NCT02953561|Avelumab|avelumab|mesh-list
64714691|NCT02953561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64714692|NCT02953561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64714693|NCT02953561|Antimetabolites|antimetabolites|mesh-ancestor
64714694|NCT02953561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714695|NCT02953561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64714696|NCT02953561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64714697|NCT02953561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64714698|NCT02953561|Immunologic Factors|immunologic factors|mesh-ancestor
64714699|NCT02953561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714700|NCT03090620|Lorazepam|lorazepam|mesh-list
64714701|NCT03090620|Physostigmine|physostigmine|mesh-list
64714702|NCT03090620|Anticonvulsants|anticonvulsants|mesh-ancestor
64714703|NCT03090620|Antiemetics|antiemetics|mesh-ancestor
64714704|NCT03090620|Autonomic Agents|autonomic agents|mesh-ancestor
64675075|NCT02299206|Zinc Oxide|zinc oxide|mesh-list
64675076|NCT02299206|Dermatologic Agents|dermatologic agents|mesh-ancestor
64675093|NCT02298192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64675095|NCT01893632|Analgesics|analgesics|mesh-ancestor
64675096|NCT01893632|Sensory System Agents|sensory system agents|mesh-ancestor
64675097|NCT01893632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675098|NCT01893632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675099|NCT01893632|Anticonvulsants|anticonvulsants|mesh-ancestor
64675100|NCT01893632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64675101|NCT01893632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64675102|NCT01893632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64675103|NCT01893632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64675104|NCT01893632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64675105|NCT01893632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64675106|NCT01893632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64675108|NCT01893632|Antimanic Agents|antimanic agents|mesh-ancestor
64675109|NCT01272141|Everolimus|everolimus|mesh-list
64675110|NCT01272141|Lapatinib|lapatinib|mesh-list
64675111|NCT01272141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675112|NCT01272141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64675113|NCT01272141|Immunologic Factors|immunologic factors|mesh-ancestor
64675114|NCT01272141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714705|NCT03090620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714706|NCT03090620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714707|NCT03090620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64714708|NCT03090620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65448533|NCT01028729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65448534|NCT01028729|Growth Substances|growth substances|mesh-ancestor
65448535|NCT01028729|Growth Inhibitors|growth inhibitors|mesh-ancestor
65448536|NCT03357419|Clindamycin|clindamycin|mesh-list
65448537|NCT03357419|Clindamycin palmitate|clindamycin palmitate|mesh-list
65448538|NCT03357419|Clindamycin phosphate|clindamycin phosphate|mesh-list
65448539|NCT03357419|Cephalexin|cephalexin|mesh-list
65448540|NCT03357419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65448541|NCT03357419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65448542|NCT03357419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65448543|NCT03357419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448544|NCT03357419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448545|NCT01031927|Glycine|glycine|mesh-list
65448546|NCT01031927|Glycine Agents|glycine agents|mesh-ancestor
65448547|NCT01031927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65448548|NCT01031927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448549|NCT01031927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448550|NCT03331289|Dapagliflozin|dapagliflozin|mesh-list
65448551|NCT03331289|Exenatide|exenatide|mesh-list
65448552|NCT03331289|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65448553|NCT03331289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448554|NCT03331289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65448555|NCT03331289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448556|NCT03331289|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65448557|NCT03331289|Incretins|incretins|mesh-ancestor
65448558|NCT03331289|Hormones|hormones|mesh-ancestor
64714709|NCT03090620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64714710|NCT03090620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64714711|NCT03090620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64714712|NCT03090620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64714713|NCT03090620|GABA Modulators|gaba modulators|mesh-ancestor
64714714|NCT03090620|GABA Agents|gaba agents|mesh-ancestor
64714715|NCT03090620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64714716|NCT03090620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714717|NCT03090620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64714718|NCT03090620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64714719|NCT03090620|Cholinergic Agents|cholinergic agents|mesh-ancestor
64714720|NCT03090620|Miotics|miotics|mesh-ancestor
64714721|NCT02953873|Mycophenolic Acid|mycophenolic acid|mesh-list
64714722|NCT02953873|Prednisone|prednisone|mesh-list
64714723|NCT02953873|Methylprednisolone|methylprednisolone|mesh-list
64714724|NCT02953873|Tacrolimus|tacrolimus|mesh-list
64714725|NCT02953873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64714726|NCT02953873|Glucocorticoids|glucocorticoids|mesh-ancestor
64714727|NCT02953873|Hormones|hormones|mesh-ancestor
64714728|NCT02953873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64323003|NCT02230033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64675115|NCT01272141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64675116|NCT01272141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675117|NCT01272141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448559|NCT03331289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65448560|NCT01032083|Citalopram|citalopram|mesh-list
65448561|NCT01032083|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65448562|NCT01032083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65448563|NCT01032083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65448564|NCT01032083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448565|NCT01032083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65448566|NCT01032083|Serotonin Agents|serotonin agents|mesh-ancestor
65448567|NCT01032083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448568|NCT01032083|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65448569|NCT01032083|Antidepressive Agents|antidepressive agents|mesh-ancestor
65448570|NCT01032083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65448571|NCT00436163|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65448572|NCT00436163|Antiviral Agents|antiviral agents|mesh-ancestor
65448573|NCT00436163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65448574|NCT01028963|Pioglitazone|pioglitazone|mesh-list
65448575|NCT01028963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65448576|NCT01028963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448577|NCT00006604|Ritonavir|ritonavir|mesh-list
65448578|NCT00006604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65448579|NCT00006604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65448580|NCT00006604|Protease Inhibitors|protease inhibitors|mesh-ancestor
65448581|NCT00006604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448582|NCT00006604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675118|NCT01895036|Naltrexone|naltrexone|mesh-list
64675119|NCT01895036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64675120|NCT01895036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64675121|NCT01895036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675122|NCT01895036|Sensory System Agents|sensory system agents|mesh-ancestor
64675145|NCT02608905|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64675146|NCT02608905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675148|NCT02608905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675149|NCT01213329|Alemtuzumab|alemtuzumab|mesh-list
64675150|NCT01213329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64675151|NCT01213329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675152|NCT03964532|Avelumab|avelumab|mesh-list
64675153|NCT03964532|Talazoparib|talazoparib|mesh-list
64675154|NCT03964532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64675155|NCT03964532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675156|NCT03964532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64675157|NCT03964532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675158|NCT03964532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675160|NCT01189071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64675161|NCT01189071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64675162|NCT01189071|Cholinergic Agents|cholinergic agents|mesh-ancestor
64714729|NCT02953873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714730|NCT02953873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64714731|NCT02953873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448583|NCT00006604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65448584|NCT00006604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65448585|NCT00006604|Antiviral Agents|antiviral agents|mesh-ancestor
65448586|NCT00006604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65448587|NCT00006604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65448588|NCT00006604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65448589|NCT00006478|Sargramostim|sargramostim|mesh-list
65448590|NCT00006478|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
65448591|NCT00006478|Immunologic Factors|immunologic factors|mesh-ancestor
65448592|NCT00006478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448593|NCT00006478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65448594|NCT01097902|Ibuprofen|ibuprofen|mesh-list
65448595|NCT01097902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64714732|NCT02953873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64714733|NCT02953873|Immunologic Factors|immunologic factors|mesh-ancestor
64714734|NCT02953873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64714735|NCT02953873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64714736|NCT02953873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714737|NCT02953873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64714738|NCT02953873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64714739|NCT02953873|Antitubercular Agents|antitubercular agents|mesh-ancestor
64714740|NCT02953873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64714741|NCT02953873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64675163|NCT01189071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64675164|NCT01189071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675166|NCT01189071|Urological Agents|urological agents|mesh-ancestor
64675167|NCT02515851|Bupivacaine|bupivacaine|mesh-list
64675168|NCT02515851|Anesthetics, Local|anesthetics, local|mesh-ancestor
64675169|NCT02515851|Anesthetics|anesthetics|mesh-ancestor
64675170|NCT02515851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64675190|NCT02468583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675192|NCT02468583|Immunologic Factors|immunologic factors|mesh-ancestor
64675193|NCT02468583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675194|NCT02468583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675195|NCT03763929|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
64675196|NCT03763929|Antioxidants|antioxidants|mesh-ancestor
64675197|NCT03763929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675198|NCT03763929|Protective Agents|protective agents|mesh-ancestor
64675199|NCT03763929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675200|NCT03763929|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64675201|NCT03763929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675202|NCT01118013|Mycophenolic Acid|mycophenolic acid|mesh-list
64675203|NCT01118013|Methotrexate|methotrexate|mesh-list
64675204|NCT01118013|Fludarabine phosphate|fludarabine phosphate|mesh-list
64675205|NCT01118013|Fludarabine|fludarabine|mesh-list
64675206|NCT01118013|Busulfan|busulfan|mesh-list
64675207|NCT01118013|Tacrolimus|tacrolimus|mesh-list
64675208|NCT01118013|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64675209|NCT01118013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64675210|NCT01118013|Abortifacient Agents|abortifacient agents|mesh-ancestor
64675211|NCT01118013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64675212|NCT01118013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675213|NCT01118013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64675214|NCT01118013|Antimetabolites|antimetabolites|mesh-ancestor
64675215|NCT01118013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675216|NCT01118013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675217|NCT01118013|Dermatologic Agents|dermatologic agents|mesh-ancestor
64675218|NCT01118013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675219|NCT01118013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64675220|NCT01118013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64675225|NCT01118013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65448596|NCT01097902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65448597|NCT01097902|Analgesics|analgesics|mesh-ancestor
65448598|NCT01097902|Sensory System Agents|sensory system agents|mesh-ancestor
65448599|NCT01097902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65448600|NCT01097902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448601|NCT01097902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65448602|NCT01097902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65448603|NCT01097902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65448604|NCT01097902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448605|NCT01097902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448606|NCT00436007|Vaccines|vaccines|mesh-list
65448607|NCT00436007|Immunologic Factors|immunologic factors|mesh-ancestor
65448608|NCT00436007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448609|NCT00435461|Fluticasone|fluticasone|mesh-list
65448610|NCT00435461|Xhance|xhance|mesh-list
65448611|NCT00435461|Fexofenadine|fexofenadine|mesh-list
65448612|NCT00435461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65448613|NCT00435461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64675226|NCT01118013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64675227|NCT01118013|Antitubercular Agents|antitubercular agents|mesh-ancestor
64675228|NCT01118013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64675229|NCT01118013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64400594|NCT04989257|Clopidogrel|clopidogrel|mesh-list
64675231|NCT01118013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64714743|NCT02953873|Autonomic Agents|autonomic agents|mesh-ancestor
64714744|NCT02953873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714745|NCT02953873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64714746|NCT02953873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64714747|NCT02953873|Protective Agents|protective agents|mesh-ancestor
64714748|NCT03091478|Pembrolizumab|pembrolizumab|mesh-list
64714749|NCT03091478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64714750|NCT03091478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64714751|NCT02867605|Hyaluronic Acid|hyaluronic acid|mesh-list
64714752|NCT02867605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64714753|NCT02867605|Immunologic Factors|immunologic factors|mesh-ancestor
64714754|NCT02867605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714755|NCT02867605|Viscosupplements|viscosupplements|mesh-ancestor
64714756|NCT02867605|Protective Agents|protective agents|mesh-ancestor
64714757|NCT00375596|Ketotifen|ketotifen|mesh-list
64714758|NCT00375596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64714759|NCT00375596|Antipruritics|antipruritics|mesh-ancestor
64714760|NCT00375596|Dermatologic Agents|dermatologic agents|mesh-ancestor
64714761|NCT00375596|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64323040|NCT02151695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675232|NCT01118013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64675233|NCT00378027|PENTA|penta|mesh-list
64675234|NCT00378027|Fondaparinux|fondaparinux|mesh-list
64675235|NCT00378027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64675236|NCT00378027|Antithrombins|antithrombins|mesh-ancestor
64675237|NCT00378027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64675238|NCT00378027|Protease Inhibitors|protease inhibitors|mesh-ancestor
64675239|NCT00378027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675240|NCT00378027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675241|NCT00378027|Anticoagulants|anticoagulants|mesh-ancestor
64675242|NCT00378027|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64675243|NCT00378027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64675244|NCT00552032|Mometasone Furoate|mometasone furoate|mesh-list
64675250|NCT02429583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675252|NCT02413047|Mercaptopurine|mercaptopurine|mesh-list
65448614|NCT00435461|Autonomic Agents|autonomic agents|mesh-ancestor
65448615|NCT00435461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65448616|NCT00435461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448617|NCT00435461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65448618|NCT00435461|Respiratory System Agents|respiratory system agents|mesh-ancestor
65448619|NCT00435461|Dermatologic Agents|dermatologic agents|mesh-ancestor
65448620|NCT00435461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65448621|NCT00435461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65448622|NCT00435461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65448623|NCT00435461|Histamine Antagonists|histamine antagonists|mesh-ancestor
65448624|NCT00435461|Histamine Agents|histamine agents|mesh-ancestor
65448625|NCT00435461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65448626|NCT00435461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448627|NCT00006436|Prednisone|prednisone|mesh-list
65448628|NCT00006436|Cyclophosphamide|cyclophosphamide|mesh-list
65448629|NCT00006436|Rituximab|rituximab|mesh-list
65448630|NCT00006436|Doxorubicin|doxorubicin|mesh-list
65448631|NCT00006436|Etoposide|etoposide|mesh-list
65448632|NCT00006436|Vincristine|vincristine|mesh-list
64444548|NCT02228720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64675253|NCT02413047|Azathioprine|azathioprine|mesh-list
64675254|NCT02413047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64675255|NCT02413047|Abortifacient Agents|abortifacient agents|mesh-ancestor
64675256|NCT02413047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64675257|NCT02413047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675258|NCT02413047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64675259|NCT02413047|Antimetabolites|antimetabolites|mesh-ancestor
64675260|NCT02413047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675273|NCT02277548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675274|NCT02277548|Anticonvulsants|anticonvulsants|mesh-ancestor
64675275|NCT02277548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64675276|NCT02277548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64675277|NCT02277548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675278|NCT02277548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64675279|NCT02277548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64714762|NCT00375596|Histamine Antagonists|histamine antagonists|mesh-ancestor
64714764|NCT00375596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64714765|NCT00375596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714766|NCT00375596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714767|NCT00375596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64714768|NCT03093272|Prednisone|prednisone|mesh-list
64714769|NCT03093272|Docetaxel|docetaxel|mesh-list
64714770|NCT03093272|Leuprolide|leuprolide|mesh-list
64323063|NCT04811001|Osimertinib|osimertinib|mesh-list
64675280|NCT02277548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64675281|NCT02277548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64675282|NCT02277548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64675283|NCT02411643|Calcipotriene|calcipotriene|mesh-list
64675284|NCT02411643|Dermatologic Agents|dermatologic agents|mesh-ancestor
64675285|NCT03029390|Metformin|metformin|mesh-list
64675286|NCT03029390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64675287|NCT03029390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675288|NCT01085643|Lubiprostone|lubiprostone|mesh-list
64675289|NCT01085643|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64675290|NCT01085643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65448633|NCT00006436|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65448634|NCT00006436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65448635|NCT00006436|Immunologic Factors|immunologic factors|mesh-ancestor
65448636|NCT00006436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448637|NCT00006436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65448638|NCT00006436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65448639|NCT00006436|Alkylating Agents|alkylating agents|mesh-ancestor
65448640|NCT00006436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448641|NCT00006436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448642|NCT00006436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65448643|NCT00006436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65448644|NCT00006436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65448645|NCT00006436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65448646|NCT00006436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65448647|NCT00006436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448648|NCT00006436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65448649|NCT00006436|Glucocorticoids|glucocorticoids|mesh-ancestor
65448650|NCT00006436|Hormones|hormones|mesh-ancestor
65448651|NCT00006436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65448652|NCT00006436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65448653|NCT00006436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65448654|NCT00006436|Tubulin Modulators|tubulin modulators|mesh-ancestor
64675291|NCT01085643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675292|NCT03028766|Adavosertib|adavosertib|mesh-list
64675293|NCT03028766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675294|NCT03028766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675295|NCT03020030|Leucovorin|leucovorin|mesh-list
64675296|NCT03020030|Cytarabine|cytarabine|mesh-list
64675297|NCT03020030|Dexamethasone|dexamethasone|mesh-list
64675298|NCT03020030|Hydrocortisone|hydrocortisone|mesh-list
64675299|NCT03020030|Cyclophosphamide|cyclophosphamide|mesh-list
64675300|NCT03020030|Doxorubicin|doxorubicin|mesh-list
64675301|NCT03020030|Methotrexate|methotrexate|mesh-list
64675302|NCT03020030|Etoposide|etoposide|mesh-list
64675303|NCT03020030|Vincristine|vincristine|mesh-list
64675304|NCT03020030|Asparaginase|asparaginase|mesh-list
64675305|NCT03020030|Dasatinib|dasatinib|mesh-list
64675306|NCT03020030|Mercaptopurine|mercaptopurine|mesh-list
64675307|NCT03020030|Pegaspargase|pegaspargase|mesh-list
64675308|NCT03020030|Dexrazoxane|dexrazoxane|mesh-list
64675318|NCT03020030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675319|NCT03020030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64675320|NCT03020030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64675321|NCT03020030|Antiemetics|antiemetics|mesh-ancestor
64675322|NCT03020030|Autonomic Agents|autonomic agents|mesh-ancestor
64675323|NCT03020030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675324|NCT03020030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64675325|NCT03020030|Glucocorticoids|glucocorticoids|mesh-ancestor
64675327|NCT03020030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64675328|NCT03020030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64675329|NCT03020030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64675330|NCT03020030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64675334|NCT03020030|Abortifacient Agents|abortifacient agents|mesh-ancestor
65448655|NCT00006436|Antimitotic Agents|antimitotic agents|mesh-ancestor
65448656|NCT00006436|Mitosis Modulators|mitosis modulators|mesh-ancestor
65448657|NCT01097980|Trazodone|trazodone|mesh-list
65448658|NCT01097980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65448659|NCT01097980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65448660|NCT01097980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65448661|NCT01097980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448662|NCT01097980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65448663|NCT01097980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65448664|NCT01097980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65448665|NCT01097980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65448666|NCT01097980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448667|NCT01097980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65448668|NCT01097980|Serotonin Agents|serotonin agents|mesh-ancestor
65448669|NCT01097980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65448670|NCT01097980|Antidepressive Agents|antidepressive agents|mesh-ancestor
65448671|NCT01029275|Octreotide|octreotide|mesh-list
65448672|NCT01029275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65448673|NCT01029275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64833405|NCT01599338|Hormones|hormones|mesh-ancestor
64675335|NCT03020030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64675336|NCT03020030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64675337|NCT03020030|Antimetabolites|antimetabolites|mesh-ancestor
64675338|NCT03020030|Dermatologic Agents|dermatologic agents|mesh-ancestor
64675339|NCT03020030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64675340|NCT03020030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64675341|NCT03020030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64675342|NCT03020030|Antiviral Agents|antiviral agents|mesh-ancestor
64675343|NCT03020030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64675344|NCT03020030|Antidotes|antidotes|mesh-ancestor
64675345|NCT03020030|Protective Agents|protective agents|mesh-ancestor
64675346|NCT03020030|Vitamin B Complex|vitamin b complex|mesh-ancestor
64675347|NCT03020030|Vitamins|vitamins|mesh-ancestor
64675348|NCT03020030|Micronutrients|micronutrients|mesh-ancestor
64675349|NCT03020030|Tubulin Modulators|tubulin modulators|mesh-ancestor
64714771|NCT03093272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64714772|NCT03093272|Tubulin Modulators|tubulin modulators|mesh-ancestor
64714773|NCT03093272|Antimitotic Agents|antimitotic agents|mesh-ancestor
64714774|NCT03093272|Mitosis Modulators|mitosis modulators|mesh-ancestor
64714775|NCT03093272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714776|NCT03093272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64714777|NCT03093272|Glucocorticoids|glucocorticoids|mesh-ancestor
64714778|NCT03093272|Hormones|hormones|mesh-ancestor
64714779|NCT03093272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64714780|NCT03093272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714781|NCT03093272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64675350|NCT03020030|Antimitotic Agents|antimitotic agents|mesh-ancestor
64675351|NCT03020030|Mitosis Modulators|mitosis modulators|mesh-ancestor
64675352|NCT03020030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64675353|NCT03020030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64675354|NCT01071993|Atorvastatin|atorvastatin|mesh-list
64675355|NCT01071993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64675356|NCT01071993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64675357|NCT01071993|Antimetabolites|antimetabolites|mesh-ancestor
65448674|NCT01029275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448675|NCT04829903|Liraglutide|liraglutide|mesh-list
65448676|NCT04829903|Dulaglutide|dulaglutide|mesh-list
65448677|NCT04829903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65448678|NCT04829903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448679|NCT04829903|Incretins|incretins|mesh-ancestor
65448680|NCT04829903|Hormones|hormones|mesh-ancestor
65448681|NCT04829903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65448682|NCT00440999|Artesunate|artesunate|mesh-list
65448683|NCT00440999|Chloroquine|chloroquine|mesh-list
65448684|NCT00440999|Pyronaridine|pyronaridine|mesh-list
65448685|NCT00440999|Antimalarials|antimalarials|mesh-ancestor
65448686|NCT00440999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65448687|NCT00440999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65448688|NCT00440999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65448689|NCT00440999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448690|NCT00440999|Antiviral Agents|antiviral agents|mesh-ancestor
65448691|NCT00440999|Schistosomicides|schistosomicides|mesh-ancestor
65448692|NCT00440999|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65448693|NCT00440999|Anthelmintics|anthelmintics|mesh-ancestor
65448694|NCT00440999|Amebicides|amebicides|mesh-ancestor
65448695|NCT00440999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65448696|NCT00434213|Methylphenidate|methylphenidate|mesh-list
65448697|NCT00434213|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65448698|NCT00434213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448699|NCT00434213|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65448700|NCT00434213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65448701|NCT00434213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65448702|NCT00434213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448703|NCT00434213|Dopamine Agents|dopamine agents|mesh-ancestor
65448704|NCT00434213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65448705|NCT01029743|Aspirin|aspirin|mesh-list
64675358|NCT01071993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675359|NCT01071993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64675360|NCT01071993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64675361|NCT01071993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675362|NCT02379585|Paclitaxel|paclitaxel|mesh-list
64675363|NCT02379585|Docetaxel|docetaxel|mesh-list
64675364|NCT02379585|Cyclophosphamide|cyclophosphamide|mesh-list
64675365|NCT02379585|Doxorubicin|doxorubicin|mesh-list
64675366|NCT02379585|Trastuzumab|trastuzumab|mesh-list
64675367|NCT02379585|Pertuzumab|pertuzumab|mesh-list
64675368|NCT02379585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64675369|NCT02379585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675370|NCT02379585|Tubulin Modulators|tubulin modulators|mesh-ancestor
65448706|NCT01029743|PENTA|penta|mesh-list
65448707|NCT01029743|Rivaroxaban|rivaroxaban|mesh-list
65448708|NCT01029743|Fondaparinux|fondaparinux|mesh-list
65448709|NCT01029743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65448710|NCT01029743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65448711|NCT01029743|Analgesics|analgesics|mesh-ancestor
65448712|NCT01029743|Sensory System Agents|sensory system agents|mesh-ancestor
65448713|NCT01029743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65448714|NCT01029743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448715|NCT01029743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65448716|NCT01029743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65448717|NCT01029743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65448718|NCT01029743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65448719|NCT01029743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448720|NCT01029743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64675371|NCT02379585|Antimitotic Agents|antimitotic agents|mesh-ancestor
64675372|NCT02379585|Mitosis Modulators|mitosis modulators|mesh-ancestor
64675373|NCT02379585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675374|NCT02379585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64675375|NCT02379585|Immunologic Factors|immunologic factors|mesh-ancestor
64675376|NCT02379585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675398|NCT01048125|Phenylephrine|phenylephrine|mesh-list
64675399|NCT01048125|Oxymetazoline|oxymetazoline|mesh-list
64675400|NCT01048125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64675401|NCT01048125|Mydriatics|mydriatics|mesh-ancestor
64675402|NCT01048125|Autonomic Agents|autonomic agents|mesh-ancestor
64675403|NCT01048125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675404|NCT01048125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675405|NCT01048125|Sympathomimetics|sympathomimetics|mesh-ancestor
64675406|NCT01048125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64675407|NCT01048125|Nasal Decongestants|nasal decongestants|mesh-ancestor
64675408|NCT01048125|Respiratory System Agents|respiratory system agents|mesh-ancestor
64675409|NCT01048125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64675410|NCT01048125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64675411|NCT01048125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64675412|NCT01048125|Adrenergic Agents|adrenergic agents|mesh-ancestor
64675413|NCT01048125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64675415|NCT01048125|Protective Agents|protective agents|mesh-ancestor
64675416|NCT01048125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64675417|NCT01048125|Vasodilator Agents|vasodilator agents|mesh-ancestor
64675418|NCT01048125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64675431|NCT01901588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64675432|NCT01901588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675433|NCT03673124|Letrozole|letrozole|mesh-list
64675434|NCT03673124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64714782|NCT03093272|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64714783|NCT03093272|Fertility Agents|fertility agents|mesh-ancestor
64714784|NCT03093272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64714786|NCT03100123|Heparin|heparin|mesh-list
64714787|NCT03100123|Enoxaparin|enoxaparin|mesh-list
64714788|NCT03100123|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64714789|NCT03100123|Tinzaparin|tinzaparin|mesh-list
64714790|NCT03100123|Dalteparin|dalteparin|mesh-list
64714791|NCT03100123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64714792|NCT03100123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64714793|NCT03100123|Analgesics|analgesics|mesh-ancestor
64714794|NCT03100123|Sensory System Agents|sensory system agents|mesh-ancestor
64714795|NCT03100123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714796|NCT03100123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714797|NCT03100123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64714798|NCT03100123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65448721|NCT01029743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65448722|NCT01029743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198234|NCT02865174|Tinzaparin|tinzaparin|mesh-list
65448723|NCT01029743|Antipyretics|antipyretics|mesh-ancestor
65448724|NCT01029743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65448725|NCT01029743|Antithrombins|antithrombins|mesh-ancestor
65448726|NCT01029743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65448727|NCT01029743|Protease Inhibitors|protease inhibitors|mesh-ancestor
65448728|NCT01029743|Anticoagulants|anticoagulants|mesh-ancestor
65448729|NCT01029821|Heparin|heparin|mesh-list
65448730|NCT01029821|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65448731|NCT01029821|Tinzaparin|tinzaparin|mesh-list
65448732|NCT01029821|Dalteparin|dalteparin|mesh-list
65448733|NCT01029821|Anticoagulants|anticoagulants|mesh-ancestor
65448734|NCT01029821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65448735|NCT01029821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65448736|NCT01029821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448737|NCT00006184|Cyclosporine|cyclosporine|mesh-list
65448738|NCT00006184|Prednisone|prednisone|mesh-list
65448739|NCT00006184|Cyclophosphamide|cyclophosphamide|mesh-list
65448740|NCT00006184|Doxorubicin|doxorubicin|mesh-list
65448741|NCT00006184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65448742|NCT00006184|Methotrexate|methotrexate|mesh-list
65448743|NCT00006184|Fludarabine|fludarabine|mesh-list
65448744|NCT00006184|Fludarabine phosphate|fludarabine phosphate|mesh-list
65448745|NCT00006184|Etoposide|etoposide|mesh-list
65448746|NCT00006184|Vincristine|vincristine|mesh-list
65448747|NCT00006184|Bortezomib|bortezomib|mesh-list
65448748|NCT00006184|Molgramostim|molgramostim|mesh-list
65448749|NCT00006184|Cyclosporins|cyclosporins|mesh-list
65448750|NCT00006184|Immunoglobulins|immunoglobulins|mesh-list
65448751|NCT00006184|Lenograstim|lenograstim|mesh-list
65448752|NCT00006184|Sargramostim|sargramostim|mesh-list
64714799|NCT03100123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64714800|NCT03100123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64714801|NCT03100123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714802|NCT03100123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64714803|NCT03100123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64714804|NCT03100123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64714805|NCT03100123|Antipyretics|antipyretics|mesh-ancestor
64714806|NCT03100123|Anticoagulants|anticoagulants|mesh-ancestor
64714807|NCT02957305|Misoprostol|misoprostol|mesh-list
64714808|NCT02957305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64714809|NCT02957305|Abortifacient Agents|abortifacient agents|mesh-ancestor
64714810|NCT02957305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64714811|NCT02957305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714812|NCT02957305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64714813|NCT02957305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64714814|NCT02957305|Oxytocics|oxytocics|mesh-ancestor
64714826|NCT03104725|Expectorants|expectorants|mesh-ancestor
64714827|NCT03104725|Respiratory System Agents|respiratory system agents|mesh-ancestor
65448753|NCT00006184|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
65448754|NCT00006184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65448755|NCT00006184|Immunologic Factors|immunologic factors|mesh-ancestor
65448756|NCT00006184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448757|NCT00006184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65448758|NCT00006184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65448759|NCT00006184|Alkylating Agents|alkylating agents|mesh-ancestor
65448760|NCT00006184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448761|NCT00006184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448762|NCT00006184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65448763|NCT00006184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65448764|NCT00006184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65448765|NCT00006184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65448766|NCT00006184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448767|NCT00006184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65448768|NCT00006184|Glucocorticoids|glucocorticoids|mesh-ancestor
65448769|NCT00006184|Hormones|hormones|mesh-ancestor
65448770|NCT00006184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65448771|NCT00006184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65448772|NCT00006184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65448773|NCT00006184|Abortifacient Agents|abortifacient agents|mesh-ancestor
65448774|NCT00006184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64833492|NCT05690191|Rituximab|rituximab|mesh-list
64714828|NCT03104725|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64714829|NCT03104725|Antioxidants|antioxidants|mesh-ancestor
64714830|NCT03104725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714831|NCT03104725|Protective Agents|protective agents|mesh-ancestor
64714832|NCT03104725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714833|NCT03104725|Antidotes|antidotes|mesh-ancestor
64714834|NCT03154658|Ropivacaine|ropivacaine|mesh-list
64714835|NCT03154658|Anesthetics, Local|anesthetics, local|mesh-ancestor
64714836|NCT03154658|Anesthetics|anesthetics|mesh-ancestor
64714837|NCT03154658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64675435|NCT03673124|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64675436|NCT03673124|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64675437|NCT03673124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675438|NCT03673124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675439|NCT03673124|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64675440|NCT03673124|Hormone Antagonists|hormone antagonists|mesh-ancestor
64675441|NCT03673124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64675442|NCT03673124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675443|NCT01025271|Daptomycin|daptomycin|mesh-list
64675444|NCT01025271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64675445|NCT01025271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64675446|NCT01902758|Ambrisentan|ambrisentan|mesh-list
64675447|NCT01902758|Theophylline|theophylline|mesh-list
64675448|NCT01902758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64675449|NCT01902758|Autonomic Agents|autonomic agents|mesh-ancestor
64675450|NCT01902758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65448775|NCT00006184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65448776|NCT00006184|Antimetabolites|antimetabolites|mesh-ancestor
65448777|NCT00006184|Dermatologic Agents|dermatologic agents|mesh-ancestor
65448778|NCT00006184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65448779|NCT00006184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65448780|NCT00006184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65448781|NCT00006184|Tubulin Modulators|tubulin modulators|mesh-ancestor
65448782|NCT00006184|Antimitotic Agents|antimitotic agents|mesh-ancestor
65448783|NCT00006184|Mitosis Modulators|mitosis modulators|mesh-ancestor
65448784|NCT00006184|Antifungal Agents|antifungal agents|mesh-ancestor
65448785|NCT00006184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65448786|NCT00006184|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65448787|NCT00006184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65448788|NCT00433199|Testosterone|testosterone|mesh-list
65448789|NCT00433199|Androgens|androgens|mesh-ancestor
65448790|NCT00433199|Hormones|hormones|mesh-ancestor
65448791|NCT00433199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65448792|NCT00433199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448793|NCT00006046|Antibodies|antibodies|mesh-list
65448794|NCT00006046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65448795|NCT00006046|Immunologic Factors|immunologic factors|mesh-ancestor
65448796|NCT00006046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448797|NCT01098448|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65448798|NCT01098448|Amoxicillin|amoxicillin|mesh-list
65448799|NCT01098448|Metronidazole|metronidazole|mesh-list
65448800|NCT01098448|Tetracycline|tetracycline|mesh-list
65448801|NCT01098448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65448802|NCT01098448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65448803|NCT01098448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65448804|NCT01098448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65448805|NCT01098448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448819|NCT01098526|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65448820|NCT01098526|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65448821|NCT01098526|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65448822|NCT01098526|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65448823|NCT01098526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65448824|NCT01098526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65448825|NCT00005908|Tamoxifen|tamoxifen|mesh-list
65448826|NCT00005908|Cyclophosphamide|cyclophosphamide|mesh-list
65448827|NCT00005908|Docetaxel|docetaxel|mesh-list
65448828|NCT00005908|Doxorubicin|doxorubicin|mesh-list
65448829|NCT00005908|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65448830|NCT00005908|Capecitabine|capecitabine|mesh-list
65448831|NCT00005908|Anastrozole|anastrozole|mesh-list
65448832|NCT00005908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65448833|NCT00005908|Immunologic Factors|immunologic factors|mesh-ancestor
65448834|NCT00005908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448835|NCT00005908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65448836|NCT00005908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65448837|NCT00005908|Alkylating Agents|alkylating agents|mesh-ancestor
65448838|NCT00005908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448839|NCT00005908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448840|NCT00005908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65448841|NCT00005908|Tubulin Modulators|tubulin modulators|mesh-ancestor
65448842|NCT00005908|Antimitotic Agents|antimitotic agents|mesh-ancestor
65448843|NCT00005908|Mitosis Modulators|mitosis modulators|mesh-ancestor
65448844|NCT00005908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65448845|NCT00005908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65448846|NCT00005908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65448847|NCT00005908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448848|NCT00005908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65448849|NCT00005908|Antimetabolites|antimetabolites|mesh-ancestor
65448850|NCT00005908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65448851|NCT00005908|Hormone Antagonists|hormone antagonists|mesh-ancestor
64675451|NCT01902758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675452|NCT01902758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64675453|NCT01902758|Respiratory System Agents|respiratory system agents|mesh-ancestor
64675454|NCT01902758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64675455|NCT01902758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675458|NCT01902758|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64675459|NCT01902758|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64675461|NCT01902758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64675462|NCT01902758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64675463|NCT01020903|Aprepitant|aprepitant|mesh-list
65448852|NCT00005908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65448853|NCT00005908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65448854|NCT00005908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65448855|NCT00005908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65448856|NCT00005908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65448857|NCT00005908|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65448858|NCT00005908|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65448859|NCT03160079|Pembrolizumab|pembrolizumab|mesh-list
65448860|NCT03160079|Blinatumomab|blinatumomab|mesh-list
65448861|NCT03160079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65448862|NCT03160079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448863|NCT00004978|Aldesleukin|aldesleukin|mesh-list
65448864|NCT00004978|Interleukin-2|interleukin-2|mesh-list
65448865|NCT00004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448866|NCT00004978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65448867|NCT00004978|Analgesics|analgesics|mesh-ancestor
65448868|NCT00004978|Sensory System Agents|sensory system agents|mesh-ancestor
65448869|NCT00004978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65448870|NCT00004978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448871|NCT00004978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65448872|NCT00004978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65448873|NCT00004978|Antiviral Agents|antiviral agents|mesh-ancestor
65448874|NCT00004978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65448875|NCT01030601|Dexamethasone|dexamethasone|mesh-list
65448876|NCT01030601|Dexamethasone acetate|dexamethasone acetate|mesh-list
65448877|NCT01030601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64675464|NCT01020903|Antiemetics|antiemetics|mesh-ancestor
64675465|NCT01020903|Autonomic Agents|autonomic agents|mesh-ancestor
64675466|NCT01020903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675467|NCT01020903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675468|NCT01020903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64675469|NCT01020903|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64675470|NCT01020903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64675471|NCT01020903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675472|NCT02318901|Pembrolizumab|pembrolizumab|mesh-list
64675473|NCT02318901|Trastuzumab|trastuzumab|mesh-list
64675474|NCT02318901|Cetuximab|cetuximab|mesh-list
64675475|NCT02318901|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64675476|NCT02318901|Maytansine|maytansine|mesh-list
64675477|NCT02318901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64675478|NCT02318901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675479|NCT02318901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64675480|NCT02318901|Tubulin Modulators|tubulin modulators|mesh-ancestor
64675484|NCT01904864|Iron|iron|mesh-list
64675485|NCT01904864|Micronutrients|micronutrients|mesh-ancestor
64675486|NCT01904864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675487|NCT01904864|Trace Elements|trace elements|mesh-ancestor
64675488|NCT01016847|Montelukast|montelukast|mesh-list
64714838|NCT03154658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448878|NCT01030601|BB 1101|bb 1101|mesh-list
65448879|NCT01030601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65448880|NCT01030601|Antiemetics|antiemetics|mesh-ancestor
65448881|NCT01030601|Autonomic Agents|autonomic agents|mesh-ancestor
65448882|NCT01030601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65448883|NCT01030601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448884|NCT01030601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65448885|NCT01030601|Glucocorticoids|glucocorticoids|mesh-ancestor
65448886|NCT01030601|Hormones|hormones|mesh-ancestor
65448887|NCT01030601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65448888|NCT01030601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65448889|NCT01030601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448890|NCT01030601|Protease Inhibitors|protease inhibitors|mesh-ancestor
65448891|NCT01030601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448892|NCT01030601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448893|NCT00430937|Vancomycin|vancomycin|mesh-list
65448894|NCT00430937|Daptomycin|daptomycin|mesh-list
65448895|NCT00430937|Teicoplanin|teicoplanin|mesh-list
65448896|NCT00430937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65448897|NCT00430937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65448898|NCT01101412|Calcium, Dietary|calcium, dietary|mesh-list
65448899|NCT01101412|Ethanol|ethanol|mesh-list
65448900|NCT01101412|Trimethoprim|trimethoprim|mesh-list
65448901|NCT01101412|Sulfamethoxazole|sulfamethoxazole|mesh-list
65448902|NCT01101412|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64833621|NCT05553808|Docetaxel|docetaxel|mesh-list
64714839|NCT03154658|Sensory System Agents|sensory system agents|mesh-ancestor
64714840|NCT03154658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714841|NCT03098420|Dexamethasone|dexamethasone|mesh-list
64714842|NCT03098420|Dexamethasone acetate|dexamethasone acetate|mesh-list
64714843|NCT03098420|Morphine|morphine|mesh-list
64714844|NCT03098420|Bupivacaine|bupivacaine|mesh-list
64714845|NCT03098420|Ropivacaine|ropivacaine|mesh-list
64714846|NCT03098420|BB 1101|bb 1101|mesh-list
64675489|NCT01016847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64675490|NCT01016847|Respiratory System Agents|respiratory system agents|mesh-ancestor
64675491|NCT01016847|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64675492|NCT01016847|Hormone Antagonists|hormone antagonists|mesh-ancestor
64675493|NCT01016847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64675494|NCT01016847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675495|NCT01016847|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64675496|NCT01016847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64675497|NCT01016847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675498|NCT00989937|Oxytocin|oxytocin|mesh-list
64675499|NCT00989937|Oxytocics|oxytocics|mesh-ancestor
64675500|NCT00989937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64675501|NCT00989937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675502|NCT00982995|Palonosetron|palonosetron|mesh-list
64675503|NCT00982995|Antiemetics|antiemetics|mesh-ancestor
64675504|NCT00982995|Autonomic Agents|autonomic agents|mesh-ancestor
64675505|NCT00982995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675506|NCT00982995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448903|NCT01101412|Edetic Acid|edetic acid|mesh-list
65448904|NCT01101412|Calcium|calcium|mesh-list
65448905|NCT01101412|Pentetic Acid|pentetic acid|mesh-list
65448906|NCT01101412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65448907|NCT01101412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448908|NCT01101412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65448909|NCT01101412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65448910|NCT01101412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65448911|NCT01101412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65448912|NCT01101412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65448913|NCT01101412|Renal Agents|renal agents|mesh-ancestor
65448914|NCT01101412|Antimalarials|antimalarials|mesh-ancestor
65448915|NCT01101412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65448916|NCT01101412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65448917|NCT01101412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65448918|NCT01101412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448919|NCT01101412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448920|NCT01101412|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65448921|NCT01101412|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65448922|NCT01101412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65448923|NCT01101412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65448924|NCT01101412|Anticoagulants|anticoagulants|mesh-ancestor
65448925|NCT01101412|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65448926|NCT01101412|Chelating Agents|chelating agents|mesh-ancestor
65448927|NCT01101412|Sequestering Agents|sequestering agents|mesh-ancestor
65448928|NCT01101412|Antidotes|antidotes|mesh-ancestor
65448929|NCT01101412|Protective Agents|protective agents|mesh-ancestor
65448930|NCT01101412|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65448931|NCT03122717|Gefitinib|gefitinib|mesh-list
65448932|NCT03122717|Osimertinib|osimertinib|mesh-list
65448933|NCT03122717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675507|NCT00982995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64675508|NCT00982995|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64675509|NCT00982995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64675510|NCT00982995|Serotonin Agents|serotonin agents|mesh-ancestor
64675511|NCT00982995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64675512|NCT00982995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675513|NCT00965055|Atorvastatin|atorvastatin|mesh-list
64675514|NCT00965055|Ezetimibe|ezetimibe|mesh-list
64675515|NCT00965055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64675516|NCT00965055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64675517|NCT00965055|Antimetabolites|antimetabolites|mesh-ancestor
64675518|NCT00965055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675519|NCT00965055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65448934|NCT03122717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65448935|NCT03122717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448936|NCT03122717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448937|NCT00004888|Docetaxel|docetaxel|mesh-list
65448938|NCT00004888|Doxorubicin|doxorubicin|mesh-list
65448939|NCT00004888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65448940|NCT00004888|Trastuzumab|trastuzumab|mesh-list
65448941|NCT00004888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448942|NCT00004888|Tubulin Modulators|tubulin modulators|mesh-ancestor
65448943|NCT00004888|Antimitotic Agents|antimitotic agents|mesh-ancestor
65448944|NCT00004888|Mitosis Modulators|mitosis modulators|mesh-ancestor
65448945|NCT00004888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448946|NCT00004888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65448947|NCT00004888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65448948|NCT00004888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65448949|NCT00004888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448950|NCT00004888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65448951|NCT01098760|Sorafenib|sorafenib|mesh-list
65448952|NCT01098760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448953|NCT01098760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65448954|NCT01098760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448955|NCT01098760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448956|NCT03950830|Disulfiram|disulfiram|mesh-list
65448957|NCT03950830|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65448958|NCT03950830|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65448959|NCT03950830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448960|NCT03950830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448961|NCT00430781|Lapatinib|lapatinib|mesh-list
65448962|NCT00430781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448963|NCT00430781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65448964|NCT00430781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448965|NCT00430781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448966|NCT01033097|Betamethasone|betamethasone|mesh-list
65448967|NCT01033097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65448968|NCT01033097|Glucocorticoids|glucocorticoids|mesh-ancestor
65448969|NCT01033097|Hormones|hormones|mesh-ancestor
64833694|NCT05344911|Alfentanil|alfentanil|mesh-list
64675520|NCT00965055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65448970|NCT01033097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65448971|NCT01033097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448972|NCT01033097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65448973|NCT01033097|Respiratory System Agents|respiratory system agents|mesh-ancestor
65448974|NCT00429299|Paclitaxel|paclitaxel|mesh-list
65448975|NCT00429299|Cyclophosphamide|cyclophosphamide|mesh-list
65448976|NCT00429299|Fluorouracil|fluorouracil|mesh-list
65448977|NCT00429299|Trastuzumab|trastuzumab|mesh-list
65448978|NCT00429299|Lapatinib|lapatinib|mesh-list
65448979|NCT00429299|Epirubicin|epirubicin|mesh-list
65448980|NCT00429299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65448981|NCT00429299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65448982|NCT00429299|Tubulin Modulators|tubulin modulators|mesh-ancestor
65448983|NCT00429299|Antimitotic Agents|antimitotic agents|mesh-ancestor
64675521|NCT00965055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675522|NCT02266797|Dexamethasone|dexamethasone|mesh-list
64675523|NCT02266797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64675525|NCT02266797|Autonomic Agents|autonomic agents|mesh-ancestor
64675526|NCT02266797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675527|NCT02266797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675561|NCT00924807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675562|NCT00924807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675563|NCT00924807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64675564|NCT00924807|Fertility Agents|fertility agents|mesh-ancestor
64675565|NCT00924807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64675566|NCT00924807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675567|NCT00924807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64675587|NCT02162979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675588|NCT02162979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675589|NCT02162979|Urological Agents|urological agents|mesh-ancestor
64675590|NCT03734601|Mycophenolic Acid|mycophenolic acid|mesh-list
64675592|NCT03734601|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64675593|NCT03734601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64675594|NCT03734601|Immunologic Factors|immunologic factors|mesh-ancestor
64675595|NCT03734601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675596|NCT03734601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64675597|NCT03734601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675598|NCT03734601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714847|NCT03098420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64714849|NCT03098420|Autonomic Agents|autonomic agents|mesh-ancestor
64714850|NCT03098420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714851|NCT03098420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714852|NCT03098420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64714853|NCT03098420|Glucocorticoids|glucocorticoids|mesh-ancestor
64714854|NCT03098420|Hormones|hormones|mesh-ancestor
64714855|NCT03098420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64714856|NCT03098420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64714857|NCT03098420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64714858|NCT03098420|Protease Inhibitors|protease inhibitors|mesh-ancestor
64675599|NCT03734601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64675600|NCT03734601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675601|NCT03734601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64675602|NCT03734601|Antitubercular Agents|antitubercular agents|mesh-ancestor
64675603|NCT03734601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64675604|NCT03734601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64675605|NCT01908842|Buprenorphine|buprenorphine|mesh-list
64675606|NCT01908842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64675607|NCT01908842|Narcotics|narcotics|mesh-ancestor
64675608|NCT01908842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64675609|NCT01908842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675610|NCT01908842|Analgesics|analgesics|mesh-ancestor
65448984|NCT00429299|Mitosis Modulators|mitosis modulators|mesh-ancestor
65448985|NCT00429299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65448986|NCT00429299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65448987|NCT00429299|Immunologic Factors|immunologic factors|mesh-ancestor
65448988|NCT00429299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65448989|NCT00429299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65448990|NCT00429299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65448991|NCT00429299|Alkylating Agents|alkylating agents|mesh-ancestor
65448992|NCT00429299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65448993|NCT00429299|Antimetabolites|antimetabolites|mesh-ancestor
65448994|NCT00429299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64444910|NCT04481009|Paclitaxel|paclitaxel|mesh-list
64833729|NCT05265208|Capecitabine|capecitabine|mesh-list
64675611|NCT01908842|Sensory System Agents|sensory system agents|mesh-ancestor
64675612|NCT01908842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675613|NCT01908842|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64675614|NCT00833859|Gemcitabine|gemcitabine|mesh-list
64675615|NCT00833859|Capecitabine|capecitabine|mesh-list
64675616|NCT00833859|Docetaxel|docetaxel|mesh-list
64675617|NCT00833859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64675618|NCT00833859|Antimetabolites|antimetabolites|mesh-ancestor
64675638|NCT00832299|Immunologic Factors|immunologic factors|mesh-ancestor
64675639|NCT00832299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675640|NCT00832299|Antidotes|antidotes|mesh-ancestor
64675641|NCT00832299|Protective Agents|protective agents|mesh-ancestor
64675642|NCT00832299|Vitamin B Complex|vitamin b complex|mesh-ancestor
64675643|NCT00832299|Vitamins|vitamins|mesh-ancestor
64675644|NCT00832299|Micronutrients|micronutrients|mesh-ancestor
64675645|NCT03723447|Dexamethasone|dexamethasone|mesh-list
64675646|NCT03723447|Epinephrine|epinephrine|mesh-list
64675647|NCT03723447|Bupivacaine|bupivacaine|mesh-list
64675648|NCT03723447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64675649|NCT03723447|Antiemetics|antiemetics|mesh-ancestor
64675650|NCT03723447|Autonomic Agents|autonomic agents|mesh-ancestor
64675651|NCT03723447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675652|NCT03723447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675653|NCT03723447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64675654|NCT03723447|Glucocorticoids|glucocorticoids|mesh-ancestor
64675655|NCT03723447|Hormones|hormones|mesh-ancestor
64675656|NCT03723447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64675657|NCT03723447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64675658|NCT03723447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675659|NCT03723447|Anesthetics, Local|anesthetics, local|mesh-ancestor
64675662|NCT03723447|Sensory System Agents|sensory system agents|mesh-ancestor
64675663|NCT03723447|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64675664|NCT03723447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64675665|NCT03723447|Adrenergic Agents|adrenergic agents|mesh-ancestor
64675666|NCT03723447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64675667|NCT03723447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675668|NCT03723447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64675669|NCT03723447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64714859|NCT03098420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64714860|NCT03098420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714861|NCT03098420|Anesthetics, Local|anesthetics, local|mesh-ancestor
64714862|NCT03098420|Anesthetics|anesthetics|mesh-ancestor
64714863|NCT03098420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64714864|NCT03098420|Sensory System Agents|sensory system agents|mesh-ancestor
64714865|NCT03098420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64714866|NCT03098420|Narcotics|narcotics|mesh-ancestor
64714867|NCT03098420|Analgesics|analgesics|mesh-ancestor
64714868|NCT02878057|Apatinib|apatinib|mesh-list
64714869|NCT02878057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64714870|NCT02878057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64714871|NCT02878057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448995|NCT00429299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65448996|NCT00429299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65448997|NCT00429299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65448998|NCT00429299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65448999|NCT00429299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65449000|NCT00429299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65449001|NCT01033877|Vaccines|vaccines|mesh-list
65449002|NCT01033877|Immunologic Factors|immunologic factors|mesh-ancestor
65449003|NCT01033877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449004|NCT00428597|Sunitinib|sunitinib|mesh-list
65449005|NCT00428597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449006|NCT00428597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65449007|NCT00428597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65449008|NCT00428597|Growth Substances|growth substances|mesh-ancestor
65449009|NCT00428597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449010|NCT00428597|Growth Inhibitors|growth inhibitors|mesh-ancestor
65449011|NCT00428597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65449012|NCT00428597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449013|NCT00428597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449014|NCT01033955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65449015|NCT01033955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65449016|NCT01033955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65449017|NCT01033955|Antimetabolites|antimetabolites|mesh-ancestor
65449018|NCT01033955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449019|NCT01033955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65449020|NCT01033955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65449021|NCT01033955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449022|NCT00428441|Warfarin|warfarin|mesh-list
65449023|NCT00428441|Anticoagulants|anticoagulants|mesh-ancestor
65449024|NCT03994211|Itraconazole|itraconazole|mesh-list
65449025|NCT03994211|Rifampin|rifampin|mesh-list
64714872|NCT02878057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714873|NCT00422617|Alefacept|alefacept|mesh-list
64714874|NCT00422617|Dermatologic Agents|dermatologic agents|mesh-ancestor
64714875|NCT00422617|Immunologic Factors|immunologic factors|mesh-ancestor
64714876|NCT00422617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714877|NCT03104738|Insulin|insulin|mesh-list
64714878|NCT03104738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64714879|NCT03104738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714880|NCT03163472|Anesthetics|anesthetics|mesh-list
64714881|NCT03163472|Anesthetics, Local|anesthetics, local|mesh-list
64714882|NCT03163472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64323150|NCT02230735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65449026|NCT03994211|Antifungal Agents|antifungal agents|mesh-ancestor
65449027|NCT03994211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449028|NCT03994211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65198534|NCT01077713|Bevacizumab|bevacizumab|mesh-list
65449029|NCT03994211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65449030|NCT03994211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449031|NCT03994211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449032|NCT03994211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65449033|NCT03994211|Hormone Antagonists|hormone antagonists|mesh-ancestor
65449034|NCT03994211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65449035|NCT03994211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449036|NCT03994211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65449037|NCT03994211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65449038|NCT03994211|Antitubercular Agents|antitubercular agents|mesh-ancestor
65449039|NCT03994211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65449040|NCT03994211|Leprostatic Agents|leprostatic agents|mesh-ancestor
65449041|NCT03994211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65449042|NCT03994211|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65449043|NCT03994211|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65449044|NCT03994211|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65449045|NCT03994211|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65449046|NCT03994211|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65449047|NCT03994211|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65449048|NCT02488967|Paclitaxel|paclitaxel|mesh-list
65449049|NCT02488967|Cyclophosphamide|cyclophosphamide|mesh-list
64323152|NCT02230735|Mydriatics|mydriatics|mesh-ancestor
64675670|NCT03723447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64675671|NCT03723447|Respiratory System Agents|respiratory system agents|mesh-ancestor
64675672|NCT03723447|Mydriatics|mydriatics|mesh-ancestor
64675673|NCT03723447|Sympathomimetics|sympathomimetics|mesh-ancestor
64675674|NCT03723447|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64675675|NCT00836355|Minocycline|minocycline|mesh-list
64675676|NCT00836355|Enoxaparin|enoxaparin|mesh-list
64675697|NCT00823095|Antioxidants|antioxidants|mesh-ancestor
64675698|NCT00823095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675699|NCT00823095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64675700|NCT00823095|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64675701|NCT00823095|Vasodilator Agents|vasodilator agents|mesh-ancestor
64675702|NCT00823095|Gasotransmitters|gasotransmitters|mesh-ancestor
64675703|NCT00823095|Protective Agents|protective agents|mesh-ancestor
64675704|NCT00803283|Morphine|morphine|mesh-list
64675705|NCT00803283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64675706|NCT00803283|Narcotics|narcotics|mesh-ancestor
64675707|NCT00803283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64675708|NCT00803283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675709|NCT00803283|Analgesics|analgesics|mesh-ancestor
64675710|NCT00803283|Sensory System Agents|sensory system agents|mesh-ancestor
65449050|NCT02488967|Carboplatin|carboplatin|mesh-list
65449051|NCT02488967|Doxorubicin|doxorubicin|mesh-list
65449052|NCT02488967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65449053|NCT02488967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65449054|NCT02488967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65449055|NCT02488967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449056|NCT02488967|Tubulin Modulators|tubulin modulators|mesh-ancestor
65449057|NCT02488967|Antimitotic Agents|antimitotic agents|mesh-ancestor
65449058|NCT02488967|Mitosis Modulators|mitosis modulators|mesh-ancestor
65449059|NCT02488967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449060|NCT02488967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65449061|NCT02488967|Immunologic Factors|immunologic factors|mesh-ancestor
65449062|NCT02488967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449063|NCT02488967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65449064|NCT02488967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65449065|NCT02488967|Alkylating Agents|alkylating agents|mesh-ancestor
64675711|NCT00803283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675712|NCT03701295|Azacitidine|azacitidine|mesh-list
64675713|NCT03701295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64675714|NCT03701295|Antimetabolites|antimetabolites|mesh-ancestor
64714883|NCT03163472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714884|NCT03163472|Sensory System Agents|sensory system agents|mesh-ancestor
64714885|NCT03163472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714886|NCT04468568|Terbutaline|terbutaline|mesh-list
64714887|NCT04468568|Atosiban|atosiban|mesh-list
64714888|NCT04468568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64714889|NCT04468568|Autonomic Agents|autonomic agents|mesh-ancestor
64714890|NCT04468568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714891|NCT04468568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714892|NCT04468568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64714893|NCT04468568|Respiratory System Agents|respiratory system agents|mesh-ancestor
64714894|NCT04468568|Sympathomimetics|sympathomimetics|mesh-ancestor
64714895|NCT04468568|Tocolytic Agents|tocolytic agents|mesh-ancestor
64714896|NCT04468568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64675726|NCT00765765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64675727|NCT00765765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64675728|NCT00765765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64675729|NCT00765765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675736|NCT00760461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675737|NCT00760461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64675738|NCT00760461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64675739|NCT00760461|Dopamine Agents|dopamine agents|mesh-ancestor
64675740|NCT00760461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64675741|NCT00760461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675742|NCT00750555|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64675743|NCT00750555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675744|NCT00750555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64675745|NCT00750555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675746|NCT00750555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675747|NCT01941615|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64675748|NCT01941615|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
64675749|NCT01941615|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64675750|NCT01941615|Contraceptive Agents|contraceptive agents|mesh-ancestor
64714904|NCT04468568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64714905|NCT04393454|Sirolimus|sirolimus|mesh-list
64714906|NCT04393454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64714907|NCT04393454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449066|NCT02488967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65449067|NCT02488967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65449068|NCT02488967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65449069|NCT02488967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65449070|NCT02488967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449071|NCT00144339|Tiotropium Bromide|tiotropium bromide|mesh-list
65449072|NCT00144339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65449073|NCT00144339|Autonomic Agents|autonomic agents|mesh-ancestor
65449074|NCT00144339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65449075|NCT00144339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449076|NCT00144339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64833811|NCT05106192|Hormones|hormones|mesh-ancestor
64714908|NCT04393454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64714909|NCT04393454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64714910|NCT04393454|Antifungal Agents|antifungal agents|mesh-ancestor
64714911|NCT04393454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64714912|NCT04393454|Immunologic Factors|immunologic factors|mesh-ancestor
64714913|NCT04393454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714914|NCT03168308|Glycopyrrolate|glycopyrrolate|mesh-list
64714915|NCT03168308|Neostigmine|neostigmine|mesh-list
64714916|NCT03168308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64714917|NCT03168308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64714918|NCT03168308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714919|NCT03168308|Cholinergic Agents|cholinergic agents|mesh-ancestor
64714920|NCT03168308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64675764|NCT01901679|Analgesics|analgesics|mesh-ancestor
64675765|NCT01901679|Sensory System Agents|sensory system agents|mesh-ancestor
64675766|NCT01901679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675767|NCT01901679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675768|NCT01901679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64675769|NCT01901679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64675770|NCT01901679|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64675771|NCT01901679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64675772|NCT01901679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675773|NCT01901679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675774|NCT00688935|Melatonin|melatonin|mesh-list
64675775|NCT00688935|Antioxidants|antioxidants|mesh-ancestor
64675776|NCT00688935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675777|NCT00688935|Protective Agents|protective agents|mesh-ancestor
64675778|NCT00688935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675779|NCT00688935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64675780|NCT00684255|Fludarabine|fludarabine|mesh-list
64675781|NCT00684255|Busulfan|busulfan|mesh-list
64675782|NCT00684255|Alemtuzumab|alemtuzumab|mesh-list
64675785|NCT00684255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64675786|NCT00684255|Immunologic Factors|immunologic factors|mesh-ancestor
64675787|NCT00684255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714923|NCT03168308|Autonomic Agents|autonomic agents|mesh-ancestor
64714924|NCT03168308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714925|NCT03168308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64714926|NCT03168308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64714927|NCT03168308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64714928|NCT03109015|Sunitinib|sunitinib|mesh-list
64714929|NCT03109015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64714930|NCT03109015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64714931|NCT03109015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64714932|NCT03109015|Growth Substances|growth substances|mesh-ancestor
64714933|NCT03109015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714934|NCT03109015|Growth Inhibitors|growth inhibitors|mesh-ancestor
64714935|NCT03109015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64714936|NCT03109015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64714937|NCT03109015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714938|NCT03115177|Doxycycline|doxycycline|mesh-list
65449077|NCT00144339|Respiratory System Agents|respiratory system agents|mesh-ancestor
65449078|NCT00144339|Parasympatholytics|parasympatholytics|mesh-ancestor
65449079|NCT00144339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65449080|NCT00144339|Cholinergic Agents|cholinergic agents|mesh-ancestor
65449081|NCT00144339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65449082|NCT00144339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449083|NCT03967665|Acetylcysteine|acetylcysteine|mesh-list
65449084|NCT03967665|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65449085|NCT03967665|Antiviral Agents|antiviral agents|mesh-ancestor
65449086|NCT03967665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449087|NCT03967665|Expectorants|expectorants|mesh-ancestor
65449088|NCT03967665|Respiratory System Agents|respiratory system agents|mesh-ancestor
65449089|NCT03967665|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65449090|NCT03967665|Antioxidants|antioxidants|mesh-ancestor
65449091|NCT03967665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449092|NCT03967665|Protective Agents|protective agents|mesh-ancestor
65449093|NCT03967665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449094|NCT03967665|Antidotes|antidotes|mesh-ancestor
65449095|NCT00144027|Antipsychotic Agents|antipsychotic agents|mesh-list
65449096|NCT00144027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65449097|NCT00144027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65449098|NCT00144027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449099|NCT00144027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64714939|NCT03115177|Cefazolin|cefazolin|mesh-list
64714940|NCT03115177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64714941|NCT03115177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64714942|NCT03115177|Antimalarials|antimalarials|mesh-ancestor
64714943|NCT03115177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64714944|NCT03115177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64714945|NCT03174158|Nicotine|nicotine|mesh-list
64714948|NCT03174158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714949|NCT03174158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714950|NCT03174158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64714951|NCT03174158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64714952|NCT03174158|Cholinergic Agents|cholinergic agents|mesh-ancestor
64714953|NCT03174158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64714954|NCT03174158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714955|NCT03115801|Pembrolizumab|pembrolizumab|mesh-list
64714956|NCT03115801|Nivolumab|nivolumab|mesh-list
64714957|NCT03115801|Atezolizumab|atezolizumab|mesh-list
64714958|NCT03115801|Immunologic Factors|immunologic factors|mesh-list
64714959|NCT03115801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64714961|NCT03115801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64714962|NCT03115801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714963|NCT03115801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454280|NCT01911260|Chelating Agents|chelating agents|mesh-list
64714966|NCT00422708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714967|NCT05405257|Oxytocin|oxytocin|mesh-list
64714968|NCT05405257|Oxytocics|oxytocics|mesh-ancestor
64714969|NCT05405257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64714970|NCT05405257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714971|NCT03117517|Metformin|metformin|mesh-list
64714972|NCT03117517|Pioglitazone|pioglitazone|mesh-list
65449100|NCT00127803|Vaccines|vaccines|mesh-list
65449101|NCT00127803|Immunologic Factors|immunologic factors|mesh-ancestor
65449102|NCT00127803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449103|NCT01077999|Paclitaxel|paclitaxel|mesh-list
65449104|NCT01077999|Carboplatin|carboplatin|mesh-list
65449105|NCT01077999|Panitumumab|panitumumab|mesh-list
65449106|NCT01077999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65449107|NCT01077999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449108|NCT01077999|Tubulin Modulators|tubulin modulators|mesh-ancestor
65449109|NCT01077999|Antimitotic Agents|antimitotic agents|mesh-ancestor
65449110|NCT01077999|Mitosis Modulators|mitosis modulators|mesh-ancestor
65449111|NCT01077999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449112|NCT01077999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65449113|NCT01033409|Vaccines|vaccines|mesh-list
65449114|NCT01033409|Immunologic Factors|immunologic factors|mesh-ancestor
65449115|NCT01033409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449116|NCT01037465|Acetylcysteine|acetylcysteine|mesh-list
65449117|NCT01037465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65449118|NCT01037465|Antiviral Agents|antiviral agents|mesh-ancestor
65449119|NCT01037465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449120|NCT01037465|Expectorants|expectorants|mesh-ancestor
65449121|NCT01037465|Respiratory System Agents|respiratory system agents|mesh-ancestor
65449122|NCT01037465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65449123|NCT01037465|Antioxidants|antioxidants|mesh-ancestor
65449124|NCT01037465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449125|NCT01037465|Protective Agents|protective agents|mesh-ancestor
65449126|NCT01037465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833842|NCT04965077|Antibodies|antibodies|mesh-list
64714973|NCT03117517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64714974|NCT03117517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714975|NCT00375284|Pramipexole|pramipexole|mesh-list
64714976|NCT00375284|Antioxidants|antioxidants|mesh-ancestor
64714977|NCT00375284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714978|NCT00375284|Protective Agents|protective agents|mesh-ancestor
64714979|NCT00375284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714980|NCT00375284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64714981|NCT00375284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64714982|NCT00375284|Dopamine Agonists|dopamine agonists|mesh-ancestor
64714983|NCT00375284|Dopamine Agents|dopamine agents|mesh-ancestor
64714984|NCT00375284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64714985|NCT02966275|Glucagon|glucagon|mesh-list
64714986|NCT02966275|Pancrelipase|pancrelipase|mesh-list
64714987|NCT02966275|Pancreatin|pancreatin|mesh-list
64714988|NCT02966275|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64714989|NCT02966275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64714990|NCT02966275|Hormones|hormones|mesh-ancestor
64323252|NCT05746065|Antiviral Agents|antiviral agents|mesh-ancestor
64675788|NCT00684255|Alkylating Agents|alkylating agents|mesh-ancestor
64675789|NCT00684255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64675790|NCT00684255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65449127|NCT01037465|Antidotes|antidotes|mesh-ancestor
65449128|NCT01582425|Isavuconazole|isavuconazole|mesh-list
65449129|NCT01582425|Methadone|methadone|mesh-list
65449130|NCT01582425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65449131|NCT01582425|Narcotics|narcotics|mesh-ancestor
65449132|NCT01582425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65449133|NCT01582425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449134|NCT01582425|Analgesics|analgesics|mesh-ancestor
65449135|NCT01582425|Sensory System Agents|sensory system agents|mesh-ancestor
65449136|NCT01582425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65449137|NCT01582425|Antitussive Agents|antitussive agents|mesh-ancestor
65449138|NCT01582425|Respiratory System Agents|respiratory system agents|mesh-ancestor
65449139|NCT01582425|Antifungal Agents|antifungal agents|mesh-ancestor
64675791|NCT00684255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64675792|NCT00668265|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64675793|NCT00668265|Antidepressive Agents|antidepressive agents|mesh-ancestor
64675794|NCT00668265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64675795|NCT00668265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64675796|NCT00668265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64675797|NCT00668265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64675798|NCT00668265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675800|NCT01856361|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64675801|NCT01856361|Protease Inhibitors|protease inhibitors|mesh-ancestor
64675802|NCT01856361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675803|NCT01856361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714991|NCT02966275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64714992|NCT02966275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714993|NCT02966275|Incretins|incretins|mesh-ancestor
64714994|NCT04122170|Aspirin|aspirin|mesh-list
64714995|NCT04122170|Ticagrelor|ticagrelor|mesh-list
64714996|NCT04122170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64714997|NCT04122170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64714998|NCT04122170|Analgesics|analgesics|mesh-ancestor
64714999|NCT04122170|Sensory System Agents|sensory system agents|mesh-ancestor
64715000|NCT04122170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715001|NCT04122170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715002|NCT04122170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64715003|NCT04122170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64323286|NCT01131169|Vidarabine|vidarabine|mesh-list
64675804|NCT01856361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64675810|NCT00642603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675811|NCT00642603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64675812|NCT00642603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64675813|NCT00642603|Growth Substances|growth substances|mesh-ancestor
64675814|NCT00642603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675815|NCT00642603|Growth Inhibitors|growth inhibitors|mesh-ancestor
64675816|NCT00642603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64675817|NCT00642603|Antimetabolites|antimetabolites|mesh-ancestor
64675818|NCT00642603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675819|NCT00642603|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64675820|NCT00642603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64675821|NCT00642603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675822|NCT01841931|Buprenorphine|buprenorphine|mesh-list
64675823|NCT01841931|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64675824|NCT01841931|Naloxone|naloxone|mesh-list
64675825|NCT01841931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64675826|NCT01841931|Narcotics|narcotics|mesh-ancestor
64675827|NCT01841931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64675828|NCT01841931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675829|NCT01841931|Analgesics|analgesics|mesh-ancestor
64675830|NCT01841931|Sensory System Agents|sensory system agents|mesh-ancestor
64675831|NCT01841931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675832|NCT01841931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65449140|NCT01582425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449141|NCT00143403|Leucovorin|leucovorin|mesh-list
65449142|NCT00143403|Folic Acid|folic acid|mesh-list
65449143|NCT00143403|Irinotecan|irinotecan|mesh-list
65449144|NCT00143403|Fluorouracil|fluorouracil|mesh-list
65449145|NCT00143403|Levoleucovorin|levoleucovorin|mesh-list
65449146|NCT00143403|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65449147|NCT00143403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65449148|NCT00143403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449149|NCT00143403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449150|NCT00143403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833886|NCT04789616|Maraviroc|maraviroc|mesh-list
64675844|NCT00379509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675845|NCT00379509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64675846|NCT00379509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675847|NCT00379509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675848|NCT04706247|Anesthetics|anesthetics|mesh-list
64675849|NCT04706247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64675850|NCT04706247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675851|NCT00597909|Sodium Benzoate|sodium benzoate|mesh-list
64675852|NCT00597909|Phenylacetic acid|phenylacetic acid|mesh-list
64675853|NCT00597909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64675854|NCT00597909|Antimetabolites|antimetabolites|mesh-ancestor
64675855|NCT00597909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675856|NCT00597909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675857|NCT00597909|Antifungal Agents|antifungal agents|mesh-ancestor
64675858|NCT00597909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64675859|NCT00422955|Rosiglitazone|rosiglitazone|mesh-list
64675860|NCT00422955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64675861|NCT00422955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715004|NCT04122170|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64715005|NCT04122170|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64715006|NCT04122170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715007|NCT04122170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64715008|NCT04122170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64715009|NCT04122170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715010|NCT04122170|Antipyretics|antipyretics|mesh-ancestor
64715011|NCT04122170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64715012|NCT04122170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64715013|NCT04122170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64715014|NCT04122170|Purinergic Agents|purinergic agents|mesh-ancestor
64715015|NCT04122170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64715016|NCT03795350|Beclomethasone|beclomethasone|mesh-list
64715017|NCT03795350|Glycopyrrolate|glycopyrrolate|mesh-list
64715018|NCT03795350|Bromides|bromides|mesh-list
64715019|NCT03795350|Formoterol Fumarate|formoterol fumarate|mesh-list
64715020|NCT03795350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64715021|NCT03795350|Autonomic Agents|autonomic agents|mesh-ancestor
64715022|NCT03795350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715023|NCT03795350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715024|NCT03795350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64715025|NCT03795350|Respiratory System Agents|respiratory system agents|mesh-ancestor
64715026|NCT03795350|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64715027|NCT03795350|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64715028|NCT03795350|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64715048|NCT02222922|Fluconazole|fluconazole|mesh-list
64715049|NCT02222922|Avelumab|avelumab|mesh-list
64715050|NCT02222922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64715051|NCT02222922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715052|NCT02222922|Antifungal Agents|antifungal agents|mesh-ancestor
64715053|NCT02222922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64715054|NCT02222922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64715055|NCT02222922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64715056|NCT02222922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449151|NCT00143403|Antimetabolites|antimetabolites|mesh-ancestor
65449152|NCT00143403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65449153|NCT00143403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65449154|NCT00143403|Immunologic Factors|immunologic factors|mesh-ancestor
65449155|NCT00143403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449156|NCT00143403|Antidotes|antidotes|mesh-ancestor
65449157|NCT00143403|Protective Agents|protective agents|mesh-ancestor
65449158|NCT00143403|Vitamin B Complex|vitamin b complex|mesh-ancestor
65449159|NCT00143403|Vitamins|vitamins|mesh-ancestor
65449160|NCT00143403|Micronutrients|micronutrients|mesh-ancestor
65449161|NCT00143403|Hematinics|hematinics|mesh-ancestor
65449162|NCT00220701|Dexetimide|dexetimide|mesh-list
65449163|NCT00220701|Citalopram|citalopram|mesh-list
65449164|NCT00220701|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65449165|NCT00220701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65449166|NCT00220701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65449167|NCT00220701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449168|NCT00220701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65449169|NCT00220701|Serotonin Agents|serotonin agents|mesh-ancestor
65449170|NCT00220701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449171|NCT00220701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65449172|NCT00220701|Antidepressive Agents|antidepressive agents|mesh-ancestor
65449173|NCT00220701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65449174|NCT00220701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65449175|NCT00220701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65449176|NCT00220701|Parasympatholytics|parasympatholytics|mesh-ancestor
65449177|NCT00220701|Autonomic Agents|autonomic agents|mesh-ancestor
65449178|NCT00220701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65449179|NCT00220701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65449180|NCT00220701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64715057|NCT02222922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715058|NCT02222922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64715059|NCT02222922|Hormone Antagonists|hormone antagonists|mesh-ancestor
64715060|NCT02222922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64715061|NCT02222922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715062|NCT02222922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64675862|NCT00588471|Simvastatin|simvastatin|mesh-list
64675863|NCT00588471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64675864|NCT00588471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64675865|NCT00588471|Antimetabolites|antimetabolites|mesh-ancestor
64675866|NCT00588471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675867|NCT00588471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64675868|NCT00588471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65449181|NCT00220701|Cholinergic Agents|cholinergic agents|mesh-ancestor
65449182|NCT00127101|Vorinostat|vorinostat|mesh-list
65449183|NCT00127101|Bexarotene|bexarotene|mesh-list
65449184|NCT00127101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449185|NCT00127101|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65449186|NCT00127101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449187|NCT00127101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449188|NCT00126555|Gefitinib|gefitinib|mesh-list
65449189|NCT00126555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449190|NCT00126555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65449191|NCT00126555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449192|NCT00126555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449193|NCT00004228|Leucovorin|leucovorin|mesh-list
65449194|NCT00004228|Cytarabine|cytarabine|mesh-list
65449195|NCT00004228|Dexamethasone|dexamethasone|mesh-list
65449196|NCT00004228|Prednisone|prednisone|mesh-list
65449197|NCT00004228|Cyclophosphamide|cyclophosphamide|mesh-list
65449198|NCT00004228|Doxorubicin|doxorubicin|mesh-list
65449199|NCT00004228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65449200|NCT00004228|Methotrexate|methotrexate|mesh-list
65449201|NCT00004228|Vincristine|vincristine|mesh-list
65449202|NCT00004228|Daunorubicin|daunorubicin|mesh-list
65449203|NCT00004228|Asparaginase|asparaginase|mesh-list
64675869|NCT00588471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675870|NCT05600673|Bimatoprost|bimatoprost|mesh-list
64675871|NCT05600673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64675872|NCT01784991|Morphine|morphine|mesh-list
64675873|NCT01784991|Hydromorphone|hydromorphone|mesh-list
64675874|NCT01784991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64675875|NCT01784991|Narcotics|narcotics|mesh-ancestor
64675876|NCT01784991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64675877|NCT01784991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675878|NCT01784991|Analgesics|analgesics|mesh-ancestor
64675879|NCT01784991|Sensory System Agents|sensory system agents|mesh-ancestor
64675880|NCT01784991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675881|NCT01760889|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64675882|NCT01760889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64675883|NCT01760889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675884|NCT01760889|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64675915|NCT01691079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64675916|NCT01691079|Respiratory System Agents|respiratory system agents|mesh-ancestor
64675917|NCT01691079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64675918|NCT01691079|Cholinergic Agents|cholinergic agents|mesh-ancestor
64675919|NCT01691079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64675920|NCT01691079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675921|NCT01673061|Lidocaine|lidocaine|mesh-list
64675922|NCT01673061|Epinephrine|epinephrine|mesh-list
64675923|NCT01673061|Norflurane|norflurane|mesh-list
64675924|NCT01673061|Anesthetics, Local|anesthetics, local|mesh-ancestor
64675925|NCT01673061|Anesthetics|anesthetics|mesh-ancestor
64675926|NCT01673061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64675927|NCT01673061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675928|NCT01673061|Sensory System Agents|sensory system agents|mesh-ancestor
64715063|NCT02222922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64715064|NCT03503942|Metformin|metformin|mesh-list
64715065|NCT03503942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64715066|NCT03503942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449204|NCT00004228|Mercaptopurine|mercaptopurine|mesh-list
65449205|NCT00004228|Thioguanine|thioguanine|mesh-list
65449206|NCT00004228|Levoleucovorin|levoleucovorin|mesh-list
65449207|NCT00004228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65449208|NCT00004228|Immunologic Factors|immunologic factors|mesh-ancestor
65449209|NCT00004228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449210|NCT00004228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65449211|NCT00004228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65449212|NCT00004228|Alkylating Agents|alkylating agents|mesh-ancestor
65449213|NCT00004228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449214|NCT00004228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449215|NCT00004228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65449216|NCT00004228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65449217|NCT00004228|Antiemetics|antiemetics|mesh-ancestor
65449218|NCT00004228|Autonomic Agents|autonomic agents|mesh-ancestor
65449219|NCT00004228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715067|NCT03122587|Dihydrotachysterol|dihydrotachysterol|mesh-list
64715068|NCT03122587|Vitamins|vitamins|mesh-ancestor
64675929|NCT01673061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675960|NCT01598025|Fludarabine phosphate|fludarabine phosphate|mesh-list
64675961|NCT01598025|Melphalan|melphalan|mesh-list
64675962|NCT01598025|Thiotepa|thiotepa|mesh-list
64675963|NCT01598025|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64675964|NCT01598025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675965|NCT01598025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64675966|NCT01598025|Antimetabolites|antimetabolites|mesh-ancestor
64675967|NCT01598025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675968|NCT01598025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64675969|NCT01598025|Immunologic Factors|immunologic factors|mesh-ancestor
64675970|NCT01598025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675971|NCT01598025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64675972|NCT01598025|Alkylating Agents|alkylating agents|mesh-ancestor
64675973|NCT01598025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64675974|NCT01587963|Ascorbic Acid|ascorbic acid|mesh-list
64675975|NCT01587963|Antioxidants|antioxidants|mesh-ancestor
64675976|NCT01587963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675985|NCT05550519|Tenofovir|tenofovir|mesh-list
64675986|NCT05550519|Entecavir|entecavir|mesh-list
64675987|NCT05550519|Antiviral Agents|antiviral agents|mesh-ancestor
64675988|NCT05550519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64675989|NCT05550519|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64675990|NCT05550519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64675991|NCT05550519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675992|NCT05550519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675993|NCT05550519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64675994|NCT05550519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64675995|NCT01203371|Naftopidil|naftopidil|mesh-list
64675996|NCT01203371|Tamsulosin|tamsulosin|mesh-list
64675997|NCT01203371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64675998|NCT01203371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64675999|NCT01203371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64676000|NCT01203371|Adrenergic Agents|adrenergic agents|mesh-ancestor
64676001|NCT01203371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64676002|NCT01203371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676003|NCT01203371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676004|NCT01203371|Urological Agents|urological agents|mesh-ancestor
64676005|NCT01203371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64676006|NCT01203371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64676007|NCT01203371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64676008|NCT01203371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65449220|NCT00004228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65449221|NCT00004228|Glucocorticoids|glucocorticoids|mesh-ancestor
65449222|NCT00004228|Hormones|hormones|mesh-ancestor
65449223|NCT00004228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65449224|NCT00004228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65449225|NCT00004228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65449226|NCT00004228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65449227|NCT00004228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65449228|NCT00004228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449229|NCT00004228|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65449230|NCT00004228|Abortifacient Agents|abortifacient agents|mesh-ancestor
65449231|NCT00004228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65449232|NCT00004228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65449233|NCT00004228|Antimetabolites|antimetabolites|mesh-ancestor
65449234|NCT00004228|Dermatologic Agents|dermatologic agents|mesh-ancestor
65449235|NCT00004228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64833958|NCT04689945|Analgesics|analgesics|mesh-ancestor
64676009|NCT01203371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64676010|NCT01549977|Febuxostat|febuxostat|mesh-list
64676011|NCT01549977|Gout Suppressants|gout suppressants|mesh-ancestor
64676012|NCT01549977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64676013|NCT05494125|Ropivacaine|ropivacaine|mesh-list
64676014|NCT05494125|Anesthetics, Local|anesthetics, local|mesh-ancestor
64676015|NCT05494125|Anesthetics|anesthetics|mesh-ancestor
64676016|NCT05494125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64676017|NCT05494125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676018|NCT05494125|Sensory System Agents|sensory system agents|mesh-ancestor
64676019|NCT05494125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64676020|NCT00357617|Celecoxib|celecoxib|mesh-list
64676021|NCT00357617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64676022|NCT00357617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64676023|NCT00357617|Analgesics|analgesics|mesh-ancestor
64676024|NCT00357617|Sensory System Agents|sensory system agents|mesh-ancestor
64676025|NCT00357617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715071|NCT03122587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64715072|NCT05347771|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64715073|NCT05347771|Immunologic Factors|immunologic factors|mesh-ancestor
64715074|NCT05347771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715075|NCT04736966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64715076|NCT04736966|Immunologic Factors|immunologic factors|mesh-ancestor
64715077|NCT04736966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715078|NCT02161146|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64715079|NCT02161146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64676026|NCT00357617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676030|NCT00357617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64676031|NCT00357617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676032|NCT00357617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676033|NCT01548651|Saxagliptin|saxagliptin|mesh-list
64676034|NCT01548651|Incretins|incretins|mesh-ancestor
64676035|NCT01548651|Hormones|hormones|mesh-ancestor
64676036|NCT01548651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64676037|NCT01548651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676038|NCT01548651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64676050|NCT01533753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64676051|NCT01533753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64676052|NCT01533753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65449236|NCT00004228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65449237|NCT00004228|Antiviral Agents|antiviral agents|mesh-ancestor
65449238|NCT00004228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449239|NCT00004228|Antidotes|antidotes|mesh-ancestor
65449240|NCT00004228|Protective Agents|protective agents|mesh-ancestor
65449241|NCT00004228|Vitamin B Complex|vitamin b complex|mesh-ancestor
65449242|NCT00004228|Vitamins|vitamins|mesh-ancestor
65449243|NCT00004228|Micronutrients|micronutrients|mesh-ancestor
65449244|NCT00004228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64676053|NCT01533753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64676054|NCT01533753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64676055|NCT01533753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64676056|NCT01533753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64676057|NCT01533753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676058|NCT01533753|Antimanic Agents|antimanic agents|mesh-ancestor
64676059|NCT01533753|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64676060|NCT01533753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64676061|NCT01533753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64676062|NCT01533753|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64676063|NCT01533753|Antidepressive Agents|antidepressive agents|mesh-ancestor
64676064|NCT05722301|Methyltestosterone|methyltestosterone|mesh-list
64676066|NCT05722301|Testosterone undecanoate|testosterone undecanoate|mesh-list
64676067|NCT05722301|Testosterone enanthate|testosterone enanthate|mesh-list
64676068|NCT05722301|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64676069|NCT05722301|Androgens|androgens|mesh-ancestor
64676071|NCT05722301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64676072|NCT05722301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676073|NCT05722301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64676074|NCT05722301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676075|NCT05722301|Anabolic Agents|anabolic agents|mesh-ancestor
64676076|NCT01534143|Sirolimus|sirolimus|mesh-list
64676077|NCT01534143|Fludarabine|fludarabine|mesh-list
64676078|NCT01534143|Fludarabine phosphate|fludarabine phosphate|mesh-list
64676079|NCT01534143|Bortezomib|bortezomib|mesh-list
64676080|NCT01534143|Busulfan|busulfan|mesh-list
64676081|NCT01534143|Tacrolimus|tacrolimus|mesh-list
64676091|NCT01534143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676092|NCT01534143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64676093|NCT01534143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676094|NCT01534143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64676095|NCT01534143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64676096|NCT01534143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64676097|NCT01534143|Antifungal Agents|antifungal agents|mesh-ancestor
64676098|NCT01534143|Alkylating Agents|alkylating agents|mesh-ancestor
64676099|NCT01534143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64676100|NCT01534143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64676101|NCT05722067|Calcium|calcium|mesh-list
64676102|NCT05722067|Ionophores|ionophores|mesh-list
64715080|NCT02161146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64715081|NCT02161146|Analgesics|analgesics|mesh-ancestor
64715082|NCT02161146|Sensory System Agents|sensory system agents|mesh-ancestor
64715083|NCT02161146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715084|NCT02161146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715085|NCT02161146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64676103|NCT05722067|Calcium Ionophores|calcium ionophores|mesh-list
64676104|NCT05722067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64676105|NCT05722067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676106|NCT05722067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64676107|NCT05722067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676108|NCT01692171|Heparin|heparin|mesh-list
64676109|NCT01692171|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64676110|NCT01692171|Tinzaparin|tinzaparin|mesh-list
64676111|NCT01692171|Dalteparin|dalteparin|mesh-list
64676112|NCT01692171|Anticoagulants|anticoagulants|mesh-ancestor
64676113|NCT01692171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64676116|NCT05723315|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64676117|NCT05723315|Natriuretic Agents|natriuretic agents|mesh-ancestor
65449245|NCT00004228|Tubulin Modulators|tubulin modulators|mesh-ancestor
65449246|NCT00004228|Antimitotic Agents|antimitotic agents|mesh-ancestor
65449247|NCT00004228|Mitosis Modulators|mitosis modulators|mesh-ancestor
65449248|NCT01101568|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65449249|NCT01101568|Simvastatin|simvastatin|mesh-list
65449250|NCT01101568|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65449251|NCT01101568|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65449252|NCT01101568|Antimetabolites|antimetabolites|mesh-ancestor
65449253|NCT01101568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449254|NCT01101568|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64676118|NCT05723315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676120|NCT05721755|Cisplatin|cisplatin|mesh-list
64676121|NCT05721755|Carboplatin|carboplatin|mesh-list
64676153|NCT00570531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64676154|NCT00570531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64676155|NCT00570531|Immunologic Factors|immunologic factors|mesh-ancestor
64676156|NCT05258565|Plasminogen|plasminogen|mesh-list
64676157|NCT05258565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64676158|NCT05258565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64676159|NCT05258565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64676160|NCT05258565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676161|NCT05715437|Ketamine|ketamine|mesh-list
64676162|NCT05715437|Bupivacaine|bupivacaine|mesh-list
64676163|NCT05715437|Anesthetics, Local|anesthetics, local|mesh-ancestor
64676164|NCT05715437|Anesthetics|anesthetics|mesh-ancestor
64676196|NCT00523809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64676197|NCT00523809|Immunologic Factors|immunologic factors|mesh-ancestor
64676198|NCT00523809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64676199|NCT00523809|Alkylating Agents|alkylating agents|mesh-ancestor
64676200|NCT00523809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64676202|NCT00501345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64676203|NCT00501345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64676204|NCT00501345|Analgesics|analgesics|mesh-ancestor
64676222|NCT00487461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64676223|NCT00487461|Antimetabolites|antimetabolites|mesh-ancestor
64676224|NCT00487461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676225|NCT00487461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64676226|NCT00487461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64676227|NCT00487461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676228|NCT04972383|Hyaluronic Acid|hyaluronic acid|mesh-list
64676229|NCT04972383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64676230|NCT04972383|Immunologic Factors|immunologic factors|mesh-ancestor
64676231|NCT04972383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676232|NCT04972383|Viscosupplements|viscosupplements|mesh-ancestor
64676233|NCT04972383|Protective Agents|protective agents|mesh-ancestor
64676234|NCT00356187|Propranolol|propranolol|mesh-list
64676235|NCT00356187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64676236|NCT00356187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64676237|NCT00356187|Adrenergic Agents|adrenergic agents|mesh-ancestor
64676238|NCT00356187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64676239|NCT00356187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676240|NCT00356187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676241|NCT00356187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64676242|NCT00356187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64676243|NCT00356187|Vasodilator Agents|vasodilator agents|mesh-ancestor
64676244|NCT02224729|Dexamethasone|dexamethasone|mesh-list
64676245|NCT02224729|Bortezomib|bortezomib|mesh-list
64715086|NCT02161146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64715087|NCT02161146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64676246|NCT02224729|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64676247|NCT02224729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64676248|NCT02224729|Antiemetics|antiemetics|mesh-ancestor
64676249|NCT02224729|Autonomic Agents|autonomic agents|mesh-ancestor
64676250|NCT02224729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64676251|NCT02224729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676252|NCT02224729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65449255|NCT01101568|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65449256|NCT01101568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449257|NCT01087840|Tenofovir|tenofovir|mesh-list
65449258|NCT01087840|Emtricitabine|emtricitabine|mesh-list
65449259|NCT01087840|Raltegravir Potassium|raltegravir potassium|mesh-list
65449260|NCT01087840|Antiviral Agents|antiviral agents|mesh-ancestor
65449261|NCT01087840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449262|NCT01087840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65449263|NCT01087840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65449264|NCT01087840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449265|NCT01087840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449266|NCT01087840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65449267|NCT01087840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65449268|NCT01087840|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65449269|NCT01087840|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65449270|NCT01098994|Vitamin E|vitamin e|mesh-list
64676253|NCT02224729|Glucocorticoids|glucocorticoids|mesh-ancestor
64676254|NCT02224729|Hormones|hormones|mesh-ancestor
64676255|NCT02224729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64676289|NCT00271011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64676290|NCT00271011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676291|NCT00271011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676292|NCT00271011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676293|NCT00271011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64676294|NCT00271011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64676325|NCT00183963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64676326|NCT00183963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64676328|NCT00176631|Docetaxel|docetaxel|mesh-list
64676329|NCT00176631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676330|NCT00176631|Tubulin Modulators|tubulin modulators|mesh-ancestor
64676331|NCT00176631|Antimitotic Agents|antimitotic agents|mesh-ancestor
64676332|NCT00176631|Mitosis Modulators|mitosis modulators|mesh-ancestor
64676333|NCT00176631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676334|NCT05719961|Insulin|insulin|mesh-list
64676359|NCT04225611|Autonomic Agents|autonomic agents|mesh-ancestor
64676360|NCT04225611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64676361|NCT04225611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676362|NCT04225611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64676363|NCT04225611|Glucocorticoids|glucocorticoids|mesh-ancestor
64676364|NCT04225611|Hormones|hormones|mesh-ancestor
64676365|NCT04225611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64676366|NCT04225611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64676367|NCT04225611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676368|NCT00379977|Vaccines|vaccines|mesh-list
64676369|NCT00379977|Immunologic Factors|immunologic factors|mesh-ancestor
64676370|NCT00379977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676371|NCT05669885|Sildenafil Citrate|sildenafil citrate|mesh-list
64676372|NCT05669885|Vasodilator Agents|vasodilator agents|mesh-ancestor
64676373|NCT05669885|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64676374|NCT05669885|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64676375|NCT05669885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676376|NCT05669885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676377|NCT05669885|Urological Agents|urological agents|mesh-ancestor
64676378|NCT00955929|Sildenafil Citrate|sildenafil citrate|mesh-list
64676379|NCT00955929|Alprostadil|alprostadil|mesh-list
64676380|NCT00955929|Vasodilator Agents|vasodilator agents|mesh-ancestor
64676381|NCT00955929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64676382|NCT00955929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64834005|NCT04541173|Growth Inhibitors|growth inhibitors|mesh-ancestor
65449271|NCT01098994|Tocopherols|tocopherols|mesh-list
65449272|NCT01098994|alpha-Tocopherol|alpha-tocopherol|mesh-list
65449273|NCT01098994|Vitamins|vitamins|mesh-ancestor
65449274|NCT01098994|Micronutrients|micronutrients|mesh-ancestor
65449275|NCT01098994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449276|NCT01098994|Antioxidants|antioxidants|mesh-ancestor
65449277|NCT01098994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449278|NCT01098994|Protective Agents|protective agents|mesh-ancestor
65449279|NCT01099072|Methylphenidate|methylphenidate|mesh-list
65449280|NCT01099072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65449281|NCT01099072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449282|NCT01099072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65449283|NCT01099072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65449284|NCT01099072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65449285|NCT01099072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449286|NCT01099072|Dopamine Agents|dopamine agents|mesh-ancestor
65449287|NCT01099072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65449288|NCT00031486|Valacyclovir|valacyclovir|mesh-list
65449289|NCT00031486|Antiviral Agents|antiviral agents|mesh-ancestor
65449290|NCT00031486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449291|NCT01099150|Proanthocyanidin|proanthocyanidin|mesh-list
65449292|NCT01099150|Procyanidin|procyanidin|mesh-list
64834006|NCT04530747|Metformin|metformin|mesh-list
64676383|NCT00955929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676384|NCT00955929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676385|NCT00955929|Urological Agents|urological agents|mesh-ancestor
64676386|NCT00955929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64676387|NCT00357851|Aprotinin|aprotinin|mesh-list
64676423|NCT05663801|Sensory System Agents|sensory system agents|mesh-ancestor
64676424|NCT05663801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64676426|NCT05663801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64676427|NCT05663801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64676428|NCT05663801|Anesthetics, General|anesthetics, general|mesh-ancestor
64676429|NCT05663801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64676430|NCT05663801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64676437|NCT05663801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64676438|NCT05663801|Tocolytic Agents|tocolytic agents|mesh-ancestor
64676439|NCT05663801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64676441|NCT03866499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676442|NCT03866499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64676443|NCT03866499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715088|NCT02161146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64715090|NCT02161146|Histamine Antagonists|histamine antagonists|mesh-ancestor
64715091|NCT02161146|Histamine Agents|histamine agents|mesh-ancestor
64715092|NCT02161146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64715093|NCT02161146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715094|NCT03447782|Naltrexone|naltrexone|mesh-list
64715095|NCT03447782|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64715096|NCT03447782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65449293|NCT01099150|Antioxidants|antioxidants|mesh-ancestor
65449294|NCT01099150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449295|NCT01099150|Protective Agents|protective agents|mesh-ancestor
65449296|NCT01099150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449297|NCT01099150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65449298|NCT01099150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65449299|NCT01099150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449300|NCT02530060|Tenofovir|tenofovir|mesh-list
65449301|NCT02530060|Emtricitabine|emtricitabine|mesh-list
65449302|NCT02530060|Rilpivirine|rilpivirine|mesh-list
65449303|NCT02530060|Antiviral Agents|antiviral agents|mesh-ancestor
65449304|NCT02530060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449305|NCT02530060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65449306|NCT02530060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65449307|NCT02530060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449308|NCT02530060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449309|NCT02530060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65449310|NCT02530060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65449311|NCT01101646|Rabeprazole|rabeprazole|mesh-list
65449312|NCT01101646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65449313|NCT01101646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65449314|NCT01101646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65449315|NCT01101646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715097|NCT03447782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676444|NCT03866499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676445|NCT00000105|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64676446|NCT00000105|Freund's Adjuvant|freund's adjuvant|mesh-list
64676447|NCT00000105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64676448|NCT00000105|Immunologic Factors|immunologic factors|mesh-ancestor
64676449|NCT00000105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676450|NCT00000117|Immunoglobulins|immunoglobulins|mesh-list
64676451|NCT00000117|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64676452|NCT00000117|Antibodies|antibodies|mesh-list
64676453|NCT00000117|Immunologic Factors|immunologic factors|mesh-ancestor
64676454|NCT00000117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676455|NCT00000123|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
64676456|NCT00000123|Vasodilator Agents|vasodilator agents|mesh-ancestor
64332359|NCT03027388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676459|NCT00000123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676461|NCT00380133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64676462|NCT00380133|Glucocorticoids|glucocorticoids|mesh-ancestor
64676463|NCT00380133|Hormones|hormones|mesh-ancestor
64676464|NCT00380133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64676465|NCT00380133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676466|NCT00380133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64676467|NCT00380133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676468|NCT02959229|Lactoferrin|lactoferrin|mesh-list
64676469|NCT02959229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64676470|NCT02953665|Liraglutide|liraglutide|mesh-list
64676471|NCT02953665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64676472|NCT02953665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676473|NCT02953665|Incretins|incretins|mesh-ancestor
64676474|NCT02953665|Hormones|hormones|mesh-ancestor
65449316|NCT01101646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449317|NCT01101802|Mycophenolic Acid|mycophenolic acid|mesh-list
65449318|NCT01101802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65449319|NCT01101802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449320|NCT01101802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65449321|NCT01101802|Antitubercular Agents|antitubercular agents|mesh-ancestor
65449322|NCT01101802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65449323|NCT01101802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449324|NCT01101802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449325|NCT01101802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449326|NCT01099228|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65449327|NCT01099228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449328|NCT01099228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449329|NCT01099228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834047|NCT04456296|Anabolic Agents|anabolic agents|mesh-ancestor
64676475|NCT02953665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64676476|NCT00000189|Gepirone|gepirone|mesh-list
64676477|NCT00000189|Antidepressive Agents|antidepressive agents|mesh-ancestor
64676478|NCT00000189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64676479|NCT00000189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64676480|NCT00000189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64676496|NCT02681211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676497|NCT02681211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64676499|NCT02681211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64676500|NCT02681211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676501|NCT02681211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676502|NCT02681211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64676503|NCT02681211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64676504|NCT02681211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64676505|NCT02681211|Anesthetics, Local|anesthetics, local|mesh-ancestor
64676506|NCT02681211|Anesthetics|anesthetics|mesh-ancestor
64676507|NCT02681211|Antiemetics|antiemetics|mesh-ancestor
64401867|NCT04447235|Ivermectin|ivermectin|mesh-list
64676508|NCT02681211|Autonomic Agents|autonomic agents|mesh-ancestor
64676509|NCT02681211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64676510|NCT02681211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64676511|NCT02681211|Histamine Antagonists|histamine antagonists|mesh-ancestor
64676512|NCT02681211|Histamine Agents|histamine agents|mesh-ancestor
64715099|NCT03447782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715100|NCT03123055|Pembrolizumab|pembrolizumab|mesh-list
64715101|NCT03123055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64715102|NCT03123055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715103|NCT02969317|Tiotropium Bromide|tiotropium bromide|mesh-list
64715104|NCT02969317|Olodaterol|olodaterol|mesh-list
64715105|NCT02969317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64715106|NCT02969317|Autonomic Agents|autonomic agents|mesh-ancestor
64715107|NCT02969317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715108|NCT02969317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715109|NCT02969317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64715110|NCT02969317|Respiratory System Agents|respiratory system agents|mesh-ancestor
64715111|NCT02969317|Parasympatholytics|parasympatholytics|mesh-ancestor
64715112|NCT02969317|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64715113|NCT02969317|Cholinergic Agents|cholinergic agents|mesh-ancestor
64454506|NCT01910402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64715115|NCT02969317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715116|NCT00375362|Nitroglycerin|nitroglycerin|mesh-list
64715117|NCT00375362|Vasodilator Agents|vasodilator agents|mesh-ancestor
64715118|NCT05347082|Cholecalciferol|cholecalciferol|mesh-list
65449330|NCT01099228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65449331|NCT01088230|Botulinum Toxins|botulinum toxins|mesh-list
65449332|NCT01088230|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65449333|NCT01088230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65449334|NCT01088230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449335|NCT01088230|Cholinergic Agents|cholinergic agents|mesh-ancestor
65449336|NCT01088230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65449337|NCT01088230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449338|NCT01099462|Ibuprofen|ibuprofen|mesh-list
65449339|NCT01099462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65449340|NCT01099462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65449341|NCT01099462|Analgesics|analgesics|mesh-ancestor
65449342|NCT01099462|Sensory System Agents|sensory system agents|mesh-ancestor
65449343|NCT01099462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65449344|NCT01099462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449345|NCT01099462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64834063|NCT04332744|Talazoparib|talazoparib|mesh-list
64715119|NCT05347082|Vitamin D|vitamin d|mesh-list
64715120|NCT05347082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64715121|NCT05347082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715122|NCT05347082|Vitamins|vitamins|mesh-ancestor
64715123|NCT05347082|Micronutrients|micronutrients|mesh-ancestor
64715124|NCT05347082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64715125|NCT04736420|Warfarin|warfarin|mesh-list
64676513|NCT02681211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64676514|NCT02681211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64676515|NCT02681211|Antipruritics|antipruritics|mesh-ancestor
64676516|NCT02681211|Dermatologic Agents|dermatologic agents|mesh-ancestor
64676517|NCT02681211|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64676518|NCT02681211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64676522|NCT00000195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64676523|NCT00000195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676524|NCT00000195|Sensory System Agents|sensory system agents|mesh-ancestor
64676529|NCT05688371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64676530|NCT05688371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676531|NCT05688371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64676532|NCT05688371|Analgesics|analgesics|mesh-ancestor
64676533|NCT05688371|Sensory System Agents|sensory system agents|mesh-ancestor
64676534|NCT05688371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715126|NCT04736420|Rivaroxaban|rivaroxaban|mesh-list
64715127|NCT04736420|Anticoagulants|anticoagulants|mesh-ancestor
64715128|NCT04736420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64715129|NCT04736420|Antithrombins|antithrombins|mesh-ancestor
64715130|NCT04736420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64715131|NCT04736420|Protease Inhibitors|protease inhibitors|mesh-ancestor
64715132|NCT04736420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715133|NCT04736420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715134|NCT03087578|Mirabegron|mirabegron|mesh-list
64715135|NCT03087578|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64715136|NCT03087578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64323420|NCT03659929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676535|NCT05688371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64676536|NCT05688371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64676537|NCT05688371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64676538|NCT05688371|Adrenergic Agents|adrenergic agents|mesh-ancestor
64676539|NCT05688371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64676540|NCT05688371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449346|NCT01099462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65449347|NCT01099462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65449348|NCT01099462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449349|NCT01099462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449350|NCT00003298|Leucovorin|leucovorin|mesh-list
65449351|NCT00003298|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
65449352|NCT00003298|Tetrahydrofolates|tetrahydrofolates|mesh-list
65449353|NCT00003298|Paclitaxel|paclitaxel|mesh-list
65449354|NCT00003298|Cisplatin|cisplatin|mesh-list
65449355|NCT00003298|Fluorouracil|fluorouracil|mesh-list
65449356|NCT00003298|Calcium|calcium|mesh-list
65449357|NCT00003298|Levoleucovorin|levoleucovorin|mesh-list
65449358|NCT00003298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64676541|NCT05688371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64676542|NCT05688371|Narcotics|narcotics|mesh-ancestor
64676543|NCT00000201|Selegiline|selegiline|mesh-list
64676544|NCT00000201|Antidepressive Agents|antidepressive agents|mesh-ancestor
64676545|NCT00000201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64676546|NCT00000201|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64676547|NCT00000201|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64676548|NCT00000201|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64676549|NCT00000201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676550|NCT00000201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676551|NCT00000201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64676552|NCT00000201|Protective Agents|protective agents|mesh-ancestor
64676553|NCT00000201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676554|NCT00000207|Buprenorphine|buprenorphine|mesh-list
64676555|NCT00000207|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64676556|NCT00000207|Narcotics|narcotics|mesh-ancestor
64676557|NCT00000207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64676558|NCT00000207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676559|NCT00000207|Analgesics|analgesics|mesh-ancestor
64676560|NCT00000207|Sensory System Agents|sensory system agents|mesh-ancestor
64676561|NCT00000207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64676562|NCT00000207|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64676563|NCT02295774|Methylene Blue|methylene blue|mesh-list
64676564|NCT02295774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676565|NCT02295774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676566|NCT01807611|Mycophenolic Acid|mycophenolic acid|mesh-list
64676567|NCT01807611|Cyclophosphamide|cyclophosphamide|mesh-list
64676568|NCT01807611|Melphalan|melphalan|mesh-list
64676569|NCT01807611|Mechlorethamine|mechlorethamine|mesh-list
64676570|NCT01807611|Thiotepa|thiotepa|mesh-list
64676571|NCT01807611|Fludarabine|fludarabine|mesh-list
64676572|NCT01807611|Lenograstim|lenograstim|mesh-list
64676573|NCT01807611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64676574|NCT01807611|Immunologic Factors|immunologic factors|mesh-ancestor
64676575|NCT01807611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676576|NCT01807611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64676577|NCT01807611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64676578|NCT01807611|Alkylating Agents|alkylating agents|mesh-ancestor
64676599|NCT01692717|Atorvastatin|atorvastatin|mesh-list
64676600|NCT01692717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64676601|NCT01692717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64676602|NCT01692717|Antimetabolites|antimetabolites|mesh-ancestor
64676603|NCT01692717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676604|NCT01692717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64715138|NCT03087578|Adrenergic Agents|adrenergic agents|mesh-ancestor
64715139|NCT03087578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64715140|NCT03087578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715141|NCT03087578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715142|NCT03087578|Urological Agents|urological agents|mesh-ancestor
64715143|NCT02807558|Azacitidine|azacitidine|mesh-list
64715144|NCT02807558|Daratumumab|daratumumab|mesh-list
64715145|NCT02807558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64715146|NCT02807558|Antimetabolites|antimetabolites|mesh-ancestor
65449359|NCT00003298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449360|NCT00003298|Tubulin Modulators|tubulin modulators|mesh-ancestor
65449361|NCT00003298|Antimitotic Agents|antimitotic agents|mesh-ancestor
65449362|NCT00003298|Mitosis Modulators|mitosis modulators|mesh-ancestor
65449363|NCT00003298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449364|NCT00003298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65449365|NCT00003298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449366|NCT00003298|Antimetabolites|antimetabolites|mesh-ancestor
65449367|NCT00003298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65449368|NCT00003298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65449369|NCT00003298|Immunologic Factors|immunologic factors|mesh-ancestor
65449370|NCT00003298|Antidotes|antidotes|mesh-ancestor
65449371|NCT00003298|Protective Agents|protective agents|mesh-ancestor
65449372|NCT00003298|Vitamin B Complex|vitamin b complex|mesh-ancestor
64715147|NCT02807558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715148|NCT02807558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676606|NCT01692717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676607|NCT01692717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64676608|NCT01692717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64676609|NCT01692717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64676610|NCT01692717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64676611|NCT01692717|Diuretics|diuretics|mesh-ancestor
64676612|NCT01692717|Natriuretic Agents|natriuretic agents|mesh-ancestor
64676613|NCT01692717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676614|NCT01692717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64676615|NCT01692717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64676616|NCT00355277|Amitriptyline|amitriptyline|mesh-list
64676617|NCT00355277|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64676618|NCT00355277|Antidepressive Agents|antidepressive agents|mesh-ancestor
64676619|NCT00355277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64676620|NCT00355277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64676621|NCT00355277|Analgesics|analgesics|mesh-ancestor
64676649|NCT00000219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64676650|NCT00000219|Narcotics|narcotics|mesh-ancestor
64676651|NCT00000219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64676652|NCT00000219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676653|NCT00000219|Analgesics|analgesics|mesh-ancestor
64676654|NCT00000219|Sensory System Agents|sensory system agents|mesh-ancestor
64676655|NCT00000219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64676656|NCT00000219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64676657|NCT00000225|Buprenorphine|buprenorphine|mesh-list
64676658|NCT00000225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64676659|NCT00000225|Narcotics|narcotics|mesh-ancestor
64676660|NCT00000225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64676661|NCT00000225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676662|NCT00000225|Analgesics|analgesics|mesh-ancestor
64676663|NCT00000225|Sensory System Agents|sensory system agents|mesh-ancestor
64676664|NCT00000225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64676665|NCT00000225|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64676676|NCT01645176|Hydroxychloroquine|hydroxychloroquine|mesh-list
64676677|NCT01645176|Atorvastatin|atorvastatin|mesh-list
64676678|NCT01645176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64676679|NCT01645176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64676680|NCT01645176|Antimetabolites|antimetabolites|mesh-ancestor
64676681|NCT01645176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676682|NCT01645176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64676683|NCT01645176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64676684|NCT01645176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676685|NCT01645176|Antimalarials|antimalarials|mesh-ancestor
64676686|NCT01645176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65449373|NCT00003298|Vitamins|vitamins|mesh-ancestor
65449374|NCT00003298|Micronutrients|micronutrients|mesh-ancestor
65449375|NCT03960970|Azithromycin|azithromycin|mesh-list
65449376|NCT03960970|Cefoxitin|cefoxitin|mesh-list
65449377|NCT03960970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65449378|NCT03960970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449379|NCT00002842|Leucovorin|leucovorin|mesh-list
65449380|NCT00002842|Fluorouracil|fluorouracil|mesh-list
65449381|NCT00002842|Floxuridine|floxuridine|mesh-list
65449382|NCT00002842|Calcium|calcium|mesh-list
65449383|NCT00002842|Levoleucovorin|levoleucovorin|mesh-list
65449384|NCT00002842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65449385|NCT00002842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449386|NCT00002842|Antimetabolites|antimetabolites|mesh-ancestor
65449387|NCT00002842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449388|NCT00002842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65449389|NCT00002842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449390|NCT00002842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65449391|NCT00002842|Immunologic Factors|immunologic factors|mesh-ancestor
64676687|NCT01645176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64676688|NCT01645176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64676689|NCT01645176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64676690|NCT03465735|Heparin|heparin|mesh-list
64676691|NCT03465735|Enoxaparin|enoxaparin|mesh-list
64676692|NCT03465735|Dalteparin|dalteparin|mesh-list
64676693|NCT03465735|Warfarin|warfarin|mesh-list
64676694|NCT03465735|Rivaroxaban|rivaroxaban|mesh-list
64715149|NCT02807558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715151|NCT05324384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64715152|NCT05324384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64715153|NCT05324384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64715154|NCT05324384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715155|NCT05324384|Antifungal Agents|antifungal agents|mesh-ancestor
64715156|NCT05324384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64715157|NCT05324384|Immunologic Factors|immunologic factors|mesh-ancestor
64715158|NCT05324384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715161|NCT02975557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64715162|NCT02975557|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64715163|NCT02975557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64715164|NCT02975557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64715165|NCT02975557|Adrenergic Agents|adrenergic agents|mesh-ancestor
64715166|NCT02975557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64715167|NCT02975557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715168|NCT02975557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715169|NCT02975557|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64715170|NCT02975557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64715171|NCT04736810|Gemcitabine|gemcitabine|mesh-list
64715172|NCT04736810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715173|NCT04736810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64715174|NCT04736810|Antimetabolites|antimetabolites|mesh-ancestor
64323447|NCT02232685|Choline|choline|mesh-list
64676695|NCT03465735|Dabigatran|dabigatran|mesh-list
64676696|NCT03465735|Apixaban|apixaban|mesh-list
64676697|NCT03465735|Edoxaban|edoxaban|mesh-list
64676698|NCT03465735|Anticoagulants|anticoagulants|mesh-ancestor
64676699|NCT03465735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64676700|NCT03465735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64676701|NCT03465735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676702|NCT03465735|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64676703|NCT03465735|Antithrombins|antithrombins|mesh-ancestor
64676704|NCT03465735|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65449392|NCT00002842|Antidotes|antidotes|mesh-ancestor
65449393|NCT00002842|Protective Agents|protective agents|mesh-ancestor
65449394|NCT00002842|Vitamin B Complex|vitamin b complex|mesh-ancestor
65449395|NCT00002842|Vitamins|vitamins|mesh-ancestor
65449396|NCT00002842|Micronutrients|micronutrients|mesh-ancestor
65449397|NCT00143247|Insulin|insulin|mesh-list
65449398|NCT00143247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65449399|NCT00143247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449400|NCT00125853|Atenolol|atenolol|mesh-list
65449401|NCT00125853|Nebivolol|nebivolol|mesh-list
65449402|NCT00125853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65449403|NCT00125853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65449404|NCT00125853|Sympatholytics|sympatholytics|mesh-ancestor
65449405|NCT00125853|Autonomic Agents|autonomic agents|mesh-ancestor
65449406|NCT00125853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65198910|NCT03925194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65449407|NCT00125853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449408|NCT00125853|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65449409|NCT00125853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65449410|NCT00125853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65449411|NCT00125853|Adrenergic Agents|adrenergic agents|mesh-ancestor
64834120|NCT04002115|Cyclophosphamide|cyclophosphamide|mesh-list
64834121|NCT04002115|Busulfan|busulfan|mesh-list
64676705|NCT03465735|Protease Inhibitors|protease inhibitors|mesh-ancestor
64676706|NCT03465735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676707|NCT05637671|Paroxetine|paroxetine|mesh-list
64676708|NCT05637671|Oxybutynin|oxybutynin|mesh-list
64676709|NCT05637671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64676710|NCT05637671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64676711|NCT05637671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64676712|NCT05637671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676713|NCT05637671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64676714|NCT05637671|Serotonin Agents|serotonin agents|mesh-ancestor
64676715|NCT05637671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715175|NCT04736810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715177|NCT04736810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64715178|NCT04736810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715179|NCT04736810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64715180|NCT04736810|Immunologic Factors|immunologic factors|mesh-ancestor
64715181|NCT04736810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715182|NCT03132571|Naltrexone|naltrexone|mesh-list
64715183|NCT03132571|Bupropion|bupropion|mesh-list
64715184|NCT03132571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64715185|NCT03132571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64715186|NCT03132571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715187|NCT03132571|Sensory System Agents|sensory system agents|mesh-ancestor
64715188|NCT03132571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715189|NCT03132571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64715190|NCT03132571|Antidepressive Agents|antidepressive agents|mesh-ancestor
64715191|NCT03132571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64715192|NCT03132571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64715193|NCT03132571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64715194|NCT03132571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64715195|NCT03132571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449412|NCT00125853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65449413|NCT00125853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449414|NCT00125853|Vasodilator Agents|vasodilator agents|mesh-ancestor
65449415|NCT00125853|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65449416|NCT00125853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65449417|NCT00125853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65449418|NCT00219141|Losartan|losartan|mesh-list
65449419|NCT00219141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65449420|NCT00219141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65449421|NCT00219141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65449422|NCT00219141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64834140|NCT04002115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64715196|NCT03132571|Dopamine Agents|dopamine agents|mesh-ancestor
64715197|NCT03132571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64715198|NCT03132571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64715199|NCT03132571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64715200|NCT03132571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715201|NCT05267054|Rituximab|rituximab|mesh-list
64715202|NCT05267054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64323469|NCT04294784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676716|NCT05637671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64676717|NCT05637671|Antidepressive Agents|antidepressive agents|mesh-ancestor
64676718|NCT05637671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64676719|NCT05637671|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64676720|NCT05637671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64676721|NCT05637671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676732|NCT02322216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64676733|NCT02322216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64676734|NCT02322216|Analgesics|analgesics|mesh-ancestor
64676735|NCT02322216|Sensory System Agents|sensory system agents|mesh-ancestor
64715203|NCT05267054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715204|NCT05267054|Immunologic Factors|immunologic factors|mesh-ancestor
64715205|NCT05267054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715206|NCT05267054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64715207|NCT02374424|Obinutuzumab|obinutuzumab|mesh-list
64715208|NCT02374424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64715209|NCT02374424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715210|NCT04964089|Aflibercept|aflibercept|mesh-list
64715211|NCT04964089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64715212|NCT04964089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64715213|NCT04964089|Growth Substances|growth substances|mesh-ancestor
64715214|NCT04964089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715215|NCT04964089|Growth Inhibitors|growth inhibitors|mesh-ancestor
64715216|NCT04964089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323504|NCT02262637|Diuretics|diuretics|mesh-ancestor
64676736|NCT02322216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64676737|NCT02322216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676738|NCT02322216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64676739|NCT02322216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64676740|NCT02322216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64676741|NCT02322216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64676742|NCT02322216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64676743|NCT02322216|Histamine Antagonists|histamine antagonists|mesh-ancestor
64676744|NCT02322216|Histamine Agents|histamine agents|mesh-ancestor
64676745|NCT02322216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64676746|NCT02322216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676747|NCT03447639|Povidone-Iodine|povidone-iodine|mesh-list
64676748|NCT03447639|Povidone|povidone|mesh-list
64676749|NCT03447639|Plasma Substitutes|plasma substitutes|mesh-ancestor
64676750|NCT03447639|Blood Substitutes|blood substitutes|mesh-ancestor
65449423|NCT00219141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449424|NCT03971487|Ocrelizumab|ocrelizumab|mesh-list
65449425|NCT03971487|Immunologic Factors|immunologic factors|mesh-ancestor
65449426|NCT03971487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449427|NCT00233948|Nelfinavir|nelfinavir|mesh-list
65449428|NCT00233948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65449429|NCT00233948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65449430|NCT00233948|Protease Inhibitors|protease inhibitors|mesh-ancestor
65449431|NCT00233948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449432|NCT00233948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449433|NCT00233948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65449434|NCT00233948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64676751|NCT03447639|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64676752|NCT03447639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64676753|NCT03425799|Tranexamic Acid|tranexamic acid|mesh-list
64676754|NCT03425799|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64676755|NCT03425799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64676756|NCT03425799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676757|NCT03425799|Hemostatics|hemostatics|mesh-ancestor
64676758|NCT03425799|Coagulants|coagulants|mesh-ancestor
64676759|NCT03363633|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
64676760|NCT03363633|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64676761|NCT03363633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64676762|NCT03360903|Caffeine|caffeine|mesh-list
64676763|NCT03360903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64676764|NCT03360903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676765|NCT03360903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64676766|NCT03360903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676767|NCT03360903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676768|NCT03360903|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64676769|NCT03360903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64676770|NCT03360903|Purinergic Agents|purinergic agents|mesh-ancestor
64676771|NCT03360903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64676772|NCT00000231|Buprenorphine|buprenorphine|mesh-list
64676773|NCT00000231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64676774|NCT00000231|Narcotics|narcotics|mesh-ancestor
64676775|NCT00000231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64676776|NCT00000231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676777|NCT00000231|Analgesics|analgesics|mesh-ancestor
64676778|NCT00000231|Sensory System Agents|sensory system agents|mesh-ancestor
64676779|NCT00000231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64676780|NCT00000231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64715218|NCT02002130|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
64715219|NCT02002130|Butyric Acid|butyric acid|mesh-list
64715220|NCT02002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64715221|NCT02002130|Immunologic Factors|immunologic factors|mesh-ancestor
64715222|NCT02002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715223|NCT02002130|GABA Agents|gaba agents|mesh-ancestor
64715224|NCT02002130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64715225|NCT02002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715226|NCT02002130|Histamine Antagonists|histamine antagonists|mesh-ancestor
64715228|NCT01306994|Adenosine|adenosine|mesh-list
64715229|NCT01306994|Analgesics|analgesics|mesh-ancestor
64715230|NCT01306994|Sensory System Agents|sensory system agents|mesh-ancestor
64676781|NCT00000237|Buprenorphine|buprenorphine|mesh-list
64676782|NCT00000237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64676783|NCT00000237|Narcotics|narcotics|mesh-ancestor
64676784|NCT00000237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64676794|NCT00000765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64676795|NCT00000765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676796|NCT00000765|Antiviral Agents|antiviral agents|mesh-ancestor
64676797|NCT00000765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64676798|NCT00000765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65449435|NCT00233948|Antiviral Agents|antiviral agents|mesh-ancestor
65449436|NCT00233948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449437|NCT00233480|Atorvastatin|atorvastatin|mesh-list
65449438|NCT00233480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65449439|NCT00233480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65449440|NCT00233480|Antimetabolites|antimetabolites|mesh-ancestor
65449441|NCT00233480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449442|NCT00233480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65449443|NCT00233480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65449444|NCT00233480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449445|NCT03801928|Infliximab|infliximab|mesh-list
65449446|NCT03801928|Dermatologic Agents|dermatologic agents|mesh-ancestor
65449447|NCT03801928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65449448|NCT03801928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65449449|NCT02530918|Ranibizumab|ranibizumab|mesh-list
65449450|NCT02530918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65449451|NCT02530918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65449452|NCT02530918|Growth Substances|growth substances|mesh-ancestor
65449453|NCT02530918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449454|NCT02530918|Growth Inhibitors|growth inhibitors|mesh-ancestor
65449455|NCT02530918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449456|NCT03950518|Levamisole|levamisole|mesh-list
65449457|NCT03950518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65449458|NCT03950518|Immunologic Factors|immunologic factors|mesh-ancestor
65449459|NCT03950518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449460|NCT03950518|Antinematodal Agents|antinematodal agents|mesh-ancestor
65449461|NCT03950518|Anthelmintics|anthelmintics|mesh-ancestor
65449462|NCT03950518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65449463|NCT03950518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449464|NCT03950518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65449465|NCT01100164|Eszopiclone|eszopiclone|mesh-list
65449466|NCT01100164|Zopiclone|zopiclone|mesh-list
64676799|NCT00000765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64676801|NCT00000243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64676802|NCT00000243|Narcotics|narcotics|mesh-ancestor
64676803|NCT00000243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64676804|NCT00000243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676805|NCT00000243|Analgesics|analgesics|mesh-ancestor
64676806|NCT00000243|Sensory System Agents|sensory system agents|mesh-ancestor
64676807|NCT00000243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64676808|NCT00000243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64676809|NCT00000771|Paromomycin|paromomycin|mesh-list
64676810|NCT00000771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64676812|NCT00000771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64676813|NCT00000771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65449467|NCT01100164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65449468|NCT01100164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65449469|NCT01100164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449470|NCT01102114|Vaccines|vaccines|mesh-list
65449471|NCT01102114|Immunologic Factors|immunologic factors|mesh-ancestor
65449472|NCT01102114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449473|NCT01327222|Bevacizumab|bevacizumab|mesh-list
65449474|NCT01327222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65449475|NCT01327222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449476|NCT01327222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65449477|NCT01327222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65449478|NCT01327222|Growth Substances|growth substances|mesh-ancestor
65449479|NCT01327222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449480|NCT01327222|Growth Inhibitors|growth inhibitors|mesh-ancestor
65449481|NCT03950362|Avelumab|avelumab|mesh-list
64834193|NCT03547999|Nivolumab|nivolumab|mesh-list
64834198|NCT03536728|Eflornithine|eflornithine|mesh-list
64676814|NCT05575505|Pentoxifylline|pentoxifylline|mesh-list
64676815|NCT05575505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64676816|NCT05575505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676817|NCT05575505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676818|NCT05575505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64676819|NCT05575505|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64676820|NCT05575505|Protective Agents|protective agents|mesh-ancestor
64676821|NCT05575505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676822|NCT05575505|Vasodilator Agents|vasodilator agents|mesh-ancestor
64676823|NCT05575505|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64676824|NCT05575505|Antioxidants|antioxidants|mesh-ancestor
64676825|NCT00000249|Nitrous Oxide|nitrous oxide|mesh-list
64676826|NCT00000249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64676827|NCT00000249|Anesthetics, General|anesthetics, general|mesh-ancestor
64676828|NCT00000249|Anesthetics|anesthetics|mesh-ancestor
64676829|NCT00000249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64676830|NCT00000249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676831|NCT00000249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64676832|NCT00000249|Analgesics|analgesics|mesh-ancestor
64676833|NCT00000249|Sensory System Agents|sensory system agents|mesh-ancestor
64676834|NCT00000249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64676835|NCT00000261|Nitrous Oxide|nitrous oxide|mesh-list
64676836|NCT00000261|Sevoflurane|sevoflurane|mesh-list
64676837|NCT00000261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64676838|NCT00000261|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64676839|NCT00000261|Anesthetics, General|anesthetics, general|mesh-ancestor
64676840|NCT00000261|Anesthetics|anesthetics|mesh-ancestor
64715232|NCT01306994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715233|NCT01306994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64715234|NCT01306994|Vasodilator Agents|vasodilator agents|mesh-ancestor
64715235|NCT01306994|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64715236|NCT01306994|Purinergic Agonists|purinergic agonists|mesh-ancestor
64715237|NCT01306994|Purinergic Agents|purinergic agents|mesh-ancestor
64715238|NCT01306994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64715239|NCT01306994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715240|NCT02979301|Tamoxifen|tamoxifen|mesh-list
64676841|NCT00000261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64676842|NCT00000261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676843|NCT00000261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64676844|NCT00000261|Analgesics|analgesics|mesh-ancestor
64676845|NCT00000261|Sensory System Agents|sensory system agents|mesh-ancestor
64676846|NCT00000261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65449482|NCT03950362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65449483|NCT03950362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449484|NCT00263588|Lapatinib|lapatinib|mesh-list
65449485|NCT00263588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449486|NCT00263588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65449487|NCT00263588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449488|NCT00263588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449489|NCT00213135|Cladribine|cladribine|mesh-list
65449490|NCT00213135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449491|NCT00213135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65449492|NCT00213135|Immunologic Factors|immunologic factors|mesh-ancestor
64834206|NCT03536728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676847|NCT00000801|Cytarabine|cytarabine|mesh-list
64676848|NCT00000801|Dexamethasone|dexamethasone|mesh-list
64676849|NCT00000801|Cyclophosphamide|cyclophosphamide|mesh-list
64676850|NCT00000801|Doxorubicin|doxorubicin|mesh-list
64676851|NCT00000801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64676864|NCT00000801|Autonomic Agents|autonomic agents|mesh-ancestor
64676865|NCT00000801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64676866|NCT00000801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64676867|NCT00000801|Glucocorticoids|glucocorticoids|mesh-ancestor
64676872|NCT00000801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64676873|NCT00000801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64676874|NCT00000801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676875|NCT00000801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64676876|NCT00000801|Antimetabolites|antimetabolites|mesh-ancestor
64676877|NCT00000801|Antiviral Agents|antiviral agents|mesh-ancestor
64676878|NCT00000801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64676879|NCT00000801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64676880|NCT00000801|Tubulin Modulators|tubulin modulators|mesh-ancestor
64676881|NCT00000801|Antimitotic Agents|antimitotic agents|mesh-ancestor
64676882|NCT00000801|Mitosis Modulators|mitosis modulators|mesh-ancestor
64676883|NCT00000267|Risperidone|risperidone|mesh-list
64676884|NCT00000267|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64676885|NCT00000267|Serotonin Agents|serotonin agents|mesh-ancestor
64676886|NCT00000267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64676887|NCT00000267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676888|NCT00000267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676889|NCT00000267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64676890|NCT00000267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64676891|NCT00000267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64676892|NCT00000267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64676893|NCT00000267|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64676894|NCT00000267|Dopamine Agents|dopamine agents|mesh-ancestor
64676895|NCT00000807|Etoposide|etoposide|mesh-list
64676896|NCT00000807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64676897|NCT00000807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676898|NCT00000807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64676899|NCT00000807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64676900|NCT00000807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676901|NCT00000807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676902|NCT00001677|Methotrexate|methotrexate|mesh-list
64676903|NCT00001677|Fludarabine|fludarabine|mesh-list
64676904|NCT00001677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64676905|NCT00001677|Abortifacient Agents|abortifacient agents|mesh-ancestor
64715242|NCT02979301|Hormone Antagonists|hormone antagonists|mesh-ancestor
64715243|NCT02979301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64715244|NCT02979301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715245|NCT02979301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64715246|NCT02979301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715247|NCT02979301|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64715248|NCT02979301|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65449493|NCT00213135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449494|NCT00077974|Sunitinib|sunitinib|mesh-list
65449495|NCT00077974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449496|NCT00077974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65449497|NCT00077974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65449498|NCT00077974|Growth Substances|growth substances|mesh-ancestor
65449499|NCT00077974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449500|NCT00077974|Growth Inhibitors|growth inhibitors|mesh-ancestor
65449501|NCT00077974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65449502|NCT00077974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449503|NCT00077974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449504|NCT00141921|Etanercept|etanercept|mesh-list
64834218|NCT03470675|Anesthetics|anesthetics|mesh-ancestor
64715249|NCT02979301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64715250|NCT00375440|Tranexamic Acid|tranexamic acid|mesh-list
64715251|NCT00375440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64715252|NCT00375440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64715253|NCT00375440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715254|NCT00375440|Hemostatics|hemostatics|mesh-ancestor
64715255|NCT00375440|Coagulants|coagulants|mesh-ancestor
64715256|NCT04791943|Melatonin|melatonin|mesh-list
64715257|NCT04791943|Antioxidants|antioxidants|mesh-ancestor
64715258|NCT04791943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715259|NCT04791943|Protective Agents|protective agents|mesh-ancestor
64715260|NCT04791943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715261|NCT04791943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64715263|NCT05113004|Hydroxychloroquine|hydroxychloroquine|mesh-list
64715264|NCT05113004|Leflunomide|leflunomide|mesh-list
64715265|NCT05113004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64715266|NCT05113004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715267|NCT05113004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64715268|NCT05113004|Antitubercular Agents|antitubercular agents|mesh-ancestor
64715269|NCT05113004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64715270|NCT05113004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64715271|NCT05113004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715272|NCT05113004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715273|NCT05113004|Antimalarials|antimalarials|mesh-ancestor
64715275|NCT05113004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64715276|NCT05113004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64676906|NCT00001677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64715278|NCT05113004|Immunologic Factors|immunologic factors|mesh-ancestor
64715279|NCT05113004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715281|NCT02983981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64715282|NCT02983981|Glucocorticoids|glucocorticoids|mesh-ancestor
64715283|NCT02983981|Hormones|hormones|mesh-ancestor
64715284|NCT02983981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64715285|NCT02983981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715286|NCT00375583|Albendazole|albendazole|mesh-list
64715287|NCT00375583|Anthelmintics|anthelmintics|mesh-ancestor
64715288|NCT00375583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64715289|NCT00375583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64715290|NCT00375583|Anticestodal Agents|anticestodal agents|mesh-ancestor
64715291|NCT00375583|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64715292|NCT00375583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64715293|NCT00375583|Tubulin Modulators|tubulin modulators|mesh-ancestor
64676907|NCT00001677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676908|NCT00001677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64676909|NCT00001677|Antimetabolites|antimetabolites|mesh-ancestor
64676910|NCT00001677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676911|NCT00001677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676912|NCT00001677|Dermatologic Agents|dermatologic agents|mesh-ancestor
65449505|NCT00141921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65449506|NCT00141921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65449507|NCT00141921|Analgesics|analgesics|mesh-ancestor
65449508|NCT00141921|Sensory System Agents|sensory system agents|mesh-ancestor
65449509|NCT00141921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65449510|NCT00141921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449511|NCT00141921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65449512|NCT00141921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65449513|NCT00141921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65449514|NCT00141921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65449515|NCT00141921|Immunologic Factors|immunologic factors|mesh-ancestor
65449516|NCT01088620|Pemetrexed|pemetrexed|mesh-list
65449517|NCT01088620|Panitumumab|panitumumab|mesh-list
64325185|NCT02484404|Durvalumab|durvalumab|mesh-list
64676928|NCT00001713|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64676929|NCT00001713|Warfarin|warfarin|mesh-list
64676930|NCT00001713|Anticoagulants|anticoagulants|mesh-ancestor
64676931|NCT00001713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64676932|NCT00001713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64676933|NCT00001713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676934|NCT00000273|Fentanyl|fentanyl|mesh-list
64676935|NCT00000273|Morphine|morphine|mesh-list
64676936|NCT00000273|Oxycodone|oxycodone|mesh-list
64676937|NCT00000273|Buprenorphine|buprenorphine|mesh-list
64676938|NCT00000273|Methadone|methadone|mesh-list
64676939|NCT00000273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64676940|NCT00000273|Narcotics|narcotics|mesh-ancestor
64676941|NCT00000273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64676942|NCT00000273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676943|NCT00000273|Analgesics|analgesics|mesh-ancestor
64676944|NCT00000273|Sensory System Agents|sensory system agents|mesh-ancestor
64676945|NCT00000273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64676946|NCT00000273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64676947|NCT00000273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64676948|NCT00000273|Anesthetics, General|anesthetics, general|mesh-ancestor
64676949|NCT00000273|Anesthetics|anesthetics|mesh-ancestor
64676950|NCT00000273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64676951|NCT00000273|Antitussive Agents|antitussive agents|mesh-ancestor
64676952|NCT00000273|Respiratory System Agents|respiratory system agents|mesh-ancestor
64676953|NCT00000819|Prednisone|prednisone|mesh-list
64676954|NCT00000819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64676955|NCT00000819|Glucocorticoids|glucocorticoids|mesh-ancestor
64676956|NCT00000819|Hormones|hormones|mesh-ancestor
64676957|NCT00000819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64676958|NCT00000819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676959|NCT00000819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64484374|NCT04718350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64676960|NCT00000819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676961|NCT00000279|Clonidine|clonidine|mesh-list
64676962|NCT00000279|Analgesics|analgesics|mesh-ancestor
64715294|NCT00375583|Antimitotic Agents|antimitotic agents|mesh-ancestor
64715295|NCT00375583|Mitosis Modulators|mitosis modulators|mesh-ancestor
64715296|NCT00375583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715297|NCT00375583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715298|NCT03143569|Heparin|heparin|mesh-list
64715299|NCT03143569|Calcium heparin|calcium heparin|mesh-list
64715300|NCT03143569|Anticoagulants|anticoagulants|mesh-ancestor
64715301|NCT03143569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64715302|NCT03143569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64323593|NCT05496764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676963|NCT00000279|Sensory System Agents|sensory system agents|mesh-ancestor
64676964|NCT00000279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64676965|NCT00000279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332612|NCT02379416|Paclitaxel|paclitaxel|mesh-list
65449518|NCT01088620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449519|NCT01088620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449520|NCT01088620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449521|NCT01088620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65449522|NCT01088620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65449523|NCT01088620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65449524|NCT00026494|Temozolomide|temozolomide|mesh-list
65449525|NCT00026494|Vinorelbine|vinorelbine|mesh-list
65449526|NCT00026494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65449527|NCT00026494|Alkylating Agents|alkylating agents|mesh-ancestor
65449528|NCT00026494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449529|NCT00026494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676969|NCT00000279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64676970|NCT00000279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64676972|NCT00000279|Adrenergic Agents|adrenergic agents|mesh-ancestor
64676973|NCT00000279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64676975|NCT00000825|Aldesleukin|aldesleukin|mesh-list
64676976|NCT00000825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676977|NCT00000825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64676978|NCT00000825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64676979|NCT00000825|Antiviral Agents|antiviral agents|mesh-ancestor
64676980|NCT00000825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64676981|NCT00000285|Phenytoin|phenytoin|mesh-list
64676982|NCT00000285|Anticonvulsants|anticonvulsants|mesh-ancestor
64676983|NCT00000285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64676984|NCT00000285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64676985|NCT00000285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64676986|NCT00000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676987|NCT00000285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64676988|NCT00000285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64676989|NCT00001737|Cyclosporine|cyclosporine|mesh-list
64676990|NCT00001737|Cyclosporins|cyclosporins|mesh-list
64676991|NCT00001737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676992|NCT00001737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676993|NCT00001737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64676994|NCT00001737|Immunologic Factors|immunologic factors|mesh-ancestor
64676995|NCT00001737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676996|NCT00001737|Antifungal Agents|antifungal agents|mesh-ancestor
64676997|NCT00001737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64676998|NCT00001737|Dermatologic Agents|dermatologic agents|mesh-ancestor
64676999|NCT00001737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64677000|NCT00001737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64677001|NCT00000843|Adefovir|adefovir|mesh-list
64677002|NCT00000843|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64677003|NCT00000843|Antiviral Agents|antiviral agents|mesh-ancestor
64677004|NCT00000843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677005|NCT00000843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64677006|NCT00000843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64677007|NCT00000843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677008|NCT00000843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677009|NCT05362487|Bromides|bromides|mesh-list
64677010|NCT05362487|Tiotropium Bromide|tiotropium bromide|mesh-list
64677011|NCT05362487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64677012|NCT05362487|Autonomic Agents|autonomic agents|mesh-ancestor
64677013|NCT05362487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64677014|NCT05362487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677015|NCT05362487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64677016|NCT05362487|Respiratory System Agents|respiratory system agents|mesh-ancestor
64677017|NCT05362487|Parasympatholytics|parasympatholytics|mesh-ancestor
64677018|NCT05362487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64715303|NCT03143569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449530|NCT00026494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65449531|NCT00026494|Tubulin Modulators|tubulin modulators|mesh-ancestor
65449532|NCT00026494|Antimitotic Agents|antimitotic agents|mesh-ancestor
65449533|NCT00026494|Mitosis Modulators|mitosis modulators|mesh-ancestor
65449534|NCT03950050|Ambroxol|ambroxol|mesh-list
65449535|NCT03950050|Expectorants|expectorants|mesh-ancestor
65449536|NCT03950050|Respiratory System Agents|respiratory system agents|mesh-ancestor
65449537|NCT00023764|Bortezomib|bortezomib|mesh-list
65449538|NCT00023764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449539|NCT03961126|Clobetasol|clobetasol|mesh-list
65449540|NCT03961126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65449541|NCT03961126|Glucocorticoids|glucocorticoids|mesh-ancestor
65449542|NCT03961126|Hormones|hormones|mesh-ancestor
65449543|NCT03961126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65449544|NCT03961126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449545|NCT01584778|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
65449546|NCT01584778|Immunologic Factors|immunologic factors|mesh-ancestor
65449547|NCT01584778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449548|NCT00189488|Methotrexate|methotrexate|mesh-list
65449549|NCT00189488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65449550|NCT00189488|Abortifacient Agents|abortifacient agents|mesh-ancestor
65449551|NCT00189488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65449552|NCT00189488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449553|NCT00189488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65449554|NCT00189488|Antimetabolites|antimetabolites|mesh-ancestor
65449555|NCT00189488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449556|NCT00189488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834255|NCT03418038|Cytarabine|cytarabine|mesh-list
64715305|NCT05271240|Temozolomide|temozolomide|mesh-list
64715306|NCT05271240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64715307|NCT05271240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715308|NCT05271240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64715309|NCT05271240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64715310|NCT05271240|Growth Substances|growth substances|mesh-ancestor
64715311|NCT05271240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715312|NCT05271240|Growth Inhibitors|growth inhibitors|mesh-ancestor
64715313|NCT05271240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64715314|NCT05271240|Alkylating Agents|alkylating agents|mesh-ancestor
64715315|NCT05271240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715316|NCT03149887|Bupivacaine|bupivacaine|mesh-list
64715317|NCT03149887|Anesthetics, Local|anesthetics, local|mesh-ancestor
64715318|NCT03149887|Anesthetics|anesthetics|mesh-ancestor
64715319|NCT03149887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64715320|NCT03149887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715321|NCT03149887|Sensory System Agents|sensory system agents|mesh-ancestor
64715322|NCT03149887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65449557|NCT00189488|Dermatologic Agents|dermatologic agents|mesh-ancestor
65449558|NCT00189488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449559|NCT00189488|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65199060|NCT05779020|Vaccines|vaccines|mesh-list
65449560|NCT00189488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65449561|NCT00189488|Immunologic Factors|immunologic factors|mesh-ancestor
65449562|NCT00189488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65449563|NCT00189488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65449564|NCT00233324|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65449565|NCT00233324|Respiratory System Agents|respiratory system agents|mesh-ancestor
65449566|NCT00023452|Isoniazid|isoniazid|mesh-list
65449567|NCT00023452|Rifapentine|rifapentine|mesh-list
65449568|NCT00023452|Antitubercular Agents|antitubercular agents|mesh-ancestor
65449569|NCT00023452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65449570|NCT00023452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449571|NCT00023452|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65449572|NCT00023452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65449573|NCT00023452|Antimetabolites|antimetabolites|mesh-ancestor
65449574|NCT00023452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449575|NCT00023452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65449576|NCT00023452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65449577|NCT00023452|Leprostatic Agents|leprostatic agents|mesh-ancestor
65449578|NCT01088932|SRX246|srx246|mesh-list
64677021|NCT05362487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677022|NCT05362487|Anticonvulsants|anticonvulsants|mesh-ancestor
64677023|NCT00000291|Labetalol|labetalol|mesh-list
64677024|NCT00000291|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64677025|NCT00000291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64677026|NCT00000291|Adrenergic Agents|adrenergic agents|mesh-ancestor
64677027|NCT00000291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64677028|NCT00000291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677029|NCT00000291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677030|NCT00000291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64677031|NCT00000291|Sympathomimetics|sympathomimetics|mesh-ancestor
64677032|NCT00000291|Autonomic Agents|autonomic agents|mesh-ancestor
64677033|NCT00000291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64677034|NCT00000291|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64677035|NCT00000291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64677037|NCT00000861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64677038|NCT00000861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64677039|NCT00000861|Protease Inhibitors|protease inhibitors|mesh-ancestor
64677040|NCT00000861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677041|NCT00000861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677042|NCT00000861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64677043|NCT00000861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64677044|NCT00000861|Antiviral Agents|antiviral agents|mesh-ancestor
64677051|NCT00000297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677052|NCT00000297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677053|NCT00000297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64677054|NCT00000297|Sympathomimetics|sympathomimetics|mesh-ancestor
64677055|NCT00000297|Autonomic Agents|autonomic agents|mesh-ancestor
64677056|NCT00000297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65449579|NCT01088932|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65449580|NCT01088932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449581|NCT01088932|Natriuretic Agents|natriuretic agents|mesh-ancestor
65449582|NCT01088932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449583|NCT03961048|Ropivacaine|ropivacaine|mesh-list
65449584|NCT03961048|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65449585|NCT03961048|Anesthetics, Local|anesthetics, local|mesh-ancestor
65449586|NCT03961048|Anesthetics|anesthetics|mesh-ancestor
65449587|NCT03961048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65449588|NCT03961048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449589|NCT03961048|Sensory System Agents|sensory system agents|mesh-ancestor
65449590|NCT03961048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65449591|NCT00022672|Trastuzumab|trastuzumab|mesh-list
65449592|NCT00022672|Anastrozole|anastrozole|mesh-list
65449593|NCT00022672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65449594|NCT00022672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449595|NCT00022672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65449596|NCT00022672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65449597|NCT00022672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65449598|NCT00022672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449599|NCT00022672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449600|NCT00022672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65449601|NCT00022672|Hormone Antagonists|hormone antagonists|mesh-ancestor
65449602|NCT00022672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65449603|NCT00022672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449604|NCT00141453|Olmesartan|olmesartan|mesh-list
65449605|NCT00141453|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65449606|NCT00141453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65449607|NCT00141453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64715324|NCT02988349|Sodium Fluoride|sodium fluoride|mesh-list
64715325|NCT02988349|Cariostatic Agents|cariostatic agents|mesh-ancestor
64715326|NCT02988349|Protective Agents|protective agents|mesh-ancestor
64715327|NCT02988349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715328|NCT02988349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64715329|NCT02988349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64715330|NCT02159352|Ritonavir|ritonavir|mesh-list
64715331|NCT02159352|Lopinavir|lopinavir|mesh-list
64715332|NCT02159352|Darunavir|darunavir|mesh-list
64715333|NCT02159352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64323621|NCT02234869|Interferon beta-1a|interferon beta-1a|mesh-list
64677057|NCT00000297|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64677058|NCT00000297|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64677059|NCT00359879|Exenatide|exenatide|mesh-list
64677060|NCT00359879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65449608|NCT00141453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65449609|NCT00141453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449610|NCT00076570|Sirolimus|sirolimus|mesh-list
65449611|NCT00076570|Tacrolimus|tacrolimus|mesh-list
65449612|NCT00076570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65449613|NCT00076570|Immunologic Factors|immunologic factors|mesh-ancestor
65449614|NCT00076570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449615|NCT00076570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65449616|NCT00076570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449617|NCT00076570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449618|NCT00076570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65449619|NCT00076570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449620|NCT00076570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65449621|NCT00076570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449622|NCT00076570|Antifungal Agents|antifungal agents|mesh-ancestor
65449623|NCT00124449|Abatacept|abatacept|mesh-list
65449624|NCT00124449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65449625|NCT00124449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449626|NCT00124449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449627|NCT00124449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65449628|NCT00124449|Immunologic Factors|immunologic factors|mesh-ancestor
65449629|NCT00124449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449630|NCT00124449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65449631|NCT00076336|Lamivudine|lamivudine|mesh-list
65449632|NCT00076336|Telbivudine|telbivudine|mesh-list
65449633|NCT00076336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64677061|NCT00359879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677062|NCT00359879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64677063|NCT00359879|Incretins|incretins|mesh-ancestor
64677064|NCT00359879|Hormones|hormones|mesh-ancestor
64677065|NCT00359879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64677066|NCT00000303|Baclofen|baclofen|mesh-list
64677067|NCT00000303|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64677068|NCT00000303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677069|NCT00000303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64677070|NCT00000303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64677071|NCT00000303|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64677072|NCT00000303|GABA Agonists|gaba agonists|mesh-ancestor
64677073|NCT00000303|GABA Agents|gaba agents|mesh-ancestor
64677074|NCT00000303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64677075|NCT00000303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677076|NCT00001785|Interferons|interferons|mesh-list
64677077|NCT00001785|Interferon-beta|interferon-beta|mesh-list
64677078|NCT00001785|Interferon beta-1a|interferon beta-1a|mesh-list
64677079|NCT00001785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677080|NCT00001785|Antiviral Agents|antiviral agents|mesh-ancestor
64677081|NCT00001785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677082|NCT00001785|Immunologic Factors|immunologic factors|mesh-ancestor
64677083|NCT00001785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449634|NCT00076336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65449635|NCT00076336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449636|NCT00076336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449637|NCT00076336|Antiviral Agents|antiviral agents|mesh-ancestor
65449638|NCT00076336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449639|NCT00076336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65449640|NCT00076336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65449641|NCT00185588|Gemcitabine|gemcitabine|mesh-list
65449642|NCT00185588|Vatalanib|vatalanib|mesh-list
65449643|NCT00185588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65449644|NCT00185588|Antimetabolites|antimetabolites|mesh-ancestor
65449645|NCT00185588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834368|NCT03272685|Nicotine|nicotine|mesh-list
64677084|NCT00001785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64677085|NCT00001827|Aldesleukin|aldesleukin|mesh-list
64677086|NCT00001827|Sargramostim|sargramostim|mesh-list
64677087|NCT00001827|Freund's Adjuvant|freund's adjuvant|mesh-list
64677088|NCT00001827|Immunologic Factors|immunologic factors|mesh-ancestor
64677091|NCT00001827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64677092|NCT00001827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64677093|NCT00001827|Antiviral Agents|antiviral agents|mesh-ancestor
64677094|NCT00001827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677095|NCT00001827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64677096|NCT01647516|Ozanimod|ozanimod|mesh-list
64677097|NCT01647516|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64677098|NCT01647516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677099|NCT01647516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64677100|NCT01647516|Immunologic Factors|immunologic factors|mesh-ancestor
64677101|NCT01647516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677102|NCT00001839|Cyclosporine|cyclosporine|mesh-list
64677103|NCT00001839|Cyclosporins|cyclosporins|mesh-list
64677104|NCT00001839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64677105|NCT00001839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677106|NCT00001839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677107|NCT00001839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64677108|NCT00001839|Immunologic Factors|immunologic factors|mesh-ancestor
64715334|NCT02159352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64715335|NCT02159352|Protease Inhibitors|protease inhibitors|mesh-ancestor
64715336|NCT02159352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715337|NCT02159352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715338|NCT02159352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64715339|NCT02159352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64715340|NCT02159352|Antiviral Agents|antiviral agents|mesh-ancestor
64715341|NCT02159352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64715342|NCT02159352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64715343|NCT02159352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64677109|NCT00001839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677110|NCT00001839|Antifungal Agents|antifungal agents|mesh-ancestor
64677111|NCT00001839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677112|NCT00001839|Dermatologic Agents|dermatologic agents|mesh-ancestor
64677113|NCT00001839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64677144|NCT01647282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64677145|NCT01647282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677146|NCT00000897|Zidovudine|zidovudine|mesh-list
64677147|NCT00000897|Antimetabolites|antimetabolites|mesh-ancestor
64677148|NCT00000897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677149|NCT00000897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64677150|NCT00000897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64677151|NCT00000897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677152|NCT00000897|Antiviral Agents|antiviral agents|mesh-ancestor
64677153|NCT00000897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677154|NCT00000897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65449646|NCT00185588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449647|NCT00185588|Antiviral Agents|antiviral agents|mesh-ancestor
65449648|NCT00185588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449649|NCT00185588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449650|NCT00185588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65449651|NCT00185588|Immunologic Factors|immunologic factors|mesh-ancestor
65449652|NCT00185588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449653|NCT00185588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65449654|NCT00231842|Ifosfamide|ifosfamide|mesh-list
65449655|NCT00231842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449656|NCT00231842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65449657|NCT00231842|Alkylating Agents|alkylating agents|mesh-ancestor
65449658|NCT00231842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449659|NCT01073150|Tea Tree Oil|tea tree oil|mesh-list
65449660|NCT01073150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65449661|NCT01073150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449662|NCT00076102|Pirfenidone|pirfenidone|mesh-list
65449663|NCT00076102|Analgesics|analgesics|mesh-ancestor
65449664|NCT00076102|Sensory System Agents|sensory system agents|mesh-ancestor
65449665|NCT00076102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65449666|NCT00076102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449667|NCT00076102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65449668|NCT00076102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65449669|NCT00076102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65449670|NCT00076102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65449671|NCT00076102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449672|NCT03968588|Mycophenolic Acid|mycophenolic acid|mesh-list
64677155|NCT00000897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64677156|NCT05347979|Dabigatran|dabigatran|mesh-list
64677157|NCT05347979|Antithrombins|antithrombins|mesh-ancestor
64677158|NCT05347979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64677159|NCT05347979|Protease Inhibitors|protease inhibitors|mesh-ancestor
64677160|NCT05347979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677161|NCT05347979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677180|NCT05444699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677181|NCT05444699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64677182|NCT05444699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677183|NCT05444699|Antiemetics|antiemetics|mesh-ancestor
64677184|NCT05444699|Autonomic Agents|autonomic agents|mesh-ancestor
64677185|NCT05444699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64677186|NCT05444699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64677187|NCT05444699|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64677188|NCT05444699|Protective Agents|protective agents|mesh-ancestor
64402541|NCT02592317|Pioglitazone|pioglitazone|mesh-list
64677189|NCT00001863|Leflunomide|leflunomide|mesh-list
64677190|NCT00001863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677191|NCT00001863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449673|NCT03968588|Tacrolimus|tacrolimus|mesh-list
65449674|NCT03968588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65449675|NCT03968588|Immunologic Factors|immunologic factors|mesh-ancestor
65449676|NCT03968588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449677|NCT03968588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65449678|NCT03968588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449679|NCT03968588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449680|NCT03968588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65449681|NCT03968588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449682|NCT03968588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65449683|NCT03968588|Antitubercular Agents|antitubercular agents|mesh-ancestor
65449684|NCT03968588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65449685|NCT03968588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449686|NCT01582646|Terbutaline|terbutaline|mesh-list
65449687|NCT01582646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65449688|NCT01582646|Autonomic Agents|autonomic agents|mesh-ancestor
65449689|NCT01582646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65449690|NCT01582646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449691|NCT01582646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65449692|NCT01582646|Respiratory System Agents|respiratory system agents|mesh-ancestor
65449693|NCT01582646|Sympathomimetics|sympathomimetics|mesh-ancestor
65449694|NCT01582646|Tocolytic Agents|tocolytic agents|mesh-ancestor
65449695|NCT01582646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65449696|NCT01582646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65449697|NCT01582646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64677192|NCT00001863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64677193|NCT00001863|Immunologic Factors|immunologic factors|mesh-ancestor
64677194|NCT00001863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677195|NCT05530655|Lisinopril|lisinopril|mesh-list
64677196|NCT05530655|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64677197|NCT05530655|Protease Inhibitors|protease inhibitors|mesh-ancestor
64677198|NCT05530655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677200|NCT05530655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64677201|NCT05530655|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64677202|NCT05530655|Protective Agents|protective agents|mesh-ancestor
64677203|NCT05530655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677205|NCT00000921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64677206|NCT00000921|Glucocorticoids|glucocorticoids|mesh-ancestor
64677207|NCT00000921|Hormones|hormones|mesh-ancestor
64715345|NCT02187744|Docetaxel|docetaxel|mesh-list
64715346|NCT02187744|Trastuzumab|trastuzumab|mesh-list
64715347|NCT02187744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715348|NCT02187744|Tubulin Modulators|tubulin modulators|mesh-ancestor
64715349|NCT02187744|Antimitotic Agents|antimitotic agents|mesh-ancestor
64715350|NCT02187744|Mitosis Modulators|mitosis modulators|mesh-ancestor
64715351|NCT02187744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715352|NCT02187744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64715353|NCT03154333|Diacetylrhein|diacetylrhein|mesh-list
64715354|NCT03154333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64715355|NCT04393441|Lubricant Eye Drops|lubricant eye drops|mesh-list
64715356|NCT04393441|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65449698|NCT01582646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65449699|NCT01582646|Adrenergic Agents|adrenergic agents|mesh-ancestor
65449700|NCT01582646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65449701|NCT01582646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449702|NCT03974360|Erenumab|erenumab|mesh-list
65449703|NCT03974360|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65449704|NCT03974360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449705|NCT03974360|Analgesics|analgesics|mesh-ancestor
65449706|NCT03974360|Sensory System Agents|sensory system agents|mesh-ancestor
65199209|NCT05614609|Lidocaine|lidocaine|mesh-list
65449707|NCT03974360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65449708|NCT03974360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449710|NCT00184028|Docetaxel|docetaxel|mesh-list
65449711|NCT00184028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449712|NCT00184028|Tubulin Modulators|tubulin modulators|mesh-ancestor
64834423|NCT05705037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834425|NCT05704959|Povidone|povidone|mesh-list
64715357|NCT04393441|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64715358|NCT02995915|Bupropion|bupropion|mesh-list
64715359|NCT02995915|Nicotine|nicotine|mesh-list
64715360|NCT02995915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64715361|NCT02995915|Autonomic Agents|autonomic agents|mesh-ancestor
64715362|NCT02995915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715363|NCT02995915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715364|NCT02995915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64715365|NCT02995915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64715366|NCT02995915|Cholinergic Agents|cholinergic agents|mesh-ancestor
64715367|NCT02995915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64715368|NCT02995915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715369|NCT02995915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64715370|NCT02995915|Antidepressive Agents|antidepressive agents|mesh-ancestor
64715371|NCT02995915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64715372|NCT02995915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64715373|NCT02995915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64715374|NCT02995915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64715375|NCT02995915|Dopamine Agents|dopamine agents|mesh-ancestor
64715376|NCT02995915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64715377|NCT02995915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64715378|NCT02995915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715379|NCT03163303|Nicotine|nicotine|mesh-list
64323652|NCT05498636|Prednisone|prednisone|mesh-list
64677208|NCT00000921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64677209|NCT00000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715381|NCT03163303|Autonomic Agents|autonomic agents|mesh-ancestor
64715382|NCT03163303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715383|NCT03163303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715384|NCT03163303|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64715385|NCT03163303|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64715386|NCT03163303|Cholinergic Agents|cholinergic agents|mesh-ancestor
64715387|NCT03163303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64715388|NCT03163303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715389|NCT03000283|Conivaptan|conivaptan|mesh-list
64323679|NCT03137407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64677210|NCT00000921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64677211|NCT00000921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677212|NCT02321436|Botulinum Toxins|botulinum toxins|mesh-list
65449713|NCT00184028|Antimitotic Agents|antimitotic agents|mesh-ancestor
65449714|NCT00184028|Mitosis Modulators|mitosis modulators|mesh-ancestor
65449715|NCT00184028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449716|NCT00183872|Docetaxel|docetaxel|mesh-list
65449717|NCT00183872|Irinotecan|irinotecan|mesh-list
65449718|NCT00183872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449719|NCT00183872|Tubulin Modulators|tubulin modulators|mesh-ancestor
65449720|NCT00183872|Antimitotic Agents|antimitotic agents|mesh-ancestor
65449721|NCT00183872|Mitosis Modulators|mitosis modulators|mesh-ancestor
65449722|NCT00183872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677213|NCT02321436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64677214|NCT02321436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64677215|NCT02321436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64677216|NCT02321436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64677217|NCT02321436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677218|NCT02321436|Cholinergic Agents|cholinergic agents|mesh-ancestor
64677220|NCT02321436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677222|NCT02321436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64677223|NCT05325515|Alendronate|alendronate|mesh-list
64677224|NCT05325515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64677225|NCT05325515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677226|NCT00000939|Efavirenz|efavirenz|mesh-list
64677227|NCT00000939|Stavudine|stavudine|mesh-list
64677231|NCT00000939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64677233|NCT00000939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677234|NCT00000939|Antiviral Agents|antiviral agents|mesh-ancestor
64677235|NCT00000939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677236|NCT00000939|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64677237|NCT00000939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64677238|NCT00000939|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64677239|NCT00000939|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64677240|NCT00000939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64677241|NCT00000939|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64677242|NCT00000939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677243|NCT00000939|Antisickling Agents|antisickling agents|mesh-ancestor
64677244|NCT00000939|Antimetabolites|antimetabolites|mesh-ancestor
64677245|NCT00000939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64677246|NCT00000939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64677247|NCT00000945|Cidofovir|cidofovir|mesh-list
64677248|NCT00000945|Probenecid|probenecid|mesh-list
64677249|NCT00000945|Uricosuric Agents|uricosuric agents|mesh-ancestor
64677250|NCT00000945|Gout Suppressants|gout suppressants|mesh-ancestor
64677251|NCT00000945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64677252|NCT00000945|Renal Agents|renal agents|mesh-ancestor
64677253|NCT00000945|Antiviral Agents|antiviral agents|mesh-ancestor
64677254|NCT00000945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677255|NCT00000945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677256|NCT00000945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677257|NCT04344041|Cholecalciferol|cholecalciferol|mesh-list
64677258|NCT04344041|Vitamin D|vitamin d|mesh-list
64677259|NCT04344041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64677260|NCT04344041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677261|NCT04344041|Vitamins|vitamins|mesh-ancestor
64677262|NCT04344041|Micronutrients|micronutrients|mesh-ancestor
64677263|NCT04344041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64715390|NCT03000283|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64715391|NCT03000283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715392|NCT03000283|Natriuretic Agents|natriuretic agents|mesh-ancestor
64715393|NCT03000283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323688|NCT02588677|Riluzole|riluzole|mesh-list
64677265|NCT00000963|Antimetabolites|antimetabolites|mesh-ancestor
64677266|NCT00000963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677267|NCT00000963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65449723|NCT00183872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65449724|NCT00183872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65449725|NCT00183872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449726|NCT03815175|Aspirin|aspirin|mesh-list
65449727|NCT03815175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65449728|NCT03815175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65449729|NCT03815175|Analgesics|analgesics|mesh-ancestor
65449730|NCT03815175|Sensory System Agents|sensory system agents|mesh-ancestor
65449731|NCT03815175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65449732|NCT03815175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677268|NCT00000963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64677269|NCT00000963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677270|NCT00000963|Antiviral Agents|antiviral agents|mesh-ancestor
64677271|NCT00000963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677272|NCT00000963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64677273|NCT00000963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64677274|NCT05322707|Budesonide|budesonide|mesh-list
64677275|NCT05322707|Formoterol Fumarate|formoterol fumarate|mesh-list
64677276|NCT05322707|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64677277|NCT05322707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64677278|NCT05322707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64677279|NCT05322707|Autonomic Agents|autonomic agents|mesh-ancestor
64677280|NCT05322707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64677281|NCT05322707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677282|NCT05322707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64677283|NCT05322707|Respiratory System Agents|respiratory system agents|mesh-ancestor
64677284|NCT05322707|Glucocorticoids|glucocorticoids|mesh-ancestor
64677285|NCT05322707|Hormones|hormones|mesh-ancestor
64677286|NCT05322707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64677300|NCT00001893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64677301|NCT00001893|Analgesics|analgesics|mesh-ancestor
64677302|NCT00001893|Sensory System Agents|sensory system agents|mesh-ancestor
64677303|NCT00001893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64677304|NCT00001893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677305|NCT00001893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64677306|NCT00001893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64677307|NCT00001893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64677309|NCT00001893|Immunologic Factors|immunologic factors|mesh-ancestor
64677310|NCT00000981|Fiacitabine|fiacitabine|mesh-list
64677311|NCT00000981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677312|NCT00000981|Antiviral Agents|antiviral agents|mesh-ancestor
64677313|NCT00000981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677314|NCT02280096|4-Aminopyridine|4-aminopyridine|mesh-list
64677315|NCT02280096|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64677316|NCT02280096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64677317|NCT02280096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677318|NCT00001905|Interferons|interferons|mesh-list
64677319|NCT00001905|Interferon-gamma|interferon-gamma|mesh-list
64677320|NCT00001905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677321|NCT00001905|Antiviral Agents|antiviral agents|mesh-ancestor
64677322|NCT00001905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677323|NCT00000987|Zidovudine|zidovudine|mesh-list
64677324|NCT00000987|Doxorubicin|doxorubicin|mesh-list
64677325|NCT00000987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64677326|NCT00000987|Bleomycin|bleomycin|mesh-list
64677327|NCT00000987|Vincristine|vincristine|mesh-list
64677328|NCT00000987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64677329|NCT00000987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677330|NCT00000987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64677331|NCT00000987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64677332|NCT00000987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677333|NCT00000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677334|NCT00000987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64677335|NCT00000987|Tubulin Modulators|tubulin modulators|mesh-ancestor
64677336|NCT00000987|Antimitotic Agents|antimitotic agents|mesh-ancestor
64677337|NCT00000987|Mitosis Modulators|mitosis modulators|mesh-ancestor
65449733|NCT03815175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65449734|NCT03815175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65449735|NCT03815175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65449736|NCT03815175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65449737|NCT03815175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449738|NCT03815175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65449739|NCT03815175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65449740|NCT03815175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449741|NCT03815175|Antipyretics|antipyretics|mesh-ancestor
65449742|NCT01080027|Interferons|interferons|mesh-list
65449743|NCT01080027|Interferon-beta|interferon-beta|mesh-list
64834459|NCT05704374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64677338|NCT00000987|Antimetabolites|antimetabolites|mesh-ancestor
64677339|NCT00000987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64677340|NCT00000987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64715394|NCT03168295|Dapagliflozin|dapagliflozin|mesh-list
64715395|NCT03168295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64715396|NCT03168295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715397|NCT03168295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64715398|NCT03168295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715399|NCT03168841|Efinaconazole|efinaconazole|mesh-list
64715400|NCT03168841|Antifungal Agents|antifungal agents|mesh-ancestor
64715401|NCT03168841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64715402|NCT03865615|Oxytocin|oxytocin|mesh-list
64715403|NCT03865615|Oxytocics|oxytocics|mesh-ancestor
64715404|NCT03865615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64715405|NCT03865615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715406|NCT03185546|Nicotine|nicotine|mesh-list
64677341|NCT00000987|Antiviral Agents|antiviral agents|mesh-ancestor
64677342|NCT00000987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677343|NCT00000987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64677344|NCT00000987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64677345|NCT00001911|Interleukin-12|interleukin-12|mesh-list
64677346|NCT00001911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64677347|NCT00001911|Immunologic Factors|immunologic factors|mesh-ancestor
64677348|NCT00001911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677355|NCT00001929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64677356|NCT00001929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64677357|NCT00001929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64677358|NCT00001929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677359|NCT00001929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677360|NCT00001929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64677361|NCT00001929|Protective Agents|protective agents|mesh-ancestor
64677362|NCT00358553|Insulin|insulin|mesh-list
64677363|NCT00358553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64677364|NCT00358553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677365|NCT00000993|Zidovudine|zidovudine|mesh-list
64677366|NCT00000993|Antimetabolites|antimetabolites|mesh-ancestor
64677367|NCT00000993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677368|NCT00000993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64677369|NCT00000993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64677370|NCT00000993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677371|NCT00000993|Antiviral Agents|antiviral agents|mesh-ancestor
64677372|NCT00000993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677373|NCT00000993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64677374|NCT00000993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64677375|NCT00359177|Casopitant|casopitant|mesh-list
64677376|NCT00359177|Antiemetics|antiemetics|mesh-ancestor
64677379|NCT00359177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677380|NCT00359177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64677381|NCT00359177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64677382|NCT00359177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64677383|NCT00359177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449744|NCT01080027|Interferon beta-1a|interferon beta-1a|mesh-list
65449745|NCT01080027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449746|NCT01080027|Antiviral Agents|antiviral agents|mesh-ancestor
65449747|NCT01080027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449748|NCT01080027|Immunologic Factors|immunologic factors|mesh-ancestor
65449749|NCT01080027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449750|NCT01080027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65449751|NCT00262028|Vaccines|vaccines|mesh-list
65449752|NCT00262028|Immunologic Factors|immunologic factors|mesh-ancestor
65449753|NCT00262028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449754|NCT00183248|Mycophenolic Acid|mycophenolic acid|mesh-list
65449755|NCT00183248|Sirolimus|sirolimus|mesh-list
64834469|NCT05704166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64677384|NCT00001017|Fluconazole|fluconazole|mesh-list
64677385|NCT00001017|Amphotericin B|amphotericin b|mesh-list
64677386|NCT00001017|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64677387|NCT00001017|Antifungal Agents|antifungal agents|mesh-ancestor
64677388|NCT00001017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677389|NCT00001017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64677390|NCT00001017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64677391|NCT00001017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677392|NCT00001017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677393|NCT00001017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64677394|NCT00001017|Hormone Antagonists|hormone antagonists|mesh-ancestor
64715407|NCT03185546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64715408|NCT03185546|Autonomic Agents|autonomic agents|mesh-ancestor
64715409|NCT03185546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715410|NCT03185546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715411|NCT03185546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64715412|NCT03185546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64715413|NCT03185546|Cholinergic Agents|cholinergic agents|mesh-ancestor
64715414|NCT03185546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64715415|NCT03185546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323704|NCT04424420|Acetaminophen|acetaminophen|mesh-list
64677395|NCT00001017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64677396|NCT00001017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677397|NCT00001017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64677398|NCT00001017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64677399|NCT00001017|Amebicides|amebicides|mesh-ancestor
64677400|NCT00001017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64677401|NCT00001017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64677402|NCT00001017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64677403|NCT02279862|Ipilimumab|ipilimumab|mesh-list
64677404|NCT02279862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64677405|NCT02279862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677406|NCT02279862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64677407|NCT02279862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677408|NCT00001965|Cyclosporine|cyclosporine|mesh-list
64677409|NCT00001965|Cyclosporins|cyclosporins|mesh-list
64677410|NCT00001965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677411|NCT00001965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677412|NCT00001965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64677413|NCT00001965|Immunologic Factors|immunologic factors|mesh-ancestor
64677414|NCT00001965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677415|NCT00001965|Antifungal Agents|antifungal agents|mesh-ancestor
64677416|NCT00001965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677417|NCT00001965|Dermatologic Agents|dermatologic agents|mesh-ancestor
64677427|NCT00001023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677428|NCT00001023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64677430|NCT00001023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677431|NCT00001023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65449756|NCT00183248|Alemtuzumab|alemtuzumab|mesh-list
65449757|NCT00183248|Tacrolimus|tacrolimus|mesh-list
65449758|NCT00183248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65449759|NCT00183248|Immunologic Factors|immunologic factors|mesh-ancestor
65449760|NCT00183248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449761|NCT00183248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65449762|NCT00183248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449763|NCT00183248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449764|NCT00183248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65449765|NCT00183248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449766|NCT00183248|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64677432|NCT00001023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64677433|NCT00001023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64677434|NCT00001023|Antitubercular Agents|antitubercular agents|mesh-ancestor
64677435|NCT00001035|Interferons|interferons|mesh-list
64677436|NCT00001035|Interferon-alpha|interferon-alpha|mesh-list
64677437|NCT00001035|Interferon alpha-2|interferon alpha-2|mesh-list
64677438|NCT00001035|Zidovudine|zidovudine|mesh-list
64677439|NCT00001035|Didanosine|didanosine|mesh-list
64677440|NCT00001035|Zalcitabine|zalcitabine|mesh-list
64677441|NCT00001035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677442|NCT00001035|Antiviral Agents|antiviral agents|mesh-ancestor
64677443|NCT00001035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677444|NCT00001035|Immunologic Factors|immunologic factors|mesh-ancestor
64677445|NCT00001035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677446|NCT00001035|Antimetabolites|antimetabolites|mesh-ancestor
64677447|NCT00001035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677448|NCT00001035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64677449|NCT00001035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64677450|NCT00001035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677451|NCT00001035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64677452|NCT00001035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64677453|NCT05503901|Timolol|timolol|mesh-list
64677454|NCT05503901|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64677455|NCT05503901|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64677456|NCT05503901|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64677457|NCT05503901|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64715416|NCT02186652|Pantoprazole|pantoprazole|mesh-list
64715417|NCT02186652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64715418|NCT02186652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64715419|NCT02186652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64715420|NCT02186652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715421|NCT02186652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715422|NCT03606889|Bupivacaine|bupivacaine|mesh-list
64715423|NCT03606889|Anesthetics, Local|anesthetics, local|mesh-ancestor
64715424|NCT03606889|Anesthetics|anesthetics|mesh-ancestor
64715425|NCT03606889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64715426|NCT03606889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715427|NCT03606889|Sensory System Agents|sensory system agents|mesh-ancestor
64715428|NCT03606889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715429|NCT05363917|Folic Acid|folic acid|mesh-list
64715430|NCT05363917|Vitamin B Complex|vitamin b complex|mesh-list
64715431|NCT05363917|Hematinics|hematinics|mesh-ancestor
64715432|NCT05363917|Vitamins|vitamins|mesh-ancestor
64715433|NCT05363917|Micronutrients|micronutrients|mesh-ancestor
64715434|NCT05363917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715435|NCT03187730|Nicotine|nicotine|mesh-list
64715436|NCT03187730|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64715437|NCT03187730|Autonomic Agents|autonomic agents|mesh-ancestor
64715438|NCT03187730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715439|NCT03187730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715440|NCT03187730|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64715441|NCT03187730|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64715468|NCT04736186|Protective Agents|protective agents|mesh-ancestor
64715469|NCT04736186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449767|NCT00183248|Antitubercular Agents|antitubercular agents|mesh-ancestor
65449768|NCT00183248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65449769|NCT00183248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449770|NCT00183248|Antifungal Agents|antifungal agents|mesh-ancestor
65449771|NCT00183248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65449772|NCT00230282|Cyclophosphamide|cyclophosphamide|mesh-list
65449773|NCT00230282|Fludarabine|fludarabine|mesh-list
65449774|NCT00230282|Alemtuzumab|alemtuzumab|mesh-list
65449775|NCT00230282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65449776|NCT00230282|Immunologic Factors|immunologic factors|mesh-ancestor
65449777|NCT00230282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449778|NCT00230282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65449779|NCT00230282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65199281|NCT05550402|Autonomic Agents|autonomic agents|mesh-ancestor
65449780|NCT00230282|Alkylating Agents|alkylating agents|mesh-ancestor
65449781|NCT00230282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834492|NCT05703659|Sulfalene|sulfalene|mesh-list
64715471|NCT03085147|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64715472|NCT03085147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715473|NCT03085147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715474|NCT03085147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715475|NCT04941170|Bupivacaine|bupivacaine|mesh-list
64715476|NCT04941170|Anesthetics, Local|anesthetics, local|mesh-ancestor
64715477|NCT04941170|Anesthetics|anesthetics|mesh-ancestor
64715478|NCT04941170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64715479|NCT04941170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715480|NCT04941170|Sensory System Agents|sensory system agents|mesh-ancestor
64715481|NCT04941170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715482|NCT05357911|Digoxin|digoxin|mesh-list
64715483|NCT05357911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64715484|NCT05357911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64715485|NCT05357911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715486|NCT05357911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715487|NCT05357911|Protective Agents|protective agents|mesh-ancestor
64715488|NCT05357911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715489|NCT03374839|Nivolumab|nivolumab|mesh-list
64715490|NCT03374839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64715491|NCT03374839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715492|NCT03374839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64715493|NCT03374839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715494|NCT03347929|Naproxen|naproxen|mesh-list
64715495|NCT03347929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64715496|NCT03347929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64715497|NCT03347929|Analgesics|analgesics|mesh-ancestor
64715498|NCT03347929|Sensory System Agents|sensory system agents|mesh-ancestor
64715499|NCT03347929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715500|NCT03347929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323777|NCT05485766|Paclitaxel|paclitaxel|mesh-list
64677458|NCT05503901|Adrenergic Agents|adrenergic agents|mesh-ancestor
64677459|NCT05503901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64677460|NCT05503901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677461|NCT05503901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715501|NCT03347929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64715502|NCT03347929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64715506|NCT03347929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715507|NCT02221674|Tapentadol|tapentadol|mesh-list
65449782|NCT00230282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449783|NCT00230282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65449784|NCT00230282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65449785|NCT00261950|Cinacalcet|cinacalcet|mesh-list
65449786|NCT00261950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65449787|NCT00261950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449788|NCT00261950|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65449789|NCT00261950|Hormone Antagonists|hormone antagonists|mesh-ancestor
65449790|NCT00261950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65449791|NCT00229658|Pramlintide|pramlintide|mesh-list
65449792|NCT00229658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65449793|NCT00229658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449794|NCT00182078|Sertraline|sertraline|mesh-list
65449795|NCT00182078|Antidepressive Agents|antidepressive agents|mesh-ancestor
65449796|NCT00182078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64834507|NCT05703373|Trace Elements|trace elements|mesh-list
64715508|NCT02221674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64715509|NCT02221674|Narcotics|narcotics|mesh-ancestor
64715510|NCT02221674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64715511|NCT02221674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323798|NCT04402723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64677462|NCT05503901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64677463|NCT05503901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64677464|NCT00001053|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64677465|NCT00001053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64677466|NCT00001053|Immunologic Factors|immunologic factors|mesh-ancestor
64677467|NCT00001053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677468|NCT00001053|Antacids|antacids|mesh-ancestor
64677469|NCT00001053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677470|NCT00001053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64677471|NCT00001989|Zidovudine|zidovudine|mesh-list
64677472|NCT00001989|Trichosanthin|trichosanthin|mesh-list
64677473|NCT00001989|Antimetabolites|antimetabolites|mesh-ancestor
64677474|NCT00001989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677475|NCT00001989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64677476|NCT00001989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64677478|NCT00001989|Antiviral Agents|antiviral agents|mesh-ancestor
64677479|NCT00001989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677480|NCT00001989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64677481|NCT00001989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64677482|NCT00001989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64677483|NCT00001989|Abortifacient Agents|abortifacient agents|mesh-ancestor
64677498|NCT00001059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64677499|NCT00001059|Tubulin Modulators|tubulin modulators|mesh-ancestor
64677500|NCT00001059|Antimitotic Agents|antimitotic agents|mesh-ancestor
64677501|NCT00001059|Mitosis Modulators|mitosis modulators|mesh-ancestor
64677502|NCT00001065|Amphotericin B|amphotericin b|mesh-list
64677503|NCT00001065|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64677504|NCT00001065|Amebicides|amebicides|mesh-ancestor
64677505|NCT00001065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64677506|NCT00001065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64677507|NCT00001065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677508|NCT00001065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64677509|NCT00001065|Antifungal Agents|antifungal agents|mesh-ancestor
64677510|NCT02977637|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64677511|NCT02977637|Hematinics|hematinics|mesh-ancestor
64677512|NCT02977637|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64677513|NCT02977637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64677514|NCT00001995|Rifabutin|rifabutin|mesh-list
65449797|NCT00182078|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65449798|NCT00182078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65449799|NCT00182078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65449800|NCT00182078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449801|NCT00182078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65449802|NCT00182078|Serotonin Agents|serotonin agents|mesh-ancestor
65449803|NCT00182078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449804|NCT00181844|Lamotrigine|lamotrigine|mesh-list
65449805|NCT00181844|Anticonvulsants|anticonvulsants|mesh-ancestor
65449806|NCT00181844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65449807|NCT00181844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65449808|NCT00181844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449809|NCT00181844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65449810|NCT00181844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449811|NCT00181844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65449812|NCT00181844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65449813|NCT00181844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64834524|NCT05701124|Growth Substances|growth substances|mesh-ancestor
64677515|NCT00001995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64677516|NCT00001995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677517|NCT00001995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64677518|NCT00001995|Antitubercular Agents|antitubercular agents|mesh-ancestor
64677519|NCT05501483|Pioglitazone|pioglitazone|mesh-list
64677520|NCT05501483|Empagliflozin|empagliflozin|mesh-list
64677521|NCT05501483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64677522|NCT05501483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677523|NCT05501483|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64677524|NCT05501483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677525|NCT00002001|Zidovudine|zidovudine|mesh-list
64677526|NCT00002001|Didanosine|didanosine|mesh-list
64677527|NCT00002001|Zalcitabine|zalcitabine|mesh-list
64715512|NCT02221674|Analgesics|analgesics|mesh-ancestor
64715513|NCT02221674|Sensory System Agents|sensory system agents|mesh-ancestor
64715514|NCT02221674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715515|NCT02221674|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64715516|NCT02221674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64715517|NCT02221674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64715518|NCT02221674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715519|NCT02221674|Adrenergic Agents|adrenergic agents|mesh-ancestor
64715520|NCT02221674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64715521|NCT04736719|Warfarin|warfarin|mesh-list
64715522|NCT04736719|Apixaban|apixaban|mesh-list
64715523|NCT04736719|Anticoagulants|anticoagulants|mesh-ancestor
64715524|NCT04736719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64715526|NCT04736719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64715527|NCT04736719|Protease Inhibitors|protease inhibitors|mesh-ancestor
64715528|NCT04736719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715529|NCT04736719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715530|NCT02221284|Alogliptin|alogliptin|mesh-list
64323819|NCT02263027|Vaccines|vaccines|mesh-list
64677528|NCT00002001|Antimetabolites|antimetabolites|mesh-ancestor
64677529|NCT00002001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677530|NCT00002001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65449814|NCT00181844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65449815|NCT00181844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65449816|NCT00181766|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65449817|NCT00181766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65449818|NCT00181766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65449819|NCT00181766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65449820|NCT00181766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449821|NCT00181766|Adrenergic Agents|adrenergic agents|mesh-ancestor
65449822|NCT00181766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65449823|NCT00181766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449824|NCT00180674|Warfarin|warfarin|mesh-list
65449825|NCT00180674|Anticoagulants|anticoagulants|mesh-ancestor
65449826|NCT01074632|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65449827|NCT01074632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65449828|NCT01074632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65449829|NCT01074632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65449830|NCT01074632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449831|NCT01074632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65449832|NCT01074632|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65449833|NCT01074632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65449834|NCT01074632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65449835|NCT01074632|Adrenergic Agents|adrenergic agents|mesh-ancestor
65449836|NCT01074632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65449837|NCT01074632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449838|NCT01074632|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64834541|NCT05645380|Docetaxel|docetaxel|mesh-list
64834542|NCT05645380|Doxorubicin|doxorubicin|mesh-list
64834543|NCT05645380|Pembrolizumab|pembrolizumab|mesh-list
64834544|NCT05645380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64834545|NCT05645380|Immunologic Factors|immunologic factors|mesh-ancestor
64834546|NCT05645380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834547|NCT05645380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64834548|NCT05645380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64834549|NCT05645380|Alkylating Agents|alkylating agents|mesh-ancestor
64677531|NCT00002001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64677532|NCT00002001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677533|NCT00002001|Antiviral Agents|antiviral agents|mesh-ancestor
64677534|NCT00002001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449839|NCT01074632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65449840|NCT01074632|Serotonin Agents|serotonin agents|mesh-ancestor
65449841|NCT01074632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65449842|NCT01074632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65449843|NCT01074632|Dopamine Agents|dopamine agents|mesh-ancestor
65449844|NCT00076024|Docetaxel|docetaxel|mesh-list
65449845|NCT00076024|Axitinib|axitinib|mesh-list
65449846|NCT00076024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449847|NCT00076024|Tubulin Modulators|tubulin modulators|mesh-ancestor
65449848|NCT00076024|Antimitotic Agents|antimitotic agents|mesh-ancestor
65449849|NCT00076024|Mitosis Modulators|mitosis modulators|mesh-ancestor
65449850|NCT00076024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449851|NCT00076024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65449852|NCT00076024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449853|NCT01103050|Cetirizine|cetirizine|mesh-list
65449854|NCT01103050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65449855|NCT01103050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65449856|NCT01103050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64677535|NCT00002001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64677536|NCT00002001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64677537|NCT00002007|Zidovudine|zidovudine|mesh-list
64677538|NCT00002007|Sargramostim|sargramostim|mesh-list
64677539|NCT00002007|Antimetabolites|antimetabolites|mesh-ancestor
64677540|NCT00002007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677541|NCT00002007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64677555|NCT00001095|Amprenavir|amprenavir|mesh-list
64677556|NCT00001095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64677557|NCT00001095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64677558|NCT00001095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677559|NCT00001095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677560|NCT00001095|Antiviral Agents|antiviral agents|mesh-ancestor
64677561|NCT00001095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677562|NCT00001095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64677563|NCT00001095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64677564|NCT00001095|Antimetabolites|antimetabolites|mesh-ancestor
64677565|NCT00001095|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64677566|NCT00001095|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64677567|NCT00001095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64677568|NCT00001095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64677569|NCT00001095|Protease Inhibitors|protease inhibitors|mesh-ancestor
64677570|NCT00001095|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64677571|NCT00001095|Antitubercular Agents|antitubercular agents|mesh-ancestor
64677572|NCT00001095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64677574|NCT02294058|Interferon-beta|interferon-beta|mesh-list
64677575|NCT02294058|Interferon beta-1a|interferon beta-1a|mesh-list
64677576|NCT02294058|Ozanimod|ozanimod|mesh-list
64715532|NCT02221284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715533|NCT02221284|Incretins|incretins|mesh-ancestor
64715534|NCT02221284|Hormones|hormones|mesh-ancestor
64715535|NCT02221284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64715536|NCT02221284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64715537|NCT02221284|Protease Inhibitors|protease inhibitors|mesh-ancestor
64715538|NCT02221284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715539|NCT02221284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715540|NCT04736108|Prednisolone|prednisolone|mesh-list
64715541|NCT04736108|Goserelin|goserelin|mesh-list
64715542|NCT04736108|Abiraterone Acetate|abiraterone acetate|mesh-list
64323830|NCT05485064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64677577|NCT02294058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449857|NCT01103050|Histamine Antagonists|histamine antagonists|mesh-ancestor
65449858|NCT01103050|Histamine Agents|histamine agents|mesh-ancestor
65449859|NCT01103050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65449860|NCT01103050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449861|NCT01103050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449862|NCT00075478|Cyclosporine|cyclosporine|mesh-list
65449863|NCT00075478|Mycophenolic Acid|mycophenolic acid|mesh-list
65449864|NCT00075478|Fludarabine|fludarabine|mesh-list
65449865|NCT00075478|Fludarabine phosphate|fludarabine phosphate|mesh-list
65449866|NCT00075478|Cyclosporins|cyclosporins|mesh-list
65449867|NCT00075478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449868|NCT00075478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65449869|NCT00075478|Antimetabolites|antimetabolites|mesh-ancestor
64677578|NCT02294058|Antiviral Agents|antiviral agents|mesh-ancestor
64677579|NCT02294058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677580|NCT02294058|Immunologic Factors|immunologic factors|mesh-ancestor
64677581|NCT02294058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677582|NCT02294058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64677583|NCT02294058|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64677584|NCT02294058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677585|NCT02294058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64677586|NCT05493215|Imatinib Mesylate|imatinib mesylate|mesh-list
64677587|NCT05493215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677588|NCT05493215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64677589|NCT05493215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677590|NCT05493215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677591|NCT00002013|Zidovudine|zidovudine|mesh-list
64677592|NCT00002013|Antimetabolites|antimetabolites|mesh-ancestor
64677593|NCT00002013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677594|NCT00002013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64677595|NCT00002013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64677597|NCT00002013|Antiviral Agents|antiviral agents|mesh-ancestor
64677598|NCT00002013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677599|NCT00002013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64677600|NCT00002013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64677601|NCT00359333|Gemcitabine|gemcitabine|mesh-list
64677602|NCT00359333|Docetaxel|docetaxel|mesh-list
64677603|NCT00359333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64677604|NCT00359333|Antimetabolites|antimetabolites|mesh-ancestor
64677605|NCT00359333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677606|NCT00359333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677607|NCT00359333|Antiviral Agents|antiviral agents|mesh-ancestor
64677608|NCT00359333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677613|NCT00359333|Tubulin Modulators|tubulin modulators|mesh-ancestor
64677614|NCT00359333|Antimitotic Agents|antimitotic agents|mesh-ancestor
64677615|NCT00359333|Mitosis Modulators|mitosis modulators|mesh-ancestor
64677616|NCT00001101|Doxycycline|doxycycline|mesh-list
64677617|NCT00001101|Ceftriaxone|ceftriaxone|mesh-list
64677618|NCT00001101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64677619|NCT00001101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677620|NCT00001101|Antimalarials|antimalarials|mesh-ancestor
64677621|NCT00001101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64677622|NCT00001101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64677623|NCT00001107|Fluconazole|fluconazole|mesh-list
64677624|NCT00001107|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64677625|NCT00001107|Antifungal Agents|antifungal agents|mesh-ancestor
64677626|NCT00001107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677627|NCT00001107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64677628|NCT00001107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64715543|NCT04736108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64715544|NCT04736108|Glucocorticoids|glucocorticoids|mesh-ancestor
64715545|NCT04736108|Hormones|hormones|mesh-ancestor
65449870|NCT00075478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449871|NCT00075478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65449872|NCT00075478|Immunologic Factors|immunologic factors|mesh-ancestor
65449873|NCT00075478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449874|NCT00075478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449875|NCT00075478|Antifungal Agents|antifungal agents|mesh-ancestor
65449876|NCT00075478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449877|NCT00075478|Dermatologic Agents|dermatologic agents|mesh-ancestor
65449878|NCT00075478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65449879|NCT00075478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64834597|NCT05458232|Tadalafil|tadalafil|mesh-list
64715546|NCT04736108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64715547|NCT04736108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715548|NCT04736108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64715549|NCT04736108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715550|NCT04736108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64715551|NCT04736108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715552|NCT04736108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715553|NCT04736108|Hormone Antagonists|hormone antagonists|mesh-ancestor
64715554|NCT04736108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64715555|NCT04736329|Telmisartan|telmisartan|mesh-list
64715556|NCT04736329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64715557|NCT04736329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64715558|NCT04736329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64715559|NCT04736329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715560|NCT02971033|Ezetimibe|ezetimibe|mesh-list
64715561|NCT02971033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64715562|NCT02971033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64715563|NCT02971033|Antimetabolites|antimetabolites|mesh-ancestor
64715564|NCT02971033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715565|NCT02971033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64715566|NCT05406674|Cisplatin|cisplatin|mesh-list
64715567|NCT05406674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715568|NCT05341375|Anesthetics|anesthetics|mesh-list
64715569|NCT05341375|Esketamine|esketamine|mesh-list
64715570|NCT05341375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64715571|NCT05341375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715572|NCT05341375|Antidepressive Agents|antidepressive agents|mesh-ancestor
64715573|NCT05341375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64715574|NCT03196232|Pembrolizumab|pembrolizumab|mesh-list
64715575|NCT03196232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64715576|NCT03196232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715577|NCT04356716|Sildenafil Citrate|sildenafil citrate|mesh-list
64677629|NCT00001107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715579|NCT04356716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64715580|NCT04356716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64715581|NCT04356716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715582|NCT04356716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715583|NCT04356716|Urological Agents|urological agents|mesh-ancestor
64715584|NCT03200587|Avelumab|avelumab|mesh-list
64715585|NCT03200587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64715586|NCT03200587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715587|NCT03198884|Dolutegravir|dolutegravir|mesh-list
64715588|NCT03198884|Darunavir|darunavir|mesh-list
64677630|NCT00001107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677631|NCT00001107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64677632|NCT00001107|Hormone Antagonists|hormone antagonists|mesh-ancestor
64677633|NCT00001107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64677634|NCT00001107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677635|NCT00001107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64677636|NCT00001107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65449880|NCT00075478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65449881|NCT00075478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65449882|NCT00075478|Antitubercular Agents|antitubercular agents|mesh-ancestor
65449883|NCT00075478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65449884|NCT00175916|Brivaracetam|brivaracetam|mesh-list
65449885|NCT00175916|Anticonvulsants|anticonvulsants|mesh-ancestor
65449886|NCT01089088|Gemcitabine|gemcitabine|mesh-list
65449887|NCT01089088|Sunitinib|sunitinib|mesh-list
65449888|NCT01089088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449889|NCT01089088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65449890|NCT01089088|Antimetabolites|antimetabolites|mesh-ancestor
64834612|NCT05429502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677637|NCT00001107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64677638|NCT00001107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64677639|NCT00002019|Amphotericin B|amphotericin b|mesh-list
64677640|NCT00002019|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64677641|NCT00002019|Amebicides|amebicides|mesh-ancestor
64677642|NCT00002019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64677643|NCT00002019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64677644|NCT00002019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677645|NCT00002019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64677646|NCT00002019|Antifungal Agents|antifungal agents|mesh-ancestor
64677647|NCT00002025|Ganciclovir|ganciclovir|mesh-list
64677648|NCT00002025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64677649|NCT00002025|Antiviral Agents|antiviral agents|mesh-ancestor
64677650|NCT00002025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677651|NCT00002025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64677652|NCT00002025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677653|NCT00002025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677654|NCT05060237|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64677655|NCT05060237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64677656|NCT05060237|Dermatologic Agents|dermatologic agents|mesh-ancestor
64677657|NCT00001131|Aldesleukin|aldesleukin|mesh-list
64677658|NCT00001131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677659|NCT00001131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64677660|NCT00001131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64677661|NCT00001131|Antiviral Agents|antiviral agents|mesh-ancestor
64677662|NCT00001131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677663|NCT00001155|Cyclophosphamide|cyclophosphamide|mesh-list
64677664|NCT00001155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64677665|NCT00001155|Immunologic Factors|immunologic factors|mesh-ancestor
64677666|NCT00001155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677667|NCT00001155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64677668|NCT00001155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64677669|NCT00001155|Alkylating Agents|alkylating agents|mesh-ancestor
64677670|NCT00001155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677671|NCT00001155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677685|NCT05270057|Cyclophosphamide|cyclophosphamide|mesh-list
64677686|NCT05270057|Rituximab|rituximab|mesh-list
64677687|NCT05270057|Doxorubicin|doxorubicin|mesh-list
64677688|NCT05270057|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64677689|NCT05270057|Etoposide|etoposide|mesh-list
64715591|NCT03198884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715592|NCT03198884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715593|NCT03198884|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64715594|NCT03198884|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64715595|NCT03198884|Antiviral Agents|antiviral agents|mesh-ancestor
64715596|NCT03198884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64715597|NCT03198884|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64677690|NCT05270057|Vincristine|vincristine|mesh-list
64677691|NCT05270057|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
64677692|NCT05270057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64677693|NCT05270057|Immunologic Factors|immunologic factors|mesh-ancestor
64677694|NCT05270057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677695|NCT05270057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64677696|NCT05270057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65449891|NCT01089088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449892|NCT01089088|Antiviral Agents|antiviral agents|mesh-ancestor
65449893|NCT01089088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449894|NCT01089088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449895|NCT01089088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65449896|NCT01089088|Immunologic Factors|immunologic factors|mesh-ancestor
65449897|NCT01089088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449898|NCT01089088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65449899|NCT01089088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65449900|NCT01089088|Growth Substances|growth substances|mesh-ancestor
65449901|NCT01089088|Growth Inhibitors|growth inhibitors|mesh-ancestor
65449902|NCT01089088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65449903|NCT00075400|Imatinib Mesylate|imatinib mesylate|mesh-list
64834618|NCT05274243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64677697|NCT05270057|Alkylating Agents|alkylating agents|mesh-ancestor
64677698|NCT05270057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677699|NCT05270057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677700|NCT05270057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64677701|NCT05270057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64677702|NCT05270057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64677703|NCT05270057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64677704|NCT05270057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64677706|NCT05270057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64677707|NCT05270057|Glucocorticoids|glucocorticoids|mesh-ancestor
64677709|NCT05270057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64677710|NCT05270057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64677711|NCT05270057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64677712|NCT05270057|Tubulin Modulators|tubulin modulators|mesh-ancestor
64484375|NCT01729819|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64677713|NCT05270057|Antimitotic Agents|antimitotic agents|mesh-ancestor
64677714|NCT05270057|Mitosis Modulators|mitosis modulators|mesh-ancestor
64677716|NCT00002043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677717|NCT00002043|Antimalarials|antimalarials|mesh-ancestor
64677718|NCT00002043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64677719|NCT00002043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64677720|NCT00002043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64677721|NCT00002043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677722|NCT00002043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677723|NCT00002043|Leprostatic Agents|leprostatic agents|mesh-ancestor
64677724|NCT00002043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64677725|NCT00001209|Cyclophosphamide|cyclophosphamide|mesh-list
64677726|NCT00001209|Ifosfamide|ifosfamide|mesh-list
64677727|NCT00001209|Vincristine|vincristine|mesh-list
64677728|NCT00001209|Doxorubicin|doxorubicin|mesh-list
64677729|NCT00001209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64677730|NCT00001209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64677731|NCT00001209|Immunologic Factors|immunologic factors|mesh-ancestor
64677732|NCT00001209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677733|NCT00001209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64677744|NCT00001209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64677745|NCT00001209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64677746|NCT00001209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677747|NCT00002049|Thymopentin|thymopentin|mesh-list
64677748|NCT00002049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64677749|NCT00002049|Immunologic Factors|immunologic factors|mesh-ancestor
64677750|NCT00002049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677751|NCT05044637|Primaquine|primaquine|mesh-list
64677752|NCT05044637|Antimalarials|antimalarials|mesh-ancestor
64677753|NCT05044637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64677754|NCT05044637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65449904|NCT00075400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449905|NCT00075400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65449906|NCT00075400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449907|NCT00075400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449908|NCT01103206|Cinacalcet|cinacalcet|mesh-list
65449909|NCT01103206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65449910|NCT01103206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449911|NCT01103206|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65449912|NCT01103206|Hormone Antagonists|hormone antagonists|mesh-ancestor
65449913|NCT01103206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65449914|NCT00228566|Modafinil|modafinil|mesh-list
65449915|NCT00228566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65449916|NCT00228566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449917|NCT00228566|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65449918|NCT00228566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65449919|NCT00228566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65449920|NCT00228566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449921|NCT05625724|Aspirin|aspirin|mesh-list
65449922|NCT05625724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65449923|NCT05625724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65449924|NCT05625724|Analgesics|analgesics|mesh-ancestor
64677755|NCT05044637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677756|NCT05043077|Phenylephrine|phenylephrine|mesh-list
64677757|NCT05043077|Oxymetazoline|oxymetazoline|mesh-list
64677758|NCT05043077|Tropicamide|tropicamide|mesh-list
64677759|NCT05043077|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64677760|NCT05043077|Mydriatics|mydriatics|mesh-ancestor
64677761|NCT05043077|Autonomic Agents|autonomic agents|mesh-ancestor
64715598|NCT03198884|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64715599|NCT03198884|Protease Inhibitors|protease inhibitors|mesh-ancestor
64715600|NCT01801189|Pregabalin|pregabalin|mesh-list
64715601|NCT01801189|Analgesics|analgesics|mesh-ancestor
64715602|NCT01801189|Sensory System Agents|sensory system agents|mesh-ancestor
64677762|NCT05043077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64677763|NCT05043077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677764|NCT05043077|Sympathomimetics|sympathomimetics|mesh-ancestor
64677765|NCT05043077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64677766|NCT05043077|Nasal Decongestants|nasal decongestants|mesh-ancestor
64677767|NCT05043077|Respiratory System Agents|respiratory system agents|mesh-ancestor
64677768|NCT05043077|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64677769|NCT05043077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64677770|NCT05043077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64677771|NCT05043077|Adrenergic Agents|adrenergic agents|mesh-ancestor
64677772|NCT05043077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64677773|NCT05043077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677774|NCT05043077|Protective Agents|protective agents|mesh-ancestor
64677775|NCT05043077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64677776|NCT05043077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64677777|NCT05043077|Cholinergic Agents|cholinergic agents|mesh-ancestor
64677778|NCT00002055|Pentamidine|pentamidine|mesh-list
64677779|NCT00002055|Antifungal Agents|antifungal agents|mesh-ancestor
64677780|NCT00002055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65449925|NCT05625724|Sensory System Agents|sensory system agents|mesh-ancestor
65449926|NCT05625724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65449927|NCT05625724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199439|NCT05188677|Vaccines|vaccines|mesh-list
65449928|NCT05625724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65449929|NCT05625724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65449930|NCT05625724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65449931|NCT05625724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65449932|NCT05625724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449933|NCT05625724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65449934|NCT05625724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65449935|NCT05625724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65449936|NCT05625724|Antipyretics|antipyretics|mesh-ancestor
65449937|NCT01089166|Metformin|metformin|mesh-list
65449938|NCT01089166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65449939|NCT01089166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449940|NCT00203502|Cyclophosphamide|cyclophosphamide|mesh-list
65449941|NCT00203502|Bevacizumab|bevacizumab|mesh-list
65449942|NCT00203502|Docetaxel|docetaxel|mesh-list
64677781|NCT00002055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64677782|NCT00002055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64677783|NCT00002055|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64677784|NCT05031455|Aspirin|aspirin|mesh-list
64677785|NCT05031455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64677786|NCT05031455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64677787|NCT05031455|Analgesics|analgesics|mesh-ancestor
64677788|NCT05031455|Sensory System Agents|sensory system agents|mesh-ancestor
64677789|NCT05031455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64677790|NCT05031455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677791|NCT05031455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64677792|NCT05031455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64677793|NCT05031455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64677794|NCT05031455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64677795|NCT05031455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677796|NCT05031455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64677808|NCT00002061|Inosine Pranobex|inosine pranobex|mesh-list
64677809|NCT00002061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64677810|NCT00002061|Immunologic Factors|immunologic factors|mesh-ancestor
64677811|NCT00002061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677812|NCT00002061|Antiviral Agents|antiviral agents|mesh-ancestor
64677813|NCT00002061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677814|NCT00002067|Megestrol|megestrol|mesh-list
64677815|NCT00002067|Megestrol Acetate|megestrol acetate|mesh-list
64677816|NCT00002067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64677817|NCT00002067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64677818|NCT00002067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64677819|NCT00002067|Contraceptive Agents|contraceptive agents|mesh-ancestor
64677820|NCT00002067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64677821|NCT00002067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677822|NCT00002067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64677823|NCT00002067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64677824|NCT00002067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64677825|NCT00002067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677826|NCT00002067|Appetite Stimulants|appetite stimulants|mesh-ancestor
64677827|NCT00002067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64677828|NCT05442983|Probenecid|probenecid|mesh-list
64677829|NCT05442983|Uricosuric Agents|uricosuric agents|mesh-ancestor
65449943|NCT00203502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65449944|NCT00203502|Immunologic Factors|immunologic factors|mesh-ancestor
65449945|NCT00203502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449946|NCT00203502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65449947|NCT00203502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65449948|NCT00203502|Alkylating Agents|alkylating agents|mesh-ancestor
65449949|NCT00203502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449950|NCT00203502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449951|NCT00203502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65449952|NCT00203502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65449953|NCT00203502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65449954|NCT00203502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65449955|NCT00203502|Growth Substances|growth substances|mesh-ancestor
64677830|NCT05442983|Gout Suppressants|gout suppressants|mesh-ancestor
64677831|NCT05442983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64677832|NCT05442983|Renal Agents|renal agents|mesh-ancestor
64677833|NCT00380835|Amrubicin|amrubicin|mesh-list
64677834|NCT00380835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715608|NCT01801189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715609|NCT01801189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64715610|NCT01801189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64715611|NCT01801189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64715612|NCT01801189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64715613|NCT01801189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64715614|NCT04275362|Cimetidine|cimetidine|mesh-list
64715615|NCT04275362|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64715616|NCT04275362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64715617|NCT04275362|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64715618|NCT04275362|Histamine Antagonists|histamine antagonists|mesh-ancestor
64715619|NCT04275362|Histamine Agents|histamine agents|mesh-ancestor
64677843|NCT00001311|Heparin|heparin|mesh-list
64677844|NCT00001311|Anticoagulants|anticoagulants|mesh-ancestor
64677845|NCT00001311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64677846|NCT00001311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64677847|NCT00001311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677848|NCT05016713|Chlorhexidine|chlorhexidine|mesh-list
64677849|NCT05016713|Fluorides|fluorides|mesh-list
64677850|NCT05016713|Cariostatic Agents|cariostatic agents|mesh-ancestor
64677851|NCT05016713|Protective Agents|protective agents|mesh-ancestor
64677852|NCT05016713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677853|NCT05016713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64677854|NCT05016713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677855|NCT05016713|Disinfectants|disinfectants|mesh-ancestor
64677856|NCT00002073|Epoetin Alfa|epoetin alfa|mesh-list
64677857|NCT00002073|Hematinics|hematinics|mesh-ancestor
64677858|NCT00001317|Interferons|interferons|mesh-list
64677859|NCT00001317|Interferon-gamma|interferon-gamma|mesh-list
64677860|NCT00001317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677861|NCT00001317|Antiviral Agents|antiviral agents|mesh-ancestor
64677862|NCT00001317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677863|NCT00001335|Topotecan|topotecan|mesh-list
64677871|NCT00002079|Antimetabolites|antimetabolites|mesh-ancestor
64677872|NCT00002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677873|NCT00002079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64677874|NCT00002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64677875|NCT00002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677876|NCT00002079|Antiviral Agents|antiviral agents|mesh-ancestor
64677880|NCT00002079|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64677881|NCT00002079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64677882|NCT00002079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677883|NCT00002085|Azithromycin|azithromycin|mesh-list
64677884|NCT00002085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65449956|NCT00203502|Growth Inhibitors|growth inhibitors|mesh-ancestor
65449957|NCT00203502|Tubulin Modulators|tubulin modulators|mesh-ancestor
65449958|NCT00203502|Antimitotic Agents|antimitotic agents|mesh-ancestor
65449959|NCT00203502|Mitosis Modulators|mitosis modulators|mesh-ancestor
65449960|NCT01103518|Cyproterone Acetate|cyproterone acetate|mesh-list
65449961|NCT01103518|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65449962|NCT01103518|Estradiol|estradiol|mesh-list
65449963|NCT01103518|Cyproterone|cyproterone|mesh-list
65449964|NCT01103518|Estrogens|estrogens|mesh-ancestor
65449965|NCT01103518|Hormones|hormones|mesh-ancestor
65449966|NCT01103518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64677885|NCT00002085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64715620|NCT04275362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64715621|NCT04275362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715622|NCT04275362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715623|NCT04275362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64715624|NCT04275362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64715625|NCT04275362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677887|NCT00001383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64677888|NCT00001383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677889|NCT00001383|Tubulin Modulators|tubulin modulators|mesh-ancestor
64677890|NCT00001383|Antimitotic Agents|antimitotic agents|mesh-ancestor
64677891|NCT00001383|Mitosis Modulators|mitosis modulators|mesh-ancestor
64677892|NCT00001383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677893|NCT00002091|Pentoxifylline|pentoxifylline|mesh-list
64677894|NCT00002091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64677895|NCT00002091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677896|NCT00002091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677897|NCT00002091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64677898|NCT00002091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64677899|NCT00002091|Protective Agents|protective agents|mesh-ancestor
64677900|NCT00002091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677901|NCT00002091|Vasodilator Agents|vasodilator agents|mesh-ancestor
64677902|NCT00002091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64677903|NCT00002091|Antioxidants|antioxidants|mesh-ancestor
64677904|NCT00001407|Interferons|interferons|mesh-list
64677905|NCT00001407|Interferon-gamma|interferon-gamma|mesh-list
64677906|NCT00001407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677907|NCT00001407|Antiviral Agents|antiviral agents|mesh-ancestor
64677908|NCT00001407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677909|NCT00002097|Nystatin|nystatin|mesh-list
64677910|NCT00002097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64677911|NCT00002097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677912|NCT00002097|Antifungal Agents|antifungal agents|mesh-ancestor
64677913|NCT00002097|Ionophores|ionophores|mesh-ancestor
64677914|NCT00002097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64677915|NCT00002097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677916|NCT00001431|Gemcitabine|gemcitabine|mesh-list
64677917|NCT00001431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64677918|NCT00001431|Antimetabolites|antimetabolites|mesh-ancestor
64677919|NCT00001431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677920|NCT00001431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677921|NCT00001431|Antiviral Agents|antiviral agents|mesh-ancestor
64677922|NCT00001431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677923|NCT00001431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677924|NCT00001431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64677925|NCT00001431|Immunologic Factors|immunologic factors|mesh-ancestor
64677926|NCT00001431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677927|NCT05428007|Nivolumab|nivolumab|mesh-list
64677928|NCT05428007|Ipilimumab|ipilimumab|mesh-list
64677929|NCT05428007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64677930|NCT05428007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677941|NCT00002103|Vitamin B Complex|vitamin b complex|mesh-ancestor
64677943|NCT00002103|Micronutrients|micronutrients|mesh-ancestor
64677944|NCT00002103|Antifungal Agents|antifungal agents|mesh-ancestor
65449967|NCT01103518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449968|NCT01103518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65449969|NCT01103518|Contraceptive Agents|contraceptive agents|mesh-ancestor
65449970|NCT01103518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65449971|NCT01103518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65449972|NCT01103518|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65449973|NCT01103518|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65449974|NCT01103518|Androgen Antagonists|androgen antagonists|mesh-ancestor
65449975|NCT01103518|Hormone Antagonists|hormone antagonists|mesh-ancestor
65449976|NCT01103518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65449977|NCT01103518|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65449978|NCT01327534|Clopidogrel|clopidogrel|mesh-list
65449979|NCT01327534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65449980|NCT01327534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65449981|NCT01327534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65449982|NCT01327534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65449983|NCT01327534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65449984|NCT01327534|Purinergic Agents|purinergic agents|mesh-ancestor
65449985|NCT01327534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65449986|NCT01327534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449987|NCT01327534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65449988|NCT00232596|Ezogabine|ezogabine|mesh-list
65449989|NCT00232596|Anticonvulsants|anticonvulsants|mesh-ancestor
65449990|NCT00232596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64677945|NCT00002103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677946|NCT00002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64677947|NCT00002103|Antimetabolites|antimetabolites|mesh-ancestor
64677948|NCT00002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677949|NCT00002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677950|NCT00002103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64677951|NCT00002103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677952|NCT00001437|Pentoxifylline|pentoxifylline|mesh-list
64677953|NCT00001437|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64677954|NCT00001437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677956|NCT00001437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64715626|NCT05178043|Nivolumab|nivolumab|mesh-list
64715627|NCT05178043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64715628|NCT05178043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715629|NCT05178043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64715630|NCT05178043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677958|NCT00001437|Protective Agents|protective agents|mesh-ancestor
64677959|NCT00001437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677960|NCT00001437|Vasodilator Agents|vasodilator agents|mesh-ancestor
64677961|NCT00001437|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64677962|NCT00001437|Antioxidants|antioxidants|mesh-ancestor
64677964|NCT00360191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64677965|NCT00360191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64677966|NCT00360191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65449991|NCT00232596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65449992|NCT00073918|Iodine|iodine|mesh-list
65449993|NCT00073918|Cadexomer iodine|cadexomer iodine|mesh-list
65449994|NCT00073918|Cyclophosphamide|cyclophosphamide|mesh-list
65449995|NCT00073918|Etoposide|etoposide|mesh-list
65449996|NCT00073918|Etoposide phosphate|etoposide phosphate|mesh-list
65449997|NCT00073918|Tositumomab I-131|tositumomab i-131|mesh-list
65449998|NCT00073918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65449999|NCT00073918|Antibodies|antibodies|mesh-list
65450000|NCT00073918|Immunoglobulins|immunoglobulins|mesh-list
65450001|NCT00073918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65450002|NCT00073918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65450003|NCT00073918|Immunologic Factors|immunologic factors|mesh-ancestor
65450004|NCT00073918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450005|NCT00073918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65450006|NCT00073918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65450007|NCT00073918|Alkylating Agents|alkylating agents|mesh-ancestor
65450008|NCT00073918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450009|NCT00073918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450010|NCT00073918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65450011|NCT00073918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65450012|NCT00073918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65450013|NCT00073918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64834726|NCT04484532|Vaccines|vaccines|mesh-list
64677967|NCT00360191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677968|NCT00360191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64677969|NCT00360191|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64677970|NCT00360191|Serotonin Agents|serotonin agents|mesh-ancestor
64677971|NCT00360191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64677972|NCT00360191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677973|NCT00001443|Indinavir|indinavir|mesh-list
64677974|NCT00001443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64677975|NCT00001443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64677976|NCT00001443|Protease Inhibitors|protease inhibitors|mesh-ancestor
64677977|NCT00001443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677978|NCT00001443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677979|NCT00001443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64677980|NCT00001443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64677981|NCT00001443|Antiviral Agents|antiviral agents|mesh-ancestor
64677982|NCT00001443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677983|NCT00001449|Leucovorin|leucovorin|mesh-list
64677984|NCT00001449|Gemcitabine|gemcitabine|mesh-list
64677985|NCT00001449|Floxuridine|floxuridine|mesh-list
64677986|NCT00001449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64677987|NCT00001449|Antimetabolites|antimetabolites|mesh-ancestor
64677988|NCT00001449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677989|NCT00001449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677990|NCT00001449|Antiviral Agents|antiviral agents|mesh-ancestor
64677991|NCT00001449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677992|NCT00001449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677993|NCT00001449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65450014|NCT00073918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450015|NCT00073918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65450016|NCT00073918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65450017|NCT00073918|Trace Elements|trace elements|mesh-ancestor
65450018|NCT00073918|Micronutrients|micronutrients|mesh-ancestor
65450019|NCT00231894|Pioglitazone|pioglitazone|mesh-list
65450020|NCT00231894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65450021|NCT00231894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450022|NCT00203424|Bevacizumab|bevacizumab|mesh-list
65450023|NCT00203424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65450024|NCT00203424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65450025|NCT00203424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450026|NCT00203424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65450027|NCT00203424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65450028|NCT00203424|Growth Substances|growth substances|mesh-ancestor
65450029|NCT00203424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450030|NCT00203424|Growth Inhibitors|growth inhibitors|mesh-ancestor
65450031|NCT00203424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65450032|NCT00203424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450033|NCT00203424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450034|NCT00203268|Dihydroergotamine|dihydroergotamine|mesh-list
65450035|NCT00203268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65450036|NCT00203268|Dopamine Agonists|dopamine agonists|mesh-ancestor
64677994|NCT00001449|Immunologic Factors|immunologic factors|mesh-ancestor
64677995|NCT00001449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677997|NCT00001449|Protective Agents|protective agents|mesh-ancestor
64677998|NCT00001449|Vitamin B Complex|vitamin b complex|mesh-ancestor
64677999|NCT00001449|Vitamins|vitamins|mesh-ancestor
64678001|NCT00002109|Zidovudine|zidovudine|mesh-list
64678002|NCT00002109|Stavudine|stavudine|mesh-list
64678003|NCT00002109|Didanosine|didanosine|mesh-list
64678004|NCT00002109|Zalcitabine|zalcitabine|mesh-list
64678005|NCT00002109|Thymopentin|thymopentin|mesh-list
64678006|NCT00002109|Antimetabolites|antimetabolites|mesh-ancestor
64678007|NCT00002109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678008|NCT00002109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64678009|NCT00002109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678010|NCT00002109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678011|NCT00002109|Antiviral Agents|antiviral agents|mesh-ancestor
64678012|NCT00002109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678013|NCT00002109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64678014|NCT00002109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678015|NCT00002109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64678016|NCT00002109|Immunologic Factors|immunologic factors|mesh-ancestor
64678017|NCT00002109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484377|NCT01729819|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64678019|NCT00359567|Granisetron|granisetron|mesh-list
64678020|NCT00359567|Antiemetics|antiemetics|mesh-ancestor
64678021|NCT00359567|Autonomic Agents|autonomic agents|mesh-ancestor
64678022|NCT00359567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64678023|NCT00359567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678024|NCT00359567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64678025|NCT00359567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65450037|NCT00203268|Dopamine Agents|dopamine agents|mesh-ancestor
65450038|NCT00203268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65450039|NCT00203268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450040|NCT00203268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450041|NCT00203268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65450042|NCT00203268|Analgesics|analgesics|mesh-ancestor
65450043|NCT00203268|Sensory System Agents|sensory system agents|mesh-ancestor
65450044|NCT00203268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65450046|NCT00168818|Dabigatran|dabigatran|mesh-list
65450047|NCT00168818|Anticoagulants|anticoagulants|mesh-ancestor
65450048|NCT00168818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65450049|NCT00168818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65450050|NCT00168818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450051|NCT00168818|Antithrombins|antithrombins|mesh-ancestor
65450052|NCT00168818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64715631|NCT00716755|Olanzapine|olanzapine|mesh-list
64678026|NCT00359567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64678028|NCT00359567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64678029|NCT00359567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678030|NCT00381147|Clarithromycin|clarithromycin|mesh-list
64678031|NCT00381147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64678032|NCT00381147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678033|NCT00381147|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64678034|NCT00381147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678035|NCT00381147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678036|NCT00381147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64678037|NCT00381147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64678038|NCT05210465|Dobutamine|dobutamine|mesh-list
64678039|NCT05210465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64678040|NCT05210465|Sympathomimetics|sympathomimetics|mesh-ancestor
64678041|NCT05210465|Autonomic Agents|autonomic agents|mesh-ancestor
64678042|NCT05210465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64678043|NCT05210465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678044|NCT05210465|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64678045|NCT05210465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64678046|NCT05210465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64678047|NCT05210465|Adrenergic Agents|adrenergic agents|mesh-ancestor
64678048|NCT05210465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64678049|NCT05210465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678050|NCT05210465|Protective Agents|protective agents|mesh-ancestor
64678051|NCT00002115|Adefovir|adefovir|mesh-list
64678052|NCT00002115|Antiviral Agents|antiviral agents|mesh-ancestor
64678053|NCT00002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678054|NCT00002115|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64678055|NCT00002115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678056|NCT00002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678057|NCT00002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678058|NCT04983407|Gemcitabine|gemcitabine|mesh-list
64678059|NCT04983407|Paclitaxel|paclitaxel|mesh-list
64678060|NCT04983407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64678061|NCT04983407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678062|NCT04983407|Tubulin Modulators|tubulin modulators|mesh-ancestor
64678063|NCT04983407|Antimitotic Agents|antimitotic agents|mesh-ancestor
64678064|NCT04983407|Mitosis Modulators|mitosis modulators|mesh-ancestor
64678077|NCT00001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678078|NCT00001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
64678079|NCT00001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
64678080|NCT00001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
64678081|NCT00001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450053|NCT00168818|Protease Inhibitors|protease inhibitors|mesh-ancestor
65450054|NCT00168818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450055|NCT00260832|Cytarabine|cytarabine|mesh-list
65450056|NCT00260832|Decitabine|decitabine|mesh-list
65450057|NCT00260832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65450058|NCT00260832|Antimetabolites|antimetabolites|mesh-ancestor
65450059|NCT00260832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450060|NCT00260832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450061|NCT00260832|Antiviral Agents|antiviral agents|mesh-ancestor
65450062|NCT00260832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65450063|NCT00260832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65450064|NCT00260832|Immunologic Factors|immunologic factors|mesh-ancestor
65450065|NCT00260832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450066|NCT00260832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450067|NCT00168038|Immunoglobulins|immunoglobulins|mesh-list
65450068|NCT00168038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65450069|NCT00168038|Antibodies|antibodies|mesh-list
65450070|NCT00168038|Immunologic Factors|immunologic factors|mesh-ancestor
65450071|NCT00168038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450072|NCT00166712|Mycophenolic Acid|mycophenolic acid|mesh-list
65450073|NCT00166712|Sirolimus|sirolimus|mesh-list
65450074|NCT00166712|Alemtuzumab|alemtuzumab|mesh-list
65450075|NCT00166712|Tacrolimus|tacrolimus|mesh-list
65450076|NCT00166712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64678083|NCT00001587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64678084|NCT00001587|Alkylating Agents|alkylating agents|mesh-ancestor
64678085|NCT00001587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678086|NCT00001587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678087|NCT00001587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64678088|NCT00001587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64678089|NCT00001587|Immunologic Factors|immunologic factors|mesh-ancestor
64678090|NCT00001587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678091|NCT00002127|Thalidomide|thalidomide|mesh-list
64678092|NCT00002127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64678093|NCT00002127|Immunologic Factors|immunologic factors|mesh-ancestor
64678094|NCT00002127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678095|NCT00002127|Leprostatic Agents|leprostatic agents|mesh-ancestor
64678096|NCT00002127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64678097|NCT00002127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678098|NCT00002127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64678099|NCT00002127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64678100|NCT00002127|Growth Substances|growth substances|mesh-ancestor
64678101|NCT00002127|Growth Inhibitors|growth inhibitors|mesh-ancestor
64678102|NCT00002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678103|NCT00001599|Thalidomide|thalidomide|mesh-list
64678104|NCT00001599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64678105|NCT00001599|Immunologic Factors|immunologic factors|mesh-ancestor
64678106|NCT00001599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678107|NCT00001599|Leprostatic Agents|leprostatic agents|mesh-ancestor
64715634|NCT00716755|Serotonin Agents|serotonin agents|mesh-ancestor
64715636|NCT00716755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715637|NCT00716755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715638|NCT00716755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65450077|NCT00166712|Immunologic Factors|immunologic factors|mesh-ancestor
65450078|NCT00166712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199583|NCT04903054|Tacrolimus|tacrolimus|mesh-list
65450080|NCT00166712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450081|NCT00166712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450082|NCT00166712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65450083|NCT00166712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450084|NCT00166712|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65450085|NCT00166712|Antitubercular Agents|antitubercular agents|mesh-ancestor
65450086|NCT00166712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65450087|NCT00166712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65450088|NCT00166712|Antifungal Agents|antifungal agents|mesh-ancestor
65450089|NCT00166712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65450090|NCT00073528|Letrozole|letrozole|mesh-list
65450091|NCT00073528|Lapatinib|lapatinib|mesh-list
65450092|NCT00073528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450093|NCT00073528|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65450094|NCT00073528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64715639|NCT00716755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64715640|NCT00716755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64715641|NCT00716755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64715642|NCT00716755|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64715644|NCT00716755|Antiemetics|antiemetics|mesh-ancestor
64715645|NCT00716755|Autonomic Agents|autonomic agents|mesh-ancestor
64715646|NCT00716755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715647|NCT00716755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64715648|NCT00716755|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64715649|NCT00716755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64715650|NCT00716755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64715651|NCT05406050|Eldecalcitol|eldecalcitol|mesh-list
64715652|NCT05406050|Vitamin D|vitamin d|mesh-list
64715653|NCT05406050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64715654|NCT05406050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715655|NCT05406050|Vitamins|vitamins|mesh-ancestor
64715656|NCT05406050|Micronutrients|micronutrients|mesh-ancestor
64715657|NCT03202550|Oxycodone|oxycodone|mesh-list
64715658|NCT03202550|Lorazepam|lorazepam|mesh-list
64715659|NCT03202550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64715660|NCT03202550|Narcotics|narcotics|mesh-ancestor
64715661|NCT03202550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64715662|NCT03202550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715663|NCT03202550|Analgesics|analgesics|mesh-ancestor
64715664|NCT03202550|Sensory System Agents|sensory system agents|mesh-ancestor
64678108|NCT00001599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64678109|NCT00001599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678110|NCT00001599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64678111|NCT00001599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64678112|NCT00001599|Growth Substances|growth substances|mesh-ancestor
64678113|NCT00001599|Growth Inhibitors|growth inhibitors|mesh-ancestor
64678114|NCT00001599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678115|NCT00380913|Nabilone|nabilone|mesh-list
64678116|NCT00380913|Antiemetics|antiemetics|mesh-ancestor
64678117|NCT00380913|Autonomic Agents|autonomic agents|mesh-ancestor
64678118|NCT00380913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64678119|NCT00380913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678120|NCT00380913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64678121|NCT00380913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64715666|NCT03202550|Anticonvulsants|anticonvulsants|mesh-ancestor
64715667|NCT03202550|Antiemetics|antiemetics|mesh-ancestor
64715668|NCT03202550|Autonomic Agents|autonomic agents|mesh-ancestor
65450095|NCT00073528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450096|NCT00073528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450097|NCT00073528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65450098|NCT00073528|Hormone Antagonists|hormone antagonists|mesh-ancestor
65450099|NCT00073528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65450100|NCT00073528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450101|NCT00073528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65450102|NCT03801148|Dexlansoprazole|dexlansoprazole|mesh-list
65450103|NCT03801148|Lansoprazole|lansoprazole|mesh-list
65450104|NCT03801148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65450105|NCT03801148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65450106|NCT03801148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65450107|NCT03801148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450108|NCT03801148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715669|NCT03202550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64715670|NCT03202550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64715671|NCT03202550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64715672|NCT03202550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64715673|NCT03202550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64715674|NCT03202550|GABA Modulators|gaba modulators|mesh-ancestor
64715675|NCT03202550|GABA Agents|gaba agents|mesh-ancestor
64715676|NCT03202550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64715677|NCT03202550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715678|NCT04088786|Irinotecan|irinotecan|mesh-list
64715679|NCT04088786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64715680|NCT04088786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64715681|NCT04088786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715682|NCT04088786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715683|NCT04088786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715684|NCT00392821|Everolimus|everolimus|mesh-list
64715685|NCT00392821|Sorafenib|sorafenib|mesh-list
64678122|NCT00380913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64678123|NCT00380913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64678124|NCT00380913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64678125|NCT00002133|Itraconazole|itraconazole|mesh-list
64678126|NCT00002133|Antifungal Agents|antifungal agents|mesh-ancestor
64678127|NCT00002133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678137|NCT00001629|Angiotensin II|angiotensin ii|mesh-list
64678138|NCT00001629|Giapreza|giapreza|mesh-list
64678139|NCT00001629|Angiotensinogen|angiotensinogen|mesh-list
64678140|NCT00001629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
64678141|NCT00001629|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64678142|NCT00001629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64678146|NCT00001629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64678149|NCT00002139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678150|NCT00002295|Inosine Pranobex|inosine pranobex|mesh-list
64678151|NCT00002295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64678152|NCT00002295|Immunologic Factors|immunologic factors|mesh-ancestor
64678153|NCT00002295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678154|NCT00002295|Antiviral Agents|antiviral agents|mesh-ancestor
64678155|NCT00002295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678156|NCT00002145|Foscarnet|foscarnet|mesh-list
64678157|NCT00002145|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
64678158|NCT00002145|Antiviral Agents|antiviral agents|mesh-ancestor
64678159|NCT00002145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678160|NCT00002145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64678161|NCT00002145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678162|NCT00002145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678163|NCT00002145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678164|NCT00002301|Foscarnet|foscarnet|mesh-list
65450109|NCT03960814|Insulin Detemir|insulin detemir|mesh-list
65450110|NCT03960814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65450111|NCT03960814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450112|NCT01103830|Moxifloxacin|moxifloxacin|mesh-list
65450113|NCT01103830|Lumefantrine|lumefantrine|mesh-list
65450114|NCT01103830|Artemether|artemether|mesh-list
65450115|NCT01103830|Piperaquine|piperaquine|mesh-list
64678165|NCT00002301|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
64403526|NCT04943237|Sulfasalazine|sulfasalazine|mesh-list
64715686|NCT00392821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715687|NCT00392821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64715688|NCT00392821|Immunologic Factors|immunologic factors|mesh-ancestor
64715689|NCT00392821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715690|NCT00392821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64715691|NCT00392821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678167|NCT00002301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678168|NCT00002301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64678169|NCT00002301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678170|NCT00002301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678171|NCT00002301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678172|NCT05414201|Adalimumab|adalimumab|mesh-list
64678173|NCT05414201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64678174|NCT05414201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64678175|NCT00002307|Zidovudine|zidovudine|mesh-list
64678176|NCT00002307|Stavudine|stavudine|mesh-list
64678177|NCT00002307|Antimetabolites|antimetabolites|mesh-ancestor
64678178|NCT00002307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678179|NCT00002307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64678180|NCT00002307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678181|NCT00002307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678182|NCT00002307|Antiviral Agents|antiviral agents|mesh-ancestor
64678183|NCT00002307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678184|NCT00002307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64678185|NCT00002307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678186|NCT00002313|Didanosine|didanosine|mesh-list
64678187|NCT00002313|Nystatin|nystatin|mesh-list
64678188|NCT00002313|Antimetabolites|antimetabolites|mesh-ancestor
64678189|NCT00002313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678190|NCT00002313|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64678196|NCT00002313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678197|NCT00002313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64678199|NCT00002313|Ionophores|ionophores|mesh-ancestor
64678200|NCT00002313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64678201|NCT00002157|Thalidomide|thalidomide|mesh-list
64678202|NCT00002157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64678203|NCT00002157|Immunologic Factors|immunologic factors|mesh-ancestor
64678204|NCT00002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678205|NCT00002157|Leprostatic Agents|leprostatic agents|mesh-ancestor
64678206|NCT00002157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64678207|NCT00002157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678208|NCT00002157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64678209|NCT00002157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64678210|NCT00002157|Growth Substances|growth substances|mesh-ancestor
64678211|NCT00002157|Growth Inhibitors|growth inhibitors|mesh-ancestor
64678212|NCT00002157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678213|NCT04685421|Bupivacaine|bupivacaine|mesh-list
64678214|NCT04685421|Anesthetics, Local|anesthetics, local|mesh-ancestor
64678215|NCT04685421|Anesthetics|anesthetics|mesh-ancestor
64678216|NCT04685421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64678217|NCT04685421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678218|NCT04685421|Sensory System Agents|sensory system agents|mesh-ancestor
64678219|NCT04685421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64678222|NCT00002319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64678223|NCT00002319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678224|NCT00002319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64678225|NCT00002319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64678226|NCT00002319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678227|NCT00002319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678228|NCT00002163|Abacavir|abacavir|mesh-list
64678229|NCT00002163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65450116|NCT01103830|Artenimol|artenimol|mesh-list
65450117|NCT01103830|Artemisinins|artemisinins|mesh-list
65450118|NCT01103830|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65450119|NCT01103830|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65450120|NCT01103830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65450121|NCT01103830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65450122|NCT01103830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65450123|NCT01103830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65450124|NCT01103830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450125|NCT01103830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450126|NCT01103830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450127|NCT01103830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65450128|NCT01103830|Contraceptive Agents|contraceptive agents|mesh-ancestor
65450129|NCT01103830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64834844|NCT04009044|Tamoxifen|tamoxifen|mesh-list
64678230|NCT00002163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678231|NCT00002163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678232|NCT00002163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678233|NCT00002163|Antiviral Agents|antiviral agents|mesh-ancestor
64678234|NCT00002163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678235|NCT00002163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64715692|NCT00392821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715693|NCT04708171|Anesthetics|anesthetics|mesh-list
64715694|NCT04708171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64715695|NCT04708171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715696|NCT03290378|Tramadol|tramadol|mesh-list
64678236|NCT00002163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678237|NCT05180591|BCG Vaccine|bcg vaccine|mesh-list
64678238|NCT05180591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64678239|NCT05180591|Immunologic Factors|immunologic factors|mesh-ancestor
64678240|NCT05180591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678241|NCT00002325|Fluconazole|fluconazole|mesh-list
64678242|NCT00002325|Antifungal Agents|antifungal agents|mesh-ancestor
64678243|NCT00002325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678244|NCT00002325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64678245|NCT00002325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64678246|NCT00002325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678247|NCT00002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678248|NCT00002325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64678249|NCT00002325|Hormone Antagonists|hormone antagonists|mesh-ancestor
64678250|NCT00002325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64678251|NCT00002325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678252|NCT00002325|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64678253|NCT00002325|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64678254|NCT00002331|Clarithromycin|clarithromycin|mesh-list
64678255|NCT00002331|Ethambutol|ethambutol|mesh-list
64678256|NCT00002331|Clofazimine|clofazimine|mesh-list
64678257|NCT00002331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64678258|NCT00002331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678259|NCT00002331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64678260|NCT00002331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678265|NCT00002331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64678266|NCT00002331|Leprostatic Agents|leprostatic agents|mesh-ancestor
64678268|NCT00002337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64678269|NCT00002337|Immunologic Factors|immunologic factors|mesh-ancestor
64678270|NCT00002337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678271|NCT00002337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678272|NCT00002337|Antiviral Agents|antiviral agents|mesh-ancestor
65450130|NCT01103830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450131|NCT01103830|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65450132|NCT01103830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65450133|NCT01103830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65450134|NCT01103830|Antimalarials|antimalarials|mesh-ancestor
65450135|NCT01103830|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65450136|NCT01103830|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65450137|NCT00072280|Dactinomycin|dactinomycin|mesh-list
65450138|NCT00072280|Cyclophosphamide|cyclophosphamide|mesh-list
65450139|NCT00072280|Ifosfamide|ifosfamide|mesh-list
65450140|NCT00072280|Isophosphamide mustard|isophosphamide mustard|mesh-list
65450141|NCT00072280|Etoposide|etoposide|mesh-list
65450142|NCT00072280|Vincristine|vincristine|mesh-list
64678273|NCT00002337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678274|NCT00002337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64678275|NCT00002337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64678276|NCT00002337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678277|NCT00002337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678278|NCT00002337|Protective Agents|protective agents|mesh-ancestor
64678279|NCT00002169|Nelfinavir|nelfinavir|mesh-list
64678280|NCT00002169|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64678281|NCT00002169|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64678282|NCT00002169|Protease Inhibitors|protease inhibitors|mesh-ancestor
64678283|NCT00002169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678284|NCT00002169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678285|NCT00002169|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64678286|NCT00002169|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678287|NCT00002169|Antiviral Agents|antiviral agents|mesh-ancestor
64678288|NCT00002169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678289|NCT02293902|Folic Acid|folic acid|mesh-list
64678294|NCT02293902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678295|NCT02293902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64678296|NCT02293902|Antimetabolites|antimetabolites|mesh-ancestor
64678297|NCT02293902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678298|NCT02293902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678299|NCT02293902|Dermatologic Agents|dermatologic agents|mesh-ancestor
64678300|NCT02293902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678301|NCT02293902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64678302|NCT02293902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64678303|NCT02293902|Immunologic Factors|immunologic factors|mesh-ancestor
64678304|NCT02293902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64715697|NCT03290378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64715698|NCT03290378|Narcotics|narcotics|mesh-ancestor
64715699|NCT03290378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64715700|NCT03290378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715701|NCT03290378|Analgesics|analgesics|mesh-ancestor
64715702|NCT03290378|Sensory System Agents|sensory system agents|mesh-ancestor
64715703|NCT03290378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715705|NCT02076217|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64715706|NCT02076217|Contraceptive Agents|contraceptive agents|mesh-list
64715707|NCT02076217|Medroxyprogesterone|medroxyprogesterone|mesh-list
64715708|NCT02076217|Etonogestrel|etonogestrel|mesh-list
64715709|NCT02076217|Desogestrel|desogestrel|mesh-list
64715710|NCT02076217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64455032|NCT01417078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64715711|NCT02076217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715712|NCT02076217|Trace Elements|trace elements|mesh-ancestor
64324001|NCT02741791|Bupropion|bupropion|mesh-list
64678305|NCT02293902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678306|NCT02293902|Hematinics|hematinics|mesh-ancestor
64678307|NCT02293902|Vitamin B Complex|vitamin b complex|mesh-ancestor
64678308|NCT02293902|Vitamins|vitamins|mesh-ancestor
64678309|NCT02293902|Micronutrients|micronutrients|mesh-ancestor
64678310|NCT00002343|Ethambutol|ethambutol|mesh-list
64678311|NCT00002343|Rifabutin|rifabutin|mesh-list
64678312|NCT00002343|Antitubercular Agents|antitubercular agents|mesh-ancestor
65450143|NCT00072280|Lenograstim|lenograstim|mesh-list
65450144|NCT00072280|Mesna|mesna|mesh-list
65450145|NCT00072280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65450146|NCT00072280|Immunologic Factors|immunologic factors|mesh-ancestor
65450147|NCT00072280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450148|NCT00072280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65450149|NCT00072280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65450150|NCT00072280|Alkylating Agents|alkylating agents|mesh-ancestor
65450151|NCT00072280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450152|NCT00072280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450153|NCT00072280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64834869|NCT03980769|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64834870|NCT03980769|Thymoglobulin|thymoglobulin|mesh-list
64678313|NCT00002343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64678314|NCT00002343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678315|NCT00002343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64678316|NCT05168735|Ketamine|ketamine|mesh-list
64678317|NCT05168735|Analgesics|analgesics|mesh-ancestor
64678318|NCT05168735|Sensory System Agents|sensory system agents|mesh-ancestor
64678319|NCT05168735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64678320|NCT05168735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678321|NCT05168735|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64678322|NCT05168735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64678323|NCT05168735|Anesthetics, General|anesthetics, general|mesh-ancestor
64678324|NCT05168735|Anesthetics|anesthetics|mesh-ancestor
64678325|NCT05168735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64678326|NCT05168735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64678327|NCT05168735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64678328|NCT05168735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64678329|NCT05168735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678330|NCT00002349|Stavudine|stavudine|mesh-list
64678331|NCT00002349|Antimetabolites|antimetabolites|mesh-ancestor
64678332|NCT00002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678333|NCT00002349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64678334|NCT00002349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678335|NCT00002349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678336|NCT00002349|Antiviral Agents|antiviral agents|mesh-ancestor
64678337|NCT00002349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678338|NCT00002349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64678339|NCT00002349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678340|NCT04706013|Pyridoxal|pyridoxal|mesh-list
64678341|NCT04706013|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
64678342|NCT04706013|Vitamin B Complex|vitamin b complex|mesh-ancestor
64678343|NCT04706013|Vitamins|vitamins|mesh-ancestor
64678344|NCT04706013|Micronutrients|micronutrients|mesh-ancestor
64678345|NCT04706013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678346|NCT00002355|Fomivirsen|fomivirsen|mesh-list
64678347|NCT00002355|Antiviral Agents|antiviral agents|mesh-ancestor
64715713|NCT02076217|Micronutrients|micronutrients|mesh-ancestor
64715716|NCT02076217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64715717|NCT02076217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64715718|NCT02076217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64715719|NCT02076217|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64715720|NCT02076217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64715722|NCT02076217|Progestins|progestins|mesh-ancestor
64715723|NCT02076217|Hormones|hormones|mesh-ancestor
64715724|NCT02076217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64715725|NCT03291080|Tretinoin|tretinoin|mesh-list
64715726|NCT03291080|Isotretinoin|isotretinoin|mesh-list
64715727|NCT03291080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715728|NCT03291080|Keratolytic Agents|keratolytic agents|mesh-ancestor
64324013|NCT02741791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64678348|NCT00002355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65450154|NCT00072280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65450155|NCT00072280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65450156|NCT00072280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65450157|NCT00072280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450158|NCT00072280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65450159|NCT00072280|Tubulin Modulators|tubulin modulators|mesh-ancestor
65450160|NCT00072280|Antimitotic Agents|antimitotic agents|mesh-ancestor
65450161|NCT00072280|Mitosis Modulators|mitosis modulators|mesh-ancestor
65450162|NCT00072280|Protective Agents|protective agents|mesh-ancestor
65450163|NCT00072280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65450164|NCT00072280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65450165|NCT00072280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65450166|NCT00072280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65450167|NCT00072280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65450168|NCT05527834|Ceftibuten|ceftibuten|mesh-list
65450169|NCT05527834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65450170|NCT05527834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65450171|NCT01106716|Lidocaine|lidocaine|mesh-list
65450172|NCT01106716|Anesthetics, Local|anesthetics, local|mesh-ancestor
65450173|NCT01106716|Anesthetics|anesthetics|mesh-ancestor
65450174|NCT01106716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64678349|NCT02278614|Timolol|timolol|mesh-list
64678350|NCT02278614|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64678351|NCT02278614|Latanoprost|latanoprost|mesh-list
64678352|NCT02278614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64678353|NCT02278614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64678354|NCT02278614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64678355|NCT02278614|Adrenergic Agents|adrenergic agents|mesh-ancestor
64678356|NCT02278614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64678357|NCT02278614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678358|NCT02278614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678359|NCT02278614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64678360|NCT02278614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64678361|NCT00002361|Ritonavir|ritonavir|mesh-list
64678362|NCT00002361|Indinavir|indinavir|mesh-list
64678363|NCT00002361|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64678364|NCT00002361|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64678365|NCT00002361|Protease Inhibitors|protease inhibitors|mesh-ancestor
64678366|NCT00002361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678367|NCT00002361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678368|NCT00002361|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64678369|NCT00002361|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678370|NCT00002361|Antiviral Agents|antiviral agents|mesh-ancestor
64678371|NCT00002361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678372|NCT00002361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64678373|NCT00002361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64678374|NCT00002181|Cidofovir|cidofovir|mesh-list
64678375|NCT00002181|Antiviral Agents|antiviral agents|mesh-ancestor
64678376|NCT00002181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678377|NCT00002181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678378|NCT00002181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678379|NCT00002367|Lamivudine|lamivudine|mesh-list
64678380|NCT00002367|Zidovudine|zidovudine|mesh-list
64678381|NCT00002367|Saquinavir|saquinavir|mesh-list
64678382|NCT00002367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65450175|NCT01106716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450176|NCT01106716|Sensory System Agents|sensory system agents|mesh-ancestor
65450177|NCT01106716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65450178|NCT01106716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65450179|NCT01106716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65450180|NCT01106716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65450181|NCT01106716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65450182|NCT01106716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450183|NCT00071812|Belimumab|belimumab|mesh-list
65450184|NCT00071812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65450185|NCT00071812|Immunologic Factors|immunologic factors|mesh-ancestor
65450186|NCT00071812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450187|NCT01104298|Doxorubicin|doxorubicin|mesh-list
65450188|NCT01104298|Trabectedin|trabectedin|mesh-list
64678383|NCT00002367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678384|NCT00002367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678385|NCT00002367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678386|NCT00002367|Antiviral Agents|antiviral agents|mesh-ancestor
64678387|NCT00002367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678388|NCT00002367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64715729|NCT03291080|Dermatologic Agents|dermatologic agents|mesh-ancestor
64715730|NCT04874545|Propofol|propofol|mesh-list
64715731|NCT04874545|Sevoflurane|sevoflurane|mesh-list
64715732|NCT04874545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64715733|NCT04874545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64715734|NCT04874545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715735|NCT04874545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64715736|NCT04874545|Anesthetics, General|anesthetics, general|mesh-ancestor
64715737|NCT04874545|Anesthetics|anesthetics|mesh-ancestor
64715738|NCT04874545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64678389|NCT00002367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678390|NCT00002367|Antimetabolites|antimetabolites|mesh-ancestor
64678391|NCT00002367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64678392|NCT00002367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64678393|NCT00002367|Protease Inhibitors|protease inhibitors|mesh-ancestor
64678394|NCT00002367|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64678397|NCT00002187|Antiviral Agents|antiviral agents|mesh-ancestor
64678398|NCT00002187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678399|NCT00002373|Maribavir|maribavir|mesh-list
64678400|NCT00002373|Antiviral Agents|antiviral agents|mesh-ancestor
64678403|NCT00002379|Zidovudine|zidovudine|mesh-list
64678404|NCT00002379|Stavudine|stavudine|mesh-list
64678405|NCT00002379|Adefovir|adefovir|mesh-list
64678406|NCT00002379|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64678407|NCT00002379|Indinavir|indinavir|mesh-list
64678408|NCT00002379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64678409|NCT00002379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678410|NCT00002379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678411|NCT00002379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678412|NCT00002379|Antiviral Agents|antiviral agents|mesh-ancestor
64678413|NCT00002379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678414|NCT00002379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64678415|NCT00002379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678416|NCT00002379|Antimetabolites|antimetabolites|mesh-ancestor
64678417|NCT00002379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64678418|NCT00002379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64678419|NCT00002379|Protease Inhibitors|protease inhibitors|mesh-ancestor
64678420|NCT00359723|Methylphenidate|methylphenidate|mesh-list
64678421|NCT00359723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64678422|NCT00359723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678423|NCT00359723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65450189|NCT01104298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65450190|NCT01104298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450191|NCT01104298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65450192|NCT01104298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65450193|NCT01104298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450194|NCT01104298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450195|NCT01104298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65450196|NCT01104298|Alkylating Agents|alkylating agents|mesh-ancestor
65450197|NCT01106872|Gemcitabine|gemcitabine|mesh-list
65450198|NCT01106872|Bevacizumab|bevacizumab|mesh-list
65450199|NCT01106872|Docetaxel|docetaxel|mesh-list
65450200|NCT01106872|Valproic Acid|valproic acid|mesh-list
65450201|NCT01106872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65450202|NCT01106872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450203|NCT01106872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65450204|NCT01106872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65450205|NCT01106872|Growth Substances|growth substances|mesh-ancestor
65450206|NCT01106872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678424|NCT00359723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64678425|NCT00359723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64678426|NCT00359723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678427|NCT00359723|Dopamine Agents|dopamine agents|mesh-ancestor
64678428|NCT00359723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64678429|NCT00002193|Amprenavir|amprenavir|mesh-list
64678430|NCT00002193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64678431|NCT00002193|Antitubercular Agents|antitubercular agents|mesh-ancestor
64678432|NCT00002193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64678433|NCT00002193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678434|NCT00002193|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64678435|NCT00002193|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64678436|NCT00002193|Protease Inhibitors|protease inhibitors|mesh-ancestor
64678437|NCT00002193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678438|NCT00002193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678439|NCT00002193|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64678440|NCT00002193|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678441|NCT00002193|Antiviral Agents|antiviral agents|mesh-ancestor
64678442|NCT00002391|Lamivudine|lamivudine|mesh-list
64678443|NCT00002391|Zidovudine|zidovudine|mesh-list
64678444|NCT00002391|Abacavir|abacavir|mesh-list
64678445|NCT00002391|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64678446|NCT00002391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678447|NCT00002391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715739|NCT04874545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64715740|NCT04535713|Gemcitabine|gemcitabine|mesh-list
64715741|NCT04535713|Docetaxel|docetaxel|mesh-list
64715742|NCT04535713|Doxorubicin|doxorubicin|mesh-list
64715743|NCT04535713|Nivolumab|nivolumab|mesh-list
64715744|NCT04535713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64715745|NCT04535713|Antimetabolites|antimetabolites|mesh-ancestor
64715746|NCT04535713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715747|NCT04535713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715748|NCT04535713|Antiviral Agents|antiviral agents|mesh-ancestor
64715749|NCT04535713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64715750|NCT04535713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715751|NCT04535713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64715752|NCT04535713|Immunologic Factors|immunologic factors|mesh-ancestor
64715753|NCT04535713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450207|NCT01106872|Growth Inhibitors|growth inhibitors|mesh-ancestor
65450208|NCT01106872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65450209|NCT01106872|Antimetabolites|antimetabolites|mesh-ancestor
65450210|NCT01106872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450211|NCT01106872|Antiviral Agents|antiviral agents|mesh-ancestor
65450212|NCT01106872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65450213|NCT01106872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450214|NCT01106872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65450215|NCT01106872|Immunologic Factors|immunologic factors|mesh-ancestor
65450216|NCT01106872|Tubulin Modulators|tubulin modulators|mesh-ancestor
65450217|NCT01106872|Antimitotic Agents|antimitotic agents|mesh-ancestor
65450218|NCT01106872|Mitosis Modulators|mitosis modulators|mesh-ancestor
65450219|NCT01106872|Anticonvulsants|anticonvulsants|mesh-ancestor
65450220|NCT01106872|GABA Agents|gaba agents|mesh-ancestor
65450221|NCT01106872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65450222|NCT01106872|Antimanic Agents|antimanic agents|mesh-ancestor
65450223|NCT01106872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65450224|NCT01106872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64834934|NCT03802630|Growth Inhibitors|growth inhibitors|mesh-ancestor
64715754|NCT04535713|Tubulin Modulators|tubulin modulators|mesh-ancestor
64715755|NCT04535713|Antimitotic Agents|antimitotic agents|mesh-ancestor
64715756|NCT04535713|Mitosis Modulators|mitosis modulators|mesh-ancestor
64715757|NCT04535713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64715758|NCT04535713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64678448|NCT00002391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678449|NCT00002391|Antiviral Agents|antiviral agents|mesh-ancestor
64678450|NCT00002391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678451|NCT00002391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64678452|NCT00002391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678453|NCT00002391|Antimetabolites|antimetabolites|mesh-ancestor
64678457|NCT00002199|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64678458|NCT00002199|Indinavir|indinavir|mesh-list
64678459|NCT00002199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64678460|NCT00002199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678461|NCT00002199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678462|NCT00002199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678463|NCT00002199|Antiviral Agents|antiviral agents|mesh-ancestor
64678464|NCT00002199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678465|NCT00002199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64678466|NCT00002199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678467|NCT00002199|Antimetabolites|antimetabolites|mesh-ancestor
64678468|NCT00002199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64678469|NCT00002199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64678476|NCT00002397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678477|NCT00002397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678478|NCT00002397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678479|NCT00002397|Antiviral Agents|antiviral agents|mesh-ancestor
64678480|NCT00002397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678481|NCT00002397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64678482|NCT00002397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678483|NCT00002397|Antimetabolites|antimetabolites|mesh-ancestor
64678484|NCT00002397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64678485|NCT00002397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64678486|NCT00002397|Protease Inhibitors|protease inhibitors|mesh-ancestor
64678487|NCT00002397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64678488|NCT00002397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65450225|NCT01106872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65450226|NCT03960268|Brodalumab|brodalumab|mesh-list
65450227|NCT03960268|Dermatologic Agents|dermatologic agents|mesh-ancestor
65450228|NCT05485480|Analgesics, Opioid|analgesics, opioid|mesh-list
65450229|NCT05485480|Narcotics|narcotics|mesh-ancestor
65450230|NCT05485480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64678489|NCT00002205|Abacavir|abacavir|mesh-list
64678490|NCT00002205|Amprenavir|amprenavir|mesh-list
64715759|NCT04535713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64715760|NCT04535713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64715761|NCT04535713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64715762|NCT03181009|Omalizumab|omalizumab|mesh-list
64715763|NCT03181009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64715764|NCT03181009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64715765|NCT03181009|Respiratory System Agents|respiratory system agents|mesh-ancestor
64715766|NCT04430569|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64715767|NCT04430569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64715768|NCT04430569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64715769|NCT04430569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715770|NCT03296072|Listerine|listerine|mesh-list
64678491|NCT00002205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64678492|NCT00002205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678493|NCT00002205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678494|NCT00002205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678495|NCT00002205|Antiviral Agents|antiviral agents|mesh-ancestor
64678496|NCT00002205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678497|NCT00002205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64678498|NCT00002205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678499|NCT00002205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64678500|NCT00002205|Antitubercular Agents|antitubercular agents|mesh-ancestor
64678501|NCT00002205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64678502|NCT00002205|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64678503|NCT00002205|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64678504|NCT00002205|Protease Inhibitors|protease inhibitors|mesh-ancestor
64678505|NCT02977169|Cisplatin|cisplatin|mesh-list
64678506|NCT02977169|Carboplatin|carboplatin|mesh-list
64678507|NCT02977169|Pemetrexed|pemetrexed|mesh-list
64678508|NCT02977169|Vinorelbine|vinorelbine|mesh-list
64678509|NCT02977169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678510|NCT02977169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678511|NCT02977169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678512|NCT02977169|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64678513|NCT02977169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678514|NCT02977169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64678515|NCT02977169|Tubulin Modulators|tubulin modulators|mesh-ancestor
64678516|NCT02977169|Antimitotic Agents|antimitotic agents|mesh-ancestor
64678517|NCT02977169|Mitosis Modulators|mitosis modulators|mesh-ancestor
64678518|NCT00002409|Lamivudine|lamivudine|mesh-list
64678519|NCT00002409|Zidovudine|zidovudine|mesh-list
64678520|NCT00002409|Abacavir|abacavir|mesh-list
64678521|NCT00002409|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64678523|NCT00002409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678524|NCT00002409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678525|NCT00002409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678526|NCT00002409|Antiviral Agents|antiviral agents|mesh-ancestor
64678527|NCT00002409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678528|NCT00002409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64678529|NCT00002409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678530|NCT00002409|Antimetabolites|antimetabolites|mesh-ancestor
64678531|NCT00002211|Stavudine|stavudine|mesh-list
64678532|NCT00002211|Didanosine|didanosine|mesh-list
64678533|NCT00002211|Delavirdine|delavirdine|mesh-list
64678534|NCT00002211|Nelfinavir|nelfinavir|mesh-list
64678535|NCT00002211|Antimetabolites|antimetabolites|mesh-ancestor
64678536|NCT00002211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678537|NCT00002211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64678538|NCT00002211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678539|NCT00002211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678540|NCT00002211|Antiviral Agents|antiviral agents|mesh-ancestor
64678541|NCT00002211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64715772|NCT03296072|Sodium Fluoride|sodium fluoride|mesh-list
65450231|NCT05485480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450232|NCT05485480|Analgesics|analgesics|mesh-ancestor
65450233|NCT05485480|Sensory System Agents|sensory system agents|mesh-ancestor
65450234|NCT05485480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65450235|NCT05470270|Hydroxyurea|hydroxyurea|mesh-list
65450236|NCT05470270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450237|NCT05470270|Antisickling Agents|antisickling agents|mesh-ancestor
65450238|NCT05470270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450239|NCT05470270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450240|NCT05470270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65450241|NCT01107106|Ulipristal acetate|ulipristal acetate|mesh-list
65450242|NCT01107106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65450243|NCT01107106|Contraceptive Agents|contraceptive agents|mesh-ancestor
65450244|NCT01107106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65450245|NCT01107106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450246|NCT01107106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65450247|NCT00259610|Hydroxychloroquine|hydroxychloroquine|mesh-list
65450248|NCT00259610|Sulfasalazine|sulfasalazine|mesh-list
65450249|NCT00259610|Etanercept|etanercept|mesh-list
65450250|NCT00259610|Methotrexate|methotrexate|mesh-list
65450251|NCT00259610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65450252|NCT00259610|Abortifacient Agents|abortifacient agents|mesh-ancestor
65450253|NCT00259610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65450254|NCT00259610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834957|NCT03785691|Histamine Agents|histamine agents|mesh-ancestor
64715773|NCT03296072|Tin Fluorides|tin fluorides|mesh-list
64715774|NCT03296072|Cariostatic Agents|cariostatic agents|mesh-ancestor
64715775|NCT03296072|Protective Agents|protective agents|mesh-ancestor
64715776|NCT03296072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715777|NCT03296072|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64715778|NCT03296072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64715779|NCT03185065|Amantadine|amantadine|mesh-list
64715780|NCT03185065|Methylphenidate|methylphenidate|mesh-list
64715781|NCT03185065|Modafinil|modafinil|mesh-list
64715782|NCT03185065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64715783|NCT03185065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455120|NCT04767178|Ibuprofen|ibuprofen|mesh-list
64715784|NCT03185065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64715785|NCT03185065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64715786|NCT03185065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64715787|NCT03185065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715788|NCT03185065|Dopamine Agents|dopamine agents|mesh-ancestor
64324071|NCT03859687|Vitamins|vitamins|mesh-list
64678548|NCT00002415|Antiviral Agents|antiviral agents|mesh-ancestor
64678549|NCT00002415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678550|NCT00002415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64678551|NCT00002415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678552|NCT00002415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678553|NCT00002415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678554|NCT00002415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65450255|NCT00259610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65450256|NCT00259610|Antimetabolites|antimetabolites|mesh-ancestor
65450257|NCT00259610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450258|NCT00259610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450259|NCT00259610|Dermatologic Agents|dermatologic agents|mesh-ancestor
65450260|NCT00259610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450261|NCT00259610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65450262|NCT00259610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65450263|NCT00259610|Immunologic Factors|immunologic factors|mesh-ancestor
65450264|NCT00259610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65450265|NCT00259610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65450266|NCT00259610|Antimalarials|antimalarials|mesh-ancestor
65450267|NCT00259610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64678555|NCT00002415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678556|NCT00381537|Carbamazepine|carbamazepine|mesh-list
64678557|NCT00381537|Phenobarbital|phenobarbital|mesh-list
64678558|NCT00381537|Anticonvulsants|anticonvulsants|mesh-ancestor
64678559|NCT00381537|Antimanic Agents|antimanic agents|mesh-ancestor
64678560|NCT00381537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64678561|NCT00381537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64678562|NCT00381537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678563|NCT00381537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64678564|NCT00381537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64678565|NCT00381537|Analgesics|analgesics|mesh-ancestor
64678566|NCT00381537|Sensory System Agents|sensory system agents|mesh-ancestor
64678567|NCT00381537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64678568|NCT00381537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64678569|NCT00381537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64678570|NCT00381537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678571|NCT00381537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64678572|NCT00381537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64678573|NCT00381537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64678574|NCT00381537|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64678575|NCT00381537|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64678576|NCT00381537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64678577|NCT00381537|GABA Modulators|gaba modulators|mesh-ancestor
64678578|NCT00381537|GABA Agents|gaba agents|mesh-ancestor
64678579|NCT00381537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64678580|NCT00002427|Stavudine|stavudine|mesh-list
64678581|NCT00002427|Didanosine|didanosine|mesh-list
64678582|NCT00002427|Hydroxyurea|hydroxyurea|mesh-list
64678583|NCT00002427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715793|NCT03185065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64715794|NCT03185065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64715796|NCT03185065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64715797|NCT03185065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64715799|NCT03185065|Sensory System Agents|sensory system agents|mesh-ancestor
64715800|NCT03185065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715801|NCT02220894|Paclitaxel|paclitaxel|mesh-list
64715802|NCT02220894|Carboplatin|carboplatin|mesh-list
64715803|NCT02220894|Pembrolizumab|pembrolizumab|mesh-list
64715804|NCT02220894|Pemetrexed|pemetrexed|mesh-list
64715805|NCT02220894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64715806|NCT02220894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678584|NCT00002427|Antisickling Agents|antisickling agents|mesh-ancestor
64678585|NCT00002427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678586|NCT00002427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678587|NCT00002427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678588|NCT00002427|Antimetabolites|antimetabolites|mesh-ancestor
64678589|NCT00002427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64678590|NCT00002427|Antiviral Agents|antiviral agents|mesh-ancestor
64678591|NCT00002427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65450268|NCT00259610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65450269|NCT00259610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65450270|NCT00259610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65450271|NCT00259610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65450272|NCT00259610|Analgesics|analgesics|mesh-ancestor
65450273|NCT00259610|Sensory System Agents|sensory system agents|mesh-ancestor
65450274|NCT00259610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65450275|NCT00259610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65450276|NCT00259610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65450277|NCT05371132|Deferoxamine|deferoxamine|mesh-list
65450278|NCT05371132|Siderophores|siderophores|mesh-ancestor
65450279|NCT05371132|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65450280|NCT05371132|Chelating Agents|chelating agents|mesh-ancestor
65450281|NCT05371132|Sequestering Agents|sequestering agents|mesh-ancestor
65450282|NCT05371132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450283|NCT00165776|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
64678592|NCT00002427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64678593|NCT00002427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678594|NCT00002217|Lamivudine|lamivudine|mesh-list
64678595|NCT00002217|Zidovudine|zidovudine|mesh-list
64678596|NCT00002217|Abacavir|abacavir|mesh-list
64678597|NCT00002217|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64678598|NCT00002217|Amprenavir|amprenavir|mesh-list
64678599|NCT00002217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64678600|NCT00002217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678601|NCT00002217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678602|NCT00002217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678603|NCT00002217|Antiviral Agents|antiviral agents|mesh-ancestor
64678604|NCT00002217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678605|NCT00002217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64678606|NCT00002217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678607|NCT00002217|Antimetabolites|antimetabolites|mesh-ancestor
64678608|NCT00002217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64678609|NCT00002217|Antitubercular Agents|antitubercular agents|mesh-ancestor
64678610|NCT00002217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64678615|NCT00002223|Indinavir|indinavir|mesh-list
64678616|NCT00002223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64678617|NCT00002223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64678618|NCT00002223|Protease Inhibitors|protease inhibitors|mesh-ancestor
64678619|NCT00002223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678620|NCT00002223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678621|NCT00002223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64678622|NCT00002223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678623|NCT00002223|Antiviral Agents|antiviral agents|mesh-ancestor
64678624|NCT00002223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678625|NCT00002223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64678626|NCT00002223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64678627|NCT00002433|Interferons|interferons|mesh-list
64715807|NCT02220894|Tubulin Modulators|tubulin modulators|mesh-ancestor
64715808|NCT02220894|Antimitotic Agents|antimitotic agents|mesh-ancestor
64715809|NCT02220894|Mitosis Modulators|mitosis modulators|mesh-ancestor
64715810|NCT02220894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715811|NCT02220894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64715812|NCT02220894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715813|NCT02220894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64715814|NCT02220894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64715815|NCT02159040|Azacitidine|azacitidine|mesh-list
64715816|NCT02159040|Deferasirox|deferasirox|mesh-list
64715817|NCT02159040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64715818|NCT02159040|Antimetabolites|antimetabolites|mesh-ancestor
65450284|NCT00165776|Botulinum Toxins|botulinum toxins|mesh-list
65450285|NCT00165776|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65450286|NCT00165776|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65450287|NCT00165776|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65450288|NCT00165776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65450289|NCT00165776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450290|NCT00165776|Cholinergic Agents|cholinergic agents|mesh-ancestor
65450291|NCT00165776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65450292|NCT00165776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450293|NCT00165776|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65450294|NCT00165776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65450295|NCT00165776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65450296|NCT04459468|Ethiodized Oil|ethiodized oil|mesh-list
65450297|NCT04459468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450298|NCT00165698|Alfacalcidol|alfacalcidol|mesh-list
65450299|NCT00165698|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65450300|NCT00165698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65450301|NCT00165698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450302|NCT00165698|Vitamins|vitamins|mesh-ancestor
65450303|NCT00165698|Micronutrients|micronutrients|mesh-ancestor
65450304|NCT01075022|Vitamin D|vitamin d|mesh-list
65450305|NCT01075022|Cholecalciferol|cholecalciferol|mesh-list
65450306|NCT01075022|Vitamins|vitamins|mesh-ancestor
65450307|NCT01075022|Micronutrients|micronutrients|mesh-ancestor
65450308|NCT01075022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450309|NCT01075022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64835007|NCT03602066|Dental Disinfectants|dental disinfectants|mesh-ancestor
64715819|NCT02159040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715820|NCT02159040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715821|NCT02159040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324108|NCT01591447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678628|NCT00002433|Interferon-gamma|interferon-gamma|mesh-list
64678632|NCT00002439|Alitretinoin|alitretinoin|mesh-list
64678633|NCT00002439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678634|NCT00002439|Dermatologic Agents|dermatologic agents|mesh-ancestor
64678635|NCT00002229|Saquinavir|saquinavir|mesh-list
64678636|NCT00002229|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64678637|NCT00002229|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64678638|NCT00002229|Protease Inhibitors|protease inhibitors|mesh-ancestor
64678639|NCT00002229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678640|NCT00002229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678641|NCT00002229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64678642|NCT00002229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678643|NCT00002229|Antiviral Agents|antiviral agents|mesh-ancestor
64678644|NCT00002229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678645|NCT00002229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64678646|NCT00002229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64678647|NCT04963673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
64678648|NCT04963673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450310|NCT01075022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65450311|NCT00225758|Lapatinib|lapatinib|mesh-list
65450312|NCT00225758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450313|NCT00225758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65450314|NCT00225758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450315|NCT00225758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450316|NCT01104532|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65450317|NCT01104532|Ipragliflozin|ipragliflozin|mesh-list
65450318|NCT01104532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65450319|NCT01104532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450320|NCT01104532|Incretins|incretins|mesh-ancestor
65450321|NCT01104532|Hormones|hormones|mesh-ancestor
64678649|NCT04963673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678650|NCT05381909|Paclitaxel|paclitaxel|mesh-list
64678651|NCT05381909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64678652|NCT05381909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678653|NCT05381909|Tubulin Modulators|tubulin modulators|mesh-ancestor
64678654|NCT05381909|Antimitotic Agents|antimitotic agents|mesh-ancestor
64678655|NCT05381909|Mitosis Modulators|mitosis modulators|mesh-ancestor
64678656|NCT05381909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678657|NCT00002451|Ritonavir|ritonavir|mesh-list
64678658|NCT00002451|Indinavir|indinavir|mesh-list
64678659|NCT00002451|Lamivudine|lamivudine|mesh-list
64678660|NCT00002451|Stavudine|stavudine|mesh-list
64678661|NCT00002451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64678662|NCT00002451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64678663|NCT00002451|Protease Inhibitors|protease inhibitors|mesh-ancestor
64678664|NCT00002451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678665|NCT00002451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678666|NCT00002451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64678667|NCT00002451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678668|NCT00002451|Antiviral Agents|antiviral agents|mesh-ancestor
64678669|NCT00002451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64715822|NCT02159040|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64715823|NCT02159040|Chelating Agents|chelating agents|mesh-ancestor
64715824|NCT02159040|Sequestering Agents|sequestering agents|mesh-ancestor
64715825|NCT03189589|Nemiralisib|nemiralisib|mesh-list
64715826|NCT03189589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64715827|NCT03189589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715828|NCT03189589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715829|NCT03216902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64715830|NCT03216902|Latanoprost|latanoprost|mesh-list
64715831|NCT03216902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64715832|NCT03190213|Pembrolizumab|pembrolizumab|mesh-list
64715833|NCT03190213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64678670|NCT00002451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64678671|NCT00002451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64678672|NCT00002451|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64678673|NCT00002451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678675|NCT00002235|Efavirenz|efavirenz|mesh-list
64678676|NCT00002235|Nelfinavir|nelfinavir|mesh-list
64678677|NCT00002235|Indinavir|indinavir|mesh-list
64678678|NCT00002235|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64678679|NCT00002235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678680|NCT00002235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678685|NCT00002235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64678686|NCT00002235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64678687|NCT00002235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64678688|NCT00002235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64678689|NCT00002235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64678690|NCT00002235|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64678691|NCT00002235|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65450322|NCT01104532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65450323|NCT01104532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65450324|NCT01104532|Protease Inhibitors|protease inhibitors|mesh-ancestor
65450325|NCT01104532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450326|NCT01104532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450327|NCT01104532|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65450328|NCT01107574|Gabapentin|gabapentin|mesh-list
65450329|NCT01107574|Analgesics|analgesics|mesh-ancestor
65450330|NCT01107574|Sensory System Agents|sensory system agents|mesh-ancestor
65450331|NCT01107574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65450332|NCT01107574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450333|NCT01107574|Anticonvulsants|anticonvulsants|mesh-ancestor
65450334|NCT01107574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65450335|NCT01107574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65450336|NCT01107574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65450337|NCT01107574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64678692|NCT00002235|Protease Inhibitors|protease inhibitors|mesh-ancestor
64678693|NCT00002235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64678694|NCT00002235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678700|NCT00002241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64678701|NCT00002241|Protease Inhibitors|protease inhibitors|mesh-ancestor
64678702|NCT00002241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678703|NCT00002241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678704|NCT00002241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64678705|NCT00002241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678706|NCT00002241|Antiviral Agents|antiviral agents|mesh-ancestor
64678707|NCT00002241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678708|NCT00002241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64678709|NCT00002241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64678710|NCT00002241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64678711|NCT00002241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678712|NCT00002241|Antimetabolites|antimetabolites|mesh-ancestor
64678713|NCT00002463|Leucovorin|leucovorin|mesh-list
64678714|NCT00002463|Prednisone|prednisone|mesh-list
64678715|NCT00002463|Methotrexate|methotrexate|mesh-list
64678716|NCT00002463|Vincristine|vincristine|mesh-list
64678717|NCT00002463|Procarbazine|procarbazine|mesh-list
64678718|NCT00002463|Mechlorethamine|mechlorethamine|mesh-list
64678719|NCT00002463|Calcium|calcium|mesh-list
64678720|NCT00002463|Levoleucovorin|levoleucovorin|mesh-list
64678721|NCT00002463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64678722|NCT00002463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678723|NCT00002463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64678724|NCT00002463|Glucocorticoids|glucocorticoids|mesh-ancestor
64678725|NCT00002463|Hormones|hormones|mesh-ancestor
64678726|NCT00002463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64715834|NCT03190213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715835|NCT01632150|Thalidomide|thalidomide|mesh-list
64715836|NCT01632150|Dexamethasone|dexamethasone|mesh-list
64715837|NCT01632150|Dexamethasone acetate|dexamethasone acetate|mesh-list
64715838|NCT01632150|Cyclophosphamide|cyclophosphamide|mesh-list
64715839|NCT01632150|Elotuzumab|elotuzumab|mesh-list
64715840|NCT01632150|BB 1101|bb 1101|mesh-list
64715841|NCT01632150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64715842|NCT01632150|Immunologic Factors|immunologic factors|mesh-ancestor
64715843|NCT01632150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715844|NCT01632150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64715845|NCT01632150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64835062|NCT03291028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450338|NCT01107574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65450339|NCT01107574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65450340|NCT01107574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65450341|NCT01107574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450342|NCT01107574|Antimanic Agents|antimanic agents|mesh-ancestor
65450343|NCT03971500|Ticagrelor|ticagrelor|mesh-list
65450344|NCT03971500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450345|NCT03971500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450346|NCT03971500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65450347|NCT03971500|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65450348|NCT03971500|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65450349|NCT03971500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65450350|NCT03971500|Purinergic Agents|purinergic agents|mesh-ancestor
65450351|NCT03971500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65450352|NCT00259298|Teriparatide|teriparatide|mesh-list
65450353|NCT00259298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65450354|NCT00259298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450355|NCT00259298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65450356|NCT01108744|Mannitol|mannitol|mesh-list
65450357|NCT01108744|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65450358|NCT01108744|Diuretics|diuretics|mesh-ancestor
65450359|NCT01108744|Natriuretic Agents|natriuretic agents|mesh-ancestor
65450360|NCT01108744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450361|NCT01581866|Ziprasidone|ziprasidone|mesh-list
64715846|NCT01632150|Alkylating Agents|alkylating agents|mesh-ancestor
64715847|NCT01632150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715848|NCT01632150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324136|NCT05361447|Anesthetics|anesthetics|mesh-ancestor
64678727|NCT00002463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64678728|NCT00002463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678729|NCT00002463|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64678730|NCT00002463|Abortifacient Agents|abortifacient agents|mesh-ancestor
64678731|NCT00002463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64678732|NCT00002463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64678733|NCT00002463|Antimetabolites|antimetabolites|mesh-ancestor
64678734|NCT00002463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678735|NCT00002463|Dermatologic Agents|dermatologic agents|mesh-ancestor
64678736|NCT00002463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678737|NCT00002463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64678738|NCT00002463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64678739|NCT00002463|Immunologic Factors|immunologic factors|mesh-ancestor
64678740|NCT00002463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64678741|NCT00002463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678742|NCT00002463|Antidotes|antidotes|mesh-ancestor
64678743|NCT00002463|Protective Agents|protective agents|mesh-ancestor
64678744|NCT00002463|Vitamin B Complex|vitamin b complex|mesh-ancestor
64678745|NCT00002463|Vitamins|vitamins|mesh-ancestor
65450362|NCT01581866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65450363|NCT01581866|Serotonin Agents|serotonin agents|mesh-ancestor
65450364|NCT01581866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65450365|NCT01581866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450366|NCT01581866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450367|NCT01581866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65450368|NCT01581866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65450369|NCT01581866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65450370|NCT01581866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65450371|NCT01581866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65450372|NCT01581866|Dopamine Agents|dopamine agents|mesh-ancestor
65450373|NCT03892642|Avelumab|avelumab|mesh-list
65450374|NCT03892642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65450375|NCT03892642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450376|NCT01107808|Calcium, Dietary|calcium, dietary|mesh-list
65450377|NCT01107808|Vitamin D|vitamin d|mesh-list
65450378|NCT01107808|Ergocalciferols|ergocalciferols|mesh-list
65450379|NCT01107808|Metformin|metformin|mesh-list
65450380|NCT01107808|Calcium|calcium|mesh-list
65450381|NCT01107808|Vitamins|vitamins|mesh-ancestor
65450382|NCT01107808|Micronutrients|micronutrients|mesh-ancestor
65450383|NCT01107808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450384|NCT01107808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65450385|NCT01107808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64678746|NCT00002463|Micronutrients|micronutrients|mesh-ancestor
64678747|NCT00002463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64678748|NCT00002463|Tubulin Modulators|tubulin modulators|mesh-ancestor
64678749|NCT00002463|Antimitotic Agents|antimitotic agents|mesh-ancestor
64678750|NCT00002463|Mitosis Modulators|mitosis modulators|mesh-ancestor
64678751|NCT00002463|Alkylating Agents|alkylating agents|mesh-ancestor
64678758|NCT04500899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678761|NCT04500899|Nasal Decongestants|nasal decongestants|mesh-ancestor
64678762|NCT04500899|Respiratory System Agents|respiratory system agents|mesh-ancestor
64678763|NCT04500899|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64678764|NCT04500899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64678765|NCT04500899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64678766|NCT04500899|Adrenergic Agents|adrenergic agents|mesh-ancestor
64678767|NCT04500899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64678768|NCT04500899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678769|NCT04500899|Protective Agents|protective agents|mesh-ancestor
64678771|NCT00002247|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64678772|NCT00002247|Antiviral Agents|antiviral agents|mesh-ancestor
64484378|NCT01729819|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64678773|NCT00002247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678774|NCT00002247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678775|NCT00002247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715849|NCT01632150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64715850|NCT01632150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64715851|NCT01632150|Antiemetics|antiemetics|mesh-ancestor
64715852|NCT01632150|Autonomic Agents|autonomic agents|mesh-ancestor
64715853|NCT01632150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715854|NCT01632150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64715855|NCT01632150|Glucocorticoids|glucocorticoids|mesh-ancestor
64715856|NCT01632150|Hormones|hormones|mesh-ancestor
65450386|NCT01107808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65450387|NCT01104844|Acetaminophen|acetaminophen|mesh-list
65450388|NCT01104844|Ibuprofen|ibuprofen|mesh-list
65450389|NCT01104844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65450390|NCT01104844|Analgesics|analgesics|mesh-ancestor
65450391|NCT01104844|Sensory System Agents|sensory system agents|mesh-ancestor
65450392|NCT01104844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65450393|NCT01104844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450394|NCT01104844|Antipyretics|antipyretics|mesh-ancestor
65450395|NCT01104844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65450396|NCT01104844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65450397|NCT01104844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65450398|NCT01104844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64715857|NCT01632150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64715858|NCT01632150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64715859|NCT01632150|Protease Inhibitors|protease inhibitors|mesh-ancestor
64715860|NCT01632150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324152|NCT01573351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324153|NCT01573351|Antimetabolites|antimetabolites|mesh-ancestor
64678776|NCT00002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678777|NCT00002475|Interferons|interferons|mesh-list
64678778|NCT00002475|Interferon-alpha|interferon-alpha|mesh-list
64678779|NCT00002475|Interferon-gamma|interferon-gamma|mesh-list
64678780|NCT00002475|Cyclophosphamide|cyclophosphamide|mesh-list
64678781|NCT00002475|Vaccines|vaccines|mesh-list
64678782|NCT00002475|Sargramostim|sargramostim|mesh-list
64678783|NCT00002475|Immunologic Factors|immunologic factors|mesh-ancestor
64678784|NCT00002475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678785|NCT00002475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64678786|NCT00002475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64678787|NCT00002475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64678788|NCT00002475|Alkylating Agents|alkylating agents|mesh-ancestor
64678789|NCT00002475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678790|NCT00002475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678791|NCT00002475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64678792|NCT00002475|Antiviral Agents|antiviral agents|mesh-ancestor
64678793|NCT00002475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678794|NCT00002481|Cytarabine|cytarabine|mesh-list
64678795|NCT00002481|Dexamethasone|dexamethasone|mesh-list
64678796|NCT00002481|Cyclophosphamide|cyclophosphamide|mesh-list
64678797|NCT00002481|Etoposide|etoposide|mesh-list
64678798|NCT00002481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64678799|NCT00002481|Immunologic Factors|immunologic factors|mesh-ancestor
64678800|NCT00002481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678801|NCT00002481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64678802|NCT00002481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64678803|NCT00002481|Alkylating Agents|alkylating agents|mesh-ancestor
64678804|NCT00002481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678805|NCT00002481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678806|NCT00002481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64678807|NCT00002481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64678808|NCT00002481|Antiemetics|antiemetics|mesh-ancestor
64678809|NCT00002481|Autonomic Agents|autonomic agents|mesh-ancestor
64678810|NCT00002481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64678811|NCT00002481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64678812|NCT00002481|Glucocorticoids|glucocorticoids|mesh-ancestor
64678813|NCT00002481|Hormones|hormones|mesh-ancestor
64678814|NCT00002481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64678815|NCT00002481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64678816|NCT00002481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64678817|NCT00002481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64678818|NCT00002481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65450399|NCT01104844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450400|NCT01104844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450401|NCT03750136|Furosemide|furosemide|mesh-list
65450402|NCT03750136|Diuretics|diuretics|mesh-ancestor
65450403|NCT03750136|Natriuretic Agents|natriuretic agents|mesh-ancestor
65450404|NCT03750136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450405|NCT03750136|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65450406|NCT03750136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65450407|NCT03750136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450408|NCT01108042|Docetaxel|docetaxel|mesh-list
65450409|NCT01108042|Fluorouracil|fluorouracil|mesh-list
65450410|NCT01108042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450411|NCT01108042|Tubulin Modulators|tubulin modulators|mesh-ancestor
65450412|NCT01108042|Antimitotic Agents|antimitotic agents|mesh-ancestor
65450413|NCT01108042|Mitosis Modulators|mitosis modulators|mesh-ancestor
65450414|NCT01108042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450415|NCT01108042|Antimetabolites|antimetabolites|mesh-ancestor
65450416|NCT01108042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65450417|NCT01108042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65450418|NCT01108042|Immunologic Factors|immunologic factors|mesh-ancestor
65450419|NCT01108042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835124|NCT02990806|Infliximab|infliximab|mesh-list
64678830|NCT04862585|Dexamethasone|dexamethasone|mesh-list
64678831|NCT04862585|Dexamethasone acetate|dexamethasone acetate|mesh-list
64455183|NCT01415440|Dopamine Agents|dopamine agents|mesh-ancestor
64715861|NCT01632150|Leprostatic Agents|leprostatic agents|mesh-ancestor
64715862|NCT01632150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64715863|NCT01632150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64715864|NCT01632150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64715865|NCT01632150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64715866|NCT01632150|Growth Substances|growth substances|mesh-ancestor
64715867|NCT01632150|Growth Inhibitors|growth inhibitors|mesh-ancestor
64715869|NCT02185014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64715870|NCT02185014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64715871|NCT03297944|Zolpidem|zolpidem|mesh-list
64715872|NCT03297944|Alprazolam|alprazolam|mesh-list
64715873|NCT03297944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64715874|NCT03297944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64678832|NCT04862585|Paclitaxel|paclitaxel|mesh-list
64678833|NCT04862585|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64678834|NCT04862585|Famotidine|famotidine|mesh-list
64678835|NCT04862585|Ranitidine|ranitidine|mesh-list
64678836|NCT04862585|Cimetidine|cimetidine|mesh-list
64678837|NCT04862585|BB 1101|bb 1101|mesh-list
64678838|NCT04862585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64678839|NCT04862585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678840|NCT04862585|Tubulin Modulators|tubulin modulators|mesh-ancestor
64678841|NCT04862585|Antimitotic Agents|antimitotic agents|mesh-ancestor
64678842|NCT04862585|Mitosis Modulators|mitosis modulators|mesh-ancestor
64678843|NCT04862585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678844|NCT04862585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64678845|NCT04862585|Antiemetics|antiemetics|mesh-ancestor
64678846|NCT04862585|Autonomic Agents|autonomic agents|mesh-ancestor
64678847|NCT04862585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64835143|NCT02965703|Antipyretics|antipyretics|mesh-ancestor
65450420|NCT01105234|Vitamin D|vitamin d|mesh-list
65450421|NCT01105234|Calcipotriene|calcipotriene|mesh-list
65450422|NCT01105234|Vitamins|vitamins|mesh-ancestor
65450423|NCT01105234|Micronutrients|micronutrients|mesh-ancestor
65450424|NCT01105234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450425|NCT01105234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65450426|NCT01105234|Dermatologic Agents|dermatologic agents|mesh-ancestor
65450427|NCT01108198|Mometasone Furoate|mometasone furoate|mesh-list
65450428|NCT01108198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65450429|NCT01108198|Dermatologic Agents|dermatologic agents|mesh-ancestor
65450430|NCT01108198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65450431|NCT01108900|Sildenafil Citrate|sildenafil citrate|mesh-list
65450432|NCT01108900|Vasodilator Agents|vasodilator agents|mesh-ancestor
65450433|NCT01108900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65450434|NCT01108900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65450435|NCT01108900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450436|NCT01108900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678848|NCT04862585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678849|NCT04862585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64678850|NCT04862585|Glucocorticoids|glucocorticoids|mesh-ancestor
64678851|NCT04862585|Hormones|hormones|mesh-ancestor
64678852|NCT04862585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64678853|NCT04862585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64678854|NCT04862585|Protease Inhibitors|protease inhibitors|mesh-ancestor
64678855|NCT04862585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678856|NCT04862585|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64678857|NCT04862585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64678858|NCT04862585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64678859|NCT04862585|Anesthetics, Local|anesthetics, local|mesh-ancestor
64678860|NCT04862585|Anesthetics|anesthetics|mesh-ancestor
64678861|NCT04862585|Sensory System Agents|sensory system agents|mesh-ancestor
64678862|NCT04862585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64678863|NCT04862585|Histamine Antagonists|histamine antagonists|mesh-ancestor
64678864|NCT04862585|Histamine Agents|histamine agents|mesh-ancestor
64678865|NCT04862585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64678866|NCT04862585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64678867|NCT04862585|Antipruritics|antipruritics|mesh-ancestor
64678868|NCT04862585|Dermatologic Agents|dermatologic agents|mesh-ancestor
64678869|NCT04862585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64678870|NCT04862585|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64678871|NCT04862585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64678872|NCT04862585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64678873|NCT00002487|Methotrexate|methotrexate|mesh-list
64678874|NCT00002487|Dipyridamole|dipyridamole|mesh-list
64678875|NCT00002487|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64678876|NCT00002487|Abortifacient Agents|abortifacient agents|mesh-ancestor
64678877|NCT00002487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64678878|NCT00002487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678879|NCT00002487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64678880|NCT00002487|Antimetabolites|antimetabolites|mesh-ancestor
64715875|NCT03297944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64715876|NCT03297944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715877|NCT03297944|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64715879|NCT03297944|GABA Agents|gaba agents|mesh-ancestor
64678881|NCT00002487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678882|NCT00002487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678883|NCT00002487|Dermatologic Agents|dermatologic agents|mesh-ancestor
65450437|NCT01108900|Urological Agents|urological agents|mesh-ancestor
65450438|NCT01105390|Pemetrexed|pemetrexed|mesh-list
65450439|NCT01105390|Rilotumumab|rilotumumab|mesh-list
65450440|NCT01105390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65450441|NCT01105390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450442|NCT01105390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450443|NCT01105390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450444|NCT01105390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65450445|NCT01105390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65450446|NCT01105390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65450447|NCT01105390|Immunologic Factors|immunologic factors|mesh-ancestor
64678889|NCT00002487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678890|NCT00002487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64678891|NCT00002487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64678892|NCT00002487|Vasodilator Agents|vasodilator agents|mesh-ancestor
64678894|NCT00002493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64678895|NCT00002493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678896|NCT00002493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64678897|NCT00002493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64678898|NCT00002493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64678899|NCT00002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678900|NCT00002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678901|NCT00002259|Mitoxantrone|mitoxantrone|mesh-list
64678902|NCT00002259|Analgesics|analgesics|mesh-ancestor
64678903|NCT00002259|Sensory System Agents|sensory system agents|mesh-ancestor
64678904|NCT00002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64678905|NCT00002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678906|NCT00002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678907|NCT00002259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64678908|NCT00002259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64678909|NCT00002259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678910|NCT00002259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678911|NCT00002499|Cytarabine|cytarabine|mesh-list
64678912|NCT00002499|Dexamethasone|dexamethasone|mesh-list
64678913|NCT00002499|Prednisone|prednisone|mesh-list
64678914|NCT00002499|Methotrexate|methotrexate|mesh-list
64678915|NCT00002499|Vincristine|vincristine|mesh-list
64678916|NCT00002499|Daunorubicin|daunorubicin|mesh-list
64678917|NCT00002499|Asparaginase|asparaginase|mesh-list
64678918|NCT00002499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64678919|NCT00002499|Antiemetics|antiemetics|mesh-ancestor
64678920|NCT00002499|Autonomic Agents|autonomic agents|mesh-ancestor
64678921|NCT00002499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64678922|NCT00002499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678923|NCT00002499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64678924|NCT00002499|Glucocorticoids|glucocorticoids|mesh-ancestor
64678925|NCT00002499|Hormones|hormones|mesh-ancestor
64678926|NCT00002499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64678927|NCT00002499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64678928|NCT00002499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678929|NCT00002499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64678930|NCT00002499|Abortifacient Agents|abortifacient agents|mesh-ancestor
64678931|NCT00002499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64678932|NCT00002499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64678933|NCT00002499|Antimetabolites|antimetabolites|mesh-ancestor
64678934|NCT00002499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678935|NCT00002499|Dermatologic Agents|dermatologic agents|mesh-ancestor
64678936|NCT00002499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678937|NCT00002499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64678938|NCT00002499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64678939|NCT00002499|Immunologic Factors|immunologic factors|mesh-ancestor
64678940|NCT00002499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64678941|NCT00002499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678942|NCT00002499|Antiviral Agents|antiviral agents|mesh-ancestor
65450448|NCT01105390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450449|NCT03947242|Trastuzumab|trastuzumab|mesh-list
65450450|NCT03947242|Vinorelbine|vinorelbine|mesh-list
65450451|NCT03947242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65450452|NCT03947242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450453|NCT03947242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65450454|NCT03947242|Tubulin Modulators|tubulin modulators|mesh-ancestor
65450455|NCT03947242|Antimitotic Agents|antimitotic agents|mesh-ancestor
65450456|NCT03947242|Mitosis Modulators|mitosis modulators|mesh-ancestor
65450457|NCT03947242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450458|NCT03944980|Docetaxel|docetaxel|mesh-list
65450459|NCT03944980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450460|NCT03944980|Tubulin Modulators|tubulin modulators|mesh-ancestor
65450461|NCT03944980|Antimitotic Agents|antimitotic agents|mesh-ancestor
65450462|NCT03944980|Mitosis Modulators|mitosis modulators|mesh-ancestor
64678943|NCT00002499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678944|NCT00002499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64678945|NCT00002499|Tubulin Modulators|tubulin modulators|mesh-ancestor
64678946|NCT00002499|Antimitotic Agents|antimitotic agents|mesh-ancestor
64678947|NCT00002499|Mitosis Modulators|mitosis modulators|mesh-ancestor
64715880|NCT03297944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64715881|NCT03297944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715882|NCT03297944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64715883|NCT03297944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64715884|NCT03297944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64715885|NCT03297944|GABA Modulators|gaba modulators|mesh-ancestor
64715886|NCT04333004|Pembrolizumab|pembrolizumab|mesh-list
64715887|NCT04333004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64324184|NCT00258427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64678948|NCT00002499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64678949|NCT00002499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64678950|NCT00002499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64678957|NCT00002505|Immunologic Factors|immunologic factors|mesh-ancestor
64678972|NCT04933331|Cariostatic Agents|cariostatic agents|mesh-ancestor
64678973|NCT04933331|Protective Agents|protective agents|mesh-ancestor
64678974|NCT04933331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678975|NCT04933331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64678976|NCT04933331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678977|NCT00002271|Alovudine|alovudine|mesh-list
64678978|NCT00002271|Antiviral Agents|antiviral agents|mesh-ancestor
64678979|NCT00002271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678980|NCT00002517|Cytarabine|cytarabine|mesh-list
64678981|NCT00002517|Dexamethasone|dexamethasone|mesh-list
64678982|NCT00002517|Etoposide|etoposide|mesh-list
64678983|NCT00002517|Daunorubicin|daunorubicin|mesh-list
64678984|NCT00002517|Mitoxantrone|mitoxantrone|mesh-list
64678985|NCT00002517|Idarubicin|idarubicin|mesh-list
64678986|NCT00002517|Thioguanine|thioguanine|mesh-list
64678987|NCT00002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64678988|NCT00002517|Antiemetics|antiemetics|mesh-ancestor
64678989|NCT00002517|Autonomic Agents|autonomic agents|mesh-ancestor
64678990|NCT00002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64678991|NCT00002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678992|NCT00002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64678993|NCT00002517|Glucocorticoids|glucocorticoids|mesh-ancestor
64678994|NCT00002517|Hormones|hormones|mesh-ancestor
64678995|NCT00002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64678996|NCT00002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64678997|NCT00002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678998|NCT00002517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64678999|NCT00002517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64679000|NCT00002517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65450463|NCT03944980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450464|NCT03576664|Carvedilol|carvedilol|mesh-list
65450465|NCT03576664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65450466|NCT03576664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65450467|NCT03576664|Adrenergic Agents|adrenergic agents|mesh-ancestor
65450468|NCT03576664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65450469|NCT03576664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450470|NCT03576664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450471|NCT03576664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65450472|NCT03576664|Antioxidants|antioxidants|mesh-ancestor
65450473|NCT03576664|Protective Agents|protective agents|mesh-ancestor
65450474|NCT03576664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65450475|NCT03576664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65450476|NCT03576664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65450477|NCT03576664|Vasodilator Agents|vasodilator agents|mesh-ancestor
65450478|NCT03576664|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65450479|NCT03576664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65450480|NCT01109134|Tirofiban|tirofiban|mesh-list
65450481|NCT01109134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65450482|NCT01109134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65450483|NCT01109134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835181|NCT02814916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64679001|NCT00002517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679002|NCT00002517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679003|NCT00002517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64679004|NCT00002517|Antimetabolites|antimetabolites|mesh-ancestor
64679005|NCT00002517|Antiviral Agents|antiviral agents|mesh-ancestor
64679006|NCT00002517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64679007|NCT00002517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64679008|NCT00002517|Immunologic Factors|immunologic factors|mesh-ancestor
64679009|NCT00002517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64679011|NCT00002517|Sensory System Agents|sensory system agents|mesh-ancestor
64679012|NCT00002277|Fluconazole|fluconazole|mesh-list
64679013|NCT00002277|Amphotericin B|amphotericin b|mesh-list
64679014|NCT00002277|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64679015|NCT00002277|Antifungal Agents|antifungal agents|mesh-ancestor
64679016|NCT00002277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64679017|NCT00002277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64679018|NCT00002277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64679019|NCT00002277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679020|NCT00002277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679021|NCT00002277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64715888|NCT04333004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715889|NCT03219866|Budesonide|budesonide|mesh-list
64715890|NCT03219866|Tiotropium Bromide|tiotropium bromide|mesh-list
64715891|NCT03219866|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64715892|NCT03219866|Ipratropium|ipratropium|mesh-list
64715893|NCT03219866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64715894|NCT03219866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64715895|NCT03219866|Autonomic Agents|autonomic agents|mesh-ancestor
65450484|NCT01109134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65450485|NCT01108588|Aspirin|aspirin|mesh-list
65450486|NCT01108588|Clopidogrel|clopidogrel|mesh-list
65450487|NCT01108588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65450488|NCT01108588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65450489|NCT01108588|Analgesics|analgesics|mesh-ancestor
65450490|NCT01108588|Sensory System Agents|sensory system agents|mesh-ancestor
65450491|NCT01108588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65450492|NCT01108588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450493|NCT01108588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65450494|NCT01108588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65450495|NCT01108588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65450496|NCT01108588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65450497|NCT01108588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450498|NCT01108588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65450499|NCT01108588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65450500|NCT01108588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450501|NCT01108588|Antipyretics|antipyretics|mesh-ancestor
65450502|NCT01108588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65450503|NCT01108588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65450504|NCT01108588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65450505|NCT01108588|Purinergic Agents|purinergic agents|mesh-ancestor
65450506|NCT01108588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65450507|NCT01208740|Metformin|metformin|mesh-list
65450508|NCT01208740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65450509|NCT01208740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835205|NCT02420821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64835206|NCT02420821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835207|NCT02420821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64835208|NCT02420821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65450510|NCT01208818|Dexamethasone|dexamethasone|mesh-list
65450511|NCT01208818|Dexamethasone acetate|dexamethasone acetate|mesh-list
65450512|NCT01208818|Cyclophosphamide|cyclophosphamide|mesh-list
65450513|NCT01208818|Bortezomib|bortezomib|mesh-list
65450514|NCT01208818|BB 1101|bb 1101|mesh-list
65450515|NCT01208818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65450516|NCT01208818|Immunologic Factors|immunologic factors|mesh-ancestor
65450517|NCT01208818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450518|NCT01208818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65450519|NCT01208818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65450520|NCT01208818|Alkylating Agents|alkylating agents|mesh-ancestor
65450521|NCT01208818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450522|NCT01208818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450523|NCT01208818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65450524|NCT01208818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65450525|NCT01208818|Antiemetics|antiemetics|mesh-ancestor
65450526|NCT01208818|Autonomic Agents|autonomic agents|mesh-ancestor
65450527|NCT01208818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65450528|NCT01208818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65450529|NCT01208818|Glucocorticoids|glucocorticoids|mesh-ancestor
65450530|NCT01208818|Hormones|hormones|mesh-ancestor
65450531|NCT01208818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65450532|NCT01208818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65450533|NCT01208818|Protease Inhibitors|protease inhibitors|mesh-ancestor
65450534|NCT01208818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450535|NCT01111630|Epoetin Alfa|epoetin alfa|mesh-list
65450536|NCT01111630|Hematinics|hematinics|mesh-ancestor
65450537|NCT03942796|Pregabalin|pregabalin|mesh-list
65450538|NCT03942796|Analgesics|analgesics|mesh-ancestor
65450539|NCT03942796|Sensory System Agents|sensory system agents|mesh-ancestor
65450540|NCT03942796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65450541|NCT03942796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450542|NCT03942796|Anticonvulsants|anticonvulsants|mesh-ancestor
65450543|NCT03942796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65450544|NCT03942796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64835233|NCT02229084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64715896|NCT03219866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715897|NCT03219866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715898|NCT03219866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64715899|NCT03219866|Respiratory System Agents|respiratory system agents|mesh-ancestor
65450545|NCT03942796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450546|NCT03942796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65450547|NCT03942796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65450548|NCT03942796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65450549|NCT03942796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65450550|NCT03942796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65450551|NCT01114282|Bortezomib|bortezomib|mesh-list
65450552|NCT01114282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450553|NCT01109212|Bindarit|bindarit|mesh-list
65450554|NCT01109212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65450555|NCT01109212|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65450556|NCT01109212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450557|NCT01109212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450558|NCT01111864|Micronutrients|micronutrients|mesh-list
65450559|NCT01111864|Trace Elements|trace elements|mesh-list
65450560|NCT01111864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450561|NCT01111942|Cisplatin|cisplatin|mesh-list
65450562|NCT01111942|Carboplatin|carboplatin|mesh-list
65450563|NCT01111942|Docetaxel|docetaxel|mesh-list
65450564|NCT01111942|Fluorouracil|fluorouracil|mesh-list
65450565|NCT01111942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835265|NCT02059265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64835266|NCT02059265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835267|NCT02059265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835268|NCT02039063|Quetmolimab|quetmolimab|mesh-list
64835269|NCT02039063|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64835270|NCT02039063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64835271|NCT02039063|Immunologic Factors|immunologic factors|mesh-ancestor
64835272|NCT02039063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835273|NCT01970410|Teriflunomide|teriflunomide|mesh-list
64835276|NCT01970410|Analgesics|analgesics|mesh-ancestor
64715900|NCT03219866|Glucocorticoids|glucocorticoids|mesh-ancestor
64679033|NCT04469075|Clindamycin phosphate|clindamycin phosphate|mesh-list
64679034|NCT04469075|Triamcinolone|triamcinolone|mesh-list
64679035|NCT04469075|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64679036|NCT04469075|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64679037|NCT04469075|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64679041|NCT04469075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64679042|NCT04469075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679043|NCT04469075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64679044|NCT04469075|Immunologic Factors|immunologic factors|mesh-ancestor
64679045|NCT04469075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679046|NCT04469075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679047|NCT04469075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64679048|NCT04469075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65450566|NCT01111942|Tubulin Modulators|tubulin modulators|mesh-ancestor
65450567|NCT01111942|Antimitotic Agents|antimitotic agents|mesh-ancestor
65450568|NCT01111942|Mitosis Modulators|mitosis modulators|mesh-ancestor
65450569|NCT01111942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450570|NCT01111942|Antimetabolites|antimetabolites|mesh-ancestor
65450571|NCT01111942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65450572|NCT01111942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65450573|NCT01111942|Immunologic Factors|immunologic factors|mesh-ancestor
65450574|NCT01111942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450575|NCT01211860|Diazoxide|diazoxide|mesh-list
65450576|NCT01211860|Choline|choline|mesh-list
65450577|NCT01211860|Lipotropic Agents|lipotropic agents|mesh-ancestor
65450578|NCT01211860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65450579|NCT01211860|Antimetabolites|antimetabolites|mesh-ancestor
65450580|NCT01211860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450581|NCT01211860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64835285|NCT01950520|Phentermine|phentermine|mesh-list
64835286|NCT01950520|Magnesium Sulfate|magnesium sulfate|mesh-list
64835287|NCT01950520|Propranolol|propranolol|mesh-list
64835288|NCT01950520|Pindolol|pindolol|mesh-list
64835289|NCT01950520|Naltrexone|naltrexone|mesh-list
64835290|NCT01950520|Caffeine|caffeine|mesh-list
64835291|NCT01950520|Dantrolene|dantrolene|mesh-list
64835292|NCT01950520|Mirabegron|mirabegron|mesh-list
64835293|NCT01950520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64679049|NCT04469075|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64679050|NCT00002523|Leucovorin|leucovorin|mesh-list
64679051|NCT00002523|Fluorouracil|fluorouracil|mesh-list
64679052|NCT00002523|Calcium|calcium|mesh-list
64679053|NCT00002523|Levoleucovorin|levoleucovorin|mesh-list
64679054|NCT00002523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64679055|NCT00002523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679056|NCT00002523|Antimetabolites|antimetabolites|mesh-ancestor
64679057|NCT00002523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679058|NCT00002523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64679059|NCT00002523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679060|NCT00002523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64679061|NCT00002523|Immunologic Factors|immunologic factors|mesh-ancestor
64679062|NCT00002523|Antidotes|antidotes|mesh-ancestor
64679063|NCT00002523|Protective Agents|protective agents|mesh-ancestor
64679064|NCT00002523|Vitamin B Complex|vitamin b complex|mesh-ancestor
64679065|NCT00002523|Vitamins|vitamins|mesh-ancestor
64679066|NCT00002523|Micronutrients|micronutrients|mesh-ancestor
64679067|NCT00002529|Tamoxifen|tamoxifen|mesh-list
64679068|NCT00002529|Toremifene|toremifene|mesh-list
64679069|NCT00002529|Cyclophosphamide|cyclophosphamide|mesh-list
64679070|NCT00002529|Doxorubicin|doxorubicin|mesh-list
64679071|NCT00002529|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64679072|NCT00002529|Epirubicin|epirubicin|mesh-list
64679073|NCT00002529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64679074|NCT00002529|Immunologic Factors|immunologic factors|mesh-ancestor
64679075|NCT00002529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679076|NCT00002529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64679077|NCT00002529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64679078|NCT00002529|Alkylating Agents|alkylating agents|mesh-ancestor
64404430|NCT03490903|Midazolam|midazolam|mesh-list
65450582|NCT01211860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65450583|NCT01211860|Nootropic Agents|nootropic agents|mesh-ancestor
65450584|NCT01211860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65450585|NCT01211860|Vasodilator Agents|vasodilator agents|mesh-ancestor
65450586|NCT01211938|Cetuximab|cetuximab|mesh-list
65450587|NCT01211938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65450588|NCT01211938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450589|NCT02947438|Epoetin Alfa|epoetin alfa|mesh-list
65450590|NCT02947438|Hematinics|hematinics|mesh-ancestor
65450591|NCT01209130|Rituximab|rituximab|mesh-list
65450592|NCT01209130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65450593|NCT01209130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450594|NCT01209130|Immunologic Factors|immunologic factors|mesh-ancestor
65450595|NCT01209130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450596|NCT01209130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65450597|NCT01209208|Budesonide|budesonide|mesh-list
64679079|NCT00002529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679080|NCT00002529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679081|NCT00002529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64679082|NCT00002529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64715901|NCT03219866|Hormones|hormones|mesh-ancestor
64715902|NCT03219866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64715903|NCT03219866|Parasympatholytics|parasympatholytics|mesh-ancestor
64715904|NCT03219866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64715905|NCT03219866|Cholinergic Agents|cholinergic agents|mesh-ancestor
64715906|NCT03219866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64715907|NCT03219866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715908|NCT03219866|Sympathomimetics|sympathomimetics|mesh-ancestor
64324206|NCT02233621|Hormones|hormones|mesh-ancestor
64324207|NCT02233621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64324208|NCT02233621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324209|NCT02233621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64324213|NCT02557100|Adalimumab|adalimumab|mesh-list
64679083|NCT00002529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64679084|NCT00002529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64679085|NCT00002529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679095|NCT04832087|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64679096|NCT04832087|Protective Agents|protective agents|mesh-ancestor
64679097|NCT04832087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679098|NCT00002283|Trimethoprim|trimethoprim|mesh-list
64679100|NCT00002283|Sulfamethoxazole|sulfamethoxazole|mesh-list
64679101|NCT00002283|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64679102|NCT00002283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64679103|NCT00002283|Renal Agents|renal agents|mesh-ancestor
64679104|NCT00002283|Antimalarials|antimalarials|mesh-ancestor
64679105|NCT00002283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64679106|NCT00002283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64679107|NCT00002283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64679111|NCT00002283|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64679112|NCT00002283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64679114|NCT00002283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64679115|NCT04826237|Dexamethasone|dexamethasone|mesh-list
64679116|NCT04826237|Methylprednisolone|methylprednisolone|mesh-list
64679117|NCT04826237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64679118|NCT04826237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64679119|NCT04826237|Prednisolone|prednisolone|mesh-list
64679120|NCT04826237|Prednisolone acetate|prednisolone acetate|mesh-list
64679121|NCT04826237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
64679122|NCT04826237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64679123|NCT04826237|Prednisolone phosphate|prednisolone phosphate|mesh-list
65450598|NCT01209208|Mesalamine|mesalamine|mesh-list
65450599|NCT01209208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65450600|NCT01209208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65450601|NCT01209208|Autonomic Agents|autonomic agents|mesh-ancestor
65450602|NCT01209208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65200107|NCT03280563|Tamoxifen|tamoxifen|mesh-list
65450603|NCT01209208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450604|NCT01209208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65450605|NCT01209208|Respiratory System Agents|respiratory system agents|mesh-ancestor
65450606|NCT01209208|Glucocorticoids|glucocorticoids|mesh-ancestor
65450607|NCT01209208|Hormones|hormones|mesh-ancestor
65450608|NCT01209208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65450609|NCT01209208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65450610|NCT01209208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65450611|NCT01209208|Analgesics|analgesics|mesh-ancestor
65450612|NCT01209208|Sensory System Agents|sensory system agents|mesh-ancestor
65450613|NCT01209208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65450614|NCT01114750|Dextrans|dextrans|mesh-list
65450615|NCT01114750|Anticoagulants|anticoagulants|mesh-ancestor
65450616|NCT01114750|Plasma Substitutes|plasma substitutes|mesh-ancestor
65450617|NCT01114750|Blood Substitutes|blood substitutes|mesh-ancestor
65450618|NCT01328470|Cilostazol|cilostazol|mesh-list
65450619|NCT01328470|Clopidogrel|clopidogrel|mesh-list
65450620|NCT01328470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65450621|NCT01328470|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65450622|NCT01328470|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65450623|NCT01328470|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65450624|NCT01328470|Purinergic Agents|purinergic agents|mesh-ancestor
64679124|NCT04826237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64679125|NCT04826237|Antiemetics|antiemetics|mesh-ancestor
64679126|NCT04826237|Autonomic Agents|autonomic agents|mesh-ancestor
64679127|NCT04826237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64679128|NCT04826237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679129|NCT04826237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64679130|NCT04826237|Glucocorticoids|glucocorticoids|mesh-ancestor
64679132|NCT04826237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64679133|NCT04826237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64679134|NCT04826237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679135|NCT04826237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64679136|NCT04826237|Protective Agents|protective agents|mesh-ancestor
64679137|NCT04826237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64679138|NCT04826237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64679139|NCT04826237|Antimetabolites|antimetabolites|mesh-ancestor
64715909|NCT03300674|Lidocaine|lidocaine|mesh-list
64715910|NCT03300674|Hydromorphone|hydromorphone|mesh-list
64715911|NCT03300674|Anesthetics, Local|anesthetics, local|mesh-ancestor
64715912|NCT03300674|Anesthetics|anesthetics|mesh-ancestor
65450625|NCT01328470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65450626|NCT01328470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450627|NCT01328470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450628|NCT01328470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65450629|NCT01328470|Autonomic Agents|autonomic agents|mesh-ancestor
65450630|NCT01328470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65450631|NCT01328470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65450632|NCT01328470|Respiratory System Agents|respiratory system agents|mesh-ancestor
65450633|NCT01328470|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65450634|NCT01328470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65450635|NCT01328470|Vasodilator Agents|vasodilator agents|mesh-ancestor
65450636|NCT01328470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65450637|NCT01328470|Protective Agents|protective agents|mesh-ancestor
65450638|NCT01328470|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65450639|NCT01328470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65450640|NCT01328470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450641|NCT01109446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65450642|NCT03940378|Levamisole|levamisole|mesh-list
65450643|NCT03940378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64835343|NCT01746173|Gemcitabine|gemcitabine|mesh-list
64715913|NCT03300674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64715914|NCT03300674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715915|NCT03300674|Sensory System Agents|sensory system agents|mesh-ancestor
64715916|NCT03300674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715917|NCT03300674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64715918|NCT03300674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64715919|NCT03300674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64715920|NCT03300674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64715921|NCT03300674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715922|NCT03300674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64679140|NCT04826237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679141|NCT04826237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679142|NCT04826237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64679143|NCT00002535|Aldesleukin|aldesleukin|mesh-list
64679144|NCT00002535|Indomethacin|indomethacin|mesh-list
64679145|NCT00002535|Cyclophosphamide|cyclophosphamide|mesh-list
64679146|NCT00002535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64679147|NCT00002535|Immunologic Factors|immunologic factors|mesh-ancestor
64679148|NCT00002535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679149|NCT00002535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64679150|NCT00002535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64679151|NCT00002535|Alkylating Agents|alkylating agents|mesh-ancestor
64679172|NCT00002547|Cyclophosphamide|cyclophosphamide|mesh-list
64679173|NCT00002547|Busulfan|busulfan|mesh-list
64679174|NCT00002547|Methotrexate|methotrexate|mesh-list
64679175|NCT00002547|Cyclosporins|cyclosporins|mesh-list
64679176|NCT00002547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64679177|NCT00002547|Immunologic Factors|immunologic factors|mesh-ancestor
64679178|NCT00002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679179|NCT00002547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64679180|NCT00002547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64679181|NCT00002547|Alkylating Agents|alkylating agents|mesh-ancestor
64679182|NCT00002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450644|NCT03940378|Immunologic Factors|immunologic factors|mesh-ancestor
65450645|NCT03940378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450646|NCT03940378|Antinematodal Agents|antinematodal agents|mesh-ancestor
65450647|NCT03940378|Anthelmintics|anthelmintics|mesh-ancestor
65450648|NCT03940378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65450649|NCT03940378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65450650|NCT03940378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65450651|NCT01115062|Lidocaine|lidocaine|mesh-list
65450652|NCT01115062|Anesthetics, Local|anesthetics, local|mesh-ancestor
65450653|NCT01115062|Anesthetics|anesthetics|mesh-ancestor
65450654|NCT01115062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65450655|NCT01115062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450656|NCT01115062|Sensory System Agents|sensory system agents|mesh-ancestor
65450657|NCT01115062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65450658|NCT01115062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65450659|NCT01115062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65450660|NCT01115062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65450661|NCT01115062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65450662|NCT01115062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450663|NCT01115140|Folic Acid|folic acid|mesh-list
65450664|NCT01115140|Vitamin B Complex|vitamin b complex|mesh-list
65450665|NCT01115140|Metformin|metformin|mesh-list
65450666|NCT01115140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64835372|NCT01746173|Hormones|hormones|mesh-ancestor
64679183|NCT00002547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679184|NCT00002547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64679186|NCT00002547|Abortifacient Agents|abortifacient agents|mesh-ancestor
64679187|NCT00002547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64679188|NCT00002547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64679189|NCT00002547|Antimetabolites|antimetabolites|mesh-ancestor
64679190|NCT00002547|Dermatologic Agents|dermatologic agents|mesh-ancestor
64679191|NCT00002547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679192|NCT00002547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64679193|NCT00002547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64679194|NCT00002547|Antiviral Agents|antiviral agents|mesh-ancestor
64679195|NCT00002547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64679196|NCT00002547|Antifungal Agents|antifungal agents|mesh-ancestor
64679197|NCT00002547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64679198|NCT00002289|Thymopentin|thymopentin|mesh-list
64679199|NCT00002289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64679200|NCT00002289|Immunologic Factors|immunologic factors|mesh-ancestor
64679201|NCT00002289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679203|NCT00002553|Cyclophosphamide|cyclophosphamide|mesh-list
64679204|NCT00002553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64679205|NCT00002553|Immunologic Factors|immunologic factors|mesh-ancestor
64715923|NCT03300674|Narcotics|narcotics|mesh-ancestor
64715924|NCT03300674|Analgesics|analgesics|mesh-ancestor
64715925|NCT02158806|Aspirin|aspirin|mesh-list
64715926|NCT02158806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64715927|NCT02158806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64715928|NCT02158806|Analgesics|analgesics|mesh-ancestor
64715929|NCT02158806|Sensory System Agents|sensory system agents|mesh-ancestor
64715930|NCT02158806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65450667|NCT01115140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450668|NCT01115140|Hematinics|hematinics|mesh-ancestor
65450669|NCT01115140|Vitamins|vitamins|mesh-ancestor
65450670|NCT01115140|Micronutrients|micronutrients|mesh-ancestor
65450671|NCT01112644|Oxycodone|oxycodone|mesh-list
65450672|NCT01112644|Naloxone|naloxone|mesh-list
65450673|NCT01112644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65450674|NCT01112644|Narcotics|narcotics|mesh-ancestor
65450675|NCT01112644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65450676|NCT01112644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450677|NCT01112644|Analgesics|analgesics|mesh-ancestor
65450678|NCT01112644|Sensory System Agents|sensory system agents|mesh-ancestor
65450679|NCT01112644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65450680|NCT01112644|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65450681|NCT01112722|Histamine|histamine|mesh-list
65450682|NCT01112722|Histamine Agonists|histamine agonists|mesh-ancestor
64835388|NCT01545843|Fluoxetine|fluoxetine|mesh-list
64715931|NCT02158806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715932|NCT02158806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64715933|NCT02158806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64715934|NCT02158806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64715935|NCT02158806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64324228|NCT02557100|Immunologic Factors|immunologic factors|mesh-ancestor
64679206|NCT00002553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679207|NCT00002553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64679220|NCT00002559|Antimitotic Agents|antimitotic agents|mesh-ancestor
64679221|NCT00002559|Mitosis Modulators|mitosis modulators|mesh-ancestor
64679222|NCT00002559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679223|NCT00002559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64679224|NCT00002559|Alkylating Agents|alkylating agents|mesh-ancestor
64679226|NCT00002565|Prednisone|prednisone|mesh-list
64679227|NCT00002565|Methylprednisolone|methylprednisolone|mesh-list
64679228|NCT00002565|Cyclophosphamide|cyclophosphamide|mesh-list
64484379|NCT01729819|Cholinergic Agents|cholinergic agents|mesh-ancestor
64679229|NCT00002565|Ifosfamide|ifosfamide|mesh-list
64679230|NCT00002565|Doxorubicin|doxorubicin|mesh-list
64679231|NCT00002565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64679232|NCT00002565|Etoposide|etoposide|mesh-list
64679233|NCT00002565|Vincristine|vincristine|mesh-list
64679234|NCT00002565|Mitoxantrone|mitoxantrone|mesh-list
64679235|NCT00002565|Idarubicin|idarubicin|mesh-list
64679236|NCT00002565|Bleomycin|bleomycin|mesh-list
64679237|NCT00002565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64679238|NCT00002565|Immunologic Factors|immunologic factors|mesh-ancestor
64679239|NCT00002565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679240|NCT00002565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64679241|NCT00002565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64679242|NCT00002565|Alkylating Agents|alkylating agents|mesh-ancestor
64679243|NCT00002565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679244|NCT00002565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679245|NCT00002565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64679246|NCT00002565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64679247|NCT00002565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64679248|NCT00002565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64679249|NCT00002565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679250|NCT00002565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64679251|NCT00002565|Glucocorticoids|glucocorticoids|mesh-ancestor
64679252|NCT00002565|Hormones|hormones|mesh-ancestor
64679253|NCT00002565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64679254|NCT00002565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64679255|NCT00002565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64679256|NCT00002565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65450683|NCT01112722|Histamine Agents|histamine agents|mesh-ancestor
65450684|NCT01112722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65450685|NCT01112722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450686|NCT01112722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450687|NCT01015222|Paclitaxel|paclitaxel|mesh-list
65450688|NCT01015222|Bevacizumab|bevacizumab|mesh-list
65450689|NCT01015222|Dasatinib|dasatinib|mesh-list
65450690|NCT01015222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65450691|NCT01015222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450692|NCT01015222|Tubulin Modulators|tubulin modulators|mesh-ancestor
65450693|NCT01015222|Antimitotic Agents|antimitotic agents|mesh-ancestor
65450694|NCT01015222|Mitosis Modulators|mitosis modulators|mesh-ancestor
65450695|NCT01015222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450696|NCT01015222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65450697|NCT01015222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65450698|NCT01015222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65450699|NCT01015222|Growth Substances|growth substances|mesh-ancestor
65450700|NCT01015222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450701|NCT01015222|Growth Inhibitors|growth inhibitors|mesh-ancestor
65450702|NCT01015222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65450703|NCT01015222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450704|NCT01212250|Carvedilol|carvedilol|mesh-list
65450705|NCT01212250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65450706|NCT01212250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65450707|NCT01212250|Adrenergic Agents|adrenergic agents|mesh-ancestor
65450708|NCT01212250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65450709|NCT01212250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450710|NCT01212250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450711|NCT01212250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65450712|NCT01212250|Antioxidants|antioxidants|mesh-ancestor
65450725|NCT01209988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65450726|NCT01209988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450727|NCT01209988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450728|NCT01209988|Urological Agents|urological agents|mesh-ancestor
65450729|NCT03943186|Hyaluronic Acid|hyaluronic acid|mesh-list
65450730|NCT03943186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65450731|NCT03943186|Immunologic Factors|immunologic factors|mesh-ancestor
65450732|NCT03943186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450733|NCT03943186|Viscosupplements|viscosupplements|mesh-ancestor
65450734|NCT03943186|Protective Agents|protective agents|mesh-ancestor
65450735|NCT01210066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65450736|NCT01210066|Fentanyl|fentanyl|mesh-list
65450737|NCT01210066|Analgesics, Opioid|analgesics, opioid|mesh-list
65450738|NCT01210066|Narcotics|narcotics|mesh-ancestor
65450739|NCT01210066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65450740|NCT01210066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450741|NCT01210066|Analgesics|analgesics|mesh-ancestor
65450742|NCT01210066|Sensory System Agents|sensory system agents|mesh-ancestor
65450743|NCT01210066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65450744|NCT01210066|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65450745|NCT01210066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65450746|NCT01210066|Anesthetics, General|anesthetics, general|mesh-ancestor
64835443|NCT03161353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64679257|NCT00002565|Antimetabolites|antimetabolites|mesh-ancestor
64679258|NCT00002565|Antiviral Agents|antiviral agents|mesh-ancestor
64679264|NCT00002565|Autonomic Agents|autonomic agents|mesh-ancestor
64679265|NCT00002565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64679266|NCT00002565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64715936|NCT02158806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715937|NCT02158806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64715938|NCT02158806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64715940|NCT02158806|Antipyretics|antipyretics|mesh-ancestor
64715941|NCT03197389|Pembrolizumab|pembrolizumab|mesh-list
64715942|NCT03197389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64715943|NCT03197389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679267|NCT00002565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64679268|NCT00002565|Protective Agents|protective agents|mesh-ancestor
64679269|NCT00002565|Analgesics|analgesics|mesh-ancestor
64679270|NCT00002565|Sensory System Agents|sensory system agents|mesh-ancestor
64679271|NCT00002571|Leucovorin|leucovorin|mesh-list
64679272|NCT00002571|Cytarabine|cytarabine|mesh-list
64679273|NCT00002571|Trimethoprim|trimethoprim|mesh-list
64679289|NCT00002571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64679290|NCT00002571|Alkylating Agents|alkylating agents|mesh-ancestor
64679291|NCT00002571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679292|NCT00002571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679293|NCT00002571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64679294|NCT00002571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64679295|NCT00002571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64679296|NCT00002571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64679297|NCT00002571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679298|NCT00002571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65450747|NCT01210066|Anesthetics|anesthetics|mesh-ancestor
65450748|NCT01112878|Clonidine|clonidine|mesh-list
65450749|NCT01112878|Gabapentin|gabapentin|mesh-list
65450750|NCT01112878|Analgesics|analgesics|mesh-ancestor
65450751|NCT01112878|Sensory System Agents|sensory system agents|mesh-ancestor
65450752|NCT01112878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65450753|NCT01112878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450754|NCT01112878|Anticonvulsants|anticonvulsants|mesh-ancestor
65450755|NCT01112878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65450756|NCT01112878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65450757|NCT01112878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65450758|NCT01112878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65450759|NCT01112878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65450760|NCT01112878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65450761|NCT01112878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65450762|NCT01112878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450763|NCT01112878|Antimanic Agents|antimanic agents|mesh-ancestor
65450764|NCT01112878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64679300|NCT00002571|Hormones|hormones|mesh-ancestor
64679301|NCT00002571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64679302|NCT00002571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64679303|NCT00002571|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64679304|NCT00002571|Abortifacient Agents|abortifacient agents|mesh-ancestor
64679305|NCT00002571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64679306|NCT00002571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64679307|NCT00002571|Antimetabolites|antimetabolites|mesh-ancestor
64679308|NCT00002571|Dermatologic Agents|dermatologic agents|mesh-ancestor
64679309|NCT00002571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64679310|NCT00002571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64679311|NCT00002571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64679312|NCT00002571|Antiviral Agents|antiviral agents|mesh-ancestor
64679313|NCT00002571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64679314|NCT00002571|Antidotes|antidotes|mesh-ancestor
64679315|NCT00002571|Protective Agents|protective agents|mesh-ancestor
64679316|NCT00002571|Vitamin B Complex|vitamin b complex|mesh-ancestor
64679317|NCT00002571|Vitamins|vitamins|mesh-ancestor
64679318|NCT00002571|Micronutrients|micronutrients|mesh-ancestor
64679319|NCT00002571|Tubulin Modulators|tubulin modulators|mesh-ancestor
64679320|NCT00002571|Antimitotic Agents|antimitotic agents|mesh-ancestor
64679321|NCT00002571|Mitosis Modulators|mitosis modulators|mesh-ancestor
64679322|NCT00002571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64679323|NCT00002571|Renal Agents|renal agents|mesh-ancestor
64679362|NCT00002583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679364|NCT00002589|Muromonab-CD3|muromonab-cd3|mesh-list
64679369|NCT00002589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64679370|NCT00002589|Immunologic Factors|immunologic factors|mesh-ancestor
64679371|NCT00002589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679372|NCT00002589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64679373|NCT02223871|Lumefantrine|lumefantrine|mesh-list
64679374|NCT02223871|Artemether|artemether|mesh-list
64679375|NCT02223871|Primaquine|primaquine|mesh-list
64679376|NCT02223871|Antimalarials|antimalarials|mesh-ancestor
64679377|NCT02223871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64679378|NCT02223871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64679379|NCT02223871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64679380|NCT00002595|Toremifene|toremifene|mesh-list
64679381|NCT00002595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64679382|NCT00002595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332948|NCT04468711|Vitamin D|vitamin d|mesh-list
65450765|NCT01112878|Sympatholytics|sympatholytics|mesh-ancestor
65450766|NCT01112878|Autonomic Agents|autonomic agents|mesh-ancestor
65450767|NCT01112878|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65450768|NCT01112878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65450769|NCT01112878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65450770|NCT01112878|Adrenergic Agents|adrenergic agents|mesh-ancestor
65450772|NCT01212406|Vitamins|vitamins|mesh-ancestor
65450773|NCT01212406|Micronutrients|micronutrients|mesh-ancestor
65450774|NCT01212406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450775|NCT01212406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65450776|NCT01109758|Fenofibrate|fenofibrate|mesh-list
65450777|NCT01109758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65450778|NCT01109758|Antimetabolites|antimetabolites|mesh-ancestor
65450779|NCT01109758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450780|NCT01109758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65450781|NCT01328236|Dexamethasone|dexamethasone|mesh-list
65450782|NCT01328236|Doxorubicin|doxorubicin|mesh-list
65450783|NCT01328236|Bortezomib|bortezomib|mesh-list
65450784|NCT01328236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65450785|NCT01328236|Antiemetics|antiemetics|mesh-ancestor
65450786|NCT01328236|Autonomic Agents|autonomic agents|mesh-ancestor
65450787|NCT01328236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65450788|NCT01328236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450789|NCT01328236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65450790|NCT01328236|Glucocorticoids|glucocorticoids|mesh-ancestor
65450791|NCT01328236|Hormones|hormones|mesh-ancestor
65450792|NCT01328236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65450793|NCT01328236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65450794|NCT01328236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450795|NCT01328236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64679384|NCT00002595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64679385|NCT00002595|Hormone Antagonists|hormone antagonists|mesh-ancestor
64679386|NCT00002595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64715944|NCT03198871|Acetaminophen|acetaminophen|mesh-list
64715945|NCT03198871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64715946|NCT03198871|Analgesics|analgesics|mesh-ancestor
64715947|NCT03198871|Sensory System Agents|sensory system agents|mesh-ancestor
64715948|NCT03198871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715949|NCT03198871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715950|NCT03198871|Antipyretics|antipyretics|mesh-ancestor
64715951|NCT02157948|Denosumab|denosumab|mesh-list
64679387|NCT00002595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679388|NCT00002595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64679389|NCT03004339|Betamethasone|betamethasone|mesh-list
64679390|NCT03004339|Betamethasone Valerate|betamethasone valerate|mesh-list
65450796|NCT01328236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65450797|NCT01328236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65450798|NCT01328236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450799|NCT01328236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450800|NCT01328392|Dexlansoprazole|dexlansoprazole|mesh-list
65450801|NCT01328392|Lansoprazole|lansoprazole|mesh-list
65450802|NCT01328392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65450803|NCT01328392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65450804|NCT01328392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65450805|NCT01328392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450806|NCT01328392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450807|NCT01115842|Vitamin D|vitamin d|mesh-list
65450808|NCT01115842|Vitamins|vitamins|mesh-ancestor
65450809|NCT01115842|Micronutrients|micronutrients|mesh-ancestor
65450810|NCT01115842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450811|NCT01115842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65450812|NCT01210378|Nitroglycerin|nitroglycerin|mesh-list
65450813|NCT01210378|Vasodilator Agents|vasodilator agents|mesh-ancestor
65450814|NCT01116154|Lenalidomide|lenalidomide|mesh-list
65450815|NCT01116154|Vorinostat|vorinostat|mesh-list
65450816|NCT01116154|Immunologic Factors|immunologic factors|mesh-ancestor
65450817|NCT01116154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450818|NCT01116154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65450819|NCT01116154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65450820|NCT01116154|Growth Substances|growth substances|mesh-ancestor
64679391|NCT03004339|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64679392|NCT03004339|Betamethasone benzoate|betamethasone benzoate|mesh-list
64679393|NCT03004339|Calcipotriene|calcipotriene|mesh-list
64679394|NCT03004339|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64679395|NCT03004339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64679396|NCT03004339|Glucocorticoids|glucocorticoids|mesh-ancestor
64679397|NCT03004339|Hormones|hormones|mesh-ancestor
64679398|NCT03004339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64679399|NCT03004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679400|NCT03004339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64679401|NCT03004339|Respiratory System Agents|respiratory system agents|mesh-ancestor
64679402|NCT03004339|Dermatologic Agents|dermatologic agents|mesh-ancestor
64679403|NCT00002619|Carboplatin|carboplatin|mesh-list
64679404|NCT00002619|Thiotepa|thiotepa|mesh-list
64679405|NCT00002619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679406|NCT00002619|Immunologic Factors|immunologic factors|mesh-ancestor
64679407|NCT00002619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679408|NCT00002619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64679429|NCT05752305|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64679430|NCT05752305|Prednisolone phosphate|prednisolone phosphate|mesh-list
64679431|NCT05752305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64679432|NCT05752305|Antiemetics|antiemetics|mesh-ancestor
64679433|NCT05752305|Autonomic Agents|autonomic agents|mesh-ancestor
64679434|NCT05752305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64679435|NCT05752305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679436|NCT05752305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65450821|NCT01116154|Growth Inhibitors|growth inhibitors|mesh-ancestor
65450822|NCT01116154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450823|NCT01116154|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65450824|NCT01116154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450825|NCT01116154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450826|NCT01210456|Acetylcysteine|acetylcysteine|mesh-list
65450827|NCT01210456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65450828|NCT01210456|Antiviral Agents|antiviral agents|mesh-ancestor
65450829|NCT01210456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65450830|NCT01210456|Expectorants|expectorants|mesh-ancestor
65450831|NCT01210456|Respiratory System Agents|respiratory system agents|mesh-ancestor
65450832|NCT01210456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65450833|NCT01210456|Antioxidants|antioxidants|mesh-ancestor
64835538|NCT02815566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64679437|NCT05752305|Glucocorticoids|glucocorticoids|mesh-ancestor
64679438|NCT05752305|Hormones|hormones|mesh-ancestor
64679439|NCT05752305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64679440|NCT05752305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64679441|NCT05752305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679442|NCT05752305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64679443|NCT05752305|Protective Agents|protective agents|mesh-ancestor
64679444|NCT04343729|Methylprednisolone|methylprednisolone|mesh-list
64679445|NCT04343729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64679446|NCT04343729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64679447|NCT04343729|Prednisolone|prednisolone|mesh-list
64679448|NCT04343729|Prednisolone acetate|prednisolone acetate|mesh-list
64679449|NCT04343729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64679450|NCT04343729|Prednisolone phosphate|prednisolone phosphate|mesh-list
64679451|NCT04343729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64679452|NCT04343729|Antiemetics|antiemetics|mesh-ancestor
64679484|NCT02977013|Dalteparin|dalteparin|mesh-list
64679485|NCT02977013|Anticoagulants|anticoagulants|mesh-ancestor
64679486|NCT02977013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64679487|NCT02977013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64679488|NCT02977013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679489|NCT04416737|Insulin|insulin|mesh-list
64679490|NCT04416737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64679491|NCT04416737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679492|NCT05807048|Daratumumab|daratumumab|mesh-list
64679493|NCT05807048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679494|NCT05806931|Bevacizumab|bevacizumab|mesh-list
64679495|NCT05806931|Oxaliplatin|oxaliplatin|mesh-list
64679496|NCT05806931|Irinotecan|irinotecan|mesh-list
64679497|NCT05806931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64679499|NCT05806931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64679500|NCT05806931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64715952|NCT02157948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64715955|NCT03220958|Promethazine|promethazine|mesh-list
64715956|NCT03220958|Metoclopramide|metoclopramide|mesh-list
64715957|NCT03220958|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64715958|NCT03220958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64715959|NCT03220958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64715960|NCT03220958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715961|NCT03220958|Anesthetics, Local|anesthetics, local|mesh-ancestor
64715962|NCT03220958|Anesthetics|anesthetics|mesh-ancestor
64715963|NCT03220958|Sensory System Agents|sensory system agents|mesh-ancestor
64715964|NCT03220958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715965|NCT03220958|Antiemetics|antiemetics|mesh-ancestor
64715966|NCT03220958|Autonomic Agents|autonomic agents|mesh-ancestor
64715967|NCT03220958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64324253|NCT01520545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64679501|NCT05806931|Growth Substances|growth substances|mesh-ancestor
64679502|NCT05806931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679503|NCT05806931|Growth Inhibitors|growth inhibitors|mesh-ancestor
65450834|NCT01210456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450835|NCT01210456|Protective Agents|protective agents|mesh-ancestor
65450836|NCT01210456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450837|NCT01210456|Antidotes|antidotes|mesh-ancestor
65450838|NCT01116310|Glycine|glycine|mesh-list
65450839|NCT01116310|Glycine Agents|glycine agents|mesh-ancestor
65450840|NCT01116310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65450841|NCT01116310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450842|NCT01116310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679504|NCT05806931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64679505|NCT05806931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64679506|NCT05806931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679507|NCT05806931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679508|NCT05806918|Interferons|interferons|mesh-list
64679509|NCT05806918|Interferon alpha-2|interferon alpha-2|mesh-list
64679510|NCT05806918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679511|NCT05806918|Antiviral Agents|antiviral agents|mesh-ancestor
64679512|NCT05806918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64679513|NCT05806853|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64679514|NCT05806853|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64679515|NCT05806853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679516|NCT05806749|Belumosudil|belumosudil|mesh-list
64679517|NCT05806749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64679518|NCT05806749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679519|NCT05806749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679520|NCT05806723|Atorvastatin|atorvastatin|mesh-list
64679521|NCT05806723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64679522|NCT05806723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64679523|NCT05806723|Antimetabolites|antimetabolites|mesh-ancestor
64679524|NCT05806723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679525|NCT05806723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64679526|NCT05806723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64679527|NCT05806723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679528|NCT05806697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64679529|NCT05806697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64679530|NCT05806697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679531|NCT05806671|Fulvestrant|fulvestrant|mesh-list
64679532|NCT05806671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64679533|NCT05806671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679534|NCT05806671|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64679535|NCT05806671|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64679536|NCT05806671|Hormone Antagonists|hormone antagonists|mesh-ancestor
64679537|NCT05806671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64679538|NCT05806671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679540|NCT05806515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715968|NCT03220958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64715969|NCT03220958|Histamine Antagonists|histamine antagonists|mesh-ancestor
64715970|NCT03220958|Histamine Agents|histamine agents|mesh-ancestor
64715971|NCT03220958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64715972|NCT03220958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715973|NCT03220958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64715974|NCT03220958|Antipruritics|antipruritics|mesh-ancestor
64715975|NCT03220958|Dermatologic Agents|dermatologic agents|mesh-ancestor
64715976|NCT03220958|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64715977|NCT03220958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64715978|NCT03220958|Dopamine Agents|dopamine agents|mesh-ancestor
64715979|NCT02182830|Empagliflozin|empagliflozin|mesh-list
64679541|NCT05806476|Caffeine|caffeine|mesh-list
64679542|NCT05806476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64679543|NCT05806476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679544|NCT05806476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64679545|NCT05806476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679548|NCT05806476|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64679549|NCT05806476|Purinergic Agents|purinergic agents|mesh-ancestor
65450843|NCT01116388|Caseins|caseins|mesh-list
65450844|NCT01116388|Chelating Agents|chelating agents|mesh-ancestor
65450845|NCT01116388|Sequestering Agents|sequestering agents|mesh-ancestor
65450846|NCT01116388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450847|NCT01116622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65450848|NCT01116622|Bexarotene|bexarotene|mesh-list
65450849|NCT01116622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450850|NCT01116622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65450851|NCT01116622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450852|NCT01116622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450853|NCT01211002|Endostatins|endostatins|mesh-list
65450854|NCT01211002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450855|NCT01211002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65450856|NCT01211002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65450857|NCT01211002|Growth Substances|growth substances|mesh-ancestor
65450858|NCT01211002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450859|NCT01211002|Growth Inhibitors|growth inhibitors|mesh-ancestor
65450860|NCT01211080|Propranolol|propranolol|mesh-list
65450861|NCT01211080|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65450862|NCT01211080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65450863|NCT01211080|Adrenergic Agents|adrenergic agents|mesh-ancestor
65450864|NCT01211080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64679550|NCT05806476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64679564|NCT05806307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64679565|NCT05806307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679566|NCT05806307|Sensory System Agents|sensory system agents|mesh-ancestor
64679567|NCT05806307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64679569|NCT05806307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64679570|NCT05806307|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64679571|NCT05806307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64679572|NCT05806307|Adrenergic Agents|adrenergic agents|mesh-ancestor
64679573|NCT05806307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64679574|NCT05806307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679575|NCT05806307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64679576|NCT05806307|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64679577|NCT05806307|Autonomic Agents|autonomic agents|mesh-ancestor
64679578|NCT05806307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64679579|NCT05806307|Respiratory System Agents|respiratory system agents|mesh-ancestor
64679581|NCT05806307|Sympathomimetics|sympathomimetics|mesh-ancestor
64679582|NCT05806307|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64679583|NCT05806307|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64679584|NCT05806307|Abortifacient Agents|abortifacient agents|mesh-ancestor
64679585|NCT05806307|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64679586|NCT05806307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64679587|NCT05806307|Hemostatics|hemostatics|mesh-ancestor
64679588|NCT05806307|Coagulants|coagulants|mesh-ancestor
64679589|NCT05806307|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64679590|NCT05806307|Natriuretic Agents|natriuretic agents|mesh-ancestor
64679591|NCT05806164|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64679592|NCT05806164|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64679593|NCT05806164|Adrenergic Agents|adrenergic agents|mesh-list
64679594|NCT05806164|Adrenergic Agonists|adrenergic agonists|mesh-list
64679595|NCT05806164|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
65450865|NCT01211080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450866|NCT01211080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450867|NCT01211080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65450868|NCT01211080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65450869|NCT01211080|Vasodilator Agents|vasodilator agents|mesh-ancestor
65450870|NCT01116700|Dexmedetomidine|dexmedetomidine|mesh-list
65450871|NCT01116700|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65450872|NCT01116700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65450873|NCT01116700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450874|NCT01116700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65450875|NCT01116700|Analgesics|analgesics|mesh-ancestor
65450876|NCT01116700|Sensory System Agents|sensory system agents|mesh-ancestor
65450877|NCT01116700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65450878|NCT01116700|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64835582|NCT02702492|Vitamins|vitamins|mesh-ancestor
64679596|NCT05806164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64679597|NCT05806164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64679598|NCT05806164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679599|NCT05806164|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64679600|NCT05806164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64679601|NCT05806164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679602|NCT05806164|Cholinergic Agents|cholinergic agents|mesh-ancestor
64679603|NCT05806164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64679604|NCT05806164|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64715980|NCT02182830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64715981|NCT02182830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715982|NCT02182830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64715983|NCT02182830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715984|NCT03424681|Modafinil|modafinil|mesh-list
64715985|NCT03424681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64715986|NCT03424681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715987|NCT03424681|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64715988|NCT03424681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64715989|NCT03424681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64715990|NCT03424681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715991|NCT03303794|Bupivacaine|bupivacaine|mesh-list
64715992|NCT03303794|Anesthetics, Local|anesthetics, local|mesh-ancestor
64715993|NCT03303794|Anesthetics|anesthetics|mesh-ancestor
64715994|NCT03303794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64715995|NCT03303794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715996|NCT03303794|Sensory System Agents|sensory system agents|mesh-ancestor
64715997|NCT03303794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715998|NCT03305822|Insulin Lispro|insulin lispro|mesh-list
64715999|NCT03305822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64716000|NCT03305822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716001|NCT03435614|Analgesics|analgesics|mesh-list
64679605|NCT05806060|Paclitaxel|paclitaxel|mesh-list
64679621|NCT05806047|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64679622|NCT05806047|Hormone Antagonists|hormone antagonists|mesh-ancestor
64679638|NCT05805930|Prednisone|prednisone|mesh-list
64679639|NCT05805930|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64679640|NCT05805930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64679641|NCT05805930|Glucocorticoids|glucocorticoids|mesh-ancestor
64679642|NCT05805930|Hormones|hormones|mesh-ancestor
64679643|NCT05805930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64679644|NCT05805930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450879|NCT01116700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65450880|NCT01116700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65450881|NCT01116700|Adrenergic Agents|adrenergic agents|mesh-ancestor
65450882|NCT01116700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65450883|NCT01116700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450884|NCT01113424|Nicotine|nicotine|mesh-list
65450885|NCT01113424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65450886|NCT01113424|Autonomic Agents|autonomic agents|mesh-ancestor
65450887|NCT01113424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65450888|NCT01113424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450889|NCT01113424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65450890|NCT01113424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65450891|NCT01113424|Cholinergic Agents|cholinergic agents|mesh-ancestor
65450892|NCT01113424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65450893|NCT01113424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450894|NCT01211158|Ketamine|ketamine|mesh-list
65450895|NCT01211158|Propofol|propofol|mesh-list
65450896|NCT01211158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65450897|NCT01211158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65450898|NCT01211158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450899|NCT01211158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65450900|NCT01211158|Anesthetics, General|anesthetics, general|mesh-ancestor
64679645|NCT05805930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64679646|NCT05805930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679647|NCT05805930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64679648|NCT05805891|Bortezomib|bortezomib|mesh-list
64679649|NCT05805891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679650|NCT05805839|Corticosterone|corticosterone|mesh-list
64679651|NCT05805839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64679655|NCT05805800|Dexamethasone|dexamethasone|mesh-list
64679656|NCT05805800|Olanzapine|olanzapine|mesh-list
64679657|NCT05805800|Serotonin|serotonin|mesh-list
64679658|NCT05805800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64679659|NCT05805800|Antiemetics|antiemetics|mesh-ancestor
64679660|NCT05805800|Autonomic Agents|autonomic agents|mesh-ancestor
64679661|NCT05805800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64679662|NCT05805800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679663|NCT05805800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64679664|NCT05805800|Glucocorticoids|glucocorticoids|mesh-ancestor
64716002|NCT03435614|Narcotics|narcotics|mesh-list
64716003|NCT03435614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64716004|NCT03435614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716005|NCT03435614|Sensory System Agents|sensory system agents|mesh-ancestor
64716006|NCT03435614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716007|NCT03437564|Vortioxetine|vortioxetine|mesh-list
64324308|NCT02264041|Hormone Antagonists|hormone antagonists|mesh-ancestor
64679665|NCT05805800|Hormones|hormones|mesh-ancestor
64679666|NCT05805800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64679686|NCT05805683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64405037|NCT04907747|Amoxicillin|amoxicillin|mesh-list
64679687|NCT05805683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679688|NCT05805683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64679689|NCT05805683|Vasodilator Agents|vasodilator agents|mesh-ancestor
65450901|NCT01211158|Anesthetics|anesthetics|mesh-ancestor
65450902|NCT01211158|Analgesics|analgesics|mesh-ancestor
65450903|NCT01211158|Sensory System Agents|sensory system agents|mesh-ancestor
65450904|NCT01211158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65450905|NCT01211158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65450906|NCT01211158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65450907|NCT01211158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65450908|NCT01211158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65200413|NCT00408447|Busulfan|busulfan|mesh-list
65450909|NCT01211158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450910|NCT01110226|Cisplatin|cisplatin|mesh-list
65450911|NCT01110226|Sodium arsenite|sodium arsenite|mesh-list
65450912|NCT01110226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450913|NCT01110226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450914|NCT01110226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450915|NCT03789292|Adalimumab|adalimumab|mesh-list
65450916|NCT03789292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65450917|NCT03789292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64679690|NCT05805631|Pemetrexed|pemetrexed|mesh-list
64679691|NCT05805631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679692|NCT05805631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679693|NCT05805631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679694|NCT05805631|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64679695|NCT05805631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64679696|NCT05805553|Nandrolone Decanoate|nandrolone decanoate|mesh-list
64679697|NCT05805553|Propranolol|propranolol|mesh-list
64679698|NCT05805553|Nandrolone|nandrolone|mesh-list
64679699|NCT05805553|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
64679700|NCT05805553|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64679701|NCT05805553|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64679702|NCT05805553|Adrenergic Agents|adrenergic agents|mesh-ancestor
64679703|NCT05805553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64679704|NCT05805553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679705|NCT05805553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679706|NCT05805553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64679707|NCT05805553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64679708|NCT05805553|Vasodilator Agents|vasodilator agents|mesh-ancestor
64679709|NCT05805553|Androgens|androgens|mesh-ancestor
64679710|NCT05805553|Hormones|hormones|mesh-ancestor
64679743|NCT05797935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64679744|NCT05797935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679745|NCT05776823|Naloxone|naloxone|mesh-list
64679746|NCT05776823|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64679747|NCT05776823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679748|NCT05776823|Sensory System Agents|sensory system agents|mesh-ancestor
64679749|NCT05776823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64679750|NCT05775237|Vitamins|vitamins|mesh-list
64679751|NCT05775237|Ascorbic Acid|ascorbic acid|mesh-list
64679752|NCT05775237|Curcumin|curcumin|mesh-list
64679753|NCT05775237|Micronutrients|micronutrients|mesh-ancestor
64679754|NCT05775237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679755|NCT05775237|Antioxidants|antioxidants|mesh-ancestor
64679757|NCT05775237|Protective Agents|protective agents|mesh-ancestor
64679758|NCT05775237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64679759|NCT05775237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64679760|NCT05775237|Analgesics|analgesics|mesh-ancestor
64679763|NCT05775237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64679765|NCT05775237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679766|NCT05775237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450918|NCT01211314|Enalapril|enalapril|mesh-list
65450919|NCT01211314|Lercanidipine|lercanidipine|mesh-list
65450920|NCT01211314|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65450921|NCT01211314|Protease Inhibitors|protease inhibitors|mesh-ancestor
65450922|NCT01211314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65450923|NCT01211314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450924|NCT01211314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65450925|NCT01211314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65450926|NCT01211314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65450927|NCT01211314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65450928|NCT01211314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835637|NCT02578680|Vitamin B Complex|vitamin b complex|mesh-ancestor
64679767|NCT05773365|Anesthetics|anesthetics|mesh-list
64679768|NCT05773365|Anesthetics, Local|anesthetics, local|mesh-list
64679769|NCT05773365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64679770|NCT05773365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679771|NCT05773365|Sensory System Agents|sensory system agents|mesh-ancestor
64679772|NCT05773365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64679773|NCT05756166|Interferons|interferons|mesh-list
64679774|NCT05756166|Interferon-alpha|interferon-alpha|mesh-list
64679775|NCT05756166|Interferon alpha-2|interferon alpha-2|mesh-list
64679776|NCT05756166|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
64679777|NCT05756166|Celecoxib|celecoxib|mesh-list
64679778|NCT05756166|Pembrolizumab|pembrolizumab|mesh-list
64679779|NCT05756166|Benzenesulfonamide|benzenesulfonamide|mesh-list
64716008|NCT03437564|Antidepressive Agents|antidepressive agents|mesh-ancestor
64716009|NCT03437564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64716010|NCT03437564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64716011|NCT03437564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64716012|NCT03437564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64716013|NCT03437564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716014|NCT03437564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64716015|NCT03437564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64716016|NCT03437564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64716017|NCT03437564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716018|NCT03437564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64716019|NCT03437564|Serotonin Agents|serotonin agents|mesh-ancestor
64716020|NCT03437564|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64716021|NCT03437564|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64716022|NCT03437564|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64716023|NCT03437564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64716024|NCT03438266|Hyaluronic Acid|hyaluronic acid|mesh-list
64324311|NCT02264041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64679780|NCT05756166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64679781|NCT05756166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679782|NCT05756166|Antiviral Agents|antiviral agents|mesh-ancestor
64679783|NCT05756166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64679784|NCT05756166|Immunologic Factors|immunologic factors|mesh-ancestor
64679785|NCT05756166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679786|NCT05756166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64679787|NCT05756166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64679788|NCT05756166|Analgesics|analgesics|mesh-ancestor
64679789|NCT05756166|Sensory System Agents|sensory system agents|mesh-ancestor
64679790|NCT05756166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64679791|NCT05756166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64679792|NCT05756166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64679793|NCT05756166|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64679794|NCT05756166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64679795|NCT05756166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679796|NCT05756166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450929|NCT01110304|Analgesics|analgesics|mesh-list
65450930|NCT01110304|Sensory System Agents|sensory system agents|mesh-ancestor
65450931|NCT01110304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65450932|NCT01110304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450933|NCT02529514|Baclofen|baclofen|mesh-list
65450934|NCT02529514|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65450935|NCT02529514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450936|NCT02529514|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65450937|NCT02529514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65450938|NCT02529514|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65450939|NCT02529514|GABA Agonists|gaba agonists|mesh-ancestor
65450940|NCT02529514|GABA Agents|gaba agents|mesh-ancestor
65450941|NCT02529514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64835650|NCT02491983|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64679797|NCT05756166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64679798|NCT05751044|Cytarabine|cytarabine|mesh-list
64679799|NCT05751044|Dexamethasone|dexamethasone|mesh-list
64679800|NCT05751044|Cyclophosphamide|cyclophosphamide|mesh-list
64679801|NCT05751044|Venetoclax|venetoclax|mesh-list
64679803|NCT05751044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64679804|NCT05751044|Immunologic Factors|immunologic factors|mesh-ancestor
64679805|NCT05751044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679806|NCT05751044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64679807|NCT05751044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64679808|NCT05751044|Alkylating Agents|alkylating agents|mesh-ancestor
64679809|NCT05751044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679810|NCT05751044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679811|NCT05751044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64679812|NCT05751044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64679813|NCT05751044|Antiemetics|antiemetics|mesh-ancestor
64679814|NCT05751044|Autonomic Agents|autonomic agents|mesh-ancestor
64716025|NCT03438266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64716026|NCT03438266|Immunologic Factors|immunologic factors|mesh-ancestor
64716027|NCT03438266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716028|NCT03438266|Viscosupplements|viscosupplements|mesh-ancestor
64716029|NCT03438266|Protective Agents|protective agents|mesh-ancestor
64716030|NCT03315104|Immunoglobulins|immunoglobulins|mesh-list
64716031|NCT03315104|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64716032|NCT03315104|gamma-Globulins|gamma-globulins|mesh-list
64716033|NCT03315104|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64716034|NCT03315104|Immunologic Factors|immunologic factors|mesh-ancestor
64679816|NCT05751044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64679817|NCT05751044|Glucocorticoids|glucocorticoids|mesh-ancestor
64679819|NCT05751044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64679820|NCT05751044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64679821|NCT05751044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64679843|NCT05730712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679844|NCT05709093|Azacitidine|azacitidine|mesh-list
64679845|NCT05709093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64679846|NCT05709093|Antimetabolites|antimetabolites|mesh-ancestor
64679847|NCT05709093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679848|NCT05709093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679849|NCT05709093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679850|NCT05690646|Ritonavir|ritonavir|mesh-list
64679851|NCT05690646|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64679852|NCT05690646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64679853|NCT05690646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64679854|NCT05690646|Protease Inhibitors|protease inhibitors|mesh-ancestor
64679855|NCT05690646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679856|NCT05690646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679857|NCT05690646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64679858|NCT05690646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64679859|NCT05690646|Antiviral Agents|antiviral agents|mesh-ancestor
65450942|NCT02529514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450943|NCT01211470|Daptomycin|daptomycin|mesh-list
65450944|NCT01211470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65450945|NCT01211470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65450946|NCT01114048|Thalidomide|thalidomide|mesh-list
65450947|NCT01114048|Dexamethasone|dexamethasone|mesh-list
65450948|NCT01114048|Cyclophosphamide|cyclophosphamide|mesh-list
65450949|NCT01114048|Bortezomib|bortezomib|mesh-list
65450950|NCT01114048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65450951|NCT01114048|Immunologic Factors|immunologic factors|mesh-ancestor
65450952|NCT01114048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450953|NCT01114048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65450954|NCT01114048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65450955|NCT01114048|Alkylating Agents|alkylating agents|mesh-ancestor
65450956|NCT01114048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450957|NCT01114048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65450958|NCT01114048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65450959|NCT01114048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65450960|NCT01114048|Antiemetics|antiemetics|mesh-ancestor
65450961|NCT01114048|Autonomic Agents|autonomic agents|mesh-ancestor
65450962|NCT01114048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65450963|NCT01114048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65450964|NCT01114048|Glucocorticoids|glucocorticoids|mesh-ancestor
65450965|NCT01114048|Hormones|hormones|mesh-ancestor
65450966|NCT01114048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65450967|NCT01114048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65450968|NCT01114048|Leprostatic Agents|leprostatic agents|mesh-ancestor
65450969|NCT01114048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65450970|NCT01114048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65450971|NCT01114048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65450972|NCT01114048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65450973|NCT01114048|Growth Substances|growth substances|mesh-ancestor
65450974|NCT01114048|Growth Inhibitors|growth inhibitors|mesh-ancestor
65450975|NCT01208194|Immunologic Factors|immunologic factors|mesh-list
64835661|NCT02467478|Hormones|hormones|mesh-ancestor
64679860|NCT05690646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64679861|NCT05690646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64679862|NCT05690646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64679863|NCT05690646|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64679864|NCT05690646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64679865|NCT05650554|Vaccines|vaccines|mesh-list
65450976|NCT01208194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450977|NCT01211704|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65450978|NCT01211704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65450979|NCT01211704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65450980|NCT01211704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65450981|NCT01211704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450982|NCT01211704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65450983|NCT01211704|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65450984|NCT01211704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65450985|NCT01211704|Serotonin Agents|serotonin agents|mesh-ancestor
64679866|NCT05650554|Immunologic Factors|immunologic factors|mesh-ancestor
64679867|NCT05650554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679868|NCT05648201|Raltegravir Potassium|raltegravir potassium|mesh-list
64679869|NCT05648201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64679885|NCT05631236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679886|NCT05631236|Adrenergic Agents|adrenergic agents|mesh-ancestor
64679887|NCT05631236|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64679888|NCT05631236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64679889|NCT05631236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64679890|NCT05631236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64679891|NCT05627635|Calcium, Dietary|calcium, dietary|mesh-list
64679892|NCT05627635|Leucovorin|leucovorin|mesh-list
64679893|NCT05627635|Folic Acid|folic acid|mesh-list
64679894|NCT05627635|Bevacizumab|bevacizumab|mesh-list
64679895|NCT05627635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64679896|NCT05627635|Fluorouracil|fluorouracil|mesh-list
64679897|NCT05627635|Oxaliplatin|oxaliplatin|mesh-list
64679898|NCT05627635|Endothelial Growth Factors|endothelial growth factors|mesh-list
64679899|NCT05627635|Antibodies|antibodies|mesh-list
64679900|NCT05627635|Immunoglobulins|immunoglobulins|mesh-list
64679901|NCT05627635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64679902|NCT05627635|Immunoglobulin G|immunoglobulin g|mesh-list
64679903|NCT05627635|Calcium|calcium|mesh-list
64679904|NCT05627635|Levoleucovorin|levoleucovorin|mesh-list
64679905|NCT05627635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679906|NCT05627635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64679907|NCT05627635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64679908|NCT05627635|Growth Substances|growth substances|mesh-ancestor
64716035|NCT03315104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716036|NCT03228914|Phenylephrine|phenylephrine|mesh-list
64716037|NCT03228914|Epinephrine|epinephrine|mesh-list
64716038|NCT03228914|Oxymetazoline|oxymetazoline|mesh-list
64716039|NCT03228914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64324341|NCT05491928|Tempol|tempol|mesh-list
64679909|NCT05627635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679910|NCT05627635|Growth Inhibitors|growth inhibitors|mesh-ancestor
64679911|NCT05627635|Immunologic Factors|immunologic factors|mesh-ancestor
64679928|NCT05607004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64679929|NCT05607004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679930|NCT05607004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679931|NCT05607004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64679932|NCT05607004|Hormone Antagonists|hormone antagonists|mesh-ancestor
64679933|NCT05607004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64679934|NCT05607004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679935|NCT05607004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64679936|NCT05604300|Vitamin E|vitamin e|mesh-list
64679937|NCT05604300|Vitamins|vitamins|mesh-ancestor
64679938|NCT05604300|Micronutrients|micronutrients|mesh-ancestor
64679939|NCT05604300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679940|NCT05604300|Antioxidants|antioxidants|mesh-ancestor
64679941|NCT05604300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679942|NCT05604300|Protective Agents|protective agents|mesh-ancestor
64679943|NCT05597722|Amphetamine|amphetamine|mesh-list
64679944|NCT05597722|Adderall|adderall|mesh-list
64679945|NCT05597722|Dextroamphetamine|dextroamphetamine|mesh-list
64679946|NCT05597722|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65450986|NCT01211704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65450987|NCT01211704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65450988|NCT01211704|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65450989|NCT01211704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65450990|NCT01211704|Dopamine Agents|dopamine agents|mesh-ancestor
65450991|NCT02529670|Lidocaine|lidocaine|mesh-list
65450992|NCT02529670|Anesthetics, Local|anesthetics, local|mesh-ancestor
65450993|NCT02529670|Anesthetics|anesthetics|mesh-ancestor
65450994|NCT02529670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65450995|NCT02529670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65450996|NCT02529670|Sensory System Agents|sensory system agents|mesh-ancestor
65450997|NCT02529670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65450998|NCT02529670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65450999|NCT02529670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65451000|NCT02529670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65451001|NCT02529670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65451002|NCT02529670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451003|NCT01117636|Aspirin|aspirin|mesh-list
65451004|NCT01117636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65451005|NCT01117636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65451006|NCT01117636|Analgesics|analgesics|mesh-ancestor
65451007|NCT01117636|Sensory System Agents|sensory system agents|mesh-ancestor
65451008|NCT01117636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65451009|NCT01117636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451010|NCT01117636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64679947|NCT05597722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679948|NCT05597722|Sympathomimetics|sympathomimetics|mesh-ancestor
64679949|NCT05597722|Autonomic Agents|autonomic agents|mesh-ancestor
64679950|NCT05597722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64679951|NCT05597722|Dopamine Agents|dopamine agents|mesh-ancestor
64679957|NCT05597722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64679958|NCT05597722|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64679959|NCT05593497|Abiraterone Acetate|abiraterone acetate|mesh-list
64679960|NCT05593497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679961|NCT05593497|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64679962|NCT05593497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679963|NCT05593497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679964|NCT05593497|Hormone Antagonists|hormone antagonists|mesh-ancestor
64679965|NCT05593497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64679966|NCT05593497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679967|NCT05593497|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64679981|NCT05492851|Protective Agents|protective agents|mesh-ancestor
64679982|NCT05492851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679983|NCT05486104|Hemay005|hemay005|mesh-list
64679984|NCT05486104|Dermatologic Agents|dermatologic agents|mesh-ancestor
65451011|NCT01117636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65451012|NCT01117636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65451013|NCT01117636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65451014|NCT01117636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451015|NCT01117636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65451016|NCT01117636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65451017|NCT01117636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451018|NCT01117636|Antipyretics|antipyretics|mesh-ancestor
65451019|NCT03938740|Insulin|insulin|mesh-list
65451020|NCT03938740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65451021|NCT03938740|Insulin Lispro|insulin lispro|mesh-list
65451022|NCT03938740|Insulin, Long-Acting|insulin, long-acting|mesh-list
65451023|NCT03938740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65451024|NCT03938740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451025|NCT01110616|Lorazepam|lorazepam|mesh-list
65451026|NCT01110616|Anticonvulsants|anticonvulsants|mesh-ancestor
65451027|NCT01110616|Antiemetics|antiemetics|mesh-ancestor
65451028|NCT01110616|Autonomic Agents|autonomic agents|mesh-ancestor
65451029|NCT01110616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64835726|NCT01657591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835733|NCT01599572|Zinc|zinc|mesh-list
64679985|NCT05486104|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64679986|NCT05486104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64679987|NCT05486104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679988|NCT05486104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679990|NCT05481528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64679991|NCT05481528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64679992|NCT05481528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64679993|NCT05481528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64679994|NCT05481528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679995|NCT05481528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679996|NCT05481528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680002|NCT05471830|Apixaban|apixaban|mesh-list
64680003|NCT05471830|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64680004|NCT05471830|Antithrombins|antithrombins|mesh-ancestor
64680005|NCT05471830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64680006|NCT05471830|Protease Inhibitors|protease inhibitors|mesh-ancestor
64716040|NCT03228914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64716041|NCT03228914|Adrenergic Agents|adrenergic agents|mesh-ancestor
64716042|NCT03228914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64716043|NCT03228914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716044|NCT03228914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716045|NCT03228914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64716046|NCT03228914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64716047|NCT03228914|Autonomic Agents|autonomic agents|mesh-ancestor
64716048|NCT03228914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716049|NCT03228914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64716052|NCT03228914|Sympathomimetics|sympathomimetics|mesh-ancestor
64716053|NCT03228914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64716054|NCT03228914|Nasal Decongestants|nasal decongestants|mesh-ancestor
64716055|NCT03228914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64716056|NCT03228914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64716057|NCT03228914|Protective Agents|protective agents|mesh-ancestor
64716058|NCT03316976|Dexlansoprazole|dexlansoprazole|mesh-list
64716059|NCT03316976|Lansoprazole|lansoprazole|mesh-list
65451030|NCT01110616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451031|NCT01110616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65451032|NCT01110616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65451033|NCT01110616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65451034|NCT01110616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65451035|NCT01110616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65451036|NCT01110616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65451037|NCT01110616|GABA Modulators|gaba modulators|mesh-ancestor
64716060|NCT03316976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64324344|NCT05491928|Protective Agents|protective agents|mesh-ancestor
64680007|NCT05471830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680008|NCT05471830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680009|NCT05471830|Anticoagulants|anticoagulants|mesh-ancestor
64680010|NCT05434663|Granisetron|granisetron|mesh-list
64680011|NCT05434663|Antiemetics|antiemetics|mesh-ancestor
64680012|NCT05434663|Autonomic Agents|autonomic agents|mesh-ancestor
64680013|NCT05434663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64680014|NCT05434663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680015|NCT05434663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64680016|NCT05434663|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64680017|NCT05434663|Serotonin Agents|serotonin agents|mesh-ancestor
64680018|NCT05434663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64680019|NCT05434663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680021|NCT05429762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64680022|NCT05429762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680023|NCT05429762|Tubulin Modulators|tubulin modulators|mesh-ancestor
64680024|NCT05429762|Antimitotic Agents|antimitotic agents|mesh-ancestor
64680025|NCT05429762|Mitosis Modulators|mitosis modulators|mesh-ancestor
64680026|NCT05429762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680028|NCT05423535|Hemostatics|hemostatics|mesh-ancestor
64680029|NCT05423535|Coagulants|coagulants|mesh-ancestor
64680030|NCT05414409|Metformin|metformin|mesh-list
64680031|NCT05414409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64680032|NCT05414409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680033|NCT05411575|Plerixafor|plerixafor|mesh-list
64680034|NCT05411575|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64680039|NCT05367401|Magrolimab|magrolimab|mesh-list
64680040|NCT05367401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64680041|NCT05367401|Antimetabolites|antimetabolites|mesh-ancestor
64680042|NCT05367401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716061|NCT03316976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64716062|NCT03316976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64716063|NCT03316976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64716064|NCT03316976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716065|NCT03234374|Bupivacaine|bupivacaine|mesh-list
64680043|NCT05367401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680044|NCT05367401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680045|NCT05367401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64680046|NCT05363319|Cemiplimab|cemiplimab|mesh-list
64680047|NCT05363319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64680048|NCT05363319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680049|NCT05316233|Hyaluronic Acid|hyaluronic acid|mesh-list
64680050|NCT05316233|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64680051|NCT05316233|Immunologic Factors|immunologic factors|mesh-ancestor
64680052|NCT05316233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680053|NCT05316233|Viscosupplements|viscosupplements|mesh-ancestor
64680054|NCT05316233|Protective Agents|protective agents|mesh-ancestor
64680055|NCT05297448|Rifaximin|rifaximin|mesh-list
64680056|NCT05297448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64680057|NCT05297448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64680058|NCT05297448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64680059|NCT05286814|Leucovorin|leucovorin|mesh-list
64680060|NCT05286814|Gemcitabine|gemcitabine|mesh-list
64680061|NCT05286814|Dexamethasone|dexamethasone|mesh-list
64680062|NCT05286814|Fluorouracil|fluorouracil|mesh-list
64680063|NCT05286814|Oxaliplatin|oxaliplatin|mesh-list
64680064|NCT05286814|Irinotecan|irinotecan|mesh-list
64680065|NCT05286814|Floxuridine|floxuridine|mesh-list
64680066|NCT05286814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64680068|NCT05286814|Autonomic Agents|autonomic agents|mesh-ancestor
65451038|NCT01110616|GABA Agents|gaba agents|mesh-ancestor
65451039|NCT01110616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65451040|NCT01110616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451041|NCT03938662|Choline|choline|mesh-list
65451042|NCT03938662|Lipotropic Agents|lipotropic agents|mesh-ancestor
65451043|NCT03938662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65451044|NCT03938662|Antimetabolites|antimetabolites|mesh-ancestor
65451045|NCT03938662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451046|NCT03938662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65451047|NCT03938662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65451048|NCT03938662|Nootropic Agents|nootropic agents|mesh-ancestor
65451049|NCT01213498|Atorvastatin|atorvastatin|mesh-list
65451050|NCT01213498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65451051|NCT01213498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65451052|NCT01213498|Antimetabolites|antimetabolites|mesh-ancestor
65451053|NCT01213498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451054|NCT01213498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65451055|NCT01213498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65451056|NCT01213498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835753|NCT01599858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64680069|NCT05286814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64680070|NCT05286814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680071|NCT05286814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64680072|NCT05286814|Glucocorticoids|glucocorticoids|mesh-ancestor
64680073|NCT05286814|Hormones|hormones|mesh-ancestor
64680075|NCT05286814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64680076|NCT05286814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680077|NCT05286814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64680078|NCT05286814|Antimetabolites|antimetabolites|mesh-ancestor
64680083|NCT05286814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64680084|NCT05286814|Immunologic Factors|immunologic factors|mesh-ancestor
64680085|NCT05286814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64680086|NCT05286814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64680087|NCT05286814|Antidotes|antidotes|mesh-ancestor
64680088|NCT05286814|Protective Agents|protective agents|mesh-ancestor
64680089|NCT05286814|Vitamin B Complex|vitamin b complex|mesh-ancestor
64680090|NCT05286814|Vitamins|vitamins|mesh-ancestor
64680091|NCT05286814|Micronutrients|micronutrients|mesh-ancestor
64680092|NCT05283720|Prednisone|prednisone|mesh-list
64680093|NCT05283720|Cyclophosphamide|cyclophosphamide|mesh-list
64680094|NCT05283720|Rituximab|rituximab|mesh-list
64680095|NCT05283720|Doxorubicin|doxorubicin|mesh-list
64680096|NCT05283720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64680097|NCT05283720|Lenalidomide|lenalidomide|mesh-list
64680098|NCT05283720|Venetoclax|venetoclax|mesh-list
64680099|NCT05283720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64680100|NCT05283720|Immunologic Factors|immunologic factors|mesh-ancestor
64680101|NCT05283720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680102|NCT05283720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64680103|NCT05283720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64680104|NCT05283720|Alkylating Agents|alkylating agents|mesh-ancestor
64680105|NCT05283720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680107|NCT05283720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64680108|NCT05283720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64680109|NCT05283720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65451057|NCT01111084|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65451058|NCT01111084|Hormones|hormones|mesh-ancestor
65451059|NCT01111084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65451060|NCT01111084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451061|NCT01118260|Anesthetics|anesthetics|mesh-list
65451062|NCT01118260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65451063|NCT01118260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451064|NCT01121770|PENTA|penta|mesh-list
65451065|NCT01121770|Fondaparinux|fondaparinux|mesh-list
65451066|NCT01121770|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65451067|NCT01121770|Antithrombins|antithrombins|mesh-ancestor
65451068|NCT01121770|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65451069|NCT01121770|Protease Inhibitors|protease inhibitors|mesh-ancestor
65451070|NCT01121770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680110|NCT05283720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64680111|NCT05283720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64680112|NCT05283720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680113|NCT05283720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64680114|NCT05283720|Glucocorticoids|glucocorticoids|mesh-ancestor
64680115|NCT05283720|Hormones|hormones|mesh-ancestor
64716066|NCT03234374|Anesthetics, Local|anesthetics, local|mesh-ancestor
64716067|NCT03234374|Anesthetics|anesthetics|mesh-ancestor
64716068|NCT03234374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64716069|NCT03234374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716070|NCT03234374|Sensory System Agents|sensory system agents|mesh-ancestor
64716071|NCT03234374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716072|NCT04332536|Codeine|codeine|mesh-list
64324372|NCT02262169|Omeprazole|omeprazole|mesh-list
64680116|NCT05283720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64680117|NCT05283720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64680118|NCT05283720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64680119|NCT05283720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64680120|NCT05283720|Growth Substances|growth substances|mesh-ancestor
64680121|NCT05283720|Growth Inhibitors|growth inhibitors|mesh-ancestor
64680122|NCT05262400|Letrozole|letrozole|mesh-list
64680137|NCT05259839|Daratumumab|daratumumab|mesh-list
64680138|NCT05259839|Pomalidomide|pomalidomide|mesh-list
64680139|NCT05259839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64680140|NCT05259839|Antiemetics|antiemetics|mesh-ancestor
64680141|NCT05259839|Autonomic Agents|autonomic agents|mesh-ancestor
64680142|NCT05259839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64680143|NCT05259839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680144|NCT05259839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64680145|NCT05259839|Glucocorticoids|glucocorticoids|mesh-ancestor
64680146|NCT05259839|Hormones|hormones|mesh-ancestor
64680147|NCT05259839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64680148|NCT05259839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64680149|NCT05259839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680150|NCT05259839|Immunologic Factors|immunologic factors|mesh-ancestor
64680151|NCT05259839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64680152|NCT05259839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64680153|NCT05259839|Growth Substances|growth substances|mesh-ancestor
64680154|NCT05259839|Growth Inhibitors|growth inhibitors|mesh-ancestor
64680155|NCT05201066|Azacitidine|azacitidine|mesh-list
64680156|NCT05201066|Decitabine|decitabine|mesh-list
64680157|NCT05201066|Venetoclax|venetoclax|mesh-list
64680158|NCT05201066|Spartalizumab|spartalizumab|mesh-list
64680159|NCT05201066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64680160|NCT05201066|Antimetabolites|antimetabolites|mesh-ancestor
64680196|NCT05045950|Dopamine Agents|dopamine agents|mesh-ancestor
64680197|NCT05045950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64680198|NCT05045950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451071|NCT01121770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451072|NCT01121770|Anticoagulants|anticoagulants|mesh-ancestor
65451073|NCT01121770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65451074|NCT01121770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65451075|NCT01121848|Leucovorin|leucovorin|mesh-list
65451076|NCT01121848|Fluorouracil|fluorouracil|mesh-list
65451077|NCT01121848|Oxaliplatin|oxaliplatin|mesh-list
65451078|NCT01121848|Antimetabolites|antimetabolites|mesh-ancestor
65451079|NCT01121848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451080|NCT01121848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64680199|NCT05045950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680200|NCT05045950|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64680201|NCT05045950|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64680202|NCT05036278|Factor VIII|factor viii|mesh-list
64680203|NCT05036278|Coagulants|coagulants|mesh-ancestor
64680204|NCT04947514|Tranexamic Acid|tranexamic acid|mesh-list
64680205|NCT04947514|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64680206|NCT04947514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64680207|NCT04947514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680208|NCT04947514|Hemostatics|hemostatics|mesh-ancestor
64680209|NCT04947514|Coagulants|coagulants|mesh-ancestor
64680210|NCT04925479|Niacinamide|niacinamide|mesh-list
64680218|NCT04924101|Etoposide|etoposide|mesh-list
64680219|NCT04924101|Etoposide phosphate|etoposide phosphate|mesh-list
64680220|NCT04924101|Lenvatinib|lenvatinib|mesh-list
64680221|NCT04924101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680222|NCT04924101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64680223|NCT04924101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64680224|NCT04924101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64680225|NCT04924101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64680226|NCT04924101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64716073|NCT04332536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64716074|NCT04332536|Narcotics|narcotics|mesh-ancestor
64716075|NCT04332536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64716076|NCT04332536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716077|NCT04332536|Analgesics|analgesics|mesh-ancestor
64716078|NCT04332536|Sensory System Agents|sensory system agents|mesh-ancestor
64716079|NCT04332536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716080|NCT04332536|Antitussive Agents|antitussive agents|mesh-ancestor
64716081|NCT04332536|Respiratory System Agents|respiratory system agents|mesh-ancestor
64716082|NCT03236168|Ivermectin|ivermectin|mesh-list
64716083|NCT03236168|Permethrin|permethrin|mesh-list
64716084|NCT03236168|Malathion|malathion|mesh-list
64716085|NCT03236168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64716086|NCT03236168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64716087|NCT03236168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64716088|NCT03236168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716089|NCT03236168|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64716090|NCT03236168|Cholinergic Agents|cholinergic agents|mesh-ancestor
64716091|NCT03236168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64716092|NCT03236168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716093|NCT03306589|Molgramostim|molgramostim|mesh-list
64716094|NCT03306589|Sargramostim|sargramostim|mesh-list
64716095|NCT03306589|Cantharidin|cantharidin|mesh-list
64716096|NCT03306589|Immunologic Factors|immunologic factors|mesh-ancestor
64680227|NCT04924101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680228|NCT04924101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64680229|NCT04860011|Dapagliflozin|dapagliflozin|mesh-list
64680230|NCT04860011|Metolazone|metolazone|mesh-list
64680231|NCT04860011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64680232|NCT04860011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680233|NCT04860011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64680234|NCT04860011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680235|NCT04860011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64680236|NCT04860011|Diuretics|diuretics|mesh-ancestor
64680237|NCT04860011|Natriuretic Agents|natriuretic agents|mesh-ancestor
65451081|NCT01121848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451082|NCT01121848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65451083|NCT01121848|Immunologic Factors|immunologic factors|mesh-ancestor
65451084|NCT01121848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451085|NCT01121848|Antidotes|antidotes|mesh-ancestor
65451086|NCT01121848|Protective Agents|protective agents|mesh-ancestor
65451087|NCT01121848|Vitamin B Complex|vitamin b complex|mesh-ancestor
65451088|NCT01121848|Vitamins|vitamins|mesh-ancestor
65451089|NCT01121848|Micronutrients|micronutrients|mesh-ancestor
65451090|NCT01122004|Pregabalin|pregabalin|mesh-list
65451091|NCT01122004|Analgesics|analgesics|mesh-ancestor
64835793|NCT01599962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680238|NCT04860011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64680239|NCT04860011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64680240|NCT04837014|Acetaminophen|acetaminophen|mesh-list
64680241|NCT04837014|Naproxen|naproxen|mesh-list
64680242|NCT04837014|Hydromorphone|hydromorphone|mesh-list
64680243|NCT04837014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64680244|NCT04837014|Analgesics|analgesics|mesh-ancestor
64680313|NCT04696146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64680314|NCT04691986|Niacinamide|niacinamide|mesh-list
64680315|NCT04691986|Niacin|niacin|mesh-list
64680316|NCT04691986|Nicotinic Acids|nicotinic acids|mesh-list
64680317|NCT04691986|Vitamin B Complex|vitamin b complex|mesh-ancestor
64680318|NCT04691986|Vitamins|vitamins|mesh-ancestor
64680319|NCT04691986|Micronutrients|micronutrients|mesh-ancestor
64680320|NCT04691986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680321|NCT04691986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64716097|NCT03306589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716098|NCT03306589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64716099|NCT03306589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64716100|NCT03306589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716102|NCT03312517|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64716103|NCT03312517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64716104|NCT03312517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64716105|NCT03312517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716106|NCT03312517|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64716107|NCT03312517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64716108|NCT03312517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716109|NCT03315559|Nemiralisib|nemiralisib|mesh-list
64680323|NCT04691986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680324|NCT04691986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64680325|NCT04691986|Vasodilator Agents|vasodilator agents|mesh-ancestor
64680326|NCT04669210|Mycophenolic Acid|mycophenolic acid|mesh-list
64680327|NCT04669210|Tacrolimus|tacrolimus|mesh-list
64680328|NCT04669210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64680329|NCT04669210|Immunologic Factors|immunologic factors|mesh-ancestor
64680330|NCT04669210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680344|NCT04665739|Immunologic Factors|immunologic factors|mesh-ancestor
64680345|NCT04665739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680346|NCT04665739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680347|NCT04665739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64680348|NCT04658849|Pioglitazone|pioglitazone|mesh-list
64680349|NCT04658849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64680350|NCT04658849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680351|NCT04655157|Nivolumab|nivolumab|mesh-list
64680352|NCT04655157|Ipilimumab|ipilimumab|mesh-list
64680353|NCT04655157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64680354|NCT04655157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680355|NCT04655157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64680356|NCT04655157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680357|NCT04650269|Emtricitabine|emtricitabine|mesh-list
64680358|NCT04650269|Antiviral Agents|antiviral agents|mesh-ancestor
64680359|NCT04650269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64680360|NCT04650269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65451092|NCT01122004|Sensory System Agents|sensory system agents|mesh-ancestor
65451093|NCT01122004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65451094|NCT01122004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451095|NCT01122004|Anticonvulsants|anticonvulsants|mesh-ancestor
65451096|NCT01122004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65451097|NCT01122004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65451098|NCT01122004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451099|NCT01122004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65451100|NCT01122004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65451101|NCT01122004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65451102|NCT01122004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65451103|NCT01122004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65451104|NCT03933982|Vinorelbine|vinorelbine|mesh-list
65451105|NCT03933982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65451106|NCT03933982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451107|NCT03933982|Tubulin Modulators|tubulin modulators|mesh-ancestor
65451108|NCT03933982|Antimitotic Agents|antimitotic agents|mesh-ancestor
65451109|NCT03933982|Mitosis Modulators|mitosis modulators|mesh-ancestor
65451110|NCT03933982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451111|NCT01118572|Celecoxib|celecoxib|mesh-list
65451112|NCT01118572|Etodolac|etodolac|mesh-list
65451113|NCT01118572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65451114|NCT01118572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64835802|NCT01599975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64680361|NCT04650269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64680362|NCT04650269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680363|NCT04650269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680364|NCT04650269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64680365|NCT04650269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64680366|NCT04633252|Prednisone|prednisone|mesh-list
64680367|NCT04633252|Docetaxel|docetaxel|mesh-list
64680368|NCT04633252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680369|NCT04633252|Tubulin Modulators|tubulin modulators|mesh-ancestor
64680370|NCT04633252|Antimitotic Agents|antimitotic agents|mesh-ancestor
64680371|NCT04633252|Mitosis Modulators|mitosis modulators|mesh-ancestor
64680372|NCT04633252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680374|NCT04633252|Glucocorticoids|glucocorticoids|mesh-ancestor
64680375|NCT04633252|Hormones|hormones|mesh-ancestor
64680376|NCT04633252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64680377|NCT04633252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680378|NCT04633252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64680379|NCT04629196|Ustekinumab|ustekinumab|mesh-list
64680380|NCT04629196|Dermatologic Agents|dermatologic agents|mesh-ancestor
64680381|NCT04628338|Interferons|interferons|mesh-list
64680382|NCT04628338|Interferon-gamma|interferon-gamma|mesh-list
64680383|NCT04628338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680384|NCT04628338|Antiviral Agents|antiviral agents|mesh-ancestor
64716110|NCT03315559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65451115|NCT01118572|Analgesics|analgesics|mesh-ancestor
65451116|NCT01118572|Sensory System Agents|sensory system agents|mesh-ancestor
65451117|NCT01118572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65451118|NCT01118572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451119|NCT01118572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65451120|NCT01118572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65451121|NCT01118572|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65451122|NCT01118572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65451123|NCT01118572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451124|NCT01118572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451125|NCT03937648|Lasmiditan|lasmiditan|mesh-list
65451126|NCT03937648|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65451127|NCT03937648|Serotonin Agents|serotonin agents|mesh-ancestor
65451128|NCT03937648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65451129|NCT03937648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451130|NCT03937648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451131|NCT01219036|Budesonide|budesonide|mesh-list
64835825|NCT01601028|Antimalarials|antimalarials|mesh-ancestor
64716111|NCT03315559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64716112|NCT03315559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716113|NCT03239522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64716115|NCT03239522|Glycine Agents|glycine agents|mesh-ancestor
64716116|NCT03239522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64716117|NCT03239522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716118|NCT03239522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716119|NCT03210337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64716120|NCT03242408|Methyltestosterone|methyltestosterone|mesh-list
64716121|NCT03242408|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64716122|NCT03242408|Testosterone|testosterone|mesh-list
64716123|NCT03242408|Testosterone undecanoate|testosterone undecanoate|mesh-list
64716124|NCT03242408|Testosterone enanthate|testosterone enanthate|mesh-list
64716125|NCT03242408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64716126|NCT03242408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680385|NCT04628338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64680399|NCT04612790|Respiratory System Agents|respiratory system agents|mesh-ancestor
64680400|NCT04591808|Perindopril|perindopril|mesh-list
64680401|NCT04591808|Atorvastatin|atorvastatin|mesh-list
64680402|NCT04591808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64680403|NCT04591808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64680404|NCT04591808|Antimetabolites|antimetabolites|mesh-ancestor
64680405|NCT04591808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680406|NCT04591808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64680407|NCT04591808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64680408|NCT04591808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680409|NCT04591808|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64680410|NCT04591808|Protease Inhibitors|protease inhibitors|mesh-ancestor
64680411|NCT04591808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64680412|NCT04587687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64680413|NCT04587687|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64680414|NCT04587687|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64680415|NCT04587687|Antibodies|antibodies|mesh-list
64680416|NCT04587687|Immunoglobulins|immunoglobulins|mesh-list
64680417|NCT04587687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64680418|NCT04587687|Immunoconjugates|immunoconjugates|mesh-list
64680419|NCT04587687|Immunologic Factors|immunologic factors|mesh-ancestor
65451132|NCT01219036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65451133|NCT01219036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65451135|NCT01219036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65451136|NCT01219036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451137|NCT01219036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65451138|NCT01219036|Respiratory System Agents|respiratory system agents|mesh-ancestor
65451139|NCT01219036|Glucocorticoids|glucocorticoids|mesh-ancestor
65451140|NCT01219036|Hormones|hormones|mesh-ancestor
65451141|NCT01219036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65451142|NCT03936010|Canagliflozin|canagliflozin|mesh-list
65451143|NCT03936010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65451144|NCT03936010|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65451145|NCT03936010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451146|NCT03936010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65451147|NCT03936010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451148|NCT03936010|Protease Inhibitors|protease inhibitors|mesh-ancestor
64680420|NCT04587687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680421|NCT04587687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680422|NCT04587687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64680423|NCT04587687|Alkylating Agents|alkylating agents|mesh-ancestor
64680424|NCT04587687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680425|NCT04585750|Pembrolizumab|pembrolizumab|mesh-list
64680426|NCT04585750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64680427|NCT04585750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680428|NCT04578600|Lenalidomide|lenalidomide|mesh-list
64680429|NCT04578600|Azacitidine|azacitidine|mesh-list
64680430|NCT04578600|Obinutuzumab|obinutuzumab|mesh-list
64680431|NCT04578600|Immunologic Factors|immunologic factors|mesh-ancestor
64680432|NCT04578600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680433|NCT04578600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64680434|NCT04578600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64680435|NCT04578600|Growth Substances|growth substances|mesh-ancestor
64680436|NCT04578600|Growth Inhibitors|growth inhibitors|mesh-ancestor
64680437|NCT04578600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64716127|NCT03242408|Anabolic Agents|anabolic agents|mesh-ancestor
64716129|NCT03242408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64716130|NCT03242408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716131|NCT03242408|Androgens|androgens|mesh-ancestor
64716132|NCT03459794|Ivermectin|ivermectin|mesh-list
64716133|NCT03459794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64680438|NCT04578600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64680439|NCT04578600|Antimetabolites|antimetabolites|mesh-ancestor
64680440|NCT04578600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680441|NCT04578600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680442|NCT04578600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64680443|NCT04538352|Insulin|insulin|mesh-list
64680479|NCT04389177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64680480|NCT04389177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680481|NCT04389177|Tubulin Modulators|tubulin modulators|mesh-ancestor
64680482|NCT04389177|Antimitotic Agents|antimitotic agents|mesh-ancestor
64680483|NCT04389177|Mitosis Modulators|mitosis modulators|mesh-ancestor
64680484|NCT04389177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680485|NCT04389177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64680486|NCT04368988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64680515|NCT04219722|Hyaluronic Acid|hyaluronic acid|mesh-list
64680516|NCT04219722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65451149|NCT03936010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451150|NCT01124500|Methylphenidate|methylphenidate|mesh-list
65451151|NCT01124500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65451152|NCT01124500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451153|NCT01124500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65451154|NCT01124500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65451155|NCT01124500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65451156|NCT01124500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451157|NCT01124500|Dopamine Agents|dopamine agents|mesh-ancestor
65451158|NCT01124500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65451159|NCT01118884|Promethazine|promethazine|mesh-list
65451160|NCT01118884|Diphenhydramine|diphenhydramine|mesh-list
65451161|NCT01118884|Antipruritics|antipruritics|mesh-ancestor
65451162|NCT01118884|Dermatologic Agents|dermatologic agents|mesh-ancestor
65451163|NCT01118884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64680517|NCT04219722|Immunologic Factors|immunologic factors|mesh-ancestor
64680518|NCT04219722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680519|NCT04219722|Viscosupplements|viscosupplements|mesh-ancestor
64680520|NCT04219722|Protective Agents|protective agents|mesh-ancestor
64680522|NCT04191304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64680523|NCT04191304|Respiratory System Agents|respiratory system agents|mesh-ancestor
64680525|NCT04186299|Epinephrine|epinephrine|mesh-list
64680526|NCT04186299|Carticaine|carticaine|mesh-list
64680527|NCT04186299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64680528|NCT04186299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64680529|NCT04186299|Adrenergic Agents|adrenergic agents|mesh-ancestor
64680530|NCT04186299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64680531|NCT04186299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680532|NCT04186299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680533|NCT04186299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64680542|NCT04186299|Analgesics|analgesics|mesh-ancestor
64680543|NCT04186299|Sensory System Agents|sensory system agents|mesh-ancestor
64680544|NCT04186299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64680545|NCT04186299|Sympatholytics|sympatholytics|mesh-ancestor
64680546|NCT04186299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64680547|NCT04186299|Anesthetics, Local|anesthetics, local|mesh-ancestor
64680548|NCT04186299|Anesthetics|anesthetics|mesh-ancestor
64680549|NCT04186299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64680551|NCT04177355|1018 oligonucleotide|1018 oligonucleotide|mesh-list
64680552|NCT04177355|MEDI9197|medi9197|mesh-list
64680553|NCT04177355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64680554|NCT04177355|Immunologic Factors|immunologic factors|mesh-ancestor
64680555|NCT04177355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680556|NCT04177355|Antacids|antacids|mesh-ancestor
64680557|NCT04177355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680558|NCT04177355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64680559|NCT04165096|Acetaminophen|acetaminophen|mesh-list
64680560|NCT04165096|Diphenhydramine|diphenhydramine|mesh-list
64680561|NCT04165096|Promethazine|promethazine|mesh-list
64680562|NCT04165096|Pembrolizumab|pembrolizumab|mesh-list
64680563|NCT04165096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64680564|NCT04165096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680565|NCT04165096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64680566|NCT04165096|Analgesics|analgesics|mesh-ancestor
64680567|NCT04165096|Sensory System Agents|sensory system agents|mesh-ancestor
64680568|NCT04165096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64680569|NCT04165096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680570|NCT04165096|Antipyretics|antipyretics|mesh-ancestor
64716134|NCT03459794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64716136|NCT03211117|Doxorubicin|doxorubicin|mesh-list
64716137|NCT03211117|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65451164|NCT01118884|Histamine Antagonists|histamine antagonists|mesh-ancestor
65451165|NCT01118884|Histamine Agents|histamine agents|mesh-ancestor
65451166|NCT01118884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65451167|NCT01118884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451168|NCT01118884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451169|NCT01118884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65451170|NCT01118884|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65451171|NCT01118884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65451172|NCT01118884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65451173|NCT01118884|Anesthetics, Local|anesthetics, local|mesh-ancestor
64716138|NCT03211117|Pembrolizumab|pembrolizumab|mesh-list
64716139|NCT03211117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680571|NCT04165096|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64680572|NCT04165096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64680573|NCT04165096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64680574|NCT04165096|Anesthetics, Local|anesthetics, local|mesh-ancestor
64680575|NCT04165096|Anesthetics|anesthetics|mesh-ancestor
64680576|NCT04165096|Antiemetics|antiemetics|mesh-ancestor
64680577|NCT04165096|Autonomic Agents|autonomic agents|mesh-ancestor
64680578|NCT04165096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64680579|NCT04165096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64680580|NCT04165096|Histamine Antagonists|histamine antagonists|mesh-ancestor
64680581|NCT04165096|Histamine Agents|histamine agents|mesh-ancestor
64680582|NCT04165096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64680583|NCT04165096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680584|NCT04165096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64680585|NCT04165096|Antipruritics|antipruritics|mesh-ancestor
64680586|NCT04165096|Dermatologic Agents|dermatologic agents|mesh-ancestor
64680587|NCT04165070|Paclitaxel|paclitaxel|mesh-list
64680588|NCT04165070|Carboplatin|carboplatin|mesh-list
64680589|NCT04165070|Pembrolizumab|pembrolizumab|mesh-list
64680590|NCT04165070|Pemetrexed|pemetrexed|mesh-list
64680591|NCT04165070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64680592|NCT04165070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680593|NCT04165070|Tubulin Modulators|tubulin modulators|mesh-ancestor
64680597|NCT04165070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64680598|NCT04165070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680599|NCT04165070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64680600|NCT04165070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64680601|NCT04145700|Gemcitabine|gemcitabine|mesh-list
64680602|NCT04145700|Docetaxel|docetaxel|mesh-list
64680603|NCT04145700|Ramucirumab|ramucirumab|mesh-list
64680604|NCT04145700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64680624|NCT04145349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64680625|NCT04145349|Alkylating Agents|alkylating agents|mesh-ancestor
64680650|NCT04005690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680651|NCT04005690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64680652|NCT03973268|Complement Factor H|complement factor h|mesh-list
64680653|NCT03973268|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64680654|NCT03973268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64680655|NCT03973268|Immunologic Factors|immunologic factors|mesh-ancestor
64680656|NCT03973268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680657|NCT03927222|Temozolomide|temozolomide|mesh-list
64680658|NCT03927222|Molgramostim|molgramostim|mesh-list
64680659|NCT03927222|Sargramostim|sargramostim|mesh-list
64680660|NCT03927222|Immunologic Factors|immunologic factors|mesh-ancestor
64680661|NCT03927222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680662|NCT03927222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64680663|NCT03927222|Alkylating Agents|alkylating agents|mesh-ancestor
64680664|NCT03927222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680665|NCT03927222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680771|NCT03822663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680772|NCT03822663|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64680773|NCT03822663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64835883|NCT01603680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65451174|NCT01118884|Anesthetics|anesthetics|mesh-ancestor
65451175|NCT01118884|Sensory System Agents|sensory system agents|mesh-ancestor
65451176|NCT01118884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65451177|NCT01118884|Antiemetics|antiemetics|mesh-ancestor
65451178|NCT01118884|Autonomic Agents|autonomic agents|mesh-ancestor
65451179|NCT01118884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65451180|NCT01119196|Dialysis Solutions|dialysis solutions|mesh-list
65451181|NCT01119196|Icodextrin|icodextrin|mesh-list
65451182|NCT01119196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65451183|NCT01213888|Trientine|trientine|mesh-list
65451184|NCT01213888|Chelating Agents|chelating agents|mesh-ancestor
65451185|NCT01213888|Sequestering Agents|sequestering agents|mesh-ancestor
65451186|NCT01213888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451187|NCT01119430|Fluoxetine|fluoxetine|mesh-list
65451188|NCT01119430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65451189|NCT01119430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65451190|NCT01119430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65451191|NCT01119430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451192|NCT01119430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65451193|NCT01119430|Serotonin Agents|serotonin agents|mesh-ancestor
65451194|NCT01119430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451195|NCT01119430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64680774|NCT03822663|Purinergic Agents|purinergic agents|mesh-ancestor
64680775|NCT03822663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64680777|NCT03801525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680784|NCT03778957|Bevacizumab|bevacizumab|mesh-list
64680785|NCT03778957|Durvalumab|durvalumab|mesh-list
64680786|NCT03778957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64680787|NCT03778957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680788|NCT03778957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64680789|NCT03778957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64716140|NCT03211117|Tubulin Modulators|tubulin modulators|mesh-ancestor
64716141|NCT03211117|Antimitotic Agents|antimitotic agents|mesh-ancestor
64716142|NCT03211117|Mitosis Modulators|mitosis modulators|mesh-ancestor
64716143|NCT03211117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716144|NCT03211117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64324441|NCT02264119|Pantoprazole|pantoprazole|mesh-list
64680810|NCT03767933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64680811|NCT03701919|Botulinum Toxins|botulinum toxins|mesh-list
64680812|NCT03701919|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64680813|NCT03701919|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64680814|NCT03701919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64680815|NCT03701919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680816|NCT03701919|Cholinergic Agents|cholinergic agents|mesh-ancestor
64680817|NCT03701919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64680818|NCT03701919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680819|NCT03701919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64680820|NCT03701919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64680821|NCT03636152|Hydroxychloroquine|hydroxychloroquine|mesh-list
64680822|NCT03636152|Chloroquine|chloroquine|mesh-list
65451196|NCT01119430|Antidepressive Agents|antidepressive agents|mesh-ancestor
65451197|NCT01119430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65451198|NCT01119430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65451199|NCT01119430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65451200|NCT01119430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451201|NCT02529124|Caseins|caseins|mesh-list
65451202|NCT02529124|Chelating Agents|chelating agents|mesh-ancestor
65451203|NCT02529124|Sequestering Agents|sequestering agents|mesh-ancestor
64835893|NCT01605240|Ibuprofen|ibuprofen|mesh-list
64680823|NCT03636152|Antimalarials|antimalarials|mesh-ancestor
64680824|NCT03636152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64680825|NCT03636152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64680826|NCT03636152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64680827|NCT03636152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680828|NCT03636152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680829|NCT03636152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64406163|NCT03044795|Veliparib|veliparib|mesh-list
64680830|NCT03636152|Amebicides|amebicides|mesh-ancestor
64680831|NCT03633604|HBOC 201|hboc 201|mesh-list
64680832|NCT03633604|Blood Substitutes|blood substitutes|mesh-ancestor
64680836|NCT03555916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680837|NCT03555916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64680838|NCT03555916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64680839|NCT03555916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680840|NCT03555916|Cholinergic Agents|cholinergic agents|mesh-ancestor
64680841|NCT03555916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64680842|NCT03474497|Pembrolizumab|pembrolizumab|mesh-list
64680843|NCT03474497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64680856|NCT03289650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680858|NCT03255070|Immunologic Factors|immunologic factors|mesh-ancestor
64680859|NCT03255070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680877|NCT03215030|Dexamethasone|dexamethasone|mesh-list
64680878|NCT03215030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64680879|NCT03215030|Antiemetics|antiemetics|mesh-ancestor
64680880|NCT03215030|Autonomic Agents|autonomic agents|mesh-ancestor
64680881|NCT03215030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64680882|NCT03215030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680883|NCT03215030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64680884|NCT03215030|Glucocorticoids|glucocorticoids|mesh-ancestor
64680885|NCT03215030|Hormones|hormones|mesh-ancestor
64680922|NCT03072238|Glucocorticoids|glucocorticoids|mesh-ancestor
64680923|NCT03072238|Hormones|hormones|mesh-ancestor
64680924|NCT03072238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64680925|NCT03072238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680926|NCT03072238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64680927|NCT03072238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680928|NCT02975492|Vitamin D|vitamin d|mesh-list
64680960|NCT02821832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680961|NCT02821832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680962|NCT02821832|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64680963|NCT02821832|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64680964|NCT02821832|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64680965|NCT02821832|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64716145|NCT03211117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64716146|NCT03211117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64716148|NCT03211117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64716149|NCT00376285|Fenofibrate|fenofibrate|mesh-list
64680966|NCT02821832|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64680985|NCT02799602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64680986|NCT02799602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680987|NCT02756611|Venetoclax|venetoclax|mesh-list
64680988|NCT02756611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680989|NCT02673359|Progesterone|progesterone|mesh-list
64680990|NCT02673359|Progestins|progestins|mesh-ancestor
64680991|NCT02673359|Hormones|hormones|mesh-ancestor
65451204|NCT02529124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451205|NCT03780244|Mannitol|mannitol|mesh-list
65200706|NCT01142726|Antimetabolites|antimetabolites|mesh-ancestor
65451206|NCT03780244|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65451207|NCT03780244|Diuretics|diuretics|mesh-ancestor
65451208|NCT03780244|Natriuretic Agents|natriuretic agents|mesh-ancestor
65451209|NCT03780244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451210|NCT01119742|Butenafine|butenafine|mesh-list
65451211|NCT01119742|Antifungal Agents|antifungal agents|mesh-ancestor
65451212|NCT01119742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65451213|NCT01216696|Ipilimumab|ipilimumab|mesh-list
65451214|NCT01216696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65451215|NCT01216696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451216|NCT01216696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65451217|NCT01216696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451218|NCT03937258|Probenecid|probenecid|mesh-list
65451219|NCT03937258|Abrocitinib|abrocitinib|mesh-list
65451220|NCT03937258|Uricosuric Agents|uricosuric agents|mesh-ancestor
65451221|NCT03937258|Gout Suppressants|gout suppressants|mesh-ancestor
65451222|NCT03937258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65451223|NCT03937258|Renal Agents|renal agents|mesh-ancestor
64680992|NCT02673359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64680993|NCT02673359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680994|NCT02629809|Cyclophosphamide|cyclophosphamide|mesh-list
64680995|NCT02629809|Fludarabine|fludarabine|mesh-list
64680996|NCT02629809|Fludarabine phosphate|fludarabine phosphate|mesh-list
64680997|NCT02629809|Obinutuzumab|obinutuzumab|mesh-list
64680998|NCT02629809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64680999|NCT02629809|Immunologic Factors|immunologic factors|mesh-ancestor
64681000|NCT02629809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681001|NCT02629809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64681002|NCT02629809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64681003|NCT02629809|Alkylating Agents|alkylating agents|mesh-ancestor
64681004|NCT02629809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681005|NCT02629809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681006|NCT02629809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64681007|NCT02629809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64681008|NCT02629809|Antimetabolites|antimetabolites|mesh-ancestor
64681009|NCT02629809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64681010|NCT02624518|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
64681011|NCT02624518|Bombesin|bombesin|mesh-list
64681012|NCT02624518|Gastrins|gastrins|mesh-list
64681013|NCT02624518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64681016|NCT02624518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64681017|NCT02624518|Hormones|hormones|mesh-ancestor
64681018|NCT02624518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64681019|NCT02603146|Hydroxychloroquine|hydroxychloroquine|mesh-list
64681020|NCT02603146|Antimalarials|antimalarials|mesh-ancestor
64681021|NCT02603146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64681022|NCT02603146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64681023|NCT02603146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64681024|NCT02603146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681060|NCT02303171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681061|NCT02287623|Bupivacaine|bupivacaine|mesh-list
64681062|NCT02287623|Anesthetics, Local|anesthetics, local|mesh-ancestor
64681063|NCT02287623|Anesthetics|anesthetics|mesh-ancestor
65451224|NCT03937258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65451225|NCT03937258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451226|NCT03937258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451227|NCT01124656|Pioglitazone|pioglitazone|mesh-list
65451228|NCT01124656|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65451229|NCT01124656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65451230|NCT01124656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451231|NCT01124656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65451232|NCT01124656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65451233|NCT01124656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451234|NCT01122472|Lenalidomide|lenalidomide|mesh-list
65451235|NCT01122472|Immunologic Factors|immunologic factors|mesh-ancestor
65451236|NCT01122472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451237|NCT01122472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65451238|NCT01122472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65451239|NCT01122472|Growth Substances|growth substances|mesh-ancestor
65451240|NCT01122472|Growth Inhibitors|growth inhibitors|mesh-ancestor
65451241|NCT01122472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451242|NCT01214122|Warfarin|warfarin|mesh-list
65451243|NCT01214122|Anticoagulants|anticoagulants|mesh-ancestor
65451244|NCT03935152|Dydrogesterone|dydrogesterone|mesh-list
65451245|NCT03935152|Progestins|progestins|mesh-ancestor
65451246|NCT03935152|Hormones|hormones|mesh-ancestor
64835921|NCT01605279|Adrenergic Agents|adrenergic agents|mesh-ancestor
64681064|NCT02287623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64681065|NCT02287623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681072|NCT02266329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64681073|NCT02266329|Adrenergic Agents|adrenergic agents|mesh-ancestor
64681074|NCT02266329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64681075|NCT02266329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681076|NCT02266329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681077|NCT01840566|Cytarabine|cytarabine|mesh-list
64681078|NCT01840566|Etoposide|etoposide|mesh-list
64681079|NCT01840566|Melphalan|melphalan|mesh-list
64681080|NCT01840566|Carmustine|carmustine|mesh-list
64681081|NCT01840566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64681082|NCT01840566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681083|NCT01840566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64681084|NCT01840566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64681085|NCT01840566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681086|NCT01840566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681087|NCT01840566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64681088|NCT01840566|Antimetabolites|antimetabolites|mesh-ancestor
64716152|NCT00376285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716153|NCT00376285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64716154|NCT03460652|Serdexmethylphenidate and dexmethylphenidate|serdexmethylphenidate and dexmethylphenidate|mesh-list
64716155|NCT03460652|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64716156|NCT03460652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716157|NCT03321097|Botulinum Toxins|botulinum toxins|mesh-list
64716158|NCT03321097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65451247|NCT03935152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65451248|NCT03935152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451249|NCT01216852|Losartan|losartan|mesh-list
65451250|NCT01216852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65451251|NCT01216852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65451252|NCT01216852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65451253|NCT01216852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65451254|NCT01216852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451255|NCT03933748|Teicoplanin|teicoplanin|mesh-list
65451256|NCT03933748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65451257|NCT03933748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65451258|NCT01120366|Methotrexate|methotrexate|mesh-list
64716159|NCT03321097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64716160|NCT03321097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716161|NCT03321097|Cholinergic Agents|cholinergic agents|mesh-ancestor
64716162|NCT03321097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64681089|NCT01840566|Antiviral Agents|antiviral agents|mesh-ancestor
64681090|NCT01840566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64681091|NCT01840566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64681092|NCT01840566|Immunologic Factors|immunologic factors|mesh-ancestor
64681093|NCT01840566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681094|NCT01840566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64681095|NCT01840566|Alkylating Agents|alkylating agents|mesh-ancestor
64681096|NCT01840566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64681097|NCT01794520|Dexamethasone|dexamethasone|mesh-list
64681098|NCT01794520|Venetoclax|venetoclax|mesh-list
64681099|NCT01794520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64681100|NCT01794520|Antiemetics|antiemetics|mesh-ancestor
64681101|NCT01794520|Autonomic Agents|autonomic agents|mesh-ancestor
64681102|NCT01794520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64681103|NCT01794520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681104|NCT01794520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64681105|NCT01794520|Glucocorticoids|glucocorticoids|mesh-ancestor
64681106|NCT01794520|Hormones|hormones|mesh-ancestor
64681107|NCT01794520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64681108|NCT01794520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64681110|NCT01787487|Azacitidine|azacitidine|mesh-list
64681122|NCT01653678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64681123|NCT01653678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64681125|NCT01370811|Clonidine|clonidine|mesh-list
64681126|NCT01370811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64681127|NCT01370811|Oxybutynin|oxybutynin|mesh-list
64681131|NCT01370811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681132|NCT01370811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64681133|NCT01370811|Sympatholytics|sympatholytics|mesh-ancestor
64681134|NCT01370811|Autonomic Agents|autonomic agents|mesh-ancestor
64681135|NCT01370811|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64681136|NCT01370811|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64681137|NCT01370811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64681138|NCT01370811|Adrenergic Agents|adrenergic agents|mesh-ancestor
64681139|NCT01370811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64681140|NCT01370811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681141|NCT01370811|Parasympatholytics|parasympatholytics|mesh-ancestor
64681142|NCT01370811|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64681143|NCT01370811|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64681144|NCT01370811|Cholinergic Agents|cholinergic agents|mesh-ancestor
64681145|NCT01370811|Urological Agents|urological agents|mesh-ancestor
64716163|NCT03321097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716165|NCT03245762|Oxytocics|oxytocics|mesh-ancestor
64716166|NCT03245762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65451259|NCT01120366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65451260|NCT01120366|Abortifacient Agents|abortifacient agents|mesh-ancestor
65451261|NCT01120366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65451262|NCT01120366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451263|NCT01120366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65451264|NCT01120366|Antimetabolites|antimetabolites|mesh-ancestor
65451265|NCT01120366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451266|NCT01120366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451267|NCT01120366|Dermatologic Agents|dermatologic agents|mesh-ancestor
65451268|NCT01120366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451269|NCT01120366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65451270|NCT01120366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65451271|NCT01120366|Immunologic Factors|immunologic factors|mesh-ancestor
65451272|NCT01120366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65451273|NCT01120366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65451274|NCT01217086|Infliximab|infliximab|mesh-list
65451275|NCT01217086|Dermatologic Agents|dermatologic agents|mesh-ancestor
65451276|NCT01217086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65451277|NCT01217086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65451278|NCT01120444|Insulin|insulin|mesh-list
64325696|NCT02266927|Xhance|xhance|mesh-list
64716167|NCT03245762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716168|NCT03322657|Glycopyrrolate|glycopyrrolate|mesh-list
64716169|NCT03322657|Neostigmine|neostigmine|mesh-list
64716170|NCT03322657|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64716171|NCT03322657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64716172|NCT03322657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716173|NCT03322657|Cholinergic Agents|cholinergic agents|mesh-ancestor
64716174|NCT03322657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64716175|NCT03322657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716176|NCT03322657|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64716177|NCT03322657|Autonomic Agents|autonomic agents|mesh-ancestor
64716178|NCT03322657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716179|NCT03322657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64716180|NCT03322657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64716181|NCT03322657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64716182|NCT03324451|Insulin|insulin|mesh-list
64716183|NCT03324451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64716184|NCT03324451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716185|NCT03247790|Lasmiditan|lasmiditan|mesh-list
64716186|NCT03247790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64716187|NCT03247790|Serotonin Agents|serotonin agents|mesh-ancestor
64716188|NCT03247790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64716189|NCT03247790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681146|NCT01370811|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64681147|NCT01370811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64681148|NCT01370811|Renal Agents|renal agents|mesh-ancestor
64681149|NCT01323569|Nabiximols|nabiximols|mesh-list
64681150|NCT01323569|Dronabinol|dronabinol|mesh-list
64681151|NCT01323569|Analgesics|analgesics|mesh-ancestor
64681152|NCT01323569|Sensory System Agents|sensory system agents|mesh-ancestor
64681153|NCT01323569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64681154|NCT01323569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681155|NCT01323569|Hallucinogens|hallucinogens|mesh-ancestor
64681156|NCT01323569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65451279|NCT01120444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65200778|NCT01115738|Clopidogrel|clopidogrel|mesh-list
65451280|NCT01120444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451282|NCT01217398|Temozolomide|temozolomide|mesh-list
65451283|NCT01217398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65451284|NCT01217398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451285|NCT01217398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65451286|NCT01217398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65451287|NCT01217398|Growth Substances|growth substances|mesh-ancestor
65451288|NCT01217398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451289|NCT01217398|Growth Inhibitors|growth inhibitors|mesh-ancestor
65451290|NCT01217398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65451291|NCT01217398|Alkylating Agents|alkylating agents|mesh-ancestor
65451292|NCT01217398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451293|NCT01125124|Silver Nitrate|silver nitrate|mesh-list
65451294|NCT01125124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65451295|NCT01125124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65451296|NCT01214746|Atorvastatin|atorvastatin|mesh-list
65451297|NCT01214746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65451298|NCT01214746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65451299|NCT01214746|Antimetabolites|antimetabolites|mesh-ancestor
65451300|NCT01214746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681157|NCT01323569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64681158|NCT01323569|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64681159|NCT01323569|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64681160|NCT01323569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64681161|NCT01323569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681184|NCT01323465|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64681186|NCT01323465|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64681187|NCT01323465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64681188|NCT01323465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64681189|NCT01323465|Hormone Antagonists|hormone antagonists|mesh-ancestor
64716190|NCT03247790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716192|NCT03249272|Regadenoson|regadenoson|mesh-list
64716193|NCT03249272|Analgesics|analgesics|mesh-ancestor
64716194|NCT03249272|Sensory System Agents|sensory system agents|mesh-ancestor
64716195|NCT03249272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716196|NCT03249272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716197|NCT03249272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64716200|NCT03249272|Purinergic Agonists|purinergic agonists|mesh-ancestor
64716201|NCT03249272|Purinergic Agents|purinergic agents|mesh-ancestor
64716202|NCT03249272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64716203|NCT03249272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716204|NCT03249272|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64716205|NCT03468920|Acetaminophen|acetaminophen|mesh-list
64716206|NCT03468920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64324484|NCT01484119|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64681190|NCT01323465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64681191|NCT01323465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451301|NCT01214746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65451302|NCT01214746|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65451303|NCT01214746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451304|NCT03935074|Melphalan|melphalan|mesh-list
65451305|NCT03935074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65451306|NCT03935074|Alkylating Agents|alkylating agents|mesh-ancestor
65451307|NCT03935074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451308|NCT03935074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451309|NCT03935074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65451310|NCT03935074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65451311|NCT03935074|Immunologic Factors|immunologic factors|mesh-ancestor
65451312|NCT03935074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451313|NCT01217632|Entecavir|entecavir|mesh-list
65451314|NCT01217632|Antiviral Agents|antiviral agents|mesh-ancestor
65451315|NCT01217632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65451316|NCT03933280|Dexmedetomidine|dexmedetomidine|mesh-list
65451317|NCT03933280|Nalbuphine|nalbuphine|mesh-list
65451318|NCT03933280|Propofol|propofol|mesh-list
65451319|NCT03933280|Benoxinate|benoxinate|mesh-list
65451320|NCT03933280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65451321|NCT03933280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65451322|NCT03933280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65451323|NCT03933280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451324|NCT03933280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65451325|NCT03933280|Anesthetics, General|anesthetics, general|mesh-ancestor
65451326|NCT03933280|Anesthetics|anesthetics|mesh-ancestor
65451327|NCT03933280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65451328|NCT03933280|Analgesics|analgesics|mesh-ancestor
65451329|NCT03933280|Sensory System Agents|sensory system agents|mesh-ancestor
64681192|NCT01323465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64681194|NCT01323465|Sensory System Agents|sensory system agents|mesh-ancestor
64681195|NCT01323465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64681196|NCT01322464|Nabiximols|nabiximols|mesh-list
64681197|NCT01322464|Analgesics|analgesics|mesh-ancestor
64681198|NCT01322464|Sensory System Agents|sensory system agents|mesh-ancestor
64681199|NCT01322464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64681200|NCT01322464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681201|NCT01322139|Moxifloxacin|moxifloxacin|mesh-list
64681202|NCT01322139|Nabiximols|nabiximols|mesh-list
64681203|NCT01322139|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64681204|NCT01322139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64681205|NCT01322139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64681206|NCT01322139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64681207|NCT01322139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64681208|NCT01322139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681209|NCT01322139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451330|NCT03933280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65451331|NCT03933280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65451332|NCT03933280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65451333|NCT03933280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65451334|NCT03933280|Adrenergic Agents|adrenergic agents|mesh-ancestor
65451335|NCT03933280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65451336|NCT03933280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451337|NCT03933280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65451338|NCT03933280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65451339|NCT03933280|Narcotics|narcotics|mesh-ancestor
65451340|NCT03933280|Anesthetics, Local|anesthetics, local|mesh-ancestor
65451341|NCT01120912|Insulin|insulin|mesh-list
65451342|NCT01120912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65451343|NCT01120912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451344|NCT01219582|Metformin|metformin|mesh-list
65451345|NCT01219582|Acarbose|acarbose|mesh-list
65451346|NCT01219582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65451347|NCT01219582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451348|NCT01219582|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65451349|NCT01219582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451350|NCT01219582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681210|NCT01322139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681211|NCT01322139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64681239|NCT01169259|Vitamins|vitamins|mesh-list
64681240|NCT01169259|Micronutrients|micronutrients|mesh-ancestor
64681241|NCT01169259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681242|NCT01169259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64681243|NCT01169259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64681244|NCT01165632|Fluorides|fluorides|mesh-list
64681245|NCT01165632|Cariostatic Agents|cariostatic agents|mesh-ancestor
64681246|NCT01165632|Protective Agents|protective agents|mesh-ancestor
64681247|NCT01165632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681248|NCT01019850|Vorinostat|vorinostat|mesh-list
64681249|NCT01019850|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64681250|NCT01019850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681251|NCT01019850|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64681252|NCT01019850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681253|NCT01019850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681254|NCT01019850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64716207|NCT03468920|Analgesics|analgesics|mesh-ancestor
64716208|NCT03468920|Sensory System Agents|sensory system agents|mesh-ancestor
64716209|NCT03468920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716210|NCT03468920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716211|NCT03468920|Antipyretics|antipyretics|mesh-ancestor
64716212|NCT02181816|Amlodipine|amlodipine|mesh-list
64716213|NCT02181816|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
64716214|NCT02181816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64716215|NCT02181816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64716216|NCT02181816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64716217|NCT02181816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324501|NCT01481077|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64681255|NCT00885326|Zoledronic Acid|zoledronic acid|mesh-list
64681256|NCT00885326|Cyclophosphamide|cyclophosphamide|mesh-list
64681258|NCT00885326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65451351|NCT03933358|Hormones|hormones|mesh-list
65451352|NCT03933358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65451353|NCT03933358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451354|NCT01122940|Phenytoin|phenytoin|mesh-list
65451355|NCT01122940|Anticonvulsants|anticonvulsants|mesh-ancestor
65451356|NCT01122940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65451357|NCT01122940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65451358|NCT01122940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65451359|NCT01122940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451360|NCT01122940|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65451361|NCT01122940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65451362|NCT01219816|Epratuzumab|epratuzumab|mesh-list
65451363|NCT01219816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65451364|NCT01219816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451366|NCT01215136|Everolimus|everolimus|mesh-list
65451367|NCT01215136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65451368|NCT01215136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451369|NCT01215136|Tubulin Modulators|tubulin modulators|mesh-ancestor
64681259|NCT00885326|Immunologic Factors|immunologic factors|mesh-ancestor
64681260|NCT00885326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681291|NCT00390793|Dexamethasone|dexamethasone|mesh-list
64681292|NCT00390793|Prednisone|prednisone|mesh-list
64681293|NCT00390793|Dexamethasone acetate|dexamethasone acetate|mesh-list
64681294|NCT00390793|Cortisone|cortisone|mesh-list
64681295|NCT00390793|Cyclophosphamide|cyclophosphamide|mesh-list
64681296|NCT00390793|Doxorubicin|doxorubicin|mesh-list
64681297|NCT00390793|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64681298|NCT00390793|Methotrexate|methotrexate|mesh-list
64681299|NCT00390793|Vincristine|vincristine|mesh-list
64681300|NCT00390793|Daunorubicin|daunorubicin|mesh-list
64681308|NCT00390793|Alkylating Agents|alkylating agents|mesh-ancestor
64681309|NCT00390793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681310|NCT00390793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681311|NCT00390793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64681312|NCT00390793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64681313|NCT00390793|Antiemetics|antiemetics|mesh-ancestor
64681314|NCT00390793|Autonomic Agents|autonomic agents|mesh-ancestor
64681315|NCT00390793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64681316|NCT00390793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64681317|NCT00390793|Glucocorticoids|glucocorticoids|mesh-ancestor
64681318|NCT00390793|Hormones|hormones|mesh-ancestor
64681319|NCT00390793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64681320|NCT00390793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64681321|NCT00390793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64681322|NCT00390793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64681323|NCT00390793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64681324|NCT00390793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681325|NCT00390793|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64681326|NCT00390793|Abortifacient Agents|abortifacient agents|mesh-ancestor
64681327|NCT00390793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64681328|NCT00390793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64681329|NCT00390793|Antimetabolites|antimetabolites|mesh-ancestor
64681330|NCT00390793|Dermatologic Agents|dermatologic agents|mesh-ancestor
64681331|NCT00390793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64681332|NCT00390793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64681333|NCT00390793|Antiviral Agents|antiviral agents|mesh-ancestor
65451370|NCT01215136|Antimitotic Agents|antimitotic agents|mesh-ancestor
65451371|NCT01215136|Mitosis Modulators|mitosis modulators|mesh-ancestor
65451372|NCT01215136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451373|NCT01215136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65451374|NCT01215136|Immunologic Factors|immunologic factors|mesh-ancestor
65451375|NCT01215136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451376|NCT01218022|Losartan|losartan|mesh-list
65451377|NCT01218022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65451378|NCT01218022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65451379|NCT01218022|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65451380|NCT01218022|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65451381|NCT01218022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451382|NCT01121458|Clevidipine|clevidipine|mesh-list
65451383|NCT01121458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65451384|NCT01121458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65451385|NCT01121458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451386|NCT01121458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64836068|NCT01610934|Immunologic Factors|immunologic factors|mesh-ancestor
64681334|NCT00390793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64681335|NCT00390793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64681336|NCT00390793|Tubulin Modulators|tubulin modulators|mesh-ancestor
64681337|NCT00390793|Antimitotic Agents|antimitotic agents|mesh-ancestor
64681338|NCT00390793|Mitosis Modulators|mitosis modulators|mesh-ancestor
64681339|NCT00390793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64716218|NCT02181816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64716219|NCT02181816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716220|NCT02181816|Vasodilator Agents|vasodilator agents|mesh-ancestor
64716221|NCT02181816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64716222|NCT02181816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64716224|NCT04761822|Immunologic Factors|immunologic factors|mesh-ancestor
64681340|NCT00390793|Protease Inhibitors|protease inhibitors|mesh-ancestor
64681341|NCT00005835|Melphalan|melphalan|mesh-list
64681342|NCT00005835|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
64681343|NCT00005835|Immunologic Factors|immunologic factors|mesh-ancestor
64681344|NCT00005835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681345|NCT00005835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64681346|NCT00005835|Alkylating Agents|alkylating agents|mesh-ancestor
64681347|NCT00005835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681348|NCT00005835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681349|NCT00005835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64681350|NCT00005835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64681351|NCT00005835|Antimetabolites|antimetabolites|mesh-ancestor
64681352|NCT00005835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64681353|NCT00005835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681354|NCT00005835|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64681355|NCT00005835|Protective Agents|protective agents|mesh-ancestor
64681356|NCT04401995|Nivolumab|nivolumab|mesh-list
64681357|NCT04401995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64681358|NCT04401995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681359|NCT04401995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64681360|NCT04401995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681381|NCT00002643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65451387|NCT01121458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451388|NCT01215214|Midazolam|midazolam|mesh-list
65451389|NCT01215214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65451390|NCT01215214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65451391|NCT01215214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65451392|NCT01215214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451393|NCT01215214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65451394|NCT01215214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65451395|NCT01215214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65451396|NCT01215214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64836086|NCT01610947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64681382|NCT00002643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681383|NCT00002643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64681384|NCT00002643|Tubulin Modulators|tubulin modulators|mesh-ancestor
64681385|NCT00002643|Antimitotic Agents|antimitotic agents|mesh-ancestor
64681390|NCT00002643|Trace Elements|trace elements|mesh-ancestor
64681391|NCT00002643|Micronutrients|micronutrients|mesh-ancestor
64681392|NCT00002649|Aldesleukin|aldesleukin|mesh-list
64681393|NCT00002649|Cyclophosphamide|cyclophosphamide|mesh-list
64681394|NCT00002649|Etoposide|etoposide|mesh-list
64681395|NCT00002649|Etoposide phosphate|etoposide phosphate|mesh-list
64681396|NCT00002649|Interleukin-2|interleukin-2|mesh-list
64681397|NCT00002649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64681398|NCT00002649|Immunologic Factors|immunologic factors|mesh-ancestor
64681399|NCT00002649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681400|NCT00002649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64681401|NCT00002649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64681402|NCT00002649|Alkylating Agents|alkylating agents|mesh-ancestor
64681403|NCT00002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681404|NCT00002649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681405|NCT00002649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64681407|NCT00002649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64681408|NCT00002649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64681409|NCT00002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681410|NCT00002649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64681416|NCT00002649|Antiviral Agents|antiviral agents|mesh-ancestor
64681417|NCT00002649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64681419|NCT01151605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64681420|NCT01151605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64681421|NCT01151605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681422|NCT03003871|Chlorhexidine|chlorhexidine|mesh-list
64681423|NCT03003871|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64681424|NCT03003871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64716225|NCT04761822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716226|NCT03256136|Carboplatin|carboplatin|mesh-list
64716227|NCT03256136|Nivolumab|nivolumab|mesh-list
64716228|NCT03256136|Pemetrexed|pemetrexed|mesh-list
64716229|NCT03256136|Ipilimumab|ipilimumab|mesh-list
64716230|NCT03256136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64716231|NCT03256136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64716232|NCT03256136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64681425|NCT03003871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64681426|NCT03003871|Disinfectants|disinfectants|mesh-ancestor
64681427|NCT03003871|Dermatologic Agents|dermatologic agents|mesh-ancestor
64681428|NCT00995059|Sirolimus|sirolimus|mesh-list
64681429|NCT00995059|Bortezomib|bortezomib|mesh-list
64681430|NCT00995059|Melphalan|melphalan|mesh-list
64681431|NCT00995059|Tacrolimus|tacrolimus|mesh-list
64681432|NCT00995059|Thymoglobulin|thymoglobulin|mesh-list
64681433|NCT00995059|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64681434|NCT00995059|Immunoglobulins|immunoglobulins|mesh-list
64681435|NCT00995059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64406771|NCT04847687|Prednisolone|prednisolone|mesh-list
64681436|NCT00995059|Immunologic Factors|immunologic factors|mesh-ancestor
64681437|NCT00995059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681438|NCT00995059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64681439|NCT00995059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451397|NCT01215214|Anesthetics, General|anesthetics, general|mesh-ancestor
65451398|NCT01215214|Anesthetics|anesthetics|mesh-ancestor
65451399|NCT01215214|GABA Modulators|gaba modulators|mesh-ancestor
65451400|NCT01215214|GABA Agents|gaba agents|mesh-ancestor
65451401|NCT01215214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65451402|NCT01215214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451403|NCT03936166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65451404|NCT01125670|Darexaban|darexaban|mesh-list
65451405|NCT01125670|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65451406|NCT01125670|Antithrombins|antithrombins|mesh-ancestor
65451407|NCT01125670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65451408|NCT01125670|Protease Inhibitors|protease inhibitors|mesh-ancestor
65451409|NCT01125670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451410|NCT01125670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681440|NCT00995059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681441|NCT00995059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681442|NCT00995059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64681443|NCT00995059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64681444|NCT00995059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64681445|NCT00995059|Antifungal Agents|antifungal agents|mesh-ancestor
64681446|NCT00995059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64681447|NCT00995059|Alkylating Agents|alkylating agents|mesh-ancestor
64681448|NCT00995059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64681449|NCT02249299|Nabiximols|nabiximols|mesh-list
64681450|NCT02249299|Analgesics|analgesics|mesh-ancestor
64681451|NCT02249299|Sensory System Agents|sensory system agents|mesh-ancestor
64681464|NCT00002679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681466|NCT00002679|Immunologic Factors|immunologic factors|mesh-ancestor
64681467|NCT00002679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681468|NCT00002679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64681469|NCT00002679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64681470|NCT00002679|Alkylating Agents|alkylating agents|mesh-ancestor
64681473|NCT00002679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64681474|NCT00002679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64681475|NCT00002679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681476|NCT00002679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64681477|NCT00002679|Hormone Antagonists|hormone antagonists|mesh-ancestor
64681478|NCT00002679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64681479|NCT00002679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64681480|NCT00002679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64681481|NCT00002679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64681482|NCT00002679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64681484|NCT00002691|Cytarabine|cytarabine|mesh-list
64681485|NCT00002691|Dexamethasone|dexamethasone|mesh-list
64681486|NCT00002691|Cyclophosphamide|cyclophosphamide|mesh-list
64681487|NCT00002691|Methotrexate|methotrexate|mesh-list
64681488|NCT00002691|Etoposide|etoposide|mesh-list
64681489|NCT00002691|Vincristine|vincristine|mesh-list
64681490|NCT00002691|Daunorubicin|daunorubicin|mesh-list
64681491|NCT00002691|Asparaginase|asparaginase|mesh-list
64681492|NCT00002691|Levoleucovorin|levoleucovorin|mesh-list
64681493|NCT00002691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64681494|NCT00002691|Immunologic Factors|immunologic factors|mesh-ancestor
64681495|NCT00002691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681496|NCT00002691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64681497|NCT00002691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64681498|NCT00002691|Alkylating Agents|alkylating agents|mesh-ancestor
64681499|NCT00002691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716233|NCT03256136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716234|NCT03256136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64716235|NCT03256136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65451411|NCT01125670|Anticoagulants|anticoagulants|mesh-ancestor
65451412|NCT03934450|Primaquine|primaquine|mesh-list
65451413|NCT03934450|Antimalarials|antimalarials|mesh-ancestor
65451414|NCT03934450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65451415|NCT03934450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65451416|NCT03934450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65451417|NCT01215682|Vitamin D|vitamin d|mesh-list
65451418|NCT01215682|Vitamins|vitamins|mesh-ancestor
65451419|NCT01215682|Micronutrients|micronutrients|mesh-ancestor
65451420|NCT01215682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451421|NCT01215682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65451422|NCT03932344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65451423|NCT03932344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65451424|NCT01123408|Haloperidol|haloperidol|mesh-list
65451425|NCT01123408|Olanzapine|olanzapine|mesh-list
65451426|NCT01123408|Haloperidol decanoate|haloperidol decanoate|mesh-list
65451427|NCT01123408|Clozapine|clozapine|mesh-list
64716236|NCT03256136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64681500|NCT00002691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681501|NCT00002691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64681502|NCT00002691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64681503|NCT00002691|Antiemetics|antiemetics|mesh-ancestor
64681504|NCT00002691|Autonomic Agents|autonomic agents|mesh-ancestor
64681505|NCT00002691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64681506|NCT00002691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64681507|NCT00002691|Glucocorticoids|glucocorticoids|mesh-ancestor
64681508|NCT00002691|Hormones|hormones|mesh-ancestor
64681509|NCT00002691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64681510|NCT00002691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64681511|NCT00002691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64406851|NCT05430217|Serotonin Agents|serotonin agents|mesh-ancestor
64681513|NCT00002691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64681514|NCT00002691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64681515|NCT00002691|Antimetabolites|antimetabolites|mesh-ancestor
64681532|NCT00002691|Mitosis Modulators|mitosis modulators|mesh-ancestor
64681533|NCT00002691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64681534|NCT03003637|Nivolumab|nivolumab|mesh-list
64681535|NCT03003637|Ipilimumab|ipilimumab|mesh-list
64681536|NCT03003637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64681537|NCT03003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681538|NCT03003637|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64681539|NCT03003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681540|NCT04054115|Alprostadil|alprostadil|mesh-list
64681541|NCT04054115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64681542|NCT04054115|Vasodilator Agents|vasodilator agents|mesh-ancestor
64681543|NCT04054115|Urological Agents|urological agents|mesh-ancestor
64681544|NCT00002697|Carboplatin|carboplatin|mesh-list
64681545|NCT00002697|Etoposide|etoposide|mesh-list
64681546|NCT00002697|Ifosfamide|ifosfamide|mesh-list
64681547|NCT00002697|Sargramostim|sargramostim|mesh-list
64681548|NCT00002697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681549|NCT00002697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64681550|NCT00002697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64681551|NCT00002697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64681552|NCT00002697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681553|NCT00002697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681554|NCT00002697|Immunologic Factors|immunologic factors|mesh-ancestor
64681555|NCT00002697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681556|NCT00002697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64681559|NCT04488601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64681560|NCT04488601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65451428|NCT01123408|Antiemetics|antiemetics|mesh-ancestor
65451429|NCT01123408|Autonomic Agents|autonomic agents|mesh-ancestor
65451430|NCT01123408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65451431|NCT01123408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451432|NCT01123408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65451433|NCT01123408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65451434|NCT01123408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65451435|NCT01123408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65451436|NCT01123408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65451437|NCT01123408|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65451438|NCT01123408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65451439|NCT01123408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65451440|NCT01123408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451441|NCT01123408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64681561|NCT04488601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64681562|NCT04488601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681563|NCT04488601|Antifungal Agents|antifungal agents|mesh-ancestor
64681564|NCT04488601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64681565|NCT04488601|Immunologic Factors|immunologic factors|mesh-ancestor
64681566|NCT04488601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681567|NCT05032807|Cannabidiol|cannabidiol|mesh-list
64681568|NCT05032807|Anticonvulsants|anticonvulsants|mesh-ancestor
64681569|NCT00002715|Prednisone|prednisone|mesh-list
64681570|NCT00002715|Doxorubicin|doxorubicin|mesh-list
64681571|NCT00002715|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64681572|NCT00002715|Bleomycin|bleomycin|mesh-list
64681573|NCT00002715|Etoposide|etoposide|mesh-list
64681574|NCT00002715|Vincristine|vincristine|mesh-list
64681575|NCT00002715|Vinblastine|vinblastine|mesh-list
64681576|NCT00002715|Mechlorethamine|mechlorethamine|mesh-list
64681577|NCT00002715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64681578|NCT00002715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681590|NCT00002715|Tubulin Modulators|tubulin modulators|mesh-ancestor
64681591|NCT00002715|Antimitotic Agents|antimitotic agents|mesh-ancestor
64681592|NCT00002715|Mitosis Modulators|mitosis modulators|mesh-ancestor
64681593|NCT00002715|Alkylating Agents|alkylating agents|mesh-ancestor
64681594|NCT00002715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64716237|NCT03344510|Anesthetics|anesthetics|mesh-list
64716238|NCT03344510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64716239|NCT03344510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716240|NCT03478982|Alprazolam|alprazolam|mesh-list
64716241|NCT03478982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64716242|NCT03478982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64716243|NCT03478982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716244|NCT03478982|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64716245|NCT03478982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64716246|NCT03478982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64716247|NCT03478982|GABA Modulators|gaba modulators|mesh-ancestor
64324529|NCT04476121|Analgesics|analgesics|mesh-ancestor
64681595|NCT04972513|Nitric Oxide|nitric oxide|mesh-list
64681596|NCT04972513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64681597|NCT04972513|Autonomic Agents|autonomic agents|mesh-ancestor
64681598|NCT04972513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64681599|NCT04972513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681600|NCT04972513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64681601|NCT04972513|Respiratory System Agents|respiratory system agents|mesh-ancestor
64681602|NCT04972513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64681603|NCT04972513|Antioxidants|antioxidants|mesh-ancestor
64681604|NCT04972513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681605|NCT04972513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64681606|NCT04972513|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65451442|NCT01123408|Serotonin Agents|serotonin agents|mesh-ancestor
65451443|NCT01123408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65451444|NCT01123408|Dopamine Agents|dopamine agents|mesh-ancestor
65451445|NCT01123408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65451446|NCT01123408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65451447|NCT01123408|GABA Antagonists|gaba antagonists|mesh-ancestor
65451448|NCT01123408|GABA Agents|gaba agents|mesh-ancestor
65451449|NCT00141297|Palbociclib|palbociclib|mesh-list
65451450|NCT00141297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451451|NCT00141297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65451452|NCT00141297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451453|NCT00141297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451454|NCT01123486|Hydromorphone|hydromorphone|mesh-list
64681607|NCT04972513|Vasodilator Agents|vasodilator agents|mesh-ancestor
64681608|NCT04972513|Gasotransmitters|gasotransmitters|mesh-ancestor
64681609|NCT04972513|Protective Agents|protective agents|mesh-ancestor
64681610|NCT02976467|Fulacimstat|fulacimstat|mesh-list
64681611|NCT02976467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681612|NCT02976467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681613|NCT02981095|Bupivacaine|bupivacaine|mesh-list
64681614|NCT02981095|Anesthetics, Local|anesthetics, local|mesh-ancestor
64681615|NCT02981095|Anesthetics|anesthetics|mesh-ancestor
64681616|NCT02981095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64681617|NCT02981095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681618|NCT02981095|Sensory System Agents|sensory system agents|mesh-ancestor
64681619|NCT02981095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64681620|NCT00002721|Doxorubicin|doxorubicin|mesh-list
64681621|NCT00002721|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64681622|NCT00002721|Estramustine|estramustine|mesh-list
64681623|NCT00002721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64681624|NCT00002721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681625|NCT00002721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64681626|NCT00002721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64681627|NCT00002721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681656|NCT01625455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64681657|NCT01625455|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64681658|NCT01625455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64681659|NCT01625455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716250|NCT03478982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716251|NCT03270332|Albuterol|albuterol|mesh-list
64716252|NCT03270332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64681702|NCT04311671|Anticestodal Agents|anticestodal agents|mesh-ancestor
64681703|NCT04311671|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64681704|NCT04311671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64681705|NCT04311671|Tubulin Modulators|tubulin modulators|mesh-ancestor
64681706|NCT04311671|Antimitotic Agents|antimitotic agents|mesh-ancestor
64681707|NCT04311671|Mitosis Modulators|mitosis modulators|mesh-ancestor
64681708|NCT04311671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681709|NCT04311671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681710|NCT04311671|Antinematodal Agents|antinematodal agents|mesh-ancestor
64681711|NCT01625923|Olanzapine|olanzapine|mesh-list
64681712|NCT01625923|Antiemetics|antiemetics|mesh-ancestor
64681713|NCT01625923|Autonomic Agents|autonomic agents|mesh-ancestor
64681714|NCT01625923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64681715|NCT01625923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681716|NCT01625923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64681717|NCT01625923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64681718|NCT01625923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64681719|NCT01625923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64681720|NCT01625923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64681721|NCT01625923|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64681722|NCT01625923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64681723|NCT01625923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65451455|NCT01123486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65451456|NCT01123486|Narcotics|narcotics|mesh-ancestor
65451457|NCT01123486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65451458|NCT01123486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451459|NCT01123486|Analgesics|analgesics|mesh-ancestor
65451460|NCT01123486|Sensory System Agents|sensory system agents|mesh-ancestor
65451461|NCT01123486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65451462|NCT01123564|Ranibizumab|ranibizumab|mesh-list
65451463|NCT01123564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65451464|NCT01123564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65451465|NCT01123564|Growth Substances|growth substances|mesh-ancestor
65451466|NCT01123564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451467|NCT01123564|Growth Inhibitors|growth inhibitors|mesh-ancestor
65451468|NCT01123564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451469|NCT01222312|Docetaxel|docetaxel|mesh-list
65451470|NCT01222312|Oxaliplatin|oxaliplatin|mesh-list
65451471|NCT01222312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451472|NCT01222312|Tubulin Modulators|tubulin modulators|mesh-ancestor
65451473|NCT01222312|Antimitotic Agents|antimitotic agents|mesh-ancestor
65451474|NCT01222312|Mitosis Modulators|mitosis modulators|mesh-ancestor
65451475|NCT01222312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451476|NCT03932266|Docetaxel|docetaxel|mesh-list
65451477|NCT03932266|Endostar protein|endostar protein|mesh-list
65451478|NCT03932266|Endostatins|endostatins|mesh-list
64836150|NCT01611415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681744|NCT00002757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64681745|NCT00002757|Immunologic Factors|immunologic factors|mesh-ancestor
64681746|NCT00002757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681747|NCT00002757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64681748|NCT00002757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64681749|NCT00002757|Alkylating Agents|alkylating agents|mesh-ancestor
64681750|NCT00002757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681751|NCT00002757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681752|NCT00002757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64681753|NCT00002757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64681754|NCT00002757|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64681755|NCT00002757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64681756|NCT00002757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681757|NCT00002757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64681758|NCT00002757|Glucocorticoids|glucocorticoids|mesh-ancestor
64681759|NCT00002757|Hormones|hormones|mesh-ancestor
64681760|NCT00002757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64681762|NCT00002757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64681764|NCT00002757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64681765|NCT00002757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64681766|NCT00002757|Antimetabolites|antimetabolites|mesh-ancestor
64681767|NCT00002757|Dermatologic Agents|dermatologic agents|mesh-ancestor
64681768|NCT00002757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64681769|NCT00002757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65451479|NCT03932266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451480|NCT03932266|Tubulin Modulators|tubulin modulators|mesh-ancestor
65451481|NCT03932266|Antimitotic Agents|antimitotic agents|mesh-ancestor
65451482|NCT03932266|Mitosis Modulators|mitosis modulators|mesh-ancestor
65451483|NCT03932266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451484|NCT03932266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65451485|NCT03932266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65451486|NCT03932266|Growth Substances|growth substances|mesh-ancestor
65451487|NCT03932266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451488|NCT03932266|Growth Inhibitors|growth inhibitors|mesh-ancestor
65451489|NCT00141219|Pregabalin|pregabalin|mesh-list
65451490|NCT00141219|Analgesics|analgesics|mesh-ancestor
65451491|NCT00141219|Sensory System Agents|sensory system agents|mesh-ancestor
65451492|NCT00141219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65451493|NCT00141219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451494|NCT00141219|Anticonvulsants|anticonvulsants|mesh-ancestor
65451495|NCT00141219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65451496|NCT00141219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65451497|NCT00141219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451498|NCT00141219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65451499|NCT00141219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65451500|NCT00141219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65451501|NCT00141219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65451502|NCT00141219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64681770|NCT00002757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64681771|NCT00002757|Antiviral Agents|antiviral agents|mesh-ancestor
64681772|NCT00002757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64681773|NCT00002757|Tubulin Modulators|tubulin modulators|mesh-ancestor
64681774|NCT00002757|Antimitotic Agents|antimitotic agents|mesh-ancestor
64681796|NCT01631149|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64681797|NCT01631149|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64681799|NCT01631149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64681800|NCT01631149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681801|NCT01631149|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64681802|NCT01631149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64681803|NCT01631149|Cholinergic Agents|cholinergic agents|mesh-ancestor
64681804|NCT01631149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64716253|NCT03270332|Autonomic Agents|autonomic agents|mesh-ancestor
64716254|NCT03270332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716255|NCT03270332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716256|NCT03270332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64716257|NCT03270332|Respiratory System Agents|respiratory system agents|mesh-ancestor
64716258|NCT03270332|Tocolytic Agents|tocolytic agents|mesh-ancestor
64716259|NCT03270332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64681805|NCT01631149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681806|NCT00002787|Aldesleukin|aldesleukin|mesh-list
64681807|NCT00002787|Interleukin-2|interleukin-2|mesh-list
64681808|NCT00002787|Vaccines|vaccines|mesh-list
64681809|NCT00002787|Immunoglobulins|immunoglobulins|mesh-list
65451503|NCT01222468|Nabilone|nabilone|mesh-list
65451504|NCT01222468|Antiemetics|antiemetics|mesh-ancestor
65451505|NCT01222468|Autonomic Agents|autonomic agents|mesh-ancestor
65451506|NCT01222468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65451507|NCT01222468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451508|NCT01222468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65451509|NCT01222468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65451510|NCT01222468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65451511|NCT01222468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65451512|NCT01222468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65451513|NCT01220284|Vinorelbine|vinorelbine|mesh-list
65451514|NCT01220284|Satraplatin|satraplatin|mesh-list
65451515|NCT01220284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65451516|NCT01220284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451517|NCT01220284|Tubulin Modulators|tubulin modulators|mesh-ancestor
64681810|NCT00002787|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64681811|NCT00002787|Antibodies|antibodies|mesh-list
64681812|NCT00002787|Sargramostim|sargramostim|mesh-list
64407153|NCT03040193|Lidocaine|lidocaine|mesh-list
64681813|NCT00002787|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
64681814|NCT00002787|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
64681815|NCT00002787|Immunologic Factors|immunologic factors|mesh-ancestor
64681816|NCT00002787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681817|NCT00002787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681818|NCT00002787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64681819|NCT00002787|Analgesics|analgesics|mesh-ancestor
64681820|NCT00002787|Sensory System Agents|sensory system agents|mesh-ancestor
64681821|NCT00002787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64681822|NCT00002787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64681823|NCT00002787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64681824|NCT00002787|Antiviral Agents|antiviral agents|mesh-ancestor
64681825|NCT00002787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64681826|NCT00002787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64681827|NCT02975453|Rivaroxaban|rivaroxaban|mesh-list
64681828|NCT02975453|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64681836|NCT00002793|Fluorouracil|fluorouracil|mesh-list
64681837|NCT00002793|Calcium|calcium|mesh-list
64681838|NCT00002793|Levoleucovorin|levoleucovorin|mesh-list
64681839|NCT00002793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64681840|NCT00002793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681841|NCT00002793|Antimetabolites|antimetabolites|mesh-ancestor
64681842|NCT00002793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681843|NCT00002793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64681844|NCT00002793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681845|NCT00002793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64681846|NCT00002793|Immunologic Factors|immunologic factors|mesh-ancestor
64681847|NCT00002793|Antidotes|antidotes|mesh-ancestor
64681848|NCT00002793|Protective Agents|protective agents|mesh-ancestor
64681849|NCT00002793|Vitamin B Complex|vitamin b complex|mesh-ancestor
64681850|NCT00002793|Vitamins|vitamins|mesh-ancestor
64681851|NCT00002793|Micronutrients|micronutrients|mesh-ancestor
64681852|NCT01632709|Bupivacaine|bupivacaine|mesh-list
64681853|NCT01632709|Anesthetics, Local|anesthetics, local|mesh-ancestor
64681854|NCT01632709|Anesthetics|anesthetics|mesh-ancestor
64681855|NCT01632709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64333188|NCT05488405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64681858|NCT01632709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64681859|NCT05751291|Bupivacaine|bupivacaine|mesh-list
64681860|NCT05751291|Anesthetics, Local|anesthetics, local|mesh-ancestor
64681861|NCT05751291|Anesthetics|anesthetics|mesh-ancestor
64681862|NCT05751291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64681863|NCT05751291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681864|NCT05751291|Sensory System Agents|sensory system agents|mesh-ancestor
65451518|NCT01220284|Antimitotic Agents|antimitotic agents|mesh-ancestor
65451519|NCT01220284|Mitosis Modulators|mitosis modulators|mesh-ancestor
65451520|NCT01220284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451521|NCT01127464|Poly ICLC|poly iclc|mesh-list
65451522|NCT01127464|Interferon Inducers|interferon inducers|mesh-ancestor
65451523|NCT01127464|Immunologic Factors|immunologic factors|mesh-ancestor
65451524|NCT01127464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451525|NCT01222780|Vincristine|vincristine|mesh-list
65451526|NCT01222780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65451527|NCT01222780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451528|NCT01222780|Tubulin Modulators|tubulin modulators|mesh-ancestor
65451529|NCT01222780|Antimitotic Agents|antimitotic agents|mesh-ancestor
64681865|NCT05751291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64681866|NCT05720949|Dexamethasone|dexamethasone|mesh-list
64681867|NCT05720949|Bupivacaine|bupivacaine|mesh-list
64681868|NCT05720949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64681869|NCT05720949|Antiemetics|antiemetics|mesh-ancestor
64681870|NCT05720949|Autonomic Agents|autonomic agents|mesh-ancestor
64681871|NCT05720949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64681872|NCT05720949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681873|NCT05720949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64681874|NCT05720949|Glucocorticoids|glucocorticoids|mesh-ancestor
64716260|NCT03270332|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64716261|NCT03270332|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64716262|NCT03270332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64681875|NCT05720949|Hormones|hormones|mesh-ancestor
64681876|NCT05720949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64681877|NCT05720949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64681878|NCT05720949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681879|NCT05720949|Anesthetics, Local|anesthetics, local|mesh-ancestor
64681880|NCT05720949|Anesthetics|anesthetics|mesh-ancestor
64681881|NCT05720949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64681882|NCT05720949|Sensory System Agents|sensory system agents|mesh-ancestor
64681883|NCT01634191|Apremilast|apremilast|mesh-list
64681884|NCT01634191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64681885|NCT01634191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64681886|NCT01634191|Analgesics|analgesics|mesh-ancestor
64681887|NCT01634191|Sensory System Agents|sensory system agents|mesh-ancestor
64681906|NCT05713851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681908|NCT05713851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681909|NCT00361907|Insulin|insulin|mesh-list
64681910|NCT00361907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64681911|NCT00361907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64681912|NCT00361907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681913|NCT04276493|Docetaxel|docetaxel|mesh-list
64681914|NCT04276493|Capecitabine|capecitabine|mesh-list
64681915|NCT04276493|Oxaliplatin|oxaliplatin|mesh-list
64681916|NCT04276493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681917|NCT04276493|Tubulin Modulators|tubulin modulators|mesh-ancestor
64681918|NCT04276493|Antimitotic Agents|antimitotic agents|mesh-ancestor
64681919|NCT04276493|Mitosis Modulators|mitosis modulators|mesh-ancestor
64681920|NCT04276493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681921|NCT04276493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64681922|NCT04276493|Antimetabolites|antimetabolites|mesh-ancestor
64681923|NCT05670795|Clomiphene|clomiphene|mesh-list
64681924|NCT05670795|Enclomiphene|enclomiphene|mesh-list
64681925|NCT05670795|Zuclomiphene|zuclomiphene|mesh-list
64681926|NCT05670795|Hormones|hormones|mesh-list
64681927|NCT05670795|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64681928|NCT05670795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64681929|NCT05670795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681930|NCT05670795|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64681931|NCT05670795|Hormone Antagonists|hormone antagonists|mesh-ancestor
64681932|NCT05670795|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65451530|NCT01222780|Mitosis Modulators|mitosis modulators|mesh-ancestor
65451531|NCT01222780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451532|NCT01222936|Panobinostat|panobinostat|mesh-list
65451533|NCT01222936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451534|NCT01222936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65451535|NCT01222936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451536|NCT01222936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451537|NCT01125904|Crizotinib|crizotinib|mesh-list
65451538|NCT01125904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451539|NCT01125904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65451540|NCT01125904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451541|NCT01125904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451542|NCT01125982|Propofol|propofol|mesh-list
64681933|NCT05670795|Fertility Agents|fertility agents|mesh-ancestor
64681934|NCT05670795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64681935|NCT05670795|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64681936|NCT05670795|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64681937|NCT04266197|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
64681938|NCT04266197|Vasodilator Agents|vasodilator agents|mesh-ancestor
64681939|NCT04266197|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64681940|NCT04266197|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64681950|NCT03942419|Autonomic Agents|autonomic agents|mesh-ancestor
64681951|NCT03942419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64681952|NCT03942419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681953|NCT03942419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64681956|NCT03942419|Parasympatholytics|parasympatholytics|mesh-ancestor
64681957|NCT03942419|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64681958|NCT03942419|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64681959|NCT03942419|Cholinergic Agents|cholinergic agents|mesh-ancestor
64681960|NCT03942419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64681961|NCT03942419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681962|NCT05669313|Rivaroxaban|rivaroxaban|mesh-list
64681963|NCT05669313|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64681964|NCT05669313|Antithrombins|antithrombins|mesh-ancestor
64681965|NCT05669313|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64681966|NCT05669313|Protease Inhibitors|protease inhibitors|mesh-ancestor
64681967|NCT05669313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681968|NCT05669313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681969|NCT05669313|Anticoagulants|anticoagulants|mesh-ancestor
64716263|NCT03270332|Adrenergic Agents|adrenergic agents|mesh-ancestor
64716264|NCT03270332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64716265|NCT03270332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716266|NCT03355820|Antibodies|antibodies|mesh-list
64716267|NCT03355820|Immunologic Factors|immunologic factors|mesh-ancestor
64716268|NCT03355820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716269|NCT03357614|Amoxicillin|amoxicillin|mesh-list
64716270|NCT03357614|Ciprofloxacin|ciprofloxacin|mesh-list
64681971|NCT04343963|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
64681972|NCT04343963|Anticonvulsants|anticonvulsants|mesh-ancestor
64681973|NCT04343963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64681974|NCT04343963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681975|NCT04343963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681976|NCT04343963|Cholinergic Agents|cholinergic agents|mesh-ancestor
64681977|NCT04343963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64681978|NCT04343963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681979|NCT04248179|Sufentanil|sufentanil|mesh-list
64681980|NCT04248179|Ropivacaine|ropivacaine|mesh-list
64681981|NCT04248179|Anesthetics, Local|anesthetics, local|mesh-ancestor
64681982|NCT04248179|Anesthetics|anesthetics|mesh-ancestor
64681983|NCT04248179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64681984|NCT04248179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451543|NCT01125982|Desflurane|desflurane|mesh-list
65451544|NCT01125982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65451545|NCT01125982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65451546|NCT01125982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451547|NCT01125982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65451548|NCT01125982|Anesthetics, General|anesthetics, general|mesh-ancestor
65451549|NCT01125982|Anesthetics|anesthetics|mesh-ancestor
65451550|NCT01125982|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65451551|NCT01220362|Fentanyl|fentanyl|mesh-list
65451552|NCT01220362|Bupivacaine|bupivacaine|mesh-list
64836234|NCT01612247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64681985|NCT04248179|Sensory System Agents|sensory system agents|mesh-ancestor
64681986|NCT04248179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64681987|NCT04248179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64681988|NCT04248179|Narcotics|narcotics|mesh-ancestor
64681989|NCT04248179|Analgesics|analgesics|mesh-ancestor
64681990|NCT04248179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64682015|NCT05447507|Analgesics|analgesics|mesh-ancestor
64682016|NCT05447507|Sensory System Agents|sensory system agents|mesh-ancestor
64682017|NCT05447507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682018|NCT05447507|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64682019|NCT05447507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64682020|NCT05447507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64682021|NCT05447507|Adrenergic Agents|adrenergic agents|mesh-ancestor
64682022|NCT05447507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64682023|NCT05447507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682024|NCT01635439|Dinoprostone|dinoprostone|mesh-list
64682025|NCT01635439|Oxytocics|oxytocics|mesh-ancestor
64682026|NCT01635439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64682027|NCT01635439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682028|NCT01636063|Misoprostol|misoprostol|mesh-list
64682029|NCT01636063|Mifepristone|mifepristone|mesh-list
64682030|NCT01636063|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64682031|NCT01636063|Abortifacient Agents|abortifacient agents|mesh-ancestor
64682062|NCT04387201|Vitamin B Complex|vitamin b complex|mesh-ancestor
64682064|NCT04387201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64682065|NCT04370587|Pembrolizumab|pembrolizumab|mesh-list
64682066|NCT04370587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64682067|NCT04370587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682068|NCT04178005|Cladribine|cladribine|mesh-list
64682069|NCT04178005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682070|NCT04178005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64682071|NCT04178005|Immunologic Factors|immunologic factors|mesh-ancestor
64682072|NCT04178005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682073|NCT05623761|Fluorides|fluorides|mesh-list
64682074|NCT05623761|Cariostatic Agents|cariostatic agents|mesh-ancestor
64682075|NCT05623761|Protective Agents|protective agents|mesh-ancestor
64682083|NCT04231331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64682084|NCT04231331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682085|NCT04231331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64682086|NCT04231331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682087|NCT00361985|Esomeprazole|esomeprazole|mesh-list
64682088|NCT00361985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64716272|NCT03357614|Clavulanic Acids|clavulanic acids|mesh-list
64716273|NCT03357614|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64716274|NCT03357614|Ertapenem|ertapenem|mesh-list
64716275|NCT03357614|Lactams|lactams|mesh-list
64716276|NCT03357614|Probenecid|probenecid|mesh-list
64716277|NCT03357614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64716278|NCT03357614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64716279|NCT03357614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64716280|NCT03357614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64716281|NCT03357614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64682089|NCT00361985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64682090|NCT00361985|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64682091|NCT00361985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451553|NCT01220362|Anesthetics, Local|anesthetics, local|mesh-ancestor
65451554|NCT01220362|Anesthetics|anesthetics|mesh-ancestor
65451555|NCT01220362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65451556|NCT01220362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451557|NCT01220362|Sensory System Agents|sensory system agents|mesh-ancestor
65451558|NCT01220362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65451559|NCT01220362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65451560|NCT01220362|Narcotics|narcotics|mesh-ancestor
65451561|NCT01220362|Analgesics|analgesics|mesh-ancestor
65451562|NCT01220362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65451563|NCT01220362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65451564|NCT01220362|Anesthetics, General|anesthetics, general|mesh-ancestor
65451565|NCT01220440|Methylphenidate|methylphenidate|mesh-list
65451566|NCT01220440|Dextroamphetamine|dextroamphetamine|mesh-list
65451567|NCT01220440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65451568|NCT01220440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451569|NCT01220440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65451570|NCT01220440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65451571|NCT01220440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65451572|NCT01220440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451573|NCT01220440|Dopamine Agents|dopamine agents|mesh-ancestor
65451574|NCT01220440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65451575|NCT01123876|Veliparib|veliparib|mesh-list
65451576|NCT01123876|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65451577|NCT01123876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451578|NCT01123876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451579|NCT01123876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682092|NCT00361985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682093|NCT00362063|Hormones|hormones|mesh-list
64682094|NCT00362063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64682095|NCT00362063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682096|NCT00382239|Exenatide|exenatide|mesh-list
64682097|NCT00382239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64682098|NCT00382239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682099|NCT00382239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64682100|NCT00382239|Incretins|incretins|mesh-ancestor
64682101|NCT00382239|Hormones|hormones|mesh-ancestor
64682102|NCT00382239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64682103|NCT04004845|Misoprostol|misoprostol|mesh-list
64682104|NCT04004845|Oxytocin|oxytocin|mesh-list
64682105|NCT04004845|Oxytocics|oxytocics|mesh-ancestor
64682106|NCT04004845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64682107|NCT04004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682108|NCT04004845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64682109|NCT04004845|Abortifacient Agents|abortifacient agents|mesh-ancestor
65451580|NCT01124032|Methylphenidate|methylphenidate|mesh-list
65451581|NCT01124032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65451582|NCT01124032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451583|NCT01124032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65451584|NCT01124032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65451585|NCT01124032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65451586|NCT01124032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451588|NCT01124032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65451589|NCT03934294|Metoclopramide|metoclopramide|mesh-list
65451590|NCT03934294|Antiemetics|antiemetics|mesh-ancestor
65451591|NCT03934294|Autonomic Agents|autonomic agents|mesh-ancestor
65451592|NCT03934294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64836270|NCT01612299|Everolimus|everolimus|mesh-list
64682110|NCT04004845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64682111|NCT04004845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64682112|NCT03968419|Pembrolizumab|pembrolizumab|mesh-list
64682113|NCT03968419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64682114|NCT03968419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682115|NCT05571735|Vaccines|vaccines|mesh-list
64682116|NCT05571735|Immunologic Factors|immunologic factors|mesh-ancestor
64682117|NCT05571735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682118|NCT04218851|Posaconazole|posaconazole|mesh-list
64682119|NCT04218851|Antifungal Agents|antifungal agents|mesh-ancestor
64682120|NCT04218851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64682121|NCT04218851|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64682122|NCT04218851|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64682123|NCT04218851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64682124|NCT04218851|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64682125|NCT04218851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64682126|NCT04218851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64682134|NCT01637935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682135|NCT00382083|Acetaminophen|acetaminophen|mesh-list
64682136|NCT00382083|Ibuprofen|ibuprofen|mesh-list
64682137|NCT00382083|Lidocaine|lidocaine|mesh-list
64682138|NCT00382083|Anesthetics, Local|anesthetics, local|mesh-ancestor
64682139|NCT00382083|Anesthetics|anesthetics|mesh-ancestor
64682140|NCT00382083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64682141|NCT00382083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682142|NCT00382083|Sensory System Agents|sensory system agents|mesh-ancestor
64682143|NCT00382083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682144|NCT00382083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64682145|NCT00382083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64682146|NCT00382083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64682147|NCT00382083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64716283|NCT03357614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64716284|NCT03357614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64716285|NCT03357614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64716286|NCT03357614|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64682149|NCT00382083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64682150|NCT00382083|Analgesics|analgesics|mesh-ancestor
64682151|NCT00382083|Antipyretics|antipyretics|mesh-ancestor
64682152|NCT00382083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64682153|NCT00382083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64682154|NCT00382083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64682155|NCT00382083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64682156|NCT00382083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64682157|NCT01640197|Resveratrol|resveratrol|mesh-list
64682158|NCT01640197|Antioxidants|antioxidants|mesh-ancestor
64682159|NCT01640197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682160|NCT01640197|Protective Agents|protective agents|mesh-ancestor
64682161|NCT01640197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836283|NCT01612377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65451593|NCT03934294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451594|NCT03934294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65451595|NCT03934294|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65451596|NCT03934294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65451597|NCT03934294|Dopamine Agents|dopamine agents|mesh-ancestor
65451598|NCT03934294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65451599|NCT03934294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451600|NCT01126138|Docetaxel|docetaxel|mesh-list
65451601|NCT01126138|Capecitabine|capecitabine|mesh-list
64682162|NCT01640197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64682163|NCT01640197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64682164|NCT05742399|Hyaluronic Acid|hyaluronic acid|mesh-list
64682165|NCT05742399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64682166|NCT05742399|Immunologic Factors|immunologic factors|mesh-ancestor
64682167|NCT05742399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682168|NCT05742399|Viscosupplements|viscosupplements|mesh-ancestor
64682169|NCT05742399|Protective Agents|protective agents|mesh-ancestor
64682171|NCT01641445|Anticonvulsants|anticonvulsants|mesh-ancestor
64682172|NCT01641445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64682173|NCT01641445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682174|NCT04185311|Nivolumab|nivolumab|mesh-list
64682175|NCT04185311|Ipilimumab|ipilimumab|mesh-list
64682176|NCT04185311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
64682177|NCT04185311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64682178|NCT04185311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682179|NCT04185311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64682180|NCT04185311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682181|NCT05513937|Amlodipine|amlodipine|mesh-list
64682182|NCT05513937|Nebivolol|nebivolol|mesh-list
64682200|NCT04584749|Anesthetics|anesthetics|mesh-ancestor
64682201|NCT04584749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64682202|NCT04584749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682203|NCT04584749|Sensory System Agents|sensory system agents|mesh-ancestor
64682204|NCT04584749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682205|NCT04584749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64682206|NCT04584749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64682207|NCT04584749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64682208|NCT04584749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64682209|NCT04584749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682211|NCT05502315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64682212|NCT05502315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682213|NCT05502315|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64682214|NCT05502315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682215|NCT01644331|Tolvaptan|tolvaptan|mesh-list
64682216|NCT01644331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64682217|NCT01644331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682218|NCT01644331|Natriuretic Agents|natriuretic agents|mesh-ancestor
64682219|NCT01644331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682285|NCT03762317|Clonidine|clonidine|mesh-list
64682286|NCT03762317|Analgesics|analgesics|mesh-ancestor
64682287|NCT03762317|Sensory System Agents|sensory system agents|mesh-ancestor
64682288|NCT03762317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682289|NCT03762317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682290|NCT03762317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64682291|NCT03762317|Sympatholytics|sympatholytics|mesh-ancestor
64682292|NCT03762317|Autonomic Agents|autonomic agents|mesh-ancestor
64682293|NCT03762317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64682294|NCT03762317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64716288|NCT03357614|Gout Suppressants|gout suppressants|mesh-ancestor
64716289|NCT03357614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64682296|NCT03762317|Adrenergic Agents|adrenergic agents|mesh-ancestor
64682297|NCT03762317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65451602|NCT01126138|Vinorelbine|vinorelbine|mesh-list
65451603|NCT01126138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451604|NCT01126138|Tubulin Modulators|tubulin modulators|mesh-ancestor
65451605|NCT01126138|Antimitotic Agents|antimitotic agents|mesh-ancestor
65451606|NCT01126138|Mitosis Modulators|mitosis modulators|mesh-ancestor
65451607|NCT01126138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451608|NCT01126138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65451609|NCT01126138|Antimetabolites|antimetabolites|mesh-ancestor
65451610|NCT01126138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65451611|NCT01218568|Rifaximin|rifaximin|mesh-list
65451612|NCT01218568|Lactulose|lactulose|mesh-list
65451613|NCT01218568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65451614|NCT01218568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65451615|NCT01218568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65451616|NCT01127542|Lenalidomide|lenalidomide|mesh-list
65451617|NCT01127542|Immunologic Factors|immunologic factors|mesh-ancestor
65451618|NCT01127542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451619|NCT01127542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65451620|NCT01127542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65451621|NCT01127542|Growth Substances|growth substances|mesh-ancestor
65451622|NCT01127542|Growth Inhibitors|growth inhibitors|mesh-ancestor
65451623|NCT01127542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451624|NCT01127620|Cetirizine|cetirizine|mesh-list
65451625|NCT01127620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64682298|NCT03762317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682299|NCT04383639|Locust bean gum|locust bean gum|mesh-list
64682300|NCT04383639|Antidiarrheals|antidiarrheals|mesh-ancestor
64682301|NCT04383639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64682302|NCT03083431|Propranolol|propranolol|mesh-list
64682308|NCT03083431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682309|NCT03083431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64682310|NCT03083431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64682311|NCT03083431|Vasodilator Agents|vasodilator agents|mesh-ancestor
64682312|NCT02975921|Povidone-Iodine|povidone-iodine|mesh-list
64682313|NCT02975921|Povidone|povidone|mesh-list
64682314|NCT02975921|Plasma Substitutes|plasma substitutes|mesh-ancestor
64682315|NCT02975921|Blood Substitutes|blood substitutes|mesh-ancestor
64682316|NCT02975921|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64682317|NCT02975921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64682318|NCT05452785|Minocycline|minocycline|mesh-list
64682319|NCT05452785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64682320|NCT05452785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64682321|NCT03002545|Magnesium citrate|magnesium citrate|mesh-list
64682322|NCT03002545|Cathartics|cathartics|mesh-ancestor
64682323|NCT03002545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64682324|NCT04517747|Ramucirumab|ramucirumab|mesh-list
64682325|NCT04517747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682326|NCT02219581|Dexamethasone|dexamethasone|mesh-list
64682327|NCT02219581|Dexamethasone acetate|dexamethasone acetate|mesh-list
64682328|NCT02219581|BB 1101|bb 1101|mesh-list
64682329|NCT02219581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64682330|NCT02219581|Antiemetics|antiemetics|mesh-ancestor
64682331|NCT02219581|Autonomic Agents|autonomic agents|mesh-ancestor
64682332|NCT02219581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65451626|NCT01127620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65451627|NCT01127620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65451628|NCT01127620|Histamine Antagonists|histamine antagonists|mesh-ancestor
65451629|NCT01127620|Histamine Agents|histamine agents|mesh-ancestor
65451630|NCT01127620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65451631|NCT01127620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451632|NCT01127620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451633|NCT01220518|Infliximab|infliximab|mesh-list
65451634|NCT01220518|Dermatologic Agents|dermatologic agents|mesh-ancestor
65451635|NCT01220518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65451636|NCT01220518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65451637|NCT01220596|Interferons|interferons|mesh-list
65451638|NCT01220596|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65451639|NCT01220596|Interferon-alpha|interferon-alpha|mesh-list
65451640|NCT01220596|Entecavir|entecavir|mesh-list
64682333|NCT02219581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682334|NCT02219581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64682335|NCT02219581|Glucocorticoids|glucocorticoids|mesh-ancestor
64682336|NCT02219581|Hormones|hormones|mesh-ancestor
64682337|NCT02219581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64682338|NCT02219581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64682339|NCT02219581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682340|NCT02219581|Protease Inhibitors|protease inhibitors|mesh-ancestor
64682341|NCT02219581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64682342|NCT02219581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682343|NCT01437709|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64682344|NCT01437709|Ofatumumab|ofatumumab|mesh-list
64682345|NCT01437709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64682346|NCT01437709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64682347|NCT01437709|Alkylating Agents|alkylating agents|mesh-ancestor
64682348|NCT01437709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682349|NCT01437709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682350|NCT01437709|Immunologic Factors|immunologic factors|mesh-ancestor
64682351|NCT01437709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682352|NCT03740165|Paclitaxel|paclitaxel|mesh-list
64682353|NCT03740165|Docetaxel|docetaxel|mesh-list
64682354|NCT03740165|Bevacizumab|bevacizumab|mesh-list
64682355|NCT03740165|Carboplatin|carboplatin|mesh-list
64682356|NCT03740165|Pembrolizumab|pembrolizumab|mesh-list
64682357|NCT03740165|Olaparib|olaparib|mesh-list
64682358|NCT03740165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64682359|NCT03740165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682360|NCT03740165|Tubulin Modulators|tubulin modulators|mesh-ancestor
64682361|NCT03740165|Antimitotic Agents|antimitotic agents|mesh-ancestor
64682362|NCT03740165|Mitosis Modulators|mitosis modulators|mesh-ancestor
64716295|NCT03275870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64716296|NCT03275870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64716297|NCT03275870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716298|NCT03275870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64716299|NCT02216214|Mirabegron|mirabegron|mesh-list
64716302|NCT02216214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64716303|NCT02216214|Adrenergic Agents|adrenergic agents|mesh-ancestor
64716304|NCT02216214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64324582|NCT02264587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64324583|NCT02264587|Dopamine Agents|dopamine agents|mesh-ancestor
64324584|NCT02264587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64682363|NCT03740165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682364|NCT03740165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64682365|NCT03740165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64682366|NCT03740165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64682367|NCT03740165|Growth Substances|growth substances|mesh-ancestor
64836332|NCT01612871|Tamoxifen|tamoxifen|mesh-list
65451641|NCT01220596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451642|NCT01220596|Antiviral Agents|antiviral agents|mesh-ancestor
65451643|NCT01220596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65451644|NCT01220596|Immunologic Factors|immunologic factors|mesh-ancestor
65451645|NCT01220596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451646|NCT01218724|Losartan|losartan|mesh-list
65451647|NCT01218724|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65451648|NCT01218724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65451649|NCT01218724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65451650|NCT01218724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65451651|NCT01218724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65451652|NCT01218724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451653|NCT01218724|Diuretics|diuretics|mesh-ancestor
65451654|NCT01218724|Natriuretic Agents|natriuretic agents|mesh-ancestor
65451655|NCT01218724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451656|NCT01218724|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65451657|NCT01218724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64682368|NCT03740165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682369|NCT03740165|Growth Inhibitors|growth inhibitors|mesh-ancestor
64682370|NCT03740165|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64682371|NCT03740165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64682372|NCT01912274|Azacitidine|azacitidine|mesh-list
64682381|NCT01654861|Micronutrients|micronutrients|mesh-ancestor
64682382|NCT01654861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682383|NCT01654861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64682384|NCT01654861|Antimetabolites|antimetabolites|mesh-ancestor
64682385|NCT01654861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682386|NCT01654861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682387|NCT01654861|Antiviral Agents|antiviral agents|mesh-ancestor
64682388|NCT01654861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64682389|NCT01654861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64682390|NCT01654861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64682391|NCT01654861|Immunologic Factors|immunologic factors|mesh-ancestor
64682392|NCT01654861|Antioxidants|antioxidants|mesh-ancestor
64682393|NCT01654861|Protective Agents|protective agents|mesh-ancestor
64682394|NCT01934582|Treprostinil|treprostinil|mesh-list
64682395|NCT01934582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64682396|NCT05735834|Rituximab|rituximab|mesh-list
64682397|NCT05735834|Zanubrutinib|zanubrutinib|mesh-list
64682398|NCT05735834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64682399|NCT05735834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682400|NCT05735834|Immunologic Factors|immunologic factors|mesh-ancestor
64682401|NCT05735834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682402|NCT05735834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64682403|NCT05735834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64682404|NCT05735834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64682405|NCT05735834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682406|NCT05184777|Estradiol|estradiol|mesh-list
64682407|NCT05184777|Progesterone|progesterone|mesh-list
64682408|NCT05184777|Estrogens|estrogens|mesh-ancestor
64682409|NCT05184777|Hormones|hormones|mesh-ancestor
64682410|NCT05184777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64682411|NCT05184777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682412|NCT05184777|Progestins|progestins|mesh-ancestor
64682413|NCT01912352|Methylphenidate|methylphenidate|mesh-list
65451659|NCT01126216|Cisplatin|cisplatin|mesh-list
65451660|NCT01126216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65451661|NCT01126216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451662|NCT01126216|Tubulin Modulators|tubulin modulators|mesh-ancestor
65451663|NCT01126216|Antimitotic Agents|antimitotic agents|mesh-ancestor
65451664|NCT01126216|Mitosis Modulators|mitosis modulators|mesh-ancestor
65451665|NCT01126216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451666|NCT01329016|Metformin|metformin|mesh-list
65451667|NCT01329016|Glyburide|glyburide|mesh-list
65451668|NCT01329016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65451669|NCT01329016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451670|NCT01223326|Acetylcysteine|acetylcysteine|mesh-list
65451671|NCT01223326|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65451672|NCT01223326|Antiviral Agents|antiviral agents|mesh-ancestor
65451673|NCT01223326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65451674|NCT01223326|Expectorants|expectorants|mesh-ancestor
65451675|NCT01223326|Respiratory System Agents|respiratory system agents|mesh-ancestor
65451676|NCT01223326|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65451677|NCT01223326|Antioxidants|antioxidants|mesh-ancestor
65451678|NCT01223326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451679|NCT01223326|Protective Agents|protective agents|mesh-ancestor
65451680|NCT01223326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451681|NCT01223326|Antidotes|antidotes|mesh-ancestor
64682414|NCT01912352|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64682415|NCT01912352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682416|NCT01912352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64682417|NCT01912352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64682418|NCT01912352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64716305|NCT02216214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716306|NCT02216214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716307|NCT02216214|Urological Agents|urological agents|mesh-ancestor
64716308|NCT00376376|Levofloxacin|levofloxacin|mesh-list
64716309|NCT00376376|Ofloxacin|ofloxacin|mesh-list
64716310|NCT00376376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64455628|NCT01918033|Histamine Agents|histamine agents|mesh-ancestor
64716311|NCT00376376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324594|NCT02264665|Immunologic Factors|immunologic factors|mesh-ancestor
64682419|NCT01912352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682420|NCT01912352|Dopamine Agents|dopamine agents|mesh-ancestor
64682421|NCT01912352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64682422|NCT02975843|Beclomethasone|beclomethasone|mesh-list
64682423|NCT02975843|Glycopyrrolate|glycopyrrolate|mesh-list
64682424|NCT02975843|Formoterol Fumarate|formoterol fumarate|mesh-list
64682425|NCT02975843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64682426|NCT02975843|Autonomic Agents|autonomic agents|mesh-ancestor
64682434|NCT02975843|Adrenergic Agents|adrenergic agents|mesh-ancestor
64682435|NCT02975843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64682436|NCT02975843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682437|NCT02975843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64682438|NCT02975843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64682439|NCT02975843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64682449|NCT01655563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64682450|NCT01655563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451682|NCT01223560|Insulin Aspart|insulin aspart|mesh-list
65451683|NCT01223560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65451684|NCT01223560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451685|NCT01126294|Melatonin|melatonin|mesh-list
65451686|NCT01126294|Antioxidants|antioxidants|mesh-ancestor
65451687|NCT01126294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451688|NCT01126294|Protective Agents|protective agents|mesh-ancestor
65451689|NCT01126294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451690|NCT01126294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65451691|NCT00162266|Abatacept|abatacept|mesh-list
65451692|NCT00162266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65451693|NCT00162266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451694|NCT00162266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451695|NCT00162266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65451696|NCT00162266|Immunologic Factors|immunologic factors|mesh-ancestor
65451697|NCT00162266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451698|NCT00162266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65451699|NCT01126450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65451700|NCT01126450|Cetuximab|cetuximab|mesh-list
65451701|NCT01126450|Lenalidomide|lenalidomide|mesh-list
65451702|NCT01126450|Antibodies|antibodies|mesh-list
65451703|NCT01126450|Immunoglobulins|immunoglobulins|mesh-list
65451704|NCT01126450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65451705|NCT01126450|Immunologic Factors|immunologic factors|mesh-ancestor
64682451|NCT01655563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682453|NCT01655719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64682454|NCT01655719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682455|NCT05735756|Citalopram|citalopram|mesh-list
64682456|NCT05735756|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64682457|NCT05735756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64682458|NCT05735756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64682459|NCT05735756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682460|NCT05735756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64682461|NCT05735756|Serotonin Agents|serotonin agents|mesh-ancestor
64682462|NCT05735756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682463|NCT05735756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64682464|NCT05735756|Antidepressive Agents|antidepressive agents|mesh-ancestor
64682465|NCT05735756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64682466|NCT01936844|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64682467|NCT01936844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64682468|NCT02987348|Insulin|insulin|mesh-list
64682469|NCT02987348|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64682470|NCT02987348|Exenatide|exenatide|mesh-list
64682471|NCT02987348|Insulin, Long-Acting|insulin, long-acting|mesh-list
64682472|NCT02987348|Glucagon|glucagon|mesh-list
64682473|NCT02987348|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64682474|NCT02987348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64682475|NCT02987348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682476|NCT02987348|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64682477|NCT02987348|Incretins|incretins|mesh-ancestor
64682478|NCT02987348|Hormones|hormones|mesh-ancestor
65451706|NCT01126450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451707|NCT01126450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451708|NCT01126450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65451709|NCT01126450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65451710|NCT01126450|Growth Substances|growth substances|mesh-ancestor
65451711|NCT01126450|Growth Inhibitors|growth inhibitors|mesh-ancestor
65451712|NCT01073384|Beclomethasone|beclomethasone|mesh-list
65451713|NCT01073384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65451714|NCT01073384|Glucocorticoids|glucocorticoids|mesh-ancestor
65451715|NCT01073384|Hormones|hormones|mesh-ancestor
65451716|NCT01073384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65451717|NCT01073384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451718|NCT01073384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65451719|NCT01073384|Respiratory System Agents|respiratory system agents|mesh-ancestor
65451720|NCT01126528|Vitamin D|vitamin d|mesh-list
65451721|NCT01126528|Cholecalciferol|cholecalciferol|mesh-list
65451722|NCT01126528|Vitamins|vitamins|mesh-ancestor
65451723|NCT01126528|Micronutrients|micronutrients|mesh-ancestor
65451724|NCT01126528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451725|NCT01126528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65451726|NCT01126528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65451727|NCT00225212|Rituximab|rituximab|mesh-list
65451728|NCT00225212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65451729|NCT00225212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451730|NCT00225212|Immunologic Factors|immunologic factors|mesh-ancestor
64836386|NCT01613053|Imatinib Mesylate|imatinib mesylate|mesh-list
64682479|NCT02987348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64682480|NCT02987348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64682481|NCT01656031|Cytarabine|cytarabine|mesh-list
64682482|NCT01656031|Clofarabine|clofarabine|mesh-list
64682483|NCT01656031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64682484|NCT01656031|Antimetabolites|antimetabolites|mesh-ancestor
64716313|NCT00376376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64716314|NCT00376376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64716315|NCT00376376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64716316|NCT00376376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64682485|NCT01656031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682486|NCT01656031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682487|NCT01656031|Antiviral Agents|antiviral agents|mesh-ancestor
64682488|NCT01656031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64682489|NCT01656031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64682490|NCT01656031|Immunologic Factors|immunologic factors|mesh-ancestor
64682491|NCT01656031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682492|NCT01656187|Memantine|memantine|mesh-list
64682493|NCT01656187|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64682494|NCT01656187|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64682495|NCT01656187|Dopamine Agents|dopamine agents|mesh-ancestor
64682496|NCT01656187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65451731|NCT00225212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201260|NCT00911157|PENTA|penta|mesh-list
65451732|NCT00225212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65451733|NCT03853330|Bupivacaine|bupivacaine|mesh-list
65451734|NCT03853330|Anesthetics, Local|anesthetics, local|mesh-ancestor
65451735|NCT03853330|Anesthetics|anesthetics|mesh-ancestor
65451736|NCT03853330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65451737|NCT03853330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451738|NCT03853330|Sensory System Agents|sensory system agents|mesh-ancestor
65451739|NCT03853330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65451741|NCT01581944|Hormones|hormones|mesh-list
65451742|NCT01581944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64682497|NCT01656187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682498|NCT01656187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682502|NCT01658839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64682503|NCT01658839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64682504|NCT01658839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64682505|NCT01658995|Doxycycline|doxycycline|mesh-list
64682515|NCT01350141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682516|NCT01350141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64682517|NCT01662115|Nicotine|nicotine|mesh-list
64682518|NCT01662115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64682519|NCT01662115|Autonomic Agents|autonomic agents|mesh-ancestor
64682520|NCT01662115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682521|NCT01662115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682522|NCT01662115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64682523|NCT01662115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64682524|NCT01662115|Cholinergic Agents|cholinergic agents|mesh-ancestor
64682525|NCT01662115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64682526|NCT01662115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682545|NCT01598545|Hydromorphone|hydromorphone|mesh-list
64682546|NCT01598545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64682547|NCT01598545|Narcotics|narcotics|mesh-ancestor
64682548|NCT01598545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64682549|NCT01598545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682550|NCT01598545|Analgesics|analgesics|mesh-ancestor
64682551|NCT01598545|Sensory System Agents|sensory system agents|mesh-ancestor
64682552|NCT01598545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682553|NCT01598701|Acetaminophen|acetaminophen|mesh-list
64682554|NCT01598701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64682555|NCT01598701|Analgesics|analgesics|mesh-ancestor
64682556|NCT01598701|Sensory System Agents|sensory system agents|mesh-ancestor
64682557|NCT01598701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682558|NCT01598701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682559|NCT01598701|Antipyretics|antipyretics|mesh-ancestor
64716317|NCT00376376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716318|NCT00376376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64716319|NCT00376376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64716320|NCT00376376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64716321|NCT02181504|Ranibizumab|ranibizumab|mesh-list
64716322|NCT02181504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64324609|NCT05232123|Cannabidiol|cannabidiol|mesh-list
64682560|NCT00000309|Risperidone|risperidone|mesh-list
64682561|NCT00000309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64682562|NCT00000309|Serotonin Agents|serotonin agents|mesh-ancestor
64682563|NCT00000309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64682564|NCT00000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682565|NCT00000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682566|NCT00000309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64682567|NCT00000309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64682568|NCT00000309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64682569|NCT00000309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65451743|NCT01581944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451744|NCT01581944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65451745|NCT01581944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451746|NCT01226056|Everolimus|everolimus|mesh-list
65451747|NCT01226056|Sorafenib|sorafenib|mesh-list
65451748|NCT01226056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451749|NCT01226056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65451750|NCT01226056|Immunologic Factors|immunologic factors|mesh-ancestor
65451751|NCT01226056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451752|NCT01226056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65451753|NCT01226056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451754|NCT01226056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451755|NCT00162032|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
65451756|NCT00162032|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65451757|NCT00162032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451758|NCT01126606|Glycerol|glycerol|mesh-list
65451759|NCT01126606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64836424|NCT01613170|Estrogens|estrogens|mesh-list
64682570|NCT00000309|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64682572|NCT00000315|Cocaine|cocaine|mesh-list
64682584|NCT00000315|Dopamine Agents|dopamine agents|mesh-ancestor
64682585|NCT00000315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64682586|NCT00000321|Desipramine|desipramine|mesh-list
64682587|NCT00000321|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64682588|NCT00000321|Antidepressive Agents|antidepressive agents|mesh-ancestor
64682589|NCT00000321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64682590|NCT00000321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64682591|NCT00000321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682592|NCT00000321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64682593|NCT00000321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64682594|NCT00000321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64682595|NCT00000321|Adrenergic Agents|adrenergic agents|mesh-ancestor
64682596|NCT00000321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64682597|NCT00000321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682598|NCT05125029|Botulinum Toxins|botulinum toxins|mesh-list
64682599|NCT05125029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64682600|NCT05125029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64682601|NCT05125029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682604|NCT05125029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682605|NCT01940276|Prednisone|prednisone|mesh-list
64682606|NCT01940276|Abiraterone Acetate|abiraterone acetate|mesh-list
64682607|NCT01940276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64682608|NCT01940276|Glucocorticoids|glucocorticoids|mesh-ancestor
64682609|NCT01940276|Hormones|hormones|mesh-ancestor
64682610|NCT01940276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64682611|NCT01940276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682612|NCT01940276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64682613|NCT01940276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682614|NCT01940276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64682615|NCT01940276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64682616|NCT01940276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682617|NCT01940276|Hormone Antagonists|hormone antagonists|mesh-ancestor
64682618|NCT01940276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64682619|NCT00000327|Heroin|heroin|mesh-list
64682620|NCT00000327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65451760|NCT01126606|Protective Agents|protective agents|mesh-ancestor
65451761|NCT01126606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451762|NCT01329406|Milnacipran|milnacipran|mesh-list
65451763|NCT01329406|Levomilnacipran|levomilnacipran|mesh-list
65451764|NCT01329406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65451765|NCT01329406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65451766|NCT01329406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65451767|NCT01329406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451768|NCT01329406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65451769|NCT01329406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451770|NCT01329406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65451771|NCT01329406|Analgesics|analgesics|mesh-ancestor
65451772|NCT01329406|Sensory System Agents|sensory system agents|mesh-ancestor
65451773|NCT01329406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65451774|NCT01329406|Antidepressive Agents|antidepressive agents|mesh-ancestor
64682621|NCT00000327|Narcotics|narcotics|mesh-ancestor
64682622|NCT00000327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64682623|NCT00000327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682624|NCT00000327|Analgesics|analgesics|mesh-ancestor
64682625|NCT00000327|Sensory System Agents|sensory system agents|mesh-ancestor
64682626|NCT00000327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682627|NCT01919216|Citalopram|citalopram|mesh-list
64682628|NCT01919216|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64682629|NCT01919216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64716323|NCT02181504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64716324|NCT02181504|Growth Substances|growth substances|mesh-ancestor
64716325|NCT02181504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716326|NCT02181504|Growth Inhibitors|growth inhibitors|mesh-ancestor
64716327|NCT02181504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64716328|NCT02213094|Vitamins|vitamins|mesh-list
64716329|NCT02213094|Niacinamide|niacinamide|mesh-list
64716330|NCT02213094|Niacin|niacin|mesh-list
64716331|NCT02213094|Nicotinic Acids|nicotinic acids|mesh-list
64716332|NCT02213094|Vitamin B Complex|vitamin b complex|mesh-list
64716333|NCT02213094|Micronutrients|micronutrients|mesh-ancestor
64716334|NCT02213094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716335|NCT02213094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64716336|NCT02213094|Antimetabolites|antimetabolites|mesh-ancestor
64716337|NCT02213094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324614|NCT01225393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64682634|NCT01919216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682635|NCT01919216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64682637|NCT01919216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64682638|NCT01940510|Rifampin|rifampin|mesh-list
64682639|NCT01940510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64682640|NCT01940510|Antitubercular Agents|antitubercular agents|mesh-ancestor
64682641|NCT01940510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64682642|NCT01940510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64682643|NCT01940510|Leprostatic Agents|leprostatic agents|mesh-ancestor
64682644|NCT01940510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64682645|NCT01940510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64682646|NCT01940510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682647|NCT01940510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64682648|NCT01940510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64682649|NCT01940510|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64682650|NCT01940510|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64682651|NCT01940510|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65451775|NCT01329406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65451776|NCT01126684|Atorvastatin|atorvastatin|mesh-list
65451777|NCT01126684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65451778|NCT01126684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65451779|NCT01126684|Antimetabolites|antimetabolites|mesh-ancestor
65451780|NCT01126684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451781|NCT01126684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65451782|NCT01126684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65451783|NCT01126684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451784|NCT01224028|Tacrolimus|tacrolimus|mesh-list
65451785|NCT01224028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65451786|NCT01224028|Immunologic Factors|immunologic factors|mesh-ancestor
65451787|NCT01224028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451788|NCT01224028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64682652|NCT01940510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64682653|NCT00380289|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64682654|NCT00380289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64682655|NCT00380289|Adrenergic Agents|adrenergic agents|mesh-ancestor
64682656|NCT00380289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64682657|NCT00380289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682658|NCT00380289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682659|NCT05364645|Carboplatin|carboplatin|mesh-list
64682660|NCT05364645|Pemetrexed|pemetrexed|mesh-list
64682661|NCT05364645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682662|NCT05364645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64682663|NCT05364645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682664|NCT05364645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64682665|NCT05364645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64682666|NCT01919450|Regadenoson|regadenoson|mesh-list
64682667|NCT01919450|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64682668|NCT01919450|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64682669|NCT01919450|Purinergic Agonists|purinergic agonists|mesh-ancestor
64682670|NCT01919450|Purinergic Agents|purinergic agents|mesh-ancestor
64682671|NCT01919450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64682672|NCT01919450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682673|NCT01919450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682674|NCT01602679|Progesterone|progesterone|mesh-list
64682675|NCT01602679|Progestins|progestins|mesh-ancestor
64716338|NCT02213094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64716339|NCT02213094|Vasodilator Agents|vasodilator agents|mesh-ancestor
64716340|NCT01629966|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
64716341|NCT01629966|Antidepressive Agents|antidepressive agents|mesh-ancestor
64716342|NCT01629966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64716343|NCT01629966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64716344|NCT01629966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64716345|NCT01629966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64324628|NCT01225393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64682677|NCT01602679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64682678|NCT01602679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682680|NCT01919606|Anesthetics, Local|anesthetics, local|mesh-ancestor
64682681|NCT01919606|Anesthetics|anesthetics|mesh-ancestor
64682682|NCT01919606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64682683|NCT01919606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682684|NCT01919606|Sensory System Agents|sensory system agents|mesh-ancestor
64682685|NCT01919606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682686|NCT01919996|Azithromycin|azithromycin|mesh-list
64682687|NCT01919996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64682688|NCT01919996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65451789|NCT01224028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451790|NCT01224028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451791|NCT01226212|Sulfalene|sulfalene|mesh-list
65451792|NCT01226212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65451793|NCT01226212|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65451794|NCT01226212|Renal Agents|renal agents|mesh-ancestor
65451795|NCT01226212|Antimalarials|antimalarials|mesh-ancestor
65451796|NCT01226212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65451797|NCT01226212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65451798|NCT01075490|Clonidine|clonidine|mesh-list
65451799|NCT01075490|Analgesics|analgesics|mesh-ancestor
65451800|NCT01075490|Sensory System Agents|sensory system agents|mesh-ancestor
65451801|NCT01075490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65451802|NCT01075490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451803|NCT01075490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65451804|NCT01075490|Sympatholytics|sympatholytics|mesh-ancestor
65451805|NCT01075490|Autonomic Agents|autonomic agents|mesh-ancestor
65451806|NCT01075490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65451807|NCT01075490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65451808|NCT01075490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65451809|NCT01075490|Adrenergic Agents|adrenergic agents|mesh-ancestor
65451810|NCT01075490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65451811|NCT01075490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451812|NCT03930706|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65451813|NCT03930706|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64682689|NCT05735132|Lidocaine|lidocaine|mesh-list
64682690|NCT05735132|Anesthetics, Local|anesthetics, local|mesh-ancestor
64682691|NCT05735132|Anesthetics|anesthetics|mesh-ancestor
64682692|NCT05735132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64682693|NCT05735132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682694|NCT05735132|Sensory System Agents|sensory system agents|mesh-ancestor
64682695|NCT05735132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682696|NCT05735132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64682697|NCT05735132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64682699|NCT05735132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64682700|NCT05735132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682701|NCT01667029|Sulfasalazine|sulfasalazine|mesh-list
64682702|NCT01667029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64682703|NCT01667029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64682704|NCT01667029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64682705|NCT01667029|Analgesics|analgesics|mesh-ancestor
64682706|NCT01667029|Sensory System Agents|sensory system agents|mesh-ancestor
64682707|NCT01667029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682708|NCT01667029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682709|NCT01667029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64682710|NCT01667029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64682711|NCT01667029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64682712|NCT01943864|Trametinib|trametinib|mesh-list
64682713|NCT01943864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682714|NCT01943864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65451814|NCT03930706|Estradiol|estradiol|mesh-list
65451815|NCT03930706|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65451816|NCT03930706|Estrogens|estrogens|mesh-ancestor
65451817|NCT03930706|Hormones|hormones|mesh-ancestor
65451818|NCT03930706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65451819|NCT03930706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451820|NCT03930706|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65451821|NCT03930706|Contraceptive Agents|contraceptive agents|mesh-ancestor
65451822|NCT03930706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64447587|NCT02139644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64682715|NCT01943864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64682716|NCT01943864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682717|NCT01607203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64682718|NCT01607203|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64682719|NCT01607203|Luteolytic Agents|luteolytic agents|mesh-ancestor
64682720|NCT01607203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64682721|NCT01607203|Contraceptive Agents|contraceptive agents|mesh-ancestor
64682722|NCT01607203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64682723|NCT01607203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682724|NCT01607203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64682725|NCT01607203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64682726|NCT01607203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333283|NCT02220647|Metformin|metformin|mesh-list
64682730|NCT00000333|Parasympatholytics|parasympatholytics|mesh-ancestor
64682731|NCT00000333|Autonomic Agents|autonomic agents|mesh-ancestor
64716346|NCT01629966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716347|NCT01629966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64716348|NCT01629966|Serotonin Agents|serotonin agents|mesh-ancestor
64716349|NCT01629966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716350|NCT01629966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64716351|NCT01629966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64716353|NCT02177838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64716354|NCT02177838|Antibodies|antibodies|mesh-list
64716355|NCT02177838|Immunoglobulins|immunoglobulins|mesh-list
64716356|NCT02177838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64716357|NCT02177838|Immunologic Factors|immunologic factors|mesh-ancestor
64682732|NCT00000333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682733|NCT00000333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682734|NCT00000333|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64682735|NCT00000333|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64682736|NCT00000333|Cholinergic Agents|cholinergic agents|mesh-ancestor
64682737|NCT00000333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64682738|NCT00000333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682739|NCT00000333|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64682740|NCT00000333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64682741|NCT00000333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64682742|NCT00000333|Dopamine Agents|dopamine agents|mesh-ancestor
64682743|NCT00000339|Risperidone|risperidone|mesh-list
64682744|NCT00000339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64682745|NCT00000339|Serotonin Agents|serotonin agents|mesh-ancestor
64682746|NCT00000339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64682747|NCT00000339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682748|NCT00000339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682749|NCT00000339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64682750|NCT00000339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64682751|NCT00000339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64682753|NCT00000339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64682754|NCT00000339|Dopamine Agents|dopamine agents|mesh-ancestor
64682755|NCT00000345|Lofexidine|lofexidine|mesh-list
64682756|NCT00000345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64682757|NCT00000345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64682758|NCT00000345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682759|NCT00000345|Sensory System Agents|sensory system agents|mesh-ancestor
65451823|NCT03930706|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65451824|NCT03932578|Atropine|atropine|mesh-list
65451825|NCT03932578|Metoclopramide|metoclopramide|mesh-list
65451826|NCT03932578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65451827|NCT03932578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65451828|NCT03932578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65451829|NCT03932578|Autonomic Agents|autonomic agents|mesh-ancestor
65451830|NCT03932578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65451831|NCT03932578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451832|NCT03932578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65451833|NCT03932578|Respiratory System Agents|respiratory system agents|mesh-ancestor
65451834|NCT03932578|Mydriatics|mydriatics|mesh-ancestor
65451835|NCT03932578|Parasympatholytics|parasympatholytics|mesh-ancestor
64836497|NCT01613794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64682760|NCT00000345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682761|NCT00000345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64682762|NCT00000345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64682780|NCT05095311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64682781|NCT05095311|Histamine Antagonists|histamine antagonists|mesh-ancestor
64682782|NCT05095311|Histamine Agents|histamine agents|mesh-ancestor
64682783|NCT05095311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64682784|NCT05095311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682785|NCT05095311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682786|NCT05095311|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
64682787|NCT05095311|Immunologic Factors|immunologic factors|mesh-ancestor
64682788|NCT05095311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64682789|NCT05095311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64682790|NCT05095311|Respiratory System Agents|respiratory system agents|mesh-ancestor
64682791|NCT01922336|Infliximab|infliximab|mesh-list
64682792|NCT01922336|Dermatologic Agents|dermatologic agents|mesh-ancestor
64682793|NCT01922336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64682794|NCT01922336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64682795|NCT04330755|Magnesium Sulfate|magnesium sulfate|mesh-list
64682796|NCT04330755|Simendan|simendan|mesh-list
64682797|NCT04330755|Analgesics|analgesics|mesh-ancestor
64682798|NCT04330755|Sensory System Agents|sensory system agents|mesh-ancestor
64682799|NCT04330755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716358|NCT02177838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716359|NCT02177838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64716360|NCT03283436|Bupivacaine|bupivacaine|mesh-list
64716361|NCT03283436|Anesthetics, Local|anesthetics, local|mesh-ancestor
64716362|NCT03283436|Anesthetics|anesthetics|mesh-ancestor
64716363|NCT03283436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64716367|NCT00376064|Octreotide|octreotide|mesh-list
64716368|NCT00376064|Cabergoline|cabergoline|mesh-list
64716369|NCT00376064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64716370|NCT00376064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64716371|NCT00376064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64716372|NCT00376064|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64716373|NCT00376064|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64716374|NCT00376064|Dopamine Agonists|dopamine agonists|mesh-ancestor
64324650|NCT01220947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64682800|NCT04330755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682801|NCT04330755|Anesthetics|anesthetics|mesh-ancestor
64682802|NCT04330755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64682803|NCT04330755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64682804|NCT04330755|Anticonvulsants|anticonvulsants|mesh-ancestor
64682805|NCT04330755|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64682806|NCT04330755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64682807|NCT04330755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682808|NCT04330755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64682809|NCT04330755|Tocolytic Agents|tocolytic agents|mesh-ancestor
65451836|NCT03932578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65451837|NCT03932578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65451838|NCT03932578|Cholinergic Agents|cholinergic agents|mesh-ancestor
65451839|NCT03932578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65451840|NCT03932578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451841|NCT03932578|Antiemetics|antiemetics|mesh-ancestor
65451842|NCT03932578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65451843|NCT03932578|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65451844|NCT03932578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65451845|NCT03932578|Dopamine Agents|dopamine agents|mesh-ancestor
65451846|NCT00258440|Epoetin Alfa|epoetin alfa|mesh-list
65451847|NCT00258440|Hematinics|hematinics|mesh-ancestor
65451848|NCT01329250|Moxifloxacin|moxifloxacin|mesh-list
65451849|NCT01329250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65451850|NCT01329250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65451851|NCT01329250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65451852|NCT01329250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65451853|NCT01329250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451854|NCT01329250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451855|NCT01329250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451856|NCT00224120|Silodosin|silodosin|mesh-list
65451857|NCT00224120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64682844|NCT04713189|Anesthetics, General|anesthetics, general|mesh-ancestor
64682846|NCT01610011|Glycine|glycine|mesh-list
64682847|NCT01610011|Glycine Agents|glycine agents|mesh-ancestor
64682852|NCT00000399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64682853|NCT00000399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682854|NCT02237989|Acetaminophen|acetaminophen|mesh-list
64682855|NCT02237989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64682856|NCT02237989|Analgesics|analgesics|mesh-ancestor
64682857|NCT02237989|Sensory System Agents|sensory system agents|mesh-ancestor
64682858|NCT02237989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682859|NCT02237989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682860|NCT02237989|Antipyretics|antipyretics|mesh-ancestor
64682861|NCT00000429|Calcium Carbonate|calcium carbonate|mesh-list
64682862|NCT00000429|Calcium|calcium|mesh-list
64682863|NCT00000429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64682864|NCT00000429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682865|NCT00000429|Antacids|antacids|mesh-ancestor
64682866|NCT00000429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682867|NCT00000429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64682868|NCT01673191|Dexamethasone|dexamethasone|mesh-list
64682869|NCT01673191|Prednisolone acetate|prednisolone acetate|mesh-list
64682870|NCT01673191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64682871|NCT01673191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64682872|NCT01673191|Antiemetics|antiemetics|mesh-ancestor
64682873|NCT01673191|Autonomic Agents|autonomic agents|mesh-ancestor
64682874|NCT01673191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682875|NCT01673191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682876|NCT01673191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64682877|NCT01673191|Glucocorticoids|glucocorticoids|mesh-ancestor
64682878|NCT01673191|Hormones|hormones|mesh-ancestor
64716375|NCT00376064|Dopamine Agents|dopamine agents|mesh-ancestor
64716376|NCT00376064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65451858|NCT00224120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65451859|NCT00224120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65451860|NCT00224120|Adrenergic Agents|adrenergic agents|mesh-ancestor
65451861|NCT00224120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65451862|NCT00224120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451863|NCT00224120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451864|NCT00224120|Urological Agents|urological agents|mesh-ancestor
65451865|NCT01226446|Vitamin D|vitamin d|mesh-list
65451866|NCT01226446|Vitamins|vitamins|mesh-ancestor
65451867|NCT01226446|Micronutrients|micronutrients|mesh-ancestor
65451868|NCT01226446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451869|NCT01226446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65451870|NCT01224418|Tacrolimus|tacrolimus|mesh-list
65451871|NCT01224418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65451872|NCT01224418|Immunologic Factors|immunologic factors|mesh-ancestor
65451873|NCT01224418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451874|NCT01224418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65451875|NCT01224418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451876|NCT01224418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451877|NCT00257660|Botulinum Toxins|botulinum toxins|mesh-list
64836531|NCT01613820|Mydriatics|mydriatics|mesh-ancestor
64836536|NCT01613846|Sorafenib|sorafenib|mesh-list
64716377|NCT00376064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716378|NCT00376064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716379|NCT03581084|Acetylcysteine|acetylcysteine|mesh-list
64716380|NCT03581084|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64716381|NCT03581084|Antiviral Agents|antiviral agents|mesh-ancestor
64682879|NCT01673191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64682880|NCT01673191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64682881|NCT01673191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682882|NCT01673191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64682883|NCT04502433|Poractant alfa|poractant alfa|mesh-list
64682884|NCT04502433|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
64682885|NCT04502433|Respiratory System Agents|respiratory system agents|mesh-ancestor
64682887|NCT01925144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64682888|NCT01925144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64682889|NCT01925144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64682890|NCT01925144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64682891|NCT01925144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682892|NCT00000441|Carbamazepine|carbamazepine|mesh-list
64682897|NCT00000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682898|NCT00000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682899|NCT00000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64682900|NCT00000441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64682901|NCT00000441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64682916|NCT00000441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64682918|NCT00000447|Nicotine|nicotine|mesh-list
64682919|NCT00000447|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64682920|NCT00000447|Autonomic Agents|autonomic agents|mesh-ancestor
64682921|NCT00000447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682922|NCT00000447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682923|NCT00000447|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65451878|NCT00257660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65451879|NCT00257660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65451880|NCT00257660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65451881|NCT00257660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65451882|NCT00257660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451883|NCT00257660|Cholinergic Agents|cholinergic agents|mesh-ancestor
65451884|NCT00257660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65451885|NCT00257660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451886|NCT00257660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65451887|NCT00257660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65451888|NCT01129180|Azacitidine|azacitidine|mesh-list
65451889|NCT01129180|Bortezomib|bortezomib|mesh-list
65451890|NCT01129180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65451891|NCT01129180|Antimetabolites|antimetabolites|mesh-ancestor
65451892|NCT01129180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451893|NCT01129180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451894|NCT01129180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451895|NCT00224042|Ferric gluconate|ferric gluconate|mesh-list
65451896|NCT00224042|Hematinics|hematinics|mesh-ancestor
65451897|NCT01129258|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
65451898|NCT01129258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451899|NCT01129258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451900|NCT01221376|Imatinib Mesylate|imatinib mesylate|mesh-list
64836561|NCT01613963|Antimetabolites|antimetabolites|mesh-ancestor
64682924|NCT00000447|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64682925|NCT00000447|Cholinergic Agents|cholinergic agents|mesh-ancestor
64682926|NCT00000447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64682927|NCT00000447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682928|NCT00000447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64682929|NCT00000447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64682930|NCT00000447|Sensory System Agents|sensory system agents|mesh-ancestor
64682931|NCT01927718|Thalidomide|thalidomide|mesh-list
64682932|NCT01927718|Lenalidomide|lenalidomide|mesh-list
64682933|NCT01927718|Immunologic Factors|immunologic factors|mesh-ancestor
64682934|NCT01927718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682935|NCT01927718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64682936|NCT01927718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64682937|NCT01927718|Growth Substances|growth substances|mesh-ancestor
64682938|NCT01927718|Growth Inhibitors|growth inhibitors|mesh-ancestor
64682939|NCT01927718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682940|NCT01927718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64682941|NCT01927718|Leprostatic Agents|leprostatic agents|mesh-ancestor
64682942|NCT01927718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64682943|NCT01927718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64682944|NCT05066607|Dexamethasone|dexamethasone|mesh-list
64682945|NCT05066607|Pomalidomide|pomalidomide|mesh-list
64682946|NCT05066607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64682947|NCT05066607|Antiemetics|antiemetics|mesh-ancestor
64682948|NCT05066607|Autonomic Agents|autonomic agents|mesh-ancestor
65451901|NCT01221376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451902|NCT01221376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65451903|NCT01221376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451904|NCT01221376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451905|NCT01224652|Paclitaxel|paclitaxel|mesh-list
65451906|NCT01224652|Irinotecan|irinotecan|mesh-list
65451907|NCT01224652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65451908|NCT01224652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451909|NCT01224652|Tubulin Modulators|tubulin modulators|mesh-ancestor
65451910|NCT01224652|Antimitotic Agents|antimitotic agents|mesh-ancestor
65451911|NCT01224652|Mitosis Modulators|mitosis modulators|mesh-ancestor
65451912|NCT01224652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451913|NCT01224652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65451914|NCT01224652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65451915|NCT01224652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451916|NCT00160706|Certolizumab Pegol|certolizumab pegol|mesh-list
65451917|NCT00160706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65451918|NCT00160706|Immunologic Factors|immunologic factors|mesh-ancestor
65451919|NCT00160706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451920|NCT00160706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65451921|NCT03928210|Digoxin|digoxin|mesh-list
65451922|NCT03928210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65451923|NCT03928210|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64682949|NCT05066607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682950|NCT05066607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682951|NCT05066607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64682952|NCT05066607|Glucocorticoids|glucocorticoids|mesh-ancestor
64682953|NCT05066607|Hormones|hormones|mesh-ancestor
64682954|NCT05066607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64716382|NCT03581084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64716383|NCT03581084|Expectorants|expectorants|mesh-ancestor
64716384|NCT03581084|Respiratory System Agents|respiratory system agents|mesh-ancestor
64455705|NCT02092961|Adalimumab|adalimumab|mesh-list
64716385|NCT03581084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64682955|NCT05066607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64682956|NCT05066607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682957|NCT05066607|Immunologic Factors|immunologic factors|mesh-ancestor
64682958|NCT05066607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64682959|NCT05066607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64682960|NCT05066607|Growth Substances|growth substances|mesh-ancestor
64682961|NCT05066607|Growth Inhibitors|growth inhibitors|mesh-ancestor
64682969|NCT01948388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682970|NCT01675297|Cholecalciferol|cholecalciferol|mesh-list
64682971|NCT01675297|Vitamin D|vitamin d|mesh-list
64682972|NCT01675297|Risedronic Acid|risedronic acid|mesh-list
64682973|NCT01675297|Etidronic Acid|etidronic acid|mesh-list
64682974|NCT01675297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64682975|NCT01675297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682976|NCT01675297|Vitamins|vitamins|mesh-ancestor
64682977|NCT01675297|Micronutrients|micronutrients|mesh-ancestor
64682978|NCT01675297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64682979|NCT01675297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65451924|NCT03928210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451925|NCT03928210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451926|NCT03928210|Protective Agents|protective agents|mesh-ancestor
65451927|NCT03928210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451928|NCT01226602|Ticagrelor|ticagrelor|mesh-list
65451929|NCT01226602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65451930|NCT01226602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65451931|NCT01226602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65451932|NCT01226602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65451933|NCT01226602|Purinergic Agents|purinergic agents|mesh-ancestor
65451934|NCT01226602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65451935|NCT01226602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451936|NCT01226602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451937|NCT01226680|Tofacitinib|tofacitinib|mesh-list
65451938|NCT01226680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65451939|NCT01226680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451940|NCT01226680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451941|NCT00257192|Ziprasidone|ziprasidone|mesh-list
65451942|NCT00257192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65451943|NCT00257192|Serotonin Agents|serotonin agents|mesh-ancestor
65451944|NCT00257192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65451945|NCT00257192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451946|NCT00257192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451947|NCT00257192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65451948|NCT00257192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65451949|NCT00257192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65451950|NCT00257192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65451951|NCT00257192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64682980|NCT01675297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64682981|NCT01675297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682982|NCT05295537|Liver Extracts|liver extracts|mesh-list
64682983|NCT05295537|Hematinics|hematinics|mesh-ancestor
64682986|NCT02287376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64682987|NCT02287376|Analgesics|analgesics|mesh-ancestor
64682988|NCT02287376|Sensory System Agents|sensory system agents|mesh-ancestor
64682989|NCT02287376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682990|NCT02287376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682991|NCT02287376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64682992|NCT02287376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64682993|NCT02287376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64682994|NCT02287376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64682995|NCT02287376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682997|NCT01928186|Antiviral Agents|antiviral agents|mesh-ancestor
65451952|NCT00257192|Dopamine Agents|dopamine agents|mesh-ancestor
65451953|NCT01224964|Montelukast|montelukast|mesh-list
65201476|NCT02946996|Metformin|metformin|mesh-list
65451954|NCT01224964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65451955|NCT01224964|Respiratory System Agents|respiratory system agents|mesh-ancestor
65451956|NCT01224964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65451957|NCT01224964|Hormone Antagonists|hormone antagonists|mesh-ancestor
65451958|NCT01224964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65451959|NCT01224964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451960|NCT01224964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65451961|NCT01224964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65451962|NCT01224964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451963|NCT03967964|Methyltestosterone|methyltestosterone|mesh-list
64447723|NCT02207621|Timolol|timolol|mesh-list
64682998|NCT01928186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64682999|NCT01611571|Teriparatide|teriparatide|mesh-list
64683000|NCT01611571|Risedronic Acid|risedronic acid|mesh-list
64683001|NCT01611571|Etidronic Acid|etidronic acid|mesh-list
64683002|NCT01611571|Parathyroid Hormone|parathyroid hormone|mesh-list
64683003|NCT01611571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64683004|NCT01611571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683005|NCT01611571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64683006|NCT01611571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64683007|NCT01611571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64683008|NCT01611571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683009|NCT00000477|Lovastatin|lovastatin|mesh-list
64683010|NCT00000477|L 647318|l 647318|mesh-list
64683011|NCT00000477|Dihydromevinolin|dihydromevinolin|mesh-list
64683012|NCT00000477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64683013|NCT00000477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64408363|NCT05029453|Apatinib|apatinib|mesh-list
64683015|NCT00000477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683016|NCT00000477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64683017|NCT00000477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64683018|NCT00000477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683019|NCT00000483|Niacin|niacin|mesh-list
64683020|NCT00000483|Clofibrate|clofibrate|mesh-list
64683021|NCT00000483|Estrogens|estrogens|mesh-list
64683022|NCT00000483|Hormones|hormones|mesh-ancestor
64683023|NCT00000483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64683024|NCT00000483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683025|NCT00000483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64683026|NCT00000483|Antimetabolites|antimetabolites|mesh-ancestor
64683027|NCT00000483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716386|NCT03581084|Antioxidants|antioxidants|mesh-ancestor
64683028|NCT00000483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64683037|NCT05276973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64683038|NCT05276973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683039|NCT05276973|Tubulin Modulators|tubulin modulators|mesh-ancestor
64683040|NCT05276973|Antimitotic Agents|antimitotic agents|mesh-ancestor
64683041|NCT05276973|Mitosis Modulators|mitosis modulators|mesh-ancestor
64683042|NCT05276973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683044|NCT00000507|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64683045|NCT00000507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64683046|NCT00000507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683047|NCT00380445|Vildagliptin|vildagliptin|mesh-list
64683048|NCT00380445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64683049|NCT00380445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683050|NCT00380445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65451964|NCT03967964|Testosterone|testosterone|mesh-list
65451965|NCT03967964|Testosterone undecanoate|testosterone undecanoate|mesh-list
65451966|NCT03967964|Testosterone enanthate|testosterone enanthate|mesh-list
65451967|NCT03967964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65451968|NCT03967964|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65451969|NCT03967964|Androgens|androgens|mesh-ancestor
65451970|NCT03967964|Hormones|hormones|mesh-ancestor
65451971|NCT03967964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65451972|NCT03967964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451973|NCT03967964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65451974|NCT03967964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65451975|NCT03967964|Anabolic Agents|anabolic agents|mesh-ancestor
65451976|NCT03967964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65451977|NCT03967964|Immunologic Factors|immunologic factors|mesh-ancestor
65451978|NCT01129414|Omeprazole|omeprazole|mesh-list
65451979|NCT01129414|Clopidogrel|clopidogrel|mesh-list
65451980|NCT01129414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64836640|NCT01614197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64683051|NCT00380445|Protease Inhibitors|protease inhibitors|mesh-ancestor
64683052|NCT00380445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683053|NCT00380445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683055|NCT01950260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64683056|NCT01950260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683057|NCT01676311|Huperzine A|huperzine a|mesh-list
64683058|NCT01676311|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64683059|NCT01676311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683060|NCT01676311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683061|NCT01676311|Cholinergic Agents|cholinergic agents|mesh-ancestor
64683062|NCT01676311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64683063|NCT01676311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683069|NCT01951118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683070|NCT01951118|Cholinergic Agents|cholinergic agents|mesh-ancestor
64683071|NCT01951118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64683072|NCT01951118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683073|NCT01951118|Nootropic Agents|nootropic agents|mesh-ancestor
64683075|NCT01951820|Tetracaine|tetracaine|mesh-list
64683076|NCT01951820|Carticaine|carticaine|mesh-list
64683077|NCT01951820|Benzocaine|benzocaine|mesh-list
64683078|NCT01951820|Anesthetics, Local|anesthetics, local|mesh-ancestor
64683079|NCT01951820|Anesthetics|anesthetics|mesh-ancestor
64683080|NCT01951820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64683081|NCT01951820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683082|NCT01951820|Sensory System Agents|sensory system agents|mesh-ancestor
64683083|NCT01951820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64683084|NCT01951820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64683085|NCT01951820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64683086|NCT01951820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64683087|NCT01951820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64683088|NCT01951820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683089|NCT01952444|Ciprofloxacin|ciprofloxacin|mesh-list
64683090|NCT01952444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64683091|NCT01952444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64683092|NCT01952444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64683093|NCT01952444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64683103|NCT00382629|Antioxidants|antioxidants|mesh-ancestor
64683104|NCT00382629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451981|NCT01129414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65451982|NCT01129414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65451983|NCT01129414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65451984|NCT01129414|Purinergic Agents|purinergic agents|mesh-ancestor
65451985|NCT01129414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65451986|NCT01129414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451987|NCT01129414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65451988|NCT01129414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65451989|NCT01129414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65451990|NCT01129414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65451991|NCT01129414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451992|NCT03967886|Esomeprazole|esomeprazole|mesh-list
65451993|NCT03967886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64683105|NCT00382629|Protective Agents|protective agents|mesh-ancestor
64683106|NCT00382629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683107|NCT00000513|Atenolol|atenolol|mesh-list
64683108|NCT00000513|Chlorthalidone|chlorthalidone|mesh-list
64683109|NCT00000513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64683110|NCT00000513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64683111|NCT00000513|Sympatholytics|sympatholytics|mesh-ancestor
64683112|NCT00000513|Autonomic Agents|autonomic agents|mesh-ancestor
64683113|NCT00000513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64683114|NCT00000513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683115|NCT00000513|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64683116|NCT00000513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64683117|NCT00000513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64716387|NCT03581084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716389|NCT03581084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716390|NCT03581084|Antidotes|antidotes|mesh-ancestor
64683118|NCT00000513|Adrenergic Agents|adrenergic agents|mesh-ancestor
64683119|NCT00000513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64683120|NCT00000513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683121|NCT00000513|Diuretics|diuretics|mesh-ancestor
64683122|NCT00000513|Natriuretic Agents|natriuretic agents|mesh-ancestor
64683123|NCT00000513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64683124|NCT00000513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64683125|NCT00000543|Calcium|calcium|mesh-list
64683126|NCT00000543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64683127|NCT00000543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683128|NCT00000549|Hormones|hormones|mesh-list
64683129|NCT00000549|Estrogens|estrogens|mesh-list
64683130|NCT00000549|Progestins|progestins|mesh-list
64683131|NCT00000549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64683132|NCT00000549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683133|NCT01617577|Lenograstim|lenograstim|mesh-list
64683134|NCT01617577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64683135|NCT01617577|Immunologic Factors|immunologic factors|mesh-ancestor
64683136|NCT01617577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683137|NCT01701037|Trametinib|trametinib|mesh-list
64683138|NCT01701037|Dabrafenib|dabrafenib|mesh-list
64683139|NCT01701037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683141|NCT01701037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683142|NCT01701037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683143|NCT00000585|Penicillins|penicillins|mesh-list
64683144|NCT00000585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64683145|NCT00000585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64683146|NCT01701115|Bupivacaine|bupivacaine|mesh-list
64683147|NCT01701115|Anesthetics, Local|anesthetics, local|mesh-list
64683148|NCT01701115|Mepivacaine|mepivacaine|mesh-list
64683149|NCT01701115|Anesthetics|anesthetics|mesh-list
64683150|NCT01701115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65451994|NCT03967886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65451995|NCT03967886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65451996|NCT03967886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65451997|NCT03967886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65451998|NCT03968042|Thiamine|thiamine|mesh-list
65451999|NCT03968042|Edaravone|edaravone|mesh-list
65452000|NCT03968042|Mitogens|mitogens|mesh-list
65452001|NCT03968042|Vitamins|vitamins|mesh-ancestor
65452002|NCT03968042|Micronutrients|micronutrients|mesh-ancestor
64683151|NCT01701115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683152|NCT01701115|Sensory System Agents|sensory system agents|mesh-ancestor
64683153|NCT01701115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64683154|NCT00000597|Nandrolone Decanoate|nandrolone decanoate|mesh-list
64683155|NCT00000597|Nandrolone|nandrolone|mesh-list
64683156|NCT00000597|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
64683157|NCT00000597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64683158|NCT00000597|Androgens|androgens|mesh-ancestor
64683159|NCT00000597|Hormones|hormones|mesh-ancestor
64683176|NCT01621009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683177|NCT01621009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64683178|NCT01621009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64683179|NCT01621009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683180|NCT04830969|Chlorhexidine|chlorhexidine|mesh-list
64683181|NCT04830969|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64683182|NCT04830969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64683183|NCT04830969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64683184|NCT04830969|Disinfectants|disinfectants|mesh-ancestor
64683185|NCT04830969|Dermatologic Agents|dermatologic agents|mesh-ancestor
64683186|NCT01683331|Insulin|insulin|mesh-list
64683187|NCT01683331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64683188|NCT01683331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683189|NCT02986880|Botulinum Toxins|botulinum toxins|mesh-list
64683190|NCT02986880|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64683191|NCT02986880|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64683192|NCT02986880|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64683193|NCT02986880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64683194|NCT02986880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683195|NCT02986880|Cholinergic Agents|cholinergic agents|mesh-ancestor
64683196|NCT02986880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64683197|NCT02986880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683198|NCT02986880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64683199|NCT02986880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716391|NCT03383588|Epinephrine|epinephrine|mesh-list
64716392|NCT03383588|Fentanyl|fentanyl|mesh-list
64716393|NCT03383588|Morphine|morphine|mesh-list
64716394|NCT03383588|Bupivacaine|bupivacaine|mesh-list
64716395|NCT03383588|Anesthetics, Local|anesthetics, local|mesh-ancestor
64716396|NCT03383588|Anesthetics|anesthetics|mesh-ancestor
64716397|NCT03383588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64716398|NCT03383588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683200|NCT02290106|Pitavastatin|pitavastatin|mesh-list
64683201|NCT02290106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64683202|NCT02290106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64683203|NCT02290106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64683204|NCT02290106|Antimetabolites|antimetabolites|mesh-ancestor
64683205|NCT02290106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683206|NCT02290106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683207|NCT02290106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64683208|NCT00000621|Tretinoin|tretinoin|mesh-list
64683209|NCT00000621|Isotretinoin|isotretinoin|mesh-list
64683210|NCT00000621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683211|NCT00000621|Keratolytic Agents|keratolytic agents|mesh-ancestor
64683212|NCT00000621|Dermatologic Agents|dermatologic agents|mesh-ancestor
64683213|NCT04818957|Vitamin D|vitamin d|mesh-list
64683214|NCT04818957|Cholecalciferol|cholecalciferol|mesh-list
64683215|NCT04818957|Vitamins|vitamins|mesh-ancestor
64683216|NCT04818957|Micronutrients|micronutrients|mesh-ancestor
64683245|NCT01621477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64683247|NCT01621477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64683248|NCT01621477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65452003|NCT03968042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452004|NCT03968042|Mitosis Modulators|mitosis modulators|mesh-ancestor
65452005|NCT03968042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452006|NCT03968042|Vitamin B Complex|vitamin b complex|mesh-ancestor
65452007|NCT03968042|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65452008|NCT03968042|Antioxidants|antioxidants|mesh-ancestor
65452009|NCT03968042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65452010|NCT03968042|Protective Agents|protective agents|mesh-ancestor
65452011|NCT01128322|Niacin|niacin|mesh-list
65452012|NCT01128322|Amlodipine|amlodipine|mesh-list
65452013|NCT01128322|Telmisartan|telmisartan|mesh-list
65452014|NCT01128322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64683249|NCT01621477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64683250|NCT00000627|Fluconazole|fluconazole|mesh-list
64683251|NCT00000627|Antifungal Agents|antifungal agents|mesh-ancestor
64683252|NCT00000627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64683253|NCT00000627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64683256|NCT00000627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683258|NCT00000627|Hormone Antagonists|hormone antagonists|mesh-ancestor
64683259|NCT00000627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64683260|NCT00000627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683261|NCT00000627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64683262|NCT00000627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64683270|NCT05479214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64683271|NCT05479214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683272|NCT00000657|Zidovudine|zidovudine|mesh-list
64683273|NCT00000657|Didanosine|didanosine|mesh-list
64683274|NCT00000657|Antimetabolites|antimetabolites|mesh-ancestor
64683275|NCT00000657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683276|NCT00000657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64683277|NCT00000657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64683278|NCT00000657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683279|NCT00000657|Antiviral Agents|antiviral agents|mesh-ancestor
64683280|NCT00000657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64683281|NCT00000657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64683282|NCT00000657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64683283|NCT01701505|Phenylephrine|phenylephrine|mesh-list
64683284|NCT01701505|Oxymetazoline|oxymetazoline|mesh-list
64683285|NCT01701505|Tetracaine|tetracaine|mesh-list
64683286|NCT01701505|Anesthetics, Local|anesthetics, local|mesh-ancestor
64683287|NCT01701505|Anesthetics|anesthetics|mesh-ancestor
64683288|NCT01701505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64683289|NCT01701505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683290|NCT01701505|Sensory System Agents|sensory system agents|mesh-ancestor
64683291|NCT01701505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64683292|NCT01701505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64683293|NCT01701505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64683294|NCT01701505|Adrenergic Agents|adrenergic agents|mesh-ancestor
64683295|NCT01701505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64716399|NCT03383588|Sensory System Agents|sensory system agents|mesh-ancestor
64716400|NCT03383588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716401|NCT03383588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64716402|NCT03383588|Narcotics|narcotics|mesh-ancestor
64716403|NCT03383588|Analgesics|analgesics|mesh-ancestor
64716404|NCT03383588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64683296|NCT01701505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683297|NCT01701505|Sympathomimetics|sympathomimetics|mesh-ancestor
64683298|NCT01701505|Autonomic Agents|autonomic agents|mesh-ancestor
64683299|NCT01701505|Nasal Decongestants|nasal decongestants|mesh-ancestor
64683300|NCT01701505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64683301|NCT01701505|Respiratory System Agents|respiratory system agents|mesh-ancestor
64683302|NCT01701505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64683303|NCT01701505|Mydriatics|mydriatics|mesh-ancestor
64683304|NCT01701505|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65452015|NCT01128322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65452016|NCT01128322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65452017|NCT01128322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452018|NCT01128322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65452019|NCT01128322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452020|NCT01128322|Vasodilator Agents|vasodilator agents|mesh-ancestor
65452021|NCT01128322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65452022|NCT01128322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65452023|NCT01128322|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64836690|NCT01614366|Amlodipine|amlodipine|mesh-list
64683305|NCT01701505|Protective Agents|protective agents|mesh-ancestor
64683306|NCT00000663|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
64683307|NCT00000663|Immunologic Factors|immunologic factors|mesh-ancestor
64683308|NCT00000663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683309|NCT00000669|Didanosine|didanosine|mesh-list
64683310|NCT00000669|Antimetabolites|antimetabolites|mesh-ancestor
64683311|NCT00000669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683312|NCT00000669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64683313|NCT00000669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64683315|NCT00000669|Antiviral Agents|antiviral agents|mesh-ancestor
64683316|NCT00000669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64683317|NCT00000669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64683318|NCT00000669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64683319|NCT01622257|Metformin|metformin|mesh-list
64683320|NCT01622257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64683321|NCT01622257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683322|NCT04942899|Capecitabine|capecitabine|mesh-list
64683323|NCT04942899|Letrozole|letrozole|mesh-list
64683324|NCT04942899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64683325|NCT04942899|Antimetabolites|antimetabolites|mesh-ancestor
64683326|NCT04942899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683327|NCT04942899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683331|NCT04942899|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64683332|NCT04942899|Hormone Antagonists|hormone antagonists|mesh-ancestor
64683333|NCT04942899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64683334|NCT04942899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683335|NCT00000693|Zidovudine|zidovudine|mesh-list
64683336|NCT00000693|Acyclovir|acyclovir|mesh-list
64683337|NCT00000693|Antimetabolites|antimetabolites|mesh-ancestor
64683338|NCT00000693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683340|NCT00000693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64683341|NCT00000693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683342|NCT00000693|Antiviral Agents|antiviral agents|mesh-ancestor
64683343|NCT00000693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64683344|NCT00000693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64683345|NCT00000693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64683346|NCT04752033|Morphine|morphine|mesh-list
64683347|NCT04752033|Hydromorphone|hydromorphone|mesh-list
64683348|NCT04752033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64683349|NCT04752033|Narcotics|narcotics|mesh-ancestor
64683350|NCT04752033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64683351|NCT04752033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683352|NCT04752033|Analgesics|analgesics|mesh-ancestor
64683353|NCT04752033|Sensory System Agents|sensory system agents|mesh-ancestor
64683354|NCT04752033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64683355|NCT02987270|Piperaquine|piperaquine|mesh-list
64683356|NCT02987270|Artenimol|artenimol|mesh-list
64683357|NCT02987270|Antimalarials|antimalarials|mesh-ancestor
64683358|NCT02987270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64683359|NCT02987270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64683360|NCT02987270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64683361|NCT00000699|Ribavirin|ribavirin|mesh-list
64683362|NCT00000699|Inosine Pranobex|inosine pranobex|mesh-list
64683363|NCT00000699|Antimetabolites|antimetabolites|mesh-ancestor
64716405|NCT03383588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65452024|NCT01128322|Antimetabolites|antimetabolites|mesh-ancestor
65452025|NCT01128322|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65452026|NCT01128322|Vitamin B Complex|vitamin b complex|mesh-ancestor
65452027|NCT01128322|Vitamins|vitamins|mesh-ancestor
65452028|NCT01128322|Micronutrients|micronutrients|mesh-ancestor
65452029|NCT01129570|Silybin|silybin|mesh-list
65452030|NCT01129570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65452031|NCT01129570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452032|NCT01129570|Protective Agents|protective agents|mesh-ancestor
65452033|NCT01129570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452034|NCT01073540|Cephalexin|cephalexin|mesh-list
65452035|NCT01073540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65452036|NCT01073540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65452037|NCT03740386|Phentolamine|phentolamine|mesh-list
65452038|NCT03740386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65452039|NCT03740386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65452040|NCT03740386|Adrenergic Agents|adrenergic agents|mesh-ancestor
65452041|NCT03740386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65452042|NCT03740386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452043|NCT03740386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452044|NCT03740386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65452045|NCT03927352|Adalimumab|adalimumab|mesh-list
65452046|NCT03927352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65452047|NCT03927352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65452048|NCT01225198|Vitamins|vitamins|mesh-list
65452049|NCT01225198|Micronutrients|micronutrients|mesh-ancestor
65452050|NCT01225198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452051|NCT01226992|Vancomycin|vancomycin|mesh-list
65452052|NCT01226992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65452053|NCT01226992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65452054|NCT01128556|Bepotastine besilate|bepotastine besilate|mesh-list
65452055|NCT01128556|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65452056|NCT03740464|Lenograstim|lenograstim|mesh-list
65452057|NCT03740464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65452058|NCT03740464|Immunologic Factors|immunologic factors|mesh-ancestor
65452059|NCT03740464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452060|NCT03927118|Dexamethasone|dexamethasone|mesh-list
65452066|NCT03927118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452067|NCT03927118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452068|NCT03927118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65452069|NCT03927118|Glucocorticoids|glucocorticoids|mesh-ancestor
65452070|NCT03927118|Hormones|hormones|mesh-ancestor
65452071|NCT03927118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65452072|NCT03927118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65452073|NCT03927118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452074|NCT03927118|Protease Inhibitors|protease inhibitors|mesh-ancestor
65452075|NCT03927118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452076|NCT03927118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452077|NCT01227148|Insulin|insulin|mesh-list
64716406|NCT03383588|Anesthetics, General|anesthetics, general|mesh-ancestor
64716407|NCT03383588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64716408|NCT03383588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64716409|NCT03383588|Adrenergic Agents|adrenergic agents|mesh-ancestor
64716410|NCT03383588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64716411|NCT03383588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324695|NCT01379209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64324700|NCT01204099|Docetaxel|docetaxel|mesh-list
64683364|NCT00000699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683365|NCT00000699|Antiviral Agents|antiviral agents|mesh-ancestor
64683366|NCT00000699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64683367|NCT00000699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64683368|NCT00000699|Immunologic Factors|immunologic factors|mesh-ancestor
64683369|NCT00000699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683370|NCT04931979|Pembrolizumab|pembrolizumab|mesh-list
64683371|NCT04931979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64683372|NCT04931979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683373|NCT00000723|Leucovorin|leucovorin|mesh-list
64683374|NCT00000723|Zidovudine|zidovudine|mesh-list
64683375|NCT00000723|Dexamethasone|dexamethasone|mesh-list
64683376|NCT00000723|Methotrexate|methotrexate|mesh-list
64683377|NCT00000723|Calcium|calcium|mesh-list
64683378|NCT00000723|Levoleucovorin|levoleucovorin|mesh-list
64683379|NCT00000723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64683380|NCT00000723|Antiemetics|antiemetics|mesh-ancestor
64683381|NCT00000723|Autonomic Agents|autonomic agents|mesh-ancestor
64683382|NCT00000723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64683383|NCT00000723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683384|NCT00000723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64683392|NCT00000723|Abortifacient Agents|abortifacient agents|mesh-ancestor
64683393|NCT00000723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64683394|NCT00000723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64683395|NCT00000723|Antimetabolites|antimetabolites|mesh-ancestor
64683396|NCT00000723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683397|NCT00000723|Dermatologic Agents|dermatologic agents|mesh-ancestor
64683398|NCT00000723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683399|NCT00000723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64683400|NCT00000723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64683401|NCT00000723|Immunologic Factors|immunologic factors|mesh-ancestor
64683402|NCT00000723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64683403|NCT00000723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64683408|NCT00000723|Micronutrients|micronutrients|mesh-ancestor
64683409|NCT00000723|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64683410|NCT00000723|Antiviral Agents|antiviral agents|mesh-ancestor
64683411|NCT00000723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64683412|NCT00000723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64683413|NCT00000723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64683414|NCT02329964|Neostigmine|neostigmine|mesh-list
64683415|NCT02329964|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
64683417|NCT02329964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452078|NCT01227148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65452079|NCT01227148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452080|NCT01227226|Lubricant Eye Drops|lubricant eye drops|mesh-list
65452081|NCT01227226|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65452082|NCT01227226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65452083|NCT01127308|Ertugliflozin|ertugliflozin|mesh-list
65452084|NCT01127308|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65452085|NCT01127308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452086|NCT01127308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65452087|NCT01127308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452088|NCT01128712|Pregabalin|pregabalin|mesh-list
65452089|NCT01128712|Analgesics|analgesics|mesh-ancestor
65452090|NCT01128712|Sensory System Agents|sensory system agents|mesh-ancestor
65452091|NCT01128712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452092|NCT01128712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452093|NCT01128712|Anticonvulsants|anticonvulsants|mesh-ancestor
65452094|NCT01128712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65452095|NCT01128712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64836751|NCT01614964|Antimalarials|antimalarials|mesh-ancestor
64683418|NCT02329964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683419|NCT02329964|Cholinergic Agents|cholinergic agents|mesh-ancestor
64683420|NCT02329964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64683421|NCT02329964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683422|NCT02329964|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64683423|NCT02329964|Autonomic Agents|autonomic agents|mesh-ancestor
64683424|NCT02329964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64683425|NCT04750395|Haloperidol|haloperidol|mesh-list
64683426|NCT04750395|Olanzapine|olanzapine|mesh-list
64683427|NCT04750395|Haloperidol decanoate|haloperidol decanoate|mesh-list
64683428|NCT04750395|Antiemetics|antiemetics|mesh-ancestor
64683429|NCT04750395|Autonomic Agents|autonomic agents|mesh-ancestor
64683430|NCT04750395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716412|NCT03383588|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64716413|NCT03383588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64716414|NCT03383588|Autonomic Agents|autonomic agents|mesh-ancestor
64716415|NCT03383588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64716416|NCT03383588|Respiratory System Agents|respiratory system agents|mesh-ancestor
64683431|NCT04750395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683432|NCT04750395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64683433|NCT04750395|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64683434|NCT04750395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64683435|NCT04750395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64683436|NCT04750395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64683437|NCT04750395|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64683438|NCT04750395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64683439|NCT04750395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64683440|NCT04750395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683457|NCT03438773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683458|NCT03438773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64683459|NCT03438773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683460|NCT03438773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683461|NCT02974985|Hyaluronic Acid|hyaluronic acid|mesh-list
64683462|NCT02974985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64683463|NCT02974985|Immunologic Factors|immunologic factors|mesh-ancestor
64683464|NCT02974985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452096|NCT01128712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452097|NCT01128712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65452098|NCT01128712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65452099|NCT01128712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65452100|NCT01128712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65452101|NCT01128712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65452102|NCT01127386|Lenalidomide|lenalidomide|mesh-list
65452103|NCT01127386|Immunologic Factors|immunologic factors|mesh-ancestor
65452104|NCT01127386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452105|NCT01127386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65452106|NCT01127386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65452107|NCT01127386|Growth Substances|growth substances|mesh-ancestor
65452108|NCT01127386|Growth Inhibitors|growth inhibitors|mesh-ancestor
65452109|NCT01127386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452110|NCT01130194|Procarbazine|procarbazine|mesh-list
64683465|NCT02974985|Viscosupplements|viscosupplements|mesh-ancestor
64683466|NCT02974985|Protective Agents|protective agents|mesh-ancestor
64683468|NCT01704781|Immunologic Factors|immunologic factors|mesh-ancestor
64683469|NCT01704781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683470|NCT01704781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64683471|NCT01704781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64683472|NCT01704781|Growth Substances|growth substances|mesh-ancestor
64683473|NCT01704781|Growth Inhibitors|growth inhibitors|mesh-ancestor
64683474|NCT01704781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683475|NCT02288156|Capsaicin|capsaicin|mesh-list
64683476|NCT02288156|Antipruritics|antipruritics|mesh-ancestor
64683477|NCT02288156|Dermatologic Agents|dermatologic agents|mesh-ancestor
64683478|NCT02288156|Sensory System Agents|sensory system agents|mesh-ancestor
64683479|NCT02288156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64683480|NCT02288156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683481|NCT04699383|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
64683482|NCT04699383|Allopurinol|allopurinol|mesh-list
64683483|NCT04699383|Antimetabolites|antimetabolites|mesh-ancestor
64683484|NCT04699383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683485|NCT04699383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683486|NCT04699383|Gout Suppressants|gout suppressants|mesh-ancestor
64683487|NCT04699383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64683488|NCT04699383|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64683489|NCT04699383|Antioxidants|antioxidants|mesh-ancestor
64683491|NCT04699383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683492|NCT04699383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64683493|NCT04699383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64683494|NCT04699383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64683495|NCT04699383|Schistosomicides|schistosomicides|mesh-ancestor
64683496|NCT04699383|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64683497|NCT04699383|Anthelmintics|anthelmintics|mesh-ancestor
64683498|NCT05700266|Aspirin|aspirin|mesh-list
64683499|NCT05700266|Rivaroxaban|rivaroxaban|mesh-list
64683500|NCT05700266|Clopidogrel|clopidogrel|mesh-list
64683501|NCT05700266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64683515|NCT05700266|Antipyretics|antipyretics|mesh-ancestor
64683516|NCT05700266|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64683517|NCT05700266|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64683518|NCT05700266|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64683519|NCT05700266|Purinergic Agents|purinergic agents|mesh-ancestor
64683520|NCT05700266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64683521|NCT05700266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64683522|NCT05700266|Antithrombins|antithrombins|mesh-ancestor
64683523|NCT05700266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64683524|NCT05700266|Protease Inhibitors|protease inhibitors|mesh-ancestor
65452111|NCT01130194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452112|NCT03925090|Cisplatin|cisplatin|mesh-list
65452113|NCT03925090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452114|NCT01225744|Oxaliplatin|oxaliplatin|mesh-list
65452115|NCT01225744|Irinotecan|irinotecan|mesh-list
65452116|NCT01225744|Cetuximab|cetuximab|mesh-list
65452117|NCT01225744|Tegafur|tegafur|mesh-list
65452118|NCT01225744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452119|NCT01225744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65452120|NCT01225744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65452121|NCT01225744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452122|NCT01225744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452123|NCT01225744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65452124|NCT01225744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65452125|NCT01225744|Antimetabolites|antimetabolites|mesh-ancestor
65452126|NCT03926806|Vitamins|vitamins|mesh-list
65452127|NCT03926806|Vitamin B Complex|vitamin b complex|mesh-list
65452128|NCT03926806|Micronutrients|micronutrients|mesh-ancestor
65452129|NCT03926806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452130|NCT03926962|Nafithromycin|nafithromycin|mesh-list
65452131|NCT03926962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65452132|NCT03926962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65452133|NCT03926962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65452134|NCT03926962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452135|NCT03926962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452136|NCT01228240|Metformin|metformin|mesh-list
65452137|NCT01228240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65452138|NCT01228240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452139|NCT03919786|Anesthetics|anesthetics|mesh-list
65452140|NCT03919786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65452141|NCT03919786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452142|NCT03924544|Mitomycins|mitomycins|mesh-list
65452143|NCT03924544|Mitomycin|mitomycin|mesh-list
65452144|NCT03924544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65452145|NCT03924544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452146|NCT03924544|Alkylating Agents|alkylating agents|mesh-ancestor
64836785|NCT01615107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683525|NCT05700266|Anticoagulants|anticoagulants|mesh-ancestor
64716418|NCT03383588|Sympathomimetics|sympathomimetics|mesh-ancestor
64716419|NCT03383588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64683527|NCT04340193|Ipilimumab|ipilimumab|mesh-list
65452147|NCT03924544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452148|NCT03924544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65452149|NCT03924544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452150|NCT01131364|Doxorubicin|doxorubicin|mesh-list
65452151|NCT01131364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65452152|NCT01131364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452153|NCT01131364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65452154|NCT01131364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65452155|NCT01131364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452156|NCT01131364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452157|NCT02529202|Dexmedetomidine|dexmedetomidine|mesh-list
65452158|NCT02529202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65452159|NCT02529202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65452160|NCT02529202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452161|NCT02529202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65452162|NCT02529202|Analgesics|analgesics|mesh-ancestor
65452163|NCT02529202|Sensory System Agents|sensory system agents|mesh-ancestor
65452164|NCT02529202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452165|NCT02529202|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64683528|NCT04340193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64683529|NCT04340193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683530|NCT04340193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64683531|NCT04340193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683532|NCT05423132|Ropivacaine|ropivacaine|mesh-list
64683533|NCT05423132|Anesthetics, Local|anesthetics, local|mesh-ancestor
64683534|NCT05423132|Anesthetics|anesthetics|mesh-ancestor
64683535|NCT05423132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64683536|NCT05423132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683537|NCT05423132|Sensory System Agents|sensory system agents|mesh-ancestor
64683538|NCT05423132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64683539|NCT02975219|Bevacizumab|bevacizumab|mesh-list
64683540|NCT02975219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64408897|NCT05339529|Glycine|glycine|mesh-list
64683542|NCT02975219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64683543|NCT02975219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64683544|NCT02975219|Growth Substances|growth substances|mesh-ancestor
64683545|NCT02975219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683546|NCT02975219|Growth Inhibitors|growth inhibitors|mesh-ancestor
64683547|NCT01686451|Simvastatin|simvastatin|mesh-list
64683548|NCT01686451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64683549|NCT01686451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64683550|NCT01686451|Antimetabolites|antimetabolites|mesh-ancestor
64683551|NCT01686451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683552|NCT01686451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64683553|NCT01686451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64683554|NCT01686451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683555|NCT00361751|Fenofibrate|fenofibrate|mesh-list
64683556|NCT00361751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64683557|NCT00361751|Antimetabolites|antimetabolites|mesh-ancestor
64683558|NCT00361751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683559|NCT00361751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64683560|NCT05681702|Aspirin|aspirin|mesh-list
65452166|NCT02529202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65452167|NCT02529202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65452168|NCT02529202|Adrenergic Agents|adrenergic agents|mesh-ancestor
65452169|NCT02529202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65452170|NCT02529202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452171|NCT00154310|Cyclosporine|cyclosporine|mesh-list
65452172|NCT00154310|Mycophenolic Acid|mycophenolic acid|mesh-list
65452173|NCT00154310|Everolimus|everolimus|mesh-list
65452174|NCT00154310|Cyclosporins|cyclosporins|mesh-list
65452175|NCT00154310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452176|NCT00154310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452177|NCT00154310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65452178|NCT00154310|Immunologic Factors|immunologic factors|mesh-ancestor
65201670|NCT02819856|Analgesics|analgesics|mesh-ancestor
65452179|NCT00154310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452180|NCT00154310|Antifungal Agents|antifungal agents|mesh-ancestor
65452181|NCT00154310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65452182|NCT00154310|Dermatologic Agents|dermatologic agents|mesh-ancestor
65452183|NCT00154310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65452184|NCT00154310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65452185|NCT00154310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452186|NCT00154310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64683561|NCT05681702|Clopidogrel|clopidogrel|mesh-list
64683562|NCT05681702|Ticagrelor|ticagrelor|mesh-list
64683573|NCT05681702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64683574|NCT05681702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683575|NCT05681702|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64683576|NCT05681702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64683577|NCT05681702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683578|NCT05681702|Antipyretics|antipyretics|mesh-ancestor
64683579|NCT05681702|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64683580|NCT05681702|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64683581|NCT05681702|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64683582|NCT05681702|Purinergic Agents|purinergic agents|mesh-ancestor
64683583|NCT05681702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64683584|NCT04675983|Fluorouracil|fluorouracil|mesh-list
64683585|NCT04675983|Capecitabine|capecitabine|mesh-list
64683586|NCT04675983|Oxaliplatin|oxaliplatin|mesh-list
64683587|NCT04675983|Ramucirumab|ramucirumab|mesh-list
64683590|NCT04675983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683591|NCT04675983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64683592|NCT04675983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64683593|NCT04675983|Immunologic Factors|immunologic factors|mesh-ancestor
64683594|NCT04675983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683595|NCT03668951|Dexmedetomidine|dexmedetomidine|mesh-list
64683596|NCT03668951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64683597|NCT03668951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64683598|NCT03668951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683599|NCT03668951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64683600|NCT03668951|Analgesics|analgesics|mesh-ancestor
64683601|NCT03668951|Sensory System Agents|sensory system agents|mesh-ancestor
64683602|NCT03668951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64683603|NCT03668951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65452187|NCT00154310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65452188|NCT00154310|Antitubercular Agents|antitubercular agents|mesh-ancestor
65452189|NCT00154310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65452190|NCT03770728|Metformin|metformin|mesh-list
65452191|NCT03770728|Efpeglenatide|efpeglenatide|mesh-list
65452192|NCT03770728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65452193|NCT03770728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452194|NCT01132222|Ibuprofen|ibuprofen|mesh-list
65452195|NCT01132222|Pseudoephedrine|pseudoephedrine|mesh-list
65452196|NCT01132222|Ephedrine|ephedrine|mesh-list
65452197|NCT01132222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65452198|NCT01132222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65452199|NCT01132222|Analgesics|analgesics|mesh-ancestor
64836863|NCT01615614|Rilpivirine|rilpivirine|mesh-list
64683604|NCT03668951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64683605|NCT03668951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64716421|NCT03388268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64716422|NCT03388268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64716423|NCT03393494|Adapalene|adapalene|mesh-list
64716424|NCT03393494|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64683606|NCT03668951|Adrenergic Agents|adrenergic agents|mesh-ancestor
64683607|NCT03668951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64683608|NCT03668951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683609|NCT04889703|Salicylic Acid|salicylic acid|mesh-list
64683610|NCT04889703|Salicylates|salicylates|mesh-list
64683611|NCT04889703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64683612|NCT04889703|Antifungal Agents|antifungal agents|mesh-ancestor
64683613|NCT04889703|Keratolytic Agents|keratolytic agents|mesh-ancestor
64683614|NCT04889703|Dermatologic Agents|dermatologic agents|mesh-ancestor
64683615|NCT04889703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64683616|NCT04889703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64683617|NCT04889703|Analgesics|analgesics|mesh-ancestor
64683618|NCT04889703|Sensory System Agents|sensory system agents|mesh-ancestor
64683619|NCT04889703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64683620|NCT04889703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683621|NCT04889703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64683622|NCT04889703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64683623|NCT04889703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64683624|NCT04889703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683625|NCT04889703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683627|NCT00421811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64683637|NCT03363893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64683638|NCT03363893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683639|NCT03363893|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64683641|NCT03363893|Hormone Antagonists|hormone antagonists|mesh-ancestor
64683642|NCT03363893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64683643|NCT03363893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683644|NCT04659603|Gemcitabine|gemcitabine|mesh-list
64683645|NCT04659603|Maytansine|maytansine|mesh-list
64683646|NCT04659603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64683647|NCT04659603|Antimetabolites|antimetabolites|mesh-ancestor
64683648|NCT04659603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683649|NCT04659603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683650|NCT04659603|Antiviral Agents|antiviral agents|mesh-ancestor
64683651|NCT04659603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64683652|NCT04659603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683653|NCT04659603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64683654|NCT04659603|Immunologic Factors|immunologic factors|mesh-ancestor
64683655|NCT04659603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683656|NCT04659603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64683657|NCT04659603|Tubulin Modulators|tubulin modulators|mesh-ancestor
64683658|NCT04659603|Antimitotic Agents|antimitotic agents|mesh-ancestor
65452200|NCT01132222|Sensory System Agents|sensory system agents|mesh-ancestor
65452201|NCT01132222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452202|NCT01132222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452203|NCT01132222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65452204|NCT01132222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65452205|NCT01132222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65452206|NCT01132222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452207|NCT01132222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452208|NCT01132222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65452209|NCT01132222|Autonomic Agents|autonomic agents|mesh-ancestor
65452210|NCT01132222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64836876|NCT01615627|Treprostinil|treprostinil|mesh-list
64683659|NCT04659603|Mitosis Modulators|mitosis modulators|mesh-ancestor
64683660|NCT01687387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64683661|NCT04642365|Atezolizumab|atezolizumab|mesh-list
64683662|NCT04642365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683663|NCT02403323|Etrolizumab|etrolizumab|mesh-list
64683664|NCT02403323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64683665|NCT02403323|Immunologic Factors|immunologic factors|mesh-ancestor
64683666|NCT02403323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683673|NCT01706263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64683675|NCT01706263|Analgesics|analgesics|mesh-ancestor
64683676|NCT01706263|Sensory System Agents|sensory system agents|mesh-ancestor
64683677|NCT01706263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64683678|NCT01706263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683679|NCT01706263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64683680|NCT01706263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64716425|NCT03393494|Dermatologic Agents|dermatologic agents|mesh-ancestor
64716426|NCT03393494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64716427|NCT03393494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64683681|NCT01706263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64683682|NCT01706263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683683|NCT01706263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683684|NCT05641298|Fusidic Acid|fusidic acid|mesh-list
64683685|NCT05641298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64683686|NCT05641298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64683687|NCT05641298|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64683688|NCT05641298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683689|NCT05641298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683690|NCT04342247|Methyltestosterone|methyltestosterone|mesh-list
64683691|NCT04342247|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64683693|NCT04342247|Testosterone undecanoate|testosterone undecanoate|mesh-list
64683703|NCT05738642|Hemostatics|hemostatics|mesh-ancestor
64683704|NCT05738642|Coagulants|coagulants|mesh-ancestor
64683705|NCT01690663|Dexamethasone|dexamethasone|mesh-list
64683706|NCT01690663|Bupivacaine|bupivacaine|mesh-list
64683707|NCT01690663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64683708|NCT01690663|Antiemetics|antiemetics|mesh-ancestor
64683709|NCT01690663|Autonomic Agents|autonomic agents|mesh-ancestor
64683710|NCT01690663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64683711|NCT01690663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683712|NCT01690663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64683713|NCT01690663|Glucocorticoids|glucocorticoids|mesh-ancestor
64683714|NCT01690663|Hormones|hormones|mesh-ancestor
64683715|NCT01690663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64683716|NCT01690663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64683717|NCT01690663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683718|NCT01690663|Anesthetics, Local|anesthetics, local|mesh-ancestor
64683719|NCT01690663|Anesthetics|anesthetics|mesh-ancestor
64683720|NCT01690663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64683721|NCT01690663|Sensory System Agents|sensory system agents|mesh-ancestor
64683722|NCT05738564|Lidocaine|lidocaine|mesh-list
64683723|NCT05738564|Epinephrine|epinephrine|mesh-list
65452211|NCT01132222|Respiratory System Agents|respiratory system agents|mesh-ancestor
65452212|NCT01132222|Nasal Decongestants|nasal decongestants|mesh-ancestor
65452213|NCT01132222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65452214|NCT01132222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65452215|NCT01132222|Sympathomimetics|sympathomimetics|mesh-ancestor
65452216|NCT01132222|Adrenergic Agents|adrenergic agents|mesh-ancestor
65452217|NCT01132222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65452218|NCT03926182|Aflutinib|aflutinib|mesh-list
65452219|NCT03926182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65452220|NCT03926182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452221|NCT03926182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452222|NCT01130506|Cytarabine|cytarabine|mesh-list
65452223|NCT01130506|Decitabine|decitabine|mesh-list
65452224|NCT01130506|Vorinostat|vorinostat|mesh-list
65452225|NCT01130506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65452226|NCT01130506|Antimetabolites|antimetabolites|mesh-ancestor
65452227|NCT01130506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452228|NCT01130506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452229|NCT01130506|Antiviral Agents|antiviral agents|mesh-ancestor
65452230|NCT01130506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64683724|NCT05738564|Oxymetazoline|oxymetazoline|mesh-list
64683725|NCT05738564|Anesthetics, Local|anesthetics, local|mesh-ancestor
64683726|NCT05738564|Anesthetics|anesthetics|mesh-ancestor
64683727|NCT05738564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64683728|NCT05738564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683729|NCT05738564|Sensory System Agents|sensory system agents|mesh-ancestor
64683730|NCT05738564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64683731|NCT05738564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64683732|NCT05738564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64683733|NCT05738564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64683734|NCT05738564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64683735|NCT05738564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683736|NCT05738564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64683737|NCT05738564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64683738|NCT05738564|Adrenergic Agents|adrenergic agents|mesh-ancestor
64683739|NCT05738564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64683740|NCT05738564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64683741|NCT05738564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64683742|NCT05738564|Autonomic Agents|autonomic agents|mesh-ancestor
64683746|NCT05738564|Sympathomimetics|sympathomimetics|mesh-ancestor
64683747|NCT05738564|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64683748|NCT05738564|Nasal Decongestants|nasal decongestants|mesh-ancestor
64683750|NCT05343572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64683751|NCT05343572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64683752|NCT05343572|Antiviral Agents|antiviral agents|mesh-ancestor
64683753|NCT05343572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64683754|NCT04350086|Dexmedetomidine|dexmedetomidine|mesh-list
64683755|NCT04350086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64683756|NCT04350086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64683757|NCT04350086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683758|NCT04350086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64683759|NCT04350086|Analgesics|analgesics|mesh-ancestor
64716428|NCT03393494|Analgesics|analgesics|mesh-ancestor
64716429|NCT03393494|Sensory System Agents|sensory system agents|mesh-ancestor
64716430|NCT03393494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452231|NCT01130506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65452232|NCT01130506|Immunologic Factors|immunologic factors|mesh-ancestor
65452233|NCT01130506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452234|NCT01130506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452235|NCT01130506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65452236|NCT01130662|Decitabine|decitabine|mesh-list
65452237|NCT01130662|Midostaurin|midostaurin|mesh-list
65452238|NCT01130662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65452239|NCT01130662|Antimetabolites|antimetabolites|mesh-ancestor
65452240|NCT01130662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452241|NCT01130662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452242|NCT01130662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452243|NCT01130662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65452244|NCT03919552|Cisplatin|cisplatin|mesh-list
65452245|NCT03919552|Carboplatin|carboplatin|mesh-list
65452246|NCT03919552|Docetaxel|docetaxel|mesh-list
65452247|NCT03919552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452248|NCT03919552|Tubulin Modulators|tubulin modulators|mesh-ancestor
65452249|NCT03919552|Antimitotic Agents|antimitotic agents|mesh-ancestor
65452250|NCT03919552|Mitosis Modulators|mitosis modulators|mesh-ancestor
65452251|NCT03919552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716431|NCT03393494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716432|NCT03393494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64716433|NCT03393494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64683760|NCT04350086|Sensory System Agents|sensory system agents|mesh-ancestor
64683771|NCT05738408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64683772|NCT05738408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683774|NCT05738408|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64683775|NCT05738408|Cholinergic Agents|cholinergic agents|mesh-ancestor
64683776|NCT05738408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64683777|NCT05738408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683778|NCT03414229|Pembrolizumab|pembrolizumab|mesh-list
64683779|NCT03414229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64683780|NCT03414229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683781|NCT01352117|Tenofovir|tenofovir|mesh-list
64683782|NCT01352117|Emtricitabine|emtricitabine|mesh-list
64683783|NCT01352117|Efavirenz|efavirenz|mesh-list
64683784|NCT01352117|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64683785|NCT01352117|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64683786|NCT01352117|Etoposide|etoposide|mesh-list
64683787|NCT01352117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64683788|NCT01352117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683789|NCT01352117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64683790|NCT01352117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64683791|NCT01352117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683792|NCT01352117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683793|NCT01352117|Antiviral Agents|antiviral agents|mesh-ancestor
64683794|NCT01352117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64683795|NCT01352117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64683796|NCT01352117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64683797|NCT01352117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64683798|NCT01352117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65452252|NCT03925714|Metformin|metformin|mesh-list
65452253|NCT03925714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65452254|NCT03925714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452255|NCT01228552|Ketoprofen|ketoprofen|mesh-list
65452256|NCT01228552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65452258|NCT01228552|Analgesics|analgesics|mesh-ancestor
65452259|NCT01228552|Sensory System Agents|sensory system agents|mesh-ancestor
65452260|NCT01228552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452261|NCT01228552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452262|NCT01228552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65452263|NCT01228552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65452264|NCT01228552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65452265|NCT01228552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452266|NCT01228552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452267|NCT03919084|Nicotine|nicotine|mesh-list
65452268|NCT03919084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65452269|NCT03919084|Autonomic Agents|autonomic agents|mesh-ancestor
65452270|NCT03919084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452271|NCT03919084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683799|NCT01352117|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64683800|NCT01352117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64683801|NCT01352117|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64683802|NCT01352117|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64683803|NCT01352117|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64683804|NCT01352117|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64683805|NCT03379207|Dimercaprol|dimercaprol|mesh-list
64683806|NCT03379207|Chelating Agents|chelating agents|mesh-ancestor
64683807|NCT03379207|Sequestering Agents|sequestering agents|mesh-ancestor
64683808|NCT03379207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683809|NCT03369223|Nivolumab|nivolumab|mesh-list
64683810|NCT03369223|Ipilimumab|ipilimumab|mesh-list
64683811|NCT03369223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64683812|NCT03369223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683813|NCT03369223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64683814|NCT03369223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683815|NCT02974439|Amlodipine|amlodipine|mesh-list
64683816|NCT02974439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64683817|NCT02974439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64683819|NCT02974439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683820|NCT02974439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64683830|NCT03340727|Caffeine citrate|caffeine citrate|mesh-list
64683831|NCT03340727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683832|NCT03340727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64683833|NCT03340727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683834|NCT03340727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64683835|NCT03340727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683836|NCT03340727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64716435|NCT03588806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64716436|NCT03588806|Narcotics|narcotics|mesh-ancestor
64716437|NCT03588806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64716438|NCT03588806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716439|NCT03588806|Analgesics|analgesics|mesh-ancestor
64716440|NCT03588806|Sensory System Agents|sensory system agents|mesh-ancestor
65452272|NCT03919084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65452273|NCT03919084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65452274|NCT03919084|Cholinergic Agents|cholinergic agents|mesh-ancestor
65452275|NCT03919084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65452276|NCT03919084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452277|NCT03923842|Denosumab|denosumab|mesh-list
65452278|NCT03923842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65452279|NCT03923842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452280|NCT01132768|Atenolol|atenolol|mesh-list
65452281|NCT01132768|Olmesartan|olmesartan|mesh-list
65452282|NCT01132768|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65452283|NCT01132768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65452284|NCT01132768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65452285|NCT01132768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65452286|NCT01132768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452287|NCT01132768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65452288|NCT01132768|Sympatholytics|sympatholytics|mesh-ancestor
65452289|NCT01132768|Autonomic Agents|autonomic agents|mesh-ancestor
65452290|NCT01132768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452291|NCT01132768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452292|NCT01132768|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65452293|NCT01132768|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65452294|NCT01132768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64716441|NCT03588806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716442|NCT02176356|Bimatoprost|bimatoprost|mesh-list
64324722|NCT01188187|Glucocorticoids|glucocorticoids|mesh-ancestor
64683837|NCT03340727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64683838|NCT03340727|Purinergic Agents|purinergic agents|mesh-ancestor
64683839|NCT03340727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64683840|NCT04612179|Sirolimus|sirolimus|mesh-list
64683841|NCT04612179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64683842|NCT04612179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64683843|NCT04612179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64683844|NCT04612179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683845|NCT04612179|Antifungal Agents|antifungal agents|mesh-ancestor
64683846|NCT04612179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64683847|NCT04612179|Immunologic Factors|immunologic factors|mesh-ancestor
64683848|NCT04612179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683849|NCT05578820|Ganciclovir|ganciclovir|mesh-list
64683850|NCT05578820|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64683851|NCT05578820|Antiviral Agents|antiviral agents|mesh-ancestor
64683852|NCT05578820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64683853|NCT05578820|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64683854|NCT05578820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683855|NCT05578820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683856|NCT01707043|Calcitriol|calcitriol|mesh-list
64683857|NCT01707043|Betamethasone|betamethasone|mesh-list
64683858|NCT01707043|Betamethasone Valerate|betamethasone valerate|mesh-list
64683859|NCT01707043|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64683860|NCT01707043|Betamethasone benzoate|betamethasone benzoate|mesh-list
64683861|NCT01707043|Calcipotriene|calcipotriene|mesh-list
65452295|NCT01132768|Adrenergic Agents|adrenergic agents|mesh-ancestor
65452296|NCT01132768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65452297|NCT01230034|Ramipril|ramipril|mesh-list
65452298|NCT01230034|Imidapril|imidapril|mesh-list
65452299|NCT01230034|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65452300|NCT01230034|Protease Inhibitors|protease inhibitors|mesh-ancestor
65452301|NCT01230034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452302|NCT01230034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452303|NCT01230034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65452304|NCT03918616|Dopamine|dopamine|mesh-list
65452305|NCT03918616|Memantine|memantine|mesh-list
65452306|NCT03918616|Dopamine Agonists|dopamine agonists|mesh-list
65452307|NCT03918616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65452308|NCT03918616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65452309|NCT03918616|Dopamine Agents|dopamine agents|mesh-ancestor
65452310|NCT03918616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65452311|NCT03918616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452312|NCT03918616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683863|NCT01707043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64683864|NCT01707043|Glucocorticoids|glucocorticoids|mesh-ancestor
64683865|NCT01707043|Hormones|hormones|mesh-ancestor
64683866|NCT01707043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64683867|NCT01707043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683868|NCT01707043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64683869|NCT01707043|Respiratory System Agents|respiratory system agents|mesh-ancestor
64683870|NCT01707043|Dermatologic Agents|dermatologic agents|mesh-ancestor
64683871|NCT01707043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64683872|NCT01707043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64683873|NCT01707043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64683874|NCT01707043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683875|NCT01707043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64683876|NCT01707043|Vitamins|vitamins|mesh-ancestor
64683877|NCT01707043|Micronutrients|micronutrients|mesh-ancestor
64683878|NCT01707043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64683879|NCT05559164|Atorvastatin|atorvastatin|mesh-list
64683880|NCT05559164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64683881|NCT05559164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64683885|NCT05559164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64683887|NCT04258839|Brexpiprazole|brexpiprazole|mesh-list
64683888|NCT04258839|Serotonin Agents|serotonin agents|mesh-ancestor
64683889|NCT04258839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64683890|NCT04258839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683891|NCT04258839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683892|NCT04258839|Dopamine Agonists|dopamine agonists|mesh-ancestor
64683893|NCT04258839|Dopamine Agents|dopamine agents|mesh-ancestor
64683897|NCT01708525|Protective Agents|protective agents|mesh-ancestor
64716443|NCT02176356|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64716444|NCT02176356|Botulinum Toxins|botulinum toxins|mesh-list
64716445|NCT02176356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64716446|NCT02176356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64716447|NCT02176356|Hyaluronic Acid|hyaluronic acid|mesh-list
64716448|NCT02176356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64716449|NCT02176356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64716450|NCT02176356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64683898|NCT01708525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683899|NCT03634917|Calcium, Dietary|calcium, dietary|mesh-list
64683900|NCT03634917|Acamprosate|acamprosate|mesh-list
64683901|NCT03634917|Calcium Carbonate|calcium carbonate|mesh-list
65452313|NCT03918616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65452314|NCT03918616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65452315|NCT03918616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65452316|NCT03918616|Sympathomimetics|sympathomimetics|mesh-ancestor
65452317|NCT03918616|Autonomic Agents|autonomic agents|mesh-ancestor
65452318|NCT03918616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452319|NCT03918616|Protective Agents|protective agents|mesh-ancestor
65452320|NCT01228630|Loratadine|loratadine|mesh-list
65452321|NCT01228630|Fexofenadine|fexofenadine|mesh-list
65452322|NCT01228630|Pseudoephedrine|pseudoephedrine|mesh-list
65452323|NCT01228630|Ephedrine|ephedrine|mesh-list
65452324|NCT01228630|Antipruritics|antipruritics|mesh-ancestor
65452325|NCT01228630|Dermatologic Agents|dermatologic agents|mesh-ancestor
65452326|NCT01228630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65452327|NCT01228630|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65452328|NCT01228630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65452329|NCT01228630|Histamine Antagonists|histamine antagonists|mesh-ancestor
65452330|NCT01228630|Histamine Agents|histamine agents|mesh-ancestor
65452331|NCT01228630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65452332|NCT01228630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452333|NCT01228630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683902|NCT03634917|Calcium|calcium|mesh-list
64683903|NCT03634917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64683904|NCT03634917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683905|NCT03634917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64683906|NCT03634917|Antacids|antacids|mesh-ancestor
64683907|NCT03634917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683908|NCT03634917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64683909|NCT03634917|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64683910|NCT05058872|Levonorgestrel|levonorgestrel|mesh-list
64683911|NCT05058872|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64683912|NCT05058872|Estradiol|estradiol|mesh-list
64683913|NCT05058872|Estrogens|estrogens|mesh-ancestor
64683914|NCT05058872|Hormones|hormones|mesh-ancestor
64683915|NCT05058872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64683916|NCT05058872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683917|NCT05058872|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64683918|NCT05058872|Contraceptive Agents|contraceptive agents|mesh-ancestor
64683919|NCT05058872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64683920|NCT05058872|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64683921|NCT05058872|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64683922|NCT05058872|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64683923|NCT05058872|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64683924|NCT04595565|Carboplatin|carboplatin|mesh-list
64683925|NCT04595565|Capecitabine|capecitabine|mesh-list
64683926|NCT04595565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683927|NCT04595565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64683928|NCT04595565|Antimetabolites|antimetabolites|mesh-ancestor
64683929|NCT04595565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683930|NCT02284880|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64683931|NCT02284880|Anticonvulsants|anticonvulsants|mesh-ancestor
64683932|NCT02284880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64683933|NCT02284880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64683934|NCT02284880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65452334|NCT01228630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65452335|NCT01228630|Autonomic Agents|autonomic agents|mesh-ancestor
65452336|NCT01228630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452337|NCT01228630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65452338|NCT01228630|Respiratory System Agents|respiratory system agents|mesh-ancestor
65452339|NCT01228630|Nasal Decongestants|nasal decongestants|mesh-ancestor
65452340|NCT01228630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65452341|NCT01228630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65452342|NCT01228630|Sympathomimetics|sympathomimetics|mesh-ancestor
65452343|NCT01228630|Adrenergic Agents|adrenergic agents|mesh-ancestor
65452344|NCT01134406|Hylan|hylan|mesh-list
65452345|NCT01134406|Viscosupplements|viscosupplements|mesh-ancestor
65452346|NCT01134406|Protective Agents|protective agents|mesh-ancestor
65452347|NCT01134406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452348|NCT01231828|Lactulose|lactulose|mesh-list
65452349|NCT01231828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65452350|NCT03923218|Vitamin D|vitamin d|mesh-list
65452351|NCT03923218|Cholecalciferol|cholecalciferol|mesh-list
65452352|NCT03923218|Vitamins|vitamins|mesh-ancestor
65452353|NCT03923218|Micronutrients|micronutrients|mesh-ancestor
65452354|NCT03923218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452355|NCT03923218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65452356|NCT03923218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64683935|NCT02284880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683936|NCT03614949|Atezolizumab|atezolizumab|mesh-list
64683937|NCT03614949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683938|NCT03538899|Busulfan|busulfan|mesh-list
64683939|NCT03538899|Alkylating Agents|alkylating agents|mesh-ancestor
64683950|NCT04230681|Narcotics|narcotics|mesh-ancestor
64683951|NCT04230681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64683952|NCT04230681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683953|NCT04230681|Analgesics|analgesics|mesh-ancestor
64683954|NCT04230681|Sensory System Agents|sensory system agents|mesh-ancestor
64683955|NCT04230681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64683956|NCT04230681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64683957|NCT04230681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64683958|NCT04230681|Anesthetics, General|anesthetics, general|mesh-ancestor
64683959|NCT04230681|Anesthetics|anesthetics|mesh-ancestor
64683960|NCT02324543|Gemcitabine|gemcitabine|mesh-list
64683961|NCT02324543|Docetaxel|docetaxel|mesh-list
64683962|NCT02324543|Capecitabine|capecitabine|mesh-list
64683963|NCT02324543|Irinotecan|irinotecan|mesh-list
64683964|NCT02324543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683965|NCT02324543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64683966|NCT02324543|Antimetabolites|antimetabolites|mesh-ancestor
64716451|NCT02176356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716454|NCT02176356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716456|NCT02176356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716457|NCT02176356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64324737|NCT05478356|Autonomic Agents|autonomic agents|mesh-ancestor
64683967|NCT02324543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683968|NCT02324543|Antiviral Agents|antiviral agents|mesh-ancestor
64683969|NCT02324543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64683970|NCT02324543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452357|NCT03923140|Tranilast|tranilast|mesh-list
65452358|NCT03923140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65452359|NCT03923140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65452360|NCT03923140|Analgesics|analgesics|mesh-ancestor
65452361|NCT03923140|Sensory System Agents|sensory system agents|mesh-ancestor
65452362|NCT03923140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452363|NCT03923140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452364|NCT03923140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65452365|NCT03923140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65452366|NCT03923140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65452367|NCT03923140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64837026|NCT01616732|Hormones|hormones|mesh-ancestor
64683971|NCT02324543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64683972|NCT02324543|Immunologic Factors|immunologic factors|mesh-ancestor
64683973|NCT02324543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683974|NCT02324543|Tubulin Modulators|tubulin modulators|mesh-ancestor
64683975|NCT02324543|Antimitotic Agents|antimitotic agents|mesh-ancestor
64683976|NCT02324543|Mitosis Modulators|mitosis modulators|mesh-ancestor
64683977|NCT02324543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64683978|NCT02324543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64683979|NCT01708603|Ustekinumab|ustekinumab|mesh-list
64683980|NCT01708603|Brodalumab|brodalumab|mesh-list
64683981|NCT01708603|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64683982|NCT01708603|Dermatologic Agents|dermatologic agents|mesh-ancestor
64683983|NCT01708603|Immunologic Factors|immunologic factors|mesh-ancestor
64683984|NCT01708603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683985|NCT03523221|Dexamethasone|dexamethasone|mesh-list
64683986|NCT03523221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64683987|NCT03523221|Antiemetics|antiemetics|mesh-ancestor
64683988|NCT03523221|Autonomic Agents|autonomic agents|mesh-ancestor
64683989|NCT03523221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64683990|NCT03523221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683991|NCT03523221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64683992|NCT03523221|Glucocorticoids|glucocorticoids|mesh-ancestor
64683993|NCT03523221|Hormones|hormones|mesh-ancestor
64683994|NCT03523221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64683995|NCT03523221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64683996|NCT03523221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683997|NCT03337919|Nivolumab|nivolumab|mesh-list
64683998|NCT03337919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64683999|NCT03337919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684000|NCT03337919|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64684001|NCT03337919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684002|NCT03590171|Bortezomib|bortezomib|mesh-list
64684003|NCT03590171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684004|NCT03467373|Prednisone|prednisone|mesh-list
64684013|NCT03467373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64684014|NCT03467373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64684015|NCT03467373|Alkylating Agents|alkylating agents|mesh-ancestor
64684016|NCT03467373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684017|NCT03467373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684018|NCT03467373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64684019|NCT03467373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64684020|NCT03467373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64684021|NCT03467373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64684022|NCT03467373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64684023|NCT03467373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684024|NCT03467373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64684027|NCT03467373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64684028|NCT03467373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64684029|NCT03467373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64684030|NCT03467373|Tubulin Modulators|tubulin modulators|mesh-ancestor
65452368|NCT03923140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452369|NCT03923140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65452370|NCT03923140|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65452371|NCT03923140|Histamine Antagonists|histamine antagonists|mesh-ancestor
65452372|NCT03923140|Histamine Agents|histamine agents|mesh-ancestor
65452373|NCT03923140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65452374|NCT03923140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65452375|NCT03923140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65452376|NCT01133080|Minocycline|minocycline|mesh-list
65452377|NCT01133080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65452378|NCT01133080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65452379|NCT01230580|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65452380|NCT01230580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
65452381|NCT01230580|Protease Inhibitors|protease inhibitors|mesh-list
65452382|NCT01230580|Antiviral Agents|antiviral agents|mesh-ancestor
65452383|NCT01230580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65452384|NCT01230580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452385|NCT01230580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452386|NCT01230580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65452387|NCT01230580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65452388|NCT01585792|Glimepiride|glimepiride|mesh-list
65452389|NCT01585792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65452390|NCT01585792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65452391|NCT01585792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452392|NCT01585792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65452393|NCT01585792|Immunologic Factors|immunologic factors|mesh-ancestor
65452394|NCT01134484|Thalidomide|thalidomide|mesh-list
65452395|NCT01134484|Dexamethasone|dexamethasone|mesh-list
64684031|NCT03467373|Antimitotic Agents|antimitotic agents|mesh-ancestor
64684032|NCT03467373|Mitosis Modulators|mitosis modulators|mesh-ancestor
64684033|NCT00362765|Metformin|metformin|mesh-list
64716458|NCT02176356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64455781|NCT01915303|Cabergoline|cabergoline|mesh-list
64716459|NCT02176356|Immunologic Factors|immunologic factors|mesh-ancestor
64716460|NCT02176356|Viscosupplements|viscosupplements|mesh-ancestor
64716461|NCT02176356|Protective Agents|protective agents|mesh-ancestor
64716462|NCT03591068|Fluticasone|fluticasone|mesh-list
64684034|NCT00362765|Fenofibrate|fenofibrate|mesh-list
64684035|NCT00362765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64684036|NCT00362765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684041|NCT03430011|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64684042|NCT03430011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64684043|NCT04174365|Brexpiprazole|brexpiprazole|mesh-list
64684044|NCT04174365|Serotonin Agents|serotonin agents|mesh-ancestor
64684045|NCT04174365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64684046|NCT04174365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684047|NCT04174365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684048|NCT04174365|Dopamine Agonists|dopamine agonists|mesh-ancestor
64684049|NCT04174365|Dopamine Agents|dopamine agents|mesh-ancestor
65452396|NCT01134484|Bortezomib|bortezomib|mesh-list
65452397|NCT01134484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65452398|NCT01134484|Antiemetics|antiemetics|mesh-ancestor
65452399|NCT01134484|Autonomic Agents|autonomic agents|mesh-ancestor
65452400|NCT01134484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452401|NCT01134484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452402|NCT01134484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65452403|NCT01134484|Glucocorticoids|glucocorticoids|mesh-ancestor
65452404|NCT01134484|Hormones|hormones|mesh-ancestor
65452405|NCT01134484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65452406|NCT01134484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65452407|NCT01134484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452408|NCT01134484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65452409|NCT01134484|Immunologic Factors|immunologic factors|mesh-ancestor
65452410|NCT01134484|Leprostatic Agents|leprostatic agents|mesh-ancestor
65452411|NCT01134484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65452412|NCT01134484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65452413|NCT01134484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65452414|NCT01134484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65452415|NCT01134484|Growth Substances|growth substances|mesh-ancestor
65452416|NCT01134484|Growth Inhibitors|growth inhibitors|mesh-ancestor
64684050|NCT03300947|Lorazepam|lorazepam|mesh-list
64684051|NCT03300947|Psilocybin|psilocybin|mesh-list
64684052|NCT03300947|Hallucinogens|hallucinogens|mesh-ancestor
64684053|NCT03300947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684054|NCT03300947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64684055|NCT03300947|Anticonvulsants|anticonvulsants|mesh-ancestor
64684056|NCT03300947|Antiemetics|antiemetics|mesh-ancestor
64684057|NCT03300947|Autonomic Agents|autonomic agents|mesh-ancestor
64684058|NCT03300947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64684059|NCT03300947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64684060|NCT03300947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64684061|NCT03300947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64684062|NCT03300947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64684063|NCT03300947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64684064|NCT03300947|GABA Modulators|gaba modulators|mesh-ancestor
64684065|NCT03300947|GABA Agents|gaba agents|mesh-ancestor
64684066|NCT03300947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64684067|NCT03300947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684068|NCT03543839|Belimumab|belimumab|mesh-list
64684069|NCT03543839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64684070|NCT03543839|Immunologic Factors|immunologic factors|mesh-ancestor
64684071|NCT03543839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684072|NCT04173507|Avelumab|avelumab|mesh-list
64684073|NCT04173507|Talazoparib|talazoparib|mesh-list
64684074|NCT04173507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64684079|NCT04173507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684081|NCT04173507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684082|NCT05033756|Pembrolizumab|pembrolizumab|mesh-list
64684083|NCT05033756|Olaparib|olaparib|mesh-list
64684084|NCT05033756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64684085|NCT05033756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684086|NCT05033756|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64684087|NCT05033756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452417|NCT01133470|Fexofenadine|fexofenadine|mesh-list
65452418|NCT01133470|Pseudoephedrine|pseudoephedrine|mesh-list
65452419|NCT01133470|Ephedrine|ephedrine|mesh-list
65452420|NCT01133470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65452421|NCT01133470|Autonomic Agents|autonomic agents|mesh-ancestor
65452422|NCT01133470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452423|NCT01133470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452424|NCT01133470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65452425|NCT01133470|Respiratory System Agents|respiratory system agents|mesh-ancestor
65452426|NCT01133470|Nasal Decongestants|nasal decongestants|mesh-ancestor
65452427|NCT01133470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65452428|NCT01133470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65452429|NCT01133470|Sympathomimetics|sympathomimetics|mesh-ancestor
65452430|NCT01133470|Adrenergic Agents|adrenergic agents|mesh-ancestor
64837083|NCT01617135|Dopamine Agents|dopamine agents|mesh-ancestor
64684088|NCT05033756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684089|NCT03532295|Bevacizumab|bevacizumab|mesh-list
64684090|NCT03532295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64684091|NCT03532295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684092|NCT03532295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64684093|NCT03532295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64684094|NCT03532295|Growth Substances|growth substances|mesh-ancestor
64684095|NCT03532295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684096|NCT03532295|Growth Inhibitors|growth inhibitors|mesh-ancestor
64684097|NCT03522077|Hemostatics|hemostatics|mesh-list
64684098|NCT03522077|Coagulants|coagulants|mesh-ancestor
64684099|NCT02980562|Bisacodyl|bisacodyl|mesh-list
64684100|NCT02980562|Cathartics|cathartics|mesh-ancestor
64684101|NCT02980562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64684102|NCT02980562|Laxatives|laxatives|mesh-ancestor
64684103|NCT03266393|Tacrolimus|tacrolimus|mesh-list
64684104|NCT03266393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64716464|NCT03591068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64716465|NCT03591068|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64716466|NCT03591068|Autonomic Agents|autonomic agents|mesh-ancestor
64716467|NCT03591068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64684105|NCT03266393|Immunologic Factors|immunologic factors|mesh-ancestor
64684106|NCT03266393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684107|NCT03266393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64684108|NCT03266393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684109|NCT03266393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684114|NCT03246347|Mitosis Modulators|mitosis modulators|mesh-ancestor
64684115|NCT03246347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684116|NCT03223103|Poly ICLC|poly iclc|mesh-list
64684117|NCT03223103|Interferon Inducers|interferon inducers|mesh-ancestor
64684118|NCT03223103|Immunologic Factors|immunologic factors|mesh-ancestor
64684119|NCT03223103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684120|NCT00421967|Ketorolac|ketorolac|mesh-list
64684121|NCT00421967|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64684122|NCT00421967|Epinephrine|epinephrine|mesh-list
64684123|NCT00421967|Racepinephrine|racepinephrine|mesh-list
64684124|NCT00421967|Ropivacaine|ropivacaine|mesh-list
64684125|NCT00421967|Epinephryl borate|epinephryl borate|mesh-list
64684126|NCT00421967|Anesthetics, Local|anesthetics, local|mesh-ancestor
64684127|NCT00421967|Anesthetics|anesthetics|mesh-ancestor
64684128|NCT00421967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64684144|NCT00421967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64684145|NCT00421967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64684146|NCT00421967|Autonomic Agents|autonomic agents|mesh-ancestor
64684147|NCT00421967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64684148|NCT00421967|Respiratory System Agents|respiratory system agents|mesh-ancestor
64684149|NCT00421967|Mydriatics|mydriatics|mesh-ancestor
64684150|NCT00421967|Sympathomimetics|sympathomimetics|mesh-ancestor
65452431|NCT01133470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65452432|NCT01133470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452433|NCT01133470|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65452434|NCT01133470|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65452435|NCT01133470|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65452436|NCT01133470|Histamine Antagonists|histamine antagonists|mesh-ancestor
65452437|NCT01133470|Histamine Agents|histamine agents|mesh-ancestor
65452438|NCT01134718|Simeprevir|simeprevir|mesh-list
65452439|NCT01134718|Antiviral Agents|antiviral agents|mesh-ancestor
65452440|NCT01134718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65452441|NCT01134718|Protease Inhibitors|protease inhibitors|mesh-ancestor
65452442|NCT01134718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452443|NCT01134718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452444|NCT03917758|Dapagliflozin|dapagliflozin|mesh-list
65452445|NCT03917758|Empagliflozin|empagliflozin|mesh-list
65452446|NCT03917758|Canagliflozin|canagliflozin|mesh-list
65452447|NCT03917758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65452448|NCT03917758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452449|NCT03917758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65452450|NCT03917758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452451|NCT01230736|Timolol|timolol|mesh-list
65452452|NCT01230736|Travoprost|travoprost|mesh-list
65452453|NCT01230736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65452454|NCT01230736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65452455|NCT01230736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65452456|NCT01230736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65452457|NCT01230736|Adrenergic Agents|adrenergic agents|mesh-ancestor
65452458|NCT01230736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64837095|NCT01617200|Autonomic Agents|autonomic agents|mesh-ancestor
64684151|NCT00421967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64684152|NCT03209687|Menotropins|menotropins|mesh-list
64684153|NCT03209687|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64684154|NCT03209687|Fertility Agents|fertility agents|mesh-ancestor
64684155|NCT03209687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64684156|NCT03209687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684157|NCT04997798|Trastuzumab|trastuzumab|mesh-list
64684158|NCT04997798|Exemestane|exemestane|mesh-list
64684159|NCT04997798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64684160|NCT04997798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684161|NCT04997798|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64684162|NCT04997798|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64684163|NCT04997798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684164|NCT04997798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684165|NCT04997798|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64684166|NCT04997798|Hormone Antagonists|hormone antagonists|mesh-ancestor
64684167|NCT04997798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65452459|NCT01230736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452460|NCT01230736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452461|NCT01230736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65452462|NCT01230736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65452463|NCT01133548|Methyltestosterone|methyltestosterone|mesh-list
65452464|NCT01133548|Testosterone|testosterone|mesh-list
65452465|NCT01133548|Testosterone undecanoate|testosterone undecanoate|mesh-list
65452466|NCT01133548|Testosterone enanthate|testosterone enanthate|mesh-list
65452467|NCT01133548|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65452468|NCT01133548|Androgens|androgens|mesh-ancestor
65452469|NCT01133548|Hormones|hormones|mesh-ancestor
65452470|NCT01133548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65452471|NCT01133548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452472|NCT01133548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65452473|NCT01133548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684168|NCT04997798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684169|NCT00362531|Prednisone|prednisone|mesh-list
64684170|NCT00362531|Tacrolimus|tacrolimus|mesh-list
64684171|NCT00362531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64684172|NCT00362531|Glucocorticoids|glucocorticoids|mesh-ancestor
64684173|NCT00362531|Hormones|hormones|mesh-ancestor
64684174|NCT00362531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64684201|NCT02422615|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64684202|NCT02422615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64684203|NCT02422615|Hormone Antagonists|hormone antagonists|mesh-ancestor
64684204|NCT02422615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64684205|NCT02422615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684206|NCT04964960|Paclitaxel|paclitaxel|mesh-list
64684207|NCT04964960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64684208|NCT04964960|Carboplatin|carboplatin|mesh-list
64684209|NCT04964960|Pembrolizumab|pembrolizumab|mesh-list
64684210|NCT04964960|Pemetrexed|pemetrexed|mesh-list
64684211|NCT04964960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64684212|NCT04964960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684213|NCT04964960|Tubulin Modulators|tubulin modulators|mesh-ancestor
64684214|NCT04964960|Antimitotic Agents|antimitotic agents|mesh-ancestor
64324753|NCT01186861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716468|NCT03591068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716469|NCT03591068|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64716470|NCT03591068|Respiratory System Agents|respiratory system agents|mesh-ancestor
64716471|NCT03591068|Dermatologic Agents|dermatologic agents|mesh-ancestor
64716472|NCT03591068|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64716473|NCT03395990|Chloroprocaine|chloroprocaine|mesh-list
64716474|NCT03395990|Procaine|procaine|mesh-list
64716475|NCT03395990|Anesthetics, Local|anesthetics, local|mesh-ancestor
64716476|NCT03395990|Anesthetics|anesthetics|mesh-ancestor
64684218|NCT04964960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684219|NCT04964960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64684220|NCT04964960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64684221|NCT05114486|Pilocarpine|pilocarpine|mesh-list
64684228|NCT05114486|Cholinergic Agents|cholinergic agents|mesh-ancestor
64684229|NCT05114486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64684230|NCT05114486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684231|NCT03200847|Pembrolizumab|pembrolizumab|mesh-list
64684232|NCT03200847|Tretinoin|tretinoin|mesh-list
64684233|NCT03200847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64684235|NCT03200847|Keratolytic Agents|keratolytic agents|mesh-ancestor
64684236|NCT03200847|Dermatologic Agents|dermatologic agents|mesh-ancestor
64684237|NCT02259517|Guanfacine|guanfacine|mesh-list
64684238|NCT02259517|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65452474|NCT01133548|Anabolic Agents|anabolic agents|mesh-ancestor
65452475|NCT03917134|Metronidazole|metronidazole|mesh-list
65452476|NCT03917134|Cephalosporins|cephalosporins|mesh-list
65452477|NCT03917134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65452478|NCT03917134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65452479|NCT03917134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65452480|NCT03917134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65201971|NCT00811057|Anesthetics|anesthetics|mesh-ancestor
65452481|NCT01232140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65452482|NCT01232140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65452483|NCT01231126|Misoprostol|misoprostol|mesh-list
65452484|NCT01231126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65452485|NCT01231126|Abortifacient Agents|abortifacient agents|mesh-ancestor
65452486|NCT01231126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65452487|NCT01231126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452488|NCT01231126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65452489|NCT01231126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65452490|NCT01231126|Oxytocics|oxytocics|mesh-ancestor
65452491|NCT03769090|Budesonide|budesonide|mesh-list
65452492|NCT03769090|Albuterol|albuterol|mesh-list
65452493|NCT03769090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65452494|NCT03769090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65452495|NCT03769090|Autonomic Agents|autonomic agents|mesh-ancestor
65452496|NCT03769090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452497|NCT03769090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684239|NCT02259517|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64684240|NCT02259517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684241|NCT02259517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64684242|NCT02259517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64684243|NCT02259517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64684244|NCT02259517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684245|NCT02259517|Dopamine Agents|dopamine agents|mesh-ancestor
64684246|NCT02259517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64684247|NCT02259517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64684248|NCT02259517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64684249|NCT02259517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64684250|NCT02259517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64684251|NCT02259517|Adrenergic Agents|adrenergic agents|mesh-ancestor
64684252|NCT04358588|Nitric Oxide|nitric oxide|mesh-list
64684253|NCT04358588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64684254|NCT04358588|Autonomic Agents|autonomic agents|mesh-ancestor
64684255|NCT04358588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64684256|NCT04358588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684257|NCT04358588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64684258|NCT04358588|Respiratory System Agents|respiratory system agents|mesh-ancestor
64684259|NCT04358588|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64684260|NCT04358588|Antioxidants|antioxidants|mesh-ancestor
64684261|NCT04358588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684262|NCT04358588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64684263|NCT04358588|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64684264|NCT04358588|Vasodilator Agents|vasodilator agents|mesh-ancestor
65452498|NCT03769090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65452499|NCT03769090|Respiratory System Agents|respiratory system agents|mesh-ancestor
65452500|NCT03769090|Glucocorticoids|glucocorticoids|mesh-ancestor
65452501|NCT03769090|Hormones|hormones|mesh-ancestor
65452502|NCT03769090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65452503|NCT03769090|Tocolytic Agents|tocolytic agents|mesh-ancestor
65452504|NCT03769090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65452505|NCT03769090|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65452506|NCT03769090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65452507|NCT03769090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65452508|NCT03769090|Adrenergic Agents|adrenergic agents|mesh-ancestor
65452509|NCT03769090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65452510|NCT03769090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452511|NCT03921736|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65452512|NCT03921736|Perindopril|perindopril|mesh-list
65452513|NCT03921736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65452514|NCT03921736|Diuretics|diuretics|mesh-ancestor
65452515|NCT03921736|Natriuretic Agents|natriuretic agents|mesh-ancestor
65452516|NCT03921736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452517|NCT03921736|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64684265|NCT04358588|Gasotransmitters|gasotransmitters|mesh-ancestor
64684266|NCT04358588|Protective Agents|protective agents|mesh-ancestor
64684276|NCT03166761|Antiemetics|antiemetics|mesh-ancestor
64716479|NCT03395990|Sensory System Agents|sensory system agents|mesh-ancestor
64716480|NCT03395990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716481|NCT02175966|Ribavirin|ribavirin|mesh-list
64716482|NCT02175966|Sofosbuvir|sofosbuvir|mesh-list
64716483|NCT02175966|Antimetabolites|antimetabolites|mesh-ancestor
64716484|NCT02175966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716485|NCT02175966|Antiviral Agents|antiviral agents|mesh-ancestor
64716486|NCT02175966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64716487|NCT01599234|Nabiximols|nabiximols|mesh-list
64716488|NCT01599234|Analgesics|analgesics|mesh-ancestor
64716489|NCT01599234|Sensory System Agents|sensory system agents|mesh-ancestor
64684277|NCT03166761|Autonomic Agents|autonomic agents|mesh-ancestor
64684278|NCT03166761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64684279|NCT03166761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684280|NCT03166761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64684281|NCT03166761|Glucocorticoids|glucocorticoids|mesh-ancestor
64684285|NCT03166761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684286|NCT03166761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64684287|NCT03166761|Immunologic Factors|immunologic factors|mesh-ancestor
64684288|NCT03166761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684289|NCT03166761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684290|NCT04377555|Ocrelizumab|ocrelizumab|mesh-list
64684291|NCT04377555|Immunologic Factors|immunologic factors|mesh-ancestor
64684292|NCT04377555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684293|NCT04042155|Rivaroxaban|rivaroxaban|mesh-list
64684294|NCT04042155|Apixaban|apixaban|mesh-list
64684295|NCT04042155|Edoxaban|edoxaban|mesh-list
64684296|NCT04042155|Dabigatran|dabigatran|mesh-list
64684297|NCT04042155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64684298|NCT04042155|Antithrombins|antithrombins|mesh-ancestor
64684299|NCT04042155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64684300|NCT04042155|Protease Inhibitors|protease inhibitors|mesh-ancestor
64684301|NCT04042155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452518|NCT03921736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65452519|NCT03921736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452520|NCT03921736|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65452521|NCT03921736|Protease Inhibitors|protease inhibitors|mesh-ancestor
65452522|NCT03921736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452523|NCT05401006|Acitretin|acitretin|mesh-list
65452524|NCT05401006|Keratolytic Agents|keratolytic agents|mesh-ancestor
65452525|NCT05401006|Dermatologic Agents|dermatologic agents|mesh-ancestor
65452526|NCT01232374|Nimotuzumab|nimotuzumab|mesh-list
65452527|NCT01232374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452528|NCT01232374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65452529|NCT01231438|Alfacalcidol|alfacalcidol|mesh-list
65452530|NCT01231438|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65452531|NCT01231438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452532|NCT01131754|Heparin|heparin|mesh-list
65452533|NCT01131754|Anticoagulants|anticoagulants|mesh-ancestor
65452534|NCT01131754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65452535|NCT01131754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65452536|NCT01131754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684302|NCT04042155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684303|NCT04042155|Anticoagulants|anticoagulants|mesh-ancestor
64684304|NCT04195256|Dexmedetomidine|dexmedetomidine|mesh-list
64684305|NCT04195256|Ketamine|ketamine|mesh-list
64684306|NCT04195256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64684307|NCT04195256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64684308|NCT04195256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684310|NCT04195256|Analgesics|analgesics|mesh-ancestor
64684311|NCT04195256|Sensory System Agents|sensory system agents|mesh-ancestor
64684312|NCT04195256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64684313|NCT04195256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64684314|NCT04195256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64684315|NCT04195256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64684316|NCT04195256|Adrenergic Agents|adrenergic agents|mesh-ancestor
64684317|NCT04195256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64684318|NCT04195256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684319|NCT04195256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64684320|NCT04195256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64684321|NCT04195256|Anesthetics, General|anesthetics, general|mesh-ancestor
64684322|NCT04195256|Anesthetics|anesthetics|mesh-ancestor
64684323|NCT04195256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64684324|NCT04195256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64684325|NCT00002901|Docetaxel|docetaxel|mesh-list
64684326|NCT00002901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684334|NCT00002907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684335|NCT00002907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684336|NCT01710787|Phenylephrine|phenylephrine|mesh-list
64684337|NCT01710787|Oxymetazoline|oxymetazoline|mesh-list
64684338|NCT01710787|Tetracaine|tetracaine|mesh-list
64684339|NCT01710787|Anesthetics, Local|anesthetics, local|mesh-ancestor
64684340|NCT01710787|Anesthetics|anesthetics|mesh-ancestor
64324774|NCT01175785|Dermatologic Agents|dermatologic agents|mesh-ancestor
64716490|NCT01599234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716491|NCT01599234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716492|NCT02136576|Listerine|listerine|mesh-list
64716493|NCT02136576|Sodium Fluoride|sodium fluoride|mesh-list
64716494|NCT02136576|Cariostatic Agents|cariostatic agents|mesh-ancestor
65452537|NCT01231594|Trametinib|trametinib|mesh-list
65452538|NCT01231594|Dabrafenib|dabrafenib|mesh-list
65452539|NCT01231594|Antineoplastic Agents|antineoplastic agents|mesh-list
65452540|NCT01231594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65452541|NCT01231594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452542|NCT01231594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452543|NCT01136278|Clonidine|clonidine|mesh-list
65452544|NCT01136278|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65452545|NCT01136278|Analgesics|analgesics|mesh-ancestor
65452546|NCT01136278|Sensory System Agents|sensory system agents|mesh-ancestor
64837199|NCT01617707|Midazolam|midazolam|mesh-list
64716495|NCT02136576|Protective Agents|protective agents|mesh-ancestor
64716496|NCT02136576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716497|NCT02136576|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64716498|NCT02136576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64716499|NCT03397394|Rucaparib|rucaparib|mesh-list
64716500|NCT03397394|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64716501|NCT03397394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64716502|NCT03397394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324775|NCT01175785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64324781|NCT05478044|Vitamins|vitamins|mesh-ancestor
64684341|NCT01710787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64684342|NCT01710787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684343|NCT01710787|Sensory System Agents|sensory system agents|mesh-ancestor
64684344|NCT01710787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64684345|NCT01710787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64684346|NCT01710787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64684347|NCT01710787|Adrenergic Agents|adrenergic agents|mesh-ancestor
64684351|NCT01710787|Autonomic Agents|autonomic agents|mesh-ancestor
64684352|NCT01710787|Nasal Decongestants|nasal decongestants|mesh-ancestor
64684353|NCT01710787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64684354|NCT01710787|Respiratory System Agents|respiratory system agents|mesh-ancestor
64684355|NCT01710787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64684356|NCT01710787|Mydriatics|mydriatics|mesh-ancestor
64684357|NCT01710787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64684358|NCT01710787|Protective Agents|protective agents|mesh-ancestor
64684359|NCT01711177|Travoprost|travoprost|mesh-list
64684360|NCT01711177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64684361|NCT02277990|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64684362|NCT02277990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64684363|NCT01715233|Leucovorin|leucovorin|mesh-list
64684364|NCT01715233|Carboplatin|carboplatin|mesh-list
64684365|NCT01715233|Docetaxel|docetaxel|mesh-list
64484380|NCT01729819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64684366|NCT01715233|Fluorouracil|fluorouracil|mesh-list
64684367|NCT01715233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684368|NCT01715233|Tubulin Modulators|tubulin modulators|mesh-ancestor
64684369|NCT01715233|Antimitotic Agents|antimitotic agents|mesh-ancestor
64684370|NCT01715233|Mitosis Modulators|mitosis modulators|mesh-ancestor
64684371|NCT01715233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684372|NCT01715233|Antimetabolites|antimetabolites|mesh-ancestor
64684374|NCT01715233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64684375|NCT01715233|Immunologic Factors|immunologic factors|mesh-ancestor
64684376|NCT01715233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684378|NCT01715233|Protective Agents|protective agents|mesh-ancestor
64684379|NCT01715233|Vitamin B Complex|vitamin b complex|mesh-ancestor
64684380|NCT01715233|Vitamins|vitamins|mesh-ancestor
64684381|NCT01715233|Micronutrients|micronutrients|mesh-ancestor
64684382|NCT05145283|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64684383|NCT05145283|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64684384|NCT05145283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64684385|NCT05145283|Immunologic Factors|immunologic factors|mesh-ancestor
64716503|NCT03397394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64716505|NCT03398330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64716506|NCT03398330|Narcotics|narcotics|mesh-ancestor
64716507|NCT03398330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64716508|NCT03398330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452547|NCT01136278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452548|NCT01136278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452549|NCT01136278|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65452550|NCT01136278|Sympatholytics|sympatholytics|mesh-ancestor
65452551|NCT01136278|Autonomic Agents|autonomic agents|mesh-ancestor
65452552|NCT01136278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65452553|NCT01136278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65452554|NCT01136278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65452555|NCT01136278|Adrenergic Agents|adrenergic agents|mesh-ancestor
65452556|NCT01136278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65452557|NCT01136278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452558|NCT01136278|Hallucinogens|hallucinogens|mesh-ancestor
64684386|NCT05145283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684387|NCT04826588|Methylprednisolone|methylprednisolone|mesh-list
64684388|NCT04826588|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64684389|NCT04826588|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64684390|NCT04826588|Prednisolone|prednisolone|mesh-list
64684391|NCT04826588|Prednisolone acetate|prednisolone acetate|mesh-list
64684392|NCT04826588|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64684393|NCT04826588|Prednisolone phosphate|prednisolone phosphate|mesh-list
64684394|NCT04826588|Immunoglobulins|immunoglobulins|mesh-list
64684395|NCT04826588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64684396|NCT04826588|Antiemetics|antiemetics|mesh-ancestor
64684397|NCT04826588|Autonomic Agents|autonomic agents|mesh-ancestor
64684398|NCT04826588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64684399|NCT04826588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684400|NCT04826588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64684401|NCT04826588|Glucocorticoids|glucocorticoids|mesh-ancestor
64684402|NCT04826588|Hormones|hormones|mesh-ancestor
64684403|NCT04826588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64684404|NCT04826588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64684405|NCT04826588|Protective Agents|protective agents|mesh-ancestor
64684406|NCT04826588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64684407|NCT04826588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684408|NCT04826588|Immunologic Factors|immunologic factors|mesh-ancestor
64684409|NCT01719367|Atenolol|atenolol|mesh-list
64684410|NCT01719367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64684411|NCT01719367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64684412|NCT01719367|Sympatholytics|sympatholytics|mesh-ancestor
64684413|NCT01719367|Autonomic Agents|autonomic agents|mesh-ancestor
64684414|NCT01719367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64684415|NCT01719367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684416|NCT01719367|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64684417|NCT01719367|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64684422|NCT02276040|Bupivacaine|bupivacaine|mesh-list
64684423|NCT02276040|Anesthetics, Local|anesthetics, local|mesh-ancestor
64684424|NCT02276040|Anesthetics|anesthetics|mesh-ancestor
64684425|NCT02276040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64684440|NCT02250703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64684441|NCT02250703|Adrenergic Agents|adrenergic agents|mesh-ancestor
64684442|NCT02250703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64684443|NCT02250703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684444|NCT02250703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64684445|NCT02250703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64684446|NCT02250703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64684447|NCT02250703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64684448|NCT02250703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64684449|NCT02250703|Anesthetics, General|anesthetics, general|mesh-ancestor
64684450|NCT02250703|Anesthetics|anesthetics|mesh-ancestor
64684451|NCT02250703|GABA Modulators|gaba modulators|mesh-ancestor
64684452|NCT02250703|GABA Agents|gaba agents|mesh-ancestor
64684453|NCT02314728|Misoprostol|misoprostol|mesh-list
64684454|NCT02314728|Oxytocin|oxytocin|mesh-list
64684455|NCT02314728|Oxytocics|oxytocics|mesh-ancestor
65452559|NCT01136278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65452560|NCT01136278|Serotonin Agents|serotonin agents|mesh-ancestor
65452561|NCT01136278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65452562|NCT01136278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65452563|NCT01136278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65452564|NCT05402722|Antibodies|antibodies|mesh-list
65452565|NCT05402722|Immunologic Factors|immunologic factors|mesh-ancestor
65452566|NCT05402722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452567|NCT05480488|Midazolam|midazolam|mesh-list
65452568|NCT05480488|Warfarin|warfarin|mesh-list
65452569|NCT05480488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65452570|NCT05480488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65452571|NCT05480488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64448295|NCT01500226|Rolapitant|rolapitant|mesh-list
64684456|NCT02314728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64684457|NCT02314728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684458|NCT02314728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64684459|NCT02314728|Abortifacient Agents|abortifacient agents|mesh-ancestor
64684460|NCT02314728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64684461|NCT02314728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64684462|NCT03135860|Nitric Oxide|nitric oxide|mesh-list
64684463|NCT03135860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64684464|NCT03135860|Autonomic Agents|autonomic agents|mesh-ancestor
64716510|NCT03398330|Sensory System Agents|sensory system agents|mesh-ancestor
64716511|NCT03398330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716512|NCT00376766|Levetiracetam|levetiracetam|mesh-list
64716513|NCT00376766|Anticonvulsants|anticonvulsants|mesh-ancestor
64716514|NCT00376766|Nootropic Agents|nootropic agents|mesh-ancestor
64716515|NCT03403712|Dexamethasone|dexamethasone|mesh-list
64716516|NCT03403712|Palonosetron|palonosetron|mesh-list
64684465|NCT03135860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64684466|NCT03135860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684467|NCT03135860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64684468|NCT03135860|Respiratory System Agents|respiratory system agents|mesh-ancestor
64684469|NCT03135860|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64684470|NCT03135860|Antioxidants|antioxidants|mesh-ancestor
64684471|NCT03135860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684472|NCT03135860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64684473|NCT03135860|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64684474|NCT03135860|Vasodilator Agents|vasodilator agents|mesh-ancestor
64684475|NCT03135860|Gasotransmitters|gasotransmitters|mesh-ancestor
64684476|NCT03135860|Protective Agents|protective agents|mesh-ancestor
64684477|NCT02275338|Lanreotide|lanreotide|mesh-list
64684478|NCT02275338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684479|NCT01646268|Rotigotine|rotigotine|mesh-list
64684480|NCT01646268|Dopamine Agonists|dopamine agonists|mesh-ancestor
64684481|NCT01646268|Dopamine Agents|dopamine agents|mesh-ancestor
64684482|NCT01646268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64684483|NCT01646268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684484|NCT01646268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684485|NCT03070184|Metoprolol|metoprolol|mesh-list
64684486|NCT03070184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64684496|NCT03070184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64684497|NCT03070184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684498|NCT03988634|Valsartan|valsartan|mesh-list
64684499|NCT03988634|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64684500|NCT03988634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64684501|NCT03988634|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64684502|NCT03988634|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64684503|NCT03988634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684504|NCT02294630|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65452572|NCT05480488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452573|NCT05480488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65452574|NCT05480488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65452575|NCT05480488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65452576|NCT05480488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65452577|NCT05480488|Anesthetics, General|anesthetics, general|mesh-ancestor
65452578|NCT05480488|Anesthetics|anesthetics|mesh-ancestor
65452579|NCT05480488|GABA Modulators|gaba modulators|mesh-ancestor
65452580|NCT05480488|GABA Agents|gaba agents|mesh-ancestor
65452581|NCT05480488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65452582|NCT05480488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837232|NCT01617798|Metolazone|metolazone|mesh-list
64684509|NCT01722487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684510|NCT01722487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684512|NCT02795858|Ramucirumab|ramucirumab|mesh-list
64684513|NCT02795858|Lanreotide|lanreotide|mesh-list
64684514|NCT02795858|Somatostatin|somatostatin|mesh-list
64684515|NCT02795858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64684516|NCT02795858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64684517|NCT02795858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684518|NCT02795858|Hormones|hormones|mesh-ancestor
64684519|NCT02795858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64684520|NCT02795858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684521|NCT02730962|Vancomycin|vancomycin|mesh-list
64684522|NCT02730962|Clindamycin|clindamycin|mesh-list
64684523|NCT02730962|Clindamycin palmitate|clindamycin palmitate|mesh-list
64684524|NCT02730962|Clindamycin phosphate|clindamycin phosphate|mesh-list
64684525|NCT02730962|Neomycin|neomycin|mesh-list
64684526|NCT02730962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64684527|NCT02730962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64684528|NCT02730962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64684529|NCT02730962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684530|NCT02730962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684531|NCT02296346|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64684532|NCT02296346|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64684533|NCT02296346|Methylprednisolone|methylprednisolone|mesh-list
64716517|NCT03403712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64716518|NCT03403712|Antiemetics|antiemetics|mesh-ancestor
64716519|NCT03403712|Autonomic Agents|autonomic agents|mesh-ancestor
64716520|NCT03403712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716521|NCT03403712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716522|NCT03403712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64716523|NCT03403712|Glucocorticoids|glucocorticoids|mesh-ancestor
64716525|NCT03403712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64716526|NCT03403712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64716527|NCT03403712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64716528|NCT03403712|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64716529|NCT03403712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64716530|NCT03403712|Serotonin Agents|serotonin agents|mesh-ancestor
64716531|NCT03403712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64324800|NCT03649724|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64684534|NCT02296346|Prednisolone|prednisolone|mesh-list
64684535|NCT02296346|Prednisolone acetate|prednisolone acetate|mesh-list
64684536|NCT02296346|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64684537|NCT02296346|Prednisolone phosphate|prednisolone phosphate|mesh-list
64684538|NCT02296346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64684539|NCT02296346|Glucocorticoids|glucocorticoids|mesh-ancestor
64684540|NCT02296346|Hormones|hormones|mesh-ancestor
64684541|NCT02296346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64684542|NCT02296346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684543|NCT02296346|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64684544|NCT02296346|Protective Agents|protective agents|mesh-ancestor
64684545|NCT02296346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64684546|NCT02296346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452583|NCT05480488|Anticoagulants|anticoagulants|mesh-ancestor
65452584|NCT01229332|Carbidopa|carbidopa|mesh-list
65452585|NCT01229332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65452586|NCT01229332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65452587|NCT01229332|Dopamine Agents|dopamine agents|mesh-ancestor
65452588|NCT01229332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65452589|NCT01229332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452590|NCT01229332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452591|NCT01229332|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65452592|NCT01229332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452593|NCT03921034|Ropivacaine|ropivacaine|mesh-list
65452594|NCT03921034|Anesthetics, Local|anesthetics, local|mesh-ancestor
65452595|NCT03921034|Anesthetics|anesthetics|mesh-ancestor
65452596|NCT03921034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65452597|NCT03921034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452598|NCT03921034|Sensory System Agents|sensory system agents|mesh-ancestor
65452599|NCT03921034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452600|NCT01136590|Tranexamic Acid|tranexamic acid|mesh-list
65452601|NCT01136590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65452602|NCT01136590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65452603|NCT01136590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452604|NCT01136590|Hemostatics|hemostatics|mesh-ancestor
65452605|NCT01136590|Coagulants|coagulants|mesh-ancestor
65452606|NCT03920878|Aflibercept|aflibercept|mesh-list
64837241|NCT01617798|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64684547|NCT02296346|Antiemetics|antiemetics|mesh-ancestor
64684548|NCT02296346|Autonomic Agents|autonomic agents|mesh-ancestor
64684549|NCT02296346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64684550|NCT02296346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64684551|NCT01726621|Insulin|insulin|mesh-list
64684558|NCT02372630|Hormones|hormones|mesh-ancestor
64684559|NCT02372630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64684560|NCT02372630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64684561|NCT02372630|Protease Inhibitors|protease inhibitors|mesh-ancestor
64684562|NCT02372630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684563|NCT02372630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684564|NCT02318654|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64684565|NCT02318654|Anesthetics, Local|anesthetics, local|mesh-ancestor
64684569|NCT02318654|Sensory System Agents|sensory system agents|mesh-ancestor
64684570|NCT02318654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64684571|NCT02318654|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64684572|NCT04349930|Cannabidiol|cannabidiol|mesh-list
64684573|NCT04349930|Anticonvulsants|anticonvulsants|mesh-ancestor
64684574|NCT02303990|Pembrolizumab|pembrolizumab|mesh-list
64684575|NCT02303990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64684576|NCT02303990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684577|NCT04585958|Trastuzumab|trastuzumab|mesh-list
64684578|NCT04585958|Olaparib|olaparib|mesh-list
64684579|NCT04585958|Camptothecin|camptothecin|mesh-list
65452607|NCT03920878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65452608|NCT03920878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65452609|NCT03920878|Growth Substances|growth substances|mesh-ancestor
65452610|NCT03920878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452611|NCT03920878|Growth Inhibitors|growth inhibitors|mesh-ancestor
65452612|NCT03920878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452613|NCT03920644|Scopolamine|scopolamine|mesh-list
65452614|NCT03920644|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65452615|NCT03920644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65452616|NCT03920644|Antiemetics|antiemetics|mesh-ancestor
65452617|NCT03920644|Autonomic Agents|autonomic agents|mesh-ancestor
65452618|NCT03920644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452619|NCT03920644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452620|NCT03920644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65452621|NCT03920644|Mydriatics|mydriatics|mesh-ancestor
65452622|NCT03920644|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65452623|NCT03920644|Cholinergic Agents|cholinergic agents|mesh-ancestor
64684580|NCT04585958|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64324815|NCT01358695|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64716532|NCT03403712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716534|NCT03404648|Lipotropic Agents|lipotropic agents|mesh-ancestor
64716535|NCT03404648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64455863|NCT01789047|Topiramate|topiramate|mesh-list
64716536|NCT03404648|Antimetabolites|antimetabolites|mesh-ancestor
64716537|NCT03404648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716538|NCT03404648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64455928|NCT01787097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716539|NCT03404648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64324817|NCT02266303|Insulin|insulin|mesh-list
64684581|NCT04585958|Immunoconjugates|immunoconjugates|mesh-list
64684582|NCT04585958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64684583|NCT04585958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684584|NCT04585958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684585|NCT04585958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684586|NCT04585958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64684587|NCT04585958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64684588|NCT04585958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64684589|NCT04585958|Immunologic Factors|immunologic factors|mesh-ancestor
64684590|NCT04585958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409947|NCT05221749|Fluorides|fluorides|mesh-list
64684591|NCT01727089|Bevacizumab|bevacizumab|mesh-list
64684592|NCT01727089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64684593|NCT01727089|Endothelial Growth Factors|endothelial growth factors|mesh-list
64684594|NCT01727089|Antibodies|antibodies|mesh-list
64684595|NCT01727089|Immunoglobulins|immunoglobulins|mesh-list
64684596|NCT01727089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64684597|NCT01727089|Immunoglobulin G|immunoglobulin g|mesh-list
64684598|NCT01727089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684599|NCT01727089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64684600|NCT01727089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64684601|NCT01727089|Growth Substances|growth substances|mesh-ancestor
64684602|NCT01727089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684603|NCT01727089|Growth Inhibitors|growth inhibitors|mesh-ancestor
64684604|NCT01727089|Immunologic Factors|immunologic factors|mesh-ancestor
64684605|NCT01727791|Pregabalin|pregabalin|mesh-list
64684606|NCT01727791|Analgesics|analgesics|mesh-ancestor
64684607|NCT01727791|Sensory System Agents|sensory system agents|mesh-ancestor
64684608|NCT01727791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452624|NCT03920644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65452625|NCT03920644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452626|NCT03920644|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65452627|NCT03920644|Parasympatholytics|parasympatholytics|mesh-ancestor
65452628|NCT01137916|Imatinib Mesylate|imatinib mesylate|mesh-list
65452629|NCT01137916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452630|NCT01137916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65452631|NCT01137916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452632|NCT01137916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452633|NCT01137994|Paclitaxel|paclitaxel|mesh-list
65452634|NCT01137994|Vinorelbine|vinorelbine|mesh-list
65452635|NCT01137994|Docetaxel|docetaxel|mesh-list
65452636|NCT01137994|Trastuzumab|trastuzumab|mesh-list
65452637|NCT01137994|Lapatinib|lapatinib|mesh-list
65452638|NCT01137994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65452639|NCT01137994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452640|NCT01137994|Tubulin Modulators|tubulin modulators|mesh-ancestor
65452641|NCT01137994|Antimitotic Agents|antimitotic agents|mesh-ancestor
65452642|NCT01137994|Mitosis Modulators|mitosis modulators|mesh-ancestor
65452643|NCT01137994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452644|NCT01137994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65452645|NCT01137994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64684609|NCT01727791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684610|NCT01727791|Anticonvulsants|anticonvulsants|mesh-ancestor
64684611|NCT01727791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64684612|NCT01727791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64684613|NCT01727791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684614|NCT01727791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64684615|NCT01727791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64684616|NCT01727791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64684617|NCT01727791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64684618|NCT01727791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64684619|NCT01728337|Botulinum Toxins|botulinum toxins|mesh-list
64684629|NCT01728337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64684630|NCT02247193|Botulinum Toxins|botulinum toxins|mesh-list
64684631|NCT02247193|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64684632|NCT02247193|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64684633|NCT02247193|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64684634|NCT02247193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64684636|NCT02247193|Cholinergic Agents|cholinergic agents|mesh-ancestor
64684637|NCT02247193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64684638|NCT02247193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716542|NCT03383198|Anesthetics, Local|anesthetics, local|mesh-ancestor
64716543|NCT03383198|Anesthetics|anesthetics|mesh-ancestor
64716544|NCT03383198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64716545|NCT03383198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716546|NCT03383198|Sensory System Agents|sensory system agents|mesh-ancestor
64716547|NCT03383198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716548|NCT03413618|Rivaroxaban|rivaroxaban|mesh-list
64716549|NCT03413618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64324825|NCT02551874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452646|NCT01137994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452647|NCT01138072|Atorvastatin|atorvastatin|mesh-list
65452648|NCT01138072|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65452649|NCT01138072|Simvastatin|simvastatin|mesh-list
65452650|NCT01138072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65452651|NCT01138072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65452652|NCT01138072|Antimetabolites|antimetabolites|mesh-ancestor
65452653|NCT01138072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452654|NCT01138072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65452655|NCT01138072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65452656|NCT01138072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452657|NCT01131910|Vaccines|vaccines|mesh-list
65452658|NCT01131910|Immunologic Factors|immunologic factors|mesh-ancestor
65452659|NCT01131910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452660|NCT03739606|Antibodies|antibodies|mesh-list
64684639|NCT02247193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64684640|NCT02247193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64684641|NCT02245087|Atorvastatin|atorvastatin|mesh-list
64684642|NCT02245087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64684643|NCT02245087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64684644|NCT02245087|Antimetabolites|antimetabolites|mesh-ancestor
64684645|NCT02245087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684646|NCT02245087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64684647|NCT02245087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64684648|NCT02245087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684649|NCT04726969|Ivermectin|ivermectin|mesh-list
64684650|NCT04726969|Albendazole|albendazole|mesh-list
64684651|NCT04726969|Moxidectin|moxidectin|mesh-list
64684652|NCT04726969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64684653|NCT04726969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64684654|NCT04726969|Anthelmintics|anthelmintics|mesh-ancestor
64684655|NCT04726969|Anticestodal Agents|anticestodal agents|mesh-ancestor
64684656|NCT04726969|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64684657|NCT04726969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64684658|NCT04726969|Tubulin Modulators|tubulin modulators|mesh-ancestor
64684659|NCT04726969|Antimitotic Agents|antimitotic agents|mesh-ancestor
64684660|NCT04726969|Mitosis Modulators|mitosis modulators|mesh-ancestor
64684661|NCT04726969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684662|NCT04726969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684663|NCT04726969|Antinematodal Agents|antinematodal agents|mesh-ancestor
64684664|NCT03174275|Paclitaxel|paclitaxel|mesh-list
64684665|NCT03174275|Carboplatin|carboplatin|mesh-list
64684666|NCT03174275|Durvalumab|durvalumab|mesh-list
64684667|NCT03174275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64684668|NCT03174275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684669|NCT03174275|Tubulin Modulators|tubulin modulators|mesh-ancestor
64684670|NCT03174275|Antimitotic Agents|antimitotic agents|mesh-ancestor
64684671|NCT03174275|Mitosis Modulators|mitosis modulators|mesh-ancestor
64684672|NCT03174275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684673|NCT03174275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64684674|NCT01731691|Protease Inhibitors|protease inhibitors|mesh-list
64684675|NCT01731691|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64684676|NCT01731691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684677|NCT01731691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684678|NCT01731691|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64684699|NCT02975141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684700|NCT02975141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64684701|NCT02975141|Immunologic Factors|immunologic factors|mesh-ancestor
64684702|NCT02975141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684703|NCT02975141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64684704|NCT03452891|Simvastatin|simvastatin|mesh-list
65452661|NCT03739606|Immunoglobulins|immunoglobulins|mesh-list
65452662|NCT03739606|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65452663|NCT03739606|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65452664|NCT03739606|Immunologic Factors|immunologic factors|mesh-ancestor
65452665|NCT03739606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452666|NCT01138384|Lapatinib|lapatinib|mesh-list
65452667|NCT01138384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452668|NCT01138384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65452669|NCT01138384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452670|NCT01138384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452671|NCT05533372|Methotrexate|methotrexate|mesh-list
65452672|NCT05533372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65452673|NCT05533372|Abortifacient Agents|abortifacient agents|mesh-ancestor
65452674|NCT05533372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65452675|NCT05533372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452676|NCT05533372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65452677|NCT05533372|Antimetabolites|antimetabolites|mesh-ancestor
65452678|NCT05533372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452679|NCT05533372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452680|NCT05533372|Dermatologic Agents|dermatologic agents|mesh-ancestor
65452681|NCT05533372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452682|NCT05533372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65452683|NCT05533372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65452684|NCT05533372|Immunologic Factors|immunologic factors|mesh-ancestor
65452685|NCT05533372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65452686|NCT05533372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65452687|NCT01233622|Vildagliptin|vildagliptin|mesh-list
64684705|NCT03452891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64684706|NCT03452891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64684707|NCT03452891|Antimetabolites|antimetabolites|mesh-ancestor
64684708|NCT03452891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684709|NCT03452891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64684710|NCT03452891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64684711|NCT03452891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684712|NCT04341935|Linagliptin|linagliptin|mesh-list
64716551|NCT03413618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64716552|NCT03413618|Protease Inhibitors|protease inhibitors|mesh-ancestor
64716553|NCT03413618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64716554|NCT03413618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716555|NCT03413618|Anticoagulants|anticoagulants|mesh-ancestor
64684717|NCT04341935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64684718|NCT04341935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64684719|NCT04341935|Protease Inhibitors|protease inhibitors|mesh-ancestor
64684720|NCT04341935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684721|NCT04341935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684723|NCT05317039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65452688|NCT01233622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65452689|NCT01233622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452690|NCT01233622|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65452691|NCT01233622|Protease Inhibitors|protease inhibitors|mesh-ancestor
65452692|NCT01233622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452693|NCT01233622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452694|NCT01138774|Thioctic Acid|thioctic acid|mesh-list
65452695|NCT01138774|Antioxidants|antioxidants|mesh-ancestor
65452696|NCT01138774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452697|NCT01138774|Protective Agents|protective agents|mesh-ancestor
65452698|NCT01138774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452699|NCT01138774|Vitamin B Complex|vitamin b complex|mesh-ancestor
65452700|NCT01138774|Vitamins|vitamins|mesh-ancestor
65452701|NCT01138774|Micronutrients|micronutrients|mesh-ancestor
65452702|NCT01131988|Tacrolimus|tacrolimus|mesh-list
65452703|NCT01131988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65452704|NCT01131988|Immunologic Factors|immunologic factors|mesh-ancestor
65452705|NCT01131988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452706|NCT01131988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65452707|NCT01131988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684724|NCT05317039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684725|NCT05316883|Clozapine|clozapine|mesh-list
64684726|NCT05316883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64684727|NCT05316883|Serotonin Agents|serotonin agents|mesh-ancestor
64684728|NCT05316883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64684729|NCT05316883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684740|NCT05316649|Analgesics|analgesics|mesh-ancestor
64684741|NCT05316649|Sensory System Agents|sensory system agents|mesh-ancestor
64684742|NCT05316649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64684743|NCT05316649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684744|NCT05316649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64684745|NCT05316649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64684746|NCT03990363|Allopurinol|allopurinol|mesh-list
64684747|NCT03990363|Verinurad|verinurad|mesh-list
64684748|NCT03990363|Antimetabolites|antimetabolites|mesh-ancestor
64684749|NCT03990363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684750|NCT03990363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684751|NCT03990363|Gout Suppressants|gout suppressants|mesh-ancestor
64684752|NCT03990363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64684753|NCT03990363|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64684754|NCT03990363|Antioxidants|antioxidants|mesh-ancestor
64684755|NCT03990363|Protective Agents|protective agents|mesh-ancestor
64684756|NCT03990363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684757|NCT04341857|Antibodies|antibodies|mesh-list
64684758|NCT04341857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64684759|NCT04341857|Immunologic Factors|immunologic factors|mesh-ancestor
64684760|NCT04341857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684761|NCT00002913|Paclitaxel|paclitaxel|mesh-list
64684762|NCT00002913|Topotecan|topotecan|mesh-list
64684763|NCT00002913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64684764|NCT00002913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684765|NCT00002913|Tubulin Modulators|tubulin modulators|mesh-ancestor
64684766|NCT00002913|Antimitotic Agents|antimitotic agents|mesh-ancestor
64684767|NCT00002913|Mitosis Modulators|mitosis modulators|mesh-ancestor
64684768|NCT00002913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684769|NCT00002913|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65452708|NCT01131988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452709|NCT01138852|Ampicillin|ampicillin|mesh-list
65452710|NCT01138852|Cefuroxime|cefuroxime|mesh-list
65452711|NCT01138852|Cefuroxime axetil|cefuroxime axetil|mesh-list
65452712|NCT01138852|Sulbactam|sulbactam|mesh-list
65452713|NCT01138852|Sultamicillin|sultamicillin|mesh-list
65452714|NCT01138852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65452715|NCT01138852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65452716|NCT01138852|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65452717|NCT01138852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452718|NCT01138852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452719|NCT05487196|Clonidine|clonidine|mesh-list
65452720|NCT05487196|Fentanyl|fentanyl|mesh-list
65452721|NCT05487196|Dexmedetomidine|dexmedetomidine|mesh-list
65452722|NCT05487196|Ropivacaine|ropivacaine|mesh-list
65452723|NCT05487196|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64684770|NCT00002913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64684771|NCT00002913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684772|NCT00002919|Doxorubicin|doxorubicin|mesh-list
64684773|NCT00002919|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64684774|NCT00002919|Methotrexate|methotrexate|mesh-list
64684775|NCT00002919|Vinblastine|vinblastine|mesh-list
64684776|NCT00002919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684777|NCT00002919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64684778|NCT00002919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64684779|NCT00002919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64684780|NCT00002919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684781|NCT00002919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684782|NCT00002919|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64684783|NCT00002919|Abortifacient Agents|abortifacient agents|mesh-ancestor
64716557|NCT03523988|Ibuprofen|ibuprofen|mesh-list
64716558|NCT03523988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64716559|NCT03523988|Analgesics|analgesics|mesh-ancestor
64716560|NCT03523988|Sensory System Agents|sensory system agents|mesh-ancestor
64716561|NCT03523988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64684784|NCT00002919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64684785|NCT00002919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684786|NCT00002919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64684787|NCT00002919|Antimetabolites|antimetabolites|mesh-ancestor
64684811|NCT00383799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64684812|NCT00383799|Vasodilator Agents|vasodilator agents|mesh-ancestor
64684813|NCT00383799|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64684814|NCT00383799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64684815|NCT00383799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684816|NCT00383799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64684817|NCT00383799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64684818|NCT00383799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64684819|NCT00383799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684820|NCT00383799|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64684821|NCT00383799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64684822|NCT00383799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64684823|NCT00383799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64684826|NCT04635241|Anticoagulants|anticoagulants|mesh-ancestor
64684827|NCT04635241|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64684828|NCT04635241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64684829|NCT04635241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684830|NCT03954483|Triazolam|triazolam|mesh-list
64684831|NCT03954483|Buspirone|buspirone|mesh-list
64684832|NCT03954483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64684833|NCT03954483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65452724|NCT05487196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65452725|NCT05487196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452726|NCT05487196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65452727|NCT05487196|Analgesics|analgesics|mesh-ancestor
65452728|NCT05487196|Sensory System Agents|sensory system agents|mesh-ancestor
65452729|NCT05487196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452730|NCT05487196|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65452731|NCT05487196|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65452732|NCT05487196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65452733|NCT05487196|Adrenergic Agents|adrenergic agents|mesh-ancestor
65452734|NCT05487196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65452735|NCT05487196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452736|NCT05487196|Anesthetics, Local|anesthetics, local|mesh-ancestor
65452737|NCT05487196|Anesthetics|anesthetics|mesh-ancestor
65452738|NCT05487196|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65452739|NCT05487196|Narcotics|narcotics|mesh-ancestor
65452740|NCT05487196|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65452741|NCT05487196|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65452742|NCT05487196|Anesthetics, General|anesthetics, general|mesh-ancestor
65452743|NCT05487196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65452744|NCT05487196|Sympatholytics|sympatholytics|mesh-ancestor
65452745|NCT05487196|Autonomic Agents|autonomic agents|mesh-ancestor
65452746|NCT01585870|Sorafenib|sorafenib|mesh-list
65452747|NCT01585870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452748|NCT01585870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65452749|NCT01585870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452750|NCT01585870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452751|NCT05210140|Citalopram|citalopram|mesh-list
65452752|NCT05210140|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64684834|NCT03954483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64684835|NCT03954483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684836|NCT03954483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64684837|NCT03954483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64684838|NCT03954483|Serotonin Agents|serotonin agents|mesh-ancestor
64684839|NCT03954483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64684840|NCT03954483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684841|NCT03954483|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64684842|NCT03954483|GABA Modulators|gaba modulators|mesh-ancestor
64684843|NCT03954483|GABA Agents|gaba agents|mesh-ancestor
64684844|NCT04545541|Heparin|heparin|mesh-list
64684845|NCT04545541|Calcium heparin|calcium heparin|mesh-list
64684846|NCT04545541|Anticoagulants|anticoagulants|mesh-ancestor
64684847|NCT04545541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64684848|NCT04545541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64684849|NCT04545541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684850|NCT00002925|Aldesleukin|aldesleukin|mesh-list
64684851|NCT00002925|Etoposide|etoposide|mesh-list
65452753|NCT05210140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65452754|NCT05210140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65452755|NCT05210140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452756|NCT05210140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65452757|NCT05210140|Serotonin Agents|serotonin agents|mesh-ancestor
65452758|NCT05210140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452759|NCT05210140|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64837404|NCT01618799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64684852|NCT00002925|Daunorubicin|daunorubicin|mesh-list
64684879|NCT02922777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684881|NCT02918955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684882|NCT00002943|Cyclophosphamide|cyclophosphamide|mesh-list
64684883|NCT00002943|Carboplatin|carboplatin|mesh-list
64684884|NCT00002943|Etoposide|etoposide|mesh-list
64684885|NCT00002943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64684886|NCT00002943|Immunologic Factors|immunologic factors|mesh-ancestor
64684887|NCT00002943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684888|NCT00002943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64684889|NCT00002943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64684890|NCT00002943|Alkylating Agents|alkylating agents|mesh-ancestor
64684891|NCT00002943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716562|NCT03523988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716564|NCT03523988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64716565|NCT03523988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64716566|NCT03523988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64716567|NCT03523988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64684894|NCT00002943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64684895|NCT00002943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64684896|NCT00002943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64684897|NCT00002943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684899|NCT00002949|Vinorelbine|vinorelbine|mesh-list
64684900|NCT00002949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64684901|NCT00002949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684902|NCT00002949|Tubulin Modulators|tubulin modulators|mesh-ancestor
64684903|NCT00002949|Antimitotic Agents|antimitotic agents|mesh-ancestor
64684904|NCT00002949|Mitosis Modulators|mitosis modulators|mesh-ancestor
64684930|NCT00002955|Protective Agents|protective agents|mesh-ancestor
64684931|NCT00002955|Vitamin B Complex|vitamin b complex|mesh-ancestor
64684932|NCT00002955|Vitamins|vitamins|mesh-ancestor
64684933|NCT00002955|Micronutrients|micronutrients|mesh-ancestor
64684934|NCT00002955|Antifungal Agents|antifungal agents|mesh-ancestor
64684935|NCT00002955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64684936|NCT00002955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64684937|NCT00002955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684938|NCT00002961|Cyclosporine|cyclosporine|mesh-list
64684939|NCT00002961|Cyclophosphamide|cyclophosphamide|mesh-list
64684940|NCT00002961|Busulfan|busulfan|mesh-list
64684941|NCT00002961|Methotrexate|methotrexate|mesh-list
64684942|NCT00002961|Etoposide|etoposide|mesh-list
64684943|NCT00002961|Etoposide phosphate|etoposide phosphate|mesh-list
64684944|NCT00002961|Cyclosporins|cyclosporins|mesh-list
64684945|NCT00002961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64684946|NCT00002961|Immunologic Factors|immunologic factors|mesh-ancestor
64684947|NCT00002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684948|NCT00002961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64684949|NCT00002961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64684950|NCT00002961|Alkylating Agents|alkylating agents|mesh-ancestor
64684951|NCT00002961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684952|NCT00002961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684953|NCT00002961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64684954|NCT00002961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64684955|NCT00002961|Abortifacient Agents|abortifacient agents|mesh-ancestor
64684956|NCT00002961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64684968|NCT00002961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64684970|NCT00002967|Cyclophosphamide|cyclophosphamide|mesh-list
64684971|NCT00002967|Doxorubicin|doxorubicin|mesh-list
65452760|NCT05210140|Antidepressive Agents|antidepressive agents|mesh-ancestor
65452761|NCT05210140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65452762|NCT01233934|Chlorpheniramine|chlorpheniramine|mesh-list
65452763|NCT01233934|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
65452764|NCT01233934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65452765|NCT01233934|Histamine Antagonists|histamine antagonists|mesh-ancestor
65452766|NCT01233934|Histamine Agents|histamine agents|mesh-ancestor
65452767|NCT01233934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65452768|NCT01233934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452769|NCT01233934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452770|NCT01233934|Antipruritics|antipruritics|mesh-ancestor
65452771|NCT01233934|Dermatologic Agents|dermatologic agents|mesh-ancestor
64684972|NCT00002967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64716577|NCT03528512|Ketamine|ketamine|mesh-list
64716578|NCT03528512|Analgesics|analgesics|mesh-ancestor
64716579|NCT03528512|Sensory System Agents|sensory system agents|mesh-ancestor
64716580|NCT03528512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716581|NCT03528512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684973|NCT00002967|Octreotide|octreotide|mesh-list
64684974|NCT00002967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64684975|NCT00002967|Immunologic Factors|immunologic factors|mesh-ancestor
64684976|NCT00002967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684977|NCT00002967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64684987|NCT00002967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64684988|NCT00002967|Hormone Antagonists|hormone antagonists|mesh-ancestor
64684989|NCT00002967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64684990|NCT00002967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64684991|NCT00002967|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64684992|NCT00002967|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64684993|NCT00002967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64684994|NCT00002967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64684995|NCT04246177|Pembrolizumab|pembrolizumab|mesh-list
64684996|NCT04246177|Lenvatinib|lenvatinib|mesh-list
64684997|NCT04246177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64684998|NCT04246177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684999|NCT04246177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64685000|NCT04246177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685001|NCT04246177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685002|NCT00002973|Melphalan|melphalan|mesh-list
64685003|NCT00002973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64685004|NCT00002973|Alkylating Agents|alkylating agents|mesh-ancestor
64685005|NCT00002973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685006|NCT00002973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685007|NCT00002973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64685008|NCT00002973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64685009|NCT00002973|Immunologic Factors|immunologic factors|mesh-ancestor
64685010|NCT00002973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685011|NCT00002985|Doxorubicin|doxorubicin|mesh-list
64685012|NCT00002985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64685013|NCT00002985|Daunorubicin|daunorubicin|mesh-list
64685014|NCT00002985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64685015|NCT00002985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685016|NCT00002985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64685017|NCT00002985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64685018|NCT00002985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685027|NCT02767557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685028|NCT02767557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64685029|NCT02767557|Antimetabolites|antimetabolites|mesh-ancestor
64685030|NCT02767557|Antiviral Agents|antiviral agents|mesh-ancestor
64685031|NCT02767557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64685032|NCT02767557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685033|NCT02767557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65452772|NCT01233934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65452773|NCT01236508|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65452774|NCT01236508|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65452775|NCT01236508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452776|NCT05195944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65452777|NCT05195944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65452778|NCT05195944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452779|NCT05195944|Incretins|incretins|mesh-ancestor
65452780|NCT05195944|Hormones|hormones|mesh-ancestor
65452781|NCT05195944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65452782|NCT05195944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64685034|NCT02767557|Immunologic Factors|immunologic factors|mesh-ancestor
64685035|NCT02767557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685036|NCT00363389|Misoprostol|misoprostol|mesh-list
64685037|NCT00363389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64685038|NCT00363389|Abortifacient Agents|abortifacient agents|mesh-ancestor
64685039|NCT00363389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64410401|NCT02633059|Glycine|glycine|mesh-list
64685040|NCT00363389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685041|NCT00363389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64685042|NCT00363389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64716582|NCT03528512|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64716583|NCT03528512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64716585|NCT03528512|Anesthetics|anesthetics|mesh-ancestor
64716586|NCT03528512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64685043|NCT00363389|Oxytocics|oxytocics|mesh-ancestor
64685044|NCT03057431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64685045|NCT03057431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64685046|NCT03057431|Diuretics|diuretics|mesh-ancestor
64685047|NCT03057431|Natriuretic Agents|natriuretic agents|mesh-ancestor
64685048|NCT03057431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685049|NCT03057431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64685050|NCT03057431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64685051|NCT03057431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685052|NCT00003003|Mitoxantrone|mitoxantrone|mesh-list
64685053|NCT00003003|Mitomycins|mitomycins|mesh-list
64685054|NCT00003003|Mitomycin|mitomycin|mesh-list
64685055|NCT00003003|Sargramostim|sargramostim|mesh-list
64685056|NCT00003003|Immunologic Factors|immunologic factors|mesh-ancestor
64685057|NCT00003003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685058|NCT00003003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685059|NCT00003003|Analgesics|analgesics|mesh-ancestor
64685060|NCT00003003|Sensory System Agents|sensory system agents|mesh-ancestor
64685061|NCT00003003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64685062|NCT00003003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64685063|NCT00003003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64685064|NCT00003003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685065|NCT00003003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685066|NCT00003003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64685067|NCT00003003|Alkylating Agents|alkylating agents|mesh-ancestor
64685068|NCT00003003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64685069|NCT00003009|Aldesleukin|aldesleukin|mesh-list
64685070|NCT00003009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685071|NCT00003009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64685072|NCT00003009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64685073|NCT00003009|Antiviral Agents|antiviral agents|mesh-ancestor
64685074|NCT00003009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64685075|NCT00003015|Carboplatin|carboplatin|mesh-list
64685076|NCT00003015|Vincristine|vincristine|mesh-list
64685077|NCT00003015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685078|NCT00003015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64685079|NCT00003015|Tubulin Modulators|tubulin modulators|mesh-ancestor
64685080|NCT00003015|Antimitotic Agents|antimitotic agents|mesh-ancestor
65452783|NCT05195944|Protease Inhibitors|protease inhibitors|mesh-ancestor
65452784|NCT05195944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452785|NCT05195944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452786|NCT01236586|Dexamethasone|dexamethasone|mesh-list
65452787|NCT01236586|R04929097|r04929097|mesh-list
65452788|NCT01236586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65452789|NCT01236586|Antiemetics|antiemetics|mesh-ancestor
65452790|NCT01236586|Autonomic Agents|autonomic agents|mesh-ancestor
65452791|NCT01236586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452792|NCT01236586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452793|NCT01236586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65452794|NCT01236586|Glucocorticoids|glucocorticoids|mesh-ancestor
65452795|NCT01236586|Hormones|hormones|mesh-ancestor
65452796|NCT01236586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65452797|NCT01236586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65452798|NCT01236586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452799|NCT01236586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685081|NCT00003015|Mitosis Modulators|mitosis modulators|mesh-ancestor
64685082|NCT00003015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685083|NCT04204837|Nivolumab|nivolumab|mesh-list
64685084|NCT04204837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64685085|NCT04204837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685093|NCT00003021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685095|NCT03839823|Paclitaxel|paclitaxel|mesh-list
64685096|NCT03839823|Vinorelbine|vinorelbine|mesh-list
64685097|NCT03839823|Docetaxel|docetaxel|mesh-list
64685098|NCT03839823|Capecitabine|capecitabine|mesh-list
64685099|NCT03839823|Letrozole|letrozole|mesh-list
64685100|NCT03839823|Anastrozole|anastrozole|mesh-list
64685101|NCT03839823|Goserelin|goserelin|mesh-list
64685102|NCT03839823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64685103|NCT03839823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685104|NCT03839823|Tubulin Modulators|tubulin modulators|mesh-ancestor
64685105|NCT03839823|Antimitotic Agents|antimitotic agents|mesh-ancestor
64685106|NCT03839823|Mitosis Modulators|mitosis modulators|mesh-ancestor
64685107|NCT03839823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685108|NCT03839823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64685109|NCT03839823|Antimetabolites|antimetabolites|mesh-ancestor
64685110|NCT03839823|Antiviral Agents|antiviral agents|mesh-ancestor
64685111|NCT03839823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64685112|NCT03839823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685113|NCT03839823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64685114|NCT03839823|Immunologic Factors|immunologic factors|mesh-ancestor
64716588|NCT03528512|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64716589|NCT03528512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64716590|NCT03528512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716591|NCT03528512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64716592|NCT03528512|Narcotics|narcotics|mesh-ancestor
64716593|NCT03528512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64685115|NCT03839823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685116|NCT03839823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64685117|NCT03839823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64685118|NCT03839823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64685121|NCT03839823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64685122|NCT00003027|Interferons|interferons|mesh-list
64685123|NCT00003027|Interferon-alpha|interferon-alpha|mesh-list
64685124|NCT00003027|Aldesleukin|aldesleukin|mesh-list
64685125|NCT00003027|Dacarbazine|dacarbazine|mesh-list
64685126|NCT00003027|Vinblastine|vinblastine|mesh-list
65452800|NCT01236586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452801|NCT01234792|Nicotine|nicotine|mesh-list
65452802|NCT01234792|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65452803|NCT01234792|Autonomic Agents|autonomic agents|mesh-ancestor
65452804|NCT01234792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452805|NCT01234792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452806|NCT01234792|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65452807|NCT01234792|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65452808|NCT01234792|Cholinergic Agents|cholinergic agents|mesh-ancestor
65452809|NCT01234792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65452810|NCT01234792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452811|NCT03513328|Thiotepa|thiotepa|mesh-list
64685127|NCT00003027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685128|NCT00003027|Antiviral Agents|antiviral agents|mesh-ancestor
64685129|NCT00003027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64685130|NCT00003027|Immunologic Factors|immunologic factors|mesh-ancestor
64685131|NCT00003027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685133|NCT00003027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64685134|NCT00003027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64685135|NCT00003027|Alkylating Agents|alkylating agents|mesh-ancestor
64685136|NCT00003027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685137|NCT00003027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64685138|NCT00003027|Tubulin Modulators|tubulin modulators|mesh-ancestor
64685139|NCT00003027|Antimitotic Agents|antimitotic agents|mesh-ancestor
64685140|NCT00003027|Mitosis Modulators|mitosis modulators|mesh-ancestor
64685141|NCT00003039|Alvocidib|alvocidib|mesh-list
64685142|NCT00003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685143|NCT00003039|Growth Inhibitors|growth inhibitors|mesh-ancestor
64685144|NCT00003039|Growth Substances|growth substances|mesh-ancestor
64685145|NCT00003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685146|NCT00003039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64685147|NCT00003039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685148|NCT00003039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685149|NCT00383877|Insulin|insulin|mesh-list
64685150|NCT00383877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64685151|NCT00383877|Insulin Detemir|insulin detemir|mesh-list
64685152|NCT00383877|Isophane Insulin, Human|isophane insulin, human|mesh-list
64685153|NCT00383877|Insulin, Isophane|insulin, isophane|mesh-list
64685154|NCT00383877|Isophane insulin, beef|isophane insulin, beef|mesh-list
64685173|NCT00003063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685174|NCT00003063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64685176|NCT00003063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64685177|NCT00003063|Immunologic Factors|immunologic factors|mesh-ancestor
64685178|NCT00003063|Antiviral Agents|antiviral agents|mesh-ancestor
64685179|NCT00003063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64685180|NCT00003063|Antidotes|antidotes|mesh-ancestor
64685181|NCT00003063|Protective Agents|protective agents|mesh-ancestor
64685182|NCT00003063|Vitamin B Complex|vitamin b complex|mesh-ancestor
64685183|NCT00003063|Vitamins|vitamins|mesh-ancestor
64685184|NCT00003063|Micronutrients|micronutrients|mesh-ancestor
64685185|NCT00003063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64685186|NCT00003063|Antinematodal Agents|antinematodal agents|mesh-ancestor
64685187|NCT00003063|Anthelmintics|anthelmintics|mesh-ancestor
64685188|NCT00003063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64685189|NCT00003063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64685190|NCT00003075|Fenretinide|fenretinide|mesh-list
64685191|NCT00003075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685192|NCT00003075|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64685193|NCT00003075|Protective Agents|protective agents|mesh-ancestor
64685194|NCT00003075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685195|NCT00003081|Melphalan|melphalan|mesh-list
64685196|NCT00003081|Busulfan|busulfan|mesh-list
64685197|NCT00003081|Thiotepa|thiotepa|mesh-list
65452812|NCT03513328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65452813|NCT03513328|Alkylating Agents|alkylating agents|mesh-ancestor
65452814|NCT03513328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452815|NCT03513328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452816|NCT03513328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65452817|NCT03513328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65452818|NCT03513328|Immunologic Factors|immunologic factors|mesh-ancestor
65452819|NCT03513328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452820|NCT03467932|Insulin|insulin|mesh-list
65452821|NCT03467932|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65452822|NCT03467932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65452823|NCT03467932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685198|NCT00003081|Immunologic Factors|immunologic factors|mesh-ancestor
64685199|NCT00003081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716594|NCT03528512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64716595|NCT03528512|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64716596|NCT03528512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64716597|NCT03528512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64716598|NCT03528512|GABA Modulators|gaba modulators|mesh-ancestor
64716599|NCT03528512|GABA Agents|gaba agents|mesh-ancestor
64716600|NCT02133924|Prednisone|prednisone|mesh-list
64716601|NCT02133924|Methylprednisolone|methylprednisolone|mesh-list
64685200|NCT00003081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64685201|NCT00003081|Alkylating Agents|alkylating agents|mesh-ancestor
64685202|NCT00003081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685203|NCT00003081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685204|NCT00003081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64685205|NCT00003081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64685213|NCT02348385|Dopamine Agents|dopamine agents|mesh-ancestor
64685214|NCT02348385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64685215|NCT02348385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685232|NCT00003093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64685233|NCT00003093|Etoposide|etoposide|mesh-list
64685234|NCT00003093|Molgramostim|molgramostim|mesh-list
64685235|NCT00003093|Lenograstim|lenograstim|mesh-list
64685236|NCT00003093|Sargramostim|sargramostim|mesh-list
64685237|NCT00003093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64685238|NCT00003093|Immunologic Factors|immunologic factors|mesh-ancestor
64685239|NCT00003093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685240|NCT00003093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64685241|NCT00003093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64685242|NCT00003093|Alkylating Agents|alkylating agents|mesh-ancestor
64685243|NCT00003093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685244|NCT00003093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685245|NCT00003093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64685246|NCT00003093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64685247|NCT00003093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64685248|NCT00003093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64685249|NCT00003093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685250|NCT00003093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64685251|NCT00003093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64685252|NCT00003099|Tamoxifen|tamoxifen|mesh-list
64685253|NCT00003099|Fenretinide|fenretinide|mesh-list
64685254|NCT00003099|Retinamide|retinamide|mesh-list
64685255|NCT00003099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64685256|NCT00003099|Hormone Antagonists|hormone antagonists|mesh-ancestor
64685257|NCT00003099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64685258|NCT00003099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685259|NCT00003099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64685260|NCT00003099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685261|NCT00003099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64685262|NCT00003099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65452824|NCT05110300|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65452825|NCT05110300|Luteolytic Agents|luteolytic agents|mesh-ancestor
65452826|NCT05110300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65452827|NCT05110300|Contraceptive Agents|contraceptive agents|mesh-ancestor
65452828|NCT05110300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65452829|NCT05110300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452830|NCT05110300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65452831|NCT05110300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65452832|NCT05110300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452833|NCT05109052|Bevacizumab|bevacizumab|mesh-list
65452834|NCT05109052|Atezolizumab|atezolizumab|mesh-list
64837475|NCT01619150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64685263|NCT00003099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64685264|NCT00003099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64685265|NCT00003099|Protective Agents|protective agents|mesh-ancestor
64685266|NCT00003105|Gemcitabine|gemcitabine|mesh-list
64685267|NCT00003105|Paclitaxel|paclitaxel|mesh-list
64685268|NCT00003105|Doxorubicin|doxorubicin|mesh-list
64685269|NCT00003105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64685270|NCT00003105|Ifosfamide|ifosfamide|mesh-list
64685271|NCT00003105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64685272|NCT00003105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685273|NCT00003105|Tubulin Modulators|tubulin modulators|mesh-ancestor
64685274|NCT00003105|Antimitotic Agents|antimitotic agents|mesh-ancestor
64685275|NCT00003105|Mitosis Modulators|mitosis modulators|mesh-ancestor
64685288|NCT00003105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64716603|NCT02133924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64716604|NCT02133924|Glucocorticoids|glucocorticoids|mesh-ancestor
64716605|NCT02133924|Hormones|hormones|mesh-ancestor
64716606|NCT02133924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64324873|NCT01159249|Protease Inhibitors|protease inhibitors|mesh-ancestor
64685289|NCT00003105|Alkylating Agents|alkylating agents|mesh-ancestor
64685291|NCT00003111|Carboplatin|carboplatin|mesh-list
64685292|NCT00003111|Irinotecan|irinotecan|mesh-list
64685293|NCT00003111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64685294|NCT00003111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685295|NCT00003111|Tubulin Modulators|tubulin modulators|mesh-ancestor
64685296|NCT00003111|Antimitotic Agents|antimitotic agents|mesh-ancestor
64685297|NCT00003111|Mitosis Modulators|mitosis modulators|mesh-ancestor
64685298|NCT00003111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685301|NCT00003111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685302|NCT05709301|Donepezil|donepezil|mesh-list
64685303|NCT05709301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64685304|NCT05709301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685305|NCT05709301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685306|NCT05709301|Cholinergic Agents|cholinergic agents|mesh-ancestor
64685307|NCT05709301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64685308|NCT05709301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685309|NCT05709301|Nootropic Agents|nootropic agents|mesh-ancestor
64685310|NCT00003117|Paclitaxel|paclitaxel|mesh-list
64685311|NCT00003117|Carboplatin|carboplatin|mesh-list
64685312|NCT00003117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64685313|NCT00003117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685314|NCT00003117|Tubulin Modulators|tubulin modulators|mesh-ancestor
64685315|NCT00003117|Antimitotic Agents|antimitotic agents|mesh-ancestor
64685316|NCT00003117|Mitosis Modulators|mitosis modulators|mesh-ancestor
64685317|NCT00003117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685318|NCT02240329|Capsaicin|capsaicin|mesh-list
64685319|NCT02240329|Antipruritics|antipruritics|mesh-ancestor
64685320|NCT02240329|Dermatologic Agents|dermatologic agents|mesh-ancestor
64685321|NCT02240329|Sensory System Agents|sensory system agents|mesh-ancestor
64685322|NCT02240329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64685323|NCT02240329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685324|NCT00003123|Amifostine|amifostine|mesh-list
65452835|NCT05109052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65452836|NCT05109052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452837|NCT05109052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65452838|NCT05109052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65452839|NCT05109052|Growth Substances|growth substances|mesh-ancestor
65452840|NCT05109052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452841|NCT05109052|Growth Inhibitors|growth inhibitors|mesh-ancestor
65452842|NCT03414502|Hydroxychloroquine|hydroxychloroquine|mesh-list
65452843|NCT03414502|Minocycline|minocycline|mesh-list
65452844|NCT03414502|Sulfasalazine|sulfasalazine|mesh-list
65452845|NCT03414502|Adalimumab|adalimumab|mesh-list
65452846|NCT03414502|Etanercept|etanercept|mesh-list
65452847|NCT03414502|Golimumab|golimumab|mesh-list
65452848|NCT03414502|Rituximab|rituximab|mesh-list
64685325|NCT00003123|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64685326|NCT00003123|Protective Agents|protective agents|mesh-ancestor
64685327|NCT00003123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685328|NCT05115409|Rituximab|rituximab|mesh-list
64685329|NCT05115409|Antibodies|antibodies|mesh-list
64685330|NCT05115409|Immunologic Factors|immunologic factors|mesh-ancestor
64685331|NCT05115409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685332|NCT05115409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64685333|NCT05115409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685334|NCT05115409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64685335|NCT03981523|Benzonidazole|benzonidazole|mesh-list
64685336|NCT03981523|Nifurtimox|nifurtimox|mesh-list
64685337|NCT03981523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64685338|NCT03981523|Immunologic Factors|immunologic factors|mesh-ancestor
64685339|NCT03981523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685348|NCT03965923|Antiviral Agents|antiviral agents|mesh-ancestor
64685349|NCT03965923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64685350|NCT03965923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64685351|NCT03965923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64685352|NCT03965923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685353|NCT03965923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685354|NCT03965923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64685355|NCT03965923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64685356|NCT03962725|Dexmedetomidine|dexmedetomidine|mesh-list
64685358|NCT03962725|Propofol|propofol|mesh-list
64685359|NCT03962725|Anesthetics|anesthetics|mesh-list
64685360|NCT03962725|Rocuronium|rocuronium|mesh-list
64685361|NCT03962725|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
64685362|NCT03962725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64685363|NCT03962725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64716607|NCT02133924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716608|NCT02133924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64716609|NCT02133924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64716610|NCT02133924|Antiemetics|antiemetics|mesh-ancestor
64716611|NCT02133924|Autonomic Agents|autonomic agents|mesh-ancestor
64716612|NCT02133924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716613|NCT02133924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64716614|NCT02133924|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64716615|NCT02133924|Protective Agents|protective agents|mesh-ancestor
64716616|NCT02133924|Immunologic Factors|immunologic factors|mesh-ancestor
64716618|NCT03537404|Tenofovir|tenofovir|mesh-list
64716619|NCT03537404|Raltegravir Potassium|raltegravir potassium|mesh-list
64716620|NCT03537404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64716621|NCT03537404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64716622|NCT03537404|Protease Inhibitors|protease inhibitors|mesh-ancestor
64716623|NCT03537404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64716624|NCT03537404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716625|NCT03537404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64716626|NCT03537404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64716630|NCT03537404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65452849|NCT03414502|Methotrexate|methotrexate|mesh-list
65452850|NCT03414502|Abatacept|abatacept|mesh-list
65452851|NCT03414502|Azathioprine|azathioprine|mesh-list
65452852|NCT03414502|Infliximab|infliximab|mesh-list
65452853|NCT03414502|Certolizumab Pegol|certolizumab pegol|mesh-list
65452854|NCT03414502|Leflunomide|leflunomide|mesh-list
65452855|NCT03414502|Tofacitinib|tofacitinib|mesh-list
65452856|NCT03414502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65452857|NCT03414502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452858|NCT03414502|Immunologic Factors|immunologic factors|mesh-ancestor
65452859|NCT03414502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452860|NCT03414502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65452861|NCT03414502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65452862|NCT03414502|Abortifacient Agents|abortifacient agents|mesh-ancestor
65452863|NCT03414502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65452864|NCT03414502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64837511|NCT01619176|Analgesics|analgesics|mesh-ancestor
64716631|NCT03537404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64716632|NCT03537404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64716633|NCT03537404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64716634|NCT03537404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64716636|NCT03626714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64685364|NCT03962725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685365|NCT03962725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64685366|NCT03962725|Anesthetics, General|anesthetics, general|mesh-ancestor
64685367|NCT03962725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64685368|NCT03962725|Analgesics|analgesics|mesh-ancestor
64685369|NCT03962725|Sensory System Agents|sensory system agents|mesh-ancestor
64685370|NCT03962725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64685371|NCT03962725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64685372|NCT03962725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64685373|NCT03962725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64685374|NCT03962725|Adrenergic Agents|adrenergic agents|mesh-ancestor
64685375|NCT03962725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64685376|NCT03962725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685377|NCT03962725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64685378|NCT03962725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64685379|NCT03962725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64716637|NCT03626714|Immunologic Factors|immunologic factors|mesh-ancestor
64716638|NCT03626714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716639|NCT03626714|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64716640|NCT03626714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64716641|NCT03626714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716642|NCT03538808|Varenicline|varenicline|mesh-list
64716643|NCT03538808|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64716644|NCT03538808|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64716645|NCT03538808|Cholinergic Agents|cholinergic agents|mesh-ancestor
64324906|NCT01338883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685380|NCT03962725|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64685381|NCT03962725|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64685382|NCT05699473|Calcium, Dietary|calcium, dietary|mesh-list
64685383|NCT05699473|Tetrahydrofolates|tetrahydrofolates|mesh-list
64685384|NCT05699473|Calcium|calcium|mesh-list
64685385|NCT05699473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64685386|NCT05699473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685387|NCT05699473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64685388|NCT05699473|Vitamin B Complex|vitamin b complex|mesh-ancestor
64685389|NCT05699473|Vitamins|vitamins|mesh-ancestor
64685390|NCT05699473|Micronutrients|micronutrients|mesh-ancestor
64685391|NCT02210559|Gemcitabine|gemcitabine|mesh-list
65452866|NCT03414502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452867|NCT03414502|Dermatologic Agents|dermatologic agents|mesh-ancestor
65452868|NCT03414502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452869|NCT03414502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65452870|NCT03414502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65452871|NCT03414502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65452872|NCT03414502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65452873|NCT03414502|Antimalarials|antimalarials|mesh-ancestor
64837514|NCT01619280|Nitroprusside|nitroprusside|mesh-list
64685392|NCT02210559|Paclitaxel|paclitaxel|mesh-list
64685393|NCT02210559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64685394|NCT02210559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685395|NCT02210559|Tubulin Modulators|tubulin modulators|mesh-ancestor
64685396|NCT02210559|Antimitotic Agents|antimitotic agents|mesh-ancestor
64685397|NCT02210559|Mitosis Modulators|mitosis modulators|mesh-ancestor
64685398|NCT02210559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685399|NCT02210559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64685400|NCT02210559|Antimetabolites|antimetabolites|mesh-ancestor
64685401|NCT02210559|Antiviral Agents|antiviral agents|mesh-ancestor
64685402|NCT02210559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64685403|NCT02210559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685404|NCT02210559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64685405|NCT02210559|Immunologic Factors|immunologic factors|mesh-ancestor
64685414|NCT00003135|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64685415|NCT00003135|Fluorouracil|fluorouracil|mesh-list
64685416|NCT00003135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64685417|NCT00003135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685418|NCT00003135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64685419|NCT00003135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64685420|NCT00003135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685421|NCT00003135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685422|NCT00003135|Antimetabolites|antimetabolites|mesh-ancestor
64685426|NCT00003135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685427|NCT03669133|Vitamin E|vitamin e|mesh-list
64685428|NCT03669133|Vitamins|vitamins|mesh-ancestor
64685429|NCT03669133|Micronutrients|micronutrients|mesh-ancestor
64685430|NCT03669133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685431|NCT03669133|Antioxidants|antioxidants|mesh-ancestor
64685432|NCT03669133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685433|NCT03669133|Protective Agents|protective agents|mesh-ancestor
64685434|NCT02114229|Cyclophosphamide|cyclophosphamide|mesh-list
64685435|NCT02114229|Carboplatin|carboplatin|mesh-list
64685436|NCT02114229|Methotrexate|methotrexate|mesh-list
64685437|NCT02114229|Etoposide|etoposide|mesh-list
64685438|NCT02114229|Etoposide phosphate|etoposide phosphate|mesh-list
64685439|NCT02114229|Vincristine|vincristine|mesh-list
64685440|NCT02114229|Topotecan|topotecan|mesh-list
64685441|NCT02114229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64685442|NCT02114229|Immunologic Factors|immunologic factors|mesh-ancestor
64685443|NCT02114229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685444|NCT02114229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64716647|NCT03538808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716648|NCT03538808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716649|NCT00377000|Clindamycin|clindamycin|mesh-list
64716650|NCT00377000|Clindamycin palmitate|clindamycin palmitate|mesh-list
64685445|NCT02114229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64685446|NCT02114229|Alkylating Agents|alkylating agents|mesh-ancestor
64685447|NCT02114229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685448|NCT02114229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685449|NCT02114229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64685450|NCT02114229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64685451|NCT02114229|Abortifacient Agents|abortifacient agents|mesh-ancestor
64685452|NCT02114229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64685453|NCT02114229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64685454|NCT02114229|Antimetabolites|antimetabolites|mesh-ancestor
64685455|NCT02114229|Dermatologic Agents|dermatologic agents|mesh-ancestor
64685456|NCT02114229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452874|NCT03414502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65452875|NCT03414502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65452876|NCT03414502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65452877|NCT03414502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65452878|NCT03414502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65452879|NCT03414502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65452880|NCT03414502|Analgesics|analgesics|mesh-ancestor
65452881|NCT03414502|Sensory System Agents|sensory system agents|mesh-ancestor
65452882|NCT03414502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452883|NCT03414502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65452884|NCT03414502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65452885|NCT03414502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65452886|NCT03414502|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65452887|NCT03199612|Sildenafil Citrate|sildenafil citrate|mesh-list
65452888|NCT03199612|Vasodilator Agents|vasodilator agents|mesh-ancestor
64837521|NCT01619436|Sensory System Agents|sensory system agents|mesh-ancestor
64685457|NCT02114229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64685458|NCT02114229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64685459|NCT02114229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64685460|NCT02114229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64685461|NCT02114229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64685462|NCT02114229|Tubulin Modulators|tubulin modulators|mesh-ancestor
64685463|NCT02114229|Antimitotic Agents|antimitotic agents|mesh-ancestor
64685464|NCT02114229|Mitosis Modulators|mitosis modulators|mesh-ancestor
64685465|NCT02114229|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64685466|NCT03439891|Nivolumab|nivolumab|mesh-list
64685467|NCT03439891|Sorafenib|sorafenib|mesh-list
64685468|NCT03439891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64685469|NCT03439891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685470|NCT03439891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64685471|NCT03439891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685472|NCT03439891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64685483|NCT00003141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685484|NCT00003141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64685485|NCT00003141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64685486|NCT00003141|Alkylating Agents|alkylating agents|mesh-ancestor
64685487|NCT00003141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685488|NCT00003141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685489|NCT00003141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64685490|NCT00003141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64685491|NCT00003141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64685492|NCT00003141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64685493|NCT00003141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685494|NCT00003141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64685495|NCT00003141|Tubulin Modulators|tubulin modulators|mesh-ancestor
64685496|NCT00003141|Antimitotic Agents|antimitotic agents|mesh-ancestor
64685497|NCT00003141|Mitosis Modulators|mitosis modulators|mesh-ancestor
64685498|NCT04867135|Amikacin|amikacin|mesh-list
64685499|NCT04867135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64685500|NCT04867135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64685505|NCT01740817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64685506|NCT01740817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64685507|NCT01740817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64685509|NCT04728217|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
64685510|NCT04728217|Coagulants|coagulants|mesh-ancestor
64685511|NCT04728217|Immunologic Factors|immunologic factors|mesh-ancestor
64685512|NCT04728217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685514|NCT04581343|Paclitaxel|paclitaxel|mesh-list
65452889|NCT03199612|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65452890|NCT03199612|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65452891|NCT03199612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65452892|NCT03199612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452893|NCT03199612|Urological Agents|urological agents|mesh-ancestor
65452894|NCT01140100|Thiopental|thiopental|mesh-list
65452895|NCT01140100|Propofol|propofol|mesh-list
65452896|NCT01140100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65452897|NCT01140100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65452898|NCT01140100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452899|NCT01140100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65452900|NCT01140100|Anesthetics, General|anesthetics, general|mesh-ancestor
65452901|NCT01140100|Anesthetics|anesthetics|mesh-ancestor
65452902|NCT01140100|Anticonvulsants|anticonvulsants|mesh-ancestor
65452903|NCT01140100|GABA Modulators|gaba modulators|mesh-ancestor
65452904|NCT01140100|GABA Agents|gaba agents|mesh-ancestor
65452905|NCT01140100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65452906|NCT01140100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452907|NCT01141036|Midazolam|midazolam|mesh-list
64685515|NCT04581343|Spartalizumab|spartalizumab|mesh-list
64685516|NCT04581343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64685517|NCT04581343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685518|NCT04581343|Tubulin Modulators|tubulin modulators|mesh-ancestor
64716652|NCT00377000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64716653|NCT00377000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64716654|NCT00377000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324919|NCT05625919|Sirolimus|sirolimus|mesh-list
64685519|NCT04581343|Antimitotic Agents|antimitotic agents|mesh-ancestor
64685520|NCT04581343|Mitosis Modulators|mitosis modulators|mesh-ancestor
64685521|NCT04581343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685522|NCT04581343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64685523|NCT04581343|Antimetabolites|antimetabolites|mesh-ancestor
64685524|NCT04581343|Antiviral Agents|antiviral agents|mesh-ancestor
64685525|NCT04581343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64685526|NCT04581343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685527|NCT04581343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64685528|NCT04581343|Immunologic Factors|immunologic factors|mesh-ancestor
64685529|NCT04581343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685530|NCT04581343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64685531|NCT01743859|Lenalidomide|lenalidomide|mesh-list
64685532|NCT01743859|Azacitidine|azacitidine|mesh-list
64685533|NCT01743859|Immunologic Factors|immunologic factors|mesh-ancestor
64685534|NCT01743859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685535|NCT01743859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64685536|NCT01743859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64685537|NCT01743859|Growth Substances|growth substances|mesh-ancestor
64685538|NCT01743859|Growth Inhibitors|growth inhibitors|mesh-ancestor
64685539|NCT01743859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685540|NCT01743859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64685541|NCT01743859|Antimetabolites|antimetabolites|mesh-ancestor
64685542|NCT01743859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685566|NCT05635903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64685567|NCT05635903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64685568|NCT05635903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64685569|NCT05635903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64685570|NCT05635903|Anesthetics, General|anesthetics, general|mesh-ancestor
64685572|NCT05635903|GABA Modulators|gaba modulators|mesh-ancestor
64685573|NCT05635903|GABA Agents|gaba agents|mesh-ancestor
65452908|NCT01141036|Propofol|propofol|mesh-list
65452909|NCT01141036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65452910|NCT01141036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65452911|NCT01141036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452912|NCT01141036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65452913|NCT01141036|Anesthetics, General|anesthetics, general|mesh-ancestor
65452914|NCT01141036|Anesthetics|anesthetics|mesh-ancestor
65452915|NCT01141036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65452916|NCT01141036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65452917|NCT01141036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65452918|NCT01141036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65452919|NCT01141036|GABA Modulators|gaba modulators|mesh-ancestor
65452920|NCT01141036|GABA Agents|gaba agents|mesh-ancestor
65452921|NCT01141036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65452922|NCT01141036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452923|NCT04983940|Methyltestosterone|methyltestosterone|mesh-list
65452924|NCT04983940|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65452925|NCT04983940|Testosterone|testosterone|mesh-list
65452926|NCT04983940|Testosterone undecanoate|testosterone undecanoate|mesh-list
65452927|NCT04983940|Testosterone enanthate|testosterone enanthate|mesh-list
65452928|NCT04983940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64685574|NCT05635903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64685575|NCT05635903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685576|NCT01746511|Glycerol|glycerol|mesh-list
64685577|NCT01746511|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64685578|NCT01746511|Protective Agents|protective agents|mesh-ancestor
64685579|NCT01746511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685580|NCT01746979|Gemcitabine|gemcitabine|mesh-list
64685581|NCT01746979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64685582|NCT01746979|Antimetabolites|antimetabolites|mesh-ancestor
64685583|NCT01746979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685584|NCT01746979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685585|NCT01746979|Antiviral Agents|antiviral agents|mesh-ancestor
64685586|NCT01746979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64685587|NCT01746979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685588|NCT01746979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64685589|NCT01746979|Immunologic Factors|immunologic factors|mesh-ancestor
64685590|NCT01746979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685591|NCT04514653|Ranibizumab|ranibizumab|mesh-list
64685592|NCT04514653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64685593|NCT04514653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64685609|NCT01754389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64685610|NCT01754389|Antimetabolites|antimetabolites|mesh-ancestor
64685611|NCT01754389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685612|NCT01754389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685613|NCT01754389|Dermatologic Agents|dermatologic agents|mesh-ancestor
64685614|NCT01754389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685615|NCT01754389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64685616|NCT01754389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64685617|NCT01754389|Immunologic Factors|immunologic factors|mesh-ancestor
64685618|NCT01754389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64716655|NCT00377000|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64716656|NCT00377000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64716657|NCT00377000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452929|NCT04983940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452930|NCT04983940|Anabolic Agents|anabolic agents|mesh-ancestor
65452931|NCT04983940|Hormones|hormones|mesh-ancestor
65452932|NCT04983940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65452933|NCT04983940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452934|NCT04983940|Androgens|androgens|mesh-ancestor
65452935|NCT02902198|Quinine|quinine|mesh-list
65452936|NCT02902198|Antimalarials|antimalarials|mesh-ancestor
65452937|NCT02902198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65202424|NCT00877006|Hormones|hormones|mesh-ancestor
65452938|NCT02902198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65452939|NCT02902198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65452940|NCT02902198|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64716658|NCT00377000|Dermatologic Agents|dermatologic agents|mesh-ancestor
64716659|NCT02173548|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64716660|NCT02173548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64716662|NCT04501640|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64716663|NCT04501640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64716664|NCT04501640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64716665|NCT04501640|Adrenergic Agents|adrenergic agents|mesh-ancestor
64716666|NCT04501640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64716667|NCT04501640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716668|NCT04501640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716669|NCT04501640|Urological Agents|urological agents|mesh-ancestor
64716670|NCT04757610|Ranibizumab|ranibizumab|mesh-list
64716671|NCT04757610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64716672|NCT04757610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64716673|NCT04757610|Growth Substances|growth substances|mesh-ancestor
64716674|NCT04757610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716675|NCT04757610|Growth Inhibitors|growth inhibitors|mesh-ancestor
64716676|NCT04757610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64716677|NCT03633344|Silicon|silicon|mesh-list
64716678|NCT03633344|Trace Elements|trace elements|mesh-ancestor
64324922|NCT05625919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64685619|NCT01754389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64685620|NCT01754389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64685621|NCT01754389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64685622|NCT01754389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64685623|NCT01754389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64685624|NCT01754389|Antifungal Agents|antifungal agents|mesh-ancestor
64685625|NCT01754623|Gemcitabine|gemcitabine|mesh-list
64685626|NCT01754623|Fluorouracil|fluorouracil|mesh-list
64685627|NCT01754623|Capecitabine|capecitabine|mesh-list
64685628|NCT01754623|Docetaxel|docetaxel|mesh-list
64685629|NCT01754623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64685630|NCT01754623|Antimetabolites|antimetabolites|mesh-ancestor
64685631|NCT01754623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685632|NCT01754623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685633|NCT01754623|Antiviral Agents|antiviral agents|mesh-ancestor
64685634|NCT01754623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64685635|NCT01754623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685636|NCT01754623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64685637|NCT01754623|Immunologic Factors|immunologic factors|mesh-ancestor
64685638|NCT01754623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685639|NCT01754623|Tubulin Modulators|tubulin modulators|mesh-ancestor
64685640|NCT01754623|Antimitotic Agents|antimitotic agents|mesh-ancestor
64685641|NCT01754623|Mitosis Modulators|mitosis modulators|mesh-ancestor
64685642|NCT01755169|Ketamine|ketamine|mesh-list
64716680|NCT03633344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716681|NCT02171130|Glucagon|glucagon|mesh-list
64716682|NCT02171130|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64716683|NCT02171130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64716684|NCT02171130|Hormones|hormones|mesh-ancestor
64716685|NCT02171130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65452941|NCT02902198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452942|NCT02902198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65452943|NCT02902198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452944|NCT02902198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65452945|NCT02902198|Analgesics|analgesics|mesh-ancestor
65452946|NCT02902198|Sensory System Agents|sensory system agents|mesh-ancestor
65452947|NCT04917406|Dexamethasone|dexamethasone|mesh-list
65452948|NCT04917406|Lidocaine|lidocaine|mesh-list
65452949|NCT04917406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65452950|NCT04917406|Antiemetics|antiemetics|mesh-ancestor
64716686|NCT02171130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324947|NCT02266537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64685643|NCT01755169|Analgesics|analgesics|mesh-ancestor
64685644|NCT01755169|Sensory System Agents|sensory system agents|mesh-ancestor
64685645|NCT01755169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64685646|NCT01755169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685647|NCT01755169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64685648|NCT01755169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64685649|NCT01755169|Anesthetics, General|anesthetics, general|mesh-ancestor
64685650|NCT01755169|Anesthetics|anesthetics|mesh-ancestor
64685651|NCT01755169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64685652|NCT01755169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64685653|NCT01755169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64685654|NCT01755169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64685655|NCT01755169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685656|NCT01755949|Colchicine|colchicine|mesh-list
64685657|NCT01755949|Gout Suppressants|gout suppressants|mesh-ancestor
64685658|NCT01755949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64685659|NCT01755949|Tubulin Modulators|tubulin modulators|mesh-ancestor
64685660|NCT01755949|Antimitotic Agents|antimitotic agents|mesh-ancestor
64685692|NCT01760785|Anticonvulsants|anticonvulsants|mesh-ancestor
64685693|NCT01760785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685694|NCT01760785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685695|NCT01760785|GABA Agents|gaba agents|mesh-ancestor
64685696|NCT01760785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64685697|NCT01760785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685698|NCT01760785|Antimanic Agents|antimanic agents|mesh-ancestor
64685699|NCT01760785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64685700|NCT01760785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64685711|NCT04062097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685712|NCT04062097|Anticoagulants|anticoagulants|mesh-ancestor
64685713|NCT04062097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64685714|NCT04062097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64685715|NCT04062097|Hemostatics|hemostatics|mesh-ancestor
64685716|NCT04062097|Coagulants|coagulants|mesh-ancestor
64685717|NCT02241655|Anesthetics|anesthetics|mesh-list
64685718|NCT02241655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64685719|NCT02241655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685720|NCT04005079|Ofloxacin|ofloxacin|mesh-list
64685721|NCT04005079|Prednisolone|prednisolone|mesh-list
64685722|NCT04005079|Pilocarpine|pilocarpine|mesh-list
64685723|NCT04005079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64685724|NCT04005079|Glucocorticoids|glucocorticoids|mesh-ancestor
64685725|NCT04005079|Hormones|hormones|mesh-ancestor
64685726|NCT04005079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64685727|NCT04005079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411074|NCT05023473|Morphine|morphine|mesh-list
64685728|NCT04005079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64685729|NCT04005079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685730|NCT04005079|Autonomic Agents|autonomic agents|mesh-ancestor
64685731|NCT04005079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64685732|NCT04005079|Miotics|miotics|mesh-ancestor
64685733|NCT04005079|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64685734|NCT04005079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64716689|NCT04749810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64716690|NCT04749810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64716691|NCT04749810|Immunologic Factors|immunologic factors|mesh-ancestor
65452951|NCT04917406|Autonomic Agents|autonomic agents|mesh-ancestor
65452952|NCT04917406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452953|NCT04917406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452954|NCT04917406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65452955|NCT04917406|Glucocorticoids|glucocorticoids|mesh-ancestor
65452956|NCT04917406|Hormones|hormones|mesh-ancestor
65452957|NCT04917406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65452958|NCT04917406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65452959|NCT04917406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452960|NCT04917406|Anesthetics, Local|anesthetics, local|mesh-ancestor
65452961|NCT04917406|Anesthetics|anesthetics|mesh-ancestor
65452962|NCT04917406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65452963|NCT04917406|Sensory System Agents|sensory system agents|mesh-ancestor
65452964|NCT04917406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65452965|NCT04917406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64685735|NCT04005079|Cholinergic Agents|cholinergic agents|mesh-ancestor
64685736|NCT04005079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64685737|NCT04005079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685738|NCT04005079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64685739|NCT04005079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64685740|NCT04005079|Renal Agents|renal agents|mesh-ancestor
64685741|NCT04005079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64685742|NCT04005079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64685743|NCT04005079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64685744|NCT04005079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685745|NCT04005079|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64685746|NCT04005079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64685747|NCT01762501|Amlodipine|amlodipine|mesh-list
64685748|NCT01762501|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
64685754|NCT01762501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685755|NCT01762501|Vasodilator Agents|vasodilator agents|mesh-ancestor
64685756|NCT01762501|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64685757|NCT01762501|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64685758|NCT01764607|Sirolimus|sirolimus|mesh-list
64685759|NCT01764607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64685760|NCT01764607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64685761|NCT01764607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64685762|NCT01764607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685763|NCT01764607|Antifungal Agents|antifungal agents|mesh-ancestor
64685764|NCT01764607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64685765|NCT01764607|Immunologic Factors|immunologic factors|mesh-ancestor
64685766|NCT01764607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685822|NCT01769209|Antimitotic Agents|antimitotic agents|mesh-ancestor
64685823|NCT01769209|Mitosis Modulators|mitosis modulators|mesh-ancestor
64685824|NCT01769365|Amoxicillin|amoxicillin|mesh-list
64685825|NCT01769365|Metronidazole|metronidazole|mesh-list
64685826|NCT01769365|Clarithromycin|clarithromycin|mesh-list
64685827|NCT01769365|Pantoprazole|pantoprazole|mesh-list
64685828|NCT01769365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64685829|NCT01769365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64685830|NCT01769365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64685831|NCT01769365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64685832|NCT01769365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64685833|NCT01769365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685834|NCT01769365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685835|NCT01769365|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64685836|NCT01769365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64685837|NCT01769365|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65452966|NCT04917406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65452967|NCT04917406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65452968|NCT04917406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452969|NCT02685826|Dexamethasone|dexamethasone|mesh-list
65452970|NCT02685826|Lenalidomide|lenalidomide|mesh-list
65452971|NCT02685826|Durvalumab|durvalumab|mesh-list
65452972|NCT02685826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65452973|NCT02685826|Antiemetics|antiemetics|mesh-ancestor
65452974|NCT02685826|Autonomic Agents|autonomic agents|mesh-ancestor
65452975|NCT02685826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65452976|NCT02685826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65452977|NCT02685826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64685838|NCT01769365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64685839|NCT01769365|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64685840|NCT01771627|Nicotine|nicotine|mesh-list
64685841|NCT01771627|Varenicline|varenicline|mesh-list
64685842|NCT01771627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64685843|NCT01771627|Autonomic Agents|autonomic agents|mesh-ancestor
64685844|NCT01771627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64685845|NCT01771627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685846|NCT01771627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64685847|NCT01771627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64685848|NCT01771627|Cholinergic Agents|cholinergic agents|mesh-ancestor
64685849|NCT01771627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64685850|NCT01771627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685851|NCT03749629|Psychotropic Drugs|psychotropic drugs|mesh-list
64685852|NCT03682393|Hydrocortisone|hydrocortisone|mesh-list
64685853|NCT03682393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64685854|NCT03499483|Tenofovir|tenofovir|mesh-list
64685855|NCT03499483|Emtricitabine|emtricitabine|mesh-list
64685856|NCT03499483|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64324960|NCT01038739|Analgesics|analgesics|mesh-ancestor
64324977|NCT01336465|Etrolizumab|etrolizumab|mesh-list
64716692|NCT04749810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716693|NCT00377078|Lactoferrin|lactoferrin|mesh-list
64716694|NCT00377078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64716695|NCT04495712|Spironolactone|spironolactone|mesh-list
64716696|NCT04495712|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64716697|NCT04495712|Hormone Antagonists|hormone antagonists|mesh-ancestor
64716698|NCT04495712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64685857|NCT03499483|Antiviral Agents|antiviral agents|mesh-ancestor
64685858|NCT03499483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64685859|NCT03499483|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64685860|NCT03499483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64685861|NCT03499483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685926|NCT05451043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64685927|NCT05451043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64685930|NCT05451043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64685931|NCT05451043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64685932|NCT05451043|Vasodilator Agents|vasodilator agents|mesh-ancestor
64685934|NCT02652169|Teicoplanin|teicoplanin|mesh-list
64685935|NCT02652169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64685936|NCT02652169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64685937|NCT02478775|Cetrorelix|cetrorelix|mesh-list
64685938|NCT02478775|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64685939|NCT02478775|Fertility Agents|fertility agents|mesh-ancestor
64685940|NCT02478775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64685941|NCT02478775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685942|NCT02478775|Hormone Antagonists|hormone antagonists|mesh-ancestor
64685943|NCT02478775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64685944|NCT01783561|Caffeine|caffeine|mesh-list
64685945|NCT01783561|Caffeine citrate|caffeine citrate|mesh-list
64685946|NCT01783561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65452978|NCT02685826|Glucocorticoids|glucocorticoids|mesh-ancestor
65452979|NCT02685826|Hormones|hormones|mesh-ancestor
65452980|NCT02685826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65452981|NCT02685826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65452982|NCT02685826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452983|NCT02685826|Immunologic Factors|immunologic factors|mesh-ancestor
65452984|NCT02685826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65452985|NCT02685826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65452986|NCT02685826|Growth Substances|growth substances|mesh-ancestor
65452987|NCT02685826|Growth Inhibitors|growth inhibitors|mesh-ancestor
65452988|NCT02685826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65452989|NCT04906720|Colchicine|colchicine|mesh-list
65452990|NCT04906720|Gout Suppressants|gout suppressants|mesh-ancestor
65452991|NCT04906720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65452992|NCT04906720|Tubulin Modulators|tubulin modulators|mesh-ancestor
65452993|NCT04906720|Antimitotic Agents|antimitotic agents|mesh-ancestor
65452994|NCT04906720|Mitosis Modulators|mitosis modulators|mesh-ancestor
65452995|NCT04906720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685947|NCT01783561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64685948|NCT01783561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685958|NCT02452931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64685959|NCT02452931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685960|NCT02452931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64685961|NCT02452931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685962|NCT04744727|Acetaminophen|acetaminophen|mesh-list
64685964|NCT04744727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64685965|NCT04744727|Analgesics|analgesics|mesh-ancestor
64685966|NCT04744727|Sensory System Agents|sensory system agents|mesh-ancestor
64685967|NCT04744727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64685968|NCT04744727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685969|NCT04744727|Antipyretics|antipyretics|mesh-ancestor
64685970|NCT04744727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64685971|NCT04744727|Narcotics|narcotics|mesh-ancestor
64685972|NCT04744727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64685973|NCT04744727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64685974|NCT02454179|Pembrolizumab|pembrolizumab|mesh-list
64716699|NCT04495712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716700|NCT04495712|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64716702|NCT04495712|Natriuretic Agents|natriuretic agents|mesh-ancestor
64716703|NCT03553940|Vaccines|vaccines|mesh-list
64716704|NCT03553940|Immunologic Factors|immunologic factors|mesh-ancestor
64716705|NCT03553940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716706|NCT04456634|Lumefantrine|lumefantrine|mesh-list
64716707|NCT04456634|Artemether|artemether|mesh-list
64716708|NCT04456634|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64716709|NCT04456634|Antimalarials|antimalarials|mesh-ancestor
64716710|NCT04456634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64716711|NCT04456634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64716712|NCT04456634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64716713|NCT00377624|Hyaluronic Acid|hyaluronic acid|mesh-list
64716714|NCT00377624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64716715|NCT00377624|Immunologic Factors|immunologic factors|mesh-ancestor
64716716|NCT00377624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716717|NCT00377624|Viscosupplements|viscosupplements|mesh-ancestor
64685975|NCT02454179|Acalabrutinib|acalabrutinib|mesh-list
64685976|NCT02454179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64685977|NCT02454179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452996|NCT04906720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65452997|NCT01141192|Vitamin D|vitamin d|mesh-list
65452998|NCT01141192|Cholecalciferol|cholecalciferol|mesh-list
65452999|NCT01141192|Vitamins|vitamins|mesh-ancestor
65453000|NCT01141192|Micronutrients|micronutrients|mesh-ancestor
65453001|NCT01141192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453002|NCT01141192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65453003|NCT01141192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65453004|NCT01144000|Daptomycin|daptomycin|mesh-list
65453005|NCT01144000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65453006|NCT01144000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65453007|NCT01140412|Ritonavir|ritonavir|mesh-list
65453008|NCT01140412|Fosamprenavir|fosamprenavir|mesh-list
65453009|NCT01140412|Maraviroc|maraviroc|mesh-list
65453010|NCT01140412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65453011|NCT01140412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65453012|NCT01140412|Protease Inhibitors|protease inhibitors|mesh-ancestor
65453013|NCT01140412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453014|NCT01140412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453015|NCT01140412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64685978|NCT02041533|Gemcitabine|gemcitabine|mesh-list
64685979|NCT02041533|Paclitaxel|paclitaxel|mesh-list
64685980|NCT02041533|Carboplatin|carboplatin|mesh-list
64685981|NCT02041533|Nivolumab|nivolumab|mesh-list
64685982|NCT02041533|Pemetrexed|pemetrexed|mesh-list
64685983|NCT02041533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64685984|NCT02041533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685985|NCT02041533|Tubulin Modulators|tubulin modulators|mesh-ancestor
64685986|NCT02041533|Antimitotic Agents|antimitotic agents|mesh-ancestor
64685987|NCT02041533|Mitosis Modulators|mitosis modulators|mesh-ancestor
64685988|NCT02041533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685989|NCT02041533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64685990|NCT02041533|Antimetabolites|antimetabolites|mesh-ancestor
64685991|NCT02041533|Antiviral Agents|antiviral agents|mesh-ancestor
64685992|NCT02041533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64685993|NCT02041533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685994|NCT02041533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64685997|NCT02041533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64685998|NCT02041533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64685999|NCT02041533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64686000|NCT02041533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64686001|NCT02260531|Trastuzumab|trastuzumab|mesh-list
64686002|NCT02260531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64686003|NCT02260531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686004|NCT02458235|Azacitidine|azacitidine|mesh-list
64686005|NCT02458235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64686006|NCT02458235|Antimetabolites|antimetabolites|mesh-ancestor
64686007|NCT02458235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686008|NCT02458235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686009|NCT02458235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686010|NCT02115997|Prednisone|prednisone|mesh-list
64686011|NCT02115997|Methylprednisolone|methylprednisolone|mesh-list
64686012|NCT02115997|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64686013|NCT02115997|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64716719|NCT03562988|Vitamins|vitamins|mesh-list
64716720|NCT03562988|Ascorbic Acid|ascorbic acid|mesh-list
64716721|NCT03562988|Micronutrients|micronutrients|mesh-ancestor
64716722|NCT03562988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453016|NCT01140412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65453017|NCT01140412|Antiviral Agents|antiviral agents|mesh-ancestor
65453018|NCT01140412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65453019|NCT01140412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65453020|NCT01140412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65453021|NCT01140412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65453022|NCT01140412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65453023|NCT01140412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65453024|NCT01234324|Cisplatin|cisplatin|mesh-list
65453025|NCT01234324|Capecitabine|capecitabine|mesh-list
65453026|NCT01234324|Epirubicin|epirubicin|mesh-list
65453027|NCT01234324|Panitumumab|panitumumab|mesh-list
65453028|NCT01234324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453029|NCT01234324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64716723|NCT03562988|Antioxidants|antioxidants|mesh-ancestor
64716724|NCT03562988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716725|NCT03562988|Protective Agents|protective agents|mesh-ancestor
64716726|NCT03644108|Guaifenesin|guaifenesin|mesh-list
64716727|NCT03644108|Expectorants|expectorants|mesh-ancestor
64686014|NCT02115997|Prednisolone|prednisolone|mesh-list
64686015|NCT02115997|Prednisolone acetate|prednisolone acetate|mesh-list
64686016|NCT02115997|Rituximab|rituximab|mesh-list
64686017|NCT02115997|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64686034|NCT02115997|Protective Agents|protective agents|mesh-ancestor
64686036|NCT01805323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64686037|NCT01805323|Antiemetics|antiemetics|mesh-ancestor
64686038|NCT01805323|Autonomic Agents|autonomic agents|mesh-ancestor
64686039|NCT01805323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686040|NCT01805323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686041|NCT01805323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64686042|NCT01805323|Glucocorticoids|glucocorticoids|mesh-ancestor
64686043|NCT01805323|Hormones|hormones|mesh-ancestor
64686044|NCT01805323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64686045|NCT01805323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64686046|NCT01805323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686047|NCT01641055|Caseins|caseins|mesh-list
64686048|NCT01641055|Chelating Agents|chelating agents|mesh-ancestor
64686049|NCT01641055|Sequestering Agents|sequestering agents|mesh-ancestor
64686050|NCT01641055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686051|NCT01788631|Regadenoson|regadenoson|mesh-list
64686052|NCT01788631|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64686053|NCT01788631|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64686054|NCT01788631|Purinergic Agonists|purinergic agonists|mesh-ancestor
64686055|NCT01788631|Purinergic Agents|purinergic agents|mesh-ancestor
64686056|NCT01788631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64686057|NCT01788631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686058|NCT01788631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686059|NCT00907283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64686060|NCT00907283|Deferiprone|deferiprone|mesh-list
64686061|NCT00907283|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64686062|NCT00907283|Chelating Agents|chelating agents|mesh-ancestor
64686063|NCT00907283|Sequestering Agents|sequestering agents|mesh-ancestor
64686064|NCT00907283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686065|NCT01789255|Cyclosporine|cyclosporine|mesh-list
64686066|NCT01789255|Methotrexate|methotrexate|mesh-list
64686067|NCT01789255|Vorinostat|vorinostat|mesh-list
64686068|NCT01789255|Tacrolimus|tacrolimus|mesh-list
64686069|NCT01789255|Cyclosporins|cyclosporins|mesh-list
64686070|NCT01789255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64686071|NCT01789255|Abortifacient Agents|abortifacient agents|mesh-ancestor
64686072|NCT01789255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64686073|NCT01789255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453030|NCT01234324|Antimetabolites|antimetabolites|mesh-ancestor
65453031|NCT01234324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453032|NCT01234324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65453033|NCT01234324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65453034|NCT01234324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65453035|NCT01234324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453036|NCT01234324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65453037|NCT02334124|Ceftriaxone|ceftriaxone|mesh-list
65453038|NCT02334124|Floxacillin|floxacillin|mesh-list
65453039|NCT02334124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65453040|NCT02334124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65453041|NCT01144156|Adalimumab|adalimumab|mesh-list
65453042|NCT01144156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65453043|NCT01144156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65453044|NCT01235260|Becaplermin|becaplermin|mesh-list
65453045|NCT01235260|Anticoagulants|anticoagulants|mesh-ancestor
65453046|NCT01235260|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
65453047|NCT01235260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65453048|NCT01235260|Growth Substances|growth substances|mesh-ancestor
65453049|NCT01235260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453050|NCT01144312|Fentanyl|fentanyl|mesh-list
65453051|NCT01144312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64686074|NCT01789255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64686075|NCT01789255|Antimetabolites|antimetabolites|mesh-ancestor
64686076|NCT01789255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686096|NCT01808755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64686097|NCT01808755|Renal Agents|renal agents|mesh-ancestor
64686098|NCT01808755|Antimalarials|antimalarials|mesh-ancestor
64686099|NCT01808755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64686100|NCT01808755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64686101|NCT01808755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64686102|NCT01808755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686103|NCT01808755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716728|NCT03644108|Respiratory System Agents|respiratory system agents|mesh-ancestor
64716729|NCT04713956|Cyclophosphamide|cyclophosphamide|mesh-list
64686104|NCT01808755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64686105|NCT01808755|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64686106|NCT01808755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64686107|NCT02694809|Bazedoxifene|bazedoxifene|mesh-list
64686109|NCT02694809|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64686110|NCT02694809|Hormones|hormones|mesh-ancestor
64686111|NCT02694809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64686112|NCT02694809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686113|NCT02694809|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64686114|NCT02694809|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64686115|NCT02694809|Hormone Antagonists|hormone antagonists|mesh-ancestor
64686116|NCT02694809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64686117|NCT00568997|Pimecrolimus|pimecrolimus|mesh-list
64686118|NCT00568997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64686119|NCT00568997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64686120|NCT00568997|Analgesics|analgesics|mesh-ancestor
64686121|NCT00568997|Sensory System Agents|sensory system agents|mesh-ancestor
65453052|NCT01144312|Narcotics|narcotics|mesh-ancestor
65453053|NCT01144312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65453054|NCT01144312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453055|NCT01144312|Analgesics|analgesics|mesh-ancestor
65453056|NCT01144312|Sensory System Agents|sensory system agents|mesh-ancestor
65453057|NCT01144312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65453058|NCT01144312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65453059|NCT01144312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65453060|NCT01144312|Anesthetics, General|anesthetics, general|mesh-ancestor
65453061|NCT01144312|Anesthetics|anesthetics|mesh-ancestor
64686122|NCT00568997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686123|NCT00568997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686124|NCT00568997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64686125|NCT00568997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64686126|NCT00568997|Dermatologic Agents|dermatologic agents|mesh-ancestor
64686127|NCT00568997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64686128|NCT00568997|Immunologic Factors|immunologic factors|mesh-ancestor
64686129|NCT00568997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64686130|NCT00568997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686131|NCT00568997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686132|NCT00362687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64686146|NCT01790659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686147|NCT01790659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686148|NCT01790659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64686149|NCT01790659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64686151|NCT00544115|Sirolimus|sirolimus|mesh-list
64686152|NCT00544115|Mycophenolic Acid|mycophenolic acid|mesh-list
64686153|NCT00544115|Cyclophosphamide|cyclophosphamide|mesh-list
64686154|NCT00544115|Melphalan|melphalan|mesh-list
64686155|NCT00544115|Busulfan|busulfan|mesh-list
64686156|NCT00544115|Methotrexate|methotrexate|mesh-list
64686157|NCT00544115|Fludarabine|fludarabine|mesh-list
64686158|NCT00544115|Fludarabine phosphate|fludarabine phosphate|mesh-list
64686159|NCT00544115|Etoposide|etoposide|mesh-list
64686160|NCT00544115|Tacrolimus|tacrolimus|mesh-list
64686161|NCT00544115|Cyclosporins|cyclosporins|mesh-list
64686162|NCT00544115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64686163|NCT00544115|Immunologic Factors|immunologic factors|mesh-ancestor
64686164|NCT00544115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686165|NCT00544115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64686166|NCT00544115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64686167|NCT00544115|Alkylating Agents|alkylating agents|mesh-ancestor
64686168|NCT00544115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686169|NCT00544115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686170|NCT00544115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64686171|NCT00544115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64686172|NCT00544115|Abortifacient Agents|abortifacient agents|mesh-ancestor
64686173|NCT00544115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64686174|NCT00544115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64686175|NCT00544115|Antimetabolites|antimetabolites|mesh-ancestor
64686176|NCT00544115|Dermatologic Agents|dermatologic agents|mesh-ancestor
64686177|NCT00544115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686178|NCT00544115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64686179|NCT00544115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64686183|NCT00544115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64686184|NCT00544115|Antifungal Agents|antifungal agents|mesh-ancestor
64686185|NCT00544115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64686186|NCT00544115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64716732|NCT04713956|Decitabine|decitabine|mesh-list
64716733|NCT04713956|Lenograstim|lenograstim|mesh-list
64716734|NCT04713956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64716735|NCT04713956|Immunologic Factors|immunologic factors|mesh-ancestor
64716736|NCT04713956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716737|NCT04713956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64716738|NCT04713956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64716739|NCT04713956|Alkylating Agents|alkylating agents|mesh-ancestor
65453062|NCT01144390|Methadone|methadone|mesh-list
65453063|NCT01144390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65453064|NCT01144390|Narcotics|narcotics|mesh-ancestor
65453065|NCT01144390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65453066|NCT01144390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453067|NCT01144390|Analgesics|analgesics|mesh-ancestor
65453068|NCT01144390|Sensory System Agents|sensory system agents|mesh-ancestor
65453069|NCT01144390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65453070|NCT01144390|Antitussive Agents|antitussive agents|mesh-ancestor
65453071|NCT01144390|Respiratory System Agents|respiratory system agents|mesh-ancestor
65453072|NCT01329640|Paclitaxel|paclitaxel|mesh-list
65453073|NCT01329640|Cyclophosphamide|cyclophosphamide|mesh-list
65453074|NCT01329640|Trastuzumab|trastuzumab|mesh-list
65453075|NCT01329640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64716740|NCT04713956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716741|NCT04713956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64716742|NCT04713956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64716743|NCT04713956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64716744|NCT04713956|Antimetabolites|antimetabolites|mesh-ancestor
64716745|NCT04713956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64716746|NCT04713956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64716747|NCT04425746|Afamelanotide|afamelanotide|mesh-list
64686187|NCT00544115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64686188|NCT00544115|Antitubercular Agents|antitubercular agents|mesh-ancestor
64686189|NCT00544115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64686190|NCT02469701|Nivolumab|nivolumab|mesh-list
64686191|NCT02469701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64686192|NCT02469701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686193|NCT02469701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64686194|NCT02469701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686221|NCT01796665|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64686222|NCT01796665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686223|NCT01796665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686224|NCT01796665|Dermatologic Agents|dermatologic agents|mesh-ancestor
64686225|NCT02586857|Acalabrutinib|acalabrutinib|mesh-list
64686226|NCT02586857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686227|NCT01798225|Doxycycline|doxycycline|mesh-list
64686228|NCT01798225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64686229|NCT01798225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64686230|NCT01798225|Antimalarials|antimalarials|mesh-ancestor
64686231|NCT01798225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64686232|NCT01798225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64686233|NCT02581085|Tocotrienols|tocotrienols|mesh-list
64686234|NCT02581085|Vitamin E|vitamin e|mesh-list
64686235|NCT02581085|Tocopherols|tocopherols|mesh-list
64686236|NCT02581085|Antioxidants|antioxidants|mesh-ancestor
64686237|NCT02581085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686238|NCT02581085|Protective Agents|protective agents|mesh-ancestor
64686239|NCT02581085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686240|NCT02581085|Vitamins|vitamins|mesh-ancestor
64686241|NCT02581085|Micronutrients|micronutrients|mesh-ancestor
64686242|NCT01800877|Phenylephrine|phenylephrine|mesh-list
64686243|NCT01800877|Dopamine|dopamine|mesh-list
64686244|NCT01800877|Vasopressins|vasopressins|mesh-list
64686245|NCT01800877|Epinephrine|epinephrine|mesh-list
64686265|NCT01800877|Protective Agents|protective agents|mesh-ancestor
64686266|NCT01800877|Hemostatics|hemostatics|mesh-ancestor
64686267|NCT01800877|Coagulants|coagulants|mesh-ancestor
64686268|NCT01800877|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64686269|NCT01800877|Natriuretic Agents|natriuretic agents|mesh-ancestor
64686270|NCT01800877|Dopamine Agents|dopamine agents|mesh-ancestor
64686271|NCT02471651|Dexamethasone|dexamethasone|mesh-list
64686272|NCT02471651|Ranibizumab|ranibizumab|mesh-list
64686273|NCT02471651|Aflibercept|aflibercept|mesh-list
64686274|NCT02471651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453076|NCT01329640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453077|NCT01329640|Tubulin Modulators|tubulin modulators|mesh-ancestor
65453078|NCT01329640|Antimitotic Agents|antimitotic agents|mesh-ancestor
65453079|NCT01329640|Mitosis Modulators|mitosis modulators|mesh-ancestor
65453080|NCT01329640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453081|NCT01329640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65453082|NCT01329640|Immunologic Factors|immunologic factors|mesh-ancestor
65453083|NCT01329640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453084|NCT01329640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65453085|NCT01329640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65453086|NCT01329640|Alkylating Agents|alkylating agents|mesh-ancestor
65453087|NCT01329640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64686275|NCT02471651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64716748|NCT04425746|Dermatologic Agents|dermatologic agents|mesh-ancestor
64716749|NCT04392362|Adenosine|adenosine|mesh-list
64716750|NCT04392362|Analgesics|analgesics|mesh-ancestor
64716751|NCT04392362|Sensory System Agents|sensory system agents|mesh-ancestor
64716752|NCT04392362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716753|NCT04392362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716754|NCT04392362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64686278|NCT02471651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686279|NCT02471651|Growth Inhibitors|growth inhibitors|mesh-ancestor
64686280|NCT02471651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64686281|NCT02471651|Antiemetics|antiemetics|mesh-ancestor
64686282|NCT02471651|Autonomic Agents|autonomic agents|mesh-ancestor
64686283|NCT02471651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686284|NCT02471651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64686285|NCT02471651|Glucocorticoids|glucocorticoids|mesh-ancestor
64686287|NCT02471651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64686288|NCT02471651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64686289|NCT02477423|Gentamicins|gentamicins|mesh-list
64686290|NCT02477423|Ampicillin|ampicillin|mesh-list
64686291|NCT02477423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64686292|NCT02477423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64686293|NCT02477423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64686294|NCT02477423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686295|NCT02477423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686296|NCT00363701|Esomeprazole|esomeprazole|mesh-list
64686297|NCT00363701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64686298|NCT00363701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64686299|NCT00363701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64686300|NCT00363701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686301|NCT00363701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686322|NCT04744571|Antipyretics|antipyretics|mesh-ancestor
64686323|NCT04744571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64686324|NCT04744571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64686325|NCT04744571|Antimetabolites|antimetabolites|mesh-ancestor
64686326|NCT04744571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64686327|NCT04744571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64686328|NCT04744571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64686329|NCT04744571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64686330|NCT04744571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64686331|NCT04744571|Purinergic Agents|purinergic agents|mesh-ancestor
64686332|NCT04744571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64686333|NCT04744571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64686334|NCT04744571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64686335|NCT04744571|Sympatholytics|sympatholytics|mesh-ancestor
64686336|NCT04744571|Autonomic Agents|autonomic agents|mesh-ancestor
64686337|NCT04744571|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64686338|NCT04744571|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64686339|NCT04744571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65453088|NCT01329640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65453089|NCT05335018|Lenalidomide|lenalidomide|mesh-list
65453090|NCT05335018|Immunologic Factors|immunologic factors|mesh-ancestor
65453091|NCT05335018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453092|NCT05335018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65453093|NCT05335018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65453094|NCT05335018|Growth Substances|growth substances|mesh-ancestor
65453095|NCT05335018|Growth Inhibitors|growth inhibitors|mesh-ancestor
65453096|NCT05335018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453097|NCT00114777|Cyclosporine|cyclosporine|mesh-list
65453098|NCT00114777|Abatacept|abatacept|mesh-list
65453099|NCT00114777|Cyclosporins|cyclosporins|mesh-list
65453100|NCT00114777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453101|NCT00114777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453102|NCT00114777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65453103|NCT00114777|Immunologic Factors|immunologic factors|mesh-ancestor
65453104|NCT00114777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453105|NCT00114777|Antifungal Agents|antifungal agents|mesh-ancestor
65453106|NCT00114777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64837729|NCT01620476|Liraglutide|liraglutide|mesh-list
64686340|NCT04744571|Adrenergic Agents|adrenergic agents|mesh-ancestor
64686341|NCT00363155|KRN 7000|krn 7000|mesh-list
64686342|NCT00363155|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64686343|NCT00363155|Immunologic Factors|immunologic factors|mesh-ancestor
64686344|NCT00363155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686345|NCT00363155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686347|NCT02519387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64686348|NCT02519387|Narcotics|narcotics|mesh-ancestor
64686349|NCT02519387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64686350|NCT02519387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686351|NCT02519387|Analgesics|analgesics|mesh-ancestor
64686352|NCT02519387|Sensory System Agents|sensory system agents|mesh-ancestor
64686353|NCT02519387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686354|NCT02519387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64686355|NCT02257957|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64686356|NCT02257957|Hyaluronic Acid|hyaluronic acid|mesh-list
64686357|NCT02257957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64686368|NCT02525549|Adapalene|adapalene|mesh-list
64716755|NCT04392362|Vasodilator Agents|vasodilator agents|mesh-ancestor
64716756|NCT04392362|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64716757|NCT04392362|Purinergic Agonists|purinergic agonists|mesh-ancestor
64716758|NCT04392362|Purinergic Agents|purinergic agents|mesh-ancestor
64716759|NCT04392362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64716760|NCT04392362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716761|NCT04734782|Antibodies|antibodies|mesh-list
64716762|NCT04734782|Immunologic Factors|immunologic factors|mesh-ancestor
64716763|NCT04734782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716764|NCT04390022|Ivermectin|ivermectin|mesh-list
64716765|NCT04390022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64716766|NCT04390022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64716773|NCT04374500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64716774|NCT04374500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64716775|NCT04374500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64716776|NCT04374500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716777|NCT04374500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64716778|NCT04374500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453107|NCT00114777|Dermatologic Agents|dermatologic agents|mesh-ancestor
65453108|NCT00114777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65453109|NCT00114777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65453110|NCT00114777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65453111|NCT00114777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453112|NCT00139737|Ziprasidone|ziprasidone|mesh-list
65453113|NCT00139737|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65453114|NCT00139737|Serotonin Agents|serotonin agents|mesh-ancestor
65453115|NCT00139737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65453116|NCT00139737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453117|NCT00139737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453118|NCT00139737|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65453119|NCT00139737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65453120|NCT00139737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65453121|NCT00139737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65453122|NCT00139737|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65453123|NCT00139737|Dopamine Agents|dopamine agents|mesh-ancestor
65453124|NCT00139659|Insulin|insulin|mesh-list
64716779|NCT04374500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64716780|NCT04374500|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64716781|NCT04374500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64716782|NCT04374500|Cholinergic Agents|cholinergic agents|mesh-ancestor
64716783|NCT04374500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64325044|NCT03164421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686369|NCT02525549|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64686370|NCT02525549|Dermatologic Agents|dermatologic agents|mesh-ancestor
64686371|NCT02525549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64686372|NCT02525549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64686373|NCT02525549|Analgesics|analgesics|mesh-ancestor
64686374|NCT02525549|Sensory System Agents|sensory system agents|mesh-ancestor
64686375|NCT02525549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686376|NCT02525549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686377|NCT02525549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64686378|NCT02525549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64686379|NCT01878799|Sofosbuvir|sofosbuvir|mesh-list
64686380|NCT01878799|Ledipasvir|ledipasvir|mesh-list
64686381|NCT01878799|Antiviral Agents|antiviral agents|mesh-ancestor
64686382|NCT01878799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64716785|NCT04370834|Immunoglobulin G|immunoglobulin g|mesh-list
64716786|NCT04370834|Immunologic Factors|immunologic factors|mesh-ancestor
64716787|NCT04370834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716788|NCT03570476|Olaparib|olaparib|mesh-list
64716789|NCT03570476|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64716790|NCT03570476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64716791|NCT03570476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716792|NCT03570476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64716793|NCT03571724|Menthol|menthol|mesh-list
64716794|NCT03571724|Nicotine|nicotine|mesh-list
64716795|NCT03571724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64716796|NCT03571724|Autonomic Agents|autonomic agents|mesh-ancestor
64716797|NCT03571724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716798|NCT03571724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325070|NCT02628704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64686383|NCT02527265|Insulin|insulin|mesh-list
64686384|NCT02527265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64686385|NCT02527265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686386|NCT01879345|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64686387|NCT01879345|Anticonvulsants|anticonvulsants|mesh-ancestor
65453125|NCT00139659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65453126|NCT00139659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65453127|NCT00139659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453128|NCT01076439|Fluticasone|fluticasone|mesh-list
65453129|NCT01076439|Xhance|xhance|mesh-list
65453130|NCT01076439|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
65453131|NCT01076439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65453132|NCT01076439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65453133|NCT01076439|Autonomic Agents|autonomic agents|mesh-ancestor
65453134|NCT01076439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65453135|NCT01076439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453136|NCT01076439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65453137|NCT01076439|Respiratory System Agents|respiratory system agents|mesh-ancestor
65453138|NCT01076439|Dermatologic Agents|dermatologic agents|mesh-ancestor
65453139|NCT01076439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65453140|NCT01076439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65453141|NCT01076439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65453142|NCT01076439|Analgesics|analgesics|mesh-ancestor
65453143|NCT01076439|Sensory System Agents|sensory system agents|mesh-ancestor
65453144|NCT01076439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65453145|NCT01076439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64686388|NCT01879345|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64686389|NCT01879345|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64686390|NCT01879345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64686391|NCT01879345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686392|NCT01804075|Morphine|morphine|mesh-list
64686393|NCT01804075|Methadone|methadone|mesh-list
64686394|NCT01804075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64686395|NCT01804075|Narcotics|narcotics|mesh-ancestor
64686396|NCT01804075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64686397|NCT01804075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686398|NCT01804075|Analgesics|analgesics|mesh-ancestor
64686399|NCT01804075|Sensory System Agents|sensory system agents|mesh-ancestor
64686400|NCT01804075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686401|NCT01804075|Antitussive Agents|antitussive agents|mesh-ancestor
64686402|NCT01804075|Respiratory System Agents|respiratory system agents|mesh-ancestor
64686403|NCT02416193|Vitamin D|vitamin d|mesh-list
64686404|NCT02416193|Ergocalciferols|ergocalciferols|mesh-list
64686405|NCT02416193|Cholecalciferol|cholecalciferol|mesh-list
64686406|NCT02416193|Vitamins|vitamins|mesh-list
64686412|NCT02530151|Morphine|morphine|mesh-list
64686413|NCT02530151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64686414|NCT02530151|Narcotics|narcotics|mesh-ancestor
64686415|NCT02530151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64686416|NCT02530151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686417|NCT02530151|Analgesics|analgesics|mesh-ancestor
64686418|NCT02530151|Sensory System Agents|sensory system agents|mesh-ancestor
64686419|NCT02530151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686420|NCT02530151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64686421|NCT02530151|Sympatholytics|sympatholytics|mesh-ancestor
64686422|NCT02530151|Autonomic Agents|autonomic agents|mesh-ancestor
64686441|NCT02531321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64686442|NCT02531321|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64686444|NCT02531321|Estrogens|estrogens|mesh-ancestor
64686445|NCT02531321|Hormones|hormones|mesh-ancestor
65453146|NCT01076439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65453147|NCT01076439|Histamine Antagonists|histamine antagonists|mesh-ancestor
65453148|NCT01076439|Histamine Agents|histamine agents|mesh-ancestor
65453149|NCT01076439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65453150|NCT01076439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453151|NCT03965637|Ascorbic Acid|ascorbic acid|mesh-list
65453152|NCT03965637|Vitamins|vitamins|mesh-ancestor
65453153|NCT03965637|Micronutrients|micronutrients|mesh-ancestor
65453154|NCT03965637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453155|NCT03965637|Antioxidants|antioxidants|mesh-ancestor
65453156|NCT03965637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453157|NCT03965637|Protective Agents|protective agents|mesh-ancestor
64716800|NCT03571724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64716801|NCT03571724|Cholinergic Agents|cholinergic agents|mesh-ancestor
64716802|NCT03571724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64716803|NCT03571724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716804|NCT03571724|Antipruritics|antipruritics|mesh-ancestor
64686446|NCT02531321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64686447|NCT02531321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686448|NCT02531321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64686449|NCT02531321|Contraceptive Agents|contraceptive agents|mesh-ancestor
64686450|NCT02531321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64686451|NCT02531321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64686452|NCT02531321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64686453|NCT02531321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64686454|NCT02531321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64686455|NCT02531321|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64686456|NCT01805089|Melatonin|melatonin|mesh-list
64686457|NCT01805089|Antioxidants|antioxidants|mesh-ancestor
64686458|NCT01805089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686459|NCT01805089|Protective Agents|protective agents|mesh-ancestor
64686460|NCT01805089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686461|NCT01805089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64686462|NCT02417129|Rituximab|rituximab|mesh-list
64686463|NCT02417129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64686464|NCT02417129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686465|NCT02417129|Immunologic Factors|immunologic factors|mesh-ancestor
64686466|NCT02417129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686467|NCT02417129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64686468|NCT01879735|Cholylsarcosine|cholylsarcosine|mesh-list
64686469|NCT01879735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64686470|NCT02417831|Tamsulosin|tamsulosin|mesh-list
64686471|NCT02417831|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64686472|NCT02417831|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64686473|NCT02417831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64686474|NCT02417831|Adrenergic Agents|adrenergic agents|mesh-ancestor
64686475|NCT02417831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64686476|NCT02417831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686490|NCT02419547|Narcotics|narcotics|mesh-ancestor
64686491|NCT02419547|Analgesics|analgesics|mesh-ancestor
64686492|NCT02419547|Sensory System Agents|sensory system agents|mesh-ancestor
64686493|NCT02419547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686494|NCT02419547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64686495|NCT02419547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64686496|NCT02419547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64686497|NCT02419547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64686498|NCT02419547|GABA Modulators|gaba modulators|mesh-ancestor
64686499|NCT02419547|GABA Agents|gaba agents|mesh-ancestor
64686500|NCT02419547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64686501|NCT02419547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686505|NCT02533427|Norgestimate|norgestimate|mesh-list
64686506|NCT02533427|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65453158|NCT01078779|Chloroquine|chloroquine|mesh-list
65453159|NCT01078779|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65453160|NCT01078779|Amebicides|amebicides|mesh-ancestor
65453161|NCT01078779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65453162|NCT01078779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65453163|NCT01078779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65453164|NCT01078779|Antimalarials|antimalarials|mesh-ancestor
65453165|NCT01078779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65453166|NCT01078779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65453167|NCT01078779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65453168|NCT01078779|Analgesics|analgesics|mesh-ancestor
65453169|NCT01078779|Sensory System Agents|sensory system agents|mesh-ancestor
65453170|NCT01078779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686507|NCT02533427|Estradiol|estradiol|mesh-list
64686508|NCT02533427|Estrogens|estrogens|mesh-ancestor
64686509|NCT02533427|Hormones|hormones|mesh-ancestor
64686510|NCT02533427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64686511|NCT02533427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686512|NCT02533427|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64686513|NCT02533427|Contraceptive Agents|contraceptive agents|mesh-ancestor
64686514|NCT02533427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64686515|NCT02533427|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64686516|NCT02533427|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64686517|NCT02533427|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64686518|NCT02533427|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64686519|NCT02533427|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64716805|NCT03571724|Dermatologic Agents|dermatologic agents|mesh-ancestor
64716806|NCT03572972|Warfarin|warfarin|mesh-list
64716807|NCT03572972|Rivaroxaban|rivaroxaban|mesh-list
64716808|NCT03572972|Dabigatran|dabigatran|mesh-list
64716809|NCT03572972|Apixaban|apixaban|mesh-list
64716810|NCT03572972|Anticoagulants|anticoagulants|mesh-ancestor
64716811|NCT03572972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64716812|NCT03572972|Antithrombins|antithrombins|mesh-ancestor
64716813|NCT03572972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64716814|NCT03572972|Protease Inhibitors|protease inhibitors|mesh-ancestor
64716815|NCT03572972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686520|NCT05328817|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64686521|NCT05328817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64686522|NCT05328817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64686523|NCT05328817|Antitubercular Agents|antitubercular agents|mesh-ancestor
64686524|NCT05328427|Tin Fluorides|tin fluorides|mesh-list
64686525|NCT05328427|Cariostatic Agents|cariostatic agents|mesh-ancestor
64686526|NCT05328427|Protective Agents|protective agents|mesh-ancestor
64686527|NCT05328427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686528|NCT02533505|Budesonide|budesonide|mesh-list
64686529|NCT02533505|Formoterol Fumarate|formoterol fumarate|mesh-list
64686530|NCT02533505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64686531|NCT02533505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64686532|NCT02533505|Autonomic Agents|autonomic agents|mesh-ancestor
64686533|NCT02533505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686534|NCT02533505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686535|NCT02533505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64686536|NCT02533505|Respiratory System Agents|respiratory system agents|mesh-ancestor
64686537|NCT02533505|Glucocorticoids|glucocorticoids|mesh-ancestor
64686538|NCT02533505|Hormones|hormones|mesh-ancestor
64686539|NCT02533505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64686540|NCT02533505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64686556|NCT02420015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686557|NCT02420015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64686559|NCT02420015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64411839|NCT05541185|Analgesics|analgesics|mesh-ancestor
64686560|NCT02420015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65453171|NCT01078779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453172|NCT01078779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65453173|NCT01078779|Filaricides|filaricides|mesh-ancestor
65453174|NCT01078779|Antinematodal Agents|antinematodal agents|mesh-ancestor
65453175|NCT01078779|Anthelmintics|anthelmintics|mesh-ancestor
65453176|NCT00114231|Capecitabine|capecitabine|mesh-list
65453177|NCT00114231|Oxaliplatin|oxaliplatin|mesh-list
65453178|NCT00114231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65453179|NCT00114231|Antimetabolites|antimetabolites|mesh-ancestor
65453180|NCT00114231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453181|NCT00114231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453182|NCT00113919|Busulfan|busulfan|mesh-list
65453183|NCT00113919|Alkylating Agents|alkylating agents|mesh-ancestor
64686561|NCT02420015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64686562|NCT02420015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64686563|NCT02420015|Dopamine Agents|dopamine agents|mesh-ancestor
64686564|NCT02420015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64686565|NCT02420015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64686566|NCT02420015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686567|NCT05326867|Lidocaine|lidocaine|mesh-list
64686568|NCT05326867|Anesthetics, Local|anesthetics, local|mesh-ancestor
64686569|NCT05326867|Anesthetics|anesthetics|mesh-ancestor
64686570|NCT05326867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64686571|NCT05326867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686572|NCT05326867|Sensory System Agents|sensory system agents|mesh-ancestor
64686573|NCT05326867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686574|NCT05326867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64686575|NCT05326867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64686576|NCT05326867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64686577|NCT05326867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64686583|NCT05324995|Adrenergic Agents|adrenergic agents|mesh-ancestor
64686584|NCT05324995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64686585|NCT05324995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686586|NCT05324995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686587|NCT05324995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64686588|NCT05324995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64716816|NCT03572972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716818|NCT04352660|Mitomycin|mitomycin|mesh-list
64716819|NCT04352660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64716820|NCT04352660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64716821|NCT04352660|Alkylating Agents|alkylating agents|mesh-ancestor
64716822|NCT04352660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686589|NCT05324995|Autonomic Agents|autonomic agents|mesh-ancestor
64686590|NCT05324995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686591|NCT05324995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64686592|NCT05324995|Respiratory System Agents|respiratory system agents|mesh-ancestor
64686593|NCT05324995|Mydriatics|mydriatics|mesh-ancestor
64686594|NCT05324995|Sympathomimetics|sympathomimetics|mesh-ancestor
64686595|NCT05324995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64686596|NCT05324995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64686604|NCT05324995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686605|NCT05318521|Ibuprofen|ibuprofen|mesh-list
64686606|NCT05318521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64686607|NCT05318521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64686608|NCT05318521|Analgesics|analgesics|mesh-ancestor
64686609|NCT05318521|Sensory System Agents|sensory system agents|mesh-ancestor
64686610|NCT05318521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686611|NCT05318521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686612|NCT05318521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64686613|NCT05318521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64686614|NCT05318521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65453184|NCT00113919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453185|NCT00113919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65453186|NCT00113919|Immunologic Factors|immunologic factors|mesh-ancestor
65453187|NCT00113919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453188|NCT00113919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65453189|NCT00113919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453190|NCT00113919|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65453191|NCT00113841|Curcumin|curcumin|mesh-list
65453192|NCT00113841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65453193|NCT00113841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65453194|NCT00113841|Analgesics|analgesics|mesh-ancestor
65453195|NCT00113841|Sensory System Agents|sensory system agents|mesh-ancestor
65453196|NCT00113841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65453197|NCT00113841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453198|NCT00113841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65453199|NCT00113841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65453200|NCT00113841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453201|NCT00113841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453202|NCT00113841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453203|NCT00113607|Dexamethasone|dexamethasone|mesh-list
65453204|NCT00113607|Trabectedin|trabectedin|mesh-list
64686615|NCT05318521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686616|NCT05318521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686617|NCT02420873|Maytansine|maytansine|mesh-list
64686618|NCT02420873|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
64686619|NCT02420873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64686620|NCT02420873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686621|NCT02420873|Tubulin Modulators|tubulin modulators|mesh-ancestor
64686622|NCT02420873|Antimitotic Agents|antimitotic agents|mesh-ancestor
64686623|NCT02420873|Mitosis Modulators|mitosis modulators|mesh-ancestor
64686624|NCT02420873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686625|NCT02420873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64686626|NCT02534129|Petrolatum|petrolatum|mesh-list
64686627|NCT02534129|Emollients|emollients|mesh-ancestor
64686628|NCT02534129|Dermatologic Agents|dermatologic agents|mesh-ancestor
64686629|NCT02420951|Bupivacaine|bupivacaine|mesh-list
64686630|NCT02420951|Anesthetics, Local|anesthetics, local|mesh-ancestor
64686631|NCT02420951|Anesthetics|anesthetics|mesh-ancestor
64686632|NCT02420951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64686633|NCT02420951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686634|NCT02420951|Sensory System Agents|sensory system agents|mesh-ancestor
64686635|NCT02420951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686637|NCT02267083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64686638|NCT02267083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686639|NCT02267083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64686641|NCT02267083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686642|NCT02267083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686643|NCT05748145|Metronidazole|metronidazole|mesh-list
64686644|NCT05748145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64686645|NCT05748145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64686646|NCT05748145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64686647|NCT05748145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65453205|NCT00113607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65453206|NCT00113607|Antiemetics|antiemetics|mesh-ancestor
65453207|NCT00113607|Autonomic Agents|autonomic agents|mesh-ancestor
65453208|NCT00113607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65453209|NCT00113607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453210|NCT00113607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65453211|NCT00113607|Glucocorticoids|glucocorticoids|mesh-ancestor
65453212|NCT00113607|Hormones|hormones|mesh-ancestor
65453213|NCT00113607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65453214|NCT00113607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65453215|NCT00113607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453216|NCT00113607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65453217|NCT00113607|Alkylating Agents|alkylating agents|mesh-ancestor
65453218|NCT00113607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686648|NCT02535611|Memantine|memantine|mesh-list
64686652|NCT02535611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64686653|NCT02535611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686654|NCT02535611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686655|NCT02535611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64686656|NCT02535611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64716823|NCT04352660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64716824|NCT04352660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64716826|NCT04343222|Lubricant Eye Drops|lubricant eye drops|mesh-list
64716827|NCT04343222|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64716828|NCT04343222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64716829|NCT04343222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64686658|NCT01823497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64686659|NCT01823497|Narcotics|narcotics|mesh-ancestor
64686660|NCT01823497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64686661|NCT01823497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686662|NCT01823497|Analgesics|analgesics|mesh-ancestor
64686663|NCT01823497|Sensory System Agents|sensory system agents|mesh-ancestor
64686664|NCT01823497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686665|NCT00363935|Dexmedetomidine|dexmedetomidine|mesh-list
64686676|NCT00363935|Adrenergic Agents|adrenergic agents|mesh-ancestor
64686677|NCT00363935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64686678|NCT00363935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686679|NCT05747521|Doxorubicin|doxorubicin|mesh-list
64686680|NCT05747521|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64686681|NCT05747521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64686682|NCT05747521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686683|NCT05747521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64686684|NCT05747521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64686685|NCT05747521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686686|NCT05747521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686687|NCT02537873|Cocaine|cocaine|mesh-list
64686688|NCT02537873|Anesthetics, Local|anesthetics, local|mesh-ancestor
64686689|NCT02537873|Anesthetics|anesthetics|mesh-ancestor
64686690|NCT02537873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64686691|NCT02537873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686692|NCT02537873|Sensory System Agents|sensory system agents|mesh-ancestor
64686693|NCT02537873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686694|NCT02537873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64686695|NCT02537873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64686696|NCT02537873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64686697|NCT02537873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64686698|NCT02537873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453219|NCT00113529|Sunitinib|sunitinib|mesh-list
65453220|NCT00113529|Gefitinib|gefitinib|mesh-list
65453221|NCT00113529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453222|NCT00113529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65453223|NCT00113529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65453224|NCT00113529|Growth Substances|growth substances|mesh-ancestor
65453225|NCT00113529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453226|NCT00113529|Growth Inhibitors|growth inhibitors|mesh-ancestor
65453227|NCT00113529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65453228|NCT00113529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453229|NCT00113529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453230|NCT01079013|Treosulfan|treosulfan|mesh-list
65453231|NCT01079013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65453232|NCT01079013|Alkylating Agents|alkylating agents|mesh-ancestor
65453233|NCT01079013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453234|NCT01079013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453235|NCT00134901|Memantine|memantine|mesh-list
65453236|NCT00134901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65453237|NCT00134901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65453238|NCT00134901|Dopamine Agents|dopamine agents|mesh-ancestor
65453239|NCT00134901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64686699|NCT02537873|Dopamine Agents|dopamine agents|mesh-ancestor
64686700|NCT02537873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64686701|NCT02537951|Lidocaine|lidocaine|mesh-list
64686702|NCT02537951|Prilocaine|prilocaine|mesh-list
64686703|NCT02537951|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64686704|NCT02537951|Capsaicin|capsaicin|mesh-list
64686705|NCT02537951|Anesthetics, Local|anesthetics, local|mesh-ancestor
64686706|NCT02537951|Anesthetics|anesthetics|mesh-ancestor
64411994|NCT04428307|Antimalarials|antimalarials|mesh-ancestor
64686707|NCT02537951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64686708|NCT02537951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686709|NCT02537951|Sensory System Agents|sensory system agents|mesh-ancestor
64686710|NCT02537951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686711|NCT02537951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64686712|NCT02537951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64686713|NCT02537951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64686714|NCT02537951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64686715|NCT02537951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686716|NCT02537951|Antipruritics|antipruritics|mesh-ancestor
64686717|NCT02537951|Dermatologic Agents|dermatologic agents|mesh-ancestor
64686718|NCT02537951|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64686719|NCT02487485|Sirolimus|sirolimus|mesh-list
64686720|NCT02487485|Ketamine|ketamine|mesh-list
64686721|NCT02487485|Analgesics|analgesics|mesh-ancestor
64686722|NCT02487485|Sensory System Agents|sensory system agents|mesh-ancestor
64686725|NCT02487485|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64716830|NCT04343222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64716831|NCT04343222|Analgesics|analgesics|mesh-ancestor
64716832|NCT04343222|Sensory System Agents|sensory system agents|mesh-ancestor
64716833|NCT04343222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716834|NCT04343222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716835|NCT04343222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64716836|NCT04343222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64716837|NCT04342130|Morphine|morphine|mesh-list
65453240|NCT00134901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453241|NCT00134901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453242|NCT00134901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65453244|NCT01076595|Interferons|interferons|mesh-list
65453245|NCT01076595|Interferon-beta|interferon-beta|mesh-list
65453246|NCT01076595|Interferon beta-1b|interferon beta-1b|mesh-list
65453247|NCT01076595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453248|NCT01076595|Antiviral Agents|antiviral agents|mesh-ancestor
65453249|NCT01076595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65453250|NCT01076595|Immunologic Factors|immunologic factors|mesh-ancestor
65453251|NCT01076595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837872|NCT01621321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64716838|NCT04342130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64716839|NCT04342130|Narcotics|narcotics|mesh-ancestor
64716840|NCT04342130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64325110|NCT02159573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686726|NCT02487485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64686727|NCT02487485|Anesthetics, General|anesthetics, general|mesh-ancestor
64686736|NCT02487485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64686737|NCT02487485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686738|NCT02487485|Antifungal Agents|antifungal agents|mesh-ancestor
64686739|NCT02487485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64686740|NCT02487485|Immunologic Factors|immunologic factors|mesh-ancestor
64686741|NCT02487563|Decitabine|decitabine|mesh-list
64686742|NCT02487563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64686743|NCT02487563|Antimetabolites|antimetabolites|mesh-ancestor
64686744|NCT02487563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686745|NCT02487563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686746|NCT02487563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686747|NCT02427737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64686748|NCT02427737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64686749|NCT02427737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686750|NCT02489357|Pembrolizumab|pembrolizumab|mesh-list
64686751|NCT02489357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64686752|NCT02489357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686753|NCT02490293|Cephalosporins|cephalosporins|mesh-list
64686754|NCT02490293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64686755|NCT02490293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64686756|NCT02539511|Ketamine|ketamine|mesh-list
64686757|NCT02539511|Analgesics|analgesics|mesh-ancestor
64686758|NCT02539511|Sensory System Agents|sensory system agents|mesh-ancestor
64686759|NCT02539511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686760|NCT02539511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686761|NCT02539511|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64686762|NCT02539511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64686763|NCT02539511|Anesthetics, General|anesthetics, general|mesh-ancestor
64686764|NCT02539511|Anesthetics|anesthetics|mesh-ancestor
64686765|NCT02539511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64686766|NCT02539511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64686767|NCT02539511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64686768|NCT02539511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64686769|NCT02539511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686770|NCT02493257|Ethanol|ethanol|mesh-list
64686771|NCT02493257|Capsaicin|capsaicin|mesh-list
64686772|NCT02493257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64686773|NCT02493257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64686774|NCT02493257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64686775|NCT02493257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686776|NCT02493257|Antipruritics|antipruritics|mesh-ancestor
64686777|NCT02493257|Dermatologic Agents|dermatologic agents|mesh-ancestor
64686778|NCT02493257|Sensory System Agents|sensory system agents|mesh-ancestor
64686779|NCT02493257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686780|NCT02430389|Remifentanil|remifentanil|mesh-list
65453252|NCT01076595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65453253|NCT00113373|Lapatinib|lapatinib|mesh-list
65453254|NCT00113373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453255|NCT00113373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65453256|NCT00113373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453257|NCT00113373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453258|NCT00113295|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65453259|NCT00113295|Paroxetine|paroxetine|mesh-list
65453260|NCT00113295|Antidepressive Agents|antidepressive agents|mesh-ancestor
65453261|NCT00113295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65453262|NCT00113295|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65453263|NCT00113295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65453264|NCT00113295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65453265|NCT00113295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453266|NCT00113295|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65453267|NCT00113295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65453268|NCT00113295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65453269|NCT00113295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686781|NCT02430389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64686782|NCT02430389|Narcotics|narcotics|mesh-ancestor
64686783|NCT02430389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64686784|NCT02430389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716842|NCT04342130|Analgesics|analgesics|mesh-ancestor
64716843|NCT04342130|Sensory System Agents|sensory system agents|mesh-ancestor
64686785|NCT02430389|Analgesics|analgesics|mesh-ancestor
64686786|NCT02430389|Sensory System Agents|sensory system agents|mesh-ancestor
64686787|NCT02430389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686789|NCT02431637|Antimalarials|antimalarials|mesh-ancestor
64686790|NCT02431637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64686815|NCT02495831|Diclofenac|diclofenac|mesh-list
64686816|NCT02495831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64686817|NCT02495831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64686818|NCT02495831|Analgesics|analgesics|mesh-ancestor
64686819|NCT02495831|Sensory System Agents|sensory system agents|mesh-ancestor
64686820|NCT02495831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686821|NCT02495831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686822|NCT02495831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64686823|NCT02495831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64686824|NCT02495831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64686825|NCT02495831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686826|NCT02495831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686827|NCT02498483|Acetaminophen|acetaminophen|mesh-list
64686828|NCT02498483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64686829|NCT02498483|Analgesics|analgesics|mesh-ancestor
64686830|NCT02498483|Sensory System Agents|sensory system agents|mesh-ancestor
64686831|NCT02498483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686832|NCT02498483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686833|NCT02498483|Antipyretics|antipyretics|mesh-ancestor
64686834|NCT02547623|Dexamethasone|dexamethasone|mesh-list
64686835|NCT02547623|Prednisolone|prednisolone|mesh-list
64686836|NCT02547623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64686837|NCT02547623|Antiemetics|antiemetics|mesh-ancestor
64686838|NCT02547623|Autonomic Agents|autonomic agents|mesh-ancestor
64686839|NCT02547623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686840|NCT02547623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686841|NCT02547623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65453270|NCT00113295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65453271|NCT00113295|Serotonin Agents|serotonin agents|mesh-ancestor
65453272|NCT00113295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65453273|NCT00113295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65453274|NCT00113295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65453275|NCT00113295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453276|NCT00112905|Sorafenib|sorafenib|mesh-list
65453277|NCT00112905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453278|NCT00112905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65453279|NCT00112905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453280|NCT00112905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453281|NCT00427895|Vaccines|vaccines|mesh-list
65453282|NCT00427895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65453283|NCT00427895|Immunologic Factors|immunologic factors|mesh-ancestor
65453284|NCT00427895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453285|NCT00427349|Octreotide|octreotide|mesh-list
65453286|NCT00427349|Motesanib diphosphate|motesanib diphosphate|mesh-list
65453287|NCT00427349|Imetelstat|imetelstat|mesh-list
65453288|NCT00427349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65453289|NCT00427349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65453290|NCT00427349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453291|NCT00427349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65453292|NCT00427349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453293|NCT00427349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453294|NCT01034189|Paclitaxel|paclitaxel|mesh-list
65453295|NCT01034189|Cetuximab|cetuximab|mesh-list
65453296|NCT01034189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65453297|NCT01034189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453298|NCT01034189|Tubulin Modulators|tubulin modulators|mesh-ancestor
65453299|NCT01034189|Antimitotic Agents|antimitotic agents|mesh-ancestor
65453300|NCT01034189|Mitosis Modulators|mitosis modulators|mesh-ancestor
65453301|NCT01034189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453302|NCT01034189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65453309|NCT00425945|Protective Agents|protective agents|mesh-ancestor
65453310|NCT00425945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65453311|NCT00121641|Metformin|metformin|mesh-list
65453312|NCT00121641|Saxagliptin|saxagliptin|mesh-list
65453313|NCT00121641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65453314|NCT00121641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453315|NCT00121641|Incretins|incretins|mesh-ancestor
65453316|NCT00121641|Hormones|hormones|mesh-ancestor
65453317|NCT00121641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65453318|NCT00121641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65453319|NCT00121641|Protease Inhibitors|protease inhibitors|mesh-ancestor
65453320|NCT00121641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453321|NCT00121641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453322|NCT00425555|Panobinostat|panobinostat|mesh-list
65453323|NCT00425555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453324|NCT00425555|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65453325|NCT00425555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453326|NCT00425555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453327|NCT00424775|Vorinostat|vorinostat|mesh-list
65453328|NCT00424775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453329|NCT00424775|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65453330|NCT00424775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453331|NCT00424775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453332|NCT01034345|Sirolimus|sirolimus|mesh-list
65453333|NCT01034345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
64686842|NCT02547623|Glucocorticoids|glucocorticoids|mesh-ancestor
64686843|NCT02547623|Hormones|hormones|mesh-ancestor
64686844|NCT02547623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64686845|NCT02547623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64686846|NCT02547623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686847|NCT02547779|Plasma-lyte 148|plasma-lyte 148|mesh-list
64686848|NCT02547779|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64686852|NCT00559585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686854|NCT00559585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64686855|NCT00559585|Immunologic Factors|immunologic factors|mesh-ancestor
64686856|NCT00559585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686857|NCT00559585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64686858|NCT01824901|Docetaxel|docetaxel|mesh-list
64686859|NCT01824901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686860|NCT01824901|Tubulin Modulators|tubulin modulators|mesh-ancestor
64686861|NCT01824901|Antimitotic Agents|antimitotic agents|mesh-ancestor
64686862|NCT01824901|Mitosis Modulators|mitosis modulators|mesh-ancestor
64686863|NCT01824901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686865|NCT00559507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686866|NCT00559507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686867|NCT00559507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686868|NCT04969627|Metformin|metformin|mesh-list
64686869|NCT04969627|Exenatide|exenatide|mesh-list
65453334|NCT01034345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65453335|NCT01034345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65453336|NCT01034345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65453337|NCT01034345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453338|NCT01034345|Antifungal Agents|antifungal agents|mesh-ancestor
65453339|NCT01034345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65453340|NCT01034345|Immunologic Factors|immunologic factors|mesh-ancestor
65453341|NCT01034345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453342|NCT01034345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453343|NCT01034345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453344|NCT01763866|Atorvastatin|atorvastatin|mesh-list
65453345|NCT01763866|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65453346|NCT01763866|Simvastatin|simvastatin|mesh-list
65453347|NCT01763866|Ezetimibe|ezetimibe|mesh-list
65453348|NCT01763866|Evolocumab|evolocumab|mesh-list
65453349|NCT01763866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65453350|NCT01763866|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65453351|NCT01763866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65453352|NCT01763866|Antimetabolites|antimetabolites|mesh-ancestor
65453353|NCT01763866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453354|NCT01763866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65453355|NCT01763866|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65453356|NCT01763866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453357|NCT01763866|Immunologic Factors|immunologic factors|mesh-ancestor
65453358|NCT01763866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453359|NCT00132873|Sodium Oxybate|sodium oxybate|mesh-list
65453360|NCT00132873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64686870|NCT04969627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64686871|NCT04969627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686872|NCT04969627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64686873|NCT04969627|Incretins|incretins|mesh-ancestor
64686874|NCT04969627|Hormones|hormones|mesh-ancestor
64686875|NCT04969627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64686876|NCT04953325|Vaccines|vaccines|mesh-list
64686877|NCT04953325|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64686878|NCT04953325|Immunologic Factors|immunologic factors|mesh-ancestor
64716844|NCT04342130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716848|NCT04338074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716850|NCT04338074|Coagulants|coagulants|mesh-ancestor
64716851|NCT03964220|Tiotropium Bromide|tiotropium bromide|mesh-list
64716852|NCT03964220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64686879|NCT04953325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686880|NCT01826851|Bupivacaine|bupivacaine|mesh-list
64686883|NCT01826851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64686884|NCT01826851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686885|NCT01826851|Sensory System Agents|sensory system agents|mesh-ancestor
64686886|NCT01826851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686887|NCT05746897|Pembrolizumab|pembrolizumab|mesh-list
65453361|NCT00132873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65453362|NCT00132873|Anesthetics, General|anesthetics, general|mesh-ancestor
65453363|NCT00132873|Anesthetics|anesthetics|mesh-ancestor
65453364|NCT00132873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65453365|NCT00132873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453366|NCT01588925|Dexamethasone|dexamethasone|mesh-list
65453367|NCT01588925|Dexamethasone acetate|dexamethasone acetate|mesh-list
65453368|NCT01588925|BB 1101|bb 1101|mesh-list
65453369|NCT01588925|Hyaluronic Acid|hyaluronic acid|mesh-list
65453370|NCT01588925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65453371|NCT01588925|Antiemetics|antiemetics|mesh-ancestor
65453372|NCT01588925|Autonomic Agents|autonomic agents|mesh-ancestor
65453373|NCT01588925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686888|NCT05746897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64686889|NCT05746897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686890|NCT02499497|Androgens|androgens|mesh-list
64686891|NCT02499497|Hormones|hormones|mesh-ancestor
64686892|NCT02499497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64686893|NCT02499497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686894|NCT01827475|Acetaminophen|acetaminophen|mesh-list
64686895|NCT01827475|Ibuprofen|ibuprofen|mesh-list
64686896|NCT01827475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64686897|NCT01827475|Analgesics|analgesics|mesh-ancestor
64686898|NCT01827475|Sensory System Agents|sensory system agents|mesh-ancestor
64686899|NCT01827475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686900|NCT01827475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686901|NCT01827475|Antipyretics|antipyretics|mesh-ancestor
64686902|NCT01827475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64686903|NCT01827475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64686904|NCT01827475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64686905|NCT01827475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64686906|NCT01827475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686907|NCT01827475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686908|NCT02434523|Amitriptyline|amitriptyline|mesh-list
64686909|NCT02434523|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64686910|NCT02434523|Antidepressive Agents|antidepressive agents|mesh-ancestor
64686911|NCT02434523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64686912|NCT02434523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64686913|NCT02434523|Analgesics|analgesics|mesh-ancestor
64686914|NCT02434523|Sensory System Agents|sensory system agents|mesh-ancestor
64686915|NCT02434523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686916|NCT02434523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686917|NCT02434523|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64686918|NCT02434523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64686919|NCT02434523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64686941|NCT01829503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64686942|NCT01829503|Antimetabolites|antimetabolites|mesh-ancestor
64686943|NCT01829503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686944|NCT01829503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686945|NCT01829503|Antiviral Agents|antiviral agents|mesh-ancestor
64686946|NCT01829503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64686947|NCT01829503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64686948|NCT01829503|Immunologic Factors|immunologic factors|mesh-ancestor
64686949|NCT01829503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686950|NCT01829503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686951|NCT04654507|Dexamethasone|dexamethasone|mesh-list
64686952|NCT04654507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64686953|NCT04654507|Antiemetics|antiemetics|mesh-ancestor
64686954|NCT04654507|Autonomic Agents|autonomic agents|mesh-ancestor
64686955|NCT04654507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686956|NCT04654507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686957|NCT04654507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64686958|NCT04654507|Glucocorticoids|glucocorticoids|mesh-ancestor
65453374|NCT01588925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453375|NCT01588925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65453376|NCT01588925|Glucocorticoids|glucocorticoids|mesh-ancestor
65453377|NCT01588925|Hormones|hormones|mesh-ancestor
65453378|NCT01588925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65453379|NCT01588925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65453380|NCT01588925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453381|NCT01588925|Protease Inhibitors|protease inhibitors|mesh-ancestor
65453382|NCT01588925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453383|NCT01588925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453384|NCT01588925|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65453385|NCT01588925|Immunologic Factors|immunologic factors|mesh-ancestor
65453386|NCT01588925|Viscosupplements|viscosupplements|mesh-ancestor
65453387|NCT01588925|Protective Agents|protective agents|mesh-ancestor
65453388|NCT01238146|Rituximab|rituximab|mesh-list
64686959|NCT04654507|Hormones|hormones|mesh-ancestor
64686960|NCT04654507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64686961|NCT04654507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64686962|NCT04654507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64716853|NCT03964220|Autonomic Agents|autonomic agents|mesh-ancestor
64716854|NCT03964220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686963|NCT05742763|Acetaminophen|acetaminophen|mesh-list
64686964|NCT05742763|Ibuprofen|ibuprofen|mesh-list
64686965|NCT05742763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64686966|NCT05742763|Analgesics|analgesics|mesh-ancestor
64686967|NCT05742763|Sensory System Agents|sensory system agents|mesh-ancestor
64686968|NCT05742763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686969|NCT05742763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686970|NCT05742763|Antipyretics|antipyretics|mesh-ancestor
64686971|NCT05742763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64686972|NCT05742763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64686987|NCT02504723|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64686988|NCT02504723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64686989|NCT02504723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64686990|NCT02504723|Vasodilator Agents|vasodilator agents|mesh-ancestor
64686991|NCT02504723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64686992|NCT02504723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64686993|NCT02439281|Clonidine|clonidine|mesh-list
64686994|NCT02439281|Ropivacaine|ropivacaine|mesh-list
64686995|NCT02439281|Anesthetics, Local|anesthetics, local|mesh-ancestor
64686996|NCT02439281|Anesthetics|anesthetics|mesh-ancestor
64686997|NCT02439281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64686998|NCT02439281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686999|NCT02439281|Sensory System Agents|sensory system agents|mesh-ancestor
64687000|NCT02439281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64687001|NCT02439281|Analgesics|analgesics|mesh-ancestor
64687002|NCT02439281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64687003|NCT02439281|Sympatholytics|sympatholytics|mesh-ancestor
64687004|NCT02439281|Autonomic Agents|autonomic agents|mesh-ancestor
64687005|NCT02439281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64687006|NCT02439281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64687007|NCT02439281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64687008|NCT02439281|Adrenergic Agents|adrenergic agents|mesh-ancestor
64687009|NCT02439281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64414789|NCT02419755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687010|NCT02439281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687013|NCT02505269|Dacarbazine|dacarbazine|mesh-list
64687014|NCT02505269|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64687015|NCT02505269|Imidazole|imidazole|mesh-list
65453389|NCT01238146|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65453390|NCT01238146|Obatoclax|obatoclax|mesh-list
65453391|NCT01238146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65453392|NCT01238146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453393|NCT01238146|Immunologic Factors|immunologic factors|mesh-ancestor
65453394|NCT01238146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453395|NCT01238146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65453396|NCT01238146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65453397|NCT01238146|Alkylating Agents|alkylating agents|mesh-ancestor
65453398|NCT01238146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453399|NCT01238146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453400|NCT01141894|Phenylephrine|phenylephrine|mesh-list
65453402|NCT01141894|Oxymetazoline|oxymetazoline|mesh-list
65453403|NCT01141894|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65453404|NCT01141894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65453405|NCT01141894|Mydriatics|mydriatics|mesh-ancestor
65453406|NCT01141894|Autonomic Agents|autonomic agents|mesh-ancestor
65453407|NCT01141894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65453408|NCT01141894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453409|NCT01141894|Sympathomimetics|sympathomimetics|mesh-ancestor
65453410|NCT01141894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65453411|NCT01141894|Nasal Decongestants|nasal decongestants|mesh-ancestor
65453412|NCT01141894|Respiratory System Agents|respiratory system agents|mesh-ancestor
65453413|NCT01141894|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65453414|NCT01141894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64687016|NCT02505269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64687017|NCT02505269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687018|NCT02505269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64687019|NCT02505269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64687020|NCT02505269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687021|NCT02505269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687022|NCT02505269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64687023|NCT02505269|Alkylating Agents|alkylating agents|mesh-ancestor
64687024|NCT02505269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64687025|NCT00422123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64687026|NCT00422123|Antidepressive Agents|antidepressive agents|mesh-ancestor
64687027|NCT00422123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64687028|NCT00422123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64687029|NCT00422123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64687030|NCT00422123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64687031|NCT00422123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687032|NCT00559273|Darbepoetin alfa|darbepoetin alfa|mesh-list
64687033|NCT00559273|Hematinics|hematinics|mesh-ancestor
64687034|NCT02506673|Midazolam|midazolam|mesh-list
64687035|NCT02506673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64687036|NCT02506673|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64687037|NCT02506673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64687087|NCT00558259|Anticoagulants|anticoagulants|mesh-ancestor
64687089|NCT02508389|Antioxidants|antioxidants|mesh-ancestor
65453415|NCT01141894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65453416|NCT01141894|Adrenergic Agents|adrenergic agents|mesh-ancestor
65453417|NCT01141894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65453418|NCT01141894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453419|NCT01141894|Protective Agents|protective agents|mesh-ancestor
65453420|NCT01141894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65453421|NCT01141894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65453422|NCT01141894|Plasma Substitutes|plasma substitutes|mesh-ancestor
65453423|NCT01141894|Blood Substitutes|blood substitutes|mesh-ancestor
65453424|NCT01238224|Tadalafil|tadalafil|mesh-list
65453425|NCT01238224|Vasodilator Agents|vasodilator agents|mesh-ancestor
65453426|NCT01238224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64687090|NCT02508389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687091|NCT02508389|Protective Agents|protective agents|mesh-ancestor
64687092|NCT02508389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687093|NCT02509481|Ivermectin|ivermectin|mesh-list
64716855|NCT03964220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716856|NCT03964220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64716857|NCT03964220|Respiratory System Agents|respiratory system agents|mesh-ancestor
64716858|NCT03964220|Parasympatholytics|parasympatholytics|mesh-ancestor
64716859|NCT03964220|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64716860|NCT03964220|Cholinergic Agents|cholinergic agents|mesh-ancestor
64716861|NCT03964220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64687094|NCT02509481|Albendazole|albendazole|mesh-list
64687095|NCT02509481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64687096|NCT02509481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64687097|NCT02509481|Anthelmintics|anthelmintics|mesh-ancestor
64687102|NCT02509481|Antimitotic Agents|antimitotic agents|mesh-ancestor
64687103|NCT02509481|Mitosis Modulators|mitosis modulators|mesh-ancestor
64687104|NCT02509481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687105|NCT02509481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687107|NCT02561897|Edoxaban|edoxaban|mesh-list
64687108|NCT02561897|Anticoagulants|anticoagulants|mesh-ancestor
64687109|NCT02561897|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64687110|NCT02561897|Antithrombins|antithrombins|mesh-ancestor
64687111|NCT02561897|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64687112|NCT02561897|Protease Inhibitors|protease inhibitors|mesh-ancestor
64687113|NCT02561897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687114|NCT02561897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687115|NCT02512679|Cyclophosphamide|cyclophosphamide|mesh-list
64687116|NCT02512679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64687117|NCT02512679|Immunologic Factors|immunologic factors|mesh-ancestor
64687118|NCT02512679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687119|NCT02512679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64687120|NCT02512679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64687121|NCT02512679|Alkylating Agents|alkylating agents|mesh-ancestor
64687122|NCT02512679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687123|NCT02512679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687124|NCT02512679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64687125|NCT02562521|Nicotine|nicotine|mesh-list
64687126|NCT02562521|Varenicline|varenicline|mesh-list
64687127|NCT02562521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64687128|NCT02562521|Autonomic Agents|autonomic agents|mesh-ancestor
64687129|NCT02562521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64687130|NCT02562521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687131|NCT02562521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64687132|NCT02562521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64687133|NCT02562521|Cholinergic Agents|cholinergic agents|mesh-ancestor
64687134|NCT02562521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64687135|NCT02562521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687136|NCT02562755|Sorafenib|sorafenib|mesh-list
64687145|NCT05446883|Tubulin Modulators|tubulin modulators|mesh-ancestor
64687146|NCT05446883|Antimitotic Agents|antimitotic agents|mesh-ancestor
65453427|NCT01238224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65453428|NCT01238224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453429|NCT01238224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453430|NCT01238224|Urological Agents|urological agents|mesh-ancestor
65453431|NCT01237444|Ritonavir|ritonavir|mesh-list
65453432|NCT01237444|Lopinavir|lopinavir|mesh-list
65453433|NCT01237444|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65453434|NCT01237444|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65453435|NCT01237444|Protease Inhibitors|protease inhibitors|mesh-ancestor
65453436|NCT01237444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453437|NCT01237444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453438|NCT01237444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65453439|NCT01237444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65453440|NCT01237444|Antiviral Agents|antiviral agents|mesh-ancestor
64687147|NCT05446883|Mitosis Modulators|mitosis modulators|mesh-ancestor
64687148|NCT05446883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687149|NCT00363857|Ropinirole|ropinirole|mesh-list
64687150|NCT00363857|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64687151|NCT00363857|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64687152|NCT00363857|Dopamine Agonists|dopamine agonists|mesh-ancestor
64687153|NCT00363857|Dopamine Agents|dopamine agents|mesh-ancestor
64687154|NCT00363857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64687155|NCT00363857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687156|NCT00363857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687157|NCT04563923|Avdoralimab|avdoralimab|mesh-list
64687158|NCT04563923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64687159|NCT04563923|Antiviral Agents|antiviral agents|mesh-ancestor
64687160|NCT04563923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64687161|NCT00558103|Lapatinib|lapatinib|mesh-list
64687162|NCT00558103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64716862|NCT03964220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716864|NCT04337138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64716865|NCT04337138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64716870|NCT00422773|Cetuximab|cetuximab|mesh-list
64716871|NCT00422773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64716872|NCT00422773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64716873|NCT03329209|Vedolizumab|vedolizumab|mesh-list
64687163|NCT00558103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64687164|NCT00558103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687165|NCT00558103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687167|NCT02974361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64687168|NCT02974361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64687169|NCT02974361|Analgesics|analgesics|mesh-ancestor
64687170|NCT02974361|Sensory System Agents|sensory system agents|mesh-ancestor
64687173|NCT02974361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64687174|NCT02974361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64687175|NCT02974361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64687176|NCT02974361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687177|NCT02974361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687178|NCT05690815|Tenofovir|tenofovir|mesh-list
64687179|NCT05690815|Emtricitabine|emtricitabine|mesh-list
64687180|NCT05690815|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64687181|NCT05690815|Antiviral Agents|antiviral agents|mesh-ancestor
64687182|NCT05690815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64687183|NCT05690815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64687184|NCT05690815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64687185|NCT05690815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687186|NCT05690815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687187|NCT05690815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64687188|NCT05690815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65453441|NCT01237444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65453442|NCT01237444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65453443|NCT01237444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65453444|NCT01145170|Nimotuzumab|nimotuzumab|mesh-list
65453445|NCT01145170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65453446|NCT01145170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453447|NCT01141972|Vitamin D|vitamin d|mesh-list
65453448|NCT01141972|Vitamins|vitamins|mesh-ancestor
65453449|NCT01141972|Micronutrients|micronutrients|mesh-ancestor
65453450|NCT01141972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453451|NCT01141972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65453452|NCT04316806|Rifaximin|rifaximin|mesh-list
65453453|NCT04316806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64838071|NCT01622439|GABA Agents|gaba agents|mesh-ancestor
64687189|NCT02569541|Fusidic Acid|fusidic acid|mesh-list
64687190|NCT02569541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64687191|NCT02569541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64687192|NCT02569541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64687193|NCT02569541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687194|NCT02569541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687195|NCT04477733|Butorphanol|butorphanol|mesh-list
64687196|NCT04477733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64687197|NCT04477733|Narcotics|narcotics|mesh-ancestor
64687198|NCT04477733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64687199|NCT04477733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687200|NCT04477733|Analgesics|analgesics|mesh-ancestor
64687201|NCT04477733|Sensory System Agents|sensory system agents|mesh-ancestor
64687202|NCT04477733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64687213|NCT04218773|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64687215|NCT04218773|Autonomic Agents|autonomic agents|mesh-ancestor
64687216|NCT04218773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64687217|NCT04218773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687218|NCT04218773|Sympathomimetics|sympathomimetics|mesh-ancestor
64687219|NCT04218773|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64687220|NCT04218773|Nasal Decongestants|nasal decongestants|mesh-ancestor
64687221|NCT04218773|Respiratory System Agents|respiratory system agents|mesh-ancestor
64687222|NCT04218773|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64687223|NCT04218773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64687224|NCT04218773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64687225|NCT04218773|Adrenergic Agents|adrenergic agents|mesh-ancestor
64687226|NCT04218773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64687227|NCT04218773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687228|NCT04218773|Protective Agents|protective agents|mesh-ancestor
64687229|NCT00558025|Pramipexole|pramipexole|mesh-list
64687230|NCT00558025|Antioxidants|antioxidants|mesh-ancestor
64716874|NCT03329209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64716875|NCT03661346|Labetalol|labetalol|mesh-list
64716876|NCT03661346|Esmolol|esmolol|mesh-list
64716877|NCT03661346|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64716878|NCT03661346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64716879|NCT03661346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64716880|NCT03661346|Adrenergic Agents|adrenergic agents|mesh-ancestor
64716881|NCT03661346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64716882|NCT03661346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716883|NCT03661346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716884|NCT03661346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64716885|NCT03661346|Sympathomimetics|sympathomimetics|mesh-ancestor
64716886|NCT03661346|Autonomic Agents|autonomic agents|mesh-ancestor
64716887|NCT03661346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64325144|NCT02765399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64687231|NCT00558025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453454|NCT04316806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65453455|NCT04316806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65453456|NCT01145326|Lidocaine|lidocaine|mesh-list
65453457|NCT01145326|Anesthetics, Local|anesthetics, local|mesh-ancestor
65453458|NCT01145326|Anesthetics|anesthetics|mesh-ancestor
65453459|NCT01145326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65453460|NCT01145326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453461|NCT01145326|Sensory System Agents|sensory system agents|mesh-ancestor
65453462|NCT01145326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65453463|NCT01145326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65453464|NCT01145326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65453465|NCT01145326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65453466|NCT01145326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64838076|NCT01622439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64687232|NCT00558025|Protective Agents|protective agents|mesh-ancestor
64687233|NCT00558025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687234|NCT00558025|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64687235|NCT00558025|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64687237|NCT00558025|Dopamine Agents|dopamine agents|mesh-ancestor
64687238|NCT00558025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64687239|NCT02576249|Methylprednisolone|methylprednisolone|mesh-list
64687246|NCT02576249|Prednisolone phosphate|prednisolone phosphate|mesh-list
64687247|NCT02576249|Anesthetics, Local|anesthetics, local|mesh-ancestor
64687248|NCT02576249|Anesthetics|anesthetics|mesh-ancestor
64687249|NCT02576249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64687250|NCT02576249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687251|NCT02576249|Sensory System Agents|sensory system agents|mesh-ancestor
64687252|NCT02576249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64687253|NCT02576249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64687254|NCT02576249|Antiemetics|antiemetics|mesh-ancestor
64687255|NCT02576249|Autonomic Agents|autonomic agents|mesh-ancestor
64687256|NCT02576249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64687257|NCT02576249|Glucocorticoids|glucocorticoids|mesh-ancestor
64687258|NCT02576249|Hormones|hormones|mesh-ancestor
64687259|NCT02576249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64687260|NCT02576249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64687261|NCT02576249|Protective Agents|protective agents|mesh-ancestor
64687262|NCT02576249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64687263|NCT02576249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687264|NCT03868657|Moxifloxacin|moxifloxacin|mesh-list
64687265|NCT03868657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64687266|NCT03868657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64687267|NCT03868657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64687268|NCT03868657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64687269|NCT03868657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687287|NCT02579057|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64687288|NCT02579057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64687289|NCT02579057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687290|NCT00557245|Tenofovir|tenofovir|mesh-list
64687291|NCT00557245|Emtricitabine|emtricitabine|mesh-list
64716888|NCT03661346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64716889|NCT03661346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64716890|NCT03329911|Paclitaxel|paclitaxel|mesh-list
64716891|NCT03329911|Carboplatin|carboplatin|mesh-list
64716892|NCT03329911|Bevacizumab|bevacizumab|mesh-list
64716893|NCT03329911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64716894|NCT03329911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64716895|NCT03329911|Tubulin Modulators|tubulin modulators|mesh-ancestor
64325159|NCT01037179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64325160|NCT01037179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453467|NCT01145326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453468|NCT01144702|Artesunate|artesunate|mesh-list
65453469|NCT01144702|Mefloquine|mefloquine|mesh-list
65453470|NCT01144702|Antimalarials|antimalarials|mesh-ancestor
65453471|NCT01144702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65453472|NCT01144702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65453473|NCT01144702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65453474|NCT01144702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453475|NCT01144702|Antiviral Agents|antiviral agents|mesh-ancestor
65453476|NCT01144702|Schistosomicides|schistosomicides|mesh-ancestor
65453477|NCT01144702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65453478|NCT01144702|Anthelmintics|anthelmintics|mesh-ancestor
65453479|NCT01145404|Capecitabine|capecitabine|mesh-list
65453480|NCT01145404|Lapatinib|lapatinib|mesh-list
65453481|NCT01145404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65453482|NCT01145404|Antimetabolites|antimetabolites|mesh-ancestor
65453483|NCT01145404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453484|NCT01145404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453485|NCT01145404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65453486|NCT01145404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453487|NCT01237522|Metformin|metformin|mesh-list
64687292|NCT00557245|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64687293|NCT00557245|Antiviral Agents|antiviral agents|mesh-ancestor
64687294|NCT00557245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64687295|NCT00557245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64687296|NCT00557245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64687297|NCT00557245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687298|NCT00557245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687299|NCT00557245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64687300|NCT00557245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64687301|NCT00364091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64687302|NCT00364091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64687303|NCT04743011|Heparin|heparin|mesh-list
64687304|NCT04743011|Calcium heparin|calcium heparin|mesh-list
64687305|NCT04743011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64687306|NCT04743011|Anticoagulants|anticoagulants|mesh-ancestor
64687307|NCT04743011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64687308|NCT04743011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64687309|NCT04743011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687310|NCT03528941|Lamivudine|lamivudine|mesh-list
64687311|NCT03528941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64687312|NCT03528941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64687313|NCT03528941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687314|NCT03528941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687320|NCT01836133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687321|NCT01836133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64687322|NCT01836133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687323|NCT01836133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687324|NCT00365183|Pemetrexed|pemetrexed|mesh-list
64687325|NCT00365183|Motexafin gadolinium|motexafin gadolinium|mesh-list
64687332|NCT00365183|Dermatologic Agents|dermatologic agents|mesh-ancestor
64687333|NCT03422861|Nabilone|nabilone|mesh-list
64687334|NCT03422861|Antiemetics|antiemetics|mesh-ancestor
64687335|NCT03422861|Autonomic Agents|autonomic agents|mesh-ancestor
64687336|NCT03422861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65453488|NCT01237522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65453489|NCT01237522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453490|NCT01235416|Motesanib diphosphate|motesanib diphosphate|mesh-list
65453491|NCT01235416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65453492|NCT01235416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453493|NCT01235416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453494|NCT04246996|Gentamicins|gentamicins|mesh-list
65453495|NCT04246996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65453496|NCT04246996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65453497|NCT04246996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65453498|NCT04246996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453499|NCT04246996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453500|NCT00424463|Edaravone|edaravone|mesh-list
65453501|NCT00424463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65453502|NCT00424463|Antioxidants|antioxidants|mesh-ancestor
65453503|NCT00424463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453504|NCT00424463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64687337|NCT03422861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687338|NCT03422861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64687339|NCT03422861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64687340|NCT03422861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64687341|NCT03422861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64687342|NCT03422861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64687343|NCT01837069|Metoprolol|metoprolol|mesh-list
64687344|NCT01837069|Lisinopril|lisinopril|mesh-list
64687345|NCT01837069|Atorvastatin|atorvastatin|mesh-list
64687346|NCT01837069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64687347|NCT01837069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64687348|NCT01837069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64687349|NCT01837069|Antimetabolites|antimetabolites|mesh-ancestor
64716896|NCT03329911|Antimitotic Agents|antimitotic agents|mesh-ancestor
64716897|NCT03329911|Mitosis Modulators|mitosis modulators|mesh-ancestor
64716898|NCT03329911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716899|NCT03329911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64716900|NCT03329911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64325167|NCT01037179|Histamine Agents|histamine agents|mesh-ancestor
64687350|NCT01837069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687351|NCT01837069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64687352|NCT01837069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64687353|NCT01837069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687354|NCT01837069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64687355|NCT01837069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64687356|NCT01837069|Sympatholytics|sympatholytics|mesh-ancestor
64687357|NCT01837069|Autonomic Agents|autonomic agents|mesh-ancestor
64687358|NCT01837069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64687359|NCT01837069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687360|NCT01837069|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64687361|NCT01837069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64687362|NCT01837069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64687363|NCT01837069|Adrenergic Agents|adrenergic agents|mesh-ancestor
64687364|NCT01837069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64687365|NCT01837069|Protease Inhibitors|protease inhibitors|mesh-ancestor
64687366|NCT01837069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64687367|NCT01837069|Protective Agents|protective agents|mesh-ancestor
64687368|NCT00555061|Retapamulin|retapamulin|mesh-list
64687369|NCT00555061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65453505|NCT00424463|Protective Agents|protective agents|mesh-ancestor
65453506|NCT00424463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453507|NCT01324115|Nitroarginine|nitroarginine|mesh-list
65453508|NCT01324115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453509|NCT01324115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453510|NCT01037621|Valacyclovir|valacyclovir|mesh-list
65453511|NCT01037621|Antiviral Agents|antiviral agents|mesh-ancestor
65453512|NCT01037621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65453513|NCT00424385|Sorafenib|sorafenib|mesh-list
65453514|NCT00424385|Imatinib Mesylate|imatinib mesylate|mesh-list
65453515|NCT00424385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453516|NCT00424385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65453517|NCT00424385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453518|NCT00424385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453519|NCT03994055|Antioxidants|antioxidants|mesh-list
65453520|NCT03994055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687370|NCT00555061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64687371|NCT02289690|Carboplatin|carboplatin|mesh-list
64687372|NCT02289690|Etoposide|etoposide|mesh-list
64687373|NCT02289690|Veliparib|veliparib|mesh-list
64687374|NCT02289690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687375|NCT02289690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64687376|NCT02289690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64687377|NCT02289690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64687378|NCT02289690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687379|NCT02289690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687380|NCT02289690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64687381|NCT02268955|Ibuprofen|ibuprofen|mesh-list
64687382|NCT02268955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64687383|NCT02268955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64687384|NCT02268955|Analgesics|analgesics|mesh-ancestor
64687386|NCT02268955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64687418|NCT05249153|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64687419|NCT05249153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64687420|NCT05249153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64687421|NCT05249153|Adrenergic Agents|adrenergic agents|mesh-ancestor
64687422|NCT05249153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64687423|NCT05249153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687424|NCT05249153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64687425|NCT05249153|Narcotics|narcotics|mesh-ancestor
64687426|NCT05249153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64687427|NCT05249153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64687428|NCT05249153|Anesthetics, General|anesthetics, general|mesh-ancestor
64687429|NCT05249153|Anesthetics|anesthetics|mesh-ancestor
64687430|NCT02961257|Prednisone|prednisone|mesh-list
64687431|NCT02961257|Lenograstim|lenograstim|mesh-list
64687432|NCT02961257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64687433|NCT02961257|Glucocorticoids|glucocorticoids|mesh-ancestor
64687434|NCT02961257|Hormones|hormones|mesh-ancestor
64687435|NCT02961257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64716901|NCT03329911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64716902|NCT03329911|Growth Substances|growth substances|mesh-ancestor
64716903|NCT03329911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716904|NCT03329911|Growth Inhibitors|growth inhibitors|mesh-ancestor
64716905|NCT04322396|Azithromycin|azithromycin|mesh-list
64687436|NCT02961257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687437|NCT02961257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64687438|NCT02961257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687439|NCT02961257|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65453521|NCT03994055|Protective Agents|protective agents|mesh-ancestor
65453522|NCT03994055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453523|NCT01037699|Hormones|hormones|mesh-list
65453524|NCT01037699|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65453525|NCT01037699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65453526|NCT01037699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453527|NCT00423917|Bevacizumab|bevacizumab|mesh-list
65453528|NCT00423917|Fulvestrant|fulvestrant|mesh-list
65453529|NCT00423917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65453530|NCT00423917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453531|NCT00423917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65453532|NCT00423917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64687440|NCT02961257|Immunologic Factors|immunologic factors|mesh-ancestor
64687441|NCT02271217|4-Aminopyridine|4-aminopyridine|mesh-list
64687442|NCT02271217|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64687443|NCT02271217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64687453|NCT02429375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64687454|NCT02429375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687455|NCT02429375|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64687456|NCT02429375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687457|NCT02429375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687458|NCT02289456|Paclitaxel|paclitaxel|mesh-list
64687459|NCT02289456|Carboplatin|carboplatin|mesh-list
64412751|NCT05678621|Amoxicillin|amoxicillin|mesh-list
64687460|NCT02289456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64687461|NCT02289456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687462|NCT02289456|Tubulin Modulators|tubulin modulators|mesh-ancestor
64687463|NCT02289456|Antimitotic Agents|antimitotic agents|mesh-ancestor
64687464|NCT02289456|Mitosis Modulators|mitosis modulators|mesh-ancestor
64687465|NCT02289456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687466|NCT02589977|Regadenoson|regadenoson|mesh-list
64687467|NCT02589977|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64687468|NCT02589977|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64687469|NCT02589977|Purinergic Agonists|purinergic agonists|mesh-ancestor
64687470|NCT02589977|Purinergic Agents|purinergic agents|mesh-ancestor
64687471|NCT02589977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64687472|NCT02589977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687473|NCT02589977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687474|NCT02274948|Metformin|metformin|mesh-list
64687475|NCT02274948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64687476|NCT02274948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687477|NCT02274792|Etanercept|etanercept|mesh-list
64687478|NCT02274792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64687479|NCT02274792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64687480|NCT02274792|Analgesics|analgesics|mesh-ancestor
64687481|NCT02274792|Sensory System Agents|sensory system agents|mesh-ancestor
64687482|NCT02274792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64687483|NCT02274792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687484|NCT02274792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64687485|NCT02274792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64687486|NCT02274792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64687487|NCT02274792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64687488|NCT02274792|Immunologic Factors|immunologic factors|mesh-ancestor
64687490|NCT05432466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64687491|NCT05432466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64687492|NCT05432466|Sympathomimetics|sympathomimetics|mesh-ancestor
64687493|NCT05432466|Autonomic Agents|autonomic agents|mesh-ancestor
64687494|NCT05432466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64687495|NCT05432466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687496|NCT05432466|Vasodilator Agents|vasodilator agents|mesh-ancestor
64687497|NCT05432466|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65453533|NCT00423917|Growth Substances|growth substances|mesh-ancestor
65453534|NCT00423917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453535|NCT00423917|Growth Inhibitors|growth inhibitors|mesh-ancestor
65453536|NCT00423917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65453537|NCT00423917|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65453538|NCT00423917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65453539|NCT00423917|Hormone Antagonists|hormone antagonists|mesh-ancestor
65453540|NCT00423917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65453541|NCT00845026|Olanzapine|olanzapine|mesh-list
65453543|NCT00845026|Aripiprazole|aripiprazole|mesh-list
65453544|NCT00845026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65453545|NCT00845026|Serotonin Agents|serotonin agents|mesh-ancestor
65453546|NCT00845026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65453547|NCT00845026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453548|NCT00845026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453549|NCT00845026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65453550|NCT00845026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64838156|NCT01623102|Antiviral Agents|antiviral agents|mesh-ancestor
64687498|NCT05432466|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64687499|NCT05432466|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64687500|NCT05432466|Adrenergic Agents|adrenergic agents|mesh-ancestor
64687501|NCT05432466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64687502|NCT05432466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687503|NCT02592629|Triamcinolone|triamcinolone|mesh-list
64687504|NCT02592629|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64687505|NCT02592629|Lidocaine|lidocaine|mesh-list
64687506|NCT02592629|Ethyl Chloride|ethyl chloride|mesh-list
64687507|NCT02592629|Anesthetics, Local|anesthetics, local|mesh-ancestor
64716906|NCT04322396|Hydroxychloroquine|hydroxychloroquine|mesh-list
64716907|NCT04322396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64716908|NCT04322396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64716909|NCT04322396|Antimalarials|antimalarials|mesh-ancestor
64716910|NCT04322396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64716911|NCT04322396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64716912|NCT04322396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687515|NCT02592629|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64687516|NCT02592629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64687517|NCT02592629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687518|NCT02592629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64687520|NCT02592629|Hormones|hormones|mesh-ancestor
64687521|NCT02592629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64687522|NCT02592629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64687523|NCT02592629|Immunologic Factors|immunologic factors|mesh-ancestor
64687524|NCT02596451|Diclofenac|diclofenac|mesh-list
64687525|NCT02596451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64687526|NCT02596451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64687527|NCT02596451|Analgesics|analgesics|mesh-ancestor
64687528|NCT02596451|Sensory System Agents|sensory system agents|mesh-ancestor
64687529|NCT02596451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64687530|NCT02596451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687531|NCT02596451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64687532|NCT02596451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64687533|NCT02596451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64687534|NCT02596451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687535|NCT02596451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687536|NCT01839799|Gemcitabine|gemcitabine|mesh-list
65453551|NCT00845026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65453552|NCT00845026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65453553|NCT00845026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65453554|NCT00845026|Dopamine Agents|dopamine agents|mesh-ancestor
65453555|NCT00845026|Antiemetics|antiemetics|mesh-ancestor
65453556|NCT00845026|Autonomic Agents|autonomic agents|mesh-ancestor
65453557|NCT00845026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65453558|NCT00845026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65453559|NCT00845026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65453560|NCT00845026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65453561|NCT00845026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64687537|NCT01839799|Paclitaxel|paclitaxel|mesh-list
64687538|NCT01839799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64687539|NCT01839799|Folfirinox|folfirinox|mesh-list
64687540|NCT01839799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64687541|NCT01839799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687542|NCT01839799|Tubulin Modulators|tubulin modulators|mesh-ancestor
64687543|NCT01839799|Antimitotic Agents|antimitotic agents|mesh-ancestor
64687544|NCT01839799|Mitosis Modulators|mitosis modulators|mesh-ancestor
64687545|NCT01839799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687546|NCT01839799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64687547|NCT01839799|Antimetabolites|antimetabolites|mesh-ancestor
64687548|NCT01839799|Antiviral Agents|antiviral agents|mesh-ancestor
64687549|NCT01839799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64687550|NCT01839799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687551|NCT01839799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64687552|NCT01839799|Immunologic Factors|immunologic factors|mesh-ancestor
64687553|NCT01839799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687554|NCT03062059|Gemcitabine|gemcitabine|mesh-list
64687555|NCT03062059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64687556|NCT03062059|Antimetabolites|antimetabolites|mesh-ancestor
64687560|NCT03062059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64687561|NCT03062059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687562|NCT03062059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64687563|NCT03062059|Immunologic Factors|immunologic factors|mesh-ancestor
64687564|NCT03062059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687565|NCT02597543|Regadenoson|regadenoson|mesh-list
64687566|NCT02597543|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64687567|NCT02597543|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64687568|NCT02597543|Purinergic Agonists|purinergic agonists|mesh-ancestor
64687569|NCT02597543|Purinergic Agents|purinergic agents|mesh-ancestor
64687570|NCT02597543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64687571|NCT02597543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687572|NCT02597543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687573|NCT00553501|Rituximab|rituximab|mesh-list
64687574|NCT00553501|Epratuzumab|epratuzumab|mesh-list
64687586|NCT02599649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64716913|NCT04322396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716914|NCT04322396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64716915|NCT03330457|Betrixaban|betrixaban|mesh-list
64716916|NCT03330457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64716917|NCT03330457|Antithrombins|antithrombins|mesh-ancestor
64716918|NCT03330457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64687587|NCT02599649|Antimetabolites|antimetabolites|mesh-ancestor
64687588|NCT02599649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687589|NCT01840345|Acetylcysteine|acetylcysteine|mesh-list
64687590|NCT01840345|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64687591|NCT01840345|Antiviral Agents|antiviral agents|mesh-ancestor
64687592|NCT01840345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64687593|NCT01840345|Expectorants|expectorants|mesh-ancestor
64687594|NCT01840345|Respiratory System Agents|respiratory system agents|mesh-ancestor
64687595|NCT01840345|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64687596|NCT01840345|Antioxidants|antioxidants|mesh-ancestor
64687597|NCT01840345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687598|NCT01840345|Protective Agents|protective agents|mesh-ancestor
65453562|NCT00845026|Antidepressive Agents|antidepressive agents|mesh-ancestor
65453563|NCT00845026|Dopamine Agonists|dopamine agonists|mesh-ancestor
65453564|NCT00845026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65453565|NCT00845026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65453566|NCT00845026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65453567|NCT00845026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65453568|NCT02445131|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65453569|NCT02445131|Obinutuzumab|obinutuzumab|mesh-list
65453570|NCT02445131|Idelalisib|idelalisib|mesh-list
64838183|NCT01623362|Cariostatic Agents|cariostatic agents|mesh-ancestor
64838186|NCT01623375|Insulin|insulin|mesh-list
64687599|NCT01840345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687600|NCT01840345|Antidotes|antidotes|mesh-ancestor
64687613|NCT00364481|Omeprazole|omeprazole|mesh-list
64687614|NCT00364481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64687615|NCT00364481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64687616|NCT00364481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64687617|NCT00364481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687618|NCT00364481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687619|NCT02601833|Fluorides|fluorides|mesh-list
64687620|NCT02601833|Cariostatic Agents|cariostatic agents|mesh-ancestor
64687621|NCT02601833|Protective Agents|protective agents|mesh-ancestor
64687622|NCT02601833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687623|NCT00553267|Amlodipine|amlodipine|mesh-list
64687624|NCT00553267|Telmisartan|telmisartan|mesh-list
64687625|NCT00553267|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
64687626|NCT00553267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64687627|NCT00553267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64687628|NCT00553267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64687629|NCT00553267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687630|NCT00553267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64687631|NCT00553267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687632|NCT00553267|Vasodilator Agents|vasodilator agents|mesh-ancestor
64687633|NCT00553267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64687634|NCT00553267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64687635|NCT00364559|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64687636|NCT00364559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64687637|NCT00364559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64687638|NCT00364559|Antimetabolites|antimetabolites|mesh-ancestor
64687646|NCT02271984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64687648|NCT02604173|Acetazolamide|acetazolamide|mesh-list
64687649|NCT02604173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64687650|NCT02604173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64687651|NCT02604173|Autonomic Agents|autonomic agents|mesh-ancestor
64687652|NCT02604173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64687653|NCT02604173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687658|NCT02604173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64716920|NCT03330457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64716921|NCT03330457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716922|NCT03330457|Anticoagulants|anticoagulants|mesh-ancestor
64687659|NCT02604173|Anticonvulsants|anticonvulsants|mesh-ancestor
64687660|NCT02604173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64687661|NCT02604173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687662|NCT02604173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687663|NCT02604173|Diuretics|diuretics|mesh-ancestor
64687664|NCT02604173|Natriuretic Agents|natriuretic agents|mesh-ancestor
64687665|NCT02287038|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64687666|NCT02287038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64687667|NCT02287038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64687668|NCT02287038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64687669|NCT02287038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687670|NCT02287038|Adrenergic Agents|adrenergic agents|mesh-ancestor
65453571|NCT02445131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65453572|NCT02445131|Alkylating Agents|alkylating agents|mesh-ancestor
65453573|NCT02445131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453574|NCT02445131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453575|NCT02445131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65453576|NCT02445131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453577|NCT00003838|Cyclosporine|cyclosporine|mesh-list
64838192|NCT01623401|Tedizolid phosphate|tedizolid phosphate|mesh-list
64687671|NCT02287038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64687672|NCT02287038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687673|NCT00365339|Ritonavir|ritonavir|mesh-list
64687674|NCT00365339|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64687675|NCT00365339|Tenofovir|tenofovir|mesh-list
64687676|NCT00365339|Aripiprazole|aripiprazole|mesh-list
64687677|NCT00365339|Famotidine|famotidine|mesh-list
64687678|NCT00365339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64687679|NCT00365339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64687680|NCT00365339|Protease Inhibitors|protease inhibitors|mesh-ancestor
64687681|NCT00365339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687682|NCT00365339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687683|NCT00365339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64687684|NCT00365339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64687685|NCT00365339|Antiviral Agents|antiviral agents|mesh-ancestor
64687686|NCT00365339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64687687|NCT00365339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64687688|NCT00365339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64687689|NCT00365339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64687690|NCT00365339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64687691|NCT00365339|Antidepressive Agents|antidepressive agents|mesh-ancestor
64687692|NCT00365339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64687693|NCT00365339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64687694|NCT00365339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64687695|NCT00365339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64687696|NCT00365339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687697|NCT00365339|Dopamine Agonists|dopamine agonists|mesh-ancestor
64687698|NCT00365339|Dopamine Agents|dopamine agents|mesh-ancestor
64687699|NCT00365339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64687700|NCT00365339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64687701|NCT00365339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64687702|NCT00365339|Serotonin Agents|serotonin agents|mesh-ancestor
64687703|NCT00365339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64687724|NCT05589181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687725|NCT05589181|Analgesics|analgesics|mesh-ancestor
64687726|NCT05589181|Sensory System Agents|sensory system agents|mesh-ancestor
64687727|NCT05589181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64687728|NCT05589181|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64687729|NCT00366119|Ramipril|ramipril|mesh-list
64687730|NCT00366119|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64687731|NCT00366119|Protease Inhibitors|protease inhibitors|mesh-ancestor
64687732|NCT00366119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687733|NCT00366119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687734|NCT00366119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64687735|NCT05371301|Paclitaxel|paclitaxel|mesh-list
64687736|NCT05371301|Carboplatin|carboplatin|mesh-list
64687737|NCT05371301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64687738|NCT05371301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687739|NCT05371301|Tubulin Modulators|tubulin modulators|mesh-ancestor
64716925|NCT03961100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64716926|NCT03961100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716928|NCT03336853|Dental Disinfectants|dental disinfectants|mesh-ancestor
64716929|NCT03336853|Disinfectants|disinfectants|mesh-ancestor
64716930|NCT03336853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64716931|NCT03664544|Edaravone|edaravone|mesh-list
64716932|NCT03664544|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64716933|NCT03664544|Antioxidants|antioxidants|mesh-ancestor
64716934|NCT03664544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453578|NCT00003838|Methotrexate|methotrexate|mesh-list
65453579|NCT00003838|Cyclosporins|cyclosporins|mesh-list
65453580|NCT00003838|Lenograstim|lenograstim|mesh-list
65453581|NCT00003838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65453582|NCT00003838|Abortifacient Agents|abortifacient agents|mesh-ancestor
65453583|NCT00003838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65453584|NCT00003838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453585|NCT00003838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65453586|NCT00003838|Antimetabolites|antimetabolites|mesh-ancestor
65453587|NCT00003838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453588|NCT00003838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453589|NCT00003838|Dermatologic Agents|dermatologic agents|mesh-ancestor
65453590|NCT00003838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64716935|NCT03664544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64716936|NCT03664544|Protective Agents|protective agents|mesh-ancestor
64716937|NCT03664544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716938|NCT03225313|Bupivacaine|bupivacaine|mesh-list
64716939|NCT03225313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64716940|NCT03225313|Anesthetics, Local|anesthetics, local|mesh-ancestor
64716941|NCT03225313|Anesthetics|anesthetics|mesh-ancestor
64325191|NCT02484404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687742|NCT05371301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687743|NCT02285166|Hypolipidemic Agents|hypolipidemic agents|mesh-list
64687744|NCT02285166|Antimetabolites|antimetabolites|mesh-ancestor
64687745|NCT02285166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687746|NCT02285166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64687747|NCT02605187|Acetaminophen|acetaminophen|mesh-list
64687748|NCT02605187|Ibuprofen|ibuprofen|mesh-list
64687749|NCT02605187|Morphine|morphine|mesh-list
64687750|NCT02605187|Gabapentin|gabapentin|mesh-list
64687751|NCT02605187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64687752|NCT02605187|Narcotics|narcotics|mesh-ancestor
64687753|NCT02605187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64687754|NCT02605187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687755|NCT02605187|Analgesics|analgesics|mesh-ancestor
64687756|NCT02605187|Sensory System Agents|sensory system agents|mesh-ancestor
64687757|NCT02605187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64687758|NCT02605187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64413051|NCT04970329|Dextrans|dextrans|mesh-list
64687759|NCT02605187|Antipyretics|antipyretics|mesh-ancestor
64687778|NCT05592197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687779|NCT02989207|Mitomycins|mitomycins|mesh-list
64687780|NCT02989207|Mitomycin|mitomycin|mesh-list
64687781|NCT02989207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64687782|NCT02989207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687783|NCT02989207|Alkylating Agents|alkylating agents|mesh-ancestor
64687784|NCT02989207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687785|NCT02989207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64687786|NCT02989207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687787|NCT02647099|Aspirin|aspirin|mesh-list
64687788|NCT02647099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64687789|NCT02647099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64687790|NCT02647099|Analgesics|analgesics|mesh-ancestor
64687791|NCT02647099|Sensory System Agents|sensory system agents|mesh-ancestor
64687792|NCT02647099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64687793|NCT02647099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687794|NCT02647099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64687795|NCT02647099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64687796|NCT02647099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64687797|NCT02647099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64716942|NCT03225313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64716943|NCT03225313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716944|NCT03225313|Sensory System Agents|sensory system agents|mesh-ancestor
65453591|NCT00003838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65453592|NCT00003838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65453593|NCT00003838|Immunologic Factors|immunologic factors|mesh-ancestor
65453594|NCT00003838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65453595|NCT00003838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65453596|NCT00003838|Antifungal Agents|antifungal agents|mesh-ancestor
65453597|NCT00003838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65453598|NCT00003838|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65453599|NCT00003838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65453600|NCT01238770|Cyclophosphamide|cyclophosphamide|mesh-list
65453601|NCT01238770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65453602|NCT01238770|Immunologic Factors|immunologic factors|mesh-ancestor
65453603|NCT01238770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453604|NCT01238770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64838214|NCT01623570|Fertility Agents|fertility agents|mesh-ancestor
64716945|NCT03225313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716946|NCT03949244|Latanoprost|latanoprost|mesh-list
64716947|NCT03949244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64716948|NCT03949244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64716949|NCT03948386|Bupivacaine|bupivacaine|mesh-list
64716950|NCT03948386|Mepivacaine|mepivacaine|mesh-list
64716951|NCT03948386|Anesthetics, Local|anesthetics, local|mesh-ancestor
64325208|NCT02547974|Immunologic Factors|immunologic factors|mesh-ancestor
64325209|NCT02547974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687798|NCT02647099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687805|NCT01843621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687806|NCT02608229|Gemcitabine|gemcitabine|mesh-list
64687807|NCT02608229|Paclitaxel|paclitaxel|mesh-list
64687808|NCT02608229|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64687809|NCT02608229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64687810|NCT02608229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687811|NCT02608229|Tubulin Modulators|tubulin modulators|mesh-ancestor
64687812|NCT02608229|Antimitotic Agents|antimitotic agents|mesh-ancestor
64687813|NCT02608229|Mitosis Modulators|mitosis modulators|mesh-ancestor
64687814|NCT02608229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687824|NCT01642212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64687825|NCT01642212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64687826|NCT01642212|Autonomic Agents|autonomic agents|mesh-ancestor
64687827|NCT01642212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64687828|NCT01642212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687830|NCT01642212|Respiratory System Agents|respiratory system agents|mesh-ancestor
64687831|NCT01642212|Glucocorticoids|glucocorticoids|mesh-ancestor
64687832|NCT01642212|Hormones|hormones|mesh-ancestor
64687833|NCT01642212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64687834|NCT05649618|Cyclophosphamide|cyclophosphamide|mesh-list
64687835|NCT05649618|Fludarabine|fludarabine|mesh-list
64687836|NCT05649618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64687837|NCT05649618|Immunologic Factors|immunologic factors|mesh-ancestor
64687838|NCT05649618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687839|NCT05649618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64687840|NCT05649618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64687841|NCT05649618|Alkylating Agents|alkylating agents|mesh-ancestor
64687842|NCT05649618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687843|NCT05649618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687844|NCT05649618|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64687845|NCT00552175|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64687846|NCT00552175|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64687847|NCT00552175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64687848|NCT00552175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65453605|NCT01238770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65453606|NCT01238770|Alkylating Agents|alkylating agents|mesh-ancestor
65453607|NCT01238770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453608|NCT01238770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453609|NCT01238770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65453610|NCT01145950|Etanercept|etanercept|mesh-list
65453611|NCT01145950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65453612|NCT01145950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65453613|NCT01145950|Analgesics|analgesics|mesh-ancestor
65453614|NCT01145950|Sensory System Agents|sensory system agents|mesh-ancestor
65203099|NCT02854722|Vitamin D|vitamin d|mesh-list
65453615|NCT01145950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65453616|NCT01145950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453617|NCT01145950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65453619|NCT01145950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64687849|NCT00552175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687850|NCT00552175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64687851|NCT00552175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687852|NCT00552175|Analgesics|analgesics|mesh-ancestor
64687853|NCT00552175|Sensory System Agents|sensory system agents|mesh-ancestor
64687854|NCT00552175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64687855|NCT00552175|Antidepressive Agents|antidepressive agents|mesh-ancestor
64716952|NCT03948386|Anesthetics|anesthetics|mesh-ancestor
64716953|NCT03948386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64716954|NCT03948386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716955|NCT03948386|Sensory System Agents|sensory system agents|mesh-ancestor
64716956|NCT03948386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716957|NCT03445195|Imipenem|imipenem|mesh-list
64716958|NCT03445195|Sulbactam|sulbactam|mesh-list
64716959|NCT03445195|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
64716960|NCT03445195|Cilastatin|cilastatin|mesh-list
64716961|NCT03445195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64716962|NCT03445195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64716963|NCT03445195|Protease Inhibitors|protease inhibitors|mesh-ancestor
64716964|NCT03445195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64716965|NCT03445195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325230|NCT01033123|Iniparib|iniparib|mesh-list
64687856|NCT00552175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64687857|NCT00552175|Dopamine Agents|dopamine agents|mesh-ancestor
64687858|NCT01644474|Ezetimibe|ezetimibe|mesh-list
64687859|NCT01644474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64687860|NCT01644474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64687861|NCT01644474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64687862|NCT01644474|Antimetabolites|antimetabolites|mesh-ancestor
64687866|NCT01644474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687867|NCT02989129|Quercetin|quercetin|mesh-list
64687868|NCT02989129|Antioxidants|antioxidants|mesh-ancestor
64687869|NCT02989129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687870|NCT02989129|Protective Agents|protective agents|mesh-ancestor
64687871|NCT02989129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687872|NCT04879524|Botulinum Toxins|botulinum toxins|mesh-list
64687873|NCT04879524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64687874|NCT04879524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64687875|NCT04879524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687876|NCT04879524|Cholinergic Agents|cholinergic agents|mesh-ancestor
64687877|NCT04879524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64687878|NCT04879524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687879|NCT01847131|Phenylephrine|phenylephrine|mesh-list
64687880|NCT01847131|Oxymetazoline|oxymetazoline|mesh-list
64687890|NCT01847131|Nasal Decongestants|nasal decongestants|mesh-ancestor
65453620|NCT01145950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65453621|NCT01145950|Immunologic Factors|immunologic factors|mesh-ancestor
65453622|NCT01238926|Vitamins|vitamins|mesh-list
65453623|NCT01238926|Folic Acid|folic acid|mesh-list
65453624|NCT01238926|Hydroxocobalamin|hydroxocobalamin|mesh-list
65453625|NCT01238926|Vitamin B 12|vitamin b 12|mesh-list
65453626|NCT01238926|Vitamin B 6|vitamin b 6|mesh-list
65453627|NCT01238926|Pyridoxal|pyridoxal|mesh-list
65453628|NCT01238926|Pyridoxine|pyridoxine|mesh-list
65453629|NCT01238926|Vitamin B Complex|vitamin b complex|mesh-list
65453630|NCT01238926|Micronutrients|micronutrients|mesh-ancestor
65453631|NCT01238926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453632|NCT01238926|Hematinics|hematinics|mesh-ancestor
65453633|NCT01239004|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65453634|NCT01239004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65453635|NCT01239004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65453636|NCT01239004|Antimetabolites|antimetabolites|mesh-ancestor
65453637|NCT01239004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453638|NCT01239004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65453639|NCT01142518|Interferons|interferons|mesh-list
65453640|NCT01142518|Interferon-beta|interferon-beta|mesh-list
65453641|NCT01142518|Interferon beta-1a|interferon beta-1a|mesh-list
65453642|NCT01142518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453643|NCT01142518|Antiviral Agents|antiviral agents|mesh-ancestor
65453644|NCT01142518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65453645|NCT01142518|Immunologic Factors|immunologic factors|mesh-ancestor
65453646|NCT01142518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453647|NCT01142518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65453648|NCT00423449|Gemcitabine|gemcitabine|mesh-list
65453649|NCT00423449|Vorinostat|vorinostat|mesh-list
65453650|NCT00423449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65453651|NCT00423449|Antimetabolites|antimetabolites|mesh-ancestor
65453652|NCT00423449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453653|NCT00423449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453654|NCT00423449|Antiviral Agents|antiviral agents|mesh-ancestor
65453655|NCT00423449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65453656|NCT00423449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453657|NCT00423449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65453658|NCT00423449|Immunologic Factors|immunologic factors|mesh-ancestor
65453660|NCT00423449|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65453661|NCT00423293|Fluorouracil|fluorouracil|mesh-list
65453662|NCT00423293|Mitomycins|mitomycins|mesh-list
65453663|NCT00423293|Mitomycin|mitomycin|mesh-list
65453664|NCT00423293|Antimetabolites|antimetabolites|mesh-ancestor
65453665|NCT00423293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453666|NCT00423293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65453667|NCT00423293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453668|NCT00423293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65453669|NCT00423293|Immunologic Factors|immunologic factors|mesh-ancestor
65453670|NCT00423293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453671|NCT00423293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65453672|NCT00423293|Alkylating Agents|alkylating agents|mesh-ancestor
65453673|NCT00423293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65453674|NCT00423293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453675|NCT00422903|Letrozole|letrozole|mesh-list
65453676|NCT00422903|Lapatinib|lapatinib|mesh-list
65453677|NCT00422903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453678|NCT00422903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65453679|NCT00422903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65453680|NCT00422903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453681|NCT00422903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453682|NCT00422903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65453683|NCT00422903|Hormone Antagonists|hormone antagonists|mesh-ancestor
65453684|NCT00422903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64687891|NCT01847131|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64687892|NCT01847131|Respiratory System Agents|respiratory system agents|mesh-ancestor
64687893|NCT01847131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64687894|NCT01847131|Mydriatics|mydriatics|mesh-ancestor
64687895|NCT01847131|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64687896|NCT01847131|Protective Agents|protective agents|mesh-ancestor
64687897|NCT02285010|Pregabalin|pregabalin|mesh-list
64687898|NCT02285010|Analgesics|analgesics|mesh-ancestor
64687899|NCT02285010|Sensory System Agents|sensory system agents|mesh-ancestor
64687900|NCT02285010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64687901|NCT02285010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687902|NCT02285010|Anticonvulsants|anticonvulsants|mesh-ancestor
64687903|NCT02285010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64687904|NCT02285010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64687905|NCT02285010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687906|NCT02285010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64687907|NCT02285010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64687908|NCT02285010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64687909|NCT02285010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64716966|NCT03445195|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64716967|NCT04277936|Levetiracetam|levetiracetam|mesh-list
64716968|NCT04277936|Anticonvulsants|anticonvulsants|mesh-ancestor
64716969|NCT04277936|Nootropic Agents|nootropic agents|mesh-ancestor
64716970|NCT03670160|Clonidine|clonidine|mesh-list
65453685|NCT00422903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453686|NCT00422903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65453687|NCT00422591|Cytarabine|cytarabine|mesh-list
65453688|NCT00422591|Idarubicin|idarubicin|mesh-list
65453689|NCT00422591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65453690|NCT00422591|Antimetabolites|antimetabolites|mesh-ancestor
65453691|NCT00422591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453692|NCT00422591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453693|NCT00422591|Antiviral Agents|antiviral agents|mesh-ancestor
65453694|NCT00422591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65453695|NCT00422591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65453696|NCT00422591|Immunologic Factors|immunologic factors|mesh-ancestor
65453697|NCT00422591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453698|NCT00422591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65453699|NCT00422591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65453700|NCT00422591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65453701|NCT00422591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453702|NCT00422513|Epoetin Alfa|epoetin alfa|mesh-list
65453703|NCT00422513|Hematinics|hematinics|mesh-ancestor
64716971|NCT03670160|Phenobarbital|phenobarbital|mesh-list
64716972|NCT03670160|Analgesics|analgesics|mesh-ancestor
64716973|NCT03670160|Sensory System Agents|sensory system agents|mesh-ancestor
64716974|NCT03670160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716975|NCT03670160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716976|NCT03670160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64687910|NCT02285010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64687911|NCT02617667|Cyclosporine|cyclosporine|mesh-list
64687912|NCT02617667|Cyclosporins|cyclosporins|mesh-list
64687913|NCT02617667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687914|NCT02617667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687915|NCT02617667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64687916|NCT02617667|Immunologic Factors|immunologic factors|mesh-ancestor
64687917|NCT02617667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687918|NCT02617667|Antifungal Agents|antifungal agents|mesh-ancestor
64687919|NCT02617667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64687920|NCT02617667|Dermatologic Agents|dermatologic agents|mesh-ancestor
64687921|NCT02617667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64687922|NCT02617667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64687923|NCT03023449|Nitric Oxide|nitric oxide|mesh-list
64687924|NCT03023449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64687925|NCT03023449|Autonomic Agents|autonomic agents|mesh-ancestor
64687926|NCT03023449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64687927|NCT03023449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687928|NCT03023449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64687929|NCT03023449|Respiratory System Agents|respiratory system agents|mesh-ancestor
64687930|NCT03023449|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64687931|NCT03023449|Antioxidants|antioxidants|mesh-ancestor
64687932|NCT03023449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687939|NCT01848067|Abiraterone Acetate|abiraterone acetate|mesh-list
64687940|NCT01848067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64687941|NCT01848067|Glucocorticoids|glucocorticoids|mesh-ancestor
64687942|NCT01848067|Hormones|hormones|mesh-ancestor
64687943|NCT01848067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64687944|NCT01848067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687960|NCT05731973|Sensory System Agents|sensory system agents|mesh-ancestor
64687961|NCT05731973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65453704|NCT00202878|Simvastatin|simvastatin|mesh-list
65453705|NCT00202878|Ezetimibe|ezetimibe|mesh-list
65453706|NCT00202878|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
65453707|NCT00202878|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65453708|NCT00202878|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65453709|NCT00202878|Antimetabolites|antimetabolites|mesh-ancestor
65453710|NCT00202878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453711|NCT00202878|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65453712|NCT00202878|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65453713|NCT00202878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453714|NCT00414011|Moxifloxacin|moxifloxacin|mesh-list
65453715|NCT00414011|Gatifloxacin|gatifloxacin|mesh-list
65453716|NCT00414011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65453717|NCT00414011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65453718|NCT00414011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64687962|NCT05731973|Narcotics|narcotics|mesh-ancestor
64687963|NCT05731973|Analgesics|analgesics|mesh-ancestor
64687964|NCT05731973|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64687965|NCT05731973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64687966|NCT05731973|Anesthetics, General|anesthetics, general|mesh-ancestor
64687967|NCT05068349|3-n-butylphthalide|3-n-butylphthalide|mesh-list
64687968|NCT05068349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64687969|NCT05068349|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64687970|NCT05068349|Protective Agents|protective agents|mesh-ancestor
64687971|NCT05068349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687972|NCT04665037|Posaconazole|posaconazole|mesh-list
64687973|NCT04665037|Antifungal Agents|antifungal agents|mesh-ancestor
64687974|NCT04665037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64687976|NCT04665037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64687977|NCT04665037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64687978|NCT04665037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64716978|NCT03670160|Autonomic Agents|autonomic agents|mesh-ancestor
64687979|NCT04665037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64687980|NCT04665037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687981|NCT04665037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413325|NCT04957927|Xhance|xhance|mesh-list
64687982|NCT04665037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64687983|NCT04665037|Hormone Antagonists|hormone antagonists|mesh-ancestor
64687984|NCT04665037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64687985|NCT04665037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687986|NCT05452577|Estazolam|estazolam|mesh-list
64687987|NCT05452577|Anticonvulsants|anticonvulsants|mesh-ancestor
64687988|NCT05452577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64687989|NCT05452577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64687990|NCT05452577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64687991|NCT05452577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687992|NCT05452577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64687993|NCT05452577|GABA Modulators|gaba modulators|mesh-ancestor
64687994|NCT05452577|GABA Agents|gaba agents|mesh-ancestor
64687995|NCT05452577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64687996|NCT05452577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687997|NCT05464615|Amoxicillin|amoxicillin|mesh-list
64687998|NCT05464615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64687999|NCT05464615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64688000|NCT00364871|Naltrexone|naltrexone|mesh-list
64688001|NCT00364871|Bupropion|bupropion|mesh-list
64688002|NCT00364871|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64688003|NCT00364871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64688004|NCT00364871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688013|NCT00364871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453719|NCT00414011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65453720|NCT00414011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453721|NCT00414011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453722|NCT00414011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453723|NCT00414011|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65453724|NCT00414011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65453725|NCT00260208|Cyclosporine|cyclosporine|mesh-list
65453726|NCT00260208|Tacrolimus|tacrolimus|mesh-list
65453727|NCT00260208|Cyclosporins|cyclosporins|mesh-list
65453728|NCT00260208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65453729|NCT00260208|Immunologic Factors|immunologic factors|mesh-ancestor
65453730|NCT00260208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453731|NCT00260208|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65453732|NCT00260208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453733|NCT00260208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453734|NCT00260208|Antifungal Agents|antifungal agents|mesh-ancestor
65453735|NCT00260208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64688014|NCT00364871|Dopamine Agents|dopamine agents|mesh-ancestor
64688015|NCT00364871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64688016|NCT00364871|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64688017|NCT00364871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64688018|NCT00364871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688019|NCT00551161|Memantine|memantine|mesh-list
64688020|NCT00551161|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64688021|NCT00551161|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64688022|NCT00551161|Dopamine Agents|dopamine agents|mesh-ancestor
64688023|NCT00551161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64688024|NCT00551161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688026|NCT00551161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64688027|NCT00551161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64688028|NCT00550771|Paclitaxel|paclitaxel|mesh-list
64688029|NCT00550771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64688030|NCT00550771|Cyclophosphamide|cyclophosphamide|mesh-list
64688031|NCT00550771|Doxorubicin|doxorubicin|mesh-list
64688032|NCT00550771|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64688033|NCT00550771|Trastuzumab|trastuzumab|mesh-list
64688034|NCT00550771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64688035|NCT00550771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688036|NCT00550771|Tubulin Modulators|tubulin modulators|mesh-ancestor
64688037|NCT00550771|Antimitotic Agents|antimitotic agents|mesh-ancestor
64688038|NCT00550771|Mitosis Modulators|mitosis modulators|mesh-ancestor
64688039|NCT00550771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688040|NCT00550771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64688041|NCT00550771|Immunologic Factors|immunologic factors|mesh-ancestor
64688042|NCT00550771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688043|NCT00550771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64688044|NCT00550771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64688045|NCT00550771|Alkylating Agents|alkylating agents|mesh-ancestor
64688046|NCT00550771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64688048|NCT00550771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64688049|NCT00550771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64688050|NCT00550771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688051|NCT00550771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64688052|NCT05298449|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64688053|NCT05298449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64688054|NCT05298449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64688055|NCT05298449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65453736|NCT00260208|Dermatologic Agents|dermatologic agents|mesh-ancestor
65453737|NCT00260208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65453738|NCT00202644|Hydroxyurea|hydroxyurea|mesh-list
65453739|NCT00202644|Anagrelide|anagrelide|mesh-list
65453740|NCT00202644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453741|NCT00202644|Antisickling Agents|antisickling agents|mesh-ancestor
65453742|NCT00202644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453743|NCT00202644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453744|NCT00202644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65453745|NCT00202644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65453746|NCT00202644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65453747|NCT00202644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65453748|NCT00259740|Denosumab|denosumab|mesh-list
65453749|NCT00259740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65453750|NCT00259740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688056|NCT05298449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716979|NCT03670160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64716980|NCT03670160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64716981|NCT03670160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64716982|NCT03670160|Adrenergic Agents|adrenergic agents|mesh-ancestor
64716983|NCT03670160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64325243|NCT01323205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64688057|NCT05298449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64688058|NCT05298449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64688059|NCT05298449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688060|NCT05298449|Cholinergic Agents|cholinergic agents|mesh-ancestor
64688061|NCT05298449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64688063|NCT01852669|Diuretics|diuretics|mesh-ancestor
64688064|NCT01852669|Natriuretic Agents|natriuretic agents|mesh-ancestor
64688065|NCT01852669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688066|NCT01852669|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64688067|NCT01852669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64688068|NCT01852669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688081|NCT04484623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64688082|NCT04484623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688083|NCT04484623|Immunologic Factors|immunologic factors|mesh-ancestor
64688084|NCT04484623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64688085|NCT04484623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64688086|NCT04484623|Growth Substances|growth substances|mesh-ancestor
64688087|NCT04484623|Growth Inhibitors|growth inhibitors|mesh-ancestor
64688088|NCT04741295|Heparin|heparin|mesh-list
64688089|NCT04741295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64688090|NCT04741295|Tinzaparin|tinzaparin|mesh-list
64688091|NCT04741295|Dalteparin|dalteparin|mesh-list
64688092|NCT04741295|Anticoagulants|anticoagulants|mesh-ancestor
64688093|NCT04741295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64688094|NCT04741295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64688095|NCT04741295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688096|NCT00550537|Paclitaxel|paclitaxel|mesh-list
64688097|NCT00550537|Bevacizumab|bevacizumab|mesh-list
64688098|NCT00550537|Carboplatin|carboplatin|mesh-list
64688099|NCT00550537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64688100|NCT00550537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64688101|NCT00550537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688102|NCT00550537|Tubulin Modulators|tubulin modulators|mesh-ancestor
64688103|NCT00550537|Antimitotic Agents|antimitotic agents|mesh-ancestor
64688104|NCT00550537|Mitosis Modulators|mitosis modulators|mesh-ancestor
64688105|NCT00550537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688109|NCT00550537|Growth Substances|growth substances|mesh-ancestor
65453751|NCT01073202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65453752|NCT01073202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65453753|NCT01073202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65453754|NCT01236040|Vaccines|vaccines|mesh-list
65453755|NCT01236040|Immunologic Factors|immunologic factors|mesh-ancestor
65453756|NCT01236040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453757|NCT03812224|Erenumab|erenumab|mesh-list
65453758|NCT03812224|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65453759|NCT03812224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453760|NCT03812224|Analgesics|analgesics|mesh-ancestor
65453761|NCT03812224|Sensory System Agents|sensory system agents|mesh-ancestor
65453762|NCT03812224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65453763|NCT03812224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453764|NCT01146028|Tizanidine|tizanidine|mesh-list
65453765|NCT01146028|Analgesics|analgesics|mesh-ancestor
65453766|NCT01146028|Sensory System Agents|sensory system agents|mesh-ancestor
65453767|NCT01146028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65453768|NCT01146028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453769|NCT01146028|Anticonvulsants|anticonvulsants|mesh-ancestor
64688110|NCT00550537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688111|NCT00550537|Growth Inhibitors|growth inhibitors|mesh-ancestor
64688112|NCT00550537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64688113|NCT00550537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688114|NCT04801043|Imipenem|imipenem|mesh-list
64688115|NCT04801043|Cilastatin|cilastatin|mesh-list
64688116|NCT04801043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64688117|NCT04801043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64688118|NCT04801043|Protease Inhibitors|protease inhibitors|mesh-ancestor
64688119|NCT04801043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688120|NCT04801043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688122|NCT05706701|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64688123|NCT05706701|Autonomic Agents|autonomic agents|mesh-ancestor
64688124|NCT05706701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64688125|NCT05706701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688126|NCT05706701|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64688127|NCT05706701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64688128|NCT05706701|Cholinergic Agents|cholinergic agents|mesh-ancestor
64688129|NCT05706701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64688130|NCT05706701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688131|NCT04734197|Cyclosporine|cyclosporine|mesh-list
64716984|NCT03670160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716985|NCT03670160|Anticonvulsants|anticonvulsants|mesh-ancestor
64716986|NCT03670160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64716987|NCT03670160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64716988|NCT03670160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64716989|NCT03670160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64716990|NCT03670160|GABA Modulators|gaba modulators|mesh-ancestor
64688132|NCT04734197|Mycophenolic Acid|mycophenolic acid|mesh-list
64688133|NCT04734197|Betamethasone|betamethasone|mesh-list
64688134|NCT04734197|Betamethasone Valerate|betamethasone valerate|mesh-list
64688148|NCT04734197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64688150|NCT04734197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64688151|NCT04734197|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64688152|NCT04734197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64688153|NCT04734197|Glucocorticoids|glucocorticoids|mesh-ancestor
65453770|NCT01146028|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65453771|NCT01146028|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65453772|NCT01146028|Parasympatholytics|parasympatholytics|mesh-ancestor
65453773|NCT01146028|Autonomic Agents|autonomic agents|mesh-ancestor
65453774|NCT01146028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65453775|NCT01146028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65453776|NCT01146028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65453777|NCT01146028|Adrenergic Agents|adrenergic agents|mesh-ancestor
65453778|NCT01146028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65453779|NCT01146028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453781|NCT03530800|Hallucinogens|hallucinogens|mesh-ancestor
65453782|NCT03530800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453783|NCT03530800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65453784|NCT03530800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65453785|NCT03530800|Analgesics|analgesics|mesh-ancestor
65453786|NCT03530800|Sensory System Agents|sensory system agents|mesh-ancestor
64688154|NCT04734197|Hormones|hormones|mesh-ancestor
64688155|NCT04734197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64688156|NCT04734197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64688157|NCT04734197|Respiratory System Agents|respiratory system agents|mesh-ancestor
64688158|NCT04734197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64688159|NCT04734197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688160|NCT04734197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64688161|NCT04734197|Antitubercular Agents|antitubercular agents|mesh-ancestor
64688162|NCT04734197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64688163|NCT00550147|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64688164|NCT00550147|Methylphenidate|methylphenidate|mesh-list
64688165|NCT00550147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64688166|NCT00550147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688167|NCT00550147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64688168|NCT00550147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64688169|NCT00550147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64688170|NCT00550147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688171|NCT00550147|Dopamine Agents|dopamine agents|mesh-ancestor
64688172|NCT00550147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64688173|NCT00550147|Antidepressive Agents|antidepressive agents|mesh-ancestor
64688174|NCT00550147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64688175|NCT00550147|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64688176|NCT00550147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64688177|NCT00550147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64688178|NCT05688215|Calcium, Dietary|calcium, dietary|mesh-list
64688179|NCT05688215|Leucovorin|leucovorin|mesh-list
64688180|NCT05688215|Folic Acid|folic acid|mesh-list
64688181|NCT05688215|Fluorouracil|fluorouracil|mesh-list
64688182|NCT05688215|Oxaliplatin|oxaliplatin|mesh-list
64688183|NCT05688215|Irinotecan|irinotecan|mesh-list
64688184|NCT05688215|Calcium|calcium|mesh-list
64688185|NCT05688215|Levoleucovorin|levoleucovorin|mesh-list
64688189|NCT05688215|Antimetabolites|antimetabolites|mesh-ancestor
64688190|NCT05688215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688191|NCT05688215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64688192|NCT05688215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688193|NCT05688215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64688194|NCT05688215|Immunologic Factors|immunologic factors|mesh-ancestor
64688195|NCT05688215|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64688220|NCT02264353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64688221|NCT02264353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688222|NCT02264353|Nootropic Agents|nootropic agents|mesh-ancestor
64688223|NCT02265913|Acyclovir|acyclovir|mesh-list
65453787|NCT03530800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65453788|NCT03530800|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65453789|NCT03530800|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65453790|NCT03530800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65453791|NCT03530800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453792|NCT03530800|Hormones|hormones|mesh-ancestor
65453793|NCT03530800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65453794|NCT04982146|Acetylcysteine|acetylcysteine|mesh-list
64688224|NCT02265913|Antiviral Agents|antiviral agents|mesh-ancestor
64688225|NCT02265913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64688226|NCT02624843|Ethanol|ethanol|mesh-list
64688227|NCT02624843|Benzyl Alcohol|benzyl alcohol|mesh-list
64688228|NCT02624843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64688229|NCT02624843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64716991|NCT03670160|GABA Agents|gaba agents|mesh-ancestor
64716992|NCT03670160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64716993|NCT03670160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64716994|NCT03670160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64716995|NCT00375895|Cyclosporine|cyclosporine|mesh-list
64716996|NCT00375895|Cyclosporins|cyclosporins|mesh-list
64716997|NCT00375895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688230|NCT02624843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64688231|NCT02624843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688232|NCT02624843|Anesthetics, Local|anesthetics, local|mesh-ancestor
64688233|NCT02624843|Anesthetics|anesthetics|mesh-ancestor
64688234|NCT02624843|Sensory System Agents|sensory system agents|mesh-ancestor
64688235|NCT02624843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64688236|NCT02279641|Allopurinol|allopurinol|mesh-list
64688237|NCT02279641|Verinurad|verinurad|mesh-list
64688238|NCT02279641|Antimetabolites|antimetabolites|mesh-ancestor
64688239|NCT02279641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688240|NCT02279641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688241|NCT02279641|Gout Suppressants|gout suppressants|mesh-ancestor
64688242|NCT02279641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64688243|NCT02279641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64688244|NCT02279641|Antioxidants|antioxidants|mesh-ancestor
64688245|NCT02279641|Protective Agents|protective agents|mesh-ancestor
64688246|NCT02279641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688247|NCT02629991|Oxytocin|oxytocin|mesh-list
64688248|NCT02629991|Oxytocics|oxytocics|mesh-ancestor
64688249|NCT02629991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64688250|NCT02629991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688262|NCT05142709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688263|NCT04992143|Sorafenib|sorafenib|mesh-list
64688264|NCT04992143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688265|NCT04992143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64688266|NCT04992143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688267|NCT04992143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688268|NCT04485065|Azacitidine|azacitidine|mesh-list
64688269|NCT04485065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64688270|NCT04485065|Antimetabolites|antimetabolites|mesh-ancestor
64688271|NCT04485065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688273|NCT04485065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688274|NCT03769129|Pembrolizumab|pembrolizumab|mesh-list
64688275|NCT03769129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64688276|NCT03769129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688277|NCT00367445|Insulin|insulin|mesh-list
64688278|NCT00367445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64688279|NCT00367445|Insulin Glargine|insulin glargine|mesh-list
64688280|NCT00367445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64688281|NCT00367445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688282|NCT01866943|Tranexamic Acid|tranexamic acid|mesh-list
64333952|NCT02225093|Purinergic Agents|purinergic agents|mesh-ancestor
64688283|NCT01866943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64688284|NCT01866943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64688285|NCT01866943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688289|NCT01868425|Ketamine|ketamine|mesh-list
65453795|NCT04982146|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65453796|NCT04982146|Antiviral Agents|antiviral agents|mesh-ancestor
65453797|NCT04982146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65453798|NCT04982146|Expectorants|expectorants|mesh-ancestor
65453799|NCT04982146|Respiratory System Agents|respiratory system agents|mesh-ancestor
65453800|NCT04982146|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65453801|NCT04982146|Antioxidants|antioxidants|mesh-ancestor
65453802|NCT04982146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453803|NCT04982146|Protective Agents|protective agents|mesh-ancestor
65453804|NCT04982146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453805|NCT04982146|Antidotes|antidotes|mesh-ancestor
65453806|NCT04958746|Propofol|propofol|mesh-list
65453807|NCT04958746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65453808|NCT04958746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65453809|NCT04958746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453810|NCT04958746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65453811|NCT04958746|Anesthetics, General|anesthetics, general|mesh-ancestor
65453812|NCT04958746|Anesthetics|anesthetics|mesh-ancestor
65453813|NCT01146106|Pravastatin|pravastatin|mesh-list
65453814|NCT01146106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65453815|NCT01146106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65453816|NCT01146106|Antimetabolites|antimetabolites|mesh-ancestor
65453817|NCT01146106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453818|NCT01146106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65453819|NCT01146106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65453820|NCT01146106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453821|NCT03431584|Hyaluronic Acid|hyaluronic acid|mesh-list
65453822|NCT03431584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65453823|NCT03431584|Immunologic Factors|immunologic factors|mesh-ancestor
65453824|NCT03431584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453825|NCT03431584|Viscosupplements|viscosupplements|mesh-ancestor
64688290|NCT01868425|Gabapentin|gabapentin|mesh-list
64688291|NCT01868425|Bupivacaine|bupivacaine|mesh-list
64688292|NCT01868425|Anesthetics, Local|anesthetics, local|mesh-ancestor
64688293|NCT01868425|Anesthetics|anesthetics|mesh-ancestor
64688294|NCT01868425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64688295|NCT01868425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688296|NCT01868425|Sensory System Agents|sensory system agents|mesh-ancestor
64688297|NCT01868425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64688298|NCT01868425|Analgesics|analgesics|mesh-ancestor
64688299|NCT01868425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64688300|NCT01868425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64688301|NCT01868425|Anesthetics, General|anesthetics, general|mesh-ancestor
64688302|NCT01868425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65453826|NCT03431584|Protective Agents|protective agents|mesh-ancestor
65453827|NCT04916392|Bupivacaine|bupivacaine|mesh-list
65453828|NCT04916392|Anesthetics, Local|anesthetics, local|mesh-ancestor
65453829|NCT04916392|Anesthetics|anesthetics|mesh-ancestor
65453830|NCT04916392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65453831|NCT04916392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453832|NCT04916392|Sensory System Agents|sensory system agents|mesh-ancestor
65453833|NCT04916392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65453834|NCT00259272|Olanzapine|olanzapine|mesh-list
65453835|NCT00259272|Antiemetics|antiemetics|mesh-ancestor
65453836|NCT00259272|Autonomic Agents|autonomic agents|mesh-ancestor
65453837|NCT00259272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65453838|NCT00259272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453839|NCT00259272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65453840|NCT00259272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65453841|NCT00259272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65203312|NCT03522831|Respiratory System Agents|respiratory system agents|mesh-ancestor
65453842|NCT00259272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65453843|NCT00259272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65453844|NCT00259272|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65453845|NCT00259272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65453846|NCT00259272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65453847|NCT00259272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453848|NCT00259272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65453849|NCT00259272|Serotonin Agents|serotonin agents|mesh-ancestor
65453850|NCT03172624|Nivolumab|nivolumab|mesh-list
65453851|NCT03172624|Ipilimumab|ipilimumab|mesh-list
64688303|NCT01868425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64688304|NCT01868425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64716998|NCT00375895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716999|NCT00375895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64717000|NCT00375895|Immunologic Factors|immunologic factors|mesh-ancestor
64717001|NCT00375895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717002|NCT00375895|Antifungal Agents|antifungal agents|mesh-ancestor
64717003|NCT00375895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64717004|NCT00375895|Dermatologic Agents|dermatologic agents|mesh-ancestor
64717005|NCT00375895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64717006|NCT00375895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64717007|NCT03338803|Linagliptin|linagliptin|mesh-list
64717008|NCT03338803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64717009|NCT03338803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717010|NCT03338803|Incretins|incretins|mesh-ancestor
64717011|NCT03338803|Hormones|hormones|mesh-ancestor
64717012|NCT03338803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64717013|NCT03338803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64717014|NCT03338803|Protease Inhibitors|protease inhibitors|mesh-ancestor
64717015|NCT03338803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453852|NCT03172624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65453853|NCT03172624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453854|NCT03172624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65453855|NCT03172624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453856|NCT03106324|Lenalidomide|lenalidomide|mesh-list
65453857|NCT03106324|Immunologic Factors|immunologic factors|mesh-ancestor
65453858|NCT03106324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453859|NCT03106324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65453860|NCT03106324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65453861|NCT03106324|Growth Substances|growth substances|mesh-ancestor
65453862|NCT03106324|Growth Inhibitors|growth inhibitors|mesh-ancestor
65453863|NCT03106324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453864|NCT01147276|Vildagliptin|vildagliptin|mesh-list
65453865|NCT01147276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65453866|NCT01147276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453867|NCT01147276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65453868|NCT01147276|Protease Inhibitors|protease inhibitors|mesh-ancestor
65453869|NCT01147276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838468|NCT01625351|Antifungal Agents|antifungal agents|mesh-ancestor
64717016|NCT03338803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717017|NCT00422864|Leucovorin|leucovorin|mesh-list
64717018|NCT00422864|Fluorouracil|fluorouracil|mesh-list
64717019|NCT00422864|Oxaliplatin|oxaliplatin|mesh-list
64717020|NCT00422864|Antimetabolites|antimetabolites|mesh-ancestor
64717021|NCT00422864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717022|NCT00422864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64717023|NCT00422864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64717024|NCT00422864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64717025|NCT00422864|Immunologic Factors|immunologic factors|mesh-ancestor
64717026|NCT00422864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717027|NCT00422864|Antidotes|antidotes|mesh-ancestor
64688305|NCT01868425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688306|NCT01868425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64688307|NCT01868425|Antipyretics|antipyretics|mesh-ancestor
64688308|NCT01868425|Anticonvulsants|anticonvulsants|mesh-ancestor
64688309|NCT01868425|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64688310|NCT01868425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64688311|NCT01868425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64688312|NCT01868425|Antimanic Agents|antimanic agents|mesh-ancestor
64688313|NCT00550459|Tolvaptan|tolvaptan|mesh-list
64688314|NCT00550459|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64688333|NCT04896073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688334|NCT04896073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688336|NCT01874119|Aprepitant|aprepitant|mesh-list
64717028|NCT00422864|Protective Agents|protective agents|mesh-ancestor
64717029|NCT00422864|Vitamin B Complex|vitamin b complex|mesh-ancestor
64717030|NCT00422864|Vitamins|vitamins|mesh-ancestor
64717031|NCT00422864|Micronutrients|micronutrients|mesh-ancestor
64688337|NCT01874119|Antiemetics|antiemetics|mesh-ancestor
64688338|NCT01874119|Autonomic Agents|autonomic agents|mesh-ancestor
64688339|NCT01874119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64688340|NCT01874119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688341|NCT01874119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64688342|NCT01874119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64688343|NCT01874119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65453870|NCT01147276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453871|NCT01239940|Paclitaxel|paclitaxel|mesh-list
65453872|NCT01239940|Everolimus|everolimus|mesh-list
65453873|NCT01239940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65453874|NCT01239940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453875|NCT01239940|Tubulin Modulators|tubulin modulators|mesh-ancestor
65453876|NCT01239940|Antimitotic Agents|antimitotic agents|mesh-ancestor
65453877|NCT01239940|Mitosis Modulators|mitosis modulators|mesh-ancestor
65453878|NCT01239940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453879|NCT01239940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65453880|NCT01239940|Immunologic Factors|immunologic factors|mesh-ancestor
65453881|NCT01239940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453882|NCT02526004|Tobramycin|tobramycin|mesh-list
65453883|NCT02526004|Ceftazidime|ceftazidime|mesh-list
65453884|NCT02526004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64688344|NCT01874119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688345|NCT03123913|Methyltestosterone|methyltestosterone|mesh-list
64688346|NCT03123913|Testosterone|testosterone|mesh-list
64688350|NCT03123913|Androgens|androgens|mesh-ancestor
64688352|NCT03123913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64688353|NCT03123913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688354|NCT03123913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64688355|NCT03123913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688356|NCT03123913|Anabolic Agents|anabolic agents|mesh-ancestor
64688357|NCT02823145|Fenfluramine|fenfluramine|mesh-list
64688358|NCT02823145|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64688359|NCT02823145|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64688360|NCT02823145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64688361|NCT02823145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688362|NCT02823145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64688363|NCT02823145|Serotonin Agents|serotonin agents|mesh-ancestor
64688364|NCT02823145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688365|NCT02280811|Aldesleukin|aldesleukin|mesh-list
64688366|NCT02280811|Cyclophosphamide|cyclophosphamide|mesh-list
64688367|NCT02280811|Fludarabine|fludarabine|mesh-list
64688370|NCT02280811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688371|NCT02280811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64688372|NCT02280811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64688373|NCT02280811|Alkylating Agents|alkylating agents|mesh-ancestor
64688374|NCT02280811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688375|NCT02280811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688376|NCT02280811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64688377|NCT02280811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64688378|NCT02280811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64688379|NCT02280811|Antiviral Agents|antiviral agents|mesh-ancestor
64688380|NCT02280811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64688381|NCT01930747|Remifentanil|remifentanil|mesh-list
64688382|NCT01930747|Sevoflurane|sevoflurane|mesh-list
64688383|NCT01930747|Rocuronium|rocuronium|mesh-list
64688384|NCT01930747|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64688385|NCT01930747|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64688386|NCT01930747|Anesthetics, General|anesthetics, general|mesh-ancestor
64688387|NCT01930747|Anesthetics|anesthetics|mesh-ancestor
64688388|NCT01930747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64688389|NCT01930747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688390|NCT01930747|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64688391|NCT01930747|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64688392|NCT01930747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64688393|NCT01930747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64838501|NCT01625572|Narcotics|narcotics|mesh-ancestor
65453885|NCT02526004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65453886|NCT00421889|Paclitaxel|paclitaxel|mesh-list
65453887|NCT00421889|Carboplatin|carboplatin|mesh-list
65453888|NCT00421889|Belinostat|belinostat|mesh-list
65453889|NCT00421889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65453890|NCT00421889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453891|NCT00421889|Tubulin Modulators|tubulin modulators|mesh-ancestor
65453892|NCT00421889|Antimitotic Agents|antimitotic agents|mesh-ancestor
65453893|NCT00421889|Mitosis Modulators|mitosis modulators|mesh-ancestor
65453894|NCT00421889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453895|NCT00421889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65453896|NCT00421889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453897|NCT03913468|Ascorbic Acid|ascorbic acid|mesh-list
65453898|NCT03913468|Antioxidants|antioxidants|mesh-ancestor
65453899|NCT03913468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453900|NCT03913468|Protective Agents|protective agents|mesh-ancestor
65453901|NCT03913468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453902|NCT03913468|Vitamins|vitamins|mesh-ancestor
65453903|NCT03913468|Micronutrients|micronutrients|mesh-ancestor
65453904|NCT01147354|Selenium|selenium|mesh-list
65453905|NCT01147354|Antioxidants|antioxidants|mesh-ancestor
65453906|NCT01147354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453907|NCT01147354|Protective Agents|protective agents|mesh-ancestor
65453908|NCT01147354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453909|NCT01147354|Trace Elements|trace elements|mesh-ancestor
65453910|NCT01147354|Micronutrients|micronutrients|mesh-ancestor
64688394|NCT01930747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64688395|NCT01930747|Narcotics|narcotics|mesh-ancestor
64688396|NCT01930747|Analgesics|analgesics|mesh-ancestor
64688397|NCT01930747|Sensory System Agents|sensory system agents|mesh-ancestor
64688398|NCT01931527|Rasburicase|rasburicase|mesh-list
64688399|NCT01931527|Gout Suppressants|gout suppressants|mesh-ancestor
64688400|NCT01931527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64688401|NCT02639429|Misoprostol|misoprostol|mesh-list
64688402|NCT02639429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64688403|NCT02639429|Abortifacient Agents|abortifacient agents|mesh-ancestor
64688404|NCT02639429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64688405|NCT02639429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688406|NCT02639429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64688407|NCT02639429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64717032|NCT00377936|Gemcitabine|gemcitabine|mesh-list
64717033|NCT00377936|Paclitaxel|paclitaxel|mesh-list
64717034|NCT00377936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64717035|NCT00377936|Antimetabolites|antimetabolites|mesh-ancestor
64717036|NCT00377936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688408|NCT02639429|Oxytocics|oxytocics|mesh-ancestor
64688409|NCT01936363|Niacinamide|niacinamide|mesh-list
64688410|NCT01936363|Vitamin B Complex|vitamin b complex|mesh-ancestor
64688411|NCT01936363|Vitamins|vitamins|mesh-ancestor
64688412|NCT01936363|Micronutrients|micronutrients|mesh-ancestor
64688413|NCT01936363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688414|NCT04893629|Digoxin|digoxin|mesh-list
65453911|NCT04744480|Anesthetics|anesthetics|mesh-list
65453912|NCT04744480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65453913|NCT04744480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453914|NCT01147432|Capsaicin|capsaicin|mesh-list
65453915|NCT01147432|Antipruritics|antipruritics|mesh-ancestor
65453916|NCT01147432|Dermatologic Agents|dermatologic agents|mesh-ancestor
65453917|NCT01147432|Sensory System Agents|sensory system agents|mesh-ancestor
65453918|NCT01147432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65453919|NCT01147432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453920|NCT03916510|Capecitabine|capecitabine|mesh-list
65453921|NCT03916510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64688415|NCT04893629|Captopril|captopril|mesh-list
64688416|NCT04893629|Furosemide|furosemide|mesh-list
64688417|NCT04893629|Diuretics|diuretics|mesh-ancestor
64688418|NCT04893629|Natriuretic Agents|natriuretic agents|mesh-ancestor
64688422|NCT04893629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688424|NCT04893629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64688425|NCT04893629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688426|NCT04893629|Protective Agents|protective agents|mesh-ancestor
64688427|NCT04893629|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64688428|NCT04893629|Protease Inhibitors|protease inhibitors|mesh-ancestor
64688429|NCT04893629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64688431|NCT04891991|Dermatologic Agents|dermatologic agents|mesh-ancestor
64688432|NCT04891991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64688433|NCT04891991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64688434|NCT01936519|Cyclosporine|cyclosporine|mesh-list
64688435|NCT01936519|Mycophenolic Acid|mycophenolic acid|mesh-list
64688436|NCT01936519|Everolimus|everolimus|mesh-list
64688437|NCT01936519|Tacrolimus|tacrolimus|mesh-list
64688438|NCT01936519|Cyclosporins|cyclosporins|mesh-list
64688439|NCT01936519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
64688440|NCT01936519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64688441|NCT01936519|Immunologic Factors|immunologic factors|mesh-ancestor
64688442|NCT01936519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688443|NCT01936519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688451|NCT01936519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64688452|NCT01936519|Antitubercular Agents|antitubercular agents|mesh-ancestor
64688453|NCT01936519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64688454|NCT04507841|Niraparib|niraparib|mesh-list
64688455|NCT04507841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64688456|NCT04507841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688457|NCT04507841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688458|NCT04507841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688459|NCT01936909|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64688460|NCT01936909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64688461|NCT01938079|Ketamine|ketamine|mesh-list
64688462|NCT01938079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64688463|NCT01938079|Analgesics|analgesics|mesh-ancestor
64688464|NCT01938079|Sensory System Agents|sensory system agents|mesh-ancestor
64688465|NCT01938079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64688466|NCT01938079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688467|NCT01938079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64688468|NCT01938079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64688469|NCT01938079|Anesthetics, General|anesthetics, general|mesh-ancestor
64688470|NCT01938079|Anesthetics|anesthetics|mesh-ancestor
64688471|NCT01938079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64688472|NCT01938079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64688473|NCT01938079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64688474|NCT01938079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64688475|NCT01938079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688476|NCT02641691|Leucovorin|leucovorin|mesh-list
64688477|NCT02641691|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
64688478|NCT02641691|Tetrahydrofolates|tetrahydrofolates|mesh-list
64688479|NCT02641691|Fluorouracil|fluorouracil|mesh-list
64688480|NCT02641691|Oxaliplatin|oxaliplatin|mesh-list
65453922|NCT03916510|Antimetabolites|antimetabolites|mesh-ancestor
65453923|NCT03916510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453924|NCT03916510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453925|NCT01147510|Montelukast|montelukast|mesh-list
65453926|NCT01147510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65453927|NCT01147510|Respiratory System Agents|respiratory system agents|mesh-ancestor
65453928|NCT01147510|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65453929|NCT01147510|Hormone Antagonists|hormone antagonists|mesh-ancestor
65453930|NCT01147510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65453931|NCT01147510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453932|NCT01147510|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65453933|NCT01147510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65453934|NCT01147510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453935|NCT03916432|Sirolimus|sirolimus|mesh-list
65453936|NCT03916432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65453937|NCT03916432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65453938|NCT03916432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65453939|NCT03916432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453940|NCT03916432|Antifungal Agents|antifungal agents|mesh-ancestor
65453941|NCT03916432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65453942|NCT03916432|Immunologic Factors|immunologic factors|mesh-ancestor
65453943|NCT03916432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453944|NCT00421733|Ergocalciferols|ergocalciferols|mesh-list
65453945|NCT00421733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65453946|NCT00421733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453947|NCT00421733|Vitamins|vitamins|mesh-ancestor
65453948|NCT00421733|Micronutrients|micronutrients|mesh-ancestor
65453949|NCT00421733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65453950|NCT00421343|Cholecalciferol|cholecalciferol|mesh-list
65453951|NCT00421343|Vitamin D|vitamin d|mesh-list
65453952|NCT00421343|Alendronate|alendronate|mesh-list
65453964|NCT01147588|Omeprazole|omeprazole|mesh-list
65453965|NCT01147588|Lansoprazole|lansoprazole|mesh-list
65453966|NCT01147588|Dexlansoprazole|dexlansoprazole|mesh-list
65453967|NCT01147588|Clopidogrel|clopidogrel|mesh-list
65453968|NCT01147588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65453969|NCT01147588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65453970|NCT01147588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65453971|NCT01147588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65453972|NCT01147588|Purinergic Agents|purinergic agents|mesh-ancestor
65453973|NCT01147588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65453974|NCT01147588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453975|NCT01147588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453976|NCT01147588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65453977|NCT01147588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65453978|NCT01147588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65453979|NCT01147588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453980|NCT03908242|Salvianolic acid A|salvianolic acid a|mesh-list
65453981|NCT03908242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65453982|NCT03908242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453983|NCT03908242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453984|NCT03908242|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64688481|NCT02641691|Levoleucovorin|levoleucovorin|mesh-list
64688482|NCT02641691|Antimetabolites|antimetabolites|mesh-ancestor
64717038|NCT00377936|Antiviral Agents|antiviral agents|mesh-ancestor
64717039|NCT00377936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64717040|NCT00377936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64717041|NCT00377936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64717042|NCT00377936|Immunologic Factors|immunologic factors|mesh-ancestor
64717043|NCT00377936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717044|NCT00377936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64717045|NCT00377936|Tubulin Modulators|tubulin modulators|mesh-ancestor
64717046|NCT00377936|Antimitotic Agents|antimitotic agents|mesh-ancestor
64688483|NCT02641691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688484|NCT02641691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64688485|NCT02641691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688486|NCT02641691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64688487|NCT02641691|Immunologic Factors|immunologic factors|mesh-ancestor
64688488|NCT02641691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688496|NCT04047251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64688497|NCT04047251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688498|NCT04047251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688499|NCT04047251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688500|NCT04045613|Atezolizumab|atezolizumab|mesh-list
64688501|NCT04045613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64688502|NCT04045613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688503|NCT04045613|Immunologic Factors|immunologic factors|mesh-ancestor
64688504|NCT04045613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688505|NCT05588999|Salicylic Acid|salicylic acid|mesh-list
64688506|NCT05588999|Salicylates|salicylates|mesh-list
64688507|NCT05588999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64688508|NCT05588999|Antifungal Agents|antifungal agents|mesh-ancestor
64688509|NCT05588999|Keratolytic Agents|keratolytic agents|mesh-ancestor
64688510|NCT05588999|Dermatologic Agents|dermatologic agents|mesh-ancestor
65453985|NCT00230178|Allopurinol|allopurinol|mesh-list
65453986|NCT00230178|Rasburicase|rasburicase|mesh-list
65453987|NCT00230178|Antimetabolites|antimetabolites|mesh-ancestor
65453988|NCT00230178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65453989|NCT00230178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65453990|NCT00230178|Gout Suppressants|gout suppressants|mesh-ancestor
65453991|NCT00230178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65203463|NCT00946920|Goserelin|goserelin|mesh-list
65453992|NCT00230178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65453993|NCT00230178|Antioxidants|antioxidants|mesh-ancestor
65453994|NCT00230178|Protective Agents|protective agents|mesh-ancestor
65453995|NCT00230178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65453996|NCT03908008|Botulinum Toxins|botulinum toxins|mesh-list
65453997|NCT03908008|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65453998|NCT03908008|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65453999|NCT03908008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65454000|NCT03908008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65454001|NCT03908008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454002|NCT03908008|Cholinergic Agents|cholinergic agents|mesh-ancestor
65454003|NCT03908008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64838583|NCT01626443|Vitamins|vitamins|mesh-ancestor
64688511|NCT05588999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64688529|NCT04234997|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64688530|NCT04234997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64688531|NCT04234997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64688532|NCT04234997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688533|NCT04234997|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64688534|NCT04234997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64688535|NCT04234997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688536|NCT03750071|Avelumab|avelumab|mesh-list
64688537|NCT03750071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64688538|NCT03750071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688539|NCT03635567|Paclitaxel|paclitaxel|mesh-list
64688540|NCT03635567|Bevacizumab|bevacizumab|mesh-list
64688541|NCT03635567|Carboplatin|carboplatin|mesh-list
64688542|NCT03635567|Pembrolizumab|pembrolizumab|mesh-list
64688543|NCT03635567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64688544|NCT03635567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688545|NCT03635567|Tubulin Modulators|tubulin modulators|mesh-ancestor
64688546|NCT03635567|Antimitotic Agents|antimitotic agents|mesh-ancestor
64688547|NCT03635567|Mitosis Modulators|mitosis modulators|mesh-ancestor
64688548|NCT03635567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688549|NCT03635567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64688550|NCT03635567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64688551|NCT03635567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64688552|NCT03635567|Growth Substances|growth substances|mesh-ancestor
64688553|NCT03635567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688554|NCT03635567|Growth Inhibitors|growth inhibitors|mesh-ancestor
64717047|NCT00377936|Mitosis Modulators|mitosis modulators|mesh-ancestor
64717048|NCT03696758|Metoprolol|metoprolol|mesh-list
64717049|NCT03696758|Sildenafil Citrate|sildenafil citrate|mesh-list
64717050|NCT03696758|Vasodilator Agents|vasodilator agents|mesh-ancestor
64717051|NCT03696758|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64717052|NCT03696758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65454004|NCT03908008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454005|NCT03908008|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65454006|NCT03908008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65454007|NCT01251172|Melphalan|melphalan|mesh-list
65454008|NCT01251172|Mechlorethamine|mechlorethamine|mesh-list
65454009|NCT01251172|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65454010|NCT01251172|R04929097|r04929097|mesh-list
65454011|NCT01251172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65454012|NCT01251172|Alkylating Agents|alkylating agents|mesh-ancestor
64838602|NCT01626560|Daptomycin|daptomycin|mesh-list
64717053|NCT03696758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64717054|NCT03696758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717055|NCT03696758|Urological Agents|urological agents|mesh-ancestor
64717056|NCT03696758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64717057|NCT03696758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64688555|NCT05588531|Cefepime|cefepime|mesh-list
64688556|NCT05588531|Avibactam|avibactam|mesh-list
64688557|NCT05588531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64688558|NCT05588531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64688559|NCT05588531|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64688560|NCT05588531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688561|NCT05588531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688562|NCT05588297|Bevacizumab|bevacizumab|mesh-list
64688563|NCT05588297|Nivolumab|nivolumab|mesh-list
64688564|NCT05588297|Capecitabine|capecitabine|mesh-list
64688565|NCT05588297|Oxaliplatin|oxaliplatin|mesh-list
64688579|NCT05588219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688580|NCT05588219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688581|NCT02303405|Pioglitazone|pioglitazone|mesh-list
64688582|NCT02303405|Hydroxychloroquine|hydroxychloroquine|mesh-list
64688583|NCT02303405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64688584|NCT02303405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688585|NCT02303405|Antimalarials|antimalarials|mesh-ancestor
64688586|NCT02303405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64688587|NCT02303405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64688588|NCT02303405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64688589|NCT02303405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688590|NCT02303405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688591|NCT02303405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64688592|NCT02164955|Pomalidomide|pomalidomide|mesh-list
64688593|NCT02164955|Immunologic Factors|immunologic factors|mesh-ancestor
64688594|NCT02164955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688595|NCT02164955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64688596|NCT02164955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64688597|NCT02164955|Growth Substances|growth substances|mesh-ancestor
64688598|NCT02164955|Growth Inhibitors|growth inhibitors|mesh-ancestor
64688599|NCT02164955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688600|NCT05587361|Propranolol|propranolol|mesh-list
64688601|NCT05587361|Nicotine|nicotine|mesh-list
64688602|NCT05587361|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64688603|NCT05587361|Autonomic Agents|autonomic agents|mesh-ancestor
64688604|NCT05587361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64688605|NCT05587361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688606|NCT05587361|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64688607|NCT05587361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64688608|NCT05587361|Cholinergic Agents|cholinergic agents|mesh-ancestor
64688609|NCT05587361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64688610|NCT05587361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688611|NCT05587361|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64688612|NCT05587361|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64688613|NCT05587361|Adrenergic Agents|adrenergic agents|mesh-ancestor
64688614|NCT05587361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64688615|NCT05587361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64688616|NCT05587361|Vasodilator Agents|vasodilator agents|mesh-ancestor
64688617|NCT01943461|Avelumab|avelumab|mesh-list
64688618|NCT01943461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64717058|NCT03696758|Sympatholytics|sympatholytics|mesh-ancestor
64717059|NCT03696758|Autonomic Agents|autonomic agents|mesh-ancestor
65454013|NCT01251172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454014|NCT01251172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454015|NCT01251172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65454016|NCT01251172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65454017|NCT01251172|Immunologic Factors|immunologic factors|mesh-ancestor
65454018|NCT01251172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454019|NCT01251172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454020|NCT00413777|Tolvaptan|tolvaptan|mesh-list
65454021|NCT00413777|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65454022|NCT00413777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454023|NCT00413777|Natriuretic Agents|natriuretic agents|mesh-ancestor
65454024|NCT00413777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454025|NCT01250236|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65454026|NCT01250236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65454027|NCT01250236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65454028|NCT01250236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65454029|NCT01250236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65454030|NCT01250236|Adrenergic Agents|adrenergic agents|mesh-ancestor
65454031|NCT01250236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65454032|NCT01250236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454033|NCT01250236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454034|NCT01074060|Plerixafor|plerixafor|mesh-list
65454035|NCT01074060|Cyclophosphamide|cyclophosphamide|mesh-list
64717060|NCT03696758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717061|NCT03696758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717062|NCT03696758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64717063|NCT03696758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64717064|NCT03696758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64717065|NCT03696758|Adrenergic Agents|adrenergic agents|mesh-ancestor
64717066|NCT03696758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64717067|NCT03233737|Anesthetics|anesthetics|mesh-list
64717068|NCT03233737|Tetracaine|tetracaine|mesh-list
64717069|NCT03233737|Benzocaine|benzocaine|mesh-list
64717070|NCT03233737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64325312|NCT02152943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64688619|NCT01943461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64688620|NCT01943461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688621|NCT01943461|Immunologic Factors|immunologic factors|mesh-ancestor
64688622|NCT01943461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688623|NCT00422435|Paclitaxel|paclitaxel|mesh-list
64688624|NCT00422435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64688625|NCT00422435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688626|NCT00422435|Tubulin Modulators|tubulin modulators|mesh-ancestor
64688627|NCT00422435|Antimitotic Agents|antimitotic agents|mesh-ancestor
64688628|NCT00422435|Mitosis Modulators|mitosis modulators|mesh-ancestor
64688629|NCT00422435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688630|NCT05586971|Allopurinol|allopurinol|mesh-list
64688631|NCT05586971|Antimetabolites|antimetabolites|mesh-ancestor
65454036|NCT01074060|Lenograstim|lenograstim|mesh-list
65454037|NCT01074060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65454038|NCT01074060|Immunologic Factors|immunologic factors|mesh-ancestor
65454039|NCT01074060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454040|NCT01074060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65454041|NCT01074060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65454042|NCT01074060|Alkylating Agents|alkylating agents|mesh-ancestor
65454043|NCT01074060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454044|NCT01074060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454045|NCT01074060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65454046|NCT01074060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65454047|NCT01074060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65454048|NCT01074060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65454049|NCT01074060|Antiviral Agents|antiviral agents|mesh-ancestor
65454050|NCT01074060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65454051|NCT03915340|Propafenone|propafenone|mesh-list
64688632|NCT05586971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688633|NCT05586971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688656|NCT05559437|Anesthetics, Local|anesthetics, local|mesh-ancestor
64688657|NCT05559437|Anesthetics|anesthetics|mesh-ancestor
64688658|NCT05559437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64688659|NCT05559437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413950|NCT04935541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64688660|NCT05559437|Sensory System Agents|sensory system agents|mesh-ancestor
64688661|NCT05559437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64688662|NCT00367211|Naproxen|naproxen|mesh-list
64688663|NCT00367211|Omeprazole|omeprazole|mesh-list
64688664|NCT00367211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64688665|NCT00367211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64688666|NCT00367211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64688667|NCT00367211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688668|NCT00367211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688669|NCT00367211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64688670|NCT00367211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64688671|NCT00367211|Analgesics|analgesics|mesh-ancestor
64688672|NCT00367211|Sensory System Agents|sensory system agents|mesh-ancestor
64688673|NCT00367211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64688674|NCT00367211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688675|NCT00367211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64688676|NCT00367211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64688677|NCT00367211|Gout Suppressants|gout suppressants|mesh-ancestor
64688678|NCT00367211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64688679|NCT02646449|Mirtazapine|mirtazapine|mesh-list
64688680|NCT02646449|Antidepressive Agents|antidepressive agents|mesh-ancestor
64688681|NCT02646449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64688682|NCT02646449|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64717071|NCT03233737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717073|NCT03233737|Sensory System Agents|sensory system agents|mesh-ancestor
64717074|NCT03233737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717076|NCT03711578|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
64717077|NCT03711578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64717078|NCT03711578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325325|NCT05014581|Norepinephrine|norepinephrine|mesh-list
64688683|NCT02646449|Histamine Antagonists|histamine antagonists|mesh-ancestor
64688684|NCT02646449|Histamine Agents|histamine agents|mesh-ancestor
64688685|NCT02646449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64688686|NCT02646449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454052|NCT03915340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65454053|NCT03915340|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65454054|NCT03915340|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65454055|NCT03915340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65454056|NCT03915340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454057|NCT01581918|Carbamazepine|carbamazepine|mesh-list
65454058|NCT01581918|Anticonvulsants|anticonvulsants|mesh-ancestor
65454059|NCT01581918|Antimanic Agents|antimanic agents|mesh-ancestor
65454060|NCT01581918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65454061|NCT01581918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65454062|NCT01581918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454063|NCT01581918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65454064|NCT01581918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65454065|NCT01581918|Analgesics|analgesics|mesh-ancestor
65454066|NCT01581918|Sensory System Agents|sensory system agents|mesh-ancestor
65454067|NCT01581918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65454068|NCT01581918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65454069|NCT01581918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65454070|NCT01581918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454071|NCT01581918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65454072|NCT01581918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65454073|NCT01582542|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65454074|NCT01582542|Hemostatics|hemostatics|mesh-ancestor
65454075|NCT01582542|Coagulants|coagulants|mesh-ancestor
65454076|NCT01582542|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65454077|NCT01582542|Natriuretic Agents|natriuretic agents|mesh-ancestor
65454078|NCT01582542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454079|NCT03912766|Arginine Vasopressin|arginine vasopressin|mesh-list
65454080|NCT03912766|Hemostatics|hemostatics|mesh-ancestor
65454081|NCT03912766|Coagulants|coagulants|mesh-ancestor
65454082|NCT03912766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65454083|NCT03912766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65454084|NCT03912766|Natriuretic Agents|natriuretic agents|mesh-ancestor
64688687|NCT02646449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688688|NCT02646449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64688689|NCT02646449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64688690|NCT02646449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64688708|NCT04339361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64688709|NCT04339361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64688710|NCT04339361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65454085|NCT03912766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454086|NCT01251328|Anesthetics|anesthetics|mesh-list
65454087|NCT01251328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65454088|NCT01251328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454089|NCT00420641|Paroxetine|paroxetine|mesh-list
65454090|NCT00420641|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65454091|NCT00420641|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65454092|NCT00420641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65454093|NCT00420641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454094|NCT00420641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65454095|NCT00420641|Serotonin Agents|serotonin agents|mesh-ancestor
65454096|NCT00420641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454097|NCT00420641|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65454098|NCT00420641|Antidepressive Agents|antidepressive agents|mesh-ancestor
65454099|NCT00420641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65454100|NCT00420641|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65454101|NCT00420641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65454102|NCT00420641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454103|NCT00257556|Menotropins|menotropins|mesh-list
64688711|NCT04339361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688712|NCT04339361|Oxytocics|oxytocics|mesh-ancestor
64688713|NCT04339361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64688714|NCT05369351|Mirabegron|mirabegron|mesh-list
64688715|NCT05369351|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64688716|NCT05369351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64688717|NCT05369351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64688718|NCT05369351|Adrenergic Agents|adrenergic agents|mesh-ancestor
64688719|NCT05369351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64688720|NCT05369351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688721|NCT05369351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688722|NCT05369351|Urological Agents|urological agents|mesh-ancestor
64688723|NCT05318573|Gemcitabine|gemcitabine|mesh-list
64688724|NCT05318573|Pembrolizumab|pembrolizumab|mesh-list
64688725|NCT05318573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64688726|NCT05318573|Antimetabolites|antimetabolites|mesh-ancestor
64688727|NCT05318573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688728|NCT05318573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688729|NCT05318573|Antiviral Agents|antiviral agents|mesh-ancestor
64688734|NCT05318573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688735|NCT05318573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64688736|NCT02653391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64688737|NCT02653391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64688738|NCT05303987|Dexmedetomidine|dexmedetomidine|mesh-list
64688740|NCT05303987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64688741|NCT05303987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64688742|NCT05303987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688743|NCT05303987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64688744|NCT05303987|Anesthetics, General|anesthetics, general|mesh-ancestor
64688746|NCT05303987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64688747|NCT05303987|Analgesics|analgesics|mesh-ancestor
64688757|NCT02654483|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64688758|NCT02654483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65454104|NCT00257556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65454105|NCT00257556|Hormones|hormones|mesh-ancestor
65454106|NCT00257556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65454107|NCT00257556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454108|NCT00257556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65454109|NCT00257556|Fertility Agents|fertility agents|mesh-ancestor
65454110|NCT00257556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65454111|NCT03906916|Micafungin|micafungin|mesh-list
65454112|NCT03906916|Antifungal Agents|antifungal agents|mesh-ancestor
65454113|NCT03906916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65454114|NCT03741426|Durvalumab|durvalumab|mesh-list
65454115|NCT03741426|Olaparib|olaparib|mesh-list
65454116|NCT03741426|Cediranib|cediranib|mesh-list
65454117|NCT03741426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65454118|NCT03741426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454119|NCT03741426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65454120|NCT03741426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454121|NCT03741426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688759|NCT02654483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688760|NCT02654483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688761|NCT02655653|Tranexamic Acid|tranexamic acid|mesh-list
64688762|NCT02655653|Aminocaproic Acid|aminocaproic acid|mesh-list
64688763|NCT02655653|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64688764|NCT02655653|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64717079|NCT03463915|Triamcinolone|triamcinolone|mesh-list
64717080|NCT03463915|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64717081|NCT03463915|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64717082|NCT03463915|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64717083|NCT03463915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64717084|NCT03463915|Glucocorticoids|glucocorticoids|mesh-ancestor
64717085|NCT03463915|Hormones|hormones|mesh-ancestor
64688765|NCT02655653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688766|NCT02655653|Hemostatics|hemostatics|mesh-ancestor
64688767|NCT02655653|Coagulants|coagulants|mesh-ancestor
64688768|NCT05167487|Cisplatin|cisplatin|mesh-list
64688769|NCT05167487|Carboplatin|carboplatin|mesh-list
64688770|NCT05167487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688771|NCT03081143|Paclitaxel|paclitaxel|mesh-list
64688772|NCT03081143|Ramucirumab|ramucirumab|mesh-list
64688773|NCT03081143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64688774|NCT03081143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688775|NCT03081143|Tubulin Modulators|tubulin modulators|mesh-ancestor
64688776|NCT03081143|Antimitotic Agents|antimitotic agents|mesh-ancestor
64688777|NCT03081143|Mitosis Modulators|mitosis modulators|mesh-ancestor
64688778|NCT03081143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688779|NCT02658461|Trastuzumab|trastuzumab|mesh-list
64688780|NCT02658461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64688781|NCT02658461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688782|NCT00367913|Clarithromycin|clarithromycin|mesh-list
64688783|NCT00367913|Ciprofloxacin|ciprofloxacin|mesh-list
64688784|NCT00367913|Rifampin|rifampin|mesh-list
64688785|NCT00367913|Ethambutol|ethambutol|mesh-list
64688786|NCT00367913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64688787|NCT00367913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64688788|NCT00367913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64688789|NCT00367913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688790|NCT00367913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688791|NCT00367913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65454122|NCT03741426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65454123|NCT01250470|Sargramostim|sargramostim|mesh-list
65454124|NCT01250470|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65454125|NCT01250470|Immunologic Factors|immunologic factors|mesh-ancestor
65454126|NCT01250470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454127|NCT01250470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65454128|NCT01250548|Apremilast|apremilast|mesh-list
65454129|NCT01250548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65454130|NCT01250548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65454131|NCT01250548|Analgesics|analgesics|mesh-ancestor
65454132|NCT01250548|Sensory System Agents|sensory system agents|mesh-ancestor
65454133|NCT01250548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64688792|NCT00367913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64688793|NCT00367913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64688794|NCT00367913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64688795|NCT00367913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688796|NCT00367913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64688797|NCT00367913|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64688798|NCT00367913|Antitubercular Agents|antitubercular agents|mesh-ancestor
64688799|NCT00367913|Leprostatic Agents|leprostatic agents|mesh-ancestor
64688800|NCT00367913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64688801|NCT00367913|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64688802|NCT00367913|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64688803|NCT00367913|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64688806|NCT00367913|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64688808|NCT02659787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64414104|NCT04912297|Immunologic Factors|immunologic factors|mesh-ancestor
64688809|NCT02659787|Narcotics|narcotics|mesh-ancestor
64688810|NCT02659787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64688824|NCT05044871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688825|NCT05044871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64688826|NCT05044871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64688827|NCT05044871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64688828|NCT05044871|Growth Substances|growth substances|mesh-ancestor
64688829|NCT05044871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688830|NCT05044871|Growth Inhibitors|growth inhibitors|mesh-ancestor
64688831|NCT04931693|Acetaminophen|acetaminophen|mesh-list
64688832|NCT04931693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64688833|NCT04931693|Analgesics|analgesics|mesh-ancestor
64688834|NCT04931693|Sensory System Agents|sensory system agents|mesh-ancestor
64688835|NCT04931693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64688836|NCT04931693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717086|NCT03463915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64717087|NCT03463915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717088|NCT03463915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64717089|NCT03463915|Immunologic Factors|immunologic factors|mesh-ancestor
64717090|NCT03463915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64717091|NCT03463915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717094|NCT03473665|Indomethacin|indomethacin|mesh-list
64717095|NCT03473665|Meloxicam|meloxicam|mesh-list
64717096|NCT03473665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64717097|NCT03473665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64717098|NCT03473665|Analgesics|analgesics|mesh-ancestor
64688837|NCT04931693|Antipyretics|antipyretics|mesh-ancestor
64688839|NCT02271594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64688840|NCT02271594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688841|NCT04817969|Cimetidine|cimetidine|mesh-list
64688842|NCT04817969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64688843|NCT04817969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64688844|NCT04817969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64688845|NCT04817969|Histamine Antagonists|histamine antagonists|mesh-ancestor
64688846|NCT04817969|Histamine Agents|histamine agents|mesh-ancestor
65454134|NCT01250548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454135|NCT01250548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65454136|NCT01250548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65454137|NCT01250548|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65454138|NCT01250548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65454139|NCT01250548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454140|NCT01250548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454141|NCT03906838|Ropivacaine|ropivacaine|mesh-list
65454142|NCT03906838|Anesthetics, Local|anesthetics, local|mesh-ancestor
65454143|NCT03906838|Anesthetics|anesthetics|mesh-ancestor
65454144|NCT03906838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65454145|NCT03906838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454146|NCT03906838|Sensory System Agents|sensory system agents|mesh-ancestor
65454147|NCT03906838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65454148|NCT01251484|Nintedanib|nintedanib|mesh-list
65454149|NCT01251484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454150|NCT01251484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65454151|NCT01251484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454152|NCT01251484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454153|NCT03914638|Albuterol|albuterol|mesh-list
65454154|NCT03914638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65454155|NCT03914638|Autonomic Agents|autonomic agents|mesh-ancestor
65454156|NCT03914638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64838723|NCT01627236|Protective Agents|protective agents|mesh-ancestor
64688847|NCT04817969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64688848|NCT04817969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688849|NCT04817969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688850|NCT04817969|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64688851|NCT04817969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64688852|NCT04817969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688853|NCT05649228|Capsaicin|capsaicin|mesh-list
64688854|NCT05649228|Antipruritics|antipruritics|mesh-ancestor
64688855|NCT05649228|Dermatologic Agents|dermatologic agents|mesh-ancestor
64688856|NCT05649228|Sensory System Agents|sensory system agents|mesh-ancestor
64688857|NCT05649228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64688858|NCT05649228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688859|NCT02350517|Paclitaxel|paclitaxel|mesh-list
64688860|NCT02350517|Endostar protein|endostar protein|mesh-list
64688861|NCT02350517|Endostatins|endostatins|mesh-list
64688862|NCT02350517|Nedaplatin|nedaplatin|mesh-list
64688863|NCT02350517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64688864|NCT02350517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688865|NCT02350517|Tubulin Modulators|tubulin modulators|mesh-ancestor
64688866|NCT02350517|Antimitotic Agents|antimitotic agents|mesh-ancestor
64688867|NCT02350517|Mitosis Modulators|mitosis modulators|mesh-ancestor
64688868|NCT02350517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688869|NCT02350517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64688870|NCT02350517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64688871|NCT02350517|Growth Substances|growth substances|mesh-ancestor
64688872|NCT02350517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454157|NCT03914638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454158|NCT03914638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65454159|NCT03914638|Respiratory System Agents|respiratory system agents|mesh-ancestor
65454160|NCT03914638|Tocolytic Agents|tocolytic agents|mesh-ancestor
65454161|NCT03914638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65454162|NCT03914638|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65454163|NCT03914638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65454164|NCT03914638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65454165|NCT03914638|Adrenergic Agents|adrenergic agents|mesh-ancestor
65454166|NCT03914638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65454167|NCT03914638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454168|NCT01148446|Prednisone|prednisone|mesh-list
65454169|NCT01148446|Cyclophosphamide|cyclophosphamide|mesh-list
65454170|NCT01148446|Rituximab|rituximab|mesh-list
65454171|NCT01148446|Doxorubicin|doxorubicin|mesh-list
65454172|NCT01148446|Vincristine|vincristine|mesh-list
65454173|NCT01148446|Epirubicin|epirubicin|mesh-list
65454174|NCT01148446|Vinblastine|vinblastine|mesh-list
65454175|NCT01148446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65454176|NCT01148446|Immunologic Factors|immunologic factors|mesh-ancestor
65454177|NCT01148446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454178|NCT01148446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65454179|NCT01148446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65454180|NCT01148446|Alkylating Agents|alkylating agents|mesh-ancestor
64449771|NCT02159807|Fentanyl|fentanyl|mesh-list
64688873|NCT02350517|Growth Inhibitors|growth inhibitors|mesh-ancestor
64688874|NCT02270736|Botulinum Toxins|botulinum toxins|mesh-list
64688887|NCT02205047|Capecitabine|capecitabine|mesh-list
64688888|NCT02205047|Trastuzumab|trastuzumab|mesh-list
64688890|NCT02205047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64717100|NCT03473665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717101|NCT03473665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717102|NCT03473665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64717103|NCT03473665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64717104|NCT03473665|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64717105|NCT03473665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64717106|NCT03473665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64717107|NCT03473665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325347|NCT04719273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64325348|NCT04719273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64325349|NCT04719273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325350|NCT04719273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64325351|NCT04719273|Hormone Antagonists|hormone antagonists|mesh-ancestor
64325352|NCT04719273|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64688901|NCT01585805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688902|NCT01585805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64688903|NCT01585805|Antimetabolites|antimetabolites|mesh-ancestor
64688904|NCT01585805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688905|NCT01585805|Antiviral Agents|antiviral agents|mesh-ancestor
64688906|NCT01585805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64688907|NCT01585805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688908|NCT01585805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65454181|NCT01148446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454182|NCT01148446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454183|NCT01148446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65454184|NCT01148446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65454185|NCT01148446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65454186|NCT01148446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65454187|NCT01148446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65454188|NCT01148446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688909|NCT01585805|Immunologic Factors|immunologic factors|mesh-ancestor
64688910|NCT01585805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688911|NCT01585805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64688912|NCT04878198|Melatonin|melatonin|mesh-list
64688913|NCT04878198|Antioxidants|antioxidants|mesh-ancestor
64688914|NCT04878198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688915|NCT04878198|Protective Agents|protective agents|mesh-ancestor
64688916|NCT04878198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688917|NCT04878198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64688918|NCT04651595|Morphine|morphine|mesh-list
64688919|NCT04651595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64688920|NCT04651595|Narcotics|narcotics|mesh-ancestor
64688921|NCT04651595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64688922|NCT04651595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688923|NCT04651595|Analgesics|analgesics|mesh-ancestor
64688924|NCT04651595|Sensory System Agents|sensory system agents|mesh-ancestor
64688925|NCT04651595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64688926|NCT02669615|Melphalan|melphalan|mesh-list
64688927|NCT02669615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64688928|NCT02669615|Alkylating Agents|alkylating agents|mesh-ancestor
64688929|NCT02669615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688930|NCT02669615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688931|NCT02669615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64688932|NCT02669615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64688933|NCT02669615|Immunologic Factors|immunologic factors|mesh-ancestor
64688934|NCT02669615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688965|NCT05411471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688967|NCT02677493|Immunologic Factors|immunologic factors|mesh-ancestor
64717109|NCT03473665|Tocolytic Agents|tocolytic agents|mesh-ancestor
64717110|NCT03473665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64717111|NCT03717506|Clindamycin|clindamycin|mesh-list
64717112|NCT03717506|Clindamycin palmitate|clindamycin palmitate|mesh-list
64717113|NCT03717506|Clindamycin phosphate|clindamycin phosphate|mesh-list
64717114|NCT03717506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64717115|NCT03717506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64717116|NCT03717506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64717117|NCT03717506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64717118|NCT03717506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717119|NCT03861338|Buprenorphine|buprenorphine|mesh-list
64717120|NCT03861338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64717121|NCT03861338|Narcotics|narcotics|mesh-ancestor
64688974|NCT02680301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64688975|NCT02680301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64688976|NCT02680301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64688977|NCT02680301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64688978|NCT02680301|Glucocorticoids|glucocorticoids|mesh-ancestor
64688985|NCT02680301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688987|NCT02680457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64688988|NCT02680457|Insulin Glargine|insulin glargine|mesh-list
64688989|NCT02680457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64688990|NCT02680457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688991|NCT02283762|Riociguat|riociguat|mesh-list
64688992|NCT02283762|Enzyme Activators|enzyme activators|mesh-ancestor
64688993|NCT02283762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688994|NCT02692391|Indomethacin|indomethacin|mesh-list
64688995|NCT02692391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64688996|NCT02692391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65454189|NCT01148446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65454190|NCT01148446|Glucocorticoids|glucocorticoids|mesh-ancestor
65454191|NCT01148446|Hormones|hormones|mesh-ancestor
65454192|NCT01148446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65454193|NCT01148446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65454194|NCT01148446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65454195|NCT01148446|Tubulin Modulators|tubulin modulators|mesh-ancestor
65454196|NCT01148446|Antimitotic Agents|antimitotic agents|mesh-ancestor
65454197|NCT01148446|Mitosis Modulators|mitosis modulators|mesh-ancestor
65454198|NCT03914404|Thioctic Acid|thioctic acid|mesh-list
65454199|NCT03914404|Antioxidants|antioxidants|mesh-ancestor
64449802|NCT02183519|Antipruritics|antipruritics|mesh-ancestor
64688997|NCT02692391|Analgesics|analgesics|mesh-ancestor
64688998|NCT02692391|Sensory System Agents|sensory system agents|mesh-ancestor
64688999|NCT02692391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689000|NCT02692391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689001|NCT02692391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64689002|NCT02692391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64689003|NCT02692391|Gout Suppressants|gout suppressants|mesh-ancestor
64689004|NCT02692391|Tocolytic Agents|tocolytic agents|mesh-ancestor
64689005|NCT02692391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64689006|NCT02692391|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64689007|NCT02692391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64689008|NCT02692391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689009|NCT05407961|Dulaglutide|dulaglutide|mesh-list
64689010|NCT05407961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64689011|NCT05407961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689012|NCT02696291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64689013|NCT02682563|Dapagliflozin|dapagliflozin|mesh-list
64689014|NCT02682563|Gliclazide|gliclazide|mesh-list
64689015|NCT02682563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64689016|NCT02682563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689017|NCT02682563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64689018|NCT02682563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689020|NCT02697071|Analgesics|analgesics|mesh-ancestor
64689021|NCT02697071|Sensory System Agents|sensory system agents|mesh-ancestor
64689022|NCT02697071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689023|NCT02697071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689024|NCT02697071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64689025|NCT02697071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64689026|NCT02697071|Anesthetics, General|anesthetics, general|mesh-ancestor
64689027|NCT02697071|Anesthetics|anesthetics|mesh-ancestor
64689028|NCT02697071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717122|NCT03861338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717123|NCT03861338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689034|NCT02283294|Apixaban|apixaban|mesh-list
64689035|NCT02283294|Anticoagulants|anticoagulants|mesh-ancestor
64689036|NCT02283294|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64689037|NCT02283294|Antithrombins|antithrombins|mesh-ancestor
64689038|NCT02283294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64689039|NCT02283294|Protease Inhibitors|protease inhibitors|mesh-ancestor
64689040|NCT02283294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64689041|NCT02283294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689042|NCT05648994|Paclitaxel|paclitaxel|mesh-list
64689043|NCT05648994|Cyclophosphamide|cyclophosphamide|mesh-list
64689044|NCT05648994|Fludarabine|fludarabine|mesh-list
64689045|NCT05648994|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64689046|NCT05648994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64689047|NCT05648994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689059|NCT04869306|Hyaluronic Acid|hyaluronic acid|mesh-list
64689060|NCT04869306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64689061|NCT04869306|Immunologic Factors|immunologic factors|mesh-ancestor
64689062|NCT04869306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454200|NCT03914404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454201|NCT03914404|Protective Agents|protective agents|mesh-ancestor
65454202|NCT03914404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454203|NCT03914404|Vitamin B Complex|vitamin b complex|mesh-ancestor
65454204|NCT03914404|Vitamins|vitamins|mesh-ancestor
65454205|NCT03914404|Micronutrients|micronutrients|mesh-ancestor
65454206|NCT01251640|Gemcitabine|gemcitabine|mesh-list
65454207|NCT01251640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65454208|NCT01251640|Antimetabolites|antimetabolites|mesh-ancestor
65454209|NCT01251640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454210|NCT01251640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454211|NCT01251640|Antiviral Agents|antiviral agents|mesh-ancestor
65454212|NCT01251640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65454213|NCT01251640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454214|NCT01251640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65454215|NCT01251640|Immunologic Factors|immunologic factors|mesh-ancestor
65454216|NCT01251640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454217|NCT00257166|Ziprasidone|ziprasidone|mesh-list
65454218|NCT00257166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65454219|NCT00257166|Serotonin Agents|serotonin agents|mesh-ancestor
65454220|NCT00257166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65454221|NCT00257166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454222|NCT00257166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454223|NCT00257166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65454224|NCT00257166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65454225|NCT00257166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65454226|NCT00257166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65454227|NCT00257166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65454228|NCT00257166|Dopamine Agents|dopamine agents|mesh-ancestor
65454229|NCT03914092|Triamcinolone|triamcinolone|mesh-list
65454230|NCT03914092|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65454231|NCT03914092|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65454232|NCT03914092|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65454233|NCT03914092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65454234|NCT03914092|Glucocorticoids|glucocorticoids|mesh-ancestor
65454235|NCT03914092|Hormones|hormones|mesh-ancestor
64838789|NCT01627587|Ketoconazole|ketoconazole|mesh-list
65454237|NCT03914092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454238|NCT03914092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65454239|NCT03914092|Immunologic Factors|immunologic factors|mesh-ancestor
65454240|NCT03914092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454241|NCT03914092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454242|NCT01251718|Donepezil|donepezil|mesh-list
65454243|NCT01251718|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65454244|NCT01251718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454245|NCT01251718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454246|NCT01251718|Cholinergic Agents|cholinergic agents|mesh-ancestor
65454247|NCT01251718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64689063|NCT04869306|Viscosupplements|viscosupplements|mesh-ancestor
64689064|NCT04869306|Protective Agents|protective agents|mesh-ancestor
64689065|NCT02268864|Simeprevir|simeprevir|mesh-list
64689066|NCT02268864|Antiviral Agents|antiviral agents|mesh-ancestor
64689067|NCT02268864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64689068|NCT02268864|Protease Inhibitors|protease inhibitors|mesh-ancestor
64689069|NCT02268864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64689070|NCT02268864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689071|NCT04859946|Cyclophosphamide|cyclophosphamide|mesh-list
64689072|NCT04859946|Busulfan|busulfan|mesh-list
64689073|NCT04859946|Thiotepa|thiotepa|mesh-list
64689074|NCT04859946|Fludarabine|fludarabine|mesh-list
64689075|NCT04859946|Tacrolimus|tacrolimus|mesh-list
64689076|NCT04859946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64689077|NCT04859946|Immunologic Factors|immunologic factors|mesh-ancestor
64689078|NCT04859946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689079|NCT04859946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64689080|NCT04859946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64689081|NCT04859946|Alkylating Agents|alkylating agents|mesh-ancestor
64689082|NCT04859946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689083|NCT04859946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689084|NCT04859946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64689085|NCT04859946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64689086|NCT04859946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64689087|NCT02703779|Plerixafor|plerixafor|mesh-list
64689088|NCT02703779|Bortezomib|bortezomib|mesh-list
64689089|NCT02703779|Lenograstim|lenograstim|mesh-list
64689090|NCT02703779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64689091|NCT02703779|Immunologic Factors|immunologic factors|mesh-ancestor
64689092|NCT02703779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689093|NCT02703779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689094|NCT02703779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64689095|NCT02703779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64689096|NCT02703779|Antiviral Agents|antiviral agents|mesh-ancestor
64689097|NCT02703779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64689098|NCT04738955|Micafungin|micafungin|mesh-list
64689099|NCT04738955|Antifungal Agents|antifungal agents|mesh-ancestor
64689100|NCT04738955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64689101|NCT02268396|Glycopyrrolate|glycopyrrolate|mesh-list
64689102|NCT02268396|Formoterol Fumarate|formoterol fumarate|mesh-list
64689103|NCT02268396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64689104|NCT02268396|Autonomic Agents|autonomic agents|mesh-ancestor
64689105|NCT02268396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689106|NCT02268396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689107|NCT02268396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64689108|NCT02268396|Respiratory System Agents|respiratory system agents|mesh-ancestor
64717126|NCT03861338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717133|NCT00377780|Tubulin Modulators|tubulin modulators|mesh-ancestor
64717134|NCT00377780|Antimitotic Agents|antimitotic agents|mesh-ancestor
64717135|NCT00377780|Mitosis Modulators|mitosis modulators|mesh-ancestor
64325364|NCT02774681|Palbociclib|palbociclib|mesh-list
64689109|NCT02268396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64689110|NCT02268396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64689111|NCT02268396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64689112|NCT02268396|Adrenergic Agents|adrenergic agents|mesh-ancestor
65454248|NCT01251718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454249|NCT01251718|Nootropic Agents|nootropic agents|mesh-ancestor
65454250|NCT03913858|Anesthetics|anesthetics|mesh-list
65454251|NCT03913858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65454252|NCT03913858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454253|NCT00227370|Valganciclovir|valganciclovir|mesh-list
65454254|NCT00227370|Antiviral Agents|antiviral agents|mesh-ancestor
65454255|NCT00227370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65454256|NCT01251796|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65454257|NCT01251796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689138|NCT01643772|Oxycodone|oxycodone|mesh-list
64689139|NCT01643772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64689140|NCT01643772|Narcotics|narcotics|mesh-ancestor
64689141|NCT01643772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64689142|NCT01643772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689143|NCT01643772|Analgesics|analgesics|mesh-ancestor
64689144|NCT01643772|Sensory System Agents|sensory system agents|mesh-ancestor
64689145|NCT01643772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689146|NCT02707523|Azithromycin|azithromycin|mesh-list
64689147|NCT02707523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64689148|NCT02707523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64689149|NCT04868838|Daratumumab|daratumumab|mesh-list
64689150|NCT04868838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689151|NCT05278715|Carboplatin|carboplatin|mesh-list
64689152|NCT05278715|Vincristine|vincristine|mesh-list
64689153|NCT05278715|Endostatins|endostatins|mesh-list
64689154|NCT05278715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689155|NCT05278715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64689156|NCT05278715|Tubulin Modulators|tubulin modulators|mesh-ancestor
64689157|NCT05278715|Antimitotic Agents|antimitotic agents|mesh-ancestor
64689158|NCT05278715|Mitosis Modulators|mitosis modulators|mesh-ancestor
64689159|NCT05278715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689160|NCT05278715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64689161|NCT05278715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64689186|NCT00369239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64689187|NCT00369239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64689188|NCT00369239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64689189|NCT00369239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64689190|NCT00369239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64689191|NCT00369239|Dopamine Agents|dopamine agents|mesh-ancestor
64689192|NCT03833921|Prednisone|prednisone|mesh-list
64689193|NCT03833921|Abiraterone Acetate|abiraterone acetate|mesh-list
64689194|NCT03833921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64689195|NCT03833921|Glucocorticoids|glucocorticoids|mesh-ancestor
64689196|NCT03833921|Hormones|hormones|mesh-ancestor
64689197|NCT03833921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64689198|NCT03833921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689199|NCT03833921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64689200|NCT03833921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689201|NCT03833921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64689202|NCT03833921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64689203|NCT03833921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689204|NCT03833921|Hormone Antagonists|hormone antagonists|mesh-ancestor
64689205|NCT03833921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64689206|NCT05215925|Carboplatin|carboplatin|mesh-list
64689207|NCT05215925|Docetaxel|docetaxel|mesh-list
64689208|NCT05215925|Pemetrexed|pemetrexed|mesh-list
64689209|NCT05215925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689210|NCT05215925|Tubulin Modulators|tubulin modulators|mesh-ancestor
64689211|NCT05215925|Antimitotic Agents|antimitotic agents|mesh-ancestor
64689212|NCT05215925|Mitosis Modulators|mitosis modulators|mesh-ancestor
64717136|NCT00377780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717137|NCT00377780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64717138|NCT00377780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64717139|NCT00377780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64717140|NCT00377780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454258|NCT01251796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65454259|NCT01251796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454260|NCT01251796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454261|NCT01251874|Alovudine|alovudine|mesh-list
65454262|NCT01251874|Carboplatin|carboplatin|mesh-list
65454263|NCT01251874|Veliparib|veliparib|mesh-list
65454264|NCT01251874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454265|NCT01251874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65454266|NCT01251874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454267|NCT01251874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454268|NCT01251874|Antiviral Agents|antiviral agents|mesh-ancestor
65454269|NCT01251874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65454270|NCT03911440|Azithromycin|azithromycin|mesh-list
65454271|NCT03911440|Doxycycline|doxycycline|mesh-list
65454272|NCT03911440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65454273|NCT03911440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65454274|NCT03911440|Antimalarials|antimalarials|mesh-ancestor
65454275|NCT03911440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65454276|NCT03911440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65454277|NCT00191100|Gemcitabine|gemcitabine|mesh-list
65454278|NCT00191100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454279|NCT00191100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65454280|NCT00191100|Antimetabolites|antimetabolites|mesh-ancestor
65454281|NCT00191100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454282|NCT00191100|Antiviral Agents|antiviral agents|mesh-ancestor
65454283|NCT00191100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65454284|NCT00191100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454285|NCT00191100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64717141|NCT00377780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64717142|NCT00376519|Cyclosporine|cyclosporine|mesh-list
64689242|NCT03649061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64689244|NCT03649061|Analgesics|analgesics|mesh-ancestor
64689245|NCT03649061|Sensory System Agents|sensory system agents|mesh-ancestor
64689246|NCT03649061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689247|NCT03649061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689248|NCT03649061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64689249|NCT03649061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64689250|NCT03649061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64689251|NCT03649061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64689252|NCT03649061|Immunologic Factors|immunologic factors|mesh-ancestor
64689253|NCT03649061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64689254|NCT03649061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689255|NCT02265744|Antibodies|antibodies|mesh-list
64689256|NCT02265744|Immunologic Factors|immunologic factors|mesh-ancestor
64689257|NCT02265744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689258|NCT05109143|Indomethacin|indomethacin|mesh-list
64689259|NCT05109143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65454286|NCT00191100|Immunologic Factors|immunologic factors|mesh-ancestor
65454287|NCT00191100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454288|NCT03902782|Dexamethasone|dexamethasone|mesh-list
65454289|NCT03902782|Dexamethasone acetate|dexamethasone acetate|mesh-list
65454290|NCT03902782|Epinephrine|epinephrine|mesh-list
65454291|NCT03902782|Bupivacaine|bupivacaine|mesh-list
65454292|NCT03902782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65454293|NCT03902782|Antiemetics|antiemetics|mesh-ancestor
65454294|NCT03902782|Autonomic Agents|autonomic agents|mesh-ancestor
65454295|NCT03902782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65454296|NCT03902782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454297|NCT03902782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65454298|NCT03902782|Glucocorticoids|glucocorticoids|mesh-ancestor
65454299|NCT03902782|Hormones|hormones|mesh-ancestor
64689260|NCT05109143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64689289|NCT00085735|Tubulin Modulators|tubulin modulators|mesh-ancestor
64689290|NCT00085735|Antimitotic Agents|antimitotic agents|mesh-ancestor
64689291|NCT00085735|Mitosis Modulators|mitosis modulators|mesh-ancestor
64689292|NCT03578783|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64689293|NCT03578783|Anesthetics, Local|anesthetics, local|mesh-ancestor
64689294|NCT03578783|Anesthetics|anesthetics|mesh-ancestor
64689295|NCT03578783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64689296|NCT03578783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689297|NCT03578783|Sensory System Agents|sensory system agents|mesh-ancestor
64689298|NCT03578783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689299|NCT03578783|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64689300|NCT03538457|Acetaminophen|acetaminophen|mesh-list
64689301|NCT03538457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64689302|NCT03538457|Analgesics|analgesics|mesh-ancestor
64689303|NCT03538457|Sensory System Agents|sensory system agents|mesh-ancestor
64689304|NCT03538457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689305|NCT03538457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689306|NCT03538457|Antipyretics|antipyretics|mesh-ancestor
64689307|NCT05544786|Ritonavir|ritonavir|mesh-list
64689330|NCT02731313|Trastuzumab|trastuzumab|mesh-list
64689331|NCT02731313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64689332|NCT02731313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689333|NCT02281591|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64689334|NCT02281591|Anticonvulsants|anticonvulsants|mesh-ancestor
64689335|NCT02281591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64689336|NCT02281591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64689337|NCT02281591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64689338|NCT02281591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689339|NCT02731469|Darbepoetin alfa|darbepoetin alfa|mesh-list
64689340|NCT02731469|Hematinics|hematinics|mesh-ancestor
64717146|NCT00376519|Fludarabine phosphate|fludarabine phosphate|mesh-list
64456446|NCT01890746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64717147|NCT00376519|Cyclosporins|cyclosporins|mesh-list
64717148|NCT00376519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64717149|NCT00376519|Immunologic Factors|immunologic factors|mesh-ancestor
64717150|NCT00376519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717151|NCT00376519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64717152|NCT00376519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64717153|NCT00376519|Alkylating Agents|alkylating agents|mesh-ancestor
64717154|NCT00376519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689344|NCT01944319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64689345|NCT00368303|Paroxetine|paroxetine|mesh-list
64689346|NCT00368303|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64689347|NCT00368303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64689348|NCT00368303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64689349|NCT00368303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689350|NCT00368303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65454300|NCT03902782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65454301|NCT03902782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65454302|NCT03902782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454303|NCT03902782|Anesthetics, Local|anesthetics, local|mesh-ancestor
65454304|NCT03902782|Anesthetics|anesthetics|mesh-ancestor
65454305|NCT03902782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64689351|NCT00368303|Serotonin Agents|serotonin agents|mesh-ancestor
64689352|NCT00368303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689353|NCT00368303|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64689354|NCT00368303|Antidepressive Agents|antidepressive agents|mesh-ancestor
64689355|NCT00368303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64689356|NCT00368303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64689357|NCT00368303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64689363|NCT05020145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689364|NCT02734355|Amlodipine|amlodipine|mesh-list
64689365|NCT02734355|Telmisartan|telmisartan|mesh-list
64689366|NCT02734355|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
64689367|NCT02734355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64689368|NCT02734355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64689369|NCT02734355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64689370|NCT02734355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689371|NCT02734355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64689372|NCT02734355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689373|NCT02734355|Vasodilator Agents|vasodilator agents|mesh-ancestor
64689374|NCT02734355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64689375|NCT02734355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64689376|NCT00369395|Volociximab|volociximab|mesh-list
64689377|NCT00369395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64689378|NCT00369395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64689379|NCT00369395|Growth Substances|growth substances|mesh-ancestor
64689380|NCT00369395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689381|NCT00369395|Growth Inhibitors|growth inhibitors|mesh-ancestor
64689382|NCT00369395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689383|NCT01947907|Hormones|hormones|mesh-list
64689384|NCT01947907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64689385|NCT01947907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689386|NCT01948141|Nintedanib|nintedanib|mesh-list
64689387|NCT01948141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689388|NCT01948141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64717158|NCT00376519|Antimetabolites|antimetabolites|mesh-ancestor
64717159|NCT00376519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64717160|NCT00376519|Antifungal Agents|antifungal agents|mesh-ancestor
64717161|NCT00376519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64717162|NCT00376519|Dermatologic Agents|dermatologic agents|mesh-ancestor
64717163|NCT00376519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64717164|NCT00376519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64717165|NCT00376519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64717166|NCT00376519|Antitubercular Agents|antitubercular agents|mesh-ancestor
64717167|NCT00376519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64717168|NCT03373591|Bupivacaine|bupivacaine|mesh-list
64717169|NCT03373591|Anesthetics, Local|anesthetics, local|mesh-ancestor
64325397|NCT02157311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64689390|NCT01948141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689391|NCT04938323|BCG Vaccine|bcg vaccine|mesh-list
64689392|NCT04938323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64689393|NCT04938323|Immunologic Factors|immunologic factors|mesh-ancestor
64689394|NCT04938323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689395|NCT05446493|Tadalafil|tadalafil|mesh-list
64689396|NCT05446493|Vasodilator Agents|vasodilator agents|mesh-ancestor
64689405|NCT02863055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64689406|NCT02863055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689407|NCT05445479|Doxycycline|doxycycline|mesh-list
64689408|NCT05445479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64689409|NCT05445479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64689410|NCT05445479|Antimalarials|antimalarials|mesh-ancestor
64689411|NCT05445479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65454306|NCT03902782|Sensory System Agents|sensory system agents|mesh-ancestor
65454307|NCT03902782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65454308|NCT03902782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65454309|NCT03902782|Adrenergic Agents|adrenergic agents|mesh-ancestor
65454310|NCT03902782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65454311|NCT03902782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454312|NCT03902782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65454313|NCT03902782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65454314|NCT03902782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65454315|NCT03902782|Respiratory System Agents|respiratory system agents|mesh-ancestor
65454316|NCT03902782|Mydriatics|mydriatics|mesh-ancestor
65454317|NCT03902782|Sympathomimetics|sympathomimetics|mesh-ancestor
65454318|NCT03902782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65454319|NCT01149226|Chloral Hydrate|chloral hydrate|mesh-list
65454320|NCT01149226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65454321|NCT01149226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65454322|NCT01149226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454323|NCT01252342|Oxytocin|oxytocin|mesh-list
65454324|NCT01252342|Oxytocics|oxytocics|mesh-ancestor
65454325|NCT01252342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65454326|NCT01252342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454327|NCT01254994|Entecavir|entecavir|mesh-list
65454328|NCT01254994|Antiviral Agents|antiviral agents|mesh-ancestor
65454329|NCT01254994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65454330|NCT03904732|Aspirin|aspirin|mesh-list
65454331|NCT03904732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65454332|NCT03904732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65454333|NCT03904732|Analgesics|analgesics|mesh-ancestor
65454334|NCT03904732|Sensory System Agents|sensory system agents|mesh-ancestor
65454335|NCT03904732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65454336|NCT03904732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689412|NCT05445479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64689413|NCT02711735|Vaccines|vaccines|mesh-list
64689414|NCT02711735|Immunologic Factors|immunologic factors|mesh-ancestor
64689415|NCT02711735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689416|NCT05445011|Cyclophosphamide|cyclophosphamide|mesh-list
64689417|NCT05445011|Fludarabine|fludarabine|mesh-list
64689418|NCT05445011|Fludarabine phosphate|fludarabine phosphate|mesh-list
64689419|NCT05445011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64689420|NCT05445011|Immunologic Factors|immunologic factors|mesh-ancestor
64689421|NCT05445011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689422|NCT05445011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64689423|NCT05445011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64689424|NCT05445011|Alkylating Agents|alkylating agents|mesh-ancestor
65454337|NCT03904732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65454338|NCT03904732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65454339|NCT03904732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65454340|NCT03904732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65454341|NCT03904732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454342|NCT03904732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65454343|NCT03904732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65454344|NCT03904732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454345|NCT03904732|Antipyretics|antipyretics|mesh-ancestor
65454346|NCT01252420|Enoxaparin|enoxaparin|mesh-list
65454347|NCT01252420|Anticoagulants|anticoagulants|mesh-ancestor
64689425|NCT05445011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689426|NCT05445011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689427|NCT05445011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64689428|NCT05445011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64689444|NCT04770155|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64689446|NCT04744181|Vitamin B Complex|vitamin b complex|mesh-list
64689447|NCT04744181|Vitamins|vitamins|mesh-ancestor
64689448|NCT04744181|Micronutrients|micronutrients|mesh-ancestor
64689449|NCT04744181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689450|NCT04744181|Hematinics|hematinics|mesh-ancestor
64689451|NCT05444543|Fluticasone|fluticasone|mesh-list
64689452|NCT05444543|Xhance|xhance|mesh-list
64689453|NCT05444543|Budesonide|budesonide|mesh-list
64689454|NCT05444543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64689455|NCT05444543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64689456|NCT05444543|Autonomic Agents|autonomic agents|mesh-ancestor
64717170|NCT03373591|Anesthetics|anesthetics|mesh-ancestor
64717171|NCT03373591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717172|NCT03373591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717173|NCT03373591|Sensory System Agents|sensory system agents|mesh-ancestor
64717174|NCT03373591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689457|NCT05444543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689458|NCT05444543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689459|NCT05444543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64689460|NCT05444543|Respiratory System Agents|respiratory system agents|mesh-ancestor
64689461|NCT05444543|Dermatologic Agents|dermatologic agents|mesh-ancestor
64689462|NCT05444543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64689463|NCT05444543|Glucocorticoids|glucocorticoids|mesh-ancestor
64689464|NCT05444543|Hormones|hormones|mesh-ancestor
64689465|NCT05444543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64689467|NCT01970345|Growth Substances|growth substances|mesh-ancestor
64689468|NCT01970345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689475|NCT00619931|APD791|apd791|mesh-list
64689476|NCT00619931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64689477|NCT00619931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64689478|NCT00619931|Serotonin Agents|serotonin agents|mesh-ancestor
64689479|NCT00619931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64689480|NCT00619931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689481|NCT00619931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689506|NCT01889797|Obinutuzumab|obinutuzumab|mesh-list
64689507|NCT01889797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64689508|NCT01889797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689509|NCT01889797|Immunologic Factors|immunologic factors|mesh-ancestor
64689510|NCT01889797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689511|NCT01889797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64689512|NCT00369551|Paclitaxel|paclitaxel|mesh-list
64689513|NCT00369551|Bevacizumab|bevacizumab|mesh-list
64689514|NCT00369551|Carboplatin|carboplatin|mesh-list
64689515|NCT00369551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64689516|NCT00369551|Antibodies|antibodies|mesh-list
64689517|NCT00369551|Immunoglobulins|immunoglobulins|mesh-list
64689518|NCT00369551|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64689519|NCT00369551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64689520|NCT00369551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454348|NCT01252420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65454349|NCT01252420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65454350|NCT01252420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454351|NCT01149304|Enoxaparin|enoxaparin|mesh-list
65454352|NCT01149304|Pentoxifylline|pentoxifylline|mesh-list
65454353|NCT01149304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65454354|NCT01149304|Anticoagulants|anticoagulants|mesh-ancestor
65454355|NCT01149304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65454356|NCT01149304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64689521|NCT00369551|Tubulin Modulators|tubulin modulators|mesh-ancestor
64689522|NCT00369551|Antimitotic Agents|antimitotic agents|mesh-ancestor
64689523|NCT00369551|Mitosis Modulators|mitosis modulators|mesh-ancestor
64689524|NCT00369551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689525|NCT00369551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64689526|NCT00369551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64717175|NCT03378973|Dexmedetomidine|dexmedetomidine|mesh-list
64717176|NCT03378973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64717177|NCT03378973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717178|NCT03378973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717179|NCT03378973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64717180|NCT03378973|Analgesics|analgesics|mesh-ancestor
64717181|NCT03378973|Sensory System Agents|sensory system agents|mesh-ancestor
64717182|NCT03378973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717183|NCT03378973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64717184|NCT03378973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64717185|NCT03378973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64717186|NCT03378973|Adrenergic Agents|adrenergic agents|mesh-ancestor
64717187|NCT03378973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64717188|NCT03378973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689540|NCT05437601|Antioxidants|antioxidants|mesh-ancestor
64689541|NCT05437601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689542|NCT05437601|Protective Agents|protective agents|mesh-ancestor
64689543|NCT05437601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689545|NCT05449145|Vitamins|vitamins|mesh-ancestor
64689546|NCT05449145|Micronutrients|micronutrients|mesh-ancestor
64689547|NCT05449145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689548|NCT05449145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64689549|NCT05447039|Montelukast|montelukast|mesh-list
64689550|NCT05447039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64689551|NCT05447039|Respiratory System Agents|respiratory system agents|mesh-ancestor
64689552|NCT05447039|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64689553|NCT05447039|Hormone Antagonists|hormone antagonists|mesh-ancestor
64689554|NCT05447039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64689555|NCT05447039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689556|NCT05447039|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64689557|NCT05447039|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64689565|NCT05446727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717195|NCT04121078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64717196|NCT04121078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64717197|NCT04121078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717198|NCT04121078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64717199|NCT04121078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64717200|NCT04121078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64689566|NCT05446727|Sensory System Agents|sensory system agents|mesh-ancestor
64689567|NCT05446727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689569|NCT05446415|Incretins|incretins|mesh-list
64689570|NCT05446415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64689571|NCT05446415|Hormones|hormones|mesh-ancestor
64689572|NCT05446415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64689573|NCT05446415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689574|NCT05448365|Vitamin D|vitamin d|mesh-list
64689575|NCT05448365|Vitamins|vitamins|mesh-list
64689576|NCT05448365|Inositol|inositol|mesh-list
65454357|NCT01149304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454358|NCT01149304|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65454359|NCT01149304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454360|NCT01149304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65454361|NCT01149304|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65454362|NCT01149304|Protective Agents|protective agents|mesh-ancestor
65454363|NCT01149304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454364|NCT01149304|Vasodilator Agents|vasodilator agents|mesh-ancestor
65454365|NCT01149304|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65454366|NCT01149304|Antioxidants|antioxidants|mesh-ancestor
65454367|NCT01149304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65454368|NCT01149304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65454369|NCT01254526|Paclitaxel|paclitaxel|mesh-list
65454370|NCT01254526|Bevacizumab|bevacizumab|mesh-list
65454371|NCT01254526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64689586|NCT05448365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689587|NCT05448365|Protective Agents|protective agents|mesh-ancestor
64689588|NCT05448365|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64689589|NCT05448365|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64689590|NCT05448365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689591|NCT05448365|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64689592|NCT03137771|Gemcitabine|gemcitabine|mesh-list
64689593|NCT03137771|Docetaxel|docetaxel|mesh-list
64689594|NCT03137771|Pembrolizumab|pembrolizumab|mesh-list
64689595|NCT03137771|Pemetrexed|pemetrexed|mesh-list
64689596|NCT03137771|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64689597|NCT03137771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64689598|NCT03137771|Antimetabolites|antimetabolites|mesh-ancestor
64689599|NCT03137771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689600|NCT03137771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689601|NCT03137771|Antiviral Agents|antiviral agents|mesh-ancestor
64689602|NCT03137771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64689603|NCT03137771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64689604|NCT03137771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64689605|NCT03137771|Immunologic Factors|immunologic factors|mesh-ancestor
64689606|NCT03137771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689607|NCT03137771|Tubulin Modulators|tubulin modulators|mesh-ancestor
64689608|NCT03137771|Antimitotic Agents|antimitotic agents|mesh-ancestor
64689609|NCT03137771|Mitosis Modulators|mitosis modulators|mesh-ancestor
64689610|NCT03137771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64689611|NCT03137771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64689612|NCT03137771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64689613|NCT03137771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64689614|NCT00370799|Betamethasone|betamethasone|mesh-list
64689615|NCT00370799|Betamethasone Valerate|betamethasone valerate|mesh-list
64689616|NCT00370799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64689617|NCT00370799|Betamethasone benzoate|betamethasone benzoate|mesh-list
64689618|NCT00370799|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64689619|NCT00370799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64689620|NCT00370799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64689621|NCT00370799|Glucocorticoids|glucocorticoids|mesh-ancestor
64689622|NCT00370799|Hormones|hormones|mesh-ancestor
64689623|NCT00370799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64689624|NCT00370799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689625|NCT00370799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64689626|NCT00370799|Respiratory System Agents|respiratory system agents|mesh-ancestor
64689627|NCT05444777|Ketamine|ketamine|mesh-list
64689639|NCT05444777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64717201|NCT04121078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65454372|NCT01254526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454373|NCT01254526|Tubulin Modulators|tubulin modulators|mesh-ancestor
65454374|NCT01254526|Antimitotic Agents|antimitotic agents|mesh-ancestor
65454375|NCT01254526|Mitosis Modulators|mitosis modulators|mesh-ancestor
65454376|NCT01254526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454377|NCT01254526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65454378|NCT01254526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65454379|NCT01254526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65454380|NCT01254526|Growth Substances|growth substances|mesh-ancestor
65454381|NCT01254526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454382|NCT01254526|Growth Inhibitors|growth inhibitors|mesh-ancestor
65454383|NCT01148992|Lofexidine|lofexidine|mesh-list
65454384|NCT01148992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65454385|NCT01148992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65454386|NCT01148992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454387|NCT01148992|Sensory System Agents|sensory system agents|mesh-ancestor
65454388|NCT01148992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65454389|NCT01148992|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65454390|NCT01148992|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65454391|NCT01148992|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65454392|NCT01148992|Adrenergic Agents|adrenergic agents|mesh-ancestor
65454393|NCT01148992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64717202|NCT04121078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64717203|NCT04121078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64717204|NCT03248947|Buprenorphine|buprenorphine|mesh-list
64717205|NCT03248947|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64717206|NCT03248947|Naloxone|naloxone|mesh-list
64717207|NCT03248947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64689640|NCT05444777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689641|NCT02661971|Leucovorin|leucovorin|mesh-list
64689642|NCT02661971|Docetaxel|docetaxel|mesh-list
64689643|NCT02661971|Fluorouracil|fluorouracil|mesh-list
64689644|NCT02661971|Oxaliplatin|oxaliplatin|mesh-list
64689645|NCT02661971|Ramucirumab|ramucirumab|mesh-list
64689646|NCT02661971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689647|NCT02661971|Tubulin Modulators|tubulin modulators|mesh-ancestor
64689648|NCT02661971|Antimitotic Agents|antimitotic agents|mesh-ancestor
64689649|NCT02661971|Mitosis Modulators|mitosis modulators|mesh-ancestor
64689654|NCT02661971|Immunologic Factors|immunologic factors|mesh-ancestor
64689655|NCT02661971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689656|NCT02661971|Antidotes|antidotes|mesh-ancestor
64689657|NCT02661971|Protective Agents|protective agents|mesh-ancestor
64689658|NCT02661971|Vitamin B Complex|vitamin b complex|mesh-ancestor
64689659|NCT02661971|Vitamins|vitamins|mesh-ancestor
64689660|NCT02661971|Micronutrients|micronutrients|mesh-ancestor
64689661|NCT05442905|Anesthetics|anesthetics|mesh-list
64689662|NCT05442905|Propofol|propofol|mesh-list
64689663|NCT05442905|Sevoflurane|sevoflurane|mesh-list
64689664|NCT05442905|Atracurium|atracurium|mesh-list
64689665|NCT05442905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64689666|NCT05442905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689667|NCT05442905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64689668|NCT05442905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64689669|NCT05442905|Anesthetics, General|anesthetics, general|mesh-ancestor
64838976|NCT01628952|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65454394|NCT01148992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454395|NCT03901612|Ropivacaine|ropivacaine|mesh-list
65454396|NCT03901612|Anesthetics, Local|anesthetics, local|mesh-ancestor
65454397|NCT03901612|Anesthetics|anesthetics|mesh-ancestor
65454398|NCT03901612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65454399|NCT03901612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454400|NCT03901612|Sensory System Agents|sensory system agents|mesh-ancestor
65454401|NCT03901612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65454402|NCT03903952|Vitamin B 12|vitamin b 12|mesh-list
65454403|NCT03903952|Hydroxocobalamin|hydroxocobalamin|mesh-list
65454404|NCT03903952|Vitamins|vitamins|mesh-ancestor
65454405|NCT03903952|Micronutrients|micronutrients|mesh-ancestor
65454406|NCT03903952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454407|NCT03903952|Vitamin B Complex|vitamin b complex|mesh-ancestor
65454408|NCT03903952|Hematinics|hematinics|mesh-ancestor
65454409|NCT00257010|Almotriptan|almotriptan|mesh-list
65454410|NCT00257010|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65454411|NCT00257010|Serotonin Agents|serotonin agents|mesh-ancestor
65454412|NCT00257010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64689670|NCT05442905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64689671|NCT05442905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64689672|NCT05442905|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64689673|NCT05442905|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64689674|NCT05442905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64689675|NCT05442905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689676|NCT05442905|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64689677|NCT05442905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64689678|NCT05442905|Cholinergic Agents|cholinergic agents|mesh-ancestor
64689679|NCT05442905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64689680|NCT05442905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689681|NCT00369863|Triamcinolone|triamcinolone|mesh-list
64689682|NCT00369863|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64689683|NCT00369863|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64689684|NCT00369863|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64689685|NCT00369863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64689686|NCT00369863|Glucocorticoids|glucocorticoids|mesh-ancestor
64689687|NCT00369863|Hormones|hormones|mesh-ancestor
64689688|NCT00369863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64689689|NCT00369863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689690|NCT00369863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64689691|NCT00369863|Immunologic Factors|immunologic factors|mesh-ancestor
64689707|NCT01890343|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64689708|NCT01890343|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64689709|NCT01890343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689710|NCT02588027|Ibuprofen|ibuprofen|mesh-list
64689711|NCT02588027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64689712|NCT02588027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64717208|NCT03248947|Narcotics|narcotics|mesh-ancestor
64717209|NCT03248947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717210|NCT03248947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717211|NCT03248947|Analgesics|analgesics|mesh-ancestor
64717212|NCT03248947|Sensory System Agents|sensory system agents|mesh-ancestor
64325448|NCT04675827|Pertuzumab|pertuzumab|mesh-list
64689713|NCT02588027|Analgesics|analgesics|mesh-ancestor
64689714|NCT02588027|Sensory System Agents|sensory system agents|mesh-ancestor
65454413|NCT00257010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454414|NCT00257010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454415|NCT03901768|Dexamethasone|dexamethasone|mesh-list
65454416|NCT03901768|Triamcinolone|triamcinolone|mesh-list
65454417|NCT03901768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65454418|NCT03901768|Antiemetics|antiemetics|mesh-ancestor
65454419|NCT03901768|Autonomic Agents|autonomic agents|mesh-ancestor
65454420|NCT03901768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65454421|NCT03901768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454422|NCT03901768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65454423|NCT03901768|Glucocorticoids|glucocorticoids|mesh-ancestor
65454424|NCT03901768|Hormones|hormones|mesh-ancestor
64838985|NCT01629082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64689715|NCT02588027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689716|NCT02588027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689717|NCT02588027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64689718|NCT02588027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64689719|NCT02588027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64689720|NCT02588027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64689721|NCT02588027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689722|NCT04483583|Clopidogrel|clopidogrel|mesh-list
64689723|NCT04483583|Ticagrelor|ticagrelor|mesh-list
64689724|NCT04483583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64689725|NCT04483583|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64689726|NCT04483583|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64689727|NCT04483583|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64689728|NCT04483583|Purinergic Agents|purinergic agents|mesh-ancestor
64689737|NCT04449965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64689738|NCT01951339|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64689739|NCT01951339|Glimepiride|glimepiride|mesh-list
64689740|NCT01951339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64689741|NCT01951339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689742|NCT01951339|Incretins|incretins|mesh-ancestor
64689743|NCT01951339|Hormones|hormones|mesh-ancestor
64689744|NCT01951339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64689745|NCT01951339|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64689746|NCT01951339|Protease Inhibitors|protease inhibitors|mesh-ancestor
64689747|NCT01951339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64689748|NCT01951339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689749|NCT01951339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64689750|NCT01951339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64689751|NCT01951339|Immunologic Factors|immunologic factors|mesh-ancestor
64689752|NCT05431673|Doxycycline|doxycycline|mesh-list
64689753|NCT05431673|Ciprofloxacin|ciprofloxacin|mesh-list
64689754|NCT05431673|Rifampin|rifampin|mesh-list
64689755|NCT05431673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64689756|NCT05431673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64689766|NCT05431673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64689767|NCT05431673|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64689768|NCT05431673|Antitubercular Agents|antitubercular agents|mesh-ancestor
64689769|NCT05431673|Leprostatic Agents|leprostatic agents|mesh-ancestor
64689770|NCT05431673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64689771|NCT05431673|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64689772|NCT05431673|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64689773|NCT05431673|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64689774|NCT05431673|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64689775|NCT05431673|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64689776|NCT05431673|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64689777|NCT01951651|Exenatide|exenatide|mesh-list
64689778|NCT01951651|Glipizide|glipizide|mesh-list
64689779|NCT01951651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65454425|NCT03901768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65454426|NCT03901768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65454427|NCT03901768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454428|NCT03903718|Oseltamivir|oseltamivir|mesh-list
65454429|NCT03903718|MEDI8852|medi8852|mesh-list
65454430|NCT03903718|Antiviral Agents|antiviral agents|mesh-ancestor
65454431|NCT03903718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65454432|NCT03903718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454433|NCT03903718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454434|NCT03910504|Rocuronium|rocuronium|mesh-list
65454435|NCT03910504|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65454436|NCT03910504|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64689780|NCT01951651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689781|NCT01951651|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64689782|NCT01951651|Incretins|incretins|mesh-ancestor
64689783|NCT01951651|Hormones|hormones|mesh-ancestor
64689784|NCT01951651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64717213|NCT03248947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717214|NCT03248947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64717215|NCT04114058|Bupivacaine|bupivacaine|mesh-list
64717216|NCT04114058|Anesthetics, Local|anesthetics, local|mesh-ancestor
64717217|NCT04114058|Anesthetics|anesthetics|mesh-ancestor
64717218|NCT04114058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717219|NCT04114058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456520|NCT01780545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64717220|NCT04114058|Sensory System Agents|sensory system agents|mesh-ancestor
64689785|NCT02466581|Hydroxychloroquine|hydroxychloroquine|mesh-list
64415079|NCT01595581|Androgens|androgens|mesh-ancestor
64689786|NCT02466581|Sulfasalazine|sulfasalazine|mesh-list
64689787|NCT02466581|Prednisolone|prednisolone|mesh-list
64689788|NCT02466581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64689789|NCT02466581|Methylprednisolone|methylprednisolone|mesh-list
64689790|NCT02466581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64689791|NCT02466581|Prednisolone acetate|prednisolone acetate|mesh-list
64689792|NCT02466581|Abatacept|abatacept|mesh-list
64689793|NCT02466581|Certolizumab Pegol|certolizumab pegol|mesh-list
64689794|NCT02466581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64689795|NCT02466581|Prednisolone phosphate|prednisolone phosphate|mesh-list
64689801|NCT02466581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64689802|NCT02466581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689804|NCT02466581|Autonomic Agents|autonomic agents|mesh-ancestor
64689805|NCT02466581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689806|NCT02466581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64689807|NCT02466581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64689808|NCT02466581|Protective Agents|protective agents|mesh-ancestor
64689809|NCT02466581|Antimalarials|antimalarials|mesh-ancestor
64689810|NCT02466581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64689811|NCT02466581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64689812|NCT02466581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64689813|NCT02466581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64689814|NCT02466581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689815|NCT02466581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64689816|NCT02466581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64689817|NCT02466581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64689818|NCT02466581|Immunologic Factors|immunologic factors|mesh-ancestor
64689831|NCT01951963|Anesthetics, General|anesthetics, general|mesh-ancestor
64689832|NCT01951963|Anesthetics|anesthetics|mesh-ancestor
64689833|NCT01951963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64689834|NCT01951963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64689835|NCT01951963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64689836|NCT01951963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64689837|NCT01951963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454437|NCT03910504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65454438|NCT03910504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65454439|NCT03910504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454440|NCT03901690|Imiquimod|imiquimod|mesh-list
65454441|NCT03901690|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65454442|NCT03901690|Immunologic Factors|immunologic factors|mesh-ancestor
65454443|NCT03901690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454445|NCT03901690|Interferon Inducers|interferon inducers|mesh-ancestor
64689852|NCT01894555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64689853|NCT01894555|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64689854|NCT01894555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64689855|NCT01894555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689856|NCT01894555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64689857|NCT01894555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64689858|NCT01894555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64689859|NCT01894555|Antipyretics|antipyretics|mesh-ancestor
64689860|NCT02344355|Ascorbic Acid|ascorbic acid|mesh-list
64689861|NCT02344355|Temozolomide|temozolomide|mesh-list
64689863|NCT02344355|Micronutrients|micronutrients|mesh-ancestor
64689864|NCT02344355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689865|NCT02344355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64689866|NCT02344355|Alkylating Agents|alkylating agents|mesh-ancestor
64717221|NCT04114058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717223|NCT03862040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64717224|NCT00376831|Fentanyl|fentanyl|mesh-list
64717225|NCT00376831|Midazolam|midazolam|mesh-list
64717226|NCT00376831|Ketamine|ketamine|mesh-list
64717227|NCT00376831|Analgesics|analgesics|mesh-ancestor
64717228|NCT00376831|Sensory System Agents|sensory system agents|mesh-ancestor
64717229|NCT00376831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717230|NCT00376831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717231|NCT00376831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64717232|NCT00376831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64717233|NCT00376831|Anesthetics, General|anesthetics, general|mesh-ancestor
64717234|NCT00376831|Anesthetics|anesthetics|mesh-ancestor
64717235|NCT00376831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64689867|NCT02344355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689868|NCT02344355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689869|NCT02344355|Antioxidants|antioxidants|mesh-ancestor
64689870|NCT02344355|Protective Agents|protective agents|mesh-ancestor
64689885|NCT01953211|Contraceptive Agents|contraceptive agents|mesh-list
64689886|NCT01953211|Norinyl|norinyl|mesh-list
64689887|NCT01953211|Contraceptives, Oral|contraceptives, oral|mesh-list
64689888|NCT01953211|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64689889|NCT01953211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64689890|NCT01953211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689891|NCT01953211|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64689900|NCT05735197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64689901|NCT05735197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689902|NCT00370097|Fluticasone|fluticasone|mesh-list
64689904|NCT00370097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64689905|NCT00370097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64689906|NCT00370097|Autonomic Agents|autonomic agents|mesh-ancestor
64689907|NCT00370097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689908|NCT00370097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689909|NCT00370097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64689910|NCT00370097|Respiratory System Agents|respiratory system agents|mesh-ancestor
64689926|NCT00370253|Sympathomimetics|sympathomimetics|mesh-ancestor
64689927|NCT00370253|Autonomic Agents|autonomic agents|mesh-ancestor
64689928|NCT00370253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689930|NCT01491815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64689931|NCT01491815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689932|NCT01491815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689933|NCT01491815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64689934|NCT01491815|Immunologic Factors|immunologic factors|mesh-ancestor
64689935|NCT01491815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689936|NCT01491815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65454446|NCT03901378|Pembrolizumab|pembrolizumab|mesh-list
65454447|NCT03901378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65454448|NCT03901378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454449|NCT00256854|Ropinirole|ropinirole|mesh-list
65454450|NCT00256854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65454451|NCT00256854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65454452|NCT00256854|Dopamine Agonists|dopamine agonists|mesh-ancestor
65454453|NCT00256854|Dopamine Agents|dopamine agents|mesh-ancestor
65454454|NCT00256854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65454455|NCT00256854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454456|NCT00256854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454457|NCT00189462|Montelukast|montelukast|mesh-list
65454458|NCT00189462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65454459|NCT00189462|Respiratory System Agents|respiratory system agents|mesh-ancestor
64689937|NCT04359953|Azithromycin|azithromycin|mesh-list
64689938|NCT04359953|Hydroxychloroquine|hydroxychloroquine|mesh-list
64689939|NCT04359953|Telmisartan|telmisartan|mesh-list
64689940|NCT04359953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64689941|NCT04359953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64689942|NCT04359953|Antimalarials|antimalarials|mesh-ancestor
64689943|NCT04359953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64689944|NCT04359953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64689945|NCT04359953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64717236|NCT00376831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64717237|NCT00376831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64717238|NCT00376831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64717239|NCT00376831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717240|NCT00376831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64717241|NCT00376831|Narcotics|narcotics|mesh-ancestor
64717242|NCT00376831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64717243|NCT00376831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64717244|NCT00376831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64717245|NCT00376831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64325473|NCT04620135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64325474|NCT02160275|Insulin|insulin|mesh-list
64689946|NCT04359953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689947|NCT04359953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64689948|NCT04359953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64689949|NCT04359953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64689950|NCT04359953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64689951|NCT05364515|Clobetasol|clobetasol|mesh-list
64689952|NCT05364515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64689953|NCT05364515|Glucocorticoids|glucocorticoids|mesh-ancestor
64689954|NCT05364515|Hormones|hormones|mesh-ancestor
64689955|NCT05364515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64689956|NCT05364515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689957|NCT01438073|Hormones|hormones|mesh-list
64689958|NCT01438073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64689959|NCT01438073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689960|NCT01211405|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
64689961|NCT01211405|Hallucinogens|hallucinogens|mesh-ancestor
64689982|NCT04338191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689983|NCT04338191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64689984|NCT04338191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64689985|NCT04338191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64689987|NCT04338191|Protective Agents|protective agents|mesh-ancestor
64689988|NCT04338191|Vitamin B Complex|vitamin b complex|mesh-ancestor
64689990|NCT04338191|Micronutrients|micronutrients|mesh-ancestor
64689991|NCT00481091|Navitoclax|navitoclax|mesh-list
64689992|NCT00481091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689993|NCT00371033|Pregabalin|pregabalin|mesh-list
64689994|NCT00371033|Analgesics|analgesics|mesh-ancestor
65454460|NCT00189462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65454461|NCT00189462|Hormone Antagonists|hormone antagonists|mesh-ancestor
65454462|NCT00189462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65454463|NCT00189462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454464|NCT00189462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65454465|NCT00189462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65454466|NCT00189462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454467|NCT01150318|Iodine|iodine|mesh-list
65454468|NCT01150318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65454469|NCT01150318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65454470|NCT01150318|Trace Elements|trace elements|mesh-ancestor
65454471|NCT01150318|Micronutrients|micronutrients|mesh-ancestor
65454472|NCT01150318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454473|NCT01256632|Ranibizumab|ranibizumab|mesh-list
65454474|NCT01256632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65454475|NCT01256632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65454476|NCT01256632|Growth Substances|growth substances|mesh-ancestor
65454477|NCT01256632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454478|NCT01256632|Growth Inhibitors|growth inhibitors|mesh-ancestor
65454479|NCT01256632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454480|NCT00256698|Fulvestrant|fulvestrant|mesh-list
65454481|NCT00256698|Anastrozole|anastrozole|mesh-list
65454482|NCT00256698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65454483|NCT00256698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689995|NCT00371033|Sensory System Agents|sensory system agents|mesh-ancestor
64689996|NCT00371033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689997|NCT00371033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689998|NCT00371033|Anticonvulsants|anticonvulsants|mesh-ancestor
64689999|NCT00371033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64690000|NCT00371033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64690001|NCT00371033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690002|NCT00371033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64690003|NCT00371033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64690004|NCT00371033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64690005|NCT00371033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717246|NCT00376831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64717247|NCT00376831|GABA Modulators|gaba modulators|mesh-ancestor
64717248|NCT00376831|GABA Agents|gaba agents|mesh-ancestor
64717249|NCT03857750|Rocuronium|rocuronium|mesh-list
64717250|NCT03857750|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64717251|NCT03857750|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64717252|NCT03857750|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64717253|NCT03857750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717254|NCT03857750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717255|NCT03828422|Calcium|calcium|mesh-list
64717256|NCT03828422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64717257|NCT03828422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717258|NCT03852524|Methylnaltrexone|methylnaltrexone|mesh-list
64717259|NCT03852524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65454484|NCT00256698|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65454485|NCT00256698|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65454486|NCT00256698|Hormone Antagonists|hormone antagonists|mesh-ancestor
65454487|NCT00256698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65454488|NCT00256698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454489|NCT00256698|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65454490|NCT00256698|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65454491|NCT00256698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454492|NCT00256698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454493|NCT01150630|Gemcitabine|gemcitabine|mesh-list
65454494|NCT01150630|Capecitabine|capecitabine|mesh-list
65454495|NCT01150630|Epirubicin|epirubicin|mesh-list
64717260|NCT03852524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717261|NCT03852524|Sensory System Agents|sensory system agents|mesh-ancestor
64325483|NCT03126968|Adrenergic Agents|adrenergic agents|mesh-ancestor
64325484|NCT03126968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64690006|NCT00371033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64690007|NCT00371111|Triamcinolone|triamcinolone|mesh-list
64690008|NCT00371111|Bevacizumab|bevacizumab|mesh-list
64690009|NCT00371111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64690010|NCT00371111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690011|NCT00371111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64690013|NCT00371111|Growth Substances|growth substances|mesh-ancestor
64690014|NCT00371111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690015|NCT00371111|Growth Inhibitors|growth inhibitors|mesh-ancestor
64690016|NCT00371111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64690017|NCT00371111|Glucocorticoids|glucocorticoids|mesh-ancestor
64690018|NCT00371111|Hormones|hormones|mesh-ancestor
64690019|NCT00371111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64690020|NCT05454683|Melatonin|melatonin|mesh-list
64690028|NCT05193071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64690029|NCT05193071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64690030|NCT05193071|Analgesics|analgesics|mesh-ancestor
64690031|NCT05193071|Sensory System Agents|sensory system agents|mesh-ancestor
64690032|NCT05193071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690033|NCT05193071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690034|NCT05193071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64690035|NCT05193071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64690036|NCT05193071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64690053|NCT05180825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690054|NCT05180825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64690056|NCT05180825|Antimitotic Agents|antimitotic agents|mesh-ancestor
64690057|NCT05180825|Mitosis Modulators|mitosis modulators|mesh-ancestor
64690058|NCT05139095|Apatinib|apatinib|mesh-list
64690059|NCT05139095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690060|NCT05139095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64690061|NCT05139095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64717262|NCT03852524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717264|NCT04081610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64717265|NCT04081610|Immunologic Factors|immunologic factors|mesh-ancestor
64717266|NCT04081610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717267|NCT04081610|Viscosupplements|viscosupplements|mesh-ancestor
64690062|NCT05139095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690063|NCT05453435|Entecavir|entecavir|mesh-list
64690064|NCT05453435|Antiviral Agents|antiviral agents|mesh-ancestor
64690065|NCT05453435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64690066|NCT03029845|Propranolol|propranolol|mesh-list
64690067|NCT03029845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64690068|NCT03029845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64690069|NCT03029845|Adrenergic Agents|adrenergic agents|mesh-ancestor
64690070|NCT03029845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64690071|NCT03029845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454496|NCT01150630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454497|NCT01150630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65454498|NCT01150630|Antimetabolites|antimetabolites|mesh-ancestor
65454499|NCT01150630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454500|NCT01150630|Antiviral Agents|antiviral agents|mesh-ancestor
65454501|NCT01150630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65454502|NCT01150630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454503|NCT01150630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65454504|NCT01150630|Immunologic Factors|immunologic factors|mesh-ancestor
65454505|NCT01150630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454506|NCT01150630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65454507|NCT01150630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65454508|NCT01150630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65454509|NCT00189306|Imiquimod|imiquimod|mesh-list
65454510|NCT00189306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64839066|NCT01629511|Gemcitabine|gemcitabine|mesh-list
64690072|NCT03029845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690073|NCT03029845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64690074|NCT03029845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64690075|NCT03029845|Vasodilator Agents|vasodilator agents|mesh-ancestor
64690076|NCT05451719|Capecitabine|capecitabine|mesh-list
64690077|NCT05451719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64690078|NCT05451719|Antimetabolites|antimetabolites|mesh-ancestor
64690079|NCT05451719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690080|NCT05451719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690081|NCT01955629|Capecitabine|capecitabine|mesh-list
64690082|NCT01955629|Oxaliplatin|oxaliplatin|mesh-list
64690083|NCT01955629|Aflibercept|aflibercept|mesh-list
64690084|NCT01955629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64690085|NCT01955629|Antimetabolites|antimetabolites|mesh-ancestor
64690086|NCT01955629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690087|NCT01955629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690088|NCT01955629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64690089|NCT01955629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64690090|NCT01955629|Growth Substances|growth substances|mesh-ancestor
64690091|NCT01955629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690092|NCT01955629|Growth Inhibitors|growth inhibitors|mesh-ancestor
64690094|NCT01898689|Anesthetics, Local|anesthetics, local|mesh-ancestor
64690111|NCT05062577|Narcotics|narcotics|mesh-ancestor
64690112|NCT05062577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64690113|NCT05062577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690114|NCT05062577|Analgesics|analgesics|mesh-ancestor
64690115|NCT05062577|Sensory System Agents|sensory system agents|mesh-ancestor
64690116|NCT05062577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690123|NCT05448989|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64690124|NCT05448989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64690125|NCT05448989|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64690126|NCT05448989|Autonomic Agents|autonomic agents|mesh-ancestor
64690127|NCT05448989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690128|NCT05448989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690129|NCT05448989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64690130|NCT05448989|Respiratory System Agents|respiratory system agents|mesh-ancestor
64690131|NCT05448989|Mydriatics|mydriatics|mesh-ancestor
64690132|NCT05448989|Parasympatholytics|parasympatholytics|mesh-ancestor
64690133|NCT05448989|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64690134|NCT05448989|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64690135|NCT05448989|Cholinergic Agents|cholinergic agents|mesh-ancestor
64690136|NCT05448989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64690137|NCT05448989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454511|NCT00189306|Immunologic Factors|immunologic factors|mesh-ancestor
65454512|NCT00189306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454513|NCT00189306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454514|NCT00189306|Interferon Inducers|interferon inducers|mesh-ancestor
65454515|NCT03898336|Micronutrients|micronutrients|mesh-list
65454516|NCT03898336|Trace Elements|trace elements|mesh-list
65454517|NCT03898336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454519|NCT03972462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65454520|NCT03972462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65454521|NCT03972462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65454522|NCT03972462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454523|NCT03972462|Antifungal Agents|antifungal agents|mesh-ancestor
65454524|NCT03972462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65454525|NCT03972462|Immunologic Factors|immunologic factors|mesh-ancestor
65454526|NCT03972462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454527|NCT01150786|Selenium|selenium|mesh-list
65454528|NCT01150786|Antioxidants|antioxidants|mesh-ancestor
65454529|NCT01150786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454530|NCT01150786|Protective Agents|protective agents|mesh-ancestor
65454531|NCT01150786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454532|NCT01150786|Trace Elements|trace elements|mesh-ancestor
65454533|NCT01150786|Micronutrients|micronutrients|mesh-ancestor
65454534|NCT03909724|Sunitinib|sunitinib|mesh-list
65454535|NCT03909724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839096|NCT01629628|Adalimumab|adalimumab|mesh-list
64690139|NCT00370565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64690140|NCT00370565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64690141|NCT00370565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690142|NCT05039723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64717268|NCT04081610|Protective Agents|protective agents|mesh-ancestor
64717269|NCT03840278|Pancrelipase|pancrelipase|mesh-list
64717270|NCT03840278|Pancreatin|pancreatin|mesh-list
64717271|NCT03840278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64717272|NCT03838874|Bupivacaine|bupivacaine|mesh-list
64717273|NCT03838874|Mepivacaine|mepivacaine|mesh-list
64717274|NCT03838874|Anesthetics, Local|anesthetics, local|mesh-ancestor
64717275|NCT03838874|Anesthetics|anesthetics|mesh-ancestor
64690143|NCT05039723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64690144|NCT05039723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690145|NCT05039723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690146|NCT05039723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64690147|NCT05039723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64690148|NCT05039723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690149|NCT05039723|Cholinergic Agents|cholinergic agents|mesh-ancestor
64690150|NCT05039723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64690151|NCT03970655|Dexamethasone|dexamethasone|mesh-list
64690152|NCT03970655|Dexamethasone acetate|dexamethasone acetate|mesh-list
64690153|NCT03970655|Epinephrine|epinephrine|mesh-list
64690154|NCT03970655|Racepinephrine|racepinephrine|mesh-list
64690181|NCT03970655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64690182|NCT03970655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64690183|NCT03970655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64690184|NCT03970655|Respiratory System Agents|respiratory system agents|mesh-ancestor
65454536|NCT03909724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65454537|NCT03909724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65454538|NCT03909724|Growth Substances|growth substances|mesh-ancestor
65454539|NCT03909724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454540|NCT03909724|Growth Inhibitors|growth inhibitors|mesh-ancestor
65454541|NCT03909724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65454542|NCT03909724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454543|NCT03909724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454544|NCT03909646|Fluorouracil|fluorouracil|mesh-list
65454545|NCT03909646|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65454546|NCT03909646|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65454547|NCT03909646|Antimetabolites|antimetabolites|mesh-ancestor
65454548|NCT03909646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454549|NCT03909646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65454550|NCT03909646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454551|NCT03909646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65454552|NCT03909646|Immunologic Factors|immunologic factors|mesh-ancestor
65454553|NCT03909646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454554|NCT03909646|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65454555|NCT03909646|Dermatologic Agents|dermatologic agents|mesh-ancestor
65454556|NCT01256866|Midazolam|midazolam|mesh-list
65454557|NCT01256866|Dexmedetomidine|dexmedetomidine|mesh-list
65454558|NCT01256866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65454559|NCT01256866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65454560|NCT01256866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839109|NCT01629680|Moxaverine|moxaverine|mesh-list
64690185|NCT03970655|Mydriatics|mydriatics|mesh-ancestor
64690186|NCT03970655|Sympathomimetics|sympathomimetics|mesh-ancestor
64690187|NCT03970655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64690188|NCT00370019|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64690189|NCT00370019|Medroxyprogesterone|medroxyprogesterone|mesh-list
64690190|NCT00370019|Estradiol|estradiol|mesh-list
64690191|NCT00370019|Estrogens|estrogens|mesh-ancestor
64690192|NCT00370019|Hormones|hormones|mesh-ancestor
64690193|NCT00370019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64690194|NCT00370019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690195|NCT00370019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64690196|NCT00370019|Contraceptive Agents|contraceptive agents|mesh-ancestor
64690197|NCT00370019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64690198|NCT00370019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64690199|NCT00370019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64690200|NCT00370019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64690201|NCT00370019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64415536|NCT05100017|Cholinergic Agents|cholinergic agents|mesh-ancestor
64690235|NCT03754049|Hormones|hormones|mesh-ancestor
64690236|NCT03754049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64690237|NCT03754049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65454561|NCT01256866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65454562|NCT01256866|Analgesics|analgesics|mesh-ancestor
65454563|NCT01256866|Sensory System Agents|sensory system agents|mesh-ancestor
65454564|NCT01256866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65454565|NCT01256866|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65454566|NCT01256866|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65454567|NCT01256866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65454568|NCT01256866|Adrenergic Agents|adrenergic agents|mesh-ancestor
65454569|NCT01256866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65454570|NCT01256866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454571|NCT01256866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65454572|NCT01256866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65454573|NCT01256866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65454574|NCT01256866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65454575|NCT01256866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65454576|NCT01256866|Anesthetics, General|anesthetics, general|mesh-ancestor
65454577|NCT01256866|Anesthetics|anesthetics|mesh-ancestor
65454578|NCT01256866|GABA Modulators|gaba modulators|mesh-ancestor
65454579|NCT01256866|GABA Agents|gaba agents|mesh-ancestor
65454580|NCT03908944|Methadone|methadone|mesh-list
65454581|NCT03908944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65454582|NCT03908944|Narcotics|narcotics|mesh-ancestor
65454583|NCT03908944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65454584|NCT03908944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454585|NCT03908944|Analgesics|analgesics|mesh-ancestor
65454586|NCT03908944|Sensory System Agents|sensory system agents|mesh-ancestor
65454587|NCT03908944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65454588|NCT03908944|Antitussive Agents|antitussive agents|mesh-ancestor
65454589|NCT03908944|Respiratory System Agents|respiratory system agents|mesh-ancestor
65454590|NCT03899506|Midazolam|midazolam|mesh-list
65454591|NCT03899506|Olanzapine|olanzapine|mesh-list
65454592|NCT03899506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65454593|NCT03899506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65454594|NCT03899506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65454595|NCT03899506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454596|NCT03899506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64690264|NCT05005403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690265|NCT03029533|Leuprolide|leuprolide|mesh-list
64690266|NCT03029533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64690267|NCT03029533|Fertility Agents|fertility agents|mesh-ancestor
65454597|NCT03899506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65454598|NCT03899506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65454599|NCT03899506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65454600|NCT03899506|Anesthetics, General|anesthetics, general|mesh-ancestor
65454601|NCT03899506|Anesthetics|anesthetics|mesh-ancestor
65454602|NCT03899506|GABA Modulators|gaba modulators|mesh-ancestor
65454603|NCT03899506|GABA Agents|gaba agents|mesh-ancestor
65454604|NCT03899506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65454605|NCT03899506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454606|NCT03899506|Antiemetics|antiemetics|mesh-ancestor
65454607|NCT03899506|Autonomic Agents|autonomic agents|mesh-ancestor
65454608|NCT03899506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65454609|NCT03899506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65454610|NCT03899506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65454611|NCT03899506|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65454612|NCT03899506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64839164|NCT01630083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64839165|NCT01630083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839166|NCT01630096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64839167|NCT01630096|Laxatives|laxatives|mesh-ancestor
64839168|NCT01630096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64839169|NCT01630148|Bemiparin|bemiparin|mesh-list
64839170|NCT01630148|Anticoagulants|anticoagulants|mesh-ancestor
64839171|NCT01630187|Carbetocin|carbetocin|mesh-list
64839172|NCT01630187|Oxytocin|oxytocin|mesh-list
64839173|NCT01630187|Oxytocics|oxytocics|mesh-ancestor
64839174|NCT01630187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64839175|NCT01630187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839176|NCT01630226|Cisplatin|cisplatin|mesh-list
64839177|NCT01630226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839178|NCT01630278|Ibuprofen|ibuprofen|mesh-list
64839179|NCT01630278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64839180|NCT01630278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65454613|NCT03899506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65454614|NCT03899506|Serotonin Agents|serotonin agents|mesh-ancestor
65454615|NCT03896932|Immunoglobulins|immunoglobulins|mesh-list
65454616|NCT03896932|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65454617|NCT03896932|Antibodies|antibodies|mesh-list
65454618|NCT03896932|gamma-Globulins|gamma-globulins|mesh-list
65454619|NCT03896932|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65454620|NCT03896932|Immunologic Factors|immunologic factors|mesh-ancestor
65454621|NCT03896932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454622|NCT01257334|Empagliflozin|empagliflozin|mesh-list
65454623|NCT01257334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65454624|NCT01257334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454625|NCT01257334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65454626|NCT01257334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454627|NCT01151176|Insulin|insulin|mesh-list
65454628|NCT01151176|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65454629|NCT01151176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65454630|NCT01151176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454631|NCT01257412|Dapagliflozin|dapagliflozin|mesh-list
65454632|NCT01257412|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65454633|NCT01257412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454634|NCT01257412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64839190|NCT01630343|Acetaminophen|acetaminophen|mesh-list
64690268|NCT03029533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64690269|NCT03029533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690270|NCT03029533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64690271|NCT03029533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690272|NCT04921007|Bupivacaine|bupivacaine|mesh-list
64690273|NCT04921007|Anesthetics, Local|anesthetics, local|mesh-ancestor
64690274|NCT04921007|Anesthetics|anesthetics|mesh-ancestor
64690275|NCT04921007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64690276|NCT04921007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690277|NCT04921007|Sensory System Agents|sensory system agents|mesh-ancestor
64690278|NCT04921007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717276|NCT03838874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717277|NCT03838874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717278|NCT03838874|Sensory System Agents|sensory system agents|mesh-ancestor
64717279|NCT03838874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717280|NCT04045964|Nicotine|nicotine|mesh-list
64717281|NCT04045964|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64717282|NCT04045964|Autonomic Agents|autonomic agents|mesh-ancestor
64325509|NCT01309945|Antidepressive Agents|antidepressive agents|mesh-ancestor
64690279|NCT01904071|Morphine|morphine|mesh-list
64690280|NCT01904071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64690281|NCT01904071|Narcotics|narcotics|mesh-ancestor
64690282|NCT01904071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64690283|NCT01904071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690284|NCT01904071|Analgesics|analgesics|mesh-ancestor
64690285|NCT01904071|Sensory System Agents|sensory system agents|mesh-ancestor
64484492|NCT01976507|Antithrombins|antithrombins|mesh-ancestor
64690299|NCT04903223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64690300|NCT04903223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65454635|NCT01257412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454636|NCT01257490|Bupropion|bupropion|mesh-list
65454637|NCT01257490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65454638|NCT01257490|Antidepressive Agents|antidepressive agents|mesh-ancestor
65454639|NCT01257490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65454640|NCT01257490|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65454641|NCT01257490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65454642|NCT01257490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65454643|NCT01257490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454644|NCT01257490|Dopamine Agents|dopamine agents|mesh-ancestor
65454645|NCT01257490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65454646|NCT01257490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454647|NCT01257490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65454648|NCT01257490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65454649|NCT01257490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454650|NCT03894280|Fluticasone|fluticasone|mesh-list
65454652|NCT03894280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65454653|NCT03894280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65454654|NCT03894280|Charcoal|charcoal|mesh-list
65454655|NCT03894280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65454656|NCT03894280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65454657|NCT03894280|Autonomic Agents|autonomic agents|mesh-ancestor
65454658|NCT03894280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65454659|NCT03894280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454660|NCT03894280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65454661|NCT03894280|Respiratory System Agents|respiratory system agents|mesh-ancestor
65454662|NCT03894280|Dermatologic Agents|dermatologic agents|mesh-ancestor
65454663|NCT03894280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65454664|NCT03894280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65454665|NCT03894280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65204142|NCT04527549|Antioxidants|antioxidants|mesh-ancestor
65454666|NCT03894280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64690301|NCT04903223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690302|NCT01907113|Empagliflozin|empagliflozin|mesh-list
64690303|NCT01907113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64690304|NCT01907113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690305|NCT01907113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64690306|NCT01907113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690307|NCT00370643|Insulin|insulin|mesh-list
64690308|NCT00370643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65454667|NCT03894280|Adrenergic Agents|adrenergic agents|mesh-ancestor
65454668|NCT03894280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65454669|NCT03894280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454670|NCT03894280|Glucocorticoids|glucocorticoids|mesh-ancestor
65454671|NCT03894280|Hormones|hormones|mesh-ancestor
65454672|NCT03894280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65454673|NCT03894280|Sympathomimetics|sympathomimetics|mesh-ancestor
65454674|NCT03894280|Antidotes|antidotes|mesh-ancestor
65454675|NCT03894280|Protective Agents|protective agents|mesh-ancestor
65454676|NCT03899584|4-Aminopyridine|4-aminopyridine|mesh-list
65454677|NCT03899584|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65454678|NCT03899584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65454679|NCT03899584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454680|NCT01150162|Omeprazole|omeprazole|mesh-list
65454681|NCT01150162|Rebamipide|rebamipide|mesh-list
65454682|NCT01150162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64839236|NCT01630655|Felodipine|felodipine|mesh-list
64839244|NCT01630655|Vasodilator Agents|vasodilator agents|mesh-ancestor
64415612|NCT04876261|Protective Agents|protective agents|mesh-ancestor
64690309|NCT00370643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64690310|NCT00370643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690311|NCT01908127|Salicylic Acid|salicylic acid|mesh-list
64690312|NCT01908127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64690313|NCT01908127|Antifungal Agents|antifungal agents|mesh-ancestor
64690325|NCT01908751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690326|NCT01908751|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64690327|NCT01908751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64690328|NCT00370721|Bevacizumab|bevacizumab|mesh-list
64690329|NCT00370721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64690330|NCT00370721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690331|NCT00370721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64690332|NCT00370721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64690333|NCT00370721|Growth Substances|growth substances|mesh-ancestor
64690346|NCT01909141|Progesterone|progesterone|mesh-list
64690347|NCT01909141|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64690348|NCT01909141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64690349|NCT01909141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690350|NCT01909141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690351|NCT01909141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64690352|NCT01909141|Estrogens|estrogens|mesh-ancestor
64690353|NCT01909141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64690354|NCT01909141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690355|NCT01909141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64690356|NCT01909141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64690357|NCT01909141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690358|NCT01909141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64690359|NCT01909141|Hormone Antagonists|hormone antagonists|mesh-ancestor
64690360|NCT01909141|Androgens|androgens|mesh-ancestor
64690361|NCT01909141|Progestins|progestins|mesh-ancestor
64717283|NCT04045964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717284|NCT04045964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717285|NCT04045964|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64690362|NCT01909141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64690363|NCT01909141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64690364|NCT01909141|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64690365|NCT01909141|Fertility Agents|fertility agents|mesh-ancestor
64690366|NCT01909141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65454683|NCT01150162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65454684|NCT01150162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65454685|NCT01150162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454686|NCT01150162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454687|NCT01150162|Antioxidants|antioxidants|mesh-ancestor
65454688|NCT01150162|Protective Agents|protective agents|mesh-ancestor
65454689|NCT01150162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454690|NCT03893734|Methadone|methadone|mesh-list
65454691|NCT03893734|Hydromorphone|hydromorphone|mesh-list
65454692|NCT03893734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65454693|NCT03893734|Narcotics|narcotics|mesh-ancestor
65454694|NCT03893734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65454695|NCT03893734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454696|NCT03893734|Analgesics|analgesics|mesh-ancestor
65454697|NCT03893734|Sensory System Agents|sensory system agents|mesh-ancestor
65454698|NCT03893734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65454699|NCT03893734|Antitussive Agents|antitussive agents|mesh-ancestor
65454700|NCT03893734|Respiratory System Agents|respiratory system agents|mesh-ancestor
65454701|NCT03899194|Citalopram|citalopram|mesh-list
65454702|NCT03899194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65454703|NCT03899194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64839251|NCT01630733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690367|NCT01909141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64690368|NCT04527887|Dexamethasone|dexamethasone|mesh-list
64690369|NCT04527887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64690370|NCT04527887|Antiemetics|antiemetics|mesh-ancestor
64690371|NCT04527887|Autonomic Agents|autonomic agents|mesh-ancestor
64690372|NCT04527887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690373|NCT04527887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690374|NCT04527887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64690375|NCT04527887|Glucocorticoids|glucocorticoids|mesh-ancestor
64690376|NCT04527887|Hormones|hormones|mesh-ancestor
64690377|NCT04527887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64690378|NCT04527887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64690379|NCT04527887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690380|NCT04486859|Rivaroxaban|rivaroxaban|mesh-list
64690381|NCT04486859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64690382|NCT04486859|Antithrombins|antithrombins|mesh-ancestor
64690391|NCT01910311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64690392|NCT01910311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64690393|NCT01910311|Leprostatic Agents|leprostatic agents|mesh-ancestor
64690394|NCT01910311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64690395|NCT01910311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690396|NCT01910311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690397|NCT01910311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64690398|NCT01910311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64690399|NCT01910311|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64690400|NCT01910311|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64690401|NCT01910311|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64690402|NCT01910311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64690403|NCT04404959|Ropivacaine|ropivacaine|mesh-list
64690404|NCT04404959|Anesthetics|anesthetics|mesh-list
64690410|NCT04403711|Dexmedetomidine|dexmedetomidine|mesh-list
65454704|NCT03899194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65454705|NCT03899194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454706|NCT03899194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65454707|NCT03899194|Serotonin Agents|serotonin agents|mesh-ancestor
65454708|NCT03899194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454709|NCT03899194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65454710|NCT03899194|Antidepressive Agents|antidepressive agents|mesh-ancestor
65454711|NCT03899194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65454712|NCT01151800|Benzocaine|benzocaine|mesh-list
65454713|NCT01151800|Anesthetics, Local|anesthetics, local|mesh-ancestor
65454714|NCT01151800|Anesthetics|anesthetics|mesh-ancestor
65454715|NCT01151800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65454716|NCT01151800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454717|NCT01151800|Sensory System Agents|sensory system agents|mesh-ancestor
65454718|NCT01151800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65454719|NCT03896074|Bevacizumab|bevacizumab|mesh-list
65454720|NCT03896074|Atezolizumab|atezolizumab|mesh-list
65454721|NCT03896074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65454722|NCT03896074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454723|NCT03896074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65454724|NCT03896074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65454725|NCT03896074|Growth Substances|growth substances|mesh-ancestor
65454726|NCT03896074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454727|NCT03896074|Growth Inhibitors|growth inhibitors|mesh-ancestor
65454728|NCT03899038|Anesthetics|anesthetics|mesh-list
65454729|NCT03899038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65454730|NCT03899038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454731|NCT01151878|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
65454732|NCT01151878|Cathartics|cathartics|mesh-ancestor
65454733|NCT01151878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65454734|NCT03898882|Oxytocin|oxytocin|mesh-list
65454735|NCT03898882|Oxytocics|oxytocics|mesh-ancestor
65454736|NCT03898882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65454737|NCT03898882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690412|NCT04403711|Anesthetics, Local|anesthetics, local|mesh-list
64690413|NCT04403711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64690414|NCT04403711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64690415|NCT04403711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690416|NCT04403711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65454738|NCT01151254|Propofol|propofol|mesh-list
65454739|NCT01151254|Sevoflurane|sevoflurane|mesh-list
65454740|NCT01151254|Isoflurane|isoflurane|mesh-list
65454741|NCT01151254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65454742|NCT01151254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65454743|NCT01151254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454744|NCT01151254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65454745|NCT01151254|Anesthetics, General|anesthetics, general|mesh-ancestor
65454746|NCT01151254|Anesthetics|anesthetics|mesh-ancestor
65454747|NCT01151254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65454748|NCT01151254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65454749|NCT01255774|Ranibizumab|ranibizumab|mesh-list
65454750|NCT01255774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64839304|NCT01631136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64690417|NCT04403711|Analgesics|analgesics|mesh-ancestor
64690418|NCT04403711|Sensory System Agents|sensory system agents|mesh-ancestor
64690419|NCT04403711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690420|NCT04403711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64690421|NCT04403711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64690422|NCT04403711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64690423|NCT04403711|Adrenergic Agents|adrenergic agents|mesh-ancestor
64690424|NCT04403711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64690425|NCT04403711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690426|NCT01911169|Vitamin D|vitamin d|mesh-list
64690427|NCT01911169|Cholecalciferol|cholecalciferol|mesh-list
64690428|NCT01911169|Vitamins|vitamins|mesh-list
64690429|NCT01911169|Micronutrients|micronutrients|mesh-ancestor
64690430|NCT01911169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690431|NCT01911169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64690432|NCT01911169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64690433|NCT04403087|Trimebutine|trimebutine|mesh-list
64690434|NCT04403087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64690435|NCT04403087|Parasympatholytics|parasympatholytics|mesh-ancestor
64690436|NCT04403087|Autonomic Agents|autonomic agents|mesh-ancestor
64717286|NCT04045964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64717287|NCT04045964|Cholinergic Agents|cholinergic agents|mesh-ancestor
64717288|NCT04045964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64717289|NCT04045964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717290|NCT05314400|Liver Extracts|liver extracts|mesh-list
64717291|NCT05314400|Hematinics|hematinics|mesh-ancestor
64717292|NCT04039412|Levofloxacin|levofloxacin|mesh-list
64717293|NCT04039412|Ofloxacin|ofloxacin|mesh-list
64690437|NCT04403087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690438|NCT04403087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690439|NCT04389671|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64690440|NCT04389671|Respiratory System Agents|respiratory system agents|mesh-ancestor
64690441|NCT04358393|Azacitidine|azacitidine|mesh-list
64690442|NCT04358393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64690443|NCT04358393|Antimetabolites|antimetabolites|mesh-ancestor
64690444|NCT04358393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690445|NCT04358393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690446|NCT04358393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690447|NCT04748887|Superoxide Dismutase|superoxide dismutase|mesh-list
64690448|NCT04748887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64690449|NCT04748887|Antioxidants|antioxidants|mesh-ancestor
64415759|NCT05531123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690460|NCT03298451|Tremelimumab|tremelimumab|mesh-list
64690461|NCT03298451|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64690462|NCT03298451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690463|NCT03298451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64690464|NCT03298451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690465|NCT03298451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690466|NCT03298451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65454751|NCT01255774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65454752|NCT01255774|Growth Substances|growth substances|mesh-ancestor
65454753|NCT01255774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454754|NCT01255774|Growth Inhibitors|growth inhibitors|mesh-ancestor
65454755|NCT01255774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454756|NCT01255852|Atorvastatin|atorvastatin|mesh-list
65454757|NCT01255852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65454758|NCT01255852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65454759|NCT01255852|Antimetabolites|antimetabolites|mesh-ancestor
65454760|NCT01255852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454761|NCT01255852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65454762|NCT01255852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65454763|NCT01255852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454764|NCT03895528|Lonafarnib|lonafarnib|mesh-list
65454765|NCT03895528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839317|NCT01631305|Antacids|antacids|mesh-ancestor
64690467|NCT03298451|Immunologic Factors|immunologic factors|mesh-ancestor
64690468|NCT03298451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690469|NCT01916941|Prazosin|prazosin|mesh-list
64690470|NCT01916941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64690471|NCT01916941|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64690472|NCT01916941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64690473|NCT01916941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64690474|NCT01916941|Adrenergic Agents|adrenergic agents|mesh-ancestor
64690486|NCT05732701|Autonomic Agents|autonomic agents|mesh-ancestor
64690487|NCT05732701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690488|NCT05732701|Nasal Decongestants|nasal decongestants|mesh-ancestor
64690489|NCT05732701|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64690490|NCT05732701|Respiratory System Agents|respiratory system agents|mesh-ancestor
64690491|NCT04768985|Acalabrutinib|acalabrutinib|mesh-list
64690492|NCT04768985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690493|NCT04210037|Paclitaxel|paclitaxel|mesh-list
64690494|NCT04210037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64690495|NCT04210037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690496|NCT04210037|Tubulin Modulators|tubulin modulators|mesh-ancestor
64690497|NCT04210037|Antimitotic Agents|antimitotic agents|mesh-ancestor
64690498|NCT04210037|Mitosis Modulators|mitosis modulators|mesh-ancestor
64690499|NCT04210037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690500|NCT04184609|Bromides|bromides|mesh-list
64690501|NCT04184609|Albuterol|albuterol|mesh-list
64690502|NCT04184609|Ipratropium|ipratropium|mesh-list
64690503|NCT04184609|Anticonvulsants|anticonvulsants|mesh-ancestor
64690504|NCT04184609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64690505|NCT04184609|Autonomic Agents|autonomic agents|mesh-ancestor
64717294|NCT04039412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64717295|NCT04039412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64717297|NCT04039412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64717298|NCT04039412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64717299|NCT04039412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64325529|NCT01303783|Candesartan|candesartan|mesh-list
64690506|NCT04184609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690507|NCT04184609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690508|NCT04184609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64690509|NCT04184609|Respiratory System Agents|respiratory system agents|mesh-ancestor
64690510|NCT04184609|Tocolytic Agents|tocolytic agents|mesh-ancestor
64690511|NCT04184609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64690512|NCT04184609|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64690523|NCT03273023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64690524|NCT03273023|Immunologic Factors|immunologic factors|mesh-ancestor
65454766|NCT03895528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454767|NCT01257958|Vitamin D|vitamin d|mesh-list
65454768|NCT01257958|Vitamins|vitamins|mesh-ancestor
65454769|NCT01257958|Micronutrients|micronutrients|mesh-ancestor
65454770|NCT01257958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454771|NCT01257958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65454772|NCT03893032|Modafinil|modafinil|mesh-list
65454773|NCT03893032|Amphetamine|amphetamine|mesh-list
65454774|NCT03893032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65454775|NCT03893032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454776|NCT03893032|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65454777|NCT03893032|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65454778|NCT03893032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65454779|NCT03893032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454780|NCT03893032|Sympathomimetics|sympathomimetics|mesh-ancestor
65454781|NCT03893032|Autonomic Agents|autonomic agents|mesh-ancestor
64690525|NCT03273023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690526|NCT03273023|Trace Elements|trace elements|mesh-ancestor
64690527|NCT03273023|Micronutrients|micronutrients|mesh-ancestor
64690528|NCT00371501|Aspirin|aspirin|mesh-list
64690529|NCT00371501|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64690530|NCT00371501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64690531|NCT00371501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64690532|NCT00371501|Analgesics|analgesics|mesh-ancestor
64690533|NCT00371501|Sensory System Agents|sensory system agents|mesh-ancestor
64690534|NCT00371501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690535|NCT00371501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690536|NCT00371501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64690537|NCT00371501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64690538|NCT00371501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64690539|NCT00371501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64690540|NCT00371501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690541|NCT00371501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64690547|NCT00371501|Antimetabolites|antimetabolites|mesh-ancestor
64690548|NCT00371501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64690549|NCT00371501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64690550|NCT03251651|Dexmedetomidine|dexmedetomidine|mesh-list
64690551|NCT03251651|Propofol|propofol|mesh-list
64690552|NCT03251651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64690553|NCT03251651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64690554|NCT03251651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690555|NCT03251651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64690556|NCT03251651|Anesthetics, General|anesthetics, general|mesh-ancestor
64690557|NCT03251651|Anesthetics|anesthetics|mesh-ancestor
64690558|NCT03251651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64690559|NCT03251651|Analgesics|analgesics|mesh-ancestor
64690560|NCT03251651|Sensory System Agents|sensory system agents|mesh-ancestor
64690561|NCT03251651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690562|NCT03251651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64690563|NCT03251651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64690564|NCT03251651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64690565|NCT03251651|Adrenergic Agents|adrenergic agents|mesh-ancestor
64690566|NCT03251651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64690567|NCT03251651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690568|NCT05738707|Vaccines|vaccines|mesh-list
64690569|NCT05738707|Immunologic Factors|immunologic factors|mesh-ancestor
64690570|NCT05738707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454782|NCT03893032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65454783|NCT03893032|Dopamine Agents|dopamine agents|mesh-ancestor
65454784|NCT03893032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65454785|NCT03893032|Adrenergic Agents|adrenergic agents|mesh-ancestor
65454786|NCT03893032|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65454787|NCT03893032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65454788|NCT03893032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65454789|NCT03893032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65454790|NCT01258036|Hormones|hormones|mesh-list
65454791|NCT01258036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65454792|NCT01258036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454793|NCT03889366|Aprepitant|aprepitant|mesh-list
65454794|NCT03889366|Antiemetics|antiemetics|mesh-ancestor
65454795|NCT03889366|Autonomic Agents|autonomic agents|mesh-ancestor
65454796|NCT03889366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65454797|NCT03889366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454798|NCT03889366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65454799|NCT03889366|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65454800|NCT03889366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65454801|NCT03889366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454802|NCT03894826|Vorinostat|vorinostat|mesh-list
65454803|NCT03894826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454804|NCT03894826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65454805|NCT03894826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690571|NCT05738629|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64690572|NCT05738629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64690573|NCT05349071|Methylprednisolone|methylprednisolone|mesh-list
64690574|NCT05349071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64690575|NCT05349071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64690576|NCT05349071|Prednisolone|prednisolone|mesh-list
64717300|NCT04039412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64717301|NCT04039412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717302|NCT04039412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64717303|NCT04039412|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64717304|NCT04039412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64690577|NCT05349071|Prednisolone acetate|prednisolone acetate|mesh-list
64690578|NCT05349071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64690603|NCT04335461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64690604|NCT04335461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690605|NCT04335461|Sensory System Agents|sensory system agents|mesh-ancestor
64690606|NCT04335461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690608|NCT05725135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64690609|NCT05725135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64690610|NCT05725135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690611|NCT05725135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64690612|NCT05725135|Anesthetics, General|anesthetics, general|mesh-ancestor
64690613|NCT05725135|Anesthetics|anesthetics|mesh-ancestor
64690614|NCT05738317|Paclitaxel|paclitaxel|mesh-list
64690615|NCT05738317|Bevacizumab|bevacizumab|mesh-list
65454806|NCT03894826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454807|NCT03894748|Botulinum Toxins|botulinum toxins|mesh-list
65454808|NCT03894748|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65454809|NCT03894748|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65454810|NCT03894748|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65454811|NCT03894748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65454812|NCT03894748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454813|NCT03894748|Cholinergic Agents|cholinergic agents|mesh-ancestor
65454814|NCT03894748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65454815|NCT03894748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454817|NCT03894748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65454818|NCT01153750|Imatinib Mesylate|imatinib mesylate|mesh-list
65454819|NCT01153750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454820|NCT01153750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65454821|NCT01153750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454822|NCT01153750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454823|NCT03888664|Interferons|interferons|mesh-list
65454824|NCT03888664|Interferon-gamma|interferon-gamma|mesh-list
65454825|NCT03888664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454826|NCT03888664|Antiviral Agents|antiviral agents|mesh-ancestor
65454827|NCT03888664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65454828|NCT00256308|Oxaliplatin|oxaliplatin|mesh-list
65454829|NCT00256308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454830|NCT01153828|Mupirocin|mupirocin|mesh-list
65454831|NCT01153828|Retapamulin|retapamulin|mesh-list
65454832|NCT01153828|Fusidic Acid|fusidic acid|mesh-list
65454833|NCT01153828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65454834|NCT01153828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65454835|NCT01153828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65454836|NCT01153828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454851|NCT01258192|Antimitotic Agents|antimitotic agents|mesh-ancestor
65454852|NCT01258192|Mitosis Modulators|mitosis modulators|mesh-ancestor
65454853|NCT01258192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454854|NCT01326078|Propofol|propofol|mesh-list
65454855|NCT01326078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65454856|NCT01326078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65454857|NCT01326078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454858|NCT01326078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65454859|NCT01326078|Anesthetics, General|anesthetics, general|mesh-ancestor
65454860|NCT01326078|Anesthetics|anesthetics|mesh-ancestor
65454861|NCT01260376|Acipimox|acipimox|mesh-list
65454862|NCT01260376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65454863|NCT01260376|Antimetabolites|antimetabolites|mesh-ancestor
65454864|NCT01260376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454865|NCT01260376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65454866|NCT01259050|Copper|copper|mesh-list
65454867|NCT01259050|Trace Elements|trace elements|mesh-ancestor
65454868|NCT01259050|Micronutrients|micronutrients|mesh-ancestor
65454869|NCT01259050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454870|NCT00255840|Ritonavir|ritonavir|mesh-list
65454871|NCT00255840|Lopinavir|lopinavir|mesh-list
65454872|NCT00255840|Lamivudine|lamivudine|mesh-list
65454873|NCT00255840|Nevirapine|nevirapine|mesh-list
65454874|NCT00255840|Stavudine|stavudine|mesh-list
65454875|NCT00255840|Efavirenz|efavirenz|mesh-list
65454876|NCT00255840|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65454877|NCT00255840|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65454878|NCT00255840|Protease Inhibitors|protease inhibitors|mesh-ancestor
65454879|NCT00255840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690616|NCT05738317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64690617|NCT05738317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690618|NCT05738317|Tubulin Modulators|tubulin modulators|mesh-ancestor
64690619|NCT05738317|Antimitotic Agents|antimitotic agents|mesh-ancestor
64690620|NCT05738317|Mitosis Modulators|mitosis modulators|mesh-ancestor
64690621|NCT05738317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690622|NCT05738317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64690623|NCT05738317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64690624|NCT05738317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64690625|NCT05738317|Growth Substances|growth substances|mesh-ancestor
64690626|NCT05738317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690627|NCT05738317|Growth Inhibitors|growth inhibitors|mesh-ancestor
64690628|NCT02284555|Mupirocin|mupirocin|mesh-list
64690629|NCT02284555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64690650|NCT02287909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64690656|NCT02287909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690657|NCT02287909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690659|NCT04335383|Immunologic Factors|immunologic factors|mesh-ancestor
64690660|NCT04335383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690661|NCT00371579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64690662|NCT00371579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65454880|NCT00255840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454881|NCT00255840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65454882|NCT00255840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65454883|NCT00255840|Antiviral Agents|antiviral agents|mesh-ancestor
65454884|NCT00255840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65454885|NCT00255840|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65454886|NCT00255840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65454887|NCT00255840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65454888|NCT00255840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65454889|NCT00255840|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65454890|NCT00255840|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65454891|NCT00255840|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65454892|NCT00255840|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65454893|NCT00255840|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65454894|NCT00255840|Antimetabolites|antimetabolites|mesh-ancestor
65454895|NCT03972228|Antineoplastic Agents|antineoplastic agents|mesh-list
65454896|NCT00224874|Mycophenolic Acid|mycophenolic acid|mesh-list
65454897|NCT00224874|Etanercept|etanercept|mesh-list
64690663|NCT00371579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64690665|NCT00371579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690666|NCT00371579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64690667|NCT00371579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64690668|NCT00371579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690669|NCT02833805|Mycophenolic Acid|mycophenolic acid|mesh-list
64690670|NCT02833805|Cyclophosphamide|cyclophosphamide|mesh-list
64690671|NCT02833805|Fludarabine|fludarabine|mesh-list
64690672|NCT02833805|Tacrolimus|tacrolimus|mesh-list
64690673|NCT02833805|Thymoglobulin|thymoglobulin|mesh-list
64690674|NCT02833805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64690675|NCT02833805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64690676|NCT02833805|Immunologic Factors|immunologic factors|mesh-ancestor
64690677|NCT02833805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690678|NCT02833805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64690679|NCT02833805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64690680|NCT02833805|Alkylating Agents|alkylating agents|mesh-ancestor
64690681|NCT02833805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690682|NCT02833805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64717306|NCT03831854|Ketamine|ketamine|mesh-list
64717307|NCT03831854|Analgesics|analgesics|mesh-ancestor
64717308|NCT03831854|Sensory System Agents|sensory system agents|mesh-ancestor
64717309|NCT03831854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717310|NCT03831854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717311|NCT03831854|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64690697|NCT02327195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690699|NCT02327195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64690700|NCT04768465|Prednisone|prednisone|mesh-list
64690701|NCT04768465|Bromides|bromides|mesh-list
64690702|NCT04768465|Tacrolimus|tacrolimus|mesh-list
64690703|NCT04768465|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
64690704|NCT04768465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64690705|NCT04768465|Glucocorticoids|glucocorticoids|mesh-ancestor
64690706|NCT04768465|Hormones|hormones|mesh-ancestor
64690707|NCT04768465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64690708|NCT04768465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454898|NCT00224874|Pentostatin|pentostatin|mesh-list
65454899|NCT00224874|Denileukin diftitox|denileukin diftitox|mesh-list
65454900|NCT00224874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65454901|NCT00224874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454902|NCT00224874|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65454903|NCT00224874|Antitubercular Agents|antitubercular agents|mesh-ancestor
65454904|NCT00224874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65454905|NCT00224874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65454906|NCT00224874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454907|NCT00224874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454908|NCT00224874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65454909|NCT00224874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65454910|NCT00224874|Analgesics|analgesics|mesh-ancestor
65454911|NCT00224874|Sensory System Agents|sensory system agents|mesh-ancestor
65454912|NCT00224874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65454913|NCT00224874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454914|NCT00224874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65454915|NCT00224874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65454916|NCT00224874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64839459|NCT01631838|Antioxidants|antioxidants|mesh-ancestor
64690709|NCT04768465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64690710|NCT04768465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690711|NCT04768465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64690712|NCT04768465|Immunologic Factors|immunologic factors|mesh-ancestor
64690713|NCT04768465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64690714|NCT04768465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690715|NCT04768465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690716|NCT04768465|Anticonvulsants|anticonvulsants|mesh-ancestor
64690717|NCT04768465|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64690718|NCT04768465|Cholinergic Agents|cholinergic agents|mesh-ancestor
64690719|NCT04768465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64690720|NCT05448547|Hormones|hormones|mesh-list
64690721|NCT05448547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64690722|NCT05448547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690723|NCT01614665|Tacrolimus|tacrolimus|mesh-list
64690724|NCT01614665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64690725|NCT01614665|Immunologic Factors|immunologic factors|mesh-ancestor
64690726|NCT01614665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690727|NCT01614665|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64690728|NCT01614665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690731|NCT05691829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64690732|NCT05691829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690735|NCT00371735|Chlorproguanil|chlorproguanil|mesh-list
64690736|NCT00371735|Proguanil|proguanil|mesh-list
64690737|NCT00371735|Antimalarials|antimalarials|mesh-ancestor
64690738|NCT00371735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64690739|NCT00371735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64690740|NCT00371735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64690741|NCT00371735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690742|NCT00371735|Antiviral Agents|antiviral agents|mesh-ancestor
64690761|NCT05688475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64690763|NCT05688475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690764|NCT05052307|Vaccines|vaccines|mesh-list
64690765|NCT05052307|Immunologic Factors|immunologic factors|mesh-ancestor
65454917|NCT00224874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65454918|NCT00224874|Immunologic Factors|immunologic factors|mesh-ancestor
65454919|NCT00224874|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65454920|NCT03892330|Oxytetracycline|oxytetracycline|mesh-list
65454921|NCT03892330|Cyclophosphamide|cyclophosphamide|mesh-list
65454922|NCT03892330|Doxorubicin|doxorubicin|mesh-list
65454923|NCT03892330|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65454924|NCT03892330|Vincristine|vincristine|mesh-list
65454925|NCT03892330|Pirarubicin|pirarubicin|mesh-list
65454926|NCT03892330|Epirubicin|epirubicin|mesh-list
65454927|NCT03892330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65454928|NCT03892330|Immunologic Factors|immunologic factors|mesh-ancestor
65454929|NCT03892330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454930|NCT03892330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65454931|NCT03892330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65454932|NCT03892330|Alkylating Agents|alkylating agents|mesh-ancestor
65454933|NCT03892330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454934|NCT03892330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454935|NCT03892330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65454936|NCT03892330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65454937|NCT03892330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64690766|NCT05052307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690767|NCT05332457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64690768|NCT05332457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64690769|NCT05332457|Adrenergic Agents|adrenergic agents|mesh-ancestor
64690770|NCT05332457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64690771|NCT05332457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690772|NCT05332457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690774|NCT05417659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64690775|NCT05417659|Antimetabolites|antimetabolites|mesh-ancestor
64690776|NCT05417659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690777|NCT05417659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64690778|NCT05417659|Vasodilator Agents|vasodilator agents|mesh-ancestor
64717312|NCT03831854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64717313|NCT03831854|Anesthetics, General|anesthetics, general|mesh-ancestor
64717314|NCT03831854|Anesthetics|anesthetics|mesh-ancestor
64717315|NCT03831854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717316|NCT03831854|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64717317|NCT03831854|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64717318|NCT03831854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64717319|NCT03831854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717320|NCT03831854|Anticonvulsants|anticonvulsants|mesh-ancestor
64717321|NCT03831854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64325543|NCT02160587|Chlorhexidine|chlorhexidine|mesh-list
64690779|NCT05417659|Vitamin B Complex|vitamin b complex|mesh-ancestor
64690780|NCT05417659|Vitamins|vitamins|mesh-ancestor
64690781|NCT05417659|Micronutrients|micronutrients|mesh-ancestor
64690782|NCT05417659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690783|NCT02762513|Axitinib|axitinib|mesh-list
64690784|NCT02762513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690785|NCT02762513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64690786|NCT02762513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690787|NCT02762513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690788|NCT05668585|Trametinib|trametinib|mesh-list
65454938|NCT03892330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65454939|NCT03892330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454940|NCT03892330|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65454941|NCT03892330|Tubulin Modulators|tubulin modulators|mesh-ancestor
65454942|NCT03892330|Antimitotic Agents|antimitotic agents|mesh-ancestor
65454943|NCT03892330|Mitosis Modulators|mitosis modulators|mesh-ancestor
65454944|NCT03892330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65454945|NCT03892330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65454946|NCT00186186|Valproic Acid|valproic acid|mesh-list
65454947|NCT00186186|Anticonvulsants|anticonvulsants|mesh-ancestor
65454948|NCT00186186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454949|NCT00186186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454950|NCT00186186|GABA Agents|gaba agents|mesh-ancestor
65454951|NCT00186186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65454952|NCT00186186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454953|NCT00186186|Antimanic Agents|antimanic agents|mesh-ancestor
65454954|NCT00186186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65454955|NCT00186186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65454956|NCT00186186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65454957|NCT00185640|Cyclosporine|cyclosporine|mesh-list
65454958|NCT00185640|Mycophenolic Acid|mycophenolic acid|mesh-list
65454959|NCT00185640|Lenograstim|lenograstim|mesh-list
65454960|NCT00185640|Cyclosporins|cyclosporins|mesh-list
65454961|NCT00185640|Thymoglobulin|thymoglobulin|mesh-list
65454962|NCT00185640|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65454963|NCT00185640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65204445|NCT00652431|Vitamins|vitamins|mesh-ancestor
65454964|NCT00185640|Immunologic Factors|immunologic factors|mesh-ancestor
65454965|NCT00185640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454966|NCT00185640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454967|NCT00185640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65454968|NCT00185640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64690789|NCT05668585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690790|NCT05668585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64690791|NCT05668585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690792|NCT05668585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690793|NCT02958761|Hyaluronic Acid|hyaluronic acid|mesh-list
64690794|NCT02958761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64690795|NCT02958761|Immunologic Factors|immunologic factors|mesh-ancestor
64690796|NCT02958761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690797|NCT02958761|Viscosupplements|viscosupplements|mesh-ancestor
64690798|NCT02958761|Protective Agents|protective agents|mesh-ancestor
64690799|NCT05215535|Liver Extracts|liver extracts|mesh-list
64690800|NCT05215535|Hematinics|hematinics|mesh-ancestor
64690809|NCT02741687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65454969|NCT00185640|Antifungal Agents|antifungal agents|mesh-ancestor
65454970|NCT00185640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65454971|NCT00185640|Dermatologic Agents|dermatologic agents|mesh-ancestor
65454972|NCT00185640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65454973|NCT00185640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65454974|NCT00185640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65454975|NCT00185640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454976|NCT00185640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65454977|NCT00185640|Antitubercular Agents|antitubercular agents|mesh-ancestor
65454978|NCT00185640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65454979|NCT03885388|Dactinomycin|dactinomycin|mesh-list
65454980|NCT03885388|Methotrexate|methotrexate|mesh-list
65454981|NCT03885388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65454982|NCT03885388|Abortifacient Agents|abortifacient agents|mesh-ancestor
65454983|NCT03885388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65454984|NCT03885388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65454985|NCT03885388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65454986|NCT03885388|Antimetabolites|antimetabolites|mesh-ancestor
65454987|NCT03885388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690810|NCT02741687|Insulin Glargine|insulin glargine|mesh-list
64690811|NCT02741687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64690813|NCT02741687|Insulin Lispro|insulin lispro|mesh-list
64690814|NCT02741687|Insulin Detemir|insulin detemir|mesh-list
64690815|NCT02741687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64690816|NCT02741687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690817|NCT02741687|Incretins|incretins|mesh-ancestor
64690818|NCT02741687|Hormones|hormones|mesh-ancestor
64690819|NCT02741687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64690820|NCT02741687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64690836|NCT04337099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64690837|NCT04337099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64690838|NCT05630677|Rabeprazole|rabeprazole|mesh-list
64690839|NCT05630677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64690840|NCT05630677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64690841|NCT05630677|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64717322|NCT03831854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64717323|NCT03831854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64717324|NCT03831854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64717325|NCT03831854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64690842|NCT05630677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690843|NCT05630677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690844|NCT05627791|Oxytocin|oxytocin|mesh-list
64690845|NCT05627791|Oxytocics|oxytocics|mesh-ancestor
64690846|NCT05627791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64690847|NCT05627791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690848|NCT02771093|Alogliptin|alogliptin|mesh-list
64690849|NCT02771093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64690850|NCT02771093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690851|NCT02771093|Incretins|incretins|mesh-ancestor
64690852|NCT02771093|Hormones|hormones|mesh-ancestor
64690853|NCT02771093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64690854|NCT02771093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64690855|NCT02771093|Protease Inhibitors|protease inhibitors|mesh-ancestor
64690856|NCT02771093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454988|NCT03885388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65454989|NCT03885388|Dermatologic Agents|dermatologic agents|mesh-ancestor
65454990|NCT03885388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65454991|NCT03885388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65454992|NCT03885388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65454993|NCT03885388|Immunologic Factors|immunologic factors|mesh-ancestor
65454994|NCT03885388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65454995|NCT03885388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65454996|NCT03885388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65454997|NCT03885388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65454998|NCT03885388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65454999|NCT03885388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65455000|NCT03968640|Coenzyme Q10|coenzyme q10|mesh-list
65455001|NCT03968640|Vitamins|vitamins|mesh-ancestor
65455002|NCT03968640|Micronutrients|micronutrients|mesh-ancestor
65455003|NCT03968640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455004|NCT01152346|Azacitidine|azacitidine|mesh-list
65455005|NCT01152346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65455006|NCT01152346|Antimetabolites|antimetabolites|mesh-ancestor
65455007|NCT01152346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455008|NCT01152346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455009|NCT01152346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455010|NCT01260610|Tenofovir|tenofovir|mesh-list
65455011|NCT01260610|Telbivudine|telbivudine|mesh-list
65455012|NCT01260610|Antiviral Agents|antiviral agents|mesh-ancestor
65455013|NCT01260610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65455014|NCT01260610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65455015|NCT01260610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65455016|NCT01260610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455017|NCT01260610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690857|NCT02771093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690858|NCT05306587|Daratumumab|daratumumab|mesh-list
64690859|NCT05306587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690860|NCT04337879|Oxaliplatin|oxaliplatin|mesh-list
64690861|NCT04337879|Irinotecan|irinotecan|mesh-list
64690862|NCT04337879|Calcium|calcium|mesh-list
64690863|NCT04337879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64690864|NCT04337879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690865|NCT04337879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690866|NCT04337879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64690867|NCT04337879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64690868|NCT04337879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690869|NCT04337879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690870|NCT02745353|Naloxegol|naloxegol|mesh-list
64690871|NCT02745353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65455018|NCT01260610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65455019|NCT01260610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65455020|NCT01155700|Omalizumab|omalizumab|mesh-list
65455021|NCT01155700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65455022|NCT01155700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65455023|NCT01155700|Respiratory System Agents|respiratory system agents|mesh-ancestor
65455024|NCT03887884|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65455025|NCT03887884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65455026|NCT03887884|Immunologic Factors|immunologic factors|mesh-ancestor
65455027|NCT03887884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455028|NCT03887884|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65455029|NCT03887884|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64839580|NCT01633086|Antioxidants|antioxidants|mesh-ancestor
64690882|NCT04778839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690883|NCT05602207|Abrocitinib|abrocitinib|mesh-list
64690884|NCT05602207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64690885|NCT05602207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690895|NCT05598619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690896|NCT05598619|Protective Agents|protective agents|mesh-ancestor
64690897|NCT02746991|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
64690898|NCT02746991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64690899|NCT02746991|Glucocorticoids|glucocorticoids|mesh-ancestor
64690900|NCT02746991|Hormones|hormones|mesh-ancestor
64690901|NCT02746991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64690902|NCT02746991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690903|NCT02747615|Tranexamic Acid|tranexamic acid|mesh-list
64690904|NCT02747615|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64690905|NCT02747615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64690906|NCT02747615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690907|NCT02747615|Hemostatics|hemostatics|mesh-ancestor
64690908|NCT02747615|Coagulants|coagulants|mesh-ancestor
64690909|NCT02775617|Azithromycin|azithromycin|mesh-list
64690910|NCT02775617|Ivermectin|ivermectin|mesh-list
64690911|NCT02775617|Permethrin|permethrin|mesh-list
64690912|NCT02775617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64690913|NCT02775617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64690914|NCT02775617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64690915|NCT02775617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690916|NCT02775617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690917|NCT00371813|Varenicline|varenicline|mesh-list
64717326|NCT03831854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64717327|NCT03831854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64717328|NCT03806270|Midazolam|midazolam|mesh-list
64717329|NCT03806270|Hydroxyzine|hydroxyzine|mesh-list
64717330|NCT03806270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64717331|NCT03806270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64717332|NCT03806270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717333|NCT03806270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717334|NCT03806270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64717335|NCT03806270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64717336|NCT03806270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64717337|NCT03806270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64717338|NCT03806270|Anesthetics, General|anesthetics, general|mesh-ancestor
64717339|NCT03806270|Anesthetics|anesthetics|mesh-ancestor
64690918|NCT00371813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64690919|NCT00371813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64690920|NCT00371813|Cholinergic Agents|cholinergic agents|mesh-ancestor
64690921|NCT00371813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64690922|NCT00371813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690923|NCT00371813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690924|NCT04711135|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64690925|NCT04711135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64690926|NCT04711135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455030|NCT03887884|Dopamine Agonists|dopamine agonists|mesh-ancestor
65455031|NCT03887884|Dopamine Agents|dopamine agents|mesh-ancestor
65455032|NCT03887884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65455033|NCT03887884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455034|NCT03887650|Dexamethasone|dexamethasone|mesh-list
65455035|NCT03887650|Epinephrine|epinephrine|mesh-list
65455036|NCT03887650|Bupivacaine|bupivacaine|mesh-list
65455037|NCT03887650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65455038|NCT03887650|Antiemetics|antiemetics|mesh-ancestor
65455039|NCT03887650|Autonomic Agents|autonomic agents|mesh-ancestor
65455040|NCT03887650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65204518|NCT02842125|Pembrolizumab|pembrolizumab|mesh-list
65455041|NCT03887650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455042|NCT03887650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65455043|NCT03887650|Glucocorticoids|glucocorticoids|mesh-ancestor
65455044|NCT03887650|Hormones|hormones|mesh-ancestor
65455045|NCT03887650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65455046|NCT03887650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65455047|NCT03887650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455048|NCT03887650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455049|NCT03887650|Anesthetics, Local|anesthetics, local|mesh-ancestor
65455050|NCT03887650|Anesthetics|anesthetics|mesh-ancestor
65455051|NCT03887650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65455052|NCT03887650|Sensory System Agents|sensory system agents|mesh-ancestor
65455053|NCT03887650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65455054|NCT03887650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65455055|NCT03887650|Adrenergic Agents|adrenergic agents|mesh-ancestor
65455056|NCT03887650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64690927|NCT02748785|Methotrexate|methotrexate|mesh-list
64690928|NCT02748785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64690929|NCT02748785|Abortifacient Agents|abortifacient agents|mesh-ancestor
64690930|NCT02748785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64690931|NCT02748785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690932|NCT02748785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64690933|NCT02748785|Antimetabolites|antimetabolites|mesh-ancestor
64690934|NCT02748785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690935|NCT02748785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690941|NCT02748785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64690942|NCT02748785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64690951|NCT02295553|Analgesics|analgesics|mesh-ancestor
64690952|NCT02295553|Sensory System Agents|sensory system agents|mesh-ancestor
64690953|NCT02295553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690954|NCT02295553|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64690955|NCT02295553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64690956|NCT02295553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65455057|NCT03887650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65455058|NCT03887650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65455059|NCT03887650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65455060|NCT03887650|Respiratory System Agents|respiratory system agents|mesh-ancestor
65455061|NCT03887650|Mydriatics|mydriatics|mesh-ancestor
65455062|NCT03887650|Sympathomimetics|sympathomimetics|mesh-ancestor
65455063|NCT03887650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65455064|NCT01154530|Chlorhexidine|chlorhexidine|mesh-list
65455065|NCT01154530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65455066|NCT01154530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65455067|NCT01154530|Disinfectants|disinfectants|mesh-ancestor
65455068|NCT03887416|Dapagliflozin|dapagliflozin|mesh-list
65455069|NCT03887416|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65455070|NCT03887416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455071|NCT03887416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65455072|NCT03887416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455073|NCT01260844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65455074|NCT01260844|Immunologic Factors|immunologic factors|mesh-ancestor
65455075|NCT01260844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690957|NCT02295553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64690958|NCT02295553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690959|NCT02296099|Bupivacaine|bupivacaine|mesh-list
64690960|NCT02296099|Anesthetics, Local|anesthetics, local|mesh-ancestor
64690962|NCT02296099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64690963|NCT02296099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690964|NCT02296099|Sensory System Agents|sensory system agents|mesh-ancestor
64690965|NCT02296099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690967|NCT05455073|Hematinics|hematinics|mesh-ancestor
64690968|NCT05455073|Vitamin B Complex|vitamin b complex|mesh-ancestor
64690969|NCT05455073|Vitamins|vitamins|mesh-ancestor
64690970|NCT05455073|Micronutrients|micronutrients|mesh-ancestor
64717340|NCT03806270|GABA Modulators|gaba modulators|mesh-ancestor
64717341|NCT03806270|GABA Agents|gaba agents|mesh-ancestor
64717342|NCT03806270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64717343|NCT03806270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717344|NCT03806270|Antipruritics|antipruritics|mesh-ancestor
64717345|NCT03806270|Dermatologic Agents|dermatologic agents|mesh-ancestor
64717346|NCT03806270|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64690971|NCT05455073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690972|NCT04334993|Blinatumomab|blinatumomab|mesh-list
64690973|NCT04334993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690974|NCT05349929|Ibuprofen|ibuprofen|mesh-list
64690975|NCT05349929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64690976|NCT05349929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64690977|NCT05349929|Analgesics|analgesics|mesh-ancestor
64690978|NCT05349929|Sensory System Agents|sensory system agents|mesh-ancestor
64690979|NCT05349929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690980|NCT05349929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690981|NCT05349929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64690982|NCT05349929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64690983|NCT05349929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64690984|NCT05349929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690985|NCT05349929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690986|NCT04692103|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64690987|NCT04692103|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64690988|NCT04692103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455076|NCT03891472|Fluorouracil|fluorouracil|mesh-list
65455077|NCT03891472|Oxaliplatin|oxaliplatin|mesh-list
65455078|NCT03891472|Irinotecan|irinotecan|mesh-list
65455079|NCT03891472|Antimetabolites|antimetabolites|mesh-ancestor
65455080|NCT03891472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455081|NCT03891472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65455082|NCT03891472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455083|NCT03891472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65455084|NCT03891472|Immunologic Factors|immunologic factors|mesh-ancestor
65455085|NCT03891472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455086|NCT03891472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65455087|NCT03891472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65455088|NCT03891472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455089|NCT01262482|Oxaliplatin|oxaliplatin|mesh-list
65455090|NCT01262482|Sorafenib|sorafenib|mesh-list
65455091|NCT01262482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455092|NCT01262482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65455093|NCT01262482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455094|NCT01262482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455095|NCT01261078|Epinephrine|epinephrine|mesh-list
64839642|NCT01633645|Bortezomib|bortezomib|mesh-list
64690989|NCT05559931|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
64690990|NCT05559931|Hallucinogens|hallucinogens|mesh-ancestor
64690991|NCT05559931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690992|NCT05559931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64690993|NCT05559931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64690994|NCT05559931|Serotonin Agents|serotonin agents|mesh-ancestor
64690995|NCT05559931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64690996|NCT05559931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690997|NCT05559931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64690999|NCT04669171|Lenalidomide|lenalidomide|mesh-list
64691000|NCT04669171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64691001|NCT04669171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691002|NCT04669171|Immunologic Factors|immunologic factors|mesh-ancestor
64691003|NCT04669171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691004|NCT04669171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64691021|NCT05545891|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64691022|NCT05545891|Serotonin Agents|serotonin agents|mesh-ancestor
64691023|NCT05545891|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64691024|NCT05545891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64691025|NCT05545891|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64691026|NCT05545891|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64691027|NCT04757675|Dexmedetomidine|dexmedetomidine|mesh-list
64691029|NCT04757675|Esketamine|esketamine|mesh-list
64691030|NCT04757675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64691031|NCT04757675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64691032|NCT04757675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691033|NCT04757675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64691034|NCT04757675|Analgesics|analgesics|mesh-ancestor
64691035|NCT04757675|Sensory System Agents|sensory system agents|mesh-ancestor
64691036|NCT04757675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64691037|NCT04757675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64691038|NCT04757675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64691040|NCT04757675|Adrenergic Agents|adrenergic agents|mesh-ancestor
64717347|NCT03806270|Histamine Antagonists|histamine antagonists|mesh-ancestor
65455096|NCT01261078|Racepinephrine|racepinephrine|mesh-list
65455097|NCT01261078|Epinephryl borate|epinephryl borate|mesh-list
65455098|NCT01261078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65455099|NCT01261078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65455100|NCT01261078|Adrenergic Agents|adrenergic agents|mesh-ancestor
65455101|NCT01261078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65455102|NCT01261078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455103|NCT01261078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455104|NCT01261078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65455105|NCT01261078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65455106|NCT01261078|Autonomic Agents|autonomic agents|mesh-ancestor
65455107|NCT01261078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455108|NCT01261078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65455109|NCT01261078|Respiratory System Agents|respiratory system agents|mesh-ancestor
65455110|NCT01261078|Mydriatics|mydriatics|mesh-ancestor
65455111|NCT01261078|Sympathomimetics|sympathomimetics|mesh-ancestor
65455112|NCT01261078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65455113|NCT01155934|Risperidone|risperidone|mesh-list
65455114|NCT01155934|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65204586|NCT00127179|Hormone Antagonists|hormone antagonists|mesh-ancestor
65455115|NCT01155934|Serotonin Agents|serotonin agents|mesh-ancestor
65455116|NCT01155934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64839658|NCT01633658|Micronutrients|micronutrients|mesh-ancestor
64717348|NCT03806270|Histamine Agents|histamine agents|mesh-ancestor
64717349|NCT03497845|Vaccines|vaccines|mesh-list
64717350|NCT03497845|Immunologic Factors|immunologic factors|mesh-ancestor
64717351|NCT03497845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717352|NCT04036292|Varenicline|varenicline|mesh-list
64717353|NCT04036292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64717354|NCT04036292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64717355|NCT04036292|Cholinergic Agents|cholinergic agents|mesh-ancestor
64691041|NCT04757675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64691042|NCT04757675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691043|NCT04757675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64691044|NCT04757675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64691045|NCT04757675|Anesthetics, General|anesthetics, general|mesh-ancestor
64691046|NCT04757675|Anesthetics|anesthetics|mesh-ancestor
64691047|NCT04757675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64691048|NCT04757675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64691049|NCT04757675|Antidepressive Agents|antidepressive agents|mesh-ancestor
64691050|NCT04757675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64691051|NCT04611529|Ibuprofen|ibuprofen|mesh-list
64691052|NCT04611529|Diclofenac|diclofenac|mesh-list
64691053|NCT04611529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64691054|NCT04611529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64691055|NCT04611529|Analgesics|analgesics|mesh-ancestor
64691056|NCT04611529|Sensory System Agents|sensory system agents|mesh-ancestor
64691057|NCT04611529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64691058|NCT04611529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691059|NCT04611529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64691060|NCT04611529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64691061|NCT04611529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64691062|NCT04611529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455117|NCT01155934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455118|NCT01155934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455119|NCT01155934|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65455120|NCT01155934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65455121|NCT01155934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65455122|NCT01155934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65455123|NCT01155934|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65455124|NCT01155934|Dopamine Agents|dopamine agents|mesh-ancestor
65455125|NCT03891550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65455126|NCT03891550|Antiviral Agents|antiviral agents|mesh-ancestor
65455127|NCT03891550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65455128|NCT01261156|Diltiazem|diltiazem|mesh-list
65455129|NCT01261156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65455130|NCT01261156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65455131|NCT01261156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64839693|NCT01633970|Antidotes|antidotes|mesh-ancestor
64691063|NCT04611529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691064|NCT05323721|Pyrimethamine|pyrimethamine|mesh-list
64691065|NCT05323721|Piperaquine|piperaquine|mesh-list
64691066|NCT05323721|Sulfadoxine|sulfadoxine|mesh-list
64691067|NCT05323721|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64691068|NCT05323721|Amodiaquine|amodiaquine|mesh-list
64691069|NCT05323721|Artenimol|artenimol|mesh-list
64691070|NCT05323721|Antimalarials|antimalarials|mesh-ancestor
64691071|NCT05323721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64691072|NCT05323721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64691111|NCT04535401|Folic Acid|folic acid|mesh-list
64691113|NCT04535401|Irinotecan|irinotecan|mesh-list
64691114|NCT04535401|Camptothecin|camptothecin|mesh-list
64691115|NCT04535401|Calcium|calcium|mesh-list
64691116|NCT04535401|Levoleucovorin|levoleucovorin|mesh-list
64691117|NCT04535401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64691118|NCT04535401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691119|NCT04535401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64691120|NCT04535401|Antimetabolites|antimetabolites|mesh-ancestor
64691131|NCT04535401|Vitamin B Complex|vitamin b complex|mesh-ancestor
64691133|NCT04535401|Micronutrients|micronutrients|mesh-ancestor
64691134|NCT04535401|Hematinics|hematinics|mesh-ancestor
64691135|NCT04535401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64691136|NCT04665089|Erythromycin|erythromycin|mesh-list
64691137|NCT04665089|Erythromycin Estolate|erythromycin estolate|mesh-list
64691138|NCT04665089|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64691139|NCT04665089|Erythromycin stearate|erythromycin stearate|mesh-list
64691140|NCT04665089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64691141|NCT04665089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64717356|NCT04036292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64717357|NCT04036292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717358|NCT04036292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717359|NCT03501043|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64717360|NCT03501043|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64717361|NCT03501043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64717362|NCT03501043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691142|NCT04665089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64691143|NCT04665089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64691144|NCT04665089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691145|NCT04665089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691146|NCT04645823|Lidocaine|lidocaine|mesh-list
64691147|NCT04645823|Fentanyl|fentanyl|mesh-list
64691148|NCT04645823|Citric Acid|citric acid|mesh-list
64691149|NCT04645823|Sodium Citrate|sodium citrate|mesh-list
65455132|NCT01261156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455133|NCT01261156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65455134|NCT01261156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455135|NCT01261156|Vasodilator Agents|vasodilator agents|mesh-ancestor
65455136|NCT03884530|Aspirin|aspirin|mesh-list
65455137|NCT03884530|Ticagrelor|ticagrelor|mesh-list
65455138|NCT03884530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65455139|NCT03884530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65455140|NCT03884530|Analgesics|analgesics|mesh-ancestor
65455141|NCT03884530|Sensory System Agents|sensory system agents|mesh-ancestor
65455142|NCT03884530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455143|NCT03884530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455144|NCT03884530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65455145|NCT03884530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65455146|NCT03884530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65455147|NCT03884530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65455148|NCT03884530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455149|NCT03884530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65455150|NCT03884530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65455151|NCT03884530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455152|NCT03884530|Antipyretics|antipyretics|mesh-ancestor
65455153|NCT03884530|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65455154|NCT03884530|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65455155|NCT03884530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65455156|NCT03884530|Purinergic Agents|purinergic agents|mesh-ancestor
65455157|NCT03884530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65455158|NCT03891316|Sevoflurane|sevoflurane|mesh-list
65455159|NCT03891316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65455160|NCT03891316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65455161|NCT03891316|Anesthetics, General|anesthetics, general|mesh-ancestor
64691150|NCT04645823|Anesthetics, Local|anesthetics, local|mesh-ancestor
64691151|NCT04645823|Anesthetics|anesthetics|mesh-ancestor
64691152|NCT04645823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64691153|NCT04645823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691154|NCT04645823|Sensory System Agents|sensory system agents|mesh-ancestor
64691155|NCT04645823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64691156|NCT04645823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64691157|NCT04645823|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64691158|NCT04645823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64691159|NCT04645823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64691160|NCT04645823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691161|NCT04645823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65455162|NCT03891316|Anesthetics|anesthetics|mesh-ancestor
65455163|NCT03891316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65455164|NCT03891316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455165|NCT03887260|Fentanyl|fentanyl|mesh-list
65455166|NCT03887260|Morphine|morphine|mesh-list
65455167|NCT03887260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65455168|NCT03887260|Narcotics|narcotics|mesh-ancestor
65455169|NCT03887260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65455170|NCT03887260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455171|NCT03887260|Analgesics|analgesics|mesh-ancestor
65455172|NCT03887260|Sensory System Agents|sensory system agents|mesh-ancestor
65455173|NCT03887260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455174|NCT03887260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65455175|NCT03887260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65455176|NCT03887260|Anesthetics, General|anesthetics, general|mesh-ancestor
65455177|NCT03887260|Anesthetics|anesthetics|mesh-ancestor
65455178|NCT03883984|Cysteamine|cysteamine|mesh-list
65455179|NCT03883984|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
65455180|NCT03883984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455181|NCT01586494|Tramadol|tramadol|mesh-list
65455182|NCT01586494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65455183|NCT01586494|Narcotics|narcotics|mesh-ancestor
65455184|NCT01586494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65455185|NCT01586494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455186|NCT01586494|Analgesics|analgesics|mesh-ancestor
65455187|NCT01586494|Sensory System Agents|sensory system agents|mesh-ancestor
65455188|NCT01586494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64691162|NCT04645823|Narcotics|narcotics|mesh-ancestor
64691163|NCT04645823|Analgesics|analgesics|mesh-ancestor
64691164|NCT04645823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64691165|NCT04645823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64691166|NCT04645823|Anesthetics, General|anesthetics, general|mesh-ancestor
64691167|NCT04645823|Anticoagulants|anticoagulants|mesh-ancestor
64691168|NCT04645823|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64691169|NCT04645823|Chelating Agents|chelating agents|mesh-ancestor
64691170|NCT04645823|Sequestering Agents|sequestering agents|mesh-ancestor
64691171|NCT03860207|Antibodies|antibodies|mesh-list
64691172|NCT03860207|Immunoglobulins|immunoglobulins|mesh-list
64691173|NCT03860207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64691174|NCT03860207|Immunologic Factors|immunologic factors|mesh-ancestor
64691184|NCT03763175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64691185|NCT03763175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691186|NCT04396873|11C-PS13|11c-ps13|mesh-list
64691203|NCT04365049|Immunologic Factors|immunologic factors|mesh-ancestor
64691204|NCT04365049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691206|NCT04606901|Neostigmine|neostigmine|mesh-list
64691207|NCT04606901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64691208|NCT04606901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691209|NCT04606901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691210|NCT04606901|Cholinergic Agents|cholinergic agents|mesh-ancestor
65455189|NCT03886948|Mirikizumab|mirikizumab|mesh-list
65455190|NCT03886948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65455191|NCT03886948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65455192|NCT03886948|Analgesics|analgesics|mesh-ancestor
65455193|NCT03886948|Sensory System Agents|sensory system agents|mesh-ancestor
65455194|NCT03886948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455195|NCT03886948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455196|NCT03886948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65455197|NCT03886948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65455198|NCT03886948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65455199|NCT03886948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65455200|NCT01259362|Cocaine|cocaine|mesh-list
65455201|NCT01259362|Anesthetics, Local|anesthetics, local|mesh-ancestor
65455202|NCT01259362|Anesthetics|anesthetics|mesh-ancestor
65455203|NCT01259362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65455204|NCT01259362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455205|NCT01259362|Sensory System Agents|sensory system agents|mesh-ancestor
65455206|NCT01259362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455207|NCT01259362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65455208|NCT01259362|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65455209|NCT01259362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65455210|NCT01259362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65455211|NCT01259362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455212|NCT01259362|Dopamine Agents|dopamine agents|mesh-ancestor
65455213|NCT01259362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65455214|NCT03891238|Avelumab|avelumab|mesh-list
65455215|NCT03891238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65455216|NCT03891238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455217|NCT01261234|Cilostazol|cilostazol|mesh-list
65455218|NCT01261234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65455219|NCT01261234|Autonomic Agents|autonomic agents|mesh-ancestor
64691211|NCT04606901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64691212|NCT04606901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691213|NCT04606901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64691214|NCT04606901|Autonomic Agents|autonomic agents|mesh-ancestor
64691215|NCT04606901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717363|NCT03501043|Cholinergic Agents|cholinergic agents|mesh-ancestor
64717364|NCT03501043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64717365|NCT03501043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717366|NCT00377390|Omalizumab|omalizumab|mesh-list
64717367|NCT00377390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64691216|NCT04606901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64691217|NCT04606901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65455220|NCT01261234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455221|NCT01261234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455222|NCT01261234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65455223|NCT01261234|Respiratory System Agents|respiratory system agents|mesh-ancestor
65455224|NCT01261234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65455225|NCT01261234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65455226|NCT01261234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455227|NCT01261234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65455228|NCT01261234|Vasodilator Agents|vasodilator agents|mesh-ancestor
65455229|NCT01261234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65455230|NCT01261234|Protective Agents|protective agents|mesh-ancestor
65455231|NCT01261234|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65455232|NCT01261234|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65455233|NCT01261234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455234|NCT01152736|Nicotine|nicotine|mesh-list
65455235|NCT01152736|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64691218|NCT04606901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64691219|NCT03092011|Clonidine|clonidine|mesh-list
64691220|NCT03092011|Morphine|morphine|mesh-list
64691221|NCT03092011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64691222|NCT03092011|Narcotics|narcotics|mesh-ancestor
64691223|NCT03092011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64691224|NCT03092011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691225|NCT03092011|Analgesics|analgesics|mesh-ancestor
64691226|NCT03092011|Sensory System Agents|sensory system agents|mesh-ancestor
64691227|NCT03092011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64691228|NCT03092011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64691229|NCT03092011|Sympatholytics|sympatholytics|mesh-ancestor
64691230|NCT03092011|Autonomic Agents|autonomic agents|mesh-ancestor
64691231|NCT03092011|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64691232|NCT03092011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64691233|NCT03092011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64691234|NCT03092011|Adrenergic Agents|adrenergic agents|mesh-ancestor
64691235|NCT03092011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64691236|NCT03092011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691237|NCT00372515|Gefitinib|gefitinib|mesh-list
64691238|NCT00372515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691239|NCT00372515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64691240|NCT00372515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691241|NCT00372515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691242|NCT04448119|Favipiravir|favipiravir|mesh-list
64691243|NCT04448119|Antiviral Agents|antiviral agents|mesh-ancestor
64691244|NCT04448119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64691264|NCT03339635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64691265|NCT03339635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691266|NCT03339635|Anabolic Agents|anabolic agents|mesh-ancestor
64691267|NCT03069131|Rifaximin|rifaximin|mesh-list
64691268|NCT03069131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64691269|NCT03069131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64691270|NCT03069131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64691271|NCT02990845|Pembrolizumab|pembrolizumab|mesh-list
64691272|NCT02990845|Leuprolide|leuprolide|mesh-list
64691273|NCT02990845|Exemestane|exemestane|mesh-list
64691278|NCT02990845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64691279|NCT02990845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691280|NCT02990845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64691282|NCT02990845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64691283|NCT02990845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691284|NCT02990845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455236|NCT01152736|Autonomic Agents|autonomic agents|mesh-ancestor
65455237|NCT01152736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455238|NCT01152736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455239|NCT01152736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65455240|NCT01152736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65455241|NCT01152736|Cholinergic Agents|cholinergic agents|mesh-ancestor
65455242|NCT01152736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65455243|NCT01152736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455244|NCT01154764|Ketoconazole|ketoconazole|mesh-list
65455245|NCT01154764|Antifungal Agents|antifungal agents|mesh-ancestor
64691285|NCT02990845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64691286|NCT02990845|Hormone Antagonists|hormone antagonists|mesh-ancestor
64691287|NCT02990845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64691288|NCT04438213|Ertugliflozin|ertugliflozin|mesh-list
64691289|NCT04438213|Metolazone|metolazone|mesh-list
64691290|NCT04438213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64691291|NCT04438213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691292|NCT04438213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64691293|NCT04438213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691294|NCT04438213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64691295|NCT04438213|Diuretics|diuretics|mesh-ancestor
64691296|NCT04438213|Natriuretic Agents|natriuretic agents|mesh-ancestor
64691297|NCT04438213|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64691298|NCT04438213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64691299|NCT01987219|Bromides|bromides|mesh-list
64691300|NCT01987219|Albuterol|albuterol|mesh-list
64717368|NCT00377390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64717369|NCT00377390|Respiratory System Agents|respiratory system agents|mesh-ancestor
64717370|NCT03820388|Propofol|propofol|mesh-list
64717371|NCT03820388|Etomidate|etomidate|mesh-list
64717372|NCT03820388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64717373|NCT03820388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64691301|NCT01987219|Ipratropium|ipratropium|mesh-list
64691302|NCT01987219|Anticonvulsants|anticonvulsants|mesh-ancestor
64691310|NCT01987219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64691311|NCT01987219|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64691312|NCT01987219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64691314|NCT01987219|Adrenergic Agents|adrenergic agents|mesh-ancestor
64691315|NCT01987219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64691316|NCT01987219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691317|NCT01987219|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64691318|NCT01987219|Cholinergic Agents|cholinergic agents|mesh-ancestor
64691319|NCT02917993|Osimertinib|osimertinib|mesh-list
64691320|NCT02917993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691321|NCT02917993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64691322|NCT02917993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691323|NCT02917993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691324|NCT04405349|Atezolizumab|atezolizumab|mesh-list
64691325|NCT04405349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691326|NCT04265053|Ketorolac|ketorolac|mesh-list
64691327|NCT04265053|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64691328|NCT04265053|Estradiol|estradiol|mesh-list
64691329|NCT04265053|Testosterone|testosterone|mesh-list
64691330|NCT04265053|Ganirelix|ganirelix|mesh-list
64691331|NCT04265053|Estrogens|estrogens|mesh-ancestor
64691332|NCT04265053|Hormones|hormones|mesh-ancestor
64691333|NCT04265053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64691334|NCT04265053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691335|NCT04265053|Androgens|androgens|mesh-ancestor
64691336|NCT04265053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64691337|NCT04265053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64691338|NCT04265053|Analgesics|analgesics|mesh-ancestor
64691339|NCT04265053|Sensory System Agents|sensory system agents|mesh-ancestor
64691340|NCT04265053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64691341|NCT04265053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64691342|NCT04265053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65455246|NCT01154764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65455247|NCT01154764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65455248|NCT01154764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65455249|NCT01154764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455250|NCT01154764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455251|NCT01154764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65455252|NCT01154764|Hormone Antagonists|hormone antagonists|mesh-ancestor
65455253|NCT01154764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65455254|NCT01154764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455255|NCT01154764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65455256|NCT01261546|Dexamethasone|dexamethasone|mesh-list
65455257|NCT01261546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65455258|NCT01261546|Antiemetics|antiemetics|mesh-ancestor
65455259|NCT01261546|Autonomic Agents|autonomic agents|mesh-ancestor
65455260|NCT01261546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455261|NCT01261546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691343|NCT04265053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64691344|NCT04265053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691345|NCT04265053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691354|NCT04332497|Sensory System Agents|sensory system agents|mesh-ancestor
64691355|NCT04332497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64691356|NCT04332497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64691357|NCT04332497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64691358|NCT04332497|Anesthetics, General|anesthetics, general|mesh-ancestor
64691359|NCT04332497|Anesthetics|anesthetics|mesh-ancestor
64691360|NCT04332497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64691361|NCT04332497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64691362|NCT04332497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64691363|NCT04332497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64691364|NCT04332497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64691365|NCT04332497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691366|NCT04332497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691367|NCT02633137|Cytarabine|cytarabine|mesh-list
64691368|NCT02633137|Lenalidomide|lenalidomide|mesh-list
64691369|NCT02633137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64691370|NCT02633137|Antimetabolites|antimetabolites|mesh-ancestor
64691382|NCT04258397|Pirfenidone|pirfenidone|mesh-list
64691383|NCT04258397|Analgesics|analgesics|mesh-ancestor
64691384|NCT04258397|Sensory System Agents|sensory system agents|mesh-ancestor
64717374|NCT03820388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717375|NCT03820388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64717376|NCT03820388|Anesthetics, General|anesthetics, general|mesh-ancestor
64717377|NCT03820388|Anesthetics|anesthetics|mesh-ancestor
64691385|NCT04258397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64691386|NCT04258397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691387|NCT04258397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64691388|NCT04258397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64691389|NCT04258397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64691390|NCT04258397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64691391|NCT04258397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691392|NCT04707209|Sirolimus|sirolimus|mesh-list
64691393|NCT04707209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64691394|NCT04707209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64691395|NCT04707209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64691396|NCT04707209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691397|NCT04707209|Antifungal Agents|antifungal agents|mesh-ancestor
65455262|NCT01261546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65455263|NCT01261546|Glucocorticoids|glucocorticoids|mesh-ancestor
65204733|NCT02852694|Antimetabolites|antimetabolites|mesh-ancestor
65455264|NCT01261546|Hormones|hormones|mesh-ancestor
65455265|NCT01261546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65455266|NCT01261546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65455267|NCT01261546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455268|NCT03883360|Cannabidiol|cannabidiol|mesh-list
65455269|NCT03883360|Anticonvulsants|anticonvulsants|mesh-ancestor
65455270|NCT01261702|Magnesium Sulfate|magnesium sulfate|mesh-list
65455271|NCT01261702|Analgesics|analgesics|mesh-ancestor
65455272|NCT01261702|Sensory System Agents|sensory system agents|mesh-ancestor
65455273|NCT01261702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455274|NCT01261702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455275|NCT01261702|Anesthetics|anesthetics|mesh-ancestor
65455276|NCT01261702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65455277|NCT01261702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65455278|NCT01261702|Anticonvulsants|anticonvulsants|mesh-ancestor
65455279|NCT01261702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65455280|NCT01261702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65455281|NCT01261702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455282|NCT01261702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65455283|NCT01261702|Tocolytic Agents|tocolytic agents|mesh-ancestor
65455284|NCT01261702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65455285|NCT01156246|Metformin|metformin|mesh-list
65455286|NCT01156246|Dapagliflozin|dapagliflozin|mesh-list
64691398|NCT04707209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64691399|NCT04707209|Immunologic Factors|immunologic factors|mesh-ancestor
64691400|NCT04707209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691401|NCT01989793|Losartan|losartan|mesh-list
64691402|NCT01989793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64691403|NCT01989793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64691404|NCT01989793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64691405|NCT01989793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64691406|NCT01989793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691407|NCT01992523|Ticagrelor|ticagrelor|mesh-list
64691408|NCT01992523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64691409|NCT01992523|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64691410|NCT01992523|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64691411|NCT01992523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64691412|NCT01992523|Purinergic Agents|purinergic agents|mesh-ancestor
64691413|NCT01992523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64691414|NCT01992523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691415|NCT01992523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691417|NCT04188665|Agglutinins|agglutinins|mesh-ancestor
64691418|NCT04188665|Immunologic Factors|immunologic factors|mesh-ancestor
64691419|NCT04188665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455287|NCT01156246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65455288|NCT01156246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455289|NCT01156246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65455290|NCT01156246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455291|NCT03890770|BMS-986165|bms-986165|mesh-list
65455292|NCT03890770|Dermatologic Agents|dermatologic agents|mesh-ancestor
65455293|NCT03890770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65455294|NCT03890770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455295|NCT03890770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455296|NCT03883204|Risperidone|risperidone|mesh-list
65455297|NCT03883204|Aripiprazole|aripiprazole|mesh-list
65455298|NCT03883204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65455299|NCT03883204|Serotonin Agents|serotonin agents|mesh-ancestor
65455300|NCT03883204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65455301|NCT03883204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455302|NCT03883204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455303|NCT03883204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65455304|NCT03883204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64691420|NCT04188665|Coagulants|coagulants|mesh-ancestor
64691421|NCT04186247|Azithromycin|azithromycin|mesh-list
64691425|NCT04186247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64691426|NCT04186247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64691427|NCT04181255|Poractant alfa|poractant alfa|mesh-list
64691428|NCT04181255|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
64691429|NCT04181255|Respiratory System Agents|respiratory system agents|mesh-ancestor
64691430|NCT00373373|Sorafenib|sorafenib|mesh-list
64691431|NCT00373373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691432|NCT00373373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64691433|NCT00373373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691447|NCT00373451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64691449|NCT01387763|Interferon-alpha|interferon-alpha|mesh-list
64691450|NCT01387763|Interferon alpha-2|interferon alpha-2|mesh-list
64691451|NCT01387763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64691452|NCT01387763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64691453|NCT01387763|Hydroxyurea|hydroxyurea|mesh-list
64691454|NCT01387763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691455|NCT01387763|Antiviral Agents|antiviral agents|mesh-ancestor
64691456|NCT01387763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64691457|NCT01387763|Immunologic Factors|immunologic factors|mesh-ancestor
64691458|NCT01387763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691459|NCT01387763|Antisickling Agents|antisickling agents|mesh-ancestor
64691460|NCT01387763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691461|NCT01387763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691462|NCT01387763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64691464|NCT00373061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64691465|NCT00373061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64691466|NCT00373061|Respiratory System Agents|respiratory system agents|mesh-ancestor
64691467|NCT00707213|Deoxyglucose|deoxyglucose|mesh-list
64717378|NCT03264157|Vaccines|vaccines|mesh-list
64717379|NCT03264157|Immunologic Factors|immunologic factors|mesh-ancestor
64717380|NCT03264157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717381|NCT04029584|Rifampin|rifampin|mesh-list
64717382|NCT04029584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64717383|NCT04029584|Antitubercular Agents|antitubercular agents|mesh-ancestor
64717384|NCT04029584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64717385|NCT04029584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64717386|NCT04029584|Leprostatic Agents|leprostatic agents|mesh-ancestor
65455305|NCT03883204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65455306|NCT03883204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65455307|NCT03883204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65455308|NCT03883204|Dopamine Agents|dopamine agents|mesh-ancestor
65455309|NCT03883204|Antidepressive Agents|antidepressive agents|mesh-ancestor
65455310|NCT03883204|Dopamine Agonists|dopamine agonists|mesh-ancestor
65455311|NCT03883204|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65455312|NCT03883204|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65455313|NCT03883204|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65455314|NCT03883204|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65455315|NCT01263418|Ofatumumab|ofatumumab|mesh-list
65455316|NCT01263418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455317|NCT03882814|Meperidine|meperidine|mesh-list
65455318|NCT03882814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65455319|NCT03882814|Narcotics|narcotics|mesh-ancestor
64839872|NCT01634893|Antimalarials|antimalarials|mesh-ancestor
64691468|NCT00707213|Antimetabolites|antimetabolites|mesh-ancestor
64691469|NCT00707213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691470|NCT00707213|Antiviral Agents|antiviral agents|mesh-ancestor
64691471|NCT00707213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64691472|NCT01993849|Acetylcysteine|acetylcysteine|mesh-list
64691473|NCT01993849|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64691474|NCT01993849|Antiviral Agents|antiviral agents|mesh-ancestor
64691475|NCT01993849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64691476|NCT01993849|Expectorants|expectorants|mesh-ancestor
64691477|NCT01993849|Respiratory System Agents|respiratory system agents|mesh-ancestor
64691478|NCT01993849|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64691479|NCT01993849|Antioxidants|antioxidants|mesh-ancestor
64691480|NCT01993849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691481|NCT01993849|Protective Agents|protective agents|mesh-ancestor
64691482|NCT01993849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691483|NCT01993849|Antidotes|antidotes|mesh-ancestor
64691484|NCT02778113|Glucagon|glucagon|mesh-list
64691485|NCT02778113|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64691486|NCT02778113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64691487|NCT02778113|Hormones|hormones|mesh-ancestor
64691488|NCT02778113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64691489|NCT02778113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691490|NCT02778113|Incretins|incretins|mesh-ancestor
64691492|NCT04982237|Bevacizumab|bevacizumab|mesh-list
64691493|NCT04982237|Carboplatin|carboplatin|mesh-list
64691494|NCT04982237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64691495|NCT04982237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691496|NCT04982237|Tubulin Modulators|tubulin modulators|mesh-ancestor
64691497|NCT04982237|Antimitotic Agents|antimitotic agents|mesh-ancestor
64691498|NCT04982237|Mitosis Modulators|mitosis modulators|mesh-ancestor
64691513|NCT04227847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691515|NCT02316379|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64691516|NCT02316379|Anesthetics, General|anesthetics, general|mesh-ancestor
64691517|NCT02316379|Anesthetics|anesthetics|mesh-ancestor
64691518|NCT02316379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64691527|NCT02303977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64691528|NCT02303977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691529|NCT02303977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64691530|NCT02303977|Immunologic Factors|immunologic factors|mesh-ancestor
64691531|NCT02303977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691532|NCT01997515|Ketamine|ketamine|mesh-list
64691533|NCT01997515|Analgesics|analgesics|mesh-ancestor
64691534|NCT01997515|Sensory System Agents|sensory system agents|mesh-ancestor
64691535|NCT01997515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64691536|NCT01997515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455320|NCT03882814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65455321|NCT03882814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455322|NCT03882814|Analgesics|analgesics|mesh-ancestor
65455323|NCT03882814|Sensory System Agents|sensory system agents|mesh-ancestor
65455324|NCT03882814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455325|NCT03882814|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65455326|NCT01155232|Teriparatide|teriparatide|mesh-list
65455327|NCT01155232|Parathyroid Hormone|parathyroid hormone|mesh-list
65455328|NCT01155232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455329|NCT01155232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65455330|NCT01155232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65455331|NCT03647566|Listerine|listerine|mesh-list
65455332|NCT03647566|Fluorides|fluorides|mesh-list
65455333|NCT03647566|Sodium Fluoride|sodium fluoride|mesh-list
64691537|NCT01997515|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64691538|NCT01997515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64691539|NCT01997515|Anesthetics, General|anesthetics, general|mesh-ancestor
64691540|NCT01997515|Anesthetics|anesthetics|mesh-ancestor
64691541|NCT01997515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717387|NCT04029584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64717388|NCT04029584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64717389|NCT04029584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717390|NCT04029584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64325608|NCT05468138|Antibodies|antibodies|mesh-list
64691542|NCT01997515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64691543|NCT01997515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64691544|NCT01997515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64691545|NCT01997515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691546|NCT04333823|Dapagliflozin|dapagliflozin|mesh-list
64691547|NCT04333823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64691548|NCT04333823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691549|NCT04333823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64691550|NCT04333823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691551|NCT01997905|Protein S|protein s|mesh-list
64691552|NCT01997905|Anticoagulants|anticoagulants|mesh-ancestor
64691553|NCT02788019|Ropivacaine|ropivacaine|mesh-list
64691554|NCT02788019|Anesthetics, Local|anesthetics, local|mesh-ancestor
64691555|NCT02788019|Anesthetics|anesthetics|mesh-ancestor
64691556|NCT02788019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64691567|NCT02789033|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64691568|NCT02789033|Chitosan|chitosan|mesh-list
64691569|NCT02789033|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64691570|NCT02789033|Diuretics|diuretics|mesh-ancestor
64691571|NCT02789033|Natriuretic Agents|natriuretic agents|mesh-ancestor
64691572|NCT02789033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691573|NCT02789033|Vasodilator Agents|vasodilator agents|mesh-ancestor
64691574|NCT02789033|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64691575|NCT02789033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691576|NCT02789033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64691577|NCT02789033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64691578|NCT02789033|Antimetabolites|antimetabolites|mesh-ancestor
64691579|NCT02789033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64691580|NCT02789033|Chelating Agents|chelating agents|mesh-ancestor
64691581|NCT02789033|Sequestering Agents|sequestering agents|mesh-ancestor
64691582|NCT02789033|Hemostatics|hemostatics|mesh-ancestor
64691583|NCT02789033|Coagulants|coagulants|mesh-ancestor
64691584|NCT00372827|Travoprost|travoprost|mesh-list
64691585|NCT00372827|Brinzolamide|brinzolamide|mesh-list
64691586|NCT00372827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64691587|NCT00372827|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64691588|NCT00372827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455334|NCT03647566|Cariostatic Agents|cariostatic agents|mesh-ancestor
65455335|NCT03647566|Protective Agents|protective agents|mesh-ancestor
65455336|NCT03647566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455337|NCT03647566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65455338|NCT03647566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65455339|NCT01156636|Sildenafil Citrate|sildenafil citrate|mesh-list
65455340|NCT01156636|Vasodilator Agents|vasodilator agents|mesh-ancestor
65455341|NCT01156636|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65455342|NCT01156636|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65455343|NCT01156636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455344|NCT01156636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455345|NCT01156636|Urological Agents|urological agents|mesh-ancestor
65455346|NCT03889288|Analgesics|analgesics|mesh-list
65455347|NCT03889288|Sensory System Agents|sensory system agents|mesh-ancestor
65455348|NCT03889288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455349|NCT03889288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455350|NCT01153204|Sildenafil Citrate|sildenafil citrate|mesh-list
65455351|NCT01153204|Citric Acid|citric acid|mesh-list
65455352|NCT01153204|Sodium Citrate|sodium citrate|mesh-list
65455353|NCT01153204|Anticoagulants|anticoagulants|mesh-ancestor
65455354|NCT01153204|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65455355|NCT01153204|Chelating Agents|chelating agents|mesh-ancestor
65455356|NCT01153204|Sequestering Agents|sequestering agents|mesh-ancestor
65455357|NCT01153204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455358|NCT01153204|Vasodilator Agents|vasodilator agents|mesh-ancestor
65455359|NCT01153204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65455360|NCT01153204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65455361|NCT01153204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691589|NCT00372827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691598|NCT02278315|Hormones|hormones|mesh-ancestor
64691599|NCT02278315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64691600|NCT02278315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64691601|NCT02278315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691602|NCT02795117|Ivermectin|ivermectin|mesh-list
64691603|NCT02795117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64691604|NCT02795117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64691614|NCT02882633|Bupivacaine|bupivacaine|mesh-list
64717391|NCT04029584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64717392|NCT04029584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64717393|NCT04029584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64717394|NCT04029584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64325612|NCT01140217|Norethindrone Acetate|norethindrone acetate|mesh-list
64691615|NCT02882633|Anesthetics, Local|anesthetics, local|mesh-ancestor
64691616|NCT02882633|Anesthetics|anesthetics|mesh-ancestor
64691617|NCT02882633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65455362|NCT01153204|Urological Agents|urological agents|mesh-ancestor
65455363|NCT03760666|Ribavirin|ribavirin|mesh-list
65455364|NCT03760666|Brequinar|brequinar|mesh-list
65455365|NCT03760666|Antimetabolites|antimetabolites|mesh-ancestor
65455366|NCT03760666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455367|NCT03760666|Antiviral Agents|antiviral agents|mesh-ancestor
65455368|NCT03760666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65455369|NCT03760666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455370|NCT03760666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455371|NCT03760666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65455372|NCT03760666|Immunologic Factors|immunologic factors|mesh-ancestor
65455373|NCT03760666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455374|NCT01263574|Ethanol|ethanol|mesh-list
64691618|NCT02882633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691619|NCT02882633|Sensory System Agents|sensory system agents|mesh-ancestor
64691620|NCT02882633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64691621|NCT00373607|Artesunate|artesunate|mesh-list
64691622|NCT00373607|Piperaquine|piperaquine|mesh-list
64691623|NCT00373607|Mefloquine|mefloquine|mesh-list
64691643|NCT02882711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64691644|NCT02882711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64691645|NCT02882711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64691646|NCT02882711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691648|NCT02794337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691649|NCT02794337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64691650|NCT02794337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691651|NCT02794337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691652|NCT02590523|Moxifloxacin|moxifloxacin|mesh-list
64691653|NCT02590523|Vancomycin|vancomycin|mesh-list
64691654|NCT02590523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64691655|NCT02590523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64691656|NCT02590523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64691657|NCT02590523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64691658|NCT02590523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691659|NCT02590523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691660|NCT02590523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691661|NCT02895035|Ketorolac|ketorolac|mesh-list
64691662|NCT02895035|Phenylephrine|phenylephrine|mesh-list
64691663|NCT02895035|Epinephrine|epinephrine|mesh-list
64691664|NCT02895035|Oxymetazoline|oxymetazoline|mesh-list
64691665|NCT02895035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64691666|NCT02895035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64691667|NCT02895035|Adrenergic Agents|adrenergic agents|mesh-ancestor
64691668|NCT02895035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64691669|NCT02895035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691670|NCT02895035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691671|NCT02895035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64691672|NCT02895035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64691673|NCT02895035|Autonomic Agents|autonomic agents|mesh-ancestor
64691674|NCT02895035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64691675|NCT02895035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64691676|NCT02895035|Respiratory System Agents|respiratory system agents|mesh-ancestor
64691677|NCT02895035|Mydriatics|mydriatics|mesh-ancestor
64691678|NCT02895035|Sympathomimetics|sympathomimetics|mesh-ancestor
64691679|NCT02895035|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64691680|NCT02895035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64691711|NCT02803229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691713|NCT02803229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64691714|NCT02803229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64691715|NCT02803229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64691722|NCT01938001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691723|NCT01938001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65455375|NCT01263574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65455376|NCT01263574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65455377|NCT01263574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65455378|NCT01263574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455379|NCT03464734|Paclitaxel|paclitaxel|mesh-list
65455380|NCT03464734|Pembrolizumab|pembrolizumab|mesh-list
65455381|NCT03464734|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65455382|NCT03464734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65455383|NCT03464734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455384|NCT03464734|Tubulin Modulators|tubulin modulators|mesh-ancestor
65455385|NCT03464734|Antimitotic Agents|antimitotic agents|mesh-ancestor
65455386|NCT03464734|Mitosis Modulators|mitosis modulators|mesh-ancestor
65455387|NCT03464734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455388|NCT03464734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65455389|NCT01156948|Misoprostol|misoprostol|mesh-list
64691724|NCT01938001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64691725|NCT01938001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64717395|NCT04029584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64717397|NCT04028960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64717398|NCT04028960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64717399|NCT04028960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691726|NCT01938001|Growth Substances|growth substances|mesh-ancestor
64691727|NCT01938001|Growth Inhibitors|growth inhibitors|mesh-ancestor
64691728|NCT02805179|Temozolomide|temozolomide|mesh-list
64691729|NCT02805179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64691730|NCT02805179|Alkylating Agents|alkylating agents|mesh-ancestor
64691731|NCT02805179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691732|NCT02805179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691733|NCT02896595|Anesthetics|anesthetics|mesh-list
64691734|NCT02896595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64691735|NCT02896595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691736|NCT02003911|Azithromycin|azithromycin|mesh-list
64691737|NCT02003911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64691738|NCT02003911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64691739|NCT04147351|Bevacizumab|bevacizumab|mesh-list
64691740|NCT04147351|Atezolizumab|atezolizumab|mesh-list
64691741|NCT04147351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64691767|NCT01754779|Chelating Agents|chelating agents|mesh-ancestor
64691768|NCT01754779|Sequestering Agents|sequestering agents|mesh-ancestor
64691769|NCT01754779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691770|NCT01754779|Diuretics|diuretics|mesh-ancestor
64691771|NCT01754779|Natriuretic Agents|natriuretic agents|mesh-ancestor
64691772|NCT01754779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691773|NCT01754779|Expectorants|expectorants|mesh-ancestor
64691774|NCT01754779|Respiratory System Agents|respiratory system agents|mesh-ancestor
64691781|NCT02149277|Lenograstim|lenograstim|mesh-list
64691782|NCT02149277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64691783|NCT02149277|Immunologic Factors|immunologic factors|mesh-ancestor
64691784|NCT02149277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691785|NCT02896907|Calcium, Dietary|calcium, dietary|mesh-list
64691786|NCT02896907|Vitamins|vitamins|mesh-list
64691787|NCT02896907|Leucovorin|leucovorin|mesh-list
64691788|NCT02896907|Ascorbic Acid|ascorbic acid|mesh-list
64691789|NCT02896907|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
64691790|NCT02896907|Tetrahydrofolates|tetrahydrofolates|mesh-list
64691791|NCT02896907|Fluorouracil|fluorouracil|mesh-list
64691792|NCT02896907|Oxaliplatin|oxaliplatin|mesh-list
64691793|NCT02896907|Irinotecan|irinotecan|mesh-list
64691794|NCT02896907|Camptothecin|camptothecin|mesh-list
64691795|NCT02896907|Calcium|calcium|mesh-list
64691796|NCT02896907|Levoleucovorin|levoleucovorin|mesh-list
65455390|NCT01156948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65455391|NCT01156948|Abortifacient Agents|abortifacient agents|mesh-ancestor
65455392|NCT01156948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65455393|NCT01156948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455394|NCT01156948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65455395|NCT01156948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65455396|NCT01156948|Oxytocics|oxytocics|mesh-ancestor
65455397|NCT01157026|Tamoxifen|tamoxifen|mesh-list
65455398|NCT01157026|Tocotrienols|tocotrienols|mesh-list
65455399|NCT01157026|Vitamin E|vitamin e|mesh-list
65455400|NCT01157026|Tocopherols|tocopherols|mesh-list
65455401|NCT01157026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64839961|NCT01635608|Acetaminophen|acetaminophen|mesh-list
64691797|NCT02896907|Micronutrients|micronutrients|mesh-ancestor
64691798|NCT02896907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691828|NCT02005549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691829|NCT02005549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64691830|NCT02005549|Antimetabolites|antimetabolites|mesh-ancestor
64691832|NCT04349696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64691840|NCT02810873|Micronutrients|micronutrients|mesh-ancestor
64691841|NCT02810873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691842|NCT02810873|Antimetabolites|antimetabolites|mesh-ancestor
64691843|NCT02810873|Antiviral Agents|antiviral agents|mesh-ancestor
64691844|NCT02810873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64691845|NCT01716806|Nivolumab|nivolumab|mesh-list
64691874|NCT03526874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691875|NCT03526874|Sensory System Agents|sensory system agents|mesh-ancestor
64691876|NCT03526874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64691877|NCT03526874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64691878|NCT03526874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64691879|NCT03526874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64691880|NCT03526874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64691881|NCT03526874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717400|NCT03502915|Nitrous Oxide|nitrous oxide|mesh-list
64717401|NCT03502915|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64717402|NCT03502915|Anesthetics, General|anesthetics, general|mesh-ancestor
64717403|NCT03502915|Anesthetics|anesthetics|mesh-ancestor
64717404|NCT03502915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717405|NCT03502915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717406|NCT03502915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64717407|NCT03502915|Analgesics|analgesics|mesh-ancestor
64717408|NCT03502915|Sensory System Agents|sensory system agents|mesh-ancestor
64325620|NCT01140217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64691882|NCT03488420|Edoxaban|edoxaban|mesh-list
64691883|NCT03488420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64691884|NCT03488420|Antithrombins|antithrombins|mesh-ancestor
64691885|NCT03488420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64691886|NCT03488420|Protease Inhibitors|protease inhibitors|mesh-ancestor
64691887|NCT03488420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691888|NCT03488420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691889|NCT03488420|Anticoagulants|anticoagulants|mesh-ancestor
64691890|NCT01081951|Paclitaxel|paclitaxel|mesh-list
64691891|NCT01081951|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64691892|NCT01081951|Carboplatin|carboplatin|mesh-list
64691893|NCT01081951|Olaparib|olaparib|mesh-list
64691894|NCT01081951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64691895|NCT01081951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691896|NCT01081951|Tubulin Modulators|tubulin modulators|mesh-ancestor
64691897|NCT01081951|Antimitotic Agents|antimitotic agents|mesh-ancestor
64691925|NCT01959685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64691926|NCT01959685|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64691927|NCT01959685|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64691932|NCT02901899|Pembrolizumab|pembrolizumab|mesh-list
64691933|NCT02901899|Guadecitabine|guadecitabine|mesh-list
64691934|NCT02901899|Azacitidine|azacitidine|mesh-list
65455402|NCT01157026|Hormone Antagonists|hormone antagonists|mesh-ancestor
65455403|NCT01157026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65455404|NCT01157026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455405|NCT01157026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65455406|NCT01157026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455407|NCT01157026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65455408|NCT01157026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65455409|NCT01157026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65455410|NCT01157026|Antioxidants|antioxidants|mesh-ancestor
65455411|NCT01157026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455412|NCT01157026|Protective Agents|protective agents|mesh-ancestor
65455413|NCT01157026|Vitamins|vitamins|mesh-ancestor
65455414|NCT01157026|Micronutrients|micronutrients|mesh-ancestor
65455415|NCT01263652|Dipyrone|dipyrone|mesh-list
65455416|NCT01263652|Diclofenac|diclofenac|mesh-list
65455417|NCT01263652|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
65455418|NCT01263652|Tramadol|tramadol|mesh-list
65455419|NCT01263652|Orphenadrine|orphenadrine|mesh-list
65455420|NCT01263652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65455421|NCT01263652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65455422|NCT01263652|Analgesics|analgesics|mesh-ancestor
65455423|NCT01263652|Sensory System Agents|sensory system agents|mesh-ancestor
64691935|NCT02901899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64691936|NCT02901899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691937|NCT02901899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64691938|NCT02901899|Antimetabolites|antimetabolites|mesh-ancestor
64691939|NCT02901899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691940|NCT02901899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691941|NCT04333589|Favipiravir|favipiravir|mesh-list
64691942|NCT04333589|Antiviral Agents|antiviral agents|mesh-ancestor
64691943|NCT04333589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64691944|NCT02902913|Ibuprofen|ibuprofen|mesh-list
64691945|NCT02902913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64691946|NCT02902913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64691947|NCT02902913|Analgesics|analgesics|mesh-ancestor
64691948|NCT02902913|Sensory System Agents|sensory system agents|mesh-ancestor
64691949|NCT02902913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64691950|NCT02902913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691959|NCT03417986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64691960|NCT03417986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691976|NCT02301416|Anticonvulsants|anticonvulsants|mesh-ancestor
64691977|NCT02301416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64691978|NCT02301416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691979|NCT02301416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64691980|NCT02301416|Appetite Depressants|appetite depressants|mesh-ancestor
64691981|NCT02301416|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64691982|NCT02301416|Sympathomimetics|sympathomimetics|mesh-ancestor
64691983|NCT02301416|Autonomic Agents|autonomic agents|mesh-ancestor
64717409|NCT03502915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717410|NCT04018664|Nalbuphine|nalbuphine|mesh-list
64717411|NCT04018664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64717412|NCT04018664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64717413|NCT04018664|Narcotics|narcotics|mesh-ancestor
65455424|NCT01263652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455425|NCT01263652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455426|NCT01263652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65455427|NCT01263652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65455428|NCT01263652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65455429|NCT01263652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455430|NCT01263652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455431|NCT01263652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65455432|NCT01263652|Narcotics|narcotics|mesh-ancestor
65455433|NCT01263652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65455434|NCT01263652|Antipyretics|antipyretics|mesh-ancestor
65455435|NCT01263652|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65455436|NCT01263652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65455437|NCT01263652|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64717414|NCT04018664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717415|NCT04018664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717416|NCT04018664|Analgesics|analgesics|mesh-ancestor
64717417|NCT04018664|Sensory System Agents|sensory system agents|mesh-ancestor
64717418|NCT04018664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717419|NCT03506347|Vancomycin|vancomycin|mesh-list
64717420|NCT03506347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64717421|NCT03506347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64717422|NCT03266419|Rocuronium|rocuronium|mesh-list
64717423|NCT03266419|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64717424|NCT03266419|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64717425|NCT03266419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64717426|NCT03266419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717427|NCT03266419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717428|NCT00377468|Dronabinol|dronabinol|mesh-list
64717429|NCT00377468|Hallucinogens|hallucinogens|mesh-ancestor
64717430|NCT00377468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717431|NCT00377468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64325628|NCT01297543|Lenograstim|lenograstim|mesh-list
64691984|NCT02301416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64691985|NCT02301416|Adrenergic Agents|adrenergic agents|mesh-ancestor
64691986|NCT02301416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64691987|NCT02301416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691988|NCT02815709|Morphine|morphine|mesh-list
64691989|NCT02815709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64691990|NCT02815709|Narcotics|narcotics|mesh-ancestor
64691991|NCT02815709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64691992|NCT02815709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691993|NCT02815709|Analgesics|analgesics|mesh-ancestor
64691994|NCT02815709|Sensory System Agents|sensory system agents|mesh-ancestor
64691995|NCT02815709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64691996|NCT02912195|Lidocaine|lidocaine|mesh-list
64691997|NCT02912195|Morphine|morphine|mesh-list
64691998|NCT02912195|Anesthetics, Local|anesthetics, local|mesh-ancestor
64691999|NCT02912195|Anesthetics|anesthetics|mesh-ancestor
64692000|NCT02912195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64692001|NCT02912195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692002|NCT02912195|Sensory System Agents|sensory system agents|mesh-ancestor
64692003|NCT02912195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692004|NCT02912195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64692005|NCT02912195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64692006|NCT02912195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64692007|NCT02912195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64692008|NCT02912195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692013|NCT01960075|Levetiracetam|levetiracetam|mesh-list
64692014|NCT01960075|Valproic Acid|valproic acid|mesh-list
65455438|NCT01263652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65455439|NCT01263652|Parasympatholytics|parasympatholytics|mesh-ancestor
65455440|NCT01263652|Autonomic Agents|autonomic agents|mesh-ancestor
65455441|NCT01263652|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65455442|NCT01263652|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65455443|NCT01263652|Cholinergic Agents|cholinergic agents|mesh-ancestor
65455444|NCT01263652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65455445|NCT01263652|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
65455446|NCT01263652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65455447|NCT03881644|Sumatriptan|sumatriptan|mesh-list
64692015|NCT01960075|Anticonvulsants|anticonvulsants|mesh-ancestor
64692016|NCT01960075|Nootropic Agents|nootropic agents|mesh-ancestor
64692017|NCT01960075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692018|NCT01960075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692019|NCT01960075|GABA Agents|gaba agents|mesh-ancestor
64692020|NCT01960075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64692021|NCT01960075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692044|NCT01990898|Dermatologic Agents|dermatologic agents|mesh-ancestor
64692045|NCT01990898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64692046|NCT01990898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64692048|NCT01960387|Clofarabine|clofarabine|mesh-list
64692049|NCT01960387|Antimetabolites|antimetabolites|mesh-list
64692050|NCT01960387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64692051|NCT01960387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692052|NCT01960387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64692053|NCT01960387|Antiviral Agents|antiviral agents|mesh-ancestor
64692054|NCT01960387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64692055|NCT01960387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64692056|NCT01960387|Immunologic Factors|immunologic factors|mesh-ancestor
64692057|NCT01960387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692059|NCT02823431|Anesthetics, Local|anesthetics, local|mesh-ancestor
64692060|NCT02823431|Anesthetics|anesthetics|mesh-ancestor
64692061|NCT02823431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64692062|NCT02823431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692063|NCT02823431|Sensory System Agents|sensory system agents|mesh-ancestor
64692064|NCT02823431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692065|NCT02823431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64692066|NCT02823431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64692067|NCT02823431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64692068|NCT02823431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64692069|NCT02823431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692070|NCT02824913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64692071|NCT02824913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64692072|NCT03008213|Palonosetron|palonosetron|mesh-list
64692073|NCT03008213|Antiemetics|antiemetics|mesh-ancestor
64692074|NCT03008213|Autonomic Agents|autonomic agents|mesh-ancestor
64692099|NCT01962961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692100|NCT01962961|Protective Agents|protective agents|mesh-ancestor
64692101|NCT01962961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692102|NCT01962961|Antidotes|antidotes|mesh-ancestor
64692103|NCT03010631|Lubiprostone|lubiprostone|mesh-list
64692104|NCT03010631|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64692105|NCT03010631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64692106|NCT03010631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692107|NCT00374621|Isosorbide|isosorbide|mesh-list
64692108|NCT00374621|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64692109|NCT00374621|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64692110|NCT00374621|Misoprostol|misoprostol|mesh-list
64692111|NCT00374621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64692112|NCT00374621|Abortifacient Agents|abortifacient agents|mesh-ancestor
64692113|NCT00374621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64717440|NCT00377468|Hormones|hormones|mesh-ancestor
64717441|NCT00377468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64717442|NCT03799484|Lidocaine|lidocaine|mesh-list
65455448|NCT03881644|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
65455449|NCT03881644|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65455450|NCT03881644|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65455451|NCT03881644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65455452|NCT03881644|Serotonin Agents|serotonin agents|mesh-ancestor
65455453|NCT03881644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65455454|NCT03881644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455455|NCT03881644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455456|NCT03881644|Growth Substances|growth substances|mesh-ancestor
65455457|NCT03881644|Vasodilator Agents|vasodilator agents|mesh-ancestor
65455458|NCT01259830|Etoricoxib|etoricoxib|mesh-list
65455459|NCT01259830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65455460|NCT01259830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65455461|NCT01259830|Analgesics|analgesics|mesh-ancestor
65455462|NCT01259830|Sensory System Agents|sensory system agents|mesh-ancestor
65455463|NCT01259830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455464|NCT01259830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455465|NCT01259830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65455466|NCT01259830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65455467|NCT01259830|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65455468|NCT01259830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65455469|NCT01259830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840014|NCT01635790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64717443|NCT03799484|Prilocaine|prilocaine|mesh-list
64717444|NCT03799484|Petrolatum|petrolatum|mesh-list
64717445|NCT03799484|Botulinum Toxins|botulinum toxins|mesh-list
64325658|NCT02547038|Antacids|antacids|mesh-ancestor
64325660|NCT04984317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64692120|NCT00374621|Natriuretic Agents|natriuretic agents|mesh-ancestor
64692121|NCT00374621|Vasodilator Agents|vasodilator agents|mesh-ancestor
64692122|NCT00374621|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64692123|NCT00374621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692124|NCT03012191|Gentamicins|gentamicins|mesh-list
64692136|NCT01967641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64692137|NCT01967641|Narcotics|narcotics|mesh-ancestor
64692138|NCT01967641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64692139|NCT01967641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692140|NCT01967641|Analgesics|analgesics|mesh-ancestor
64692141|NCT01967641|Sensory System Agents|sensory system agents|mesh-ancestor
64692142|NCT01967641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692143|NCT01967641|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64692144|NCT01968421|Broncho-Vaxom|broncho-vaxom|mesh-list
64692145|NCT01968421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64692146|NCT01968421|Immunologic Factors|immunologic factors|mesh-ancestor
64692147|NCT01968421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692149|NCT02913521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64692150|NCT02913521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64692151|NCT02913521|Analgesics|analgesics|mesh-ancestor
64692152|NCT02913521|Sensory System Agents|sensory system agents|mesh-ancestor
64692153|NCT02913521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455470|NCT01259830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455471|NCT00224484|Vaccines|vaccines|mesh-list
65455472|NCT00224484|Immunologic Factors|immunologic factors|mesh-ancestor
65455473|NCT00224484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455474|NCT01265680|Epoetin Alfa|epoetin alfa|mesh-list
65455475|NCT01265680|Hematinics|hematinics|mesh-ancestor
65455476|NCT01263808|Moxifloxacin|moxifloxacin|mesh-list
65455477|NCT01263808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65455478|NCT01263808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65455479|NCT01263808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65455480|NCT01263808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65455481|NCT01263808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455482|NCT01263808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455483|NCT01263808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455484|NCT01157572|Metoprolol|metoprolol|mesh-list
65455485|NCT01157572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65455486|NCT01157572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65455487|NCT01157572|Sympatholytics|sympatholytics|mesh-ancestor
65455488|NCT01157572|Autonomic Agents|autonomic agents|mesh-ancestor
65455489|NCT01157572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455490|NCT01157572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455491|NCT01157572|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65455492|NCT01157572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65455493|NCT01157572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65455494|NCT01157572|Adrenergic Agents|adrenergic agents|mesh-ancestor
65455495|NCT01157572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65455496|NCT01157572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455497|NCT01267942|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65455498|NCT01267942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65455499|NCT01267942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65455500|NCT01267942|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64692154|NCT02913521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692155|NCT02913521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64692156|NCT02913521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64692157|NCT02913521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64692158|NCT02913521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692159|NCT02913521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692160|NCT01969201|Hormones|hormones|mesh-list
64692161|NCT01969201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64692162|NCT01969201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692163|NCT01962428|Ticagrelor|ticagrelor|mesh-list
64692164|NCT01962428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65455501|NCT01267942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455502|NCT01267942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455503|NCT00254982|Infliximab|infliximab|mesh-list
65455504|NCT00254982|Dermatologic Agents|dermatologic agents|mesh-ancestor
65455505|NCT00254982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65455506|NCT00254982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65455507|NCT01586572|Vaccines|vaccines|mesh-list
65455508|NCT01586572|Immunologic Factors|immunologic factors|mesh-ancestor
65455509|NCT01586572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455510|NCT00224016|Mandelic Acids|mandelic acids|mesh-list
65455511|NCT00224016|Oxybutynin|oxybutynin|mesh-list
65455512|NCT00224016|Parasympatholytics|parasympatholytics|mesh-ancestor
65455513|NCT00224016|Autonomic Agents|autonomic agents|mesh-ancestor
65455514|NCT00224016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455515|NCT00224016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455516|NCT00224016|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65455517|NCT00224016|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65455518|NCT00224016|Cholinergic Agents|cholinergic agents|mesh-ancestor
65455519|NCT00224016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64840071|NCT01635972|Dopamine Agents|dopamine agents|mesh-ancestor
64692165|NCT01962428|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64692166|NCT01962428|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64692167|NCT01962428|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64692168|NCT01962428|Purinergic Agents|purinergic agents|mesh-ancestor
64692169|NCT01962428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64692170|NCT01962428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692171|NCT01962428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692172|NCT01999400|Mesalamine|mesalamine|mesh-list
64692173|NCT01999400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64692174|NCT01999400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64692175|NCT01999400|Analgesics|analgesics|mesh-ancestor
64692176|NCT01999400|Sensory System Agents|sensory system agents|mesh-ancestor
64692177|NCT01999400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692178|NCT01999400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692179|NCT01999400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64692180|NCT01999400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64692181|NCT01969435|Cytarabine|cytarabine|mesh-list
64692182|NCT01969435|Etoposide|etoposide|mesh-list
64717450|NCT03799484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717451|NCT03799484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717452|NCT03799484|Sensory System Agents|sensory system agents|mesh-ancestor
64717453|NCT03799484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717454|NCT03799484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64325665|NCT04984317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64325666|NCT04984317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692186|NCT01969435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64692201|NCT01969435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64417487|NCT04804423|Listerine|listerine|mesh-list
64692203|NCT01965002|Enoxaparin|enoxaparin|mesh-list
64692204|NCT01965002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64692205|NCT01965002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64692206|NCT01965002|Analgesics|analgesics|mesh-ancestor
64692207|NCT01965002|Sensory System Agents|sensory system agents|mesh-ancestor
64692208|NCT01965002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692209|NCT01965002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455520|NCT00224016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455521|NCT00224016|Urological Agents|urological agents|mesh-ancestor
65455522|NCT00224016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65455523|NCT00224016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65455524|NCT00224016|Renal Agents|renal agents|mesh-ancestor
65455525|NCT02527174|Cytarabine|cytarabine|mesh-list
65455526|NCT02527174|Idarubicin|idarubicin|mesh-list
65455527|NCT02527174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65455528|NCT02527174|Antimetabolites|antimetabolites|mesh-ancestor
65455529|NCT02527174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455530|NCT02527174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455531|NCT02527174|Antiviral Agents|antiviral agents|mesh-ancestor
65455532|NCT02527174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65455533|NCT02527174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65455534|NCT02527174|Immunologic Factors|immunologic factors|mesh-ancestor
65455535|NCT02527174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455536|NCT02527174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65455537|NCT02527174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65455538|NCT02527174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65455539|NCT02527174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455540|NCT01161940|Nizatidine|nizatidine|mesh-list
65455541|NCT01161940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65455542|NCT01161940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65455543|NCT01161940|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65455544|NCT01161940|Histamine Antagonists|histamine antagonists|mesh-ancestor
65455545|NCT01161940|Histamine Agents|histamine agents|mesh-ancestor
65455546|NCT01161940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65455547|NCT01161940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455548|NCT01161940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455549|NCT01160068|Metformin|metformin|mesh-list
65455550|NCT01160068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65455551|NCT01160068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455552|NCT01266694|Colchicine|colchicine|mesh-list
65455553|NCT01266694|Gout Suppressants|gout suppressants|mesh-ancestor
65455554|NCT01266694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65455559|NCT01266694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455560|NCT03876886|Paclitaxel|paclitaxel|mesh-list
65455561|NCT03876886|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65455562|NCT03876886|Cyclophosphamide|cyclophosphamide|mesh-list
65455563|NCT03876886|Carboplatin|carboplatin|mesh-list
65455564|NCT03876886|Epirubicin|epirubicin|mesh-list
65205052|NCT00684268|Silybin|silybin|mesh-list
65455565|NCT03876886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65455566|NCT03876886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455567|NCT03876886|Tubulin Modulators|tubulin modulators|mesh-ancestor
65455568|NCT03876886|Antimitotic Agents|antimitotic agents|mesh-ancestor
65455569|NCT03876886|Mitosis Modulators|mitosis modulators|mesh-ancestor
65455570|NCT03876886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455571|NCT03876886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65455572|NCT03876886|Immunologic Factors|immunologic factors|mesh-ancestor
64692210|NCT01965002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64692211|NCT01965002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64692212|NCT01965002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64692213|NCT01965002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64692214|NCT01965002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692215|NCT01965002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64692216|NCT01965002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64692217|NCT01965002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692218|NCT01965002|Antipyretics|antipyretics|mesh-ancestor
64692219|NCT01965002|Anticoagulants|anticoagulants|mesh-ancestor
64692220|NCT02304757|Alendronate|alendronate|mesh-list
64692221|NCT02304757|Methylene diphosphonate|methylene diphosphonate|mesh-list
64692222|NCT02304757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64692223|NCT02304757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692224|NCT01969747|Empagliflozin|empagliflozin|mesh-list
64692225|NCT01969747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64692226|NCT01969747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692227|NCT01969747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64692228|NCT01969747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692229|NCT02002832|Risperidone|risperidone|mesh-list
64692230|NCT02002832|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64692231|NCT02002832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64692232|NCT02002832|Serotonin Agents|serotonin agents|mesh-ancestor
64692233|NCT02002832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64692234|NCT02002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692235|NCT02002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692236|NCT02002832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64692237|NCT02002832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64692238|NCT02002832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64692239|NCT02002832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64692240|NCT02002832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64692241|NCT02002832|Dopamine Agents|dopamine agents|mesh-ancestor
64692242|NCT02002832|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64692243|NCT02002832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64692244|NCT02002832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64692260|NCT02006108|Hematinics|hematinics|mesh-ancestor
64692261|NCT02006108|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64692262|NCT02006108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64692263|NCT02006342|Insulin|insulin|mesh-list
64717455|NCT03799484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64717456|NCT03799484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64717457|NCT03799484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64717458|NCT03799484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717459|NCT03799484|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65455573|NCT03876886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455574|NCT03876886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65455575|NCT03876886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65455576|NCT03876886|Alkylating Agents|alkylating agents|mesh-ancestor
65455577|NCT03876886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65455578|NCT03876886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65455579|NCT03876886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65455580|NCT03876886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65455581|NCT03876886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455582|NCT01266772|Budesonide|budesonide|mesh-list
65455583|NCT01266772|Montelukast|montelukast|mesh-list
65455584|NCT01266772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65455585|NCT01266772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65455586|NCT01266772|Autonomic Agents|autonomic agents|mesh-ancestor
65455587|NCT01266772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455588|NCT01266772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455589|NCT01266772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65455590|NCT01266772|Respiratory System Agents|respiratory system agents|mesh-ancestor
65455591|NCT01266772|Glucocorticoids|glucocorticoids|mesh-ancestor
65455592|NCT01266772|Hormones|hormones|mesh-ancestor
65455593|NCT01266772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65455594|NCT01266772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65455595|NCT01266772|Hormone Antagonists|hormone antagonists|mesh-ancestor
64840138|NCT01636310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64692271|NCT01968356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64692273|NCT01968356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64692274|NCT01968356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692275|NCT01968356|Disinfectants|disinfectants|mesh-ancestor
64692276|NCT01968356|Dermatologic Agents|dermatologic agents|mesh-ancestor
64692277|NCT02008682|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64692278|NCT02008682|Liraglutide|liraglutide|mesh-list
64692279|NCT02008682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64692280|NCT02008682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692281|NCT02008682|Incretins|incretins|mesh-ancestor
64692282|NCT02008682|Hormones|hormones|mesh-ancestor
64692283|NCT02008682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64692284|NCT02008682|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64692285|NCT02008682|Protease Inhibitors|protease inhibitors|mesh-ancestor
64692286|NCT02008682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692287|NCT02008682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692288|NCT01969916|Regadenoson|regadenoson|mesh-list
64692289|NCT01969916|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64692290|NCT01969916|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64692291|NCT01969916|Purinergic Agonists|purinergic agonists|mesh-ancestor
64692292|NCT01969916|Purinergic Agents|purinergic agents|mesh-ancestor
64692293|NCT01969916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64692294|NCT01969916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692295|NCT01969916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692296|NCT00373919|Erythromycin|erythromycin|mesh-list
65455596|NCT01266772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65455597|NCT01266772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65455598|NCT01266772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455599|NCT01264354|Adefovir|adefovir|mesh-list
65455600|NCT01264354|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65455601|NCT01264354|Clevudine|clevudine|mesh-list
65455602|NCT01264354|Antiviral Agents|antiviral agents|mesh-ancestor
65455603|NCT01264354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65455604|NCT01264354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65455605|NCT01264354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65455606|NCT01264354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455607|NCT01264354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455608|NCT01264432|Veliparib|veliparib|mesh-list
64840161|NCT01636336|Progestins|progestins|mesh-ancestor
64692297|NCT00373919|Erythromycin Estolate|erythromycin estolate|mesh-list
64692298|NCT00373919|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64692299|NCT00373919|Erythromycin stearate|erythromycin stearate|mesh-list
64692300|NCT00373919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64692301|NCT00373919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64692302|NCT00373919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64692316|NCT02918357|Chelating Agents|chelating agents|mesh-ancestor
64692317|NCT02918357|Sequestering Agents|sequestering agents|mesh-ancestor
64692318|NCT02918357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692319|NCT02918357|Anticoagulants|anticoagulants|mesh-ancestor
64692320|NCT02918357|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64692321|NCT02918357|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64692322|NCT02829983|Clarithromycin|clarithromycin|mesh-list
64692323|NCT02829983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64692324|NCT02829983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64692325|NCT02829983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64692326|NCT02829983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692327|NCT02829983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692328|NCT02829983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64692329|NCT02829983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64717463|NCT03799484|Emollients|emollients|mesh-ancestor
64717464|NCT03799484|Dermatologic Agents|dermatologic agents|mesh-ancestor
64717465|NCT00377546|Ketorolac|ketorolac|mesh-list
64717466|NCT00377546|Nepafenac|nepafenac|mesh-list
64717467|NCT00377546|Bromfenac|bromfenac|mesh-list
64717468|NCT00377546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64692334|NCT02012192|Antimitotic Agents|antimitotic agents|mesh-ancestor
64692335|NCT02012192|Mitosis Modulators|mitosis modulators|mesh-ancestor
64692336|NCT02012192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692338|NCT02066792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64692339|NCT02066792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64692340|NCT02066792|Renal Agents|renal agents|mesh-ancestor
64692341|NCT02066792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64692342|NCT02066792|Antitubercular Agents|antitubercular agents|mesh-ancestor
64692343|NCT02066792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64692344|NCT02066792|Antimetabolites|antimetabolites|mesh-ancestor
64692345|NCT02066792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692346|NCT02922959|Naloxone|naloxone|mesh-list
64692347|NCT02922959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692348|NCT02922959|Sensory System Agents|sensory system agents|mesh-ancestor
64692349|NCT02922959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692350|NCT02922959|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64692351|NCT02014363|Amitriptyline|amitriptyline|mesh-list
64692352|NCT02014363|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64692353|NCT02014363|Antidepressive Agents|antidepressive agents|mesh-ancestor
64692354|NCT02014363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65455609|NCT01264432|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65455610|NCT01264432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455611|NCT01264432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455612|NCT01264432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455613|NCT02527096|Lamivudine|lamivudine|mesh-list
65455614|NCT02527096|Dolutegravir|dolutegravir|mesh-list
65455615|NCT02527096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65455616|NCT02527096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65455617|NCT02527096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455618|NCT02527096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455619|NCT02527096|Antiviral Agents|antiviral agents|mesh-ancestor
65455620|NCT02527096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65455621|NCT02527096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65455622|NCT02527096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65455623|NCT02527096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65455624|NCT02527096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65455625|NCT01160302|Curcumin|curcumin|mesh-list
64840176|NCT01636531|Immunologic Factors|immunologic factors|mesh-ancestor
64692355|NCT02014363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64692356|NCT02014363|Analgesics|analgesics|mesh-ancestor
64692357|NCT02014363|Sensory System Agents|sensory system agents|mesh-ancestor
64692358|NCT02014363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692359|NCT02014363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692360|NCT02014363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64692361|NCT02014363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64692362|NCT02014363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64692386|NCT02834663|Ranibizumab|ranibizumab|mesh-list
64692387|NCT02834663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64692388|NCT02834663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64692389|NCT02834663|Growth Substances|growth substances|mesh-ancestor
64692390|NCT02834663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692391|NCT02834663|Growth Inhibitors|growth inhibitors|mesh-ancestor
64692392|NCT02834663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64692393|NCT01973036|Oxytocin|oxytocin|mesh-list
64692394|NCT01973036|Oxytocics|oxytocics|mesh-ancestor
64692395|NCT01973036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64692396|NCT01973036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692397|NCT02017327|Bimatoprost|bimatoprost|mesh-list
64692398|NCT02017327|Latanoprost|latanoprost|mesh-list
64692399|NCT02017327|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64692400|NCT02017327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64692401|NCT02017327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64692402|NCT02837237|Mineralocorticoids|mineralocorticoids|mesh-list
64692403|NCT02837237|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
64692404|NCT02837237|Hormones|hormones|mesh-ancestor
64692405|NCT02837237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64692406|NCT02837237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692407|NCT02837237|Hormone Antagonists|hormone antagonists|mesh-ancestor
64692408|NCT02837237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64692409|NCT02837237|Diuretics|diuretics|mesh-ancestor
64692410|NCT02837237|Natriuretic Agents|natriuretic agents|mesh-ancestor
64717471|NCT00377546|Sensory System Agents|sensory system agents|mesh-ancestor
64717472|NCT00377546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717473|NCT00377546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717474|NCT00377546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64717475|NCT00377546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65455626|NCT01160302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65455627|NCT01160302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65455628|NCT01160302|Analgesics|analgesics|mesh-ancestor
65455629|NCT01160302|Sensory System Agents|sensory system agents|mesh-ancestor
65455630|NCT01160302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455631|NCT01160302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455632|NCT01160302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65455633|NCT01160302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65455634|NCT01160302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455635|NCT01160302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455636|NCT01160302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455637|NCT01162720|Oxymetazoline|oxymetazoline|mesh-list
65455638|NCT01162720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65455639|NCT01162720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65455640|NCT01162720|Adrenergic Agents|adrenergic agents|mesh-ancestor
65455641|NCT01162720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64840194|NCT01636557|Anesthetics|anesthetics|mesh-ancestor
64717476|NCT00377546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64717477|NCT00377546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692445|NCT01973348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64692447|NCT02839889|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64692448|NCT02839889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692449|NCT02839889|Sensory System Agents|sensory system agents|mesh-ancestor
64692450|NCT02839889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692451|NCT01971385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64692452|NCT01971385|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
64692453|NCT01971385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64692454|NCT01971385|Immunologic Factors|immunologic factors|mesh-ancestor
64692455|NCT01971385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692456|NCT02925611|Desflurane|desflurane|mesh-list
64692457|NCT02925611|Isoflurane|isoflurane|mesh-list
64692458|NCT02925611|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64692459|NCT02925611|Anesthetics, General|anesthetics, general|mesh-ancestor
64692479|NCT01973335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64692481|NCT01973335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64692482|NCT01973335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692483|NCT01973335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64692484|NCT01973335|Natriuretic Agents|natriuretic agents|mesh-ancestor
64692485|NCT01973335|Anticonvulsants|anticonvulsants|mesh-ancestor
64692486|NCT01973335|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64692487|NCT01973335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692488|NCT01973335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692489|NCT01973335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64692490|NCT01973413|Insulin|insulin|mesh-list
64692491|NCT01973413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64692492|NCT01973413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692493|NCT02021461|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64692494|NCT02021461|Anticonvulsants|anticonvulsants|mesh-ancestor
64692495|NCT02021461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64692496|NCT02021461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64692497|NCT02021461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64692498|NCT02021461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692499|NCT02929667|Fluoxetine|fluoxetine|mesh-list
64417790|NCT04786327|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64692500|NCT02929667|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64692501|NCT02929667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65455642|NCT01162720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455643|NCT01162720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455644|NCT01162720|Sympathomimetics|sympathomimetics|mesh-ancestor
65455645|NCT01162720|Autonomic Agents|autonomic agents|mesh-ancestor
65455646|NCT01162720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455647|NCT01162720|Nasal Decongestants|nasal decongestants|mesh-ancestor
65455648|NCT01162720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65455649|NCT01162720|Respiratory System Agents|respiratory system agents|mesh-ancestor
65455650|NCT01268176|Vitamin D|vitamin d|mesh-list
65455651|NCT01268176|Cholecalciferol|cholecalciferol|mesh-list
65455652|NCT01268176|Vitamins|vitamins|mesh-ancestor
65455653|NCT01268176|Micronutrients|micronutrients|mesh-ancestor
65455654|NCT01268176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455655|NCT01268176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65455656|NCT01268176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65455657|NCT01264588|Calcium|calcium|mesh-list
65455658|NCT01264588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65455659|NCT01264588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455660|NCT05075200|Tranexamic Acid|tranexamic acid|mesh-list
64692502|NCT02929667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64692503|NCT02929667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692504|NCT02929667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64692505|NCT02929667|Serotonin Agents|serotonin agents|mesh-ancestor
64692506|NCT02929667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692507|NCT02929667|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64692508|NCT02929667|Antidepressive Agents|antidepressive agents|mesh-ancestor
64692509|NCT02929667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64692510|NCT02929667|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64692511|NCT02929667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64717478|NCT00377546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717479|NCT04290494|Plasminogen|plasminogen|mesh-list
64717480|NCT04290494|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64717481|NCT04290494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64717482|NCT04290494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717483|NCT04005404|Ropivacaine|ropivacaine|mesh-list
64692534|NCT02934191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692535|NCT02934191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64692537|NCT02934191|Sensory System Agents|sensory system agents|mesh-ancestor
64692545|NCT02934191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64692546|NCT02934191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64692547|NCT02934191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64692548|NCT02934191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692549|NCT02934191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692551|NCT02934191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64692552|NCT02937623|Calcium|calcium|mesh-list
64692553|NCT02937623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64692554|NCT02937623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692555|NCT01977781|Methylprednisolone|methylprednisolone|mesh-list
64692556|NCT01977781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64692557|NCT01977781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64692558|NCT01977781|Prednisolone|prednisolone|mesh-list
64692559|NCT01977781|Prednisolone acetate|prednisolone acetate|mesh-list
64692560|NCT01977781|Tacrolimus|tacrolimus|mesh-list
65455661|NCT05075200|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65455662|NCT05075200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65455663|NCT05075200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455664|NCT05075200|Hemostatics|hemostatics|mesh-ancestor
65455665|NCT05075200|Coagulants|coagulants|mesh-ancestor
65455666|NCT01158274|Capecitabine|capecitabine|mesh-list
65455667|NCT01158274|R04929097|r04929097|mesh-list
65455668|NCT01158274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65455669|NCT01158274|Antimetabolites|antimetabolites|mesh-ancestor
65455670|NCT01158274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455671|NCT01158274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455672|NCT01158274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455673|NCT01267084|Ketoconazole|ketoconazole|mesh-list
65455674|NCT01267084|Dexamethasone|dexamethasone|mesh-list
65455675|NCT01267084|Trabectedin|trabectedin|mesh-list
65455676|NCT01267084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65455677|NCT01267084|Antiemetics|antiemetics|mesh-ancestor
65455678|NCT01267084|Autonomic Agents|autonomic agents|mesh-ancestor
64692561|NCT01977781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64692562|NCT01977781|Prednisolone phosphate|prednisolone phosphate|mesh-list
64692563|NCT01977781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64692564|NCT01977781|Immunologic Factors|immunologic factors|mesh-ancestor
64692565|NCT01977781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692585|NCT02070302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64692586|NCT02070302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692587|NCT02070302|Cholinergic Agents|cholinergic agents|mesh-ancestor
64692588|NCT02070302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64692589|NCT02070302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692590|NCT02070302|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64692591|NCT02070302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692592|NCT02025439|Amantadine|amantadine|mesh-list
64692593|NCT02025439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64692594|NCT02025439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64692595|NCT02025439|Antiviral Agents|antiviral agents|mesh-ancestor
64692596|NCT02025439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64692597|NCT02025439|Dopamine Agents|dopamine agents|mesh-ancestor
64692599|NCT02025439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692600|NCT02025439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692601|NCT02025439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64692602|NCT02025439|Analgesics|analgesics|mesh-ancestor
64692603|NCT02025439|Sensory System Agents|sensory system agents|mesh-ancestor
64692604|NCT02025439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692605|NCT02939651|Pembrolizumab|pembrolizumab|mesh-list
64692606|NCT02939651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64692607|NCT02939651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64692608|NCT02026297|Tranexamic Acid|tranexamic acid|mesh-list
64692609|NCT02026297|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64692610|NCT02026297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64692611|NCT02026297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692612|NCT02026297|Hemostatics|hemostatics|mesh-ancestor
64692613|NCT02026297|Coagulants|coagulants|mesh-ancestor
64692614|NCT02070692|Tamoxifen|tamoxifen|mesh-list
64717484|NCT04005404|Anesthetics, Local|anesthetics, local|mesh-ancestor
64717485|NCT04005404|Anesthetics|anesthetics|mesh-ancestor
64717486|NCT04005404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717487|NCT04005404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717488|NCT04005404|Sensory System Agents|sensory system agents|mesh-ancestor
64717489|NCT04005404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717490|NCT03232892|Trametinib|trametinib|mesh-list
65455679|NCT01267084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455680|NCT01267084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455681|NCT01267084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65455682|NCT01267084|Glucocorticoids|glucocorticoids|mesh-ancestor
65455683|NCT01267084|Hormones|hormones|mesh-ancestor
65455684|NCT01267084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65455685|NCT01267084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65455686|NCT01267084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455687|NCT01267084|Antifungal Agents|antifungal agents|mesh-ancestor
65455688|NCT01267084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65455689|NCT01267084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65455690|NCT01267084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65455691|NCT01267084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455692|NCT01267084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840249|NCT01636622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692615|NCT02070692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64692616|NCT02070692|Hormone Antagonists|hormone antagonists|mesh-ancestor
64692620|NCT02070692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64692621|NCT02070692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64692648|NCT02869451|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64692649|NCT02869451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64692650|NCT02869451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64692652|NCT02869451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64692653|NCT02869451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64692654|NCT02869451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692655|NCT02305316|Opicapone|opicapone|mesh-list
64692656|NCT02305316|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64692657|NCT02305316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692658|NCT02305316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692659|NCT02305316|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64692660|NCT02305316|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64692661|NCT02944565|Daratumumab|daratumumab|mesh-list
64692662|NCT02944565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64692663|NCT02870309|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64692664|NCT02870309|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64692665|NCT02870309|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64692666|NCT02870309|Protease Inhibitors|protease inhibitors|mesh-ancestor
64692678|NCT01979276|Glucocorticoids|glucocorticoids|mesh-ancestor
64692679|NCT01979276|Hormones|hormones|mesh-ancestor
64692680|NCT01979276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64692681|NCT01979276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64692682|NCT01979276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64692683|NCT01979276|Immunologic Factors|immunologic factors|mesh-ancestor
64692684|NCT01979276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64692685|NCT01979276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64692686|NCT01979276|Growth Substances|growth substances|mesh-ancestor
64692687|NCT01979276|Growth Inhibitors|growth inhibitors|mesh-ancestor
64692688|NCT01979276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64692689|NCT02871011|Nitric Oxide|nitric oxide|mesh-list
64692690|NCT02871011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64692691|NCT02871011|Autonomic Agents|autonomic agents|mesh-ancestor
64692692|NCT02871011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692693|NCT02871011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692694|NCT02871011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64692695|NCT02871011|Respiratory System Agents|respiratory system agents|mesh-ancestor
64692696|NCT02871011|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65455693|NCT01267084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65455694|NCT01267084|Hormone Antagonists|hormone antagonists|mesh-ancestor
65455695|NCT01267084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65455696|NCT01267084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65455697|NCT01267084|Alkylating Agents|alkylating agents|mesh-ancestor
65455698|NCT01264822|Rabeprazole|rabeprazole|mesh-list
65455699|NCT01264822|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65455700|NCT01264822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65455701|NCT01264822|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65455702|NCT01264822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455703|NCT01264822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455704|NCT03876574|Gemcitabine|gemcitabine|mesh-list
65455705|NCT03876574|Dexamethasone|dexamethasone|mesh-list
65455706|NCT03876574|Floxuridine|floxuridine|mesh-list
65455707|NCT03876574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65455708|NCT03876574|Antiemetics|antiemetics|mesh-ancestor
65455709|NCT03876574|Autonomic Agents|autonomic agents|mesh-ancestor
65455710|NCT03876574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455711|NCT03876574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455712|NCT03876574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65455713|NCT03876574|Glucocorticoids|glucocorticoids|mesh-ancestor
65455714|NCT03876574|Hormones|hormones|mesh-ancestor
65455715|NCT03876574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65455716|NCT03876574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65455717|NCT03876574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64692697|NCT02871011|Antioxidants|antioxidants|mesh-ancestor
64692698|NCT02871011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692699|NCT02871011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64692700|NCT02871011|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64692701|NCT02871011|Vasodilator Agents|vasodilator agents|mesh-ancestor
64692702|NCT02871011|Gasotransmitters|gasotransmitters|mesh-ancestor
64692703|NCT02871011|Protective Agents|protective agents|mesh-ancestor
64692704|NCT02344238|Riboflavin|riboflavin|mesh-list
64692705|NCT02344238|Vitamin B Complex|vitamin b complex|mesh-ancestor
64692706|NCT02344238|Vitamins|vitamins|mesh-ancestor
64692707|NCT02344238|Micronutrients|micronutrients|mesh-ancestor
64692708|NCT02344238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692709|NCT02344238|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64692710|NCT02344238|Dermatologic Agents|dermatologic agents|mesh-ancestor
64692711|NCT02344316|Melatonin|melatonin|mesh-list
64717491|NCT03232892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64717492|NCT03232892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64717493|NCT03232892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64717494|NCT03232892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692712|NCT02344316|Antioxidants|antioxidants|mesh-ancestor
64692713|NCT02344316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692714|NCT02344316|Protective Agents|protective agents|mesh-ancestor
64692715|NCT02344316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692716|NCT02344316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64692717|NCT02344628|Azithromycin|azithromycin|mesh-list
65455718|NCT03876574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65455719|NCT03876574|Antimetabolites|antimetabolites|mesh-ancestor
65455720|NCT03876574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455721|NCT03876574|Antiviral Agents|antiviral agents|mesh-ancestor
65455722|NCT03876574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65455723|NCT03876574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455724|NCT03876574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65455725|NCT03876574|Immunologic Factors|immunologic factors|mesh-ancestor
65455726|NCT01158586|Levobupivacaine|levobupivacaine|mesh-list
65455727|NCT01158586|Anesthetics, Local|anesthetics, local|mesh-ancestor
65455728|NCT01158586|Anesthetics|anesthetics|mesh-ancestor
65455729|NCT01158586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65455730|NCT01158586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455731|NCT01158586|Sensory System Agents|sensory system agents|mesh-ancestor
65455732|NCT01158586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455733|NCT01267396|Sertraline|sertraline|mesh-list
65455734|NCT01267396|Antidepressive Agents|antidepressive agents|mesh-ancestor
65455735|NCT01267396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65455736|NCT01267396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65455737|NCT01267396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65455738|NCT01267396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65455739|NCT01267396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455740|NCT01267396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65455741|NCT01267396|Serotonin Agents|serotonin agents|mesh-ancestor
65455742|NCT01267396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455743|NCT01159132|Raltegravir Potassium|raltegravir potassium|mesh-list
65455744|NCT01159132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65455745|NCT01159132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65455746|NCT01159132|Antiviral Agents|antiviral agents|mesh-ancestor
65455763|NCT01161550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455764|NCT01161550|Antiviral Agents|antiviral agents|mesh-ancestor
65455765|NCT01161550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65455766|NCT01161550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65455767|NCT01161550|Immunologic Factors|immunologic factors|mesh-ancestor
65455768|NCT01161550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455769|NCT01161550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65455770|NCT01161550|Keratolytic Agents|keratolytic agents|mesh-ancestor
65455771|NCT01161550|Dermatologic Agents|dermatologic agents|mesh-ancestor
65455772|NCT01161550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65455773|NCT01161550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455774|NCT01159210|Thrombin|thrombin|mesh-list
65455775|NCT01159210|Hemostatics|hemostatics|mesh-ancestor
65455776|NCT01159210|Coagulants|coagulants|mesh-ancestor
65455777|NCT03879460|Naltrexone|naltrexone|mesh-list
65455778|NCT03879460|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65455779|NCT03879460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65455780|NCT03879460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455781|NCT03879460|Sensory System Agents|sensory system agents|mesh-ancestor
65455782|NCT03879460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455783|NCT03877120|Diazepam|diazepam|mesh-list
65455820|NCT03879382|Alkylating Agents|alkylating agents|mesh-ancestor
65455821|NCT03879382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455822|NCT03879382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455823|NCT03879382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65455824|NCT01166932|Amoxicillin|amoxicillin|mesh-list
65455825|NCT01166932|Ceftriaxone|ceftriaxone|mesh-list
65455826|NCT01166932|Clavulanic Acids|clavulanic acids|mesh-list
65455890|NCT01165372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65455891|NCT01165372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65455892|NCT01165372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65455893|NCT01165372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455894|NCT01165372|Antiviral Agents|antiviral agents|mesh-ancestor
65455895|NCT01165372|Schistosomicides|schistosomicides|mesh-ancestor
65455896|NCT01165372|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65455897|NCT01165372|Anthelmintics|anthelmintics|mesh-ancestor
65455898|NCT01280734|Melatonin|melatonin|mesh-list
65455899|NCT01280734|Antioxidants|antioxidants|mesh-ancestor
65455900|NCT01280734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455901|NCT01280734|Protective Agents|protective agents|mesh-ancestor
65455902|NCT01280734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455903|NCT01280734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65455952|NCT01167478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65455953|NCT01167478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455954|NCT01167478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65455955|NCT01167478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455956|NCT01167478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455957|NCT01167478|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65455958|NCT01167478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65455959|NCT01167478|Purinergic Agents|purinergic agents|mesh-ancestor
65455960|NCT01167478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65455961|NCT01587196|Naltrexone|naltrexone|mesh-list
65455962|NCT01587196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65455963|NCT01587196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65455964|NCT01587196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455965|NCT01587196|Sensory System Agents|sensory system agents|mesh-ancestor
65455966|NCT01587196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65455967|NCT01281514|Carboplatin|carboplatin|mesh-list
65455968|NCT01281514|Doxorubicin|doxorubicin|mesh-list
65455969|NCT01281514|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65455970|NCT01281514|Everolimus|everolimus|mesh-list
65455971|NCT01281514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65455972|NCT01281514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65455973|NCT01281514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65455974|NCT01281514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65455975|NCT01281514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65455976|NCT01281514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455977|NCT01281514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65455978|NCT01281514|Immunologic Factors|immunologic factors|mesh-ancestor
65455979|NCT01281514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455980|NCT00223080|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65455981|NCT00223080|Immunologic Factors|immunologic factors|mesh-ancestor
65455982|NCT00223080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455983|NCT00223080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65455984|NCT00223080|Antacids|antacids|mesh-ancestor
65455985|NCT00223080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455986|NCT00223080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65455987|NCT03971604|Vitamins|vitamins|mesh-list
65455988|NCT03971604|Vitamin E|vitamin e|mesh-list
65455989|NCT03971604|Vitamin A|vitamin a|mesh-list
65455990|NCT03971604|Micronutrients|micronutrients|mesh-ancestor
65455991|NCT03971604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65455992|NCT03971604|Antioxidants|antioxidants|mesh-ancestor
65455993|NCT03971604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65455994|NCT03971604|Protective Agents|protective agents|mesh-ancestor
65455995|NCT02531490|Labetalol|labetalol|mesh-list
65455996|NCT02531490|Methyldopa|methyldopa|mesh-list
65455997|NCT02531490|Nifedipine|nifedipine|mesh-list
65455998|NCT02531490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65455999|NCT02531490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65456000|NCT02531490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456001|NCT02531490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65456002|NCT02531490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456003|NCT02531490|Vasodilator Agents|vasodilator agents|mesh-ancestor
65456004|NCT02531490|Tocolytic Agents|tocolytic agents|mesh-ancestor
65456005|NCT02531490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65456006|NCT02531490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65456007|NCT02531490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65456008|NCT02531490|Adrenergic Agents|adrenergic agents|mesh-ancestor
65456009|NCT02531490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65456010|NCT02531490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65456011|NCT02531490|Sympathomimetics|sympathomimetics|mesh-ancestor
65456012|NCT02531490|Autonomic Agents|autonomic agents|mesh-ancestor
65456013|NCT02531490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65456014|NCT02531490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65456015|NCT02531490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65456016|NCT02531490|Sympatholytics|sympatholytics|mesh-ancestor
64692718|NCT02344628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64692719|NCT02344628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64692729|NCT02019758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692730|NCT02019758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64692731|NCT02019758|Respiratory System Agents|respiratory system agents|mesh-ancestor
64692732|NCT02019758|Dermatologic Agents|dermatologic agents|mesh-ancestor
64692733|NCT02019758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64692743|NCT01980589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64692744|NCT01980589|Alkylating Agents|alkylating agents|mesh-ancestor
64692745|NCT01980589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692746|NCT01980589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64692747|NCT01980589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64692748|NCT01980589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64692749|NCT01980589|Antiemetics|antiemetics|mesh-ancestor
64692750|NCT01980589|Autonomic Agents|autonomic agents|mesh-ancestor
64692751|NCT01980589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692752|NCT01980589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64692753|NCT01980589|Glucocorticoids|glucocorticoids|mesh-ancestor
64692754|NCT01980589|Hormones|hormones|mesh-ancestor
65456017|NCT02531490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65456018|NCT02531490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65456020|NCT03871114|Triamcinolone|triamcinolone|mesh-list
65456021|NCT03871114|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65456022|NCT03871114|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65456023|NCT03871114|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65456024|NCT03871114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65456025|NCT03871114|Glucocorticoids|glucocorticoids|mesh-ancestor
65456026|NCT03871114|Hormones|hormones|mesh-ancestor
65456027|NCT03871114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65456028|NCT03871114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456029|NCT03871114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65456030|NCT03871114|Immunologic Factors|immunologic factors|mesh-ancestor
65456031|NCT03871114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456032|NCT03871114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456033|NCT01281748|Methylprednisolone|methylprednisolone|mesh-list
65456034|NCT01281748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65456035|NCT01281748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65456036|NCT01281748|Prednisolone|prednisolone|mesh-list
65456037|NCT01281748|Prednisolone acetate|prednisolone acetate|mesh-list
65456038|NCT01281748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65456039|NCT01281748|Prednisolone phosphate|prednisolone phosphate|mesh-list
65456040|NCT01281748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65456041|NCT01281748|Antiemetics|antiemetics|mesh-ancestor
65456042|NCT01281748|Autonomic Agents|autonomic agents|mesh-ancestor
65456043|NCT01281748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65456044|NCT01281748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456045|NCT01281748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65456046|NCT01281748|Glucocorticoids|glucocorticoids|mesh-ancestor
64692755|NCT01980589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64692756|NCT01980589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64692757|NCT02021942|Pasireotide|pasireotide|mesh-list
64692758|NCT02021942|Hormones|hormones|mesh-ancestor
64692759|NCT02021942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64692760|NCT02021942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692761|NCT01981759|Cycloserine|cycloserine|mesh-list
64692762|NCT01981759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64692763|NCT01981759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64692764|NCT01981759|Renal Agents|renal agents|mesh-ancestor
64692765|NCT01981759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64692766|NCT01981759|Antitubercular Agents|antitubercular agents|mesh-ancestor
64692767|NCT01981759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64692768|NCT01981759|Antimetabolites|antimetabolites|mesh-ancestor
64692769|NCT01981759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456047|NCT01281748|Hormones|hormones|mesh-ancestor
65456048|NCT01281748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65456049|NCT01281748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65456050|NCT01281748|Protective Agents|protective agents|mesh-ancestor
65456051|NCT01281748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65456052|NCT01281748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456053|NCT00220740|Immunoglobulins|immunoglobulins|mesh-list
65456054|NCT00220740|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65456055|NCT00220740|Antibodies|antibodies|mesh-list
65456056|NCT00220740|gamma-Globulins|gamma-globulins|mesh-list
65456057|NCT00220740|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64692770|NCT01980524|Acipimox|acipimox|mesh-list
64692771|NCT01980524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64692772|NCT01980524|Antimetabolites|antimetabolites|mesh-ancestor
64692773|NCT01980524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692774|NCT01980524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64692775|NCT01982539|Diclofenac|diclofenac|mesh-list
64692776|NCT01982539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64692777|NCT01982539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64692778|NCT01982539|Analgesics|analgesics|mesh-ancestor
64692779|NCT01982539|Sensory System Agents|sensory system agents|mesh-ancestor
64692780|NCT01982539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692781|NCT01982539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692782|NCT01982539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64692783|NCT01982539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64692784|NCT01982539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64692785|NCT01982539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64717496|NCT03510481|Artemether|artemether|mesh-list
64717497|NCT03510481|Antimalarials|antimalarials|mesh-ancestor
64717498|NCT03510481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64717499|NCT03510481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64717500|NCT03510481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64717501|NCT03109418|Ketamine|ketamine|mesh-list
64717502|NCT03109418|Analgesics|analgesics|mesh-ancestor
64692786|NCT01982539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692787|NCT01982695|Losartan|losartan|mesh-list
64692788|NCT01982695|Lisinopril|lisinopril|mesh-list
64692789|NCT01982695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64692790|NCT01982695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64418088|NCT05700955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64692796|NCT01982695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692797|NCT01982695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64692806|NCT01981772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64692807|NCT01981772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692808|NCT01981772|Sensory System Agents|sensory system agents|mesh-ancestor
64692809|NCT01981772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692810|NCT01981772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64692811|NCT01981772|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64692812|NCT01981772|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64692813|NCT01981772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64692814|NCT01981772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692815|NCT01981772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64692816|NCT01981772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64692817|NCT01981772|Adrenergic Agents|adrenergic agents|mesh-ancestor
64692819|NCT01981772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64692820|NCT01981772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64692821|NCT01981772|Autonomic Agents|autonomic agents|mesh-ancestor
64692822|NCT01981772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64692823|NCT01981772|Respiratory System Agents|respiratory system agents|mesh-ancestor
64692825|NCT01981772|Sympathomimetics|sympathomimetics|mesh-ancestor
64692826|NCT01981772|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64692827|NCT01982240|Bisacodyl|bisacodyl|mesh-list
64692828|NCT01982240|Plecanatide|plecanatide|mesh-list
64692829|NCT01982240|Cathartics|cathartics|mesh-ancestor
64692830|NCT01982240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64692831|NCT01982240|Laxatives|laxatives|mesh-ancestor
65456058|NCT00220740|Immunoglobulin G|immunoglobulin g|mesh-list
65456059|NCT00220740|Immunologic Factors|immunologic factors|mesh-ancestor
65456060|NCT00220740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456061|NCT01273402|Antibodies|antibodies|mesh-list
65456062|NCT01273402|Immunoglobulins|immunoglobulins|mesh-list
65456063|NCT01273402|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65456064|NCT01273402|Immunologic Factors|immunologic factors|mesh-ancestor
65456065|NCT01273402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456066|NCT03873298|Nitric Oxide|nitric oxide|mesh-list
65456067|NCT03873298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65456068|NCT03873298|Autonomic Agents|autonomic agents|mesh-ancestor
65456069|NCT03873298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65456070|NCT03873298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456071|NCT03873298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65456072|NCT03873298|Respiratory System Agents|respiratory system agents|mesh-ancestor
65456073|NCT03873298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65456074|NCT03873298|Antioxidants|antioxidants|mesh-ancestor
64840628|NCT01638377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692832|NCT01982240|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64692833|NCT01982240|Enzyme Activators|enzyme activators|mesh-ancestor
64692834|NCT01982240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692835|NCT02029495|Brodalumab|brodalumab|mesh-list
64692836|NCT02029495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64692837|NCT02029495|Dermatologic Agents|dermatologic agents|mesh-ancestor
64692838|NCT02029495|Immunologic Factors|immunologic factors|mesh-ancestor
64692839|NCT02029495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692840|NCT01985425|Colchicine|colchicine|mesh-list
64692841|NCT01985425|Gout Suppressants|gout suppressants|mesh-ancestor
64692842|NCT01985425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64692843|NCT01985425|Tubulin Modulators|tubulin modulators|mesh-ancestor
64692844|NCT01985425|Antimitotic Agents|antimitotic agents|mesh-ancestor
64692845|NCT01985425|Mitosis Modulators|mitosis modulators|mesh-ancestor
64692846|NCT01985425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692847|NCT01985425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64692848|NCT02348918|Bevacizumab|bevacizumab|mesh-list
64692849|NCT02348918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64692850|NCT02348918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64692851|NCT02348918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64692852|NCT02348918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64692853|NCT02348918|Growth Substances|growth substances|mesh-ancestor
64692854|NCT02348918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692855|NCT02348918|Growth Inhibitors|growth inhibitors|mesh-ancestor
64717503|NCT03109418|Sensory System Agents|sensory system agents|mesh-ancestor
64717504|NCT03109418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717505|NCT03109418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717506|NCT03109418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64717507|NCT03109418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64717508|NCT03109418|Anesthetics, General|anesthetics, general|mesh-ancestor
64717510|NCT03109418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717511|NCT03109418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64717512|NCT03109418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64717513|NCT03109418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64692856|NCT01985581|Guanfacine|guanfacine|mesh-list
64692876|NCT02024204|Dermatologic Agents|dermatologic agents|mesh-ancestor
64692877|NCT02024204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64692878|NCT02024204|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64692879|NCT02024204|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64692880|NCT02024204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65456075|NCT03873298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456076|NCT03873298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65456077|NCT03873298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65456078|NCT03873298|Vasodilator Agents|vasodilator agents|mesh-ancestor
65456079|NCT03873298|Gasotransmitters|gasotransmitters|mesh-ancestor
65456080|NCT03873298|Protective Agents|protective agents|mesh-ancestor
65456081|NCT00184002|Prednisone|prednisone|mesh-list
65456082|NCT00184002|Cyclophosphamide|cyclophosphamide|mesh-list
65456083|NCT00184002|Doxorubicin|doxorubicin|mesh-list
65456084|NCT00184002|Vincristine|vincristine|mesh-list
65456085|NCT00184002|Rituximab|rituximab|mesh-list
65456086|NCT00184002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65456087|NCT00184002|Immunologic Factors|immunologic factors|mesh-ancestor
65456088|NCT00184002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456089|NCT00184002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65456090|NCT00184002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65456091|NCT00184002|Alkylating Agents|alkylating agents|mesh-ancestor
65456092|NCT00184002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456093|NCT00184002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456094|NCT00184002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64840645|NCT01638624|Propofol|propofol|mesh-list
64692881|NCT02024204|Adrenergic Agents|adrenergic agents|mesh-ancestor
64692882|NCT02024204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64692883|NCT02024204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692884|NCT02024204|Glucocorticoids|glucocorticoids|mesh-ancestor
64692886|NCT02024204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64692887|NCT02024204|Sympathomimetics|sympathomimetics|mesh-ancestor
64692888|NCT03930745|TOL-463|tol-463|mesh-list
64692889|NCT03930745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64692890|NCT02034019|Dexamethasone|dexamethasone|mesh-list
64692891|NCT02034019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64692892|NCT02034019|Antiemetics|antiemetics|mesh-ancestor
64692893|NCT02034019|Autonomic Agents|autonomic agents|mesh-ancestor
64692894|NCT02034019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692895|NCT02034019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692896|NCT02034019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64692897|NCT02034019|Glucocorticoids|glucocorticoids|mesh-ancestor
64692898|NCT02034019|Hormones|hormones|mesh-ancestor
64692899|NCT02034019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64692900|NCT02034019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64692901|NCT02034019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64692902|NCT02349152|Fentanyl|fentanyl|mesh-list
64692903|NCT02349152|Remifentanil|remifentanil|mesh-list
64692904|NCT02349152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64692905|NCT02349152|Narcotics|narcotics|mesh-ancestor
64692906|NCT02349152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64692907|NCT02349152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692908|NCT02349152|Analgesics|analgesics|mesh-ancestor
64692909|NCT02349152|Sensory System Agents|sensory system agents|mesh-ancestor
64692910|NCT02349152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692911|NCT02349152|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64692912|NCT02349152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64692913|NCT02349152|Anesthetics, General|anesthetics, general|mesh-ancestor
64717514|NCT03109418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456095|NCT00184002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65456096|NCT00184002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65456097|NCT00184002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65456098|NCT00184002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456099|NCT00184002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65456100|NCT00184002|Glucocorticoids|glucocorticoids|mesh-ancestor
65456101|NCT00184002|Hormones|hormones|mesh-ancestor
65456102|NCT00184002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65456103|NCT00184002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65456104|NCT00184002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65456105|NCT00184002|Tubulin Modulators|tubulin modulators|mesh-ancestor
65456106|NCT00184002|Antimitotic Agents|antimitotic agents|mesh-ancestor
65456107|NCT00184002|Mitosis Modulators|mitosis modulators|mesh-ancestor
65456108|NCT00184002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65456109|NCT01167946|Methylprednisolone|methylprednisolone|mesh-list
64840667|NCT01638663|Tolvaptan|tolvaptan|mesh-list
64717515|NCT03771560|Leucovorin|leucovorin|mesh-list
64717516|NCT03771560|Folic Acid|folic acid|mesh-list
64717517|NCT03771560|Levoleucovorin|levoleucovorin|mesh-list
64717518|NCT03771560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717519|NCT03771560|Antidotes|antidotes|mesh-ancestor
64717520|NCT03771560|Protective Agents|protective agents|mesh-ancestor
64717521|NCT03771560|Vitamin B Complex|vitamin b complex|mesh-ancestor
64717522|NCT03771560|Vitamins|vitamins|mesh-ancestor
64717523|NCT03771560|Micronutrients|micronutrients|mesh-ancestor
64692914|NCT02349152|Anesthetics|anesthetics|mesh-ancestor
64692915|NCT02035345|Carboplatin|carboplatin|mesh-list
64692923|NCT01986361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64692924|NCT01986361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64692925|NCT01986361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64692926|NCT01986361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64692927|NCT01986361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692928|NCT01986361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692930|NCT01983020|Ketamine|ketamine|mesh-list
64692931|NCT01983020|Anesthetics, Local|anesthetics, local|mesh-ancestor
64692932|NCT01983020|Anesthetics|anesthetics|mesh-ancestor
64692933|NCT01983020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64692934|NCT01983020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692935|NCT01983020|Sensory System Agents|sensory system agents|mesh-ancestor
64692941|NCT01983020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692942|NCT01983020|Analgesics|analgesics|mesh-ancestor
64692943|NCT01983020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64692944|NCT01983020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64692945|NCT01983020|Anesthetics, General|anesthetics, general|mesh-ancestor
64692946|NCT01983020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64692947|NCT01983020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64692948|NCT01983020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64692950|NCT02058511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64692951|NCT02058511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692952|NCT01983566|Omeprazole|omeprazole|mesh-list
64692953|NCT01983566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64692954|NCT01983566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64692955|NCT01983566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64692956|NCT01983566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692957|NCT01983566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692958|NCT01983878|Ramucirumab|ramucirumab|mesh-list
64692959|NCT01983878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64692960|NCT02396732|Aspirin|aspirin|mesh-list
64692961|NCT02396732|Enoxaparin|enoxaparin|mesh-list
64692962|NCT02396732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65456110|NCT01167946|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65456111|NCT01167946|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65456112|NCT01167946|Prednisolone|prednisolone|mesh-list
65456113|NCT01167946|Prednisolone acetate|prednisolone acetate|mesh-list
65456114|NCT01167946|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65456115|NCT01167946|Prednisolone phosphate|prednisolone phosphate|mesh-list
65456116|NCT01167946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65456117|NCT01167946|Antiemetics|antiemetics|mesh-ancestor
65456118|NCT01167946|Autonomic Agents|autonomic agents|mesh-ancestor
65456119|NCT01167946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65456120|NCT01167946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456121|NCT01167946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65456122|NCT01167946|Glucocorticoids|glucocorticoids|mesh-ancestor
65456123|NCT01167946|Hormones|hormones|mesh-ancestor
65456124|NCT01167946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65456125|NCT01167946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65456126|NCT01167946|Protective Agents|protective agents|mesh-ancestor
65456127|NCT01167946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65456128|NCT01167946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456129|NCT01275508|Adalimumab|adalimumab|mesh-list
65456130|NCT01275508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65456131|NCT01275508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65456132|NCT01073670|Acetaminophen|acetaminophen|mesh-list
65456133|NCT01073670|Indomethacin|indomethacin|mesh-list
65456134|NCT01073670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65456135|NCT01073670|Analgesics|analgesics|mesh-ancestor
65456136|NCT01073670|Sensory System Agents|sensory system agents|mesh-ancestor
65456137|NCT01073670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65456138|NCT01073670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456139|NCT01073670|Antipyretics|antipyretics|mesh-ancestor
65456140|NCT01073670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65456141|NCT01073670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65456142|NCT01073670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65456143|NCT01073670|Gout Suppressants|gout suppressants|mesh-ancestor
65456144|NCT01073670|Tocolytic Agents|tocolytic agents|mesh-ancestor
64840680|NCT01638689|Citalopram|citalopram|mesh-list
64692963|NCT02396732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64692964|NCT02396732|Analgesics|analgesics|mesh-ancestor
64692965|NCT02396732|Sensory System Agents|sensory system agents|mesh-ancestor
64692966|NCT02396732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692967|NCT02396732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456145|NCT01073670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65456146|NCT01073670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65456147|NCT01073670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456148|NCT01073670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456149|NCT03971370|Vaccines|vaccines|mesh-list
65456150|NCT03971370|Immunologic Factors|immunologic factors|mesh-ancestor
65456151|NCT03971370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456152|NCT01168336|Betahistine|betahistine|mesh-list
65456153|NCT01168336|Vasodilator Agents|vasodilator agents|mesh-ancestor
65456154|NCT01168336|Histamine Agonists|histamine agonists|mesh-ancestor
65456155|NCT01168336|Histamine Agents|histamine agents|mesh-ancestor
65456156|NCT01168336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65456157|NCT01168336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456158|NCT01168336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456159|NCT00165672|Rabeprazole|rabeprazole|mesh-list
65456160|NCT00165672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65456161|NCT00165672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64840725|NCT01638936|Maytansine|maytansine|mesh-list
64692968|NCT02396732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64692969|NCT02396732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64692970|NCT02396732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64692971|NCT02396732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64692972|NCT02396732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692973|NCT02396732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64692974|NCT02396732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64692975|NCT02396732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692976|NCT02396732|Antipyretics|antipyretics|mesh-ancestor
64717524|NCT03771560|Hematinics|hematinics|mesh-ancestor
64717525|NCT03767738|Aflibercept|aflibercept|mesh-list
64717526|NCT03767738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64717527|NCT03767738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64717528|NCT03767738|Growth Substances|growth substances|mesh-ancestor
64717529|NCT03767738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717530|NCT03767738|Growth Inhibitors|growth inhibitors|mesh-ancestor
64692977|NCT02396732|Anticoagulants|anticoagulants|mesh-ancestor
64692978|NCT02352974|Vitamin D|vitamin d|mesh-list
64692979|NCT02352974|Vitamins|vitamins|mesh-ancestor
64692980|NCT02352974|Micronutrients|micronutrients|mesh-ancestor
64692981|NCT02352974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692990|NCT02353754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692991|NCT02353754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64692992|NCT02353754|Narcotics|narcotics|mesh-ancestor
64692993|NCT02353754|Analgesics|analgesics|mesh-ancestor
64692994|NCT02354378|Dexmedetomidine|dexmedetomidine|mesh-list
64692995|NCT02354378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64692996|NCT02354378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64692997|NCT02354378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692998|NCT02354378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64692999|NCT02354378|Analgesics|analgesics|mesh-ancestor
64693000|NCT02354378|Sensory System Agents|sensory system agents|mesh-ancestor
64693001|NCT02354378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693002|NCT02354378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64693003|NCT02354378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64693004|NCT02354378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64693005|NCT02354378|Adrenergic Agents|adrenergic agents|mesh-ancestor
64693015|NCT02059213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693016|NCT02059213|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64693017|NCT02059213|Fertility Agents|fertility agents|mesh-ancestor
65456162|NCT00165672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65456163|NCT00165672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456164|NCT00165672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456165|NCT03870646|Hyaluronic Acid|hyaluronic acid|mesh-list
65456166|NCT03870646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65456167|NCT03870646|Immunologic Factors|immunologic factors|mesh-ancestor
65456168|NCT03870646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456169|NCT03870646|Viscosupplements|viscosupplements|mesh-ancestor
65456170|NCT03870646|Protective Agents|protective agents|mesh-ancestor
65456171|NCT01168492|Ketamine|ketamine|mesh-list
65456172|NCT01168492|Analgesics|analgesics|mesh-ancestor
65456173|NCT01168492|Sensory System Agents|sensory system agents|mesh-ancestor
65456174|NCT01168492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65456175|NCT01168492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456176|NCT01168492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65456177|NCT01168492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65456178|NCT01168492|Anesthetics, General|anesthetics, general|mesh-ancestor
65456179|NCT01168492|Anesthetics|anesthetics|mesh-ancestor
65456180|NCT01168492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65456181|NCT01168492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65456182|NCT01168492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65456183|NCT01168492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65456184|NCT01168492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456185|NCT03870490|Cefepime|cefepime|mesh-list
65456186|NCT03870490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65456187|NCT03870490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65456188|NCT01278082|Budesonide|budesonide|mesh-list
65456189|NCT01278082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65456190|NCT01278082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65456191|NCT01278082|Autonomic Agents|autonomic agents|mesh-ancestor
65456192|NCT01278082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65456193|NCT01278082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456194|NCT01278082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64693018|NCT02059213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64693019|NCT02059213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693020|NCT02059213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64693021|NCT02059213|Androgen Antagonists|androgen antagonists|mesh-ancestor
64693022|NCT02059213|Hormone Antagonists|hormone antagonists|mesh-ancestor
64693023|NCT02059213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64693024|NCT02037061|Bupivacaine|bupivacaine|mesh-list
65456195|NCT01278082|Respiratory System Agents|respiratory system agents|mesh-ancestor
65456196|NCT01278082|Glucocorticoids|glucocorticoids|mesh-ancestor
65456197|NCT01278082|Hormones|hormones|mesh-ancestor
65456198|NCT01278082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65456199|NCT03870256|Misoprostol|misoprostol|mesh-list
65456200|NCT03870256|Carbetocin|carbetocin|mesh-list
65456201|NCT03870256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65456202|NCT03870256|Abortifacient Agents|abortifacient agents|mesh-ancestor
65456203|NCT03870256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65456204|NCT03870256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456205|NCT03870256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65456206|NCT03870256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65456207|NCT03870256|Oxytocics|oxytocics|mesh-ancestor
65456208|NCT01166542|Paclitaxel|paclitaxel|mesh-list
65456209|NCT01166542|Carboplatin|carboplatin|mesh-list
65456210|NCT01166542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65456211|NCT01166542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456212|NCT01166542|Tubulin Modulators|tubulin modulators|mesh-ancestor
65456213|NCT01166542|Antimitotic Agents|antimitotic agents|mesh-ancestor
65456214|NCT01166542|Mitosis Modulators|mitosis modulators|mesh-ancestor
65456215|NCT01166542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456216|NCT00169104|Trastuzumab|trastuzumab|mesh-list
65456217|NCT00169104|Vinorelbine|vinorelbine|mesh-list
65456218|NCT00169104|Lenograstim|lenograstim|mesh-list
65456219|NCT00169104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65456220|NCT00169104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456221|NCT00169104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65456222|NCT00169104|Immunologic Factors|immunologic factors|mesh-ancestor
65456223|NCT00169104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840768|NCT01638988|Enclomiphene|enclomiphene|mesh-list
64693025|NCT02037061|Anesthetics, Local|anesthetics, local|mesh-ancestor
64693026|NCT02037061|Anesthetics|anesthetics|mesh-ancestor
64693027|NCT02037061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64693028|NCT02037061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693029|NCT02037061|Sensory System Agents|sensory system agents|mesh-ancestor
64693030|NCT02037061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693031|NCT02354534|Artesunate|artesunate|mesh-list
64693032|NCT02354534|Antimalarials|antimalarials|mesh-ancestor
64693033|NCT02354534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64693034|NCT02354534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64693035|NCT02354534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64693036|NCT02354534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64693037|NCT02354534|Antiviral Agents|antiviral agents|mesh-ancestor
64693038|NCT02354534|Schistosomicides|schistosomicides|mesh-ancestor
64693039|NCT02354534|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64693040|NCT02354534|Anthelmintics|anthelmintics|mesh-ancestor
64693041|NCT02355158|Clonidine|clonidine|mesh-list
65456224|NCT00169104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65456225|NCT00169104|Tubulin Modulators|tubulin modulators|mesh-ancestor
65456226|NCT00169104|Antimitotic Agents|antimitotic agents|mesh-ancestor
65456227|NCT00169104|Mitosis Modulators|mitosis modulators|mesh-ancestor
65456228|NCT00169104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456229|NCT03872830|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
65456230|NCT03872830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65456231|NCT03872830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65456232|NCT03872830|Analgesics|analgesics|mesh-ancestor
65456233|NCT03872830|Sensory System Agents|sensory system agents|mesh-ancestor
65456234|NCT03872830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65456235|NCT03872830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456236|NCT03872830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65456237|NCT03872830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65456238|NCT02526316|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65456239|NCT02526316|Freund's Adjuvant|freund's adjuvant|mesh-list
64693042|NCT02355158|Analgesics|analgesics|mesh-ancestor
64693043|NCT02355158|Sensory System Agents|sensory system agents|mesh-ancestor
64693044|NCT02355158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693045|NCT02355158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693046|NCT02355158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64717531|NCT03767738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64717533|NCT02973620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64717534|NCT02973620|Vasodilator Agents|vasodilator agents|mesh-ancestor
64717535|NCT02973620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64717536|NCT02973620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64717537|NCT02973620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64717538|NCT02973620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325745|NCT04965597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64693047|NCT02355158|Sympatholytics|sympatholytics|mesh-ancestor
64693048|NCT02355158|Autonomic Agents|autonomic agents|mesh-ancestor
64693054|NCT02355158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693056|NCT02033876|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64693057|NCT02033876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64693058|NCT02061397|Sirolimus|sirolimus|mesh-list
64693059|NCT02061397|Everolimus|everolimus|mesh-list
64693060|NCT02061397|Simvastatin|simvastatin|mesh-list
64693061|NCT02061397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64693062|NCT02061397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64693063|NCT02061397|Immunologic Factors|immunologic factors|mesh-ancestor
64693064|NCT02061397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693065|NCT02061397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64693066|NCT02061397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64693067|NCT02061397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64693068|NCT02061397|Antifungal Agents|antifungal agents|mesh-ancestor
64693069|NCT02061397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64693070|NCT02061397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64693071|NCT02061397|Antimetabolites|antimetabolites|mesh-ancestor
64693072|NCT02061397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693087|NCT02062177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64693089|NCT02062177|GABA Agents|gaba agents|mesh-ancestor
64693090|NCT02062177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693091|NCT02062177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693092|NCT02034578|Apixaban|apixaban|mesh-list
64693093|NCT02034578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64693094|NCT02034578|Antithrombins|antithrombins|mesh-ancestor
64693095|NCT02034578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64693096|NCT02034578|Protease Inhibitors|protease inhibitors|mesh-ancestor
65456240|NCT02526316|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65456241|NCT02526316|Immunologic Factors|immunologic factors|mesh-ancestor
65456242|NCT02526316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456243|NCT03872596|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65205711|NCT00693862|Levodopa|levodopa|mesh-list
65456244|NCT03872596|Antidepressive Agents|antidepressive agents|mesh-ancestor
65456246|NCT03872596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65456247|NCT03872596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65456248|NCT03872596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65456249|NCT03872596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456250|NCT00163020|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
65456251|NCT00163020|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
65456252|NCT00163020|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65456253|NCT00163020|Hormone Antagonists|hormone antagonists|mesh-ancestor
65456254|NCT00163020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65456255|NCT00163020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456256|NCT00163020|Progestins|progestins|mesh-ancestor
65456257|NCT00163020|Hormones|hormones|mesh-ancestor
65456258|NCT01168804|Dexamethasone|dexamethasone|mesh-list
65456259|NCT01168804|Bortezomib|bortezomib|mesh-list
65456260|NCT01168804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65456261|NCT01168804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65456262|NCT01168804|Antiemetics|antiemetics|mesh-ancestor
65456263|NCT01168804|Autonomic Agents|autonomic agents|mesh-ancestor
65456264|NCT01168804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65456265|NCT01168804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456266|NCT01168804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65456267|NCT01168804|Glucocorticoids|glucocorticoids|mesh-ancestor
65456268|NCT01168804|Hormones|hormones|mesh-ancestor
65456269|NCT01168804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65456284|NCT01169506|Silicon|silicon|mesh-list
65456285|NCT01169506|Trace Elements|trace elements|mesh-ancestor
65456286|NCT01169506|Micronutrients|micronutrients|mesh-ancestor
65456287|NCT01169506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456288|NCT01169740|Bilirubin|bilirubin|mesh-list
65456289|NCT01169740|Antioxidants|antioxidants|mesh-ancestor
65456290|NCT01169740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456291|NCT01169740|Protective Agents|protective agents|mesh-ancestor
65456292|NCT01169740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456293|NCT01169584|Molgramostim|molgramostim|mesh-list
65456294|NCT01169584|Sargramostim|sargramostim|mesh-list
65456295|NCT01169584|Immunologic Factors|immunologic factors|mesh-ancestor
65456296|NCT01169584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456297|NCT01169584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456298|NCT01169818|Insulin Glargine|insulin glargine|mesh-list
65456299|NCT01169818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64840861|NCT01639521|Tubulin Modulators|tubulin modulators|mesh-ancestor
64693097|NCT02034578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64693098|NCT02034578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693099|NCT02034578|Anticoagulants|anticoagulants|mesh-ancestor
64693100|NCT02403830|Morphine|morphine|mesh-list
64693101|NCT02403830|Methylnaltrexone|methylnaltrexone|mesh-list
64693102|NCT02403830|Ticagrelor|ticagrelor|mesh-list
64693103|NCT02403830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64693104|NCT02403830|Narcotics|narcotics|mesh-ancestor
64693105|NCT02403830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64693106|NCT02403830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693107|NCT02403830|Analgesics|analgesics|mesh-ancestor
64693108|NCT02403830|Sensory System Agents|sensory system agents|mesh-ancestor
64693109|NCT02403830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693110|NCT02403830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64693111|NCT02403830|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64693112|NCT02403830|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64693113|NCT02403830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64693114|NCT02403830|Purinergic Agents|purinergic agents|mesh-ancestor
64693115|NCT02403830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693116|NCT02403830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693117|NCT02403830|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64717539|NCT02973620|Protective Agents|protective agents|mesh-ancestor
64717540|NCT02973620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717541|NCT05313386|Dexmedetomidine|dexmedetomidine|mesh-list
64717542|NCT05313386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64717543|NCT05313386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717544|NCT05313386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717545|NCT05313386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64717546|NCT05313386|Analgesics|analgesics|mesh-ancestor
64325754|NCT02154269|Immunologic Factors|immunologic factors|mesh-ancestor
64693118|NCT02036840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64693120|NCT02951195|Ivacaftor|ivacaftor|mesh-list
64693121|NCT02951195|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64693122|NCT02951195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64693123|NCT02951195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693124|NCT02037230|Gemcitabine|gemcitabine|mesh-list
64693170|NCT03023891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693171|NCT03023891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64693172|NCT03023891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64693174|NCT03028025|Coagulants|coagulants|mesh-ancestor
64693175|NCT02955329|Nicotine|nicotine|mesh-list
64693176|NCT02955329|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64693177|NCT02955329|Autonomic Agents|autonomic agents|mesh-ancestor
65456300|NCT01169818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456301|NCT01282762|Vaccines|vaccines|mesh-list
65456302|NCT01282762|Immunologic Factors|immunologic factors|mesh-ancestor
65456303|NCT01282762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456304|NCT01282840|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65456305|NCT01282840|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65456306|NCT01282840|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65456307|NCT01282840|Cholinergic Agents|cholinergic agents|mesh-ancestor
65456308|NCT01282840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65456309|NCT01282840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456310|NCT01282840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693178|NCT02955329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693179|NCT02955329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693180|NCT02955329|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64693181|NCT02955329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64693182|NCT02955329|Cholinergic Agents|cholinergic agents|mesh-ancestor
64693183|NCT02955329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693184|NCT02955329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693185|NCT02359058|Capecitabine|capecitabine|mesh-list
64693186|NCT02359058|Oxaliplatin|oxaliplatin|mesh-list
64693205|NCT03028103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64693206|NCT03028103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693207|NCT03028103|Antifungal Agents|antifungal agents|mesh-ancestor
64693208|NCT03028103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64693209|NCT03028103|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64693210|NCT03028103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64693211|NCT03028103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64693212|NCT03028103|Hormone Antagonists|hormone antagonists|mesh-ancestor
64717552|NCT05313386|Adrenergic Agents|adrenergic agents|mesh-ancestor
64717553|NCT05313386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64717554|NCT05313386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717556|NCT03031340|Analgesics|analgesics|mesh-ancestor
64717557|NCT03031340|Sensory System Agents|sensory system agents|mesh-ancestor
64693214|NCT03028103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693215|NCT03028103|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64693216|NCT03028103|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64693217|NCT03028103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64693218|NCT03110003|Bupivacaine|bupivacaine|mesh-list
64693219|NCT03110003|Anesthetics, Local|anesthetics, local|mesh-ancestor
64693220|NCT03110003|Anesthetics|anesthetics|mesh-ancestor
64693221|NCT03110003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64693222|NCT03110003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693223|NCT03110003|Sensory System Agents|sensory system agents|mesh-ancestor
64693224|NCT03110003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693225|NCT03114995|Tirofiban|tirofiban|mesh-list
64693226|NCT03114995|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64693227|NCT03114995|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64693228|NCT03114995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693229|NCT03114995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64693230|NCT02959853|Anastrozole|anastrozole|mesh-list
64693231|NCT02959853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64693232|NCT02959853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64693233|NCT02959853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64693234|NCT02959853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64693235|NCT02959853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64693236|NCT02959853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693237|NCT02959853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64693238|NCT02959853|Hormone Antagonists|hormone antagonists|mesh-ancestor
64693239|NCT02959853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64693240|NCT02959853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693241|NCT00374465|Verapamil|verapamil|mesh-list
65456311|NCT01282840|Urological Agents|urological agents|mesh-ancestor
65456312|NCT01172548|Imatinib Mesylate|imatinib mesylate|mesh-list
65456313|NCT01172548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456314|NCT01172548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65456315|NCT01172548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456316|NCT01172548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456317|NCT01172626|Valproic Acid|valproic acid|mesh-list
65456318|NCT01172626|Anticonvulsants|anticonvulsants|mesh-ancestor
65456319|NCT01172626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456320|NCT01172626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456321|NCT01172626|GABA Agents|gaba agents|mesh-ancestor
65456322|NCT01172626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65456323|NCT01172626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456324|NCT01172626|Antimanic Agents|antimanic agents|mesh-ancestor
65456325|NCT01172626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65456326|NCT01172626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65456327|NCT01172626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65456328|NCT01172782|Hydromorphone|hydromorphone|mesh-list
65456329|NCT01172782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65456330|NCT01172782|Narcotics|narcotics|mesh-ancestor
65456331|NCT01172782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65456332|NCT01172782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456333|NCT01172782|Analgesics|analgesics|mesh-ancestor
65456334|NCT01172782|Sensory System Agents|sensory system agents|mesh-ancestor
65456335|NCT01172782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65456336|NCT03866746|Aflibercept|aflibercept|mesh-list
65456337|NCT03866746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65456338|NCT03866746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65456339|NCT03866746|Growth Substances|growth substances|mesh-ancestor
65456340|NCT03866746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456341|NCT03866746|Growth Inhibitors|growth inhibitors|mesh-ancestor
65456342|NCT03866746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456343|NCT03869398|Calcitriol|calcitriol|mesh-list
65456344|NCT03869398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64840885|NCT01639885|Interferon-alpha|interferon-alpha|mesh-list
64693242|NCT00374465|Carvedilol|carvedilol|mesh-list
64693256|NCT00374465|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64693257|NCT00374465|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64693258|NCT00374465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64693259|NCT02040116|Rituximab|rituximab|mesh-list
65456345|NCT03869398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456346|NCT03869398|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65456347|NCT03869398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65456348|NCT03869398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456349|NCT03869398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65456350|NCT03869398|Vitamins|vitamins|mesh-ancestor
65456351|NCT03869398|Micronutrients|micronutrients|mesh-ancestor
65456352|NCT03869398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65456353|NCT01170052|Sirolimus|sirolimus|mesh-list
65456354|NCT01170052|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65456355|NCT01170052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65456356|NCT01170052|Alkylating Agents|alkylating agents|mesh-ancestor
65456357|NCT01170052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456358|NCT01170052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456359|NCT01170052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65456360|NCT01170052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65456361|NCT01170052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65456362|NCT01170052|Antifungal Agents|antifungal agents|mesh-ancestor
65456363|NCT01170052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65456364|NCT01170052|Immunologic Factors|immunologic factors|mesh-ancestor
65456365|NCT01170052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456366|NCT01284478|Dexamethasone|dexamethasone|mesh-list
65456367|NCT01284478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65456368|NCT01284478|Antiemetics|antiemetics|mesh-ancestor
65456369|NCT01284478|Autonomic Agents|autonomic agents|mesh-ancestor
65456370|NCT01284478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65456371|NCT01284478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693260|NCT02040116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64693261|NCT02040116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64693262|NCT02040116|Immunologic Factors|immunologic factors|mesh-ancestor
64693263|NCT02040116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693264|NCT02040116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64693265|NCT02360774|Canagliflozin|canagliflozin|mesh-list
64693266|NCT02360774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64693267|NCT02360774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693269|NCT02360774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693270|NCT02361476|Clonidine|clonidine|mesh-list
64693271|NCT02361476|Analgesics|analgesics|mesh-ancestor
64693272|NCT02361476|Sensory System Agents|sensory system agents|mesh-ancestor
64693273|NCT02361476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693274|NCT02361476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693275|NCT02361476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64693276|NCT02361476|Sympatholytics|sympatholytics|mesh-ancestor
64717558|NCT03031340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717559|NCT03031340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717561|NCT03031340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65456372|NCT01284478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65456373|NCT01284478|Glucocorticoids|glucocorticoids|mesh-ancestor
65456374|NCT01284478|Hormones|hormones|mesh-ancestor
65456375|NCT01284478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65456376|NCT01284478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65456377|NCT01284478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456378|NCT00252720|Candesartan|candesartan|mesh-list
65456379|NCT00252720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65456380|NCT00252720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65456381|NCT00252720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65456382|NCT00252720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456383|NCT01284556|Phenobarbital|phenobarbital|mesh-list
65456384|NCT01284556|Anticonvulsants|anticonvulsants|mesh-ancestor
65456385|NCT01284556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65456386|NCT01284556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65456387|NCT01284556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456388|NCT01284556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65456389|NCT01284556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65456390|NCT01284556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65456391|NCT01284556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205865|NCT00696748|Hormones|hormones|mesh-ancestor
65456392|NCT01284556|GABA Modulators|gaba modulators|mesh-ancestor
65456393|NCT01284556|GABA Agents|gaba agents|mesh-ancestor
65456394|NCT01284556|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64840948|NCT01641016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64693285|NCT02363270|Analgesics|analgesics|mesh-ancestor
64693286|NCT02363270|Sensory System Agents|sensory system agents|mesh-ancestor
64693287|NCT02363270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693288|NCT02363270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693289|NCT02363270|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64693290|NCT02363270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64693291|NCT02363270|Anesthetics, General|anesthetics, general|mesh-ancestor
64693292|NCT02363270|Anesthetics|anesthetics|mesh-ancestor
64693293|NCT02363270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64693294|NCT02363270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64693295|NCT02363270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64693296|NCT02363270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693297|NCT02363270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693298|NCT02042534|Warfarin|warfarin|mesh-list
64693299|NCT02042534|Rivaroxaban|rivaroxaban|mesh-list
64693300|NCT02042534|Anticoagulants|anticoagulants|mesh-ancestor
64693301|NCT02042534|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64693302|NCT02042534|Antithrombins|antithrombins|mesh-ancestor
64693309|NCT02043704|Analgesics|analgesics|mesh-ancestor
64693310|NCT02043704|Sensory System Agents|sensory system agents|mesh-ancestor
64693311|NCT02043704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693312|NCT02043704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693313|NCT02043704|Antipyretics|antipyretics|mesh-ancestor
65456395|NCT01284556|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65456396|NCT01284556|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65456397|NCT01170130|Lidocaine|lidocaine|mesh-list
65456398|NCT01170130|Anesthetics, Local|anesthetics, local|mesh-ancestor
65456399|NCT01170130|Anesthetics|anesthetics|mesh-ancestor
65456400|NCT01170130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65456401|NCT01170130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456402|NCT01170130|Sensory System Agents|sensory system agents|mesh-ancestor
65456403|NCT01170130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65456404|NCT01170130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65456405|NCT01170130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65456406|NCT01170130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65456407|NCT01170130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65456408|NCT01170130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456409|NCT03868852|Apatinib|apatinib|mesh-list
65456410|NCT03868852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456411|NCT03868852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65456412|NCT03868852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456413|NCT03868852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456414|NCT01283776|Cyclophosphamide|cyclophosphamide|mesh-list
65456415|NCT01283776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65456416|NCT01283776|Immunologic Factors|immunologic factors|mesh-ancestor
65456417|NCT01283776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456418|NCT01283776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65456419|NCT01283776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65456420|NCT01283776|Alkylating Agents|alkylating agents|mesh-ancestor
65456421|NCT01283776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456422|NCT01283776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456423|NCT01283776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65456424|NCT01163500|Ubiquinone|ubiquinone|mesh-list
65456425|NCT01163500|Coenzyme Q10|coenzyme q10|mesh-list
65456426|NCT01163500|Micronutrients|micronutrients|mesh-ancestor
65456427|NCT01163500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693314|NCT02410382|Dexamethasone|dexamethasone|mesh-list
64693315|NCT02410382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64693316|NCT02410382|Antiemetics|antiemetics|mesh-ancestor
64693317|NCT02410382|Autonomic Agents|autonomic agents|mesh-ancestor
64693318|NCT02410382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693319|NCT02410382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693320|NCT02410382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65456428|NCT01163500|Vitamins|vitamins|mesh-ancestor
65456429|NCT01163734|Ranolazine|ranolazine|mesh-list
65456430|NCT01163734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65456431|NCT01163734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65456432|NCT01163734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456433|NCT01284868|Propranolol|propranolol|mesh-list
65456434|NCT01284868|Bisoprolol|bisoprolol|mesh-list
65456435|NCT01284868|Mirabegron|mirabegron|mesh-list
65456436|NCT01284868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65456437|NCT01284868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65456438|NCT01284868|Adrenergic Agents|adrenergic agents|mesh-ancestor
65456439|NCT01284868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65456440|NCT01284868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456441|NCT01284868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456442|NCT01284868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65456443|NCT01284868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65456444|NCT01284868|Vasodilator Agents|vasodilator agents|mesh-ancestor
65456445|NCT01284868|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65456446|NCT01284868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65456447|NCT01284868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64693321|NCT02410382|Glucocorticoids|glucocorticoids|mesh-ancestor
64693322|NCT02410382|Hormones|hormones|mesh-ancestor
64693323|NCT02410382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64693324|NCT02410382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64693325|NCT02410382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64693326|NCT03038867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64693327|NCT03038867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64693328|NCT03038867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64693329|NCT03038867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64693330|NCT03038867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693331|NCT03038867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693332|NCT03038867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693333|NCT03038867|Analgesics|analgesics|mesh-ancestor
64693334|NCT03038867|Sensory System Agents|sensory system agents|mesh-ancestor
64693335|NCT03038867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693336|NCT03038867|Antidepressive Agents|antidepressive agents|mesh-ancestor
64693337|NCT03038867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64693338|NCT03038867|Dopamine Agents|dopamine agents|mesh-ancestor
64693340|NCT03119831|Chlorhexidine|chlorhexidine|mesh-list
64693341|NCT03119831|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64693342|NCT03119831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64693343|NCT03119831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64693344|NCT03119831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64693345|NCT03119831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693346|NCT03119831|Disinfectants|disinfectants|mesh-ancestor
64693347|NCT03119831|Dermatologic Agents|dermatologic agents|mesh-ancestor
64693348|NCT02965781|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
64693351|NCT02965781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693353|NCT03124121|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64693354|NCT03124121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64693355|NCT03124121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64693356|NCT03124121|Immunologic Factors|immunologic factors|mesh-ancestor
64693357|NCT03124121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693358|NCT03042299|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65456448|NCT01284868|Urological Agents|urological agents|mesh-ancestor
65456449|NCT01284868|Sympatholytics|sympatholytics|mesh-ancestor
65456450|NCT01284868|Autonomic Agents|autonomic agents|mesh-ancestor
65456451|NCT01284868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65456452|NCT01284868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65456453|NCT01170442|Vitamin D|vitamin d|mesh-list
65456454|NCT01170442|Ergocalciferols|ergocalciferols|mesh-list
65456455|NCT01170442|Cholecalciferol|cholecalciferol|mesh-list
65456456|NCT01170442|Vitamins|vitamins|mesh-list
65456457|NCT01170442|Micronutrients|micronutrients|mesh-ancestor
65456458|NCT01170442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456459|NCT01170442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65456460|NCT01170442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65456461|NCT00252564|Leucovorin|leucovorin|mesh-list
65456462|NCT00252564|Bevacizumab|bevacizumab|mesh-list
65456463|NCT00252564|Cetuximab|cetuximab|mesh-list
65456464|NCT00252564|Fluorouracil|fluorouracil|mesh-list
65456465|NCT00252564|Oxaliplatin|oxaliplatin|mesh-list
65456466|NCT00252564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65456467|NCT00252564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456468|NCT00252564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65456469|NCT00252564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65456470|NCT00252564|Growth Substances|growth substances|mesh-ancestor
65456471|NCT00252564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456472|NCT00252564|Growth Inhibitors|growth inhibitors|mesh-ancestor
65456473|NCT00252564|Antimetabolites|antimetabolites|mesh-ancestor
65456474|NCT00252564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456475|NCT00252564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65456476|NCT00252564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65456477|NCT00252564|Immunologic Factors|immunologic factors|mesh-ancestor
64841032|NCT01643980|Hormones|hormones|mesh-ancestor
64693359|NCT03042299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64693360|NCT03042299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64693361|NCT03042299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693362|NCT00374699|Bortezomib|bortezomib|mesh-list
64693363|NCT00374699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64693364|NCT00374777|Nitrazepam|nitrazepam|mesh-list
64693365|NCT00374777|Zolpidem|zolpidem|mesh-list
64693366|NCT00374777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64693367|NCT00374777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64693368|NCT00374777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64693369|NCT00374777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693370|NCT00374777|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64693371|NCT00374777|GABA Agonists|gaba agonists|mesh-ancestor
64693391|NCT02044796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64693392|NCT02044796|Immunologic Factors|immunologic factors|mesh-ancestor
65456478|NCT00252564|Antidotes|antidotes|mesh-ancestor
65456479|NCT00252564|Protective Agents|protective agents|mesh-ancestor
65456480|NCT00252564|Vitamin B Complex|vitamin b complex|mesh-ancestor
65456481|NCT00252564|Vitamins|vitamins|mesh-ancestor
65456482|NCT00252564|Micronutrients|micronutrients|mesh-ancestor
65456483|NCT01284946|Deferasirox|deferasirox|mesh-list
65456484|NCT01284946|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65456485|NCT01284946|Chelating Agents|chelating agents|mesh-ancestor
65456486|NCT01284946|Sequestering Agents|sequestering agents|mesh-ancestor
65456487|NCT01284946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456488|NCT01173562|Mebendazole|mebendazole|mesh-list
65456489|NCT01173562|Piperazine|piperazine|mesh-list
65456490|NCT01173562|Piperazine citrate|piperazine citrate|mesh-list
65456491|NCT01173562|DMP 777|dmp 777|mesh-list
65456492|NCT01173562|Antinematodal Agents|antinematodal agents|mesh-ancestor
65456493|NCT01173562|Anthelmintics|anthelmintics|mesh-ancestor
65456494|NCT01173562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65456495|NCT01173562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65456496|NCT01173562|Tubulin Modulators|tubulin modulators|mesh-ancestor
65456497|NCT01173562|Antimitotic Agents|antimitotic agents|mesh-ancestor
65456498|NCT01173562|Mitosis Modulators|mitosis modulators|mesh-ancestor
65456499|NCT01173562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841068|NCT01646437|Antipyretics|antipyretics|mesh-ancestor
64693393|NCT02044796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693394|NCT02044796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64693396|NCT02044796|Sensory System Agents|sensory system agents|mesh-ancestor
64693397|NCT02044796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693398|NCT02044796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64693399|NCT02044796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64693401|NCT02973503|Grazoprevir|grazoprevir|mesh-list
64693402|NCT02973503|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
64693403|NCT02973503|Antiviral Agents|antiviral agents|mesh-ancestor
64693404|NCT02973503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64693405|NCT03127943|Lidocaine|lidocaine|mesh-list
64693406|NCT03127943|Anesthetics, Local|anesthetics, local|mesh-ancestor
64693407|NCT03127943|Anesthetics|anesthetics|mesh-ancestor
64693408|NCT03127943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64693409|NCT03127943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693410|NCT03127943|Sensory System Agents|sensory system agents|mesh-ancestor
64693411|NCT03127943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693412|NCT03127943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64693413|NCT03127943|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64693414|NCT03127943|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64693415|NCT03127943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64693416|NCT03127943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693418|NCT03048383|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64693419|NCT03048383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64693420|NCT03048383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693421|NCT03048383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693422|NCT03048383|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64693423|NCT03048383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64693424|NCT03048383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693425|NCT03048383|Cholinergic Agents|cholinergic agents|mesh-ancestor
64693426|NCT03048383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65456500|NCT01173562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456501|NCT01173562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456502|NCT00166296|Citalopram|citalopram|mesh-list
65456503|NCT00166296|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65456504|NCT00166296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65456505|NCT00166296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65456506|NCT00166296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456507|NCT00166296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65456508|NCT00166296|Serotonin Agents|serotonin agents|mesh-ancestor
65456509|NCT00166296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456510|NCT00166296|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64693427|NCT02045264|Icatibant|icatibant|mesh-list
64693428|NCT02045264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64693439|NCT02045264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64693440|NCT02045264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64693441|NCT02045264|Immunologic Factors|immunologic factors|mesh-ancestor
64693442|NCT02975297|Exenatide|exenatide|mesh-list
64693443|NCT02975297|Nicotine|nicotine|mesh-list
64693444|NCT02975297|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64693445|NCT02975297|Autonomic Agents|autonomic agents|mesh-ancestor
64717571|NCT03405259|Cariostatic Agents|cariostatic agents|mesh-ancestor
64717572|NCT03405259|Protective Agents|protective agents|mesh-ancestor
64693446|NCT02975297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693447|NCT02975297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693448|NCT02975297|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64693449|NCT02975297|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64693450|NCT02975297|Cholinergic Agents|cholinergic agents|mesh-ancestor
64693451|NCT02975297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693452|NCT02975297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693453|NCT02975297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64693454|NCT02975297|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64693455|NCT02975297|Incretins|incretins|mesh-ancestor
64693456|NCT02975297|Hormones|hormones|mesh-ancestor
64693457|NCT02975297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64693458|NCT02046200|Ethanol|ethanol|mesh-list
64693459|NCT02046200|Ivermectin|ivermectin|mesh-list
64693460|NCT02046200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64693461|NCT02046200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64693462|NCT02046200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64693463|NCT02046200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693464|NCT02046200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64693465|NCT02978339|Curcumin|curcumin|mesh-list
64693466|NCT02978339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64693467|NCT02978339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64693468|NCT02978339|Analgesics|analgesics|mesh-ancestor
64693469|NCT02978339|Sensory System Agents|sensory system agents|mesh-ancestor
64693470|NCT02978339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693471|NCT02978339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693472|NCT02978339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64693473|NCT02978339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64693474|NCT02978339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64693475|NCT02978339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64693476|NCT02978339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693477|NCT02367872|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
64693478|NCT02367872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64693479|NCT02367872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693480|NCT00374855|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64693481|NCT00374855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64693482|NCT00374855|Diuretics|diuretics|mesh-ancestor
64693483|NCT00374855|Natriuretic Agents|natriuretic agents|mesh-ancestor
64693484|NCT00374855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693485|NCT00374855|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65456511|NCT00166296|Antidepressive Agents|antidepressive agents|mesh-ancestor
65456512|NCT00166296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65456513|NCT01173640|Midazolam|midazolam|mesh-list
65456514|NCT01173640|Resveratrol|resveratrol|mesh-list
65456515|NCT01173640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65456516|NCT01173640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65456517|NCT01173640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65456518|NCT01173640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456519|NCT01173640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65456520|NCT01173640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65456521|NCT01173640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65456522|NCT01173640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65456523|NCT01173640|Anesthetics, General|anesthetics, general|mesh-ancestor
65456524|NCT01173640|Anesthetics|anesthetics|mesh-ancestor
65456525|NCT01173640|GABA Modulators|gaba modulators|mesh-ancestor
65456526|NCT01173640|GABA Agents|gaba agents|mesh-ancestor
65456527|NCT01173640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65456528|NCT01173640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456529|NCT01173640|Antioxidants|antioxidants|mesh-ancestor
65456530|NCT01173640|Protective Agents|protective agents|mesh-ancestor
65456531|NCT01173640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456532|NCT01173640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65456533|NCT00252174|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
64693486|NCT00374855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64693487|NCT00374855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693488|NCT02412644|Apremilast|apremilast|mesh-list
64693489|NCT02412644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64693490|NCT02412644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64693500|NCT02412644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693502|NCT02413034|Cefazolin|cefazolin|mesh-list
64693503|NCT02413034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64693504|NCT02413034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64693505|NCT04737473|Anesthetics|anesthetics|mesh-list
64693506|NCT04737473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64693507|NCT04737473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693508|NCT02369900|Esmolol|esmolol|mesh-list
64693509|NCT02369900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64693510|NCT02369900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64693511|NCT02369900|Adrenergic Agents|adrenergic agents|mesh-ancestor
64693512|NCT02369900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693513|NCT02369900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717573|NCT03405259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717574|NCT03513757|Lidocaine|lidocaine|mesh-list
64693517|NCT03054857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64693518|NCT03054857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64693519|NCT03054857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693520|NCT03054857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64693521|NCT03054857|Analgesics|analgesics|mesh-ancestor
64693522|NCT03054857|Sensory System Agents|sensory system agents|mesh-ancestor
64693523|NCT03054857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693524|NCT03054857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65456534|NCT00252174|Hallucinogens|hallucinogens|mesh-ancestor
65456535|NCT00252174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456536|NCT00252174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65456537|NCT00252174|Serotonin Agents|serotonin agents|mesh-ancestor
65456538|NCT00252174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65456539|NCT00252174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456540|NCT00252174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65456541|NCT00252174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65456542|NCT00252174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65456543|NCT00252174|Adrenergic Agents|adrenergic agents|mesh-ancestor
65456544|NCT03868306|Chrysarobin|chrysarobin|mesh-list
65456545|NCT03868306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65456546|NCT03868306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65456547|NCT03868306|Analgesics|analgesics|mesh-ancestor
65456548|NCT03868306|Sensory System Agents|sensory system agents|mesh-ancestor
65456549|NCT03868306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693525|NCT03054857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64693526|NCT03054857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64693527|NCT03054857|Adrenergic Agents|adrenergic agents|mesh-ancestor
64693528|NCT03054857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693529|NCT03054857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693530|NCT02414204|Sildenafil Citrate|sildenafil citrate|mesh-list
64693531|NCT02414204|Vasodilator Agents|vasodilator agents|mesh-ancestor
64693532|NCT02414204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64693533|NCT02414204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64693534|NCT02414204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64693535|NCT02414204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693536|NCT02414204|Urological Agents|urological agents|mesh-ancestor
64693537|NCT02049476|Dexamethasone|dexamethasone|mesh-list
64693538|NCT02049476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64693539|NCT02049476|Antiemetics|antiemetics|mesh-ancestor
64418844|NCT01664533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64693540|NCT02049476|Autonomic Agents|autonomic agents|mesh-ancestor
64693541|NCT02049476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693542|NCT02049476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693543|NCT02049476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64693544|NCT02049476|Glucocorticoids|glucocorticoids|mesh-ancestor
64693545|NCT02049476|Hormones|hormones|mesh-ancestor
64693546|NCT02049476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64693547|NCT02049476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64693548|NCT02049476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64693549|NCT02989493|Doxazosin|doxazosin|mesh-list
64693550|NCT02989493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64693551|NCT02989493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64693552|NCT02989493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64693564|NCT02371850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64693565|NCT02371850|Autonomic Agents|autonomic agents|mesh-ancestor
64693566|NCT02371850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693567|NCT02371850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693568|NCT02371850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64693569|NCT02371850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64693570|NCT02371850|Cholinergic Agents|cholinergic agents|mesh-ancestor
64693571|NCT02371850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693572|NCT02371850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693573|NCT03144635|Grazoprevir|grazoprevir|mesh-list
64693574|NCT03144635|Antiviral Agents|antiviral agents|mesh-ancestor
64693575|NCT03144635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65456550|NCT03868306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456551|NCT03868306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65456552|NCT03868306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65456553|NCT01164046|Vitamin K|vitamin k|mesh-list
65456554|NCT01164046|Heparin|heparin|mesh-list
65456555|NCT01164046|Enoxaparin|enoxaparin|mesh-list
65456556|NCT01164046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65456557|NCT01164046|Tinzaparin|tinzaparin|mesh-list
65456558|NCT01164046|Dalteparin|dalteparin|mesh-list
65456559|NCT01164046|Nadroparin|nadroparin|mesh-list
65456560|NCT01164046|Reviparin|reviparin|mesh-list
65456561|NCT01164046|Warfarin|warfarin|mesh-list
65456562|NCT01164046|Acenocoumarol|acenocoumarol|mesh-list
65456563|NCT01164046|Phenprocoumon|phenprocoumon|mesh-list
65456564|NCT01164046|Bemiparin|bemiparin|mesh-list
65456565|NCT01164046|Certoparin|certoparin|mesh-list
65456566|NCT01164046|Vitamins|vitamins|mesh-ancestor
65456567|NCT01164046|Micronutrients|micronutrients|mesh-ancestor
65456568|NCT01164046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456569|NCT01164046|Anticoagulants|anticoagulants|mesh-ancestor
65456570|NCT01164046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65456571|NCT01164046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65456572|NCT01164046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456573|NCT01164046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65456574|NCT01164046|Hemostatics|hemostatics|mesh-ancestor
65456575|NCT01164046|Coagulants|coagulants|mesh-ancestor
64693576|NCT03145259|Diclofenac|diclofenac|mesh-list
64693577|NCT03145259|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
64693578|NCT03145259|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64693579|NCT03145259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64693580|NCT03145259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64693581|NCT03145259|Analgesics|analgesics|mesh-ancestor
64693582|NCT03145259|Sensory System Agents|sensory system agents|mesh-ancestor
64693583|NCT03145259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693584|NCT03145259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693585|NCT03145259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64693586|NCT03145259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64693587|NCT03145259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64693588|NCT03145259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64693589|NCT03145259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693590|NCT00354692|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64693591|NCT00354692|Ferric gluconate|ferric gluconate|mesh-list
64693592|NCT00354692|Hematinics|hematinics|mesh-ancestor
64693593|NCT02989727|Lamotrigine|lamotrigine|mesh-list
64693594|NCT02989727|Anticonvulsants|anticonvulsants|mesh-ancestor
64693595|NCT02989727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64693596|NCT02989727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64693597|NCT02989727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693598|NCT02989727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64693599|NCT02989727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693600|NCT02989727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64693601|NCT02989727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64693602|NCT02989727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64693603|NCT02989727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64693604|NCT02989727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65456576|NCT01075464|Paclitaxel|paclitaxel|mesh-list
65456577|NCT01075464|Bevacizumab|bevacizumab|mesh-list
65456578|NCT01075464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65456579|NCT01075464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456580|NCT01075464|Tubulin Modulators|tubulin modulators|mesh-ancestor
65456581|NCT01075464|Antimitotic Agents|antimitotic agents|mesh-ancestor
65456582|NCT01075464|Mitosis Modulators|mitosis modulators|mesh-ancestor
65456583|NCT01075464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456584|NCT01075464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65456585|NCT01075464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65456586|NCT01075464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65456587|NCT01075464|Growth Substances|growth substances|mesh-ancestor
65456588|NCT01075464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456589|NCT01075464|Growth Inhibitors|growth inhibitors|mesh-ancestor
65456590|NCT01074996|Leucovorin|leucovorin|mesh-list
65456591|NCT01074996|Antidotes|antidotes|mesh-ancestor
64841156|NCT01650181|Vitamins|vitamins|mesh-ancestor
64693606|NCT02039947|Dabrafenib|dabrafenib|mesh-list
64693607|NCT02039947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64693608|NCT02039947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64693609|NCT02039947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64693610|NCT02039947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693611|NCT02052752|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64693612|NCT02052752|Dermatologic Agents|dermatologic agents|mesh-ancestor
64418928|NCT05628883|Analgesics|analgesics|mesh-ancestor
64693613|NCT02996591|Dexamethasone|dexamethasone|mesh-list
64693614|NCT02996591|Dexamethasone acetate|dexamethasone acetate|mesh-list
64693642|NCT02996591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64693643|NCT02996591|Anesthetics, General|anesthetics, general|mesh-ancestor
64693645|NCT02996591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64693646|NCT02996591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64693647|NCT02996591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64693648|NCT02996591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693649|NCT02996591|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64693650|NCT02996591|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64693651|NCT02996591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64693652|NCT02996591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64693653|NCT02996591|GABA Modulators|gaba modulators|mesh-ancestor
64693655|NCT02996591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64693656|NCT02996591|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64693657|NCT02996591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64693658|NCT02996591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64693659|NCT02996591|Cholinergic Agents|cholinergic agents|mesh-ancestor
64693660|NCT03066947|Interferons|interferons|mesh-list
64693661|NCT03066947|Interferon-alpha|interferon-alpha|mesh-list
64693662|NCT03066947|Interferon alpha-2|interferon alpha-2|mesh-list
64693663|NCT03066947|Cyclophosphamide|cyclophosphamide|mesh-list
64693664|NCT03066947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64693665|NCT03066947|Immunologic Factors|immunologic factors|mesh-ancestor
64693666|NCT03066947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693678|NCT02043145|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64693679|NCT02043145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64693680|NCT02043145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693681|NCT02043145|Cholinergic Agents|cholinergic agents|mesh-ancestor
64693682|NCT02043145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693683|NCT02043145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693684|NCT02043145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64693685|NCT02043145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693686|NCT02062801|Ephedrine|ephedrine|mesh-list
65456592|NCT01074996|Protective Agents|protective agents|mesh-ancestor
65456593|NCT01074996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456594|NCT01074996|Vitamin B Complex|vitamin b complex|mesh-ancestor
65456595|NCT01074996|Vitamins|vitamins|mesh-ancestor
65456596|NCT01074996|Micronutrients|micronutrients|mesh-ancestor
65456597|NCT00160680|Levocetirizine|levocetirizine|mesh-list
65456598|NCT00160680|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65456599|NCT00160680|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65456600|NCT00160680|Histamine Antagonists|histamine antagonists|mesh-ancestor
65456601|NCT00160680|Histamine Agents|histamine agents|mesh-ancestor
65456602|NCT00160680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65456603|NCT00160680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456604|NCT00160680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456605|NCT00160524|Certolizumab Pegol|certolizumab pegol|mesh-list
65456606|NCT00160524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65456607|NCT00160524|Immunologic Factors|immunologic factors|mesh-ancestor
65456608|NCT00160524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456609|NCT00160524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65456610|NCT01077570|Repaglinide|repaglinide|mesh-list
65456611|NCT01077570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65456612|NCT01077570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717586|NCT03513757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64717587|NCT03513757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64325797|NCT02267239|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64325799|NCT02267239|Hexetidine|hexetidine|mesh-list
64325800|NCT02267239|Menthol|menthol|mesh-list
64693687|NCT02062801|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64693688|NCT02062801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693689|NCT02062801|Sympathomimetics|sympathomimetics|mesh-ancestor
64693690|NCT02062801|Autonomic Agents|autonomic agents|mesh-ancestor
64693691|NCT02062801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693692|NCT02062801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64693693|NCT02062801|Adrenergic Agents|adrenergic agents|mesh-ancestor
64693694|NCT02062801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693695|NCT02062801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693696|NCT03152591|Licogliflozin|licogliflozin|mesh-list
64693697|NCT03152591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64693698|NCT03152591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693699|NCT03152591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64693700|NCT03152591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693701|NCT02063035|Tranexamic Acid|tranexamic acid|mesh-list
64693702|NCT02063035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64693703|NCT02063035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64693704|NCT02063035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693705|NCT02063035|Hemostatics|hemostatics|mesh-ancestor
64693706|NCT02063035|Coagulants|coagulants|mesh-ancestor
64693707|NCT00375245|Sirolimus|sirolimus|mesh-list
64693708|NCT00375245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64693710|NCT00375245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64693711|NCT00375245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64693712|NCT00375245|Antifungal Agents|antifungal agents|mesh-ancestor
64693713|NCT00375245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64693714|NCT00375245|Immunologic Factors|immunologic factors|mesh-ancestor
65456613|NCT01075698|Telmisartan|telmisartan|mesh-list
65456614|NCT01075698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65456615|NCT01075698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65456616|NCT01075698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65456617|NCT01075698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456618|NCT00159822|Voriconazole|voriconazole|mesh-list
65456619|NCT00159822|Antifungal Agents|antifungal agents|mesh-ancestor
65456620|NCT00159822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65456621|NCT00159822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65456622|NCT00159822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65456623|NCT00159822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456624|NCT00159822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456625|NCT00159822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65456626|NCT00159822|Hormone Antagonists|hormone antagonists|mesh-ancestor
65456627|NCT00159822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65456628|NCT00159822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456629|NCT00159822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65456630|NCT00158262|Propranolol|propranolol|mesh-list
65456631|NCT00158262|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65456632|NCT00158262|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65456633|NCT00158262|Adrenergic Agents|adrenergic agents|mesh-ancestor
65456634|NCT00158262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64841187|NCT01650428|Growth Substances|growth substances|mesh-ancestor
64693715|NCT00375245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693716|NCT02043379|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64693717|NCT02043379|Immunologic Factors|immunologic factors|mesh-ancestor
64693718|NCT02043379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693719|NCT02054156|Azithromycin|azithromycin|mesh-list
64693720|NCT02054156|Tobramycin|tobramycin|mesh-list
64693721|NCT02054156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64693722|NCT02054156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64693723|NCT03159143|Docetaxel|docetaxel|mesh-list
64693724|NCT03159143|Oxaliplatin|oxaliplatin|mesh-list
64693725|NCT03159143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64693726|NCT03159143|Tubulin Modulators|tubulin modulators|mesh-ancestor
64693727|NCT03159143|Antimitotic Agents|antimitotic agents|mesh-ancestor
64693728|NCT03159143|Mitosis Modulators|mitosis modulators|mesh-ancestor
64693729|NCT03159143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693730|NCT03068897|Ibuprofen|ibuprofen|mesh-list
64693749|NCT03068897|GABA Agents|gaba agents|mesh-ancestor
64693750|NCT03068897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693751|NCT03068897|Anticonvulsants|anticonvulsants|mesh-ancestor
64693752|NCT03068897|Parasympatholytics|parasympatholytics|mesh-ancestor
64693753|NCT03068897|Autonomic Agents|autonomic agents|mesh-ancestor
64693754|NCT03068897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64693755|NCT03068897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64693756|NCT03068897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64717594|NCT03513757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64717595|NCT03513757|Analgesics|analgesics|mesh-ancestor
65456635|NCT00158262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456636|NCT00158262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456637|NCT00158262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65456638|NCT00158262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65456639|NCT00158262|Vasodilator Agents|vasodilator agents|mesh-ancestor
65456640|NCT03868072|Tofacitinib|tofacitinib|mesh-list
65456641|NCT03868072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65456642|NCT03868072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456643|NCT03868072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456644|NCT02526394|Vaccines|vaccines|mesh-list
65456645|NCT02526394|Immunologic Factors|immunologic factors|mesh-ancestor
64841214|NCT01650441|Hormones|hormones|mesh-ancestor
64717596|NCT03513757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64717597|NCT03513757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64717598|NCT03513757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64456896|NCT01733121|Tetrabenazine|tetrabenazine|mesh-list
64717599|NCT03513757|Adrenergic Agents|adrenergic agents|mesh-ancestor
64717600|NCT03513757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64717601|NCT03513757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64693766|NCT03069677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693767|NCT03069677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64693768|NCT03069677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64693769|NCT03069677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64693770|NCT03069677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64693771|NCT03069677|Anesthetics, General|anesthetics, general|mesh-ancestor
64693772|NCT03069677|Anesthetics|anesthetics|mesh-ancestor
64693773|NCT03069677|GABA Modulators|gaba modulators|mesh-ancestor
64693774|NCT03069677|GABA Agents|gaba agents|mesh-ancestor
64693775|NCT03069677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693776|NCT03069677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693777|NCT02055638|SRX246|srx246|mesh-list
64693778|NCT02055638|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64693779|NCT02055638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693780|NCT02055638|Natriuretic Agents|natriuretic agents|mesh-ancestor
64693781|NCT02055638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693782|NCT02044393|Itraconazole|itraconazole|mesh-list
64693783|NCT02044393|Antifungal Agents|antifungal agents|mesh-ancestor
64693784|NCT02044393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64693785|NCT02044393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64693786|NCT02044393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64693797|NCT05405465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64693799|NCT05405465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693800|NCT02064907|Dexlansoprazole|dexlansoprazole|mesh-list
64693801|NCT02064907|Lansoprazole|lansoprazole|mesh-list
64693802|NCT02064907|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64693803|NCT02064907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64693804|NCT02064907|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64693805|NCT02064907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64693806|NCT02064907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693807|NCT02064985|Ticagrelor|ticagrelor|mesh-list
64693808|NCT02064985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64693809|NCT02064985|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64693810|NCT02064985|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64693811|NCT02064985|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64693812|NCT02064985|Purinergic Agents|purinergic agents|mesh-ancestor
64693813|NCT02064985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693814|NCT02064985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693815|NCT02064985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693816|NCT03170219|Furosemide|furosemide|mesh-list
64693817|NCT03170219|Diuretics|diuretics|mesh-ancestor
64693818|NCT03170219|Natriuretic Agents|natriuretic agents|mesh-ancestor
64693819|NCT03170219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456646|NCT02526394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456647|NCT01283932|Pantoprazole|pantoprazole|mesh-list
65456648|NCT01283932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65456649|NCT01283932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65456650|NCT01283932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65456651|NCT01283932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456652|NCT01283932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456653|NCT01075308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65456654|NCT01075308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456655|NCT01075308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456656|NCT01171300|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65456657|NCT01171300|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65456658|NCT01171300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456659|NCT01171378|Ofatumumab|ofatumumab|mesh-list
65456660|NCT01171378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456661|NCT01171456|Metformin|metformin|mesh-list
65456662|NCT01171456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65456663|NCT01171456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456664|NCT03865888|Cyclosporine|cyclosporine|mesh-list
65456665|NCT03865888|Tacrolimus|tacrolimus|mesh-list
65456666|NCT03865888|Cyclosporins|cyclosporins|mesh-list
65456667|NCT03865888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65456668|NCT03865888|Immunologic Factors|immunologic factors|mesh-ancestor
65456669|NCT03865888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456670|NCT03865888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65456671|NCT03865888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456672|NCT03865888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456673|NCT03865888|Antifungal Agents|antifungal agents|mesh-ancestor
65456674|NCT03865888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64693820|NCT03170219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64693821|NCT03170219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64693822|NCT03170219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693823|NCT00375557|Valproic Acid|valproic acid|mesh-list
64717602|NCT03513757|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64717603|NCT03513757|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64717604|NCT03513757|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64693826|NCT00375557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64693827|NCT00375557|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64693828|NCT00375557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64693829|NCT00375557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64693830|NCT00375557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693831|NCT00375557|Anticonvulsants|anticonvulsants|mesh-ancestor
64693832|NCT00375557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64693833|NCT00375557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456675|NCT03865888|Dermatologic Agents|dermatologic agents|mesh-ancestor
65456676|NCT03865888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65456677|NCT01284166|Timolol|timolol|mesh-list
65456678|NCT01284166|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65456679|NCT01284166|Dorzolamide|dorzolamide|mesh-list
65456680|NCT01284166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65456681|NCT01284166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65456682|NCT01284166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65456683|NCT01284166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65456684|NCT01284166|Adrenergic Agents|adrenergic agents|mesh-ancestor
65456685|NCT01284166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65456686|NCT01284166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456687|NCT01284166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456688|NCT01284166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65456689|NCT01284166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65456690|NCT01284166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65456691|NCT01284166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65456692|NCT01284166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65456693|NCT01284166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65456694|NCT01284166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456695|NCT01285414|Temozolomide|temozolomide|mesh-list
65456696|NCT01285414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65456698|NCT01285414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456699|NCT01285414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456700|NCT01172002|Azathioprine|azathioprine|mesh-list
65456701|NCT01172002|Leflunomide|leflunomide|mesh-list
65456702|NCT01172002|Antimetabolites|antimetabolites|mesh-ancestor
65456703|NCT01172002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456704|NCT01172002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65456705|NCT01172002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456706|NCT01172002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65456707|NCT01172002|Immunologic Factors|immunologic factors|mesh-ancestor
64841250|NCT01650662|Cyclosporine|cyclosporine|mesh-list
64693834|NCT00375557|GABA Agents|gaba agents|mesh-ancestor
64693835|NCT00375557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693836|NCT00375557|Antimanic Agents|antimanic agents|mesh-ancestor
64693837|NCT03177395|Acetylcysteine|acetylcysteine|mesh-list
64693838|NCT03177395|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64693839|NCT03177395|Antiviral Agents|antiviral agents|mesh-ancestor
64693840|NCT03177395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64693841|NCT03177395|Expectorants|expectorants|mesh-ancestor
65456708|NCT01172002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456709|NCT01172002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65456710|NCT01172002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456711|NCT03867994|Carvedilol|carvedilol|mesh-list
65456712|NCT03867994|Atorvastatin|atorvastatin|mesh-list
65456713|NCT03867994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65456714|NCT03867994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65456715|NCT03867994|Antimetabolites|antimetabolites|mesh-ancestor
65456716|NCT03867994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456717|NCT03867994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64841283|NCT01650883|Vitamin D|vitamin d|mesh-list
64693842|NCT03177395|Respiratory System Agents|respiratory system agents|mesh-ancestor
64693843|NCT03177395|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64693844|NCT03177395|Antioxidants|antioxidants|mesh-ancestor
64693845|NCT03177395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693846|NCT03177395|Protective Agents|protective agents|mesh-ancestor
64693847|NCT03177395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693863|NCT03179345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693864|NCT03179345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693865|NCT03179345|Anticonvulsants|anticonvulsants|mesh-ancestor
64693866|NCT03179345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64693867|NCT03179345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64693868|NCT03179345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693869|NCT03179345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64693870|NCT03179345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64693871|NCT03179345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64693872|NCT03179345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64693873|NCT03179345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64693874|NCT03179345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64693875|NCT03179345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64325822|NCT02766023|Metronidazole|metronidazole|mesh-list
64717610|NCT03275623|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64717611|NCT03275623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64717613|NCT03756038|Anticonvulsants|anticonvulsants|mesh-ancestor
64717614|NCT03756038|Antiemetics|antiemetics|mesh-ancestor
64717615|NCT03756038|Autonomic Agents|autonomic agents|mesh-ancestor
64717616|NCT03756038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717617|NCT03756038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325823|NCT02766023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64693876|NCT03179345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693877|NCT03179345|Antimanic Agents|antimanic agents|mesh-ancestor
64693878|NCT03086213|Lidocaine|lidocaine|mesh-list
64693879|NCT03086213|Sufentanil|sufentanil|mesh-list
64693880|NCT03086213|Dexmedetomidine|dexmedetomidine|mesh-list
64693882|NCT03086213|Ropivacaine|ropivacaine|mesh-list
64693883|NCT03086213|Propofol|propofol|mesh-list
64693884|NCT03086213|Anesthetics, Local|anesthetics, local|mesh-ancestor
64693885|NCT03086213|Anesthetics|anesthetics|mesh-ancestor
64693886|NCT03086213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64693887|NCT03086213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693888|NCT03086213|Sensory System Agents|sensory system agents|mesh-ancestor
64693889|NCT03086213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693890|NCT03086213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64693891|NCT03086213|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64693892|NCT03086213|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64693893|NCT03086213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64693899|NCT03086213|Analgesics|analgesics|mesh-ancestor
64693900|NCT03086213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64693901|NCT03086213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64693902|NCT03086213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64693903|NCT03086213|Adrenergic Agents|adrenergic agents|mesh-ancestor
64693904|NCT03086213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693905|NCT03086213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64693906|NCT03086213|Narcotics|narcotics|mesh-ancestor
64693907|NCT03086213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65456718|NCT03867994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65456719|NCT03867994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456720|NCT03867994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65456721|NCT03867994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65456722|NCT03867994|Adrenergic Agents|adrenergic agents|mesh-ancestor
65456723|NCT03867994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65456724|NCT03867994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456725|NCT03867994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65456726|NCT03867994|Antioxidants|antioxidants|mesh-ancestor
65456727|NCT03867994|Protective Agents|protective agents|mesh-ancestor
65456728|NCT03867994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65456729|NCT03867994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64841296|NCT01650961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64693908|NCT02378714|Varenicline|varenicline|mesh-list
64693909|NCT02378714|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64693910|NCT02378714|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64693917|NCT03091673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64693919|NCT03091673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64693920|NCT03091673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693921|NCT03091673|Incretins|incretins|mesh-ancestor
64693922|NCT02382848|Prazosin|prazosin|mesh-list
64693923|NCT02382848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64693924|NCT02382848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64693925|NCT02382848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64693926|NCT02382848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64693927|NCT02382848|Adrenergic Agents|adrenergic agents|mesh-ancestor
64693928|NCT02382848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693929|NCT02382848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693930|NCT02382848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693931|NCT02065687|Metformin|metformin|mesh-list
64693932|NCT02065687|Paclitaxel|paclitaxel|mesh-list
64693933|NCT02065687|Carboplatin|carboplatin|mesh-list
64693934|NCT02065687|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64693935|NCT02065687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64693936|NCT02065687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64693937|NCT02065687|Tubulin Modulators|tubulin modulators|mesh-ancestor
64693938|NCT02065687|Antimitotic Agents|antimitotic agents|mesh-ancestor
64693939|NCT02065687|Mitosis Modulators|mitosis modulators|mesh-ancestor
64717618|NCT03756038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64717619|NCT03756038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64717620|NCT03756038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717621|NCT03756038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64717622|NCT03756038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64717623|NCT03756038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64717624|NCT03756038|GABA Modulators|gaba modulators|mesh-ancestor
64693940|NCT02065687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693941|NCT02065687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64693942|NCT02065687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693943|NCT03096353|Naloxone|naloxone|mesh-list
64693944|NCT03096353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64693945|NCT03096353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693946|NCT03096353|Sensory System Agents|sensory system agents|mesh-ancestor
64693947|NCT03096353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693948|NCT03098615|Efinaconazole|efinaconazole|mesh-list
64693949|NCT03098615|Antifungal Agents|antifungal agents|mesh-ancestor
64693950|NCT03098615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64693951|NCT05363501|Naloxone|naloxone|mesh-list
64693952|NCT05363501|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64693953|NCT05363501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693954|NCT05363501|Sensory System Agents|sensory system agents|mesh-ancestor
64693955|NCT05363501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65456730|NCT03867994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65456731|NCT03867994|Vasodilator Agents|vasodilator agents|mesh-ancestor
65456732|NCT03867994|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65456733|NCT03867994|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65456734|NCT01172236|Lactoferrin|lactoferrin|mesh-list
65456735|NCT01172236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65456736|NCT02525848|Dexamethasone|dexamethasone|mesh-list
65456737|NCT02525848|Gabapentin|gabapentin|mesh-list
65456738|NCT02525848|Aprepitant|aprepitant|mesh-list
65456739|NCT02525848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65456740|NCT02525848|Antiemetics|antiemetics|mesh-ancestor
65456741|NCT02525848|Autonomic Agents|autonomic agents|mesh-ancestor
65456742|NCT02525848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65456743|NCT02525848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693956|NCT04736927|Midazolam|midazolam|mesh-list
64693957|NCT04736927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64693958|NCT04736927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64693959|NCT04736927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64693960|NCT04736927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693961|NCT04736927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64693962|NCT04736927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64693963|NCT04736927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64693972|NCT03810703|Dextroamphetamine|dextroamphetamine|mesh-list
64693973|NCT03810703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64693974|NCT03810703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693975|NCT03810703|Sympathomimetics|sympathomimetics|mesh-ancestor
64693976|NCT03810703|Autonomic Agents|autonomic agents|mesh-ancestor
64693977|NCT03810703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693978|NCT03810703|Dopamine Agents|dopamine agents|mesh-ancestor
64693989|NCT05304455|Dalteparin|dalteparin|mesh-list
64693991|NCT05304455|Apixaban|apixaban|mesh-list
64693992|NCT05304455|Anticoagulants|anticoagulants|mesh-ancestor
64693993|NCT05304455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64693994|NCT05304455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64693995|NCT05304455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693996|NCT05304455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64693997|NCT05304455|Antithrombins|antithrombins|mesh-ancestor
64693998|NCT05304455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64693999|NCT05304455|Protease Inhibitors|protease inhibitors|mesh-ancestor
64694000|NCT05304455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64694001|NCT05304455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64694002|NCT05304455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64694003|NCT05304455|Vasodilator Agents|vasodilator agents|mesh-ancestor
64694004|NCT02389088|Letrozole|letrozole|mesh-list
64694005|NCT02389088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694006|NCT02389088|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64694007|NCT02389088|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64694008|NCT02389088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64694009|NCT02389088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694010|NCT02389088|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64694011|NCT02389088|Hormone Antagonists|hormone antagonists|mesh-ancestor
64717625|NCT03756038|GABA Agents|gaba agents|mesh-ancestor
64717626|NCT03756038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64717627|NCT03756038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717628|NCT03754556|Levonorgestrel|levonorgestrel|mesh-list
64325837|NCT05466500|Glucocorticoids|glucocorticoids|mesh-ancestor
64694012|NCT02389088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64694013|NCT02389088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694015|NCT02068027|Analgesics|analgesics|mesh-ancestor
64694016|NCT02068027|Sensory System Agents|sensory system agents|mesh-ancestor
64694017|NCT02068027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64694018|NCT02068027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456744|NCT02525848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65456745|NCT02525848|Glucocorticoids|glucocorticoids|mesh-ancestor
65456746|NCT02525848|Hormones|hormones|mesh-ancestor
65456747|NCT02525848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65456748|NCT02525848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65456749|NCT02525848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456750|NCT02525848|Analgesics|analgesics|mesh-ancestor
65456751|NCT02525848|Sensory System Agents|sensory system agents|mesh-ancestor
65456752|NCT02525848|Anticonvulsants|anticonvulsants|mesh-ancestor
65456753|NCT02525848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65456754|NCT02525848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65456755|NCT02525848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65456756|NCT02525848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65456757|NCT02525848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65456758|NCT02525848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65456759|NCT02525848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65456760|NCT02525848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456761|NCT02525848|Antimanic Agents|antimanic agents|mesh-ancestor
65456762|NCT02525848|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65456763|NCT01269112|Citric Acid|citric acid|mesh-list
65456764|NCT01269112|Sodium Citrate|sodium citrate|mesh-list
65456765|NCT01269112|Anticoagulants|anticoagulants|mesh-ancestor
65456766|NCT01269112|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65456767|NCT01269112|Chelating Agents|chelating agents|mesh-ancestor
64694019|NCT02068027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64694020|NCT02068027|Sympatholytics|sympatholytics|mesh-ancestor
64694021|NCT02068027|Autonomic Agents|autonomic agents|mesh-ancestor
64694022|NCT02068027|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64694023|NCT02068027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64694024|NCT02068027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64694025|NCT02068027|Adrenergic Agents|adrenergic agents|mesh-ancestor
64694026|NCT02068027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64694027|NCT02068027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694029|NCT02392208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64694030|NCT02392208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64694031|NCT05185583|Methylphenidate|methylphenidate|mesh-list
64694032|NCT05185583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64694033|NCT05185583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694034|NCT05185583|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64694035|NCT05185583|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64694036|NCT05185583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64694037|NCT05185583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694038|NCT05185583|Dopamine Agents|dopamine agents|mesh-ancestor
64694056|NCT02392286|Glucocorticoids|glucocorticoids|mesh-ancestor
64694057|NCT02392286|Hormones|hormones|mesh-ancestor
64694058|NCT02392286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64694059|NCT02392286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694060|NCT02392286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65456768|NCT01269112|Sequestering Agents|sequestering agents|mesh-ancestor
65456769|NCT01269112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456770|NCT01174420|Mitomycins|mitomycins|mesh-list
65456771|NCT01174420|Mitomycin|mitomycin|mesh-list
65456772|NCT01174420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65456773|NCT01174420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456774|NCT01174420|Alkylating Agents|alkylating agents|mesh-ancestor
65456775|NCT01174420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456776|NCT01174420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65456777|NCT01174420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456778|NCT01164826|Nabumetone|nabumetone|mesh-list
65456779|NCT01164826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65456780|NCT01164826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65456781|NCT01164826|Analgesics|analgesics|mesh-ancestor
65456782|NCT01164826|Sensory System Agents|sensory system agents|mesh-ancestor
65456783|NCT01164826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65456784|NCT01164826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456785|NCT01164826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65456786|NCT01164826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65456787|NCT01164826|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65456788|NCT01164826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65456789|NCT01164826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456790|NCT01164826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694061|NCT02392286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694062|NCT02392286|Antiemetics|antiemetics|mesh-ancestor
64694063|NCT02392286|Autonomic Agents|autonomic agents|mesh-ancestor
64694064|NCT02392286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64694065|NCT02392286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64694066|NCT02392286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64694067|NCT02392286|Protective Agents|protective agents|mesh-ancestor
64694068|NCT04586153|Meplazumab|meplazumab|mesh-list
64694069|NCT04586153|Antiviral Agents|antiviral agents|mesh-ancestor
64694070|NCT04586153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64694071|NCT05717738|Bevacizumab|bevacizumab|mesh-list
64694072|NCT05717738|Sorafenib|sorafenib|mesh-list
64694073|NCT05717738|Atezolizumab|atezolizumab|mesh-list
64694074|NCT05717738|Apatinib|apatinib|mesh-list
64694075|NCT05717738|Lenvatinib|lenvatinib|mesh-list
64694076|NCT05717738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64694077|NCT05717738|Antibodies|antibodies|mesh-list
64694078|NCT05717738|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64694079|NCT05717738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64694080|NCT05717738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694081|NCT05717738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64694082|NCT05717738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64694083|NCT05717738|Growth Substances|growth substances|mesh-ancestor
64694084|NCT05717738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694085|NCT05717738|Growth Inhibitors|growth inhibitors|mesh-ancestor
64717629|NCT03754556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64717630|NCT03754556|Contraceptive Agents|contraceptive agents|mesh-ancestor
64717631|NCT03754556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65456791|NCT03867370|Lenvatinib|lenvatinib|mesh-list
65456792|NCT03867370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456793|NCT03867370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65456794|NCT03867370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456795|NCT03867370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456796|NCT01172392|Interferons|interferons|mesh-list
65456797|NCT01172392|Interferon-alpha|interferon-alpha|mesh-list
65456798|NCT01172392|Interferon alpha-2|interferon alpha-2|mesh-list
65456799|NCT01172392|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65456800|NCT01172392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456801|NCT01172392|Antiviral Agents|antiviral agents|mesh-ancestor
65456802|NCT01172392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65456803|NCT01172392|Immunologic Factors|immunologic factors|mesh-ancestor
65456804|NCT01172392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456805|NCT01172470|Gemcitabine|gemcitabine|mesh-list
65456806|NCT01172470|Carboplatin|carboplatin|mesh-list
65456807|NCT01172470|Pemetrexed|pemetrexed|mesh-list
65456808|NCT01172470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456809|NCT01172470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65456810|NCT01172470|Antimetabolites|antimetabolites|mesh-ancestor
64841365|NCT01651390|Paclitaxel|paclitaxel|mesh-list
64717632|NCT03754556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717633|NCT03754556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64717634|NCT03754556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64717635|NCT03754556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64717636|NCT03521479|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
64717637|NCT03521479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64717638|NCT03521479|Immunologic Factors|immunologic factors|mesh-ancestor
64717639|NCT03521479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717640|NCT01495988|Bevacizumab|bevacizumab|mesh-list
64717641|NCT01495988|Vemurafenib|vemurafenib|mesh-list
64717642|NCT01495988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64717643|NCT01495988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325839|NCT05466500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64694086|NCT05717738|Immunologic Factors|immunologic factors|mesh-ancestor
64694087|NCT05717738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64694088|NCT05717738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64694089|NCT05717738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694090|NCT02393378|Folic Acid|folic acid|mesh-list
64694091|NCT02393378|Adalimumab|adalimumab|mesh-list
64694092|NCT02393378|Methotrexate|methotrexate|mesh-list
64694093|NCT02393378|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64694094|NCT02393378|Abortifacient Agents|abortifacient agents|mesh-ancestor
64694095|NCT02393378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64694096|NCT02393378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694097|NCT02393378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64694098|NCT02393378|Antimetabolites|antimetabolites|mesh-ancestor
64694104|NCT02393378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64694105|NCT02393378|Immunologic Factors|immunologic factors|mesh-ancestor
64694106|NCT02393378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64694107|NCT02393378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64694108|NCT02393378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64694109|NCT02393378|Hematinics|hematinics|mesh-ancestor
64694117|NCT04949477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694118|NCT04949477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64694119|NCT04949477|Analgesics|analgesics|mesh-ancestor
65456811|NCT01172470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456812|NCT01172470|Antiviral Agents|antiviral agents|mesh-ancestor
65456813|NCT01172470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65456814|NCT01172470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456815|NCT01172470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65456816|NCT01172470|Immunologic Factors|immunologic factors|mesh-ancestor
65456817|NCT01172470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456818|NCT01172470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65456819|NCT01172470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65456820|NCT01175044|Povidone-Iodine|povidone-iodine|mesh-list
65456821|NCT01175044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65456822|NCT01175044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65456823|NCT03864016|Sufentanil|sufentanil|mesh-list
65456824|NCT03864016|Dsuvia|dsuvia|mesh-list
65456825|NCT03864016|Anesthetics|anesthetics|mesh-ancestor
65456826|NCT03864016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65456827|NCT03864016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456828|NCT03864016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65456829|NCT03864016|Narcotics|narcotics|mesh-ancestor
65456830|NCT03864016|Analgesics|analgesics|mesh-ancestor
65456831|NCT03864016|Sensory System Agents|sensory system agents|mesh-ancestor
65456832|NCT03864016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65456833|NCT03864016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65456834|NCT03864016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65456835|NCT03864016|Anesthetics, General|anesthetics, general|mesh-ancestor
65456836|NCT03860662|Baclofen|baclofen|mesh-list
65456837|NCT03860662|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65456838|NCT03860662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456839|NCT03860662|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65456840|NCT03860662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65456841|NCT03860662|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65456842|NCT03860662|GABA Agonists|gaba agonists|mesh-ancestor
65206308|NCT00698464|Pasireotide|pasireotide|mesh-list
65456843|NCT03860662|GABA Agents|gaba agents|mesh-ancestor
65456844|NCT03860662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65456852|NCT01177852|Ephedrine|ephedrine|mesh-list
65456853|NCT01177852|Dipropizine|dipropizine|mesh-list
65456854|NCT01177852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456855|NCT01177852|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65456856|NCT01177852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65456857|NCT01177852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65456858|NCT01177852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456859|NCT01177852|Anesthetics, Local|anesthetics, local|mesh-ancestor
65456860|NCT01177852|Anesthetics|anesthetics|mesh-ancestor
65456861|NCT01177852|Sensory System Agents|sensory system agents|mesh-ancestor
65456862|NCT01177852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65456863|NCT01177852|Antiemetics|antiemetics|mesh-ancestor
65456864|NCT01177852|Autonomic Agents|autonomic agents|mesh-ancestor
65456865|NCT01177852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65456866|NCT01177852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65456867|NCT01177852|Histamine Antagonists|histamine antagonists|mesh-ancestor
65456868|NCT01177852|Histamine Agents|histamine agents|mesh-ancestor
65456869|NCT01177852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65456870|NCT01177852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65456871|NCT01177852|Antipruritics|antipruritics|mesh-ancestor
65456872|NCT01177852|Dermatologic Agents|dermatologic agents|mesh-ancestor
65456873|NCT01177852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65456874|NCT01177852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65456875|NCT01177852|Respiratory System Agents|respiratory system agents|mesh-ancestor
65456876|NCT01177852|Nasal Decongestants|nasal decongestants|mesh-ancestor
65456877|NCT01177852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65456878|NCT01177852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65456879|NCT01177852|Sympathomimetics|sympathomimetics|mesh-ancestor
65456880|NCT01177852|Adrenergic Agents|adrenergic agents|mesh-ancestor
65456881|NCT01177852|Antitussive Agents|antitussive agents|mesh-ancestor
65456882|NCT03863392|Misoprostol|misoprostol|mesh-list
65456883|NCT03863392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65456884|NCT03863392|Abortifacient Agents|abortifacient agents|mesh-ancestor
65456885|NCT03863392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65456886|NCT03863392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456887|NCT03863392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65456888|NCT03863392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64694120|NCT04949477|Sensory System Agents|sensory system agents|mesh-ancestor
64694121|NCT04949477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65456889|NCT03863392|Oxytocics|oxytocics|mesh-ancestor
65456890|NCT01175200|Lansoprazole|lansoprazole|mesh-list
65456891|NCT01175200|Dexlansoprazole|dexlansoprazole|mesh-list
65456892|NCT01175200|Clopidogrel|clopidogrel|mesh-list
65456893|NCT01175200|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65456894|NCT01175200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65456895|NCT01175200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65456896|NCT01175200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65456897|NCT01175200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65456898|NCT01175200|Purinergic Agents|purinergic agents|mesh-ancestor
65456899|NCT01175200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65456900|NCT01175200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456901|NCT01175200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456902|NCT01175200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65456903|NCT01175200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65456904|NCT01175200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65456905|NCT01175200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456906|NCT03863626|Furosemide|furosemide|mesh-list
65456907|NCT03863626|Diuretics|diuretics|mesh-ancestor
65456908|NCT03863626|Natriuretic Agents|natriuretic agents|mesh-ancestor
65456909|NCT03863626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456910|NCT03863626|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65456911|NCT03863626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65456912|NCT03863626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456913|NCT01288378|Caspofungin|caspofungin|mesh-list
65456914|NCT01288378|Antifungal Agents|antifungal agents|mesh-ancestor
64694122|NCT04949477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64694123|NCT04949477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64694124|NCT04949477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64694125|NCT04949477|Adrenergic Agents|adrenergic agents|mesh-ancestor
64694126|NCT04949477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64694127|NCT04949477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694128|NCT04949477|Antipyretics|antipyretics|mesh-ancestor
64694129|NCT05437796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64694130|NCT05437796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64694131|NCT05437796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694132|NCT04873895|Hydroxychloroquine|hydroxychloroquine|mesh-list
64717644|NCT01495988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64717645|NCT01495988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64717646|NCT01495988|Growth Substances|growth substances|mesh-ancestor
64717647|NCT01495988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717648|NCT01495988|Growth Inhibitors|growth inhibitors|mesh-ancestor
64717649|NCT01495988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64717650|NCT01495988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64325855|NCT04475107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694134|NCT04873895|Antimalarials|antimalarials|mesh-ancestor
64694135|NCT04873895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64694136|NCT04873895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65456915|NCT01288378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65456916|NCT01288378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456917|NCT01288378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456918|NCT01178320|Niacin|niacin|mesh-list
65456919|NCT01178320|Niacinamide|niacinamide|mesh-list
65456920|NCT01178320|Nicotinic Acids|nicotinic acids|mesh-list
65456921|NCT01178320|Simvastatin|simvastatin|mesh-list
65206382|NCT00696982|Hormones|hormones|mesh-ancestor
65456922|NCT01178320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65456923|NCT01178320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65456924|NCT01178320|Antimetabolites|antimetabolites|mesh-ancestor
65456925|NCT01178320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456926|NCT01178320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65456927|NCT01178320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65456928|NCT01178320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456929|NCT01178320|Vasodilator Agents|vasodilator agents|mesh-ancestor
65456930|NCT01178320|Vitamin B Complex|vitamin b complex|mesh-ancestor
65456931|NCT01178320|Vitamins|vitamins|mesh-ancestor
65456932|NCT01178320|Micronutrients|micronutrients|mesh-ancestor
65456933|NCT01178320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456934|NCT01175512|Naltrexone|naltrexone|mesh-list
65456935|NCT01175512|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64841498|NCT01652014|Antimetabolites|antimetabolites|mesh-ancestor
64694137|NCT04873895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64694138|NCT04873895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64694139|NCT04873895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694140|NCT04873895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64694141|NCT04873895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694142|NCT04873895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64694143|NCT05717582|Androgens|androgens|mesh-list
64694144|NCT05717582|Hormones|hormones|mesh-ancestor
64694145|NCT05717582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64694146|NCT05717582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694147|NCT03101033|Betamethasone|betamethasone|mesh-list
64694148|NCT03101033|Betamethasone Valerate|betamethasone valerate|mesh-list
64694149|NCT03101033|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64694150|NCT03101033|Betamethasone benzoate|betamethasone benzoate|mesh-list
64694151|NCT03101033|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64694152|NCT03101033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64694153|NCT03101033|Glucocorticoids|glucocorticoids|mesh-ancestor
64694154|NCT03101033|Hormones|hormones|mesh-ancestor
64694155|NCT03101033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64694156|NCT03101033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694157|NCT03101033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64694158|NCT03101033|Respiratory System Agents|respiratory system agents|mesh-ancestor
64694159|NCT02069041|Leucovorin|leucovorin|mesh-list
64694160|NCT02069041|Fluorouracil|fluorouracil|mesh-list
64694161|NCT02069041|Oxaliplatin|oxaliplatin|mesh-list
64694162|NCT02069041|Ramucirumab|ramucirumab|mesh-list
64694163|NCT02069041|Antimetabolites|antimetabolites|mesh-ancestor
64694164|NCT02069041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694165|NCT02069041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64694166|NCT02069041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694167|NCT02069041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64694172|NCT02069041|Vitamin B Complex|vitamin b complex|mesh-ancestor
65456936|NCT01175512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65456937|NCT01175512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456938|NCT01175512|Sensory System Agents|sensory system agents|mesh-ancestor
65456939|NCT01175512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65456940|NCT03859570|Pentoxifylline|pentoxifylline|mesh-list
65456941|NCT03859570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65456942|NCT03859570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456943|NCT03859570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456944|NCT03859570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65456945|NCT03859570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65456946|NCT03859570|Protective Agents|protective agents|mesh-ancestor
65456947|NCT03859570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456948|NCT03859570|Vasodilator Agents|vasodilator agents|mesh-ancestor
65456949|NCT03859570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65456950|NCT03859570|Antioxidants|antioxidants|mesh-ancestor
65456951|NCT01286584|Varenicline|varenicline|mesh-list
65456952|NCT01286584|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65456953|NCT01286584|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65456954|NCT01286584|Cholinergic Agents|cholinergic agents|mesh-ancestor
65456955|NCT01286584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65456956|NCT01286584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456957|NCT01286584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456958|NCT03743038|Minocycline|minocycline|mesh-list
65456959|NCT03743038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65456960|NCT03743038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65456961|NCT03864250|Prednisone|prednisone|mesh-list
65456962|NCT03864250|Tacrolimus|tacrolimus|mesh-list
64841514|NCT01652157|Pancrelipase|pancrelipase|mesh-list
64694174|NCT02069041|Micronutrients|micronutrients|mesh-ancestor
64694175|NCT04920344|Cisplatin|cisplatin|mesh-list
64694176|NCT04920344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694177|NCT03101111|Vaccines|vaccines|mesh-list
64694178|NCT03101111|Immunologic Factors|immunologic factors|mesh-ancestor
64694179|NCT03101111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694189|NCT05423834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64694190|NCT03103061|Regadenoson|regadenoson|mesh-list
64694191|NCT03103061|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64694192|NCT03103061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64694193|NCT03103061|Purinergic Agonists|purinergic agonists|mesh-ancestor
64694194|NCT03103061|Purinergic Agents|purinergic agents|mesh-ancestor
64694195|NCT03103061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64694196|NCT03103061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694197|NCT03103061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694198|NCT03105479|Vancomycin|vancomycin|mesh-list
64694199|NCT03105479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64694200|NCT03105479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64694201|NCT00355862|Cyclosporine|cyclosporine|mesh-list
64717651|NCT01495988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456963|NCT03864250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65456964|NCT03864250|Glucocorticoids|glucocorticoids|mesh-ancestor
65456965|NCT03864250|Hormones|hormones|mesh-ancestor
65456966|NCT03864250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65456967|NCT03864250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456968|NCT03864250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65456969|NCT03864250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65456970|NCT03864250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65456971|NCT03864250|Immunologic Factors|immunologic factors|mesh-ancestor
65456972|NCT03864250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65456973|NCT03864250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65456974|NCT03864250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456975|NCT01175746|Nicardipine|nicardipine|mesh-list
65456976|NCT01175746|Remifentanil|remifentanil|mesh-list
65456977|NCT01175746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65456978|NCT01175746|Narcotics|narcotics|mesh-ancestor
65456979|NCT01175746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65456980|NCT01175746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456981|NCT01175746|Analgesics|analgesics|mesh-ancestor
65456982|NCT01175746|Sensory System Agents|sensory system agents|mesh-ancestor
65456983|NCT01175746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65456984|NCT01175746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65456985|NCT01175746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64841537|NCT01652196|Antidotes|antidotes|mesh-ancestor
64717653|NCT02934932|Serotonin Agents|serotonin agents|mesh-ancestor
64717654|NCT02934932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64717655|NCT02934932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717656|NCT02934932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717657|NCT02934932|Dopamine Agonists|dopamine agonists|mesh-ancestor
64717658|NCT02934932|Dopamine Agents|dopamine agents|mesh-ancestor
64717659|NCT03415243|Acetaminophen|acetaminophen|mesh-list
64694202|NCT00355862|Sirolimus|sirolimus|mesh-list
64694203|NCT00355862|Prednisolone|prednisolone|mesh-list
64694204|NCT00355862|Azathioprine|azathioprine|mesh-list
64694205|NCT00355862|Tacrolimus|tacrolimus|mesh-list
64694206|NCT00355862|Cyclosporins|cyclosporins|mesh-list
64694207|NCT00355862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64694208|NCT00355862|Immunologic Factors|immunologic factors|mesh-ancestor
64694209|NCT00355862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694210|NCT00355862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64694211|NCT00355862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64694212|NCT00355862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694213|NCT00355862|Antifungal Agents|antifungal agents|mesh-ancestor
64694214|NCT00355862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64694215|NCT00355862|Dermatologic Agents|dermatologic agents|mesh-ancestor
64694216|NCT00355862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64694217|NCT00355862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64694218|NCT00355862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64694219|NCT00355862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694220|NCT00355862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64694221|NCT00355862|Glucocorticoids|glucocorticoids|mesh-ancestor
65456986|NCT01175746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65456987|NCT01175746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65456988|NCT01175746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65456989|NCT01175746|Vasodilator Agents|vasodilator agents|mesh-ancestor
65456990|NCT01174810|Exenatide|exenatide|mesh-list
65456991|NCT01174810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65456992|NCT01174810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65456993|NCT01174810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65456994|NCT01174810|Incretins|incretins|mesh-ancestor
65456995|NCT01174810|Hormones|hormones|mesh-ancestor
65456996|NCT01174810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65456997|NCT01178710|Simvastatin|simvastatin|mesh-list
65456998|NCT01178710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65456999|NCT01178710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65457000|NCT01178710|Antimetabolites|antimetabolites|mesh-ancestor
65457001|NCT01178710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694222|NCT00355862|Hormones|hormones|mesh-ancestor
64694223|NCT00355862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64694224|NCT00355862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64694225|NCT00355862|Antimetabolites|antimetabolites|mesh-ancestor
64694226|NCT00355862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64694227|NCT02049151|Cyclophosphamide|cyclophosphamide|mesh-list
64694228|NCT02049151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64694229|NCT02049151|Immunologic Factors|immunologic factors|mesh-ancestor
64694230|NCT02049151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694231|NCT02049151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64694232|NCT02049151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64694233|NCT02049151|Alkylating Agents|alkylating agents|mesh-ancestor
64694234|NCT02049151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694235|NCT02049151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694236|NCT02049151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64694237|NCT02049307|Losartan|losartan|mesh-list
64694238|NCT02049307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64694239|NCT02049307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64694240|NCT02049307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64694276|NCT03717155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64694277|NCT03717155|Immunologic Factors|immunologic factors|mesh-ancestor
64694278|NCT03717155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694279|NCT03717155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64694280|NCT03789097|Pembrolizumab|pembrolizumab|mesh-list
64694281|NCT03789097|Poly ICLC|poly iclc|mesh-list
64694282|NCT03789097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64694283|NCT03789097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694284|NCT03789097|Interferon Inducers|interferon inducers|mesh-ancestor
64694285|NCT03789097|Immunologic Factors|immunologic factors|mesh-ancestor
64694286|NCT03789097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717660|NCT03415243|Phenylephrine|phenylephrine|mesh-list
64717661|NCT03415243|Oxymetazoline|oxymetazoline|mesh-list
64717662|NCT03415243|Dextromethorphan|dextromethorphan|mesh-list
64717663|NCT03415243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64717664|NCT03415243|Analgesics|analgesics|mesh-ancestor
64717665|NCT03415243|Sensory System Agents|sensory system agents|mesh-ancestor
64717666|NCT03415243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717667|NCT03415243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325871|NCT05444036|Anesthetics, General|anesthetics, general|mesh-ancestor
64694287|NCT03655613|Nivolumab|nivolumab|mesh-list
64694288|NCT03655613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65457002|NCT01178710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65457003|NCT01178710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65457004|NCT01178710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457005|NCT01174888|Cytarabine|cytarabine|mesh-list
65457006|NCT01174888|Etoposide|etoposide|mesh-list
65457007|NCT01174888|Podophyllotoxin|podophyllotoxin|mesh-list
65457008|NCT01174888|Mitoxantrone|mitoxantrone|mesh-list
65457009|NCT01174888|Etoposide phosphate|etoposide phosphate|mesh-list
65457010|NCT01174888|Bortezomib|bortezomib|mesh-list
65457011|NCT01174888|Midostaurin|midostaurin|mesh-list
65457012|NCT01174888|Staurosporine|staurosporine|mesh-list
65457013|NCT01174888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65457014|NCT01174888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457015|NCT01174888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65457016|NCT01174888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65457017|NCT01174888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457018|NCT01174888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457019|NCT01174888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65457020|NCT01174888|Antimetabolites|antimetabolites|mesh-ancestor
65457021|NCT01174888|Antiviral Agents|antiviral agents|mesh-ancestor
65457022|NCT01174888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65457023|NCT01174888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65457024|NCT01174888|Immunologic Factors|immunologic factors|mesh-ancestor
65457025|NCT01174888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457026|NCT01174888|Analgesics|analgesics|mesh-ancestor
65457027|NCT01174888|Sensory System Agents|sensory system agents|mesh-ancestor
65457028|NCT01174888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457029|NCT01174888|Keratolytic Agents|keratolytic agents|mesh-ancestor
65457030|NCT01174888|Dermatologic Agents|dermatologic agents|mesh-ancestor
65457031|NCT01174888|Tubulin Modulators|tubulin modulators|mesh-ancestor
65457032|NCT01174888|Antimitotic Agents|antimitotic agents|mesh-ancestor
65457033|NCT01174888|Mitosis Modulators|mitosis modulators|mesh-ancestor
65457034|NCT01174888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65457035|NCT01178788|Progesterone|progesterone|mesh-list
65457036|NCT01178788|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
65457037|NCT01178788|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
65457039|NCT01178788|Hormones|hormones|mesh-ancestor
65457042|NCT01178788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65457043|NCT01178788|Hormone Antagonists|hormone antagonists|mesh-ancestor
65457044|NCT00153816|Vitamin D|vitamin d|mesh-list
65457045|NCT00153816|Cholecalciferol|cholecalciferol|mesh-list
65457046|NCT00153816|Calcium Carbonate|calcium carbonate|mesh-list
65457047|NCT00153816|Calcium|calcium|mesh-list
65457048|NCT00153816|Vitamins|vitamins|mesh-ancestor
65457049|NCT00153816|Micronutrients|micronutrients|mesh-ancestor
65457050|NCT00153816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457051|NCT00153816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65457052|NCT00153816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65457053|NCT00153816|Antacids|antacids|mesh-ancestor
65457054|NCT00153816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457055|NCT00153816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65457056|NCT02525146|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65457057|NCT02525146|Antiviral Agents|antiviral agents|mesh-ancestor
65457058|NCT02525146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65457059|NCT01077648|Trastuzumab|trastuzumab|mesh-list
65457060|NCT01077648|Lapatinib|lapatinib|mesh-list
65457061|NCT01077648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65457062|NCT01077648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457063|NCT01077648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65457064|NCT01077648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457065|NCT01077648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457066|NCT00151476|Celecoxib|celecoxib|mesh-list
65457067|NCT00151476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65457068|NCT00151476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65457069|NCT00151476|Analgesics|analgesics|mesh-ancestor
64841616|NCT01652417|Prednisolone|prednisolone|mesh-list
64694289|NCT03655613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694290|NCT03655613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64694291|NCT03655613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419607|NCT04292743|Antidotes|antidotes|mesh-ancestor
64694292|NCT04820036|Insulin|insulin|mesh-list
64694311|NCT02051335|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64694312|NCT02051335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64694313|NCT02051335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694314|NCT02051335|Cholinergic Agents|cholinergic agents|mesh-ancestor
64694315|NCT02051335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64694316|NCT02051335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694317|NCT02051335|Nootropic Agents|nootropic agents|mesh-ancestor
64694318|NCT02051335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64694319|NCT02051335|Antiemetics|antiemetics|mesh-ancestor
64694320|NCT02051335|Autonomic Agents|autonomic agents|mesh-ancestor
64694321|NCT02051335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64694322|NCT02051335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64694323|NCT02051335|Mydriatics|mydriatics|mesh-ancestor
64694324|NCT02051335|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65457070|NCT00151476|Sensory System Agents|sensory system agents|mesh-ancestor
65457071|NCT00151476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457072|NCT00151476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457073|NCT00151476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65457074|NCT00151476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65457075|NCT00151476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65457076|NCT00151476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65457077|NCT00151476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457078|NCT00151476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457079|NCT01077726|Capecitabine|capecitabine|mesh-list
64841648|NCT01652547|Hormones|hormones|mesh-ancestor
64694325|NCT02051335|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64694326|NCT02051335|Parasympatholytics|parasympatholytics|mesh-ancestor
64694327|NCT03290027|Tazarotene|tazarotene|mesh-list
64694328|NCT03290027|Dermatologic Agents|dermatologic agents|mesh-ancestor
64694329|NCT03290027|Keratolytic Agents|keratolytic agents|mesh-ancestor
64694330|NCT02300077|Fentanyl|fentanyl|mesh-list
64694331|NCT02300077|Morphine|morphine|mesh-list
64694332|NCT02300077|Methadone|methadone|mesh-list
64694333|NCT02300077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64694334|NCT02300077|Narcotics|narcotics|mesh-ancestor
64694335|NCT02300077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64694336|NCT02300077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694337|NCT02300077|Analgesics|analgesics|mesh-ancestor
64694338|NCT02300077|Sensory System Agents|sensory system agents|mesh-ancestor
64694339|NCT02300077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64694340|NCT02300077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64694341|NCT02300077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64694342|NCT02300077|Anesthetics, General|anesthetics, general|mesh-ancestor
64694343|NCT02300077|Anesthetics|anesthetics|mesh-ancestor
64694344|NCT02300077|Antitussive Agents|antitussive agents|mesh-ancestor
64694345|NCT02300077|Respiratory System Agents|respiratory system agents|mesh-ancestor
64694346|NCT05272826|Dexamethasone|dexamethasone|mesh-list
64694347|NCT05272826|Bortezomib|bortezomib|mesh-list
64694348|NCT05272826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64694349|NCT05272826|Antiemetics|antiemetics|mesh-ancestor
64694350|NCT05272826|Autonomic Agents|autonomic agents|mesh-ancestor
64694373|NCT05638880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64694374|NCT05638880|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64717668|NCT03415243|Antipyretics|antipyretics|mesh-ancestor
64717669|NCT03415243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64717670|NCT03415243|Mydriatics|mydriatics|mesh-ancestor
64717671|NCT03415243|Autonomic Agents|autonomic agents|mesh-ancestor
64717672|NCT03415243|Sympathomimetics|sympathomimetics|mesh-ancestor
64717673|NCT03415243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64717674|NCT03415243|Nasal Decongestants|nasal decongestants|mesh-ancestor
64325878|NCT03923959|Tranexamic Acid|tranexamic acid|mesh-list
64694375|NCT05638880|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64694376|NCT05638880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694377|NCT05638880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64694378|NCT05638880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64694379|NCT05638880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694380|NCT05638880|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64694381|NCT05638880|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64694382|NCT05638880|Histamine Antagonists|histamine antagonists|mesh-ancestor
64694383|NCT05638880|Histamine Agents|histamine agents|mesh-ancestor
64694384|NCT05638880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64694385|NCT00356096|Pramipexole|pramipexole|mesh-list
64694386|NCT00356096|Antioxidants|antioxidants|mesh-ancestor
64694387|NCT00356096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694388|NCT00356096|Protective Agents|protective agents|mesh-ancestor
64694389|NCT00356096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694390|NCT00356096|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64694391|NCT00356096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64694392|NCT00356096|Dopamine Agonists|dopamine agonists|mesh-ancestor
64694393|NCT00356096|Dopamine Agents|dopamine agents|mesh-ancestor
65457080|NCT01077726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65457081|NCT01077726|Antimetabolites|antimetabolites|mesh-ancestor
65457082|NCT01077726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457083|NCT01077726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457084|NCT01179100|Lidocaine|lidocaine|mesh-list
65457085|NCT01179100|Anesthetics, Local|anesthetics, local|mesh-ancestor
65457086|NCT01179100|Anesthetics|anesthetics|mesh-ancestor
65457087|NCT01179100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65457088|NCT01179100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457089|NCT01179100|Sensory System Agents|sensory system agents|mesh-ancestor
65457090|NCT01179100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457091|NCT01179100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65457092|NCT01179100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64694394|NCT00356096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64694396|NCT05637086|Pentoxifylline|pentoxifylline|mesh-list
64694397|NCT05637086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64694398|NCT05637086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64694399|NCT05637086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694400|NCT05637086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64694401|NCT05637086|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64694402|NCT05637086|Protective Agents|protective agents|mesh-ancestor
64694403|NCT05637086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694404|NCT05637086|Vasodilator Agents|vasodilator agents|mesh-ancestor
64694405|NCT05637086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64694406|NCT05637086|Antioxidants|antioxidants|mesh-ancestor
64694407|NCT05637086|Anticonvulsants|anticonvulsants|mesh-ancestor
64694408|NCT05637086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64694409|NCT05637086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64694410|NCT05637086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64694411|NCT05637086|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64694412|NCT05637086|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64694413|NCT03243461|Temozolomide|temozolomide|mesh-list
64694414|NCT03243461|Valproic Acid|valproic acid|mesh-list
64694415|NCT03243461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64694416|NCT03243461|Alkylating Agents|alkylating agents|mesh-ancestor
64694437|NCT03296345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64694438|NCT03296345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64694439|NCT03296345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64694440|NCT03296345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64694441|NCT03296345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694442|NCT00421694|Bicalutamide|bicalutamide|mesh-list
64694443|NCT00421694|Androgen Antagonists|androgen antagonists|mesh-ancestor
64694444|NCT00421694|Hormone Antagonists|hormone antagonists|mesh-ancestor
64419746|NCT04843579|Autonomic Agents|autonomic agents|mesh-ancestor
64717675|NCT03415243|Respiratory System Agents|respiratory system agents|mesh-ancestor
64717676|NCT03415243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64717677|NCT03415243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64717678|NCT03415243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64717679|NCT03415243|Adrenergic Agents|adrenergic agents|mesh-ancestor
64717680|NCT03415243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64717681|NCT03415243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717682|NCT03415243|Protective Agents|protective agents|mesh-ancestor
64717683|NCT03415243|Antitussive Agents|antitussive agents|mesh-ancestor
64717684|NCT03415243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64717685|NCT03415243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64717687|NCT02892500|Betamethasone Valerate|betamethasone valerate|mesh-list
64694445|NCT00421694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64694446|NCT00421694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457093|NCT01179100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65457094|NCT01179100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65457095|NCT01179100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457096|NCT03864172|Calcium, Dietary|calcium, dietary|mesh-list
65457097|NCT03864172|Calcium|calcium|mesh-list
65457098|NCT03864172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65457099|NCT03864172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457100|NCT03864172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65457101|NCT02525302|Halofuginone|halofuginone|mesh-list
65457102|NCT02525302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457103|NCT02525302|Coccidiostats|coccidiostats|mesh-ancestor
65457104|NCT02525302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65457105|NCT02525302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65457106|NCT02525302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65457107|NCT02525302|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65457108|NCT02525302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457109|NCT02525302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457110|NCT02525302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65457111|NCT02525302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65457112|NCT02525302|Growth Substances|growth substances|mesh-ancestor
64841665|NCT01652586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64694447|NCT00421694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694448|NCT03237689|Hydrocortisone|hydrocortisone|mesh-list
64694449|NCT03237689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64694450|NCT00376181|Pioglitazone|pioglitazone|mesh-list
64694451|NCT00376181|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
64694452|NCT00376181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64694453|NCT00376181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694454|NCT00376181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64694455|NCT00376181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64694456|NCT00376181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694457|NCT04736693|Zoledronic Acid|zoledronic acid|mesh-list
64694458|NCT04736693|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64694459|NCT04736693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64694460|NCT04736693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694461|NCT04736693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64694462|NCT04736693|Hormone Antagonists|hormone antagonists|mesh-ancestor
64694463|NCT04736693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64694464|NCT04736693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64694465|NCT04736693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64694466|NCT04652414|Prednisone|prednisone|mesh-list
64694467|NCT04652414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64694468|NCT04652414|Glucocorticoids|glucocorticoids|mesh-ancestor
64694469|NCT04652414|Hormones|hormones|mesh-ancestor
64694470|NCT04652414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64694471|NCT04652414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694472|NCT04652414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64694473|NCT04652414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694474|NCT04630964|Niacin|niacin|mesh-list
64694475|NCT04630964|Psilocybin|psilocybin|mesh-list
64694476|NCT04630964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65457113|NCT02525302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457114|NCT02525302|Growth Inhibitors|growth inhibitors|mesh-ancestor
65457115|NCT01286194|Rabeprazole|rabeprazole|mesh-list
65457116|NCT01286194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65457117|NCT01286194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65457118|NCT01286194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65457119|NCT01286194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457120|NCT01286194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457121|NCT01179256|Curcumin|curcumin|mesh-list
65457122|NCT01179256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65457123|NCT01179256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65457124|NCT01179256|Analgesics|analgesics|mesh-ancestor
65457125|NCT01179256|Sensory System Agents|sensory system agents|mesh-ancestor
65457126|NCT01179256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457127|NCT01179256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457128|NCT01179256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65457129|NCT01179256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65457130|NCT01179256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457131|NCT01179256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457132|NCT01179256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457133|NCT01179412|Iodine|iodine|mesh-list
65457134|NCT01179412|Cadexomer iodine|cadexomer iodine|mesh-list
65457135|NCT01179412|Povidone-Iodine|povidone-iodine|mesh-list
65457136|NCT01179412|Povidone|povidone|mesh-list
65457137|NCT01179412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65457138|NCT01179412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65457139|NCT01179412|Trace Elements|trace elements|mesh-ancestor
65457140|NCT01179412|Micronutrients|micronutrients|mesh-ancestor
65457141|NCT01179412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457142|NCT01179412|Plasma Substitutes|plasma substitutes|mesh-ancestor
64694494|NCT03138161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64694496|NCT05595044|Vitamin D|vitamin d|mesh-list
64694497|NCT05595044|Vitamins|vitamins|mesh-ancestor
64694498|NCT05595044|Micronutrients|micronutrients|mesh-ancestor
64694499|NCT05595044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694500|NCT05595044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64694501|NCT04736381|Mycophenolic Acid|mycophenolic acid|mesh-list
64694502|NCT04736381|Abatacept|abatacept|mesh-list
64694503|NCT04736381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64694504|NCT04736381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64717688|NCT02892500|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64717689|NCT02892500|Betamethasone benzoate|betamethasone benzoate|mesh-list
64717690|NCT02892500|Bupivacaine|bupivacaine|mesh-list
64717691|NCT02892500|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64717692|NCT02892500|Anesthetics, Local|anesthetics, local|mesh-ancestor
64325899|NCT01001923|Fasinumab|fasinumab|mesh-list
65457143|NCT01179412|Blood Substitutes|blood substitutes|mesh-ancestor
65457144|NCT03862690|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65457145|NCT03862690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65457146|NCT03862690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457147|NCT03862768|Sunitinib|sunitinib|mesh-list
65457148|NCT03862768|Imatinib Mesylate|imatinib mesylate|mesh-list
65457149|NCT03862768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457150|NCT03862768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65457151|NCT03862768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65457152|NCT03862768|Growth Substances|growth substances|mesh-ancestor
65457153|NCT03862768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457154|NCT03862768|Growth Inhibitors|growth inhibitors|mesh-ancestor
65457155|NCT03862768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65457156|NCT03862768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457157|NCT03862768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457158|NCT03862456|Azithromycin|azithromycin|mesh-list
65457159|NCT03862456|Metronidazole|metronidazole|mesh-list
65457160|NCT03862456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65457161|NCT03862456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65457162|NCT03862456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65457163|NCT03862456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65457164|NCT03859102|Acetaminophen|acetaminophen|mesh-list
65457165|NCT03859102|Dexamethasone|dexamethasone|mesh-list
65457166|NCT03859102|Gabapentin|gabapentin|mesh-list
65457167|NCT03859102|Ondansetron|ondansetron|mesh-list
65457168|NCT03859102|Anesthetics|anesthetics|mesh-list
65457169|NCT03859102|Anesthetics, Local|anesthetics, local|mesh-list
65457170|NCT03859102|Lansoprazole|lansoprazole|mesh-list
65457171|NCT03859102|Dexlansoprazole|dexlansoprazole|mesh-list
65457172|NCT03859102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65457173|NCT03859102|Antiemetics|antiemetics|mesh-ancestor
65457174|NCT03859102|Autonomic Agents|autonomic agents|mesh-ancestor
65457175|NCT03859102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64841716|NCT01652794|Antiviral Agents|antiviral agents|mesh-ancestor
64694505|NCT04736381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64694506|NCT04736381|Antitubercular Agents|antitubercular agents|mesh-ancestor
64694507|NCT04736381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64694508|NCT04736381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64694509|NCT04736381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64694510|NCT04736381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694511|NCT04736381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64694512|NCT04736381|Immunologic Factors|immunologic factors|mesh-ancestor
64694513|NCT04736381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457176|NCT03859102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457177|NCT03859102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65457178|NCT03859102|Glucocorticoids|glucocorticoids|mesh-ancestor
65457179|NCT03859102|Hormones|hormones|mesh-ancestor
65457180|NCT03859102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65457181|NCT03859102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65457182|NCT03859102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457183|NCT03859102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65457184|NCT03859102|Analgesics|analgesics|mesh-ancestor
65457185|NCT03859102|Sensory System Agents|sensory system agents|mesh-ancestor
65457186|NCT03859102|Antipyretics|antipyretics|mesh-ancestor
65457187|NCT03859102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65457188|NCT03859102|Anticonvulsants|anticonvulsants|mesh-ancestor
65457189|NCT03859102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65457190|NCT03859102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65457191|NCT03859102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65457192|NCT03859102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65457193|NCT03859102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65457194|NCT03859102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65457195|NCT03859102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457196|NCT03859102|Antimanic Agents|antimanic agents|mesh-ancestor
65457197|NCT03859102|Antipruritics|antipruritics|mesh-ancestor
65457198|NCT03859102|Dermatologic Agents|dermatologic agents|mesh-ancestor
65457199|NCT03859102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65457200|NCT03859102|Serotonin Agents|serotonin agents|mesh-ancestor
64694514|NCT04736381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64694515|NCT04736381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64694516|NCT03302741|Botulinum Toxins|botulinum toxins|mesh-list
64694517|NCT03302741|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64694518|NCT03302741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64694519|NCT03302741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694521|NCT03302741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64694522|NCT03302741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694524|NCT02792465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64694525|NCT02792465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694526|NCT02792465|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64694527|NCT02792465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64694528|NCT02792465|Hormone Antagonists|hormone antagonists|mesh-ancestor
64694529|NCT02792465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64694530|NCT02792465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694531|NCT05573828|Parathyroid Hormone|parathyroid hormone|mesh-list
64694532|NCT05573828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64694533|NCT05573828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694534|NCT02769611|Ruboxistaurin|ruboxistaurin|mesh-list
64694535|NCT02769611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64694536|NCT02769611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694537|NCT05132504|Pembrolizumab|pembrolizumab|mesh-list
65457201|NCT03859102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65457202|NCT03859102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65457203|NCT03859102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65457204|NCT03859102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457205|NCT00149994|Cyclosporine|cyclosporine|mesh-list
65457206|NCT00149994|Prednisone|prednisone|mesh-list
65457207|NCT00149994|Methylprednisolone|methylprednisolone|mesh-list
65457208|NCT00149994|Tacrolimus|tacrolimus|mesh-list
65457209|NCT00149994|Cyclosporins|cyclosporins|mesh-list
65457210|NCT00149994|Basiliximab|basiliximab|mesh-list
65457211|NCT00149994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65457212|NCT00149994|Glucocorticoids|glucocorticoids|mesh-ancestor
65457213|NCT00149994|Hormones|hormones|mesh-ancestor
65457214|NCT00149994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65457215|NCT00149994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457216|NCT00149994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65457217|NCT00149994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457218|NCT00149994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65457219|NCT00149994|Immunologic Factors|immunologic factors|mesh-ancestor
65457220|NCT00149994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65457221|NCT00149994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457222|NCT00149994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457223|NCT00149994|Antifungal Agents|antifungal agents|mesh-ancestor
65457224|NCT00149994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65457225|NCT00149994|Dermatologic Agents|dermatologic agents|mesh-ancestor
65457226|NCT00149994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65457227|NCT00149994|Antiemetics|antiemetics|mesh-ancestor
65457228|NCT00149994|Autonomic Agents|autonomic agents|mesh-ancestor
65457229|NCT00149994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457230|NCT00149994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65457231|NCT00149994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65457232|NCT00149994|Protective Agents|protective agents|mesh-ancestor
65457233|NCT01179646|Pantoprazole|pantoprazole|mesh-list
64694538|NCT05132504|Folfirinox|folfirinox|mesh-list
64694539|NCT05132504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64694540|NCT05132504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694541|NCT04525820|Vitamin D|vitamin d|mesh-list
64694542|NCT04525820|Ergocalciferols|ergocalciferols|mesh-list
64694556|NCT05117450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64694557|NCT05117450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64694558|NCT05117450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694559|NCT03305159|Chlorhexidine|chlorhexidine|mesh-list
64694560|NCT03305159|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64694561|NCT03305159|Povidone-Iodine|povidone-iodine|mesh-list
64694562|NCT03305159|Povidone|povidone|mesh-list
65457234|NCT01179646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65457235|NCT01179646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65457236|NCT01179646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65457237|NCT01179646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457238|NCT01179646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457239|NCT01075776|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
65457240|NCT01075776|Acetylcholine|acetylcholine|mesh-list
65457241|NCT01075776|Vasodilator Agents|vasodilator agents|mesh-ancestor
65457242|NCT01075776|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65457243|NCT01075776|Cholinergic Agents|cholinergic agents|mesh-ancestor
65457244|NCT01075776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65457245|NCT01075776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457246|NCT01075776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457247|NCT01075776|Natriuretic Agents|natriuretic agents|mesh-ancestor
65457248|NCT01079910|Fluorides|fluorides|mesh-list
65457249|NCT01079910|Cariostatic Agents|cariostatic agents|mesh-ancestor
65457250|NCT01079910|Protective Agents|protective agents|mesh-ancestor
65457251|NCT01079910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457252|NCT01286896|Sunitinib|sunitinib|mesh-list
65457253|NCT01286896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457254|NCT01286896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65457255|NCT01286896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65457256|NCT01286896|Growth Substances|growth substances|mesh-ancestor
65457257|NCT01286896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457258|NCT01286896|Growth Inhibitors|growth inhibitors|mesh-ancestor
65457259|NCT01286896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65457260|NCT01286896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457261|NCT01286896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457262|NCT03857854|Pirfenidone|pirfenidone|mesh-list
64694563|NCT03305159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64694564|NCT03305159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64694565|NCT03305159|Disinfectants|disinfectants|mesh-ancestor
64694566|NCT03305159|Dermatologic Agents|dermatologic agents|mesh-ancestor
64694567|NCT03305159|Plasma Substitutes|plasma substitutes|mesh-ancestor
64694568|NCT03305159|Blood Substitutes|blood substitutes|mesh-ancestor
64717707|NCT00378872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717709|NCT00378872|Coagulants|coagulants|mesh-ancestor
64325903|NCT01001923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64325905|NCT02154503|Minoxidil|minoxidil|mesh-list
64694591|NCT02192021|Doxorubicin|doxorubicin|mesh-list
64694592|NCT02192021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64694593|NCT02192021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64694594|NCT02192021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694595|NCT02192021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64694596|NCT02192021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64694597|NCT02192021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457263|NCT03857854|Analgesics|analgesics|mesh-ancestor
65457264|NCT03857854|Sensory System Agents|sensory system agents|mesh-ancestor
65457265|NCT03857854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457266|NCT03857854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457267|NCT03857854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65457268|NCT03857854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65457269|NCT03857854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65457270|NCT03857854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65457271|NCT03857854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457272|NCT01287052|Nitrous Oxide|nitrous oxide|mesh-list
65457273|NCT01287052|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65457274|NCT01287052|Anesthetics, General|anesthetics, general|mesh-ancestor
65457275|NCT01287052|Anesthetics|anesthetics|mesh-ancestor
65457276|NCT01287052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65457277|NCT01287052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457278|NCT01287052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65457279|NCT01287052|Analgesics|analgesics|mesh-ancestor
65457280|NCT01287052|Sensory System Agents|sensory system agents|mesh-ancestor
65457281|NCT01287052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457282|NCT01288924|Parecoxib|parecoxib|mesh-list
65457283|NCT01288924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65457284|NCT01288924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65457285|NCT01288924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457286|NCT01288924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457287|NCT01288924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65457288|NCT01288924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65457289|NCT01288924|Analgesics|analgesics|mesh-ancestor
64694598|NCT02192021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694599|NCT05552144|Listerine|listerine|mesh-list
64694600|NCT05552144|Sodium Fluoride|sodium fluoride|mesh-list
64694601|NCT05552144|Cariostatic Agents|cariostatic agents|mesh-ancestor
64694602|NCT05552144|Protective Agents|protective agents|mesh-ancestor
64694603|NCT05552144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694604|NCT05552144|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64694605|NCT05552144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64694606|NCT03308669|Topiramate|topiramate|mesh-list
64694607|NCT03308669|Lasmiditan|lasmiditan|mesh-list
64694608|NCT03308669|Anticonvulsants|anticonvulsants|mesh-ancestor
64694617|NCT00356252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694618|NCT00356252|Protective Agents|protective agents|mesh-ancestor
64694619|NCT00356252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694620|NCT02056171|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64694621|NCT02056171|Antidepressive Agents|antidepressive agents|mesh-ancestor
64694622|NCT02056171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64694623|NCT02056171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64694624|NCT02056171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64694625|NCT02056171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65457290|NCT01288924|Sensory System Agents|sensory system agents|mesh-ancestor
65457291|NCT01288924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457292|NCT01288924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457293|NCT01288924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65457294|NCT01288924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65457295|NCT01179724|Pantoprazole|pantoprazole|mesh-list
65457296|NCT01179724|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65457297|NCT01179724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65457298|NCT01179724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65457299|NCT01179724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457300|NCT01179724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457301|NCT03862612|Anesthetics|anesthetics|mesh-list
65457302|NCT03862612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65457303|NCT03862612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694626|NCT02056171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694627|NCT03312023|Sofosbuvir|sofosbuvir|mesh-list
64717710|NCT00378404|Docetaxel|docetaxel|mesh-list
64717711|NCT00378404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64717712|NCT00378404|Tubulin Modulators|tubulin modulators|mesh-ancestor
64717713|NCT00378404|Antimitotic Agents|antimitotic agents|mesh-ancestor
64717714|NCT00378404|Mitosis Modulators|mitosis modulators|mesh-ancestor
64717715|NCT00378404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717716|NCT03742154|Varenicline|varenicline|mesh-list
64694628|NCT03312023|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64694629|NCT03312023|Ledipasvir|ledipasvir|mesh-list
64694630|NCT03312023|Antiviral Agents|antiviral agents|mesh-ancestor
64694631|NCT03312023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64694632|NCT04776395|Dexamethasone|dexamethasone|mesh-list
64694633|NCT04776395|Dexamethasone acetate|dexamethasone acetate|mesh-list
64694634|NCT04776395|Ichthammol|ichthammol|mesh-list
64694635|NCT04776395|BB 1101|bb 1101|mesh-list
64694636|NCT04776395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64694637|NCT04776395|Antiemetics|antiemetics|mesh-ancestor
64694638|NCT04776395|Autonomic Agents|autonomic agents|mesh-ancestor
64694639|NCT04776395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64694640|NCT04776395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694641|NCT04776395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64694642|NCT04776395|Glucocorticoids|glucocorticoids|mesh-ancestor
64694643|NCT04776395|Hormones|hormones|mesh-ancestor
64694644|NCT04776395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64694645|NCT04776395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64694646|NCT04776395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694647|NCT04776395|Protease Inhibitors|protease inhibitors|mesh-ancestor
64694648|NCT04776395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64694655|NCT02342197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64694656|NCT02342197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694657|NCT02342197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64694658|NCT02342197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64694659|NCT02342197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694660|NCT02344225|Ibuprofen|ibuprofen|mesh-list
64694661|NCT02344225|Ketorolac|ketorolac|mesh-list
64694662|NCT02344225|Caffeine|caffeine|mesh-list
64694663|NCT02344225|Caffeine citrate|caffeine citrate|mesh-list
64694664|NCT02344225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694665|NCT02344225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64694666|NCT02344225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64694667|NCT02344225|Analgesics|analgesics|mesh-ancestor
64694668|NCT02344225|Sensory System Agents|sensory system agents|mesh-ancestor
64694669|NCT02344225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64694670|NCT02344225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694671|NCT02344225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65457304|NCT01287130|Cetuximab|cetuximab|mesh-list
65457305|NCT01287130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65457306|NCT01287130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457307|NCT00149214|Cyclophosphamide|cyclophosphamide|mesh-list
65457308|NCT00149214|Docetaxel|docetaxel|mesh-list
65457309|NCT00149214|Doxorubicin|doxorubicin|mesh-list
65457310|NCT00149214|Pemetrexed|pemetrexed|mesh-list
65457311|NCT00149214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65457312|NCT00149214|Immunologic Factors|immunologic factors|mesh-ancestor
65457313|NCT00149214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457314|NCT00149214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65457315|NCT00149214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65457316|NCT00149214|Alkylating Agents|alkylating agents|mesh-ancestor
65457317|NCT00149214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457318|NCT00149214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457319|NCT00149214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65457320|NCT00149214|Tubulin Modulators|tubulin modulators|mesh-ancestor
65457321|NCT00149214|Antimitotic Agents|antimitotic agents|mesh-ancestor
65457322|NCT00149214|Mitosis Modulators|mitosis modulators|mesh-ancestor
65457323|NCT00149214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65457324|NCT00149214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65457325|NCT00149214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65457326|NCT00149214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457327|NCT00149214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65457328|NCT00149214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65457329|NCT03034018|Suvorexant|suvorexant|mesh-list
65457330|NCT03034018|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65457331|NCT03034018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65457332|NCT03034018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65457333|NCT03034018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457334|NCT03034018|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65457335|NCT03034018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65457336|NCT03034018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457337|NCT02525458|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
65457338|NCT02525458|Vasodilator Agents|vasodilator agents|mesh-ancestor
65457339|NCT02525458|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64694672|NCT02344225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64694673|NCT02344225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65457340|NCT02525458|Protective Agents|protective agents|mesh-ancestor
65457341|NCT02525458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457342|NCT02555254|Methamphetamine|methamphetamine|mesh-list
65457343|NCT02555254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65457344|NCT02555254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457345|NCT02555254|Sympathomimetics|sympathomimetics|mesh-ancestor
65457346|NCT02555254|Autonomic Agents|autonomic agents|mesh-ancestor
65457347|NCT02555254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457348|NCT02555254|Dopamine Agents|dopamine agents|mesh-ancestor
65457349|NCT02555254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65457350|NCT02555254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457351|NCT02555254|Adrenergic Agents|adrenergic agents|mesh-ancestor
65457352|NCT02555254|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65457353|NCT02555254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65457354|NCT02555254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65457355|NCT02555254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65457356|NCT00114972|Paclitaxel|paclitaxel|mesh-list
65457357|NCT00114972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65457358|NCT00114972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65457359|NCT00114972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457360|NCT00114972|Tubulin Modulators|tubulin modulators|mesh-ancestor
65457361|NCT00114972|Antimitotic Agents|antimitotic agents|mesh-ancestor
65457362|NCT00114972|Mitosis Modulators|mitosis modulators|mesh-ancestor
65457363|NCT00114972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457364|NCT02444728|Hydroxychloroquine|hydroxychloroquine|mesh-list
65457365|NCT02444728|Methylprednisolone|methylprednisolone|mesh-list
65457366|NCT02444728|Cyclophosphamide|cyclophosphamide|mesh-list
64694674|NCT02344225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64694675|NCT02344225|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64694686|NCT04319588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64694687|NCT05065736|Clofarabine|clofarabine|mesh-list
64694688|NCT05065736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64694689|NCT05065736|Antimetabolites|antimetabolites|mesh-ancestor
64694690|NCT05065736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694691|NCT05065736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694693|NCT04298606|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64694694|NCT04298606|Mitogens|mitogens|mesh-list
64694695|NCT04298606|Immunologic Factors|immunologic factors|mesh-ancestor
64694696|NCT04298606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694697|NCT04298606|Mitosis Modulators|mitosis modulators|mesh-ancestor
64694698|NCT04298606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694699|NCT04298606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64694700|NCT03769844|Molgramostim|molgramostim|mesh-list
64717717|NCT03742154|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64717718|NCT03742154|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64717719|NCT03742154|Cholinergic Agents|cholinergic agents|mesh-ancestor
64717720|NCT03742154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65457367|NCT02444728|Azathioprine|azathioprine|mesh-list
65457368|NCT02444728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65457369|NCT02444728|Immunologic Factors|immunologic factors|mesh-ancestor
65457370|NCT02444728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457371|NCT02444728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65457372|NCT02444728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65457373|NCT02444728|Alkylating Agents|alkylating agents|mesh-ancestor
65457374|NCT02444728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457375|NCT02444728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457376|NCT02444728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65457377|NCT02444728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65457378|NCT02444728|Antiemetics|antiemetics|mesh-ancestor
65457379|NCT02444728|Autonomic Agents|autonomic agents|mesh-ancestor
65457380|NCT02444728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457381|NCT02444728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65457382|NCT02444728|Glucocorticoids|glucocorticoids|mesh-ancestor
65457383|NCT02444728|Hormones|hormones|mesh-ancestor
65457384|NCT02444728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65457385|NCT02444728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65457386|NCT02444728|Protective Agents|protective agents|mesh-ancestor
65457387|NCT02444728|Antimalarials|antimalarials|mesh-ancestor
65457388|NCT02444728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65457389|NCT02444728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65457390|NCT02444728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65457391|NCT02444728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457392|NCT02444728|Antimetabolites|antimetabolites|mesh-ancestor
65457393|NCT02444728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65457394|NCT00129402|Simvastatin|simvastatin|mesh-list
65457395|NCT00129402|Ezetimibe|ezetimibe|mesh-list
65457396|NCT00129402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65457397|NCT00129402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65457398|NCT00129402|Antimetabolites|antimetabolites|mesh-ancestor
65457399|NCT00129402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457400|NCT00129402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65457401|NCT00129402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65457402|NCT00129402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457403|NCT03739528|Levofloxacin|levofloxacin|mesh-list
65457404|NCT03739528|Ofloxacin|ofloxacin|mesh-list
65457405|NCT03739528|Tobramycin|tobramycin|mesh-list
65457406|NCT03739528|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
65457407|NCT03739528|Dexamethasone|dexamethasone|mesh-list
65457408|NCT03739528|Dexamethasone acetate|dexamethasone acetate|mesh-list
65457409|NCT03739528|BB 1101|bb 1101|mesh-list
65457410|NCT03739528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65457411|NCT03739528|Antiemetics|antiemetics|mesh-ancestor
65457412|NCT03739528|Autonomic Agents|autonomic agents|mesh-ancestor
65457413|NCT03739528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457414|NCT03739528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457415|NCT03739528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65457416|NCT03739528|Glucocorticoids|glucocorticoids|mesh-ancestor
65457417|NCT03739528|Hormones|hormones|mesh-ancestor
65457418|NCT03739528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65457419|NCT03739528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65457420|NCT03739528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457421|NCT03739528|Protease Inhibitors|protease inhibitors|mesh-ancestor
65457422|NCT03739528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457423|NCT03739528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457424|NCT03739528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65457425|NCT03739528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65457426|NCT03739528|Renal Agents|renal agents|mesh-ancestor
65457427|NCT03739528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65457428|NCT03739528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65457429|NCT03739528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64841978|NCT01654497|Protective Agents|protective agents|mesh-ancestor
64717721|NCT03742154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717722|NCT03742154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694701|NCT03769844|Sargramostim|sargramostim|mesh-list
64694702|NCT03769844|Immunologic Factors|immunologic factors|mesh-ancestor
64694703|NCT03769844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694704|NCT03769844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694705|NCT02347345|Sofosbuvir|sofosbuvir|mesh-list
64694706|NCT02347345|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64694707|NCT02347345|Ledipasvir|ledipasvir|mesh-list
64694708|NCT02347345|Antiviral Agents|antiviral agents|mesh-ancestor
64694709|NCT02347345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64694710|NCT04624295|Aspirin|aspirin|mesh-list
64694711|NCT04624295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64694712|NCT04624295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64694713|NCT04624295|Analgesics|analgesics|mesh-ancestor
64694714|NCT04624295|Sensory System Agents|sensory system agents|mesh-ancestor
64694715|NCT04624295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64694716|NCT04624295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694717|NCT04624295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64694718|NCT04624295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64694719|NCT04624295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64694720|NCT04624295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64694721|NCT04624295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457430|NCT03739528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65457431|NCT03739528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65457432|NCT03739528|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65457433|NCT03739528|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65457434|NCT03857386|Anesthetics|anesthetics|mesh-list
65457435|NCT03857386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65457436|NCT03857386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457437|NCT01587586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65457438|NCT01587586|Antiviral Agents|antiviral agents|mesh-ancestor
65457439|NCT01587586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65457440|NCT01289236|Milnacipran|milnacipran|mesh-list
65457441|NCT01289236|Levomilnacipran|levomilnacipran|mesh-list
65457442|NCT01289236|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65457443|NCT01289236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65457444|NCT01289236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65457445|NCT01289236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457446|NCT01289236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65457447|NCT01289236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457448|NCT01289236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65457449|NCT01289236|Analgesics|analgesics|mesh-ancestor
65457451|NCT01289236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457452|NCT01289236|Antidepressive Agents|antidepressive agents|mesh-ancestor
65457453|NCT01289236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65457454|NCT01289938|Diphenhydramine|diphenhydramine|mesh-list
65457455|NCT01289938|Promethazine|promethazine|mesh-list
65457456|NCT01289938|Metoclopramide|metoclopramide|mesh-list
65457457|NCT01289938|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65457458|NCT01289938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65457459|NCT01289938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65457460|NCT01289938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457461|NCT01289938|Anesthetics, Local|anesthetics, local|mesh-ancestor
64842043|NCT01654965|Immunologic Factors|immunologic factors|mesh-ancestor
65457472|NCT01289938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457473|NCT01289938|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65457474|NCT01289938|Antipruritics|antipruritics|mesh-ancestor
65457475|NCT01289938|Dermatologic Agents|dermatologic agents|mesh-ancestor
65457476|NCT01289938|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65457477|NCT01289938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65457478|NCT01289938|Dopamine Agents|dopamine agents|mesh-ancestor
65457479|NCT00114738|Rituximab|rituximab|mesh-list
65457480|NCT00114738|Bortezomib|bortezomib|mesh-list
65457481|NCT00114738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65457482|NCT00114738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457483|NCT00114738|Immunologic Factors|immunologic factors|mesh-ancestor
65457484|NCT00114738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457485|NCT00114738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65457486|NCT01180348|Botulinum Toxins|botulinum toxins|mesh-list
65457487|NCT01180348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65457488|NCT01180348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65457489|NCT01180348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65457490|NCT01180348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65457491|NCT01180348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457492|NCT01180348|Cholinergic Agents|cholinergic agents|mesh-ancestor
65457493|NCT01180348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65457494|NCT01180348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457495|NCT01180348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65457496|NCT01180348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457497|NCT01180426|Tosedostat|tosedostat|mesh-list
65457498|NCT01180426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457499|NCT01180426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457500|NCT00148122|Docetaxel|docetaxel|mesh-list
65457501|NCT00148122|Capecitabine|capecitabine|mesh-list
65457502|NCT00148122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457503|NCT00148122|Tubulin Modulators|tubulin modulators|mesh-ancestor
64842044|NCT01654965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694726|NCT03319277|Opiate Alkaloids|opiate alkaloids|mesh-list
64694727|NCT03319277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64694729|NCT03319277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64694730|NCT03319277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694731|NCT03319277|Analgesics|analgesics|mesh-ancestor
64694732|NCT03319277|Sensory System Agents|sensory system agents|mesh-ancestor
64694733|NCT03319277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842073|NCT01655082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65457504|NCT00148122|Antimitotic Agents|antimitotic agents|mesh-ancestor
65457505|NCT00148122|Mitosis Modulators|mitosis modulators|mesh-ancestor
65457506|NCT00148122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457507|NCT00148122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65457508|NCT00148122|Antimetabolites|antimetabolites|mesh-ancestor
65457509|NCT01182142|Capecitabine|capecitabine|mesh-list
65457510|NCT01182142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65457511|NCT01182142|Antimetabolites|antimetabolites|mesh-ancestor
65457512|NCT01182142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457513|NCT01182142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457514|NCT01180816|Temozolomide|temozolomide|mesh-list
65457515|NCT01180816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65457516|NCT01180816|Alkylating Agents|alkylating agents|mesh-ancestor
65457517|NCT01180816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457518|NCT01180816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457519|NCT01287598|Rosiglitazone|rosiglitazone|mesh-list
65457520|NCT01287598|Midazolam|midazolam|mesh-list
65457521|NCT01287598|Omeprazole|omeprazole|mesh-list
65457522|NCT01287598|Warfarin|warfarin|mesh-list
65457523|NCT01287598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65457524|NCT01287598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65206989|NCT00799903|Darapladib|darapladib|mesh-list
65457525|NCT01287598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65457526|NCT01287598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694734|NCT03768440|Ropivacaine|ropivacaine|mesh-list
64694735|NCT03768440|Anesthetics, Local|anesthetics, local|mesh-ancestor
64694736|NCT03768440|Anesthetics|anesthetics|mesh-ancestor
64694737|NCT03768440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64694738|NCT03768440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694739|NCT03768440|Sensory System Agents|sensory system agents|mesh-ancestor
64694740|NCT03768440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64694741|NCT03323801|Tretinoin|tretinoin|mesh-list
64694766|NCT02397265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694768|NCT00356720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64694769|NCT00356720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64694770|NCT04121780|Hormones|hormones|mesh-list
64694771|NCT04121780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64694772|NCT04121780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694773|NCT00375869|Darbepoetin alfa|darbepoetin alfa|mesh-list
64694774|NCT00375869|Hematinics|hematinics|mesh-ancestor
64694775|NCT03198221|Picosulfate sodium|picosulfate sodium|mesh-list
64694776|NCT03198221|Magnesium Oxide|magnesium oxide|mesh-list
64694777|NCT03198221|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64694778|NCT03198221|Citric Acid|citric acid|mesh-list
64694779|NCT03198221|Anticoagulants|anticoagulants|mesh-ancestor
64694780|NCT03198221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64694781|NCT03198221|Chelating Agents|chelating agents|mesh-ancestor
64694782|NCT03198221|Sequestering Agents|sequestering agents|mesh-ancestor
64694783|NCT03198221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694784|NCT03198221|Cathartics|cathartics|mesh-ancestor
65457527|NCT01287598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65457528|NCT01287598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65457529|NCT01287598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65457530|NCT01287598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65457531|NCT01287598|Anesthetics, General|anesthetics, general|mesh-ancestor
65457532|NCT01287598|Anesthetics|anesthetics|mesh-ancestor
65457533|NCT01287598|GABA Modulators|gaba modulators|mesh-ancestor
65457534|NCT01287598|GABA Agents|gaba agents|mesh-ancestor
65457535|NCT01287598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65457536|NCT01287598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457537|NCT01287598|Anticoagulants|anticoagulants|mesh-ancestor
65457538|NCT01287598|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65457539|NCT01287598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65457540|NCT01287598|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65457541|NCT01287598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457542|NCT01287598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65457543|NCT03862144|Palonosetron|palonosetron|mesh-list
65457544|NCT03862144|Antiemetics|antiemetics|mesh-ancestor
65457545|NCT03862144|Autonomic Agents|autonomic agents|mesh-ancestor
65457546|NCT03862144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457547|NCT03862144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457548|NCT03862144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65457549|NCT03862144|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65457550|NCT03862144|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65457551|NCT03862144|Serotonin Agents|serotonin agents|mesh-ancestor
64842115|NCT01655199|Ipratropium|ipratropium|mesh-list
64694785|NCT03198221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64694786|NCT03198221|Antacids|antacids|mesh-ancestor
64694787|NCT03198221|Laxatives|laxatives|mesh-ancestor
64694788|NCT03203681|Methyltestosterone|methyltestosterone|mesh-list
64717724|NCT02734940|Fentanyl|fentanyl|mesh-list
64717725|NCT02734940|Ketamine|ketamine|mesh-list
64717726|NCT02734940|Dexmedetomidine|dexmedetomidine|mesh-list
64717727|NCT02734940|Morphine|morphine|mesh-list
64717728|NCT02734940|Anesthetics, Local|anesthetics, local|mesh-ancestor
64717729|NCT02734940|Anesthetics|anesthetics|mesh-ancestor
64717730|NCT02734940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717731|NCT02734940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694789|NCT03203681|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64694790|NCT03203681|Testosterone|testosterone|mesh-list
64694791|NCT03203681|Testosterone undecanoate|testosterone undecanoate|mesh-list
64694792|NCT03203681|Testosterone enanthate|testosterone enanthate|mesh-list
64694793|NCT03203681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64694794|NCT03203681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694795|NCT03203681|Anabolic Agents|anabolic agents|mesh-ancestor
64694814|NCT00356486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694816|NCT03331835|Dermatologic Agents|dermatologic agents|mesh-ancestor
64694817|NCT02403895|Paclitaxel|paclitaxel|mesh-list
64694818|NCT02403895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64694819|NCT02403895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694820|NCT02403895|Tubulin Modulators|tubulin modulators|mesh-ancestor
64694821|NCT02403895|Antimitotic Agents|antimitotic agents|mesh-ancestor
64694822|NCT02403895|Mitosis Modulators|mitosis modulators|mesh-ancestor
65457552|NCT03862144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65457553|NCT03862144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457554|NCT01290172|Somatostatin|somatostatin|mesh-list
65457555|NCT01290172|Hormones|hormones|mesh-ancestor
65457556|NCT01290172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65457557|NCT01290172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457558|NCT03861598|Carvedilol|carvedilol|mesh-list
65457559|NCT03861598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65457560|NCT03861598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65457561|NCT03861598|Adrenergic Agents|adrenergic agents|mesh-ancestor
65457562|NCT03861598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65457563|NCT03861598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457564|NCT03861598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457565|NCT03861598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65457566|NCT03861598|Antioxidants|antioxidants|mesh-ancestor
65457567|NCT03861598|Protective Agents|protective agents|mesh-ancestor
65457568|NCT03861598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65457569|NCT03861598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65457570|NCT03861598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65457571|NCT03861598|Vasodilator Agents|vasodilator agents|mesh-ancestor
65457572|NCT03861598|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64842132|NCT01655212|Valganciclovir|valganciclovir|mesh-list
64694823|NCT02403895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694824|NCT03994874|Furosemide|furosemide|mesh-list
64694825|NCT03994874|Dialysis Solutions|dialysis solutions|mesh-list
64694826|NCT03994874|Diuretics|diuretics|mesh-list
64694827|NCT03994874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
64694829|NCT03994874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694830|NCT03994874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64694831|NCT03994874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694835|NCT05722340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64694836|NCT05722340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694837|NCT02354833|Phenylephrine|phenylephrine|mesh-list
64694838|NCT02354833|Oxymetazoline|oxymetazoline|mesh-list
64694839|NCT02354833|Norepinephrine|norepinephrine|mesh-list
64694840|NCT02354833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64694841|NCT02354833|Mydriatics|mydriatics|mesh-ancestor
64694842|NCT02354833|Autonomic Agents|autonomic agents|mesh-ancestor
64694843|NCT02354833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64694844|NCT02354833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694845|NCT02354833|Sympathomimetics|sympathomimetics|mesh-ancestor
64694846|NCT02354833|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64694847|NCT02354833|Nasal Decongestants|nasal decongestants|mesh-ancestor
64694848|NCT02354833|Respiratory System Agents|respiratory system agents|mesh-ancestor
64694849|NCT02354833|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64694850|NCT02354833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64694851|NCT02354833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64694852|NCT02354833|Adrenergic Agents|adrenergic agents|mesh-ancestor
64694862|NCT03337724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457573|NCT03861598|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65457574|NCT01184482|Cetuximab|cetuximab|mesh-list
65457575|NCT01184482|Lapatinib|lapatinib|mesh-list
65457576|NCT01184482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65457577|NCT01184482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457578|NCT01184482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65457579|NCT01184482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457580|NCT01184482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457581|NCT01184560|Orlistat|orlistat|mesh-list
65457582|NCT01184560|Sibutramine|sibutramine|mesh-list
65457583|NCT01184560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457584|NCT01184560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457585|NCT01184560|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65457586|NCT01184560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65457587|NCT01184560|Antidepressive Agents|antidepressive agents|mesh-ancestor
65457588|NCT01184560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65457589|NCT01184560|Appetite Depressants|appetite depressants|mesh-ancestor
65457590|NCT01184638|Propofol|propofol|mesh-list
65457591|NCT01184638|Sevoflurane|sevoflurane|mesh-list
65457592|NCT01184638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65457597|NCT01184638|Anesthetics|anesthetics|mesh-ancestor
65457629|NCT01587508|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65457630|NCT01587508|Antidepressive Agents|antidepressive agents|mesh-ancestor
65457631|NCT01587508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65457632|NCT01587508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65457633|NCT01587508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65457634|NCT01587508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65457635|NCT01587508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65457636|NCT01587508|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65457637|NCT01587508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65457638|NCT01587508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65457639|NCT01587508|Adrenergic Agents|adrenergic agents|mesh-ancestor
65457640|NCT01587508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65457641|NCT00147498|Tofacitinib|tofacitinib|mesh-list
65457642|NCT00147498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65457643|NCT00147498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457644|NCT00147498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457645|NCT01176760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65457646|NCT01176760|Protease Inhibitors|protease inhibitors|mesh-ancestor
65457647|NCT01176760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457648|NCT01176760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457649|NCT01176760|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65457650|NCT01176760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457651|NCT01080066|Cetuximab|cetuximab|mesh-list
65457652|NCT01080066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65457653|NCT01080066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457654|NCT01185184|Tofacitinib|tofacitinib|mesh-list
65457655|NCT01185184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65457656|NCT01185184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64694864|NCT03838484|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64694865|NCT03838484|Autonomic Agents|autonomic agents|mesh-ancestor
64694866|NCT03838484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64694867|NCT03838484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694868|NCT03838484|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64694869|NCT03838484|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64694870|NCT03838484|Cholinergic Agents|cholinergic agents|mesh-ancestor
64694871|NCT03838484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64694872|NCT03838484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694873|NCT03307616|Nivolumab|nivolumab|mesh-list
64694874|NCT03307616|Ipilimumab|ipilimumab|mesh-list
64694875|NCT03307616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64694876|NCT03307616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694877|NCT03307616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64717732|NCT02734940|Sensory System Agents|sensory system agents|mesh-ancestor
64717733|NCT02734940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457657|NCT01185184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457658|NCT00113568|Tranexamic Acid|tranexamic acid|mesh-list
65457659|NCT00113568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65457660|NCT00113568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65457661|NCT00113568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457662|NCT00113568|Hemostatics|hemostatics|mesh-ancestor
65457663|NCT00113568|Coagulants|coagulants|mesh-ancestor
65457664|NCT01185262|Rituximab|rituximab|mesh-list
65457665|NCT01185262|Lenalidomide|lenalidomide|mesh-list
65457666|NCT01185262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65457667|NCT01185262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457668|NCT01185262|Immunologic Factors|immunologic factors|mesh-ancestor
65457669|NCT01185262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457670|NCT01185262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65457671|NCT01185262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64842221|NCT01655745|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64842224|NCT01655758|Timolol|timolol|mesh-list
64717734|NCT02734940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64717735|NCT02734940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64717736|NCT02734940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64717737|NCT02734940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64694878|NCT03307616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694879|NCT05721872|Arsenic Trioxide|arsenic trioxide|mesh-list
64694880|NCT05721872|Isoascorbic acid|isoascorbic acid|mesh-list
64694881|NCT05721872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694882|NCT05721872|Antioxidants|antioxidants|mesh-ancestor
64694883|NCT05721872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694884|NCT05721872|Protective Agents|protective agents|mesh-ancestor
64694885|NCT05721872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694886|NCT02408965|Methylergonovine|methylergonovine|mesh-list
64694887|NCT02408965|Oxytocics|oxytocics|mesh-ancestor
64694888|NCT02408965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64694889|NCT02408965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694890|NCT03299426|Vaccines|vaccines|mesh-list
64694891|NCT03299426|Immunologic Factors|immunologic factors|mesh-ancestor
64694892|NCT03299426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694893|NCT03220022|Prednisone|prednisone|mesh-list
64694894|NCT03220022|Cortisone|cortisone|mesh-list
64694895|NCT03220022|Cyclophosphamide|cyclophosphamide|mesh-list
64694896|NCT03220022|Rituximab|rituximab|mesh-list
64694897|NCT03220022|Doxorubicin|doxorubicin|mesh-list
64694898|NCT03220022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64694899|NCT03220022|Etoposide|etoposide|mesh-list
64694900|NCT03220022|Vincristine|vincristine|mesh-list
64694901|NCT03220022|Etoposide phosphate|etoposide phosphate|mesh-list
64694902|NCT03220022|Podophyllotoxin|podophyllotoxin|mesh-list
64694903|NCT03220022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64694905|NCT03220022|Immunoglobulins|immunoglobulins|mesh-list
64694906|NCT03220022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64694907|NCT03220022|Lenograstim|lenograstim|mesh-list
64694908|NCT03220022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64694909|NCT03220022|Immunologic Factors|immunologic factors|mesh-ancestor
64694910|NCT03220022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694917|NCT03220022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64694918|NCT03220022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64694919|NCT03220022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64694945|NCT02411929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64694946|NCT02411929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694947|NCT05721404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64694948|NCT05721404|Icodextrin|icodextrin|mesh-list
65457672|NCT01185262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65457673|NCT01185262|Growth Substances|growth substances|mesh-ancestor
65457674|NCT01185262|Growth Inhibitors|growth inhibitors|mesh-ancestor
65457675|NCT00113490|Palivizumab|palivizumab|mesh-list
65457676|NCT00113490|Antiviral Agents|antiviral agents|mesh-ancestor
65457677|NCT00113490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65457679|NCT00146640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65457680|NCT00146640|Glucocorticoids|glucocorticoids|mesh-ancestor
65457681|NCT00146640|Hormones|hormones|mesh-ancestor
65457682|NCT00146640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65457683|NCT00146640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457684|NCT00146640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65457685|NCT00146640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457686|NCT01185418|Haloperidol|haloperidol|mesh-list
65457687|NCT01185418|Risperidone|risperidone|mesh-list
65457688|NCT01185418|Aripiprazole|aripiprazole|mesh-list
65457689|NCT01185418|Haloperidol decanoate|haloperidol decanoate|mesh-list
65457690|NCT01185418|Amisulpride|amisulpride|mesh-list
65457691|NCT01185418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65457692|NCT01185418|Serotonin Agents|serotonin agents|mesh-ancestor
64842236|NCT01655758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64842237|NCT01655758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64842238|NCT01655758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64842239|NCT01655758|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64842240|NCT01655758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842241|NCT01655810|Vitamin D|vitamin d|mesh-list
64842242|NCT01655810|Ergocalciferols|ergocalciferols|mesh-list
64842243|NCT01655810|Cholecalciferol|cholecalciferol|mesh-list
64694949|NCT05721404|Dialysis Solutions|dialysis solutions|mesh-list
64694950|NCT00356954|Ascorbic Acid|ascorbic acid|mesh-list
64694951|NCT00356954|Antioxidants|antioxidants|mesh-ancestor
64694952|NCT00356954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694953|NCT00356954|Protective Agents|protective agents|mesh-ancestor
64694954|NCT00356954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694955|NCT00356954|Vitamins|vitamins|mesh-ancestor
64694956|NCT00356954|Micronutrients|micronutrients|mesh-ancestor
64694957|NCT02358889|Ranibizumab|ranibizumab|mesh-list
64694958|NCT02358889|Immunoconjugates|immunoconjugates|mesh-list
64694959|NCT02358889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64694960|NCT02358889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64694961|NCT02358889|Growth Substances|growth substances|mesh-ancestor
64694962|NCT02358889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694963|NCT02358889|Growth Inhibitors|growth inhibitors|mesh-ancestor
64694964|NCT02358889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694965|NCT02358889|Immunologic Factors|immunologic factors|mesh-ancestor
64694966|NCT05721170|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64694967|NCT05721170|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64717738|NCT02734940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717739|NCT02734940|Analgesics|analgesics|mesh-ancestor
64717740|NCT02734940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65457693|NCT01185418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65457694|NCT01185418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457695|NCT01185418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457696|NCT01185418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65457697|NCT01185418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65457698|NCT01185418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65457699|NCT01185418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65457700|NCT01185418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65457701|NCT01185418|Dopamine Agents|dopamine agents|mesh-ancestor
65457702|NCT01185418|Antidepressive Agents|antidepressive agents|mesh-ancestor
65457703|NCT01185418|Dopamine Agonists|dopamine agonists|mesh-ancestor
65457704|NCT01185418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65457705|NCT01185418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65457706|NCT01185418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65457707|NCT01185418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65457708|NCT01185418|Antiemetics|antiemetics|mesh-ancestor
65457709|NCT01185418|Autonomic Agents|autonomic agents|mesh-ancestor
65457710|NCT01185418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457711|NCT01185418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65457712|NCT01185418|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65457713|NCT01185418|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65457714|NCT01185574|Vitamin D|vitamin d|mesh-list
65457715|NCT01185574|Vitamins|vitamins|mesh-ancestor
65457716|NCT01185574|Micronutrients|micronutrients|mesh-ancestor
65457717|NCT01185574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457718|NCT01185574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64717741|NCT02734940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64717742|NCT02734940|Anesthetics, General|anesthetics, general|mesh-ancestor
64717743|NCT02734940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64717744|NCT02734940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64717745|NCT02734940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64717746|NCT02734940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64717747|NCT02734940|Narcotics|narcotics|mesh-ancestor
64325945|NCT02267707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64694968|NCT05721170|Adrenergic Agents|adrenergic agents|mesh-ancestor
64694990|NCT00358202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64694991|NCT02802566|Vitamins|vitamins|mesh-list
64694992|NCT02802566|Micronutrients|micronutrients|mesh-ancestor
64694993|NCT02802566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694994|NCT02770040|Infliximab|infliximab|mesh-list
64694995|NCT02770040|Dermatologic Agents|dermatologic agents|mesh-ancestor
64694996|NCT02770040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64694997|NCT02770040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64694998|NCT04736225|Insulin|insulin|mesh-list
64694999|NCT04736225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64695000|NCT04736225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695001|NCT03344861|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
64695002|NCT03344861|Trioxsalen|trioxsalen|mesh-list
65457719|NCT03861364|Propofol|propofol|mesh-list
65457720|NCT03861364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65457721|NCT03861364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65457722|NCT03861364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457723|NCT03861364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65457724|NCT03861364|Anesthetics, General|anesthetics, general|mesh-ancestor
65457725|NCT03861364|Anesthetics|anesthetics|mesh-ancestor
65457726|NCT01185808|Vitamin D|vitamin d|mesh-list
65457727|NCT01185808|Ergocalciferols|ergocalciferols|mesh-list
65457728|NCT01185808|Cholecalciferol|cholecalciferol|mesh-list
65457729|NCT01185808|Vitamins|vitamins|mesh-list
65457730|NCT01185808|Micronutrients|micronutrients|mesh-ancestor
65457731|NCT01185808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457732|NCT01185808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65457733|NCT01185808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65457734|NCT01183624|Analgesics|analgesics|mesh-list
65457735|NCT01183624|Sensory System Agents|sensory system agents|mesh-ancestor
65457736|NCT01183624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457737|NCT01183624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457738|NCT01291186|Epinephrine|epinephrine|mesh-list
65457739|NCT01291186|Racepinephrine|racepinephrine|mesh-list
65457740|NCT01291186|Bupivacaine|bupivacaine|mesh-list
65457741|NCT01291186|Epinephryl borate|epinephryl borate|mesh-list
65457742|NCT01291186|Anesthetics, Local|anesthetics, local|mesh-ancestor
65457743|NCT01291186|Anesthetics|anesthetics|mesh-ancestor
65457744|NCT01291186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65457745|NCT01291186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695003|NCT03344861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695004|NCT03344861|Dermatologic Agents|dermatologic agents|mesh-ancestor
64695005|NCT03344861|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64695006|NCT03348683|Propranolol|propranolol|mesh-list
64695007|NCT03348683|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64695008|NCT03348683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64695009|NCT03348683|Adrenergic Agents|adrenergic agents|mesh-ancestor
64695010|NCT03348683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64695011|NCT03348683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695012|NCT03348683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695013|NCT03348683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64695014|NCT03348683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64695015|NCT03348683|Vasodilator Agents|vasodilator agents|mesh-ancestor
64695026|NCT00357188|Efavirenz|efavirenz|mesh-list
64695027|NCT00357188|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64695028|NCT00357188|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64695029|NCT00357188|Protease Inhibitors|protease inhibitors|mesh-ancestor
64695030|NCT00357188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64695031|NCT00357188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695032|NCT00357188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64695033|NCT00357188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64695034|NCT00357188|Antiviral Agents|antiviral agents|mesh-ancestor
64695035|NCT00357188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65457746|NCT01291186|Sensory System Agents|sensory system agents|mesh-ancestor
65457747|NCT01291186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457748|NCT01291186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65457749|NCT01291186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65457750|NCT01291186|Adrenergic Agents|adrenergic agents|mesh-ancestor
65457751|NCT01291186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65457752|NCT01291186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457753|NCT01291186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65457754|NCT01291186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65457755|NCT01291186|Autonomic Agents|autonomic agents|mesh-ancestor
65457756|NCT01291186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65457757|NCT01291186|Respiratory System Agents|respiratory system agents|mesh-ancestor
65457758|NCT01291186|Mydriatics|mydriatics|mesh-ancestor
65457759|NCT01291186|Sympathomimetics|sympathomimetics|mesh-ancestor
65457760|NCT01291186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65457761|NCT04979338|Bupivacaine|bupivacaine|mesh-list
65457762|NCT04979338|Anesthetics, Local|anesthetics, local|mesh-list
65457763|NCT04979338|Anesthetics|anesthetics|mesh-list
65457764|NCT04979338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65457765|NCT04979338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457766|NCT04979338|Sensory System Agents|sensory system agents|mesh-ancestor
65457767|NCT04979338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457768|NCT01177306|Guanfacine|guanfacine|mesh-list
65457769|NCT01177306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65457770|NCT01177306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65457771|NCT01177306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65457772|NCT01177306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65457773|NCT01177306|Adrenergic Agents|adrenergic agents|mesh-ancestor
64695036|NCT00357188|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64695037|NCT00357188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64695038|NCT00357188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64695039|NCT00357188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64695040|NCT00357188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64695041|NCT00357188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64695042|NCT00357188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64717748|NCT02734940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64717749|NCT02734940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64717750|NCT02734940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64717751|NCT02734940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64717752|NCT02734940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64717753|NCT02734940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64717754|NCT02734940|Adrenergic Agents|adrenergic agents|mesh-ancestor
64717755|NCT00378092|Risperidone|risperidone|mesh-list
64325955|NCT01373229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325956|NCT01373229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64695043|NCT00357188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64842335|NCT01656005|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65457774|NCT01177306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65457775|NCT01177306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457776|NCT01177306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457777|NCT01290406|Dactolisib|dactolisib|mesh-list
65457778|NCT01290406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457779|NCT03854812|Magnesium Sulfate|magnesium sulfate|mesh-list
65457780|NCT03854812|Fentanyl|fentanyl|mesh-list
65457781|NCT03854812|Propofol|propofol|mesh-list
65457782|NCT03854812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65457783|NCT03854812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65457784|NCT03854812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457785|NCT03854812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65457786|NCT03854812|Anesthetics, General|anesthetics, general|mesh-ancestor
65457787|NCT03854812|Anesthetics|anesthetics|mesh-ancestor
65457788|NCT03854812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65457789|NCT03854812|Narcotics|narcotics|mesh-ancestor
65457790|NCT03854812|Analgesics|analgesics|mesh-ancestor
64695044|NCT00357188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64695045|NCT02360215|Memantine|memantine|mesh-list
64695046|NCT02360215|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64695047|NCT02360215|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64695048|NCT02360215|Dopamine Agents|dopamine agents|mesh-ancestor
64695049|NCT02360215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64695050|NCT02360215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695051|NCT02360215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695052|NCT02360215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64695053|NCT02360215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64695055|NCT01349192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64695056|NCT01349192|Minocycline|minocycline|mesh-list
64695057|NCT01349192|Rifampin|rifampin|mesh-list
64695058|NCT01349192|Trimethoprim|trimethoprim|mesh-list
64695059|NCT01349192|Sulfamethoxazole|sulfamethoxazole|mesh-list
64695060|NCT01349192|Mupirocin|mupirocin|mesh-list
64695061|NCT01349192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64695062|NCT01349192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64695063|NCT01349192|Disinfectants|disinfectants|mesh-ancestor
64695064|NCT01349192|Dermatologic Agents|dermatologic agents|mesh-ancestor
64695065|NCT01349192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64695066|NCT01349192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64695067|NCT01349192|Antitubercular Agents|antitubercular agents|mesh-ancestor
64695068|NCT01349192|Leprostatic Agents|leprostatic agents|mesh-ancestor
64695069|NCT01349192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64695070|NCT01349192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64695071|NCT01349192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695072|NCT01349192|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64695073|NCT01349192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64695074|NCT01349192|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64695075|NCT01349192|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64695084|NCT01349192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64695085|NCT01349192|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64695086|NCT01349192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64695087|NCT01349192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64695088|NCT02362321|Dexamethasone|dexamethasone|mesh-list
64695089|NCT02362321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64695090|NCT02362321|Antiemetics|antiemetics|mesh-ancestor
64695091|NCT02362321|Autonomic Agents|autonomic agents|mesh-ancestor
65457791|NCT03854812|Sensory System Agents|sensory system agents|mesh-ancestor
65457792|NCT03854812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457793|NCT03854812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65457794|NCT03854812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65457795|NCT03854812|Anticonvulsants|anticonvulsants|mesh-ancestor
65457796|NCT03854812|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65457797|NCT03854812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65457798|NCT03854812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457799|NCT03854812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65457800|NCT03854812|Tocolytic Agents|tocolytic agents|mesh-ancestor
65457801|NCT03854812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65457802|NCT01186120|Umirolimus|umirolimus|mesh-list
65457803|NCT01186120|Everolimus|everolimus|mesh-list
65457804|NCT01186120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842349|NCT01656057|Acetaminophen|acetaminophen|mesh-list
64695092|NCT02362321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695093|NCT02362321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695094|NCT02362321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64695102|NCT00354991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64695103|NCT00354991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64695104|NCT00354991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64717756|NCT00378092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64717758|NCT00378092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64717759|NCT00378092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695105|NCT00354991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64695106|NCT00354991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695108|NCT00354991|Natriuretic Agents|natriuretic agents|mesh-ancestor
64695109|NCT00354991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695110|NCT00354991|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64695111|NCT00354991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64695112|NCT00357890|Insulin|insulin|mesh-list
64695113|NCT00357890|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64695114|NCT00357890|Insulin Glargine|insulin glargine|mesh-list
64695115|NCT00357890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64695116|NCT00357890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695117|NCT02112578|Meclizine|meclizine|mesh-list
64695118|NCT02112578|Dimenhydrinate|dimenhydrinate|mesh-list
64695119|NCT02112578|Antiemetics|antiemetics|mesh-ancestor
64695120|NCT02112578|Autonomic Agents|autonomic agents|mesh-ancestor
64695121|NCT02112578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695122|NCT02112578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695123|NCT02112578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64695124|NCT02112578|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64695125|NCT02112578|Histamine Antagonists|histamine antagonists|mesh-ancestor
64695126|NCT02112578|Histamine Agents|histamine agents|mesh-ancestor
64695127|NCT02112578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64695128|NCT02112578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695129|NCT02112578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64695131|NCT00358280|Ropivacaine|ropivacaine|mesh-list
64695132|NCT00358280|Anesthetics, Local|anesthetics, local|mesh-ancestor
64695133|NCT00358280|Anesthetics|anesthetics|mesh-ancestor
64695134|NCT00358280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64695135|NCT00358280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695136|NCT00358280|Sensory System Agents|sensory system agents|mesh-ancestor
64695137|NCT00358280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695138|NCT05719285|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64695139|NCT05719285|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64695140|NCT05719285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65457805|NCT01186120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65457806|NCT01186120|Immunologic Factors|immunologic factors|mesh-ancestor
65457807|NCT01186120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457808|NCT01186120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65457809|NCT03855826|Amiodarone|amiodarone|mesh-list
65457810|NCT03855826|Nifekalant|nifekalant|mesh-list
65457811|NCT03855826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65457812|NCT03855826|Vasodilator Agents|vasodilator agents|mesh-ancestor
65457813|NCT03855826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65457814|NCT03855826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65457815|NCT03855826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457816|NCT03855826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65457817|NCT03855826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65457818|NCT03855826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64842367|NCT01656070|Vitamin D|vitamin d|mesh-list
64695141|NCT05719285|Antitubercular Agents|antitubercular agents|mesh-ancestor
64695142|NCT02363803|Lidocaine|lidocaine|mesh-list
64695143|NCT02363803|Anesthetics, Local|anesthetics, local|mesh-ancestor
64695144|NCT02363803|Anesthetics|anesthetics|mesh-ancestor
64695145|NCT02363803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64695146|NCT02363803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695147|NCT02363803|Sensory System Agents|sensory system agents|mesh-ancestor
64695155|NCT03417193|Anesthetics|anesthetics|mesh-list
64695156|NCT03417193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64695157|NCT03417193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695158|NCT03417193|Narcotics|narcotics|mesh-ancestor
64695159|NCT03417193|Analgesics|analgesics|mesh-ancestor
64695160|NCT03417193|Sensory System Agents|sensory system agents|mesh-ancestor
64695161|NCT03417193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695162|NCT02367859|Trametinib|trametinib|mesh-list
64695166|NCT02367859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64695167|NCT02367859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695168|NCT02368093|Dextromethorphan|dextromethorphan|mesh-list
64695169|NCT02368093|Antitussive Agents|antitussive agents|mesh-ancestor
64695170|NCT02368093|Respiratory System Agents|respiratory system agents|mesh-ancestor
64695171|NCT02368093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64695172|NCT02368093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64695173|NCT02368093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64695174|NCT02368093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717760|NCT00378092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717761|NCT00378092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64717762|NCT00378092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64717763|NCT00378092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64695175|NCT02368093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695176|NCT03342937|Pembrolizumab|pembrolizumab|mesh-list
64695177|NCT03342937|Capecitabine|capecitabine|mesh-list
64695178|NCT03342937|Oxaliplatin|oxaliplatin|mesh-list
64695179|NCT03342937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64695180|NCT03342937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695181|NCT03342937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64695182|NCT03342937|Antimetabolites|antimetabolites|mesh-ancestor
64695183|NCT03342937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695184|NCT05718661|Methamphetamine|methamphetamine|mesh-list
64695185|NCT05718661|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64695186|NCT05718661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695187|NCT05718661|Sympathomimetics|sympathomimetics|mesh-ancestor
64695188|NCT05718661|Autonomic Agents|autonomic agents|mesh-ancestor
64695189|NCT05718661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695190|NCT05718661|Dopamine Agents|dopamine agents|mesh-ancestor
65457819|NCT03855826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457820|NCT03855826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65457821|NCT03855826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65457822|NCT03855826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65457823|NCT01184404|Bosentan|bosentan|mesh-list
65457824|NCT01184404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65457825|NCT01184404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65457826|NCT01184404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457827|NCT01186588|Canagliflozin|canagliflozin|mesh-list
65457828|NCT01186588|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65457829|NCT01186588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695191|NCT05718661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64695192|NCT05718661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695193|NCT05718661|Adrenergic Agents|adrenergic agents|mesh-ancestor
64695194|NCT05718661|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64695195|NCT05718661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64695196|NCT05718661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64695197|NCT05718661|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64695198|NCT00354757|Rabeprazole|rabeprazole|mesh-list
64695199|NCT00354757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64695200|NCT00354757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64695201|NCT00354757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64695202|NCT00354757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64695203|NCT00354757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695204|NCT02376283|Clopidogrel|clopidogrel|mesh-list
64695205|NCT02376283|Ticagrelor|ticagrelor|mesh-list
64695206|NCT02376283|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64695207|NCT02376283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64695208|NCT02376283|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64695209|NCT02376283|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64695210|NCT02376283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64695216|NCT00425347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695217|NCT05718037|Vaccines|vaccines|mesh-list
64695218|NCT05718037|Immunologic Factors|immunologic factors|mesh-ancestor
64695219|NCT05718037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695220|NCT05717881|Propolis|propolis|mesh-list
64695221|NCT05717881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64695222|NCT00355303|Misoprostol|misoprostol|mesh-list
64695223|NCT00355303|Dinoprostone|dinoprostone|mesh-list
64695224|NCT00355303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64695225|NCT00355303|Abortifacient Agents|abortifacient agents|mesh-ancestor
64695226|NCT00355303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64695227|NCT00355303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695228|NCT00355303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64695229|NCT00355303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64695230|NCT00355303|Oxytocics|oxytocics|mesh-ancestor
64695231|NCT05717569|Vitamin D|vitamin d|mesh-list
64695232|NCT05717569|Vitamins|vitamins|mesh-ancestor
64695233|NCT05717569|Micronutrients|micronutrients|mesh-ancestor
64695234|NCT05717569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695238|NCT02385097|Anesthetics, Local|anesthetics, local|mesh-ancestor
64695239|NCT02385097|Anesthetics|anesthetics|mesh-ancestor
64695240|NCT02385097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64695241|NCT02385097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695242|NCT02385097|Sensory System Agents|sensory system agents|mesh-ancestor
64695243|NCT02385097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695244|NCT02387359|Plecanatide|plecanatide|mesh-list
64717764|NCT00378092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64717765|NCT00378092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64717766|NCT00378092|Dopamine Agents|dopamine agents|mesh-ancestor
64717767|NCT01347632|Metronidazole|metronidazole|mesh-list
64717768|NCT01347632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65457830|NCT01186588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65457831|NCT01186588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457832|NCT03854266|Heparin|heparin|mesh-list
65457833|NCT03854266|Calcium heparin|calcium heparin|mesh-list
65457834|NCT03854266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65457835|NCT03854266|Anticoagulants|anticoagulants|mesh-ancestor
65457836|NCT03854266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65457837|NCT03854266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65457838|NCT03854266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457839|NCT01187992|Atorvastatin|atorvastatin|mesh-list
65457840|NCT01187992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65457841|NCT01187992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64717769|NCT01347632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64717770|NCT01347632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64717771|NCT01347632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64717772|NCT02679560|Bupivacaine|bupivacaine|mesh-list
64717773|NCT02679560|Ropivacaine|ropivacaine|mesh-list
64717774|NCT02679560|Anesthetics, Local|anesthetics, local|mesh-ancestor
64717775|NCT02679560|Anesthetics|anesthetics|mesh-ancestor
64717776|NCT02679560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717777|NCT02679560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717778|NCT02679560|Sensory System Agents|sensory system agents|mesh-ancestor
64717779|NCT02679560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717782|NCT03723980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64717783|NCT03723980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717784|NCT03723980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64717785|NCT01240304|Gemcitabine|gemcitabine|mesh-list
64717786|NCT01240304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64717787|NCT01240304|Antimetabolites|antimetabolites|mesh-ancestor
64717788|NCT01240304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717789|NCT01240304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64717790|NCT01240304|Antiviral Agents|antiviral agents|mesh-ancestor
64717791|NCT01240304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64717792|NCT01240304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64717793|NCT01240304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64717794|NCT01240304|Immunologic Factors|immunologic factors|mesh-ancestor
64717795|NCT01240304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717796|NCT02614586|Ondansetron|ondansetron|mesh-list
64717797|NCT02614586|Antiemetics|antiemetics|mesh-ancestor
64717798|NCT02614586|Autonomic Agents|autonomic agents|mesh-ancestor
64717799|NCT02614586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695245|NCT02387359|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64695246|NCT02387359|Enzyme Activators|enzyme activators|mesh-ancestor
64695247|NCT02387359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695248|NCT02387359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64695249|NCT00355459|Doxycycline|doxycycline|mesh-list
64695250|NCT00355459|Tetracycline|tetracycline|mesh-list
64717800|NCT02614586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717803|NCT02614586|Dermatologic Agents|dermatologic agents|mesh-ancestor
64717804|NCT02614586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64717805|NCT02614586|Serotonin Agents|serotonin agents|mesh-ancestor
64717806|NCT02614586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64326004|NCT02268019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695251|NCT00355459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64695252|NCT00355459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64695253|NCT00355459|Antimalarials|antimalarials|mesh-ancestor
64695254|NCT00355459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64695255|NCT00355459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64695256|NCT00355459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64695257|NCT00355459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64695258|NCT00355459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695259|NCT02393677|Dexmedetomidine|dexmedetomidine|mesh-list
64695261|NCT02393677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64695262|NCT02393677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65457842|NCT01187992|Antimetabolites|antimetabolites|mesh-ancestor
65457843|NCT01187992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457844|NCT01187992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65457845|NCT01187992|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65457846|NCT01187992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457847|NCT01191034|Imiquimod|imiquimod|mesh-list
65457848|NCT01191034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65457849|NCT01191034|Immunologic Factors|immunologic factors|mesh-ancestor
65457850|NCT01191034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457851|NCT01191034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457852|NCT01191034|Interferon Inducers|interferon inducers|mesh-ancestor
65457853|NCT01188148|Memantine|memantine|mesh-list
65457854|NCT01188148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65457855|NCT01188148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65457856|NCT01188148|Dopamine Agents|dopamine agents|mesh-ancestor
65457857|NCT01188148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65457858|NCT01188148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457859|NCT01188148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457860|NCT01188148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65457861|NCT01188148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65457862|NCT03852628|Naltrexone|naltrexone|mesh-list
65457863|NCT03852628|Buprenorphine|buprenorphine|mesh-list
64695263|NCT02393677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695264|NCT02393677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64695265|NCT02393677|Analgesics|analgesics|mesh-ancestor
64695266|NCT02393677|Sensory System Agents|sensory system agents|mesh-ancestor
64695267|NCT02393677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695268|NCT02393677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64695269|NCT02393677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64695270|NCT02393677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64695271|NCT02393677|Adrenergic Agents|adrenergic agents|mesh-ancestor
64695272|NCT02393677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64695273|NCT02393677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420571|NCT05484193|Progesterone|progesterone|mesh-list
64695274|NCT02393677|Anesthetics, Local|anesthetics, local|mesh-ancestor
64695275|NCT02393677|Anesthetics|anesthetics|mesh-ancestor
64695276|NCT02394457|Cosyntropin|cosyntropin|mesh-list
64695277|NCT02394457|Hormones|hormones|mesh-ancestor
64695278|NCT02394457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64695279|NCT02394457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695280|NCT00355771|Levocetirizine|levocetirizine|mesh-list
64695281|NCT00355771|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64695282|NCT00355771|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64695283|NCT00355771|Histamine Antagonists|histamine antagonists|mesh-ancestor
64695284|NCT00355771|Histamine Agents|histamine agents|mesh-ancestor
64695285|NCT00355771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64695286|NCT00355771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695287|NCT00355771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695289|NCT05664139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64695290|NCT05664139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695291|NCT05664139|Tubulin Modulators|tubulin modulators|mesh-ancestor
64695292|NCT05664139|Antimitotic Agents|antimitotic agents|mesh-ancestor
65457864|NCT03852628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65457865|NCT03852628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65457866|NCT03852628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457867|NCT03852628|Sensory System Agents|sensory system agents|mesh-ancestor
65457868|NCT03852628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457869|NCT03852628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65457870|NCT03852628|Narcotics|narcotics|mesh-ancestor
65457871|NCT03852628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65457872|NCT03852628|Analgesics|analgesics|mesh-ancestor
65457873|NCT01187212|Cisplatin|cisplatin|mesh-list
65457874|NCT01187212|Capecitabine|capecitabine|mesh-list
65457875|NCT01187212|Sorafenib|sorafenib|mesh-list
65457876|NCT01187212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457877|NCT01187212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65457878|NCT01187212|Antimetabolites|antimetabolites|mesh-ancestor
65457879|NCT01187212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457880|NCT01187212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65457881|NCT01187212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457882|NCT03853954|Methoxyflurane|methoxyflurane|mesh-list
65457883|NCT03853954|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64695293|NCT05664139|Mitosis Modulators|mitosis modulators|mesh-ancestor
64695294|NCT05664139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695295|NCT03224351|Ivacaftor|ivacaftor|mesh-list
64695297|NCT03224351|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64695298|NCT03224351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64695299|NCT03224351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695300|NCT05658055|Amoxicillin|amoxicillin|mesh-list
64695301|NCT05658055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64695302|NCT05658055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64695303|NCT05642923|Thiamine|thiamine|mesh-list
64695304|NCT05642923|Vitamins|vitamins|mesh-ancestor
64695305|NCT05642923|Micronutrients|micronutrients|mesh-ancestor
64695306|NCT05642923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695327|NCT03224585|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64695328|NCT03224585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64695329|NCT03423641|Antiviral Agents|antiviral agents|mesh-list
64717807|NCT02614586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717808|NCT02614586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64717809|NCT02614586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64717810|NCT02614586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717811|NCT02614586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64717812|NCT02614586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64717814|NCT01211756|Oxytocics|oxytocics|mesh-ancestor
64695341|NCT04825795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695342|NCT04825795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64695343|NCT04825795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695344|NCT05662202|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64695345|NCT05662202|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64695346|NCT05662202|Dermatologic Agents|dermatologic agents|mesh-ancestor
64695347|NCT02029443|Acalabrutinib|acalabrutinib|mesh-list
64695348|NCT02029443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695349|NCT03226223|Methamphetamine|methamphetamine|mesh-list
64695350|NCT03226223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64695351|NCT03226223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695352|NCT03226223|Sympathomimetics|sympathomimetics|mesh-ancestor
64695353|NCT03226223|Autonomic Agents|autonomic agents|mesh-ancestor
65457884|NCT03853954|Anesthetics, General|anesthetics, general|mesh-ancestor
65457885|NCT03853954|Anesthetics|anesthetics|mesh-ancestor
65457886|NCT03853954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65457887|NCT03853954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457888|NCT03849508|Phenylephrine|phenylephrine|mesh-list
65457889|NCT03849508|Oxymetazoline|oxymetazoline|mesh-list
65457890|NCT03849508|Norepinephrine|norepinephrine|mesh-list
65457891|NCT03849508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65457892|NCT03849508|Mydriatics|mydriatics|mesh-ancestor
65457893|NCT03849508|Autonomic Agents|autonomic agents|mesh-ancestor
65457894|NCT03849508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457895|NCT03849508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457896|NCT03849508|Sympathomimetics|sympathomimetics|mesh-ancestor
65457897|NCT03849508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65457898|NCT03849508|Nasal Decongestants|nasal decongestants|mesh-ancestor
65457899|NCT03849508|Respiratory System Agents|respiratory system agents|mesh-ancestor
65457900|NCT03849508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65457901|NCT03849508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64842445|NCT01656720|Methoxamine|methoxamine|mesh-list
64695354|NCT03226223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695355|NCT03226223|Dopamine Agents|dopamine agents|mesh-ancestor
64695356|NCT03226223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64695357|NCT03226223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695358|NCT03226223|Adrenergic Agents|adrenergic agents|mesh-ancestor
64695359|NCT03226223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64695360|NCT03226223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64695389|NCT03226457|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64695390|NCT03226457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64695392|NCT03226691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64695393|NCT03226691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64695394|NCT03226691|Antiviral Agents|antiviral agents|mesh-ancestor
64695395|NCT03226691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64695396|NCT00003159|Gemcitabine|gemcitabine|mesh-list
64695398|NCT00003159|Vinorelbine|vinorelbine|mesh-list
64695399|NCT00003159|Vinblastine|vinblastine|mesh-list
64695400|NCT00003159|Docetaxel|docetaxel|mesh-list
64695401|NCT00003159|Carboplatin|carboplatin|mesh-list
64695402|NCT00003159|Ifosfamide|ifosfamide|mesh-list
64695403|NCT00003159|Mitomycins|mitomycins|mesh-list
64695404|NCT00003159|Mitomycin|mitomycin|mesh-list
64695405|NCT00003159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64695406|NCT00003159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695407|NCT00003159|Tubulin Modulators|tubulin modulators|mesh-ancestor
64695408|NCT00003159|Antimitotic Agents|antimitotic agents|mesh-ancestor
64695416|NCT00003159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64695417|NCT00003159|Immunologic Factors|immunologic factors|mesh-ancestor
64695418|NCT00003159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695419|NCT00003159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64695420|NCT00003159|Alkylating Agents|alkylating agents|mesh-ancestor
64695421|NCT00003159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64695422|NCT00003159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64695424|NCT03228017|Atorvastatin|atorvastatin|mesh-list
64695425|NCT03228017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64695426|NCT03228017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64717816|NCT01211756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717817|NCT03591458|Amitriptyline|amitriptyline|mesh-list
64717818|NCT03591458|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65457902|NCT03849508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65457903|NCT03849508|Adrenergic Agents|adrenergic agents|mesh-ancestor
65457904|NCT03849508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65457905|NCT03849508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457906|NCT03849508|Protective Agents|protective agents|mesh-ancestor
65457907|NCT03849664|Riboflavin|riboflavin|mesh-list
65457908|NCT03849664|Niacinamide|niacinamide|mesh-list
65457909|NCT03849664|Niacin|niacin|mesh-list
65457910|NCT03849664|Nicotinic Acids|nicotinic acids|mesh-list
65457911|NCT03849664|Flavin Mononucleotide|flavin mononucleotide|mesh-list
65457912|NCT03849664|Povidone|povidone|mesh-list
65457913|NCT03849664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65457914|NCT03849664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457915|NCT03849664|Plasma Substitutes|plasma substitutes|mesh-ancestor
65457916|NCT03849664|Blood Substitutes|blood substitutes|mesh-ancestor
65457917|NCT03849664|Vitamin B Complex|vitamin b complex|mesh-ancestor
65457918|NCT03849664|Vitamins|vitamins|mesh-ancestor
65457919|NCT03849664|Micronutrients|micronutrients|mesh-ancestor
65457920|NCT03849664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65457921|NCT03849664|Dermatologic Agents|dermatologic agents|mesh-ancestor
65457922|NCT03849664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65457923|NCT03849664|Antimetabolites|antimetabolites|mesh-ancestor
64717819|NCT03591458|Antidepressive Agents|antidepressive agents|mesh-ancestor
64717820|NCT03591458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64717825|NCT03591458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717826|NCT03591458|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64717827|NCT03591458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64717828|NCT03591458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64326019|NCT01106989|Anesthetics, Local|anesthetics, local|mesh-ancestor
64695427|NCT03228017|Analgesics|analgesics|mesh-ancestor
64695428|NCT03228017|Sensory System Agents|sensory system agents|mesh-ancestor
64695429|NCT03228017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695430|NCT03228017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695431|NCT03228017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64695432|NCT03228017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64695433|NCT03228017|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64695434|NCT03228017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64695435|NCT03228017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695436|NCT03228017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64695437|NCT03228017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64695438|NCT03228017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64695439|NCT03228017|Antipyretics|antipyretics|mesh-ancestor
64695440|NCT03228017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64695441|NCT03228017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64695442|NCT03228017|Antimetabolites|antimetabolites|mesh-ancestor
64695443|NCT03228017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64695444|NCT03228017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64695446|NCT00355927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64695447|NCT00355927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64695448|NCT00355927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695449|NCT00355927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64695450|NCT00355927|Anesthetics, General|anesthetics, general|mesh-ancestor
64695451|NCT00355927|Anesthetics|anesthetics|mesh-ancestor
64695452|NCT00357422|Ethanol|ethanol|mesh-list
64695453|NCT00357422|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64695454|NCT00357422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65457924|NCT03849664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457925|NCT03849664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65457926|NCT03849664|Vasodilator Agents|vasodilator agents|mesh-ancestor
65457927|NCT01293838|Citalopram|citalopram|mesh-list
65457928|NCT01293838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65457929|NCT01293838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65457930|NCT01293838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65457931|NCT01293838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457932|NCT01293838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65457933|NCT01293838|Serotonin Agents|serotonin agents|mesh-ancestor
65457934|NCT01293838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457935|NCT01293838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65457936|NCT01293838|Antidepressive Agents|antidepressive agents|mesh-ancestor
65457937|NCT01293838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65457938|NCT01188304|Aspirin|aspirin|mesh-list
65457939|NCT01188304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65457940|NCT01188304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65457941|NCT01188304|Analgesics|analgesics|mesh-ancestor
65457942|NCT01188304|Sensory System Agents|sensory system agents|mesh-ancestor
65457943|NCT01188304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457944|NCT01188304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457945|NCT01188304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64610991|NCT03406793|Iron|iron|mesh-list
64695455|NCT00357422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64695456|NCT00357422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695457|NCT05418049|Memantine|memantine|mesh-list
64695458|NCT05418049|Baclofen|baclofen|mesh-list
64695459|NCT05418049|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64695460|NCT05418049|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64695461|NCT05418049|Dopamine Agents|dopamine agents|mesh-ancestor
64695462|NCT05418049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64695463|NCT05418049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695464|NCT05418049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695465|NCT05418049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64695466|NCT05418049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64695467|NCT05418049|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64695468|NCT05418049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64717829|NCT03591458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717830|NCT03591458|Adrenergic Agents|adrenergic agents|mesh-ancestor
64717831|NCT03591458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64717832|NCT03565328|Niacinamide|niacinamide|mesh-list
64717833|NCT03565328|Niacin|niacin|mesh-list
64695469|NCT05418049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695470|NCT05418049|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64695471|NCT05418049|GABA Agonists|gaba agonists|mesh-ancestor
64695472|NCT05418049|GABA Agents|gaba agents|mesh-ancestor
64695473|NCT00356005|Azithromycin|azithromycin|mesh-list
64695474|NCT00356005|Artesunate|artesunate|mesh-list
64695475|NCT00356005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64695476|NCT00356005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65457946|NCT01188304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65457947|NCT01188304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65457948|NCT01188304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65457949|NCT01188304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457950|NCT01188304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65457951|NCT01188304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65457952|NCT01188304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457953|NCT01188304|Antipyretics|antipyretics|mesh-ancestor
65457954|NCT02524444|Pyrimethamine|pyrimethamine|mesh-list
65457955|NCT02524444|Sulfadoxine|sulfadoxine|mesh-list
65457956|NCT02524444|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65457957|NCT02524444|Mefloquine|mefloquine|mesh-list
65457958|NCT02524444|Antimalarials|antimalarials|mesh-ancestor
65457959|NCT02524444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65457960|NCT02524444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65457961|NCT02524444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65457962|NCT02524444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65457963|NCT02524444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457964|NCT02524444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695489|NCT00376337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64695490|NCT00376337|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64695491|NCT00376337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64695492|NCT00376337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64695493|NCT00376337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64695494|NCT00376337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695500|NCT00376337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64695502|NCT00003165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64695503|NCT00003165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695504|NCT00003165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64695505|NCT00003165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64695506|NCT00003165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64695507|NCT00003165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695508|NCT05723510|Rivaroxaban|rivaroxaban|mesh-list
64695509|NCT05723510|Apixaban|apixaban|mesh-list
64695510|NCT05723510|Edoxaban|edoxaban|mesh-list
64695511|NCT05723510|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64695512|NCT05723510|Antithrombins|antithrombins|mesh-ancestor
64695513|NCT05723510|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64695514|NCT05723510|Protease Inhibitors|protease inhibitors|mesh-ancestor
64695515|NCT05723510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64695516|NCT05723510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695517|NCT05723510|Anticoagulants|anticoagulants|mesh-ancestor
64695518|NCT00003171|Bryostatin 1|bryostatin 1|mesh-list
64695519|NCT00003171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64695520|NCT00003171|Immunologic Factors|immunologic factors|mesh-ancestor
64695521|NCT00003171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695522|NCT00003171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695523|NCT00003183|Mitoxantrone|mitoxantrone|mesh-list
64695524|NCT00003183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695525|NCT00003183|Analgesics|analgesics|mesh-ancestor
64695526|NCT00003183|Sensory System Agents|sensory system agents|mesh-ancestor
64695527|NCT00003183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695528|NCT00003183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695529|NCT00003183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64695530|NCT00003183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64695531|NCT00003183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65457965|NCT02524444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65457966|NCT02524444|Renal Agents|renal agents|mesh-ancestor
65457967|NCT03853642|Nitric Oxide|nitric oxide|mesh-list
65457968|NCT03853642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65457969|NCT03853642|Autonomic Agents|autonomic agents|mesh-ancestor
65457970|NCT03853642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457971|NCT03853642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457972|NCT03853642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65457973|NCT03853642|Respiratory System Agents|respiratory system agents|mesh-ancestor
64695532|NCT00003183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695533|NCT00376493|Metronidazole|metronidazole|mesh-list
64695534|NCT00376493|Doxycycline|doxycycline|mesh-list
64695535|NCT00376493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64695536|NCT00376493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64695537|NCT00376493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64695538|NCT00376493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64695539|NCT00376493|Antimalarials|antimalarials|mesh-ancestor
64695540|NCT02979223|Ascorbic Acid|ascorbic acid|mesh-list
64695541|NCT02979223|Magnesium citrate|magnesium citrate|mesh-list
64695549|NCT02979223|Cathartics|cathartics|mesh-ancestor
64695550|NCT02979223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64695551|NCT05640674|Acetaminophen|acetaminophen|mesh-list
64695552|NCT05640674|Ibuprofen|ibuprofen|mesh-list
64717834|NCT03565328|Nicotinic Acids|nicotinic acids|mesh-list
64717835|NCT03565328|Vitamin B Complex|vitamin b complex|mesh-ancestor
64717836|NCT03565328|Vitamins|vitamins|mesh-ancestor
64717837|NCT03565328|Micronutrients|micronutrients|mesh-ancestor
64717838|NCT03565328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717839|NCT03565328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64717840|NCT03565328|Antimetabolites|antimetabolites|mesh-ancestor
64717841|NCT03565328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717842|NCT03565328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64717843|NCT03565328|Vasodilator Agents|vasodilator agents|mesh-ancestor
64717844|NCT01206296|Gemcitabine|gemcitabine|mesh-list
64717845|NCT01206296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64717846|NCT01206296|Antimetabolites|antimetabolites|mesh-ancestor
64717847|NCT01206296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717848|NCT01206296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64717849|NCT01206296|Antiviral Agents|antiviral agents|mesh-ancestor
64717850|NCT01206296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64717851|NCT01206296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64717852|NCT01206296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64717859|NCT02593682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717860|NCT02593682|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64717861|NCT02593682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64717862|NCT02593682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717863|NCT01200602|Megestrol|megestrol|mesh-list
64695553|NCT05640674|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64695554|NCT05640674|Hydrocodone|hydrocodone|mesh-list
64695555|NCT05640674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64695556|NCT05640674|Analgesics|analgesics|mesh-ancestor
64695557|NCT05640674|Sensory System Agents|sensory system agents|mesh-ancestor
64695558|NCT05640674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695559|NCT05640674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695560|NCT05640674|Antipyretics|antipyretics|mesh-ancestor
64695561|NCT05640674|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64695562|NCT05640674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64695563|NCT05640674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64695564|NCT05640674|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64695565|NCT05640674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64717864|NCT01200602|Megestrol Acetate|megestrol acetate|mesh-list
64717865|NCT01200602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64717866|NCT01200602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64717867|NCT01200602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64717868|NCT01200602|Contraceptive Agents|contraceptive agents|mesh-ancestor
64717869|NCT01200602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65457974|NCT03853642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65457975|NCT03853642|Antioxidants|antioxidants|mesh-ancestor
65457976|NCT03853642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65457977|NCT03853642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65457978|NCT03853642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65457979|NCT03853642|Vasodilator Agents|vasodilator agents|mesh-ancestor
65457980|NCT03853642|Gasotransmitters|gasotransmitters|mesh-ancestor
65457981|NCT03853642|Protective Agents|protective agents|mesh-ancestor
65457983|NCT02296918|Obinutuzumab|obinutuzumab|mesh-list
65457984|NCT02296918|Venetoclax|venetoclax|mesh-list
65457985|NCT02296918|Acalabrutinib|acalabrutinib|mesh-list
65457986|NCT02296918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65457987|NCT02296918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65457988|NCT02296918|Immunologic Factors|immunologic factors|mesh-ancestor
65457989|NCT02296918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457990|NCT02296918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65457991|NCT01294072|Curcumin|curcumin|mesh-list
65457992|NCT01294072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65457993|NCT01294072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65457994|NCT01294072|Analgesics|analgesics|mesh-ancestor
65457995|NCT01294072|Sensory System Agents|sensory system agents|mesh-ancestor
65457996|NCT01294072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65457997|NCT01294072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65457998|NCT01294072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65457999|NCT01294072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65458000|NCT01294072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458001|NCT01294072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458002|NCT01294072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458003|NCT01191424|Formoterol Fumarate|formoterol fumarate|mesh-list
65458004|NCT01191424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65458005|NCT01191424|Autonomic Agents|autonomic agents|mesh-ancestor
65458006|NCT01191424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458007|NCT01191424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458008|NCT01191424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65458009|NCT01191424|Respiratory System Agents|respiratory system agents|mesh-ancestor
64717870|NCT01200602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326070|NCT03949478|Ibuprofen|ibuprofen|mesh-list
64695566|NCT05640674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695567|NCT05640674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64695568|NCT05640674|Narcotics|narcotics|mesh-ancestor
65458010|NCT01191424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65458011|NCT01191424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65458012|NCT01191424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65458013|NCT01191424|Adrenergic Agents|adrenergic agents|mesh-ancestor
65458014|NCT01191424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65458015|NCT01191424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458016|NCT01291654|Acetaminophen|acetaminophen|mesh-list
65458017|NCT01291654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65458018|NCT01291654|Analgesics|analgesics|mesh-ancestor
65458019|NCT01291654|Sensory System Agents|sensory system agents|mesh-ancestor
65458020|NCT01291654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458021|NCT01291654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458022|NCT01291654|Antipyretics|antipyretics|mesh-ancestor
65458023|NCT03853096|Cefazolin|cefazolin|mesh-list
65458024|NCT03853096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64695569|NCT05640674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64695570|NCT05640674|Antitussive Agents|antitussive agents|mesh-ancestor
64695571|NCT05640674|Respiratory System Agents|respiratory system agents|mesh-ancestor
64695572|NCT01805271|Everolimus|everolimus|mesh-list
64695573|NCT01805271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695574|NCT01805271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64695575|NCT01805271|Immunologic Factors|immunologic factors|mesh-ancestor
64695576|NCT01805271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420875|NCT01646073|Adalimumab|adalimumab|mesh-list
64695577|NCT05723276|Psilocybin|psilocybin|mesh-list
64695578|NCT05723276|Hallucinogens|hallucinogens|mesh-ancestor
64695579|NCT05723276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695582|NCT01768767|Analgesics|analgesics|mesh-ancestor
64695583|NCT01768767|Sensory System Agents|sensory system agents|mesh-ancestor
64695584|NCT01768767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695585|NCT01768767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695586|NCT01768767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64695587|NCT01768767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64695588|NCT01768767|Anesthetics, General|anesthetics, general|mesh-ancestor
64695589|NCT01768767|Anesthetics|anesthetics|mesh-ancestor
64695590|NCT01768767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64695591|NCT01768767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64695592|NCT01768767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64695593|NCT01768767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64695594|NCT01768767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695595|NCT00003195|Interferons|interferons|mesh-list
64695596|NCT00003195|Interferon-alpha|interferon-alpha|mesh-list
64695597|NCT00003195|Busulfan|busulfan|mesh-list
64695598|NCT00003195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695599|NCT00003195|Antiviral Agents|antiviral agents|mesh-ancestor
64695600|NCT00003195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64695601|NCT00003195|Immunologic Factors|immunologic factors|mesh-ancestor
64695602|NCT00003195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695603|NCT00003195|Alkylating Agents|alkylating agents|mesh-ancestor
64695610|NCT03671109|Antimalarials|antimalarials|mesh-ancestor
64695611|NCT03671109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64695612|NCT03671109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64695624|NCT00356083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695626|NCT00356083|Sensory System Agents|sensory system agents|mesh-ancestor
64695627|NCT00356083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695628|NCT00356083|Antitussive Agents|antitussive agents|mesh-ancestor
64695629|NCT00356083|Respiratory System Agents|respiratory system agents|mesh-ancestor
64695630|NCT02977832|Alfuzosin|alfuzosin|mesh-list
64695631|NCT02977832|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64695632|NCT02977832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64695633|NCT02977832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65458025|NCT03853096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65458026|NCT05671276|Aspirin|aspirin|mesh-list
65458027|NCT05671276|Rivaroxaban|rivaroxaban|mesh-list
65458028|NCT05671276|Clopidogrel|clopidogrel|mesh-list
65458029|NCT05671276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65458030|NCT05671276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65458031|NCT05671276|Analgesics|analgesics|mesh-ancestor
65458032|NCT05671276|Sensory System Agents|sensory system agents|mesh-ancestor
65458033|NCT05671276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458034|NCT05671276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453535|NCT02053493|Isosorbide|isosorbide|mesh-list
64695634|NCT02977832|Adrenergic Agents|adrenergic agents|mesh-ancestor
64695635|NCT02977832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64695636|NCT02977832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695637|NCT02977832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717871|NCT01200602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64717872|NCT01200602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64717873|NCT01200602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64717874|NCT01200602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64717875|NCT01200602|Appetite Stimulants|appetite stimulants|mesh-ancestor
64717876|NCT01200602|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64717878|NCT01194908|Decitabine|decitabine|mesh-list
64717879|NCT01194908|Panobinostat|panobinostat|mesh-list
64717880|NCT01194908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64717881|NCT01194908|Antimetabolites|antimetabolites|mesh-ancestor
64695638|NCT02977832|Urological Agents|urological agents|mesh-ancestor
64695639|NCT04344236|Chlorhexidine|chlorhexidine|mesh-list
64695640|NCT04344236|Povidone-Iodine|povidone-iodine|mesh-list
64695641|NCT04344236|Povidone|povidone|mesh-list
64695642|NCT04344236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64695643|NCT04344236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64695644|NCT04344236|Disinfectants|disinfectants|mesh-ancestor
64695645|NCT04344236|Plasma Substitutes|plasma substitutes|mesh-ancestor
64695646|NCT04344236|Blood Substitutes|blood substitutes|mesh-ancestor
64695647|NCT00355537|Testosterone|testosterone|mesh-list
64695648|NCT00355537|Androgens|androgens|mesh-ancestor
64695649|NCT00355537|Hormones|hormones|mesh-ancestor
64695650|NCT00355537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64695651|NCT00355537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695652|NCT00003207|Doxorubicin|doxorubicin|mesh-list
64695653|NCT00003207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64695654|NCT00003207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64695655|NCT00003207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695656|NCT00003207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64695657|NCT00003207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64695658|NCT00003207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64695659|NCT00003207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695660|NCT00003387|Paclitaxel|paclitaxel|mesh-list
64695661|NCT00003387|Carboplatin|carboplatin|mesh-list
64695662|NCT00003387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64695663|NCT00003387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695664|NCT00003387|Tubulin Modulators|tubulin modulators|mesh-ancestor
64695665|NCT00003387|Antimitotic Agents|antimitotic agents|mesh-ancestor
64695666|NCT00003387|Mitosis Modulators|mitosis modulators|mesh-ancestor
64695667|NCT00003387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695668|NCT05552443|Hydromorphone|hydromorphone|mesh-list
64695669|NCT05552443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64695670|NCT05552443|Narcotics|narcotics|mesh-ancestor
64695671|NCT05552443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64695672|NCT05552443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695673|NCT05552443|Analgesics|analgesics|mesh-ancestor
64695674|NCT05552443|Sensory System Agents|sensory system agents|mesh-ancestor
64695696|NCT04706897|Analgesics|analgesics|mesh-ancestor
64695697|NCT04706897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64695698|NCT04706897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64695699|NCT04706897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65458035|NCT05671276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65458036|NCT05671276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65458037|NCT05671276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65458038|NCT05671276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65458039|NCT05671276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458040|NCT05671276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65458041|NCT05671276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65458042|NCT05671276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458043|NCT05671276|Antipyretics|antipyretics|mesh-ancestor
65458044|NCT05671276|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65458045|NCT05671276|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65458046|NCT05671276|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65458047|NCT05671276|Purinergic Agents|purinergic agents|mesh-ancestor
65458048|NCT05671276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65458049|NCT05671276|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65458050|NCT05671276|Antithrombins|antithrombins|mesh-ancestor
65458051|NCT05671276|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65458052|NCT05671276|Protease Inhibitors|protease inhibitors|mesh-ancestor
65458053|NCT05671276|Anticoagulants|anticoagulants|mesh-ancestor
65207518|NCT04133974|Methadone|methadone|mesh-list
65458054|NCT03852160|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65458055|NCT03852160|Mirtazapine|mirtazapine|mesh-list
65458056|NCT03852160|Trazodone|trazodone|mesh-list
65458057|NCT03852160|S 20098|s 20098|mesh-list
65458058|NCT03852160|Citalopram|citalopram|mesh-list
65458059|NCT03852160|Bupropion|bupropion|mesh-list
65458060|NCT03852160|Sertraline|sertraline|mesh-list
65458061|NCT03852160|Esketamine|esketamine|mesh-list
65458062|NCT03852160|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65458063|NCT03852160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65458064|NCT03852160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64842598|NCT01657487|Xhance|xhance|mesh-list
64695700|NCT04706897|Adrenergic Agents|adrenergic agents|mesh-ancestor
64695701|NCT04706897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64695702|NCT04706897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64695703|NCT04706897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64695704|NCT04706897|Anesthetics, General|anesthetics, general|mesh-ancestor
64695705|NCT04706897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64695706|NCT04706897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64717882|NCT01194908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717883|NCT01194908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64717884|NCT01194908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64717885|NCT01194908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64717886|NCT01194908|Hormone Antagonists|hormone antagonists|mesh-ancestor
64717887|NCT01194908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65458065|NCT03852160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458066|NCT03852160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65458067|NCT03852160|Serotonin Agents|serotonin agents|mesh-ancestor
65458068|NCT03852160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458069|NCT03852160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65458070|NCT03852160|Antidepressive Agents|antidepressive agents|mesh-ancestor
65458071|NCT03852160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65458072|NCT03852160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458073|NCT03852160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65458074|NCT03852160|Dopamine Agents|dopamine agents|mesh-ancestor
65458075|NCT03852160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65458076|NCT03852160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65458077|NCT03852160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458078|NCT03852160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65458079|NCT03852160|Analgesics|analgesics|mesh-ancestor
65458080|NCT03852160|Sensory System Agents|sensory system agents|mesh-ancestor
65458081|NCT03852160|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65458082|NCT03852160|Histamine Antagonists|histamine antagonists|mesh-ancestor
65458083|NCT03852160|Histamine Agents|histamine agents|mesh-ancestor
65458084|NCT03852160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65458085|NCT03852160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65458086|NCT03852160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65458087|NCT03852160|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65458088|NCT03852160|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65458089|NCT03852160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65458090|NCT03852160|Adrenergic Agents|adrenergic agents|mesh-ancestor
65458091|NCT03852160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65458092|NCT03852160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65458093|NCT03852160|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65458094|NCT03852160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65458095|NCT02524210|Omeprazole|omeprazole|mesh-list
65458096|NCT02524210|Rabeprazole|rabeprazole|mesh-list
65458104|NCT02524210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65458105|NCT02524210|Protease Inhibitors|protease inhibitors|mesh-ancestor
65458106|NCT02524210|Anticoagulants|anticoagulants|mesh-ancestor
65458107|NCT03847792|Dexamethasone|dexamethasone|mesh-list
65458108|NCT03847792|Fentanyl|fentanyl|mesh-list
65458109|NCT03847792|Bupivacaine|bupivacaine|mesh-list
65458110|NCT03847792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65458111|NCT03847792|Antiemetics|antiemetics|mesh-ancestor
65458112|NCT03847792|Autonomic Agents|autonomic agents|mesh-ancestor
65458113|NCT03847792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458114|NCT03847792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458115|NCT03847792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65458116|NCT03847792|Glucocorticoids|glucocorticoids|mesh-ancestor
65458117|NCT03847792|Hormones|hormones|mesh-ancestor
65458118|NCT03847792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65458119|NCT03847792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65458120|NCT03847792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458121|NCT03847792|Anesthetics, Local|anesthetics, local|mesh-ancestor
65458122|NCT03847792|Anesthetics|anesthetics|mesh-ancestor
65458123|NCT03847792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65458124|NCT03847792|Sensory System Agents|sensory system agents|mesh-ancestor
65458125|NCT03847792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65458126|NCT03847792|Narcotics|narcotics|mesh-ancestor
65458127|NCT03847792|Analgesics|analgesics|mesh-ancestor
64695708|NCT00003213|Dexamethasone acetate|dexamethasone acetate|mesh-list
64695709|NCT00003213|Metoclopramide|metoclopramide|mesh-list
64695710|NCT00003213|Granisetron|granisetron|mesh-list
64695711|NCT00003213|BB 1101|bb 1101|mesh-list
64695712|NCT00003213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64695713|NCT00003213|Antiemetics|antiemetics|mesh-ancestor
64695714|NCT00003213|Autonomic Agents|autonomic agents|mesh-ancestor
64695715|NCT00003213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695716|NCT00003213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695717|NCT00003213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64695718|NCT00003213|Glucocorticoids|glucocorticoids|mesh-ancestor
64695719|NCT00003213|Hormones|hormones|mesh-ancestor
64695720|NCT00003213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64695721|NCT00003213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64695722|NCT00003213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695723|NCT00003213|Protease Inhibitors|protease inhibitors|mesh-ancestor
64695724|NCT00003213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64695725|NCT00003213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695726|NCT00003213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64695727|NCT00003213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64695728|NCT00003213|Dopamine Agents|dopamine agents|mesh-ancestor
64695729|NCT00003213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64695731|NCT00003213|Serotonin Agents|serotonin agents|mesh-ancestor
64695732|NCT01445067|Calcitonin|calcitonin|mesh-list
64695733|NCT01445067|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
64695734|NCT01445067|Katacalcin|katacalcin|mesh-list
64695735|NCT01445067|Vasodilator Agents|vasodilator agents|mesh-ancestor
64695736|NCT01445067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64695744|NCT00003399|Etoposide|etoposide|mesh-list
64695745|NCT00003399|Cyclophosphamide|cyclophosphamide|mesh-list
64695746|NCT00003399|Melphalan|melphalan|mesh-list
65458128|NCT03847792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65458129|NCT03847792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65458130|NCT03847792|Anesthetics, General|anesthetics, general|mesh-ancestor
65458131|NCT01294618|Interferons|interferons|mesh-list
65458132|NCT01294618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458133|NCT01294618|Antiviral Agents|antiviral agents|mesh-ancestor
65458134|NCT01294618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65458135|NCT01194232|Sildenafil Citrate|sildenafil citrate|mesh-list
65458136|NCT01194232|Vasodilator Agents|vasodilator agents|mesh-ancestor
65458137|NCT01194232|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65458138|NCT01194232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65458139|NCT01194232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458140|NCT01194232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458141|NCT01194232|Urological Agents|urological agents|mesh-ancestor
65458142|NCT01296334|Morphine|morphine|mesh-list
65458143|NCT01296334|Buprenorphine|buprenorphine|mesh-list
65458144|NCT01296334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65458145|NCT01296334|Narcotics|narcotics|mesh-ancestor
65458146|NCT01296334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65458147|NCT01296334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458148|NCT01296334|Analgesics|analgesics|mesh-ancestor
64695747|NCT00003399|Carmustine|carmustine|mesh-list
64695748|NCT00003399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64695749|NCT00003399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695750|NCT00003399|Tubulin Modulators|tubulin modulators|mesh-ancestor
64695751|NCT00003399|Antimitotic Agents|antimitotic agents|mesh-ancestor
64695752|NCT00003399|Mitosis Modulators|mitosis modulators|mesh-ancestor
64695753|NCT00003399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695754|NCT00003399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64695755|NCT00003399|Immunologic Factors|immunologic factors|mesh-ancestor
64695756|NCT00003399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695757|NCT00003399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64695758|NCT00003399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64695759|NCT00003399|Alkylating Agents|alkylating agents|mesh-ancestor
64695760|NCT00003399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64695761|NCT00003399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64717888|NCT01194908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717889|NCT01194908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64717890|NCT01194908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64717891|NCT01194908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64717892|NCT01194908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64717893|NCT01194908|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64717894|NCT01163084|Leuprolide|leuprolide|mesh-list
64717895|NCT01163084|Goserelin|goserelin|mesh-list
64717896|NCT01163084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64717897|NCT01163084|Fertility Agents|fertility agents|mesh-ancestor
64717898|NCT01163084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64717899|NCT01163084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695776|NCT03376061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695777|NCT03376061|Hemostatics|hemostatics|mesh-ancestor
64695778|NCT03376061|Coagulants|coagulants|mesh-ancestor
64695779|NCT03376295|Tiotropium Bromide|tiotropium bromide|mesh-list
64695780|NCT03376295|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64695781|NCT03376295|Autonomic Agents|autonomic agents|mesh-ancestor
64695782|NCT03376295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458149|NCT01296334|Sensory System Agents|sensory system agents|mesh-ancestor
65458150|NCT01296334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458151|NCT01296334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65458152|NCT03847558|Hormones|hormones|mesh-list
65458153|NCT03847558|Testosterone|testosterone|mesh-list
65458154|NCT03847558|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65458155|NCT03847558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65458156|NCT03847558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458157|NCT03847558|Androgens|androgens|mesh-ancestor
65458158|NCT01189006|Dextromethorphan|dextromethorphan|mesh-list
65458159|NCT01189006|Antitussive Agents|antitussive agents|mesh-ancestor
64842693|NCT01657851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64695783|NCT03376295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695784|NCT03376295|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64695785|NCT03376295|Respiratory System Agents|respiratory system agents|mesh-ancestor
64695786|NCT03376295|Parasympatholytics|parasympatholytics|mesh-ancestor
64695787|NCT03376295|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64695788|NCT03376295|Cholinergic Agents|cholinergic agents|mesh-ancestor
64695789|NCT03376295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64695790|NCT03376295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695791|NCT03822793|Tranexamic Acid|tranexamic acid|mesh-list
64695792|NCT03822793|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64695793|NCT03822793|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64695794|NCT03822793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695795|NCT03822793|Hemostatics|hemostatics|mesh-ancestor
64695796|NCT03822793|Coagulants|coagulants|mesh-ancestor
64695797|NCT04735523|Warfarin|warfarin|mesh-list
64695798|NCT04735523|Dabigatran|dabigatran|mesh-list
64695799|NCT04735523|Anticoagulants|anticoagulants|mesh-ancestor
64695800|NCT04735523|Antithrombins|antithrombins|mesh-ancestor
64695801|NCT04735523|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64695802|NCT04735523|Protease Inhibitors|protease inhibitors|mesh-ancestor
64695803|NCT04735523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64695804|NCT04735523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695811|NCT05715788|Autonomic Agents|autonomic agents|mesh-ancestor
64695812|NCT05715788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695813|NCT05715788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695814|NCT05715788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64695822|NCT05715788|Gasotransmitters|gasotransmitters|mesh-ancestor
64695823|NCT05715788|Protective Agents|protective agents|mesh-ancestor
64695825|NCT00003225|Amifostine|amifostine|mesh-list
64695826|NCT00003225|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64695827|NCT00003225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64695828|NCT00003225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64695829|NCT00003225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695830|NCT00003225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457197|NCT04599140|Nivolumab|nivolumab|mesh-list
64717900|NCT01163084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64717901|NCT01163084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64717902|NCT01155518|Clomiphene|clomiphene|mesh-list
64717903|NCT01155518|Testosterone|testosterone|mesh-list
64717904|NCT01155518|Androgens|androgens|mesh-ancestor
64717905|NCT01155518|Hormones|hormones|mesh-ancestor
64717906|NCT01155518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64326107|NCT02670915|Insulin|insulin|mesh-list
64695831|NCT00003225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64695832|NCT00003225|Protective Agents|protective agents|mesh-ancestor
64695833|NCT00003225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695834|NCT05372588|Vaccines|vaccines|mesh-list
64695835|NCT05372588|Immunologic Factors|immunologic factors|mesh-ancestor
64695836|NCT05372588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695837|NCT03838094|Calcium|calcium|mesh-list
64695838|NCT03838094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64695839|NCT03838094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458160|NCT01189006|Respiratory System Agents|respiratory system agents|mesh-ancestor
65458161|NCT01189006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65458162|NCT01189006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65458163|NCT01189006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65458164|NCT01189006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458165|NCT01189006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458166|NCT01292356|Cetuximab|cetuximab|mesh-list
65458167|NCT01292356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65458168|NCT01292356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458169|NCT01294852|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65458170|NCT01294852|Respiratory System Agents|respiratory system agents|mesh-ancestor
65458171|NCT03847246|Entecavir|entecavir|mesh-list
65458172|NCT03847246|Antiviral Agents|antiviral agents|mesh-ancestor
65458173|NCT03847246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65458174|NCT03849196|Bisacodyl|bisacodyl|mesh-list
65458175|NCT03849196|Cathartics|cathartics|mesh-ancestor
65458219|NCT01194700|Hormones|hormones|mesh-ancestor
65458220|NCT01194700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65458221|NCT01194700|Sympathomimetics|sympathomimetics|mesh-ancestor
65458222|NCT01189318|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65458223|NCT01189318|Antidepressive Agents|antidepressive agents|mesh-ancestor
65458224|NCT01189318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65458225|NCT01189318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65458226|NCT01189318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65458227|NCT01189318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65458228|NCT01189318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458229|NCT01194778|Vitamins|vitamins|mesh-list
65458230|NCT01194778|Vitamin K|vitamin k|mesh-list
65458231|NCT01194778|Vitamin K 2|vitamin k 2|mesh-list
65458232|NCT01194778|Vitamin K 1|vitamin k 1|mesh-list
65458233|NCT01194778|Micronutrients|micronutrients|mesh-ancestor
65458234|NCT01194778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695840|NCT03441269|Ibuprofen|ibuprofen|mesh-list
64695841|NCT03441269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64695842|NCT03441269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64695843|NCT03441269|Analgesics|analgesics|mesh-ancestor
64695844|NCT03441269|Sensory System Agents|sensory system agents|mesh-ancestor
64695845|NCT03441269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695846|NCT03441269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695847|NCT03441269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64695848|NCT03441269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64695849|NCT03441269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64695850|NCT03441269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64695851|NCT03441269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695852|NCT03252353|Octreotide|octreotide|mesh-list
64695853|NCT03252353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64695854|NCT03252353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64695855|NCT03252353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695856|NCT05355272|Hormones|hormones|mesh-list
64695857|NCT05355272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64695858|NCT05355272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695859|NCT00358358|Fluticasone|fluticasone|mesh-list
64695860|NCT00358358|Xhance|xhance|mesh-list
64695861|NCT00358358|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64695862|NCT00358358|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64695863|NCT00358358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64695864|NCT00358358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64695865|NCT00358358|Autonomic Agents|autonomic agents|mesh-ancestor
64695866|NCT00358358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695867|NCT00358358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695868|NCT00358358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64695869|NCT00358358|Respiratory System Agents|respiratory system agents|mesh-ancestor
64695870|NCT00358358|Dermatologic Agents|dermatologic agents|mesh-ancestor
64695871|NCT00358358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64695872|NCT00358358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64695896|NCT02265510|Pomalidomide|pomalidomide|mesh-list
64695897|NCT02265510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64695898|NCT02265510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695899|NCT02265510|Tubulin Modulators|tubulin modulators|mesh-ancestor
64695900|NCT02265510|Antimitotic Agents|antimitotic agents|mesh-ancestor
64695901|NCT02265510|Mitosis Modulators|mitosis modulators|mesh-ancestor
64717907|NCT01155518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717909|NCT01155518|Hormone Antagonists|hormone antagonists|mesh-ancestor
64717910|NCT01155518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64717911|NCT01155518|Fertility Agents|fertility agents|mesh-ancestor
64695902|NCT02265510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458235|NCT01194778|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65458236|NCT01194778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65458237|NCT01194778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458238|NCT01194778|Hemostatics|hemostatics|mesh-ancestor
65458239|NCT01194778|Coagulants|coagulants|mesh-ancestor
65458240|NCT01194934|Lenograstim|lenograstim|mesh-list
65458241|NCT01194934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65458242|NCT01194934|Immunologic Factors|immunologic factors|mesh-ancestor
65458243|NCT01194934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458244|NCT01297036|Donepezil|donepezil|mesh-list
65458245|NCT01297036|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65458246|NCT01297036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458247|NCT01297036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458248|NCT01297036|Cholinergic Agents|cholinergic agents|mesh-ancestor
65458249|NCT01297036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64695903|NCT02265510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64695904|NCT02265510|Antiemetics|antiemetics|mesh-ancestor
64695905|NCT02265510|Autonomic Agents|autonomic agents|mesh-ancestor
64695906|NCT02265510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695907|NCT02265510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695908|NCT02265510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64695909|NCT02265510|Glucocorticoids|glucocorticoids|mesh-ancestor
64695910|NCT02265510|Hormones|hormones|mesh-ancestor
64695911|NCT02265510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64695912|NCT02265510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64695913|NCT02265510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64695914|NCT02265510|Antimetabolites|antimetabolites|mesh-ancestor
64695915|NCT02265510|Antiviral Agents|antiviral agents|mesh-ancestor
64695916|NCT02265510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64695917|NCT02265510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64695918|NCT02265510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64695919|NCT02265510|Immunologic Factors|immunologic factors|mesh-ancestor
64695920|NCT02265510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64695921|NCT02265510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64695922|NCT02265510|Growth Substances|growth substances|mesh-ancestor
64695923|NCT02265510|Growth Inhibitors|growth inhibitors|mesh-ancestor
64695924|NCT03254147|Warfarin|warfarin|mesh-list
64695925|NCT03254147|Rivaroxaban|rivaroxaban|mesh-list
64695926|NCT03254147|Dabigatran|dabigatran|mesh-list
64695927|NCT03254147|Apixaban|apixaban|mesh-list
64695928|NCT03254147|Edoxaban|edoxaban|mesh-list
64695929|NCT03254147|Anticoagulants|anticoagulants|mesh-ancestor
64695930|NCT03254147|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64695931|NCT03254147|Antithrombins|antithrombins|mesh-ancestor
64695932|NCT03254147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64695933|NCT03254147|Protease Inhibitors|protease inhibitors|mesh-ancestor
64695934|NCT03254147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64695935|NCT03254147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695936|NCT03384329|Resveratrol|resveratrol|mesh-list
64695937|NCT03384329|Antioxidants|antioxidants|mesh-ancestor
64695938|NCT03384329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695939|NCT03384329|Protective Agents|protective agents|mesh-ancestor
64695956|NCT05327972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64695957|NCT05327972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695958|NCT05327972|Cholinergic Agents|cholinergic agents|mesh-ancestor
64695959|NCT05327972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64695961|NCT03256253|Analgesics|analgesics|mesh-ancestor
64695962|NCT03256253|Sensory System Agents|sensory system agents|mesh-ancestor
64695970|NCT03256253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64695971|NCT03256253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64695972|NCT03256253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64695973|NCT03256253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65458250|NCT01297036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458251|NCT01297036|Nootropic Agents|nootropic agents|mesh-ancestor
65458252|NCT03848806|Calcitriol|calcitriol|mesh-list
65458253|NCT03848806|Calcipotriene|calcipotriene|mesh-list
65458254|NCT03848806|Dermatologic Agents|dermatologic agents|mesh-ancestor
65458255|NCT03848806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65458256|NCT03848806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458257|NCT03848806|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65458258|NCT03848806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65458259|NCT03848806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458260|NCT03848806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65458261|NCT03848806|Vitamins|vitamins|mesh-ancestor
65458262|NCT03848806|Micronutrients|micronutrients|mesh-ancestor
65458263|NCT03848806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65458264|NCT03737110|Rilonacept|rilonacept|mesh-list
65458265|NCT03737110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65458266|NCT01189864|Diclofenac|diclofenac|mesh-list
65458267|NCT01189864|Prednisolone acetate|prednisolone acetate|mesh-list
65458268|NCT01189864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65458269|NCT01189864|Methylprednisolone|methylprednisolone|mesh-list
65458270|NCT01189864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65458271|NCT01189864|Prednisolone|prednisolone|mesh-list
65458272|NCT01189864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65458273|NCT01189864|Prednisolone phosphate|prednisolone phosphate|mesh-list
65458274|NCT01189864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65458275|NCT01189864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65458276|NCT01189864|Analgesics|analgesics|mesh-ancestor
65458277|NCT01189864|Sensory System Agents|sensory system agents|mesh-ancestor
65458278|NCT01189864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458279|NCT01189864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458280|NCT01189864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64695974|NCT03256799|Ivacaftor|ivacaftor|mesh-list
64695975|NCT03256799|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64695976|NCT03256799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64695977|NCT03256799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695978|NCT01238211|Cytarabine|cytarabine|mesh-list
64695979|NCT01238211|Daunorubicin|daunorubicin|mesh-list
64695980|NCT01238211|Dasatinib|dasatinib|mesh-list
64695981|NCT01238211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64695982|NCT01238211|Antimetabolites|antimetabolites|mesh-ancestor
64717912|NCT01155518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64717913|NCT01155518|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64717914|NCT01155518|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64717915|NCT03490916|Acetazolamide|acetazolamide|mesh-list
64695983|NCT01238211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458281|NCT01189864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65458282|NCT01189864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65458283|NCT01189864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458284|NCT01189864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458286|NCT01189864|Autonomic Agents|autonomic agents|mesh-ancestor
65458287|NCT01189864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65458288|NCT01189864|Glucocorticoids|glucocorticoids|mesh-ancestor
65458289|NCT01189864|Hormones|hormones|mesh-ancestor
65458290|NCT01189864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65458291|NCT01189864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65458292|NCT01189864|Protective Agents|protective agents|mesh-ancestor
65458293|NCT01189864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65458294|NCT01189864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458295|NCT01195246|Vaccines|vaccines|mesh-list
65458296|NCT01195246|Immunologic Factors|immunologic factors|mesh-ancestor
65458297|NCT01195246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458298|NCT01191892|Gemcitabine|gemcitabine|mesh-list
65458299|NCT01191892|Carboplatin|carboplatin|mesh-list
65458300|NCT01191892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458301|NCT01191892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65458302|NCT01191892|Antimetabolites|antimetabolites|mesh-ancestor
65458303|NCT01191892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695984|NCT01238211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695985|NCT01238211|Antiviral Agents|antiviral agents|mesh-ancestor
64695986|NCT01238211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64695987|NCT01238211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64695988|NCT01238211|Immunologic Factors|immunologic factors|mesh-ancestor
64695989|NCT01238211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695990|NCT01238211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64695991|NCT01238211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64695992|NCT01238211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64695993|NCT01238211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696014|NCT00003405|Antiviral Agents|antiviral agents|mesh-ancestor
64696015|NCT00003405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64696016|NCT00003405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64696017|NCT00003405|Antimetabolites|antimetabolites|mesh-ancestor
64696018|NCT00003405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696019|NCT00003405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64696020|NCT00003405|Immunologic Factors|immunologic factors|mesh-ancestor
64696021|NCT00003405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696022|NCT00003405|Analgesics|analgesics|mesh-ancestor
64696023|NCT00003405|Sensory System Agents|sensory system agents|mesh-ancestor
64696024|NCT00003405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64696025|NCT00003405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64696026|NCT00003405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64696027|NCT00003405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696028|NCT00003405|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64696029|NCT00003405|Dermatologic Agents|dermatologic agents|mesh-ancestor
64696030|NCT00003405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64696031|NCT00003405|Protective Agents|protective agents|mesh-ancestor
64696032|NCT00003405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64696033|NCT05131646|Axitinib|axitinib|mesh-list
65458304|NCT01191892|Antiviral Agents|antiviral agents|mesh-ancestor
65458305|NCT01191892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65458306|NCT01191892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458307|NCT01191892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65458308|NCT01191892|Immunologic Factors|immunologic factors|mesh-ancestor
65458309|NCT01191892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458310|NCT01293058|Naloxone|naloxone|mesh-list
65458311|NCT01293058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65458312|NCT01293058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458313|NCT01293058|Sensory System Agents|sensory system agents|mesh-ancestor
65458314|NCT01293058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458315|NCT01195324|Canagliflozin|canagliflozin|mesh-list
65458316|NCT01195324|Warfarin|warfarin|mesh-list
65458317|NCT01195324|Anticoagulants|anticoagulants|mesh-ancestor
65458318|NCT01195324|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65458319|NCT01195324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458320|NCT01195324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65458321|NCT01195324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458322|NCT01293136|Analgesics, Opioid|analgesics, opioid|mesh-list
65458323|NCT01293136|Narcotics|narcotics|mesh-ancestor
65458324|NCT01293136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65458325|NCT01293136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696034|NCT05131646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696035|NCT05131646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64696036|NCT05131646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334699|NCT03146871|Antimetabolites|antimetabolites|mesh-ancestor
64696037|NCT05131646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696038|NCT00003237|Paclitaxel|paclitaxel|mesh-list
64696039|NCT00003237|Cisplatin|cisplatin|mesh-list
64696040|NCT00003237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64696041|NCT00003237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696042|NCT00003237|Tubulin Modulators|tubulin modulators|mesh-ancestor
64334703|NCT02231957|Vaccines|vaccines|mesh-list
64696049|NCT00003411|Dermatologic Agents|dermatologic agents|mesh-ancestor
64696050|NCT00003243|Aldesleukin|aldesleukin|mesh-list
64696051|NCT00003243|Cyclophosphamide|cyclophosphamide|mesh-list
64696052|NCT00003243|Doxorubicin|doxorubicin|mesh-list
64696053|NCT00003243|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64696054|NCT00003243|Etoposide|etoposide|mesh-list
64696083|NCT00003249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64696085|NCT00003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696086|NCT00003249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64696087|NCT00003249|Hormone Antagonists|hormone antagonists|mesh-ancestor
64696088|NCT00003249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64696089|NCT00003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696090|NCT00003249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64696091|NCT00003249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696092|NCT00003249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64696093|NCT00003249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64696094|NCT00003249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64696095|NCT00003255|Carboplatin|carboplatin|mesh-list
64696096|NCT00003255|Topotecan|topotecan|mesh-list
64717917|NCT03490916|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65458326|NCT01293136|Analgesics|analgesics|mesh-ancestor
65458327|NCT01293136|Sensory System Agents|sensory system agents|mesh-ancestor
65458328|NCT01293136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458329|NCT01293292|Teriparatide|teriparatide|mesh-list
65458330|NCT01293292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65458331|NCT01293292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458332|NCT01293292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65458333|NCT03846388|Hormones|hormones|mesh-list
65458334|NCT03846388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65458335|NCT03846388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64717918|NCT03490916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64717919|NCT03490916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717920|NCT03490916|Diuretics|diuretics|mesh-ancestor
64717921|NCT03490916|Natriuretic Agents|natriuretic agents|mesh-ancestor
64696109|NCT03269435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64696110|NCT03269435|Antiemetics|antiemetics|mesh-ancestor
64696111|NCT03269435|Autonomic Agents|autonomic agents|mesh-ancestor
64696112|NCT03269435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64696113|NCT03269435|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64696114|NCT03269435|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64696115|NCT03269435|Dopamine Agents|dopamine agents|mesh-ancestor
64696116|NCT03269435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64696117|NCT03269435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696118|NCT00003261|Zidovudine|zidovudine|mesh-list
64696119|NCT00003261|Methotrexate|methotrexate|mesh-list
64696120|NCT00003261|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64696121|NCT00003261|Abortifacient Agents|abortifacient agents|mesh-ancestor
64696122|NCT00003261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64696123|NCT00003261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696124|NCT00003261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64696125|NCT00003261|Antimetabolites|antimetabolites|mesh-ancestor
64696126|NCT00003261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696127|NCT00003261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696128|NCT00003261|Dermatologic Agents|dermatologic agents|mesh-ancestor
64696129|NCT00003261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696130|NCT00003261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64696131|NCT00003261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64696132|NCT00003261|Immunologic Factors|immunologic factors|mesh-ancestor
64696133|NCT00003261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64696134|NCT00003261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64696135|NCT00003261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64696136|NCT00003261|Antiviral Agents|antiviral agents|mesh-ancestor
64696137|NCT00003261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64696138|NCT00003261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64696139|NCT00003261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64696140|NCT03279731|Liraglutide|liraglutide|mesh-list
64696141|NCT03279731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64696142|NCT03279731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696143|NCT03279731|Incretins|incretins|mesh-ancestor
64696144|NCT03279731|Hormones|hormones|mesh-ancestor
64696145|NCT03279731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64696146|NCT04530409|Dexamethasone|dexamethasone|mesh-list
64696154|NCT04530409|Glucocorticoids|glucocorticoids|mesh-ancestor
64696155|NCT04530409|Hormones|hormones|mesh-ancestor
64696156|NCT04530409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64696157|NCT04530409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64696158|NCT04530409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696159|NCT04530409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64696160|NCT04530409|Protective Agents|protective agents|mesh-ancestor
64696182|NCT02264574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696183|NCT02264574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64696184|NCT02264574|Alkylating Agents|alkylating agents|mesh-ancestor
64696185|NCT02264574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458336|NCT03846388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458337|NCT01195714|Ofatumumab|ofatumumab|mesh-list
65458338|NCT01195714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458339|NCT01190722|Diclofenac|diclofenac|mesh-list
65458340|NCT01190722|Etoricoxib|etoricoxib|mesh-list
65458341|NCT01190722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65458342|NCT01190722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65458343|NCT01190722|Analgesics|analgesics|mesh-ancestor
65458344|NCT01190722|Sensory System Agents|sensory system agents|mesh-ancestor
65458345|NCT01190722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458346|NCT01190722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458347|NCT01190722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65458348|NCT01190722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65458349|NCT01190722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65458350|NCT01190722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842874|NCT01658878|Nivolumab|nivolumab|mesh-list
64696186|NCT04412863|Interferons|interferons|mesh-list
64696187|NCT04412863|Interferon-alpha|interferon-alpha|mesh-list
64696188|NCT04412863|Interferon alpha-2|interferon alpha-2|mesh-list
64696189|NCT04412863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64696190|NCT04412863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696191|NCT04412863|Antiviral Agents|antiviral agents|mesh-ancestor
64717922|NCT03490916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717923|NCT03333746|Nivolumab|nivolumab|mesh-list
64717924|NCT03333746|Lenalidomide|lenalidomide|mesh-list
64717925|NCT03333746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64717926|NCT03333746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696192|NCT04412863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64696193|NCT04412863|Immunologic Factors|immunologic factors|mesh-ancestor
64696194|NCT04412863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696195|NCT03400475|Simvastatin|simvastatin|mesh-list
64696196|NCT03400475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64696197|NCT03400475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64696198|NCT03400475|Antimetabolites|antimetabolites|mesh-ancestor
64696199|NCT03400475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696200|NCT03400475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64696201|NCT03400475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64696202|NCT03400475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696203|NCT01641900|Eszopiclone|eszopiclone|mesh-list
64696204|NCT01641900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64696205|NCT01641900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64696206|NCT01641900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696207|NCT03834571|Paclitaxel|paclitaxel|mesh-list
64696208|NCT03834571|Cisplatin|cisplatin|mesh-list
64696209|NCT03834571|Carboplatin|carboplatin|mesh-list
64696210|NCT03834571|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64696211|NCT03834571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64696212|NCT03834571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696213|NCT03834571|Tubulin Modulators|tubulin modulators|mesh-ancestor
64696214|NCT03834571|Antimitotic Agents|antimitotic agents|mesh-ancestor
64696215|NCT03834571|Mitosis Modulators|mitosis modulators|mesh-ancestor
64696216|NCT03834571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696217|NCT05088980|Lidocaine|lidocaine|mesh-list
64696247|NCT04290871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696249|NCT04290871|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64696250|NCT04290871|Vasodilator Agents|vasodilator agents|mesh-ancestor
64696251|NCT04290871|Gasotransmitters|gasotransmitters|mesh-ancestor
64696252|NCT04290871|Protective Agents|protective agents|mesh-ancestor
64696253|NCT03501979|Capecitabine|capecitabine|mesh-list
64696254|NCT03501979|Trastuzumab|trastuzumab|mesh-list
64696255|NCT03501979|Tucatinib|tucatinib|mesh-list
65458351|NCT01190722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458352|NCT01190722|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65458353|NCT01196260|Capecitabine|capecitabine|mesh-list
65458354|NCT01196260|Oxaliplatin|oxaliplatin|mesh-list
65458355|NCT01196260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65458356|NCT01196260|Antimetabolites|antimetabolites|mesh-ancestor
65458357|NCT01196260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458358|NCT01196260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458359|NCT01192984|Mogamulizumab|mogamulizumab|mesh-list
65458360|NCT01192984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458361|NCT05412082|Leucovorin|leucovorin|mesh-list
65458362|NCT05412082|Fluorouracil|fluorouracil|mesh-list
65458363|NCT05412082|Capecitabine|capecitabine|mesh-list
65458364|NCT05412082|Oxaliplatin|oxaliplatin|mesh-list
64696256|NCT03501979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64696257|NCT03501979|Antimetabolites|antimetabolites|mesh-ancestor
64696258|NCT03501979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696259|NCT03501979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696269|NCT03465787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64696274|NCT03465787|Adrenergic Agents|adrenergic agents|mesh-ancestor
64696275|NCT03465787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64696276|NCT03465787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696277|NCT03465787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64696278|NCT03465787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64696280|NCT03465787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64696281|NCT03465787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64696282|NCT03465787|Dopamine Agents|dopamine agents|mesh-ancestor
64696284|NCT05071352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64696285|NCT05071352|Analgesics|analgesics|mesh-ancestor
64696286|NCT05071352|Sensory System Agents|sensory system agents|mesh-ancestor
64696287|NCT05071352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64696288|NCT05071352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696289|NCT00376025|Antioxidants|antioxidants|mesh-list
64696290|NCT00376025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696291|NCT00376025|Protective Agents|protective agents|mesh-ancestor
64696292|NCT00376025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696293|NCT00376103|Temozolomide|temozolomide|mesh-list
64717927|NCT03333746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64717928|NCT03333746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717929|NCT03333746|Immunologic Factors|immunologic factors|mesh-ancestor
64717930|NCT03333746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717931|NCT03333746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64717932|NCT03333746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64717933|NCT03333746|Growth Substances|growth substances|mesh-ancestor
64326134|NCT04745949|Prednisone|prednisone|mesh-list
64696294|NCT00376103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64696295|NCT00376103|Alkylating Agents|alkylating agents|mesh-ancestor
64696296|NCT00376103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696297|NCT00376103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696298|NCT03836287|Bromides|bromides|mesh-list
64696299|NCT03836287|Anticonvulsants|anticonvulsants|mesh-ancestor
64696300|NCT03403517|Dexamethasone|dexamethasone|mesh-list
64696301|NCT03403517|Methylprednisolone|methylprednisolone|mesh-list
64696302|NCT03403517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64696303|NCT03403517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64696304|NCT03403517|Prednisolone|prednisolone|mesh-list
64696305|NCT03403517|Prednisolone acetate|prednisolone acetate|mesh-list
64696306|NCT03403517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64696307|NCT03403517|Prednisolone phosphate|prednisolone phosphate|mesh-list
64696308|NCT03403517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65458365|NCT05412082|Antimetabolites|antimetabolites|mesh-ancestor
65458366|NCT05412082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458367|NCT05412082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65458368|NCT05412082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458369|NCT05412082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65458370|NCT05412082|Immunologic Factors|immunologic factors|mesh-ancestor
65458371|NCT05412082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458372|NCT05412082|Antidotes|antidotes|mesh-ancestor
65458373|NCT05412082|Protective Agents|protective agents|mesh-ancestor
65458374|NCT05412082|Vitamin B Complex|vitamin b complex|mesh-ancestor
65458375|NCT05412082|Vitamins|vitamins|mesh-ancestor
65458376|NCT05412082|Micronutrients|micronutrients|mesh-ancestor
65458377|NCT01193296|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65458378|NCT01193296|Vildagliptin|vildagliptin|mesh-list
65458379|NCT01193296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65458380|NCT01193296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458381|NCT01193296|Incretins|incretins|mesh-ancestor
65458382|NCT01193296|Hormones|hormones|mesh-ancestor
65458383|NCT01193296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65458384|NCT01193296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65458385|NCT01193296|Protease Inhibitors|protease inhibitors|mesh-ancestor
65458386|NCT01193296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458387|NCT01193296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458388|NCT01197040|Mycophenolic Acid|mycophenolic acid|mesh-list
65458389|NCT01197040|Prednisone|prednisone|mesh-list
65458390|NCT01197040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65458391|NCT01197040|Glucocorticoids|glucocorticoids|mesh-ancestor
65458392|NCT01197040|Hormones|hormones|mesh-ancestor
65458393|NCT01197040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65458394|NCT01197040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458395|NCT01197040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65458396|NCT01197040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458397|NCT01197040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65458406|NCT05440864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65458407|NCT05440864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458408|NCT01193452|Leucovorin|leucovorin|mesh-list
65458409|NCT01193452|Fluorouracil|fluorouracil|mesh-list
65458410|NCT01193452|Levoleucovorin|levoleucovorin|mesh-list
65458411|NCT01193452|Antimetabolites|antimetabolites|mesh-ancestor
65458412|NCT01193452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458413|NCT01193452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65458414|NCT01193452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458415|NCT01193452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65458416|NCT01193452|Immunologic Factors|immunologic factors|mesh-ancestor
65458417|NCT01193452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458418|NCT01193452|Antidotes|antidotes|mesh-ancestor
65458419|NCT01193452|Protective Agents|protective agents|mesh-ancestor
65458420|NCT01193452|Vitamin B Complex|vitamin b complex|mesh-ancestor
65458421|NCT01193452|Vitamins|vitamins|mesh-ancestor
65458422|NCT01193452|Micronutrients|micronutrients|mesh-ancestor
65458423|NCT05670886|Carbetocin|carbetocin|mesh-list
64696309|NCT03403517|Antiemetics|antiemetics|mesh-ancestor
64696310|NCT03403517|Autonomic Agents|autonomic agents|mesh-ancestor
64696311|NCT03403517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64696312|NCT03403517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696313|NCT03403517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64696314|NCT03403517|Glucocorticoids|glucocorticoids|mesh-ancestor
64696315|NCT03403517|Hormones|hormones|mesh-ancestor
64696316|NCT03403517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64696317|NCT03403517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64696318|NCT03403517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696319|NCT03403517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64696320|NCT03403517|Protective Agents|protective agents|mesh-ancestor
64696321|NCT05247788|Ethanol|ethanol|mesh-list
64696322|NCT05247788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64696323|NCT05247788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64696324|NCT05247788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64696344|NCT05463848|Alkylating Agents|alkylating agents|mesh-ancestor
64696345|NCT05463848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696346|NCT05463848|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64696347|NCT05463848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696348|NCT05647512|Dexamethasone|dexamethasone|mesh-list
64696349|NCT05647512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64696350|NCT05647512|Antiemetics|antiemetics|mesh-ancestor
64696351|NCT05647512|Autonomic Agents|autonomic agents|mesh-ancestor
64696357|NCT05647512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64696359|NCT05647512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696360|NCT00356395|Candesartan|candesartan|mesh-list
64696361|NCT00356395|Ramipril|ramipril|mesh-list
64696362|NCT00356395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64696363|NCT00356395|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64696364|NCT00356395|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64696365|NCT00356395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696366|NCT00356395|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64696367|NCT00356395|Protease Inhibitors|protease inhibitors|mesh-ancestor
64696368|NCT00356395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696369|NCT00356473|Atorvastatin|atorvastatin|mesh-list
64717934|NCT03333746|Growth Inhibitors|growth inhibitors|mesh-ancestor
64717935|NCT01139996|Clonidine|clonidine|mesh-list
64717936|NCT01139996|Analgesics|analgesics|mesh-ancestor
64717937|NCT01139996|Sensory System Agents|sensory system agents|mesh-ancestor
65458424|NCT05670886|Oxytocics|oxytocics|mesh-ancestor
65458425|NCT05670886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65458426|NCT05670886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458427|NCT03844594|Eptifibatide|eptifibatide|mesh-list
65458428|NCT03844594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65458429|NCT03848182|Gemcitabine|gemcitabine|mesh-list
65458430|NCT03848182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65458431|NCT03848182|Antimetabolites|antimetabolites|mesh-ancestor
65458432|NCT03848182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458433|NCT03848182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64717938|NCT01139996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717939|NCT01139996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717940|NCT01139996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64717941|NCT01139996|Sympatholytics|sympatholytics|mesh-ancestor
64717942|NCT01139996|Autonomic Agents|autonomic agents|mesh-ancestor
64326140|NCT04745949|Nivolumab|nivolumab|mesh-list
64696370|NCT00356473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64696371|NCT00356473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64696372|NCT00356473|Antimetabolites|antimetabolites|mesh-ancestor
64696373|NCT00356473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696374|NCT00356473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64696375|NCT00356473|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64696376|NCT00356473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696377|NCT03410875|Obinutuzumab|obinutuzumab|mesh-list
64696378|NCT03410875|Vemurafenib|vemurafenib|mesh-list
64696379|NCT03410875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64696380|NCT03410875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696381|NCT03410875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64696382|NCT03410875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696400|NCT03450083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64696401|NCT03450083|Respiratory System Agents|respiratory system agents|mesh-ancestor
64696402|NCT05455658|Vaccines|vaccines|mesh-list
64696403|NCT05455658|Sargramostim|sargramostim|mesh-list
64696404|NCT05455658|Immunologic Factors|immunologic factors|mesh-ancestor
64696405|NCT05455658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696406|NCT03580343|Tofacitinib|tofacitinib|mesh-list
64696407|NCT03580343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64696408|NCT03580343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696409|NCT03580343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696410|NCT05445440|Leucovorin|leucovorin|mesh-list
64696411|NCT05445440|Sulfasalazine|sulfasalazine|mesh-list
64696412|NCT05445440|Methotrexate|methotrexate|mesh-list
64696413|NCT05445440|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64696414|NCT05445440|Abortifacient Agents|abortifacient agents|mesh-ancestor
64696415|NCT05445440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64696416|NCT05445440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696417|NCT05445440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64696418|NCT05445440|Antimetabolites|antimetabolites|mesh-ancestor
64696419|NCT05445440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696420|NCT05445440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696421|NCT05445440|Dermatologic Agents|dermatologic agents|mesh-ancestor
64696422|NCT05445440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696423|NCT05445440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64696424|NCT05445440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64696425|NCT05445440|Immunologic Factors|immunologic factors|mesh-ancestor
64696426|NCT05445440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64696427|NCT05445440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64696437|NCT05445440|Sensory System Agents|sensory system agents|mesh-ancestor
64696438|NCT05445440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64696439|NCT05445440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64696440|NCT05445440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64696441|NCT05041322|Buspirone|buspirone|mesh-list
64696442|NCT05041322|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64717943|NCT01139996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65458434|NCT03848182|Antiviral Agents|antiviral agents|mesh-ancestor
65207878|NCT00899847|Promethazine|promethazine|mesh-list
65458435|NCT03848182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65458436|NCT03848182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458437|NCT03848182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65458438|NCT03848182|Immunologic Factors|immunologic factors|mesh-ancestor
65458439|NCT03848182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458441|NCT00146328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65458442|NCT00146328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65458443|NCT00146328|Antiviral Agents|antiviral agents|mesh-ancestor
65458444|NCT00146328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65458445|NCT04916938|Psychotropic Drugs|psychotropic drugs|mesh-list
65458446|NCT01295866|Nitric Oxide|nitric oxide|mesh-list
65458447|NCT01295866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65458448|NCT01295866|Autonomic Agents|autonomic agents|mesh-ancestor
65458449|NCT01295866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458450|NCT01295866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458451|NCT01295866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65458452|NCT01295866|Respiratory System Agents|respiratory system agents|mesh-ancestor
65458453|NCT01295866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65458454|NCT01295866|Antioxidants|antioxidants|mesh-ancestor
65458455|NCT01295866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458456|NCT01295866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65458457|NCT01295866|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64717944|NCT01139996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64717945|NCT01139996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64717946|NCT01139996|Adrenergic Agents|adrenergic agents|mesh-ancestor
64717947|NCT01139996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64696453|NCT00422825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64696454|NCT00422825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696455|NCT00422825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696457|NCT05229614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64696458|NCT05229614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696459|NCT05445128|Plerixafor|plerixafor|mesh-list
64696460|NCT05445128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64696461|NCT05445128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64696462|NCT05445128|Antiviral Agents|antiviral agents|mesh-ancestor
64696463|NCT05445128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64696464|NCT02260986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64696465|NCT02260986|Immunologic Factors|immunologic factors|mesh-ancestor
64696466|NCT02260986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696467|NCT05483010|Atorvastatin|atorvastatin|mesh-list
64696468|NCT05483010|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64696469|NCT05483010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64696470|NCT05483010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64696471|NCT05483010|Antimetabolites|antimetabolites|mesh-ancestor
64696472|NCT05483010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696473|NCT05483010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64696474|NCT05483010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64696475|NCT05483010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696476|NCT05210582|Afamelanotide|afamelanotide|mesh-list
65458458|NCT01295866|Vasodilator Agents|vasodilator agents|mesh-ancestor
65458459|NCT01295866|Gasotransmitters|gasotransmitters|mesh-ancestor
65458460|NCT01295866|Protective Agents|protective agents|mesh-ancestor
65458461|NCT03848104|Cefoxitin|cefoxitin|mesh-list
65458462|NCT03848104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65458463|NCT03848104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65458464|NCT03345784|Cisplatin|cisplatin|mesh-list
65458465|NCT03345784|Adavosertib|adavosertib|mesh-list
65458466|NCT03345784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458467|NCT03345784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458468|NCT03345784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458469|NCT05670808|Epinephrine|epinephrine|mesh-list
65458470|NCT05670808|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65458471|NCT05670808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65458472|NCT05670808|Adrenergic Agents|adrenergic agents|mesh-ancestor
65458473|NCT05670808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65458474|NCT05670808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458475|NCT05670808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458476|NCT05670808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65458477|NCT05670808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65458478|NCT05670808|Autonomic Agents|autonomic agents|mesh-ancestor
65458479|NCT05670808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458480|NCT05670808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65458481|NCT05670808|Respiratory System Agents|respiratory system agents|mesh-ancestor
65458482|NCT05670808|Mydriatics|mydriatics|mesh-ancestor
65458483|NCT05670808|Sympathomimetics|sympathomimetics|mesh-ancestor
65458484|NCT05670808|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65458485|NCT01197664|Fluorouracil|fluorouracil|mesh-list
65458486|NCT01197664|Antimetabolites|antimetabolites|mesh-ancestor
65458487|NCT01197664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458488|NCT01197664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65458489|NCT01197664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696477|NCT05210582|Dermatologic Agents|dermatologic agents|mesh-ancestor
64696478|NCT04995536|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
64696479|NCT04995536|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64696480|NCT04995536|Immunologic Factors|immunologic factors|mesh-ancestor
64696481|NCT04995536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696482|NCT05647356|Bicalutamide|bicalutamide|mesh-list
64696483|NCT05647356|Androgen Antagonists|androgen antagonists|mesh-ancestor
64696484|NCT05647356|Hormone Antagonists|hormone antagonists|mesh-ancestor
64696485|NCT05647356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64696486|NCT05647356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696487|NCT05647356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458490|NCT01197664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65458491|NCT01197664|Immunologic Factors|immunologic factors|mesh-ancestor
65458492|NCT01197664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458493|NCT01199458|Alfentanil|alfentanil|mesh-list
65458494|NCT01199458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65458495|NCT01199458|Narcotics|narcotics|mesh-ancestor
65458496|NCT01199458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65458497|NCT01199458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458498|NCT01199458|Analgesics|analgesics|mesh-ancestor
65458499|NCT01199458|Sensory System Agents|sensory system agents|mesh-ancestor
65458500|NCT01199458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458501|NCT01199458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65458502|NCT01199458|Anesthetics, General|anesthetics, general|mesh-ancestor
65458503|NCT01199458|Anesthetics|anesthetics|mesh-ancestor
65458504|NCT01199614|Parathyroid Hormone|parathyroid hormone|mesh-list
65458505|NCT01199614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458506|NCT01199614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65458507|NCT01588522|Calcitriol|calcitriol|mesh-list
65458508|NCT01588522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64850718|NCT03190369|Hylan|hylan|mesh-list
65458509|NCT01588522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458510|NCT01588522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65458511|NCT01588522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65458512|NCT01588522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458513|NCT01588522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64843035|NCT01659476|Miotics|miotics|mesh-ancestor
64696488|NCT05647278|Esomeprazole|esomeprazole|mesh-list
64696489|NCT05647278|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64696490|NCT05647278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64696491|NCT05647278|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64696492|NCT05647278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696493|NCT05647278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696494|NCT00358748|Hydrocortisone|hydrocortisone|mesh-list
64696495|NCT00358748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64696496|NCT00359606|Tetrahydrouridine|tetrahydrouridine|mesh-list
64696497|NCT00359606|Antimetabolites|antimetabolites|mesh-ancestor
64696498|NCT00359606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696499|NCT00359840|Darbepoetin alfa|darbepoetin alfa|mesh-list
64696500|NCT00359840|Hematinics|hematinics|mesh-ancestor
64696521|NCT02977208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696524|NCT02977208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64696525|NCT02977208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64696526|NCT02977208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64696527|NCT02977208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64696528|NCT02977208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64696529|NCT02977208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64696530|NCT02977208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458515|NCT01588522|Micronutrients|micronutrients|mesh-ancestor
65458516|NCT01588522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65458517|NCT01296178|Idarubicin|idarubicin|mesh-list
65458518|NCT01296178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65458519|NCT01296178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458520|NCT01296178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65458521|NCT01296178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65458522|NCT01296178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458523|NCT01296178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458524|NCT01296256|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65458525|NCT01296256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65458526|NCT01296256|Alkylating Agents|alkylating agents|mesh-ancestor
65458527|NCT01296256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458528|NCT01296256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458529|NCT03731182|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65458530|NCT03731182|Immunologic Factors|immunologic factors|mesh-ancestor
65458531|NCT03731182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458532|NCT03730012|Atezolizumab|atezolizumab|mesh-list
65458533|NCT03730012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458534|NCT03844360|Anti-Infective Agents|anti-infective agents|mesh-list
65458535|NCT03844360|Bortezomib|bortezomib|mesh-list
65458536|NCT03844360|Imatinib Mesylate|imatinib mesylate|mesh-list
65458537|NCT03844360|Dasatinib|dasatinib|mesh-list
65458538|NCT03844360|Pegaspargase|pegaspargase|mesh-list
65458539|NCT03844360|Lenograstim|lenograstim|mesh-list
65458540|NCT03844360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458541|NCT03844360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65458542|NCT03844360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458543|NCT03844360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458544|NCT03844360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65458545|NCT03844360|Immunologic Factors|immunologic factors|mesh-ancestor
65458546|NCT03844360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458547|NCT01198054|Lenalidomide|lenalidomide|mesh-list
65458548|NCT01198054|Immunologic Factors|immunologic factors|mesh-ancestor
65458555|NCT01202032|Bevacizumab|bevacizumab|mesh-list
65458556|NCT01202032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65458557|NCT01202032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458558|NCT01202032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65458559|NCT01202032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65458560|NCT01202032|Growth Substances|growth substances|mesh-ancestor
65458561|NCT01202032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458562|NCT01202032|Growth Inhibitors|growth inhibitors|mesh-ancestor
65458563|NCT03844984|Lidocaine|lidocaine|mesh-list
65458564|NCT03844984|Midazolam|midazolam|mesh-list
65458565|NCT03844984|Ketamine|ketamine|mesh-list
65458566|NCT03844984|Anesthetics, Local|anesthetics, local|mesh-ancestor
65458567|NCT03844984|Anesthetics|anesthetics|mesh-ancestor
65458568|NCT03844984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717948|NCT01139996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717950|NCT02417870|Interleukin-2|interleukin-2|mesh-list
64717951|NCT02417870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64717952|NCT02417870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64717953|NCT02417870|Analgesics|analgesics|mesh-ancestor
64717954|NCT02417870|Sensory System Agents|sensory system agents|mesh-ancestor
64717955|NCT02417870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717956|NCT02417870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717957|NCT02417870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64717958|NCT02417870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64717959|NCT02417870|Antiviral Agents|antiviral agents|mesh-ancestor
64717960|NCT02417870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64717961|NCT01131884|Alendronate|alendronate|mesh-list
64717962|NCT01131884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64717963|NCT01131884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717964|NCT02389712|Lamotrigine|lamotrigine|mesh-list
64717965|NCT02389712|Fluoxetine|fluoxetine|mesh-list
64717966|NCT02389712|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64326153|NCT04745949|Alkylating Agents|alkylating agents|mesh-ancestor
64696531|NCT02977208|Antimanic Agents|antimanic agents|mesh-ancestor
64696532|NCT04866108|Capecitabine|capecitabine|mesh-list
64696533|NCT04866108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64696534|NCT04866108|Antimetabolites|antimetabolites|mesh-ancestor
64696535|NCT04866108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696536|NCT04866108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696537|NCT04343768|Interferons|interferons|mesh-list
64696538|NCT04343768|Ritonavir|ritonavir|mesh-list
64696539|NCT04343768|Lopinavir|lopinavir|mesh-list
64696540|NCT04343768|Interferon-beta|interferon-beta|mesh-list
64696541|NCT04343768|Interferon beta-1a|interferon beta-1a|mesh-list
64696542|NCT04343768|Hydroxychloroquine|hydroxychloroquine|mesh-list
64696543|NCT04343768|Interferon beta-1b|interferon beta-1b|mesh-list
64696544|NCT04343768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696545|NCT04343768|Antiviral Agents|antiviral agents|mesh-ancestor
64696546|NCT04343768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64696547|NCT04343768|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64696548|NCT04343768|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64696549|NCT04343768|Protease Inhibitors|protease inhibitors|mesh-ancestor
64696550|NCT04343768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696551|NCT04343768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696557|NCT04343768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64421855|NCT05486819|Anesthetics, General|anesthetics, general|mesh-ancestor
64696558|NCT04343768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64696559|NCT04343768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64696560|NCT04343768|Immunologic Factors|immunologic factors|mesh-ancestor
64696561|NCT04343768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696562|NCT04343768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64696563|NCT05475522|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64696564|NCT05475522|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64696565|NCT05475522|Dermatologic Agents|dermatologic agents|mesh-ancestor
65458569|NCT03844984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458570|NCT03844984|Sensory System Agents|sensory system agents|mesh-ancestor
65458571|NCT03844984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458572|NCT03844984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65458573|NCT03844984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65458574|NCT03844984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65458575|NCT03844984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65458576|NCT03844984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458577|NCT03844984|Analgesics|analgesics|mesh-ancestor
64696567|NCT02259348|Cyclophosphamide|cyclophosphamide|mesh-list
64696568|NCT02259348|Melphalan|melphalan|mesh-list
64717970|NCT02389712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64717971|NCT02389712|Serotonin Agents|serotonin agents|mesh-ancestor
64696585|NCT02259348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64696587|NCT02259348|Antiviral Agents|antiviral agents|mesh-ancestor
64696588|NCT02259348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64696589|NCT02259348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64696590|NCT02259348|Analgesics|analgesics|mesh-ancestor
64696591|NCT02259348|Sensory System Agents|sensory system agents|mesh-ancestor
64696592|NCT02259348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64696593|NCT02259348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64696594|NCT02259348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64696600|NCT00357019|Isospaglumic acid|isospaglumic acid|mesh-list
64696601|NCT00357019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64696602|NCT00357019|Autonomic Agents|autonomic agents|mesh-ancestor
64696603|NCT00357019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64696604|NCT00357019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696605|NCT00357019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64696606|NCT00357019|Respiratory System Agents|respiratory system agents|mesh-ancestor
64696607|NCT00357019|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64696608|NCT00357019|Histamine Antagonists|histamine antagonists|mesh-ancestor
64696609|NCT00357019|Histamine Agents|histamine agents|mesh-ancestor
64696610|NCT00357019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64696611|NCT00357019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696612|NCT00357019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64696613|NCT00357019|Protective Agents|protective agents|mesh-ancestor
64696614|NCT00357019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64696615|NCT03994705|Cyclophosphamide|cyclophosphamide|mesh-list
64696616|NCT03994705|Fludarabine|fludarabine|mesh-list
64696617|NCT03994705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64696618|NCT03994705|Immunologic Factors|immunologic factors|mesh-ancestor
64696619|NCT03994705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696620|NCT03994705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64696621|NCT03994705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64696622|NCT03994705|Alkylating Agents|alkylating agents|mesh-ancestor
64696623|NCT03994705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696624|NCT03994705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696625|NCT03994705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64696626|NCT03587207|Vaccines|vaccines|mesh-list
64696627|NCT03587207|Immunologic Factors|immunologic factors|mesh-ancestor
64696628|NCT03587207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696629|NCT03592121|Phenylephrine|phenylephrine|mesh-list
64696630|NCT03592121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64696631|NCT03592121|Mydriatics|mydriatics|mesh-ancestor
64696632|NCT03592121|Autonomic Agents|autonomic agents|mesh-ancestor
64696633|NCT03592121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64696634|NCT03592121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696635|NCT03592121|Sympathomimetics|sympathomimetics|mesh-ancestor
64696636|NCT03592121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64696637|NCT03592121|Nasal Decongestants|nasal decongestants|mesh-ancestor
64696638|NCT03592121|Respiratory System Agents|respiratory system agents|mesh-ancestor
64696639|NCT03592121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64696640|NCT03592121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64696665|NCT03596723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458578|NCT03844984|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65458579|NCT03844984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65458580|NCT03844984|Anesthetics, General|anesthetics, general|mesh-ancestor
65458581|NCT03844984|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65458582|NCT03844984|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65208029|NCT02842983|Adrenergic Agents|adrenergic agents|mesh-ancestor
65458584|NCT03844984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65458585|NCT03844984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65458586|NCT03844984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65458587|NCT03844984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65458588|NCT03844984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65458589|NCT03844984|GABA Modulators|gaba modulators|mesh-ancestor
65458590|NCT03844984|GABA Agents|gaba agents|mesh-ancestor
65458591|NCT03842020|Amiodarone|amiodarone|mesh-list
65458592|NCT03842020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65458593|NCT03842020|Vasodilator Agents|vasodilator agents|mesh-ancestor
64696666|NCT03596723|Antiemetics|antiemetics|mesh-ancestor
64696667|NCT03596723|Autonomic Agents|autonomic agents|mesh-ancestor
64696668|NCT03596723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64696669|NCT03596723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64696670|NCT03596723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64696671|NCT03596723|Protective Agents|protective agents|mesh-ancestor
64696672|NCT03463889|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64717973|NCT02389712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64326179|NCT00961675|Glucocorticoids|glucocorticoids|mesh-ancestor
64696681|NCT03472469|Gabapentin|gabapentin|mesh-list
64696682|NCT03472469|Tramadol|tramadol|mesh-list
64696683|NCT03472469|Anesthetics, Local|anesthetics, local|mesh-ancestor
64696684|NCT03472469|Anesthetics|anesthetics|mesh-ancestor
64696685|NCT03472469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64696686|NCT03472469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696687|NCT03472469|Sensory System Agents|sensory system agents|mesh-ancestor
64696688|NCT03472469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64696689|NCT03472469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64696690|NCT03472469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64696691|NCT03472469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64696692|NCT03472469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64696721|NCT04926233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64696722|NCT04926233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696723|NCT04926233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64696724|NCT04926233|Respiratory System Agents|respiratory system agents|mesh-ancestor
64696725|NCT04926233|Parasympatholytics|parasympatholytics|mesh-ancestor
64696726|NCT04926233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64696727|NCT04926233|Cholinergic Agents|cholinergic agents|mesh-ancestor
64696728|NCT04926233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64696729|NCT04926233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696730|NCT04926233|Anticonvulsants|anticonvulsants|mesh-ancestor
64696732|NCT04943159|Dermatologic Agents|dermatologic agents|mesh-ancestor
64696733|NCT04525157|Afamelanotide|afamelanotide|mesh-list
64696734|NCT04525157|Dermatologic Agents|dermatologic agents|mesh-ancestor
64696735|NCT04734665|Bevacizumab|bevacizumab|mesh-list
64696736|NCT04734665|Niraparib|niraparib|mesh-list
64696737|NCT04734665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64696738|NCT04734665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696739|NCT04734665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64696740|NCT04734665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64696741|NCT04734665|Growth Substances|growth substances|mesh-ancestor
64696742|NCT04734665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696743|NCT04734665|Growth Inhibitors|growth inhibitors|mesh-ancestor
64696752|NCT03112603|Imatinib Mesylate|imatinib mesylate|mesh-list
64696753|NCT03112603|Pentostatin|pentostatin|mesh-list
65458594|NCT03842020|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65458595|NCT03842020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65458596|NCT03842020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458597|NCT03842020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65458598|NCT03842020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65458599|NCT03842020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65458600|NCT03842020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458601|NCT03842020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65458602|NCT03842020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65458603|NCT03842020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65458604|NCT01200004|Lenalidomide|lenalidomide|mesh-list
65458605|NCT01200004|Azacitidine|azacitidine|mesh-list
65458606|NCT01200004|Immunologic Factors|immunologic factors|mesh-ancestor
65458607|NCT01200004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458608|NCT01200004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65458609|NCT01200004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65458610|NCT01200004|Growth Substances|growth substances|mesh-ancestor
65458611|NCT01200004|Growth Inhibitors|growth inhibitors|mesh-ancestor
65458612|NCT01200004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458613|NCT01200004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65458614|NCT01200004|Antimetabolites|antimetabolites|mesh-ancestor
64843116|NCT01659918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64696754|NCT03112603|Infliximab|infliximab|mesh-list
64696755|NCT03112603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64696756|NCT03112603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696757|NCT03112603|Immunologic Factors|immunologic factors|mesh-ancestor
64696758|NCT03112603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696759|NCT03112603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64696760|NCT03112603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64696761|NCT03112603|Abortifacient Agents|abortifacient agents|mesh-ancestor
64696762|NCT03112603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64696763|NCT03112603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64696764|NCT03112603|Antimetabolites|antimetabolites|mesh-ancestor
64696765|NCT03112603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696766|NCT03112603|Dermatologic Agents|dermatologic agents|mesh-ancestor
64696767|NCT03112603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696768|NCT03112603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64696769|NCT03112603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64696770|NCT03112603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64696771|NCT03112603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64696772|NCT03112603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64696773|NCT03112603|Antitubercular Agents|antitubercular agents|mesh-ancestor
64696774|NCT03112603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64696784|NCT03478163|Clindamycin palmitate|clindamycin palmitate|mesh-list
64696785|NCT03478163|Clindamycin phosphate|clindamycin phosphate|mesh-list
64717974|NCT02389712|Antidepressive Agents|antidepressive agents|mesh-ancestor
64717975|NCT02389712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64717976|NCT02389712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64717977|NCT02389712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65458615|NCT01200004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458616|NCT01200004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458617|NCT01198210|Dexamethasone|dexamethasone|mesh-list
65458618|NCT01198210|Dexamethasone acetate|dexamethasone acetate|mesh-list
65458619|NCT01198210|Ketamine|ketamine|mesh-list
65458620|NCT01198210|BB 1101|bb 1101|mesh-list
65458621|NCT01198210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65458622|NCT01198210|Antiemetics|antiemetics|mesh-ancestor
65458623|NCT01198210|Autonomic Agents|autonomic agents|mesh-ancestor
65458624|NCT01198210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458625|NCT01198210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458626|NCT01198210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65458627|NCT01198210|Glucocorticoids|glucocorticoids|mesh-ancestor
65458628|NCT01198210|Hormones|hormones|mesh-ancestor
65458629|NCT01198210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65458630|NCT01198210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65458631|NCT01198210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458632|NCT01198210|Protease Inhibitors|protease inhibitors|mesh-ancestor
65458633|NCT01198210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458634|NCT01198210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458635|NCT01198210|Analgesics|analgesics|mesh-ancestor
65458636|NCT01198210|Sensory System Agents|sensory system agents|mesh-ancestor
65458637|NCT01198210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65458638|NCT01198210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65458639|NCT01198210|Anesthetics, General|anesthetics, general|mesh-ancestor
65458664|NCT01200472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65458665|NCT01200472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65458666|NCT01200472|Analgesics|analgesics|mesh-ancestor
65458667|NCT01200472|Sensory System Agents|sensory system agents|mesh-ancestor
65458668|NCT01200472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458669|NCT01200472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458670|NCT01200472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64717978|NCT02389712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696786|NCT03478163|Cefazolin|cefazolin|mesh-list
64696787|NCT03478163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64696788|NCT03478163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64696789|NCT03478163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64696790|NCT03478163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696791|NCT03478163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696792|NCT05646810|Lidocaine|lidocaine|mesh-list
64696793|NCT05646810|Anesthetics, Local|anesthetics, local|mesh-ancestor
64696794|NCT05646810|Anesthetics|anesthetics|mesh-ancestor
64696795|NCT05646810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64696796|NCT05646810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696797|NCT05646810|Sensory System Agents|sensory system agents|mesh-ancestor
64696798|NCT05646810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64696799|NCT05646810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64696800|NCT05646810|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64696801|NCT05646810|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64696802|NCT05646810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64696803|NCT05646810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696804|NCT04960202|Ritonavir|ritonavir|mesh-list
64696805|NCT04960202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64696806|NCT04960202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64696807|NCT04960202|Protease Inhibitors|protease inhibitors|mesh-ancestor
64696808|NCT04960202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696809|NCT04960202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696810|NCT04960202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64696827|NCT02959112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64696828|NCT02959112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64696829|NCT02959112|Respiratory System Agents|respiratory system agents|mesh-ancestor
64696830|NCT02959112|Mydriatics|mydriatics|mesh-ancestor
64696831|NCT02959112|Sympathomimetics|sympathomimetics|mesh-ancestor
64696832|NCT02959112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64696833|NCT02959112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64696834|NCT02959112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64696835|NCT02959112|Analgesics|analgesics|mesh-ancestor
64696836|NCT02959112|Sensory System Agents|sensory system agents|mesh-ancestor
64696837|NCT02959112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64696838|NCT02959112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64696839|NCT02959112|Gout Suppressants|gout suppressants|mesh-ancestor
64696840|NCT02959112|Tocolytic Agents|tocolytic agents|mesh-ancestor
64696841|NCT02959112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64696842|NCT02959112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64696843|NCT02959112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696844|NCT05377034|Bevacizumab|bevacizumab|mesh-list
64696845|NCT05377034|Atezolizumab|atezolizumab|mesh-list
64696846|NCT05377034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64696847|NCT05377034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696848|NCT05377034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64696849|NCT05377034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64696850|NCT05377034|Growth Substances|growth substances|mesh-ancestor
64717988|NCT02369744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64696868|NCT02257632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696869|NCT02257632|Growth Inhibitors|growth inhibitors|mesh-ancestor
64696870|NCT02257632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696886|NCT01642914|Enzyme Activators|enzyme activators|mesh-ancestor
64696887|NCT01642914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696888|NCT01642914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64696890|NCT04497116|Talazoparib|talazoparib|mesh-list
64696891|NCT04497116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64696892|NCT04497116|Antimetabolites|antimetabolites|mesh-ancestor
65458671|NCT01200472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65458672|NCT01200472|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65458673|NCT01200472|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65458674|NCT01200472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458675|NCT01200472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458676|NCT04638790|Dexamethasone|dexamethasone|mesh-list
65458677|NCT04638790|Cyclophosphamide|cyclophosphamide|mesh-list
65458678|NCT04638790|Dacarbazine|dacarbazine|mesh-list
65458679|NCT04638790|Doxorubicin|doxorubicin|mesh-list
65458680|NCT04638790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65458681|NCT04638790|Etoposide|etoposide|mesh-list
65458682|NCT04638790|Vincristine|vincristine|mesh-list
65458683|NCT04638790|Bleomycin|bleomycin|mesh-list
64696893|NCT04497116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696894|NCT04497116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696895|NCT04497116|Antiviral Agents|antiviral agents|mesh-ancestor
64696896|NCT04497116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64696897|NCT04497116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696898|NCT04497116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64696899|NCT04497116|Immunologic Factors|immunologic factors|mesh-ancestor
64696900|NCT04497116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696901|NCT04497116|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64696902|NCT04486352|Bevacizumab|bevacizumab|mesh-list
64696903|NCT04486352|Trastuzumab|trastuzumab|mesh-list
64696904|NCT04486352|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64696905|NCT04486352|Atezolizumab|atezolizumab|mesh-list
64696906|NCT04486352|Letrozole|letrozole|mesh-list
64696907|NCT04486352|Maytansine|maytansine|mesh-list
64696908|NCT04486352|Talazoparib|talazoparib|mesh-list
64696909|NCT04486352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64696910|NCT04486352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64696919|NCT04486352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64696920|NCT04486352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696921|NCT04486352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696922|NCT04486352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64696923|NCT04486352|Hormone Antagonists|hormone antagonists|mesh-ancestor
64696924|NCT04486352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64696925|NCT04486352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64696926|NCT04486352|Tubulin Modulators|tubulin modulators|mesh-ancestor
64696927|NCT04486352|Antimitotic Agents|antimitotic agents|mesh-ancestor
64696928|NCT04486352|Mitosis Modulators|mitosis modulators|mesh-ancestor
64696935|NCT01642602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696936|NCT01642602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696937|NCT02256540|Resveratrol|resveratrol|mesh-list
64696938|NCT02256540|Estradiol|estradiol|mesh-list
64696956|NCT05646264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64696957|NCT05646264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696959|NCT01640184|Vitamins|vitamins|mesh-ancestor
64696960|NCT01640184|Micronutrients|micronutrients|mesh-ancestor
64717989|NCT02369744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64717990|NCT02369744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64717991|NCT02369744|Adrenergic Agents|adrenergic agents|mesh-ancestor
64717992|NCT02369744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64717993|NCT02369744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717994|NCT02369744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717995|NCT02369744|Urological Agents|urological agents|mesh-ancestor
64696961|NCT01640184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696962|NCT01640184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64696964|NCT04904978|Sodium Fluoride|sodium fluoride|mesh-list
64696965|NCT04904978|Cariostatic Agents|cariostatic agents|mesh-ancestor
64696966|NCT04904978|Protective Agents|protective agents|mesh-ancestor
64696967|NCT04904978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696968|NCT04904978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65458684|NCT04638790|Vinblastine|vinblastine|mesh-list
65458685|NCT04638790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65458686|NCT04638790|Immunologic Factors|immunologic factors|mesh-ancestor
65458687|NCT04638790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458688|NCT04638790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65458689|NCT04638790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65458690|NCT04638790|Alkylating Agents|alkylating agents|mesh-ancestor
65458691|NCT04638790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458692|NCT04638790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458693|NCT04638790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65458694|NCT04638790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65458695|NCT04638790|Antiemetics|antiemetics|mesh-ancestor
65458696|NCT04638790|Autonomic Agents|autonomic agents|mesh-ancestor
65458697|NCT04638790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458698|NCT04638790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65458699|NCT04638790|Glucocorticoids|glucocorticoids|mesh-ancestor
65458700|NCT04638790|Hormones|hormones|mesh-ancestor
65458701|NCT04638790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65458702|NCT04638790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65458703|NCT04638790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65458704|NCT04638790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65458705|NCT04638790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65458706|NCT04638790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458707|NCT04638790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65458708|NCT04638790|Tubulin Modulators|tubulin modulators|mesh-ancestor
64843207|NCT01660477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64696969|NCT04904978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64696970|NCT03631433|Acetaminophen|acetaminophen|mesh-list
64696971|NCT03631433|Ibuprofen|ibuprofen|mesh-list
64696972|NCT03631433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64696973|NCT03631433|Analgesics|analgesics|mesh-ancestor
64696974|NCT03631433|Sensory System Agents|sensory system agents|mesh-ancestor
64696975|NCT03631433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64696976|NCT03631433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696977|NCT03631433|Antipyretics|antipyretics|mesh-ancestor
64696978|NCT03631433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64696979|NCT03631433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64696980|NCT03631433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64696981|NCT03631433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64696982|NCT03631433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696983|NCT03631433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696984|NCT02973659|Oxybutynin|oxybutynin|mesh-list
64696985|NCT02973659|Parasympatholytics|parasympatholytics|mesh-ancestor
64696986|NCT02973659|Autonomic Agents|autonomic agents|mesh-ancestor
64696987|NCT02973659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64696988|NCT02973659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696989|NCT02973659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64696990|NCT02973659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65458709|NCT04638790|Antimitotic Agents|antimitotic agents|mesh-ancestor
65458710|NCT04638790|Mitosis Modulators|mitosis modulators|mesh-ancestor
65458711|NCT03249142|Durvalumab|durvalumab|mesh-list
65458712|NCT03249142|Tremelimumab|tremelimumab|mesh-list
65458713|NCT03249142|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65458714|NCT03249142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65458715|NCT03249142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458716|NCT03249142|Immunologic Factors|immunologic factors|mesh-ancestor
65458717|NCT03249142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458718|NCT01200706|Amoxicillin|amoxicillin|mesh-list
65458719|NCT01200706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65458720|NCT01200706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65458721|NCT01200784|Niacinamide|niacinamide|mesh-list
65458722|NCT01200784|Niacin|niacin|mesh-list
65458723|NCT01200784|Nicotinic Acids|nicotinic acids|mesh-list
65458724|NCT01200784|Vitamin B Complex|vitamin b complex|mesh-ancestor
65458725|NCT01200784|Vitamins|vitamins|mesh-ancestor
65458726|NCT01200784|Micronutrients|micronutrients|mesh-ancestor
65458727|NCT01200784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458728|NCT01200784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65458729|NCT01200784|Antimetabolites|antimetabolites|mesh-ancestor
65458730|NCT01200784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458731|NCT01200784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65458732|NCT01200784|Vasodilator Agents|vasodilator agents|mesh-ancestor
65458733|NCT05132920|Dexamethasone|dexamethasone|mesh-list
65458734|NCT05132920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65458735|NCT05132920|Antiemetics|antiemetics|mesh-ancestor
65458736|NCT05132920|Autonomic Agents|autonomic agents|mesh-ancestor
65458737|NCT05132920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458738|NCT05132920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458739|NCT05132920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65458741|NCT05132920|Hormones|hormones|mesh-ancestor
65458754|NCT03841474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65458755|NCT03841474|Antidepressive Agents|antidepressive agents|mesh-ancestor
65458756|NCT03841474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65458757|NCT01198444|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65458758|NCT01198444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65458759|NCT01198444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458760|NCT05670184|Ethanol|ethanol|mesh-list
65458761|NCT05670184|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
65458762|NCT05670184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65458763|NCT05670184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65458764|NCT05670184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65458765|NCT05670184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458766|NCT05670184|Hallucinogens|hallucinogens|mesh-ancestor
65458767|NCT05670184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65458768|NCT05670184|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65458769|NCT05670184|Serotonin Agents|serotonin agents|mesh-ancestor
65458770|NCT05670184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65458771|NCT05670184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458772|NCT05670184|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65458773|NCT05084248|Vitamin D|vitamin d|mesh-list
65458774|NCT05084248|Ergocalciferols|ergocalciferols|mesh-list
65458775|NCT05084248|Vitamins|vitamins|mesh-ancestor
65458776|NCT05084248|Micronutrients|micronutrients|mesh-ancestor
64696991|NCT02973659|Cholinergic Agents|cholinergic agents|mesh-ancestor
64696992|NCT02973659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64696993|NCT02973659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697002|NCT04439396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697003|NCT04439396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64697004|NCT04439396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64697005|NCT04439396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64697006|NCT04439396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697007|NCT04439396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697029|NCT04434092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697030|NCT05651256|Botulinum Toxins|botulinum toxins|mesh-list
64697031|NCT05651256|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64697032|NCT05651256|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64697033|NCT05651256|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64697034|NCT05651256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64697035|NCT05651256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697036|NCT05651256|Cholinergic Agents|cholinergic agents|mesh-ancestor
64697037|NCT05651256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64697038|NCT05651256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697039|NCT05651256|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64697040|NCT05651256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717997|NCT03577171|Antiviral Agents|antiviral agents|mesh-ancestor
64717998|NCT03577171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64717999|NCT02367170|Midazolam|midazolam|mesh-list
64718000|NCT02367170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64718001|NCT02367170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65458777|NCT05084248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458778|NCT05084248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65458779|NCT05084248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65458780|NCT03842800|Ketamine|ketamine|mesh-list
65458781|NCT03842800|Analgesics|analgesics|mesh-ancestor
65458782|NCT03842800|Sensory System Agents|sensory system agents|mesh-ancestor
65458783|NCT03842800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458784|NCT03842800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458785|NCT03842800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65458786|NCT03842800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65458787|NCT03842800|Anesthetics, General|anesthetics, general|mesh-ancestor
65458788|NCT03842800|Anesthetics|anesthetics|mesh-ancestor
65458789|NCT03842800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65458790|NCT03842800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65458791|NCT03842800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64718002|NCT02367170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64326200|NCT02161679|Camptothecin|camptothecin|mesh-list
64697041|NCT04297631|Tobramycin|tobramycin|mesh-list
64697042|NCT04297631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64697043|NCT04297631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64697044|NCT04812470|Melphalan|melphalan|mesh-list
64697045|NCT04812470|Interleukin-2|interleukin-2|mesh-list
64697046|NCT04812470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64697047|NCT04812470|Alkylating Agents|alkylating agents|mesh-ancestor
64697048|NCT04812470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697049|NCT04812470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697050|NCT04812470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64697051|NCT04812470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64697052|NCT04812470|Immunologic Factors|immunologic factors|mesh-ancestor
64697053|NCT04812470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697054|NCT04812470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64697055|NCT04812470|Analgesics|analgesics|mesh-ancestor
64697056|NCT04812470|Sensory System Agents|sensory system agents|mesh-ancestor
64697057|NCT04812470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64697058|NCT02976194|Ranibizumab|ranibizumab|mesh-list
64697059|NCT02976194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64697060|NCT02976194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64697061|NCT02976194|Growth Substances|growth substances|mesh-ancestor
64697085|NCT04714073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64697086|NCT04714073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64697087|NCT04714073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697088|NCT04714073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697089|NCT04714073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64697091|NCT04714073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64697092|NCT04714073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697093|NCT04714073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64697094|NCT04342676|Panitumumab|panitumumab|mesh-list
64697095|NCT04342676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64697106|NCT04398368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64697107|NCT04398368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697108|NCT04398368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64697109|NCT04398368|Immunologic Factors|immunologic factors|mesh-ancestor
64697110|NCT04398368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697111|NCT05364762|Cyclophosphamide|cyclophosphamide|mesh-list
64697112|NCT05364762|Tacrolimus|tacrolimus|mesh-list
64697113|NCT05364762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64697114|NCT05364762|Immunologic Factors|immunologic factors|mesh-ancestor
64843307|NCT01661101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65458792|NCT03842800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65458793|NCT03842800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458794|NCT01202422|Pregabalin|pregabalin|mesh-list
65458795|NCT01202422|Analgesics|analgesics|mesh-ancestor
65458796|NCT01202422|Sensory System Agents|sensory system agents|mesh-ancestor
65458797|NCT01202422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458798|NCT01202422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458799|NCT01202422|Anticonvulsants|anticonvulsants|mesh-ancestor
65458800|NCT01202422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65458801|NCT01202422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65458802|NCT01202422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843308|NCT01661101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64843309|NCT01661101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64843310|NCT01661101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697115|NCT05364762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697131|NCT04342598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64697133|NCT00360854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697134|NCT00360854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64697135|NCT00360854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697136|NCT00360854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697137|NCT04771130|Posaconazole|posaconazole|mesh-list
64697138|NCT04771130|Azacitidine|azacitidine|mesh-list
64697139|NCT04771130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64697140|NCT04771130|Antimetabolites|antimetabolites|mesh-ancestor
64718003|NCT02367170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718004|NCT02367170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64718005|NCT02367170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64718006|NCT02367170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64718007|NCT02367170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64718008|NCT02367170|Anesthetics, General|anesthetics, general|mesh-ancestor
64718009|NCT02367170|Anesthetics|anesthetics|mesh-ancestor
64718010|NCT02367170|GABA Modulators|gaba modulators|mesh-ancestor
64718011|NCT02367170|GABA Agents|gaba agents|mesh-ancestor
64718012|NCT02367170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64718013|NCT02367170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718014|NCT01078844|Memantine|memantine|mesh-list
64718015|NCT01078844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64718016|NCT01078844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64718017|NCT01078844|Dopamine Agents|dopamine agents|mesh-ancestor
64718018|NCT01078844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64718019|NCT01078844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718020|NCT01078844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718021|NCT01078844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64718022|NCT01078844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64326208|NCT02161679|Immunologic Factors|immunologic factors|mesh-ancestor
64697141|NCT04771130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697142|NCT04771130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697143|NCT04771130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697144|NCT04771130|Antifungal Agents|antifungal agents|mesh-ancestor
64697145|NCT04771130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64697146|NCT04771130|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64697147|NCT04771130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64697148|NCT04771130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64697149|NCT04771130|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64697150|NCT04771130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64697151|NCT04771130|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64697152|NCT04771130|Hormone Antagonists|hormone antagonists|mesh-ancestor
65458803|NCT01202422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65458804|NCT01202422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65458805|NCT01202422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65458806|NCT01202422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65458808|NCT03892018|Paclitaxel|paclitaxel|mesh-list
65458809|NCT03892018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65458810|NCT03892018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458811|NCT03892018|Tubulin Modulators|tubulin modulators|mesh-ancestor
65458812|NCT03892018|Antimitotic Agents|antimitotic agents|mesh-ancestor
65458813|NCT03892018|Mitosis Modulators|mitosis modulators|mesh-ancestor
65458814|NCT03892018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458815|NCT01198912|Doxycycline|doxycycline|mesh-list
65458816|NCT01198912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65458817|NCT01198912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64843323|NCT01661257|Infliximab|infliximab|mesh-list
64697153|NCT04771130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64697154|NCT04771130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697155|NCT05641818|Vitamin D|vitamin d|mesh-list
64697156|NCT05641818|Vitamins|vitamins|mesh-ancestor
64697165|NCT04762082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697166|NCT04762082|Urological Agents|urological agents|mesh-ancestor
64697167|NCT03514277|Bupivacaine|bupivacaine|mesh-list
64697168|NCT03514277|Anesthetics, Local|anesthetics, local|mesh-ancestor
64697169|NCT03514277|Anesthetics|anesthetics|mesh-ancestor
64697170|NCT03514277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64697171|NCT03514277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718024|NCT00376051|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64718025|NCT00376051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64718026|NCT00376051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64718027|NCT00376051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718028|NCT00376051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64718029|NCT00376051|Serotonin Agents|serotonin agents|mesh-ancestor
64697172|NCT03514277|Sensory System Agents|sensory system agents|mesh-ancestor
64697173|NCT03514277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64697208|NCT04329494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697209|NCT04329494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64697210|NCT04329494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64697211|NCT04329494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64697212|NCT04329494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697213|NCT04329494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697214|NCT04329494|Antimetabolites|antimetabolites|mesh-ancestor
64697215|NCT04329494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64697216|NCT04329494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64697229|NCT03655301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697230|NCT05625594|Cyclophosphamide|cyclophosphamide|mesh-list
64697231|NCT05625594|Fludarabine|fludarabine|mesh-list
64697232|NCT05625594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64697233|NCT05625594|Immunologic Factors|immunologic factors|mesh-ancestor
64697234|NCT05625594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697235|NCT05625594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64697236|NCT05625594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64697237|NCT05625594|Alkylating Agents|alkylating agents|mesh-ancestor
64697238|NCT05625594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697239|NCT05625594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697240|NCT05625594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64697242|NCT04870866|Niacin|niacin|mesh-list
64697243|NCT04870866|Nicotinic Acids|nicotinic acids|mesh-list
64697244|NCT04870866|Vitamin B Complex|vitamin b complex|mesh-ancestor
65458818|NCT01198912|Antimalarials|antimalarials|mesh-ancestor
65458819|NCT01198912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65458820|NCT01198912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65458821|NCT03842488|Raltegravir Potassium|raltegravir potassium|mesh-list
65458822|NCT03842488|Darunavir|darunavir|mesh-list
65458823|NCT03842488|Cobicistat|cobicistat|mesh-list
65458824|NCT03842488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65458825|NCT03842488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65458826|NCT03842488|Antiviral Agents|antiviral agents|mesh-ancestor
65458827|NCT03842488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65458828|NCT03842488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65458829|NCT03842488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65458830|NCT03842488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458831|NCT03842488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458832|NCT03842488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65458833|NCT03842488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65458834|NCT03842488|Protease Inhibitors|protease inhibitors|mesh-ancestor
65458835|NCT03842488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65458836|NCT03842488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65458837|NCT04256824|Triclosan|triclosan|mesh-list
65458838|NCT04256824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65458839|NCT04256824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65458840|NCT04256824|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65458841|NCT04256824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65458842|NCT04256824|Antimetabolites|antimetabolites|mesh-ancestor
64843333|NCT01661296|Anthelmintics|anthelmintics|mesh-ancestor
64697245|NCT04870866|Vitamins|vitamins|mesh-ancestor
64697246|NCT04870866|Micronutrients|micronutrients|mesh-ancestor
64697247|NCT04870866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697248|NCT04870866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64697249|NCT04870866|Antimetabolites|antimetabolites|mesh-ancestor
64697250|NCT04870866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697251|NCT04870866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64697252|NCT04870866|Vasodilator Agents|vasodilator agents|mesh-ancestor
64697253|NCT03657407|Glycerol|glycerol|mesh-list
64697254|NCT03657407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64697255|NCT03657407|Protective Agents|protective agents|mesh-ancestor
64697256|NCT03657407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697257|NCT01639560|Varenicline|varenicline|mesh-list
64697258|NCT01639560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64697259|NCT01639560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64697260|NCT01639560|Cholinergic Agents|cholinergic agents|mesh-ancestor
64697261|NCT01639560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64697262|NCT01639560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697271|NCT04243616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697272|NCT04243616|Tubulin Modulators|tubulin modulators|mesh-ancestor
64697273|NCT04243616|Antimitotic Agents|antimitotic agents|mesh-ancestor
64697274|NCT04243616|Mitosis Modulators|mitosis modulators|mesh-ancestor
64697275|NCT04243616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697276|NCT04243616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65458843|NCT04256824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458844|NCT04256824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65458845|NCT03842254|Epoetin Alfa|epoetin alfa|mesh-list
65458846|NCT03842254|Hematinics|hematinics|mesh-ancestor
65458847|NCT01201642|Prednisolone|prednisolone|mesh-list
65458848|NCT01201642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65458849|NCT01201642|Glucocorticoids|glucocorticoids|mesh-ancestor
65458850|NCT01201642|Hormones|hormones|mesh-ancestor
65458851|NCT01201642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65458852|NCT01201642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458853|NCT01201642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65458854|NCT01201642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458855|NCT05004064|Rituximab|rituximab|mesh-list
65458856|NCT05004064|Acalabrutinib|acalabrutinib|mesh-list
65458857|NCT05004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65458858|NCT05004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458859|NCT05004064|Immunologic Factors|immunologic factors|mesh-ancestor
65458860|NCT05004064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458861|NCT05004064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65458862|NCT04982692|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65458863|NCT04982692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65458864|NCT04982692|Immunologic Factors|immunologic factors|mesh-ancestor
65458865|NCT04982692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458866|NCT01202734|Methylphenidate|methylphenidate|mesh-list
65458867|NCT01202734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65458868|NCT01202734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458869|NCT01202734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65458870|NCT01202734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65458871|NCT01202734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65458872|NCT01202734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458873|NCT01202734|Dopamine Agents|dopamine agents|mesh-ancestor
65458874|NCT01202734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65458875|NCT03173092|Dexamethasone|dexamethasone|mesh-list
64697277|NCT04243616|Immunologic Factors|immunologic factors|mesh-ancestor
64718030|NCT00376051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718031|NCT00376051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64718032|NCT00376051|Antidepressive Agents|antidepressive agents|mesh-ancestor
64718033|NCT00376051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64697278|NCT04243616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458876|NCT03173092|Lenalidomide|lenalidomide|mesh-list
65458877|NCT03173092|Ixazomib|ixazomib|mesh-list
65458878|NCT03173092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65458879|NCT03173092|Antiemetics|antiemetics|mesh-ancestor
65458880|NCT03173092|Autonomic Agents|autonomic agents|mesh-ancestor
65208334|NCT01067144|Gabapentin|gabapentin|mesh-list
65458881|NCT03173092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458882|NCT03173092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458883|NCT03173092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65458885|NCT03173092|Hormones|hormones|mesh-ancestor
65458886|NCT03173092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65458887|NCT03173092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65458888|NCT03173092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458889|NCT03173092|Immunologic Factors|immunologic factors|mesh-ancestor
65458890|NCT03173092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65458891|NCT03173092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65458892|NCT03173092|Growth Substances|growth substances|mesh-ancestor
65458893|NCT03173092|Growth Inhibitors|growth inhibitors|mesh-ancestor
65458894|NCT03173092|Protease Inhibitors|protease inhibitors|mesh-ancestor
65458895|NCT03173092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458896|NCT03173092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458897|NCT02966314|Omalizumab|omalizumab|mesh-list
65458898|NCT02966314|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65458899|NCT02966314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65458900|NCT02966314|Respiratory System Agents|respiratory system agents|mesh-ancestor
65458901|NCT01203982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65458902|NCT01203982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65458903|NCT01203982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65458904|NCT01203982|Antimetabolites|antimetabolites|mesh-ancestor
65458905|NCT01203982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458906|NCT01203982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64697279|NCT04243616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64697280|NCT04243616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64697281|NCT04243616|Alkylating Agents|alkylating agents|mesh-ancestor
64697282|NCT04243616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64697283|NCT04243616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64697307|NCT04852068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697308|NCT03661541|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
64697309|NCT03661541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64697310|NCT03661541|Immunologic Factors|immunologic factors|mesh-ancestor
64697311|NCT03661541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697313|NCT03925532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64697314|NCT03925532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458907|NCT01203982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65458908|NCT01203982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458909|NCT01202890|Bevacizumab|bevacizumab|mesh-list
65458910|NCT01202890|Lenalidomide|lenalidomide|mesh-list
65458911|NCT01202890|Doxorubicin|doxorubicin|mesh-list
65458912|NCT01202890|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65458913|NCT01202890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65458914|NCT01202890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458915|NCT01202890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65458916|NCT01202890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65458917|NCT01202890|Growth Substances|growth substances|mesh-ancestor
65458918|NCT01202890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458919|NCT01202890|Growth Inhibitors|growth inhibitors|mesh-ancestor
65458920|NCT01202890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65458921|NCT01202890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65458922|NCT01202890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65458923|NCT01202890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458924|NCT01202890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458925|NCT01202890|Immunologic Factors|immunologic factors|mesh-ancestor
65458926|NCT03743428|Bevacizumab|bevacizumab|mesh-list
65458927|NCT03743428|Apatinib|apatinib|mesh-list
65458928|NCT03743428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65458929|NCT03743428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458930|NCT03743428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65458931|NCT03743428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65458932|NCT03743428|Growth Substances|growth substances|mesh-ancestor
65458933|NCT03743428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458934|NCT03743428|Growth Inhibitors|growth inhibitors|mesh-ancestor
64697316|NCT05430828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64697317|NCT05430828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64697318|NCT05430828|Antimetabolites|antimetabolites|mesh-ancestor
64697319|NCT05430828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697320|NCT05430828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64697321|NCT01640964|Terlipressin|terlipressin|mesh-list
64697322|NCT01640964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64697323|NCT01640964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64697324|NCT03663101|Lidocaine|lidocaine|mesh-list
64697325|NCT03663101|Botulinum Toxins|botulinum toxins|mesh-list
64697326|NCT03663101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64697327|NCT03663101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64697328|NCT03663101|Anesthetics, Local|anesthetics, local|mesh-ancestor
64697329|NCT03663101|Anesthetics|anesthetics|mesh-ancestor
64697330|NCT03663101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64697331|NCT03663101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697332|NCT03663101|Sensory System Agents|sensory system agents|mesh-ancestor
64697333|NCT03663101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458935|NCT03743428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65458936|NCT03743428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458937|NCT03743428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458938|NCT01199224|Veliparib|veliparib|mesh-list
65458939|NCT01199224|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65458940|NCT01199224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458941|NCT01199224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458942|NCT01199224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458943|NCT01204138|Apremilast|apremilast|mesh-list
65458944|NCT01204138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65458945|NCT01204138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65458946|NCT01204138|Analgesics|analgesics|mesh-ancestor
65458947|NCT01204138|Sensory System Agents|sensory system agents|mesh-ancestor
65458948|NCT01204138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65458949|NCT01204138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458950|NCT01204138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65458951|NCT01204138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65458952|NCT01204138|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65458953|NCT01204138|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65458954|NCT01204138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843446|NCT01661868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697334|NCT03663101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64697335|NCT03663101|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64697350|NCT05430048|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64697351|NCT05430048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64697352|NCT05430048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64697353|NCT05430048|Adrenergic Agents|adrenergic agents|mesh-ancestor
64697354|NCT05430048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64697355|NCT05430048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697356|NCT05430048|Hemostatics|hemostatics|mesh-ancestor
64697357|NCT05430048|Coagulants|coagulants|mesh-ancestor
64697358|NCT05430048|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64697359|NCT05430048|Natriuretic Agents|natriuretic agents|mesh-ancestor
64697360|NCT02975570|Levofloxacin|levofloxacin|mesh-list
64697361|NCT02975570|Ofloxacin|ofloxacin|mesh-list
64697362|NCT02975570|Linezolid|linezolid|mesh-list
64697363|NCT02975570|Pyrazinamide|pyrazinamide|mesh-list
64697364|NCT02975570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64697373|NCT02975570|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64697374|NCT02975570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64697375|NCT02975570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64697377|NCT04184999|Dexamethasone|dexamethasone|mesh-list
64697378|NCT04184999|Prednisolone|prednisolone|mesh-list
64697379|NCT04184999|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64697380|NCT04184999|Methylprednisolone|methylprednisolone|mesh-list
64718036|NCT01072526|Cyclosporins|cyclosporins|mesh-list
64718037|NCT01072526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718038|NCT01072526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718039|NCT01072526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64718040|NCT01072526|Immunologic Factors|immunologic factors|mesh-ancestor
64718041|NCT01072526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718042|NCT01072526|Antifungal Agents|antifungal agents|mesh-ancestor
65458955|NCT01204138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458956|NCT02927392|Leuprolide|leuprolide|mesh-list
65458957|NCT02927392|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65458958|NCT02927392|Fertility Agents|fertility agents|mesh-ancestor
65458959|NCT02927392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65458960|NCT02927392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458961|NCT02927392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65458962|NCT02927392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458963|NCT01204216|Biotin|biotin|mesh-list
65458964|NCT01204216|Vitamin B Complex|vitamin b complex|mesh-ancestor
65458965|NCT01204216|Vitamins|vitamins|mesh-ancestor
64697381|NCT04184999|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64697382|NCT04184999|Prednisolone acetate|prednisolone acetate|mesh-list
64697383|NCT04184999|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64697384|NCT04184999|Prednisolone phosphate|prednisolone phosphate|mesh-list
64697385|NCT04184999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64697386|NCT04184999|Antiemetics|antiemetics|mesh-ancestor
64697387|NCT04184999|Autonomic Agents|autonomic agents|mesh-ancestor
64697388|NCT04184999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64697389|NCT04184999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697390|NCT04184999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64422681|NCT05443555|Analgesics|analgesics|mesh-ancestor
64697391|NCT04184999|Glucocorticoids|glucocorticoids|mesh-ancestor
64697393|NCT04184999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64697394|NCT04184999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64697395|NCT04184999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697411|NCT03524339|Tamsulosin|tamsulosin|mesh-list
64697412|NCT03524339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64697413|NCT03524339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64697414|NCT03524339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64697415|NCT03524339|Adrenergic Agents|adrenergic agents|mesh-ancestor
64697416|NCT03524339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64697417|NCT03524339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697418|NCT03524339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697419|NCT03524339|Urological Agents|urological agents|mesh-ancestor
64697420|NCT05427474|Propranolol|propranolol|mesh-list
64697421|NCT05427474|Gabapentin|gabapentin|mesh-list
64697422|NCT05427474|Analgesics|analgesics|mesh-ancestor
64697423|NCT05427474|Sensory System Agents|sensory system agents|mesh-ancestor
64697424|NCT05427474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64697425|NCT05427474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697426|NCT05427474|Anticonvulsants|anticonvulsants|mesh-ancestor
64697427|NCT05427474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64697428|NCT05427474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64697429|NCT05427474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64697430|NCT05427474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64697431|NCT05427474|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64697432|NCT05427474|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64697433|NCT05427474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64697434|NCT05427474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697435|NCT05427474|Antimanic Agents|antimanic agents|mesh-ancestor
64697436|NCT05427474|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64697451|NCT00361010|Levetiracetam|levetiracetam|mesh-list
64697452|NCT00361010|Anticonvulsants|anticonvulsants|mesh-ancestor
64697453|NCT00361010|Nootropic Agents|nootropic agents|mesh-ancestor
64718043|NCT01072526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64718044|NCT01072526|Dermatologic Agents|dermatologic agents|mesh-ancestor
64718045|NCT01072526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64718046|NCT01072526|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64718047|NCT01072526|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64718048|NCT01072526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64718049|NCT05312840|Gemcitabine|gemcitabine|mesh-list
64718050|NCT05312840|Carboplatin|carboplatin|mesh-list
64718051|NCT05312840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718052|NCT05312840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65458966|NCT01204216|Micronutrients|micronutrients|mesh-ancestor
65458967|NCT01204216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458968|NCT01204372|Gemcitabine|gemcitabine|mesh-list
65458969|NCT01204372|Trastuzumab|trastuzumab|mesh-list
65458970|NCT01204372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65458971|NCT01204372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65458972|NCT01204372|Antimetabolites|antimetabolites|mesh-ancestor
65458973|NCT01204372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458974|NCT01204372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458975|NCT01204372|Antiviral Agents|antiviral agents|mesh-ancestor
65458976|NCT01204372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65458977|NCT01204372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458978|NCT01204372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65458979|NCT01204372|Immunologic Factors|immunologic factors|mesh-ancestor
65458980|NCT01204372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458981|NCT01204372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65458982|NCT01204372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65458983|NCT01204450|Sirolimus|sirolimus|mesh-list
65458984|NCT01204450|Valproic Acid|valproic acid|mesh-list
65458985|NCT01204450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64843478|NCT01662193|Vitamins|vitamins|mesh-list
64718053|NCT05312840|Antimetabolites|antimetabolites|mesh-ancestor
64697454|NCT00361088|Bortezomib|bortezomib|mesh-list
64697471|NCT04662242|Selenium|selenium|mesh-list
64697472|NCT04662242|Antioxidants|antioxidants|mesh-ancestor
64697473|NCT04662242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697474|NCT04662242|Protective Agents|protective agents|mesh-ancestor
64697475|NCT04662242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697476|NCT04662242|Trace Elements|trace elements|mesh-ancestor
64697477|NCT04662242|Micronutrients|micronutrients|mesh-ancestor
64697478|NCT04848792|Sulforaphane|sulforaphane|mesh-list
64334799|NCT02347839|Gefitinib|gefitinib|mesh-list
64697479|NCT04848792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64697480|NCT04848792|Protective Agents|protective agents|mesh-ancestor
64697481|NCT04848792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697482|NCT04848792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697483|NCT04160546|Aspirin|aspirin|mesh-list
64697484|NCT04160546|Ponatinib|ponatinib|mesh-list
64697485|NCT04160546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64697486|NCT04160546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64697487|NCT04160546|Analgesics|analgesics|mesh-ancestor
64697488|NCT04160546|Sensory System Agents|sensory system agents|mesh-ancestor
64697489|NCT04160546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64697490|NCT04160546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718059|NCT05312840|Immunologic Factors|immunologic factors|mesh-ancestor
64718060|NCT05312840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718061|NCT00376129|Alefacept|alefacept|mesh-list
64718062|NCT00376129|Dermatologic Agents|dermatologic agents|mesh-ancestor
64718063|NCT00376129|Immunologic Factors|immunologic factors|mesh-ancestor
64718064|NCT00376129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718065|NCT01035944|Chitosan|chitosan|mesh-list
64718066|NCT01035944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64718067|NCT01035944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64718068|NCT01035944|Antimetabolites|antimetabolites|mesh-ancestor
64718069|NCT01035944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718070|NCT01035944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64718071|NCT01035944|Chelating Agents|chelating agents|mesh-ancestor
65458986|NCT01204450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65458987|NCT01204450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65458988|NCT01204450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65458989|NCT01204450|Antifungal Agents|antifungal agents|mesh-ancestor
65458990|NCT01204450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65458991|NCT01204450|Immunologic Factors|immunologic factors|mesh-ancestor
65458992|NCT01204450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65458993|NCT01204450|Anticonvulsants|anticonvulsants|mesh-ancestor
65458994|NCT01204450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65458995|NCT01204450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65458996|NCT01204450|GABA Agents|gaba agents|mesh-ancestor
65458997|NCT01204450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65458998|NCT01204450|Antimanic Agents|antimanic agents|mesh-ancestor
65458999|NCT01204450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65459000|NCT01204450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65459001|NCT01204450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64843497|NCT01662466|Methyltestosterone|methyltestosterone|mesh-list
65459002|NCT02605486|Palbociclib|palbociclib|mesh-list
65459003|NCT02605486|Bicalutamide|bicalutamide|mesh-list
65459004|NCT02605486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459005|NCT02605486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65459006|NCT02605486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459007|NCT02605486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459008|NCT02605486|Androgen Antagonists|androgen antagonists|mesh-ancestor
65459009|NCT02605486|Hormone Antagonists|hormone antagonists|mesh-ancestor
65459010|NCT02605486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65459011|NCT02605486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459012|NCT03834454|Bupivacaine|bupivacaine|mesh-list
65459013|NCT03834454|Anesthetics, Local|anesthetics, local|mesh-ancestor
65459014|NCT03834454|Anesthetics|anesthetics|mesh-ancestor
65459015|NCT03834454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65459016|NCT03834454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459017|NCT03834454|Sensory System Agents|sensory system agents|mesh-ancestor
64718072|NCT01035944|Sequestering Agents|sequestering agents|mesh-ancestor
64697495|NCT04160546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697496|NCT04160546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64697497|NCT04160546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64697498|NCT04160546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697499|NCT04160546|Antipyretics|antipyretics|mesh-ancestor
64697500|NCT04160546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697501|NCT04160546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65459018|NCT03834454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65459019|NCT02428270|Trametinib|trametinib|mesh-list
65459020|NCT02428270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459021|NCT02428270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65459022|NCT02428270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459023|NCT02428270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459024|NCT03829930|Entinostat|entinostat|mesh-list
65459025|NCT03829930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459026|NCT03829930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65459027|NCT03829930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459028|NCT03829930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208478|NCT02836509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65459029|NCT01203202|Clomipramine|clomipramine|mesh-list
65459030|NCT01203202|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65459031|NCT01203202|Antidepressive Agents|antidepressive agents|mesh-ancestor
65459032|NCT01203202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65459033|NCT01203202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65459034|NCT01203202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64697502|NCT03675581|Nintedanib|nintedanib|mesh-list
64697503|NCT03675581|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64697504|NCT03675581|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
64697505|NCT03675581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697506|NCT03675581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64697507|NCT03675581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697508|NCT03675581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697509|NCT03675581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64697510|NCT03675581|Contraceptive Agents|contraceptive agents|mesh-ancestor
64697511|NCT03675581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64697512|NCT03675581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697513|NCT03675581|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64697523|NCT05142228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697524|NCT05142228|Analgesics|analgesics|mesh-ancestor
64697525|NCT05142228|Sensory System Agents|sensory system agents|mesh-ancestor
64697526|NCT05142228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64697527|NCT05142228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697528|NCT00362102|Cetuximab|cetuximab|mesh-list
64697529|NCT00362102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64697530|NCT00362102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697531|NCT05122026|Isoniazid|isoniazid|mesh-list
64697532|NCT05122026|Rifapentine|rifapentine|mesh-list
64697533|NCT05122026|Antitubercular Agents|antitubercular agents|mesh-ancestor
64697534|NCT05122026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64697535|NCT05122026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64697536|NCT05122026|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64697537|NCT05122026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64697538|NCT05122026|Antimetabolites|antimetabolites|mesh-ancestor
64718073|NCT01035944|Hemostatics|hemostatics|mesh-ancestor
64718074|NCT01035944|Coagulants|coagulants|mesh-ancestor
64718075|NCT00378638|Bevacizumab|bevacizumab|mesh-list
64718076|NCT00378638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64718077|NCT00378638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718078|NCT00378638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64718079|NCT00378638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64718080|NCT00378638|Growth Substances|growth substances|mesh-ancestor
65459035|NCT01203202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65459036|NCT01203202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459037|NCT01203202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65459038|NCT01203202|Serotonin Agents|serotonin agents|mesh-ancestor
65459039|NCT01203202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459040|NCT02047474|Leucovorin|leucovorin|mesh-list
65459041|NCT02047474|Fluorouracil|fluorouracil|mesh-list
65459042|NCT02047474|Oxaliplatin|oxaliplatin|mesh-list
65459043|NCT02047474|Irinotecan|irinotecan|mesh-list
65459044|NCT02047474|Calcium|calcium|mesh-list
65459045|NCT02047474|Levoleucovorin|levoleucovorin|mesh-list
65459046|NCT02047474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65459047|NCT02047474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459048|NCT02047474|Antimetabolites|antimetabolites|mesh-ancestor
65459049|NCT02047474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459050|NCT02047474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65459051|NCT02047474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459052|NCT02047474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65459053|NCT02047474|Immunologic Factors|immunologic factors|mesh-ancestor
65459054|NCT02047474|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65459055|NCT02047474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65459056|NCT02047474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459057|NCT02047474|Antidotes|antidotes|mesh-ancestor
65459058|NCT02047474|Protective Agents|protective agents|mesh-ancestor
65459059|NCT02047474|Vitamin B Complex|vitamin b complex|mesh-ancestor
65459060|NCT02047474|Vitamins|vitamins|mesh-ancestor
65459061|NCT02047474|Micronutrients|micronutrients|mesh-ancestor
64718081|NCT00378638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697539|NCT05122026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697541|NCT05122026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64697543|NCT02958878|Tamsulosin|tamsulosin|mesh-list
64697544|NCT02958878|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64697545|NCT02958878|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64697546|NCT02958878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64697547|NCT02958878|Adrenergic Agents|adrenergic agents|mesh-ancestor
64697548|NCT02958878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64697549|NCT02958878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697550|NCT02958878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697551|NCT02958878|Urological Agents|urological agents|mesh-ancestor
64697552|NCT02976116|Gefitinib|gefitinib|mesh-list
64697553|NCT02976116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697554|NCT02976116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64697555|NCT02976116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718102|NCT04331834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718103|NCT04331834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64718105|NCT01023620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64718106|NCT01023620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718107|NCT03595579|Bupropion|bupropion|mesh-list
65459062|NCT01298284|Propranolol|propranolol|mesh-list
65459063|NCT01298284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65459064|NCT01298284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65459065|NCT01298284|Adrenergic Agents|adrenergic agents|mesh-ancestor
65459066|NCT01298284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65459067|NCT01298284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459068|NCT01298284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459069|NCT01298284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65459070|NCT01298284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65459071|NCT01298284|Vasodilator Agents|vasodilator agents|mesh-ancestor
65459072|NCT01204840|Hormones|hormones|mesh-list
65459073|NCT01204840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65459074|NCT01204840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459075|NCT01203358|Beractant|beractant|mesh-list
65459076|NCT01203358|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
65459077|NCT01203358|Respiratory System Agents|respiratory system agents|mesh-ancestor
65459078|NCT05669560|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65459079|NCT05669560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65459080|NCT05669560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65459081|NCT03832426|Ritonavir|ritonavir|mesh-list
65459082|NCT03832426|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65459083|NCT03832426|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65459084|NCT03832426|Protease Inhibitors|protease inhibitors|mesh-ancestor
65459085|NCT03832426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718108|NCT03595579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64718109|NCT03595579|Antidepressive Agents|antidepressive agents|mesh-ancestor
64718110|NCT03595579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64697556|NCT02976116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697557|NCT01600716|Botulinum Toxins|botulinum toxins|mesh-list
64697558|NCT01600716|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64697559|NCT01600716|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64697560|NCT01600716|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64697561|NCT01600716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64697562|NCT01600716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697563|NCT01600716|Cholinergic Agents|cholinergic agents|mesh-ancestor
64334804|NCT02289547|Capecitabine|capecitabine|mesh-list
64697573|NCT02975258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697574|NCT02975258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64697575|NCT02975258|Respiratory System Agents|respiratory system agents|mesh-ancestor
64697576|NCT02975258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64697609|NCT04833114|Rituximab|rituximab|mesh-list
64697610|NCT04833114|Ifosfamide|ifosfamide|mesh-list
64697611|NCT04833114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697612|NCT04833114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64697613|NCT04833114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64697614|NCT04833114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64697615|NCT04833114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697616|NCT04833114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459086|NCT03832426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459087|NCT03832426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65459088|NCT03832426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65459089|NCT03832426|Antiviral Agents|antiviral agents|mesh-ancestor
65459090|NCT03832426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65459091|NCT03832426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65459092|NCT03832426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65459093|NCT03840070|Hyaluronic Acid|hyaluronic acid|mesh-list
65459094|NCT03840070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65459095|NCT03840070|Immunologic Factors|immunologic factors|mesh-ancestor
65459096|NCT03840070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459097|NCT03840070|Viscosupplements|viscosupplements|mesh-ancestor
65459098|NCT03840070|Protective Agents|protective agents|mesh-ancestor
65459099|NCT03272698|Ketamine|ketamine|mesh-list
65459100|NCT03272698|Analgesics|analgesics|mesh-ancestor
65459101|NCT03272698|Sensory System Agents|sensory system agents|mesh-ancestor
65459102|NCT03272698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65459103|NCT03272698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843583|NCT01662869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64697617|NCT04833114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64697618|NCT04833114|Immunologic Factors|immunologic factors|mesh-ancestor
64697619|NCT04833114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697649|NCT03785210|Vasodilator Agents|vasodilator agents|mesh-ancestor
64697650|NCT03785210|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64697651|NCT03785210|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64697652|NCT03785210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697653|NCT03785210|Urological Agents|urological agents|mesh-ancestor
64697654|NCT04098575|Empagliflozin|empagliflozin|mesh-list
64697655|NCT04098575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64697656|NCT04098575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697657|NCT04098575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64697658|NCT04098575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697659|NCT03776240|Trastuzumab|trastuzumab|mesh-list
64697660|NCT03776240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64697661|NCT03776240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697662|NCT04832100|Pregabalin|pregabalin|mesh-list
64697663|NCT04832100|Imipramine|imipramine|mesh-list
64697664|NCT04832100|Analgesics|analgesics|mesh-ancestor
64697665|NCT04832100|Sensory System Agents|sensory system agents|mesh-ancestor
64697687|NCT00361790|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64697688|NCT00361790|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64697689|NCT00361790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64697690|NCT00361790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697691|NCT00361790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64718111|NCT03595579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64718112|NCT03595579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64718113|NCT03595579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64718114|NCT03595579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718115|NCT03595579|Dopamine Agents|dopamine agents|mesh-ancestor
64718116|NCT03595579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64718117|NCT03595579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697692|NCT00361790|Serotonin Agents|serotonin agents|mesh-ancestor
64697693|NCT00361790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459104|NCT03272698|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65459105|NCT03272698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65459106|NCT03272698|Anesthetics, General|anesthetics, general|mesh-ancestor
65459107|NCT03272698|Anesthetics|anesthetics|mesh-ancestor
65459108|NCT03272698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65459109|NCT03272698|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65459110|NCT03272698|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65459111|NCT03272698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65459112|NCT03272698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459113|NCT01203514|Epoetin Alfa|epoetin alfa|mesh-list
65459114|NCT01203514|Hematinics|hematinics|mesh-ancestor
65459115|NCT01204996|Gemcitabine|gemcitabine|mesh-list
65459116|NCT01204996|Paclitaxel|paclitaxel|mesh-list
65459117|NCT01204996|Docetaxel|docetaxel|mesh-list
65459118|NCT01204996|Carboplatin|carboplatin|mesh-list
65459119|NCT01204996|Doxorubicin|doxorubicin|mesh-list
64697694|NCT00361790|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64697695|NCT00361790|Antidepressive Agents|antidepressive agents|mesh-ancestor
64697696|NCT00361790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64697697|NCT00361790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64697698|NCT00361790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64697699|NCT00361790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64697700|NCT00361790|Dopamine Agonists|dopamine agonists|mesh-ancestor
64697701|NCT00361790|Dopamine Agents|dopamine agents|mesh-ancestor
64697709|NCT04570332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64697710|NCT04570332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697711|NCT00361868|Metformin|metformin|mesh-list
64697712|NCT00361868|Rosiglitazone|rosiglitazone|mesh-list
64697713|NCT00361868|Fenofibrate|fenofibrate|mesh-list
64697714|NCT00361868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64697719|NCT00361868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64697720|NCT04564872|Linagliptin|linagliptin|mesh-list
64697721|NCT04564872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64697722|NCT04564872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697723|NCT04564872|Incretins|incretins|mesh-ancestor
64697725|NCT04564872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64697726|NCT04564872|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64697727|NCT04564872|Protease Inhibitors|protease inhibitors|mesh-ancestor
64697728|NCT04564872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697729|NCT04564872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697730|NCT04343144|Nivolumab|nivolumab|mesh-list
64697731|NCT04343144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64697732|NCT04343144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697733|NCT04343144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64697734|NCT04343144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697735|NCT03743246|Cyclophosphamide|cyclophosphamide|mesh-list
64697736|NCT03743246|Fludarabine|fludarabine|mesh-list
64697737|NCT03743246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64697738|NCT03743246|Immunologic Factors|immunologic factors|mesh-ancestor
64697739|NCT03743246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697740|NCT03743246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64697741|NCT03743246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64697742|NCT03743246|Alkylating Agents|alkylating agents|mesh-ancestor
64697743|NCT03743246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697744|NCT03743246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697745|NCT03743246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64697746|NCT03703778|Ascorbic Acid|ascorbic acid|mesh-list
64697747|NCT03703778|Methyltestosterone|methyltestosterone|mesh-list
64697748|NCT03703778|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64697749|NCT03703778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65459120|NCT01204996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65459121|NCT01204996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65459122|NCT01204996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459123|NCT01204996|Tubulin Modulators|tubulin modulators|mesh-ancestor
65459124|NCT01204996|Antimitotic Agents|antimitotic agents|mesh-ancestor
65459125|NCT01204996|Mitosis Modulators|mitosis modulators|mesh-ancestor
65459126|NCT01204996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459127|NCT01204996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65459128|NCT01204996|Antimetabolites|antimetabolites|mesh-ancestor
65459129|NCT01204996|Antiviral Agents|antiviral agents|mesh-ancestor
65459130|NCT01204996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65459131|NCT01204996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459132|NCT01204996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65459133|NCT01204996|Immunologic Factors|immunologic factors|mesh-ancestor
65459134|NCT01204996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459135|NCT01204996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65459177|NCT03722524|Amlodipine|amlodipine|mesh-list
65459178|NCT03722524|Perindopril|perindopril|mesh-list
65459179|NCT03722524|Indapamide|indapamide|mesh-list
65208623|NCT02833701|Immunoglobulin G|immunoglobulin g|mesh-list
65459180|NCT03722524|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
65459181|NCT03722524|Diuretics|diuretics|mesh-list
65459182|NCT03722524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65459183|NCT03722524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65459184|NCT03722524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65459185|NCT03722524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65459186|NCT03722524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459187|NCT03722524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65459188|NCT03722524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459189|NCT03722524|Vasodilator Agents|vasodilator agents|mesh-ancestor
65459190|NCT03722524|Natriuretic Agents|natriuretic agents|mesh-ancestor
65459191|NCT03722524|Protease Inhibitors|protease inhibitors|mesh-ancestor
65459192|NCT03722524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459193|NCT03722524|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65459194|NCT05667220|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65459195|NCT05667220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65459196|NCT05667220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697750|NCT03703778|Androgens|androgens|mesh-list
64697752|NCT03703778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64697753|NCT03703778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697754|NCT03703778|Antioxidants|antioxidants|mesh-ancestor
64718118|NCT03595579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64718119|NCT03595579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64718120|NCT03595579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718121|NCT02200328|Metronidazole|metronidazole|mesh-list
64718122|NCT02200328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64326289|NCT04030455|Cisplatin|cisplatin|mesh-list
64697755|NCT03703778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697756|NCT03703778|Protective Agents|protective agents|mesh-ancestor
64697757|NCT03703778|Vitamins|vitamins|mesh-ancestor
64697758|NCT03703778|Micronutrients|micronutrients|mesh-ancestor
64697759|NCT03703778|Estrogens|estrogens|mesh-ancestor
64697760|NCT03703778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64697761|NCT03703778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697762|NCT03703778|Anabolic Agents|anabolic agents|mesh-ancestor
64697763|NCT05346666|Midazolam|midazolam|mesh-list
64697764|NCT05346666|Phenobarbital|phenobarbital|mesh-list
64697765|NCT05346666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64697766|NCT05346666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64697767|NCT05346666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64334813|NCT02232971|Hormones|hormones|mesh-ancestor
64697775|NCT05346666|GABA Modulators|gaba modulators|mesh-ancestor
64697776|NCT05346666|GABA Agents|gaba agents|mesh-ancestor
64697777|NCT05346666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64697778|NCT05346666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697779|NCT05346666|Anticonvulsants|anticonvulsants|mesh-ancestor
64697780|NCT05346666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64697781|NCT05346666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64697782|NCT05346666|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65459197|NCT05667220|Incretins|incretins|mesh-ancestor
65459198|NCT05667220|Hormones|hormones|mesh-ancestor
65459199|NCT05667220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65459200|NCT05667220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65459201|NCT05667220|Protease Inhibitors|protease inhibitors|mesh-ancestor
65459202|NCT05667220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459203|NCT05667220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459204|NCT01203592|Albuterol|albuterol|mesh-list
65459205|NCT01203592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65459206|NCT01203592|Autonomic Agents|autonomic agents|mesh-ancestor
65459207|NCT01203592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65459208|NCT01203592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459209|NCT01203592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65459210|NCT01203592|Respiratory System Agents|respiratory system agents|mesh-ancestor
65459211|NCT01203592|Tocolytic Agents|tocolytic agents|mesh-ancestor
64697783|NCT05346666|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64697784|NCT05346666|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64697797|NCT00361166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697798|NCT03674294|Dexamethasone|dexamethasone|mesh-list
64697799|NCT03674294|Aprepitant|aprepitant|mesh-list
64697800|NCT03674294|Palonosetron|palonosetron|mesh-list
64697801|NCT03674294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64697802|NCT03674294|Antiemetics|antiemetics|mesh-ancestor
64697803|NCT03674294|Autonomic Agents|autonomic agents|mesh-ancestor
64697804|NCT03674294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64697805|NCT03674294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697806|NCT03674294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64697807|NCT03674294|Glucocorticoids|glucocorticoids|mesh-ancestor
64697808|NCT03674294|Hormones|hormones|mesh-ancestor
64697809|NCT03674294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64697810|NCT03674294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64697811|NCT03674294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697812|NCT03674294|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64697813|NCT03674294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64697814|NCT03674294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697815|NCT03674294|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64697816|NCT03674294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64697817|NCT03674294|Serotonin Agents|serotonin agents|mesh-ancestor
64697818|NCT00377273|Fluorouracil|fluorouracil|mesh-list
64697819|NCT00377273|Antimetabolites|antimetabolites|mesh-ancestor
64697820|NCT00377273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697821|NCT00377273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64697822|NCT00377273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697823|NCT00377273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64697824|NCT00377273|Immunologic Factors|immunologic factors|mesh-ancestor
64697825|NCT00377273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697826|NCT03706313|Bupivacaine|bupivacaine|mesh-list
64697827|NCT03706313|Anesthetics, Local|anesthetics, local|mesh-ancestor
64697828|NCT03706313|Anesthetics|anesthetics|mesh-ancestor
64697829|NCT03706313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64718123|NCT02200328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64718124|NCT02200328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64718125|NCT02200328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64718127|NCT04327843|Haloperidol decanoate|haloperidol decanoate|mesh-list
64334821|NCT02296333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64718129|NCT04327843|Autonomic Agents|autonomic agents|mesh-ancestor
64718130|NCT04327843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64718131|NCT04327843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459212|NCT01203592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65459213|NCT01203592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65459214|NCT01203592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65459215|NCT01203592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65459216|NCT01203592|Adrenergic Agents|adrenergic agents|mesh-ancestor
65459217|NCT01203592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65459218|NCT01203592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459219|NCT05281276|Celecoxib|celecoxib|mesh-list
65459220|NCT05281276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65459221|NCT05281276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65459222|NCT05281276|Analgesics|analgesics|mesh-ancestor
64718132|NCT04327843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64718133|NCT04327843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64697830|NCT03706313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697831|NCT03706313|Sensory System Agents|sensory system agents|mesh-ancestor
64697832|NCT03706313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64697833|NCT05369364|Dexamethasone|dexamethasone|mesh-list
64697834|NCT05369364|Zanubrutinib|zanubrutinib|mesh-list
64697845|NCT05369364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697846|NCT05369364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64697847|NCT05369364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697868|NCT03390686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697869|NCT03390686|Tubulin Modulators|tubulin modulators|mesh-ancestor
64697870|NCT03390686|Antimitotic Agents|antimitotic agents|mesh-ancestor
64697871|NCT03390686|Mitosis Modulators|mitosis modulators|mesh-ancestor
64697872|NCT03390686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697873|NCT03390686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64697874|NCT03390686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64697875|NCT03390686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64697876|NCT03390686|Growth Substances|growth substances|mesh-ancestor
64697877|NCT03390686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697878|NCT03390686|Growth Inhibitors|growth inhibitors|mesh-ancestor
64697879|NCT03381482|Anesthetics|anesthetics|mesh-list
64697880|NCT03381482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64697881|NCT03381482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697882|NCT03545165|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64697883|NCT03545165|177Lu-PSMA-617|177lu-psma-617|mesh-list
64697884|NCT03545165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64697885|NCT03545165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697886|NCT04968522|Methylphenidate|methylphenidate|mesh-list
64697887|NCT04968522|Dextroamphetamine|dextroamphetamine|mesh-list
64697888|NCT04968522|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64697889|NCT04968522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697890|NCT04968522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64697891|NCT04968522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64697892|NCT04968522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64697893|NCT04968522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697894|NCT04968522|Dopamine Agents|dopamine agents|mesh-ancestor
64697895|NCT04968522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64697896|NCT00361322|Clindamycin|clindamycin|mesh-list
64697897|NCT00361322|Clindamycin palmitate|clindamycin palmitate|mesh-list
64697899|NCT00361322|Salicylic Acid|salicylic acid|mesh-list
64697900|NCT00361322|Salicylates|salicylates|mesh-list
64697901|NCT00361322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64697902|NCT00361322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64697919|NCT02974712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64697920|NCT02974712|Narcotics|narcotics|mesh-ancestor
64697921|NCT02974712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64718134|NCT04327843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64718135|NCT04327843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64718136|NCT04327843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64718137|NCT04327843|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64718138|NCT04327843|Dopamine Agents|dopamine agents|mesh-ancestor
65459223|NCT05281276|Sensory System Agents|sensory system agents|mesh-ancestor
65459224|NCT05281276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65459225|NCT05281276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459226|NCT05281276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65459227|NCT05281276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65459228|NCT05281276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65459229|NCT05281276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65459230|NCT05281276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459231|NCT05281276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459232|NCT03829150|Amoxicillin|amoxicillin|mesh-list
65459233|NCT03829150|Metronidazole|metronidazole|mesh-list
65459234|NCT03829150|Clarithromycin|clarithromycin|mesh-list
65459235|NCT03829150|Dexlansoprazole|dexlansoprazole|mesh-list
65459236|NCT03829150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65459237|NCT03829150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65459238|NCT03829150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65459239|NCT03829150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65459240|NCT03829150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65459241|NCT03829150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459242|NCT03829150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459243|NCT03829150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65459244|NCT03829150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64843723|NCT01664650|Phytoestrogens|phytoestrogens|mesh-ancestor
64718139|NCT04327843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64718140|NCT04327843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718141|NCT04327843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64697922|NCT02974712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697923|NCT02974712|Analgesics|analgesics|mesh-ancestor
64697924|NCT02974712|Sensory System Agents|sensory system agents|mesh-ancestor
64697925|NCT02974712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64697926|NCT02974712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64334828|NCT02296333|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64334833|NCT03149913|Paclitaxel|paclitaxel|mesh-list
64697946|NCT03557333|Analgesics|analgesics|mesh-ancestor
64697947|NCT03557333|Sensory System Agents|sensory system agents|mesh-ancestor
64697948|NCT03557333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64697949|NCT04527380|Adalimumab|adalimumab|mesh-list
64697950|NCT04527380|Ixekizumab|ixekizumab|mesh-list
64697951|NCT04527380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64697952|NCT04527380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64697953|NCT04527380|Dermatologic Agents|dermatologic agents|mesh-ancestor
64697954|NCT04957368|Midazolam|midazolam|mesh-list
64697955|NCT04957368|Nitrous Oxide|nitrous oxide|mesh-list
64697956|NCT04957368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64697957|NCT04957368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64697958|NCT04957368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64697959|NCT04957368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697975|NCT04818450|Gabapentin|gabapentin|mesh-list
64697976|NCT04818450|Analgesics|analgesics|mesh-ancestor
64697977|NCT04818450|Sensory System Agents|sensory system agents|mesh-ancestor
64697978|NCT04818450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64697979|NCT04818450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459245|NCT03829150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65459246|NCT03829150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65459247|NCT03829150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65459248|NCT01205464|Doxycycline|doxycycline|mesh-list
65459249|NCT01205464|Tetracycline|tetracycline|mesh-list
65459250|NCT01205464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65459251|NCT01205464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65208700|NCT02835183|Insulin|insulin|mesh-list
65459252|NCT01205464|Antimalarials|antimalarials|mesh-ancestor
65459253|NCT01205464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65459254|NCT01205464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65459255|NCT01205464|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65459256|NCT01205464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697980|NCT04818450|Anticonvulsants|anticonvulsants|mesh-ancestor
64697981|NCT04818450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64697982|NCT04818450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64697983|NCT04818450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64697984|NCT04818450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64697985|NCT04818450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64697986|NCT04818450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64697987|NCT04818450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64697988|NCT04818450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697989|NCT04818450|Antimanic Agents|antimanic agents|mesh-ancestor
64697990|NCT04841148|Hydroxychloroquine|hydroxychloroquine|mesh-list
64697991|NCT04841148|Palbociclib|palbociclib|mesh-list
64697992|NCT04841148|Avelumab|avelumab|mesh-list
64697993|NCT04841148|Antimalarials|antimalarials|mesh-ancestor
64697994|NCT04841148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64697995|NCT04841148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64697996|NCT04841148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64697997|NCT04841148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334838|NCT03149913|Mitosis Modulators|mitosis modulators|mesh-ancestor
64334840|NCT02289703|Rivaroxaban|rivaroxaban|mesh-list
64698007|NCT04830462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64698008|NCT04830462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64698009|NCT04830462|Leprostatic Agents|leprostatic agents|mesh-ancestor
64698010|NCT04830462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64698011|NCT04830462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698012|NCT04830462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698013|NCT04830462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64698014|NCT04830462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64698015|NCT04830462|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64698016|NCT04830462|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64698017|NCT04830462|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64698018|NCT04830462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64698043|NCT05289804|Sensory System Agents|sensory system agents|mesh-ancestor
64698044|NCT05289804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64698045|NCT05289804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64698046|NCT05289804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64698047|NCT05289804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64698048|NCT05289804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64698049|NCT05289804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698050|NCT05289804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64698052|NCT05448872|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64698053|NCT05448872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64698054|NCT05448872|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64698055|NCT05448872|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64698056|NCT05448872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698058|NCT04817826|Tremelimumab|tremelimumab|mesh-list
64698059|NCT04817826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64698060|NCT04817826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459257|NCT01205464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459258|NCT03828838|177Lu-PSMA-617|177lu-psma-617|mesh-list
65459259|NCT03828838|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65459260|NCT03828838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459261|NCT03819010|Letrozole|letrozole|mesh-list
65459262|NCT03819010|Palbociclib|palbociclib|mesh-list
65459263|NCT03819010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459264|NCT03819010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65459265|NCT03819010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65459266|NCT03819010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459267|NCT03819010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459268|NCT03819010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64698061|NCT00362258|Irbesartan|irbesartan|mesh-list
64698062|NCT00362258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64698063|NCT00362258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64698064|NCT00362258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64698065|NCT00362258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698066|NCT00362726|Rosiglitazone|rosiglitazone|mesh-list
64698067|NCT00362726|Ritonavir|ritonavir|mesh-list
64698068|NCT00362726|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64698069|NCT00362726|Maleic acid|maleic acid|mesh-list
64698070|NCT00362726|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64698071|NCT00362726|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64698072|NCT00362726|Protease Inhibitors|protease inhibitors|mesh-ancestor
64698073|NCT00362726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698074|NCT00362726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698075|NCT00362726|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64698076|NCT00362726|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64698077|NCT00362726|Antiviral Agents|antiviral agents|mesh-ancestor
64698078|NCT00362726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64698079|NCT00362726|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64698080|NCT00362726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64698081|NCT00362726|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64698082|NCT00362726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698083|NCT04474470|Cetuximab|cetuximab|mesh-list
64698084|NCT04474470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64698111|NCT03829488|Plasma-lyte 148|plasma-lyte 148|mesh-list
64698112|NCT03829488|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64698113|NCT03829488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64698114|NCT05369052|Linezolid|linezolid|mesh-list
64698115|NCT05369052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64698116|NCT05369052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64698117|NCT05369052|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64698118|NCT05369052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698119|NCT05369052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698120|NCT04049123|Insulin Lispro|insulin lispro|mesh-list
64698121|NCT04049123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64698122|NCT04049123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698123|NCT04051463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64698124|NCT04051463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64698125|NCT04184297|Tiotropium Bromide|tiotropium bromide|mesh-list
64698126|NCT04184297|Olodaterol|olodaterol|mesh-list
64698127|NCT04184297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64698128|NCT04184297|Autonomic Agents|autonomic agents|mesh-ancestor
64698129|NCT04184297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64698130|NCT04184297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698131|NCT04184297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64698132|NCT04184297|Respiratory System Agents|respiratory system agents|mesh-ancestor
64698133|NCT04184297|Parasympatholytics|parasympatholytics|mesh-ancestor
64698134|NCT04184297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64698135|NCT04184297|Cholinergic Agents|cholinergic agents|mesh-ancestor
64698136|NCT04184297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65459269|NCT03819010|Hormone Antagonists|hormone antagonists|mesh-ancestor
65459270|NCT03819010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65459271|NCT03819010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459272|NCT03819010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65459273|NCT03818932|Acetaminophen|acetaminophen|mesh-list
65459274|NCT03818932|Celecoxib|celecoxib|mesh-list
65459275|NCT03818932|Ketorolac|ketorolac|mesh-list
65459276|NCT03818932|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65459277|NCT03818932|Diazepam|diazepam|mesh-list
64698137|NCT04184297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698139|NCT04031885|Docetaxel|docetaxel|mesh-list
64698140|NCT04031885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64698141|NCT04031885|Capecitabine|capecitabine|mesh-list
64698142|NCT04031885|Fulvestrant|fulvestrant|mesh-list
64698143|NCT04031885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64698165|NCT01638000|Urological Agents|urological agents|mesh-ancestor
64698166|NCT01638000|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64698167|NCT01638000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64698168|NCT01638000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64698169|NCT01638000|Adrenergic Agents|adrenergic agents|mesh-ancestor
64698170|NCT04023695|Lidocaine|lidocaine|mesh-list
64698171|NCT04023695|Epinephrine|epinephrine|mesh-list
64698172|NCT04023695|Anesthetics, Local|anesthetics, local|mesh-ancestor
64698173|NCT04023695|Anesthetics|anesthetics|mesh-ancestor
64698174|NCT04023695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64698175|NCT04023695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698176|NCT04023695|Sensory System Agents|sensory system agents|mesh-ancestor
64698177|NCT04023695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64698178|NCT04023695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64698179|NCT04023695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64698180|NCT04023695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64698181|NCT04023695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64698182|NCT04023695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698183|NCT04023695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64698184|NCT04023695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64698185|NCT04023695|Adrenergic Agents|adrenergic agents|mesh-ancestor
64698186|NCT04023695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64334864|NCT02232347|Narcotics|narcotics|mesh-ancestor
64698210|NCT04223843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64698211|NCT04223843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698213|NCT05722951|Levetiracetam|levetiracetam|mesh-list
64698214|NCT05722951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64698215|NCT05722951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698216|NCT05722951|Anticonvulsants|anticonvulsants|mesh-ancestor
64698217|NCT05722951|Nootropic Agents|nootropic agents|mesh-ancestor
64698218|NCT04838652|Pembrolizumab|pembrolizumab|mesh-list
64698219|NCT04838652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64698220|NCT04838652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698221|NCT05722795|Imatinib Mesylate|imatinib mesylate|mesh-list
64698222|NCT05722795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698223|NCT05722795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64698224|NCT05722795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698225|NCT05722795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698226|NCT03778554|Metoprolol|metoprolol|mesh-list
64698227|NCT03778554|Carvedilol|carvedilol|mesh-list
64698228|NCT03778554|Nebivolol|nebivolol|mesh-list
64698229|NCT03778554|Bisoprolol|bisoprolol|mesh-list
64698230|NCT03778554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64698231|NCT03778554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64698232|NCT03778554|Sympatholytics|sympatholytics|mesh-ancestor
64698233|NCT03778554|Autonomic Agents|autonomic agents|mesh-ancestor
64698234|NCT03778554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64698235|NCT03778554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698236|NCT03778554|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64698237|NCT03778554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64698238|NCT03778554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65459278|NCT03818932|Gabapentin|gabapentin|mesh-list
65459279|NCT03818932|Hydrocodone|hydrocodone|mesh-list
65459280|NCT03818932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65459281|NCT03818932|Analgesics|analgesics|mesh-ancestor
65459282|NCT03818932|Sensory System Agents|sensory system agents|mesh-ancestor
65459283|NCT03818932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65459284|NCT03818932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459285|NCT03818932|Antipyretics|antipyretics|mesh-ancestor
65459286|NCT03818932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65459287|NCT03818932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65459288|NCT03818932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65459289|NCT03818932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65459290|NCT03818932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65459291|NCT03818932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459292|NCT03818932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459293|NCT03818932|Anticonvulsants|anticonvulsants|mesh-ancestor
65459294|NCT03818932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65459295|NCT03818932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65459296|NCT03818932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65459297|NCT03818932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65459298|NCT03818932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65459299|NCT03818932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65459300|NCT03818932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65459301|NCT03818932|Antimanic Agents|antimanic agents|mesh-ancestor
65459302|NCT03818932|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65459303|NCT03818932|Narcotics|narcotics|mesh-ancestor
64698239|NCT03778554|Adrenergic Agents|adrenergic agents|mesh-ancestor
64698240|NCT03778554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64698241|NCT03778554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698242|NCT03778554|Antioxidants|antioxidants|mesh-ancestor
64698243|NCT03778554|Protective Agents|protective agents|mesh-ancestor
64698244|NCT03778554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64698245|NCT03778554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64698246|NCT03778554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64698247|NCT03778554|Vasodilator Agents|vasodilator agents|mesh-ancestor
64698248|NCT03778554|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64698249|NCT03778554|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64698250|NCT03778554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64698251|NCT03778554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64698259|NCT04810494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64698260|NCT04810494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64698287|NCT05722405|Immunologic Factors|immunologic factors|mesh-ancestor
64698288|NCT05722405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698289|NCT05722405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64698290|NCT05722405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64698291|NCT05722405|Growth Substances|growth substances|mesh-ancestor
64698292|NCT05722405|Growth Inhibitors|growth inhibitors|mesh-ancestor
64698293|NCT05722405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459304|NCT03818932|Antitussive Agents|antitussive agents|mesh-ancestor
65459305|NCT03818932|Respiratory System Agents|respiratory system agents|mesh-ancestor
65459306|NCT03818932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65459307|NCT03818932|Antiemetics|antiemetics|mesh-ancestor
65459308|NCT03818932|Autonomic Agents|autonomic agents|mesh-ancestor
65459309|NCT03818932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65459310|NCT03818932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65459311|NCT03818932|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65459312|NCT03818932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65459313|NCT03818932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65459314|NCT03818932|Anesthetics, General|anesthetics, general|mesh-ancestor
65459315|NCT03818932|Anesthetics|anesthetics|mesh-ancestor
65459316|NCT03818932|GABA Modulators|gaba modulators|mesh-ancestor
65459317|NCT03818932|GABA Agents|gaba agents|mesh-ancestor
65459318|NCT01205932|Enoxaparin|enoxaparin|mesh-list
65459319|NCT01205932|Rivaroxaban|rivaroxaban|mesh-list
65459320|NCT01205932|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65459321|NCT01205932|Antithrombins|antithrombins|mesh-ancestor
65459322|NCT01205932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65459323|NCT01205932|Protease Inhibitors|protease inhibitors|mesh-ancestor
65459324|NCT01205932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843799|NCT01665196|Antimetabolites|antimetabolites|mesh-ancestor
64698294|NCT05722405|Protease Inhibitors|protease inhibitors|mesh-ancestor
64698295|NCT05722405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698296|NCT05722405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698297|NCT05722405|Glycine Agents|glycine agents|mesh-ancestor
64698298|NCT05722405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64698299|NCT05722327|Irinotecan|irinotecan|mesh-list
64718154|NCT00966992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718155|NCT00379730|Prednisolone|prednisolone|mesh-list
64718156|NCT00379730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64718157|NCT00379730|Glucocorticoids|glucocorticoids|mesh-ancestor
64718158|NCT00379730|Hormones|hormones|mesh-ancestor
64718159|NCT00379730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64718160|NCT00379730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718161|NCT00379730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64326322|NCT04474093|Antimanic Agents|antimanic agents|mesh-ancestor
64698300|NCT05722327|Cetuximab|cetuximab|mesh-list
64698301|NCT05722327|Adagrasib|adagrasib|mesh-list
64698302|NCT05722327|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64698303|NCT05722327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64698304|NCT05722327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698305|NCT05722327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698306|NCT05722327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698307|NCT05722327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64698308|NCT04259658|Calcium|calcium|mesh-list
64698309|NCT04259658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64698310|NCT04259658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698311|NCT02767531|Orlistat|orlistat|mesh-list
64698312|NCT02767531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698313|NCT02767531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698314|NCT02767531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64698315|NCT02767531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64698316|NCT04419246|Tranexamic Acid|tranexamic acid|mesh-list
64698317|NCT04419246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64698318|NCT04419246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65459325|NCT01205932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208774|NCT00783835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65459326|NCT01205932|Anticoagulants|anticoagulants|mesh-ancestor
65459327|NCT01205932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65459328|NCT01205932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65459329|NCT01300780|Etoricoxib|etoricoxib|mesh-list
65459330|NCT01300780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65459331|NCT01300780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65459332|NCT01300780|Analgesics|analgesics|mesh-ancestor
64698319|NCT04419246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698320|NCT04419246|Hemostatics|hemostatics|mesh-ancestor
64698321|NCT04419246|Coagulants|coagulants|mesh-ancestor
64698322|NCT04195698|Upadacitinib|upadacitinib|mesh-list
64698323|NCT04195698|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64698324|NCT04195698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64698325|NCT04195698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698326|NCT04195698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698327|NCT04195698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64698328|NCT02521753|Metformin|metformin|mesh-list
64698329|NCT02521753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64698330|NCT02521753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698331|NCT04229303|Voriconazole|voriconazole|mesh-list
64698364|NCT05395494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64698365|NCT05395494|Antimetabolites|antimetabolites|mesh-ancestor
64698366|NCT05395494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698367|NCT00357721|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64334890|NCT03541655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64698397|NCT02464969|Apixaban|apixaban|mesh-list
64698398|NCT02464969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64698399|NCT02464969|Antithrombins|antithrombins|mesh-ancestor
64698400|NCT02464969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64698401|NCT02464969|Protease Inhibitors|protease inhibitors|mesh-ancestor
64698402|NCT02464969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698403|NCT02464969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718163|NCT02074904|Topiramate|topiramate|mesh-list
64718164|NCT02074904|Anticonvulsants|anticonvulsants|mesh-ancestor
64718165|NCT02074904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64718166|NCT02074904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718167|NCT02043860|Melphalan|melphalan|mesh-list
64718168|NCT02043860|Immunologic Factors|immunologic factors|mesh-ancestor
64698404|NCT02464969|Anticoagulants|anticoagulants|mesh-ancestor
64698405|NCT05392530|Macitentan|macitentan|mesh-list
64698406|NCT05392530|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64698407|NCT05392530|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64698408|NCT05392530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698409|NCT05392530|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64698410|NCT03498014|Analgesics, Opioid|analgesics, opioid|mesh-list
64698411|NCT03498014|Narcotics|narcotics|mesh-ancestor
64698412|NCT03498014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64698413|NCT03498014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698414|NCT03498014|Analgesics|analgesics|mesh-ancestor
64698415|NCT03498014|Sensory System Agents|sensory system agents|mesh-ancestor
64698416|NCT03498014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64698417|NCT02460133|Ritonavir|ritonavir|mesh-list
64698418|NCT02460133|Ribavirin|ribavirin|mesh-list
64698421|NCT02460133|Protease Inhibitors|protease inhibitors|mesh-ancestor
64698422|NCT02460133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698423|NCT02460133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698424|NCT02460133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64698425|NCT02460133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64698426|NCT02460133|Antiviral Agents|antiviral agents|mesh-ancestor
64698427|NCT02460133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64698428|NCT02460133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64698429|NCT02460133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64698431|NCT02220452|Anesthetics|anesthetics|mesh-list
64698432|NCT02220452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65459333|NCT01300780|Sensory System Agents|sensory system agents|mesh-ancestor
65459334|NCT01300780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65459335|NCT01300780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459336|NCT01300780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65459337|NCT01300780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65459338|NCT01300780|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65459339|NCT01300780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65459340|NCT01300780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459341|NCT01300780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459342|NCT01297816|Minocycline|minocycline|mesh-list
65459343|NCT01297816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65459344|NCT01297816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65459345|NCT01297894|Colistin|colistin|mesh-list
65459346|NCT01297894|Fosfomycin|fosfomycin|mesh-list
65459347|NCT01297894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65459348|NCT01297894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65459349|NCT05666362|Benoxinate|benoxinate|mesh-list
65459350|NCT05666362|Anesthetics, Local|anesthetics, local|mesh-ancestor
65459351|NCT05666362|Anesthetics|anesthetics|mesh-ancestor
65459352|NCT05666362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65459353|NCT05666362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459354|NCT05666362|Sensory System Agents|sensory system agents|mesh-ancestor
65459355|NCT05666362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65459356|NCT01206010|Varenicline|varenicline|mesh-list
65459357|NCT01206010|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65459358|NCT01206010|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65459359|NCT01206010|Cholinergic Agents|cholinergic agents|mesh-ancestor
65459360|NCT01206010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65459361|NCT01206010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459362|NCT01206010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459363|NCT05665114|Cytarabine|cytarabine|mesh-list
65459364|NCT05665114|Cyclophosphamide|cyclophosphamide|mesh-list
65459365|NCT05665114|Fludarabine|fludarabine|mesh-list
65459366|NCT05665114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65459367|NCT05665114|Immunologic Factors|immunologic factors|mesh-ancestor
65459368|NCT05665114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459369|NCT05665114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65459370|NCT05665114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65459371|NCT05665114|Alkylating Agents|alkylating agents|mesh-ancestor
65459372|NCT05665114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459373|NCT05665114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459374|NCT05665114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65459375|NCT05665114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65459376|NCT05665114|Antimetabolites|antimetabolites|mesh-ancestor
65459377|NCT05665114|Antiviral Agents|antiviral agents|mesh-ancestor
65459378|NCT05665114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65459379|NCT05345002|Tretinoin|tretinoin|mesh-list
65459380|NCT05345002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459381|NCT05345002|Keratolytic Agents|keratolytic agents|mesh-ancestor
65459382|NCT05345002|Dermatologic Agents|dermatologic agents|mesh-ancestor
65459383|NCT05618314|Probenecid|probenecid|mesh-list
65459384|NCT05618314|Uricosuric Agents|uricosuric agents|mesh-ancestor
65459385|NCT05618314|Gout Suppressants|gout suppressants|mesh-ancestor
65459386|NCT05618314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65459387|NCT05618314|Renal Agents|renal agents|mesh-ancestor
64698433|NCT02220452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698434|NCT04256603|Gabapentin|gabapentin|mesh-list
64698435|NCT04256603|Analgesics|analgesics|mesh-ancestor
64698436|NCT04256603|Sensory System Agents|sensory system agents|mesh-ancestor
64698470|NCT03541902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64698471|NCT03541902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64698472|NCT03541902|Growth Substances|growth substances|mesh-ancestor
64698473|NCT03541902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334894|NCT03541655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64698497|NCT03138512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64698498|NCT03138512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698499|NCT03138512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64698500|NCT03138512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698502|NCT03137888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64698503|NCT03137888|Alkylating Agents|alkylating agents|mesh-ancestor
64423805|NCT05148949|Vaccines|vaccines|mesh-list
64698504|NCT03137888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698505|NCT03137888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698506|NCT03127592|Etodolac|etodolac|mesh-list
64698507|NCT03127592|Cyclobenzaprine|cyclobenzaprine|mesh-list
64698508|NCT03127592|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64698509|NCT03127592|Antidepressive Agents|antidepressive agents|mesh-ancestor
64698510|NCT03127592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64698511|NCT03127592|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64718169|NCT02043860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718170|NCT02043860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64718171|NCT02043860|Alkylating Agents|alkylating agents|mesh-ancestor
64718172|NCT02043860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718173|NCT02043860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718174|NCT02043860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64718175|NCT02043860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64718176|NCT01974284|Ethanol|ethanol|mesh-list
64718177|NCT01974284|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64718178|NCT01974284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64718179|NCT01974284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64718180|NCT01974284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698512|NCT03127592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698513|NCT03127592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65459388|NCT03814642|Esomeprazole|esomeprazole|mesh-list
65459389|NCT03814642|Clopidogrel|clopidogrel|mesh-list
65459390|NCT03814642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65459391|NCT03814642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65459392|NCT03814642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65459393|NCT03814642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65459394|NCT03814642|Purinergic Agents|purinergic agents|mesh-ancestor
65459395|NCT03814642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65459396|NCT03814642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459397|NCT03814642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459398|NCT03814642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65459399|NCT03814642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65459400|NCT03814642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65208851|NCT00847912|Fluorouracil|fluorouracil|mesh-list
65459401|NCT03814642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459402|NCT01299220|Acitretin|acitretin|mesh-list
65459403|NCT01299220|Keratolytic Agents|keratolytic agents|mesh-ancestor
65459405|NCT03813784|Capecitabine|capecitabine|mesh-list
65459406|NCT03813784|Oxaliplatin|oxaliplatin|mesh-list
65459407|NCT03813784|Apatinib|apatinib|mesh-list
64698514|NCT03127592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64698515|NCT03127592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64698516|NCT03127592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64698517|NCT03127592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64698518|NCT03127592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64698519|NCT03127592|Analgesics|analgesics|mesh-ancestor
64698520|NCT03127592|Sensory System Agents|sensory system agents|mesh-ancestor
64698521|NCT03127592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64698522|NCT03127592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64698523|NCT03127592|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64698524|NCT03127592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64698525|NCT03127592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698526|NCT03127592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698527|NCT02444234|Tedizolid|tedizolid|mesh-list
64698528|NCT02444234|Oxazolidinones|oxazolidinones|mesh-list
64698529|NCT02444234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64698530|NCT02444234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64698531|NCT02444234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64698532|NCT02444234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334897|NCT03541655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698540|NCT02445326|Autonomic Agents|autonomic agents|mesh-ancestor
64698541|NCT02445326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64698542|NCT02445326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698560|NCT04344457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64698561|NCT04344457|Analgesics|analgesics|mesh-ancestor
64698562|NCT04344457|Sensory System Agents|sensory system agents|mesh-ancestor
64698563|NCT04344457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64698564|NCT04344457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698565|NCT04344457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64698566|NCT04344457|Gout Suppressants|gout suppressants|mesh-ancestor
64698567|NCT04344457|Tocolytic Agents|tocolytic agents|mesh-ancestor
64698568|NCT04344457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64698569|NCT04344457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64698570|NCT04344457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64698571|NCT01920932|Prednisone|prednisone|mesh-list
64698572|NCT01920932|Prednisolone|prednisolone|mesh-list
64698573|NCT01920932|Cyclophosphamide|cyclophosphamide|mesh-list
65459408|NCT03813784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65459409|NCT03813784|Antimetabolites|antimetabolites|mesh-ancestor
65459410|NCT03813784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459411|NCT03813784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459412|NCT03813784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65459413|NCT03813784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459414|NCT03818308|Sofosbuvir|sofosbuvir|mesh-list
65459415|NCT03818308|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65459416|NCT03818308|Velpatasvir|velpatasvir|mesh-list
65459417|NCT03818308|Antiviral Agents|antiviral agents|mesh-ancestor
65459418|NCT03818308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65459419|NCT03827044|Avelumab|avelumab|mesh-list
65459420|NCT03827044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65459421|NCT03827044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459422|NCT00145626|Cyclophosphamide|cyclophosphamide|mesh-list
65459423|NCT00145626|Melphalan|melphalan|mesh-list
65459424|NCT00145626|Thiotepa|thiotepa|mesh-list
65459425|NCT00145626|Fludarabine|fludarabine|mesh-list
65459426|NCT00145626|Antibodies|antibodies|mesh-list
65459427|NCT00145626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65459428|NCT00145626|Immunologic Factors|immunologic factors|mesh-ancestor
65459429|NCT00145626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459430|NCT00145626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65459431|NCT00145626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65459432|NCT00145626|Alkylating Agents|alkylating agents|mesh-ancestor
65459433|NCT00145626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459434|NCT00145626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459435|NCT00145626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65459436|NCT01206946|Betamethasone|betamethasone|mesh-list
65459437|NCT01206946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65459438|NCT01206946|Glucocorticoids|glucocorticoids|mesh-ancestor
64698574|NCT01920932|Dacarbazine|dacarbazine|mesh-list
64698575|NCT01920932|Doxorubicin|doxorubicin|mesh-list
64698576|NCT01920932|Etoposide|etoposide|mesh-list
64698577|NCT01920932|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64698578|NCT01920932|Imidazole|imidazole|mesh-list
64718181|NCT00869414|Insulin|insulin|mesh-list
64718182|NCT00869414|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64718183|NCT00869414|Insulin Glargine|insulin glargine|mesh-list
64718184|NCT00869414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64718185|NCT00869414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718186|NCT00843986|Conivaptan|conivaptan|mesh-list
64698579|NCT01920932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64698580|NCT01920932|Immunologic Factors|immunologic factors|mesh-ancestor
64698581|NCT01920932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698582|NCT01920932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64698583|NCT01920932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65459439|NCT01206946|Hormones|hormones|mesh-ancestor
65459440|NCT01206946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65459441|NCT01206946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459442|NCT01206946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65459443|NCT01206946|Respiratory System Agents|respiratory system agents|mesh-ancestor
65459444|NCT03813940|Vaccines|vaccines|mesh-list
65459445|NCT03813940|Immunologic Factors|immunologic factors|mesh-ancestor
65459446|NCT03813940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459447|NCT03967938|Olaparib|olaparib|mesh-list
65459448|NCT03967938|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65459449|NCT03967938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459450|NCT03967938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459451|NCT03967938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459452|NCT01299298|Mipomersen|mipomersen|mesh-list
64843915|NCT01664507|Mydriatics|mydriatics|mesh-ancestor
65459453|NCT01299298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65459454|NCT01299298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65459455|NCT01299298|Antimetabolites|antimetabolites|mesh-ancestor
65459456|NCT01299298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459457|NCT01299298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65459458|NCT00153062|Telmisartan|telmisartan|mesh-list
65459459|NCT00153062|Clopidogrel|clopidogrel|mesh-list
65459460|NCT00153062|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
65459461|NCT00153062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65459462|NCT00153062|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65459463|NCT00153062|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65459464|NCT00153062|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65459465|NCT00153062|Purinergic Agents|purinergic agents|mesh-ancestor
65459466|NCT00153062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65459467|NCT00153062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459468|NCT00153062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459469|NCT00153062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65459470|NCT00153062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65459471|NCT00153062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64698584|NCT01920932|Alkylating Agents|alkylating agents|mesh-ancestor
65459472|NCT05264974|Vaccines|vaccines|mesh-list
65459473|NCT05264974|Immunologic Factors|immunologic factors|mesh-ancestor
65459474|NCT05264974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459475|NCT00145470|Asenapine|asenapine|mesh-list
65459476|NCT00145470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65459477|NCT00145470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65459478|NCT00145470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65459479|NCT00145470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459480|NCT00145470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65459481|NCT03813394|Bevacizumab|bevacizumab|mesh-list
65459482|NCT03813394|Pembrolizumab|pembrolizumab|mesh-list
65459483|NCT03813394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65459484|NCT03813394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459485|NCT03813394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65459486|NCT03813394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65459487|NCT03813394|Growth Substances|growth substances|mesh-ancestor
65459488|NCT03813394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459489|NCT03813394|Growth Inhibitors|growth inhibitors|mesh-ancestor
64843932|NCT01665638|Canagliflozin|canagliflozin|mesh-list
64698585|NCT01920932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698586|NCT01920932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698587|NCT01920932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64698588|NCT01920932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64698589|NCT01920932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64698590|NCT01920932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64698591|NCT01920932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698592|NCT01920932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64698593|NCT01920932|Glucocorticoids|glucocorticoids|mesh-ancestor
64698594|NCT01920932|Hormones|hormones|mesh-ancestor
64698595|NCT01920932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64698596|NCT01920932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64698597|NCT01920932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64698598|NCT01920932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64698599|NCT02446496|Cefadroxil|cefadroxil|mesh-list
64698600|NCT02446496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64698633|NCT03496662|Antiviral Agents|antiviral agents|mesh-ancestor
64698634|NCT03496662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64698635|NCT03496662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698636|NCT03496662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64698637|NCT03496662|Immunologic Factors|immunologic factors|mesh-ancestor
64698638|NCT03496662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698639|NCT03496662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64334901|NCT02296411|Anticonvulsants|anticonvulsants|mesh-ancestor
64698640|NCT03496662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64698641|NCT05002309|Antidepressive Agents|antidepressive agents|mesh-list
64698642|NCT05002309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64698643|NCT05720065|Botulinum Toxins|botulinum toxins|mesh-list
64417300|NCT04819243|Atezolizumab|atezolizumab|mesh-list
64698682|NCT04948489|Contraceptive Agents|contraceptive agents|mesh-ancestor
64698683|NCT04948489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64698684|NCT04948489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698685|NCT04948489|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64698686|NCT04948489|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64698687|NCT01593254|Imatinib Mesylate|imatinib mesylate|mesh-list
64698688|NCT01593254|Dasatinib|dasatinib|mesh-list
64698689|NCT01593254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459490|NCT03813316|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65459491|NCT03813316|Ertugliflozin|ertugliflozin|mesh-list
65459492|NCT03813316|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65459493|NCT03813316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65459494|NCT03813316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65459495|NCT03813316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459496|NCT03813316|Incretins|incretins|mesh-ancestor
65459497|NCT03813316|Hormones|hormones|mesh-ancestor
65459498|NCT03813316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65459499|NCT03813316|Protease Inhibitors|protease inhibitors|mesh-ancestor
65459500|NCT03813316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459501|NCT03813316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493992|NCT03897439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493993|NCT03897439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65493994|NCT03897439|Antidepressive Agents|antidepressive agents|mesh-ancestor
65493995|NCT03897439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65493996|NCT03897439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65493997|NCT03897439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64698690|NCT01593254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64698691|NCT01593254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698692|NCT01593254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698722|NCT05717257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64698723|NCT05717257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698725|NCT04341818|Ergocalciferols|ergocalciferols|mesh-list
64698726|NCT04341818|Cholecalciferol|cholecalciferol|mesh-list
64698728|NCT04341818|Micronutrients|micronutrients|mesh-ancestor
64698729|NCT04341818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698730|NCT04341818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64718187|NCT00843986|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64718188|NCT00843986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698731|NCT04341818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64698732|NCT00362804|Tetrabenazine|tetrabenazine|mesh-list
64698733|NCT00362804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64698734|NCT00362804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64698735|NCT00362804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64698736|NCT00362804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698737|NCT00362804|Adrenergic Agents|adrenergic agents|mesh-ancestor
64698738|NCT00362804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64698739|NCT00362804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698755|NCT02452346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698757|NCT02959255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64698758|NCT02959255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64698759|NCT02959255|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64698760|NCT02959255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698761|NCT02959255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698762|NCT05716945|Fluorometholone|fluorometholone|mesh-list
64698763|NCT05716945|Dexamethasone|dexamethasone|mesh-list
64698764|NCT05716945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64698765|NCT05716945|Antiemetics|antiemetics|mesh-ancestor
64698766|NCT05716945|Autonomic Agents|autonomic agents|mesh-ancestor
64698767|NCT05716945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65493998|NCT03897439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65493999|NCT03897439|Dopamine Agents|dopamine agents|mesh-ancestor
65494000|NCT03897439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65494001|NCT03897439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65494002|NCT03897439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494003|NCT03830164|Vitamins|vitamins|mesh-list
65494004|NCT03830164|Vitamin E|vitamin e|mesh-list
65494005|NCT03830164|Tocopherols|tocopherols|mesh-list
65494006|NCT03830164|Tocotrienols|tocotrienols|mesh-list
65494007|NCT03830164|alpha-Tocopherol|alpha-tocopherol|mesh-list
65494008|NCT03830164|Pentoxifylline|pentoxifylline|mesh-list
65494009|NCT03830164|Atorvastatin|atorvastatin|mesh-list
65494010|NCT03830164|Micronutrients|micronutrients|mesh-ancestor
64698768|NCT05716945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698769|NCT05716945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64698770|NCT05716945|Glucocorticoids|glucocorticoids|mesh-ancestor
64698771|NCT05716945|Hormones|hormones|mesh-ancestor
64698772|NCT05716945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64698773|NCT05716945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64698774|NCT05716945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698775|NCT05716945|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64698789|NCT01345136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64698790|NCT01345136|Immunologic Factors|immunologic factors|mesh-ancestor
64698791|NCT01345136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698792|NCT04341428|Lansoprazole|lansoprazole|mesh-list
64698793|NCT04341428|Dexlansoprazole|dexlansoprazole|mesh-list
64698794|NCT04341428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64484534|NCT04382950|Tretinoin|tretinoin|mesh-list
64698795|NCT04341428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64698796|NCT04341428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64698797|NCT04341428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698798|NCT04341428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698799|NCT02453360|Bupivacaine|bupivacaine|mesh-list
64698800|NCT02453360|Anesthetics, Local|anesthetics, local|mesh-ancestor
64698816|NCT02453672|Growth Substances|growth substances|mesh-ancestor
64698817|NCT02453672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698818|NCT02453672|Growth Inhibitors|growth inhibitors|mesh-ancestor
64698820|NCT03119064|Temozolomide|temozolomide|mesh-list
64698821|NCT03119064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64698822|NCT03119064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64698823|NCT03119064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698824|NCT03119064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698825|NCT03119064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698826|NCT03119064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64698827|NCT03119064|Alkylating Agents|alkylating agents|mesh-ancestor
64718190|NCT00843986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718191|NCT03608839|Dexamethasone|dexamethasone|mesh-list
64718192|NCT03608839|Dexamethasone acetate|dexamethasone acetate|mesh-list
64718193|NCT03608839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64718194|NCT03608839|BB 1101|bb 1101|mesh-list
64718195|NCT03608839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64698828|NCT02453750|Bronchodilator Agents|bronchodilator agents|mesh-list
64698829|NCT02453750|Autonomic Agents|autonomic agents|mesh-ancestor
64698830|NCT02453750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64698831|NCT02453750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698832|NCT02453750|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64698833|NCT02453750|Respiratory System Agents|respiratory system agents|mesh-ancestor
64698834|NCT03831295|Antibodies|antibodies|mesh-list
64698835|NCT03831295|Immunologic Factors|immunologic factors|mesh-ancestor
64698836|NCT03831295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698837|NCT05215158|Dexmedetomidine|dexmedetomidine|mesh-list
64698838|NCT05215158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64698839|NCT05215158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64698840|NCT05215158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698841|NCT05215158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65494011|NCT03830164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494012|NCT03830164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65494013|NCT03830164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65494014|NCT03830164|Antimetabolites|antimetabolites|mesh-ancestor
65494015|NCT03830164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494016|NCT03830164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65494017|NCT03830164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65494018|NCT03830164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494019|NCT03830164|Antioxidants|antioxidants|mesh-ancestor
65494020|NCT03830164|Protective Agents|protective agents|mesh-ancestor
65494021|NCT03830164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65494022|NCT03830164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65494023|NCT03830164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64698842|NCT05215158|Analgesics|analgesics|mesh-ancestor
64698843|NCT05215158|Sensory System Agents|sensory system agents|mesh-ancestor
64334907|NCT02296411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698844|NCT05215158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64698845|NCT05215158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64698890|NCT03101748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698892|NCT03101748|Immunologic Factors|immunologic factors|mesh-ancestor
64698893|NCT03101748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698894|NCT03101748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64698895|NCT03101748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64698896|NCT03101748|Alkylating Agents|alkylating agents|mesh-ancestor
64698897|NCT03101748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64698910|NCT05710471|Growth Inhibitors|growth inhibitors|mesh-ancestor
64698911|NCT05710471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698912|NCT00358969|Guanfacine|guanfacine|mesh-list
64698913|NCT00358969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64698914|NCT00358969|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64698915|NCT00358969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64698916|NCT00358969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64698917|NCT00358969|Adrenergic Agents|adrenergic agents|mesh-ancestor
64698918|NCT00358969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64698919|NCT00358969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698920|NCT00358969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698921|NCT02896712|Modafinil|modafinil|mesh-list
64698943|NCT04344379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64698944|NCT04344379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64698945|NCT04344379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698946|NCT04344379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698947|NCT04344379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64698948|NCT00359125|Mifepristone|mifepristone|mesh-list
64698949|NCT00359125|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64698950|NCT00359125|Abortifacient Agents|abortifacient agents|mesh-ancestor
64698951|NCT00359125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64698952|NCT00359125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698953|NCT00359125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64698954|NCT00359125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64698955|NCT00359125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64698956|NCT00359125|Contraceptive Agents|contraceptive agents|mesh-ancestor
64698957|NCT00359125|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64698958|NCT00359125|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64698959|NCT00359125|Hormone Antagonists|hormone antagonists|mesh-ancestor
64698960|NCT00359125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64698961|NCT00359125|Luteolytic Agents|luteolytic agents|mesh-ancestor
64698962|NCT00359125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64698963|NCT00359125|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65494024|NCT03830164|Vasodilator Agents|vasodilator agents|mesh-ancestor
65494025|NCT03830164|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65494026|NCT03784326|Fluorouracil|fluorouracil|mesh-list
65494027|NCT03784326|Oxaliplatin|oxaliplatin|mesh-list
65494028|NCT03784326|Atezolizumab|atezolizumab|mesh-list
65494029|NCT03784326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65494030|NCT03784326|Antimetabolites|antimetabolites|mesh-ancestor
65494031|NCT03784326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494032|NCT03784326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65494033|NCT03784326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494034|NCT03784326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65494035|NCT03784326|Immunologic Factors|immunologic factors|mesh-ancestor
65494036|NCT03784326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494037|NCT03777436|Apremilast|apremilast|mesh-list
65494038|NCT03777436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65494039|NCT03777436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65494040|NCT03777436|Analgesics|analgesics|mesh-ancestor
65494041|NCT03777436|Sensory System Agents|sensory system agents|mesh-ancestor
65494042|NCT03777436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65209001|NCT04901676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65459503|NCT01301248|Cetuximab|cetuximab|mesh-list
65459504|NCT01301248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459505|NCT01301248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65459506|NCT01302028|Ipragliflozin|ipragliflozin|mesh-list
65459507|NCT01302028|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64843991|NCT01666236|Verteporfin|verteporfin|mesh-list
64698964|NCT03042468|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64698965|NCT03042468|177Lu-PSMA-617|177lu-psma-617|mesh-list
64698966|NCT03042468|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64698967|NCT03042468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698968|NCT04450836|Trifluridine|trifluridine|mesh-list
64698969|NCT04450836|Antimetabolites|antimetabolites|mesh-ancestor
64698983|NCT05679193|Adrenergic Agents|adrenergic agents|mesh-ancestor
64698984|NCT05679193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64698985|NCT05679193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698994|NCT04795752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64698995|NCT04795752|Immunologic Factors|immunologic factors|mesh-ancestor
64698996|NCT04795752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698997|NCT04795752|Antifungal Agents|antifungal agents|mesh-ancestor
64698998|NCT04795752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64698999|NCT04795752|Dermatologic Agents|dermatologic agents|mesh-ancestor
64699000|NCT04795752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64699001|NCT04795752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64718200|NCT03608839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64718202|NCT03608839|Hormones|hormones|mesh-ancestor
64718203|NCT03608839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64718204|NCT03608839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64718205|NCT03608839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718206|NCT03608839|Protease Inhibitors|protease inhibitors|mesh-ancestor
65459508|NCT01302028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459509|NCT01302028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65459510|NCT01302028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459511|NCT01302106|Clofarabine|clofarabine|mesh-list
65459512|NCT01302106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65459513|NCT01302106|Antimetabolites|antimetabolites|mesh-ancestor
65459514|NCT01302106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066890|NCT00307944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066891|NCT00416507|Gemcitabine|gemcitabine|mesh-list
64844017|NCT01666379|Fentanyl|fentanyl|mesh-list
64718207|NCT03608839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326366|NCT02159105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699002|NCT02977741|Olanzapine|olanzapine|mesh-list
64699003|NCT02977741|Antiemetics|antiemetics|mesh-ancestor
64699004|NCT02977741|Autonomic Agents|autonomic agents|mesh-ancestor
64699005|NCT02977741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699006|NCT02977741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699007|NCT02977741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64699008|NCT02977741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64699009|NCT02977741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64699010|NCT02977741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64699011|NCT02977741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64699012|NCT02977741|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64699013|NCT02977741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64699014|NCT02977741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64699015|NCT02977741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699016|NCT02977741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64699017|NCT02977741|Serotonin Agents|serotonin agents|mesh-ancestor
64699018|NCT04334070|Clofazimine|clofazimine|mesh-list
64699019|NCT04334070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64699020|NCT04334070|Leprostatic Agents|leprostatic agents|mesh-ancestor
64699021|NCT04334070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64699022|NCT04334070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64699023|NCT05292001|Dextrans|dextrans|mesh-list
64699024|NCT05292001|Iron-Dextran Complex|iron-dextran complex|mesh-list
64699025|NCT05292001|Anticoagulants|anticoagulants|mesh-ancestor
64699026|NCT05292001|Plasma Substitutes|plasma substitutes|mesh-ancestor
64699027|NCT05292001|Blood Substitutes|blood substitutes|mesh-ancestor
64699028|NCT05292001|Hematinics|hematinics|mesh-ancestor
64424327|NCT02515045|Analgesics|analgesics|mesh-ancestor
64699029|NCT01634178|Apremilast|apremilast|mesh-list
64699030|NCT01634178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64699031|NCT01634178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64699043|NCT00359359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699044|NCT04782804|Capecitabine|capecitabine|mesh-list
64699045|NCT04782804|Antibodies|antibodies|mesh-list
64699046|NCT04782804|Immunologic Factors|immunologic factors|mesh-ancestor
64699047|NCT04782804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699048|NCT04782804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64699049|NCT04782804|Antimetabolites|antimetabolites|mesh-ancestor
64699050|NCT04782804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334936|NCT02229617|Anabolic Agents|anabolic agents|mesh-ancestor
64699061|NCT04227288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64699063|NCT04227288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64699064|NCT04227288|Respiratory System Agents|respiratory system agents|mesh-ancestor
64699065|NCT04227288|Dermatologic Agents|dermatologic agents|mesh-ancestor
64699066|NCT02724228|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
64699067|NCT02724228|Natriuretic Agents|natriuretic agents|mesh-ancestor
64699068|NCT02724228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699069|NCT05668429|Ibrexafungerp|ibrexafungerp|mesh-list
64699070|NCT05668429|Antifungal Agents|antifungal agents|mesh-ancestor
64718208|NCT03608839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718209|NCT00845702|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
65066892|NCT00416507|Fluorouracil|fluorouracil|mesh-list
65066893|NCT00416507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066894|NCT00416507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65066895|NCT00416507|Antimetabolites|antimetabolites|mesh-ancestor
65066896|NCT00416507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066897|NCT00416507|Antiviral Agents|antiviral agents|mesh-ancestor
65066898|NCT00416507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65066899|NCT00416507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066900|NCT00416507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65066901|NCT00416507|Immunologic Factors|immunologic factors|mesh-ancestor
65066902|NCT00416507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066903|NCT00282126|Potassium Citrate|potassium citrate|mesh-list
65066904|NCT00282126|Diuretics|diuretics|mesh-ancestor
64718210|NCT00845702|Chelating Agents|chelating agents|mesh-ancestor
64718211|NCT00845702|Sequestering Agents|sequestering agents|mesh-ancestor
64718212|NCT00845702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718213|NCT03610399|Primaquine|primaquine|mesh-list
64718214|NCT03610399|Antimalarials|antimalarials|mesh-ancestor
64699071|NCT05668429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64699072|NCT02698254|Bevacizumab|bevacizumab|mesh-list
64699073|NCT02698254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64699074|NCT02698254|Endothelial Growth Factors|endothelial growth factors|mesh-list
64699075|NCT02698254|Antibodies|antibodies|mesh-list
64699076|NCT02698254|Immunoglobulins|immunoglobulins|mesh-list
64699077|NCT02698254|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64699078|NCT02698254|Immunoglobulin G|immunoglobulin g|mesh-list
64699079|NCT02698254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699080|NCT02698254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64699081|NCT02698254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64699082|NCT02698254|Growth Substances|growth substances|mesh-ancestor
64699083|NCT02698254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699084|NCT02698254|Growth Inhibitors|growth inhibitors|mesh-ancestor
64699085|NCT02698254|Immunologic Factors|immunologic factors|mesh-ancestor
64699086|NCT02978443|Nivolumab|nivolumab|mesh-list
64699087|NCT02978443|Ipilimumab|ipilimumab|mesh-list
64699088|NCT02978443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64699089|NCT02978443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699090|NCT02978443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64699091|NCT02978443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699092|NCT02465450|Lenabasum|lenabasum|mesh-list
64699093|NCT02465450|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64699094|NCT02465450|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64699095|NCT02465450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64699108|NCT00608972|Growth Inhibitors|growth inhibitors|mesh-ancestor
64699109|NCT04804722|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64699110|NCT04804722|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64699111|NCT04804722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699112|NCT02729714|Suvorexant|suvorexant|mesh-list
64699113|NCT02729714|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64699114|NCT02729714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64699115|NCT02729714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64699116|NCT02729714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699117|NCT02729714|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64699118|NCT02729714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64699119|NCT02729714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699127|NCT05648916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64699129|NCT05648916|Analgesics|analgesics|mesh-ancestor
64699130|NCT05648916|Sensory System Agents|sensory system agents|mesh-ancestor
64699131|NCT05648916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699132|NCT05648916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699133|NCT05648916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64699134|NCT05648916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65066905|NCT00282126|Natriuretic Agents|natriuretic agents|mesh-ancestor
65066906|NCT00282126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066907|NCT00282126|Expectorants|expectorants|mesh-ancestor
65066908|NCT00282126|Respiratory System Agents|respiratory system agents|mesh-ancestor
65066909|NCT00272870|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
65066910|NCT00272870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066911|NCT00272870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066912|NCT00272870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066913|NCT00272909|Piclozotan|piclozotan|mesh-list
65066914|NCT00272909|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65066915|NCT00272909|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65066916|NCT00272909|Serotonin Agents|serotonin agents|mesh-ancestor
65066917|NCT00272909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65066918|NCT00272909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066919|NCT00272909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066920|NCT00282165|Naratriptan|naratriptan|mesh-list
65066921|NCT00282165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64508344|NCT04058470|Prednisone|prednisone|mesh-list
65066922|NCT00282165|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64844041|NCT01666522|Vitamin D|vitamin d|mesh-list
64699135|NCT05648916|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64699136|NCT05648916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64699137|NCT05648916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64699138|NCT05648916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699139|NCT05458609|Naltrexone|naltrexone|mesh-list
64699140|NCT05458609|Lemborexant|lemborexant|mesh-list
64699141|NCT05458609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64718215|NCT03610399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64718216|NCT03610399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64718217|NCT03610399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64718219|NCT03610633|Oxytocics|oxytocics|mesh-ancestor
64718220|NCT03610633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64718221|NCT03610633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718222|NCT00832520|Mirtazapine|mirtazapine|mesh-list
64718223|NCT00832520|Antidepressive Agents|antidepressive agents|mesh-ancestor
64699142|NCT05458609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64699143|NCT05458609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699144|NCT05458609|Sensory System Agents|sensory system agents|mesh-ancestor
64699145|NCT05458609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699146|NCT05458609|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64699147|NCT05458609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64699148|NCT05458609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699149|NCT05458609|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64699150|NCT05458609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64699151|NCT05458609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64699152|NCT05648058|Diphenhydramine|diphenhydramine|mesh-list
64699153|NCT05648058|Promethazine|promethazine|mesh-list
64699154|NCT05648058|Nefopam|nefopam|mesh-list
64699155|NCT05648058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64699187|NCT05639712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699188|NCT05639712|Analgesics|analgesics|mesh-ancestor
64699189|NCT05639712|Sensory System Agents|sensory system agents|mesh-ancestor
64699190|NCT05639712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699191|NCT05639712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65066923|NCT00282165|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65066924|NCT00282165|Serotonin Agents|serotonin agents|mesh-ancestor
65066925|NCT00282165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65066926|NCT00282165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066927|NCT00282165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066928|NCT00272948|Defibrotide|defibrotide|mesh-list
65066929|NCT00272948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65066930|NCT00272948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65066931|NCT00272948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066932|NCT00272948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65066933|NCT00308100|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65066934|NCT00308100|Plasma Substitutes|plasma substitutes|mesh-ancestor
65066935|NCT00308100|Blood Substitutes|blood substitutes|mesh-ancestor
65066936|NCT00273026|Fluticasone|fluticasone|mesh-list
65066937|NCT00273026|Xhance|xhance|mesh-list
65066938|NCT00273026|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65066939|NCT00273026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65066940|NCT00273026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65066941|NCT00273026|Autonomic Agents|autonomic agents|mesh-ancestor
65066942|NCT00273026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066943|NCT00273026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699192|NCT05639712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64699193|NCT05639712|Anesthetics, General|anesthetics, general|mesh-ancestor
64699194|NCT05639712|Anesthetics|anesthetics|mesh-ancestor
64699195|NCT02959411|Tolvaptan|tolvaptan|mesh-list
64699196|NCT02959411|Diuretics|diuretics|mesh-list
64699197|NCT02959411|Natriuretic Agents|natriuretic agents|mesh-ancestor
64699198|NCT02959411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699199|NCT02959411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64699200|NCT02959411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699201|NCT05426161|Botulinum Toxins|botulinum toxins|mesh-list
64699202|NCT05426161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64699203|NCT05426161|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64699204|NCT05426161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64699205|NCT05426161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64699220|NCT00359671|Antimitotic Agents|antimitotic agents|mesh-ancestor
64699221|NCT00359671|Mitosis Modulators|mitosis modulators|mesh-ancestor
64699222|NCT00359671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699223|NCT05409391|Insulin|insulin|mesh-list
64699224|NCT05409391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64699234|NCT05141149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64699235|NCT05141149|Immunologic Factors|immunologic factors|mesh-ancestor
64699236|NCT05141149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699237|NCT02977897|Octreotide|octreotide|mesh-list
64699238|NCT02977897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64699239|NCT02977897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64699240|NCT02977897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699241|NCT05114941|Immunoglobulins|immunoglobulins|mesh-list
64699242|NCT05114941|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64699243|NCT05114941|Antibodies|antibodies|mesh-list
64699244|NCT05114941|gamma-Globulins|gamma-globulins|mesh-list
64718224|NCT00832520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64718225|NCT00832520|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65066944|NCT00273026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65066945|NCT00273026|Respiratory System Agents|respiratory system agents|mesh-ancestor
65066946|NCT00273026|Dermatologic Agents|dermatologic agents|mesh-ancestor
65066947|NCT00273026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65066948|NCT00273026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65209074|NCT04252248|Decitabine|decitabine|mesh-list
65459515|NCT01302106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459516|NCT00152516|Levetiracetam|levetiracetam|mesh-list
65459517|NCT00152516|Anticonvulsants|anticonvulsants|mesh-ancestor
65459518|NCT00152516|Nootropic Agents|nootropic agents|mesh-ancestor
65459519|NCT00145158|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65459520|NCT00145158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65459521|NCT00145158|Immunologic Factors|immunologic factors|mesh-ancestor
65459522|NCT00145158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459523|NCT05624008|Methamphetamine|methamphetamine|mesh-list
65459524|NCT05624008|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65459525|NCT05624008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459526|NCT05624008|Sympathomimetics|sympathomimetics|mesh-ancestor
65459527|NCT05624008|Autonomic Agents|autonomic agents|mesh-ancestor
65459528|NCT05624008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65459529|NCT05624008|Dopamine Agents|dopamine agents|mesh-ancestor
65459530|NCT05624008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65459531|NCT05624008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459532|NCT05624008|Adrenergic Agents|adrenergic agents|mesh-ancestor
65459533|NCT05624008|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64718226|NCT00832520|Histamine Antagonists|histamine antagonists|mesh-ancestor
64718227|NCT00832520|Histamine Agents|histamine agents|mesh-ancestor
64718228|NCT00832520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64718229|NCT00832520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718230|NCT00832520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718231|NCT00832520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64699245|NCT05114941|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64699246|NCT05114941|Immunologic Factors|immunologic factors|mesh-ancestor
64699247|NCT05114941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699248|NCT00359905|Tamsulosin|tamsulosin|mesh-list
64699249|NCT00359905|Silodosin|silodosin|mesh-list
64699250|NCT00359905|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64699251|NCT00359905|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64699252|NCT00359905|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64699253|NCT00359905|Adrenergic Agents|adrenergic agents|mesh-ancestor
64699254|NCT00359905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64699255|NCT00359905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699256|NCT00359905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699257|NCT00359905|Urological Agents|urological agents|mesh-ancestor
64699258|NCT05086939|Hyaluronic Acid|hyaluronic acid|mesh-list
64699259|NCT05086939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64699260|NCT05086939|Immunologic Factors|immunologic factors|mesh-ancestor
64699261|NCT05086939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699262|NCT05086939|Viscosupplements|viscosupplements|mesh-ancestor
64699263|NCT05086939|Protective Agents|protective agents|mesh-ancestor
64699264|NCT00358813|Casopitant|casopitant|mesh-list
65459534|NCT05624008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65459535|NCT05624008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65459536|NCT05624008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65459538|NCT05623852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65459539|NCT05623852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65459540|NCT05623852|Anticoagulants|anticoagulants|mesh-ancestor
65459541|NCT05623852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459542|NCT01302340|Dronabinol|dronabinol|mesh-list
65459543|NCT01302340|Hallucinogens|hallucinogens|mesh-ancestor
65459544|NCT01302340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459545|NCT01302340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65459546|NCT01302340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64699265|NCT00358813|Antiemetics|antiemetics|mesh-ancestor
64699266|NCT00358813|Autonomic Agents|autonomic agents|mesh-ancestor
64699267|NCT00358813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699279|NCT05064085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64699281|NCT04871191|Abatacept|abatacept|mesh-list
64699282|NCT04871191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64699283|NCT04871191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699284|NCT04871191|Immunologic Factors|immunologic factors|mesh-ancestor
64699285|NCT04871191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699286|NCT04871191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64699287|NCT04871191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64699288|NCT04871191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699289|NCT04871191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64699290|NCT02976805|Bisacodyl|bisacodyl|mesh-list
64699291|NCT02976805|Cathartics|cathartics|mesh-ancestor
64699292|NCT02976805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64699293|NCT02976805|Laxatives|laxatives|mesh-ancestor
64699294|NCT04835623|Cyclosporine|cyclosporine|mesh-list
64334949|NCT02347059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64718236|NCT00832520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64718237|NCT00832520|Adrenergic Agents|adrenergic agents|mesh-ancestor
64718238|NCT00832520|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64718239|NCT00832520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64718240|NCT00832520|Serotonin Agents|serotonin agents|mesh-ancestor
64718241|NCT00832520|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64718242|NCT03545893|Ibuprofen|ibuprofen|mesh-list
64718243|NCT03545893|Oxycodone|oxycodone|mesh-list
64326397|NCT00890149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64326398|NCT00890149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64326399|NCT00890149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64326400|NCT00890149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64326401|NCT02155049|Bimatoprost|bimatoprost|mesh-list
64699317|NCT04500613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64699318|NCT04500613|Glucocorticoids|glucocorticoids|mesh-ancestor
64699320|NCT04500613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64699321|NCT04500613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64699322|NCT04500613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699323|NCT04500613|Protease Inhibitors|protease inhibitors|mesh-ancestor
64699324|NCT04500613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64699325|NCT04500613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699326|NCT04500613|Anesthetics, Local|anesthetics, local|mesh-ancestor
64699327|NCT04500613|Anesthetics|anesthetics|mesh-ancestor
64699328|NCT04500613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64699358|NCT02976727|Lidocaine|lidocaine|mesh-list
64699359|NCT02976727|Prilocaine|prilocaine|mesh-list
64699360|NCT02976727|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64699361|NCT02976727|Calcipotriene|calcipotriene|mesh-list
64699362|NCT02976727|Vitamins|vitamins|mesh-ancestor
64699363|NCT02976727|Micronutrients|micronutrients|mesh-ancestor
64699364|NCT02976727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699365|NCT02976727|Anesthetics, Local|anesthetics, local|mesh-ancestor
64699366|NCT02976727|Anesthetics|anesthetics|mesh-ancestor
64699367|NCT02976727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65459547|NCT01302340|Analgesics|analgesics|mesh-ancestor
65459548|NCT01302340|Sensory System Agents|sensory system agents|mesh-ancestor
65459549|NCT01302340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65459550|NCT01302340|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65459551|NCT01302340|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65459552|NCT01302340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65459553|NCT01302340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459554|NCT01302340|Hormones|hormones|mesh-ancestor
65459555|NCT01302340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65459556|NCT00150800|Brivaracetam|brivaracetam|mesh-list
65459557|NCT00150800|Anticonvulsants|anticonvulsants|mesh-ancestor
65459558|NCT03812770|Leucovorin|leucovorin|mesh-list
64699368|NCT02976727|Sensory System Agents|sensory system agents|mesh-ancestor
64699369|NCT02976727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699370|NCT02976727|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64699371|NCT02976727|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64699372|NCT02976727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64699373|NCT02976727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64699374|NCT02976727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699375|NCT02976727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64699376|NCT02976727|Dermatologic Agents|dermatologic agents|mesh-ancestor
64699377|NCT02976727|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64718244|NCT03545893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64718245|NCT03545893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64718246|NCT03545893|Analgesics|analgesics|mesh-ancestor
64718247|NCT03545893|Sensory System Agents|sensory system agents|mesh-ancestor
64718248|NCT03545893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64718249|NCT03545893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718250|NCT03545893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64718251|NCT03545893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64718252|NCT03545893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64718253|NCT03545893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718254|NCT03545893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699378|NCT02977117|Dialysis Solutions|dialysis solutions|mesh-list
64699379|NCT02977117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64699380|NCT00360607|Metronidazole|metronidazole|mesh-list
64699381|NCT00360607|Amikacin|amikacin|mesh-list
64699382|NCT00360607|Ceftazidime|ceftazidime|mesh-list
64699383|NCT00360607|Sulbactam|sulbactam|mesh-list
64699384|NCT00360607|Cefoperazone|cefoperazone|mesh-list
64699385|NCT00360607|Sulperazone|sulperazone|mesh-list
64699386|NCT00360607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64699387|NCT00360607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64699388|NCT00360607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64699389|NCT00360607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64699404|NCT04032301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699405|NCT04032301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699406|NCT04032301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64699408|NCT04032301|Anesthetics, General|anesthetics, general|mesh-ancestor
64699409|NCT04032301|Anesthetics|anesthetics|mesh-ancestor
64424702|NCT02495077|Anesthetics|anesthetics|mesh-ancestor
64699410|NCT04032301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64699411|NCT04032301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64699412|NCT04032301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64699413|NCT04032301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64699414|NCT04032301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699416|NCT04010305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64699417|NCT04010305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64699418|NCT04010305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699428|NCT04010305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459559|NCT03812770|Fluorouracil|fluorouracil|mesh-list
65459560|NCT03812770|Oxaliplatin|oxaliplatin|mesh-list
65459561|NCT03812770|Sorafenib|sorafenib|mesh-list
65459562|NCT03812770|Antimetabolites|antimetabolites|mesh-ancestor
65459563|NCT03812770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459564|NCT03812770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65459565|NCT03812770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459566|NCT03812770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65459567|NCT03812770|Immunologic Factors|immunologic factors|mesh-ancestor
65459568|NCT03812770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459569|NCT03812770|Antidotes|antidotes|mesh-ancestor
65459570|NCT03812770|Protective Agents|protective agents|mesh-ancestor
65459571|NCT03812770|Vitamin B Complex|vitamin b complex|mesh-ancestor
65459572|NCT03812770|Vitamins|vitamins|mesh-ancestor
64844128|NCT01667094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64699430|NCT00361933|Antiviral Agents|antiviral agents|mesh-ancestor
64699431|NCT00361933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64699432|NCT04786093|Durvalumab|durvalumab|mesh-list
64699433|NCT04786093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64699434|NCT04786093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699435|NCT02976571|Bupivacaine|bupivacaine|mesh-list
64699436|NCT02976571|Anesthetics, Local|anesthetics, local|mesh-ancestor
64699437|NCT02976571|Anesthetics|anesthetics|mesh-ancestor
64699438|NCT02976571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64699439|NCT02976571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699440|NCT02976571|Sensory System Agents|sensory system agents|mesh-ancestor
64699441|NCT02976571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699442|NCT04731025|Vancomycin|vancomycin|mesh-list
64699443|NCT04731025|Gentamicins|gentamicins|mesh-list
64699444|NCT04731025|Cefazolin|cefazolin|mesh-list
64699445|NCT04731025|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64718256|NCT03545893|Narcotics|narcotics|mesh-ancestor
64718257|NCT03545893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64718258|NCT01877564|Metformin|metformin|mesh-list
64718259|NCT01877564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64718260|NCT01877564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718261|NCT00376987|Zinc Oxide|zinc oxide|mesh-list
64718262|NCT00376987|Dermatologic Agents|dermatologic agents|mesh-ancestor
64718263|NCT00376987|Sunscreening Agents|sunscreening agents|mesh-ancestor
64718264|NCT00376987|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64718265|NCT00376987|Protective Agents|protective agents|mesh-ancestor
64718266|NCT00376987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718267|NCT01889420|Everolimus|everolimus|mesh-list
64718268|NCT01889420|Pomalidomide|pomalidomide|mesh-list
64718269|NCT01889420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718270|NCT01889420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64326420|NCT00794677|Antimetabolites|antimetabolites|mesh-ancestor
64699446|NCT04731025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64699474|NCT04676035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64699475|NCT04676035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64699476|NCT04676035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64334959|NCT02296567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64417488|NCT04804423|Fluorides|fluorides|mesh-list
64699477|NCT04676035|Anesthetics, General|anesthetics, general|mesh-ancestor
64699478|NCT04676035|Anesthetics|anesthetics|mesh-ancestor
64699479|NCT04676035|GABA Modulators|gaba modulators|mesh-ancestor
64699480|NCT04676035|GABA Agents|gaba agents|mesh-ancestor
64699481|NCT04676035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64699482|NCT04676035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699483|NCT04676035|Anticoagulants|anticoagulants|mesh-ancestor
64699484|NCT04676035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64699485|NCT04676035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64699486|NCT04676035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64699487|NCT04676035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459573|NCT03812770|Micronutrients|micronutrients|mesh-ancestor
65459574|NCT03812770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65459575|NCT03812770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459576|NCT00144300|Pramipexole|pramipexole|mesh-list
65459577|NCT00144300|Antioxidants|antioxidants|mesh-ancestor
65459578|NCT00144300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459579|NCT00144300|Protective Agents|protective agents|mesh-ancestor
65459580|NCT00144300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459581|NCT00144300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65459582|NCT00144300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64699488|NCT04676035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64699489|NCT04676035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64699490|NCT04676035|Hemostatics|hemostatics|mesh-ancestor
64699491|NCT04676035|Coagulants|coagulants|mesh-ancestor
64699492|NCT04676035|Vitamins|vitamins|mesh-ancestor
64699493|NCT04676035|Micronutrients|micronutrients|mesh-ancestor
64699494|NCT03926299|Clobetasol|clobetasol|mesh-list
64699495|NCT03926299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64699496|NCT03926299|Glucocorticoids|glucocorticoids|mesh-ancestor
64699541|NCT00362089|Dronabinol|dronabinol|mesh-list
64699542|NCT00362089|Hallucinogens|hallucinogens|mesh-ancestor
64484539|NCT04537156|Vaccines|vaccines|mesh-list
64699543|NCT00362089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699544|NCT00362089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64699573|NCT03822637|Respiratory System Agents|respiratory system agents|mesh-ancestor
64718271|NCT01889420|Immunologic Factors|immunologic factors|mesh-ancestor
64718272|NCT01889420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718273|NCT01889420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64718274|NCT01889420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64718275|NCT01889420|Growth Substances|growth substances|mesh-ancestor
64718276|NCT01889420|Growth Inhibitors|growth inhibitors|mesh-ancestor
64718278|NCT00379028|Budesonide|budesonide|mesh-list
64699575|NCT03822637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64699576|NCT03822637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64699577|NCT03822637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64699578|NCT03822637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64699579|NCT03822637|Adrenergic Agents|adrenergic agents|mesh-ancestor
64699580|NCT03822637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64699581|NCT03822637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699582|NCT03822637|Antiviral Agents|antiviral agents|mesh-ancestor
64699583|NCT03822637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64699584|NCT03822637|Expectorants|expectorants|mesh-ancestor
64699585|NCT03822637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64699586|NCT03822637|Antioxidants|antioxidants|mesh-ancestor
64699587|NCT03822637|Protective Agents|protective agents|mesh-ancestor
64699588|NCT03822637|Antidotes|antidotes|mesh-ancestor
64699589|NCT05444101|Nicotine|nicotine|mesh-list
64699590|NCT05444101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64699626|NCT03659136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64699627|NCT03659136|Immunologic Factors|immunologic factors|mesh-ancestor
64699628|NCT03659136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699644|NCT01352221|Hematinics|hematinics|mesh-ancestor
64699645|NCT03583710|Cisplatin|cisplatin|mesh-list
64699646|NCT03583710|Etoposide|etoposide|mesh-list
64699647|NCT03583710|Etoposide phosphate|etoposide phosphate|mesh-list
64699648|NCT03583710|Podophyllotoxin|podophyllotoxin|mesh-list
64699649|NCT03583710|Mitotane|mitotane|mesh-list
64699650|NCT03583710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699651|NCT03583710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64699652|NCT03583710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64699653|NCT03583710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64699654|NCT03583710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334964|NCT02296567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334965|NCT02296567|Growth Inhibitors|growth inhibitors|mesh-ancestor
64699668|NCT04418154|Tubulin Modulators|tubulin modulators|mesh-ancestor
64699669|NCT04418154|Antimitotic Agents|antimitotic agents|mesh-ancestor
64699670|NCT04418154|Mitosis Modulators|mitosis modulators|mesh-ancestor
64699671|NCT04418154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699672|NCT04418154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65459583|NCT00144300|Dopamine Agonists|dopamine agonists|mesh-ancestor
65459584|NCT00144300|Dopamine Agents|dopamine agents|mesh-ancestor
65459585|NCT00144300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65459586|NCT00149630|Disulfiram|disulfiram|mesh-list
65459587|NCT00149630|Methadone|methadone|mesh-list
65459588|NCT00149630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65459589|NCT00149630|Narcotics|narcotics|mesh-ancestor
65459590|NCT00149630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65459591|NCT00149630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459592|NCT00149630|Analgesics|analgesics|mesh-ancestor
65459593|NCT00149630|Sensory System Agents|sensory system agents|mesh-ancestor
65459594|NCT00149630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65459595|NCT00149630|Antitussive Agents|antitussive agents|mesh-ancestor
64844150|NCT01667263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64699673|NCT04418154|Immunologic Factors|immunologic factors|mesh-ancestor
64699674|NCT04418154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699675|NCT04418154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64699676|NCT04418154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64699677|NCT04418154|Alkylating Agents|alkylating agents|mesh-ancestor
64699678|NCT04418154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64699679|NCT04418154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64699680|NCT04418154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64699681|NCT04418154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64699682|NCT04418154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64699683|NCT05195034|Dexmedetomidine|dexmedetomidine|mesh-list
64699684|NCT05195034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64699685|NCT05195034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64718279|NCT00379028|Formoterol Fumarate|formoterol fumarate|mesh-list
64718280|NCT00379028|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64718281|NCT00379028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64718282|NCT00379028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64718283|NCT00379028|Autonomic Agents|autonomic agents|mesh-ancestor
64718284|NCT00379028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699714|NCT02065362|Alkylating Agents|alkylating agents|mesh-ancestor
64699715|NCT02065362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699716|NCT02065362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699717|NCT02065362|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64699718|NCT02021604|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
64699719|NCT02021604|Dopamine Agents|dopamine agents|mesh-ancestor
64699720|NCT02021604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64699721|NCT02021604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699722|NCT02021604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699723|NCT03518034|Testosterone|testosterone|mesh-list
64699724|NCT03518034|Androgens|androgens|mesh-ancestor
64699725|NCT03518034|Hormones|hormones|mesh-ancestor
64699726|NCT03518034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64699727|NCT03518034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699728|NCT04789668|Atezolizumab|atezolizumab|mesh-list
64699760|NCT01634100|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64699761|NCT01634100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699762|NCT01634100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64699763|NCT01634100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699764|NCT01634100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64699765|NCT01634100|Antitubercular Agents|antitubercular agents|mesh-ancestor
64699766|NCT01634100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64699768|NCT01634100|Leprostatic Agents|leprostatic agents|mesh-ancestor
64699804|NCT03661645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64699805|NCT03661645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699806|NCT03661645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64699807|NCT03661645|Protective Agents|protective agents|mesh-ancestor
64699809|NCT01633944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65459596|NCT00149630|Respiratory System Agents|respiratory system agents|mesh-ancestor
65459597|NCT00149630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65459598|NCT00149630|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65459599|NCT00149630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459600|NCT00149630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459601|NCT01302496|Ipilimumab|ipilimumab|mesh-list
65459602|NCT01302496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65459603|NCT01302496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459604|NCT01302496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65459605|NCT01302496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699810|NCT01633944|Narcotics|narcotics|mesh-ancestor
64699811|NCT01633944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64699812|NCT01633944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699813|NCT01633944|Analgesics|analgesics|mesh-ancestor
64699814|NCT01633944|Sensory System Agents|sensory system agents|mesh-ancestor
64699815|NCT01633944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699816|NCT01633944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64699817|NCT04592419|Aflibercept|aflibercept|mesh-list
64699818|NCT04592419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64699819|NCT04592419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64699853|NCT00589316|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64699854|NCT00589316|Trace Elements|trace elements|mesh-ancestor
64699855|NCT00589316|Micronutrients|micronutrients|mesh-ancestor
64699856|NCT00544466|Fludarabine|fludarabine|mesh-list
64699857|NCT00544466|Fludarabine phosphate|fludarabine phosphate|mesh-list
64699858|NCT00544466|Melphalan|melphalan|mesh-list
64425149|NCT04875585|Pembrolizumab|pembrolizumab|mesh-list
64699859|NCT00544466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699860|NCT00544466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64699861|NCT00544466|Antimetabolites|antimetabolites|mesh-ancestor
64699862|NCT00544466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699886|NCT00361543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64699887|NCT00361543|Hormone Antagonists|hormone antagonists|mesh-ancestor
64699888|NCT00361543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64699889|NCT00361543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718285|NCT00379028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718286|NCT00379028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64718287|NCT00379028|Respiratory System Agents|respiratory system agents|mesh-ancestor
64699890|NCT00361543|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64699891|NCT00361543|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64699892|NCT00361543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64699893|NCT00003417|Carmustine|carmustine|mesh-list
64699894|NCT00003417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64699895|NCT00003417|Alkylating Agents|alkylating agents|mesh-ancestor
64699896|NCT00003417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699897|NCT00003417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699898|NCT04329429|Trastuzumab|trastuzumab|mesh-list
64699899|NCT04329429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64699900|NCT04329429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699901|NCT00003423|Cytarabine|cytarabine|mesh-list
64699902|NCT00003423|Dexamethasone|dexamethasone|mesh-list
64699903|NCT00003423|Prednisolone|prednisolone|mesh-list
64699904|NCT00003423|Cyclophosphamide|cyclophosphamide|mesh-list
64699905|NCT00003423|Methotrexate|methotrexate|mesh-list
64699906|NCT00003423|Etoposide|etoposide|mesh-list
64699907|NCT00003423|Vincristine|vincristine|mesh-list
64699908|NCT00003423|Daunorubicin|daunorubicin|mesh-list
64699909|NCT00003423|Asparaginase|asparaginase|mesh-list
64699910|NCT00003423|Mercaptopurine|mercaptopurine|mesh-list
64699911|NCT00003423|Thioguanine|thioguanine|mesh-list
64699912|NCT00003423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64699913|NCT00003423|Immunologic Factors|immunologic factors|mesh-ancestor
64699914|NCT00003423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699915|NCT00003423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65459606|NCT00127842|Etanercept|etanercept|mesh-list
65459607|NCT00127842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65459608|NCT00127842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65459609|NCT00127842|Analgesics|analgesics|mesh-ancestor
65459610|NCT00127842|Sensory System Agents|sensory system agents|mesh-ancestor
65459611|NCT00127842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65459612|NCT00127842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459613|NCT00127842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65459614|NCT00127842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65459615|NCT00127842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65459616|NCT00127842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65459617|NCT00127842|Immunologic Factors|immunologic factors|mesh-ancestor
65459618|NCT01075802|Tamoxifen|tamoxifen|mesh-list
65459619|NCT01075802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65459620|NCT01075802|Hormone Antagonists|hormone antagonists|mesh-ancestor
65459621|NCT01075802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65459622|NCT01075802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459623|NCT01075802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65459624|NCT01075802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459625|NCT01075802|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65459626|NCT01075802|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65459627|NCT01075802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65459628|NCT03816592|Analgesics, Opioid|analgesics, opioid|mesh-list
65459629|NCT03816592|Anesthetics|anesthetics|mesh-list
64844176|NCT01667523|Cinnamaldehyde|cinnamaldehyde|mesh-list
64699939|NCT00003423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64699940|NCT00003423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64699959|NCT00003273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699960|NCT00003273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64699961|NCT00003273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64699962|NCT00003273|Alkylating Agents|alkylating agents|mesh-ancestor
64699977|NCT00003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64699978|NCT00003273|Antidotes|antidotes|mesh-ancestor
64699979|NCT00003273|Protective Agents|protective agents|mesh-ancestor
64699980|NCT00003273|Vitamin B Complex|vitamin b complex|mesh-ancestor
64699982|NCT00003273|Micronutrients|micronutrients|mesh-ancestor
64699983|NCT00003273|Tubulin Modulators|tubulin modulators|mesh-ancestor
64699984|NCT00003273|Antimitotic Agents|antimitotic agents|mesh-ancestor
64699985|NCT00003273|Mitosis Modulators|mitosis modulators|mesh-ancestor
64699986|NCT04329585|Flumazenil|flumazenil|mesh-list
64699987|NCT04329585|Antidotes|antidotes|mesh-ancestor
64699988|NCT04329585|Protective Agents|protective agents|mesh-ancestor
64699989|NCT04329585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699990|NCT04329585|GABA Modulators|gaba modulators|mesh-ancestor
64699991|NCT04329585|GABA Agents|gaba agents|mesh-ancestor
64699992|NCT04329585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64699993|NCT04329585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699994|NCT00003279|Antibodies|antibodies|mesh-list
64699995|NCT00003279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64699996|NCT00003279|BCG Vaccine|bcg vaccine|mesh-list
64699997|NCT00003279|Immunologic Factors|immunologic factors|mesh-ancestor
65459630|NCT03816592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65459631|NCT03816592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459632|NCT03816592|Narcotics|narcotics|mesh-ancestor
65459633|NCT03816592|Analgesics|analgesics|mesh-ancestor
65459634|NCT03816592|Sensory System Agents|sensory system agents|mesh-ancestor
65459635|NCT03816592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65459636|NCT01078038|Sirolimus|sirolimus|mesh-list
65459637|NCT01078038|Everolimus|everolimus|mesh-list
65459638|NCT01078038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459639|NCT01078038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65459640|NCT01078038|Immunologic Factors|immunologic factors|mesh-ancestor
65459641|NCT01078038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459642|NCT01078038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65459643|NCT01078038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65459644|NCT01078038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65459645|NCT01078038|Antifungal Agents|antifungal agents|mesh-ancestor
65459646|NCT00223496|Aripiprazole|aripiprazole|mesh-list
65459647|NCT00223496|Antidepressive Agents|antidepressive agents|mesh-ancestor
65459648|NCT00223496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65459649|NCT00223496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65459650|NCT00223496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64699998|NCT00003279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699999|NCT00003279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64700000|NCT00383487|Calcitriol|calcitriol|mesh-list
64718288|NCT00379028|Dermatologic Agents|dermatologic agents|mesh-ancestor
64718289|NCT00379028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64718290|NCT00379028|Glucocorticoids|glucocorticoids|mesh-ancestor
64718292|NCT00379028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64718293|NCT00379028|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64700001|NCT00383487|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
64700002|NCT00383487|Naproxen|naproxen|mesh-list
64700003|NCT00383487|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
64700004|NCT00383487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64700005|NCT00383487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64700006|NCT00383487|Analgesics|analgesics|mesh-ancestor
64700007|NCT00383487|Sensory System Agents|sensory system agents|mesh-ancestor
64700008|NCT00383487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64700009|NCT00383487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700010|NCT00383487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64700011|NCT00383487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64700012|NCT00383487|Gout Suppressants|gout suppressants|mesh-ancestor
64334976|NCT03446807|Droxidopa|droxidopa|mesh-list
64334977|NCT03446807|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64700058|NCT00002805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64700060|NCT00002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700061|NCT00002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700062|NCT00002805|Dermatologic Agents|dermatologic agents|mesh-ancestor
64700099|NCT00003309|Etoposide|etoposide|mesh-list
64700100|NCT00003309|Vincristine|vincristine|mesh-list
64700101|NCT00003309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64700130|NCT00003447|Tubulin Modulators|tubulin modulators|mesh-ancestor
64700131|NCT00003447|Antimitotic Agents|antimitotic agents|mesh-ancestor
64700132|NCT00003447|Mitosis Modulators|mitosis modulators|mesh-ancestor
64700133|NCT00003315|Amphotericin B|amphotericin b|mesh-list
64700134|NCT00003315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64700135|NCT00003315|Sargramostim|sargramostim|mesh-list
64700136|NCT00003315|Immunologic Factors|immunologic factors|mesh-ancestor
65459651|NCT00223496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65459652|NCT00223496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459653|NCT00223496|Dopamine Agonists|dopamine agonists|mesh-ancestor
65459654|NCT00223496|Dopamine Agents|dopamine agents|mesh-ancestor
65459655|NCT00223496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65459656|NCT00223496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459657|NCT00223496|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65459658|NCT00223496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64844215|NCT01667614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700137|NCT00003315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700138|NCT00003315|Amebicides|amebicides|mesh-ancestor
64700139|NCT00003315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64700140|NCT00003315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64700141|NCT00003315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64700142|NCT00003315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64700143|NCT00003315|Antifungal Agents|antifungal agents|mesh-ancestor
64700144|NCT00002817|Sargramostim|sargramostim|mesh-list
64700145|NCT00002817|Immunologic Factors|immunologic factors|mesh-ancestor
64700146|NCT00002817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700147|NCT00003465|Temozolomide|temozolomide|mesh-list
64700180|NCT00361621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64700181|NCT00361621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64700182|NCT00361621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64700183|NCT00361621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64700184|NCT00361621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700185|NCT00361621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64700186|NCT00361621|Glucocorticoids|glucocorticoids|mesh-ancestor
64700187|NCT00361621|Hormones|hormones|mesh-ancestor
64700188|NCT00361621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64700189|NCT00361621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64700190|NCT00361621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64718294|NCT00379028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64718295|NCT00379028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64718296|NCT00379028|Adrenergic Agents|adrenergic agents|mesh-ancestor
64718297|NCT00379028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64326454|NCT02770391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64700221|NCT00002829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700222|NCT00002829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700223|NCT00002829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64700224|NCT00002829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64700225|NCT00002829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64700226|NCT00002829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64334980|NCT03519061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64700275|NCT00002835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64700276|NCT00002835|Alkylating Agents|alkylating agents|mesh-ancestor
64700277|NCT00002835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700278|NCT00002835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700279|NCT00002835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64700280|NCT00002835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64700311|NCT00002835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64700313|NCT00002835|Sensory System Agents|sensory system agents|mesh-ancestor
64700314|NCT00002835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64700315|NCT04560673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64700316|NCT04560673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64700317|NCT04560673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64700318|NCT04560673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64700319|NCT04560673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700320|NCT04560673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64700321|NCT04560673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700322|NCT04560673|Analgesics|analgesics|mesh-ancestor
65459659|NCT00223496|Serotonin Agents|serotonin agents|mesh-ancestor
65459660|NCT00223496|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65459661|NCT00223496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65459662|NCT00223496|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65459663|NCT00223496|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65459664|NCT02531412|Spironolactone|spironolactone|mesh-list
65494043|NCT03777436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459665|NCT02531412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65459666|NCT02531412|Hormone Antagonists|hormone antagonists|mesh-ancestor
65459667|NCT02531412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64700323|NCT04560673|Sensory System Agents|sensory system agents|mesh-ancestor
64700324|NCT04560673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64700325|NCT04560673|Antidepressive Agents|antidepressive agents|mesh-ancestor
64700326|NCT04560673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64700338|NCT00361153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700339|NCT00361153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64700341|NCT00002847|Interferon-alpha|interferon-alpha|mesh-list
64700342|NCT00002847|Aldesleukin|aldesleukin|mesh-list
64700343|NCT00002847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700344|NCT00002847|Antiviral Agents|antiviral agents|mesh-ancestor
64700345|NCT00002847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64700346|NCT00002847|Immunologic Factors|immunologic factors|mesh-ancestor
64700347|NCT00002847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700348|NCT00002847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64700349|NCT00002847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64700350|NCT03576001|Methyltestosterone|methyltestosterone|mesh-list
64334988|NCT03519061|Hormones|hormones|mesh-ancestor
64700351|NCT03576001|Testosterone|testosterone|mesh-list
64700352|NCT03576001|Testosterone undecanoate|testosterone undecanoate|mesh-list
64700353|NCT03576001|Testosterone enanthate|testosterone enanthate|mesh-list
64700354|NCT03576001|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64700355|NCT03576001|Androgens|androgens|mesh-ancestor
64700356|NCT03576001|Hormones|hormones|mesh-ancestor
64700357|NCT03576001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64700358|NCT03576001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700359|NCT03576001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64700360|NCT03576001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718298|NCT00379028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718299|NCT05286554|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64718300|NCT05286554|Hormones|hormones|mesh-list
64718301|NCT05286554|Progesterone|progesterone|mesh-list
64326457|NCT02155205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64700371|NCT00003519|Alkylating Agents|alkylating agents|mesh-ancestor
64700372|NCT00003519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700373|NCT00003519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700374|NCT00003519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64700375|NCT00003519|Tubulin Modulators|tubulin modulators|mesh-ancestor
64700376|NCT00003519|Antimitotic Agents|antimitotic agents|mesh-ancestor
64700377|NCT00003519|Mitosis Modulators|mitosis modulators|mesh-ancestor
64700378|NCT00003519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64700379|NCT00003519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64700380|NCT00003519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64700381|NCT00003519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700382|NCT04220827|Paclitaxel|paclitaxel|mesh-list
64700383|NCT04220827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64700384|NCT04220827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64700385|NCT04220827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700386|NCT04220827|Tubulin Modulators|tubulin modulators|mesh-ancestor
64700387|NCT04220827|Antimitotic Agents|antimitotic agents|mesh-ancestor
64700388|NCT04220827|Mitosis Modulators|mitosis modulators|mesh-ancestor
64700389|NCT04220827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700390|NCT04552795|Lamivudine|lamivudine|mesh-list
64700422|NCT00002865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459668|NCT02531412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459669|NCT02531412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65459670|NCT02531412|Diuretics|diuretics|mesh-ancestor
65459671|NCT02531412|Natriuretic Agents|natriuretic agents|mesh-ancestor
65459672|NCT00126672|Sirolimus|sirolimus|mesh-list
65459673|NCT00126672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65459674|NCT00126672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65459675|NCT00126672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65459676|NCT00126672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459677|NCT00126672|Antifungal Agents|antifungal agents|mesh-ancestor
65459678|NCT00126672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65459679|NCT00126672|Immunologic Factors|immunologic factors|mesh-ancestor
65459680|NCT00126672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459681|NCT00145574|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65459682|NCT00145574|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65459683|NCT00145574|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65459684|NCT00145574|Antimetabolites|antimetabolites|mesh-ancestor
65459685|NCT00145574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459686|NCT00145574|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65459687|NCT05034562|Edetic Acid|edetic acid|mesh-list
65459688|NCT05034562|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64700423|NCT00002865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64700424|NCT00002865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64700425|NCT00002865|Antiemetics|antiemetics|mesh-ancestor
64700426|NCT00002865|Autonomic Agents|autonomic agents|mesh-ancestor
64700427|NCT00002865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64700428|NCT00002865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64700429|NCT00002865|Glucocorticoids|glucocorticoids|mesh-ancestor
64700430|NCT00002865|Hormones|hormones|mesh-ancestor
64700431|NCT00002865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64700432|NCT00002865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64700433|NCT00002865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64700434|NCT00002865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64700435|NCT00002865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64700466|NCT00361309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700468|NCT04154943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64700469|NCT04154943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700470|NCT00361387|Methylphenidate|methylphenidate|mesh-list
64700471|NCT00361387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64700472|NCT00361387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700473|NCT00361387|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64700474|NCT00361387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64700475|NCT00361387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64700476|NCT00361387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700477|NCT00361387|Dopamine Agents|dopamine agents|mesh-ancestor
64700478|NCT00361387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64700479|NCT04530487|Cyclosporine|cyclosporine|mesh-list
64700500|NCT04530487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64700501|NCT04530487|Antimetabolites|antimetabolites|mesh-ancestor
64700502|NCT04530487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700503|NCT04530487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64700504|NCT04530487|Immunologic Factors|immunologic factors|mesh-ancestor
65459689|NCT05034562|Chelating Agents|chelating agents|mesh-ancestor
65459690|NCT05034562|Sequestering Agents|sequestering agents|mesh-ancestor
65459691|NCT05034562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459692|NCT05034562|Anticoagulants|anticoagulants|mesh-ancestor
65459693|NCT05034562|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65459694|NCT05034562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65459695|NCT00145496|Olanzapine|olanzapine|mesh-list
65459696|NCT00145496|Asenapine|asenapine|mesh-list
65459697|NCT00145496|Antiemetics|antiemetics|mesh-ancestor
65459698|NCT00145496|Autonomic Agents|autonomic agents|mesh-ancestor
65459699|NCT00145496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65459700|NCT00145496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459701|NCT00145496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65459702|NCT00145496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64700505|NCT04530487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334990|NCT02229773|Pravastatin|pravastatin|mesh-list
64700515|NCT04530487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64700516|NCT04530487|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64700517|NCT04530487|Antitubercular Agents|antitubercular agents|mesh-ancestor
64700518|NCT04530487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64700519|NCT04530487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64700520|NCT04530487|Alkylating Agents|alkylating agents|mesh-ancestor
64700521|NCT04530487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64700522|NCT04530487|Keratolytic Agents|keratolytic agents|mesh-ancestor
64700523|NCT04530487|Tubulin Modulators|tubulin modulators|mesh-ancestor
64700524|NCT04530487|Antimitotic Agents|antimitotic agents|mesh-ancestor
64700525|NCT04530487|Mitosis Modulators|mitosis modulators|mesh-ancestor
64700526|NCT00003369|Tirapazamine|tirapazamine|mesh-list
64700527|NCT00003369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700528|NCT04342351|Valsartan|valsartan|mesh-list
64700529|NCT04342351|Perindopril|perindopril|mesh-list
64700530|NCT04342351|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64700531|NCT04342351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64700532|NCT04342351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64700533|NCT04342351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64700534|NCT04342351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700535|NCT04342351|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64700536|NCT04342351|Protease Inhibitors|protease inhibitors|mesh-ancestor
64700537|NCT04342351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700538|NCT04342273|Moxifloxacin|moxifloxacin|mesh-list
64700539|NCT04342273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64700555|NCT03504241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700556|NCT03504241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64700557|NCT03504241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700558|NCT03504241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64700559|NCT03504241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64700560|NCT03504241|Antitubercular Agents|antitubercular agents|mesh-ancestor
64700561|NCT03504241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64700562|NCT03504241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64700563|NCT03504241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700564|NCT03504241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700565|NCT03504241|Antifungal Agents|antifungal agents|mesh-ancestor
64700566|NCT03504241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64700567|NCT03504241|Immunologic Factors|immunologic factors|mesh-ancestor
64700568|NCT03504241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64700569|NCT03504241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64700570|NCT03504241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64700571|NCT00003375|Vincristine|vincristine|mesh-list
64700572|NCT00003375|Lomustine|lomustine|mesh-list
64700584|NCT03499249|Antiviral Agents|antiviral agents|mesh-ancestor
64700585|NCT03499249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64700586|NCT03499249|Expectorants|expectorants|mesh-ancestor
65459703|NCT00145496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65459704|NCT00145496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65459705|NCT00145496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65459706|NCT00145496|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65459707|NCT00145496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65459708|NCT00145496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65459709|NCT00145496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459710|NCT00145496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65459711|NCT00145496|Serotonin Agents|serotonin agents|mesh-ancestor
65459712|NCT01299922|Cyclosporine|cyclosporine|mesh-list
65459713|NCT01299922|Mycophenolic Acid|mycophenolic acid|mesh-list
65459714|NCT01299922|Cyclosporins|cyclosporins|mesh-list
65459715|NCT01299922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459716|NCT01299922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459717|NCT01299922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65459718|NCT01299922|Immunologic Factors|immunologic factors|mesh-ancestor
65459719|NCT01299922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459720|NCT01299922|Antifungal Agents|antifungal agents|mesh-ancestor
65459721|NCT01299922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65459722|NCT01299922|Dermatologic Agents|dermatologic agents|mesh-ancestor
64700587|NCT03499249|Respiratory System Agents|respiratory system agents|mesh-ancestor
64700588|NCT03499249|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64700589|NCT03499249|Antioxidants|antioxidants|mesh-ancestor
64700590|NCT03499249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700591|NCT03499249|Protective Agents|protective agents|mesh-ancestor
64700592|NCT03499249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700593|NCT03499249|Antidotes|antidotes|mesh-ancestor
64700595|NCT03498391|Propofol|propofol|mesh-list
64700596|NCT03498391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64700597|NCT03498391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64700598|NCT03498391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700599|NCT03498391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64700600|NCT03498391|Anesthetics, General|anesthetics, general|mesh-ancestor
64700602|NCT03498391|Analgesics|analgesics|mesh-ancestor
64700637|NCT00003549|Methotrexate|methotrexate|mesh-list
64700638|NCT00003549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64700639|NCT00003549|Immunologic Factors|immunologic factors|mesh-ancestor
64700640|NCT00003549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700670|NCT00002889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700671|NCT00002889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64700673|NCT00002889|Androgen Antagonists|androgen antagonists|mesh-ancestor
64700674|NCT00002889|Hormone Antagonists|hormone antagonists|mesh-ancestor
64700675|NCT00002889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64700676|NCT03492463|Nicotine|nicotine|mesh-list
64700677|NCT03492463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64700678|NCT03492463|Autonomic Agents|autonomic agents|mesh-ancestor
64700679|NCT03492463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64700680|NCT03492463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700681|NCT03492463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64700682|NCT03492463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64700683|NCT03492463|Cholinergic Agents|cholinergic agents|mesh-ancestor
64700717|NCT00003957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64700718|NCT00003957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64700719|NCT00003957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459723|NCT01299922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65459724|NCT01299922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65459725|NCT01299922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65459726|NCT01299922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459727|NCT01299922|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65459728|NCT01299922|Antitubercular Agents|antitubercular agents|mesh-ancestor
65459729|NCT01299922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65459730|NCT05030818|Aspirin|aspirin|mesh-list
65459731|NCT05030818|Ramipril|ramipril|mesh-list
65459732|NCT05030818|Atorvastatin|atorvastatin|mesh-list
65459733|NCT05030818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65459734|NCT05030818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65459735|NCT05030818|Antimetabolites|antimetabolites|mesh-ancestor
65459736|NCT05030818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459737|NCT05030818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65459738|NCT05030818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65459739|NCT05030818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459740|NCT05030818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65459741|NCT05030818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64700720|NCT00003957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64417601|NCT02598193|Analgesics|analgesics|mesh-ancestor
64700759|NCT00004845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64700761|NCT00004845|Analgesics|analgesics|mesh-ancestor
64700762|NCT00004845|Sensory System Agents|sensory system agents|mesh-ancestor
64700763|NCT00004845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64700764|NCT00004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700765|NCT00004845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64700766|NCT00004845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64700767|NCT00004845|Gout Suppressants|gout suppressants|mesh-ancestor
64700768|NCT00004845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64700782|NCT00003993|Antiviral Agents|antiviral agents|mesh-ancestor
64700783|NCT00003993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64700784|NCT00003993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64700785|NCT00003993|Immunologic Factors|immunologic factors|mesh-ancestor
64700786|NCT00003993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718314|NCT00379262|Antimetabolites|antimetabolites|mesh-ancestor
64718315|NCT00379262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718316|NCT00379262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64700787|NCT00004857|Fludarabine|fludarabine|mesh-list
64700788|NCT00004857|Fludarabine phosphate|fludarabine phosphate|mesh-list
64700789|NCT00004857|Alemtuzumab|alemtuzumab|mesh-list
64700790|NCT00004857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700791|NCT00004857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64700792|NCT00004857|Antimetabolites|antimetabolites|mesh-ancestor
64700793|NCT00004857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700794|NCT00004857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64700795|NCT00004857|Immunologic Factors|immunologic factors|mesh-ancestor
64700796|NCT00004857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700797|NCT00004857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64700798|NCT03476239|Blinatumomab|blinatumomab|mesh-list
64700799|NCT03476239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700800|NCT00004863|Paclitaxel|paclitaxel|mesh-list
64700801|NCT00004863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64700802|NCT00004863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700803|NCT00004863|Tubulin Modulators|tubulin modulators|mesh-ancestor
65459742|NCT05030818|Analgesics|analgesics|mesh-ancestor
65459743|NCT05030818|Sensory System Agents|sensory system agents|mesh-ancestor
65459744|NCT05030818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65459745|NCT05030818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459746|NCT05030818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65459747|NCT05030818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65459748|NCT05030818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65459749|NCT05030818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65459750|NCT05030818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65459751|NCT05030818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65459752|NCT05030818|Antipyretics|antipyretics|mesh-ancestor
65459753|NCT05030818|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65459754|NCT05030818|Protease Inhibitors|protease inhibitors|mesh-ancestor
65459755|NCT05030818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65459756|NCT01582022|Bupivacaine|bupivacaine|mesh-list
65459757|NCT01582022|Anesthetics, Local|anesthetics, local|mesh-ancestor
65459758|NCT01582022|Anesthetics|anesthetics|mesh-ancestor
65459759|NCT01582022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65459760|NCT01582022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459761|NCT01582022|Sensory System Agents|sensory system agents|mesh-ancestor
65459762|NCT01582022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65459763|NCT01582412|Isavuconazole|isavuconazole|mesh-list
65459764|NCT01582412|Digoxin|digoxin|mesh-list
65459765|NCT01582412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65459766|NCT01582412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65459767|NCT01582412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459768|NCT01582412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459769|NCT01582412|Protective Agents|protective agents|mesh-ancestor
65459770|NCT01582412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459771|NCT01582412|Antifungal Agents|antifungal agents|mesh-ancestor
65459772|NCT01582412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65459773|NCT04979806|Meropenem|meropenem|mesh-list
65459774|NCT04979806|Cefepime|cefepime|mesh-list
65459778|NCT00255164|Lansoprazole|lansoprazole|mesh-list
65459784|NCT01300156|Oxaliplatin|oxaliplatin|mesh-list
65459785|NCT01300156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459786|NCT00126594|Interferons|interferons|mesh-list
65459787|NCT00126594|Interferon-alpha|interferon-alpha|mesh-list
65459788|NCT00126594|Interferon alpha-2|interferon alpha-2|mesh-list
65459789|NCT00126594|Sorafenib|sorafenib|mesh-list
65459790|NCT00126594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459791|NCT00126594|Antiviral Agents|antiviral agents|mesh-ancestor
65459792|NCT00126594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65459793|NCT00126594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65459794|NCT00126594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459795|NCT00126594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459796|NCT00126594|Immunologic Factors|immunologic factors|mesh-ancestor
65459797|NCT00126594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459798|NCT01080456|Tacrolimus|tacrolimus|mesh-list
65459799|NCT01080456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65459800|NCT01080456|Immunologic Factors|immunologic factors|mesh-ancestor
65459801|NCT01080456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459802|NCT01080456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65459803|NCT01080456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844349|NCT01668680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64700804|NCT00004863|Antimitotic Agents|antimitotic agents|mesh-ancestor
64700805|NCT00004863|Mitosis Modulators|mitosis modulators|mesh-ancestor
64700806|NCT00004863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700807|NCT00004875|Heparin|heparin|mesh-list
64700808|NCT00004875|Enoxaparin|enoxaparin|mesh-list
64700809|NCT00004875|Anticoagulants|anticoagulants|mesh-ancestor
64700810|NCT00004875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64700811|NCT00004875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64700812|NCT00004875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700813|NCT00003561|Interferons|interferons|mesh-list
64700814|NCT00003561|Interferon-alpha|interferon-alpha|mesh-list
64700815|NCT00003561|Sargramostim|sargramostim|mesh-list
64700816|NCT00003561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700817|NCT00003561|Antiviral Agents|antiviral agents|mesh-ancestor
64700818|NCT00003561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64700819|NCT00003561|Immunologic Factors|immunologic factors|mesh-ancestor
64700820|NCT00003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700821|NCT00003567|Temozolomide|temozolomide|mesh-list
64700822|NCT00003567|Carmustine|carmustine|mesh-list
64700823|NCT00003567|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64700824|NCT00003567|Sargramostim|sargramostim|mesh-list
64700825|NCT00003567|Immunologic Factors|immunologic factors|mesh-ancestor
64700826|NCT00003567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700827|NCT00003567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64700828|NCT00003567|Alkylating Agents|alkylating agents|mesh-ancestor
64700829|NCT00003567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700865|NCT00003585|Antimetabolites|antimetabolites|mesh-ancestor
64700882|NCT00003591|Mitosis Modulators|mitosis modulators|mesh-ancestor
64700883|NCT00003591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700885|NCT02975323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64700886|NCT02975323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64700887|NCT02975323|Adrenergic Agents|adrenergic agents|mesh-ancestor
64700888|NCT02975323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64700889|NCT02975323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700890|NCT02975323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459804|NCT01080456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459805|NCT03811054|Apatinib|apatinib|mesh-list
65459806|NCT03811054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459807|NCT03811054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65459808|NCT03811054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459809|NCT03811054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459810|NCT00126438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65459811|NCT00126438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459812|NCT00126438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459813|NCT00126438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459814|NCT00126438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65209340|NCT00704392|XL647|xl647|mesh-list
65459815|NCT01075854|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64700891|NCT02975323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64700892|NCT02975323|Antioxidants|antioxidants|mesh-ancestor
64700893|NCT02975323|Protective Agents|protective agents|mesh-ancestor
64700894|NCT02975323|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64700895|NCT02975323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64700896|NCT02975323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64700897|NCT02975323|Vasodilator Agents|vasodilator agents|mesh-ancestor
64718317|NCT00379262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718318|NCT00379262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64718319|NCT00379262|Immunologic Factors|immunologic factors|mesh-ancestor
64718320|NCT00379262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718321|NCT00793520|Milnacipran|milnacipran|mesh-list
64718322|NCT00793520|Levomilnacipran|levomilnacipran|mesh-list
64700898|NCT02975323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64700899|NCT02975323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64700900|NCT00003597|Carboplatin|carboplatin|mesh-list
64700901|NCT00003597|Etoposide|etoposide|mesh-list
64700902|NCT00003597|Ifosfamide|ifosfamide|mesh-list
64700903|NCT00003597|Lenograstim|lenograstim|mesh-list
64700904|NCT00003597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700905|NCT00003597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64700906|NCT00003597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64700907|NCT00003597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64700908|NCT00003597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700909|NCT00003597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700910|NCT00003597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64700911|NCT00003597|Alkylating Agents|alkylating agents|mesh-ancestor
64700912|NCT00003597|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64700913|NCT00003597|Immunologic Factors|immunologic factors|mesh-ancestor
64700914|NCT00003597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700915|NCT00004005|Leucovorin|leucovorin|mesh-list
64700916|NCT00004005|Fluorouracil|fluorouracil|mesh-list
64700917|NCT00004005|Irinotecan|irinotecan|mesh-list
64700918|NCT00004005|Calcium|calcium|mesh-list
64700919|NCT00004005|Levoleucovorin|levoleucovorin|mesh-list
64700920|NCT00004005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64700921|NCT00004005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700922|NCT00004005|Antimetabolites|antimetabolites|mesh-ancestor
64426211|NCT02775435|Paclitaxel|paclitaxel|mesh-list
64700923|NCT00004005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700924|NCT00004005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64700925|NCT00004005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700926|NCT00004005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64700927|NCT00004005|Immunologic Factors|immunologic factors|mesh-ancestor
64700928|NCT00004005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64700929|NCT00004005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64700930|NCT00004005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700931|NCT00004005|Antidotes|antidotes|mesh-ancestor
64700932|NCT00004005|Protective Agents|protective agents|mesh-ancestor
65459816|NCT01075854|Hormones|hormones|mesh-ancestor
65459817|NCT01075854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65459818|NCT01075854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459819|NCT03967392|Lidocaine|lidocaine|mesh-list
65459820|NCT03967392|Anesthetics, Local|anesthetics, local|mesh-ancestor
65459821|NCT03967392|Anesthetics|anesthetics|mesh-ancestor
65459822|NCT03967392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65459823|NCT03967392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459824|NCT03967392|Sensory System Agents|sensory system agents|mesh-ancestor
65459825|NCT03967392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65459826|NCT03967392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65459827|NCT03967392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65459828|NCT03967392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65459829|NCT03967392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65459830|NCT03967392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459831|NCT04898764|Mometasone Furoate|mometasone furoate|mesh-list
65459832|NCT04898764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64844384|NCT01668901|Antipyretics|antipyretics|mesh-ancestor
64700977|NCT00004887|Alkylating Agents|alkylating agents|mesh-ancestor
64700978|NCT00004887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64700979|NCT00004887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64700980|NCT00004887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700982|NCT00004893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64700983|NCT00004893|Immunologic Factors|immunologic factors|mesh-ancestor
64700984|NCT00004893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700992|NCT04513951|Oxaliplatin|oxaliplatin|mesh-list
64700994|NCT04513951|Cetuximab|cetuximab|mesh-list
64700995|NCT04513951|Avelumab|avelumab|mesh-list
64700996|NCT04513951|Levoleucovorin|levoleucovorin|mesh-list
64700997|NCT04513951|Antimetabolites|antimetabolites|mesh-ancestor
64426280|NCT04803201|Doxorubicin|doxorubicin|mesh-list
64700998|NCT04513951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700999|NCT04513951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64701000|NCT04513951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701001|NCT04513951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64701002|NCT04513951|Immunologic Factors|immunologic factors|mesh-ancestor
64701003|NCT04513951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718323|NCT00793520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64718324|NCT00793520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64718325|NCT00793520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64718326|NCT00793520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718327|NCT00793520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64718328|NCT00793520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718329|NCT00793520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64701004|NCT04513951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64701005|NCT04513951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64701006|NCT04513951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701007|NCT04513951|Antidotes|antidotes|mesh-ancestor
64701008|NCT04513951|Protective Agents|protective agents|mesh-ancestor
64701009|NCT04513951|Vitamin B Complex|vitamin b complex|mesh-ancestor
64701010|NCT04513951|Vitamins|vitamins|mesh-ancestor
64701011|NCT04513951|Micronutrients|micronutrients|mesh-ancestor
64701012|NCT04513951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64701013|NCT00004011|Paclitaxel|paclitaxel|mesh-list
64701014|NCT00004011|Carboplatin|carboplatin|mesh-list
65459833|NCT04898764|Dermatologic Agents|dermatologic agents|mesh-ancestor
65459834|NCT04898764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65459835|NCT00142584|Metoprolol|metoprolol|mesh-list
65459836|NCT00142584|Nebivolol|nebivolol|mesh-list
65459837|NCT00142584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65459838|NCT00142584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65459839|NCT00142584|Sympatholytics|sympatholytics|mesh-ancestor
65459840|NCT00142584|Autonomic Agents|autonomic agents|mesh-ancestor
65459841|NCT00142584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65459842|NCT00142584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459843|NCT00142584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65459844|NCT00142584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65459845|NCT00142584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65459846|NCT00142584|Adrenergic Agents|adrenergic agents|mesh-ancestor
65459847|NCT00142584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65459848|NCT00142584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459849|NCT00142584|Vasodilator Agents|vasodilator agents|mesh-ancestor
65459850|NCT00142584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64701015|NCT00004011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64701016|NCT00004011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701017|NCT00004011|Tubulin Modulators|tubulin modulators|mesh-ancestor
64701018|NCT00004011|Antimitotic Agents|antimitotic agents|mesh-ancestor
64701019|NCT00004011|Mitosis Modulators|mitosis modulators|mesh-ancestor
64701020|NCT00004011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701021|NCT03448393|Cyclophosphamide|cyclophosphamide|mesh-list
64701022|NCT03448393|Fludarabine|fludarabine|mesh-list
64701023|NCT03448393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64701024|NCT03448393|Immunologic Factors|immunologic factors|mesh-ancestor
64701025|NCT03448393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701026|NCT03448393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64701027|NCT03448393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64701028|NCT03448393|Alkylating Agents|alkylating agents|mesh-ancestor
64701029|NCT03448393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701030|NCT03448393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701031|NCT03448393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64335015|NCT03515707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701047|NCT00004905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64701048|NCT00004905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64701049|NCT00004905|Alkylating Agents|alkylating agents|mesh-ancestor
64701050|NCT00004905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701051|NCT00004905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701052|NCT00004905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64701053|NCT00004905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64701054|NCT00004905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64701084|NCT00421915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64701085|NCT00421915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64701086|NCT00421915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64701087|NCT00421915|Immunologic Factors|immunologic factors|mesh-ancestor
64701089|NCT00362713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64701090|NCT00362713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701091|NCT00362713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64701092|NCT00362713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718331|NCT00793520|Sensory System Agents|sensory system agents|mesh-ancestor
64718332|NCT00793520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65459851|NCT00142584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65459852|NCT00142584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65459853|NCT04848064|Cyclophosphamide|cyclophosphamide|mesh-list
65459854|NCT04848064|Fludarabine|fludarabine|mesh-list
65459855|NCT04848064|Mogamulizumab|mogamulizumab|mesh-list
65459856|NCT04848064|Immunoglobulins|immunoglobulins|mesh-list
65459857|NCT04848064|Immunoglobulin G|immunoglobulin g|mesh-list
65459858|NCT04848064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65459859|NCT04848064|Immunologic Factors|immunologic factors|mesh-ancestor
65459860|NCT04848064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459861|NCT04848064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65459862|NCT04848064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65459863|NCT04848064|Alkylating Agents|alkylating agents|mesh-ancestor
65459864|NCT04848064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459865|NCT04848064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459866|NCT04848064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65459867|NCT03816046|Botulinum Toxins|botulinum toxins|mesh-list
65459868|NCT03816046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65459869|NCT03816046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65459870|NCT03816046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65459871|NCT03816046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65459872|NCT03816046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459873|NCT03816046|Cholinergic Agents|cholinergic agents|mesh-ancestor
65459874|NCT03816046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65459875|NCT03816046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459876|NCT03816046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65459877|NCT03816046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65459878|NCT01080534|Tacrolimus|tacrolimus|mesh-list
65459879|NCT01080534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65459880|NCT01080534|Immunologic Factors|immunologic factors|mesh-ancestor
65459881|NCT01080534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459882|NCT01080534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65459883|NCT01080534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718333|NCT00793520|Antidepressive Agents|antidepressive agents|mesh-ancestor
64718334|NCT00793520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64718335|NCT03621085|Ketamine|ketamine|mesh-list
64718336|NCT03621085|Analgesics|analgesics|mesh-ancestor
64718337|NCT03621085|Sensory System Agents|sensory system agents|mesh-ancestor
64718338|NCT03621085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64718339|NCT03621085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718340|NCT03621085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64718341|NCT03621085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64718342|NCT03621085|Anesthetics, General|anesthetics, general|mesh-ancestor
65459884|NCT01080534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459885|NCT00125190|Mecasermin|mecasermin|mesh-list
65459886|NCT00125190|Growth Substances|growth substances|mesh-ancestor
65459887|NCT00125190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459888|NCT00141726|Etanercept|etanercept|mesh-list
65459889|NCT00141726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65459890|NCT00141726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65459891|NCT00141726|Analgesics|analgesics|mesh-ancestor
65459892|NCT00141726|Sensory System Agents|sensory system agents|mesh-ancestor
65459893|NCT00141726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65459894|NCT00141726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459895|NCT00141726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65459896|NCT00141726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65459897|NCT00141726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65459898|NCT00141726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65459899|NCT00141726|Immunologic Factors|immunologic factors|mesh-ancestor
65459900|NCT03967548|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65459901|NCT03967548|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65459902|NCT01301716|Paclitaxel|paclitaxel|mesh-list
65459903|NCT01301716|Bevacizumab|bevacizumab|mesh-list
65459904|NCT01301716|Carboplatin|carboplatin|mesh-list
65459905|NCT01301716|Pemetrexed|pemetrexed|mesh-list
64844456|NCT01669226|Taxane|taxane|mesh-list
64718343|NCT03621085|Anesthetics|anesthetics|mesh-ancestor
64718344|NCT03621085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64718345|NCT03621085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64718346|NCT03621085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64718347|NCT03621085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64718348|NCT03621085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718349|NCT00795236|Melatonin|melatonin|mesh-list
64718350|NCT00795236|Antioxidants|antioxidants|mesh-ancestor
64718351|NCT00795236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718352|NCT00795236|Protective Agents|protective agents|mesh-ancestor
64326492|NCT04729387|Paclitaxel|paclitaxel|mesh-list
64701093|NCT00004047|Exatecan|exatecan|mesh-list
64701094|NCT00004047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64701095|NCT00004047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64701096|NCT00004047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701097|NCT00004047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701098|NCT00004047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701099|NCT00003627|Fluorouracil|fluorouracil|mesh-list
64335019|NCT03515707|Immunologic Factors|immunologic factors|mesh-ancestor
64718353|NCT00795236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718354|NCT00795236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64718355|NCT00790478|Melatonin|melatonin|mesh-list
64701145|NCT02363335|Hormones|hormones|mesh-ancestor
64701146|NCT02363335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64701147|NCT02363335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64701148|NCT02363335|Protease Inhibitors|protease inhibitors|mesh-ancestor
64701171|NCT00003639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64701172|NCT00003639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64701173|NCT00003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701174|NCT00003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459906|NCT01301716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65459907|NCT01301716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459908|NCT01301716|Tubulin Modulators|tubulin modulators|mesh-ancestor
65459909|NCT01301716|Antimitotic Agents|antimitotic agents|mesh-ancestor
65459910|NCT01301716|Mitosis Modulators|mitosis modulators|mesh-ancestor
65459911|NCT01301716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459912|NCT01301716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65459913|NCT01301716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65459914|NCT01301716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65459915|NCT01301716|Growth Substances|growth substances|mesh-ancestor
65459916|NCT01301716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459917|NCT01301716|Growth Inhibitors|growth inhibitors|mesh-ancestor
65459918|NCT01301716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459919|NCT01301716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65459920|NCT01301716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65459921|NCT01303042|Insulin Lispro|insulin lispro|mesh-list
65459922|NCT01303042|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
64701175|NCT00003639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64701176|NCT00003639|Alkylating Agents|alkylating agents|mesh-ancestor
64701177|NCT00004923|Docetaxel|docetaxel|mesh-list
64701178|NCT00004923|Irinotecan|irinotecan|mesh-list
64701179|NCT00004923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701180|NCT00004923|Tubulin Modulators|tubulin modulators|mesh-ancestor
64701181|NCT00004923|Antimitotic Agents|antimitotic agents|mesh-ancestor
64701182|NCT00004923|Mitosis Modulators|mitosis modulators|mesh-ancestor
64701183|NCT00004923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701184|NCT00004923|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64701185|NCT00004923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64701186|NCT00004923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701187|NCT02317783|Deoxyglucose|deoxyglucose|mesh-list
64701188|NCT02317783|Flutemetamol|flutemetamol|mesh-list
64701189|NCT02317783|Antimetabolites|antimetabolites|mesh-ancestor
64701190|NCT02317783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701191|NCT02317783|Antiviral Agents|antiviral agents|mesh-ancestor
64701192|NCT02317783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64701193|NCT02317783|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64701194|NCT00004071|Prednisone|prednisone|mesh-list
64701195|NCT00004071|Mitoxantrone|mitoxantrone|mesh-list
64701196|NCT00004071|Leflunomide|leflunomide|mesh-list
64701197|NCT00004071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64701198|NCT00004071|Glucocorticoids|glucocorticoids|mesh-ancestor
64701199|NCT00004071|Hormones|hormones|mesh-ancestor
64335028|NCT02298205|Beclomethasone|beclomethasone|mesh-list
64701245|NCT00003657|Alkylating Agents|alkylating agents|mesh-ancestor
64701246|NCT00003657|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64701247|NCT00003657|Protective Agents|protective agents|mesh-ancestor
64701248|NCT00004089|Paclitaxel|paclitaxel|mesh-list
64701249|NCT00004089|Fluorouracil|fluorouracil|mesh-list
64701250|NCT00004089|Hydroxyurea|hydroxyurea|mesh-list
64701275|NCT00004095|Immunologic Factors|immunologic factors|mesh-ancestor
64701276|NCT00004095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701277|NCT00004095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64701278|NCT00004095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64701280|NCT00003663|Rituximab|rituximab|mesh-list
64701281|NCT00003663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64701282|NCT00003663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701283|NCT00003663|Immunologic Factors|immunologic factors|mesh-ancestor
64701284|NCT00003663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459923|NCT01303042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65459924|NCT01303042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459925|NCT01300312|Diclofenac|diclofenac|mesh-list
65459926|NCT01300312|Eperisone|eperisone|mesh-list
65459927|NCT01300312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65459928|NCT01300312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65459929|NCT01300312|Analgesics|analgesics|mesh-ancestor
65459930|NCT01300312|Sensory System Agents|sensory system agents|mesh-ancestor
65459931|NCT01300312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844489|NCT01669304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64844490|NCT01669304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64844492|NCT01669304|Vasodilator Agents|vasodilator agents|mesh-ancestor
64701285|NCT00003663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64701286|NCT00003663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64701287|NCT00003663|Antiemetics|antiemetics|mesh-ancestor
64701288|NCT00003663|Autonomic Agents|autonomic agents|mesh-ancestor
64701289|NCT00003663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64701290|NCT00003663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64701291|NCT00003663|Glucocorticoids|glucocorticoids|mesh-ancestor
64701292|NCT00003663|Hormones|hormones|mesh-ancestor
64718357|NCT00790478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718358|NCT00790478|Protective Agents|protective agents|mesh-ancestor
64718359|NCT00790478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718360|NCT00790478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64718361|NCT04490239|Heparin|heparin|mesh-list
64718362|NCT04490239|Calcium heparin|calcium heparin|mesh-list
64701293|NCT00003663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64701294|NCT00003663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64701295|NCT00004107|Epratuzumab|epratuzumab|mesh-list
64701296|NCT00004107|Antibodies|antibodies|mesh-list
64701297|NCT00004107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64701298|NCT00004107|Immunologic Factors|immunologic factors|mesh-ancestor
64701299|NCT00004107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701311|NCT00004125|Doxorubicin|doxorubicin|mesh-list
64701312|NCT00004125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64701313|NCT00004125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64701314|NCT00004125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701315|NCT00004125|Tubulin Modulators|tubulin modulators|mesh-ancestor
64701316|NCT00004125|Antimitotic Agents|antimitotic agents|mesh-ancestor
64701317|NCT00004125|Mitosis Modulators|mitosis modulators|mesh-ancestor
64701318|NCT00004125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701319|NCT00004125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64701320|NCT00004125|Immunologic Factors|immunologic factors|mesh-ancestor
64701321|NCT00004125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701322|NCT00004125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64701334|NCT00004125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64701335|NCT00004125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64701336|NCT00004125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64701338|NCT00003675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64701339|NCT00003675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64701340|NCT00003675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701341|NCT00003675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701342|NCT00003675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701343|NCT00004137|Paclitaxel|paclitaxel|mesh-list
64701344|NCT00004137|Carboplatin|carboplatin|mesh-list
64701345|NCT00004137|Topotecan|topotecan|mesh-list
64701346|NCT00004137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64701347|NCT00004137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701348|NCT00004137|Tubulin Modulators|tubulin modulators|mesh-ancestor
64701349|NCT00004137|Antimitotic Agents|antimitotic agents|mesh-ancestor
64701350|NCT00004137|Mitosis Modulators|mitosis modulators|mesh-ancestor
64701351|NCT00004137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701352|NCT00004137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65459932|NCT01300312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459933|NCT01300312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65459934|NCT01300312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65459935|NCT01300312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65459936|NCT01300312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459937|NCT01300312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459938|NCT01300312|Anticonvulsants|anticonvulsants|mesh-ancestor
65459939|NCT01300312|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65459940|NCT01300312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65459941|NCT01300312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65459942|NCT01300312|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65459943|NCT01300312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65459944|NCT01300312|Parasympatholytics|parasympatholytics|mesh-ancestor
65459945|NCT01300312|Autonomic Agents|autonomic agents|mesh-ancestor
64701353|NCT00004137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64701354|NCT00004137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701355|NCT00003681|Epoetin Alfa|epoetin alfa|mesh-list
64701356|NCT00003681|Amifostine|amifostine|mesh-list
64701357|NCT00003681|Hematinics|hematinics|mesh-ancestor
64701358|NCT00003681|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64701359|NCT00003681|Protective Agents|protective agents|mesh-ancestor
64701360|NCT00003681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701361|NCT00005007|Etanercept|etanercept|mesh-list
64701362|NCT00005007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64718364|NCT04490239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64718365|NCT04490239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64718366|NCT04490239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718367|NCT00791336|Nelfinavir|nelfinavir|mesh-list
64718368|NCT00791336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64326528|NCT04681105|Glucocorticoids|glucocorticoids|mesh-ancestor
64701363|NCT00005007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64701364|NCT00005007|Analgesics|analgesics|mesh-ancestor
64701387|NCT00384657|Hematinics|hematinics|mesh-ancestor
64701388|NCT00005013|Sertraline|sertraline|mesh-list
64701389|NCT00005013|Antidepressive Agents|antidepressive agents|mesh-ancestor
64701390|NCT00005013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64701391|NCT00005013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64701392|NCT00005013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64701393|NCT00005013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64701394|NCT00005013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701395|NCT00005013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64701396|NCT00005013|Serotonin Agents|serotonin agents|mesh-ancestor
64701397|NCT00005013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701398|NCT00004161|Fenretinide|fenretinide|mesh-list
64701399|NCT00004161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701400|NCT00004161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64701409|NCT00004173|Mitosis Modulators|mitosis modulators|mesh-ancestor
64701410|NCT00004173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701411|NCT00005025|Ganciclovir|ganciclovir|mesh-list
64701412|NCT00005025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64701413|NCT00005025|Antiviral Agents|antiviral agents|mesh-ancestor
64701414|NCT00005025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64701415|NCT00005025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64701416|NCT00005025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701448|NCT00003687|Dextromethorphan|dextromethorphan|mesh-list
64701449|NCT00003687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64701450|NCT00003687|Narcotics|narcotics|mesh-ancestor
64701451|NCT00003687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64701452|NCT00003687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701453|NCT00003687|Analgesics|analgesics|mesh-ancestor
65459946|NCT01300312|Vasodilator Agents|vasodilator agents|mesh-ancestor
65459947|NCT01567384|Pemetrexed|pemetrexed|mesh-list
65459948|NCT01567384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459949|NCT01567384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65459950|NCT01567384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459951|NCT01567384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65459952|NCT01567384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65459953|NCT01080612|Pregabalin|pregabalin|mesh-list
65459954|NCT01080612|Analgesics|analgesics|mesh-ancestor
65459955|NCT01080612|Sensory System Agents|sensory system agents|mesh-ancestor
65459956|NCT01080612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65459957|NCT01080612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459958|NCT01080612|Anticonvulsants|anticonvulsants|mesh-ancestor
65459959|NCT01080612|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65459960|NCT01080612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65459961|NCT01080612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65459962|NCT01080612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64701454|NCT00003687|Sensory System Agents|sensory system agents|mesh-ancestor
64701455|NCT00003687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64701456|NCT00003687|Antitussive Agents|antitussive agents|mesh-ancestor
64701457|NCT00003687|Respiratory System Agents|respiratory system agents|mesh-ancestor
64701489|NCT00004197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64701490|NCT00004197|Tubulin Modulators|tubulin modulators|mesh-ancestor
64701491|NCT00004197|Antimitotic Agents|antimitotic agents|mesh-ancestor
64701492|NCT00004197|Mitosis Modulators|mitosis modulators|mesh-ancestor
64701493|NCT00004197|Analgesics|analgesics|mesh-ancestor
64701494|NCT00004197|Sensory System Agents|sensory system agents|mesh-ancestor
64335060|NCT02298283|Immunologic Factors|immunologic factors|mesh-ancestor
64701495|NCT00004197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64701496|NCT00004197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64701497|NCT00003693|Dolastatin 10|dolastatin 10|mesh-list
64335061|NCT02298283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701498|NCT00003693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701499|NCT00003693|Tubulin Modulators|tubulin modulators|mesh-ancestor
64701500|NCT00003693|Antimitotic Agents|antimitotic agents|mesh-ancestor
64701501|NCT00003693|Mitosis Modulators|mitosis modulators|mesh-ancestor
64701529|NCT00005049|Floxuridine|floxuridine|mesh-list
64701530|NCT00005049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701531|NCT00005049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64701532|NCT00005049|Antimetabolites|antimetabolites|mesh-ancestor
64701533|NCT00005049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718369|NCT00791336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64718370|NCT00791336|Protease Inhibitors|protease inhibitors|mesh-ancestor
64718371|NCT00791336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718372|NCT00791336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718373|NCT00791336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64718374|NCT00791336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64718375|NCT00791336|Antiviral Agents|antiviral agents|mesh-ancestor
64718376|NCT00791336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64718377|NCT00771602|Rituximab|rituximab|mesh-list
64718378|NCT00771602|Alemtuzumab|alemtuzumab|mesh-list
64701534|NCT00004215|Cytarabine|cytarabine|mesh-list
64701535|NCT00004215|Daunorubicin|daunorubicin|mesh-list
64701536|NCT00004215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64701537|NCT00004215|Antimetabolites|antimetabolites|mesh-ancestor
64701538|NCT00004215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701539|NCT00004215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459963|NCT01080612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65459964|NCT01080612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65459965|NCT01080612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65459966|NCT01080612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65459967|NCT03815344|Misoprostol|misoprostol|mesh-list
65459968|NCT03815344|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65459969|NCT03815344|Abortifacient Agents|abortifacient agents|mesh-ancestor
65459970|NCT03815344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65459971|NCT03815344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459972|NCT03815344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65459973|NCT03815344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65459974|NCT03815344|Oxytocics|oxytocics|mesh-ancestor
65459975|NCT03819790|Insulin|insulin|mesh-list
64844533|NCT01669824|Aspirin|aspirin|mesh-list
64701540|NCT00004215|Antiviral Agents|antiviral agents|mesh-ancestor
64701541|NCT00004215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64701542|NCT00004215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64701543|NCT00004215|Immunologic Factors|immunologic factors|mesh-ancestor
64701574|NCT00003711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64701575|NCT00003711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64701576|NCT00003711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701577|NCT00003711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701578|NCT00003711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701579|NCT00003711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64701580|NCT00003711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64701581|NCT00004227|Cetuximab|cetuximab|mesh-list
64701582|NCT00004227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64701583|NCT00004227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701584|NCT00003621|Etoposide|etoposide|mesh-list
64701586|NCT00003621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701587|NCT00003621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64701588|NCT00003621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64701589|NCT00003621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64701590|NCT00003621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701591|NCT00003621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701592|NCT00003621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64701593|NCT00003621|Alkylating Agents|alkylating agents|mesh-ancestor
64701594|NCT00385359|Albuterol|albuterol|mesh-list
64701595|NCT00385359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64701596|NCT00385359|Autonomic Agents|autonomic agents|mesh-ancestor
64701597|NCT00385359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64701598|NCT00385359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701599|NCT00385359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64701600|NCT00385359|Respiratory System Agents|respiratory system agents|mesh-ancestor
64701601|NCT00385359|Tocolytic Agents|tocolytic agents|mesh-ancestor
64701602|NCT00385359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64718379|NCT00771602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64718380|NCT00771602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718381|NCT00771602|Immunologic Factors|immunologic factors|mesh-ancestor
64718382|NCT00771602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718383|NCT00771602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64718384|NCT01804166|Golimumab|golimumab|mesh-list
64718385|NCT01804166|Infliximab|infliximab|mesh-list
64718386|NCT01804166|Dermatologic Agents|dermatologic agents|mesh-ancestor
64718387|NCT01804166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64718388|NCT01804166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64718389|NCT01804166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64326542|NCT04681105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64417713|NCT04810819|Dyphylline|dyphylline|mesh-list
64701608|NCT00385359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701610|NCT00004233|Fluorouracil|fluorouracil|mesh-list
64701624|NCT00004233|Vitamins|vitamins|mesh-ancestor
65459976|NCT03819790|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65459977|NCT03819790|Metformin|metformin|mesh-list
65459978|NCT03819790|Insulin Glargine|insulin glargine|mesh-list
65459979|NCT03819790|Lixisenatide|lixisenatide|mesh-list
65459980|NCT03819790|Gliclazide|gliclazide|mesh-list
65459981|NCT03819790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65459982|NCT03819790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459983|NCT01560442|Buprenorphine|buprenorphine|mesh-list
65459984|NCT01560442|Methadone|methadone|mesh-list
65459985|NCT01560442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65459986|NCT01560442|Narcotics|narcotics|mesh-ancestor
65459987|NCT01560442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65459988|NCT01560442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65459989|NCT01560442|Analgesics|analgesics|mesh-ancestor
65459990|NCT01560442|Sensory System Agents|sensory system agents|mesh-ancestor
65459991|NCT01560442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64701625|NCT00004233|Micronutrients|micronutrients|mesh-ancestor
64701626|NCT00003717|Paclitaxel|paclitaxel|mesh-list
64701627|NCT00003717|Estramustine|estramustine|mesh-list
64701628|NCT00003717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64701629|NCT00003717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701630|NCT00003717|Tubulin Modulators|tubulin modulators|mesh-ancestor
64701631|NCT00003717|Antimitotic Agents|antimitotic agents|mesh-ancestor
64701632|NCT00003717|Mitosis Modulators|mitosis modulators|mesh-ancestor
64701633|NCT00003717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701634|NCT00003717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64701635|NCT00003717|Alkylating Agents|alkylating agents|mesh-ancestor
64701636|NCT00003717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64701637|NCT00003723|Gemcitabine|gemcitabine|mesh-list
64701638|NCT00003723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64701639|NCT00003723|Antimetabolites|antimetabolites|mesh-ancestor
64701640|NCT00003723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701641|NCT00003723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701642|NCT00003723|Antiviral Agents|antiviral agents|mesh-ancestor
64701643|NCT00003723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64701644|NCT00003723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701645|NCT00003723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64701646|NCT00003723|Immunologic Factors|immunologic factors|mesh-ancestor
64701647|NCT00003723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701648|NCT00005061|Bevacizumab|bevacizumab|mesh-list
64701649|NCT00005061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64701650|NCT00005061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701651|NCT00005061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64701652|NCT00005061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64701653|NCT00005061|Growth Substances|growth substances|mesh-ancestor
64701654|NCT00005061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701655|NCT00005061|Growth Inhibitors|growth inhibitors|mesh-ancestor
64701656|NCT00004245|Salicylates|salicylates|mesh-list
64701657|NCT00004245|Sodium Salicylate|sodium salicylate|mesh-list
64701658|NCT00004245|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
64701659|NCT00004245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64701660|NCT00004245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64701661|NCT00004245|Analgesics|analgesics|mesh-ancestor
64701662|NCT00004245|Sensory System Agents|sensory system agents|mesh-ancestor
64701663|NCT00004245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64701664|NCT00004245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701665|NCT00004245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64718390|NCT01804166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64718391|NCT01804166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64718392|NCT01804166|Immunologic Factors|immunologic factors|mesh-ancestor
64718393|NCT01804166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718394|NCT04459585|Dabigatran|dabigatran|mesh-list
65459992|NCT01560442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65459993|NCT01560442|Antitussive Agents|antitussive agents|mesh-ancestor
65459994|NCT01560442|Respiratory System Agents|respiratory system agents|mesh-ancestor
65459995|NCT00110994|Sorafenib|sorafenib|mesh-list
65459996|NCT00110994|Dacarbazine|dacarbazine|mesh-list
65459997|NCT00110994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65459998|NCT00110994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65459999|NCT00110994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460000|NCT00110994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460001|NCT00110994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65460002|NCT00110994|Alkylating Agents|alkylating agents|mesh-ancestor
65460003|NCT01560052|Methylprednisolone|methylprednisolone|mesh-list
65460004|NCT01560052|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65460005|NCT01560052|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65460006|NCT01560052|Prednisolone|prednisolone|mesh-list
65460007|NCT01560052|Prednisolone acetate|prednisolone acetate|mesh-list
65460008|NCT01560052|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64718395|NCT04459585|Antithrombins|antithrombins|mesh-ancestor
64718396|NCT04459585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64718397|NCT04459585|Protease Inhibitors|protease inhibitors|mesh-ancestor
64718398|NCT04459585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718399|NCT04459585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718400|NCT04459585|Anticoagulants|anticoagulants|mesh-ancestor
64718401|NCT05080556|Carboplatin|carboplatin|mesh-list
64335067|NCT02298283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64417715|NCT04810819|Prednisolone phosphate|prednisolone phosphate|mesh-list
64718402|NCT05080556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718403|NCT01797380|Citalopram|citalopram|mesh-list
64718404|NCT01797380|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64718405|NCT01797380|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64701666|NCT00004245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64701667|NCT00004245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64701668|NCT00004245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701669|NCT00004245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701670|NCT00004251|Letrozole|letrozole|mesh-list
64701671|NCT00004251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701672|NCT00004251|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64701705|NCT00004263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701707|NCT00004263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64701708|NCT00004263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64701709|NCT00004263|Immunologic Factors|immunologic factors|mesh-ancestor
64701710|NCT00004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701711|NCT00004263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64701712|NCT00004263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701713|NCT00003735|Topotecan|topotecan|mesh-list
64701745|NCT00004311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701746|NCT00004311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64701747|NCT00004311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701748|NCT00004311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64701749|NCT00004311|Hormone Antagonists|hormone antagonists|mesh-ancestor
64701750|NCT00004311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64701751|NCT00004311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64701752|NCT00004311|Diuretics|diuretics|mesh-ancestor
64701753|NCT00004311|Natriuretic Agents|natriuretic agents|mesh-ancestor
64701755|NCT00004317|Pyrimethamine|pyrimethamine|mesh-list
64701780|NCT00005091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718413|NCT01797380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64718414|NCT00732680|Botulinum Toxins|botulinum toxins|mesh-list
65460009|NCT01560052|Prednisolone phosphate|prednisolone phosphate|mesh-list
65460010|NCT01560052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65460011|NCT01560052|Antiemetics|antiemetics|mesh-ancestor
65460012|NCT01560052|Autonomic Agents|autonomic agents|mesh-ancestor
65460013|NCT01560052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460014|NCT01560052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460015|NCT01560052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65460016|NCT01560052|Glucocorticoids|glucocorticoids|mesh-ancestor
65460017|NCT01560052|Hormones|hormones|mesh-ancestor
65460018|NCT01560052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64844571|NCT01669967|Autonomic Agents|autonomic agents|mesh-ancestor
64718415|NCT00732680|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64718416|NCT00732680|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64701781|NCT00005091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701782|NCT00004323|Cyclosporine|cyclosporine|mesh-list
64701783|NCT00004323|Methylprednisolone|methylprednisolone|mesh-list
64701784|NCT00004323|Cyclophosphamide|cyclophosphamide|mesh-list
64701785|NCT00004323|Methotrexate|methotrexate|mesh-list
64701786|NCT00004323|Cyclosporins|cyclosporins|mesh-list
64701787|NCT00004323|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64701788|NCT00004323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64701789|NCT00004323|Immunologic Factors|immunologic factors|mesh-ancestor
64701790|NCT00004323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701791|NCT00004323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64701792|NCT00004323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64701793|NCT00004323|Alkylating Agents|alkylating agents|mesh-ancestor
64701794|NCT00004323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701795|NCT00004323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701796|NCT00004323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64701797|NCT00004323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64701798|NCT00004323|Abortifacient Agents|abortifacient agents|mesh-ancestor
64701799|NCT00004323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64701800|NCT00004323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64701801|NCT00004323|Antimetabolites|antimetabolites|mesh-ancestor
64701802|NCT00004323|Dermatologic Agents|dermatologic agents|mesh-ancestor
64701803|NCT00004323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701804|NCT00004323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64701805|NCT00004323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64701806|NCT00004323|Antifungal Agents|antifungal agents|mesh-ancestor
64701807|NCT00004323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64701808|NCT00004323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64701846|NCT00003759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64701847|NCT00003759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701848|NCT00003759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701850|NCT00003765|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64701851|NCT00003765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64701852|NCT00003765|Alkylating Agents|alkylating agents|mesh-ancestor
64701859|NCT00003771|Norethindrone Acetate|norethindrone acetate|mesh-list
64701860|NCT00003771|Estradiol|estradiol|mesh-list
64701861|NCT00003771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64701862|NCT00003771|Estrogens|estrogens|mesh-ancestor
64701863|NCT00003771|Hormones|hormones|mesh-ancestor
64701864|NCT00003771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64701865|NCT00003771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701866|NCT00003771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64701867|NCT00003771|Contraceptive Agents|contraceptive agents|mesh-ancestor
64701868|NCT00003771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64701869|NCT00003771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64701870|NCT00003771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64701871|NCT00003771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64701872|NCT00003771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64701873|NCT00004359|Methoxsalen|methoxsalen|mesh-list
64701874|NCT00004359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64701875|NCT00004359|Dermatologic Agents|dermatologic agents|mesh-ancestor
64701876|NCT00004401|Immunoglobulins|immunoglobulins|mesh-list
65460019|NCT01560052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65460020|NCT01560052|Protective Agents|protective agents|mesh-ancestor
65460021|NCT01560052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65460022|NCT01560052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460023|NCT05098132|Pembrolizumab|pembrolizumab|mesh-list
65460024|NCT05098132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65460025|NCT05098132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460026|NCT04356352|Lidocaine|lidocaine|mesh-list
65460027|NCT04356352|Esmolol|esmolol|mesh-list
65460028|NCT04356352|Anesthetics, Local|anesthetics, local|mesh-ancestor
65460029|NCT04356352|Anesthetics|anesthetics|mesh-ancestor
65460030|NCT04356352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64844582|NCT01670149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64844584|NCT01670370|Gemcitabine|gemcitabine|mesh-list
64701877|NCT00004401|Antibodies|antibodies|mesh-list
64701878|NCT00004401|gamma-Globulins|gamma-globulins|mesh-list
64701879|NCT00004401|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64701880|NCT00004401|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64701881|NCT00004401|Immunologic Factors|immunologic factors|mesh-ancestor
64701882|NCT00004401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718417|NCT00732680|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64718418|NCT00732680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64718419|NCT00732680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718420|NCT00732680|Cholinergic Agents|cholinergic agents|mesh-ancestor
64718421|NCT00732680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64718422|NCT00732680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718423|NCT00732680|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64718424|NCT00732680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64326582|NCT05429450|Triamcinolone|triamcinolone|mesh-list
64945557|NCT05450692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701884|NCT00003783|Cytarabine|cytarabine|mesh-list
64701885|NCT00003783|Dexamethasone|dexamethasone|mesh-list
64701886|NCT00003783|Prednisone|prednisone|mesh-list
64701887|NCT00003783|Cyclophosphamide|cyclophosphamide|mesh-list
64701888|NCT00003783|Methotrexate|methotrexate|mesh-list
64701889|NCT00003783|Etoposide|etoposide|mesh-list
64701890|NCT00003783|Vincristine|vincristine|mesh-list
64701891|NCT00003783|Daunorubicin|daunorubicin|mesh-list
64701892|NCT00003783|Asparaginase|asparaginase|mesh-list
64701893|NCT00003783|Mercaptopurine|mercaptopurine|mesh-list
64701894|NCT00003783|Idarubicin|idarubicin|mesh-list
64701895|NCT00003783|Levoleucovorin|levoleucovorin|mesh-list
64701896|NCT00003783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64701897|NCT00003783|Immunologic Factors|immunologic factors|mesh-ancestor
64701898|NCT00003783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701899|NCT00003783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64701900|NCT00003783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64701901|NCT00003783|Alkylating Agents|alkylating agents|mesh-ancestor
64701913|NCT00003783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64701914|NCT00003783|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64701915|NCT00003783|Abortifacient Agents|abortifacient agents|mesh-ancestor
64701916|NCT00003783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64701917|NCT00003783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64701918|NCT00003783|Antimetabolites|antimetabolites|mesh-ancestor
64701919|NCT00003783|Dermatologic Agents|dermatologic agents|mesh-ancestor
64701920|NCT00003783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701921|NCT00003783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64701922|NCT00003783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64701936|NCT00003783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64701938|NCT00003789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64701939|NCT00003789|Alkylating Agents|alkylating agents|mesh-ancestor
64701940|NCT00003789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701941|NCT00003789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701942|NCT00003789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65460031|NCT04356352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460032|NCT04356352|Sensory System Agents|sensory system agents|mesh-ancestor
65460033|NCT04356352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460034|NCT04356352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65460035|NCT04356352|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65460036|NCT04356352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65460037|NCT04356352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65460038|NCT04356352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701943|NCT00003789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64701944|NCT00003789|Immunologic Factors|immunologic factors|mesh-ancestor
64701945|NCT00003789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701946|NCT00004407|Immunoglobulins|immunoglobulins|mesh-list
64701947|NCT00004407|Antibodies|antibodies|mesh-list
64701948|NCT00004407|gamma-Globulins|gamma-globulins|mesh-list
64701949|NCT00004407|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64701950|NCT00004407|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64701951|NCT00004407|Immunologic Factors|immunologic factors|mesh-ancestor
64701952|NCT00004407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718427|NCT00726830|Methadone|methadone|mesh-list
64718428|NCT00726830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64718429|NCT00726830|Narcotics|narcotics|mesh-ancestor
64718430|NCT00726830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64718431|NCT00726830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701953|NCT00004419|Mitogens|mitogens|mesh-list
64701954|NCT00004419|Mitosis Modulators|mitosis modulators|mesh-ancestor
64701955|NCT00004419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701956|NCT00004431|Baclofen|baclofen|mesh-list
64701957|NCT00004431|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64701958|NCT00004431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701959|NCT00004431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64701960|NCT00004431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64701961|NCT00004431|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64701963|NCT00004431|GABA Agents|gaba agents|mesh-ancestor
64701964|NCT00004431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64701965|NCT00004431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701966|NCT00384891|BCG Vaccine|bcg vaccine|mesh-list
64701967|NCT00384891|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64701968|NCT00384891|Immunologic Factors|immunologic factors|mesh-ancestor
64701969|NCT00384891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701970|NCT04712799|Xylometazoline|xylometazoline|mesh-list
64701971|NCT04712799|Nasal Decongestants|nasal decongestants|mesh-ancestor
64701972|NCT04712799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64417723|NCT04810819|Hormones|hormones|mesh-ancestor
64701982|NCT00384969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701983|NCT00385437|Mirtazapine|mirtazapine|mesh-list
64701984|NCT00385437|Antidepressive Agents|antidepressive agents|mesh-ancestor
64701985|NCT00385437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64701986|NCT00385437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64702002|NCT00385437|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64702004|NCT00004467|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64702005|NCT00004467|Antiviral Agents|antiviral agents|mesh-ancestor
64702006|NCT00004467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64702007|NCT00004467|Expectorants|expectorants|mesh-ancestor
64702008|NCT00004467|Respiratory System Agents|respiratory system agents|mesh-ancestor
64702009|NCT00004467|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64702010|NCT00004467|Antioxidants|antioxidants|mesh-ancestor
64702011|NCT00004467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702012|NCT00004467|Protective Agents|protective agents|mesh-ancestor
64702013|NCT00004467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702014|NCT00004467|Antidotes|antidotes|mesh-ancestor
64702015|NCT00004479|Midodrine|midodrine|mesh-list
64702016|NCT00004479|Sympathomimetics|sympathomimetics|mesh-ancestor
64702017|NCT00004479|Autonomic Agents|autonomic agents|mesh-ancestor
64702018|NCT00004479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64702019|NCT00004479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702020|NCT00004479|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65494044|NCT03777436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65460039|NCT04356352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65460040|NCT04356352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65460041|NCT04356352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65460042|NCT04356352|Adrenergic Agents|adrenergic agents|mesh-ancestor
65460043|NCT04356352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65460044|NCT05622994|Rimonabant|rimonabant|mesh-list
65460045|NCT05622994|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65460046|NCT05622994|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65460047|NCT05622994|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65460048|NCT05622994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64844606|NCT01670552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64702021|NCT00004479|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64702022|NCT00004479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64702023|NCT00004479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64702024|NCT00004479|Adrenergic Agents|adrenergic agents|mesh-ancestor
64702025|NCT00004479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64702026|NCT00004479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702027|NCT00004485|Cyclosporine|cyclosporine|mesh-list
64702028|NCT00004485|Mycophenolic Acid|mycophenolic acid|mesh-list
64702029|NCT00004485|Fludarabine|fludarabine|mesh-list
64702030|NCT00004485|Cyclosporins|cyclosporins|mesh-list
64702031|NCT00004485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702032|NCT00004485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702033|NCT00004485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64718432|NCT00726830|Analgesics|analgesics|mesh-ancestor
64718433|NCT00726830|Sensory System Agents|sensory system agents|mesh-ancestor
64718434|NCT00726830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64718435|NCT00726830|Antitussive Agents|antitussive agents|mesh-ancestor
64718436|NCT00726830|Respiratory System Agents|respiratory system agents|mesh-ancestor
64718437|NCT00691652|Rituximab|rituximab|mesh-list
64718438|NCT00691652|Clofarabine|clofarabine|mesh-list
64718439|NCT00691652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64718440|NCT00691652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718441|NCT00691652|Immunologic Factors|immunologic factors|mesh-ancestor
64718442|NCT00691652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718443|NCT00691652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64718444|NCT00691652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64718445|NCT00691652|Antimetabolites|antimetabolites|mesh-ancestor
64326595|NCT05429450|Dermatologic Agents|dermatologic agents|mesh-ancestor
64702034|NCT00004485|Immunologic Factors|immunologic factors|mesh-ancestor
64702035|NCT00004485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702036|NCT00004485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702037|NCT00004485|Antifungal Agents|antifungal agents|mesh-ancestor
64702038|NCT00004485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64702039|NCT00004485|Dermatologic Agents|dermatologic agents|mesh-ancestor
64702040|NCT00004485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64702080|NCT02678312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64702100|NCT00004575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64702101|NCT00004575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64702102|NCT00004575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64702103|NCT00004575|Hormone Antagonists|hormone antagonists|mesh-ancestor
64702104|NCT00004575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64702105|NCT00004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702106|NCT00004575|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64702107|NCT00004575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64702108|NCT00004575|Vasodilator Agents|vasodilator agents|mesh-ancestor
64702109|NCT00004575|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64702110|NCT00004575|Protease Inhibitors|protease inhibitors|mesh-ancestor
64702111|NCT00004581|Ritonavir|ritonavir|mesh-list
64702112|NCT00004581|Lopinavir|lopinavir|mesh-list
64702113|NCT00004581|Nevirapine|nevirapine|mesh-list
65460049|NCT05622994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460050|NCT05622994|Hormones|hormones|mesh-ancestor
65460051|NCT05622994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65460052|NCT05622994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460053|NCT05622916|Ethanol|ethanol|mesh-list
65460054|NCT05622916|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65460055|NCT05622916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65460056|NCT05622916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65460057|NCT05622916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460058|NCT03819556|Caseins|caseins|mesh-list
65460059|NCT03819556|Chelating Agents|chelating agents|mesh-ancestor
65460060|NCT03819556|Sequestering Agents|sequestering agents|mesh-ancestor
64702114|NCT00004581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64702115|NCT00004581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64702116|NCT00004581|Protease Inhibitors|protease inhibitors|mesh-ancestor
64702117|NCT00004581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702118|NCT00004581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702119|NCT00004581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64702120|NCT00004581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64702121|NCT00004581|Antiviral Agents|antiviral agents|mesh-ancestor
64702122|NCT00004581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64702123|NCT00004581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64702124|NCT00004581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64718446|NCT00691652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718447|NCT00691574|Melatonin|melatonin|mesh-list
64718448|NCT00691574|Antioxidants|antioxidants|mesh-ancestor
64702125|NCT00004581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64702126|NCT00004581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64702127|NCT00004581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64702128|NCT00004581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64702129|NCT00004257|Fluorouracil|fluorouracil|mesh-list
64702130|NCT00004257|Oxaliplatin|oxaliplatin|mesh-list
64702131|NCT00004257|Antimetabolites|antimetabolites|mesh-ancestor
64702132|NCT00004257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702133|NCT00004257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64702134|NCT00004257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702135|NCT00004257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64702136|NCT00004257|Immunologic Factors|immunologic factors|mesh-ancestor
64702158|NCT00362960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702159|NCT00003867|Capecitabine|capecitabine|mesh-list
64702160|NCT00003867|Irinotecan|irinotecan|mesh-list
64702161|NCT00003867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64702162|NCT00003867|Antimetabolites|antimetabolites|mesh-ancestor
64702163|NCT00003867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702164|NCT00003867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702165|NCT00003867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64702166|NCT00003867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64702167|NCT00003867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702168|NCT00004665|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64702169|NCT00004665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64702170|NCT00004665|Immunologic Factors|immunologic factors|mesh-ancestor
64702184|NCT00003873|Immunologic Factors|immunologic factors|mesh-ancestor
64702185|NCT00003873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702186|NCT00003873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702209|NCT00004689|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64702210|NCT00004689|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64702211|NCT00004689|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64702212|NCT00004689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64702214|NCT00004695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702215|NCT00004695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65460061|NCT03819556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460062|NCT03804034|Molybdenum|molybdenum|mesh-list
65460063|NCT03804034|Trace Elements|trace elements|mesh-ancestor
65460064|NCT03804034|Micronutrients|micronutrients|mesh-ancestor
65460065|NCT03804034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460066|NCT04246762|Vitamin K|vitamin k|mesh-list
65460067|NCT04246762|Midazolam|midazolam|mesh-list
65460068|NCT04246762|Caffeine|caffeine|mesh-list
65460069|NCT04246762|Omeprazole|omeprazole|mesh-list
65460070|NCT04246762|Warfarin|warfarin|mesh-list
65460071|NCT04246762|Vitamins|vitamins|mesh-ancestor
65460072|NCT04246762|Micronutrients|micronutrients|mesh-ancestor
65460073|NCT04246762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460074|NCT04246762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65460075|NCT04246762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65460076|NCT04246762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65460077|NCT04246762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65460078|NCT04246762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65460079|NCT04246762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65460080|NCT04246762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65460081|NCT04246762|Anesthetics, General|anesthetics, general|mesh-ancestor
65460082|NCT04246762|Anesthetics|anesthetics|mesh-ancestor
65460083|NCT04246762|GABA Modulators|gaba modulators|mesh-ancestor
65460084|NCT04246762|GABA Agents|gaba agents|mesh-ancestor
65460085|NCT04246762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64702216|NCT00004695|Analgesics|analgesics|mesh-ancestor
64702217|NCT00004695|Sensory System Agents|sensory system agents|mesh-ancestor
64702218|NCT00004695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64702219|NCT00004695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702220|NCT02570984|Omalizumab|omalizumab|mesh-list
64702221|NCT02570984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64702222|NCT02570984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64702223|NCT02570984|Respiratory System Agents|respiratory system agents|mesh-ancestor
64702224|NCT00004731|Ubiquinone|ubiquinone|mesh-list
64702225|NCT00004731|Coenzyme Q10|coenzyme q10|mesh-list
64702226|NCT00004731|Micronutrients|micronutrients|mesh-ancestor
64702227|NCT00004731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702228|NCT00004731|Vitamins|vitamins|mesh-ancestor
64702229|NCT00003885|Arsenic Trioxide|arsenic trioxide|mesh-list
64702230|NCT00003885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702231|NCT00003891|Lurtotecan|lurtotecan|mesh-list
64702232|NCT00003891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702233|NCT02472314|Bupivacaine|bupivacaine|mesh-list
64718449|NCT00691574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718450|NCT00691574|Protective Agents|protective agents|mesh-ancestor
64718451|NCT00691574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718452|NCT00691574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64718453|NCT00685880|Betamethasone|betamethasone|mesh-list
64718454|NCT00685880|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
64718455|NCT00685880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64326612|NCT00103259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702234|NCT02472314|Anesthetics, Local|anesthetics, local|mesh-ancestor
64702235|NCT02472314|Anesthetics|anesthetics|mesh-ancestor
64702236|NCT02472314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64702237|NCT02472314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460086|NCT04246762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460087|NCT04246762|Anticoagulants|anticoagulants|mesh-ancestor
65460088|NCT04246762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65460089|NCT04246762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65460090|NCT04246762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460091|NCT04246762|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65460092|NCT04246762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65460093|NCT04246762|Purinergic Agents|purinergic agents|mesh-ancestor
65460094|NCT04246762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65460095|NCT04246762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65460096|NCT04246762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65460097|NCT04246762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65460098|NCT04246762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65460099|NCT04246762|Hemostatics|hemostatics|mesh-ancestor
65460100|NCT04246762|Coagulants|coagulants|mesh-ancestor
65460101|NCT03799120|Tamsulosin|tamsulosin|mesh-list
65460102|NCT03799120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65460103|NCT03799120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65460104|NCT03799120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65460105|NCT03799120|Adrenergic Agents|adrenergic agents|mesh-ancestor
65460106|NCT03799120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65460107|NCT03799120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460108|NCT03799120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460109|NCT03799120|Urological Agents|urological agents|mesh-ancestor
65460110|NCT03792724|Nivolumab|nivolumab|mesh-list
65460111|NCT03792724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65460112|NCT03792724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460113|NCT03792724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65460114|NCT03792724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702238|NCT02472314|Sensory System Agents|sensory system agents|mesh-ancestor
64702239|NCT02472314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64702269|NCT00004767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64335111|NCT03146325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64335112|NCT03146325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64702282|NCT00004785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702283|NCT00004785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64702284|NCT00004785|Glucocorticoids|glucocorticoids|mesh-ancestor
64702313|NCT00005571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64702314|NCT00005571|Immunologic Factors|immunologic factors|mesh-ancestor
64702315|NCT00005571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702316|NCT00005577|Gemcitabine|gemcitabine|mesh-list
64702317|NCT00005577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64702318|NCT00005577|Antimetabolites|antimetabolites|mesh-ancestor
64702319|NCT00005577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460115|NCT00144170|Ritonavir|ritonavir|mesh-list
65460116|NCT00144170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
65460117|NCT00144170|Tipranavir|tipranavir|mesh-list
65460118|NCT00144170|Protease Inhibitors|protease inhibitors|mesh-list
65460119|NCT00144170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65460120|NCT00144170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460121|NCT00144170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460122|NCT00144170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65460123|NCT00144170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65460124|NCT00144170|Antiviral Agents|antiviral agents|mesh-ancestor
65460125|NCT00144170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65460126|NCT00144170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65460127|NCT00144170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65460128|NCT00255086|Memantine|memantine|mesh-list
65460129|NCT00255086|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65460130|NCT00255086|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64844680|NCT01675115|Aspirin|aspirin|mesh-list
64702320|NCT00005577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702321|NCT00005577|Antiviral Agents|antiviral agents|mesh-ancestor
64702322|NCT00005577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64702323|NCT00005577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702324|NCT00005577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64702325|NCT00005577|Immunologic Factors|immunologic factors|mesh-ancestor
64702326|NCT00005577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702327|NCT00005583|Doxorubicin|doxorubicin|mesh-list
64702328|NCT00005583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64702329|NCT00005583|Epirubicin|epirubicin|mesh-list
64702342|NCT00005589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64702343|NCT00005589|Immunologic Factors|immunologic factors|mesh-ancestor
64702344|NCT00005589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702345|NCT00005589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64702346|NCT00005589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64702347|NCT00005589|Alkylating Agents|alkylating agents|mesh-ancestor
64702348|NCT00005589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702349|NCT00005589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702350|NCT00005589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64702351|NCT00005589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64702352|NCT00005589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64702353|NCT00005589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64702354|NCT00005589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64702355|NCT00005589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702356|NCT00005589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64702357|NCT00005589|Antimetabolites|antimetabolites|mesh-ancestor
64702358|NCT00005589|Antiviral Agents|antiviral agents|mesh-ancestor
64702359|NCT00005589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64718457|NCT00685880|Hormones|hormones|mesh-ancestor
64718458|NCT00685880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64718459|NCT00685880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718460|NCT00685880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64718461|NCT00685880|Respiratory System Agents|respiratory system agents|mesh-ancestor
64718462|NCT00685880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64718463|NCT00685880|Autonomic Agents|autonomic agents|mesh-ancestor
64326620|NCT02162381|Dopamine Agents|dopamine agents|mesh-ancestor
64702360|NCT00005601|Cytarabine|cytarabine|mesh-list
64702361|NCT00005601|Dexamethasone|dexamethasone|mesh-list
64702362|NCT00005601|Rituximab|rituximab|mesh-list
64702363|NCT00005601|Sargramostim|sargramostim|mesh-list
64702364|NCT00005601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64702365|NCT00005601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702366|NCT00005601|Immunologic Factors|immunologic factors|mesh-ancestor
65460131|NCT00255086|Dopamine Agents|dopamine agents|mesh-ancestor
65460132|NCT00255086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65460133|NCT00255086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460134|NCT00255086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460135|NCT00255086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65460136|NCT00255086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65460137|NCT00110214|Prednisone|prednisone|mesh-list
65460138|NCT00110214|Bevacizumab|bevacizumab|mesh-list
65460139|NCT00110214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65460140|NCT00110214|Docetaxel|docetaxel|mesh-list
65460141|NCT00110214|Antibodies|antibodies|mesh-list
65460142|NCT00110214|Immunoglobulins|immunoglobulins|mesh-list
65460143|NCT00110214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65460144|NCT00110214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460145|NCT00110214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65460146|NCT00110214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65460147|NCT00110214|Growth Substances|growth substances|mesh-ancestor
65460148|NCT00110214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460149|NCT00110214|Growth Inhibitors|growth inhibitors|mesh-ancestor
65460150|NCT00110214|Immunologic Factors|immunologic factors|mesh-ancestor
65460151|NCT00110214|Tubulin Modulators|tubulin modulators|mesh-ancestor
65460152|NCT00110214|Antimitotic Agents|antimitotic agents|mesh-ancestor
65460153|NCT00110214|Mitosis Modulators|mitosis modulators|mesh-ancestor
65460154|NCT00110214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460155|NCT00110214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65460156|NCT00110214|Glucocorticoids|glucocorticoids|mesh-ancestor
64702376|NCT00005601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64702377|NCT00005601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64702378|NCT00005601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64702379|NCT00005601|Antimetabolites|antimetabolites|mesh-ancestor
64702380|NCT00005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702381|NCT00005601|Antiviral Agents|antiviral agents|mesh-ancestor
64702382|NCT00005601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64702383|NCT00005601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64702384|NCT00005607|Leucovorin|leucovorin|mesh-list
64702385|NCT00005607|Fluorouracil|fluorouracil|mesh-list
64702386|NCT00005607|Irinotecan|irinotecan|mesh-list
64702387|NCT00005607|Calcium|calcium|mesh-list
64702388|NCT00005607|Levoleucovorin|levoleucovorin|mesh-list
64702389|NCT00005607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64702390|NCT00005607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702391|NCT00005607|Antimetabolites|antimetabolites|mesh-ancestor
64702392|NCT00005607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702393|NCT00005607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64702394|NCT00005607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702395|NCT00005607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64702424|NCT00005625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702425|NCT00005625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702427|NCT00005631|Carboplatin|carboplatin|mesh-list
65460157|NCT00110214|Hormones|hormones|mesh-ancestor
65460158|NCT00110214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65460159|NCT00110214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65460160|NCT04176172|Nicotine|nicotine|mesh-list
65460161|NCT04176172|Varenicline|varenicline|mesh-list
65460162|NCT04176172|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65460163|NCT04176172|Autonomic Agents|autonomic agents|mesh-ancestor
65460164|NCT04176172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460165|NCT04176172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460166|NCT04176172|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65460167|NCT04176172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65460168|NCT04176172|Cholinergic Agents|cholinergic agents|mesh-ancestor
65460169|NCT04176172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65460170|NCT04176172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460171|NCT05625334|Aspirin|aspirin|mesh-list
65460172|NCT05625334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65460173|NCT05625334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65460174|NCT05625334|Analgesics|analgesics|mesh-ancestor
65460175|NCT05625334|Sensory System Agents|sensory system agents|mesh-ancestor
65460176|NCT05625334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460177|NCT05625334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460178|NCT05625334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65460179|NCT05625334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65460180|NCT05625334|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65460181|NCT05625334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64844719|NCT01676987|Glucocorticoids|glucocorticoids|mesh-ancestor
64702428|NCT00005631|Etoposide|etoposide|mesh-list
64702429|NCT00005631|Ifosfamide|ifosfamide|mesh-list
64702430|NCT00005631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64702431|NCT00005631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702432|NCT00005631|Immunologic Factors|immunologic factors|mesh-ancestor
64702433|NCT00005631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702434|NCT00005631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64702435|NCT00005631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64702436|NCT00005631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64702437|NCT00005631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64702438|NCT00005631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702439|NCT00005631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702440|NCT00005631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64702441|NCT00005631|Alkylating Agents|alkylating agents|mesh-ancestor
64335153|NCT02350335|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64702442|NCT00005637|Temozolomide|temozolomide|mesh-list
64702443|NCT00005637|Carmustine|carmustine|mesh-list
64702444|NCT00005637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64702475|NCT02247349|Nivolumab|nivolumab|mesh-list
64718464|NCT00685880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64718465|NCT00681044|Melphalan|melphalan|mesh-list
64718466|NCT00681044|Immunologic Factors|immunologic factors|mesh-ancestor
65460182|NCT05625334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460183|NCT05625334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65460184|NCT05625334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65460185|NCT05625334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460186|NCT05625334|Antipyretics|antipyretics|mesh-ancestor
65460187|NCT03795844|Liver Extracts|liver extracts|mesh-list
65460188|NCT03795844|Hematinics|hematinics|mesh-ancestor
65460189|NCT05669170|Methylphenidate|methylphenidate|mesh-list
65460190|NCT05669170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65460191|NCT05669170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460192|NCT05669170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65460193|NCT05669170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65460194|NCT05669170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65460195|NCT05669170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460196|NCT05669170|Dopamine Agents|dopamine agents|mesh-ancestor
65460197|NCT05669170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65460198|NCT03798106|Durvalumab|durvalumab|mesh-list
65460199|NCT03798106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65460200|NCT03798106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460201|NCT03799822|Vitamin K|vitamin k|mesh-list
65460202|NCT03799822|Rivaroxaban|rivaroxaban|mesh-list
65460203|NCT03799822|Vitamins|vitamins|mesh-ancestor
65460204|NCT03799822|Micronutrients|micronutrients|mesh-ancestor
65460205|NCT03799822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460206|NCT03799822|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64718467|NCT00681044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718468|NCT00681044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64718469|NCT00681044|Alkylating Agents|alkylating agents|mesh-ancestor
64718470|NCT00681044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718471|NCT00681044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326625|NCT02155439|Triamcinolone|triamcinolone|mesh-list
64702476|NCT02247349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64702477|NCT02247349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702478|NCT02247349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64702479|NCT02247349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702480|NCT03390673|Bevacizumab|bevacizumab|mesh-list
64702501|NCT00005775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64702502|NCT00005787|Epoetin Alfa|epoetin alfa|mesh-list
64702503|NCT00005787|Flt3 ligand protein|flt3 ligand protein|mesh-list
64702504|NCT00005787|Sargramostim|sargramostim|mesh-list
64702505|NCT00005787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64702506|NCT00005787|Immunologic Factors|immunologic factors|mesh-ancestor
64702507|NCT00005787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702508|NCT00005787|Hematinics|hematinics|mesh-ancestor
64702509|NCT00005787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64702510|NCT00005787|Protective Agents|protective agents|mesh-ancestor
64702511|NCT00005793|Cytarabine|cytarabine|mesh-list
64702512|NCT00005793|Etoposide|etoposide|mesh-list
64702513|NCT00005793|Daunorubicin|daunorubicin|mesh-list
64702514|NCT00005793|Topotecan|topotecan|mesh-list
65460207|NCT03799822|Antithrombins|antithrombins|mesh-ancestor
65460208|NCT03799822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65460209|NCT03799822|Protease Inhibitors|protease inhibitors|mesh-ancestor
65460210|NCT03799822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460211|NCT03799822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460212|NCT03799822|Anticoagulants|anticoagulants|mesh-ancestor
65460213|NCT03799822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65460214|NCT03799822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65460215|NCT03799822|Hemostatics|hemostatics|mesh-ancestor
65460216|NCT03799822|Coagulants|coagulants|mesh-ancestor
65460217|NCT05589688|Acyclovir|acyclovir|mesh-list
65460218|NCT05589688|Antiviral Agents|antiviral agents|mesh-ancestor
65460219|NCT05589688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65460220|NCT03799900|Ketamine|ketamine|mesh-list
65460221|NCT03799900|Analgesics|analgesics|mesh-ancestor
65460222|NCT03799900|Sensory System Agents|sensory system agents|mesh-ancestor
65460223|NCT03799900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460224|NCT03799900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460225|NCT03799900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65460226|NCT03799900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65460227|NCT03799900|Anesthetics, General|anesthetics, general|mesh-ancestor
64702515|NCT00005793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64702516|NCT00005793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702517|NCT00005793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64702518|NCT00005793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64702519|NCT00005793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702520|NCT00005793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702521|NCT00005793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64702522|NCT00005793|Antimetabolites|antimetabolites|mesh-ancestor
64702523|NCT00005793|Antiviral Agents|antiviral agents|mesh-ancestor
64702524|NCT00005793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64702525|NCT00005793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64702526|NCT00005793|Immunologic Factors|immunologic factors|mesh-ancestor
64702527|NCT00005793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702528|NCT00005793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64702529|NCT00005793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64702530|NCT00005799|Cyclosporine|cyclosporine|mesh-list
64702531|NCT00005799|Mycophenolic Acid|mycophenolic acid|mesh-list
64702532|NCT00005799|Fludarabine|fludarabine|mesh-list
64702533|NCT00005799|Fludarabine phosphate|fludarabine phosphate|mesh-list
64702534|NCT00005799|Cyclosporins|cyclosporins|mesh-list
64702535|NCT00005799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702536|NCT00005799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64702537|NCT00005799|Antimetabolites|antimetabolites|mesh-ancestor
64702538|NCT00005799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702539|NCT00005799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64702540|NCT00005799|Immunologic Factors|immunologic factors|mesh-ancestor
64702541|NCT00005799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702542|NCT00005799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702543|NCT00005799|Antifungal Agents|antifungal agents|mesh-ancestor
64702544|NCT00005799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64718472|NCT00681044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64718473|NCT00681044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64718474|NCT03632083|Contact Lens Solutions|contact lens solutions|mesh-list
64702545|NCT00005799|Dermatologic Agents|dermatologic agents|mesh-ancestor
64702546|NCT00005799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65460228|NCT03799900|Anesthetics|anesthetics|mesh-ancestor
65460229|NCT03799900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65460230|NCT03799900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65460231|NCT03799900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65460232|NCT03799900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65460233|NCT03799900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460234|NCT05624866|Triamcinolone|triamcinolone|mesh-list
65460235|NCT05624866|Dexmedetomidine|dexmedetomidine|mesh-list
65460236|NCT05624866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65460237|NCT05624866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65460238|NCT05624866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460239|NCT05624866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65460240|NCT05624866|Analgesics|analgesics|mesh-ancestor
65460241|NCT05624866|Sensory System Agents|sensory system agents|mesh-ancestor
64702547|NCT00005799|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64702548|NCT00005799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64702569|NCT01689987|Hydroxychloroquine|hydroxychloroquine|mesh-list
64702570|NCT01689987|Dexamethasone|dexamethasone|mesh-list
64702571|NCT01689987|Dexamethasone acetate|dexamethasone acetate|mesh-list
64702572|NCT01689987|Cyclophosphamide|cyclophosphamide|mesh-list
64702573|NCT01689987|Ichthammol|ichthammol|mesh-list
64702574|NCT01689987|BB 1101|bb 1101|mesh-list
64702575|NCT01689987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64702576|NCT01689987|Immunologic Factors|immunologic factors|mesh-ancestor
64702577|NCT01689987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702578|NCT01689987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64702579|NCT01689987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64702589|NCT01689987|Glucocorticoids|glucocorticoids|mesh-ancestor
64702590|NCT01689987|Hormones|hormones|mesh-ancestor
64702591|NCT01689987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64702592|NCT01689987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64702593|NCT01689987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64702594|NCT01689987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64702595|NCT01689987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64702596|NCT01689987|Antifungal Agents|antifungal agents|mesh-ancestor
64702597|NCT01689987|Antimalarials|antimalarials|mesh-ancestor
64702598|NCT01689987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64702599|NCT01689987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64702600|NCT01689987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702601|NCT01689987|Protease Inhibitors|protease inhibitors|mesh-ancestor
64702602|NCT01689987|Dermatologic Agents|dermatologic agents|mesh-ancestor
64702603|NCT01680939|Ibuprofen|ibuprofen|mesh-list
64702604|NCT01680939|Morphine|morphine|mesh-list
64702605|NCT01680939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64702627|NCT02163733|Osimertinib|osimertinib|mesh-list
64702628|NCT02163733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702629|NCT02163733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64702631|NCT02163733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702632|NCT04823247|Interleukin-23|interleukin-23|mesh-list
64702633|NCT04823247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64702634|NCT04823247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64702635|NCT04823247|Growth Substances|growth substances|mesh-ancestor
64702636|NCT04823247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702637|NCT04823247|Growth Inhibitors|growth inhibitors|mesh-ancestor
64702638|NCT04823247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702639|NCT02483000|Biotin|biotin|mesh-list
64702640|NCT02483000|Cytarabine|cytarabine|mesh-list
64702641|NCT02483000|Etoposide|etoposide|mesh-list
64702642|NCT02483000|Podophyllotoxin|podophyllotoxin|mesh-list
64702643|NCT02483000|Etoposide phosphate|etoposide phosphate|mesh-list
64702644|NCT02483000|Melphalan|melphalan|mesh-list
64702645|NCT02483000|Mechlorethamine|mechlorethamine|mesh-list
64702646|NCT02483000|Carmustine|carmustine|mesh-list
65460242|NCT05624866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460243|NCT05624866|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65460244|NCT05624866|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65460245|NCT05624866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65460246|NCT05624866|Adrenergic Agents|adrenergic agents|mesh-ancestor
65460247|NCT05624866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65460248|NCT05624866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460249|NCT05624866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65460250|NCT05624866|Glucocorticoids|glucocorticoids|mesh-ancestor
65460251|NCT05624866|Hormones|hormones|mesh-ancestor
65460252|NCT05624866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65460253|NCT01304602|Irinotecan|irinotecan|mesh-list
65460254|NCT01304602|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65460255|NCT01304602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64702647|NCT02483000|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64702648|NCT02483000|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
64702649|NCT02483000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64702650|NCT02483000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702651|NCT02483000|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64702652|NCT02483000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64702653|NCT02483000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702654|NCT02483000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702655|NCT02483000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64702656|NCT02483000|Antimetabolites|antimetabolites|mesh-ancestor
64702657|NCT02483000|Antiviral Agents|antiviral agents|mesh-ancestor
64702658|NCT02483000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64718475|NCT03632083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64718476|NCT03632083|Disinfectants|disinfectants|mesh-ancestor
64718477|NCT03632083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64718478|NCT03633487|Guaifenesin|guaifenesin|mesh-list
64718479|NCT03633487|Expectorants|expectorants|mesh-ancestor
64718480|NCT03633487|Respiratory System Agents|respiratory system agents|mesh-ancestor
64702659|NCT02483000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64702672|NCT02483000|Vitamin B Complex|vitamin b complex|mesh-ancestor
64702674|NCT02483000|Micronutrients|micronutrients|mesh-ancestor
64702675|NCT02420210|Dexamethasone|dexamethasone|mesh-list
64702676|NCT02420210|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64702677|NCT02420210|Obinutuzumab|obinutuzumab|mesh-list
64702678|NCT02420210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64702686|NCT02420210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64702687|NCT02420210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64702688|NCT02420210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702689|NCT02420210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64702691|NCT02420210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702692|NCT02420210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64702693|NCT04829799|Ketorolac|ketorolac|mesh-list
64702694|NCT04829799|Lidocaine|lidocaine|mesh-list
64702695|NCT04829799|Phenylephrine|phenylephrine|mesh-list
64702696|NCT04829799|Oxymetazoline|oxymetazoline|mesh-list
64702697|NCT04829799|Anesthetics, Local|anesthetics, local|mesh-ancestor
64702698|NCT04829799|Anesthetics|anesthetics|mesh-ancestor
64702699|NCT04829799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64702700|NCT04829799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702701|NCT04829799|Sensory System Agents|sensory system agents|mesh-ancestor
64702702|NCT04829799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64702703|NCT04829799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64702704|NCT04829799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64702705|NCT04829799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64702706|NCT04829799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65460256|NCT01304602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460257|NCT01304602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460258|NCT01304602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460259|NCT01304134|Morphine|morphine|mesh-list
65460260|NCT01304134|Oxycodone|oxycodone|mesh-list
65460261|NCT01304134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65460262|NCT01304134|Narcotics|narcotics|mesh-ancestor
65460263|NCT01304134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65460264|NCT01304134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460265|NCT01304134|Analgesics|analgesics|mesh-ancestor
64702707|NCT04829799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702708|NCT04829799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64702709|NCT04829799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64702711|NCT04829799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64702712|NCT04829799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64702713|NCT04829799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64702714|NCT04829799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702715|NCT04829799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64702716|NCT04829799|Mydriatics|mydriatics|mesh-ancestor
64702717|NCT04829799|Autonomic Agents|autonomic agents|mesh-ancestor
64702718|NCT04829799|Sympathomimetics|sympathomimetics|mesh-ancestor
64702719|NCT04829799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64702720|NCT04829799|Nasal Decongestants|nasal decongestants|mesh-ancestor
64702721|NCT04829799|Respiratory System Agents|respiratory system agents|mesh-ancestor
64702722|NCT04829799|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64702723|NCT04829799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64702744|NCT01761877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64702745|NCT01761877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64702746|NCT01761877|Analgesics|analgesics|mesh-ancestor
64702747|NCT01761877|Sensory System Agents|sensory system agents|mesh-ancestor
64702748|NCT01761877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64702749|NCT01761877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702750|NCT01761877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64702751|NCT01761877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64702752|NCT01761877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702753|NCT01761877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64702754|NCT01761877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702755|NCT01761877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718482|NCT00423020|Hematinics|hematinics|mesh-ancestor
64718483|NCT01756586|Dexamethasone|dexamethasone|mesh-list
64718484|NCT01756586|Bupivacaine|bupivacaine|mesh-list
64718485|NCT01756586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64718486|NCT01756586|Antiemetics|antiemetics|mesh-ancestor
64702756|NCT04821375|Bazedoxifene|bazedoxifene|mesh-list
64702757|NCT04821375|Estrogens|estrogens|mesh-list
64702758|NCT04821375|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64702759|NCT04821375|Hormones|hormones|mesh-ancestor
64702760|NCT04821375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64702761|NCT04821375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702781|NCT04822467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64702782|NCT04822467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64702783|NCT04822467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64702784|NCT04822467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702786|NCT03306979|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64702787|NCT03306979|Antiviral Agents|antiviral agents|mesh-ancestor
64702788|NCT03306979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64702789|NCT03306979|Expectorants|expectorants|mesh-ancestor
64702790|NCT03306979|Respiratory System Agents|respiratory system agents|mesh-ancestor
64702791|NCT03306979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64702792|NCT03306979|Antioxidants|antioxidants|mesh-ancestor
64702793|NCT03306979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702794|NCT03306979|Protective Agents|protective agents|mesh-ancestor
64702795|NCT03306979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702796|NCT03306979|Antidotes|antidotes|mesh-ancestor
64702797|NCT00362869|Levofloxacin|levofloxacin|mesh-list
65494045|NCT03777436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65460266|NCT01304134|Sensory System Agents|sensory system agents|mesh-ancestor
65460267|NCT01304134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460268|NCT00124020|Vancomycin|vancomycin|mesh-list
65460269|NCT00124020|Telavancin|telavancin|mesh-list
65460270|NCT00124020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65460271|NCT00124020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65460272|NCT05630794|TIC10 compound|tic10 compound|mesh-list
65460273|NCT05630794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460274|NCT01080846|Misoprostol|misoprostol|mesh-list
65460275|NCT01080846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65460276|NCT01080846|Abortifacient Agents|abortifacient agents|mesh-ancestor
65460277|NCT01080846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65460278|NCT01080846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460279|NCT01080846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65460280|NCT01080846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65460281|NCT01080846|Oxytocics|oxytocics|mesh-ancestor
65460282|NCT01076322|Albuterol|albuterol|mesh-list
64702799|NCT00362869|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64702800|NCT00362869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64702801|NCT00362869|Renal Agents|renal agents|mesh-ancestor
64702802|NCT00362869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64702803|NCT00362869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64702804|NCT00362869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64702805|NCT00362869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702806|NCT00362869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702807|NCT00362869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702808|NCT00362869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64702809|NCT00362869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64702810|NCT03257215|Vitamin D|vitamin d|mesh-list
64702811|NCT03257215|Ergocalciferols|ergocalciferols|mesh-list
64428084|NCT02188719|Hormones|hormones|mesh-ancestor
64702813|NCT03257215|Vitamins|vitamins|mesh-list
64702814|NCT03257215|Micronutrients|micronutrients|mesh-ancestor
64702815|NCT03257215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702816|NCT03257215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64702817|NCT03257215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64702818|NCT02422940|4-Aminopyridine|4-aminopyridine|mesh-list
64718491|NCT01756586|Glucocorticoids|glucocorticoids|mesh-ancestor
64718492|NCT01756586|Hormones|hormones|mesh-ancestor
64718493|NCT01756586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64702822|NCT00588523|Temozolomide|temozolomide|mesh-list
64702823|NCT00588523|Busulfan|busulfan|mesh-list
64702824|NCT00588523|Thiotepa|thiotepa|mesh-list
64702825|NCT00588523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64702826|NCT00588523|Alkylating Agents|alkylating agents|mesh-ancestor
64702827|NCT00588523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702828|NCT00588523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702829|NCT00588523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64702830|NCT00588523|Immunologic Factors|immunologic factors|mesh-ancestor
64702831|NCT00588523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702832|NCT00588523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64702833|NCT02974387|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64702834|NCT02974387|Fluorometholone|fluorometholone|mesh-list
64702835|NCT02974387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64702836|NCT02974387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64702837|NCT02974387|Glucocorticoids|glucocorticoids|mesh-ancestor
64702838|NCT02974387|Hormones|hormones|mesh-ancestor
64702839|NCT02974387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65460283|NCT01076322|Procaterol|procaterol|mesh-list
65460284|NCT01076322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65460285|NCT01076322|Autonomic Agents|autonomic agents|mesh-ancestor
65460286|NCT01076322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460287|NCT01076322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460288|NCT01076322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65460289|NCT01076322|Respiratory System Agents|respiratory system agents|mesh-ancestor
65460290|NCT01076322|Tocolytic Agents|tocolytic agents|mesh-ancestor
65460291|NCT01076322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65460292|NCT01076322|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65460293|NCT01076322|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65460294|NCT01076322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65460295|NCT01076322|Adrenergic Agents|adrenergic agents|mesh-ancestor
65460296|NCT01076322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65460297|NCT01076322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460298|NCT01076322|Sympathomimetics|sympathomimetics|mesh-ancestor
65460299|NCT03966066|Erythromycin|erythromycin|mesh-list
65460300|NCT03966066|Erythromycin Estolate|erythromycin estolate|mesh-list
65460301|NCT03966066|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65460302|NCT03966066|Erythromycin stearate|erythromycin stearate|mesh-list
65460303|NCT03966066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65460304|NCT03966066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65460305|NCT03966066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65460306|NCT03966066|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65460307|NCT03966066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460308|NCT03966066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460309|NCT00215540|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65460310|NCT00215540|Respiratory System Agents|respiratory system agents|mesh-ancestor
65460311|NCT01304212|Ketorolac|ketorolac|mesh-list
65460312|NCT01304212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64702840|NCT02974387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702841|NCT00493831|Nicotine|nicotine|mesh-list
64702842|NCT00493831|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64702843|NCT00493831|Autonomic Agents|autonomic agents|mesh-ancestor
64702844|NCT00493831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64702845|NCT00493831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702846|NCT00493831|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64702847|NCT00493831|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64702848|NCT00493831|Cholinergic Agents|cholinergic agents|mesh-ancestor
64702849|NCT00493831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64702850|NCT00493831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702851|NCT00430183|Docetaxel|docetaxel|mesh-list
64702852|NCT00430183|Leuprolide|leuprolide|mesh-list
64702853|NCT00430183|Goserelin|goserelin|mesh-list
64702854|NCT00430183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702855|NCT00430183|Tubulin Modulators|tubulin modulators|mesh-ancestor
65460313|NCT01304212|Epinephrine|epinephrine|mesh-list
65460314|NCT01304212|Racepinephrine|racepinephrine|mesh-list
65460315|NCT01304212|Morphine|morphine|mesh-list
65460316|NCT01304212|Ropivacaine|ropivacaine|mesh-list
65460317|NCT01304212|Epinephryl borate|epinephryl borate|mesh-list
65460318|NCT01304212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65460319|NCT01304212|Narcotics|narcotics|mesh-ancestor
65460320|NCT01304212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65460321|NCT01304212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460322|NCT01304212|Analgesics|analgesics|mesh-ancestor
65460323|NCT01304212|Sensory System Agents|sensory system agents|mesh-ancestor
65460324|NCT01304212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460325|NCT01304212|Anesthetics, Local|anesthetics, local|mesh-ancestor
65460326|NCT01304212|Anesthetics|anesthetics|mesh-ancestor
65460327|NCT01304212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65460328|NCT01304212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65460329|NCT01304212|Adrenergic Agents|adrenergic agents|mesh-ancestor
65460330|NCT01304212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65460331|NCT01304212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460332|NCT01304212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65460333|NCT01304212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64702856|NCT00430183|Antimitotic Agents|antimitotic agents|mesh-ancestor
64702857|NCT00430183|Mitosis Modulators|mitosis modulators|mesh-ancestor
64702886|NCT03161431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702888|NCT02445859|Cefuroxime axetil|cefuroxime axetil|mesh-list
64702889|NCT02445859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64702890|NCT02445859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64702891|NCT02446483|Rabeprazole|rabeprazole|mesh-list
64702892|NCT02446483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64702893|NCT02446483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64702894|NCT02446483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64702895|NCT02446483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702896|NCT02446483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702897|NCT00362635|Clevudine|clevudine|mesh-list
64702898|NCT00362635|Antiviral Agents|antiviral agents|mesh-ancestor
64702899|NCT00362635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64702900|NCT04744753|Calcium|calcium|mesh-list
64702901|NCT04744753|Ionophores|ionophores|mesh-list
64702912|NCT02420041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702913|NCT02420041|Sensory System Agents|sensory system agents|mesh-ancestor
64702914|NCT02420041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64702915|NCT02420041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64702916|NCT02420041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64702917|NCT02420041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64718499|NCT01756586|Sensory System Agents|sensory system agents|mesh-ancestor
64718500|NCT03636061|Varenicline|varenicline|mesh-list
64718501|NCT03636061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64718502|NCT03636061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64718503|NCT03636061|Cholinergic Agents|cholinergic agents|mesh-ancestor
64718504|NCT03636061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64718505|NCT03636061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718506|NCT03636061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718507|NCT00661466|Bupivacaine|bupivacaine|mesh-list
64718508|NCT00661466|Anesthetics, Local|anesthetics, local|mesh-ancestor
64718509|NCT00661466|Anesthetics|anesthetics|mesh-ancestor
64718510|NCT00661466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65460334|NCT01304212|Autonomic Agents|autonomic agents|mesh-ancestor
65460335|NCT01304212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65460336|NCT01304212|Respiratory System Agents|respiratory system agents|mesh-ancestor
65460337|NCT01304212|Mydriatics|mydriatics|mesh-ancestor
65460338|NCT01304212|Sympathomimetics|sympathomimetics|mesh-ancestor
65460339|NCT01304212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65460340|NCT01304212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65460341|NCT01304212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65460342|NCT01304212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65209841|NCT00778375|Cytarabine|cytarabine|mesh-list
65460343|NCT01304212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65460344|NCT01304212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65460345|NCT01304212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460346|NCT00143390|Anastrozole|anastrozole|mesh-list
65460347|NCT00143390|Exemestane|exemestane|mesh-list
65460348|NCT00143390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65460349|NCT00143390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460350|NCT00143390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64718511|NCT00661466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718512|NCT00661466|Sensory System Agents|sensory system agents|mesh-ancestor
64718513|NCT00661466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64718514|NCT00639626|Insulin Detemir|insulin detemir|mesh-list
64718515|NCT00639626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64718516|NCT00639626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718517|NCT01718444|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64718518|NCT01718444|Clomiphene|clomiphene|mesh-list
64718519|NCT01718444|Enclomiphene|enclomiphene|mesh-list
64718520|NCT01718444|Zuclomiphene|zuclomiphene|mesh-list
64718521|NCT01718444|Medroxyprogesterone|medroxyprogesterone|mesh-list
64718522|NCT01718444|Progestins|progestins|mesh-list
64718523|NCT01718444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64702922|NCT02420041|Hormones|hormones|mesh-ancestor
64702923|NCT02420041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64702924|NCT02421211|Sofosbuvir|sofosbuvir|mesh-list
64702925|NCT02421211|Ledipasvir|ledipasvir|mesh-list
64702926|NCT02421211|Simeprevir|simeprevir|mesh-list
64702927|NCT02421211|Antiviral Agents|antiviral agents|mesh-ancestor
64702928|NCT02421211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64702929|NCT02421211|Protease Inhibitors|protease inhibitors|mesh-ancestor
64702930|NCT02421211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702931|NCT02421211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702932|NCT00363259|Ribavirin|ribavirin|mesh-list
64702934|NCT00363259|Antimetabolites|antimetabolites|mesh-ancestor
64702935|NCT00363259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702936|NCT00363259|Antiviral Agents|antiviral agents|mesh-ancestor
64702937|NCT00363259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64702938|NCT03091075|Oxandrolone|oxandrolone|mesh-list
64702939|NCT03091075|Androgens|androgens|mesh-ancestor
64718524|NCT01718444|Hormone Antagonists|hormone antagonists|mesh-ancestor
64718525|NCT01718444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64718526|NCT01718444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718527|NCT01718444|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64718528|NCT01718444|Fertility Agents|fertility agents|mesh-ancestor
64718529|NCT01718444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64718530|NCT01718444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64718531|NCT01718444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64718532|NCT01718444|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64718533|NCT01718444|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64718534|NCT01718444|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64718535|NCT01718444|Contraceptive Agents|contraceptive agents|mesh-ancestor
65460351|NCT00143390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65460352|NCT00143390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460353|NCT00143390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460354|NCT00143390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65460355|NCT00143390|Hormone Antagonists|hormone antagonists|mesh-ancestor
65460356|NCT00143390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65460357|NCT00143390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460358|NCT03238534|Omeprazole|omeprazole|mesh-list
65460359|NCT03238534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65460360|NCT03238534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65460361|NCT03238534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65460362|NCT03238534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460363|NCT03238534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460364|NCT00141102|Celecoxib|celecoxib|mesh-list
65460365|NCT00141102|Diclofenac|diclofenac|mesh-list
65460366|NCT00141102|Omeprazole|omeprazole|mesh-list
65460367|NCT00141102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65460368|NCT00141102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65460369|NCT00141102|Analgesics|analgesics|mesh-ancestor
65460370|NCT00141102|Sensory System Agents|sensory system agents|mesh-ancestor
65460371|NCT00141102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460372|NCT00141102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460373|NCT00141102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65460374|NCT00141102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65460375|NCT00141102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65460376|NCT00141102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65460377|NCT00141102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718536|NCT01718444|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64718537|NCT01718444|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64335294|NCT02299063|Analgesics|analgesics|mesh-ancestor
64702945|NCT03089905|Remifentanil|remifentanil|mesh-list
64702946|NCT03089905|Sevoflurane|sevoflurane|mesh-list
64702947|NCT03089905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64702948|NCT03089905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64702949|NCT03089905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702950|NCT03089905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64702951|NCT03089905|Analgesics|analgesics|mesh-ancestor
64702952|NCT03089905|Sensory System Agents|sensory system agents|mesh-ancestor
64702953|NCT03089905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64702954|NCT03089905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64702955|NCT03089905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64702956|NCT03089905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64702957|NCT03089905|Adrenergic Agents|adrenergic agents|mesh-ancestor
64702958|NCT03089905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64702959|NCT03089905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702960|NCT03089905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65460378|NCT00141102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460379|NCT00141102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65460380|NCT00141102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65460381|NCT00141102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65460382|NCT03663712|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
65460383|NCT03663712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65460384|NCT03663712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460385|NCT01078428|Petrolatum|petrolatum|mesh-list
65460386|NCT01078428|Emollients|emollients|mesh-ancestor
65460387|NCT01078428|Dermatologic Agents|dermatologic agents|mesh-ancestor
65460388|NCT01081002|Lidocaine|lidocaine|mesh-list
65460389|NCT01081002|Anesthetics, Local|anesthetics, local|mesh-ancestor
65460390|NCT01081002|Anesthetics|anesthetics|mesh-ancestor
65460391|NCT01081002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65460392|NCT01081002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460393|NCT01081002|Sensory System Agents|sensory system agents|mesh-ancestor
65460394|NCT01081002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460395|NCT01081002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65460396|NCT01081002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65460397|NCT01081002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65460398|NCT01081002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64844938|NCT05596227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702961|NCT03089905|Narcotics|narcotics|mesh-ancestor
64702962|NCT03089905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64702963|NCT03089905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64702964|NCT03089905|Anesthetics, General|anesthetics, general|mesh-ancestor
64702965|NCT03089905|Anesthetics|anesthetics|mesh-ancestor
64702966|NCT02424968|Cyclosporine|cyclosporine|mesh-list
64702972|NCT02424968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702973|NCT02424968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64702974|NCT02424968|Immunologic Factors|immunologic factors|mesh-ancestor
64702975|NCT02424968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702976|NCT02424968|Antifungal Agents|antifungal agents|mesh-ancestor
64702977|NCT02424968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64702978|NCT02424968|Dermatologic Agents|dermatologic agents|mesh-ancestor
64702979|NCT02424968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64718542|NCT00638222|Carvedilol|carvedilol|mesh-list
64718543|NCT00638222|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64718544|NCT00638222|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64718545|NCT00638222|Adrenergic Agents|adrenergic agents|mesh-ancestor
64718546|NCT00638222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64718547|NCT00638222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718548|NCT00638222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718549|NCT00638222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64718550|NCT00638222|Antioxidants|antioxidants|mesh-ancestor
64718551|NCT00638222|Protective Agents|protective agents|mesh-ancestor
64718552|NCT00638222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64718553|NCT00638222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64718554|NCT00638222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64718555|NCT00638222|Vasodilator Agents|vasodilator agents|mesh-ancestor
64718556|NCT00638222|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65460399|NCT01081002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460400|NCT03789058|Ibuprofen|ibuprofen|mesh-list
65460401|NCT03789058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65460402|NCT03789058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65460403|NCT03789058|Analgesics|analgesics|mesh-ancestor
65460404|NCT03789058|Sensory System Agents|sensory system agents|mesh-ancestor
65460405|NCT03789058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460406|NCT03789058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460407|NCT03789058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65460408|NCT03789058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65460409|NCT03789058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65460410|NCT03789058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460411|NCT03789058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844959|NCT05596214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64844960|NCT05596214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844961|NCT05596214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844962|NCT05596214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844963|NCT05596149|Listerine|listerine|mesh-list
64844964|NCT05596149|Fluorides|fluorides|mesh-list
64844965|NCT05596149|Sodium Fluoride|sodium fluoride|mesh-list
64844966|NCT05596149|Fluorophosphate|fluorophosphate|mesh-list
64844967|NCT05596149|Cariostatic Agents|cariostatic agents|mesh-ancestor
64844968|NCT05596149|Protective Agents|protective agents|mesh-ancestor
64844969|NCT05596149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844970|NCT05596149|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64844971|NCT05596149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64718557|NCT00638222|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64702980|NCT02424968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64702981|NCT02424968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64702982|NCT02424968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702983|NCT02424968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64702984|NCT02424968|Antitubercular Agents|antitubercular agents|mesh-ancestor
64702985|NCT02424968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64702987|NCT02424799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64702988|NCT02424799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702989|NCT02424799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703000|NCT02492750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703001|NCT02492750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65460412|NCT03788902|Methylphenidate|methylphenidate|mesh-list
65460413|NCT03788902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65460414|NCT03788902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460415|NCT03788902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65209918|NCT00916123|Prednisone|prednisone|mesh-list
65460416|NCT03788902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65460417|NCT03788902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65460418|NCT03788902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460419|NCT03788902|Dopamine Agents|dopamine agents|mesh-ancestor
65460420|NCT03788902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65460421|NCT05669092|Capecitabine|capecitabine|mesh-list
65460422|NCT05669092|Oxaliplatin|oxaliplatin|mesh-list
65460423|NCT05669092|Irinotecan|irinotecan|mesh-list
65460424|NCT05669092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65460425|NCT05669092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65460426|NCT05669092|Antimetabolites|antimetabolites|mesh-ancestor
65460427|NCT05669092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460428|NCT05669092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844973|NCT05596097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844974|NCT05596097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64844975|NCT05596097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844976|NCT05596097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844977|NCT05596071|Sufentanil|sufentanil|mesh-list
64844978|NCT05596071|Dsuvia|dsuvia|mesh-list
64844979|NCT05596071|Ropivacaine|ropivacaine|mesh-list
64844980|NCT05596071|Anesthetics, Local|anesthetics, local|mesh-ancestor
64844981|NCT05596071|Anesthetics|anesthetics|mesh-ancestor
64844982|NCT05596071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64844983|NCT05596071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844984|NCT05596071|Sensory System Agents|sensory system agents|mesh-ancestor
64844985|NCT05596071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844986|NCT05596071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64844987|NCT05596071|Narcotics|narcotics|mesh-ancestor
64844988|NCT05596071|Analgesics|analgesics|mesh-ancestor
64844989|NCT05596071|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64844990|NCT05596071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64703002|NCT02492750|Glucocorticoids|glucocorticoids|mesh-ancestor
64703003|NCT02492750|Hormones|hormones|mesh-ancestor
65460429|NCT05669092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65460430|NCT05669092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65460431|NCT05669092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460432|NCT00255008|Ribavirin|ribavirin|mesh-list
65460433|NCT00255008|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65460434|NCT00255008|Interferon-alpha|interferon-alpha|mesh-list
65460435|NCT00255008|Antimetabolites|antimetabolites|mesh-ancestor
65460436|NCT00255008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460437|NCT00255008|Antiviral Agents|antiviral agents|mesh-ancestor
65460438|NCT00255008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65460439|NCT00255008|Immunologic Factors|immunologic factors|mesh-ancestor
65460440|NCT00255008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460441|NCT01306240|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65460442|NCT01306240|Respiratory System Agents|respiratory system agents|mesh-ancestor
65460443|NCT03714022|Abatacept|abatacept|mesh-list
65460444|NCT03714022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65460445|NCT03714022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844991|NCT05596071|Anesthetics, General|anesthetics, general|mesh-ancestor
64844992|NCT05595447|Pembrolizumab|pembrolizumab|mesh-list
64844993|NCT05595447|Nivolumab|nivolumab|mesh-list
64844994|NCT05595447|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64844995|NCT05595447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64844996|NCT05595447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844997|NCT05595447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64844998|NCT05595447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844999|NCT05567822|Esmolol|esmolol|mesh-list
64845000|NCT05567822|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64845001|NCT05567822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64845002|NCT05567822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64845003|NCT05567822|Adrenergic Agents|adrenergic agents|mesh-ancestor
64845004|NCT05567822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64845005|NCT05567822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845006|NCT05567822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845007|NCT05557253|Anesthetics|anesthetics|mesh-list
65460446|NCT03714022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460447|NCT03714022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65460448|NCT03714022|Immunologic Factors|immunologic factors|mesh-ancestor
65460449|NCT03714022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460450|NCT03714022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65460451|NCT00143312|Voriconazole|voriconazole|mesh-list
65460452|NCT00143312|Antifungal Agents|antifungal agents|mesh-ancestor
65460453|NCT00143312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65460454|NCT00143312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65460455|NCT00143312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65460456|NCT00143312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460457|NCT00143312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845008|NCT05557253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64845009|NCT05557253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703004|NCT02492750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64703005|NCT02492750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64703006|NCT02492750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64703007|NCT02492750|Immunologic Factors|immunologic factors|mesh-ancestor
64945561|NCT05447559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64703008|NCT02492750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64703009|NCT02492750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64703010|NCT02492750|Growth Substances|growth substances|mesh-ancestor
64703011|NCT02492750|Growth Inhibitors|growth inhibitors|mesh-ancestor
64703012|NCT02492750|Protease Inhibitors|protease inhibitors|mesh-ancestor
64703013|NCT02492750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703014|NCT02492750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703015|NCT02492750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64703016|NCT02492750|Dermatologic Agents|dermatologic agents|mesh-ancestor
64703017|NCT00363337|Aripiprazole|aripiprazole|mesh-list
64703018|NCT00363337|Antidepressive Agents|antidepressive agents|mesh-ancestor
64703019|NCT00363337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64718558|NCT00634322|Leucovorin|leucovorin|mesh-list
64718559|NCT00634322|Antidotes|antidotes|mesh-ancestor
64718560|NCT00634322|Protective Agents|protective agents|mesh-ancestor
64718561|NCT00634322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718562|NCT00634322|Vitamin B Complex|vitamin b complex|mesh-ancestor
64718563|NCT00634322|Vitamins|vitamins|mesh-ancestor
64718564|NCT00634322|Micronutrients|micronutrients|mesh-ancestor
64718565|NCT00379886|Thiopental|thiopental|mesh-list
64718566|NCT00379886|Propofol|propofol|mesh-list
64718567|NCT00379886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64718568|NCT00379886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64718569|NCT00379886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703020|NCT00363337|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64703021|NCT00363337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64703022|NCT00363337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64703023|NCT00363337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703024|NCT00363337|Dopamine Agonists|dopamine agonists|mesh-ancestor
64703025|NCT00363337|Dopamine Agents|dopamine agents|mesh-ancestor
64703026|NCT00363337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703027|NCT00363337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703028|NCT00363337|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64703029|NCT00363337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64703030|NCT00363337|Serotonin Agents|serotonin agents|mesh-ancestor
64703031|NCT00363337|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64703032|NCT00363337|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64703033|NCT00363337|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64703034|NCT00363337|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64428315|NCT02527421|Hormones|hormones|mesh-ancestor
65460458|NCT00143312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65460459|NCT00143312|Hormone Antagonists|hormone antagonists|mesh-ancestor
65460460|NCT00143312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65460461|NCT00143312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460462|NCT00143312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65460463|NCT04833946|Andrographolide|andrographolide|mesh-list
65460464|NCT04833946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64845020|NCT05539924|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64845021|NCT05539924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64845022|NCT05539924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845023|NCT05539924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64845024|NCT05539924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64845025|NCT05539924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64845026|NCT05539924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64328195|NCT00595699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328196|NCT00595699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64328197|NCT00595699|Serotonin Agents|serotonin agents|mesh-ancestor
64328198|NCT00595699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328199|NCT00595699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64328225|NCT02663271|Growth Substances|growth substances|mesh-ancestor
64328226|NCT02663271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328227|NCT02663271|Growth Inhibitors|growth inhibitors|mesh-ancestor
64328228|NCT00659191|Cabotegravir|cabotegravir|mesh-list
64703042|NCT02429869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64703043|NCT02429869|Immunologic Factors|immunologic factors|mesh-ancestor
64703044|NCT02429869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703045|NCT02428478|Desipramine|desipramine|mesh-list
64703046|NCT02428478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64703047|NCT02428478|Antidepressive Agents|antidepressive agents|mesh-ancestor
64703048|NCT02428478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64703063|NCT04341493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703064|NCT04341493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703065|NCT04341493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64703066|NCT02432287|Metformin|metformin|mesh-list
64703067|NCT02432287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64703068|NCT02432287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703069|NCT02532998|Fludrocortisone|fludrocortisone|mesh-list
64703070|NCT02532998|Eplerenone|eplerenone|mesh-list
64703071|NCT02532998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64703072|NCT02532998|Hormone Antagonists|hormone antagonists|mesh-ancestor
64703073|NCT02532998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64703074|NCT02532998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703075|NCT02532998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64718570|NCT00379886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64718571|NCT00379886|Anesthetics, General|anesthetics, general|mesh-ancestor
64718572|NCT00379886|Anesthetics|anesthetics|mesh-ancestor
65460465|NCT04833946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65460466|NCT04833946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65460467|NCT04833946|Analgesics|analgesics|mesh-ancestor
65460468|NCT04833946|Sensory System Agents|sensory system agents|mesh-ancestor
65460469|NCT04833946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460470|NCT04833946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460471|NCT04833946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65460472|NCT04833946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65460473|NCT04833946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65460474|NCT04833946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65460475|NCT04833946|Antiviral Agents|antiviral agents|mesh-ancestor
65460476|NCT04833946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65460477|NCT01077206|Simvastatin|simvastatin|mesh-list
65460478|NCT01077206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65460479|NCT01077206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65460480|NCT01077206|Antimetabolites|antimetabolites|mesh-ancestor
65460481|NCT01077206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460482|NCT01077206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65460483|NCT01077206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64845027|NCT05539924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64845028|NCT05539924|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64845029|NCT05539924|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64845030|NCT05539924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64845031|NCT05539924|Antimanic Agents|antimanic agents|mesh-ancestor
64845032|NCT05539924|Vitamin B Complex|vitamin b complex|mesh-ancestor
64845033|NCT05514782|Sunscreening Agents|sunscreening agents|mesh-list
64845034|NCT05514782|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64718573|NCT00379886|Anticonvulsants|anticonvulsants|mesh-ancestor
64457869|NCT03594214|Vitamin D|vitamin d|mesh-list
64718574|NCT00379886|GABA Modulators|gaba modulators|mesh-ancestor
64718575|NCT00379886|GABA Agents|gaba agents|mesh-ancestor
64718576|NCT00379886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64718577|NCT00379886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718578|NCT01705106|Celecoxib|celecoxib|mesh-list
64703076|NCT02532998|Diuretics|diuretics|mesh-ancestor
64703077|NCT02532998|Natriuretic Agents|natriuretic agents|mesh-ancestor
64703078|NCT02532998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64945562|NCT05438043|Dexamethasone|dexamethasone|mesh-list
64945563|NCT05438043|Lenalidomide|lenalidomide|mesh-list
64945564|NCT05438043|Daratumumab|daratumumab|mesh-list
64703079|NCT02532998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64703080|NCT03026101|Nitroglycerin|nitroglycerin|mesh-list
64703081|NCT03026101|Vasodilator Agents|vasodilator agents|mesh-ancestor
64703082|NCT02453581|Artefenomel|artefenomel|mesh-list
64703083|NCT02453581|Antimalarials|antimalarials|mesh-ancestor
64703084|NCT02453581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64703085|NCT02453581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64703086|NCT02453581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64703087|NCT02533466|Listerine|listerine|mesh-list
65460484|NCT01077206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460485|NCT05623540|Diphosphonates|diphosphonates|mesh-list
65460486|NCT05623540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65460487|NCT05623540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209990|NCT01059812|Insulin|insulin|mesh-list
65460488|NCT05622838|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65460489|NCT05622838|Protein C Inhibitor|protein c inhibitor|mesh-list
65460490|NCT05622838|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65460491|NCT05622838|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65460492|NCT05622838|Protease Inhibitors|protease inhibitors|mesh-ancestor
65460493|NCT05622838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460494|NCT05622838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460496|NCT01306318|Eperisone|eperisone|mesh-list
65460497|NCT01306318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65460498|NCT01306318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64845049|NCT05488847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64845051|NCT05488847|Autonomic Agents|autonomic agents|mesh-ancestor
64845052|NCT05488847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845053|NCT05488847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845054|NCT05488847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64845055|NCT05488847|Glucocorticoids|glucocorticoids|mesh-ancestor
64845056|NCT05488847|Hormones|hormones|mesh-ancestor
64845057|NCT05488847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64845058|NCT05488847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64845059|NCT05488847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845060|NCT05488847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64845061|NCT05488847|Analgesics|analgesics|mesh-ancestor
64845062|NCT05488847|Sensory System Agents|sensory system agents|mesh-ancestor
64845063|NCT05488847|Antipyretics|antipyretics|mesh-ancestor
64845064|NCT05488847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64328348|NCT02403687|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64328349|NCT02403687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64328350|NCT02403687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65460499|NCT01306318|Analgesics|analgesics|mesh-ancestor
65460500|NCT01306318|Sensory System Agents|sensory system agents|mesh-ancestor
65460501|NCT01306318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460502|NCT01306318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460503|NCT01306318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65460504|NCT01306318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65460505|NCT01306318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65460506|NCT01306318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460507|NCT01306318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460508|NCT01306318|Anticonvulsants|anticonvulsants|mesh-ancestor
65460509|NCT01306318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65460510|NCT01306318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65460511|NCT01306318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65460512|NCT01306318|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65460513|NCT01306318|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65460514|NCT01306318|Parasympatholytics|parasympatholytics|mesh-ancestor
64845065|NCT05488847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64845066|NCT05488847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64845067|NCT05488847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845068|NCT05488847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845069|NCT05488847|Anticonvulsants|anticonvulsants|mesh-ancestor
64845070|NCT05488847|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64845071|NCT05488847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64845072|NCT05488847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64845073|NCT05488847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64845074|NCT05488847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64845075|NCT05488847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64845076|NCT05488847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64845077|NCT05488847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64845078|NCT05488847|Narcotics|narcotics|mesh-ancestor
64845079|NCT05488847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64845080|NCT05488847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64845081|NCT05488847|Adrenergic Agents|adrenergic agents|mesh-ancestor
64328377|NCT02403687|GABA Agents|gaba agents|mesh-ancestor
64328378|NCT02403687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64328379|NCT02403687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65460515|NCT01306318|Autonomic Agents|autonomic agents|mesh-ancestor
65460516|NCT01306318|Vasodilator Agents|vasodilator agents|mesh-ancestor
65460517|NCT00254540|Sunitinib|sunitinib|mesh-list
65460518|NCT00254540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460519|NCT00254540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65460520|NCT00254540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65460521|NCT00254540|Growth Substances|growth substances|mesh-ancestor
65460522|NCT00254540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460523|NCT00254540|Growth Inhibitors|growth inhibitors|mesh-ancestor
65460524|NCT00254540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65460525|NCT00254540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460526|NCT00254540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460527|NCT01326494|Prednisone|prednisone|mesh-list
65460528|NCT01326494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65460529|NCT01326494|Glucocorticoids|glucocorticoids|mesh-ancestor
65460530|NCT01326494|Hormones|hormones|mesh-ancestor
65460531|NCT01326494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65460532|NCT01326494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460533|NCT01326494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65460534|NCT01326494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460535|NCT05316220|Mesalamine|mesalamine|mesh-list
65460536|NCT05316220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65460537|NCT05316220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65460538|NCT05316220|Analgesics|analgesics|mesh-ancestor
65460539|NCT05316220|Sensory System Agents|sensory system agents|mesh-ancestor
65460540|NCT05316220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460541|NCT05316220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460542|NCT05316220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65460543|NCT05316220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65460544|NCT01305850|Losartan|losartan|mesh-list
65460545|NCT01305850|Enalapril|enalapril|mesh-list
65460546|NCT01305850|Enalaprilat|enalaprilat|mesh-list
65460547|NCT01305850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65460548|NCT01305850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65460549|NCT01305850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65460554|NCT01305850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460555|NCT01306630|Capecitabine|capecitabine|mesh-list
65460556|NCT01306630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65460557|NCT01306630|Antimetabolites|antimetabolites|mesh-ancestor
65460558|NCT01306630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460559|NCT01306630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460560|NCT01306708|Amitriptyline|amitriptyline|mesh-list
65210067|NCT00887679|Serotonin Agents|serotonin agents|mesh-ancestor
65460562|NCT01306708|Antidepressive Agents|antidepressive agents|mesh-ancestor
65460563|NCT01306708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65460564|NCT01306708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65460565|NCT01306708|Analgesics|analgesics|mesh-ancestor
65460566|NCT01306708|Sensory System Agents|sensory system agents|mesh-ancestor
65460567|NCT01306708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460568|NCT01306708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460569|NCT01306708|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65460570|NCT01306708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65460571|NCT01306708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65460572|NCT01306708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460573|NCT01306708|Adrenergic Agents|adrenergic agents|mesh-ancestor
65460574|NCT01306708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64845123|NCT05423951|Rocuronium|rocuronium|mesh-list
64845124|NCT05423951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64845125|NCT05423951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64845126|NCT05423951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845127|NCT05423951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64845128|NCT05423951|Anesthetics, General|anesthetics, general|mesh-ancestor
64845129|NCT05423951|Anesthetics|anesthetics|mesh-ancestor
64845130|NCT05423951|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64845131|NCT05423951|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64845132|NCT05423951|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64845133|NCT05423951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845134|NCT05423951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64845135|NCT05423951|Narcotics|narcotics|mesh-ancestor
64703088|NCT02533466|Fluorides|fluorides|mesh-list
64703089|NCT02533466|Sodium Fluoride|sodium fluoride|mesh-list
64703090|NCT02533466|Cariostatic Agents|cariostatic agents|mesh-ancestor
64703091|NCT02533466|Protective Agents|protective agents|mesh-ancestor
64703092|NCT02533466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460575|NCT03794518|Pioglitazone|pioglitazone|mesh-list
65460576|NCT03794518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65460577|NCT03794518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460578|NCT05566288|Moxifloxacin|moxifloxacin|mesh-list
65460579|NCT05566288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65460580|NCT05566288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65460581|NCT05566288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65460582|NCT05566288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65460583|NCT05566288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460584|NCT05566288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460585|NCT05566288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460586|NCT03790540|Benzocaine|benzocaine|mesh-list
65460587|NCT03790540|Anesthetics, Local|anesthetics, local|mesh-ancestor
65460588|NCT03790540|Anesthetics|anesthetics|mesh-ancestor
64845144|NCT05405621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845145|NCT05383196|Paclitaxel|paclitaxel|mesh-list
64845146|NCT05383196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64845147|NCT05383196|Onvansertib|onvansertib|mesh-list
64845148|NCT05383196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64703093|NCT02533466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64703094|NCT02533466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64703095|NCT02974244|Exenatide|exenatide|mesh-list
64703096|NCT02974244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64703097|NCT02974244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703098|NCT02974244|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64703099|NCT02974244|Incretins|incretins|mesh-ancestor
64703121|NCT02454283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703123|NCT02437669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64703124|NCT02437669|Narcotics|narcotics|mesh-ancestor
64703125|NCT02437669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64703126|NCT02437669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703127|NCT02437669|Analgesics|analgesics|mesh-ancestor
64703128|NCT02437669|Sensory System Agents|sensory system agents|mesh-ancestor
64703129|NCT02437669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64703130|NCT02430818|Ketamine|ketamine|mesh-list
64703131|NCT02430818|Morphine|morphine|mesh-list
64703132|NCT02430818|Analgesics|analgesics|mesh-ancestor
64703133|NCT02430818|Sensory System Agents|sensory system agents|mesh-ancestor
64703134|NCT02430818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64703135|NCT02430818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703136|NCT02430818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64703137|NCT02430818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64703138|NCT02430818|Anesthetics, General|anesthetics, general|mesh-ancestor
64718579|NCT01705106|Capecitabine|capecitabine|mesh-list
64718580|NCT01705106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64718581|NCT01705106|Antimetabolites|antimetabolites|mesh-ancestor
64718582|NCT01705106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718583|NCT01705106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718584|NCT01705106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64718585|NCT01705106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64718586|NCT01705106|Analgesics|analgesics|mesh-ancestor
64718587|NCT01705106|Sensory System Agents|sensory system agents|mesh-ancestor
64718588|NCT01705106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64718589|NCT01705106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718590|NCT01705106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64718591|NCT01705106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64703139|NCT02430818|Anesthetics|anesthetics|mesh-ancestor
65460589|NCT03790540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65460590|NCT03790540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460591|NCT03790540|Sensory System Agents|sensory system agents|mesh-ancestor
65460592|NCT03790540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460593|NCT03794596|Aspirin|aspirin|mesh-list
65460594|NCT03794596|Avelumab|avelumab|mesh-list
65460595|NCT03794596|Lansoprazole|lansoprazole|mesh-list
65460596|NCT03794596|Dexlansoprazole|dexlansoprazole|mesh-list
65460597|NCT03794596|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65460598|NCT03794596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65460599|NCT03794596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65460600|NCT03794596|Analgesics|analgesics|mesh-ancestor
65460601|NCT03794596|Sensory System Agents|sensory system agents|mesh-ancestor
65460602|NCT03794596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460603|NCT03794596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460604|NCT03794596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65460605|NCT03794596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65460606|NCT03794596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65460607|NCT03794596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65460608|NCT03794596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460609|NCT03794596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65460610|NCT03794596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65460611|NCT03794596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460612|NCT03794596|Antipyretics|antipyretics|mesh-ancestor
65460613|NCT03794596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65460614|NCT03794596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460615|NCT03794596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65460616|NCT03794596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65460617|NCT05571748|Thioctic Acid|thioctic acid|mesh-list
65460618|NCT05571748|Antioxidants|antioxidants|mesh-ancestor
65460619|NCT05571748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460620|NCT05571748|Protective Agents|protective agents|mesh-ancestor
64845159|NCT05351541|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
64703140|NCT02430818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64703141|NCT02430818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64703142|NCT02430818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64703143|NCT02430818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703144|NCT02430818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703145|NCT02430818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64703146|NCT02430818|Narcotics|narcotics|mesh-ancestor
65460621|NCT05571748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460622|NCT05571748|Vitamin B Complex|vitamin b complex|mesh-ancestor
65460623|NCT05571748|Vitamins|vitamins|mesh-ancestor
65460624|NCT05571748|Micronutrients|micronutrients|mesh-ancestor
65460625|NCT03790618|Methamphetamine|methamphetamine|mesh-list
65460626|NCT03790618|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65460627|NCT03790618|Hallucinogens|hallucinogens|mesh-ancestor
65460628|NCT03790618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460629|NCT03790618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65460630|NCT03790618|Serotonin Agents|serotonin agents|mesh-ancestor
65460631|NCT03790618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65460632|NCT03790618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460633|NCT03790618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65210141|NCT00702442|Dopamine Agents|dopamine agents|mesh-ancestor
65460634|NCT03790618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64845191|NCT05301361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64845192|NCT05301361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845193|NCT05301361|Dopamine Agents|dopamine agents|mesh-ancestor
64845194|NCT05301361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64845195|NCT05291156|Cetuximab|cetuximab|mesh-list
64845196|NCT05291156|Avelumab|avelumab|mesh-list
64845197|NCT05291156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64845198|NCT05291156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845200|NCT05253118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845201|NCT05253118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845202|NCT05253118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845203|NCT05253118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64845204|NCT05253118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64845205|NCT05226923|Meropenem|meropenem|mesh-list
64328798|NCT02180321|Hemostatics|hemostatics|mesh-ancestor
64328799|NCT02180321|Coagulants|coagulants|mesh-ancestor
64328800|NCT00547651|Topotecan|topotecan|mesh-list
64328801|NCT00547651|Amrubicin|amrubicin|mesh-list
64328802|NCT00547651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64328819|NCT02386059|Dexamethasone|dexamethasone|mesh-list
64328820|NCT02386059|Dexamethasone acetate|dexamethasone acetate|mesh-list
64703147|NCT02455453|Estradiol|estradiol|mesh-list
64703148|NCT02455453|Estrogens|estrogens|mesh-ancestor
64703149|NCT02455453|Hormones|hormones|mesh-ancestor
65460635|NCT03790618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65460636|NCT03790618|Adrenergic Agents|adrenergic agents|mesh-ancestor
65460637|NCT03790618|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65460638|NCT03790618|Sympathomimetics|sympathomimetics|mesh-ancestor
65460639|NCT03790618|Autonomic Agents|autonomic agents|mesh-ancestor
65460640|NCT03790618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460641|NCT03790618|Dopamine Agents|dopamine agents|mesh-ancestor
65460642|NCT03790618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65460644|NCT03790228|Pemetrexed|pemetrexed|mesh-list
65460645|NCT03790228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460646|NCT03790228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460647|NCT03790228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460648|NCT03790228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65460649|NCT03790228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65460650|NCT01304836|Mycophenolic Acid|mycophenolic acid|mesh-list
65460651|NCT01304836|Methylprednisolone|methylprednisolone|mesh-list
65460652|NCT01304836|Prednisolone|prednisolone|mesh-list
65460653|NCT01304836|Tacrolimus|tacrolimus|mesh-list
65460654|NCT01304836|Basiliximab|basiliximab|mesh-list
65460655|NCT01304836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65460656|NCT01304836|Immunologic Factors|immunologic factors|mesh-ancestor
65460657|NCT01304836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460658|NCT01304836|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65460659|NCT01304836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460660|NCT01304836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460661|NCT01304836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65460662|NCT01304836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460663|NCT01304836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65460664|NCT01304836|Antitubercular Agents|antitubercular agents|mesh-ancestor
65460665|NCT01304836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65460666|NCT01304836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65460667|NCT01304836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65460668|NCT01304836|Antiemetics|antiemetics|mesh-ancestor
65460669|NCT01304836|Autonomic Agents|autonomic agents|mesh-ancestor
65460670|NCT01304836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845206|NCT05226923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64845207|NCT05226923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65460671|NCT01304836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65460672|NCT01304836|Glucocorticoids|glucocorticoids|mesh-ancestor
65460673|NCT01304836|Hormones|hormones|mesh-ancestor
65460674|NCT01304836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65460675|NCT01304836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65460676|NCT01304836|Protective Agents|protective agents|mesh-ancestor
65460677|NCT01304836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65460678|NCT01306864|Hemostatics|hemostatics|mesh-list
65460679|NCT01306864|Coagulants|coagulants|mesh-ancestor
65460680|NCT01307332|Alemtuzumab|alemtuzumab|mesh-list
65460681|NCT01307332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65460682|NCT01307332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460683|NCT03790384|Mitomycins|mitomycins|mesh-list
65460684|NCT03790384|Mitomycin|mitomycin|mesh-list
65460685|NCT03790384|BCG Vaccine|bcg vaccine|mesh-list
65460686|NCT03790384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65460687|NCT03790384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460688|NCT03790384|Alkylating Agents|alkylating agents|mesh-ancestor
65460689|NCT03790384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460690|NCT03790384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65460691|NCT03790384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845241|NCT05076838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64845242|NCT05076838|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64845243|NCT05076838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64845244|NCT05076838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64845245|NCT05076838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64845246|NCT05076838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64845247|NCT05076838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64845248|NCT05076838|Anesthetics, General|anesthetics, general|mesh-ancestor
64845249|NCT05076838|Anesthetics|anesthetics|mesh-ancestor
64845250|NCT05076838|GABA Modulators|gaba modulators|mesh-ancestor
64845251|NCT05076838|GABA Agents|gaba agents|mesh-ancestor
64845252|NCT05076838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64845253|NCT05076838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845256|NCT05057949|Rifampin|rifampin|mesh-list
64703150|NCT02455453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64703151|NCT02455453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703161|NCT02519023|Anesthetics|anesthetics|mesh-ancestor
64703162|NCT02519023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64703163|NCT02519023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460692|NCT03790384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65460693|NCT03790384|Immunologic Factors|immunologic factors|mesh-ancestor
65460694|NCT03790384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460695|NCT01307488|Ritonavir|ritonavir|mesh-list
65460696|NCT01307488|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65460697|NCT01307488|Lamivudine|lamivudine|mesh-list
65460698|NCT01307488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65460699|NCT01307488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65460700|NCT01307488|Protease Inhibitors|protease inhibitors|mesh-ancestor
65460701|NCT01307488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460702|NCT01307488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460703|NCT01307488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65460704|NCT01307488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65460705|NCT01307488|Antiviral Agents|antiviral agents|mesh-ancestor
65460706|NCT01307488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65460707|NCT01307488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65210215|NCT04166292|Lidocaine|lidocaine|mesh-list
65460708|NCT01307488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65460709|NCT01307488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65460710|NCT01307488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65460711|NCT03790072|Cyclophosphamide|cyclophosphamide|mesh-list
65460712|NCT03790072|Fludarabine|fludarabine|mesh-list
65460713|NCT03790072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65460714|NCT03790072|Immunologic Factors|immunologic factors|mesh-ancestor
65460715|NCT03790072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460716|NCT03790072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65460717|NCT03790072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65460718|NCT03790072|Alkylating Agents|alkylating agents|mesh-ancestor
65460719|NCT03790072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460720|NCT03790072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460721|NCT03790072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65460722|NCT01306006|Vaccines|vaccines|mesh-list
65460723|NCT01306006|Immunologic Factors|immunologic factors|mesh-ancestor
65460724|NCT01306006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845262|NCT05057949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845293|NCT04892303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845294|NCT04886297|Resveratrol|resveratrol|mesh-list
64845295|NCT04886297|Antioxidants|antioxidants|mesh-ancestor
64845296|NCT04886297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845297|NCT04886297|Protective Agents|protective agents|mesh-ancestor
64845298|NCT04886297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845299|NCT04886297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845300|NCT04886297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64845301|NCT04830410|Levan|levan|mesh-list
64845302|NCT04830410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845315|NCT04810793|Amoxicillin|amoxicillin|mesh-list
64845316|NCT04810793|Levofloxacin|levofloxacin|mesh-list
65460725|NCT03794440|Sorafenib|sorafenib|mesh-list
65460726|NCT03794440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460727|NCT03794440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65460728|NCT03794440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460729|NCT03794440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460730|NCT00139776|Celecoxib|celecoxib|mesh-list
65460731|NCT00139776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65460732|NCT00139776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65460733|NCT00139776|Analgesics|analgesics|mesh-ancestor
65460734|NCT00139776|Sensory System Agents|sensory system agents|mesh-ancestor
65460735|NCT00139776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460736|NCT00139776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460737|NCT00139776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65460761|NCT03789370|Sevoflurane|sevoflurane|mesh-list
65460762|NCT03789370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65460763|NCT03789370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65460764|NCT03789370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460765|NCT03789370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65460766|NCT03789370|Anesthetics, General|anesthetics, general|mesh-ancestor
65460767|NCT03789370|Anesthetics|anesthetics|mesh-ancestor
65460768|NCT03789370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65460769|NCT03789370|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65460770|NCT00420095|Insulin|insulin|mesh-list
65460771|NCT00420095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65460772|NCT00420095|Insulin Lispro|insulin lispro|mesh-list
65460773|NCT00420095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65460774|NCT00420095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460775|NCT04904692|Dimercaprol|dimercaprol|mesh-list
64845331|NCT04810793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64845332|NCT04810793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845333|NCT04810793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64845334|NCT04810793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64845335|NCT04810793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64845336|NCT04810793|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64845337|NCT04810793|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64845338|NCT04810793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64845339|NCT04810793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64845340|NCT04810793|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64845341|NCT04797832|Ferric gluconate|ferric gluconate|mesh-list
64845342|NCT04797832|Hematinics|hematinics|mesh-ancestor
64845343|NCT04684511|Rofecoxib|rofecoxib|mesh-list
64845344|NCT04684511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64845345|NCT04684511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64329168|NCT05089175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64329169|NCT05089175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64329170|NCT05089175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64329171|NCT05089175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64329172|NCT05089175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329173|NCT05089175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64703164|NCT02519023|Sensory System Agents|sensory system agents|mesh-ancestor
64703165|NCT02519023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460776|NCT04904692|Chelating Agents|chelating agents|mesh-ancestor
65460777|NCT04904692|Sequestering Agents|sequestering agents|mesh-ancestor
65460778|NCT04904692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460779|NCT01038089|Resveratrol|resveratrol|mesh-list
65460780|NCT01038089|Antioxidants|antioxidants|mesh-ancestor
65460781|NCT01038089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460782|NCT01038089|Protective Agents|protective agents|mesh-ancestor
65460783|NCT01038089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460784|NCT01038089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460785|NCT01038089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65460786|NCT05495464|Cyclophosphamide|cyclophosphamide|mesh-list
65460788|NCT05495464|Fludarabine|fludarabine|mesh-list
65460789|NCT05495464|Fludarabine phosphate|fludarabine phosphate|mesh-list
64613857|NCT01014403|Enoxaparin|enoxaparin|mesh-list
64845346|NCT04684511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845347|NCT04684511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845348|NCT04684511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64845349|NCT04684511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64845350|NCT04684511|Analgesics|analgesics|mesh-ancestor
64845351|NCT04684511|Sensory System Agents|sensory system agents|mesh-ancestor
64845352|NCT04684511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845353|NCT04684511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845354|NCT04684511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64845355|NCT04684511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64845356|NCT04650841|Naloxone|naloxone|mesh-list
64845357|NCT04650841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64329291|NCT02384967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64329292|NCT02384967|Protease Inhibitors|protease inhibitors|mesh-ancestor
64329293|NCT02384967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329294|NCT02384967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703166|NCT02519023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64703167|NCT02519023|Analgesics|analgesics|mesh-ancestor
64703168|NCT02519023|Antipyretics|antipyretics|mesh-ancestor
64703169|NCT02519023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64703182|NCT02519023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64703183|NCT02519023|Autonomic Agents|autonomic agents|mesh-ancestor
64703184|NCT02519023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64703185|NCT02519023|Respiratory System Agents|respiratory system agents|mesh-ancestor
64703186|NCT02519023|Mydriatics|mydriatics|mesh-ancestor
64428459|NCT05368415|Sympathomimetics|sympathomimetics|mesh-ancestor
64703188|NCT02519023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64703189|NCT02497040|Bupivacaine|bupivacaine|mesh-list
64703190|NCT02497040|Levobupivacaine|levobupivacaine|mesh-list
64703191|NCT02497040|Anesthetics, Local|anesthetics, local|mesh-ancestor
64703192|NCT02497040|Anesthetics|anesthetics|mesh-ancestor
65460790|NCT05495464|Acalabrutinib|acalabrutinib|mesh-list
65460791|NCT05495464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65460792|NCT05495464|Immunologic Factors|immunologic factors|mesh-ancestor
65460793|NCT05495464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460794|NCT05495464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65460795|NCT05495464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65460796|NCT05495464|Alkylating Agents|alkylating agents|mesh-ancestor
65460797|NCT05495464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460798|NCT05495464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460799|NCT05495464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65460800|NCT05495464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65460801|NCT05495464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65460802|NCT05495464|Antimetabolites|antimetabolites|mesh-ancestor
65460803|NCT00419393|Levetiracetam|levetiracetam|mesh-list
65460804|NCT00419393|Anticonvulsants|anticonvulsants|mesh-ancestor
65460805|NCT00419393|Nootropic Agents|nootropic agents|mesh-ancestor
65460806|NCT01038167|Cyclosporine|cyclosporine|mesh-list
65460807|NCT01038167|Tacrolimus|tacrolimus|mesh-list
65460808|NCT01038167|Cyclosporins|cyclosporins|mesh-list
65460809|NCT01038167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64845358|NCT04650841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845359|NCT04650841|Sensory System Agents|sensory system agents|mesh-ancestor
64845360|NCT04650841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845361|NCT04624854|Aspirin|aspirin|mesh-list
64845362|NCT04624854|Clopidogrel|clopidogrel|mesh-list
64845363|NCT04624854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64845364|NCT04624854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64703193|NCT02497040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64703194|NCT02497040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703195|NCT02497040|Sensory System Agents|sensory system agents|mesh-ancestor
64703196|NCT02497040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64703197|NCT02523235|Ropivacaine|ropivacaine|mesh-list
64703198|NCT02523235|Anesthetics, Local|anesthetics, local|mesh-ancestor
64703199|NCT02523235|Anesthetics|anesthetics|mesh-ancestor
64718592|NCT01705106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64718593|NCT01705106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64718594|NCT01705106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718595|NCT00624650|Phenylephrine|phenylephrine|mesh-list
64718597|NCT00624650|Furosemide|furosemide|mesh-list
64718598|NCT00624650|Vasopressins|vasopressins|mesh-list
64718599|NCT00624650|Arginine Vasopressin|arginine vasopressin|mesh-list
64718600|NCT00624650|Epinephrine|epinephrine|mesh-list
64718601|NCT00624650|Racepinephrine|racepinephrine|mesh-list
64326754|NCT04706741|Hormones|hormones|mesh-ancestor
64703200|NCT02523235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64703201|NCT02523235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703202|NCT02523235|Sensory System Agents|sensory system agents|mesh-ancestor
64703203|NCT02523235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64703204|NCT02498522|Metformin|metformin|mesh-list
65460810|NCT01038167|Immunologic Factors|immunologic factors|mesh-ancestor
65460811|NCT01038167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460812|NCT01038167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65460813|NCT01038167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460814|NCT01038167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460815|NCT01038167|Antifungal Agents|antifungal agents|mesh-ancestor
65460816|NCT01038167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65460817|NCT01038167|Dermatologic Agents|dermatologic agents|mesh-ancestor
65460818|NCT01038167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65460819|NCT03787030|Vitamin E|vitamin e|mesh-list
65460820|NCT03787030|Tocopherols|tocopherols|mesh-list
65460821|NCT03787030|alpha-Tocopherol|alpha-tocopherol|mesh-list
65460822|NCT03787030|Nitroglycerin|nitroglycerin|mesh-list
65460823|NCT03787030|Vitamins|vitamins|mesh-ancestor
65460824|NCT03787030|Micronutrients|micronutrients|mesh-ancestor
64845375|NCT04624854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64845376|NCT04624854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845377|NCT04624854|Antipyretics|antipyretics|mesh-ancestor
64845378|NCT04624854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64845379|NCT04624854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64845380|NCT04624854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64845381|NCT04624854|Purinergic Agents|purinergic agents|mesh-ancestor
64845382|NCT04624854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64845383|NCT04602598|Zanubrutinib|zanubrutinib|mesh-list
64845384|NCT04602598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845385|NCT04602598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64845386|NCT04602598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845387|NCT04602598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329561|NCT02296840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64329562|NCT02296840|Analgesics|analgesics|mesh-ancestor
64329563|NCT02296840|Sensory System Agents|sensory system agents|mesh-ancestor
64329564|NCT02296840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64329565|NCT02296840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460825|NCT03787030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460826|NCT03787030|Antioxidants|antioxidants|mesh-ancestor
65460827|NCT03787030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460828|NCT03787030|Protective Agents|protective agents|mesh-ancestor
65460829|NCT03787030|Vasodilator Agents|vasodilator agents|mesh-ancestor
65460830|NCT02174549|Tirapazamine|tirapazamine|mesh-list
65460831|NCT02174549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460832|NCT03786562|Morphine|morphine|mesh-list
65460833|NCT03786562|Nalbuphine|nalbuphine|mesh-list
65460834|NCT03786562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65460835|NCT03786562|Narcotics|narcotics|mesh-ancestor
65460836|NCT03786562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65460837|NCT03786562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460838|NCT03786562|Analgesics|analgesics|mesh-ancestor
65460839|NCT03786562|Sensory System Agents|sensory system agents|mesh-ancestor
65460840|NCT03786562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460841|NCT05694364|Cyclophosphamide|cyclophosphamide|mesh-list
65460842|NCT05694364|Fludarabine|fludarabine|mesh-list
65460843|NCT05694364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65460844|NCT05694364|Immunologic Factors|immunologic factors|mesh-ancestor
65460845|NCT05694364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460846|NCT05694364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65460847|NCT05694364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64845388|NCT04565171|Yimitasvir|yimitasvir|mesh-list
64845389|NCT04565171|Antiviral Agents|antiviral agents|mesh-ancestor
64845390|NCT04565171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64845391|NCT04504331|Tamoxifen|tamoxifen|mesh-list
64845392|NCT04504331|Infigratinib|infigratinib|mesh-list
64845393|NCT04504331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64845394|NCT04504331|Hormone Antagonists|hormone antagonists|mesh-ancestor
64845395|NCT04504331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64845396|NCT04504331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703205|NCT02498522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64703206|NCT02498522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703207|NCT02919787|Irinotecan|irinotecan|mesh-list
64703208|NCT02919787|Fluorouracil|fluorouracil|mesh-list
64703209|NCT02919787|Oxaliplatin|oxaliplatin|mesh-list
64703210|NCT02919787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64703211|NCT02919787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64703212|NCT02919787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703213|NCT02919787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703214|NCT02919787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64703215|NCT02919787|Antimetabolites|antimetabolites|mesh-ancestor
64703216|NCT02919787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65460848|NCT05694364|Alkylating Agents|alkylating agents|mesh-ancestor
65460849|NCT05694364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460850|NCT05694364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460851|NCT05694364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65460852|NCT05694286|Hyaluronic Acid|hyaluronic acid|mesh-list
65460853|NCT05694286|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65460854|NCT05694286|Immunologic Factors|immunologic factors|mesh-ancestor
65460855|NCT05694286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460856|NCT05694286|Viscosupplements|viscosupplements|mesh-ancestor
65460857|NCT05694286|Protective Agents|protective agents|mesh-ancestor
65210378|NCT02822937|Triazolam|triazolam|mesh-list
65460858|NCT01305148|Warfarin|warfarin|mesh-list
65460859|NCT01305148|Anticoagulants|anticoagulants|mesh-ancestor
65460860|NCT01305226|Streptokinase|streptokinase|mesh-list
65460861|NCT01305226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65460862|NCT01305226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65460863|NCT01305226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460864|NCT01308268|Ivermectin|ivermectin|mesh-list
65460865|NCT01308268|Albendazole|albendazole|mesh-list
65460866|NCT01308268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64845409|NCT04452344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845410|NCT04452344|Sensory System Agents|sensory system agents|mesh-ancestor
64845411|NCT04452344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845412|NCT04450407|Insulin|insulin|mesh-list
64845413|NCT04450407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64845414|NCT04450407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845415|NCT04432506|Cyclophosphamide|cyclophosphamide|mesh-list
64845416|NCT04432506|Fludarabine|fludarabine|mesh-list
64845417|NCT04432506|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64845419|NCT04432506|Immunologic Factors|immunologic factors|mesh-ancestor
65460867|NCT01308268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65460868|NCT01308268|Anthelmintics|anthelmintics|mesh-ancestor
65460869|NCT01308268|Anticestodal Agents|anticestodal agents|mesh-ancestor
65460870|NCT01308268|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65460871|NCT01308268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65460872|NCT01308268|Tubulin Modulators|tubulin modulators|mesh-ancestor
65460873|NCT01308268|Antimitotic Agents|antimitotic agents|mesh-ancestor
65460874|NCT01308268|Mitosis Modulators|mitosis modulators|mesh-ancestor
65460875|NCT01308268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460876|NCT01308268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460877|NCT01308346|Everolimus|everolimus|mesh-list
65460878|NCT01308346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845428|NCT04281017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64845429|NCT04281017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845430|NCT04231838|Nicotine|nicotine|mesh-list
64845431|NCT04231838|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64845432|NCT04231838|Autonomic Agents|autonomic agents|mesh-ancestor
64845433|NCT04231838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64703217|NCT02919787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64703218|NCT02919787|Immunologic Factors|immunologic factors|mesh-ancestor
64703219|NCT02919787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703220|NCT02459275|Metoclopramide|metoclopramide|mesh-list
64703221|NCT02459275|Antiemetics|antiemetics|mesh-ancestor
64703222|NCT02459275|Autonomic Agents|autonomic agents|mesh-ancestor
64703223|NCT02459275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64703224|NCT02459275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703244|NCT04743739|Cyclosporins|cyclosporins|mesh-list
64703245|NCT04743739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64703246|NCT04743739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64703247|NCT04743739|Immunologic Factors|immunologic factors|mesh-ancestor
64703248|NCT04743739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703249|NCT04743739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64703250|NCT04743739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703251|NCT04743739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703252|NCT04743739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64703253|NCT04743739|Antifungal Agents|antifungal agents|mesh-ancestor
64703254|NCT04743739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64703255|NCT04743739|Dermatologic Agents|dermatologic agents|mesh-ancestor
64703256|NCT04743739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64703257|NCT02461693|Caffeine|caffeine|mesh-list
64703258|NCT02461693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64703259|NCT02461693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703260|NCT02461693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64718602|NCT00624650|Oxymetazoline|oxymetazoline|mesh-list
64718603|NCT00624650|Norepinephrine|norepinephrine|mesh-list
64718604|NCT00624650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64718605|NCT00624650|Epinephryl borate|epinephryl borate|mesh-list
64718606|NCT00624650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64718607|NCT00624650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64718608|NCT00624650|Adrenergic Agents|adrenergic agents|mesh-ancestor
64718609|NCT00624650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64326763|NCT02171039|Antimetabolites|antimetabolites|mesh-ancestor
64703261|NCT02461693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703262|NCT02461693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703263|NCT02461693|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64703264|NCT02461693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64703265|NCT02461693|Purinergic Agents|purinergic agents|mesh-ancestor
65460879|NCT01308346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65460880|NCT01308346|Immunologic Factors|immunologic factors|mesh-ancestor
65460881|NCT01308346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460882|NCT05694130|Prednisolone|prednisolone|mesh-list
65460883|NCT05694130|Tacrolimus|tacrolimus|mesh-list
65460884|NCT05694130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65460885|NCT05694130|Immunologic Factors|immunologic factors|mesh-ancestor
65460886|NCT05694130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460887|NCT05694130|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65460888|NCT05694130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460889|NCT05694130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460890|NCT05694130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65460891|NCT05694130|Glucocorticoids|glucocorticoids|mesh-ancestor
65460892|NCT05694130|Hormones|hormones|mesh-ancestor
65460893|NCT05694130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65460894|NCT05694130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64703266|NCT02461693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703267|NCT02525653|Gemcitabine|gemcitabine|mesh-list
64703269|NCT02525653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64703270|NCT02525653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64703271|NCT02525653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64703272|NCT02525653|Tubulin Modulators|tubulin modulators|mesh-ancestor
64703273|NCT02525653|Antimitotic Agents|antimitotic agents|mesh-ancestor
64703274|NCT02525653|Mitosis Modulators|mitosis modulators|mesh-ancestor
64703275|NCT02525653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703276|NCT02525653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64703277|NCT02525653|Antimetabolites|antimetabolites|mesh-ancestor
64703278|NCT02525653|Antiviral Agents|antiviral agents|mesh-ancestor
64703279|NCT02525653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64703280|NCT02525653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703281|NCT02525653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64703282|NCT02525653|Immunologic Factors|immunologic factors|mesh-ancestor
64703290|NCT02431754|Urological Agents|urological agents|mesh-ancestor
64703291|NCT02500628|Metformin|metformin|mesh-list
64703292|NCT02500628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64703293|NCT02500628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703294|NCT02526667|Chlorhexidine|chlorhexidine|mesh-list
64703295|NCT02526667|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64703296|NCT02526667|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64703297|NCT02526667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64703298|NCT02526667|Disinfectants|disinfectants|mesh-ancestor
64703299|NCT02526667|Dermatologic Agents|dermatologic agents|mesh-ancestor
64703300|NCT02535806|Cytarabine|cytarabine|mesh-list
64703301|NCT02535806|Dexamethasone|dexamethasone|mesh-list
64703302|NCT02535806|Hydrocortisone|hydrocortisone|mesh-list
64703303|NCT02535806|Methotrexate|methotrexate|mesh-list
64703307|NCT02535806|Pegaspargase|pegaspargase|mesh-list
64703308|NCT02535806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64703309|NCT02535806|Antiemetics|antiemetics|mesh-ancestor
64703310|NCT02535806|Autonomic Agents|autonomic agents|mesh-ancestor
64703311|NCT02535806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64703312|NCT02535806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703313|NCT02535806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64703314|NCT02535806|Glucocorticoids|glucocorticoids|mesh-ancestor
64703315|NCT02535806|Hormones|hormones|mesh-ancestor
64703316|NCT02535806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64703317|NCT02535806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64703318|NCT02535806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64703319|NCT02535806|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65460895|NCT05694130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460896|NCT00419159|Everolimus|everolimus|mesh-list
65460897|NCT00419159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460898|NCT00419159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65460899|NCT00419159|Immunologic Factors|immunologic factors|mesh-ancestor
65460900|NCT00419159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460901|NCT03717064|Pitavastatin|pitavastatin|mesh-list
65460902|NCT03717064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65460903|NCT03717064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65460904|NCT03717064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65460905|NCT03717064|Antimetabolites|antimetabolites|mesh-ancestor
65460906|NCT03717064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460907|NCT03717064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460908|NCT03717064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64845455|NCT04068246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64845456|NCT04068246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845457|NCT04063033|Ferric gluconate|ferric gluconate|mesh-list
64845458|NCT04063033|Hematinics|hematinics|mesh-ancestor
64845459|NCT04038255|Nicotine|nicotine|mesh-list
64703320|NCT02535806|Abortifacient Agents|abortifacient agents|mesh-ancestor
64703321|NCT02535806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64703322|NCT02535806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64718610|NCT00624650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718611|NCT00624650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718612|NCT00624650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64718613|NCT00624650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64718614|NCT00624650|Autonomic Agents|autonomic agents|mesh-ancestor
64703323|NCT02535806|Antimetabolites|antimetabolites|mesh-ancestor
64703324|NCT02535806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703325|NCT02535806|Dermatologic Agents|dermatologic agents|mesh-ancestor
64703326|NCT02535806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703327|NCT02535806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64703328|NCT02535806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64703329|NCT02535806|Immunologic Factors|immunologic factors|mesh-ancestor
64703330|NCT02535806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64703331|NCT02535806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64703332|NCT02535806|Antiviral Agents|antiviral agents|mesh-ancestor
64703333|NCT02535806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64703334|NCT02535806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64703335|NCT02535806|Tubulin Modulators|tubulin modulators|mesh-ancestor
64703336|NCT02535806|Antimitotic Agents|antimitotic agents|mesh-ancestor
64703337|NCT02535806|Mitosis Modulators|mitosis modulators|mesh-ancestor
64703338|NCT02535806|Analgesics|analgesics|mesh-ancestor
64703339|NCT02535806|Sensory System Agents|sensory system agents|mesh-ancestor
64703340|NCT02535806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64703341|NCT02535806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64703343|NCT02536040|Cariostatic Agents|cariostatic agents|mesh-ancestor
64703344|NCT02536040|Protective Agents|protective agents|mesh-ancestor
64703345|NCT02536040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703346|NCT02537444|Pembrolizumab|pembrolizumab|mesh-list
64703347|NCT02537444|Acalabrutinib|acalabrutinib|mesh-list
64703348|NCT02537444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64703349|NCT02537444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64703350|NCT02464033|Vitamin D|vitamin d|mesh-list
64703361|NCT02464033|Sensory System Agents|sensory system agents|mesh-ancestor
64703362|NCT02464033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460909|NCT03716050|Nitroglycerin|nitroglycerin|mesh-list
65460910|NCT03716050|Vasodilator Agents|vasodilator agents|mesh-ancestor
65460911|NCT02113163|Metformin|metformin|mesh-list
65460912|NCT02113163|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
65460913|NCT02113163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65460914|NCT02113163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460915|NCT02113163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65460916|NCT02113163|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65460917|NCT00413153|Ritonavir|ritonavir|mesh-list
65460918|NCT00413153|Lopinavir|lopinavir|mesh-list
65460919|NCT00413153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65460920|NCT00413153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65460921|NCT00413153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65460922|NCT00413153|Protease Inhibitors|protease inhibitors|mesh-ancestor
65460923|NCT00413153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845469|NCT04037605|Ketoconazole|ketoconazole|mesh-list
64845470|NCT04037605|Dexamethasone|dexamethasone|mesh-list
64845471|NCT04037605|Dexamethasone acetate|dexamethasone acetate|mesh-list
64845472|NCT04037605|Hydrocortisone|hydrocortisone|mesh-list
64845473|NCT04037605|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64845474|NCT04037605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64845475|NCT04037605|Hormones|hormones|mesh-list
64845476|NCT04037605|Cosyntropin|cosyntropin|mesh-list
64845477|NCT04037605|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64845478|NCT04037605|BB 1101|bb 1101|mesh-list
64845479|NCT04037605|Ganirelix|ganirelix|mesh-list
64845480|NCT04037605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64845481|NCT04037605|Antiemetics|antiemetics|mesh-ancestor
64845482|NCT04037605|Autonomic Agents|autonomic agents|mesh-ancestor
64845483|NCT04037605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845484|NCT04037605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330053|NCT00004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330054|NCT00004171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64330055|NCT00004171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64330056|NCT00004171|Alkylating Agents|alkylating agents|mesh-ancestor
64330057|NCT00004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330119|NCT05715385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64330120|NCT05715385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64703363|NCT02464033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65460924|NCT00413153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460925|NCT00413153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65460926|NCT00413153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65460927|NCT00413153|Antiviral Agents|antiviral agents|mesh-ancestor
65460928|NCT00413153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65460929|NCT00413153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65460930|NCT00413153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65460931|NCT02107937|Paclitaxel|paclitaxel|mesh-list
65460932|NCT02107937|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65460933|NCT02107937|Carboplatin|carboplatin|mesh-list
65460934|NCT02107937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65460935|NCT02107937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460936|NCT02107937|Tubulin Modulators|tubulin modulators|mesh-ancestor
65460937|NCT02107937|Antimitotic Agents|antimitotic agents|mesh-ancestor
64845485|NCT04037605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64845486|NCT04037605|Glucocorticoids|glucocorticoids|mesh-ancestor
64845487|NCT04037605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64845488|NCT04037605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64845489|NCT04037605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845490|NCT04037605|Protease Inhibitors|protease inhibitors|mesh-ancestor
64845491|NCT04037605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845492|NCT04037605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845493|NCT04037605|Antifungal Agents|antifungal agents|mesh-ancestor
64845494|NCT04037605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64845495|NCT04037605|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64845496|NCT04037605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64330190|NCT02378415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330191|NCT02378415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330192|NCT02378415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64330193|NCT02378415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65460938|NCT02107937|Mitosis Modulators|mitosis modulators|mesh-ancestor
65460939|NCT02107937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460940|NCT01312402|Brinzolamide|brinzolamide|mesh-list
65460941|NCT01312402|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65460942|NCT01312402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65460943|NCT01312402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460944|NCT05693428|Propofol|propofol|mesh-list
65460945|NCT05693428|Sevoflurane|sevoflurane|mesh-list
65460946|NCT05693428|Isoflurane|isoflurane|mesh-list
65460947|NCT05693428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65460948|NCT05693428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65460949|NCT05693428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460950|NCT05693428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65460951|NCT05693428|Anesthetics, General|anesthetics, general|mesh-ancestor
65460952|NCT05693428|Anesthetics|anesthetics|mesh-ancestor
65460953|NCT05693428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65460954|NCT05693428|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65460955|NCT01035281|Nabilone|nabilone|mesh-list
65460956|NCT01035281|Antiemetics|antiemetics|mesh-ancestor
65460957|NCT01035281|Autonomic Agents|autonomic agents|mesh-ancestor
65460958|NCT01035281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460959|NCT01035281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460960|NCT01035281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65460961|NCT01035281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64845497|NCT04037605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64845498|NCT04037605|Hormone Antagonists|hormone antagonists|mesh-ancestor
64845499|NCT04037605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64845500|NCT04002258|Antipsychotic Agents|antipsychotic agents|mesh-list
64845501|NCT04002258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64845502|NCT04002258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64845503|NCT04002258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845504|NCT04002258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64845505|NCT03928093|Pregabalin|pregabalin|mesh-list
64845506|NCT03928093|Analgesics|analgesics|mesh-ancestor
64845507|NCT03928093|Sensory System Agents|sensory system agents|mesh-ancestor
64703364|NCT02464033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64703365|NCT02464033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64703366|NCT02464033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64703367|NCT02464033|Immunologic Factors|immunologic factors|mesh-ancestor
64703368|NCT02432456|Acetaminophen|acetaminophen|mesh-list
64703369|NCT02432456|Ibuprofen|ibuprofen|mesh-list
65460962|NCT01035281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65460963|NCT01035281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65460964|NCT01035281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65460965|NCT01561066|Octreotide|octreotide|mesh-list
65460966|NCT01561066|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65460967|NCT01561066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65460968|NCT01561066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65460969|NCT01561066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65460970|NCT01561066|Hemostatics|hemostatics|mesh-ancestor
65460971|NCT01561066|Coagulants|coagulants|mesh-ancestor
65460972|NCT00419003|Lamotrigine|lamotrigine|mesh-list
65460973|NCT00419003|Ketamine|ketamine|mesh-list
65460974|NCT00419003|Riluzole|riluzole|mesh-list
65460975|NCT00419003|Analgesics|analgesics|mesh-ancestor
65460976|NCT00419003|Sensory System Agents|sensory system agents|mesh-ancestor
65460977|NCT00419003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65460978|NCT00419003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65460979|NCT00419003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65460980|NCT00419003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65460981|NCT00419003|Anesthetics, General|anesthetics, general|mesh-ancestor
65460982|NCT00419003|Anesthetics|anesthetics|mesh-ancestor
65460983|NCT00419003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64845519|NCT03907800|Paclitaxel|paclitaxel|mesh-list
64845520|NCT03907800|Carboplatin|carboplatin|mesh-list
64845521|NCT03907800|Trastuzumab|trastuzumab|mesh-list
64845522|NCT03907800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64845523|NCT03907800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845524|NCT03907800|Tubulin Modulators|tubulin modulators|mesh-ancestor
64845525|NCT03907800|Antimitotic Agents|antimitotic agents|mesh-ancestor
64845526|NCT03907800|Mitosis Modulators|mitosis modulators|mesh-ancestor
64845527|NCT03907800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845528|NCT03907800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64845529|NCT03894904|Heparin|heparin|mesh-list
64845530|NCT03894904|Papaverine|papaverine|mesh-list
64845531|NCT03894904|Anticoagulants|anticoagulants|mesh-ancestor
64845532|NCT03894904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65460984|NCT00419003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65460985|NCT00419003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65460986|NCT00419003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65460987|NCT00419003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65460988|NCT00419003|Anticonvulsants|anticonvulsants|mesh-ancestor
65460989|NCT00419003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65460990|NCT00419003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65460991|NCT00419003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65460992|NCT00419003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65460993|NCT00419003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64845539|NCT03797833|Anesthetics|anesthetics|mesh-list
64845540|NCT03797833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64845541|NCT03797833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845542|NCT03749174|Anesthetics|anesthetics|mesh-list
64845543|NCT03749174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64845544|NCT03749174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845545|NCT03722927|Bupivacaine|bupivacaine|mesh-list
64845546|NCT03722927|Anesthetics, Local|anesthetics, local|mesh-ancestor
64845547|NCT03722927|Anesthetics|anesthetics|mesh-ancestor
64845548|NCT03722927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64845549|NCT03722927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330388|NCT04109885|Anesthetics, Local|anesthetics, local|mesh-ancestor
64330414|NCT03533699|Adrenergic Agents|adrenergic agents|mesh-ancestor
64330415|NCT03533699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64330416|NCT03533699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330417|NCT03533699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330418|NCT03533699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64330419|NCT03533699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64330420|NCT03533699|Vasodilator Agents|vasodilator agents|mesh-ancestor
64330421|NCT00135421|Citalopram|citalopram|mesh-list
64330422|NCT00135421|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64330423|NCT00135421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64330424|NCT00135421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64703370|NCT02432456|Ketamine|ketamine|mesh-list
65460994|NCT00419003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65460995|NCT00419003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65460996|NCT00419003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65460997|NCT00419003|Protective Agents|protective agents|mesh-ancestor
65460998|NCT00418691|Methylphenidate|methylphenidate|mesh-list
65460999|NCT00418691|Modafinil|modafinil|mesh-list
65461000|NCT00418691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65461001|NCT00418691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461002|NCT00418691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65461003|NCT00418691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65461004|NCT00418691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65461005|NCT00418691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461006|NCT00418691|Dopamine Agents|dopamine agents|mesh-ancestor
65461007|NCT00418691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65461008|NCT00418691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65461009|NCT00418691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65461010|NCT00418691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65461011|NCT03781258|Warfarin|warfarin|mesh-list
65461012|NCT03781258|Anticoagulants|anticoagulants|mesh-ancestor
65461013|NCT00412373|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65461014|NCT00412373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65461015|NCT00412373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65461016|NCT00412373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64845550|NCT03722927|Sensory System Agents|sensory system agents|mesh-ancestor
64845551|NCT03722927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845552|NCT03705169|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64845553|NCT03705169|Antiviral Agents|antiviral agents|mesh-ancestor
64845554|NCT03705169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64845555|NCT03681652|Azathioprine|azathioprine|mesh-list
64845564|NCT03671525|Nimodipine|nimodipine|mesh-list
65461017|NCT00412373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461018|NCT00412373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65461019|NCT00412373|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65461020|NCT00412373|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65461021|NCT00412373|Serotonin Agents|serotonin agents|mesh-ancestor
65461022|NCT00412373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65461023|NCT00412373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461024|NCT00412373|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65461025|NCT00412373|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65461026|NCT00412373|Dopamine Agents|dopamine agents|mesh-ancestor
65461027|NCT01308658|Ritonavir|ritonavir|mesh-list
64845574|NCT03600155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64845575|NCT03600155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845576|NCT03600155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64845577|NCT03600155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845578|NCT03578198|Rituximab|rituximab|mesh-list
64845579|NCT03578198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64845580|NCT03578198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845581|NCT03578198|Immunologic Factors|immunologic factors|mesh-ancestor
64845582|NCT03578198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845583|NCT03578198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64845584|NCT03571308|Prednisolone|prednisolone|mesh-list
64330739|NCT02202707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64330740|NCT02202707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64330741|NCT02202707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64330742|NCT02202707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703371|NCT02432456|Narcotics|narcotics|mesh-list
64703372|NCT02432456|Methocarbamol|methocarbamol|mesh-list
64703373|NCT02432456|Pantoprazole|pantoprazole|mesh-list
64703374|NCT02432456|Analgesics|analgesics|mesh-ancestor
64703375|NCT02432456|Sensory System Agents|sensory system agents|mesh-ancestor
64703376|NCT02432456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64703394|NCT02432456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64703395|NCT02432456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64703396|NCT02432456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64703397|NCT02432456|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64703398|NCT02432456|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64703400|NCT02531971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64703401|NCT02531971|Narcotics|narcotics|mesh-ancestor
64703402|NCT02531971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64703403|NCT02531971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703404|NCT02531971|Analgesics|analgesics|mesh-ancestor
64703405|NCT02531971|Sensory System Agents|sensory system agents|mesh-ancestor
64703406|NCT02531971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64703407|NCT02531971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64703408|NCT02531971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64718615|NCT00624650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65461028|NCT01308658|Darunavir|darunavir|mesh-list
65461029|NCT01308658|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65461030|NCT01308658|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65461031|NCT01308658|Protease Inhibitors|protease inhibitors|mesh-ancestor
65461032|NCT01308658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461033|NCT01308658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461034|NCT01308658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65461035|NCT01308658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65461036|NCT01308658|Antiviral Agents|antiviral agents|mesh-ancestor
65461037|NCT01308658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65461038|NCT01308658|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65461039|NCT01308658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65461040|NCT03777514|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65461041|NCT03777514|Hematinics|hematinics|mesh-ancestor
65461042|NCT03777514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65461043|NCT03777514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65461044|NCT03777124|Carboplatin|carboplatin|mesh-list
65461045|NCT03777124|Pemetrexed|pemetrexed|mesh-list
65461046|NCT03777124|Apatinib|apatinib|mesh-list
65461047|NCT03777124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461048|NCT03777124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461049|NCT03777124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461050|NCT03777124|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65461051|NCT03777124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65461052|NCT03777124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65461053|NCT00418379|Immunologic Factors|immunologic factors|mesh-list
64718617|NCT00624650|Respiratory System Agents|respiratory system agents|mesh-ancestor
64718618|NCT00624650|Mydriatics|mydriatics|mesh-ancestor
64718619|NCT00624650|Sympathomimetics|sympathomimetics|mesh-ancestor
64703409|NCT02531971|Anesthetics, General|anesthetics, general|mesh-ancestor
64703410|NCT02531971|Anesthetics|anesthetics|mesh-ancestor
64703411|NCT02464657|Cytarabine|cytarabine|mesh-list
64703412|NCT02464657|Dexamethasone|dexamethasone|mesh-list
64703413|NCT02464657|Methylprednisolone|methylprednisolone|mesh-list
64703414|NCT02464657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64703415|NCT02464657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64703416|NCT02464657|Prednisolone|prednisolone|mesh-list
64703417|NCT02464657|Prednisolone acetate|prednisolone acetate|mesh-list
64703418|NCT02464657|Nivolumab|nivolumab|mesh-list
64703419|NCT02464657|Idarubicin|idarubicin|mesh-list
64703420|NCT02464657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64703421|NCT02464657|Prednisolone phosphate|prednisolone phosphate|mesh-list
64703422|NCT02464657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64703423|NCT02464657|Antiemetics|antiemetics|mesh-ancestor
64703424|NCT02464657|Autonomic Agents|autonomic agents|mesh-ancestor
64703425|NCT02464657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64703426|NCT02464657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703427|NCT02464657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64703428|NCT02464657|Glucocorticoids|glucocorticoids|mesh-ancestor
64703429|NCT02464657|Hormones|hormones|mesh-ancestor
64703430|NCT02464657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65461054|NCT00418379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461055|NCT03780556|Lornoxicam|lornoxicam|mesh-list
65461056|NCT03780556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65461057|NCT03780556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65461058|NCT03780556|Analgesics|analgesics|mesh-ancestor
65461059|NCT03780556|Sensory System Agents|sensory system agents|mesh-ancestor
65461060|NCT03780556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65461061|NCT03780556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461062|NCT03780556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65461063|NCT03780556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65461064|NCT00418145|Methylprednisolone|methylprednisolone|mesh-list
65461065|NCT00418145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65461066|NCT00418145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65461067|NCT00418145|Prednisolone|prednisolone|mesh-list
65461068|NCT00418145|Prednisolone acetate|prednisolone acetate|mesh-list
64845610|NCT03571308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64703431|NCT02464657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64703438|NCT02464657|Antiviral Agents|antiviral agents|mesh-ancestor
64703455|NCT02536105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64703456|NCT02536105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703457|NCT02536105|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64703458|NCT02536105|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64703459|NCT02536105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64703460|NCT02536105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703461|NCT02536105|Dopamine Agents|dopamine agents|mesh-ancestor
64703462|NCT02536105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703463|NCT02758951|Bevacizumab|bevacizumab|mesh-list
64703464|NCT02758951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64703465|NCT02758951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64703466|NCT02758951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64703467|NCT02758951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64703468|NCT02758951|Growth Substances|growth substances|mesh-ancestor
64703469|NCT02758951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703470|NCT02758951|Growth Inhibitors|growth inhibitors|mesh-ancestor
64703471|NCT02436668|Gemcitabine|gemcitabine|mesh-list
64703472|NCT02436668|Paclitaxel|paclitaxel|mesh-list
64703473|NCT02436668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64703474|NCT02436668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64703475|NCT02436668|Tubulin Modulators|tubulin modulators|mesh-ancestor
64703476|NCT02436668|Antimitotic Agents|antimitotic agents|mesh-ancestor
64703477|NCT02436668|Mitosis Modulators|mitosis modulators|mesh-ancestor
64703478|NCT02436668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703479|NCT02436668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64703480|NCT02436668|Antimetabolites|antimetabolites|mesh-ancestor
64718620|NCT00624650|Diuretics|diuretics|mesh-ancestor
64718621|NCT00624650|Natriuretic Agents|natriuretic agents|mesh-ancestor
64718622|NCT00624650|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64718623|NCT00624650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64718624|NCT00624650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64718625|NCT00624650|Nasal Decongestants|nasal decongestants|mesh-ancestor
64703481|NCT02436668|Antiviral Agents|antiviral agents|mesh-ancestor
64703482|NCT02436668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64703483|NCT02436668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703484|NCT02436668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64703485|NCT02436668|Immunologic Factors|immunologic factors|mesh-ancestor
64703486|NCT02436668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703487|NCT02503982|Valganciclovir|valganciclovir|mesh-list
64703488|NCT02503982|Antiviral Agents|antiviral agents|mesh-ancestor
65461069|NCT00418145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65461070|NCT00418145|Prednisolone phosphate|prednisolone phosphate|mesh-list
65461071|NCT00418145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65461072|NCT00418145|Antiemetics|antiemetics|mesh-ancestor
65461073|NCT00418145|Autonomic Agents|autonomic agents|mesh-ancestor
65461074|NCT00418145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65461075|NCT00418145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461076|NCT00418145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65461077|NCT00418145|Glucocorticoids|glucocorticoids|mesh-ancestor
65461078|NCT00418145|Hormones|hormones|mesh-ancestor
65461079|NCT00418145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65461080|NCT00418145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65461081|NCT00418145|Protective Agents|protective agents|mesh-ancestor
65461082|NCT00418145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64845624|NCT03518086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64703489|NCT02503982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64703490|NCT02438540|Metformin|metformin|mesh-list
64703491|NCT02438540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64335494|NCT02302495|Alkylating Agents|alkylating agents|mesh-ancestor
64703498|NCT02506634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703499|NCT02506868|Darbepoetin alfa|darbepoetin alfa|mesh-list
64703506|NCT02541422|Respiratory System Agents|respiratory system agents|mesh-ancestor
64703507|NCT02541422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64703508|NCT02541422|Antioxidants|antioxidants|mesh-ancestor
64703509|NCT02541422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703510|NCT02541422|Protective Agents|protective agents|mesh-ancestor
64703511|NCT02541422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703512|NCT02541422|Antidotes|antidotes|mesh-ancestor
64703514|NCT02439164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64703515|NCT02439164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64703516|NCT02439164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64703517|NCT02439164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703518|NCT02439164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64703519|NCT02439164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64703520|NCT02439164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64703521|NCT02439164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64703522|NCT02439164|Anesthetics, General|anesthetics, general|mesh-ancestor
64703523|NCT02439164|Anesthetics|anesthetics|mesh-ancestor
64703524|NCT02439164|GABA Modulators|gaba modulators|mesh-ancestor
64703525|NCT02439164|GABA Agents|gaba agents|mesh-ancestor
64703526|NCT02439164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703527|NCT02439164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703528|NCT02440178|Micafungin|micafungin|mesh-list
64703529|NCT02440178|Antifungal Agents|antifungal agents|mesh-ancestor
64703530|NCT02440178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64703531|NCT05078606|Anesthetics|anesthetics|mesh-list
64703532|NCT05078606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64703533|NCT05078606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703534|NCT02546570|Oxytocin|oxytocin|mesh-list
64703535|NCT02546570|Oxytocics|oxytocics|mesh-ancestor
64703536|NCT02546570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64703537|NCT02546570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703538|NCT02548910|Sodium Citrate|sodium citrate|mesh-list
64703539|NCT02548910|Citric Acid|citric acid|mesh-list
64703540|NCT02548910|Anticoagulants|anticoagulants|mesh-ancestor
64703541|NCT02548910|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64703542|NCT02548910|Chelating Agents|chelating agents|mesh-ancestor
64703543|NCT02548910|Sequestering Agents|sequestering agents|mesh-ancestor
64703544|NCT02548910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703545|NCT02510144|Chlorhexidine|chlorhexidine|mesh-list
64703546|NCT02510144|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65461083|NCT00418145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461084|NCT03780634|Sorafenib|sorafenib|mesh-list
65461085|NCT03780634|Antibodies|antibodies|mesh-list
65461086|NCT03780634|Immunoglobulins|immunoglobulins|mesh-list
65461087|NCT03780634|Immunologic Factors|immunologic factors|mesh-ancestor
65461088|NCT03780634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461089|NCT03780634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461090|NCT03780634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65461091|NCT03780634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461092|NCT03780634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461094|NCT03777280|Chromium|chromium|mesh-list
65461095|NCT03777280|Trace Elements|trace elements|mesh-ancestor
65461096|NCT03777280|Micronutrients|micronutrients|mesh-ancestor
65461097|NCT03777280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461098|NCT02043587|Leucovorin|leucovorin|mesh-list
65461099|NCT02043587|Cytarabine|cytarabine|mesh-list
65461100|NCT02043587|Prednisone|prednisone|mesh-list
65461101|NCT02043587|Hydrocortisone|hydrocortisone|mesh-list
65461102|NCT02043587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65461103|NCT02043587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65461104|NCT02043587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65461105|NCT02043587|Cyclophosphamide|cyclophosphamide|mesh-list
65461106|NCT02043587|Rituximab|rituximab|mesh-list
65461107|NCT02043587|Methotrexate|methotrexate|mesh-list
65461108|NCT02043587|Etoposide|etoposide|mesh-list
65461109|NCT02043587|Vincristine|vincristine|mesh-list
65461110|NCT02043587|Daunorubicin|daunorubicin|mesh-list
65461111|NCT02043587|Asparaginase|asparaginase|mesh-list
65461112|NCT02043587|Dasatinib|dasatinib|mesh-list
64703547|NCT02510144|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64703548|NCT02510144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64703549|NCT02510144|Disinfectants|disinfectants|mesh-ancestor
64703550|NCT02510144|Dermatologic Agents|dermatologic agents|mesh-ancestor
64703551|NCT02538679|Epinephrine|epinephrine|mesh-list
64703552|NCT02538679|Racepinephrine|racepinephrine|mesh-list
64718626|NCT00624650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64718627|NCT00624650|Protective Agents|protective agents|mesh-ancestor
64718628|NCT00624650|Hemostatics|hemostatics|mesh-ancestor
64703553|NCT02538679|Bupivacaine|bupivacaine|mesh-list
64703554|NCT02538679|Epinephryl borate|epinephryl borate|mesh-list
64703555|NCT02538679|Anesthetics, Local|anesthetics, local|mesh-ancestor
64703556|NCT02538679|Anesthetics|anesthetics|mesh-ancestor
64703557|NCT02538679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64703558|NCT02538679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703559|NCT02538679|Sensory System Agents|sensory system agents|mesh-ancestor
64703560|NCT02538679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64703561|NCT02538679|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64703562|NCT02538679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64703563|NCT02538679|Adrenergic Agents|adrenergic agents|mesh-ancestor
64703591|NCT02551094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64703593|NCT02513498|Glycine|glycine|mesh-list
64703594|NCT02513498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703595|NCT02513498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461113|NCT02043587|Pegaspargase|pegaspargase|mesh-list
65461114|NCT02043587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65461115|NCT02043587|Immunologic Factors|immunologic factors|mesh-ancestor
65461116|NCT02043587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461117|NCT02043587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65461118|NCT02043587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65461119|NCT02043587|Alkylating Agents|alkylating agents|mesh-ancestor
65461120|NCT02043587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461121|NCT02043587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461122|NCT02043587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65461123|NCT02043587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65461124|NCT02043587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65461125|NCT02043587|Glucocorticoids|glucocorticoids|mesh-ancestor
65461126|NCT02043587|Hormones|hormones|mesh-ancestor
64845664|NCT03476109|Omalizumab|omalizumab|mesh-list
64703596|NCT02513498|Protease Inhibitors|protease inhibitors|mesh-ancestor
64703597|NCT02513498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703598|NCT02513498|Glycine Agents|glycine agents|mesh-ancestor
64703599|NCT02513498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703600|NCT02513498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703601|NCT04787354|Capecitabine|capecitabine|mesh-list
64703602|NCT04787354|Oxaliplatin|oxaliplatin|mesh-list
64703603|NCT04787354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64703604|NCT04787354|Antimetabolites|antimetabolites|mesh-ancestor
64703605|NCT04787354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703606|NCT04787354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64703607|NCT02514044|Adderall|adderall|mesh-list
64703608|NCT02514044|Dextroamphetamine|dextroamphetamine|mesh-list
64703609|NCT02514044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64703610|NCT02514044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703611|NCT02514044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64703612|NCT02514044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64703613|NCT02514044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64703614|NCT02514044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703615|NCT02514044|Dopamine Agents|dopamine agents|mesh-ancestor
64703616|NCT02514044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703617|NCT02555228|Simethicone|simethicone|mesh-list
64703618|NCT02555228|Antifoaming Agents|antifoaming agents|mesh-ancestor
64703619|NCT02555228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703620|NCT02555228|Emollients|emollients|mesh-ancestor
64703621|NCT02555228|Dermatologic Agents|dermatologic agents|mesh-ancestor
64703622|NCT02556788|Trifarotene|trifarotene|mesh-list
64703623|NCT02556788|Dermatologic Agents|dermatologic agents|mesh-ancestor
64703624|NCT02516150|Ethanol|ethanol|mesh-list
64703625|NCT02516150|Glucagon|glucagon|mesh-list
64703626|NCT02516150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64703627|NCT02516150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64703628|NCT02516150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64703629|NCT02516150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703630|NCT02516150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64703631|NCT02516150|Hormones|hormones|mesh-ancestor
64335504|NCT02813447|Sertraline|sertraline|mesh-list
64703634|NCT04025060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64703635|NCT04025060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703636|NCT04025060|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64703641|NCT04025060|Purinergic Agents|purinergic agents|mesh-ancestor
64703642|NCT04025060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703643|NCT04631510|Gabapentin|gabapentin|mesh-list
64703644|NCT04631510|Analgesics|analgesics|mesh-ancestor
64703645|NCT04631510|Sensory System Agents|sensory system agents|mesh-ancestor
65461127|NCT02043587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65461128|NCT02043587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65461129|NCT02043587|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65461130|NCT02043587|Abortifacient Agents|abortifacient agents|mesh-ancestor
65461131|NCT02043587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65461132|NCT02043587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65461133|NCT02043587|Antimetabolites|antimetabolites|mesh-ancestor
65461134|NCT02043587|Dermatologic Agents|dermatologic agents|mesh-ancestor
65461135|NCT02043587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461136|NCT02043587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65461137|NCT02043587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65461138|NCT02043587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65461139|NCT02043587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65461140|NCT02043587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65461141|NCT02043587|Antiviral Agents|antiviral agents|mesh-ancestor
65461142|NCT02043587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65461143|NCT02043587|Antidotes|antidotes|mesh-ancestor
65461144|NCT02043587|Protective Agents|protective agents|mesh-ancestor
65461145|NCT02043587|Vitamin B Complex|vitamin b complex|mesh-ancestor
65461146|NCT02043587|Vitamins|vitamins|mesh-ancestor
65461147|NCT02043587|Micronutrients|micronutrients|mesh-ancestor
65461148|NCT02043587|Tubulin Modulators|tubulin modulators|mesh-ancestor
65461149|NCT02043587|Antimitotic Agents|antimitotic agents|mesh-ancestor
65461150|NCT02043587|Mitosis Modulators|mitosis modulators|mesh-ancestor
65461151|NCT02043587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65461152|NCT02043587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65461153|NCT01561222|Calcitriol|calcitriol|mesh-list
65461154|NCT01561222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65461155|NCT01561222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461156|NCT01561222|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65461157|NCT01561222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65461159|NCT01561222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65461165|NCT01035515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65461166|NCT01035515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65461167|NCT01035515|Purinergic Agents|purinergic agents|mesh-ancestor
65461168|NCT01035515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65461169|NCT01035515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461170|NCT01035515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461171|NCT01039025|Cyclophosphamide|cyclophosphamide|mesh-list
65461172|NCT01039025|Melphalan|melphalan|mesh-list
65461173|NCT01039025|Topotecan|topotecan|mesh-list
65461174|NCT01039025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65461175|NCT01039025|Immunologic Factors|immunologic factors|mesh-ancestor
65461176|NCT01039025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461177|NCT01039025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65461178|NCT01039025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65461179|NCT01039025|Alkylating Agents|alkylating agents|mesh-ancestor
65461180|NCT01039025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461181|NCT01039025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461182|NCT01039025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65461183|NCT01039025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65461184|NCT01039025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65461185|NCT01039025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461186|NCT03779776|Vitamins|vitamins|mesh-list
65461187|NCT03779776|Micronutrients|micronutrients|mesh-ancestor
64703646|NCT04631510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64703647|NCT04631510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703648|NCT04631510|Anticonvulsants|anticonvulsants|mesh-ancestor
64703649|NCT04631510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64703650|NCT04631510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64703651|NCT04631510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64703652|NCT04631510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64703653|NCT04631510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64703654|NCT04631510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64703655|NCT04631510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703656|NCT04631510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703657|NCT04631510|Antimanic Agents|antimanic agents|mesh-ancestor
64703658|NCT04542434|Niclosamide|niclosamide|mesh-list
64703659|NCT04542434|Anticestodal Agents|anticestodal agents|mesh-ancestor
64703660|NCT04542434|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64703661|NCT04542434|Anthelmintics|anthelmintics|mesh-ancestor
64703662|NCT04542434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64703663|NCT04542434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64703664|NCT04542434|Antinematodal Agents|antinematodal agents|mesh-ancestor
64703665|NCT04186286|Propranolol|propranolol|mesh-list
64703666|NCT04186286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64703667|NCT04186286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64703668|NCT04186286|Adrenergic Agents|adrenergic agents|mesh-ancestor
64703669|NCT04186286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703670|NCT04186286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703671|NCT04186286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703672|NCT04186286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64703673|NCT04186286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65461188|NCT03779776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461189|NCT00412217|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65461190|NCT00412217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461191|NCT00412217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65461192|NCT00412217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461193|NCT00412217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461194|NCT01035593|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
65461195|NCT01035593|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65461196|NCT01035593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65461197|NCT01035593|Immunologic Factors|immunologic factors|mesh-ancestor
65461198|NCT01035593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461199|NCT01317784|Antibodies|antibodies|mesh-list
65461200|NCT01317784|Immunoglobulins|immunoglobulins|mesh-list
64703674|NCT04186286|Vasodilator Agents|vasodilator agents|mesh-ancestor
64703675|NCT04341038|Methylprednisolone|methylprednisolone|mesh-list
64703676|NCT04341038|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64703677|NCT04341038|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64703678|NCT04341038|Prednisolone|prednisolone|mesh-list
64703679|NCT04341038|Prednisolone acetate|prednisolone acetate|mesh-list
64703680|NCT04341038|Tacrolimus|tacrolimus|mesh-list
64703681|NCT04341038|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64703682|NCT04341038|Prednisolone phosphate|prednisolone phosphate|mesh-list
64703683|NCT04341038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64703684|NCT04341038|Immunologic Factors|immunologic factors|mesh-ancestor
64703685|NCT04341038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703686|NCT04341038|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64703687|NCT04341038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703688|NCT04341038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703689|NCT04341038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64703691|NCT04341038|Autonomic Agents|autonomic agents|mesh-ancestor
64703692|NCT04341038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64703693|NCT04341038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64703694|NCT04341038|Glucocorticoids|glucocorticoids|mesh-ancestor
64703695|NCT04341038|Hormones|hormones|mesh-ancestor
64335518|NCT02342145|Basiliximab|basiliximab|mesh-list
64718638|NCT00377065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64718639|NCT00377065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718640|NCT00377065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703702|NCT02561702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64703703|NCT02561702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64703704|NCT02561702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64703705|NCT02561702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64703706|NCT02561702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703707|NCT02563496|Chloroquine|chloroquine|mesh-list
64703708|NCT02563496|Tafenoquine|tafenoquine|mesh-list
64703709|NCT02563496|Amebicides|amebicides|mesh-ancestor
64703727|NCT02568644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64703728|NCT02568644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703729|NCT02568644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703730|NCT02541409|Interferons|interferons|mesh-list
64703731|NCT02541409|Ribavirin|ribavirin|mesh-list
64703732|NCT02541409|Interferon-alpha|interferon-alpha|mesh-list
64703733|NCT02541409|Interferon alpha-2|interferon alpha-2|mesh-list
64703734|NCT02541409|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64703735|NCT02541409|Sofosbuvir|sofosbuvir|mesh-list
64703736|NCT02541409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64703737|NCT02541409|Antiviral Agents|antiviral agents|mesh-ancestor
64703738|NCT02541409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64703739|NCT02541409|Antimetabolites|antimetabolites|mesh-ancestor
64703740|NCT02541409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703741|NCT02541409|Immunologic Factors|immunologic factors|mesh-ancestor
65461201|NCT01317784|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
65461202|NCT01317784|Immunologic Factors|immunologic factors|mesh-ancestor
65461203|NCT01317784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461204|NCT03779464|Gemcitabine|gemcitabine|mesh-list
65461205|NCT03779464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65461206|NCT03779464|Antimetabolites|antimetabolites|mesh-ancestor
65461207|NCT03779464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461208|NCT03779464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461209|NCT03779464|Antiviral Agents|antiviral agents|mesh-ancestor
65461210|NCT03779464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64845755|NCT03119038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703742|NCT02541409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703743|NCT02569658|Tranexamic Acid|tranexamic acid|mesh-list
64703744|NCT02569658|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64703745|NCT02569658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64703746|NCT02569658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703747|NCT02569658|Hemostatics|hemostatics|mesh-ancestor
64703748|NCT02569658|Coagulants|coagulants|mesh-ancestor
64703749|NCT02541565|Prednisone|prednisone|mesh-list
64703750|NCT02541565|Cortisone|cortisone|mesh-list
64703751|NCT02541565|Cyclophosphamide|cyclophosphamide|mesh-list
64703752|NCT02541565|Rituximab|rituximab|mesh-list
64703753|NCT02541565|Doxorubicin|doxorubicin|mesh-list
64703754|NCT02541565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64703755|NCT02541565|Pembrolizumab|pembrolizumab|mesh-list
64703756|NCT02541565|Vincristine|vincristine|mesh-list
64703757|NCT02541565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64703758|NCT02541565|Antibodies|antibodies|mesh-list
64703759|NCT02541565|Immunoglobulins|immunoglobulins|mesh-list
64703760|NCT02541565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64703761|NCT02541565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64703762|NCT02541565|Immunologic Factors|immunologic factors|mesh-ancestor
64703763|NCT02541565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703764|NCT02541565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64703765|NCT02541565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64703766|NCT02541565|Alkylating Agents|alkylating agents|mesh-ancestor
64703767|NCT02541565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703768|NCT02541565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64703777|NCT02541565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64703778|NCT02541565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64718647|NCT00610532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64718648|NCT00610532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64703788|NCT04707950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64703789|NCT04707950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64703790|NCT04707950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703792|NCT04707950|Coagulants|coagulants|mesh-ancestor
64703793|NCT04044560|Blinatumomab|blinatumomab|mesh-list
64703794|NCT04044560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64703795|NCT03807440|Empagliflozin|empagliflozin|mesh-list
64703796|NCT03807440|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64703797|NCT03807440|Linagliptin|linagliptin|mesh-list
64703798|NCT03807440|Metformin|metformin|mesh-list
64703799|NCT03807440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64703800|NCT03807440|Glucagon|glucagon|mesh-list
64703801|NCT03807440|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64703802|NCT03807440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703803|NCT03807440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64703804|NCT03807440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703805|NCT03807440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64703806|NCT03807440|Hormones|hormones|mesh-ancestor
64703807|NCT03807440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64703808|NCT03807440|Incretins|incretins|mesh-ancestor
64703809|NCT03807440|Protease Inhibitors|protease inhibitors|mesh-ancestor
64703810|NCT03807440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703811|NCT03256916|Nelfinavir|nelfinavir|mesh-list
65461211|NCT03779464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461212|NCT03779464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65461213|NCT03779464|Immunologic Factors|immunologic factors|mesh-ancestor
65461214|NCT03779464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461215|NCT01309126|Cetuximab|cetuximab|mesh-list
65461216|NCT01309126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65461217|NCT01309126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461218|NCT03784378|Agerafenib|agerafenib|mesh-list
65461219|NCT03784378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65461220|NCT03784378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461221|NCT03784378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461222|NCT01314898|Spironolactone|spironolactone|mesh-list
65461223|NCT01314898|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65461224|NCT01314898|Hormone Antagonists|hormone antagonists|mesh-ancestor
65461225|NCT01314898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65461226|NCT01314898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845764|NCT03119038|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64703812|NCT03256916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64703813|NCT03256916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64703814|NCT03256916|Protease Inhibitors|protease inhibitors|mesh-ancestor
64703815|NCT03256916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703816|NCT03256916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703817|NCT03256916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64703818|NCT03256916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64703819|NCT03256916|Antiviral Agents|antiviral agents|mesh-ancestor
64703820|NCT03256916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64703821|NCT02579876|Immunologic Factors|immunologic factors|mesh-list
64703822|NCT02579876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703823|NCT00364052|Valganciclovir|valganciclovir|mesh-list
64703824|NCT00364052|Ganciclovir|ganciclovir|mesh-list
64703825|NCT00364052|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64703826|NCT00364052|Antiviral Agents|antiviral agents|mesh-ancestor
64703827|NCT00364052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64703828|NCT00364052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64703829|NCT00364052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703830|NCT00364052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703831|NCT03169166|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64335539|NCT02342145|Antitubercular Agents|antitubercular agents|mesh-ancestor
64703832|NCT03169166|Luteolytic Agents|luteolytic agents|mesh-ancestor
64703833|NCT03169166|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64703853|NCT00364988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703854|NCT00365222|Temozolomide|temozolomide|mesh-list
64718649|NCT00610532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718650|NCT00610532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64718651|NCT00610532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64718652|NCT00610532|Uricosuric Agents|uricosuric agents|mesh-ancestor
64718653|NCT00610532|Gout Suppressants|gout suppressants|mesh-ancestor
64703855|NCT00365222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64703856|NCT00365222|Alkylating Agents|alkylating agents|mesh-ancestor
64703857|NCT00365222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703858|NCT00365222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64703860|NCT03119012|Clopidogrel|clopidogrel|mesh-list
64703861|NCT03119012|Ticagrelor|ticagrelor|mesh-list
64703862|NCT03119012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64703863|NCT03119012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65461227|NCT01314898|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65461228|NCT01314898|Diuretics|diuretics|mesh-ancestor
65461229|NCT01314898|Natriuretic Agents|natriuretic agents|mesh-ancestor
65461230|NCT01315912|Letrozole|letrozole|mesh-list
65461231|NCT01315912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461232|NCT01315912|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65461233|NCT01315912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65461234|NCT01315912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461235|NCT01315912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461236|NCT01315912|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65461237|NCT01315912|Hormone Antagonists|hormone antagonists|mesh-ancestor
65210736|NCT02817477|Anesthetics, General|anesthetics, general|mesh-ancestor
65461238|NCT01315912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65461239|NCT01315912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461240|NCT03778450|Analgesics, Opioid|analgesics, opioid|mesh-list
65461241|NCT03778450|Analgesics|analgesics|mesh-list
65461242|NCT03778450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
65461243|NCT03778450|Narcotics|narcotics|mesh-ancestor
65461244|NCT03778450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65461245|NCT03778450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461246|NCT03778450|Sensory System Agents|sensory system agents|mesh-ancestor
65461247|NCT03778450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65461248|NCT03776500|Macozinone|macozinone|mesh-list
65461249|NCT03776500|Antitubercular Agents|antitubercular agents|mesh-ancestor
65461250|NCT03776500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65461251|NCT03776500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65461252|NCT04996264|Varespladib methyl|varespladib methyl|mesh-list
65461253|NCT04996264|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
65461254|NCT04996264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845782|NCT03099265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64703864|NCT03119012|Analgesics|analgesics|mesh-ancestor
64703865|NCT03119012|Sensory System Agents|sensory system agents|mesh-ancestor
64703866|NCT03119012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64703867|NCT03119012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703868|NCT03119012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64703869|NCT03119012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64703870|NCT03119012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64703871|NCT03119012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64703872|NCT03119012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703873|NCT03119012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64703874|NCT03119012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64703875|NCT03119012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703876|NCT03119012|Antipyretics|antipyretics|mesh-ancestor
64703877|NCT03119012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65461255|NCT04996264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461256|NCT03778138|Pemetrexed|pemetrexed|mesh-list
65461257|NCT03778138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461258|NCT03778138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461259|NCT03778138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461260|NCT03778138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65461261|NCT03778138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65461262|NCT04933552|Siponimod|siponimod|mesh-list
65461263|NCT04933552|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65461264|NCT04933552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461265|NCT04933552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65461266|NCT04933552|Immunologic Factors|immunologic factors|mesh-ancestor
65461267|NCT04933552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461268|NCT03783754|Amlodipine|amlodipine|mesh-list
65461269|NCT03783754|Telmisartan|telmisartan|mesh-list
65461270|NCT03783754|Indapamide|indapamide|mesh-list
65461271|NCT03783754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65461272|NCT03783754|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65461273|NCT03783754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64703878|NCT03119012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64703879|NCT03119012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64703880|NCT03119012|Purinergic Agents|purinergic agents|mesh-ancestor
64703881|NCT03119012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703882|NCT02584868|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
64703883|NCT02584868|Plasma Substitutes|plasma substitutes|mesh-ancestor
64703884|NCT02584868|Blood Substitutes|blood substitutes|mesh-ancestor
64703885|NCT02791568|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64703886|NCT02791568|Hematinics|hematinics|mesh-ancestor
64703887|NCT02791568|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64703888|NCT02791568|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64703889|NCT05248022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64703890|NCT05248022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703891|NCT05248022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64703892|NCT05247554|Hydroxychloroquine|hydroxychloroquine|mesh-list
64703893|NCT05247554|Prednisone|prednisone|mesh-list
64703894|NCT05247554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64703895|NCT05247554|Glucocorticoids|glucocorticoids|mesh-ancestor
64703896|NCT05247554|Hormones|hormones|mesh-ancestor
64335547|NCT02349399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64703916|NCT02596022|Anesthetics|anesthetics|mesh-ancestor
64703917|NCT02596022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64703918|NCT02596022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64703919|NCT02596022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64703920|NCT02596022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703921|NCT02596022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703922|NCT00364442|Fluticasone|fluticasone|mesh-list
64703923|NCT00364442|Xhance|xhance|mesh-list
64703924|NCT00364442|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64718654|NCT00610532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64718655|NCT00610532|Renal Agents|renal agents|mesh-ancestor
64718656|NCT03642457|Bupivacaine|bupivacaine|mesh-list
64718657|NCT03642457|Anesthetics, Local|anesthetics, local|mesh-ancestor
64718658|NCT03642457|Anesthetics|anesthetics|mesh-ancestor
64326810|NCT03134677|Anesthetics|anesthetics|mesh-ancestor
64703925|NCT00364442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65461274|NCT03783754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461275|NCT03783754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65461276|NCT03783754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461277|NCT03783754|Vasodilator Agents|vasodilator agents|mesh-ancestor
65461278|NCT03783754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65461279|NCT03783754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65461280|NCT03783754|Diuretics|diuretics|mesh-ancestor
65461281|NCT03783754|Natriuretic Agents|natriuretic agents|mesh-ancestor
65461282|NCT03783754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65461283|NCT01309438|Erythromycin|erythromycin|mesh-list
65461284|NCT01309438|Erythromycin Estolate|erythromycin estolate|mesh-list
65461285|NCT01309438|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65461286|NCT01309438|Erythromycin stearate|erythromycin stearate|mesh-list
65461287|NCT01309438|Rivaroxaban|rivaroxaban|mesh-list
65461288|NCT01309438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64845831|NCT02975037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64845832|NCT02975037|Antifungal Agents|antifungal agents|mesh-ancestor
64703926|NCT00364442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64703927|NCT00364442|Autonomic Agents|autonomic agents|mesh-ancestor
64703928|NCT00364442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64703929|NCT00364442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703930|NCT00364442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64703931|NCT00364442|Respiratory System Agents|respiratory system agents|mesh-ancestor
64703932|NCT00364442|Dermatologic Agents|dermatologic agents|mesh-ancestor
64703933|NCT00364442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64703934|NCT00364442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64703935|NCT00364442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64703936|NCT00364442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64703937|NCT00364442|Adrenergic Agents|adrenergic agents|mesh-ancestor
64703938|NCT00364442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703939|NCT00364442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703940|NCT05371574|Clonidine|clonidine|mesh-list
64703941|NCT05371574|Analgesics|analgesics|mesh-ancestor
64703942|NCT05371574|Sensory System Agents|sensory system agents|mesh-ancestor
64703943|NCT05371574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64703944|NCT05371574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703945|NCT05371574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64703946|NCT05371574|Sympatholytics|sympatholytics|mesh-ancestor
64703947|NCT05371574|Autonomic Agents|autonomic agents|mesh-ancestor
64703948|NCT05371574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64703949|NCT05371574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64703950|NCT05371574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64703951|NCT05371574|Adrenergic Agents|adrenergic agents|mesh-ancestor
64703952|NCT05371574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703953|NCT05371574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703954|NCT05371340|Quercetin|quercetin|mesh-list
64703955|NCT05371340|Antioxidants|antioxidants|mesh-ancestor
64703956|NCT05371340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703957|NCT05371340|Protective Agents|protective agents|mesh-ancestor
64703958|NCT05371340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703959|NCT02601170|Hyaluronic Acid|hyaluronic acid|mesh-list
64703960|NCT02601170|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64703980|NCT00422240|Sensory System Agents|sensory system agents|mesh-ancestor
64703981|NCT00422240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64703982|NCT00422240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461289|NCT01309438|Antithrombins|antithrombins|mesh-ancestor
65461290|NCT01309438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65461291|NCT01309438|Protease Inhibitors|protease inhibitors|mesh-ancestor
65461292|NCT01309438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461293|NCT01309438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845851|NCT02914405|Nivolumab|nivolumab|mesh-list
64703983|NCT00422240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64703984|NCT00422240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64703985|NCT02605304|Ribavirin|ribavirin|mesh-list
64703986|NCT02605304|Sofosbuvir|sofosbuvir|mesh-list
64703987|NCT02605304|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64703989|NCT02605304|Antimetabolites|antimetabolites|mesh-ancestor
64703990|NCT02605304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703991|NCT02605304|Antiviral Agents|antiviral agents|mesh-ancestor
64703992|NCT02605304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64703993|NCT05365880|Lidocaine|lidocaine|mesh-list
64703994|NCT05365880|Anesthetics, Local|anesthetics, local|mesh-ancestor
64703995|NCT05365880|Anesthetics|anesthetics|mesh-ancestor
64718659|NCT03642457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64718660|NCT03642457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718662|NCT03642457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64718663|NCT00379418|Abciximab|abciximab|mesh-list
64718664|NCT00379418|Anticoagulants|anticoagulants|mesh-ancestor
64718665|NCT00379418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64718666|NCT00379496|Antidepressive Agents|antidepressive agents|mesh-list
64718667|NCT00379496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64703996|NCT05365880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64703997|NCT05365880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703998|NCT05365880|Sensory System Agents|sensory system agents|mesh-ancestor
64703999|NCT05365880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64704000|NCT05365880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64704001|NCT05365880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64704002|NCT05365880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64704003|NCT05365880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64704004|NCT05365880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704005|NCT05362994|Sirolimus|sirolimus|mesh-list
64704006|NCT05362994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64704007|NCT05362994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64704008|NCT05362994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64704009|NCT05362994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704010|NCT05362994|Antifungal Agents|antifungal agents|mesh-ancestor
64704011|NCT05362994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64704012|NCT05362994|Immunologic Factors|immunologic factors|mesh-ancestor
64704013|NCT05362994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704014|NCT02607254|Pregabalin|pregabalin|mesh-list
64704015|NCT02607254|Analgesics|analgesics|mesh-ancestor
64704016|NCT02607254|Sensory System Agents|sensory system agents|mesh-ancestor
64704017|NCT02607254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64704018|NCT02607254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704019|NCT02607254|Anticonvulsants|anticonvulsants|mesh-ancestor
64335601|NCT02342067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64704047|NCT00365612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64704048|NCT00365612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704049|NCT00365612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704051|NCT00365612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64704052|NCT00365612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64704053|NCT00365612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64718668|NCT00378716|Leucovorin|leucovorin|mesh-list
64718669|NCT00378716|Fluorouracil|fluorouracil|mesh-list
64718670|NCT00378716|Tegafur|tegafur|mesh-list
64704054|NCT00365612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64704055|NCT00365612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64704056|NCT00365612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64704057|NCT00365612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64704058|NCT02974166|Ibuprofen|ibuprofen|mesh-list
64704059|NCT02974166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64945570|NCT05438043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704060|NCT02974166|Cyclobenzaprine|cyclobenzaprine|mesh-list
65461294|NCT01309438|Anticoagulants|anticoagulants|mesh-ancestor
65461295|NCT01309438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65461296|NCT01309438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65461297|NCT01309438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65461298|NCT01309438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65461299|NCT03776032|Darbepoetin alfa|darbepoetin alfa|mesh-list
65461300|NCT03776032|Hematinics|hematinics|mesh-ancestor
65461301|NCT03775798|Antiviral Agents|antiviral agents|mesh-list
65461302|NCT03775798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65461303|NCT03775876|Dexmedetomidine|dexmedetomidine|mesh-list
65461304|NCT03775876|Propofol|propofol|mesh-list
65461305|NCT03775876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65461306|NCT03775876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65461307|NCT03775876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461308|NCT03775876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65461309|NCT03775876|Anesthetics, General|anesthetics, general|mesh-ancestor
65461310|NCT03775876|Anesthetics|anesthetics|mesh-ancestor
65461311|NCT03775876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65210810|NCT00843856|Mycophenolic Acid|mycophenolic acid|mesh-list
65461312|NCT03775876|Analgesics|analgesics|mesh-ancestor
65461313|NCT03775876|Sensory System Agents|sensory system agents|mesh-ancestor
65461314|NCT03775876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65461315|NCT03775876|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65461316|NCT03775876|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65461317|NCT03775876|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64704061|NCT02974166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64704062|NCT02974166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64704063|NCT02974166|Analgesics|analgesics|mesh-ancestor
64704064|NCT02974166|Sensory System Agents|sensory system agents|mesh-ancestor
64704065|NCT02974166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64704066|NCT02974166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704067|NCT02974166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64704068|NCT02974166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64704069|NCT02974166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335605|NCT02344017|Prednisone|prednisone|mesh-list
64704098|NCT00364754|Histamine Antagonists|histamine antagonists|mesh-ancestor
64704099|NCT00364754|Histamine Agents|histamine agents|mesh-ancestor
64704100|NCT00364754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64704101|NCT00364754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704102|NCT00364754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704103|NCT00364754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64704104|NCT00366236|Nitazoxanide|nitazoxanide|mesh-list
64704108|NCT04741880|Anesthetics, Local|anesthetics, local|mesh-ancestor
64704109|NCT04741880|Anesthetics|anesthetics|mesh-ancestor
64704110|NCT04741880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64704111|NCT04741880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704112|NCT04741880|Sensory System Agents|sensory system agents|mesh-ancestor
64704113|NCT04741880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64704114|NCT04741880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64704115|NCT04741880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64704116|NCT04741880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65461318|NCT03775876|Adrenergic Agents|adrenergic agents|mesh-ancestor
65461319|NCT03775876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65461320|NCT03775876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461321|NCT01320514|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65461322|NCT01320514|Hemostatics|hemostatics|mesh-ancestor
65461323|NCT01320514|Coagulants|coagulants|mesh-ancestor
65461324|NCT03773536|Artesunate|artesunate|mesh-list
65461325|NCT03773536|Primaquine|primaquine|mesh-list
65461326|NCT03773536|Amodiaquine|amodiaquine|mesh-list
65461327|NCT03773536|Antimalarials|antimalarials|mesh-ancestor
65461328|NCT03773536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65461329|NCT03773536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65461330|NCT03773536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65461331|NCT03773536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461332|NCT03773536|Antiviral Agents|antiviral agents|mesh-ancestor
64704117|NCT04741880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64335613|NCT02343861|Emollients|emollients|mesh-list
64945575|NCT05438043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64945576|NCT05438043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945577|NCT05438043|Immunologic Factors|immunologic factors|mesh-ancestor
64945578|NCT05438043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64945579|NCT05438043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64704134|NCT05360030|Anesthetics, General|anesthetics, general|mesh-ancestor
64704135|NCT05360030|Anesthetics|anesthetics|mesh-ancestor
64704136|NCT05360030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64704137|NCT05360030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64704138|NCT05360030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64704139|NCT05360030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64704140|NCT05360030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704141|NCT05360030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64704142|NCT04158362|Paclitaxel|paclitaxel|mesh-list
64704143|NCT04158362|Capecitabine|capecitabine|mesh-list
64704144|NCT04158362|Letrozole|letrozole|mesh-list
64704145|NCT04158362|Fulvestrant|fulvestrant|mesh-list
64704146|NCT04158362|Anastrozole|anastrozole|mesh-list
64704147|NCT04158362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64704148|NCT04158362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704149|NCT04158362|Tubulin Modulators|tubulin modulators|mesh-ancestor
64704158|NCT04158362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64704159|NCT04158362|Hormone Antagonists|hormone antagonists|mesh-ancestor
64704160|NCT04158362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64704161|NCT04158362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704162|NCT04158362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64704163|NCT04158362|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64704164|NCT05272202|Propofol|propofol|mesh-list
64704165|NCT05272202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64704166|NCT05272202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64704172|NCT01575834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64704173|NCT01575834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704174|NCT04718792|Psilocybin|psilocybin|mesh-list
64704175|NCT04718792|Hallucinogens|hallucinogens|mesh-ancestor
64704176|NCT04718792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704177|NCT04718792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64704178|NCT05707442|Acetazolamide|acetazolamide|mesh-list
64704179|NCT05707442|Anticonvulsants|anticonvulsants|mesh-ancestor
64704180|NCT05707442|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64704181|NCT05707442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718677|NCT00378716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64718678|NCT00378716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718679|NCT00378716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64718680|NCT00378716|Immunologic Factors|immunologic factors|mesh-ancestor
64718681|NCT00378716|Antidotes|antidotes|mesh-ancestor
64718682|NCT00378716|Protective Agents|protective agents|mesh-ancestor
65461333|NCT03773536|Schistosomicides|schistosomicides|mesh-ancestor
65461334|NCT03773536|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65461335|NCT03773536|Anthelmintics|anthelmintics|mesh-ancestor
65461336|NCT01320592|Paclitaxel|paclitaxel|mesh-list
65461337|NCT01320592|Palbociclib|palbociclib|mesh-list
65461338|NCT01320592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65461339|NCT01320592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461340|NCT01320592|Tubulin Modulators|tubulin modulators|mesh-ancestor
65461341|NCT01320592|Antimitotic Agents|antimitotic agents|mesh-ancestor
65461342|NCT01320592|Mitosis Modulators|mitosis modulators|mesh-ancestor
65461343|NCT01320592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461344|NCT01320592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65461345|NCT01320592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461346|NCT03783676|Remifentanil|remifentanil|mesh-list
65461347|NCT03783676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65461348|NCT03783676|Narcotics|narcotics|mesh-ancestor
65461349|NCT03783676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65461350|NCT03783676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461351|NCT03783676|Analgesics|analgesics|mesh-ancestor
65461352|NCT03783676|Sensory System Agents|sensory system agents|mesh-ancestor
65461353|NCT03783676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64718683|NCT00378716|Vitamin B Complex|vitamin b complex|mesh-ancestor
64704182|NCT05707442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704183|NCT05707442|Diuretics|diuretics|mesh-ancestor
64704184|NCT05707442|Natriuretic Agents|natriuretic agents|mesh-ancestor
64704185|NCT05707442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704186|NCT04604132|Paclitaxel|paclitaxel|mesh-list
64704187|NCT04604132|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64704188|NCT04604132|Atezolizumab|atezolizumab|mesh-list
64704189|NCT04604132|Ramucirumab|ramucirumab|mesh-list
64704190|NCT04604132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64704191|NCT04604132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64704192|NCT04604132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704193|NCT04604132|Tubulin Modulators|tubulin modulators|mesh-ancestor
64704194|NCT04604132|Antimitotic Agents|antimitotic agents|mesh-ancestor
64704195|NCT04604132|Mitosis Modulators|mitosis modulators|mesh-ancestor
64704196|NCT04604132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704197|NCT04604132|Immunologic Factors|immunologic factors|mesh-ancestor
64704198|NCT04604132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704199|NCT05193188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64945580|NCT05438043|Growth Substances|growth substances|mesh-ancestor
64704200|NCT05193188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704201|NCT05193188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704202|NCT04799262|Prednisone|prednisone|mesh-list
64704203|NCT04799262|Tofacitinib|tofacitinib|mesh-list
64704204|NCT04799262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64704205|NCT04799262|Glucocorticoids|glucocorticoids|mesh-ancestor
64704206|NCT04799262|Hormones|hormones|mesh-ancestor
64704207|NCT04799262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64704208|NCT04799262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704209|NCT04799262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64704210|NCT04799262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704211|NCT04799262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64704212|NCT04799262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704230|NCT04798482|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65461354|NCT03783520|Sodium Hypochlorite|sodium hypochlorite|mesh-list
65461355|NCT03783520|Eusol|eusol|mesh-list
65461356|NCT03783520|Disinfectants|disinfectants|mesh-ancestor
65461357|NCT03783520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65461358|NCT01320982|Aspirin|aspirin|mesh-list
65461359|NCT01320982|Minocycline|minocycline|mesh-list
65461360|NCT01320982|Pramipexole|pramipexole|mesh-list
65461361|NCT01320982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65461362|NCT01320982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65461363|NCT01320982|Analgesics|analgesics|mesh-ancestor
65461364|NCT01320982|Sensory System Agents|sensory system agents|mesh-ancestor
65461365|NCT01320982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65461366|NCT01320982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461367|NCT01320982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64845908|NCT02450253|Vasodilator Agents|vasodilator agents|mesh-ancestor
64845914|NCT02257970|Ketoprofen|ketoprofen|mesh-list
64704231|NCT04798482|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64704232|NCT04798482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64704233|NCT04798482|Adrenergic Agents|adrenergic agents|mesh-ancestor
64704234|NCT04798482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64704235|NCT04798482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704240|NCT00366470|Vitamins|vitamins|mesh-ancestor
64704241|NCT00366470|Micronutrients|micronutrients|mesh-ancestor
64704242|NCT00366470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64704243|NCT04537286|Paclitaxel|paclitaxel|mesh-list
64704244|NCT04537286|Cisplatin|cisplatin|mesh-list
64718685|NCT00378716|Micronutrients|micronutrients|mesh-ancestor
64718686|NCT03644095|Phenylpropanolamine|phenylpropanolamine|mesh-list
64718687|NCT03644095|Guaifenesin|guaifenesin|mesh-list
64718688|NCT03644095|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
64718689|NCT03644095|Expectorants|expectorants|mesh-ancestor
64326837|NCT02171507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64704245|NCT04537286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64704246|NCT04537286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704247|NCT04537286|Tubulin Modulators|tubulin modulators|mesh-ancestor
64704248|NCT04537286|Antimitotic Agents|antimitotic agents|mesh-ancestor
64704249|NCT04537286|Mitosis Modulators|mitosis modulators|mesh-ancestor
64704250|NCT04537286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704251|NCT02620904|Mifepristone|mifepristone|mesh-list
64704252|NCT02620904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64704253|NCT02620904|Abortifacient Agents|abortifacient agents|mesh-ancestor
64704254|NCT02620904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64704255|NCT02620904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704256|NCT02620904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64704257|NCT02620904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64704258|NCT02620904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64704259|NCT02620904|Contraceptive Agents|contraceptive agents|mesh-ancestor
64704260|NCT02620904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64704261|NCT02620904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64704262|NCT02620904|Hormone Antagonists|hormone antagonists|mesh-ancestor
64704263|NCT02620904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64704264|NCT02620904|Luteolytic Agents|luteolytic agents|mesh-ancestor
64704265|NCT02620904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64704273|NCT02621060|Magnesium Oxide|magnesium oxide|mesh-list
64704275|NCT02621060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704276|NCT02621060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64704277|NCT04740554|Prednisone|prednisone|mesh-list
64704278|NCT04740554|Deflazacort|deflazacort|mesh-list
64704279|NCT04740554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64704280|NCT04740554|Glucocorticoids|glucocorticoids|mesh-ancestor
64704281|NCT04740554|Hormones|hormones|mesh-ancestor
65461368|NCT01320982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65461369|NCT01320982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65461370|NCT01320982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65461371|NCT01320982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461372|NCT01320982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65461373|NCT01320982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65461374|NCT01320982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461375|NCT01320982|Antipyretics|antipyretics|mesh-ancestor
65461376|NCT01320982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65461377|NCT01320982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65461378|NCT01320982|Antioxidants|antioxidants|mesh-ancestor
65461379|NCT01320982|Protective Agents|protective agents|mesh-ancestor
64704282|NCT04740554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64704283|NCT04740554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704284|NCT04740554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64704285|NCT04740554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704286|NCT04740554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64704287|NCT04740554|Immunologic Factors|immunologic factors|mesh-ancestor
64704288|NCT04506086|Blinatumomab|blinatumomab|mesh-list
64704289|NCT04506086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704290|NCT02624180|Colchicine|colchicine|mesh-list
64704291|NCT02624180|Gout Suppressants|gout suppressants|mesh-ancestor
64704292|NCT02624180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64704293|NCT02624180|Tubulin Modulators|tubulin modulators|mesh-ancestor
64704294|NCT02624180|Antimitotic Agents|antimitotic agents|mesh-ancestor
64704295|NCT02624180|Mitosis Modulators|mitosis modulators|mesh-ancestor
64704296|NCT02624180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704297|NCT02624180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704298|NCT05068232|Carboplatin|carboplatin|mesh-list
64704299|NCT05068232|Etoposide|etoposide|mesh-list
64704300|NCT05068232|Durvalumab|durvalumab|mesh-list
64704301|NCT05068232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704302|NCT05068232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64704303|NCT05068232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64704304|NCT05068232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64704305|NCT05068232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704306|NCT05068232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718690|NCT03644095|Respiratory System Agents|respiratory system agents|mesh-ancestor
64718691|NCT03644095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64718692|NCT03644095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64718693|NCT03644095|Adrenergic Agents|adrenergic agents|mesh-ancestor
64718694|NCT03644095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64718695|NCT03644095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326842|NCT02171507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64704307|NCT05068232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64704313|NCT02628236|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64704314|NCT02628236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64704315|NCT02628236|Dermatologic Agents|dermatologic agents|mesh-ancestor
64704316|NCT02629094|Eplerenone|eplerenone|mesh-list
64704317|NCT02629094|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64704318|NCT02629094|Hormone Antagonists|hormone antagonists|mesh-ancestor
64704319|NCT02629094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64704321|NCT02629094|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64704322|NCT02629094|Diuretics|diuretics|mesh-ancestor
64704323|NCT02629094|Natriuretic Agents|natriuretic agents|mesh-ancestor
64704324|NCT02629094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64704325|NCT02630030|Ixazomib|ixazomib|mesh-list
64704326|NCT02630030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704327|NCT02630030|Protease Inhibitors|protease inhibitors|mesh-ancestor
64704328|NCT02630030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704329|NCT02630030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704330|NCT04289792|Gemcitabine|gemcitabine|mesh-list
64704331|NCT04289792|Paclitaxel|paclitaxel|mesh-list
65461380|NCT01320982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65461381|NCT01320982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65461382|NCT01320982|Dopamine Agonists|dopamine agonists|mesh-ancestor
65210888|NCT02237508|Glucocorticoids|glucocorticoids|mesh-ancestor
65461383|NCT01320982|Dopamine Agents|dopamine agents|mesh-ancestor
65461384|NCT01320982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65461385|NCT04893382|Plasma-lyte 148|plasma-lyte 148|mesh-list
65461386|NCT04893382|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65461387|NCT04893382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65461388|NCT01321138|Morphine|morphine|mesh-list
65461389|NCT01321138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65461390|NCT01321138|Narcotics|narcotics|mesh-ancestor
65461391|NCT01321138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65461392|NCT01321138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461393|NCT01321138|Analgesics|analgesics|mesh-ancestor
65461394|NCT01321138|Sensory System Agents|sensory system agents|mesh-ancestor
65461395|NCT01321138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65461396|NCT04628572|Ceftazidime|ceftazidime|mesh-list
65461397|NCT04628572|Avibactam|avibactam|mesh-list
65461398|NCT04628572|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
65461399|NCT04628572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65461400|NCT04628572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65461401|NCT04628572|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65461402|NCT04628572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845934|NCT02066636|Nivolumab|nivolumab|mesh-list
64704332|NCT04289792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64704349|NCT02631590|Antimetabolites|antimetabolites|mesh-ancestor
64704350|NCT02631590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704351|NCT02631590|Antiviral Agents|antiviral agents|mesh-ancestor
64704352|NCT02631590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64704353|NCT02631590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704354|NCT02631590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64704355|NCT02631590|Immunologic Factors|immunologic factors|mesh-ancestor
64704356|NCT02631590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704358|NCT02253654|Hematinics|hematinics|mesh-ancestor
64704359|NCT02252406|Ranolazine|ranolazine|mesh-list
64704360|NCT02252406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64704361|NCT02252406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64704362|NCT02252406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704363|NCT02252016|Grazoprevir|grazoprevir|mesh-list
64704364|NCT02252016|Antiviral Agents|antiviral agents|mesh-ancestor
64704365|NCT02252016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64704366|NCT04784442|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
64704367|NCT04784442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64704368|NCT04784442|Antimetabolites|antimetabolites|mesh-ancestor
64704369|NCT04784442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704370|NCT04784442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64704371|NCT04784442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704372|NCT04784442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64718696|NCT03644095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718697|NCT03644095|Appetite Depressants|appetite depressants|mesh-ancestor
64718698|NCT03644095|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65461403|NCT04628572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461404|NCT03772990|Calcium|calcium|mesh-list
65461405|NCT03772990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65461406|NCT03772990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461407|NCT03782662|Itraconazole|itraconazole|mesh-list
65461408|NCT03782662|Rifampin|rifampin|mesh-list
65461409|NCT03782662|Verapamil|verapamil|mesh-list
65461410|NCT03782662|Midazolam|midazolam|mesh-list
65461411|NCT03782662|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65461412|NCT03782662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65461413|NCT03782662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65461414|NCT03782662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461415|NCT03782662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65461416|NCT03782662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65461417|NCT03782662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65461418|NCT03782662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65461419|NCT03782662|Anesthetics, General|anesthetics, general|mesh-ancestor
65461420|NCT03782662|Anesthetics|anesthetics|mesh-ancestor
65461421|NCT03782662|GABA Modulators|gaba modulators|mesh-ancestor
65461422|NCT03782662|GABA Agents|gaba agents|mesh-ancestor
65461423|NCT03782662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65461424|NCT03782662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461425|NCT03782662|Antifungal Agents|antifungal agents|mesh-ancestor
65461426|NCT03782662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65461427|NCT03782662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64718699|NCT03644095|Sympathomimetics|sympathomimetics|mesh-ancestor
64718700|NCT03644095|Autonomic Agents|autonomic agents|mesh-ancestor
64718701|NCT03644095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64704373|NCT04784442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704374|NCT02706847|Upadacitinib|upadacitinib|mesh-list
64704375|NCT02706847|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64704376|NCT02706847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64704377|NCT02706847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704378|NCT02706847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704389|NCT02470741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704390|NCT02544607|Ketamine|ketamine|mesh-list
64704391|NCT02544607|Analgesics|analgesics|mesh-ancestor
64704392|NCT02544607|Sensory System Agents|sensory system agents|mesh-ancestor
64704393|NCT02544607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64704394|NCT02544607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704395|NCT02544607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64335729|NCT02299765|Gemcitabine|gemcitabine|mesh-list
64704401|NCT02544607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64704402|NCT02544607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64704403|NCT02544607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704404|NCT00363571|Acetazolamide|acetazolamide|mesh-list
64704405|NCT00363571|Anticonvulsants|anticonvulsants|mesh-ancestor
64704406|NCT00363571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64704407|NCT00363571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461428|NCT03782662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65461429|NCT03782662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461430|NCT03782662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65461431|NCT03782662|Hormone Antagonists|hormone antagonists|mesh-ancestor
65461432|NCT03782662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65461433|NCT03782662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65461434|NCT03782662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65461435|NCT03782662|Antitubercular Agents|antitubercular agents|mesh-ancestor
65461436|NCT03782662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65461437|NCT03782662|Leprostatic Agents|leprostatic agents|mesh-ancestor
65461438|NCT03782662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65461439|NCT03782662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65461440|NCT03782662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65461441|NCT03782662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65461442|NCT03782662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65461443|NCT03782662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65461444|NCT03782662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65461445|NCT03782662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65461446|NCT03782662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65461447|NCT03782662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65461448|NCT03782662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65461449|NCT03782662|Vasodilator Agents|vasodilator agents|mesh-ancestor
65461450|NCT01309984|Propofol|propofol|mesh-list
65461451|NCT01309984|Fospropofol|fospropofol|mesh-list
64704408|NCT00363571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704409|NCT00363571|Diuretics|diuretics|mesh-ancestor
64704410|NCT00363571|Natriuretic Agents|natriuretic agents|mesh-ancestor
64704411|NCT00363571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704412|NCT04744675|Triamcinolone|triamcinolone|mesh-list
64704413|NCT04744675|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64704414|NCT04744675|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64704415|NCT04744675|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64704416|NCT04744675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64704417|NCT04744675|Glucocorticoids|glucocorticoids|mesh-ancestor
64704418|NCT04744675|Hormones|hormones|mesh-ancestor
64704419|NCT04744675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64704420|NCT04744675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704421|NCT04744675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64704422|NCT04744675|Immunologic Factors|immunologic factors|mesh-ancestor
64704423|NCT04744675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704424|NCT04744675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704425|NCT02471521|Rocuronium|rocuronium|mesh-list
64704426|NCT02471521|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64704427|NCT02471521|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64704428|NCT02471521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64704429|NCT02471521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65461452|NCT01309984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65461453|NCT01309984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65461454|NCT01309984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461455|NCT01309984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65461456|NCT01309984|Anesthetics, General|anesthetics, general|mesh-ancestor
65461457|NCT01309984|Anesthetics|anesthetics|mesh-ancestor
65461458|NCT03772054|Propofol|propofol|mesh-list
65461459|NCT03772054|Sevoflurane|sevoflurane|mesh-list
65461460|NCT03772054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65461461|NCT03772054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65461462|NCT03772054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461463|NCT03772054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65461464|NCT03772054|Anesthetics, General|anesthetics, general|mesh-ancestor
65461466|NCT03772054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65461467|NCT03772054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65461468|NCT03771820|Pembrolizumab|pembrolizumab|mesh-list
65461469|NCT03771820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65461470|NCT03771820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461471|NCT05531890|Betamethasone|betamethasone|mesh-list
65461472|NCT05531890|Betamethasone Valerate|betamethasone valerate|mesh-list
65461473|NCT05531890|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65461474|NCT05531890|Betamethasone benzoate|betamethasone benzoate|mesh-list
65461475|NCT05531890|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65461476|NCT05531890|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65461477|NCT05531890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65461478|NCT05531890|Glucocorticoids|glucocorticoids|mesh-ancestor
65461479|NCT05531890|Hormones|hormones|mesh-ancestor
65461480|NCT05531890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65461481|NCT05531890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461482|NCT05531890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65461483|NCT05531890|Respiratory System Agents|respiratory system agents|mesh-ancestor
65461484|NCT00123474|Dasatinib|dasatinib|mesh-list
65461485|NCT00123474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461486|NCT00123474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65461487|NCT00123474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461488|NCT00123474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704430|NCT02471521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704431|NCT02624479|Sodium thiosulfate|sodium thiosulfate|mesh-list
65461489|NCT00142298|Telbivudine|telbivudine|mesh-list
65461490|NCT00142298|Antiviral Agents|antiviral agents|mesh-ancestor
65461491|NCT00142298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65461492|NCT00142298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65461493|NCT00142298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461494|NCT00142298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461495|NCT03774706|Misoprostol|misoprostol|mesh-list
65461496|NCT03774706|Tranexamic Acid|tranexamic acid|mesh-list
65461497|NCT03774706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65461498|NCT03774706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65461499|NCT03774706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461500|NCT03774706|Hemostatics|hemostatics|mesh-ancestor
65461501|NCT03774706|Coagulants|coagulants|mesh-ancestor
65461502|NCT03774706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65461503|NCT03774706|Abortifacient Agents|abortifacient agents|mesh-ancestor
65461504|NCT03774706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65461505|NCT03774706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461506|NCT03774706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65461507|NCT03774706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65461508|NCT03774706|Oxytocics|oxytocics|mesh-ancestor
65461509|NCT03967496|Metformin|metformin|mesh-list
65461510|NCT03967496|Amlodipine|amlodipine|mesh-list
65461511|NCT03967496|Lisinopril|lisinopril|mesh-list
65461512|NCT03967496|Bisoprolol|bisoprolol|mesh-list
65461513|NCT03967496|Hydralazine|hydralazine|mesh-list
65461514|NCT03967496|Anesthetics|anesthetics|mesh-list
65461515|NCT03967496|Atorvastatin|atorvastatin|mesh-list
65461516|NCT03967496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65461517|NCT03967496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461518|NCT03967496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65461519|NCT03967496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65461520|NCT03967496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65461521|NCT03967496|Antimetabolites|antimetabolites|mesh-ancestor
64704432|NCT02624479|Antidotes|antidotes|mesh-ancestor
64704433|NCT02624479|Protective Agents|protective agents|mesh-ancestor
64704434|NCT02624479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704435|NCT02624479|Antioxidants|antioxidants|mesh-ancestor
64704436|NCT02624479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704437|NCT02624479|Antitubercular Agents|antitubercular agents|mesh-ancestor
64704438|NCT02624479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64704439|NCT02624479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64704440|NCT02624479|Chelating Agents|chelating agents|mesh-ancestor
64704441|NCT02624479|Sequestering Agents|sequestering agents|mesh-ancestor
64704443|NCT02472223|Povidone|povidone|mesh-list
64704444|NCT02472223|Lubricant Eye Drops|lubricant eye drops|mesh-list
65461522|NCT03967496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461523|NCT03967496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65461524|NCT03967496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65461525|NCT03967496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461526|NCT03967496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65461527|NCT03967496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65461528|NCT03967496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65461529|NCT03967496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65461530|NCT03967496|Vasodilator Agents|vasodilator agents|mesh-ancestor
65461531|NCT03967496|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65461532|NCT03967496|Protease Inhibitors|protease inhibitors|mesh-ancestor
65461533|NCT03967496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65461534|NCT03967496|Protective Agents|protective agents|mesh-ancestor
65461535|NCT03967496|Sympatholytics|sympatholytics|mesh-ancestor
65461536|NCT03967496|Autonomic Agents|autonomic agents|mesh-ancestor
65461537|NCT03967496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65461538|NCT03967496|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65461540|NCT03967496|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65461541|NCT03967496|Adrenergic Agents|adrenergic agents|mesh-ancestor
65461542|NCT03967496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65461543|NCT00412061|Everolimus|everolimus|mesh-list
65461544|NCT00412061|Octreotide|octreotide|mesh-list
65461545|NCT00412061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461546|NCT00412061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65461547|NCT00412061|Immunologic Factors|immunologic factors|mesh-ancestor
65461548|NCT00412061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461549|NCT00412061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65461550|NCT00412061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65461551|NCT03964350|Ethanol|ethanol|mesh-list
65461552|NCT03964350|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65461566|NCT01035671|Tocopherylquinone|tocopherylquinone|mesh-list
65461567|NCT01035671|Anticoagulants|anticoagulants|mesh-ancestor
65461568|NCT01035671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65461569|NCT01035671|Antioxidants|antioxidants|mesh-ancestor
65461570|NCT01035671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461571|NCT01035671|Protective Agents|protective agents|mesh-ancestor
65461572|NCT01035671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461573|NCT01035671|Vitamins|vitamins|mesh-ancestor
65461574|NCT01035671|Micronutrients|micronutrients|mesh-ancestor
65461575|NCT04560868|Nicotine|nicotine|mesh-list
65461576|NCT04560868|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65461577|NCT04560868|Autonomic Agents|autonomic agents|mesh-ancestor
65461578|NCT04560868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65461579|NCT04560868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461580|NCT04560868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65461581|NCT04560868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65461582|NCT04560868|Cholinergic Agents|cholinergic agents|mesh-ancestor
65461583|NCT04560868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65461584|NCT04560868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461585|NCT03769714|Bupivacaine|bupivacaine|mesh-list
65461586|NCT03769714|Anesthetics, Local|anesthetics, local|mesh-ancestor
65461587|NCT03769714|Anesthetics|anesthetics|mesh-ancestor
65461588|NCT03769714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65461589|NCT03769714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461590|NCT03769714|Sensory System Agents|sensory system agents|mesh-ancestor
65461591|NCT03769714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65461592|NCT03769402|Citric Acid|citric acid|mesh-list
65461593|NCT03769402|Sodium Citrate|sodium citrate|mesh-list
65461594|NCT03769402|Anticoagulants|anticoagulants|mesh-ancestor
65461595|NCT03769402|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65461612|NCT03770806|Oxycodone|oxycodone|mesh-list
65461613|NCT03770806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65461614|NCT03770806|Analgesics|analgesics|mesh-ancestor
65461615|NCT03770806|Sensory System Agents|sensory system agents|mesh-ancestor
65461616|NCT03770806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65461617|NCT03770806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461619|NCT03770806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65461620|NCT03770806|Narcotics|narcotics|mesh-ancestor
65461621|NCT03770806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65461622|NCT03770806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65461623|NCT03770806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65461624|NCT03770806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65461625|NCT03770806|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65461626|NCT03770806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65461627|NCT03770806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461628|NCT03770806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461629|NCT01039103|Methylprednisolone|methylprednisolone|mesh-list
65461630|NCT01039103|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65461631|NCT01039103|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65461632|NCT01039103|Prednisolone|prednisolone|mesh-list
65461633|NCT01039103|Prednisolone acetate|prednisolone acetate|mesh-list
64846125|NCT01690104|Rifampin|rifampin|mesh-list
64704445|NCT02472223|Plasma Substitutes|plasma substitutes|mesh-ancestor
64718702|NCT03644095|Nasal Decongestants|nasal decongestants|mesh-ancestor
64718703|NCT03644095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64718704|NCT01633814|Estradiol|estradiol|mesh-list
64718705|NCT01633814|Estrogens|estrogens|mesh-ancestor
64718706|NCT01633814|Hormones|hormones|mesh-ancestor
64704446|NCT02472223|Blood Substitutes|blood substitutes|mesh-ancestor
64704447|NCT02472223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64704448|NCT02472223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64335759|NCT04771923|Autonomic Agents|autonomic agents|mesh-ancestor
64704449|NCT02472223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64704450|NCT02472223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64704451|NCT02247960|Ciprofloxacin|ciprofloxacin|mesh-list
64704452|NCT02247960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64704453|NCT02247960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64704454|NCT02247960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64704455|NCT02247960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64704456|NCT02247960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704457|NCT02247960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704458|NCT02247960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704476|NCT02247804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64704477|NCT02247804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704478|NCT02247804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704479|NCT02247804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64704480|NCT02247804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64704481|NCT00366938|Lumiracoxib|lumiracoxib|mesh-list
64704482|NCT00366938|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64704483|NCT00366938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64704484|NCT00366938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704485|NCT00366938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461634|NCT01039103|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65461635|NCT01039103|Prednisolone phosphate|prednisolone phosphate|mesh-list
65461636|NCT01039103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65461637|NCT01039103|Antiemetics|antiemetics|mesh-ancestor
65461638|NCT01039103|Autonomic Agents|autonomic agents|mesh-ancestor
65461639|NCT01039103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65461640|NCT01039103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461641|NCT01039103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65461642|NCT01039103|Glucocorticoids|glucocorticoids|mesh-ancestor
65461643|NCT01039103|Hormones|hormones|mesh-ancestor
65461644|NCT01039103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65461645|NCT01039103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65461646|NCT01039103|Protective Agents|protective agents|mesh-ancestor
65461647|NCT01039103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65461648|NCT01039103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461649|NCT01039181|Vitamin D|vitamin d|mesh-list
65461650|NCT01039181|Calcitriol|calcitriol|mesh-list
65461651|NCT01039181|Vitamins|vitamins|mesh-ancestor
65461652|NCT01039181|Micronutrients|micronutrients|mesh-ancestor
65461653|NCT01039181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461654|NCT01039181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64704486|NCT00366938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64704487|NCT00366938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64704488|NCT00366938|Analgesics|analgesics|mesh-ancestor
64704489|NCT00366938|Sensory System Agents|sensory system agents|mesh-ancestor
64704490|NCT00366938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64704491|NCT00366938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704492|NCT00366938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64704493|NCT00366938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64704494|NCT05026320|Diclofenac|diclofenac|mesh-list
64704495|NCT05026320|Naproxen|naproxen|mesh-list
64945581|NCT05438043|Growth Inhibitors|growth inhibitors|mesh-ancestor
64704496|NCT05026320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64704497|NCT05026320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64704498|NCT05026320|Analgesics|analgesics|mesh-ancestor
64704499|NCT05026320|Sensory System Agents|sensory system agents|mesh-ancestor
64704500|NCT05026320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64704501|NCT05026320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704502|NCT05026320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64704503|NCT05026320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64704504|NCT05026320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64704505|NCT05026320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704506|NCT05026320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704507|NCT05026320|Gout Suppressants|gout suppressants|mesh-ancestor
64704508|NCT04068272|Bosentan|bosentan|mesh-list
64704509|NCT04068272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64718707|NCT01633814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64718708|NCT01633814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704518|NCT02243202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64704519|NCT02243202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704521|NCT02243202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704522|NCT02243202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64704523|NCT02243202|Appetite Depressants|appetite depressants|mesh-ancestor
65461655|NCT01039181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65461656|NCT01039181|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65461657|NCT01039181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65461658|NCT01039181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461659|NCT01039181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65461660|NCT03770026|Clomiphene|clomiphene|mesh-list
65461661|NCT03770026|Enclomiphene|enclomiphene|mesh-list
65461662|NCT03770026|Zuclomiphene|zuclomiphene|mesh-list
65461663|NCT03770026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65461664|NCT03770026|Hormone Antagonists|hormone antagonists|mesh-ancestor
65461665|NCT03770026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65461666|NCT03770026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461667|NCT03770026|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65461668|NCT03770026|Fertility Agents|fertility agents|mesh-ancestor
65461669|NCT03770026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65461670|NCT03770026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65461671|NCT03770026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65461672|NCT03769870|Atorvastatin|atorvastatin|mesh-list
65461673|NCT03769870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65461674|NCT03769870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65461675|NCT03769870|Antimetabolites|antimetabolites|mesh-ancestor
65461676|NCT03769870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461677|NCT03769870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65461678|NCT03769870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65461679|NCT03769870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704524|NCT02243202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64704525|NCT02243202|Sympathomimetics|sympathomimetics|mesh-ancestor
64704526|NCT02243202|Autonomic Agents|autonomic agents|mesh-ancestor
64704527|NCT02243202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64704528|NCT02243202|Adrenergic Agents|adrenergic agents|mesh-ancestor
64704529|NCT02243202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64704530|NCT04050410|Moxonidine|moxonidine|mesh-list
64704531|NCT04050410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64704532|NCT02207946|Botulinum Toxins|botulinum toxins|mesh-list
64704533|NCT02207946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64704534|NCT02207946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64704535|NCT02207946|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64704536|NCT02207946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64429815|NCT04757883|Antibodies|antibodies|mesh-list
64704537|NCT02207946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64704538|NCT02207946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704539|NCT02207946|Cholinergic Agents|cholinergic agents|mesh-ancestor
64704540|NCT02207946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64704541|NCT02207946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704542|NCT02207946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64704543|NCT02207946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64704544|NCT04235036|Rituximab|rituximab|mesh-list
65461680|NCT01589081|Nicotine|nicotine|mesh-list
65461681|NCT01589081|Progesterone|progesterone|mesh-list
65461682|NCT01589081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65461683|NCT01589081|Autonomic Agents|autonomic agents|mesh-ancestor
65461684|NCT01589081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65461685|NCT01589081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461686|NCT01589081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65461687|NCT01589081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65461688|NCT01589081|Cholinergic Agents|cholinergic agents|mesh-ancestor
65461689|NCT01589081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65461690|NCT01589081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461691|NCT01589081|Progestins|progestins|mesh-ancestor
65461692|NCT01589081|Hormones|hormones|mesh-ancestor
65461693|NCT01589081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65461694|NCT01567540|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65461695|NCT01567540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65461696|NCT01567540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461697|NCT01567540|Incretins|incretins|mesh-ancestor
65461698|NCT01567540|Hormones|hormones|mesh-ancestor
65461699|NCT01567540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65461700|NCT01567540|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65461701|NCT01567540|Protease Inhibitors|protease inhibitors|mesh-ancestor
65461702|NCT01567540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461703|NCT01567540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461704|NCT01036841|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65461705|NCT01036841|Hemostatics|hemostatics|mesh-ancestor
65461706|NCT01036841|Coagulants|coagulants|mesh-ancestor
65461707|NCT01036841|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65461708|NCT01036841|Natriuretic Agents|natriuretic agents|mesh-ancestor
65461709|NCT01036841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461710|NCT03709576|Azacitidine|azacitidine|mesh-list
65461711|NCT03709576|Pevonedistat|pevonedistat|mesh-list
64704545|NCT04235036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64704546|NCT04235036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704547|NCT04235036|Immunologic Factors|immunologic factors|mesh-ancestor
64704548|NCT04235036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704549|NCT04235036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64704550|NCT02560051|Ketoconazole|ketoconazole|mesh-list
64704551|NCT02560051|Docetaxel|docetaxel|mesh-list
64704552|NCT02560051|Doxorubicin|doxorubicin|mesh-list
64704553|NCT02560051|Estramustine|estramustine|mesh-list
64704554|NCT02560051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704555|NCT02560051|Tubulin Modulators|tubulin modulators|mesh-ancestor
65461712|NCT03709576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65461713|NCT03709576|Antimetabolites|antimetabolites|mesh-ancestor
65461714|NCT03709576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461715|NCT03709576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461716|NCT03709576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461717|NCT00122460|Cisplatin|cisplatin|mesh-list
65461718|NCT00122460|Carboplatin|carboplatin|mesh-list
65461719|NCT00122460|Fluorouracil|fluorouracil|mesh-list
65461720|NCT00122460|Cetuximab|cetuximab|mesh-list
65461721|NCT00122460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461722|NCT00122460|Antimetabolites|antimetabolites|mesh-ancestor
65461723|NCT00122460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461724|NCT00122460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65461725|NCT00122460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65461726|NCT00122460|Immunologic Factors|immunologic factors|mesh-ancestor
65461727|NCT00122460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461728|NCT00122460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65461729|NCT03763396|Ketoconazole|ketoconazole|mesh-list
65461730|NCT03763396|Posaconazole|posaconazole|mesh-list
65461731|NCT03763396|Antifungal Agents|antifungal agents|mesh-ancestor
65461732|NCT03763396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65461733|NCT03763396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65461734|NCT03763396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64846219|NCT01690403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64704556|NCT02560051|Antimitotic Agents|antimitotic agents|mesh-ancestor
64704557|NCT02560051|Mitosis Modulators|mitosis modulators|mesh-ancestor
64704558|NCT02560051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704559|NCT02560051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64704560|NCT02560051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64704561|NCT02560051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64704562|NCT02560051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704563|NCT02560051|Antifungal Agents|antifungal agents|mesh-ancestor
64704564|NCT02560051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64704565|NCT02560051|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64704566|NCT02560051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64704567|NCT02560051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64704568|NCT02560051|Hormone Antagonists|hormone antagonists|mesh-ancestor
64704569|NCT02560051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64704570|NCT02560051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704571|NCT02560051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64704572|NCT02560051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64704573|NCT02560051|Alkylating Agents|alkylating agents|mesh-ancestor
64704578|NCT03786770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64704579|NCT03786770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704580|NCT03786770|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64704581|NCT03786770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64704582|NCT03786770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704587|NCT04219280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461735|NCT03763396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461736|NCT03763396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461737|NCT03763396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65461738|NCT03763396|Hormone Antagonists|hormone antagonists|mesh-ancestor
65461739|NCT03763396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65461740|NCT03763396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461741|NCT03763396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65461742|NCT03763396|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65461743|NCT03763396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65461744|NCT03763396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65461745|NCT01320436|Aminosalicylic Acid|aminosalicylic acid|mesh-list
65461746|NCT01320436|Curcumin|curcumin|mesh-list
65461747|NCT01320436|Mesalamine|mesalamine|mesh-list
65461748|NCT01320436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65461749|NCT01320436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65461750|NCT01320436|Analgesics|analgesics|mesh-ancestor
65461751|NCT01320436|Sensory System Agents|sensory system agents|mesh-ancestor
65461752|NCT01320436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65461753|NCT01320436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461754|NCT01320436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65461755|NCT01320436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65461756|NCT01320436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461757|NCT01320436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461758|NCT01320436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704588|NCT04219280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64704589|NCT04219280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64704590|NCT04219280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64704591|NCT04219280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704592|NCT04219280|Dopamine Agents|dopamine agents|mesh-ancestor
64704593|NCT04219280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64704594|NCT00367718|Bortezomib|bortezomib|mesh-list
64704595|NCT00367718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704596|NCT02474407|Diazepam|diazepam|mesh-list
64704597|NCT02474407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64704598|NCT02474407|Anticonvulsants|anticonvulsants|mesh-ancestor
64704599|NCT02474407|Antiemetics|antiemetics|mesh-ancestor
64704600|NCT02474407|Autonomic Agents|autonomic agents|mesh-ancestor
64704601|NCT02474407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64704602|NCT02474407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704603|NCT02474407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64704604|NCT02474407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64704605|NCT02474407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64704606|NCT02474407|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64704607|NCT02474407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64704608|NCT02474407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64704609|NCT02474407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64704610|NCT02474407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64704611|NCT02474407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65461759|NCT01320436|Antitubercular Agents|antitubercular agents|mesh-ancestor
65461760|NCT01320436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65461761|NCT01320436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65461762|NCT04794088|Imatinib Mesylate|imatinib mesylate|mesh-list
65461763|NCT04794088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461764|NCT04794088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65461765|NCT04794088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461766|NCT04794088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461767|NCT03763084|Acetaminophen|acetaminophen|mesh-list
65461768|NCT03763084|Sufentanil|sufentanil|mesh-list
65461769|NCT03763084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65461770|NCT03763084|Analgesics|analgesics|mesh-ancestor
65461771|NCT03763084|Sensory System Agents|sensory system agents|mesh-ancestor
65461772|NCT03763084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65461773|NCT03763084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461774|NCT03763084|Antipyretics|antipyretics|mesh-ancestor
65461775|NCT03763084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65461776|NCT03763084|Narcotics|narcotics|mesh-ancestor
65461777|NCT03763084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65461778|NCT03763084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65461779|NCT03763084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65461780|NCT03763084|Anesthetics, General|anesthetics, general|mesh-ancestor
65461781|NCT03763084|Anesthetics|anesthetics|mesh-ancestor
65461782|NCT01567618|Docetaxel|docetaxel|mesh-list
65461783|NCT01567618|Fluorouracil|fluorouracil|mesh-list
65461784|NCT01567618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461785|NCT01567618|Tubulin Modulators|tubulin modulators|mesh-ancestor
65461786|NCT01567618|Antimitotic Agents|antimitotic agents|mesh-ancestor
65461787|NCT01567618|Mitosis Modulators|mitosis modulators|mesh-ancestor
65461788|NCT01567618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461789|NCT01567618|Antimetabolites|antimetabolites|mesh-ancestor
65461790|NCT01567618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65461791|NCT01567618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65461792|NCT01567618|Immunologic Factors|immunologic factors|mesh-ancestor
65461793|NCT01567618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461800|NCT03762928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65461801|NCT03762928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65461802|NCT03762928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65461803|NCT03762928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65461804|NCT03762928|Anesthetics, General|anesthetics, general|mesh-ancestor
65461805|NCT03762928|Anesthetics|anesthetics|mesh-ancestor
65461806|NCT03762928|GABA Modulators|gaba modulators|mesh-ancestor
65461807|NCT03762928|GABA Agents|gaba agents|mesh-ancestor
65461808|NCT03762928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65461809|NCT03762928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461810|NCT03762928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65461811|NCT03762928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65461812|NCT03762928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461813|NCT03762928|Antiviral Agents|antiviral agents|mesh-ancestor
65461814|NCT03762928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65461815|NCT03762928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65461816|NCT03762928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65461817|NCT03762928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65461818|NCT03762928|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65461819|NCT03762928|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65461820|NCT03762928|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65461821|NCT01561456|Docetaxel|docetaxel|mesh-list
65461822|NCT01561456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461823|NCT01561456|Tubulin Modulators|tubulin modulators|mesh-ancestor
65461824|NCT01561456|Antimitotic Agents|antimitotic agents|mesh-ancestor
65461825|NCT01561456|Mitosis Modulators|mitosis modulators|mesh-ancestor
65461826|NCT01561456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461827|NCT00137436|Prednisone|prednisone|mesh-list
65461828|NCT00137436|Docetaxel|docetaxel|mesh-list
64704612|NCT02474407|Anesthetics, General|anesthetics, general|mesh-ancestor
64704613|NCT02474407|Anesthetics|anesthetics|mesh-ancestor
64704614|NCT02474407|GABA Modulators|gaba modulators|mesh-ancestor
64704615|NCT02474407|GABA Agents|gaba agents|mesh-ancestor
64704616|NCT02474407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64704617|NCT02474407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704618|NCT05588492|Rifamycins|rifamycins|mesh-list
64704619|NCT05588492|Rifamycin SV|rifamycin sv|mesh-list
64704620|NCT05588492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64704621|NCT05588492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64704622|NCT05588492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64704623|NCT03777956|Lacosamide|lacosamide|mesh-list
64704624|NCT03777956|Anticonvulsants|anticonvulsants|mesh-ancestor
64704625|NCT03777956|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64704626|NCT03777956|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64704627|NCT03777956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64704628|NCT03777956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461829|NCT00137436|Sunitinib|sunitinib|mesh-list
65461830|NCT00137436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461831|NCT00137436|Tubulin Modulators|tubulin modulators|mesh-ancestor
65461832|NCT00137436|Antimitotic Agents|antimitotic agents|mesh-ancestor
65461833|NCT00137436|Mitosis Modulators|mitosis modulators|mesh-ancestor
65461834|NCT00137436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461835|NCT00137436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65461836|NCT00137436|Glucocorticoids|glucocorticoids|mesh-ancestor
65461837|NCT00137436|Hormones|hormones|mesh-ancestor
65461838|NCT00137436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65211328|NCT00770653|Immunologic Factors|immunologic factors|mesh-ancestor
65461839|NCT00137436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461840|NCT00137436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65461841|NCT00137436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65461842|NCT00137436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65461843|NCT00137436|Growth Substances|growth substances|mesh-ancestor
65461844|NCT00137436|Growth Inhibitors|growth inhibitors|mesh-ancestor
65461845|NCT00137436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65461846|NCT00137436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461847|NCT03762538|Propofol|propofol|mesh-list
65461848|NCT03762538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65461849|NCT03762538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65461850|NCT03762538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461851|NCT03762538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65461852|NCT03762538|Anesthetics, General|anesthetics, general|mesh-ancestor
65461853|NCT03762538|Anesthetics|anesthetics|mesh-ancestor
65461854|NCT03762382|Tenofovir|tenofovir|mesh-list
65461875|NCT04005352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461876|NCT04005352|Growth Inhibitors|growth inhibitors|mesh-ancestor
65461877|NCT04005352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461878|NCT03767920|Dexamethasone|dexamethasone|mesh-list
65461879|NCT03767920|Dexamethasone acetate|dexamethasone acetate|mesh-list
65461880|NCT03767920|Bupivacaine|bupivacaine|mesh-list
65461881|NCT03767920|BB 1101|bb 1101|mesh-list
65461882|NCT03767920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65461883|NCT03767920|Antiemetics|antiemetics|mesh-ancestor
65461884|NCT03767920|Autonomic Agents|autonomic agents|mesh-ancestor
65461885|NCT03767920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65461886|NCT03767920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461887|NCT03767920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65461888|NCT03767920|Glucocorticoids|glucocorticoids|mesh-ancestor
65461889|NCT03767920|Hormones|hormones|mesh-ancestor
65461890|NCT03767920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65461891|NCT03767920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65461892|NCT03767920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461893|NCT03767920|Protease Inhibitors|protease inhibitors|mesh-ancestor
64704629|NCT02481505|Chloroprocaine|chloroprocaine|mesh-list
64704630|NCT02481505|Anesthetics, Local|anesthetics, local|mesh-ancestor
64704631|NCT02481505|Anesthetics|anesthetics|mesh-ancestor
64704632|NCT02481505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64704633|NCT02481505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704634|NCT02481505|Sensory System Agents|sensory system agents|mesh-ancestor
64704635|NCT02481505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64704636|NCT02563093|Vaccines|vaccines|mesh-list
64704637|NCT02563093|Immunologic Factors|immunologic factors|mesh-ancestor
64704638|NCT02563093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704639|NCT02564029|Lorazepam|lorazepam|mesh-list
64704640|NCT02564029|PF-06372865|pf-06372865|mesh-list
64704641|NCT02564029|Anticonvulsants|anticonvulsants|mesh-ancestor
64718723|NCT04585490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64326863|NCT00758563|Cariostatic Agents|cariostatic agents|mesh-ancestor
64704647|NCT02564029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64704648|NCT02564029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64704649|NCT02564029|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64704650|NCT02564029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64704651|NCT02564029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64704652|NCT02564029|GABA Modulators|gaba modulators|mesh-ancestor
64704654|NCT02564029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64704668|NCT02564497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64704669|NCT02564497|Immunologic Factors|immunologic factors|mesh-ancestor
64704670|NCT02564497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704671|NCT02564497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64704673|NCT03678428|Oxaliplatin|oxaliplatin|mesh-list
64704674|NCT03678428|Irinotecan|irinotecan|mesh-list
64704675|NCT03678428|Floxuridine|floxuridine|mesh-list
64704676|NCT03678428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704677|NCT03678428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64704678|NCT03678428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64704679|NCT03678428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704680|NCT03678428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704681|NCT03678428|Antidotes|antidotes|mesh-ancestor
64704682|NCT03678428|Protective Agents|protective agents|mesh-ancestor
64704683|NCT03678428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704684|NCT03678428|Vitamin B Complex|vitamin b complex|mesh-ancestor
64704685|NCT03678428|Vitamins|vitamins|mesh-ancestor
64704686|NCT03678428|Micronutrients|micronutrients|mesh-ancestor
65461894|NCT03767920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461895|NCT03767920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461896|NCT03767920|Anesthetics, Local|anesthetics, local|mesh-ancestor
65461897|NCT03767920|Anesthetics|anesthetics|mesh-ancestor
65461898|NCT03767920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65461899|NCT03767920|Sensory System Agents|sensory system agents|mesh-ancestor
65461900|NCT03834623|Nivolumab|nivolumab|mesh-list
65461901|NCT03834623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65461902|NCT03834623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461903|NCT03834623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65461904|NCT03834623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461905|NCT03762148|Vitamins|vitamins|mesh-list
65461906|NCT03762148|Ascorbic Acid|ascorbic acid|mesh-list
65461907|NCT03762148|Ferrous fumarate|ferrous fumarate|mesh-list
65461908|NCT03762148|Iron|iron|mesh-list
65461909|NCT03762148|Micronutrients|micronutrients|mesh-ancestor
65461910|NCT03762148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461911|NCT03762148|Antioxidants|antioxidants|mesh-ancestor
65461912|NCT03762148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461913|NCT03762148|Protective Agents|protective agents|mesh-ancestor
65211403|NCT04236219|Rasburicase|rasburicase|mesh-list
65461914|NCT03762148|Trace Elements|trace elements|mesh-ancestor
65461915|NCT01589159|Capecitabine|capecitabine|mesh-list
65461916|NCT01589159|Etoposide|etoposide|mesh-list
65461917|NCT01589159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65461918|NCT01589159|Antimetabolites|antimetabolites|mesh-ancestor
65461919|NCT01589159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461920|NCT01589159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461921|NCT01589159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65461922|NCT01589159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65461923|NCT01589159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65461924|NCT01589159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461925|NCT03711292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65461926|NCT03711292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65461927|NCT03937895|Pembrolizumab|pembrolizumab|mesh-list
64846396|NCT01691053|Natriuretic Agents|natriuretic agents|mesh-ancestor
64704687|NCT03678428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64704688|NCT03678428|Antimetabolites|antimetabolites|mesh-ancestor
64704689|NCT02565901|Sirolimus|sirolimus|mesh-list
64704690|NCT02565901|Carboplatin|carboplatin|mesh-list
64704691|NCT02565901|Docetaxel|docetaxel|mesh-list
65461928|NCT03937895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65461929|NCT03937895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65461930|NCT03625648|Pentoxifylline|pentoxifylline|mesh-list
65461931|NCT03625648|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65461932|NCT03625648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65461933|NCT03625648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461934|NCT03625648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65461935|NCT03625648|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65461936|NCT03625648|Protective Agents|protective agents|mesh-ancestor
65461937|NCT03625648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461938|NCT03625648|Vasodilator Agents|vasodilator agents|mesh-ancestor
65461939|NCT03625648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65461940|NCT03625648|Antioxidants|antioxidants|mesh-ancestor
65461941|NCT03767296|Phenylephrine|phenylephrine|mesh-list
65461942|NCT03767296|Oxymetazoline|oxymetazoline|mesh-list
65461943|NCT03767296|Ephedrine|ephedrine|mesh-list
65461944|NCT03767296|Pseudoephedrine|pseudoephedrine|mesh-list
65461945|NCT03767296|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65461946|NCT03767296|Mydriatics|mydriatics|mesh-ancestor
65461947|NCT03767296|Autonomic Agents|autonomic agents|mesh-ancestor
65461948|NCT03767296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65461949|NCT03767296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461950|NCT03767296|Sympathomimetics|sympathomimetics|mesh-ancestor
65461951|NCT03767296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65461952|NCT03767296|Nasal Decongestants|nasal decongestants|mesh-ancestor
65461953|NCT03767296|Respiratory System Agents|respiratory system agents|mesh-ancestor
65461954|NCT03767296|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65461955|NCT03767296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65461956|NCT03767296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65461957|NCT03767296|Adrenergic Agents|adrenergic agents|mesh-ancestor
65461958|NCT03767296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65461959|NCT03767296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461960|NCT03767296|Protective Agents|protective agents|mesh-ancestor
65461969|NCT03767218|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65461970|NCT03767218|Hormones|hormones|mesh-ancestor
65461971|NCT03767218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65461972|NCT03767218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461973|NCT03760978|Dexmedetomidine|dexmedetomidine|mesh-list
65461974|NCT03760978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65461975|NCT03760978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65461976|NCT03760978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65461977|NCT03760978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65461978|NCT03760978|Analgesics|analgesics|mesh-ancestor
65461979|NCT03760978|Sensory System Agents|sensory system agents|mesh-ancestor
65461980|NCT03760978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65461981|NCT03760978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65461982|NCT03760978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65461983|NCT03760978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65461984|NCT03760978|Adrenergic Agents|adrenergic agents|mesh-ancestor
65461985|NCT03760978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65461986|NCT03760978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65461987|NCT03766984|Diclofenac|diclofenac|mesh-list
65461988|NCT03766984|Tramadol|tramadol|mesh-list
65461989|NCT03766984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65462020|NCT03924856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462021|NCT03924856|Antiviral Agents|antiviral agents|mesh-ancestor
65462022|NCT03924856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65462023|NCT03924856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462024|NCT03924856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65462025|NCT03924856|Immunologic Factors|immunologic factors|mesh-ancestor
65462026|NCT03924856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462027|NCT03924856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65462028|NCT03760822|Paclitaxel|paclitaxel|mesh-list
65462029|NCT03760822|Ramucirumab|ramucirumab|mesh-list
65462030|NCT03760822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65462031|NCT03760822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462032|NCT03760822|Tubulin Modulators|tubulin modulators|mesh-ancestor
65462033|NCT03760822|Antimitotic Agents|antimitotic agents|mesh-ancestor
65462034|NCT03760822|Mitosis Modulators|mitosis modulators|mesh-ancestor
65462035|NCT03760822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462036|NCT01322152|Capecitabine|capecitabine|mesh-list
65462037|NCT01322152|Irinotecan|irinotecan|mesh-list
65462038|NCT01322152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65462039|NCT01322152|Antimetabolites|antimetabolites|mesh-ancestor
65462040|NCT01322152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462041|NCT01322152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462042|NCT01322152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65462043|NCT01322152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65462044|NCT01322152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462045|NCT01446016|Paclitaxel|paclitaxel|mesh-list
65462046|NCT01446016|Docetaxel|docetaxel|mesh-list
65462047|NCT01446016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65462048|NCT01446016|Taxane|taxane|mesh-list
65462049|NCT01446016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65462050|NCT01446016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462051|NCT01446016|Tubulin Modulators|tubulin modulators|mesh-ancestor
65462052|NCT01446016|Antimitotic Agents|antimitotic agents|mesh-ancestor
65462053|NCT01446016|Mitosis Modulators|mitosis modulators|mesh-ancestor
65462054|NCT01446016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462055|NCT00137046|Insulin|insulin|mesh-list
64704692|NCT02565901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704693|NCT02565901|Tubulin Modulators|tubulin modulators|mesh-ancestor
64704694|NCT02565901|Antimitotic Agents|antimitotic agents|mesh-ancestor
65462056|NCT00137046|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65462057|NCT00137046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65462058|NCT00137046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462059|NCT03383458|Nivolumab|nivolumab|mesh-list
65462060|NCT03383458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65462061|NCT03383458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462062|NCT03383458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65462063|NCT03383458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462064|NCT03760354|Methylprednisolone|methylprednisolone|mesh-list
65462065|NCT03760354|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65462066|NCT03760354|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65462067|NCT03760354|Prednisolone|prednisolone|mesh-list
65462068|NCT03760354|Prednisolone acetate|prednisolone acetate|mesh-list
65462069|NCT03760354|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65462070|NCT03760354|Prednisolone phosphate|prednisolone phosphate|mesh-list
65462071|NCT03760354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65462072|NCT03760354|Antiemetics|antiemetics|mesh-ancestor
65462073|NCT03760354|Autonomic Agents|autonomic agents|mesh-ancestor
65462096|NCT03766594|Folic Acid|folic acid|mesh-list
65462112|NCT03923374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65462113|NCT03923374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462114|NCT03923374|Analgesics|analgesics|mesh-ancestor
65462115|NCT03923374|Sensory System Agents|sensory system agents|mesh-ancestor
65462116|NCT03923374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65462117|NCT03923374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65462118|NCT00122382|Methotrexate|methotrexate|mesh-list
65462119|NCT00122382|Abatacept|abatacept|mesh-list
65462120|NCT00122382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65462121|NCT00122382|Abortifacient Agents|abortifacient agents|mesh-ancestor
65462122|NCT00122382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65462123|NCT00122382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462124|NCT00122382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65462125|NCT00122382|Antimetabolites|antimetabolites|mesh-ancestor
65462126|NCT00122382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462127|NCT00122382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462128|NCT00122382|Dermatologic Agents|dermatologic agents|mesh-ancestor
65462129|NCT00122382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462130|NCT00122382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65462131|NCT00122382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65462132|NCT00122382|Immunologic Factors|immunologic factors|mesh-ancestor
65462133|NCT00122382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65462134|NCT00122382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65462135|NCT00122382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65462136|NCT01028716|Mycophenolic Acid|mycophenolic acid|mesh-list
65462137|NCT01028716|Cyclophosphamide|cyclophosphamide|mesh-list
65211636|NCT00762073|Hormones|hormones|mesh-ancestor
65462138|NCT01028716|Fludarabine|fludarabine|mesh-list
65462139|NCT01028716|Fludarabine phosphate|fludarabine phosphate|mesh-list
65462140|NCT01028716|Tacrolimus|tacrolimus|mesh-list
65462141|NCT01028716|Lenograstim|lenograstim|mesh-list
65462142|NCT01028716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65462143|NCT01028716|Immunologic Factors|immunologic factors|mesh-ancestor
65462144|NCT01028716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462145|NCT01028716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65462146|NCT01028716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64704695|NCT02565901|Mitosis Modulators|mitosis modulators|mesh-ancestor
64704696|NCT02565901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704697|NCT02565901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65462147|NCT01028716|Alkylating Agents|alkylating agents|mesh-ancestor
65462148|NCT01028716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462149|NCT01028716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462150|NCT01028716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65462151|NCT01028716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65462152|NCT01028716|Antimetabolites|antimetabolites|mesh-ancestor
65462153|NCT01028716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65462154|NCT01028716|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65462155|NCT01028716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462156|NCT01028716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65462157|NCT01028716|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65462158|NCT01028716|Antitubercular Agents|antitubercular agents|mesh-ancestor
65462159|NCT01028716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65462160|NCT01028716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65462161|NCT02531724|Simendan|simendan|mesh-list
65462162|NCT02531724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65462163|NCT02531724|Vasodilator Agents|vasodilator agents|mesh-ancestor
65462164|NCT02531724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65462165|NCT02531724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65462166|NCT02531724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462167|NCT02531724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462168|NCT02531724|Protective Agents|protective agents|mesh-ancestor
65462169|NCT02531724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462170|NCT03760198|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65462171|NCT03760198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65462172|NCT03760198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65462173|NCT03760198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462174|NCT03760198|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65462175|NCT03760198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65462189|NCT00106704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462190|NCT03759886|Metronidazole|metronidazole|mesh-list
65462191|NCT03759886|Paromomycin|paromomycin|mesh-list
65462192|NCT03759886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65462193|NCT03759886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65462194|NCT03759886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65462195|NCT03759886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65462196|NCT01081158|Ritonavir|ritonavir|mesh-list
65462197|NCT01081158|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65462198|NCT01081158|Interferon-alpha|interferon-alpha|mesh-list
65462199|NCT01081158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65462200|NCT01081158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65462201|NCT01081158|Protease Inhibitors|protease inhibitors|mesh-ancestor
65462202|NCT01081158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462203|NCT01081158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462204|NCT01081158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65462205|NCT01081158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65462206|NCT01081158|Antiviral Agents|antiviral agents|mesh-ancestor
65462207|NCT01081158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65462208|NCT01081158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65462209|NCT01081158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65462210|NCT01081158|Immunologic Factors|immunologic factors|mesh-ancestor
65462211|NCT01081158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211702|NCT00761527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65462212|NCT00105066|Metformin|metformin|mesh-list
65462213|NCT00105066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65462214|NCT00105066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462215|NCT01322308|Pioglitazone|pioglitazone|mesh-list
64704698|NCT02565901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64704699|NCT02565901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64704700|NCT02565901|Antifungal Agents|antifungal agents|mesh-ancestor
64704701|NCT02565901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64704702|NCT02565901|Immunologic Factors|immunologic factors|mesh-ancestor
64704703|NCT02565901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704704|NCT03926624|Cytarabine|cytarabine|mesh-list
64335841|NCT03510325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64704705|NCT03926624|Fludarabine|fludarabine|mesh-list
64704706|NCT03926624|Etoposide|etoposide|mesh-list
64704707|NCT03926624|Azacitidine|azacitidine|mesh-list
64704708|NCT03926624|Decitabine|decitabine|mesh-list
64704709|NCT03926624|Venetoclax|venetoclax|mesh-list
64704710|NCT03926624|Mitoxantrone|mitoxantrone|mesh-list
64704752|NCT05588102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64704753|NCT05588102|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64704754|NCT05588102|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64704755|NCT04744441|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64704756|NCT04744441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64704757|NCT03551210|Levofloxacin|levofloxacin|mesh-list
64704759|NCT03551210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65462216|NCT01322308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65462217|NCT01322308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462218|NCT05208268|Rabeprazole|rabeprazole|mesh-list
65462219|NCT05208268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65462220|NCT05208268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65462221|NCT05208268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65462222|NCT05208268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462223|NCT05208268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462224|NCT03165292|Topotecan|topotecan|mesh-list
65462225|NCT03165292|Thiotepa|thiotepa|mesh-list
65462226|NCT03165292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65462227|NCT03165292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65462228|NCT03165292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462229|NCT03165292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462230|NCT03165292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462231|NCT03165292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65462232|NCT03165292|Alkylating Agents|alkylating agents|mesh-ancestor
65462233|NCT03165292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65462234|NCT03165292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65462235|NCT03165292|Immunologic Factors|immunologic factors|mesh-ancestor
65462236|NCT03165292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462237|NCT03109288|Pioglitazone|pioglitazone|mesh-list
65462238|NCT03109288|Clemastine|clemastine|mesh-list
65462239|NCT03109288|Pirfenidone|pirfenidone|mesh-list
65462240|NCT03109288|Dantrolene|dantrolene|mesh-list
65462241|NCT03109288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65462242|NCT03109288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462243|NCT03109288|Analgesics|analgesics|mesh-ancestor
65462244|NCT03109288|Sensory System Agents|sensory system agents|mesh-ancestor
65462245|NCT03109288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65462246|NCT03109288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65462247|NCT03109288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65462248|NCT03109288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65462249|NCT03109288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65462250|NCT03109288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846726|NCT01693809|Caffeine|caffeine|mesh-list
64704760|NCT03551210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64704761|NCT03551210|Renal Agents|renal agents|mesh-ancestor
64704762|NCT03551210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64704763|NCT03551210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64704764|NCT03551210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65462251|NCT03109288|Antipruritics|antipruritics|mesh-ancestor
65462252|NCT03109288|Dermatologic Agents|dermatologic agents|mesh-ancestor
65462253|NCT03109288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65462254|NCT03109288|Histamine Antagonists|histamine antagonists|mesh-ancestor
65462255|NCT03109288|Histamine Agents|histamine agents|mesh-ancestor
65462256|NCT03109288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65462257|NCT03109288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462258|NCT03109288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65462259|NCT03109288|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65462260|NCT03109288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65462261|NCT03759262|Vitamin D|vitamin d|mesh-list
65462262|NCT03759262|Cholecalciferol|cholecalciferol|mesh-list
65462263|NCT03759262|Vitamins|vitamins|mesh-ancestor
65462264|NCT03759262|Micronutrients|micronutrients|mesh-ancestor
65462265|NCT03759262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462266|NCT03759262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65462267|NCT03759262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65462268|NCT00135330|Exenatide|exenatide|mesh-list
65462269|NCT00135330|Rosiglitazone|rosiglitazone|mesh-list
65462270|NCT00135330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65462271|NCT00135330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462272|NCT00135330|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65462273|NCT00135330|Incretins|incretins|mesh-ancestor
65462274|NCT00135330|Hormones|hormones|mesh-ancestor
65462275|NCT00135330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65462276|NCT01076478|Cilostazol|cilostazol|mesh-list
65462277|NCT01076478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65462278|NCT01076478|Autonomic Agents|autonomic agents|mesh-ancestor
65462279|NCT01076478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65462280|NCT01076478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462281|NCT01076478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65462295|NCT01076556|Alvocidib|alvocidib|mesh-list
65462296|NCT01076556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65462297|NCT01076556|Antibodies|antibodies|mesh-list
65462298|NCT01076556|Immunoglobulins|immunoglobulins|mesh-list
65462299|NCT01076556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65462300|NCT01076556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65462301|NCT01076556|Immunologic Factors|immunologic factors|mesh-ancestor
65462302|NCT01076556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462303|NCT01076556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65462304|NCT01076556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65462305|NCT01076556|Alkylating Agents|alkylating agents|mesh-ancestor
65462306|NCT01076556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462307|NCT01076556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462308|NCT01076556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65462309|NCT01076556|Growth Inhibitors|growth inhibitors|mesh-ancestor
65462310|NCT01076556|Growth Substances|growth substances|mesh-ancestor
65462311|NCT01076556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65462312|NCT01076556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462313|NCT03965442|Esmolol|esmolol|mesh-list
65462314|NCT03965442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65462315|NCT03965442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65462316|NCT03965442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65462317|NCT03965442|Adrenergic Agents|adrenergic agents|mesh-ancestor
65462318|NCT03965442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65462319|NCT03965442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462320|NCT03965442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462321|NCT00134082|Cyclophosphamide|cyclophosphamide|mesh-list
65462322|NCT00134082|Rituximab|rituximab|mesh-list
65462323|NCT00134082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65462324|NCT00134082|Immunologic Factors|immunologic factors|mesh-ancestor
65462325|NCT00134082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462326|NCT00134082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65462327|NCT00134082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65462335|NCT01326312|Fertility Agents|fertility agents|mesh-ancestor
65462336|NCT01326312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65462337|NCT01326312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462338|NCT01326312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65462339|NCT01326312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462340|NCT03765346|Oxycodone|oxycodone|mesh-list
65462341|NCT03765346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65462342|NCT03765346|Narcotics|narcotics|mesh-ancestor
65462343|NCT03765346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65462344|NCT03765346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462345|NCT03765346|Analgesics|analgesics|mesh-ancestor
65462346|NCT03765346|Sensory System Agents|sensory system agents|mesh-ancestor
65462347|NCT03765346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65462348|NCT01078818|Ferrous fumarate|ferrous fumarate|mesh-list
65462349|NCT01078818|Trace Elements|trace elements|mesh-ancestor
65462350|NCT01078818|Micronutrients|micronutrients|mesh-ancestor
65462351|NCT01078818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462352|NCT01079052|Famotidine|famotidine|mesh-list
65462353|NCT01079052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65462354|NCT01079052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65462355|NCT01079052|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65462356|NCT01079052|Histamine Antagonists|histamine antagonists|mesh-ancestor
65462357|NCT01079052|Histamine Agents|histamine agents|mesh-ancestor
65462358|NCT01079052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65462359|NCT01079052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462360|NCT01079052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462361|NCT01326468|Sirolimus|sirolimus|mesh-list
65462362|NCT01326468|Cisplatin|cisplatin|mesh-list
65462363|NCT01326468|Cetuximab|cetuximab|mesh-list
65462364|NCT01326468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846835|NCT05288127|Talazoparib|talazoparib|mesh-list
64704765|NCT03551210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704766|NCT03551210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704767|NCT03551210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704768|NCT03551210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64704769|NCT03551210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64704770|NCT02482675|Caseins|caseins|mesh-list
64704771|NCT02482675|Chelating Agents|chelating agents|mesh-ancestor
64704772|NCT02482675|Sequestering Agents|sequestering agents|mesh-ancestor
64704773|NCT02482675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704774|NCT00364195|Tesmilifene|tesmilifene|mesh-list
64704775|NCT00364195|Histamine Antagonists|histamine antagonists|mesh-ancestor
64704776|NCT00364195|Histamine Agents|histamine agents|mesh-ancestor
64704777|NCT00364195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64704778|NCT00364195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462365|NCT01326468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65462366|NCT01326468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65462367|NCT01326468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65462368|NCT01326468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65462369|NCT01326468|Antifungal Agents|antifungal agents|mesh-ancestor
65462370|NCT01326468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65462371|NCT01326468|Immunologic Factors|immunologic factors|mesh-ancestor
65462372|NCT01326468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462373|NCT01076634|Insulin|insulin|mesh-list
65462374|NCT01076634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65462375|NCT01076634|Insulin, Long-Acting|insulin, long-acting|mesh-list
65462376|NCT01076634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65462377|NCT01076634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462378|NCT00132678|Risperidone|risperidone|mesh-list
65462379|NCT00132678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65462380|NCT00132678|Serotonin Agents|serotonin agents|mesh-ancestor
65462381|NCT00132678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65462382|NCT00132678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462383|NCT00132678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462384|NCT00132678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65462385|NCT00132678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65462386|NCT00132678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65462387|NCT00132678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65462388|NCT00132678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65462389|NCT00132678|Dopamine Agents|dopamine agents|mesh-ancestor
65462390|NCT01081548|Atorvastatin|atorvastatin|mesh-list
65462391|NCT01081548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65462412|NCT01076790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65462413|NCT01076790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65462414|NCT01076790|Adrenergic Agents|adrenergic agents|mesh-ancestor
65462415|NCT01076790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65462416|NCT01076790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462417|NCT01582932|Calcipotriene|calcipotriene|mesh-list
65462418|NCT01582932|Dermatologic Agents|dermatologic agents|mesh-ancestor
65462419|NCT03965286|Sofosbuvir|sofosbuvir|mesh-list
65462420|NCT03965286|Ledipasvir|ledipasvir|mesh-list
65462421|NCT03965286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
65462422|NCT03965286|Antiviral Agents|antiviral agents|mesh-ancestor
65462423|NCT03965286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65462424|NCT01079286|Sirolimus|sirolimus|mesh-list
65462425|NCT01079286|Nelfinavir|nelfinavir|mesh-list
65462426|NCT01079286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65462427|NCT01079286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65462428|NCT01079286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65462429|NCT01079286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462430|NCT01079286|Antifungal Agents|antifungal agents|mesh-ancestor
65462431|NCT01079286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65462432|NCT01079286|Immunologic Factors|immunologic factors|mesh-ancestor
65462433|NCT01079286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462434|NCT01079286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65462435|NCT01079286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65462436|NCT01079286|Protease Inhibitors|protease inhibitors|mesh-ancestor
65462437|NCT01079286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462438|NCT01079286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462439|NCT01079286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65462440|NCT01079286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64704794|NCT02571439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64704796|NCT02572609|Expectorants|expectorants|mesh-ancestor
64704797|NCT02572609|Respiratory System Agents|respiratory system agents|mesh-ancestor
64704798|NCT02573857|Artefenomel|artefenomel|mesh-list
64704799|NCT02573857|Antimalarials|antimalarials|mesh-ancestor
64704800|NCT02573857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64704801|NCT02573857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64704802|NCT02573857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64704803|NCT02577601|Levonorgestrel|levonorgestrel|mesh-list
64704804|NCT02577601|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64704805|NCT02577601|Ulipristal acetate|ulipristal acetate|mesh-list
64718728|NCT04714099|Cyclosporins|cyclosporins|mesh-list
64718729|NCT04714099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718730|NCT04714099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718731|NCT04714099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64704806|NCT02577601|Contraceptives, Oral|contraceptives, oral|mesh-list
64704807|NCT02577601|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64704808|NCT02577601|Estradiol|estradiol|mesh-list
64704809|NCT02577601|Estrogens|estrogens|mesh-ancestor
65462441|NCT01079286|Antiviral Agents|antiviral agents|mesh-ancestor
65462442|NCT01081704|Ustekinumab|ustekinumab|mesh-list
65462443|NCT01081704|Dermatologic Agents|dermatologic agents|mesh-ancestor
65462444|NCT00141518|Levodopa|levodopa|mesh-list
65462445|NCT00141518|Carbidopa|carbidopa|mesh-list
65462446|NCT00141518|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65462447|NCT00141518|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65462448|NCT00141518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65462449|NCT00141518|Dopamine Agents|dopamine agents|mesh-ancestor
65462450|NCT00141518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65462451|NCT00141518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462452|NCT00141518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462453|NCT00141518|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65462454|NCT00141518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462455|NCT00141518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65462456|NCT00141518|Immunologic Factors|immunologic factors|mesh-ancestor
65462457|NCT00141518|Dopamine Agonists|dopamine agonists|mesh-ancestor
65462458|NCT01075880|Interferons|interferons|mesh-list
65462459|NCT01075880|Interferon-beta|interferon-beta|mesh-list
65462460|NCT01075880|Interferon beta-1a|interferon beta-1a|mesh-list
65462461|NCT01075880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462462|NCT01075880|Antiviral Agents|antiviral agents|mesh-ancestor
65462463|NCT01075880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65462464|NCT01075880|Immunologic Factors|immunologic factors|mesh-ancestor
65462465|NCT01075880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462467|NCT00098748|Maraviroc|maraviroc|mesh-list
65462490|NCT00130442|Alkylating Agents|alkylating agents|mesh-ancestor
65462491|NCT00130442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462492|NCT00130442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462493|NCT00130208|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
65462494|NCT00130208|Anticoagulants|anticoagulants|mesh-ancestor
65462495|NCT00130208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65462496|NCT00130208|Antimetabolites|antimetabolites|mesh-ancestor
65462497|NCT00130208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462498|NCT00130208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65462499|NCT00130208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65462500|NCT00130208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65462501|NCT00130208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65462502|NCT00130208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462503|NCT00253370|Cisplatin|cisplatin|mesh-list
65462504|NCT00253370|Docetaxel|docetaxel|mesh-list
65462505|NCT00253370|Sorafenib|sorafenib|mesh-list
65462506|NCT00253370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462507|NCT00253370|Tubulin Modulators|tubulin modulators|mesh-ancestor
65462508|NCT00253370|Antimitotic Agents|antimitotic agents|mesh-ancestor
65462509|NCT00253370|Mitosis Modulators|mitosis modulators|mesh-ancestor
65462510|NCT00253370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462511|NCT00253370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65462512|NCT00253370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462513|NCT03966170|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
65212003|NCT05803070|Hormones|hormones|mesh-ancestor
65462514|NCT03966170|Nootropic Agents|nootropic agents|mesh-ancestor
65462515|NCT00140426|Risperidone|risperidone|mesh-list
65462516|NCT00140426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65462517|NCT00140426|Serotonin Agents|serotonin agents|mesh-ancestor
65462518|NCT00140426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65462519|NCT00140426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462520|NCT00140426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462521|NCT00140426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65462522|NCT00140426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65462523|NCT00140426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64704810|NCT02577601|Hormones|hormones|mesh-ancestor
64704811|NCT02577601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64704812|NCT02577601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704813|NCT02577601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64704814|NCT02577601|Contraceptive Agents|contraceptive agents|mesh-ancestor
65462524|NCT00140426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65462525|NCT00140426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65462526|NCT00140426|Dopamine Agents|dopamine agents|mesh-ancestor
65462527|NCT03966560|Timolol|timolol|mesh-list
65462528|NCT03966560|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65462529|NCT03966560|Bimatoprost|bimatoprost|mesh-list
65462530|NCT03966560|Travoprost|travoprost|mesh-list
65462531|NCT03966560|Dorzolamide|dorzolamide|mesh-list
65462532|NCT03966560|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65462533|NCT03966560|Latanoprost|latanoprost|mesh-list
65462534|NCT03966560|Brinzolamide|brinzolamide|mesh-list
65462535|NCT03966560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65462536|NCT03966560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462537|NCT03966560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462538|NCT03966560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65462539|NCT03966560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65462540|NCT03966560|Adrenergic Agents|adrenergic agents|mesh-ancestor
65462541|NCT03966560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65462542|NCT03966560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462543|NCT03966560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65462544|NCT03966560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65462545|NCT03966560|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65462546|NCT03966560|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65462547|NCT03966560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65462548|NCT03966560|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65462549|NCT01072058|Adalimumab|adalimumab|mesh-list
65462550|NCT01072058|Etanercept|etanercept|mesh-list
65462551|NCT01072058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
65462552|NCT01072058|Infliximab|infliximab|mesh-list
65462573|NCT00121134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65462574|NCT00121134|Alkylating Agents|alkylating agents|mesh-ancestor
65462575|NCT00121134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462576|NCT00121134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462577|NCT00121134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65462578|NCT00121134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65462579|NCT00121134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65462580|NCT00121134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65462581|NCT00121134|Growth Substances|growth substances|mesh-ancestor
65462582|NCT00121134|Growth Inhibitors|growth inhibitors|mesh-ancestor
65462583|NCT00121134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65462584|NCT00121134|Antimetabolites|antimetabolites|mesh-ancestor
65462585|NCT00121134|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65462586|NCT00121134|Abortifacient Agents|abortifacient agents|mesh-ancestor
65462587|NCT00121134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65462588|NCT00121134|Dermatologic Agents|dermatologic agents|mesh-ancestor
65462589|NCT00121134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462590|NCT00121134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65462591|NCT00121134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65462592|NCT03966378|Grape Seed Extract|grape seed extract|mesh-list
65462593|NCT03966378|Calcium|calcium|mesh-list
65462594|NCT03966378|Caseins|caseins|mesh-list
64847074|NCT05294640|Lidocaine|lidocaine|mesh-list
64704815|NCT02577601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64704816|NCT02577601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64704817|NCT02577601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64704818|NCT02577601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64704819|NCT02577991|Triamcinolone|triamcinolone|mesh-list
64704820|NCT02577991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64704821|NCT02577991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704822|NCT02577991|Glucocorticoids|glucocorticoids|mesh-ancestor
64704823|NCT02577991|Hormones|hormones|mesh-ancestor
64704824|NCT02577991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64704825|NCT02207634|Evolocumab|evolocumab|mesh-list
64704826|NCT02207634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64704827|NCT02207634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64704828|NCT02207634|Antimetabolites|antimetabolites|mesh-ancestor
64335874|NCT02336529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335877|NCT04636437|Tenofovir|tenofovir|mesh-list
64704841|NCT02484859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64704842|NCT02484859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64704843|NCT02484859|Sympatholytics|sympatholytics|mesh-ancestor
64704844|NCT02484859|Autonomic Agents|autonomic agents|mesh-ancestor
64704845|NCT02484859|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64704846|NCT02484859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64704847|NCT02484859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64704848|NCT02484859|Adrenergic Agents|adrenergic agents|mesh-ancestor
64704852|NCT04341727|Hydroxychloroquine|hydroxychloroquine|mesh-list
64704854|NCT04341727|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64704855|NCT04341727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64704856|NCT04341727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64704857|NCT04341727|Antimalarials|antimalarials|mesh-ancestor
65462595|NCT03966378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65462596|NCT03966378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462597|NCT03966378|Chelating Agents|chelating agents|mesh-ancestor
65462598|NCT03966378|Sequestering Agents|sequestering agents|mesh-ancestor
65462599|NCT03966378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462600|NCT03966378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65462601|NCT03966378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462602|NCT03966378|Antioxidants|antioxidants|mesh-ancestor
65462603|NCT03966378|Protective Agents|protective agents|mesh-ancestor
65462604|NCT02657434|Carboplatin|carboplatin|mesh-list
65462605|NCT02657434|Pemetrexed|pemetrexed|mesh-list
65462606|NCT02657434|Atezolizumab|atezolizumab|mesh-list
65462607|NCT02657434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462608|NCT02657434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462609|NCT02657434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462610|NCT02657434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65462611|NCT02657434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65462612|NCT02652052|Dasatinib|dasatinib|mesh-list
65462613|NCT02652052|Quercetin|quercetin|mesh-list
65462614|NCT02652052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462615|NCT02652052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65462616|NCT02652052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462617|NCT02652052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462618|NCT02652052|Antioxidants|antioxidants|mesh-ancestor
65462619|NCT02652052|Protective Agents|protective agents|mesh-ancestor
65462620|NCT02652052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462621|NCT00119262|Tamoxifen|tamoxifen|mesh-list
65462642|NCT00119262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65462643|NCT00119262|Growth Substances|growth substances|mesh-ancestor
65462644|NCT00119262|Growth Inhibitors|growth inhibitors|mesh-ancestor
65462645|NCT00119262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65462646|NCT00119262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65462647|NCT00119262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65462648|NCT00119262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462649|NCT00119262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65462650|NCT00119262|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65462651|NCT00119262|Hormone Antagonists|hormone antagonists|mesh-ancestor
65462652|NCT00119262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65462653|NCT00119262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65462654|NCT00119262|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65462655|NCT00119262|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65462656|NCT00119262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65462657|NCT00119262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65462658|NCT00131664|Metformin|metformin|mesh-list
65462659|NCT00131664|Glimepiride|glimepiride|mesh-list
65462660|NCT00131664|Rosiglitazone|rosiglitazone|mesh-list
65462661|NCT00131664|Maleic acid|maleic acid|mesh-list
65462662|NCT00131664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65462663|NCT00131664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462664|NCT00131664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462665|NCT00131664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462666|NCT00131664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65462667|NCT00131664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65462668|NCT00131664|Immunologic Factors|immunologic factors|mesh-ancestor
65462670|NCT05050318|Immunologic Factors|immunologic factors|mesh-ancestor
65462671|NCT05050318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462672|NCT03778996|Sirolimus|sirolimus|mesh-list
65462673|NCT03778996|Phenytoin|phenytoin|mesh-list
65462674|NCT03778996|Methoxsalen|methoxsalen|mesh-list
65462675|NCT03778996|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
65462676|NCT03778996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64847146|NCT05293808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64704858|NCT04341727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64704859|NCT04341727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64704860|NCT04341727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704861|NCT04341727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462677|NCT03778996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65462678|NCT03778996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65462679|NCT03778996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462680|NCT03778996|Antifungal Agents|antifungal agents|mesh-ancestor
65462681|NCT03778996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65462682|NCT03778996|Immunologic Factors|immunologic factors|mesh-ancestor
65462683|NCT03778996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462684|NCT03778996|Anticonvulsants|anticonvulsants|mesh-ancestor
65462685|NCT03778996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65462686|NCT03778996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65462687|NCT03778996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65462688|NCT03778996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462689|NCT03778996|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65462690|NCT03778996|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65462691|NCT03778996|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64847184|NCT05293132|Coenzyme Q10|coenzyme q10|mesh-list
64704862|NCT04341727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64704863|NCT04341727|Amebicides|amebicides|mesh-ancestor
64704864|NCT04341727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64704865|NCT04341727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64704866|NCT04341727|Analgesics|analgesics|mesh-ancestor
64704867|NCT04341727|Sensory System Agents|sensory system agents|mesh-ancestor
64704868|NCT04341727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64704869|NCT04341727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704871|NCT04341727|Filaricides|filaricides|mesh-ancestor
64704872|NCT04341727|Antinematodal Agents|antinematodal agents|mesh-ancestor
64704873|NCT04341727|Anthelmintics|anthelmintics|mesh-ancestor
64704874|NCT00367094|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64718733|NCT04714099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718734|NCT04714099|Antifungal Agents|antifungal agents|mesh-ancestor
64704875|NCT00367094|Benazepril|benazepril|mesh-list
64704876|NCT00367094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64704877|NCT00367094|Diuretics|diuretics|mesh-ancestor
64704878|NCT00367094|Natriuretic Agents|natriuretic agents|mesh-ancestor
64704879|NCT00367094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704880|NCT00367094|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64704881|NCT00367094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64704882|NCT00367094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704883|NCT00367094|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64704884|NCT00367094|Protease Inhibitors|protease inhibitors|mesh-ancestor
64704885|NCT00367094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704886|NCT02581111|Naloxone|naloxone|mesh-list
64704887|NCT02581111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64704888|NCT02581111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704889|NCT02581111|Sensory System Agents|sensory system agents|mesh-ancestor
64704890|NCT02581111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64704891|NCT05587400|Dobutamine|dobutamine|mesh-list
64704892|NCT05587400|Nitric Oxide|nitric oxide|mesh-list
64704893|NCT05587400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64704894|NCT05587400|Autonomic Agents|autonomic agents|mesh-ancestor
64704907|NCT05587400|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64704908|NCT05587400|Sympathomimetics|sympathomimetics|mesh-ancestor
64704909|NCT05587400|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64704910|NCT05587400|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64704911|NCT05587400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64704912|NCT05587400|Adrenergic Agents|adrenergic agents|mesh-ancestor
64704913|NCT04339868|Terlipressin|terlipressin|mesh-list
64704914|NCT04339868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64430183|NCT02069379|Metformin|metformin|mesh-list
65462692|NCT03778996|Dermatologic Agents|dermatologic agents|mesh-ancestor
65462693|NCT03778996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462694|NCT03764722|Simendan|simendan|mesh-list
65462695|NCT03764722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65462696|NCT03764722|Vasodilator Agents|vasodilator agents|mesh-ancestor
65462697|NCT03764722|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65462698|NCT03764722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65462699|NCT03764722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462700|NCT03764722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462701|NCT03764722|Protective Agents|protective agents|mesh-ancestor
65462702|NCT03764722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462703|NCT05024734|Gemcitabine|gemcitabine|mesh-list
65462704|NCT05024734|Docetaxel|docetaxel|mesh-list
65462705|NCT05024734|Epirubicin|epirubicin|mesh-list
65462706|NCT05024734|Mitomycins|mitomycins|mesh-list
65462707|NCT05024734|Mitomycin|mitomycin|mesh-list
65462708|NCT05024734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65462709|NCT05024734|Antimetabolites|antimetabolites|mesh-ancestor
65462710|NCT05024734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462711|NCT05024734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462712|NCT05024734|Antiviral Agents|antiviral agents|mesh-ancestor
65462713|NCT05024734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65462714|NCT05024734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462715|NCT05024734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65462716|NCT05024734|Immunologic Factors|immunologic factors|mesh-ancestor
65462717|NCT05024734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462718|NCT05024734|Tubulin Modulators|tubulin modulators|mesh-ancestor
65462719|NCT05024734|Antimitotic Agents|antimitotic agents|mesh-ancestor
65462720|NCT05024734|Mitosis Modulators|mitosis modulators|mesh-ancestor
65462721|NCT05024734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65462722|NCT05024734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65462723|NCT05024734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64704915|NCT04339868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64704916|NCT00367172|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64704918|NCT00367172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64704919|NCT00367250|Trastuzumab|trastuzumab|mesh-list
64704920|NCT00367250|Cetuximab|cetuximab|mesh-list
64704921|NCT00367250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64704922|NCT00367250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704925|NCT02489227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64704927|NCT02490631|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64704928|NCT02490631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64704929|NCT02490631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64704930|NCT02490631|Disinfectants|disinfectants|mesh-ancestor
64704931|NCT02490631|Dermatologic Agents|dermatologic agents|mesh-ancestor
65462724|NCT05024734|Alkylating Agents|alkylating agents|mesh-ancestor
65462725|NCT05024734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65462726|NCT03764488|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
65462727|NCT03764488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65462728|NCT03764488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462729|NCT03756298|Capecitabine|capecitabine|mesh-list
65462730|NCT03756298|Atezolizumab|atezolizumab|mesh-list
65462731|NCT03756298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65462732|NCT03756298|Antimetabolites|antimetabolites|mesh-ancestor
64704932|NCT02207556|Doxycycline|doxycycline|mesh-list
64704933|NCT02207556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64704934|NCT02207556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64704935|NCT02207556|Antimalarials|antimalarials|mesh-ancestor
64704936|NCT02207556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64704937|NCT02207556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64704938|NCT02587117|Prednisolone|prednisolone|mesh-list
64704939|NCT02587117|Lycopene|lycopene|mesh-list
64704940|NCT02587117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64704941|NCT02587117|Glucocorticoids|glucocorticoids|mesh-ancestor
64704942|NCT02587117|Hormones|hormones|mesh-ancestor
64704943|NCT02587117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64704944|NCT02587117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704945|NCT02587117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64704946|NCT02587117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704947|NCT02587117|Protective Agents|protective agents|mesh-ancestor
64704948|NCT02587117|Antioxidants|antioxidants|mesh-ancestor
64718735|NCT04714099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64718736|NCT04714099|Dermatologic Agents|dermatologic agents|mesh-ancestor
64718737|NCT04714099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64718738|NCT04714099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64704949|NCT02587117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704950|NCT02587117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64704951|NCT02587117|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64704952|NCT02587351|Metoprolol|metoprolol|mesh-list
64704953|NCT02587351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64704954|NCT02587351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64704955|NCT02587351|Sympatholytics|sympatholytics|mesh-ancestor
64704956|NCT02587351|Autonomic Agents|autonomic agents|mesh-ancestor
64335909|NCT03510013|Anesthetics|anesthetics|mesh-list
64704969|NCT05553314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64704970|NCT05553314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704971|NCT05553314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704972|NCT05553314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64704974|NCT05553314|Protective Agents|protective agents|mesh-ancestor
64704975|NCT05553314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64704976|NCT05553314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64704977|NCT05553314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64704978|NCT05553314|Vasodilator Agents|vasodilator agents|mesh-ancestor
64704979|NCT05553314|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64704980|NCT05553314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64704981|NCT03260504|Aldesleukin|aldesleukin|mesh-list
64704982|NCT03260504|Pembrolizumab|pembrolizumab|mesh-list
64704983|NCT03260504|Interleukin-2|interleukin-2|mesh-list
64704984|NCT03260504|Immunoglobulins|immunoglobulins|mesh-list
64704985|NCT03260504|Immunoglobulin G|immunoglobulin g|mesh-list
64704986|NCT03260504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64704987|NCT03260504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704988|NCT03260504|Immunologic Factors|immunologic factors|mesh-ancestor
64704989|NCT03260504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704990|NCT03260504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64704991|NCT03260504|Analgesics|analgesics|mesh-ancestor
64704992|NCT03260504|Sensory System Agents|sensory system agents|mesh-ancestor
64704993|NCT03260504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64704994|NCT03260504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64704995|NCT03260504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64704996|NCT03260504|Antiviral Agents|antiviral agents|mesh-ancestor
65462733|NCT03756298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462734|NCT03756298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462735|NCT03756220|Ascorbic Acid|ascorbic acid|mesh-list
65462736|NCT03756220|Thiamine|thiamine|mesh-list
65462737|NCT03756220|Vitamins|vitamins|mesh-ancestor
65462738|NCT03756220|Micronutrients|micronutrients|mesh-ancestor
65462739|NCT03756220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462740|NCT03756220|Antioxidants|antioxidants|mesh-ancestor
65462741|NCT03756220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462742|NCT03756220|Protective Agents|protective agents|mesh-ancestor
65462744|NCT04980040|Alogliptin|alogliptin|mesh-list
65462745|NCT04980040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65462746|NCT04980040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462747|NCT04980040|Incretins|incretins|mesh-ancestor
65462748|NCT04980040|Hormones|hormones|mesh-ancestor
65462749|NCT04980040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65462750|NCT04980040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65462751|NCT04980040|Protease Inhibitors|protease inhibitors|mesh-ancestor
65462752|NCT04980040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64847236|NCT05296317|Cyclophosphamide|cyclophosphamide|mesh-list
64705001|NCT00422396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705002|NCT00422396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64705003|NCT00364273|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64705004|NCT00364273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64705006|NCT00364273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64705007|NCT00364273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705008|NCT00364273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64705009|NCT00364273|Respiratory System Agents|respiratory system agents|mesh-ancestor
64705010|NCT00364273|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64705011|NCT00364273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64705012|NCT00364273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64705013|NCT00364273|Adrenergic Agents|adrenergic agents|mesh-ancestor
64705014|NCT00364273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64705015|NCT00364273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705016|NCT02495467|Nitroglycerin|nitroglycerin|mesh-list
64705017|NCT02495467|Vasodilator Agents|vasodilator agents|mesh-ancestor
64705018|NCT05249023|Butyric Acid|butyric acid|mesh-list
64705019|NCT05249023|Histamine Antagonists|histamine antagonists|mesh-ancestor
64718740|NCT04566770|Immunologic Factors|immunologic factors|mesh-ancestor
64718741|NCT04566770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705031|NCT02495779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705033|NCT02495779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64705034|NCT03241771|Naloxone|naloxone|mesh-list
64705035|NCT03241771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64705036|NCT03241771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705037|NCT03241771|Sensory System Agents|sensory system agents|mesh-ancestor
64705038|NCT03241771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64705039|NCT05216497|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
64705040|NCT05216497|Antiviral Agents|antiviral agents|mesh-ancestor
64705041|NCT05216497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64705042|NCT02502487|Ropivacaine|ropivacaine|mesh-list
64705043|NCT02502487|Tetracaine|tetracaine|mesh-list
64705044|NCT02502487|Anesthetics, Local|anesthetics, local|mesh-ancestor
64705045|NCT02502487|Anesthetics|anesthetics|mesh-ancestor
65462753|NCT04980040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462754|NCT04647916|Camptothecin|camptothecin|mesh-list
65462755|NCT04647916|Irinotecan|irinotecan|mesh-list
65462756|NCT04647916|Immunoconjugates|immunoconjugates|mesh-list
65462757|NCT04647916|Immunologic Factors|immunologic factors|mesh-ancestor
65462758|NCT04647916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462759|NCT04647916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65462760|NCT04647916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462761|NCT04647916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65462762|NCT04647916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65462763|NCT04647916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462764|NCT04647916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462765|NCT00131352|Hylan|hylan|mesh-list
65462766|NCT00131352|Viscosupplements|viscosupplements|mesh-ancestor
65462767|NCT00131352|Protective Agents|protective agents|mesh-ancestor
65462768|NCT00131352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462769|NCT00136916|Insulin|insulin|mesh-list
65462770|NCT00136916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65462771|NCT00136916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65462772|NCT00136916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462773|NCT04633564|Bevacizumab|bevacizumab|mesh-list
65462774|NCT04633564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65462775|NCT04633564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462776|NCT04633564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64847271|NCT05296005|Vitamins|vitamins|mesh-ancestor
64705046|NCT02502487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64705047|NCT02502487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705048|NCT02502487|Sensory System Agents|sensory system agents|mesh-ancestor
64705049|NCT02502487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64705050|NCT03238196|Fulvestrant|fulvestrant|mesh-list
64705051|NCT03238196|Palbociclib|palbociclib|mesh-list
64705052|NCT03238196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64705053|NCT03238196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64705054|NCT03238196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64705055|NCT03238196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64705056|NCT03238196|Hormone Antagonists|hormone antagonists|mesh-ancestor
64705057|NCT03238196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64705058|NCT03238196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705059|NCT03238196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64705060|NCT03238196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705061|NCT03238196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705062|NCT02632045|Fulvestrant|fulvestrant|mesh-list
64705063|NCT02632045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64705064|NCT02632045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64705070|NCT02503735|Sofosbuvir|sofosbuvir|mesh-list
64705071|NCT02503735|Ledipasvir|ledipasvir|mesh-list
64705072|NCT02503735|Antiviral Agents|antiviral agents|mesh-ancestor
64705073|NCT02503735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64705074|NCT04001881|Anesthetics|anesthetics|mesh-list
64705075|NCT04001881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65462777|NCT04633564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65462778|NCT04633564|Growth Substances|growth substances|mesh-ancestor
65462779|NCT04633564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462780|NCT04633564|Growth Inhibitors|growth inhibitors|mesh-ancestor
65462781|NCT03756064|Carboplatin|carboplatin|mesh-list
65462782|NCT03756064|Docetaxel|docetaxel|mesh-list
65462783|NCT03756064|Trastuzumab|trastuzumab|mesh-list
65462784|NCT03756064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462785|NCT03756064|Tubulin Modulators|tubulin modulators|mesh-ancestor
65462786|NCT03756064|Antimitotic Agents|antimitotic agents|mesh-ancestor
65462787|NCT03756064|Mitosis Modulators|mitosis modulators|mesh-ancestor
65462788|NCT03756064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462789|NCT03756064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65462790|NCT04607980|Ustekinumab|ustekinumab|mesh-list
65462791|NCT04607980|Dermatologic Agents|dermatologic agents|mesh-ancestor
65462792|NCT04953910|Decitabine|decitabine|mesh-list
65462793|NCT04953910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65462794|NCT04953910|Antimetabolites|antimetabolites|mesh-ancestor
65462795|NCT04953910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462796|NCT04953910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462797|NCT04953910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462798|NCT03764020|Melatonin|melatonin|mesh-list
65462799|NCT03764020|Antioxidants|antioxidants|mesh-ancestor
65462800|NCT03764020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462801|NCT03764020|Protective Agents|protective agents|mesh-ancestor
65462802|NCT03764020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462803|NCT03764020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65462822|NCT00130728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65462823|NCT00130728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65462824|NCT00130728|Growth Substances|growth substances|mesh-ancestor
65462825|NCT00130728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462826|NCT00130728|Growth Inhibitors|growth inhibitors|mesh-ancestor
65462827|NCT00130728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65462828|NCT00130728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462829|NCT00130728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462830|NCT00129974|Gemcitabine|gemcitabine|mesh-list
65462831|NCT00129974|Pemetrexed|pemetrexed|mesh-list
65462832|NCT00129974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65462833|NCT00129974|Antimetabolites|antimetabolites|mesh-ancestor
65462834|NCT00129974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462835|NCT00129974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462836|NCT00129974|Antiviral Agents|antiviral agents|mesh-ancestor
65462837|NCT00129974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65462838|NCT00129974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462839|NCT00129974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65462840|NCT00129974|Immunologic Factors|immunologic factors|mesh-ancestor
65462841|NCT00129974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462842|NCT00129974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65462843|NCT00129974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65462844|NCT03966326|Fentanyl|fentanyl|mesh-list
65462845|NCT03966326|Anesthetics|anesthetics|mesh-list
65462846|NCT03966326|Sevoflurane|sevoflurane|mesh-list
65462847|NCT03966326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65462870|NCT03758014|Alkylating Agents|alkylating agents|mesh-ancestor
65462871|NCT03758014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462872|NCT03758014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65462873|NCT00135356|Ritonavir|ritonavir|mesh-list
65462874|NCT00135356|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65462875|NCT00135356|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
65462876|NCT00135356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
65462877|NCT00135356|Protease Inhibitors|protease inhibitors|mesh-list
65462878|NCT00135356|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65462879|NCT00135356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65462880|NCT00135356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462881|NCT00135356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65462882|NCT00135356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65462883|NCT00135356|Antiviral Agents|antiviral agents|mesh-ancestor
65462884|NCT00135356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65462885|NCT00135356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65462886|NCT00135356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65462887|NCT00135356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65462888|NCT00118716|Fluticasone|fluticasone|mesh-list
65462889|NCT00118716|Xhance|xhance|mesh-list
65462890|NCT00118716|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65462891|NCT00118716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65462892|NCT00118716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65462893|NCT00118716|Autonomic Agents|autonomic agents|mesh-ancestor
65462894|NCT00118716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65462895|NCT00118716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462896|NCT00118716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64847376|NCT05264896|Mitosis Modulators|mitosis modulators|mesh-ancestor
64705076|NCT04001881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705077|NCT03019640|Cytarabine|cytarabine|mesh-list
64705078|NCT03019640|Rituximab|rituximab|mesh-list
64705079|NCT03019640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64705080|NCT03019640|Etoposide|etoposide|mesh-list
64718745|NCT04342663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64718746|NCT04342663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718747|NCT04342663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64718748|NCT04342663|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64718749|NCT04342663|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64718750|NCT04342663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64718751|NCT04342663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718752|NCT04342663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64718753|NCT04342663|Serotonin Agents|serotonin agents|mesh-ancestor
64718754|NCT04342663|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64718755|NCT04342663|Antidepressive Agents|antidepressive agents|mesh-ancestor
65462897|NCT00118716|Respiratory System Agents|respiratory system agents|mesh-ancestor
65462898|NCT00118716|Dermatologic Agents|dermatologic agents|mesh-ancestor
65462899|NCT00118716|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65462900|NCT00118716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65462901|NCT00118716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65462902|NCT00118716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65462903|NCT00118716|Adrenergic Agents|adrenergic agents|mesh-ancestor
65462904|NCT00118716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65462905|NCT00118716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462907|NCT04907032|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65462908|NCT04907032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65462909|NCT04907032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65462910|NCT04907032|Adrenergic Agents|adrenergic agents|mesh-ancestor
65462911|NCT04907032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65462912|NCT04907032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462913|NCT04907032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462914|NCT04907032|Urological Agents|urological agents|mesh-ancestor
65462915|NCT00118482|Fludrocortisone|fludrocortisone|mesh-list
65462916|NCT00118482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65462917|NCT03966950|Melatonin|melatonin|mesh-list
65462918|NCT03966950|Antioxidants|antioxidants|mesh-ancestor
65462919|NCT03966950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462920|NCT03966950|Protective Agents|protective agents|mesh-ancestor
65462921|NCT03966950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462922|NCT03966950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65462923|NCT03755752|Diminazene aceturate|diminazene aceturate|mesh-list
65462924|NCT03755752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65462925|NCT03755752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65462926|NCT03755752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65462927|NCT03755752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65462928|NCT01076582|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65462938|NCT01076582|Hormones|hormones|mesh-ancestor
65462939|NCT01076582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65462940|NCT01076582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65462941|NCT01076582|Progestins|progestins|mesh-ancestor
65462942|NCT01081938|Insulin|insulin|mesh-list
65462943|NCT01081938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65462944|NCT01081938|Insulin Glargine|insulin glargine|mesh-list
65462945|NCT01081938|Insulin glulisine|insulin glulisine|mesh-list
65462946|NCT01081938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65462947|NCT01081938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462948|NCT01082796|Glipizide|glipizide|mesh-list
65462949|NCT01082796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65462950|NCT01082796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462951|NCT03763786|Cetrorelix|cetrorelix|mesh-list
65462952|NCT03763786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65462953|NCT03763786|Fertility Agents|fertility agents|mesh-ancestor
65462954|NCT03763786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65462955|NCT03763786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462956|NCT03763786|Hormone Antagonists|hormone antagonists|mesh-ancestor
65462957|NCT03763786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65462958|NCT01079364|Insulin|insulin|mesh-list
65462959|NCT01079364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65462960|NCT01079364|Insulin Glargine|insulin glargine|mesh-list
65462961|NCT01079364|Insulin Aspart|insulin aspart|mesh-list
65462962|NCT01079364|Insulin glulisine|insulin glulisine|mesh-list
65462963|NCT01079364|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65462964|NCT01079364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65212459|NCT05517668|Antiviral Agents|antiviral agents|mesh-ancestor
65462965|NCT01079364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462966|NCT01077752|Acetaminophen|acetaminophen|mesh-list
65462967|NCT01077752|Lidocaine|lidocaine|mesh-list
64718756|NCT04342663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64718757|NCT04342663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64705091|NCT03019640|Lenograstim|lenograstim|mesh-list
64705092|NCT03019640|Immunologic Factors|immunologic factors|mesh-ancestor
64705093|NCT03019640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705094|NCT03019640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64705095|NCT03019640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64945586|NCT05427786|Vitamin B Complex|vitamin b complex|mesh-ancestor
64705096|NCT03019640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64705097|NCT03019640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64705098|NCT03019640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64705099|NCT03019640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705100|NCT03019640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705101|NCT03019640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64705102|NCT03019640|Antimetabolites|antimetabolites|mesh-ancestor
64705103|NCT03019640|Antiviral Agents|antiviral agents|mesh-ancestor
65462968|NCT01077752|Morphine|morphine|mesh-list
65462969|NCT01077752|Ropivacaine|ropivacaine|mesh-list
65462970|NCT01077752|Anesthetics, Local|anesthetics, local|mesh-ancestor
65462971|NCT01077752|Anesthetics|anesthetics|mesh-ancestor
65462972|NCT01077752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65462973|NCT01077752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65462974|NCT01077752|Sensory System Agents|sensory system agents|mesh-ancestor
65462975|NCT01077752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65462976|NCT01077752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65462977|NCT01077752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65462978|NCT01077752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65462979|NCT01077752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65462980|NCT01077752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65462981|NCT01077752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65462982|NCT01077752|Narcotics|narcotics|mesh-ancestor
65462983|NCT01077752|Analgesics|analgesics|mesh-ancestor
65462984|NCT01077752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65462985|NCT01077752|Antipyretics|antipyretics|mesh-ancestor
65462986|NCT00129272|Bupropion|bupropion|mesh-list
65462987|NCT00129272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65462988|NCT00129272|Antidepressive Agents|antidepressive agents|mesh-ancestor
65462989|NCT00129272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65462990|NCT00129272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65462991|NCT00129272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65462992|NCT00129272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65462993|NCT00129272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463014|NCT03963648|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65463015|NCT03963648|Vasodilator Agents|vasodilator agents|mesh-ancestor
65463016|NCT03963648|Gasotransmitters|gasotransmitters|mesh-ancestor
65463017|NCT03963648|Protective Agents|protective agents|mesh-ancestor
65463018|NCT04899232|Antithrombins|antithrombins|mesh-list
65463019|NCT04899232|Antithrombin III|antithrombin iii|mesh-list
65463020|NCT04899232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65463021|NCT04899232|Protease Inhibitors|protease inhibitors|mesh-ancestor
65463022|NCT04899232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463023|NCT04899232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463024|NCT04899232|Anticoagulants|anticoagulants|mesh-ancestor
65463025|NCT00096174|Cisplatin|cisplatin|mesh-list
65463026|NCT00096174|Cetuximab|cetuximab|mesh-list
65463027|NCT00096174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463028|NCT00096174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65463029|NCT03757858|Antibodies|antibodies|mesh-list
65463030|NCT03757858|Immunologic Factors|immunologic factors|mesh-ancestor
65463031|NCT03757858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463032|NCT01079676|Lenograstim|lenograstim|mesh-list
65463033|NCT01079676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65463034|NCT01079676|Immunologic Factors|immunologic factors|mesh-ancestor
65463035|NCT01079676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463036|NCT01082250|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65463037|NCT01082250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65463038|NCT01082250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65212536|NCT05459571|Dexamethasone|dexamethasone|mesh-list
65463039|NCT01082250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65463040|NCT01082250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463042|NCT01082250|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65463043|NCT01082250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65463044|NCT01082250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65463045|NCT01082250|Adrenergic Agents|adrenergic agents|mesh-ancestor
65463046|NCT01082250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65463047|NCT01082250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463048|NCT01082250|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65463049|NCT01082250|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64705104|NCT03019640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64705105|NCT03019640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65463050|NCT01082250|Serotonin Agents|serotonin agents|mesh-ancestor
65463051|NCT01082250|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65463052|NCT01082250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65463053|NCT01082250|Dopamine Agents|dopamine agents|mesh-ancestor
65463054|NCT00133952|Ruboxistaurin|ruboxistaurin|mesh-list
65463055|NCT00133952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463056|NCT00133952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463057|NCT03965208|Heparin|heparin|mesh-list
65463058|NCT03965208|Calcium heparin|calcium heparin|mesh-list
65463059|NCT03965208|Bivalirudin|bivalirudin|mesh-list
65463060|NCT03965208|Anticoagulants|anticoagulants|mesh-ancestor
65463061|NCT03965208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65463062|NCT03965208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65463063|NCT03965208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463064|NCT03965208|Antithrombins|antithrombins|mesh-ancestor
65463065|NCT03965208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65463066|NCT03965208|Protease Inhibitors|protease inhibitors|mesh-ancestor
65463067|NCT03965208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463068|NCT04555096|Avasopasem manganese|avasopasem manganese|mesh-list
65463069|NCT04555096|Antioxidants|antioxidants|mesh-ancestor
65463070|NCT04555096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463071|NCT04555096|Protective Agents|protective agents|mesh-ancestor
65463072|NCT04555096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463073|NCT00097500|Metformin|metformin|mesh-list
65463074|NCT00097500|Insulin Glargine|insulin glargine|mesh-list
65463075|NCT00097500|Exenatide|exenatide|mesh-list
65463076|NCT00097500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65463077|NCT00097500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463078|NCT00097500|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65463079|NCT00097500|Incretins|incretins|mesh-ancestor
65463080|NCT00097500|Hormones|hormones|mesh-ancestor
65463081|NCT00097500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65463082|NCT01082484|Treprostinil|treprostinil|mesh-list
65463083|NCT01082484|Iloprost|iloprost|mesh-list
65463084|NCT01082484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65463085|NCT01082484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65463086|NCT01082484|Vasodilator Agents|vasodilator agents|mesh-ancestor
64705106|NCT03019640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64705107|NCT03019640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64705108|NCT03019640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65463087|NCT05459974|Colchicine|colchicine|mesh-list
65463088|NCT05459974|Gout Suppressants|gout suppressants|mesh-ancestor
65463089|NCT05459974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65463090|NCT05459974|Tubulin Modulators|tubulin modulators|mesh-ancestor
65463091|NCT05459974|Antimitotic Agents|antimitotic agents|mesh-ancestor
65463092|NCT05459974|Mitosis Modulators|mitosis modulators|mesh-ancestor
65463093|NCT05459974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463094|NCT05459974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463095|NCT03754816|Anesthetics|anesthetics|mesh-list
65463096|NCT03754816|Levobupivacaine|levobupivacaine|mesh-list
65463097|NCT03754816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65463098|NCT03754816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463099|NCT03754816|Anesthetics, Local|anesthetics, local|mesh-ancestor
65463100|NCT03754816|Sensory System Agents|sensory system agents|mesh-ancestor
65463101|NCT03754816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65463102|NCT04542694|Favipiravir|favipiravir|mesh-list
65463103|NCT04542694|Antiviral Agents|antiviral agents|mesh-ancestor
65463104|NCT04542694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65463105|NCT01083264|Gestodene|gestodene|mesh-list
65463106|NCT01083264|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64847597|NCT05033743|Secnidazole|secnidazole|mesh-list
64705109|NCT03019640|Growth Substances|growth substances|mesh-ancestor
64705110|NCT03019640|Growth Inhibitors|growth inhibitors|mesh-ancestor
64705111|NCT03019640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64705112|NCT03019640|Alkylating Agents|alkylating agents|mesh-ancestor
64705113|NCT03019640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64705114|NCT03019640|Keratolytic Agents|keratolytic agents|mesh-ancestor
64705115|NCT03019640|Dermatologic Agents|dermatologic agents|mesh-ancestor
64705116|NCT03019640|Tubulin Modulators|tubulin modulators|mesh-ancestor
64705117|NCT03019640|Antimitotic Agents|antimitotic agents|mesh-ancestor
64705118|NCT03019640|Mitosis Modulators|mitosis modulators|mesh-ancestor
64705119|NCT02136901|Hyaluronic Acid|hyaluronic acid|mesh-list
64705120|NCT02136901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64705121|NCT02136901|Immunologic Factors|immunologic factors|mesh-ancestor
64705122|NCT02136901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705123|NCT02136901|Viscosupplements|viscosupplements|mesh-ancestor
64705124|NCT02136901|Protective Agents|protective agents|mesh-ancestor
64705125|NCT02507011|Carvedilol|carvedilol|mesh-list
64705126|NCT02507011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64705127|NCT02507011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64705128|NCT02507011|Adrenergic Agents|adrenergic agents|mesh-ancestor
64705129|NCT02507011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64705130|NCT02507011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705131|NCT02507011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705142|NCT02977286|Naloxegol|naloxegol|mesh-list
64705143|NCT02977286|Bisacodyl|bisacodyl|mesh-list
64705145|NCT02977286|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
64705146|NCT02977286|Cathartics|cathartics|mesh-ancestor
64705147|NCT02977286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64705148|NCT02977286|Laxatives|laxatives|mesh-ancestor
64705149|NCT02977286|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64705150|NCT02977286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705151|NCT02977286|Sensory System Agents|sensory system agents|mesh-ancestor
64705152|NCT02977286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64705153|NCT02977286|Antidiarrheals|antidiarrheals|mesh-ancestor
64705154|NCT05345210|Amoxicillin|amoxicillin|mesh-list
64705155|NCT05345210|Clarithromycin|clarithromycin|mesh-list
65463107|NCT01083264|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65463108|NCT01083264|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65463109|NCT01083264|Contraceptive Agents|contraceptive agents|mesh-ancestor
65463110|NCT01083264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65463111|NCT01083264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463112|NCT01083264|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65463113|NCT01083264|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65463114|NCT01083264|Progestins|progestins|mesh-ancestor
65463115|NCT01083264|Hormones|hormones|mesh-ancestor
65463116|NCT01083264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65463117|NCT00129116|Vaccines|vaccines|mesh-list
65463118|NCT00129116|Immunologic Factors|immunologic factors|mesh-ancestor
65463119|NCT00129116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463120|NCT00117156|Rituximab|rituximab|mesh-list
65463121|NCT00117156|Fludarabine|fludarabine|mesh-list
65463122|NCT00117156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65463123|NCT00117156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463124|NCT00117156|Immunologic Factors|immunologic factors|mesh-ancestor
65463125|NCT00117156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463126|NCT00117156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65463127|NCT01083420|Minocycline|minocycline|mesh-list
65463128|NCT01083420|Dexamethasone|dexamethasone|mesh-list
65463129|NCT01083420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65463130|NCT01083420|Antiemetics|antiemetics|mesh-ancestor
65463131|NCT01083420|Autonomic Agents|autonomic agents|mesh-ancestor
65463132|NCT01083420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65463133|NCT01083420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463134|NCT01083420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65463135|NCT01083420|Glucocorticoids|glucocorticoids|mesh-ancestor
65463136|NCT01083420|Hormones|hormones|mesh-ancestor
65463137|NCT01083420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65463138|NCT01083420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65463139|NCT01083420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847620|NCT05013567|Analgesics|analgesics|mesh-ancestor
64705156|NCT05345210|Tetracycline|tetracycline|mesh-list
64705157|NCT05345210|Furazolidone|furazolidone|mesh-list
64705158|NCT05345210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64705159|NCT05345210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64705160|NCT05345210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64705161|NCT05345210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705162|NCT05345210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463140|NCT01083420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65463141|NCT01083420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65463142|NCT00096954|Omalizumab|omalizumab|mesh-list
65463143|NCT00096954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65463144|NCT00096954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65463145|NCT00096954|Respiratory System Agents|respiratory system agents|mesh-ancestor
65463146|NCT00096486|Everolimus|everolimus|mesh-list
65463147|NCT00096486|Gefitinib|gefitinib|mesh-list
65463148|NCT00096486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463149|NCT00096486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65463150|NCT00096486|Immunologic Factors|immunologic factors|mesh-ancestor
65463151|NCT00096486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463152|NCT00096486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65463153|NCT00096486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463154|NCT00096486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463155|NCT00116844|Valacyclovir|valacyclovir|mesh-list
65463156|NCT00116844|Antiviral Agents|antiviral agents|mesh-ancestor
64705163|NCT05345210|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64705164|NCT05345210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64705165|NCT05345210|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64705166|NCT05345210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64705167|NCT05345210|Renal Agents|renal agents|mesh-ancestor
64705168|NCT05345210|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64705169|NCT05345210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64705170|NCT05345210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64705171|NCT05345210|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64705172|NCT02976896|Apatinib|apatinib|mesh-list
64705173|NCT02976896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64705174|NCT02976896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64705175|NCT02976896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705176|NCT02976896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705177|NCT01810705|Asparaginase|asparaginase|mesh-list
64705178|NCT01810705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64705179|NCT02508103|Oxytocin|oxytocin|mesh-list
64705180|NCT02508103|Oxytocics|oxytocics|mesh-ancestor
64705181|NCT02508103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64705182|NCT02508103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705183|NCT02508259|Suramin|suramin|mesh-list
64705184|NCT02508259|Antinematodal Agents|antinematodal agents|mesh-ancestor
64705185|NCT02508259|Anthelmintics|anthelmintics|mesh-ancestor
64705186|NCT02508259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64705187|NCT02508259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64705188|NCT02508259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64705189|NCT02508259|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64705190|NCT02508259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64705191|NCT02848820|Amoxicillin|amoxicillin|mesh-list
64705192|NCT02848820|Gentamicins|gentamicins|mesh-list
64705193|NCT02848820|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64705194|NCT02848820|Clavulanic Acids|clavulanic acids|mesh-list
64705195|NCT02848820|Clavulanic Acid|clavulanic acid|mesh-list
64705196|NCT02848820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64705197|NCT02848820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64336038|NCT02300935|Trametinib|trametinib|mesh-list
64705207|NCT00534469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64705208|NCT00534469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718762|NCT00589550|Interferon alpha-2|interferon alpha-2|mesh-list
64718763|NCT00589550|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64718764|NCT00589550|Sorafenib|sorafenib|mesh-list
64718765|NCT00589550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64705209|NCT00534469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65463157|NCT00116844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65463158|NCT03963336|Acetazolamide|acetazolamide|mesh-list
65463159|NCT03963336|Anticonvulsants|anticonvulsants|mesh-ancestor
65463160|NCT03963336|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65463161|NCT03963336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463162|NCT03963336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463163|NCT03963336|Diuretics|diuretics|mesh-ancestor
65463164|NCT03963336|Natriuretic Agents|natriuretic agents|mesh-ancestor
65463165|NCT03963336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463166|NCT00132314|Risperidone|risperidone|mesh-list
65463167|NCT00132314|Antipsychotic Agents|antipsychotic agents|mesh-list
64616149|NCT05593627|Calcium|calcium|mesh-list
64705212|NCT00534469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705213|NCT00534469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64705215|NCT00534469|Antiviral Agents|antiviral agents|mesh-ancestor
64705216|NCT00534469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64705217|NCT00534469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64705218|NCT00534469|Immunologic Factors|immunologic factors|mesh-ancestor
64705219|NCT00534469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705220|NCT00534469|Alkylating Agents|alkylating agents|mesh-ancestor
64705221|NCT00534469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64705222|NCT00534469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64705223|NCT00534469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64705224|NCT00534469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64705225|NCT00534469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64705226|NCT02240628|Lidocaine|lidocaine|mesh-list
64705227|NCT02240628|Tetracaine|tetracaine|mesh-list
64705228|NCT02240628|Anesthetics, Local|anesthetics, local|mesh-ancestor
64705229|NCT02240628|Anesthetics|anesthetics|mesh-ancestor
64705230|NCT02240628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64705231|NCT02240628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705232|NCT02240628|Sensory System Agents|sensory system agents|mesh-ancestor
64705233|NCT02240628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64705234|NCT02240628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64705235|NCT02240628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64705236|NCT02240628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64705237|NCT02240628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64705238|NCT02240628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705239|NCT02589067|Chlorhexidine|chlorhexidine|mesh-list
64705240|NCT02589067|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64705241|NCT02589067|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64705242|NCT02589067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64705243|NCT02589067|Disinfectants|disinfectants|mesh-ancestor
64705244|NCT02589067|Dermatologic Agents|dermatologic agents|mesh-ancestor
64705245|NCT02511379|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64705246|NCT02511379|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64705247|NCT02207400|Listerine|listerine|mesh-list
64705248|NCT02207400|Fluorides|fluorides|mesh-list
64705249|NCT02207400|Sodium Fluoride|sodium fluoride|mesh-list
64705250|NCT02207400|Cariostatic Agents|cariostatic agents|mesh-ancestor
64705251|NCT02207400|Protective Agents|protective agents|mesh-ancestor
64705252|NCT02207400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705253|NCT02207400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64705254|NCT02207400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64705255|NCT02511535|Vaccines|vaccines|mesh-list
64705256|NCT02511535|Immunologic Factors|immunologic factors|mesh-ancestor
64705257|NCT02511535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705258|NCT03545035|Rituximab|rituximab|mesh-list
64705259|NCT03545035|Idelalisib|idelalisib|mesh-list
64705260|NCT03545035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64705261|NCT03545035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64705262|NCT03545035|Immunologic Factors|immunologic factors|mesh-ancestor
64705263|NCT03545035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705272|NCT02592421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65463168|NCT00132314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65463169|NCT00132314|Serotonin Agents|serotonin agents|mesh-ancestor
65463170|NCT00132314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65463171|NCT00132314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463172|NCT00132314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463173|NCT00132314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65463174|NCT00132314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65463175|NCT00132314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65463176|NCT00132314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65463177|NCT00132314|Dopamine Agents|dopamine agents|mesh-ancestor
65463178|NCT04539262|Remdesivir|remdesivir|mesh-list
65463179|NCT04539262|Antimetabolites|antimetabolites|mesh-ancestor
65463180|NCT04539262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463181|NCT04539262|Antiviral Agents|antiviral agents|mesh-ancestor
65463182|NCT04539262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65463183|NCT04537234|Vaccines|vaccines|mesh-list
65463184|NCT04537234|Immunologic Factors|immunologic factors|mesh-ancestor
65463185|NCT04537234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463186|NCT04537078|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65463187|NCT04537078|Contraceptive Agents|contraceptive agents|mesh-list
65463188|NCT04537078|Contraceptives, Oral|contraceptives, oral|mesh-list
65463189|NCT04537078|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65463190|NCT04537078|Cetrorelix|cetrorelix|mesh-list
65463191|NCT04537078|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65212687|NCT05248321|Hemostatics|hemostatics|mesh-ancestor
64847678|NCT04921527|Paclitaxel|paclitaxel|mesh-list
64705273|NCT02592421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705274|NCT02592421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64705275|NCT02592421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705276|NCT02512783|Lidocaine|lidocaine|mesh-list
64705277|NCT02512783|Propofol|propofol|mesh-list
64705278|NCT02512783|Anesthetics, Local|anesthetics, local|mesh-ancestor
64718766|NCT00589550|Antiviral Agents|antiviral agents|mesh-ancestor
64718767|NCT00589550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64718768|NCT00589550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64718769|NCT00589550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718770|NCT00589550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718771|NCT00589550|Immunologic Factors|immunologic factors|mesh-ancestor
64718772|NCT00589550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718773|NCT01636466|Everolimus|everolimus|mesh-list
64326905|NCT02171741|Docetaxel|docetaxel|mesh-list
64705279|NCT02512783|Anesthetics|anesthetics|mesh-ancestor
64705280|NCT02512783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64705281|NCT02512783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705282|NCT02512783|Sensory System Agents|sensory system agents|mesh-ancestor
64705288|NCT02512783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705289|NCT02512783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64705290|NCT02512783|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64705291|NCT02512783|Anesthetics, General|anesthetics, general|mesh-ancestor
64430545|NCT02100657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705292|NCT02513095|Dantrolene|dantrolene|mesh-list
65463192|NCT04537078|Progesterone|progesterone|mesh-list
65463193|NCT04537078|Dydrogesterone|dydrogesterone|mesh-list
65463194|NCT04537078|Estradiol|estradiol|mesh-list
65463195|NCT04537078|Progestins|progestins|mesh-ancestor
65463196|NCT04537078|Hormones|hormones|mesh-ancestor
65463197|NCT04537078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65463198|NCT04537078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463199|NCT04537078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65463200|NCT04537078|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65463201|NCT04537078|Luteolytic Agents|luteolytic agents|mesh-ancestor
65463202|NCT04537078|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65463203|NCT04537078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64705293|NCT02513095|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64705294|NCT02513095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705295|NCT02513095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64705296|NCT02513095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64705297|NCT02513719|Everolimus|everolimus|mesh-list
64705298|NCT02513719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64705299|NCT02513719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64705300|NCT02513719|Immunologic Factors|immunologic factors|mesh-ancestor
64705301|NCT02513719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705302|NCT00363727|Ropinirole|ropinirole|mesh-list
64705303|NCT00363727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64705304|NCT00363727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64705305|NCT00363727|Dopamine Agonists|dopamine agonists|mesh-ancestor
64705306|NCT00363727|Dopamine Agents|dopamine agents|mesh-ancestor
64705307|NCT00363727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64705308|NCT00363727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705309|NCT00363727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705310|NCT05673811|Gemcitabine|gemcitabine|mesh-list
64705311|NCT05673811|Paclitaxel|paclitaxel|mesh-list
64705312|NCT05673811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64705313|NCT05673811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64705314|NCT05673811|Tubulin Modulators|tubulin modulators|mesh-ancestor
64705315|NCT05673811|Antimitotic Agents|antimitotic agents|mesh-ancestor
64705316|NCT05673811|Mitosis Modulators|mitosis modulators|mesh-ancestor
64705317|NCT05673811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705318|NCT05673811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64705319|NCT05673811|Antimetabolites|antimetabolites|mesh-ancestor
64705320|NCT05673811|Antiviral Agents|antiviral agents|mesh-ancestor
64705321|NCT05673811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64705322|NCT05673811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705323|NCT05673811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64945587|NCT05427786|Vitamins|vitamins|mesh-ancestor
64705324|NCT05673811|Immunologic Factors|immunologic factors|mesh-ancestor
64705333|NCT04340869|Vasodilator Agents|vasodilator agents|mesh-ancestor
64705334|NCT00366067|Phenytoin|phenytoin|mesh-list
64705335|NCT00366067|Anticonvulsants|anticonvulsants|mesh-ancestor
64705336|NCT00366067|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64705337|NCT00366067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64705338|NCT00366067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64718774|NCT01636466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718775|NCT01636466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64718776|NCT01636466|Immunologic Factors|immunologic factors|mesh-ancestor
64718777|NCT01636466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718778|NCT00568802|Hydroxyurea|hydroxyurea|mesh-list
64718779|NCT00568802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326914|NCT00835705|Amoxicillin|amoxicillin|mesh-list
64705339|NCT00366067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705340|NCT00366067|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64705341|NCT00366067|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64705342|NCT00364429|Lorazepam|lorazepam|mesh-list
64705343|NCT00364429|Risperidone|risperidone|mesh-list
64705344|NCT00364429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65463204|NCT04537078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463205|NCT04537078|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65463206|NCT04537078|Fertility Agents|fertility agents|mesh-ancestor
65463207|NCT04537078|Hormone Antagonists|hormone antagonists|mesh-ancestor
65463208|NCT04537078|Estrogens|estrogens|mesh-ancestor
65463209|NCT04532164|Antifungal Agents|antifungal agents|mesh-list
65463210|NCT04532164|Clotrimazole|clotrimazole|mesh-list
65463211|NCT04532164|Miconazole|miconazole|mesh-list
65463212|NCT04532164|Butenafine|butenafine|mesh-list
65463213|NCT04532164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65463214|NCT04532164|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64705345|NCT00364429|Serotonin Agents|serotonin agents|mesh-ancestor
64705346|NCT00364429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64705347|NCT00364429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705348|NCT00364429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705349|NCT00364429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64705352|NCT00364429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64705353|NCT00364429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64705354|NCT00364429|Dopamine Agents|dopamine agents|mesh-ancestor
64705355|NCT00364429|Anticonvulsants|anticonvulsants|mesh-ancestor
64705356|NCT00364429|Antiemetics|antiemetics|mesh-ancestor
64705357|NCT00364429|Autonomic Agents|autonomic agents|mesh-ancestor
64705358|NCT00364429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64705359|NCT00364429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64705360|NCT00364429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64705361|NCT00364429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64705362|NCT00364429|GABA Modulators|gaba modulators|mesh-ancestor
64705363|NCT00364429|GABA Agents|gaba agents|mesh-ancestor
64705364|NCT02593903|Trimethoprim|trimethoprim|mesh-list
64705365|NCT02593903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64705366|NCT02593903|Sulfamethoxazole|sulfamethoxazole|mesh-list
64705367|NCT02593903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64705368|NCT02593903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64705369|NCT02593903|Renal Agents|renal agents|mesh-ancestor
64705370|NCT02593903|Antimalarials|antimalarials|mesh-ancestor
64705372|NCT02593903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64705373|NCT02593903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64705374|NCT02593903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705375|NCT02593903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705376|NCT02593903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64705377|NCT02593903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64705378|NCT02593903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64705379|NCT02593903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64705380|NCT02596867|Propranolol|propranolol|mesh-list
64705381|NCT02596867|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64705382|NCT02596867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64705383|NCT02596867|Adrenergic Agents|adrenergic agents|mesh-ancestor
64705384|NCT02596867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64705385|NCT02596867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705386|NCT02596867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705387|NCT02596867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64705396|NCT02597101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64705397|NCT02597101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64705398|NCT02597101|Protease Inhibitors|protease inhibitors|mesh-ancestor
64705399|NCT02597101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705400|NCT02597101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705401|NCT02600611|Vancomycin|vancomycin|mesh-list
64705402|NCT02600611|Iclaprim|iclaprim|mesh-list
64705403|NCT02600611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64718780|NCT00568802|Antisickling Agents|antisickling agents|mesh-ancestor
64705404|NCT02600611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64705405|NCT02600611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64705406|NCT02600611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705407|NCT02600611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705408|NCT02600767|Lumefantrine|lumefantrine|mesh-list
64705409|NCT02600767|Artemether|artemether|mesh-list
65463215|NCT04532164|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65463216|NCT04532164|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65463217|NCT04532164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463218|NCT04532164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463219|NCT04532164|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65463220|NCT04532164|Hormone Antagonists|hormone antagonists|mesh-ancestor
65463221|NCT04532164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65463222|NCT04532164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463223|NCT04532164|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65463224|NCT04532164|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65463225|NCT04531540|Butenafine|butenafine|mesh-list
65463226|NCT04531540|Antifungal Agents|antifungal agents|mesh-ancestor
65463227|NCT04531540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64705410|NCT02600767|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64705411|NCT02600767|Antimalarials|antimalarials|mesh-ancestor
64705412|NCT02600767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64705413|NCT02600767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64705414|NCT02600767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64705415|NCT00365287|Cyclosporine|cyclosporine|mesh-list
64705416|NCT00365287|Mycophenolic Acid|mycophenolic acid|mesh-list
64705417|NCT00365287|Cyclophosphamide|cyclophosphamide|mesh-list
64705418|NCT00365287|Fludarabine|fludarabine|mesh-list
64705419|NCT00365287|Fludarabine phosphate|fludarabine phosphate|mesh-list
64705420|NCT00365287|Cyclosporins|cyclosporins|mesh-list
64705421|NCT00365287|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64705422|NCT00365287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64705423|NCT00365287|Immunologic Factors|immunologic factors|mesh-ancestor
64705424|NCT00365287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705425|NCT00365287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64705427|NCT00365287|Alkylating Agents|alkylating agents|mesh-ancestor
64705428|NCT00365287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705429|NCT00365287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64705430|NCT00365287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64705431|NCT00365287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64705432|NCT00365287|Antimetabolites|antimetabolites|mesh-ancestor
64705433|NCT00365287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705434|NCT00365287|Antifungal Agents|antifungal agents|mesh-ancestor
64705435|NCT00365287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64705436|NCT00365287|Dermatologic Agents|dermatologic agents|mesh-ancestor
64705437|NCT00365287|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64705438|NCT00365287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64705439|NCT00365287|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64705440|NCT00365287|Antitubercular Agents|antitubercular agents|mesh-ancestor
64705441|NCT00365287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64705442|NCT04743193|Sevoflurane|sevoflurane|mesh-list
64705443|NCT04743193|Anesthetics|anesthetics|mesh-ancestor
64705444|NCT04743193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64705445|NCT04743193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705446|NCT04743193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64705447|NCT04743193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64705448|NCT04743193|Anesthetics, General|anesthetics, general|mesh-ancestor
64705449|NCT05572645|Trastuzumab|trastuzumab|mesh-list
64705450|NCT05572645|Pertuzumab|pertuzumab|mesh-list
64705451|NCT05572645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64705452|NCT05572645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64705453|NCT02608177|Linagliptin|linagliptin|mesh-list
64705454|NCT02608177|Glipizide|glipizide|mesh-list
64705455|NCT02608177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64705456|NCT02608177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705457|NCT02608177|Incretins|incretins|mesh-ancestor
64705458|NCT02608177|Hormones|hormones|mesh-ancestor
65463228|NCT04799782|Mirtazapine|mirtazapine|mesh-list
65463229|NCT04799782|Antidepressive Agents|antidepressive agents|mesh-ancestor
65463230|NCT04799782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65463231|NCT04799782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65463232|NCT04799782|Histamine Antagonists|histamine antagonists|mesh-ancestor
65463233|NCT04799782|Histamine Agents|histamine agents|mesh-ancestor
65463234|NCT04799782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65463235|NCT04799782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463236|NCT04799782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463237|NCT04799782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65463238|NCT04799782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65463239|NCT04799782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65463240|NCT04799782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65463241|NCT04799782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65463242|NCT04799782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65463243|NCT04799782|Adrenergic Agents|adrenergic agents|mesh-ancestor
65463244|NCT04799782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65463245|NCT04799782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64705466|NCT02608489|Immunologic Factors|immunologic factors|mesh-ancestor
64705467|NCT02608489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705469|NCT02608489|Protective Agents|protective agents|mesh-ancestor
64705470|NCT02611765|Penicillins|penicillins|mesh-list
64705471|NCT02611765|Penicillin G|penicillin g|mesh-list
64705472|NCT02611765|Penicillin G Benzathine|penicillin g benzathine|mesh-list
64705473|NCT02611765|Penicillin G Procaine|penicillin g procaine|mesh-list
64705474|NCT02611765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64705475|NCT02611765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64705477|NCT05552287|Dermatologic Agents|dermatologic agents|mesh-ancestor
64705478|NCT05552287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64705479|NCT05552287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64718781|NCT00568802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718782|NCT00568802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718783|NCT00568802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64718784|NCT04499924|Paclitaxel|paclitaxel|mesh-list
64718785|NCT04499924|Trastuzumab|trastuzumab|mesh-list
64718786|NCT04499924|Ramucirumab|ramucirumab|mesh-list
64718787|NCT04499924|Tucatinib|tucatinib|mesh-list
64718788|NCT04499924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64718789|NCT04499924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718790|NCT04499924|Tubulin Modulators|tubulin modulators|mesh-ancestor
64718791|NCT04499924|Antimitotic Agents|antimitotic agents|mesh-ancestor
64718792|NCT04499924|Mitosis Modulators|mitosis modulators|mesh-ancestor
64326924|NCT02938520|Cabotegravir|cabotegravir|mesh-list
64705480|NCT02616523|Lidocaine|lidocaine|mesh-list
64705481|NCT02616523|Fentanyl|fentanyl|mesh-list
64705482|NCT02616523|Dexmedetomidine|dexmedetomidine|mesh-list
64705483|NCT02616523|Anesthetics, Local|anesthetics, local|mesh-ancestor
64705484|NCT02616523|Anesthetics|anesthetics|mesh-ancestor
64705485|NCT02616523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64705486|NCT02616523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705487|NCT02616523|Sensory System Agents|sensory system agents|mesh-ancestor
64705488|NCT02616523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64705489|NCT02616523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64705490|NCT02616523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64705491|NCT02616523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64705492|NCT02616523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65463246|NCT04799782|Serotonin Agents|serotonin agents|mesh-ancestor
65463247|NCT04799782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65463248|NCT04790812|Acetaminophen|acetaminophen|mesh-list
65463249|NCT04790812|Celecoxib|celecoxib|mesh-list
65463250|NCT04790812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65463251|NCT04790812|Analgesics|analgesics|mesh-ancestor
65463252|NCT04790812|Sensory System Agents|sensory system agents|mesh-ancestor
65463253|NCT04790812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65463254|NCT04790812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463255|NCT04790812|Antipyretics|antipyretics|mesh-ancestor
65463256|NCT04790812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65463257|NCT04790812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65463258|NCT04790812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65463259|NCT04790812|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65463260|NCT04790812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65463261|NCT04790812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463262|NCT04790812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463263|NCT03697252|Xanomeline|xanomeline|mesh-list
65463264|NCT03697252|Trospium chloride|trospium chloride|mesh-list
65463265|NCT03697252|Parasympatholytics|parasympatholytics|mesh-ancestor
65463266|NCT03697252|Autonomic Agents|autonomic agents|mesh-ancestor
65463267|NCT03697252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64705493|NCT02616523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705494|NCT02616523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64705495|NCT02616523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64705496|NCT02616523|Analgesics|analgesics|mesh-ancestor
64705497|NCT02616523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64705498|NCT02616523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64705499|NCT02616523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64705500|NCT02616523|Adrenergic Agents|adrenergic agents|mesh-ancestor
64705509|NCT05732155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705510|NCT05732155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64705511|NCT05732155|Serotonin Agents|serotonin agents|mesh-ancestor
64705512|NCT05732155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64705513|NCT05732155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705514|NCT05732155|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64705515|NCT05732155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64705516|NCT05732155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64705517|NCT05732155|Adrenergic Agents|adrenergic agents|mesh-ancestor
64705518|NCT05528419|Valsartan|valsartan|mesh-list
64705519|NCT05528419|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64430766|NCT04415476|Sirolimus|sirolimus|mesh-list
64705536|NCT05449327|Rivaroxaban|rivaroxaban|mesh-list
64718793|NCT04499924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718794|NCT04499924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64718795|NCT04499924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64718796|NCT04499924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718797|NCT03949621|Vedolizumab|vedolizumab|mesh-list
64718798|NCT03949621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64718799|NCT04429880|Oxytocin|oxytocin|mesh-list
64326935|NCT00713401|Esmolol|esmolol|mesh-list
64705537|NCT05449327|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65463268|NCT03697252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463269|NCT03697252|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65463270|NCT03697252|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65463271|NCT03697252|Cholinergic Agents|cholinergic agents|mesh-ancestor
65463272|NCT03697252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65463273|NCT03697252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463274|NCT03697252|Urological Agents|urological agents|mesh-ancestor
65463275|NCT03697252|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65463276|NCT03697252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65463277|NCT03697252|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65463278|NCT03697252|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65463279|NCT03701074|Acetaminophen|acetaminophen|mesh-list
65463280|NCT03701074|Ibuprofen|ibuprofen|mesh-list
65463281|NCT03701074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64705538|NCT05449327|Antithrombins|antithrombins|mesh-ancestor
64705539|NCT05449327|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64705540|NCT05449327|Protease Inhibitors|protease inhibitors|mesh-ancestor
64705541|NCT05449327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705542|NCT05449327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705543|NCT05449327|Anticoagulants|anticoagulants|mesh-ancestor
64705544|NCT00365755|Cyclophosphamide|cyclophosphamide|mesh-list
64705545|NCT00365755|Melphalan|melphalan|mesh-list
64705546|NCT00365755|Carboplatin|carboplatin|mesh-list
64705547|NCT00365755|Etoposide|etoposide|mesh-list
64705548|NCT00365755|Vincristine|vincristine|mesh-list
64705549|NCT00365755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64705550|NCT00365755|Immunologic Factors|immunologic factors|mesh-ancestor
64705551|NCT00365755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705552|NCT00365755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64705553|NCT00365755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64705554|NCT00365755|Alkylating Agents|alkylating agents|mesh-ancestor
64705555|NCT00365755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705556|NCT00365755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64705557|NCT00365755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64705558|NCT00365755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64705559|NCT00365755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64705560|NCT00365755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64705561|NCT00365755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705562|NCT00365755|Tubulin Modulators|tubulin modulators|mesh-ancestor
64705563|NCT00365755|Antimitotic Agents|antimitotic agents|mesh-ancestor
64705564|NCT00365755|Mitosis Modulators|mitosis modulators|mesh-ancestor
64705566|NCT05730907|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64705567|NCT05730907|Vasodilator Agents|vasodilator agents|mesh-ancestor
64705570|NCT05730907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705571|NCT05730907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705572|NCT05730907|Protective Agents|protective agents|mesh-ancestor
64705573|NCT05730907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705574|NCT05384665|Sufentanil|sufentanil|mesh-list
64705585|NCT05384665|Anesthetics, General|anesthetics, general|mesh-ancestor
64705586|NCT05384665|Anesthetics|anesthetics|mesh-ancestor
64705587|NCT05730751|Anesthetics|anesthetics|mesh-list
64705588|NCT05730751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64705589|NCT05730751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705590|NCT05355337|Pramipexole|pramipexole|mesh-list
64705591|NCT05355337|Antioxidants|antioxidants|mesh-ancestor
64705592|NCT05355337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705593|NCT05355337|Protective Agents|protective agents|mesh-ancestor
64705594|NCT05355337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430843|NCT02499575|Sensory System Agents|sensory system agents|mesh-ancestor
64705595|NCT05355337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64705596|NCT05355337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64705597|NCT05355337|Dopamine Agonists|dopamine agonists|mesh-ancestor
64718800|NCT04429880|Oxytocics|oxytocics|mesh-ancestor
65463282|NCT03701074|Analgesics|analgesics|mesh-ancestor
65463283|NCT03701074|Sensory System Agents|sensory system agents|mesh-ancestor
65463284|NCT03701074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65463285|NCT03701074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463286|NCT03701074|Antipyretics|antipyretics|mesh-ancestor
65463287|NCT03701074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65463288|NCT03701074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65463289|NCT03701074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65463290|NCT03701074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65463291|NCT03701074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463292|NCT03701074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463293|NCT03757390|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
65463294|NCT03757390|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65463295|NCT03757390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64718801|NCT04429880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64718802|NCT04429880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718803|NCT04706546|Sildenafil Citrate|sildenafil citrate|mesh-list
64718804|NCT04706546|Vasodilator Agents|vasodilator agents|mesh-ancestor
64705598|NCT05355337|Dopamine Agents|dopamine agents|mesh-ancestor
64705599|NCT05355337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64705600|NCT04340401|Capecitabine|capecitabine|mesh-list
64705601|NCT04340401|Oxaliplatin|oxaliplatin|mesh-list
64705602|NCT04340401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64705603|NCT04340401|Antimetabolites|antimetabolites|mesh-ancestor
64705604|NCT04340401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705605|NCT04340401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64705606|NCT05281471|Gemcitabine|gemcitabine|mesh-list
64705607|NCT05281471|Paclitaxel|paclitaxel|mesh-list
64705608|NCT05281471|Docetaxel|docetaxel|mesh-list
64705609|NCT05281471|Bevacizumab|bevacizumab|mesh-list
64705610|NCT05281471|Carboplatin|carboplatin|mesh-list
64705611|NCT05281471|Doxorubicin|doxorubicin|mesh-list
64705612|NCT05281471|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64705613|NCT05281471|Taxane|taxane|mesh-list
64705614|NCT05281471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64705615|NCT05281471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64705616|NCT05281471|Tubulin Modulators|tubulin modulators|mesh-ancestor
64705617|NCT05281471|Antimitotic Agents|antimitotic agents|mesh-ancestor
64705618|NCT05281471|Mitosis Modulators|mitosis modulators|mesh-ancestor
64705619|NCT05281471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705620|NCT05281471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64705621|NCT05281471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64705622|NCT05281471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64705623|NCT05281471|Growth Substances|growth substances|mesh-ancestor
64705624|NCT05281471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945588|NCT05427786|Micronutrients|micronutrients|mesh-ancestor
64945589|NCT05427786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705625|NCT05281471|Growth Inhibitors|growth inhibitors|mesh-ancestor
64705626|NCT05281471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64705627|NCT05281471|Antimetabolites|antimetabolites|mesh-ancestor
64705628|NCT05281471|Antiviral Agents|antiviral agents|mesh-ancestor
64705629|NCT05281471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64336120|NCT03509701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336129|NCT02303587|Methylprednisolone|methylprednisolone|mesh-list
64705630|NCT05281471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705631|NCT05281471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64705644|NCT05725837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705645|NCT05725837|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64705647|NCT05725837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64705648|NCT05725837|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65463296|NCT03757390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65463297|NCT03757390|Antimetabolites|antimetabolites|mesh-ancestor
65463298|NCT03757390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463299|NCT03757390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65463300|NCT03757390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65463301|NCT03757390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463302|NCT03757390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65463303|NCT03757156|Aspirin|aspirin|mesh-list
65463304|NCT03757156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65463305|NCT03757156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64705649|NCT05725837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64705650|NCT05725837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705651|NCT04143607|Gefitinib|gefitinib|mesh-list
64705652|NCT04143607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64705653|NCT04143607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64705654|NCT04143607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705655|NCT04143607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705656|NCT04802863|Imipenem|imipenem|mesh-list
64705657|NCT04802863|Cilastatin|cilastatin|mesh-list
64705658|NCT04802863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64705659|NCT04802863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64705660|NCT04802863|Protease Inhibitors|protease inhibitors|mesh-ancestor
64705661|NCT04802863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705662|NCT04802863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705663|NCT04682431|Pembrolizumab|pembrolizumab|mesh-list
64705664|NCT04682431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64705665|NCT04682431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64705666|NCT04622839|Acetaminophen|acetaminophen|mesh-list
64718805|NCT04706546|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64718806|NCT04706546|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64718807|NCT04706546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718808|NCT04706546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718809|NCT04706546|Urological Agents|urological agents|mesh-ancestor
64718810|NCT04311632|Mycophenolic Acid|mycophenolic acid|mesh-list
64718811|NCT04311632|Tacrolimus|tacrolimus|mesh-list
64718812|NCT04311632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64718813|NCT04311632|Immunologic Factors|immunologic factors|mesh-ancestor
64718814|NCT04311632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718815|NCT04311632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64718816|NCT04311632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718817|NCT04311632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718818|NCT04311632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64718819|NCT04311632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718820|NCT04311632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64718821|NCT04311632|Antitubercular Agents|antitubercular agents|mesh-ancestor
64718822|NCT04311632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64718823|NCT04311632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64718824|NCT01692158|Heparin|heparin|mesh-list
64718825|NCT01692158|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64326938|NCT00713401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64326939|NCT00713401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64326940|NCT00713401|Adrenergic Agents|adrenergic agents|mesh-ancestor
64326941|NCT00713401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64326942|NCT00713401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326943|NCT00713401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326944|NCT00713401|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64705667|NCT04622839|Ibuprofen|ibuprofen|mesh-list
64705668|NCT04622839|Diclofenac|diclofenac|mesh-list
64705669|NCT04622839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64705670|NCT04622839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64430917|NCT02476175|Mirabegron|mirabegron|mesh-list
64705671|NCT04622839|Analgesics|analgesics|mesh-ancestor
64336130|NCT02303587|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65463306|NCT03757156|Analgesics|analgesics|mesh-ancestor
65463307|NCT03757156|Sensory System Agents|sensory system agents|mesh-ancestor
65463308|NCT03757156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65463309|NCT03757156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463310|NCT03757156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65463311|NCT03757156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65463312|NCT03757156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65463313|NCT03757156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65463314|NCT03757156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463315|NCT03757156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65463316|NCT03757156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65463317|NCT03757156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463318|NCT03757156|Antipyretics|antipyretics|mesh-ancestor
65463319|NCT03750916|Docetaxel|docetaxel|mesh-list
65463320|NCT03750916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463321|NCT03750916|Tubulin Modulators|tubulin modulators|mesh-ancestor
65463322|NCT03750916|Antimitotic Agents|antimitotic agents|mesh-ancestor
65463323|NCT03750916|Mitosis Modulators|mitosis modulators|mesh-ancestor
65463324|NCT03750916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463325|NCT05322148|Loteprednol Etabonate|loteprednol etabonate|mesh-list
65463326|NCT05322148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65463327|NCT03750760|Atorvastatin|atorvastatin|mesh-list
65463328|NCT03750760|Ezetimibe|ezetimibe|mesh-list
65463329|NCT03750760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64847816|NCT04672772|Paclitaxel|paclitaxel|mesh-list
64705679|NCT04622839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705681|NCT02619409|Bupivacaine|bupivacaine|mesh-list
64705682|NCT02619409|Anesthetics, Local|anesthetics, local|mesh-ancestor
64705683|NCT02619409|Anesthetics|anesthetics|mesh-ancestor
64718826|NCT01692158|Tinzaparin|tinzaparin|mesh-list
64718827|NCT01692158|Dalteparin|dalteparin|mesh-list
64718828|NCT01692158|Anticoagulants|anticoagulants|mesh-ancestor
64718829|NCT01692158|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64718830|NCT01692158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64718831|NCT01692158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705684|NCT02619409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64705685|NCT02619409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705686|NCT02619409|Sensory System Agents|sensory system agents|mesh-ancestor
64705687|NCT02619409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64705688|NCT02619799|Magnesium Sulfate|magnesium sulfate|mesh-list
64705689|NCT02619799|Midazolam|midazolam|mesh-list
64705690|NCT02619799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64705691|NCT02619799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64705692|NCT02619799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64705693|NCT02619799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705694|NCT02619799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64705695|NCT02619799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64705696|NCT02619799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64705697|NCT02619799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64705698|NCT02619799|Anesthetics, General|anesthetics, general|mesh-ancestor
64705699|NCT02619799|Anesthetics|anesthetics|mesh-ancestor
64705700|NCT02619799|GABA Modulators|gaba modulators|mesh-ancestor
64705701|NCT02619799|GABA Agents|gaba agents|mesh-ancestor
65463330|NCT03750760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65463331|NCT03750760|Antimetabolites|antimetabolites|mesh-ancestor
65463332|NCT03750760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463333|NCT03750760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65463334|NCT03750760|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65463335|NCT03750760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463336|NCT01076816|Dexmedetomidine|dexmedetomidine|mesh-list
65463337|NCT01076816|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65463338|NCT01076816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65463339|NCT01076816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65212837|NCT05061017|Nivolumab|nivolumab|mesh-list
65463340|NCT01076816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65463341|NCT01076816|Analgesics|analgesics|mesh-ancestor
64847839|NCT04659382|Bevacizumab|bevacizumab|mesh-list
64705702|NCT02619799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64705703|NCT02619799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705704|NCT02619799|Analgesics|analgesics|mesh-ancestor
64705705|NCT02619799|Sensory System Agents|sensory system agents|mesh-ancestor
64705706|NCT02619799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64705707|NCT02619799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64705708|NCT02619799|Anticonvulsants|anticonvulsants|mesh-ancestor
64705709|NCT02619799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64705710|NCT02619799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64705721|NCT04592809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64705722|NCT04592809|Anesthetics, General|anesthetics, general|mesh-ancestor
64705724|NCT04592809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64705725|NCT04592809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64705726|NCT04592809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64705727|NCT04592809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64705728|NCT04592809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705729|NCT04592809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64705730|NCT04592809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64705731|NCT04592809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64705732|NCT04592809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64705733|NCT04592809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64705734|NCT04592809|GABA Modulators|gaba modulators|mesh-ancestor
64705735|NCT04592809|GABA Agents|gaba agents|mesh-ancestor
64705736|NCT04741165|Bevacizumab|bevacizumab|mesh-list
64705737|NCT04741165|Lenvatinib|lenvatinib|mesh-list
64705738|NCT04741165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64705739|NCT04741165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64705740|NCT04741165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64705741|NCT04741165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64705742|NCT04741165|Growth Substances|growth substances|mesh-ancestor
64705743|NCT04741165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705744|NCT04741165|Growth Inhibitors|growth inhibitors|mesh-ancestor
64705745|NCT04741165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64705756|NCT02625181|Meperidine|meperidine|mesh-list
64705757|NCT02625181|Droperidol|droperidol|mesh-list
64705758|NCT02625181|Ketamine|ketamine|mesh-list
64705759|NCT02625181|Morphine|morphine|mesh-list
64705760|NCT02625181|Remifentanil|remifentanil|mesh-list
64705761|NCT02625181|Oxycodone|oxycodone|mesh-list
64718833|NCT01570634|Loperamide|loperamide|mesh-list
64718834|NCT01570634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
64718835|NCT01570634|Calcium|calcium|mesh-list
64718836|NCT01570634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64718837|NCT01570634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705762|NCT02625181|Methadone|methadone|mesh-list
64705763|NCT02625181|Hydromorphone|hydromorphone|mesh-list
64705764|NCT02625181|Hydrocodone|hydrocodone|mesh-list
64705765|NCT02625181|Alfentanil|alfentanil|mesh-list
64705766|NCT02625181|Haloperidol|haloperidol|mesh-list
65463342|NCT01076816|Sensory System Agents|sensory system agents|mesh-ancestor
65463343|NCT01076816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65463344|NCT01076816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65463345|NCT01076816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65463346|NCT01076816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65463347|NCT01076816|Adrenergic Agents|adrenergic agents|mesh-ancestor
65463348|NCT01076816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65463349|NCT01076816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463350|NCT01076894|Anesthetics|anesthetics|mesh-list
65463351|NCT01076894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65463352|NCT01076894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463353|NCT00130832|Vaccines|vaccines|mesh-list
65463354|NCT00130832|Immunologic Factors|immunologic factors|mesh-ancestor
65463355|NCT00130832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463356|NCT00096018|Thalidomide|thalidomide|mesh-list
64705767|NCT02625181|Ondansetron|ondansetron|mesh-list
64705768|NCT02625181|Aprepitant|aprepitant|mesh-list
64705769|NCT02625181|Palonosetron|palonosetron|mesh-list
64705770|NCT02625181|Metoclopramide|metoclopramide|mesh-list
64705771|NCT02625181|Granisetron|granisetron|mesh-list
64705772|NCT02625181|Ramosetron|ramosetron|mesh-list
64705773|NCT02625181|Tropisetron|tropisetron|mesh-list
64705774|NCT02625181|Dolasetron|dolasetron|mesh-list
64705775|NCT02625181|Anesthetics|anesthetics|mesh-list
64705776|NCT02625181|Propofol|propofol|mesh-list
64705777|NCT02625181|Sevoflurane|sevoflurane|mesh-list
64705778|NCT02625181|Desflurane|desflurane|mesh-list
64705779|NCT02625181|Isoflurane|isoflurane|mesh-list
64705780|NCT02625181|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64705781|NCT02625181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64705782|NCT02625181|Antiemetics|antiemetics|mesh-ancestor
64705783|NCT02625181|Autonomic Agents|autonomic agents|mesh-ancestor
64705786|NCT02625181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64705787|NCT02625181|Glucocorticoids|glucocorticoids|mesh-ancestor
64705788|NCT02625181|Hormones|hormones|mesh-ancestor
64705789|NCT02625181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64705790|NCT02625181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64705791|NCT02625181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64705792|NCT02625181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64705793|NCT02625181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64705794|NCT02625181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64705795|NCT02625181|Anesthetics, General|anesthetics, general|mesh-ancestor
64705796|NCT02625181|Analgesics|analgesics|mesh-ancestor
64705797|NCT02625181|Sensory System Agents|sensory system agents|mesh-ancestor
64705798|NCT02625181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64705799|NCT02625181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64705800|NCT02625181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64705801|NCT02625181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64705802|NCT02625181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705803|NCT02625181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64705804|NCT02625181|Narcotics|narcotics|mesh-ancestor
64705805|NCT02625181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64705806|NCT02625181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64705807|NCT02625181|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64705808|NCT02625181|Antipruritics|antipruritics|mesh-ancestor
64705809|NCT02625181|Dermatologic Agents|dermatologic agents|mesh-ancestor
64705810|NCT02625181|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64705811|NCT02625181|Serotonin Agents|serotonin agents|mesh-ancestor
64705812|NCT02625181|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64705813|NCT02625181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64705814|NCT02625181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64705815|NCT02625181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65463357|NCT00096018|Fludarabine|fludarabine|mesh-list
65463358|NCT00096018|Fludarabine phosphate|fludarabine phosphate|mesh-list
65463359|NCT00096018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463360|NCT00096018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65463361|NCT00096018|Antimetabolites|antimetabolites|mesh-ancestor
65463362|NCT00096018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463363|NCT00096018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65463364|NCT00096018|Immunologic Factors|immunologic factors|mesh-ancestor
65463365|NCT00096018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463366|NCT00096018|Leprostatic Agents|leprostatic agents|mesh-ancestor
65463367|NCT00096018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65463368|NCT00096018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65463369|NCT00096018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65463370|NCT00096018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65463371|NCT00096018|Growth Substances|growth substances|mesh-ancestor
64705816|NCT02625181|Antitussive Agents|antitussive agents|mesh-ancestor
64705817|NCT02625181|Respiratory System Agents|respiratory system agents|mesh-ancestor
64705826|NCT02625181|Cholinergic Agents|cholinergic agents|mesh-ancestor
64705827|NCT02625181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64705828|NCT02625181|Parasympatholytics|parasympatholytics|mesh-ancestor
64705829|NCT02625181|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64705830|NCT02625181|Histamine Antagonists|histamine antagonists|mesh-ancestor
64705831|NCT02625181|Histamine Agents|histamine agents|mesh-ancestor
64705832|NCT02625181|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64718838|NCT01570634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64718839|NCT03928327|Itraconazole|itraconazole|mesh-list
64718840|NCT03928327|Rifampin|rifampin|mesh-list
64718841|NCT03928327|Antifungal Agents|antifungal agents|mesh-ancestor
64718842|NCT03928327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64718843|NCT03928327|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64705833|NCT02625181|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64705834|NCT02625181|Anesthetics, Local|anesthetics, local|mesh-ancestor
64705835|NCT02630017|Methylphenidate|methylphenidate|mesh-list
64705836|NCT02630017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64705837|NCT02630017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705838|NCT02630017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64705839|NCT02630017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64705840|NCT02630017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64705841|NCT02630017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705842|NCT02630017|Dopamine Agents|dopamine agents|mesh-ancestor
64705843|NCT02630017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64705844|NCT02630719|Timolol|timolol|mesh-list
64705845|NCT02630719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64705846|NCT02630719|Lubricant Eye Drops|lubricant eye drops|mesh-list
64705847|NCT02630719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64705848|NCT02630719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64705849|NCT02630719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64705850|NCT02630719|Adrenergic Agents|adrenergic agents|mesh-ancestor
64705851|NCT02630719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64945592|NCT05426525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705854|NCT02630719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64705855|NCT02630719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64705856|NCT04979377|Insulin|insulin|mesh-list
64705857|NCT04979377|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64705858|NCT04979377|Hormones|hormones|mesh-list
64705859|NCT04979377|Testosterone|testosterone|mesh-list
64705860|NCT04979377|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64705861|NCT04979377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64705862|NCT04979377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705863|NCT04979377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65463372|NCT00096018|Growth Inhibitors|growth inhibitors|mesh-ancestor
65463373|NCT01079754|Morphine|morphine|mesh-list
65463374|NCT01079754|Analgesics, Opioid|analgesics, opioid|mesh-list
65463375|NCT01079754|Narcotics|narcotics|mesh-ancestor
65463376|NCT01079754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65463377|NCT01079754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463378|NCT01079754|Analgesics|analgesics|mesh-ancestor
65463379|NCT01079754|Sensory System Agents|sensory system agents|mesh-ancestor
65463380|NCT01079754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65463381|NCT04701658|Bamlanivimab|bamlanivimab|mesh-list
65463382|NCT04701658|Antiviral Agents|antiviral agents|mesh-ancestor
65463383|NCT04701658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64847881|NCT04602078|Antiviral Agents|antiviral agents|mesh-ancestor
64847882|NCT04602078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64847883|NCT04602078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705864|NCT04979377|Androgens|androgens|mesh-ancestor
64705865|NCT04979377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64705866|NCT04979377|Immunologic Factors|immunologic factors|mesh-ancestor
64705867|NCT02633371|Oxybutynin|oxybutynin|mesh-list
64705868|NCT02633371|Parasympatholytics|parasympatholytics|mesh-ancestor
64705869|NCT02633371|Autonomic Agents|autonomic agents|mesh-ancestor
64705870|NCT02633371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64705871|NCT02633371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705872|NCT02633371|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64336159|NCT02301481|Oxaliplatin|oxaliplatin|mesh-list
64705873|NCT02633371|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64705874|NCT02633371|Cholinergic Agents|cholinergic agents|mesh-ancestor
64705875|NCT02633371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64705876|NCT02633371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705877|NCT02633371|Urological Agents|urological agents|mesh-ancestor
64705878|NCT04159519|Budesonide|budesonide|mesh-list
64705879|NCT04159519|Albuterol|albuterol|mesh-list
64705888|NCT04159519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64705889|NCT04159519|Respiratory System Agents|respiratory system agents|mesh-ancestor
64705890|NCT04159519|Glucocorticoids|glucocorticoids|mesh-ancestor
64705891|NCT04159519|Hormones|hormones|mesh-ancestor
64705892|NCT04159519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64705893|NCT04159519|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64705894|NCT04159519|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64705895|NCT04159519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64705896|NCT04159519|Adrenergic Agents|adrenergic agents|mesh-ancestor
64718844|NCT03928327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64718845|NCT03928327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718846|NCT03928327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718847|NCT03928327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64718848|NCT03928327|Hormone Antagonists|hormone antagonists|mesh-ancestor
64326975|NCT03945825|Immunologic Factors|immunologic factors|mesh-ancestor
64705897|NCT04159519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64705898|NCT04159519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705899|NCT04159519|Tocolytic Agents|tocolytic agents|mesh-ancestor
64705900|NCT04159519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64705901|NCT04913311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64705902|NCT04913311|Dimercaprol|dimercaprol|mesh-list
64705903|NCT04913311|Chelating Agents|chelating agents|mesh-ancestor
64431142|NCT04967495|Chlorotrianisene|chlorotrianisene|mesh-list
64705904|NCT04913311|Sequestering Agents|sequestering agents|mesh-ancestor
64705905|NCT04913311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705906|NCT04913311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64705908|NCT04054375|Prednisolone|prednisolone|mesh-list
64705909|NCT04054375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64705910|NCT04054375|Glucocorticoids|glucocorticoids|mesh-ancestor
64705911|NCT04054375|Hormones|hormones|mesh-ancestor
65463384|NCT01322776|Cyclophosphamide|cyclophosphamide|mesh-list
65463385|NCT01322776|Fludarabine|fludarabine|mesh-list
65463386|NCT01322776|Bortezomib|bortezomib|mesh-list
65463387|NCT01322776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65463388|NCT01322776|Immunologic Factors|immunologic factors|mesh-ancestor
65463389|NCT01322776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463390|NCT01322776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65463391|NCT01322776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65463392|NCT01322776|Alkylating Agents|alkylating agents|mesh-ancestor
65463393|NCT01322776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463394|NCT01322776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463395|NCT01322776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65463396|NCT00128102|Vorinostat|vorinostat|mesh-list
65463397|NCT00128102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463398|NCT00128102|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65463399|NCT00128102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64847893|NCT04588857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64705912|NCT04054375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64705913|NCT04054375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705914|NCT04054375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64705915|NCT04054375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64705916|NCT02634073|Lamivudine|lamivudine|mesh-list
64705917|NCT02634073|Sorbitol|sorbitol|mesh-list
64705918|NCT02634073|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64705919|NCT02634073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64705920|NCT02634073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705923|NCT02634073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64705924|NCT02634073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64705925|NCT02634073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64705926|NCT02634073|Cathartics|cathartics|mesh-ancestor
64705927|NCT02634073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64705928|NCT00366691|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64705929|NCT00366691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64705930|NCT00367393|Pimecrolimus|pimecrolimus|mesh-list
64705931|NCT00367393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64705932|NCT00367393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64705933|NCT00367393|Analgesics|analgesics|mesh-ancestor
64705934|NCT00367393|Sensory System Agents|sensory system agents|mesh-ancestor
64705935|NCT00367393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64705936|NCT00367393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705937|NCT00367393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64705938|NCT00367393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64705939|NCT00367393|Dermatologic Agents|dermatologic agents|mesh-ancestor
64705940|NCT00367393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64705941|NCT00367393|Immunologic Factors|immunologic factors|mesh-ancestor
64705955|NCT00367471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64705956|NCT00367471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64705957|NCT00367471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705958|NCT02207244|Adalimumab|adalimumab|mesh-list
64705959|NCT02207244|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64705960|NCT02207244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64718849|NCT03928327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64718850|NCT03928327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718851|NCT03928327|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64718852|NCT03928327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64718853|NCT03928327|Antitubercular Agents|antitubercular agents|mesh-ancestor
64718854|NCT03928327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65463400|NCT00128102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463401|NCT03965858|Esketamine|esketamine|mesh-list
65463402|NCT03965858|Antidepressive Agents|antidepressive agents|mesh-ancestor
65463403|NCT03965858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65463404|NCT04668274|Resveratrol|resveratrol|mesh-list
65463405|NCT04668274|Antioxidants|antioxidants|mesh-ancestor
65463406|NCT04668274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463407|NCT04668274|Protective Agents|protective agents|mesh-ancestor
65463408|NCT04668274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463409|NCT04668274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463410|NCT04668274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65463411|NCT01077908|Antiviral Agents|antiviral agents|mesh-list
65463412|NCT01077908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65463413|NCT04406194|Favipiravir|favipiravir|mesh-list
65463414|NCT04406194|Antiviral Agents|antiviral agents|mesh-ancestor
65463415|NCT04406194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65463417|NCT03822884|Hematinics|hematinics|mesh-ancestor
65463418|NCT03822416|Nicotine|nicotine|mesh-list
65463419|NCT03822416|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65463420|NCT03822416|Autonomic Agents|autonomic agents|mesh-ancestor
64847906|NCT04566887|Acalabrutinib|acalabrutinib|mesh-list
64718855|NCT03928327|Leprostatic Agents|leprostatic agents|mesh-ancestor
64718856|NCT03928327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64705961|NCT02207244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64705962|NCT02207244|Immunologic Factors|immunologic factors|mesh-ancestor
64705963|NCT02207244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705965|NCT02207088|Ribavirin|ribavirin|mesh-list
64705966|NCT02207088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64705967|NCT02207088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64705968|NCT02207088|Protease Inhibitors|protease inhibitors|mesh-ancestor
64705969|NCT02207088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705970|NCT02207088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705971|NCT02207088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64705972|NCT02207088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64705973|NCT02207088|Antiviral Agents|antiviral agents|mesh-ancestor
64705974|NCT02207088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64705975|NCT02207088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64705976|NCT02207088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64705977|NCT02207088|Antimetabolites|antimetabolites|mesh-ancestor
64705978|NCT02638597|Gemfibrozil|gemfibrozil|mesh-list
64705979|NCT02638597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64705980|NCT02638597|Antimetabolites|antimetabolites|mesh-ancestor
64705981|NCT02638597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705982|NCT02638597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64705983|NCT02638597|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64705984|NCT02638597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64705985|NCT02638597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705986|NCT02206620|Donepezil|donepezil|mesh-list
64705987|NCT02206620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64705988|NCT02206620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705989|NCT02206620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705990|NCT02206620|Cholinergic Agents|cholinergic agents|mesh-ancestor
64705991|NCT02206620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64705992|NCT02206620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705993|NCT02206620|Nootropic Agents|nootropic agents|mesh-ancestor
65463421|NCT03822416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65463422|NCT03822416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463423|NCT03822416|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65463424|NCT03822416|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65463425|NCT03822416|Cholinergic Agents|cholinergic agents|mesh-ancestor
65463426|NCT03822416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65463427|NCT03822416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463428|NCT00127712|Amiodarone|amiodarone|mesh-list
65463429|NCT00127712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65463430|NCT00127712|Vasodilator Agents|vasodilator agents|mesh-ancestor
65463431|NCT00127712|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65463432|NCT00127712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65463433|NCT00127712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463434|NCT00127712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65463435|NCT00127712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65463436|NCT00127712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64847925|NCT04545242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705997|NCT02239926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705998|NCT02239692|Picosulfate sodium|picosulfate sodium|mesh-list
64706009|NCT02641561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64706010|NCT02641561|Gout Suppressants|gout suppressants|mesh-ancestor
64706011|NCT02641561|Tocolytic Agents|tocolytic agents|mesh-ancestor
64706012|NCT02641561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64706013|NCT02641561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64706014|NCT02641561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706015|NCT02641561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706016|NCT02206152|Acetylcysteine|acetylcysteine|mesh-list
64706017|NCT02206152|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64718857|NCT03928327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64718858|NCT03928327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64706018|NCT02206152|Antiviral Agents|antiviral agents|mesh-ancestor
64706019|NCT02206152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64706020|NCT02206152|Expectorants|expectorants|mesh-ancestor
64706021|NCT02206152|Respiratory System Agents|respiratory system agents|mesh-ancestor
64706022|NCT02206152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64706023|NCT02206152|Antioxidants|antioxidants|mesh-ancestor
64706024|NCT02206152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706025|NCT02206152|Protective Agents|protective agents|mesh-ancestor
64706026|NCT02206152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706027|NCT02206152|Antidotes|antidotes|mesh-ancestor
64706029|NCT04781088|Pembrolizumab|pembrolizumab|mesh-list
64706030|NCT04781088|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64706031|NCT04781088|Lenvatinib|lenvatinib|mesh-list
64706032|NCT04781088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64706033|NCT04781088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706034|NCT04781088|Tubulin Modulators|tubulin modulators|mesh-ancestor
64706035|NCT04781088|Antimitotic Agents|antimitotic agents|mesh-ancestor
64706036|NCT04781088|Mitosis Modulators|mitosis modulators|mesh-ancestor
64706037|NCT04781088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706038|NCT04781088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64706039|NCT04781088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64706040|NCT04781088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706041|NCT00367081|Pyrimethamine|pyrimethamine|mesh-list
64706042|NCT00367081|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65463437|NCT00127712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463438|NCT00127712|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65463439|NCT00127712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65463440|NCT00127712|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65463441|NCT01082744|Sufentanil|sufentanil|mesh-list
65463442|NCT01082744|Ropivacaine|ropivacaine|mesh-list
65463443|NCT01082744|Anesthetics, Local|anesthetics, local|mesh-ancestor
65463444|NCT01082744|Anesthetics|anesthetics|mesh-ancestor
65463445|NCT01082744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65463446|NCT01082744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463447|NCT01082744|Sensory System Agents|sensory system agents|mesh-ancestor
65463448|NCT01082744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65463449|NCT01082744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65463450|NCT01082744|Narcotics|narcotics|mesh-ancestor
65463451|NCT01082744|Analgesics|analgesics|mesh-ancestor
65463452|NCT01082744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65463453|NCT01082744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65463454|NCT01082744|Anesthetics, General|anesthetics, general|mesh-ancestor
65463455|NCT00096356|Vitamins|vitamins|mesh-list
65463456|NCT00096356|Vitamin E|vitamin e|mesh-list
65463457|NCT00096356|Tocopherols|tocopherols|mesh-list
65463458|NCT00096356|Tocotrienols|tocotrienols|mesh-list
64706043|NCT00367081|Sulfadiazine|sulfadiazine|mesh-list
64706044|NCT00367081|Antimalarials|antimalarials|mesh-ancestor
64706045|NCT00367081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64706046|NCT00367081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64706047|NCT00367081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64706048|NCT00367081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64706049|NCT00367081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706050|NCT00367081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706051|NCT00367081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64706052|NCT00367081|Renal Agents|renal agents|mesh-ancestor
64706053|NCT00367081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64706054|NCT00367081|Coccidiostats|coccidiostats|mesh-ancestor
64706056|NCT04146571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706057|NCT04146571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64706058|NCT04146571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706059|NCT04146571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706081|NCT04074265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64706082|NCT04074265|Autonomic Agents|autonomic agents|mesh-ancestor
64706083|NCT04074265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64706084|NCT04074265|Respiratory System Agents|respiratory system agents|mesh-ancestor
64706085|NCT04074265|Mydriatics|mydriatics|mesh-ancestor
64706086|NCT04074265|Sympathomimetics|sympathomimetics|mesh-ancestor
64706087|NCT04074265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64706088|NCT04074265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64706089|NCT04074265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64706090|NCT04074265|Analgesics|analgesics|mesh-ancestor
64706091|NCT04074265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64706092|NCT04074265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64706093|NCT04074265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64718859|NCT03928327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64718860|NCT03928327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64718861|NCT03928327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64718862|NCT03928327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65463459|NCT00096356|alpha-Tocopherol|alpha-tocopherol|mesh-list
65463460|NCT00096356|Micronutrients|micronutrients|mesh-ancestor
65463461|NCT00096356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463462|NCT00096356|Antioxidants|antioxidants|mesh-ancestor
65463463|NCT00096356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463464|NCT00096356|Protective Agents|protective agents|mesh-ancestor
65463465|NCT03749590|Magnesium Sulfate|magnesium sulfate|mesh-list
65463466|NCT03749590|Analgesics|analgesics|mesh-ancestor
65463467|NCT03749590|Sensory System Agents|sensory system agents|mesh-ancestor
65463468|NCT03749590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65463469|NCT03749590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463470|NCT03749590|Anesthetics|anesthetics|mesh-ancestor
64718863|NCT01055756|Loratadine|loratadine|mesh-list
64718864|NCT01055756|Pseudoephedrine|pseudoephedrine|mesh-list
64718865|NCT01055756|Ephedrine|ephedrine|mesh-list
64718866|NCT01055756|Antipruritics|antipruritics|mesh-ancestor
64718867|NCT01055756|Dermatologic Agents|dermatologic agents|mesh-ancestor
64718868|NCT01055756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64718869|NCT01055756|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64718870|NCT01055756|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64706094|NCT04074265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706095|NCT05342376|Dexmedetomidine|dexmedetomidine|mesh-list
64706096|NCT05342376|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64706097|NCT05342376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64706098|NCT05342376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706099|NCT05342376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64706100|NCT05342376|Analgesics|analgesics|mesh-ancestor
64706101|NCT05342376|Sensory System Agents|sensory system agents|mesh-ancestor
64706102|NCT05342376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706103|NCT05342376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64706104|NCT05342376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64706105|NCT05342376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64706106|NCT05342376|Adrenergic Agents|adrenergic agents|mesh-ancestor
64706107|NCT05342376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64706108|NCT05342376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706109|NCT03330847|Olaparib|olaparib|mesh-list
64706110|NCT03330847|Adavosertib|adavosertib|mesh-list
64706111|NCT03330847|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64706112|NCT03330847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706119|NCT04776096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64706120|NCT04776096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64706121|NCT04776096|Analgesics|analgesics|mesh-ancestor
64706122|NCT04776096|Sensory System Agents|sensory system agents|mesh-ancestor
64706123|NCT04776096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706124|NCT04776096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706125|NCT04776096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64706126|NCT04776096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64706127|NCT04776096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64431368|NCT02318095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706128|NCT04776096|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64706129|NCT04776096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64706139|NCT04684212|Betrixaban|betrixaban|mesh-list
64706140|NCT04684212|Anticoagulants|anticoagulants|mesh-ancestor
64706141|NCT04684212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64706142|NCT04684212|Antithrombins|antithrombins|mesh-ancestor
64706143|NCT04684212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64706144|NCT04684212|Protease Inhibitors|protease inhibitors|mesh-ancestor
64706145|NCT04684212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706146|NCT04684212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706147|NCT03260491|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
64706148|NCT03260491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64706149|NCT03260491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706150|NCT03250273|Nivolumab|nivolumab|mesh-list
64706151|NCT03250273|Entinostat|entinostat|mesh-list
65463471|NCT03749590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65463472|NCT03749590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65463473|NCT03749590|Anticonvulsants|anticonvulsants|mesh-ancestor
65463474|NCT03749590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65463475|NCT03749590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65463476|NCT03749590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463477|NCT03749590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65463478|NCT03749590|Tocolytic Agents|tocolytic agents|mesh-ancestor
65463479|NCT03749590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65463480|NCT04391842|Diclofenac|diclofenac|mesh-list
65463481|NCT04391842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65463482|NCT04391842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65463483|NCT04391842|Analgesics|analgesics|mesh-ancestor
65463484|NCT04391842|Sensory System Agents|sensory system agents|mesh-ancestor
65463485|NCT04391842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65463486|NCT04391842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463487|NCT04391842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65463488|NCT04391842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65463489|NCT04391842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65463490|NCT04391842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64847974|NCT04490707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718871|NCT01055756|Histamine Antagonists|histamine antagonists|mesh-ancestor
64718872|NCT01055756|Histamine Agents|histamine agents|mesh-ancestor
64718873|NCT01055756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64718874|NCT01055756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458173|NCT04196608|Renal Agents|renal agents|mesh-ancestor
64945596|NCT05423106|Entecavir|entecavir|mesh-list
64945597|NCT05423106|Antiviral Agents|antiviral agents|mesh-ancestor
64706152|NCT03250273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64706153|NCT03250273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706154|NCT03250273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64706155|NCT03250273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706156|NCT03250273|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64706157|NCT03250273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706158|NCT02203032|Ustekinumab|ustekinumab|mesh-list
64706159|NCT02203032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64706160|NCT02203032|Dermatologic Agents|dermatologic agents|mesh-ancestor
64706161|NCT02203032|Immunologic Factors|immunologic factors|mesh-ancestor
64706162|NCT02203032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706163|NCT03587701|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64706164|NCT03587701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64706165|NCT02169414|Levodopa|levodopa|mesh-list
64706166|NCT02169414|Carbidopa|carbidopa|mesh-list
64706167|NCT02169414|Opicapone|opicapone|mesh-list
64706168|NCT02169414|Benserazide|benserazide|mesh-list
64706169|NCT02169414|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64706170|NCT02169414|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64706171|NCT02169414|Dopamine Agents|dopamine agents|mesh-ancestor
64706172|NCT02169414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64706173|NCT02169414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706174|NCT02169414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706175|NCT02169414|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65463491|NCT04391842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463492|NCT03777982|Prednisone|prednisone|mesh-list
65463493|NCT03777982|Abiraterone Acetate|abiraterone acetate|mesh-list
65463494|NCT03777982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65463495|NCT03777982|Glucocorticoids|glucocorticoids|mesh-ancestor
65463496|NCT03777982|Hormones|hormones|mesh-ancestor
65463497|NCT03777982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65463498|NCT03777982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463499|NCT03777982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65463500|NCT03777982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463501|NCT03777982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65463502|NCT03777982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463503|NCT03777982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463504|NCT03777982|Hormone Antagonists|hormone antagonists|mesh-ancestor
65463505|NCT03777982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65463506|NCT03749356|Tacrolimus|tacrolimus|mesh-list
65463507|NCT03749356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65463508|NCT03749356|Immunologic Factors|immunologic factors|mesh-ancestor
65463509|NCT03749356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847995|NCT04464577|Antifungal Agents|antifungal agents|mesh-ancestor
64706176|NCT02169414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706177|NCT02169414|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64706178|NCT03213457|Norethindrone|norethindrone|mesh-list
64706206|NCT05588869|Dermatologic Agents|dermatologic agents|mesh-ancestor
64706207|NCT05588869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64706208|NCT05588869|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64706209|NCT02169336|Dexmedetomidine|dexmedetomidine|mesh-list
64706210|NCT02169336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64706211|NCT02169336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64706212|NCT02169336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706213|NCT02169336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64706214|NCT02169336|Analgesics|analgesics|mesh-ancestor
64706215|NCT02169336|Sensory System Agents|sensory system agents|mesh-ancestor
64706216|NCT02169336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706217|NCT02169336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64706218|NCT02169336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64718875|NCT01055756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718876|NCT01055756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64718877|NCT01055756|Autonomic Agents|autonomic agents|mesh-ancestor
64718878|NCT01055756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64718879|NCT01055756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64706219|NCT02169336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64706220|NCT02169336|Adrenergic Agents|adrenergic agents|mesh-ancestor
64706221|NCT02169336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64706222|NCT02169336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706224|NCT03043807|Leuprolide|leuprolide|mesh-list
64706225|NCT03043807|Abiraterone Acetate|abiraterone acetate|mesh-list
64706226|NCT03043807|Bicalutamide|bicalutamide|mesh-list
64706227|NCT03043807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336207|NCT02335203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336210|NCT02335203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64706242|NCT03043807|Androgen Antagonists|androgen antagonists|mesh-ancestor
64706244|NCT02609828|Analgesics|analgesics|mesh-ancestor
65463510|NCT03749356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65463511|NCT03749356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463512|NCT03749356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463513|NCT04358068|Azithromycin|azithromycin|mesh-list
65463514|NCT04358068|Hydroxychloroquine|hydroxychloroquine|mesh-list
65463515|NCT04358068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65463516|NCT04358068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65463517|NCT04358068|Antimalarials|antimalarials|mesh-ancestor
65463518|NCT04358068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65463519|NCT04358068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65463520|NCT04358068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463521|NCT04358068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463522|NCT04358068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65463523|NCT00096278|Calcium, Dietary|calcium, dietary|mesh-list
65463524|NCT00096278|Leucovorin|leucovorin|mesh-list
65463525|NCT00096278|Folic Acid|folic acid|mesh-list
65463526|NCT00096278|Bevacizumab|bevacizumab|mesh-list
64706245|NCT02609828|Sensory System Agents|sensory system agents|mesh-ancestor
64706246|NCT02609828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706247|NCT02609828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706248|NCT05588557|Bupivacaine|bupivacaine|mesh-list
64706249|NCT05588557|Anesthetics, Local|anesthetics, local|mesh-ancestor
64706250|NCT05588557|Anesthetics|anesthetics|mesh-ancestor
64706251|NCT05588557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64706252|NCT05588557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706253|NCT05588557|Sensory System Agents|sensory system agents|mesh-ancestor
64706254|NCT05588557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706255|NCT02672917|Gemcitabine|gemcitabine|mesh-list
64706256|NCT02672917|Paclitaxel|paclitaxel|mesh-list
64706257|NCT02672917|Folfirinox|folfirinox|mesh-list
64706258|NCT02672917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64706259|NCT02672917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706260|NCT02672917|Tubulin Modulators|tubulin modulators|mesh-ancestor
64706261|NCT02672917|Antimitotic Agents|antimitotic agents|mesh-ancestor
64706262|NCT02672917|Mitosis Modulators|mitosis modulators|mesh-ancestor
64706263|NCT02672917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706264|NCT02672917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64706265|NCT02672917|Antimetabolites|antimetabolites|mesh-ancestor
64706266|NCT02672917|Antiviral Agents|antiviral agents|mesh-ancestor
64706267|NCT02672917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64706268|NCT02672917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706269|NCT02672917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64706270|NCT02672917|Immunologic Factors|immunologic factors|mesh-ancestor
64706280|NCT01632306|Antimitotic Agents|antimitotic agents|mesh-ancestor
64706281|NCT01632306|Mitosis Modulators|mitosis modulators|mesh-ancestor
64706282|NCT01632306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706283|NCT01632306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64706284|NCT01632306|Antimetabolites|antimetabolites|mesh-ancestor
64706285|NCT01632306|Antiviral Agents|antiviral agents|mesh-ancestor
64706286|NCT01632306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64706287|NCT01632306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706288|NCT01632306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64706289|NCT01632306|Immunologic Factors|immunologic factors|mesh-ancestor
64706290|NCT01632306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706291|NCT01632306|Antidotes|antidotes|mesh-ancestor
64706292|NCT01632306|Protective Agents|protective agents|mesh-ancestor
64706293|NCT01632306|Vitamin B Complex|vitamin b complex|mesh-ancestor
64718880|NCT01055756|Respiratory System Agents|respiratory system agents|mesh-ancestor
64718881|NCT01055756|Nasal Decongestants|nasal decongestants|mesh-ancestor
64945598|NCT05423106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65463527|NCT00096278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65463528|NCT00096278|Fluorouracil|fluorouracil|mesh-list
65463529|NCT00096278|Oxaliplatin|oxaliplatin|mesh-list
65463530|NCT00096278|Endothelial Growth Factors|endothelial growth factors|mesh-list
65463531|NCT00096278|Antibodies|antibodies|mesh-list
65463532|NCT00096278|Immunoglobulins|immunoglobulins|mesh-list
65463533|NCT00096278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65463534|NCT00096278|Immunoglobulin G|immunoglobulin g|mesh-list
65463535|NCT00096278|Calcium|calcium|mesh-list
65463536|NCT00096278|Levoleucovorin|levoleucovorin|mesh-list
65463537|NCT00096278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463538|NCT00096278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65463539|NCT00096278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64706300|NCT02201784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64706301|NCT02201784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706302|NCT02201784|Sensory System Agents|sensory system agents|mesh-ancestor
64706303|NCT02201784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706304|NCT05587933|Parasympatholytics|parasympatholytics|mesh-list
64706305|NCT05587933|Autonomic Agents|autonomic agents|mesh-ancestor
64706306|NCT05587933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706307|NCT05587933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706308|NCT02018263|Cocaine|cocaine|mesh-list
64706309|NCT02018263|Nicotine|nicotine|mesh-list
64706310|NCT02018263|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64706311|NCT02018263|Autonomic Agents|autonomic agents|mesh-ancestor
64706312|NCT02018263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706313|NCT02018263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706314|NCT02018263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64706315|NCT02018263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64706316|NCT02018263|Cholinergic Agents|cholinergic agents|mesh-ancestor
64706317|NCT02018263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64706318|NCT02018263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706319|NCT02018263|Anesthetics, Local|anesthetics, local|mesh-ancestor
64706320|NCT02018263|Anesthetics|anesthetics|mesh-ancestor
64706321|NCT02018263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64706322|NCT02018263|Sensory System Agents|sensory system agents|mesh-ancestor
64706323|NCT02018263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64706324|NCT02018263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64706325|NCT02018263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64706326|NCT02018263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64706327|NCT02018263|Dopamine Agents|dopamine agents|mesh-ancestor
64706328|NCT02168946|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64706329|NCT02168946|Meropenem|meropenem|mesh-list
64706330|NCT02168946|Vaborbactam|vaborbactam|mesh-list
64706331|NCT02168946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64706332|NCT02168946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
64706333|NCT02168946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64706334|NCT02168946|Antitubercular Agents|antitubercular agents|mesh-ancestor
64706335|NCT02168946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706336|NCT02168946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706337|NCT02650856|Tranexamic Acid|tranexamic acid|mesh-list
64706338|NCT02650856|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64706363|NCT00367874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64706364|NCT00367874|Antimanic Agents|antimanic agents|mesh-ancestor
64706365|NCT00367874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64706366|NCT00367874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64706367|NCT00367562|Valsartan|valsartan|mesh-list
64706368|NCT00367562|Enalapril|enalapril|mesh-list
64706369|NCT00367562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64706370|NCT00367562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64706371|NCT00367562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64706372|NCT00367562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706373|NCT00367562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64706374|NCT00367562|Protease Inhibitors|protease inhibitors|mesh-ancestor
65463540|NCT00096278|Growth Substances|growth substances|mesh-ancestor
65463541|NCT00096278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463542|NCT00096278|Growth Inhibitors|growth inhibitors|mesh-ancestor
65463543|NCT00096278|Immunologic Factors|immunologic factors|mesh-ancestor
65463544|NCT00096278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65463545|NCT00096278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65463546|NCT00096278|Antimetabolites|antimetabolites|mesh-ancestor
65463547|NCT00096278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706375|NCT00367562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706376|NCT02302976|Exenatide|exenatide|mesh-list
64706377|NCT02302976|Cocaine|cocaine|mesh-list
64706378|NCT02302976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64484561|NCT03839134|Epinephrine|epinephrine|mesh-list
64706379|NCT02302976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706383|NCT02302976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64706384|NCT02302976|Anesthetics, Local|anesthetics, local|mesh-ancestor
64706386|NCT02302976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64706387|NCT02302976|Sensory System Agents|sensory system agents|mesh-ancestor
64706388|NCT02302976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706389|NCT02302976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64706390|NCT02302976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64706391|NCT02302976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64706394|NCT02302976|Dopamine Agents|dopamine agents|mesh-ancestor
64706395|NCT02302976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64706397|NCT05073692|Empagliflozin|empagliflozin|mesh-list
64706398|NCT05073692|Exenatide|exenatide|mesh-list
64706399|NCT05073692|Glimepiride|glimepiride|mesh-list
64706400|NCT05073692|Linagliptin|linagliptin|mesh-list
64706401|NCT05073692|Saxagliptin|saxagliptin|mesh-list
64706402|NCT05073692|Alogliptin|alogliptin|mesh-list
64706403|NCT05073692|Glipizide|glipizide|mesh-list
64706404|NCT05073692|Glucagon|glucagon|mesh-list
64706405|NCT05073692|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64706406|NCT05073692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64706407|NCT05073692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706408|NCT05073692|Incretins|incretins|mesh-ancestor
64706409|NCT05073692|Hormones|hormones|mesh-ancestor
64706410|NCT05073692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64706411|NCT05073692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64706412|NCT05073692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706413|NCT05073692|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64706414|NCT05073692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64706415|NCT05073692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64706416|NCT05073692|Immunologic Factors|immunologic factors|mesh-ancestor
64706417|NCT05073692|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64706418|NCT05073692|Protease Inhibitors|protease inhibitors|mesh-ancestor
64706419|NCT05073692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706420|NCT05073692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64706421|NCT02244164|Liraglutide|liraglutide|mesh-list
64706422|NCT02244164|Exenatide|exenatide|mesh-list
64706423|NCT02244164|Lixisenatide|lixisenatide|mesh-list
64706424|NCT02244164|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64706425|NCT02244164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64706426|NCT02244164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706427|NCT02244164|Incretins|incretins|mesh-ancestor
64706428|NCT02244164|Hormones|hormones|mesh-ancestor
64706429|NCT02244164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64706430|NCT02244164|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64706431|NCT02244164|Protease Inhibitors|protease inhibitors|mesh-ancestor
64706432|NCT02244164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706433|NCT02244164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706435|NCT02152670|Methylphenidate|methylphenidate|mesh-list
64706436|NCT02152670|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
64706437|NCT02152670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64706438|NCT02152670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706439|NCT02152670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64706440|NCT02152670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65463548|NCT00096278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65463549|NCT00096278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65463550|NCT00096278|Antidotes|antidotes|mesh-ancestor
65463551|NCT00096278|Protective Agents|protective agents|mesh-ancestor
65463552|NCT00096278|Vitamin B Complex|vitamin b complex|mesh-ancestor
65463553|NCT00096278|Vitamins|vitamins|mesh-ancestor
65463554|NCT00096278|Micronutrients|micronutrients|mesh-ancestor
65463555|NCT00096278|Hematinics|hematinics|mesh-ancestor
65463556|NCT00095940|Lapatinib|lapatinib|mesh-list
65463557|NCT00095940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463558|NCT00095940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65463559|NCT00095940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463560|NCT00095940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463561|NCT00114218|Gemcitabine|gemcitabine|mesh-list
65463562|NCT00114218|Docetaxel|docetaxel|mesh-list
65463563|NCT00114218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65463564|NCT00114218|Antimetabolites|antimetabolites|mesh-ancestor
65213060|NCT04740918|Antimitotic Agents|antimitotic agents|mesh-ancestor
65463565|NCT00114218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463566|NCT00114218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463567|NCT00114218|Antiviral Agents|antiviral agents|mesh-ancestor
65463568|NCT00114218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65463569|NCT00114218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463570|NCT00114218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65463571|NCT00114218|Immunologic Factors|immunologic factors|mesh-ancestor
65463572|NCT00114218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463573|NCT00114218|Tubulin Modulators|tubulin modulators|mesh-ancestor
65463574|NCT00114218|Antimitotic Agents|antimitotic agents|mesh-ancestor
65463575|NCT00114218|Mitosis Modulators|mitosis modulators|mesh-ancestor
65463576|NCT04380688|Acalabrutinib|acalabrutinib|mesh-list
65463577|NCT04380688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463578|NCT01077986|Capecitabine|capecitabine|mesh-list
65463579|NCT01077986|Cetuximab|cetuximab|mesh-list
65463580|NCT01077986|Everolimus|everolimus|mesh-list
65463581|NCT01077986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65463582|NCT01077986|Antimetabolites|antimetabolites|mesh-ancestor
65463583|NCT01077986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463584|NCT01077986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848046|NCT04348864|Antibodies|antibodies|mesh-list
65463585|NCT01077986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65463586|NCT01077986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65463587|NCT01077986|Immunologic Factors|immunologic factors|mesh-ancestor
65463588|NCT01077986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463589|NCT03963024|Treosulfan|treosulfan|mesh-list
65463590|NCT03963024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65463591|NCT03963024|Alkylating Agents|alkylating agents|mesh-ancestor
65463592|NCT03963024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463593|NCT03963024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463594|NCT01082718|Artesunate|artesunate|mesh-list
65463595|NCT01082718|Mefloquine|mefloquine|mesh-list
65463596|NCT01082718|Antimalarials|antimalarials|mesh-ancestor
65463597|NCT01082718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65463598|NCT01082718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65463599|NCT01082718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65463600|NCT01082718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463601|NCT01082718|Antiviral Agents|antiviral agents|mesh-ancestor
65463602|NCT01082718|Schistosomicides|schistosomicides|mesh-ancestor
65463603|NCT01082718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65463604|NCT01082718|Anthelmintics|anthelmintics|mesh-ancestor
65463605|NCT04380142|Levodopa|levodopa|mesh-list
65463606|NCT04380142|Carbidopa|carbidopa|mesh-list
64706441|NCT02152670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64706442|NCT02152670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327027|NCT02172131|Respiratory System Agents|respiratory system agents|mesh-ancestor
64706445|NCT02152670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64706446|NCT02152670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64706447|NCT02152670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64706448|NCT02152670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64706449|NCT02152670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64706450|NCT02152670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706451|NCT02028806|Leucovorin|leucovorin|mesh-list
64706452|NCT02028806|Oxaliplatin|oxaliplatin|mesh-list
64706453|NCT02028806|Irinotecan|irinotecan|mesh-list
64706454|NCT02028806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706455|NCT02028806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64706456|NCT02028806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64706457|NCT02028806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706458|NCT02028806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706460|NCT02028806|Protective Agents|protective agents|mesh-ancestor
64706461|NCT02028806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706462|NCT02028806|Vitamin B Complex|vitamin b complex|mesh-ancestor
64706463|NCT02028806|Vitamins|vitamins|mesh-ancestor
64706464|NCT02028806|Micronutrients|micronutrients|mesh-ancestor
64706465|NCT01756118|Dactolisib|dactolisib|mesh-list
64706466|NCT01756118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706470|NCT02656160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64706471|NCT02656160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64706472|NCT02656160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706473|NCT02657252|Polidocanol|polidocanol|mesh-list
64706474|NCT02657252|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64706475|NCT02657252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64706476|NCT04740086|Calcium|calcium|mesh-list
64706477|NCT04740086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64706478|NCT04740086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463607|NCT04380142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65463608|NCT04380142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65463609|NCT04380142|Dopamine Agents|dopamine agents|mesh-ancestor
65463610|NCT04380142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65463611|NCT04380142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463612|NCT04380142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463613|NCT04380142|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65463614|NCT04380142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463615|NCT04336228|Dexetimide|dexetimide|mesh-list
65463616|NCT04336228|Citalopram|citalopram|mesh-list
65463617|NCT04336228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463618|NCT04336228|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65463619|NCT04336228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65463620|NCT04336228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65463621|NCT04336228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463622|NCT04336228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65463623|NCT04336228|Serotonin Agents|serotonin agents|mesh-ancestor
65463624|NCT04336228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65463625|NCT04336228|Antidepressive Agents|antidepressive agents|mesh-ancestor
65463626|NCT04336228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65463627|NCT04336228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65463628|NCT04336228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65463629|NCT04336228|Parasympatholytics|parasympatholytics|mesh-ancestor
65463630|NCT04336228|Autonomic Agents|autonomic agents|mesh-ancestor
64706479|NCT04739618|Pembrolizumab|pembrolizumab|mesh-list
64706480|NCT04739618|Ipilimumab|ipilimumab|mesh-list
64706481|NCT04739618|Sargramostim|sargramostim|mesh-list
64706482|NCT04739618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64706483|NCT04739618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706484|NCT04739618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64706485|NCT04739618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706486|NCT04739618|Immunologic Factors|immunologic factors|mesh-ancestor
64706487|NCT04739618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706488|NCT02684942|Fentanyl|fentanyl|mesh-list
64706489|NCT02684942|Meperidine|meperidine|mesh-list
64706490|NCT02684942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64706491|NCT02684942|Narcotics|narcotics|mesh-ancestor
64706492|NCT02684942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64706493|NCT02684942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706494|NCT02684942|Analgesics|analgesics|mesh-ancestor
64706495|NCT02684942|Sensory System Agents|sensory system agents|mesh-ancestor
64706496|NCT02684942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706497|NCT02684942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64706498|NCT02684942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64706499|NCT02684942|Anesthetics, General|anesthetics, general|mesh-ancestor
64706500|NCT02684942|Anesthetics|anesthetics|mesh-ancestor
64706501|NCT04739774|Itraconazole|itraconazole|mesh-list
64706502|NCT04739774|Antifungal Agents|antifungal agents|mesh-ancestor
64706503|NCT04739774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64706504|NCT04739774|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65463631|NCT04336228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65463632|NCT04336228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65463633|NCT04336228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65463634|NCT04336228|Cholinergic Agents|cholinergic agents|mesh-ancestor
65463635|NCT03917446|Propofol|propofol|mesh-list
65463636|NCT03917446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65463637|NCT03917446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65463638|NCT03917446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463639|NCT03917446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65463640|NCT03917446|Anesthetics, General|anesthetics, general|mesh-ancestor
65463641|NCT03917446|Anesthetics|anesthetics|mesh-ancestor
65213140|NCT04580121|Anesthetics|anesthetics|mesh-ancestor
65463642|NCT04332874|Dactinomycin|dactinomycin|mesh-list
65463644|NCT04332874|Melphalan|melphalan|mesh-list
65463645|NCT04332874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65463646|NCT04332874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463647|NCT04332874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65463648|NCT04332874|Alkylating Agents|alkylating agents|mesh-ancestor
65463649|NCT04332874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463650|NCT04332874|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65463651|NCT04332874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65463652|NCT04332874|Immunologic Factors|immunologic factors|mesh-ancestor
64848128|NCT04223570|Levulinic acid|levulinic acid|mesh-list
64848133|NCT04180085|Abatacept|abatacept|mesh-list
64706505|NCT04739774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64706506|NCT04739774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706513|NCT02660918|Bupivacaine|bupivacaine|mesh-list
64706514|NCT02660918|Anesthetics, Local|anesthetics, local|mesh-ancestor
64706515|NCT02660918|Anesthetics|anesthetics|mesh-ancestor
64706516|NCT02660918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64706517|NCT02660918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706518|NCT02660918|Sensory System Agents|sensory system agents|mesh-ancestor
64706519|NCT02660918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706520|NCT00367315|Lumiracoxib|lumiracoxib|mesh-list
64706521|NCT00367315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64706522|NCT00367315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64706523|NCT00367315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706524|NCT00367315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706525|NCT00367315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64706526|NCT00367315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64706527|NCT00367315|Analgesics|analgesics|mesh-ancestor
64706528|NCT00367315|Sensory System Agents|sensory system agents|mesh-ancestor
64484562|NCT03839134|Racepinephrine|racepinephrine|mesh-list
64706529|NCT00367315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706530|NCT00367315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706531|NCT00367315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64706532|NCT00367315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64706533|NCT01192555|Cyclophosphamide|cyclophosphamide|mesh-list
64706534|NCT01192555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64706535|NCT01192555|Immunologic Factors|immunologic factors|mesh-ancestor
64706536|NCT01192555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463653|NCT04332874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463654|NCT04332874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65463655|NCT04332874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65463656|NCT04332874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65463657|NCT04332874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65463658|NCT04332874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463659|NCT04332874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65463660|NCT03748108|Lidocaine|lidocaine|mesh-list
65463661|NCT03748108|Anesthetics, Local|anesthetics, local|mesh-ancestor
65463662|NCT03748108|Anesthetics|anesthetics|mesh-ancestor
65463663|NCT03748108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65463664|NCT03748108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463665|NCT03748108|Sensory System Agents|sensory system agents|mesh-ancestor
65463666|NCT03748108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64848149|NCT04169451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64706537|NCT01192555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64706540|NCT01192555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706541|NCT01192555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706542|NCT01192555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64706543|NCT05441761|Gemcitabine|gemcitabine|mesh-list
64706544|NCT05441761|Dexamethasone|dexamethasone|mesh-list
64706545|NCT05441761|Mitoxantrone|mitoxantrone|mesh-list
64706546|NCT05441761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64706547|NCT05441761|Antiemetics|antiemetics|mesh-ancestor
64706548|NCT05441761|Autonomic Agents|autonomic agents|mesh-ancestor
64706549|NCT05441761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706550|NCT05441761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706551|NCT05441761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64706552|NCT05441761|Glucocorticoids|glucocorticoids|mesh-ancestor
64706553|NCT05441761|Hormones|hormones|mesh-ancestor
64706554|NCT05441761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64706555|NCT05441761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64706556|NCT05441761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706557|NCT05441761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64706558|NCT05441761|Antimetabolites|antimetabolites|mesh-ancestor
64706559|NCT05441761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706560|NCT05441761|Antiviral Agents|antiviral agents|mesh-ancestor
64706561|NCT05441761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64706562|NCT05441761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706563|NCT05441761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64706564|NCT05441761|Immunologic Factors|immunologic factors|mesh-ancestor
64706565|NCT05441761|Analgesics|analgesics|mesh-ancestor
64706566|NCT05441761|Sensory System Agents|sensory system agents|mesh-ancestor
64706567|NCT05441761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64718904|NCT01550510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64718906|NCT04333225|Antimalarials|antimalarials|mesh-ancestor
64706576|NCT05587621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64706577|NCT05587621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706578|NCT05587621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64706579|NCT05587621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706580|NCT04739215|Dapagliflozin|dapagliflozin|mesh-list
64706581|NCT04739215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64706582|NCT04739215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336393|NCT02304289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64706583|NCT04739215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64706584|NCT04739215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706585|NCT02688829|Sirolimus|sirolimus|mesh-list
64706586|NCT02688829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65463667|NCT03748108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65463668|NCT03748108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65463669|NCT03748108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65463670|NCT03748108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65463671|NCT03748108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463672|NCT04171414|Adalimumab|adalimumab|mesh-list
65463673|NCT04171414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65463674|NCT04171414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65463675|NCT04167670|Amoxicillin|amoxicillin|mesh-list
65463676|NCT04167670|Clarithromycin|clarithromycin|mesh-list
65463677|NCT04167670|Lansoprazole|lansoprazole|mesh-list
65463678|NCT04167670|Dexlansoprazole|dexlansoprazole|mesh-list
65463679|NCT04167670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65463680|NCT04167670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65463681|NCT04167670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65463682|NCT04167670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463683|NCT04167670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463684|NCT04167670|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65463685|NCT04167670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64706587|NCT02688829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64706588|NCT02688829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64706589|NCT02688829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706590|NCT02688829|Antifungal Agents|antifungal agents|mesh-ancestor
64706591|NCT02688829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64706592|NCT02688829|Immunologic Factors|immunologic factors|mesh-ancestor
64706593|NCT02688829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706594|NCT02688842|Sirolimus|sirolimus|mesh-list
64706595|NCT02688842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64706596|NCT02688842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64706597|NCT02688842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64706598|NCT02688842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706599|NCT02688842|Antifungal Agents|antifungal agents|mesh-ancestor
64706600|NCT02688842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64706601|NCT02688842|Immunologic Factors|immunologic factors|mesh-ancestor
64706602|NCT02688842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945599|NCT05423106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64706603|NCT02689063|Acetaminophen|acetaminophen|mesh-list
64706604|NCT02689063|Ibuprofen|ibuprofen|mesh-list
64706605|NCT02689063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64706606|NCT02689063|Analgesics|analgesics|mesh-ancestor
64706607|NCT02689063|Sensory System Agents|sensory system agents|mesh-ancestor
64706608|NCT02689063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706609|NCT02689063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706625|NCT02666846|Methyl salicylate|methyl salicylate|mesh-list
64706626|NCT02666846|Menthol|menthol|mesh-list
64706627|NCT02666846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64706628|NCT02666846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64706629|NCT02666846|Analgesics|analgesics|mesh-ancestor
64706630|NCT02666846|Sensory System Agents|sensory system agents|mesh-ancestor
64706631|NCT02666846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706632|NCT02666846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706633|NCT02666846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64706634|NCT02666846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64706635|NCT02666846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64706636|NCT02666846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463686|NCT04167670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65463687|NCT04167670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65463688|NCT04167670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65463689|NCT00113516|Paclitaxel|paclitaxel|mesh-list
65463690|NCT00113516|Carboplatin|carboplatin|mesh-list
65463691|NCT00113516|Sunitinib|sunitinib|mesh-list
65463692|NCT00113516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65463693|NCT00113516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463694|NCT00113516|Tubulin Modulators|tubulin modulators|mesh-ancestor
65463695|NCT00113516|Antimitotic Agents|antimitotic agents|mesh-ancestor
65463696|NCT00113516|Mitosis Modulators|mitosis modulators|mesh-ancestor
65463697|NCT00113516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463698|NCT00113516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65463699|NCT00113516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65463700|NCT00113516|Growth Substances|growth substances|mesh-ancestor
65463701|NCT00113516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463702|NCT00113516|Growth Inhibitors|growth inhibitors|mesh-ancestor
65463703|NCT00113516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65463704|NCT00113516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463705|NCT04142242|Vaccines|vaccines|mesh-list
65463706|NCT04142242|Immunologic Factors|immunologic factors|mesh-ancestor
65463707|NCT04142242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463708|NCT03251326|Propranolol|propranolol|mesh-list
65463709|NCT03251326|Nabilone|nabilone|mesh-list
65463710|NCT03251326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65463711|NCT03251326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65463712|NCT03251326|Adrenergic Agents|adrenergic agents|mesh-ancestor
65463713|NCT03251326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65463714|NCT03251326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463715|NCT03251326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463716|NCT03251326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65463717|NCT03251326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65463719|NCT03251326|Antiemetics|antiemetics|mesh-ancestor
65463720|NCT03251326|Autonomic Agents|autonomic agents|mesh-ancestor
65463721|NCT03251326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706637|NCT02666846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706638|NCT02666846|Antipruritics|antipruritics|mesh-ancestor
64706639|NCT02666846|Dermatologic Agents|dermatologic agents|mesh-ancestor
64706640|NCT02643979|Ketamine|ketamine|mesh-list
64706641|NCT02643979|Propofol|propofol|mesh-list
64706642|NCT02643979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65463722|NCT03251326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65463723|NCT03251326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65463724|NCT03251326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65463725|NCT03251326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65463726|NCT03251326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65463727|NCT04140292|Vitamin D|vitamin d|mesh-list
65463728|NCT04140292|Cholecalciferol|cholecalciferol|mesh-list
65463729|NCT04140292|Vitamins|vitamins|mesh-ancestor
65463730|NCT04140292|Micronutrients|micronutrients|mesh-ancestor
65463731|NCT04140292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463732|NCT04140292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65463733|NCT04140292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65463734|NCT00127166|Fluticasone|fluticasone|mesh-list
65463735|NCT00127166|Xhance|xhance|mesh-list
65463736|NCT00127166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65463737|NCT00127166|Montelukast|montelukast|mesh-list
65463738|NCT00127166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65463739|NCT00127166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65463740|NCT00127166|Autonomic Agents|autonomic agents|mesh-ancestor
65463741|NCT00127166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65463742|NCT00127166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463743|NCT00127166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65463744|NCT00127166|Respiratory System Agents|respiratory system agents|mesh-ancestor
65463745|NCT00127166|Dermatologic Agents|dermatologic agents|mesh-ancestor
65463746|NCT00127166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65463747|NCT00127166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65463748|NCT00127166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65463749|NCT00127166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65463750|NCT00127166|Adrenergic Agents|adrenergic agents|mesh-ancestor
65463751|NCT00127166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65463752|NCT00127166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463753|NCT00127166|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64706643|NCT02643979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64706644|NCT02643979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706645|NCT02643979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64706666|NCT02667704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64706667|NCT02667704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706668|NCT02667704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706669|NCT02667704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64706672|NCT02645617|Cholinergic Agents|cholinergic agents|mesh-ancestor
64706673|NCT02645617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64706674|NCT02645617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463754|NCT00127166|Hormone Antagonists|hormone antagonists|mesh-ancestor
65463755|NCT00127166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65463756|NCT00127166|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65463757|NCT00127166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65463758|NCT00125138|Metylperon|metylperon|mesh-list
65463759|NCT00125138|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65463760|NCT00125138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65463761|NCT00125138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65463762|NCT00125138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463763|NCT00125138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65463764|NCT04132336|Naproxen|naproxen|mesh-list
65463765|NCT04132336|Caffeine|caffeine|mesh-list
65463766|NCT04132336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65463767|NCT04132336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463768|NCT04132336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65463769|NCT04132336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463770|NCT04132336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463771|NCT04132336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65463772|NCT04132336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65463773|NCT04132336|Purinergic Agents|purinergic agents|mesh-ancestor
65463774|NCT04132336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65463775|NCT04132336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64706675|NCT02645617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484563|NCT03839134|Epinephryl borate|epinephryl borate|mesh-list
64706677|NCT02694601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64706678|NCT02694601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706680|NCT02694601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706681|NCT02694601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706682|NCT02694601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64706683|NCT02694601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64706684|NCT02694601|Purinergic Agents|purinergic agents|mesh-ancestor
64706685|NCT02694601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64706686|NCT02690948|Pembrolizumab|pembrolizumab|mesh-list
64706687|NCT02690948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64706688|NCT02690948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706689|NCT02698735|Gentamicins|gentamicins|mesh-list
64706690|NCT02698735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64706691|NCT02698735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64706692|NCT02698735|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64706693|NCT02698735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706694|NCT02698735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706710|NCT05502211|Anesthetics, Local|anesthetics, local|mesh-ancestor
64706711|NCT05502211|Anesthetics|anesthetics|mesh-ancestor
64706712|NCT05502211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64706713|NCT05502211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706714|NCT05502211|Sensory System Agents|sensory system agents|mesh-ancestor
64706715|NCT05502211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706716|NCT05502211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65463776|NCT04132336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65463777|NCT04132336|Analgesics|analgesics|mesh-ancestor
65463778|NCT04132336|Sensory System Agents|sensory system agents|mesh-ancestor
65463779|NCT04132336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65463780|NCT04132336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65463781|NCT04132336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65463782|NCT04132336|Gout Suppressants|gout suppressants|mesh-ancestor
65463783|NCT04132336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65463784|NCT04131556|Maribavir|maribavir|mesh-list
65463785|NCT04131556|Antiviral Agents|antiviral agents|mesh-ancestor
65463786|NCT04131556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65463787|NCT04315636|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65463788|NCT04315636|Respiratory System Agents|respiratory system agents|mesh-ancestor
65463789|NCT03691948|Analgesics, Opioid|analgesics, opioid|mesh-list
65463790|NCT03691948|Narcotics|narcotics|mesh-ancestor
65463791|NCT03691948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65463792|NCT03691948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463794|NCT03691948|Sensory System Agents|sensory system agents|mesh-ancestor
65463795|NCT03691948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65463796|NCT04124926|Lansoprazole|lansoprazole|mesh-list
65463797|NCT04124926|Dexlansoprazole|dexlansoprazole|mesh-list
65463798|NCT04124926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65463799|NCT04124926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65463800|NCT04124926|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65463801|NCT04124926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463802|NCT04124926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463803|NCT03746158|Curcumin|curcumin|mesh-list
65463804|NCT03746158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65463805|NCT03746158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64706717|NCT05502211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64706718|NCT05502211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64706719|NCT05502211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64706720|NCT05502211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706721|NCT05502211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64706722|NCT05502211|Narcotics|narcotics|mesh-ancestor
64706723|NCT05502211|Analgesics|analgesics|mesh-ancestor
64706724|NCT05502211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64706725|NCT05502211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64706726|NCT05502211|Anesthetics, General|anesthetics, general|mesh-ancestor
64706727|NCT02674412|Buspirone|buspirone|mesh-list
64706728|NCT02674412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64718911|NCT04333225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718912|NCT04333225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64718913|NCT00556400|Contraceptive Agents|contraceptive agents|mesh-list
64718914|NCT00556400|Contraceptives, Oral|contraceptives, oral|mesh-list
64706729|NCT02674412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64706730|NCT02674412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65463806|NCT03746158|Analgesics|analgesics|mesh-ancestor
65463807|NCT03746158|Sensory System Agents|sensory system agents|mesh-ancestor
65463808|NCT03746158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65463809|NCT03746158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463810|NCT03746158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65463811|NCT03746158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65463812|NCT03746158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463813|NCT03746158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463814|NCT03746158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463815|NCT03747094|Fentanyl|fentanyl|mesh-list
65463816|NCT03747094|Ketamine|ketamine|mesh-list
65463817|NCT03747094|Analgesics|analgesics|mesh-ancestor
65463818|NCT03747094|Sensory System Agents|sensory system agents|mesh-ancestor
64706731|NCT02674412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706732|NCT02674412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64706733|NCT02674412|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64706734|NCT02674412|Serotonin Agents|serotonin agents|mesh-ancestor
64706735|NCT02674412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64706736|NCT02674412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706738|NCT04708106|Antipruritics|antipruritics|mesh-ancestor
64706739|NCT04708106|Dermatologic Agents|dermatologic agents|mesh-ancestor
64706740|NCT02697188|Methyltestosterone|methyltestosterone|mesh-list
64706741|NCT02697188|Testosterone|testosterone|mesh-list
64706767|NCT05403710|Botulinum Toxins|botulinum toxins|mesh-list
64706768|NCT05403710|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64706769|NCT05403710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64706770|NCT05403710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706771|NCT05403710|Cholinergic Agents|cholinergic agents|mesh-ancestor
64706772|NCT05403710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64706773|NCT05403710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706774|NCT02703350|Insulin Lispro|insulin lispro|mesh-list
64706775|NCT02703350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64336469|NCT03867123|Temozolomide|temozolomide|mesh-list
64706807|NCT02656069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64706810|NCT05351762|Paclitaxel|paclitaxel|mesh-list
64706811|NCT05351762|Nimotuzumab|nimotuzumab|mesh-list
64706812|NCT05351762|Nedaplatin|nedaplatin|mesh-list
64706813|NCT05351762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64706814|NCT05351762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706815|NCT05351762|Tubulin Modulators|tubulin modulators|mesh-ancestor
64706816|NCT05351762|Antimitotic Agents|antimitotic agents|mesh-ancestor
64706817|NCT05351762|Mitosis Modulators|mitosis modulators|mesh-ancestor
64706818|NCT05351762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706819|NCT05351762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64706820|NCT02708641|Pembrolizumab|pembrolizumab|mesh-list
64706821|NCT02708641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64706822|NCT02708641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706823|NCT02710981|Sildenafil Citrate|sildenafil citrate|mesh-list
64706824|NCT02710981|Clomiphene|clomiphene|mesh-list
64945600|NCT05423106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64706825|NCT02710981|Enclomiphene|enclomiphene|mesh-list
64706826|NCT02710981|Zuclomiphene|zuclomiphene|mesh-list
64706827|NCT02710981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706828|NCT02710981|Vasodilator Agents|vasodilator agents|mesh-ancestor
64706829|NCT02710981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64706830|NCT02710981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64706831|NCT02710981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706832|NCT02710981|Urological Agents|urological agents|mesh-ancestor
64706833|NCT02710981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64706834|NCT02710981|Hormone Antagonists|hormone antagonists|mesh-ancestor
64718915|NCT00556400|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64718916|NCT00556400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65463819|NCT03747094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65463820|NCT03747094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463821|NCT03747094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65463822|NCT03747094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65463823|NCT03747094|Anesthetics, General|anesthetics, general|mesh-ancestor
65463824|NCT03747094|Anesthetics|anesthetics|mesh-ancestor
65463825|NCT03747094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65463826|NCT03747094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65463827|NCT03747094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65463828|NCT03747094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65463829|NCT03747094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463830|NCT03747094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65463831|NCT03747094|Narcotics|narcotics|mesh-ancestor
65463832|NCT03747094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65463833|NCT04105972|Ivacaftor|ivacaftor|mesh-list
65463834|NCT04105972|Elexacaftor|elexacaftor|mesh-list
65463835|NCT04105972|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65463836|NCT04105972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64848310|NCT03926091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64718917|NCT00556400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718918|NCT00556400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64718919|NCT00521924|Cyclosporine|cyclosporine|mesh-list
64718920|NCT00521924|Chloroquine|chloroquine|mesh-list
64718921|NCT00521924|Sulfasalazine|sulfasalazine|mesh-list
64718922|NCT00521924|Methotrexate|methotrexate|mesh-list
64327050|NCT03539003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64706835|NCT02710981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64706836|NCT02710981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706837|NCT02710981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64706838|NCT02710981|Fertility Agents|fertility agents|mesh-ancestor
64706839|NCT02710981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64336514|NCT02333799|Antitubercular Agents|antitubercular agents|mesh-ancestor
64706854|NCT05343481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64706855|NCT05343481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706856|NCT05343481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64706857|NCT05343481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706858|NCT05303636|Drospirenone|drospirenone|mesh-list
64706859|NCT05303636|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64706860|NCT05303636|Hormone Antagonists|hormone antagonists|mesh-ancestor
64706861|NCT05303636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64706862|NCT05303636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706863|NCT05303636|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64706864|NCT05303636|Diuretics|diuretics|mesh-ancestor
64706865|NCT05303636|Natriuretic Agents|natriuretic agents|mesh-ancestor
64706866|NCT02659501|Acetaminophen|acetaminophen|mesh-list
64706867|NCT02659501|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64706868|NCT02659501|Epinephrine|epinephrine|mesh-list
64706869|NCT02659501|Diazepam|diazepam|mesh-list
64706870|NCT02659501|Morphine|morphine|mesh-list
64706871|NCT02659501|Hydrocodone|hydrocodone|mesh-list
64706872|NCT02659501|Bupivacaine|bupivacaine|mesh-list
64706873|NCT02659501|Anesthetics, Local|anesthetics, local|mesh-ancestor
64706874|NCT02659501|Anesthetics|anesthetics|mesh-ancestor
64706875|NCT02659501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64706876|NCT02659501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463837|NCT04105972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463838|NCT00124982|Abatacept|abatacept|mesh-list
65463839|NCT00124982|Antirheumatic Agents|antirheumatic agents|mesh-list
65463840|NCT00124982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65463841|NCT00124982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463842|NCT00124982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463843|NCT00124982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65463844|NCT00124982|Immunologic Factors|immunologic factors|mesh-ancestor
65463845|NCT00124982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463846|NCT04090528|Pembrolizumab|pembrolizumab|mesh-list
65463847|NCT04090528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65463848|NCT04090528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463849|NCT04249336|Listerine|listerine|mesh-list
65463850|NCT04249336|Calcium|calcium|mesh-list
65463851|NCT04249336|Fluorides|fluorides|mesh-list
65463852|NCT04249336|Sodium Fluoride|sodium fluoride|mesh-list
65463853|NCT04249336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65463854|NCT04249336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463855|NCT04249336|Cariostatic Agents|cariostatic agents|mesh-ancestor
65463856|NCT04249336|Protective Agents|protective agents|mesh-ancestor
65463857|NCT04249336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65463858|NCT04249336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65463859|NCT03752476|Lactams|lactams|mesh-list
65463860|NCT03752476|beta-Lactams|beta-lactams|mesh-list
65463861|NCT03752476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65463862|NCT03752476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65463863|NCT04078126|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65463864|NCT04078126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65463865|NCT04078126|Respiratory System Agents|respiratory system agents|mesh-ancestor
65213361|NCT04165083|Pembrolizumab|pembrolizumab|mesh-list
65463866|NCT00124748|Imatinib Mesylate|imatinib mesylate|mesh-list
65463867|NCT00124748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848328|NCT03922451|Tazobactam|tazobactam|mesh-list
64706877|NCT02659501|Sensory System Agents|sensory system agents|mesh-ancestor
64432120|NCT04891484|Serotonin Agents|serotonin agents|mesh-ancestor
64706878|NCT02659501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706879|NCT02659501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64706880|NCT02659501|Narcotics|narcotics|mesh-ancestor
64706881|NCT02659501|Analgesics|analgesics|mesh-ancestor
64706882|NCT02659501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64706883|NCT02659501|Antipyretics|antipyretics|mesh-ancestor
64706884|NCT02659501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64706885|NCT02659501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65463868|NCT00124748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65463869|NCT00124748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463870|NCT00124748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463871|NCT01078142|Sirolimus|sirolimus|mesh-list
65463872|NCT01078142|Rituximab|rituximab|mesh-list
65463873|NCT01078142|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65463874|NCT01078142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65463875|NCT01078142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463876|NCT01078142|Immunologic Factors|immunologic factors|mesh-ancestor
65463877|NCT01078142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463878|NCT01078142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65463879|NCT01078142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65463880|NCT01078142|Alkylating Agents|alkylating agents|mesh-ancestor
65463881|NCT01078142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463882|NCT01078142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65463883|NCT01078142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65463884|NCT01078142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65463885|NCT01078142|Antifungal Agents|antifungal agents|mesh-ancestor
65463886|NCT01078142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65463887|NCT04060654|Buprenorphine|buprenorphine|mesh-list
65463888|NCT04060654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65463889|NCT04060654|Narcotics|narcotics|mesh-ancestor
64848360|NCT05802303|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64848361|NCT05802290|Nivolumab|nivolumab|mesh-list
64848362|NCT05802290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64848363|NCT05802290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848364|NCT05802290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64848365|NCT05802290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706886|NCT02659501|Adrenergic Agents|adrenergic agents|mesh-ancestor
64706887|NCT02659501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64706888|NCT02659501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706889|NCT02659501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64706890|NCT02659501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64706891|NCT02659501|Autonomic Agents|autonomic agents|mesh-ancestor
64706892|NCT02659501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64706893|NCT02659501|Respiratory System Agents|respiratory system agents|mesh-ancestor
64706894|NCT02659501|Mydriatics|mydriatics|mesh-ancestor
64718923|NCT00521924|Infliximab|infliximab|mesh-list
64718924|NCT00521924|Antirheumatic Agents|antirheumatic agents|mesh-list
64718925|NCT00521924|Cyclosporins|cyclosporins|mesh-list
64718926|NCT00521924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64718927|NCT00521924|Abortifacient Agents|abortifacient agents|mesh-ancestor
64718928|NCT00521924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64718929|NCT00521924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706895|NCT02659501|Sympathomimetics|sympathomimetics|mesh-ancestor
65463890|NCT04060654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65463891|NCT04060654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463892|NCT04060654|Analgesics|analgesics|mesh-ancestor
65463893|NCT04060654|Sensory System Agents|sensory system agents|mesh-ancestor
65463894|NCT04060654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65463895|NCT04060654|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65463896|NCT00096200|Paclitaxel|paclitaxel|mesh-list
65463897|NCT00096200|Carboplatin|carboplatin|mesh-list
65463898|NCT00096200|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65463899|NCT00096200|Sorafenib|sorafenib|mesh-list
65463900|NCT00096200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65463901|NCT00096200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463902|NCT00096200|Tubulin Modulators|tubulin modulators|mesh-ancestor
65463903|NCT00096200|Antimitotic Agents|antimitotic agents|mesh-ancestor
65463904|NCT00096200|Mitosis Modulators|mitosis modulators|mesh-ancestor
65463905|NCT00096200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463906|NCT00096200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65463907|NCT00096200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463908|NCT00096044|Rituximab|rituximab|mesh-list
65463909|NCT00096044|Lenalidomide|lenalidomide|mesh-list
65463910|NCT00096044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64848382|NCT05802108|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
64706896|NCT02659501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64706897|NCT02659501|Antitussive Agents|antitussive agents|mesh-ancestor
64706898|NCT02659501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64706899|NCT02659501|Anticonvulsants|anticonvulsants|mesh-ancestor
64706908|NCT02659501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64706909|NCT02659501|Anesthetics, General|anesthetics, general|mesh-ancestor
64706910|NCT02659501|GABA Modulators|gaba modulators|mesh-ancestor
64706912|NCT02659501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64706913|NCT02659501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64706914|NCT02659501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64706915|NCT00367939|Amlodipine|amlodipine|mesh-list
64706916|NCT00367939|Valsartan|valsartan|mesh-list
64706917|NCT00367939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64706918|NCT00367939|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64706919|NCT00367939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64706922|NCT00367939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706923|NCT00367939|Vasodilator Agents|vasodilator agents|mesh-ancestor
64706924|NCT00367939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64706925|NCT00367939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64706926|NCT02720107|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64706927|NCT02720107|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64706928|NCT02720107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706929|NCT02720107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64706930|NCT02720107|Immunologic Factors|immunologic factors|mesh-ancestor
64706931|NCT02720107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706932|NCT02722837|Sofosbuvir|sofosbuvir|mesh-list
64706933|NCT02722837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64706934|NCT02722837|Velpatasvir|velpatasvir|mesh-list
64706935|NCT02722837|Antiviral Agents|antiviral agents|mesh-ancestor
64706936|NCT02722837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65463911|NCT00096044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463912|NCT00096044|Immunologic Factors|immunologic factors|mesh-ancestor
65463913|NCT00096044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463914|NCT00096044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65463915|NCT00096044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65463916|NCT00096044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65463917|NCT00096044|Growth Substances|growth substances|mesh-ancestor
65463918|NCT00096044|Growth Inhibitors|growth inhibitors|mesh-ancestor
65463919|NCT03963128|Vitamin D|vitamin d|mesh-list
65463920|NCT03963128|Cholecalciferol|cholecalciferol|mesh-list
65463921|NCT03963128|Vitamins|vitamins|mesh-ancestor
65463922|NCT03963128|Micronutrients|micronutrients|mesh-ancestor
65463923|NCT03963128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463924|NCT03963128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65463925|NCT03963128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65463926|NCT01083212|Gemfibrozil|gemfibrozil|mesh-list
65463927|NCT01083212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65463928|NCT01083212|Antimetabolites|antimetabolites|mesh-ancestor
65463929|NCT01083212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463930|NCT01083212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65463931|NCT01083212|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65463932|NCT01083212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65463933|NCT01083212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463934|NCT01083290|Spironolactone|spironolactone|mesh-list
65463935|NCT01083290|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65463936|NCT01083290|Hormone Antagonists|hormone antagonists|mesh-ancestor
64706937|NCT02710526|Buprenorphine|buprenorphine|mesh-list
64706938|NCT02710526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64706939|NCT02710526|Narcotics|narcotics|mesh-ancestor
64706940|NCT02710526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64706941|NCT02710526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706942|NCT02710526|Analgesics|analgesics|mesh-ancestor
64706943|NCT02710526|Sensory System Agents|sensory system agents|mesh-ancestor
64706944|NCT02710526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706945|NCT02710526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64706946|NCT02664961|Bevacizumab|bevacizumab|mesh-list
64706947|NCT02664961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64706948|NCT02664961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706949|NCT02664961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64706950|NCT02664961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64706951|NCT02664961|Growth Substances|growth substances|mesh-ancestor
64706952|NCT02664961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706953|NCT02664961|Growth Inhibitors|growth inhibitors|mesh-ancestor
64706955|NCT02665273|Anesthetics, Local|anesthetics, local|mesh-ancestor
64706956|NCT02665273|Anesthetics|anesthetics|mesh-ancestor
64706957|NCT02665273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64706958|NCT02665273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706959|NCT02665273|Sensory System Agents|sensory system agents|mesh-ancestor
64718930|NCT00521924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65463937|NCT01083290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65463938|NCT01083290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463939|NCT01083290|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65213436|NCT04039867|Antimetabolites|antimetabolites|mesh-ancestor
65463940|NCT01083290|Diuretics|diuretics|mesh-ancestor
65463941|NCT01083290|Natriuretic Agents|natriuretic agents|mesh-ancestor
65463942|NCT01326650|Vitamin D|vitamin d|mesh-list
65463943|NCT01326650|Ergocalciferols|ergocalciferols|mesh-list
65463944|NCT01326650|Cholecalciferol|cholecalciferol|mesh-list
65463945|NCT01326650|Vitamins|vitamins|mesh-list
65463946|NCT01326650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65463947|NCT01326650|Micronutrients|micronutrients|mesh-ancestor
65463948|NCT01326650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463949|NCT01326650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65463950|NCT01326650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65463951|NCT03689374|Insulin|insulin|mesh-list
65463952|NCT03689374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65463953|NCT03689374|Insulin Glargine|insulin glargine|mesh-list
65463954|NCT03689374|Insulin Aspart|insulin aspart|mesh-list
65463955|NCT03689374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64848430|NCT05801757|Anesthetics|anesthetics|mesh-ancestor
64718931|NCT00521924|Antimetabolites|antimetabolites|mesh-ancestor
64718932|NCT00521924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718933|NCT00521924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718934|NCT00521924|Dermatologic Agents|dermatologic agents|mesh-ancestor
64718935|NCT00521924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718936|NCT00521924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64718937|NCT00521924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64706960|NCT02665273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706978|NCT04130438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706979|NCT04130438|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64706980|NCT04130438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64706981|NCT04130438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64706982|NCT04048850|Grazoprevir|grazoprevir|mesh-list
64706983|NCT04048850|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
64706984|NCT04048850|Antiviral Agents|antiviral agents|mesh-ancestor
64706985|NCT04048850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64706986|NCT05261672|Midazolam|midazolam|mesh-list
64706987|NCT05261672|Bupivacaine|bupivacaine|mesh-list
64706988|NCT05261672|Anesthetics, Local|anesthetics, local|mesh-ancestor
64706989|NCT05261672|Anesthetics|anesthetics|mesh-ancestor
64706990|NCT05261672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64706993|NCT05261672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706994|NCT05261672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64706995|NCT05261672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64706996|NCT05261672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64706997|NCT05261672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64706998|NCT05261672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64706999|NCT05261672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64707000|NCT05261672|Anesthetics, General|anesthetics, general|mesh-ancestor
64707001|NCT05261672|GABA Modulators|gaba modulators|mesh-ancestor
64707002|NCT05261672|GABA Agents|gaba agents|mesh-ancestor
64707003|NCT05261672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64707004|NCT05261672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707005|NCT02714504|Voriconazole|voriconazole|mesh-list
64707006|NCT02714504|Posaconazole|posaconazole|mesh-list
65463956|NCT03689374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463957|NCT00113360|Everolimus|everolimus|mesh-list
65463958|NCT00113360|Octreotide|octreotide|mesh-list
65463959|NCT00113360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463960|NCT00113360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65463961|NCT00113360|Immunologic Factors|immunologic factors|mesh-ancestor
65463962|NCT00113360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463963|NCT00113360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65463964|NCT00113360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65463965|NCT03745300|Atorvastatin|atorvastatin|mesh-list
65463966|NCT03745300|Simvastatin|simvastatin|mesh-list
65463967|NCT03745300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65463968|NCT03745300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65463969|NCT03745300|Antimetabolites|antimetabolites|mesh-ancestor
65463970|NCT03745300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463971|NCT03745300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65463972|NCT03745300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65463973|NCT03745300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463974|NCT00112736|Sirolimus|sirolimus|mesh-list
65463975|NCT00112736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65463976|NCT00112736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65463977|NCT00112736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65463978|NCT00112736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463979|NCT00112736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463980|NCT00112736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65463981|NCT00112736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65463982|NCT00112736|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65463983|NCT00112736|Antifungal Agents|antifungal agents|mesh-ancestor
65463984|NCT00112736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65463985|NCT00112736|Immunologic Factors|immunologic factors|mesh-ancestor
65463986|NCT00112736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65463987|NCT04052620|Diclofenac|diclofenac|mesh-list
65463988|NCT04052620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65463989|NCT04052620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65463996|NCT04052620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65463997|NCT04052620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65463998|NCT04052620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65463999|NCT00112580|Ipilimumab|ipilimumab|mesh-list
65464000|NCT00112580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65464001|NCT00112580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464002|NCT00112580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65464003|NCT00112580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464004|NCT04238650|Bevacizumab|bevacizumab|mesh-list
65464005|NCT04238650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65464006|NCT04238650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464007|NCT04238650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65464008|NCT04238650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65464009|NCT04238650|Growth Substances|growth substances|mesh-ancestor
65464010|NCT04238650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464011|NCT04238650|Growth Inhibitors|growth inhibitors|mesh-ancestor
65464012|NCT00095498|Denosumab|denosumab|mesh-list
65464013|NCT00095498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65464014|NCT00095498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707007|NCT02714504|Antifungal Agents|antifungal agents|mesh-ancestor
64707008|NCT02714504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64707009|NCT02714504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64707010|NCT02714504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64707011|NCT02714504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64707012|NCT02714504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707013|NCT02714504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64707014|NCT02714504|Hormone Antagonists|hormone antagonists|mesh-ancestor
64336581|NCT02039661|Anesthetics|anesthetics|mesh-ancestor
64707015|NCT02714504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64707016|NCT02714504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336591|NCT02326779|Aspirin|aspirin|mesh-list
64707023|NCT05221502|Antitubercular Agents|antitubercular agents|mesh-ancestor
64707024|NCT05221502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64707025|NCT05221502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64707026|NCT02730247|Paclitaxel|paclitaxel|mesh-list
64336625|NCT03144453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707027|NCT02730247|Ramucirumab|ramucirumab|mesh-list
64707028|NCT02730247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64707029|NCT02730247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707030|NCT02730247|Tubulin Modulators|tubulin modulators|mesh-ancestor
64707031|NCT02730247|Antimitotic Agents|antimitotic agents|mesh-ancestor
64707032|NCT02730247|Mitosis Modulators|mitosis modulators|mesh-ancestor
64707033|NCT02730247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707034|NCT03889106|Ribavirin|ribavirin|mesh-list
64707035|NCT03889106|Antimetabolites|antimetabolites|mesh-ancestor
64707036|NCT03889106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707037|NCT03889106|Antiviral Agents|antiviral agents|mesh-ancestor
64707038|NCT03889106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64707039|NCT00368329|Carboplatin|carboplatin|mesh-list
64707040|NCT00368329|Fluorouracil|fluorouracil|mesh-list
64707041|NCT00368329|Capecitabine|capecitabine|mesh-list
64707042|NCT00368329|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64707043|NCT00368329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707044|NCT00368329|Antimetabolites|antimetabolites|mesh-ancestor
65464015|NCT04237792|Dexmedetomidine|dexmedetomidine|mesh-list
65464016|NCT04237792|Propofol|propofol|mesh-list
65464017|NCT04237792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65464018|NCT04237792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65464019|NCT04237792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464020|NCT04237792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65464021|NCT04237792|Anesthetics, General|anesthetics, general|mesh-ancestor
65464022|NCT04237792|Anesthetics|anesthetics|mesh-ancestor
65464023|NCT04237792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65464024|NCT04237792|Analgesics|analgesics|mesh-ancestor
65464025|NCT04237792|Sensory System Agents|sensory system agents|mesh-ancestor
65464026|NCT04237792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464027|NCT04237792|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65464028|NCT04237792|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65464029|NCT04237792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65464030|NCT04237792|Adrenergic Agents|adrenergic agents|mesh-ancestor
65464031|NCT04237792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65464032|NCT04237792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464033|NCT04233580|Chlorhexidine|chlorhexidine|mesh-list
65464034|NCT04233580|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65464035|NCT04233580|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65464036|NCT04233580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65464037|NCT04233580|Disinfectants|disinfectants|mesh-ancestor
65464038|NCT04233580|Dermatologic Agents|dermatologic agents|mesh-ancestor
65464039|NCT03414034|Prednisone|prednisone|mesh-list
65464040|NCT03414034|Onvansertib|onvansertib|mesh-list
65464041|NCT03414034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65464042|NCT03414034|Glucocorticoids|glucocorticoids|mesh-ancestor
65464043|NCT03414034|Hormones|hormones|mesh-ancestor
65464045|NCT03414034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464061|NCT03746782|Hemostatics|hemostatics|mesh-ancestor
65464062|NCT03746782|Coagulants|coagulants|mesh-ancestor
65464063|NCT04026568|4-Aminopyridine|4-aminopyridine|mesh-list
65464064|NCT04026568|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65464065|NCT04026568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65464066|NCT04026568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464067|NCT04024228|Vaccines|vaccines|mesh-list
65464068|NCT04024228|Hemagglutinins|hemagglutinins|mesh-list
65464069|NCT04024228|Immunologic Factors|immunologic factors|mesh-ancestor
65464070|NCT04024228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464071|NCT04024228|Agglutinins|agglutinins|mesh-ancestor
65464072|NCT04023682|Hand Sanitizers|hand sanitizers|mesh-list
65464073|NCT04023682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65464074|NCT04023682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65464075|NCT04023682|Disinfectants|disinfectants|mesh-ancestor
64848549|NCT05800860|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
64707045|NCT00368329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707046|NCT00368329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64707047|NCT00368329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64707048|NCT00368329|Immunologic Factors|immunologic factors|mesh-ancestor
64707049|NCT00368329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707050|NCT00368329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64707051|NCT02670343|Methyltestosterone|methyltestosterone|mesh-list
64707052|NCT02670343|Testosterone|testosterone|mesh-list
64707053|NCT02670343|Testosterone undecanoate|testosterone undecanoate|mesh-list
64707054|NCT02670343|Testosterone enanthate|testosterone enanthate|mesh-list
64707055|NCT02670343|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64707056|NCT02670343|Androgens|androgens|mesh-ancestor
64707057|NCT02670343|Hormones|hormones|mesh-ancestor
64707058|NCT02670343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64707059|NCT02670343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707060|NCT02670343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64707061|NCT02670343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707062|NCT02670343|Anabolic Agents|anabolic agents|mesh-ancestor
64707067|NCT02730884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64707068|NCT02730884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64707069|NCT02730884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707070|NCT02732587|Saracatinib|saracatinib|mesh-list
64707079|NCT02731820|Vitamins|vitamins|mesh-ancestor
64718946|NCT00521924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64718947|NCT00521924|Antimalarials|antimalarials|mesh-ancestor
64718948|NCT00521924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64718949|NCT00521924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64458245|NCT04028830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64718950|NCT00521924|Analgesics|analgesics|mesh-ancestor
64327076|NCT00750295|Hematinics|hematinics|mesh-ancestor
64707080|NCT02731820|Micronutrients|micronutrients|mesh-ancestor
64707081|NCT02731820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707082|NCT02731820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64707083|NCT02731820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64707084|NCT02731820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707085|NCT02731820|Antacids|antacids|mesh-ancestor
64707086|NCT02731820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64707087|NCT02731820|Diuretics|diuretics|mesh-ancestor
64707088|NCT02731820|Natriuretic Agents|natriuretic agents|mesh-ancestor
64707089|NCT02731820|Expectorants|expectorants|mesh-ancestor
64707090|NCT02731820|Respiratory System Agents|respiratory system agents|mesh-ancestor
64707091|NCT02732899|Sirolimus|sirolimus|mesh-list
64707092|NCT02732899|Aflibercept|aflibercept|mesh-list
64707093|NCT02732899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64707094|NCT02732899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65464076|NCT04018612|Acetaminophen|acetaminophen|mesh-list
65464077|NCT04018612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65464078|NCT04018612|Analgesics|analgesics|mesh-ancestor
65464079|NCT04018612|Sensory System Agents|sensory system agents|mesh-ancestor
65464080|NCT04018612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464081|NCT04018612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464082|NCT04018612|Antipyretics|antipyretics|mesh-ancestor
65464083|NCT03395080|Paclitaxel|paclitaxel|mesh-list
65464084|NCT03395080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65464085|NCT03395080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464086|NCT03395080|Tubulin Modulators|tubulin modulators|mesh-ancestor
65464087|NCT03395080|Antimitotic Agents|antimitotic agents|mesh-ancestor
65464088|NCT03395080|Mitosis Modulators|mitosis modulators|mesh-ancestor
65464089|NCT03395080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464090|NCT04207840|Epinephrine|epinephrine|mesh-list
65464091|NCT04207840|Racepinephrine|racepinephrine|mesh-list
65213590|NCT03578367|Vitamins|vitamins|mesh-ancestor
65464092|NCT04207840|Albuterol|albuterol|mesh-list
65464093|NCT04207840|Epinephryl borate|epinephryl borate|mesh-list
65464094|NCT04207840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65464095|NCT04207840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65464096|NCT04207840|Adrenergic Agents|adrenergic agents|mesh-ancestor
65464097|NCT04207840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64848563|NCT05800847|Anticonvulsants|anticonvulsants|mesh-ancestor
64707095|NCT02732899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64707096|NCT02732899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707097|NCT02732899|Antifungal Agents|antifungal agents|mesh-ancestor
64707098|NCT02732899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64707099|NCT02732899|Immunologic Factors|immunologic factors|mesh-ancestor
64432345|NCT02401256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64707100|NCT02732899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707101|NCT02732899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64707102|NCT02732899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64707103|NCT02732899|Growth Substances|growth substances|mesh-ancestor
64707104|NCT02732899|Growth Inhibitors|growth inhibitors|mesh-ancestor
64707105|NCT02733757|Clonidine|clonidine|mesh-list
64707106|NCT02733757|Analgesics|analgesics|mesh-ancestor
64707107|NCT02733757|Sensory System Agents|sensory system agents|mesh-ancestor
64707108|NCT02733757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64707109|NCT02733757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707110|NCT02733757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64707111|NCT02733757|Sympatholytics|sympatholytics|mesh-ancestor
64707112|NCT02733757|Autonomic Agents|autonomic agents|mesh-ancestor
64707113|NCT02733757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64707114|NCT02733757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64707115|NCT02733757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64707116|NCT02733757|Adrenergic Agents|adrenergic agents|mesh-ancestor
64707117|NCT02733757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64707118|NCT02733757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707119|NCT00368264|Infliximab|infliximab|mesh-list
64707120|NCT00368264|Dermatologic Agents|dermatologic agents|mesh-ancestor
64707121|NCT00368264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64945602|NCT05423106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707122|NCT00368264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65464098|NCT04207840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464099|NCT04207840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464100|NCT04207840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65464101|NCT04207840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65464102|NCT04207840|Autonomic Agents|autonomic agents|mesh-ancestor
65464103|NCT04207840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464104|NCT04207840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65464105|NCT04207840|Respiratory System Agents|respiratory system agents|mesh-ancestor
65464106|NCT04207840|Mydriatics|mydriatics|mesh-ancestor
65464107|NCT04207840|Sympathomimetics|sympathomimetics|mesh-ancestor
65464108|NCT04207840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65464109|NCT04207840|Tocolytic Agents|tocolytic agents|mesh-ancestor
65464110|NCT04207840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65464111|NCT04207840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65464112|NCT04195828|Paclitaxel|paclitaxel|mesh-list
65464113|NCT04195828|Apatinib|apatinib|mesh-list
65464114|NCT04195828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65464115|NCT04195828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464116|NCT04195828|Tubulin Modulators|tubulin modulators|mesh-ancestor
65464117|NCT04195828|Antimitotic Agents|antimitotic agents|mesh-ancestor
64707123|NCT02734147|Ascorbic Acid|ascorbic acid|mesh-list
64707124|NCT02734147|Antioxidants|antioxidants|mesh-ancestor
64707125|NCT02734147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707126|NCT02734147|Protective Agents|protective agents|mesh-ancestor
64707127|NCT02734147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707128|NCT02734147|Vitamins|vitamins|mesh-ancestor
64707129|NCT02734147|Micronutrients|micronutrients|mesh-ancestor
64707130|NCT00368342|Azithromycin|azithromycin|mesh-list
64707131|NCT00368342|Clarithromycin|clarithromycin|mesh-list
64707174|NCT03535376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64707175|NCT03535376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707177|NCT02736175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64707178|NCT02736175|Antiemetics|antiemetics|mesh-ancestor
64432416|NCT02400476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64707179|NCT02736175|Autonomic Agents|autonomic agents|mesh-ancestor
64707180|NCT02736175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64707181|NCT02736175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707182|NCT02736175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64707183|NCT02736175|Glucocorticoids|glucocorticoids|mesh-ancestor
64707184|NCT02736175|Hormones|hormones|mesh-ancestor
64336684|NCT02330991|Temozolomide|temozolomide|mesh-list
64336686|NCT02330991|Alkylating Agents|alkylating agents|mesh-ancestor
64707199|NCT04947085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64707200|NCT04947085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707201|NCT04947085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64707202|NCT04947085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64707203|NCT04947085|Anesthetics, General|anesthetics, general|mesh-ancestor
64707204|NCT04947085|Anesthetics|anesthetics|mesh-ancestor
64707205|NCT04947085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64707206|NCT04947085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64707207|NCT04947085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64707208|NCT04947085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64707209|NCT04947085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707210|NCT03357224|Atezolizumab|atezolizumab|mesh-list
64707211|NCT03357224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464118|NCT04195828|Mitosis Modulators|mitosis modulators|mesh-ancestor
65464119|NCT04195828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464120|NCT04195828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65464121|NCT04195828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464122|NCT05163496|Psilocybin|psilocybin|mesh-list
65464123|NCT05163496|Hallucinogens|hallucinogens|mesh-ancestor
65464124|NCT05163496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464125|NCT05163496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65464126|NCT03744364|Misoprostol|misoprostol|mesh-list
65464127|NCT03744364|Dinoprostone|dinoprostone|mesh-list
65464128|NCT03744364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64707213|NCT04947020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64707214|NCT04947020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707215|NCT02679469|Nalmefene|nalmefene|mesh-list
64707216|NCT02679469|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64707217|NCT02679469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707218|NCT02679469|Sensory System Agents|sensory system agents|mesh-ancestor
64707219|NCT02679469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64707220|NCT04915508|Hormones|hormones|mesh-list
64707221|NCT04915508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64707222|NCT04915508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707223|NCT02681809|Fibrinolysin|fibrinolysin|mesh-list
64718956|NCT03927781|Sensory System Agents|sensory system agents|mesh-ancestor
64718957|NCT03927781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64718958|NCT03927781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718959|NCT03927781|Anticonvulsants|anticonvulsants|mesh-ancestor
64718960|NCT03927781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64718961|NCT03927781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64327087|NCT01372995|Cholecalciferol|cholecalciferol|mesh-list
64707224|NCT02681809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64707225|NCT02681809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64707226|NCT02681809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707227|NCT05445661|Mannitol|mannitol|mesh-list
64707228|NCT05445661|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64707229|NCT05445661|Diuretics|diuretics|mesh-ancestor
64707230|NCT05445661|Natriuretic Agents|natriuretic agents|mesh-ancestor
64707231|NCT05445661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707232|NCT04805125|Vaccines|vaccines|mesh-list
64707233|NCT04805125|Immunologic Factors|immunologic factors|mesh-ancestor
64707234|NCT04805125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707235|NCT00368017|Pioglitazone|pioglitazone|mesh-list
64707236|NCT00368017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64707237|NCT00368017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707238|NCT00367627|Albendazole|albendazole|mesh-list
64707239|NCT00367627|Anthelmintics|anthelmintics|mesh-ancestor
64707240|NCT00367627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64707241|NCT00367627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64707242|NCT00367627|Anticestodal Agents|anticestodal agents|mesh-ancestor
64707257|NCT05428969|Azacitidine|azacitidine|mesh-list
64707258|NCT05428969|Venetoclax|venetoclax|mesh-list
64707259|NCT05428969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64707260|NCT05428969|Antimetabolites|antimetabolites|mesh-ancestor
64707261|NCT05428969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707266|NCT05424523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64707267|NCT05424523|Respiratory System Agents|respiratory system agents|mesh-ancestor
64707268|NCT05442931|Magnesium Sulfate|magnesium sulfate|mesh-list
64707269|NCT05442931|Pregabalin|pregabalin|mesh-list
64707270|NCT05442931|Nitroglycerin|nitroglycerin|mesh-list
64707271|NCT05442931|Analgesics|analgesics|mesh-ancestor
64707272|NCT05442931|Sensory System Agents|sensory system agents|mesh-ancestor
64707278|NCT05442931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707279|NCT05442931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64707280|NCT05442931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64707281|NCT05442931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64707282|NCT05442931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65464129|NCT03744364|Abortifacient Agents|abortifacient agents|mesh-ancestor
65464130|NCT03744364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65464131|NCT03744364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464132|NCT03744364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65464133|NCT03744364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65464134|NCT03744364|Oxytocics|oxytocics|mesh-ancestor
65464135|NCT03744208|Antibodies|antibodies|mesh-list
65464136|NCT03744208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65464137|NCT03744208|Immunologic Factors|immunologic factors|mesh-ancestor
65464138|NCT03744208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464139|NCT05069896|Mirikizumab|mirikizumab|mesh-list
65464140|NCT05069896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65464141|NCT05069896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65464142|NCT05069896|Analgesics|analgesics|mesh-ancestor
65464143|NCT05069896|Sensory System Agents|sensory system agents|mesh-ancestor
65464144|NCT05069896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464145|NCT05069896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464146|NCT05069896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64848626|NCT05797597|Aspirin|aspirin|mesh-list
64707283|NCT05442931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64707284|NCT05442931|Anesthetics|anesthetics|mesh-ancestor
64707285|NCT05442931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64707286|NCT05442931|Tocolytic Agents|tocolytic agents|mesh-ancestor
64707287|NCT05442931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64707288|NCT05442931|Vasodilator Agents|vasodilator agents|mesh-ancestor
64707289|NCT05439499|Letrozole|letrozole|mesh-list
64707290|NCT05439499|Anastrozole|anastrozole|mesh-list
64707291|NCT05439499|Goserelin|goserelin|mesh-list
64707292|NCT05439499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707293|NCT05439499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64707294|NCT05439499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64707295|NCT05439499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718962|NCT03927781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718963|NCT03927781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64718964|NCT03927781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64707296|NCT05439499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707297|NCT05439499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64707298|NCT05439499|Hormone Antagonists|hormone antagonists|mesh-ancestor
64707299|NCT05439499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64707300|NCT05439499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707301|NCT05439499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64707307|NCT04003987|Bupivacaine|bupivacaine|mesh-list
64707308|NCT04003987|Anesthetics, Local|anesthetics, local|mesh-ancestor
64707309|NCT04003987|Anesthetics|anesthetics|mesh-ancestor
64707310|NCT04003987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64707311|NCT04003987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707312|NCT04003987|Sensory System Agents|sensory system agents|mesh-ancestor
64707313|NCT04003987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64707328|NCT05447455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707329|NCT05447455|Sensory System Agents|sensory system agents|mesh-ancestor
64707330|NCT05447455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64707331|NCT00369733|Darbepoetin alfa|darbepoetin alfa|mesh-list
64707333|NCT00368719|Tacrolimus|tacrolimus|mesh-list
64707334|NCT00368719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64707335|NCT00368719|Immunologic Factors|immunologic factors|mesh-ancestor
64707336|NCT00368719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464147|NCT05069896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65464148|NCT05069896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65464149|NCT05069896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65464150|NCT01562626|Flucytosine|flucytosine|mesh-list
65464151|NCT01562626|Antifungal Agents|antifungal agents|mesh-ancestor
65464152|NCT01562626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65464153|NCT01562626|Antimetabolites|antimetabolites|mesh-ancestor
65464154|NCT01562626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464155|NCT04470622|Aprepitant|aprepitant|mesh-list
65464156|NCT04470622|Antiemetics|antiemetics|mesh-ancestor
65464157|NCT04470622|Autonomic Agents|autonomic agents|mesh-ancestor
65464158|NCT04470622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464159|NCT04470622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464160|NCT04470622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65464161|NCT04470622|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65464162|NCT04470622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65464163|NCT04470622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464164|NCT04465396|Teduglutide|teduglutide|mesh-list
65464165|NCT04465396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65464166|NCT04465396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65464167|NCT04465396|Protective Agents|protective agents|mesh-ancestor
65464168|NCT04465396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464170|NCT03996694|Buprenorphine|buprenorphine|mesh-list
65464171|NCT03996694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65464172|NCT03996694|Narcotics|narcotics|mesh-ancestor
65464173|NCT03996694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65464174|NCT03996694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464175|NCT03996694|Analgesics|analgesics|mesh-ancestor
65464176|NCT03996694|Sensory System Agents|sensory system agents|mesh-ancestor
64707337|NCT00368719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64707338|NCT00368719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64707339|NCT00368719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707340|NCT00369811|Fentanyl|fentanyl|mesh-list
64707341|NCT00369811|Oxycodone|oxycodone|mesh-list
64707342|NCT00369811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64707343|NCT00369811|Narcotics|narcotics|mesh-ancestor
64707344|NCT00369811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64707345|NCT00369811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707346|NCT00369811|Analgesics|analgesics|mesh-ancestor
64707348|NCT00369811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64707349|NCT00369811|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64707350|NCT00369811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64707351|NCT00369811|Anesthetics, General|anesthetics, general|mesh-ancestor
64707352|NCT00369811|Anesthetics|anesthetics|mesh-ancestor
64707353|NCT03615547|Clomiphene|clomiphene|mesh-list
64707354|NCT03615547|Enclomiphene|enclomiphene|mesh-list
65464177|NCT03996694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464178|NCT03996694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65464179|NCT03743896|Capsaicin|capsaicin|mesh-list
65464180|NCT03743896|Antipruritics|antipruritics|mesh-ancestor
65464181|NCT03743896|Dermatologic Agents|dermatologic agents|mesh-ancestor
65464182|NCT03743896|Sensory System Agents|sensory system agents|mesh-ancestor
65464183|NCT03743896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464184|NCT03743896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464185|NCT03737344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65464186|NCT03737344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65464187|NCT03751228|BMS-986165|bms-986165|mesh-list
65464188|NCT03751228|Dermatologic Agents|dermatologic agents|mesh-ancestor
65464189|NCT03751228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65464190|NCT03751228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464191|NCT03751228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464192|NCT03656692|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65464193|NCT03656692|Hormones|hormones|mesh-ancestor
65464194|NCT03656692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65464195|NCT03656692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464196|NCT04439266|Crizotinib|crizotinib|mesh-list
65464197|NCT04439266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707355|NCT03615547|Zuclomiphene|zuclomiphene|mesh-list
64707356|NCT03615547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64707357|NCT03615547|Hormone Antagonists|hormone antagonists|mesh-ancestor
64707358|NCT03615547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64707359|NCT03615547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707360|NCT03615547|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64707361|NCT03615547|Fertility Agents|fertility agents|mesh-ancestor
64707362|NCT03615547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64707363|NCT03615547|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64707364|NCT03615547|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64707365|NCT03593317|Spironolactone|spironolactone|mesh-list
64707366|NCT03593317|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64707367|NCT03593317|Hormone Antagonists|hormone antagonists|mesh-ancestor
64707368|NCT03593317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64707369|NCT03593317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718965|NCT03927781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64718966|NCT03927781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64718967|NCT03927781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64718968|NCT00379964|Caspofungin|caspofungin|mesh-list
64718969|NCT00379964|Antifungal Agents|antifungal agents|mesh-ancestor
64718970|NCT00379964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64718971|NCT00379964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327102|NCT04239859|Antimetabolites|antimetabolites|mesh-ancestor
64336882|NCT02305927|Vitamin D|vitamin d|mesh-list
64707389|NCT05023993|Vasodilator Agents|vasodilator agents|mesh-ancestor
64707390|NCT03105128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64707391|NCT03105128|Immunologic Factors|immunologic factors|mesh-ancestor
64707392|NCT03105128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707393|NCT03122509|Durvalumab|durvalumab|mesh-list
64707394|NCT03122509|Tremelimumab|tremelimumab|mesh-list
64707395|NCT03122509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64707396|NCT03122509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464198|NCT04439266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65464199|NCT04439266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464200|NCT04439266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464201|NCT01329796|Lidocaine|lidocaine|mesh-list
65464202|NCT01329796|Anesthetics, Local|anesthetics, local|mesh-ancestor
65464203|NCT01329796|Anesthetics|anesthetics|mesh-ancestor
65464204|NCT01329796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65464205|NCT01329796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464206|NCT01329796|Sensory System Agents|sensory system agents|mesh-ancestor
65464207|NCT01329796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464208|NCT01329796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65464209|NCT01329796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65464210|NCT01329796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65464211|NCT01329796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65464212|NCT01329796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464213|NCT04428502|Etanercept|etanercept|mesh-list
65464214|NCT04428502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65464215|NCT04428502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65464216|NCT04428502|Analgesics|analgesics|mesh-ancestor
65464217|NCT04428502|Sensory System Agents|sensory system agents|mesh-ancestor
65464249|NCT01084044|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65464250|NCT01084044|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65464251|NCT01084044|Protease Inhibitors|protease inhibitors|mesh-ancestor
65464252|NCT01084044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464253|NCT01084044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464254|NCT01090518|Hydrocortisone|hydrocortisone|mesh-list
65464255|NCT01090518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65464256|NCT01090596|Naproxen|naproxen|mesh-list
65464257|NCT01090596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65464258|NCT01090596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65464259|NCT01090596|Analgesics|analgesics|mesh-ancestor
65464260|NCT01090596|Sensory System Agents|sensory system agents|mesh-ancestor
65464261|NCT01090596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464262|NCT01090596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464263|NCT01090596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65464264|NCT01090596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65464265|NCT01090596|Gout Suppressants|gout suppressants|mesh-ancestor
65464266|NCT01090596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65464267|NCT01090596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464268|NCT01090596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464269|NCT01084122|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65464270|NCT01084122|Hematinics|hematinics|mesh-ancestor
65464271|NCT01084200|Propofol|propofol|mesh-list
65464272|NCT01084200|Sevoflurane|sevoflurane|mesh-list
65464273|NCT01084200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65464274|NCT01084200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65464275|NCT01084200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464276|NCT01084200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65464277|NCT01084200|Anesthetics, General|anesthetics, general|mesh-ancestor
65464278|NCT01084200|Anesthetics|anesthetics|mesh-ancestor
65464279|NCT01084200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65464280|NCT01084200|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65464281|NCT00094770|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65464282|NCT00094770|Glipizide|glipizide|mesh-list
65464283|NCT00094770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65464284|NCT00094770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464285|NCT00094770|Incretins|incretins|mesh-ancestor
64707397|NCT03113695|Lenalidomide|lenalidomide|mesh-list
65464286|NCT00094770|Hormones|hormones|mesh-ancestor
65464287|NCT00094770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65464288|NCT00094770|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65464289|NCT00094770|Protease Inhibitors|protease inhibitors|mesh-ancestor
65464290|NCT00094770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464291|NCT00094770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464292|NCT01087398|Cyclosporine|cyclosporine|mesh-list
65464293|NCT01087398|Cyclophosphamide|cyclophosphamide|mesh-list
65464294|NCT01087398|Busulfan|busulfan|mesh-list
65464295|NCT01087398|Methotrexate|methotrexate|mesh-list
65464296|NCT01087398|Fludarabine|fludarabine|mesh-list
65464297|NCT01087398|Cyclosporins|cyclosporins|mesh-list
65464298|NCT01087398|Thymoglobulin|thymoglobulin|mesh-list
65464299|NCT01087398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65464300|NCT01087398|Immunologic Factors|immunologic factors|mesh-ancestor
65464301|NCT01087398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464302|NCT01087398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65464303|NCT01087398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65464304|NCT01087398|Alkylating Agents|alkylating agents|mesh-ancestor
65464305|NCT01087398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464306|NCT01087398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464307|NCT01087398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65464308|NCT01087398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65464309|NCT01087398|Abortifacient Agents|abortifacient agents|mesh-ancestor
65464310|NCT01087398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65464311|NCT01087398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65464312|NCT01087398|Antimetabolites|antimetabolites|mesh-ancestor
65464313|NCT01087398|Dermatologic Agents|dermatologic agents|mesh-ancestor
65464314|NCT01087398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64707398|NCT03113695|Obinutuzumab|obinutuzumab|mesh-list
64707399|NCT03113695|Immunologic Factors|immunologic factors|mesh-ancestor
64707400|NCT03113695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707401|NCT03113695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64432641|NCT01850524|Growth Substances|growth substances|mesh-ancestor
64707402|NCT03113695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64707403|NCT03113695|Growth Substances|growth substances|mesh-ancestor
64707404|NCT03113695|Growth Inhibitors|growth inhibitors|mesh-ancestor
64707405|NCT03113695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707406|NCT03113695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64707407|NCT05320393|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64707408|NCT05320393|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64707409|NCT05320393|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64707410|NCT05320393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64707411|NCT05320393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707412|NCT05320393|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64707413|NCT05320393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65464315|NCT01087398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65464316|NCT01087398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65464317|NCT01087398|Antifungal Agents|antifungal agents|mesh-ancestor
65464318|NCT01087398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65464319|NCT01087398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65464320|NCT01087476|Doxycycline|doxycycline|mesh-list
65464321|NCT01087476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65464322|NCT01087476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65464323|NCT01087476|Antimalarials|antimalarials|mesh-ancestor
65464324|NCT01087476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65464325|NCT01087476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65464326|NCT00069108|Leucovorin|leucovorin|mesh-list
65464327|NCT00069108|Capecitabine|capecitabine|mesh-list
65464328|NCT00069108|Oxaliplatin|oxaliplatin|mesh-list
65464329|NCT00069108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65464330|NCT00069108|Antimetabolites|antimetabolites|mesh-ancestor
65464331|NCT00069108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464332|NCT00069108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464333|NCT00069108|Antidotes|antidotes|mesh-ancestor
65464334|NCT00069108|Protective Agents|protective agents|mesh-ancestor
65464335|NCT00069108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464336|NCT00069108|Vitamin B Complex|vitamin b complex|mesh-ancestor
65464337|NCT00069108|Vitamins|vitamins|mesh-ancestor
65464338|NCT00069108|Micronutrients|micronutrients|mesh-ancestor
65464339|NCT00405587|Vemurafenib|vemurafenib|mesh-list
65464340|NCT00405587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464341|NCT00405587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65464342|NCT00405587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64707414|NCT05320393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707415|NCT05320393|Cholinergic Agents|cholinergic agents|mesh-ancestor
64707416|NCT05320393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64707418|NCT05315947|Anticonvulsants|anticonvulsants|mesh-ancestor
64707419|NCT00369434|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64707429|NCT05444738|Oxytocics|oxytocics|mesh-ancestor
64707430|NCT05444738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64707431|NCT05444738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707433|NCT05243953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64707434|NCT05243953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64707435|NCT05243953|Autonomic Agents|autonomic agents|mesh-ancestor
64707436|NCT05243953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64707437|NCT05243953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718976|NCT01526408|Famciclovir|famciclovir|mesh-list
64707441|NCT05243953|Vasodilator Agents|vasodilator agents|mesh-ancestor
64707442|NCT02757313|Dronabinol|dronabinol|mesh-list
64707443|NCT02757313|Hallucinogens|hallucinogens|mesh-ancestor
64707444|NCT02757313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707445|NCT02757313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64707446|NCT02757313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64707447|NCT02757313|Analgesics|analgesics|mesh-ancestor
64707448|NCT02757313|Sensory System Agents|sensory system agents|mesh-ancestor
64707449|NCT02757313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464343|NCT00405587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464344|NCT01040429|Clonidine|clonidine|mesh-list
65464345|NCT01040429|Analgesics|analgesics|mesh-ancestor
65464346|NCT01040429|Sensory System Agents|sensory system agents|mesh-ancestor
65464347|NCT01040429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464348|NCT01040429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464349|NCT01040429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65464350|NCT01040429|Sympatholytics|sympatholytics|mesh-ancestor
65464351|NCT01040429|Autonomic Agents|autonomic agents|mesh-ancestor
65464352|NCT01040429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65464353|NCT01040429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65464354|NCT01040429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65464355|NCT01040429|Adrenergic Agents|adrenergic agents|mesh-ancestor
65464356|NCT01040429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65464357|NCT01040429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464358|NCT01039883|Albaconazole|albaconazole|mesh-list
65464359|NCT01039883|Antifungal Agents|antifungal agents|mesh-ancestor
65464360|NCT01039883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65464361|NCT00405275|Hydroxychloroquine|hydroxychloroquine|mesh-list
65464362|NCT00405275|Sulfasalazine|sulfasalazine|mesh-list
65464363|NCT00405275|Etanercept|etanercept|mesh-list
65464364|NCT00405275|Methotrexate|methotrexate|mesh-list
65464365|NCT00405275|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65464366|NCT00405275|Abortifacient Agents|abortifacient agents|mesh-ancestor
65464367|NCT00405275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65464368|NCT00405275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464369|NCT00405275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65464370|NCT00405275|Antimetabolites|antimetabolites|mesh-ancestor
64707450|NCT02757313|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64707451|NCT02757313|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64707452|NCT02757313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64707453|NCT02757313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707454|NCT02757313|Hormones|hormones|mesh-ancestor
64707455|NCT02757313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64707456|NCT02514278|Capecitabine|capecitabine|mesh-list
64707457|NCT02514278|Folfirinox|folfirinox|mesh-list
64707458|NCT02514278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64707459|NCT02514278|Antimetabolites|antimetabolites|mesh-ancestor
64707460|NCT02514278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707461|NCT02514278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707462|NCT02379806|Enoxaparin|enoxaparin|mesh-list
64707463|NCT02379806|Anticoagulants|anticoagulants|mesh-ancestor
64707464|NCT02379806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64707465|NCT02379806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64707466|NCT02379806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707467|NCT02358356|Capecitabine|capecitabine|mesh-list
64707468|NCT02358356|Temozolomide|temozolomide|mesh-list
65464371|NCT00405275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464372|NCT00405275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464373|NCT00405275|Dermatologic Agents|dermatologic agents|mesh-ancestor
65464374|NCT00405275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464375|NCT00405275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65464376|NCT00405275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65464377|NCT00405275|Immunologic Factors|immunologic factors|mesh-ancestor
65464378|NCT00405275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65464379|NCT00405275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65464380|NCT00405275|Antimalarials|antimalarials|mesh-ancestor
65464381|NCT00405275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65464382|NCT00405275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65464383|NCT00405275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65464384|NCT00405275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65464385|NCT00405275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65464386|NCT00405275|Analgesics|analgesics|mesh-ancestor
65464387|NCT00405275|Sensory System Agents|sensory system agents|mesh-ancestor
65464388|NCT00405275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464389|NCT00405275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65464390|NCT00405275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65213890|NCT02646839|Biotin|biotin|mesh-list
65464391|NCT00404651|Vaccines|vaccines|mesh-list
65464392|NCT00404651|Immunologic Factors|immunologic factors|mesh-ancestor
65464393|NCT00404651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464394|NCT00404495|Irinotecan|irinotecan|mesh-list
65464395|NCT00404495|Temozolomide|temozolomide|mesh-list
65464396|NCT00404495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65464397|NCT00404495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65464398|NCT00404495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464399|NCT00404495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464403|NCT00409331|Amifostine|amifostine|mesh-list
65464414|NCT00362219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464415|NCT01040585|Linezolid|linezolid|mesh-list
65464416|NCT01040585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65464417|NCT01040585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65464418|NCT01040585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65464419|NCT01040585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464420|NCT01040585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464421|NCT00215813|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
65464422|NCT00215813|Poly I-C|poly i-c|mesh-list
65464423|NCT00215813|Antiviral Agents|antiviral agents|mesh-ancestor
65464424|NCT00215813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65464425|NCT00215813|Interferon Inducers|interferon inducers|mesh-ancestor
65464426|NCT00215813|Immunologic Factors|immunologic factors|mesh-ancestor
65464427|NCT00215813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464428|NCT01040195|Hydroxychloroquine|hydroxychloroquine|mesh-list
65464429|NCT01040195|Methotrexate|methotrexate|mesh-list
65464430|NCT01040195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65464431|NCT01040195|Abortifacient Agents|abortifacient agents|mesh-ancestor
65464432|NCT01040195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65464433|NCT01040195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464434|NCT01040195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65464435|NCT01040195|Antimetabolites|antimetabolites|mesh-ancestor
65464436|NCT01040195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464437|NCT01040195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464438|NCT01040195|Dermatologic Agents|dermatologic agents|mesh-ancestor
65464439|NCT01040195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464440|NCT01040195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65464441|NCT01040195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65464442|NCT01040195|Immunologic Factors|immunologic factors|mesh-ancestor
65464443|NCT01040195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65464444|NCT01040195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65464445|NCT01040195|Antimalarials|antimalarials|mesh-ancestor
65464446|NCT01040195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65464447|NCT01040195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64707469|NCT02358356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64707470|NCT02358356|Antimetabolites|antimetabolites|mesh-ancestor
64707471|NCT02358356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707472|NCT02358356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707473|NCT02358356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64707474|NCT02358356|Alkylating Agents|alkylating agents|mesh-ancestor
64707475|NCT04700761|Analgesics, Opioid|analgesics, opioid|mesh-list
65464448|NCT01040195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65464449|NCT01040273|Bupivacaine|bupivacaine|mesh-list
65464450|NCT01040273|Anesthetics, Local|anesthetics, local|mesh-ancestor
65464451|NCT01040273|Anesthetics|anesthetics|mesh-ancestor
65464452|NCT01040273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65464453|NCT01040273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464454|NCT01040273|Sensory System Agents|sensory system agents|mesh-ancestor
65464455|NCT01040273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464456|NCT00408629|Adalimumab|adalimumab|mesh-list
65464457|NCT00408629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65464458|NCT00408629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65464459|NCT00408317|Pancrelipase|pancrelipase|mesh-list
65464460|NCT00408317|Pancreatin|pancreatin|mesh-list
65464461|NCT00408317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65464462|NCT00112502|Thalidomide|thalidomide|mesh-list
65464463|NCT00112502|Celecoxib|celecoxib|mesh-list
65464464|NCT00112502|Temozolomide|temozolomide|mesh-list
64848931|NCT05516498|Dapagliflozin|dapagliflozin|mesh-list
64707476|NCT04700761|Anesthetics|anesthetics|mesh-list
64432715|NCT02325518|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64707477|NCT04700761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64707478|NCT04700761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707479|NCT04700761|Narcotics|narcotics|mesh-ancestor
64707484|NCT04651088|Diuretics|diuretics|mesh-ancestor
64707485|NCT04651088|Natriuretic Agents|natriuretic agents|mesh-ancestor
64707486|NCT04651088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707487|NCT04651088|Expectorants|expectorants|mesh-ancestor
64707488|NCT04651088|Respiratory System Agents|respiratory system agents|mesh-ancestor
64707489|NCT02315768|Obinutuzumab|obinutuzumab|mesh-list
64707490|NCT02315768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64707491|NCT02315768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707492|NCT04595617|Antibodies|antibodies|mesh-list
64707493|NCT04595617|Immunologic Factors|immunologic factors|mesh-ancestor
64707494|NCT04595617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707495|NCT02162810|Prednisolone|prednisolone|mesh-list
64707496|NCT02162810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64707497|NCT02162810|Glucocorticoids|glucocorticoids|mesh-ancestor
64707498|NCT02162810|Hormones|hormones|mesh-ancestor
64707499|NCT02162810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64707500|NCT02162810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707501|NCT02162810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64707502|NCT02162810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707514|NCT04563325|Dicloxacillin|dicloxacillin|mesh-list
64707515|NCT04563325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64707516|NCT04563325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64707517|NCT04563325|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64707518|NCT04563325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64707519|NCT04563325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707520|NCT01689740|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
64707521|NCT01689740|Hallucinogens|hallucinogens|mesh-ancestor
64707522|NCT01689740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707523|NCT01689740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64707524|NCT01689740|Serotonin Agents|serotonin agents|mesh-ancestor
64707525|NCT01689740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64707526|NCT01689740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707527|NCT01689740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64707528|NCT01689740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64707529|NCT01689740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64707530|NCT01689740|Adrenergic Agents|adrenergic agents|mesh-ancestor
65464465|NCT00112502|Isotretinoin|isotretinoin|mesh-list
65464466|NCT00112502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65464467|NCT00112502|Alkylating Agents|alkylating agents|mesh-ancestor
65464468|NCT00112502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464469|NCT00112502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464470|NCT00112502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65464471|NCT00112502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65464472|NCT00112502|Analgesics|analgesics|mesh-ancestor
65464473|NCT00112502|Sensory System Agents|sensory system agents|mesh-ancestor
65464474|NCT00112502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464475|NCT00112502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464476|NCT00112502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65464477|NCT00112502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65464478|NCT00112502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65464479|NCT00112502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65464480|NCT00112502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464481|NCT00112502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65464482|NCT00112502|Immunologic Factors|immunologic factors|mesh-ancestor
65464483|NCT00112502|Leprostatic Agents|leprostatic agents|mesh-ancestor
64707532|NCT04545151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64707533|NCT04545151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64707534|NCT04545151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64707535|NCT04545151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707536|NCT04545151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64707537|NCT04545151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707538|NCT04545151|Vasodilator Agents|vasodilator agents|mesh-ancestor
64707539|NCT00961142|Fludarabine|fludarabine|mesh-list
64707540|NCT00961142|Melphalan|melphalan|mesh-list
64707541|NCT00961142|Thiotepa|thiotepa|mesh-list
64707542|NCT00961142|Thymoglobulin|thymoglobulin|mesh-list
64707543|NCT00961142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707544|NCT00961142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707545|NCT00961142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64707546|NCT00961142|Immunologic Factors|immunologic factors|mesh-ancestor
64707547|NCT00961142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707548|NCT00961142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64707549|NCT00961142|Alkylating Agents|alkylating agents|mesh-ancestor
64432790|NCT01846624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707555|NCT04562792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64707556|NCT04562792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64707557|NCT04562792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707559|NCT04523701|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64707568|NCT04338373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707569|NCT04338373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64707570|NCT04338373|Respiratory System Agents|respiratory system agents|mesh-ancestor
64707571|NCT04338373|Mydriatics|mydriatics|mesh-ancestor
64707572|NCT04338373|Parasympatholytics|parasympatholytics|mesh-ancestor
64707573|NCT04338373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64707574|NCT04338373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64707575|NCT04338373|Cholinergic Agents|cholinergic agents|mesh-ancestor
64707576|NCT04338373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64718982|NCT04713644|Propofol|propofol|mesh-list
64718983|NCT04713644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64718984|NCT04713644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65464484|NCT00112502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65464485|NCT00112502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65464486|NCT00112502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65464487|NCT00112502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65464488|NCT00112502|Growth Substances|growth substances|mesh-ancestor
65464489|NCT00112502|Growth Inhibitors|growth inhibitors|mesh-ancestor
65464490|NCT00112502|Dermatologic Agents|dermatologic agents|mesh-ancestor
65464491|NCT03965546|Sorafenib|sorafenib|mesh-list
65464492|NCT03965546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464493|NCT03965546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65464494|NCT03965546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464495|NCT03965546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464496|NCT01083992|Vitamin D|vitamin d|mesh-list
65464497|NCT01083992|Vildagliptin|vildagliptin|mesh-list
65464498|NCT01083992|Vitamins|vitamins|mesh-ancestor
65464499|NCT01083992|Micronutrients|micronutrients|mesh-ancestor
65464500|NCT01083992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464501|NCT01083992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65464502|NCT01083992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65464503|NCT01083992|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65464504|NCT01083992|Protease Inhibitors|protease inhibitors|mesh-ancestor
65464505|NCT01083992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464506|NCT01083992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464507|NCT03822182|Dexamethasone|dexamethasone|mesh-list
65464508|NCT03822182|Bupivacaine|bupivacaine|mesh-list
65464509|NCT03822182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65464510|NCT03822182|Antiemetics|antiemetics|mesh-ancestor
65464511|NCT03822182|Autonomic Agents|autonomic agents|mesh-ancestor
65464512|NCT03822182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464513|NCT03822182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848966|NCT05463965|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64718985|NCT04713644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707577|NCT04338373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707578|NCT00059930|Leucovorin|leucovorin|mesh-list
64707579|NCT00059930|Dexamethasone|dexamethasone|mesh-list
64707580|NCT00059930|Fluorouracil|fluorouracil|mesh-list
64707581|NCT00059930|Oxaliplatin|oxaliplatin|mesh-list
64707582|NCT00059930|Floxuridine|floxuridine|mesh-list
64707583|NCT00059930|Calcium|calcium|mesh-list
64707584|NCT00059930|Levoleucovorin|levoleucovorin|mesh-list
64707585|NCT00059930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64707586|NCT00059930|Antiemetics|antiemetics|mesh-ancestor
64707587|NCT00059930|Autonomic Agents|autonomic agents|mesh-ancestor
64707588|NCT00059930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64707589|NCT00059930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707590|NCT00059930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65464514|NCT03822182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65464515|NCT03822182|Glucocorticoids|glucocorticoids|mesh-ancestor
65464516|NCT03822182|Hormones|hormones|mesh-ancestor
65464517|NCT03822182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65464518|NCT03822182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65464519|NCT03822182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464520|NCT03822182|Anesthetics, Local|anesthetics, local|mesh-ancestor
65464521|NCT03822182|Anesthetics|anesthetics|mesh-ancestor
65464522|NCT03822182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65464523|NCT03822182|Sensory System Agents|sensory system agents|mesh-ancestor
65464524|NCT01078610|Adalimumab|adalimumab|mesh-list
65464525|NCT01078610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65464526|NCT01078610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65464527|NCT01080482|Tacrolimus|tacrolimus|mesh-list
65464528|NCT01080482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65464529|NCT01080482|Immunologic Factors|immunologic factors|mesh-ancestor
65464530|NCT01080482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464531|NCT01080482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65464532|NCT01080482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464533|NCT01080482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464534|NCT03965624|Ixazomib|ixazomib|mesh-list
65464535|NCT03965624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464536|NCT03965624|Protease Inhibitors|protease inhibitors|mesh-ancestor
65464537|NCT03965624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464538|NCT03965624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464539|NCT01080560|Cyclosporine|cyclosporine|mesh-list
65464540|NCT01080560|Cyclosporins|cyclosporins|mesh-list
65464541|NCT01080560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464542|NCT01080560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464543|NCT01080560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65464544|NCT01080560|Immunologic Factors|immunologic factors|mesh-ancestor
65214052|NCT00544414|Antidotes|antidotes|mesh-ancestor
65464556|NCT00094328|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65464557|NCT00094328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464558|NCT00094328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464559|NCT00094328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65464560|NCT00094328|Hormone Antagonists|hormone antagonists|mesh-ancestor
65464561|NCT00094328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65464562|NCT00094328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464563|NCT00094328|Androgen Antagonists|androgen antagonists|mesh-ancestor
65464564|NCT00094172|Atorvastatin|atorvastatin|mesh-list
65464565|NCT00094172|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65464566|NCT00094172|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65464567|NCT00094172|Antimetabolites|antimetabolites|mesh-ancestor
65464568|NCT00094172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464569|NCT00094172|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65464570|NCT00094172|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65464571|NCT00094172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464572|NCT00094094|Axitinib|axitinib|mesh-list
65464573|NCT00094094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464574|NCT00094094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65464575|NCT00094094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464576|NCT00094094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464577|NCT03962816|Vaccines|vaccines|mesh-list
65464578|NCT03962816|Immunologic Factors|immunologic factors|mesh-ancestor
65464579|NCT03962816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464580|NCT01080638|polysaccharide-K|polysaccharide-k|mesh-list
65464581|NCT01080638|Abciximab|abciximab|mesh-list
65464582|NCT01080638|Anticoagulants|anticoagulants|mesh-ancestor
64707591|NCT00059930|Glucocorticoids|glucocorticoids|mesh-ancestor
64707592|NCT00059930|Hormones|hormones|mesh-ancestor
64707593|NCT00059930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64707594|NCT00059930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64707595|NCT00059930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707596|NCT00059930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64707597|NCT00059930|Antimetabolites|antimetabolites|mesh-ancestor
64707598|NCT00059930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707599|NCT00059930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64707600|NCT00059930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64707601|NCT00059930|Immunologic Factors|immunologic factors|mesh-ancestor
64707602|NCT00059930|Antidotes|antidotes|mesh-ancestor
64707603|NCT00059930|Protective Agents|protective agents|mesh-ancestor
64707604|NCT00059930|Vitamin B Complex|vitamin b complex|mesh-ancestor
64707605|NCT00059930|Vitamins|vitamins|mesh-ancestor
64707606|NCT00059930|Micronutrients|micronutrients|mesh-ancestor
64707607|NCT00369031|polysaccharide-K|polysaccharide-k|mesh-list
64707608|NCT00369031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64707609|NCT00369031|Immunologic Factors|immunologic factors|mesh-ancestor
65464583|NCT01080638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65464584|NCT01080638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65464585|NCT01080638|Immunologic Factors|immunologic factors|mesh-ancestor
65464586|NCT01080638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464587|NCT01080638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65464588|NCT01080638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464589|NCT01080638|Antiviral Agents|antiviral agents|mesh-ancestor
65464590|NCT01080638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65464591|NCT01080638|Interferon Inducers|interferon inducers|mesh-ancestor
65464592|NCT01080638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65464593|NCT01080638|Protective Agents|protective agents|mesh-ancestor
65464594|NCT00110396|Interferons|interferons|mesh-list
65464595|NCT00110396|Interferon-beta|interferon-beta|mesh-list
65464596|NCT00110396|Interferon beta-1a|interferon beta-1a|mesh-list
65464597|NCT00110396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464598|NCT00110396|Antiviral Agents|antiviral agents|mesh-ancestor
65464599|NCT00110396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64849064|NCT05309655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64707610|NCT00369031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707611|NCT00369031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64707612|NCT00369031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707613|NCT00369031|Antiviral Agents|antiviral agents|mesh-ancestor
64707614|NCT00369031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64337028|NCT03499639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64707615|NCT00369031|Interferon Inducers|interferon inducers|mesh-ancestor
64707616|NCT00369031|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64707617|NCT00369031|Protective Agents|protective agents|mesh-ancestor
64707618|NCT05443178|Isoniazid|isoniazid|mesh-list
64707619|NCT05443178|Ethambutol|ethambutol|mesh-list
64707620|NCT05443178|Chloroquine|chloroquine|mesh-list
64707621|NCT05443178|Antitubercular Agents|antitubercular agents|mesh-ancestor
64707622|NCT05443178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64707624|NCT05443178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707638|NCT05064319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707639|NCT05064319|Anticonvulsants|anticonvulsants|mesh-ancestor
64707640|NCT05064319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64707641|NCT05064319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64707642|NCT05064319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64707643|NCT05064319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64707644|NCT05064319|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64707645|NCT05064319|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64707646|NCT05064319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64718986|NCT04713644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64718987|NCT04713644|Anesthetics, General|anesthetics, general|mesh-ancestor
64718988|NCT04713644|Anesthetics|anesthetics|mesh-ancestor
64718989|NCT00000734|Zidovudine|zidovudine|mesh-list
64718990|NCT00000734|Trimethoprim|trimethoprim|mesh-list
64718991|NCT00000734|Sulfamethoxazole|sulfamethoxazole|mesh-list
64718992|NCT00000734|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64707647|NCT05064319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707648|NCT05064319|Antimanic Agents|antimanic agents|mesh-ancestor
64707650|NCT05061901|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64707651|NCT05061901|Protease Inhibitors|protease inhibitors|mesh-ancestor
64707652|NCT05061901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64707653|NCT05061901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707654|NCT05061901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64707655|NCT05061901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65464600|NCT00110396|Immunologic Factors|immunologic factors|mesh-ancestor
65464601|NCT00110396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464602|NCT00110396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65464603|NCT00093470|Tipifarnib|tipifarnib|mesh-list
65464604|NCT00093470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464605|NCT00407537|Amlodipine|amlodipine|mesh-list
65464606|NCT00407537|Atorvastatin|atorvastatin|mesh-list
65464607|NCT00407537|Calcium|calcium|mesh-list
65464608|NCT00407537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65464609|NCT00407537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464610|NCT00407537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65464611|NCT00407537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65464612|NCT00407537|Antimetabolites|antimetabolites|mesh-ancestor
65464613|NCT00407537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464614|NCT00407537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65464615|NCT00407537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65464616|NCT00407537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464617|NCT00407537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65464618|NCT00407537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65464619|NCT00407537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65464620|NCT00407537|Vasodilator Agents|vasodilator agents|mesh-ancestor
65214116|NCT02795949|Amoxicillin|amoxicillin|mesh-list
65464621|NCT00094458|Azathioprine|azathioprine|mesh-list
65464623|NCT00094458|Dermatologic Agents|dermatologic agents|mesh-ancestor
65464624|NCT00094458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64707656|NCT05061901|Protective Agents|protective agents|mesh-ancestor
64707657|NCT05061901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707658|NCT04338919|Aspirin|aspirin|mesh-list
64707659|NCT04338919|Ticagrelor|ticagrelor|mesh-list
64707660|NCT04338919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64707661|NCT04338919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64707662|NCT04338919|Analgesics|analgesics|mesh-ancestor
64707663|NCT04338919|Sensory System Agents|sensory system agents|mesh-ancestor
64707664|NCT04338919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64707665|NCT04338919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707666|NCT04338919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64707667|NCT04338919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64707668|NCT04338919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64707669|NCT04338919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64707670|NCT04338919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707671|NCT04338919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64707672|NCT04338919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64707673|NCT04338919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64707674|NCT04338919|Antipyretics|antipyretics|mesh-ancestor
64707675|NCT04338919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64707676|NCT04338919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64707677|NCT04338919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64707678|NCT04338919|Purinergic Agents|purinergic agents|mesh-ancestor
64707679|NCT04338919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64707680|NCT05451290|Gemcitabine|gemcitabine|mesh-list
65464625|NCT00094458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65464626|NCT00094458|Antimetabolites|antimetabolites|mesh-ancestor
65464627|NCT00094458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464628|NCT00094458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65464629|NCT00094458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464630|NCT00094458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65464631|NCT00094458|Immunologic Factors|immunologic factors|mesh-ancestor
65464632|NCT00094458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464633|NCT00406367|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65464634|NCT00406367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65464635|NCT00406367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464636|NCT00406367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464637|NCT00406367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65464638|NCT00406367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65464639|NCT00406367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464640|NCT00406367|Cholinergic Agents|cholinergic agents|mesh-ancestor
65464641|NCT00406367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65464642|NCT01041443|Tetrahydrouridine|tetrahydrouridine|mesh-list
65464643|NCT01041443|Antimetabolites|antimetabolites|mesh-ancestor
65464644|NCT01041443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464645|NCT03961464|Cycloserine|cycloserine|mesh-list
65464646|NCT03961464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65464647|NCT03961464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65464648|NCT03961464|Renal Agents|renal agents|mesh-ancestor
65464649|NCT03961464|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65464650|NCT03961464|Antitubercular Agents|antitubercular agents|mesh-ancestor
65464651|NCT03961464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65464652|NCT03961464|Antimetabolites|antimetabolites|mesh-ancestor
65464653|NCT03961464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464654|NCT01087554|Sirolimus|sirolimus|mesh-list
65464655|NCT01087554|Everolimus|everolimus|mesh-list
64849147|NCT05215951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849151|NCT05171387|Androgens|androgens|mesh-list
65464666|NCT01087554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464667|NCT01087554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464668|NCT01087632|Folic Acid|folic acid|mesh-list
65464669|NCT01087632|Coenzyme Q10|coenzyme q10|mesh-list
65464670|NCT01087632|Policosanol|policosanol|mesh-list
65464671|NCT01087632|Red yeast rice|red yeast rice|mesh-list
65464672|NCT01087632|Hematinics|hematinics|mesh-ancestor
65464673|NCT01087632|Vitamin B Complex|vitamin b complex|mesh-ancestor
65464674|NCT01087632|Vitamins|vitamins|mesh-ancestor
65464675|NCT01087632|Micronutrients|micronutrients|mesh-ancestor
65464676|NCT01087632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464677|NCT01087632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65464678|NCT01087632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65464679|NCT01087632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65464680|NCT01087632|Antimetabolites|antimetabolites|mesh-ancestor
65464681|NCT01087632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464682|NCT01087632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464683|NCT01087632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65464684|NCT01087632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65464685|NCT00394589|Infliximab|infliximab|mesh-list
65464686|NCT00394589|Dermatologic Agents|dermatologic agents|mesh-ancestor
65464687|NCT00394589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65464688|NCT00394589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65464689|NCT00068406|Cisplatin|cisplatin|mesh-list
65464690|NCT00068406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464691|NCT00403559|Ketoconazole|ketoconazole|mesh-list
65464692|NCT00403559|Pimecrolimus|pimecrolimus|mesh-list
65464693|NCT00403559|Antifungal Agents|antifungal agents|mesh-ancestor
65464694|NCT00403559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65464706|NCT00403559|Analgesics|analgesics|mesh-ancestor
65464709|NCT00403559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65464710|NCT00403559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65464711|NCT00403559|Dermatologic Agents|dermatologic agents|mesh-ancestor
65464712|NCT00403559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65464713|NCT00403559|Immunologic Factors|immunologic factors|mesh-ancestor
65464714|NCT00403559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65464715|NCT01087710|Vitamins|vitamins|mesh-list
65464716|NCT01087710|Antioxidants|antioxidants|mesh-list
65464717|NCT01087710|Micronutrients|micronutrients|mesh-ancestor
65464718|NCT01087710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464719|NCT01087710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464720|NCT01087710|Protective Agents|protective agents|mesh-ancestor
65464721|NCT00403481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65464722|NCT00403481|Olmesartan|olmesartan|mesh-list
65464723|NCT00403481|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65464724|NCT00403481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65464725|NCT00403481|Diuretics|diuretics|mesh-ancestor
65464726|NCT00403481|Natriuretic Agents|natriuretic agents|mesh-ancestor
65464727|NCT00403481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464728|NCT00403481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65464729|NCT00403481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64849190|NCT05104762|gamma-Globulins|gamma-globulins|mesh-list
64707681|NCT05451290|Tegafur|tegafur|mesh-list
64707682|NCT05451290|Oxaliplatin|oxaliplatin|mesh-list
64707683|NCT05451290|Apatinib|apatinib|mesh-list
64707710|NCT00369889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64707711|NCT00369889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718993|NCT00000734|Antimetabolites|antimetabolites|mesh-ancestor
64718994|NCT00000734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718995|NCT00000734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64718996|NCT00000734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64707712|NCT00369889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707714|NCT00369044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64707715|NCT00369044|Glucocorticoids|glucocorticoids|mesh-ancestor
64707716|NCT00369044|Hormones|hormones|mesh-ancestor
64707717|NCT00369044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64707718|NCT00369044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945605|NCT05417776|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
64707719|NCT00369044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64707720|NCT00369044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707721|NCT00370045|Bivalirudin|bivalirudin|mesh-list
64707722|NCT00370045|Eptifibatide|eptifibatide|mesh-list
64707723|NCT00370045|Antithrombins|antithrombins|mesh-ancestor
64707724|NCT00370045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64707725|NCT00370045|Protease Inhibitors|protease inhibitors|mesh-ancestor
64707726|NCT00370045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64707727|NCT00370045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707728|NCT00370045|Anticoagulants|anticoagulants|mesh-ancestor
64707729|NCT00370045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64707730|NCT05441150|Ketamine|ketamine|mesh-list
64707731|NCT05441150|Analgesics|analgesics|mesh-ancestor
64337079|NCT03132259|Adrenergic Agents|adrenergic agents|mesh-ancestor
64707743|NCT05441150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464730|NCT00403481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464731|NCT00403481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65464732|NCT00403481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65464733|NCT00402779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65464734|NCT00402779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464735|NCT00402779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65464736|NCT00402779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464737|NCT00402779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464738|NCT00394433|Bevacizumab|bevacizumab|mesh-list
65464739|NCT00394433|Cisplatin|cisplatin|mesh-list
65464740|NCT00394433|Docetaxel|docetaxel|mesh-list
65464741|NCT00394433|Irinotecan|irinotecan|mesh-list
65464742|NCT00394433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65464743|NCT00394433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464744|NCT00394433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65464745|NCT00394433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65464746|NCT00394433|Growth Substances|growth substances|mesh-ancestor
65464747|NCT00394433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464748|NCT00394433|Growth Inhibitors|growth inhibitors|mesh-ancestor
65464749|NCT00394433|Tubulin Modulators|tubulin modulators|mesh-ancestor
65464750|NCT00394433|Antimitotic Agents|antimitotic agents|mesh-ancestor
65464751|NCT00394433|Mitosis Modulators|mitosis modulators|mesh-ancestor
65464752|NCT00394433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464753|NCT00394433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65464754|NCT00394433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65464755|NCT00394433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464756|NCT00092534|Vaccines|vaccines|mesh-list
65464757|NCT00092534|Immunologic Factors|immunologic factors|mesh-ancestor
65464758|NCT00092534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464759|NCT00068250|Rituximab|rituximab|mesh-list
65464760|NCT00068250|Methotrexate|methotrexate|mesh-list
65464761|NCT00068250|Temozolomide|temozolomide|mesh-list
64707745|NCT04270214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64707746|NCT04270214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64707747|NCT04270214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707748|NCT04270214|Cholinergic Agents|cholinergic agents|mesh-ancestor
64707749|NCT04270214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64707750|NCT04270214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707751|NCT04238624|Trametinib|trametinib|mesh-list
64707752|NCT04238624|Dabrafenib|dabrafenib|mesh-list
64707753|NCT04238624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707754|NCT04238624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64707755|NCT04238624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464762|NCT00068250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65464763|NCT00068250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464764|NCT00068250|Immunologic Factors|immunologic factors|mesh-ancestor
65464765|NCT00068250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464766|NCT00068250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65464767|NCT00068250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65464768|NCT00068250|Abortifacient Agents|abortifacient agents|mesh-ancestor
65464769|NCT00068250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65214281|NCT02801487|Cisplatin|cisplatin|mesh-list
65464770|NCT00068250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65464771|NCT00068250|Antimetabolites|antimetabolites|mesh-ancestor
65464772|NCT00068250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464773|NCT00068250|Dermatologic Agents|dermatologic agents|mesh-ancestor
65464774|NCT00068250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464775|NCT00068250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65464776|NCT00068250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65464777|NCT00068250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65464778|NCT00068250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65464779|NCT00068250|Alkylating Agents|alkylating agents|mesh-ancestor
65464780|NCT03957720|Penicillamine|penicillamine|mesh-list
65464781|NCT03957720|Succimer|succimer|mesh-list
65464782|NCT03957720|Antidotes|antidotes|mesh-ancestor
64707756|NCT04238624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707757|NCT05438810|Fulvestrant|fulvestrant|mesh-list
64707758|NCT05438810|Goserelin|goserelin|mesh-list
64707759|NCT05438810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64707760|NCT05438810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707761|NCT05438810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64707762|NCT05438810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64707763|NCT05438810|Hormone Antagonists|hormone antagonists|mesh-ancestor
64707764|NCT05438810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64707774|NCT05451121|Dexmedetomidine|dexmedetomidine|mesh-list
64707775|NCT05451121|Propofol|propofol|mesh-list
64707776|NCT05451121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64707777|NCT05451121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64707778|NCT05451121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707779|NCT05451121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64707780|NCT05451121|Anesthetics, General|anesthetics, general|mesh-ancestor
64707781|NCT05451121|Anesthetics|anesthetics|mesh-ancestor
64707782|NCT05451121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64718997|NCT00000734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718998|NCT00000734|Antiviral Agents|antiviral agents|mesh-ancestor
64718999|NCT00000734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719000|NCT00000734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64719001|NCT00000734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64707783|NCT05451121|Analgesics|analgesics|mesh-ancestor
64707784|NCT05451121|Sensory System Agents|sensory system agents|mesh-ancestor
64707785|NCT05451121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64707786|NCT05451121|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64707787|NCT05451121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64707788|NCT05451121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64707789|NCT05451121|Adrenergic Agents|adrenergic agents|mesh-ancestor
65464783|NCT03957720|Protective Agents|protective agents|mesh-ancestor
65464784|NCT03957720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464785|NCT03957720|Chelating Agents|chelating agents|mesh-ancestor
65464786|NCT03957720|Sequestering Agents|sequestering agents|mesh-ancestor
65464787|NCT03957720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464788|NCT03957720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65464789|NCT00393029|Aldesleukin|aldesleukin|mesh-list
65464790|NCT00393029|Cyclophosphamide|cyclophosphamide|mesh-list
65464791|NCT00393029|Fludarabine|fludarabine|mesh-list
65464792|NCT00393029|Fludarabine phosphate|fludarabine phosphate|mesh-list
65464793|NCT00393029|Interleukin-2|interleukin-2|mesh-list
65464794|NCT00393029|Lenograstim|lenograstim|mesh-list
65464795|NCT00393029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65464796|NCT00393029|Immunologic Factors|immunologic factors|mesh-ancestor
65464797|NCT00393029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464798|NCT00393029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65464799|NCT00393029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65464800|NCT00393029|Alkylating Agents|alkylating agents|mesh-ancestor
65464801|NCT00393029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464802|NCT00393029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464803|NCT00393029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65464804|NCT00393029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65464805|NCT00393029|Antimetabolites|antimetabolites|mesh-ancestor
64849267|NCT04991480|Niraparib|niraparib|mesh-list
64707790|NCT05451121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64707791|NCT05451121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707792|NCT04967443|Prazosin|prazosin|mesh-list
64707793|NCT04967443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64707794|NCT04967443|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64337082|NCT03499171|Citalopram|citalopram|mesh-list
64707806|NCT02230956|Botulinum Toxins|botulinum toxins|mesh-list
64707807|NCT02230956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64707808|NCT02230956|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64707809|NCT02230956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64707810|NCT02230956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64707811|NCT02230956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707812|NCT02230956|Cholinergic Agents|cholinergic agents|mesh-ancestor
64707813|NCT02230956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64707814|NCT02230956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707815|NCT02230956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64707816|NCT02230956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64707818|NCT05450042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64707819|NCT05450042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707820|NCT05450042|Tubulin Modulators|tubulin modulators|mesh-ancestor
64707821|NCT05450042|Antimitotic Agents|antimitotic agents|mesh-ancestor
64707822|NCT05450042|Mitosis Modulators|mitosis modulators|mesh-ancestor
64707823|NCT05450042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707824|NCT05447936|Vitamin D|vitamin d|mesh-list
64707825|NCT05447936|Vitamins|vitamins|mesh-ancestor
64707826|NCT05447936|Micronutrients|micronutrients|mesh-ancestor
64707827|NCT05447936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849301|NCT04977453|Pembrolizumab|pembrolizumab|mesh-list
64849302|NCT04977453|Lenvatinib|lenvatinib|mesh-list
65464806|NCT00393029|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65464807|NCT00393029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65464808|NCT00393029|Analgesics|analgesics|mesh-ancestor
65464809|NCT00393029|Sensory System Agents|sensory system agents|mesh-ancestor
65464810|NCT00393029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464811|NCT00393029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65464812|NCT00393029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65464813|NCT00393029|Antiviral Agents|antiviral agents|mesh-ancestor
65464814|NCT00393029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65464815|NCT00402233|Pramipexole|pramipexole|mesh-list
65464816|NCT00402233|Antioxidants|antioxidants|mesh-ancestor
65464817|NCT00402233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464818|NCT00402233|Protective Agents|protective agents|mesh-ancestor
65464819|NCT00402233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464820|NCT00402233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65464821|NCT00402233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65464822|NCT00402233|Dopamine Agonists|dopamine agonists|mesh-ancestor
65464823|NCT00402233|Dopamine Agents|dopamine agents|mesh-ancestor
65464824|NCT00402233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65464825|NCT03993431|Methamphetamine|methamphetamine|mesh-list
65464826|NCT03993431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65464827|NCT03993431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464828|NCT03993431|Sympathomimetics|sympathomimetics|mesh-ancestor
65464829|NCT03993431|Autonomic Agents|autonomic agents|mesh-ancestor
65464830|NCT03993431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464831|NCT03993431|Dopamine Agents|dopamine agents|mesh-ancestor
65464832|NCT03993431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65464833|NCT03993431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464834|NCT03993431|Adrenergic Agents|adrenergic agents|mesh-ancestor
65464835|NCT03993431|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65464836|NCT03993431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65464837|NCT03993431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65464838|NCT03993431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64707828|NCT05447936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64707829|NCT04739384|Ticagrelor|ticagrelor|mesh-list
64707842|NCT05450497|Propofol|propofol|mesh-list
64707843|NCT05450497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64707844|NCT05450497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64849322|NCT04931342|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65464839|NCT00401843|Dexamethasone|dexamethasone|mesh-list
65464840|NCT00401843|Bortezomib|bortezomib|mesh-list
65464841|NCT00401843|Siltuximab|siltuximab|mesh-list
65464842|NCT00401843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65464843|NCT00401843|Antiemetics|antiemetics|mesh-ancestor
65464844|NCT00401843|Autonomic Agents|autonomic agents|mesh-ancestor
65464845|NCT00401843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65214346|NCT02791815|Selexipag|selexipag|mesh-list
65464846|NCT00401843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464847|NCT00401843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65464848|NCT00401843|Glucocorticoids|glucocorticoids|mesh-ancestor
65464849|NCT00401843|Hormones|hormones|mesh-ancestor
65464850|NCT00401843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65464851|NCT00401843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65464852|NCT00401843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464853|NCT00401531|Vaccines|vaccines|mesh-list
65464854|NCT00401531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65464855|NCT00401531|Immunologic Factors|immunologic factors|mesh-ancestor
65464856|NCT00401531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464857|NCT00401375|Methylnaltrexone|methylnaltrexone|mesh-list
65464858|NCT00401375|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65464859|NCT00401375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464860|NCT00401375|Sensory System Agents|sensory system agents|mesh-ancestor
65464861|NCT00401375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464862|NCT00400517|Thalidomide|thalidomide|mesh-list
64707845|NCT05450497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707846|NCT05450497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64707847|NCT05450497|Anesthetics, General|anesthetics, general|mesh-ancestor
64707848|NCT05450497|Anesthetics|anesthetics|mesh-ancestor
64707849|NCT05450497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64707850|NCT05450497|Analgesics|analgesics|mesh-ancestor
64707851|NCT05450497|Sensory System Agents|sensory system agents|mesh-ancestor
64707852|NCT05450497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64707853|NCT05450497|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64707854|NCT05450497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64707855|NCT05450497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64707856|NCT05450497|Adrenergic Agents|adrenergic agents|mesh-ancestor
64707857|NCT05450497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64707858|NCT05450497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719002|NCT00000734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64719003|NCT00000734|Renal Agents|renal agents|mesh-ancestor
64719004|NCT00000734|Antimalarials|antimalarials|mesh-ancestor
64719005|NCT00000734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64719006|NCT00000734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64719007|NCT00000734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64719008|NCT00000734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64719009|NCT00000734|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64707859|NCT02230332|Alendronate|alendronate|mesh-list
64707860|NCT02230332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65464863|NCT00400517|Sargramostim|sargramostim|mesh-list
65464864|NCT00400517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65464865|NCT00400517|Immunologic Factors|immunologic factors|mesh-ancestor
65464866|NCT00400517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464867|NCT00400517|Leprostatic Agents|leprostatic agents|mesh-ancestor
65464868|NCT00400517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65464869|NCT00400517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65464870|NCT00400517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65464871|NCT00400517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65464872|NCT00400517|Growth Substances|growth substances|mesh-ancestor
65464873|NCT00400517|Growth Inhibitors|growth inhibitors|mesh-ancestor
65464874|NCT00400517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464875|NCT01044095|Vaccines|vaccines|mesh-list
65464876|NCT01044095|Immunologic Factors|immunologic factors|mesh-ancestor
65464877|NCT01044095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464878|NCT00392171|Temozolomide|temozolomide|mesh-list
65464879|NCT00392171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65464880|NCT00392171|Alkylating Agents|alkylating agents|mesh-ancestor
65464881|NCT00392171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464882|NCT00392171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464917|NCT00091442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65464918|NCT00091442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464919|NCT00091442|Tubulin Modulators|tubulin modulators|mesh-ancestor
65464920|NCT00091442|Antimitotic Agents|antimitotic agents|mesh-ancestor
65464921|NCT00091442|Mitosis Modulators|mitosis modulators|mesh-ancestor
65464922|NCT00091442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464923|NCT00091442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65464924|NCT00390689|Pramipexole|pramipexole|mesh-list
65464925|NCT00390689|Antioxidants|antioxidants|mesh-ancestor
65464926|NCT00390689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464927|NCT00390689|Protective Agents|protective agents|mesh-ancestor
65464928|NCT00390689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464929|NCT00390689|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65464930|NCT00390689|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65464931|NCT00390689|Dopamine Agonists|dopamine agonists|mesh-ancestor
65464932|NCT00390689|Dopamine Agents|dopamine agents|mesh-ancestor
65464933|NCT00390689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65464934|NCT01079078|Acetaminophen|acetaminophen|mesh-list
65464935|NCT01079078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65464936|NCT01079078|Analgesics|analgesics|mesh-ancestor
65464937|NCT01079078|Sensory System Agents|sensory system agents|mesh-ancestor
65464938|NCT01079078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65464939|NCT01079078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464940|NCT01079078|Antipyretics|antipyretics|mesh-ancestor
65464941|NCT00390455|Fulvestrant|fulvestrant|mesh-list
65464942|NCT00390455|Lapatinib|lapatinib|mesh-list
65464943|NCT00390455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65464944|NCT00390455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707861|NCT02230332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707870|NCT05447702|Mitosis Modulators|mitosis modulators|mesh-ancestor
64707871|NCT05447702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707872|NCT05447702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64707873|NCT05447702|Immunologic Factors|immunologic factors|mesh-ancestor
64707874|NCT05447702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707875|NCT05447702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64707876|NCT05447702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64707877|NCT05447702|Alkylating Agents|alkylating agents|mesh-ancestor
64707878|NCT05447702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64707879|NCT05447702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64707880|NCT05447702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64707881|NCT05447702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64707882|NCT05447702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64707883|NCT05447702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64707885|NCT05449028|Antacids|antacids|mesh-ancestor
64707886|NCT05449028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707887|NCT05449028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64707888|NCT04845139|Nivolumab|nivolumab|mesh-list
65464945|NCT00390455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65464946|NCT00390455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65464947|NCT00390455|Hormone Antagonists|hormone antagonists|mesh-ancestor
65464948|NCT00390455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65464949|NCT00390455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464950|NCT00390455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65464951|NCT00390455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464952|NCT00390455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464953|NCT03812510|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65464954|NCT03812510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65464955|NCT03812510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65464956|NCT01583114|Perindopril|perindopril|mesh-list
65464957|NCT01583114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65464958|NCT01583114|Protease Inhibitors|protease inhibitors|mesh-ancestor
65464959|NCT01583114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464960|NCT01583114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464961|NCT01583114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65464962|NCT04258046|Trametinib|trametinib|mesh-list
65464963|NCT04258046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65464964|NCT04258046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65464965|NCT04258046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464966|NCT04258046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65464967|NCT01079312|Fentanyl|fentanyl|mesh-list
65464968|NCT01079312|Remifentanil|remifentanil|mesh-list
65464969|NCT01079312|Propofol|propofol|mesh-list
65464970|NCT01079312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65464971|NCT01079312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65464972|NCT01079312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464990|NCT01044485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65464991|NCT00119678|Prednisone|prednisone|mesh-list
65464992|NCT00119678|Abatacept|abatacept|mesh-list
65464993|NCT00119678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65214492|NCT00816166|Clopidogrel|clopidogrel|mesh-list
65464994|NCT00119678|Glucocorticoids|glucocorticoids|mesh-ancestor
65464995|NCT00119678|Hormones|hormones|mesh-ancestor
65494046|NCT03777436|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65464996|NCT00119678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65464997|NCT00119678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65464998|NCT00119678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65465000|NCT00119678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65465001|NCT00119678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465002|NCT00119678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65465003|NCT00119678|Immunologic Factors|immunologic factors|mesh-ancestor
65465004|NCT00119678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65465005|NCT00110084|Gemcitabine|gemcitabine|mesh-list
65465006|NCT00110084|Paclitaxel|paclitaxel|mesh-list
65465007|NCT00110084|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65465008|NCT00110084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65465009|NCT00110084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707893|NCT04738526|Lithium Carbonate|lithium carbonate|mesh-list
64707894|NCT04738526|Antidepressive Agents|antidepressive agents|mesh-ancestor
64707895|NCT04738526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64707896|NCT04738526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64707897|NCT04738526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707898|NCT04738526|Antimanic Agents|antimanic agents|mesh-ancestor
64707899|NCT04738526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64707900|NCT04738526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64707901|NCT04738526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707902|NCT05449483|Paclitaxel|paclitaxel|mesh-list
64707903|NCT05449483|Cisplatin|cisplatin|mesh-list
64707904|NCT05449483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64707905|NCT05449483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707906|NCT05449483|Tubulin Modulators|tubulin modulators|mesh-ancestor
64707907|NCT05449483|Antimitotic Agents|antimitotic agents|mesh-ancestor
64707908|NCT05449483|Mitosis Modulators|mitosis modulators|mesh-ancestor
64707909|NCT05449483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707910|NCT05448404|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64707911|NCT05448404|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64707912|NCT05448404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707913|NCT04806919|Progesterone|progesterone|mesh-list
64707914|NCT04806919|Progestins|progestins|mesh-ancestor
64707915|NCT04806919|Hormones|hormones|mesh-ancestor
64707916|NCT04806919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64707917|NCT04806919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707918|NCT04793659|Fasudil|fasudil|mesh-list
64707919|NCT04793659|1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine|1-(5-isoquinolinesulfonyl)-2-methylpiperazine|mesh-list
64707920|NCT04793659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64719010|NCT00000734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64719011|NCT00000734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64719012|NCT03663283|Bupivacaine|bupivacaine|mesh-list
64719013|NCT03663283|Anesthetics, Local|anesthetics, local|mesh-ancestor
65465010|NCT00110084|Tubulin Modulators|tubulin modulators|mesh-ancestor
65465011|NCT00110084|Antimitotic Agents|antimitotic agents|mesh-ancestor
65465012|NCT00110084|Mitosis Modulators|mitosis modulators|mesh-ancestor
65465013|NCT00110084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465014|NCT00110084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65465015|NCT00110084|Antimetabolites|antimetabolites|mesh-ancestor
65465016|NCT00110084|Antiviral Agents|antiviral agents|mesh-ancestor
65465017|NCT00110084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65465018|NCT00110084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465019|NCT00110084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65465020|NCT00110084|Immunologic Factors|immunologic factors|mesh-ancestor
65465021|NCT00110084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465022|NCT00390221|Daclizumab|daclizumab|mesh-list
65465023|NCT00390221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65465024|NCT00390221|Immunologic Factors|immunologic factors|mesh-ancestor
65465025|NCT00390221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465026|NCT00389831|Rotigotine|rotigotine|mesh-list
65465027|NCT00389831|Dopamine Agonists|dopamine agonists|mesh-ancestor
65465028|NCT00389831|Dopamine Agents|dopamine agents|mesh-ancestor
65465029|NCT00389831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65465030|NCT00389831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849498|NCT04665895|Xhance|xhance|mesh-list
64719014|NCT03663283|Anesthetics|anesthetics|mesh-ancestor
64719015|NCT03663283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64719016|NCT03663283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719017|NCT03663283|Sensory System Agents|sensory system agents|mesh-ancestor
64719018|NCT03663283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64707928|NCT05448937|Eugenol|eugenol|mesh-list
64707929|NCT05448937|Zinc Oxide|zinc oxide|mesh-list
64707930|NCT05448937|Dermatologic Agents|dermatologic agents|mesh-ancestor
64707931|NCT05448937|Sunscreening Agents|sunscreening agents|mesh-ancestor
64707932|NCT05448937|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64707933|NCT05448937|Protective Agents|protective agents|mesh-ancestor
64707934|NCT05448937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707935|NCT05448937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64707936|NCT00370201|Colchicine|colchicine|mesh-list
64707937|NCT00370201|Gout Suppressants|gout suppressants|mesh-ancestor
64719039|NCT00484718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719040|NCT00484718|Analgesics|analgesics|mesh-ancestor
64719041|NCT00484718|Sensory System Agents|sensory system agents|mesh-ancestor
64719042|NCT00484718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719043|NCT00484718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64719044|NCT00484718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64719045|NCT00484718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64719046|NCT00484718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64337117|NCT02324413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64719060|NCT00448682|Tubulin Modulators|tubulin modulators|mesh-ancestor
64719061|NCT00448682|Antimitotic Agents|antimitotic agents|mesh-ancestor
64719062|NCT00448682|Mitosis Modulators|mitosis modulators|mesh-ancestor
64719063|NCT00448682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719064|NCT00448682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707938|NCT00370201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64707939|NCT00370201|Tubulin Modulators|tubulin modulators|mesh-ancestor
64707940|NCT00370201|Antimitotic Agents|antimitotic agents|mesh-ancestor
65465031|NCT00389831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465032|NCT00389519|Ramipril|ramipril|mesh-list
65465033|NCT00389519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65465034|NCT00389519|Protease Inhibitors|protease inhibitors|mesh-ancestor
65465035|NCT00389519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465036|NCT00389519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465037|NCT00389519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65465038|NCT00389441|Axitinib|axitinib|mesh-list
65465039|NCT00389441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465040|NCT00389441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65465041|NCT00389441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465042|NCT00389441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465043|NCT00118898|Ritonavir|ritonavir|mesh-list
65465044|NCT00118898|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65465045|NCT00118898|Tenofovir|tenofovir|mesh-list
65465046|NCT00118898|Lamivudine|lamivudine|mesh-list
65465047|NCT00118898|Emtricitabine|emtricitabine|mesh-list
65465048|NCT00118898|Abacavir|abacavir|mesh-list
65465049|NCT00118898|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65465050|NCT00118898|Efavirenz|efavirenz|mesh-list
65465051|NCT00118898|Dideoxynucleosides|dideoxynucleosides|mesh-list
65465052|NCT00118898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65465053|NCT00118898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65465054|NCT00118898|Protease Inhibitors|protease inhibitors|mesh-ancestor
65465055|NCT00118898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465056|NCT00118898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465057|NCT00118898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65465058|NCT00118898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65465059|NCT00118898|Antiviral Agents|antiviral agents|mesh-ancestor
65465060|NCT00118898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65465061|NCT00118898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65465062|NCT00118898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65465063|NCT00118898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65465064|NCT00118898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65465065|NCT00118898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65465068|NCT00118898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65465069|NCT00118898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65465070|NCT00118898|Antimetabolites|antimetabolites|mesh-ancestor
65465071|NCT00118430|Antidepressive Agents|antidepressive agents|mesh-list
65465072|NCT00118430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65465073|NCT01085552|Epoetin Alfa|epoetin alfa|mesh-list
65465074|NCT01085552|Hematinics|hematinics|mesh-ancestor
65465075|NCT01085708|Rabeprazole|rabeprazole|mesh-list
65465076|NCT01085708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65465077|NCT01085708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65465078|NCT01085708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65465079|NCT01085708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465080|NCT01085708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465081|NCT00090584|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65465082|NCT00090584|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65465083|NCT00090584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65465084|NCT00090584|Cholinergic Agents|cholinergic agents|mesh-ancestor
64707941|NCT00370201|Mitosis Modulators|mitosis modulators|mesh-ancestor
64707942|NCT00370201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707943|NCT00370201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707944|NCT05448781|Paclitaxel|paclitaxel|mesh-list
64707945|NCT05448781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64707946|NCT05448781|Carboplatin|carboplatin|mesh-list
64707947|NCT05448781|Pemetrexed|pemetrexed|mesh-list
64707948|NCT05448781|Endostatins|endostatins|mesh-list
64707949|NCT05448781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64707950|NCT05448781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707951|NCT05448781|Tubulin Modulators|tubulin modulators|mesh-ancestor
64707952|NCT05448781|Antimitotic Agents|antimitotic agents|mesh-ancestor
64707953|NCT05448781|Mitosis Modulators|mitosis modulators|mesh-ancestor
64707954|NCT05448781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707955|NCT05448781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64707956|NCT05448781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64707958|NCT05448781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64707959|NCT05448781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64719066|NCT00448682|Protective Agents|protective agents|mesh-ancestor
64719067|NCT00448682|Vitamin B Complex|vitamin b complex|mesh-ancestor
64719068|NCT00448682|Vitamins|vitamins|mesh-ancestor
64719069|NCT00448682|Micronutrients|micronutrients|mesh-ancestor
64719070|NCT00448682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64719071|NCT00448682|Antimetabolites|antimetabolites|mesh-ancestor
64719072|NCT04713488|Vaccines|vaccines|mesh-list
64719073|NCT04713488|Immunologic Factors|immunologic factors|mesh-ancestor
64719074|NCT04713488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719075|NCT03675451|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64719076|NCT03675451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64719077|NCT03675451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719078|NCT00380120|Warfarin|warfarin|mesh-list
64719079|NCT00380120|Anticoagulants|anticoagulants|mesh-ancestor
64719080|NCT00000770|Zidovudine|zidovudine|mesh-list
64337125|NCT03498703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64719081|NCT00000770|Nevirapine|nevirapine|mesh-list
64719082|NCT00000770|Didanosine|didanosine|mesh-list
64719083|NCT00000770|Antimetabolites|antimetabolites|mesh-ancestor
64719084|NCT00000770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719085|NCT00000770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64719086|NCT00000770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64719087|NCT00000770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719088|NCT00000770|Antiviral Agents|antiviral agents|mesh-ancestor
64719089|NCT00000770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719090|NCT00000770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65465085|NCT00090584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65465086|NCT00090584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465087|NCT00090584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465088|NCT00090584|Urological Agents|urological agents|mesh-ancestor
65465090|NCT01079624|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65465091|NCT01079624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65465092|NCT01079624|Hormones|hormones|mesh-ancestor
65465093|NCT01079624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65465094|NCT01079624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465095|NCT01079624|Incretins|incretins|mesh-ancestor
65465096|NCT01086020|Atorvastatin|atorvastatin|mesh-list
65465097|NCT01086020|Ezetimibe|ezetimibe|mesh-list
65465098|NCT01086020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65465099|NCT01086020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65465100|NCT01086020|Antimetabolites|antimetabolites|mesh-ancestor
65465101|NCT01086020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465102|NCT01086020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65465103|NCT01086020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65465104|NCT01086020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465105|NCT03670810|Lasmiditan|lasmiditan|mesh-list
65465106|NCT03670810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65465107|NCT03670810|Serotonin Agents|serotonin agents|mesh-ancestor
65465108|NCT03670810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65465109|NCT03670810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465110|NCT03670810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465111|NCT01086254|Gemcitabine|gemcitabine|mesh-list
65465112|NCT01086254|Iniparib|iniparib|mesh-list
65465113|NCT01086254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465114|NCT01086254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65465115|NCT01086254|Antimetabolites|antimetabolites|mesh-ancestor
65465116|NCT01086254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465117|NCT01086254|Antiviral Agents|antiviral agents|mesh-ancestor
65465118|NCT01086254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65465119|NCT01086254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64707963|NCT03182426|Liraglutide|liraglutide|mesh-list
64707964|NCT03182426|Plerixafor|plerixafor|mesh-list
64707965|NCT03182426|Etanercept|etanercept|mesh-list
64707966|NCT03182426|Alemtuzumab|alemtuzumab|mesh-list
64707967|NCT03182426|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64707968|NCT03182426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64849609|NCT04281108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65465120|NCT01086254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65465121|NCT01086254|Immunologic Factors|immunologic factors|mesh-ancestor
65465122|NCT01086254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465123|NCT01086254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65465124|NCT01086332|Gemcitabine|gemcitabine|mesh-list
65465125|NCT01086332|Nelfinavir|nelfinavir|mesh-list
65465126|NCT01086332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65465127|NCT01086332|Antimetabolites|antimetabolites|mesh-ancestor
65465128|NCT01086332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465129|NCT01086332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465130|NCT01086332|Antiviral Agents|antiviral agents|mesh-ancestor
65465131|NCT01086332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65465132|NCT01086332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465133|NCT01086332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65465134|NCT01086332|Immunologic Factors|immunologic factors|mesh-ancestor
65465135|NCT01086332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465136|NCT01086332|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65465137|NCT01086332|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65465138|NCT01086332|Protease Inhibitors|protease inhibitors|mesh-ancestor
65465139|NCT01086332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65465140|NCT01086332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64707969|NCT03182426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707970|NCT03182426|Incretins|incretins|mesh-ancestor
64707971|NCT03182426|Hormones|hormones|mesh-ancestor
64707972|NCT03182426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64707973|NCT03182426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64707974|NCT03182426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64707975|NCT03182426|Analgesics|analgesics|mesh-ancestor
64707976|NCT03182426|Sensory System Agents|sensory system agents|mesh-ancestor
64719096|NCT00368654|Abortifacient Agents|abortifacient agents|mesh-ancestor
64719097|NCT00368654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64719098|NCT00368654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719099|NCT00368654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64458395|NCT04020016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64719100|NCT00368654|Antimetabolites|antimetabolites|mesh-ancestor
64719101|NCT00368654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719102|NCT00368654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707977|NCT03182426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64707978|NCT03182426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64707979|NCT03182426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64707980|NCT03182426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64707981|NCT03182426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64707982|NCT03182426|Immunologic Factors|immunologic factors|mesh-ancestor
64707983|NCT03182426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64707984|NCT03182426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707985|NCT03182426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64707986|NCT03182426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64707987|NCT03182426|Antiviral Agents|antiviral agents|mesh-ancestor
64707988|NCT03182426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64707989|NCT03233347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64707990|NCT03233347|Nivolumab|nivolumab|mesh-list
64331633|NCT05122182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331634|NCT05122182|Interferon Inducers|interferon inducers|mesh-ancestor
64331635|NCT05122182|Immunologic Factors|immunologic factors|mesh-ancestor
64331636|NCT05122182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331637|NCT05092360|Gemcitabine|gemcitabine|mesh-list
65465141|NCT01811368|Cyclosporine|cyclosporine|mesh-list
65465142|NCT01811368|Mycophenolic Acid|mycophenolic acid|mesh-list
65465143|NCT01811368|Rituximab|rituximab|mesh-list
65214646|NCT02611492|Cytarabine|cytarabine|mesh-list
65465144|NCT01811368|Cyclosporins|cyclosporins|mesh-list
65465145|NCT01811368|Thymoglobulin|thymoglobulin|mesh-list
65465146|NCT01811368|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65465147|NCT01811368|Immunoglobulins|immunoglobulins|mesh-list
65465148|NCT01811368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65465149|NCT01811368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465150|NCT01811368|Immunologic Factors|immunologic factors|mesh-ancestor
65465151|NCT01811368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465152|NCT01811368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65465153|NCT01811368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465154|NCT01811368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465155|NCT01811368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65465156|NCT01811368|Antifungal Agents|antifungal agents|mesh-ancestor
65465157|NCT01811368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65465158|NCT01811368|Dermatologic Agents|dermatologic agents|mesh-ancestor
65465159|NCT01811368|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65465160|NCT01811368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65465161|NCT01811368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64707991|NCT03233347|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64707992|NCT03233347|Doxorubicin|doxorubicin|mesh-list
64707993|NCT03233347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64707994|NCT03233347|Daunorubicin|daunorubicin|mesh-list
64707995|NCT03233347|Dacarbazine|dacarbazine|mesh-list
64707996|NCT03233347|Vinblastine|vinblastine|mesh-list
64707997|NCT03233347|Antibodies|antibodies|mesh-list
64707998|NCT03233347|Immunoglobulins|immunoglobulins|mesh-list
64849657|NCT04170946|Talazoparib|talazoparib|mesh-list
64849658|NCT04170946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64849659|NCT04170946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849661|NCT04170946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465162|NCT01811368|Antitubercular Agents|antitubercular agents|mesh-ancestor
65465163|NCT01811368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65465164|NCT00089648|Sunitinib|sunitinib|mesh-list
65465165|NCT00089648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465166|NCT00089648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65465167|NCT00089648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65465168|NCT00089648|Growth Substances|growth substances|mesh-ancestor
65465169|NCT00089648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465170|NCT00089648|Growth Inhibitors|growth inhibitors|mesh-ancestor
65465171|NCT00089648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65465172|NCT00089648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465173|NCT00089648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465174|NCT01079702|Capecitabine|capecitabine|mesh-list
65465175|NCT01079702|Everolimus|everolimus|mesh-list
65465176|NCT01079702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65465177|NCT01079702|Antimetabolites|antimetabolites|mesh-ancestor
65465178|NCT01079702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465179|NCT01079702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465180|NCT01079702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65465181|NCT01079702|Immunologic Factors|immunologic factors|mesh-ancestor
65465182|NCT01079702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465183|NCT00118040|Genistein|genistein|mesh-list
65465184|NCT00118040|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65465185|NCT00118040|Protective Agents|protective agents|mesh-ancestor
65465186|NCT00118040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465187|NCT00118040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465188|NCT00118040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65465189|NCT00118040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465190|NCT00118040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465191|NCT00118040|Phytoestrogens|phytoestrogens|mesh-ancestor
65465192|NCT00118040|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65465194|NCT00118040|Hormones|hormones|mesh-ancestor
65465197|NCT03961958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65465198|NCT03961958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65465199|NCT03961958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465200|NCT03961958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65465201|NCT03961958|Anesthetics, General|anesthetics, general|mesh-ancestor
65465202|NCT03961958|Anesthetics|anesthetics|mesh-ancestor
65465203|NCT00389207|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65465204|NCT00389207|Nevirapine|nevirapine|mesh-list
65465205|NCT00389207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65465206|NCT00389207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65465207|NCT00389207|Protease Inhibitors|protease inhibitors|mesh-ancestor
65465208|NCT00389207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465209|NCT00389207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465210|NCT00389207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65465211|NCT00389207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65465212|NCT00389207|Antiviral Agents|antiviral agents|mesh-ancestor
65465213|NCT00389207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65465214|NCT00389207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64707999|NCT03233347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64708000|NCT03233347|Immunoconjugates|immunoconjugates|mesh-list
64708001|NCT03233347|Imidazole|imidazole|mesh-list
64708002|NCT03233347|Immunologic Factors|immunologic factors|mesh-ancestor
64708003|NCT03233347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708004|NCT03233347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708005|NCT03233347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64708006|NCT03233347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64708007|NCT03233347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64708008|NCT03233347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708009|NCT03233347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708010|NCT03233347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64708011|NCT03233347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64708012|NCT03233347|Alkylating Agents|alkylating agents|mesh-ancestor
64708014|NCT03233347|Tubulin Modulators|tubulin modulators|mesh-ancestor
64708015|NCT03233347|Antimitotic Agents|antimitotic agents|mesh-ancestor
64708032|NCT03036488|Lenograstim|lenograstim|mesh-list
64708033|NCT03036488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64708034|NCT03036488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708035|NCT03036488|Tubulin Modulators|tubulin modulators|mesh-ancestor
64719103|NCT00368654|Dermatologic Agents|dermatologic agents|mesh-ancestor
64719104|NCT00368654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719105|NCT00368654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64719106|NCT00368654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64719107|NCT00368654|Immunologic Factors|immunologic factors|mesh-ancestor
64719108|NCT00368654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64327226|NCT00834613|Metformin|metformin|mesh-list
64708048|NCT03036488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64708049|NCT03036488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708050|NCT03036488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64708051|NCT03036488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64708052|NCT04417465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64708053|NCT04417465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708054|NCT04417465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708056|NCT02966756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708057|NCT04475432|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64708058|NCT04475432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64708059|NCT00370825|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64708060|NCT00370825|Miltefosine|miltefosine|mesh-list
64708061|NCT00370825|Antifungal Agents|antifungal agents|mesh-ancestor
65465215|NCT00389207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65465216|NCT00389207|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65465217|NCT00389207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65465218|NCT00388973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65465219|NCT00388973|Antidepressive Agents|antidepressive agents|mesh-ancestor
65465220|NCT00388973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65465221|NCT00388973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65465222|NCT00388973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65465223|NCT00388973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65465224|NCT00388973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465225|NCT00085202|Cyclophosphamide|cyclophosphamide|mesh-list
65465226|NCT00085202|Vincristine|vincristine|mesh-list
65465227|NCT00085202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65465228|NCT00085202|Immunologic Factors|immunologic factors|mesh-ancestor
64849704|NCT04002947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64708062|NCT00370825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64708063|NCT00370825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64708064|NCT00370825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64708065|NCT00370825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708066|NCT04450316|Naltrexone|naltrexone|mesh-list
64708067|NCT04450316|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64708068|NCT04450316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64708069|NCT04450316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708070|NCT04450316|Sensory System Agents|sensory system agents|mesh-ancestor
64708071|NCT04450316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64708072|NCT05377424|Istradefylline|istradefylline|mesh-list
64708073|NCT05377424|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
64708074|NCT05377424|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64708075|NCT05377424|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64708076|NCT05377424|Purinergic Agents|purinergic agents|mesh-ancestor
64708077|NCT05377424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64433333|NCT02048241|Guanfacine|guanfacine|mesh-list
64708078|NCT05377424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708080|NCT02535247|Pembrolizumab|pembrolizumab|mesh-list
64708081|NCT02535247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64708082|NCT02535247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708083|NCT04417920|Mitomycins|mitomycins|mesh-list
64708084|NCT04417920|Mitomycin|mitomycin|mesh-list
64708085|NCT04417920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64708128|NCT03758989|Tubulin Modulators|tubulin modulators|mesh-ancestor
64708129|NCT03758989|Antimitotic Agents|antimitotic agents|mesh-ancestor
64708130|NCT03758989|Mitosis Modulators|mitosis modulators|mesh-ancestor
64708131|NCT03657043|Tisotumab vedotin|tisotumab vedotin|mesh-list
64708132|NCT03657043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64708133|NCT03657043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708134|NCT02042989|Vorinostat|vorinostat|mesh-list
64708135|NCT02042989|Ixazomib|ixazomib|mesh-list
64719109|NCT00368654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64719111|NCT00000776|Amphotericin B|amphotericin b|mesh-list
64719112|NCT00000776|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64719113|NCT00000776|Flucytosine|flucytosine|mesh-list
64719114|NCT00000776|Dexamethasone|dexamethasone|mesh-list
64719115|NCT00000776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64719116|NCT00000776|Antiemetics|antiemetics|mesh-ancestor
64719117|NCT00000776|Autonomic Agents|autonomic agents|mesh-ancestor
64719118|NCT00000776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719119|NCT00000776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719120|NCT00000776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64719121|NCT00000776|Glucocorticoids|glucocorticoids|mesh-ancestor
64719122|NCT00000776|Hormones|hormones|mesh-ancestor
64719123|NCT00000776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65465229|NCT00085202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465230|NCT00085202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65465231|NCT00085202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65465232|NCT00085202|Alkylating Agents|alkylating agents|mesh-ancestor
65465233|NCT00085202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465234|NCT00085202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465235|NCT00085202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65465236|NCT00085202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65465237|NCT00085202|Tubulin Modulators|tubulin modulators|mesh-ancestor
65465238|NCT00085202|Antimitotic Agents|antimitotic agents|mesh-ancestor
65465239|NCT00085202|Mitosis Modulators|mitosis modulators|mesh-ancestor
65465240|NCT00388583|Vaccines|vaccines|mesh-list
65465241|NCT00388583|Immunologic Factors|immunologic factors|mesh-ancestor
64849716|NCT03961360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64708136|NCT02042989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708137|NCT02042989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64708138|NCT02042989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708139|NCT02042989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708140|NCT02042989|Protease Inhibitors|protease inhibitors|mesh-ancestor
64708141|NCT02229578|Lidocaine|lidocaine|mesh-list
64708142|NCT02229578|Anesthetics, Local|anesthetics, local|mesh-ancestor
64708143|NCT02229578|Anesthetics|anesthetics|mesh-ancestor
64708144|NCT02229578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64708145|NCT02229578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708166|NCT04065841|Licogliflozin|licogliflozin|mesh-list
64708167|NCT04065841|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64708168|NCT04065841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708169|NCT04065841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64708170|NCT04065841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708181|NCT01809379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708182|NCT02229396|Dapagliflozin|dapagliflozin|mesh-list
64708183|NCT02229396|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64708184|NCT02229396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708185|NCT02229396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64708186|NCT02229396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708188|NCT04046575|Carboplatin|carboplatin|mesh-list
64708189|NCT04046575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64708190|NCT04046575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708191|NCT04046575|Tubulin Modulators|tubulin modulators|mesh-ancestor
64708192|NCT04046575|Antimitotic Agents|antimitotic agents|mesh-ancestor
64708193|NCT04046575|Mitosis Modulators|mitosis modulators|mesh-ancestor
64708194|NCT04046575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708195|NCT05202158|Gentamicins|gentamicins|mesh-list
64708196|NCT05202158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64708216|NCT00370370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64708217|NCT00370370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64719124|NCT00000776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64719125|NCT00000776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64719126|NCT00000776|Antifungal Agents|antifungal agents|mesh-ancestor
64719127|NCT00000776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719128|NCT00000776|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64719129|NCT00000776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64719130|NCT00000776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719131|NCT00000776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719132|NCT00000776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64719133|NCT00000776|Hormone Antagonists|hormone antagonists|mesh-ancestor
65465242|NCT00388583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465243|NCT00117572|Docetaxel|docetaxel|mesh-list
65465244|NCT00117572|Fluorouracil|fluorouracil|mesh-list
65465245|NCT00117572|Hydroxyurea|hydroxyurea|mesh-list
65465246|NCT00117572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465247|NCT00117572|Tubulin Modulators|tubulin modulators|mesh-ancestor
65465248|NCT00117572|Antimitotic Agents|antimitotic agents|mesh-ancestor
65465249|NCT00117572|Mitosis Modulators|mitosis modulators|mesh-ancestor
65465250|NCT00117572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465251|NCT00117572|Antimetabolites|antimetabolites|mesh-ancestor
65465252|NCT00117572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65465253|NCT00117572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65465254|NCT00117572|Immunologic Factors|immunologic factors|mesh-ancestor
65465255|NCT00117572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465256|NCT00117572|Antisickling Agents|antisickling agents|mesh-ancestor
65465257|NCT00117572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465258|NCT00117572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65465259|NCT00388505|Tobramycin|tobramycin|mesh-list
65465260|NCT00388505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65465261|NCT00388505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64849740|NCT03769285|Niacin|niacin|mesh-list
64327244|NCT00834535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64708218|NCT00370370|Immunologic Factors|immunologic factors|mesh-ancestor
64708219|NCT00370370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708220|NCT00370370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708221|NCT01265030|Sirolimus|sirolimus|mesh-list
64708222|NCT01265030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64708223|NCT01265030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64708224|NCT01265030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64708225|NCT01265030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708226|NCT01265030|Antifungal Agents|antifungal agents|mesh-ancestor
64708227|NCT01265030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64708228|NCT01265030|Immunologic Factors|immunologic factors|mesh-ancestor
64708229|NCT01265030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708231|NCT03236935|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
64708232|NCT03236935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64708233|NCT03236935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708234|NCT03236935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708235|NCT03236935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708237|NCT02197416|Antithrombins|antithrombins|mesh-ancestor
64708238|NCT02197416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64708239|NCT02197416|Protease Inhibitors|protease inhibitors|mesh-ancestor
64708240|NCT02197416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708241|NCT02197416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337170|NCT03498235|Propofol|propofol|mesh-list
64708270|NCT00371527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64708272|NCT00371527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64708273|NCT00371527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708274|NCT00392756|Hormones|hormones|mesh-list
64708275|NCT00392756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64708276|NCT00392756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708277|NCT03941743|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64708278|NCT03941743|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65465262|NCT00388349|Gemcitabine|gemcitabine|mesh-list
65465263|NCT00388349|Cyclophosphamide|cyclophosphamide|mesh-list
65465264|NCT00388349|Carmustine|carmustine|mesh-list
65465265|NCT00388349|Etoposide|etoposide|mesh-list
65465266|NCT00388349|Vinorelbine|vinorelbine|mesh-list
65465267|NCT00388349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65465268|NCT00388349|Immunologic Factors|immunologic factors|mesh-ancestor
65465269|NCT00388349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465270|NCT00388349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65465271|NCT00388349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65465272|NCT00388349|Alkylating Agents|alkylating agents|mesh-ancestor
65465273|NCT00388349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465274|NCT00388349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465275|NCT00388349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65465276|NCT00388349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65465277|NCT00388349|Antimetabolites|antimetabolites|mesh-ancestor
65465278|NCT00388349|Antiviral Agents|antiviral agents|mesh-ancestor
65465279|NCT00388349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65465280|NCT00388349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465281|NCT00388349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65465282|NCT00388349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65465283|NCT00388349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64849751|NCT03749187|Temozolomide|temozolomide|mesh-list
64708279|NCT03941743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708280|NCT03941743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64708281|NCT03941743|Immunologic Factors|immunologic factors|mesh-ancestor
64708282|NCT03941743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708283|NCT03908593|Pantoprazole|pantoprazole|mesh-list
64708284|NCT03908593|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64719134|NCT00000776|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64719135|NCT00000776|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64719136|NCT00000776|Amebicides|amebicides|mesh-ancestor
64719137|NCT00000776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64719138|NCT00000776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64719139|NCT00000776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64719140|NCT00000776|Antimetabolites|antimetabolites|mesh-ancestor
64719142|NCT04283773|Immunoglobulins|immunoglobulins|mesh-list
64719143|NCT04283773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64708285|NCT03908593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64708286|NCT03908593|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64708287|NCT03908593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708288|NCT03908593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708289|NCT04027322|Dexamethasone|dexamethasone|mesh-list
64708290|NCT04027322|Budesonide|budesonide|mesh-list
64708291|NCT04027322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64708292|NCT04027322|Antiemetics|antiemetics|mesh-ancestor
64708293|NCT04027322|Autonomic Agents|autonomic agents|mesh-ancestor
64708294|NCT04027322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64708295|NCT04027322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708296|NCT04027322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64708297|NCT04027322|Glucocorticoids|glucocorticoids|mesh-ancestor
64708298|NCT04027322|Hormones|hormones|mesh-ancestor
64708299|NCT04027322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65465284|NCT00388349|Tubulin Modulators|tubulin modulators|mesh-ancestor
65465285|NCT00388349|Antimitotic Agents|antimitotic agents|mesh-ancestor
65465286|NCT00388349|Mitosis Modulators|mitosis modulators|mesh-ancestor
65465287|NCT00117338|Montelukast|montelukast|mesh-list
65465288|NCT00117338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65465289|NCT00117338|Respiratory System Agents|respiratory system agents|mesh-ancestor
65465290|NCT00117338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65465291|NCT00117338|Hormone Antagonists|hormone antagonists|mesh-ancestor
65465292|NCT00117338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65465293|NCT00117338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465294|NCT00117338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65465295|NCT00117338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65465296|NCT00117338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465298|NCT00388037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465299|NCT00388037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65465300|NCT00388037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65465301|NCT00388037|Growth Substances|growth substances|mesh-ancestor
64618254|NCT00952133|Palonosetron|palonosetron|mesh-list
64708300|NCT04027322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64708301|NCT04027322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708302|NCT04027322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64708303|NCT04027322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64708304|NCT04027322|Respiratory System Agents|respiratory system agents|mesh-ancestor
64708305|NCT03845257|Dimercaprol|dimercaprol|mesh-list
64708306|NCT03845257|Chelating Agents|chelating agents|mesh-ancestor
64708307|NCT03845257|Sequestering Agents|sequestering agents|mesh-ancestor
64708308|NCT03845257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708309|NCT00371072|Mitomycins|mitomycins|mesh-list
64708310|NCT00371072|Mitomycin|mitomycin|mesh-list
64337198|NCT04461925|Azithromycin|azithromycin|mesh-list
64708351|NCT05454085|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64708352|NCT05454085|Estrogens|estrogens|mesh-ancestor
64708353|NCT05454085|Hormones|hormones|mesh-ancestor
64708354|NCT05454085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64708355|NCT05454085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708356|NCT05454085|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64708357|NCT05454085|Antioxidants|antioxidants|mesh-ancestor
64708358|NCT05454085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708359|NCT05454085|Protective Agents|protective agents|mesh-ancestor
64708360|NCT03886922|Cromakalim|cromakalim|mesh-list
64708381|NCT05453552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708383|NCT05453552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64708384|NCT05453552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64708386|NCT05453552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719144|NCT04283773|Immunologic Factors|immunologic factors|mesh-ancestor
64719145|NCT04283773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719146|NCT00329732|Lidocaine|lidocaine|mesh-list
64719147|NCT00329732|Bupivacaine|bupivacaine|mesh-list
64719148|NCT00329732|Anesthetics, Local|anesthetics, local|mesh-ancestor
64719149|NCT00329732|Anesthetics|anesthetics|mesh-ancestor
64719150|NCT00329732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64719151|NCT00329732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719152|NCT00329732|Sensory System Agents|sensory system agents|mesh-ancestor
64719153|NCT00329732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719154|NCT00329732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65465302|NCT00388037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465303|NCT00388037|Growth Inhibitors|growth inhibitors|mesh-ancestor
65465304|NCT00388037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65465305|NCT00388037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465306|NCT00388037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465307|NCT00387881|Naproxen|naproxen|mesh-list
65465308|NCT00387881|Sumatriptan|sumatriptan|mesh-list
65465309|NCT00387881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65465310|NCT00387881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65465311|NCT00387881|Analgesics|analgesics|mesh-ancestor
65465312|NCT00387881|Sensory System Agents|sensory system agents|mesh-ancestor
65465313|NCT00387881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65465314|NCT00387881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465315|NCT00387881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65465316|NCT00387881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65465317|NCT00387881|Gout Suppressants|gout suppressants|mesh-ancestor
65465318|NCT00387881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65465319|NCT00387881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465320|NCT00387881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465321|NCT00387881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65465322|NCT00387881|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65465323|NCT00387881|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65465324|NCT00387881|Serotonin Agents|serotonin agents|mesh-ancestor
65465325|NCT00387881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65465326|NCT00084656|Ipilimumab|ipilimumab|mesh-list
65465327|NCT00084656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65465328|NCT00084656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465329|NCT00084656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65465330|NCT00084656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465331|NCT00387647|Azacitidine|azacitidine|mesh-list
65465332|NCT00387647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65465333|NCT00387647|Antimetabolites|antimetabolites|mesh-ancestor
64849787|NCT03642132|Growth Inhibitors|growth inhibitors|mesh-ancestor
64719155|NCT00329732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64327265|NCT00834067|Protease Inhibitors|protease inhibitors|mesh-ancestor
64708387|NCT05453552|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64708388|NCT03787082|Chlorhexidine|chlorhexidine|mesh-list
64708389|NCT03787082|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64708390|NCT03787082|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64708391|NCT03787082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65465334|NCT00387647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465335|NCT00387647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465336|NCT00387647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465337|NCT00386009|Tadalafil|tadalafil|mesh-list
65465338|NCT00386009|Vasodilator Agents|vasodilator agents|mesh-ancestor
65465339|NCT00386009|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65465340|NCT00386009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65465341|NCT00386009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465342|NCT00386009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465343|NCT00386009|Urological Agents|urological agents|mesh-ancestor
65465344|NCT01045889|Prednisone|prednisone|mesh-list
65465345|NCT01045889|Cyclophosphamide|cyclophosphamide|mesh-list
65465346|NCT01045889|Melphalan|melphalan|mesh-list
65465347|NCT01045889|Rituximab|rituximab|mesh-list
65465348|NCT01045889|Etoposide|etoposide|mesh-list
65465349|NCT01045889|Vincristine|vincristine|mesh-list
65465350|NCT01045889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65465351|NCT01045889|Immunologic Factors|immunologic factors|mesh-ancestor
65465352|NCT01045889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465353|NCT01045889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65465354|NCT01045889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65465355|NCT01045889|Alkylating Agents|alkylating agents|mesh-ancestor
65465356|NCT01045889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465357|NCT01045889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465358|NCT01045889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65465359|NCT01045889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65465360|NCT01045889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64708392|NCT03787082|Disinfectants|disinfectants|mesh-ancestor
64708393|NCT03787082|Dermatologic Agents|dermatologic agents|mesh-ancestor
64708394|NCT02165202|Rilpivirine|rilpivirine|mesh-list
64708395|NCT02165202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64708396|NCT02165202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64708397|NCT02165202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708398|NCT02165202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708399|NCT02165202|Antiviral Agents|antiviral agents|mesh-ancestor
64708400|NCT02165202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64708401|NCT02165202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64708421|NCT04891718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708423|NCT03770689|Peposertib|peposertib|mesh-list
64708424|NCT03770689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64708425|NCT03770689|Antimetabolites|antimetabolites|mesh-ancestor
64708426|NCT03770689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708427|NCT03770689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708428|NCT03770689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64708429|NCT03770689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708430|NCT00371306|Metformin|metformin|mesh-list
64708431|NCT00371306|Glyburide|glyburide|mesh-list
64708432|NCT00371306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65465361|NCT01045889|Glucocorticoids|glucocorticoids|mesh-ancestor
65465362|NCT01045889|Hormones|hormones|mesh-ancestor
65465363|NCT01045889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65465364|NCT01045889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65465365|NCT01045889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65465366|NCT01045889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65465367|NCT01045889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65465368|NCT01045889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465369|NCT01045889|Tubulin Modulators|tubulin modulators|mesh-ancestor
65465370|NCT01045889|Antimitotic Agents|antimitotic agents|mesh-ancestor
65465371|NCT01045889|Mitosis Modulators|mitosis modulators|mesh-ancestor
65465372|NCT00373685|Celecoxib|celecoxib|mesh-list
65465373|NCT00373685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65465374|NCT00373685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65465375|NCT00373685|Analgesics|analgesics|mesh-ancestor
65465376|NCT00373685|Sensory System Agents|sensory system agents|mesh-ancestor
65465377|NCT00373685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65465378|NCT00373685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465379|NCT00373685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65465380|NCT00373685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65465381|NCT00373685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65465382|NCT00373685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65465383|NCT00373685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465384|NCT00373685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465385|NCT00373529|Clofarabine|clofarabine|mesh-list
65465386|NCT00373529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65465387|NCT00373529|Antimetabolites|antimetabolites|mesh-ancestor
64849847|NCT03506061|Elexacaftor|elexacaftor|mesh-list
64708433|NCT00371306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708434|NCT02196714|Glycopyrrolate|glycopyrrolate|mesh-list
64708435|NCT02196714|Formoterol Fumarate|formoterol fumarate|mesh-list
64708436|NCT02196714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64708437|NCT02196714|Autonomic Agents|autonomic agents|mesh-ancestor
64708438|NCT02196714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64708439|NCT02196714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708440|NCT02196714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64719156|NCT00329732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64719157|NCT00329732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64719158|NCT00329732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719159|NCT00000782|Vaccines|vaccines|mesh-list
64719160|NCT00000782|Immunologic Factors|immunologic factors|mesh-ancestor
64719161|NCT00000782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719162|NCT00000800|Zidovudine|zidovudine|mesh-list
64719163|NCT00000800|Methadone|methadone|mesh-list
64719164|NCT00000800|Antimetabolites|antimetabolites|mesh-ancestor
65465388|NCT00373529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465389|NCT00373529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465390|NCT00373295|Baclofen|baclofen|mesh-list
65465391|NCT00373295|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65465392|NCT00373295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465393|NCT00373295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65465394|NCT00373295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65465395|NCT00373295|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65465396|NCT00373295|GABA Agonists|gaba agonists|mesh-ancestor
65465397|NCT00373295|GABA Agents|gaba agents|mesh-ancestor
65465398|NCT00373295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65465399|NCT00373295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849869|NCT03466151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64719165|NCT00000800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719166|NCT00000800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64719167|NCT00000800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64719168|NCT00000800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719169|NCT00000800|Antiviral Agents|antiviral agents|mesh-ancestor
64719170|NCT00000800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719171|NCT00000800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64719172|NCT00000800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64719173|NCT00000800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64719174|NCT00000800|Narcotics|narcotics|mesh-ancestor
64719175|NCT00000800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64327276|NCT00833521|Zolpidem|zolpidem|mesh-list
64708441|NCT02196714|Respiratory System Agents|respiratory system agents|mesh-ancestor
64708442|NCT02196714|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64708443|NCT02196714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64708444|NCT02196714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64708445|NCT02196714|Adrenergic Agents|adrenergic agents|mesh-ancestor
64708453|NCT05453929|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64708454|NCT05453929|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64708455|NCT05453929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64708456|NCT05453929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64708458|NCT00370760|Dexamethasone|dexamethasone|mesh-list
64708459|NCT00370760|Colchicine|colchicine|mesh-list
64708460|NCT00370760|Heparin|heparin|mesh-list
64708461|NCT00370760|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64708462|NCT00370760|Tinzaparin|tinzaparin|mesh-list
64708463|NCT00370760|Dalteparin|dalteparin|mesh-list
64708464|NCT00370760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64708465|NCT00370760|Antiemetics|antiemetics|mesh-ancestor
64708466|NCT00370760|Autonomic Agents|autonomic agents|mesh-ancestor
64708467|NCT00370760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64708468|NCT00370760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708469|NCT00370760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64708470|NCT00370760|Glucocorticoids|glucocorticoids|mesh-ancestor
64708471|NCT00370760|Hormones|hormones|mesh-ancestor
64708472|NCT00370760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64708473|NCT00370760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64708474|NCT00370760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64719176|NCT00000800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719178|NCT00000800|Sensory System Agents|sensory system agents|mesh-ancestor
64719179|NCT00000800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719180|NCT00000800|Antitussive Agents|antitussive agents|mesh-ancestor
64719181|NCT00000800|Respiratory System Agents|respiratory system agents|mesh-ancestor
64719182|NCT03679975|Riluzole|riluzole|mesh-list
64719183|NCT03679975|Anticonvulsants|anticonvulsants|mesh-ancestor
64719184|NCT03679975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64327300|NCT02721459|Vemurafenib|vemurafenib|mesh-list
64708475|NCT00370760|Anticoagulants|anticoagulants|mesh-ancestor
65465400|NCT00385541|Morphine|morphine|mesh-list
65465401|NCT00385541|Hydromorphone|hydromorphone|mesh-list
65465402|NCT00385541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65465403|NCT00385541|Narcotics|narcotics|mesh-ancestor
65465404|NCT00385541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65465405|NCT00385541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465406|NCT00385541|Analgesics|analgesics|mesh-ancestor
65465407|NCT00385541|Sensory System Agents|sensory system agents|mesh-ancestor
65465408|NCT00385541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65465409|NCT01046045|Everolimus|everolimus|mesh-list
65465410|NCT01046045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465411|NCT01046045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65465412|NCT01046045|Immunologic Factors|immunologic factors|mesh-ancestor
65465413|NCT01046045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465414|NCT01044719|Meropenem|meropenem|mesh-list
65465415|NCT01044719|Tobramycin|tobramycin|mesh-list
65465416|NCT01044719|Ceftazidime|ceftazidime|mesh-list
65465417|NCT01044719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65465418|NCT01044719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65465419|NCT01045109|Vitamin D|vitamin d|mesh-list
65465420|NCT01045109|Ergocalciferols|ergocalciferols|mesh-list
65465421|NCT01045109|Cholecalciferol|cholecalciferol|mesh-list
65465422|NCT01045109|Vitamins|vitamins|mesh-list
65465423|NCT01045109|Micronutrients|micronutrients|mesh-ancestor
64849883|NCT03331341|Doxorubicin|doxorubicin|mesh-list
64337253|NCT03491527|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64708476|NCT00370760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64708477|NCT00370760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64708478|NCT00370760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708479|NCT00370760|Gout Suppressants|gout suppressants|mesh-ancestor
64708480|NCT00370760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64708481|NCT00370760|Tubulin Modulators|tubulin modulators|mesh-ancestor
64708482|NCT00370760|Antimitotic Agents|antimitotic agents|mesh-ancestor
64708483|NCT00370760|Mitosis Modulators|mitosis modulators|mesh-ancestor
64708484|NCT03737461|Lidocaine|lidocaine|mesh-list
64708497|NCT05203562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708498|NCT05203562|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64708499|NCT05203562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64708500|NCT05203562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708501|NCT05203562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708502|NCT05203562|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64708503|NCT05203562|Hormone Antagonists|hormone antagonists|mesh-ancestor
64708504|NCT05203562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64708505|NCT05203562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708506|NCT03448718|Olaparib|olaparib|mesh-list
64708507|NCT03448718|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64708508|NCT03448718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708509|NCT03448718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708510|NCT03448718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708511|NCT04766762|Flunarizine|flunarizine|mesh-list
64708512|NCT04766762|Anticonvulsants|anticonvulsants|mesh-ancestor
64708513|NCT04766762|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64433826|NCT01817764|Xhance|xhance|mesh-list
64708521|NCT04766762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64708522|NCT04766762|Vasodilator Agents|vasodilator agents|mesh-ancestor
65465424|NCT01045109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465425|NCT01045109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65465426|NCT01045109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65465427|NCT00094302|Spironolactone|spironolactone|mesh-list
65465428|NCT00094302|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
65465429|NCT00094302|Hormone Antagonists|hormone antagonists|mesh-ancestor
65465430|NCT00094302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65465431|NCT00094302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465432|NCT00094302|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65465433|NCT00094302|Diuretics|diuretics|mesh-ancestor
65465434|NCT00094302|Natriuretic Agents|natriuretic agents|mesh-ancestor
65465435|NCT00372905|Rituximab|rituximab|mesh-list
65465436|NCT00372905|Bortezomib|bortezomib|mesh-list
65465437|NCT00372905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65465438|NCT00372905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65465439|NCT00372905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465440|NCT00372905|Immunologic Factors|immunologic factors|mesh-ancestor
65465441|NCT00372905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465442|NCT00372905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65465443|NCT00384839|Azacitidine|azacitidine|mesh-list
65465444|NCT00384839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65465445|NCT00384839|Antimetabolites|antimetabolites|mesh-ancestor
65465446|NCT00384839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465447|NCT00384839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465448|NCT00384839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465449|NCT01046279|Bevacizumab|bevacizumab|mesh-list
65465450|NCT01046279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65465451|NCT01046279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465452|NCT01046279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65465453|NCT01046279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65465454|NCT01046279|Growth Substances|growth substances|mesh-ancestor
64849916|NCT03227705|Hormones|hormones|mesh-ancestor
64708524|NCT04330040|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64708525|NCT04330040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708526|NCT04330040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708527|NCT04330040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708528|NCT02737891|Metoprolol|metoprolol|mesh-list
64708529|NCT02737891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64708531|NCT02737891|Sympatholytics|sympatholytics|mesh-ancestor
64708532|NCT02737891|Autonomic Agents|autonomic agents|mesh-ancestor
64708533|NCT02737891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64849922|NCT03188432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465455|NCT01046279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465456|NCT01046279|Growth Inhibitors|growth inhibitors|mesh-ancestor
65465458|NCT00384293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65465459|NCT00384293|Antimetabolites|antimetabolites|mesh-ancestor
65465460|NCT00384293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465461|NCT00384293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65465462|NCT00384293|Vasodilator Agents|vasodilator agents|mesh-ancestor
65465463|NCT00384293|Vitamin B Complex|vitamin b complex|mesh-ancestor
65465464|NCT00384293|Vitamins|vitamins|mesh-ancestor
65465465|NCT00384293|Micronutrients|micronutrients|mesh-ancestor
65465466|NCT00384293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465467|NCT01087866|Metformin|metformin|mesh-list
65465468|NCT01087866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65465469|NCT01087866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465470|NCT01090830|Paclitaxel|paclitaxel|mesh-list
64708534|NCT02737891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708535|NCT02737891|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64708536|NCT02737891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64708537|NCT02737891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64708538|NCT02737891|Adrenergic Agents|adrenergic agents|mesh-ancestor
64708539|NCT02737891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64708540|NCT02737891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719185|NCT03679975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64719186|NCT03679975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64719187|NCT03679975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719188|NCT03679975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719189|NCT03679975|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64719190|NCT03679975|Protective Agents|protective agents|mesh-ancestor
64719191|NCT03887299|Disinfectants|disinfectants|mesh-list
64719192|NCT03887299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719193|NCT03684265|Meloxicam|meloxicam|mesh-list
64719194|NCT03684265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64719195|NCT03684265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64719196|NCT03684265|Analgesics|analgesics|mesh-ancestor
64719197|NCT03684265|Sensory System Agents|sensory system agents|mesh-ancestor
64719198|NCT03684265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719199|NCT03684265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719200|NCT03684265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64708541|NCT05055050|Imiquimod|imiquimod|mesh-list
64708542|NCT05055050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64708543|NCT05055050|Immunologic Factors|immunologic factors|mesh-ancestor
64708544|NCT05055050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708553|NCT04852484|Analgesics|analgesics|mesh-ancestor
64708554|NCT04852484|Sensory System Agents|sensory system agents|mesh-ancestor
64708555|NCT04852484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64708556|NCT04852484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708557|NCT04852484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64708558|NCT04852484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64708559|NCT04852484|Anesthetics, General|anesthetics, general|mesh-ancestor
64708560|NCT04852484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64708561|NCT04852484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64708562|NCT04852484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64708563|NCT04852484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64708564|NCT04852484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708565|NCT04852484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64708566|NCT04852484|Narcotics|narcotics|mesh-ancestor
64708567|NCT04809662|Imiquimod|imiquimod|mesh-list
65465471|NCT01090830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65465472|NCT01090830|Bevacizumab|bevacizumab|mesh-list
65465473|NCT01090830|Carboplatin|carboplatin|mesh-list
65465474|NCT01090830|Belinostat|belinostat|mesh-list
65465475|NCT01090830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65465476|NCT01090830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465477|NCT01090830|Tubulin Modulators|tubulin modulators|mesh-ancestor
65465478|NCT01090830|Antimitotic Agents|antimitotic agents|mesh-ancestor
65465479|NCT01090830|Mitosis Modulators|mitosis modulators|mesh-ancestor
65465480|NCT01090830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465481|NCT01090830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65465482|NCT01090830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65465483|NCT01090830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65465484|NCT01090830|Growth Substances|growth substances|mesh-ancestor
65465485|NCT01090830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465486|NCT01090830|Growth Inhibitors|growth inhibitors|mesh-ancestor
65465487|NCT01090830|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65465488|NCT01090830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465489|NCT01084824|Cantharidin|cantharidin|mesh-list
65465490|NCT01084824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465491|NCT01084824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465492|NCT01088022|Dexamethasone|dexamethasone|mesh-list
64708568|NCT04809662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64708569|NCT04809662|Immunologic Factors|immunologic factors|mesh-ancestor
64708570|NCT04809662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708571|NCT04809662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708588|NCT05443009|Anesthetics|anesthetics|mesh-ancestor
64708589|NCT05443009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64708590|NCT05443009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719201|NCT03684265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64719202|NCT03684265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64719203|NCT03684265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64719204|NCT03684265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719205|NCT03684265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719206|NCT00218036|Dexetimide|dexetimide|mesh-list
64719207|NCT00218036|Modafinil|modafinil|mesh-list
64719208|NCT00218036|Citalopram|citalopram|mesh-list
64719209|NCT00218036|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64327320|NCT02165033|Glucocorticoids|glucocorticoids|mesh-ancestor
64708591|NCT05443009|Sensory System Agents|sensory system agents|mesh-ancestor
64708592|NCT05443009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64708593|NCT05443009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64708594|NCT05443009|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64708595|NCT05443009|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64708596|NCT05443009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64708597|NCT05443009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708598|NCT00370669|Triamcinolone|triamcinolone|mesh-list
64708599|NCT00370669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64708600|NCT00370669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64708601|NCT00370669|Bevacizumab|bevacizumab|mesh-list
64708602|NCT00370669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64708603|NCT00370669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65465493|NCT01088022|Dexamethasone acetate|dexamethasone acetate|mesh-list
65465494|NCT01088022|Aprepitant|aprepitant|mesh-list
65465495|NCT01088022|Palonosetron|palonosetron|mesh-list
65465496|NCT01088022|BB 1101|bb 1101|mesh-list
65465497|NCT01088022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65465498|NCT01088022|Antiemetics|antiemetics|mesh-ancestor
65465499|NCT01088022|Autonomic Agents|autonomic agents|mesh-ancestor
65465500|NCT01088022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65465501|NCT01088022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465502|NCT01088022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65465503|NCT01088022|Glucocorticoids|glucocorticoids|mesh-ancestor
65465504|NCT01088022|Hormones|hormones|mesh-ancestor
65465505|NCT01088022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65465506|NCT01088022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65465507|NCT01088022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465508|NCT01088022|Protease Inhibitors|protease inhibitors|mesh-ancestor
65465509|NCT01088022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465510|NCT01088022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849959|NCT03151811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708604|NCT00370669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708605|NCT00370669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64708606|NCT00370669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64708608|NCT00370669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708609|NCT00370669|Growth Inhibitors|growth inhibitors|mesh-ancestor
64708610|NCT00370669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64708611|NCT00370669|Glucocorticoids|glucocorticoids|mesh-ancestor
64708612|NCT00370669|Hormones|hormones|mesh-ancestor
64708613|NCT00370669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64708625|NCT05378971|Pomalidomide|pomalidomide|mesh-list
64708626|NCT05378971|Immunologic Factors|immunologic factors|mesh-ancestor
64708627|NCT05378971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708628|NCT05378971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64708629|NCT05378971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64708630|NCT05378971|Growth Substances|growth substances|mesh-ancestor
64708631|NCT05378971|Growth Inhibitors|growth inhibitors|mesh-ancestor
64708632|NCT05378971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708648|NCT02740543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64708649|NCT02740543|Autonomic Agents|autonomic agents|mesh-ancestor
64708650|NCT02740543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64708651|NCT02740543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708652|NCT02740543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64708653|NCT02740543|Respiratory System Agents|respiratory system agents|mesh-ancestor
64708654|NCT02740543|Dermatologic Agents|dermatologic agents|mesh-ancestor
64708655|NCT02740543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64708656|NCT00370747|Ecabet|ecabet|mesh-list
64708657|NCT00370747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64708658|NCT00370747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64708659|NCT00370747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64719210|NCT00218036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64719211|NCT00218036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64719212|NCT00218036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719214|NCT00218036|Serotonin Agents|serotonin agents|mesh-ancestor
64719215|NCT00218036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327330|NCT00734461|Naltrexone|naltrexone|mesh-list
64708660|NCT00370747|Protease Inhibitors|protease inhibitors|mesh-ancestor
64708661|NCT00370747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465511|NCT01088022|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65465512|NCT01088022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65465513|NCT01088022|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65465514|NCT01088022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65465515|NCT01088022|Serotonin Agents|serotonin agents|mesh-ancestor
65465516|NCT00067002|Cyclophosphamide|cyclophosphamide|mesh-list
65465517|NCT00067002|Melphalan|melphalan|mesh-list
65465518|NCT00067002|Thiotepa|thiotepa|mesh-list
65465519|NCT00067002|Rituximab|rituximab|mesh-list
65465520|NCT00067002|Fludarabine|fludarabine|mesh-list
65465521|NCT00067002|Fludarabine phosphate|fludarabine phosphate|mesh-list
65465522|NCT00067002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65465523|NCT00067002|Immunologic Factors|immunologic factors|mesh-ancestor
65465524|NCT00067002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465525|NCT00067002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65465526|NCT00067002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65465527|NCT00067002|Alkylating Agents|alkylating agents|mesh-ancestor
65465528|NCT00067002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465529|NCT00067002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465530|NCT00067002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65465531|NCT00067002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65465532|NCT00067002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65465533|NCT00067002|Antimetabolites|antimetabolites|mesh-ancestor
65465534|NCT03961698|Paclitaxel|paclitaxel|mesh-list
65465535|NCT03961698|Bevacizumab|bevacizumab|mesh-list
65465536|NCT03961698|Atezolizumab|atezolizumab|mesh-list
65465537|NCT03961698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65465538|NCT03961698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465539|NCT03961698|Tubulin Modulators|tubulin modulators|mesh-ancestor
65465540|NCT03961698|Antimitotic Agents|antimitotic agents|mesh-ancestor
65465541|NCT03961698|Mitosis Modulators|mitosis modulators|mesh-ancestor
65465542|NCT03961698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465543|NCT03961698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65465544|NCT03961698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65465545|NCT03961698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64708662|NCT00370747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708663|NCT00370747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64708664|NCT00370747|Protective Agents|protective agents|mesh-ancestor
64708665|NCT00370747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465546|NCT03961698|Growth Substances|growth substances|mesh-ancestor
65465547|NCT03961698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465548|NCT03961698|Growth Inhibitors|growth inhibitors|mesh-ancestor
65465549|NCT01090908|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65465550|NCT01090908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65465551|NCT01084902|Latanoprost|latanoprost|mesh-list
65465552|NCT01084902|Brinzolamide|brinzolamide|mesh-list
65465553|NCT01084902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65465554|NCT01084902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65465555|NCT01084902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65465556|NCT01084902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465557|NCT01084902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465558|NCT01084980|Tacrolimus|tacrolimus|mesh-list
65465559|NCT01084980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65465560|NCT01084980|Immunologic Factors|immunologic factors|mesh-ancestor
65465561|NCT01084980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465562|NCT01084980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65465563|NCT01084980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465564|NCT01084980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465565|NCT01085058|Lenograstim|lenograstim|mesh-list
65465566|NCT01085058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65465567|NCT01085058|Immunologic Factors|immunologic factors|mesh-ancestor
65465568|NCT01085058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465569|NCT01088178|Levonorgestrel|levonorgestrel|mesh-list
65465570|NCT01088178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65465571|NCT01088178|Contraceptive Agents|contraceptive agents|mesh-ancestor
65465572|NCT01088178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65465573|NCT01088178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708666|NCT00370747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708667|NCT02752256|Plasminogen|plasminogen|mesh-list
64708668|NCT02752256|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64708669|NCT02752256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64708670|NCT02752256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64708671|NCT02752256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708672|NCT02227446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64708673|NCT02227446|Vancomycin|vancomycin|mesh-list
64708674|NCT02227446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64708675|NCT04738058|Lactoferrin|lactoferrin|mesh-list
64708676|NCT04738058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64708677|NCT04092452|PF-06700841|pf-06700841|mesh-list
64708678|NCT04092452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64708688|NCT02227368|Purinergic Agents|purinergic agents|mesh-ancestor
64708689|NCT02227368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64708690|NCT05291299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64708691|NCT02162862|Bupropion|bupropion|mesh-list
64708692|NCT02162862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64708693|NCT02162862|Antidepressive Agents|antidepressive agents|mesh-ancestor
64708694|NCT02162862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65465574|NCT01088178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65465575|NCT01088178|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65465576|NCT01088178|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65465577|NCT01088256|Etoricoxib|etoricoxib|mesh-list
65465578|NCT01088256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65465579|NCT01088256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65465580|NCT01088256|Analgesics|analgesics|mesh-ancestor
65465581|NCT01088256|Sensory System Agents|sensory system agents|mesh-ancestor
65465582|NCT01088256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65465583|NCT01088256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465584|NCT01088256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65465585|NCT01088256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65465586|NCT01088256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65465587|NCT01088256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65465588|NCT01088256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850042|NCT03056339|Fludarabine|fludarabine|mesh-list
64708695|NCT02162862|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64708696|NCT02162862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64708697|NCT02162862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64708713|NCT02226198|Antimetabolites|antimetabolites|mesh-ancestor
64708714|NCT02226198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708715|NCT02226198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64708716|NCT02226198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64708717|NCT02226198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708718|NCT02754518|Valsartan|valsartan|mesh-list
64708719|NCT02754518|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64708720|NCT02754518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64708721|NCT02754518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64708722|NCT02754518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64708723|NCT02754518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708724|NCT02751385|Nintedanib|nintedanib|mesh-list
64708725|NCT02751385|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64719216|NCT00218036|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64719218|NCT00218036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64719219|NCT00218036|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64719220|NCT00218036|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64719221|NCT00218036|Parasympatholytics|parasympatholytics|mesh-ancestor
64719222|NCT00218036|Autonomic Agents|autonomic agents|mesh-ancestor
64719223|NCT00218036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719224|NCT00218036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64719225|NCT00218036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64719226|NCT00218036|Cholinergic Agents|cholinergic agents|mesh-ancestor
64719227|NCT00218036|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64719228|NCT00218036|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64719229|NCT00218036|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64719230|NCT00218036|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64719231|NCT00233090|Modafinil|modafinil|mesh-list
64719232|NCT00233090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64327336|NCT00734461|Analgesics|analgesics|mesh-ancestor
64708726|NCT02751385|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
64708727|NCT02751385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708728|NCT02751385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64708729|NCT02751385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708730|NCT02751385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708731|NCT02751385|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65465589|NCT01088256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465590|NCT01326858|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
65465591|NCT01326858|Ketotifen|ketotifen|mesh-list
65465592|NCT01326858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65465593|NCT01326858|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65465594|NCT01326858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65465595|NCT01326858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65465596|NCT01326858|Analgesics|analgesics|mesh-ancestor
65465597|NCT01326858|Sensory System Agents|sensory system agents|mesh-ancestor
65465598|NCT01326858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65465599|NCT01326858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465600|NCT01326858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65465601|NCT01326858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65465602|NCT01326858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65465603|NCT01326858|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65465604|NCT01326858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65465605|NCT01326858|Histamine Antagonists|histamine antagonists|mesh-ancestor
65465606|NCT01326858|Histamine Agents|histamine agents|mesh-ancestor
65465607|NCT01326858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65465608|NCT01326858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465609|NCT01326858|Antipruritics|antipruritics|mesh-ancestor
65465610|NCT01326858|Dermatologic Agents|dermatologic agents|mesh-ancestor
64708732|NCT02751385|Contraceptive Agents|contraceptive agents|mesh-ancestor
64708733|NCT02751385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64708734|NCT02751385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337335|NCT02922985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64337337|NCT02922985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708757|NCT05057689|Dexmedetomidine|dexmedetomidine|mesh-list
64708758|NCT05057689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64708759|NCT05057689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64708760|NCT05057689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708761|NCT05057689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64708762|NCT05057689|Analgesics|analgesics|mesh-ancestor
64708763|NCT05057689|Sensory System Agents|sensory system agents|mesh-ancestor
64708764|NCT05057689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64708765|NCT05057689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64708766|NCT05057689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64708767|NCT05057689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64708768|NCT05057689|Adrenergic Agents|adrenergic agents|mesh-ancestor
64708769|NCT05057689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64708770|NCT05057689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708771|NCT05057689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64708772|NCT05057689|Narcotics|narcotics|mesh-ancestor
64708773|NCT05057689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64719233|NCT00233090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719234|NCT00233090|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64719235|NCT00233090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64719236|NCT00233090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64719237|NCT00233090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719238|NCT02921906|Acetaminophen|acetaminophen|mesh-list
65465611|NCT00091572|Temozolomide|temozolomide|mesh-list
65465612|NCT00091572|Dacarbazine|dacarbazine|mesh-list
65465613|NCT00091572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65465614|NCT00091572|Alkylating Agents|alkylating agents|mesh-ancestor
65465615|NCT00091572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465616|NCT00091572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465617|NCT01091220|Certolizumab Pegol|certolizumab pegol|mesh-list
65465618|NCT01091220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65465619|NCT01091220|Immunologic Factors|immunologic factors|mesh-ancestor
65465620|NCT01091220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465621|NCT01091220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65465622|NCT00084266|Vancomycin|vancomycin|mesh-list
65465623|NCT00084266|Linezolid|linezolid|mesh-list
65465624|NCT00084266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65465625|NCT00084266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65465626|NCT00084266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65465627|NCT00084266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850076|NCT02744053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719239|NCT02921906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64719240|NCT02921906|Analgesics|analgesics|mesh-ancestor
64719241|NCT02921906|Sensory System Agents|sensory system agents|mesh-ancestor
64719242|NCT02921906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719243|NCT02921906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719244|NCT02921906|Antipyretics|antipyretics|mesh-ancestor
64719245|NCT00000812|Thalidomide|thalidomide|mesh-list
64708774|NCT05057689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64708775|NCT05057689|Anesthetics, General|anesthetics, general|mesh-ancestor
64708776|NCT05057689|Anesthetics|anesthetics|mesh-ancestor
64708777|NCT05057689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64708778|NCT05057689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64708779|NCT05057689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64708780|NCT05057689|GABA Modulators|gaba modulators|mesh-ancestor
64708781|NCT05057689|GABA Agents|gaba agents|mesh-ancestor
64708782|NCT05032183|Leucovorin|leucovorin|mesh-list
64708783|NCT05032183|Cytarabine|cytarabine|mesh-list
64708784|NCT05032183|Dexamethasone|dexamethasone|mesh-list
64708785|NCT05032183|Dexamethasone acetate|dexamethasone acetate|mesh-list
64708786|NCT05032183|Prednisone|prednisone|mesh-list
64708787|NCT05032183|Cortisone|cortisone|mesh-list
64708788|NCT05032183|Cyclophosphamide|cyclophosphamide|mesh-list
64708789|NCT05032183|Rituximab|rituximab|mesh-list
64708790|NCT05032183|Methotrexate|methotrexate|mesh-list
64708791|NCT05032183|Vincristine|vincristine|mesh-list
64708792|NCT05032183|Mercaptopurine|mercaptopurine|mesh-list
64708793|NCT05032183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64708794|NCT05032183|Antibodies|antibodies|mesh-list
64708795|NCT05032183|Immunoglobulins|immunoglobulins|mesh-list
64708796|NCT05032183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64708797|NCT05032183|Lenograstim|lenograstim|mesh-list
64708798|NCT05032183|BB 1101|bb 1101|mesh-list
64708799|NCT05032183|Mesna|mesna|mesh-list
64708818|NCT05032183|Protease Inhibitors|protease inhibitors|mesh-ancestor
64708819|NCT05032183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708820|NCT05032183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64708821|NCT05032183|Abortifacient Agents|abortifacient agents|mesh-ancestor
64708822|NCT05032183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64708823|NCT05032183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64708824|NCT05032183|Antimetabolites|antimetabolites|mesh-ancestor
64708825|NCT05032183|Dermatologic Agents|dermatologic agents|mesh-ancestor
64708826|NCT05032183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64708827|NCT05032183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64708828|NCT05032183|Antiviral Agents|antiviral agents|mesh-ancestor
65465628|NCT00084266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465629|NCT01086878|Trimethoprim|trimethoprim|mesh-list
65465630|NCT01086878|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65465631|NCT01086878|Sulfamethoxazole|sulfamethoxazole|mesh-list
65465632|NCT01086878|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65465633|NCT01086878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65465634|NCT01086878|Renal Agents|renal agents|mesh-ancestor
65465635|NCT01086878|Antimalarials|antimalarials|mesh-ancestor
65465636|NCT01086878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65465637|NCT01086878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65465638|NCT01086878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65465639|NCT01086878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465640|NCT01086878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465641|NCT01086878|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65465642|NCT01086878|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64850092|NCT02395666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64708829|NCT05032183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64708831|NCT05032183|Protective Agents|protective agents|mesh-ancestor
64708832|NCT05032183|Vitamin B Complex|vitamin b complex|mesh-ancestor
64708833|NCT05032183|Vitamins|vitamins|mesh-ancestor
64719246|NCT00000812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64719247|NCT00000812|Immunologic Factors|immunologic factors|mesh-ancestor
64719248|NCT00000812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719249|NCT00000812|Leprostatic Agents|leprostatic agents|mesh-ancestor
64719250|NCT00000812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64458547|NCT03022240|Serotonin Agents|serotonin agents|mesh-ancestor
64719251|NCT00000812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719252|NCT00000812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64719253|NCT00000812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64719254|NCT00000812|Growth Substances|growth substances|mesh-ancestor
64719255|NCT00000812|Growth Inhibitors|growth inhibitors|mesh-ancestor
64719256|NCT00000812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64719257|NCT00000818|Zidovudine|zidovudine|mesh-list
64719258|NCT00000818|Antimetabolites|antimetabolites|mesh-ancestor
64719259|NCT00000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708834|NCT05032183|Micronutrients|micronutrients|mesh-ancestor
64708835|NCT05032183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64708836|NCT05032183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64708837|NCT05032183|Tubulin Modulators|tubulin modulators|mesh-ancestor
64337380|NCT04715191|Antimetabolites|antimetabolites|mesh-ancestor
64708838|NCT05032183|Antimitotic Agents|antimitotic agents|mesh-ancestor
64708839|NCT05032183|Mitosis Modulators|mitosis modulators|mesh-ancestor
64708840|NCT04737980|Dexamethasone|dexamethasone|mesh-list
64708841|NCT04737980|Bupivacaine|bupivacaine|mesh-list
64708842|NCT04737980|Ropivacaine|ropivacaine|mesh-list
64708843|NCT04737980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64708844|NCT04737980|Antiemetics|antiemetics|mesh-ancestor
64708845|NCT04737980|Autonomic Agents|autonomic agents|mesh-ancestor
64708846|NCT04737980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64708847|NCT04737980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708848|NCT04737980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64708849|NCT04737980|Glucocorticoids|glucocorticoids|mesh-ancestor
64708850|NCT04737980|Hormones|hormones|mesh-ancestor
64708851|NCT04737980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64708852|NCT04737980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64708853|NCT04737980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708854|NCT04737980|Anesthetics, Local|anesthetics, local|mesh-ancestor
64708855|NCT04737980|Anesthetics|anesthetics|mesh-ancestor
64708866|NCT00371696|Diclofenac|diclofenac|mesh-list
64708867|NCT00371696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65465643|NCT01086878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65465644|NCT01086878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65465645|NCT01086956|Sufentanil|sufentanil|mesh-list
65465646|NCT01086956|Ropivacaine|ropivacaine|mesh-list
65465647|NCT01086956|Anesthetics, Local|anesthetics, local|mesh-ancestor
65465648|NCT01086956|Anesthetics|anesthetics|mesh-ancestor
65465649|NCT01086956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65465650|NCT01086956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465651|NCT01086956|Sensory System Agents|sensory system agents|mesh-ancestor
65465652|NCT01086956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65465653|NCT01086956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65465654|NCT01086956|Narcotics|narcotics|mesh-ancestor
65465655|NCT01086956|Analgesics|analgesics|mesh-ancestor
65465656|NCT01086956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64850109|NCT02351869|Anesthetics|anesthetics|mesh-ancestor
64708868|NCT00371696|Analgesics|analgesics|mesh-ancestor
64708869|NCT00371696|Sensory System Agents|sensory system agents|mesh-ancestor
64708870|NCT00371696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64708871|NCT00371696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708872|NCT00371696|Antipyretics|antipyretics|mesh-ancestor
64708873|NCT00371696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64708874|NCT00371696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64708890|NCT02958800|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64708891|NCT02958800|Antipsychotic Agents|antipsychotic agents|mesh-list
64708892|NCT02958800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64434137|NCT01868542|Insulin Detemir|insulin detemir|mesh-list
64708893|NCT02958800|Serotonin Agents|serotonin agents|mesh-ancestor
64719260|NCT00000818|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64719261|NCT00000818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64719262|NCT00000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719264|NCT00000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719265|NCT00000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64719266|NCT00000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64719267|NCT00177866|Celecoxib|celecoxib|mesh-list
64719268|NCT00177866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64719269|NCT00177866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64719270|NCT00177866|Analgesics|analgesics|mesh-ancestor
64719271|NCT00177866|Sensory System Agents|sensory system agents|mesh-ancestor
64327385|NCT00725881|Antioxidants|antioxidants|mesh-ancestor
64708894|NCT02958800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64708895|NCT02958800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708896|NCT02958800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708897|NCT02958800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64708898|NCT02958800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64708899|NCT02958800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64708900|NCT02958800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64708901|NCT02958800|Dopamine Agents|dopamine agents|mesh-ancestor
64708902|NCT02958800|Antiemetics|antiemetics|mesh-ancestor
64708903|NCT02958800|Autonomic Agents|autonomic agents|mesh-ancestor
64708904|NCT02958800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64708905|NCT02958800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64708906|NCT02958800|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64708907|NCT02958800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64708908|NCT02958800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64708909|NCT02958800|Antidepressive Agents|antidepressive agents|mesh-ancestor
64708910|NCT00372086|Rosiglitazone|rosiglitazone|mesh-list
64708911|NCT00372086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64708912|NCT00372086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708913|NCT04738045|Ritonavir|ritonavir|mesh-list
64708914|NCT04738045|Lopinavir|lopinavir|mesh-list
64708915|NCT04738045|Remdesivir|remdesivir|mesh-list
64708916|NCT04738045|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65465657|NCT01086956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65465658|NCT01086956|Anesthetics, General|anesthetics, general|mesh-ancestor
65465659|NCT00091026|Gemcitabine|gemcitabine|mesh-list
65465660|NCT00091026|Bevacizumab|bevacizumab|mesh-list
65465661|NCT00091026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65465662|NCT00091026|Cetuximab|cetuximab|mesh-list
65465663|NCT00091026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65465664|NCT00091026|Antibodies|antibodies|mesh-list
65465665|NCT00091026|Immunoglobulins|immunoglobulins|mesh-list
65465666|NCT00091026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65465667|NCT00091026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465668|NCT00091026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65465669|NCT00091026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65465670|NCT00091026|Growth Substances|growth substances|mesh-ancestor
65465671|NCT00091026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465672|NCT00091026|Growth Inhibitors|growth inhibitors|mesh-ancestor
65465673|NCT00091026|Immunologic Factors|immunologic factors|mesh-ancestor
65465674|NCT00091026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65465675|NCT00091026|Antimetabolites|antimetabolites|mesh-ancestor
65465676|NCT00091026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465677|NCT00091026|Antiviral Agents|antiviral agents|mesh-ancestor
65465678|NCT00091026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65465679|NCT00091026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465680|NCT00091026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65465681|NCT00091026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65465682|NCT01091376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65465683|NCT01091376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465684|NCT01091376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65465685|NCT01091376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465686|NCT01091376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465687|NCT00115778|Immunoglobulins|immunoglobulins|mesh-list
65465688|NCT00115778|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65465689|NCT00115778|gamma-Globulins|gamma-globulins|mesh-list
65465690|NCT00115778|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65465691|NCT00115778|Immunologic Factors|immunologic factors|mesh-ancestor
64708917|NCT04738045|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64708918|NCT04738045|Protease Inhibitors|protease inhibitors|mesh-ancestor
64708919|NCT04738045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708920|NCT04738045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708921|NCT04738045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65465692|NCT00115778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465693|NCT00100178|Mycophenolic Acid|mycophenolic acid|mesh-list
65465694|NCT00100178|Daclizumab|daclizumab|mesh-list
65465695|NCT00100178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65465696|NCT00100178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465697|NCT00100178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65465698|NCT00100178|Antitubercular Agents|antitubercular agents|mesh-ancestor
65465699|NCT00100178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65465700|NCT00100178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65465701|NCT00100178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465702|NCT00100178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465703|NCT00100178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65465704|NCT00100178|Immunologic Factors|immunologic factors|mesh-ancestor
65465705|NCT00100178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465706|NCT00099632|Ritonavir|ritonavir|mesh-list
65465707|NCT00099632|Lopinavir|lopinavir|mesh-list
65465708|NCT00099632|Tenofovir|tenofovir|mesh-list
65465709|NCT00099632|Lamivudine|lamivudine|mesh-list
65465710|NCT00099632|Zidovudine|zidovudine|mesh-list
65465711|NCT00099632|Emtricitabine|emtricitabine|mesh-list
65465712|NCT00099632|Nevirapine|nevirapine|mesh-list
65465713|NCT00099632|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65465714|NCT00099632|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
65465715|NCT00099632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65465716|NCT00099632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65465717|NCT00099632|Protease Inhibitors|protease inhibitors|mesh-ancestor
65465718|NCT00099632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465719|NCT00099632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465720|NCT00099632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65465721|NCT00099632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65465722|NCT00099632|Antiviral Agents|antiviral agents|mesh-ancestor
65465723|NCT00099632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65465735|NCT01087190|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65465736|NCT01087190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65465737|NCT01087190|Antimetabolites|antimetabolites|mesh-ancestor
65465738|NCT01087190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465739|NCT01087190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65465740|NCT01090466|Gemcitabine|gemcitabine|mesh-list
65465741|NCT01090466|Sirolimus|sirolimus|mesh-list
65465742|NCT01090466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465743|NCT01090466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65465744|NCT01090466|Antimetabolites|antimetabolites|mesh-ancestor
65465745|NCT01090466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465746|NCT01090466|Antiviral Agents|antiviral agents|mesh-ancestor
65465747|NCT01090466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65465748|NCT01090466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465749|NCT01090466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65465750|NCT01090466|Immunologic Factors|immunologic factors|mesh-ancestor
65465751|NCT01090466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465752|NCT01090466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65465753|NCT01090466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65465754|NCT01090466|Antifungal Agents|antifungal agents|mesh-ancestor
65465755|NCT04116398|Dexamethasone|dexamethasone|mesh-list
65465756|NCT04116398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65465757|NCT04116398|Antiemetics|antiemetics|mesh-ancestor
65465758|NCT04116398|Autonomic Agents|autonomic agents|mesh-ancestor
65465759|NCT04116398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65465760|NCT04116398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465761|NCT04116398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65465762|NCT04116398|Glucocorticoids|glucocorticoids|mesh-ancestor
65465763|NCT04116398|Hormones|hormones|mesh-ancestor
65465764|NCT04116398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65465781|NCT00098774|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65465782|NCT00098774|Abortifacient Agents|abortifacient agents|mesh-ancestor
65465783|NCT00098774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65465784|NCT00098774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65465785|NCT00098774|Antimetabolites|antimetabolites|mesh-ancestor
65465786|NCT00098774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465787|NCT00098774|Dermatologic Agents|dermatologic agents|mesh-ancestor
65465788|NCT00098774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708922|NCT04738045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64708948|NCT04516915|Oseltamivir|oseltamivir|mesh-list
64708949|NCT04516915|Antiviral Agents|antiviral agents|mesh-ancestor
64708950|NCT04516915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64708951|NCT04516915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719272|NCT00177866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719273|NCT00177866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719274|NCT00177866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64719275|NCT00177866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64719276|NCT00177866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64327391|NCT02292225|Obinutuzumab|obinutuzumab|mesh-list
64708952|NCT04516915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708953|NCT02753881|Doxorubicin|doxorubicin|mesh-list
64708954|NCT02753881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64708955|NCT02753881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64708956|NCT02753881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708957|NCT02753881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64708958|NCT02753881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64708959|NCT02753881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708960|NCT02753881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708961|NCT00425360|Gemcitabine|gemcitabine|mesh-list
64708962|NCT00425360|Capecitabine|capecitabine|mesh-list
64708963|NCT00425360|Sargramostim|sargramostim|mesh-list
64708964|NCT00425360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64708965|NCT00425360|Antimetabolites|antimetabolites|mesh-ancestor
64708966|NCT00425360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708967|NCT00425360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708968|NCT00425360|Antiviral Agents|antiviral agents|mesh-ancestor
64708969|NCT00425360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64708970|NCT00425360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708971|NCT00425360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64708972|NCT00425360|Immunologic Factors|immunologic factors|mesh-ancestor
64708973|NCT00425360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708974|NCT04337606|Decitabine|decitabine|mesh-list
64708975|NCT04337606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64708976|NCT04337606|Antimetabolites|antimetabolites|mesh-ancestor
64708977|NCT04337606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708978|NCT04337606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708979|NCT04337606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708981|NCT01190306|Vitamin B Complex|vitamin b complex|mesh-ancestor
64708982|NCT01190306|Vitamins|vitamins|mesh-ancestor
64708983|NCT01190306|Micronutrients|micronutrients|mesh-ancestor
64337413|NCT04674241|Analgesics|analgesics|mesh-ancestor
64709016|NCT02194998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709017|NCT02194998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64709018|NCT02194998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64709019|NCT02194998|Antiviral Agents|antiviral agents|mesh-ancestor
64709020|NCT02194998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64709021|NCT02194998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64709022|NCT02194998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64709023|NCT02194998|Antimetabolites|antimetabolites|mesh-ancestor
64709024|NCT02194062|Fluticasone|fluticasone|mesh-list
64709025|NCT02194062|Xhance|xhance|mesh-list
64709026|NCT02194062|Budesonide|budesonide|mesh-list
64709027|NCT02194062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64709028|NCT02194062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64709029|NCT02194062|Autonomic Agents|autonomic agents|mesh-ancestor
64709030|NCT02194062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64709031|NCT02194062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465789|NCT00098774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65465790|NCT00098774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65465791|NCT00098774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65465792|NCT00098774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65465793|NCT00098774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65465794|NCT00098774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65465795|NCT00098774|Antiviral Agents|antiviral agents|mesh-ancestor
65465796|NCT00098774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65465797|NCT00098774|Antidotes|antidotes|mesh-ancestor
65465798|NCT00098774|Protective Agents|protective agents|mesh-ancestor
65465799|NCT00098774|Vitamin B Complex|vitamin b complex|mesh-ancestor
65465800|NCT00098774|Vitamins|vitamins|mesh-ancestor
65465801|NCT00098774|Micronutrients|micronutrients|mesh-ancestor
65465802|NCT00098774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65465803|NCT00098774|Alkylating Agents|alkylating agents|mesh-ancestor
65465804|NCT01081652|Progesterone|progesterone|mesh-list
64709032|NCT02194062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64327398|NCT00677053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64719277|NCT00177866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64719278|NCT00177866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719279|NCT00177866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719280|NCT00089414|Drospirenone|drospirenone|mesh-list
64719281|NCT00089414|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64719282|NCT00089414|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
64719283|NCT00089414|Estradiol|estradiol|mesh-list
64719284|NCT00089414|Progesterone|progesterone|mesh-list
64709033|NCT02194062|Respiratory System Agents|respiratory system agents|mesh-ancestor
64709034|NCT02194062|Dermatologic Agents|dermatologic agents|mesh-ancestor
64709035|NCT02194062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64709036|NCT02194062|Glucocorticoids|glucocorticoids|mesh-ancestor
64709037|NCT02194062|Hormones|hormones|mesh-ancestor
64709038|NCT02194062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64709039|NCT02768558|Nivolumab|nivolumab|mesh-list
64709040|NCT02768558|Etoposide|etoposide|mesh-list
64709041|NCT02768558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709042|NCT02768558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64709043|NCT02768558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64709044|NCT02768558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709045|NCT02768558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64709046|NCT02768558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64709048|NCT02768558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709049|NCT02192970|Bevacizumab|bevacizumab|mesh-list
64709050|NCT02192970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64709051|NCT02192970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709052|NCT02192970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64709073|NCT05180318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64709074|NCT05457296|Hydrocortisone|hydrocortisone|mesh-list
64709075|NCT05457296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64709076|NCT05456438|Tea Tree Oil|tea tree oil|mesh-list
64709077|NCT05456438|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64709078|NCT05456438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64709079|NCT02744846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64709080|NCT02744846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64709081|NCT02762071|Bupivacaine|bupivacaine|mesh-list
64709082|NCT02762071|Anesthetics, Local|anesthetics, local|mesh-ancestor
64709083|NCT02762071|Anesthetics|anesthetics|mesh-ancestor
64709084|NCT02762071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64709085|NCT02762071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709086|NCT02762071|Sensory System Agents|sensory system agents|mesh-ancestor
64709087|NCT02762071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65465805|NCT01081652|Progestins|progestins|mesh-ancestor
65465806|NCT01081652|Hormones|hormones|mesh-ancestor
65465807|NCT01081652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65465808|NCT01081652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465809|NCT01087580|Prednisone|prednisone|mesh-list
65465810|NCT01087580|Docetaxel|docetaxel|mesh-list
65465811|NCT01087580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465812|NCT01087580|Tubulin Modulators|tubulin modulators|mesh-ancestor
65465813|NCT01087580|Antimitotic Agents|antimitotic agents|mesh-ancestor
65465814|NCT01087580|Mitosis Modulators|mitosis modulators|mesh-ancestor
65465815|NCT01087580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465816|NCT01087580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65465817|NCT01087580|Glucocorticoids|glucocorticoids|mesh-ancestor
65465818|NCT01087580|Hormones|hormones|mesh-ancestor
65465819|NCT01087580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65465820|NCT01087580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465821|NCT01087580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65465822|NCT01087658|Calcium|calcium|mesh-list
65494047|NCT03777436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64850269|NCT00217425|Glucocorticoids|glucocorticoids|mesh-ancestor
64709088|NCT04336891|Methyltestosterone|methyltestosterone|mesh-list
64709089|NCT04336891|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64709090|NCT04336891|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64709091|NCT04336891|Estradiol|estradiol|mesh-list
64709092|NCT04336891|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64709093|NCT04336891|Testosterone|testosterone|mesh-list
64709094|NCT04336891|Testosterone undecanoate|testosterone undecanoate|mesh-list
64709095|NCT04336891|Testosterone enanthate|testosterone enanthate|mesh-list
64709096|NCT04336891|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64709097|NCT04336891|Estrogens|estrogens|mesh-ancestor
64709098|NCT04336891|Hormones|hormones|mesh-ancestor
64709099|NCT04336891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64709100|NCT04336891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709101|NCT04336891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64709102|NCT04336891|Contraceptive Agents|contraceptive agents|mesh-ancestor
64709103|NCT04336891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64709104|NCT04336891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64719285|NCT00089414|Estrogens|estrogens|mesh-ancestor
64719286|NCT00089414|Hormones|hormones|mesh-ancestor
64719287|NCT00089414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64719288|NCT00089414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719289|NCT00089414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64719290|NCT00089414|Contraceptive Agents|contraceptive agents|mesh-ancestor
64719291|NCT00089414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64719292|NCT00089414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64719293|NCT00089414|Progestins|progestins|mesh-ancestor
64327401|NCT00677053|Protease Inhibitors|protease inhibitors|mesh-ancestor
64327402|NCT00677053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327404|NCT00677053|Anticoagulants|anticoagulants|mesh-ancestor
64709105|NCT04336891|Androgens|androgens|mesh-ancestor
64709106|NCT04336891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64709107|NCT04336891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709108|NCT04336891|Anabolic Agents|anabolic agents|mesh-ancestor
64709109|NCT04337918|Nitric Oxide|nitric oxide|mesh-list
64709110|NCT04337918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65465823|NCT01087658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65465824|NCT01087658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465825|NCT03958058|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65465826|NCT03958058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65465827|NCT03958058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65465828|NCT03958058|Antitubercular Agents|antitubercular agents|mesh-ancestor
65465829|NCT01081730|Ustekinumab|ustekinumab|mesh-list
65465830|NCT01081730|Dermatologic Agents|dermatologic agents|mesh-ancestor
65465831|NCT01090700|Simeprevir|simeprevir|mesh-list
65465832|NCT01090700|Dexetimide|dexetimide|mesh-list
65465833|NCT01090700|Citalopram|citalopram|mesh-list
65465834|NCT01090700|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65465835|NCT01090700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65465836|NCT01090700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64709111|NCT04337918|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64709112|NCT04337918|Autonomic Agents|autonomic agents|mesh-ancestor
64709113|NCT04337918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64709114|NCT04337918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709115|NCT04337918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64709116|NCT04337918|Respiratory System Agents|respiratory system agents|mesh-ancestor
64709117|NCT04337918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64709118|NCT04337918|Antioxidants|antioxidants|mesh-ancestor
64709119|NCT04337918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709120|NCT04337918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64337530|NCT03736265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64709151|NCT05348239|Chlorophyllin|chlorophyllin|mesh-list
64709152|NCT05348239|Trace Elements|trace elements|mesh-ancestor
64709153|NCT05348239|Micronutrients|micronutrients|mesh-ancestor
64709154|NCT05348239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709155|NCT05348239|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64709156|NCT05348239|Protective Agents|protective agents|mesh-ancestor
64709157|NCT02766673|Albuterol|albuterol|mesh-list
64709158|NCT02766673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64709159|NCT02766673|Autonomic Agents|autonomic agents|mesh-ancestor
64709160|NCT02766673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64709161|NCT02766673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709162|NCT02766673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64709163|NCT02766673|Respiratory System Agents|respiratory system agents|mesh-ancestor
64709164|NCT02766673|Tocolytic Agents|tocolytic agents|mesh-ancestor
64719294|NCT00089414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64719295|NCT00089414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64719296|NCT00089414|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64719297|NCT00089414|Hormone Antagonists|hormone antagonists|mesh-ancestor
64719298|NCT00089414|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64709165|NCT02766673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64709166|NCT02766673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64709167|NCT02766673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64709168|NCT02766673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64709169|NCT02766673|Adrenergic Agents|adrenergic agents|mesh-ancestor
64709170|NCT02766673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64709171|NCT02766673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709172|NCT00372008|Testosterone|testosterone|mesh-list
64709173|NCT00372008|Androgens|androgens|mesh-ancestor
64709174|NCT00372008|Hormones|hormones|mesh-ancestor
64709175|NCT00372008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64337552|NCT02934529|Fluorouracil|fluorouracil|mesh-list
64337553|NCT02934529|Capecitabine|capecitabine|mesh-list
64709185|NCT04337593|Immunologic Factors|immunologic factors|mesh-ancestor
64709186|NCT04337593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709187|NCT05339581|Pembrolizumab|pembrolizumab|mesh-list
64709199|NCT04766918|Protective Agents|protective agents|mesh-ancestor
64709201|NCT04064684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65465837|NCT01090700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465838|NCT01090700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65465839|NCT01090700|Serotonin Agents|serotonin agents|mesh-ancestor
65465840|NCT01090700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465841|NCT01090700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65465842|NCT01090700|Antidepressive Agents|antidepressive agents|mesh-ancestor
65465843|NCT01090700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65465844|NCT01090700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65465845|NCT01090700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65465846|NCT01090700|Parasympatholytics|parasympatholytics|mesh-ancestor
65465847|NCT01090700|Autonomic Agents|autonomic agents|mesh-ancestor
65465848|NCT01090700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65465849|NCT01090700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65465850|NCT01090700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65465851|NCT01090700|Cholinergic Agents|cholinergic agents|mesh-ancestor
65465852|NCT01090700|Antiviral Agents|antiviral agents|mesh-ancestor
65465853|NCT01090700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64850299|NCT03870880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64709202|NCT04064684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64709203|NCT04064684|Autonomic Agents|autonomic agents|mesh-ancestor
64945609|NCT05406505|Dapagliflozin|dapagliflozin|mesh-list
64709204|NCT04064684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64709205|NCT04064684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709206|NCT04064684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64709207|NCT04064684|Respiratory System Agents|respiratory system agents|mesh-ancestor
64709208|NCT04064684|Glucocorticoids|glucocorticoids|mesh-ancestor
64709209|NCT04064684|Hormones|hormones|mesh-ancestor
64709210|NCT04064684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64709211|NCT02192190|Celecoxib|celecoxib|mesh-list
64709212|NCT02192190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64709213|NCT02192190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64709214|NCT02192190|Analgesics|analgesics|mesh-ancestor
64709215|NCT02192190|Sensory System Agents|sensory system agents|mesh-ancestor
64709216|NCT02192190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64709217|NCT02192190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709218|NCT02192190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64709219|NCT02192190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64709220|NCT02192190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64709221|NCT02192190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64709222|NCT02192190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709223|NCT02192190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709224|NCT02748889|Carboplatin|carboplatin|mesh-list
64709225|NCT02748889|Etoposide|etoposide|mesh-list
64709226|NCT02748889|Atezolizumab|atezolizumab|mesh-list
64709227|NCT02748889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709228|NCT02748889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64709229|NCT02748889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64709230|NCT02748889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64709231|NCT02748889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709232|NCT02748889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709233|NCT05390528|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64709234|NCT05390528|Immunologic Factors|immunologic factors|mesh-ancestor
64709235|NCT05390528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709236|NCT04654988|Prednisone|prednisone|mesh-list
64709237|NCT04654988|Azathioprine|azathioprine|mesh-list
65465854|NCT01090700|Protease Inhibitors|protease inhibitors|mesh-ancestor
65465855|NCT01090700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465856|NCT03957902|Aspirin|aspirin|mesh-list
65465857|NCT03957902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65465858|NCT03957902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65465859|NCT03957902|Analgesics|analgesics|mesh-ancestor
65465860|NCT03957902|Sensory System Agents|sensory system agents|mesh-ancestor
65465861|NCT03957902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65465862|NCT03957902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465863|NCT03957902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65465864|NCT03957902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65465865|NCT03957902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65465866|NCT03957902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65465867|NCT03957902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465868|NCT03957902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65465869|NCT03957902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65465870|NCT03957902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465871|NCT03957902|Antipyretics|antipyretics|mesh-ancestor
65465872|NCT00384059|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65465873|NCT00384059|Immunologic Factors|immunologic factors|mesh-ancestor
65465874|NCT00384059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465875|NCT01046435|Amoxicillin|amoxicillin|mesh-list
65465876|NCT01046435|Metronidazole|metronidazole|mesh-list
65465877|NCT01046435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65465878|NCT01046435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65465879|NCT01046435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65465880|NCT01046435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65465881|NCT00858364|Darbepoetin alfa|darbepoetin alfa|mesh-list
65465882|NCT00858364|Hematinics|hematinics|mesh-ancestor
65465883|NCT00382733|Topotecan|topotecan|mesh-list
65465884|NCT00382733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65465885|NCT00382733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65465886|NCT00382733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465887|NCT00382733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465888|NCT00382733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709238|NCT04654988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64709239|NCT04654988|Glucocorticoids|glucocorticoids|mesh-ancestor
64709240|NCT04654988|Hormones|hormones|mesh-ancestor
64719299|NCT00089414|Diuretics|diuretics|mesh-ancestor
64719300|NCT00089414|Natriuretic Agents|natriuretic agents|mesh-ancestor
65465889|NCT03992885|Pemetrexed|pemetrexed|mesh-list
65465890|NCT03992885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465891|NCT03992885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465892|NCT03992885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465893|NCT03992885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65465894|NCT03992885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65465895|NCT03739294|Fluticasone|fluticasone|mesh-list
65465896|NCT03739294|Xhance|xhance|mesh-list
65465897|NCT03739294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65465898|NCT03739294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65465899|NCT03739294|Autonomic Agents|autonomic agents|mesh-ancestor
65465900|NCT03739294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65465901|NCT03739294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465902|NCT03739294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65465903|NCT03739294|Respiratory System Agents|respiratory system agents|mesh-ancestor
65465904|NCT03739294|Dermatologic Agents|dermatologic agents|mesh-ancestor
65465905|NCT03739294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65465906|NCT03732508|Fluorouracil|fluorouracil|mesh-list
65465907|NCT03732508|Irinotecan|irinotecan|mesh-list
65465908|NCT03732508|Antimetabolites|antimetabolites|mesh-ancestor
65465909|NCT03732508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465910|NCT03732508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65465911|NCT03732508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465912|NCT03732508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65465913|NCT03732508|Immunologic Factors|immunologic factors|mesh-ancestor
65465914|NCT03732508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465915|NCT03732508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65465916|NCT03732508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65465917|NCT03732508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465918|NCT03628924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65465919|NCT03628924|Immunologic Factors|immunologic factors|mesh-ancestor
65465920|NCT03628924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465921|NCT00112437|Vitamin D|vitamin d|mesh-list
65465922|NCT00112437|Cholecalciferol|cholecalciferol|mesh-list
65465923|NCT00112437|Calcium Carbonate|calcium carbonate|mesh-list
65465924|NCT00112437|Calcium|calcium|mesh-list
65465925|NCT00112437|Vitamins|vitamins|mesh-ancestor
64719301|NCT00075608|Melphalan|melphalan|mesh-list
64719302|NCT00075608|Immunologic Factors|immunologic factors|mesh-ancestor
64719303|NCT00075608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465926|NCT00112437|Micronutrients|micronutrients|mesh-ancestor
65465927|NCT00112437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465928|NCT00112437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65465929|NCT00112437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65465930|NCT00112437|Antacids|antacids|mesh-ancestor
65465931|NCT00112437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465932|NCT00112437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65465933|NCT03653416|Bupivacaine|bupivacaine|mesh-list
65465934|NCT03653416|Anesthetics, Local|anesthetics, local|mesh-ancestor
65465935|NCT03653416|Anesthetics|anesthetics|mesh-ancestor
65465936|NCT03653416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65465937|NCT03653416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465938|NCT03653416|Sensory System Agents|sensory system agents|mesh-ancestor
65465939|NCT03653416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65465940|NCT01076673|Hyaluronic Acid|hyaluronic acid|mesh-list
65465941|NCT01076673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65465942|NCT01076673|Immunologic Factors|immunologic factors|mesh-ancestor
65465943|NCT01076673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465944|NCT01076673|Viscosupplements|viscosupplements|mesh-ancestor
65465945|NCT01076673|Protective Agents|protective agents|mesh-ancestor
65465946|NCT00119379|Tenofovir|tenofovir|mesh-list
65465947|NCT00119379|Antiviral Agents|antiviral agents|mesh-ancestor
65465948|NCT00119379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65465949|NCT00119379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65465950|NCT00119379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65465951|NCT00119379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465952|NCT00119379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465953|NCT00119379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65465954|NCT00119379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65465955|NCT01080417|Mycophenolic Acid|mycophenolic acid|mesh-list
65465956|NCT01080417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65465957|NCT01080417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465958|NCT01080417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65465959|NCT01080417|Antitubercular Agents|antitubercular agents|mesh-ancestor
65465960|NCT01080417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65465961|NCT01080417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65465963|NCT01080417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465964|NCT01079481|Everolimus|everolimus|mesh-list
65465965|NCT01079481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465966|NCT01079481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65465967|NCT01079481|Immunologic Factors|immunologic factors|mesh-ancestor
65465968|NCT01079481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465969|NCT03964779|Antibodies|antibodies|mesh-list
65465970|NCT03964779|Immunoglobulins|immunoglobulins|mesh-list
65465971|NCT03964779|Immunologic Factors|immunologic factors|mesh-ancestor
65465972|NCT03964779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465973|NCT00131937|Sorafenib|sorafenib|mesh-list
65465974|NCT00131937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215476|NCT02845908|Leucovorin|leucovorin|mesh-list
65465975|NCT00131937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65465976|NCT00131937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465977|NCT00131937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465978|NCT01079559|Tobramycin|tobramycin|mesh-list
65465979|NCT01079559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65465980|NCT01079559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65465981|NCT00131469|Teriparatide|teriparatide|mesh-list
65465982|NCT00131469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65465983|NCT00131469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65465984|NCT00131469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65465985|NCT00372593|Cytarabine|cytarabine|mesh-list
65465986|NCT00372593|Etoposide|etoposide|mesh-list
65465987|NCT00372593|Daunorubicin|daunorubicin|mesh-list
65465988|NCT00372593|Mitoxantrone|mitoxantrone|mesh-list
65465989|NCT00372593|Asparaginase|asparaginase|mesh-list
65465990|NCT00372593|Gemtuzumab|gemtuzumab|mesh-list
65465991|NCT00372593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65465992|NCT00372593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65465993|NCT00372593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65465994|NCT00372593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65465995|NCT00372593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65465996|NCT00372593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465997|NCT00372593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64719304|NCT00075608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64719305|NCT00075608|Alkylating Agents|alkylating agents|mesh-ancestor
64719306|NCT00075608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65465998|NCT00372593|Antimetabolites|antimetabolites|mesh-ancestor
65465999|NCT00372593|Antiviral Agents|antiviral agents|mesh-ancestor
65466000|NCT00372593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65466001|NCT00372593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65466002|NCT00372593|Immunologic Factors|immunologic factors|mesh-ancestor
65466003|NCT00372593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466004|NCT00372593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65466005|NCT00372593|Analgesics|analgesics|mesh-ancestor
65466006|NCT00372593|Sensory System Agents|sensory system agents|mesh-ancestor
65466007|NCT00372593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65466008|NCT00372593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65466009|NCT01324583|Prednisolone|prednisolone|mesh-list
65466010|NCT01324583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65466011|NCT01324583|Glucocorticoids|glucocorticoids|mesh-ancestor
65466012|NCT01324583|Hormones|hormones|mesh-ancestor
65466013|NCT01324583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65466014|NCT01324583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466015|NCT01324583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65466016|NCT01324583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466017|NCT00382109|Sirolimus|sirolimus|mesh-list
65466018|NCT00382109|Cyclophosphamide|cyclophosphamide|mesh-list
65466019|NCT00382109|Thiotepa|thiotepa|mesh-list
65466020|NCT00382109|Methotrexate|methotrexate|mesh-list
65466021|NCT00382109|Tacrolimus|tacrolimus|mesh-list
65466022|NCT00382109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65466023|NCT00382109|Immunologic Factors|immunologic factors|mesh-ancestor
65466024|NCT00382109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466025|NCT00382109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65466026|NCT00382109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65466027|NCT00382109|Alkylating Agents|alkylating agents|mesh-ancestor
65466028|NCT00382109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466029|NCT00382109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850430|NCT03727750|Gemtuzumab|gemtuzumab|mesh-list
64719307|NCT00075608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327416|NCT00629941|Azithromycin|azithromycin|mesh-list
64709241|NCT04654988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64709242|NCT04654988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709263|NCT02161458|Dexetimide|dexetimide|mesh-list
64709264|NCT02161458|Citalopram|citalopram|mesh-list
64709265|NCT02161458|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64709266|NCT02161458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64709267|NCT02161458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65466030|NCT00382109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65466031|NCT00382109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65466032|NCT00382109|Abortifacient Agents|abortifacient agents|mesh-ancestor
65466033|NCT00382109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65466034|NCT00382109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65466035|NCT00382109|Antimetabolites|antimetabolites|mesh-ancestor
65466036|NCT00382109|Dermatologic Agents|dermatologic agents|mesh-ancestor
65466037|NCT00382109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466038|NCT00382109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65466039|NCT00382109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65466040|NCT00382109|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65466041|NCT00382109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65466042|NCT00382109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65466043|NCT00382109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65466044|NCT00382109|Antifungal Agents|antifungal agents|mesh-ancestor
65466045|NCT00381797|Deoxyglucose|deoxyglucose|mesh-list
65466046|NCT00381797|Bevacizumab|bevacizumab|mesh-list
65466047|NCT00381797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65466048|NCT00381797|Irinotecan|irinotecan|mesh-list
65466049|NCT00381797|Camptothecin|camptothecin|mesh-list
65466050|NCT00381797|Endothelial Growth Factors|endothelial growth factors|mesh-list
65466051|NCT00381797|Antibodies|antibodies|mesh-list
65466052|NCT00381797|Immunoglobulins|immunoglobulins|mesh-list
65466053|NCT00381797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65466054|NCT00381797|Immunoglobulin G|immunoglobulin g|mesh-list
65466055|NCT00381797|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65466056|NCT00381797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466057|NCT00381797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65466058|NCT00381797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65466059|NCT00381797|Growth Substances|growth substances|mesh-ancestor
65466060|NCT00381797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466061|NCT00381797|Growth Inhibitors|growth inhibitors|mesh-ancestor
65466062|NCT00381797|Immunologic Factors|immunologic factors|mesh-ancestor
65466063|NCT00381797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65466064|NCT00381797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65466065|NCT00381797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466067|NCT00381797|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65466069|NCT00381797|Antimetabolites|antimetabolites|mesh-ancestor
65466070|NCT00381797|Antiviral Agents|antiviral agents|mesh-ancestor
65466071|NCT00381797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65466072|NCT03665038|Brexanolone|brexanolone|mesh-list
65466073|NCT03665038|Neurosteroids|neurosteroids|mesh-ancestor
65466074|NCT03665038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65466075|NCT03665038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466076|NCT03665038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466077|NCT03665038|GABA Modulators|gaba modulators|mesh-ancestor
65466078|NCT03665038|GABA Agents|gaba agents|mesh-ancestor
65466079|NCT03664024|Carboplatin|carboplatin|mesh-list
65466080|NCT03664024|Pembrolizumab|pembrolizumab|mesh-list
65466081|NCT03664024|Pemetrexed|pemetrexed|mesh-list
65466082|NCT03664024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466083|NCT03664024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65466084|NCT03664024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466085|NCT03664024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466086|NCT03664024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65466087|NCT03664024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65466088|NCT00381641|Sunitinib|sunitinib|mesh-list
65466089|NCT00381641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466090|NCT00381641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65466091|NCT00381641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65466092|NCT00381641|Growth Substances|growth substances|mesh-ancestor
65466093|NCT00381641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466094|NCT00381641|Growth Inhibitors|growth inhibitors|mesh-ancestor
65466095|NCT00381641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65466096|NCT00381641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850497|NCT03660839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64709268|NCT02161458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709269|NCT02161458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64709270|NCT02161458|Serotonin Agents|serotonin agents|mesh-ancestor
64709271|NCT02161458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709272|NCT02161458|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64709273|NCT02161458|Antidepressive Agents|antidepressive agents|mesh-ancestor
64709274|NCT02161458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64709275|NCT02161458|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64709276|NCT02161458|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64709277|NCT02161458|Parasympatholytics|parasympatholytics|mesh-ancestor
64709278|NCT02161458|Autonomic Agents|autonomic agents|mesh-ancestor
64709279|NCT02161458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64709280|NCT02161458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64709281|NCT02161458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64709282|NCT02161458|Cholinergic Agents|cholinergic agents|mesh-ancestor
64709283|NCT04737889|Rituximab|rituximab|mesh-list
64709284|NCT04737889|Methotrexate|methotrexate|mesh-list
64709285|NCT04737889|Lenalidomide|lenalidomide|mesh-list
65466097|NCT00381641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466098|NCT03624946|Immunoglobulins|immunoglobulins|mesh-list
65466099|NCT03624946|Antibodies|antibodies|mesh-list
65466100|NCT03624946|gamma-Globulins|gamma-globulins|mesh-list
65466101|NCT03624946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65466102|NCT03624946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65466103|NCT03624946|Immunoglobulin G|immunoglobulin g|mesh-list
65466104|NCT03624946|Immunologic Factors|immunologic factors|mesh-ancestor
65466105|NCT03624946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466106|NCT03735082|Paclitaxel|paclitaxel|mesh-list
65466107|NCT03735082|Carboplatin|carboplatin|mesh-list
65466108|NCT03735082|Apatinib|apatinib|mesh-list
65466109|NCT03735082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65466110|NCT03735082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466111|NCT03735082|Tubulin Modulators|tubulin modulators|mesh-ancestor
65466112|NCT03735082|Antimitotic Agents|antimitotic agents|mesh-ancestor
65466113|NCT03735082|Mitosis Modulators|mitosis modulators|mesh-ancestor
65466114|NCT03735082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466115|NCT03735082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65466116|NCT03735082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466117|NCT00381095|Pregabalin|pregabalin|mesh-list
65466118|NCT00381095|Analgesics|analgesics|mesh-ancestor
65466119|NCT00381095|Sensory System Agents|sensory system agents|mesh-ancestor
65466120|NCT00381095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65466121|NCT00381095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466122|NCT00381095|Anticonvulsants|anticonvulsants|mesh-ancestor
65466123|NCT00381095|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65466124|NCT00381095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65466125|NCT00381095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466126|NCT00381095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65466127|NCT00381095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64850523|NCT03649802|Vitamins|vitamins|mesh-list
64709286|NCT04737889|Temozolomide|temozolomide|mesh-list
64709287|NCT04737889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64709288|NCT04737889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709289|NCT04737889|Immunologic Factors|immunologic factors|mesh-ancestor
64709290|NCT04737889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709291|NCT04737889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64709292|NCT04737889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64709293|NCT04737889|Abortifacient Agents|abortifacient agents|mesh-ancestor
64709294|NCT04737889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64709295|NCT04737889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64709296|NCT04737889|Antimetabolites|antimetabolites|mesh-ancestor
65466128|NCT00381095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65466129|NCT00381095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65466130|NCT00381095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65466131|NCT03737656|Progesterone|progesterone|mesh-list
65466132|NCT03737656|Progestins|progestins|mesh-ancestor
65466133|NCT03737656|Hormones|hormones|mesh-ancestor
65466134|NCT03737656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65466135|NCT03737656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466136|NCT00112047|Tenofovir|tenofovir|mesh-list
65466137|NCT00112047|Lamivudine|lamivudine|mesh-list
65466138|NCT00112047|Zidovudine|zidovudine|mesh-list
65466139|NCT00112047|Emtricitabine|emtricitabine|mesh-list
65466140|NCT00112047|Efavirenz|efavirenz|mesh-list
65466141|NCT00112047|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
65466142|NCT00112047|Antiviral Agents|antiviral agents|mesh-ancestor
65466143|NCT00112047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65466144|NCT00112047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65466145|NCT00112047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65466146|NCT00112047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466147|NCT00112047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466148|NCT00112047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65466149|NCT00112047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65466150|NCT00112047|Antimetabolites|antimetabolites|mesh-ancestor
65466151|NCT00112047|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65466152|NCT00112047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65466153|NCT00112047|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65466154|NCT00112047|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65466155|NCT00112047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65466174|NCT03734614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65466175|NCT03734614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65466176|NCT03734614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65466177|NCT03734614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65466178|NCT03734614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466179|NCT03734614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65466180|NCT03734614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65466181|NCT03734614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466182|NCT03734614|Antipyretics|antipyretics|mesh-ancestor
65466183|NCT00380393|Vaccines|vaccines|mesh-list
65466184|NCT00380393|Immunologic Factors|immunologic factors|mesh-ancestor
65466185|NCT00380393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466186|NCT00380081|Zolpidem|zolpidem|mesh-list
65466187|NCT00380081|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65466188|NCT00380081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65466189|NCT00380081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65466190|NCT00380081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719308|NCT00075608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64719309|NCT00075608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64719310|NCT03704467|Carboplatin|carboplatin|mesh-list
64719311|NCT03704467|Avelumab|avelumab|mesh-list
64719312|NCT03704467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337567|NCT02934529|Immunologic Factors|immunologic factors|mesh-ancestor
64709322|NCT04507022|Estrogens|estrogens|mesh-ancestor
64709323|NCT04507022|Hormones|hormones|mesh-ancestor
64709327|NCT04507022|Contraceptive Agents|contraceptive agents|mesh-ancestor
64709328|NCT04507022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64709329|NCT04507022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64709330|NCT04507022|Progestins|progestins|mesh-ancestor
64709331|NCT04507022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64709332|NCT04507022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709333|NCT04507022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709334|NCT04507022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64709335|NCT04507022|Hormone Antagonists|hormone antagonists|mesh-ancestor
64709336|NCT00372788|Pemetrexed|pemetrexed|mesh-list
64709337|NCT00372788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709338|NCT00372788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709339|NCT00372788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709340|NCT00372788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64709341|NCT00372788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64709342|NCT00372476|Imatinib Mesylate|imatinib mesylate|mesh-list
64709343|NCT00372476|Vinorelbine|vinorelbine|mesh-list
64709344|NCT00372476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709345|NCT00372476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64709346|NCT00372476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709347|NCT00372476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337579|NCT02638805|Exenatide|exenatide|mesh-list
64337582|NCT02638805|Incretins|incretins|mesh-ancestor
64709362|NCT04737967|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64709363|NCT04737967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64709364|NCT04737967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64719313|NCT03704467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64719314|NCT00000842|Mitogens|mitogens|mesh-list
64719315|NCT00000842|Mitosis Modulators|mitosis modulators|mesh-ancestor
64719316|NCT00000842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719317|NCT02145260|Dialysis Solutions|dialysis solutions|mesh-list
64719318|NCT02145260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64719319|NCT00000848|Indinavir|indinavir|mesh-list
65466191|NCT00380081|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65466192|NCT00380081|GABA Agonists|gaba agonists|mesh-ancestor
65466193|NCT00380081|GABA Agents|gaba agents|mesh-ancestor
65466194|NCT00380081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65466195|NCT00380081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466196|NCT03579940|Lasmiditan|lasmiditan|mesh-list
65466197|NCT03579940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65466198|NCT03579940|Serotonin Agents|serotonin agents|mesh-ancestor
65466199|NCT03579940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65466200|NCT03579940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494048|NCT03777436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066949|NCT00273026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65466201|NCT03579940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466203|NCT03732040|Cariostatic Agents|cariostatic agents|mesh-ancestor
65466204|NCT03732040|Protective Agents|protective agents|mesh-ancestor
65466205|NCT03732040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466206|NCT00098306|Maraviroc|maraviroc|mesh-list
65466207|NCT00098306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65466208|NCT00098306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65466209|NCT00098306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466210|NCT00098306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64850613|NCT03523520|Methylnaltrexone|methylnaltrexone|mesh-list
64719320|NCT00000848|Saquinavir|saquinavir|mesh-list
64709365|NCT04737967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64709366|NCT04737967|Antidepressive Agents|antidepressive agents|mesh-ancestor
64709367|NCT04737967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64709368|NCT04334629|Ibuprofen|ibuprofen|mesh-list
64709369|NCT04334629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64709370|NCT04334629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64709371|NCT04334629|Analgesics|analgesics|mesh-ancestor
64709372|NCT04334629|Sensory System Agents|sensory system agents|mesh-ancestor
64709373|NCT04334629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64709374|NCT04334629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709375|NCT04334629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64709376|NCT04334629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64709377|NCT04334629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64709378|NCT04334629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709379|NCT04334629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709380|NCT03365414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64709381|NCT05158153|Furosemide|furosemide|mesh-list
64709382|NCT05158153|Diuretics|diuretics|mesh-ancestor
64709383|NCT05158153|Natriuretic Agents|natriuretic agents|mesh-ancestor
64709384|NCT05158153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709385|NCT05158153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64709386|NCT05158153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64709387|NCT05158153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709388|NCT04367090|Docetaxel|docetaxel|mesh-list
64709389|NCT04367090|Trastuzumab|trastuzumab|mesh-list
64709390|NCT04367090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709413|NCT04767074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64709414|NCT04767074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65466211|NCT00098306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65466212|NCT00098306|Antiviral Agents|antiviral agents|mesh-ancestor
65466213|NCT00098306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65466214|NCT00098306|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65466215|NCT03615040|Astegolimab|astegolimab|mesh-list
65466216|NCT03615040|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65466217|NCT03615040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65466218|NCT03615040|Antiviral Agents|antiviral agents|mesh-ancestor
65466219|NCT03615040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65466220|NCT01090778|Hormones|hormones|mesh-list
65466221|NCT01090778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65466222|NCT01090778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466223|NCT00068588|Capecitabine|capecitabine|mesh-list
65466224|NCT00068588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65466225|NCT00068588|Antimetabolites|antimetabolites|mesh-ancestor
65466226|NCT00068588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466227|NCT00068588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466228|NCT01088282|Dipivefrin|dipivefrin|mesh-list
65466229|NCT01088282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65466230|NCT01088282|Adrenergic Agents|adrenergic agents|mesh-ancestor
65466231|NCT01088282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65466232|NCT01088282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466233|NCT01088282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466234|NCT03963752|Megestrol|megestrol|mesh-list
65466235|NCT03963752|Megestrol Acetate|megestrol acetate|mesh-list
65466236|NCT03963752|Leuprolide|leuprolide|mesh-list
65466237|NCT03963752|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65466238|NCT03963752|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65466239|NCT03963752|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65466240|NCT03963752|Contraceptive Agents|contraceptive agents|mesh-ancestor
65466241|NCT03963752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65466242|NCT03963752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466243|NCT03963752|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65466244|NCT03963752|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65466245|NCT03963752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65466249|NCT03963752|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65466250|NCT03963752|Fertility Agents|fertility agents|mesh-ancestor
65466251|NCT03734302|Brexpiprazole|brexpiprazole|mesh-list
65466252|NCT03734302|Serotonin Agents|serotonin agents|mesh-ancestor
65466253|NCT03734302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65466254|NCT03734302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466255|NCT03734302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466256|NCT03734302|Dopamine Agonists|dopamine agonists|mesh-ancestor
65466257|NCT03734302|Dopamine Agents|dopamine agents|mesh-ancestor
65466258|NCT01310296|Lofexidine|lofexidine|mesh-list
65466259|NCT01310296|Clonidine|clonidine|mesh-list
65466260|NCT01310296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65466261|NCT01310296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65466262|NCT01310296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466263|NCT01310296|Sensory System Agents|sensory system agents|mesh-ancestor
65466264|NCT01310296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65466265|NCT01310296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65466266|NCT01310296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65466267|NCT01310296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65466268|NCT01310296|Adrenergic Agents|adrenergic agents|mesh-ancestor
65466269|NCT01310296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65466270|NCT01310296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466271|NCT01310296|Analgesics|analgesics|mesh-ancestor
65466272|NCT01310296|Sympatholytics|sympatholytics|mesh-ancestor
65466273|NCT01310296|Autonomic Agents|autonomic agents|mesh-ancestor
65466274|NCT03734068|Doxorubicin|doxorubicin|mesh-list
65215780|NCT00902538|Diuretics|diuretics|mesh-ancestor
65466275|NCT03734068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65466276|NCT03734068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466277|NCT03734068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65466278|NCT03734068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65466279|NCT03734068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466291|NCT03606460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466292|NCT03729310|Triamcinolone|triamcinolone|mesh-list
65466293|NCT03729310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65466294|NCT03729310|Glucocorticoids|glucocorticoids|mesh-ancestor
65466295|NCT03729310|Hormones|hormones|mesh-ancestor
65466296|NCT03729310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65466297|NCT03729310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466298|NCT03731494|Nickel|nickel|mesh-list
65466299|NCT03731494|Trace Elements|trace elements|mesh-ancestor
65466300|NCT03731494|Micronutrients|micronutrients|mesh-ancestor
65466301|NCT03731494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466302|NCT00111813|Bortezomib|bortezomib|mesh-list
65466303|NCT00111813|Vorinostat|vorinostat|mesh-list
65466304|NCT00111813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466305|NCT00111813|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65466306|NCT00111813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466307|NCT00111813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466308|NCT00118287|Etanercept|etanercept|mesh-list
65466309|NCT00118287|Azacitidine|azacitidine|mesh-list
65466310|NCT00118287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65466311|NCT00118287|Antimetabolites|antimetabolites|mesh-ancestor
65466312|NCT00118287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466313|NCT00118287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466314|NCT00118287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466315|NCT00118287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65466316|NCT00118287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65466317|NCT00118287|Analgesics|analgesics|mesh-ancestor
65466318|NCT00118287|Sensory System Agents|sensory system agents|mesh-ancestor
65466319|NCT00118287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65466321|NCT00118287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65466336|NCT01079715|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65466337|NCT01079715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65466338|NCT01079715|Adrenergic Agents|adrenergic agents|mesh-ancestor
65466339|NCT01079715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65466340|NCT01079715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466341|NCT01079715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466342|NCT01079715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65466343|NCT01079715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65466344|NCT01079715|Vasodilator Agents|vasodilator agents|mesh-ancestor
65466345|NCT00130689|Cetuximab|cetuximab|mesh-list
65466346|NCT00130689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65466347|NCT00130689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466348|NCT01326585|Dexamethasone|dexamethasone|mesh-list
65466349|NCT01326585|Dexamethasone acetate|dexamethasone acetate|mesh-list
65466350|NCT01326585|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65466352|NCT01326585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65466353|NCT01326585|Antiemetics|antiemetics|mesh-ancestor
65466354|NCT01326585|Autonomic Agents|autonomic agents|mesh-ancestor
65466355|NCT01326585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65466356|NCT01326585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466357|NCT01326585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65466358|NCT01326585|Glucocorticoids|glucocorticoids|mesh-ancestor
65466359|NCT01326585|Hormones|hormones|mesh-ancestor
65466360|NCT01326585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65466361|NCT01326585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65466362|NCT01326585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466363|NCT01326585|Protease Inhibitors|protease inhibitors|mesh-ancestor
65466364|NCT01326585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466365|NCT01326585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466366|NCT03964935|Minocycline|minocycline|mesh-list
65466367|NCT03964935|Lycopene|lycopene|mesh-list
65466368|NCT03964935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65466369|NCT03964935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65466370|NCT03964935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65466371|NCT03964935|Antioxidants|antioxidants|mesh-ancestor
65466372|NCT03964935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466373|NCT03964935|Protective Agents|protective agents|mesh-ancestor
65466374|NCT03964935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466375|NCT03964935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65466376|NCT03964935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65466377|NCT03964935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466378|NCT03605212|Febuxostat|febuxostat|mesh-list
65466379|NCT03605212|Gout Suppressants|gout suppressants|mesh-ancestor
65466380|NCT03605212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65466381|NCT00117507|Deferasirox|deferasirox|mesh-list
65466382|NCT00117507|Chelating Agents|chelating agents|mesh-list
65466383|NCT00117507|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65466384|NCT00117507|Sequestering Agents|sequestering agents|mesh-ancestor
65466385|NCT00117507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466386|NCT03621046|Zolpidem|zolpidem|mesh-list
65466387|NCT03621046|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65466388|NCT03621046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65466389|NCT03621046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65466390|NCT03621046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466391|NCT03621046|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65466392|NCT03621046|GABA Agonists|gaba agonists|mesh-ancestor
65466393|NCT03621046|GABA Agents|gaba agents|mesh-ancestor
65466394|NCT03621046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65466395|NCT03621046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466396|NCT03965013|Insulin Glargine|insulin glargine|mesh-list
65466397|NCT03965013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65466398|NCT03965013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466399|NCT03603496|Nicotine|nicotine|mesh-list
65466400|NCT03603496|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65466401|NCT03603496|Autonomic Agents|autonomic agents|mesh-ancestor
65466402|NCT03603496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65466403|NCT03603496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466404|NCT03603496|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65466405|NCT03603496|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65466406|NCT03603496|Cholinergic Agents|cholinergic agents|mesh-ancestor
65466409|NCT00096135|Leucovorin|leucovorin|mesh-list
65466413|NCT00096135|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65466414|NCT00096135|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65466415|NCT00096135|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65466416|NCT00096135|Cyclophosphamide|cyclophosphamide|mesh-list
64850802|NCT05436964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65466417|NCT00096135|Methotrexate|methotrexate|mesh-list
65466418|NCT00096135|Etoposide|etoposide|mesh-list
65466419|NCT00096135|Vincristine|vincristine|mesh-list
65466420|NCT00096135|Daunorubicin|daunorubicin|mesh-list
65466421|NCT00096135|Asparaginase|asparaginase|mesh-list
65466422|NCT00096135|Mercaptopurine|mercaptopurine|mesh-list
65466423|NCT00096135|Pegaspargase|pegaspargase|mesh-list
65466424|NCT00096135|Lenograstim|lenograstim|mesh-list
65466425|NCT00096135|Levoleucovorin|levoleucovorin|mesh-list
65466426|NCT00096135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65466427|NCT00096135|Immunologic Factors|immunologic factors|mesh-ancestor
65466428|NCT00096135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466430|NCT00096135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65466431|NCT00096135|Alkylating Agents|alkylating agents|mesh-ancestor
65466432|NCT00096135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466433|NCT00096135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466434|NCT00096135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65466435|NCT00096135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65466436|NCT00096135|Antiemetics|antiemetics|mesh-ancestor
65466437|NCT00096135|Autonomic Agents|autonomic agents|mesh-ancestor
65466438|NCT00096135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65466439|NCT00096135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65466440|NCT00096135|Glucocorticoids|glucocorticoids|mesh-ancestor
65466441|NCT00096135|Hormones|hormones|mesh-ancestor
65466442|NCT00096135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65466443|NCT00096135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65466444|NCT00096135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65466445|NCT00096135|Abortifacient Agents|abortifacient agents|mesh-ancestor
65466456|NCT00096135|Antiviral Agents|antiviral agents|mesh-ancestor
65466457|NCT00096135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65466458|NCT00096135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65466459|NCT00096135|Antidotes|antidotes|mesh-ancestor
65466460|NCT00096135|Protective Agents|protective agents|mesh-ancestor
65466461|NCT00096135|Vitamin B Complex|vitamin b complex|mesh-ancestor
65466462|NCT00096135|Vitamins|vitamins|mesh-ancestor
65466463|NCT00096135|Micronutrients|micronutrients|mesh-ancestor
65466464|NCT00096135|Tubulin Modulators|tubulin modulators|mesh-ancestor
65466465|NCT00096135|Antimitotic Agents|antimitotic agents|mesh-ancestor
65466466|NCT00096135|Mitosis Modulators|mitosis modulators|mesh-ancestor
65466467|NCT00096135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65466468|NCT00116805|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65466469|NCT00116805|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65466470|NCT00116805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65466471|NCT00116805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65466472|NCT00116805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466473|NCT00116805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466474|NCT00116805|Antiviral Agents|antiviral agents|mesh-ancestor
65466475|NCT00116805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65466476|NCT00116805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65466477|NCT00116805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65466478|NCT00116649|Imiquimod|imiquimod|mesh-list
65466479|NCT00116649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65466480|NCT00116649|Immunologic Factors|immunologic factors|mesh-ancestor
65466481|NCT00116649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466482|NCT00116649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466483|NCT00116649|Interferon Inducers|interferon inducers|mesh-ancestor
65466484|NCT01080651|Voriconazole|voriconazole|mesh-list
65466485|NCT01080651|Antifungal Agents|antifungal agents|mesh-ancestor
65466486|NCT01080651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65466487|NCT01080651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65466488|NCT01080651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65466489|NCT01080651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466492|NCT01080651|Hormone Antagonists|hormone antagonists|mesh-ancestor
65466495|NCT01080651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65466496|NCT01080729|Hormones|hormones|mesh-list
65466497|NCT01080729|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65466498|NCT01080729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65216004|NCT04300322|Progesterone|progesterone|mesh-list
65466499|NCT01080729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466500|NCT03962907|Chlorhexidine|chlorhexidine|mesh-list
65466501|NCT03962907|Mupirocin|mupirocin|mesh-list
65466502|NCT03962907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65466503|NCT03962907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65466504|NCT03962907|Disinfectants|disinfectants|mesh-ancestor
65466505|NCT03962907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65466506|NCT03962907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65466507|NCT03962907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466508|NCT03962907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466509|NCT00083889|Interferons|interferons|mesh-list
65466510|NCT00083889|Interferon-alpha|interferon-alpha|mesh-list
65466511|NCT00083889|Sunitinib|sunitinib|mesh-list
65466512|NCT00083889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466513|NCT00083889|Antiviral Agents|antiviral agents|mesh-ancestor
65466514|NCT00083889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65466515|NCT00083889|Immunologic Factors|immunologic factors|mesh-ancestor
65466516|NCT00083889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466517|NCT00083889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65466518|NCT00083889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65466519|NCT00083889|Growth Substances|growth substances|mesh-ancestor
65466520|NCT00083889|Growth Inhibitors|growth inhibitors|mesh-ancestor
65466521|NCT00083889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65466522|NCT00083889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466523|NCT00083889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466524|NCT03639532|Tacrine|tacrine|mesh-list
65466525|NCT03639532|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65466526|NCT03639532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466527|NCT03639532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466528|NCT03639532|Cholinergic Agents|cholinergic agents|mesh-ancestor
64850854|NCT04970381|Protease Inhibitors|protease inhibitors|mesh-ancestor
64709415|NCT04767074|Adrenergic Agents|adrenergic agents|mesh-ancestor
64709416|NCT04767074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65466529|NCT03639532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65466530|NCT03639532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466531|NCT03639532|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65466532|NCT03639532|Autonomic Agents|autonomic agents|mesh-ancestor
64850877|NCT04590586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65466533|NCT03639532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65466534|NCT03639532|Nootropic Agents|nootropic agents|mesh-ancestor
65466535|NCT03571516|Teduglutide|teduglutide|mesh-list
65466536|NCT03571516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65466537|NCT03571516|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65466538|NCT03571516|Protective Agents|protective agents|mesh-ancestor
65466539|NCT03571516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466540|NCT03600376|Dantrolene|dantrolene|mesh-list
65466541|NCT03600376|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65466542|NCT03600376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466543|NCT03600376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65466544|NCT03600376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65466545|NCT03961659|Metformin|metformin|mesh-list
65466546|NCT03961659|Dapagliflozin|dapagliflozin|mesh-list
65466547|NCT03961659|Acarbose|acarbose|mesh-list
65466548|NCT03961659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65466549|NCT03961659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466550|NCT03961659|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65466551|NCT03961659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466552|NCT03961659|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65466553|NCT03961659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466554|NCT03599362|Nivolumab|nivolumab|mesh-list
65466555|NCT03599362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65466556|NCT03599362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466557|NCT03599362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65466558|NCT03599362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466559|NCT03741309|Calcium|calcium|mesh-list
64850880|NCT04590586|Analgesics|analgesics|mesh-ancestor
64709417|NCT04767074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709418|NCT04767074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337601|NCT02262143|Fenofibrate|fenofibrate|mesh-list
64709430|NCT00372307|Sensory System Agents|sensory system agents|mesh-ancestor
64709431|NCT00372307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64709432|NCT00372307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709433|NCT00372307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64709434|NCT00372307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65466560|NCT03741309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65466561|NCT03741309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466562|NCT00082407|Insulin Aspart|insulin aspart|mesh-list
65466563|NCT00082407|Exenatide|exenatide|mesh-list
65466564|NCT00082407|Biphasic Insulins|biphasic insulins|mesh-list
64850889|NCT04590586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466565|NCT00082407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65466566|NCT00082407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466567|NCT00082407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65466568|NCT00082407|Incretins|incretins|mesh-ancestor
65466569|NCT00082407|Hormones|hormones|mesh-ancestor
65466570|NCT00082407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65466571|NCT01080963|Daptomycin|daptomycin|mesh-list
65466572|NCT01080963|Cefuroxime|cefuroxime|mesh-list
65466573|NCT01080963|Cefuroxime axetil|cefuroxime axetil|mesh-list
65466574|NCT01080963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65466576|NCT01083381|Risperidone|risperidone|mesh-list
65466577|NCT01083381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65466578|NCT01083381|Serotonin Agents|serotonin agents|mesh-ancestor
65466579|NCT01083381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65466580|NCT01083381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466581|NCT01083381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466582|NCT01083381|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65466583|NCT01083381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65466584|NCT01083381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65466585|NCT01083381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65466586|NCT01083381|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65466587|NCT01083381|Dopamine Agents|dopamine agents|mesh-ancestor
65466588|NCT01087359|Melatonin|melatonin|mesh-list
65466589|NCT01087359|Antioxidants|antioxidants|mesh-ancestor
65466594|NCT01087437|Calcium|calcium|mesh-list
65466605|NCT03597022|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
65466606|NCT03597022|Immunoglobulins|immunoglobulins|mesh-list
65466607|NCT03597022|Immunoglobulin G|immunoglobulin g|mesh-list
65466608|NCT03597022|Immunologic Factors|immunologic factors|mesh-ancestor
65466609|NCT03597022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466610|NCT03597022|Anticoagulants|anticoagulants|mesh-ancestor
65466611|NCT03597022|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65466612|NCT03597022|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65466613|NCT03597022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466614|NCT03597022|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65466615|NCT03597022|Protease Inhibitors|protease inhibitors|mesh-ancestor
65466616|NCT03597022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466617|NCT03597022|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65466618|NCT03597022|Antithrombins|antithrombins|mesh-ancestor
65466619|NCT03569098|Botulinum Toxins|botulinum toxins|mesh-list
65466620|NCT03569098|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65466621|NCT03569098|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65466622|NCT03569098|Hemagglutinins|hemagglutinins|mesh-list
65466623|NCT03569098|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65466624|NCT03569098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65466625|NCT03569098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466626|NCT03569098|Cholinergic Agents|cholinergic agents|mesh-ancestor
65466627|NCT03569098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65466628|NCT03569098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466629|NCT03569098|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65466630|NCT03569098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65466631|NCT03569098|Agglutinins|agglutinins|mesh-ancestor
65466632|NCT03569098|Immunologic Factors|immunologic factors|mesh-ancestor
65466633|NCT03727282|Dobutamine|dobutamine|mesh-list
65466634|NCT03727282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65466635|NCT03727282|Sympathomimetics|sympathomimetics|mesh-ancestor
65466636|NCT03727282|Autonomic Agents|autonomic agents|mesh-ancestor
65466637|NCT03727282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65466638|NCT03727282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466639|NCT03727282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65466640|NCT03727282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65466641|NCT03727282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64850940|NCT03563742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64850941|NCT03563742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850942|NCT03563742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850943|NCT03563742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64850944|NCT03563742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64850945|NCT03537014|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65466642|NCT03727282|Adrenergic Agents|adrenergic agents|mesh-ancestor
65466643|NCT03727282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65466644|NCT03727282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466645|NCT03727282|Protective Agents|protective agents|mesh-ancestor
65466646|NCT00110019|Paclitaxel|paclitaxel|mesh-list
65466647|NCT00110019|Carboplatin|carboplatin|mesh-list
65466648|NCT00110019|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65466649|NCT00110019|Sorafenib|sorafenib|mesh-list
65466650|NCT00110019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65466651|NCT00110019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466652|NCT00110019|Tubulin Modulators|tubulin modulators|mesh-ancestor
65466653|NCT00110019|Antimitotic Agents|antimitotic agents|mesh-ancestor
65466654|NCT00110019|Mitosis Modulators|mitosis modulators|mesh-ancestor
65466655|NCT00110019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466656|NCT00110019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65466657|NCT00110019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466658|NCT03642262|Guaifenesin|guaifenesin|mesh-list
65466659|NCT03642262|Expectorants|expectorants|mesh-ancestor
65466660|NCT03642262|Respiratory System Agents|respiratory system agents|mesh-ancestor
65466662|NCT03727048|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65466663|NCT03727048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65466664|NCT03727048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65466665|NCT03727048|Analgesics|analgesics|mesh-ancestor
65466666|NCT03727048|Sensory System Agents|sensory system agents|mesh-ancestor
64709435|NCT00372307|Dermatologic Agents|dermatologic agents|mesh-ancestor
64709436|NCT00372307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64709437|NCT00372307|Immunologic Factors|immunologic factors|mesh-ancestor
64709438|NCT00372307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64709439|NCT00372307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709440|NCT00372307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709441|NCT04647110|Crizotinib|crizotinib|mesh-list
64709442|NCT04647110|Ceritinib|ceritinib|mesh-list
64709446|NCT04647110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719321|NCT00000848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64719322|NCT00000848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64719323|NCT00000848|Protease Inhibitors|protease inhibitors|mesh-ancestor
64719324|NCT00000848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850967|NCT03473925|Pembrolizumab|pembrolizumab|mesh-list
64850968|NCT03473925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64850969|NCT03473925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850970|NCT03424122|Rituximab|rituximab|mesh-list
64850971|NCT03424122|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65466667|NCT03727048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65466668|NCT03727048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466669|NCT03727048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65466670|NCT03727048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65466671|NCT03727048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65466672|NCT03727048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466673|NCT03727048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466674|NCT00095979|Epothilones|epothilones|mesh-list
65466675|NCT00095979|Epothilone B|epothilone b|mesh-list
65466676|NCT00095979|Tubulin Modulators|tubulin modulators|mesh-ancestor
65466677|NCT00095979|Antimitotic Agents|antimitotic agents|mesh-ancestor
65466678|NCT00095979|Mitosis Modulators|mitosis modulators|mesh-ancestor
65466679|NCT00095979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466680|NCT00095979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466681|NCT01087593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65466682|NCT01087593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65466683|NCT01087593|Estradiol|estradiol|mesh-list
65466684|NCT01087593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65466685|NCT01087593|Estrogens|estrogens|mesh-ancestor
65466686|NCT01087593|Hormones|hormones|mesh-ancestor
65466687|NCT01087593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65466688|NCT01087593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466708|NCT01087749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65466709|NCT01087749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466710|NCT01087749|Diuretics|diuretics|mesh-ancestor
65466711|NCT01087749|Natriuretic Agents|natriuretic agents|mesh-ancestor
65466712|NCT01087749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466713|NCT01087749|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65466714|NCT01087749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65466715|NCT01087749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65466716|NCT01087749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65466717|NCT01087749|Adrenergic Agents|adrenergic agents|mesh-ancestor
65466718|NCT01087749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65466719|NCT01087749|Vasodilator Agents|vasodilator agents|mesh-ancestor
65466720|NCT01087749|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
65466721|NCT03568318|Upadacitinib|upadacitinib|mesh-list
65466722|NCT03568318|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64851002|NCT02663908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64719325|NCT00000848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719326|NCT00000848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64719327|NCT00000848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64719328|NCT00000848|Antiviral Agents|antiviral agents|mesh-ancestor
64719329|NCT00000848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64327431|NCT00629551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709447|NCT04061330|Ketamine|ketamine|mesh-list
64709448|NCT04061330|Morphine|morphine|mesh-list
64709449|NCT04061330|Analgesics|analgesics|mesh-ancestor
64709450|NCT04061330|Sensory System Agents|sensory system agents|mesh-ancestor
64709451|NCT04061330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64709452|NCT04061330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709453|NCT04061330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64709454|NCT04061330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64709455|NCT04061330|Anesthetics, General|anesthetics, general|mesh-ancestor
64709456|NCT04061330|Anesthetics|anesthetics|mesh-ancestor
64709457|NCT04061330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64709458|NCT04061330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64709459|NCT04061330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64709460|NCT04061330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64709461|NCT04061330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709462|NCT04061330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64709463|NCT04061330|Narcotics|narcotics|mesh-ancestor
64709464|NCT00372632|Pyrimethamine|pyrimethamine|mesh-list
64709465|NCT00372632|Sulfadoxine|sulfadoxine|mesh-list
64709466|NCT00372632|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64709467|NCT00372632|Antimalarials|antimalarials|mesh-ancestor
64709468|NCT00372632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64709469|NCT00372632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64709470|NCT00372632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64709471|NCT00372632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64709472|NCT00372632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709473|NCT00372632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709483|NCT05125237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64709484|NCT05125237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709485|NCT05125237|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64709486|NCT05125237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64709487|NCT04792021|Acetylcysteine|acetylcysteine|mesh-list
64709488|NCT04792021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64709489|NCT04792021|Antiviral Agents|antiviral agents|mesh-ancestor
65466723|NCT03568318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65466724|NCT03568318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466725|NCT03568318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466726|NCT03568318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65466727|NCT00108069|Tamoxifen|tamoxifen|mesh-list
65466728|NCT00108069|Bortezomib|bortezomib|mesh-list
65466729|NCT00108069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466730|NCT00108069|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65466731|NCT00108069|Hormone Antagonists|hormone antagonists|mesh-ancestor
65466732|NCT00108069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65466733|NCT00108069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466734|NCT00108069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65466735|NCT00108069|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65466736|NCT00108069|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65466737|NCT00108069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65466738|NCT00079274|Leucovorin|leucovorin|mesh-list
65466739|NCT00079274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65466740|NCT00079274|Cetuximab|cetuximab|mesh-list
65466741|NCT00079274|Fluorouracil|fluorouracil|mesh-list
65466742|NCT00079274|Oxaliplatin|oxaliplatin|mesh-list
65466743|NCT00079274|Irinotecan|irinotecan|mesh-list
64851020|NCT02203773|Posaconazole|posaconazole|mesh-list
64709490|NCT04792021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64709491|NCT04792021|Expectorants|expectorants|mesh-ancestor
64709492|NCT04792021|Respiratory System Agents|respiratory system agents|mesh-ancestor
64709493|NCT04792021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64709494|NCT04792021|Antioxidants|antioxidants|mesh-ancestor
64709495|NCT04792021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709496|NCT04792021|Protective Agents|protective agents|mesh-ancestor
64709497|NCT04792021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709498|NCT04792021|Antidotes|antidotes|mesh-ancestor
64709499|NCT03713437|Insulin|insulin|mesh-list
64709500|NCT03713437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64709501|NCT03713437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719330|NCT00000848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64719331|NCT00000848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64719332|NCT01795586|Carboplatin|carboplatin|mesh-list
64719333|NCT01795586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64719334|NCT02212574|Cyclophosphamide|cyclophosphamide|mesh-list
64719335|NCT02212574|Lomustine|lomustine|mesh-list
64719336|NCT02212574|Vincristine|vincristine|mesh-list
64709502|NCT04334005|Vitamin D|vitamin d|mesh-list
64709503|NCT04334005|Vitamins|vitamins|mesh-ancestor
64709504|NCT04334005|Micronutrients|micronutrients|mesh-ancestor
64709505|NCT04334005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709506|NCT04334005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64709507|NCT00966914|Paclitaxel|paclitaxel|mesh-list
64709508|NCT00966914|Docetaxel|docetaxel|mesh-list
64709509|NCT00966914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64709510|NCT00966914|Cisplatin|cisplatin|mesh-list
64709511|NCT00966914|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
64709512|NCT00966914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64709513|NCT00966914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709514|NCT00966914|Tubulin Modulators|tubulin modulators|mesh-ancestor
64709515|NCT00966914|Antimitotic Agents|antimitotic agents|mesh-ancestor
65466744|NCT00079274|Antibodies|antibodies|mesh-list
65466745|NCT00079274|Immunoglobulins|immunoglobulins|mesh-list
65466746|NCT00079274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65466747|NCT00079274|Levoleucovorin|levoleucovorin|mesh-list
65466748|NCT00079274|Immunologic Factors|immunologic factors|mesh-ancestor
65466749|NCT00079274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466750|NCT00079274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466751|NCT00079274|Antimetabolites|antimetabolites|mesh-ancestor
65466752|NCT00079274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466753|NCT00079274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65466754|NCT00079274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65466755|NCT00079274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65466756|NCT00079274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65466757|NCT00079274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466758|NCT00079274|Antidotes|antidotes|mesh-ancestor
65466759|NCT00079274|Protective Agents|protective agents|mesh-ancestor
65466760|NCT00079274|Vitamin B Complex|vitamin b complex|mesh-ancestor
65466761|NCT00079274|Vitamins|vitamins|mesh-ancestor
65466762|NCT00079274|Micronutrients|micronutrients|mesh-ancestor
65466763|NCT01081964|Levofloxacin|levofloxacin|mesh-list
65466764|NCT01081964|Ofloxacin|ofloxacin|mesh-list
65466765|NCT01081964|Fluoroquinolones|fluoroquinolones|mesh-list
65466766|NCT01081964|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65466767|NCT01081964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65466768|NCT01081964|Renal Agents|renal agents|mesh-ancestor
65466769|NCT01081964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65466770|NCT01081964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65466771|NCT01081964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65466772|NCT01081964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466792|NCT00079040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65466793|NCT00079040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65466794|NCT00079040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65466795|NCT00079040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466796|NCT00079040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466797|NCT01088516|Ritonavir|ritonavir|mesh-list
65466798|NCT01088516|Lopinavir|lopinavir|mesh-list
65466799|NCT01088516|Zidovudine|zidovudine|mesh-list
65466800|NCT01088516|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65466801|NCT01088516|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65466802|NCT01088516|Protease Inhibitors|protease inhibitors|mesh-ancestor
65466803|NCT01088516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466804|NCT01088516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466805|NCT01088516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65466806|NCT01088516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65466807|NCT01088516|Antiviral Agents|antiviral agents|mesh-ancestor
65466808|NCT01088516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65466809|NCT01088516|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65466810|NCT01088516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65466811|NCT01088516|Antimetabolites|antimetabolites|mesh-ancestor
65466812|NCT01088516|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65466813|NCT01088516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65466814|NCT00078806|Etanercept|etanercept|mesh-list
65466815|NCT00078806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65466816|NCT00078806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65466817|NCT00078806|Analgesics|analgesics|mesh-ancestor
64851091|NCT01398839|Riboflavin|riboflavin|mesh-list
64709524|NCT04432285|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64709525|NCT04432285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64709526|NCT04432285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709527|NCT04432285|Cholinergic Agents|cholinergic agents|mesh-ancestor
64709528|NCT04432285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64709529|NCT04432285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709531|NCT04430959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64709532|NCT04430959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64709533|NCT04430959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64709534|NCT04430959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709535|NCT04737655|Beclomethasone|beclomethasone|mesh-list
64709536|NCT04737655|Glycopyrrolate|glycopyrrolate|mesh-list
64709537|NCT04737655|Formoterol Fumarate|formoterol fumarate|mesh-list
64709538|NCT04737655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64709539|NCT04737655|Autonomic Agents|autonomic agents|mesh-ancestor
64709540|NCT04737655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64709541|NCT04737655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709542|NCT04737655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65466818|NCT00078806|Sensory System Agents|sensory system agents|mesh-ancestor
65466819|NCT00078806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65466820|NCT00078806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466821|NCT00078806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65466822|NCT00078806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65466823|NCT00078806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65466824|NCT00078806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65466825|NCT00078806|Immunologic Factors|immunologic factors|mesh-ancestor
65466826|NCT00078338|Interferons|interferons|mesh-list
65466827|NCT00078338|Interferon-beta|interferon-beta|mesh-list
65466828|NCT00078338|Interferon beta-1a|interferon beta-1a|mesh-list
65466829|NCT00078338|Glatiramer Acetate|glatiramer acetate|mesh-list
65466830|NCT00078338|(T,G)-A-L|(t,g)-a-l|mesh-list
65466831|NCT00078338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466832|NCT00078338|Antiviral Agents|antiviral agents|mesh-ancestor
65466833|NCT00078338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65466834|NCT00078338|Immunologic Factors|immunologic factors|mesh-ancestor
65466835|NCT00078338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466836|NCT00078338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65466837|NCT00078338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65466838|NCT00078338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65466839|NCT01088594|Pioglitazone|pioglitazone|mesh-list
65466840|NCT01088594|Rosiglitazone|rosiglitazone|mesh-list
65466841|NCT01088594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65466842|NCT01088594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466843|NCT01082120|Pioglitazone|pioglitazone|mesh-list
65466844|NCT01082120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65466845|NCT01082120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466846|NCT03808688|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65466847|NCT03808688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65466848|NCT03808298|Moxifloxacin|moxifloxacin|mesh-list
65466849|NCT03808298|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65466850|NCT03808298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65466851|NCT03808298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65466852|NCT03808298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64709561|NCT05063396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709562|NCT05063396|Narcotics|narcotics|mesh-ancestor
64709563|NCT05063396|Analgesics|analgesics|mesh-ancestor
64709564|NCT05063396|Sensory System Agents|sensory system agents|mesh-ancestor
64709565|NCT05063396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64709566|NCT05055752|Aspirin|aspirin|mesh-list
64709567|NCT05055752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65466853|NCT03808298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65466854|NCT03808298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466855|NCT03808298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466856|NCT03808298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466857|NCT03808298|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65466858|NCT03808298|Contraceptive Agents|contraceptive agents|mesh-ancestor
65466859|NCT03808298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65466860|NCT03808298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466861|NCT03808298|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65466862|NCT03808298|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65466863|NCT03808298|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65466864|NCT03961334|Aspirin|aspirin|mesh-list
65466865|NCT03961334|Dabigatran|dabigatran|mesh-list
65466866|NCT03961334|Apixaban|apixaban|mesh-list
65466867|NCT03961334|Edoxaban|edoxaban|mesh-list
65466868|NCT03961334|Clopidogrel|clopidogrel|mesh-list
65466869|NCT03961334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65466870|NCT03961334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65466871|NCT03961334|Analgesics|analgesics|mesh-ancestor
65466872|NCT03961334|Sensory System Agents|sensory system agents|mesh-ancestor
65466873|NCT03961334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65466874|NCT03961334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466875|NCT03961334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65466876|NCT03961334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65466877|NCT03961334|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65466878|NCT03961334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65466879|NCT03961334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851147|NCT03126812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64851149|NCT03126812|Tubulin Modulators|tubulin modulators|mesh-ancestor
64709568|NCT05055752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64709569|NCT05055752|Analgesics|analgesics|mesh-ancestor
64709570|NCT05055752|Sensory System Agents|sensory system agents|mesh-ancestor
64709571|NCT05055752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719337|NCT02212574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64719338|NCT02212574|Immunologic Factors|immunologic factors|mesh-ancestor
64719339|NCT02212574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719340|NCT02212574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64719341|NCT02212574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64719342|NCT02212574|Alkylating Agents|alkylating agents|mesh-ancestor
64719343|NCT02212574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709572|NCT05055752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945611|NCT05406505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709579|NCT05055752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64709580|NCT05055752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709581|NCT05055752|Antipyretics|antipyretics|mesh-ancestor
64851172|NCT03056014|Acetylcysteine|acetylcysteine|mesh-list
65466880|NCT03961334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65466881|NCT03961334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65466882|NCT03961334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466883|NCT03961334|Antipyretics|antipyretics|mesh-ancestor
65466884|NCT03961334|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65466885|NCT03961334|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65466886|NCT03961334|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65466887|NCT03961334|Purinergic Agents|purinergic agents|mesh-ancestor
65466888|NCT03961334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65466889|NCT03961334|Antithrombins|antithrombins|mesh-ancestor
65466890|NCT03961334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65466891|NCT03961334|Protease Inhibitors|protease inhibitors|mesh-ancestor
65466892|NCT03961334|Anticoagulants|anticoagulants|mesh-ancestor
65466893|NCT03961334|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65466894|NCT00077636|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65466895|NCT00077636|Interferon-alpha|interferon-alpha|mesh-list
65466896|NCT00077636|Ribavirin|ribavirin|mesh-list
65466897|NCT00077636|Antiviral Agents|antiviral agents|mesh-ancestor
65466898|NCT00077636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65466899|NCT00077636|Immunologic Factors|immunologic factors|mesh-ancestor
65466900|NCT00077636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466901|NCT00077636|Antimetabolites|antimetabolites|mesh-ancestor
64851173|NCT03056014|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64851174|NCT03056014|Antiviral Agents|antiviral agents|mesh-ancestor
64709582|NCT04336189|Pyrimethamine|pyrimethamine|mesh-list
64709583|NCT04336189|Piperaquine|piperaquine|mesh-list
64709584|NCT04336189|Sulfadoxine|sulfadoxine|mesh-list
64709585|NCT04336189|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64709604|NCT04101877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64709605|NCT04101877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709606|NCT04101877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64709607|NCT04101877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64709608|NCT04101877|Growth Substances|growth substances|mesh-ancestor
64709609|NCT04101877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709610|NCT04101877|Growth Inhibitors|growth inhibitors|mesh-ancestor
64709611|NCT04209140|Lithium Carbonate|lithium carbonate|mesh-list
64709612|NCT04209140|Antidepressive Agents|antidepressive agents|mesh-ancestor
64709613|NCT04209140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64337645|NCT02608697|Atorvastatin|atorvastatin|mesh-list
64709621|NCT00372541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64709622|NCT00372541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64709624|NCT04762381|Glucocorticoids|glucocorticoids|mesh-list
64709625|NCT04762381|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64709626|NCT04762381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64709627|NCT04762381|Antiemetics|antiemetics|mesh-ancestor
64709628|NCT04762381|Autonomic Agents|autonomic agents|mesh-ancestor
64709629|NCT04762381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64709630|NCT04762381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709631|NCT04762381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64709633|NCT04762381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64709634|NCT04762381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65466902|NCT00077636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466903|NCT01082198|Vaccines|vaccines|mesh-list
65466904|NCT01082198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
65466905|NCT01082198|Immunologic Factors|immunologic factors|mesh-ancestor
65466906|NCT01082198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466907|NCT01082198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65466908|NCT01088750|Prednisolone|prednisolone|mesh-list
65466909|NCT01088750|Cyclophosphamide|cyclophosphamide|mesh-list
65466910|NCT01088750|Vinblastine|vinblastine|mesh-list
65466911|NCT01088750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65466912|NCT01088750|Immunologic Factors|immunologic factors|mesh-ancestor
65466913|NCT01088750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466914|NCT01088750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65466915|NCT01088750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65466916|NCT01088750|Alkylating Agents|alkylating agents|mesh-ancestor
65466917|NCT01088750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466918|NCT01088750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466919|NCT01088750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65466920|NCT01088750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65466921|NCT01088750|Glucocorticoids|glucocorticoids|mesh-ancestor
65466922|NCT01088750|Hormones|hormones|mesh-ancestor
65466923|NCT01088750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65466924|NCT01088750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65466925|NCT01088750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65466926|NCT01088750|Tubulin Modulators|tubulin modulators|mesh-ancestor
65466927|NCT01088750|Antimitotic Agents|antimitotic agents|mesh-ancestor
65466928|NCT01088750|Mitosis Modulators|mitosis modulators|mesh-ancestor
64709635|NCT04762381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709636|NCT01547468|Analgesics, Opioid|analgesics, opioid|mesh-list
64709637|NCT01547468|Narcotics|narcotics|mesh-ancestor
64709638|NCT01547468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64709639|NCT01547468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709640|NCT01547468|Analgesics|analgesics|mesh-ancestor
64709641|NCT01547468|Sensory System Agents|sensory system agents|mesh-ancestor
64709642|NCT01547468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64709678|NCT00373178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64709679|NCT00373178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709680|NCT03254732|Pembrolizumab|pembrolizumab|mesh-list
64709681|NCT03254732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64709682|NCT03254732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709683|NCT01163383|Iodine|iodine|mesh-list
64709684|NCT01163383|Cadexomer iodine|cadexomer iodine|mesh-list
64709685|NCT01163383|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64709686|NCT01163383|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64709687|NCT01163383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64709688|NCT01163383|Trace Elements|trace elements|mesh-ancestor
64709689|NCT01163383|Micronutrients|micronutrients|mesh-ancestor
65466929|NCT01091012|Sildenafil Citrate|sildenafil citrate|mesh-list
65466930|NCT01091012|Vasodilator Agents|vasodilator agents|mesh-ancestor
65466931|NCT01091012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65466932|NCT01091012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65466933|NCT01091012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466934|NCT01091012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466935|NCT01091012|Urological Agents|urological agents|mesh-ancestor
65466936|NCT01082276|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65466937|NCT01082276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65466938|NCT01082276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65466939|NCT01082276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65466940|NCT01082276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466941|NCT01082276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65466942|NCT01082276|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65466943|NCT01082276|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65466944|NCT01082276|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65466945|NCT01082276|Adrenergic Agents|adrenergic agents|mesh-ancestor
65466946|NCT01082276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65466947|NCT01082276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466948|NCT01082276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65466949|NCT01082276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65466950|NCT01082276|Serotonin Agents|serotonin agents|mesh-ancestor
65466951|NCT01082276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65466952|NCT01082276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65466953|NCT01082276|Dopamine Agents|dopamine agents|mesh-ancestor
65466954|NCT01088906|Pemetrexed|pemetrexed|mesh-list
65466955|NCT01088906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466956|NCT01088906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466957|NCT01088906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466958|NCT01088906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65466959|NCT01088906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65466960|NCT00095199|Docetaxel|docetaxel|mesh-list
65466961|NCT00095199|Pemetrexed|pemetrexed|mesh-list
65466962|NCT00095199|Cetuximab|cetuximab|mesh-list
65466963|NCT00095199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64719344|NCT02212574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64719345|NCT02212574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65466964|NCT00095199|Tubulin Modulators|tubulin modulators|mesh-ancestor
65466965|NCT00095199|Antimitotic Agents|antimitotic agents|mesh-ancestor
65466966|NCT00095199|Mitosis Modulators|mitosis modulators|mesh-ancestor
65466967|NCT00095199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466968|NCT00095199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466969|NCT00095199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65466970|NCT00095199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65466971|NCT00095199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65466972|NCT00075764|Fulvestrant|fulvestrant|mesh-list
65466973|NCT00075764|Anastrozole|anastrozole|mesh-list
65466974|NCT00075764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65466975|NCT00075764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466976|NCT00075764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65466977|NCT00075764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65466978|NCT00075764|Hormone Antagonists|hormone antagonists|mesh-ancestor
65466979|NCT00075764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65466980|NCT00075764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719346|NCT02212574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64719347|NCT02212574|Tubulin Modulators|tubulin modulators|mesh-ancestor
64719348|NCT02212574|Antimitotic Agents|antimitotic agents|mesh-ancestor
64719349|NCT02212574|Mitosis Modulators|mitosis modulators|mesh-ancestor
64719350|NCT00000854|Nandrolone Decanoate|nandrolone decanoate|mesh-list
64719351|NCT00000854|Nandrolone|nandrolone|mesh-list
64719352|NCT00000854|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
64719353|NCT00000854|Androgens|androgens|mesh-ancestor
64327454|NCT00672997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64709690|NCT01163383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709691|NCT01163383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709692|NCT01163383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709693|NCT01163383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709694|NCT01163383|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64709695|NCT02923466|Interferon-beta|interferon-beta|mesh-list
64709696|NCT02923466|Avelumab|avelumab|mesh-list
64709697|NCT02923466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64709698|NCT02923466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709699|NCT02923466|Antiviral Agents|antiviral agents|mesh-ancestor
64709700|NCT02923466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64709701|NCT02923466|Immunologic Factors|immunologic factors|mesh-ancestor
64709702|NCT02923466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709703|NCT00813566|Deoxyglucose|deoxyglucose|mesh-list
64709704|NCT00813566|Antimetabolites|antimetabolites|mesh-ancestor
64709705|NCT00813566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709706|NCT00813566|Antiviral Agents|antiviral agents|mesh-ancestor
64709725|NCT00372853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709727|NCT00372853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64709728|NCT00372853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709729|NCT02885636|Albuterol|albuterol|mesh-list
64709730|NCT02885636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64709736|NCT02885636|Tocolytic Agents|tocolytic agents|mesh-ancestor
64709737|NCT02885636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64709738|NCT02885636|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64709739|NCT02885636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64709740|NCT02885636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64709741|NCT02885636|Adrenergic Agents|adrenergic agents|mesh-ancestor
64709742|NCT02885636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64709743|NCT02885636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709744|NCT00373087|Entacapone|entacapone|mesh-list
65466981|NCT00075764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65466982|NCT00075764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65466983|NCT00075764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65466984|NCT00075764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65466985|NCT03567616|Dexamethasone|dexamethasone|mesh-list
65466986|NCT03567616|Venetoclax|venetoclax|mesh-list
65466987|NCT03567616|Pomalidomide|pomalidomide|mesh-list
65466988|NCT03567616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65466989|NCT03567616|Antiemetics|antiemetics|mesh-ancestor
65466990|NCT03567616|Autonomic Agents|autonomic agents|mesh-ancestor
65466991|NCT03567616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65466992|NCT03567616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65466993|NCT03567616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65466994|NCT03567616|Glucocorticoids|glucocorticoids|mesh-ancestor
65466995|NCT03567616|Hormones|hormones|mesh-ancestor
65466996|NCT03567616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65466997|NCT03567616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65466998|NCT03567616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65466999|NCT03567616|Immunologic Factors|immunologic factors|mesh-ancestor
65467000|NCT03567616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65467001|NCT03567616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65467002|NCT03567616|Growth Substances|growth substances|mesh-ancestor
65467003|NCT03567616|Growth Inhibitors|growth inhibitors|mesh-ancestor
65467004|NCT03567382|Tenofovir|tenofovir|mesh-list
65467005|NCT03567382|Antiviral Agents|antiviral agents|mesh-ancestor
65467006|NCT03567382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65467007|NCT03567382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65467008|NCT03567382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65467009|NCT03567382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467010|NCT03567382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467011|NCT03567382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65467012|NCT03567382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65467013|NCT03591874|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65467014|NCT03591874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65467015|NCT03591874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65467016|NCT03591874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65467019|NCT03591874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65467020|NCT03591874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467021|NCT03591874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467022|NCT03730714|Epinephrine|epinephrine|mesh-list
65467023|NCT03730714|Racepinephrine|racepinephrine|mesh-list
65467024|NCT03730714|Morphine|morphine|mesh-list
65467025|NCT03730714|Anesthetics|anesthetics|mesh-list
65467026|NCT03730714|Anesthetics, Local|anesthetics, local|mesh-list
65467027|NCT03730714|Epinephryl borate|epinephryl borate|mesh-list
65467028|NCT03730714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65467029|NCT03730714|Narcotics|narcotics|mesh-ancestor
65467030|NCT03730714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65467031|NCT03730714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467032|NCT03730714|Analgesics|analgesics|mesh-ancestor
65467033|NCT03730714|Sensory System Agents|sensory system agents|mesh-ancestor
65467034|NCT03730714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467035|NCT03730714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65467036|NCT03730714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65467037|NCT03730714|Adrenergic Agents|adrenergic agents|mesh-ancestor
65467038|NCT03730714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65467039|NCT03730714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851317|NCT02886286|Bupivacaine|bupivacaine|mesh-list
64709745|NCT00373087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64709746|NCT00373087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64709747|NCT00373087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709748|NCT00373087|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64709749|NCT00373087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709750|NCT03619213|Dapagliflozin|dapagliflozin|mesh-list
64709751|NCT03619213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64709752|NCT03619213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709753|NCT03619213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64719354|NCT00000854|Hormones|hormones|mesh-ancestor
64719355|NCT00000854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64719356|NCT00000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719357|NCT00000854|Anabolic Agents|anabolic agents|mesh-ancestor
64719358|NCT00000854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64719359|NCT04298918|Trastuzumab|trastuzumab|mesh-list
64719360|NCT04298918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64719361|NCT04298918|Venetoclax|venetoclax|mesh-list
64719362|NCT04298918|Maytansine|maytansine|mesh-list
64719363|NCT04298918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64719364|NCT04298918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64719365|NCT04298918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64719366|NCT04298918|Tubulin Modulators|tubulin modulators|mesh-ancestor
64719367|NCT04298918|Antimitotic Agents|antimitotic agents|mesh-ancestor
64719368|NCT04298918|Mitosis Modulators|mitosis modulators|mesh-ancestor
64719369|NCT04298918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719370|NCT00001676|Fludarabine|fludarabine|mesh-list
64719371|NCT00001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64719372|NCT03714919|Acetaminophen|acetaminophen|mesh-list
64719373|NCT03714919|Dexmedetomidine|dexmedetomidine|mesh-list
64719374|NCT03714919|Ketamine|ketamine|mesh-list
64709754|NCT03619213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467040|NCT03730714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65467041|NCT03730714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65467042|NCT03730714|Autonomic Agents|autonomic agents|mesh-ancestor
65467043|NCT03730714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65467044|NCT03730714|Respiratory System Agents|respiratory system agents|mesh-ancestor
65467045|NCT03730714|Mydriatics|mydriatics|mesh-ancestor
65467046|NCT03730714|Sympathomimetics|sympathomimetics|mesh-ancestor
65467047|NCT03730714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65467048|NCT00106353|Sirolimus|sirolimus|mesh-list
65467049|NCT00106353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65467050|NCT00106353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65467051|NCT00106353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65467052|NCT00106353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467053|NCT00106353|Antifungal Agents|antifungal agents|mesh-ancestor
65467054|NCT00106353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65467055|NCT00106353|Immunologic Factors|immunologic factors|mesh-ancestor
65467056|NCT00106353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467057|NCT01087983|Metformin|metformin|mesh-list
65467058|NCT01087983|Sirolimus|sirolimus|mesh-list
65467059|NCT01087983|Lapatinib|lapatinib|mesh-list
65467060|NCT01087983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65467061|NCT01087983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467062|NCT01087983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65467063|NCT01087983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65467064|NCT01087983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65467065|NCT01087983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467066|NCT01087983|Antifungal Agents|antifungal agents|mesh-ancestor
65467067|NCT01087983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65467068|NCT01087983|Immunologic Factors|immunologic factors|mesh-ancestor
65467069|NCT01087983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65467070|NCT01087983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467086|NCT00079677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65467087|NCT00079677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467088|NCT00079677|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65467089|NCT00079677|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65467090|NCT00079677|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65467091|NCT00079677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851387|NCT02608684|Gemcitabine|gemcitabine|mesh-list
65467092|NCT01081353|Aspirin|aspirin|mesh-list
65467093|NCT01081353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65467094|NCT01081353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65467095|NCT01081353|Analgesics|analgesics|mesh-ancestor
65467096|NCT01081353|Sensory System Agents|sensory system agents|mesh-ancestor
65467097|NCT01081353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467098|NCT01081353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467099|NCT01081353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65467100|NCT01081353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65467101|NCT01081353|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65467102|NCT01081353|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65467103|NCT01081353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467104|NCT01081353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65467105|NCT01081353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65467106|NCT01081353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467107|NCT01081353|Antipyretics|antipyretics|mesh-ancestor
65467108|NCT00095121|Lamivudine|lamivudine|mesh-list
65467109|NCT00095121|Adefovir|adefovir|mesh-list
65467110|NCT00095121|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65467111|NCT00095121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65467112|NCT00095121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65467113|NCT00095121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467114|NCT00095121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467115|NCT00095121|Antiviral Agents|antiviral agents|mesh-ancestor
65467126|NCT01081431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467127|NCT03962829|1-(3-chlorophenyl)piperazine|1-(3-chlorophenyl)piperazine|mesh-list
65467128|NCT03962829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65467129|NCT03962829|Serotonin Agents|serotonin agents|mesh-ancestor
65467130|NCT03962829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65467131|NCT03962829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467132|NCT03962829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467133|NCT01084473|Dexmedetomidine|dexmedetomidine|mesh-list
65467134|NCT01084473|Morphine|morphine|mesh-list
65467135|NCT01084473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65467136|NCT01084473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65467137|NCT01084473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467138|NCT01084473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65467139|NCT01084473|Analgesics|analgesics|mesh-ancestor
65467140|NCT01084473|Sensory System Agents|sensory system agents|mesh-ancestor
65467141|NCT01084473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467142|NCT01084473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65467143|NCT01084473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65467144|NCT01084473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65467145|NCT01084473|Adrenergic Agents|adrenergic agents|mesh-ancestor
65467146|NCT01084473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65467147|NCT01084473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467148|NCT01084473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65467149|NCT01084473|Narcotics|narcotics|mesh-ancestor
65467150|NCT01088373|Lenalidomide|lenalidomide|mesh-list
65467151|NCT01088373|Azacitidine|azacitidine|mesh-list
65467152|NCT01088373|Immunologic Factors|immunologic factors|mesh-ancestor
65467153|NCT01088373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467154|NCT01088373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65467155|NCT01088373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65467156|NCT01088373|Growth Substances|growth substances|mesh-ancestor
65467157|NCT01088373|Growth Inhibitors|growth inhibitors|mesh-ancestor
65467158|NCT01088373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467159|NCT01088373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65467160|NCT01088373|Antimetabolites|antimetabolites|mesh-ancestor
65467162|NCT01088373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467163|NCT01088451|Insulin|insulin|mesh-list
65467164|NCT01088451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65467165|NCT01088451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467166|NCT00075218|Sunitinib|sunitinib|mesh-list
65467167|NCT00075218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467168|NCT00075218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65467169|NCT00075218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65467170|NCT00075218|Growth Substances|growth substances|mesh-ancestor
65467171|NCT00075218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467172|NCT00075218|Growth Inhibitors|growth inhibitors|mesh-ancestor
65467173|NCT00075218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65467174|NCT00075218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467175|NCT00075218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467176|NCT01089140|Tranexamic Acid|tranexamic acid|mesh-list
65467177|NCT01089140|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65467178|NCT01089140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65467179|NCT01089140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467181|NCT01089140|Coagulants|coagulants|mesh-ancestor
65467182|NCT00094653|Ipilimumab|ipilimumab|mesh-list
65467183|NCT00094653|Vaccines|vaccines|mesh-list
65467184|NCT00094653|Antibodies|antibodies|mesh-list
65467185|NCT00094653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65467186|NCT00094653|Immunologic Factors|immunologic factors|mesh-ancestor
65467187|NCT00094653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467188|NCT00094653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65467189|NCT00094653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467190|NCT00094653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65467191|NCT00094653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467192|NCT00104247|Verapamil|verapamil|mesh-list
65467193|NCT00104247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65467194|NCT00104247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65467195|NCT00104247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65467196|NCT00104247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467197|NCT00104247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64709755|NCT02892110|Varenicline|varenicline|mesh-list
65467203|NCT05665348|Bevacizumab|bevacizumab|mesh-list
65467204|NCT05665348|Ipilimumab|ipilimumab|mesh-list
65467205|NCT05665348|Atezolizumab|atezolizumab|mesh-list
65467206|NCT05665348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65467207|NCT05665348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65467208|NCT05665348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467209|NCT05665348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65467210|NCT05665348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65467211|NCT05665348|Growth Substances|growth substances|mesh-ancestor
65467212|NCT05665348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467213|NCT05665348|Growth Inhibitors|growth inhibitors|mesh-ancestor
65467214|NCT05665348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65467215|NCT05665348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467216|NCT05665348|Immunologic Factors|immunologic factors|mesh-ancestor
65467217|NCT03726736|Docetaxel|docetaxel|mesh-list
65467218|NCT03726736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467219|NCT03726736|Tubulin Modulators|tubulin modulators|mesh-ancestor
65467220|NCT03726736|Antimitotic Agents|antimitotic agents|mesh-ancestor
65467221|NCT03726736|Mitosis Modulators|mitosis modulators|mesh-ancestor
65467222|NCT03726736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467223|NCT03591406|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65467224|NCT03591406|Hematinics|hematinics|mesh-ancestor
65467225|NCT03726580|Propofol|propofol|mesh-list
65467226|NCT03726580|Sevoflurane|sevoflurane|mesh-list
65467227|NCT03726580|Isoflurane|isoflurane|mesh-list
65467228|NCT03726580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65467229|NCT03726580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65467230|NCT03726580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467231|NCT03726580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65467232|NCT03726580|Anesthetics, General|anesthetics, general|mesh-ancestor
65467233|NCT03726580|Anesthetics|anesthetics|mesh-ancestor
65467234|NCT03726580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65467235|NCT03726580|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65467236|NCT03730558|Aflibercept|aflibercept|mesh-list
65467239|NCT03730558|Growth Substances|growth substances|mesh-ancestor
65467245|NCT03588910|Oxycodone|oxycodone|mesh-list
65467246|NCT03588910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65467247|NCT03588910|Analgesics|analgesics|mesh-ancestor
65467248|NCT03588910|Sensory System Agents|sensory system agents|mesh-ancestor
65467249|NCT03588910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467250|NCT03588910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216756|NCT04091971|Anesthetics|anesthetics|mesh-ancestor
65467251|NCT03588910|Antipyretics|antipyretics|mesh-ancestor
65467252|NCT03588910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65467253|NCT03588910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65467254|NCT03588910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65467255|NCT03588910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65467256|NCT03588910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467257|NCT03588910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467258|NCT03588910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65467259|NCT03588910|Narcotics|narcotics|mesh-ancestor
65467260|NCT03588910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65467261|NCT03730402|Bupivacaine|bupivacaine|mesh-list
65467262|NCT03730402|Anesthetics, Local|anesthetics, local|mesh-ancestor
65467263|NCT03730402|Anesthetics|anesthetics|mesh-ancestor
65467264|NCT03730402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65467265|NCT03730402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467266|NCT03730402|Sensory System Agents|sensory system agents|mesh-ancestor
65467267|NCT03730402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467268|NCT00103857|Metformin|metformin|mesh-list
65467269|NCT00103857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65467270|NCT00103857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65467271|NCT00103857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467272|NCT00103857|Incretins|incretins|mesh-ancestor
65467273|NCT00103857|Hormones|hormones|mesh-ancestor
65467274|NCT00103857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65467276|NCT00103857|Protease Inhibitors|protease inhibitors|mesh-ancestor
65467287|NCT03586726|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65467288|NCT03586726|Antitubercular Agents|antitubercular agents|mesh-ancestor
65467289|NCT03586726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65467290|NCT03586726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65467291|NCT03586726|Leprostatic Agents|leprostatic agents|mesh-ancestor
65467292|NCT03586726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65467293|NCT03586726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467294|NCT03586726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467295|NCT03586726|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65467296|NCT03586726|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65467297|NCT03586726|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65467298|NCT03586726|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65467299|NCT03586726|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65467300|NCT03586726|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65467301|NCT03725878|Folic Acid|folic acid|mesh-list
65467302|NCT03725878|Hematinics|hematinics|mesh-ancestor
65467303|NCT03725878|Vitamin B Complex|vitamin b complex|mesh-ancestor
65467304|NCT03725878|Vitamins|vitamins|mesh-ancestor
65467305|NCT03725878|Micronutrients|micronutrients|mesh-ancestor
65467306|NCT03725878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467307|NCT03721900|Ketamine|ketamine|mesh-list
65467308|NCT03721900|Analgesics|analgesics|mesh-ancestor
65467309|NCT03721900|Sensory System Agents|sensory system agents|mesh-ancestor
65467310|NCT03721900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467311|NCT03721900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467312|NCT03721900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65467313|NCT03721900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65467314|NCT03721900|Anesthetics, General|anesthetics, general|mesh-ancestor
65467315|NCT03721900|Anesthetics|anesthetics|mesh-ancestor
65467316|NCT03721900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64709756|NCT02892110|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64709757|NCT02892110|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64709758|NCT02892110|Cholinergic Agents|cholinergic agents|mesh-ancestor
64709774|NCT02779166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709775|NCT00373165|Ganciclovir|ganciclovir|mesh-list
64709776|NCT00373165|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64709777|NCT00373165|Antiviral Agents|antiviral agents|mesh-ancestor
64709778|NCT00373165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64709779|NCT00373165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64709780|NCT00373165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709781|NCT00373165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709782|NCT04333550|Deferoxamine|deferoxamine|mesh-list
64709783|NCT04333550|Siderophores|siderophores|mesh-ancestor
64709784|NCT04333550|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65467317|NCT03721900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65467318|NCT03721900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65467319|NCT03721900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65467320|NCT03721900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467321|NCT03585712|Norgestrel|norgestrel|mesh-list
65467322|NCT03585712|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65467323|NCT03585712|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65467324|NCT03585712|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65467325|NCT03585712|Contraceptive Agents|contraceptive agents|mesh-ancestor
65467326|NCT03585712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65467327|NCT03585712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467328|NCT03585712|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65467329|NCT03585712|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65467330|NCT01082510|Tegafur|tegafur|mesh-list
65467331|NCT01082510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65467332|NCT01082510|Antimetabolites|antimetabolites|mesh-ancestor
65467333|NCT01082510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467334|NCT01082510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467335|NCT03583372|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65467336|NCT03583372|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65467337|NCT03583372|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65467338|NCT03583372|Cholinergic Agents|cholinergic agents|mesh-ancestor
65467339|NCT03583372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65467340|NCT03583372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467341|NCT03583372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467342|NCT03583372|Urological Agents|urological agents|mesh-ancestor
65467343|NCT00074282|Cyclophosphamide|cyclophosphamide|mesh-list
65467344|NCT00074282|Rituximab|rituximab|mesh-list
65467345|NCT00074282|Alemtuzumab|alemtuzumab|mesh-list
65467346|NCT00074282|Pentostatin|pentostatin|mesh-list
65467347|NCT00074282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65467348|NCT00074282|Immunologic Factors|immunologic factors|mesh-ancestor
64851546|NCT02355379|Antimetabolites|antimetabolites|mesh-ancestor
64709785|NCT04333550|Chelating Agents|chelating agents|mesh-ancestor
64709786|NCT04333550|Sequestering Agents|sequestering agents|mesh-ancestor
64719376|NCT03714919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64719377|NCT03714919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64719378|NCT03714919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719379|NCT03714919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64719380|NCT03714919|Analgesics|analgesics|mesh-ancestor
65467349|NCT00074282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467350|NCT00074282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65467351|NCT00074282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65467352|NCT00074282|Alkylating Agents|alkylating agents|mesh-ancestor
65467353|NCT00074282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467354|NCT00074282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467355|NCT00074282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65467356|NCT00074282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65467357|NCT00074282|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65467358|NCT00074282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467359|NCT01091324|Dextromethorphan|dextromethorphan|mesh-list
65467360|NCT01091324|Silymarin|silymarin|mesh-list
65467361|NCT01091324|Antitussive Agents|antitussive agents|mesh-ancestor
65467362|NCT01091324|Respiratory System Agents|respiratory system agents|mesh-ancestor
65467363|NCT01091324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65467364|NCT01091324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65467365|NCT01091324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65467366|NCT01091324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467367|NCT01091324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467368|NCT01091324|Antioxidants|antioxidants|mesh-ancestor
65467369|NCT01091324|Protective Agents|protective agents|mesh-ancestor
65467370|NCT05782608|Ibuprofen|ibuprofen|mesh-list
65467371|NCT05782608|Ketorolac|ketorolac|mesh-list
65467372|NCT05782608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65467373|NCT05782608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65467374|NCT05782608|Analgesics|analgesics|mesh-ancestor
65467375|NCT05782608|Sensory System Agents|sensory system agents|mesh-ancestor
64851591|NCT02283281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65467394|NCT05782348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467395|NCT05782348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65467396|NCT05782348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65467397|NCT05782244|Sildenafil Citrate|sildenafil citrate|mesh-list
65467398|NCT05782244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216901|NCT02765373|Letrozole|letrozole|mesh-list
65467399|NCT05782244|Vasodilator Agents|vasodilator agents|mesh-ancestor
65467400|NCT05782244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65467401|NCT05782244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65467402|NCT05782244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467403|NCT05782244|Urological Agents|urological agents|mesh-ancestor
65467405|NCT05782192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65467406|NCT05782192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467407|NCT05782192|Incretins|incretins|mesh-ancestor
65467408|NCT05782192|Hormones|hormones|mesh-ancestor
65467409|NCT05782192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65467410|NCT05782192|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65467411|NCT05782192|Protease Inhibitors|protease inhibitors|mesh-ancestor
65467412|NCT05782192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467413|NCT05782192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467414|NCT05781997|Mydriatics|mydriatics|mesh-list
65467415|NCT05781997|Autonomic Agents|autonomic agents|mesh-ancestor
65467416|NCT05781997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467417|NCT05781997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467418|NCT05781854|Dexmedetomidine|dexmedetomidine|mesh-list
65467419|NCT05781854|Bupivacaine|bupivacaine|mesh-list
65467420|NCT05781854|Anesthetics, Local|anesthetics, local|mesh-ancestor
65467421|NCT05781854|Anesthetics|anesthetics|mesh-ancestor
65467422|NCT05781854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65467423|NCT05781854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467424|NCT05781854|Sensory System Agents|sensory system agents|mesh-ancestor
65467425|NCT05781854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467433|NCT05781854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65467434|NCT05781854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467435|NCT05781685|Testosterone|testosterone|mesh-list
65467436|NCT05781685|Androgens|androgens|mesh-ancestor
65467437|NCT05781685|Hormones|hormones|mesh-ancestor
65467438|NCT05781685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65467439|NCT05781685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467440|NCT05781633|Bevacizumab|bevacizumab|mesh-list
65467441|NCT05781633|Etoposide|etoposide|mesh-list
65467442|NCT05781633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65467443|NCT05781633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467444|NCT05781633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65467445|NCT05781633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65467446|NCT05781633|Growth Substances|growth substances|mesh-ancestor
65467447|NCT05781633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467448|NCT05781633|Growth Inhibitors|growth inhibitors|mesh-ancestor
65467449|NCT05781633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65467450|NCT05781633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65467451|NCT05781633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65467452|NCT05781633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467453|NCT05781633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467454|NCT05781620|Vitamin D|vitamin d|mesh-list
65467455|NCT05781620|Vitamins|vitamins|mesh-ancestor
65467456|NCT05781620|Micronutrients|micronutrients|mesh-ancestor
65467457|NCT05781620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467458|NCT05781620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65467459|NCT05781529|Hyaluronic Acid|hyaluronic acid|mesh-list
65467460|NCT05781529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65467461|NCT05781529|Immunologic Factors|immunologic factors|mesh-ancestor
65467462|NCT05781529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467463|NCT05781529|Viscosupplements|viscosupplements|mesh-ancestor
65467464|NCT05781529|Protective Agents|protective agents|mesh-ancestor
65467465|NCT05781308|Paclitaxel|paclitaxel|mesh-list
65467466|NCT05781308|Bevacizumab|bevacizumab|mesh-list
65467467|NCT05781308|Atezolizumab|atezolizumab|mesh-list
65467468|NCT05781308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65467469|NCT05781308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467470|NCT05781308|Tubulin Modulators|tubulin modulators|mesh-ancestor
65467471|NCT05781308|Antimitotic Agents|antimitotic agents|mesh-ancestor
65467472|NCT05781308|Mitosis Modulators|mitosis modulators|mesh-ancestor
65467473|NCT05781308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467474|NCT05781308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65467476|NCT05781308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65467477|NCT05781308|Growth Substances|growth substances|mesh-ancestor
65467478|NCT05781308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467479|NCT05781308|Growth Inhibitors|growth inhibitors|mesh-ancestor
65467480|NCT05781035|Dexmedetomidine|dexmedetomidine|mesh-list
65467481|NCT05781035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65467482|NCT05781035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467483|NCT05781035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65467484|NCT05781035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65467485|NCT05781035|Analgesics|analgesics|mesh-ancestor
65467486|NCT05781035|Sensory System Agents|sensory system agents|mesh-ancestor
65467487|NCT05781035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467488|NCT05781035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65467489|NCT05781035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65467490|NCT05781035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65467491|NCT05781035|Adrenergic Agents|adrenergic agents|mesh-ancestor
65467492|NCT05781035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65467493|NCT05781035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467494|NCT05780801|Glycerol|glycerol|mesh-list
65467495|NCT05780801|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65467496|NCT05780801|Protective Agents|protective agents|mesh-ancestor
65467497|NCT05780801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467498|NCT05780554|Cyclophosphamide|cyclophosphamide|mesh-list
65467499|NCT05780554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65467500|NCT05780554|Immunologic Factors|immunologic factors|mesh-ancestor
65467501|NCT05780554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467512|NCT05743946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467513|NCT05739292|Vaccines|vaccines|mesh-list
65467514|NCT05739292|Immunologic Factors|immunologic factors|mesh-ancestor
65467515|NCT05739292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467516|NCT05710081|Broncho-Vaxom|broncho-vaxom|mesh-list
65467517|NCT05710081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65467518|NCT05710081|Immunologic Factors|immunologic factors|mesh-ancestor
65467519|NCT05710081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467520|NCT05703191|Nitric Oxide|nitric oxide|mesh-list
65467521|NCT05703191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65467522|NCT05703191|Autonomic Agents|autonomic agents|mesh-ancestor
65467523|NCT05703191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467524|NCT05703191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467525|NCT05703191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65467526|NCT05703191|Respiratory System Agents|respiratory system agents|mesh-ancestor
65467527|NCT05703191|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65467528|NCT05703191|Antioxidants|antioxidants|mesh-ancestor
65467529|NCT05703191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467530|NCT05703191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65467531|NCT05703191|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65467532|NCT05703191|Vasodilator Agents|vasodilator agents|mesh-ancestor
65467533|NCT05703191|Gasotransmitters|gasotransmitters|mesh-ancestor
65467534|NCT05703191|Protective Agents|protective agents|mesh-ancestor
65467535|NCT05689424|Insulin Lispro|insulin lispro|mesh-list
65467536|NCT05689424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65467537|NCT05689424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467538|NCT05687071|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
65467539|NCT05687071|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65467540|NCT05687071|Antimetabolites|antimetabolites|mesh-ancestor
65467541|NCT05687071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467542|NCT05687071|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65467543|NCT05687071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467544|NCT05687071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65467551|NCT05681611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467552|NCT05657470|Tenecteplase|tenecteplase|mesh-list
65467553|NCT05657470|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65467554|NCT05657470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65467555|NCT05657470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467556|NCT05649059|Cannabidiol|cannabidiol|mesh-list
65467557|NCT05649059|Anticonvulsants|anticonvulsants|mesh-ancestor
65467558|NCT05639686|Remifentanil|remifentanil|mesh-list
65467559|NCT05639686|Anesthetics|anesthetics|mesh-list
65467560|NCT05639686|Propofol|propofol|mesh-list
65467561|NCT05639686|Isoflurane|isoflurane|mesh-list
65467562|NCT05639686|Tranexamic Acid|tranexamic acid|mesh-list
65467563|NCT05639686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65467564|NCT05639686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467565|NCT05639686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65467566|NCT05639686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65467567|NCT05639686|Anesthetics, General|anesthetics, general|mesh-ancestor
65467568|NCT05639686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65467569|NCT05639686|Narcotics|narcotics|mesh-ancestor
65467570|NCT05639686|Analgesics|analgesics|mesh-ancestor
65467571|NCT05639686|Sensory System Agents|sensory system agents|mesh-ancestor
65467572|NCT05639686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467573|NCT05639686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65467574|NCT05639686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65467575|NCT05639686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467576|NCT05639686|Hemostatics|hemostatics|mesh-ancestor
65467577|NCT05639686|Coagulants|coagulants|mesh-ancestor
65467578|NCT05639686|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65467579|NCT05633576|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65467580|NCT05633576|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65467581|NCT05590234|Dexmedetomidine|dexmedetomidine|mesh-list
64719381|NCT03714919|Sensory System Agents|sensory system agents|mesh-ancestor
64719382|NCT03714919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719383|NCT03714919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64719384|NCT03714919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64719385|NCT03714919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64327481|NCT02760407|Adalimumab|adalimumab|mesh-list
64709787|NCT04333550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709788|NCT02827838|Durvalumab|durvalumab|mesh-list
64709789|NCT02827838|Immunoglobulins|immunoglobulins|mesh-list
64709790|NCT02827838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64709791|NCT02827838|Immunoglobulin G|immunoglobulin g|mesh-list
64709792|NCT02827838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64709793|NCT02827838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709794|NCT02827838|Immunologic Factors|immunologic factors|mesh-ancestor
64709795|NCT02827838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467582|NCT05590234|Bupivacaine|bupivacaine|mesh-list
65467583|NCT05590234|Anesthetics, Local|anesthetics, local|mesh-ancestor
65467584|NCT05590234|Anesthetics|anesthetics|mesh-ancestor
65467585|NCT05590234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65467586|NCT05590234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467587|NCT05590234|Sensory System Agents|sensory system agents|mesh-ancestor
65467588|NCT05590234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467589|NCT05590234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65467590|NCT05590234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65467591|NCT05590234|Analgesics|analgesics|mesh-ancestor
65467592|NCT05590234|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65467593|NCT05590234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65467594|NCT05590234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65467595|NCT05590234|Adrenergic Agents|adrenergic agents|mesh-ancestor
65467596|NCT05590234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65467597|NCT05590234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467598|NCT05586074|Cytarabine|cytarabine|mesh-list
65467599|NCT05586074|Fludarabine|fludarabine|mesh-list
65467600|NCT05586074|Azacitidine|azacitidine|mesh-list
65467601|NCT05586074|Decitabine|decitabine|mesh-list
65467602|NCT05586074|Idarubicin|idarubicin|mesh-list
65467603|NCT05586074|Lenograstim|lenograstim|mesh-list
65467604|NCT05586074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467605|NCT05586074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65467606|NCT05586074|Antimetabolites|antimetabolites|mesh-ancestor
65467607|NCT05586074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467608|NCT05586074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65467609|NCT05586074|Immunologic Factors|immunologic factors|mesh-ancestor
65467610|NCT05586074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467611|NCT05586074|Antiviral Agents|antiviral agents|mesh-ancestor
65467612|NCT05586074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65467613|NCT05586074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467614|NCT05586074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65467615|NCT05586074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64851723|NCT01997463|Albuterol|albuterol|mesh-list
64709796|NCT02902172|Acetaminophen|acetaminophen|mesh-list
64709797|NCT02902172|Ibuprofen|ibuprofen|mesh-list
64945612|NCT05406505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64709803|NCT02902172|Antipyretics|antipyretics|mesh-ancestor
64709804|NCT02902172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64709805|NCT02902172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64709806|NCT02902172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65467616|NCT05586074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65467617|NCT05586074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65467618|NCT05568615|Edaravone|edaravone|mesh-list
65467619|NCT05568615|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65467620|NCT05568615|Antioxidants|antioxidants|mesh-ancestor
65467621|NCT05568615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467622|NCT05568615|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65467623|NCT05568615|Protective Agents|protective agents|mesh-ancestor
65467624|NCT05568615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467625|NCT05565937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65467626|NCT05553522|Capecitabine|capecitabine|mesh-list
65467627|NCT05553522|Trastuzumab|trastuzumab|mesh-list
65467628|NCT05553522|Tucatinib|tucatinib|mesh-list
65467629|NCT05553522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65467630|NCT05553522|Antimetabolites|antimetabolites|mesh-ancestor
65467631|NCT05553522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467632|NCT05553522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467633|NCT05553522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65467634|NCT05553522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65467635|NCT05553522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467636|NCT05552859|Insulin|insulin|mesh-list
65467637|NCT05552859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65467638|NCT05552859|Insulin Glargine|insulin glargine|mesh-list
64709807|NCT02902172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64709808|NCT02902172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337670|NCT02262533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64709818|NCT04208347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709819|NCT02777749|Bupivacaine|bupivacaine|mesh-list
64709820|NCT02777749|Anesthetics, Local|anesthetics, local|mesh-ancestor
64709821|NCT02777749|Anesthetics|anesthetics|mesh-ancestor
64709822|NCT02777749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64709823|NCT02777749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709824|NCT02777749|Sensory System Agents|sensory system agents|mesh-ancestor
64709825|NCT02777749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64709826|NCT02785172|Clobetasol|clobetasol|mesh-list
64709827|NCT02785172|Halobetasol|halobetasol|mesh-list
64709828|NCT02785172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64709829|NCT02785172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64709830|NCT02785172|Glucocorticoids|glucocorticoids|mesh-ancestor
64709831|NCT02785172|Hormones|hormones|mesh-ancestor
64709832|NCT02785172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64709833|NCT02785172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709834|NCT02582125|Nivolumab|nivolumab|mesh-list
64709835|NCT02582125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64709836|NCT02582125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709837|NCT02582125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64709838|NCT02582125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709839|NCT02785406|Suvorexant|suvorexant|mesh-list
64709840|NCT02785406|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64719386|NCT03714919|Adrenergic Agents|adrenergic agents|mesh-ancestor
64719387|NCT03714919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64719388|NCT03714919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467639|NCT05552859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65467640|NCT05552859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467641|NCT05541146|Paclitaxel|paclitaxel|mesh-list
65467642|NCT05541146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65467643|NCT05541146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467644|NCT05541146|Tubulin Modulators|tubulin modulators|mesh-ancestor
65467645|NCT05541146|Antimitotic Agents|antimitotic agents|mesh-ancestor
65467646|NCT05541146|Mitosis Modulators|mitosis modulators|mesh-ancestor
65467647|NCT05541146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467648|NCT05537935|Naltrexone|naltrexone|mesh-list
65467649|NCT05537935|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65467650|NCT05537935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65467651|NCT05537935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467652|NCT05537935|Sensory System Agents|sensory system agents|mesh-ancestor
65467653|NCT05537935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467654|NCT05532358|Midazolam|midazolam|mesh-list
65467655|NCT05532358|Fluvoxamine|fluvoxamine|mesh-list
65467656|NCT05532358|Caffeine|caffeine|mesh-list
65467657|NCT05532358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65467658|NCT05532358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65467659|NCT05532358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65467660|NCT05532358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467661|NCT05532358|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65467662|NCT05532358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65467663|NCT05532358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65467664|NCT05532358|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65467665|NCT05532358|Anesthetics, General|anesthetics, general|mesh-ancestor
65467666|NCT05532358|Anesthetics|anesthetics|mesh-ancestor
65467667|NCT05532358|GABA Modulators|gaba modulators|mesh-ancestor
65467668|NCT05532358|GABA Agents|gaba agents|mesh-ancestor
65467669|NCT05532358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65467670|NCT05532358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467671|NCT05532358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65467672|NCT05532358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65467673|NCT05532358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467678|NCT05532358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65467679|NCT05532358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65467680|NCT05532358|Serotonin Agents|serotonin agents|mesh-ancestor
65467681|NCT05532358|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65467682|NCT05532358|Antidepressive Agents|antidepressive agents|mesh-ancestor
65467683|NCT05532358|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65467684|NCT05532358|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65467685|NCT05532358|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65467686|NCT05525416|Propranolol|propranolol|mesh-list
65467687|NCT05525416|Nitroprusside|nitroprusside|mesh-list
65467688|NCT05525416|Phentolamine|phentolamine|mesh-list
65467689|NCT05525416|Phenylephrine|phenylephrine|mesh-list
65467690|NCT05525416|Oxymetazoline|oxymetazoline|mesh-list
65467691|NCT05525416|Norepinephrine|norepinephrine|mesh-list
65467692|NCT05525416|Synephrine|synephrine|mesh-list
65467693|NCT05525416|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65467694|NCT05525416|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65467695|NCT05525416|Adrenergic Agents|adrenergic agents|mesh-ancestor
65467696|NCT05525416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65467697|NCT05525416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467698|NCT05525416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467699|NCT05525416|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65467700|NCT05525416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65467701|NCT05525416|Vasodilator Agents|vasodilator agents|mesh-ancestor
65467702|NCT05525416|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65467703|NCT05525416|Mydriatics|mydriatics|mesh-ancestor
65467704|NCT05525416|Autonomic Agents|autonomic agents|mesh-ancestor
65467705|NCT05525416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467706|NCT05525416|Sympathomimetics|sympathomimetics|mesh-ancestor
65467707|NCT05525416|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65467708|NCT05525416|Nasal Decongestants|nasal decongestants|mesh-ancestor
65467709|NCT05525416|Respiratory System Agents|respiratory system agents|mesh-ancestor
65467710|NCT05525416|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65467711|NCT05525416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64719389|NCT03714919|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64719390|NCT03714919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64719391|NCT03714919|Anesthetics, General|anesthetics, general|mesh-ancestor
64719392|NCT03714919|Anesthetics|anesthetics|mesh-ancestor
64719393|NCT03714919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64709841|NCT02785406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65467712|NCT05525416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65467713|NCT05525416|Protective Agents|protective agents|mesh-ancestor
65467714|NCT05525416|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65467715|NCT05525416|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65467716|NCT05491512|Carboplatin|carboplatin|mesh-list
65467717|NCT05491512|Fluorouracil|fluorouracil|mesh-list
65467718|NCT05491512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467719|NCT05491512|Antimetabolites|antimetabolites|mesh-ancestor
65467720|NCT05491512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467721|NCT05491512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65467722|NCT05491512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65467723|NCT05491512|Immunologic Factors|immunologic factors|mesh-ancestor
65467724|NCT05491512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467725|NCT05449405|Chlorpheniramine|chlorpheniramine|mesh-list
65467726|NCT05449405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467727|NCT05449405|Antipruritics|antipruritics|mesh-ancestor
65467728|NCT05449405|Dermatologic Agents|dermatologic agents|mesh-ancestor
65467729|NCT05449405|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65467730|NCT05449405|Histamine Antagonists|histamine antagonists|mesh-ancestor
65467731|NCT05449405|Histamine Agents|histamine agents|mesh-ancestor
65467732|NCT05449405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65467733|NCT05449405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467734|NCT05449405|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65467736|NCT05432518|Dasatinib|dasatinib|mesh-list
64851841|NCT01619085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709842|NCT02785406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64709843|NCT02785406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709844|NCT02785406|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64709845|NCT02785406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64709846|NCT02785406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709847|NCT02062489|Tamoxifen|tamoxifen|mesh-list
64709848|NCT02062489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64709849|NCT02062489|Hormone Antagonists|hormone antagonists|mesh-ancestor
64709850|NCT02062489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64709851|NCT02062489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709852|NCT02062489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64709853|NCT02062489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709854|NCT02062489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64709855|NCT02062489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64709856|NCT02062489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64709857|NCT02780869|Thrombin|thrombin|mesh-list
64709858|NCT02780869|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
64709859|NCT02780869|Hemostatics|hemostatics|mesh-ancestor
64709860|NCT02780869|Coagulants|coagulants|mesh-ancestor
64709861|NCT02908490|Sildenafil Citrate|sildenafil citrate|mesh-list
64709862|NCT02908490|Vasodilator Agents|vasodilator agents|mesh-ancestor
64709863|NCT02908490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64709864|NCT02908490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65467737|NCT05432518|Olaparib|olaparib|mesh-list
65467738|NCT05432518|Palbociclib|palbociclib|mesh-list
65467739|NCT05432518|Afatinib|afatinib|mesh-list
65467740|NCT05432518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467741|NCT05432518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65467742|NCT05432518|Immunologic Factors|immunologic factors|mesh-ancestor
65467743|NCT05432518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467744|NCT05432518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65467745|NCT05432518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467746|NCT05432518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467747|NCT05432518|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65467748|NCT05412706|Niraparib|niraparib|mesh-list
65467749|NCT05412706|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65467750|NCT05412706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467751|NCT05412706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467752|NCT05412706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467753|NCT05407675|Nivolumab|nivolumab|mesh-list
65467754|NCT05407675|Ipilimumab|ipilimumab|mesh-list
64709865|NCT02908490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709899|NCT02888665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64709900|NCT02888665|Pembrolizumab|pembrolizumab|mesh-list
64709901|NCT02888665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64709902|NCT02888665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709903|NCT02888665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64709904|NCT02888665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64709905|NCT02888665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709906|NCT02888665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709907|NCT02888665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64709909|NCT02781571|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64709923|NCT02781649|Ribavirin|ribavirin|mesh-list
64709924|NCT02781649|Sofosbuvir|sofosbuvir|mesh-list
64709925|NCT02781649|Grazoprevir|grazoprevir|mesh-list
64709926|NCT02781649|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
64709927|NCT02781649|Antimetabolites|antimetabolites|mesh-ancestor
64709928|NCT02781649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709929|NCT02781649|Antiviral Agents|antiviral agents|mesh-ancestor
64709930|NCT02781649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64709931|NCT01821781|Fludarabine|fludarabine|mesh-list
64709932|NCT01821781|Melphalan|melphalan|mesh-list
64709933|NCT01821781|Alemtuzumab|alemtuzumab|mesh-list
64709934|NCT01821781|Thiotepa|thiotepa|mesh-list
64709935|NCT01821781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64719394|NCT03714919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64719395|NCT03714919|Antipyretics|antipyretics|mesh-ancestor
64719396|NCT03714919|Antitussive Agents|antitussive agents|mesh-ancestor
64719397|NCT03714919|Respiratory System Agents|respiratory system agents|mesh-ancestor
64719398|NCT00000872|Lamivudine|lamivudine|mesh-list
64719399|NCT00000872|Zidovudine|zidovudine|mesh-list
64719400|NCT00000872|Nevirapine|nevirapine|mesh-list
64719401|NCT00000872|Abacavir|abacavir|mesh-list
64719402|NCT00000872|Stavudine|stavudine|mesh-list
64719403|NCT00000872|Nelfinavir|nelfinavir|mesh-list
64719404|NCT00000872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64719405|NCT00000872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64719406|NCT00000872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719407|NCT00000872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719408|NCT00000872|Antiviral Agents|antiviral agents|mesh-ancestor
64327505|NCT02281045|Citric Acid|citric acid|mesh-list
64709936|NCT01821781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709937|NCT01821781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65467755|NCT05407675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65467756|NCT05407675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467757|NCT05407675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65467758|NCT05407675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467759|NCT05403385|Carboplatin|carboplatin|mesh-list
65467760|NCT05403385|Pemetrexed|pemetrexed|mesh-list
65467761|NCT05403385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467762|NCT05403385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467763|NCT05403385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467764|NCT05403385|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65467765|NCT05403385|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65467766|NCT05394740|Leucovorin|leucovorin|mesh-list
65467767|NCT05394740|Fluorouracil|fluorouracil|mesh-list
65467768|NCT05394740|Capecitabine|capecitabine|mesh-list
65467769|NCT05394740|Oxaliplatin|oxaliplatin|mesh-list
65467770|NCT05394740|Nivolumab|nivolumab|mesh-list
65467771|NCT05394740|Antimetabolites|antimetabolites|mesh-ancestor
65467772|NCT05394740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467773|NCT05394740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65467774|NCT05394740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467775|NCT05394740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65467776|NCT05394740|Immunologic Factors|immunologic factors|mesh-ancestor
65467777|NCT05394740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467778|NCT05394740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65467779|NCT05394740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65467780|NCT05394740|Antidotes|antidotes|mesh-ancestor
65467781|NCT05394740|Protective Agents|protective agents|mesh-ancestor
65467782|NCT05394740|Vitamin B Complex|vitamin b complex|mesh-ancestor
65467783|NCT05394740|Vitamins|vitamins|mesh-ancestor
64709938|NCT01821781|Immunologic Factors|immunologic factors|mesh-ancestor
64709939|NCT01821781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709940|NCT01821781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64709941|NCT01821781|Alkylating Agents|alkylating agents|mesh-ancestor
64709942|NCT01821781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64484578|NCT03839134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64945614|NCT05402553|Ondansetron|ondansetron|mesh-list
64945615|NCT05402553|Antiemetics|antiemetics|mesh-ancestor
64945616|NCT05402553|Autonomic Agents|autonomic agents|mesh-ancestor
64709943|NCT01821781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64709944|NCT02794844|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64435187|NCT02364947|Nalmefene|nalmefene|mesh-list
64709945|NCT02794844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709946|NCT02794844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709947|NCT02783443|Anesthetics|anesthetics|mesh-list
64709948|NCT02783443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64709949|NCT02783443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467784|NCT05394740|Micronutrients|micronutrients|mesh-ancestor
65467785|NCT05390021|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65467786|NCT05390021|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65467787|NCT05390021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467788|NCT05334056|Cocaine|cocaine|mesh-list
65467789|NCT05334056|Anesthetics, Local|anesthetics, local|mesh-ancestor
65467790|NCT05334056|Anesthetics|anesthetics|mesh-ancestor
65467791|NCT05334056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65467792|NCT05334056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467793|NCT05334056|Sensory System Agents|sensory system agents|mesh-ancestor
65467794|NCT05334056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467795|NCT05334056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65467796|NCT05334056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65467797|NCT05334056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65467798|NCT05334056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65467799|NCT05334056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851911|NCT01346787|Hormones|hormones|mesh-ancestor
64851914|NCT01254422|Vaccines|vaccines|mesh-list
64709950|NCT00373568|Miltefosine|miltefosine|mesh-list
64709961|NCT03002012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64709962|NCT03002012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64709963|NCT03002012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709964|NCT03002012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64709965|NCT03002012|Serotonin Agents|serotonin agents|mesh-ancestor
64709966|NCT03002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709967|NCT03002012|Antifungal Agents|antifungal agents|mesh-ancestor
64709968|NCT03002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64709977|NCT00373646|Thalidomide|thalidomide|mesh-list
64709978|NCT00373646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64709979|NCT00373646|Immunologic Factors|immunologic factors|mesh-ancestor
64709980|NCT00373646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709981|NCT00373646|Leprostatic Agents|leprostatic agents|mesh-ancestor
64709982|NCT00373646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64709983|NCT00373646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64709984|NCT00373646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64719409|NCT00000872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719410|NCT00000872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64719411|NCT00000872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64719412|NCT00000872|Antimetabolites|antimetabolites|mesh-ancestor
64719413|NCT00000872|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64719414|NCT00000872|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64719415|NCT00000872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64327512|NCT04472689|Lidocaine|lidocaine|mesh-list
64327513|NCT04472689|Anesthetics, Local|anesthetics, local|mesh-ancestor
64709985|NCT00373646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64709986|NCT00373646|Growth Substances|growth substances|mesh-ancestor
64709987|NCT00373646|Growth Inhibitors|growth inhibitors|mesh-ancestor
64709988|NCT00373646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709989|NCT03001453|Epinephrine|epinephrine|mesh-list
64709990|NCT03001453|Bupivacaine|bupivacaine|mesh-list
64709991|NCT03001453|Anesthetics, Local|anesthetics, local|mesh-ancestor
64709992|NCT03001453|Anesthetics|anesthetics|mesh-ancestor
64709993|NCT03001453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64709994|NCT03001453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709995|NCT03001453|Sensory System Agents|sensory system agents|mesh-ancestor
64709996|NCT03001453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467800|NCT05334056|Dopamine Agents|dopamine agents|mesh-ancestor
65467801|NCT05334056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65467802|NCT05299242|Adalimumab|adalimumab|mesh-list
65467803|NCT05299242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65467804|NCT05299242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65467805|NCT05273996|Bupropion|bupropion|mesh-list
65467806|NCT05273996|Sertraline|sertraline|mesh-list
65467807|NCT05273996|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65467808|NCT05273996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65467809|NCT05273996|Antidepressive Agents|antidepressive agents|mesh-ancestor
65467810|NCT05273996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65467811|NCT05273996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65467812|NCT05273996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65467813|NCT05273996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65467814|NCT05273996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467815|NCT05273996|Dopamine Agents|dopamine agents|mesh-ancestor
65467816|NCT05273996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65467817|NCT05273996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467818|NCT05273996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65467819|NCT05273996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65467820|NCT05273996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467821|NCT05273996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65467822|NCT05273996|Serotonin Agents|serotonin agents|mesh-ancestor
64851929|NCT01187433|Vaccines|vaccines|mesh-list
64709997|NCT03001453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64709998|NCT03001453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64709999|NCT03001453|Adrenergic Agents|adrenergic agents|mesh-ancestor
64710000|NCT03001453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64710001|NCT03001453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710002|NCT03001453|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64710003|NCT03001453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64710004|NCT03001453|Autonomic Agents|autonomic agents|mesh-ancestor
64710005|NCT03001453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64710006|NCT03001453|Respiratory System Agents|respiratory system agents|mesh-ancestor
64710007|NCT03001453|Mydriatics|mydriatics|mesh-ancestor
64710008|NCT03001453|Sympathomimetics|sympathomimetics|mesh-ancestor
64710009|NCT03001453|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64710010|NCT03001843|Ketamine|ketamine|mesh-list
64710011|NCT03001843|Narcotics|narcotics|mesh-list
64710012|NCT03001843|Analgesics|analgesics|mesh-ancestor
64710013|NCT03001843|Sensory System Agents|sensory system agents|mesh-ancestor
64710014|NCT03001843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710015|NCT03001843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945617|NCT05402553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710026|NCT02785159|Dermatologic Agents|dermatologic agents|mesh-ancestor
64710027|NCT02785159|Keratolytic Agents|keratolytic agents|mesh-ancestor
64710029|NCT02786719|Doxorubicin|doxorubicin|mesh-list
64710031|NCT02786719|Vincristine|vincristine|mesh-list
64710032|NCT02786719|Topotecan|topotecan|mesh-list
64710033|NCT02786719|Sargramostim|sargramostim|mesh-list
64710034|NCT02786719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64710035|NCT02786719|Immunologic Factors|immunologic factors|mesh-ancestor
65467823|NCT05273996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65467824|NCT05264025|Fexofenadine|fexofenadine|mesh-list
65467825|NCT05264025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65467826|NCT05264025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65467827|NCT05264025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65467828|NCT05264025|Histamine Antagonists|histamine antagonists|mesh-ancestor
65467829|NCT05264025|Histamine Agents|histamine agents|mesh-ancestor
65467830|NCT05264025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65467831|NCT05264025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467832|NCT05264025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467833|NCT05262244|Bevacizumab|bevacizumab|mesh-list
65467834|NCT05262244|Vedolizumab|vedolizumab|mesh-list
65467835|NCT05262244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65467836|NCT05262244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467837|NCT05262244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65467838|NCT05262244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65467839|NCT05262244|Growth Substances|growth substances|mesh-ancestor
65467840|NCT05262244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467841|NCT05262244|Growth Inhibitors|growth inhibitors|mesh-ancestor
65467842|NCT05262244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65467843|NCT05255666|Pembrolizumab|pembrolizumab|mesh-list
65467844|NCT05255666|Irinotecan|irinotecan|mesh-list
65467845|NCT05255666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65467846|NCT05255666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467847|NCT05255666|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65467848|NCT05255666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65467849|NCT05255666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467850|NCT05255666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467851|NCT05251948|Capecitabine|capecitabine|mesh-list
65467852|NCT05251948|Oxaliplatin|oxaliplatin|mesh-list
65467853|NCT05251948|Atezolizumab|atezolizumab|mesh-list
65467854|NCT05251948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65467855|NCT05251948|Antimetabolites|antimetabolites|mesh-ancestor
65467856|NCT05251948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467861|NCT05250011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65467862|NCT05250011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467863|NCT05244213|Paclitaxel|paclitaxel|mesh-list
65467864|NCT05244213|Carboplatin|carboplatin|mesh-list
65467865|NCT05244213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65467866|NCT05244213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467867|NCT05244213|Tubulin Modulators|tubulin modulators|mesh-ancestor
65467868|NCT05244213|Antimitotic Agents|antimitotic agents|mesh-ancestor
65467869|NCT05244213|Mitosis Modulators|mitosis modulators|mesh-ancestor
65467870|NCT05244213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467871|NCT05233956|Chrysarobin|chrysarobin|mesh-list
65467872|NCT05233956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65467873|NCT05233956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65467874|NCT05233956|Analgesics|analgesics|mesh-ancestor
65467875|NCT05233956|Sensory System Agents|sensory system agents|mesh-ancestor
65467876|NCT05233956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467877|NCT05233956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467878|NCT05233956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65467879|NCT05233956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65467880|NCT05231148|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65467881|NCT05231148|Calcium|calcium|mesh-list
65467882|NCT05231148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65467883|NCT05231148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467884|NCT05231148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65467885|NCT05219487|Risdiplam|risdiplam|mesh-list
65467886|NCT05219487|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65467887|NCT05219487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467888|NCT05219487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467889|NCT05198934|Trifluridine|trifluridine|mesh-list
65467890|NCT05198934|Panitumumab|panitumumab|mesh-list
65467891|NCT05198934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65467892|NCT05198934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467893|NCT05198934|Antimetabolites|antimetabolites|mesh-ancestor
65467894|NCT05198934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467895|NCT05198934|Antiviral Agents|antiviral agents|mesh-ancestor
65467896|NCT05198934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65467897|NCT05169112|Leuprolide|leuprolide|mesh-list
65467898|NCT05169112|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65467899|NCT05169112|Fertility Agents|fertility agents|mesh-ancestor
65467900|NCT05169112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65467901|NCT05169112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467902|NCT05169112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65467903|NCT05169112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467904|NCT05139420|Topiramate|topiramate|mesh-list
65467905|NCT05139420|Phentermine|phentermine|mesh-list
65467906|NCT05139420|Anticonvulsants|anticonvulsants|mesh-ancestor
65467907|NCT05139420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65467908|NCT05139420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467909|NCT05139420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65467910|NCT05139420|Appetite Depressants|appetite depressants|mesh-ancestor
65467911|NCT05139420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65467912|NCT05139420|Sympathomimetics|sympathomimetics|mesh-ancestor
65467913|NCT05139420|Autonomic Agents|autonomic agents|mesh-ancestor
65467914|NCT05139420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467915|NCT05139420|Adrenergic Agents|adrenergic agents|mesh-ancestor
65467916|NCT05139420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65467917|NCT05139420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710039|NCT02786719|Alkylating Agents|alkylating agents|mesh-ancestor
64710040|NCT02786719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710041|NCT02786719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64710042|NCT02786719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64710043|NCT02786719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64710044|NCT02786719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64710045|NCT02786719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64710046|NCT02786719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719416|NCT00000872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64719417|NCT00000872|Protease Inhibitors|protease inhibitors|mesh-ancestor
64719418|NCT00000878|Lamivudine|lamivudine|mesh-list
64719419|NCT00000878|Zidovudine|zidovudine|mesh-list
64719420|NCT00000878|Stavudine|stavudine|mesh-list
64719421|NCT00000878|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64327524|NCT02405013|Ribavirin|ribavirin|mesh-list
64710047|NCT02786719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64710048|NCT02786719|Tubulin Modulators|tubulin modulators|mesh-ancestor
64710049|NCT02786719|Antimitotic Agents|antimitotic agents|mesh-ancestor
64710050|NCT02786719|Mitosis Modulators|mitosis modulators|mesh-ancestor
64710051|NCT02786719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64710053|NCT03003949|Progesterone|progesterone|mesh-list
64710054|NCT03003949|Estrogens|estrogens|mesh-ancestor
64710055|NCT03003949|Hormones|hormones|mesh-ancestor
64710056|NCT03003949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64710057|NCT03003949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710058|NCT03003949|Progestins|progestins|mesh-ancestor
64710059|NCT03007225|Chlorotrianisene|chlorotrianisene|mesh-list
64710060|NCT03007225|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64710061|NCT03007225|Estrogens|estrogens|mesh-ancestor
64710062|NCT03007225|Hormones|hormones|mesh-ancestor
64710063|NCT03007225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64710064|NCT03007225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710065|NCT03007225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64710066|NCT03007225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64710067|NCT02800148|Azelaic acid|azelaic acid|mesh-list
65467918|NCT05137184|Fentanyl|fentanyl|mesh-list
65467919|NCT05137184|Morphine|morphine|mesh-list
65467920|NCT05137184|Methoxyflurane|methoxyflurane|mesh-list
65467921|NCT05137184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65467922|NCT05137184|Narcotics|narcotics|mesh-ancestor
65467923|NCT05137184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65467924|NCT05137184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467925|NCT05137184|Analgesics|analgesics|mesh-ancestor
65467926|NCT05137184|Sensory System Agents|sensory system agents|mesh-ancestor
65467927|NCT05137184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467928|NCT05137184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65467929|NCT05137184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65467930|NCT05137184|Anesthetics, General|anesthetics, general|mesh-ancestor
65467931|NCT05137184|Anesthetics|anesthetics|mesh-ancestor
65467932|NCT05137184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65467933|NCT05128734|Temozolomide|temozolomide|mesh-list
65467934|NCT05128734|Olaparib|olaparib|mesh-list
65467935|NCT05128734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65467936|NCT05128734|Alkylating Agents|alkylating agents|mesh-ancestor
65467937|NCT05128734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467938|NCT05128734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467939|NCT05128734|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65467940|NCT05128734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467941|NCT05097209|Gemcitabine|gemcitabine|mesh-list
65467942|NCT05097209|Cisplatin|cisplatin|mesh-list
65467943|NCT05097209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467944|NCT05097209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65467945|NCT05097209|Antimetabolites|antimetabolites|mesh-ancestor
65467946|NCT05097209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467947|NCT05097209|Antiviral Agents|antiviral agents|mesh-ancestor
65467948|NCT05097209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65467949|NCT05097209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467950|NCT05097209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64710068|NCT02800148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64710069|NCT02800148|Dermatologic Agents|dermatologic agents|mesh-ancestor
64710070|NCT02902081|Cannabidiol|cannabidiol|mesh-list
64710071|NCT02902081|Anticonvulsants|anticonvulsants|mesh-ancestor
64710072|NCT02791945|Acetylcysteine|acetylcysteine|mesh-list
64710073|NCT02791945|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64710074|NCT02791945|Antiviral Agents|antiviral agents|mesh-ancestor
64710075|NCT02791945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64710076|NCT02791945|Expectorants|expectorants|mesh-ancestor
64710077|NCT02791945|Respiratory System Agents|respiratory system agents|mesh-ancestor
64710078|NCT02791945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65467951|NCT05097209|Immunologic Factors|immunologic factors|mesh-ancestor
65467952|NCT05097209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467953|NCT05090384|Prednisone|prednisone|mesh-list
65467954|NCT05090384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65467955|NCT05090384|Glucocorticoids|glucocorticoids|mesh-ancestor
65467956|NCT05090384|Hormones|hormones|mesh-ancestor
65467957|NCT05090384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65467958|NCT05090384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467959|NCT05090384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65467960|NCT05090384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467961|NCT05069038|Palbociclib|palbociclib|mesh-list
65467962|NCT05069038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467963|NCT05069038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65467964|NCT05069038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467965|NCT05069038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467966|NCT05067998|Vitamins|vitamins|mesh-list
65467967|NCT05067998|Micronutrients|micronutrients|mesh-ancestor
65467968|NCT05067998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467969|NCT05065411|Everolimus|everolimus|mesh-list
65467970|NCT05065411|Fulvestrant|fulvestrant|mesh-list
65467971|NCT05065411|Exemestane|exemestane|mesh-list
65467972|NCT05065411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65467973|NCT05065411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65467974|NCT05065411|Immunologic Factors|immunologic factors|mesh-ancestor
65467975|NCT05065411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467976|NCT05065411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65467977|NCT05065411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65467978|NCT05065411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65467979|NCT05065411|Hormone Antagonists|hormone antagonists|mesh-ancestor
65467980|NCT05065411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65467981|NCT05065411|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65467982|NCT05065411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65467983|NCT05065411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65467984|NCT05065411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65467985|NCT05025293|Zoledronic Acid|zoledronic acid|mesh-list
64852082|NCT00579527|Antifungal Agents|antifungal agents|mesh-ancestor
64337714|NCT02580305|Cholinergic Agents|cholinergic agents|mesh-ancestor
64710079|NCT02791945|Antioxidants|antioxidants|mesh-ancestor
65467986|NCT05025293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65467987|NCT05025293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467988|NCT05021991|Pramoxine|pramoxine|mesh-list
65467989|NCT05021991|Anesthetics, Local|anesthetics, local|mesh-ancestor
65467990|NCT05021991|Anesthetics|anesthetics|mesh-ancestor
65467991|NCT05021991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65467992|NCT05021991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65467993|NCT05021991|Sensory System Agents|sensory system agents|mesh-ancestor
65467994|NCT05021991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65467995|NCT05001776|PENTA|penta|mesh-list
65467996|NCT05001776|Fondaparinux|fondaparinux|mesh-list
65467997|NCT05001776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65467998|NCT05001776|Antithrombins|antithrombins|mesh-ancestor
65467999|NCT05001776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65468000|NCT05001776|Protease Inhibitors|protease inhibitors|mesh-ancestor
65468001|NCT05001776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468002|NCT05001776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468003|NCT05001776|Anticoagulants|anticoagulants|mesh-ancestor
65468004|NCT05001776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65468005|NCT05001776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65468006|NCT04991974|Buprenorphine|buprenorphine|mesh-list
65468007|NCT04991974|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65468008|NCT04991974|Naloxone|naloxone|mesh-list
65468009|NCT04991974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65468010|NCT04991974|Narcotics|narcotics|mesh-ancestor
65468011|NCT04991974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65468012|NCT04991974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468013|NCT04991974|Analgesics|analgesics|mesh-ancestor
65468014|NCT04991974|Sensory System Agents|sensory system agents|mesh-ancestor
65468015|NCT04991974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65468016|NCT04991974|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65468017|NCT04977479|Vaccines|vaccines|mesh-list
65468018|NCT04977479|Immunologic Factors|immunologic factors|mesh-ancestor
65468019|NCT04977479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468020|NCT04971473|Hormones|hormones|mesh-list
65468027|NCT04943588|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
65468028|NCT04943588|Immunologic Factors|immunologic factors|mesh-ancestor
65468029|NCT04943588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468030|NCT04917692|Empagliflozin|empagliflozin|mesh-list
65468031|NCT04917692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65468032|NCT04917692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468033|NCT04917692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65468034|NCT04917692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468035|NCT04915248|Dexamethasone|dexamethasone|mesh-list
65468036|NCT04915248|Dexamethasone acetate|dexamethasone acetate|mesh-list
65468037|NCT04915248|Bortezomib|bortezomib|mesh-list
65468038|NCT04915248|Daratumumab|daratumumab|mesh-list
65468039|NCT04915248|BB 1101|bb 1101|mesh-list
65468040|NCT04915248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65468041|NCT04915248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65468042|NCT04915248|Antiemetics|antiemetics|mesh-ancestor
65468043|NCT04915248|Autonomic Agents|autonomic agents|mesh-ancestor
65468044|NCT04915248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65468045|NCT04915248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468046|NCT04915248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65468047|NCT04915248|Glucocorticoids|glucocorticoids|mesh-ancestor
65468048|NCT04915248|Hormones|hormones|mesh-ancestor
65468049|NCT04915248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65468050|NCT04915248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65468051|NCT04915248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468052|NCT04915248|Protease Inhibitors|protease inhibitors|mesh-ancestor
65468053|NCT04915248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468054|NCT04915248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468055|NCT04915248|Immunologic Factors|immunologic factors|mesh-ancestor
65468056|NCT04898114|Magnesium Sulfate|magnesium sulfate|mesh-list
65468057|NCT04898114|Sildenafil Citrate|sildenafil citrate|mesh-list
65468058|NCT04898114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468059|NCT04898114|Vasodilator Agents|vasodilator agents|mesh-ancestor
65468060|NCT04898114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64852156|NCT00379340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64710080|NCT02791945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710092|NCT02804594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64710094|NCT02804594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468061|NCT04898114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65468062|NCT04898114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468063|NCT04898114|Urological Agents|urological agents|mesh-ancestor
65468064|NCT04898114|Analgesics|analgesics|mesh-ancestor
65468065|NCT04898114|Sensory System Agents|sensory system agents|mesh-ancestor
65468066|NCT04898114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65468067|NCT04898114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468068|NCT04898114|Anesthetics|anesthetics|mesh-ancestor
65468069|NCT04898114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65468070|NCT04898114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65468071|NCT04898114|Anticonvulsants|anticonvulsants|mesh-ancestor
65468072|NCT04898114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65468073|NCT04898114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65468074|NCT04898114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65468075|NCT04898114|Tocolytic Agents|tocolytic agents|mesh-ancestor
65468076|NCT04898114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65468077|NCT04893785|Temozolomide|temozolomide|mesh-list
65468078|NCT04893785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65468079|NCT04893785|Alkylating Agents|alkylating agents|mesh-ancestor
65468080|NCT04893785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468081|NCT04893785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468082|NCT04881747|Lasmiditan|lasmiditan|mesh-list
65468083|NCT04881747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65468084|NCT04881747|Serotonin Agents|serotonin agents|mesh-ancestor
65468085|NCT04881747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65468086|NCT04881747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468087|NCT04881747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468088|NCT04862949|Bevacizumab|bevacizumab|mesh-list
65468089|NCT04862949|Atezolizumab|atezolizumab|mesh-list
65468090|NCT04862949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65468091|NCT04862949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468092|NCT04862949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65468093|NCT04862949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65468094|NCT04862949|Growth Substances|growth substances|mesh-ancestor
64852195|NCT01694134|Hormones|hormones|mesh-ancestor
64710095|NCT02804594|Protective Agents|protective agents|mesh-ancestor
64710096|NCT02804594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710097|NCT02804594|Antidotes|antidotes|mesh-ancestor
65468095|NCT04862949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468096|NCT04862949|Growth Inhibitors|growth inhibitors|mesh-ancestor
65468097|NCT04862663|Fulvestrant|fulvestrant|mesh-list
65468098|NCT04862663|Palbociclib|palbociclib|mesh-list
65468099|NCT04862663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65468100|NCT04862663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468101|NCT04862663|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65468102|NCT04862663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65468103|NCT04862663|Hormone Antagonists|hormone antagonists|mesh-ancestor
65468104|NCT04862663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65468105|NCT04862663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468106|NCT04862663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65468107|NCT04862663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468108|NCT04862663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710098|NCT00374192|Eszopiclone|eszopiclone|mesh-list
64710099|NCT00374192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64710100|NCT00374192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64710101|NCT00374192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710103|NCT02806544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64710104|NCT02806544|Hormone Antagonists|hormone antagonists|mesh-ancestor
64710105|NCT02806544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64710106|NCT02806544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710107|NCT02806544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64710113|NCT00374348|Antidepressive Agents|antidepressive agents|mesh-ancestor
64710114|NCT00374348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64710115|NCT00374348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64710116|NCT00374348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64719422|NCT00000878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64719423|NCT00000878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719424|NCT00000878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719425|NCT00000878|Antiviral Agents|antiviral agents|mesh-ancestor
64719426|NCT00000878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719427|NCT00000878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64719428|NCT00000878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64719429|NCT00000878|Antimetabolites|antimetabolites|mesh-ancestor
64710117|NCT00374348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64710118|NCT00374348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710119|NCT00374348|Dopamine Agonists|dopamine agonists|mesh-ancestor
64710120|NCT00374348|Dopamine Agents|dopamine agents|mesh-ancestor
64710121|NCT00374348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64710122|NCT00374348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710123|NCT00374348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64710124|NCT00374348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64710125|NCT00374348|Serotonin Agents|serotonin agents|mesh-ancestor
64710126|NCT00374348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64710127|NCT00374348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64710128|NCT00374348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64710129|NCT00374348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64710130|NCT02933372|Varenicline|varenicline|mesh-list
64710131|NCT02933372|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64710132|NCT02933372|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64710133|NCT02933372|Cholinergic Agents|cholinergic agents|mesh-ancestor
64710134|NCT02933372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64710135|NCT02933372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710136|NCT02933372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710137|NCT02902237|Thromboplastin|thromboplastin|mesh-list
64710138|NCT02902237|Hemostatics|hemostatics|mesh-ancestor
64710139|NCT02902237|Coagulants|coagulants|mesh-ancestor
65468109|NCT04848974|Cytarabine|cytarabine|mesh-list
65468110|NCT04848974|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
65468111|NCT04848974|Cladribine|cladribine|mesh-list
65468112|NCT04848974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65468113|NCT04848974|Antimetabolites|antimetabolites|mesh-ancestor
65468114|NCT04848974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468115|NCT04848974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468116|NCT04848974|Antiviral Agents|antiviral agents|mesh-ancestor
65468117|NCT04848974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65468118|NCT04848974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65468119|NCT04848974|Immunologic Factors|immunologic factors|mesh-ancestor
65468120|NCT04848974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468121|NCT04844866|Gemcitabine|gemcitabine|mesh-list
65468122|NCT04844866|Rituximab|rituximab|mesh-list
65468123|NCT04844866|Oxaliplatin|oxaliplatin|mesh-list
65468124|NCT04844866|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65468125|NCT04844866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65468126|NCT04844866|Immunoconjugates|immunoconjugates|mesh-list
65468127|NCT04844866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65468128|NCT04844866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468129|NCT04844866|Immunologic Factors|immunologic factors|mesh-ancestor
65468130|NCT04844866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468131|NCT04844866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65468132|NCT04844866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65468133|NCT04844866|Antimetabolites|antimetabolites|mesh-ancestor
65468134|NCT04844866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468135|NCT04844866|Antiviral Agents|antiviral agents|mesh-ancestor
65468136|NCT04844866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65468137|NCT04844866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468138|NCT04844866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65468139|NCT04844866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65468140|NCT04844866|Alkylating Agents|alkylating agents|mesh-ancestor
64852245|NCT01694498|Hemostatics|hemostatics|mesh-ancestor
64710155|NCT02903407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64710156|NCT02903407|Adrenergic Agents|adrenergic agents|mesh-ancestor
64710157|NCT02903407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64710158|NCT02903407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710159|NCT02903407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64710160|NCT02903407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64710161|NCT02903407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64710162|NCT02903407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64710163|NCT02903407|GABA Modulators|gaba modulators|mesh-ancestor
64710164|NCT02903407|GABA Agents|gaba agents|mesh-ancestor
65468141|NCT04840823|Enoxacin|enoxacin|mesh-list
65468142|NCT04840823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65468143|NCT04840823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65468144|NCT04840823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65468145|NCT04840823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65468146|NCT04840823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468147|NCT04840823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468148|NCT04840823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468149|NCT04840823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65468150|NCT04840823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65468151|NCT04825704|Bupivacaine|bupivacaine|mesh-list
65468152|NCT04825704|Anesthetics, Local|anesthetics, local|mesh-ancestor
65468153|NCT04825704|Anesthetics|anesthetics|mesh-ancestor
64852273|NCT01694797|Metoprolol|metoprolol|mesh-list
64710165|NCT02905981|Citric Acid|citric acid|mesh-list
64710166|NCT02905981|Sodium Citrate|sodium citrate|mesh-list
64710167|NCT02905981|Anticoagulants|anticoagulants|mesh-ancestor
64710168|NCT02905981|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64710169|NCT02905981|Chelating Agents|chelating agents|mesh-ancestor
64710170|NCT02905981|Sequestering Agents|sequestering agents|mesh-ancestor
64710171|NCT02905981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710172|NCT00374023|Vitamin A|vitamin a|mesh-list
64710173|NCT00374023|Vitamins|vitamins|mesh-ancestor
64710174|NCT00374023|Micronutrients|micronutrients|mesh-ancestor
64710175|NCT00374023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710176|NCT02812238|Niacinamide|niacinamide|mesh-list
64710177|NCT02812238|Niacin|niacin|mesh-list
64719430|NCT04218799|Chlorhexidine|chlorhexidine|mesh-list
64719431|NCT04218799|Mupirocin|mupirocin|mesh-list
64719432|NCT04218799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64719433|NCT04218799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719434|NCT04218799|Disinfectants|disinfectants|mesh-ancestor
64719435|NCT04218799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64719436|NCT04218799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64719437|NCT04218799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64710178|NCT02812238|Nicotinic Acids|nicotinic acids|mesh-list
64710179|NCT02812238|Vitamin B Complex|vitamin b complex|mesh-ancestor
64710195|NCT03018223|Mycophenolic Acid|mycophenolic acid|mesh-list
64710196|NCT03018223|Sirolimus|sirolimus|mesh-list
64710197|NCT03018223|Cyclophosphamide|cyclophosphamide|mesh-list
64710198|NCT03018223|Busulfan|busulfan|mesh-list
64710199|NCT03018223|Fludarabine|fludarabine|mesh-list
64710200|NCT03018223|Lenograstim|lenograstim|mesh-list
64710201|NCT03018223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64710202|NCT03018223|Immunologic Factors|immunologic factors|mesh-ancestor
64710203|NCT03018223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710204|NCT03018223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64710205|NCT03018223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64710206|NCT03018223|Alkylating Agents|alkylating agents|mesh-ancestor
64710207|NCT03018223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710208|NCT03018223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64710209|NCT03018223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64710210|NCT03018223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64710221|NCT03018925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64710222|NCT03018925|Immunologic Factors|immunologic factors|mesh-ancestor
64710223|NCT03018925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710224|NCT03019783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64710225|NCT03019783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64710226|NCT03019783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64710227|NCT03019783|Protease Inhibitors|protease inhibitors|mesh-ancestor
64710228|NCT03019783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64710229|NCT03019783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710230|NCT03019783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64710231|NCT03019783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65468154|NCT04825704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65468155|NCT04825704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468156|NCT04825704|Sensory System Agents|sensory system agents|mesh-ancestor
65468157|NCT04825704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65468158|NCT04781959|Lenograstim|lenograstim|mesh-list
65468159|NCT04781959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65468160|NCT04781959|Immunologic Factors|immunologic factors|mesh-ancestor
65468161|NCT04781959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468162|NCT04777851|Nivolumab|nivolumab|mesh-list
65468163|NCT04777851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65468164|NCT04777851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468165|NCT04777851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65468166|NCT04777851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468167|NCT04729608|Paclitaxel|paclitaxel|mesh-list
65468168|NCT04729608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65468169|NCT04729608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468170|NCT04729608|Tubulin Modulators|tubulin modulators|mesh-ancestor
65468171|NCT04729608|Antimitotic Agents|antimitotic agents|mesh-ancestor
65468172|NCT04729608|Mitosis Modulators|mitosis modulators|mesh-ancestor
65468173|NCT04729608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468174|NCT04712903|Carboplatin|carboplatin|mesh-list
65468175|NCT04712903|Etoposide|etoposide|mesh-list
65468176|NCT04712903|Durvalumab|durvalumab|mesh-list
65468177|NCT04712903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468178|NCT04712903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65468179|NCT04712903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65468180|NCT04712903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65468181|NCT04712903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468182|NCT04712903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468183|NCT04712903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65468184|NCT04710277|Analgesics, Opioid|analgesics, opioid|mesh-list
65468185|NCT04710277|Narcotics|narcotics|mesh-ancestor
65468186|NCT04710277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65468187|NCT04710277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468192|NCT04677049|Nicotinic Acids|nicotinic acids|mesh-list
65468193|NCT04677049|Vitamins|vitamins|mesh-ancestor
65468194|NCT04677049|Micronutrients|micronutrients|mesh-ancestor
65468195|NCT04677049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468196|NCT04677049|Vitamin B Complex|vitamin b complex|mesh-ancestor
65468197|NCT04677049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65468198|NCT04677049|Antimetabolites|antimetabolites|mesh-ancestor
65468199|NCT04677049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468200|NCT04677049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65468201|NCT04677049|Vasodilator Agents|vasodilator agents|mesh-ancestor
65468202|NCT04652245|Fluticasone|fluticasone|mesh-list
65468203|NCT04652245|Xhance|xhance|mesh-list
65468204|NCT04652245|Azelastine|azelastine|mesh-list
65468205|NCT04652245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65468206|NCT04652245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65468207|NCT04652245|Autonomic Agents|autonomic agents|mesh-ancestor
65468208|NCT04652245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65468209|NCT04652245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468210|NCT04652245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65468211|NCT04652245|Respiratory System Agents|respiratory system agents|mesh-ancestor
65468212|NCT04652245|Dermatologic Agents|dermatologic agents|mesh-ancestor
65468213|NCT04652245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65468214|NCT04652245|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65468215|NCT04652245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468216|NCT04652245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468217|NCT04652245|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65468218|NCT04652245|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65468219|NCT04652245|Histamine Antagonists|histamine antagonists|mesh-ancestor
65468220|NCT04652245|Histamine Agents|histamine agents|mesh-ancestor
65468222|NCT04642287|Fluorouracil|fluorouracil|mesh-list
65468239|NCT04595513|Sirolimus|sirolimus|mesh-list
65468240|NCT04595513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65468241|NCT04595513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65468242|NCT04595513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65468243|NCT04595513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468244|NCT04595513|Antifungal Agents|antifungal agents|mesh-ancestor
65468245|NCT04595513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65468246|NCT04595513|Immunologic Factors|immunologic factors|mesh-ancestor
65468247|NCT04595513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468248|NCT04592237|Carboplatin|carboplatin|mesh-list
65468249|NCT04592237|Niraparib|niraparib|mesh-list
65468250|NCT04592237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468251|NCT04592237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65468252|NCT04592237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468253|NCT04592237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468254|NCT04564339|Ravulizumab|ravulizumab|mesh-list
65468255|NCT04564339|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65468256|NCT04564339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65468257|NCT04564339|Immunologic Factors|immunologic factors|mesh-ancestor
65468258|NCT04564339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468259|NCT04543110|Durvalumab|durvalumab|mesh-list
65468260|NCT04543110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65468261|NCT04543110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468262|NCT04487652|Coenzyme Q10|coenzyme q10|mesh-list
65468263|NCT04487652|Vitamins|vitamins|mesh-ancestor
65468264|NCT04487652|Micronutrients|micronutrients|mesh-ancestor
65468265|NCT04487652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468266|NCT04454489|Pembrolizumab|pembrolizumab|mesh-list
65468267|NCT04454489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65468268|NCT04454489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468269|NCT04447183|Iodine|iodine|mesh-list
65468270|NCT04447183|Hormones|hormones|mesh-list
65468271|NCT04447183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64710232|NCT03019783|Antiviral Agents|antiviral agents|mesh-ancestor
64710233|NCT03019783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64710234|NCT03019939|Isavuconazole|isavuconazole|mesh-list
64710235|NCT03019939|Antifungal Agents|antifungal agents|mesh-ancestor
64710236|NCT03019939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64710237|NCT03020095|Ritonavir|ritonavir|mesh-list
64710238|NCT03020095|Ribavirin|ribavirin|mesh-list
64710239|NCT03020095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64710240|NCT03020095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64710241|NCT03020095|Protease Inhibitors|protease inhibitors|mesh-ancestor
65468272|NCT04447183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468273|NCT04447183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65468274|NCT04447183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65468275|NCT04447183|Trace Elements|trace elements|mesh-ancestor
65468276|NCT04447183|Micronutrients|micronutrients|mesh-ancestor
65468277|NCT04429334|Nangibotide|nangibotide|mesh-list
65468278|NCT04429334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65468279|NCT04421820|Leucovorin|leucovorin|mesh-list
65468280|NCT04421820|Fluorouracil|fluorouracil|mesh-list
65468281|NCT04421820|Oxaliplatin|oxaliplatin|mesh-list
65468282|NCT04421820|Antimetabolites|antimetabolites|mesh-ancestor
65468283|NCT04421820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468284|NCT04421820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65468285|NCT04421820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468286|NCT04421820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65468287|NCT04421820|Immunologic Factors|immunologic factors|mesh-ancestor
65468288|NCT04421820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468289|NCT04421820|Antidotes|antidotes|mesh-ancestor
65468290|NCT04421820|Protective Agents|protective agents|mesh-ancestor
65468291|NCT04421820|Vitamin B Complex|vitamin b complex|mesh-ancestor
65468292|NCT04421820|Vitamins|vitamins|mesh-ancestor
65468293|NCT04421820|Micronutrients|micronutrients|mesh-ancestor
65468294|NCT04408443|Vitamin D|vitamin d|mesh-list
65468295|NCT04408443|Cholecalciferol|cholecalciferol|mesh-list
65468296|NCT04408443|Vitamins|vitamins|mesh-ancestor
65468297|NCT04408443|Micronutrients|micronutrients|mesh-ancestor
65468298|NCT04408443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468299|NCT04408443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64852396|NCT01696110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852397|NCT01696110|Antithrombins|antithrombins|mesh-ancestor
64852398|NCT01696110|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64852399|NCT01696110|Protease Inhibitors|protease inhibitors|mesh-ancestor
64852400|NCT01696110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64710257|NCT03021343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64710258|NCT03021343|Tubulin Modulators|tubulin modulators|mesh-ancestor
64710259|NCT03021343|Antimitotic Agents|antimitotic agents|mesh-ancestor
64710260|NCT03021343|Mitosis Modulators|mitosis modulators|mesh-ancestor
64710261|NCT03021343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710262|NCT03021343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64710263|NCT03025945|Nepafenac|nepafenac|mesh-list
64710264|NCT03025945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64710265|NCT03025945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64710266|NCT03025945|Analgesics|analgesics|mesh-ancestor
64710267|NCT03025945|Sensory System Agents|sensory system agents|mesh-ancestor
65468300|NCT04408443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65468301|NCT04396457|Pembrolizumab|pembrolizumab|mesh-list
65468302|NCT04396457|Pemetrexed|pemetrexed|mesh-list
65468303|NCT04396457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65468304|NCT04396457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468305|NCT04396457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468306|NCT04396457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468307|NCT04396457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65468308|NCT04396457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65468309|NCT04380740|Abatacept|abatacept|mesh-list
65468310|NCT04380740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65468311|NCT04380740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468312|NCT04380740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468313|NCT04380740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65468314|NCT04380740|Immunologic Factors|immunologic factors|mesh-ancestor
65468315|NCT04380740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468316|NCT04380740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65468317|NCT04377204|Lidocaine|lidocaine|mesh-list
65468318|NCT04377204|Bupivacaine|bupivacaine|mesh-list
65468319|NCT04377204|Anesthetics, Local|anesthetics, local|mesh-ancestor
65468320|NCT04377204|Anesthetics|anesthetics|mesh-ancestor
65468321|NCT04377204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65468322|NCT04377204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468323|NCT04377204|Sensory System Agents|sensory system agents|mesh-ancestor
65468324|NCT04377204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65468325|NCT04377204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65468326|NCT04377204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65468327|NCT04377204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65468328|NCT04377204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65468329|NCT04377204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468330|NCT04349267|Nivolumab|nivolumab|mesh-list
65468331|NCT04349267|Cetuximab|cetuximab|mesh-list
65468332|NCT04349267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64710268|NCT03025945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710269|NCT03025945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719438|NCT04218799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719440|NCT04204057|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
64719441|NCT04204057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468333|NCT04349267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468334|NCT04349267|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65468335|NCT04349267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468336|NCT04346589|Antibodies|antibodies|mesh-list
65468337|NCT04346589|Immunoglobulins|immunoglobulins|mesh-list
65468338|NCT04346589|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65468339|NCT04346589|Immunologic Factors|immunologic factors|mesh-ancestor
65468340|NCT04346589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468341|NCT04331067|Paclitaxel|paclitaxel|mesh-list
65468342|NCT04331067|Carboplatin|carboplatin|mesh-list
65468343|NCT04331067|Nivolumab|nivolumab|mesh-list
65468344|NCT04331067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65468345|NCT04331067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468346|NCT04331067|Tubulin Modulators|tubulin modulators|mesh-ancestor
65468347|NCT04331067|Antimitotic Agents|antimitotic agents|mesh-ancestor
65468348|NCT04331067|Mitosis Modulators|mitosis modulators|mesh-ancestor
65468349|NCT04331067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468350|NCT04331067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65468351|NCT04331067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65468352|NCT04329221|Calcitriol|calcitriol|mesh-list
65468353|NCT04329221|Fluorouracil|fluorouracil|mesh-list
64852459|NCT01696552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64852460|NCT01696552|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64852461|NCT01696552|Histamine Antagonists|histamine antagonists|mesh-ancestor
64852462|NCT01696552|Histamine Agents|histamine agents|mesh-ancestor
64852463|NCT01696552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64852464|NCT01696552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852465|NCT01696552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719442|NCT04204057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719443|NCT00001736|Cysteamine|cysteamine|mesh-list
64719444|NCT00001736|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
64710270|NCT03025945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64710271|NCT03025945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64710272|NCT02937506|Fentanyl|fentanyl|mesh-list
64710273|NCT02937506|Midazolam|midazolam|mesh-list
64710274|NCT02937506|Propofol|propofol|mesh-list
64710275|NCT02937506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64710276|NCT02937506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64710277|NCT02937506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710278|NCT02937506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64710279|NCT02937506|Anesthetics, General|anesthetics, general|mesh-ancestor
64710280|NCT02937506|Anesthetics|anesthetics|mesh-ancestor
64710281|NCT02937506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64710282|NCT02937506|Narcotics|narcotics|mesh-ancestor
64710283|NCT02937506|Analgesics|analgesics|mesh-ancestor
64710284|NCT02937506|Sensory System Agents|sensory system agents|mesh-ancestor
64710285|NCT02937506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65468354|NCT04329221|Calcipotriene|calcipotriene|mesh-list
65468355|NCT04329221|Petrolatum|petrolatum|mesh-list
65468356|NCT04329221|Antimetabolites|antimetabolites|mesh-ancestor
65468357|NCT04329221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468358|NCT04329221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65468359|NCT04329221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468360|NCT04329221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65468361|NCT04329221|Immunologic Factors|immunologic factors|mesh-ancestor
65468362|NCT04329221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468363|NCT04329221|Dermatologic Agents|dermatologic agents|mesh-ancestor
65468364|NCT04329221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65468365|NCT04329221|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64852479|NCT01696617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852480|NCT01696617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64852481|NCT01696617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64852482|NCT01696617|Serotonin Agents|serotonin agents|mesh-ancestor
64337738|NCT01616303|Carboplatin|carboplatin|mesh-list
64710309|NCT03022526|Anesthetics, Local|anesthetics, local|mesh-ancestor
64710310|NCT03022526|Anesthetics|anesthetics|mesh-ancestor
64710311|NCT03022526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64710312|NCT03022526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710313|NCT03022526|Sensory System Agents|sensory system agents|mesh-ancestor
64710314|NCT03022526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710315|NCT03022526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64710316|NCT03022526|Narcotics|narcotics|mesh-ancestor
64710317|NCT03022526|Analgesics|analgesics|mesh-ancestor
64710318|NCT03022526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64710319|NCT03022526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64710320|NCT03022526|Anesthetics, General|anesthetics, general|mesh-ancestor
64710321|NCT02794441|Dexamethasone|dexamethasone|mesh-list
64710322|NCT02794441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64435562|NCT04666701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64710324|NCT02794441|Autonomic Agents|autonomic agents|mesh-ancestor
64710325|NCT02794441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710326|NCT02794441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710327|NCT02794441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64710328|NCT02794441|Glucocorticoids|glucocorticoids|mesh-ancestor
64710329|NCT02794441|Hormones|hormones|mesh-ancestor
64710330|NCT02794441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64710331|NCT02794441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64710332|NCT02794441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64710333|NCT02941640|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64710334|NCT02941640|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64710335|NCT02941640|beta-Endorphin|beta-endorphin|mesh-list
64710336|NCT02941640|Hormones|hormones|mesh-ancestor
64719445|NCT00001736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719446|NCT00000884|polysaccharide-K|polysaccharide-k|mesh-list
64719447|NCT00000884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64719448|NCT00000884|Immunologic Factors|immunologic factors|mesh-ancestor
64719449|NCT00000884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719450|NCT00000884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64719451|NCT00000884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327547|NCT02283775|Glucocorticoids|glucocorticoids|mesh-ancestor
64327548|NCT02283775|Hormones|hormones|mesh-ancestor
64327551|NCT02283775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64710337|NCT02941640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64337780|NCT02264015|Moxifloxacin|moxifloxacin|mesh-list
65468366|NCT04329221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65468367|NCT04329221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65468368|NCT04329221|Vitamins|vitamins|mesh-ancestor
65468369|NCT04329221|Micronutrients|micronutrients|mesh-ancestor
65468370|NCT04329221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65468371|NCT04329221|Emollients|emollients|mesh-ancestor
65468372|NCT04324840|Temozolomide|temozolomide|mesh-list
65468373|NCT04324840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65468374|NCT04324840|Alkylating Agents|alkylating agents|mesh-ancestor
65468375|NCT04324840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468376|NCT04324840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468377|NCT04316013|Lidocaine|lidocaine|mesh-list
65468378|NCT04316013|Propofol|propofol|mesh-list
65468379|NCT04316013|Sevoflurane|sevoflurane|mesh-list
65468380|NCT04316013|Anesthetics, Local|anesthetics, local|mesh-ancestor
65468381|NCT04316013|Anesthetics|anesthetics|mesh-ancestor
65468382|NCT04316013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65468383|NCT04316013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468384|NCT04316013|Sensory System Agents|sensory system agents|mesh-ancestor
65468385|NCT04316013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65468386|NCT04316013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65468387|NCT04316013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65468388|NCT04316013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65468389|NCT04316013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65468390|NCT04316013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468391|NCT04316013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65468392|NCT04316013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65468393|NCT04316013|Anesthetics, General|anesthetics, general|mesh-ancestor
65468394|NCT04316013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64852491|NCT01696630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64852492|NCT01696630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852493|NCT01696656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64852494|NCT01696656|Gastrointestinal Agents|gastrointestinal agents|mesh-list
64852496|NCT01696799|Econazole|econazole|mesh-list
64710344|NCT02823080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64710345|NCT02823080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710346|NCT02823080|Hormone Antagonists|hormone antagonists|mesh-ancestor
64710347|NCT02823080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64710348|NCT03022916|Efinaconazole|efinaconazole|mesh-list
65468395|NCT04316013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65468396|NCT04312594|Acetylcysteine|acetylcysteine|mesh-list
65468397|NCT04312594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65468398|NCT04312594|Antiviral Agents|antiviral agents|mesh-ancestor
65468399|NCT04312594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65468400|NCT04312594|Expectorants|expectorants|mesh-ancestor
65468401|NCT04312594|Respiratory System Agents|respiratory system agents|mesh-ancestor
65468402|NCT04312594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65468403|NCT04312594|Antioxidants|antioxidants|mesh-ancestor
65468404|NCT04312594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468405|NCT04312594|Protective Agents|protective agents|mesh-ancestor
65468406|NCT04312594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468407|NCT04312594|Antidotes|antidotes|mesh-ancestor
65468408|NCT04270474|Cholinergic Antagonists|cholinergic antagonists|mesh-list
64852518|NCT01696825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64852519|NCT01696825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64852520|NCT01696825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64852521|NCT01696825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64852522|NCT01696825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64852523|NCT01696825|Anesthetics, General|anesthetics, general|mesh-ancestor
64852524|NCT01696825|Anesthetics|anesthetics|mesh-ancestor
64710349|NCT03022916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64710350|NCT03022916|Antifungal Agents|antifungal agents|mesh-ancestor
64710351|NCT03022916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64710352|NCT03031795|Ketorolac|ketorolac|mesh-list
64710353|NCT03031795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64710354|NCT03031795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64710355|NCT03031795|Analgesics|analgesics|mesh-ancestor
64710356|NCT03031795|Sensory System Agents|sensory system agents|mesh-ancestor
64710357|NCT03031795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710358|NCT03031795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710359|NCT03031795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64710360|NCT03031795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64710361|NCT03031795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64710362|NCT03031795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64710363|NCT03031795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710364|NCT02942654|Insulin Lispro|insulin lispro|mesh-list
64710365|NCT02942654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64710366|NCT02942654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710367|NCT02909959|Sulforaphane|sulforaphane|mesh-list
64710368|NCT02909959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64710369|NCT02909959|Protective Agents|protective agents|mesh-ancestor
64710375|NCT00373802|Mydriatics|mydriatics|mesh-ancestor
64710376|NCT00373802|Autonomic Agents|autonomic agents|mesh-ancestor
64710377|NCT00373802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710378|NCT00373802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710379|NCT00373802|Sympathomimetics|sympathomimetics|mesh-ancestor
64710380|NCT00373802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64710381|NCT00373802|Nasal Decongestants|nasal decongestants|mesh-ancestor
64710382|NCT00373802|Respiratory System Agents|respiratory system agents|mesh-ancestor
64710383|NCT00373802|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64710384|NCT00373802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64710385|NCT00373802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64710386|NCT00373802|Adrenergic Agents|adrenergic agents|mesh-ancestor
64710387|NCT00373802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65468409|NCT04270474|Cholinergic Agents|cholinergic agents|mesh-ancestor
65468410|NCT04270474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65468411|NCT04270474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468412|NCT04270474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468413|NCT04264897|Metformin|metformin|mesh-list
65468414|NCT04264897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65468415|NCT04264897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468416|NCT04254107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65468417|NCT04254107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65468418|NCT04254107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468419|NCT04225026|Manganese|manganese|mesh-list
65468420|NCT04225026|Avasopasem manganese|avasopasem manganese|mesh-list
65468421|NCT04225026|Trace Elements|trace elements|mesh-ancestor
65468422|NCT04225026|Micronutrients|micronutrients|mesh-ancestor
65468423|NCT04225026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468424|NCT04225026|Antioxidants|antioxidants|mesh-ancestor
64852535|NCT01697020|Immunologic Factors|immunologic factors|mesh-ancestor
64710388|NCT00373802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710389|NCT00373802|Protective Agents|protective agents|mesh-ancestor
64710390|NCT02945150|Grazoprevir|grazoprevir|mesh-list
64710391|NCT02945150|Antiviral Agents|antiviral agents|mesh-ancestor
64710392|NCT02945150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64710393|NCT03032965|Adenosine|adenosine|mesh-list
64710394|NCT03032965|Isoproterenol|isoproterenol|mesh-list
64710395|NCT03032965|Analgesics|analgesics|mesh-ancestor
64710396|NCT03032965|Sensory System Agents|sensory system agents|mesh-ancestor
64719452|NCT00000884|Antiviral Agents|antiviral agents|mesh-ancestor
64719453|NCT00000884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719454|NCT00000884|Interferon Inducers|interferon inducers|mesh-ancestor
64719455|NCT00000884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64719456|NCT00000884|Protective Agents|protective agents|mesh-ancestor
64710397|NCT03032965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710398|NCT03032965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710399|NCT03032965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64710400|NCT03032965|Vasodilator Agents|vasodilator agents|mesh-ancestor
64710401|NCT03032965|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64710402|NCT03032965|Purinergic Agonists|purinergic agonists|mesh-ancestor
64710403|NCT03032965|Purinergic Agents|purinergic agents|mesh-ancestor
64710404|NCT03032965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64710417|NCT02948426|Antiviral Agents|antiviral agents|mesh-ancestor
64710418|NCT02948426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64710419|NCT03030638|Olodaterol|olodaterol|mesh-list
64710420|NCT03030638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64710421|NCT03030638|Autonomic Agents|autonomic agents|mesh-ancestor
64710422|NCT03030638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710423|NCT03030638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710424|NCT03030638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64710425|NCT03030638|Respiratory System Agents|respiratory system agents|mesh-ancestor
64710426|NCT02949674|Bupivacaine|bupivacaine|mesh-list
64710427|NCT02949674|Ropivacaine|ropivacaine|mesh-list
64710428|NCT02949674|Anesthetics, Local|anesthetics, local|mesh-ancestor
64710429|NCT02949674|Anesthetics|anesthetics|mesh-ancestor
64710430|NCT02949674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64710431|NCT02949674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710432|NCT02949674|Sensory System Agents|sensory system agents|mesh-ancestor
64710433|NCT02949674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710434|NCT03033511|Dexamethasone|dexamethasone|mesh-list
64710435|NCT03033511|Dexamethasone acetate|dexamethasone acetate|mesh-list
64710436|NCT03033511|BB 1101|bb 1101|mesh-list
64710437|NCT03033511|Immunoconjugates|immunoconjugates|mesh-list
65468425|NCT04225026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468426|NCT04225026|Protective Agents|protective agents|mesh-ancestor
65468427|NCT04177108|Paclitaxel|paclitaxel|mesh-list
65468428|NCT04177108|Atezolizumab|atezolizumab|mesh-list
65468429|NCT04177108|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65468430|NCT04177108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65468431|NCT04177108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468432|NCT04177108|Tubulin Modulators|tubulin modulators|mesh-ancestor
65468433|NCT04177108|Antimitotic Agents|antimitotic agents|mesh-ancestor
65468434|NCT04177108|Mitosis Modulators|mitosis modulators|mesh-ancestor
65468435|NCT04177108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468436|NCT04177108|Immunologic Factors|immunologic factors|mesh-ancestor
65468437|NCT04177108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468438|NCT04140513|Deoxyglucose|deoxyglucose|mesh-list
65468439|NCT04140513|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65468440|NCT04140513|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65468441|NCT04140513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852547|NCT01697046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64710438|NCT03033511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64710439|NCT03033511|Antiemetics|antiemetics|mesh-ancestor
64710440|NCT03033511|Autonomic Agents|autonomic agents|mesh-ancestor
64710441|NCT03033511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710450|NCT03033511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64710451|NCT03033511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710452|NCT03033511|Immunologic Factors|immunologic factors|mesh-ancestor
64710454|NCT02951312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64710455|NCT02951312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64710456|NCT02951312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64710457|NCT02951312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64710458|NCT02951312|Cholinergic Agents|cholinergic agents|mesh-ancestor
64710459|NCT02951312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64710460|NCT02951312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710461|NCT02951312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710462|NCT03035929|Dexamethasone|dexamethasone|mesh-list
64710463|NCT03035929|Dexamethasone acetate|dexamethasone acetate|mesh-list
64710464|NCT03035929|BB 1101|bb 1101|mesh-list
64710465|NCT03035929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64710466|NCT03035929|Antiemetics|antiemetics|mesh-ancestor
64710467|NCT03035929|Autonomic Agents|autonomic agents|mesh-ancestor
64710468|NCT03035929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710469|NCT03035929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710470|NCT03035929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64710471|NCT03035929|Glucocorticoids|glucocorticoids|mesh-ancestor
64719458|NCT00000896|Zidovudine|zidovudine|mesh-list
64719459|NCT00000896|Nevirapine|nevirapine|mesh-list
64719460|NCT00000896|Stavudine|stavudine|mesh-list
64719461|NCT00000896|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64719462|NCT00000896|Indinavir|indinavir|mesh-list
64719463|NCT00000896|Interleukin-12|interleukin-12|mesh-list
64719464|NCT00000896|Sargramostim|sargramostim|mesh-list
64710497|NCT02953886|Protective Agents|protective agents|mesh-ancestor
64710498|NCT02953886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710499|NCT02802241|Peppermint oil|peppermint oil|mesh-list
64710500|NCT02802241|Antiemetics|antiemetics|mesh-ancestor
64710501|NCT02802241|Autonomic Agents|autonomic agents|mesh-ancestor
64710502|NCT02802241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710503|NCT02802241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710504|NCT02802241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65468442|NCT04140513|Antimetabolites|antimetabolites|mesh-ancestor
65468443|NCT04140513|Antiviral Agents|antiviral agents|mesh-ancestor
65468444|NCT04140513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65468445|NCT04111627|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65468446|NCT04111627|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65468447|NCT04111627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65468448|NCT04111627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65468449|NCT04111627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468450|NCT04111627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65468451|NCT04111627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468452|NCT04111627|Analgesics|analgesics|mesh-ancestor
65468453|NCT04111627|Sensory System Agents|sensory system agents|mesh-ancestor
65468454|NCT04111627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65468455|NCT04111627|Antidepressive Agents|antidepressive agents|mesh-ancestor
65468456|NCT04111627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65468457|NCT04111627|Dopamine Agents|dopamine agents|mesh-ancestor
65468458|NCT04090710|Nivolumab|nivolumab|mesh-list
65468459|NCT04090710|Ipilimumab|ipilimumab|mesh-list
65468460|NCT04090710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65468461|NCT04090710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468462|NCT04090710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64852563|NCT01697098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64710505|NCT02802241|Parasympatholytics|parasympatholytics|mesh-ancestor
64710506|NCT03035708|Varenicline|varenicline|mesh-list
64710507|NCT03035708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64710509|NCT03035708|Cholinergic Agents|cholinergic agents|mesh-ancestor
64710510|NCT03035708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64710511|NCT03035708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710512|NCT03035708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710513|NCT00374426|Sertraline|sertraline|mesh-list
64710514|NCT00374426|Antidepressive Agents|antidepressive agents|mesh-ancestor
64710515|NCT00374426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64710516|NCT00374426|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64710517|NCT00374426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64710518|NCT00374426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64710519|NCT00374426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710520|NCT00374426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64710521|NCT00374426|Serotonin Agents|serotonin agents|mesh-ancestor
64710535|NCT02954198|Hormones|hormones|mesh-ancestor
64719465|NCT00000896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64719466|NCT00000896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64719468|NCT00000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719469|NCT00000896|Antiviral Agents|antiviral agents|mesh-ancestor
64719470|NCT00000896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719471|NCT00000896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64719472|NCT00000896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64710536|NCT02954198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64710537|NCT02954198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710538|NCT02954198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64710539|NCT02954198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468463|NCT04090710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468464|NCT04085445|Paclitaxel|paclitaxel|mesh-list
65468465|NCT04085445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65468466|NCT04085445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468467|NCT04085445|Tubulin Modulators|tubulin modulators|mesh-ancestor
65468468|NCT04085445|Antimitotic Agents|antimitotic agents|mesh-ancestor
65468469|NCT04085445|Mitosis Modulators|mitosis modulators|mesh-ancestor
65468470|NCT04085445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468471|NCT04069312|Azithromycin|azithromycin|mesh-list
65468472|NCT04069312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65468473|NCT04069312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65468474|NCT03983954|Durvalumab|durvalumab|mesh-list
65468475|NCT03983954|Obinutuzumab|obinutuzumab|mesh-list
64852591|NCT01697228|Vitamin D|vitamin d|mesh-list
64710540|NCT02954198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64710541|NCT02954198|Immunologic Factors|immunologic factors|mesh-ancestor
64710542|NCT02954198|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64710543|NCT02954198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64710544|NCT02954198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710545|NCT02954198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64710546|NCT02954198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64945620|NCT05402553|Antipruritics|antipruritics|mesh-ancestor
64710547|NCT02954198|Antitubercular Agents|antitubercular agents|mesh-ancestor
64710548|NCT02954198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64710549|NCT02954198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64710550|NCT02954198|Antiemetics|antiemetics|mesh-ancestor
64710551|NCT02954198|Autonomic Agents|autonomic agents|mesh-ancestor
64710552|NCT02954198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710553|NCT02954198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64710554|NCT02954198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64710555|NCT02954198|Protective Agents|protective agents|mesh-ancestor
64710556|NCT02956070|Dexamethasone|dexamethasone|mesh-list
64710557|NCT02956070|Dexamethasone acetate|dexamethasone acetate|mesh-list
64710559|NCT02956070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64710560|NCT02956070|Antiemetics|antiemetics|mesh-ancestor
64710561|NCT02956070|Autonomic Agents|autonomic agents|mesh-ancestor
64710562|NCT02956070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710563|NCT02956070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710564|NCT02956070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64710565|NCT02956070|Glucocorticoids|glucocorticoids|mesh-ancestor
64710566|NCT02956070|Hormones|hormones|mesh-ancestor
64710567|NCT02956070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64710568|NCT02956070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64710569|NCT02956070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64710570|NCT02956070|Protease Inhibitors|protease inhibitors|mesh-ancestor
64710571|NCT02956070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64710572|NCT02956070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710573|NCT02956616|Ketorolac|ketorolac|mesh-list
64710574|NCT02956616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64710575|NCT02956616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64710576|NCT02956616|Analgesics|analgesics|mesh-ancestor
64710577|NCT02956616|Sensory System Agents|sensory system agents|mesh-ancestor
64337836|NCT01495013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64710594|NCT05829603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710596|NCT05829551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64710597|NCT05829551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64710598|NCT05829551|Protease Inhibitors|protease inhibitors|mesh-ancestor
64710599|NCT05829551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719476|NCT00000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64719477|NCT00000896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64719478|NCT00000896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65468476|NCT03983954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65468477|NCT03983954|Immunoconjugates|immunoconjugates|mesh-list
65468478|NCT03983954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65468479|NCT03983954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468480|NCT03983954|Immunologic Factors|immunologic factors|mesh-ancestor
65468481|NCT03983954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468482|NCT03982277|Rifampin|rifampin|mesh-list
65468483|NCT03982277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65468484|NCT03982277|Antitubercular Agents|antitubercular agents|mesh-ancestor
65468485|NCT03982277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65468486|NCT03982277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65468487|NCT03982277|Leprostatic Agents|leprostatic agents|mesh-ancestor
65468488|NCT03982277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65468489|NCT03982277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468490|NCT03982277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468491|NCT03982277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65468492|NCT03982277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65468493|NCT03982277|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65468494|NCT03982277|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65468495|NCT03982277|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65468496|NCT03982277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65468497|NCT03940352|Venetoclax|venetoclax|mesh-list
65468498|NCT03940352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468499|NCT03918499|Cyclophosphamide|cyclophosphamide|mesh-list
65468500|NCT03918499|Pembrolizumab|pembrolizumab|mesh-list
65468501|NCT03918499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65468502|NCT03918499|Immunologic Factors|immunologic factors|mesh-ancestor
64719479|NCT00000896|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64719480|NCT00000896|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64719481|NCT00000896|Protease Inhibitors|protease inhibitors|mesh-ancestor
64719482|NCT00000896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64327571|NCT02281201|Coagulants|coagulants|mesh-ancestor
64710600|NCT05829551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710601|NCT05829551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64710602|NCT05829551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64710603|NCT05829551|Antiviral Agents|antiviral agents|mesh-ancestor
64710604|NCT05829551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64710605|NCT05829551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64710606|NCT05829551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64710607|NCT05829499|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64710608|NCT05829499|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64710609|NCT05829460|Progestins|progestins|mesh-list
64710610|NCT05829460|Hormones|hormones|mesh-ancestor
64710611|NCT05829460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64710612|NCT05829460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710613|NCT05829434|Cytarabine|cytarabine|mesh-list
65468503|NCT03918499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468504|NCT03918499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65468505|NCT03918499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65468506|NCT03918499|Alkylating Agents|alkylating agents|mesh-ancestor
65468507|NCT03918499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468508|NCT03918499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468509|NCT03918499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65468510|NCT03918499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65468511|NCT03914443|Cisplatin|cisplatin|mesh-list
65468512|NCT03914443|Docetaxel|docetaxel|mesh-list
65468513|NCT03914443|Fluorouracil|fluorouracil|mesh-list
65468514|NCT03914443|Nivolumab|nivolumab|mesh-list
65468515|NCT03914443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468516|NCT03914443|Tubulin Modulators|tubulin modulators|mesh-ancestor
65468517|NCT03914443|Antimitotic Agents|antimitotic agents|mesh-ancestor
65468518|NCT03914443|Mitosis Modulators|mitosis modulators|mesh-ancestor
65468519|NCT03914443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468520|NCT03914443|Antimetabolites|antimetabolites|mesh-ancestor
65468521|NCT03914443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65468522|NCT03914443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65468523|NCT03914443|Immunologic Factors|immunologic factors|mesh-ancestor
65468524|NCT03914443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468525|NCT03914443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65468526|NCT03914443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65468527|NCT03815890|Nivolumab|nivolumab|mesh-list
65468528|NCT03815890|Ipilimumab|ipilimumab|mesh-list
65468529|NCT03815890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65468530|NCT03815890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468531|NCT03815890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65468532|NCT03815890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468533|NCT03794583|Treprostinil|treprostinil|mesh-list
65468534|NCT03794583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65468535|NCT03777657|Capecitabine|capecitabine|mesh-list
64710614|NCT05829434|Magrolimab|magrolimab|mesh-list
64710615|NCT05829434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64710616|NCT05829434|Antimetabolites|antimetabolites|mesh-ancestor
64710617|NCT05829434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710618|NCT05829434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64710619|NCT05829434|Antiviral Agents|antiviral agents|mesh-ancestor
64710620|NCT05829434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64945621|NCT05402553|Dermatologic Agents|dermatologic agents|mesh-ancestor
65468536|NCT03777657|Oxaliplatin|oxaliplatin|mesh-list
65468537|NCT03777657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468538|NCT03777657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65468539|NCT03777657|Antimetabolites|antimetabolites|mesh-ancestor
65468540|NCT03777657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468541|NCT03711474|Dexamethasone|dexamethasone|mesh-list
65468542|NCT03711474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65468543|NCT03711474|Antiemetics|antiemetics|mesh-ancestor
65468544|NCT03711474|Autonomic Agents|autonomic agents|mesh-ancestor
65468545|NCT03711474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65468546|NCT03711474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468547|NCT03711474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65468548|NCT03711474|Glucocorticoids|glucocorticoids|mesh-ancestor
65468549|NCT03711474|Hormones|hormones|mesh-ancestor
65468550|NCT03711474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65468551|NCT03711474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65468552|NCT03711474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468553|NCT03675893|Metformin|metformin|mesh-list
65468554|NCT03675893|Letrozole|letrozole|mesh-list
65468555|NCT03675893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65468556|NCT03675893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468557|NCT03675893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468558|NCT03675893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65468559|NCT03675893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65468560|NCT03675893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468561|NCT03675893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468562|NCT03675893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65468563|NCT03675893|Hormone Antagonists|hormone antagonists|mesh-ancestor
65468564|NCT03675893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65468565|NCT03622788|Cyclophosphamide|cyclophosphamide|mesh-list
65468566|NCT03622788|Fludarabine|fludarabine|mesh-list
65468567|NCT03622788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65468568|NCT03622788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65468569|NCT03622788|Immunologic Factors|immunologic factors|mesh-ancestor
65468570|NCT03622788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468571|NCT03622788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65468573|NCT03622788|Alkylating Agents|alkylating agents|mesh-ancestor
65468574|NCT03622788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468575|NCT03622788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468576|NCT03622788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65468577|NCT03482024|Tirzepatide|tirzepatide|mesh-list
65468578|NCT03482024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65468579|NCT03482024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468580|NCT03482024|Incretins|incretins|mesh-ancestor
65468581|NCT03482024|Hormones|hormones|mesh-ancestor
65468582|NCT03482024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65468583|NCT03423199|Tamoxifen|tamoxifen|mesh-list
65468584|NCT03423199|Goserelin|goserelin|mesh-list
65468585|NCT03423199|Palbociclib|palbociclib|mesh-list
65468586|NCT03423199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65468587|NCT03423199|Hormone Antagonists|hormone antagonists|mesh-ancestor
64852698|NCT01697787|Artemether|artemether|mesh-list
64945622|NCT05402553|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64710621|NCT05829434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64710622|NCT05829434|Immunologic Factors|immunologic factors|mesh-ancestor
64710623|NCT05829434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710624|NCT05829434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64710628|NCT05829317|Magnesium Sulfate|magnesium sulfate|mesh-list
64710629|NCT05829317|Analgesics|analgesics|mesh-ancestor
64710630|NCT05829317|Sensory System Agents|sensory system agents|mesh-ancestor
64710631|NCT05829317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710632|NCT05829317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710633|NCT05829317|Anesthetics|anesthetics|mesh-ancestor
64710634|NCT05829317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64710635|NCT05829317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64710636|NCT05829317|Anticonvulsants|anticonvulsants|mesh-ancestor
64710637|NCT05829317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64710638|NCT05829317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64337866|NCT01481051|Latanoprost|latanoprost|mesh-list
64710672|NCT05829148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64710673|NCT05829148|Antioxidants|antioxidants|mesh-ancestor
64710674|NCT05829148|Protective Agents|protective agents|mesh-ancestor
64710675|NCT05829057|Interleukin-2|interleukin-2|mesh-list
64719483|NCT00000896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64719484|NCT00000896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64719486|NCT00000896|Growth Inhibitors|growth inhibitors|mesh-ancestor
64719487|NCT00001790|Micafungin|micafungin|mesh-list
64719488|NCT00001790|Antifungal Agents|antifungal agents|mesh-ancestor
64719489|NCT00001790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719490|NCT00000902|Ritonavir|ritonavir|mesh-list
64719491|NCT00000902|Nelfinavir|nelfinavir|mesh-list
64719492|NCT00000902|Lamivudine|lamivudine|mesh-list
64719493|NCT00000902|Zidovudine|zidovudine|mesh-list
64719494|NCT00000902|Nevirapine|nevirapine|mesh-list
64719495|NCT00000902|Stavudine|stavudine|mesh-list
64719496|NCT00000902|Didanosine|didanosine|mesh-list
64719497|NCT00000902|Zalcitabine|zalcitabine|mesh-list
64719498|NCT00000902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64719499|NCT00000902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64719500|NCT00000902|Protease Inhibitors|protease inhibitors|mesh-ancestor
64327582|NCT02281279|Growth Substances|growth substances|mesh-ancestor
64710676|NCT05829057|Antibodies|antibodies|mesh-list
64710677|NCT05829057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64710678|NCT05829057|Immunologic Factors|immunologic factors|mesh-ancestor
64710679|NCT05829057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710680|NCT05829057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64710681|NCT05829057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64710682|NCT05829057|Analgesics|analgesics|mesh-ancestor
64710683|NCT05829057|Sensory System Agents|sensory system agents|mesh-ancestor
64710684|NCT05829057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710685|NCT05829044|Melatonin|melatonin|mesh-list
65468588|NCT03423199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65468589|NCT03423199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468590|NCT03423199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65468591|NCT03423199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468592|NCT03423199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65468593|NCT03423199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65468594|NCT03423199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65468595|NCT03423199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65468596|NCT03423199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468597|NCT03423199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468598|NCT03423147|Chlorhexidine|chlorhexidine|mesh-list
65468599|NCT03423147|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65468600|NCT03423147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65468601|NCT03423147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65468602|NCT03423147|Disinfectants|disinfectants|mesh-ancestor
65468603|NCT03423147|Dermatologic Agents|dermatologic agents|mesh-ancestor
65468604|NCT03418532|Osimertinib|osimertinib|mesh-list
65468605|NCT03418532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468606|NCT03418532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65468607|NCT03418532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852714|NCT01697826|Miconazole|miconazole|mesh-list
64710686|NCT05829044|Antioxidants|antioxidants|mesh-ancestor
64710687|NCT05829044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710688|NCT05829044|Protective Agents|protective agents|mesh-ancestor
64710689|NCT05829044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710690|NCT05829044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64710691|NCT05828966|Magnesium Sulfate|magnesium sulfate|mesh-list
64710692|NCT05828966|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64710693|NCT05828966|Analgesics|analgesics|mesh-ancestor
64710694|NCT05828966|Sensory System Agents|sensory system agents|mesh-ancestor
64710695|NCT05828966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710696|NCT05828966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710713|NCT05828836|Allopurinol|allopurinol|mesh-list
64710714|NCT05828836|Antimetabolites|antimetabolites|mesh-ancestor
64710730|NCT05828550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64710731|NCT05828550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64710749|NCT05828381|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64710750|NCT05828381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64710768|NCT05828199|Dexmedetomidine|dexmedetomidine|mesh-list
64710770|NCT05828199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64710771|NCT05828199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64710772|NCT05828199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710773|NCT05828199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64710774|NCT05828199|Analgesics|analgesics|mesh-ancestor
64710775|NCT05828199|Sensory System Agents|sensory system agents|mesh-ancestor
64710776|NCT05828199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710777|NCT05828199|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64710778|NCT05828199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64710779|NCT05828199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64436015|NCT04877639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64710781|NCT05828199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64710791|NCT05828147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468608|NCT03418532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468609|NCT03417401|Plasminogen|plasminogen|mesh-list
65468610|NCT03417401|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65468611|NCT03417401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65468612|NCT03417401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65468613|NCT03417401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468614|NCT03391973|Pembrolizumab|pembrolizumab|mesh-list
65468615|NCT03391973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65468616|NCT03391973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468617|NCT03322631|Tirzepatide|tirzepatide|mesh-list
65468618|NCT03322631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65468619|NCT03322631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468620|NCT03322631|Incretins|incretins|mesh-ancestor
65468621|NCT03322631|Hormones|hormones|mesh-ancestor
65468622|NCT03322631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65468623|NCT03290612|Ascorbic Acid|ascorbic acid|mesh-list
65468624|NCT03290612|Vitamins|vitamins|mesh-ancestor
65468625|NCT03290612|Micronutrients|micronutrients|mesh-ancestor
65468626|NCT03290612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468627|NCT03290612|Antioxidants|antioxidants|mesh-ancestor
65468628|NCT03290612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468629|NCT03290612|Protective Agents|protective agents|mesh-ancestor
65468630|NCT03262142|Ciprofloxacin|ciprofloxacin|mesh-list
65468631|NCT03262142|Tazobactam|tazobactam|mesh-list
65468632|NCT03262142|Piperacillin|piperacillin|mesh-list
65468633|NCT03262142|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65468634|NCT03262142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65468635|NCT03262142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65468636|NCT03262142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65468637|NCT03262142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65468638|NCT03262142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468639|NCT03262142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710792|NCT05828147|Immunologic Factors|immunologic factors|mesh-ancestor
64710793|NCT05828147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710794|NCT05828147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64710795|NCT05828095|MEDI9197|medi9197|mesh-list
64710796|NCT05828095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64710797|NCT05828095|Immunologic Factors|immunologic factors|mesh-ancestor
64710798|NCT05828095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710799|NCT05827991|Minoxidil|minoxidil|mesh-list
64710800|NCT05827991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64710801|NCT05827991|Vasodilator Agents|vasodilator agents|mesh-ancestor
64710802|NCT05827978|Vaccines|vaccines|mesh-list
64710803|NCT05827978|Immunologic Factors|immunologic factors|mesh-ancestor
65468640|NCT03262142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468641|NCT03262142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65468642|NCT03262142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65468643|NCT03262142|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65468644|NCT03161522|Fluorouracil|fluorouracil|mesh-list
65468645|NCT03161522|Capecitabine|capecitabine|mesh-list
65468646|NCT03161522|Antimetabolites|antimetabolites|mesh-ancestor
65468647|NCT03161522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468648|NCT03161522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65468649|NCT03161522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468650|NCT03161522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65468651|NCT03161522|Immunologic Factors|immunologic factors|mesh-ancestor
65468652|NCT03161522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468653|NCT03086642|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
65468654|NCT03086642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65468655|NCT03086642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852767|NCT01698541|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64710804|NCT05827978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710805|NCT05827874|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64710806|NCT05827874|Immunologic Factors|immunologic factors|mesh-ancestor
64710807|NCT05827874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710808|NCT05827796|Gemcitabine|gemcitabine|mesh-list
64710809|NCT05827796|Paclitaxel|paclitaxel|mesh-list
64710810|NCT05827796|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64710811|NCT05827796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64710812|NCT05827796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64710813|NCT05827796|Tubulin Modulators|tubulin modulators|mesh-ancestor
64710814|NCT05827796|Antimitotic Agents|antimitotic agents|mesh-ancestor
64710815|NCT05827796|Mitosis Modulators|mitosis modulators|mesh-ancestor
64710835|NCT05827705|Autonomic Agents|autonomic agents|mesh-ancestor
64710836|NCT05827705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710837|NCT05827705|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64710838|NCT05827705|Adrenergic Agents|adrenergic agents|mesh-ancestor
64710839|NCT05827705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64337993|NCT00156065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710840|NCT05827705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710841|NCT05827705|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64710842|NCT05827705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64710843|NCT05827705|Respiratory System Agents|respiratory system agents|mesh-ancestor
64710844|NCT05827705|Nasal Decongestants|nasal decongestants|mesh-ancestor
64710850|NCT05827497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64710851|NCT05827497|Abortifacient Agents|abortifacient agents|mesh-ancestor
64710852|NCT05827497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64710853|NCT05827497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710854|NCT05827497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64710855|NCT05827497|Antimetabolites|antimetabolites|mesh-ancestor
64710856|NCT05827497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710857|NCT05827497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64710858|NCT05827497|Dermatologic Agents|dermatologic agents|mesh-ancestor
64710859|NCT05827497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64710860|NCT05827497|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64710868|NCT05827484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64710869|NCT05827484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64710870|NCT05827484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468656|NCT03057795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65468657|NCT03057795|Nivolumab|nivolumab|mesh-list
65468658|NCT03057795|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65468659|NCT03057795|Antibodies|antibodies|mesh-list
65468660|NCT03057795|Immunoglobulins|immunoglobulins|mesh-list
65468661|NCT03057795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65468662|NCT03057795|Immunoconjugates|immunoconjugates|mesh-list
65468663|NCT03057795|Immunologic Factors|immunologic factors|mesh-ancestor
65468664|NCT03057795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468665|NCT03057795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468666|NCT03057795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65468667|NCT03057795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468668|NCT03018704|Topiramate|topiramate|mesh-list
65468669|NCT03018704|Anticonvulsants|anticonvulsants|mesh-ancestor
65468670|NCT03018704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65468671|NCT03018704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468672|NCT03012529|Riboflavin|riboflavin|mesh-list
65468673|NCT03012529|Rifampin|rifampin|mesh-list
65468674|NCT03012529|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65468675|NCT03012529|Antitubercular Agents|antitubercular agents|mesh-ancestor
65468676|NCT03012529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65468677|NCT03012529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65468679|NCT03012529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65468680|NCT03012529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468681|NCT03012529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468682|NCT03012529|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65468683|NCT03012529|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65468684|NCT03012529|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64710871|NCT05827263|Salicylic Acid|salicylic acid|mesh-list
64710872|NCT05827263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719506|NCT00000902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719507|NCT00000902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64719508|NCT00000902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64719509|NCT00000902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64719510|NCT00000902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64719511|NCT00000902|Antimetabolites|antimetabolites|mesh-ancestor
64719512|NCT00000902|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64719513|NCT00000902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64719514|NCT04331600|Chloroquine|chloroquine|mesh-list
64710876|NCT05826119|Magnesium Sulfate|magnesium sulfate|mesh-list
64710877|NCT05826119|Analgesics|analgesics|mesh-ancestor
64710878|NCT05826119|Sensory System Agents|sensory system agents|mesh-ancestor
64710879|NCT05826119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710880|NCT05826119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710881|NCT05826119|Anesthetics|anesthetics|mesh-ancestor
64710882|NCT05826119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65468685|NCT03012529|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65468686|NCT03012529|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65468687|NCT03012529|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65468688|NCT03012529|Vitamin B Complex|vitamin b complex|mesh-ancestor
65468689|NCT03012529|Vitamins|vitamins|mesh-ancestor
65468690|NCT03012529|Micronutrients|micronutrients|mesh-ancestor
65468691|NCT03012529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468692|NCT03012529|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65468693|NCT03012529|Dermatologic Agents|dermatologic agents|mesh-ancestor
65468694|NCT02978612|Capecitabine|capecitabine|mesh-list
65468695|NCT02978612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65468696|NCT02978612|Antimetabolites|antimetabolites|mesh-ancestor
65468697|NCT02978612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468698|NCT02978612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468699|NCT02970500|Methylphenidate|methylphenidate|mesh-list
65468700|NCT02970500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65468701|NCT02970500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468702|NCT02970500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65468703|NCT02970500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65468704|NCT02970500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65468705|NCT02970500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468706|NCT02970500|Dopamine Agents|dopamine agents|mesh-ancestor
65468707|NCT02970500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65468708|NCT02951130|Milrinone|milrinone|mesh-list
65468709|NCT02951130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65468710|NCT02951130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64710883|NCT05826119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64710884|NCT05826119|Anticonvulsants|anticonvulsants|mesh-ancestor
64710885|NCT05826119|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64710886|NCT05826119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64710887|NCT05826119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710888|NCT05826119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64710889|NCT05826119|Tocolytic Agents|tocolytic agents|mesh-ancestor
64710890|NCT05826119|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64710891|NCT05825443|Paclitaxel|paclitaxel|mesh-list
64710892|NCT05825443|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64710893|NCT05825443|Cisplatin|cisplatin|mesh-list
64710894|NCT05825443|Carboplatin|carboplatin|mesh-list
64710895|NCT05825443|Pemetrexed|pemetrexed|mesh-list
64710896|NCT05825443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64710897|NCT05825443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64710898|NCT05825443|Tubulin Modulators|tubulin modulators|mesh-ancestor
64710899|NCT05825443|Antimitotic Agents|antimitotic agents|mesh-ancestor
64710900|NCT05825443|Mitosis Modulators|mitosis modulators|mesh-ancestor
64710901|NCT05825443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710902|NCT05825443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468711|NCT02951130|Vasodilator Agents|vasodilator agents|mesh-ancestor
65468712|NCT02951130|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65468713|NCT02951130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65468714|NCT02951130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468715|NCT02951130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468716|NCT02951130|Protective Agents|protective agents|mesh-ancestor
65468717|NCT02951130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468718|NCT02810743|Olaparib|olaparib|mesh-list
65468719|NCT02810743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65468720|NCT02810743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468721|NCT02810743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468722|NCT02810743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468723|NCT02704858|Perillyl alcohol|perillyl alcohol|mesh-list
65468724|NCT02704858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468725|NCT02704858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468726|NCT02704858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468727|NCT02617407|Listerine|listerine|mesh-list
65468728|NCT02617407|Sodium Fluoride|sodium fluoride|mesh-list
65468729|NCT02617407|Cariostatic Agents|cariostatic agents|mesh-ancestor
65468730|NCT02617407|Protective Agents|protective agents|mesh-ancestor
65468731|NCT02617407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468732|NCT02617407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65468733|NCT02617407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65468734|NCT02537509|Cholecalciferol|cholecalciferol|mesh-list
65468735|NCT02537509|Vitamin D|vitamin d|mesh-list
65468736|NCT02537509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64710903|NCT05825443|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64710904|NCT05825443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64710905|NCT05824299|Anesthetics|anesthetics|mesh-list
64710906|NCT05824299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64710907|NCT05824299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710908|NCT05822934|Gemcitabine|gemcitabine|mesh-list
64710909|NCT05822934|Carboplatin|carboplatin|mesh-list
64710910|NCT05822934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64710911|NCT05822934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64710912|NCT05822934|Antimetabolites|antimetabolites|mesh-ancestor
64710913|NCT05822934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710914|NCT05822934|Antiviral Agents|antiviral agents|mesh-ancestor
64710915|NCT05822934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64710916|NCT05822934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64710917|NCT05822934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64710918|NCT05822934|Immunologic Factors|immunologic factors|mesh-ancestor
64710927|NCT05821972|Sensory System Agents|sensory system agents|mesh-ancestor
64710928|NCT05821972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64338011|NCT04476173|Analgesics|analgesics|mesh-ancestor
64719518|NCT04331600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64719519|NCT04331600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719520|NCT04331600|Antimalarials|antimalarials|mesh-ancestor
65468737|NCT02537509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468738|NCT02537509|Vitamins|vitamins|mesh-ancestor
65468739|NCT02537509|Micronutrients|micronutrients|mesh-ancestor
65468740|NCT02537509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65468741|NCT02490878|Bevacizumab|bevacizumab|mesh-list
65468742|NCT02490878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65468743|NCT02490878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468744|NCT02490878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65468745|NCT02490878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65468746|NCT02490878|Growth Substances|growth substances|mesh-ancestor
64719521|NCT04331600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64327612|NCT00501709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710937|NCT05821972|Anesthetics, General|anesthetics, general|mesh-ancestor
64710939|NCT05821972|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64710940|NCT05821972|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64710942|NCT05821296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64710943|NCT05821296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710944|NCT05821296|Sympathomimetics|sympathomimetics|mesh-ancestor
64710945|NCT05821296|Autonomic Agents|autonomic agents|mesh-ancestor
64710946|NCT05821296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710947|NCT05821296|Dopamine Agents|dopamine agents|mesh-ancestor
64710948|NCT05821296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64710949|NCT05821296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710950|NCT05821296|Adrenergic Agents|adrenergic agents|mesh-ancestor
64710951|NCT05821296|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64710952|NCT05821296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64710953|NCT05821296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64711002|NCT05784753|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
64711005|NCT05784753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711017|NCT05774236|Oxytocics|oxytocics|mesh-ancestor
64711018|NCT05774236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64711019|NCT05774236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711021|NCT05757544|Neurosteroids|neurosteroids|mesh-ancestor
64711022|NCT05757544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64711023|NCT05757544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711024|NCT05757544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711025|NCT05757544|GABA Modulators|gaba modulators|mesh-ancestor
64711026|NCT05757544|GABA Agents|gaba agents|mesh-ancestor
64711027|NCT05750745|Fluorides|fluorides|mesh-list
64711028|NCT05750745|Cariostatic Agents|cariostatic agents|mesh-ancestor
64711029|NCT05750745|Protective Agents|protective agents|mesh-ancestor
64711030|NCT05750745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711031|NCT05748587|Iron|iron|mesh-list
64711032|NCT05748587|Deferoxamine|deferoxamine|mesh-list
64711033|NCT05748587|Trace Elements|trace elements|mesh-ancestor
64711034|NCT05748587|Micronutrients|micronutrients|mesh-ancestor
64711035|NCT05748587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711036|NCT05748587|Siderophores|siderophores|mesh-ancestor
64711037|NCT05748587|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64711038|NCT05748587|Chelating Agents|chelating agents|mesh-ancestor
64711039|NCT05748587|Sequestering Agents|sequestering agents|mesh-ancestor
64711040|NCT05748587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945624|NCT05402553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64711074|NCT05709990|Vitamins|vitamins|mesh-ancestor
64711075|NCT05709990|Micronutrients|micronutrients|mesh-ancestor
64711076|NCT05709990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711077|NCT05709990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64711078|NCT05709990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64711079|NCT05709990|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64711080|NCT05709990|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64711081|NCT05709990|Cholinergic Agents|cholinergic agents|mesh-ancestor
64711082|NCT05709990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64338034|NCT01355393|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
64711092|NCT05700903|Hormones|hormones|mesh-list
64711093|NCT05700903|Androgens|androgens|mesh-list
65468747|NCT02490878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468748|NCT02490878|Growth Inhibitors|growth inhibitors|mesh-ancestor
65468749|NCT02411656|Pembrolizumab|pembrolizumab|mesh-list
65468750|NCT02411656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65468751|NCT02411656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468752|NCT02359175|Acetaminophen|acetaminophen|mesh-list
65468753|NCT02359175|Fentanyl|fentanyl|mesh-list
65468754|NCT02359175|Analgesics, Opioid|analgesics, opioid|mesh-list
65468755|NCT02359175|Bupivacaine|bupivacaine|mesh-list
65468756|NCT02359175|Anesthetics, Local|anesthetics, local|mesh-ancestor
65468757|NCT02359175|Anesthetics|anesthetics|mesh-ancestor
65468758|NCT02359175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65468759|NCT02359175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468760|NCT02359175|Sensory System Agents|sensory system agents|mesh-ancestor
65468761|NCT02359175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65468762|NCT02359175|Narcotics|narcotics|mesh-ancestor
65468763|NCT02359175|Analgesics|analgesics|mesh-ancestor
65468764|NCT02359175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65468765|NCT02359175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65468766|NCT02359175|Anesthetics, General|anesthetics, general|mesh-ancestor
65468767|NCT02359175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65468768|NCT02359175|Antipyretics|antipyretics|mesh-ancestor
65468769|NCT02332850|Dexamethasone|dexamethasone|mesh-list
64711094|NCT05700903|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
64711095|NCT05700903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64711096|NCT05700903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711097|NCT05700903|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64711098|NCT05700903|Fertility Agents|fertility agents|mesh-ancestor
64711099|NCT05700903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64711100|NCT05700903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64711101|NCT05700903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711102|NCT05700903|Androgen Antagonists|androgen antagonists|mesh-ancestor
64711103|NCT05700903|Hormone Antagonists|hormone antagonists|mesh-ancestor
64711104|NCT05698381|Acetic Acid|acetic acid|mesh-list
64711105|NCT05698381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64711106|NCT05698381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64711107|NCT05691465|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64711108|NCT05691465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711109|NCT05691465|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64711110|NCT05689021|Prednisone|prednisone|mesh-list
64711111|NCT05689021|Cortisone|cortisone|mesh-list
64711112|NCT05689021|Abiraterone Acetate|abiraterone acetate|mesh-list
64711113|NCT05689021|Niraparib|niraparib|mesh-list
64711114|NCT05689021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64711115|NCT05689021|Glucocorticoids|glucocorticoids|mesh-ancestor
64711116|NCT05689021|Hormones|hormones|mesh-ancestor
64711117|NCT05689021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64711118|NCT05689021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711119|NCT05689021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64711120|NCT05689021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711121|NCT05689021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64711122|NCT05689021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64711123|NCT05689021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711124|NCT05689021|Hormone Antagonists|hormone antagonists|mesh-ancestor
65468770|NCT02332850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65468771|NCT02332850|Antiemetics|antiemetics|mesh-ancestor
65468772|NCT02332850|Autonomic Agents|autonomic agents|mesh-ancestor
65468773|NCT02332850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65468774|NCT02332850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468775|NCT02332850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65468776|NCT02332850|Glucocorticoids|glucocorticoids|mesh-ancestor
65468777|NCT02332850|Hormones|hormones|mesh-ancestor
65468778|NCT02332850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65468779|NCT02332850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65468780|NCT02332850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468781|NCT02310321|Cytarabine|cytarabine|mesh-list
65468782|NCT02310321|Idarubicin|idarubicin|mesh-list
65468783|NCT02310321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65468784|NCT02310321|Antimetabolites|antimetabolites|mesh-ancestor
65468785|NCT02310321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468786|NCT02310321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468787|NCT02310321|Antiviral Agents|antiviral agents|mesh-ancestor
65468788|NCT02310321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65468789|NCT02310321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65468790|NCT02310321|Immunologic Factors|immunologic factors|mesh-ancestor
65468791|NCT02310321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468792|NCT02310321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65468793|NCT02310321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65468794|NCT02310321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65468795|NCT02310321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64711125|NCT05689021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64711126|NCT05689021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64711127|NCT05683535|Atropine|atropine|mesh-list
64338048|NCT01348919|Antiemetics|antiemetics|mesh-ancestor
64711128|NCT05683535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64711129|NCT05683535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64711130|NCT05683535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64711131|NCT05683535|Autonomic Agents|autonomic agents|mesh-ancestor
64711132|NCT05683535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64711133|NCT05683535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711134|NCT05683535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64711135|NCT05683535|Respiratory System Agents|respiratory system agents|mesh-ancestor
64711136|NCT05683535|Mydriatics|mydriatics|mesh-ancestor
64711137|NCT05683535|Parasympatholytics|parasympatholytics|mesh-ancestor
64711138|NCT05683535|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64711139|NCT05683535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64711161|NCT05675319|Pomalidomide|pomalidomide|mesh-list
64711162|NCT05675319|Ixazomib|ixazomib|mesh-list
64719528|NCT04331600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64719529|NCT04331600|Filaricides|filaricides|mesh-ancestor
64719530|NCT04331600|Antinematodal Agents|antinematodal agents|mesh-ancestor
64719531|NCT04331600|Anthelmintics|anthelmintics|mesh-ancestor
64719532|NCT00000188|Selegiline|selegiline|mesh-list
64719533|NCT00000188|Antidepressive Agents|antidepressive agents|mesh-ancestor
65468796|NCT02262325|Etoposide|etoposide|mesh-list
65468797|NCT02262325|Etoposide phosphate|etoposide phosphate|mesh-list
65468798|NCT02262325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468799|NCT02262325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65468800|NCT02262325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65468801|NCT02262325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65468802|NCT02262325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468803|NCT02262325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468804|NCT02205762|Cytarabine|cytarabine|mesh-list
65468805|NCT02205762|Prednisone|prednisone|mesh-list
65468806|NCT02205762|Indomethacin|indomethacin|mesh-list
65468807|NCT02205762|Methotrexate|methotrexate|mesh-list
65468808|NCT02205762|Mercaptopurine|mercaptopurine|mesh-list
65468809|NCT02205762|Vinblastine|vinblastine|mesh-list
65468810|NCT02205762|Cladribine|cladribine|mesh-list
65468811|NCT02205762|Immunoglobulins|immunoglobulins|mesh-list
65468812|NCT02205762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65468813|NCT02205762|gamma-Globulins|gamma-globulins|mesh-list
65468814|NCT02205762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65468815|NCT02205762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65468816|NCT02205762|Glucocorticoids|glucocorticoids|mesh-ancestor
65468817|NCT02205762|Hormones|hormones|mesh-ancestor
65468818|NCT02205762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65468819|NCT02205762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719534|NCT00000188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64719535|NCT00000188|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64719536|NCT00000188|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64719537|NCT00000188|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64711163|NCT05675319|Elotuzumab|elotuzumab|mesh-list
64711164|NCT05675319|BB 1101|bb 1101|mesh-list
64711165|NCT05675319|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64711166|NCT05675319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64711167|NCT05675319|Antiemetics|antiemetics|mesh-ancestor
64711168|NCT05675319|Autonomic Agents|autonomic agents|mesh-ancestor
64711169|NCT05675319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64711170|NCT05675319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711171|NCT05675319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64711175|NCT05675319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64711176|NCT05675319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711177|NCT05675319|Protease Inhibitors|protease inhibitors|mesh-ancestor
64711178|NCT05675319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64711179|NCT05675319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711180|NCT05675319|Immunologic Factors|immunologic factors|mesh-ancestor
64711181|NCT05675319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64711182|NCT05675319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64711183|NCT05675319|Growth Substances|growth substances|mesh-ancestor
64711184|NCT05675319|Growth Inhibitors|growth inhibitors|mesh-ancestor
64711185|NCT05674487|Misoprostol|misoprostol|mesh-list
64711186|NCT05674487|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64711187|NCT05674487|Abortifacient Agents|abortifacient agents|mesh-ancestor
64711188|NCT05674487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64711189|NCT05674487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711190|NCT05674487|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64711191|NCT05674487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65468820|NCT02205762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65468821|NCT02205762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65218331|NCT02731287|Timolol|timolol|mesh-list
65468822|NCT02205762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65468823|NCT02205762|Abortifacient Agents|abortifacient agents|mesh-ancestor
65468824|NCT02205762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65468825|NCT02205762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65468826|NCT02205762|Antimetabolites|antimetabolites|mesh-ancestor
65468827|NCT02205762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468828|NCT02205762|Dermatologic Agents|dermatologic agents|mesh-ancestor
65468829|NCT02205762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468830|NCT02205762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65468831|NCT02205762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65468832|NCT02205762|Immunologic Factors|immunologic factors|mesh-ancestor
65468833|NCT02205762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65468834|NCT02205762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65468835|NCT02205762|Antiviral Agents|antiviral agents|mesh-ancestor
65468836|NCT02205762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65468837|NCT02205762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65468838|NCT02205762|Tubulin Modulators|tubulin modulators|mesh-ancestor
65468839|NCT02205762|Antimitotic Agents|antimitotic agents|mesh-ancestor
65468840|NCT02205762|Mitosis Modulators|mitosis modulators|mesh-ancestor
65468841|NCT02205762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64711192|NCT05674487|Oxytocics|oxytocics|mesh-ancestor
64711205|NCT05644873|Magnesium Sulfate|magnesium sulfate|mesh-list
64711206|NCT05644873|Analgesics|analgesics|mesh-ancestor
64711207|NCT05644873|Sensory System Agents|sensory system agents|mesh-ancestor
64711208|NCT05644873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64711209|NCT05644873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711210|NCT05644873|Anesthetics|anesthetics|mesh-ancestor
64711211|NCT05644873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64711212|NCT05644873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64711213|NCT05644873|Anticonvulsants|anticonvulsants|mesh-ancestor
64711214|NCT05644873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64711215|NCT05644873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64711216|NCT05644873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711217|NCT05644873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64711218|NCT05644873|Tocolytic Agents|tocolytic agents|mesh-ancestor
64711219|NCT05644873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64711259|NCT05593939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711260|NCT05593939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64711261|NCT05593939|Antimetabolites|antimetabolites|mesh-ancestor
64711262|NCT05593939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711304|NCT05577845|Serotonin Agents|serotonin agents|mesh-ancestor
64711305|NCT05577845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64711306|NCT05577845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719538|NCT00000188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719539|NCT00000188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719540|NCT00000188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65468842|NCT02205762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65468844|NCT02205762|Sensory System Agents|sensory system agents|mesh-ancestor
65468845|NCT02205762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65468846|NCT02205762|Gout Suppressants|gout suppressants|mesh-ancestor
65468847|NCT02205762|Tocolytic Agents|tocolytic agents|mesh-ancestor
65468848|NCT02205762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65468849|NCT01996267|Paclitaxel|paclitaxel|mesh-list
65468850|NCT01996267|Cyclophosphamide|cyclophosphamide|mesh-list
65468851|NCT01996267|Carboplatin|carboplatin|mesh-list
65468852|NCT01996267|Fluorouracil|fluorouracil|mesh-list
65468853|NCT01996267|Trastuzumab|trastuzumab|mesh-list
65468854|NCT01996267|Pertuzumab|pertuzumab|mesh-list
65468855|NCT01996267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65468856|NCT01996267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468857|NCT01996267|Tubulin Modulators|tubulin modulators|mesh-ancestor
65468858|NCT01996267|Antimitotic Agents|antimitotic agents|mesh-ancestor
65468859|NCT01996267|Mitosis Modulators|mitosis modulators|mesh-ancestor
65468860|NCT01996267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468861|NCT01996267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65468862|NCT01996267|Immunologic Factors|immunologic factors|mesh-ancestor
65468863|NCT01996267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468864|NCT01996267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65468865|NCT01996267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65468866|NCT01996267|Alkylating Agents|alkylating agents|mesh-ancestor
65468867|NCT01996267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65468868|NCT01996267|Antimetabolites|antimetabolites|mesh-ancestor
65468869|NCT01996267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65468870|NCT01996267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65468871|NCT01934218|Hyaluronic Acid|hyaluronic acid|mesh-list
65468872|NCT01934218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65468873|NCT01934218|Immunologic Factors|immunologic factors|mesh-ancestor
65468874|NCT01934218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468875|NCT01934218|Viscosupplements|viscosupplements|mesh-ancestor
65468876|NCT01934218|Protective Agents|protective agents|mesh-ancestor
65468877|NCT01898117|Paclitaxel|paclitaxel|mesh-list
65468885|NCT01898117|Tubulin Modulators|tubulin modulators|mesh-ancestor
65468886|NCT01898117|Antimitotic Agents|antimitotic agents|mesh-ancestor
65468887|NCT01898117|Mitosis Modulators|mitosis modulators|mesh-ancestor
65468888|NCT01898117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468889|NCT01898117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65468890|NCT01898117|Immunologic Factors|immunologic factors|mesh-ancestor
65468891|NCT01898117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468892|NCT01898117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65468893|NCT01898117|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65468894|NCT01898117|Alkylating Agents|alkylating agents|mesh-ancestor
65468895|NCT01898117|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65468896|NCT01623167|Cyclosporine|cyclosporine|mesh-list
65468897|NCT01623167|Cyclosporins|cyclosporins|mesh-list
65468898|NCT01623167|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65468899|NCT01623167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066950|NCT00273026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65468900|NCT01623167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468901|NCT01623167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65468902|NCT01623167|Immunologic Factors|immunologic factors|mesh-ancestor
65468903|NCT01623167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468904|NCT01623167|Antifungal Agents|antifungal agents|mesh-ancestor
64719541|NCT00000188|Protective Agents|protective agents|mesh-ancestor
64719542|NCT00000188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719543|NCT00000914|Ritonavir|ritonavir|mesh-list
64719544|NCT00000914|Nelfinavir|nelfinavir|mesh-list
64719545|NCT00000914|Indinavir|indinavir|mesh-list
64719546|NCT00000914|Efavirenz|efavirenz|mesh-list
64711308|NCT05570825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64711309|NCT05570825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711314|NCT05536791|Antithrombins|antithrombins|mesh-ancestor
64711315|NCT05536791|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64711316|NCT05536791|Protease Inhibitors|protease inhibitors|mesh-ancestor
64711317|NCT05536791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64711318|NCT05536791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711319|NCT05536791|Anticoagulants|anticoagulants|mesh-ancestor
64711320|NCT05527912|Rituximab|rituximab|mesh-list
64711321|NCT05527912|Zanubrutinib|zanubrutinib|mesh-list
64711322|NCT05527912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64711323|NCT05527912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711324|NCT05527912|Immunologic Factors|immunologic factors|mesh-ancestor
64711325|NCT05527912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711326|NCT05527912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64711327|NCT05527912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64711328|NCT05527912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64711329|NCT05527912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711330|NCT05504083|Benzbromarone|benzbromarone|mesh-list
64711331|NCT05504083|Uricosuric Agents|uricosuric agents|mesh-ancestor
64711332|NCT05504083|Gout Suppressants|gout suppressants|mesh-ancestor
64711341|NCT05491187|Bupivacaine|bupivacaine|mesh-list
64711342|NCT05491187|Anesthetics, Local|anesthetics, local|mesh-ancestor
64711343|NCT05491187|Anesthetics|anesthetics|mesh-ancestor
64711344|NCT05491187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64711345|NCT05491187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711346|NCT05491187|Sensory System Agents|sensory system agents|mesh-ancestor
64711347|NCT05491187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65468905|NCT01623167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65468906|NCT01623167|Dermatologic Agents|dermatologic agents|mesh-ancestor
65468907|NCT01623167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65468908|NCT01623167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65468909|NCT01597388|Fulvestrant|fulvestrant|mesh-list
65468910|NCT01597388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65468911|NCT01597388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468912|NCT01597388|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65468913|NCT01597388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65468914|NCT01597388|Hormone Antagonists|hormone antagonists|mesh-ancestor
65468915|NCT01597388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65468916|NCT01597388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468917|NCT01233635|Losartan|losartan|mesh-list
65468918|NCT01233635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65468919|NCT01233635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65468920|NCT01233635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65468921|NCT01233635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65468922|NCT01233635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468923|NCT00385606|Gemcitabine|gemcitabine|mesh-list
65468924|NCT00385606|Rofecoxib|rofecoxib|mesh-list
65468925|NCT00385606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468926|NCT00385606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64711348|NCT05491187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64711349|NCT05491187|Narcotics|narcotics|mesh-ancestor
64711350|NCT05491187|Analgesics|analgesics|mesh-ancestor
64711351|NCT05491187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64711352|NCT05491187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64711353|NCT05491187|Anesthetics, General|anesthetics, general|mesh-ancestor
64711354|NCT05480878|Nitazoxanide|nitazoxanide|mesh-list
64711355|NCT05480878|Citalopram|citalopram|mesh-list
64711356|NCT05480878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64711357|NCT05480878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64711358|NCT05480878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64711359|NCT05480878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711360|NCT05480878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64711361|NCT05480878|Serotonin Agents|serotonin agents|mesh-ancestor
64711362|NCT05480878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711363|NCT05480878|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64711364|NCT05480878|Antidepressive Agents|antidepressive agents|mesh-ancestor
64711365|NCT05480878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64711366|NCT05480878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64711367|NCT05480878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64711368|NCT05464680|Dimercaprol|dimercaprol|mesh-list
64719549|NCT00000914|Protease Inhibitors|protease inhibitors|mesh-ancestor
64719550|NCT00000914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719551|NCT00000914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719552|NCT00000914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64711378|NCT05462730|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64711379|NCT05462730|Prednisolone|prednisolone|mesh-list
64711380|NCT05462730|Prednisolone acetate|prednisolone acetate|mesh-list
64436611|NCT04781647|Entecavir|entecavir|mesh-list
65468927|NCT00385606|Antimetabolites|antimetabolites|mesh-ancestor
65468928|NCT00385606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468929|NCT00385606|Antiviral Agents|antiviral agents|mesh-ancestor
65468930|NCT00385606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65468931|NCT00385606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468932|NCT00385606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65468933|NCT00385606|Immunologic Factors|immunologic factors|mesh-ancestor
65468934|NCT00385606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468935|NCT00385606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65468936|NCT00385606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65468937|NCT00385606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65468938|NCT00385606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65468939|NCT00385606|Analgesics|analgesics|mesh-ancestor
65468940|NCT00385606|Sensory System Agents|sensory system agents|mesh-ancestor
65468941|NCT00385606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65468942|NCT00385606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65468943|NCT00385606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65468944|NCT00353158|Doxycycline|doxycycline|mesh-list
65468945|NCT00353158|Voriconazole|voriconazole|mesh-list
65468946|NCT00353158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65468947|NCT00353158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65468948|NCT00353158|Antimalarials|antimalarials|mesh-ancestor
64711381|NCT05462730|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64711382|NCT05462730|Prednisolone phosphate|prednisolone phosphate|mesh-list
64711383|NCT05462730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64711384|NCT05462730|Antiemetics|antiemetics|mesh-ancestor
64711385|NCT05462730|Autonomic Agents|autonomic agents|mesh-ancestor
64711386|NCT05462730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64711387|NCT05462730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711388|NCT05462730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64711389|NCT05462730|Glucocorticoids|glucocorticoids|mesh-ancestor
64711390|NCT05462730|Hormones|hormones|mesh-ancestor
64711391|NCT05462730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64711392|NCT05462730|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64711393|NCT05462730|Protective Agents|protective agents|mesh-ancestor
64711394|NCT05462730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64711395|NCT05462730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711396|NCT05462236|Pembrolizumab|pembrolizumab|mesh-list
64711397|NCT05462236|Irinotecan|irinotecan|mesh-list
64711398|NCT05462236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64711412|NCT05461053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64711413|NCT05461053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64711414|NCT05461053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64711415|NCT05461053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711416|NCT05417594|Temozolomide|temozolomide|mesh-list
64711417|NCT05417594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64711418|NCT05417594|Alkylating Agents|alkylating agents|mesh-ancestor
64711419|NCT05417594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711420|NCT05417594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711421|NCT05414331|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64711422|NCT05414331|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64711423|NCT05414331|Adrenergic Agents|adrenergic agents|mesh-ancestor
65468949|NCT00353158|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65468950|NCT00353158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65468951|NCT00353158|Antifungal Agents|antifungal agents|mesh-ancestor
65468952|NCT00353158|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65468953|NCT00353158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65468954|NCT00353158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468955|NCT00353158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468956|NCT00353158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65468957|NCT00353158|Hormone Antagonists|hormone antagonists|mesh-ancestor
65468958|NCT00353158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65468959|NCT00353158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468960|NCT00353158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65468961|NCT03721744|Gemcitabine|gemcitabine|mesh-list
65468962|NCT03721744|Paclitaxel|paclitaxel|mesh-list
64853066|NCT01700400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64853067|NCT01700400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711424|NCT05414331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64711425|NCT05414331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711426|NCT05414331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711427|NCT05407441|Nivolumab|nivolumab|mesh-list
64711428|NCT05407441|Ipilimumab|ipilimumab|mesh-list
64711429|NCT05407441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64711430|NCT05407441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711431|NCT05407441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64711432|NCT05407441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711433|NCT05400369|Moxifloxacin|moxifloxacin|mesh-list
64711434|NCT05400369|Sitafloxacin|sitafloxacin|mesh-list
64711514|NCT05374512|Antimetabolites|antimetabolites|mesh-ancestor
64711515|NCT05362877|Salicylic Acid|salicylic acid|mesh-list
64458892|NCT01710345|Dsuvia|dsuvia|mesh-list
64719553|NCT00000914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64719554|NCT00000914|Antiviral Agents|antiviral agents|mesh-ancestor
64719555|NCT00000914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719556|NCT00000914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64719557|NCT00000914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64719558|NCT00000914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64719559|NCT00000914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64711516|NCT05362877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64711517|NCT05362877|Antifungal Agents|antifungal agents|mesh-ancestor
64711518|NCT05362877|Keratolytic Agents|keratolytic agents|mesh-ancestor
64711519|NCT05362877|Dermatologic Agents|dermatologic agents|mesh-ancestor
64711520|NCT05362058|Insulin|insulin|mesh-list
64711521|NCT05362058|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64711522|NCT05362058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64711557|NCT05330377|Immunologic Factors|immunologic factors|mesh-ancestor
64711558|NCT05330377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711559|NCT05330377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64711560|NCT05330377|Analgesics|analgesics|mesh-ancestor
64711561|NCT05330377|Sensory System Agents|sensory system agents|mesh-ancestor
64711562|NCT05330377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64711563|NCT05330377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64711564|NCT05330377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64711565|NCT05330377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64711566|NCT05328908|Trifluridine|trifluridine|mesh-list
64711567|NCT05328908|Nivolumab|nivolumab|mesh-list
64711568|NCT05328908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64711569|NCT05328908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468963|NCT03721744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65468964|NCT03721744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65468965|NCT03721744|Tubulin Modulators|tubulin modulators|mesh-ancestor
65468966|NCT03721744|Antimitotic Agents|antimitotic agents|mesh-ancestor
65468967|NCT03721744|Mitosis Modulators|mitosis modulators|mesh-ancestor
65468968|NCT03721744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65468969|NCT03721744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65468970|NCT03721744|Antimetabolites|antimetabolites|mesh-ancestor
65468971|NCT03721744|Antiviral Agents|antiviral agents|mesh-ancestor
65468972|NCT03721744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65468973|NCT03721744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65468974|NCT03721744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65218478|NCT02593669|Hormones|hormones|mesh-ancestor
65468975|NCT03721744|Immunologic Factors|immunologic factors|mesh-ancestor
65468976|NCT03721744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468978|NCT01589354|Anesthetics, Local|anesthetics, local|mesh-ancestor
65468979|NCT01589354|Anesthetics|anesthetics|mesh-ancestor
65468980|NCT01589354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65468981|NCT01589354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468982|NCT01589354|Sensory System Agents|sensory system agents|mesh-ancestor
65468983|NCT01589354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65468984|NCT01583660|Acetaminophen|acetaminophen|mesh-list
65468985|NCT01583660|Celecoxib|celecoxib|mesh-list
65468986|NCT01583660|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65468987|NCT01583660|Oxycodone|oxycodone|mesh-list
65468988|NCT01583660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65468989|NCT01583660|Analgesics|analgesics|mesh-ancestor
65468990|NCT01583660|Sensory System Agents|sensory system agents|mesh-ancestor
65468991|NCT01583660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64711570|NCT05328908|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64711571|NCT05328908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711572|NCT05328908|Antimetabolites|antimetabolites|mesh-ancestor
64711573|NCT05328908|Antiviral Agents|antiviral agents|mesh-ancestor
64711574|NCT05328908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64711575|NCT05326087|Cetrorelix|cetrorelix|mesh-list
64711576|NCT05326087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64711577|NCT05326087|Fertility Agents|fertility agents|mesh-ancestor
64711578|NCT05326087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64711579|NCT05326087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711580|NCT05326087|Hormone Antagonists|hormone antagonists|mesh-ancestor
64711581|NCT05326087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64711582|NCT05323617|Cyclosporine|cyclosporine|mesh-list
64711583|NCT05323617|Cyclosporins|cyclosporins|mesh-list
64711584|NCT05323617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64711585|NCT05323617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64711607|NCT05322252|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65468992|NCT01583660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65468993|NCT01583660|Antipyretics|antipyretics|mesh-ancestor
65468994|NCT01583660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65468995|NCT01583660|Narcotics|narcotics|mesh-ancestor
65468996|NCT01583660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65468997|NCT01583660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65468998|NCT01583660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65468999|NCT01583660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65469000|NCT01583660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65469001|NCT01583660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65469002|NCT01583660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469003|NCT01583660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469004|NCT03960866|Phentolamine|phentolamine|mesh-list
65469005|NCT03960866|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65469006|NCT03960866|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65469007|NCT03960866|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65469008|NCT03960866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65469009|NCT03960866|Adrenergic Agents|adrenergic agents|mesh-ancestor
64711608|NCT05322252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64711609|NCT05322252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64711610|NCT05322252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64711611|NCT05322252|Contraceptive Agents|contraceptive agents|mesh-ancestor
64711612|NCT05322252|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64711613|NCT05322252|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64711614|NCT05322252|Hormone Antagonists|hormone antagonists|mesh-ancestor
64719561|NCT00000914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64719562|NCT00000914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64719563|NCT00000914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64719564|NCT00000914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64719565|NCT00000920|Ritonavir|ritonavir|mesh-list
64711615|NCT05322252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64711628|NCT05288062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64711629|NCT05288062|Antiemetics|antiemetics|mesh-ancestor
64711630|NCT05288062|Autonomic Agents|autonomic agents|mesh-ancestor
64711631|NCT05288062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64711632|NCT05288062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711633|NCT05288062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64711634|NCT05288062|Glucocorticoids|glucocorticoids|mesh-ancestor
64711635|NCT05288062|Hormones|hormones|mesh-ancestor
64711636|NCT05288062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64711637|NCT05288062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64711638|NCT05288062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711639|NCT05288062|Protease Inhibitors|protease inhibitors|mesh-ancestor
64711640|NCT05288062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64711641|NCT05288062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711642|NCT05288062|Immunologic Factors|immunologic factors|mesh-ancestor
64711643|NCT05288062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64711644|NCT05288062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64711645|NCT05288062|Growth Substances|growth substances|mesh-ancestor
64711646|NCT05288062|Growth Inhibitors|growth inhibitors|mesh-ancestor
64711647|NCT05288062|Dermatologic Agents|dermatologic agents|mesh-ancestor
64711653|NCT05283304|Buprenorphine|buprenorphine|mesh-list
64711654|NCT05283304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64711655|NCT05283304|Narcotics|narcotics|mesh-ancestor
64711656|NCT05283304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65469010|NCT03960866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65469011|NCT03960866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469012|NCT03960866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469013|NCT03960866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65469014|NCT01089218|Amoxicillin|amoxicillin|mesh-list
65469015|NCT01089218|Clavulanic Acid|clavulanic acid|mesh-list
65469016|NCT01089218|Clavulanic Acids|clavulanic acids|mesh-list
65469017|NCT01089218|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65469018|NCT01089218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65469019|NCT01089218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65469020|NCT01089218|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65469021|NCT01089218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469022|NCT01089218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469023|NCT03957668|Lactulose|lactulose|mesh-list
65469024|NCT03957668|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65469025|NCT03957668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65469026|NCT03957668|Laxatives|laxatives|mesh-ancestor
65469027|NCT01089452|Amlodipine|amlodipine|mesh-list
65469028|NCT01089452|Olmesartan|olmesartan|mesh-list
65469029|NCT01089452|Perindopril|perindopril|mesh-list
65469030|NCT01089452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65469031|NCT01089452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65469032|NCT01089452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65469033|NCT01089452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469034|NCT01089452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65469035|NCT01089452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711657|NCT05283304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711658|NCT05283304|Analgesics|analgesics|mesh-ancestor
64711659|NCT05283304|Sensory System Agents|sensory system agents|mesh-ancestor
64711660|NCT05283304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64711661|NCT05283304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64711662|NCT05257408|Paclitaxel|paclitaxel|mesh-list
64711692|NCT05239468|Bezafibrate|bezafibrate|mesh-list
64711693|NCT05239468|Cathartics|cathartics|mesh-ancestor
64711694|NCT05239468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64711695|NCT05239468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64711696|NCT05239468|Antimetabolites|antimetabolites|mesh-ancestor
64711697|NCT05239468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711698|NCT05239468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64711699|NCT05212454|Capecitabine|capecitabine|mesh-list
64711700|NCT05212454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64711701|NCT05212454|Antimetabolites|antimetabolites|mesh-ancestor
64711702|NCT05212454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711703|NCT05212454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711704|NCT05157581|Methoxsalen|methoxsalen|mesh-list
64711705|NCT05157581|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64711717|NCT05148234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64711724|NCT05116189|Docetaxel|docetaxel|mesh-list
65469036|NCT01089452|Vasodilator Agents|vasodilator agents|mesh-ancestor
65469037|NCT01089452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65469038|NCT01089452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65469039|NCT01089452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65469040|NCT01089452|Protease Inhibitors|protease inhibitors|mesh-ancestor
65469041|NCT01089452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469042|NCT04880980|Itraconazole|itraconazole|mesh-list
65469043|NCT04880980|Terbinafine|terbinafine|mesh-list
65469044|NCT04880980|Antifungal Agents|antifungal agents|mesh-ancestor
65469045|NCT04880980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65469046|NCT04880980|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65469047|NCT04880980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65469048|NCT04880980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469049|NCT04880980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469050|NCT04880980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64711725|NCT05116189|Bevacizumab|bevacizumab|mesh-list
64711726|NCT05116189|Pembrolizumab|pembrolizumab|mesh-list
64711727|NCT05116189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64711728|NCT05116189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711729|NCT05116189|Tubulin Modulators|tubulin modulators|mesh-ancestor
64711730|NCT05116189|Antimitotic Agents|antimitotic agents|mesh-ancestor
64719567|NCT00000920|Lamivudine|lamivudine|mesh-list
64719568|NCT00000920|Zidovudine|zidovudine|mesh-list
64719569|NCT00000920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64327659|NCT02173691|Parasympatholytics|parasympatholytics|mesh-ancestor
64711731|NCT05116189|Mitosis Modulators|mitosis modulators|mesh-ancestor
64711732|NCT05116189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711733|NCT05116189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64711734|NCT05116189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64711735|NCT05116189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64711736|NCT05116189|Growth Substances|growth substances|mesh-ancestor
64711737|NCT05116189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711738|NCT05116189|Growth Inhibitors|growth inhibitors|mesh-ancestor
64711739|NCT05096845|Vaccines|vaccines|mesh-list
64711740|NCT05096845|Immunologic Factors|immunologic factors|mesh-ancestor
64711741|NCT05096845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711742|NCT05096663|Vitamins|vitamins|mesh-list
64711743|NCT05096663|Folic Acid|folic acid|mesh-list
64711744|NCT05096663|Hydroxocobalamin|hydroxocobalamin|mesh-list
64711745|NCT05096663|Vitamin B 12|vitamin b 12|mesh-list
64711746|NCT05096663|Vitamin B Complex|vitamin b complex|mesh-list
64711747|NCT05096663|Gemcitabine|gemcitabine|mesh-list
64711748|NCT05096663|Dexamethasone|dexamethasone|mesh-list
64711775|NCT05096663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711776|NCT05096663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64711778|NCT05096663|Antiviral Agents|antiviral agents|mesh-ancestor
64711779|NCT05096663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64338173|NCT02267915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711780|NCT05096663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64711781|NCT05096663|Tubulin Modulators|tubulin modulators|mesh-ancestor
64711782|NCT05096663|Antimitotic Agents|antimitotic agents|mesh-ancestor
64711783|NCT05096663|Mitosis Modulators|mitosis modulators|mesh-ancestor
64711784|NCT05096663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64711785|NCT05096663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64711786|NCT05096663|Hematinics|hematinics|mesh-ancestor
64711793|NCT05091866|Progesterone|progesterone|mesh-list
64711794|NCT05091866|Progestins|progestins|mesh-list
64711795|NCT05091866|Hormones|hormones|mesh-ancestor
64711796|NCT05091866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64711797|NCT05091866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469051|NCT04880980|Hormone Antagonists|hormone antagonists|mesh-ancestor
65469052|NCT04880980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65469053|NCT04880980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469054|NCT04880980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65469055|NCT01583504|Anesthetics|anesthetics|mesh-list
65469056|NCT01583504|Anesthetics, Local|anesthetics, local|mesh-list
65469057|NCT01583504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65469058|NCT01583504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469059|NCT01583504|Sensory System Agents|sensory system agents|mesh-ancestor
65469060|NCT01583504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65469061|NCT01583036|Digoxin|digoxin|mesh-list
65469062|NCT01583036|Ezogabine|ezogabine|mesh-list
65469063|NCT01583036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65469064|NCT01583036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65469065|NCT01583036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853173|NCT01701076|Glucocorticoids|glucocorticoids|mesh-ancestor
64853174|NCT01701076|Hormones|hormones|mesh-ancestor
64853175|NCT01701076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64853176|NCT01701076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64853177|NCT01701076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853178|NCT01701076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853179|NCT01701076|Immunologic Factors|immunologic factors|mesh-ancestor
64853180|NCT01701076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64853181|NCT01701076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64853182|NCT01701076|Growth Substances|growth substances|mesh-ancestor
64853183|NCT01701076|Growth Inhibitors|growth inhibitors|mesh-ancestor
64853184|NCT01701076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64853185|NCT01701076|Alkylating Agents|alkylating agents|mesh-ancestor
64853186|NCT01701089|Selegiline|selegiline|mesh-list
64853187|NCT01701089|Antidepressive Agents|antidepressive agents|mesh-ancestor
64711828|NCT05042700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711854|NCT05019222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711855|NCT05019222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64711857|NCT05019222|Anesthetics, General|anesthetics, general|mesh-ancestor
64711858|NCT05010954|Lansoprazole|lansoprazole|mesh-list
64711859|NCT05010954|Dexlansoprazole|dexlansoprazole|mesh-list
64711860|NCT05010954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64711861|NCT05010954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64711862|NCT05010954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64711863|NCT05010954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64711864|NCT05010954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711865|NCT05002569|Nivolumab|nivolumab|mesh-list
65469066|NCT01583036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469067|NCT01583036|Protective Agents|protective agents|mesh-ancestor
65469068|NCT01583036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469069|NCT01583036|Anticonvulsants|anticonvulsants|mesh-ancestor
65469070|NCT01583036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65469071|NCT01091792|Bevacizumab|bevacizumab|mesh-list
65469072|NCT01091792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65469073|NCT01091792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469074|NCT01091792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65469075|NCT01091792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65469076|NCT01091792|Growth Substances|growth substances|mesh-ancestor
65469077|NCT01091792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469078|NCT01091792|Growth Inhibitors|growth inhibitors|mesh-ancestor
65469079|NCT03510910|Acetaminophen|acetaminophen|mesh-list
65469080|NCT03510910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65469081|NCT03510910|Analgesics|analgesics|mesh-ancestor
65469082|NCT03510910|Sensory System Agents|sensory system agents|mesh-ancestor
65469083|NCT03510910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65469084|NCT03510910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469085|NCT03510910|Antipyretics|antipyretics|mesh-ancestor
65469086|NCT01091870|Sildenafil Citrate|sildenafil citrate|mesh-list
65469087|NCT01091870|Citric Acid|citric acid|mesh-list
65469088|NCT01091870|Sodium Citrate|sodium citrate|mesh-list
64853197|NCT01701180|Oxytocin|oxytocin|mesh-list
64711866|NCT05002569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64711867|NCT05002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711868|NCT05002569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64711869|NCT05002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711870|NCT05001724|Docetaxel|docetaxel|mesh-list
64711871|NCT05001724|Lenvatinib|lenvatinib|mesh-list
64711872|NCT05001724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711873|NCT05001724|Tubulin Modulators|tubulin modulators|mesh-ancestor
64711874|NCT05001724|Antimitotic Agents|antimitotic agents|mesh-ancestor
64711875|NCT05001724|Mitosis Modulators|mitosis modulators|mesh-ancestor
64711876|NCT05001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719570|NCT00000920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64719571|NCT00000920|Protease Inhibitors|protease inhibitors|mesh-ancestor
64719572|NCT00000920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719573|NCT00000920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719574|NCT00000920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64719575|NCT00000920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64719576|NCT00000920|Antiviral Agents|antiviral agents|mesh-ancestor
64719577|NCT00000920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719578|NCT00000920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64719579|NCT00000920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64719580|NCT00000920|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64719581|NCT00000920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64719582|NCT00000920|Antimetabolites|antimetabolites|mesh-ancestor
64719584|NCT00000938|Ceftriaxone|ceftriaxone|mesh-list
64711877|NCT05001724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65469089|NCT01091870|Anticoagulants|anticoagulants|mesh-ancestor
65469090|NCT01091870|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65469091|NCT01091870|Chelating Agents|chelating agents|mesh-ancestor
65469092|NCT01091870|Sequestering Agents|sequestering agents|mesh-ancestor
65469093|NCT01091870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469094|NCT01091870|Vasodilator Agents|vasodilator agents|mesh-ancestor
65469095|NCT01091870|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65469096|NCT01091870|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65469097|NCT01091870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469098|NCT01091870|Urological Agents|urological agents|mesh-ancestor
65469099|NCT03509350|Vitamins|vitamins|mesh-list
65469100|NCT03509350|Ascorbic Acid|ascorbic acid|mesh-list
65469101|NCT03509350|Thiamine|thiamine|mesh-list
65469102|NCT03509350|Hydrocortisone|hydrocortisone|mesh-list
65469103|NCT03509350|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65469104|NCT03509350|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65469105|NCT03509350|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65469106|NCT03509350|Micronutrients|micronutrients|mesh-ancestor
65469107|NCT03509350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469108|NCT03509350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65469109|NCT03509350|Antioxidants|antioxidants|mesh-ancestor
65469110|NCT03509350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469111|NCT03509350|Protective Agents|protective agents|mesh-ancestor
65469112|NCT03509350|Vitamin B Complex|vitamin b complex|mesh-ancestor
65469113|NCT00072410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65469114|NCT00072410|Antibodies|antibodies|mesh-list
65469115|NCT00072410|Immunoglobulins|immunoglobulins|mesh-list
65469116|NCT00072410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65469117|NCT00072410|Immunologic Factors|immunologic factors|mesh-ancestor
65469118|NCT00072410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469119|NCT00072410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469120|NCT03478696|Budesonide|budesonide|mesh-list
65469121|NCT03478696|Albuterol|albuterol|mesh-list
65469122|NCT03478696|Formoterol Fumarate|formoterol fumarate|mesh-list
65469132|NCT03478696|Glucocorticoids|glucocorticoids|mesh-ancestor
65469133|NCT03478696|Hormones|hormones|mesh-ancestor
65469134|NCT03478696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65469135|NCT03478696|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65469136|NCT03478696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65469137|NCT03478696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65469138|NCT03478696|Adrenergic Agents|adrenergic agents|mesh-ancestor
65469139|NCT03478696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65469140|NCT03478696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853258|NCT01701479|Interleukin-2|interleukin-2|mesh-list
64711911|NCT04976634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64711912|NCT04976634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64711913|NCT04976634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711914|NCT04966702|Ivermectin|ivermectin|mesh-list
64711915|NCT04966702|Albendazole|albendazole|mesh-list
64711916|NCT04966702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64711929|NCT04966663|Nivolumab|nivolumab|mesh-list
64711930|NCT04966663|Pemetrexed|pemetrexed|mesh-list
64711931|NCT04966663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711932|NCT04966663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64711933|NCT04966663|Antimetabolites|antimetabolites|mesh-ancestor
64711934|NCT04966663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711935|NCT04966663|Antiviral Agents|antiviral agents|mesh-ancestor
64711936|NCT04966663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64711937|NCT04966663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64711945|NCT04966481|Cetuximab|cetuximab|mesh-list
64711946|NCT04966481|Palbociclib|palbociclib|mesh-list
64711947|NCT04966481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64711948|NCT04966481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711949|NCT04966481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64711950|NCT04966481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64711951|NCT04966481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711958|NCT04922593|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64711959|NCT04922593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64711960|NCT04922593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64711961|NCT04922593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64711962|NCT04922593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711963|NCT04922593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64711964|NCT04922593|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64711965|NCT04922593|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64711966|NCT04922593|Serotonin Agents|serotonin agents|mesh-ancestor
64711967|NCT04922593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64711968|NCT04922593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711969|NCT04922593|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64711970|NCT04922593|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64711971|NCT04922593|Dopamine Agents|dopamine agents|mesh-ancestor
64719585|NCT00000938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64719586|NCT00000938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719587|NCT00000938|Antimalarials|antimalarials|mesh-ancestor
64719588|NCT00000938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64719589|NCT00000938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64719590|NCT00001862|Etanercept|etanercept|mesh-list
64719591|NCT00001862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64719592|NCT00001862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64719593|NCT00001862|Analgesics|analgesics|mesh-ancestor
64719594|NCT00001862|Sensory System Agents|sensory system agents|mesh-ancestor
64719595|NCT00001862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719596|NCT00001862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711996|NCT04901377|Contraceptive Agents|contraceptive agents|mesh-ancestor
64711997|NCT04901377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64711998|NCT04901377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64711999|NCT04901377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64712000|NCT04901377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64712001|NCT04901377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65469141|NCT03478696|Parasympatholytics|parasympatholytics|mesh-ancestor
65469142|NCT03478696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65469143|NCT03478696|Cholinergic Agents|cholinergic agents|mesh-ancestor
65469144|NCT03478696|Tocolytic Agents|tocolytic agents|mesh-ancestor
65469145|NCT03478696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65469146|NCT00072176|Sirolimus|sirolimus|mesh-list
65469147|NCT00072176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65469148|NCT00072176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65469149|NCT00072176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65469150|NCT00072176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469151|NCT00072176|Antifungal Agents|antifungal agents|mesh-ancestor
65469152|NCT00072176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65469153|NCT00072176|Immunologic Factors|immunologic factors|mesh-ancestor
65469154|NCT00072176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469155|NCT00071396|Rituximab|rituximab|mesh-list
65469156|NCT00071396|Alemtuzumab|alemtuzumab|mesh-list
65469157|NCT00071396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65469158|NCT00071396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469159|NCT00071396|Immunologic Factors|immunologic factors|mesh-ancestor
65469160|NCT00071396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469161|NCT00071396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65469162|NCT03472534|Diacetylrhein|diacetylrhein|mesh-list
65469163|NCT03472534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65469164|NCT03725020|Fluorides|fluorides|mesh-list
65469165|NCT03725020|Fluorides, Topical|fluorides, topical|mesh-list
65469166|NCT03725020|Cariostatic Agents|cariostatic agents|mesh-ancestor
65469167|NCT03725020|Protective Agents|protective agents|mesh-ancestor
65469168|NCT03725020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469169|NCT03721432|Pregabalin|pregabalin|mesh-list
64712002|NCT04901377|Hormone Antagonists|hormone antagonists|mesh-ancestor
64712069|NCT04814368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712070|NCT04765202|Carisoprodol|carisoprodol|mesh-list
64712071|NCT04765202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64712072|NCT04765202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712073|NCT04765202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64712074|NCT04765202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64712081|NCT04736706|Pembrolizumab|pembrolizumab|mesh-list
64712082|NCT04736706|Lenvatinib|lenvatinib|mesh-list
64712083|NCT04736706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64712084|NCT04736706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712085|NCT04736706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64712086|NCT04736706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712087|NCT04736706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712088|NCT04724148|Fentanyl|fentanyl|mesh-list
64712089|NCT04724148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64712090|NCT04724148|Narcotics|narcotics|mesh-ancestor
64712091|NCT04724148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64712092|NCT04724148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712093|NCT04724148|Analgesics|analgesics|mesh-ancestor
65469170|NCT03721432|Analgesics|analgesics|mesh-ancestor
65469171|NCT03721432|Sensory System Agents|sensory system agents|mesh-ancestor
65469172|NCT03721432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65469173|NCT03721432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469174|NCT03721432|Anticonvulsants|anticonvulsants|mesh-ancestor
65469175|NCT03721432|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65469176|NCT03721432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65469177|NCT03721432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469178|NCT03721432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65469179|NCT03721432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65469180|NCT03721432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65469181|NCT03721432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65469182|NCT03721432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64853291|NCT01701739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712102|NCT04712097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64712104|NCT04712097|Immunologic Factors|immunologic factors|mesh-ancestor
64712105|NCT04712097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712106|NCT04712097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64712122|NCT04704154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64712127|NCT04703803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64712129|NCT04703803|Sensory System Agents|sensory system agents|mesh-ancestor
64712130|NCT04703803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64712131|NCT04703803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64712132|NCT04703803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64712133|NCT04703803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64712134|NCT04703803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64712135|NCT04703803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712137|NCT04702893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712138|NCT04702893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64719597|NCT00001862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64719598|NCT00001862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64719599|NCT00001862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64719600|NCT00001862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64719601|NCT00001862|Immunologic Factors|immunologic factors|mesh-ancestor
64712139|NCT04702893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712140|NCT04702893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712141|NCT04700124|Gemcitabine|gemcitabine|mesh-list
64712142|NCT04700124|Cisplatin|cisplatin|mesh-list
64712143|NCT04700124|Pembrolizumab|pembrolizumab|mesh-list
64712144|NCT04700124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712145|NCT04700124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64712146|NCT04700124|Antimetabolites|antimetabolites|mesh-ancestor
64712147|NCT04700124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712148|NCT04700124|Antiviral Agents|antiviral agents|mesh-ancestor
64712149|NCT04700124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64712150|NCT04700124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712151|NCT04700124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64712152|NCT04700124|Immunologic Factors|immunologic factors|mesh-ancestor
64712153|NCT04700124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712154|NCT04700124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64712155|NCT04695080|Cladribine|cladribine|mesh-list
64712156|NCT04695080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712157|NCT04695080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64712158|NCT04695080|Immunologic Factors|immunologic factors|mesh-ancestor
64712159|NCT04695080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712160|NCT04681417|Carboplatin|carboplatin|mesh-list
64712161|NCT04681417|Etoposide|etoposide|mesh-list
64712162|NCT04681417|Etoposide phosphate|etoposide phosphate|mesh-list
64712163|NCT04681417|Vincristine|vincristine|mesh-list
65469183|NCT03469336|Betamethasone|betamethasone|mesh-list
65469184|NCT03469336|Calcipotriene|calcipotriene|mesh-list
65469185|NCT03469336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65469186|NCT03469336|Glucocorticoids|glucocorticoids|mesh-ancestor
65469187|NCT03469336|Hormones|hormones|mesh-ancestor
65469188|NCT03469336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65469189|NCT03469336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469190|NCT03469336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65469191|NCT03469336|Respiratory System Agents|respiratory system agents|mesh-ancestor
65469192|NCT03469336|Dermatologic Agents|dermatologic agents|mesh-ancestor
65469193|NCT03719560|Cytarabine|cytarabine|mesh-list
65469194|NCT03719560|Methotrexate|methotrexate|mesh-list
65469195|NCT03719560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65469196|NCT03719560|Abortifacient Agents|abortifacient agents|mesh-ancestor
65469197|NCT03719560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65469198|NCT03719560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218693|NCT00813124|Azacitidine|azacitidine|mesh-list
65469199|NCT03719560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65469200|NCT03719560|Antimetabolites|antimetabolites|mesh-ancestor
65469201|NCT03719560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469202|NCT03719560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469203|NCT03719560|Dermatologic Agents|dermatologic agents|mesh-ancestor
65469204|NCT03719560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469205|NCT03719560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65469206|NCT03719560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65469207|NCT03719560|Immunologic Factors|immunologic factors|mesh-ancestor
65469208|NCT03719560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65469209|NCT03719560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65469210|NCT03719560|Antiviral Agents|antiviral agents|mesh-ancestor
64712164|NCT04681417|Melphalan|melphalan|mesh-list
64712165|NCT04681417|Topotecan|topotecan|mesh-list
64712166|NCT04681417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712167|NCT04681417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64712168|NCT04681417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64712169|NCT04681417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64712170|NCT04681417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712171|NCT04681417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712172|NCT04681417|Tubulin Modulators|tubulin modulators|mesh-ancestor
64712193|NCT04670978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712195|NCT04657302|Obinutuzumab|obinutuzumab|mesh-list
64712196|NCT04657302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64712197|NCT04657302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712198|NCT04639180|Apatinib|apatinib|mesh-list
64712270|NCT04579224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64712271|NCT04579224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712272|NCT04579224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65469211|NCT03719560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65469212|NCT03469258|Pancrelipase|pancrelipase|mesh-list
65469213|NCT03469258|Pancreatin|pancreatin|mesh-list
65469214|NCT03469258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65469215|NCT00066170|Sodium Oxybate|sodium oxybate|mesh-list
65469216|NCT00066170|Modafinil|modafinil|mesh-list
65469217|NCT00066170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65469218|NCT00066170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469219|NCT00066170|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65469220|NCT00066170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65469221|NCT00066170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65469222|NCT00066170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469223|NCT00066170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65469224|NCT00066170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65469225|NCT00066170|Anesthetics, General|anesthetics, general|mesh-ancestor
65469226|NCT00066170|Anesthetics|anesthetics|mesh-ancestor
65469227|NCT00066170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65469228|NCT00065468|Interferons|interferons|mesh-list
65469229|NCT00065468|Interferon-alpha|interferon-alpha|mesh-list
65469230|NCT00065468|Sirolimus|sirolimus|mesh-list
65469231|NCT00065468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469232|NCT00065468|Antiviral Agents|antiviral agents|mesh-ancestor
65469233|NCT00065468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65469234|NCT00065468|Immunologic Factors|immunologic factors|mesh-ancestor
65469235|NCT00065468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469236|NCT00065468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65469237|NCT00065468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65469238|NCT00065468|Antifungal Agents|antifungal agents|mesh-ancestor
64712273|NCT04579224|Immunologic Factors|immunologic factors|mesh-ancestor
64712274|NCT04579224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712288|NCT04538378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712290|NCT04531943|Estrogens|estrogens|mesh-list
64712291|NCT04531943|Progestins|progestins|mesh-ancestor
64712292|NCT04531943|Hormones|hormones|mesh-ancestor
64712293|NCT04531943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64712294|NCT04531943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712295|NCT04528082|Apremilast|apremilast|mesh-list
64712296|NCT04528082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64712297|NCT04528082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64712298|NCT04528082|Analgesics|analgesics|mesh-ancestor
64712299|NCT04528082|Sensory System Agents|sensory system agents|mesh-ancestor
64712300|NCT04528082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64712301|NCT04528082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712302|NCT04528082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64719602|NCT00000194|Cycloserine|cycloserine|mesh-list
64719603|NCT00000194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64719604|NCT00000194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65469239|NCT00065468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65469240|NCT00071006|Axitinib|axitinib|mesh-list
65469241|NCT00071006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469242|NCT00071006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65469243|NCT00071006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469244|NCT00071006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469245|NCT01089998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65469246|NCT01089998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65469247|NCT01089998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469248|NCT00094107|Axitinib|axitinib|mesh-list
65469249|NCT00094107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469250|NCT00094107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65469251|NCT00094107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469252|NCT00094107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719605|NCT00000194|Renal Agents|renal agents|mesh-ancestor
64719606|NCT00000194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64719607|NCT00000194|Antitubercular Agents|antitubercular agents|mesh-ancestor
64719608|NCT00000194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64719609|NCT00000194|Antimetabolites|antimetabolites|mesh-ancestor
64719610|NCT00000194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719611|NCT00000200|Methadone|methadone|mesh-list
64719612|NCT00000200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64712303|NCT04528082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64712304|NCT04528082|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64712305|NCT04528082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64712306|NCT04528082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712307|NCT04528082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712308|NCT04522973|Ethanol|ethanol|mesh-list
64712309|NCT04522973|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64712310|NCT04522973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64712311|NCT04522973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64712312|NCT04522973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712313|NCT04520048|Acetylcholine|acetylcholine|mesh-list
64712314|NCT04520048|Vasodilator Agents|vasodilator agents|mesh-ancestor
64712315|NCT04520048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64712316|NCT04520048|Cholinergic Agents|cholinergic agents|mesh-ancestor
64712317|NCT04520048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64712318|NCT04520048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712319|NCT04520048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712320|NCT04516850|Steroid delta-isomerase|steroid delta-isomerase|mesh-list
64712321|NCT04516850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712322|NCT04516850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712323|NCT04505774|Dapagliflozin|dapagliflozin|mesh-list
64712324|NCT04505774|Empagliflozin|empagliflozin|mesh-list
64338213|NCT01253603|Xhance|xhance|mesh-list
64719621|NCT00000206|Buprenorphine|buprenorphine|mesh-list
64719622|NCT00000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64719623|NCT00000206|Narcotics|narcotics|mesh-ancestor
64719624|NCT00000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64719625|NCT00000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719626|NCT00000206|Analgesics|analgesics|mesh-ancestor
64327709|NCT02166359|Icodextrin|icodextrin|mesh-list
64712369|NCT04503460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64712370|NCT04503460|Sympathomimetics|sympathomimetics|mesh-ancestor
64712371|NCT04460326|Insulin|insulin|mesh-list
64712372|NCT04460326|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64712373|NCT04460326|Insulin Glargine|insulin glargine|mesh-list
64712374|NCT04460326|Insulin Aspart|insulin aspart|mesh-list
64712375|NCT04460326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64712376|NCT04460326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712377|NCT04452877|Trametinib|trametinib|mesh-list
65469253|NCT00102063|Aripiprazole|aripiprazole|mesh-list
65469254|NCT00102063|Antidepressive Agents|antidepressive agents|mesh-ancestor
65469255|NCT00102063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65469256|NCT00102063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65469257|NCT00102063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65469258|NCT00102063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65469259|NCT00102063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469260|NCT00102063|Dopamine Agonists|dopamine agonists|mesh-ancestor
65469261|NCT00102063|Dopamine Agents|dopamine agents|mesh-ancestor
65469262|NCT00102063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65469263|NCT00102063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469264|NCT00102063|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65469265|NCT00102063|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65469266|NCT00102063|Serotonin Agents|serotonin agents|mesh-ancestor
65469267|NCT00102063|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65469268|NCT00102063|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65469269|NCT00102063|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65469270|NCT00102063|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65469271|NCT00065156|Lenalidomide|lenalidomide|mesh-list
65469272|NCT00065156|Immunologic Factors|immunologic factors|mesh-ancestor
65469273|NCT00065156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469274|NCT00065156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65469275|NCT00065156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65469276|NCT00065156|Growth Substances|growth substances|mesh-ancestor
65469277|NCT00065156|Growth Inhibitors|growth inhibitors|mesh-ancestor
65469278|NCT00065156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469279|NCT01094210|Fluorides|fluorides|mesh-list
65469280|NCT01094210|Fluorides, Topical|fluorides, topical|mesh-list
65469281|NCT01094210|Cariostatic Agents|cariostatic agents|mesh-ancestor
65469282|NCT01094210|Protective Agents|protective agents|mesh-ancestor
65469283|NCT01094210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469284|NCT01094444|Vitamin K|vitamin k|mesh-list
64712393|NCT04414761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64712394|NCT04414761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64712395|NCT04414761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64712396|NCT04414761|Contraceptive Agents|contraceptive agents|mesh-ancestor
64712397|NCT04414761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64712398|NCT04414761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64712399|NCT04414761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64712422|NCT04395196|Lipotropic Agents|lipotropic agents|mesh-ancestor
64712423|NCT04395196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64712424|NCT04395196|Antimetabolites|antimetabolites|mesh-ancestor
65469285|NCT01094444|Vitamin K 3|vitamin k 3|mesh-list
65469286|NCT01094444|Vitamins|vitamins|mesh-ancestor
65469287|NCT01094444|Micronutrients|micronutrients|mesh-ancestor
65469288|NCT01094444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469289|NCT01094444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65469290|NCT01094444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65469291|NCT01094444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469292|NCT01094444|Hemostatics|hemostatics|mesh-ancestor
65469293|NCT01094444|Coagulants|coagulants|mesh-ancestor
65469294|NCT00078819|Etanercept|etanercept|mesh-list
65469295|NCT00078819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65469296|NCT00078819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65469297|NCT00078819|Analgesics|analgesics|mesh-ancestor
65469298|NCT00078819|Sensory System Agents|sensory system agents|mesh-ancestor
65469299|NCT00078819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65469300|NCT00078819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469301|NCT00078819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65469302|NCT00078819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65469303|NCT00078819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65469304|NCT00078819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65469305|NCT00078819|Immunologic Factors|immunologic factors|mesh-ancestor
65469306|NCT01088607|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65469307|NCT01088607|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65469308|NCT01088607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65469309|NCT00098865|Thalidomide|thalidomide|mesh-list
65469310|NCT00098865|Temozolomide|temozolomide|mesh-list
65469311|NCT00098865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65469312|NCT00098865|Alkylating Agents|alkylating agents|mesh-ancestor
65469313|NCT00098865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469314|NCT00098865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469315|NCT00098865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65469330|NCT00098787|Oxaliplatin|oxaliplatin|mesh-list
65469331|NCT00098787|Irinotecan|irinotecan|mesh-list
65469332|NCT00098787|Camptothecin|camptothecin|mesh-list
65469333|NCT00098787|Levoleucovorin|levoleucovorin|mesh-list
65469334|NCT00098787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65469335|NCT00098787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469336|NCT00098787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65469337|NCT00098787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65469338|NCT00098787|Growth Substances|growth substances|mesh-ancestor
65469339|NCT00098787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469340|NCT00098787|Growth Inhibitors|growth inhibitors|mesh-ancestor
65469341|NCT00098787|Antimetabolites|antimetabolites|mesh-ancestor
65469342|NCT00098787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469343|NCT00098787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65469344|NCT00098787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65469345|NCT00098787|Immunologic Factors|immunologic factors|mesh-ancestor
65469346|NCT00098787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65469347|NCT00098787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65469348|NCT00098787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469349|NCT00098787|Antidotes|antidotes|mesh-ancestor
65469350|NCT00098787|Protective Agents|protective agents|mesh-ancestor
65469351|NCT00098787|Vitamin B Complex|vitamin b complex|mesh-ancestor
65469352|NCT00098787|Vitamins|vitamins|mesh-ancestor
65469353|NCT00098787|Micronutrients|micronutrients|mesh-ancestor
65469354|NCT00098787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65469355|NCT01084863|Paclitaxel|paclitaxel|mesh-list
65469356|NCT01084863|Trastuzumab|trastuzumab|mesh-list
65469357|NCT01084863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65469358|NCT01084863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469359|NCT01084863|Tubulin Modulators|tubulin modulators|mesh-ancestor
65469360|NCT01084863|Antimitotic Agents|antimitotic agents|mesh-ancestor
65469361|NCT01084863|Mitosis Modulators|mitosis modulators|mesh-ancestor
65469362|NCT01084863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469363|NCT01084863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65469364|NCT03719404|Chlorhexidine|chlorhexidine|mesh-list
65469365|NCT03719404|Sodium Hypochlorite|sodium hypochlorite|mesh-list
65469366|NCT03719404|Eusol|eusol|mesh-list
65469367|NCT03719404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65469368|NCT03719404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65469369|NCT03719404|Disinfectants|disinfectants|mesh-ancestor
65469370|NCT03720886|Teriparatide|teriparatide|mesh-list
65469371|NCT03720886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65469372|NCT03720886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469373|NCT03720886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65469374|NCT00077649|Ribavirin|ribavirin|mesh-list
65469375|NCT00077649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65469376|NCT00077649|Interferon-alpha|interferon-alpha|mesh-list
65469377|NCT00077649|Interferon alpha-2|interferon alpha-2|mesh-list
65469378|NCT00077649|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65469379|NCT00077649|Antimetabolites|antimetabolites|mesh-ancestor
65469380|NCT00077649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469381|NCT00077649|Antiviral Agents|antiviral agents|mesh-ancestor
65469382|NCT00077649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65469383|NCT00077649|Immunologic Factors|immunologic factors|mesh-ancestor
65469384|NCT00077649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469385|NCT00077649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469386|NCT00038948|Cyclosporine|cyclosporine|mesh-list
65469387|NCT00038948|Sirolimus|sirolimus|mesh-list
65469388|NCT00038948|Tacrolimus|tacrolimus|mesh-list
65469389|NCT00038948|Cyclosporins|cyclosporins|mesh-list
65469390|NCT00038948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65469391|NCT00038948|Immunologic Factors|immunologic factors|mesh-ancestor
65469392|NCT00038948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469393|NCT00038948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65469394|NCT00038948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469395|NCT00038948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469396|NCT00038948|Antifungal Agents|antifungal agents|mesh-ancestor
65469397|NCT00038948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65469398|NCT00038948|Dermatologic Agents|dermatologic agents|mesh-ancestor
65469399|NCT00038948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65469400|NCT00038948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65469401|NCT00038948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65469402|NCT00038948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469403|NCT01096940|Simvastatin|simvastatin|mesh-list
65469404|NCT01096940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65469405|NCT01096940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65469406|NCT01096940|Antimetabolites|antimetabolites|mesh-ancestor
65469407|NCT01096940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469408|NCT01096940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65469409|NCT01096940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65469410|NCT01096940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469411|NCT02530424|Trastuzumab|trastuzumab|mesh-list
65469412|NCT02530424|Pertuzumab|pertuzumab|mesh-list
65469413|NCT02530424|Fulvestrant|fulvestrant|mesh-list
65469414|NCT02530424|Palbociclib|palbociclib|mesh-list
65469415|NCT02530424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65469416|NCT02530424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469417|NCT02530424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65469418|NCT02530424|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65469419|NCT02530424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65469420|NCT02530424|Hormone Antagonists|hormone antagonists|mesh-ancestor
65469421|NCT02530424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65469422|NCT02530424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469423|NCT02530424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65469424|NCT02530424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65218917|NCT05753566|Androgens|androgens|mesh-list
65469425|NCT02530424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469426|NCT01088763|Dexamethasone|dexamethasone|mesh-list
65469427|NCT01088763|R04929097|r04929097|mesh-list
65469428|NCT01088763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65469430|NCT01088763|Autonomic Agents|autonomic agents|mesh-ancestor
65469431|NCT01088763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65469432|NCT01088763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469433|NCT01088763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65469434|NCT01088763|Glucocorticoids|glucocorticoids|mesh-ancestor
65469435|NCT01088763|Hormones|hormones|mesh-ancestor
65469436|NCT01088763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65469437|NCT01088763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65469438|NCT01088763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469445|NCT01094600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469446|NCT01097252|Cisplatin|cisplatin|mesh-list
65469447|NCT01097252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469448|NCT02530502|Pembrolizumab|pembrolizumab|mesh-list
65469449|NCT02530502|Temozolomide|temozolomide|mesh-list
65469450|NCT02530502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65469451|NCT02530502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469452|NCT02530502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65469453|NCT02530502|Alkylating Agents|alkylating agents|mesh-ancestor
65469454|NCT02530502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469455|NCT00054704|Riluzole|riluzole|mesh-list
65469456|NCT00054704|Anticonvulsants|anticonvulsants|mesh-ancestor
65469457|NCT00054704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65469458|NCT00054704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65469459|NCT00054704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65469460|NCT00054704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469461|NCT00054704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469462|NCT00054704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65469463|NCT00054704|Protective Agents|protective agents|mesh-ancestor
65469464|NCT01092572|Simvastatin|simvastatin|mesh-list
65469465|NCT01092572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65469466|NCT01092572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65469467|NCT01092572|Antimetabolites|antimetabolites|mesh-ancestor
65469468|NCT01092572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469469|NCT01092572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64712425|NCT04395196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712467|NCT04300647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712476|NCT04284787|Pembrolizumab|pembrolizumab|mesh-list
64712477|NCT04284787|Azacitidine|azacitidine|mesh-list
64712478|NCT04284787|Venetoclax|venetoclax|mesh-list
64712479|NCT04284787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64719627|NCT00000206|Sensory System Agents|sensory system agents|mesh-ancestor
64719628|NCT00000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719629|NCT00000206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64719630|NCT00000212|Desipramine|desipramine|mesh-list
64719631|NCT00000212|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64719632|NCT00000212|Antidepressive Agents|antidepressive agents|mesh-ancestor
64712480|NCT04284787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712481|NCT04284787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64712482|NCT04284787|Antimetabolites|antimetabolites|mesh-ancestor
64712483|NCT04284787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712484|NCT04284787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712485|NCT04249622|Rifaximin|rifaximin|mesh-list
64712486|NCT04249622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64712487|NCT04249622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64712488|NCT04249622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64712489|NCT04246086|Lenalidomide|lenalidomide|mesh-list
64712490|NCT04246086|Immunologic Factors|immunologic factors|mesh-ancestor
64712491|NCT04246086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469470|NCT01092572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65469471|NCT01092572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469472|NCT03956966|Dexamethasone|dexamethasone|mesh-list
65469473|NCT03956966|Bupivacaine|bupivacaine|mesh-list
65469474|NCT03956966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65469475|NCT03956966|Antiemetics|antiemetics|mesh-ancestor
65469476|NCT03956966|Autonomic Agents|autonomic agents|mesh-ancestor
65469477|NCT03956966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65469478|NCT03956966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469479|NCT03956966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65469480|NCT03956966|Glucocorticoids|glucocorticoids|mesh-ancestor
65469481|NCT03956966|Hormones|hormones|mesh-ancestor
65469482|NCT03956966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65469483|NCT03956966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65469484|NCT03956966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469485|NCT03956966|Anesthetics, Local|anesthetics, local|mesh-ancestor
65469486|NCT03956966|Anesthetics|anesthetics|mesh-ancestor
65469487|NCT03956966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65469488|NCT03956966|Sensory System Agents|sensory system agents|mesh-ancestor
65469489|NCT00031694|Paclitaxel|paclitaxel|mesh-list
65469490|NCT00031694|Bryostatin 1|bryostatin 1|mesh-list
65469491|NCT00031694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65469492|NCT00031694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469493|NCT00031694|Tubulin Modulators|tubulin modulators|mesh-ancestor
65469494|NCT00031694|Antimitotic Agents|antimitotic agents|mesh-ancestor
65469495|NCT00031694|Mitosis Modulators|mitosis modulators|mesh-ancestor
65469496|NCT00031694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469497|NCT00031694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65469498|NCT00031694|Immunologic Factors|immunologic factors|mesh-ancestor
64712492|NCT04246086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64712493|NCT04246086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64712494|NCT04246086|Growth Substances|growth substances|mesh-ancestor
64712495|NCT04246086|Growth Inhibitors|growth inhibitors|mesh-ancestor
64712496|NCT04246086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712497|NCT04234113|Pembrolizumab|pembrolizumab|mesh-list
64712498|NCT04234113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64712499|NCT04234113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712500|NCT04233515|Anticoagulants|anticoagulants|mesh-list
64712538|NCT04195633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64712539|NCT04195633|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64712540|NCT04195633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712561|NCT04167514|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64712562|NCT04150042|Vitamins|vitamins|mesh-list
64712563|NCT04150042|Ascorbic Acid|ascorbic acid|mesh-list
64712564|NCT04150042|Vitamin B 12|vitamin b 12|mesh-list
64712565|NCT04150042|Hydroxocobalamin|hydroxocobalamin|mesh-list
64712566|NCT04150042|Ethanol|ethanol|mesh-list
65469499|NCT00031694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469500|NCT03953066|Melatonin|melatonin|mesh-list
65469501|NCT03953066|Antioxidants|antioxidants|mesh-ancestor
65469502|NCT03953066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469503|NCT03953066|Protective Agents|protective agents|mesh-ancestor
65469504|NCT03953066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469505|NCT03953066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65469506|NCT00093795|Gemcitabine|gemcitabine|mesh-list
65469507|NCT00093795|Paclitaxel|paclitaxel|mesh-list
65469508|NCT00093795|Docetaxel|docetaxel|mesh-list
65469509|NCT00093795|Cyclophosphamide|cyclophosphamide|mesh-list
65469510|NCT00093795|Doxorubicin|doxorubicin|mesh-list
65469511|NCT00093795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65469512|NCT00093795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469513|NCT00093795|Tubulin Modulators|tubulin modulators|mesh-ancestor
65469514|NCT00093795|Antimitotic Agents|antimitotic agents|mesh-ancestor
65469515|NCT00093795|Mitosis Modulators|mitosis modulators|mesh-ancestor
65469516|NCT00093795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469517|NCT00093795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65469518|NCT00093795|Immunologic Factors|immunologic factors|mesh-ancestor
65469519|NCT00093795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469520|NCT00093795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64712567|NCT04150042|Melphalan|melphalan|mesh-list
64712568|NCT04150042|Carmustine|carmustine|mesh-list
64712569|NCT04150042|Micronutrients|micronutrients|mesh-ancestor
64712570|NCT04150042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712571|NCT04150042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64712572|NCT04150042|Alkylating Agents|alkylating agents|mesh-ancestor
64712573|NCT04150042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712574|NCT04150042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712575|NCT04150042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64712576|NCT04150042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64712577|NCT04150042|Immunologic Factors|immunologic factors|mesh-ancestor
64712578|NCT04150042|Antioxidants|antioxidants|mesh-ancestor
64945634|NCT05379322|Upadacitinib|upadacitinib|mesh-list
64712593|NCT04125927|Cysteamine|cysteamine|mesh-list
64712594|NCT04125927|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
64712595|NCT04125927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712597|NCT04109729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64712598|NCT04109729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712599|NCT04109729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64712600|NCT04109729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712601|NCT04109066|Paclitaxel|paclitaxel|mesh-list
64712602|NCT04109066|Cyclophosphamide|cyclophosphamide|mesh-list
64712603|NCT04109066|Nivolumab|nivolumab|mesh-list
64712604|NCT04109066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64719633|NCT00000212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64719634|NCT00000212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719635|NCT00000212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719636|NCT00000212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64719637|NCT00000212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64719638|NCT00000212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65469521|NCT00093795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65469522|NCT00093795|Alkylating Agents|alkylating agents|mesh-ancestor
65469523|NCT00093795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65469524|NCT00093795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65469525|NCT00093795|Antimetabolites|antimetabolites|mesh-ancestor
65469526|NCT00093795|Antiviral Agents|antiviral agents|mesh-ancestor
65469527|NCT00093795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65469528|NCT00093795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469529|NCT00093795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65469530|NCT00093795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65469531|NCT00093795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65469532|NCT01092806|Tacrolimus|tacrolimus|mesh-list
65469533|NCT01092806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65469534|NCT01092806|Immunologic Factors|immunologic factors|mesh-ancestor
65469535|NCT01092806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469536|NCT01092806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65469537|NCT01092806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469538|NCT01092806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469539|NCT01094912|Analgesics, Opioid|analgesics, opioid|mesh-list
65469540|NCT01094912|Narcotics|narcotics|mesh-ancestor
65469541|NCT01094912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65469542|NCT01094912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469543|NCT01094912|Analgesics|analgesics|mesh-ancestor
65469544|NCT01094912|Sensory System Agents|sensory system agents|mesh-ancestor
65469545|NCT01094912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65469546|NCT01092962|Mycophenolic Acid|mycophenolic acid|mesh-list
65469547|NCT01092962|Cyclophosphamide|cyclophosphamide|mesh-list
65469548|NCT01092962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65469549|NCT01092962|Immunologic Factors|immunologic factors|mesh-ancestor
64719639|NCT00000212|Adrenergic Agents|adrenergic agents|mesh-ancestor
64719640|NCT00000212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64719641|NCT00000212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327724|NCT01654731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64327725|NCT01654731|Antimetabolites|antimetabolites|mesh-ancestor
64327726|NCT01654731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327727|NCT01654731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64712667|NCT04093323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64712668|NCT04093323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64712669|NCT04093323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64712670|NCT04093323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64712671|NCT04093323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64712672|NCT04093323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712673|NCT04093323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712674|NCT04093323|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64712675|NCT04093024|Nintedanib|nintedanib|mesh-list
64712676|NCT04093024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469550|NCT01092962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469551|NCT01092962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65469552|NCT01092962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65469553|NCT01092962|Alkylating Agents|alkylating agents|mesh-ancestor
65469554|NCT01092962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469555|NCT01092962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469556|NCT01092962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65469557|NCT01092962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65469558|NCT01092962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65469559|NCT01092962|Antitubercular Agents|antitubercular agents|mesh-ancestor
65469560|NCT01092962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65469561|NCT01092962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65469562|NCT01092962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469563|NCT03802994|Vaccines|vaccines|mesh-list
65469564|NCT03802994|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65469565|NCT03802994|Immunologic Factors|immunologic factors|mesh-ancestor
65469566|NCT03802994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469567|NCT01088919|Pioglitazone|pioglitazone|mesh-list
64712677|NCT04093024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64712678|NCT04093024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712679|NCT04093024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712680|NCT04091503|Temozolomide|temozolomide|mesh-list
64712681|NCT04091503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64712682|NCT04091503|Alkylating Agents|alkylating agents|mesh-ancestor
64719668|NCT00000950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64719669|NCT00000950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719670|NCT00000950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327741|NCT00485563|Sensory System Agents|sensory system agents|mesh-ancestor
64327742|NCT00485563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64327743|NCT00485563|Hematinics|hematinics|mesh-ancestor
64327744|NCT00485563|Vitamins|vitamins|mesh-ancestor
64327745|NCT00485563|Micronutrients|micronutrients|mesh-ancestor
64327746|NCT00485563|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64327747|NCT02170805|Pantoprazole|pantoprazole|mesh-list
64712683|NCT04091503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712684|NCT04091503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712685|NCT04087668|Anesthetics|anesthetics|mesh-list
64712686|NCT04087668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64712687|NCT04087668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712688|NCT04086485|Olaparib|olaparib|mesh-list
64712689|NCT04086485|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64712690|NCT04086485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712691|NCT04086485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712692|NCT04086485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712693|NCT04067752|Dialysis Solutions|dialysis solutions|mesh-list
64712694|NCT04067752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64712695|NCT04058067|Aflibercept|aflibercept|mesh-list
64712696|NCT04058067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64712709|NCT04047472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712710|NCT04047472|Growth Inhibitors|growth inhibitors|mesh-ancestor
64712711|NCT04047472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712712|NCT04044534|Insulin|insulin|mesh-list
64712713|NCT04044534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64712714|NCT04044534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712715|NCT04020913|Hormones|hormones|mesh-list
65469568|NCT01088919|Ipragliflozin|ipragliflozin|mesh-list
65469569|NCT01088919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65469570|NCT01088919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469571|NCT01088919|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65469572|NCT01088919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469573|NCT03802916|Deferiprone|deferiprone|mesh-list
65469574|NCT03802916|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65469575|NCT03802916|Chelating Agents|chelating agents|mesh-ancestor
65469576|NCT03802916|Sequestering Agents|sequestering agents|mesh-ancestor
65469577|NCT03802916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469578|NCT03720340|Oprelvekin|oprelvekin|mesh-list
65469579|NCT03720340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469580|NCT01094990|Dexamethasone|dexamethasone|mesh-list
65469581|NCT01094990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65469582|NCT01094990|Antiemetics|antiemetics|mesh-ancestor
65469583|NCT01094990|Autonomic Agents|autonomic agents|mesh-ancestor
65469584|NCT01094990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65469585|NCT01094990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469586|NCT01094990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65469587|NCT01094990|Glucocorticoids|glucocorticoids|mesh-ancestor
65469588|NCT01094990|Hormones|hormones|mesh-ancestor
65469589|NCT01094990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65469590|NCT01094990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65469591|NCT01094990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469592|NCT01584050|Folic Acid|folic acid|mesh-list
65469593|NCT01584050|Hematinics|hematinics|mesh-ancestor
65469594|NCT01584050|Vitamin B Complex|vitamin b complex|mesh-ancestor
65469595|NCT01584050|Vitamins|vitamins|mesh-ancestor
65469596|NCT01584050|Micronutrients|micronutrients|mesh-ancestor
64853688|NCT01704092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64712716|NCT04020913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64712717|NCT04020913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712718|NCT04014790|KRN 7000|krn 7000|mesh-list
64712719|NCT04014790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64712720|NCT04014790|Immunologic Factors|immunologic factors|mesh-ancestor
64712721|NCT04014790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712722|NCT04014790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712723|NCT03971474|Gemcitabine|gemcitabine|mesh-list
64712724|NCT03971474|Docetaxel|docetaxel|mesh-list
64712739|NCT03971474|Antiviral Agents|antiviral agents|mesh-ancestor
64712740|NCT03971474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64712741|NCT03971474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712742|NCT03971474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64712743|NCT03971474|Tubulin Modulators|tubulin modulators|mesh-ancestor
64712744|NCT03971474|Antimitotic Agents|antimitotic agents|mesh-ancestor
64712745|NCT03971474|Mitosis Modulators|mitosis modulators|mesh-ancestor
65469597|NCT01584050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469598|NCT03952832|Leflunomide|leflunomide|mesh-list
65469599|NCT03952832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469600|NCT03952832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469601|NCT03952832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65469602|NCT03952832|Immunologic Factors|immunologic factors|mesh-ancestor
65469603|NCT03952832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469604|NCT01311076|Insulin|insulin|mesh-list
65469605|NCT01311076|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65469606|NCT01311076|Insulin Lispro|insulin lispro|mesh-list
65469607|NCT01311076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65469608|NCT01311076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469609|NCT01098344|Gemcitabine|gemcitabine|mesh-list
65469610|NCT01098344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65469611|NCT01098344|Antimetabolites|antimetabolites|mesh-ancestor
65469612|NCT01098344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469613|NCT01098344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469614|NCT01098344|Antiviral Agents|antiviral agents|mesh-ancestor
65469615|NCT01098344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65469616|NCT01098344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469617|NCT01098344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65469618|NCT01098344|Immunologic Factors|immunologic factors|mesh-ancestor
65469619|NCT01098344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469620|NCT01098656|Lenalidomide|lenalidomide|mesh-list
65469621|NCT01098656|Immunologic Factors|immunologic factors|mesh-ancestor
65469622|NCT01098656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469623|NCT01098656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65469624|NCT01098656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64712746|NCT03971474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64712747|NCT03971474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64712757|NCT03969212|Baloxavir|baloxavir|mesh-list
64712758|NCT03969212|Antiviral Agents|antiviral agents|mesh-ancestor
64712759|NCT03969212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64712760|NCT03969212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712761|NCT03969212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712762|NCT03965234|Cisplatin|cisplatin|mesh-list
64712763|NCT03965234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712764|NCT03927690|Ranibizumab|ranibizumab|mesh-list
64712765|NCT03927690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64712766|NCT03927690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64712767|NCT03927690|Growth Substances|growth substances|mesh-ancestor
64712768|NCT03927690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712769|NCT03927690|Growth Inhibitors|growth inhibitors|mesh-ancestor
64712770|NCT03927690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712771|NCT03921060|Denosumab|denosumab|mesh-list
64712772|NCT03921060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64712773|NCT03921060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469625|NCT01098656|Growth Substances|growth substances|mesh-ancestor
65469626|NCT01098656|Growth Inhibitors|growth inhibitors|mesh-ancestor
65469627|NCT01098656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469628|NCT00076011|Mitogens|mitogens|mesh-list
65469629|NCT00076011|Endothelial Growth Factors|endothelial growth factors|mesh-list
65469630|NCT00076011|Mitosis Modulators|mitosis modulators|mesh-ancestor
65469631|NCT00076011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469632|NCT00076011|Growth Substances|growth substances|mesh-ancestor
65469633|NCT00076011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469634|NCT03465436|Moxifloxacin|moxifloxacin|mesh-list
65469635|NCT03465436|Lasmiditan|lasmiditan|mesh-list
65469636|NCT03465436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65469637|NCT03465436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65469638|NCT03465436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65469639|NCT03465436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65469640|NCT03465436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469641|NCT03465436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469642|NCT03465436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469643|NCT03465436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469644|NCT03465436|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65469645|NCT03465436|Serotonin Agents|serotonin agents|mesh-ancestor
65469646|NCT03465436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65469647|NCT01098890|Plasminogen|plasminogen|mesh-list
65469648|NCT01098890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65469649|NCT01098890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65469650|NCT01098890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65469651|NCT01098890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469652|NCT00053846|Buspirone|buspirone|mesh-list
65469653|NCT00053846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65469654|NCT00053846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65469655|NCT00053846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65469657|NCT00053846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65469667|NCT00090987|Imatinib Mesylate|imatinib mesylate|mesh-list
65469668|NCT00090987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469669|NCT00090987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65469670|NCT00090987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469671|NCT00090987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469673|NCT03489304|Anticonvulsants|anticonvulsants|mesh-ancestor
65469674|NCT03489304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65469675|NCT03489304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65469676|NCT03489304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469677|NCT03489304|GABA Modulators|gaba modulators|mesh-ancestor
65469678|NCT03489304|GABA Agents|gaba agents|mesh-ancestor
65469679|NCT03489304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65469680|NCT03489304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469681|NCT03718624|Paclitaxel|paclitaxel|mesh-list
65469682|NCT03718624|Apatinib|apatinib|mesh-list
65469683|NCT03718624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65469684|NCT03718624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469685|NCT03718624|Tubulin Modulators|tubulin modulators|mesh-ancestor
65469686|NCT03718624|Antimitotic Agents|antimitotic agents|mesh-ancestor
65469687|NCT03718624|Mitosis Modulators|mitosis modulators|mesh-ancestor
65469688|NCT03718624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469689|NCT03718624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65469690|NCT03718624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469691|NCT03543358|Immunoconjugates|immunoconjugates|mesh-list
65469692|NCT03543358|Immunologic Factors|immunologic factors|mesh-ancestor
65469718|NCT00060944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65469719|NCT00060944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469720|NCT00060944|Protease Inhibitors|protease inhibitors|mesh-ancestor
65469721|NCT00060944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469722|NCT00060944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469723|NCT00060944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65469724|NCT00060944|Alkylating Agents|alkylating agents|mesh-ancestor
65469725|NCT03956732|Vitamin D|vitamin d|mesh-list
65469726|NCT03956732|Caseins|caseins|mesh-list
65469727|NCT03956732|Vitamins|vitamins|mesh-ancestor
65469728|NCT03956732|Micronutrients|micronutrients|mesh-ancestor
65469729|NCT03956732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469730|NCT03956732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65469731|NCT03956732|Chelating Agents|chelating agents|mesh-ancestor
65469732|NCT03956732|Sequestering Agents|sequestering agents|mesh-ancestor
65469733|NCT03956732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469734|NCT01093274|Picosulfate sodium|picosulfate sodium|mesh-list
65469735|NCT01093274|Cathartics|cathartics|mesh-ancestor
65469736|NCT01093274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65469737|NCT01584206|Ezetimibe|ezetimibe|mesh-list
65469738|NCT01584206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65469739|NCT01584206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65469740|NCT01584206|Antimetabolites|antimetabolites|mesh-ancestor
65469741|NCT01584206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469742|NCT01584206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65469743|NCT03541252|Cisplatin|cisplatin|mesh-list
65469744|NCT03541252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469745|NCT00031460|Acyclovir|acyclovir|mesh-list
64853848|NCT01705002|Bevacizumab|bevacizumab|mesh-list
64712774|NCT03901001|Sirolimus|sirolimus|mesh-list
64712775|NCT03901001|Oseltamivir|oseltamivir|mesh-list
64712791|NCT03900988|Expectorants|expectorants|mesh-ancestor
64327759|NCT00606697|Vestipitant|vestipitant|mesh-list
64712792|NCT03900988|Respiratory System Agents|respiratory system agents|mesh-ancestor
64712793|NCT03900988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64712794|NCT03900988|Antioxidants|antioxidants|mesh-ancestor
64712795|NCT03900988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712796|NCT03900988|Protective Agents|protective agents|mesh-ancestor
64712797|NCT03900988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712798|NCT03900988|Antidotes|antidotes|mesh-ancestor
64712816|NCT03869190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64712817|NCT03869190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712818|NCT03869190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64712819|NCT03869190|Immunologic Factors|immunologic factors|mesh-ancestor
64712820|NCT03869190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712821|NCT03869190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64712822|NCT03869190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64712823|NCT03866239|Atezolizumab|atezolizumab|mesh-list
65469746|NCT00031460|Antiviral Agents|antiviral agents|mesh-ancestor
65469747|NCT00031460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65469748|NCT03540160|Serlopitant|serlopitant|mesh-list
65469749|NCT03540160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65469750|NCT03540160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65469751|NCT03540160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469752|NCT03540160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469753|NCT01095302|Docetaxel|docetaxel|mesh-list
65469754|NCT01095302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469755|NCT01095302|Tubulin Modulators|tubulin modulators|mesh-ancestor
65469756|NCT01095302|Antimitotic Agents|antimitotic agents|mesh-ancestor
65469757|NCT01095302|Mitosis Modulators|mitosis modulators|mesh-ancestor
65469758|NCT01095302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469759|NCT03459040|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65469760|NCT03459040|Protein C Inhibitor|protein c inhibitor|mesh-list
65469761|NCT03459040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65469762|NCT03459040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65469763|NCT03459040|Protease Inhibitors|protease inhibitors|mesh-ancestor
65469764|NCT03459040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469765|NCT03459040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469766|NCT03457636|Doxycycline|doxycycline|mesh-list
65469767|NCT03457636|Adapalene|adapalene|mesh-list
65469768|NCT03457636|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
65469769|NCT03457636|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65469770|NCT03457636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65469771|NCT03457636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65469772|NCT03457636|Antimalarials|antimalarials|mesh-ancestor
65469794|NCT01099436|Alkylating Agents|alkylating agents|mesh-ancestor
65469795|NCT01099436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469796|NCT01099436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469797|NCT01099436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65469798|NCT01099436|Tubulin Modulators|tubulin modulators|mesh-ancestor
65469799|NCT01099436|Antimitotic Agents|antimitotic agents|mesh-ancestor
65469800|NCT01099436|Mitosis Modulators|mitosis modulators|mesh-ancestor
65469801|NCT01099436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65469802|NCT01099436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65469803|NCT01099436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65469804|NCT01099436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469805|NCT01099436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65469807|NCT01099592|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65469808|NCT01099592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65469809|NCT01099592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65469810|NCT01099592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469811|NCT01099592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65469812|NCT01099592|Serotonin Agents|serotonin agents|mesh-ancestor
65469813|NCT01099592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469814|NCT01099592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65469815|NCT01099592|Antidepressive Agents|antidepressive agents|mesh-ancestor
64712824|NCT03866239|Obinutuzumab|obinutuzumab|mesh-list
64712825|NCT03866239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712826|NCT03866239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64712827|NCT03859973|BI 425809|bi 425809|mesh-list
64712828|NCT03859973|Nootropic Agents|nootropic agents|mesh-ancestor
64712829|NCT03841617|Hormones|hormones|mesh-list
64327791|NCT02174939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327792|NCT02174939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64327793|NCT02174939|Vasodilator Agents|vasodilator agents|mesh-ancestor
64327794|NCT02174939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64712841|NCT03820986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64712842|NCT03820986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712843|NCT03820986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712844|NCT03805789|Protease Inhibitors|protease inhibitors|mesh-list
64712845|NCT03805789|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64712846|NCT03805789|Protein C Inhibitor|protein c inhibitor|mesh-list
64712847|NCT03805789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712848|NCT03805789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712849|NCT03805789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64712850|NCT03805789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64712851|NCT03748303|Pregnanolone|pregnanolone|mesh-list
64712852|NCT03748303|Anesthetics|anesthetics|mesh-ancestor
64712890|NCT03672630|Antitubercular Agents|antitubercular agents|mesh-ancestor
64712891|NCT03672630|Leprostatic Agents|leprostatic agents|mesh-ancestor
64712892|NCT03672630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64712893|NCT03672630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712894|NCT03672630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712895|NCT03672630|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64719748|NCT00000242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65469816|NCT01099592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65469817|NCT01099748|Methadone|methadone|mesh-list
65469818|NCT01099748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65469819|NCT01099748|Narcotics|narcotics|mesh-ancestor
65469820|NCT01099748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65469821|NCT01099748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469822|NCT01099748|Analgesics|analgesics|mesh-ancestor
65469823|NCT01099748|Sensory System Agents|sensory system agents|mesh-ancestor
65469824|NCT01099748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65469825|NCT01099748|Antitussive Agents|antitussive agents|mesh-ancestor
65469826|NCT01099748|Respiratory System Agents|respiratory system agents|mesh-ancestor
65469827|NCT03481816|Vaccines|vaccines|mesh-list
65469828|NCT03481816|Immunologic Factors|immunologic factors|mesh-ancestor
65469829|NCT03481816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469830|NCT03956888|Acetylcysteine|acetylcysteine|mesh-list
64719749|NCT00000242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719750|NCT00000242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64719751|NCT00000242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64719752|NCT00000242|Analgesics|analgesics|mesh-ancestor
64719753|NCT00000242|Sensory System Agents|sensory system agents|mesh-ancestor
64719754|NCT00000242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719755|NCT00000242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64719756|NCT00000242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64719757|NCT00000242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719758|NCT00000242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64719759|NCT00000242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64719760|NCT00000980|Spiramycin|spiramycin|mesh-list
64719761|NCT00000980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64719762|NCT00000980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719763|NCT00000980|Coccidiostats|coccidiostats|mesh-ancestor
64719764|NCT00000980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64719765|NCT00000980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64719766|NCT00000992|Itraconazole|itraconazole|mesh-list
64719767|NCT00000992|Antifungal Agents|antifungal agents|mesh-ancestor
64719773|NCT00000992|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64719774|NCT00000992|Hormone Antagonists|hormone antagonists|mesh-ancestor
64719775|NCT00000992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64719776|NCT00000992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719777|NCT00000992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64719779|NCT00000254|Isoflurane|isoflurane|mesh-list
64719780|NCT00000254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64719781|NCT00000254|Anesthetics, General|anesthetics, general|mesh-ancestor
64719782|NCT00000254|Anesthetics|anesthetics|mesh-ancestor
64719783|NCT00000254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64459073|NCT03587194|Apremilast|apremilast|mesh-list
64719785|NCT00000254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64719786|NCT00000254|Analgesics|analgesics|mesh-ancestor
64719787|NCT00000254|Sensory System Agents|sensory system agents|mesh-ancestor
64719788|NCT00000254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719789|NCT00000260|Nitrous Oxide|nitrous oxide|mesh-list
64719790|NCT00000260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64327796|NCT02174939|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64327797|NCT02174939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64327798|NCT02174939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327799|NCT02404233|Darunavir|darunavir|mesh-list
64327800|NCT02404233|Cobicistat|cobicistat|mesh-list
64327801|NCT02404233|Rilpivirine|rilpivirine|mesh-list
64327802|NCT02404233|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
64712896|NCT03672630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64438116|NCT04375631|Cytarabine|cytarabine|mesh-list
64712897|NCT03672630|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64712898|NCT03672630|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65469831|NCT03956888|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65469832|NCT03956888|Antiviral Agents|antiviral agents|mesh-ancestor
65469833|NCT03956888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65469834|NCT03956888|Expectorants|expectorants|mesh-ancestor
65469835|NCT03956888|Respiratory System Agents|respiratory system agents|mesh-ancestor
65469836|NCT03956888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65469837|NCT03956888|Antioxidants|antioxidants|mesh-ancestor
65469838|NCT03956888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469839|NCT03956888|Protective Agents|protective agents|mesh-ancestor
65469840|NCT03956888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469841|NCT03956888|Antidotes|antidotes|mesh-ancestor
65469842|NCT03955406|Anesthetics|anesthetics|mesh-list
65469843|NCT03955406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65469844|NCT03955406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469845|NCT03538054|Dextromethorphan|dextromethorphan|mesh-list
65469846|NCT03538054|Antitussive Agents|antitussive agents|mesh-ancestor
65469847|NCT03538054|Respiratory System Agents|respiratory system agents|mesh-ancestor
65469848|NCT03538054|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65469849|NCT03538054|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65469850|NCT03538054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65469851|NCT03538054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853952|NCT01705639|Melatonin|melatonin|mesh-list
64712899|NCT03672630|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64712900|NCT03672630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64719798|NCT00000260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719799|NCT00000266|Flupenthixol|flupenthixol|mesh-list
64719800|NCT00000266|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
64719801|NCT00000266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64719802|NCT00000266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64719803|NCT00000266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64327803|NCT02404233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64327804|NCT02404233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64327805|NCT02404233|Protease Inhibitors|protease inhibitors|mesh-ancestor
64327806|NCT02404233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327807|NCT02404233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327808|NCT02404233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64712901|NCT03670966|Mycophenolic Acid|mycophenolic acid|mesh-list
64712902|NCT03670966|Cyclophosphamide|cyclophosphamide|mesh-list
64712903|NCT03670966|Fludarabine|fludarabine|mesh-list
64712904|NCT03670966|Fludarabine phosphate|fludarabine phosphate|mesh-list
64712905|NCT03670966|Tacrolimus|tacrolimus|mesh-list
64712906|NCT03670966|Antibodies|antibodies|mesh-list
64712907|NCT03670966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64712908|NCT03670966|Lenograstim|lenograstim|mesh-list
64712909|NCT03670966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64712910|NCT03670966|Immunologic Factors|immunologic factors|mesh-ancestor
64712911|NCT03670966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712915|NCT03670966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712917|NCT03670966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64712918|NCT03670966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64712919|NCT03670966|Antimetabolites|antimetabolites|mesh-ancestor
64712920|NCT03670966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64712921|NCT03670966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65469852|NCT03538054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469853|NCT03480802|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65469854|NCT03480802|Immunologic Factors|immunologic factors|mesh-ancestor
65469855|NCT03480802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469856|NCT00050960|Paclitaxel|paclitaxel|mesh-list
65469857|NCT00050960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65469858|NCT00050960|Carboplatin|carboplatin|mesh-list
65469859|NCT00050960|Bexarotene|bexarotene|mesh-list
65469860|NCT00050960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65469861|NCT00050960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469862|NCT00050960|Tubulin Modulators|tubulin modulators|mesh-ancestor
65469863|NCT00050960|Antimitotic Agents|antimitotic agents|mesh-ancestor
65469864|NCT00050960|Mitosis Modulators|mitosis modulators|mesh-ancestor
65469865|NCT00050960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469866|NCT00097773|Ciprofloxacin|ciprofloxacin|mesh-list
65469867|NCT00097773|Tobramycin|tobramycin|mesh-list
65469868|NCT00097773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65469869|NCT00097773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65469870|NCT00097773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65469871|NCT00097773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65469872|NCT00097773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469873|NCT00097773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469874|NCT00097773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469875|NCT00097773|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65469876|NCT00097773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64712922|NCT03670966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712923|NCT03670966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64712924|NCT03670966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64712925|NCT03670966|Antitubercular Agents|antitubercular agents|mesh-ancestor
64712926|NCT03670966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64327811|NCT02404233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64327812|NCT02404233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64327813|NCT02404233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64327814|NCT02404233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64327815|NCT02404233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64712927|NCT03670966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64712936|NCT03656718|Nivolumab|nivolumab|mesh-list
64712937|NCT03656718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64712938|NCT03656718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712939|NCT03656718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64712940|NCT03656718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712941|NCT03646175|Choline|choline|mesh-list
64327822|NCT00603577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327824|NCT02178293|Ketoprofen lysine|ketoprofen lysine|mesh-list
64327825|NCT02178293|Benzydamine|benzydamine|mesh-list
64327837|NCT03170895|Sorafenib|sorafenib|mesh-list
64327838|NCT03170895|Homoharringtonine|homoharringtonine|mesh-list
64327839|NCT03170895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327840|NCT03170895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65469877|NCT03480022|Liraglutide|liraglutide|mesh-list
65469878|NCT03480022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65469879|NCT03480022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469880|NCT03480022|Incretins|incretins|mesh-ancestor
65469881|NCT03480022|Hormones|hormones|mesh-ancestor
65469882|NCT03480022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65469883|NCT01093820|Epoetin Alfa|epoetin alfa|mesh-list
65469884|NCT01093820|Hematinics|hematinics|mesh-ancestor
65469885|NCT00049322|Bevacizumab|bevacizumab|mesh-list
65469886|NCT00049322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65469887|NCT00049322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469888|NCT00049322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65469889|NCT00049322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65469890|NCT00049322|Growth Substances|growth substances|mesh-ancestor
65469891|NCT00049322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469892|NCT00049322|Growth Inhibitors|growth inhibitors|mesh-ancestor
65469893|NCT00008138|Paclitaxel|paclitaxel|mesh-list
65469894|NCT00008138|Carboplatin|carboplatin|mesh-list
65469895|NCT00008138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65469896|NCT00008138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469897|NCT00008138|Tubulin Modulators|tubulin modulators|mesh-ancestor
65469898|NCT00008138|Antimitotic Agents|antimitotic agents|mesh-ancestor
65469899|NCT00008138|Mitosis Modulators|mitosis modulators|mesh-ancestor
65469900|NCT00008138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469901|NCT01100060|Azithromycin|azithromycin|mesh-list
65469902|NCT01100060|Chloroquine|chloroquine|mesh-list
65469903|NCT01100060|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65469904|NCT01100060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65469905|NCT01100060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65469906|NCT01100060|Amebicides|amebicides|mesh-ancestor
65469907|NCT01100060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65469908|NCT01100060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65469909|NCT01100060|Antimalarials|antimalarials|mesh-ancestor
65469910|NCT01100060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64853998|NCT01706055|Interferons|interferons|mesh-list
64327841|NCT03170895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712942|NCT03646175|Lipotropic Agents|lipotropic agents|mesh-ancestor
64712943|NCT03646175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64712944|NCT03646175|Antimetabolites|antimetabolites|mesh-ancestor
64712945|NCT03646175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712946|NCT03646175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64712947|NCT03646175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64712948|NCT03646175|Nootropic Agents|nootropic agents|mesh-ancestor
64712949|NCT03635164|Durvalumab|durvalumab|mesh-list
65469911|NCT01100060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65469912|NCT01100060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65469913|NCT01100060|Analgesics|analgesics|mesh-ancestor
65469914|NCT01100060|Sensory System Agents|sensory system agents|mesh-ancestor
65469915|NCT01100060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65469916|NCT01100060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469917|NCT01100060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65469918|NCT01100060|Filaricides|filaricides|mesh-ancestor
65469919|NCT01100060|Antinematodal Agents|antinematodal agents|mesh-ancestor
65469920|NCT01100060|Anthelmintics|anthelmintics|mesh-ancestor
65469921|NCT01100216|Nicotine|nicotine|mesh-list
65469922|NCT01100216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65469923|NCT01100216|Autonomic Agents|autonomic agents|mesh-ancestor
65469924|NCT01100216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65469925|NCT01100216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469926|NCT01100216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65469927|NCT01100216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64854029|NCT01706367|Vaccines|vaccines|mesh-list
64712950|NCT03635164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64712951|NCT03635164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712953|NCT03632369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64712954|NCT03632369|Anesthetics, General|anesthetics, general|mesh-ancestor
64712955|NCT03632369|Anesthetics|anesthetics|mesh-ancestor
64712956|NCT03632369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64719850|NCT05218148|Trastuzumab|trastuzumab|mesh-list
64719851|NCT05218148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64719852|NCT05218148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64327842|NCT03170895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327843|NCT03170895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64327844|NCT03170895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64327845|NCT02277847|Cytarabine|cytarabine|mesh-list
64327846|NCT02277847|Idarubicin|idarubicin|mesh-list
64327847|NCT02277847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64327848|NCT02277847|Antimetabolites|antimetabolites|mesh-ancestor
64327849|NCT02277847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327850|NCT02277847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327851|NCT02277847|Antiviral Agents|antiviral agents|mesh-ancestor
64712957|NCT03632369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712959|NCT03625687|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64712960|NCT03625687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64712961|NCT03605342|Buprenorphine|buprenorphine|mesh-list
64712962|NCT03605342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64712963|NCT03605342|Narcotics|narcotics|mesh-ancestor
64712964|NCT03605342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64712965|NCT03605342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712966|NCT03605342|Analgesics|analgesics|mesh-ancestor
64712967|NCT03605342|Sensory System Agents|sensory system agents|mesh-ancestor
64712968|NCT03605342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64712969|NCT03605342|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64712970|NCT03598842|Metronidazole|metronidazole|mesh-list
64712971|NCT03598842|Ivermectin|ivermectin|mesh-list
64719857|NCT00000278|Disulfiram|disulfiram|mesh-list
64719858|NCT00000278|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64719859|NCT00000278|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
64719860|NCT00000278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327853|NCT02277847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64327854|NCT02277847|Immunologic Factors|immunologic factors|mesh-ancestor
64327855|NCT02277847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469928|NCT01100216|Cholinergic Agents|cholinergic agents|mesh-ancestor
65469929|NCT01100216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65469930|NCT01100216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469931|NCT01100294|Vaccines|vaccines|mesh-list
65469932|NCT01100294|Immunologic Factors|immunologic factors|mesh-ancestor
65469933|NCT01100294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469934|NCT03436420|Calcium|calcium|mesh-list
65469935|NCT03436420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65469936|NCT03436420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469937|NCT01100372|Gemcitabine|gemcitabine|mesh-list
65469938|NCT01100372|Doxorubicin|doxorubicin|mesh-list
65469939|NCT01100372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65469940|NCT01100372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65469941|NCT01100372|Antimetabolites|antimetabolites|mesh-ancestor
65469942|NCT01100372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469943|NCT01100372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469944|NCT01100372|Antiviral Agents|antiviral agents|mesh-ancestor
65469945|NCT01100372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65469946|NCT01100372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469947|NCT01100372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65469948|NCT01100372|Immunologic Factors|immunologic factors|mesh-ancestor
65469949|NCT01100372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469950|NCT01100372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65469951|NCT01100372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65469952|NCT01100372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65469953|NCT00027560|Cyclosporine|cyclosporine|mesh-list
65469954|NCT00027560|Fludarabine|fludarabine|mesh-list
65469955|NCT00027560|Fludarabine phosphate|fludarabine phosphate|mesh-list
65469956|NCT00027560|Melphalan|melphalan|mesh-list
65469957|NCT00027560|Alemtuzumab|alemtuzumab|mesh-list
65469958|NCT00027560|Cyclosporins|cyclosporins|mesh-list
65469959|NCT00027560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854045|NCT01706510|Clopidogrel|clopidogrel|mesh-list
64327856|NCT02277847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64327857|NCT02277847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64327858|NCT02277847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64327859|NCT02277847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327860|NCT01457781|Nitric Oxide|nitric oxide|mesh-list
64327861|NCT01457781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64327862|NCT01457781|Autonomic Agents|autonomic agents|mesh-ancestor
64327863|NCT01457781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64327864|NCT01457781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327865|NCT01457781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64327866|NCT01457781|Respiratory System Agents|respiratory system agents|mesh-ancestor
64327867|NCT01457781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65469960|NCT00027560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65469961|NCT00027560|Antimetabolites|antimetabolites|mesh-ancestor
65469962|NCT00027560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469963|NCT00027560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65469964|NCT00027560|Immunologic Factors|immunologic factors|mesh-ancestor
65469965|NCT00027560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469966|NCT00027560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469967|NCT00027560|Antifungal Agents|antifungal agents|mesh-ancestor
65469968|NCT00027560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65469969|NCT00027560|Dermatologic Agents|dermatologic agents|mesh-ancestor
65469970|NCT00027560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65469971|NCT00027560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65469972|NCT00027560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65469973|NCT00027560|Alkylating Agents|alkylating agents|mesh-ancestor
65469974|NCT00027560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65469975|NCT00027560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65469976|NCT02529878|Paclitaxel|paclitaxel|mesh-list
65469977|NCT02529878|Apatinib|apatinib|mesh-list
65469978|NCT02529878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65469979|NCT02529878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65469980|NCT02529878|Tubulin Modulators|tubulin modulators|mesh-ancestor
65469981|NCT02529878|Antimitotic Agents|antimitotic agents|mesh-ancestor
65469982|NCT02529878|Mitosis Modulators|mitosis modulators|mesh-ancestor
65469983|NCT02529878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65469984|NCT02529878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65469985|NCT02529878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65469986|NCT03451006|Metformin|metformin|mesh-list
65469987|NCT03451006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65469988|NCT03451006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469989|NCT05625854|Cocaine|cocaine|mesh-list
65469990|NCT05625854|Anesthetics, Local|anesthetics, local|mesh-ancestor
65469991|NCT05625854|Anesthetics|anesthetics|mesh-ancestor
64712972|NCT03598842|Albendazole|albendazole|mesh-list
64327868|NCT01457781|Antioxidants|antioxidants|mesh-ancestor
64327869|NCT01457781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327870|NCT01457781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64327871|NCT01457781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64327872|NCT01457781|Vasodilator Agents|vasodilator agents|mesh-ancestor
64327873|NCT01457781|Gasotransmitters|gasotransmitters|mesh-ancestor
64327874|NCT01457781|Protective Agents|protective agents|mesh-ancestor
64327875|NCT00468403|Mycophenolic Acid|mycophenolic acid|mesh-list
64712973|NCT03598842|Antiparasitic Agents|antiparasitic agents|mesh-list
64712974|NCT03598842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65469992|NCT05625854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65469993|NCT05625854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65469994|NCT05625854|Sensory System Agents|sensory system agents|mesh-ancestor
65469995|NCT05625854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65469996|NCT05625854|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65469997|NCT05625854|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65469998|NCT05625854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65469999|NCT05625854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65470000|NCT05625854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470001|NCT05625854|Dopamine Agents|dopamine agents|mesh-ancestor
65470002|NCT05625854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65470003|NCT01327118|Dinoprost|dinoprost|mesh-list
65470004|NCT01327118|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
65470005|NCT01327118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65470006|NCT01327118|Abortifacient Agents|abortifacient agents|mesh-ancestor
65470007|NCT01327118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65470008|NCT01327118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470009|NCT01327118|Oxytocics|oxytocics|mesh-ancestor
65470010|NCT03449758|Hydroxychloroquine|hydroxychloroquine|mesh-list
65470011|NCT03449758|Chloroquine|chloroquine|mesh-list
65470012|NCT03449758|Sulfasalazine|sulfasalazine|mesh-list
65470013|NCT03449758|Methotrexate|methotrexate|mesh-list
65470014|NCT03449758|Azathioprine|azathioprine|mesh-list
65470015|NCT03449758|Leflunomide|leflunomide|mesh-list
64854103|NCT01707082|Anesthetics, General|anesthetics, general|mesh-ancestor
64854104|NCT01707082|Anesthetics|anesthetics|mesh-ancestor
64712975|NCT03598842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64712976|NCT03598842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64712977|NCT03598842|Anthelmintics|anthelmintics|mesh-ancestor
64712978|NCT03598842|Anticestodal Agents|anticestodal agents|mesh-ancestor
64712979|NCT03598842|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64712980|NCT03598842|Tubulin Modulators|tubulin modulators|mesh-ancestor
64712981|NCT03598842|Antimitotic Agents|antimitotic agents|mesh-ancestor
64712982|NCT03598842|Mitosis Modulators|mitosis modulators|mesh-ancestor
64712983|NCT03598842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712984|NCT03598842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713022|NCT03471364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64713023|NCT03471364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64713024|NCT03471364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64713025|NCT03471364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713026|NCT03471364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64713027|NCT03471364|Hormone Antagonists|hormone antagonists|mesh-ancestor
64713028|NCT03471364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64713029|NCT03471364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713030|NCT03471364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64713031|NCT03469284|Methylene Blue|methylene blue|mesh-list
64713032|NCT03469284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470016|NCT03449758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65470017|NCT03449758|Abortifacient Agents|abortifacient agents|mesh-ancestor
65470018|NCT03449758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65470019|NCT03449758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470020|NCT03449758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65470021|NCT03449758|Antimetabolites|antimetabolites|mesh-ancestor
65470022|NCT03449758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470023|NCT03449758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470024|NCT03449758|Dermatologic Agents|dermatologic agents|mesh-ancestor
65470025|NCT03449758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470026|NCT03449758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65470027|NCT03449758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65470028|NCT03449758|Immunologic Factors|immunologic factors|mesh-ancestor
65470029|NCT03449758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65219518|NCT00729859|Methyltestosterone|methyltestosterone|mesh-list
65470030|NCT03449758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65470031|NCT03449758|Antimalarials|antimalarials|mesh-ancestor
65470032|NCT03449758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65470033|NCT03449758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65470034|NCT03449758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65470036|NCT03449758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65470037|NCT03449758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65470038|NCT03449758|Analgesics|analgesics|mesh-ancestor
65470039|NCT03449758|Sensory System Agents|sensory system agents|mesh-ancestor
65470040|NCT03449758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65470041|NCT03449758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65470042|NCT03449758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65470043|NCT03449446|Firsocostat|firsocostat|mesh-list
65470044|NCT03449446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470045|NCT03449446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470046|NCT03716596|Antibodies|antibodies|mesh-list
65470047|NCT03716596|Immunologic Factors|immunologic factors|mesh-ancestor
65470048|NCT03716596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470049|NCT05650840|Calcium Carbonate|calcium carbonate|mesh-list
65470050|NCT05650840|Calcium|calcium|mesh-list
64713033|NCT03469284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713034|NCT03456076|Gemcitabine|gemcitabine|mesh-list
64719882|NCT00001940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64719883|NCT00001940|Hormone Antagonists|hormone antagonists|mesh-ancestor
65470051|NCT05650840|Charcoal|charcoal|mesh-list
65470052|NCT05650840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65470053|NCT05650840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470054|NCT05650840|Antacids|antacids|mesh-ancestor
65470055|NCT05650840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470056|NCT05650840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65470057|NCT05650840|Antidotes|antidotes|mesh-ancestor
65470058|NCT05650840|Protective Agents|protective agents|mesh-ancestor
65470059|NCT03722914|Benzonatate|benzonatate|mesh-list
65470060|NCT03722914|Antitussive Agents|antitussive agents|mesh-ancestor
65470061|NCT03722914|Respiratory System Agents|respiratory system agents|mesh-ancestor
65470062|NCT03429556|Botulinum Toxins|botulinum toxins|mesh-list
65470063|NCT03429556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65470064|NCT03429556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65470065|NCT03429556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470066|NCT03429556|Cholinergic Agents|cholinergic agents|mesh-ancestor
65470067|NCT03429556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65470068|NCT03429556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470069|NCT03444766|Nivolumab|nivolumab|mesh-list
65470070|NCT03444766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65470071|NCT03444766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470072|NCT03444766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65470073|NCT03444766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470074|NCT03526432|Bevacizumab|bevacizumab|mesh-list
65470075|NCT03526432|Atezolizumab|atezolizumab|mesh-list
65470076|NCT03526432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65470077|NCT03526432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470078|NCT03526432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65470079|NCT03526432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65470080|NCT03526432|Growth Substances|growth substances|mesh-ancestor
65470081|NCT03526432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470082|NCT03526432|Growth Inhibitors|growth inhibitors|mesh-ancestor
65470083|NCT01310842|Nicotine|nicotine|mesh-list
65470084|NCT01310842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65470085|NCT01310842|Autonomic Agents|autonomic agents|mesh-ancestor
64854165|NCT01707394|Apixaban|apixaban|mesh-list
64719884|NCT00001940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65470086|NCT01310842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65470087|NCT01310842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470088|NCT01310842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65470089|NCT01310842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65470090|NCT01310842|Cholinergic Agents|cholinergic agents|mesh-ancestor
65470091|NCT01310842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65470092|NCT01310842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470093|NCT03722290|Metformin|metformin|mesh-list
65470094|NCT03722290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65470095|NCT03722290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470096|NCT03523156|Azithromycin|azithromycin|mesh-list
65470097|NCT03523156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65470098|NCT03523156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65470099|NCT03717688|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65470100|NCT03717688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65470101|NCT03717688|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65470102|NCT03717688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65470103|NCT03717688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470104|NCT03717688|Incretins|incretins|mesh-ancestor
65470105|NCT03717688|Hormones|hormones|mesh-ancestor
64719888|NCT03907033|Anesthetics, Local|anesthetics, local|mesh-ancestor
64719889|NCT03907033|Anesthetics|anesthetics|mesh-ancestor
64327876|NCT00468403|Abatacept|abatacept|mesh-list
64327877|NCT00468403|Tacrolimus|tacrolimus|mesh-list
64327878|NCT00468403|Basiliximab|basiliximab|mesh-list
64327879|NCT00468403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64327880|NCT00468403|Immunologic Factors|immunologic factors|mesh-ancestor
64327881|NCT00468403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327882|NCT00468403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64327883|NCT00468403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327884|NCT00468403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327885|NCT00468403|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64327886|NCT00468403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327887|NCT00468403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64327888|NCT00468403|Antitubercular Agents|antitubercular agents|mesh-ancestor
64713035|NCT03456076|Carboplatin|carboplatin|mesh-list
64713050|NCT03456076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64713051|NCT03456076|Tubulin Modulators|tubulin modulators|mesh-ancestor
64713052|NCT03456076|Antimitotic Agents|antimitotic agents|mesh-ancestor
64713053|NCT03456076|Mitosis Modulators|mitosis modulators|mesh-ancestor
64713054|NCT03425331|Nivolumab|nivolumab|mesh-list
64713055|NCT03425331|Ipilimumab|ipilimumab|mesh-list
64713056|NCT03425331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64713057|NCT03425331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713058|NCT03425331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64713059|NCT03425331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713060|NCT03366155|Oxaliplatin|oxaliplatin|mesh-list
64713061|NCT03366155|Irinotecan|irinotecan|mesh-list
64713062|NCT03366155|Cetuximab|cetuximab|mesh-list
64713063|NCT03366155|Panitumumab|panitumumab|mesh-list
64713064|NCT03366155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713065|NCT03366155|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64713066|NCT03366155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64719890|NCT03907033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64719891|NCT03907033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470106|NCT03717688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65470107|NCT03717688|Protease Inhibitors|protease inhibitors|mesh-ancestor
65470108|NCT03717688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470109|NCT03717688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470110|NCT03717688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65470111|NCT02953678|Prednisone|prednisone|mesh-list
65470112|NCT02953678|Methylprednisolone|methylprednisolone|mesh-list
65470113|NCT02953678|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65470114|NCT02953678|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65470115|NCT02953678|Prednisolone|prednisolone|mesh-list
65470116|NCT02953678|Prednisolone acetate|prednisolone acetate|mesh-list
65470117|NCT02953678|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65470118|NCT02953678|Prednisolone phosphate|prednisolone phosphate|mesh-list
65470119|NCT02953678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65470120|NCT02953678|Glucocorticoids|glucocorticoids|mesh-ancestor
65470121|NCT02953678|Hormones|hormones|mesh-ancestor
64854219|NCT01707615|Proanthocyanidin|proanthocyanidin|mesh-list
64719892|NCT03907033|Sensory System Agents|sensory system agents|mesh-ancestor
64719893|NCT03907033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719894|NCT00001034|Ganciclovir|ganciclovir|mesh-list
64719895|NCT00001034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64719896|NCT00001034|Antiviral Agents|antiviral agents|mesh-ancestor
64719897|NCT00001034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719898|NCT00001034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64719899|NCT00001034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719900|NCT00001034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719901|NCT03818815|Amoxicillin|amoxicillin|mesh-list
64719902|NCT03818815|Clavulanic Acid|clavulanic acid|mesh-list
64327889|NCT00468403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64327890|NCT00468403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64327891|NCT00468403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64327892|NCT00468403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64327894|NCT02175017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64327895|NCT02175017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327896|NCT02175017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64327897|NCT02175017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327898|NCT02178449|Dexamethasone|dexamethasone|mesh-list
64327899|NCT02178449|Dexamethasone acetate|dexamethasone acetate|mesh-list
64327900|NCT02178449|Ropivacaine|ropivacaine|mesh-list
64327901|NCT02178449|BB 1101|bb 1101|mesh-list
64327902|NCT02178449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64713067|NCT03366155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64713068|NCT03366155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713069|NCT03366155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64713075|NCT03276832|Pembrolizumab|pembrolizumab|mesh-list
64713076|NCT03276832|Imiquimod|imiquimod|mesh-list
64713077|NCT03276832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64713078|NCT03276832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713079|NCT03276832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64713080|NCT03276832|Immunologic Factors|immunologic factors|mesh-ancestor
64713081|NCT03276832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713082|NCT03276832|Interferon Inducers|interferon inducers|mesh-ancestor
64719927|NCT00001964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64719928|NCT03801265|Ropivacaine|ropivacaine|mesh-list
64327910|NCT02178449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64327911|NCT02178449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64327912|NCT02178449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470122|NCT02953678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65470123|NCT02953678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470124|NCT02953678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65470125|NCT02953678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470126|NCT02953678|Antiemetics|antiemetics|mesh-ancestor
65470127|NCT02953678|Autonomic Agents|autonomic agents|mesh-ancestor
65470128|NCT02953678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65470129|NCT02953678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65470130|NCT02953678|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65470131|NCT02953678|Protective Agents|protective agents|mesh-ancestor
65470132|NCT00090753|Epoetin Alfa|epoetin alfa|mesh-list
65470133|NCT00090753|Darbepoetin alfa|darbepoetin alfa|mesh-list
65470134|NCT00090753|Hematinics|hematinics|mesh-ancestor
65470135|NCT00048932|Abatacept|abatacept|mesh-list
65470136|NCT00048932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65470137|NCT00048932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470138|NCT00048932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470139|NCT00048932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65470140|NCT00048932|Immunologic Factors|immunologic factors|mesh-ancestor
65470141|NCT00048932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327913|NCT02178449|Anesthetics, Local|anesthetics, local|mesh-ancestor
64719940|NCT00000290|Sensory System Agents|sensory system agents|mesh-ancestor
64719941|NCT00000290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719942|NCT00000290|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64719943|NCT00000290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64719944|NCT00000290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64719945|NCT00000290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64719946|NCT00000290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719947|NCT00000290|Dopamine Agents|dopamine agents|mesh-ancestor
64327914|NCT02178449|Anesthetics|anesthetics|mesh-ancestor
64327915|NCT02178449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64327916|NCT02178449|Sensory System Agents|sensory system agents|mesh-ancestor
64327917|NCT02178449|Protease Inhibitors|protease inhibitors|mesh-ancestor
64327918|NCT02178449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327919|NCT02178449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713126|NCT03149211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64713127|NCT03149211|Antiviral Agents|antiviral agents|mesh-ancestor
64713128|NCT03149211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64713129|NCT03141671|Prednisone|prednisone|mesh-list
64713130|NCT03141671|Bicalutamide|bicalutamide|mesh-list
64713131|NCT03141671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64713132|NCT03141671|Glucocorticoids|glucocorticoids|mesh-ancestor
64713133|NCT03141671|Hormones|hormones|mesh-ancestor
64713134|NCT03141671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64719953|NCT00000302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719954|NCT00000302|Analgesics|analgesics|mesh-ancestor
64719955|NCT00000302|Sensory System Agents|sensory system agents|mesh-ancestor
64719956|NCT00000302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719957|NCT00000302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64327920|NCT02387931|Vitamin D|vitamin d|mesh-list
64327921|NCT02387931|Ergocalciferols|ergocalciferols|mesh-list
64327922|NCT02387931|Cholecalciferol|cholecalciferol|mesh-list
64327923|NCT02387931|Vitamins|vitamins|mesh-list
64327924|NCT02387931|Micronutrients|micronutrients|mesh-ancestor
65470142|NCT00048932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65470143|NCT00073983|Gemcitabine|gemcitabine|mesh-list
65470144|NCT00073983|Docetaxel|docetaxel|mesh-list
65470145|NCT00073983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65470146|NCT00073983|Antimetabolites|antimetabolites|mesh-ancestor
65470147|NCT00073983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470148|NCT00073983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470149|NCT00073983|Antiviral Agents|antiviral agents|mesh-ancestor
65470150|NCT00073983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65470151|NCT00073983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470152|NCT00073983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65470153|NCT00073983|Immunologic Factors|immunologic factors|mesh-ancestor
65470154|NCT00073983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470155|NCT00073983|Tubulin Modulators|tubulin modulators|mesh-ancestor
65470156|NCT00073983|Antimitotic Agents|antimitotic agents|mesh-ancestor
65470157|NCT00073983|Mitosis Modulators|mitosis modulators|mesh-ancestor
65470158|NCT02952820|Lemborexant|lemborexant|mesh-list
65470159|NCT02952820|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65470160|NCT02952820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65470161|NCT02952820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470162|NCT02952820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65470163|NCT02952820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65470164|NCT02952820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65470165|NCT02952820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470166|NCT01583361|Oxaliplatin|oxaliplatin|mesh-list
65470167|NCT01583361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470168|NCT01085487|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
65470169|NCT01085487|Levonorgestrel|levonorgestrel|mesh-list
65470170|NCT01085487|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65470171|NCT01085487|Contraceptive Agents|contraceptive agents|mesh-ancestor
65470172|NCT01085487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65470173|NCT01085487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470174|NCT01085487|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65470175|NCT01085487|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65470176|NCT01085487|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64854255|NCT01707823|Antipyretics|antipyretics|mesh-ancestor
64327925|NCT02387931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327926|NCT02387931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65470177|NCT01085487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65470178|NCT01085487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470179|NCT01085487|Hemostatics|hemostatics|mesh-ancestor
65470180|NCT01085487|Coagulants|coagulants|mesh-ancestor
65470182|NCT01089309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65470183|NCT01089309|Hormone Antagonists|hormone antagonists|mesh-ancestor
65470184|NCT01089309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65470185|NCT01089309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470186|NCT01089309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65470187|NCT01089309|Diuretics|diuretics|mesh-ancestor
65470188|NCT01089309|Natriuretic Agents|natriuretic agents|mesh-ancestor
65470189|NCT01085721|Chlorpheniramine|chlorpheniramine|mesh-list
65470190|NCT01085721|Phenylpropanolamine|phenylpropanolamine|mesh-list
65470191|NCT01085721|Pseudoephedrine|pseudoephedrine|mesh-list
65470192|NCT01085721|Ephedrine|ephedrine|mesh-list
65470193|NCT01085721|Guaifenesin|guaifenesin|mesh-list
65470194|NCT01085721|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
65470195|NCT01085721|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
65470196|NCT01085721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65470197|NCT01085721|Autonomic Agents|autonomic agents|mesh-ancestor
65470198|NCT01085721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65470199|NCT01085721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470200|NCT01085721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65470201|NCT01085721|Respiratory System Agents|respiratory system agents|mesh-ancestor
65470202|NCT01085721|Nasal Decongestants|nasal decongestants|mesh-ancestor
65470203|NCT01085721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65470204|NCT01085721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65470205|NCT01085721|Sympathomimetics|sympathomimetics|mesh-ancestor
65470209|NCT01085721|Expectorants|expectorants|mesh-ancestor
65470224|NCT00006392|Tocotrienols|tocotrienols|mesh-list
65470225|NCT00006392|alpha-Tocopherol|alpha-tocopherol|mesh-list
65470226|NCT00006392|Selenium|selenium|mesh-list
65470227|NCT00006392|Micronutrients|micronutrients|mesh-ancestor
65470228|NCT00006392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470229|NCT00006392|Antioxidants|antioxidants|mesh-ancestor
65470230|NCT00006392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470231|NCT00006392|Protective Agents|protective agents|mesh-ancestor
65470232|NCT00006392|Trace Elements|trace elements|mesh-ancestor
65470233|NCT01089621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65470234|NCT01089621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65470235|NCT01089621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65470236|NCT01089621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65470237|NCT01089621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470238|NCT01089621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65470239|NCT01089621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470240|NCT01089621|Analgesics|analgesics|mesh-ancestor
64327927|NCT02387931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64327928|NCT02281669|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
64713135|NCT03141671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713136|NCT03141671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64713137|NCT03141671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713138|NCT03141671|Androgen Antagonists|androgen antagonists|mesh-ancestor
64713139|NCT03141671|Hormone Antagonists|hormone antagonists|mesh-ancestor
64713140|NCT03092817|Dexamethasone|dexamethasone|mesh-list
64713141|NCT03092817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64713142|NCT03092817|Antiemetics|antiemetics|mesh-ancestor
64713143|NCT03092817|Autonomic Agents|autonomic agents|mesh-ancestor
64713144|NCT03092817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64713145|NCT03092817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713146|NCT03092817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64713147|NCT03092817|Glucocorticoids|glucocorticoids|mesh-ancestor
64713148|NCT03092817|Hormones|hormones|mesh-ancestor
64713149|NCT03092817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64713150|NCT03092817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64713160|NCT03049462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64719965|NCT00001058|Ritonavir|ritonavir|mesh-list
64719966|NCT00001058|Indinavir|indinavir|mesh-list
64719967|NCT00001058|Clarithromycin|clarithromycin|mesh-list
64327929|NCT02281669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64327930|NCT02281669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64327931|NCT02281669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64327932|NCT02281669|Schistosomicides|schistosomicides|mesh-ancestor
64327933|NCT02281669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64327934|NCT02281669|Anthelmintics|anthelmintics|mesh-ancestor
64327935|NCT00829023|Povidone-Iodine|povidone-iodine|mesh-list
64327936|NCT00829023|Povidone|povidone|mesh-list
64327937|NCT00829023|Plasma Substitutes|plasma substitutes|mesh-ancestor
64327938|NCT00829023|Blood Substitutes|blood substitutes|mesh-ancestor
64713161|NCT03049462|Adrenergic Agents|adrenergic agents|mesh-ancestor
64713162|NCT03049462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64713163|NCT03049462|Urological Agents|urological agents|mesh-ancestor
64713164|NCT03043430|Midazolam|midazolam|mesh-list
64713165|NCT03043430|Ketamine|ketamine|mesh-list
64713166|NCT03043430|Analgesics|analgesics|mesh-ancestor
64713167|NCT03043430|Sensory System Agents|sensory system agents|mesh-ancestor
64713177|NCT03043430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64713178|NCT03043430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470241|NCT01089621|Sensory System Agents|sensory system agents|mesh-ancestor
65470242|NCT01089621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65470243|NCT01089621|Antidepressive Agents|antidepressive agents|mesh-ancestor
65470244|NCT01089621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65470245|NCT01089621|Dopamine Agents|dopamine agents|mesh-ancestor
65470246|NCT01101152|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65470247|NCT01101152|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65470248|NCT01101152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65470249|NCT01101152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65470250|NCT01101152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470251|NCT01101152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65470252|NCT01101152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470253|NCT01101152|Antidepressive Agents|antidepressive agents|mesh-ancestor
65066951|NCT00273026|Adrenergic Agents|adrenergic agents|mesh-ancestor
65470254|NCT01101152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65470255|NCT00379769|Metformin|metformin|mesh-list
65470256|NCT00379769|Rosiglitazone|rosiglitazone|mesh-list
65470257|NCT00379769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65470258|NCT00379769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470259|NCT00006164|Ribavirin|ribavirin|mesh-list
65470260|NCT00006164|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65470261|NCT00006164|Interferon-alpha|interferon-alpha|mesh-list
65470262|NCT00006164|Antimetabolites|antimetabolites|mesh-ancestor
65470263|NCT00006164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470264|NCT00006164|Antiviral Agents|antiviral agents|mesh-ancestor
65470265|NCT00006164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65470266|NCT00006164|Immunologic Factors|immunologic factors|mesh-ancestor
65470267|NCT00006164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470268|NCT00378599|Interferons|interferons|mesh-list
65470269|NCT00378599|Interferon-alpha|interferon-alpha|mesh-list
65470270|NCT00378599|Interferon alpha-2|interferon alpha-2|mesh-list
65470271|NCT00378599|Ribavirin|ribavirin|mesh-list
65470272|NCT00378599|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65470273|NCT00378599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470274|NCT00378599|Antiviral Agents|antiviral agents|mesh-ancestor
65470275|NCT00378599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65470279|NCT00378599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470280|NCT01046981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65470281|NCT01046981|Metronidazole|metronidazole|mesh-list
65470282|NCT01046981|Cefazolin|cefazolin|mesh-list
65470283|NCT01046981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65470284|NCT01046981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65470285|NCT01046981|Antitubercular Agents|antitubercular agents|mesh-ancestor
65470286|NCT01046981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65470287|NCT01046981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65470288|NCT00378209|Dexamethasone|dexamethasone|mesh-list
65470289|NCT00378209|Lenalidomide|lenalidomide|mesh-list
65470290|NCT00378209|Bortezomib|bortezomib|mesh-list
65470291|NCT00378209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65470292|NCT00378209|Antiemetics|antiemetics|mesh-ancestor
65470293|NCT00378209|Autonomic Agents|autonomic agents|mesh-ancestor
65470294|NCT00378209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65470295|NCT00378209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470296|NCT00378209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65470297|NCT00378209|Glucocorticoids|glucocorticoids|mesh-ancestor
65470298|NCT00378209|Hormones|hormones|mesh-ancestor
65470299|NCT00378209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65470300|NCT00378209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65470301|NCT00378209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470302|NCT00378209|Immunologic Factors|immunologic factors|mesh-ancestor
65470303|NCT00378209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65470304|NCT00378209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65470305|NCT00378209|Growth Substances|growth substances|mesh-ancestor
65470306|NCT00378209|Growth Inhibitors|growth inhibitors|mesh-ancestor
65470307|NCT01047059|Bevacizumab|bevacizumab|mesh-list
65470308|NCT01047059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64713179|NCT03043430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64713180|NCT03043430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64945636|NCT05379322|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
64713181|NCT03043430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64713182|NCT03043430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64713184|NCT03043430|GABA Modulators|gaba modulators|mesh-ancestor
64713185|NCT03043430|GABA Agents|gaba agents|mesh-ancestor
64713186|NCT03007147|Calcium, Dietary|calcium, dietary|mesh-list
64713187|NCT03007147|Leucovorin|leucovorin|mesh-list
64713188|NCT03007147|Folic Acid|folic acid|mesh-list
64713189|NCT03007147|Cytarabine|cytarabine|mesh-list
64713190|NCT03007147|Dexamethasone|dexamethasone|mesh-list
64713191|NCT03007147|Dexamethasone acetate|dexamethasone acetate|mesh-list
64713192|NCT03007147|Methylprednisolone|methylprednisolone|mesh-list
64713193|NCT03007147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64713194|NCT03007147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64327943|NCT02178683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64327944|NCT02178683|Immunologic Factors|immunologic factors|mesh-ancestor
65470309|NCT01047059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65470310|NCT01047059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470311|NCT01047059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65470312|NCT01047059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65470313|NCT01047059|Growth Substances|growth substances|mesh-ancestor
65470314|NCT01047059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470315|NCT01047059|Growth Inhibitors|growth inhibitors|mesh-ancestor
65470316|NCT01047059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65470317|NCT01047059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470318|NCT01047059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470319|NCT00377819|Denosumab|denosumab|mesh-list
65470320|NCT00377819|Alendronate|alendronate|mesh-list
65470321|NCT00377819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65470322|NCT00377819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470323|NCT00377429|Catumaxomab|catumaxomab|mesh-list
65470324|NCT00377429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65470325|NCT01047215|Aripiprazole|aripiprazole|mesh-list
65470326|NCT01047215|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65470327|NCT01047215|Antidepressive Agents|antidepressive agents|mesh-ancestor
65470328|NCT01047215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65470329|NCT01047215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65470330|NCT01047215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65470331|NCT01047215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65470332|NCT01047215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470333|NCT01047215|Dopamine Agonists|dopamine agonists|mesh-ancestor
65470334|NCT01047215|Dopamine Agents|dopamine agents|mesh-ancestor
65470335|NCT01047215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64327945|NCT02178683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327946|NCT02178683|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64327947|NCT02178683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327948|NCT02178683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327949|NCT02178683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64713195|NCT03007147|Prednisolone|prednisolone|mesh-list
64719984|NCT00001058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64719985|NCT00000308|Amphetamine|amphetamine|mesh-list
64719986|NCT00000308|Dextroamphetamine|dextroamphetamine|mesh-list
64719987|NCT00000308|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64719988|NCT00000308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719989|NCT00000308|Sympathomimetics|sympathomimetics|mesh-ancestor
64719990|NCT00000308|Autonomic Agents|autonomic agents|mesh-ancestor
64719991|NCT00000308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719992|NCT00000308|Dopamine Agents|dopamine agents|mesh-ancestor
64327950|NCT02178683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327951|NCT02178683|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64327952|NCT02178683|Antitubercular Agents|antitubercular agents|mesh-ancestor
64327958|NCT03170739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65470336|NCT01047215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470337|NCT01047215|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65470338|NCT01047215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65470339|NCT01047215|Serotonin Agents|serotonin agents|mesh-ancestor
65470340|NCT01047215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65470341|NCT01047215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65470342|NCT01047215|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65470343|NCT01047215|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65470345|NCT03715582|Vasodilator Agents|vasodilator agents|mesh-ancestor
65470346|NCT00376961|Prednisone|prednisone|mesh-list
65470347|NCT00376961|Cyclophosphamide|cyclophosphamide|mesh-list
65470348|NCT00376961|Rituximab|rituximab|mesh-list
65470349|NCT00376961|Doxorubicin|doxorubicin|mesh-list
65470350|NCT00376961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65470351|NCT00376961|Vincristine|vincristine|mesh-list
65470352|NCT00376961|Bortezomib|bortezomib|mesh-list
65470353|NCT00376961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65470354|NCT00376961|Immunologic Factors|immunologic factors|mesh-ancestor
65470355|NCT00376961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470356|NCT00376961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65470357|NCT00376961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65470358|NCT00376961|Alkylating Agents|alkylating agents|mesh-ancestor
65470359|NCT00376961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470360|NCT00376961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470361|NCT00376961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65470362|NCT00376961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65470363|NCT00376961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65470364|NCT00376961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65470365|NCT00376961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64854449|NCT01709019|Vaccines|vaccines|mesh-list
64327959|NCT03170739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327960|NCT03170739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64327962|NCT03170739|Sensory System Agents|sensory system agents|mesh-ancestor
64327963|NCT03170739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64713196|NCT03007147|Prednisolone acetate|prednisolone acetate|mesh-list
64713197|NCT03007147|Hydrocortisone|hydrocortisone|mesh-list
64438419|NCT03907423|Antimetabolites|antimetabolites|mesh-ancestor
64713198|NCT03007147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64713199|NCT03007147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64713200|NCT03007147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64713201|NCT03007147|Cyclophosphamide|cyclophosphamide|mesh-list
64713214|NCT03007147|Podophyllotoxin|podophyllotoxin|mesh-list
64713215|NCT03007147|Pegaspargase|pegaspargase|mesh-list
64713216|NCT03007147|Thioguanine|thioguanine|mesh-list
64713217|NCT03007147|Dexrazoxane|dexrazoxane|mesh-list
65470366|NCT00376961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470367|NCT00376961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65470368|NCT00376961|Glucocorticoids|glucocorticoids|mesh-ancestor
65470369|NCT00376961|Hormones|hormones|mesh-ancestor
65470370|NCT00376961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65470371|NCT00376961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65470372|NCT00376961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65470373|NCT00376961|Tubulin Modulators|tubulin modulators|mesh-ancestor
65470374|NCT00376961|Antimitotic Agents|antimitotic agents|mesh-ancestor
65470375|NCT00376961|Mitosis Modulators|mitosis modulators|mesh-ancestor
65470376|NCT00376259|Adefovir|adefovir|mesh-list
65470377|NCT00376259|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65470378|NCT00376259|Telbivudine|telbivudine|mesh-list
65470379|NCT00376259|Antiviral Agents|antiviral agents|mesh-ancestor
65470380|NCT00376259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65470381|NCT00376259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65470382|NCT00376259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65470383|NCT00376259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470384|NCT00376259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470385|NCT03715348|Thrombin|thrombin|mesh-list
65470386|NCT03715348|Hemostatics|hemostatics|mesh-ancestor
65470387|NCT03715348|Coagulants|coagulants|mesh-ancestor
65470388|NCT01041755|N-Methylaspartate|n-methylaspartate|mesh-list
65470389|NCT01041755|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
64713218|NCT03007147|Razoxane|razoxane|mesh-list
64713219|NCT03007147|Azathioprine|azathioprine|mesh-list
64713220|NCT03007147|Lenograstim|lenograstim|mesh-list
64713221|NCT03007147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64713222|NCT03007147|Prednisolone phosphate|prednisolone phosphate|mesh-list
64713223|NCT03007147|BB 1101|bb 1101|mesh-list
64713224|NCT03007147|Calcium|calcium|mesh-list
64720011|NCT00000320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720012|NCT00000320|Analgesics|analgesics|mesh-ancestor
64720013|NCT00000320|Sensory System Agents|sensory system agents|mesh-ancestor
64720014|NCT00000320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64720015|NCT00000320|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64720016|NCT00000326|Heroin|heroin|mesh-list
64720017|NCT00000326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64720018|NCT00000326|Narcotics|narcotics|mesh-ancestor
64720019|NCT00000326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64720020|NCT00000326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720021|NCT00000326|Analgesics|analgesics|mesh-ancestor
64720022|NCT00000326|Sensory System Agents|sensory system agents|mesh-ancestor
64720023|NCT00000326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64720024|NCT03978403|Zolmitriptan|zolmitriptan|mesh-list
64720025|NCT03978403|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64720026|NCT03978403|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64720027|NCT03978403|Serotonin Agents|serotonin agents|mesh-ancestor
64720028|NCT03978403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64327973|NCT03170739|Dopamine Agents|dopamine agents|mesh-ancestor
64327974|NCT03170739|Protective Agents|protective agents|mesh-ancestor
64327975|NCT03133975|Vitamin D|vitamin d|mesh-list
64327976|NCT03133975|Cholecalciferol|cholecalciferol|mesh-list
64327977|NCT03133975|Vitamins|vitamins|mesh-ancestor
64327978|NCT03133975|Micronutrients|micronutrients|mesh-ancestor
65470390|NCT01041755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65470391|NCT01041755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65470392|NCT01041755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470393|NCT01041755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470394|NCT00365105|Vitamin D|vitamin d|mesh-list
65470395|NCT00365105|Zoledronic Acid|zoledronic acid|mesh-list
65470396|NCT00365105|Calcium|calcium|mesh-list
65470397|NCT00365105|Vitamins|vitamins|mesh-ancestor
65470398|NCT00365105|Micronutrients|micronutrients|mesh-ancestor
65470399|NCT00365105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470400|NCT00365105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65470401|NCT00365105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65470402|NCT01049633|Aspirin|aspirin|mesh-list
65470403|NCT01049633|Sirolimus|sirolimus|mesh-list
65470404|NCT01049633|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65470405|NCT01049633|Antifungal Agents|antifungal agents|mesh-list
65470406|NCT01049633|Clotrimazole|clotrimazole|mesh-list
65470407|NCT01049633|Miconazole|miconazole|mesh-list
65470408|NCT01049633|Trimethoprim|trimethoprim|mesh-list
65470409|NCT01049633|Sulfamethoxazole|sulfamethoxazole|mesh-list
65470411|NCT01049633|Antiviral Agents|antiviral agents|mesh-list
65470412|NCT01049633|Heparin|heparin|mesh-list
65470413|NCT01049633|Enoxaparin|enoxaparin|mesh-list
65470414|NCT01049633|Pentoxifylline|pentoxifylline|mesh-list
65470415|NCT01049633|Tacrolimus|tacrolimus|mesh-list
65470416|NCT01049633|Basiliximab|basiliximab|mesh-list
65470417|NCT01049633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65470418|NCT01049633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65470419|NCT01049633|Analgesics|analgesics|mesh-ancestor
65470420|NCT01049633|Sensory System Agents|sensory system agents|mesh-ancestor
65470421|NCT01049633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65470422|NCT01049633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470423|NCT01049633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65470424|NCT01049633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65470425|NCT01049633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65470426|NCT01049633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65470427|NCT01049633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470433|NCT01049633|Immunologic Factors|immunologic factors|mesh-ancestor
65470434|NCT01049633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65470435|NCT01049633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65470436|NCT01049633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65470437|NCT01049633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470438|NCT01049633|Anticoagulants|anticoagulants|mesh-ancestor
65470439|NCT01049633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65470440|NCT01049633|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65470441|NCT01049633|Protective Agents|protective agents|mesh-ancestor
65470442|NCT01049633|Vasodilator Agents|vasodilator agents|mesh-ancestor
65470443|NCT01049633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65470444|NCT01049633|Antioxidants|antioxidants|mesh-ancestor
65470445|NCT01049633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65470446|NCT01049633|Renal Agents|renal agents|mesh-ancestor
65470447|NCT01049633|Antimalarials|antimalarials|mesh-ancestor
65470448|NCT01049633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65470449|NCT01049633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65470450|NCT01049633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65470451|NCT01049633|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65470452|NCT01049633|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65470453|NCT01049633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65470454|NCT01049633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65470455|NCT01049633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65470456|NCT01049633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65470457|NCT01049633|Hormone Antagonists|hormone antagonists|mesh-ancestor
65470458|NCT01049633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65470459|NCT01049633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65470460|NCT01049633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65470461|NCT00399893|Octreotide|octreotide|mesh-list
65470462|NCT00399893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64854541|NCT01709825|Sulfalene|sulfalene|mesh-list
64327979|NCT03133975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327980|NCT03133975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64327981|NCT03133975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64327982|NCT05309421|Pembrolizumab|pembrolizumab|mesh-list
64327983|NCT05309421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64327984|NCT05309421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327985|NCT00459745|Fenofibrate|fenofibrate|mesh-list
64327986|NCT00459745|Pravastatin|pravastatin|mesh-list
64327988|NCT00459745|Antimetabolites|antimetabolites|mesh-ancestor
64720033|NCT00002000|Antiviral Agents|antiviral agents|mesh-ancestor
64720034|NCT00002000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720035|NCT03979807|Bromides|bromides|mesh-list
65470463|NCT00399893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65470464|NCT00399893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470465|NCT01049711|Epoetin Alfa|epoetin alfa|mesh-list
65470466|NCT01049711|Hematinics|hematinics|mesh-ancestor
65470467|NCT00048542|Adalimumab|adalimumab|mesh-list
65470468|NCT00048542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65470469|NCT00048542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65470470|NCT03814590|Vaccines|vaccines|mesh-list
65470471|NCT03814590|Immunologic Factors|immunologic factors|mesh-ancestor
65470472|NCT03814590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470473|NCT01583244|Abatacept|abatacept|mesh-list
65470474|NCT01583244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65470475|NCT01583244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470476|NCT01583244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470477|NCT01583244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65470478|NCT01583244|Immunologic Factors|immunologic factors|mesh-ancestor
65470479|NCT01583244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470480|NCT01583244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65470481|NCT01085526|Immunologic Factors|immunologic factors|mesh-list
65470482|NCT01085526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470483|NCT00048074|Ibandronic Acid|ibandronic acid|mesh-list
65470484|NCT00048074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65470485|NCT00048074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470486|NCT01102946|Ranibizumab|ranibizumab|mesh-list
65470487|NCT01102946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65470488|NCT01102946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65470489|NCT01102946|Growth Substances|growth substances|mesh-ancestor
65470490|NCT01102946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470491|NCT01102946|Growth Inhibitors|growth inhibitors|mesh-ancestor
65470492|NCT01102946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854591|NCT01710072|Aspirin|aspirin|mesh-list
64720036|NCT03979807|Tiotropium Bromide|tiotropium bromide|mesh-list
64720037|NCT03979807|Olodaterol|olodaterol|mesh-list
64720038|NCT03979807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64720039|NCT03979807|Autonomic Agents|autonomic agents|mesh-ancestor
64327992|NCT00459745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64327993|NCT00459745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327994|NCT02178761|Chromium|chromium|mesh-list
64327995|NCT02178761|Everolimus|everolimus|mesh-list
64713225|NCT03007147|2-Aminopurine|2-aminopurine|mesh-list
64713226|NCT03007147|Levoleucovorin|levoleucovorin|mesh-list
64713227|NCT03007147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64713236|NCT03007147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64713237|NCT03007147|Antiemetics|antiemetics|mesh-ancestor
64713238|NCT03007147|Autonomic Agents|autonomic agents|mesh-ancestor
64713250|NCT03007147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64713251|NCT03007147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65470493|NCT01103024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65470494|NCT01103024|Immunologic Factors|immunologic factors|mesh-ancestor
65470495|NCT01103024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470496|NCT01101386|Voriconazole|voriconazole|mesh-list
65470497|NCT01101386|Antifungal Agents|antifungal agents|mesh-ancestor
65470498|NCT01101386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65470499|NCT01101386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65470500|NCT01101386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65470501|NCT01101386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470502|NCT01101386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470503|NCT01101386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65470504|NCT01101386|Hormone Antagonists|hormone antagonists|mesh-ancestor
65470505|NCT01101386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65470506|NCT01101386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470507|NCT01101386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65470508|NCT00005906|Octreotide|octreotide|mesh-list
65470509|NCT00005906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65470510|NCT00005906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65470511|NCT00005906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470512|NCT01103336|Nicorandil|nicorandil|mesh-list
65470513|NCT01103336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65470514|NCT01103336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65470515|NCT01103336|Vasodilator Agents|vasodilator agents|mesh-ancestor
65470516|NCT01103336|Vitamin B Complex|vitamin b complex|mesh-ancestor
65470517|NCT01103336|Vitamins|vitamins|mesh-ancestor
65470518|NCT01103336|Micronutrients|micronutrients|mesh-ancestor
65470519|NCT01103336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470520|NCT03950960|Itraconazole|itraconazole|mesh-list
65470521|NCT03950960|Antifungal Agents|antifungal agents|mesh-ancestor
64854599|NCT01710072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64713252|NCT03007147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64713253|NCT03007147|Abortifacient Agents|abortifacient agents|mesh-ancestor
64713254|NCT03007147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64713255|NCT03007147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64713256|NCT03007147|Antimetabolites|antimetabolites|mesh-ancestor
64713257|NCT03007147|Dermatologic Agents|dermatologic agents|mesh-ancestor
64713258|NCT03007147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64713259|NCT03007147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64713260|NCT03007147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64713261|NCT03007147|Antiviral Agents|antiviral agents|mesh-ancestor
64713262|NCT03007147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64713264|NCT03007147|Protective Agents|protective agents|mesh-ancestor
64713265|NCT03007147|Vitamin B Complex|vitamin b complex|mesh-ancestor
64713266|NCT03007147|Vitamins|vitamins|mesh-ancestor
65470522|NCT03950960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65470523|NCT03950960|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65470524|NCT03950960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65470525|NCT03950960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470526|NCT03950960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470527|NCT03950960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65470528|NCT03950960|Hormone Antagonists|hormone antagonists|mesh-ancestor
65470529|NCT03950960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65470530|NCT03950960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470531|NCT03950960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65470532|NCT03954860|Tranexamic Acid|tranexamic acid|mesh-list
65470533|NCT03954860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65470534|NCT03954860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65470535|NCT03954860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470536|NCT03954860|Hemostatics|hemostatics|mesh-ancestor
65470537|NCT03954860|Coagulants|coagulants|mesh-ancestor
65470538|NCT00066690|Tamoxifen|tamoxifen|mesh-list
65470539|NCT00066690|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65470540|NCT00066690|Exemestane|exemestane|mesh-list
65470541|NCT00066690|Tryptophan|tryptophan|mesh-list
64713267|NCT03007147|Micronutrients|micronutrients|mesh-ancestor
64713268|NCT03007147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64713269|NCT03007147|Tubulin Modulators|tubulin modulators|mesh-ancestor
64713271|NCT03007147|Mitosis Modulators|mitosis modulators|mesh-ancestor
64713272|NCT03007147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64713273|NCT03007147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64713275|NCT03007147|Keratolytic Agents|keratolytic agents|mesh-ancestor
64720053|NCT00001082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720054|NCT00001082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64720055|NCT00001082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720056|NCT00001082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720057|NCT00001082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720058|NCT00002006|Zidovudine|zidovudine|mesh-list
64720059|NCT00002006|Sargramostim|sargramostim|mesh-list
64720060|NCT00002006|Antimetabolites|antimetabolites|mesh-ancestor
64720061|NCT00002006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720062|NCT00002006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64720063|NCT00002006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720064|NCT00002006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720065|NCT00002006|Antiviral Agents|antiviral agents|mesh-ancestor
64720066|NCT00002006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720067|NCT00002006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64720068|NCT00002006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64720069|NCT00002006|Immunologic Factors|immunologic factors|mesh-ancestor
64720070|NCT00002006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720071|NCT04169113|Opiate Alkaloids|opiate alkaloids|mesh-list
64720072|NCT04169113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64720073|NCT04169113|Narcotics|narcotics|mesh-ancestor
64720074|NCT04169113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64720075|NCT04169113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720076|NCT04169113|Analgesics|analgesics|mesh-ancestor
64720077|NCT04169113|Sensory System Agents|sensory system agents|mesh-ancestor
64720078|NCT04169113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64720079|NCT00002012|Interferons|interferons|mesh-list
65470542|NCT00066690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470543|NCT00066690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65470544|NCT00066690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470545|NCT00066690|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65470546|NCT00066690|Hormone Antagonists|hormone antagonists|mesh-ancestor
65470547|NCT00066690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65470548|NCT00066690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470549|NCT00066690|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65470550|NCT00066690|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64854647|NCT01710384|Betamethasone|betamethasone|mesh-list
64328000|NCT02178761|Trace Elements|trace elements|mesh-ancestor
64720080|NCT00002012|Interferon-alpha|interferon-alpha|mesh-list
64720081|NCT00002012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64720082|NCT00002012|Antiviral Agents|antiviral agents|mesh-ancestor
64720083|NCT00002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720088|NCT00380354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64720089|NCT00380354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720090|NCT00380354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720091|NCT03799783|Dexmedetomidine|dexmedetomidine|mesh-list
64720092|NCT03799783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64720093|NCT03799783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64720094|NCT03799783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720095|NCT03799783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64328029|NCT00492999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328030|NCT00492999|Antidotes|antidotes|mesh-ancestor
64328031|NCT00492999|Protective Agents|protective agents|mesh-ancestor
64328032|NCT00492999|Vitamin B Complex|vitamin b complex|mesh-ancestor
64328033|NCT00492999|Vitamins|vitamins|mesh-ancestor
64328034|NCT00492999|Micronutrients|micronutrients|mesh-ancestor
64328035|NCT02742181|Alvimopan|alvimopan|mesh-list
64328036|NCT02742181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64328037|NCT02175407|Itraconazole|itraconazole|mesh-list
64328038|NCT02175407|Antifungal Agents|antifungal agents|mesh-ancestor
64328039|NCT02175407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64328040|NCT02175407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64328041|NCT02175407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64328042|NCT02175407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328043|NCT02175407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328044|NCT02175407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64328045|NCT02175407|Hormone Antagonists|hormone antagonists|mesh-ancestor
64328046|NCT02175407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64720104|NCT03799783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720105|NCT00001088|Bupivacaine|bupivacaine|mesh-list
64720106|NCT00001088|Anesthetics, Local|anesthetics, local|mesh-ancestor
64720107|NCT00001088|Anesthetics|anesthetics|mesh-ancestor
64328047|NCT02175407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328048|NCT02175407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64328049|NCT02182193|Nintedanib|nintedanib|mesh-list
64328050|NCT02182193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64328051|NCT02182193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64328052|NCT02182193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328053|NCT02182193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328054|NCT02175485|Fexofenadine|fexofenadine|mesh-list
64328055|NCT02175485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64328056|NCT02175485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64328057|NCT02175485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64713276|NCT03007147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64713277|NCT03004261|Ganciclovir|ganciclovir|mesh-list
64713278|NCT03004261|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64713279|NCT03004261|Foscarnet|foscarnet|mesh-list
64713280|NCT03004261|Antiviral Agents|antiviral agents|mesh-ancestor
64713281|NCT03004261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65470551|NCT00066690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65470552|NCT00066690|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65470553|NCT00066690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65470554|NCT00066690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470555|NCT00066690|Luteolytic Agents|luteolytic agents|mesh-ancestor
65470556|NCT00066690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65470557|NCT00066690|Contraceptive Agents|contraceptive agents|mesh-ancestor
65470558|NCT00066690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65470559|NCT00066690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65470560|NCT00066690|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65470561|NCT00066690|Antidepressive Agents|antidepressive agents|mesh-ancestor
65470562|NCT00066690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65470563|NCT03409276|Vaccines|vaccines|mesh-list
65470564|NCT03409276|Immunologic Factors|immunologic factors|mesh-ancestor
65470565|NCT03409276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470566|NCT00004562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65470567|NCT00004562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65470568|NCT00004562|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65470569|NCT00004562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65470570|NCT00004562|Adrenergic Agents|adrenergic agents|mesh-list
65470571|NCT00004562|Adrenergic Antagonists|adrenergic antagonists|mesh-list
65470572|NCT00004562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64854670|NCT01710488|Ofloxacin|ofloxacin|mesh-list
64713282|NCT03004261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64713283|NCT03004261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64713284|NCT03004261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713285|NCT03004261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64713286|NCT02998528|Gemcitabine|gemcitabine|mesh-list
64713287|NCT02998528|Paclitaxel|paclitaxel|mesh-list
64720111|NCT00001088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64720112|NCT00001094|Lamivudine|lamivudine|mesh-list
64720113|NCT00001094|Zidovudine|zidovudine|mesh-list
64720114|NCT00001094|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64720115|NCT00001094|Delavirdine|delavirdine|mesh-list
64720116|NCT00001094|Nelfinavir|nelfinavir|mesh-list
64720117|NCT00001094|Saquinavir|saquinavir|mesh-list
64720118|NCT00001094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64720119|NCT00001094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720124|NCT00001094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64328058|NCT02175485|Histamine Antagonists|histamine antagonists|mesh-ancestor
64328059|NCT02175485|Histamine Agents|histamine agents|mesh-ancestor
64328060|NCT02175485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64328061|NCT02175485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328062|NCT02175485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328063|NCT04575779|Cyclosporine|cyclosporine|mesh-list
64328064|NCT04575779|Cyclosporins|cyclosporins|mesh-list
64328065|NCT04575779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328066|NCT04575779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328067|NCT04575779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64328068|NCT04575779|Immunologic Factors|immunologic factors|mesh-ancestor
64328069|NCT04575779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470573|NCT00004562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470574|NCT00004562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470575|NCT00004562|Protease Inhibitors|protease inhibitors|mesh-ancestor
65470576|NCT00004412|Arginine butyrate|arginine butyrate|mesh-list
65470577|NCT00004412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470578|NCT00004088|Pamidronate|pamidronate|mesh-list
65470579|NCT00004088|Interferons|interferons|mesh-list
65470580|NCT00004088|Interferon-alpha|interferon-alpha|mesh-list
65470581|NCT00004088|Thalidomide|thalidomide|mesh-list
65470582|NCT00004088|Cyclophosphamide|cyclophosphamide|mesh-list
65470583|NCT00004088|Melphalan|melphalan|mesh-list
65470584|NCT00004088|Busulfan|busulfan|mesh-list
65470585|NCT00004088|Lenograstim|lenograstim|mesh-list
65470586|NCT00004088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65470587|NCT00004088|Immunologic Factors|immunologic factors|mesh-ancestor
65470588|NCT00004088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470589|NCT00004088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65470590|NCT00004088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64328070|NCT04575779|Antifungal Agents|antifungal agents|mesh-ancestor
64328071|NCT04575779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64328072|NCT04575779|Dermatologic Agents|dermatologic agents|mesh-ancestor
64328073|NCT04575779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64328079|NCT02741713|Bupivacaine|bupivacaine|mesh-list
64328080|NCT02741713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64328081|NCT02741713|Epinephryl borate|epinephryl borate|mesh-list
64328082|NCT02741713|Anesthetics, Local|anesthetics, local|mesh-ancestor
64713288|NCT02998528|Vinorelbine|vinorelbine|mesh-list
64713289|NCT02998528|Docetaxel|docetaxel|mesh-list
64713290|NCT02998528|Carboplatin|carboplatin|mesh-list
64713291|NCT02998528|Nivolumab|nivolumab|mesh-list
64713292|NCT02998528|Pemetrexed|pemetrexed|mesh-list
64713293|NCT02998528|Ipilimumab|ipilimumab|mesh-list
64713294|NCT02998528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64713295|NCT02998528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713296|NCT02998528|Tubulin Modulators|tubulin modulators|mesh-ancestor
64713297|NCT02998528|Antimitotic Agents|antimitotic agents|mesh-ancestor
64713298|NCT02998528|Mitosis Modulators|mitosis modulators|mesh-ancestor
64713299|NCT02998528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713300|NCT02998528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64720144|NCT00000332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64720146|NCT00000332|Vasodilator Agents|vasodilator agents|mesh-ancestor
64328083|NCT02741713|Anesthetics|anesthetics|mesh-ancestor
64328084|NCT02741713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64328085|NCT02741713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328086|NCT02741713|Sensory System Agents|sensory system agents|mesh-ancestor
64328087|NCT02741713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64328088|NCT02741713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64328089|NCT02741713|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64328090|NCT02741713|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64328091|NCT02741713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64328092|NCT02741713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328093|NCT02741713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64328094|NCT02741713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64713301|NCT02998528|Antimetabolites|antimetabolites|mesh-ancestor
64713331|NCT02989597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64720166|NCT04085341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720167|NCT00002018|Interferons|interferons|mesh-list
64720168|NCT00002018|Interferon-alpha|interferon-alpha|mesh-list
64720169|NCT00002018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470591|NCT00004088|Alkylating Agents|alkylating agents|mesh-ancestor
65470592|NCT00004088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470593|NCT00004088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470594|NCT00004088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65470595|NCT00004088|Antiviral Agents|antiviral agents|mesh-ancestor
65470596|NCT00004088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65470597|NCT00004088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65470598|NCT00004088|Leprostatic Agents|leprostatic agents|mesh-ancestor
65470599|NCT00004088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65470600|NCT00004088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65470601|NCT00004088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65470602|NCT00004088|Growth Substances|growth substances|mesh-ancestor
65470603|NCT00004088|Growth Inhibitors|growth inhibitors|mesh-ancestor
65470604|NCT00004088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65470605|NCT03439072|Glucagon|glucagon|mesh-list
65470606|NCT03439072|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65470607|NCT03439072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65470608|NCT03439072|Hormones|hormones|mesh-ancestor
65470609|NCT03439072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65470610|NCT03439072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470611|NCT03439072|Incretins|incretins|mesh-ancestor
65470612|NCT00078312|Modafinil|modafinil|mesh-list
64854692|NCT01710566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64720170|NCT00002018|Antiviral Agents|antiviral agents|mesh-ancestor
64720171|NCT00002018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720172|NCT00002018|Immunologic Factors|immunologic factors|mesh-ancestor
64720173|NCT00002018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720174|NCT00002024|Ganciclovir|ganciclovir|mesh-list
64720175|NCT00002024|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64720176|NCT00002024|Antiviral Agents|antiviral agents|mesh-ancestor
64720177|NCT00002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720178|NCT00002024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720179|NCT00002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720180|NCT00002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720181|NCT00001106|Zidovudine|zidovudine|mesh-list
64720182|NCT00001106|Antimetabolites|antimetabolites|mesh-ancestor
64720189|NCT00001106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64720190|NCT00001106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64720191|NCT00000344|Buprenorphine|buprenorphine|mesh-list
64720192|NCT00000344|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64720193|NCT00000344|Naloxone|naloxone|mesh-list
64720194|NCT00000344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64720195|NCT00000344|Narcotics|narcotics|mesh-ancestor
64720196|NCT00000344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64720197|NCT00000344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720198|NCT00000344|Analgesics|analgesics|mesh-ancestor
64720199|NCT00000344|Sensory System Agents|sensory system agents|mesh-ancestor
64720209|NCT04103515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720210|NCT04103515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720211|NCT04103515|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64720212|NCT04103515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65470613|NCT00078312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65470614|NCT00078312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470615|NCT00078312|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65470616|NCT00078312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65470617|NCT00078312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65470618|NCT00078312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470619|NCT01085838|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65470620|NCT01085838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470621|NCT01085838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65470622|NCT01085838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470623|NCT01085838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470624|NCT00003896|Paclitaxel|paclitaxel|mesh-list
65470625|NCT00003896|Doxorubicin|doxorubicin|mesh-list
65470626|NCT00003896|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65470627|NCT00003896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65470628|NCT00003896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64720214|NCT00002030|Pentamidine|pentamidine|mesh-list
64720215|NCT00002030|Antifungal Agents|antifungal agents|mesh-ancestor
64720216|NCT00002030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720217|NCT00002030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64720218|NCT00002030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64720219|NCT00002030|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64720220|NCT00001112|Interferons|interferons|mesh-list
64720221|NCT00001112|Zidovudine|zidovudine|mesh-list
64720222|NCT00001112|Interferon-gamma|interferon-gamma|mesh-list
64720223|NCT00001112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64720224|NCT00001112|Antiviral Agents|antiviral agents|mesh-ancestor
64720225|NCT00001112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720226|NCT00001112|Antimetabolites|antimetabolites|mesh-ancestor
64328149|NCT02182505|Autonomic Agents|autonomic agents|mesh-ancestor
64328150|NCT02182505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64328151|NCT02182505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328152|NCT02182505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64328153|NCT02182505|Respiratory System Agents|respiratory system agents|mesh-ancestor
64328154|NCT02182505|Sympathomimetics|sympathomimetics|mesh-ancestor
64328155|NCT02182505|Tocolytic Agents|tocolytic agents|mesh-ancestor
64328156|NCT02182505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64328157|NCT02182505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64328158|NCT02182505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64328159|NCT02182505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64328160|NCT02182505|Adrenergic Agents|adrenergic agents|mesh-ancestor
64720227|NCT00001112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720228|NCT00001112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64720229|NCT00001112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720230|NCT00001112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720231|NCT00001112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64720232|NCT00001112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64720234|NCT00002036|Immunologic Factors|immunologic factors|mesh-ancestor
64720235|NCT00002036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720236|NCT03782701|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64720237|NCT03782701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64720238|NCT03782701|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64720239|NCT03782701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64720240|NCT03782701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64720241|NCT03782701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64720242|NCT03782701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64720243|NCT03782701|Adrenergic Agents|adrenergic agents|mesh-ancestor
65470629|NCT00003896|Tubulin Modulators|tubulin modulators|mesh-ancestor
65470630|NCT00003896|Antimitotic Agents|antimitotic agents|mesh-ancestor
65470631|NCT00003896|Mitosis Modulators|mitosis modulators|mesh-ancestor
65470632|NCT00003896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470633|NCT00003896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65470634|NCT00003896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65470635|NCT00003896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65470636|NCT00003896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470637|NCT01091766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65470638|NCT03712540|Rifampin|rifampin|mesh-list
65470639|NCT03712540|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65470640|NCT03712540|Antitubercular Agents|antitubercular agents|mesh-ancestor
65470641|NCT03712540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65470642|NCT03712540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65470643|NCT03712540|Leprostatic Agents|leprostatic agents|mesh-ancestor
65470644|NCT03712540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65470645|NCT03712540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854733|NCT01710696|Contraceptive Agents|contraceptive agents|mesh-ancestor
64720244|NCT03782701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64720245|NCT03782701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720246|NCT03782701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720247|NCT00000374|Olanzapine|olanzapine|mesh-list
64720248|NCT00000374|Risperidone|risperidone|mesh-list
64720249|NCT00000374|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64720254|NCT00000374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64720255|NCT00000374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64720256|NCT00000374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64720257|NCT00000374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64720258|NCT00000374|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64720259|NCT00000374|Dopamine Agents|dopamine agents|mesh-ancestor
64720260|NCT00000374|Antiemetics|antiemetics|mesh-ancestor
64720261|NCT00000374|Autonomic Agents|autonomic agents|mesh-ancestor
64720262|NCT00000374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64720268|NCT00002042|Hematinics|hematinics|mesh-ancestor
64720269|NCT03789175|Niacinamide|niacinamide|mesh-list
64720271|NCT03789175|Nicotinic Acids|nicotinic acids|mesh-list
64720272|NCT03789175|Vitamin B Complex|vitamin b complex|mesh-ancestor
64720273|NCT03789175|Vitamins|vitamins|mesh-ancestor
64720274|NCT03789175|Micronutrients|micronutrients|mesh-ancestor
64720275|NCT03789175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720276|NCT03789175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64720277|NCT03789175|Antimetabolites|antimetabolites|mesh-ancestor
64720278|NCT03789175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328200|NCT00595699|Antidepressive Agents|antidepressive agents|mesh-ancestor
64328201|NCT00595699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64328202|NCT02256215|Vitamin D|vitamin d|mesh-list
64328203|NCT02256215|Vitamins|vitamins|mesh-ancestor
64328204|NCT02256215|Micronutrients|micronutrients|mesh-ancestor
64328205|NCT02256215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328206|NCT02256215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64328207|NCT02182583|Oxitropium|oxitropium|mesh-list
64328208|NCT02182583|Parasympatholytics|parasympatholytics|mesh-ancestor
64328209|NCT02182583|Autonomic Agents|autonomic agents|mesh-ancestor
64328210|NCT02182583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64328211|NCT02182583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328212|NCT02282137|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64328213|NCT02282137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64328214|NCT02282137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470646|NCT03712540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470647|NCT03712540|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65470648|NCT03712540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65470649|NCT03712540|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65470650|NCT03712540|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65470651|NCT03712540|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65470652|NCT03712540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65470653|NCT05472220|Carboplatin|carboplatin|mesh-list
65470654|NCT05472220|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
65470655|NCT05472220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470656|NCT05472220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470657|NCT05472220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470658|NCT00003782|Cyclophosphamide|cyclophosphamide|mesh-list
65470659|NCT00003782|Docetaxel|docetaxel|mesh-list
65470660|NCT00003782|Doxorubicin|doxorubicin|mesh-list
65470661|NCT00003782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65470662|NCT00003782|Immunologic Factors|immunologic factors|mesh-ancestor
65470663|NCT00003782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470664|NCT00003782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65470665|NCT00003782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65470666|NCT00003782|Alkylating Agents|alkylating agents|mesh-ancestor
65470667|NCT00003782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470668|NCT00003782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470669|NCT00003782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65470670|NCT00003782|Tubulin Modulators|tubulin modulators|mesh-ancestor
65470671|NCT00003782|Antimitotic Agents|antimitotic agents|mesh-ancestor
65470672|NCT00003782|Mitosis Modulators|mitosis modulators|mesh-ancestor
65470673|NCT00003782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65470674|NCT00003782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65470675|NCT00003782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65470676|NCT00003782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470677|NCT03389308|Diacetylrhein|diacetylrhein|mesh-list
65470678|NCT03389308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65470679|NCT03714490|Capecitabine|capecitabine|mesh-list
64854757|NCT01710748|Everolimus|everolimus|mesh-list
64713334|NCT02989597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64713335|NCT02989597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64713336|NCT02989597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65470680|NCT03714490|Oxaliplatin|oxaliplatin|mesh-list
65470681|NCT03714490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65470682|NCT03714490|Antimetabolites|antimetabolites|mesh-ancestor
65470683|NCT03714490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470684|NCT03714490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470685|NCT03407170|Pembrolizumab|pembrolizumab|mesh-list
65470686|NCT03407170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65470687|NCT03407170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470688|NCT01103648|Simvastatin|simvastatin|mesh-list
65470689|NCT01103648|Ezetimibe|ezetimibe|mesh-list
65470690|NCT01103648|Hypolipidemic Agents|hypolipidemic agents|mesh-list
65470691|NCT01103648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65470692|NCT01103648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65470693|NCT01103648|Antimetabolites|antimetabolites|mesh-ancestor
65470694|NCT01103648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470695|NCT01103648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65470696|NCT01103648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470697|NCT03406858|Pembrolizumab|pembrolizumab|mesh-list
64720287|NCT00002048|Antiviral Agents|antiviral agents|mesh-ancestor
64720288|NCT00002048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720289|NCT00002048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64720290|NCT00002048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64720291|NCT00002054|Pentamidine|pentamidine|mesh-list
64720292|NCT00002054|Antifungal Agents|antifungal agents|mesh-ancestor
64720293|NCT00002054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720294|NCT00002054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64720295|NCT00002054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64720296|NCT00002054|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64720297|NCT00002060|Inosine Pranobex|inosine pranobex|mesh-list
64720298|NCT00002060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64720299|NCT00002060|Immunologic Factors|immunologic factors|mesh-ancestor
64720300|NCT00002060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720301|NCT00002060|Antiviral Agents|antiviral agents|mesh-ancestor
64720302|NCT00002060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720303|NCT00002066|Thymopentin|thymopentin|mesh-list
64720304|NCT00002066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64720305|NCT00002066|Immunologic Factors|immunologic factors|mesh-ancestor
64720306|NCT00002066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720307|NCT00002072|Epoetin Alfa|epoetin alfa|mesh-list
64720308|NCT00002072|Hematinics|hematinics|mesh-ancestor
64720309|NCT00002078|Interferons|interferons|mesh-list
64720310|NCT00002078|Interferon-alpha|interferon-alpha|mesh-list
64720311|NCT00002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64720312|NCT00002078|Antiviral Agents|antiviral agents|mesh-ancestor
64720313|NCT00002078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720314|NCT00002078|Immunologic Factors|immunologic factors|mesh-ancestor
64720315|NCT00002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720317|NCT00000440|Sertraline|sertraline|mesh-list
64720318|NCT00000440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64720319|NCT00000440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64720320|NCT00000440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438569|NCT03598309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713396|NCT02839642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713398|NCT02839642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64713399|NCT02839642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713400|NCT02839642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64720321|NCT00000440|Sensory System Agents|sensory system agents|mesh-ancestor
64720322|NCT00000440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64720323|NCT00000440|Antidepressive Agents|antidepressive agents|mesh-ancestor
65470698|NCT03406858|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65470699|NCT03406858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65470700|NCT03406858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470701|NCT03406858|Immunologic Factors|immunologic factors|mesh-ancestor
65470702|NCT03406858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470703|NCT01095848|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65470704|NCT01095848|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65470705|NCT01095848|Immunologic Factors|immunologic factors|mesh-ancestor
65470706|NCT01095848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470707|NCT01095926|Doxorubicin|doxorubicin|mesh-list
65470708|NCT01095926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65470709|NCT01095926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470710|NCT01095926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65470711|NCT01095926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65470712|NCT01095926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470713|NCT01095926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470714|NCT00003656|Interferons|interferons|mesh-list
65470715|NCT00003656|Interferon-alpha|interferon-alpha|mesh-list
65470716|NCT00003656|Tretinoin|tretinoin|mesh-list
65470717|NCT00003656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470718|NCT00003656|Antiviral Agents|antiviral agents|mesh-ancestor
65470719|NCT00003656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65470720|NCT00003656|Immunologic Factors|immunologic factors|mesh-ancestor
65470721|NCT00003656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470722|NCT00003656|Keratolytic Agents|keratolytic agents|mesh-ancestor
65470723|NCT00003656|Dermatologic Agents|dermatologic agents|mesh-ancestor
65470724|NCT00003590|Hydroxyurea|hydroxyurea|mesh-list
65470725|NCT00003590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470726|NCT00003590|Antisickling Agents|antisickling agents|mesh-ancestor
65470727|NCT00003590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470728|NCT00003590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854803|NCT01711086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64720324|NCT00000440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64720325|NCT00000440|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64720326|NCT00000440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64720327|NCT00000440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64720328|NCT00000440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720329|NCT00000440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64720330|NCT00000440|Serotonin Agents|serotonin agents|mesh-ancestor
64720331|NCT00002084|Valacyclovir|valacyclovir|mesh-list
64720332|NCT00002084|Acyclovir|acyclovir|mesh-list
64720333|NCT00002084|Antiviral Agents|antiviral agents|mesh-ancestor
64720334|NCT00002084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65470729|NCT00003590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65470730|NCT03948620|Penicillins|penicillins|mesh-list
65470731|NCT03948620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65470732|NCT03948620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65470733|NCT03416374|Dexamethasone|dexamethasone|mesh-list
65470734|NCT03416374|Lenalidomide|lenalidomide|mesh-list
65470735|NCT03416374|Bortezomib|bortezomib|mesh-list
65470736|NCT03416374|Ixazomib|ixazomib|mesh-list
65470737|NCT03416374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65470738|NCT03416374|Antiemetics|antiemetics|mesh-ancestor
65470739|NCT03416374|Autonomic Agents|autonomic agents|mesh-ancestor
65470740|NCT03416374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65470741|NCT03416374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470742|NCT03416374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65470743|NCT03416374|Glucocorticoids|glucocorticoids|mesh-ancestor
65470744|NCT03416374|Hormones|hormones|mesh-ancestor
65470745|NCT03416374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65470746|NCT03416374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65470747|NCT03416374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470748|NCT03416374|Immunologic Factors|immunologic factors|mesh-ancestor
65470749|NCT03416374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65470750|NCT03416374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65470751|NCT03416374|Growth Substances|growth substances|mesh-ancestor
65470752|NCT03416374|Growth Inhibitors|growth inhibitors|mesh-ancestor
65470753|NCT03416374|Protease Inhibitors|protease inhibitors|mesh-ancestor
65470754|NCT03416374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470755|NCT03416374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470756|NCT00077766|Darbepoetin alfa|darbepoetin alfa|mesh-list
65470757|NCT00077766|Hematinics|hematinics|mesh-ancestor
65470758|NCT01096082|Lithium Carbonate|lithium carbonate|mesh-list
65470759|NCT01096082|Antidepressive Agents|antidepressive agents|mesh-ancestor
65470760|NCT01096082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65470761|NCT01096082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470762|NCT01096082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470763|NCT01096082|Antimanic Agents|antimanic agents|mesh-ancestor
65470764|NCT01096082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65470767|NCT03388138|Ketotifen|ketotifen|mesh-list
65470768|NCT03388138|Antipruritics|antipruritics|mesh-ancestor
65470769|NCT03388138|Dermatologic Agents|dermatologic agents|mesh-ancestor
65470770|NCT03388138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65470771|NCT03388138|Histamine Antagonists|histamine antagonists|mesh-ancestor
65470772|NCT03388138|Histamine Agents|histamine agents|mesh-ancestor
65470773|NCT03388138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65470774|NCT03388138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470775|NCT03388138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470776|NCT03388138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65470777|NCT01101620|Simendan|simendan|mesh-list
65470778|NCT01101620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65470779|NCT01101620|Vasodilator Agents|vasodilator agents|mesh-ancestor
65470780|NCT01101620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65220270|NCT04085575|Tranexamic Acid|tranexamic acid|mesh-list
65470781|NCT01101620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64854875|NCT01711476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64720335|NCT00000446|Sertraline|sertraline|mesh-list
64720336|NCT00000446|Antidepressive Agents|antidepressive agents|mesh-ancestor
64720337|NCT00000446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64720338|NCT00000446|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64720339|NCT00000446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64720340|NCT00000446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64720341|NCT00000446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720342|NCT00000446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64720343|NCT00000446|Serotonin Agents|serotonin agents|mesh-ancestor
64720344|NCT00000446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720345|NCT04131517|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64720346|NCT04131517|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
64720347|NCT04131517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64720348|NCT04131517|Contraceptive Agents|contraceptive agents|mesh-ancestor
64720349|NCT04131517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64720350|NCT04131517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720351|NCT04131517|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64720352|NCT04131517|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64720353|NCT04131517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64328255|NCT03170115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64713401|NCT02839642|Protective Agents|protective agents|mesh-ancestor
64713445|NCT02652195|Oxytocin|oxytocin|mesh-list
64713446|NCT02652195|Oxytocics|oxytocics|mesh-ancestor
64713447|NCT02652195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64720365|NCT00001256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720366|NCT00001256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64720367|NCT00001256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64720368|NCT00001256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64720369|NCT00001256|Abortifacient Agents|abortifacient agents|mesh-ancestor
64720370|NCT00001256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64720371|NCT00001256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64720372|NCT00001256|Antimetabolites|antimetabolites|mesh-ancestor
64720373|NCT00001256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720374|NCT00001256|Dermatologic Agents|dermatologic agents|mesh-ancestor
64720375|NCT00001256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720376|NCT00001256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64720377|NCT00001256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64328294|NCT02176187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64328295|NCT02176187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64328296|NCT02176187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64328297|NCT02176187|Adrenergic Agents|adrenergic agents|mesh-ancestor
65470782|NCT01101620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470783|NCT01101620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470784|NCT01101620|Protective Agents|protective agents|mesh-ancestor
65470785|NCT01101620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470786|NCT02952898|Diclofenac|diclofenac|mesh-list
65470787|NCT02952898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65470788|NCT02952898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65470789|NCT02952898|Analgesics|analgesics|mesh-ancestor
65470790|NCT02952898|Sensory System Agents|sensory system agents|mesh-ancestor
65470791|NCT02952898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65470792|NCT02952898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470793|NCT02952898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65470794|NCT02952898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65470795|NCT02952898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65470796|NCT02952898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328298|NCT02176187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64328299|NCT02176187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328300|NCT02176187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64328301|NCT02176187|Cholinergic Agents|cholinergic agents|mesh-ancestor
64328306|NCT02176499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713449|NCT02629120|Sirolimus|sirolimus|mesh-list
64713450|NCT02629120|Cyclophosphamide|cyclophosphamide|mesh-list
64713451|NCT02629120|Busulfan|busulfan|mesh-list
64713452|NCT02629120|Alemtuzumab|alemtuzumab|mesh-list
64713453|NCT02629120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64713454|NCT02629120|Immunologic Factors|immunologic factors|mesh-ancestor
64713455|NCT02629120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713456|NCT02629120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64713457|NCT02629120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64713458|NCT02629120|Alkylating Agents|alkylating agents|mesh-ancestor
64713459|NCT02629120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713460|NCT02629120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713461|NCT02629120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64713462|NCT02629120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64713463|NCT02629120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64713485|NCT02567409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64713486|NCT02567409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64713487|NCT02567409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64328311|NCT02176733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64328312|NCT02176733|Immunologic Factors|immunologic factors|mesh-ancestor
64328313|NCT02176733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713488|NCT02567409|Immunologic Factors|immunologic factors|mesh-ancestor
64713489|NCT02567409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713491|NCT02443727|Oxytocics|oxytocics|mesh-ancestor
64713492|NCT02443727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64713493|NCT02443727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713494|NCT02429700|Paclitaxel|paclitaxel|mesh-list
64713495|NCT02429700|Etoposide|etoposide|mesh-list
64713496|NCT02429700|Carboplatin|carboplatin|mesh-list
64713497|NCT02429700|Bleomycin|bleomycin|mesh-list
64713498|NCT02429700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64713499|NCT02429700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713500|NCT02429700|Tubulin Modulators|tubulin modulators|mesh-ancestor
64713501|NCT02429700|Antimitotic Agents|antimitotic agents|mesh-ancestor
64713502|NCT02429700|Mitosis Modulators|mitosis modulators|mesh-ancestor
64713503|NCT02429700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713504|NCT02429700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64713505|NCT02429700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64713506|NCT02429700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470797|NCT02952898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470798|NCT01101698|Vitamin D|vitamin d|mesh-list
65470799|NCT01101698|Cholecalciferol|cholecalciferol|mesh-list
65470800|NCT01101698|Vitamins|vitamins|mesh-list
65470801|NCT01101698|Vitamin K|vitamin k|mesh-list
65470802|NCT01101698|Vitamin K 2|vitamin k 2|mesh-list
65470803|NCT01101698|Micronutrients|micronutrients|mesh-ancestor
65470804|NCT01101698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470805|NCT01101698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65470806|NCT01101698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65470807|NCT01101698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65470808|NCT01101698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65470809|NCT01101698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470810|NCT01101698|Hemostatics|hemostatics|mesh-ancestor
65470811|NCT01101698|Coagulants|coagulants|mesh-ancestor
65470812|NCT00045734|Imatinib Mesylate|imatinib mesylate|mesh-list
65470813|NCT00045734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470814|NCT00045734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65470815|NCT00045734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470816|NCT00045734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470817|NCT05513768|Protein C|protein c|mesh-list
65470818|NCT05513768|Anticoagulants|anticoagulants|mesh-ancestor
65470819|NCT05513768|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65470820|NCT05513768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65470821|NCT05513768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470822|NCT03387046|Methylprednisolone|methylprednisolone|mesh-list
65470823|NCT03387046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65470824|NCT03387046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65470825|NCT03387046|Prednisolone|prednisolone|mesh-list
64713507|NCT02429700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64713508|NCT02429687|Paclitaxel|paclitaxel|mesh-list
64720394|NCT00000458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64720395|NCT00000458|Serotonin Agents|serotonin agents|mesh-ancestor
64720396|NCT00000458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720398|NCT03782233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64328314|NCT02176733|Antifungal Agents|antifungal agents|mesh-ancestor
64328315|NCT02176733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64328316|NCT02176733|Dermatologic Agents|dermatologic agents|mesh-ancestor
64328317|NCT02176733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64328318|NCT02176733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64328319|NCT03536741|Anesthetics|anesthetics|mesh-list
64328320|NCT03536741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
64713509|NCT02429687|Etoposide|etoposide|mesh-list
64713510|NCT02429687|Carboplatin|carboplatin|mesh-list
64713511|NCT02429687|Bleomycin|bleomycin|mesh-list
64713512|NCT02429687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64713513|NCT02429687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470826|NCT03387046|Prednisolone acetate|prednisolone acetate|mesh-list
65470827|NCT03387046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65470828|NCT03387046|Prednisolone phosphate|prednisolone phosphate|mesh-list
65470829|NCT03387046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65470830|NCT03387046|Antiemetics|antiemetics|mesh-ancestor
65470831|NCT03387046|Autonomic Agents|autonomic agents|mesh-ancestor
65470832|NCT03387046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65470833|NCT03387046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470834|NCT03387046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65470835|NCT03387046|Glucocorticoids|glucocorticoids|mesh-ancestor
65470836|NCT03387046|Hormones|hormones|mesh-ancestor
65470837|NCT03387046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65470838|NCT03387046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65470839|NCT03387046|Protective Agents|protective agents|mesh-ancestor
65470840|NCT03387046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65470841|NCT03387046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470842|NCT01101776|Interferons|interferons|mesh-list
65470843|NCT01101776|Interferon-beta|interferon-beta|mesh-list
65470844|NCT01101776|Interferon beta-1a|interferon beta-1a|mesh-list
65470845|NCT01101776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470846|NCT01101776|Antiviral Agents|antiviral agents|mesh-ancestor
65470847|NCT01101776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65470848|NCT01101776|Immunologic Factors|immunologic factors|mesh-ancestor
65470849|NCT01101776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470850|NCT01101776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65470851|NCT00045110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65470852|NCT00045110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470853|NCT00045110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65470854|NCT00045110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470855|NCT00045110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470856|NCT03353740|Edetic Acid|edetic acid|mesh-list
65470857|NCT03353740|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65220347|NCT04188483|Selenium|selenium|mesh-list
65470858|NCT03353740|Chelating Agents|chelating agents|mesh-ancestor
65470867|NCT01104038|Chlorhexidine|chlorhexidine|mesh-list
65470868|NCT01104038|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65470869|NCT01104038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65470870|NCT01104038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65470871|NCT01104038|Disinfectants|disinfectants|mesh-ancestor
65470872|NCT01104038|Dermatologic Agents|dermatologic agents|mesh-ancestor
65470873|NCT03386344|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65470874|NCT03386344|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65470875|NCT03386344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470876|NCT03386344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65470877|NCT03386344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470878|NCT00399035|Leucovorin|leucovorin|mesh-list
65470879|NCT00399035|Fluorouracil|fluorouracil|mesh-list
65470880|NCT00399035|Capecitabine|capecitabine|mesh-list
65470881|NCT00399035|Oxaliplatin|oxaliplatin|mesh-list
65470882|NCT00399035|Cediranib|cediranib|mesh-list
65470883|NCT00399035|Levoleucovorin|levoleucovorin|mesh-list
65470884|NCT00399035|Antimetabolites|antimetabolites|mesh-ancestor
65470885|NCT00399035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470886|NCT00399035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65470887|NCT00399035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470888|NCT00399035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65470889|NCT00399035|Immunologic Factors|immunologic factors|mesh-ancestor
65470890|NCT00399035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470891|NCT00399035|Antidotes|antidotes|mesh-ancestor
65470892|NCT00399035|Protective Agents|protective agents|mesh-ancestor
65470916|NCT01583439|Efavirenz|efavirenz|mesh-list
65470917|NCT01583439|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65470918|NCT01583439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65470919|NCT01583439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65470920|NCT01583439|Protease Inhibitors|protease inhibitors|mesh-ancestor
65470921|NCT01583439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470922|NCT01583439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470923|NCT01583439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65470924|NCT01583439|Antiviral Agents|antiviral agents|mesh-ancestor
65470925|NCT01583439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65470926|NCT01583439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65470927|NCT01583439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65470928|NCT01583439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65470929|NCT01583439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65470930|NCT01583439|Antimetabolites|antimetabolites|mesh-ancestor
65470931|NCT01583439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65470932|NCT01583439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65470933|NCT01583439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65470934|NCT01583439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65470935|NCT01583439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65470936|NCT02530827|Hypolipidemic Agents|hypolipidemic agents|mesh-list
65470937|NCT02530827|Antimetabolites|antimetabolites|mesh-ancestor
65470938|NCT02530827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470939|NCT02530827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65470940|NCT00398567|Trastuzumab|trastuzumab|mesh-list
65470941|NCT00398567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65470942|NCT00398567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470943|NCT01082289|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65470944|NCT01082289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65470945|NCT01082289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65470946|NCT01082289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65470947|NCT01082289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470948|NCT01082289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65470953|NCT01082289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65470954|NCT01082289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470955|NCT01082289|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65470956|NCT01082289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65470957|NCT01082289|Serotonin Agents|serotonin agents|mesh-ancestor
65470958|NCT01082289|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65470959|NCT01082289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65470960|NCT01082289|Dopamine Agents|dopamine agents|mesh-ancestor
65470961|NCT01347580|Ticagrelor|ticagrelor|mesh-list
65470962|NCT01347580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65470963|NCT01347580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65470964|NCT01347580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65470965|NCT01347580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65470966|NCT01347580|Purinergic Agents|purinergic agents|mesh-ancestor
65470967|NCT01347580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65470968|NCT01347580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470969|NCT01347580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65470970|NCT00398411|Moxifloxacin|moxifloxacin|mesh-list
65470971|NCT00398411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65470972|NCT00398411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65470973|NCT00398411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65470974|NCT00398411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65470975|NCT00398411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65470976|NCT00398411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65470977|NCT00398411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65470978|NCT03352414|Alvimopan|alvimopan|mesh-list
65470979|NCT03352414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65470980|NCT00364793|Emtricitabine|emtricitabine|mesh-list
65470981|NCT00364793|Efavirenz|efavirenz|mesh-list
65470996|NCT00364793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65470997|NCT00364793|Antimetabolites|antimetabolites|mesh-ancestor
65470998|NCT03351478|Empagliflozin|empagliflozin|mesh-list
65470999|NCT03351478|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65471000|NCT03351478|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65471001|NCT03351478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471002|NCT03351478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65471003|NCT03351478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471004|NCT00363545|Vaccines|vaccines|mesh-list
65471005|NCT00363545|Immunologic Factors|immunologic factors|mesh-ancestor
65471006|NCT00363545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713514|NCT02429687|Tubulin Modulators|tubulin modulators|mesh-ancestor
64713515|NCT02429687|Antimitotic Agents|antimitotic agents|mesh-ancestor
64713516|NCT02429687|Mitosis Modulators|mitosis modulators|mesh-ancestor
64713517|NCT02429687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713518|NCT02429687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64713519|NCT02429687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64713520|NCT02429687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64713521|NCT02429687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64720408|NCT00002090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720409|NCT00002096|Zidovudine|zidovudine|mesh-list
64328321|NCT03536741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64328322|NCT03536741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328323|NCT03536741|Anesthetics, General|anesthetics, general|mesh-ancestor
64328325|NCT02403687|Diclofenac|diclofenac|mesh-list
64328326|NCT02403687|Meloxicam|meloxicam|mesh-list
64328327|NCT02403687|Flurbiprofen|flurbiprofen|mesh-list
64328328|NCT02403687|Lidocaine|lidocaine|mesh-list
64328329|NCT02403687|Clonidine|clonidine|mesh-list
64328330|NCT02403687|Sumatriptan|sumatriptan|mesh-list
64328331|NCT02403687|Ketamine|ketamine|mesh-list
64328332|NCT02403687|Gabapentin|gabapentin|mesh-list
64328333|NCT02403687|Amitriptyline|amitriptyline|mesh-list
64713528|NCT02359565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64713529|NCT02359565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713547|NCT02278120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64713549|NCT02278120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64713550|NCT02278120|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64713551|NCT02278120|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64713552|NCT02278120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64713553|NCT02194829|Gemcitabine|gemcitabine|mesh-list
64713554|NCT02194829|Paclitaxel|paclitaxel|mesh-list
64713555|NCT02194829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64713556|NCT02194829|Adavosertib|adavosertib|mesh-list
64713557|NCT02194829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64713558|NCT02194829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713559|NCT02194829|Tubulin Modulators|tubulin modulators|mesh-ancestor
64713560|NCT02194829|Antimitotic Agents|antimitotic agents|mesh-ancestor
64713561|NCT02194829|Mitosis Modulators|mitosis modulators|mesh-ancestor
64713562|NCT02194829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713563|NCT02194829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64720411|NCT00002096|Ganciclovir|ganciclovir|mesh-list
64720412|NCT00002096|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64720413|NCT00002096|Antimetabolites|antimetabolites|mesh-ancestor
64720414|NCT00002096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720415|NCT00002096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64720416|NCT00002096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720417|NCT00002096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720418|NCT00002096|Antiviral Agents|antiviral agents|mesh-ancestor
64720419|NCT00002096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720420|NCT00002096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65471007|NCT03351244|BI 409306|bi 409306|mesh-list
65471008|NCT03351244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65471009|NCT03351244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471010|NCT03351244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471011|NCT03386032|Desonide|desonide|mesh-list
65471012|NCT03386032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65471013|NCT00077610|Epoetin Alfa|epoetin alfa|mesh-list
65471014|NCT00077610|Hematinics|hematinics|mesh-ancestor
65471015|NCT00066222|Etoposide|etoposide|mesh-list
65471016|NCT00066222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471017|NCT00066222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65471018|NCT00066222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65471019|NCT00066222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65471020|NCT00066222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471021|NCT00066222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471022|NCT00397943|Vaccines|vaccines|mesh-list
65471023|NCT00397943|Immunologic Factors|immunologic factors|mesh-ancestor
65471024|NCT00397943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471025|NCT00066066|Amoxicillin|amoxicillin|mesh-list
65471026|NCT00066066|Metronidazole|metronidazole|mesh-list
65471027|NCT00066066|Doxycycline|doxycycline|mesh-list
65471028|NCT00066066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65471029|NCT00066066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65471030|NCT00066066|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65471031|NCT00066066|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65471032|NCT00066066|Antimalarials|antimalarials|mesh-ancestor
65471033|NCT00363467|Busulfan|busulfan|mesh-list
65471034|NCT00363467|Alkylating Agents|alkylating agents|mesh-ancestor
65471035|NCT00363467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471036|NCT00363467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65471037|NCT00363467|Immunologic Factors|immunologic factors|mesh-ancestor
64855113|NCT01712828|Lenalidomide|lenalidomide|mesh-list
64720421|NCT00002096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64720422|NCT00002102|Leucovorin|leucovorin|mesh-list
64720423|NCT00002102|Trimetrexate|trimetrexate|mesh-list
64720424|NCT00002102|Calcium|calcium|mesh-list
64720425|NCT00002102|Levoleucovorin|levoleucovorin|mesh-list
64720426|NCT00002102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64720427|NCT00002102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720428|NCT00002102|Antidotes|antidotes|mesh-ancestor
64720429|NCT00002102|Protective Agents|protective agents|mesh-ancestor
64720430|NCT00002102|Vitamin B Complex|vitamin b complex|mesh-ancestor
64720431|NCT00002102|Vitamins|vitamins|mesh-ancestor
64720432|NCT00002102|Micronutrients|micronutrients|mesh-ancestor
64720433|NCT00002102|Antifungal Agents|antifungal agents|mesh-ancestor
64720434|NCT00002102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720435|NCT00002102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65471038|NCT00363467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471039|NCT00363467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65471040|NCT00363467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471041|NCT00363467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65471042|NCT00397631|Pioglitazone|pioglitazone|mesh-list
65471043|NCT00397631|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65471044|NCT00397631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65471045|NCT00397631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471046|NCT00397631|Incretins|incretins|mesh-ancestor
65471047|NCT00397631|Hormones|hormones|mesh-ancestor
65471048|NCT00397631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65471049|NCT00397631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65471050|NCT00397631|Protease Inhibitors|protease inhibitors|mesh-ancestor
65471051|NCT00397631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471052|NCT00397631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471053|NCT00077376|Carboplatin|carboplatin|mesh-list
65471054|NCT00077376|Trastuzumab|trastuzumab|mesh-list
65471055|NCT00077376|Epothilone B|epothilone b|mesh-list
65471056|NCT00077376|Epothilones|epothilones|mesh-list
65471057|NCT00077376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471058|NCT00077376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65471059|NCT00077376|Tubulin Modulators|tubulin modulators|mesh-ancestor
65471060|NCT00077376|Antimitotic Agents|antimitotic agents|mesh-ancestor
65471061|NCT00077376|Mitosis Modulators|mitosis modulators|mesh-ancestor
65471062|NCT00077376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471063|NCT01088724|Cyclophosphamide|cyclophosphamide|mesh-list
65471064|NCT01088724|Rituximab|rituximab|mesh-list
65471065|NCT01088724|Doxorubicin|doxorubicin|mesh-list
65471066|NCT01088724|Fludarabine|fludarabine|mesh-list
65471067|NCT01088724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65471068|NCT01088724|Immunologic Factors|immunologic factors|mesh-ancestor
65471069|NCT01088724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471070|NCT01088724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65471071|NCT01088724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65471078|NCT01088724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65471079|NCT01088724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65471080|NCT01088724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471082|NCT03957174|Reboxetine|reboxetine|mesh-list
65471083|NCT03957174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65471084|NCT03957174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471085|NCT03957174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471086|NCT03957174|Cholinergic Agents|cholinergic agents|mesh-ancestor
65471087|NCT03957174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65471088|NCT03957174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471089|NCT03957174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65471090|NCT03957174|Protective Agents|protective agents|mesh-ancestor
65471091|NCT03957174|Antidepressive Agents|antidepressive agents|mesh-ancestor
65471092|NCT03957174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65471093|NCT03957174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65471094|NCT03957174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65471095|NCT03957174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65471096|NCT03957174|Adrenergic Agents|adrenergic agents|mesh-ancestor
65471097|NCT03406156|Venetoclax|venetoclax|mesh-list
65471098|NCT03406156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65471099|NCT03406156|Obinutuzumab|obinutuzumab|mesh-list
65471100|NCT03406156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471101|NCT03406156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65471102|NCT03406156|Alkylating Agents|alkylating agents|mesh-ancestor
64720436|NCT00002102|Antimetabolites|antimetabolites|mesh-ancestor
64720437|NCT00002102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720438|NCT00002102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64328335|NCT02403687|Bupivacaine|bupivacaine|mesh-list
64328336|NCT02403687|Prilocaine|prilocaine|mesh-list
64720442|NCT00002108|Zidovudine|zidovudine|mesh-list
64720443|NCT00002108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64720444|NCT00002108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720445|NCT00002108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720446|NCT00002108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720447|NCT00002108|Antiviral Agents|antiviral agents|mesh-ancestor
64720448|NCT00002108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720449|NCT00002108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64720450|NCT00002108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64720451|NCT00002108|Antimetabolites|antimetabolites|mesh-ancestor
64720452|NCT00381134|Losartan|losartan|mesh-list
64720453|NCT00381134|Spironolactone|spironolactone|mesh-list
64720454|NCT00381134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64720455|NCT00381134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64720456|NCT00381134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64720457|NCT00381134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64720458|NCT00381134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720459|NCT00381134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64720461|NCT00381134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64720462|NCT00381134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720463|NCT00381134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65471103|NCT03406156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471104|NCT03406156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65471105|NCT00363311|Dutasteride|dutasteride|mesh-list
65471106|NCT00363311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65471107|NCT00363311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65471108|NCT00363311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471109|NCT00363311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471110|NCT00363311|Hormone Antagonists|hormone antagonists|mesh-ancestor
65471111|NCT00363311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65471112|NCT00363311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471113|NCT00362609|Pantoprazole|pantoprazole|mesh-list
65471114|NCT00362609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65471115|NCT00362609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65471116|NCT00362609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65471117|NCT00362609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471118|NCT00362609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471119|NCT02534753|Ascorbic Acid|ascorbic acid|mesh-list
65471120|NCT02534753|Antioxidants|antioxidants|mesh-ancestor
65471121|NCT02534753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471122|NCT02534753|Protective Agents|protective agents|mesh-ancestor
65471123|NCT02534753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471124|NCT02534753|Vitamins|vitamins|mesh-ancestor
65471125|NCT02534753|Micronutrients|micronutrients|mesh-ancestor
65471126|NCT01042457|Mycophenolic Acid|mycophenolic acid|mesh-list
65471127|NCT01042457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65471128|NCT01042457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471129|NCT01042457|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65471130|NCT01042457|Antitubercular Agents|antitubercular agents|mesh-ancestor
65471131|NCT01042457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65471132|NCT01042457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65471133|NCT01042457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471135|NCT00362297|Valacyclovir|valacyclovir|mesh-list
65471143|NCT00090402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471144|NCT00090402|Protective Agents|protective agents|mesh-ancestor
65471145|NCT00090402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471146|NCT00090402|Vitamin B Complex|vitamin b complex|mesh-ancestor
65471147|NCT00090402|Vitamins|vitamins|mesh-ancestor
65471148|NCT00090402|Micronutrients|micronutrients|mesh-ancestor
65471149|NCT00361283|Atorvastatin|atorvastatin|mesh-list
65471150|NCT00361283|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65471151|NCT00361283|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65471152|NCT00361283|Antimetabolites|antimetabolites|mesh-ancestor
65471153|NCT00361283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471154|NCT00361283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65471155|NCT00361283|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65471156|NCT00361283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471157|NCT00077064|Captopril|captopril|mesh-list
65471158|NCT00077064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65471159|NCT00077064|Protease Inhibitors|protease inhibitors|mesh-ancestor
65471160|NCT00077064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855251|NCT01713387|Gemcitabine|gemcitabine|mesh-list
64720464|NCT00381134|Diuretics|diuretics|mesh-ancestor
64720465|NCT00381134|Natriuretic Agents|natriuretic agents|mesh-ancestor
64720466|NCT00000506|Phentermine|phentermine|mesh-list
64720467|NCT00000506|Fenfluramine|fenfluramine|mesh-list
64720468|NCT00000506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64720469|NCT00000506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720470|NCT00000506|Appetite Depressants|appetite depressants|mesh-ancestor
64720471|NCT00000506|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64720472|NCT00000506|Sympathomimetics|sympathomimetics|mesh-ancestor
64720473|NCT00000506|Autonomic Agents|autonomic agents|mesh-ancestor
64720474|NCT00000506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64720475|NCT00000506|Adrenergic Agents|adrenergic agents|mesh-ancestor
64720476|NCT00000506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64720477|NCT00000506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720478|NCT00000506|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64720479|NCT00000506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64720480|NCT00000506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64720481|NCT00000506|Serotonin Agents|serotonin agents|mesh-ancestor
64720482|NCT00000512|Niacin|niacin|mesh-list
64720483|NCT00000512|Nicotinic Acids|nicotinic acids|mesh-list
64720484|NCT00000512|Lovastatin|lovastatin|mesh-list
64720485|NCT00000512|L 647318|l 647318|mesh-list
64720486|NCT00000512|Dihydromevinolin|dihydromevinolin|mesh-list
64720487|NCT00000512|Colestipol|colestipol|mesh-list
64720488|NCT00000512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64720489|NCT00000512|Antimetabolites|antimetabolites|mesh-ancestor
64720490|NCT00000512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720491|NCT00000512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64720492|NCT00000512|Vasodilator Agents|vasodilator agents|mesh-ancestor
64328397|NCT02742649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64328398|NCT02742649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64328399|NCT02742649|Adrenergic Agents|adrenergic agents|mesh-ancestor
64328400|NCT02742649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64328401|NCT02742649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328402|NCT02742649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328403|NCT02742649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64328404|NCT02742649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64328405|NCT02183051|Ibuprofen|ibuprofen|mesh-list
64328406|NCT02183051|Meloxicam|meloxicam|mesh-list
65471161|NCT00077064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471162|NCT00077064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65471163|NCT00396383|Plerixafor|plerixafor|mesh-list
65471164|NCT00396383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65471165|NCT00396383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65471166|NCT00396383|Antiviral Agents|antiviral agents|mesh-ancestor
65471167|NCT00396383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65471168|NCT02534363|Aripiprazole|aripiprazole|mesh-list
65471169|NCT02534363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65471170|NCT02534363|Ziprasidone|ziprasidone|mesh-list
65471171|NCT02534363|Antidepressive Agents|antidepressive agents|mesh-ancestor
65471172|NCT02534363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65471173|NCT02534363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65471174|NCT02534363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65471175|NCT02534363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65471176|NCT02534363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471177|NCT02534363|Dopamine Agonists|dopamine agonists|mesh-ancestor
65471178|NCT02534363|Dopamine Agents|dopamine agents|mesh-ancestor
65471179|NCT02534363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65471180|NCT02534363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471181|NCT02534363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65471182|NCT02534363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65471183|NCT02534363|Serotonin Agents|serotonin agents|mesh-ancestor
65471184|NCT02534363|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65471185|NCT02534363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65471186|NCT02534363|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65471187|NCT02534363|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65471188|NCT01050491|Sitaxsentan|sitaxsentan|mesh-list
65471189|NCT01050491|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65471190|NCT01050491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471191|NCT01088958|Micronutrients|micronutrients|mesh-list
65471192|NCT01088958|Trace Elements|trace elements|mesh-list
65471193|NCT01088958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471194|NCT03404518|Acetaminophen|acetaminophen|mesh-list
65471195|NCT03404518|Ibuprofen|ibuprofen|mesh-list
65471196|NCT03404518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64328407|NCT02183051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65471197|NCT03404518|Hydrocodone|hydrocodone|mesh-list
65471198|NCT03404518|Narcotics|narcotics|mesh-list
65471199|NCT03404518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65471200|NCT03404518|Analgesics|analgesics|mesh-ancestor
65471201|NCT03404518|Sensory System Agents|sensory system agents|mesh-ancestor
65471202|NCT03404518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65471203|NCT03404518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471204|NCT03404518|Antipyretics|antipyretics|mesh-ancestor
65471205|NCT03404518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65471206|NCT03404518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65471207|NCT03404518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65471208|NCT03404518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65471209|NCT03404518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471210|NCT03404518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471211|NCT03404518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65471212|NCT03404518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64328408|NCT02183051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64328409|NCT02183051|Analgesics|analgesics|mesh-ancestor
64328410|NCT02183051|Sensory System Agents|sensory system agents|mesh-ancestor
64328414|NCT02183051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64328418|NCT02183051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64328419|NCT03169725|Vaccines|vaccines|mesh-list
64328420|NCT03169725|Immunologic Factors|immunologic factors|mesh-ancestor
64416166|NCT01663727|Paclitaxel|paclitaxel|mesh-list
64713622|NCT02107963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64713623|NCT02107963|Alkylating Agents|alkylating agents|mesh-ancestor
64713624|NCT02107963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713625|NCT02107963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713626|NCT02107963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64713627|NCT02101788|Tamoxifen|tamoxifen|mesh-list
64713628|NCT02101788|Paclitaxel|paclitaxel|mesh-list
64720505|NCT00380822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720506|NCT00380822|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64720507|NCT00000542|Amlodipine|amlodipine|mesh-list
64720508|NCT00000542|Lisinopril|lisinopril|mesh-list
64720509|NCT00000542|Chlorthalidone|chlorthalidone|mesh-list
64720510|NCT00000542|Doxazosin|doxazosin|mesh-list
64720511|NCT00000542|Pravastatin|pravastatin|mesh-list
64720512|NCT00000542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64720513|NCT00000542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64720514|NCT00000542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64720515|NCT00000542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64720516|NCT00000542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720517|NCT00000542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64720518|NCT00000542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328421|NCT03169725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328422|NCT02403531|Docetaxel|docetaxel|mesh-list
64328423|NCT02403531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64328424|NCT02403531|Tubulin Modulators|tubulin modulators|mesh-ancestor
64328425|NCT02403531|Antimitotic Agents|antimitotic agents|mesh-ancestor
64328426|NCT02403531|Mitosis Modulators|mitosis modulators|mesh-ancestor
64328427|NCT02403531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328428|NCT02183129|Diclofenac|diclofenac|mesh-list
64328429|NCT02183129|Meloxicam|meloxicam|mesh-list
64328430|NCT02183129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64328431|NCT02183129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64328432|NCT02183129|Analgesics|analgesics|mesh-ancestor
64328433|NCT02183129|Sensory System Agents|sensory system agents|mesh-ancestor
64328434|NCT02183129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65471213|NCT03404518|Antitussive Agents|antitussive agents|mesh-ancestor
65471214|NCT03404518|Respiratory System Agents|respiratory system agents|mesh-ancestor
65471215|NCT03404206|Ibuprofen|ibuprofen|mesh-list
65471216|NCT03404206|Naproxen|naproxen|mesh-list
65471217|NCT03404206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65471218|NCT03404206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65471219|NCT03404206|Analgesics|analgesics|mesh-ancestor
65471220|NCT03404206|Sensory System Agents|sensory system agents|mesh-ancestor
65471221|NCT03404206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65471222|NCT03404206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471223|NCT03404206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65471224|NCT03404206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65471225|NCT03404206|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65471226|NCT03404206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471227|NCT03404206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471228|NCT03404206|Gout Suppressants|gout suppressants|mesh-ancestor
65471229|NCT00394901|Pregabalin|pregabalin|mesh-list
65471230|NCT00394901|Analgesics|analgesics|mesh-ancestor
65471231|NCT00394901|Sensory System Agents|sensory system agents|mesh-ancestor
65471232|NCT00394901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65471233|NCT00394901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471234|NCT00394901|Anticonvulsants|anticonvulsants|mesh-ancestor
65471235|NCT00394901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65471236|NCT00394901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65471237|NCT00394901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471238|NCT00394901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65471239|NCT00394901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65471240|NCT00394901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65471242|NCT00394901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65471258|NCT03348904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65471259|NCT03348904|Antimetabolites|antimetabolites|mesh-ancestor
65471260|NCT03348904|Antiviral Agents|antiviral agents|mesh-ancestor
65471261|NCT03348904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65471262|NCT03348904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471263|NCT03348904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65471264|NCT03348904|Immunologic Factors|immunologic factors|mesh-ancestor
65471265|NCT03348904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471266|NCT03348904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65471267|NCT03348904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65471268|NCT03348904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65471269|NCT03348904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65471270|NCT00359021|Etravirine|etravirine|mesh-list
65471271|NCT00359021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65471272|NCT00359021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65471273|NCT00359021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471274|NCT00359021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471275|NCT00359021|Antiviral Agents|antiviral agents|mesh-ancestor
65471276|NCT00359021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65471277|NCT00064350|Sorafenib|sorafenib|mesh-list
65471278|NCT00064350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471279|NCT00064350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65471280|NCT00064350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471281|NCT00064350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471282|NCT00360269|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65471290|NCT01052597|Curcumin|curcumin|mesh-list
65471304|NCT01051115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65471305|NCT01051115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471306|NCT01051115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471308|NCT00076752|Promethazine|promethazine|mesh-list
65471309|NCT00076752|Methylprednisolone|methylprednisolone|mesh-list
65471310|NCT00076752|Cyclophosphamide|cyclophosphamide|mesh-list
65471311|NCT00076752|Rituximab|rituximab|mesh-list
65471312|NCT00076752|Fludarabine|fludarabine|mesh-list
65471313|NCT00076752|Fludarabine phosphate|fludarabine phosphate|mesh-list
65471314|NCT00076752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65471315|NCT00076752|Immunologic Factors|immunologic factors|mesh-ancestor
65471316|NCT00076752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471317|NCT00076752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65471318|NCT00076752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65471319|NCT00076752|Alkylating Agents|alkylating agents|mesh-ancestor
65471320|NCT00076752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471321|NCT00076752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471322|NCT00076752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65471323|NCT00076752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65471324|NCT00076752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65471325|NCT00076752|Antimetabolites|antimetabolites|mesh-ancestor
65471326|NCT00076752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65471327|NCT00076752|Antiemetics|antiemetics|mesh-ancestor
65471328|NCT00076752|Autonomic Agents|autonomic agents|mesh-ancestor
65471329|NCT00076752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65471330|NCT00076752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65471331|NCT00076752|Glucocorticoids|glucocorticoids|mesh-ancestor
65471332|NCT00076752|Hormones|hormones|mesh-ancestor
65471333|NCT00076752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65471334|NCT00076752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65471335|NCT00076752|Protective Agents|protective agents|mesh-ancestor
65471336|NCT00076752|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65471337|NCT00076752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65471338|NCT00076752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65471339|NCT00076752|Anesthetics, Local|anesthetics, local|mesh-ancestor
65471345|NCT00076752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65471346|NCT00076752|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65471347|NCT00076752|Antipruritics|antipruritics|mesh-ancestor
65471348|NCT00076752|Dermatologic Agents|dermatologic agents|mesh-ancestor
65471349|NCT03384940|Trastuzumab|trastuzumab|mesh-list
65471350|NCT03384940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65471351|NCT03384940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471352|NCT00075582|Dactinomycin|dactinomycin|mesh-list
65471353|NCT00075582|Cactinomycin|cactinomycin|mesh-list
65471354|NCT00075582|Cyclophosphamide|cyclophosphamide|mesh-list
65471355|NCT00075582|Vincristine|vincristine|mesh-list
65471356|NCT00075582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65471411|NCT00088530|Hormones|hormones|mesh-ancestor
65471412|NCT00088530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65471413|NCT00088530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65471414|NCT00088530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65471415|NCT00088530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65471416|NCT00088530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65471417|NCT00088530|Tubulin Modulators|tubulin modulators|mesh-ancestor
65471418|NCT00088530|Antimitotic Agents|antimitotic agents|mesh-ancestor
65471419|NCT00088530|Mitosis Modulators|mitosis modulators|mesh-ancestor
65471420|NCT00359801|Insulin|insulin|mesh-list
65471421|NCT00359801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65471422|NCT00359801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65471423|NCT00359801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471424|NCT03990701|Metomidate|metomidate|mesh-list
65471425|NCT03990701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65471426|NCT03990701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65471427|NCT03990701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471428|NCT01051193|Oxcarbazepine|oxcarbazepine|mesh-list
65471429|NCT01051193|Anticonvulsants|anticonvulsants|mesh-ancestor
65471430|NCT01051193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64328435|NCT02183129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328436|NCT02183129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64720530|NCT00000542|Natriuretic Agents|natriuretic agents|mesh-ancestor
64720531|NCT00000542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64720532|NCT00000542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64720533|NCT00000542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64720534|NCT00000542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64720535|NCT00000542|Adrenergic Agents|adrenergic agents|mesh-ancestor
64720536|NCT00000542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64720537|NCT00002120|Leucovorin|leucovorin|mesh-list
64720538|NCT00002120|Trimethoprim|trimethoprim|mesh-list
64720539|NCT00002120|Dapsone|dapsone|mesh-list
64720540|NCT00002120|Sulfamethoxazole|sulfamethoxazole|mesh-list
64720541|NCT00002120|Trimetrexate|trimetrexate|mesh-list
64720542|NCT00002120|Calcium|calcium|mesh-list
64720543|NCT00002120|Levoleucovorin|levoleucovorin|mesh-list
64720544|NCT00002120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64720545|NCT00002120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720546|NCT00002120|Antidotes|antidotes|mesh-ancestor
64720547|NCT00002120|Protective Agents|protective agents|mesh-ancestor
64720548|NCT00002120|Vitamin B Complex|vitamin b complex|mesh-ancestor
64720549|NCT00002120|Vitamins|vitamins|mesh-ancestor
64720550|NCT00002120|Micronutrients|micronutrients|mesh-ancestor
64328445|NCT02279953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64328446|NCT02279953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64328447|NCT02279953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64328448|NCT02279953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328449|NCT02279953|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64328450|NCT02279953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64720566|NCT00002120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64720568|NCT00002120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64328459|NCT00578773|Moxifloxacin|moxifloxacin|mesh-list
64328466|NCT00578773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328467|NCT00578773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713630|NCT02101788|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65471431|NCT01051193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65471432|NCT01051193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65471433|NCT01051193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471434|NCT01051193|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65471435|NCT01051193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65471436|NCT01051271|Midazolam|midazolam|mesh-list
65471437|NCT01051271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65471438|NCT01051271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65471439|NCT01051271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65471440|NCT01051271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471441|NCT01051271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65471442|NCT01051271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65471443|NCT01051271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65471444|NCT01051271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65471445|NCT01051271|Anesthetics, General|anesthetics, general|mesh-ancestor
65471446|NCT01051271|Anesthetics|anesthetics|mesh-ancestor
65471447|NCT01051271|GABA Modulators|gaba modulators|mesh-ancestor
65471448|NCT01051271|GABA Agents|gaba agents|mesh-ancestor
65471449|NCT01051271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65471450|NCT01051271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471451|NCT01051427|Hemostatics|hemostatics|mesh-list
65471452|NCT01051427|Surgiflo|surgiflo|mesh-list
65471453|NCT01051427|Coagulants|coagulants|mesh-ancestor
65471454|NCT01052909|Glimepiride|glimepiride|mesh-list
64855529|NCT01714596|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64713631|NCT02101788|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64713632|NCT02101788|Letrozole|letrozole|mesh-list
64713633|NCT02101788|Topotecan|topotecan|mesh-list
64713634|NCT02101788|Trametinib|trametinib|mesh-list
64713635|NCT02101788|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
64713636|NCT02101788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64713637|NCT02101788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713638|NCT02101788|Tubulin Modulators|tubulin modulators|mesh-ancestor
64713639|NCT02101788|Antimitotic Agents|antimitotic agents|mesh-ancestor
64713640|NCT02101788|Mitosis Modulators|mitosis modulators|mesh-ancestor
64713641|NCT02101788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713642|NCT02101788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64713643|NCT02101788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64713644|NCT02101788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64720569|NCT00002126|Lenograstim|lenograstim|mesh-list
64720570|NCT00002126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64720571|NCT00002126|Immunologic Factors|immunologic factors|mesh-ancestor
64720572|NCT00002126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720573|NCT03231397|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64720574|NCT03231397|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64720575|NCT03231397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720576|NCT03189433|Dantrolene|dantrolene|mesh-list
64720577|NCT03189433|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64720578|NCT03189433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720579|NCT03189433|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64720580|NCT03189433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65471455|NCT01052909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65471456|NCT01052909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65471457|NCT01052909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471458|NCT01052909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65471459|NCT01052909|Immunologic Factors|immunologic factors|mesh-ancestor
65471460|NCT00045032|Trastuzumab|trastuzumab|mesh-list
65471461|NCT00045032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65471462|NCT00045032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471463|NCT01052987|Tranilast|tranilast|mesh-list
65471464|NCT01052987|Allopurinol|allopurinol|mesh-list
65471465|NCT01052987|Antimetabolites|antimetabolites|mesh-ancestor
65471466|NCT01052987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471467|NCT01052987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471468|NCT01052987|Gout Suppressants|gout suppressants|mesh-ancestor
65471469|NCT01052987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65471470|NCT01052987|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65471471|NCT01052987|Antioxidants|antioxidants|mesh-ancestor
65471472|NCT01052987|Protective Agents|protective agents|mesh-ancestor
65471473|NCT01052987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471474|NCT01052987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65471475|NCT01052987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65471476|NCT01052987|Analgesics|analgesics|mesh-ancestor
65471477|NCT01052987|Sensory System Agents|sensory system agents|mesh-ancestor
65471478|NCT01052987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65471479|NCT01052987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65471480|NCT01052987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64855566|NCT01714843|Linaclotide|linaclotide|mesh-list
64720581|NCT00002132|Itraconazole|itraconazole|mesh-list
64720582|NCT00002132|Fluconazole|fluconazole|mesh-list
64720583|NCT00002132|Antifungal Agents|antifungal agents|mesh-ancestor
64720584|NCT00002132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720585|NCT00002132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64720586|NCT00002132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64720587|NCT00002132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328469|NCT02387307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64328470|NCT02387307|Antiviral Agents|antiviral agents|mesh-ancestor
64328471|NCT02387307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64328472|NCT02183363|Linagliptin|linagliptin|mesh-list
64328473|NCT02183363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64328474|NCT02183363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328475|NCT02183363|Incretins|incretins|mesh-ancestor
64328476|NCT02183363|Hormones|hormones|mesh-ancestor
64328477|NCT02183363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64328478|NCT02183363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64328479|NCT02183363|Protease Inhibitors|protease inhibitors|mesh-ancestor
64328480|NCT02183363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328481|NCT02183363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328482|NCT02183441|Linagliptin|linagliptin|mesh-list
64328483|NCT02183441|Ritonavir|ritonavir|mesh-list
64328484|NCT02183441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65471481|NCT01052987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65471482|NCT01052987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65471483|NCT01052987|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65471484|NCT01052987|Histamine Antagonists|histamine antagonists|mesh-ancestor
65471485|NCT01052987|Histamine Agents|histamine agents|mesh-ancestor
65471486|NCT01052987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65471487|NCT01052987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65471488|NCT01052987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65471489|NCT02533973|Calcipotriene|calcipotriene|mesh-list
65471490|NCT02533973|Dermatologic Agents|dermatologic agents|mesh-ancestor
65471491|NCT01053065|Atorvastatin|atorvastatin|mesh-list
65471492|NCT01053065|Cholestyramine Resin|cholestyramine resin|mesh-list
65471493|NCT01053065|Gamma-sitosterol|gamma-sitosterol|mesh-list
65471494|NCT01053065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65471495|NCT01053065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65471496|NCT01053065|Antimetabolites|antimetabolites|mesh-ancestor
65471497|NCT01053065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471498|NCT01053065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64855579|NCT01714895|Insulin|insulin|mesh-list
64328485|NCT02183441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64720588|NCT00002132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720589|NCT00002132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64720590|NCT00002132|Hormone Antagonists|hormone antagonists|mesh-ancestor
64720591|NCT00002132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64720592|NCT00002132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720593|NCT00002132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64720596|NCT00002144|Foscarnet|foscarnet|mesh-list
64720663|NCT00000626|Doxorubicin|doxorubicin|mesh-list
64328558|NCT02280109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64328559|NCT02280109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64328560|NCT02280109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64328561|NCT02280109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328562|NCT02280109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328563|NCT02280109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64328564|NCT02280109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64328565|NCT00576667|Rimonabant|rimonabant|mesh-list
64945637|NCT05379322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64713645|NCT02101788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720666|NCT00000626|Dacarbazine|dacarbazine|mesh-list
64720667|NCT00000626|Vinblastine|vinblastine|mesh-list
64720668|NCT00000626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64720669|NCT00000626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64720670|NCT00000626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64720671|NCT00000626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64720672|NCT00000626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720673|NCT00000626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720674|NCT00000626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64720675|NCT00000626|Alkylating Agents|alkylating agents|mesh-ancestor
64720676|NCT00000626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64720677|NCT00000626|Tubulin Modulators|tubulin modulators|mesh-ancestor
64720678|NCT00000626|Antimitotic Agents|antimitotic agents|mesh-ancestor
64720679|NCT00000626|Mitosis Modulators|mitosis modulators|mesh-ancestor
64720680|NCT03109873|Metformin|metformin|mesh-list
64720681|NCT03109873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64720682|NCT03109873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471499|NCT01053065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65471500|NCT01053065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471501|NCT01051583|Bevacizumab|bevacizumab|mesh-list
65471502|NCT01051583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65471503|NCT01051583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471504|NCT01051583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65471505|NCT01051583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65471506|NCT01051583|Growth Substances|growth substances|mesh-ancestor
65471507|NCT01051583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471508|NCT01051583|Growth Inhibitors|growth inhibitors|mesh-ancestor
65471509|NCT05386706|Metformin|metformin|mesh-list
65471510|NCT05386706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65471511|NCT05386706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471512|NCT03950804|Eculizumab|eculizumab|mesh-list
65471513|NCT03950804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65471514|NCT03950804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65471515|NCT03950804|Immunologic Factors|immunologic factors|mesh-ancestor
65471516|NCT03950804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720683|NCT04713254|Metoprolol|metoprolol|mesh-list
64720684|NCT04713254|Midazolam|midazolam|mesh-list
64328566|NCT00576667|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64328567|NCT00576667|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
64328568|NCT00576667|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64328569|NCT00576667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64328570|NCT00576667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328571|NCT00576667|Hormones|hormones|mesh-ancestor
64328572|NCT00576667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64328573|NCT00576667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328574|NCT02403063|Neostigmine|neostigmine|mesh-list
64328575|NCT02403063|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64328576|NCT02403063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328577|NCT02403063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720698|NCT04713254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64720699|NCT04713254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720700|NCT04713254|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64328584|NCT02177357|Pramipexole|pramipexole|mesh-list
64328585|NCT02177357|Antioxidants|antioxidants|mesh-ancestor
64328586|NCT02177357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328587|NCT02177357|Protective Agents|protective agents|mesh-ancestor
64328588|NCT02177357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328589|NCT02177357|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64713646|NCT02101788|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64713662|NCT02016924|Cobicistat|cobicistat|mesh-list
64713663|NCT02016924|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64713664|NCT02016924|Emtricitabine|emtricitabine|mesh-list
64713665|NCT02016924|Tenofovir|tenofovir|mesh-list
64713666|NCT02016924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720713|NCT04713254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64720714|NCT04713254|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64720715|NCT04713254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64720716|NCT04713254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64720717|NCT04713254|Adrenergic Agents|adrenergic agents|mesh-ancestor
64720719|NCT00002156|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64720720|NCT00002156|Fomivirsen|fomivirsen|mesh-list
64328610|NCT02386449|Sequestering Agents|sequestering agents|mesh-ancestor
65471517|NCT00356915|Itraconazole|itraconazole|mesh-list
65471518|NCT00356915|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
65471519|NCT00356915|Antifungal Agents|antifungal agents|mesh-ancestor
65471520|NCT00356915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65471521|NCT00356915|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65471522|NCT00356915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65471523|NCT00356915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471524|NCT00356915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471525|NCT00356915|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65471526|NCT00356915|Hormone Antagonists|hormone antagonists|mesh-ancestor
65471527|NCT00356915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65471528|NCT00356915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471529|NCT00356915|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65471531|NCT00356759|Anticoagulants|anticoagulants|mesh-ancestor
65471532|NCT00356603|Sumatriptan|sumatriptan|mesh-list
65471533|NCT00356603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65471534|NCT00356603|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65471535|NCT00356603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65471536|NCT00356603|Serotonin Agents|serotonin agents|mesh-ancestor
65471537|NCT00356603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65471538|NCT00356603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471570|NCT00001880|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65471571|NCT00001880|Abortifacient Agents|abortifacient agents|mesh-ancestor
65471572|NCT00001880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65471573|NCT00001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471574|NCT00001880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65471575|NCT00001880|Antimetabolites|antimetabolites|mesh-ancestor
65471576|NCT00001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471577|NCT00001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471578|NCT00001880|Dermatologic Agents|dermatologic agents|mesh-ancestor
65471579|NCT00001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471580|NCT00001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65471581|NCT00001880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65471582|NCT00001880|Immunologic Factors|immunologic factors|mesh-ancestor
65471583|NCT00001880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65471584|NCT00001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65471585|NCT00001880|Antifungal Agents|antifungal agents|mesh-ancestor
65471586|NCT00001880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65471587|NCT00001880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65471588|NCT01096472|Octenidine|octenidine|mesh-list
65471589|NCT01096472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65471590|NCT01096472|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65471591|NCT05627648|Mitogens|mitogens|mesh-list
65471592|NCT05627648|Mitosis Modulators|mitosis modulators|mesh-ancestor
65471593|NCT05627648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471594|NCT05296772|Pembrolizumab|pembrolizumab|mesh-list
65471595|NCT05296772|Antibodies|antibodies|mesh-list
65471596|NCT05296772|Immunoglobulins|immunoglobulins|mesh-list
65471597|NCT05296772|Immunologic Factors|immunologic factors|mesh-ancestor
65471598|NCT05296772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471599|NCT05296772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65471615|NCT01104896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65471616|NCT01104896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65471617|NCT01104896|Cholinergic Agents|cholinergic agents|mesh-ancestor
65471618|NCT01104896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65471619|NCT01104896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471620|NCT00043550|Sertraline|sertraline|mesh-list
65471621|NCT00043550|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65471622|NCT00043550|Antidepressive Agents|antidepressive agents|mesh-ancestor
65471623|NCT00043550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65471624|NCT00043550|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65471625|NCT00043550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65471626|NCT00043550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65471627|NCT00043550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471628|NCT00043550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65471629|NCT00043550|Serotonin Agents|serotonin agents|mesh-ancestor
65471630|NCT00043550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471631|NCT00043550|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65471632|NCT00043550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65471633|NCT01102244|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
65471634|NCT01102244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65471635|NCT01102244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65471636|NCT01102244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65471637|NCT01102244|Glucocorticoids|glucocorticoids|mesh-ancestor
65471638|NCT01102244|Hormones|hormones|mesh-ancestor
65471639|NCT01102244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65471640|NCT01102244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471641|NCT01102244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65471642|NCT01102244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65471643|NCT01105208|Cephalexin|cephalexin|mesh-list
65471644|NCT01105208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65471645|NCT01105208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65471646|NCT01105286|Vitamin D|vitamin d|mesh-list
65471647|NCT01105286|Calcipotriene|calcipotriene|mesh-list
65471648|NCT01105286|Vitamins|vitamins|mesh-ancestor
65471649|NCT01105286|Micronutrients|micronutrients|mesh-ancestor
64328611|NCT02386449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328612|NCT02386449|Antacids|antacids|mesh-ancestor
64328613|NCT00656539|Azithromycin|azithromycin|mesh-list
64328614|NCT00656539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65471650|NCT01105286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471651|NCT01105286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65471652|NCT01105286|Dermatologic Agents|dermatologic agents|mesh-ancestor
65471653|NCT00041132|Leucovorin|leucovorin|mesh-list
65471654|NCT00041132|Cytarabine|cytarabine|mesh-list
65471655|NCT00041132|Dexamethasone|dexamethasone|mesh-list
65471656|NCT00041132|Cyclophosphamide|cyclophosphamide|mesh-list
65471657|NCT00041132|Rituximab|rituximab|mesh-list
65471658|NCT00041132|Doxorubicin|doxorubicin|mesh-list
65471659|NCT00041132|Methotrexate|methotrexate|mesh-list
65471660|NCT00041132|Vincristine|vincristine|mesh-list
65471661|NCT00041132|Levoleucovorin|levoleucovorin|mesh-list
65471662|NCT00041132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65471663|NCT00041132|Immunologic Factors|immunologic factors|mesh-ancestor
65471664|NCT00041132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471665|NCT00041132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65471666|NCT00041132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65471667|NCT00041132|Alkylating Agents|alkylating agents|mesh-ancestor
65471710|NCT00040664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471711|NCT00040664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65471712|NCT00040664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65471713|NCT00040664|Antiviral Agents|antiviral agents|mesh-ancestor
65471714|NCT00040664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65471715|NCT00040664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65471716|NCT00040664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65471717|NCT02952586|Avelumab|avelumab|mesh-list
65471718|NCT02952586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65471719|NCT02952586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471720|NCT05098574|Drospirenone|drospirenone|mesh-list
65471721|NCT05098574|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65471722|NCT05098574|Estradiol|estradiol|mesh-list
65471723|NCT05098574|Estrogens|estrogens|mesh-ancestor
65471724|NCT05098574|Hormones|hormones|mesh-ancestor
65471725|NCT05098574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65471726|NCT05098574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471727|NCT05098574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65471728|NCT05098574|Contraceptive Agents|contraceptive agents|mesh-ancestor
65471729|NCT05098574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65471730|NCT05098574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65471731|NCT05098574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65471732|NCT05098574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64328615|NCT00656539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64328616|NCT02179775|Propranolol|propranolol|mesh-list
64720725|NCT00002156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720726|NCT04092907|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64720727|NCT04092907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64720728|NCT00002162|Lamivudine|lamivudine|mesh-list
64720729|NCT00002162|Zidovudine|zidovudine|mesh-list
64720730|NCT00002162|Stavudine|stavudine|mesh-list
64720731|NCT00002162|Didanosine|didanosine|mesh-list
64720732|NCT00002162|Zalcitabine|zalcitabine|mesh-list
64720733|NCT00002162|Saquinavir|saquinavir|mesh-list
64720734|NCT00002162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64720735|NCT00002162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720736|NCT00002162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720737|NCT00002162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720738|NCT00002162|Antiviral Agents|antiviral agents|mesh-ancestor
64720739|NCT00002162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720740|NCT00002162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64720741|NCT00002162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64720742|NCT00002162|Antimetabolites|antimetabolites|mesh-ancestor
64720743|NCT00002162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64720744|NCT00002162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64720745|NCT00002162|Protease Inhibitors|protease inhibitors|mesh-ancestor
64328617|NCT02179775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64328618|NCT02179775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64328619|NCT02179775|Adrenergic Agents|adrenergic agents|mesh-ancestor
64328620|NCT02179775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64328621|NCT02179775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471733|NCT05098574|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65471734|NCT05098574|Hormone Antagonists|hormone antagonists|mesh-ancestor
65471735|NCT05098574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65471736|NCT05098574|Diuretics|diuretics|mesh-ancestor
65471737|NCT05098574|Natriuretic Agents|natriuretic agents|mesh-ancestor
65471738|NCT01096706|Aspirin|aspirin|mesh-list
65471739|NCT01096706|Fluconazole|fluconazole|mesh-list
65471740|NCT01096706|Substance P|substance p|mesh-list
65471741|NCT01096706|Neurokinin A|neurokinin a|mesh-list
65471742|NCT01096706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65471743|NCT01096706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65471744|NCT01096706|Analgesics|analgesics|mesh-ancestor
65471745|NCT01096706|Sensory System Agents|sensory system agents|mesh-ancestor
65471746|NCT01096706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65471747|NCT01096706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471748|NCT01096706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65471749|NCT01096706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65471750|NCT01096706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65471751|NCT01096706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65471752|NCT01096706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471753|NCT01096706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65471754|NCT01096706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65471755|NCT01096706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471757|NCT01096706|Antifungal Agents|antifungal agents|mesh-ancestor
65471758|NCT01096706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65471759|NCT01096706|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65471760|NCT01096706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65471761|NCT01096706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65471762|NCT01096706|Hormone Antagonists|hormone antagonists|mesh-ancestor
65471766|NCT01096706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65471777|NCT01102478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65471778|NCT01102478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65471779|NCT01105598|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
65471780|NCT01105598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65471781|NCT01105598|Antimetabolites|antimetabolites|mesh-ancestor
65471782|NCT01105598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471783|NCT01105598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65471784|NCT01105598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471785|NCT01105598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65471786|NCT01105598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471787|NCT03384316|Vaccines|vaccines|mesh-list
65471788|NCT03384316|Immunologic Factors|immunologic factors|mesh-ancestor
65471789|NCT03384316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471790|NCT03994172|Calcium, Dietary|calcium, dietary|mesh-list
65471791|NCT03994172|Vitamin D|vitamin d|mesh-list
65471792|NCT03994172|Cholecalciferol|cholecalciferol|mesh-list
65471793|NCT03994172|Teriparatide|teriparatide|mesh-list
65471794|NCT03994172|Citric Acid|citric acid|mesh-list
65471795|NCT03994172|Sodium Citrate|sodium citrate|mesh-list
65471796|NCT03994172|Calcium|calcium|mesh-list
65471833|NCT00356525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65471834|NCT00356525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65471835|NCT00356525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65471836|NCT00356525|Immunologic Factors|immunologic factors|mesh-ancestor
65471837|NCT00356525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471838|NCT00356525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65471839|NCT00356525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65471840|NCT01106066|Oxaliplatin|oxaliplatin|mesh-list
65471841|NCT01106066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471842|NCT01052129|Naproxen|naproxen|mesh-list
65471843|NCT01052129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65471844|NCT01052129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65471845|NCT01052129|Analgesics|analgesics|mesh-ancestor
65471846|NCT01052129|Sensory System Agents|sensory system agents|mesh-ancestor
65471847|NCT01052129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65471848|NCT01052129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471849|NCT01052129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65471891|NCT01108874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65471892|NCT01108874|Adrenergic Agents|adrenergic agents|mesh-ancestor
65471893|NCT01108874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65471894|NCT01108874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471895|NCT03383614|Emodepside|emodepside|mesh-list
65471896|NCT03383614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65471897|NCT03383614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65471898|NCT03403036|Brodalumab|brodalumab|mesh-list
65471899|NCT03403036|Dermatologic Agents|dermatologic agents|mesh-ancestor
65471900|NCT00356135|Clopidogrel|clopidogrel|mesh-list
65471901|NCT00356135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65471902|NCT00356135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65471903|NCT00356135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65471904|NCT00356135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65471905|NCT00356135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65471906|NCT00356135|Purinergic Agents|purinergic agents|mesh-ancestor
65471907|NCT00356135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65471908|NCT00356135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471909|NCT00356135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471910|NCT01052363|Bevacizumab|bevacizumab|mesh-list
64855979|NCT01717625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328622|NCT02179775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328623|NCT02179775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64720746|NCT00002162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64720747|NCT00002162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64720748|NCT00000638|Pyridoxine|pyridoxine|mesh-list
64720749|NCT00000638|Vitamin B 6|vitamin b 6|mesh-list
64720750|NCT00000638|Rifampin|rifampin|mesh-list
64720751|NCT00000638|Isoniazid|isoniazid|mesh-list
64720752|NCT00000638|Pyrazinamide|pyrazinamide|mesh-list
64720753|NCT00000638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64720754|NCT00000638|Antitubercular Agents|antitubercular agents|mesh-ancestor
64720755|NCT00000638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64720756|NCT00000638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720757|NCT00000638|Leprostatic Agents|leprostatic agents|mesh-ancestor
64720758|NCT00000638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720759|NCT00000638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720760|NCT00000638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720770|NCT00000638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64720771|NCT00000638|Vitamin B Complex|vitamin b complex|mesh-ancestor
64720794|NCT00000656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64720795|NCT00000662|Zidovudine|zidovudine|mesh-list
64720796|NCT00000662|Antimetabolites|antimetabolites|mesh-ancestor
64720797|NCT00000662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720867|NCT00000692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64720868|NCT00000692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64720869|NCT00000692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720871|NCT00000698|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64720872|NCT00000698|Antiviral Agents|antiviral agents|mesh-ancestor
64720873|NCT00000698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720874|NCT00000698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720875|NCT00000698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720876|NCT00000698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471911|NCT01052363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65471912|NCT01052363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471913|NCT01052363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65471914|NCT01052363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65471915|NCT01052363|Growth Substances|growth substances|mesh-ancestor
65471916|NCT01052363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471917|NCT01052363|Growth Inhibitors|growth inhibitors|mesh-ancestor
65471918|NCT01053611|Remifentanil|remifentanil|mesh-list
65471919|NCT01053611|Propofol|propofol|mesh-list
65471920|NCT01053611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65471921|NCT01053611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65471922|NCT01053611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471923|NCT01053611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65471924|NCT01053611|Anesthetics, General|anesthetics, general|mesh-ancestor
65471925|NCT01053611|Anesthetics|anesthetics|mesh-ancestor
65471926|NCT01053611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65471927|NCT01053611|Narcotics|narcotics|mesh-ancestor
65471928|NCT01053611|Analgesics|analgesics|mesh-ancestor
65471929|NCT01053611|Sensory System Agents|sensory system agents|mesh-ancestor
65471930|NCT01053611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65471931|NCT00350519|Epoetin Alfa|epoetin alfa|mesh-list
65471932|NCT00350519|Hematinics|hematinics|mesh-ancestor
65471933|NCT01053689|Glimepiride|glimepiride|mesh-list
65471934|NCT01053689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65471935|NCT01053689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65471936|NCT01053689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471937|NCT01053689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65471938|NCT01053689|Immunologic Factors|immunologic factors|mesh-ancestor
65471939|NCT01111448|Sirolimus|sirolimus|mesh-list
65471940|NCT01111448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65471941|NCT01111448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65471942|NCT01111448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65471943|NCT01111448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471944|NCT01111448|Antifungal Agents|antifungal agents|mesh-ancestor
65471945|NCT01111448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64720877|NCT00002180|Tenofovir|tenofovir|mesh-list
64720878|NCT00002180|Antiviral Agents|antiviral agents|mesh-ancestor
64720879|NCT00002180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720880|NCT00002180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64720881|NCT00002180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720882|NCT00002180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720883|NCT00002180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720884|NCT00002180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65471946|NCT01111448|Immunologic Factors|immunologic factors|mesh-ancestor
65471947|NCT01111448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471948|NCT03382912|Nivolumab|nivolumab|mesh-list
65471949|NCT03382912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65471950|NCT03382912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471951|NCT03382912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65471952|NCT03382912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471953|NCT03942926|Sirolimus|sirolimus|mesh-list
65471954|NCT03942926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65471955|NCT03942926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65471956|NCT03942926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65471957|NCT03942926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65471958|NCT03942926|Antifungal Agents|antifungal agents|mesh-ancestor
65471959|NCT03942926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65471960|NCT03942926|Immunologic Factors|immunologic factors|mesh-ancestor
65471961|NCT03942926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471962|NCT00350207|Bromides|bromides|mesh-list
65471963|NCT00350207|Tiotropium Bromide|tiotropium bromide|mesh-list
65471964|NCT00350207|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65471965|NCT00350207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65471966|NCT00350207|Autonomic Agents|autonomic agents|mesh-ancestor
65471967|NCT00350207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65471968|NCT00350207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471969|NCT00350207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65471970|NCT00350207|Respiratory System Agents|respiratory system agents|mesh-ancestor
65471971|NCT00350207|Parasympatholytics|parasympatholytics|mesh-ancestor
65471972|NCT00350207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65471973|NCT00350207|Cholinergic Agents|cholinergic agents|mesh-ancestor
65471974|NCT00350207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65471975|NCT00350207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65471990|NCT01311622|Warfarin|warfarin|mesh-list
65471991|NCT01311622|Anticoagulants|anticoagulants|mesh-ancestor
65471992|NCT01109030|Pioglitazone|pioglitazone|mesh-list
65471993|NCT01109030|Chlordiazepoxide|chlordiazepoxide|mesh-list
65471994|NCT01109030|Dexetimide|dexetimide|mesh-list
65471995|NCT01109030|Citalopram|citalopram|mesh-list
65471996|NCT01109030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65471997|NCT01109030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65471998|NCT01109030|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65471999|NCT01109030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65472000|NCT01109030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65472001|NCT01109030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472002|NCT01109030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65472003|NCT01109030|Serotonin Agents|serotonin agents|mesh-ancestor
65472004|NCT01109030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65472005|NCT01109030|Antidepressive Agents|antidepressive agents|mesh-ancestor
65472006|NCT01109030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65472007|NCT01109030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65472008|NCT01109030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65472009|NCT01109030|Parasympatholytics|parasympatholytics|mesh-ancestor
65472010|NCT01109030|Autonomic Agents|autonomic agents|mesh-ancestor
65472011|NCT01109030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472012|NCT01109030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65472013|NCT01109030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65472014|NCT01109030|Cholinergic Agents|cholinergic agents|mesh-ancestor
65472015|NCT01109030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65472016|NCT01109030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65472017|NCT01109030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65472039|NCT04542824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65472040|NCT04542824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65472041|NCT04542824|Antimetabolites|antimetabolites|mesh-ancestor
65472042|NCT04542824|Antiviral Agents|antiviral agents|mesh-ancestor
65472043|NCT04542824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65472044|NCT04542824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472045|NCT04542824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65472046|NCT04542824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65472047|NCT04542824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65472048|NCT04542824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65472049|NCT04542824|Glucocorticoids|glucocorticoids|mesh-ancestor
65472050|NCT04542824|Hormones|hormones|mesh-ancestor
65472051|NCT04542824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65472052|NCT04542824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65472053|NCT04542824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65472054|NCT04542824|Tubulin Modulators|tubulin modulators|mesh-ancestor
65472055|NCT04542824|Antimitotic Agents|antimitotic agents|mesh-ancestor
65472056|NCT04542824|Mitosis Modulators|mitosis modulators|mesh-ancestor
65472057|NCT04542824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65472058|NCT04542824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65472059|NCT04542824|Growth Substances|growth substances|mesh-ancestor
65472060|NCT04542824|Growth Inhibitors|growth inhibitors|mesh-ancestor
65472061|NCT00349973|Dipyridamole|dipyridamole|mesh-list
65472062|NCT00349973|Olanzapine|olanzapine|mesh-list
65472063|NCT00349973|Antiemetics|antiemetics|mesh-ancestor
65472064|NCT00349973|Autonomic Agents|autonomic agents|mesh-ancestor
65472065|NCT00349973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472066|NCT00349973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472067|NCT00349973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65472068|NCT00349973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65472083|NCT01111682|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65472084|NCT01111682|Diuretics|diuretics|mesh-ancestor
65472085|NCT01111682|Natriuretic Agents|natriuretic agents|mesh-ancestor
65472086|NCT01111682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472087|NCT04464122|Somatostatin|somatostatin|mesh-list
65472088|NCT04464122|Hormones|hormones|mesh-ancestor
65472089|NCT04464122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65472090|NCT04464122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472091|NCT01111994|Clindamycin|clindamycin|mesh-list
65472092|NCT01111994|Clindamycin palmitate|clindamycin palmitate|mesh-list
65472093|NCT01111994|Clindamycin phosphate|clindamycin phosphate|mesh-list
65472094|NCT01111994|Tretinoin|tretinoin|mesh-list
65472095|NCT01111994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65472096|NCT01111994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65472097|NCT01111994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65472098|NCT01111994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472099|NCT01111994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472100|NCT01111994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472101|NCT01111994|Keratolytic Agents|keratolytic agents|mesh-ancestor
65472102|NCT01111994|Dermatologic Agents|dermatologic agents|mesh-ancestor
65472103|NCT03187262|Daratumumab|daratumumab|mesh-list
65472104|NCT03187262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472105|NCT03944252|Cetuximab|cetuximab|mesh-list
65472106|NCT03944252|Avelumab|avelumab|mesh-list
65472107|NCT03944252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65472108|NCT03944252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472109|NCT01209026|Fluticasone|fluticasone|mesh-list
65472110|NCT01209026|Xhance|xhance|mesh-list
65472111|NCT01209026|Moxifloxacin|moxifloxacin|mesh-list
65472113|NCT01209026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65472129|NCT01209026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65472130|NCT01209026|Contraceptive Agents|contraceptive agents|mesh-ancestor
65472131|NCT01209026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65221625|NCT04110028|Vitamins|vitamins|mesh-ancestor
65472132|NCT01209026|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65472133|NCT01209026|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65472134|NCT01209026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65472135|NCT01107470|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65472136|NCT01107470|Hormones|hormones|mesh-ancestor
65472137|NCT01107470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65472138|NCT01107470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472139|NCT01109264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65472140|NCT01109264|Chlorambucil|chlorambucil|mesh-list
65472141|NCT01109264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65472142|NCT01109264|Alkylating Agents|alkylating agents|mesh-ancestor
65472143|NCT01109264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472144|NCT01109264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472145|NCT01311700|Metoprolol|metoprolol|mesh-list
64720885|NCT00002180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64720886|NCT00002186|Acyclovir|acyclovir|mesh-list
64720887|NCT00002186|Antiviral Agents|antiviral agents|mesh-ancestor
64720888|NCT00002186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720889|NCT00001502|Carboplatin|carboplatin|mesh-list
64720890|NCT00001502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64720891|NCT00002192|Azithromycin|azithromycin|mesh-list
64720892|NCT00002192|Clarithromycin|clarithromycin|mesh-list
64328752|NCT02184299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64328753|NCT02184299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328754|NCT02184299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64328755|NCT02184299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64720894|NCT00002192|Rifapentine|rifapentine|mesh-list
64720895|NCT00002192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64720896|NCT00002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720897|NCT00002192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64720898|NCT00002192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720899|NCT00002192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720900|NCT00002192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64720901|NCT00002192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64720902|NCT00002192|Antitubercular Agents|antitubercular agents|mesh-ancestor
64720903|NCT00002192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64720904|NCT00002192|Leprostatic Agents|leprostatic agents|mesh-ancestor
64720905|NCT00002198|Abacavir|abacavir|mesh-list
64720906|NCT00002198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64720907|NCT00002198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720908|NCT00002198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720909|NCT00002198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720910|NCT00002198|Antiviral Agents|antiviral agents|mesh-ancestor
64720911|NCT00002198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64416528|NCT04848181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720916|NCT00000704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720918|NCT00000704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720919|NCT00000704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720920|NCT00000704|Antiviral Agents|antiviral agents|mesh-ancestor
64720921|NCT00000704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720922|NCT00000704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65472146|NCT01311700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65472147|NCT01311700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65472148|NCT01311700|Sympatholytics|sympatholytics|mesh-ancestor
65472149|NCT01311700|Autonomic Agents|autonomic agents|mesh-ancestor
65472150|NCT01311700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472151|NCT01311700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472152|NCT01311700|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65472153|NCT01311700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65472154|NCT01311700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65472155|NCT01311700|Adrenergic Agents|adrenergic agents|mesh-ancestor
65472156|NCT01311700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65472157|NCT01311700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472158|NCT01107782|Sildenafil Citrate|sildenafil citrate|mesh-list
65472159|NCT01107782|Vasodilator Agents|vasodilator agents|mesh-ancestor
65472160|NCT01107782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65472161|NCT01107782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65472162|NCT01107782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472163|NCT01107782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472164|NCT01107782|Urological Agents|urological agents|mesh-ancestor
65472165|NCT01107938|Esomeprazole|esomeprazole|mesh-list
65472166|NCT01107938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65472167|NCT01107938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65472168|NCT01107938|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65472169|NCT01107938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472170|NCT01107938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472171|NCT02950558|Ropivacaine|ropivacaine|mesh-list
65472172|NCT02950558|Anesthetics, Local|anesthetics, local|mesh-ancestor
65472173|NCT02950558|Anesthetics|anesthetics|mesh-ancestor
65472174|NCT02950558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65472175|NCT02950558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472176|NCT02950558|Sensory System Agents|sensory system agents|mesh-ancestor
65472177|NCT02950558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472178|NCT02791334|Ramucirumab|ramucirumab|mesh-list
64720923|NCT00000704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64720924|NCT00000728|Zidovudine|zidovudine|mesh-list
64720925|NCT00000728|Aldesleukin|aldesleukin|mesh-list
64720926|NCT00000728|Antimetabolites|antimetabolites|mesh-ancestor
64328773|NCT02282371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64328774|NCT02402595|Itraconazole|itraconazole|mesh-list
64328775|NCT02402595|Antifungal Agents|antifungal agents|mesh-ancestor
64713669|NCT02016924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65472179|NCT02791334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472180|NCT03945344|Tiotropium Bromide|tiotropium bromide|mesh-list
65472181|NCT03945344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65472182|NCT03945344|Autonomic Agents|autonomic agents|mesh-ancestor
65472183|NCT03945344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472184|NCT03945344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472185|NCT03945344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65472186|NCT03945344|Respiratory System Agents|respiratory system agents|mesh-ancestor
65472187|NCT03945344|Parasympatholytics|parasympatholytics|mesh-ancestor
65472188|NCT03945344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65472189|NCT03945344|Cholinergic Agents|cholinergic agents|mesh-ancestor
65472190|NCT03945344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65472191|NCT03945344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472192|NCT05497726|Bevacizumab|bevacizumab|mesh-list
65472193|NCT05497726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65472194|NCT05497726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472195|NCT05497726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65472196|NCT05497726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65472197|NCT05497726|Growth Substances|growth substances|mesh-ancestor
65472198|NCT05497726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472199|NCT05497726|Growth Inhibitors|growth inhibitors|mesh-ancestor
65472200|NCT01209416|Acipimox|acipimox|mesh-list
65472201|NCT01209416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65472202|NCT01209416|Antimetabolites|antimetabolites|mesh-ancestor
65472230|NCT02950480|Zafirlukast|zafirlukast|mesh-list
65472231|NCT02950480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65472232|NCT02950480|Respiratory System Agents|respiratory system agents|mesh-ancestor
65472233|NCT02950480|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65472234|NCT02950480|Hormone Antagonists|hormone antagonists|mesh-ancestor
65472235|NCT02950480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65472236|NCT02950480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472237|NCT05494528|Entecavir|entecavir|mesh-list
65472238|NCT05494528|Antiviral Agents|antiviral agents|mesh-ancestor
65472239|NCT05494528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65472240|NCT03987815|Nivolumab|nivolumab|mesh-list
65472241|NCT03987815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65472242|NCT03987815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472243|NCT03987815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65472244|NCT03987815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472245|NCT00348881|Vaccines|vaccines|mesh-list
65472246|NCT00348881|Immunologic Factors|immunologic factors|mesh-ancestor
65472247|NCT00348881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472248|NCT02257580|Aminocaproic Acid|aminocaproic acid|mesh-list
65472249|NCT02257580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65472250|NCT02257580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65472251|NCT02257580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713670|NCT02016924|Antiviral Agents|antiviral agents|mesh-ancestor
64713671|NCT02016924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64328804|NCT00547651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328805|NCT00547651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328806|NCT00547651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64328807|NCT00546793|Veltuzumab|veltuzumab|mesh-list
64328808|NCT00546793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64328809|NCT02402283|Metronidazole|metronidazole|mesh-list
64328810|NCT02402283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64328811|NCT02402283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64328812|NCT02402283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64713672|NCT02016924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64713673|NCT02016924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64713674|NCT02016924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64713675|NCT02016924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64713676|NCT02015013|Plerixafor|plerixafor|mesh-list
64713677|NCT02015013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64713678|NCT02015013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64713679|NCT02015013|Antiviral Agents|antiviral agents|mesh-ancestor
64713680|NCT02015013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64713681|NCT01847274|Niraparib|niraparib|mesh-list
64713682|NCT01847274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64713683|NCT01847274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720938|NCT00001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720939|NCT00001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720940|NCT00001520|Cholinergic Agents|cholinergic agents|mesh-ancestor
64720941|NCT00001520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64720942|NCT00001520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720943|NCT00001520|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64720944|NCT00001520|Autonomic Agents|autonomic agents|mesh-ancestor
65472252|NCT02257580|Hemostatics|hemostatics|mesh-ancestor
65472253|NCT02257580|Coagulants|coagulants|mesh-ancestor
65472254|NCT01055795|Bevacizumab|bevacizumab|mesh-list
65472255|NCT01055795|Everolimus|everolimus|mesh-list
65472256|NCT01055795|Panobinostat|panobinostat|mesh-list
65472257|NCT01055795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65472258|NCT01055795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472259|NCT01055795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65472260|NCT01055795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65472261|NCT01055795|Growth Substances|growth substances|mesh-ancestor
65472262|NCT01055795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472263|NCT01055795|Growth Inhibitors|growth inhibitors|mesh-ancestor
65472264|NCT01055795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65472265|NCT01055795|Immunologic Factors|immunologic factors|mesh-ancestor
65472266|NCT01055795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65472267|NCT01055795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472268|NCT01055795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472269|NCT03943784|Propranolol|propranolol|mesh-list
65472270|NCT03943784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65472271|NCT03943784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65472272|NCT03943784|Adrenergic Agents|adrenergic agents|mesh-ancestor
65472273|NCT03943784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65472274|NCT03943784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472275|NCT03943784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472276|NCT03943784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65472277|NCT03943784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65472278|NCT03943784|Vasodilator Agents|vasodilator agents|mesh-ancestor
65472279|NCT00347009|Adefovir|adefovir|mesh-list
65066952|NCT00273026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65472280|NCT00347009|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65472281|NCT00347009|Antiviral Agents|antiviral agents|mesh-ancestor
65472282|NCT00347009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65472283|NCT00347009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65472284|NCT00347009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65472285|NCT00347009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472291|NCT01209650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472292|NCT01947140|Romidepsin|romidepsin|mesh-list
65472293|NCT01947140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65472294|NCT01947140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472295|NCT00346775|Beclomethasone|beclomethasone|mesh-list
65472296|NCT00346775|Flunisolide|flunisolide|mesh-list
65472297|NCT00346775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65472298|NCT00346775|Glucocorticoids|glucocorticoids|mesh-ancestor
65472299|NCT00346775|Hormones|hormones|mesh-ancestor
65472300|NCT00346775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65472301|NCT00346775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472302|NCT00346775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65472303|NCT00346775|Respiratory System Agents|respiratory system agents|mesh-ancestor
65472304|NCT01108562|Lidocaine|lidocaine|mesh-list
65472305|NCT01108562|Anesthetics, Local|anesthetics, local|mesh-ancestor
65472306|NCT01108562|Anesthetics|anesthetics|mesh-ancestor
65472307|NCT01108562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65472308|NCT01108562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472309|NCT01108562|Sensory System Agents|sensory system agents|mesh-ancestor
65472310|NCT01108562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472311|NCT01108562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65472312|NCT01108562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65472313|NCT01108562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65472314|NCT01108562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65472315|NCT01108562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472316|NCT01112540|Morphine|morphine|mesh-list
65472317|NCT01112540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65472318|NCT01112540|Narcotics|narcotics|mesh-ancestor
65472319|NCT01112540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65472321|NCT01112540|Analgesics|analgesics|mesh-ancestor
65472333|NCT01056419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65472334|NCT01056419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472335|NCT01056497|Thioctic Acid|thioctic acid|mesh-list
65472336|NCT01056497|Antioxidants|antioxidants|mesh-ancestor
65472337|NCT01056497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472338|NCT01056497|Protective Agents|protective agents|mesh-ancestor
65472339|NCT01056497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472340|NCT01056497|Vitamin B Complex|vitamin b complex|mesh-ancestor
65472341|NCT01056497|Vitamins|vitamins|mesh-ancestor
65472342|NCT01056497|Micronutrients|micronutrients|mesh-ancestor
65472343|NCT03398356|Metformin|metformin|mesh-list
65472344|NCT03398356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65472345|NCT03398356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472346|NCT00346151|Sirolimus|sirolimus|mesh-list
65472347|NCT00346151|Methylprednisolone|methylprednisolone|mesh-list
65472348|NCT00346151|Abatacept|abatacept|mesh-list
65472349|NCT00346151|Thymoglobulin|thymoglobulin|mesh-list
65472350|NCT00346151|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65472351|NCT00346151|Immunoglobulins|immunoglobulins|mesh-list
65472352|NCT00346151|Glucocorticoids|glucocorticoids|mesh-list
65472353|NCT00346151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65472387|NCT01109498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65472388|NCT01109498|Dermatologic Agents|dermatologic agents|mesh-ancestor
65472389|NCT01109498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65472390|NCT01109498|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65472391|NCT01109498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65472392|NCT01109498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472393|NCT01109498|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65472394|NCT01109498|Antitubercular Agents|antitubercular agents|mesh-ancestor
65472395|NCT01109498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65472396|NCT00130286|Rosiglitazone|rosiglitazone|mesh-list
65472397|NCT00130286|Hormones|hormones|mesh-list
65472398|NCT00130286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65472399|NCT00130286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472400|NCT00130286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65472401|NCT03940664|Formaldehyde|formaldehyde|mesh-list
65472402|NCT03940664|Disinfectants|disinfectants|mesh-ancestor
65472403|NCT03940664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65472404|NCT01211834|Antirheumatic Agents|antirheumatic agents|mesh-list
65472405|NCT03941990|Nitrous Oxide|nitrous oxide|mesh-list
65472406|NCT03941990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65472407|NCT03941990|Anesthetics, General|anesthetics, general|mesh-ancestor
65472408|NCT03941990|Anesthetics|anesthetics|mesh-ancestor
65472409|NCT03941990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65472410|NCT03941990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472411|NCT03941990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65472412|NCT03941990|Analgesics|analgesics|mesh-ancestor
65472413|NCT03941990|Sensory System Agents|sensory system agents|mesh-ancestor
65472414|NCT03941990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472415|NCT03374488|Pembrolizumab|pembrolizumab|mesh-list
65472432|NCT00076310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472433|NCT00345683|Vaccines|vaccines|mesh-list
65472434|NCT00345683|Immunologic Factors|immunologic factors|mesh-ancestor
65472435|NCT00345683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472436|NCT01211912|Acetaminophen|acetaminophen|mesh-list
65472437|NCT01211912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65472438|NCT01211912|Analgesics|analgesics|mesh-ancestor
65472439|NCT01211912|Sensory System Agents|sensory system agents|mesh-ancestor
65472440|NCT01211912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472441|NCT01211912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472442|NCT01211912|Antipyretics|antipyretics|mesh-ancestor
65472443|NCT03943472|Cyclophosphamide|cyclophosphamide|mesh-list
65472444|NCT03943472|Fludarabine|fludarabine|mesh-list
65472445|NCT03943472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65472446|NCT03943472|Immunologic Factors|immunologic factors|mesh-ancestor
65472447|NCT03943472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472448|NCT03943472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65472449|NCT03943472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65472450|NCT03943472|Alkylating Agents|alkylating agents|mesh-ancestor
65472451|NCT03943472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472452|NCT03943472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472453|NCT03943472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65472454|NCT01114490|Anacetrapib|anacetrapib|mesh-list
65472455|NCT01114490|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65472456|NCT01114490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65472457|NCT01114490|Antimetabolites|antimetabolites|mesh-ancestor
65472458|NCT01114490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472459|NCT01114490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65472460|NCT01209806|Simethicone|simethicone|mesh-list
65472461|NCT01209806|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
65472462|NCT01209806|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65472463|NCT01209806|Magnesium Hydroxide|magnesium hydroxide|mesh-list
65472465|NCT01209806|TEMPO|tempo|mesh-list
65472474|NCT01209806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472475|NCT01209806|Antioxidants|antioxidants|mesh-ancestor
65472476|NCT01209806|Protective Agents|protective agents|mesh-ancestor
65472477|NCT01114568|Ertugliflozin|ertugliflozin|mesh-list
65472478|NCT01114568|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65472479|NCT01114568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472480|NCT01114568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65472481|NCT01114568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472482|NCT01109654|Cetrorelix|cetrorelix|mesh-list
65472483|NCT01109654|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65472484|NCT01109654|Hormones|hormones|mesh-ancestor
65472485|NCT01109654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65472486|NCT01109654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472487|NCT01109654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65472488|NCT01109654|Fertility Agents|fertility agents|mesh-ancestor
65472489|NCT01109654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65472490|NCT01109654|Hormone Antagonists|hormone antagonists|mesh-ancestor
65472491|NCT01054001|Sildenafil Citrate|sildenafil citrate|mesh-list
65472492|NCT01054001|Vasodilator Agents|vasodilator agents|mesh-ancestor
65472493|NCT01054001|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65472494|NCT01054001|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65472495|NCT01054001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472496|NCT01054001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472497|NCT01054001|Urological Agents|urological agents|mesh-ancestor
65472498|NCT01057355|Ethanol|ethanol|mesh-list
65472499|NCT01057355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65472500|NCT01057355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65472501|NCT01057355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65472502|NCT01057355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720945|NCT00001520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64720946|NCT00001526|Daclizumab|daclizumab|mesh-list
64720947|NCT00001526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64720948|NCT00001526|Immunologic Factors|immunologic factors|mesh-ancestor
64720949|NCT00001526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720950|NCT00002294|Fluconazole|fluconazole|mesh-list
64720951|NCT00002294|Antifungal Agents|antifungal agents|mesh-ancestor
64720952|NCT00002294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720953|NCT00002294|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64720954|NCT00002294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64720955|NCT00002294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720956|NCT00002294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720957|NCT00002294|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64720958|NCT00002294|Hormone Antagonists|hormone antagonists|mesh-ancestor
65472503|NCT01057511|Progesterone|progesterone|mesh-list
65472504|NCT01057511|Progestins|progestins|mesh-ancestor
65472505|NCT01057511|Hormones|hormones|mesh-ancestor
65472506|NCT01057511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65472507|NCT01057511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472508|NCT00345605|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
65472509|NCT00345605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472510|NCT01210040|Folic Acid|folic acid|mesh-list
65472511|NCT01210040|Vitamin B Complex|vitamin b complex|mesh-list
65472512|NCT01210040|Hematinics|hematinics|mesh-ancestor
65472513|NCT01210040|Vitamins|vitamins|mesh-ancestor
65472514|NCT01210040|Micronutrients|micronutrients|mesh-ancestor
65472515|NCT01210040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472516|NCT01054313|Sirolimus|sirolimus|mesh-list
65472517|NCT01054313|Prednisone|prednisone|mesh-list
65472518|NCT01054313|Docetaxel|docetaxel|mesh-list
65472519|NCT01054313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472520|NCT01054313|Tubulin Modulators|tubulin modulators|mesh-ancestor
65472521|NCT01054313|Antimitotic Agents|antimitotic agents|mesh-ancestor
65472522|NCT01054313|Mitosis Modulators|mitosis modulators|mesh-ancestor
65472523|NCT01054313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472524|NCT01054313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65472525|NCT01054313|Glucocorticoids|glucocorticoids|mesh-ancestor
65472526|NCT01054313|Hormones|hormones|mesh-ancestor
65472527|NCT01054313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65472528|NCT01054313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472529|NCT01054313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65472530|NCT01054313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65472531|NCT01054313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65472532|NCT01054313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65472533|NCT01054313|Antifungal Agents|antifungal agents|mesh-ancestor
65472534|NCT01054313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65472535|NCT01054313|Immunologic Factors|immunologic factors|mesh-ancestor
65472536|NCT01114958|Cisplatin|cisplatin|mesh-list
65472537|NCT01114958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472538|NCT03742115|Dexamethasone|dexamethasone|mesh-list
65472539|NCT03742115|Etoposide|etoposide|mesh-list
64720959|NCT00002294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64328813|NCT02402283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64328814|NCT02184533|Selenious Acid|selenious acid|mesh-list
64328815|NCT02184533|Sodium Selenite|sodium selenite|mesh-list
65472540|NCT03742115|Etoposide phosphate|etoposide phosphate|mesh-list
65472541|NCT03742115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65472542|NCT03742115|Antiemetics|antiemetics|mesh-ancestor
65472543|NCT03742115|Autonomic Agents|autonomic agents|mesh-ancestor
65472544|NCT03742115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472545|NCT03742115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472546|NCT03742115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65472547|NCT03742115|Glucocorticoids|glucocorticoids|mesh-ancestor
65472548|NCT03742115|Hormones|hormones|mesh-ancestor
65472549|NCT03742115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65472550|NCT03742115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65472551|NCT03742115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472552|NCT03742115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65472553|NCT03742115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65472554|NCT03742115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65472555|NCT03742115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472556|NCT03742115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472557|NCT01115036|Panobinostat|panobinostat|mesh-list
65472558|NCT01115036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472559|NCT01115036|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65472560|NCT01115036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472561|NCT01115036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472562|NCT01207622|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65472563|NCT01207622|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64856638|NCT01727778|Antibodies|antibodies|mesh-list
64328817|NCT02184533|Micronutrients|micronutrients|mesh-ancestor
64328818|NCT02184533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328822|NCT02386059|BB 1101|bb 1101|mesh-list
64713684|NCT01847274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713685|NCT01847274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416599|NCT04853797|Calcium|calcium|mesh-list
64713693|NCT01740557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713694|NCT01740557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64713695|NCT01740557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64713696|NCT01740557|Alkylating Agents|alkylating agents|mesh-ancestor
64720965|NCT03758365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64720966|NCT03758365|Hydrocortisone|hydrocortisone|mesh-list
64720967|NCT03758365|Betamethasone|betamethasone|mesh-list
64328839|NCT02386059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64328840|NCT02386059|Serotonin Agents|serotonin agents|mesh-ancestor
64328841|NCT02386059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64328842|NCT02386059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64328843|NCT02386059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64328844|NCT02386059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64328845|NCT02386059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64328846|NCT02386059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64328847|NCT00443287|Cilostazol|cilostazol|mesh-list
64713697|NCT01740557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472564|NCT01207622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65472565|NCT01207622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65472566|NCT01207622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472567|NCT01207622|Adrenergic Agents|adrenergic agents|mesh-ancestor
65472568|NCT01207622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65472569|NCT01207622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472570|NCT03942068|Paclitaxel|paclitaxel|mesh-list
65472571|NCT03942068|Apatinib|apatinib|mesh-list
65472572|NCT03942068|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65472573|NCT03942068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65472574|NCT03942068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472575|NCT03942068|Tubulin Modulators|tubulin modulators|mesh-ancestor
65472576|NCT03942068|Antimitotic Agents|antimitotic agents|mesh-ancestor
65472577|NCT03942068|Mitosis Modulators|mitosis modulators|mesh-ancestor
65472578|NCT03942068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472579|NCT03942068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65222074|NCT00588094|Rituximab|rituximab|mesh-list
65472581|NCT01112852|Terlipressin|terlipressin|mesh-list
65472582|NCT01112852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64856667|NCT01729195|Ciprofloxacin|ciprofloxacin|mesh-list
64713698|NCT01740557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713699|NCT01740557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64713700|NCT01740557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64713701|NCT01740557|Antimetabolites|antimetabolites|mesh-ancestor
64713702|NCT01740557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64713703|NCT01740557|Analgesics|analgesics|mesh-ancestor
64945638|NCT05379322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64713719|NCT01703949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713720|NCT01703949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64713721|NCT01703949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713724|NCT01517100|Antiemetics|antiemetics|mesh-ancestor
64713725|NCT01517100|Autonomic Agents|autonomic agents|mesh-ancestor
64713726|NCT01517100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64713727|NCT01517100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713728|NCT01517100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64713729|NCT01517100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64713730|NCT01517100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64713731|NCT01517100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64713732|NCT01517100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64713733|NCT01517100|Hallucinogens|hallucinogens|mesh-ancestor
64713734|NCT01517100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64713735|NCT01517100|Analgesics|analgesics|mesh-ancestor
64713736|NCT01517100|Sensory System Agents|sensory system agents|mesh-ancestor
64713737|NCT01517100|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64713738|NCT01517100|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64713739|NCT01517100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64713740|NCT01517100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713742|NCT01517100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64720971|NCT03758365|Clobetasol|clobetasol|mesh-list
64720972|NCT03758365|Desonide|desonide|mesh-list
64720973|NCT03758365|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
64720974|NCT03758365|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64720975|NCT03758365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64720976|NCT03758365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65472583|NCT01112852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65472584|NCT01112852|Somatostatin|somatostatin|mesh-list
65472585|NCT01112852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472586|NCT01112852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472587|NCT01112852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65472588|NCT01112852|Hormones|hormones|mesh-ancestor
65472589|NCT01112852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65472590|NCT01112852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472591|NCT01054469|Ropivacaine|ropivacaine|mesh-list
65472592|NCT01054469|Anesthetics, Local|anesthetics, local|mesh-ancestor
65472593|NCT01054469|Anesthetics|anesthetics|mesh-ancestor
65472594|NCT01054469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65472595|NCT01054469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472596|NCT01054469|Sensory System Agents|sensory system agents|mesh-ancestor
65472597|NCT01054469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472598|NCT03940430|Lactoferrin|lactoferrin|mesh-list
65472599|NCT03940430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65472600|NCT00355121|Vaccines|vaccines|mesh-list
65472601|NCT00355121|Immunologic Factors|immunologic factors|mesh-ancestor
65472602|NCT00355121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472603|NCT02533349|Pantoprazole|pantoprazole|mesh-list
65472604|NCT02533349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65472605|NCT02533349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65472606|NCT02533349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65472607|NCT02533349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472608|NCT02533349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472609|NCT01115426|Losartan|losartan|mesh-list
65472610|NCT01115426|Ramipril|ramipril|mesh-list
65472611|NCT01115426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65472612|NCT01115426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65472617|NCT01115426|Protease Inhibitors|protease inhibitors|mesh-ancestor
65472626|NCT03942458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472627|NCT03942458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472628|NCT01115504|Thiamine|thiamine|mesh-list
65472629|NCT01115504|Vitamin B Complex|vitamin b complex|mesh-ancestor
65472630|NCT01115504|Vitamins|vitamins|mesh-ancestor
65472631|NCT01115504|Micronutrients|micronutrients|mesh-ancestor
65472632|NCT01115504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472633|NCT00343889|Vaccines|vaccines|mesh-list
65472634|NCT00343889|Immunologic Factors|immunologic factors|mesh-ancestor
65472635|NCT00343889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472636|NCT03939884|Diclofenac|diclofenac|mesh-list
65472637|NCT03939884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65472638|NCT03939884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65472639|NCT03939884|Analgesics|analgesics|mesh-ancestor
65472640|NCT03939884|Sensory System Agents|sensory system agents|mesh-ancestor
65472641|NCT03939884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472642|NCT03939884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472643|NCT03939884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65472644|NCT03939884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65472645|NCT03939884|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65472646|NCT03939884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472647|NCT03939884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472648|NCT01054547|Anesthetics|anesthetics|mesh-list
65472649|NCT01054547|Ropivacaine|ropivacaine|mesh-list
65472650|NCT01054547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65472651|NCT01054547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472652|NCT01054547|Anesthetics, Local|anesthetics, local|mesh-ancestor
65472655|NCT01115894|Naltrexone|naltrexone|mesh-list
65472672|NCT01116050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65472673|NCT01116050|Oxytocics|oxytocics|mesh-ancestor
65472674|NCT03343054|Talazoparib|talazoparib|mesh-list
65472675|NCT03343054|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65472676|NCT03343054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472677|NCT03343054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472678|NCT03343054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472679|NCT01054781|Rituximab|rituximab|mesh-list
65472680|NCT01054781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65472681|NCT01054781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472682|NCT01054781|Immunologic Factors|immunologic factors|mesh-ancestor
65472683|NCT01054781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472684|NCT01054781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65472685|NCT05282290|Antihypertensive Agents|antihypertensive agents|mesh-list
65472686|NCT01311778|Fentanyl|fentanyl|mesh-list
65472687|NCT01311778|Cannabidiol|cannabidiol|mesh-list
65472688|NCT01311778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65472689|NCT01311778|Narcotics|narcotics|mesh-ancestor
65472690|NCT01311778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65472691|NCT01311778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472692|NCT01311778|Analgesics|analgesics|mesh-ancestor
65472693|NCT01311778|Sensory System Agents|sensory system agents|mesh-ancestor
65472694|NCT01311778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472695|NCT01311778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65472696|NCT01311778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65472697|NCT01311778|Anesthetics, General|anesthetics, general|mesh-ancestor
65472698|NCT01311778|Anesthetics|anesthetics|mesh-ancestor
65472699|NCT01311778|Anticonvulsants|anticonvulsants|mesh-ancestor
65472700|NCT00354341|Epoetin Alfa|epoetin alfa|mesh-list
65472701|NCT00354341|Hematinics|hematinics|mesh-ancestor
65472702|NCT03708718|Prednisolone|prednisolone|mesh-list
65472703|NCT03708718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65472704|NCT03708718|Glucocorticoids|glucocorticoids|mesh-ancestor
65472705|NCT03708718|Hormones|hormones|mesh-ancestor
65472706|NCT03708718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65472707|NCT03708718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472708|NCT03708718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65472711|NCT00354107|Hydrocortisone|hydrocortisone|mesh-list
65472712|NCT00354107|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65472713|NCT00354107|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65472714|NCT00354107|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65472715|NCT00354107|Carboplatin|carboplatin|mesh-list
65472716|NCT00354107|Methotrexate|methotrexate|mesh-list
65472717|NCT00354107|Etoposide|etoposide|mesh-list
65472718|NCT00354107|Etoposide phosphate|etoposide phosphate|mesh-list
65472719|NCT00354107|Ifosfamide|ifosfamide|mesh-list
65472720|NCT00354107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65472721|NCT00354107|Antibodies|antibodies|mesh-list
65472722|NCT00354107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65472723|NCT00354107|Immunologic Factors|immunologic factors|mesh-ancestor
65472724|NCT00354107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472725|NCT00354107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472726|NCT00354107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65472727|NCT00354107|Abortifacient Agents|abortifacient agents|mesh-ancestor
65472728|NCT00354107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65472729|NCT00354107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65472730|NCT00354107|Antimetabolites|antimetabolites|mesh-ancestor
65472731|NCT00354107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472733|NCT00354107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472734|NCT00354107|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65472735|NCT00354107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65472736|NCT00354107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65472737|NCT00354107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65472738|NCT00354107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65472739|NCT00354107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65472740|NCT00354107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65472741|NCT00354107|Antiviral Agents|antiviral agents|mesh-ancestor
65472742|NCT00354107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65472743|NCT00354107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65472744|NCT00354107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65472745|NCT00354107|Alkylating Agents|alkylating agents|mesh-ancestor
65472746|NCT00354107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65472747|NCT00354029|Ketamine|ketamine|mesh-list
65472748|NCT00354029|Analgesics|analgesics|mesh-ancestor
64856833|NCT01731132|Copper|copper|mesh-list
64720977|NCT03758365|Glucocorticoids|glucocorticoids|mesh-ancestor
64720978|NCT03758365|Hormones|hormones|mesh-ancestor
65472749|NCT00354029|Sensory System Agents|sensory system agents|mesh-ancestor
65472750|NCT00354029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472751|NCT00354029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472752|NCT00354029|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65472753|NCT00354029|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65472754|NCT00354029|Anesthetics, General|anesthetics, general|mesh-ancestor
65472755|NCT00354029|Anesthetics|anesthetics|mesh-ancestor
65472756|NCT00354029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65472757|NCT00354029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65472758|NCT00354029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65472759|NCT00354029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65472760|NCT00354029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472761|NCT00353873|Fluticasone|fluticasone|mesh-list
65472762|NCT00353873|Xhance|xhance|mesh-list
65472763|NCT00353873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65472764|NCT00353873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65472765|NCT00353873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65472766|NCT00353873|Autonomic Agents|autonomic agents|mesh-ancestor
65472767|NCT00353873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472768|NCT00353873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472769|NCT00353873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65472770|NCT00353873|Respiratory System Agents|respiratory system agents|mesh-ancestor
65472771|NCT00353873|Dermatologic Agents|dermatologic agents|mesh-ancestor
65472772|NCT00353873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65472773|NCT00353873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65472774|NCT00353873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65472775|NCT00353873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65472776|NCT00353873|Adrenergic Agents|adrenergic agents|mesh-ancestor
65472777|NCT00353873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65472778|NCT00353873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472779|NCT01058057|Atorvastatin|atorvastatin|mesh-list
65472780|NCT01058057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65472781|NCT01058057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65472782|NCT01058057|Antimetabolites|antimetabolites|mesh-ancestor
65472783|NCT01058057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720979|NCT03758365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65472784|NCT01058057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65472785|NCT01058057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65472786|NCT01058057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472787|NCT03796676|Abrocitinib|abrocitinib|mesh-list
65472788|NCT03796676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65472789|NCT03796676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472790|NCT03796676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472791|NCT00339833|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
65472792|NCT00339833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65472793|NCT00339833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65472794|NCT00339833|Analgesics|analgesics|mesh-ancestor
65472795|NCT00339833|Sensory System Agents|sensory system agents|mesh-ancestor
65472796|NCT00339833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472797|NCT00339833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472798|NCT00339833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65472799|NCT00339833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65472800|NCT01058291|Apomorphine|apomorphine|mesh-list
65472801|NCT01058291|Emetics|emetics|mesh-ancestor
65472802|NCT01058291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472803|NCT01058291|Autonomic Agents|autonomic agents|mesh-ancestor
65472804|NCT01058291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472805|NCT01058291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65472806|NCT01058291|Dopamine Agonists|dopamine agonists|mesh-ancestor
65472807|NCT01058291|Dopamine Agents|dopamine agents|mesh-ancestor
65472808|NCT01058291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65472809|NCT01058291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472810|NCT01055249|Ibuprofen|ibuprofen|mesh-list
65472811|NCT01055249|Hydrocortisone|hydrocortisone|mesh-list
65472812|NCT01055249|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65472813|NCT01055249|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65472817|NCT01055249|Analgesics|analgesics|mesh-ancestor
65472826|NCT01055327|Lamotrigine|lamotrigine|mesh-list
65472827|NCT01055327|Anticonvulsants|anticonvulsants|mesh-list
65472828|NCT01055327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65472829|NCT01055327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65472830|NCT01055327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472831|NCT01055327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65472832|NCT01055327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472833|NCT01055327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65472834|NCT01055327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65472835|NCT01055327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65472836|NCT01055327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65472837|NCT01055327|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65472838|NCT03793556|Omeprazole|omeprazole|mesh-list
65472839|NCT03793556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65472840|NCT03793556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65472841|NCT03793556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65472842|NCT03793556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472843|NCT03793556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472844|NCT01113164|Ondansetron|ondansetron|mesh-list
65472845|NCT01113164|Sertraline|sertraline|mesh-list
65472846|NCT01113164|Antiemetics|antiemetics|mesh-ancestor
65472847|NCT01113164|Autonomic Agents|autonomic agents|mesh-ancestor
65472848|NCT01113164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472849|NCT01113164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472850|NCT01113164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65472851|NCT01113164|Antipruritics|antipruritics|mesh-ancestor
65472852|NCT01113164|Dermatologic Agents|dermatologic agents|mesh-ancestor
65472853|NCT01113164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65472854|NCT01113164|Serotonin Agents|serotonin agents|mesh-ancestor
65472855|NCT01113164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65472856|NCT01113164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472857|NCT01113164|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65472858|NCT01113164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65472859|NCT01113164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65472865|NCT01113164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65472866|NCT01210430|Vitamins|vitamins|mesh-list
65472867|NCT01210430|Ascorbic Acid|ascorbic acid|mesh-list
65472868|NCT01210430|Losartan|losartan|mesh-list
65472869|NCT01210430|Micronutrients|micronutrients|mesh-ancestor
65472870|NCT01210430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472871|NCT01210430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65472872|NCT01210430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65472873|NCT01210430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65472874|NCT01210430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65472875|NCT01210430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472876|NCT01210430|Antioxidants|antioxidants|mesh-ancestor
65472877|NCT01210430|Protective Agents|protective agents|mesh-ancestor
65472879|NCT01210742|Viscosupplements|viscosupplements|mesh-ancestor
65472880|NCT01210742|Protective Agents|protective agents|mesh-ancestor
65472881|NCT01210742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472882|NCT01116128|Prednisone|prednisone|mesh-list
65472883|NCT01116128|Melphalan|melphalan|mesh-list
65472884|NCT01116128|Dasatinib|dasatinib|mesh-list
65472885|NCT01116128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65472886|NCT01116128|Glucocorticoids|glucocorticoids|mesh-ancestor
65472887|NCT01116128|Hormones|hormones|mesh-ancestor
65472888|NCT01116128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65472889|NCT01116128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472890|NCT01116128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65472891|NCT01116128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65472892|NCT01116128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65472893|NCT01116128|Alkylating Agents|alkylating agents|mesh-ancestor
65472894|NCT01116128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472895|NCT01116128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65472896|NCT01116128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65472910|NCT01116206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472911|NCT01116206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472912|NCT01210976|Simendan|simendan|mesh-list
65472913|NCT01210976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65472914|NCT01210976|Vasodilator Agents|vasodilator agents|mesh-ancestor
65472915|NCT01210976|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65472916|NCT01210976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65472917|NCT01210976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472918|NCT01210976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472919|NCT01210976|Protective Agents|protective agents|mesh-ancestor
65472920|NCT01210976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472921|NCT03828539|Topiramate|topiramate|mesh-list
65472922|NCT03828539|Erenumab|erenumab|mesh-list
65472923|NCT03828539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65472924|NCT03828539|Anticonvulsants|anticonvulsants|mesh-ancestor
65472925|NCT03828539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65472926|NCT03828539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472927|NCT03828539|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65472928|NCT03828539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472929|NCT03828539|Analgesics|analgesics|mesh-ancestor
65472930|NCT03828539|Sensory System Agents|sensory system agents|mesh-ancestor
65472931|NCT03828539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472932|NCT03828539|Immunologic Factors|immunologic factors|mesh-ancestor
65472933|NCT01109888|Cetrorelix|cetrorelix|mesh-list
65472934|NCT01109888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65472935|NCT01109888|Fertility Agents|fertility agents|mesh-ancestor
65472936|NCT01109888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65472937|NCT01109888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472938|NCT01109888|Hormone Antagonists|hormone antagonists|mesh-ancestor
65472939|NCT01109888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65472940|NCT03336502|Posaconazole|posaconazole|mesh-list
65472941|NCT03336502|Antifungal Agents|antifungal agents|mesh-ancestor
65472942|NCT03336502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720980|NCT03758365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720981|NCT03758365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64720982|NCT03758365|Immunologic Factors|immunologic factors|mesh-ancestor
64720983|NCT03758365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328848|NCT00443287|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
65472943|NCT03336502|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65472944|NCT03336502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65472945|NCT03336502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65472946|NCT03336502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65472947|NCT03336502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65472948|NCT03336502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472949|NCT03336502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472950|NCT03336502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65472951|NCT03336502|Hormone Antagonists|hormone antagonists|mesh-ancestor
65472952|NCT03336502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65472953|NCT03336502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472955|NCT01325051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65472956|NCT01325051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65472957|NCT01325051|Antiviral Agents|antiviral agents|mesh-ancestor
65472958|NCT01325051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65472959|NCT01325051|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65472960|NCT01325051|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65472961|NCT01325051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472962|NCT01325051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65472963|NCT01055405|Sildenafil Citrate|sildenafil citrate|mesh-list
65472964|NCT01055405|Vasodilator Agents|vasodilator agents|mesh-ancestor
65472965|NCT01055405|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65472966|NCT01055405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65472967|NCT01055405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65472969|NCT01055405|Urological Agents|urological agents|mesh-ancestor
65472991|NCT03985865|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65472992|NCT03985865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65472993|NCT03985865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65472994|NCT03985865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65472995|NCT03985865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65472996|NCT03985865|Analgesics|analgesics|mesh-ancestor
65472997|NCT03985865|Sensory System Agents|sensory system agents|mesh-ancestor
65472998|NCT03985865|Aversive Agents|aversive agents|mesh-ancestor
65472999|NCT03985865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473000|NCT03985865|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
65473001|NCT01116596|Acetaminophen|acetaminophen|mesh-list
65473002|NCT01116596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65473003|NCT01116596|Analgesics|analgesics|mesh-ancestor
65473004|NCT01116596|Sensory System Agents|sensory system agents|mesh-ancestor
65473005|NCT01116596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65473006|NCT01116596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473007|NCT01116596|Antipyretics|antipyretics|mesh-ancestor
65473008|NCT00351611|Pregabalin|pregabalin|mesh-list
65473009|NCT00351611|Analgesics|analgesics|mesh-ancestor
64328849|NCT00443287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64328850|NCT00443287|Autonomic Agents|autonomic agents|mesh-ancestor
64416691|NCT03038503|Methylene Blue|methylene blue|mesh-list
64328854|NCT00443287|Respiratory System Agents|respiratory system agents|mesh-ancestor
64328855|NCT00443287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64328856|NCT00443287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64328857|NCT00443287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328858|NCT00443287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64328859|NCT00443287|Vasodilator Agents|vasodilator agents|mesh-ancestor
64328860|NCT00443287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64328861|NCT00443287|Protective Agents|protective agents|mesh-ancestor
64713743|NCT01370460|Tranexamic Acid|tranexamic acid|mesh-list
64713744|NCT01370460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64713745|NCT01370460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64713746|NCT01370460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713747|NCT01370460|Hemostatics|hemostatics|mesh-ancestor
64713748|NCT01370460|Coagulants|coagulants|mesh-ancestor
64720992|NCT00002300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64720993|NCT00002300|Contraceptive Agents|contraceptive agents|mesh-ancestor
64720994|NCT00002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64720995|NCT00002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720996|NCT00002300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64328862|NCT00443287|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64328863|NCT00443287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64328864|NCT00443287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328865|NCT00443287|Enzyme Activators|enzyme activators|mesh-ancestor
64328866|NCT00442039|Lithium Carbonate|lithium carbonate|mesh-list
64328867|NCT00442039|Antidepressive Agents|antidepressive agents|mesh-ancestor
64328868|NCT00442039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64328869|NCT00442039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328870|NCT00442039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328871|NCT00442039|Antimanic Agents|antimanic agents|mesh-ancestor
64328872|NCT00442039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64328873|NCT00442039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64713750|NCT01306019|Alkylating Agents|alkylating agents|mesh-ancestor
64713751|NCT01306019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713752|NCT01306019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65473010|NCT00351611|Sensory System Agents|sensory system agents|mesh-ancestor
65473011|NCT00351611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65473012|NCT00351611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473013|NCT00351611|Anticonvulsants|anticonvulsants|mesh-ancestor
65473014|NCT00351611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65473015|NCT00351611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65473016|NCT00351611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473017|NCT00351611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65473018|NCT00351611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65473019|NCT00351611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65473020|NCT00351611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65473021|NCT00351611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65473022|NCT01211210|Fluorouracil|fluorouracil|mesh-list
65473023|NCT01211210|Oxaliplatin|oxaliplatin|mesh-list
65473024|NCT01211210|Antimetabolites|antimetabolites|mesh-ancestor
65222521|NCT02602600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473025|NCT01211210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473026|NCT01211210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65473027|NCT01211210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473028|NCT01211210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65473029|NCT01211210|Immunologic Factors|immunologic factors|mesh-ancestor
65473030|NCT01211210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473031|NCT01116830|Antipsychotic Agents|antipsychotic agents|mesh-list
65473032|NCT01116830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65473033|NCT01116830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65473034|NCT01116830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473035|NCT01116830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65473036|NCT03789110|Nivolumab|nivolumab|mesh-list
65473037|NCT03789110|Ipilimumab|ipilimumab|mesh-list
65473038|NCT03789110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65473039|NCT03789110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64857112|NCT01733030|Cycloserine|cycloserine|mesh-list
64713753|NCT01306019|Immunologic Factors|immunologic factors|mesh-ancestor
64713754|NCT01306019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721001|NCT00002300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64721002|NCT00002306|Fluconazole|fluconazole|mesh-list
64721003|NCT00002306|Antifungal Agents|antifungal agents|mesh-ancestor
64721004|NCT00002306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64328874|NCT00442039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328875|NCT02390739|Aldesleukin|aldesleukin|mesh-list
64328876|NCT02390739|Cyclophosphamide|cyclophosphamide|mesh-list
64328877|NCT02390739|Fludarabine|fludarabine|mesh-list
65473040|NCT03789110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65473041|NCT03789110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473042|NCT01208012|Liraglutide|liraglutide|mesh-list
65473043|NCT01208012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65473044|NCT01208012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473045|NCT01208012|Incretins|incretins|mesh-ancestor
65473046|NCT01208012|Hormones|hormones|mesh-ancestor
65473047|NCT01208012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65473048|NCT03939806|Oxytocin|oxytocin|mesh-list
65473049|NCT03939806|Carbetocin|carbetocin|mesh-list
65473050|NCT03939806|Oxytocics|oxytocics|mesh-ancestor
65473051|NCT03939806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65473052|NCT03939806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473053|NCT00351377|Mycophenolic Acid|mycophenolic acid|mesh-list
65473054|NCT00351377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65473055|NCT00351377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473056|NCT00351377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65473057|NCT00351377|Antitubercular Agents|antitubercular agents|mesh-ancestor
65473058|NCT00351377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65473059|NCT00351377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65473060|NCT00351377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473061|NCT00351377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473062|NCT00337727|Dexamethasone|dexamethasone|mesh-list
65473063|NCT00337727|Dexamethasone acetate|dexamethasone acetate|mesh-list
65473064|NCT00337727|Ondansetron|ondansetron|mesh-list
65473065|NCT00337727|Aprepitant|aprepitant|mesh-list
65473066|NCT00337727|Fosaprepitant|fosaprepitant|mesh-list
65473067|NCT00337727|BB 1101|bb 1101|mesh-list
65473068|NCT00337727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65473087|NCT00337727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65473088|NCT00337727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65473089|NCT00337727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65473090|NCT00337727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65473091|NCT00337727|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65473092|NCT00337727|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65473093|NCT03987893|Lactulose|lactulose|mesh-list
65473094|NCT03987893|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65473095|NCT03987893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65473096|NCT03987893|Laxatives|laxatives|mesh-ancestor
65473097|NCT01208480|Carboplatin|carboplatin|mesh-list
65222602|NCT00919555|Pioglitazone|pioglitazone|mesh-list
65473098|NCT01208480|Docetaxel|docetaxel|mesh-list
65473099|NCT01208480|Bevacizumab|bevacizumab|mesh-list
65473100|NCT01208480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473101|NCT01208480|Tubulin Modulators|tubulin modulators|mesh-ancestor
65473102|NCT01208480|Antimitotic Agents|antimitotic agents|mesh-ancestor
65473103|NCT01208480|Mitosis Modulators|mitosis modulators|mesh-ancestor
65473104|NCT01208480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473105|NCT01208480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65473106|NCT01208480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65473107|NCT01208480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65473108|NCT01208480|Growth Substances|growth substances|mesh-ancestor
65473109|NCT01208480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473110|NCT01208480|Growth Inhibitors|growth inhibitors|mesh-ancestor
65473111|NCT02949700|Metformin|metformin|mesh-list
65473112|NCT02949700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65473113|NCT02949700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473114|NCT04774120|Propofol|propofol|mesh-list
65473115|NCT04774120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65473116|NCT04774120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65473130|NCT01117220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65473131|NCT01117220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65473132|NCT01117220|Dopamine Agents|dopamine agents|mesh-ancestor
65473133|NCT05236972|Capecitabine|capecitabine|mesh-list
65473134|NCT05236972|Oxaliplatin|oxaliplatin|mesh-list
65473135|NCT05236972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65473136|NCT05236972|Antimetabolites|antimetabolites|mesh-ancestor
65473137|NCT05236972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473138|NCT05236972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473139|NCT01114100|Sertraline|sertraline|mesh-list
65473140|NCT01114100|Antidepressive Agents|antidepressive agents|mesh-ancestor
65473141|NCT01114100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65473142|NCT01114100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65473143|NCT01114100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65473144|NCT01114100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65473145|NCT01114100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473146|NCT01114100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65473147|NCT01114100|Serotonin Agents|serotonin agents|mesh-ancestor
65473148|NCT01114100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473149|NCT01110590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65473150|NCT01110590|Vasodilator Agents|vasodilator agents|mesh-ancestor
65473151|NCT01110590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65473152|NCT01110590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65473153|NCT01110590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473154|NCT01110590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473155|NCT01110590|Urological Agents|urological agents|mesh-ancestor
65473156|NCT01117298|Tadalafil|tadalafil|mesh-list
65473157|NCT01117298|Vasodilator Agents|vasodilator agents|mesh-ancestor
65473175|NCT01117376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473176|NCT01117376|Sensory System Agents|sensory system agents|mesh-ancestor
65473177|NCT01117376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65473178|NCT01213238|Bevacizumab|bevacizumab|mesh-list
65473179|NCT01213238|Capecitabine|capecitabine|mesh-list
65473180|NCT01213238|Oxaliplatin|oxaliplatin|mesh-list
65473181|NCT01213238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65473182|NCT01213238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473183|NCT01213238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65473184|NCT01213238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65473185|NCT01213238|Growth Substances|growth substances|mesh-ancestor
65473186|NCT01213238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473187|NCT01213238|Growth Inhibitors|growth inhibitors|mesh-ancestor
65473188|NCT01213238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65473189|NCT01213238|Antimetabolites|antimetabolites|mesh-ancestor
65473190|NCT01213238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473191|NCT01110824|Carvedilol|carvedilol|mesh-list
65473192|NCT01110824|Enalapril|enalapril|mesh-list
65473193|NCT01110824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65473194|NCT01110824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65473195|NCT01110824|Adrenergic Agents|adrenergic agents|mesh-ancestor
65473196|NCT01110824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65473197|NCT01110824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473198|NCT01110824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473199|NCT01110824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65473200|NCT01110824|Antioxidants|antioxidants|mesh-ancestor
65473211|NCT03936140|Iloprost|iloprost|mesh-list
65473222|NCT01215890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65473223|NCT01215890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65473224|NCT01215890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473225|NCT01215890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65473226|NCT01215890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473227|NCT01215890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65473228|NCT01213394|Mycophenolic Acid|mycophenolic acid|mesh-list
65473229|NCT01213394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65473230|NCT01213394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473231|NCT01213394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65473232|NCT01213394|Antitubercular Agents|antitubercular agents|mesh-ancestor
65473233|NCT01213394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65473234|NCT01213394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65473235|NCT01213394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473236|NCT01213394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473237|NCT01121744|Sirolimus|sirolimus|mesh-list
65473238|NCT01121744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65473239|NCT01121744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65473240|NCT01121744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65473241|NCT01121744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473242|NCT01121744|Antifungal Agents|antifungal agents|mesh-ancestor
65473243|NCT01121744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65473244|NCT01121744|Immunologic Factors|immunologic factors|mesh-ancestor
65473245|NCT01121744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473246|NCT01121822|Vaccines|vaccines|mesh-list
65473247|NCT01121822|Immunologic Factors|immunologic factors|mesh-ancestor
65222745|NCT02586961|Betamethasone|betamethasone|mesh-list
64857326|NCT01734564|Immunologic Factors|immunologic factors|mesh-ancestor
64328878|NCT02390739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64328879|NCT02390739|Immunologic Factors|immunologic factors|mesh-ancestor
64328880|NCT02390739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328881|NCT02390739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64713755|NCT01306019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64713756|NCT01306019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713757|NCT01306019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64713758|NCT01203020|Fludarabine|fludarabine|mesh-list
64713759|NCT01203020|Fludarabine phosphate|fludarabine phosphate|mesh-list
64713760|NCT01203020|Busulfan|busulfan|mesh-list
64713761|NCT01203020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713762|NCT01203020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64713763|NCT01203020|Antimetabolites|antimetabolites|mesh-ancestor
64713764|NCT01203020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713795|NCT00621192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64713796|NCT00621192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64713797|NCT00364286|Dasatinib|dasatinib|mesh-list
64713798|NCT00364286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473248|NCT01121822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473250|NCT01213550|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65473251|NCT01213550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65473252|NCT01213550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65473253|NCT01213550|Disinfectants|disinfectants|mesh-ancestor
65473254|NCT01213550|Dermatologic Agents|dermatologic agents|mesh-ancestor
65473255|NCT01213784|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65473256|NCT01213784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473257|NCT01216046|Ivacaftor|ivacaftor|mesh-list
65473258|NCT01216046|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65473259|NCT01216046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65473260|NCT01216046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473261|NCT01216124|Docetaxel|docetaxel|mesh-list
65473262|NCT01216124|Oxaliplatin|oxaliplatin|mesh-list
65473263|NCT01216124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473264|NCT01216124|Tubulin Modulators|tubulin modulators|mesh-ancestor
65473265|NCT01216124|Antimitotic Agents|antimitotic agents|mesh-ancestor
65473266|NCT01216124|Mitosis Modulators|mitosis modulators|mesh-ancestor
65473267|NCT01216124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473268|NCT01219010|Siltuximab|siltuximab|mesh-list
65473269|NCT01219010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473270|NCT01118234|Rituximab|rituximab|mesh-list
65473271|NCT01118234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65473272|NCT01118234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473273|NCT01118234|Immunologic Factors|immunologic factors|mesh-ancestor
65473274|NCT01118234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473275|NCT01118234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65473276|NCT00324155|Ipilimumab|ipilimumab|mesh-list
65473277|NCT00324155|Dacarbazine|dacarbazine|mesh-list
65473278|NCT00324155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65473279|NCT00324155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473280|NCT00324155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65473281|NCT00324155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473282|NCT00324155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65473283|NCT00324155|Alkylating Agents|alkylating agents|mesh-ancestor
65473288|NCT03937544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473289|NCT03937544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65473290|NCT03937544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65473291|NCT03937544|Alkylating Agents|alkylating agents|mesh-ancestor
65473292|NCT03937544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473293|NCT03937544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473294|NCT03937544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65473295|NCT01122056|Interferons|interferons|mesh-list
65473296|NCT01122056|Interferon beta-1b|interferon beta-1b|mesh-list
65473297|NCT01122056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473298|NCT01122056|Antiviral Agents|antiviral agents|mesh-ancestor
65473299|NCT01122056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65473300|NCT01122056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65473301|NCT01122056|Immunologic Factors|immunologic factors|mesh-ancestor
65473302|NCT01122056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473303|NCT01219088|Morphine|morphine|mesh-list
65473304|NCT01219088|Bupivacaine|bupivacaine|mesh-list
65473305|NCT01219088|Anesthetics, Local|anesthetics, local|mesh-ancestor
65473306|NCT01219088|Anesthetics|anesthetics|mesh-ancestor
65473307|NCT01219088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65473343|NCT01119014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65473344|NCT01119014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473345|NCT01119014|Dopamine Agonists|dopamine agonists|mesh-ancestor
65473346|NCT01119014|Dopamine Agents|dopamine agents|mesh-ancestor
65473347|NCT01119014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65473348|NCT01119014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473349|NCT01119014|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65473350|NCT01119014|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65473351|NCT01119014|Serotonin Agents|serotonin agents|mesh-ancestor
65473352|NCT01119014|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65473353|NCT01119014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65473354|NCT01119014|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65473355|NCT01119014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65473356|NCT01219244|Resveratrol|resveratrol|mesh-list
65473402|NCT01219400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65473403|NCT01219400|Protease Inhibitors|protease inhibitors|mesh-ancestor
65473404|NCT01219400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473405|NCT01219400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473406|NCT01124630|Leucovorin|leucovorin|mesh-list
65473407|NCT01124630|Fluorouracil|fluorouracil|mesh-list
65473408|NCT01124630|Irinotecan|irinotecan|mesh-list
65473409|NCT01124630|Antimetabolites|antimetabolites|mesh-ancestor
65473410|NCT01124630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473411|NCT01124630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65473412|NCT01124630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473413|NCT01124630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65473414|NCT01124630|Immunologic Factors|immunologic factors|mesh-ancestor
65473415|NCT01124630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473416|NCT01124630|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65473417|NCT01124630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65473418|NCT01124630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473419|NCT01124630|Antidotes|antidotes|mesh-ancestor
65473420|NCT01124630|Protective Agents|protective agents|mesh-ancestor
65473421|NCT01124630|Vitamin B Complex|vitamin b complex|mesh-ancestor
65473422|NCT01124630|Vitamins|vitamins|mesh-ancestor
65473423|NCT01124630|Micronutrients|micronutrients|mesh-ancestor
65473424|NCT05683054|Adalimumab|adalimumab|mesh-list
65473425|NCT05683054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65473426|NCT05683054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65473427|NCT01120106|Simendan|simendan|mesh-list
65473428|NCT01120106|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65473429|NCT01120106|Vasodilator Agents|vasodilator agents|mesh-ancestor
65473451|NCT01120340|Analgesics|analgesics|mesh-ancestor
65473452|NCT01120340|Sensory System Agents|sensory system agents|mesh-ancestor
65473453|NCT01120340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65473454|NCT01120340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473455|NCT01120340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65473456|NCT01120340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65473457|NCT01120418|Besifloxacin|besifloxacin|mesh-list
65473458|NCT01120418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65473459|NCT01120418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65473460|NCT01120418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65473461|NCT01120418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65473462|NCT01120418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473463|NCT01120418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473464|NCT01120418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473465|NCT01214408|Pantoprazole|pantoprazole|mesh-list
65473511|NCT01125254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65473512|NCT01125254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473513|NCT01125254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65473514|NCT01125254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473515|NCT01125254|Vasodilator Agents|vasodilator agents|mesh-ancestor
65473516|NCT03710434|Lansoprazole|lansoprazole|mesh-list
65473517|NCT03710434|Dexlansoprazole|dexlansoprazole|mesh-list
65473518|NCT03710434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65473519|NCT03710434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65473520|NCT03710434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65473521|NCT03710434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473573|NCT01121042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65473574|NCT01121042|Serotonin Agents|serotonin agents|mesh-ancestor
65473575|NCT01121042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65473576|NCT01121042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473577|NCT01121042|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65473578|NCT01121042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65473579|NCT01121042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65473580|NCT01121042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65473581|NCT01121042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65473582|NCT01121120|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
65473638|NCT01328834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473639|NCT01328834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65473640|NCT01328834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473641|NCT01328834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473642|NCT01121354|Cefazolin|cefazolin|mesh-list
65473643|NCT01121354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65473644|NCT01121354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65473645|NCT01122602|Aspirin|aspirin|mesh-list
65473646|NCT01122602|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65473647|NCT01122602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65473648|NCT01122602|Analgesics|analgesics|mesh-ancestor
65473649|NCT01122602|Sensory System Agents|sensory system agents|mesh-ancestor
65473650|NCT01122602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65473651|NCT01122602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473660|NCT01122602|Antipyretics|antipyretics|mesh-ancestor
65473695|NCT05682196|Rituximab|rituximab|mesh-list
65473696|NCT05682196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65473697|NCT05682196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473698|NCT05682196|Immunologic Factors|immunologic factors|mesh-ancestor
65473699|NCT05682196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473700|NCT05682196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65473764|NCT01222052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65473765|NCT01222052|Tubulin Modulators|tubulin modulators|mesh-ancestor
65473766|NCT01222052|Antimitotic Agents|antimitotic agents|mesh-ancestor
65473767|NCT01222052|Mitosis Modulators|mitosis modulators|mesh-ancestor
65473768|NCT01222052|Antimetabolites|antimetabolites|mesh-ancestor
65473769|NCT01222052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65473770|NCT01222052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65473833|NCT03706222|Antiviral Agents|antiviral agents|mesh-ancestor
65473834|NCT03706222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65473835|NCT01222676|Gemcitabine|gemcitabine|mesh-list
65473836|NCT01222676|Sorafenib|sorafenib|mesh-list
65473837|NCT01222676|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65473838|NCT01222676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473839|NCT01222676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65473840|NCT01222676|Antimetabolites|antimetabolites|mesh-ancestor
65473841|NCT01222676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473842|NCT01222676|Antiviral Agents|antiviral agents|mesh-ancestor
65473843|NCT01222676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65473844|NCT01222676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65473845|NCT01222676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65473846|NCT01222676|Immunologic Factors|immunologic factors|mesh-ancestor
65473847|NCT01222676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473848|NCT01222676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65473849|NCT01222676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65473850|NCT05681728|Paclitaxel|paclitaxel|mesh-list
65473851|NCT05681728|Cyclophosphamide|cyclophosphamide|mesh-list
65473852|NCT05681728|Pembrolizumab|pembrolizumab|mesh-list
65473853|NCT05681728|Epirubicin|epirubicin|mesh-list
65473854|NCT05681728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65473855|NCT05681728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65473856|NCT05681728|Tubulin Modulators|tubulin modulators|mesh-ancestor
65473857|NCT05681728|Antimitotic Agents|antimitotic agents|mesh-ancestor
65473858|NCT05681728|Mitosis Modulators|mitosis modulators|mesh-ancestor
65473859|NCT05681728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65473860|NCT05681728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65473861|NCT05681728|Immunologic Factors|immunologic factors|mesh-ancestor
65473862|NCT05681728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473863|NCT05681728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65473864|NCT05681728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65473865|NCT05681728|Alkylating Agents|alkylating agents|mesh-ancestor
65473866|NCT05681728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65473870|NCT05681728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65473874|NCT05535166|Methotrexate|methotrexate|mesh-list
65473875|NCT05535166|Etoposide|etoposide|mesh-list
65473876|NCT05535166|Vincristine|vincristine|mesh-list
65473877|NCT05535166|Topotecan|topotecan|mesh-list
65473878|NCT05535166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65473879|NCT05535166|Immunologic Factors|immunologic factors|mesh-ancestor
65473880|NCT05535166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473942|NCT04533568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65473943|NCT04533568|Analgesics|analgesics|mesh-ancestor
65473944|NCT04533568|Sensory System Agents|sensory system agents|mesh-ancestor
65473945|NCT04533568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65473946|NCT04533568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65473947|NCT04533568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65473948|NCT04533568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65474009|NCT01127672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65474010|NCT01127672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65474011|NCT01127672|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65474012|NCT01127672|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65474013|NCT01127672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65474077|NCT04724668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474078|NCT04724668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65474152|NCT01218386|Hormones|hormones|mesh-ancestor
65474153|NCT01218386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65474154|NCT01218386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474159|NCT03933098|Vaccines|vaccines|mesh-list
65474222|NCT01218620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474223|NCT01218620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65474224|NCT01218620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65474225|NCT01218620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65474226|NCT01218620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65474227|NCT01218620|Anesthetics, General|anesthetics, general|mesh-ancestor
65474228|NCT01218620|Anesthetics|anesthetics|mesh-ancestor
65474229|NCT01218620|GABA Modulators|gaba modulators|mesh-ancestor
65474230|NCT01218620|GABA Agents|gaba agents|mesh-ancestor
65474231|NCT01218620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65474232|NCT01218620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474233|NCT01218620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65474234|NCT01218620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65474235|NCT01218620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65474236|NCT01218620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474280|NCT01224860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65474281|NCT01224860|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65474282|NCT01224860|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65474283|NCT01224860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474284|NCT00323063|Gemcitabine|gemcitabine|mesh-list
65474285|NCT00323063|Imatinib Mesylate|imatinib mesylate|mesh-list
65474286|NCT00323063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65474287|NCT00323063|Antimetabolites|antimetabolites|mesh-ancestor
65474288|NCT00323063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474289|NCT00323063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474290|NCT00323063|Antiviral Agents|antiviral agents|mesh-ancestor
65474292|NCT00323063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474293|NCT00323063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65474294|NCT00323063|Immunologic Factors|immunologic factors|mesh-ancestor
65474295|NCT00323063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474296|NCT00323063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65474297|NCT03983057|Antibodies|antibodies|mesh-list
65474298|NCT03983057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65474299|NCT03983057|Immunologic Factors|immunologic factors|mesh-ancestor
65474300|NCT03983057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474301|NCT01328990|Pyrimethamine|pyrimethamine|mesh-list
65474302|NCT01328990|Sulfadoxine|sulfadoxine|mesh-list
65474303|NCT01328990|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65474304|NCT01328990|Amodiaquine|amodiaquine|mesh-list
65474305|NCT01328990|Antimalarials|antimalarials|mesh-ancestor
65474306|NCT01328990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65474307|NCT01328990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65474328|NCT03930212|Hormones|hormones|mesh-ancestor
65474329|NCT03930212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65474330|NCT03930212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474331|NCT00322049|Vaccines|vaccines|mesh-list
65474332|NCT00322049|Immunologic Factors|immunologic factors|mesh-ancestor
65474333|NCT00322049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474334|NCT01124240|Temozolomide|temozolomide|mesh-list
65474335|NCT01124240|Procarbazine|procarbazine|mesh-list
65474336|NCT01124240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65474337|NCT01124240|Alkylating Agents|alkylating agents|mesh-ancestor
65474338|NCT01124240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474339|NCT01124240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474340|NCT01124318|Lactulose|lactulose|mesh-list
65474341|NCT01124318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65474389|NCT01225484|Anesthetics, Local|anesthetics, local|mesh-ancestor
65474390|NCT01225484|Anesthetics|anesthetics|mesh-ancestor
65474391|NCT01225484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65474392|NCT01225484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474460|NCT01225874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65474461|NCT01225874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65474462|NCT03928340|Metformin|metformin|mesh-list
65474463|NCT03928340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65474464|NCT03928340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474465|NCT00371345|Dasatinib|dasatinib|mesh-list
65474529|NCT01129154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474530|NCT02309645|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65474531|NCT02309645|Hemostatics|hemostatics|mesh-ancestor
65474532|NCT02309645|Coagulants|coagulants|mesh-ancestor
65474533|NCT01047995|Ritonavir|ritonavir|mesh-list
65474534|NCT01047995|Darunavir|darunavir|mesh-list
65474535|NCT01047995|Raltegravir Potassium|raltegravir potassium|mesh-list
65474536|NCT01047995|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65474537|NCT01047995|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65474538|NCT01047995|Protease Inhibitors|protease inhibitors|mesh-ancestor
65474539|NCT01047995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65474540|NCT01047995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474541|NCT01047995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65474542|NCT01047995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65474543|NCT01047995|Antiviral Agents|antiviral agents|mesh-ancestor
65474544|NCT01047995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65474545|NCT01047995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65474546|NCT01047995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65474547|NCT01047995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65474548|NCT01047995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65474585|NCT03924596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474586|NCT03924596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65474587|NCT03924596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65474588|NCT00320801|Buprenorphine|buprenorphine|mesh-list
65474589|NCT00320801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65474590|NCT00320801|Narcotics|narcotics|mesh-ancestor
65474591|NCT00320801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65474597|NCT01127204|Lamivudine|lamivudine|mesh-list
65474652|NCT01127360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65474653|NCT01127360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65474725|NCT01129856|Sodium Citrate|sodium citrate|mesh-list
65474726|NCT01129856|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65474727|NCT01129856|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65474728|NCT01129856|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65474729|NCT01129856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65474730|NCT01129856|Antiemetics|antiemetics|mesh-ancestor
65474731|NCT01129856|Autonomic Agents|autonomic agents|mesh-ancestor
65474732|NCT01129856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65474795|NCT01228994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474796|NCT01228994|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65474797|NCT01228994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65474868|NCT01132586|Immunologic Factors|immunologic factors|mesh-ancestor
65474869|NCT01132586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474870|NCT01132586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65474871|NCT01132586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65474872|NCT01132586|Growth Substances|growth substances|mesh-ancestor
65474936|NCT01131806|Fluticasone|fluticasone|mesh-list
65474937|NCT01131806|Xhance|xhance|mesh-list
65474938|NCT01131806|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65474939|NCT01131806|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65474940|NCT01131806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65474941|NCT01131806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65474942|NCT01131806|Autonomic Agents|autonomic agents|mesh-ancestor
65474943|NCT01131806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65474944|NCT01131806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65474945|NCT01131806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65474946|NCT01131806|Respiratory System Agents|respiratory system agents|mesh-ancestor
65474947|NCT01131806|Dermatologic Agents|dermatologic agents|mesh-ancestor
65474948|NCT01131806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65474949|NCT01131806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65474950|NCT01131806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65474951|NCT01131806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65474952|NCT01131806|Adrenergic Agents|adrenergic agents|mesh-ancestor
65474953|NCT01131806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65474954|NCT01131806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65474955|NCT01131806|Glucocorticoids|glucocorticoids|mesh-ancestor
65474956|NCT01131806|Hormones|hormones|mesh-ancestor
65474957|NCT01131806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65474958|NCT01131806|Sympathomimetics|sympathomimetics|mesh-ancestor
65474959|NCT01229930|Paclitaxel|paclitaxel|mesh-list
65474960|NCT01229930|Carboplatin|carboplatin|mesh-list
65474985|NCT01131962|Sclerosing Solutions|sclerosing solutions|mesh-list
65474986|NCT01131962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65474987|NCT01130324|Telavancin|telavancin|mesh-list
65474988|NCT01130324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65474989|NCT01130324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65474990|NCT01229774|Diclofenac|diclofenac|mesh-list
65474991|NCT01229774|Etoricoxib|etoricoxib|mesh-list
65474992|NCT01229774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65475004|NCT03918590|Nepafenac|nepafenac|mesh-list
65475055|NCT01231880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65475056|NCT01231880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65475057|NCT01232036|Metformin|metformin|mesh-list
65475058|NCT01232036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65475059|NCT01232036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475060|NCT01130636|Oseltamivir|oseltamivir|mesh-list
65475061|NCT01130636|Antiviral Agents|antiviral agents|mesh-ancestor
65475062|NCT01130636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65475063|NCT01130636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475064|NCT01130636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475065|NCT03926156|Warfarin|warfarin|mesh-list
65475119|NCT01134848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475120|NCT01134848|Cholinergic Agents|cholinergic agents|mesh-ancestor
65475121|NCT01134848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65475122|NCT01134848|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65475123|NCT01134848|Autonomic Agents|autonomic agents|mesh-ancestor
65475125|NCT01134848|Hormones|hormones|mesh-ancestor
65475187|NCT01133210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65475188|NCT01133210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65475189|NCT01133210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475190|NCT01133210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65475191|NCT01133210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65475192|NCT01133210|Antiviral Agents|antiviral agents|mesh-ancestor
65475193|NCT01133210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65475194|NCT01133210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65475195|NCT01135550|Dexamethasone|dexamethasone|mesh-list
65475196|NCT01135550|Dexamethasone acetate|dexamethasone acetate|mesh-list
65475197|NCT01135550|BB 1101|bb 1101|mesh-list
65224707|NCT01000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475198|NCT01135550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65475199|NCT01135550|Antiemetics|antiemetics|mesh-ancestor
65475200|NCT01135550|Autonomic Agents|autonomic agents|mesh-ancestor
65475201|NCT01135550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65475205|NCT01135550|Hormones|hormones|mesh-ancestor
65475245|NCT01133366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65475246|NCT01133366|Antimetabolites|antimetabolites|mesh-ancestor
65475247|NCT01133366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475248|NCT01133366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65475249|NCT01232270|Propofol|propofol|mesh-list
65475250|NCT01232270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65475251|NCT01232270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65475310|NCT01136252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65475311|NCT01136252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65475312|NCT05597462|Minocycline|minocycline|mesh-list
65475315|NCT00369707|Rituximab|rituximab|mesh-list
65475383|NCT01133912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65475384|NCT01133912|Antimetabolites|antimetabolites|mesh-ancestor
65475385|NCT01133912|Antiviral Agents|antiviral agents|mesh-ancestor
65475386|NCT01133912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65475387|NCT01133912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65475388|NCT01133912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65475389|NCT01133912|Immunologic Factors|immunologic factors|mesh-ancestor
65475390|NCT01133912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475391|NCT01133912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65475392|NCT05320094|Sorbitol|sorbitol|mesh-list
65475393|NCT05320094|Charcoal|charcoal|mesh-list
65475394|NCT05320094|Antidotes|antidotes|mesh-ancestor
65475395|NCT05320094|Protective Agents|protective agents|mesh-ancestor
65475396|NCT05320094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475397|NCT05320094|Cathartics|cathartics|mesh-ancestor
65475398|NCT05320094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65475399|NCT01233752|Morphine|morphine|mesh-list
65475400|NCT01233752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65475401|NCT01233752|Narcotics|narcotics|mesh-ancestor
65475402|NCT01233752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65475403|NCT01233752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475404|NCT01233752|Analgesics|analgesics|mesh-ancestor
65475405|NCT01233752|Sensory System Agents|sensory system agents|mesh-ancestor
65475406|NCT01233752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65475437|NCT04713098|Coal Tar|coal tar|mesh-list
65475438|NCT04713098|Keratolytic Agents|keratolytic agents|mesh-ancestor
65475439|NCT04713098|Dermatologic Agents|dermatologic agents|mesh-ancestor
65475440|NCT04630730|Gemcitabine|gemcitabine|mesh-list
65475441|NCT04630730|Atezolizumab|atezolizumab|mesh-list
65475442|NCT04630730|BCG Vaccine|bcg vaccine|mesh-list
65475443|NCT04630730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475444|NCT04630730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65475445|NCT04630730|Antimetabolites|antimetabolites|mesh-ancestor
65475446|NCT04630730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475447|NCT04630730|Antiviral Agents|antiviral agents|mesh-ancestor
65475503|NCT01134224|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65475504|NCT01134224|Biphasic Insulins|biphasic insulins|mesh-list
65475505|NCT01134224|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65475506|NCT01134224|Insulin, Isophane|insulin, isophane|mesh-list
65475507|NCT01134224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65475572|NCT03638440|Sensory System Agents|sensory system agents|mesh-ancestor
65475573|NCT03638440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65475645|NCT01142258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65475646|NCT01142258|Antidepressive Agents|antidepressive agents|mesh-ancestor
65475647|NCT05152940|Ertugliflozin|ertugliflozin|mesh-list
65475648|NCT05152940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65475649|NCT05152940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65475650|NCT05152940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65475651|NCT05152940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475653|NCT01139840|Ergocalciferols|ergocalciferols|mesh-list
65475654|NCT01139840|Cholecalciferol|cholecalciferol|mesh-list
65475655|NCT01139840|Vitamins|vitamins|mesh-list
65475709|NCT02267603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65475710|NCT02267603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475711|NCT01236482|Oxytocin|oxytocin|mesh-list
65475712|NCT01236482|Ergonovine|ergonovine|mesh-list
65475713|NCT01236482|Oxytocics|oxytocics|mesh-ancestor
65475714|NCT01236482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65475715|NCT01236482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65475716|NCT01142492|Interferons|interferons|mesh-list
65475717|NCT01142492|Interferon-beta|interferon-beta|mesh-list
65475718|NCT01142492|Interferon beta-1a|interferon beta-1a|mesh-list
65475719|NCT01142492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475720|NCT01142492|Antiviral Agents|antiviral agents|mesh-ancestor
65475721|NCT01142492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65475774|NCT01142648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65475775|NCT02143726|Everolimus|everolimus|mesh-list
65475776|NCT02143726|Sorafenib|sorafenib|mesh-list
65475777|NCT02143726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475786|NCT02088112|Durvalumab|durvalumab|mesh-list
65475845|NCT01144988|Bevacizumab|bevacizumab|mesh-list
65475846|NCT01144988|Irinotecan|irinotecan|mesh-list
65475847|NCT01144988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65475848|NCT01144988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65475916|NCT01234454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65475917|NCT01234454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65475918|NCT01234454|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65475919|NCT01234454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65475920|NCT01234454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65475921|NCT01145456|Gemcitabine|gemcitabine|mesh-list
65475987|NCT01145846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476059|NCT01312792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65476060|NCT01312792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65476061|NCT03523000|Fentanyl|fentanyl|mesh-list
65476062|NCT03523000|Bupivacaine|bupivacaine|mesh-list
65476063|NCT03523000|Anesthetics, Local|anesthetics, local|mesh-ancestor
65476064|NCT03523000|Anesthetics|anesthetics|mesh-ancestor
65476065|NCT03523000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65476066|NCT03523000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476067|NCT03523000|Sensory System Agents|sensory system agents|mesh-ancestor
65476068|NCT03523000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65476069|NCT03523000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65476070|NCT03523000|Narcotics|narcotics|mesh-ancestor
65476071|NCT03523000|Analgesics|analgesics|mesh-ancestor
65476075|NCT04705480|Pregabalin|pregabalin|mesh-list
65476121|NCT01236716|Antimitotic Agents|antimitotic agents|mesh-ancestor
65476122|NCT01236716|Mitosis Modulators|mitosis modulators|mesh-ancestor
65476123|NCT01236716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476124|NCT01236716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65476125|NCT01236716|Antimetabolites|antimetabolites|mesh-ancestor
65476126|NCT01236716|Antiviral Agents|antiviral agents|mesh-ancestor
65476127|NCT01236716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65476132|NCT04154800|Itraconazole|itraconazole|mesh-list
65476188|NCT02049905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65476189|NCT02049905|Ifosfamide|ifosfamide|mesh-list
65476190|NCT02049905|Isophosphamide mustard|isophosphamide mustard|mesh-list
65476191|NCT02049905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65476192|NCT02049905|Antimetabolites|antimetabolites|mesh-ancestor
65476193|NCT02049905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476194|NCT02049905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476195|NCT02049905|Antiviral Agents|antiviral agents|mesh-ancestor
65476196|NCT02049905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65476197|NCT02049905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476198|NCT02049905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65476253|NCT02924324|Anesthetics|anesthetics|mesh-ancestor
65476254|NCT02924324|Anesthetics, Local|anesthetics, local|mesh-ancestor
65476255|NCT02924324|Sensory System Agents|sensory system agents|mesh-ancestor
65476256|NCT02924324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65476257|NCT03518606|Durvalumab|durvalumab|mesh-list
65476258|NCT03518606|Vinorelbine|vinorelbine|mesh-list
65476259|NCT03518606|Tremelimumab|tremelimumab|mesh-list
65476260|NCT03518606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65476261|NCT03518606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476262|NCT03518606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65476263|NCT03518606|Tubulin Modulators|tubulin modulators|mesh-ancestor
65476264|NCT03518606|Antimitotic Agents|antimitotic agents|mesh-ancestor
65476317|NCT01143974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476318|NCT01143974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476319|NCT01143974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476320|NCT01143974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65476321|NCT01143974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65476322|NCT00337571|Aripiprazole|aripiprazole|mesh-list
65476323|NCT00337571|Antidepressive Agents|antidepressive agents|mesh-ancestor
65476383|NCT01240850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65476384|NCT04813016|Dexmedetomidine|dexmedetomidine|mesh-list
65476385|NCT04813016|Tramadol|tramadol|mesh-list
65476386|NCT04813016|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65476387|NCT04813016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65476388|NCT04813016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476389|NCT04813016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65476390|NCT04813016|Analgesics|analgesics|mesh-ancestor
65476391|NCT04813016|Sensory System Agents|sensory system agents|mesh-ancestor
65476392|NCT04813016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65476393|NCT04813016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65476394|NCT04813016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65476395|NCT04813016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65476444|NCT01237262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476445|NCT01237262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65476446|NCT01237262|Immunologic Factors|immunologic factors|mesh-ancestor
65476447|NCT01329770|Vitamins|vitamins|mesh-list
65476448|NCT01329770|Ascorbic Acid|ascorbic acid|mesh-list
65476449|NCT01329770|Vitamin E|vitamin e|mesh-list
65476515|NCT03912974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476518|NCT03912974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65476588|NCT03912740|Dexmedetomidine|dexmedetomidine|mesh-list
65476589|NCT03912740|Remifentanil|remifentanil|mesh-list
65476590|NCT03912740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65476591|NCT03912740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65476592|NCT03912740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65476593|NCT03912740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65476594|NCT03912740|Analgesics|analgesics|mesh-ancestor
65476595|NCT03912740|Sensory System Agents|sensory system agents|mesh-ancestor
65476596|NCT03912740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65476597|NCT03912740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65476604|NCT03912740|Narcotics|narcotics|mesh-ancestor
65476652|NCT03911648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65476725|NCT01237808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65476726|NCT01237808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476727|NCT01237808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476728|NCT01237808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65476737|NCT03910634|Carboplatin|carboplatin|mesh-list
65476795|NCT03323164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65476796|NCT03323164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65476797|NCT03914690|Epoetin Alfa|epoetin alfa|mesh-list
65476798|NCT03914690|Hematinics|hematinics|mesh-ancestor
65476799|NCT03914534|Valproic Acid|valproic acid|mesh-list
65476800|NCT03914534|Anticonvulsants|anticonvulsants|mesh-ancestor
65476801|NCT03914534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476802|NCT03914534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476863|NCT05617664|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65476864|NCT05617664|Natriuretic Agents|natriuretic agents|mesh-ancestor
65476865|NCT03909776|Cisplatin|cisplatin|mesh-list
65476866|NCT03909776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476936|NCT03908528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65476937|NCT03908528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65476938|NCT03908528|Alkylating Agents|alkylating agents|mesh-ancestor
65476939|NCT03908528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476940|NCT03908528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476941|NCT03908528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65476942|NCT03908528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65476943|NCT03908528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65476944|NCT03908528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65476945|NCT03908528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65476946|NCT03908528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65476947|NCT03908528|Tubulin Modulators|tubulin modulators|mesh-ancestor
65476948|NCT03908528|Antimitotic Agents|antimitotic agents|mesh-ancestor
65476949|NCT03908528|Mitosis Modulators|mitosis modulators|mesh-ancestor
65476950|NCT03908528|Antioxidants|antioxidants|mesh-ancestor
65476951|NCT03908528|Protective Agents|protective agents|mesh-ancestor
65476952|NCT03908528|Vitamin B Complex|vitamin b complex|mesh-ancestor
65476953|NCT03908528|Vitamins|vitamins|mesh-ancestor
65476954|NCT03908528|Micronutrients|micronutrients|mesh-ancestor
65476955|NCT03903458|Nivolumab|nivolumab|mesh-list
65476956|NCT03903458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65476957|NCT03903458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65476958|NCT03903458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65476959|NCT03903458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65476960|NCT00086502|Metformin|metformin|mesh-list
65476961|NCT00086502|Pioglitazone|pioglitazone|mesh-list
65476962|NCT00086502|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65476963|NCT00086502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65476965|NCT00086502|Incretins|incretins|mesh-ancestor
65476982|NCT03903302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65476983|NCT03636542|Bupivacaine|bupivacaine|mesh-list
65476984|NCT03636542|Anesthetics, Local|anesthetics, local|mesh-ancestor
65476985|NCT03636542|Anesthetics|anesthetics|mesh-ancestor
65476988|NCT03636542|Sensory System Agents|sensory system agents|mesh-ancestor
65477051|NCT01150448|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65477052|NCT01150448|Serotonin Agents|serotonin agents|mesh-ancestor
65477053|NCT01150448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65477054|NCT01150448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477126|NCT01149278|Benzocaine|benzocaine|mesh-list
65477127|NCT01149278|Anesthetics, Local|anesthetics, local|mesh-ancestor
65477128|NCT01149278|Anesthetics|anesthetics|mesh-ancestor
65477129|NCT01149278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65477130|NCT01149278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477131|NCT01149278|Sensory System Agents|sensory system agents|mesh-ancestor
65477132|NCT01149278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65477136|NCT03902522|Leronlimab|leronlimab|mesh-list
65477194|NCT01257464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65477195|NCT01257464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477196|NCT01257464|Incretins|incretins|mesh-ancestor
65477197|NCT01257464|Hormones|hormones|mesh-ancestor
65477198|NCT01257464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65477199|NCT01257464|Protease Inhibitors|protease inhibitors|mesh-ancestor
65477264|NCT03901118|Antimitotic Agents|antimitotic agents|mesh-ancestor
65477265|NCT03901118|Mitosis Modulators|mitosis modulators|mesh-ancestor
65477266|NCT03901118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477267|NCT03901118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65477335|NCT03905564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65477336|NCT03905564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477337|NCT01151384|Docetaxel|docetaxel|mesh-list
65477338|NCT01151384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477339|NCT01151384|Tubulin Modulators|tubulin modulators|mesh-ancestor
65477343|NCT01258010|Tranexamic Acid|tranexamic acid|mesh-list
65477403|NCT01149746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477404|NCT01149746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477405|NCT01149746|Urological Agents|urological agents|mesh-ancestor
65477406|NCT01149824|Salvinorin A|salvinorin a|mesh-list
65477473|NCT01255358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477474|NCT03899246|Capsaicin|capsaicin|mesh-list
65477475|NCT03899246|Antipruritics|antipruritics|mesh-ancestor
65477476|NCT03899246|Dermatologic Agents|dermatologic agents|mesh-ancestor
65477477|NCT03899246|Sensory System Agents|sensory system agents|mesh-ancestor
65477478|NCT03899246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65477479|NCT03899246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477480|NCT03893864|Ubiquinone|ubiquinone|mesh-list
65477541|NCT01258868|Analgesics|analgesics|mesh-ancestor
65477542|NCT01258868|Sensory System Agents|sensory system agents|mesh-ancestor
65477543|NCT01258868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65477544|NCT01258868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477560|NCT03892928|Propofol|propofol|mesh-list
65477611|NCT03892148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65477612|NCT03892148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477613|NCT03892148|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65477615|NCT01152476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65477616|NCT01152476|Narcotics|narcotics|mesh-ancestor
65477617|NCT01152476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65477618|NCT01152476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477619|NCT01152476|Analgesics|analgesics|mesh-ancestor
65477620|NCT01152476|Sensory System Agents|sensory system agents|mesh-ancestor
65477621|NCT01152476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65477622|NCT03892070|Mannitol|mannitol|mesh-list
65477623|NCT03892070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65477624|NCT03892070|Diuretics|diuretics|mesh-ancestor
65477625|NCT03892070|Natriuretic Agents|natriuretic agents|mesh-ancestor
65477627|NCT01155440|Lidocaine|lidocaine|mesh-list
65477669|NCT04480372|Gemcitabine|gemcitabine|mesh-list
65477670|NCT04480372|Atezolizumab|atezolizumab|mesh-list
65477671|NCT04480372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65477672|NCT04480372|Antimetabolites|antimetabolites|mesh-ancestor
65477673|NCT04480372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477674|NCT04480372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477675|NCT04480372|Antiviral Agents|antiviral agents|mesh-ancestor
65477676|NCT04480372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65477677|NCT04480372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477737|NCT01153802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65477738|NCT01153802|Serotonin Agents|serotonin agents|mesh-ancestor
65477739|NCT01153100|Insulin Glargine|insulin glargine|mesh-list
65477740|NCT01153100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65477741|NCT01153100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477742|NCT01153256|Magnesium Sulfate|magnesium sulfate|mesh-list
65477743|NCT01153256|Analgesics|analgesics|mesh-ancestor
65477744|NCT01153256|Sensory System Agents|sensory system agents|mesh-ancestor
65477745|NCT01153256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65477746|NCT01153256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477747|NCT01153256|Anesthetics|anesthetics|mesh-ancestor
65477748|NCT01153256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65477749|NCT01153256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65477750|NCT01153256|Anticonvulsants|anticonvulsants|mesh-ancestor
65477751|NCT01153256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65477752|NCT01153256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65477753|NCT01153256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477754|NCT01153256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65477755|NCT01153256|Tocolytic Agents|tocolytic agents|mesh-ancestor
65477756|NCT01153256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65477757|NCT01153334|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65477758|NCT01153334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65477788|NCT01154114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477789|NCT01154114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477790|NCT01157312|Citric Acid|citric acid|mesh-list
65477791|NCT01157312|Sodium Citrate|sodium citrate|mesh-list
65477792|NCT01157312|Clomiphene|clomiphene|mesh-list
65477793|NCT01157312|Enclomiphene|enclomiphene|mesh-list
65477794|NCT01157312|Zuclomiphene|zuclomiphene|mesh-list
65477795|NCT01157312|Anticoagulants|anticoagulants|mesh-ancestor
65477856|NCT03884348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65477857|NCT03884348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65477858|NCT03884348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65477859|NCT03884348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65477860|NCT03884348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65477861|NCT03884348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477862|NCT03884348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65477863|NCT03884348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65477921|NCT03298984|Daunorubicin|daunorubicin|mesh-list
65477922|NCT03298984|Alvocidib|alvocidib|mesh-list
65477923|NCT03298984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65477924|NCT03298984|Antimetabolites|antimetabolites|mesh-ancestor
65477925|NCT03298984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477926|NCT03298984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65477927|NCT03298984|Antiviral Agents|antiviral agents|mesh-ancestor
65477928|NCT03298984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65477929|NCT03298984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65477940|NCT03883880|Capsaicin|capsaicin|mesh-list
65477987|NCT01157936|Gout Suppressants|gout suppressants|mesh-ancestor
65477988|NCT01157936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65477989|NCT01157936|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65477990|NCT01157936|Antioxidants|antioxidants|mesh-ancestor
65477991|NCT01157936|Protective Agents|protective agents|mesh-ancestor
65477992|NCT01157936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65477993|NCT01264484|Imidacloprid|imidacloprid|mesh-list
65477994|NCT01264484|Cholinergic Agents|cholinergic agents|mesh-ancestor
65477995|NCT01264484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65477996|NCT01264484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65477998|NCT01260818|Tranexamic Acid|tranexamic acid|mesh-list
65478052|NCT01155986|Anesthetics|anesthetics|mesh-ancestor
65478053|NCT01155986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65478054|NCT01155986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478055|NCT01155986|Sensory System Agents|sensory system agents|mesh-ancestor
65227576|NCT02865668|Metformin|metformin|mesh-list
65478056|NCT01155986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65478119|NCT03879590|Hormones|hormones|mesh-ancestor
65478194|NCT03879356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65478195|NCT03879356|Antioxidants|antioxidants|mesh-ancestor
65478196|NCT03879356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478197|NCT03879356|Protective Agents|protective agents|mesh-ancestor
65478198|NCT03879356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478199|NCT03879356|Antidotes|antidotes|mesh-ancestor
65478200|NCT01159418|Paclitaxel|paclitaxel|mesh-list
65478201|NCT01159418|Carboplatin|carboplatin|mesh-list
65478202|NCT01159418|Panobinostat|panobinostat|mesh-list
65478205|NCT01159418|Tubulin Modulators|tubulin modulators|mesh-ancestor
65478258|NCT01265576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65478259|NCT01265576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65478260|NCT01265576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65478261|NCT01265576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65478262|NCT03883022|Vancomycin|vancomycin|mesh-list
65478263|NCT03883022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65478264|NCT03883022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65478265|NCT01159652|Zaleplon|zaleplon|mesh-list
65478266|NCT01159652|Zolpidem|zolpidem|mesh-list
65478325|NCT01155206|Incretins|incretins|mesh-ancestor
65478326|NCT03879278|Immunoglobulins|immunoglobulins|mesh-list
65478327|NCT03879278|Immunoglobulin G|immunoglobulin g|mesh-list
65478328|NCT03879278|Immunologic Factors|immunologic factors|mesh-ancestor
65478329|NCT03879278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478330|NCT03878888|Bupivacaine|bupivacaine|mesh-list
65478331|NCT03878888|Anesthetics, Local|anesthetics, local|mesh-ancestor
65478332|NCT03878888|Anesthetics|anesthetics|mesh-ancestor
65478333|NCT03878888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65478334|NCT03878888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478335|NCT03878888|Sensory System Agents|sensory system agents|mesh-ancestor
65478336|NCT03878888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65478337|NCT03882710|Metoprolol|metoprolol|mesh-list
65478338|NCT03882710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65478339|NCT03882710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65478340|NCT03882710|Sympatholytics|sympatholytics|mesh-ancestor
65478384|NCT03882788|Anesthetics|anesthetics|mesh-ancestor
65478385|NCT03882788|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65478386|NCT01156688|Misoprostol|misoprostol|mesh-list
65478387|NCT01156688|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65478458|NCT03877718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65478459|NCT03877718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478460|NCT03877718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478461|NCT03877718|Antipruritics|antipruritics|mesh-ancestor
65478462|NCT03877718|Dermatologic Agents|dermatologic agents|mesh-ancestor
65478528|NCT01267214|Protective Agents|protective agents|mesh-ancestor
65478529|NCT01156922|Rituximab|rituximab|mesh-list
65478600|NCT01160900|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65478601|NCT01160900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65478602|NCT01160900|Antithrombins|antithrombins|mesh-ancestor
65478603|NCT01160900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65478604|NCT01160900|Protease Inhibitors|protease inhibitors|mesh-ancestor
65478605|NCT01160900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478606|NCT01160900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478607|NCT01160900|Anticoagulants|anticoagulants|mesh-ancestor
65478608|NCT01160978|Simvastatin|simvastatin|mesh-list
65478609|NCT01160978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65478610|NCT01160978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65478611|NCT01160978|Antimetabolites|antimetabolites|mesh-ancestor
65478612|NCT01160978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478616|NCT01161134|Meloxicam|meloxicam|mesh-list
65478660|NCT01269476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478661|NCT01269476|Cholinergic Agents|cholinergic agents|mesh-ancestor
65478662|NCT01269476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65478663|NCT01267604|Inositol|inositol|mesh-list
65478664|NCT01267604|Melatonin|melatonin|mesh-list
65478665|NCT01267604|Antioxidants|antioxidants|mesh-ancestor
65478666|NCT01267604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478667|NCT01267604|Protective Agents|protective agents|mesh-ancestor
65478668|NCT01267604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478669|NCT01267604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65478670|NCT01267604|Vitamin B Complex|vitamin b complex|mesh-ancestor
65478671|NCT01267604|Vitamins|vitamins|mesh-ancestor
65478672|NCT01267604|Micronutrients|micronutrients|mesh-ancestor
65478673|NCT01161368|Vinorelbine|vinorelbine|mesh-list
65478674|NCT01161368|Lapatinib|lapatinib|mesh-list
65478675|NCT01161368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65478718|NCT03874364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478719|NCT01163396|Leucovorin|leucovorin|mesh-list
65478720|NCT01163396|Bevacizumab|bevacizumab|mesh-list
65478721|NCT01163396|Fluorouracil|fluorouracil|mesh-list
65478722|NCT01163396|Oxaliplatin|oxaliplatin|mesh-list
65478723|NCT01163396|Irinotecan|irinotecan|mesh-list
65478724|NCT01163396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65228246|NCT00726973|Growth Substances|growth substances|mesh-ancestor
65478784|NCT01269866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65478785|NCT01269866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65478786|NCT01269866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65478787|NCT01269866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478788|NCT01269866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65478789|NCT01269866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478852|NCT00368537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65478853|NCT00368537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65478854|NCT00368537|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65478855|NCT01165580|Valganciclovir|valganciclovir|mesh-list
65478856|NCT01165580|Antiviral Agents|antiviral agents|mesh-ancestor
65478857|NCT01165580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65478858|NCT01048619|ON 01910|on 01910|mesh-list
65478919|NCT01167920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65478920|NCT03873974|Immunoglobulin G|immunoglobulin g|mesh-list
65478921|NCT03873974|Immunoglobulin M|immunoglobulin m|mesh-list
65478922|NCT03873974|Immunologic Factors|immunologic factors|mesh-ancestor
65478923|NCT03873974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478924|NCT01268930|Hemostatics|hemostatics|mesh-list
65478925|NCT01268930|Coagulants|coagulants|mesh-ancestor
65478926|NCT02526758|Budesonide|budesonide|mesh-list
65478927|NCT02526758|Beclomethasone|beclomethasone|mesh-list
65478928|NCT02526758|Formoterol Fumarate|formoterol fumarate|mesh-list
65478929|NCT02526758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65478985|NCT01168544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65478986|NCT00368069|Levetiracetam|levetiracetam|mesh-list
65478987|NCT00368069|Anticonvulsants|anticonvulsants|mesh-ancestor
65478988|NCT00368069|Nootropic Agents|nootropic agents|mesh-ancestor
65478989|NCT01165814|Naproxen|naproxen|mesh-list
65478990|NCT01165814|Tramadol|tramadol|mesh-list
65478991|NCT01165814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65478992|NCT01165814|Narcotics|narcotics|mesh-ancestor
65478993|NCT01165814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65478994|NCT01165814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65478995|NCT01165814|Analgesics|analgesics|mesh-ancestor
65478996|NCT01165814|Sensory System Agents|sensory system agents|mesh-ancestor
65478997|NCT01165814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65478998|NCT01165814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65478999|NCT01165814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65479000|NCT01165814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65479001|NCT01165814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65479002|NCT01165814|Gout Suppressants|gout suppressants|mesh-ancestor
65479003|NCT01165814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65479004|NCT01165814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479005|NCT01165814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479006|NCT00367991|Epoetin Alfa|epoetin alfa|mesh-list
65479007|NCT00367991|Hematinics|hematinics|mesh-ancestor
65479037|NCT01169012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479038|NCT01169012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65479039|NCT01169090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65479040|NCT01169090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65479041|NCT01169090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479042|NCT01169090|Incretins|incretins|mesh-ancestor
65479043|NCT01169090|Hormones|hormones|mesh-ancestor
65479044|NCT01169090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65479045|NCT01169090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65479046|NCT01169090|Protease Inhibitors|protease inhibitors|mesh-ancestor
65479047|NCT01169090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479048|NCT01169090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479049|NCT01282502|Midostaurin|midostaurin|mesh-list
65479050|NCT01282502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65479051|NCT01282502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65479052|NCT01282502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479053|NCT01282502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479054|NCT01269242|Bindarit|bindarit|mesh-list
65479055|NCT01269242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65479056|NCT01269242|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65479057|NCT01269242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479058|NCT01269242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479059|NCT01169792|Tamoxifen|tamoxifen|mesh-list
65479060|NCT01169792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65479061|NCT01169792|Hormone Antagonists|hormone antagonists|mesh-ancestor
65479062|NCT01169792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65479063|NCT01169792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479064|NCT01169792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65479065|NCT01169792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65479066|NCT01169792|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65479067|NCT01169792|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65479068|NCT01169792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65479069|NCT01169402|Fluconazole|fluconazole|mesh-list
65479070|NCT01169402|Antifungal Agents|antifungal agents|mesh-ancestor
64713799|NCT00364286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64713800|NCT00364286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479071|NCT01169402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65479072|NCT01169402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65479073|NCT01169402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65479074|NCT01169402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479075|NCT01169402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479076|NCT01169402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65479077|NCT01169402|Hormone Antagonists|hormone antagonists|mesh-ancestor
65479078|NCT01169402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65479079|NCT01169402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479080|NCT01169402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65479081|NCT01169402|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65479082|NCT01274780|Ritonavir|ritonavir|mesh-list
65479083|NCT01274780|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65479084|NCT01274780|Darunavir|darunavir|mesh-list
65479085|NCT01274780|Tenofovir|tenofovir|mesh-list
65479086|NCT01274780|Emtricitabine|emtricitabine|mesh-list
65479087|NCT01274780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65479088|NCT01274780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65479089|NCT01274780|Protease Inhibitors|protease inhibitors|mesh-ancestor
65479090|NCT01274780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479091|NCT01274780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479092|NCT01274780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65479093|NCT01274780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65479094|NCT01274780|Antiviral Agents|antiviral agents|mesh-ancestor
65479095|NCT01274780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65479096|NCT01274780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65479097|NCT01274780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65479098|NCT01274780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65479099|NCT01274780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64713801|NCT00364286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713805|NCT00329043|Sunitinib|sunitinib|mesh-list
64713806|NCT00329043|Leuprolide|leuprolide|mesh-list
64713812|NCT00329043|Growth Inhibitors|growth inhibitors|mesh-ancestor
64713813|NCT00329043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64713814|NCT00329043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64713815|NCT00329043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713816|NCT00329043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64713817|NCT00329043|Fertility Agents|fertility agents|mesh-ancestor
64713818|NCT00329043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64713819|NCT00329043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64713820|NCT00255346|Dasatinib|dasatinib|mesh-list
64713821|NCT00255346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65479101|NCT01169870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65479102|NCT01169870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65479103|NCT01169870|Tubulin Modulators|tubulin modulators|mesh-ancestor
65479104|NCT01169870|Antimitotic Agents|antimitotic agents|mesh-ancestor
65479105|NCT01169870|Mitosis Modulators|mitosis modulators|mesh-ancestor
65479106|NCT01169870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479107|NCT01165970|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65479108|NCT01165970|Laxatives|laxatives|mesh-ancestor
65479109|NCT01165970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65479110|NCT01166048|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65479111|NCT01166048|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65479112|NCT01166048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65479113|NCT01166048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65479114|NCT01166048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479115|NCT01166048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65479116|NCT01166048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479117|NCT01166048|Analgesics|analgesics|mesh-ancestor
64721005|NCT00002306|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64721006|NCT00002306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64721007|NCT00002306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721008|NCT00002306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721009|NCT00002306|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64721010|NCT00002306|Hormone Antagonists|hormone antagonists|mesh-ancestor
64713822|NCT00255346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64713823|NCT00255346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64713824|NCT00255346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713958|NCT00001337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64713959|NCT00001247|Sirolimus|sirolimus|mesh-list
64713960|NCT00001247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64713961|NCT00001247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64713962|NCT00001247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64713963|NCT00001247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713964|NCT00001247|Antifungal Agents|antifungal agents|mesh-ancestor
64713965|NCT00001247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64713966|NCT00001247|Immunologic Factors|immunologic factors|mesh-ancestor
64713967|NCT00001247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439554|NCT01939899|Ixazomib|ixazomib|mesh-list
64439703|NCT01938573|Antiviral Agents|antiviral agents|mesh-ancestor
64440228|NCT02254291|Hormones|hormones|mesh-ancestor
64440465|NCT02308046|Terconazole|terconazole|mesh-list
64440531|NCT02279732|Paclitaxel|paclitaxel|mesh-list
64721091|NCT00001628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
64721092|NCT00001628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64721093|NCT00001628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64721094|NCT00001628|Protease Inhibitors|protease inhibitors|mesh-ancestor
64721095|NCT00001628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328955|NCT00151411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328956|NCT04471441|Mycophenolic Acid|mycophenolic acid|mesh-list
64328957|NCT04471441|Everolimus|everolimus|mesh-list
64328958|NCT04471441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64328959|NCT04471441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64328960|NCT04471441|Immunologic Factors|immunologic factors|mesh-ancestor
64328961|NCT04471441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328962|NCT04471441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64328965|NCT04471441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65479118|NCT01166048|Sensory System Agents|sensory system agents|mesh-ancestor
65479119|NCT01166048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65479120|NCT01166048|Antidepressive Agents|antidepressive agents|mesh-ancestor
65479121|NCT01166048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65479122|NCT01166048|Dopamine Agents|dopamine agents|mesh-ancestor
65479123|NCT03869762|Denosumab|denosumab|mesh-list
65479124|NCT03869762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65479125|NCT03869762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479126|NCT01283126|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65479127|NCT01283126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479128|NCT01283048|Bevacizumab|bevacizumab|mesh-list
65479129|NCT01283048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65479130|NCT01283048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65479131|NCT01283048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65479132|NCT01283048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65479133|NCT01283048|Growth Substances|growth substances|mesh-ancestor
65479134|NCT01283048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328966|NCT04471441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64328967|NCT04471441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721104|NCT00002234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64721105|NCT00002234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721106|NCT00002234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328968|NCT04471441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328969|NCT02662569|Atorvastatin|atorvastatin|mesh-list
64328970|NCT02662569|Evolocumab|evolocumab|mesh-list
64328971|NCT02662569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64328972|NCT02662569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64328973|NCT02662569|Antimetabolites|antimetabolites|mesh-ancestor
64328974|NCT02662569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328975|NCT02662569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64328976|NCT02662569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64328977|NCT02662569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328978|NCT02178137|Zinc Sulfate|zinc sulfate|mesh-list
64443305|NCT00119366|Trace Elements|trace elements|mesh-ancestor
64443904|NCT01688830|Antithrombins|antithrombins|mesh-ancestor
64444585|NCT05381597|Fluorouracil|fluorouracil|mesh-list
64444666|NCT02227784|Atorvastatin|atorvastatin|mesh-list
64444736|NCT02193776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64445503|NCT04104646|Morphine|morphine|mesh-list
64445873|NCT01536262|Olodaterol|olodaterol|mesh-list
64446172|NCT02217566|Hormones|hormones|mesh-ancestor
64446333|NCT01920477|Ofatumumab|ofatumumab|mesh-list
64446547|NCT01570192|Amikacin|amikacin|mesh-list
64446621|NCT01552408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64446844|NCT01544920|Ribavirin|ribavirin|mesh-list
64447092|NCT01463098|Zolpidem|zolpidem|mesh-list
64447150|NCT01485640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64447223|NCT01462318|Vitamin K|vitamin k|mesh-list
64447375|NCT02147132|Nicotine|nicotine|mesh-list
64447456|NCT04748042|Prednisone|prednisone|mesh-list
64447827|NCT02121002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64721107|NCT00002234|Antiviral Agents|antiviral agents|mesh-ancestor
64721108|NCT00002234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721109|NCT00002234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64721110|NCT00002234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64721111|NCT00002234|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64721112|NCT00002234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64721113|NCT00002234|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64721114|NCT00002234|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65479135|NCT01283048|Growth Inhibitors|growth inhibitors|mesh-ancestor
65479136|NCT03873740|Vaccines|vaccines|mesh-list
65479137|NCT03873740|Immunologic Factors|immunologic factors|mesh-ancestor
65479138|NCT03873740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479139|NCT01172756|Riociguat|riociguat|mesh-list
65479140|NCT01172756|Enzyme Activators|enzyme activators|mesh-ancestor
65479141|NCT01172756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479142|NCT02525822|Tazarotene|tazarotene|mesh-list
65479143|NCT02525822|Dermatologic Agents|dermatologic agents|mesh-ancestor
65479144|NCT02525822|Keratolytic Agents|keratolytic agents|mesh-ancestor
65479145|NCT01172912|Dexamethasone|dexamethasone|mesh-list
65479146|NCT01172912|Carboplatin|carboplatin|mesh-list
65479147|NCT01172912|Etoposide|etoposide|mesh-list
65479148|NCT01172912|Ifosfamide|ifosfamide|mesh-list
65479149|NCT01172912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65479150|NCT01172912|Antiemetics|antiemetics|mesh-ancestor
65479151|NCT01172912|Autonomic Agents|autonomic agents|mesh-ancestor
65479152|NCT01172912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65479153|NCT01172912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479154|NCT01172912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65479155|NCT01172912|Glucocorticoids|glucocorticoids|mesh-ancestor
65479156|NCT01172912|Hormones|hormones|mesh-ancestor
65479157|NCT01172912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65479158|NCT01172912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65479159|NCT01172912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65479160|NCT01172912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65479161|NCT01172912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65479162|NCT01172912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65479163|NCT01172912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479164|NCT01172912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721115|NCT00002234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64721116|NCT00002234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64721117|NCT00002234|Antimetabolites|antimetabolites|mesh-ancestor
64721119|NCT04070287|Immunoglobulins|immunoglobulins|mesh-list
64721120|NCT04070287|Immunologic Factors|immunologic factors|mesh-ancestor
64721121|NCT04070287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721122|NCT00002324|Zidovudine|zidovudine|mesh-list
64721123|NCT00002324|Nevirapine|nevirapine|mesh-list
64721124|NCT00002324|Antimetabolites|antimetabolites|mesh-ancestor
64721125|NCT00002324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721126|NCT00002324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64721127|NCT00002324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64721128|NCT00002324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721129|NCT00002324|Antiviral Agents|antiviral agents|mesh-ancestor
64721130|NCT00002324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721131|NCT00002324|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65479165|NCT01172912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65479166|NCT01172912|Alkylating Agents|alkylating agents|mesh-ancestor
65479167|NCT01283204|Leucovorin|leucovorin|mesh-list
65479168|NCT01283204|Paclitaxel|paclitaxel|mesh-list
65479169|NCT01283204|Docetaxel|docetaxel|mesh-list
65479170|NCT01283204|Cisplatin|cisplatin|mesh-list
65479171|NCT01283204|Oxaliplatin|oxaliplatin|mesh-list
65479172|NCT01283204|Levoleucovorin|levoleucovorin|mesh-list
65479173|NCT01283204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65479174|NCT01283204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65479175|NCT01283204|Tubulin Modulators|tubulin modulators|mesh-ancestor
65479176|NCT01283204|Antimitotic Agents|antimitotic agents|mesh-ancestor
65479177|NCT01283204|Mitosis Modulators|mitosis modulators|mesh-ancestor
65479178|NCT01283204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479179|NCT01283204|Antidotes|antidotes|mesh-ancestor
65479180|NCT01283204|Protective Agents|protective agents|mesh-ancestor
65479181|NCT01283204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479182|NCT01283204|Vitamin B Complex|vitamin b complex|mesh-ancestor
65479183|NCT01283204|Vitamins|vitamins|mesh-ancestor
65479184|NCT01283204|Micronutrients|micronutrients|mesh-ancestor
65479185|NCT03869528|Lidocaine|lidocaine|mesh-list
65479186|NCT03869528|Anesthetics, Local|anesthetics, local|mesh-ancestor
65479187|NCT03869528|Anesthetics|anesthetics|mesh-ancestor
65479188|NCT03869528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65479189|NCT03869528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479190|NCT03869528|Sensory System Agents|sensory system agents|mesh-ancestor
65479191|NCT03869528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65479192|NCT03869528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65479193|NCT03869528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65479194|NCT03869528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64721132|NCT00002324|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64328979|NCT02178137|Astringents|astringents|mesh-ancestor
64328980|NCT02178137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721133|NCT00002324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64721134|NCT00002324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64721135|NCT00002330|Ganciclovir|ganciclovir|mesh-list
64721136|NCT00002330|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64721137|NCT00002330|Antiviral Agents|antiviral agents|mesh-ancestor
64721138|NCT00002330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721139|NCT00002330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64721140|NCT00002330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329009|NCT02287129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329010|NCT02287129|Tubulin Modulators|tubulin modulators|mesh-ancestor
64329011|NCT02287129|Antimitotic Agents|antimitotic agents|mesh-ancestor
64329012|NCT02287129|Mitosis Modulators|mitosis modulators|mesh-ancestor
64329013|NCT02287129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329014|NCT02287129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65479195|NCT03869528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65479196|NCT03869528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479197|NCT01283360|Tenofovir|tenofovir|mesh-list
65479198|NCT01283360|Antiviral Agents|antiviral agents|mesh-ancestor
65479199|NCT01283360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65479200|NCT01283360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65479201|NCT01283360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65479202|NCT01283360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479203|NCT01283360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479204|NCT01283360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65479205|NCT01283360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65479206|NCT01173068|Ertapenem|ertapenem|mesh-list
65479207|NCT01173068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65479208|NCT01173068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65479209|NCT03267940|Atezolizumab|atezolizumab|mesh-list
65479210|NCT03267940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65479211|NCT01284452|Hydrocortisone|hydrocortisone|mesh-list
65479212|NCT01284452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65479213|NCT01170104|Sorafenib|sorafenib|mesh-list
65479214|NCT01170104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863282|NCT01769651|Analgesics|analgesics|mesh-ancestor
64448051|NCT01893411|Cholinergic Agents|cholinergic agents|mesh-ancestor
64448821|NCT02248961|Losartan|losartan|mesh-list
64448879|NCT01479868|Ribavirin|ribavirin|mesh-list
64448951|NCT01494532|Ropinirole|ropinirole|mesh-list
64449780|NCT02159807|Narcotics|narcotics|mesh-ancestor
64450306|NCT01853475|Artefenomel|artefenomel|mesh-list
64494783|NCT02189122|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64494784|NCT02189122|Protease Inhibitors|protease inhibitors|mesh-ancestor
64494785|NCT05309460|Labetalol|labetalol|mesh-list
64494786|NCT05309460|Nifedipine|nifedipine|mesh-list
64494787|NCT05309460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64494788|NCT05309460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64494789|NCT05309460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416922|NCT03036085|Mydriatics|mydriatics|mesh-ancestor
64494797|NCT05309460|Adrenergic Agents|adrenergic agents|mesh-ancestor
64494798|NCT05309460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64494799|NCT05309460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64494800|NCT05309460|Sympathomimetics|sympathomimetics|mesh-ancestor
64494801|NCT05309460|Autonomic Agents|autonomic agents|mesh-ancestor
64494802|NCT05309460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64494803|NCT05309460|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64494804|NCT05309460|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64494806|NCT01093690|Antiemetics|antiemetics|mesh-ancestor
64494807|NCT01093690|Autonomic Agents|autonomic agents|mesh-ancestor
64494808|NCT01093690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64494809|NCT01093690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494810|NCT01093690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64494811|NCT01093690|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64494812|NCT01093690|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64494813|NCT01093690|Dopamine Agents|dopamine agents|mesh-ancestor
64494814|NCT01093690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64494815|NCT01093690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494816|NCT01143688|Albuterol|albuterol|mesh-list
64494817|NCT01143688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64494818|NCT01143688|Autonomic Agents|autonomic agents|mesh-ancestor
65479215|NCT01170104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65479216|NCT01170104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479217|NCT01170104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479218|NCT01284764|Mosapride|mosapride|mesh-list
65479219|NCT01284764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65479220|NCT01284764|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65479221|NCT01284764|Serotonin Agents|serotonin agents|mesh-ancestor
65479222|NCT01284764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65479223|NCT01284764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479224|NCT01284764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479225|NCT01170182|Omeprazole|omeprazole|mesh-list
65479226|NCT01170182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65479227|NCT01170182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65479228|NCT01170182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65479229|NCT01170182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479230|NCT01170182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479231|NCT01170260|Ethanol|ethanol|mesh-list
65479232|NCT01170260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65479233|NCT01170260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65479234|NCT01170260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65479235|NCT01170260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479236|NCT00312377|Docetaxel|docetaxel|mesh-list
65479237|NCT00312377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65479238|NCT00312377|Tubulin Modulators|tubulin modulators|mesh-ancestor
64494819|NCT01143688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64494820|NCT01143688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494821|NCT01143688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64494822|NCT01143688|Respiratory System Agents|respiratory system agents|mesh-ancestor
64721141|NCT00002330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721142|NCT03740659|Levofloxacin|levofloxacin|mesh-list
64721143|NCT03740659|Ofloxacin|ofloxacin|mesh-list
64721144|NCT03740659|Dexamethasone|dexamethasone|mesh-list
64721145|NCT03740659|Dexamethasone acetate|dexamethasone acetate|mesh-list
64721146|NCT03740659|BB 1101|bb 1101|mesh-list
64721147|NCT03740659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64721148|NCT03740659|Antiemetics|antiemetics|mesh-ancestor
64721149|NCT03740659|Autonomic Agents|autonomic agents|mesh-ancestor
64329015|NCT02287129|Antimetabolites|antimetabolites|mesh-ancestor
64329016|NCT02287129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64329017|NCT02287129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64329018|NCT02287129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64329019|NCT02287129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329020|NCT02256683|Dabigatran|dabigatran|mesh-list
64329021|NCT02256683|Phenprocoumon|phenprocoumon|mesh-list
64329022|NCT02256683|Antithrombins|antithrombins|mesh-ancestor
64494823|NCT01143688|Tocolytic Agents|tocolytic agents|mesh-ancestor
64494824|NCT01143688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64494825|NCT01143688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64494826|NCT01143688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64494827|NCT01143688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64494828|NCT01143688|Adrenergic Agents|adrenergic agents|mesh-ancestor
65479239|NCT00312377|Antimitotic Agents|antimitotic agents|mesh-ancestor
65479240|NCT00312377|Mitosis Modulators|mitosis modulators|mesh-ancestor
65479241|NCT00312377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479242|NCT01173536|Moxifloxacin|moxifloxacin|mesh-list
65479243|NCT01173536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65479244|NCT01173536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65479245|NCT01173536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65479246|NCT01173536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65479247|NCT01173536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479248|NCT01173536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479249|NCT01173536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65479250|NCT01580891|Naftifine|naftifine|mesh-list
65479251|NCT01580891|Antifungal Agents|antifungal agents|mesh-ancestor
65479252|NCT01580891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65479253|NCT01059383|Esomeprazole|esomeprazole|mesh-list
65479254|NCT01059383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65479255|NCT01059383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65479256|NCT01059383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65479257|NCT01059383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479258|NCT01059383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479259|NCT01285232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65479260|NCT01285232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65479261|NCT01166594|Bevacizumab|bevacizumab|mesh-list
64863347|NCT01769820|Hormones|hormones|mesh-ancestor
64494829|NCT01143688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64494830|NCT01143688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494831|NCT04455594|Carboplatin|carboplatin|mesh-list
64494832|NCT04455594|Pemetrexed|pemetrexed|mesh-list
64494833|NCT04455594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64494834|NCT04455594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494835|NCT04455594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494836|NCT04455594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494837|NCT04455594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64494838|NCT04455594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64494839|NCT04455594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64494840|NCT01143766|Gabapentin|gabapentin|mesh-list
64494863|NCT03011476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494864|NCT03011476|Cholinergic Agents|cholinergic agents|mesh-ancestor
64494865|NCT03011476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64494866|NCT03011476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494868|NCT02522754|Vaccines|vaccines|mesh-list
64494869|NCT02522754|Immunologic Factors|immunologic factors|mesh-ancestor
64494870|NCT02522754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494871|NCT01188694|Methylene Blue|methylene blue|mesh-list
64494872|NCT01188694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494873|NCT01188694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494874|NCT01188928|Betamethasone|betamethasone|mesh-list
64494875|NCT01188928|Betamethasone Valerate|betamethasone valerate|mesh-list
64494876|NCT01188928|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64494877|NCT01188928|Betamethasone benzoate|betamethasone benzoate|mesh-list
64494878|NCT01188928|Calcipotriene|calcipotriene|mesh-list
65479262|NCT01166594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65479263|NCT01166594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65479264|NCT01166594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65479265|NCT01166594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65479266|NCT01166594|Growth Substances|growth substances|mesh-ancestor
65479267|NCT01166594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479268|NCT01166594|Growth Inhibitors|growth inhibitors|mesh-ancestor
65479269|NCT01170338|Varenicline|varenicline|mesh-list
65479270|NCT01170338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65479271|NCT01170338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65479272|NCT01170338|Cholinergic Agents|cholinergic agents|mesh-ancestor
65479273|NCT01170338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65479274|NCT01170338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479275|NCT01170338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479276|NCT00312221|Oxycodone|oxycodone|mesh-list
65479277|NCT00312221|Buprenorphine|buprenorphine|mesh-list
65479278|NCT00312221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65479279|NCT00312221|Narcotics|narcotics|mesh-ancestor
65479280|NCT00312221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65479281|NCT00312221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479282|NCT00312221|Analgesics|analgesics|mesh-ancestor
64863349|NCT01769820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64494879|NCT01188928|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64494880|NCT01188928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64494881|NCT01188928|Glucocorticoids|glucocorticoids|mesh-ancestor
64494882|NCT01188928|Hormones|hormones|mesh-ancestor
64494883|NCT01188928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64329026|NCT02256683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329028|NCT00411385|Interferons|interferons|mesh-list
64329029|NCT00411385|Ribavirin|ribavirin|mesh-list
64329030|NCT00411385|Interferon-alpha|interferon-alpha|mesh-list
64329031|NCT00411385|Interferon alpha-2|interferon alpha-2|mesh-list
64329032|NCT00411385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64494884|NCT01188928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494885|NCT01188928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64494886|NCT01188928|Respiratory System Agents|respiratory system agents|mesh-ancestor
64494887|NCT01188928|Dermatologic Agents|dermatologic agents|mesh-ancestor
64494888|NCT05438706|Carboplatin|carboplatin|mesh-list
64494889|NCT05438706|Capecitabine|capecitabine|mesh-list
64721168|NCT03740659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64721169|NCT00002336|Clarithromycin|clarithromycin|mesh-list
64329033|NCT00411385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329034|NCT00411385|Antiviral Agents|antiviral agents|mesh-ancestor
64329035|NCT00411385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64329036|NCT00411385|Antimetabolites|antimetabolites|mesh-ancestor
64329037|NCT00411385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494890|NCT05438706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494891|NCT05438706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64494892|NCT05438706|Antimetabolites|antimetabolites|mesh-ancestor
64494893|NCT05438706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494894|NCT01189240|Bevacizumab|bevacizumab|mesh-list
64494895|NCT01189240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64494896|NCT01189240|Antibodies|antibodies|mesh-list
65479283|NCT00312221|Sensory System Agents|sensory system agents|mesh-ancestor
65479284|NCT00312221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65479285|NCT00312221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65479286|NCT03872570|Phenylephrine|phenylephrine|mesh-list
65479287|NCT03872570|Oxymetazoline|oxymetazoline|mesh-list
65479288|NCT03872570|Norepinephrine|norepinephrine|mesh-list
65479289|NCT03872570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65479290|NCT03872570|Mydriatics|mydriatics|mesh-ancestor
65479291|NCT03872570|Autonomic Agents|autonomic agents|mesh-ancestor
65479292|NCT03872570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65479293|NCT03872570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479294|NCT03872570|Sympathomimetics|sympathomimetics|mesh-ancestor
65479295|NCT03872570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65479296|NCT03872570|Nasal Decongestants|nasal decongestants|mesh-ancestor
65479297|NCT03872570|Respiratory System Agents|respiratory system agents|mesh-ancestor
65479298|NCT03872570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65479299|NCT03872570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65479300|NCT03872570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65479301|NCT03872570|Adrenergic Agents|adrenergic agents|mesh-ancestor
65479302|NCT03872570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65479303|NCT03872570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479304|NCT03872570|Protective Agents|protective agents|mesh-ancestor
65479305|NCT01173926|Insulin|insulin|mesh-list
65479306|NCT01173926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65479307|NCT01173926|Insulin Aspart|insulin aspart|mesh-list
65479308|NCT01173926|Insulin, Long-Acting|insulin, long-acting|mesh-list
65479309|NCT01173926|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65479310|NCT01173926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65479311|NCT01173926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494897|NCT01189240|Immunoglobulins|immunoglobulins|mesh-list
64494908|NCT01189240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494910|NCT03467334|Antifoaming Agents|antifoaming agents|mesh-ancestor
64494911|NCT03467334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494912|NCT03467334|Emollients|emollients|mesh-ancestor
64494913|NCT03467334|Dermatologic Agents|dermatologic agents|mesh-ancestor
64494914|NCT02874144|Mometasone Furoate|mometasone furoate|mesh-list
64494915|NCT02874144|Fluticasone|fluticasone|mesh-list
64494916|NCT02874144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64494917|NCT02874144|Dermatologic Agents|dermatologic agents|mesh-ancestor
64494918|NCT02874144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64494919|NCT02874144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64494920|NCT02874144|Autonomic Agents|autonomic agents|mesh-ancestor
64494921|NCT02874144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64494922|NCT02874144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417191|NCT02605837|Glucocorticoids|glucocorticoids|mesh-ancestor
64494923|NCT02874144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65479313|NCT03349268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65479314|NCT03349268|Anesthetics, General|anesthetics, general|mesh-ancestor
65479315|NCT03349268|Anesthetics|anesthetics|mesh-ancestor
65479316|NCT03349268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65479317|NCT03349268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479318|NCT01170494|Cholecalciferol|cholecalciferol|mesh-list
65479319|NCT01170494|Vitamin D|vitamin d|mesh-list
65479320|NCT01170494|Ergocalciferols|ergocalciferols|mesh-list
65479321|NCT01170494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65479322|NCT01170494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479323|NCT01170494|Vitamins|vitamins|mesh-ancestor
65479324|NCT01170494|Micronutrients|micronutrients|mesh-ancestor
65479325|NCT01170494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65479326|NCT01587326|Citalopram|citalopram|mesh-list
65479327|NCT01587326|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65479328|NCT01587326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65479329|NCT01587326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65479330|NCT01587326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479331|NCT01587326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65479332|NCT01587326|Serotonin Agents|serotonin agents|mesh-ancestor
65479333|NCT01587326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479334|NCT01587326|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64863397|NCT01769911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64494924|NCT02874144|Respiratory System Agents|respiratory system agents|mesh-ancestor
64494925|NCT03467178|Gemcitabine|gemcitabine|mesh-list
64494926|NCT03467178|Paclitaxel|paclitaxel|mesh-list
64494927|NCT03467178|Carboplatin|carboplatin|mesh-list
64494928|NCT03467178|Doxorubicin|doxorubicin|mesh-list
64494933|NCT03467178|Tubulin Modulators|tubulin modulators|mesh-ancestor
64494934|NCT03467178|Antimitotic Agents|antimitotic agents|mesh-ancestor
64494935|NCT03467178|Mitosis Modulators|mitosis modulators|mesh-ancestor
64494936|NCT03467178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494937|NCT03467178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64494938|NCT03467178|Antimetabolites|antimetabolites|mesh-ancestor
64494939|NCT03467178|Antiviral Agents|antiviral agents|mesh-ancestor
64494940|NCT03467178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64494941|NCT03467178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494942|NCT03467178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64494943|NCT03467178|Immunologic Factors|immunologic factors|mesh-ancestor
64494944|NCT03467178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494945|NCT03467178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64494946|NCT03467178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64494947|NCT03467178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64494949|NCT04722822|Immunologic Factors|immunologic factors|mesh-ancestor
64721178|NCT00001646|Amphotericin B|amphotericin b|mesh-list
64721179|NCT00001646|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64721180|NCT00001646|Antifungal Agents|antifungal agents|mesh-ancestor
64721181|NCT00001646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721182|NCT00001646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64721183|NCT00001646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64721184|NCT00001646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479335|NCT01587326|Antidepressive Agents|antidepressive agents|mesh-ancestor
65479336|NCT01587326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65479337|NCT03294538|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65479338|NCT03294538|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65479339|NCT03294538|Estradiol|estradiol|mesh-list
65479340|NCT03294538|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65479341|NCT03294538|Estrogens|estrogens|mesh-ancestor
65479342|NCT03294538|Hormones|hormones|mesh-ancestor
65479343|NCT03294538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65479344|NCT03294538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479345|NCT03294538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65479346|NCT03294538|Contraceptive Agents|contraceptive agents|mesh-ancestor
65479347|NCT03294538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65479348|NCT03294538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65479349|NCT03872336|Labetalol|labetalol|mesh-list
65479350|NCT03872336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65479351|NCT03872336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65479352|NCT03872336|Adrenergic Agents|adrenergic agents|mesh-ancestor
65479353|NCT03872336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65479354|NCT03872336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479355|NCT03872336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479356|NCT03872336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65479357|NCT03872336|Sympathomimetics|sympathomimetics|mesh-ancestor
65479358|NCT03872336|Autonomic Agents|autonomic agents|mesh-ancestor
65479359|NCT03872336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65479360|NCT03872336|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65479361|NCT03872336|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65479381|NCT02987530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65479382|NCT02987530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65479383|NCT03865550|Ketamine|ketamine|mesh-list
65479384|NCT03865550|Analgesics|analgesics|mesh-ancestor
65479385|NCT03865550|Sensory System Agents|sensory system agents|mesh-ancestor
65479386|NCT03865550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65479387|NCT03865550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479388|NCT03865550|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65479389|NCT03865550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65479390|NCT03865550|Anesthetics, General|anesthetics, general|mesh-ancestor
65479391|NCT03865550|Anesthetics|anesthetics|mesh-ancestor
65479392|NCT03865550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65479393|NCT03865550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65479394|NCT03865550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65479395|NCT03865550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65479396|NCT03865550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721185|NCT00001646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721186|NCT00001646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64721187|NCT00001646|Hormone Antagonists|hormone antagonists|mesh-ancestor
64721188|NCT00001646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64721189|NCT00001646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721190|NCT00001646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64329044|NCT02185547|Antidepressive Agents|antidepressive agents|mesh-ancestor
64329045|NCT02185547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64329046|NCT02185547|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64329047|NCT02185547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64329048|NCT02185547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64329049|NCT02185547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329050|NCT02185547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64329051|NCT02185547|Serotonin Agents|serotonin agents|mesh-ancestor
64329052|NCT02185547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329053|NCT02030483|Dexamethasone|dexamethasone|mesh-list
64329054|NCT02030483|Lenalidomide|lenalidomide|mesh-list
64329055|NCT02030483|Palbociclib|palbociclib|mesh-list
64329056|NCT02030483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64329057|NCT02030483|Antiemetics|antiemetics|mesh-ancestor
64494950|NCT04722822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494951|NCT02835534|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64494952|NCT02835534|Plasminogen|plasminogen|mesh-list
64494953|NCT02835534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64494954|NCT02835534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64494955|NCT02835534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494956|NCT02722200|Hydrocortisone|hydrocortisone|mesh-list
64494957|NCT02722200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64494958|NCT01094548|Cyclophosphamide|cyclophosphamide|mesh-list
64494959|NCT01094548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64494960|NCT01094548|Immunologic Factors|immunologic factors|mesh-ancestor
64494961|NCT01094548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494962|NCT01094548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64494978|NCT03461718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64721200|NCT00002252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64721201|NCT00002252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329058|NCT02030483|Autonomic Agents|autonomic agents|mesh-ancestor
64329059|NCT02030483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64329060|NCT02030483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479398|NCT02965690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65479399|NCT02965690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65479400|NCT02965690|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65479401|NCT02965690|Histamine Antagonists|histamine antagonists|mesh-ancestor
65479402|NCT02965690|Histamine Agents|histamine agents|mesh-ancestor
65479403|NCT02965690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65479404|NCT02965690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479405|NCT02965690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479406|NCT02965690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65479407|NCT02965690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65479408|NCT02965690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479409|NCT01285388|Beta-lapachone|beta-lapachone|mesh-list
65479410|NCT01285388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65479411|NCT01285388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65479412|NCT01285388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65479413|NCT01285388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479414|NCT01285388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479415|NCT01285388|Antiviral Agents|antiviral agents|mesh-ancestor
64863484|NCT01770236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64329061|NCT02030483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64329062|NCT02030483|Glucocorticoids|glucocorticoids|mesh-ancestor
64329063|NCT02030483|Hormones|hormones|mesh-ancestor
64494987|NCT03461718|Narcotics|narcotics|mesh-ancestor
64494988|NCT03461718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64494989|NCT03461718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64494990|NCT03461718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64494991|NCT03461718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64494992|NCT03461718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64494993|NCT03461718|GABA Modulators|gaba modulators|mesh-ancestor
64494994|NCT03461718|GABA Agents|gaba agents|mesh-ancestor
64494995|NCT05431920|Vitamin D|vitamin d|mesh-list
64494996|NCT05431920|Ergocalciferols|ergocalciferols|mesh-list
64494997|NCT05431920|Cholecalciferol|cholecalciferol|mesh-list
64494998|NCT05431920|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
64494999|NCT05431920|Calcifediol|calcifediol|mesh-list
64495000|NCT05431920|Vitamins|vitamins|mesh-list
64495001|NCT05431920|Micronutrients|micronutrients|mesh-ancestor
64495002|NCT05431920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721203|NCT00002348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721204|NCT00002348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721205|NCT00002348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721206|NCT02721277|SMOFlipid|smoflipid|mesh-list
64721207|NCT02721277|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64721208|NCT02721277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64721209|NCT02721277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64721210|NCT05752526|Diclofenac|diclofenac|mesh-list
64721211|NCT05752526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64721212|NCT05752526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64721213|NCT05752526|Analgesics|analgesics|mesh-ancestor
64721214|NCT05752526|Sensory System Agents|sensory system agents|mesh-ancestor
64721215|NCT05752526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64721216|NCT05752526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721217|NCT05752526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64721218|NCT05752526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64721219|NCT05752526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65479416|NCT01285466|Paclitaxel|paclitaxel|mesh-list
65479417|NCT01285466|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65479418|NCT01285466|Trastuzumab|trastuzumab|mesh-list
65479419|NCT01285466|Dactolisib|dactolisib|mesh-list
65479420|NCT01285466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65479421|NCT01285466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65479422|NCT01285466|Tubulin Modulators|tubulin modulators|mesh-ancestor
65479423|NCT01285466|Antimitotic Agents|antimitotic agents|mesh-ancestor
65479424|NCT01285466|Mitosis Modulators|mitosis modulators|mesh-ancestor
65479425|NCT01285466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479479|NCT03868436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65479480|NCT03868436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479481|NCT01280006|Celecoxib|celecoxib|mesh-list
65479482|NCT01280006|Indomethacin|indomethacin|mesh-list
65479483|NCT01280006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65479484|NCT01280006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65479485|NCT01280006|Analgesics|analgesics|mesh-ancestor
65479486|NCT01280006|Sensory System Agents|sensory system agents|mesh-ancestor
65479487|NCT01280006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65479488|NCT01280006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479489|NCT01280006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65479490|NCT01280006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65479491|NCT01280006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65479492|NCT01280006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65479493|NCT01280006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479494|NCT01280006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479495|NCT01280006|Gout Suppressants|gout suppressants|mesh-ancestor
65479496|NCT01280006|Tocolytic Agents|tocolytic agents|mesh-ancestor
65479497|NCT01280006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65479498|NCT03265132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65479499|NCT03265132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65479500|NCT03865160|Atropine|atropine|mesh-list
65479501|NCT03865160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65479502|NCT03865160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65479503|NCT03865160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65479504|NCT03865160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65479505|NCT03865160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65479506|NCT03865160|Autonomic Agents|autonomic agents|mesh-ancestor
65479507|NCT03865160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65479508|NCT03865160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479509|NCT03865160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65479510|NCT03865160|Respiratory System Agents|respiratory system agents|mesh-ancestor
65479511|NCT03865160|Mydriatics|mydriatics|mesh-ancestor
65479512|NCT03865160|Parasympatholytics|parasympatholytics|mesh-ancestor
65479513|NCT03865160|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65479514|NCT03865160|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65479516|NCT03865160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65479517|NCT03865160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479518|NCT01059461|Cerebrolysin|cerebrolysin|mesh-list
65479519|NCT01059461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65479520|NCT01059461|Protective Agents|protective agents|mesh-ancestor
65479521|NCT01059461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479522|NCT01059461|Nootropic Agents|nootropic agents|mesh-ancestor
65479523|NCT01324739|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65479524|NCT01324739|Natriuretic Agents|natriuretic agents|mesh-ancestor
65479525|NCT01324739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479526|NCT01286246|Progesterone|progesterone|mesh-list
65479527|NCT01286246|Progestins|progestins|mesh-ancestor
65479528|NCT01286246|Hormones|hormones|mesh-ancestor
65479529|NCT01286246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65479530|NCT01286246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479531|NCT03981887|Nafithromycin|nafithromycin|mesh-list
64863607|NCT01771198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64721220|NCT05752526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721221|NCT05752526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721222|NCT00002270|Interferons|interferons|mesh-list
64721223|NCT00002270|Interferon-alpha|interferon-alpha|mesh-list
64721224|NCT00002270|Interferon alpha-2|interferon alpha-2|mesh-list
64721225|NCT00002270|Zidovudine|zidovudine|mesh-list
64721226|NCT00002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721227|NCT00002270|Antiviral Agents|antiviral agents|mesh-ancestor
64329064|NCT02030483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64721228|NCT00002270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721229|NCT00002270|Immunologic Factors|immunologic factors|mesh-ancestor
64721230|NCT00002270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721231|NCT00002270|Antimetabolites|antimetabolites|mesh-ancestor
64721232|NCT00002270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721233|NCT00002270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64721234|NCT00002270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64721235|NCT00002270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721236|NCT00002270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64721237|NCT00002270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64721238|NCT00002354|Stavudine|stavudine|mesh-list
64721239|NCT00002354|Indinavir|indinavir|mesh-list
64721240|NCT00002354|Antimetabolites|antimetabolites|mesh-ancestor
64721241|NCT00002354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721242|NCT00002354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64721243|NCT00002354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64721251|NCT00002354|Protease Inhibitors|protease inhibitors|mesh-ancestor
64329087|NCT02385435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64329088|NCT02385435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329089|NCT02385435|Sensory System Agents|sensory system agents|mesh-ancestor
64329090|NCT02385435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64329091|NCT02385435|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64329093|NCT02385435|Analgesics|analgesics|mesh-ancestor
64721252|NCT00002360|Didanosine|didanosine|mesh-list
64721253|NCT00002360|Antimetabolites|antimetabolites|mesh-ancestor
64721254|NCT00002360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721255|NCT00002360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64721256|NCT00002360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64721257|NCT00002360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721258|NCT00002360|Antiviral Agents|antiviral agents|mesh-ancestor
64721259|NCT00002360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65479532|NCT03981887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65479533|NCT03981887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65479534|NCT03981887|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65479535|NCT03981887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479536|NCT03981887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479537|NCT01063127|Insulin|insulin|mesh-list
65479538|NCT01063127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65479539|NCT01063127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479540|NCT03865004|Acetaminophen|acetaminophen|mesh-list
65479541|NCT03865004|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65479542|NCT03865004|Morphine|morphine|mesh-list
65479543|NCT03865004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65479544|NCT03865004|Narcotics|narcotics|mesh-ancestor
65479545|NCT03865004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65479546|NCT03865004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479547|NCT03865004|Analgesics|analgesics|mesh-ancestor
65479548|NCT03865004|Sensory System Agents|sensory system agents|mesh-ancestor
65479549|NCT03865004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65479550|NCT03865004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65479551|NCT03865004|Antipyretics|antipyretics|mesh-ancestor
65479552|NCT03865004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64721260|NCT00002360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64721261|NCT00002360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64721262|NCT00002276|Zidovudine|zidovudine|mesh-list
64721263|NCT00002276|Ibuprofen|ibuprofen|mesh-list
64721264|NCT00002276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64721265|NCT00002276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64721266|NCT00002276|Analgesics|analgesics|mesh-ancestor
64721267|NCT00002276|Sensory System Agents|sensory system agents|mesh-ancestor
64721268|NCT00002276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64721269|NCT00002276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329111|NCT03133897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64329112|NCT03133897|Glucocorticoids|glucocorticoids|mesh-ancestor
64329113|NCT03133897|Hormones|hormones|mesh-ancestor
64329114|NCT03133897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64329115|NCT03133897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64329116|NCT03133897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329117|NCT05443425|Cholestyramine Resin|cholestyramine resin|mesh-list
64329118|NCT05443425|Leflunomide|leflunomide|mesh-list
64329119|NCT05443425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329120|NCT05443425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329121|NCT05443425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64329122|NCT05443425|Immunologic Factors|immunologic factors|mesh-ancestor
64329123|NCT05443425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329124|NCT05443425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64329125|NCT05443425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64329126|NCT05443425|Antimetabolites|antimetabolites|mesh-ancestor
64329127|NCT05443425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64495005|NCT03467022|Ascorbic Acid|ascorbic acid|mesh-list
64495007|NCT03467022|Micronutrients|micronutrients|mesh-ancestor
64495009|NCT03467022|Antioxidants|antioxidants|mesh-ancestor
64721302|NCT00378547|Analgesics|analgesics|mesh-ancestor
64329135|NCT02185859|Magnesium Sulfate|magnesium sulfate|mesh-list
64329136|NCT02185859|Anesthetics, Local|anesthetics, local|mesh-ancestor
64329137|NCT02185859|Anesthetics|anesthetics|mesh-ancestor
65479553|NCT03865004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65479554|NCT03865004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65479555|NCT00334295|Fulvestrant|fulvestrant|mesh-list
65479556|NCT00334295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65479557|NCT00334295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65479558|NCT00334295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65479559|NCT00334295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65479560|NCT00334295|Hormone Antagonists|hormone antagonists|mesh-ancestor
65479561|NCT00334295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65479562|NCT00334295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479563|NCT01285778|Panitumumab|panitumumab|mesh-list
65479564|NCT01285778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65479565|NCT01285778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65479566|NCT01063205|Acetylcysteine|acetylcysteine|mesh-list
65479567|NCT01063205|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65479568|NCT01063205|Antiviral Agents|antiviral agents|mesh-ancestor
65479569|NCT01063205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65479570|NCT01063205|Expectorants|expectorants|mesh-ancestor
65479571|NCT01063205|Respiratory System Agents|respiratory system agents|mesh-ancestor
65479572|NCT01063205|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64863643|NCT01771458|Lapatinib|lapatinib|mesh-list
64329138|NCT02185859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64329139|NCT02185859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329140|NCT02185859|Sensory System Agents|sensory system agents|mesh-ancestor
64329141|NCT02185859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64329142|NCT02185859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64329143|NCT02185859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64329144|NCT02185859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64329145|NCT02185859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64495012|NCT03129594|Glucagon|glucagon|mesh-list
64495013|NCT03129594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64495014|NCT03129594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64495015|NCT03129594|Hormones|hormones|mesh-ancestor
64495016|NCT03129594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64495022|NCT03466632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64495023|NCT03466632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945639|NCT05379322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64721315|NCT00002282|Miconazole|miconazole|mesh-list
64721316|NCT00002282|Antifungal Agents|antifungal agents|mesh-ancestor
64721317|NCT00002282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721318|NCT00002282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64721319|NCT00002282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64721320|NCT00002282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721321|NCT00002282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721322|NCT00002282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64721323|NCT00002282|Hormone Antagonists|hormone antagonists|mesh-ancestor
64721324|NCT00002282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64721325|NCT00002282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721326|NCT00002282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64721327|NCT00002282|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64721328|NCT00002282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65479573|NCT01063205|Antioxidants|antioxidants|mesh-ancestor
65479574|NCT01063205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479575|NCT01063205|Protective Agents|protective agents|mesh-ancestor
65479576|NCT01063205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479577|NCT01063205|Antidotes|antidotes|mesh-ancestor
65479578|NCT01175096|Everolimus|everolimus|mesh-list
65479579|NCT01175096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65479580|NCT01175096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65479581|NCT01175096|Immunologic Factors|immunologic factors|mesh-ancestor
65479582|NCT01175096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479583|NCT01285934|Insulin|insulin|mesh-list
65479584|NCT01285934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65479585|NCT01285934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479586|NCT01060163|Tranexamic Acid|tranexamic acid|mesh-list
65479587|NCT01060163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65479588|NCT01060163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65479589|NCT01060163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479590|NCT01060163|Hemostatics|hemostatics|mesh-ancestor
64721329|NCT00002282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64721330|NCT02658877|Omalizumab|omalizumab|mesh-list
64721331|NCT02658877|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64721332|NCT02658877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64721333|NCT02658877|Respiratory System Agents|respiratory system agents|mesh-ancestor
64721334|NCT00002288|Zidovudine|zidovudine|mesh-list
64721335|NCT00002288|Antimetabolites|antimetabolites|mesh-ancestor
64721336|NCT00002288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721337|NCT00002288|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64329152|NCT02185859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64329153|NCT02332720|Ribavirin|ribavirin|mesh-list
64329154|NCT02332720|Grazoprevir|grazoprevir|mesh-list
64329155|NCT02332720|Uprifosbuvir|uprifosbuvir|mesh-list
64329156|NCT02332720|Ruzasvir|ruzasvir|mesh-list
64329157|NCT02332720|Antimetabolites|antimetabolites|mesh-ancestor
64329158|NCT02332720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329159|NCT02332720|Antiviral Agents|antiviral agents|mesh-ancestor
64329187|NCT02181335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64329189|NCT00517153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329190|NCT00517153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329191|NCT00517153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64329192|NCT00517153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64329193|NCT00517153|Antiviral Agents|antiviral agents|mesh-ancestor
64329194|NCT00517153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64329195|NCT00517153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64495042|NCT05339334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495043|NCT05339334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64495044|NCT05339334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64495045|NCT05339334|Antiviral Agents|antiviral agents|mesh-ancestor
64495046|NCT05339334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64329196|NCT00517153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64329197|NCT00517153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329199|NCT02285101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329201|NCT00359437|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64329202|NCT00359437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329203|NCT00359437|Natriuretic Agents|natriuretic agents|mesh-ancestor
64329204|NCT00359437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329205|NCT05064449|Itraconazole|itraconazole|mesh-list
65479591|NCT01060163|Coagulants|coagulants|mesh-ancestor
65479592|NCT01063439|Cytarabine|cytarabine|mesh-list
65479593|NCT01063439|Etoposide|etoposide|mesh-list
65479594|NCT01063439|Melphalan|melphalan|mesh-list
65479595|NCT01063439|Busulfan|busulfan|mesh-list
65479596|NCT01063439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65479597|NCT01063439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65479598|NCT01063439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65479603|NCT01063439|Antimetabolites|antimetabolites|mesh-ancestor
65479659|NCT01286090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65479660|NCT01286090|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65479661|NCT01286090|Serotonin Agents|serotonin agents|mesh-ancestor
65479662|NCT01286090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65479663|NCT01286090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479664|NCT01286090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479665|NCT00310817|Vaccines|vaccines|mesh-list
65479666|NCT00310817|Immunologic Factors|immunologic factors|mesh-ancestor
65479667|NCT00310817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479668|NCT03783286|Ivacaftor|ivacaftor|mesh-list
65479669|NCT03783286|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65479670|NCT03783286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65479671|NCT03783286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479672|NCT03863366|Prucalopride|prucalopride|mesh-list
65479673|NCT03863366|Laxatives|laxatives|mesh-ancestor
65479674|NCT03863366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65479675|NCT03863366|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65479676|NCT03863366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65479677|NCT03863366|Serotonin Agents|serotonin agents|mesh-ancestor
65479678|NCT03863366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65479679|NCT03863366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479680|NCT03863366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479681|NCT01175486|Pioglitazone|pioglitazone|mesh-list
65479682|NCT01175486|Acarbose|acarbose|mesh-list
65479683|NCT01175486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65479684|NCT01175486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479685|NCT01175486|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65479686|NCT01175486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479687|NCT01175486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479688|NCT01177904|Progesterone|progesterone|mesh-list
65479689|NCT01177904|Progestins|progestins|mesh-ancestor
64329206|NCT05064449|Mefenamic Acid|mefenamic acid|mesh-list
64329207|NCT05064449|Antifungal Agents|antifungal agents|mesh-ancestor
64495047|NCT05339334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64329209|NCT05064449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64329210|NCT05064449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64329211|NCT05064449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329216|NCT05064449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495048|NCT05339334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64495049|NCT03461328|Magnesium Sulfate|magnesium sulfate|mesh-list
64495050|NCT03461328|Analgesics|analgesics|mesh-ancestor
64495051|NCT03461328|Sensory System Agents|sensory system agents|mesh-ancestor
65479690|NCT01177904|Hormones|hormones|mesh-ancestor
65479691|NCT01177904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65479692|NCT01177904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229225|NCT00738751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65479693|NCT02940886|Iron|iron|mesh-list
65479694|NCT02940886|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65479695|NCT02940886|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65479696|NCT02940886|Trace Elements|trace elements|mesh-ancestor
65479697|NCT02940886|Micronutrients|micronutrients|mesh-ancestor
65479698|NCT02940886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479699|NCT02940886|Hematinics|hematinics|mesh-ancestor
65479700|NCT05216614|Fluvoxamine|fluvoxamine|mesh-list
65479701|NCT05216614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65479702|NCT05216614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65479703|NCT05216614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65479704|NCT05216614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479705|NCT05216614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65479706|NCT05216614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65479707|NCT05216614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65479708|NCT05216614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64863773|NCT01772420|Growth Inhibitors|growth inhibitors|mesh-ancestor
64495052|NCT03461328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64495053|NCT03461328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495054|NCT03461328|Anesthetics|anesthetics|mesh-ancestor
64721383|NCT00002372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721384|NCT00002372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721385|NCT00002372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64721386|NCT00002372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64721387|NCT00002372|Antiviral Agents|antiviral agents|mesh-ancestor
64721388|NCT00002372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721389|NCT00002372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64721390|NCT00002372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64721391|NCT00002372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64721392|NCT00002372|Antitubercular Agents|antitubercular agents|mesh-ancestor
64721393|NCT00002372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64721394|NCT00002378|Ritonavir|ritonavir|mesh-list
64721395|NCT00002378|Nelfinavir|nelfinavir|mesh-list
64721396|NCT00002378|Saquinavir|saquinavir|mesh-list
64721397|NCT00002378|Lamivudine|lamivudine|mesh-list
64721398|NCT00002378|Zidovudine|zidovudine|mesh-list
64721399|NCT00002378|Stavudine|stavudine|mesh-list
64721400|NCT00002378|Delavirdine|delavirdine|mesh-list
64721401|NCT00002378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64721402|NCT00002378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64721403|NCT00002378|Protease Inhibitors|protease inhibitors|mesh-ancestor
64721404|NCT00002378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721405|NCT00002378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721406|NCT00002378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64721407|NCT00002378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64721408|NCT00002378|Antiviral Agents|antiviral agents|mesh-ancestor
64329217|NCT05064449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64329218|NCT05064449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64329219|NCT05064449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64329220|NCT05064449|Analgesics|analgesics|mesh-ancestor
64329221|NCT05064449|Sensory System Agents|sensory system agents|mesh-ancestor
65479709|NCT05216614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479710|NCT05216614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65479711|NCT05216614|Serotonin Agents|serotonin agents|mesh-ancestor
65479712|NCT05216614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65479713|NCT05216614|Antidepressive Agents|antidepressive agents|mesh-ancestor
65479714|NCT05216614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65479715|NCT05216614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65479716|NCT05216614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479717|NCT05216614|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65479718|NCT03860636|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65479719|NCT03860636|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65479720|NCT03860636|Estradiol|estradiol|mesh-list
65479721|NCT03860636|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65479722|NCT03860636|Progesterone|progesterone|mesh-list
65479723|NCT03860636|Estrogens|estrogens|mesh-ancestor
65479724|NCT03860636|Hormones|hormones|mesh-ancestor
65479725|NCT03860636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65479726|NCT03860636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479727|NCT03860636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65479728|NCT03860636|Contraceptive Agents|contraceptive agents|mesh-ancestor
65479729|NCT03860636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65479730|NCT03860636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65479731|NCT03860636|Progestins|progestins|mesh-ancestor
65479732|NCT03860480|Bupivacaine|bupivacaine|mesh-list
65479733|NCT03860480|Anesthetics, Local|anesthetics, local|mesh-ancestor
65479734|NCT03860480|Anesthetics|anesthetics|mesh-ancestor
65479735|NCT03860480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65479736|NCT03860480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329222|NCT05064449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64329223|NCT05064449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64329224|NCT05064449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64329225|NCT05064449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64329226|NCT00401011|Dexamethasone|dexamethasone|mesh-list
64329227|NCT00401011|Bortezomib|bortezomib|mesh-list
64329228|NCT00401011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64721413|NCT00002378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64721415|NCT02589145|Pyridoxine|pyridoxine|mesh-list
64721416|NCT02589145|Gemcitabine|gemcitabine|mesh-list
64721417|NCT02589145|Dexamethasone|dexamethasone|mesh-list
64721418|NCT02589145|Rituximab|rituximab|mesh-list
64721419|NCT02589145|Lenalidomide|lenalidomide|mesh-list
64721420|NCT02589145|Melphalan|melphalan|mesh-list
64721421|NCT02589145|Busulfan|busulfan|mesh-list
64721422|NCT02589145|Vorinostat|vorinostat|mesh-list
64721423|NCT02589145|Enoxaparin|enoxaparin|mesh-list
64721424|NCT02589145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64721425|NCT02589145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65479737|NCT03860480|Sensory System Agents|sensory system agents|mesh-ancestor
65479738|NCT03860480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65479739|NCT03285646|Fasinumab|fasinumab|mesh-list
65479740|NCT03285646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65479741|NCT03285646|Analgesics|analgesics|mesh-ancestor
65479742|NCT03285646|Sensory System Agents|sensory system agents|mesh-ancestor
65479743|NCT03285646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65479744|NCT03285646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479745|NCT03860012|Folic Acid|folic acid|mesh-list
65479746|NCT03860012|Hematinics|hematinics|mesh-ancestor
65479747|NCT03860012|Vitamin B Complex|vitamin b complex|mesh-ancestor
65479748|NCT03860012|Vitamins|vitamins|mesh-ancestor
65479749|NCT03860012|Micronutrients|micronutrients|mesh-ancestor
65479750|NCT03860012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479751|NCT03859934|Melatonin|melatonin|mesh-list
65479752|NCT03859934|Antioxidants|antioxidants|mesh-ancestor
65479753|NCT03859934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479754|NCT03859934|Protective Agents|protective agents|mesh-ancestor
65479755|NCT03859934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479756|NCT03859934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65479757|NCT01178372|Lactulose|lactulose|mesh-list
65479758|NCT01178372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65479759|NCT01178450|Cinacalcet|cinacalcet|mesh-list
65479760|NCT01178450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65479761|NCT01178450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479762|NCT01178450|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65479763|NCT01178450|Hormone Antagonists|hormone antagonists|mesh-ancestor
65479764|NCT01178450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65229307|NCT00732121|Hormones|hormones|mesh-ancestor
65479765|NCT00074490|Prednisone|prednisone|mesh-list
65479766|NCT00074490|Cyclophosphamide|cyclophosphamide|mesh-list
65479767|NCT00074490|Rituximab|rituximab|mesh-list
65479768|NCT00074490|Doxorubicin|doxorubicin|mesh-list
65479769|NCT00074490|Fludarabine|fludarabine|mesh-list
65479770|NCT00074490|Etoposide|etoposide|mesh-list
65479771|NCT00074490|Vincristine|vincristine|mesh-list
65479772|NCT00074490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64863819|NCT01772940|Lopinavir|lopinavir|mesh-list
64329242|NCT01645930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64329243|NCT01645930|Antiemetics|antiemetics|mesh-ancestor
64329244|NCT01645930|Autonomic Agents|autonomic agents|mesh-ancestor
64329245|NCT01645930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65479773|NCT00074490|Immunologic Factors|immunologic factors|mesh-ancestor
65479774|NCT00074490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479775|NCT00074490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65479776|NCT00074490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65479777|NCT00074490|Alkylating Agents|alkylating agents|mesh-ancestor
65479778|NCT00074490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479779|NCT00074490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65479780|NCT00074490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65479781|NCT00074490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65479782|NCT00074490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65479783|NCT00074490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65479784|NCT00074490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65479785|NCT00074490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479786|NCT00074490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65479787|NCT00074490|Glucocorticoids|glucocorticoids|mesh-ancestor
65479788|NCT00074490|Hormones|hormones|mesh-ancestor
65479789|NCT00074490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65479790|NCT00074490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65479791|NCT00074490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65479792|NCT00074490|Tubulin Modulators|tubulin modulators|mesh-ancestor
65479793|NCT00074490|Antimitotic Agents|antimitotic agents|mesh-ancestor
65479794|NCT00074490|Mitosis Modulators|mitosis modulators|mesh-ancestor
65479795|NCT03859856|Hormones|hormones|mesh-list
65479796|NCT03859856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65479797|NCT03859856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479798|NCT01094028|Oxytocin|oxytocin|mesh-list
65479799|NCT01094028|Oxytocics|oxytocics|mesh-ancestor
65479800|NCT01094028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65479801|NCT01094028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479802|NCT01288508|Psyllium|psyllium|mesh-list
65479803|NCT01288508|Cathartics|cathartics|mesh-ancestor
65479804|NCT01288508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65479805|NCT01175954|Lacosamide|lacosamide|mesh-list
64863865|NCT01773044|Lidocaine|lidocaine|mesh-list
64329246|NCT01645930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329247|NCT01645930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64329248|NCT01645930|Glucocorticoids|glucocorticoids|mesh-ancestor
64329249|NCT01645930|Hormones|hormones|mesh-ancestor
64329250|NCT01645930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64329251|NCT01645930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65479806|NCT01175954|Anticonvulsants|anticonvulsants|mesh-ancestor
65479807|NCT01175954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65479808|NCT01175954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65479809|NCT01175954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65479810|NCT01175954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479811|NCT01288664|Tacrolimus|tacrolimus|mesh-list
65479812|NCT01288664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65479813|NCT01288664|Immunologic Factors|immunologic factors|mesh-ancestor
65479814|NCT01288664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479815|NCT01288664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65479816|NCT01288664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479817|NCT01288664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479818|NCT03285490|Tirbanibulin|tirbanibulin|mesh-list
65479819|NCT03285490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479820|NCT03285490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479821|NCT02525276|Hormones|hormones|mesh-list
65479822|NCT02525276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65479823|NCT02525276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479824|NCT01172444|Mesalamine|mesalamine|mesh-list
65479825|NCT01172444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65479826|NCT01172444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65479827|NCT01172444|Analgesics|analgesics|mesh-ancestor
65479828|NCT01172444|Sensory System Agents|sensory system agents|mesh-ancestor
65479829|NCT01172444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65479830|NCT01172444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479831|NCT01172444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65479832|NCT01172444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65479833|NCT01288742|Simeprevir|simeprevir|mesh-list
65479834|NCT01288742|Digoxin|digoxin|mesh-list
65479835|NCT01288742|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65479836|NCT01288742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64495056|NCT03461328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64495057|NCT03461328|Anticonvulsants|anticonvulsants|mesh-ancestor
64721433|NCT02589145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64721434|NCT02589145|Glucocorticoids|glucocorticoids|mesh-ancestor
64721436|NCT02589145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64721437|NCT02589145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64721438|NCT02589145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64721439|NCT02589145|Antimetabolites|antimetabolites|mesh-ancestor
64721440|NCT02589145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721441|NCT02589145|Antiviral Agents|antiviral agents|mesh-ancestor
64329257|NCT01645930|Growth Inhibitors|growth inhibitors|mesh-ancestor
65479837|NCT01288742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65479838|NCT01288742|Antimetabolites|antimetabolites|mesh-ancestor
65479839|NCT01288742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479840|NCT01288742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65479841|NCT01288742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65479842|NCT01288742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479843|NCT01288742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65479845|NCT01288742|Protective Agents|protective agents|mesh-ancestor
65479846|NCT01288742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479847|NCT01288742|Antiviral Agents|antiviral agents|mesh-ancestor
65479848|NCT01288742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65479849|NCT01288742|Protease Inhibitors|protease inhibitors|mesh-ancestor
65479850|NCT01178996|Ribavirin|ribavirin|mesh-list
65479851|NCT01178996|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65479852|NCT01178996|Thymalfasin|thymalfasin|mesh-list
65479853|NCT01178996|Antimetabolites|antimetabolites|mesh-ancestor
65479854|NCT01178996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479855|NCT01178996|Antiviral Agents|antiviral agents|mesh-ancestor
65479856|NCT01178996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65479857|NCT01178996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65479858|NCT01178996|Immunologic Factors|immunologic factors|mesh-ancestor
65479859|NCT01178996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479860|NCT03862586|Acetylcysteine|acetylcysteine|mesh-list
65479861|NCT03862586|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65479862|NCT03862586|Antiviral Agents|antiviral agents|mesh-ancestor
65479863|NCT03862586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65479864|NCT03862586|Expectorants|expectorants|mesh-ancestor
65479865|NCT03862586|Respiratory System Agents|respiratory system agents|mesh-ancestor
65479866|NCT03862586|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65479867|NCT03862586|Antioxidants|antioxidants|mesh-ancestor
65479868|NCT03862586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479869|NCT03862586|Protective Agents|protective agents|mesh-ancestor
64863928|NCT01773538|Rifaximin|rifaximin|mesh-list
64329258|NCT01645930|Protease Inhibitors|protease inhibitors|mesh-ancestor
64329259|NCT01645930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329260|NCT01645930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329261|NCT02190695|Carboplatin|carboplatin|mesh-list
64329263|NCT02190695|Arsenic Trioxide|arsenic trioxide|mesh-list
64329264|NCT02190695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721451|NCT02589145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64721452|NCT02589145|Anticoagulants|anticoagulants|mesh-ancestor
64721453|NCT02589145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64721454|NCT02589145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65479870|NCT03862586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479871|NCT03862586|Antidotes|antidotes|mesh-ancestor
65479872|NCT01180946|Vitamin D|vitamin d|mesh-list
65479873|NCT01180946|Ergocalciferols|ergocalciferols|mesh-list
65479874|NCT01180946|Vitamins|vitamins|mesh-ancestor
65479875|NCT01180946|Micronutrients|micronutrients|mesh-ancestor
65479876|NCT01180946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479877|NCT01180946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65479878|NCT01180946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65479879|NCT01179152|Budesonide|budesonide|mesh-list
65479880|NCT01179152|Formoterol Fumarate|formoterol fumarate|mesh-list
65479881|NCT01179152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65479882|NCT01179152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65479883|NCT01179152|Autonomic Agents|autonomic agents|mesh-ancestor
65479884|NCT01179152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65479885|NCT01179152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479886|NCT01179152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65479887|NCT01179152|Respiratory System Agents|respiratory system agents|mesh-ancestor
65479888|NCT01179152|Glucocorticoids|glucocorticoids|mesh-ancestor
65479889|NCT01179152|Hormones|hormones|mesh-ancestor
65479890|NCT01179152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65479891|NCT01179152|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65479892|NCT01179152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64721455|NCT02589145|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64721456|NCT02589145|Vitamin B Complex|vitamin b complex|mesh-ancestor
64721457|NCT02589145|Vitamins|vitamins|mesh-ancestor
64721458|NCT02589145|Micronutrients|micronutrients|mesh-ancestor
64721459|NCT00002384|Cidofovir|cidofovir|mesh-list
64721460|NCT00002384|Antiviral Agents|antiviral agents|mesh-ancestor
64721461|NCT00002384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721462|NCT00002384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721463|NCT00002384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329268|NCT02190695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329269|NCT00514267|Prednisone|prednisone|mesh-list
64329270|NCT00514267|Docetaxel|docetaxel|mesh-list
64329271|NCT00514267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329272|NCT00514267|Tubulin Modulators|tubulin modulators|mesh-ancestor
64329273|NCT00514267|Antimitotic Agents|antimitotic agents|mesh-ancestor
64329274|NCT00514267|Mitosis Modulators|mitosis modulators|mesh-ancestor
64329275|NCT00514267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329276|NCT00514267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64329277|NCT00514267|Glucocorticoids|glucocorticoids|mesh-ancestor
64329278|NCT00514267|Hormones|hormones|mesh-ancestor
64329279|NCT00514267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64329280|NCT00514267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495059|NCT03461328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64495060|NCT03461328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495061|NCT03461328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64495062|NCT03461328|Tocolytic Agents|tocolytic agents|mesh-ancestor
64495063|NCT03461328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64495064|NCT01145638|Iron|iron|mesh-list
64495065|NCT01145638|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65479893|NCT01179152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65479894|NCT01179152|Adrenergic Agents|adrenergic agents|mesh-ancestor
65479895|NCT01179152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65479896|NCT01179152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479897|NCT01179230|Dipyridamole|dipyridamole|mesh-list
65479898|NCT01179230|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65479899|NCT01179230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479900|NCT01179230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479901|NCT01179230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65479902|NCT01179230|Vasodilator Agents|vasodilator agents|mesh-ancestor
65479903|NCT01286948|Levonorgestrel|levonorgestrel|mesh-list
65479904|NCT01286948|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65479905|NCT01286948|Contraceptive Agents|contraceptive agents|mesh-ancestor
65479906|NCT01286948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65479907|NCT01286948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479908|NCT01286948|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65479909|NCT01286948|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65479910|NCT01286948|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65479911|NCT01179308|Anesthetics|anesthetics|mesh-list
65479912|NCT01179308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64863975|NCT01773798|Insulin|insulin|mesh-list
64495066|NCT01145638|Trace Elements|trace elements|mesh-ancestor
64495067|NCT01145638|Micronutrients|micronutrients|mesh-ancestor
64495068|NCT01145638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495069|NCT01145638|Hematinics|hematinics|mesh-ancestor
64495070|NCT03466320|Cyclophosphamide|cyclophosphamide|mesh-list
64495071|NCT03466320|Fludarabine|fludarabine|mesh-list
64495072|NCT03466320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64495073|NCT03466320|Immunologic Factors|immunologic factors|mesh-ancestor
64495074|NCT03466320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495075|NCT03466320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64495076|NCT03466320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64495077|NCT03466320|Alkylating Agents|alkylating agents|mesh-ancestor
64721472|NCT02568007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721473|NCT02568007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721474|NCT02568007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64721475|NCT02568007|Serotonin Agents|serotonin agents|mesh-ancestor
64721476|NCT02568007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64721477|NCT00002390|Abacavir|abacavir|mesh-list
64721478|NCT00002390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64721479|NCT00002390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64721480|NCT00002390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721481|NCT00002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721482|NCT00002390|Antiviral Agents|antiviral agents|mesh-ancestor
64721483|NCT00002390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721484|NCT00002390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64721485|NCT00002390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64721486|NCT00002396|Tenofovir|tenofovir|mesh-list
64721487|NCT00002396|Antiviral Agents|antiviral agents|mesh-ancestor
64721488|NCT00002396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721489|NCT00002396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64721490|NCT00002396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64721491|NCT00002396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479913|NCT01179308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479914|NCT03088826|Acetaminophen|acetaminophen|mesh-list
65479915|NCT03088826|Morphine|morphine|mesh-list
65479916|NCT03088826|Oxycodone|oxycodone|mesh-list
65479917|NCT03088826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65479918|NCT03088826|Narcotics|narcotics|mesh-ancestor
65479919|NCT03088826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65479920|NCT03088826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479921|NCT03088826|Analgesics|analgesics|mesh-ancestor
65479922|NCT03088826|Sensory System Agents|sensory system agents|mesh-ancestor
65479923|NCT03088826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65479924|NCT03088826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65479925|NCT03088826|Antipyretics|antipyretics|mesh-ancestor
65479926|NCT00367133|Triamcinolone|triamcinolone|mesh-list
65479927|NCT00367133|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65479928|NCT00367133|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65479929|NCT00367133|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65479930|NCT00367133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65479931|NCT00367133|Glucocorticoids|glucocorticoids|mesh-ancestor
65479932|NCT00367133|Hormones|hormones|mesh-ancestor
64863995|NCT01773876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721492|NCT00002396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721493|NCT00002396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64721494|NCT00002396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64721495|NCT00002402|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64495078|NCT03466320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495080|NCT03466320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64495081|NCT03466242|Dexmedetomidine|dexmedetomidine|mesh-list
64495083|NCT03466242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64495084|NCT03466242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64495085|NCT03466242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495086|NCT03466242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64495100|NCT03466242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64495101|NCT03466242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64495102|NCT01190878|Bromfenac|bromfenac|mesh-list
64495103|NCT01190878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64495105|NCT01190878|Analgesics|analgesics|mesh-ancestor
64495106|NCT01190878|Sensory System Agents|sensory system agents|mesh-ancestor
64495107|NCT01190878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64495108|NCT01190878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495109|NCT01190878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64721510|NCT00002420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721511|NCT00002420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64721512|NCT00002420|Antimetabolites|antimetabolites|mesh-ancestor
64721513|NCT00002420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64460815|NCT00305344|Vaccines|vaccines|mesh-list
64721514|NCT00002420|Antiviral Agents|antiviral agents|mesh-ancestor
64721515|NCT00002420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721517|NCT00002420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64721518|NCT00381368|Ibandronic Acid|ibandronic acid|mesh-list
64329316|NCT00511459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64329317|NCT00511459|Growth Substances|growth substances|mesh-ancestor
64329318|NCT00511459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329319|NCT00511459|Growth Inhibitors|growth inhibitors|mesh-ancestor
64329320|NCT02384889|Eflornithine|eflornithine|mesh-list
65479933|NCT00367133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65479934|NCT00367133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479935|NCT00367133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65479936|NCT00367133|Immunologic Factors|immunologic factors|mesh-ancestor
65479937|NCT00367133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479938|NCT00367133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479939|NCT01179464|Simvastatin|simvastatin|mesh-list
65479940|NCT01179464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65479941|NCT01179464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65479942|NCT01179464|Antimetabolites|antimetabolites|mesh-ancestor
65479943|NCT01179464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65479944|NCT01179464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65479945|NCT01179464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65479946|NCT01179464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65479947|NCT01179620|Certoparin|certoparin|mesh-list
65479948|NCT01179620|Anticoagulants|anticoagulants|mesh-ancestor
65479949|NCT01288820|Artesunate|artesunate|mesh-list
65479950|NCT01288820|Piperaquine|piperaquine|mesh-list
65479951|NCT01288820|Primaquine|primaquine|mesh-list
65479952|NCT01288820|Amodiaquine|amodiaquine|mesh-list
65479953|NCT01288820|Artenimol|artenimol|mesh-list
64329321|NCT02384889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329322|NCT02384889|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64495110|NCT01190878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64495111|NCT01146808|Adefovir|adefovir|mesh-list
64495117|NCT01146808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64495118|NCT01146808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495120|NCT02522130|Lidocaine|lidocaine|mesh-list
64495121|NCT02522130|Misoprostol|misoprostol|mesh-list
64495122|NCT02522130|Anesthetics, Local|anesthetics, local|mesh-ancestor
64495123|NCT02522130|Anesthetics|anesthetics|mesh-ancestor
64495124|NCT02522130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64495125|NCT02522130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495126|NCT02522130|Sensory System Agents|sensory system agents|mesh-ancestor
64495127|NCT02522130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64495128|NCT02522130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64495129|NCT02522130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64495130|NCT02522130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64495131|NCT02522130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64495132|NCT02522130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495133|NCT02522130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64495134|NCT02522130|Abortifacient Agents|abortifacient agents|mesh-ancestor
64495135|NCT02522130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64495136|NCT02522130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64495137|NCT02522130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64495138|NCT02522130|Oxytocics|oxytocics|mesh-ancestor
64721519|NCT00381368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64721520|NCT00381368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721521|NCT05722418|Cyclophosphamide|cyclophosphamide|mesh-list
64721522|NCT05722418|Fludarabine|fludarabine|mesh-list
64721523|NCT05722418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64721524|NCT05722418|Immunologic Factors|immunologic factors|mesh-ancestor
64721525|NCT05722418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721526|NCT05722418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65479954|NCT01288820|Antimalarials|antimalarials|mesh-ancestor
65479955|NCT01288820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65479956|NCT01288820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65479957|NCT01288820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65479958|NCT01288820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65479959|NCT01288820|Antiviral Agents|antiviral agents|mesh-ancestor
65479960|NCT01288820|Schistosomicides|schistosomicides|mesh-ancestor
65479961|NCT01288820|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65479962|NCT01288820|Anthelmintics|anthelmintics|mesh-ancestor
65479963|NCT00367055|Metformin|metformin|mesh-list
65479964|NCT00367055|Rosiglitazone|rosiglitazone|mesh-list
65479965|NCT00367055|Gliclazide|gliclazide|mesh-list
65479966|NCT00367055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65479967|NCT00367055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479968|NCT00057330|polysaccharide-K|polysaccharide-k|mesh-list
65479969|NCT00057330|Vaccines|vaccines|mesh-list
65479970|NCT00057330|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
65479971|NCT00057330|Immunologic Factors|immunologic factors|mesh-ancestor
65479972|NCT00057330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65479973|NCT00057330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65479974|NCT00057330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65479975|NCT00057330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65479976|NCT00057330|Antiviral Agents|antiviral agents|mesh-ancestor
65479977|NCT00057330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65479978|NCT00057330|Interferon Inducers|interferon inducers|mesh-ancestor
65479979|NCT00057330|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65479980|NCT00057330|Protective Agents|protective agents|mesh-ancestor
65479981|NCT03857672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65479982|NCT03857672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65480004|NCT02530788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480005|NCT02530788|Protective Agents|protective agents|mesh-ancestor
65480006|NCT02530788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480007|NCT02530788|Trace Elements|trace elements|mesh-ancestor
65480008|NCT02530788|Micronutrients|micronutrients|mesh-ancestor
65480009|NCT01288898|Ipragliflozin|ipragliflozin|mesh-list
65480010|NCT01288898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65480011|NCT01288898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480012|NCT01288898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65480013|NCT01288898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480014|NCT01089192|Metformin|metformin|mesh-list
65480015|NCT01089192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65480016|NCT01089192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480017|NCT02564380|Pembrolizumab|pembrolizumab|mesh-list
65480018|NCT02564380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65480019|NCT02564380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480020|NCT01093092|Calcitriol|calcitriol|mesh-list
65480021|NCT01093092|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
65480022|NCT01093092|Gemcitabine|gemcitabine|mesh-list
65480023|NCT01093092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480024|NCT01093092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65480025|NCT01093092|Antimetabolites|antimetabolites|mesh-ancestor
65480026|NCT01093092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480027|NCT01093092|Antiviral Agents|antiviral agents|mesh-ancestor
65480028|NCT01093092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65480029|NCT01093092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721527|NCT05722418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64721528|NCT05722418|Alkylating Agents|alkylating agents|mesh-ancestor
64721529|NCT05722418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721530|NCT05722418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721531|NCT05722418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64721532|NCT04024501|Verinurad|verinurad|mesh-list
64721533|NCT04024501|Gout Suppressants|gout suppressants|mesh-ancestor
64721534|NCT04024501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64736768|NCT05599919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736769|NCT05599919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64329323|NCT02384889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64329324|NCT02384889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64329325|NCT02384889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64329326|NCT02384889|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64329327|NCT02384889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329328|NCT02384889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329329|NCT02299336|Aflibercept|aflibercept|mesh-list
64329330|NCT02299336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64329331|NCT02299336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64329332|NCT02299336|Growth Substances|growth substances|mesh-ancestor
64329333|NCT02299336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329334|NCT02299336|Growth Inhibitors|growth inhibitors|mesh-ancestor
65480030|NCT01093092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65480031|NCT01093092|Immunologic Factors|immunologic factors|mesh-ancestor
65480032|NCT01093092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480033|NCT01093092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65480034|NCT01093092|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65480035|NCT01093092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65480036|NCT01093092|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65480037|NCT01093092|Vitamins|vitamins|mesh-ancestor
65480038|NCT01093092|Micronutrients|micronutrients|mesh-ancestor
65480039|NCT01093092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65480040|NCT01289054|Imatinib Mesylate|imatinib mesylate|mesh-list
65480041|NCT01289054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480042|NCT01289054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65480043|NCT01289054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480044|NCT01289054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480045|NCT01179776|Iloprost|iloprost|mesh-list
65480046|NCT01179776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65480047|NCT01179776|Vasodilator Agents|vasodilator agents|mesh-ancestor
65480048|NCT00062010|Interferons|interferons|mesh-list
65480049|NCT00062010|Interferon-alpha|interferon-alpha|mesh-list
65480050|NCT00062010|Interferon alpha-2|interferon alpha-2|mesh-list
65480051|NCT00062010|Paclitaxel|paclitaxel|mesh-list
65480052|NCT00062010|Tretinoin|tretinoin|mesh-list
64329335|NCT02299336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329336|NCT02384655|Fenugreek seed meal|fenugreek seed meal|mesh-list
64329337|NCT02384655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64329338|NCT02384655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329339|NCT02186483|Metformin|metformin|mesh-list
64495139|NCT02522130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64495140|NCT02522130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64721535|NCT05722262|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
64721536|NCT05722262|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64721596|NCT00002426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721597|NCT00002432|Foscarnet|foscarnet|mesh-list
64721598|NCT00002432|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
64721599|NCT00002432|Antiviral Agents|antiviral agents|mesh-ancestor
64721600|NCT00002432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721601|NCT00002432|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64721602|NCT00002432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64721603|NCT00002432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721604|NCT00002432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721605|NCT05701436|Leucovorin|leucovorin|mesh-list
64721606|NCT05701436|Doxorubicin|doxorubicin|mesh-list
64721607|NCT05701436|Fluorouracil|fluorouracil|mesh-list
64721608|NCT05701436|Oxaliplatin|oxaliplatin|mesh-list
64721609|NCT05701436|Raltitrexed|raltitrexed|mesh-list
64721610|NCT05701436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721611|NCT05701436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64721612|NCT05701436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64329404|NCT02191007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64329405|NCT02298946|Cyclophosphamide|cyclophosphamide|mesh-list
65480053|NCT00062010|Isotretinoin|isotretinoin|mesh-list
65480054|NCT00062010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65480055|NCT00062010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480056|NCT00062010|Tubulin Modulators|tubulin modulators|mesh-ancestor
65480057|NCT00062010|Antimitotic Agents|antimitotic agents|mesh-ancestor
65480058|NCT00062010|Mitosis Modulators|mitosis modulators|mesh-ancestor
65480059|NCT00062010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480060|NCT00062010|Antiviral Agents|antiviral agents|mesh-ancestor
65480061|NCT00062010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65480062|NCT00062010|Immunologic Factors|immunologic factors|mesh-ancestor
65480063|NCT00062010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480064|NCT00062010|Keratolytic Agents|keratolytic agents|mesh-ancestor
65480065|NCT00062010|Dermatologic Agents|dermatologic agents|mesh-ancestor
65480066|NCT01181414|Amiodarone|amiodarone|mesh-list
65480067|NCT01181414|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65480068|NCT01181414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65480069|NCT01181414|Adrenergic Agents|adrenergic agents|mesh-ancestor
65480070|NCT01181414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65480071|NCT01181414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480072|NCT01181414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480073|NCT01181414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65480074|NCT01181414|Vasodilator Agents|vasodilator agents|mesh-ancestor
65480075|NCT01181414|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65480076|NCT01181414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65480077|NCT01181414|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65480078|NCT01181414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64329406|NCT02298946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64329407|NCT02298946|Immunologic Factors|immunologic factors|mesh-ancestor
64329408|NCT02298946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329409|NCT02298946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64329410|NCT02298946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64329411|NCT02298946|Alkylating Agents|alkylating agents|mesh-ancestor
64329412|NCT02298946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329413|NCT02298946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329414|NCT02298946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64329415|NCT04470115|Anesthetics|anesthetics|mesh-list
64329416|NCT04470115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64329417|NCT04470115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329426|NCT02384343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64329427|NCT02384343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64329429|NCT02384343|Adrenergic Agents|adrenergic agents|mesh-ancestor
64495141|NCT02522130|Analgesics|analgesics|mesh-ancestor
64495142|NCT02522130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64495143|NCT02522130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64495144|NCT02522130|Gout Suppressants|gout suppressants|mesh-ancestor
64721626|NCT05701436|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64721627|NCT02487277|Gemcitabine|gemcitabine|mesh-list
64721628|NCT02487277|Paclitaxel|paclitaxel|mesh-list
65480079|NCT01181414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65480080|NCT01181414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480081|NCT01181414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65480082|NCT01181414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65480083|NCT01181414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65480084|NCT01094340|Thalidomide|thalidomide|mesh-list
65480085|NCT01094340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65480086|NCT01094340|Immunologic Factors|immunologic factors|mesh-ancestor
65480087|NCT01094340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480088|NCT01094340|Leprostatic Agents|leprostatic agents|mesh-ancestor
65480089|NCT01094340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65480090|NCT01094340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65480091|NCT01094340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65480092|NCT01094340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65480093|NCT01094340|Growth Substances|growth substances|mesh-ancestor
65480094|NCT01094340|Growth Inhibitors|growth inhibitors|mesh-ancestor
65480095|NCT01094340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480096|NCT00056862|Ribavirin|ribavirin|mesh-list
65480097|NCT00056862|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65480098|NCT00056862|Interferon-alpha|interferon-alpha|mesh-list
64721629|NCT02487277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64721630|NCT02487277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721631|NCT02487277|Tubulin Modulators|tubulin modulators|mesh-ancestor
64721632|NCT02487277|Antimitotic Agents|antimitotic agents|mesh-ancestor
64721633|NCT02487277|Mitosis Modulators|mitosis modulators|mesh-ancestor
64721634|NCT02487277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721635|NCT02487277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64721636|NCT02487277|Antimetabolites|antimetabolites|mesh-ancestor
64721637|NCT02487277|Antiviral Agents|antiviral agents|mesh-ancestor
64721638|NCT02487277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721639|NCT02487277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721640|NCT02487277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64721641|NCT02487277|Immunologic Factors|immunologic factors|mesh-ancestor
64721642|NCT02487277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721643|NCT00002438|Itraconazole|itraconazole|mesh-list
64721644|NCT00002438|Antifungal Agents|antifungal agents|mesh-ancestor
64721645|NCT00002438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64329430|NCT02384343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64329433|NCT05033639|Antioxidants|antioxidants|mesh-ancestor
64329434|NCT05033639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329435|NCT05033639|Protective Agents|protective agents|mesh-ancestor
64721652|NCT00002438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64721653|NCT00002438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721654|NCT00002438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64721655|NCT00002444|Nitazoxanide|nitazoxanide|mesh-list
64721656|NCT00002444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64721657|NCT00002444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721658|NCT02436265|Dexamethasone|dexamethasone|mesh-list
64721659|NCT02436265|Ropivacaine|ropivacaine|mesh-list
64329436|NCT05033639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329437|NCT05033639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64329438|NCT02328040|Insulin|insulin|mesh-list
64329439|NCT02328040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64329440|NCT02328040|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64329441|NCT02328040|Insulin Aspart|insulin aspart|mesh-list
65480099|NCT00056862|Antimetabolites|antimetabolites|mesh-ancestor
65480100|NCT00056862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480101|NCT00056862|Antiviral Agents|antiviral agents|mesh-ancestor
65480102|NCT00056862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65480103|NCT00056862|Immunologic Factors|immunologic factors|mesh-ancestor
65480104|NCT00056862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480105|NCT01289132|Candesartan|candesartan|mesh-list
65480106|NCT01289132|Candesartan cilexetil|candesartan cilexetil|mesh-list
65480107|NCT01289132|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65480108|NCT01289132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65480109|NCT01289132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65480110|NCT01289132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65480111|NCT01289132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480112|NCT01287260|Nifedipine|nifedipine|mesh-list
65480113|NCT01287260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65480114|NCT01287260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64864171|NCT01775891|Flecainide|flecainide|mesh-list
64495145|NCT02522130|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64495146|NCT02522130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64495147|NCT01148524|Vaccines|vaccines|mesh-list
64495167|NCT05215236|Narcotics|narcotics|mesh-ancestor
64495168|NCT05215236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64495169|NCT05215236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495170|NCT05215236|Analgesics|analgesics|mesh-ancestor
64495171|NCT05215236|Sensory System Agents|sensory system agents|mesh-ancestor
64495172|NCT05215236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64495173|NCT03460782|Ipilimumab|ipilimumab|mesh-list
64495174|NCT03460782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64495175|NCT03460782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495176|NCT03460782|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64495177|NCT03460782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495178|NCT01099618|Metformin|metformin|mesh-list
64495179|NCT01099618|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64495180|NCT01099618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64495181|NCT01099618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495182|NCT01099618|Incretins|incretins|mesh-ancestor
64495183|NCT01099618|Hormones|hormones|mesh-ancestor
64721660|NCT02436265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64721661|NCT02436265|Antiemetics|antiemetics|mesh-ancestor
64721662|NCT02436265|Autonomic Agents|autonomic agents|mesh-ancestor
64721663|NCT02436265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64721664|NCT02436265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721665|NCT02436265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64721666|NCT02436265|Glucocorticoids|glucocorticoids|mesh-ancestor
64721667|NCT02436265|Hormones|hormones|mesh-ancestor
64721668|NCT02436265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64721669|NCT02436265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64721670|NCT02436265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721671|NCT02436265|Anesthetics, Local|anesthetics, local|mesh-ancestor
64721672|NCT02436265|Anesthetics|anesthetics|mesh-ancestor
64721673|NCT02436265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64721674|NCT02436265|Sensory System Agents|sensory system agents|mesh-ancestor
64721675|NCT05751746|Magnesium Sulfate|magnesium sulfate|mesh-list
64721676|NCT05751746|Analgesics|analgesics|mesh-ancestor
64721677|NCT05751746|Sensory System Agents|sensory system agents|mesh-ancestor
64721678|NCT05751746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64721679|NCT05751746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721680|NCT05751746|Anesthetics|anesthetics|mesh-ancestor
65480115|NCT01287260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480116|NCT01287260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65480117|NCT01287260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480118|NCT01287260|Vasodilator Agents|vasodilator agents|mesh-ancestor
65480119|NCT01287260|Tocolytic Agents|tocolytic agents|mesh-ancestor
65480120|NCT01287260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65480121|NCT01181570|Adalimumab|adalimumab|mesh-list
65480122|NCT01181570|Mannitol|mannitol|mesh-list
65480123|NCT01181570|Citric Acid|citric acid|mesh-list
65480124|NCT01181570|Sodium Citrate|sodium citrate|mesh-list
65480125|NCT01181570|Anticoagulants|anticoagulants|mesh-ancestor
65480126|NCT01181570|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65480127|NCT01181570|Chelating Agents|chelating agents|mesh-ancestor
65480128|NCT01181570|Sequestering Agents|sequestering agents|mesh-ancestor
65480129|NCT01181570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480130|NCT01181570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65480131|NCT01181570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64721681|NCT05751746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64721682|NCT05751746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64721683|NCT05751746|Anticonvulsants|anticonvulsants|mesh-ancestor
64721684|NCT05751746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64721685|NCT05751746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64721686|NCT05751746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721687|NCT05751746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64721688|NCT05751746|Tocolytic Agents|tocolytic agents|mesh-ancestor
64721689|NCT05751746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64721690|NCT00002450|Tenofovir|tenofovir|mesh-list
64329476|NCT02187107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329477|NCT02187107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329478|NCT02187107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64495188|NCT01099618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495189|NCT01099774|Bimatoprost|bimatoprost|mesh-list
64495190|NCT01099774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64495191|NCT01099774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64495192|NCT01099774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64495200|NCT01100242|Bortezomib|bortezomib|mesh-list
64495201|NCT01100242|Sorafenib|sorafenib|mesh-list
64495202|NCT01100242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495203|NCT01100242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64721711|NCT00002456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721712|NCT00002456|Dermatologic Agents|dermatologic agents|mesh-ancestor
64329485|NCT02285491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64329486|NCT02285491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329487|NCT02285491|Sensory System Agents|sensory system agents|mesh-ancestor
64329488|NCT02285491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64329490|NCT02298868|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64329491|NCT02298868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329492|NCT02298868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64329493|NCT02298868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64329494|NCT02298868|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64329495|NCT02298868|GABA Agonists|gaba agonists|mesh-ancestor
64418250|NCT05542381|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64329496|NCT02298868|GABA Agents|gaba agents|mesh-ancestor
64721714|NCT00002456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64721715|NCT00002456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64721716|NCT00002456|Immunologic Factors|immunologic factors|mesh-ancestor
64721717|NCT00002456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65480132|NCT01181570|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65480133|NCT01181570|Diuretics|diuretics|mesh-ancestor
65480134|NCT01181570|Natriuretic Agents|natriuretic agents|mesh-ancestor
65480135|NCT01181570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480136|NCT05200312|Prednisone|prednisone|mesh-list
65480137|NCT05200312|Cyclophosphamide|cyclophosphamide|mesh-list
65480138|NCT05200312|Rituximab|rituximab|mesh-list
65480139|NCT05200312|Doxorubicin|doxorubicin|mesh-list
65480140|NCT05200312|Vincristine|vincristine|mesh-list
65480141|NCT05200312|Lenalidomide|lenalidomide|mesh-list
65480142|NCT05200312|Zanubrutinib|zanubrutinib|mesh-list
65480143|NCT05200312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65480144|NCT05200312|Immunologic Factors|immunologic factors|mesh-ancestor
65480145|NCT05200312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480146|NCT05200312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65480147|NCT05200312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65480148|NCT05200312|Alkylating Agents|alkylating agents|mesh-ancestor
65480149|NCT05200312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480150|NCT05200312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480151|NCT05200312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64721718|NCT00002456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64721719|NCT00002456|Antifungal Agents|antifungal agents|mesh-ancestor
64721720|NCT00002456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721721|NCT00002456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64721722|NCT01525927|Cisplatin|cisplatin|mesh-list
64721723|NCT01525927|Carboplatin|carboplatin|mesh-list
64721724|NCT01525927|Etoposide|etoposide|mesh-list
64721725|NCT01525927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721726|NCT01525927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64721727|NCT01525927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64721728|NCT01525927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64721729|NCT01525927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721730|NCT01525927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329497|NCT02298868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64329498|NCT02298868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329499|NCT04881682|Immunoglobulins|immunoglobulins|mesh-list
64329500|NCT04881682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64329501|NCT04881682|Antibodies|antibodies|mesh-list
64329502|NCT04881682|Immunologic Factors|immunologic factors|mesh-ancestor
64329503|NCT04881682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329504|NCT02389179|Vitamin D|vitamin d|mesh-list
64329505|NCT02389179|Cholecalciferol|cholecalciferol|mesh-list
64329506|NCT02389179|Vitamins|vitamins|mesh-ancestor
64329507|NCT02389179|Micronutrients|micronutrients|mesh-ancestor
64329508|NCT02389179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329509|NCT02389179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64329510|NCT02389179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64329511|NCT02285647|Rolapitant|rolapitant|mesh-list
64329512|NCT02285647|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64329513|NCT02285647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64721736|NCT00002474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721737|NCT00002474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64721738|NCT00002474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64329514|NCT02285647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329515|NCT02285647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329516|NCT02187419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65480152|NCT05200312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65480153|NCT05200312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65480154|NCT05200312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65480155|NCT05200312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65480156|NCT05200312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480157|NCT05200312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65480158|NCT05200312|Glucocorticoids|glucocorticoids|mesh-ancestor
65480159|NCT05200312|Hormones|hormones|mesh-ancestor
65480160|NCT05200312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65480163|NCT05200312|Tubulin Modulators|tubulin modulators|mesh-ancestor
65480216|NCT01287338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480217|NCT01180322|Cytarabine|cytarabine|mesh-list
65480218|NCT01180322|Etoposide|etoposide|mesh-list
65480219|NCT01180322|Idarubicin|idarubicin|mesh-list
65480220|NCT01180322|Azacitidine|azacitidine|mesh-list
65480221|NCT01180322|Lenograstim|lenograstim|mesh-list
65480222|NCT01180322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65480223|NCT01180322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480224|NCT01180322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65480225|NCT01180322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65480226|NCT01180322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480227|NCT01180322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480228|NCT01180322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65480229|NCT01180322|Antimetabolites|antimetabolites|mesh-ancestor
65480230|NCT01180322|Antiviral Agents|antiviral agents|mesh-ancestor
65480231|NCT01180322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65480232|NCT01180322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65480233|NCT01180322|Immunologic Factors|immunologic factors|mesh-ancestor
65480234|NCT01180322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480235|NCT01180322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65480236|NCT01180322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65480237|NCT01287494|Sertraline|sertraline|mesh-list
65480238|NCT01287494|Antidepressive Agents|antidepressive agents|mesh-ancestor
65480239|NCT01287494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65480240|NCT01287494|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65480241|NCT01287494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65480242|NCT01287494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65480243|NCT01287494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480244|NCT01287494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65480245|NCT01287494|Serotonin Agents|serotonin agents|mesh-ancestor
65480246|NCT01287494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480247|NCT02524964|Tanshinone|tanshinone|mesh-list
65480258|NCT02524964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65480259|NCT02524964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480260|NCT02524964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65480261|NCT02524964|Immunologic Factors|immunologic factors|mesh-ancestor
65480262|NCT02639702|Clozapine|clozapine|mesh-list
65480263|NCT02639702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65480264|NCT02639702|Serotonin Agents|serotonin agents|mesh-ancestor
65480265|NCT02639702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65480266|NCT02639702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480267|NCT02639702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480268|NCT02639702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65480269|NCT02639702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65480270|NCT02639702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65480271|NCT02639702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65480272|NCT02639702|GABA Antagonists|gaba antagonists|mesh-ancestor
65480273|NCT02639702|GABA Agents|gaba agents|mesh-ancestor
65480274|NCT01289756|Clarithromycin|clarithromycin|mesh-list
65480275|NCT01289756|Paroxetine|paroxetine|mesh-list
65480276|NCT01289756|Clomiphene|clomiphene|mesh-list
65480277|NCT01289756|Enclomiphene|enclomiphene|mesh-list
65480278|NCT01289756|Zuclomiphene|zuclomiphene|mesh-list
65480279|NCT01289756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65480280|NCT01289756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65480281|NCT01289756|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65480282|NCT01289756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480283|NCT01289756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480284|NCT01289756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65480285|NCT01289756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65480286|NCT01289756|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64329517|NCT02187419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64329518|NCT02187419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329519|NCT02187497|Telmisartan|telmisartan|mesh-list
64329520|NCT02187497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64495208|NCT01148836|Micronutrients|micronutrients|mesh-ancestor
64495209|NCT01148836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495210|NCT01148836|Vitamins|vitamins|mesh-ancestor
64495211|NCT01149616|Dexamethasone|dexamethasone|mesh-list
64495212|NCT01149616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64495213|NCT01149616|Antiemetics|antiemetics|mesh-ancestor
64495214|NCT01149616|Autonomic Agents|autonomic agents|mesh-ancestor
64495215|NCT01149616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64495216|NCT01149616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495217|NCT01149616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64495218|NCT01149616|Glucocorticoids|glucocorticoids|mesh-ancestor
64495219|NCT01149616|Hormones|hormones|mesh-ancestor
64495220|NCT01149616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64495221|NCT01149616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65480287|NCT01289756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65480288|NCT01289756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65480289|NCT01289756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65480290|NCT01289756|Serotonin Agents|serotonin agents|mesh-ancestor
65480291|NCT01289756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480292|NCT01289756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65480293|NCT01289756|Antidepressive Agents|antidepressive agents|mesh-ancestor
65480294|NCT01289756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65480295|NCT01289756|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65480296|NCT01289756|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65480297|NCT01289756|Hormone Antagonists|hormone antagonists|mesh-ancestor
65480298|NCT01289756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65480299|NCT01289756|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65480300|NCT01289756|Fertility Agents|fertility agents|mesh-ancestor
65480301|NCT01289756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65480302|NCT01289756|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65480303|NCT01289756|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65480305|NCT01181882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65480306|NCT01181882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65480307|NCT01181882|Analgesics|analgesics|mesh-ancestor
65480308|NCT01181882|Sensory System Agents|sensory system agents|mesh-ancestor
65480309|NCT01181882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65480310|NCT01181882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480311|NCT01181882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65480312|NCT01181882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65480313|NCT01181882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64864358|NCT01777919|Micronutrients|micronutrients|mesh-ancestor
64495222|NCT01149616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495223|NCT03460470|Sildenafil Citrate|sildenafil citrate|mesh-list
64495224|NCT03460470|Vasodilator Agents|vasodilator agents|mesh-ancestor
64495225|NCT03460470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64495226|NCT03460470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64495227|NCT03460470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64495250|NCT03011632|Dermatologic Agents|dermatologic agents|mesh-ancestor
64495251|NCT03011632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64495252|NCT01102270|Eszopiclone|eszopiclone|mesh-list
64495253|NCT01102270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64495254|NCT01102270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64495255|NCT01102270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495256|NCT01103440|polysaccharide-K|polysaccharide-k|mesh-list
64495258|NCT01103440|Ticlopidine|ticlopidine|mesh-list
64495259|NCT01103440|Abciximab|abciximab|mesh-list
64495260|NCT01103440|Clopidogrel|clopidogrel|mesh-list
64495261|NCT01103440|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64495262|NCT01103440|Cangrelor|cangrelor|mesh-list
65480314|NCT01181882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65480315|NCT01181882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480316|NCT01181882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65480317|NCT01181882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65480318|NCT01181882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480319|NCT01181882|Antipyretics|antipyretics|mesh-ancestor
65480320|NCT01181960|Risperidone|risperidone|mesh-list
65480321|NCT01181960|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65480322|NCT01181960|Antipsychotic Agents|antipsychotic agents|mesh-list
65480323|NCT01181960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65480324|NCT01181960|Serotonin Agents|serotonin agents|mesh-ancestor
65480325|NCT01181960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65480326|NCT01181960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480332|NCT01181960|Dopamine Agents|dopamine agents|mesh-ancestor
65480375|NCT03307252|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65480376|NCT03307252|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65480377|NCT03307252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65480378|NCT03307252|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65480379|NCT03307252|Protective Agents|protective agents|mesh-ancestor
65480380|NCT03307252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65480381|NCT03307252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65480382|NCT03307252|Vasodilator Agents|vasodilator agents|mesh-ancestor
65480383|NCT03307252|Uricosuric Agents|uricosuric agents|mesh-ancestor
65480384|NCT03307252|Gout Suppressants|gout suppressants|mesh-ancestor
65480385|NCT03307252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65480386|NCT03307252|Renal Agents|renal agents|mesh-ancestor
65480387|NCT03307252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65480388|NCT03307252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65480389|NCT03307252|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65480390|NCT03307252|Histamine Antagonists|histamine antagonists|mesh-ancestor
65480391|NCT03307252|Histamine Agents|histamine agents|mesh-ancestor
65480392|NCT03307252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65480393|NCT03307252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65480394|NCT03307252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65480395|NCT03307174|Fentanyl|fentanyl|mesh-list
65480396|NCT03307174|Bupivacaine|bupivacaine|mesh-list
65480397|NCT03307174|Anesthetics, Local|anesthetics, local|mesh-ancestor
65480398|NCT03307174|Anesthetics|anesthetics|mesh-ancestor
65480399|NCT03307174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65480400|NCT03307174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480401|NCT03307174|Sensory System Agents|sensory system agents|mesh-ancestor
65480402|NCT03307174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65480403|NCT03307174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65480404|NCT03307174|Narcotics|narcotics|mesh-ancestor
64495263|NCT01103440|Eptifibatide|eptifibatide|mesh-list
64495264|NCT01103440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64495265|NCT01103440|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64495266|NCT01103440|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64495267|NCT01103440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64495268|NCT01103440|Purinergic Agents|purinergic agents|mesh-ancestor
64329522|NCT02187497|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64329523|NCT02187497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329525|NCT04195750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329526|NCT04195750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64495269|NCT01103440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64495270|NCT01103440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495271|NCT01103440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495272|NCT01103440|Anticoagulants|anticoagulants|mesh-ancestor
65480405|NCT03307174|Analgesics|analgesics|mesh-ancestor
65480406|NCT03307174|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65480407|NCT03307174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65480408|NCT03307174|Anesthetics, General|anesthetics, general|mesh-ancestor
65480409|NCT03448978|Cyclophosphamide|cyclophosphamide|mesh-list
65480410|NCT03448978|Fludarabine|fludarabine|mesh-list
65480411|NCT03448978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65480412|NCT03448978|Immunologic Factors|immunologic factors|mesh-ancestor
65480413|NCT03448978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480414|NCT03448978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65480415|NCT03448978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65480416|NCT03448978|Alkylating Agents|alkylating agents|mesh-ancestor
65480417|NCT03448978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480418|NCT03448978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480419|NCT03448978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65480420|NCT01290926|Sorafenib|sorafenib|mesh-list
65480421|NCT01290926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480422|NCT01290926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65480423|NCT01290926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480424|NCT01290926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480425|NCT01185158|Gefitinib|gefitinib|mesh-list
65480426|NCT01185158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480427|NCT01185158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65480428|NCT01185158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480429|NCT01185158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480430|NCT01185236|Atorvastatin|atorvastatin|mesh-list
65480431|NCT01185236|Simvastatin|simvastatin|mesh-list
65480432|NCT01185236|Ezetimibe|ezetimibe|mesh-list
65480433|NCT01185236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65480434|NCT01185236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65480435|NCT01185236|Antimetabolites|antimetabolites|mesh-ancestor
65480436|NCT01185236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480437|NCT01185236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65480438|NCT01185236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65480439|NCT01185236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480440|NCT02524652|Ropivacaine|ropivacaine|mesh-list
65480441|NCT02524652|Anesthetics, Local|anesthetics, local|mesh-ancestor
65480442|NCT02524652|Anesthetics|anesthetics|mesh-ancestor
65480443|NCT02524652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65480444|NCT02524652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480445|NCT02524652|Sensory System Agents|sensory system agents|mesh-ancestor
65480446|NCT02524652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65480447|NCT01182272|Sorafenib|sorafenib|mesh-list
65480448|NCT01182272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480449|NCT01182272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65480450|NCT01182272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480451|NCT01182272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480452|NCT03861416|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65480454|NCT01185470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65480455|NCT01185470|Narcotics|narcotics|mesh-ancestor
65480456|NCT01185470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65480457|NCT01185470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480458|NCT01185470|Analgesics|analgesics|mesh-ancestor
65480459|NCT01185470|Sensory System Agents|sensory system agents|mesh-ancestor
65480460|NCT01185470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65480461|NCT00056160|Dexamethasone|dexamethasone|mesh-list
65480462|NCT00056160|Lenalidomide|lenalidomide|mesh-list
65480463|NCT00056160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65480464|NCT00056160|Antiemetics|antiemetics|mesh-ancestor
65480465|NCT00056160|Autonomic Agents|autonomic agents|mesh-ancestor
65480466|NCT00056160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65480467|NCT00056160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480468|NCT00056160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65480469|NCT00056160|Glucocorticoids|glucocorticoids|mesh-ancestor
65480470|NCT00056160|Hormones|hormones|mesh-ancestor
65480471|NCT00056160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65480472|NCT00056160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65480473|NCT00056160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480479|NCT01290146|Simendan|simendan|mesh-list
65480485|NCT01290146|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65480486|NCT01290146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65480487|NCT01290146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480488|NCT01290146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480489|NCT01290146|Protective Agents|protective agents|mesh-ancestor
65480490|NCT00061932|Irinotecan|irinotecan|mesh-list
65480491|NCT00061932|Bortezomib|bortezomib|mesh-list
65480492|NCT00061932|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65480493|NCT00061932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65480494|NCT00061932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480495|NCT00061932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480496|NCT00061932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480497|NCT03856970|Glyburide|glyburide|mesh-list
65480498|NCT03856970|Digoxin|digoxin|mesh-list
65480499|NCT03856970|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65480500|NCT03856970|Norethindrone|norethindrone|mesh-list
65480501|NCT03856970|Estradiol|estradiol|mesh-list
65480502|NCT03856970|Estrogens|estrogens|mesh-ancestor
65480503|NCT03856970|Hormones|hormones|mesh-ancestor
65480504|NCT03856970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65480505|NCT03856970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495273|NCT01103440|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64495279|NCT01103440|Antiviral Agents|antiviral agents|mesh-ancestor
64495280|NCT01103440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64495281|NCT01103440|Interferon Inducers|interferon inducers|mesh-ancestor
64495282|NCT01103440|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64495283|NCT01103440|Protective Agents|protective agents|mesh-ancestor
64495300|NCT04488978|Irbesartan|irbesartan|mesh-list
64495301|NCT04488978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64495302|NCT04488978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64495303|NCT04488978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64495304|NCT04488978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721749|NCT05751668|Paclitaxel|paclitaxel|mesh-list
64721750|NCT05751668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64721751|NCT05751668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721752|NCT05751668|Tubulin Modulators|tubulin modulators|mesh-ancestor
64721753|NCT05751668|Antimitotic Agents|antimitotic agents|mesh-ancestor
64721754|NCT05751668|Mitosis Modulators|mitosis modulators|mesh-ancestor
64721755|NCT05751668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721756|NCT00002492|Doxorubicin|doxorubicin|mesh-list
64721757|NCT00002492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64721758|NCT00002492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721759|NCT00002492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64721760|NCT00002492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64721761|NCT00002492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64721762|NCT00002492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721763|NCT00002492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721764|NCT05751512|Methotrexate|methotrexate|mesh-list
64329527|NCT04195750|Immunologic Factors|immunologic factors|mesh-ancestor
64329528|NCT04195750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329529|NCT00099853|Pioglitazone|pioglitazone|mesh-list
64329530|NCT00099853|Vildagliptin|vildagliptin|mesh-list
64329531|NCT00099853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64329532|NCT00099853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329533|NCT00099853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65480506|NCT03856970|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65480507|NCT03856970|Contraceptive Agents|contraceptive agents|mesh-ancestor
65480508|NCT03856970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65480509|NCT03856970|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65480510|NCT03856970|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65480511|NCT03856970|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65480512|NCT03856970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65480513|NCT03856970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65480514|NCT03856970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480515|NCT03856970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480516|NCT03856970|Protective Agents|protective agents|mesh-ancestor
65480517|NCT03856970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65480518|NCT03856970|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65480519|NCT01089348|Metronidazole|metronidazole|mesh-list
65480520|NCT01089348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65480521|NCT01089348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65480522|NCT01089348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65480523|NCT01089348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65230048|NCT00741169|Antiviral Agents|antiviral agents|mesh-ancestor
65480524|NCT01291316|Clonazepam|clonazepam|mesh-list
65480525|NCT01291316|Clobazam|clobazam|mesh-list
65480527|NCT01291316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65480528|NCT01291316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64864575|NCT01779492|Oxycodone|oxycodone|mesh-list
64329534|NCT00099853|Protease Inhibitors|protease inhibitors|mesh-ancestor
64329535|NCT00099853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329536|NCT00099853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329537|NCT02381145|Resveratrol|resveratrol|mesh-list
64329538|NCT02381145|Antioxidants|antioxidants|mesh-ancestor
64329539|NCT02381145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329540|NCT02381145|Protective Agents|protective agents|mesh-ancestor
64721765|NCT05751512|Cetuximab|cetuximab|mesh-list
64721766|NCT05751512|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64721767|NCT05751512|Abortifacient Agents|abortifacient agents|mesh-ancestor
64721768|NCT05751512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64721769|NCT05751512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721770|NCT05751512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64721771|NCT05751512|Antimetabolites|antimetabolites|mesh-ancestor
64721772|NCT05751512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721773|NCT05751512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721774|NCT05751512|Dermatologic Agents|dermatologic agents|mesh-ancestor
64721775|NCT05751512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721776|NCT05751512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64721777|NCT05751512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64721778|NCT05751512|Immunologic Factors|immunologic factors|mesh-ancestor
64721779|NCT05751512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64721780|NCT05751512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64721781|NCT05751512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64721782|NCT02373865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64721783|NCT02373865|Glimepiride|glimepiride|mesh-list
64721784|NCT02373865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65480529|NCT01291316|Cholinergic Agents|cholinergic agents|mesh-ancestor
65480530|NCT01291316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65480531|NCT01291316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480532|NCT01291316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480533|NCT01291316|Urological Agents|urological agents|mesh-ancestor
65480534|NCT01291316|Anticonvulsants|anticonvulsants|mesh-ancestor
65480535|NCT01291316|GABA Modulators|gaba modulators|mesh-ancestor
65480536|NCT01291316|GABA Agents|gaba agents|mesh-ancestor
65480537|NCT01291316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65480538|NCT01291316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65480539|NCT01291316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65480542|NCT01291316|GABA Agonists|gaba agonists|mesh-ancestor
65480593|NCT01182662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65480594|NCT01185938|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65480595|NCT01185938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65480596|NCT01185938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65480597|NCT01185938|Antimetabolites|antimetabolites|mesh-ancestor
65480598|NCT01185938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230120|NCT00650403|Serotonin Agents|serotonin agents|mesh-ancestor
65480599|NCT01185938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65480600|NCT01185938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65480601|NCT01185938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480602|NCT00059202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65480603|NCT00059202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65480604|NCT00059202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65480605|NCT01177358|Botulinum Toxins|botulinum toxins|mesh-list
65480606|NCT01177358|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65480607|NCT01177358|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65480608|NCT01177358|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65480609|NCT01177358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65480610|NCT01177358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480611|NCT01177358|Cholinergic Agents|cholinergic agents|mesh-ancestor
65480612|NCT01177358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65480613|NCT01177358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480614|NCT01177358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65480615|NCT01177358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65480616|NCT03854942|Naltrexone|naltrexone|mesh-list
65480617|NCT03854942|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65480618|NCT03854942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65480619|NCT03854942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480620|NCT03854942|Sensory System Agents|sensory system agents|mesh-ancestor
65480621|NCT03854942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65480622|NCT03278626|Paclitaxel|paclitaxel|mesh-list
65480623|NCT03278626|Carboplatin|carboplatin|mesh-list
65480624|NCT03278626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65480625|NCT03278626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480631|NCT01186094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65480632|NCT01186094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65480633|NCT01186094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65480634|NCT01186094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480635|NCT01186094|Antifungal Agents|antifungal agents|mesh-ancestor
65480636|NCT01186094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65480637|NCT01186094|Immunologic Factors|immunologic factors|mesh-ancestor
65480638|NCT01186094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480639|NCT01287806|Urinastatin|urinastatin|mesh-list
65480640|NCT01287806|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65480641|NCT01287806|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65480642|NCT01287806|Protease Inhibitors|protease inhibitors|mesh-ancestor
65480643|NCT01287806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480644|NCT01287806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480645|NCT01186172|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65480646|NCT01186172|Ethanol|ethanol|mesh-list
65480647|NCT01186172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65480648|NCT01186172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65480649|NCT01186172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65480650|NCT01186172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480651|NCT03854708|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
65480652|NCT03854708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65480653|NCT03854708|Hormones|hormones|mesh-ancestor
65480654|NCT03854708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65480655|NCT03854708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480656|NCT03860870|Clenbuterol|clenbuterol|mesh-list
65480657|NCT03860870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64721785|NCT02373865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721786|NCT02373865|Incretins|incretins|mesh-ancestor
64721787|NCT02373865|Hormones|hormones|mesh-ancestor
64721788|NCT02373865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64329546|NCT00097357|Enoxaparin sodium|enoxaparin sodium|mesh-list
64329547|NCT00097357|Apixaban|apixaban|mesh-list
64329548|NCT00097357|Anticoagulants|anticoagulants|mesh-ancestor
64329549|NCT00097357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64329550|NCT00097357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64329551|NCT00097357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329552|NCT00097357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64329553|NCT00097357|Antithrombins|antithrombins|mesh-ancestor
64329557|NCT02296840|Acetaminophen|acetaminophen|mesh-list
64721800|NCT00002498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64721801|NCT00002498|Immunologic Factors|immunologic factors|mesh-ancestor
64721802|NCT00002498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721803|NCT00002498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64721804|NCT00002498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64721805|NCT00002498|Alkylating Agents|alkylating agents|mesh-ancestor
64329569|NCT02296840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65480658|NCT03860870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65480659|NCT03860870|Adrenergic Agents|adrenergic agents|mesh-ancestor
65480660|NCT03860870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65480661|NCT03860870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480662|NCT03860870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480663|NCT03860870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65480664|NCT03860870|Autonomic Agents|autonomic agents|mesh-ancestor
65480665|NCT03860870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65480666|NCT03860870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65480667|NCT03860870|Respiratory System Agents|respiratory system agents|mesh-ancestor
65480668|NCT03860870|Sympathomimetics|sympathomimetics|mesh-ancestor
65480669|NCT01177514|Gabapentin|gabapentin|mesh-list
65480670|NCT01177514|Analgesics|analgesics|mesh-ancestor
65480671|NCT01177514|Sensory System Agents|sensory system agents|mesh-ancestor
65480672|NCT01177514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65480673|NCT01177514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480674|NCT01177514|Anticonvulsants|anticonvulsants|mesh-ancestor
65480675|NCT01177514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65480676|NCT01177514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65480677|NCT01177514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65480678|NCT01177514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65480679|NCT01177514|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65480680|NCT01177514|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65480681|NCT01177514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65480682|NCT01177514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480683|NCT01177514|Antimanic Agents|antimanic agents|mesh-ancestor
65480684|NCT00073008|Lapatinib|lapatinib|mesh-list
65480685|NCT00073008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480686|NCT00073008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65480687|NCT00073008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480688|NCT00073008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480689|NCT01182974|Acetaminophen|acetaminophen|mesh-list
65480690|NCT01182974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65480691|NCT01182974|Analgesics|analgesics|mesh-ancestor
65480697|NCT03856502|Dexamethasone acetate|dexamethasone acetate|mesh-list
65480698|NCT03856502|Levobupivacaine|levobupivacaine|mesh-list
65480699|NCT03856502|BB 1101|bb 1101|mesh-list
65480700|NCT03856502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65480701|NCT03856502|Antiemetics|antiemetics|mesh-ancestor
65480702|NCT03856502|Autonomic Agents|autonomic agents|mesh-ancestor
65480703|NCT03856502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65480704|NCT03856502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480705|NCT03856502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65480706|NCT03856502|Glucocorticoids|glucocorticoids|mesh-ancestor
65480707|NCT03856502|Hormones|hormones|mesh-ancestor
65480708|NCT03856502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65480709|NCT03856502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65480710|NCT03856502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480711|NCT03856502|Protease Inhibitors|protease inhibitors|mesh-ancestor
65480712|NCT03856502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480713|NCT03856502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480714|NCT03856502|Anesthetics, Local|anesthetics, local|mesh-ancestor
65480715|NCT03856502|Anesthetics|anesthetics|mesh-ancestor
65480716|NCT03856502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65480717|NCT03856502|Sensory System Agents|sensory system agents|mesh-ancestor
64329570|NCT02296840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64329571|NCT02296840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329572|NCT02296840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329573|NCT02296840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64329574|NCT02296840|Narcotics|narcotics|mesh-ancestor
64329576|NCT02296840|Antitussive Agents|antitussive agents|mesh-ancestor
64329577|NCT02296840|Respiratory System Agents|respiratory system agents|mesh-ancestor
64329578|NCT02191319|Nevirapine|nevirapine|mesh-list
64329579|NCT02191319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64329580|NCT02191319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64495305|NCT04488978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64495306|NCT04488978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495307|NCT04488978|Vasodilator Agents|vasodilator agents|mesh-ancestor
64495308|NCT04488978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64495309|NCT04488978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64495310|NCT03460002|Vaccines|vaccines|mesh-list
64495311|NCT03460002|Immunologic Factors|immunologic factors|mesh-ancestor
64495312|NCT03460002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495313|NCT01105702|Bevacizumab|bevacizumab|mesh-list
64495314|NCT01105702|Temozolomide|temozolomide|mesh-list
64495315|NCT01105702|Lithium Carbonate|lithium carbonate|mesh-list
64495316|NCT01105702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64495317|NCT01105702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495318|NCT01105702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64495319|NCT01105702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64495320|NCT01105702|Growth Substances|growth substances|mesh-ancestor
64721827|NCT00002504|Antiviral Agents|antiviral agents|mesh-ancestor
64721828|NCT00002504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721829|NCT00002504|Immunologic Factors|immunologic factors|mesh-ancestor
64721830|NCT00002504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721831|NCT00002504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64721832|NCT00002504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65480718|NCT01583478|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65480719|NCT01583478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65480720|NCT01583478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65480721|NCT01583478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480722|NCT01583478|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65480723|NCT01583478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65480787|NCT01094964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65480788|NCT01291472|Ketorolac|ketorolac|mesh-list
65480789|NCT01291472|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65480790|NCT01291472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65480791|NCT01291472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65480792|NCT01291472|Analgesics|analgesics|mesh-ancestor
65480793|NCT01291472|Sensory System Agents|sensory system agents|mesh-ancestor
65480794|NCT01291472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65480795|NCT01291472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480796|NCT01291472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65480797|NCT01291472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65480798|NCT01291472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65480799|NCT01291472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480800|NCT01291472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480801|NCT02530632|Propofol|propofol|mesh-list
65480802|NCT02530632|Sevoflurane|sevoflurane|mesh-list
65480803|NCT02530632|Anesthetics|anesthetics|mesh-ancestor
65480804|NCT02530632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65480805|NCT02530632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721834|NCT02360059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64721835|NCT02360059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721836|NCT00002510|Cyclophosphamide|cyclophosphamide|mesh-list
64721837|NCT00002510|Etoposide|etoposide|mesh-list
64721838|NCT00002510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64721839|NCT00002510|Immunologic Factors|immunologic factors|mesh-ancestor
64721840|NCT00002510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721841|NCT00002510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64721842|NCT00002510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64721843|NCT00002510|Alkylating Agents|alkylating agents|mesh-ancestor
64721844|NCT00002510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721845|NCT00002510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721846|NCT00002510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64721847|NCT00002510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64721848|NCT00002510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64721849|NCT00002510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64721850|NCT00002510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721851|NCT01500109|Acetaminophen|acetaminophen|mesh-list
64721852|NCT01500109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64418521|NCT05678647|Micronutrients|micronutrients|mesh-ancestor
64721870|NCT00002516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64721872|NCT00002516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721873|NCT00002516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721874|NCT00002516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64721875|NCT00002516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64329612|NCT02191943|Fluorides|fluorides|mesh-list
64329613|NCT02191943|Fluorides, Topical|fluorides, topical|mesh-list
64329614|NCT02191943|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
64329615|NCT02191943|Cariostatic Agents|cariostatic agents|mesh-ancestor
64329616|NCT02191943|Protective Agents|protective agents|mesh-ancestor
64329617|NCT02191943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329618|NCT02663895|Treprostinil|treprostinil|mesh-list
64329619|NCT02663895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64329620|NCT00320203|Hydrocortisone|hydrocortisone|mesh-list
64329621|NCT00320203|Anecortave|anecortave|mesh-list
64329622|NCT00320203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65480806|NCT02530632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65480807|NCT02530632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65480808|NCT02530632|Anesthetics, General|anesthetics, general|mesh-ancestor
65480809|NCT02530632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65480810|NCT02530632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65480811|NCT01183364|Docetaxel|docetaxel|mesh-list
65480812|NCT01183364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480813|NCT01183364|Tubulin Modulators|tubulin modulators|mesh-ancestor
65480814|NCT01183364|Antimitotic Agents|antimitotic agents|mesh-ancestor
65480815|NCT01183364|Mitosis Modulators|mitosis modulators|mesh-ancestor
65480816|NCT01183364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480817|NCT00072384|Carboplatin|carboplatin|mesh-list
65480818|NCT00072384|Etoposide|etoposide|mesh-list
65480819|NCT00072384|Vincristine|vincristine|mesh-list
65480820|NCT00072384|Etoposide phosphate|etoposide phosphate|mesh-list
65480821|NCT00072384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480822|NCT00072384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65480823|NCT00072384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65480824|NCT00072384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65480862|NCT01187888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480863|NCT01187186|Ipragliflozin|ipragliflozin|mesh-list
65480864|NCT01187186|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65480865|NCT01187186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480866|NCT01187186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65480867|NCT01187186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480868|NCT00054132|Bevacizumab|bevacizumab|mesh-list
65480869|NCT00054132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65480870|NCT00054132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65480871|NCT00054132|Endothelial Growth Factors|endothelial growth factors|mesh-list
65480872|NCT00054132|Antibodies|antibodies|mesh-list
65480873|NCT00054132|Immunoglobulins|immunoglobulins|mesh-list
65480874|NCT00054132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65480875|NCT00054132|Immunoglobulin G|immunoglobulin g|mesh-list
65480876|NCT00054132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480877|NCT00054132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65480878|NCT00054132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65480879|NCT00054132|Growth Substances|growth substances|mesh-ancestor
65480880|NCT00054132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480881|NCT00054132|Growth Inhibitors|growth inhibitors|mesh-ancestor
65480882|NCT00054132|Immunologic Factors|immunologic factors|mesh-ancestor
65480883|NCT00054132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65480884|NCT00054132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480885|NCT00054132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480886|NCT01187264|Methotrexate|methotrexate|mesh-list
65480887|NCT01187264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65480888|NCT01187264|Abortifacient Agents|abortifacient agents|mesh-ancestor
65480889|NCT01187264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65480890|NCT01187264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480891|NCT01187264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65480892|NCT01187264|Antimetabolites|antimetabolites|mesh-ancestor
65480893|NCT01187264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480894|NCT01187264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480895|NCT01187264|Dermatologic Agents|dermatologic agents|mesh-ancestor
65480896|NCT01187264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480899|NCT01187264|Immunologic Factors|immunologic factors|mesh-ancestor
65480900|NCT01187264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65480901|NCT01187264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65480902|NCT01183676|Valproic Acid|valproic acid|mesh-list
65480903|NCT01183676|Anticonvulsants|anticonvulsants|mesh-ancestor
65480904|NCT01183676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480905|NCT01183676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480906|NCT01183676|GABA Agents|gaba agents|mesh-ancestor
65480907|NCT01183676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65480908|NCT01183676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480909|NCT01183676|Antimanic Agents|antimanic agents|mesh-ancestor
65480910|NCT01183676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65480911|NCT01183676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65480912|NCT01183676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65480913|NCT03856112|Dexamethasone|dexamethasone|mesh-list
65480914|NCT03856112|Dexamethasone acetate|dexamethasone acetate|mesh-list
65480915|NCT03856112|Venetoclax|venetoclax|mesh-list
65480916|NCT03856112|Ixazomib|ixazomib|mesh-list
65480917|NCT03856112|Ichthammol|ichthammol|mesh-list
65480918|NCT03856112|BB 1101|bb 1101|mesh-list
65480919|NCT03856112|Glycine|glycine|mesh-list
64329623|NCT00320203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64329624|NCT00320203|Growth Substances|growth substances|mesh-ancestor
64329625|NCT00320203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329626|NCT00320203|Growth Inhibitors|growth inhibitors|mesh-ancestor
64495329|NCT01105702|Antimanic Agents|antimanic agents|mesh-ancestor
64495330|NCT01105702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64721888|NCT00002516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64721889|NCT00002522|Cyclophosphamide|cyclophosphamide|mesh-list
64721890|NCT00002522|Etoposide|etoposide|mesh-list
64721891|NCT00002522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64721892|NCT00002522|Immunologic Factors|immunologic factors|mesh-ancestor
64721893|NCT00002522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721894|NCT00002522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64721895|NCT00002522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64721896|NCT00002522|Alkylating Agents|alkylating agents|mesh-ancestor
64721897|NCT00002522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721898|NCT00002522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721899|NCT00002522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64721900|NCT00002522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64721901|NCT00002522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64721902|NCT00002522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64721903|NCT00002522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721904|NCT00002528|Tamoxifen|tamoxifen|mesh-list
64721905|NCT00002528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64721906|NCT00002528|Hormone Antagonists|hormone antagonists|mesh-ancestor
64329635|NCT00069745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64329636|NCT00069745|Glucocorticoids|glucocorticoids|mesh-ancestor
64329637|NCT00069745|Hormones|hormones|mesh-ancestor
64329638|NCT00069745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64329639|NCT00069745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329656|NCT02193893|Dermatologic Agents|dermatologic agents|mesh-ancestor
64329657|NCT02384187|Gabapentin|gabapentin|mesh-list
64329658|NCT02384187|Analgesics|analgesics|mesh-ancestor
64329659|NCT02384187|Sensory System Agents|sensory system agents|mesh-ancestor
64495331|NCT01105702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64495332|NCT04453332|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65480920|NCT03856112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65480921|NCT03856112|Antiemetics|antiemetics|mesh-ancestor
65480922|NCT03856112|Autonomic Agents|autonomic agents|mesh-ancestor
65480923|NCT03856112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65480924|NCT03856112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480925|NCT03856112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65480926|NCT03856112|Glucocorticoids|glucocorticoids|mesh-ancestor
65480927|NCT03856112|Hormones|hormones|mesh-ancestor
65480928|NCT03856112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65480929|NCT03856112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65480930|NCT03856112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480931|NCT03856112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480932|NCT03856112|Protease Inhibitors|protease inhibitors|mesh-ancestor
65480933|NCT03856112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480934|NCT03856112|Glycine Agents|glycine agents|mesh-ancestor
65480935|NCT03856112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65480936|NCT03856112|Dermatologic Agents|dermatologic agents|mesh-ancestor
65480937|NCT01290380|Vadimezan|vadimezan|mesh-list
65480938|NCT01290380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480939|NCT00071760|Ritonavir|ritonavir|mesh-list
65480940|NCT00071760|Fosamprenavir|fosamprenavir|mesh-list
65480941|NCT00071760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65480942|NCT00071760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65480943|NCT00071760|Protease Inhibitors|protease inhibitors|mesh-ancestor
65480944|NCT00071760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480945|NCT00071760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480946|NCT00071760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65480947|NCT00071760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65480948|NCT00071760|Antiviral Agents|antiviral agents|mesh-ancestor
65480949|NCT00071760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65480950|NCT00071760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65480951|NCT00071760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65480952|NCT00057954|Cyclosporine|cyclosporine|mesh-list
65480962|NCT00057954|Antimetabolites|antimetabolites|mesh-ancestor
65480963|NCT00057954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480964|NCT00057954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480965|NCT00057954|Dermatologic Agents|dermatologic agents|mesh-ancestor
65480966|NCT00057954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480967|NCT00057954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65480968|NCT00057954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65480969|NCT00057954|Immunologic Factors|immunologic factors|mesh-ancestor
65480970|NCT00057954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65480971|NCT00057954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65480972|NCT00057954|Antifungal Agents|antifungal agents|mesh-ancestor
65480973|NCT00057954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65480974|NCT00057954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65480975|NCT00057954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65480976|NCT00057954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65480977|NCT00057954|Antitubercular Agents|antitubercular agents|mesh-ancestor
65480978|NCT00057954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65480979|NCT00057954|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65480980|NCT00057876|Gemcitabine|gemcitabine|mesh-list
65480981|NCT00057876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64495333|NCT04453332|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64495334|NCT04453332|Hormones|hormones|mesh-list
64495335|NCT04453332|Estradiol|estradiol|mesh-list
64495336|NCT04453332|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64495337|NCT04453332|Progesterone|progesterone|mesh-list
64495338|NCT04453332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64495339|NCT04453332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495340|NCT04453332|Estrogens|estrogens|mesh-ancestor
64495341|NCT04453332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64495376|NCT03464058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64495377|NCT03464058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495428|NCT01199926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64495430|NCT01106950|Fludarabine|fludarabine|mesh-list
64495431|NCT01106950|Interleukin-2|interleukin-2|mesh-list
64495432|NCT01106950|Denileukin diftitox|denileukin diftitox|mesh-list
64495433|NCT01106950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64495434|NCT01106950|Immunologic Factors|immunologic factors|mesh-ancestor
64495435|NCT01106950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721920|NCT02341495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721921|NCT02341495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64721922|NCT02341495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64721923|NCT02341495|Antimetabolites|antimetabolites|mesh-ancestor
64721924|NCT02341495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721925|NCT02341495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721926|NCT02341495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721927|NCT02341495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64721928|NCT02341495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64721929|NCT02341495|Chelating Agents|chelating agents|mesh-ancestor
64721930|NCT02341495|Sequestering Agents|sequestering agents|mesh-ancestor
64721931|NCT00002534|Cytarabine|cytarabine|mesh-list
64721932|NCT00002534|Methylprednisolone|methylprednisolone|mesh-list
64721933|NCT00002534|Cyclophosphamide|cyclophosphamide|mesh-list
64721934|NCT00002534|Thiotepa|thiotepa|mesh-list
64721935|NCT00002534|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65480982|NCT00057876|Antimetabolites|antimetabolites|mesh-ancestor
65480983|NCT00057876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480984|NCT00057876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65480985|NCT00057876|Antiviral Agents|antiviral agents|mesh-ancestor
65480986|NCT00057876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65480987|NCT00057876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65480988|NCT00057876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65480989|NCT00057876|Immunologic Factors|immunologic factors|mesh-ancestor
65480990|NCT00057876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480991|NCT01183910|Calcium Carbonate|calcium carbonate|mesh-list
65480992|NCT01183910|Calcium|calcium|mesh-list
65480993|NCT01183910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65480994|NCT01183910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65480995|NCT01183910|Antacids|antacids|mesh-ancestor
65480996|NCT01183910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65480997|NCT01183910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65480998|NCT03852914|Hyaluronic Acid|hyaluronic acid|mesh-list
65480999|NCT03852914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65481000|NCT03852914|Immunologic Factors|immunologic factors|mesh-ancestor
65481001|NCT03852914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481002|NCT03852914|Viscosupplements|viscosupplements|mesh-ancestor
65481003|NCT03852914|Protective Agents|protective agents|mesh-ancestor
65481004|NCT05234684|Prednisone|prednisone|mesh-list
65481005|NCT05234684|Cyclophosphamide|cyclophosphamide|mesh-list
65481006|NCT05234684|Vincristine|vincristine|mesh-list
64721936|NCT00002534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64721937|NCT00002534|Immunologic Factors|immunologic factors|mesh-ancestor
64721938|NCT00002534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721939|NCT00002534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64329660|NCT02384187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64329661|NCT02384187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329662|NCT02384187|Anticonvulsants|anticonvulsants|mesh-ancestor
64329663|NCT02384187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64329664|NCT02384187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64329665|NCT02384187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64329666|NCT02384187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64329667|NCT02384187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64721951|NCT00002534|Autonomic Agents|autonomic agents|mesh-ancestor
64329679|NCT02192723|Serotonin Agents|serotonin agents|mesh-ancestor
64329680|NCT02192723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64329681|NCT02192723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329682|NCT02192723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329683|NCT02192723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64329684|NCT02192723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64329685|NCT02192723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64329686|NCT02192723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64329687|NCT02192723|Dopamine Agents|dopamine agents|mesh-ancestor
64329688|NCT02192723|Antiemetics|antiemetics|mesh-ancestor
64329689|NCT02192723|Autonomic Agents|autonomic agents|mesh-ancestor
64329690|NCT02192723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65481007|NCT05234684|Rituximab|rituximab|mesh-list
65481008|NCT05234684|Doxorubicin|doxorubicin|mesh-list
65481009|NCT05234684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65481010|NCT05234684|Immunologic Factors|immunologic factors|mesh-ancestor
65481011|NCT05234684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481012|NCT05234684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65481013|NCT05234684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65481014|NCT05234684|Alkylating Agents|alkylating agents|mesh-ancestor
65481015|NCT05234684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481016|NCT05234684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481017|NCT05234684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65481018|NCT05234684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65481019|NCT05234684|Glucocorticoids|glucocorticoids|mesh-ancestor
65481020|NCT05234684|Hormones|hormones|mesh-ancestor
65481021|NCT05234684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65481022|NCT05234684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65481023|NCT05234684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65481024|NCT05234684|Tubulin Modulators|tubulin modulators|mesh-ancestor
65481025|NCT05234684|Antimitotic Agents|antimitotic agents|mesh-ancestor
64865085|NCT01783106|Hydroxychloroquine|hydroxychloroquine|mesh-list
64329691|NCT02192723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64495444|NCT01106950|Sensory System Agents|sensory system agents|mesh-ancestor
64495445|NCT01106950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64495447|NCT03463044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64495448|NCT02522208|Hydralazine|hydralazine|mesh-list
64495449|NCT02522208|Isosorbide|isosorbide|mesh-list
64495450|NCT02522208|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64495451|NCT02522208|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64495452|NCT02522208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64495453|NCT02522208|Diuretics|diuretics|mesh-ancestor
64495454|NCT02522208|Natriuretic Agents|natriuretic agents|mesh-ancestor
64495455|NCT02522208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495456|NCT02522208|Vasodilator Agents|vasodilator agents|mesh-ancestor
64495457|NCT02522208|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64495458|NCT02522208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495459|NCT02522208|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64495460|NCT05684172|Tenecteplase|tenecteplase|mesh-list
64495461|NCT05684172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64495462|NCT05684172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64495463|NCT05684172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495465|NCT01200160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64495466|NCT01200160|Antimetabolites|antimetabolites|mesh-ancestor
64495467|NCT01200160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495468|NCT01200160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64495469|NCT01200160|Vasodilator Agents|vasodilator agents|mesh-ancestor
64495470|NCT01200160|Vitamin B Complex|vitamin b complex|mesh-ancestor
64495471|NCT01200160|Vitamins|vitamins|mesh-ancestor
64495472|NCT01200160|Micronutrients|micronutrients|mesh-ancestor
64495473|NCT01200160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495474|NCT04908228|Obinutuzumab|obinutuzumab|mesh-list
64495475|NCT04908228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64495476|NCT04908228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495477|NCT01153672|Letrozole|letrozole|mesh-list
64495478|NCT01153672|Anastrozole|anastrozole|mesh-list
64495479|NCT01153672|Vorinostat|vorinostat|mesh-list
64495480|NCT01153672|Exemestane|exemestane|mesh-list
65481026|NCT05234684|Mitosis Modulators|mitosis modulators|mesh-ancestor
65481027|NCT05234684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65481028|NCT05234684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65481029|NCT05234684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65481030|NCT05234684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65481031|NCT05234684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481032|NCT03853538|Petrolatum|petrolatum|mesh-list
65481033|NCT03853538|Emollients|emollients|mesh-ancestor
65481034|NCT03853538|Dermatologic Agents|dermatologic agents|mesh-ancestor
65481035|NCT03853304|Folic Acid|folic acid|mesh-list
65481036|NCT03853304|Vitamin B 12|vitamin b 12|mesh-list
65481037|NCT03853304|Hydroxocobalamin|hydroxocobalamin|mesh-list
65481038|NCT03853304|Vitamins|vitamins|mesh-ancestor
65481039|NCT03853304|Micronutrients|micronutrients|mesh-ancestor
65481040|NCT03853304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481041|NCT03853304|Hematinics|hematinics|mesh-ancestor
65481042|NCT03853304|Vitamin B Complex|vitamin b complex|mesh-ancestor
65481043|NCT01290458|Vitamins|vitamins|mesh-list
65481044|NCT01290458|Ascorbic Acid|ascorbic acid|mesh-list
65481045|NCT01290458|Vitamin E|vitamin e|mesh-list
64495481|NCT01153672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495482|NCT01153672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64495483|NCT01153672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64495484|NCT01153672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64495485|NCT01153672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495505|NCT01219738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64495506|NCT01219738|Autonomic Agents|autonomic agents|mesh-ancestor
64495507|NCT01219738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64495508|NCT01219738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495509|NCT01219738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64495510|NCT01219738|Respiratory System Agents|respiratory system agents|mesh-ancestor
64721952|NCT00002534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64721953|NCT00002534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64721954|NCT00002534|Glucocorticoids|glucocorticoids|mesh-ancestor
64721955|NCT00002534|Hormones|hormones|mesh-ancestor
64721956|NCT00002534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64721957|NCT00002534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64721958|NCT00002534|Protective Agents|protective agents|mesh-ancestor
64721959|NCT00002546|Ifosfamide|ifosfamide|mesh-list
64721964|NCT00378781|Minocycline|minocycline|mesh-list
64721965|NCT00378781|Heparin|heparin|mesh-list
64721966|NCT00378781|Anticoagulants|anticoagulants|mesh-ancestor
64721967|NCT00378781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64721968|NCT00378781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64721969|NCT00378781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721970|NCT00378781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64721971|NCT00378781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721972|NCT00378625|Artesunate|artesunate|mesh-list
64721973|NCT00378625|Antimalarials|antimalarials|mesh-ancestor
64721974|NCT00378625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64721975|NCT00378625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64721976|NCT00378625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721977|NCT00378625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329693|NCT02192723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64329694|NCT02192723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64329695|NCT02192723|Antidepressive Agents|antidepressive agents|mesh-ancestor
64329696|NCT02192723|Dopamine Agonists|dopamine agonists|mesh-ancestor
64329697|NCT02192723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64329698|NCT02192723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65481046|NCT01290458|Tocopherols|tocopherols|mesh-list
65481047|NCT01290458|alpha-Tocopherol|alpha-tocopherol|mesh-list
65481048|NCT01290458|Antioxidants|antioxidants|mesh-list
65481049|NCT01290458|Micronutrients|micronutrients|mesh-ancestor
65481050|NCT01290458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481051|NCT01290458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481052|NCT01290458|Protective Agents|protective agents|mesh-ancestor
65481053|NCT01184144|Pioglitazone|pioglitazone|mesh-list
65481054|NCT01184144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65481055|NCT01184144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481057|NCT01291628|Trace Elements|trace elements|mesh-ancestor
65481058|NCT01291628|Micronutrients|micronutrients|mesh-ancestor
65481059|NCT01291628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481060|NCT00053898|Tamoxifen|tamoxifen|mesh-list
65481061|NCT00053898|Anastrozole|anastrozole|mesh-list
65481062|NCT00053898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481063|NCT00053898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65481064|NCT00053898|Hormone Antagonists|hormone antagonists|mesh-ancestor
65481065|NCT00053898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65481066|NCT00053898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481067|NCT00053898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65481068|NCT00053898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329699|NCT02192723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64329700|NCT02192723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64329721|NCT00317395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329723|NCT02383563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64329724|NCT02383563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329725|NCT03535961|Etoposide|etoposide|mesh-list
64495511|NCT01219738|Glucocorticoids|glucocorticoids|mesh-ancestor
64495512|NCT01219738|Hormones|hormones|mesh-ancestor
64495513|NCT01219738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64495514|NCT03848754|Gemtuzumab|gemtuzumab|mesh-list
64495515|NCT03848754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64495516|NCT03848754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495517|NCT01155154|Clindamycin|clindamycin|mesh-list
64495518|NCT01155154|Clindamycin palmitate|clindamycin palmitate|mesh-list
64495519|NCT01155154|Clindamycin phosphate|clindamycin phosphate|mesh-list
64495520|NCT01155154|Cephalexin|cephalexin|mesh-list
64495521|NCT01155154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64721990|NCT04005391|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64721992|NCT04005391|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64721993|NCT04005391|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64721994|NCT04005391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64721995|NCT04005391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721996|NCT00002552|Leucovorin|leucovorin|mesh-list
64721997|NCT00002552|Cytarabine|cytarabine|mesh-list
64721998|NCT00002552|Hydrocortisone|hydrocortisone|mesh-list
64721999|NCT00002552|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64329726|NCT03535961|Apatinib|apatinib|mesh-list
64329727|NCT03535961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64329728|NCT03535961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329729|NCT03535961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65481069|NCT00053898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65481070|NCT00053898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65481071|NCT00053898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65481072|NCT00053898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65481073|NCT00053898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65481074|NCT00053898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481075|NCT01293734|Budesonide|budesonide|mesh-list
65481076|NCT01293734|Theophylline|theophylline|mesh-list
65481077|NCT01293734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65481078|NCT01293734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65481079|NCT01293734|Autonomic Agents|autonomic agents|mesh-ancestor
65481080|NCT01293734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65481081|NCT01293734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481082|NCT01293734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65481083|NCT01293734|Respiratory System Agents|respiratory system agents|mesh-ancestor
65481084|NCT01293734|Glucocorticoids|glucocorticoids|mesh-ancestor
65481085|NCT01293734|Hormones|hormones|mesh-ancestor
64329730|NCT03535961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64329731|NCT03535961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329732|NCT03535961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329733|NCT03535961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64329734|NCT02380755|Clomiphene|clomiphene|mesh-list
64495522|NCT01155154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64495523|NCT01155154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64495524|NCT01155154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64495525|NCT01155154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495526|NCT04614714|Niacinamide|niacinamide|mesh-list
64495527|NCT04614714|Niacin|niacin|mesh-list
64495528|NCT04614714|Nicotinic Acids|nicotinic acids|mesh-list
64495529|NCT04614714|Vitamin B Complex|vitamin b complex|mesh-ancestor
64495530|NCT04614714|Vitamins|vitamins|mesh-ancestor
64495532|NCT04614714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495533|NCT04614714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64484592|NCT03088930|Crizotinib|crizotinib|mesh-list
64495534|NCT04614714|Antimetabolites|antimetabolites|mesh-ancestor
64495542|NCT01221298|Protease Inhibitors|protease inhibitors|mesh-ancestor
64495557|NCT01222234|Micronutrients|micronutrients|mesh-ancestor
64495558|NCT01222234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495559|NCT01222234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64495560|NCT01222234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64495561|NCT01222234|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64495562|NCT01222234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64495563|NCT01222234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495564|NCT01222234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64495565|NCT01203046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64495567|NCT01203046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64495568|NCT02460588|Prednisolone|prednisolone|mesh-list
64495569|NCT02460588|Cyclophosphamide|cyclophosphamide|mesh-list
64495570|NCT02460588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64495571|NCT02460588|Immunologic Factors|immunologic factors|mesh-ancestor
64495572|NCT02460588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495576|NCT02460588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495577|NCT02460588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495578|NCT02460588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64495579|NCT02460588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64495580|NCT02460588|Glucocorticoids|glucocorticoids|mesh-ancestor
64495581|NCT02460588|Hormones|hormones|mesh-ancestor
64722016|NCT00002552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64722017|NCT00002552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65481086|NCT01293734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65481087|NCT01293734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65481088|NCT01293734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481089|NCT01293734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481090|NCT01293734|Vasodilator Agents|vasodilator agents|mesh-ancestor
65481091|NCT01293734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65481092|NCT01293734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65481093|NCT01293734|Purinergic Agents|purinergic agents|mesh-ancestor
65481094|NCT01293734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65481095|NCT01184300|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65481096|NCT01184300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65481097|NCT01188278|Imatinib Mesylate|imatinib mesylate|mesh-list
65481098|NCT01188278|Dasatinib|dasatinib|mesh-list
65481099|NCT01188278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481100|NCT01188278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65481101|NCT01188278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481102|NCT01188278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481103|NCT03850028|Atezolizumab|atezolizumab|mesh-list
65481104|NCT03850028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481105|NCT01184378|Caseins|caseins|mesh-list
65481106|NCT01184378|Chelating Agents|chelating agents|mesh-ancestor
65481107|NCT01184378|Sequestering Agents|sequestering agents|mesh-ancestor
65481108|NCT01184378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481109|NCT03852602|Analgesics|analgesics|mesh-list
65481110|NCT03852602|Sensory System Agents|sensory system agents|mesh-ancestor
65481111|NCT03852602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65481112|NCT03852602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481113|NCT02459392|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65481114|NCT02459392|Methylprednisolone|methylprednisolone|mesh-list
65481115|NCT02459392|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65481116|NCT02459392|Prednisolone|prednisolone|mesh-list
65481117|NCT02459392|Prednisolone acetate|prednisolone acetate|mesh-list
65481118|NCT02459392|Hyaluronic Acid|hyaluronic acid|mesh-list
65481119|NCT02459392|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65481125|NCT02459392|Protective Agents|protective agents|mesh-ancestor
65481126|NCT02459392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65481127|NCT02459392|Antiemetics|antiemetics|mesh-ancestor
65481128|NCT02459392|Autonomic Agents|autonomic agents|mesh-ancestor
65481129|NCT02459392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65481130|NCT02459392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65481132|NCT02459392|Hormones|hormones|mesh-ancestor
65481133|NCT02459392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65481134|NCT02459392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65481135|NCT02459392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65481136|NCT02459392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481137|NCT03256552|Glycopyrrolate|glycopyrrolate|mesh-list
65481138|NCT03256552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65481139|NCT03256552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65481140|NCT03256552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65481141|NCT03256552|Cholinergic Agents|cholinergic agents|mesh-ancestor
65481142|NCT03256552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65481143|NCT03256552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722018|NCT00002552|Abortifacient Agents|abortifacient agents|mesh-ancestor
64722019|NCT00002552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64722020|NCT00002552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64722021|NCT00002552|Antimetabolites|antimetabolites|mesh-ancestor
64329741|NCT02380755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64329742|NCT02380755|Fertility Agents|fertility agents|mesh-ancestor
64329743|NCT02380755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64329744|NCT02380755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64329745|NCT02380755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64329746|NCT02188277|Botulinum Toxins|botulinum toxins|mesh-list
64329747|NCT02188277|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64329748|NCT02188277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64329749|NCT02188277|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64329750|NCT02188277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64329751|NCT02188277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64329752|NCT02188277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495582|NCT02460588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64495583|NCT02460588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64495584|NCT03449082|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64495585|NCT03449082|Hemostatics|hemostatics|mesh-ancestor
64495586|NCT03449082|Coagulants|coagulants|mesh-ancestor
64495587|NCT03449238|Pembrolizumab|pembrolizumab|mesh-list
64495588|NCT03449238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64495589|NCT03449238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495590|NCT03413202|3-n-butylphthalide|3-n-butylphthalide|mesh-list
64329754|NCT02188277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64329755|NCT02188277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329757|NCT02188277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64329758|NCT02380521|Exenatide|exenatide|mesh-list
64329759|NCT02380521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64329760|NCT02380521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329761|NCT02380521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64495591|NCT03413202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64495592|NCT03413202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64495593|NCT03413202|Protective Agents|protective agents|mesh-ancestor
64495594|NCT03413202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495602|NCT04169100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495603|NCT04155840|Rituximab|rituximab|mesh-list
65481144|NCT03256552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481145|NCT03852446|Tryptophan|tryptophan|mesh-list
65481146|NCT03852446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65481147|NCT03852446|Antidepressive Agents|antidepressive agents|mesh-ancestor
65481148|NCT03852446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65481149|NCT05117710|Ebselen|ebselen|mesh-list
65481150|NCT05117710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65481151|NCT05117710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65481152|NCT05117710|Analgesics|analgesics|mesh-ancestor
65481153|NCT05117710|Sensory System Agents|sensory system agents|mesh-ancestor
65481154|NCT05117710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65481155|NCT05117710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481156|NCT05117710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65481157|NCT05117710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65481158|NCT05117710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65481159|NCT05117710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65481160|NCT05117710|Antioxidants|antioxidants|mesh-ancestor
65481161|NCT05117710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481162|NCT05117710|Protective Agents|protective agents|mesh-ancestor
64495604|NCT04155840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64495621|NCT03443778|Antiemetics|antiemetics|mesh-ancestor
64495622|NCT03443778|Autonomic Agents|autonomic agents|mesh-ancestor
64495623|NCT03443778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64495624|NCT03443778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329769|NCT00315757|Immunologic Factors|immunologic factors|mesh-ancestor
64329770|NCT00315757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495625|NCT03443778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64495626|NCT03443778|Glucocorticoids|glucocorticoids|mesh-ancestor
64495627|NCT03443778|Hormones|hormones|mesh-ancestor
64495628|NCT03443778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64495629|NCT03443778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64495630|NCT03443778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495631|NCT03443778|Anesthetics, Local|anesthetics, local|mesh-ancestor
64495632|NCT03443778|Anesthetics|anesthetics|mesh-ancestor
64495633|NCT03443778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64495634|NCT03443778|Sensory System Agents|sensory system agents|mesh-ancestor
64495635|NCT03011008|Liraglutide|liraglutide|mesh-list
64722041|NCT05750966|Cefuroxime|cefuroxime|mesh-list
64722042|NCT05750966|Cefuroxime axetil|cefuroxime axetil|mesh-list
64722043|NCT05750966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64722044|NCT05750966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64722045|NCT05750966|Antitubercular Agents|antitubercular agents|mesh-ancestor
64722046|NCT05750966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64722047|NCT05750966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64722048|NCT05750966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64722049|NCT05750966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722050|NCT05750966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722051|NCT05750966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64722052|NCT05750966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64722053|NCT05750966|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64722054|NCT00377923|Progesterone|progesterone|mesh-list
64722055|NCT00377923|Progestins|progestins|mesh-ancestor
64722056|NCT00377923|Hormones|hormones|mesh-ancestor
64722057|NCT00377923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65481163|NCT05117710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65481164|NCT05117710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481165|NCT05117710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65481166|NCT03637582|Lidocaine|lidocaine|mesh-list
65481167|NCT03637582|Anesthetics, Local|anesthetics, local|mesh-ancestor
65481168|NCT03637582|Anesthetics|anesthetics|mesh-ancestor
65481169|NCT03637582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65481170|NCT03637582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481171|NCT03637582|Sensory System Agents|sensory system agents|mesh-ancestor
65481172|NCT03637582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65481173|NCT03637582|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65481174|NCT03637582|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65481175|NCT03637582|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65481176|NCT03637582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65481177|NCT03637582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481178|NCT00053352|Etoposide|etoposide|mesh-list
64329771|NCT02377401|Zanamivir|zanamivir|mesh-list
64329772|NCT02377401|Antiviral Agents|antiviral agents|mesh-ancestor
64329773|NCT02377401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64329774|NCT02377401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329775|NCT02377401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329776|NCT00312091|Lamivudine|lamivudine|mesh-list
64329777|NCT00312091|Nevirapine|nevirapine|mesh-list
64329778|NCT00312091|Stavudine|stavudine|mesh-list
64329779|NCT00312091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64329780|NCT00312091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64329781|NCT00312091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329782|NCT00312091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329783|NCT00312091|Antiviral Agents|antiviral agents|mesh-ancestor
64329784|NCT00312091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64329785|NCT00312091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64329786|NCT00312091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64329787|NCT00312091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64329788|NCT00312091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64495636|NCT03011008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64495637|NCT03011008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495638|NCT03011008|Incretins|incretins|mesh-ancestor
64495639|NCT03011008|Hormones|hormones|mesh-ancestor
64722067|NCT00002570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64722069|NCT00002570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64329792|NCT00389779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64329793|NCT00389779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64329794|NCT00389779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64329795|NCT00389779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64329796|NCT00389779|Adrenergic Agents|adrenergic agents|mesh-ancestor
64329797|NCT00389779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64329798|NCT00389779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329799|NCT00389779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495640|NCT03011008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64495641|NCT01157416|Cycloserine|cycloserine|mesh-list
64495642|NCT01157416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64495643|NCT01157416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64495644|NCT01157416|Renal Agents|renal agents|mesh-ancestor
64495645|NCT01157416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64495646|NCT01157416|Antitubercular Agents|antitubercular agents|mesh-ancestor
64495647|NCT01157416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64495648|NCT01157416|Antimetabolites|antimetabolites|mesh-ancestor
65481179|NCT00053352|Etoposide phosphate|etoposide phosphate|mesh-list
65481180|NCT00053352|Bleomycin|bleomycin|mesh-list
65481181|NCT00053352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481182|NCT00053352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65481183|NCT00053352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65481184|NCT00053352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65481185|NCT00053352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481186|NCT00053352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481187|NCT00053352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65481188|NCT01193816|Loxapine|loxapine|mesh-list
65481189|NCT01193816|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65481190|NCT01193816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65481191|NCT01193816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65481192|NCT01193816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481193|NCT01193816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65481194|NCT01193816|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65481195|NCT01193816|Dopamine Agents|dopamine agents|mesh-ancestor
65481196|NCT01193816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65481197|NCT01193816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481198|NCT05571202|Anesthetics|anesthetics|mesh-list
65481199|NCT05571202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65481200|NCT05571202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481201|NCT03245398|Mebendazole|mebendazole|mesh-list
65481202|NCT03245398|Piperazine|piperazine|mesh-list
65481203|NCT03245398|Piperazine citrate|piperazine citrate|mesh-list
65481204|NCT03245398|DMP 777|dmp 777|mesh-list
65481205|NCT03245398|Antinematodal Agents|antinematodal agents|mesh-ancestor
65481206|NCT03245398|Anthelmintics|anthelmintics|mesh-ancestor
65481226|NCT05571046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481227|NCT05571046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65481228|NCT03849404|Adalimumab|adalimumab|mesh-list
65481229|NCT03849404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65481230|NCT03849404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65481231|NCT00051636|Vitamin D|vitamin d|mesh-list
65481232|NCT00051636|Zoledronic Acid|zoledronic acid|mesh-list
65481233|NCT00051636|Risedronic Acid|risedronic acid|mesh-list
65481234|NCT00051636|Etidronic Acid|etidronic acid|mesh-list
65481235|NCT00051636|Calcium|calcium|mesh-list
65481236|NCT00051636|Vitamins|vitamins|mesh-ancestor
65481237|NCT00051636|Micronutrients|micronutrients|mesh-ancestor
65481238|NCT00051636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481239|NCT00051636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65481240|NCT00051636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65481241|NCT00051636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65481242|NCT00051636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65481243|NCT00051636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481244|NCT01294826|Cetuximab|cetuximab|mesh-list
65481245|NCT01294826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65481246|NCT01294826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481247|NCT03847922|Lidocaine|lidocaine|mesh-list
65481248|NCT03847922|Nitrous Oxide|nitrous oxide|mesh-list
65481249|NCT03847922|Anesthetics, Local|anesthetics, local|mesh-ancestor
65481250|NCT03847922|Anesthetics|anesthetics|mesh-ancestor
65481251|NCT03847922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65481252|NCT03847922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865302|NCT01784562|Riociguat|riociguat|mesh-list
64722082|NCT00002576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64329800|NCT00389779|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64329801|NCT00389155|Gemcitabine|gemcitabine|mesh-list
64329802|NCT00389155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64329803|NCT00389155|Antimetabolites|antimetabolites|mesh-ancestor
64329804|NCT00389155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329805|NCT00389155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329806|NCT00389155|Antiviral Agents|antiviral agents|mesh-ancestor
64329807|NCT00389155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64329808|NCT00389155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329809|NCT00389155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64329810|NCT00389155|Immunologic Factors|immunologic factors|mesh-ancestor
64495649|NCT01157416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495651|NCT01206478|Amitriptyline|amitriptyline|mesh-list
64495652|NCT01206478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64495653|NCT01206478|Antidepressive Agents|antidepressive agents|mesh-ancestor
64495654|NCT01206478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64495655|NCT01206478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64495656|NCT01206478|Analgesics|analgesics|mesh-ancestor
64495657|NCT01206478|Sensory System Agents|sensory system agents|mesh-ancestor
64495658|NCT01206478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65481253|NCT03847922|Sensory System Agents|sensory system agents|mesh-ancestor
65481254|NCT03847922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65481255|NCT03847922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65481256|NCT03847922|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65481257|NCT03847922|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65481263|NCT03847922|Analgesics|analgesics|mesh-ancestor
65481320|NCT03847376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481321|NCT03847376|Antiviral Agents|antiviral agents|mesh-ancestor
65481322|NCT03847376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65481323|NCT03847376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65481324|NCT03847376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65481325|NCT01090128|Paclitaxel|paclitaxel|mesh-list
65481326|NCT01090128|Cyclophosphamide|cyclophosphamide|mesh-list
65481327|NCT01090128|Doxorubicin|doxorubicin|mesh-list
65481328|NCT01090128|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65481329|NCT01090128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65481330|NCT01090128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481331|NCT01090128|Tubulin Modulators|tubulin modulators|mesh-ancestor
65481332|NCT01090128|Antimitotic Agents|antimitotic agents|mesh-ancestor
65481333|NCT01090128|Mitosis Modulators|mitosis modulators|mesh-ancestor
65481334|NCT01090128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481335|NCT01090128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65481336|NCT01090128|Immunologic Factors|immunologic factors|mesh-ancestor
65481337|NCT01090128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481338|NCT01090128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65481339|NCT01090128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65481340|NCT01090128|Alkylating Agents|alkylating agents|mesh-ancestor
65481341|NCT01090128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65481342|NCT01090128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65481343|NCT01090128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65481344|NCT01090128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64722090|NCT00002576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64329811|NCT00389155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329813|NCT02188511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64329814|NCT02188511|Autonomic Agents|autonomic agents|mesh-ancestor
64329815|NCT02188511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64329816|NCT02188511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329817|NCT02188511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64495659|NCT01206478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495660|NCT01206478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64495661|NCT01206478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64495662|NCT01206478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64495671|NCT01206478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64495672|NCT01206478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64495673|NCT01206478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64495674|NCT01206478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495675|NCT04963530|Lithium Carbonate|lithium carbonate|mesh-list
64495676|NCT04963530|Antidepressive Agents|antidepressive agents|mesh-ancestor
64495677|NCT04963530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64495678|NCT04963530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64495679|NCT04963530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495680|NCT04963530|Antimanic Agents|antimanic agents|mesh-ancestor
64495682|NCT04963530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65481345|NCT01090128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481346|NCT01292174|Ibalizumab|ibalizumab|mesh-list
65481347|NCT01292174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65481348|NCT01292174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65481349|NCT01292174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65481350|NCT01292174|Antiviral Agents|antiviral agents|mesh-ancestor
65481351|NCT01292174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65481352|NCT01292174|Immunologic Factors|immunologic factors|mesh-ancestor
65481353|NCT01292174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481354|NCT01090206|Vitamin D|vitamin d|mesh-list
65481355|NCT01090206|Calcium|calcium|mesh-list
65481356|NCT01090206|Vitamins|vitamins|mesh-ancestor
65481357|NCT01090206|Micronutrients|micronutrients|mesh-ancestor
65481358|NCT01090206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481359|NCT01090206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65481360|NCT01090206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64865422|NCT01785446|Anesthetics, General|anesthetics, general|mesh-ancestor
64495683|NCT04963530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495686|NCT01158820|Midazolam|midazolam|mesh-list
64495687|NCT01158820|Dexmedetomidine|dexmedetomidine|mesh-list
64495688|NCT01158820|Ketamine|ketamine|mesh-list
64495689|NCT01158820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64495690|NCT01158820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64495691|NCT01158820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495692|NCT01158820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64722091|NCT00002576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64722092|NCT00002576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64722093|NCT00002576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64722094|NCT00002576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64722095|NCT00002576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64722096|NCT00002576|Tubulin Modulators|tubulin modulators|mesh-ancestor
64722097|NCT00002576|Antimitotic Agents|antimitotic agents|mesh-ancestor
64722098|NCT00002576|Mitosis Modulators|mitosis modulators|mesh-ancestor
64722099|NCT00002576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64722100|NCT00002576|Glucocorticoids|glucocorticoids|mesh-ancestor
64722101|NCT00002576|Hormones|hormones|mesh-ancestor
64722102|NCT00002576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64722103|NCT00002576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64722104|NCT00002576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64722105|NCT00002576|Analgesics|analgesics|mesh-ancestor
64722106|NCT00002576|Sensory System Agents|sensory system agents|mesh-ancestor
64722107|NCT00002582|Tamoxifen|tamoxifen|mesh-list
64722108|NCT00002582|Cyclophosphamide|cyclophosphamide|mesh-list
64722109|NCT00002582|Doxorubicin|doxorubicin|mesh-list
64329818|NCT02188511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64329819|NCT02188511|Cholinergic Agents|cholinergic agents|mesh-ancestor
64329820|NCT02188511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64329821|NCT02188511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329822|NCT02380131|Capecitabine|capecitabine|mesh-list
64329823|NCT02380131|Oxaliplatin|oxaliplatin|mesh-list
64329824|NCT02380131|Trastuzumab|trastuzumab|mesh-list
64329825|NCT02380131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64329826|NCT02380131|Antimetabolites|antimetabolites|mesh-ancestor
64329827|NCT02380131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329828|NCT02380131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329829|NCT02380131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64329830|NCT03535103|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64329831|NCT03535103|Hormones|hormones|mesh-ancestor
64329832|NCT03535103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64329833|NCT03535103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481362|NCT04728646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65481363|NCT04728646|Antiemetics|antiemetics|mesh-ancestor
65481364|NCT04728646|Autonomic Agents|autonomic agents|mesh-ancestor
65481365|NCT04728646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65481366|NCT04728646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481367|NCT04728646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65481368|NCT04728646|Glucocorticoids|glucocorticoids|mesh-ancestor
65481369|NCT04728646|Hormones|hormones|mesh-ancestor
65481370|NCT04728646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65481371|NCT04728646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65481372|NCT04728646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481373|NCT04674826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65481374|NCT04674826|Immunologic Factors|immunologic factors|mesh-ancestor
65481375|NCT04674826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481376|NCT01295138|Lactulose|lactulose|mesh-list
65481377|NCT01295138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65481378|NCT01188824|Cilostazol|cilostazol|mesh-list
65481379|NCT01188824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65481380|NCT01188824|Autonomic Agents|autonomic agents|mesh-ancestor
65481381|NCT01188824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865436|NCT01785589|Vasodilator Agents|vasodilator agents|mesh-ancestor
64495697|NCT01158820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64495698|NCT01158820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64495699|NCT01158820|Adrenergic Agents|adrenergic agents|mesh-ancestor
64722110|NCT00002582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64722111|NCT00002582|Fluorouracil|fluorouracil|mesh-list
64722112|NCT00002582|Methotrexate|methotrexate|mesh-list
64722113|NCT00002582|Leuprolide|leuprolide|mesh-list
64722114|NCT00002582|Goserelin|goserelin|mesh-list
64722115|NCT00002582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64461454|NCT03466294|Venetoclax|venetoclax|mesh-list
64722116|NCT00002582|Immunologic Factors|immunologic factors|mesh-ancestor
64722117|NCT00002582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722118|NCT00002582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64722119|NCT00002582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64722120|NCT00002582|Alkylating Agents|alkylating agents|mesh-ancestor
64722121|NCT00002582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722122|NCT00002582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722123|NCT00002582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64722124|NCT00002582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64722125|NCT00002582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64722126|NCT00002582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64722127|NCT00002582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64722128|NCT00002582|Antimetabolites|antimetabolites|mesh-ancestor
64722129|NCT00002582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64722130|NCT00002582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64722131|NCT00002582|Abortifacient Agents|abortifacient agents|mesh-ancestor
64722132|NCT00002582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64722133|NCT00002582|Dermatologic Agents|dermatologic agents|mesh-ancestor
64722134|NCT00002582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64722135|NCT00002582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64722136|NCT00002582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64722137|NCT00002582|Hormone Antagonists|hormone antagonists|mesh-ancestor
64722150|NCT00002588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64722151|NCT00002588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481382|NCT01188824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481383|NCT01188824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65481384|NCT01188824|Respiratory System Agents|respiratory system agents|mesh-ancestor
65481385|NCT01188824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65481386|NCT01188824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65481387|NCT01188824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481388|NCT01188824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65481389|NCT01188824|Vasodilator Agents|vasodilator agents|mesh-ancestor
65481390|NCT01188824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65481391|NCT01188824|Protective Agents|protective agents|mesh-ancestor
65481392|NCT01188824|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65481393|NCT01188824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65481394|NCT01188824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481395|NCT01060475|Tacrolimus|tacrolimus|mesh-list
65481396|NCT01060475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65481397|NCT01060475|Immunologic Factors|immunologic factors|mesh-ancestor
65481398|NCT01060475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481399|NCT01060475|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65481400|NCT01060475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481401|NCT01060475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481402|NCT01060631|Propofol|propofol|mesh-list
65481403|NCT01060631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65481404|NCT01060631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65481405|NCT01060631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481431|NCT01295294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65481432|NCT01295294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65481433|NCT01295294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65481434|NCT01295294|Analgesics|analgesics|mesh-ancestor
65481435|NCT01295294|Sensory System Agents|sensory system agents|mesh-ancestor
65481436|NCT01295294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65481437|NCT01295294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65481438|NCT01295294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65481439|NCT01295294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65481440|NCT01295294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481441|NCT01191710|Progesterone|progesterone|mesh-list
65481442|NCT01191710|Progestins|progestins|mesh-ancestor
65481443|NCT01191710|Hormones|hormones|mesh-ancestor
65481444|NCT01191710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65481445|NCT01191710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481446|NCT04367740|Antibodies|antibodies|mesh-list
65481447|NCT04367740|Immunoglobulin G|immunoglobulin g|mesh-list
65481448|NCT04367740|Immunologic Factors|immunologic factors|mesh-ancestor
65481449|NCT04367740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481450|NCT03852056|Fluorides|fluorides|mesh-list
65481451|NCT03852056|Tin Fluorides|tin fluorides|mesh-list
65481452|NCT03852056|Cariostatic Agents|cariostatic agents|mesh-ancestor
65481453|NCT03852056|Protective Agents|protective agents|mesh-ancestor
65481454|NCT03852056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481455|NCT03242434|Mannitol|mannitol|mesh-list
65481456|NCT03242434|Lactulose|lactulose|mesh-list
65481457|NCT03242434|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65481458|NCT03242434|Diuretics|diuretics|mesh-ancestor
65481459|NCT03242434|Natriuretic Agents|natriuretic agents|mesh-ancestor
65481460|NCT03242434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481461|NCT03242434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65481462|NCT04222426|Atezolizumab|atezolizumab|mesh-list
65481463|NCT04222426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481464|NCT01292408|Hydroxychloroquine|hydroxychloroquine|mesh-list
65481465|NCT01292408|Antimalarials|antimalarials|mesh-ancestor
65481466|NCT01292408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64722152|NCT00002588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722153|NCT00002588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64722155|NCT02239627|Analgesics|analgesics|mesh-ancestor
64722156|NCT02239627|Sensory System Agents|sensory system agents|mesh-ancestor
64722157|NCT02239627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64722158|NCT02239627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481467|NCT01292408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65481468|NCT01292408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65481469|NCT01292408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481470|NCT01292408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481471|NCT01292408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65481472|NCT01295372|Risperidone|risperidone|mesh-list
65481473|NCT01295372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65481474|NCT01295372|Serotonin Agents|serotonin agents|mesh-ancestor
65481475|NCT01295372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65481476|NCT01295372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481477|NCT01295372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481478|NCT01295372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65481479|NCT01295372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65481480|NCT01295372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65481481|NCT01295372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65481482|NCT01295372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65481483|NCT01295372|Dopamine Agents|dopamine agents|mesh-ancestor
65481484|NCT05283278|Lactoferrin|lactoferrin|mesh-list
64722159|NCT02239627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64722160|NCT02239627|Sympatholytics|sympatholytics|mesh-ancestor
64722161|NCT02239627|Autonomic Agents|autonomic agents|mesh-ancestor
64722162|NCT02239627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64722163|NCT02239627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64722164|NCT02239627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64722165|NCT02239627|Adrenergic Agents|adrenergic agents|mesh-ancestor
64722166|NCT02239627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64329876|NCT02380053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64329877|NCT02380053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329878|NCT02380053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64329879|NCT02380053|Sympathomimetics|sympathomimetics|mesh-ancestor
64329880|NCT02380053|Vasodilator Agents|vasodilator agents|mesh-ancestor
64329881|NCT02193971|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64329882|NCT02193971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64329883|NCT00004915|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64329884|NCT00004915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64329891|NCT03535415|Hormones|hormones|mesh-list
64722167|NCT02239627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722169|NCT05750576|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64722170|NCT05750576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64722171|NCT05750576|Disinfectants|disinfectants|mesh-ancestor
64722172|NCT00002594|Cyclophosphamide|cyclophosphamide|mesh-list
64722173|NCT00002594|Melphalan|melphalan|mesh-list
64722174|NCT00002594|Molgramostim|molgramostim|mesh-list
64722175|NCT00002594|Sargramostim|sargramostim|mesh-list
64722176|NCT00002594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64722177|NCT00002594|Immunologic Factors|immunologic factors|mesh-ancestor
64722178|NCT00002594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722179|NCT00002594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64722180|NCT00002594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64722181|NCT00002594|Alkylating Agents|alkylating agents|mesh-ancestor
64722182|NCT00002594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722183|NCT00002594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722184|NCT00002594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64722185|NCT02234011|Ketamine|ketamine|mesh-list
64722186|NCT02234011|Analgesics|analgesics|mesh-ancestor
64722187|NCT02234011|Sensory System Agents|sensory system agents|mesh-ancestor
64722188|NCT02234011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65481485|NCT05283278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65481486|NCT05179018|Autoantibodies|autoantibodies|mesh-list
65481487|NCT05179018|Immunologic Factors|immunologic factors|mesh-ancestor
65481488|NCT05179018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481489|NCT01295450|Vitamins|vitamins|mesh-list
65481490|NCT01295450|Micronutrients|micronutrients|mesh-ancestor
65481491|NCT01295450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481492|NCT01297010|Dexamethasone|dexamethasone|mesh-list
65481493|NCT01297010|Dexamethasone acetate|dexamethasone acetate|mesh-list
65481494|NCT01297010|BB 1101|bb 1101|mesh-list
65481495|NCT01297010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65481496|NCT01297010|Antiemetics|antiemetics|mesh-ancestor
65481497|NCT01297010|Autonomic Agents|autonomic agents|mesh-ancestor
65481498|NCT01297010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65481499|NCT01297010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481500|NCT01297010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65481501|NCT01297010|Glucocorticoids|glucocorticoids|mesh-ancestor
65481502|NCT01297010|Hormones|hormones|mesh-ancestor
65481503|NCT01297010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65481504|NCT01297010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65231022|NCT04092478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481505|NCT01297010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481506|NCT01297010|Protease Inhibitors|protease inhibitors|mesh-ancestor
65481507|NCT01297010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481508|NCT01297010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481510|NCT03851432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65481511|NCT03851432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481512|NCT01192490|Lidocaine|lidocaine|mesh-list
65481513|NCT01192490|Anesthetics, Local|anesthetics, local|mesh-ancestor
65481514|NCT01192490|Anesthetics|anesthetics|mesh-ancestor
65481515|NCT01192490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65481516|NCT01192490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481517|NCT01192490|Sensory System Agents|sensory system agents|mesh-ancestor
65481526|NCT01295606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65481527|NCT01192724|Aspirin|aspirin|mesh-list
65481528|NCT01192724|Cilostazol|cilostazol|mesh-list
65481529|NCT01192724|Clopidogrel|clopidogrel|mesh-list
65481530|NCT01192724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65481531|NCT01192724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65481532|NCT01192724|Analgesics|analgesics|mesh-ancestor
65481533|NCT01192724|Sensory System Agents|sensory system agents|mesh-ancestor
65481534|NCT01192724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65481535|NCT01192724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481536|NCT01192724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65481537|NCT01192724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65481538|NCT01192724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65481539|NCT01192724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65481540|NCT01192724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481541|NCT01192724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65481542|NCT01192724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65481543|NCT01192724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481544|NCT01192724|Antipyretics|antipyretics|mesh-ancestor
65481545|NCT01192724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65481546|NCT01192724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65481547|NCT01192724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65481548|NCT01192724|Purinergic Agents|purinergic agents|mesh-ancestor
65481549|NCT01192724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65481550|NCT01192724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65481551|NCT01192724|Autonomic Agents|autonomic agents|mesh-ancestor
65481552|NCT01192724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65481553|NCT01192724|Respiratory System Agents|respiratory system agents|mesh-ancestor
65481554|NCT01192724|Vasodilator Agents|vasodilator agents|mesh-ancestor
64722189|NCT02234011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461482|NCT01679860|Alemtuzumab|alemtuzumab|mesh-list
64722190|NCT02234011|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64722191|NCT02234011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64722192|NCT02234011|Anesthetics, General|anesthetics, general|mesh-ancestor
64722193|NCT02234011|Anesthetics|anesthetics|mesh-ancestor
64329893|NCT03535415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329894|NCT02030717|Clonidine|clonidine|mesh-list
64329895|NCT02030717|Anesthetics|anesthetics|mesh-list
64329896|NCT02030717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64329897|NCT02030717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329898|NCT02030717|Analgesics|analgesics|mesh-ancestor
64722194|NCT02234011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64722195|NCT02234011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64722196|NCT02234011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64722197|NCT02234011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65481555|NCT01192724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65481556|NCT01192724|Protective Agents|protective agents|mesh-ancestor
65481557|NCT01192724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65481558|NCT01192724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65481559|NCT01192802|Albendazole|albendazole|mesh-list
65481560|NCT01192802|Anthelmintics|anthelmintics|mesh-ancestor
65481561|NCT01192802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65481562|NCT01192802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65481563|NCT01192802|Anticestodal Agents|anticestodal agents|mesh-ancestor
65481564|NCT01192802|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65481565|NCT01192802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65481566|NCT01192802|Tubulin Modulators|tubulin modulators|mesh-ancestor
65481567|NCT01192802|Antimitotic Agents|antimitotic agents|mesh-ancestor
65481568|NCT01192802|Mitosis Modulators|mitosis modulators|mesh-ancestor
65481569|NCT01192802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481570|NCT01192802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481571|NCT01292720|Vitamin D|vitamin d|mesh-list
65481572|NCT01292720|Cholecalciferol|cholecalciferol|mesh-list
65481573|NCT01292720|Vitamins|vitamins|mesh-ancestor
65481574|NCT01292720|Micronutrients|micronutrients|mesh-ancestor
65481575|NCT01292720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481576|NCT01292720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65481577|NCT01292720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65481578|NCT05671172|Bupivacaine|bupivacaine|mesh-list
65481579|NCT05671172|Anesthetics, Local|anesthetics, local|mesh-ancestor
65481580|NCT05671172|Anesthetics|anesthetics|mesh-ancestor
65481581|NCT05671172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64722202|NCT00002600|Immunologic Factors|immunologic factors|mesh-ancestor
64722203|NCT00002600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722204|NCT00002600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64722205|NCT00002600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64722206|NCT00002600|Alkylating Agents|alkylating agents|mesh-ancestor
64722207|NCT00002600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722208|NCT00002600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722209|NCT00002600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64722210|NCT02177773|Octreotide|octreotide|mesh-list
64722211|NCT02177773|Edotreotide|edotreotide|mesh-list
64722212|NCT02177773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64722213|NCT02177773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64722214|NCT02177773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722215|NCT02177773|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64722216|NCT02177773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722217|NCT02144155|Oxytocin|oxytocin|mesh-list
64722218|NCT02144155|Oxytocics|oxytocics|mesh-ancestor
64722219|NCT02144155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64722220|NCT02144155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722221|NCT00002618|Leucovorin|leucovorin|mesh-list
64722223|NCT00002618|Cytarabine|cytarabine|mesh-list
64722224|NCT00002618|Prednisone|prednisone|mesh-list
65481582|NCT05671172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481583|NCT05671172|Sensory System Agents|sensory system agents|mesh-ancestor
65481584|NCT05671172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65481585|NCT02939014|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65481586|NCT02939014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65481587|NCT02939014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481588|NCT05177926|Tenofovir|tenofovir|mesh-list
65481589|NCT05177926|Antiviral Agents|antiviral agents|mesh-list
65481590|NCT05177926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65481591|NCT05177926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65481592|NCT05177926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65481593|NCT05177926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481594|NCT05177926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481595|NCT05177926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65481596|NCT05177926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65481597|NCT01193192|Vitamins|vitamins|mesh-list
65481598|NCT01193192|Micronutrients|micronutrients|mesh-ancestor
65481599|NCT01193192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481600|NCT01193270|Vitamin E|vitamin e|mesh-list
65481601|NCT01193270|Vitamins|vitamins|mesh-ancestor
65481602|NCT01193270|Micronutrients|micronutrients|mesh-ancestor
65481603|NCT01193270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481604|NCT01193270|Antioxidants|antioxidants|mesh-ancestor
65481605|NCT01193270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481606|NCT01193270|Protective Agents|protective agents|mesh-ancestor
65481607|NCT01189214|Memantine|memantine|mesh-list
65481608|NCT01189214|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65481609|NCT01189214|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65481610|NCT01189214|Dopamine Agents|dopamine agents|mesh-ancestor
65481611|NCT01189214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64722225|NCT00002618|Doxorubicin|doxorubicin|mesh-list
64722226|NCT00002618|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64722237|NCT00002618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722238|NCT00002618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64722239|NCT00002618|Glucocorticoids|glucocorticoids|mesh-ancestor
64722240|NCT00002618|Hormones|hormones|mesh-ancestor
64722241|NCT00002618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64722242|NCT00002618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64722243|NCT00002618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64722244|NCT00002618|Abortifacient Agents|abortifacient agents|mesh-ancestor
64722245|NCT00002618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64722246|NCT00002618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64722247|NCT00002618|Antimetabolites|antimetabolites|mesh-ancestor
64722248|NCT00002618|Dermatologic Agents|dermatologic agents|mesh-ancestor
64722249|NCT00002618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64722250|NCT00002618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65481612|NCT01189214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481613|NCT01189214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481614|NCT01189214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65481615|NCT01189214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65481616|NCT01193504|Loteprednol Etabonate|loteprednol etabonate|mesh-list
65481617|NCT01193504|Prednisolone acetate|prednisolone acetate|mesh-list
65481618|NCT01193504|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65481619|NCT01193504|Methylprednisolone|methylprednisolone|mesh-list
65481620|NCT01193504|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65481621|NCT01193504|Prednisolone|prednisolone|mesh-list
65481622|NCT01193504|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65481623|NCT01193504|Prednisolone phosphate|prednisolone phosphate|mesh-list
65481624|NCT01193504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65481625|NCT01193504|Antiemetics|antiemetics|mesh-ancestor
65481626|NCT01193504|Autonomic Agents|autonomic agents|mesh-ancestor
65481627|NCT01193504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65481628|NCT01193504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481629|NCT01193504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65481630|NCT01193504|Glucocorticoids|glucocorticoids|mesh-ancestor
65481631|NCT01193504|Hormones|hormones|mesh-ancestor
64865683|NCT01787136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64722251|NCT00002618|Immunologic Factors|immunologic factors|mesh-ancestor
64722252|NCT00002618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64722253|NCT00002618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64722254|NCT00002618|Antiviral Agents|antiviral agents|mesh-ancestor
64722255|NCT00002618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64722256|NCT00002618|Antidotes|antidotes|mesh-ancestor
64722257|NCT00002618|Protective Agents|protective agents|mesh-ancestor
64722258|NCT00002618|Vitamin B Complex|vitamin b complex|mesh-ancestor
64722259|NCT00002618|Vitamins|vitamins|mesh-ancestor
64722260|NCT00002618|Micronutrients|micronutrients|mesh-ancestor
64722261|NCT00002618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64722262|NCT00002618|Tubulin Modulators|tubulin modulators|mesh-ancestor
64722263|NCT00002618|Antimitotic Agents|antimitotic agents|mesh-ancestor
64329963|NCT00004897|Leucovorin|leucovorin|mesh-list
64722265|NCT00002618|Trace Elements|trace elements|mesh-ancestor
64722266|NCT02145169|Nitrous Oxide|nitrous oxide|mesh-list
64461636|NCT05688436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64722267|NCT02145169|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64722268|NCT02145169|Anesthetics, General|anesthetics, general|mesh-ancestor
64722269|NCT02145169|Anesthetics|anesthetics|mesh-ancestor
64722270|NCT02145169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64722271|NCT02145169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722272|NCT02145169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64722273|NCT02145169|Analgesics|analgesics|mesh-ancestor
64722274|NCT02145169|Sensory System Agents|sensory system agents|mesh-ancestor
64722275|NCT02145169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64722276|NCT02110069|Sirolimus|sirolimus|mesh-list
64722277|NCT02110069|Vincristine|vincristine|mesh-list
64722278|NCT02110069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64722279|NCT02110069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722280|NCT02110069|Tubulin Modulators|tubulin modulators|mesh-ancestor
64722290|NCT02110069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722291|NCT00002630|Cobalt|cobalt|mesh-list
64722292|NCT00002630|Cyclophosphamide|cyclophosphamide|mesh-list
64329992|NCT00004231|Aldesleukin|aldesleukin|mesh-list
65481632|NCT01193504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65481633|NCT01193504|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65481634|NCT01193504|Protective Agents|protective agents|mesh-ancestor
65481635|NCT01193504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65481636|NCT01193504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481637|NCT01193504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65481638|NCT03848780|Desflurane|desflurane|mesh-list
65481639|NCT03848780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65481640|NCT03848780|Anesthetics, General|anesthetics, general|mesh-ancestor
65481641|NCT03848780|Anesthetics|anesthetics|mesh-ancestor
65481642|NCT03848780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65481643|NCT03848780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481644|NCT05599802|Vaccines|vaccines|mesh-list
65481645|NCT05599802|Immunologic Factors|immunologic factors|mesh-ancestor
65481646|NCT05599802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481647|NCT00051558|Alendronate|alendronate|mesh-list
65481648|NCT00051558|Teriparatide|teriparatide|mesh-list
65481649|NCT00051558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65481650|NCT00051558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481651|NCT00051558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65481652|NCT03848234|Estradiol|estradiol|mesh-list
65481653|NCT03848234|Estrogens|estrogens|mesh-ancestor
65481654|NCT03848234|Hormones|hormones|mesh-ancestor
65481655|NCT03848234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65481656|NCT03848234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481657|NCT01295918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65481658|NCT01295918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65481659|NCT01195298|Bevacizumab|bevacizumab|mesh-list
65481660|NCT01195298|Capecitabine|capecitabine|mesh-list
65481661|NCT01195298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65481662|NCT01195298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481663|NCT01195298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64329993|NCT00004231|Prednisone|prednisone|mesh-list
65481673|NCT01296074|Glucocorticoids|glucocorticoids|mesh-ancestor
65481674|NCT01296074|Hormones|hormones|mesh-ancestor
65481675|NCT01296074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65481676|NCT01296074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481677|NCT01296074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65481678|NCT01296074|Protective Agents|protective agents|mesh-ancestor
65481679|NCT01296074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65481680|NCT01296074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481681|NCT01189448|Pyrimethamine|pyrimethamine|mesh-list
65481682|NCT01189448|Sulfadiazine|sulfadiazine|mesh-list
65481683|NCT01189448|Spiramycin|spiramycin|mesh-list
65481684|NCT01189448|Antimalarials|antimalarials|mesh-ancestor
65481685|NCT01189448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65481686|NCT01189448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65481687|NCT01189448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65481688|NCT01189448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65481689|NCT01189448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481690|NCT01189448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329994|NCT00004231|Cyclophosphamide|cyclophosphamide|mesh-list
64329995|NCT00004231|Busulfan|busulfan|mesh-list
64329996|NCT00004231|Doxorubicin|doxorubicin|mesh-list
64329997|NCT00004231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64722294|NCT00002630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64722295|NCT00002630|Immunologic Factors|immunologic factors|mesh-ancestor
64722296|NCT00002630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722297|NCT00002630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64722298|NCT00002630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64722299|NCT00002630|Alkylating Agents|alkylating agents|mesh-ancestor
64722300|NCT00002630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722301|NCT00002630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722302|NCT00002630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64722303|NCT00002630|Trace Elements|trace elements|mesh-ancestor
64722304|NCT00002630|Micronutrients|micronutrients|mesh-ancestor
64722305|NCT00002642|Cobalt|cobalt|mesh-list
64722306|NCT00002642|Etoposide|etoposide|mesh-list
64722307|NCT00002642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722308|NCT00002642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64722309|NCT00002642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64722310|NCT00002642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64722311|NCT00002642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64722312|NCT00002642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722313|NCT00002642|Trace Elements|trace elements|mesh-ancestor
64722314|NCT00002642|Micronutrients|micronutrients|mesh-ancestor
64722315|NCT00002642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722316|NCT03983941|Ropivacaine|ropivacaine|mesh-list
64722317|NCT03983941|Anesthetics, Local|anesthetics, local|mesh-ancestor
64722318|NCT03983941|Anesthetics|anesthetics|mesh-ancestor
64722319|NCT03983941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64722320|NCT03983941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722321|NCT03983941|Sensory System Agents|sensory system agents|mesh-ancestor
64722322|NCT03983941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64722323|NCT05750030|Bevacizumab|bevacizumab|mesh-list
64722324|NCT05750030|Atezolizumab|atezolizumab|mesh-list
64722325|NCT05750030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64722326|NCT05750030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722327|NCT05750030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64722328|NCT05750030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64722329|NCT05750030|Growth Substances|growth substances|mesh-ancestor
65481691|NCT01189448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65481692|NCT01189448|Coccidiostats|coccidiostats|mesh-ancestor
65481693|NCT01195376|Dactolisib|dactolisib|mesh-list
65481694|NCT01195376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481695|NCT01189526|Ranibizumab|ranibizumab|mesh-list
65481696|NCT01189526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65481697|NCT01189526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65481698|NCT01189526|Growth Substances|growth substances|mesh-ancestor
65481699|NCT01189526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481700|NCT01189526|Growth Inhibitors|growth inhibitors|mesh-ancestor
65481701|NCT01189526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481702|NCT01296230|Hormones|hormones|mesh-list
65481703|NCT01296230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65481704|NCT01296230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481705|NCT01580696|Molgramostim|molgramostim|mesh-list
65481706|NCT01580696|Vaccines|vaccines|mesh-list
65481707|NCT01580696|Sargramostim|sargramostim|mesh-list
65481708|NCT01580696|Immunologic Factors|immunologic factors|mesh-ancestor
65481709|NCT01580696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481710|NCT01580696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481711|NCT01197014|Losartan|losartan|mesh-list
65481712|NCT01197014|Amlodipine|amlodipine|mesh-list
65481713|NCT01197014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65481714|NCT01197014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65481715|NCT01197014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65481716|NCT01197014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481717|NCT01197014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65481718|NCT01197014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481719|NCT01197014|Vasodilator Agents|vasodilator agents|mesh-ancestor
65481720|NCT01197014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65481723|NCT01195454|Insulin|insulin|mesh-list
65481737|NCT01197170|Growth Substances|growth substances|mesh-ancestor
65481738|NCT01197170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481739|NCT01197170|Growth Inhibitors|growth inhibitors|mesh-ancestor
65481740|NCT01197170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65481741|NCT01197170|Immunologic Factors|immunologic factors|mesh-ancestor
65481742|NCT01197170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65481743|NCT01197170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481744|NCT01197170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481745|NCT01197170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65481746|NCT01197170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64330059|NCT00004171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64330060|NCT00004165|Melphalan|melphalan|mesh-list
64330061|NCT00004165|Immunologic Factors|immunologic factors|mesh-ancestor
64330062|NCT00004165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330063|NCT00004165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64330064|NCT00004165|Alkylating Agents|alkylating agents|mesh-ancestor
64330065|NCT00004165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330066|NCT00004165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495700|NCT01158820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64495701|NCT01158820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495702|NCT01158820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64495703|NCT01158820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64495704|NCT01158820|Anesthetics, General|anesthetics, general|mesh-ancestor
64495712|NCT01158820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64495713|NCT01158820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64495714|NCT01158820|GABA Modulators|gaba modulators|mesh-ancestor
64495715|NCT01158820|GABA Agents|gaba agents|mesh-ancestor
64495716|NCT01158820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64495717|NCT01158820|Anesthetics, Local|anesthetics, local|mesh-ancestor
64495718|NCT01158820|Antiemetics|antiemetics|mesh-ancestor
64495719|NCT01158820|Autonomic Agents|autonomic agents|mesh-ancestor
64495720|NCT01158820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64722352|NCT01401049|Fospropofol|fospropofol|mesh-list
64722353|NCT01401049|Anesthetics, Local|anesthetics, local|mesh-ancestor
64722354|NCT01401049|Anesthetics|anesthetics|mesh-ancestor
64722355|NCT01401049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64722356|NCT01401049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722357|NCT01401049|Sensory System Agents|sensory system agents|mesh-ancestor
64722358|NCT01401049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64722359|NCT01401049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64722360|NCT01401049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64722361|NCT01401049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64722362|NCT01401049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64722363|NCT01401049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722364|NCT01401049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64722365|NCT01401049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64722366|NCT01401049|Anesthetics, General|anesthetics, general|mesh-ancestor
64722367|NCT00381758|Methylphenidate|methylphenidate|mesh-list
64330073|NCT00004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64330074|NCT00004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330075|NCT00004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
64330076|NCT00004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
64330077|NCT00004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
64330078|NCT00004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330079|NCT00004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64330080|NCT00004093|Antimetabolites|antimetabolites|mesh-ancestor
64330081|NCT00004093|Antiviral Agents|antiviral agents|mesh-ancestor
64330082|NCT00004093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64330083|NCT00004093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330084|NCT00004093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64330085|NCT00004093|Immunologic Factors|immunologic factors|mesh-ancestor
64330088|NCT02193269|Minocycline|minocycline|mesh-list
64722368|NCT00381758|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65481747|NCT01197170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65481748|NCT01197170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65481749|NCT01197170|Hormone Antagonists|hormone antagonists|mesh-ancestor
65481750|NCT01197170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65481751|NCT05516966|Dulaglutide|dulaglutide|mesh-list
65481752|NCT05516966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65481753|NCT05516966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481754|NCT01195766|Ofatumumab|ofatumumab|mesh-list
65481755|NCT01195766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481756|NCT03850886|Niacinamide|niacinamide|mesh-list
65481757|NCT03850886|Niacin|niacin|mesh-list
65481758|NCT03850886|Nicotinic Acids|nicotinic acids|mesh-list
65481759|NCT03850886|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65481760|NCT03850886|Vitamins|vitamins|mesh-ancestor
64722369|NCT00381758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722370|NCT00381758|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64722371|NCT00381758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64722372|NCT00381758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64722373|NCT00381758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722374|NCT00381758|Dopamine Agents|dopamine agents|mesh-ancestor
64330089|NCT02193269|Tetracycline|tetracycline|mesh-list
64330090|NCT02193269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64330091|NCT02193269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64330092|NCT02193269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330093|NCT02193269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330094|NCT00002479|Tretinoin|tretinoin|mesh-list
64330095|NCT00002479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330096|NCT00002479|Keratolytic Agents|keratolytic agents|mesh-ancestor
64330097|NCT00002479|Dermatologic Agents|dermatologic agents|mesh-ancestor
64495721|NCT01158820|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64495722|NCT01158820|Histamine Antagonists|histamine antagonists|mesh-ancestor
64495723|NCT01158820|Histamine Agents|histamine agents|mesh-ancestor
64495724|NCT01158820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64495725|NCT03707028|Paclitaxel|paclitaxel|mesh-list
64495726|NCT03707028|Apatinib|apatinib|mesh-list
64495727|NCT03707028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64495739|NCT04956042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495740|NCT04956042|Antiviral Agents|antiviral agents|mesh-ancestor
64495741|NCT04956042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64495742|NCT04956042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64495743|NCT04956042|Immunologic Factors|immunologic factors|mesh-ancestor
64495744|NCT04956042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495745|NCT03447678|Pembrolizumab|pembrolizumab|mesh-list
64495746|NCT03447678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64495747|NCT03447678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495748|NCT01225354|Calcium|calcium|mesh-list
64495749|NCT01225354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64495750|NCT01225354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495751|NCT02521662|Nicotine|nicotine|mesh-list
64495752|NCT02521662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64495753|NCT02521662|Autonomic Agents|autonomic agents|mesh-ancestor
64495754|NCT02521662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64495755|NCT02521662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495756|NCT02521662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64495758|NCT02521662|Cholinergic Agents|cholinergic agents|mesh-ancestor
64495759|NCT02521662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64495760|NCT02521662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495761|NCT03499704|Metformin|metformin|mesh-list
64495762|NCT03499704|Pioglitazone|pioglitazone|mesh-list
64495763|NCT03499704|Dapagliflozin|dapagliflozin|mesh-list
64495764|NCT03499704|Alogliptin|alogliptin|mesh-list
64495765|NCT03499704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64495766|NCT03499704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481761|NCT03850886|Micronutrients|micronutrients|mesh-ancestor
65481762|NCT03850886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481763|NCT03850886|Vitamin B Complex|vitamin b complex|mesh-ancestor
65481764|NCT03850886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65481765|NCT03850886|Antimetabolites|antimetabolites|mesh-ancestor
65481766|NCT03850886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481767|NCT03850886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65481768|NCT03850886|Vasodilator Agents|vasodilator agents|mesh-ancestor
65481769|NCT03251482|Apixaban|apixaban|mesh-list
65481770|NCT03251482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65481771|NCT03251482|Antithrombins|antithrombins|mesh-ancestor
65481772|NCT03251482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65481773|NCT03251482|Protease Inhibitors|protease inhibitors|mesh-ancestor
65481774|NCT03251482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481775|NCT03251482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481776|NCT03251482|Anticoagulants|anticoagulants|mesh-ancestor
65481777|NCT03732248|Sirolimus|sirolimus|mesh-list
65481778|NCT03732248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64865829|NCT01788371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64495767|NCT03499704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64495768|NCT03499704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722375|NCT00381758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64722377|NCT01402531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64722378|NCT01402531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722379|NCT01402531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64722380|NCT01402531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64722381|NCT01402531|Growth Substances|growth substances|mesh-ancestor
64722382|NCT01402531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722383|NCT01402531|Growth Inhibitors|growth inhibitors|mesh-ancestor
64722384|NCT00381836|Darbepoetin alfa|darbepoetin alfa|mesh-list
64722385|NCT00381836|Hematinics|hematinics|mesh-ancestor
64722386|NCT01971853|Analgesics|analgesics|mesh-list
64722387|NCT01971853|Sensory System Agents|sensory system agents|mesh-ancestor
64722388|NCT01971853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64722389|NCT01971853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722390|NCT00002678|Dexamethasone|dexamethasone|mesh-list
64722391|NCT00002678|Prednisone|prednisone|mesh-list
64722392|NCT00002678|Melphalan|melphalan|mesh-list
64722393|NCT00002678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64722394|NCT00002678|Antiemetics|antiemetics|mesh-ancestor
64722395|NCT00002678|Autonomic Agents|autonomic agents|mesh-ancestor
64722396|NCT00002678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64722397|NCT00002678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330098|NCT00002371|Lamivudine|lamivudine|mesh-list
64330099|NCT00002371|Zidovudine|zidovudine|mesh-list
64330100|NCT00002371|Stavudine|stavudine|mesh-list
64330101|NCT00002371|Indinavir|indinavir|mesh-list
64330102|NCT00002371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64330103|NCT00002371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64330104|NCT00002371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330105|NCT00002371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330106|NCT00002371|Antiviral Agents|antiviral agents|mesh-ancestor
64330107|NCT00002371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64495769|NCT03499704|Incretins|incretins|mesh-ancestor
64722420|NCT00002684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64722421|NCT00002684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722422|NCT00002684|Tubulin Modulators|tubulin modulators|mesh-ancestor
65481779|NCT03732248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65481780|NCT03732248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65481781|NCT03732248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481782|NCT03732248|Antifungal Agents|antifungal agents|mesh-ancestor
65481783|NCT03732248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65481784|NCT03732248|Immunologic Factors|immunologic factors|mesh-ancestor
65481785|NCT03732248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481786|NCT00310037|Bortezomib|bortezomib|mesh-list
65481787|NCT00310037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481788|NCT01196234|Paclitaxel|paclitaxel|mesh-list
65481789|NCT01196234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65481790|NCT01196234|Carboplatin|carboplatin|mesh-list
65481791|NCT01196234|Gefitinib|gefitinib|mesh-list
64722423|NCT00002684|Antimitotic Agents|antimitotic agents|mesh-ancestor
64722424|NCT00002684|Mitosis Modulators|mitosis modulators|mesh-ancestor
64418656|NCT02585713|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64330127|NCT05715385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64330128|NCT04182633|Vancomycin|vancomycin|mesh-list
64330129|NCT04182633|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64330130|NCT04182633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64330131|NCT04182633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64330132|NCT04182633|Laxatives|laxatives|mesh-ancestor
64330133|NCT04182633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64330134|NCT02194283|Ambroxol|ambroxol|mesh-list
64722426|NCT00002684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64722427|NCT00002684|Alkylating Agents|alkylating agents|mesh-ancestor
64722429|NCT02972918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64722430|NCT02972918|Vasodilator Agents|vasodilator agents|mesh-ancestor
64722431|NCT02972918|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64722432|NCT02972918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64722433|NCT02972918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64722434|NCT02972918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722435|NCT02972918|Protective Agents|protective agents|mesh-ancestor
64722436|NCT02972918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722437|NCT05600491|Temozolomide|temozolomide|mesh-list
64722438|NCT05600491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64722439|NCT05600491|Alkylating Agents|alkylating agents|mesh-ancestor
64722440|NCT05600491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722441|NCT05600491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722442|NCT00002696|Cyclophosphamide|cyclophosphamide|mesh-list
64722443|NCT00002696|Doxorubicin|doxorubicin|mesh-list
64330135|NCT02194283|Expectorants|expectorants|mesh-ancestor
64330136|NCT02194283|Respiratory System Agents|respiratory system agents|mesh-ancestor
64330137|NCT00263341|Contraceptive Agents|contraceptive agents|mesh-list
64330138|NCT00263341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64330139|NCT00263341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64330140|NCT00263341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330141|NCT00263341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64330142|NCT00263341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64330143|NCT00263341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64330144|NCT00263341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64330145|NCT00263341|Estrogens|estrogens|mesh-ancestor
64330146|NCT00263341|Hormones|hormones|mesh-ancestor
64330148|NCT03534869|Analgesics|analgesics|mesh-list
64722451|NCT00002696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64722452|NCT00002696|Alkylating Agents|alkylating agents|mesh-ancestor
64722453|NCT00002696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722454|NCT00002696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722455|NCT00002696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64722456|NCT00002696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64722457|NCT00002696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64722458|NCT00002696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64722459|NCT00002696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64722460|NCT00002696|Antimetabolites|antimetabolites|mesh-ancestor
65481792|NCT01196234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65481793|NCT01196234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481794|NCT01196234|Tubulin Modulators|tubulin modulators|mesh-ancestor
65481795|NCT01196234|Antimitotic Agents|antimitotic agents|mesh-ancestor
65481796|NCT01196234|Mitosis Modulators|mitosis modulators|mesh-ancestor
65481797|NCT01196234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481798|NCT01196234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65481799|NCT01196234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481800|NCT03007030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65481801|NCT03007030|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65481802|NCT03007030|Antibodies|antibodies|mesh-list
65481803|NCT03007030|Immunoglobulins|immunoglobulins|mesh-list
64865858|NCT01788501|Antimetabolites|antimetabolites|mesh-ancestor
64722461|NCT00002696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64330153|NCT02370849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330154|NCT02370849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64330155|NCT02378649|Sildenafil Citrate|sildenafil citrate|mesh-list
64330156|NCT02378649|Vasodilator Agents|vasodilator agents|mesh-ancestor
64330157|NCT02378649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64330158|NCT02378649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64495770|NCT03499704|Hormones|hormones|mesh-ancestor
64495771|NCT03499704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64495772|NCT03499704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64495773|NCT03499704|Protease Inhibitors|protease inhibitors|mesh-ancestor
64495774|NCT03499704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64495775|NCT05183880|Vitamins|vitamins|mesh-list
64495776|NCT05183880|Ascorbic Acid|ascorbic acid|mesh-list
64495777|NCT05183880|Micronutrients|micronutrients|mesh-ancestor
64495778|NCT05183880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495779|NCT05183880|Antioxidants|antioxidants|mesh-ancestor
64495780|NCT05183880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495781|NCT05183880|Protective Agents|protective agents|mesh-ancestor
64722463|NCT00002696|Abortifacient Agents|abortifacient agents|mesh-ancestor
64722464|NCT00002696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64722465|NCT00002696|Dermatologic Agents|dermatologic agents|mesh-ancestor
64722466|NCT00002696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64722467|NCT00002696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64722472|NCT00002702|Antiviral Agents|antiviral agents|mesh-ancestor
64722473|NCT00002702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64722474|NCT01890577|Darbepoetin alfa|darbepoetin alfa|mesh-list
64722475|NCT01890577|Hematinics|hematinics|mesh-ancestor
64330159|NCT02378649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330160|NCT02378649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330161|NCT02378649|Urological Agents|urological agents|mesh-ancestor
64330162|NCT02197169|Interferons|interferons|mesh-list
64330163|NCT02197169|Interferon-gamma|interferon-gamma|mesh-list
64330164|NCT02197169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330165|NCT02197169|Antiviral Agents|antiviral agents|mesh-ancestor
64330166|NCT02197169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64330167|NCT02376309|Nandrolone|nandrolone|mesh-list
64330168|NCT02376309|Androgens|androgens|mesh-ancestor
64330169|NCT02376309|Hormones|hormones|mesh-ancestor
64330170|NCT02376309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64495783|NCT01159054|Nicotinic Acids|nicotinic acids|mesh-list
64495784|NCT01159054|Niacinamide|niacinamide|mesh-list
64495785|NCT01159054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64495786|NCT01159054|Antimetabolites|antimetabolites|mesh-ancestor
64495787|NCT01159054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495788|NCT01159054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64495789|NCT01159054|Vasodilator Agents|vasodilator agents|mesh-ancestor
64495790|NCT01159054|Vitamin B Complex|vitamin b complex|mesh-ancestor
64495791|NCT01159054|Vitamins|vitamins|mesh-ancestor
64495792|NCT01159054|Micronutrients|micronutrients|mesh-ancestor
65481804|NCT03007030|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65481805|NCT03007030|Immunoconjugates|immunoconjugates|mesh-list
65481806|NCT03007030|Immunologic Factors|immunologic factors|mesh-ancestor
65481807|NCT03007030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481808|NCT03007030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481809|NCT03992261|Halobetasol|halobetasol|mesh-list
65481810|NCT03992261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65481811|NCT00309959|Paclitaxel|paclitaxel|mesh-list
65481812|NCT00309959|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65481813|NCT00309959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65481814|NCT00309959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481815|NCT00309959|Tubulin Modulators|tubulin modulators|mesh-ancestor
65481816|NCT00309959|Antimitotic Agents|antimitotic agents|mesh-ancestor
65481817|NCT00309959|Mitosis Modulators|mitosis modulators|mesh-ancestor
65481818|NCT00309959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481819|NCT03238924|Oxytocin|oxytocin|mesh-list
65481820|NCT03238924|Oxytocics|oxytocics|mesh-ancestor
65481821|NCT03238924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65481822|NCT03238924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481823|NCT01190384|Grape Seed Extract|grape seed extract|mesh-list
65481824|NCT01190384|Antioxidants|antioxidants|mesh-list
65481825|NCT01190384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481826|NCT01190384|Protective Agents|protective agents|mesh-ancestor
65481827|NCT01190384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481828|NCT01190384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64495793|NCT01159054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495794|NCT01209442|Bevacizumab|bevacizumab|mesh-list
64495795|NCT01209442|Temozolomide|temozolomide|mesh-list
64495796|NCT01209442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64495797|NCT01209442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495798|NCT01209442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64495799|NCT01209442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64495800|NCT01209442|Growth Substances|growth substances|mesh-ancestor
64495829|NCT04901208|Autonomic Agents|autonomic agents|mesh-ancestor
64495830|NCT04901208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64495831|NCT04901208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722485|NCT01895959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722486|NCT01895959|Viscosupplements|viscosupplements|mesh-ancestor
64722487|NCT01895959|Protective Agents|protective agents|mesh-ancestor
64330171|NCT02376309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330172|NCT02376309|Anabolic Agents|anabolic agents|mesh-ancestor
64330173|NCT00232141|Pregabalin|pregabalin|mesh-list
64330174|NCT00232141|Analgesics|analgesics|mesh-ancestor
64330175|NCT00232141|Sensory System Agents|sensory system agents|mesh-ancestor
64330176|NCT00232141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64495832|NCT04901208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64495833|NCT04901208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64495834|NCT04901208|Cholinergic Agents|cholinergic agents|mesh-ancestor
64495835|NCT04901208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64945640|NCT05379322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65481829|NCT01190384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481830|NCT02532413|Entecavir|entecavir|mesh-list
65481831|NCT02532413|Poly I-C|poly i-c|mesh-list
65481832|NCT02532413|Antiviral Agents|antiviral agents|mesh-ancestor
65481833|NCT02532413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65481834|NCT02532413|Interferon Inducers|interferon inducers|mesh-ancestor
65481835|NCT02532413|Immunologic Factors|immunologic factors|mesh-ancestor
65481836|NCT02532413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481837|NCT01190462|Cetuximab|cetuximab|mesh-list
65481838|NCT01190462|Simvastatin|simvastatin|mesh-list
65481839|NCT01190462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65481840|NCT01190462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481841|NCT01190462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65481842|NCT01190462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65481843|NCT01190462|Antimetabolites|antimetabolites|mesh-ancestor
65481844|NCT01190462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481845|NCT01190462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65481846|NCT01190462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65481847|NCT01190462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481848|NCT01198106|Cinnarizine|cinnarizine|mesh-list
65481849|NCT01198106|Scopolamine|scopolamine|mesh-list
65481850|NCT01198106|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64495836|NCT04901208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495838|NCT01212484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64495839|NCT01212484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64495840|NCT01212484|Dopamine Agents|dopamine agents|mesh-ancestor
64495841|NCT01212484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64495842|NCT01212484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495846|NCT03446976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64495847|NCT03446976|Immunologic Factors|immunologic factors|mesh-ancestor
64495848|NCT03446976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495849|NCT01212874|Nitroglycerin|nitroglycerin|mesh-list
64495850|NCT01212874|Esmolol|esmolol|mesh-list
64495851|NCT01212874|Vasodilator Agents|vasodilator agents|mesh-ancestor
64495852|NCT01212874|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64495853|NCT01212874|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64495854|NCT01212874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64495855|NCT01212874|Adrenergic Agents|adrenergic agents|mesh-ancestor
64495856|NCT01212874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64418662|NCT02585713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64722511|NCT00002714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64722512|NCT00002714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64722513|NCT00002714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722514|NCT00002714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64722515|NCT00002714|Glucocorticoids|glucocorticoids|mesh-ancestor
64722516|NCT00002714|Hormones|hormones|mesh-ancestor
64722517|NCT00002714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64722518|NCT00002714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722519|NCT00002714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64722520|NCT00002714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64722521|NCT00002714|Tubulin Modulators|tubulin modulators|mesh-ancestor
64722522|NCT00002714|Antimitotic Agents|antimitotic agents|mesh-ancestor
64722523|NCT00002714|Mitosis Modulators|mitosis modulators|mesh-ancestor
65481851|NCT01198106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65481852|NCT01198106|Antiemetics|antiemetics|mesh-ancestor
65481853|NCT01198106|Autonomic Agents|autonomic agents|mesh-ancestor
65481854|NCT01198106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65481855|NCT01198106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481856|NCT01198106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65481857|NCT01198106|Mydriatics|mydriatics|mesh-ancestor
65481858|NCT01198106|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65481859|NCT01198106|Cholinergic Agents|cholinergic agents|mesh-ancestor
65481860|NCT01198106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64865914|NCT01788774|Dopamine Agents|dopamine agents|mesh-ancestor
64722524|NCT00002714|Alkylating Agents|alkylating agents|mesh-ancestor
64722525|NCT00002714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64722526|NCT00002720|Tamoxifen|tamoxifen|mesh-list
64722527|NCT00002720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64722528|NCT00002720|Hormone Antagonists|hormone antagonists|mesh-ancestor
64722529|NCT00002720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64418666|NCT02585713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64418667|NCT05678257|Leucovorin|leucovorin|mesh-list
64722557|NCT01194427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722559|NCT01194427|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64722641|NCT00002744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64722642|NCT00002744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64722643|NCT00002744|Tubulin Modulators|tubulin modulators|mesh-ancestor
64722644|NCT00002744|Antimitotic Agents|antimitotic agents|mesh-ancestor
64330314|NCT02195375|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64330315|NCT02195375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64330316|NCT02195375|Autonomic Agents|autonomic agents|mesh-ancestor
64330317|NCT02195375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330318|NCT02195375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330319|NCT02195375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64330320|NCT02195375|Respiratory System Agents|respiratory system agents|mesh-ancestor
64330321|NCT02195375|Glucocorticoids|glucocorticoids|mesh-ancestor
64330322|NCT02195375|Hormones|hormones|mesh-ancestor
64330323|NCT02195375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64495880|NCT01212952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495881|NCT01212952|Immunologic Factors|immunologic factors|mesh-ancestor
64495882|NCT01212952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64495883|NCT01212952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64495884|NCT01212952|Growth Substances|growth substances|mesh-ancestor
64495885|NCT01212952|Growth Inhibitors|growth inhibitors|mesh-ancestor
64495886|NCT04609865|Lidocaine|lidocaine|mesh-list
64495887|NCT04609865|Anesthetics, Local|anesthetics, local|mesh-ancestor
64495888|NCT04609865|Anesthetics|anesthetics|mesh-ancestor
64495889|NCT04609865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64495890|NCT04609865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495891|NCT04609865|Sensory System Agents|sensory system agents|mesh-ancestor
64495892|NCT04609865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64495893|NCT04609865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64495894|NCT04609865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64495895|NCT04609865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64495896|NCT04609865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64495897|NCT04609865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495898|NCT01873859|Metformin|metformin|mesh-list
64495899|NCT01873859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64495900|NCT01873859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330332|NCT03601455|Tremelimumab|tremelimumab|mesh-list
64330333|NCT03601455|Immunoglobulins|immunoglobulins|mesh-list
64495901|NCT00493896|Enoxaparin|enoxaparin|mesh-list
64495902|NCT00493896|PENTA|penta|mesh-list
64495903|NCT00493896|Fondaparinux|fondaparinux|mesh-list
64495905|NCT00493896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64495906|NCT00493896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64495907|NCT00493896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481861|NCT01198106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481862|NCT01198106|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65481863|NCT01198106|Parasympatholytics|parasympatholytics|mesh-ancestor
65481864|NCT01198106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65481865|NCT01198106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65481866|NCT01198106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65481867|NCT01198106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65481868|NCT01198106|Histamine Antagonists|histamine antagonists|mesh-ancestor
65481869|NCT01198106|Histamine Agents|histamine agents|mesh-ancestor
65481870|NCT02918500|Nicotine|nicotine|mesh-list
65481871|NCT02918500|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65481872|NCT02918500|Autonomic Agents|autonomic agents|mesh-ancestor
65481873|NCT02918500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64722674|NCT00423007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64722675|NCT00423007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64722676|NCT00423007|Analgesics|analgesics|mesh-ancestor
64722677|NCT00423007|Sensory System Agents|sensory system agents|mesh-ancestor
64722678|NCT00423007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64722679|NCT00423007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722680|NCT00423007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64722681|NCT00423007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64722682|NCT04713787|Albendazole|albendazole|mesh-list
64722683|NCT04713787|Oxfendazole|oxfendazole|mesh-list
64722684|NCT04713787|Anthelmintics|anthelmintics|mesh-ancestor
64722685|NCT04713787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64722686|NCT04713787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64722687|NCT04713787|Anticestodal Agents|anticestodal agents|mesh-ancestor
64722688|NCT04713787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64722689|NCT04713787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64722690|NCT04713787|Tubulin Modulators|tubulin modulators|mesh-ancestor
64722691|NCT04713787|Antimitotic Agents|antimitotic agents|mesh-ancestor
64722692|NCT04713787|Mitosis Modulators|mitosis modulators|mesh-ancestor
64330347|NCT02369133|Sensory System Agents|sensory system agents|mesh-ancestor
64418753|NCT02582515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64330353|NCT02377635|Trace Elements|trace elements|mesh-ancestor
64330354|NCT02377635|Micronutrients|micronutrients|mesh-ancestor
64330355|NCT02377635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330356|NCT03534479|Immunoglobulins|immunoglobulins|mesh-list
64330357|NCT03534479|Immunologic Factors|immunologic factors|mesh-ancestor
64330358|NCT03534479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330359|NCT02198027|Bupivacaine|bupivacaine|mesh-list
64330360|NCT02198027|Anesthetics, Local|anesthetics, local|mesh-ancestor
64330361|NCT02198027|Anesthetics|anesthetics|mesh-ancestor
64330362|NCT02198027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64330363|NCT02198027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330364|NCT02198027|Sensory System Agents|sensory system agents|mesh-ancestor
64495911|NCT00493896|Protease Inhibitors|protease inhibitors|mesh-ancestor
64495912|NCT00493896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64495913|NCT04597619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
64722693|NCT04713787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722694|NCT04713787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722695|NCT04713787|Antinematodal Agents|antinematodal agents|mesh-ancestor
64722696|NCT00002750|Melphalan|melphalan|mesh-list
64722697|NCT00002750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64722698|NCT00002750|Alkylating Agents|alkylating agents|mesh-ancestor
64722699|NCT00002750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722700|NCT00002750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722701|NCT00002750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64722702|NCT00002750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64722703|NCT00002750|Immunologic Factors|immunologic factors|mesh-ancestor
64722704|NCT00002750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722705|NCT00002756|Leucovorin|leucovorin|mesh-list
65481874|NCT02918500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481875|NCT02918500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65481876|NCT02918500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65481877|NCT02918500|Cholinergic Agents|cholinergic agents|mesh-ancestor
65481878|NCT02918500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65481879|NCT02918500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481880|NCT03850652|Iron|iron|mesh-list
65481881|NCT03850652|Trace Elements|trace elements|mesh-ancestor
64722706|NCT00002756|Cytarabine|cytarabine|mesh-list
64722707|NCT00002756|Prednisone|prednisone|mesh-list
64722708|NCT00002756|Hydrocortisone|hydrocortisone|mesh-list
64722709|NCT00002756|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64722710|NCT00002756|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64722711|NCT00002756|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64722712|NCT00002756|Cyclophosphamide|cyclophosphamide|mesh-list
64722713|NCT00002756|Methotrexate|methotrexate|mesh-list
64722714|NCT00002756|Etoposide|etoposide|mesh-list
64722715|NCT00002756|Vincristine|vincristine|mesh-list
64330367|NCT02257463|Bronchodilator Agents|bronchodilator agents|mesh-list
64330368|NCT02257463|Autonomic Agents|autonomic agents|mesh-ancestor
64330369|NCT02257463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330370|NCT02257463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330371|NCT02257463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64330372|NCT02257463|Respiratory System Agents|respiratory system agents|mesh-ancestor
64330373|NCT02257463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64330374|NCT02257463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330375|NCT02257463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64330381|NCT04109885|Diphenhydramine|diphenhydramine|mesh-list
64495914|NCT04597619|Analgesics|analgesics|mesh-ancestor
64495925|NCT03449940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64495926|NCT03449940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495928|NCT03449940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64495929|NCT03449940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64495930|NCT03449940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64495931|NCT03449940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64495932|NCT03449940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64722716|NCT00002756|Daunorubicin|daunorubicin|mesh-list
64722717|NCT00002756|Asparaginase|asparaginase|mesh-list
64722718|NCT00002756|Mercaptopurine|mercaptopurine|mesh-list
64722719|NCT00002756|Levoleucovorin|levoleucovorin|mesh-list
64722720|NCT00002756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64722721|NCT00002756|Immunologic Factors|immunologic factors|mesh-ancestor
64722722|NCT00002756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722723|NCT00002756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64722724|NCT00002756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64722725|NCT00002756|Alkylating Agents|alkylating agents|mesh-ancestor
64418758|NCT02579629|Anesthetics|anesthetics|mesh-ancestor
64722734|NCT00002756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64722735|NCT00002756|Abortifacient Agents|abortifacient agents|mesh-ancestor
64330389|NCT04109885|Anesthetics|anesthetics|mesh-ancestor
64330390|NCT04109885|Sensory System Agents|sensory system agents|mesh-ancestor
64330391|NCT04109885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330392|NCT04109885|Antiemetics|antiemetics|mesh-ancestor
64330393|NCT04109885|Autonomic Agents|autonomic agents|mesh-ancestor
64330394|NCT04109885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64330395|NCT04109885|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64330396|NCT04109885|Histamine Antagonists|histamine antagonists|mesh-ancestor
64330397|NCT04109885|Histamine Agents|histamine agents|mesh-ancestor
64722736|NCT00002756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64722737|NCT00002756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64722738|NCT00002756|Antimetabolites|antimetabolites|mesh-ancestor
64722739|NCT00002756|Dermatologic Agents|dermatologic agents|mesh-ancestor
64722740|NCT00002756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64722741|NCT00002756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64722742|NCT00002756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64722743|NCT00002756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64722744|NCT00002756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64722745|NCT00002756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65481882|NCT03850652|Micronutrients|micronutrients|mesh-ancestor
65481883|NCT03850652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481884|NCT01198184|Sirolimus|sirolimus|mesh-list
65481885|NCT01198184|R04929097|r04929097|mesh-list
65481886|NCT01198184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65481887|NCT01198184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65481888|NCT01198184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65481889|NCT01198184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65481890|NCT01198184|Antifungal Agents|antifungal agents|mesh-ancestor
65481891|NCT01198184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65481892|NCT01198184|Immunologic Factors|immunologic factors|mesh-ancestor
65481893|NCT01198184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481894|NCT01198184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481895|NCT01198184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481896|NCT00333359|Gabapentin|gabapentin|mesh-list
65481897|NCT00333359|Analgesics|analgesics|mesh-ancestor
65481898|NCT00333359|Sensory System Agents|sensory system agents|mesh-ancestor
64722746|NCT00002756|Antiviral Agents|antiviral agents|mesh-ancestor
64722747|NCT00002756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64722748|NCT00002756|Antidotes|antidotes|mesh-ancestor
64722749|NCT00002756|Protective Agents|protective agents|mesh-ancestor
64722750|NCT00002756|Vitamin B Complex|vitamin b complex|mesh-ancestor
64722751|NCT00002756|Vitamins|vitamins|mesh-ancestor
64722752|NCT00002756|Micronutrients|micronutrients|mesh-ancestor
64722753|NCT00002756|Tubulin Modulators|tubulin modulators|mesh-ancestor
64722754|NCT00002756|Antimitotic Agents|antimitotic agents|mesh-ancestor
64722755|NCT00002756|Mitosis Modulators|mitosis modulators|mesh-ancestor
64722756|NCT00002756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64722757|NCT01183429|Tretinoin|tretinoin|mesh-list
64722758|NCT01183429|Isotretinoin|isotretinoin|mesh-list
64722759|NCT01183429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722760|NCT01183429|Keratolytic Agents|keratolytic agents|mesh-ancestor
64722761|NCT01183429|Dermatologic Agents|dermatologic agents|mesh-ancestor
64722762|NCT01157533|Vancomycin|vancomycin|mesh-list
64722763|NCT01157533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64722764|NCT01157533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64722765|NCT05558150|Aceclofenac|aceclofenac|mesh-list
64722766|NCT05558150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64722767|NCT05558150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64722768|NCT05558150|Analgesics|analgesics|mesh-ancestor
64330409|NCT02198261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64330410|NCT02198261|Vasodilator Agents|vasodilator agents|mesh-ancestor
64330411|NCT03533699|Propranolol|propranolol|mesh-list
64330412|NCT03533699|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64330413|NCT03533699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64495933|NCT03449940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722769|NCT05558150|Sensory System Agents|sensory system agents|mesh-ancestor
64722770|NCT05558150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64722771|NCT05558150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722772|NCT05558150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64722773|NCT05558150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64722775|NCT05749016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64722776|NCT05749016|Carboplatin|carboplatin|mesh-list
64722777|NCT05749016|Pertuzumab|pertuzumab|mesh-list
64722778|NCT05749016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64722779|NCT05749016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722787|NCT01756573|Anesthetics|anesthetics|mesh-ancestor
64722788|NCT01756573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64330439|NCT02200991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64330440|NCT02200991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65481899|NCT00333359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65481900|NCT00333359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481901|NCT00333359|Anticonvulsants|anticonvulsants|mesh-ancestor
65481902|NCT00333359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65481903|NCT00333359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65481904|NCT00333359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65481905|NCT00333359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65481906|NCT00333359|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65481907|NCT00333359|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65481908|NCT00333359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65481909|NCT00333359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481910|NCT00333359|Antimanic Agents|antimanic agents|mesh-ancestor
65481911|NCT03246724|Midazolam|midazolam|mesh-list
64865955|NCT01789216|Analgesics|analgesics|mesh-ancestor
64330441|NCT02200991|Protease Inhibitors|protease inhibitors|mesh-ancestor
64330442|NCT02200991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330443|NCT02200991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330444|NCT01979367|Analgesics|analgesics|mesh-list
64330445|NCT01979367|Sensory System Agents|sensory system agents|mesh-ancestor
64330446|NCT01979367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330447|NCT01979367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330448|NCT02368743|Mesalamine|mesalamine|mesh-list
64330450|NCT02368743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64495939|NCT03449940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64722798|NCT01702909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722799|NCT01702909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64722800|NCT01702909|Analgesics|analgesics|mesh-ancestor
64722801|NCT01702909|Sensory System Agents|sensory system agents|mesh-ancestor
64722802|NCT01702909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64722803|NCT01702909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722804|NCT00002768|Cytarabine|cytarabine|mesh-list
64722805|NCT00002768|Methotrexate|methotrexate|mesh-list
64722806|NCT00002768|Etoposide|etoposide|mesh-list
64722807|NCT00002768|Busulfan|busulfan|mesh-list
64722808|NCT00002768|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64722809|NCT00002768|Abortifacient Agents|abortifacient agents|mesh-ancestor
64722810|NCT00002768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64722811|NCT00002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722812|NCT00002768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64722813|NCT00002768|Antimetabolites|antimetabolites|mesh-ancestor
64722814|NCT00002768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330464|NCT00135343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330465|NCT00135343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64330466|NCT00135343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64330467|NCT00135343|Antiviral Agents|antiviral agents|mesh-ancestor
64330468|NCT00135343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64330469|NCT00135343|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64330470|NCT00135343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64330471|NCT00135343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64330472|NCT00135343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64330473|NCT00135343|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64495940|NCT03449940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64495941|NCT01230424|Triamcinolone|triamcinolone|mesh-list
64495942|NCT01230424|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64495943|NCT01230424|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64495944|NCT01230424|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64495945|NCT01230424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64495946|NCT01230424|Glucocorticoids|glucocorticoids|mesh-ancestor
64495947|NCT01230424|Hormones|hormones|mesh-ancestor
65481912|NCT03246724|Triazolam|triazolam|mesh-list
65481913|NCT03246724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65481914|NCT03246724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65481915|NCT03246724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65481916|NCT03246724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481917|NCT03246724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65481918|NCT03246724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65481919|NCT03246724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65481920|NCT03246724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65481921|NCT03246724|Anesthetics, General|anesthetics, general|mesh-ancestor
65481922|NCT03246724|Anesthetics|anesthetics|mesh-ancestor
65481923|NCT03246724|GABA Modulators|gaba modulators|mesh-ancestor
65481924|NCT03246724|GABA Agents|gaba agents|mesh-ancestor
65481925|NCT03246724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65481926|NCT03246724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481927|NCT01196546|Metformin|metformin|mesh-list
65481928|NCT01196546|Vildagliptin|vildagliptin|mesh-list
65481929|NCT01196546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65481930|NCT01196546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481931|NCT01196546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65481932|NCT01196546|Protease Inhibitors|protease inhibitors|mesh-ancestor
65481933|NCT01196546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65481934|NCT01196546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481935|NCT01293266|Propofol|propofol|mesh-list
65481936|NCT01293266|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65481937|NCT01293266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65481938|NCT01293266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481939|NCT01293266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65481940|NCT01293266|Anesthetics, General|anesthetics, general|mesh-ancestor
65481941|NCT01293266|Anesthetics|anesthetics|mesh-ancestor
65481942|NCT03948646|Bromides|bromides|mesh-list
65481943|NCT03948646|Anticonvulsants|anticonvulsants|mesh-ancestor
65481944|NCT01198340|Ropivacaine|ropivacaine|mesh-list
65481945|NCT01198340|Anesthetics, Local|anesthetics, local|mesh-list
65481946|NCT01198340|Anesthetics|anesthetics|mesh-list
65481947|NCT01198340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64495948|NCT01230424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64495949|NCT01230424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495950|NCT01230424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64495951|NCT01230424|Immunologic Factors|immunologic factors|mesh-ancestor
64865999|NCT01789385|Analgesics|analgesics|mesh-ancestor
65481948|NCT01198340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481949|NCT01198340|Sensory System Agents|sensory system agents|mesh-ancestor
65481950|NCT01198340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65481951|NCT01347112|Varenicline|varenicline|mesh-list
65481952|NCT01347112|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65481953|NCT01347112|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65481954|NCT01347112|Cholinergic Agents|cholinergic agents|mesh-ancestor
65481955|NCT01347112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65481956|NCT01347112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481957|NCT01347112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481958|NCT00308711|Misoprostol|misoprostol|mesh-list
65481959|NCT00308711|Dinoprostone|dinoprostone|mesh-list
65481960|NCT00308711|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65481961|NCT00308711|Abortifacient Agents|abortifacient agents|mesh-ancestor
65231473|NCT01023581|Protease Inhibitors|protease inhibitors|mesh-ancestor
65481962|NCT00308711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65481963|NCT00308711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481964|NCT00308711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64866005|NCT01789385|Adrenergic Agents|adrenergic agents|mesh-ancestor
64495952|NCT01230424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64495953|NCT01230424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495954|NCT01230502|Mycophenolic Acid|mycophenolic acid|mesh-list
64495955|NCT01230502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64495956|NCT01230502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495957|NCT01230502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64495964|NCT03438240|Dexmedetomidine|dexmedetomidine|mesh-list
64495965|NCT03438240|Bupivacaine|bupivacaine|mesh-list
64495966|NCT03438240|Anesthetics, Local|anesthetics, local|mesh-list
64495967|NCT03438240|Anesthetics|anesthetics|mesh-list
64495968|NCT03438240|Sympathomimetics|sympathomimetics|mesh-list
64495969|NCT03438240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64495970|NCT03438240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495971|NCT03438240|Sensory System Agents|sensory system agents|mesh-ancestor
64495972|NCT03438240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64722832|NCT05599243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64330488|NCT05724745|Autonomic Agents|autonomic agents|mesh-ancestor
64330489|NCT05724745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330490|NCT05724745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330491|NCT05724745|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64330492|NCT05724745|Respiratory System Agents|respiratory system agents|mesh-ancestor
64495973|NCT03438240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64495974|NCT03438240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64495975|NCT03438240|Analgesics|analgesics|mesh-ancestor
64495976|NCT03438240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64495977|NCT03438240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64495979|NCT03438240|Adrenergic Agents|adrenergic agents|mesh-ancestor
64495980|NCT03438240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64495992|NCT01160848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495993|NCT01213576|Ivermectin|ivermectin|mesh-list
64495994|NCT01213576|Albendazole|albendazole|mesh-list
64495995|NCT01213576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64495996|NCT01213576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64495997|NCT01213576|Anthelmintics|anthelmintics|mesh-ancestor
64495998|NCT01213576|Anticestodal Agents|anticestodal agents|mesh-ancestor
65481965|NCT00308711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65481966|NCT00308711|Oxytocics|oxytocics|mesh-ancestor
65481967|NCT04057456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65481968|NCT04057456|Nabilone|nabilone|mesh-list
65481969|NCT04057456|Antiemetics|antiemetics|mesh-ancestor
65481970|NCT04057456|Autonomic Agents|autonomic agents|mesh-ancestor
65481971|NCT04057456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65481972|NCT04057456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481973|NCT04057456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65481974|NCT04057456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65481975|NCT04057456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65481976|NCT04057456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65481977|NCT04057456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65481978|NCT01198496|Losartan|losartan|mesh-list
65481979|NCT01198496|Amlodipine|amlodipine|mesh-list
65481980|NCT01198496|Valsartan|valsartan|mesh-list
65481981|NCT01198496|Telmisartan|telmisartan|mesh-list
65481982|NCT01198496|Candesartan|candesartan|mesh-list
65481983|NCT01198496|Candesartan cilexetil|candesartan cilexetil|mesh-list
64495999|NCT01213576|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64496000|NCT01213576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64496001|NCT01213576|Tubulin Modulators|tubulin modulators|mesh-ancestor
64496002|NCT01213576|Antimitotic Agents|antimitotic agents|mesh-ancestor
64496003|NCT01213576|Mitosis Modulators|mitosis modulators|mesh-ancestor
64496004|NCT01213576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496005|NCT01213576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496006|NCT01161862|Glucagon|glucagon|mesh-list
64496007|NCT01161862|Pancrelipase|pancrelipase|mesh-list
64722837|NCT05599243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64722839|NCT00002774|Cisplatin|cisplatin|mesh-list
64722840|NCT00002774|Fluorouracil|fluorouracil|mesh-list
64722841|NCT00002774|Tirapazamine|tirapazamine|mesh-list
64722842|NCT00002774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722843|NCT00002774|Antimetabolites|antimetabolites|mesh-ancestor
64330493|NCT05724745|Tocolytic Agents|tocolytic agents|mesh-ancestor
64330494|NCT05724745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64330495|NCT05724745|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64330496|NCT05724745|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64330497|NCT05724745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64330498|NCT05724745|Adrenergic Agents|adrenergic agents|mesh-ancestor
64496008|NCT01161862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496009|NCT01161862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64496010|NCT01161862|Hormones|hormones|mesh-ancestor
64496011|NCT01161862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64496012|NCT01214356|Vitamin D|vitamin d|mesh-list
64496013|NCT01214356|Ergocalciferols|ergocalciferols|mesh-list
64496014|NCT01214356|Cholecalciferol|cholecalciferol|mesh-list
64496015|NCT01214356|Vitamins|vitamins|mesh-list
64496016|NCT01214356|Micronutrients|micronutrients|mesh-ancestor
64496017|NCT01214356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496018|NCT01214356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64496019|NCT01214356|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64496020|NCT04560660|Midazolam|midazolam|mesh-list
64496021|NCT04560660|Ketamine|ketamine|mesh-list
64496022|NCT04560660|Analgesics|analgesics|mesh-ancestor
64496023|NCT04560660|Sensory System Agents|sensory system agents|mesh-ancestor
64496024|NCT04560660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496027|NCT04560660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64496028|NCT04560660|Anesthetics, General|anesthetics, general|mesh-ancestor
64496029|NCT04560660|Anesthetics|anesthetics|mesh-ancestor
64496030|NCT04560660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65481984|NCT01198496|Olmesartan|olmesartan|mesh-list
65481985|NCT01198496|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65481986|NCT01198496|Spironolactone|spironolactone|mesh-list
65481987|NCT01198496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65481988|NCT01198496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65481989|NCT01198496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65481990|NCT01198496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65481991|NCT01198496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65481992|NCT01198496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65481993|NCT01198496|Vasodilator Agents|vasodilator agents|mesh-ancestor
65481994|NCT01198496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64866030|NCT01789710|Autonomic Agents|autonomic agents|mesh-ancestor
64496031|NCT04560660|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64496032|NCT04560660|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64496033|NCT04560660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64496034|NCT04560660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722844|NCT00002774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722845|NCT00002774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64722846|NCT00002774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64722847|NCT00002774|Immunologic Factors|immunologic factors|mesh-ancestor
64722848|NCT00002774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722849|NCT00002780|Aldesleukin|aldesleukin|mesh-list
64722850|NCT00002780|Cyclophosphamide|cyclophosphamide|mesh-list
64722851|NCT00002780|Thiotepa|thiotepa|mesh-list
64722852|NCT00002780|Carboplatin|carboplatin|mesh-list
64722853|NCT00002780|Sargramostim|sargramostim|mesh-list
64722854|NCT00002780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64722855|NCT00002780|Immunologic Factors|immunologic factors|mesh-ancestor
64722856|NCT00002780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330499|NCT05724745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64330500|NCT05724745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330501|NCT04597671|Durvalumab|durvalumab|mesh-list
64330502|NCT04597671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64330503|NCT04597671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330504|NCT02198807|Piperaquine|piperaquine|mesh-list
64330505|NCT02198807|Fosmidomycin|fosmidomycin|mesh-list
64330506|NCT02198807|Antimalarials|antimalarials|mesh-ancestor
64330507|NCT02198807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64330508|NCT02198807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64330509|NCT02198807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64330510|NCT02198807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64330511|NCT02198417|Metformin|metformin|mesh-list
64496035|NCT04560660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64496036|NCT04560660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64496037|NCT04560660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64496038|NCT04560660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64496039|NCT04560660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64496040|NCT04560660|GABA Modulators|gaba modulators|mesh-ancestor
64496041|NCT04560660|GABA Agents|gaba agents|mesh-ancestor
64496042|NCT01232920|Mycophenolic Acid|mycophenolic acid|mesh-list
64496043|NCT01232920|Methotrexate|methotrexate|mesh-list
64496044|NCT01232920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64496045|NCT01232920|Abortifacient Agents|abortifacient agents|mesh-ancestor
64496046|NCT01232920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64496059|NCT01232920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64496060|NCT01232920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64496061|NCT01232920|Antitubercular Agents|antitubercular agents|mesh-ancestor
64496062|NCT01232920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64496063|NCT01232920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64496064|NCT03445182|Anesthetics|anesthetics|mesh-list
64496065|NCT03445182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64496066|NCT03445182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496067|NCT03010540|Fentanyl|fentanyl|mesh-list
65481995|NCT01198496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65481996|NCT01198496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65481997|NCT01198496|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65481998|NCT01198496|Hormone Antagonists|hormone antagonists|mesh-ancestor
65481999|NCT01198496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65482000|NCT01198496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65482001|NCT01198496|Diuretics|diuretics|mesh-ancestor
65482002|NCT01198496|Natriuretic Agents|natriuretic agents|mesh-ancestor
65482003|NCT01066013|Anti-Infective Agents|anti-infective agents|mesh-list
65482004|NCT01066013|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65482005|NCT01066091|Palmitic Acid|palmitic acid|mesh-list
64866044|NCT01789710|Dopamine Agents|dopamine agents|mesh-ancestor
64496068|NCT03010540|Morphine|morphine|mesh-list
64496069|NCT03010540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64496070|NCT03010540|Narcotics|narcotics|mesh-ancestor
64496071|NCT03010540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64330521|NCT02201459|Immunologic Factors|immunologic factors|mesh-ancestor
64496072|NCT03010540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722866|NCT00002780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64722868|NCT01692691|Carmustine|carmustine|mesh-list
64722869|NCT01692691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64722870|NCT01692691|Alkylating Agents|alkylating agents|mesh-ancestor
64722871|NCT01692691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722872|NCT01692691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722873|NCT01127503|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
64722874|NCT01127503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64722875|NCT01127503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722876|NCT01122511|Dexamethasone|dexamethasone|mesh-list
64722877|NCT01122511|Ranibizumab|ranibizumab|mesh-list
64330525|NCT02368665|Candesartan cilexetil|candesartan cilexetil|mesh-list
64330526|NCT02368665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64330527|NCT02368665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64330528|NCT02368665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64330529|NCT02368665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330530|NCT02368665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64330531|NCT02368665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330532|NCT02368665|Vasodilator Agents|vasodilator agents|mesh-ancestor
64330533|NCT02368665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64330534|NCT02368665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64330535|NCT05724589|Mitogens|mitogens|mesh-list
64722890|NCT01122511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64722891|NCT01122511|Growth Substances|growth substances|mesh-ancestor
64722892|NCT01122511|Growth Inhibitors|growth inhibitors|mesh-ancestor
64722893|NCT05535218|Pembrolizumab|pembrolizumab|mesh-list
64722894|NCT05535218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64330536|NCT05724589|Mitosis Modulators|mitosis modulators|mesh-ancestor
64330537|NCT05724589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330538|NCT02198495|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64330539|NCT02198495|Hematinics|hematinics|mesh-ancestor
64330540|NCT02201849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64330541|NCT02201849|Dermatologic Agents|dermatologic agents|mesh-ancestor
64330542|NCT02201849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64496073|NCT03010540|Analgesics|analgesics|mesh-ancestor
64496074|NCT03010540|Sensory System Agents|sensory system agents|mesh-ancestor
64496075|NCT03010540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496076|NCT03010540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64496077|NCT03010540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64496078|NCT03010540|Anesthetics, General|anesthetics, general|mesh-ancestor
64496079|NCT03010540|Anesthetics|anesthetics|mesh-ancestor
64496080|NCT03445104|Huperzine A|huperzine a|mesh-list
64496081|NCT03445104|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64496082|NCT03445104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482006|NCT01066091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482007|NCT01066091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482008|NCT03719326|Paclitaxel|paclitaxel|mesh-list
65482009|NCT03719326|Doxorubicin|doxorubicin|mesh-list
65482010|NCT03719326|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65482011|NCT03719326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65482012|NCT03719326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65482013|NCT03719326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482014|NCT03719326|Tubulin Modulators|tubulin modulators|mesh-ancestor
65482015|NCT03719326|Antimitotic Agents|antimitotic agents|mesh-ancestor
65482016|NCT03719326|Mitosis Modulators|mitosis modulators|mesh-ancestor
65482017|NCT03719326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496083|NCT03445104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496084|NCT03445104|Cholinergic Agents|cholinergic agents|mesh-ancestor
64496085|NCT03445104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64496086|NCT03445104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496087|NCT03445104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64496088|NCT03445104|Protective Agents|protective agents|mesh-ancestor
64496089|NCT01234714|Liver Extracts|liver extracts|mesh-list
64496090|NCT01234714|Hematinics|hematinics|mesh-ancestor
64496091|NCT03440502|Anesthetics|anesthetics|mesh-list
64496092|NCT03440502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64496093|NCT03440502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330550|NCT02375217|Cholinergic Agents|cholinergic agents|mesh-ancestor
64496095|NCT01234870|Analgesics|analgesics|mesh-ancestor
64496096|NCT01234870|Sensory System Agents|sensory system agents|mesh-ancestor
64496097|NCT01234870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496098|NCT01234870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496099|NCT01234870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64496100|NCT01234870|Vasodilator Agents|vasodilator agents|mesh-ancestor
64496101|NCT01234870|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64496102|NCT01234870|Purinergic Agonists|purinergic agonists|mesh-ancestor
64496103|NCT01234870|Purinergic Agents|purinergic agents|mesh-ancestor
64496104|NCT01234870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64330554|NCT02375217|Autonomic Agents|autonomic agents|mesh-ancestor
64330555|NCT02375217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330556|NCT02375217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64330557|NCT02375217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64330558|NCT02375217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64330559|NCT02206295|Selexipag|selexipag|mesh-list
64330560|NCT02206295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64496108|NCT00861705|Bevacizumab|bevacizumab|mesh-list
64496109|NCT00861705|Carboplatin|carboplatin|mesh-list
64496120|NCT00861705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496121|NCT00861705|Tubulin Modulators|tubulin modulators|mesh-ancestor
64496122|NCT00861705|Antimitotic Agents|antimitotic agents|mesh-ancestor
64496123|NCT00861705|Mitosis Modulators|mitosis modulators|mesh-ancestor
64496124|NCT00861705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496125|NCT00861705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64722916|NCT01663285|Immunologic Factors|immunologic factors|mesh-ancestor
64722917|NCT01663285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722918|NCT00002786|Aldesleukin|aldesleukin|mesh-list
64722919|NCT00002786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722920|NCT00002786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64722921|NCT00002786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64722922|NCT00002786|Antiviral Agents|antiviral agents|mesh-ancestor
64722923|NCT00002786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64722924|NCT00378937|Acetaminophen|acetaminophen|mesh-list
64722925|NCT00378937|Morphine|morphine|mesh-list
64722926|NCT00378937|Oxycodone|oxycodone|mesh-list
64722927|NCT00378937|Codeine|codeine|mesh-list
64722928|NCT00378937|Dextropropoxyphene|dextropropoxyphene|mesh-list
64722929|NCT00378937|Levopropoxyphene|levopropoxyphene|mesh-list
64722930|NCT00378937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64330561|NCT02375139|Metformin|metformin|mesh-list
65482018|NCT03719326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65482019|NCT03719326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65482020|NCT03719326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65482021|NCT03719326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482022|NCT03846284|Magnesium Sulfate|magnesium sulfate|mesh-list
65482023|NCT03846284|Bupivacaine|bupivacaine|mesh-list
65482024|NCT03846284|Anesthetics, Local|anesthetics, local|mesh-list
65482025|NCT03846284|Anesthetics|anesthetics|mesh-list
65482026|NCT03846284|N-Methylaspartate|n-methylaspartate|mesh-list
65482027|NCT03846284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65482028|NCT03846284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482029|NCT03846284|Sensory System Agents|sensory system agents|mesh-ancestor
65482030|NCT03846284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65482031|NCT03846284|Analgesics|analgesics|mesh-ancestor
65482032|NCT03846284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65482033|NCT03846284|Anticonvulsants|anticonvulsants|mesh-ancestor
65482034|NCT03846284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65482035|NCT03846284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65482036|NCT03846284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482037|NCT03846284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64333109|NCT04441021|Penicillins|penicillins|mesh-list
64330562|NCT02375139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64330563|NCT02375139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330564|NCT02202005|Nevirapine|nevirapine|mesh-list
64330565|NCT02202005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64330566|NCT02202005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64330567|NCT02202005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330568|NCT02202005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330569|NCT02202005|Antiviral Agents|antiviral agents|mesh-ancestor
64330570|NCT02202005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64330571|NCT02202005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64330572|NCT02202005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64330573|NCT02202005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64330574|NCT02202005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64330575|NCT02741245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64330576|NCT02741245|Ezetimibe|ezetimibe|mesh-list
64722931|NCT00378937|Narcotics|narcotics|mesh-ancestor
64722932|NCT00378937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64722933|NCT00378937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722934|NCT00378937|Analgesics|analgesics|mesh-ancestor
64722935|NCT00378937|Sensory System Agents|sensory system agents|mesh-ancestor
64722936|NCT00378937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64722937|NCT00378937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64722938|NCT00378937|Antipyretics|antipyretics|mesh-ancestor
64722939|NCT00378937|Antitussive Agents|antitussive agents|mesh-ancestor
64722940|NCT00378937|Respiratory System Agents|respiratory system agents|mesh-ancestor
64722941|NCT00002792|Cyclosporine|cyclosporine|mesh-list
64330577|NCT02741245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64330578|NCT02741245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64330579|NCT02741245|Antimetabolites|antimetabolites|mesh-ancestor
64330580|NCT02741245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330581|NCT02741245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64330582|NCT02741245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65482038|NCT03846284|Tocolytic Agents|tocolytic agents|mesh-ancestor
65482039|NCT03846284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65482040|NCT03846284|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
65482041|NCT03846284|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65482042|NCT03846284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65482044|NCT01066169|Cathartics|cathartics|mesh-ancestor
65482045|NCT01066169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65482046|NCT05572060|Metformin|metformin|mesh-list
65482047|NCT05572060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65482048|NCT05572060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482049|NCT05431244|Gemcitabine|gemcitabine|mesh-list
65482050|NCT05431244|Antiviral Agents|antiviral agents|mesh-list
65482051|NCT05431244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65482052|NCT05431244|Antimetabolites|antimetabolites|mesh-ancestor
65482053|NCT05431244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482054|NCT05431244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482055|NCT05431244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65482056|NCT05431244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482057|NCT05431244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64866084|NCT01789879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64496126|NCT00861705|Immunologic Factors|immunologic factors|mesh-ancestor
64496127|NCT00861705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496128|NCT00861705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64496129|NCT00861705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64496130|NCT00861705|Alkylating Agents|alkylating agents|mesh-ancestor
64496131|NCT00861705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64496132|NCT00861705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64496133|NCT00861705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64496134|NCT00861705|Growth Substances|growth substances|mesh-ancestor
64496135|NCT00861705|Growth Inhibitors|growth inhibitors|mesh-ancestor
64496136|NCT00861705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64496137|NCT00861705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64496138|NCT00861705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64496140|NCT03437460|Ibuprofen|ibuprofen|mesh-list
64496141|NCT03437460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496150|NCT03437460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496151|NCT03437460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496152|NCT03444636|Fentanyl|fentanyl|mesh-list
64496153|NCT03444636|Bupivacaine|bupivacaine|mesh-list
64496154|NCT03444636|Ropivacaine|ropivacaine|mesh-list
64496155|NCT03444636|Anesthetics, Local|anesthetics, local|mesh-ancestor
64496156|NCT03444636|Anesthetics|anesthetics|mesh-ancestor
64496157|NCT03444636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64496158|NCT03444636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496159|NCT03444636|Sensory System Agents|sensory system agents|mesh-ancestor
64496160|NCT03444636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496161|NCT03444636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64496162|NCT03444636|Narcotics|narcotics|mesh-ancestor
64496163|NCT03444636|Analgesics|analgesics|mesh-ancestor
64496164|NCT03444636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64496166|NCT03444636|Anesthetics, General|anesthetics, general|mesh-ancestor
64496167|NCT01215292|Ketoconazole|ketoconazole|mesh-list
64496168|NCT01215292|Anastrozole|anastrozole|mesh-list
64496169|NCT01215292|Testosterone|testosterone|mesh-list
64496170|NCT01215292|Dutasteride|dutasteride|mesh-list
64496171|NCT01215292|Acyline|acyline|mesh-list
64722960|NCT00002792|Antimetabolites|antimetabolites|mesh-ancestor
65482058|NCT05431244|Immunologic Factors|immunologic factors|mesh-ancestor
65482059|NCT05431244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482060|NCT03172754|Nivolumab|nivolumab|mesh-list
65482061|NCT03172754|Axitinib|axitinib|mesh-list
65482062|NCT03172754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65482063|NCT03172754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482064|NCT03172754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65482065|NCT03172754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482066|NCT03172754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65482067|NCT03172754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482068|NCT01199432|Cyclophosphamide|cyclophosphamide|mesh-list
65482069|NCT01199432|Fluorouracil|fluorouracil|mesh-list
65482070|NCT01199432|Epirubicin|epirubicin|mesh-list
65482071|NCT01199432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65482072|NCT01199432|Immunologic Factors|immunologic factors|mesh-ancestor
64866104|NCT01789892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64866105|NCT01789892|Protective Agents|protective agents|mesh-ancestor
64866106|NCT01789892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64722961|NCT00002792|Dermatologic Agents|dermatologic agents|mesh-ancestor
64722962|NCT00002792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64722963|NCT00002792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64722964|NCT00002792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64722965|NCT00002792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64330592|NCT02202239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64330593|NCT02202239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330594|NCT02202239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64330595|NCT02202239|Anesthetics, General|anesthetics, general|mesh-ancestor
64330596|NCT02202239|Anesthetics|anesthetics|mesh-ancestor
64330597|NCT02202239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64496172|NCT01215292|Androgens|androgens|mesh-ancestor
64496173|NCT01215292|Hormones|hormones|mesh-ancestor
64496174|NCT01215292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64496175|NCT01215292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496176|NCT01215292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64496187|NCT01215292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64496188|NCT01215292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64496190|NCT04796454|Gemcitabine|gemcitabine|mesh-list
64496191|NCT04796454|Oxaliplatin|oxaliplatin|mesh-list
64496192|NCT04796454|Temozolomide|temozolomide|mesh-list
64496193|NCT04796454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496194|NCT04796454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64496195|NCT04796454|Antimetabolites|antimetabolites|mesh-ancestor
64722966|NCT00002792|Antifungal Agents|antifungal agents|mesh-ancestor
64722967|NCT00002792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64722968|NCT05521880|Oritavancin|oritavancin|mesh-list
64722969|NCT05521880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64722970|NCT05521880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64722971|NCT01090141|Micafungin|micafungin|mesh-list
64722972|NCT01090141|Antifungal Agents|antifungal agents|mesh-ancestor
64722973|NCT01090141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64722974|NCT01048723|Everolimus|everolimus|mesh-list
64722975|NCT01048723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722976|NCT01048723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64722977|NCT01048723|Immunologic Factors|immunologic factors|mesh-ancestor
64722978|NCT01048723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722979|NCT05513612|Cyclophosphamide|cyclophosphamide|mesh-list
64722980|NCT05513612|Fludarabine|fludarabine|mesh-list
64330601|NCT02202239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65482073|NCT01199432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482074|NCT01199432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65482075|NCT01199432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65482076|NCT01199432|Alkylating Agents|alkylating agents|mesh-ancestor
65482077|NCT01199432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482078|NCT01199432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482079|NCT01199432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65482080|NCT01199432|Antimetabolites|antimetabolites|mesh-ancestor
65482081|NCT01199432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65482082|NCT01199432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64866126|NCT01792570|Darunavir|darunavir|mesh-list
64330602|NCT02202239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64330603|NCT02202239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64330604|NCT02202239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64330605|NCT02202239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64330606|NCT02202239|GABA Modulators|gaba modulators|mesh-ancestor
64330607|NCT02202239|GABA Agents|gaba agents|mesh-ancestor
64330608|NCT02202239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64330609|NCT02202239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330610|NCT02202239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64330611|NCT02202239|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64496196|NCT04796454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496197|NCT04796454|Antiviral Agents|antiviral agents|mesh-ancestor
64496198|NCT04796454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64496199|NCT04796454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496200|NCT04796454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64496201|NCT04796454|Immunologic Factors|immunologic factors|mesh-ancestor
64496202|NCT04796454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496203|NCT04796454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64496204|NCT04796454|Alkylating Agents|alkylating agents|mesh-ancestor
64496205|NCT02189668|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64496206|NCT02189668|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64496207|NCT02189668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64496208|NCT02189668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64496209|NCT02189668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496210|NCT02189668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722982|NCT05513612|Immunologic Factors|immunologic factors|mesh-ancestor
64722983|NCT05513612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722984|NCT05513612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64722985|NCT05513612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64722986|NCT05513612|Alkylating Agents|alkylating agents|mesh-ancestor
64722987|NCT05513612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722988|NCT05513612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722989|NCT05513612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64722990|NCT05594407|Lidocaine|lidocaine|mesh-list
64722991|NCT05594407|Dexmedetomidine|dexmedetomidine|mesh-list
64722992|NCT05594407|Ketamine|ketamine|mesh-list
64722993|NCT05594407|Remifentanil|remifentanil|mesh-list
64722994|NCT05594407|Anesthetics, Local|anesthetics, local|mesh-ancestor
64722995|NCT05594407|Anesthetics|anesthetics|mesh-ancestor
64722996|NCT05594407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64722997|NCT05594407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722998|NCT05594407|Sensory System Agents|sensory system agents|mesh-ancestor
64722999|NCT05594407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64723000|NCT05594407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64723001|NCT05594407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64723002|NCT05594407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64330612|NCT02202239|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64330613|NCT02202239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64330614|NCT02368197|Paclitaxel|paclitaxel|mesh-list
64330615|NCT02368197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64330616|NCT02368197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482083|NCT01199432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65482084|NCT01199432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65482085|NCT01199432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482086|NCT05064020|Tenofovir|tenofovir|mesh-list
65482087|NCT05064020|Emtricitabine|emtricitabine|mesh-list
65482088|NCT05064020|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65482089|NCT05064020|Antiviral Agents|antiviral agents|mesh-ancestor
65482090|NCT05064020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65482091|NCT05064020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65482092|NCT05064020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65482093|NCT05064020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482094|NCT05064020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330617|NCT02368197|Tubulin Modulators|tubulin modulators|mesh-ancestor
64330618|NCT02368197|Antimitotic Agents|antimitotic agents|mesh-ancestor
64330619|NCT02368197|Mitosis Modulators|mitosis modulators|mesh-ancestor
64330620|NCT02368197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330621|NCT02364765|Remifentanil|remifentanil|mesh-list
64330623|NCT02364765|Narcotics|narcotics|mesh-ancestor
64330639|NCT03529201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330640|NCT03529201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64496211|NCT02981290|Mycophenolic Acid|mycophenolic acid|mesh-list
64496212|NCT02981290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64496213|NCT02981290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496214|NCT02981290|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64496215|NCT02981290|Antitubercular Agents|antitubercular agents|mesh-ancestor
64496216|NCT02981290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64496217|NCT02981290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64496223|NCT03437226|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64723013|NCT05594407|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64723014|NCT05594407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64723015|NCT05594407|Anesthetics, General|anesthetics, general|mesh-ancestor
64723016|NCT05594407|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64723017|NCT05594407|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64723018|NCT05594407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64723020|NCT00379717|Docetaxel|docetaxel|mesh-list
64723021|NCT00379717|Cisplatin|cisplatin|mesh-list
64723022|NCT00379717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330641|NCT03529201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64330642|NCT03529201|Anesthetics, General|anesthetics, general|mesh-ancestor
64330643|NCT03529201|Anesthetics|anesthetics|mesh-ancestor
64330644|NCT03529201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64330645|NCT03529201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64330646|NCT03529201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64330647|NCT03529201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64330648|NCT03529201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64330649|NCT04547049|Cytarabine|cytarabine|mesh-list
64330650|NCT04547049|Cyclosporine|cyclosporine|mesh-list
64496224|NCT03437226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64496225|NCT03437226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496226|NCT03437226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496227|NCT03437226|Protective Agents|protective agents|mesh-ancestor
64496228|NCT03437226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496229|NCT04788420|Sorafenib|sorafenib|mesh-list
64496230|NCT04788420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496231|NCT04788420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64496232|NCT04788420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496233|NCT04788420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496234|NCT01282138|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64496235|NCT01282138|Dextrans|dextrans|mesh-list
64496236|NCT01282138|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64496237|NCT01282138|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64496247|NCT01282138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65482095|NCT05064020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65482096|NCT05064020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65482097|NCT01293422|Rifampin|rifampin|mesh-list
65482098|NCT01293422|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65482099|NCT01293422|Antitubercular Agents|antitubercular agents|mesh-ancestor
65482100|NCT01293422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65482101|NCT01293422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65482102|NCT01293422|Leprostatic Agents|leprostatic agents|mesh-ancestor
65482103|NCT01293422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65482104|NCT01293422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482105|NCT01293422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496248|NCT01282138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64496249|NCT01282138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64496250|NCT01282138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64496251|NCT01282138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64496252|NCT01282138|Histamine Antagonists|histamine antagonists|mesh-ancestor
64496253|NCT01282138|Histamine Agents|histamine agents|mesh-ancestor
64496254|NCT01282138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64496255|NCT01282138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496256|NCT03444402|Esomeprazole|esomeprazole|mesh-list
64496257|NCT03444402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64496258|NCT03444402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64496259|NCT03444402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64496260|NCT03444402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496261|NCT03444402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496262|NCT01238536|Dexamethasone|dexamethasone|mesh-list
64496263|NCT01238536|Betamethasone|betamethasone|mesh-list
64723036|NCT01583647|Antimetabolites|antimetabolites|mesh-ancestor
64330651|NCT04547049|Mycophenolic Acid|mycophenolic acid|mesh-list
64330652|NCT04547049|Cyclophosphamide|cyclophosphamide|mesh-list
64330653|NCT04547049|Busulfan|busulfan|mesh-list
64330654|NCT04547049|Cyclosporins|cyclosporins|mesh-list
64330655|NCT04547049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64330656|NCT04547049|Thymoglobulin|thymoglobulin|mesh-list
64330657|NCT04547049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64330658|NCT04547049|Immunologic Factors|immunologic factors|mesh-ancestor
64330659|NCT04547049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330660|NCT04547049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64330661|NCT04547049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64330662|NCT04547049|Alkylating Agents|alkylating agents|mesh-ancestor
64330663|NCT04547049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330668|NCT04547049|Antiviral Agents|antiviral agents|mesh-ancestor
64330669|NCT04547049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64330670|NCT04547049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330671|NCT04547049|Antifungal Agents|antifungal agents|mesh-ancestor
64330672|NCT04547049|Dermatologic Agents|dermatologic agents|mesh-ancestor
64330673|NCT04547049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64330674|NCT04547049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64330675|NCT04547049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64330676|NCT04547049|Antitubercular Agents|antitubercular agents|mesh-ancestor
64330677|NCT04547049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64496265|NCT01238536|Lidocaine|lidocaine|mesh-list
64496266|NCT01238536|Anesthetics, Local|anesthetics, local|mesh-list
64496267|NCT01238536|Anesthetics|anesthetics|mesh-list
64496268|NCT01238536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64496269|NCT01238536|Antiemetics|antiemetics|mesh-ancestor
64496270|NCT01238536|Autonomic Agents|autonomic agents|mesh-ancestor
64496271|NCT01238536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496272|NCT01238536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496273|NCT01238536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64496274|NCT01238536|Glucocorticoids|glucocorticoids|mesh-ancestor
64496275|NCT01238536|Hormones|hormones|mesh-ancestor
64496276|NCT01238536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64723055|NCT04403516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65482106|NCT01293422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65482107|NCT01293422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65482108|NCT01293422|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65482109|NCT01293422|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65482110|NCT01293422|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65482111|NCT01293422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65482112|NCT01566656|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65231621|NCT02871713|Analgesics|analgesics|mesh-ancestor
65482113|NCT01566656|Immunologic Factors|immunologic factors|mesh-ancestor
65482114|NCT01566656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482115|NCT01566656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65482116|NCT01566734|Cefazolin|cefazolin|mesh-list
65482117|NCT01566734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65482118|NCT01566734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65482119|NCT00050778|Interferons|interferons|mesh-list
64866163|NCT01793038|Clomiphene|clomiphene|mesh-list
64723056|NCT04403516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723058|NCT04403516|Glucocorticoids|glucocorticoids|mesh-ancestor
64723059|NCT04403516|Hormones|hormones|mesh-ancestor
64723060|NCT04403516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64723061|NCT04403516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64723062|NCT04403516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723063|NCT04403516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64723064|NCT04403516|Protective Agents|protective agents|mesh-ancestor
64723065|NCT01555489|Ascorbic Acid|ascorbic acid|mesh-list
64723066|NCT01555489|Vitamins|vitamins|mesh-ancestor
64723067|NCT01555489|Micronutrients|micronutrients|mesh-ancestor
64330678|NCT05647291|Methylprednisolone|methylprednisolone|mesh-list
64330679|NCT05647291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64330680|NCT05647291|Antiemetics|antiemetics|mesh-ancestor
64330681|NCT05647291|Autonomic Agents|autonomic agents|mesh-ancestor
64330682|NCT05647291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330683|NCT05647291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330684|NCT05647291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64330685|NCT05647291|Glucocorticoids|glucocorticoids|mesh-ancestor
64330686|NCT05647291|Hormones|hormones|mesh-ancestor
64418914|NCT05696431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723075|NCT01035073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64723076|NCT01035073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64723077|NCT01035073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64723078|NCT01035073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64723079|NCT01035073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723080|NCT01035073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723081|NCT01035073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330694|NCT03105765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330695|NCT03105765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64330696|NCT03105765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64330697|NCT03105765|Anesthetics, General|anesthetics, general|mesh-ancestor
64330698|NCT03105765|Anesthetics|anesthetics|mesh-ancestor
64330699|NCT03105765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64330700|NCT03105765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64330701|NCT03105765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64330702|NCT03105765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64330703|NCT03105765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330705|NCT02202473|Oxymatrine|oxymatrine|mesh-list
64330706|NCT02202473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64330707|NCT02202473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65482120|NCT00050778|Interferon-beta|interferon-beta|mesh-list
65482121|NCT00050778|Interferon beta-1a|interferon beta-1a|mesh-list
65482122|NCT00050778|Alemtuzumab|alemtuzumab|mesh-list
65482123|NCT00050778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482124|NCT00050778|Antiviral Agents|antiviral agents|mesh-ancestor
65482125|NCT00050778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65482126|NCT00050778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65482127|NCT00050778|Immunologic Factors|immunologic factors|mesh-ancestor
65482128|NCT00050778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482129|NCT00050778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65482130|NCT01199510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65482131|NCT01199510|Lubricant Eye Drops|lubricant eye drops|mesh-list
65482132|NCT01199510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65482133|NCT04153682|Anti-Infective Agents|anti-infective agents|mesh-list
65482134|NCT04153682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65482135|NCT00050622|Methylphenidate|methylphenidate|mesh-list
65482136|NCT00050622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65482137|NCT00050622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866166|NCT01793038|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64330708|NCT02202473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496277|NCT01238536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64496278|NCT01238536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496279|NCT01238536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496281|NCT01238536|Sensory System Agents|sensory system agents|mesh-ancestor
64496282|NCT01238536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64496283|NCT01238536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64330710|NCT02202473|Antiviral Agents|antiviral agents|mesh-ancestor
64330711|NCT02202473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64330712|NCT02202473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64330713|NCT02202473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64330714|NCT02202473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64496284|NCT01238536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64496285|NCT01238536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64496286|NCT01238536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64945642|NCT05379322|Sensory System Agents|sensory system agents|mesh-ancestor
64496287|NCT01238536|Respiratory System Agents|respiratory system agents|mesh-ancestor
64496288|NCT03437070|Doxorubicin|doxorubicin|mesh-list
64496289|NCT03437070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64496290|NCT03437070|Trabectedin|trabectedin|mesh-list
64496292|NCT03437070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64496293|NCT03437070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496294|NCT03437070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64723103|NCT05296759|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64723104|NCT05296759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64723105|NCT05296759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330719|NCT02364531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330720|NCT02364531|Hormone Antagonists|hormone antagonists|mesh-ancestor
64330721|NCT02364531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64330722|NCT02364531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330723|NCT02364531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64330724|NCT02206763|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64330725|NCT02206763|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
64723116|NCT05296759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65482138|NCT00050622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65482139|NCT00050622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65482140|NCT00050622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65482141|NCT00050622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482142|NCT00050622|Dopamine Agents|dopamine agents|mesh-ancestor
65482143|NCT00050622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65482144|NCT00308087|Rituximab|rituximab|mesh-list
65482145|NCT00308087|Molgramostim|molgramostim|mesh-list
65482146|NCT00308087|Sargramostim|sargramostim|mesh-list
65482147|NCT00308087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65482148|NCT00308087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482149|NCT00308087|Immunologic Factors|immunologic factors|mesh-ancestor
65482150|NCT00308087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866183|NCT01794208|Hormones|hormones|mesh-ancestor
64723117|NCT05296759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64723118|NCT05296759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64723119|NCT05296759|Antimanic Agents|antimanic agents|mesh-ancestor
64723120|NCT05296759|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64723121|NCT05296759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64723122|NCT05296759|Antidepressive Agents|antidepressive agents|mesh-ancestor
64330726|NCT02206763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330727|NCT02206763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64330728|NCT02206763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330729|NCT02206763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330730|NCT02202707|Gabapentin|gabapentin|mesh-list
64330731|NCT02202707|Analgesics|analgesics|mesh-ancestor
64330732|NCT02202707|Sensory System Agents|sensory system agents|mesh-ancestor
64330733|NCT02202707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330734|NCT02202707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330735|NCT02202707|Anticonvulsants|anticonvulsants|mesh-ancestor
64330736|NCT02202707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64330737|NCT02202707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64330738|NCT02202707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64496295|NCT03437070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64496296|NCT03437070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496297|NCT03437070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723123|NCT05296759|Dopamine Agents|dopamine agents|mesh-ancestor
64723124|NCT05296759|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64723125|NCT05546047|Tacrolimus|tacrolimus|mesh-list
64723126|NCT05546047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64723127|NCT05546047|Immunologic Factors|immunologic factors|mesh-ancestor
64723128|NCT05546047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723129|NCT05546047|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64723130|NCT05546047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64723131|NCT05546047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723132|NCT01532635|Mycophenolic Acid|mycophenolic acid|mesh-list
64723133|NCT01532635|Cyclophosphamide|cyclophosphamide|mesh-list
64723134|NCT01532635|Tacrolimus|tacrolimus|mesh-list
64723135|NCT01532635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64723136|NCT01532635|Immunologic Factors|immunologic factors|mesh-ancestor
64723137|NCT01532635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723138|NCT01532635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64723139|NCT01532635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64723140|NCT01532635|Alkylating Agents|alkylating agents|mesh-ancestor
64723141|NCT01532635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723142|NCT01532635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723143|NCT01532635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64723144|NCT01532635|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64723145|NCT01532635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482151|NCT00308087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65482152|NCT04942184|Complement Factor H|complement factor h|mesh-list
65482153|NCT04942184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65482154|NCT04942184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65482155|NCT04942184|Immunologic Factors|immunologic factors|mesh-ancestor
65482156|NCT04942184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482157|NCT00307931|Certolizumab Pegol|certolizumab pegol|mesh-list
65482158|NCT00307931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65482159|NCT00307931|Immunologic Factors|immunologic factors|mesh-ancestor
65482160|NCT00307931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482161|NCT00307931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65482162|NCT01097148|Atracurium|atracurium|mesh-list
65482163|NCT01097148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65482164|NCT01097148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65482165|NCT01097148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65482166|NCT01097148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65482167|NCT01097148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482168|NCT01097148|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65482169|NCT01097148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65482170|NCT01097148|Cholinergic Agents|cholinergic agents|mesh-ancestor
65482171|NCT01097148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65482172|NCT01097148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482173|NCT01199276|Sevoflurane|sevoflurane|mesh-list
65482174|NCT01199276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65482175|NCT01199276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65482176|NCT01199276|Anesthetics, General|anesthetics, general|mesh-ancestor
65482177|NCT01199276|Anesthetics|anesthetics|mesh-ancestor
65482178|NCT01199276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65482179|NCT01199276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482180|NCT01202084|Fluticasone|fluticasone|mesh-list
65482181|NCT01202084|Xhance|xhance|mesh-list
65482182|NCT01202084|Formoterol Fumarate|formoterol fumarate|mesh-list
65482183|NCT01202084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65482184|NCT01202084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65482185|NCT01202084|Autonomic Agents|autonomic agents|mesh-ancestor
65482186|NCT01202084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65482190|NCT01202084|Dermatologic Agents|dermatologic agents|mesh-ancestor
65482191|NCT01202084|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65482192|NCT01202084|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65482193|NCT01202084|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65482194|NCT01202084|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65482195|NCT01202084|Adrenergic Agents|adrenergic agents|mesh-ancestor
65482196|NCT01202084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65482197|NCT01202084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482198|NCT04133792|Simvastatin|simvastatin|mesh-list
65482199|NCT04133792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65482200|NCT04133792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65482201|NCT04133792|Antimetabolites|antimetabolites|mesh-ancestor
64866235|NCT01796132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723156|NCT00986947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64723157|NCT05736224|Sunscreening Agents|sunscreening agents|mesh-list
64496298|NCT03437070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64496299|NCT03437070|Alkylating Agents|alkylating agents|mesh-ancestor
64496301|NCT03128736|Dexlansoprazole|dexlansoprazole|mesh-list
64496302|NCT03128736|Lansoprazole|lansoprazole|mesh-list
64496303|NCT03128736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64723158|NCT05736224|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64723159|NCT05736224|Protective Agents|protective agents|mesh-ancestor
64723160|NCT05736224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723161|NCT05736224|Dermatologic Agents|dermatologic agents|mesh-ancestor
64723163|NCT05203172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64723164|NCT05203172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723165|NCT00539617|Leucovorin|leucovorin|mesh-list
64723166|NCT00539617|Fluorouracil|fluorouracil|mesh-list
64723167|NCT00539617|Oxaliplatin|oxaliplatin|mesh-list
64723168|NCT00539617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64723169|NCT00539617|Antimetabolites|antimetabolites|mesh-ancestor
64496304|NCT03128736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64496316|NCT05054868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496317|NCT05054868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64496318|NCT05054868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64496319|NCT05054868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64496320|NCT05054868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64496321|NCT05054868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64496322|NCT05054868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496323|NCT05054868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496324|NCT01218958|Naltrexone|naltrexone|mesh-list
64496325|NCT01218958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64496326|NCT01218958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64496327|NCT01218958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496328|NCT01218958|Sensory System Agents|sensory system agents|mesh-ancestor
64496329|NCT01218958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496330|NCT03440268|Acetylcysteine|acetylcysteine|mesh-list
64496331|NCT03440268|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64496332|NCT03440268|Antiviral Agents|antiviral agents|mesh-ancestor
64496333|NCT03440268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64496334|NCT03440268|Expectorants|expectorants|mesh-ancestor
64496335|NCT03440268|Respiratory System Agents|respiratory system agents|mesh-ancestor
64496336|NCT03440268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64496337|NCT03440268|Antioxidants|antioxidants|mesh-ancestor
64496338|NCT03440268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496339|NCT03440268|Protective Agents|protective agents|mesh-ancestor
64496340|NCT03440268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496341|NCT03440268|Antidotes|antidotes|mesh-ancestor
64496342|NCT03444246|Iodine|iodine|mesh-list
64496343|NCT03444246|Cadexomer iodine|cadexomer iodine|mesh-list
64496344|NCT03444246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64496345|NCT03444246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64496346|NCT03444246|Trace Elements|trace elements|mesh-ancestor
64496347|NCT03444246|Micronutrients|micronutrients|mesh-ancestor
65482202|NCT04133792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482203|NCT04133792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65482204|NCT04133792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65482205|NCT04133792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482206|NCT01202240|Ketoconazole|ketoconazole|mesh-list
65482207|NCT01202240|Tofacitinib|tofacitinib|mesh-list
65482208|NCT01202240|Antifungal Agents|antifungal agents|mesh-ancestor
65482209|NCT01202240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65482210|NCT01202240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65482211|NCT01202240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64496348|NCT03444246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496349|NCT04369014|Anesthetics|anesthetics|mesh-list
64496350|NCT04369014|Propofol|propofol|mesh-list
64496351|NCT04369014|Etomidate|etomidate|mesh-list
64418941|NCT05575219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64496361|NCT03436836|Anesthetics|anesthetics|mesh-ancestor
64496362|NCT03436836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64496363|NCT03436836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496364|NCT03436836|Sensory System Agents|sensory system agents|mesh-ancestor
64496365|NCT03436836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496366|NCT03436836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64496367|NCT03436836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64496368|NCT03436836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64496369|NCT03436836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64723170|NCT00539617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723171|NCT00539617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64723172|NCT00539617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723173|NCT00539617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64723174|NCT00539617|Immunologic Factors|immunologic factors|mesh-ancestor
64723175|NCT00539617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723176|NCT00539617|Antidotes|antidotes|mesh-ancestor
64723177|NCT00539617|Protective Agents|protective agents|mesh-ancestor
64723178|NCT00539617|Vitamin B Complex|vitamin b complex|mesh-ancestor
64723179|NCT00539617|Vitamins|vitamins|mesh-ancestor
64723180|NCT00539617|Micronutrients|micronutrients|mesh-ancestor
64723181|NCT00539617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64723182|NCT00539617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64723183|NCT05467514|Liraglutide|liraglutide|mesh-list
64723184|NCT05467514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64723185|NCT05467514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723186|NCT05467514|Incretins|incretins|mesh-ancestor
64723187|NCT05467514|Hormones|hormones|mesh-ancestor
64723188|NCT05467514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64723189|NCT00976339|Vitamin D|vitamin d|mesh-list
64723190|NCT00976339|Cholecalciferol|cholecalciferol|mesh-list
64496370|NCT03436836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496384|NCT03440034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64496385|NCT03440034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496386|NCT03433326|Grazoprevir|grazoprevir|mesh-list
64496387|NCT03433326|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
64496388|NCT03433326|Antiviral Agents|antiviral agents|mesh-ancestor
64496389|NCT03433326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64496390|NCT00244101|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64496391|NCT00244101|Respiratory System Agents|respiratory system agents|mesh-ancestor
64496392|NCT04451382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64496393|NCT04451382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64496394|NCT04451382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64496395|NCT04451382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496396|NCT04451382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496397|NCT04451382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64496398|NCT04451382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64496399|NCT04451382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496400|NCT04451382|Cholinergic Agents|cholinergic agents|mesh-ancestor
65482212|NCT01202240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482213|NCT01202240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482214|NCT01202240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65482215|NCT01202240|Hormone Antagonists|hormone antagonists|mesh-ancestor
65482216|NCT01202240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65482217|NCT01202240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482218|NCT01202240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65482219|NCT01202240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65482220|NCT01204112|Rifampin|rifampin|mesh-list
65482221|NCT01204112|Tofacitinib|tofacitinib|mesh-list
65482222|NCT01204112|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65482223|NCT01204112|Antitubercular Agents|antitubercular agents|mesh-ancestor
65482224|NCT01204112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65482225|NCT01204112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64496401|NCT04451382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64496402|NCT04276389|Paclitaxel|paclitaxel|mesh-list
64496403|NCT04276389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64496404|NCT04276389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64496405|NCT04276389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496406|NCT04276389|Tubulin Modulators|tubulin modulators|mesh-ancestor
64496407|NCT04276389|Antimitotic Agents|antimitotic agents|mesh-ancestor
64496408|NCT04276389|Mitosis Modulators|mitosis modulators|mesh-ancestor
64496409|NCT04276389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496410|NCT03128619|Letrozole|letrozole|mesh-list
64496411|NCT03128619|Palbociclib|palbociclib|mesh-list
64496412|NCT03128619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723200|NCT04579640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64496416|NCT03128619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496417|NCT03128619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64496418|NCT03128619|Hormone Antagonists|hormone antagonists|mesh-ancestor
64496419|NCT03128619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64496420|NCT03128619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496421|NCT03128619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64496422|NCT03433092|Carotenoids|carotenoids|mesh-list
64496423|NCT03433092|Antioxidants|antioxidants|mesh-ancestor
64496424|NCT03433092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496425|NCT03433092|Protective Agents|protective agents|mesh-ancestor
64496426|NCT03433092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496427|NCT03433014|Levobupivacaine|levobupivacaine|mesh-list
64496428|NCT03433014|Anesthetics, Local|anesthetics, local|mesh-ancestor
64496429|NCT03433014|Anesthetics|anesthetics|mesh-ancestor
64496430|NCT03433014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64496437|NCT01872689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496438|NCT01872689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496439|NCT01872689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64496441|NCT01872689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64496442|NCT01872689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64496443|NCT01872689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496444|NCT03435900|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64496445|NCT03435900|Metronidazole|metronidazole|mesh-list
64496447|NCT03435900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64496448|NCT03435900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64496449|NCT03435900|Antitubercular Agents|antitubercular agents|mesh-ancestor
64496450|NCT03435900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64496451|NCT03435900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64496452|NCT00632931|Vorinostat|vorinostat|mesh-list
64496453|NCT00632931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496454|NCT00632931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65482226|NCT01204112|Leprostatic Agents|leprostatic agents|mesh-ancestor
65482227|NCT01204112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65482228|NCT01204112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482229|NCT01204112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482230|NCT01204112|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65482231|NCT01204112|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65482232|NCT01204112|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65482233|NCT01204112|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65482234|NCT01204112|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65482235|NCT01204112|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65482236|NCT01204112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65482237|NCT01204190|Gestodene|gestodene|mesh-list
65482238|NCT01204190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65482239|NCT01204190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64496455|NCT00632931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496456|NCT00632931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496457|NCT01857323|Albuterol|albuterol|mesh-list
64496458|NCT01857323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64496459|NCT01857323|Autonomic Agents|autonomic agents|mesh-ancestor
64496460|NCT01857323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496461|NCT01857323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496462|NCT01857323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64496463|NCT01857323|Respiratory System Agents|respiratory system agents|mesh-ancestor
64496464|NCT01857323|Tocolytic Agents|tocolytic agents|mesh-ancestor
64496465|NCT01857323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64496466|NCT01857323|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64496467|NCT01857323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64496468|NCT01857323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64496469|NCT01857323|Adrenergic Agents|adrenergic agents|mesh-ancestor
64496470|NCT01857323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723205|NCT00523939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723206|NCT00523939|Antiviral Agents|antiviral agents|mesh-ancestor
64496476|NCT03104439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64496477|NCT03104439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496478|NCT03432780|Docetaxel|docetaxel|mesh-list
64496479|NCT03432780|Hormones|hormones|mesh-list
64496480|NCT03432780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496481|NCT03432780|Tubulin Modulators|tubulin modulators|mesh-ancestor
64496482|NCT03432780|Antimitotic Agents|antimitotic agents|mesh-ancestor
64496483|NCT03432780|Mitosis Modulators|mitosis modulators|mesh-ancestor
64496484|NCT03432780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496485|NCT03432780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64496486|NCT03432780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496487|NCT00055731|Aspirin|aspirin|mesh-list
64496488|NCT00055731|Docetaxel|docetaxel|mesh-list
64496489|NCT00055731|Goserelin|goserelin|mesh-list
64496490|NCT00055731|Bicalutamide|bicalutamide|mesh-list
64496491|NCT00055731|Estramustine|estramustine|mesh-list
64496492|NCT00055731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496493|NCT00055731|Tubulin Modulators|tubulin modulators|mesh-ancestor
64496494|NCT00055731|Antimitotic Agents|antimitotic agents|mesh-ancestor
64496495|NCT00055731|Mitosis Modulators|mitosis modulators|mesh-ancestor
64496496|NCT00055731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496497|NCT00055731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64496498|NCT00055731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64496499|NCT00055731|Analgesics|analgesics|mesh-ancestor
64496500|NCT00055731|Sensory System Agents|sensory system agents|mesh-ancestor
64496512|NCT00055731|Androgen Antagonists|androgen antagonists|mesh-ancestor
65482240|NCT01204190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65482241|NCT01204190|Contraceptive Agents|contraceptive agents|mesh-ancestor
65482242|NCT01204190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65482243|NCT01204190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482244|NCT01204190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65482245|NCT01204190|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65482246|NCT01204190|Progestins|progestins|mesh-ancestor
65482247|NCT01204190|Hormones|hormones|mesh-ancestor
65482248|NCT01204190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64866285|NCT01796808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64496513|NCT00055731|Hormone Antagonists|hormone antagonists|mesh-ancestor
64496514|NCT00055731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64945643|NCT05379322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496515|NCT00055731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64496516|NCT00055731|Alkylating Agents|alkylating agents|mesh-ancestor
64496517|NCT03435744|Simvastatin|simvastatin|mesh-list
64496518|NCT03435744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64496519|NCT03435744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64496520|NCT03435744|Antimetabolites|antimetabolites|mesh-ancestor
64496521|NCT03435744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496522|NCT03435744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64496523|NCT03435744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64496524|NCT03435744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496525|NCT03435666|Capecitabine|capecitabine|mesh-list
64496526|NCT03435666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64496527|NCT03435666|Antimetabolites|antimetabolites|mesh-ancestor
64496528|NCT03435666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496529|NCT03435666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496530|NCT00632541|Bevacizumab|bevacizumab|mesh-list
64496531|NCT00632541|Sorafenib|sorafenib|mesh-list
64496532|NCT00632541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64496533|NCT00632541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496534|NCT00632541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64496535|NCT00632541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64496536|NCT00632541|Growth Substances|growth substances|mesh-ancestor
64496537|NCT00632541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496538|NCT00632541|Growth Inhibitors|growth inhibitors|mesh-ancestor
64496549|NCT01872611|Prednisolone phosphate|prednisolone phosphate|mesh-list
64496550|NCT01872611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64496551|NCT01872611|Glucocorticoids|glucocorticoids|mesh-ancestor
64496553|NCT01872611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64496554|NCT01872611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496555|NCT01872611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64496556|NCT01872611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496557|NCT01872611|Antiemetics|antiemetics|mesh-ancestor
64496558|NCT01872611|Autonomic Agents|autonomic agents|mesh-ancestor
64496559|NCT01872611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496560|NCT01872611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64496561|NCT01872611|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64496562|NCT01872611|Protective Agents|protective agents|mesh-ancestor
64496563|NCT01872611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64496572|NCT03432468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496574|NCT01856543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64496575|NCT01856543|Dermatologic Agents|dermatologic agents|mesh-ancestor
64496576|NCT01856543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64496578|NCT03432312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64496579|NCT03432312|Autonomic Agents|autonomic agents|mesh-ancestor
64496580|NCT03432312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496581|NCT03432312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496582|NCT03432312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64496583|NCT03432312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65482249|NCT01204268|Sevoflurane|sevoflurane|mesh-list
65482250|NCT01204268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65482251|NCT01204268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65482252|NCT01204268|Anesthetics, General|anesthetics, general|mesh-ancestor
65482253|NCT01204268|Anesthetics|anesthetics|mesh-ancestor
65482254|NCT01204268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65482255|NCT01204268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482256|NCT02965898|Vitamin D|vitamin d|mesh-list
64496584|NCT03432312|Cholinergic Agents|cholinergic agents|mesh-ancestor
64496585|NCT03432312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64496586|NCT03432312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496587|NCT03438942|Folic Acid|folic acid|mesh-list
64496588|NCT03438942|Hematinics|hematinics|mesh-ancestor
64496589|NCT03438942|Vitamin B Complex|vitamin b complex|mesh-ancestor
64496590|NCT03438942|Vitamins|vitamins|mesh-ancestor
64496591|NCT03438942|Micronutrients|micronutrients|mesh-ancestor
64496592|NCT03438942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496593|NCT04450680|Lactams|lactams|mesh-list
64496594|NCT04450680|beta-Lactams|beta-lactams|mesh-list
64496595|NCT04450680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64496596|NCT04450680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64496597|NCT03438708|Axitinib|axitinib|mesh-list
64496598|NCT03438708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496599|NCT03438708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64496600|NCT03438708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496601|NCT03438708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496616|NCT00632229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64496617|NCT00632229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64496618|NCT00632229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64496619|NCT00632229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496620|NCT00632229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64723212|NCT00382538|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64723214|NCT00382538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64723215|NCT00382538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723216|NCT00382538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64723217|NCT00382538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64723218|NCT00382538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64723219|NCT00382538|Contraceptive Agents|contraceptive agents|mesh-ancestor
64723220|NCT00382538|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64723221|NCT00382538|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64723222|NCT00382538|Hormone Antagonists|hormone antagonists|mesh-ancestor
64330823|NCT02363829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496621|NCT00632229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64496622|NCT00632229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64496623|NCT00632229|Serotonin Agents|serotonin agents|mesh-ancestor
64496624|NCT00632229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64496625|NCT00632229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496626|NCT00632229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64496627|NCT00632229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64496628|NCT00632229|Dopamine Agents|dopamine agents|mesh-ancestor
64496629|NCT00631137|Testosterone|testosterone|mesh-list
64496630|NCT00631137|Androgens|androgens|mesh-ancestor
64496631|NCT00631137|Hormones|hormones|mesh-ancestor
64496648|NCT01923831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496649|NCT01923831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64496650|NCT01923831|Glucocorticoids|glucocorticoids|mesh-ancestor
64496652|NCT01923831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64496653|NCT01923831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64496654|NCT01923831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496656|NCT01923831|Sensory System Agents|sensory system agents|mesh-ancestor
64496657|NCT01923831|Anesthetics|anesthetics|mesh-ancestor
64496658|NCT01923831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64496659|NCT01923831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64496660|NCT01923831|Anticonvulsants|anticonvulsants|mesh-ancestor
64496661|NCT01923831|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64496662|NCT01923831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65482257|NCT02965898|Ergocalciferols|ergocalciferols|mesh-list
65482258|NCT02965898|Cholecalciferol|cholecalciferol|mesh-list
65482259|NCT02965898|Vitamins|vitamins|mesh-list
65482260|NCT02965898|Micronutrients|micronutrients|mesh-ancestor
65482261|NCT02965898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482262|NCT02965898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65482263|NCT02965898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65482265|NCT02796170|Dapagliflozin|dapagliflozin|mesh-list
65482266|NCT02796170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65482267|NCT02796170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482268|NCT02796170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65482269|NCT02796170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482270|NCT03844178|Tetracaine|tetracaine|mesh-list
65482271|NCT03844178|Anesthetics, Local|anesthetics, local|mesh-ancestor
65482272|NCT03844178|Anesthetics|anesthetics|mesh-ancestor
65482273|NCT03844178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65482274|NCT03844178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482275|NCT03844178|Sensory System Agents|sensory system agents|mesh-ancestor
65482276|NCT03844178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65482277|NCT00049842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65482278|NCT00049842|Antiviral Agents|antiviral agents|mesh-ancestor
65482279|NCT00049842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65482280|NCT00307151|Ritonavir|ritonavir|mesh-list
65482281|NCT00307151|Lopinavir|lopinavir|mesh-list
65482282|NCT00307151|Lamivudine|lamivudine|mesh-list
65482283|NCT00307151|Zidovudine|zidovudine|mesh-list
65482284|NCT00307151|Nevirapine|nevirapine|mesh-list
65482285|NCT00307151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65482286|NCT00307151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65482287|NCT00307151|Protease Inhibitors|protease inhibitors|mesh-ancestor
65482288|NCT00307151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482289|NCT00307151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945644|NCT05379322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496663|NCT01923831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418983|NCT05569681|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64496677|NCT03086343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64496678|NCT03086343|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64496679|NCT03086343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64496680|NCT03086343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496681|NCT04892940|Analgesics|analgesics|mesh-list
64496682|NCT04892940|Sensory System Agents|sensory system agents|mesh-ancestor
64723223|NCT00382538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64723224|NCT00382538|Luteolytic Agents|luteolytic agents|mesh-ancestor
65482290|NCT00307151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65482291|NCT00307151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65482292|NCT00307151|Antiviral Agents|antiviral agents|mesh-ancestor
65482293|NCT00307151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65482294|NCT00307151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65482295|NCT00307151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65482296|NCT00307151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65482297|NCT00307151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65482298|NCT00307151|Antimetabolites|antimetabolites|mesh-ancestor
65482299|NCT00307151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65482300|NCT00307151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65482301|NCT03981029|Folic Acid|folic acid|mesh-list
65482302|NCT03981029|Hematinics|hematinics|mesh-ancestor
65482303|NCT03981029|Vitamin B Complex|vitamin b complex|mesh-ancestor
65482304|NCT03981029|Vitamins|vitamins|mesh-ancestor
65482305|NCT03981029|Micronutrients|micronutrients|mesh-ancestor
65482306|NCT03981029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482307|NCT02654132|Dexamethasone|dexamethasone|mesh-list
65482308|NCT02654132|Dexamethasone acetate|dexamethasone acetate|mesh-list
65482309|NCT02654132|Pomalidomide|pomalidomide|mesh-list
65482310|NCT02654132|Elotuzumab|elotuzumab|mesh-list
65482311|NCT02654132|BB 1101|bb 1101|mesh-list
65482312|NCT02654132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65482313|NCT02654132|Antiemetics|antiemetics|mesh-ancestor
65482314|NCT02654132|Autonomic Agents|autonomic agents|mesh-ancestor
65482315|NCT02654132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65482316|NCT02654132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482317|NCT02654132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65482318|NCT02654132|Glucocorticoids|glucocorticoids|mesh-ancestor
65482319|NCT02654132|Hormones|hormones|mesh-ancestor
65482320|NCT02654132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65482321|NCT02654132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65482322|NCT02654132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482323|NCT02654132|Protease Inhibitors|protease inhibitors|mesh-ancestor
64866334|NCT01798680|Vitamin D|vitamin d|mesh-list
64496683|NCT04892940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496684|NCT04892940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496685|NCT03085563|Midazolam|midazolam|mesh-list
64496686|NCT03085563|Nitrous Oxide|nitrous oxide|mesh-list
64496687|NCT03085563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64496699|NCT03085563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64496700|NCT03085563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482324|NCT02654132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482325|NCT02654132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482326|NCT02654132|Immunologic Factors|immunologic factors|mesh-ancestor
65482327|NCT02654132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65482328|NCT02654132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65482329|NCT02654132|Growth Substances|growth substances|mesh-ancestor
65482330|NCT02654132|Growth Inhibitors|growth inhibitors|mesh-ancestor
65482331|NCT01064141|Vaccines|vaccines|mesh-list
65482332|NCT01064141|Immunologic Factors|immunologic factors|mesh-ancestor
65482333|NCT01064141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482334|NCT03837470|Furosemide|furosemide|mesh-list
65231845|NCT00962390|Equol|equol|mesh-list
65482335|NCT03837470|Diuretics|diuretics|mesh-ancestor
65482336|NCT03837470|Natriuretic Agents|natriuretic agents|mesh-ancestor
65482337|NCT03837470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496701|NCT03085563|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64496702|NCT03085563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64496704|NCT03085563|Sensory System Agents|sensory system agents|mesh-ancestor
64496705|NCT03085563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496706|NCT03431766|Chlorhexidine|chlorhexidine|mesh-list
64496707|NCT03431766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64496708|NCT03431766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64496709|NCT03431766|Disinfectants|disinfectants|mesh-ancestor
64496710|NCT04450446|Heparin|heparin|mesh-list
64496711|NCT04450446|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64496712|NCT04450446|Tinzaparin|tinzaparin|mesh-list
64496713|NCT04450446|Dalteparin|dalteparin|mesh-list
64496714|NCT04450446|Anticoagulants|anticoagulants|mesh-ancestor
64496715|NCT04450446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64496716|NCT04450446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64496717|NCT04450446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496718|NCT03274752|Paroxetine|paroxetine|mesh-list
64496719|NCT03274752|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64496720|NCT03274752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64496721|NCT03274752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64496722|NCT03274752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496723|NCT03274752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64496724|NCT03274752|Serotonin Agents|serotonin agents|mesh-ancestor
64496725|NCT03274752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496726|NCT03274752|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64496728|NCT03274752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64496729|NCT03274752|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64496730|NCT03274752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64496731|NCT03274752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496732|NCT03242382|Palbociclib|palbociclib|mesh-list
64496733|NCT03242382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496736|NCT03242382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496737|NCT03902418|Tenofovir|tenofovir|mesh-list
64945645|NCT05379322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64496738|NCT03902418|Emtricitabine|emtricitabine|mesh-list
64496739|NCT03902418|Antiviral Agents|antiviral agents|mesh-ancestor
64496740|NCT03902418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64496741|NCT03902418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64496742|NCT03902418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64496743|NCT03902418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496744|NCT03902418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496745|NCT03902418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64496746|NCT03902418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64496747|NCT03428568|Clarithromycin|clarithromycin|mesh-list
64496748|NCT03428568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64496749|NCT03428568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65482338|NCT03837470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65482339|NCT03837470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65482340|NCT03837470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482341|NCT05307874|Aldesleukin|aldesleukin|mesh-list
65482342|NCT05307874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482343|NCT05307874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65482344|NCT05307874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65482345|NCT05307874|Antiviral Agents|antiviral agents|mesh-ancestor
65482346|NCT05307874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65482347|NCT01199900|Prednisone|prednisone|mesh-list
65482348|NCT01199900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65482349|NCT01199900|Glucocorticoids|glucocorticoids|mesh-ancestor
65482350|NCT01199900|Hormones|hormones|mesh-ancestor
65482351|NCT01199900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65482352|NCT01199900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482353|NCT01199900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65482354|NCT01199900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482355|NCT01200056|Atorvastatin|atorvastatin|mesh-list
65482356|NCT01200056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65482357|NCT01200056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65482358|NCT01200056|Antimetabolites|antimetabolites|mesh-ancestor
64866380|NCT01799863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64496768|NCT03434340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64496770|NCT03434340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496771|NCT03434340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64496772|NCT03434340|Serotonin Agents|serotonin agents|mesh-ancestor
64496773|NCT03434340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64496774|NCT03434340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496775|NCT03088605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64496776|NCT03088605|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64496777|NCT01923987|Cetuximab|cetuximab|mesh-list
64496778|NCT01923987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64496779|NCT01923987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496780|NCT03101163|Hyaluronic Acid|hyaluronic acid|mesh-list
64496781|NCT03101163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64723225|NCT00382538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64723226|NCT00382538|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64723227|NCT00954187|Pregabalin|pregabalin|mesh-list
64723228|NCT00954187|Gabapentin|gabapentin|mesh-list
64723229|NCT00954187|Analgesics|analgesics|mesh-ancestor
64723230|NCT00954187|Sensory System Agents|sensory system agents|mesh-ancestor
64723231|NCT00954187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64723232|NCT00954187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723233|NCT00954187|Anticonvulsants|anticonvulsants|mesh-ancestor
64723234|NCT00954187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64330837|NCT02363751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496782|NCT03101163|Immunologic Factors|immunologic factors|mesh-ancestor
64496783|NCT03101163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496784|NCT03101163|Viscosupplements|viscosupplements|mesh-ancestor
64496785|NCT03101163|Protective Agents|protective agents|mesh-ancestor
64496786|NCT01924065|Anticoagulants|anticoagulants|mesh-list
64496787|NCT03434106|Dextrans|dextrans|mesh-list
65482359|NCT01200056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482360|NCT01200056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65482361|NCT01200056|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65482362|NCT01200056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482363|NCT03841526|Glucagon|glucagon|mesh-list
65482364|NCT03841526|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65482365|NCT03841526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65482366|NCT03841526|Hormones|hormones|mesh-ancestor
65482367|NCT03841526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65482368|NCT03841526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482369|NCT03841526|Incretins|incretins|mesh-ancestor
65482370|NCT01200212|Bevacizumab|bevacizumab|mesh-list
65482371|NCT01200212|Taxane|taxane|mesh-list
65482372|NCT01200212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64496788|NCT03434106|Anticoagulants|anticoagulants|mesh-ancestor
64496789|NCT03434106|Plasma Substitutes|plasma substitutes|mesh-ancestor
64496790|NCT03434106|Blood Substitutes|blood substitutes|mesh-ancestor
64496791|NCT03179904|Paclitaxel|paclitaxel|mesh-list
64496792|NCT03179904|Trastuzumab|trastuzumab|mesh-list
64496793|NCT03179904|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64496794|NCT03179904|Letrozole|letrozole|mesh-list
64496795|NCT03179904|Fulvestrant|fulvestrant|mesh-list
64496796|NCT03179904|Anastrozole|anastrozole|mesh-list
64496797|NCT03179904|Exemestane|exemestane|mesh-list
64496798|NCT03179904|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
64496799|NCT03179904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64496800|NCT03179904|Antibodies|antibodies|mesh-list
64496801|NCT03179904|Immunoglobulins|immunoglobulins|mesh-list
64496802|NCT03179904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64496803|NCT03179904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64496804|NCT03179904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496805|NCT03179904|Tubulin Modulators|tubulin modulators|mesh-ancestor
64496815|NCT03179904|Hormone Antagonists|hormone antagonists|mesh-ancestor
64496816|NCT03179904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64496817|NCT03179904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64496818|NCT03179904|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64496819|NCT01241344|Brincidofovir|brincidofovir|mesh-list
64496820|NCT01241344|Antiviral Agents|antiviral agents|mesh-ancestor
64496821|NCT01241344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64496822|NCT01925001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64496824|NCT03009682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64496825|NCT03009682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496832|NCT03431142|Analgesics|analgesics|mesh-ancestor
64496833|NCT03431142|Sensory System Agents|sensory system agents|mesh-ancestor
64496834|NCT03431142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496835|NCT03431142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496836|NCT03431142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64496837|NCT03431142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64496838|NCT03431142|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64496839|NCT03431142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64496840|NCT03431142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496841|NCT03431142|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64496842|NCT03431142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64496843|NCT03431142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496844|NCT03431142|Antipyretics|antipyretics|mesh-ancestor
64496845|NCT03431142|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64723235|NCT00954187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64723236|NCT00954187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723237|NCT00954187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64496846|NCT03431142|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65482373|NCT01200212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482374|NCT01200212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65482375|NCT01200212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65482376|NCT01200212|Growth Substances|growth substances|mesh-ancestor
65482377|NCT01200212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482378|NCT01200212|Growth Inhibitors|growth inhibitors|mesh-ancestor
65482379|NCT03978845|Lidocaine|lidocaine|mesh-list
65482380|NCT03978845|Anesthetics, Local|anesthetics, local|mesh-list
65482381|NCT03978845|Anesthetics|anesthetics|mesh-list
65482382|NCT03978845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65482383|NCT03978845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482384|NCT03978845|Sensory System Agents|sensory system agents|mesh-ancestor
64866415|NCT01800292|Sildenafil Citrate|sildenafil citrate|mesh-list
64496847|NCT03431142|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64496848|NCT03431142|Purinergic Agents|purinergic agents|mesh-ancestor
64496849|NCT03431142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64496850|NCT03831321|Diclofenac|diclofenac|mesh-list
64496851|NCT03831321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64496852|NCT03831321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64496853|NCT03831321|Analgesics|analgesics|mesh-ancestor
64496854|NCT03831321|Sensory System Agents|sensory system agents|mesh-ancestor
64496855|NCT03831321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496856|NCT03831321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496857|NCT03831321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64496858|NCT03831321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64496859|NCT03831321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64496860|NCT03831321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496861|NCT03831321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496862|NCT04450134|Fexofenadine|fexofenadine|mesh-list
64496863|NCT04450134|Famotidine|famotidine|mesh-list
64496864|NCT04450134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64496865|NCT04450134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64496866|NCT04450134|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64496867|NCT04450134|Histamine Antagonists|histamine antagonists|mesh-ancestor
64496868|NCT04450134|Histamine Agents|histamine agents|mesh-ancestor
64496869|NCT04450134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64496885|NCT01286818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64496886|NCT01286818|Immunologic Factors|immunologic factors|mesh-ancestor
64945646|NCT05379322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64496887|NCT01286818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496888|NCT01286818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64496889|NCT01286818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64496890|NCT01286818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496892|NCT01286818|Protective Agents|protective agents|mesh-ancestor
64496893|NCT01286818|Vitamin B Complex|vitamin b complex|mesh-ancestor
64496895|NCT01286818|Micronutrients|micronutrients|mesh-ancestor
64496896|NCT03428256|Anesthetics|anesthetics|mesh-list
64496897|NCT03428256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64496898|NCT03428256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496899|NCT00635505|Albuterol|albuterol|mesh-list
64496900|NCT00635505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64496901|NCT00635505|Autonomic Agents|autonomic agents|mesh-ancestor
64496902|NCT00635505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496903|NCT00635505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496904|NCT00635505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64496905|NCT00635505|Respiratory System Agents|respiratory system agents|mesh-ancestor
64496906|NCT00635505|Tocolytic Agents|tocolytic agents|mesh-ancestor
64496911|NCT00635505|Adrenergic Agents|adrenergic agents|mesh-ancestor
64496912|NCT00635505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64496913|NCT00635505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496914|NCT01243450|Tretinoin|tretinoin|mesh-list
64496915|NCT01243450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496916|NCT01243450|Keratolytic Agents|keratolytic agents|mesh-ancestor
65482385|NCT03978845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65482386|NCT03978845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65482387|NCT03978845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65482388|NCT03978845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65482389|NCT03978845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65482390|NCT03978845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482391|NCT02387996|Nivolumab|nivolumab|mesh-list
65482392|NCT02387996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65482393|NCT02387996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482394|NCT02387996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65482395|NCT02387996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482396|NCT01204580|Metformin|metformin|mesh-list
65482397|NCT01204580|Glimepiride|glimepiride|mesh-list
65482398|NCT01204580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65482399|NCT01204580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496917|NCT01243450|Dermatologic Agents|dermatologic agents|mesh-ancestor
64496918|NCT05249751|Arginine Vasopressin|arginine vasopressin|mesh-list
64496919|NCT05249751|Hemostatics|hemostatics|mesh-ancestor
64496920|NCT05249751|Coagulants|coagulants|mesh-ancestor
64496921|NCT05249751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64496922|NCT05249751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64496923|NCT05249751|Natriuretic Agents|natriuretic agents|mesh-ancestor
64496924|NCT05249751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496925|NCT00635193|Doxorubicin|doxorubicin|mesh-list
64496926|NCT00635193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64496927|NCT00635193|Volociximab|volociximab|mesh-list
64496928|NCT00635193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64723238|NCT00954187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64723239|NCT00954187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64723240|NCT00954187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64496929|NCT00635193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64496930|NCT00635193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496963|NCT03122301|Anesthetics, Local|anesthetics, local|mesh-ancestor
64496964|NCT03122301|Anesthetics|anesthetics|mesh-ancestor
64496965|NCT03122301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64496966|NCT03122301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496967|NCT03122301|Sensory System Agents|sensory system agents|mesh-ancestor
64496968|NCT03122301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496969|NCT01925859|Dexamethasone|dexamethasone|mesh-list
64496970|NCT01925859|Dexamethasone acetate|dexamethasone acetate|mesh-list
64496971|NCT01925859|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64496972|NCT01925859|BB 1101|bb 1101|mesh-list
64496978|NCT01925859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64496979|NCT01925859|Glucocorticoids|glucocorticoids|mesh-ancestor
64496980|NCT01925859|Hormones|hormones|mesh-ancestor
64496981|NCT01925859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64496982|NCT01925859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64496983|NCT01925859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496984|NCT01925859|Protease Inhibitors|protease inhibitors|mesh-ancestor
64496985|NCT01925859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496986|NCT01925859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496987|NCT01920945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64496988|NCT01920945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64496989|NCT01920945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64496990|NCT01920945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496991|NCT01920945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496992|NCT01920945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64496993|NCT01920945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65482400|NCT01204580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65482401|NCT01204580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65482402|NCT01204580|Immunologic Factors|immunologic factors|mesh-ancestor
65482403|NCT03850366|Cyclophosphamide|cyclophosphamide|mesh-list
65482404|NCT03850366|Bortezomib|bortezomib|mesh-list
65482405|NCT03850366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65482406|NCT03850366|Immunologic Factors|immunologic factors|mesh-ancestor
65482407|NCT03850366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482408|NCT03850366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65482409|NCT03850366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65482410|NCT03850366|Alkylating Agents|alkylating agents|mesh-ancestor
65482411|NCT03850366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482412|NCT03850366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482413|NCT03850366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65482414|NCT05181592|Luspatercept|luspatercept|mesh-list
65482415|NCT05181592|Hematinics|hematinics|mesh-ancestor
65482416|NCT05181514|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65482417|NCT05181514|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65482418|NCT05181514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65482419|NCT05181514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65482420|NCT03229486|Glycopyrrolate|glycopyrrolate|mesh-list
65482421|NCT03229486|Neostigmine|neostigmine|mesh-list
65482422|NCT03229486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65482423|NCT03229486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866443|NCT01800396|Sequestering Agents|sequestering agents|mesh-ancestor
64496994|NCT01920945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496995|NCT01920945|Cholinergic Agents|cholinergic agents|mesh-ancestor
64496996|NCT01920945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64496997|NCT01926639|Rituximab|rituximab|mesh-list
64496998|NCT01926639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64496999|NCT01926639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497000|NCT01926639|Immunologic Factors|immunologic factors|mesh-ancestor
64497001|NCT01926639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497002|NCT01926639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64497003|NCT02199496|Ustekinumab|ustekinumab|mesh-list
64497004|NCT02199496|Dermatologic Agents|dermatologic agents|mesh-ancestor
64497005|NCT04395417|Hyaluronic Acid|hyaluronic acid|mesh-list
64497006|NCT04395417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64497007|NCT04395417|Immunologic Factors|immunologic factors|mesh-ancestor
64497008|NCT04395417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497009|NCT04395417|Viscosupplements|viscosupplements|mesh-ancestor
64497010|NCT04395417|Protective Agents|protective agents|mesh-ancestor
64497011|NCT02199574|Bupivacaine|bupivacaine|mesh-list
64497012|NCT02199574|Anesthetics, Local|anesthetics, local|mesh-ancestor
64497020|NCT02199652|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64497021|NCT02199652|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64497022|NCT02199652|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64497023|NCT02199652|Adrenergic Agents|adrenergic agents|mesh-ancestor
64497024|NCT02199652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64497025|NCT02199652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482424|NCT03229486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482425|NCT03229486|Cholinergic Agents|cholinergic agents|mesh-ancestor
65482426|NCT03229486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65482427|NCT03229486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482428|NCT03229486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65482429|NCT03229486|Autonomic Agents|autonomic agents|mesh-ancestor
65482430|NCT03229486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65482431|NCT03229486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65482432|NCT03229486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65482433|NCT03229486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65482435|NCT05153668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482436|NCT05153668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65482437|NCT05153668|Immunologic Factors|immunologic factors|mesh-ancestor
65482438|NCT05153668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497026|NCT02199652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497027|NCT03009916|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
64497028|NCT03009916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64497029|NCT03009916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64497030|NCT03009916|Antimetabolites|antimetabolites|mesh-ancestor
64723242|NCT00954187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64723243|NCT00954187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64723244|NCT00954187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723245|NCT00954187|Antimanic Agents|antimanic agents|mesh-ancestor
64723246|NCT04796012|Irinotecan|irinotecan|mesh-list
64723247|NCT04796012|Vincristine|vincristine|mesh-list
64723248|NCT04796012|Temozolomide|temozolomide|mesh-list
64723249|NCT04796012|Atezolizumab|atezolizumab|mesh-list
64723250|NCT04796012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64723251|NCT04796012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64723252|NCT04796012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64723253|NCT04796012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723254|NCT04796012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723255|NCT04796012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64330852|NCT03240861|Busulfan|busulfan|mesh-list
64497031|NCT03009916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497032|NCT03009916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64497033|NCT01927029|Progesterone|progesterone|mesh-list
64497034|NCT01927029|Progestins|progestins|mesh-ancestor
64945647|NCT05379322|Immunologic Factors|immunologic factors|mesh-ancestor
64497036|NCT01927029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64497038|NCT01921647|Amoxicillin|amoxicillin|mesh-list
64497039|NCT01921647|Clarithromycin|clarithromycin|mesh-list
64497040|NCT01921647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64497052|NCT01339858|Respiratory System Agents|respiratory system agents|mesh-ancestor
64497053|NCT01339858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64497055|NCT01339858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497056|NCT01339858|Protective Agents|protective agents|mesh-ancestor
64497057|NCT01339858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497058|NCT01339858|Antidotes|antidotes|mesh-ancestor
64497059|NCT01339936|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64497060|NCT01339936|Glycerol|glycerol|mesh-list
64497061|NCT01339936|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64497062|NCT01339936|Protective Agents|protective agents|mesh-ancestor
64497063|NCT01339936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497064|NCT01339936|Laxatives|laxatives|mesh-ancestor
64497065|NCT01339936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64497066|NCT05246865|Androgens|androgens|mesh-list
64497067|NCT05246865|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64497068|NCT05246865|Hormones|hormones|mesh-ancestor
64497069|NCT05246865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65482439|NCT03833570|Melatonin|melatonin|mesh-list
65482440|NCT03833570|Antioxidants|antioxidants|mesh-ancestor
65482441|NCT03833570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482442|NCT03833570|Protective Agents|protective agents|mesh-ancestor
65482443|NCT03833570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482444|NCT03833570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65482445|NCT01779050|Paclitaxel|paclitaxel|mesh-list
65482446|NCT01779050|Docetaxel|docetaxel|mesh-list
65482447|NCT01779050|Cyclophosphamide|cyclophosphamide|mesh-list
65482448|NCT01779050|Carboplatin|carboplatin|mesh-list
65482449|NCT01779050|Doxorubicin|doxorubicin|mesh-list
65482450|NCT01779050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65482451|NCT01779050|Fluorouracil|fluorouracil|mesh-list
65482452|NCT01779050|Trastuzumab|trastuzumab|mesh-list
65482453|NCT01779050|Epirubicin|epirubicin|mesh-list
65482454|NCT01779050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65482455|NCT01779050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497070|NCT05246865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497071|NCT05246865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64497072|NCT05246865|Immunologic Factors|immunologic factors|mesh-ancestor
64497073|NCT03111537|Nicotine|nicotine|mesh-list
64497074|NCT03111537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64497075|NCT03111537|Autonomic Agents|autonomic agents|mesh-ancestor
64497076|NCT03111537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64497077|NCT03111537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497078|NCT03111537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64497082|NCT03111537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497083|NCT05244525|Epinephrine|epinephrine|mesh-list
64497084|NCT05244525|Bupivacaine|bupivacaine|mesh-list
64497085|NCT05244525|Anesthetics, Local|anesthetics, local|mesh-ancestor
64497086|NCT05244525|Anesthetics|anesthetics|mesh-ancestor
64497087|NCT05244525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64723256|NCT04796012|Tubulin Modulators|tubulin modulators|mesh-ancestor
64723257|NCT04796012|Antimitotic Agents|antimitotic agents|mesh-ancestor
64723258|NCT04796012|Mitosis Modulators|mitosis modulators|mesh-ancestor
64723259|NCT04796012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64723260|NCT04796012|Alkylating Agents|alkylating agents|mesh-ancestor
64723261|NCT00947791|Midazolam|midazolam|mesh-list
64723262|NCT00947791|Ketamine|ketamine|mesh-list
64723263|NCT00947791|Analgesics|analgesics|mesh-ancestor
64723264|NCT00947791|Sensory System Agents|sensory system agents|mesh-ancestor
64723265|NCT00947791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64723266|NCT00947791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723267|NCT00947791|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64723268|NCT00947791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64723269|NCT00947791|Anesthetics, General|anesthetics, general|mesh-ancestor
64723270|NCT00947791|Anesthetics|anesthetics|mesh-ancestor
64723271|NCT00947791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64723272|NCT00947791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64723273|NCT00947791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64723274|NCT00947791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723275|NCT00947791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723276|NCT00947791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64723277|NCT00947791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64723278|NCT00947791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64723279|NCT00947791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64723280|NCT00947791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64723281|NCT00947791|GABA Modulators|gaba modulators|mesh-ancestor
64723282|NCT00947791|GABA Agents|gaba agents|mesh-ancestor
64723283|NCT05136326|Capecitabine|capecitabine|mesh-list
64723284|NCT05136326|Temozolomide|temozolomide|mesh-list
64497088|NCT05244525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482456|NCT01779050|Tubulin Modulators|tubulin modulators|mesh-ancestor
65482457|NCT01779050|Antimitotic Agents|antimitotic agents|mesh-ancestor
65482458|NCT01779050|Mitosis Modulators|mitosis modulators|mesh-ancestor
65482459|NCT01779050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482460|NCT01779050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65482461|NCT01779050|Immunologic Factors|immunologic factors|mesh-ancestor
65482462|NCT01779050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482463|NCT01779050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65482464|NCT01779050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64866499|NCT01800708|Prednisolone|prednisolone|mesh-list
64497089|NCT05244525|Sensory System Agents|sensory system agents|mesh-ancestor
64497090|NCT05244525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64497091|NCT05244525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64497092|NCT05244525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64497093|NCT05244525|Adrenergic Agents|adrenergic agents|mesh-ancestor
64497094|NCT05244525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64497095|NCT05244525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497096|NCT05244525|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64497097|NCT05244525|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64497098|NCT05244525|Autonomic Agents|autonomic agents|mesh-ancestor
64497099|NCT05244525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64497100|NCT05244525|Respiratory System Agents|respiratory system agents|mesh-ancestor
64497102|NCT05244525|Sympathomimetics|sympathomimetics|mesh-ancestor
64497103|NCT05244525|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64497105|NCT01927263|Dermatologic Agents|dermatologic agents|mesh-ancestor
64497118|NCT01341730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497119|NCT01247272|Fluoxetine|fluoxetine|mesh-list
64497120|NCT01247272|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64723285|NCT05136326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64723286|NCT05136326|Antimetabolites|antimetabolites|mesh-ancestor
64723287|NCT05136326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723288|NCT05136326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723289|NCT05136326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64723290|NCT05136326|Alkylating Agents|alkylating agents|mesh-ancestor
64723291|NCT05387941|Dexamethasone|dexamethasone|mesh-list
64723292|NCT05387941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64723293|NCT05387941|Antiemetics|antiemetics|mesh-ancestor
64723294|NCT05387941|Autonomic Agents|autonomic agents|mesh-ancestor
64723295|NCT05387941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64723296|NCT05387941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723297|NCT05387941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64723298|NCT05387941|Glucocorticoids|glucocorticoids|mesh-ancestor
64723299|NCT05387941|Hormones|hormones|mesh-ancestor
64723300|NCT05387941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64497123|NCT01247272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497125|NCT01247272|Serotonin Agents|serotonin agents|mesh-ancestor
64497126|NCT01247272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497127|NCT01247272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64497128|NCT01247272|Antidepressive Agents|antidepressive agents|mesh-ancestor
64497129|NCT01247272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64497130|NCT01247272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64497131|NCT01247272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64497132|NCT01247272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497133|NCT01290484|Sildenafil Citrate|sildenafil citrate|mesh-list
64497134|NCT01290484|Vasodilator Agents|vasodilator agents|mesh-ancestor
64497135|NCT01290484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64497136|NCT01290484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64497137|NCT01290484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497138|NCT01290484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497139|NCT01290484|Urological Agents|urological agents|mesh-ancestor
64497140|NCT04396743|Clotrimazole|clotrimazole|mesh-list
64497141|NCT04396743|Miconazole|miconazole|mesh-list
64497142|NCT04396743|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65482465|NCT01779050|Alkylating Agents|alkylating agents|mesh-ancestor
65482466|NCT01779050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65482467|NCT01779050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65482468|NCT01779050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65482469|NCT01779050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65482470|NCT01779050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482471|NCT01779050|Antimetabolites|antimetabolites|mesh-ancestor
65482472|NCT01779050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65482473|NCT01779050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65482474|NCT03841136|Etoposide|etoposide|mesh-list
65482475|NCT03841136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65482476|NCT03841136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482477|NCT03841136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65482478|NCT03841136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64866506|NCT01800708|Hormones|hormones|mesh-ancestor
64497143|NCT04396743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64497144|NCT04396743|Antifungal Agents|antifungal agents|mesh-ancestor
64497145|NCT04396743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64497146|NCT04396743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64497147|NCT04396743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497148|NCT04396743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497149|NCT04396743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64497150|NCT04396743|Hormone Antagonists|hormone antagonists|mesh-ancestor
64497151|NCT04396743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64497152|NCT04396743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497153|NCT04396743|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64497154|NCT04396743|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64497155|NCT01928043|Curcumin|curcumin|mesh-list
64723303|NCT00379015|Cyclophosphamide|cyclophosphamide|mesh-list
64723304|NCT00379015|Docetaxel|docetaxel|mesh-list
64723305|NCT00379015|Trastuzumab|trastuzumab|mesh-list
64723306|NCT00379015|Epirubicin|epirubicin|mesh-list
64723307|NCT00379015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64723308|NCT00379015|Immunologic Factors|immunologic factors|mesh-ancestor
64723309|NCT00379015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497156|NCT01928043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64497157|NCT01928043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64497158|NCT01928043|Analgesics|analgesics|mesh-ancestor
64497159|NCT01928043|Sensory System Agents|sensory system agents|mesh-ancestor
64497160|NCT01928043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64497161|NCT01928043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497162|NCT01928043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64497163|NCT01928043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64497164|NCT01928043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497165|NCT01928043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497171|NCT02979886|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64497172|NCT02979886|Menotropins|menotropins|mesh-list
64497173|NCT02979886|Luteolytic Agents|luteolytic agents|mesh-ancestor
64497174|NCT02979886|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64497175|NCT02979886|Contraceptive Agents|contraceptive agents|mesh-ancestor
64497176|NCT02979886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64497177|NCT02979886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497178|NCT02979886|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64497179|NCT02979886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64497180|NCT02979886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497181|NCT02979886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64497182|NCT02979886|Fertility Agents|fertility agents|mesh-ancestor
64497183|NCT03052608|Crizotinib|crizotinib|mesh-list
64497184|NCT03052608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497189|NCT01928511|Tenofovir|tenofovir|mesh-list
65482479|NCT03841136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482480|NCT03841136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482481|NCT05669768|Tamoxifen|tamoxifen|mesh-list
65482482|NCT05669768|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65482483|NCT05669768|Hormone Antagonists|hormone antagonists|mesh-ancestor
65482484|NCT05669768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65482485|NCT05669768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482486|NCT05669768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65482487|NCT05669768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497190|NCT01928511|Interferon-alpha|interferon-alpha|mesh-list
64497191|NCT01928511|Lamivudine|lamivudine|mesh-list
64497192|NCT01928511|Interferon alpha-2|interferon alpha-2|mesh-list
64497193|NCT01928511|Entecavir|entecavir|mesh-list
64497194|NCT01928511|Adefovir|adefovir|mesh-list
64497195|NCT01928511|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64497196|NCT01928511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497197|NCT01928511|Antiviral Agents|antiviral agents|mesh-ancestor
64497198|NCT01928511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64497199|NCT01928511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64497200|NCT01928511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64497201|NCT01928511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497202|NCT01928511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497203|NCT01928511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64497204|NCT01928511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64497205|NCT01928511|Immunologic Factors|immunologic factors|mesh-ancestor
64497206|NCT01928511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497207|NCT05241249|Gemcitabine|gemcitabine|mesh-list
64497208|NCT05241249|Paclitaxel|paclitaxel|mesh-list
64497209|NCT05241249|Bethanechol|bethanechol|mesh-list
64497210|NCT05241249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64497211|NCT05241249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497212|NCT05241249|Tubulin Modulators|tubulin modulators|mesh-ancestor
64497213|NCT05241249|Antimitotic Agents|antimitotic agents|mesh-ancestor
64497214|NCT05241249|Mitosis Modulators|mitosis modulators|mesh-ancestor
64497215|NCT05241249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497216|NCT05241249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64497217|NCT05241249|Antimetabolites|antimetabolites|mesh-ancestor
64497218|NCT05241249|Antiviral Agents|antiviral agents|mesh-ancestor
64497219|NCT05241249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64497220|NCT05241249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497221|NCT05241249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64497222|NCT05241249|Immunologic Factors|immunologic factors|mesh-ancestor
64497223|NCT05241249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497224|NCT05241249|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64497225|NCT05241249|Autonomic Agents|autonomic agents|mesh-ancestor
64723310|NCT00379015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64723311|NCT00379015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64723312|NCT00379015|Alkylating Agents|alkylating agents|mesh-ancestor
64723313|NCT00379015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723314|NCT00379015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723315|NCT00379015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64723316|NCT00379015|Tubulin Modulators|tubulin modulators|mesh-ancestor
64723317|NCT00379015|Antimitotic Agents|antimitotic agents|mesh-ancestor
64723318|NCT00379015|Mitosis Modulators|mitosis modulators|mesh-ancestor
64723319|NCT00379015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64723320|NCT00379015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64723321|NCT00379015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64723322|NCT00379015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64497226|NCT05241249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64497227|NCT05241249|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64497228|NCT05241249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64497229|NCT05241249|Cholinergic Agents|cholinergic agents|mesh-ancestor
64497230|NCT05241249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64497231|NCT01928823|Cycloserine|cycloserine|mesh-list
64497232|NCT01928823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65482488|NCT05669768|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65482489|NCT05669768|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65482490|NCT05669768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65482491|NCT00306527|Vaccines|vaccines|mesh-list
65482492|NCT00306527|Immunologic Factors|immunologic factors|mesh-ancestor
65482493|NCT00306527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482494|NCT01066247|Midazolam|midazolam|mesh-list
64497233|NCT01928823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64497234|NCT01928823|Renal Agents|renal agents|mesh-ancestor
64497235|NCT01928823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64497236|NCT01928823|Antitubercular Agents|antitubercular agents|mesh-ancestor
64497248|NCT01290874|Respiratory System Agents|respiratory system agents|mesh-ancestor
64497249|NCT01290874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64497251|NCT01290874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64497252|NCT01290874|Adrenergic Agents|adrenergic agents|mesh-ancestor
64497253|NCT01290874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64497254|NCT01290874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497255|NCT01290874|Parasympatholytics|parasympatholytics|mesh-ancestor
64497256|NCT01290874|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64497265|NCT02977494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64497266|NCT02977494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497268|NCT02977494|Glucocorticoids|glucocorticoids|mesh-ancestor
64497269|NCT02977494|Hormones|hormones|mesh-ancestor
64497270|NCT02977494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64497271|NCT02977494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64497272|NCT02977494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497273|NCT01929603|Rifampin|rifampin|mesh-list
64497274|NCT01929603|Olaparib|olaparib|mesh-list
64497275|NCT01929603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64497276|NCT01929603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497277|NCT01929603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497278|NCT01929603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497279|NCT01929603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64497280|NCT01929603|Antitubercular Agents|antitubercular agents|mesh-ancestor
64497281|NCT01929603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64497282|NCT01929603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64497283|NCT01929603|Leprostatic Agents|leprostatic agents|mesh-ancestor
64497284|NCT01929603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64497285|NCT01929603|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64497286|NCT01929603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64497287|NCT01929603|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64723324|NCT00911053|Melatonin|melatonin|mesh-list
64723325|NCT00911053|Antioxidants|antioxidants|mesh-ancestor
64723326|NCT00911053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723327|NCT00911053|Protective Agents|protective agents|mesh-ancestor
64723328|NCT00911053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723329|NCT00911053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64723330|NCT04713176|Remdesivir|remdesivir|mesh-list
64723331|NCT04713176|Antimetabolites|antimetabolites|mesh-ancestor
64723332|NCT04713176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723333|NCT04713176|Antiviral Agents|antiviral agents|mesh-ancestor
64497288|NCT01929603|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64497289|NCT01929603|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64497290|NCT01929603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64497291|NCT05241093|Cytarabine|cytarabine|mesh-list
64497292|NCT05241093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64497293|NCT05241093|Antimetabolites|antimetabolites|mesh-ancestor
64497294|NCT05241093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497295|NCT05241093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497296|NCT05241093|Antiviral Agents|antiviral agents|mesh-ancestor
64497297|NCT05241093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64497298|NCT05241093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64497299|NCT05241093|Immunologic Factors|immunologic factors|mesh-ancestor
64497300|NCT05241093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497301|NCT04178460|Niraparib|niraparib|mesh-list
64497330|NCT01291108|Bimatoprost|bimatoprost|mesh-list
65482495|NCT01066247|Morphine|morphine|mesh-list
65482496|NCT01066247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65482497|NCT01066247|Narcotics|narcotics|mesh-ancestor
65482498|NCT01066247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65482499|NCT01066247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482500|NCT01066247|Analgesics|analgesics|mesh-ancestor
65482501|NCT01066247|Sensory System Agents|sensory system agents|mesh-ancestor
65482502|NCT01066247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65482503|NCT01066247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65482504|NCT01066247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65482505|NCT01066247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65482506|NCT01066247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65482507|NCT01066247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65482508|NCT01066247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65482509|NCT01066247|Anesthetics, General|anesthetics, general|mesh-ancestor
65482510|NCT01066247|Anesthetics|anesthetics|mesh-ancestor
65482511|NCT01066247|GABA Modulators|gaba modulators|mesh-ancestor
65482512|NCT01066247|GABA Agents|gaba agents|mesh-ancestor
65482513|NCT01066247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65482514|NCT01066247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482515|NCT00306293|Valacyclovir|valacyclovir|mesh-list
65482516|NCT00306293|Antiviral Agents|antiviral agents|mesh-ancestor
65482517|NCT00306293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65482518|NCT03980951|Analgesics, Opioid|analgesics, opioid|mesh-list
65482519|NCT03980951|Narcotics|narcotics|mesh-ancestor
65482520|NCT03980951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65482521|NCT03980951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482522|NCT03980951|Analgesics|analgesics|mesh-ancestor
65482523|NCT03980951|Sensory System Agents|sensory system agents|mesh-ancestor
65482524|NCT03980951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65482525|NCT02532491|Risperidone|risperidone|mesh-list
65482526|NCT02532491|Aripiprazole|aripiprazole|mesh-list
65482527|NCT02532491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65482528|NCT02532491|Serotonin Agents|serotonin agents|mesh-ancestor
65482529|NCT02532491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65482530|NCT02532491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497331|NCT01291108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64497332|NCT01929213|Bosentan|bosentan|mesh-list
64497333|NCT01929213|Udenafil|udenafil|mesh-list
64497334|NCT01929213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64497335|NCT01929213|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65482531|NCT02532491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482532|NCT02532491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65482533|NCT02532491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65482534|NCT02532491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65482535|NCT02532491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65482536|NCT02532491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65482537|NCT02532491|Dopamine Agents|dopamine agents|mesh-ancestor
65482538|NCT02532491|Antidepressive Agents|antidepressive agents|mesh-ancestor
65482539|NCT02532491|Dopamine Agonists|dopamine agonists|mesh-ancestor
65482540|NCT02532491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65482541|NCT02532491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65482542|NCT02532491|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65482543|NCT02532491|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65482544|NCT01066403|Pergolide|pergolide|mesh-list
65482545|NCT01066403|Dopamine Agonists|dopamine agonists|mesh-ancestor
65482546|NCT01066403|Dopamine Agents|dopamine agents|mesh-ancestor
65482547|NCT01066403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65482548|NCT01066403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482549|NCT01066403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482550|NCT01064219|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65482551|NCT01064219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65482552|NCT01064219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482553|NCT00294671|Diflunisal|diflunisal|mesh-list
64497336|NCT01929213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497337|NCT01929213|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64497338|NCT01929213|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64497339|NCT01929213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497343|NCT03712098|Liraglutide|liraglutide|mesh-list
64497344|NCT03712098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64497345|NCT03712098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497346|NCT03712098|Incretins|incretins|mesh-ancestor
64497348|NCT03712098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64497349|NCT03430518|Durvalumab|durvalumab|mesh-list
64497350|NCT03430518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64497351|NCT03430518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497352|NCT05240157|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64497353|NCT05240157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64497362|NCT01925937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64497363|NCT01925937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497364|NCT01925937|Micronutrients|micronutrients|mesh-ancestor
64497371|NCT03430362|Autonomic Agents|autonomic agents|mesh-ancestor
64497372|NCT03430362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64497373|NCT03430362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497374|NCT03430362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64497376|NCT03430362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64723334|NCT04713176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64723335|NCT04725656|Nicotine|nicotine|mesh-list
64723336|NCT04725656|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64723337|NCT04725656|Autonomic Agents|autonomic agents|mesh-ancestor
64723338|NCT04725656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65482554|NCT00294671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65482555|NCT00294671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65482556|NCT00294671|Analgesics|analgesics|mesh-ancestor
65482557|NCT00294671|Sensory System Agents|sensory system agents|mesh-ancestor
65482558|NCT00294671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65482559|NCT00294671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482560|NCT00294671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65232073|NCT00743587|Naproxen|naproxen|mesh-list
65482561|NCT00294671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65482562|NCT00294671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64866590|NCT01801423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723339|NCT04725656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723340|NCT04725656|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64723341|NCT04725656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64723342|NCT04725656|Cholinergic Agents|cholinergic agents|mesh-ancestor
64723343|NCT04725656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723344|NCT04725656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723345|NCT04713410|Prednisolone|prednisolone|mesh-list
64723346|NCT04713410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64723347|NCT04713410|Glucocorticoids|glucocorticoids|mesh-ancestor
64497377|NCT03430362|Cholinergic Agents|cholinergic agents|mesh-ancestor
64497378|NCT03430362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64497379|NCT03430362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497380|NCT03430362|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64497381|NCT03430362|Parasympatholytics|parasympatholytics|mesh-ancestor
64497382|NCT03055377|Acetylcysteine|acetylcysteine|mesh-list
64497383|NCT03055377|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64497384|NCT03055377|Antiviral Agents|antiviral agents|mesh-ancestor
64497385|NCT03055377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64497386|NCT03055377|Expectorants|expectorants|mesh-ancestor
64497387|NCT03055377|Respiratory System Agents|respiratory system agents|mesh-ancestor
64497388|NCT03055377|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64497389|NCT03055377|Antioxidants|antioxidants|mesh-ancestor
64497390|NCT03055377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497391|NCT03055377|Protective Agents|protective agents|mesh-ancestor
64497392|NCT03055377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497393|NCT03055377|Antidotes|antidotes|mesh-ancestor
64497394|NCT03428022|Apatinib|apatinib|mesh-list
64497395|NCT03428022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497396|NCT03428022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64497397|NCT03428022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497398|NCT03428022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497399|NCT03054831|Oxycodone|oxycodone|mesh-list
64497400|NCT03054831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64497402|NCT03054831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64497403|NCT03054831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497404|NCT03054831|Analgesics|analgesics|mesh-ancestor
64497405|NCT03054831|Sensory System Agents|sensory system agents|mesh-ancestor
64497406|NCT03054831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64497407|NCT05069298|Silybin|silybin|mesh-list
64497408|NCT05069298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64497409|NCT05069298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497410|NCT05069298|Protective Agents|protective agents|mesh-ancestor
64497411|NCT05069298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497412|NCT00989781|Dexamethasone|dexamethasone|mesh-list
64497413|NCT00989781|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64497414|NCT00989781|Hormones|hormones|mesh-list
64419047|NCT02576977|Hormones|hormones|mesh-ancestor
64497417|NCT00989781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64497418|NCT00989781|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64497420|NCT00989781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64497421|NCT00989781|Antiemetics|antiemetics|mesh-ancestor
64497422|NCT00989781|Autonomic Agents|autonomic agents|mesh-ancestor
64497423|NCT00989781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65482563|NCT00294671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482564|NCT00294671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482565|NCT01064453|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65482566|NCT01064453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65482567|NCT01064453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482568|NCT03980249|Carvedilol|carvedilol|mesh-list
65482569|NCT03980249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65482570|NCT03980249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65482571|NCT03980249|Adrenergic Agents|adrenergic agents|mesh-ancestor
65482572|NCT03980249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65482573|NCT03980249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482574|NCT03980249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482575|NCT03980249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65482576|NCT03980249|Antioxidants|antioxidants|mesh-ancestor
65482577|NCT03980249|Protective Agents|protective agents|mesh-ancestor
65482578|NCT03980249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65482579|NCT03980249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65482580|NCT03980249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65482581|NCT03980249|Vasodilator Agents|vasodilator agents|mesh-ancestor
65482582|NCT03980249|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65482583|NCT03980249|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65482584|NCT01495598|Pomalidomide|pomalidomide|mesh-list
65482585|NCT01495598|Immunologic Factors|immunologic factors|mesh-ancestor
64497424|NCT00989781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497425|NCT00989781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64723349|NCT04713410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64723350|NCT04713410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723351|NCT04713410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64723352|NCT04713410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723353|NCT04713332|Vitamin E|vitamin e|mesh-list
64723354|NCT04713332|Tocopherols|tocopherols|mesh-list
64723355|NCT04713332|alpha-Tocopherol|alpha-tocopherol|mesh-list
64723356|NCT04713332|Vitamins|vitamins|mesh-ancestor
64723357|NCT04713332|Micronutrients|micronutrients|mesh-ancestor
64723358|NCT04713332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723359|NCT04713332|Antioxidants|antioxidants|mesh-ancestor
64723360|NCT04713332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723361|NCT04713332|Protective Agents|protective agents|mesh-ancestor
64723362|NCT00476827|Gemcitabine|gemcitabine|mesh-list
64723363|NCT00476827|Paclitaxel|paclitaxel|mesh-list
64723364|NCT00476827|Vinorelbine|vinorelbine|mesh-list
64497426|NCT00989781|Glucocorticoids|glucocorticoids|mesh-ancestor
64497427|NCT00989781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64497428|NCT00989781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64497429|NCT00989781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497430|NCT00989781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64497431|NCT00989781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64497432|NCT00989781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482586|NCT01495598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482587|NCT01495598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65482588|NCT01495598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65482589|NCT01495598|Growth Substances|growth substances|mesh-ancestor
65482590|NCT01495598|Growth Inhibitors|growth inhibitors|mesh-ancestor
65482591|NCT01495598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482592|NCT01297166|Calcitriol|calcitriol|mesh-list
65482593|NCT01297166|Calcipotriene|calcipotriene|mesh-list
65482594|NCT01297166|Dermatologic Agents|dermatologic agents|mesh-ancestor
65482595|NCT01297166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65482596|NCT01297166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482597|NCT01297166|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65482598|NCT01297166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64497433|NCT03427944|Calcium Dobesilate|calcium dobesilate|mesh-list
64497434|NCT03427944|Calcium|calcium|mesh-list
64497435|NCT03427944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64497457|NCT03079011|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64497458|NCT03079011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497459|NCT03079011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64497460|NCT03079011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497461|NCT03079011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497462|NCT03079011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64497463|NCT03079011|Hormone Antagonists|hormone antagonists|mesh-ancestor
64497464|NCT03079011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64497465|NCT03079011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497466|NCT03079011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64497467|NCT03079011|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64497468|NCT03079011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64497469|NCT03427632|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
64497470|NCT03427632|Vasodilator Agents|vasodilator agents|mesh-ancestor
64497471|NCT03427632|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64497472|NCT03427632|Protective Agents|protective agents|mesh-ancestor
64497473|NCT03427632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497475|NCT03427554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497476|NCT03427554|Keratolytic Agents|keratolytic agents|mesh-ancestor
64497477|NCT03427554|Dermatologic Agents|dermatologic agents|mesh-ancestor
64497478|NCT01349920|Infliximab|infliximab|mesh-list
64497479|NCT01349920|Dermatologic Agents|dermatologic agents|mesh-ancestor
64497480|NCT01349920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64497481|NCT01349920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64497482|NCT03128346|Aspirin|aspirin|mesh-list
64497483|NCT03128346|Acetaminophen|acetaminophen|mesh-list
64497484|NCT03128346|Fentanyl|fentanyl|mesh-list
64497485|NCT03128346|Hydromorphone|hydromorphone|mesh-list
64497486|NCT03128346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64497487|NCT03128346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64497488|NCT03128346|Analgesics|analgesics|mesh-ancestor
64497489|NCT03128346|Sensory System Agents|sensory system agents|mesh-ancestor
64723365|NCT00476827|Docetaxel|docetaxel|mesh-list
64723366|NCT00476827|Bevacizumab|bevacizumab|mesh-list
64723367|NCT00476827|Irinotecan|irinotecan|mesh-list
64723368|NCT00476827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64723369|NCT00476827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723370|NCT00476827|Tubulin Modulators|tubulin modulators|mesh-ancestor
64723376|NCT00476827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64723377|NCT00476827|Growth Substances|growth substances|mesh-ancestor
64723378|NCT00476827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330967|NCT05791721|Dexamethasone|dexamethasone|mesh-list
64497490|NCT03128346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64497491|NCT03128346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497504|NCT03128346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64497505|NCT03128346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65482599|NCT01297166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482600|NCT01297166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65482601|NCT01297166|Vitamins|vitamins|mesh-ancestor
65482602|NCT01297166|Micronutrients|micronutrients|mesh-ancestor
65482603|NCT01297166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65482604|NCT01202474|Insulin|insulin|mesh-list
65482605|NCT01202474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65482606|NCT01202474|Insulin Glargine|insulin glargine|mesh-list
65482607|NCT01202474|Insulin glulisine|insulin glulisine|mesh-list
65482608|NCT01202474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65482609|NCT01202474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482610|NCT05667818|Norfloxacin|norfloxacin|mesh-list
65482611|NCT05667818|Amlodipine|amlodipine|mesh-list
65482612|NCT05667818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65482613|NCT05667818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65482614|NCT05667818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65482615|NCT05667818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482616|NCT05667818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65482617|NCT05667818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482618|NCT05667818|Vasodilator Agents|vasodilator agents|mesh-ancestor
65482619|NCT05667818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65482620|NCT05667818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65482621|NCT05667818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65482622|NCT05667818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65482623|NCT05667818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482624|NCT05667818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497506|NCT03128346|Anesthetics, General|anesthetics, general|mesh-ancestor
64497507|NCT03128346|Anesthetics|anesthetics|mesh-ancestor
64497508|NCT03423030|Macozinone|macozinone|mesh-list
64497509|NCT03423030|Antitubercular Agents|antitubercular agents|mesh-ancestor
64497510|NCT03423030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64497511|NCT03423030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64497512|NCT03427242|Apatinib|apatinib|mesh-list
64497513|NCT03427242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497514|NCT03427242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64497515|NCT03427242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497516|NCT03427242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497517|NCT01252732|Vancomycin|vancomycin|mesh-list
64497518|NCT01252732|Oritavancin|oritavancin|mesh-list
64497519|NCT01252732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64497520|NCT01252732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64497521|NCT00989235|Abatacept|abatacept|mesh-list
64497522|NCT00989235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64497523|NCT00989235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497524|NCT00989235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497525|NCT00989235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64497526|NCT00989235|Immunologic Factors|immunologic factors|mesh-ancestor
64497527|NCT00989235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497528|NCT00989235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65482625|NCT05667818|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65482626|NCT05667818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65482627|NCT01205204|Clonidine|clonidine|mesh-list
65482628|NCT01205204|Fentanyl|fentanyl|mesh-list
65482629|NCT01205204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65482630|NCT01205204|Narcotics|narcotics|mesh-ancestor
65482631|NCT01205204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65482632|NCT01205204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482633|NCT01205204|Analgesics|analgesics|mesh-ancestor
65482634|NCT01205204|Sensory System Agents|sensory system agents|mesh-ancestor
65482635|NCT01205204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65482636|NCT01205204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65482637|NCT01205204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65482638|NCT01205204|Anesthetics, General|anesthetics, general|mesh-ancestor
65482639|NCT01205204|Anesthetics|anesthetics|mesh-ancestor
65482640|NCT01205204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65482641|NCT01205204|Sympatholytics|sympatholytics|mesh-ancestor
65482642|NCT01205204|Autonomic Agents|autonomic agents|mesh-ancestor
65482643|NCT01205204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65482644|NCT01205204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65482645|NCT01205204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65482646|NCT01205204|Adrenergic Agents|adrenergic agents|mesh-ancestor
65482647|NCT01205204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65482648|NCT01205204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482649|NCT01205282|Pioglitazone|pioglitazone|mesh-list
65482650|NCT01205282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65482651|NCT01205282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482652|NCT03902912|Prednisolone|prednisolone|mesh-list
65482653|NCT03902912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65482654|NCT03902912|Glucocorticoids|glucocorticoids|mesh-ancestor
65482656|NCT03902912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65482670|NCT01205360|Analgesics|analgesics|mesh-ancestor
65482671|NCT01205360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65482672|NCT01205360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65482673|NCT01205360|Anesthetics, General|anesthetics, general|mesh-ancestor
65482674|NCT01200914|Heparin|heparin|mesh-list
65482675|NCT01200914|Anticoagulants|anticoagulants|mesh-ancestor
65482676|NCT01200914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65482677|NCT01200914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65482678|NCT01200914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482679|NCT01205516|Morphine|morphine|mesh-list
65482680|NCT01205516|Methadone|methadone|mesh-list
65482681|NCT01205516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65482682|NCT01205516|Narcotics|narcotics|mesh-ancestor
65482683|NCT01205516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65482684|NCT01205516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482685|NCT01205516|Analgesics|analgesics|mesh-ancestor
65482686|NCT01205516|Sensory System Agents|sensory system agents|mesh-ancestor
65482687|NCT01205516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65482688|NCT01205516|Antitussive Agents|antitussive agents|mesh-ancestor
65482689|NCT01205516|Respiratory System Agents|respiratory system agents|mesh-ancestor
65482690|NCT01297634|Botulinum Toxins|botulinum toxins|mesh-list
65482691|NCT01297634|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65482692|NCT01297634|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65482693|NCT01297634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65482694|NCT01297634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65482695|NCT01297634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482696|NCT01297634|Cholinergic Agents|cholinergic agents|mesh-ancestor
65482697|NCT01297634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65482698|NCT01297634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482699|NCT01297634|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65482700|NCT01297634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65482701|NCT01201070|Antithrombins|antithrombins|mesh-list
64497529|NCT03422874|Nelfinavir|nelfinavir|mesh-list
64497530|NCT03422874|Ixazomib|ixazomib|mesh-list
64497531|NCT03422874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497532|NCT03422874|Protease Inhibitors|protease inhibitors|mesh-ancestor
64497533|NCT03422874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497534|NCT03422874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497535|NCT03422874|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64497536|NCT03422874|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64497537|NCT03422874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64497538|NCT03422874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64497539|NCT03422874|Antiviral Agents|antiviral agents|mesh-ancestor
64497540|NCT03422874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65482702|NCT01201070|Antithrombin III|antithrombin iii|mesh-list
65482703|NCT01201070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65482704|NCT01201070|Protease Inhibitors|protease inhibitors|mesh-ancestor
65482705|NCT01201070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482706|NCT01201070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482707|NCT01201070|Anticoagulants|anticoagulants|mesh-ancestor
65482708|NCT01205672|Metformin|metformin|mesh-list
65482709|NCT01205672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65482710|NCT01205672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482711|NCT03817970|Ondansetron|ondansetron|mesh-list
65482712|NCT03817970|Palonosetron|palonosetron|mesh-list
65482713|NCT03817970|Granisetron|granisetron|mesh-list
65482714|NCT03817970|Antiemetics|antiemetics|mesh-ancestor
65482715|NCT03817970|Autonomic Agents|autonomic agents|mesh-ancestor
65482716|NCT03817970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65482717|NCT03817970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482718|NCT03817970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65482719|NCT03817970|Antipruritics|antipruritics|mesh-ancestor
65482720|NCT03817970|Dermatologic Agents|dermatologic agents|mesh-ancestor
64497541|NCT01253824|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64497542|NCT01253824|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64497543|NCT01253824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64497544|NCT01253824|Norethindrone|norethindrone|mesh-list
64497545|NCT01253824|Norethindrone Acetate|norethindrone acetate|mesh-list
64497546|NCT01253824|Norinyl|norinyl|mesh-list
64497547|NCT01253824|Mestranol|mestranol|mesh-list
64723379|NCT00476827|Growth Inhibitors|growth inhibitors|mesh-ancestor
64723380|NCT00476827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64723381|NCT00476827|Antimetabolites|antimetabolites|mesh-ancestor
64723382|NCT00476827|Antiviral Agents|antiviral agents|mesh-ancestor
64723383|NCT00476827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64723384|NCT00476827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64723389|NCT00459121|Paclitaxel|paclitaxel|mesh-list
64723449|NCT00314353|Capecitabine|capecitabine|mesh-list
64723450|NCT00314353|Oxaliplatin|oxaliplatin|mesh-list
64723451|NCT00314353|Irinotecan|irinotecan|mesh-list
64723452|NCT00314353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64723453|NCT00314353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723454|NCT00314353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64723455|NCT00314353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64723456|NCT00314353|Growth Substances|growth substances|mesh-ancestor
64723457|NCT00314353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723458|NCT00314353|Growth Inhibitors|growth inhibitors|mesh-ancestor
64723464|NCT00314353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64723465|NCT00279409|Aripiprazole|aripiprazole|mesh-list
64723466|NCT00279409|Antidepressive Agents|antidepressive agents|mesh-ancestor
64331086|NCT05790629|Calcium|calcium|mesh-list
64331093|NCT05790577|Niacin|niacin|mesh-list
64497548|NCT01253824|Estradiol|estradiol|mesh-list
64497549|NCT01253824|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64497550|NCT01253824|Estrogens|estrogens|mesh-ancestor
64497551|NCT01253824|Hormones|hormones|mesh-ancestor
64497553|NCT01253824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497554|NCT01253824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64497555|NCT01253824|Contraceptive Agents|contraceptive agents|mesh-ancestor
64497556|NCT01253824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64497567|NCT03422796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497568|NCT03422796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64497569|NCT03422796|Respiratory System Agents|respiratory system agents|mesh-ancestor
64497570|NCT03422796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64497571|NCT03422796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65482721|NCT03817970|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65482722|NCT03817970|Serotonin Agents|serotonin agents|mesh-ancestor
65482723|NCT03817970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65482724|NCT03817970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482725|NCT03817970|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65482726|NCT03817970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65482727|NCT03817970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65482728|NCT03817970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65482729|NCT03817970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65482730|NCT03817970|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65482731|NCT03457948|Pembrolizumab|pembrolizumab|mesh-list
65482732|NCT03457948|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65482733|NCT03457948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64497572|NCT03422796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497573|NCT03422796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64497574|NCT03422796|Vasodilator Agents|vasodilator agents|mesh-ancestor
64497575|NCT03422796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64497576|NCT03422796|Protective Agents|protective agents|mesh-ancestor
64497577|NCT03422796|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64497578|NCT03422796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64497579|NCT03422796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497580|NCT03422796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64497581|NCT03422796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64497582|NCT03422796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64497583|NCT03422796|Serotonin Agents|serotonin agents|mesh-ancestor
64497584|NCT03422796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64497585|NCT04396977|Histamine|histamine|mesh-list
64497586|NCT04396977|Histamine Agonists|histamine agonists|mesh-ancestor
64497587|NCT04396977|Histamine Agents|histamine agents|mesh-ancestor
64497588|NCT04396977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64497589|NCT04396977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497590|NCT04396977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497591|NCT03429738|Ibuprofen|ibuprofen|mesh-list
64497592|NCT03429738|Pseudoephedrine|pseudoephedrine|mesh-list
64497593|NCT03429738|Ephedrine|ephedrine|mesh-list
64723467|NCT00279409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64723468|NCT00279409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64723469|NCT00279409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64723470|NCT00279409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64497594|NCT03429738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64497595|NCT03429738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64497596|NCT03429738|Analgesics|analgesics|mesh-ancestor
64497597|NCT03429738|Sensory System Agents|sensory system agents|mesh-ancestor
64497598|NCT03429738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64497599|NCT03429738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497600|NCT03429738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64497601|NCT03429738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64497602|NCT03429738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64497603|NCT03429738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497604|NCT03429738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497605|NCT03429738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64497606|NCT03429738|Autonomic Agents|autonomic agents|mesh-ancestor
64497607|NCT03429738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64497608|NCT03429738|Respiratory System Agents|respiratory system agents|mesh-ancestor
64497609|NCT03429738|Nasal Decongestants|nasal decongestants|mesh-ancestor
64497610|NCT03429738|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64497611|NCT03429738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64497612|NCT03429738|Sympathomimetics|sympathomimetics|mesh-ancestor
64497613|NCT03429738|Adrenergic Agents|adrenergic agents|mesh-ancestor
64497614|NCT03429738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65482734|NCT03457948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482735|NCT03457948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65482736|NCT03457948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482737|NCT01205750|Insulin|insulin|mesh-list
65482738|NCT01205750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65482739|NCT01205750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65482740|NCT01205750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482741|NCT03012386|Sildenafil Citrate|sildenafil citrate|mesh-list
65482742|NCT03012386|Citric Acid|citric acid|mesh-list
65482743|NCT03012386|Sodium Citrate|sodium citrate|mesh-list
65482744|NCT03012386|Anticoagulants|anticoagulants|mesh-ancestor
65482745|NCT03012386|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65482746|NCT03012386|Chelating Agents|chelating agents|mesh-ancestor
65482747|NCT03012386|Sequestering Agents|sequestering agents|mesh-ancestor
65482748|NCT03012386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482749|NCT03012386|Vasodilator Agents|vasodilator agents|mesh-ancestor
65482750|NCT03012386|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65482751|NCT03012386|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65482752|NCT03012386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482753|NCT03012386|Urological Agents|urological agents|mesh-ancestor
65482754|NCT01202552|Vaccines|vaccines|mesh-list
65482755|NCT01202552|Immunologic Factors|immunologic factors|mesh-ancestor
64866769|NCT01802918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497623|NCT01253980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64497630|NCT03154749|Cyclophosphamide|cyclophosphamide|mesh-list
64497632|NCT03154749|Docetaxel|docetaxel|mesh-list
64497633|NCT03154749|Epirubicin|epirubicin|mesh-list
64497634|NCT03154749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64497635|NCT03154749|Immunologic Factors|immunologic factors|mesh-ancestor
64497636|NCT03154749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497637|NCT03154749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64497638|NCT03154749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64497639|NCT03154749|Alkylating Agents|alkylating agents|mesh-ancestor
64497640|NCT03154749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497641|NCT03154749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497642|NCT03154749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64497643|NCT03154749|Tubulin Modulators|tubulin modulators|mesh-ancestor
64497644|NCT03154749|Antimitotic Agents|antimitotic agents|mesh-ancestor
64497645|NCT03154749|Mitosis Modulators|mitosis modulators|mesh-ancestor
64497646|NCT03154749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64497647|NCT03154749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64497648|NCT03154749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64497649|NCT03154749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497650|NCT03422640|Apremilast|apremilast|mesh-list
64497651|NCT03422640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64497652|NCT03422640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64497653|NCT03422640|Analgesics|analgesics|mesh-ancestor
64497654|NCT03422640|Sensory System Agents|sensory system agents|mesh-ancestor
64497655|NCT03422640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64497656|NCT03422640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497657|NCT03422640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64497658|NCT03422640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64497659|NCT03422640|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65482756|NCT01202552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482757|NCT01205984|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65482758|NCT01205984|Methylprednisolone|methylprednisolone|mesh-list
65482759|NCT01205984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65482760|NCT01205984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65482761|NCT01205984|Prednisolone|prednisolone|mesh-list
65482762|NCT01205984|Prednisolone acetate|prednisolone acetate|mesh-list
65482763|NCT01205984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65482764|NCT01205984|Prednisolone phosphate|prednisolone phosphate|mesh-list
65482765|NCT01205984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65482766|NCT01205984|Antiemetics|antiemetics|mesh-ancestor
65482767|NCT01205984|Autonomic Agents|autonomic agents|mesh-ancestor
65482768|NCT01205984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65482769|NCT01205984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482770|NCT01205984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65482771|NCT01205984|Glucocorticoids|glucocorticoids|mesh-ancestor
65482772|NCT01205984|Hormones|hormones|mesh-ancestor
64866788|NCT01802944|Insulin|insulin|mesh-list
64497660|NCT03422640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64497661|NCT03422640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497662|NCT03422640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497663|NCT01351090|Ketorolac|ketorolac|mesh-list
64497664|NCT01351090|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64497665|NCT01351090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64497666|NCT01351090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64497667|NCT01351090|Analgesics|analgesics|mesh-ancestor
64723471|NCT00279409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723472|NCT00279409|Dopamine Agonists|dopamine agonists|mesh-ancestor
64723473|NCT00279409|Dopamine Agents|dopamine agents|mesh-ancestor
64723474|NCT00279409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723475|NCT00279409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497668|NCT01351090|Sensory System Agents|sensory system agents|mesh-ancestor
64497669|NCT01351090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64497670|NCT01351090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497671|NCT01351090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64497672|NCT01351090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64497673|NCT01351090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64497674|NCT01351090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497675|NCT01351090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497676|NCT01918644|Capecitabine|capecitabine|mesh-list
64497677|NCT01918644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64497678|NCT01918644|Antimetabolites|antimetabolites|mesh-ancestor
64497679|NCT01918644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497680|NCT01918644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497681|NCT00987831|Methylprednisolone|methylprednisolone|mesh-list
64497682|NCT00987831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64497683|NCT00987831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64497686|NCT00987831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64497687|NCT00987831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497688|NCT00987831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64497689|NCT00987831|Glucocorticoids|glucocorticoids|mesh-ancestor
64497691|NCT00987831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64497692|NCT00987831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64497693|NCT00987831|Protective Agents|protective agents|mesh-ancestor
64497694|NCT03608358|Metformin|metformin|mesh-list
64497695|NCT03608358|Dapagliflozin|dapagliflozin|mesh-list
64497696|NCT03608358|Saxagliptin|saxagliptin|mesh-list
65482773|NCT01205984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65482774|NCT01205984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65482775|NCT01205984|Protective Agents|protective agents|mesh-ancestor
65482776|NCT01205984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65482777|NCT01205984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482778|NCT01205984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65482779|NCT01205984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65482780|NCT01205984|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65482781|NCT01205984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482782|NCT01205984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482783|NCT01297946|Hormones|hormones|mesh-list
65482784|NCT01297946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482785|NCT01297946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65482786|NCT03211858|Insulin|insulin|mesh-list
65482787|NCT03211858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65482788|NCT03211858|Insulin Glargine|insulin glargine|mesh-list
65482789|NCT03211858|Insulin Aspart|insulin aspart|mesh-list
65482790|NCT03211858|Insulin, Long-Acting|insulin, long-acting|mesh-list
65482791|NCT03211858|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65482792|NCT03211858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65482793|NCT03211858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497706|NCT03608358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497707|NCT04274907|Pembrolizumab|pembrolizumab|mesh-list
64497708|NCT04274907|Venetoclax|venetoclax|mesh-list
64497709|NCT04274907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64497710|NCT04274907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497711|NCT01256164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64497712|NCT01256164|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
64497713|NCT01256164|Hemostatics|hemostatics|mesh-ancestor
64497714|NCT01256164|Coagulants|coagulants|mesh-ancestor
64497715|NCT03560934|Dronabinol|dronabinol|mesh-list
64497716|NCT03560934|Hallucinogens|hallucinogens|mesh-ancestor
64497717|NCT03560934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497718|NCT03560934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64497719|NCT03560934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64497720|NCT03560934|Analgesics|analgesics|mesh-ancestor
64497721|NCT03560934|Sensory System Agents|sensory system agents|mesh-ancestor
64497722|NCT03560934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64497723|NCT03560934|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64497724|NCT03560934|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64497725|NCT03560934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64497726|NCT03560934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497727|NCT03560934|Hormones|hormones|mesh-ancestor
64497728|NCT03560934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64497729|NCT03077451|Nelfinavir|nelfinavir|mesh-list
64497730|NCT03077451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64497731|NCT03077451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64497732|NCT03077451|Protease Inhibitors|protease inhibitors|mesh-ancestor
64497733|NCT03077451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497734|NCT03077451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497735|NCT03077451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65482794|NCT01298180|Hormones|hormones|mesh-list
65482795|NCT01298180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65482796|NCT01298180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482797|NCT03211156|Amoxicillin|amoxicillin|mesh-list
65482798|NCT03211156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65482799|NCT03211156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65482800|NCT01298336|Moxifloxacin|moxifloxacin|mesh-list
65482801|NCT01298336|Clarithromycin|clarithromycin|mesh-list
65482802|NCT01298336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65482803|NCT01298336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65482804|NCT01298336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65482805|NCT01298336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65482806|NCT01298336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482807|NCT01298336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482808|NCT01298336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482809|NCT01298336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65482810|NCT01298336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65482811|NCT01298336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65482812|NCT04472494|Abatacept|abatacept|mesh-list
65482813|NCT04472494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65482814|NCT04472494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482815|NCT04472494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482816|NCT04472494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64497736|NCT03077451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64497737|NCT03077451|Antiviral Agents|antiviral agents|mesh-ancestor
64497738|NCT03077451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64497739|NCT03427086|Biotin|biotin|mesh-list
64497740|NCT03427086|Vitamins|vitamins|mesh-ancestor
64723476|NCT00279409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64462751|NCT03021460|Pembrolizumab|pembrolizumab|mesh-list
64723484|NCT05007392|Dotinurad|dotinurad|mesh-list
64723485|NCT05007392|Gout Suppressants|gout suppressants|mesh-ancestor
64723486|NCT05007392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64723487|NCT05007392|Uricosuric Agents|uricosuric agents|mesh-ancestor
64723488|NCT05007392|Renal Agents|renal agents|mesh-ancestor
64723489|NCT00379249|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64723490|NCT00379249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64723491|NCT00379249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64723492|NCT00379249|Antimetabolites|antimetabolites|mesh-ancestor
64723493|NCT00379249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723494|NCT00379249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64723495|NCT00379249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64723496|NCT00379249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64723504|NCT00801931|Cyclophosphamide|cyclophosphamide|mesh-list
64723505|NCT00801931|Melphalan|melphalan|mesh-list
64723506|NCT00801931|Busulfan|busulfan|mesh-list
64723507|NCT00801931|Thiotepa|thiotepa|mesh-list
64723508|NCT00801931|Fludarabine|fludarabine|mesh-list
64723509|NCT00801931|Alemtuzumab|alemtuzumab|mesh-list
64723510|NCT00801931|Phenytoin|phenytoin|mesh-list
64723511|NCT00801931|Fosphenytoin|fosphenytoin|mesh-list
64723512|NCT00801931|Thymoglobulin|thymoglobulin|mesh-list
64723513|NCT00801931|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65482817|NCT04472494|Immunologic Factors|immunologic factors|mesh-ancestor
65482818|NCT04472494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482819|NCT04472494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65482820|NCT04568200|Paclitaxel|paclitaxel|mesh-list
65482821|NCT04568200|Carboplatin|carboplatin|mesh-list
65482822|NCT04568200|Durvalumab|durvalumab|mesh-list
65482823|NCT04568200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65482824|NCT04568200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482825|NCT04568200|Tubulin Modulators|tubulin modulators|mesh-ancestor
65482826|NCT04568200|Antimitotic Agents|antimitotic agents|mesh-ancestor
65482827|NCT04568200|Mitosis Modulators|mitosis modulators|mesh-ancestor
65482828|NCT04568200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482829|NCT04568200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65482830|NCT03236506|Sofosbuvir|sofosbuvir|mesh-list
65482831|NCT03236506|Grazoprevir|grazoprevir|mesh-list
65482832|NCT03236506|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65482833|NCT03236506|Antiviral Agents|antiviral agents|mesh-ancestor
65482834|NCT03236506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65482835|NCT01298882|Diacetylrhein|diacetylrhein|mesh-list
65482836|NCT01298882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65482837|NCT01206530|Leucovorin|leucovorin|mesh-list
65482838|NCT01206530|Hydroxychloroquine|hydroxychloroquine|mesh-list
65482839|NCT01206530|Bevacizumab|bevacizumab|mesh-list
65482840|NCT01206530|Fluorouracil|fluorouracil|mesh-list
65482841|NCT01206530|Oxaliplatin|oxaliplatin|mesh-list
65482842|NCT01206530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65482843|NCT01206530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482844|NCT01206530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65482845|NCT01206530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64866856|NCT01803659|Vitamin A|vitamin a|mesh-list
64723514|NCT00801931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64497741|NCT03427086|Micronutrients|micronutrients|mesh-ancestor
64497742|NCT03427086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497743|NCT03427086|Vitamin B Complex|vitamin b complex|mesh-ancestor
64419069|NCT03908437|Naloxone|naloxone|mesh-list
64497748|NCT01887522|Antimitotic Agents|antimitotic agents|mesh-ancestor
64497749|NCT01887522|Mitosis Modulators|mitosis modulators|mesh-ancestor
64497750|NCT01887522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497751|NCT03422406|Iodine|iodine|mesh-list
64497752|NCT03422406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64497753|NCT03422406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64497754|NCT03422406|Trace Elements|trace elements|mesh-ancestor
64497755|NCT03422406|Micronutrients|micronutrients|mesh-ancestor
64497756|NCT03422406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497757|NCT00986427|Cyclosporine|cyclosporine|mesh-list
64497758|NCT00986427|Cyclosporins|cyclosporins|mesh-list
64497759|NCT00986427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497760|NCT00986427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482846|NCT01206530|Growth Substances|growth substances|mesh-ancestor
65482847|NCT01206530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482848|NCT01206530|Growth Inhibitors|growth inhibitors|mesh-ancestor
65482849|NCT01206530|Antimetabolites|antimetabolites|mesh-ancestor
65482850|NCT01206530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482851|NCT01206530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65482852|NCT01206530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65482853|NCT01206530|Immunologic Factors|immunologic factors|mesh-ancestor
65482854|NCT01206530|Antidotes|antidotes|mesh-ancestor
65482855|NCT01206530|Protective Agents|protective agents|mesh-ancestor
65482856|NCT01206530|Vitamin B Complex|vitamin b complex|mesh-ancestor
65482857|NCT01206530|Vitamins|vitamins|mesh-ancestor
65482858|NCT01206530|Micronutrients|micronutrients|mesh-ancestor
65482859|NCT01206530|Antimalarials|antimalarials|mesh-ancestor
65482860|NCT01206530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65232370|NCT00689611|Dopamine Agents|dopamine agents|mesh-ancestor
65482861|NCT01206530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65482862|NCT01206530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65482863|NCT01206530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482864|NCT01206530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65482865|NCT03209518|Leuprolide|leuprolide|mesh-list
65482866|NCT03209518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65482867|NCT03209518|Fertility Agents|fertility agents|mesh-ancestor
65482868|NCT03209518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65482869|NCT03209518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482870|NCT03209518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65482871|NCT03209518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482872|NCT05282420|Ranibizumab|ranibizumab|mesh-list
64497761|NCT00986427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64497762|NCT00986427|Immunologic Factors|immunologic factors|mesh-ancestor
64497763|NCT00986427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497770|NCT03529422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64497771|NCT03529422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497772|NCT03426462|Propofol|propofol|mesh-list
64497773|NCT03426462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64497774|NCT03426462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64723515|NCT00801931|Immunologic Factors|immunologic factors|mesh-ancestor
64723516|NCT00801931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723517|NCT00801931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64723518|NCT00801931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64723519|NCT00801931|Alkylating Agents|alkylating agents|mesh-ancestor
64331135|NCT05790330|Methotrexate|methotrexate|mesh-list
64497775|NCT03426462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497777|NCT03426462|Anesthetics, General|anesthetics, general|mesh-ancestor
64497778|NCT03426462|Anesthetics|anesthetics|mesh-ancestor
64497779|NCT03421860|Phenylephrine|phenylephrine|mesh-list
64497780|NCT03421860|Epinephrine|epinephrine|mesh-list
64497781|NCT03421860|Oxymetazoline|oxymetazoline|mesh-list
64497782|NCT03421860|Ephedrine|ephedrine|mesh-list
64497783|NCT03421860|Norepinephrine|norepinephrine|mesh-list
65482873|NCT05282420|Aflibercept|aflibercept|mesh-list
65482874|NCT05282420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65482875|NCT05282420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65482876|NCT05282420|Growth Substances|growth substances|mesh-ancestor
65482877|NCT05282420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482878|NCT05282420|Growth Inhibitors|growth inhibitors|mesh-ancestor
65482879|NCT05282420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482880|NCT00304031|Temozolomide|temozolomide|mesh-list
65482881|NCT00304031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65482882|NCT00304031|Alkylating Agents|alkylating agents|mesh-ancestor
65482883|NCT00304031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482884|NCT00304031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482885|NCT01567124|Moxonidine|moxonidine|mesh-list
65482886|NCT01567124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65482887|NCT03617666|Avelumab|avelumab|mesh-list
65482888|NCT03617666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65482889|NCT03617666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482890|NCT01299194|Atorvastatin|atorvastatin|mesh-list
64497784|NCT03421860|Ondansetron|ondansetron|mesh-list
64497785|NCT03421860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64497787|NCT03421860|Adrenergic Agents|adrenergic agents|mesh-ancestor
64497788|NCT03421860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64497789|NCT03421860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497790|NCT03421860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497791|NCT03421860|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64497792|NCT03421860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64497793|NCT03421860|Autonomic Agents|autonomic agents|mesh-ancestor
64497794|NCT03421860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64497795|NCT03421860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64497796|NCT03421860|Respiratory System Agents|respiratory system agents|mesh-ancestor
64497797|NCT03421860|Mydriatics|mydriatics|mesh-ancestor
64497798|NCT03421860|Sympathomimetics|sympathomimetics|mesh-ancestor
64497799|NCT03421860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64497800|NCT03421860|Antiemetics|antiemetics|mesh-ancestor
64497801|NCT03421860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64497802|NCT03421860|Antipruritics|antipruritics|mesh-ancestor
64945649|NCT05379322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497803|NCT03421860|Dermatologic Agents|dermatologic agents|mesh-ancestor
64497804|NCT03421860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64497805|NCT03421860|Serotonin Agents|serotonin agents|mesh-ancestor
64497806|NCT03421860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64497807|NCT03421860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64497808|NCT03421860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64497809|NCT03421860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64497810|NCT03421860|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64497811|NCT03421860|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64497812|NCT03421860|Nasal Decongestants|nasal decongestants|mesh-ancestor
64497813|NCT03421860|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64497814|NCT03421860|Protective Agents|protective agents|mesh-ancestor
64497815|NCT03421860|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64497816|NCT03421314|Selenium|selenium|mesh-list
64497817|NCT03421314|Antioxidants|antioxidants|mesh-ancestor
64419070|NCT03908437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64497824|NCT03425994|Cobicistat|cobicistat|mesh-list
64497825|NCT03425994|Elvitegravir|elvitegravir|mesh-list
64497826|NCT03425994|Antiviral Agents|antiviral agents|mesh-ancestor
64497827|NCT03425994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64497828|NCT03425994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65482891|NCT01299194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65482892|NCT01299194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65482893|NCT01299194|Antimetabolites|antimetabolites|mesh-ancestor
65482894|NCT01299194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482895|NCT01299194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65482896|NCT01299194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65482897|NCT01299194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482898|NCT03827408|Midazolam|midazolam|mesh-list
65482899|NCT03827408|Dexmedetomidine|dexmedetomidine|mesh-list
65482900|NCT03827408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65482901|NCT03827408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65482902|NCT03827408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482903|NCT03827408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65482904|NCT03827408|Analgesics|analgesics|mesh-ancestor
65482905|NCT03827408|Sensory System Agents|sensory system agents|mesh-ancestor
65482906|NCT03827408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65482907|NCT03827408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65482908|NCT03827408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65482909|NCT03827408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65482910|NCT03827408|Adrenergic Agents|adrenergic agents|mesh-ancestor
65482911|NCT03827408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65482912|NCT03827408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482913|NCT03827408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65482914|NCT03827408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64497829|NCT03425994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64497830|NCT03425994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497831|NCT03425994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497832|NCT03425994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64497833|NCT03425994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64497834|NCT03425994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64497835|NCT03425994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64497836|NCT03425994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64497839|NCT03421002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64497841|NCT00754260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64497842|NCT00754260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497843|NCT00754260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64331139|NCT05790330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331140|NCT05790330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64331141|NCT05790330|Antimetabolites|antimetabolites|mesh-ancestor
64331142|NCT05790330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331143|NCT05790330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331144|NCT05790330|Dermatologic Agents|dermatologic agents|mesh-ancestor
64723520|NCT00801931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723521|NCT00801931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723522|NCT00801931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64723523|NCT00801931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65482915|NCT03827408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65482916|NCT03827408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65482917|NCT03827408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65482918|NCT03827408|Anesthetics, General|anesthetics, general|mesh-ancestor
65482919|NCT03827408|Anesthetics|anesthetics|mesh-ancestor
65482920|NCT03827408|GABA Modulators|gaba modulators|mesh-ancestor
65482921|NCT03827408|GABA Agents|gaba agents|mesh-ancestor
65482922|NCT03556904|Docetaxel|docetaxel|mesh-list
65482923|NCT03556904|Hormones|hormones|mesh-list
65482924|NCT03556904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482925|NCT03556904|Tubulin Modulators|tubulin modulators|mesh-ancestor
65482926|NCT03556904|Antimitotic Agents|antimitotic agents|mesh-ancestor
65482927|NCT03556904|Mitosis Modulators|mitosis modulators|mesh-ancestor
65482928|NCT03556904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482929|NCT03556904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65482930|NCT03556904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482931|NCT00332189|Verapamil|verapamil|mesh-list
65482932|NCT00332189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65482933|NCT00332189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65482934|NCT00332189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65482935|NCT00332189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482936|NCT00332189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65482937|NCT00332189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723524|NCT00801931|Anticonvulsants|anticonvulsants|mesh-ancestor
64723525|NCT00801931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64723526|NCT00801931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64723527|NCT00801931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64723528|NCT00801931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64723529|NCT00801931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64723530|NCT00780481|Bradykinin|bradykinin|mesh-list
64723531|NCT00780481|Kininogens|kininogens|mesh-list
64723532|NCT00780481|Vasodilator Agents|vasodilator agents|mesh-ancestor
64723533|NCT00780481|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64723534|NCT00780481|Protease Inhibitors|protease inhibitors|mesh-ancestor
64723535|NCT00780481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64723536|NCT00780481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723537|NCT05345990|Immunoglobulins|immunoglobulins|mesh-list
64723538|NCT05345990|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64723539|NCT05345990|Antibodies|antibodies|mesh-list
64497844|NCT00754260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497845|NCT00754260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497846|NCT00754260|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64497847|NCT00754260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64497848|NCT00754260|Purinergic Agents|purinergic agents|mesh-ancestor
64497849|NCT00754260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64497850|NCT02546232|Paclitaxel|paclitaxel|mesh-list
64497851|NCT02546232|Carboplatin|carboplatin|mesh-list
64497852|NCT02546232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64497853|NCT02546232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497854|NCT02546232|Tubulin Modulators|tubulin modulators|mesh-ancestor
64497855|NCT02546232|Antimitotic Agents|antimitotic agents|mesh-ancestor
65482938|NCT00332189|Vasodilator Agents|vasodilator agents|mesh-ancestor
65482939|NCT01206998|Progesterone|progesterone|mesh-list
65482940|NCT01206998|Progestins|progestins|mesh-ancestor
65482941|NCT01206998|Hormones|hormones|mesh-ancestor
65482942|NCT01206998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65482943|NCT01206998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482944|NCT00331799|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65482945|NCT00331799|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65482946|NCT00331799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65482947|NCT00331799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65482948|NCT00331799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482949|NCT00331799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65482950|NCT00331799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482951|NCT00331799|Analgesics|analgesics|mesh-ancestor
65482952|NCT00331799|Sensory System Agents|sensory system agents|mesh-ancestor
65482953|NCT00331799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65482954|NCT00331799|Antidepressive Agents|antidepressive agents|mesh-ancestor
65482955|NCT00331799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65482956|NCT00331799|Dopamine Agents|dopamine agents|mesh-ancestor
64497856|NCT02546232|Mitosis Modulators|mitosis modulators|mesh-ancestor
64497857|NCT02546232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497858|NCT02521038|Ticagrelor|ticagrelor|mesh-list
64497859|NCT02521038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64497860|NCT02521038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64419074|NCT03908437|Analgesics|analgesics|mesh-ancestor
64723544|NCT00019747|Immunologic Factors|immunologic factors|mesh-ancestor
64723545|NCT00019747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723546|NCT00019747|Leprostatic Agents|leprostatic agents|mesh-ancestor
64723547|NCT00019747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64723548|NCT00019747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64723549|NCT00019747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64723550|NCT00019747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64723551|NCT00019747|Growth Substances|growth substances|mesh-ancestor
64723552|NCT00019747|Growth Inhibitors|growth inhibitors|mesh-ancestor
64331165|NCT05790239|Sympathomimetics|sympathomimetics|mesh-ancestor
64497863|NCT02521038|Purinergic Agents|purinergic agents|mesh-ancestor
64497864|NCT02521038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64497865|NCT02521038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497866|NCT02521038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497867|NCT00985959|Prednisolone|prednisolone|mesh-list
64497868|NCT00985959|Bortezomib|bortezomib|mesh-list
64497869|NCT00985959|Melphalan|melphalan|mesh-list
64497870|NCT00985959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497871|NCT00985959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64497872|NCT00985959|Alkylating Agents|alkylating agents|mesh-ancestor
64497873|NCT00985959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497874|NCT00985959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64497875|NCT00985959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64497876|NCT00985959|Immunologic Factors|immunologic factors|mesh-ancestor
64497877|NCT00985959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497878|NCT00985959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64497879|NCT00985959|Glucocorticoids|glucocorticoids|mesh-ancestor
64497880|NCT00985959|Hormones|hormones|mesh-ancestor
65482957|NCT03826940|Lovastatin|lovastatin|mesh-list
65482958|NCT03826940|L 647318|l 647318|mesh-list
65482959|NCT03826940|Dihydromevinolin|dihydromevinolin|mesh-list
65482960|NCT03826940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65482961|NCT03826940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65482962|NCT03826940|Antimetabolites|antimetabolites|mesh-ancestor
65482963|NCT03826940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482964|NCT03826940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65482965|NCT03826940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65482966|NCT03826940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482967|NCT00303953|Belinostat|belinostat|mesh-list
65482968|NCT00303953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482969|NCT00303953|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65482970|NCT00303953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482971|NCT00303953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482972|NCT01201694|Curcumin|curcumin|mesh-list
65482973|NCT01201694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65482974|NCT01201694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65482975|NCT01201694|Analgesics|analgesics|mesh-ancestor
65482976|NCT01201694|Sensory System Agents|sensory system agents|mesh-ancestor
65482977|NCT01201694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65482978|NCT01201694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497881|NCT00985959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64497882|NCT00985959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64497883|NCT00985725|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64497884|NCT00985725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64497885|NCT00985725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497886|NCT00985725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64497887|NCT00985725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64497888|NCT00985725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64497889|NCT00985725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497890|NCT00985725|Dopamine Agents|dopamine agents|mesh-ancestor
64497891|NCT00985725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64497892|NCT01294306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64497893|NCT01294306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497894|NCT01294306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64497895|NCT01294306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497896|NCT01294306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497897|NCT01351480|Abatacept|abatacept|mesh-list
64497898|NCT01351480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64497899|NCT01351480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497900|NCT01351480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497901|NCT01351480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64497902|NCT01351480|Immunologic Factors|immunologic factors|mesh-ancestor
64497903|NCT01351480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462830|NCT02511106|Osimertinib|osimertinib|mesh-list
64723553|NCT00019747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723555|NCT05048719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64723556|NCT05048719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723557|NCT00759577|Solifenacin Succinate|solifenacin succinate|mesh-list
65482979|NCT01201694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65482980|NCT01201694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65482981|NCT01201694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65482982|NCT01201694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65482983|NCT01201694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65482984|NCT01201928|Insulin|insulin|mesh-list
65482985|NCT01201928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65482986|NCT01201928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482987|NCT00303719|Cyclosporine|cyclosporine|mesh-list
65482988|NCT00303719|Mycophenolic Acid|mycophenolic acid|mesh-list
65482989|NCT00303719|Cyclophosphamide|cyclophosphamide|mesh-list
65482990|NCT00303719|Fludarabine|fludarabine|mesh-list
65482991|NCT00303719|Cyclosporins|cyclosporins|mesh-list
65482992|NCT00303719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65482993|NCT00303719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65482994|NCT00303719|Immunologic Factors|immunologic factors|mesh-ancestor
65482995|NCT00303719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65482996|NCT00303719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65482997|NCT00303719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65482998|NCT00303719|Alkylating Agents|alkylating agents|mesh-ancestor
65482999|NCT00303719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483000|NCT00303719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483001|NCT00303719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65483002|NCT00303719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483003|NCT00303719|Antifungal Agents|antifungal agents|mesh-ancestor
65483004|NCT00303719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65483005|NCT00303719|Dermatologic Agents|dermatologic agents|mesh-ancestor
65483006|NCT00303719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65483007|NCT00303719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65483008|NCT00303719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65483011|NCT01207310|Nicotine|nicotine|mesh-list
65483024|NCT00331409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65483025|NCT00331409|Immunologic Factors|immunologic factors|mesh-ancestor
65483026|NCT00331409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483027|NCT00331409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65483028|NCT00331409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483029|NCT00331409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483030|NCT01203254|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65483031|NCT01203254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65483032|NCT01203254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65483033|NCT01203254|Antimetabolites|antimetabolites|mesh-ancestor
65483034|NCT01203254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483035|NCT01203254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65483036|NCT01064921|Vorinostat|vorinostat|mesh-list
65483037|NCT01064921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483038|NCT01064921|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65483039|NCT01064921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483040|NCT01064921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483041|NCT01299662|Poly ICLC|poly iclc|mesh-list
65483042|NCT01299662|Interferon Inducers|interferon inducers|mesh-ancestor
65483043|NCT01299662|Immunologic Factors|immunologic factors|mesh-ancestor
65483044|NCT01299662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483045|NCT00303485|Vitamin D|vitamin d|mesh-list
65483046|NCT00303485|Ibandronic Acid|ibandronic acid|mesh-list
65483047|NCT00303485|Calcium|calcium|mesh-list
65483048|NCT00303485|Vitamins|vitamins|mesh-ancestor
65483049|NCT00303485|Micronutrients|micronutrients|mesh-ancestor
65483050|NCT00303485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483051|NCT00303485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65483052|NCT00303485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65483053|NCT03983915|Dexmedetomidine|dexmedetomidine|mesh-list
65483054|NCT03983915|Remifentanil|remifentanil|mesh-list
64723558|NCT00759577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64723559|NCT00759577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64497904|NCT01351480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64497924|NCT00984867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64497925|NCT00984867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497926|NCT01294384|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64497927|NCT01294384|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64497928|NCT01294384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64497929|NCT01294384|Laxatives|laxatives|mesh-ancestor
64497930|NCT01294384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64497932|NCT01257802|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64497933|NCT01257802|Fertility Agents|fertility agents|mesh-ancestor
64497934|NCT01257802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65483055|NCT03983915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65483056|NCT03983915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65483057|NCT03983915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483058|NCT03983915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65483059|NCT03983915|Analgesics|analgesics|mesh-ancestor
65483060|NCT03983915|Sensory System Agents|sensory system agents|mesh-ancestor
65483061|NCT03983915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65483062|NCT03983915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65483063|NCT03983915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65483064|NCT03983915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65483065|NCT03983915|Adrenergic Agents|adrenergic agents|mesh-ancestor
65483066|NCT03983915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65483067|NCT03983915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483068|NCT03983915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65483069|NCT03983915|Narcotics|narcotics|mesh-ancestor
65483070|NCT01300754|Lidocaine|lidocaine|mesh-list
65483071|NCT01300754|Anesthetics, Local|anesthetics, local|mesh-ancestor
65483072|NCT01300754|Anesthetics|anesthetics|mesh-ancestor
65483073|NCT01300754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65483074|NCT01300754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483075|NCT01300754|Sensory System Agents|sensory system agents|mesh-ancestor
65483076|NCT01300754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65483077|NCT01300754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65483078|NCT01300754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65483079|NCT01300754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64497935|NCT01257802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497936|NCT01257802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64497937|NCT01257802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497938|NCT05607303|Estrogens|estrogens|mesh-list
64497939|NCT05607303|Hormones|hormones|mesh-ancestor
64497940|NCT05607303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64497941|NCT05607303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497942|NCT00984009|Colchicine|colchicine|mesh-list
64497943|NCT00984009|Gout Suppressants|gout suppressants|mesh-ancestor
64497944|NCT00984009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64497945|NCT00984009|Tubulin Modulators|tubulin modulators|mesh-ancestor
64497946|NCT00984009|Antimitotic Agents|antimitotic agents|mesh-ancestor
64497947|NCT00984009|Mitosis Modulators|mitosis modulators|mesh-ancestor
64497948|NCT00984009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497949|NCT00984009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497951|NCT05604729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64497952|NCT05604729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64497953|NCT05604729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64497954|NCT05604729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64497955|NCT05604729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497956|NCT05604729|Cholinergic Agents|cholinergic agents|mesh-ancestor
64497957|NCT05604729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64497958|NCT05604729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483080|NCT01300754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65483081|NCT01300754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483082|NCT03840122|Anesthetics|anesthetics|mesh-list
65483083|NCT03840122|Anesthetics, Local|anesthetics, local|mesh-list
65483084|NCT03840122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65483085|NCT03840122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483086|NCT03840122|Sensory System Agents|sensory system agents|mesh-ancestor
65483087|NCT03840122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65483088|NCT03723590|Hyaluronic Acid|hyaluronic acid|mesh-list
65483089|NCT03723590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65483090|NCT03723590|Immunologic Factors|immunologic factors|mesh-ancestor
65483091|NCT03723590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483092|NCT03723590|Viscosupplements|viscosupplements|mesh-ancestor
65483093|NCT03723590|Protective Agents|protective agents|mesh-ancestor
65483094|NCT04343872|Metformin|metformin|mesh-list
65483095|NCT04343872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65483096|NCT04343872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483097|NCT01314274|Bevacizumab|bevacizumab|mesh-list
65483098|NCT01314274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64497959|NCT05604729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64497960|NCT05604729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64497961|NCT05606913|Dulaglutide|dulaglutide|mesh-list
64497962|NCT05606913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64497963|NCT05606913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497964|NCT00983931|Cyclosporine|cyclosporine|mesh-list
64497965|NCT00983931|Colchicine|colchicine|mesh-list
64497966|NCT00983931|Cyclosporins|cyclosporins|mesh-list
64497967|NCT00983931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497968|NCT00983931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497969|NCT00983931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64497970|NCT00983931|Immunologic Factors|immunologic factors|mesh-ancestor
64497971|NCT00983931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497984|NCT00983853|Antimetabolites|antimetabolites|mesh-ancestor
64497985|NCT00983853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497986|NCT00983853|Antiviral Agents|antiviral agents|mesh-ancestor
64497987|NCT00983853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64497988|NCT05604261|Rabeprazole|rabeprazole|mesh-list
64497989|NCT05604261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64497990|NCT05604261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64497991|NCT05604261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64723560|NCT00759577|Cholinergic Agents|cholinergic agents|mesh-ancestor
64723561|NCT00759577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723562|NCT00759577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723563|NCT00759577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723564|NCT00759577|Urological Agents|urological agents|mesh-ancestor
64723565|NCT00746239|Dexetimide|dexetimide|mesh-list
64723566|NCT00746239|Citalopram|citalopram|mesh-list
64723567|NCT00746239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64723574|NCT00746239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64497992|NCT05604261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497993|NCT05604261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497994|NCT03032601|Acetylcysteine|acetylcysteine|mesh-list
64497995|NCT03032601|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64497996|NCT03032601|Antiviral Agents|antiviral agents|mesh-ancestor
64497997|NCT03032601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64497998|NCT03032601|Expectorants|expectorants|mesh-ancestor
65483099|NCT01314274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483100|NCT01314274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65483101|NCT01314274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65483102|NCT01314274|Growth Substances|growth substances|mesh-ancestor
65483103|NCT01314274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483104|NCT01314274|Growth Inhibitors|growth inhibitors|mesh-ancestor
65483105|NCT02935894|Ibuprofen|ibuprofen|mesh-list
65483106|NCT02935894|Pilocarpine|pilocarpine|mesh-list
65483107|NCT02935894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65483108|NCT02935894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65483109|NCT02935894|Analgesics|analgesics|mesh-ancestor
65483110|NCT02935894|Sensory System Agents|sensory system agents|mesh-ancestor
65483111|NCT02935894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65483112|NCT02935894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483113|NCT02935894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65483114|NCT02935894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65483115|NCT02935894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64497999|NCT03032601|Respiratory System Agents|respiratory system agents|mesh-ancestor
64498000|NCT03032601|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64498001|NCT03032601|Antioxidants|antioxidants|mesh-ancestor
64498003|NCT03032601|Protective Agents|protective agents|mesh-ancestor
64498004|NCT03032601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498005|NCT03032601|Antidotes|antidotes|mesh-ancestor
64498006|NCT05603013|Vinorelbine|vinorelbine|mesh-list
64498007|NCT05603013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64498008|NCT05603013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64498010|NCT05603013|Tubulin Modulators|tubulin modulators|mesh-ancestor
64498011|NCT05603013|Antimitotic Agents|antimitotic agents|mesh-ancestor
64498012|NCT05603013|Mitosis Modulators|mitosis modulators|mesh-ancestor
64498013|NCT05603013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498014|NCT00983073|Tapentadol|tapentadol|mesh-list
64498015|NCT00983073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64498016|NCT00983073|Narcotics|narcotics|mesh-ancestor
64498017|NCT00983073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64498018|NCT00983073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498019|NCT00983073|Analgesics|analgesics|mesh-ancestor
64498020|NCT00983073|Sensory System Agents|sensory system agents|mesh-ancestor
64498021|NCT00983073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498022|NCT00983073|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64498023|NCT00983073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64498024|NCT00983073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64498025|NCT00983073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945650|NCT05379322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498026|NCT00983073|Adrenergic Agents|adrenergic agents|mesh-ancestor
64498027|NCT00983073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64498028|NCT05603715|Bromides|bromides|mesh-list
64498029|NCT05603715|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
64498030|NCT05603715|Anticonvulsants|anticonvulsants|mesh-ancestor
64498031|NCT05603715|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64498032|NCT05603715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64723575|NCT00746239|Antidepressive Agents|antidepressive agents|mesh-ancestor
64723576|NCT00746239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64723577|NCT00746239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64723578|NCT00746239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64723579|NCT00746239|Parasympatholytics|parasympatholytics|mesh-ancestor
64723580|NCT00746239|Autonomic Agents|autonomic agents|mesh-ancestor
64331193|NCT05789173|Efavirenz|efavirenz|mesh-list
65483116|NCT02935894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483117|NCT02935894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483118|NCT02935894|Miotics|miotics|mesh-ancestor
65483119|NCT02935894|Autonomic Agents|autonomic agents|mesh-ancestor
65483120|NCT02935894|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65483121|NCT02935894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65483122|NCT02935894|Cholinergic Agents|cholinergic agents|mesh-ancestor
65483123|NCT02935894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65483124|NCT03385226|Pembrolizumab|pembrolizumab|mesh-list
65483125|NCT03385226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65483126|NCT03385226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483127|NCT03224182|Apaziquone|apaziquone|mesh-list
65483128|NCT03224182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483129|NCT03821480|Fluconazole|fluconazole|mesh-list
65483130|NCT03821480|Antifungal Agents|antifungal agents|mesh-ancestor
65483131|NCT03821480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65483132|NCT03821480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64867148|NCT01808521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498033|NCT05603715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498034|NCT05603715|Cholinergic Agents|cholinergic agents|mesh-ancestor
64498035|NCT05603715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64498045|NCT00981747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64498046|NCT00981747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64498047|NCT00981747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64498048|NCT00981747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64498050|NCT03046251|Immunologic Factors|immunologic factors|mesh-ancestor
64498051|NCT03046251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498052|NCT03029169|Amiodarone|amiodarone|mesh-list
64498053|NCT03029169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64498054|NCT03029169|Propafenone|propafenone|mesh-list
64498063|NCT03029169|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64498064|NCT03029169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64498065|NCT03029169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64498066|NCT03029169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64498067|NCT01295710|Immunoglobulins|immunoglobulins|mesh-list
64498068|NCT01295710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64498069|NCT01295710|Immunologic Factors|immunologic factors|mesh-ancestor
64498070|NCT01295710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498071|NCT01295710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64498072|NCT01353976|Econazole|econazole|mesh-list
64498073|NCT01353976|Antifungal Agents|antifungal agents|mesh-ancestor
64498074|NCT01353976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64498075|NCT01353976|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64498076|NCT01353976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64498077|NCT01353976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498078|NCT01353976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498079|NCT01353976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64498080|NCT01353976|Hormone Antagonists|hormone antagonists|mesh-ancestor
64498081|NCT01353976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64498082|NCT01353976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498083|NCT01354444|Carvedilol|carvedilol|mesh-list
64498084|NCT01354444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64498085|NCT01354444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64498086|NCT01354444|Adrenergic Agents|adrenergic agents|mesh-ancestor
64498087|NCT01354444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65483133|NCT03821480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65483134|NCT03821480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483135|NCT03821480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483136|NCT03821480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65483137|NCT03821480|Hormone Antagonists|hormone antagonists|mesh-ancestor
65483138|NCT03821480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65483139|NCT03821480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483140|NCT03821480|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65483141|NCT03821480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65483142|NCT01203488|Vitamin A|vitamin a|mesh-list
65483143|NCT01203488|Vitamins|vitamins|mesh-ancestor
65483144|NCT01203488|Micronutrients|micronutrients|mesh-ancestor
65483145|NCT01203488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483146|NCT03697720|Naproxen|naproxen|mesh-list
65483147|NCT03697720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65483148|NCT03697720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65483149|NCT03697720|Analgesics|analgesics|mesh-ancestor
64867165|NCT01808586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867167|NCT01808586|Anesthetics|anesthetics|mesh-ancestor
64498088|NCT01354444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498089|NCT01354444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498090|NCT01354444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64498091|NCT01354444|Antioxidants|antioxidants|mesh-ancestor
64498092|NCT01354444|Protective Agents|protective agents|mesh-ancestor
64498093|NCT01354444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64498094|NCT01354444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64498095|NCT01354444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64498096|NCT01354444|Vasodilator Agents|vasodilator agents|mesh-ancestor
64498097|NCT01354444|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64498111|NCT03009526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64498113|NCT01354990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64498114|NCT01354990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64723581|NCT00746239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64723582|NCT00746239|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64723583|NCT00746239|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64723584|NCT00746239|Cholinergic Agents|cholinergic agents|mesh-ancestor
64723585|NCT04977674|Naltrexone|naltrexone|mesh-list
64723586|NCT04977674|Ketamine|ketamine|mesh-list
64723587|NCT04977674|Analgesics|analgesics|mesh-ancestor
64723588|NCT04977674|Sensory System Agents|sensory system agents|mesh-ancestor
64723589|NCT04977674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64723590|NCT04977674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723591|NCT04977674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64723592|NCT04977674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64723593|NCT04977674|Anesthetics, General|anesthetics, general|mesh-ancestor
64723594|NCT04977674|Anesthetics|anesthetics|mesh-ancestor
64723595|NCT04977674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64723596|NCT04977674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64723597|NCT04977674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64498118|NCT01354990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64498119|NCT01354990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64498120|NCT01354990|Protease Inhibitors|protease inhibitors|mesh-ancestor
65483150|NCT03697720|Sensory System Agents|sensory system agents|mesh-ancestor
65483151|NCT03697720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65483152|NCT03697720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483153|NCT03697720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65483154|NCT03697720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65483155|NCT03697720|Gout Suppressants|gout suppressants|mesh-ancestor
65483156|NCT03697720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65483157|NCT03697720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483158|NCT03697720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483159|NCT01314352|Desloratadine|desloratadine|mesh-list
65483160|NCT01314352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65232668|NCT02855294|Diuretics|diuretics|mesh-ancestor
65483161|NCT01314352|Cholinergic Agents|cholinergic agents|mesh-ancestor
65483162|NCT01314352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65483163|NCT01314352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483164|NCT01314352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483165|NCT01314352|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64498121|NCT01354990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498122|NCT01354990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498123|NCT01260454|Capsaicin|capsaicin|mesh-list
64498124|NCT01260454|Antipruritics|antipruritics|mesh-ancestor
64498125|NCT01260454|Dermatologic Agents|dermatologic agents|mesh-ancestor
64498126|NCT01260454|Sensory System Agents|sensory system agents|mesh-ancestor
64498127|NCT01260454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498128|NCT01260454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498129|NCT01296646|Naltrexone|naltrexone|mesh-list
64498130|NCT01296646|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64498131|NCT01296646|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64498132|NCT01296646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498133|NCT01296646|Sensory System Agents|sensory system agents|mesh-ancestor
64498134|NCT01296646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498135|NCT01297348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64498136|NCT01297348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64498137|NCT01297348|Levonorgestrel|levonorgestrel|mesh-list
64498138|NCT01297348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64498139|NCT01297348|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
64498140|NCT01297348|Norinyl|norinyl|mesh-list
64498141|NCT01297348|Contraceptive Agents|contraceptive agents|mesh-list
64498142|NCT01297348|Contraceptives, Oral|contraceptives, oral|mesh-list
64498143|NCT01297348|Estradiol|estradiol|mesh-list
64723604|NCT04965038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64723605|NCT04965038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723606|NCT00402883|Folic Acid|folic acid|mesh-list
64723607|NCT00402883|Vitamin B 12|vitamin b 12|mesh-list
64723608|NCT00402883|Bevacizumab|bevacizumab|mesh-list
64723609|NCT00402883|Carboplatin|carboplatin|mesh-list
64723610|NCT00402883|Pemetrexed|pemetrexed|mesh-list
64723611|NCT00402883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64723612|NCT00402883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723613|NCT00402883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64723614|NCT00402883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64723615|NCT00402883|Growth Substances|growth substances|mesh-ancestor
64723616|NCT00402883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723617|NCT00402883|Growth Inhibitors|growth inhibitors|mesh-ancestor
64723618|NCT00402883|Vitamins|vitamins|mesh-ancestor
64723619|NCT00402883|Micronutrients|micronutrients|mesh-ancestor
65483166|NCT01314352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65483167|NCT01314352|Histamine Antagonists|histamine antagonists|mesh-ancestor
65483168|NCT01314352|Histamine Agents|histamine agents|mesh-ancestor
65483169|NCT03818282|Paclitaxel|paclitaxel|mesh-list
65483170|NCT03818282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65483171|NCT03818282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483172|NCT03818282|Tubulin Modulators|tubulin modulators|mesh-ancestor
65483173|NCT03818282|Antimitotic Agents|antimitotic agents|mesh-ancestor
65483174|NCT03818282|Mitosis Modulators|mitosis modulators|mesh-ancestor
65483175|NCT03818282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483176|NCT01300364|Citalopram|citalopram|mesh-list
65483177|NCT01300364|Reboxetine|reboxetine|mesh-list
65483178|NCT01300364|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65483179|NCT01300364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65483180|NCT01300364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65483181|NCT01300364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483182|NCT01300364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65483183|NCT01300364|Serotonin Agents|serotonin agents|mesh-ancestor
65483184|NCT01300364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483185|NCT01300364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65483186|NCT01300364|Antidepressive Agents|antidepressive agents|mesh-ancestor
64867201|NCT01808898|Sensory System Agents|sensory system agents|mesh-ancestor
64867202|NCT01808898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64867203|NCT01808911|Cyclophosphamide|cyclophosphamide|mesh-list
64867204|NCT01808911|Rituximab|rituximab|mesh-list
64867205|NCT01808911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64723620|NCT00402883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498144|NCT01297348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64498145|NCT01297348|Estrogens|estrogens|mesh-ancestor
64498146|NCT01297348|Hormones|hormones|mesh-ancestor
64498147|NCT01297348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64498149|NCT01297348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64498150|NCT01297348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64498151|NCT01297348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64498152|NCT01297348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64498153|NCT01297348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64498154|NCT01297348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64498155|NCT01297348|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
64498156|NCT01856309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64498157|NCT01856309|Immunologic Factors|immunologic factors|mesh-ancestor
64498158|NCT01856309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498171|NCT01298128|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64498173|NCT01298128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64498174|NCT01298128|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64498175|NCT01298128|Progestins|progestins|mesh-ancestor
64498176|NCT01298128|Hormones|hormones|mesh-ancestor
65483187|NCT01300364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65483188|NCT01300364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65483189|NCT01300364|Adrenergic Agents|adrenergic agents|mesh-ancestor
65483190|NCT03221842|Complement C1s|complement c1s|mesh-list
65483191|NCT03221842|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
65483192|NCT03221842|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
65483193|NCT03221842|Immunologic Factors|immunologic factors|mesh-ancestor
65483194|NCT03221842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483195|NCT03221842|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65483196|NCT03221842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65483197|NCT05622890|Maytansine|maytansine|mesh-list
65483198|NCT05622890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65483199|NCT05622890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483200|NCT05622890|Tubulin Modulators|tubulin modulators|mesh-ancestor
65483201|NCT05622890|Antimitotic Agents|antimitotic agents|mesh-ancestor
65483202|NCT05622890|Mitosis Modulators|mitosis modulators|mesh-ancestor
65483203|NCT05622890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483204|NCT00303329|Deferasirox|deferasirox|mesh-list
64867222|NCT01809041|Anesthetics, General|anesthetics, general|mesh-ancestor
64867223|NCT01809041|Anesthetics|anesthetics|mesh-ancestor
64867224|NCT01809041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64867225|NCT01809041|Narcotics|narcotics|mesh-ancestor
64867226|NCT01809041|Analgesics|analgesics|mesh-ancestor
64867227|NCT01809041|Sensory System Agents|sensory system agents|mesh-ancestor
64867228|NCT01809041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64867229|NCT01809041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64867230|NCT01809041|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64867231|NCT01809158|Minocycline|minocycline|mesh-list
64867232|NCT01809158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64867233|NCT01809158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867234|NCT01809171|Vitamin D|vitamin d|mesh-list
64498177|NCT01298128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64498178|NCT02199964|Cyclosporine|cyclosporine|mesh-list
64498179|NCT02199964|Lubricant Eye Drops|lubricant eye drops|mesh-list
64498180|NCT02199964|Cyclosporins|cyclosporins|mesh-list
64498181|NCT02199964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498182|NCT02199964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498183|NCT02199964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64498184|NCT02199964|Immunologic Factors|immunologic factors|mesh-ancestor
64498185|NCT02199964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498186|NCT02199964|Antifungal Agents|antifungal agents|mesh-ancestor
64498187|NCT02199964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64498188|NCT02199964|Dermatologic Agents|dermatologic agents|mesh-ancestor
64498189|NCT02199964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64498190|NCT02199964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65483205|NCT00303329|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65483206|NCT00303329|Chelating Agents|chelating agents|mesh-ancestor
65483207|NCT00303329|Sequestering Agents|sequestering agents|mesh-ancestor
65483208|NCT00303329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483209|NCT01300988|Aprepitant|aprepitant|mesh-list
65483210|NCT01300988|Fosaprepitant|fosaprepitant|mesh-list
65483211|NCT01300988|Antiemetics|antiemetics|mesh-ancestor
65483212|NCT01300988|Autonomic Agents|autonomic agents|mesh-ancestor
65483213|NCT01300988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65483214|NCT01300988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483215|NCT01300988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65483216|NCT01300988|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65483217|NCT01300988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65483218|NCT01300988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483219|NCT01064999|Capecitabine|capecitabine|mesh-list
65483220|NCT01064999|Oxaliplatin|oxaliplatin|mesh-list
65483221|NCT01064999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65483222|NCT01064999|Antimetabolites|antimetabolites|mesh-ancestor
65483223|NCT01064999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483224|NCT01064999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483225|NCT03818048|Propofol|propofol|mesh-list
65483226|NCT03818048|Sevoflurane|sevoflurane|mesh-list
65483227|NCT03818048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64498191|NCT02199964|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64498192|NCT02199964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64723625|NCT00402883|Vitamin B Complex|vitamin b complex|mesh-ancestor
64723626|NCT04573478|Atrasentan|atrasentan|mesh-list
64723627|NCT04573478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723628|NCT04573478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64723629|NCT04573478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64723630|NCT04573478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723631|NCT04939844|Lenalidomide|lenalidomide|mesh-list
64723632|NCT04939844|Bortezomib|bortezomib|mesh-list
64723633|NCT04939844|Immunologic Factors|immunologic factors|mesh-ancestor
64723634|NCT04939844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723635|NCT04939844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64723636|NCT04939844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64723637|NCT04939844|Growth Substances|growth substances|mesh-ancestor
64723638|NCT04939844|Growth Inhibitors|growth inhibitors|mesh-ancestor
64723639|NCT04939844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723640|NCT05295212|Atezolizumab|atezolizumab|mesh-list
64723641|NCT05295212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331236|NCT05786599|Narcotics|narcotics|mesh-ancestor
64498193|NCT02323048|Methamphetamine|methamphetamine|mesh-list
64498194|NCT02323048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64498195|NCT02323048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498196|NCT02323048|Sympathomimetics|sympathomimetics|mesh-ancestor
64498197|NCT02323048|Autonomic Agents|autonomic agents|mesh-ancestor
64498198|NCT02323048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498199|NCT02323048|Dopamine Agents|dopamine agents|mesh-ancestor
64498200|NCT02323048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64498201|NCT02323048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483228|NCT03818048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65483229|NCT03818048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483230|NCT03818048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65483231|NCT03818048|Anesthetics, General|anesthetics, general|mesh-ancestor
65483232|NCT03818048|Anesthetics|anesthetics|mesh-ancestor
65483233|NCT03818048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65232745|NCT00954512|Leucovorin|leucovorin|mesh-list
65483234|NCT03818048|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65483235|NCT01301924|Meglumine Antimoniate|meglumine antimoniate|mesh-list
65483236|NCT01301924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65483237|NCT01301924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65483238|NCT01301924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65483239|NCT00329849|Vaccines|vaccines|mesh-list
65483240|NCT00329849|Immunologic Factors|immunologic factors|mesh-ancestor
65483241|NCT00329849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483242|NCT05655806|Aminophylline|aminophylline|mesh-list
65483243|NCT05655806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65483244|NCT05655806|Autonomic Agents|autonomic agents|mesh-ancestor
65483245|NCT05655806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65483246|NCT05655806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483247|NCT05655806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64498202|NCT02323048|Adrenergic Agents|adrenergic agents|mesh-ancestor
64498203|NCT02323048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64498204|NCT02323048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64498205|NCT02323048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64498206|NCT02323048|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64498207|NCT01265446|Lidocaine|lidocaine|mesh-list
64498208|NCT01265446|Anesthetics, Local|anesthetics, local|mesh-ancestor
64498209|NCT01265446|Anesthetics|anesthetics|mesh-ancestor
64498210|NCT01265446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64498211|NCT01265446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498212|NCT01265446|Sensory System Agents|sensory system agents|mesh-ancestor
64498213|NCT01265446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64723649|NCT05286320|Lenvatinib|lenvatinib|mesh-list
64723650|NCT05286320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64723651|NCT05286320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723652|NCT05286320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64723653|NCT05286320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419131|NCT05529355|Growth Inhibitors|growth inhibitors|mesh-ancestor
64498214|NCT01265446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64498215|NCT01265446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64498216|NCT01265446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64498217|NCT01265446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64498218|NCT01265446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498219|NCT04352062|Amoxicillin|amoxicillin|mesh-list
64498220|NCT04352062|Levofloxacin|levofloxacin|mesh-list
64498221|NCT04352062|Ofloxacin|ofloxacin|mesh-list
64498222|NCT04352062|Melatonin|melatonin|mesh-list
64498223|NCT04352062|Pantoprazole|pantoprazole|mesh-list
64498224|NCT04352062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64498237|NCT04352062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64498238|NCT04352062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64498239|NCT04352062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64498240|NCT04352062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64945652|NCT05351801|Dronabinol|dronabinol|mesh-list
65483248|NCT05655806|Respiratory System Agents|respiratory system agents|mesh-ancestor
65483249|NCT05655806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65483250|NCT05655806|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65483251|NCT05655806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483252|NCT05655806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483253|NCT05655806|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65483254|NCT05655806|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65483255|NCT05655806|Purinergic Agents|purinergic agents|mesh-ancestor
65483256|NCT05655806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65483257|NCT05655806|Protective Agents|protective agents|mesh-ancestor
65483258|NCT01300676|Estradiol|estradiol|mesh-list
65483259|NCT01300676|Dydrogesterone|dydrogesterone|mesh-list
65483260|NCT01300676|Estrogens|estrogens|mesh-ancestor
65483261|NCT01300676|Hormones|hormones|mesh-ancestor
65483262|NCT01300676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65483263|NCT01300676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483264|NCT01300676|Progestins|progestins|mesh-ancestor
65483265|NCT03113968|Ketamine|ketamine|mesh-list
65483266|NCT03113968|Analgesics|analgesics|mesh-ancestor
65483267|NCT03113968|Sensory System Agents|sensory system agents|mesh-ancestor
65483268|NCT03113968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64867283|NCT01809444|Glucocorticoids|glucocorticoids|mesh-ancestor
64498241|NCT04352062|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64498242|NCT01302808|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64498243|NCT01302808|Romidepsin|romidepsin|mesh-list
64498244|NCT01302808|Antiemetics|antiemetics|mesh-list
64498245|NCT01302808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498246|NCT01302808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64498247|NCT01302808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498248|NCT01302808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498249|NCT01302808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64498250|NCT01302808|Autonomic Agents|autonomic agents|mesh-ancestor
64498251|NCT01302808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498252|NCT01302808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498253|NCT01302808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64498254|NCT01267240|Capecitabine|capecitabine|mesh-list
64498255|NCT01267240|Vorinostat|vorinostat|mesh-list
64498256|NCT01267240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64498257|NCT01267240|Antimetabolites|antimetabolites|mesh-ancestor
64498258|NCT01267240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498259|NCT01267240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498260|NCT01267240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64498261|NCT01267240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498262|NCT01855919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64498263|NCT01855919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64498264|NCT01855919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64498265|NCT01855919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64498266|NCT01855919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498267|NCT01855919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64498268|NCT01855919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498269|NCT01855919|Analgesics|analgesics|mesh-ancestor
64498270|NCT01855919|Sensory System Agents|sensory system agents|mesh-ancestor
65483269|NCT03113968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483270|NCT03113968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65483271|NCT03113968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65483272|NCT03113968|Anesthetics, General|anesthetics, general|mesh-ancestor
65483273|NCT03113968|Anesthetics|anesthetics|mesh-ancestor
65483274|NCT03113968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65483275|NCT03113968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65483276|NCT03113968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65483277|NCT03113968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65483278|NCT03113968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483279|NCT00329303|Certolizumab Pegol|certolizumab pegol|mesh-list
65483280|NCT00329303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65483281|NCT00329303|Immunologic Factors|immunologic factors|mesh-ancestor
65483282|NCT00329303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483283|NCT00329303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65483284|NCT03806816|Melatonin|melatonin|mesh-list
65483285|NCT03806816|Antioxidants|antioxidants|mesh-ancestor
65483286|NCT03806816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483287|NCT03806816|Protective Agents|protective agents|mesh-ancestor
65483288|NCT03806816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483289|NCT03806816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65483290|NCT01301222|Octreotide|octreotide|mesh-list
65483291|NCT01301222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65483292|NCT01301222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65483293|NCT01301222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483294|NCT02864992|Tepotinib|tepotinib|mesh-list
65483295|NCT02864992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483296|NCT02532569|Vaccines|vaccines|mesh-list
65483297|NCT02532569|Immunologic Factors|immunologic factors|mesh-ancestor
65483298|NCT02532569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483314|NCT03814616|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65483315|NCT03814616|Anthelmintics|anthelmintics|mesh-ancestor
65483316|NCT00302159|Temozolomide|temozolomide|mesh-list
65483317|NCT00302159|Valproic Acid|valproic acid|mesh-list
65483318|NCT00302159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65483319|NCT00302159|Alkylating Agents|alkylating agents|mesh-ancestor
65483320|NCT00302159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483321|NCT00302159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483322|NCT00302159|Anticonvulsants|anticonvulsants|mesh-ancestor
65483323|NCT00302159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483324|NCT00302159|GABA Agents|gaba agents|mesh-ancestor
65483325|NCT00302159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65483326|NCT00302159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483327|NCT00302159|Antimanic Agents|antimanic agents|mesh-ancestor
65483328|NCT00302159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65483329|NCT00302159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65483330|NCT00302159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65483331|NCT03814226|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
65483332|NCT03814226|Growth Substances|growth substances|mesh-ancestor
65483333|NCT03814226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483334|NCT03814226|Vasodilator Agents|vasodilator agents|mesh-ancestor
65483335|NCT03814226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65483336|NCT03814226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483337|NCT00302081|Ribavirin|ribavirin|mesh-list
65483338|NCT00302081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64498271|NCT01855919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498272|NCT01855919|Antidepressive Agents|antidepressive agents|mesh-ancestor
64498273|NCT01855919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64723659|NCT00728845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64723660|NCT00728845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723661|NCT00728845|Tubulin Modulators|tubulin modulators|mesh-ancestor
64723662|NCT00728845|Antimitotic Agents|antimitotic agents|mesh-ancestor
64723663|NCT00728845|Mitosis Modulators|mitosis modulators|mesh-ancestor
64723664|NCT00728845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498274|NCT01855919|Dopamine Agents|dopamine agents|mesh-ancestor
64498275|NCT01871285|Morphine|morphine|mesh-list
64498276|NCT01871285|Oxycodone|oxycodone|mesh-list
64498277|NCT01871285|Buprenorphine|buprenorphine|mesh-list
64498278|NCT01871285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64498279|NCT01871285|Narcotics|narcotics|mesh-ancestor
64498280|NCT01871285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64498281|NCT01871285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498282|NCT01871285|Analgesics|analgesics|mesh-ancestor
64498307|NCT01267864|Metoclopramide|metoclopramide|mesh-list
64498308|NCT01267864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64498309|NCT01267864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64498310|NCT01267864|Analgesics|analgesics|mesh-ancestor
64498311|NCT01267864|Sensory System Agents|sensory system agents|mesh-ancestor
64498312|NCT01267864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65483339|NCT00302081|Interferon-alpha|interferon-alpha|mesh-list
65483340|NCT00302081|Antimetabolites|antimetabolites|mesh-ancestor
65483341|NCT00302081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483342|NCT00302081|Antiviral Agents|antiviral agents|mesh-ancestor
65483343|NCT00302081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65483344|NCT00302081|Immunologic Factors|immunologic factors|mesh-ancestor
65483345|NCT00302081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483346|NCT00302003|Cytarabine|cytarabine|mesh-list
65483347|NCT00302003|Dexamethasone|dexamethasone|mesh-list
65483348|NCT00302003|Prednisone|prednisone|mesh-list
65483349|NCT00302003|Cyclophosphamide|cyclophosphamide|mesh-list
65483350|NCT00302003|Ifosfamide|ifosfamide|mesh-list
65483351|NCT00302003|Doxorubicin|doxorubicin|mesh-list
65483352|NCT00302003|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65483353|NCT00302003|Etoposide|etoposide|mesh-list
65483354|NCT00302003|Vincristine|vincristine|mesh-list
65483355|NCT00302003|Vinorelbine|vinorelbine|mesh-list
65483356|NCT00302003|Etoposide phosphate|etoposide phosphate|mesh-list
65483357|NCT00302003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65483358|NCT00302003|Immunologic Factors|immunologic factors|mesh-ancestor
65483359|NCT00302003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483360|NCT00302003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65483361|NCT00302003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65483362|NCT00302003|Alkylating Agents|alkylating agents|mesh-ancestor
65483363|NCT00302003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483364|NCT00302003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483365|NCT00302003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65483366|NCT00302003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65483367|NCT00302003|Antiemetics|antiemetics|mesh-ancestor
65483368|NCT00302003|Autonomic Agents|autonomic agents|mesh-ancestor
65483369|NCT00302003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65483370|NCT00302003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65483371|NCT00302003|Glucocorticoids|glucocorticoids|mesh-ancestor
65483372|NCT00302003|Hormones|hormones|mesh-ancestor
65483373|NCT00302003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65483374|NCT00302003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65483375|NCT00302003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64498313|NCT01267864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483376|NCT00302003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65483377|NCT00302003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65483378|NCT00302003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483379|NCT00302003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65483380|NCT00302003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65483381|NCT00302003|Antimetabolites|antimetabolites|mesh-ancestor
65483382|NCT00302003|Antiviral Agents|antiviral agents|mesh-ancestor
65483383|NCT00302003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65483384|NCT00302003|Tubulin Modulators|tubulin modulators|mesh-ancestor
65483385|NCT00302003|Antimitotic Agents|antimitotic agents|mesh-ancestor
65483386|NCT00302003|Mitosis Modulators|mitosis modulators|mesh-ancestor
65483387|NCT00036270|Tamoxifen|tamoxifen|mesh-list
65483388|NCT00036270|Exemestane|exemestane|mesh-list
65483389|NCT00036270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65483390|NCT00036270|Hormone Antagonists|hormone antagonists|mesh-ancestor
65483391|NCT00036270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65483392|NCT00036270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483393|NCT00036270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65483394|NCT00036270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483395|NCT00036270|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65483396|NCT00036270|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65483397|NCT00036270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65483398|NCT00036270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65483399|NCT00036270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65483400|NCT00036270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483401|NCT00036270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483402|NCT01097382|Zolpidem|zolpidem|mesh-list
65483403|NCT01097382|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65483404|NCT01097382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65483405|NCT01097382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65483406|NCT01097382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483407|NCT01097382|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65483408|NCT01097382|GABA Agonists|gaba agonists|mesh-ancestor
65483409|NCT01097382|GABA Agents|gaba agents|mesh-ancestor
65483410|NCT01097382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64498314|NCT01267864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65483412|NCT00049530|Interferons|interferons|mesh-list
65483413|NCT00049530|Interferon-alpha|interferon-alpha|mesh-list
65483414|NCT00049530|Interferon alpha-2|interferon alpha-2|mesh-list
65483415|NCT00049530|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65483416|NCT00049530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483417|NCT00049530|Antiviral Agents|antiviral agents|mesh-ancestor
65483418|NCT00049530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65483419|NCT00049530|Immunologic Factors|immunologic factors|mesh-ancestor
65483420|NCT00049530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483421|NCT00301067|Calcitriol|calcitriol|mesh-list
65483422|NCT00301067|Temozolomide|temozolomide|mesh-list
65483423|NCT00301067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65483424|NCT00301067|Alkylating Agents|alkylating agents|mesh-ancestor
65483425|NCT00301067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483426|NCT00301067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483427|NCT00301067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65483428|NCT00301067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483429|NCT00301067|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65483430|NCT00301067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65483431|NCT00301067|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65483432|NCT00301067|Vitamins|vitamins|mesh-ancestor
65483433|NCT00301067|Micronutrients|micronutrients|mesh-ancestor
65483434|NCT00301067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65483435|NCT03979859|Nafithromycin|nafithromycin|mesh-list
65483436|NCT03979859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64867428|NCT01810458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64498315|NCT01267864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64498316|NCT01267864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64945653|NCT05351801|Nabiximols|nabiximols|mesh-list
64945654|NCT05351801|Hallucinogens|hallucinogens|mesh-ancestor
64945655|NCT05351801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945656|NCT05351801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64945657|NCT05351801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64945658|NCT05351801|Analgesics|analgesics|mesh-ancestor
64945659|NCT05351801|Sensory System Agents|sensory system agents|mesh-ancestor
64945660|NCT05351801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64945661|NCT05351801|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64945662|NCT05351801|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64498317|NCT01267864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498318|NCT01267864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498319|NCT01267864|Anticonvulsants|anticonvulsants|mesh-ancestor
64498320|NCT01267864|GABA Agents|gaba agents|mesh-ancestor
64498321|NCT01267864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64498322|NCT01267864|Antimanic Agents|antimanic agents|mesh-ancestor
64498323|NCT01267864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64498324|NCT01267864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64498325|NCT01267864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64498326|NCT01267864|Antiemetics|antiemetics|mesh-ancestor
64498327|NCT01267864|Autonomic Agents|autonomic agents|mesh-ancestor
64498328|NCT01267864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65483437|NCT03979859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65483438|NCT03979859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65483439|NCT03979859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483440|NCT03979859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483441|NCT03955458|Bupivacaine|bupivacaine|mesh-list
65483442|NCT03955458|Ropivacaine|ropivacaine|mesh-list
65483443|NCT03955458|Anesthetics, Local|anesthetics, local|mesh-ancestor
65483444|NCT03955458|Anesthetics|anesthetics|mesh-ancestor
65483445|NCT03955458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65483446|NCT03955458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483447|NCT03955458|Sensory System Agents|sensory system agents|mesh-ancestor
65483448|NCT03955458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65483449|NCT00007020|Cholic Acids|cholic acids|mesh-list
65483450|NCT00007020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65483451|NCT00300755|Pantoprazole|pantoprazole|mesh-list
65483452|NCT00300755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65483453|NCT00300755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65483454|NCT00300755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65483455|NCT00300755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483456|NCT00300755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483457|NCT00033540|Gemcitabine|gemcitabine|mesh-list
65483458|NCT00033540|Capecitabine|capecitabine|mesh-list
65483459|NCT00033540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65483460|NCT00033540|Antimetabolites|antimetabolites|mesh-ancestor
65483461|NCT00033540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483462|NCT00033540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483463|NCT00033540|Antiviral Agents|antiviral agents|mesh-ancestor
65483464|NCT00033540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65483465|NCT00033540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483466|NCT00033540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65483481|NCT00300365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65483482|NCT00300365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483483|NCT00300365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65483484|NCT00300365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65483485|NCT00300365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483486|NCT00300365|Antipyretics|antipyretics|mesh-ancestor
65483487|NCT00300365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65483488|NCT00300365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65483489|NCT00300365|Antimetabolites|antimetabolites|mesh-ancestor
65483490|NCT00300365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65483491|NCT00300365|Vasodilator Agents|vasodilator agents|mesh-ancestor
65483492|NCT00300365|Vitamin B Complex|vitamin b complex|mesh-ancestor
65483493|NCT00300365|Vitamins|vitamins|mesh-ancestor
65483494|NCT00300365|Micronutrients|micronutrients|mesh-ancestor
65483495|NCT03980015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65483496|NCT03980015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65483497|NCT00048048|Epoetin Alfa|epoetin alfa|mesh-list
65483498|NCT00048048|Hematinics|hematinics|mesh-ancestor
65483499|NCT03953118|Azithromycin|azithromycin|mesh-list
65483500|NCT03953118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65483501|NCT03953118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65483502|NCT01101204|Metformin|metformin|mesh-list
65483503|NCT01101204|Simvastatin|simvastatin|mesh-list
65483504|NCT01101204|Fenofibrate|fenofibrate|mesh-list
65483505|NCT01101204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65483506|NCT01101204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483507|NCT01101204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65483508|NCT01101204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65483509|NCT01101204|Antimetabolites|antimetabolites|mesh-ancestor
65483510|NCT01101204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483511|NCT01101204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65483512|NCT01101204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65483513|NCT01101204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483514|NCT01095822|Valsartan|valsartan|mesh-list
65483515|NCT01095822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65483516|NCT01095822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64867504|NCT01811056|Mifepristone|mifepristone|mesh-list
64498329|NCT01267864|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64498330|NCT01267864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64498331|NCT01267864|Dopamine Agents|dopamine agents|mesh-ancestor
64498332|NCT01854827|Immunoglobulins|immunoglobulins|mesh-list
65483517|NCT01095822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65483518|NCT01095822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483519|NCT01095900|Botulinum Toxins|botulinum toxins|mesh-list
65483520|NCT01095900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65483521|NCT01095900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65483522|NCT01095900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483523|NCT01095900|Cholinergic Agents|cholinergic agents|mesh-ancestor
65483524|NCT01095900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65483525|NCT01095900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483526|NCT00300053|Lenograstim|lenograstim|mesh-list
65483527|NCT00300053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65483528|NCT00300053|Immunologic Factors|immunologic factors|mesh-ancestor
65483529|NCT00300053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483530|NCT01098084|Decitabine|decitabine|mesh-list
65483531|NCT01098084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65483532|NCT01098084|Antimetabolites|antimetabolites|mesh-ancestor
65483533|NCT01098084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483534|NCT01098084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483535|NCT01098084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483536|NCT03952572|Prednisone|prednisone|mesh-list
65483537|NCT03952572|Cyclophosphamide|cyclophosphamide|mesh-list
65483538|NCT03952572|Doxorubicin|doxorubicin|mesh-list
65483539|NCT03952572|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65483540|NCT03952572|Vincristine|vincristine|mesh-list
65483541|NCT03952572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65483542|NCT03952572|Immunologic Factors|immunologic factors|mesh-ancestor
65483543|NCT03952572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483544|NCT03952572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65483545|NCT03952572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65483546|NCT03952572|Alkylating Agents|alkylating agents|mesh-ancestor
64867531|NCT01811251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64867532|NCT01811251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498333|NCT01854827|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64498334|NCT01854827|Antibodies|antibodies|mesh-list
64498335|NCT01854827|gamma-Globulins|gamma-globulins|mesh-list
64498336|NCT01854827|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64498355|NCT01303744|Sensory System Agents|sensory system agents|mesh-ancestor
64498356|NCT01303744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498357|NCT01303744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498358|NCT01303744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64498359|NCT01303744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65483547|NCT03952572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483548|NCT03952572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483549|NCT03952572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65483550|NCT03952572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65483551|NCT03952572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65483552|NCT03952572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65483553|NCT03952572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483554|NCT03952572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65483555|NCT03952572|Glucocorticoids|glucocorticoids|mesh-ancestor
65483556|NCT03952572|Hormones|hormones|mesh-ancestor
65483557|NCT03952572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65483558|NCT03952572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65483559|NCT03952572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65483560|NCT03952572|Tubulin Modulators|tubulin modulators|mesh-ancestor
65483561|NCT03952572|Antimitotic Agents|antimitotic agents|mesh-ancestor
65483562|NCT03952572|Mitosis Modulators|mitosis modulators|mesh-ancestor
65483563|NCT03954756|Apatinib|apatinib|mesh-list
65483564|NCT03954756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483565|NCT03954756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65483566|NCT03954756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483567|NCT03954756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498360|NCT01303744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64723665|NCT00728845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64723666|NCT00728845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64723667|NCT00728845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64723669|NCT00728845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723670|NCT00728845|Growth Inhibitors|growth inhibitors|mesh-ancestor
64723671|NCT00728845|Antimalarials|antimalarials|mesh-ancestor
64723672|NCT00728845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64723673|NCT00728845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64498361|NCT01303744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64498362|NCT01303744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64498363|NCT01303744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498364|NCT01303744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498365|NCT01361620|Aspirin|aspirin|mesh-list
64498371|NCT01361620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498372|NCT01361620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64498374|NCT01361620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64498375|NCT01361620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64498376|NCT01361620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498377|NCT01361620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64498378|NCT01361620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64498380|NCT01361620|Antipyretics|antipyretics|mesh-ancestor
64498381|NCT01305772|Panitumumab|panitumumab|mesh-list
64498382|NCT01305772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64498383|NCT01305772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498384|NCT01271452|Botulinum Toxins|botulinum toxins|mesh-list
64945663|NCT05351801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64498385|NCT01271452|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64498386|NCT01271452|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64498387|NCT01271452|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65483568|NCT00326963|Enfuvirtide|enfuvirtide|mesh-list
65483569|NCT00326963|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65483570|NCT00326963|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65483571|NCT00326963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483572|NCT00326963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65483573|NCT00326963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65483574|NCT00326963|Antiviral Agents|antiviral agents|mesh-ancestor
65483575|NCT00326963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65483576|NCT00326885|Catumaxomab|catumaxomab|mesh-list
65483577|NCT00326885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65483578|NCT00326495|Cetuximab|cetuximab|mesh-list
65483579|NCT00326495|Sorafenib|sorafenib|mesh-list
65483580|NCT00326495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65483581|NCT00326495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483582|NCT00326495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65483583|NCT00326495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483584|NCT00326495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483585|NCT00326417|Cyclophosphamide|cyclophosphamide|mesh-list
64498388|NCT01271452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64498389|NCT01271452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498390|NCT01271452|Cholinergic Agents|cholinergic agents|mesh-ancestor
64498391|NCT01271452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64498392|NCT01271452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498422|NCT04605731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64498423|NCT04605731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498424|NCT01307956|Calcium, Dietary|calcium, dietary|mesh-list
64498425|NCT01307956|Leucovorin|leucovorin|mesh-list
64498426|NCT01307956|Folic Acid|folic acid|mesh-list
64498427|NCT01307956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64498428|NCT01307956|Panitumumab|panitumumab|mesh-list
64498429|NCT01307956|Fluorouracil|fluorouracil|mesh-list
64498430|NCT01307956|Oxaliplatin|oxaliplatin|mesh-list
64498431|NCT01307956|Antibodies|antibodies|mesh-list
64498432|NCT01307956|Immunoglobulins|immunoglobulins|mesh-list
64498433|NCT01307956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64498434|NCT01307956|Calcium|calcium|mesh-list
64498435|NCT01307956|Levoleucovorin|levoleucovorin|mesh-list
64498436|NCT01307956|Immunologic Factors|immunologic factors|mesh-ancestor
64498437|NCT01307956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498438|NCT01307956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498439|NCT01307956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64498440|NCT01307956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64498457|NCT01870739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64498458|NCT01870739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64498459|NCT01870739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498460|NCT01870739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64498461|NCT01870739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723674|NCT00728845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64723675|NCT00728845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64723676|NCT00728845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64723677|NCT00726037|Denileukin diftitox|denileukin diftitox|mesh-list
64723678|NCT00726037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498462|NCT01870739|Vasodilator Agents|vasodilator agents|mesh-ancestor
64498463|NCT01870739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64498464|NCT01870739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64498465|NCT01272388|Tadalafil|tadalafil|mesh-list
64498466|NCT01272388|Vasodilator Agents|vasodilator agents|mesh-ancestor
65483586|NCT00326417|Fludarabine|fludarabine|mesh-list
65483587|NCT00326417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65483588|NCT00326417|Immunologic Factors|immunologic factors|mesh-ancestor
65483589|NCT00326417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483590|NCT00326417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65483591|NCT00326417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65483592|NCT00326417|Alkylating Agents|alkylating agents|mesh-ancestor
65483593|NCT00326417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483594|NCT00326417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483595|NCT00326417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65483596|NCT01060787|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
65483597|NCT01060787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65483598|NCT01060787|Glucocorticoids|glucocorticoids|mesh-ancestor
65483599|NCT01060787|Hormones|hormones|mesh-ancestor
65483600|NCT01060787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65483601|NCT01060787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483602|NCT01065467|Panobinostat|panobinostat|mesh-list
65483603|NCT01065467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483604|NCT01065467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65483605|NCT01065467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483606|NCT01065467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483607|NCT01065545|Clofarabine|clofarabine|mesh-list
65483608|NCT01065545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65483609|NCT01065545|Antimetabolites|antimetabolites|mesh-ancestor
65483610|NCT01065545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483611|NCT01065545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483612|NCT03979469|Fentanyl|fentanyl|mesh-list
65483613|NCT03979469|Dexmedetomidine|dexmedetomidine|mesh-list
65483614|NCT03979469|Ketamine|ketamine|mesh-list
65483615|NCT03979469|Remifentanil|remifentanil|mesh-list
65483616|NCT03979469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65483617|NCT03979469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65483619|NCT03979469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65483626|NCT03979469|Adrenergic Agents|adrenergic agents|mesh-ancestor
65483627|NCT03979469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65483628|NCT03979469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483629|NCT03979469|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65483630|NCT03979469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65483631|NCT03979469|Anesthetics, General|anesthetics, general|mesh-ancestor
65483632|NCT03979469|Anesthetics|anesthetics|mesh-ancestor
65483633|NCT03979469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65483634|NCT03979469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65483635|NCT03979469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65483636|NCT03979469|Narcotics|narcotics|mesh-ancestor
65483637|NCT03979469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65483638|NCT01065701|Dexmedetomidine|dexmedetomidine|mesh-list
65483639|NCT01065701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65483640|NCT01065701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65483641|NCT01065701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483642|NCT01065701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65483643|NCT01065701|Analgesics|analgesics|mesh-ancestor
65483644|NCT01065701|Sensory System Agents|sensory system agents|mesh-ancestor
65483645|NCT01065701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65483646|NCT01065701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64498467|NCT01272388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64498468|NCT01272388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64498469|NCT01272388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498470|NCT01272388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498471|NCT01272388|Urological Agents|urological agents|mesh-ancestor
64498472|NCT01364584|Exenatide|exenatide|mesh-list
64498473|NCT01364584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64498474|NCT01364584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498475|NCT01364584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64498480|NCT01870583|Chlorhexidine|chlorhexidine|mesh-list
64498481|NCT01870583|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64498482|NCT01870583|Cadexomer iodine|cadexomer iodine|mesh-list
64498483|NCT01870583|Povidone|povidone|mesh-list
64498484|NCT01870583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64498485|NCT01870583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64498486|NCT01870583|Disinfectants|disinfectants|mesh-ancestor
64498487|NCT01870583|Dermatologic Agents|dermatologic agents|mesh-ancestor
64498488|NCT01870583|Trace Elements|trace elements|mesh-ancestor
64498489|NCT01870583|Micronutrients|micronutrients|mesh-ancestor
64498490|NCT01870583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498491|NCT01870583|Plasma Substitutes|plasma substitutes|mesh-ancestor
64498492|NCT01870583|Blood Substitutes|blood substitutes|mesh-ancestor
64498493|NCT04351594|Menthol|menthol|mesh-list
64498494|NCT04351594|Antipruritics|antipruritics|mesh-ancestor
64498495|NCT04351594|Dermatologic Agents|dermatologic agents|mesh-ancestor
64498496|NCT01308814|Estradiol|estradiol|mesh-list
64498497|NCT01308814|Estrogens|estrogens|mesh-ancestor
64498498|NCT01308814|Hormones|hormones|mesh-ancestor
64498499|NCT01308814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64498500|NCT01308814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498501|NCT03009604|Simethicone|simethicone|mesh-list
64498502|NCT03009604|Antifoaming Agents|antifoaming agents|mesh-ancestor
64498520|NCT01275664|Glucocorticoids|glucocorticoids|mesh-ancestor
64498521|NCT01275664|Hormones|hormones|mesh-ancestor
65483647|NCT01065701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65483648|NCT01065701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65483649|NCT01065701|Adrenergic Agents|adrenergic agents|mesh-ancestor
65483650|NCT01065701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65483651|NCT01065701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483652|NCT03825341|Hydroxyurea|hydroxyurea|mesh-list
65483653|NCT03825341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483654|NCT03825341|Antisickling Agents|antisickling agents|mesh-ancestor
65483655|NCT03825341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483656|NCT03825341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483657|NCT03825341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65483658|NCT01065857|Picosulfate sodium|picosulfate sodium|mesh-list
65483659|NCT01065857|Sodium sulfate|sodium sulfate|mesh-list
65483660|NCT01065857|Magnesium Oxide|magnesium oxide|mesh-list
65483661|NCT01065857|Citric Acid|citric acid|mesh-list
65483662|NCT01065857|Sodium Citrate|sodium citrate|mesh-list
65483663|NCT01065857|Cathartics|cathartics|mesh-ancestor
65483664|NCT01065857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65483665|NCT01065857|Anticoagulants|anticoagulants|mesh-ancestor
65483666|NCT01065857|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64867666|NCT01812239|Hormones|hormones|mesh-ancestor
64498522|NCT01275664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64498523|NCT01275664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64498524|NCT01275664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498525|NCT01275664|Protease Inhibitors|protease inhibitors|mesh-ancestor
64498526|NCT01275664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498527|NCT01275664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498528|NCT01275664|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64498529|NCT01275664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64498530|NCT01275664|Dermatologic Agents|dermatologic agents|mesh-ancestor
64498531|NCT01275664|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64498534|NCT01613027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64498535|NCT01613027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498536|NCT01613027|Immunologic Factors|immunologic factors|mesh-ancestor
64498537|NCT01613027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498538|NCT01613027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64498539|NCT04595045|Botulinum Toxins|botulinum toxins|mesh-list
64498540|NCT04595045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64498541|NCT04595045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64498542|NCT04595045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64498543|NCT04595045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64498544|NCT04595045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498545|NCT04595045|Cholinergic Agents|cholinergic agents|mesh-ancestor
64498546|NCT04595045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723679|NCT05278676|Dotinurad|dotinurad|mesh-list
64723680|NCT05278676|Uricosuric Agents|uricosuric agents|mesh-ancestor
64723681|NCT05278676|Gout Suppressants|gout suppressants|mesh-ancestor
64723682|NCT05278676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64723683|NCT05278676|Renal Agents|renal agents|mesh-ancestor
64723684|NCT00703885|Alprazolam|alprazolam|mesh-list
64723685|NCT00703885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64723686|NCT00703885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64723687|NCT00703885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723688|NCT00703885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65483667|NCT01065857|Chelating Agents|chelating agents|mesh-ancestor
65483668|NCT01065857|Sequestering Agents|sequestering agents|mesh-ancestor
65483669|NCT01065857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483670|NCT01065857|Antacids|antacids|mesh-ancestor
65483671|NCT00297479|Nicotine|nicotine|mesh-list
65483672|NCT00297479|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65483673|NCT00297479|Autonomic Agents|autonomic agents|mesh-ancestor
65483674|NCT00297479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65483675|NCT00297479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483676|NCT00297479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65483677|NCT00297479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65483678|NCT00297479|Cholinergic Agents|cholinergic agents|mesh-ancestor
65483679|NCT00297479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65483680|NCT00297479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483681|NCT00688870|Vaccines|vaccines|mesh-list
65483682|NCT00688870|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65483683|NCT00688870|Immunologic Factors|immunologic factors|mesh-ancestor
65483684|NCT00688870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483685|NCT02532335|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
65483686|NCT02532335|Cathartics|cathartics|mesh-ancestor
65483687|NCT02532335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65483688|NCT03216226|Glucagon|glucagon|mesh-list
65483689|NCT03216226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65483691|NCT03216226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65483692|NCT03216226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483693|NCT00290771|Imatinib Mesylate|imatinib mesylate|mesh-list
65483694|NCT00290771|Hydroxyurea|hydroxyurea|mesh-list
65483695|NCT00290771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483696|NCT00290771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65483697|NCT00290771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483698|NCT00290771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483699|NCT00290771|Antisickling Agents|antisickling agents|mesh-ancestor
65483701|NCT00290693|Docetaxel|docetaxel|mesh-list
65483709|NCT00290693|Antimetabolites|antimetabolites|mesh-ancestor
65483710|NCT00274469|Fulvestrant|fulvestrant|mesh-list
65483711|NCT00274469|Anastrozole|anastrozole|mesh-list
65483712|NCT00274469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65483713|NCT00274469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483714|NCT00274469|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65483715|NCT00274469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65483716|NCT00274469|Hormone Antagonists|hormone antagonists|mesh-ancestor
65483717|NCT00274469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65483718|NCT00274469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483719|NCT00274469|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65483720|NCT00274469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65483721|NCT00274469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483722|NCT00274469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723689|NCT00703885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64723690|NCT00703885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64723691|NCT00703885|GABA Modulators|gaba modulators|mesh-ancestor
64498547|NCT04595045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498548|NCT04595045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64498549|NCT04595045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498550|NCT01369732|Epoetin Alfa|epoetin alfa|mesh-list
64498551|NCT01369732|Hematinics|hematinics|mesh-ancestor
64498552|NCT01869725|Octreotide|octreotide|mesh-list
64498553|NCT01869725|Edotreotide|edotreotide|mesh-list
64498554|NCT01869725|Indium-111-octreotide|indium-111-octreotide|mesh-list
64498555|NCT01869725|Somatostatin|somatostatin|mesh-list
64423979|NCT05081479|Acetylcysteine|acetylcysteine|mesh-list
64498559|NCT01869725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498560|NCT01869725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498561|NCT01869725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64498562|NCT01869725|Hormones|hormones|mesh-ancestor
64498563|NCT01869725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64498564|NCT01309360|Midazolam|midazolam|mesh-list
64498565|NCT01309360|Prilocaine|prilocaine|mesh-list
64498573|NCT01309360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64498575|NCT01309360|Anesthetics|anesthetics|mesh-ancestor
64498576|NCT01309360|GABA Modulators|gaba modulators|mesh-ancestor
64498577|NCT01309360|GABA Agents|gaba agents|mesh-ancestor
64498578|NCT01309360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64498579|NCT01309360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498580|NCT01309360|Anesthetics, Local|anesthetics, local|mesh-ancestor
64498581|NCT01309360|Sensory System Agents|sensory system agents|mesh-ancestor
64498582|NCT01309360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498583|NCT01851863|Flupenthixol|flupenthixol|mesh-list
64498584|NCT01851863|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
64498585|NCT01851863|Omeprazole|omeprazole|mesh-list
64498586|NCT01851863|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64498587|NCT01851863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64498588|NCT01851863|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64498589|NCT01851863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498590|NCT01851863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498591|NCT01851863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64498592|NCT01851863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64498593|NCT01851863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64498594|NCT01851863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498595|NCT01851863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64498596|NCT01851863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64498597|NCT01851863|Dopamine Agents|dopamine agents|mesh-ancestor
64498598|NCT01851863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64498599|NCT01369888|Cyclophosphamide|cyclophosphamide|mesh-list
64498601|NCT01369888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65483723|NCT01556776|Lenalidomide|lenalidomide|mesh-list
65483724|NCT01556776|Immunologic Factors|immunologic factors|mesh-ancestor
65483725|NCT01556776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483726|NCT01556776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65483727|NCT01556776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65483728|NCT01556776|Growth Substances|growth substances|mesh-ancestor
65483729|NCT01556776|Growth Inhibitors|growth inhibitors|mesh-ancestor
65483730|NCT01556776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483731|NCT02422498|Cisplatin|cisplatin|mesh-list
65483732|NCT02422498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483733|NCT01314976|Metronidazole|metronidazole|mesh-list
65483734|NCT01314976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65483735|NCT01314976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65483736|NCT01314976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65483737|NCT01314976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65483738|NCT02379520|Cyclophosphamide|cyclophosphamide|mesh-list
65483739|NCT02379520|Nivolumab|nivolumab|mesh-list
65483740|NCT02379520|Fludarabine|fludarabine|mesh-list
65483741|NCT02379520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65483742|NCT02379520|Immunologic Factors|immunologic factors|mesh-ancestor
65483743|NCT02379520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483744|NCT02379520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65483745|NCT02379520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65483746|NCT02379520|Alkylating Agents|alkylating agents|mesh-ancestor
65483747|NCT02379520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483748|NCT02379520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483749|NCT02379520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65483771|NCT04504942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65483772|NCT04504942|Antiviral Agents|antiviral agents|mesh-ancestor
65483773|NCT04504942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65483774|NCT01882816|Doxorubicin|doxorubicin|mesh-list
65483775|NCT01882816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65483776|NCT01882816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483777|NCT01882816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65483778|NCT01882816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65483779|NCT01882816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483780|NCT01882816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483781|NCT03648892|Raclopride|raclopride|mesh-list
65483782|NCT03648892|Fallypride|fallypride|mesh-list
65483783|NCT03648892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65483784|NCT03648892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65483785|NCT03648892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65483786|NCT03648892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483787|NCT03648892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65483788|NCT03648892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65483789|NCT03648892|Dopamine Agents|dopamine agents|mesh-ancestor
65483790|NCT03648892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65483791|NCT03648892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483792|NCT03648892|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65483793|NCT00272987|Paclitaxel|paclitaxel|mesh-list
65483794|NCT00272987|Trastuzumab|trastuzumab|mesh-list
65483795|NCT00272987|Lapatinib|lapatinib|mesh-list
65483796|NCT00272987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65483797|NCT00272987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483798|NCT00272987|Tubulin Modulators|tubulin modulators|mesh-ancestor
65483799|NCT00272987|Antimitotic Agents|antimitotic agents|mesh-ancestor
65483800|NCT00272987|Mitosis Modulators|mitosis modulators|mesh-ancestor
65483801|NCT00272987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483802|NCT00272987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65483803|NCT00272987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65483812|NCT01070927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483813|NCT03976271|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65483814|NCT03976271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483815|NCT01069913|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65483816|NCT01069913|Dermatologic Agents|dermatologic agents|mesh-ancestor
65483817|NCT01069913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65483818|NCT01069913|Immunologic Factors|immunologic factors|mesh-ancestor
65483819|NCT01069913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483820|NCT01730950|Bevacizumab|bevacizumab|mesh-list
65483821|NCT01730950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65483822|NCT01730950|Antibodies|antibodies|mesh-list
65483823|NCT01730950|Immunoglobulins|immunoglobulins|mesh-list
65483824|NCT01730950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65483825|NCT01730950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483826|NCT01730950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65483827|NCT01730950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65483828|NCT01730950|Growth Substances|growth substances|mesh-ancestor
65483829|NCT01730950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483830|NCT01730950|Growth Inhibitors|growth inhibitors|mesh-ancestor
65483831|NCT01730950|Immunologic Factors|immunologic factors|mesh-ancestor
65483832|NCT00271505|Bevacizumab|bevacizumab|mesh-list
65483833|NCT00271505|Carboplatin|carboplatin|mesh-list
65483834|NCT00271505|Docetaxel|docetaxel|mesh-list
65483835|NCT00271505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65483836|NCT00271505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483837|NCT00271505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65233349|NCT02593942|Narcotics|narcotics|mesh-ancestor
65483838|NCT00271505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65483839|NCT00271505|Growth Substances|growth substances|mesh-ancestor
65483840|NCT00271505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483841|NCT00271505|Growth Inhibitors|growth inhibitors|mesh-ancestor
65483842|NCT00271505|Tubulin Modulators|tubulin modulators|mesh-ancestor
65483843|NCT00271505|Antimitotic Agents|antimitotic agents|mesh-ancestor
65483844|NCT00271505|Mitosis Modulators|mitosis modulators|mesh-ancestor
64867831|NCT01813201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498602|NCT01369888|Immunologic Factors|immunologic factors|mesh-ancestor
64498603|NCT01369888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498604|NCT01369888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64498605|NCT01369888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64498606|NCT01369888|Alkylating Agents|alkylating agents|mesh-ancestor
64498607|NCT01369888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483845|NCT00271505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483846|NCT01642186|Everolimus|everolimus|mesh-list
65483847|NCT01642186|Letrozole|letrozole|mesh-list
65483848|NCT01642186|Leuprolide|leuprolide|mesh-list
65483849|NCT01642186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483850|NCT01642186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65483851|NCT01642186|Immunologic Factors|immunologic factors|mesh-ancestor
65483852|NCT01642186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483853|NCT01642186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65483854|NCT01642186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65483855|NCT01642186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483856|NCT01642186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483857|NCT01642186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65483858|NCT01642186|Hormone Antagonists|hormone antagonists|mesh-ancestor
65483859|NCT01642186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65483860|NCT01642186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64723692|NCT00703885|GABA Agents|gaba agents|mesh-ancestor
64723693|NCT00703885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723694|NCT00703885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723695|NCT00703339|Treprostinil|treprostinil|mesh-list
64723696|NCT00703339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64723697|NCT04330586|Ciclesonide|ciclesonide|mesh-list
64723698|NCT04330586|Glucocorticoids|glucocorticoids|mesh-ancestor
64723699|NCT04330586|Hormones|hormones|mesh-ancestor
64723700|NCT04330586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64723701|NCT04330586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723702|NCT04330586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64723703|NCT00382694|Fludarabine|fludarabine|mesh-list
64462981|NCT01908205|Oxytocin|oxytocin|mesh-list
64723704|NCT00382694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723705|NCT00673309|Insulin|insulin|mesh-list
64723706|NCT00673309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64723707|NCT00673309|Itraconazole|itraconazole|mesh-list
64723708|NCT00673309|Propranolol|propranolol|mesh-list
64723709|NCT00673309|Hormones|hormones|mesh-list
64498608|NCT01369888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498609|NCT01369888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64498611|NCT01850615|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64498612|NCT01850615|Insulin Aspart|insulin aspart|mesh-list
64498613|NCT01850615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64498614|NCT01850615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498615|NCT04602221|Lamotrigine|lamotrigine|mesh-list
64498616|NCT04602221|BI 425809|bi 425809|mesh-list
64498617|NCT04602221|BI 409306|bi 409306|mesh-list
64498619|NCT04602221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64498620|NCT04602221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64498621|NCT04602221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498624|NCT04602221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64498625|NCT04602221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64498626|NCT04602221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64498627|NCT04602221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64498628|NCT04602221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64498629|NCT04602221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64498630|NCT04602221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498631|NCT04602221|Nootropic Agents|nootropic agents|mesh-ancestor
64498632|NCT01280110|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64498633|NCT01280110|Laxatives|laxatives|mesh-ancestor
64498634|NCT01280110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64498635|NCT01374802|Ritonavir|ritonavir|mesh-list
64498636|NCT01374802|Darunavir|darunavir|mesh-list
64498650|NCT01375660|Vitamins|vitamins|mesh-ancestor
64498651|NCT01375660|Micronutrients|micronutrients|mesh-ancestor
65483861|NCT01642186|Fertility Agents|fertility agents|mesh-ancestor
65483862|NCT01642186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65483863|NCT01642186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65483864|NCT00423514|Mycophenolic Acid|mycophenolic acid|mesh-list
65483865|NCT00423514|Melphalan|melphalan|mesh-list
65483866|NCT00423514|Thiotepa|thiotepa|mesh-list
65483867|NCT00423514|Clofarabine|clofarabine|mesh-list
65483868|NCT00423514|Tacrolimus|tacrolimus|mesh-list
65483869|NCT00423514|Immunologic Factors|immunologic factors|mesh-ancestor
65483870|NCT00423514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483871|NCT00423514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65483872|NCT00423514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65483873|NCT00423514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483874|NCT00423514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867881|NCT01813565|Immunologic Factors|immunologic factors|mesh-ancestor
64498652|NCT01375660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498653|NCT01375660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64498654|NCT01375660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64498655|NCT01868477|Epoetin Alfa|epoetin alfa|mesh-list
64498656|NCT01868477|Deferasirox|deferasirox|mesh-list
64498657|NCT01868477|Hematinics|hematinics|mesh-ancestor
64498658|NCT01868477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64498659|NCT01868477|Chelating Agents|chelating agents|mesh-ancestor
64498660|NCT01868477|Sequestering Agents|sequestering agents|mesh-ancestor
64498661|NCT01868477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498662|NCT01849289|Insulin|insulin|mesh-list
64498663|NCT01849289|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64331320|NCT05644561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64331321|NCT05644561|Immunologic Factors|immunologic factors|mesh-ancestor
64331322|NCT05644561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723710|NCT00673309|Oxandrolone|oxandrolone|mesh-list
64723711|NCT00673309|Nandrolone|nandrolone|mesh-list
64723712|NCT00673309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64723713|NCT00673309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723714|NCT00673309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64723715|NCT00673309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723716|NCT00673309|Antifungal Agents|antifungal agents|mesh-ancestor
64723717|NCT00673309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64723718|NCT00673309|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64723719|NCT00673309|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64723720|NCT00673309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64723721|NCT00673309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64723722|NCT00673309|Hormone Antagonists|hormone antagonists|mesh-ancestor
64723723|NCT00673309|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64723724|NCT00673309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64723725|NCT00673309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64723726|NCT00673309|Adrenergic Agents|adrenergic agents|mesh-ancestor
64723727|NCT00673309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723728|NCT00673309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64723729|NCT00673309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64498664|NCT01849289|Insulin Glargine|insulin glargine|mesh-list
64498665|NCT01849289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64498666|NCT01849289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498667|NCT01868243|Warfarin|warfarin|mesh-list
64498668|NCT01868243|Dabigatran|dabigatran|mesh-list
64498669|NCT01868243|Anticoagulants|anticoagulants|mesh-ancestor
64498670|NCT01868243|Antithrombins|antithrombins|mesh-ancestor
64498671|NCT01868243|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64498672|NCT01868243|Protease Inhibitors|protease inhibitors|mesh-ancestor
64498673|NCT01868243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498674|NCT01868243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483875|NCT00423514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65483876|NCT00423514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483877|NCT00423514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65483878|NCT00423514|Antitubercular Agents|antitubercular agents|mesh-ancestor
65483879|NCT00423514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65483880|NCT00423514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65483881|NCT00423514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65483882|NCT00423514|Alkylating Agents|alkylating agents|mesh-ancestor
65483883|NCT00423514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65483884|NCT00423514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65483885|NCT00423514|Antimetabolites|antimetabolites|mesh-ancestor
65483886|NCT00120952|Cobalt|cobalt|mesh-list
65483887|NCT00120952|Chromium|chromium|mesh-list
65483888|NCT00120952|Trace Elements|trace elements|mesh-ancestor
65483889|NCT00120952|Micronutrients|micronutrients|mesh-ancestor
65483890|NCT00120952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483891|NCT00289991|Itraconazole|itraconazole|mesh-list
65483892|NCT00289991|Voriconazole|voriconazole|mesh-list
65483893|NCT00289991|Antifungal Agents|antifungal agents|mesh-ancestor
65483894|NCT00289991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65483895|NCT00289991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65483896|NCT00289991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64867898|NCT01813617|Hormones|hormones|mesh-ancestor
64498675|NCT01611935|Vasopressins|vasopressins|mesh-list
64498676|NCT01611935|Arginine Vasopressin|arginine vasopressin|mesh-list
64498677|NCT01611935|Hemostatics|hemostatics|mesh-ancestor
64498679|NCT01611935|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64498680|NCT01611935|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64498681|NCT01611935|Natriuretic Agents|natriuretic agents|mesh-ancestor
64498682|NCT01611935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498683|NCT02201212|Everolimus|everolimus|mesh-list
64498684|NCT02201212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498685|NCT02201212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64498686|NCT02201212|Immunologic Factors|immunologic factors|mesh-ancestor
64498691|NCT01376362|Antiviral Agents|antiviral agents|mesh-ancestor
64498692|NCT01376362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64498693|NCT03009292|Lenvatinib|lenvatinib|mesh-list
64498694|NCT03009292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723730|NCT00673309|Vasodilator Agents|vasodilator agents|mesh-ancestor
64723731|NCT00673309|Androgens|androgens|mesh-ancestor
64723732|NCT00673309|Anabolic Agents|anabolic agents|mesh-ancestor
64723733|NCT04508036|Fibrin fragment D|fibrin fragment d|mesh-list
64723734|NCT04508036|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64723735|NCT04508036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64498695|NCT03009292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64498696|NCT03009292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498697|NCT03009292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498699|NCT01962792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64498700|NCT01962792|Antiemetics|antiemetics|mesh-ancestor
64498701|NCT01962792|Autonomic Agents|autonomic agents|mesh-ancestor
64498702|NCT01962792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498703|NCT01962792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498728|NCT01404832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498729|NCT01404832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498730|NCT03420534|Iloperidone|iloperidone|mesh-list
65483897|NCT00289991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483898|NCT00289991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483899|NCT00289991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65483900|NCT00289991|Hormone Antagonists|hormone antagonists|mesh-ancestor
65483901|NCT00289991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65483902|NCT00289991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483903|NCT00289991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65483904|NCT00270413|Sunitinib|sunitinib|mesh-list
65483905|NCT00270413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483906|NCT00270413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65483907|NCT00270413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65483908|NCT00270413|Growth Substances|growth substances|mesh-ancestor
65483909|NCT00270413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483910|NCT00270413|Growth Inhibitors|growth inhibitors|mesh-ancestor
65483911|NCT00270413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65483912|NCT00270413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65483913|NCT00270413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483914|NCT00270257|Buprenorphine|buprenorphine|mesh-list
65483915|NCT00270257|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65483916|NCT00270257|Naloxone|naloxone|mesh-list
65483917|NCT00270257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65483918|NCT00270257|Narcotics|narcotics|mesh-ancestor
65483919|NCT00270257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64867916|NCT01813643|Aripiprazole|aripiprazole|mesh-list
64498731|NCT03420534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64498732|NCT03420534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64498733|NCT03420534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64498734|NCT03420534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498735|NCT03420534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64498736|NCT01313494|Albuterol|albuterol|mesh-list
64498737|NCT01313494|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64498738|NCT01313494|Autonomic Agents|autonomic agents|mesh-ancestor
64498739|NCT01313494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498740|NCT01313494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498741|NCT01313494|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64498742|NCT01313494|Respiratory System Agents|respiratory system agents|mesh-ancestor
64498743|NCT01313494|Tocolytic Agents|tocolytic agents|mesh-ancestor
64498744|NCT01313494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64498745|NCT01313494|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64498746|NCT01313494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64498747|NCT01313494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64498748|NCT01313494|Adrenergic Agents|adrenergic agents|mesh-ancestor
64498749|NCT01313494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64498750|NCT01313494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498751|NCT01407094|Sertraline|sertraline|mesh-list
64498752|NCT01407094|Antidepressive Agents|antidepressive agents|mesh-ancestor
64498761|NCT01867307|Empagliflozin|empagliflozin|mesh-list
64498762|NCT01867307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65483920|NCT00270257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483921|NCT00270257|Analgesics|analgesics|mesh-ancestor
65483922|NCT00270257|Sensory System Agents|sensory system agents|mesh-ancestor
65483923|NCT00270257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65483924|NCT00270257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65483925|NCT00269399|Vancomycin|vancomycin|mesh-list
65483926|NCT00269399|Rifaximin|rifaximin|mesh-list
65483927|NCT00269399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65483928|NCT00269399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65483929|NCT00269399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65483930|NCT00269087|Fluticasone|fluticasone|mesh-list
65483931|NCT00269087|Xhance|xhance|mesh-list
65483932|NCT00269087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65483933|NCT00269087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65483934|NCT00269087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65483935|NCT00269087|Autonomic Agents|autonomic agents|mesh-ancestor
65483936|NCT00269087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65483937|NCT00269087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483938|NCT00269087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65483939|NCT00269087|Respiratory System Agents|respiratory system agents|mesh-ancestor
65483940|NCT00269087|Dermatologic Agents|dermatologic agents|mesh-ancestor
64498763|NCT01867307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498764|NCT01867307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64498765|NCT01867307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498766|NCT01845077|Metformin|metformin|mesh-list
64498767|NCT01845077|Linagliptin|linagliptin|mesh-list
64498768|NCT01845077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64498769|NCT01845077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498771|NCT01845077|Hormones|hormones|mesh-ancestor
64498772|NCT01845077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64498773|NCT01845077|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64498774|NCT01845077|Protease Inhibitors|protease inhibitors|mesh-ancestor
64498775|NCT01845077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498776|NCT01845077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498777|NCT01866917|Ropivacaine|ropivacaine|mesh-list
64498778|NCT01866917|Anesthetics, Local|anesthetics, local|mesh-ancestor
64498779|NCT01866917|Anesthetics|anesthetics|mesh-ancestor
64498780|NCT01866917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64498781|NCT01866917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498782|NCT01866917|Sensory System Agents|sensory system agents|mesh-ancestor
64498783|NCT01866917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498784|NCT01316302|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64498785|NCT01316302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64498786|NCT01316302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64723737|NCT04508036|Hemostatics|hemostatics|mesh-ancestor
64723738|NCT04508036|Coagulants|coagulants|mesh-ancestor
64723739|NCT04828057|Timolol|timolol|mesh-list
64723740|NCT04828057|Bimatoprost|bimatoprost|mesh-list
64723741|NCT04828057|Travoprost|travoprost|mesh-list
64723742|NCT04828057|Latanoprost|latanoprost|mesh-list
64498789|NCT01316302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64498790|NCT01316302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498791|NCT01316302|Antidepressive Agents|antidepressive agents|mesh-ancestor
64498792|NCT01316302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64498793|NCT01410058|Efavirenz|efavirenz|mesh-list
64498794|NCT01410058|Nevirapine|nevirapine|mesh-list
65483941|NCT00269087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65483942|NCT00269087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65483943|NCT00269087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65483944|NCT00269087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65483945|NCT00269087|Adrenergic Agents|adrenergic agents|mesh-ancestor
65483946|NCT00269087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65483947|NCT00269087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483948|NCT00288587|Diuretics|diuretics|mesh-list
65483949|NCT00288587|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
65483950|NCT00288587|Natriuretic Agents|natriuretic agents|mesh-ancestor
65483951|NCT00288587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483952|NCT00288587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65483953|NCT00288587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483954|NCT00268463|Capecitabine|capecitabine|mesh-list
65483955|NCT00268463|Floxuridine|floxuridine|mesh-list
65483956|NCT00268463|Oxaliplatin|oxaliplatin|mesh-list
65483957|NCT00268463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65483958|NCT00268463|Antimetabolites|antimetabolites|mesh-ancestor
64867957|NCT01813773|Growth Inhibitors|growth inhibitors|mesh-ancestor
64498795|NCT01410058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64498796|NCT01410058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64498797|NCT01410058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498798|NCT01410058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498799|NCT01410058|Antiviral Agents|antiviral agents|mesh-ancestor
64498800|NCT01410058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64498801|NCT01410058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64498802|NCT01410058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64498803|NCT01410058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64498804|NCT01410058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64498805|NCT01410058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64498806|NCT01410058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64498807|NCT01410058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64498808|NCT01410058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64498809|NCT01380106|Lenalidomide|lenalidomide|mesh-list
64498810|NCT01380106|Immunologic Factors|immunologic factors|mesh-ancestor
64498811|NCT01380106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498812|NCT01380106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64498813|NCT01380106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64498832|NCT01381120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64498833|NCT01381120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498834|NCT01381120|Urological Agents|urological agents|mesh-ancestor
64498835|NCT01316770|Dexamethasone|dexamethasone|mesh-list
64498836|NCT01316770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64498837|NCT01316770|Antiemetics|antiemetics|mesh-ancestor
64498838|NCT01316770|Autonomic Agents|autonomic agents|mesh-ancestor
64498839|NCT01316770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498840|NCT01316770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498841|NCT01316770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64498842|NCT01316770|Glucocorticoids|glucocorticoids|mesh-ancestor
64498844|NCT01316770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64498845|NCT01316770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64498846|NCT01316770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498847|NCT01318408|Levetiracetam|levetiracetam|mesh-list
65483959|NCT00268463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483960|NCT00268463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483961|NCT00288509|Botulinum Toxins|botulinum toxins|mesh-list
65483962|NCT00288509|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65483963|NCT00288509|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65483964|NCT00288509|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65483965|NCT00288509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65483966|NCT00288509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65483967|NCT00288509|Cholinergic Agents|cholinergic agents|mesh-ancestor
65483968|NCT00288509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65483969|NCT00288509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483970|NCT00288509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65483971|NCT00288509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65483972|NCT01071005|Leuprolide|leuprolide|mesh-list
65483973|NCT01071005|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65483974|NCT01071005|Fertility Agents|fertility agents|mesh-ancestor
65483975|NCT01071005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65483976|NCT01071005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483977|NCT01071005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65483978|NCT01071005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65483979|NCT03976037|Misoprostol|misoprostol|mesh-list
65483980|NCT03976037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65483981|NCT03976037|Abortifacient Agents|abortifacient agents|mesh-ancestor
64498848|NCT01318408|Anticonvulsants|anticonvulsants|mesh-ancestor
64498849|NCT01318408|Nootropic Agents|nootropic agents|mesh-ancestor
64498850|NCT01319110|Ubiquinone|ubiquinone|mesh-list
64498851|NCT01319110|Coenzyme Q10|coenzyme q10|mesh-list
64498852|NCT01319110|Micronutrients|micronutrients|mesh-ancestor
64498853|NCT01319110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498854|NCT01319110|Vitamins|vitamins|mesh-ancestor
64498855|NCT03008512|Paclitaxel|paclitaxel|mesh-list
64498856|NCT03008512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64498857|NCT03008512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498858|NCT03008512|Tubulin Modulators|tubulin modulators|mesh-ancestor
64498859|NCT03008512|Antimitotic Agents|antimitotic agents|mesh-ancestor
64498860|NCT03008512|Mitosis Modulators|mitosis modulators|mesh-ancestor
64498861|NCT03008512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498862|NCT04351516|Hydroxychloroquine|hydroxychloroquine|mesh-list
64498863|NCT04351516|Antimalarials|antimalarials|mesh-ancestor
64498864|NCT04351516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64498865|NCT04351516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64498866|NCT04351516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64498867|NCT04351516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498868|NCT04351516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498869|NCT04351516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64331352|NCT05617625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64723743|NCT04828057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723744|NCT04828057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64723745|NCT04828057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64723746|NCT04828057|Adrenergic Agents|adrenergic agents|mesh-ancestor
65483982|NCT03976037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65483983|NCT03976037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483984|NCT03976037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65483985|NCT03976037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65483986|NCT03976037|Oxytocics|oxytocics|mesh-ancestor
65483987|NCT00265889|Cyclophosphamide|cyclophosphamide|mesh-list
65483988|NCT00265889|Melphalan|melphalan|mesh-list
65483989|NCT00265889|Busulfan|busulfan|mesh-list
65483990|NCT00265889|Etoposide|etoposide|mesh-list
65483991|NCT00265889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65483992|NCT00265889|Immunologic Factors|immunologic factors|mesh-ancestor
65483993|NCT00265889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65483994|NCT00265889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65483995|NCT00265889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65483996|NCT00265889|Alkylating Agents|alkylating agents|mesh-ancestor
65484004|NCT02795182|Zanubrutinib|zanubrutinib|mesh-list
65484041|NCT03206788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65484042|NCT03206788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65484043|NCT03206788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484044|NCT03205150|Licogliflozin|licogliflozin|mesh-list
65484045|NCT03205150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65484046|NCT03205150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484047|NCT03205150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65484048|NCT03205150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484049|NCT04936984|Abaloparatide|abaloparatide|mesh-list
65484050|NCT04936984|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
65484051|NCT04936984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65484052|NCT04936984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868056|NCT01814189|Anesthetics|anesthetics|mesh-ancestor
64723747|NCT04828057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723748|NCT04828057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723749|NCT04828057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64723750|NCT04828057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64723751|NCT04828057|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64498871|NCT01411696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64498872|NCT01411696|Antiemetics|antiemetics|mesh-ancestor
64498889|NCT01412164|Immunologic Factors|immunologic factors|mesh-ancestor
64498890|NCT01412164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498891|NCT01844687|Cannabidiol|cannabidiol|mesh-list
64498892|NCT01844687|Anticonvulsants|anticonvulsants|mesh-ancestor
64498893|NCT01844531|Metformin|metformin|mesh-list
64498894|NCT01844531|Empagliflozin|empagliflozin|mesh-list
64498895|NCT01844531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64498896|NCT01844531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498897|NCT01844531|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64498898|NCT01844531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498899|NCT02367456|Azacitidine|azacitidine|mesh-list
64498900|NCT02367456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64498901|NCT02367456|Antimetabolites|antimetabolites|mesh-ancestor
64498902|NCT02367456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498903|NCT02367456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498904|NCT02367456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498905|NCT03420378|Vitamin D|vitamin d|mesh-list
64498906|NCT03420378|Vitamins|vitamins|mesh-ancestor
64498907|NCT03420378|Micronutrients|micronutrients|mesh-ancestor
64498908|NCT03420378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498909|NCT03420378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64498910|NCT03420144|Hormones|hormones|mesh-list
64498911|NCT03420144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64498912|NCT03420144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498913|NCT03425448|Heparin|heparin|mesh-list
64498914|NCT03425448|Anticoagulants|anticoagulants|mesh-ancestor
64498915|NCT03425448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64498916|NCT03425448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64498917|NCT03425448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498918|NCT03419910|Cyclosporine|cyclosporine|mesh-list
64498919|NCT03419910|BMS-986165|bms-986165|mesh-list
64498920|NCT03419910|Cyclosporins|cyclosporins|mesh-list
64498921|NCT03419910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498922|NCT03419910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498923|NCT03419910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64498924|NCT03419910|Immunologic Factors|immunologic factors|mesh-ancestor
64498925|NCT03419910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498926|NCT03419910|Antifungal Agents|antifungal agents|mesh-ancestor
64498927|NCT03419910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65484053|NCT04936984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65484054|NCT02931838|BMS-986165|bms-986165|mesh-list
65484055|NCT02931838|Dermatologic Agents|dermatologic agents|mesh-ancestor
65484056|NCT02931838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65484057|NCT02931838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484058|NCT02931838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484059|NCT03201562|Tropicamide|tropicamide|mesh-list
65484060|NCT03201562|Aceclidine|aceclidine|mesh-list
65484061|NCT03201562|Mydriatics|mydriatics|mesh-ancestor
65484062|NCT03201562|Autonomic Agents|autonomic agents|mesh-ancestor
65484063|NCT03201562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65484064|NCT03201562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484065|NCT03201562|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65484066|NCT03201562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65484067|NCT03201562|Cholinergic Agents|cholinergic agents|mesh-ancestor
65484068|NCT03201562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65484069|NCT03201562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484070|NCT03201562|Miotics|miotics|mesh-ancestor
65484071|NCT03201562|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65484072|NCT03290950|Dexamethasone|dexamethasone|mesh-list
65484073|NCT03290950|Dexamethasone acetate|dexamethasone acetate|mesh-list
65484074|NCT03290950|Lenalidomide|lenalidomide|mesh-list
65484075|NCT03290950|Daratumumab|daratumumab|mesh-list
64498928|NCT03419910|Dermatologic Agents|dermatologic agents|mesh-ancestor
64498929|NCT03419910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64498930|NCT03419910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64498941|NCT03424746|Anticoagulants|anticoagulants|mesh-ancestor
64498942|NCT03424746|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64498943|NCT03424746|Chelating Agents|chelating agents|mesh-ancestor
64498944|NCT03424746|Sequestering Agents|sequestering agents|mesh-ancestor
64498945|NCT03424746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498946|NCT03424746|Antidotes|antidotes|mesh-ancestor
64498947|NCT03424746|Protective Agents|protective agents|mesh-ancestor
64723752|NCT04828057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64723753|NCT02973451|Bupivacaine|bupivacaine|mesh-list
64723754|NCT02973451|Anesthetics, Local|anesthetics, local|mesh-ancestor
64723755|NCT02973451|Anesthetics|anesthetics|mesh-ancestor
64723756|NCT02973451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64723757|NCT02973451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723758|NCT02973451|Sensory System Agents|sensory system agents|mesh-ancestor
64723759|NCT02973451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64723760|NCT00000199|Piracetam|piracetam|mesh-list
64723761|NCT00000199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64723762|NCT00000199|Protective Agents|protective agents|mesh-ancestor
64723763|NCT00000199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498953|NCT03414918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64498954|NCT03414918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64498955|NCT03414918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498956|NCT03414918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498957|NCT03414918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64498958|NCT03414918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64498959|NCT04448496|Dexamethasone|dexamethasone|mesh-list
64498960|NCT04448496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65484076|NCT03290950|BB 1101|bb 1101|mesh-list
65484077|NCT03290950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65484078|NCT03290950|Antiemetics|antiemetics|mesh-ancestor
65484079|NCT03290950|Autonomic Agents|autonomic agents|mesh-ancestor
65484080|NCT03290950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65484081|NCT03290950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484082|NCT03290950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65484083|NCT03290950|Glucocorticoids|glucocorticoids|mesh-ancestor
65484084|NCT03290950|Hormones|hormones|mesh-ancestor
65484085|NCT03290950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65484086|NCT03290950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65484087|NCT03290950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484088|NCT03290950|Protease Inhibitors|protease inhibitors|mesh-ancestor
65484089|NCT03290950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484090|NCT03290950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484091|NCT03290950|Immunologic Factors|immunologic factors|mesh-ancestor
65484092|NCT03290950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65484093|NCT03290950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65484094|NCT03290950|Growth Substances|growth substances|mesh-ancestor
65484095|NCT03290950|Growth Inhibitors|growth inhibitors|mesh-ancestor
65484096|NCT03200860|Empagliflozin|empagliflozin|mesh-list
65484097|NCT03200860|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65484098|NCT03200860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484099|NCT03200860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65484100|NCT03200860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484101|NCT01314508|Mecasermin|mecasermin|mesh-list
65484102|NCT01314508|Growth Substances|growth substances|mesh-ancestor
65484103|NCT01314508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484104|NCT03268954|Azacitidine|azacitidine|mesh-list
65484105|NCT03268954|Pevonedistat|pevonedistat|mesh-list
64868085|NCT01814423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64498961|NCT04448496|Antiemetics|antiemetics|mesh-ancestor
64498962|NCT04448496|Autonomic Agents|autonomic agents|mesh-ancestor
64498963|NCT04448496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498964|NCT04448496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498965|NCT04448496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64498966|NCT04448496|Glucocorticoids|glucocorticoids|mesh-ancestor
64498967|NCT04448496|Hormones|hormones|mesh-ancestor
64498968|NCT04448496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64498969|NCT04448496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64498970|NCT04448496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498971|NCT01387672|Nitroglycerin|nitroglycerin|mesh-list
64498972|NCT01387672|Vasodilator Agents|vasodilator agents|mesh-ancestor
65484106|NCT03268954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65484107|NCT03268954|Antimetabolites|antimetabolites|mesh-ancestor
65484108|NCT03268954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484109|NCT03268954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484110|NCT03268954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484111|NCT01314586|Secoisolariciresinol|secoisolariciresinol|mesh-list
65484112|NCT01314586|Phytoestrogens|phytoestrogens|mesh-ancestor
65484113|NCT01314586|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65484114|NCT01314586|Estrogens|estrogens|mesh-ancestor
65484115|NCT01314586|Hormones|hormones|mesh-ancestor
65484116|NCT01314586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65484117|NCT01314586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484118|NCT03187756|Cyclophosphamide|cyclophosphamide|mesh-list
65484119|NCT03187756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65484120|NCT03187756|Immunologic Factors|immunologic factors|mesh-ancestor
65484121|NCT03187756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484122|NCT03187756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65484123|NCT03187756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65484124|NCT03187756|Alkylating Agents|alkylating agents|mesh-ancestor
64498973|NCT03419442|Docetaxel|docetaxel|mesh-list
64498974|NCT03419442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498975|NCT03419442|Tubulin Modulators|tubulin modulators|mesh-ancestor
64498976|NCT03419442|Antimitotic Agents|antimitotic agents|mesh-ancestor
64498978|NCT03419442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498979|NCT01412710|Vitamin D|vitamin d|mesh-list
64498980|NCT01412710|Cholecalciferol|cholecalciferol|mesh-list
64498981|NCT01412710|Vitamins|vitamins|mesh-ancestor
64498982|NCT01412710|Micronutrients|micronutrients|mesh-ancestor
64498983|NCT01412710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498984|NCT01412710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64498985|NCT01412710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64498987|NCT01843205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64498988|NCT01843205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498989|NCT01843205|Sympathomimetics|sympathomimetics|mesh-ancestor
64498990|NCT01843205|Autonomic Agents|autonomic agents|mesh-ancestor
64498991|NCT01843205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498992|NCT01843205|Dopamine Agents|dopamine agents|mesh-ancestor
64498993|NCT01843205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64498994|NCT01843205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498996|NCT01843205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64498997|NCT01843205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64723766|NCT04485104|Anticonvulsants|anticonvulsants|mesh-ancestor
64723767|NCT00668785|Ranibizumab|ranibizumab|mesh-list
64723768|NCT00668785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64723769|NCT00668785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64723770|NCT00668785|Growth Substances|growth substances|mesh-ancestor
64723771|NCT00668785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723772|NCT00668785|Growth Inhibitors|growth inhibitors|mesh-ancestor
64723773|NCT00668785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723774|NCT00655057|Citalopram|citalopram|mesh-list
64331384|NCT05518734|Itraconazole|itraconazole|mesh-list
64498998|NCT01843205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64499015|NCT03418974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64499016|NCT03418974|Antimetabolites|antimetabolites|mesh-ancestor
64499017|NCT03418974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484125|NCT03187756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484126|NCT03187756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484127|NCT03187756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65484128|NCT03184558|Pembrolizumab|pembrolizumab|mesh-list
65484129|NCT03184558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65484130|NCT03184558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484131|NCT03180736|Dexamethasone|dexamethasone|mesh-list
65484132|NCT03180736|Daratumumab|daratumumab|mesh-list
65484133|NCT03180736|Pomalidomide|pomalidomide|mesh-list
65484134|NCT03180736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65484135|NCT03180736|Antiemetics|antiemetics|mesh-ancestor
65484136|NCT03180736|Autonomic Agents|autonomic agents|mesh-ancestor
65484137|NCT03180736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65484138|NCT03180736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484139|NCT03180736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65484140|NCT03180736|Glucocorticoids|glucocorticoids|mesh-ancestor
65484141|NCT03180736|Hormones|hormones|mesh-ancestor
65484142|NCT03180736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65484143|NCT03180736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65484144|NCT03180736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484145|NCT03180736|Immunologic Factors|immunologic factors|mesh-ancestor
65484146|NCT03180736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65484147|NCT03180736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65484148|NCT03180736|Growth Substances|growth substances|mesh-ancestor
65484149|NCT03180736|Growth Inhibitors|growth inhibitors|mesh-ancestor
65484150|NCT03178942|Permethrin|permethrin|mesh-list
65484151|NCT03178942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484152|NCT03178942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484153|NCT03093922|Gemcitabine|gemcitabine|mesh-list
65484154|NCT03093922|Atezolizumab|atezolizumab|mesh-list
65484155|NCT03093922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484156|NCT03093922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65484157|NCT03093922|Antimetabolites|antimetabolites|mesh-ancestor
65484159|NCT03093922|Antiviral Agents|antiviral agents|mesh-ancestor
65484166|NCT03175198|Antithrombins|antithrombins|mesh-ancestor
65484167|NCT03175198|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65484168|NCT03175198|Protease Inhibitors|protease inhibitors|mesh-ancestor
65484169|NCT03175198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484170|NCT03175198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484171|NCT03175198|Anticoagulants|anticoagulants|mesh-ancestor
65484172|NCT03087448|Trametinib|trametinib|mesh-list
65484173|NCT03087448|Ceritinib|ceritinib|mesh-list
65484174|NCT03087448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484175|NCT03087448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65484176|NCT03087448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484177|NCT03087448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484178|NCT03175120|Insulin|insulin|mesh-list
65484179|NCT03175120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65484180|NCT03175120|Liraglutide|liraglutide|mesh-list
65484181|NCT03175120|Insulin, Long-Acting|insulin, long-acting|mesh-list
65484182|NCT03175120|Xultophy|xultophy|mesh-list
65484183|NCT03175120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65484184|NCT03175120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484185|NCT03175120|Incretins|incretins|mesh-ancestor
65484186|NCT03175120|Hormones|hormones|mesh-ancestor
64499018|NCT03418974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64499019|NCT03418974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64499020|NCT03418974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64499021|NCT03424356|Fentanyl|fentanyl|mesh-list
64499022|NCT03424356|Narcotics|narcotics|mesh-list
64499023|NCT03424356|Analgesics|analgesics|mesh-list
64499024|NCT03424356|Bromides|bromides|mesh-list
64499028|NCT03424356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64499029|NCT03424356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499030|NCT03424356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64499031|NCT03424356|Anesthetics, General|anesthetics, general|mesh-ancestor
64499032|NCT03424356|Anesthetics|anesthetics|mesh-ancestor
64499033|NCT03424356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64499034|NCT03424356|Sensory System Agents|sensory system agents|mesh-ancestor
64499035|NCT03424356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499036|NCT03424356|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64499037|NCT03424356|Anticonvulsants|anticonvulsants|mesh-ancestor
64499038|NCT03424356|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64499039|NCT03424356|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64499040|NCT03424356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64499041|NCT03414450|Dasatinib|dasatinib|mesh-list
64499042|NCT03414450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64499043|NCT03414450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64499044|NCT03414450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64499045|NCT03414450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499046|NCT01389076|Methotrexate|methotrexate|mesh-list
64499047|NCT01389076|Tositumomab I-131|tositumomab i-131|mesh-list
64499048|NCT01389076|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64499049|NCT01389076|Abortifacient Agents|abortifacient agents|mesh-ancestor
64499050|NCT01389076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64499051|NCT01389076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499053|NCT01389076|Antimetabolites|antimetabolites|mesh-ancestor
64499054|NCT01389076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499055|NCT01389076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64499056|NCT01389076|Dermatologic Agents|dermatologic agents|mesh-ancestor
64499057|NCT01389076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484187|NCT03175120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65484188|NCT04942210|Vaccines|vaccines|mesh-list
65484189|NCT04942210|Immunologic Factors|immunologic factors|mesh-ancestor
65484190|NCT04942210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484191|NCT03054766|Ranibizumab|ranibizumab|mesh-list
65484192|NCT03054766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65484193|NCT03054766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65484194|NCT03054766|Growth Substances|growth substances|mesh-ancestor
65484195|NCT03054766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484196|NCT03054766|Growth Inhibitors|growth inhibitors|mesh-ancestor
65484197|NCT03054766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484198|NCT05118724|Atezolizumab|atezolizumab|mesh-list
65484199|NCT05118724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484200|NCT03036748|Amiloride|amiloride|mesh-list
65484201|NCT03036748|Diuretics|diuretics|mesh-ancestor
65484202|NCT03036748|Natriuretic Agents|natriuretic agents|mesh-ancestor
65484203|NCT03036748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484204|NCT03036748|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65484205|NCT03036748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65484206|NCT03036748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65484207|NCT03036748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484208|NCT03036748|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64499058|NCT01389076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64499081|NCT01323010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499082|NCT01323010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499083|NCT01323010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64499084|NCT01323010|Respiratory System Agents|respiratory system agents|mesh-ancestor
64499085|NCT01323010|Tocolytic Agents|tocolytic agents|mesh-ancestor
64499086|NCT01323010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64499087|NCT01323010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64499088|NCT01323010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64499089|NCT01323010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64499090|NCT01323010|Adrenergic Agents|adrenergic agents|mesh-ancestor
64499091|NCT01323010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64499092|NCT01323010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723775|NCT00655057|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64723776|NCT00655057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64723777|NCT00655057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64499093|NCT03423810|Hydralazine|hydralazine|mesh-list
64499094|NCT03423810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64499095|NCT03423810|Vasodilator Agents|vasodilator agents|mesh-ancestor
64499097|NCT01390246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64499098|NCT01390246|Antidepressive Agents|antidepressive agents|mesh-ancestor
64499099|NCT01390246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64499100|NCT01390246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64499101|NCT01390246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64499102|NCT01390246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64499103|NCT01390246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499104|NCT01390246|Dopamine Agents|dopamine agents|mesh-ancestor
65484209|NCT03036748|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65484210|NCT03167242|Lumefantrine|lumefantrine|mesh-list
65484211|NCT03167242|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65484212|NCT03167242|Antimalarials|antimalarials|mesh-ancestor
65484213|NCT03167242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65484214|NCT03167242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65484215|NCT03167242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65484216|NCT05441410|Artesunate|artesunate|mesh-list
65484217|NCT05441410|Pyronaridine|pyronaridine|mesh-list
65484218|NCT05441410|Antimalarials|antimalarials|mesh-ancestor
65484219|NCT05441410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65484220|NCT05441410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65484221|NCT05441410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65484222|NCT05441410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484223|NCT05441410|Antiviral Agents|antiviral agents|mesh-ancestor
65484224|NCT05441410|Schistosomicides|schistosomicides|mesh-ancestor
65484225|NCT05441410|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65484226|NCT05441410|Anthelmintics|anthelmintics|mesh-ancestor
65484227|NCT03636178|Daminozide|daminozide|mesh-list
65484228|NCT03636178|Plant Growth Regulators|plant growth regulators|mesh-ancestor
65484229|NCT03636178|Growth Substances|growth substances|mesh-ancestor
65484230|NCT03636178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868222|NCT01814891|Vitamin A|vitamin a|mesh-list
64499105|NCT01390246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64499106|NCT01390246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499107|NCT01390246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64499108|NCT01390246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64499109|NCT01390246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64499110|NCT01390870|Alfuzosin|alfuzosin|mesh-list
64499119|NCT03418506|Lobeline|lobeline|mesh-list
64499120|NCT03418506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64499121|NCT03418506|Autonomic Agents|autonomic agents|mesh-ancestor
64499122|NCT03418506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499123|NCT03418506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419204|NCT05532241|Chlorhexidine|chlorhexidine|mesh-list
64499126|NCT03418506|Cholinergic Agents|cholinergic agents|mesh-ancestor
64499127|NCT03418506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64499128|NCT03418506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499129|NCT03418506|Respiratory System Agents|respiratory system agents|mesh-ancestor
64499130|NCT01842581|Rifaximin|rifaximin|mesh-list
64499131|NCT01842581|Lactulose|lactulose|mesh-list
64499132|NCT01842581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64499133|NCT01842581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64499134|NCT01842581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64499135|NCT04448028|Esomeprazole|esomeprazole|mesh-list
64499136|NCT04448028|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64499137|NCT04448028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64499138|NCT04448028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64499139|NCT04448028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64499140|NCT04448028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499141|NCT01833533|Ribavirin|ribavirin|mesh-list
64499142|NCT01833533|Antimetabolites|antimetabolites|mesh-ancestor
64499143|NCT01833533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499144|NCT01833533|Antiviral Agents|antiviral agents|mesh-ancestor
64499145|NCT01833533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64499146|NCT03413436|Cisplatin|cisplatin|mesh-list
65484231|NCT04874194|Venetoclax|venetoclax|mesh-list
65484232|NCT04874194|Homoharringtonine|homoharringtonine|mesh-list
65484233|NCT04874194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484234|NCT04874194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65484235|NCT04874194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65484236|NCT04874194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484237|NCT04874194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484238|NCT01952782|Naloxone|naloxone|mesh-list
65484239|NCT01952782|Hormones|hormones|mesh-list
65484240|NCT01952782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65484241|NCT01952782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484242|NCT01952782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65484243|NCT01952782|Sensory System Agents|sensory system agents|mesh-ancestor
65484244|NCT01952782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65484245|NCT01330654|Metoprolol|metoprolol|mesh-list
65484246|NCT01330654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65484247|NCT01330654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65484248|NCT01330654|Sympatholytics|sympatholytics|mesh-ancestor
65484249|NCT01330654|Autonomic Agents|autonomic agents|mesh-ancestor
65484250|NCT01330654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65484251|NCT01330654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484252|NCT01330654|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65484253|NCT01330654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65484254|NCT01330654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65484255|NCT01330654|Adrenergic Agents|adrenergic agents|mesh-ancestor
65484256|NCT01330654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65484257|NCT01330654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484258|NCT01330810|Curcumin|curcumin|mesh-list
65484259|NCT01330810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65484260|NCT01330810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65484261|NCT01330810|Analgesics|analgesics|mesh-ancestor
65484262|NCT01330810|Sensory System Agents|sensory system agents|mesh-ancestor
65484263|NCT01330810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65484264|NCT01330810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499147|NCT03413436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64499148|NCT01833455|Flecainide|flecainide|mesh-list
64499149|NCT01833455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64499150|NCT01833455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65484265|NCT01330810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65484266|NCT01330810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65484267|NCT01330810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484268|NCT01330810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484269|NCT01330810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484270|NCT01331122|Droxidopa|droxidopa|mesh-list
65484271|NCT01331122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65484272|NCT01331122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65484273|NCT01320280|Afatinib|afatinib|mesh-list
65484274|NCT01320280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484275|NCT01320280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65484276|NCT01320280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484277|NCT01320280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484278|NCT01331434|Exemestane|exemestane|mesh-list
65484279|NCT01331434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484280|NCT01331434|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65484281|NCT01331434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65484282|NCT01331434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484283|NCT01331434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484284|NCT01331434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65484285|NCT01331434|Hormone Antagonists|hormone antagonists|mesh-ancestor
65484286|NCT01331434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65484287|NCT01331434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484289|NCT01331590|Etoposide|etoposide|mesh-list
65484290|NCT01331590|Ifosfamide|ifosfamide|mesh-list
65484291|NCT01331590|Lenograstim|lenograstim|mesh-list
65484292|NCT01331590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65484293|NCT01331590|Antiemetics|antiemetics|mesh-ancestor
65484294|NCT01331590|Autonomic Agents|autonomic agents|mesh-ancestor
65484295|NCT01331590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65484296|NCT01331590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484299|NCT01331590|Hormones|hormones|mesh-ancestor
65484308|NCT01331590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65484309|NCT01331590|Immunologic Factors|immunologic factors|mesh-ancestor
65484310|NCT01331590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65484311|NCT01331590|Alkylating Agents|alkylating agents|mesh-ancestor
65484312|NCT04447846|Cannabidiol|cannabidiol|mesh-list
65484313|NCT04447846|Anticonvulsants|anticonvulsants|mesh-ancestor
65484314|NCT01331902|Nicorandil|nicorandil|mesh-list
65484315|NCT01331902|Adenosine|adenosine|mesh-list
65484316|NCT01331902|Analgesics|analgesics|mesh-ancestor
65484317|NCT01331902|Sensory System Agents|sensory system agents|mesh-ancestor
65484318|NCT01331902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65484319|NCT01331902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484320|NCT01331902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65484321|NCT01331902|Vasodilator Agents|vasodilator agents|mesh-ancestor
65484322|NCT01331902|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65484323|NCT01331902|Purinergic Agonists|purinergic agonists|mesh-ancestor
65484324|NCT01331902|Purinergic Agents|purinergic agents|mesh-ancestor
65484325|NCT01331902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65484326|NCT01331902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484327|NCT01331902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65484328|NCT01331902|Vitamin B Complex|vitamin b complex|mesh-ancestor
65484329|NCT01331902|Vitamins|vitamins|mesh-ancestor
65484330|NCT01331902|Micronutrients|micronutrients|mesh-ancestor
65484331|NCT04245748|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65484332|NCT04245748|Citalopram|citalopram|mesh-list
65484333|NCT04245748|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65484334|NCT04245748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65484335|NCT04245748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65484336|NCT04245748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484337|NCT04245748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65484338|NCT04245748|Serotonin Agents|serotonin agents|mesh-ancestor
65484339|NCT04245748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484340|NCT04245748|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65484341|NCT04245748|Antidepressive Agents|antidepressive agents|mesh-ancestor
65484342|NCT04245748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65484343|NCT04245748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65484346|NCT04245748|Sensory System Agents|sensory system agents|mesh-ancestor
65484347|NCT04245748|Dopamine Agents|dopamine agents|mesh-ancestor
65484348|NCT04245436|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65484349|NCT04245436|Citalopram|citalopram|mesh-list
65484350|NCT04245436|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65484351|NCT04245436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65484352|NCT04245436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65484353|NCT04245436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484354|NCT04245436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65484355|NCT04245436|Serotonin Agents|serotonin agents|mesh-ancestor
65484356|NCT04245436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484357|NCT04245436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65484358|NCT04245436|Antidepressive Agents|antidepressive agents|mesh-ancestor
65484359|NCT04245436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65484360|NCT04245436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65233888|NCT01000805|Analgesics|analgesics|mesh-ancestor
65484361|NCT04245436|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65484363|NCT04245436|Sensory System Agents|sensory system agents|mesh-ancestor
65484364|NCT04245436|Dopamine Agents|dopamine agents|mesh-ancestor
65484365|NCT01332370|Metformin|metformin|mesh-list
65484366|NCT01332370|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65484367|NCT01332370|Rosiglitazone|rosiglitazone|mesh-list
65484368|NCT01332370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65484369|NCT01332370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484370|NCT01332370|Incretins|incretins|mesh-ancestor
65484371|NCT01332370|Hormones|hormones|mesh-ancestor
65484372|NCT01332370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65484373|NCT01332370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65484374|NCT01332370|Protease Inhibitors|protease inhibitors|mesh-ancestor
65484375|NCT01332370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484376|NCT01332370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484377|NCT01332448|Orlistat|orlistat|mesh-list
65484378|NCT01332448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64499151|NCT01833455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64499152|NCT01833455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64499153|NCT01833455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499154|NCT03413358|Carboplatin|carboplatin|mesh-list
64499155|NCT03413358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64499156|NCT01833143|Acyclovir|acyclovir|mesh-list
64499157|NCT01833143|Bortezomib|bortezomib|mesh-list
65484379|NCT01332448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484380|NCT01332448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65484381|NCT01332448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65484382|NCT04484428|Menthol|menthol|mesh-list
65484383|NCT04484428|Antipruritics|antipruritics|mesh-ancestor
65484384|NCT04484428|Dermatologic Agents|dermatologic agents|mesh-ancestor
65484385|NCT01332604|Bevacizumab|bevacizumab|mesh-list
65484386|NCT01332604|Capecitabine|capecitabine|mesh-list
65484387|NCT01332604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65484388|NCT01332604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484389|NCT01332604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65484390|NCT01332604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65484391|NCT01332604|Growth Substances|growth substances|mesh-ancestor
65484392|NCT01332604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484393|NCT01332604|Growth Inhibitors|growth inhibitors|mesh-ancestor
65484394|NCT01332604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65484395|NCT01332604|Antimetabolites|antimetabolites|mesh-ancestor
65484396|NCT01332604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484397|NCT03445858|Pembrolizumab|pembrolizumab|mesh-list
65484398|NCT03445858|Decitabine|decitabine|mesh-list
65484399|NCT03445858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65484400|NCT03445858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484401|NCT03445858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65484402|NCT03445858|Antimetabolites|antimetabolites|mesh-ancestor
65484403|NCT03445858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484404|NCT03445858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484405|NCT01333150|Propranolol|propranolol|mesh-list
65484406|NCT01333150|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65484407|NCT01333150|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65484408|NCT01333150|Adrenergic Agents|adrenergic agents|mesh-ancestor
65484409|NCT01333150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65484410|NCT01333150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499158|NCT01833143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64499159|NCT01833143|Antiviral Agents|antiviral agents|mesh-ancestor
64499160|NCT01833143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64499161|NCT03411096|Ropivacaine|ropivacaine|mesh-list
64499162|NCT03411096|Anesthetics, Local|anesthetics, local|mesh-ancestor
64499163|NCT03411096|Anesthetics|anesthetics|mesh-ancestor
64499164|NCT03411096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64499165|NCT03411096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499166|NCT03411096|Sensory System Agents|sensory system agents|mesh-ancestor
64499167|NCT03411096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499168|NCT03417648|Vitamin E|vitamin e|mesh-list
65484411|NCT01333150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484412|NCT01333150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65484413|NCT01333150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65484414|NCT01333150|Vasodilator Agents|vasodilator agents|mesh-ancestor
65484415|NCT02913664|Losartan|losartan|mesh-list
65484416|NCT02913664|Amlodipine|amlodipine|mesh-list
65484417|NCT02913664|Calcium Channel Blockers|calcium channel blockers|mesh-list
65484418|NCT02913664|Angiotensin II|angiotensin ii|mesh-list
65484419|NCT02913664|Giapreza|giapreza|mesh-list
65484420|NCT02913664|Calcium|calcium|mesh-list
65484421|NCT02913664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65484422|NCT02913664|Angiotensinogen|angiotensinogen|mesh-list
65484423|NCT02913664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65484424|NCT02913664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484425|NCT02913664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65484426|NCT02913664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65484427|NCT02913664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484428|NCT02913664|Vasodilator Agents|vasodilator agents|mesh-ancestor
65484429|NCT02913664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65484430|NCT02913664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65484431|NCT02913664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65484432|NCT02913664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65484433|NCT02913664|Protease Inhibitors|protease inhibitors|mesh-ancestor
65484435|NCT02818582|Remdesivir|remdesivir|mesh-list
65484463|NCT05186194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65484464|NCT01338454|Tranexamic Acid|tranexamic acid|mesh-list
65484465|NCT01338454|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65484466|NCT01338454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65484467|NCT01338454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484468|NCT01338454|Hemostatics|hemostatics|mesh-ancestor
65484469|NCT01338454|Coagulants|coagulants|mesh-ancestor
65484470|NCT02882152|Morphine|morphine|mesh-list
65484471|NCT02882152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65484472|NCT02882152|Narcotics|narcotics|mesh-ancestor
65484473|NCT02882152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65484474|NCT02882152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484475|NCT02882152|Analgesics|analgesics|mesh-ancestor
65484476|NCT02882152|Sensory System Agents|sensory system agents|mesh-ancestor
65484477|NCT02882152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65484478|NCT05185804|Enoxaparin|enoxaparin|mesh-list
65484479|NCT05185804|Enoxaparin sodium|enoxaparin sodium|mesh-list
65484480|NCT05185804|Anticoagulants|anticoagulants|mesh-ancestor
65484481|NCT05185804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65484482|NCT05185804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65484483|NCT05185804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484484|NCT01338844|Inositol|inositol|mesh-list
65484485|NCT01338844|Vitamin B Complex|vitamin b complex|mesh-ancestor
65484486|NCT01338844|Vitamins|vitamins|mesh-ancestor
65484487|NCT01338844|Micronutrients|micronutrients|mesh-ancestor
65484488|NCT01338844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484489|NCT01338922|Insulin|insulin|mesh-list
65484490|NCT01338922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65484491|NCT01338922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484492|NCT01339312|Vaccines|vaccines|mesh-list
65484493|NCT01339312|Immunologic Factors|immunologic factors|mesh-ancestor
65484494|NCT01339312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484495|NCT01339468|Tacrolimus|tacrolimus|mesh-list
65484496|NCT01339468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65484502|NCT01339624|Ketorolac|ketorolac|mesh-list
65484507|NCT01339624|Narcotics|narcotics|mesh-ancestor
65484508|NCT01339624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65234028|NCT00751153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65484509|NCT01339624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484510|NCT01339624|Analgesics|analgesics|mesh-ancestor
65484511|NCT01339624|Sensory System Agents|sensory system agents|mesh-ancestor
65484512|NCT01339624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65484513|NCT01339624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65484514|NCT01339624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65484515|NCT01339624|Anesthetics, General|anesthetics, general|mesh-ancestor
65484516|NCT01339624|Anesthetics|anesthetics|mesh-ancestor
65484517|NCT01339624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65484518|NCT01339624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65484519|NCT01339624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65484520|NCT01339624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65484521|NCT01339624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65484522|NCT01339624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484523|NCT01339624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484524|NCT01340248|Carvedilol|carvedilol|mesh-list
65484525|NCT01340248|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65484526|NCT01340248|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65484527|NCT01340248|Adrenergic Agents|adrenergic agents|mesh-ancestor
65484528|NCT01340248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65484529|NCT01340248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484530|NCT01340248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484532|NCT01340248|Antioxidants|antioxidants|mesh-ancestor
65484553|NCT01340950|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
65484554|NCT01340950|Antiviral Agents|antiviral agents|mesh-ancestor
65484555|NCT01340950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65484556|NCT01340950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65484557|NCT01340950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65484558|NCT01340950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484559|NCT01340950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484560|NCT01340950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65484561|NCT01340950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65484562|NCT01340950|Antimetabolites|antimetabolites|mesh-ancestor
65484563|NCT01340950|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65484564|NCT01340950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65484565|NCT01340950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65484566|NCT01340950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65484567|NCT01340950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65484568|NCT01340950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65484569|NCT01341106|Entecavir|entecavir|mesh-list
65484570|NCT01341106|Antiviral Agents|antiviral agents|mesh-ancestor
65484571|NCT01341106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65484572|NCT01341184|Rifampin|rifampin|mesh-list
65484573|NCT01341184|Rifabutin|rifabutin|mesh-list
65484574|NCT01341184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65484575|NCT01341184|Antitubercular Agents|antitubercular agents|mesh-ancestor
65484576|NCT01341184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65484577|NCT01341184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65484578|NCT01341184|Leprostatic Agents|leprostatic agents|mesh-ancestor
65484579|NCT01341184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65484580|NCT01341184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484581|NCT01341184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484582|NCT01341184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65484583|NCT01341184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65484584|NCT01341184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65484585|NCT01341184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65484586|NCT01341184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64499169|NCT03417648|Vitamins|vitamins|mesh-ancestor
65484588|NCT00285857|Lovastatin|lovastatin|mesh-list
65484589|NCT00285857|L 647318|l 647318|mesh-list
65484590|NCT00285857|Dihydromevinolin|dihydromevinolin|mesh-list
65484591|NCT00285857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65484592|NCT00285857|Antimetabolites|antimetabolites|mesh-ancestor
65484593|NCT00285857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484594|NCT00285857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65484595|NCT00285857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65484596|NCT00285857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65484597|NCT00285857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484598|NCT01341262|Zoledronic Acid|zoledronic acid|mesh-list
65484599|NCT01341262|Thalidomide|thalidomide|mesh-list
65484600|NCT01341262|Dexamethasone|dexamethasone|mesh-list
65484601|NCT01341262|Cyclophosphamide|cyclophosphamide|mesh-list
65484602|NCT01341262|Melphalan|melphalan|mesh-list
65484603|NCT01341262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65484604|NCT01341262|Immunologic Factors|immunologic factors|mesh-ancestor
65484605|NCT01341262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484606|NCT01341262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65484613|NCT01341262|Antiemetics|antiemetics|mesh-ancestor
65484645|NCT01341496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65484646|NCT01341496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65484647|NCT01341496|Analgesics|analgesics|mesh-ancestor
65484648|NCT01341496|Sensory System Agents|sensory system agents|mesh-ancestor
65484649|NCT01341496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65484650|NCT01341496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65484651|NCT01341496|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65484652|NCT01341496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65484653|NCT01341496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484654|NCT00284141|Aflibercept|aflibercept|mesh-list
65484655|NCT00284141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65484656|NCT00284141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65484657|NCT00284141|Growth Substances|growth substances|mesh-ancestor
65484658|NCT00284141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484659|NCT00284141|Growth Inhibitors|growth inhibitors|mesh-ancestor
65484660|NCT00284141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484661|NCT05182138|Zinc|zinc|mesh-list
65484662|NCT05182138|Trace Elements|trace elements|mesh-ancestor
65484663|NCT05182138|Micronutrients|micronutrients|mesh-ancestor
65484664|NCT05182138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484665|NCT04901494|Serotonin|serotonin|mesh-list
65484666|NCT04901494|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65484667|NCT04901494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65484668|NCT04901494|Serotonin Agents|serotonin agents|mesh-ancestor
65484669|NCT04901494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65484670|NCT04901494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484671|NCT04901494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484672|NCT04901494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65484673|NCT04901494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65484674|NCT01315990|Cetuximab|cetuximab|mesh-list
65484677|NCT00265343|Olanzapine|olanzapine|mesh-list
65484689|NCT00265343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65484690|NCT00265343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65484691|NCT00265343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484692|NCT00265343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65484693|NCT00265343|Serotonin Agents|serotonin agents|mesh-ancestor
65484694|NCT01341886|Metformin|metformin|mesh-list
65484695|NCT01341886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65484696|NCT01341886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484697|NCT00283595|Hormones|hormones|mesh-list
65484698|NCT00283595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65484699|NCT00283595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484700|NCT01341964|Aspirin|aspirin|mesh-list
65484701|NCT01341964|Clopidogrel|clopidogrel|mesh-list
65484702|NCT01341964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65484703|NCT01341964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65484704|NCT01341964|Analgesics|analgesics|mesh-ancestor
65484705|NCT01341964|Sensory System Agents|sensory system agents|mesh-ancestor
65484706|NCT01341964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65484707|NCT01341964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484708|NCT01341964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65484709|NCT01341964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65484710|NCT01341964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65484711|NCT01341964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65484738|NCT01342198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65484739|NCT01342198|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65484740|NCT01342198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65484741|NCT01342198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65484742|NCT01342198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65484743|NCT01342198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65484744|NCT01342198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65484745|NCT01342198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65484746|NCT01342198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65484747|NCT01342198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484748|NCT01342744|Metformin|metformin|mesh-list
65484749|NCT01342744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65484750|NCT01342744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484751|NCT05150782|Ascorbic Acid|ascorbic acid|mesh-list
65484752|NCT05150782|Curcumin|curcumin|mesh-list
65484753|NCT05150782|Antioxidants|antioxidants|mesh-ancestor
65484754|NCT05150782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484755|NCT05150782|Protective Agents|protective agents|mesh-ancestor
65484756|NCT05150782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484757|NCT05150782|Vitamins|vitamins|mesh-ancestor
65484758|NCT05150782|Micronutrients|micronutrients|mesh-ancestor
65484759|NCT05150782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65484760|NCT05150782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65484761|NCT05150782|Analgesics|analgesics|mesh-ancestor
65484762|NCT05150782|Sensory System Agents|sensory system agents|mesh-ancestor
65484763|NCT05150782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65484764|NCT05150782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65484765|NCT05150782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65484766|NCT05150782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484767|NCT05150782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484768|NCT01316068|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
65484769|NCT01316068|Anticoagulants|anticoagulants|mesh-ancestor
64499170|NCT03417648|Micronutrients|micronutrients|mesh-ancestor
64723778|NCT00655057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723779|NCT00655057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723780|NCT00655057|Serotonin Agents|serotonin agents|mesh-ancestor
64723781|NCT00655057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723782|NCT00655057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64723783|NCT00655057|Antidepressive Agents|antidepressive agents|mesh-ancestor
64499171|NCT03417648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499172|NCT03417648|Antioxidants|antioxidants|mesh-ancestor
64499173|NCT03417648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484770|NCT01316068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65484771|NCT01316068|Antimetabolites|antimetabolites|mesh-ancestor
65484772|NCT01316068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484773|NCT01316068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65484774|NCT01316068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65484775|NCT01316068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65484776|NCT01316068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65484777|NCT01316068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484778|NCT03233308|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65484779|NCT03233308|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65484780|NCT00283049|Insulin|insulin|mesh-list
65484781|NCT00283049|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65484782|NCT00283049|Insulin Glargine|insulin glargine|mesh-list
65484783|NCT00283049|Insulin glulisine|insulin glulisine|mesh-list
65484784|NCT00283049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65484785|NCT00283049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484786|NCT00264875|Pregabalin|pregabalin|mesh-list
65484787|NCT00264875|Analgesics|analgesics|mesh-ancestor
65484788|NCT00264875|Sensory System Agents|sensory system agents|mesh-ancestor
65484789|NCT00264875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65484790|NCT00264875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484791|NCT00264875|Anticonvulsants|anticonvulsants|mesh-ancestor
65484792|NCT00264875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65484793|NCT00264875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65484794|NCT00264875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484795|NCT00264875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64868736|NCT01818908|Glucocorticoids|glucocorticoids|mesh-ancestor
64499174|NCT03417648|Protective Agents|protective agents|mesh-ancestor
64499175|NCT01831817|Calcium, Dietary|calcium, dietary|mesh-list
64499176|NCT01831817|Listerine|listerine|mesh-list
64499177|NCT01831817|Calcium|calcium|mesh-list
64499178|NCT01831817|Fluorides|fluorides|mesh-list
64499187|NCT01831817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64499188|NCT03412500|Vancomycin|vancomycin|mesh-list
64499189|NCT03412500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64499190|NCT03412500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64499191|NCT01840943|Topotecan|topotecan|mesh-list
64499192|NCT01840943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64499193|NCT01840943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64499194|NCT01840943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64499195|NCT01840943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499196|NCT01840943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64499197|NCT05171400|Insulin|insulin|mesh-list
64499198|NCT05171400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64499199|NCT05171400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499200|NCT02203630|Phenylephrine|phenylephrine|mesh-list
64499201|NCT02203630|Oxymetazoline|oxymetazoline|mesh-list
64499210|NCT02203630|Nasal Decongestants|nasal decongestants|mesh-ancestor
64499211|NCT02203630|Respiratory System Agents|respiratory system agents|mesh-ancestor
65484796|NCT00264875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65484797|NCT00264875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65484798|NCT00264875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65484799|NCT00264875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65484800|NCT03635398|Midazolam|midazolam|mesh-list
65484801|NCT03635398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65484802|NCT03635398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65484803|NCT03635398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65484804|NCT03635398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484805|NCT03635398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65484806|NCT03635398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65484807|NCT03635398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65484808|NCT03635398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65484809|NCT03635398|Anesthetics, General|anesthetics, general|mesh-ancestor
65484810|NCT03635398|Anesthetics|anesthetics|mesh-ancestor
65484811|NCT03635398|GABA Modulators|gaba modulators|mesh-ancestor
65484813|NCT03635398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65484814|NCT03635398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484815|NCT03151408|Azacitidine|azacitidine|mesh-list
65484816|NCT03151408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65484817|NCT03151408|Antimetabolites|antimetabolites|mesh-ancestor
65484818|NCT03151408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484819|NCT03151408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484820|NCT03151408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484821|NCT05226442|Heparin|heparin|mesh-list
65484822|NCT05226442|Calcium heparin|calcium heparin|mesh-list
65484823|NCT05226442|Argatroban|argatroban|mesh-list
65484824|NCT05226442|Anticoagulants|anticoagulants|mesh-ancestor
65484825|NCT05226442|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65484826|NCT05226442|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65484827|NCT05226442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484828|NCT05226442|Antithrombins|antithrombins|mesh-ancestor
65484829|NCT05226442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64868757|NCT01819012|Isoflurane|isoflurane|mesh-list
64499212|NCT02203630|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64499213|NCT02203630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64499214|NCT02203630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64499215|NCT02203630|Adrenergic Agents|adrenergic agents|mesh-ancestor
64499216|NCT02203630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64499217|NCT02203630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499218|NCT02203630|Protective Agents|protective agents|mesh-ancestor
65484830|NCT05226442|Protease Inhibitors|protease inhibitors|mesh-ancestor
65484831|NCT05226442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484832|NCT05226442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65484833|NCT01316458|Imatinib Mesylate|imatinib mesylate|mesh-list
65484834|NCT01316458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484835|NCT01316458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65484836|NCT01316458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484837|NCT01316458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484838|NCT05198128|Calcium|calcium|mesh-list
65484839|NCT05198128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65484840|NCT05198128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484841|NCT02121184|Oxytocin|oxytocin|mesh-list
65484842|NCT02121184|Oxytocics|oxytocics|mesh-ancestor
65484843|NCT02121184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65484844|NCT02121184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484845|NCT01485874|Doxorubicin|doxorubicin|mesh-list
65484846|NCT01485874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65484847|NCT01485874|Nintedanib|nintedanib|mesh-list
65484848|NCT01485874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65484849|NCT01485874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484850|NCT01485874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65484851|NCT01485874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65484852|NCT01485874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484853|NCT01485874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484854|NCT01485874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65484855|NCT05000710|Durvalumab|durvalumab|mesh-list
65484856|NCT05000710|Tremelimumab|tremelimumab|mesh-list
65484857|NCT05000710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65484858|NCT05000710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484859|NCT04786756|Bupivacaine|bupivacaine|mesh-list
65484860|NCT04786756|Anesthetics, Local|anesthetics, local|mesh-ancestor
65484861|NCT04786756|Anesthetics|anesthetics|mesh-ancestor
65484866|NCT05073250|Rituximab|rituximab|mesh-list
65484873|NCT00546754|Valsartan|valsartan|mesh-list
65484874|NCT00546754|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65484875|NCT00546754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65484876|NCT00546754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65484877|NCT00546754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65484878|NCT00546754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484879|NCT00546754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65484880|NCT00546754|Diuretics|diuretics|mesh-ancestor
65484881|NCT00546754|Natriuretic Agents|natriuretic agents|mesh-ancestor
65484882|NCT00546754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484883|NCT00546754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65484884|NCT00546754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65484885|NCT04768426|Capecitabine|capecitabine|mesh-list
65234408|NCT00754429|Losartan|losartan|mesh-list
65484886|NCT04768426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65484887|NCT04768426|Antimetabolites|antimetabolites|mesh-ancestor
65484888|NCT04768426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484889|NCT04768426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484890|NCT04473508|Ropivacaine|ropivacaine|mesh-list
65484891|NCT04473508|Anesthetics, Local|anesthetics, local|mesh-ancestor
65484892|NCT04473508|Anesthetics|anesthetics|mesh-ancestor
65484893|NCT04473508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65484894|NCT04473508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484895|NCT04473508|Sensory System Agents|sensory system agents|mesh-ancestor
65484896|NCT04473508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65484897|NCT04471402|Dexmedetomidine|dexmedetomidine|mesh-list
65484898|NCT04471402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65484899|NCT04471402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65484900|NCT04471402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484901|NCT04471402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65484914|NCT00282347|Mycophenolic Acid|mycophenolic acid|mesh-list
65484915|NCT00282347|Prednisone|prednisone|mesh-list
65484916|NCT00282347|Methylprednisolone|methylprednisolone|mesh-list
65484917|NCT00282347|Rituximab|rituximab|mesh-list
65484918|NCT00282347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65484919|NCT00282347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484920|NCT00282347|Immunologic Factors|immunologic factors|mesh-ancestor
65484921|NCT00282347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484922|NCT00282347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65484923|NCT00282347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65484924|NCT00282347|Glucocorticoids|glucocorticoids|mesh-ancestor
65484925|NCT00282347|Hormones|hormones|mesh-ancestor
65484926|NCT00282347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65484927|NCT00282347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65484928|NCT00282347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65484929|NCT00282347|Analgesics|analgesics|mesh-ancestor
65484930|NCT00282347|Sensory System Agents|sensory system agents|mesh-ancestor
65484931|NCT00282347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65484932|NCT00282347|Antipyretics|antipyretics|mesh-ancestor
65484933|NCT00282347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65484934|NCT00282347|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65484935|NCT00282347|Antitubercular Agents|antitubercular agents|mesh-ancestor
65484936|NCT00282347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65484937|NCT00282347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65484938|NCT00282347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484939|NCT00282347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484940|NCT00282347|Antiemetics|antiemetics|mesh-ancestor
65484941|NCT00282347|Autonomic Agents|autonomic agents|mesh-ancestor
65484942|NCT00282347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65484943|NCT00282347|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65484944|NCT00282347|Protective Agents|protective agents|mesh-ancestor
65484945|NCT00282347|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65484946|NCT00282347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64499221|NCT04593329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64945664|NCT05351801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499223|NCT04593329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64499224|NCT04593329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499226|NCT04593329|Sensory System Agents|sensory system agents|mesh-ancestor
64499227|NCT04593329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499228|NCT04593329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64499229|NCT04593329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65484947|NCT00282347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65484948|NCT00282347|Anesthetics, Local|anesthetics, local|mesh-ancestor
65484949|NCT00282347|Anesthetics|anesthetics|mesh-ancestor
65484950|NCT00282347|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65484951|NCT00282347|Histamine Antagonists|histamine antagonists|mesh-ancestor
65484952|NCT00282347|Histamine Agents|histamine agents|mesh-ancestor
65484953|NCT00282347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65484954|NCT00282347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65484955|NCT00282347|Antipruritics|antipruritics|mesh-ancestor
65484956|NCT00282347|Dermatologic Agents|dermatologic agents|mesh-ancestor
65484957|NCT01334632|Morphine|morphine|mesh-list
65484958|NCT01334632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65484959|NCT01334632|Narcotics|narcotics|mesh-ancestor
65484960|NCT01334632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65484961|NCT01334632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484962|NCT01334632|Analgesics|analgesics|mesh-ancestor
65484963|NCT01334632|Sensory System Agents|sensory system agents|mesh-ancestor
65484964|NCT01334632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65484965|NCT00405964|Desloratadine|desloratadine|mesh-list
65484966|NCT00405964|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65484967|NCT00405964|Cholinergic Agents|cholinergic agents|mesh-ancestor
65484968|NCT00405964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65484969|NCT00405964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484970|NCT00405964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868894|NCT01819961|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64499230|NCT04593329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64499231|NCT04593329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64499232|NCT04593329|Antipyretics|antipyretics|mesh-ancestor
64499233|NCT03397446|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64499234|NCT03397446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64499235|NCT03397446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499236|NCT03397446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64499237|NCT03397446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64499238|NCT03397446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64499239|NCT03397446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499240|NCT03397446|Dopamine Agents|dopamine agents|mesh-ancestor
64499241|NCT03397446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723784|NCT00655057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64723785|NCT00000211|Buprenorphine|buprenorphine|mesh-list
64723786|NCT00000211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64723787|NCT00000211|Narcotics|narcotics|mesh-ancestor
64723788|NCT00000211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64723789|NCT00000211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723790|NCT00000211|Analgesics|analgesics|mesh-ancestor
64723791|NCT00000211|Sensory System Agents|sensory system agents|mesh-ancestor
64723792|NCT00000211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499242|NCT01393132|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64499243|NCT01393132|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64499244|NCT02520570|Urinastatin|urinastatin|mesh-list
64499245|NCT02520570|Trypsin Inhibitors|trypsin inhibitors|mesh-list
65484971|NCT00405964|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65484972|NCT00405964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65484973|NCT00405964|Histamine Antagonists|histamine antagonists|mesh-ancestor
65484974|NCT00405964|Histamine Agents|histamine agents|mesh-ancestor
65484975|NCT00264797|Methylphenidate|methylphenidate|mesh-list
65484976|NCT00264797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65484977|NCT00264797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65484978|NCT00264797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65484979|NCT00264797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65484980|NCT00264797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65484981|NCT00264797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484982|NCT00264797|Dopamine Agents|dopamine agents|mesh-ancestor
65484983|NCT00264797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65484984|NCT03148756|Dalbavancin|dalbavancin|mesh-list
65484985|NCT03148756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65484986|NCT03148756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65484987|NCT01343680|Heparin|heparin|mesh-list
65484988|NCT01343680|Anticoagulants|anticoagulants|mesh-ancestor
65484989|NCT01343680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65484990|NCT01343680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65484991|NCT01343680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484992|NCT00281957|Sirolimus|sirolimus|mesh-list
65484993|NCT00281957|Sorafenib|sorafenib|mesh-list
65484994|NCT00281957|Tipifarnib|tipifarnib|mesh-list
65484995|NCT00281957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65484996|NCT00281957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65484997|NCT00281957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65484998|NCT00281957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65484999|NCT00281957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65485016|NCT01070225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485017|NCT01070225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485018|NCT01070225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65485019|NCT01070225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65485020|NCT01070225|Vasodilator Agents|vasodilator agents|mesh-ancestor
65485021|NCT01070615|Prucalopride|prucalopride|mesh-list
65485022|NCT01070615|Laxatives|laxatives|mesh-ancestor
65485023|NCT01070615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65485024|NCT01070615|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65485025|NCT01070615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65485026|NCT01070615|Serotonin Agents|serotonin agents|mesh-ancestor
65485027|NCT01070615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65485028|NCT01070615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485029|NCT01070615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485030|NCT00262925|Leucovorin|leucovorin|mesh-list
65485077|NCT01581515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65485078|NCT01581515|Immunologic Factors|immunologic factors|mesh-ancestor
65485079|NCT01581515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485080|NCT03720470|Abrocitinib|abrocitinib|mesh-list
65485081|NCT03720470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65485082|NCT03720470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485083|NCT03720470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485084|NCT00262847|Paclitaxel|paclitaxel|mesh-list
65485085|NCT00262847|Bevacizumab|bevacizumab|mesh-list
65485086|NCT00262847|Carboplatin|carboplatin|mesh-list
65485087|NCT00262847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65485088|NCT00262847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65485089|NCT00262847|Endothelial Growth Factors|endothelial growth factors|mesh-list
65485090|NCT00262847|Antibodies|antibodies|mesh-list
65485091|NCT00262847|Immunoglobulins|immunoglobulins|mesh-list
65485092|NCT00262847|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65485093|NCT00262847|Immunoglobulin G|immunoglobulin g|mesh-list
65485094|NCT00262847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65485095|NCT00262847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485096|NCT00262847|Tubulin Modulators|tubulin modulators|mesh-ancestor
65485097|NCT00262847|Antimitotic Agents|antimitotic agents|mesh-ancestor
65485098|NCT00262847|Mitosis Modulators|mitosis modulators|mesh-ancestor
65485099|NCT00262847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485100|NCT00262847|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65485101|NCT00262847|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65485102|NCT00262847|Growth Substances|growth substances|mesh-ancestor
65485103|NCT00262847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485104|NCT00262847|Growth Inhibitors|growth inhibitors|mesh-ancestor
65485105|NCT00262847|Immunologic Factors|immunologic factors|mesh-ancestor
65485106|NCT05329532|Pembrolizumab|pembrolizumab|mesh-list
65485108|NCT05329532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485121|NCT00280397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65485122|NCT00280397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485123|NCT00280397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485124|NCT03817112|Dexmedetomidine|dexmedetomidine|mesh-list
65485125|NCT03817112|Propofol|propofol|mesh-list
65485126|NCT03817112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65485127|NCT03817112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65485128|NCT03817112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485129|NCT03817112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65485130|NCT03817112|Anesthetics, General|anesthetics, general|mesh-ancestor
65485131|NCT03817112|Anesthetics|anesthetics|mesh-ancestor
65485132|NCT03817112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65485133|NCT03817112|Analgesics|analgesics|mesh-ancestor
65485134|NCT03817112|Sensory System Agents|sensory system agents|mesh-ancestor
65485135|NCT03817112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65485136|NCT03817112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65485137|NCT03817112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65485138|NCT03817112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65485139|NCT03817112|Adrenergic Agents|adrenergic agents|mesh-ancestor
65485140|NCT03817112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65485141|NCT03817112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485142|NCT00262301|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
65485143|NCT00262301|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65485144|NCT00262301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65485145|NCT00262301|Immunologic Factors|immunologic factors|mesh-ancestor
65485146|NCT00262301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485147|NCT03814148|Indapamide|indapamide|mesh-list
65485148|NCT03814148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65485149|NCT03814148|Diuretics|diuretics|mesh-ancestor
65485150|NCT03814148|Natriuretic Agents|natriuretic agents|mesh-ancestor
65485164|NCT04224272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485165|NCT04224272|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65485166|NCT04224272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65485167|NCT04224272|Hormone Antagonists|hormone antagonists|mesh-ancestor
65485168|NCT04224272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65485169|NCT04224272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485170|NCT04224272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65485171|NCT04224272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485172|NCT04224272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485173|NCT03800810|Hyaluronic Acid|hyaluronic acid|mesh-list
65485174|NCT03800810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65485175|NCT03800810|Immunologic Factors|immunologic factors|mesh-ancestor
65485176|NCT03800810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485177|NCT03800810|Viscosupplements|viscosupplements|mesh-ancestor
65485178|NCT03800810|Protective Agents|protective agents|mesh-ancestor
65485179|NCT03974867|Prednisone|prednisone|mesh-list
65485180|NCT03974867|Methylprednisolone|methylprednisolone|mesh-list
65485181|NCT03974867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65485182|NCT03974867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65485183|NCT03974867|Prednisolone|prednisolone|mesh-list
65485184|NCT03974867|Prednisolone acetate|prednisolone acetate|mesh-list
65485185|NCT03974867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65485186|NCT03974867|Prednisolone phosphate|prednisolone phosphate|mesh-list
65485187|NCT03974867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65485215|NCT03799094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485216|NCT03799094|Protective Agents|protective agents|mesh-ancestor
65485217|NCT00277355|Minocycline|minocycline|mesh-list
65485218|NCT00277355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65485219|NCT00277355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65485220|NCT05593094|Trastuzumab|trastuzumab|mesh-list
65485221|NCT05593094|Pertuzumab|pertuzumab|mesh-list
65485222|NCT05593094|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65485223|NCT05593094|Maytansine|maytansine|mesh-list
65485224|NCT05593094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65485225|NCT05593094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485226|NCT05593094|Tubulin Modulators|tubulin modulators|mesh-ancestor
65485227|NCT05593094|Antimitotic Agents|antimitotic agents|mesh-ancestor
65485228|NCT05593094|Mitosis Modulators|mitosis modulators|mesh-ancestor
65485229|NCT05593094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485230|NCT05593094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65485231|NCT00262223|Sertraline|sertraline|mesh-list
65485232|NCT00262223|Antidepressive Agents|antidepressive agents|mesh-ancestor
65485233|NCT00262223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65485234|NCT00262223|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65485235|NCT00262223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65485238|NCT00262223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65485266|NCT05216432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65485267|NCT05216432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485268|NCT05216432|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65485269|NCT05216432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65485270|NCT05216432|Hormone Antagonists|hormone antagonists|mesh-ancestor
65485271|NCT05216432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65485272|NCT05216432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485273|NCT03798392|Anesthetics|anesthetics|mesh-list
65485274|NCT03798392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65485275|NCT03798392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485276|NCT03816020|Niacinamide|niacinamide|mesh-list
65485277|NCT03816020|Niacin|niacin|mesh-list
65485278|NCT03816020|Nicotinic Acids|nicotinic acids|mesh-list
65485279|NCT03816020|Vitamin B Complex|vitamin b complex|mesh-ancestor
65485280|NCT03816020|Vitamins|vitamins|mesh-ancestor
65485281|NCT03816020|Micronutrients|micronutrients|mesh-ancestor
65485282|NCT03816020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485283|NCT03816020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65485284|NCT03816020|Antimetabolites|antimetabolites|mesh-ancestor
65485285|NCT03816020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485286|NCT03816020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65485287|NCT03816020|Vasodilator Agents|vasodilator agents|mesh-ancestor
65485288|NCT03815864|Antibodies|antibodies|mesh-list
65485289|NCT03815864|Immunoglobulins|immunoglobulins|mesh-list
65485290|NCT03815864|Immunologic Factors|immunologic factors|mesh-ancestor
65485291|NCT03815864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485292|NCT03815942|Nivolumab|nivolumab|mesh-list
65485293|NCT03815942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65485294|NCT03815942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485295|NCT03815942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65485296|NCT03815942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485308|NCT01303874|Immunologic Factors|immunologic factors|mesh-ancestor
65485309|NCT03813056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65485310|NCT03813056|Lubricant Eye Drops|lubricant eye drops|mesh-list
65485311|NCT03813056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65485312|NCT04140266|Tenofovir|tenofovir|mesh-list
65485313|NCT04140266|Emtricitabine|emtricitabine|mesh-list
65485314|NCT04140266|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65485315|NCT04140266|Dapivirine|dapivirine|mesh-list
65485316|NCT04140266|Antiviral Agents|antiviral agents|mesh-ancestor
65485317|NCT04140266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65485318|NCT04140266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65485319|NCT04140266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65485320|NCT04140266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485321|NCT04140266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485322|NCT04140266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65485323|NCT04140266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65485324|NCT04109924|Trifluridine|trifluridine|mesh-list
65485325|NCT04109924|Bevacizumab|bevacizumab|mesh-list
65485326|NCT04109924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65485327|NCT04109924|Irinotecan|irinotecan|mesh-list
65485328|NCT04109924|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
65485329|NCT04109924|Antibodies|antibodies|mesh-list
65485330|NCT04109924|Immunoglobulins|immunoglobulins|mesh-list
65485331|NCT04109924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65485332|NCT04109924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485333|NCT04109924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65485334|NCT04109924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65485335|NCT04109924|Growth Substances|growth substances|mesh-ancestor
65485336|NCT04109924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485337|NCT04109924|Growth Inhibitors|growth inhibitors|mesh-ancestor
65485353|NCT01301612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485354|NCT01301612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65485355|NCT04954820|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65485356|NCT04954820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65485357|NCT04954820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485358|NCT01303952|Eculizumab|eculizumab|mesh-list
65485359|NCT01303952|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65485360|NCT01303952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65485361|NCT01303952|Immunologic Factors|immunologic factors|mesh-ancestor
65485362|NCT01303952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485363|NCT03970616|Durvalumab|durvalumab|mesh-list
65485364|NCT03970616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65485365|NCT03970616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485366|NCT03815474|Epirubicin|epirubicin|mesh-list
65485367|NCT03815474|Ifosfamide|ifosfamide|mesh-list
65485368|NCT03815474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65485369|NCT03815474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485370|NCT03815474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65485371|NCT03815474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65485372|NCT03815474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485373|NCT03815474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485374|NCT03815474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65485375|NCT03815474|Alkylating Agents|alkylating agents|mesh-ancestor
65485376|NCT01302158|Glimepiride|glimepiride|mesh-list
65485377|NCT01302158|Ipragliflozin|ipragliflozin|mesh-list
65485378|NCT01302158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65485379|NCT01302158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65485380|NCT01302158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485381|NCT01302158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65485382|NCT01302158|Immunologic Factors|immunologic factors|mesh-ancestor
65485383|NCT01302158|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65485384|NCT01302158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485393|NCT01302236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65485394|NCT01304264|Maleic acid|maleic acid|mesh-list
65485395|NCT01304264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485396|NCT01304264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485397|NCT01304342|Fentanyl|fentanyl|mesh-list
65485398|NCT01304342|Remifentanil|remifentanil|mesh-list
65485399|NCT01304342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65485400|NCT01304342|Narcotics|narcotics|mesh-ancestor
65485401|NCT01304342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65485402|NCT01304342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485403|NCT01304342|Analgesics|analgesics|mesh-ancestor
65485404|NCT01304342|Sensory System Agents|sensory system agents|mesh-ancestor
65485405|NCT01304342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65485406|NCT01304342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65485407|NCT01304342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65485408|NCT01304342|Anesthetics, General|anesthetics, general|mesh-ancestor
65485409|NCT01304342|Anesthetics|anesthetics|mesh-ancestor
65485410|NCT05651282|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65485411|NCT05651282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65485412|NCT05651282|Contraceptive Agents|contraceptive agents|mesh-ancestor
65485413|NCT05651282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65485414|NCT05651282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485415|NCT05651282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64499246|NCT02520570|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64499262|NCT03411798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64499263|NCT03411798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64499264|NCT03411798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64499265|NCT03411798|Immunologic Factors|immunologic factors|mesh-ancestor
64499266|NCT03411798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64499267|NCT03411798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64499268|NCT03411798|Antimalarials|antimalarials|mesh-ancestor
64499269|NCT03411798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64499270|NCT03411798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64499271|NCT03411798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64499272|NCT03411798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64499273|NCT03411798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64499274|NCT03411798|Analgesics|analgesics|mesh-ancestor
64499275|NCT03411798|Sensory System Agents|sensory system agents|mesh-ancestor
64499276|NCT03411798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499277|NCT03411798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64499281|NCT03408756|Abortifacient Agents|abortifacient agents|mesh-ancestor
64499282|NCT03408756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64499283|NCT03408756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499284|NCT03408756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64499285|NCT03408756|Antimetabolites|antimetabolites|mesh-ancestor
64499286|NCT03408756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499287|NCT03408756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64499288|NCT03408756|Dermatologic Agents|dermatologic agents|mesh-ancestor
64499289|NCT03408756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64499290|NCT03408756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64499291|NCT03408756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64499292|NCT03408756|Immunologic Factors|immunologic factors|mesh-ancestor
65485416|NCT05651282|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65485417|NCT05651282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65485418|NCT05651282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485419|NCT03653546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65485420|NCT03653546|Gefitinib|gefitinib|mesh-list
65485421|NCT03653546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485422|NCT03653546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65485423|NCT03653546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485424|NCT03653546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485425|NCT03812354|Nicotine|nicotine|mesh-list
65485426|NCT03812354|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65485427|NCT03812354|Autonomic Agents|autonomic agents|mesh-ancestor
65485428|NCT03812354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65485429|NCT03812354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485430|NCT03812354|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65485431|NCT03812354|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65485432|NCT03812354|Cholinergic Agents|cholinergic agents|mesh-ancestor
65485433|NCT03812354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65485434|NCT03812354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485435|NCT03812120|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65485436|NCT03812120|Hemostatics|hemostatics|mesh-ancestor
65485437|NCT03812120|Coagulants|coagulants|mesh-ancestor
65485438|NCT03796364|Endostar protein|endostar protein|mesh-list
65485439|NCT03796364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65485440|NCT03796364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65485441|NCT03796364|Growth Substances|growth substances|mesh-ancestor
65485442|NCT03796364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485443|NCT03796364|Growth Inhibitors|growth inhibitors|mesh-ancestor
65485462|NCT03795272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485463|NCT03795272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485464|NCT00980954|Paclitaxel|paclitaxel|mesh-list
65485465|NCT00980954|Carboplatin|carboplatin|mesh-list
65485466|NCT00980954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65485467|NCT00980954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485468|NCT00980954|Tubulin Modulators|tubulin modulators|mesh-ancestor
65485469|NCT00980954|Antimitotic Agents|antimitotic agents|mesh-ancestor
65485470|NCT00980954|Mitosis Modulators|mitosis modulators|mesh-ancestor
65485471|NCT00980954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485472|NCT00956930|Doxorubicin|doxorubicin|mesh-list
65485473|NCT00956930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65485474|NCT00956930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65485475|NCT00956930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485476|NCT00956930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65485477|NCT00956930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65485478|NCT00956930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485479|NCT00956930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485480|NCT00080756|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65485481|NCT00080756|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65485482|NCT00080756|Estradiol|estradiol|mesh-list
65485483|NCT00080756|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65485484|NCT00080756|Testosterone|testosterone|mesh-list
65485485|NCT00080756|Deslorelin|deslorelin|mesh-list
65485486|NCT00080756|Estrogens|estrogens|mesh-ancestor
65485487|NCT00080756|Hormones|hormones|mesh-ancestor
65485488|NCT00080756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64499293|NCT03408756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64499294|NCT03408756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64499295|NCT01394614|Vaccines|vaccines|mesh-list
64499296|NCT01394614|Immunologic Factors|immunologic factors|mesh-ancestor
64499297|NCT01394614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499298|NCT04588818|Adalimumab|adalimumab|mesh-list
64499299|NCT04588818|Methotrexate|methotrexate|mesh-list
64499300|NCT04588818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64499301|NCT04588818|Abortifacient Agents|abortifacient agents|mesh-ancestor
64499302|NCT04588818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64499303|NCT04588818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499304|NCT04588818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64499313|NCT04588818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64499314|NCT04588818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64499315|NCT04588818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64499316|NCT01422226|Alprostadil|alprostadil|mesh-list
64499317|NCT01422226|Misoprostol|misoprostol|mesh-list
64499318|NCT01422226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64499319|NCT01422226|Abortifacient Agents|abortifacient agents|mesh-ancestor
64499320|NCT01422226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64499321|NCT01422226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723793|NCT00000211|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65485489|NCT00080756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485490|NCT00080756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65485491|NCT00080756|Contraceptive Agents|contraceptive agents|mesh-ancestor
65485492|NCT00080756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65485493|NCT00080756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65485494|NCT00080756|Androgens|androgens|mesh-ancestor
65485495|NCT00080756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485496|NCT00080756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485497|NCT03792620|Daratumumab|daratumumab|mesh-list
65485498|NCT03792620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485499|NCT05027594|Dexamethasone|dexamethasone|mesh-list
65485500|NCT05027594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65485501|NCT05027594|Antiemetics|antiemetics|mesh-ancestor
65485502|NCT05027594|Autonomic Agents|autonomic agents|mesh-ancestor
65485503|NCT05027594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65485504|NCT05027594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485505|NCT05027594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65485506|NCT05027594|Glucocorticoids|glucocorticoids|mesh-ancestor
65485507|NCT05027594|Hormones|hormones|mesh-ancestor
65485508|NCT05027594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65485509|NCT05027594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65485510|NCT05027594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485511|NCT03811418|Docetaxel|docetaxel|mesh-list
64723794|NCT04358432|Ezetimibe|ezetimibe|mesh-list
64723795|NCT04358432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64723796|NCT04358432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64723797|NCT04358432|Antimetabolites|antimetabolites|mesh-ancestor
64723798|NCT04358432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723799|NCT04358432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64723800|NCT00000217|Carbamazepine|carbamazepine|mesh-list
64723801|NCT00000217|Anticonvulsants|anticonvulsants|mesh-ancestor
64723802|NCT00000217|Antimanic Agents|antimanic agents|mesh-ancestor
64723803|NCT00000217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64723804|NCT00000217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64723805|NCT00000217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331404|NCT05518734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331409|NCT05513365|Goserelin|goserelin|mesh-list
64499322|NCT01422226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64499323|NCT01422226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64499324|NCT01422226|Oxytocics|oxytocics|mesh-ancestor
64499325|NCT01422226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64499326|NCT01422226|Vasodilator Agents|vasodilator agents|mesh-ancestor
64499327|NCT01422226|Urological Agents|urological agents|mesh-ancestor
64499328|NCT01423162|Ascorbic Acid|ascorbic acid|mesh-list
64499329|NCT01423162|Antioxidants|antioxidants|mesh-ancestor
64499330|NCT01423162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499331|NCT01423162|Protective Agents|protective agents|mesh-ancestor
64499332|NCT01423162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499334|NCT01423162|Micronutrients|micronutrients|mesh-ancestor
64499335|NCT01328782|Acetaminophen|acetaminophen|mesh-list
64499336|NCT01328782|Oxycodone|oxycodone|mesh-list
64499337|NCT01328782|Bupivacaine|bupivacaine|mesh-list
64499338|NCT01328782|Ropivacaine|ropivacaine|mesh-list
65485512|NCT03811418|Trastuzumab|trastuzumab|mesh-list
65485513|NCT03811418|Vinorelbine|vinorelbine|mesh-list
65485514|NCT03811418|Pertuzumab|pertuzumab|mesh-list
65485515|NCT03811418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485516|NCT03811418|Tubulin Modulators|tubulin modulators|mesh-ancestor
65485517|NCT03811418|Antimitotic Agents|antimitotic agents|mesh-ancestor
65485518|NCT03811418|Mitosis Modulators|mitosis modulators|mesh-ancestor
65485519|NCT03811418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485520|NCT03811418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65485521|NCT03811418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65485522|NCT03794492|Mycophenolic Acid|mycophenolic acid|mesh-list
65485523|NCT03794492|Methylprednisolone|methylprednisolone|mesh-list
65485524|NCT03794492|Prednisolone|prednisolone|mesh-list
65485525|NCT03794492|Tacrolimus|tacrolimus|mesh-list
65485526|NCT03794492|Basiliximab|basiliximab|mesh-list
65485527|NCT03794492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65485528|NCT03794492|Immunologic Factors|immunologic factors|mesh-ancestor
65485529|NCT03794492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485530|NCT03794492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65485531|NCT03794492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485532|NCT03794492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485533|NCT03794492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65485534|NCT03794492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485535|NCT03794492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65485536|NCT03794492|Antitubercular Agents|antitubercular agents|mesh-ancestor
65485537|NCT03794492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65485538|NCT03794492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65485539|NCT03794492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65485540|NCT03794492|Antiemetics|antiemetics|mesh-ancestor
65485541|NCT03794492|Autonomic Agents|autonomic agents|mesh-ancestor
65485542|NCT03794492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65485543|NCT03794492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65485544|NCT03794492|Glucocorticoids|glucocorticoids|mesh-ancestor
64499339|NCT01328782|Anesthetics, Local|anesthetics, local|mesh-ancestor
64499340|NCT01328782|Anesthetics|anesthetics|mesh-ancestor
64499341|NCT01328782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64499342|NCT01328782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499343|NCT01328782|Sensory System Agents|sensory system agents|mesh-ancestor
64499344|NCT01328782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499345|NCT01328782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64499352|NCT04447326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64499353|NCT04447326|Growth Substances|growth substances|mesh-ancestor
65485545|NCT03794492|Hormones|hormones|mesh-ancestor
65485546|NCT03794492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65485547|NCT03794492|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65485548|NCT03794492|Protective Agents|protective agents|mesh-ancestor
65485549|NCT03794492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65485550|NCT05624996|Paclitaxel|paclitaxel|mesh-list
65485551|NCT05624996|Etoposide|etoposide|mesh-list
65485552|NCT05624996|Podophyllotoxin|podophyllotoxin|mesh-list
65485553|NCT05624996|Cisplatin|cisplatin|mesh-list
65485554|NCT05624996|Carboplatin|carboplatin|mesh-list
65485555|NCT05624996|Pemetrexed|pemetrexed|mesh-list
65485556|NCT05624996|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65485557|NCT05624996|Etoposide phosphate|etoposide phosphate|mesh-list
65485558|NCT05624996|Durvalumab|durvalumab|mesh-list
65485559|NCT05624996|Immunoglobulins|immunoglobulins|mesh-list
65485560|NCT05624996|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65485561|NCT05624996|Immunoglobulin G|immunoglobulin g|mesh-list
65485562|NCT05624996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65485563|NCT05624996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485564|NCT05624996|Tubulin Modulators|tubulin modulators|mesh-ancestor
65485565|NCT05624996|Antimitotic Agents|antimitotic agents|mesh-ancestor
65485566|NCT05624996|Mitosis Modulators|mitosis modulators|mesh-ancestor
65485600|NCT00275561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485601|NCT00275561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65485602|NCT00275561|Respiratory System Agents|respiratory system agents|mesh-ancestor
65485603|NCT00275561|Dermatologic Agents|dermatologic agents|mesh-ancestor
65485604|NCT00275561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65485605|NCT03810872|Paclitaxel|paclitaxel|mesh-list
65485606|NCT03810872|Afatinib|afatinib|mesh-list
65485607|NCT03810872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65485608|NCT03810872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485609|NCT03810872|Tubulin Modulators|tubulin modulators|mesh-ancestor
65485610|NCT03810872|Antimitotic Agents|antimitotic agents|mesh-ancestor
65485611|NCT03810872|Mitosis Modulators|mitosis modulators|mesh-ancestor
65485612|NCT03810872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485613|NCT03810872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65485614|NCT03810872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485615|NCT03794180|Plonmarlimab|plonmarlimab|mesh-list
65485616|NCT03794180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65485617|NCT03794180|Antiviral Agents|antiviral agents|mesh-ancestor
65485618|NCT03794180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65485619|NCT00274937|Cisplatin|cisplatin|mesh-list
65485620|NCT00274937|Fluorouracil|fluorouracil|mesh-list
65485621|NCT00274937|Amifostine|amifostine|mesh-list
65485622|NCT00274937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485623|NCT00274937|Antimetabolites|antimetabolites|mesh-ancestor
65485624|NCT00274937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485625|NCT00274937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65485626|NCT00274937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65485627|NCT00274937|Immunologic Factors|immunologic factors|mesh-ancestor
65485628|NCT00274937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485629|NCT00274937|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65485630|NCT00274937|Protective Agents|protective agents|mesh-ancestor
65485631|NCT03792074|Paclitaxel|paclitaxel|mesh-list
65485632|NCT03792074|Bevacizumab|bevacizumab|mesh-list
65485633|NCT03792074|Carboplatin|carboplatin|mesh-list
65485634|NCT03792074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65485635|NCT03792074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485636|NCT03792074|Tubulin Modulators|tubulin modulators|mesh-ancestor
65485637|NCT03792074|Antimitotic Agents|antimitotic agents|mesh-ancestor
65485639|NCT03792074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485640|NCT03792074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65235152|NCT04049539|Antiviral Agents|antiviral agents|mesh-ancestor
65485641|NCT03792074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65485642|NCT03792074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65485643|NCT03792074|Growth Substances|growth substances|mesh-ancestor
65485644|NCT03792074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485645|NCT03792074|Growth Inhibitors|growth inhibitors|mesh-ancestor
65485646|NCT05624528|Tolcapone|tolcapone|mesh-list
65485647|NCT05624528|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65485648|NCT05624528|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65485649|NCT05624528|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65485650|NCT05624528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485651|NCT05624528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485652|NCT00251693|Lansoprazole|lansoprazole|mesh-list
65485653|NCT00251693|Dexlansoprazole|dexlansoprazole|mesh-list
65485654|NCT00251693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65485655|NCT00251693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65485656|NCT00251693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65485657|NCT00251693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485658|NCT00251693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485659|NCT03791918|Lenvatinib|lenvatinib|mesh-list
65485660|NCT03791918|Chlorotrianisene|chlorotrianisene|mesh-list
65485661|NCT03791918|Antibodies|antibodies|mesh-list
65485662|NCT03791918|Immunoglobulins|immunoglobulins|mesh-list
65485663|NCT03791918|Immunologic Factors|immunologic factors|mesh-ancestor
65485664|NCT03791918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485665|NCT03791918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485666|NCT03791918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65485667|NCT03791918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485668|NCT03791918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485669|NCT03791918|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65485670|NCT03791918|Estrogens|estrogens|mesh-ancestor
65485671|NCT03791918|Hormones|hormones|mesh-ancestor
64499354|NCT04447326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499355|NCT04447326|Growth Inhibitors|growth inhibitors|mesh-ancestor
64499356|NCT04447326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64499357|NCT03411330|Lidocaine|lidocaine|mesh-list
64499358|NCT03411330|Bupivacaine|bupivacaine|mesh-list
64499359|NCT03411330|Anesthetics, Local|anesthetics, local|mesh-ancestor
64499360|NCT03411330|Anesthetics|anesthetics|mesh-ancestor
64499361|NCT03411330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65485672|NCT03791918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65485673|NCT03791918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65485674|NCT00250835|Celecoxib|celecoxib|mesh-list
65485675|NCT00250835|Capecitabine|capecitabine|mesh-list
65485676|NCT00250835|Oxaliplatin|oxaliplatin|mesh-list
65485677|NCT00250835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65485678|NCT00250835|Antimetabolites|antimetabolites|mesh-ancestor
65485679|NCT00250835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485680|NCT00250835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485681|NCT00250835|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65485682|NCT00250835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65485683|NCT00250835|Analgesics|analgesics|mesh-ancestor
65485684|NCT00250835|Sensory System Agents|sensory system agents|mesh-ancestor
65485685|NCT00250835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65485686|NCT00250835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485687|NCT00250835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65485688|NCT00250835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65485689|NCT00250835|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65485690|NCT00250835|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65485691|NCT00250835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485692|NCT01303094|Trabectedin|trabectedin|mesh-list
65485693|NCT01303094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65485694|NCT01303094|Alkylating Agents|alkylating agents|mesh-ancestor
65485695|NCT01303094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485696|NCT01303094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485697|NCT04785326|Ustekinumab|ustekinumab|mesh-list
65485698|NCT04785326|Dermatologic Agents|dermatologic agents|mesh-ancestor
65485699|NCT03791762|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
65485700|NCT03791762|Vasodilator Agents|vasodilator agents|mesh-ancestor
64499362|NCT03411330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499363|NCT03411330|Sensory System Agents|sensory system agents|mesh-ancestor
64499364|NCT03411330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499365|NCT03411330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64499366|NCT03411330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64499367|NCT03411330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64499368|NCT03411330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64499369|NCT03411330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499370|NCT03411252|Mirabegron|mirabegron|mesh-list
64723806|NCT00000217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64723807|NCT00000217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64723808|NCT00000217|Analgesics|analgesics|mesh-ancestor
64723809|NCT00000217|Sensory System Agents|sensory system agents|mesh-ancestor
64723810|NCT00000217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64723811|NCT00000217|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65485701|NCT03791762|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65485702|NCT03791762|Protective Agents|protective agents|mesh-ancestor
65485703|NCT03791762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485704|NCT04663568|Levonorgestrel|levonorgestrel|mesh-list
65485705|NCT04663568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65485706|NCT04663568|Contraceptive Agents|contraceptive agents|mesh-ancestor
65485707|NCT04663568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65485708|NCT04663568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485709|NCT04663568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65485710|NCT04663568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65485711|NCT04663568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65485712|NCT03789032|Rabeprazole|rabeprazole|mesh-list
65485713|NCT03789032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65485714|NCT03789032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65485715|NCT03789032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65485716|NCT03789032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485717|NCT03789032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485718|NCT01306370|Tranexamic Acid|tranexamic acid|mesh-list
65485719|NCT01306370|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65485720|NCT01306370|Hemostatics|hemostatics|mesh-list
65485721|NCT01306370|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65485722|NCT01306370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65485723|NCT01306370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485724|NCT01306370|Coagulants|coagulants|mesh-ancestor
65485725|NCT03716024|Linezolid|linezolid|mesh-list
65485726|NCT03716024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65485727|NCT03716024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65485728|NCT03716024|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64723812|NCT00000217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64723813|NCT00000217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723814|NCT00000217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64723815|NCT00000217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64723816|NCT00000223|Buprenorphine|buprenorphine|mesh-list
64723817|NCT00000223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64723818|NCT00000223|Narcotics|narcotics|mesh-ancestor
64723819|NCT00000223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64723820|NCT00000223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723821|NCT00000223|Analgesics|analgesics|mesh-ancestor
64723822|NCT00000223|Sensory System Agents|sensory system agents|mesh-ancestor
64499371|NCT03411252|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64499372|NCT03411252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64499381|NCT01831427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499382|NCT01830881|Ibuprofen|ibuprofen|mesh-list
64499383|NCT01830881|Lidocaine|lidocaine|mesh-list
64499384|NCT01830881|Midazolam|midazolam|mesh-list
64499385|NCT01830881|Anesthetics, Local|anesthetics, local|mesh-ancestor
64499386|NCT01830881|Anesthetics|anesthetics|mesh-ancestor
65485729|NCT03716024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485730|NCT03716024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485731|NCT00250679|Formoterol Fumarate|formoterol fumarate|mesh-list
65485732|NCT00250679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65485733|NCT00250679|Autonomic Agents|autonomic agents|mesh-ancestor
65485734|NCT00250679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65485735|NCT00250679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485736|NCT00250679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65485737|NCT00250679|Respiratory System Agents|respiratory system agents|mesh-ancestor
65485738|NCT00250679|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65485739|NCT00250679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65485740|NCT00250679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65485741|NCT00250679|Adrenergic Agents|adrenergic agents|mesh-ancestor
65485742|NCT00250679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65485743|NCT00250679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485744|NCT03791294|Titanium dioxide|titanium dioxide|mesh-list
65485745|NCT03791294|Hyaluronic Acid|hyaluronic acid|mesh-list
65485746|NCT03791294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65485747|NCT03791294|Immunologic Factors|immunologic factors|mesh-ancestor
65485748|NCT03791294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485749|NCT03791294|Viscosupplements|viscosupplements|mesh-ancestor
65485750|NCT03791294|Protective Agents|protective agents|mesh-ancestor
65485751|NCT03791294|Sunscreening Agents|sunscreening agents|mesh-ancestor
65485752|NCT03791294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65485753|NCT03791294|Dermatologic Agents|dermatologic agents|mesh-ancestor
65485754|NCT03791294|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65485755|NCT01567358|Infliximab|infliximab|mesh-list
65485756|NCT01567358|Dermatologic Agents|dermatologic agents|mesh-ancestor
65485757|NCT01567358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65485758|NCT01567358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65485759|NCT00261833|Protease Inhibitors|protease inhibitors|mesh-list
65485760|NCT00261833|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65485761|NCT00261833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485762|NCT00261833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485763|NCT00261833|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64869646|NCT01825031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64499387|NCT01830881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65485764|NCT00261833|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65485765|NCT01308242|Sevelamer|sevelamer|mesh-list
65485766|NCT01308242|Chelating Agents|chelating agents|mesh-ancestor
65485767|NCT01308242|Sequestering Agents|sequestering agents|mesh-ancestor
65485768|NCT01308242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485769|NCT01308320|Fentanyl|fentanyl|mesh-list
65485770|NCT01308320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65485771|NCT01308320|Narcotics|narcotics|mesh-ancestor
65485772|NCT01308320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65485773|NCT01308320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485774|NCT01308320|Analgesics|analgesics|mesh-ancestor
65485775|NCT01308320|Sensory System Agents|sensory system agents|mesh-ancestor
65485776|NCT01308320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65485777|NCT01308320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65485778|NCT01308320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65485779|NCT01308320|Anesthetics, General|anesthetics, general|mesh-ancestor
65485780|NCT01308320|Anesthetics|anesthetics|mesh-ancestor
65485781|NCT01306760|Ketamine|ketamine|mesh-list
65485782|NCT01306760|Propofol|propofol|mesh-list
65485783|NCT01306760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65485784|NCT01306760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65485785|NCT01306760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485786|NCT01306760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65485787|NCT01306760|Anesthetics, General|anesthetics, general|mesh-ancestor
65485788|NCT01306760|Anesthetics|anesthetics|mesh-ancestor
65485789|NCT01306760|Analgesics|analgesics|mesh-ancestor
65485790|NCT01306760|Sensory System Agents|sensory system agents|mesh-ancestor
65485791|NCT01306760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65485792|NCT01306760|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65485793|NCT01306760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65485794|NCT01306760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65485795|NCT01306760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65485796|NCT01306760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485797|NCT03787940|Isoniazid|isoniazid|mesh-list
65485798|NCT03787940|Antitubercular Agents|antitubercular agents|mesh-ancestor
65485799|NCT03787940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64499388|NCT01830881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499389|NCT01830881|Sensory System Agents|sensory system agents|mesh-ancestor
64499390|NCT01830881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65485800|NCT03787940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65485801|NCT03787940|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65485802|NCT03787940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65485803|NCT03787940|Antimetabolites|antimetabolites|mesh-ancestor
65485804|NCT03787940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485805|NCT03787940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65485806|NCT03788018|Lidocaine|lidocaine|mesh-list
65485807|NCT03788018|Dexmedetomidine|dexmedetomidine|mesh-list
65485808|NCT03788018|Anesthetics, Local|anesthetics, local|mesh-ancestor
65485809|NCT03788018|Anesthetics|anesthetics|mesh-ancestor
65485810|NCT03788018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65485811|NCT03788018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485812|NCT03788018|Sensory System Agents|sensory system agents|mesh-ancestor
65485813|NCT03788018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65485814|NCT03788018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65485815|NCT03788018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65485816|NCT03788018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65485817|NCT03788018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65485818|NCT03788018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485819|NCT03788018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65485820|NCT03788018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65485821|NCT03788018|Analgesics|analgesics|mesh-ancestor
65485822|NCT03788018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65485823|NCT03788018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65485824|NCT03788018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65485825|NCT03788018|Adrenergic Agents|adrenergic agents|mesh-ancestor
65485826|NCT03788018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65485827|NCT03785756|Ibuprofen|ibuprofen|mesh-list
64869707|NCT01825473|Erythromycin|erythromycin|mesh-list
64499391|NCT01830881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64499392|NCT01830881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64499393|NCT01830881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64499394|NCT01830881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64499395|NCT01830881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499396|NCT01830881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64499397|NCT01830881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64499398|NCT01830881|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64499399|NCT01830881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64499400|NCT01830881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64499401|NCT01830881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64499402|NCT01830881|Anesthetics, General|anesthetics, general|mesh-ancestor
64499403|NCT01830881|GABA Modulators|gaba modulators|mesh-ancestor
64499404|NCT01830881|GABA Agents|gaba agents|mesh-ancestor
64499405|NCT01830881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64499406|NCT01830881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65485828|NCT03785756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65485829|NCT03785756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65485830|NCT03785756|Analgesics|analgesics|mesh-ancestor
65485831|NCT03785756|Sensory System Agents|sensory system agents|mesh-ancestor
65485832|NCT03785756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65485833|NCT03785756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485834|NCT03785756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65485835|NCT03785756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65485836|NCT03785756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65485837|NCT03785756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485838|NCT03785756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485839|NCT03788174|Apatinib|apatinib|mesh-list
65485840|NCT03788174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485841|NCT03788174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65485842|NCT03788174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485843|NCT03788174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485844|NCT03787550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65485845|NCT03787550|Analgesics|analgesics|mesh-list
65485846|NCT03787550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65485847|NCT03787550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65485848|NCT03787550|Sensory System Agents|sensory system agents|mesh-ancestor
65485849|NCT03787550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65485850|NCT03787550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485851|NCT03787550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65485852|NCT03790358|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
65485853|NCT03790358|Hallucinogens|hallucinogens|mesh-ancestor
65485854|NCT03790358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485855|NCT03790358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65485856|NCT03790358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65485857|NCT03790358|Serotonin Agents|serotonin agents|mesh-ancestor
65485858|NCT03790358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65485859|NCT03790358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485860|NCT03790358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65485861|NCT03789890|Itraconazole|itraconazole|mesh-list
64723831|NCT00000229|Sensory System Agents|sensory system agents|mesh-ancestor
64723832|NCT00000229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64723833|NCT00000229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64723834|NCT00000235|Buprenorphine|buprenorphine|mesh-list
65485862|NCT03789890|Antifungal Agents|antifungal agents|mesh-ancestor
65485863|NCT03789890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65485864|NCT03789890|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65485865|NCT03789890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65485866|NCT03789890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485867|NCT03789890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485868|NCT03789890|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65485869|NCT03789890|Hormone Antagonists|hormone antagonists|mesh-ancestor
65485870|NCT03789890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65485871|NCT03789890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485872|NCT03789890|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65485873|NCT01308554|Bupivacaine|bupivacaine|mesh-list
65485874|NCT01308554|Anesthetics, Local|anesthetics, local|mesh-ancestor
65485875|NCT01308554|Anesthetics|anesthetics|mesh-ancestor
65485876|NCT01308554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65485877|NCT01308554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485878|NCT01308554|Sensory System Agents|sensory system agents|mesh-ancestor
65485879|NCT01308554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65485880|NCT05693402|Analgesics, Opioid|analgesics, opioid|mesh-list
65485881|NCT05693402|Anesthetics|anesthetics|mesh-list
65485882|NCT05693402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65485883|NCT05693402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485884|NCT05693402|Narcotics|narcotics|mesh-ancestor
65485885|NCT05693402|Analgesics|analgesics|mesh-ancestor
65485886|NCT05693402|Sensory System Agents|sensory system agents|mesh-ancestor
65485887|NCT05693402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64723835|NCT00000235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64723836|NCT00000235|Narcotics|narcotics|mesh-ancestor
64499421|NCT01838681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499422|NCT01838681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499423|NCT01838681|Dopamine Agonists|dopamine agonists|mesh-ancestor
64499424|NCT01838681|Dopamine Agents|dopamine agents|mesh-ancestor
64499425|NCT03404544|Carbetocin|carbetocin|mesh-list
64499426|NCT03404544|Oxytocin|oxytocin|mesh-list
64499427|NCT03404544|Oxytocics|oxytocics|mesh-ancestor
64499428|NCT03404544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64499429|NCT03404544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499431|NCT01398280|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64499432|NCT01398280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64499433|NCT01398280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499434|NCT01398280|Hemostatics|hemostatics|mesh-ancestor
64499435|NCT01398280|Coagulants|coagulants|mesh-ancestor
64499436|NCT03404310|Zinc Sulfate|zinc sulfate|mesh-list
64499437|NCT03404310|Astringents|astringents|mesh-ancestor
64499438|NCT03404310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499439|NCT03404310|Dermatologic Agents|dermatologic agents|mesh-ancestor
64499440|NCT03403842|Sufentanil|sufentanil|mesh-list
65485888|NCT05694728|Vaccines|vaccines|mesh-list
65485889|NCT05694728|Immunologic Factors|immunologic factors|mesh-ancestor
65485890|NCT05694728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485891|NCT01308632|Irinotecan|irinotecan|mesh-list
65485892|NCT01308632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65485893|NCT01308632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65485894|NCT01308632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65485895|NCT01308632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485896|NCT01308632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485897|NCT03713684|Efpeglenatide|efpeglenatide|mesh-list
65485898|NCT03713684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65485899|NCT03713684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485900|NCT03785522|Insulin|insulin|mesh-list
65485901|NCT03785522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65485902|NCT03785522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485903|NCT05694416|Etoposide|etoposide|mesh-list
65485904|NCT05694416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485905|NCT05694416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65485906|NCT05694416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65485907|NCT05694416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65485910|NCT03789422|Cetirizine|cetirizine|mesh-list
65485943|NCT05690048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485944|NCT05690048|Growth Inhibitors|growth inhibitors|mesh-ancestor
65485945|NCT05690048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65485946|NCT05690048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65485948|NCT01308086|Fluorouracil|fluorouracil|mesh-list
65485949|NCT01308086|Capecitabine|capecitabine|mesh-list
65485950|NCT01308086|Oxaliplatin|oxaliplatin|mesh-list
65485951|NCT01308086|Levoleucovorin|levoleucovorin|mesh-list
65485952|NCT01308086|Antimetabolites|antimetabolites|mesh-ancestor
65485953|NCT01308086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485954|NCT01308086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65485955|NCT01308086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485956|NCT01308086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65485957|NCT01308086|Immunologic Factors|immunologic factors|mesh-ancestor
65485958|NCT01308086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485959|NCT01308086|Antidotes|antidotes|mesh-ancestor
65485960|NCT01308086|Protective Agents|protective agents|mesh-ancestor
65485961|NCT01308086|Vitamin B Complex|vitamin b complex|mesh-ancestor
65485962|NCT01308086|Vitamins|vitamins|mesh-ancestor
65485963|NCT01308086|Micronutrients|micronutrients|mesh-ancestor
65485964|NCT05443802|Insulin|insulin|mesh-list
65485965|NCT05443802|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65485966|NCT05443802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65485967|NCT05443802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485968|NCT01308944|Propranolol|propranolol|mesh-list
65485969|NCT01308944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65485970|NCT01308944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65485971|NCT01308944|Adrenergic Agents|adrenergic agents|mesh-ancestor
65485972|NCT01308944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65485973|NCT01308944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65485974|NCT01308944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485975|NCT01308944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65485976|NCT01308944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65485977|NCT01308944|Vasodilator Agents|vasodilator agents|mesh-ancestor
65485978|NCT03777488|Tranexamic Acid|tranexamic acid|mesh-list
65485986|NCT03777254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65485987|NCT03777254|Growth Substances|growth substances|mesh-ancestor
65485988|NCT03777254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485989|NCT03777254|Growth Inhibitors|growth inhibitors|mesh-ancestor
65485990|NCT03777254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65485991|NCT01312298|Bupivacaine|bupivacaine|mesh-list
65485992|NCT01312298|Anesthetics|anesthetics|mesh-list
65485993|NCT01312298|Propofol|propofol|mesh-list
65485994|NCT01312298|Succinylcholine|succinylcholine|mesh-list
65485995|NCT01312298|Anesthetics, Local|anesthetics, local|mesh-ancestor
65485996|NCT01312298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65485997|NCT01312298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65485998|NCT01312298|Sensory System Agents|sensory system agents|mesh-ancestor
65485999|NCT01312298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65486000|NCT01312298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65486001|NCT01312298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65486002|NCT01312298|Anesthetics, General|anesthetics, general|mesh-ancestor
65486003|NCT01312298|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
65486004|NCT01312298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65486005|NCT01312298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65486006|NCT05127590|Pembrolizumab|pembrolizumab|mesh-list
65486007|NCT05127590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65486008|NCT05127590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486009|NCT01309022|Mycophenolic Acid|mycophenolic acid|mesh-list
65486010|NCT01309022|Sirolimus|sirolimus|mesh-list
65486038|NCT05401058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65486039|NCT05401058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486040|NCT05401058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65486041|NCT05401058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65486042|NCT05401058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65486043|NCT05401058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65486044|NCT05401058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65486045|NCT05401058|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65486046|NCT05401058|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65486047|NCT05401058|Dopamine Agents|dopamine agents|mesh-ancestor
65486048|NCT05401058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65486049|NCT05401058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486050|NCT03781466|Progesterone|progesterone|mesh-list
65486051|NCT03781466|Progestins|progestins|mesh-ancestor
65486052|NCT03781466|Hormones|hormones|mesh-ancestor
65486053|NCT03781466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65486054|NCT03781466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486055|NCT01318928|Metronidazole|metronidazole|mesh-list
65486056|NCT01318928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65486057|NCT01318928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65486058|NCT01318928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65486059|NCT01318928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65486060|NCT01309178|Mannitol|mannitol|mesh-list
65486061|NCT01309178|Amitriptyline|amitriptyline|mesh-list
65486062|NCT01309178|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65486063|NCT01309178|Antidepressive Agents|antidepressive agents|mesh-ancestor
65486087|NCT01335334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65486088|NCT01335334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65486089|NCT01335334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65486090|NCT01335334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65486091|NCT01335334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486092|NCT01335334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486093|NCT01335334|Antacids|antacids|mesh-ancestor
65486094|NCT01335334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65486095|NCT01344304|Aprepitant|aprepitant|mesh-list
65486096|NCT01344304|Fosaprepitant|fosaprepitant|mesh-list
65486097|NCT01344304|Antiemetics|antiemetics|mesh-ancestor
65486098|NCT01344304|Autonomic Agents|autonomic agents|mesh-ancestor
65486099|NCT01344304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65486100|NCT01344304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486101|NCT01344304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65486102|NCT01344304|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65486103|NCT01344304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65486104|NCT01344304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486105|NCT01320020|Catumaxomab|catumaxomab|mesh-list
65486106|NCT01320020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65486107|NCT05312762|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65486108|NCT05312762|Chitosan|chitosan|mesh-list
65486109|NCT05312762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65486110|NCT05312762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65486111|NCT05312762|Antimetabolites|antimetabolites|mesh-ancestor
65486112|NCT05312762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486113|NCT05312762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65486114|NCT05312762|Chelating Agents|chelating agents|mesh-ancestor
65486115|NCT05312762|Sequestering Agents|sequestering agents|mesh-ancestor
65486116|NCT05312762|Hemostatics|hemostatics|mesh-ancestor
65486117|NCT05312762|Coagulants|coagulants|mesh-ancestor
65486118|NCT05312762|Laxatives|laxatives|mesh-ancestor
65486119|NCT05312762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65486120|NCT00379288|Fluticasone|fluticasone|mesh-list
65486121|NCT00379288|Xhance|xhance|mesh-list
65486122|NCT00379288|Mometasone Furoate|mometasone furoate|mesh-list
65486123|NCT00379288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64499441|NCT03403842|Morphine|morphine|mesh-list
64499442|NCT03403842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64499454|NCT01398982|Anesthetics, Local|anesthetics, local|mesh-ancestor
64499456|NCT01398982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64499457|NCT01398982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486124|NCT00379288|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65486125|NCT00379288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65486126|NCT00379288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65486127|NCT00379288|Autonomic Agents|autonomic agents|mesh-ancestor
65486128|NCT00379288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65486129|NCT00379288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486130|NCT00379288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65486131|NCT00379288|Respiratory System Agents|respiratory system agents|mesh-ancestor
65486132|NCT00379288|Dermatologic Agents|dermatologic agents|mesh-ancestor
65486133|NCT00379288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65486134|NCT00379288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65486135|NCT00379288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65486136|NCT00379288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65486137|NCT00379288|Adrenergic Agents|adrenergic agents|mesh-ancestor
65486138|NCT00379288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65486139|NCT00379288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486140|NCT00379288|Glucocorticoids|glucocorticoids|mesh-ancestor
65486141|NCT00379288|Hormones|hormones|mesh-ancestor
65486142|NCT00379288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65486143|NCT00379288|Sympathomimetics|sympathomimetics|mesh-ancestor
65486144|NCT03784040|Nivolumab|nivolumab|mesh-list
65486145|NCT03784040|Ipilimumab|ipilimumab|mesh-list
65486146|NCT03784040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64870028|NCT01827865|Etodolac|etodolac|mesh-list
64499458|NCT01398982|Sensory System Agents|sensory system agents|mesh-ancestor
64499459|NCT01398982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499460|NCT04447560|Bupivacaine|bupivacaine|mesh-list
64499461|NCT04447560|Anesthetics, Local|anesthetics, local|mesh-ancestor
64499462|NCT04447560|Anesthetics|anesthetics|mesh-ancestor
64499463|NCT04447560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64499464|NCT04447560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499465|NCT04447560|Sensory System Agents|sensory system agents|mesh-ancestor
64499469|NCT03401736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64499470|NCT03401736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64499471|NCT03401736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499472|NCT03401736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64499473|NCT03401736|Analgesics|analgesics|mesh-ancestor
64499474|NCT03401736|Sensory System Agents|sensory system agents|mesh-ancestor
64499475|NCT03401736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499476|NCT03401736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64499477|NCT03401736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64499478|NCT03401736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64499479|NCT03401736|Adrenergic Agents|adrenergic agents|mesh-ancestor
64499480|NCT03401736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64499481|NCT03401736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723837|NCT00000235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64723838|NCT00000235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723839|NCT00000235|Analgesics|analgesics|mesh-ancestor
64723840|NCT00000235|Sensory System Agents|sensory system agents|mesh-ancestor
65486147|NCT03784040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486148|NCT03784040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65486149|NCT03784040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486150|NCT00243503|Trastuzumab|trastuzumab|mesh-list
65486151|NCT00243503|Sunitinib|sunitinib|mesh-list
65486152|NCT00243503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65486153|NCT00243503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486154|NCT00243503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65486155|NCT00243503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65486156|NCT00243503|Growth Substances|growth substances|mesh-ancestor
65486157|NCT00243503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486158|NCT00243503|Growth Inhibitors|growth inhibitors|mesh-ancestor
65486159|NCT00243503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65486160|NCT00243503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486161|NCT00243503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486162|NCT03780686|Dopamine|dopamine|mesh-list
65486163|NCT03780686|Norepinephrine|norepinephrine|mesh-list
65486164|NCT03780686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65486165|NCT03780686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65486166|NCT03780686|Adrenergic Agents|adrenergic agents|mesh-ancestor
65486167|NCT03780686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65486168|NCT03780686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486169|NCT03780686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486170|NCT03780686|Sympathomimetics|sympathomimetics|mesh-ancestor
65486171|NCT03780686|Autonomic Agents|autonomic agents|mesh-ancestor
65486172|NCT03780686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65486173|NCT03780686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65486194|NCT03775928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486195|NCT03775928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486196|NCT03775928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65486197|NCT03775928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486198|NCT03775538|Dopamine|dopamine|mesh-list
65486199|NCT03775538|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65486200|NCT03775538|Sympathomimetics|sympathomimetics|mesh-ancestor
65486201|NCT03775538|Autonomic Agents|autonomic agents|mesh-ancestor
65486202|NCT03775538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65486203|NCT03775538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486204|NCT03775538|Dopamine Agents|dopamine agents|mesh-ancestor
65486205|NCT03775538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65486206|NCT03775538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486207|NCT03775538|Protective Agents|protective agents|mesh-ancestor
65486208|NCT00259649|Eletriptan|eletriptan|mesh-list
65486209|NCT00259649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65486210|NCT00259649|Serotonin Agents|serotonin agents|mesh-ancestor
65486211|NCT00259649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65486212|NCT00259649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486213|NCT00259649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486214|NCT05668988|Carboplatin|carboplatin|mesh-list
65486215|NCT05668988|Pemetrexed|pemetrexed|mesh-list
65486216|NCT05668988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486217|NCT05668988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486218|NCT05668988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486219|NCT05668988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65486220|NCT05668988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65486221|NCT01320176|Vaccines|vaccines|mesh-list
65486222|NCT01320176|Immunologic Factors|immunologic factors|mesh-ancestor
65486223|NCT01320176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486224|NCT01335646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65486225|NCT01335646|Analgesics|analgesics|mesh-list
65486226|NCT01335646|Sensory System Agents|sensory system agents|mesh-ancestor
65486227|NCT01335646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870088|NCT01828385|Magnesium Sulfate|magnesium sulfate|mesh-list
64723841|NCT00000235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64723842|NCT00000235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64723843|NCT00000241|Flupenthixol|flupenthixol|mesh-list
64723844|NCT00000241|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
65486228|NCT01335646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486229|NCT01309412|Siltuximab|siltuximab|mesh-list
65486230|NCT01309412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486231|NCT00307060|Losartan|losartan|mesh-list
65486232|NCT00307060|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65486233|NCT00307060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65486234|NCT00307060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65486235|NCT00307060|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65486236|NCT00307060|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65486237|NCT00307060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486238|NCT00307060|Diuretics|diuretics|mesh-ancestor
65486239|NCT00307060|Natriuretic Agents|natriuretic agents|mesh-ancestor
65486240|NCT00307060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486241|NCT00307060|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65486242|NCT00307060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65486243|NCT01320254|Gemcitabine|gemcitabine|mesh-list
65486244|NCT01320254|Cisplatin|cisplatin|mesh-list
65486245|NCT01320254|Panitumumab|panitumumab|mesh-list
65235760|NCT00920296|Antiviral Agents|antiviral agents|mesh-ancestor
65486246|NCT01320254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65486247|NCT01320254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486248|NCT01320254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65486249|NCT01320254|Antimetabolites|antimetabolites|mesh-ancestor
65486251|NCT01320254|Antiviral Agents|antiviral agents|mesh-ancestor
65486280|NCT03783728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65486281|NCT03783728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65486282|NCT03783728|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65486283|NCT03783728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65486284|NCT03783728|Antimetabolites|antimetabolites|mesh-ancestor
65486285|NCT03783728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486286|NCT03783728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65486287|NCT03783728|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65486288|NCT03783728|Leprostatic Agents|leprostatic agents|mesh-ancestor
65486289|NCT03620422|Mannitol|mannitol|mesh-list
65486290|NCT03620422|Albuterol|albuterol|mesh-list
65486291|NCT03620422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65486292|NCT03620422|Autonomic Agents|autonomic agents|mesh-ancestor
65486293|NCT03620422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65486294|NCT03620422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486295|NCT03620422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65486296|NCT03620422|Respiratory System Agents|respiratory system agents|mesh-ancestor
65486297|NCT03620422|Tocolytic Agents|tocolytic agents|mesh-ancestor
65486298|NCT03620422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65486299|NCT03620422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65486300|NCT03620422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65486301|NCT03620422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65486302|NCT03620422|Adrenergic Agents|adrenergic agents|mesh-ancestor
65486303|NCT03620422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65486304|NCT03620422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486305|NCT03620422|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65486306|NCT03620422|Diuretics|diuretics|mesh-ancestor
65486307|NCT03620422|Natriuretic Agents|natriuretic agents|mesh-ancestor
65486308|NCT01309490|Ribavirin|ribavirin|mesh-list
65486309|NCT01309490|Antimetabolites|antimetabolites|mesh-ancestor
65486310|NCT01309490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486311|NCT01309490|Antiviral Agents|antiviral agents|mesh-ancestor
65486312|NCT01309490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64870168|NCT01828788|Ropivacaine|ropivacaine|mesh-list
64723845|NCT00000241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64723846|NCT00000241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64723847|NCT00000241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64723848|NCT00000241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723849|NCT00000241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64723850|NCT00000241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65486313|NCT04883840|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65486314|NCT04883840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65486315|NCT04883840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65486316|NCT04883840|Antimetabolites|antimetabolites|mesh-ancestor
65486317|NCT04883840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486318|NCT04883840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65486319|NCT04883840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65486320|NCT04883840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486321|NCT01345084|Nimotuzumab|nimotuzumab|mesh-list
65486322|NCT01345084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486323|NCT01345084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65486325|NCT03783494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65486326|NCT03783494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65486327|NCT03783494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486328|NCT03783494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65486329|NCT03783494|Anesthetics, General|anesthetics, general|mesh-ancestor
65486330|NCT03783494|Anesthetics|anesthetics|mesh-ancestor
65486331|NCT03774836|Morphine|morphine|mesh-list
65486332|NCT03774836|Tramadol|tramadol|mesh-list
65486333|NCT03774836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65486334|NCT03774836|Narcotics|narcotics|mesh-ancestor
65486335|NCT03774836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65486336|NCT03774836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486337|NCT03774836|Analgesics|analgesics|mesh-ancestor
64870193|NCT01829178|Docetaxel|docetaxel|mesh-list
64870194|NCT01829178|Fluorouracil|fluorouracil|mesh-list
64723851|NCT00000241|Dopamine Agents|dopamine agents|mesh-ancestor
64723852|NCT00000241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723853|NCT00000241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723854|NCT00000253|Nitrous Oxide|nitrous oxide|mesh-list
64723855|NCT00000253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64723856|NCT00000253|Anesthetics, General|anesthetics, general|mesh-ancestor
64723857|NCT00000253|Anesthetics|anesthetics|mesh-ancestor
64723858|NCT00000253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64723859|NCT00000253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723860|NCT00000253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64723861|NCT00000253|Analgesics|analgesics|mesh-ancestor
64723862|NCT00000253|Sensory System Agents|sensory system agents|mesh-ancestor
64723863|NCT00000253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499482|NCT03401736|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64499483|NCT03401736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64499484|NCT03401736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64499485|NCT03401736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64499486|NCT03401736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64499487|NCT03401736|Anesthetics, General|anesthetics, general|mesh-ancestor
64499488|NCT03401736|Anesthetics|anesthetics|mesh-ancestor
64499489|NCT03401736|GABA Modulators|gaba modulators|mesh-ancestor
64499490|NCT03401736|GABA Agents|gaba agents|mesh-ancestor
64499491|NCT02203786|Haloperidol|haloperidol|mesh-list
64499492|NCT02203786|Haloperidol decanoate|haloperidol decanoate|mesh-list
64499493|NCT02203786|Fluphenazine|fluphenazine|mesh-list
65486338|NCT03774836|Sensory System Agents|sensory system agents|mesh-ancestor
65486339|NCT03774836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65486340|NCT03774680|Cetuximab|cetuximab|mesh-list
65486341|NCT03774680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65486342|NCT03774680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486343|NCT03783338|Vitamin D|vitamin d|mesh-list
65486344|NCT03783338|Vitamins|vitamins|mesh-ancestor
65486345|NCT03783338|Micronutrients|micronutrients|mesh-ancestor
65486346|NCT03783338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486347|NCT03783338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65486348|NCT03774524|Misoprostol|misoprostol|mesh-list
65486349|NCT03774524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65486350|NCT03774524|Abortifacient Agents|abortifacient agents|mesh-ancestor
65486351|NCT03774524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65486352|NCT03774524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486353|NCT03774524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65486354|NCT03774524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65486355|NCT03774524|Oxytocics|oxytocics|mesh-ancestor
65486356|NCT03774446|Roscovitine|roscovitine|mesh-list
65486357|NCT03774446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486358|NCT03774446|Antiviral Agents|antiviral agents|mesh-ancestor
65486359|NCT03774446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65486360|NCT03774446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65486361|NCT03774446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486362|NCT03774446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486363|NCT03773744|Cyclophosphamide|cyclophosphamide|mesh-list
65486364|NCT03773744|Pembrolizumab|pembrolizumab|mesh-list
65486365|NCT03773744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65486366|NCT03773744|Immunologic Factors|immunologic factors|mesh-ancestor
65486367|NCT03773744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499494|NCT02203786|Fluphenazine depot|fluphenazine depot|mesh-list
64499495|NCT02203786|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
64499496|NCT02203786|Amphetamine|amphetamine|mesh-list
64499497|NCT02203786|Dextroamphetamine|dextroamphetamine|mesh-list
64499498|NCT02203786|Antiemetics|antiemetics|mesh-ancestor
64499499|NCT02203786|Autonomic Agents|autonomic agents|mesh-ancestor
64499500|NCT02203786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499501|NCT02203786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499508|NCT02203786|Dopamine Agents|dopamine agents|mesh-ancestor
64499509|NCT02203786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723864|NCT00000259|Nitrous Oxide|nitrous oxide|mesh-list
64723865|NCT00000259|Sevoflurane|sevoflurane|mesh-list
64723866|NCT00000259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64723867|NCT00000259|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64723868|NCT00000259|Anesthetics, General|anesthetics, general|mesh-ancestor
64723869|NCT00000259|Anesthetics|anesthetics|mesh-ancestor
64723870|NCT00000259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64723871|NCT00000259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486368|NCT03773744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65486369|NCT03773744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65486370|NCT03773744|Alkylating Agents|alkylating agents|mesh-ancestor
65486371|NCT03773744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486372|NCT03773744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486373|NCT03773744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65486374|NCT03773744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65486375|NCT03779516|Lidocaine|lidocaine|mesh-list
65486376|NCT03779516|Anesthetics, Local|anesthetics, local|mesh-ancestor
65486377|NCT03779516|Anesthetics|anesthetics|mesh-ancestor
65486378|NCT03779516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65486379|NCT03779516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486380|NCT03779516|Sensory System Agents|sensory system agents|mesh-ancestor
65486381|NCT03779516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65486382|NCT03779516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65486383|NCT03779516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65486384|NCT03779516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65486385|NCT03779516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65486386|NCT03779516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486387|NCT03779594|Acetazolamide|acetazolamide|mesh-list
65486388|NCT03779594|Anticonvulsants|anticonvulsants|mesh-ancestor
65486389|NCT03779594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65486390|NCT03779594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486391|NCT03779594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486392|NCT03779594|Diuretics|diuretics|mesh-ancestor
64870250|NCT01829802|Ritonavir|ritonavir|mesh-list
64723872|NCT00000259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64499511|NCT02203786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64499512|NCT02203786|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64499513|NCT02203786|Sympathomimetics|sympathomimetics|mesh-ancestor
64499514|NCT02203786|Adrenergic Agents|adrenergic agents|mesh-ancestor
64499515|NCT02203786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64499516|NCT02203786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64499517|NCT02203786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64499518|NCT02203786|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64499519|NCT03009058|Leucovorin|leucovorin|mesh-list
64499520|NCT03009058|Folic Acid|folic acid|mesh-list
64499521|NCT03009058|Gemcitabine|gemcitabine|mesh-list
64499522|NCT03009058|Cyclophosphamide|cyclophosphamide|mesh-list
64499523|NCT03009058|Pembrolizumab|pembrolizumab|mesh-list
64499525|NCT03009058|Capecitabine|capecitabine|mesh-list
64499526|NCT03009058|Oxaliplatin|oxaliplatin|mesh-list
64499527|NCT03009058|Nivolumab|nivolumab|mesh-list
64499528|NCT03009058|Irinotecan|irinotecan|mesh-list
64499529|NCT03009058|Cetuximab|cetuximab|mesh-list
64499530|NCT03009058|Ipilimumab|ipilimumab|mesh-list
64499531|NCT03009058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64499532|NCT03009058|Levoleucovorin|levoleucovorin|mesh-list
64499533|NCT03009058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65486393|NCT03779594|Natriuretic Agents|natriuretic agents|mesh-ancestor
65486394|NCT03779594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486395|NCT03779672|Memantine|memantine|mesh-list
65486396|NCT03779672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65486397|NCT03779672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65486398|NCT03779672|Dopamine Agents|dopamine agents|mesh-ancestor
65486399|NCT03779672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65486400|NCT03779672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486401|NCT03779672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486402|NCT03779672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65486403|NCT03779672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65486404|NCT03779282|Dexmedetomidine|dexmedetomidine|mesh-list
65486405|NCT03779282|Ketamine|ketamine|mesh-list
65486406|NCT03779282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65486407|NCT03779282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65486408|NCT03779282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486409|NCT03779282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65486410|NCT03779282|Analgesics|analgesics|mesh-ancestor
65486411|NCT03779282|Sensory System Agents|sensory system agents|mesh-ancestor
65486412|NCT03779282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65486413|NCT03779282|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65486414|NCT03779282|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65486415|NCT03779282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65486416|NCT03779282|Adrenergic Agents|adrenergic agents|mesh-ancestor
65486417|NCT03779282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65486418|NCT03779282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486419|NCT03779282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65486420|NCT03779282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65486421|NCT03779282|Anesthetics, General|anesthetics, general|mesh-ancestor
65486422|NCT03779282|Anesthetics|anesthetics|mesh-ancestor
65486423|NCT03779282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65486424|NCT03779282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65486425|NCT03773588|Propofol|propofol|mesh-list
65486426|NCT03773588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64870266|NCT01829841|Sunitinib|sunitinib|mesh-list
64499534|NCT03009058|Immunologic Factors|immunologic factors|mesh-ancestor
64499535|NCT03009058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499536|NCT03009058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65486427|NCT03773588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65486428|NCT03773588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486429|NCT03773588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65486430|NCT03773588|Anesthetics, General|anesthetics, general|mesh-ancestor
65486431|NCT03773588|Anesthetics|anesthetics|mesh-ancestor
65486432|NCT03773510|Trabectedin|trabectedin|mesh-list
65486433|NCT03773510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65486434|NCT03773510|Alkylating Agents|alkylating agents|mesh-ancestor
65486435|NCT03773510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486436|NCT03773510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486437|NCT03779360|Clindamycin|clindamycin|mesh-list
65486438|NCT03779360|Clindamycin palmitate|clindamycin palmitate|mesh-list
65486439|NCT03779360|Clindamycin phosphate|clindamycin phosphate|mesh-list
65486440|NCT03779360|Erythromycin|erythromycin|mesh-list
65486441|NCT03779360|Erythromycin Estolate|erythromycin estolate|mesh-list
65486442|NCT03779360|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65486443|NCT03779360|Erythromycin stearate|erythromycin stearate|mesh-list
65486444|NCT03779360|Prednisolone|prednisolone|mesh-list
65486445|NCT03779360|Clobetasol|clobetasol|mesh-list
65486446|NCT03779360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65486447|NCT03779360|Glucocorticoids|glucocorticoids|mesh-ancestor
65486448|NCT03779360|Hormones|hormones|mesh-ancestor
65486449|NCT03779360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65486450|NCT03779360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486451|NCT03779360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65486452|NCT03779360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486453|NCT03779360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65486454|NCT03779360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65486459|NCT01320878|Iloprost|iloprost|mesh-list
65486474|NCT05254184|Ipilimumab|ipilimumab|mesh-list
65486475|NCT05254184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65486476|NCT05254184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486477|NCT05254184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65486478|NCT05254184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486479|NCT03773042|Propofol|propofol|mesh-list
65486480|NCT03773042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65486481|NCT03773042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65486482|NCT03773042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486483|NCT03773042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65486484|NCT03773042|Anesthetics, General|anesthetics, general|mesh-ancestor
65486485|NCT03773042|Anesthetics|anesthetics|mesh-ancestor
65486486|NCT03782480|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65486487|NCT03782480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65486488|NCT03782480|Immunologic Factors|immunologic factors|mesh-ancestor
65486489|NCT03782480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486490|NCT03712280|Rifaximin|rifaximin|mesh-list
65486491|NCT03712280|Phenylacetic acid|phenylacetic acid|mesh-list
65486492|NCT03712280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65486493|NCT03712280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65486494|NCT03712280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65486495|NCT03712280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65486496|NCT03712280|Antimetabolites|antimetabolites|mesh-ancestor
65486497|NCT03712280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486498|NCT03712280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486499|NCT01561508|Butyric Acid|butyric acid|mesh-list
65486500|NCT01561508|Histamine Antagonists|histamine antagonists|mesh-ancestor
65486501|NCT01561508|Histamine Agents|histamine agents|mesh-ancestor
65486502|NCT01561508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64870348|NCT01832350|Quinidine|quinidine|mesh-list
64499537|NCT03009058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64499538|NCT03009058|Alkylating Agents|alkylating agents|mesh-ancestor
64499539|NCT03009058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499540|NCT03009058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64499541|NCT03009058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64499542|NCT03009058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64499543|NCT03009058|Antimetabolites|antimetabolites|mesh-ancestor
64499544|NCT03009058|Antiviral Agents|antiviral agents|mesh-ancestor
64499545|NCT03009058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64499546|NCT03009058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64499547|NCT03009058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64499548|NCT03009058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64499549|NCT03009058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64499550|NCT03009058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64499551|NCT03009058|Antidotes|antidotes|mesh-ancestor
65486503|NCT01561508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486504|NCT01561508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486505|NCT04673942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65486506|NCT04673942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486507|NCT04673942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486508|NCT03772262|Metformin|metformin|mesh-list
65486509|NCT03772262|Furosemide|furosemide|mesh-list
65486510|NCT03772262|Midazolam|midazolam|mesh-list
65486511|NCT03772262|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65486512|NCT03772262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65486513|NCT03772262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486514|NCT03772262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65486515|NCT03772262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65486516|NCT03772262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65486517|NCT03772262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65486518|NCT03772262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65486519|NCT03772262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65486520|NCT03772262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65486521|NCT03772262|Anesthetics, General|anesthetics, general|mesh-ancestor
65486522|NCT03772262|Anesthetics|anesthetics|mesh-ancestor
65486523|NCT03772262|GABA Modulators|gaba modulators|mesh-ancestor
65486524|NCT03772262|GABA Agents|gaba agents|mesh-ancestor
65486525|NCT03772262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65486526|NCT03772262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486527|NCT03772262|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65486528|NCT03772262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65486529|NCT03772262|Antimetabolites|antimetabolites|mesh-ancestor
65486551|NCT03771638|Emtricitabine|emtricitabine|mesh-list
65486552|NCT03771638|Antiviral Agents|antiviral agents|mesh-ancestor
65486553|NCT03771638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65486554|NCT03771638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65486555|NCT03771638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65486556|NCT03771638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486557|NCT03771638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486558|NCT03771638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65486559|NCT03771638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65486560|NCT00092560|Ezetimibe|ezetimibe|mesh-list
65486561|NCT00092560|Fenofibrate|fenofibrate|mesh-list
65486562|NCT00092560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65486563|NCT00092560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65486564|NCT00092560|Antimetabolites|antimetabolites|mesh-ancestor
65486565|NCT00092560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486566|NCT00092560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65486567|NCT03769064|Methylphenidate|methylphenidate|mesh-list
65486568|NCT03769064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65486569|NCT03769064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486570|NCT03769064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65486571|NCT03769064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65486572|NCT03769064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65486573|NCT03769064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486574|NCT03769064|Dopamine Agents|dopamine agents|mesh-ancestor
65486575|NCT03769064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65486576|NCT00090298|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65486577|NCT00090298|Simvastatin|simvastatin|mesh-list
65486578|NCT00090298|Ezetimibe|ezetimibe|mesh-list
65486579|NCT00090298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65486580|NCT00090298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64499552|NCT03009058|Protective Agents|protective agents|mesh-ancestor
64499553|NCT03009058|Vitamin B Complex|vitamin b complex|mesh-ancestor
64499554|NCT03009058|Vitamins|vitamins|mesh-ancestor
64499555|NCT03009058|Micronutrients|micronutrients|mesh-ancestor
64499556|NCT03009058|Hematinics|hematinics|mesh-ancestor
64499557|NCT01611857|Leucovorin|leucovorin|mesh-list
64723880|NCT00379405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64723881|NCT00379405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64723882|NCT00379405|Protease Inhibitors|protease inhibitors|mesh-ancestor
64723883|NCT00379405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331468|NCT05457257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64499558|NCT01611857|Fluorouracil|fluorouracil|mesh-list
64499559|NCT01611857|Oxaliplatin|oxaliplatin|mesh-list
64499560|NCT01611857|Levoleucovorin|levoleucovorin|mesh-list
64499561|NCT01611857|Antimetabolites|antimetabolites|mesh-ancestor
64499562|NCT01611857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486581|NCT00090298|Antimetabolites|antimetabolites|mesh-ancestor
65486582|NCT00090298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486583|NCT00090298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65486584|NCT00090298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65486585|NCT00090298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486586|NCT03771092|Ferric gluconate|ferric gluconate|mesh-list
65486587|NCT03771092|Hematinics|hematinics|mesh-ancestor
65486588|NCT02765854|Dexamethasone|dexamethasone|mesh-list
65486589|NCT02765854|Lenalidomide|lenalidomide|mesh-list
65486590|NCT02765854|Ixazomib|ixazomib|mesh-list
65486591|NCT02765854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65486592|NCT02765854|Antiemetics|antiemetics|mesh-ancestor
65486593|NCT02765854|Autonomic Agents|autonomic agents|mesh-ancestor
65486594|NCT02765854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65486595|NCT02765854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486596|NCT02765854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65486597|NCT02765854|Glucocorticoids|glucocorticoids|mesh-ancestor
65486598|NCT02765854|Hormones|hormones|mesh-ancestor
65486599|NCT02765854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65486600|NCT02765854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65486601|NCT02765854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486602|NCT02765854|Immunologic Factors|immunologic factors|mesh-ancestor
65486603|NCT02765854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65486604|NCT02765854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65486605|NCT02765854|Growth Substances|growth substances|mesh-ancestor
65486606|NCT02765854|Growth Inhibitors|growth inhibitors|mesh-ancestor
65486607|NCT02765854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486608|NCT02765854|Protease Inhibitors|protease inhibitors|mesh-ancestor
65486609|NCT02765854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486610|NCT03768908|Artesunate|artesunate|mesh-list
65486611|NCT03768908|Lumefantrine|lumefantrine|mesh-list
65486612|NCT03768908|Artemether|artemether|mesh-list
65486613|NCT03768908|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65486625|NCT03777878|Carbetocin|carbetocin|mesh-list
65486626|NCT03777878|Oxytocics|oxytocics|mesh-ancestor
65486627|NCT03777878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65486628|NCT03777878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486629|NCT03246958|Nivolumab|nivolumab|mesh-list
65486630|NCT03246958|Ipilimumab|ipilimumab|mesh-list
65486631|NCT03246958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65486632|NCT03246958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486633|NCT03246958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65486634|NCT03246958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486635|NCT01321268|Beta Carotene|beta carotene|mesh-list
65486636|NCT01321268|Lycopene|lycopene|mesh-list
65486637|NCT01321268|Resveratrol|resveratrol|mesh-list
65486638|NCT01321268|Carotenoids|carotenoids|mesh-list
65486639|NCT01321268|Antioxidants|antioxidants|mesh-ancestor
65486640|NCT01321268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486641|NCT01321268|Protective Agents|protective agents|mesh-ancestor
65486642|NCT01321268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486643|NCT01321268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486644|NCT01321268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65486645|NCT01321268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65486646|NCT01321268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65486647|NCT01321268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65486648|NCT01321268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486649|NCT01321268|Provitamins|provitamins|mesh-ancestor
65486650|NCT01321268|Vitamins|vitamins|mesh-ancestor
65486651|NCT01321268|Micronutrients|micronutrients|mesh-ancestor
65486652|NCT01561274|Bupivacaine|bupivacaine|mesh-list
65486653|NCT01561274|Anesthetics, Local|anesthetics, local|mesh-ancestor
65486654|NCT01561274|Anesthetics|anesthetics|mesh-ancestor
65486655|NCT01561274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65486656|NCT01561274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486657|NCT01561274|Sensory System Agents|sensory system agents|mesh-ancestor
65486658|NCT01561274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65486659|NCT02882854|Guanfacine|guanfacine|mesh-list
65486660|NCT02882854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65486661|NCT02882854|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65486662|NCT02882854|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65486663|NCT02882854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65486664|NCT02882854|Adrenergic Agents|adrenergic agents|mesh-ancestor
65486665|NCT02882854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65486666|NCT02882854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486667|NCT02882854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486668|NCT03770936|Candesartan|candesartan|mesh-list
65486669|NCT03770936|Ramipril|ramipril|mesh-list
65486670|NCT03770936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65486671|NCT03770936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65486672|NCT03770936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65486673|NCT03770936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486674|NCT03770936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65486675|NCT03770936|Protease Inhibitors|protease inhibitors|mesh-ancestor
65486676|NCT03770936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486677|NCT03150082|Ciprofloxacin|ciprofloxacin|mesh-list
65486678|NCT03150082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65486679|NCT03150082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65486680|NCT03150082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65486681|NCT03150082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65486682|NCT03150082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486683|NCT03150082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486684|NCT03150082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486685|NCT03150082|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65486686|NCT03150082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65486687|NCT01321346|Cytarabine|cytarabine|mesh-list
65486688|NCT01321346|Panobinostat|panobinostat|mesh-list
65486689|NCT01321346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65486690|NCT01321346|Antimetabolites|antimetabolites|mesh-ancestor
65486691|NCT01321346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486692|NCT01321346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486693|NCT01321346|Antiviral Agents|antiviral agents|mesh-ancestor
65486694|NCT01321346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64499563|NCT01611857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64499564|NCT01611857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64499565|NCT01611857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64499566|NCT01611857|Immunologic Factors|immunologic factors|mesh-ancestor
64499567|NCT01611857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499568|NCT01611857|Antidotes|antidotes|mesh-ancestor
64499569|NCT01611857|Protective Agents|protective agents|mesh-ancestor
64499570|NCT01611857|Vitamin B Complex|vitamin b complex|mesh-ancestor
64499593|NCT01829477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65486695|NCT01321346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65486696|NCT01321346|Immunologic Factors|immunologic factors|mesh-ancestor
65486697|NCT01321346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486698|NCT01321346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65486699|NCT01321346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486700|NCT04058366|Ivacaftor|ivacaftor|mesh-list
65486701|NCT04058366|Elexacaftor|elexacaftor|mesh-list
65486702|NCT04058366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65486703|NCT04058366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65486704|NCT04058366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486705|NCT02118610|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
65486706|NCT02118610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65486707|NCT02118610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65486708|NCT02118610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65486709|NCT02118610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65486710|NCT02118610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486711|NCT02118610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65486712|NCT02118610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486713|NCT02118610|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65486714|NCT02118610|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65486715|NCT02118610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65486716|NCT02118610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65486717|NCT02118610|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65486718|NCT02118610|Dopamine Agents|dopamine agents|mesh-ancestor
65486719|NCT02118610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65486720|NCT02118610|Adrenergic Agents|adrenergic agents|mesh-ancestor
65486721|NCT02118610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65486722|NCT02118610|Analgesics|analgesics|mesh-ancestor
65486723|NCT02118610|Sensory System Agents|sensory system agents|mesh-ancestor
65486724|NCT02118610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65486725|NCT01561742|Minocycline|minocycline|mesh-list
65486726|NCT01561742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65486727|NCT01561742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65486728|NCT03770702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65486729|NCT03770702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486733|NCT01345708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486734|NCT01345708|Immunologic Factors|immunologic factors|mesh-ancestor
65486735|NCT01345708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486736|NCT01345708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65486737|NCT01345708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65486738|NCT01345708|Glucocorticoids|glucocorticoids|mesh-ancestor
65486739|NCT01345708|Hormones|hormones|mesh-ancestor
65486740|NCT01345708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65486741|NCT01345708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65486742|NCT01345864|Scopolamine|scopolamine|mesh-list
65486743|NCT01345864|Donepezil|donepezil|mesh-list
65486744|NCT01345864|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65486745|NCT01345864|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65486746|NCT01345864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486747|NCT01345864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486748|NCT01345864|Cholinergic Agents|cholinergic agents|mesh-ancestor
65486749|NCT01345864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65486750|NCT01345864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486751|NCT01345864|Nootropic Agents|nootropic agents|mesh-ancestor
65486752|NCT01345864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65486753|NCT01345864|Antiemetics|antiemetics|mesh-ancestor
65486754|NCT01345864|Autonomic Agents|autonomic agents|mesh-ancestor
65486755|NCT01345864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65486756|NCT01345864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65486757|NCT01345864|Mydriatics|mydriatics|mesh-ancestor
65486758|NCT01345864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65486759|NCT01345864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65486760|NCT01345864|Parasympatholytics|parasympatholytics|mesh-ancestor
65486761|NCT04320602|Eculizumab|eculizumab|mesh-list
65486762|NCT04320602|Ravulizumab|ravulizumab|mesh-list
65486763|NCT04320602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65486764|NCT04320602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65486765|NCT04320602|Immunologic Factors|immunologic factors|mesh-ancestor
65486766|NCT04320602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486767|NCT03948022|Progesterone|progesterone|mesh-list
65486774|NCT03777644|Ropivacaine|ropivacaine|mesh-list
65486775|NCT03777644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65486776|NCT03777644|Narcotics|narcotics|mesh-ancestor
65486777|NCT03777644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65486778|NCT03777644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486779|NCT03777644|Analgesics|analgesics|mesh-ancestor
65486780|NCT03777644|Sensory System Agents|sensory system agents|mesh-ancestor
65486781|NCT03777644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65486782|NCT03777644|Anesthetics, Local|anesthetics, local|mesh-ancestor
65486783|NCT03777644|Anesthetics|anesthetics|mesh-ancestor
65486784|NCT04345666|Methyltestosterone|methyltestosterone|mesh-list
65486785|NCT04345666|Testosterone|testosterone|mesh-list
65486786|NCT04345666|Testosterone undecanoate|testosterone undecanoate|mesh-list
65486787|NCT04345666|Testosterone enanthate|testosterone enanthate|mesh-list
65486788|NCT04345666|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65486789|NCT04345666|Androgens|androgens|mesh-ancestor
65486790|NCT04345666|Hormones|hormones|mesh-ancestor
65486791|NCT04345666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65486792|NCT04345666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486793|NCT04345666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65486794|NCT04345666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486795|NCT04345666|Anabolic Agents|anabolic agents|mesh-ancestor
65486796|NCT01336192|Gemcitabine|gemcitabine|mesh-list
65486797|NCT01336192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64499594|NCT01829477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499595|NCT01829477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64499596|NCT01829477|Immunologic Factors|immunologic factors|mesh-ancestor
64499597|NCT03126864|Cyclophosphamide|cyclophosphamide|mesh-list
64499598|NCT03126864|Fludarabine|fludarabine|mesh-list
64499599|NCT03126864|Fludarabine phosphate|fludarabine phosphate|mesh-list
64499600|NCT03126864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64499601|NCT03126864|Immunologic Factors|immunologic factors|mesh-ancestor
64499602|NCT03126864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499603|NCT03126864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64499604|NCT03126864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64499605|NCT03126864|Alkylating Agents|alkylating agents|mesh-ancestor
64499606|NCT03126864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499607|NCT03126864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64499608|NCT03126864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64499609|NCT03126864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64499610|NCT03126864|Antimetabolites|antimetabolites|mesh-ancestor
64499612|NCT03399708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64499613|NCT03399708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64499614|NCT03399708|Analgesics|analgesics|mesh-ancestor
64499615|NCT03399708|Sensory System Agents|sensory system agents|mesh-ancestor
64499616|NCT03399708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499617|NCT03399708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499618|NCT03399708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64499619|NCT03399708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64499620|NCT03399708|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64499621|NCT03399708|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65486798|NCT01336192|Antimetabolites|antimetabolites|mesh-ancestor
65486799|NCT01336192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486800|NCT01336192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486801|NCT01336192|Antiviral Agents|antiviral agents|mesh-ancestor
65486802|NCT01336192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65486803|NCT01336192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486804|NCT01336192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65486805|NCT01336192|Immunologic Factors|immunologic factors|mesh-ancestor
65486806|NCT01336192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486807|NCT04296890|Maytansine|maytansine|mesh-list
65486808|NCT04296890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65486809|NCT04296890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486810|NCT04296890|Tubulin Modulators|tubulin modulators|mesh-ancestor
65486811|NCT04296890|Antimitotic Agents|antimitotic agents|mesh-ancestor
65486812|NCT04296890|Mitosis Modulators|mitosis modulators|mesh-ancestor
65486813|NCT04296890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486814|NCT04459234|Ketamine|ketamine|mesh-list
65486815|NCT04459234|Analgesics|analgesics|mesh-ancestor
65486816|NCT04459234|Sensory System Agents|sensory system agents|mesh-ancestor
65486817|NCT04459234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65486818|NCT04459234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486819|NCT04459234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65486820|NCT04459234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65486821|NCT04459234|Anesthetics, General|anesthetics, general|mesh-ancestor
65486822|NCT04459234|Anesthetics|anesthetics|mesh-ancestor
65486823|NCT04459234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65486845|NCT04592536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486846|NCT04592536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65486847|NCT04592536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65486848|NCT04592536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65486850|NCT04592536|GABA Agents|gaba agents|mesh-ancestor
65486851|NCT04592536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65486852|NCT04592536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486853|NCT01336582|Docetaxel|docetaxel|mesh-list
65486854|NCT01336582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486855|NCT01336582|Tubulin Modulators|tubulin modulators|mesh-ancestor
65486856|NCT01336582|Antimitotic Agents|antimitotic agents|mesh-ancestor
65486857|NCT01336582|Mitosis Modulators|mitosis modulators|mesh-ancestor
65486858|NCT01336582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486859|NCT03149848|Rifabutin|rifabutin|mesh-list
65486860|NCT03149848|Cabotegravir|cabotegravir|mesh-list
65486861|NCT03149848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65486862|NCT03149848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65486863|NCT03149848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65486864|NCT03149848|Antitubercular Agents|antitubercular agents|mesh-ancestor
65486865|NCT03149848|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65486866|NCT03149848|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65486867|NCT03149848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486868|NCT03149848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486869|NCT03149848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65486870|NCT03149848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65486871|NCT03149848|Antiviral Agents|antiviral agents|mesh-ancestor
65486872|NCT01346800|Ritonavir|ritonavir|mesh-list
65486873|NCT01346800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65486874|NCT01346800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65486875|NCT01346800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65486876|NCT01346800|Protease Inhibitors|protease inhibitors|mesh-ancestor
65486877|NCT01346800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486878|NCT01346800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486879|NCT01346800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64499622|NCT03399708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64499623|NCT03399708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499624|NCT03395730|Oxytocin|oxytocin|mesh-list
64499625|NCT03395730|Oxytocics|oxytocics|mesh-ancestor
64499626|NCT03395730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64499627|NCT03395730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499628|NCT01334086|Aprepitant|aprepitant|mesh-list
65486880|NCT01346800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65486881|NCT01346800|Antiviral Agents|antiviral agents|mesh-ancestor
65486882|NCT01346800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65486883|NCT01346800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65486884|NCT01346800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65486885|NCT01346800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65486886|NCT03902314|Lidocaine|lidocaine|mesh-list
65486887|NCT03902314|Anesthetics, Local|anesthetics, local|mesh-ancestor
65486888|NCT03902314|Anesthetics|anesthetics|mesh-ancestor
65486889|NCT03902314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65486890|NCT03902314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486891|NCT03902314|Sensory System Agents|sensory system agents|mesh-ancestor
65486892|NCT03902314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65486893|NCT03902314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65486894|NCT03902314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65486895|NCT03902314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65486896|NCT03902314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65486897|NCT03902314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486898|NCT01336660|Antivenins|antivenins|mesh-list
65486899|NCT01336660|Immunologic Factors|immunologic factors|mesh-ancestor
65486900|NCT01336660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486901|NCT03768518|Exenatide|exenatide|mesh-list
65486902|NCT03768518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65486903|NCT03768518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486904|NCT03768518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65486905|NCT03768518|Incretins|incretins|mesh-ancestor
65486906|NCT03768518|Hormones|hormones|mesh-ancestor
65486907|NCT03768518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65486908|NCT04276376|Atezolizumab|atezolizumab|mesh-list
65486909|NCT04276376|Rucaparib|rucaparib|mesh-list
65486914|NCT04254692|Bupivacaine|bupivacaine|mesh-list
65486923|NCT03770000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65486924|NCT03770000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486925|NCT03770000|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
65486926|NCT03770000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486927|NCT03770000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486928|NCT03770312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65486929|NCT03770312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65486930|NCT03770312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65486931|NCT03770312|Antimetabolites|antimetabolites|mesh-ancestor
65486932|NCT03770312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486933|NCT03770312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486934|NCT03770312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65486936|NCT03158272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65486937|NCT03158272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486938|NCT03158272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65486939|NCT03158272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486940|NCT01431508|Losartan|losartan|mesh-list
65486941|NCT01431508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65486942|NCT01431508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65486943|NCT01431508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65486944|NCT01431508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65486945|NCT01431508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486946|NCT01321502|Famciclovir|famciclovir|mesh-list
65486947|NCT01321502|Antiviral Agents|antiviral agents|mesh-ancestor
65486948|NCT01321502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65486949|NCT01321502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65486950|NCT01321502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870766|NCT01841775|Interferons|interferons|mesh-list
64499629|NCT01334086|Antiemetics|antiemetics|mesh-ancestor
64499630|NCT01334086|Autonomic Agents|autonomic agents|mesh-ancestor
64499631|NCT01334086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499632|NCT01334086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499633|NCT01334086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64499634|NCT01334086|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64499635|NCT01334086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723884|NCT00379405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723885|NCT00379405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64723886|NCT00379405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64723887|NCT00379405|Antiviral Agents|antiviral agents|mesh-ancestor
64723888|NCT00379405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64723889|NCT00379405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64723890|NCT00379405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65486951|NCT01321502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486952|NCT01347268|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65486953|NCT01347268|Hormones|hormones|mesh-ancestor
65486954|NCT01347268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65486955|NCT01347268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486956|NCT01347424|Paclitaxel|paclitaxel|mesh-list
65486957|NCT01347424|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65486958|NCT01347424|Carboplatin|carboplatin|mesh-list
65486959|NCT01347424|Endostatins|endostatins|mesh-list
65486960|NCT01347424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65486961|NCT01347424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65486962|NCT01347424|Tubulin Modulators|tubulin modulators|mesh-ancestor
65486963|NCT01347424|Antimitotic Agents|antimitotic agents|mesh-ancestor
65486964|NCT01347424|Mitosis Modulators|mitosis modulators|mesh-ancestor
65486965|NCT01347424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486966|NCT01347424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65486967|NCT01347424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65486968|NCT01347424|Growth Substances|growth substances|mesh-ancestor
65486969|NCT01347424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65486970|NCT01347424|Growth Inhibitors|growth inhibitors|mesh-ancestor
65486971|NCT01322438|Rifampin|rifampin|mesh-list
65486972|NCT01322438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64723891|NCT00379483|Deferasirox|deferasirox|mesh-list
64499636|NCT01334086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499637|NCT03399474|Lidocaine|lidocaine|mesh-list
64499638|NCT03399474|Dexmedetomidine|dexmedetomidine|mesh-list
64499639|NCT03399474|Anesthetics, Local|anesthetics, local|mesh-ancestor
64499640|NCT03399474|Anesthetics|anesthetics|mesh-ancestor
64499655|NCT03399474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64499656|NCT03399474|Adrenergic Agents|adrenergic agents|mesh-ancestor
64499657|NCT03399474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64499658|NCT01611155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64499659|NCT01611155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64499660|NCT01611155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64499661|NCT01611155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64499662|NCT01611155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499663|NCT01611155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64499664|NCT01611155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499665|NCT01611155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64499666|NCT01611155|Antidepressive Agents|antidepressive agents|mesh-ancestor
64499667|NCT01611155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64499670|NCT01430182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64499671|NCT01430182|Narcotics|narcotics|mesh-ancestor
64499672|NCT01430182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64499673|NCT01430182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499674|NCT01430182|Analgesics|analgesics|mesh-ancestor
64499675|NCT01430182|Sensory System Agents|sensory system agents|mesh-ancestor
64499676|NCT01430182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499677|NCT01430182|Antitussive Agents|antitussive agents|mesh-ancestor
64499678|NCT01430182|Respiratory System Agents|respiratory system agents|mesh-ancestor
65486973|NCT01322438|Antitubercular Agents|antitubercular agents|mesh-ancestor
65486974|NCT01322438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65486975|NCT01322438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65486976|NCT01322438|Leprostatic Agents|leprostatic agents|mesh-ancestor
65486977|NCT01322438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65486978|NCT01322438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65486979|NCT01322438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486980|NCT01322438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65486981|NCT01322438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65486982|NCT01322438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65486983|NCT01322438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65486984|NCT01322438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65486985|NCT01322438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65486986|NCT00654628|Simvastatin|simvastatin|mesh-list
65486987|NCT00654628|Ezetimibe|ezetimibe|mesh-list
65486988|NCT00654628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65486989|NCT00654628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65486990|NCT00654628|Antimetabolites|antimetabolites|mesh-ancestor
65486991|NCT00654628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65486992|NCT00654628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65236513|NCT04240054|Bortezomib|bortezomib|mesh-list
65486994|NCT00654628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487023|NCT00496834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65487024|NCT00496834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487025|NCT00496834|Diuretics|diuretics|mesh-ancestor
65487026|NCT00496834|Natriuretic Agents|natriuretic agents|mesh-ancestor
65487027|NCT00496834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487028|NCT00496834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65487029|NCT00496834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65487030|NCT00496834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65487031|NCT00496834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65487032|NCT00496834|Adrenergic Agents|adrenergic agents|mesh-ancestor
65487033|NCT00496834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65487034|NCT00496834|Antioxidants|antioxidants|mesh-ancestor
65487035|NCT00496834|Protective Agents|protective agents|mesh-ancestor
65487036|NCT00496834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65487037|NCT00496834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65487038|NCT00496834|Vasodilator Agents|vasodilator agents|mesh-ancestor
65487039|NCT00496834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65487040|NCT00496834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65487041|NCT00189280|Imiquimod|imiquimod|mesh-list
65487042|NCT00189280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65487043|NCT00189280|Immunologic Factors|immunologic factors|mesh-ancestor
65487044|NCT00189280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487045|NCT00189280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487046|NCT00189280|Interferon Inducers|interferon inducers|mesh-ancestor
65487047|NCT01352494|Gemcitabine|gemcitabine|mesh-list
64499680|NCT05097768|Ibuprofen|ibuprofen|mesh-list
64499681|NCT05097768|Ketorolac|ketorolac|mesh-list
64499682|NCT05097768|Meloxicam|meloxicam|mesh-list
64499683|NCT05097768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64499684|NCT05097768|Antiemetics|antiemetics|mesh-ancestor
64499685|NCT05097768|Autonomic Agents|autonomic agents|mesh-ancestor
64499686|NCT05097768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499687|NCT05097768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499688|NCT05097768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64499689|NCT05097768|Glucocorticoids|glucocorticoids|mesh-ancestor
64499690|NCT05097768|Hormones|hormones|mesh-ancestor
64499691|NCT05097768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64499692|NCT05097768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64499693|NCT05097768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64499694|NCT05097768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64499695|NCT05097768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64499696|NCT05097768|Analgesics|analgesics|mesh-ancestor
64499697|NCT05097768|Sensory System Agents|sensory system agents|mesh-ancestor
64499698|NCT05097768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64499699|NCT05097768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64499700|NCT05097768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64499713|NCT01829243|Sensory System Agents|sensory system agents|mesh-ancestor
64499714|NCT01829243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499715|NCT01829243|Antidepressive Agents|antidepressive agents|mesh-ancestor
65487048|NCT01352494|Docetaxel|docetaxel|mesh-list
65487049|NCT01352494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65487050|NCT01352494|Antimetabolites|antimetabolites|mesh-ancestor
65487051|NCT01352494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487052|NCT01352494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487053|NCT01352494|Antiviral Agents|antiviral agents|mesh-ancestor
65487054|NCT01352494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65487055|NCT01352494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487056|NCT01352494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65487057|NCT01352494|Immunologic Factors|immunologic factors|mesh-ancestor
65487058|NCT01352494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487059|NCT01352494|Tubulin Modulators|tubulin modulators|mesh-ancestor
65487060|NCT01352494|Antimitotic Agents|antimitotic agents|mesh-ancestor
65487061|NCT01352494|Mitosis Modulators|mitosis modulators|mesh-ancestor
65487062|NCT01347814|Domperidone|domperidone|mesh-list
65487063|NCT01347814|Antiemetics|antiemetics|mesh-ancestor
65487064|NCT01347814|Autonomic Agents|autonomic agents|mesh-ancestor
65487065|NCT01347814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65487066|NCT01347814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487067|NCT01347814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65487068|NCT01347814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65487069|NCT01347814|Dopamine Agents|dopamine agents|mesh-ancestor
65487070|NCT01347814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65487074|NCT04505098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65487099|NCT01348282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487100|NCT01348282|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65487101|NCT01348282|Cholinergic Agents|cholinergic agents|mesh-ancestor
65487102|NCT01348282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65487103|NCT01348282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65487104|NCT01348282|Protective Agents|protective agents|mesh-ancestor
65487105|NCT03137992|Bromides|bromides|mesh-list
65487106|NCT03137992|Tiotropium Bromide|tiotropium bromide|mesh-list
65487107|NCT03137992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65487108|NCT03137992|Autonomic Agents|autonomic agents|mesh-ancestor
65487109|NCT03137992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65487110|NCT03137992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487111|NCT03137992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65487112|NCT03137992|Respiratory System Agents|respiratory system agents|mesh-ancestor
65487113|NCT03137992|Parasympatholytics|parasympatholytics|mesh-ancestor
65487114|NCT03137992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65487115|NCT03137992|Cholinergic Agents|cholinergic agents|mesh-ancestor
65487116|NCT03137992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65487117|NCT03137992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487118|NCT03137992|Anticonvulsants|anticonvulsants|mesh-ancestor
65487119|NCT04470778|Famotidine|famotidine|mesh-list
65487120|NCT04470778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65487121|NCT04470778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65487122|NCT04470778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65487123|NCT04470778|Histamine Antagonists|histamine antagonists|mesh-ancestor
65487124|NCT04470778|Histamine Agents|histamine agents|mesh-ancestor
65487125|NCT04470778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65487126|NCT04470778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487127|NCT04470778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487128|NCT01352572|Milnacipran|milnacipran|mesh-list
65487129|NCT01352572|Mirtazapine|mirtazapine|mesh-list
65487130|NCT01352572|Sertraline|sertraline|mesh-list
65487131|NCT01352572|Fluoxetine|fluoxetine|mesh-list
65487132|NCT01352572|Paroxetine|paroxetine|mesh-list
65487133|NCT01352572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65487134|NCT01352572|Antidepressive Agents|antidepressive agents|mesh-list
65487135|NCT01352572|Levomilnacipran|levomilnacipran|mesh-list
65487139|NCT01352572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65487140|NCT01352572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65487141|NCT01352572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487142|NCT01352572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65487143|NCT01352572|Serotonin Agents|serotonin agents|mesh-ancestor
65487144|NCT01352572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487145|NCT01352572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65487146|NCT01352572|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65487147|NCT01352572|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65487148|NCT01352572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487149|NCT01352572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65487150|NCT01352572|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65487151|NCT01352572|Histamine Antagonists|histamine antagonists|mesh-ancestor
65487152|NCT01352572|Histamine Agents|histamine agents|mesh-ancestor
65487153|NCT01352572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65487154|NCT01352572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65487155|NCT01352572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65487156|NCT01352572|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65487157|NCT01352572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65487158|NCT01352572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65487159|NCT01352572|Adrenergic Agents|adrenergic agents|mesh-ancestor
65487160|NCT01352572|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65487161|NCT01352572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65487162|NCT01352572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65487163|NCT01352572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65487164|NCT01352572|Analgesics|analgesics|mesh-ancestor
65487165|NCT01352572|Sensory System Agents|sensory system agents|mesh-ancestor
65487166|NCT01352572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65487167|NCT01352572|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65487168|NCT01352572|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65487169|NCT01352650|Plerixafor|plerixafor|mesh-list
65487170|NCT01352650|Decitabine|decitabine|mesh-list
65487171|NCT01352650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64499716|NCT01829243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64499717|NCT01838447|Vitamin D|vitamin d|mesh-list
64499718|NCT01838447|Cholecalciferol|cholecalciferol|mesh-list
64499719|NCT01838447|Vitamins|vitamins|mesh-ancestor
64499720|NCT01838447|Micronutrients|micronutrients|mesh-ancestor
64723892|NCT00379483|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65487172|NCT01352650|Antimetabolites|antimetabolites|mesh-ancestor
65487173|NCT01352650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487174|NCT01352650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487175|NCT01352650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487176|NCT01352650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65487177|NCT01352650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65487178|NCT01352650|Antiviral Agents|antiviral agents|mesh-ancestor
65487179|NCT01352650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65487180|NCT01352728|Axitinib|axitinib|mesh-list
65487181|NCT01352728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487182|NCT01352728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65487183|NCT01352728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487184|NCT01352728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487185|NCT03997448|Pembrolizumab|pembrolizumab|mesh-list
65487186|NCT03997448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65487187|NCT03997448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487188|NCT03602612|Cyclophosphamide|cyclophosphamide|mesh-list
65487189|NCT03602612|Fludarabine|fludarabine|mesh-list
65487190|NCT03602612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65487191|NCT03602612|Immunologic Factors|immunologic factors|mesh-ancestor
64870989|NCT01843179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64723893|NCT00379483|Chelating Agents|chelating agents|mesh-ancestor
64723894|NCT00379483|Sequestering Agents|sequestering agents|mesh-ancestor
64723895|NCT00379483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723896|NCT00607477|Minoxidil|minoxidil|mesh-list
64723897|NCT00607477|Hydralazine|hydralazine|mesh-list
64723898|NCT00607477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64499721|NCT01838447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499722|NCT01838447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64499723|NCT01838447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64499724|NCT03395574|Terlipressin|terlipressin|mesh-list
64499725|NCT03395574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64499726|NCT03395574|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64499727|NCT05040282|Etonogestrel|etonogestrel|mesh-list
64499728|NCT05040282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64499729|NCT05040282|Contraceptive Agents|contraceptive agents|mesh-ancestor
64499731|NCT05040282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499732|NCT05040282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64499733|NCT04982172|Infliximab|infliximab|mesh-list
64499734|NCT04982172|Dermatologic Agents|dermatologic agents|mesh-ancestor
64499735|NCT04982172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64499739|NCT01837823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64499740|NCT01837823|Antimetabolites|antimetabolites|mesh-ancestor
64499741|NCT01837823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499742|NCT01837823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64499743|NCT01837823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64499744|NCT01837823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64499745|NCT03395262|Caffeine|caffeine|mesh-list
64499746|NCT03395262|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64499747|NCT03395262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499748|NCT03395262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64499749|NCT03395262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64499750|NCT03395262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487192|NCT03602612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487193|NCT03602612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65487194|NCT03602612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65487195|NCT03602612|Alkylating Agents|alkylating agents|mesh-ancestor
65487196|NCT03602612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487197|NCT03602612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487198|NCT03602612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65487199|NCT03767660|Sirolimus|sirolimus|mesh-list
65487200|NCT03767660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65487201|NCT03767660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65487202|NCT03767660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65487203|NCT03767660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487204|NCT03767660|Antifungal Agents|antifungal agents|mesh-ancestor
65487205|NCT03767660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65487206|NCT03767660|Immunologic Factors|immunologic factors|mesh-ancestor
65487207|NCT03767660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487208|NCT03767504|Thymol|thymol|mesh-list
65487209|NCT03767504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65487210|NCT03767504|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65487211|NCT03767504|Antifungal Agents|antifungal agents|mesh-ancestor
65487212|NCT01343290|Canagliflozin|canagliflozin|mesh-list
65487213|NCT01343290|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65487214|NCT01343290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487215|NCT01343290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65487216|NCT01343290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487217|NCT03761264|Amoxicillin|amoxicillin|mesh-list
65487240|NCT05096312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65487241|NCT05089916|Osimertinib|osimertinib|mesh-list
65487242|NCT05089916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487243|NCT05089916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65487244|NCT05089916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487245|NCT05089916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487246|NCT03767036|Ketorolac|ketorolac|mesh-list
65487247|NCT03767036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65487248|NCT03767036|Tramadol|tramadol|mesh-list
65487249|NCT03767036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65487250|NCT03767036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65487251|NCT03767036|Analgesics|analgesics|mesh-ancestor
65487252|NCT03767036|Sensory System Agents|sensory system agents|mesh-ancestor
65487253|NCT03767036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65487254|NCT03767036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487255|NCT03767036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65487256|NCT03767036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65487257|NCT03767036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65487258|NCT03767036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487259|NCT03767036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487260|NCT03767036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65487261|NCT03767036|Narcotics|narcotics|mesh-ancestor
65487262|NCT03767036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65487263|NCT03758144|Rifaximin|rifaximin|mesh-list
65487264|NCT03758144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65487265|NCT03758144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65487266|NCT03758144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64499751|NCT03395262|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64499752|NCT03395262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64499753|NCT03395262|Purinergic Agents|purinergic agents|mesh-ancestor
64499754|NCT03395262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64499755|NCT03852888|Methotrexate|methotrexate|mesh-list
64499756|NCT03852888|7-hydroxymethotrexate|7-hydroxymethotrexate|mesh-list
64499757|NCT03852888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64499758|NCT03852888|Abortifacient Agents|abortifacient agents|mesh-ancestor
64499759|NCT03852888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64499760|NCT03852888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499764|NCT03852888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64499765|NCT03852888|Dermatologic Agents|dermatologic agents|mesh-ancestor
64499766|NCT03852888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64499767|NCT03852888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64499768|NCT03852888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64499769|NCT03852888|Immunologic Factors|immunologic factors|mesh-ancestor
64499770|NCT03852888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64499771|NCT03852888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64499772|NCT04770012|Aspirin|aspirin|mesh-list
64499773|NCT04770012|Clopidogrel|clopidogrel|mesh-list
64499774|NCT04770012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65487267|NCT03766724|Dapagliflozin|dapagliflozin|mesh-list
65487268|NCT03766724|Empagliflozin|empagliflozin|mesh-list
65487269|NCT03766724|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65487270|NCT03766724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487271|NCT03766724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65487272|NCT03766724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487273|NCT04860518|Dexamethasone|dexamethasone|mesh-list
65487274|NCT04860518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65487275|NCT04860518|Antiemetics|antiemetics|mesh-ancestor
65487276|NCT04860518|Autonomic Agents|autonomic agents|mesh-ancestor
65487277|NCT04860518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65487278|NCT04860518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487279|NCT04860518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65487280|NCT04860518|Glucocorticoids|glucocorticoids|mesh-ancestor
65487281|NCT04860518|Hormones|hormones|mesh-ancestor
65487282|NCT04860518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65487283|NCT04860518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65487284|NCT04860518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487285|NCT03110380|Dolutegravir|dolutegravir|mesh-list
65487286|NCT03110380|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65487287|NCT03110380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65487288|NCT03110380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65487289|NCT03110380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487290|NCT03110380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487291|NCT03110380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65487292|NCT03110380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65487293|NCT03110380|Antiviral Agents|antiviral agents|mesh-ancestor
65487294|NCT03110380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65487295|NCT03110380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65487297|NCT03757910|Corticosterone|corticosterone|mesh-list
65487310|NCT03766490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487311|NCT03766490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65487312|NCT03766490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487313|NCT03766490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487314|NCT01348984|Fentanyl|fentanyl|mesh-list
65487315|NCT01348984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65487316|NCT01348984|Narcotics|narcotics|mesh-ancestor
65487317|NCT01348984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65487318|NCT01348984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487319|NCT01348984|Analgesics|analgesics|mesh-ancestor
65487320|NCT01348984|Sensory System Agents|sensory system agents|mesh-ancestor
65487321|NCT01348984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65487322|NCT01348984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65487323|NCT01348984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65487324|NCT01348984|Anesthetics, General|anesthetics, general|mesh-ancestor
65487325|NCT01348984|Anesthetics|anesthetics|mesh-ancestor
65487326|NCT01567670|Naloxone|naloxone|mesh-list
65487327|NCT01567670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65487328|NCT01567670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487329|NCT01567670|Sensory System Agents|sensory system agents|mesh-ancestor
65487330|NCT01567670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65487331|NCT04848662|Budesonide|budesonide|mesh-list
65487332|NCT04848662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65487333|NCT04848662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65487334|NCT04848662|Autonomic Agents|autonomic agents|mesh-ancestor
65487335|NCT04848662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65487336|NCT04848662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487337|NCT04848662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65487338|NCT04848662|Respiratory System Agents|respiratory system agents|mesh-ancestor
65487339|NCT04848662|Glucocorticoids|glucocorticoids|mesh-ancestor
64499775|NCT04770012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64499776|NCT04770012|Analgesics|analgesics|mesh-ancestor
64499777|NCT04770012|Sensory System Agents|sensory system agents|mesh-ancestor
64499778|NCT04770012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499779|NCT04770012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499780|NCT04770012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64499781|NCT04770012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64499782|NCT04770012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64499783|NCT04770012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64499784|NCT04770012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723899|NCT00607477|Vasodilator Agents|vasodilator agents|mesh-ancestor
64723900|NCT04423861|Nitazoxanide|nitazoxanide|mesh-list
64723901|NCT04423861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64723902|NCT04423861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64723903|NCT00000271|Desipramine|desipramine|mesh-list
65487340|NCT04848662|Hormones|hormones|mesh-ancestor
65487341|NCT04848662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65487342|NCT04351256|Durvalumab|durvalumab|mesh-list
65487343|NCT04351256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65487344|NCT04351256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487345|NCT03700892|Cinnamaldehyde|cinnamaldehyde|mesh-list
65487346|NCT03700892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65487347|NCT03700892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487348|NCT03700892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65487349|NCT03700892|Protective Agents|protective agents|mesh-ancestor
65487350|NCT03700892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487351|NCT01322282|Cetirizine|cetirizine|mesh-list
65487352|NCT01322282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65487353|NCT01322282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65487354|NCT01322282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65487355|NCT01322282|Histamine Antagonists|histamine antagonists|mesh-ancestor
65487356|NCT01322282|Histamine Agents|histamine agents|mesh-ancestor
65487357|NCT01322282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65487358|NCT01322282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487359|NCT01322282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487360|NCT03757364|Methotrexate|methotrexate|mesh-list
65487361|NCT03757364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65487362|NCT03757364|Abortifacient Agents|abortifacient agents|mesh-ancestor
65487363|NCT03757364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65487364|NCT03757364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487365|NCT03757364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65487366|NCT03757364|Antimetabolites|antimetabolites|mesh-ancestor
65487367|NCT03757364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236891|NCT03595150|Diclofenac|diclofenac|mesh-list
65487368|NCT03757364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487369|NCT03757364|Dermatologic Agents|dermatologic agents|mesh-ancestor
65487370|NCT03757364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64723904|NCT00000271|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64723905|NCT00000271|Antidepressive Agents|antidepressive agents|mesh-ancestor
64499785|NCT04770012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64499786|NCT04770012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64499787|NCT04770012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64499788|NCT04770012|Antipyretics|antipyretics|mesh-ancestor
64499789|NCT04770012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64499790|NCT04770012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65487371|NCT03757364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65487372|NCT03757364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65487373|NCT03757364|Immunologic Factors|immunologic factors|mesh-ancestor
65487374|NCT03757364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65487375|NCT03757364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65487376|NCT03766178|Nimotuzumab|nimotuzumab|mesh-list
65487377|NCT03766178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65487378|NCT03766178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487379|NCT04737278|Nicotinic Acids|nicotinic acids|mesh-list
65487381|NCT04737278|Vitamin B Complex|vitamin b complex|mesh-ancestor
65487382|NCT04737278|Vitamins|vitamins|mesh-ancestor
65487383|NCT04737278|Micronutrients|micronutrients|mesh-ancestor
65487384|NCT04737278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487385|NCT04737278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65487386|NCT04737278|Antimetabolites|antimetabolites|mesh-ancestor
65487387|NCT04737278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487388|NCT04737278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65487389|NCT04737278|Vasodilator Agents|vasodilator agents|mesh-ancestor
65487390|NCT03759860|Ranibizumab|ranibizumab|mesh-list
65487391|NCT03759860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65487392|NCT03759860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65487393|NCT03759860|Growth Substances|growth substances|mesh-ancestor
65487394|NCT03759860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487395|NCT03759860|Growth Inhibitors|growth inhibitors|mesh-ancestor
65487396|NCT03759860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487397|NCT03759782|Tenofovir|tenofovir|mesh-list
65487398|NCT03759782|Ribavirin|ribavirin|mesh-list
65487399|NCT03759782|Antiviral Agents|antiviral agents|mesh-ancestor
65487400|NCT03759782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65487401|NCT03759782|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65487402|NCT03759782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65487403|NCT03759782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487404|NCT03759782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487405|NCT03759782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65487406|NCT03759782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65487407|NCT03759782|Antimetabolites|antimetabolites|mesh-ancestor
65487412|NCT03765944|Sirolimus|sirolimus|mesh-list
65487413|NCT03765944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65487414|NCT03765944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65487415|NCT03765944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65487416|NCT03765944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487417|NCT03765944|Antifungal Agents|antifungal agents|mesh-ancestor
65487418|NCT03765944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65487419|NCT03765944|Immunologic Factors|immunologic factors|mesh-ancestor
65487420|NCT03765944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487421|NCT04684394|Aflibercept|aflibercept|mesh-list
65487422|NCT04684394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65487423|NCT04684394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65487424|NCT04684394|Growth Substances|growth substances|mesh-ancestor
65487425|NCT04684394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487426|NCT04684394|Growth Inhibitors|growth inhibitors|mesh-ancestor
65487427|NCT04684394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487428|NCT03765554|PF-06700841|pf-06700841|mesh-list
65487429|NCT03765554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65487430|NCT03765554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487431|NCT03765554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487432|NCT04668950|Fluvoxamine|fluvoxamine|mesh-list
65487433|NCT04668950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65487434|NCT04668950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65487435|NCT04668950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65487436|NCT04668950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487437|NCT04668950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65487438|NCT04668950|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65487439|NCT04668950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65487440|NCT04668950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65487441|NCT04668950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487442|NCT04668950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65487443|NCT04668950|Serotonin Agents|serotonin agents|mesh-ancestor
65487444|NCT04668950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65487445|NCT04668950|Antidepressive Agents|antidepressive agents|mesh-ancestor
64871214|NCT01844622|Antiemetics|antiemetics|mesh-ancestor
64499791|NCT04770012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64499792|NCT04770012|Purinergic Agents|purinergic agents|mesh-ancestor
64499793|NCT04770012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65487446|NCT04668950|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65487447|NCT04668950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65487448|NCT04668950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487449|NCT04668950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65487450|NCT03078478|Insulin|insulin|mesh-list
65487451|NCT03078478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65487452|NCT03078478|Insulin Glargine|insulin glargine|mesh-list
65487453|NCT03078478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65487454|NCT03078478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487455|NCT01349296|Everolimus|everolimus|mesh-list
65487456|NCT01349296|Nintedanib|nintedanib|mesh-list
65487457|NCT01349296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487458|NCT01349296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65487459|NCT01349296|Immunologic Factors|immunologic factors|mesh-ancestor
65487460|NCT01349296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487461|NCT01349296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65487462|NCT01349296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487463|NCT01349296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487464|NCT03522844|Citalopram|citalopram|mesh-list
65487465|NCT03522844|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65487466|NCT03522844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65487467|NCT03522844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65487468|NCT03522844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487469|NCT03522844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65487470|NCT03522844|Serotonin Agents|serotonin agents|mesh-ancestor
64871250|NCT01844674|Parasympatholytics|parasympatholytics|mesh-ancestor
64871257|NCT01844791|Gemcitabine|gemcitabine|mesh-list
64499794|NCT04755972|Acetylcysteine|acetylcysteine|mesh-list
64499795|NCT04755972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64499796|NCT04755972|Antiviral Agents|antiviral agents|mesh-ancestor
64499797|NCT04755972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64499798|NCT04755972|Expectorants|expectorants|mesh-ancestor
64499799|NCT04755972|Respiratory System Agents|respiratory system agents|mesh-ancestor
64499800|NCT04755972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64499801|NCT04755972|Antioxidants|antioxidants|mesh-ancestor
64499802|NCT04755972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499803|NCT04755972|Protective Agents|protective agents|mesh-ancestor
64499807|NCT01828073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64499808|NCT01828073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64499809|NCT01828073|Antiviral Agents|antiviral agents|mesh-ancestor
64499810|NCT01828073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64499811|NCT01828073|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64499812|NCT01828073|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64499813|NCT01828073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64499814|NCT01828073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499815|NCT04697693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64499817|NCT04697693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65487471|NCT03522844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487472|NCT03522844|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65487473|NCT03522844|Antidepressive Agents|antidepressive agents|mesh-ancestor
65487474|NCT03522844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65487475|NCT00045942|Itraconazole|itraconazole|mesh-list
65487476|NCT00045942|Midostaurin|midostaurin|mesh-list
65487477|NCT00045942|Antifungal Agents|antifungal agents|mesh-ancestor
65487478|NCT00045942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65487479|NCT00045942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65487480|NCT00045942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65487481|NCT00045942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487482|NCT00045942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487483|NCT00045942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65487484|NCT00045942|Hormone Antagonists|hormone antagonists|mesh-ancestor
65487485|NCT00045942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65487486|NCT00045942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487487|NCT00045942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65487488|NCT00045942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487489|NCT00045942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65487490|NCT04386616|Astegolimab|astegolimab|mesh-list
65487491|NCT04386616|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65487492|NCT04386616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65487493|NCT04386616|Antiviral Agents|antiviral agents|mesh-ancestor
65487494|NCT04386616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65487495|NCT00045708|Epothilones|epothilones|mesh-list
65487496|NCT00045708|Epothilone B|epothilone b|mesh-list
65487497|NCT00045708|Anticonvulsants|anticonvulsants|mesh-list
65487498|NCT00045708|Tubulin Modulators|tubulin modulators|mesh-ancestor
65487499|NCT00045708|Antimitotic Agents|antimitotic agents|mesh-ancestor
65487500|NCT00045708|Mitosis Modulators|mitosis modulators|mesh-ancestor
65487501|NCT00045708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487502|NCT00045708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487503|NCT01349452|Ganciclovir|ganciclovir|mesh-list
65487504|NCT01349452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65487505|NCT01349452|Lubricant Eye Drops|lubricant eye drops|mesh-list
65487506|NCT01349452|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65487507|NCT01349452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65487508|NCT01349452|Antiviral Agents|antiviral agents|mesh-ancestor
65487509|NCT01349452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65487510|NCT01349452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65487511|NCT01349452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487512|NCT01349452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487513|NCT00045630|Gemcitabine|gemcitabine|mesh-list
65487514|NCT00045630|Paclitaxel|paclitaxel|mesh-list
65487515|NCT00045630|Carboplatin|carboplatin|mesh-list
65487516|NCT00045630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65487517|NCT00045630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487518|NCT00045630|Tubulin Modulators|tubulin modulators|mesh-ancestor
65487519|NCT00045630|Antimitotic Agents|antimitotic agents|mesh-ancestor
65487520|NCT00045630|Mitosis Modulators|mitosis modulators|mesh-ancestor
65487521|NCT00045630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487522|NCT00045630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65487523|NCT00045630|Antimetabolites|antimetabolites|mesh-ancestor
65487524|NCT00045630|Antiviral Agents|antiviral agents|mesh-ancestor
65487525|NCT00045630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65487526|NCT00045630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487527|NCT00045630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65487528|NCT00045630|Immunologic Factors|immunologic factors|mesh-ancestor
65487529|NCT00045630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487530|NCT01357252|Vildagliptin|vildagliptin|mesh-list
65487531|NCT01357252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65487532|NCT01357252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487533|NCT01357252|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65487534|NCT01357252|Protease Inhibitors|protease inhibitors|mesh-ancestor
65487535|NCT01357252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487536|NCT01357252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487537|NCT03465280|Interferons|interferons|mesh-list
65487538|NCT03465280|Acyclovir|acyclovir|mesh-list
65487539|NCT03465280|Cidofovir|cidofovir|mesh-list
65487540|NCT03465280|Interferon-alpha|interferon-alpha|mesh-list
65487541|NCT03465280|Artemisinins|artemisinins|mesh-list
65487542|NCT03465280|Artemisinin|artemisinin|mesh-list
64499818|NCT04697693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64499819|NCT04697693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64499820|NCT04697693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487543|NCT03465280|Celecoxib|celecoxib|mesh-list
65487544|NCT03465280|Methotrexate|methotrexate|mesh-list
65487545|NCT03465280|Indole-3-carbinol|indole-3-carbinol|mesh-list
65487546|NCT03465280|Isotretinoin|isotretinoin|mesh-list
65487547|NCT03465280|Cimetidine|cimetidine|mesh-list
65487548|NCT03465280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487549|NCT03465280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487550|NCT03465280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65487551|NCT03465280|Abortifacient Agents|abortifacient agents|mesh-ancestor
65487552|NCT03465280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65487553|NCT03465280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65487554|NCT03465280|Antimetabolites|antimetabolites|mesh-ancestor
65487555|NCT03465280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487556|NCT03465280|Dermatologic Agents|dermatologic agents|mesh-ancestor
65487557|NCT03465280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487558|NCT03465280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65487559|NCT03465280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65487560|NCT03465280|Immunologic Factors|immunologic factors|mesh-ancestor
65487561|NCT03465280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65487562|NCT03465280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65487563|NCT03465280|Antiviral Agents|antiviral agents|mesh-ancestor
65487564|NCT03465280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65487565|NCT03465280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65487566|NCT03465280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65487567|NCT03465280|Analgesics|analgesics|mesh-ancestor
65487568|NCT03465280|Sensory System Agents|sensory system agents|mesh-ancestor
65487569|NCT03465280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65487570|NCT03465280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65487571|NCT03465280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65487572|NCT03465280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65487573|NCT03465280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64871361|NCT01845194|Narcotics|narcotics|mesh-ancestor
64499821|NCT04697693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64499822|NCT04697693|Serotonin Agents|serotonin agents|mesh-ancestor
64499823|NCT04697693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499824|NCT04697693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64499826|NCT04697693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64499827|NCT04697693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499828|NCT04697693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64499830|NCT04697693|Sensory System Agents|sensory system agents|mesh-ancestor
64499831|NCT04697693|Dopamine Agents|dopamine agents|mesh-ancestor
64499849|NCT04709250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65487574|NCT03465280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65487575|NCT03465280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65487576|NCT03465280|Histamine Antagonists|histamine antagonists|mesh-ancestor
65487577|NCT03465280|Histamine Agents|histamine agents|mesh-ancestor
65487578|NCT03465280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65487579|NCT03465280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65487580|NCT03465280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65487581|NCT03465280|Antimalarials|antimalarials|mesh-ancestor
65487582|NCT03465280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65487583|NCT03465280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65487584|NCT03465280|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65487585|NCT03465280|Protective Agents|protective agents|mesh-ancestor
65487586|NCT01349764|Vitamin D|vitamin d|mesh-list
65487587|NCT01349764|Cholecalciferol|cholecalciferol|mesh-list
65487588|NCT01349764|Vitamins|vitamins|mesh-ancestor
65487589|NCT01349764|Micronutrients|micronutrients|mesh-ancestor
65487590|NCT01349764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487591|NCT01349764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65487592|NCT01349764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65487593|NCT02924272|Ixazomib|ixazomib|mesh-list
65487594|NCT02924272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487595|NCT02924272|Protease Inhibitors|protease inhibitors|mesh-ancestor
65487596|NCT02924272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487597|NCT02924272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487598|NCT01353742|Lamivudine|lamivudine|mesh-list
65487599|NCT01353742|Adefovir|adefovir|mesh-list
65487600|NCT01353742|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65487601|NCT01353742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65487602|NCT01353742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65487603|NCT01353742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487604|NCT01353742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487605|NCT01353742|Antiviral Agents|antiviral agents|mesh-ancestor
65487606|NCT01353742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64499852|NCT01401166|Trastuzumab|trastuzumab|mesh-list
64499853|NCT01401166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64499854|NCT01401166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64499855|NCT03395028|Lenograstim|lenograstim|mesh-list
64499856|NCT03395028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64499857|NCT03395028|Immunologic Factors|immunologic factors|mesh-ancestor
64499858|NCT03395028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499859|NCT03394950|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64499860|NCT03394950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64499861|NCT03394950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65487607|NCT01353742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65487608|NCT01353742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65487609|NCT00003702|Dactinomycin|dactinomycin|mesh-list
65487610|NCT00003702|Cactinomycin|cactinomycin|mesh-list
65487611|NCT00003702|Methotrexate|methotrexate|mesh-list
65487612|NCT00003702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65487613|NCT00003702|Abortifacient Agents|abortifacient agents|mesh-ancestor
65487614|NCT00003702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65487615|NCT00003702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487616|NCT00003702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65487617|NCT00003702|Antimetabolites|antimetabolites|mesh-ancestor
65487618|NCT00003702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487619|NCT00003702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487620|NCT00003702|Dermatologic Agents|dermatologic agents|mesh-ancestor
65487621|NCT00003702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487622|NCT00003702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65487623|NCT00003702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65487624|NCT00003702|Immunologic Factors|immunologic factors|mesh-ancestor
65487625|NCT00003702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65487626|NCT00003702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65487627|NCT00003702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65487628|NCT00003702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65487629|NCT00003702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65487630|NCT00003702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65487631|NCT01350154|Sildenafil Citrate|sildenafil citrate|mesh-list
65487632|NCT01350154|Vasodilator Agents|vasodilator agents|mesh-ancestor
65487633|NCT01350154|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64499862|NCT03394950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499863|NCT01334944|Ibuprofen|ibuprofen|mesh-list
64499864|NCT01334944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64499865|NCT01334944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64723906|NCT00000271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64723907|NCT00000271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64723908|NCT00000271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723909|NCT00000271|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64723910|NCT00000271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64723911|NCT00000271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64723912|NCT00000271|Adrenergic Agents|adrenergic agents|mesh-ancestor
64723913|NCT00000271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723914|NCT00000271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723915|NCT00000277|Mazindol|mazindol|mesh-list
64723916|NCT00000277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64331491|NCT05370911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499866|NCT01334944|Analgesics|analgesics|mesh-ancestor
64499867|NCT01334944|Sensory System Agents|sensory system agents|mesh-ancestor
64499868|NCT01334944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65487634|NCT01350154|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65487635|NCT01350154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487636|NCT01350154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487637|NCT01350154|Urological Agents|urological agents|mesh-ancestor
65487638|NCT00031590|Cyclophosphamide|cyclophosphamide|mesh-list
65487639|NCT00031590|Lomustine|lomustine|mesh-list
65487640|NCT00031590|Etoposide|etoposide|mesh-list
65487641|NCT00031590|Vincristine|vincristine|mesh-list
65487642|NCT00031590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65487643|NCT00031590|Immunologic Factors|immunologic factors|mesh-ancestor
65487644|NCT00031590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487645|NCT00031590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65487646|NCT00031590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65487647|NCT00031590|Alkylating Agents|alkylating agents|mesh-ancestor
65487648|NCT00031590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487649|NCT00031590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487650|NCT00031590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65487651|NCT00031590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65487652|NCT00031590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65487653|NCT00031590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65487686|NCT00239681|Antimetabolites|antimetabolites|mesh-ancestor
65487687|NCT00239681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487688|NCT00239681|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65487689|NCT00239681|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65487690|NCT00239681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487691|NCT00238433|Melphalan|melphalan|mesh-list
65487692|NCT00238433|Busulfan|busulfan|mesh-list
65487693|NCT00238433|Thiotepa|thiotepa|mesh-list
65487694|NCT00238433|Immunologic Factors|immunologic factors|mesh-ancestor
65487695|NCT00238433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487696|NCT00238433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65487697|NCT00238433|Alkylating Agents|alkylating agents|mesh-ancestor
65487698|NCT00238433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487699|NCT00238433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487700|NCT00238433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65487701|NCT00238433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65487702|NCT02532023|Curcumin|curcumin|mesh-list
65487703|NCT02532023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65487704|NCT02532023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65487705|NCT02532023|Analgesics|analgesics|mesh-ancestor
65487706|NCT02532023|Sensory System Agents|sensory system agents|mesh-ancestor
65487707|NCT02532023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65487708|NCT02532023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487709|NCT02532023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65487710|NCT02532023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65487711|NCT02532023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487715|NCT01354522|Docetaxel|docetaxel|mesh-list
65487732|NCT01354522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65487733|NCT01354522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487734|NCT01354522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65487735|NCT01354522|Antimetabolites|antimetabolites|mesh-ancestor
65487736|NCT00045162|Irinotecan|irinotecan|mesh-list
65487737|NCT00045162|Etoposide|etoposide|mesh-list
65487738|NCT00045162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487739|NCT00045162|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65487740|NCT00045162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65487741|NCT00045162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487742|NCT00045162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487743|NCT00045162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65487744|NCT00045162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65487745|NCT02748616|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65487746|NCT02748616|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65487747|NCT02748616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65487748|NCT00238121|Sorafenib|sorafenib|mesh-list
65487749|NCT00238121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487750|NCT00238121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65487751|NCT00238121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487752|NCT00238121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487753|NCT01350622|Diclofenac|diclofenac|mesh-list
65487754|NCT01350622|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
65487755|NCT01350622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65487756|NCT01350622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65487757|NCT01350622|Analgesics|analgesics|mesh-ancestor
65487758|NCT01350622|Sensory System Agents|sensory system agents|mesh-ancestor
65487759|NCT01350622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65487760|NCT01350622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487761|NCT01350622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65487775|NCT03139240|Narcotics|narcotics|mesh-ancestor
65487776|NCT03139240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65487777|NCT03139240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487778|NCT03139240|Analgesics|analgesics|mesh-ancestor
65487779|NCT03139240|Sensory System Agents|sensory system agents|mesh-ancestor
65487780|NCT03139240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65487781|NCT01350856|Artesunate|artesunate|mesh-list
65487782|NCT01350856|Antimalarials|antimalarials|mesh-ancestor
65487783|NCT01350856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65487784|NCT01350856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65487785|NCT01350856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65487786|NCT01350856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487787|NCT01350856|Antiviral Agents|antiviral agents|mesh-ancestor
65487788|NCT01350856|Schistosomicides|schistosomicides|mesh-ancestor
65487789|NCT01350856|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65487790|NCT01350856|Anthelmintics|anthelmintics|mesh-ancestor
65487791|NCT03973775|Permethrin|permethrin|mesh-list
65487792|NCT03973775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487793|NCT03973775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487794|NCT01351168|Levodopa|levodopa|mesh-list
65487795|NCT01351168|Zolpidem|zolpidem|mesh-list
65487796|NCT01351168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65487797|NCT01351168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65487798|NCT01351168|Dopamine Agents|dopamine agents|mesh-ancestor
65487799|NCT01351168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65487800|NCT01351168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487801|NCT01351168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487802|NCT01351168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65487803|NCT01351168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65487804|NCT01351168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65487805|NCT01351168|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65487806|NCT01351168|GABA Agonists|gaba agonists|mesh-ancestor
65487807|NCT01351168|GABA Agents|gaba agents|mesh-ancestor
64499869|NCT01334944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499870|NCT01334944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64499871|NCT01334944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64499872|NCT01334944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64499873|NCT01334944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64499874|NCT01334944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499875|NCT04567992|Bupivacaine|bupivacaine|mesh-list
64499876|NCT04567992|Anesthetics, Local|anesthetics, local|mesh-ancestor
64499877|NCT04567992|Anesthetics|anesthetics|mesh-ancestor
64499878|NCT04567992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65487808|NCT01351636|Arotinolol|arotinolol|mesh-list
65487809|NCT01351636|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65487810|NCT01351636|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65487811|NCT01351636|Adrenergic Agents|adrenergic agents|mesh-ancestor
65487812|NCT01351636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65487813|NCT01351636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487814|NCT01351636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487815|NCT01351636|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65487816|NCT01351792|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65487817|NCT01351792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65487818|NCT01351792|Respiratory System Agents|respiratory system agents|mesh-ancestor
65487820|NCT03952260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65487821|NCT03952260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487822|NCT01351948|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65487823|NCT01351948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65487824|NCT01351948|Immunologic Factors|immunologic factors|mesh-ancestor
65487825|NCT01351948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487826|NCT01351948|Antacids|antacids|mesh-ancestor
65487827|NCT01351948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487828|NCT01351948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65487829|NCT01352026|Metformin|metformin|mesh-list
65487830|NCT01352026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65487831|NCT01352026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487832|NCT03136198|Vasodilator Agents|vasodilator agents|mesh-list
65487833|NCT03136198|Diuretics|diuretics|mesh-list
65487834|NCT03136198|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
65487835|NCT03136198|Natriuretic Agents|natriuretic agents|mesh-ancestor
65487836|NCT03136198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487837|NCT03136198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65487838|NCT03136198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487839|NCT01357486|Sorafenib|sorafenib|mesh-list
65487840|NCT01357486|Pravastatin|pravastatin|mesh-list
64871588|NCT01846832|Simeprevir|simeprevir|mesh-list
64499879|NCT04567992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499880|NCT04567992|Sensory System Agents|sensory system agents|mesh-ancestor
64499881|NCT04567992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499887|NCT01335724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499888|NCT01335724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871622|NCT01847144|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64871623|NCT01847144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64871624|NCT01847144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871625|NCT01847144|Incretins|incretins|mesh-ancestor
64871626|NCT01847144|Hormones|hormones|mesh-ancestor
64871627|NCT01847144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64871628|NCT01847144|Protease Inhibitors|protease inhibitors|mesh-ancestor
64871629|NCT01847144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871630|NCT01847144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871631|NCT01847157|Anesthetics|anesthetics|mesh-list
65487841|NCT01357486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487842|NCT01357486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65487843|NCT01357486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487844|NCT01357486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487845|NCT01357486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65487846|NCT01357486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65487847|NCT01357486|Antimetabolites|antimetabolites|mesh-ancestor
65487848|NCT01357486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65487849|NCT01357486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65487850|NCT01318564|Metformin|metformin|mesh-list
65487851|NCT01318564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65487852|NCT01318564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487881|NCT01542736|Vincristine|vincristine|mesh-list
65487882|NCT01542736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487883|NCT01542736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65487884|NCT01542736|Tubulin Modulators|tubulin modulators|mesh-ancestor
65487885|NCT01542736|Antimitotic Agents|antimitotic agents|mesh-ancestor
65487886|NCT01542736|Mitosis Modulators|mitosis modulators|mesh-ancestor
65487887|NCT01542736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487888|NCT01099566|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65487889|NCT01099566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65487890|NCT01099722|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65237425|NCT00669331|Mannitol|mannitol|mesh-list
65487891|NCT01099722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65487892|NCT01099722|Respiratory System Agents|respiratory system agents|mesh-ancestor
65487893|NCT01481974|Treprostinil|treprostinil|mesh-list
65487894|NCT01481974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65487895|NCT01361542|Etanercept|etanercept|mesh-list
65487896|NCT01361542|Infliximab|infliximab|mesh-list
65487897|NCT01361542|Dermatologic Agents|dermatologic agents|mesh-ancestor
65487898|NCT01361542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65487899|NCT01361542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65487900|NCT01361542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65487901|NCT01361542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65487902|NCT01361542|Analgesics|analgesics|mesh-ancestor
65487903|NCT01361542|Sensory System Agents|sensory system agents|mesh-ancestor
65487904|NCT01361542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65487905|NCT01361542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487906|NCT01361542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65487907|NCT01361542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65487908|NCT01361542|Immunologic Factors|immunologic factors|mesh-ancestor
65487909|NCT03950700|Epinephrine|epinephrine|mesh-list
65487910|NCT03950700|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65487911|NCT03950700|Bupivacaine|bupivacaine|mesh-list
65487912|NCT03950700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65487913|NCT03950700|Anesthetics, Local|anesthetics, local|mesh-ancestor
65487914|NCT03950700|Anesthetics|anesthetics|mesh-ancestor
65487919|NCT03950700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65487920|NCT03950700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65487921|NCT03950700|Adrenergic Agents|adrenergic agents|mesh-ancestor
65487922|NCT03950700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65487923|NCT03950700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487924|NCT03950700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65487925|NCT03950700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65487926|NCT03950700|Autonomic Agents|autonomic agents|mesh-ancestor
65487927|NCT03950700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65487928|NCT03950700|Respiratory System Agents|respiratory system agents|mesh-ancestor
65487929|NCT03950700|Mydriatics|mydriatics|mesh-ancestor
65487930|NCT03950700|Sympathomimetics|sympathomimetics|mesh-ancestor
65487931|NCT00237185|Imatinib Mesylate|imatinib mesylate|mesh-list
65487932|NCT00237185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487933|NCT00237185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65487934|NCT00237185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487935|NCT00237185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487936|NCT01357798|Botulinum Toxins|botulinum toxins|mesh-list
65487937|NCT01357798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65487938|NCT01357798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65487939|NCT01357798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65487940|NCT01357798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65487941|NCT01357798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487942|NCT01357798|Cholinergic Agents|cholinergic agents|mesh-ancestor
64871707|NCT01847664|Rifamycins|rifamycins|mesh-list
64499889|NCT01335724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64499890|NCT01335724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64499906|NCT01477762|Antiemetics|antiemetics|mesh-ancestor
64499907|NCT01477762|Autonomic Agents|autonomic agents|mesh-ancestor
64499908|NCT01477762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499909|NCT01477762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499910|NCT01477762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64499911|NCT01477762|Glucocorticoids|glucocorticoids|mesh-ancestor
64499913|NCT01477762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64499914|NCT01477762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64499915|NCT01477762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64499916|NCT01434472|Vidarabine|vidarabine|mesh-list
64499917|NCT01434472|Cyclosporine|cyclosporine|mesh-list
64499918|NCT01434472|Mycophenolic Acid|mycophenolic acid|mesh-list
64499919|NCT01434472|Rituximab|rituximab|mesh-list
64499920|NCT01434472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64499921|NCT01434472|Fludarabine|fludarabine|mesh-list
64499922|NCT01434472|Fludarabine phosphate|fludarabine phosphate|mesh-list
64499923|NCT01434472|Antibodies|antibodies|mesh-list
64499924|NCT01434472|Immunoglobulins|immunoglobulins|mesh-list
64499925|NCT01434472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64499926|NCT01434472|Cyclosporins|cyclosporins|mesh-list
64499927|NCT01434472|Immunologic Factors|immunologic factors|mesh-ancestor
64499928|NCT01434472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499929|NCT01434472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871725|NCT01847677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487943|NCT01357798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65487944|NCT01357798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487945|NCT01357798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65487946|NCT01357798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65487947|NCT00003222|Aldesleukin|aldesleukin|mesh-list
65487948|NCT00003222|Interleukin-2|interleukin-2|mesh-list
65487949|NCT00003222|Sargramostim|sargramostim|mesh-list
65487950|NCT00003222|Freund's Adjuvant|freund's adjuvant|mesh-list
65487951|NCT00003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487952|NCT00003222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65487953|NCT00003222|Analgesics|analgesics|mesh-ancestor
65487954|NCT00003222|Sensory System Agents|sensory system agents|mesh-ancestor
65487955|NCT00003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65487956|NCT00003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487957|NCT00003222|Immunologic Factors|immunologic factors|mesh-ancestor
65487958|NCT00003222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65487959|NCT00003222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65487960|NCT00003222|Antiviral Agents|antiviral agents|mesh-ancestor
65487961|NCT00003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65487962|NCT00003222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65487963|NCT01357876|Metformin|metformin|mesh-list
65487964|NCT01357876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65487965|NCT01357876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487966|NCT02877082|Bortezomib|bortezomib|mesh-list
65487967|NCT02877082|Tacrolimus|tacrolimus|mesh-list
65487968|NCT02877082|Thymoglobulin|thymoglobulin|mesh-list
65487969|NCT02877082|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65487970|NCT02877082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64499930|NCT01434472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64723917|NCT00000277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723918|NCT00000277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64723919|NCT00000277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64723920|NCT00000277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64723921|NCT00000277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723922|NCT00000277|Adrenergic Agents|adrenergic agents|mesh-ancestor
64723923|NCT00000277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723924|NCT00000277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64723925|NCT00000277|Dopamine Agents|dopamine agents|mesh-ancestor
64723926|NCT00599131|Docetaxel|docetaxel|mesh-list
64723927|NCT00599131|Fluorouracil|fluorouracil|mesh-list
64723928|NCT00599131|Cetuximab|cetuximab|mesh-list
64723929|NCT00599131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723930|NCT00599131|Tubulin Modulators|tubulin modulators|mesh-ancestor
64723931|NCT00599131|Antimitotic Agents|antimitotic agents|mesh-ancestor
64723932|NCT00599131|Mitosis Modulators|mitosis modulators|mesh-ancestor
64331504|NCT05355740|Chlorhexidine|chlorhexidine|mesh-list
64499931|NCT01434472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64499932|NCT01434472|Antimetabolites|antimetabolites|mesh-ancestor
65487971|NCT02877082|Immunologic Factors|immunologic factors|mesh-ancestor
65487972|NCT02877082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487973|NCT02877082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65487974|NCT02877082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65487975|NCT02877082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487976|NCT02877082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65487977|NCT03951558|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65487978|NCT03951558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65487979|NCT03951558|Diuretics|diuretics|mesh-ancestor
65487980|NCT03951558|Natriuretic Agents|natriuretic agents|mesh-ancestor
65487981|NCT03951558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487982|NCT03951558|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65487983|NCT03951558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65487984|NCT03951558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487985|NCT01362010|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65487986|NCT01362010|Minocycline|minocycline|mesh-list
65487987|NCT01362010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65487988|NCT00003138|Epoetin Alfa|epoetin alfa|mesh-list
65487989|NCT00003138|Lenograstim|lenograstim|mesh-list
65487990|NCT00003138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65487991|NCT00003138|Immunologic Factors|immunologic factors|mesh-ancestor
65487992|NCT00003138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65487993|NCT00003138|Hematinics|hematinics|mesh-ancestor
65487994|NCT02875366|Ivacaftor|ivacaftor|mesh-list
65487995|NCT02875366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65487996|NCT02875366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65487997|NCT02875366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65487998|NCT01362400|Docetaxel|docetaxel|mesh-list
65487999|NCT01362400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488000|NCT01362400|Tubulin Modulators|tubulin modulators|mesh-ancestor
65488001|NCT01362400|Antimitotic Agents|antimitotic agents|mesh-ancestor
65488002|NCT01362400|Mitosis Modulators|mitosis modulators|mesh-ancestor
65488013|NCT00002850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65488014|NCT00002850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65488015|NCT00002850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65488016|NCT00002850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488017|NCT00002850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488018|NCT00002850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488019|NCT00002850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65488020|NCT00002850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65488021|NCT00002850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65488022|NCT00002850|Renal Agents|renal agents|mesh-ancestor
65488023|NCT00002850|Antimalarials|antimalarials|mesh-ancestor
65488024|NCT00002850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65488025|NCT00002850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65488026|NCT00002850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65488027|NCT00002850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65488028|NCT00002850|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65488029|NCT04234906|Magnesium Sulfate|magnesium sulfate|mesh-list
65488030|NCT04234906|Amiodarone|amiodarone|mesh-list
65488031|NCT04234906|Procainamide|procainamide|mesh-list
65488032|NCT04234906|Dexmedetomidine|dexmedetomidine|mesh-list
65488033|NCT04234906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65488034|NCT04234906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65488035|NCT04234906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488036|NCT04234906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65488037|NCT04234906|Analgesics|analgesics|mesh-ancestor
65488038|NCT04234906|Sensory System Agents|sensory system agents|mesh-ancestor
64499933|NCT01434472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499934|NCT01434472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64499935|NCT01434472|Antiviral Agents|antiviral agents|mesh-ancestor
64499936|NCT01434472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64499937|NCT01434472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64499938|NCT01434472|Antifungal Agents|antifungal agents|mesh-ancestor
64499939|NCT01434472|Dermatologic Agents|dermatologic agents|mesh-ancestor
64499940|NCT01434472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64499941|NCT01434472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64499942|NCT01434472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64499943|NCT01434472|Antitubercular Agents|antitubercular agents|mesh-ancestor
64499944|NCT01434472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64499945|NCT01435174|Ranolazine|ranolazine|mesh-list
64499946|NCT01435174|Dialysis Solutions|dialysis solutions|mesh-list
64499947|NCT01435174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64499948|NCT01435174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64499949|NCT01435174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64499960|NCT01436266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64499961|NCT01436266|Oxytocics|oxytocics|mesh-ancestor
64499962|NCT01436266|Hematinics|hematinics|mesh-ancestor
64499963|NCT01436266|Vitamin B Complex|vitamin b complex|mesh-ancestor
64499970|NCT01439854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499971|NCT04409262|Remdesivir|remdesivir|mesh-list
65488039|NCT04234906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65488046|NCT04234906|Anesthetics|anesthetics|mesh-ancestor
65488113|NCT00002766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65488114|NCT00002766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65488115|NCT00002766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65488116|NCT01355380|Iloprost|iloprost|mesh-list
65488117|NCT01355380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65488118|NCT01355380|Vasodilator Agents|vasodilator agents|mesh-ancestor
65488119|NCT01355614|Infliximab|infliximab|mesh-list
65488120|NCT01355614|Dermatologic Agents|dermatologic agents|mesh-ancestor
65488121|NCT01355614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65488122|NCT01355614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65488123|NCT01584492|Beclomethasone|beclomethasone|mesh-list
65488124|NCT01584492|Albuterol|albuterol|mesh-list
65488125|NCT01584492|Formoterol Fumarate|formoterol fumarate|mesh-list
65488126|NCT01584492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65488127|NCT01584492|Autonomic Agents|autonomic agents|mesh-ancestor
65488128|NCT01584492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65488129|NCT01584492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488130|NCT01584492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65488131|NCT01584492|Respiratory System Agents|respiratory system agents|mesh-ancestor
65488132|NCT01584492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65488133|NCT01584492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65488134|NCT01584492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65488135|NCT01584492|Adrenergic Agents|adrenergic agents|mesh-ancestor
65488136|NCT01584492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65488137|NCT01584492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488138|NCT01584492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64871888|NCT01848769|Beclomethasone|beclomethasone|mesh-list
64499972|NCT04409262|Antimetabolites|antimetabolites|mesh-ancestor
64499973|NCT04409262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499974|NCT04409262|Antiviral Agents|antiviral agents|mesh-ancestor
64499975|NCT04409262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64945670|NCT05329766|Antimetabolites|antimetabolites|mesh-ancestor
64499976|NCT01481740|Phenylephrine|phenylephrine|mesh-list
64499977|NCT01481740|Oxymetazoline|oxymetazoline|mesh-list
64499978|NCT01481740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64499979|NCT01481740|Mydriatics|mydriatics|mesh-ancestor
64499980|NCT01481740|Autonomic Agents|autonomic agents|mesh-ancestor
64499981|NCT01481740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499982|NCT01481740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723933|NCT00599131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723934|NCT00599131|Antimetabolites|antimetabolites|mesh-ancestor
64723935|NCT00599131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64723936|NCT00599131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64723937|NCT00599131|Immunologic Factors|immunologic factors|mesh-ancestor
64331518|NCT05320887|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64499983|NCT01481740|Sympathomimetics|sympathomimetics|mesh-ancestor
64499984|NCT01481740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64499985|NCT01481740|Nasal Decongestants|nasal decongestants|mesh-ancestor
64499986|NCT01481740|Respiratory System Agents|respiratory system agents|mesh-ancestor
65488139|NCT01584492|Glucocorticoids|glucocorticoids|mesh-ancestor
65488140|NCT01584492|Hormones|hormones|mesh-ancestor
65488141|NCT01584492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65488142|NCT01584492|Tocolytic Agents|tocolytic agents|mesh-ancestor
65488143|NCT01584492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65488144|NCT00001962|Daclizumab|daclizumab|mesh-list
65488145|NCT00001962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65488146|NCT00001962|Immunologic Factors|immunologic factors|mesh-ancestor
65488147|NCT00001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488148|NCT01101984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65488149|NCT01101984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65488150|NCT01101984|Hyaluronic Acid|hyaluronic acid|mesh-list
65488151|NCT01101984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65488152|NCT01101984|Immunologic Factors|immunologic factors|mesh-ancestor
65488153|NCT01101984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488154|NCT01101984|Viscosupplements|viscosupplements|mesh-ancestor
65488155|NCT01101984|Protective Agents|protective agents|mesh-ancestor
65488156|NCT01103154|Nadolol|nadolol|mesh-list
65488157|NCT01103154|Carvedilol|carvedilol|mesh-list
65488158|NCT01103154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65488159|NCT01103154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65488160|NCT01103154|Adrenergic Agents|adrenergic agents|mesh-ancestor
65488161|NCT01103154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65488162|NCT01103154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488163|NCT01103154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488164|NCT01103154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65488165|NCT01103154|Antioxidants|antioxidants|mesh-ancestor
65488166|NCT01103154|Protective Agents|protective agents|mesh-ancestor
65488167|NCT01103154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65488168|NCT01103154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65488169|NCT01103154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65488170|NCT01103154|Vasodilator Agents|vasodilator agents|mesh-ancestor
65488171|NCT01103154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65488172|NCT01103154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65488173|NCT01103154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65488174|NCT01103154|Sympatholytics|sympatholytics|mesh-ancestor
65488177|NCT01100346|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65488178|NCT01100346|Hormones|hormones|mesh-ancestor
65488179|NCT01100346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65488180|NCT01100346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488181|NCT01103388|Rituximab|rituximab|mesh-list
65488182|NCT01103388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65488183|NCT01103388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488184|NCT01103388|Immunologic Factors|immunologic factors|mesh-ancestor
65488185|NCT01103388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488186|NCT01103388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65488187|NCT01327326|Naltrexone|naltrexone|mesh-list
65488188|NCT01327326|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65488189|NCT01327326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65488190|NCT01327326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488191|NCT01327326|Sensory System Agents|sensory system agents|mesh-ancestor
65488192|NCT01327326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65488193|NCT03950544|Meropenem|meropenem|mesh-list
65237714|NCT00661635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65488194|NCT03950544|Fosfomycin|fosfomycin|mesh-list
65488196|NCT03950544|Polymyxins|polymyxins|mesh-list
65488197|NCT03950544|Polymyxin B|polymyxin b|mesh-list
65488198|NCT03950544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65488199|NCT03950544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65488200|NCT03950544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65488201|NCT03950544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488202|NCT03950544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488203|NCT00028002|Imatinib Mesylate|imatinib mesylate|mesh-list
65488204|NCT00028002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488205|NCT00028002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65488206|NCT00028002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488207|NCT00028002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488208|NCT00256997|Risperidone|risperidone|mesh-list
65488209|NCT00256997|Antipsychotic Agents|antipsychotic agents|mesh-list
65488210|NCT00256997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65488211|NCT00256997|Serotonin Agents|serotonin agents|mesh-ancestor
65488212|NCT00256997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65488215|NCT00256997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65488216|NCT00256997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65488217|NCT00256997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65488218|NCT00256997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65488219|NCT00256997|Dopamine Agents|dopamine agents|mesh-ancestor
65488220|NCT00027846|Cyclophosphamide|cyclophosphamide|mesh-list
65488221|NCT00027846|Carboplatin|carboplatin|mesh-list
65488222|NCT00027846|Etoposide|etoposide|mesh-list
65488223|NCT00027846|Vincristine|vincristine|mesh-list
65488224|NCT00027846|Podophyllotoxin|podophyllotoxin|mesh-list
65488225|NCT00027846|Lenograstim|lenograstim|mesh-list
65488226|NCT00027846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65488227|NCT00027846|Immunologic Factors|immunologic factors|mesh-ancestor
65488228|NCT00027846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488229|NCT00027846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65488230|NCT00027846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65488231|NCT00027846|Alkylating Agents|alkylating agents|mesh-ancestor
65488232|NCT00027846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488233|NCT00027846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488234|NCT00027846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65488235|NCT00027846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65488236|NCT00027846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64871984|NCT01849757|Plasma-lyte 148|plasma-lyte 148|mesh-list
64499987|NCT01481740|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64499988|NCT01481740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64499989|NCT01481740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64499990|NCT01481740|Adrenergic Agents|adrenergic agents|mesh-ancestor
64499991|NCT01481740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64499992|NCT01481740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499993|NCT01481740|Protective Agents|protective agents|mesh-ancestor
64499994|NCT01544062|Acetaminophen|acetaminophen|mesh-list
64499995|NCT01544062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64499996|NCT01544062|Analgesics|analgesics|mesh-ancestor
64499997|NCT01544062|Sensory System Agents|sensory system agents|mesh-ancestor
64499998|NCT01544062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499999|NCT01544062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500000|NCT01544062|Antipyretics|antipyretics|mesh-ancestor
64500001|NCT03126084|Acetaminophen|acetaminophen|mesh-list
64500002|NCT03126084|Tramadol|tramadol|mesh-list
64500003|NCT03126084|Bupivacaine|bupivacaine|mesh-list
64500004|NCT03126084|Anesthetics, Local|anesthetics, local|mesh-ancestor
64500005|NCT03126084|Anesthetics|anesthetics|mesh-ancestor
64500006|NCT03126084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64500007|NCT03126084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500008|NCT03126084|Sensory System Agents|sensory system agents|mesh-ancestor
64500009|NCT03126084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500010|NCT03126084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64500011|NCT03126084|Analgesics|analgesics|mesh-ancestor
64500012|NCT03126084|Antipyretics|antipyretics|mesh-ancestor
64500013|NCT03126084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64500014|NCT03126084|Narcotics|narcotics|mesh-ancestor
64500015|NCT01544998|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64500016|NCT01544998|Tadalafil|tadalafil|mesh-list
64500017|NCT01544998|Vasodilator Agents|vasodilator agents|mesh-ancestor
65488237|NCT00027846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65488238|NCT00027846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488239|NCT00027846|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65488240|NCT00027846|Tubulin Modulators|tubulin modulators|mesh-ancestor
65488241|NCT00027846|Antimitotic Agents|antimitotic agents|mesh-ancestor
65488242|NCT00027846|Mitosis Modulators|mitosis modulators|mesh-ancestor
65488243|NCT00027846|Keratolytic Agents|keratolytic agents|mesh-ancestor
65488244|NCT00027846|Dermatologic Agents|dermatologic agents|mesh-ancestor
65488245|NCT00027378|Fluoxetine|fluoxetine|mesh-list
65488246|NCT00027378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65488247|NCT00027378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65488248|NCT00027378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65488249|NCT00027378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488250|NCT00027378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65488251|NCT00027378|Serotonin Agents|serotonin agents|mesh-ancestor
65488252|NCT00027378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488253|NCT00027378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65488254|NCT00027378|Antidepressive Agents|antidepressive agents|mesh-ancestor
65488255|NCT00027378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65488256|NCT00027378|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65488257|NCT00027378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65488258|NCT00027378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488259|NCT03950154|Bevacizumab|bevacizumab|mesh-list
65488260|NCT03950154|Capecitabine|capecitabine|mesh-list
65488261|NCT03950154|Oxaliplatin|oxaliplatin|mesh-list
65488262|NCT03950154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65488263|NCT03950154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488264|NCT03950154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65488265|NCT03950154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64500032|NCT03391830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64500034|NCT03391830|Antioxidants|antioxidants|mesh-ancestor
64500035|NCT03391830|Protective Agents|protective agents|mesh-ancestor
64500036|NCT03391830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500038|NCT03391830|Micronutrients|micronutrients|mesh-ancestor
64500039|NCT01441570|Metoprolol|metoprolol|mesh-list
64500040|NCT01441570|Nebivolol|nebivolol|mesh-list
64500041|NCT01441570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64500042|NCT01441570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64500043|NCT01441570|Sympatholytics|sympatholytics|mesh-ancestor
64500044|NCT01441570|Autonomic Agents|autonomic agents|mesh-ancestor
64500050|NCT01441570|Adrenergic Agents|adrenergic agents|mesh-ancestor
64500051|NCT01441570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64500052|NCT01441570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500054|NCT01441570|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65488266|NCT03950154|Growth Substances|growth substances|mesh-ancestor
65488267|NCT03950154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488268|NCT03950154|Growth Inhibitors|growth inhibitors|mesh-ancestor
65237820|NCT00662805|Xhance|xhance|mesh-list
65488269|NCT03950154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65488270|NCT03950154|Antimetabolites|antimetabolites|mesh-ancestor
65488271|NCT03950154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488272|NCT03949062|Rituximab|rituximab|mesh-list
65488273|NCT03949062|Lenalidomide|lenalidomide|mesh-list
65488333|NCT02955290|Nivolumab|nivolumab|mesh-list
65488334|NCT02955290|Vaccines|vaccines|mesh-list
65488335|NCT02955290|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65488336|NCT02955290|Mitogens|mitogens|mesh-list
65488337|NCT02955290|Immunologic Factors|immunologic factors|mesh-ancestor
65488338|NCT02955290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488339|NCT02955290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65488340|NCT02955290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488341|NCT02955290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65488342|NCT02955290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488343|NCT02955290|Mitosis Modulators|mitosis modulators|mesh-ancestor
65488344|NCT02955290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65488345|NCT00025662|Interleukin-2|interleukin-2|mesh-list
65488347|NCT00025662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488348|NCT00025662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65488349|NCT00025662|Analgesics|analgesics|mesh-ancestor
65488350|NCT00025662|Sensory System Agents|sensory system agents|mesh-ancestor
65488351|NCT00025662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65488352|NCT00025662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488353|NCT00025662|Immunologic Factors|immunologic factors|mesh-ancestor
65488354|NCT03759158|Acetylcysteine|acetylcysteine|mesh-list
65488355|NCT03759158|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65488356|NCT03759158|Antiviral Agents|antiviral agents|mesh-ancestor
65488357|NCT03759158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65488358|NCT03759158|Expectorants|expectorants|mesh-ancestor
65488359|NCT03759158|Respiratory System Agents|respiratory system agents|mesh-ancestor
65488360|NCT03759158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65488361|NCT03759158|Antioxidants|antioxidants|mesh-ancestor
65488362|NCT03759158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488363|NCT03759158|Protective Agents|protective agents|mesh-ancestor
65488364|NCT03759158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488365|NCT03759158|Antidotes|antidotes|mesh-ancestor
65488366|NCT02922764|Carboplatin|carboplatin|mesh-list
65488378|NCT02922764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65488379|NCT02922764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65488380|NCT02922764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65488381|NCT00025506|Thalidomide|thalidomide|mesh-list
65488382|NCT00025506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65488383|NCT00025506|Immunologic Factors|immunologic factors|mesh-ancestor
65488384|NCT00025506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488385|NCT00025506|Leprostatic Agents|leprostatic agents|mesh-ancestor
65488386|NCT00025506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65488387|NCT00025506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65488388|NCT00025506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65488389|NCT00025506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65488390|NCT00025506|Growth Substances|growth substances|mesh-ancestor
65488391|NCT00025506|Growth Inhibitors|growth inhibitors|mesh-ancestor
65488392|NCT00025506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488393|NCT00024258|Arsenic Trioxide|arsenic trioxide|mesh-list
65488394|NCT00024258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488395|NCT03756272|Bupivacaine|bupivacaine|mesh-list
65488396|NCT03756272|Anesthetics, Local|anesthetics, local|mesh-ancestor
65488397|NCT03756272|Anesthetics|anesthetics|mesh-ancestor
65488398|NCT03756272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65488399|NCT03756272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488400|NCT03756272|Sensory System Agents|sensory system agents|mesh-ancestor
65488401|NCT03756272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65488402|NCT03756194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65488403|NCT03756116|Epinephrine|epinephrine|mesh-list
65488404|NCT03756116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65488405|NCT03756116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65488406|NCT03756116|Adrenergic Agents|adrenergic agents|mesh-ancestor
65488407|NCT03756116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65488408|NCT03756116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488409|NCT03756116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500055|NCT01441570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64500056|NCT01441570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64500058|NCT05238012|Calcium|calcium|mesh-list
64500059|NCT05238012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64500060|NCT05238012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500061|NCT05238012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64500062|NCT05238012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64723938|NCT00599131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723939|NCT00599131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65488410|NCT03756116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65488411|NCT03756116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65488412|NCT03756116|Autonomic Agents|autonomic agents|mesh-ancestor
65488413|NCT03756116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65488414|NCT03756116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65488415|NCT03756116|Respiratory System Agents|respiratory system agents|mesh-ancestor
65488416|NCT03756116|Mydriatics|mydriatics|mesh-ancestor
65488417|NCT03756116|Sympathomimetics|sympathomimetics|mesh-ancestor
65488418|NCT03756116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65488419|NCT00023712|Bortezomib|bortezomib|mesh-list
65488420|NCT00023712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488421|NCT00023322|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65488422|NCT00023322|Antiviral Agents|antiviral agents|mesh-ancestor
65488423|NCT00023322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65488424|NCT04640168|Remdesivir|remdesivir|mesh-list
65488425|NCT04640168|Dexamethasone|dexamethasone|mesh-list
65488426|NCT04640168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65488427|NCT04640168|Antiemetics|antiemetics|mesh-ancestor
65488428|NCT04640168|Autonomic Agents|autonomic agents|mesh-ancestor
65488429|NCT04640168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65488430|NCT04640168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488431|NCT04640168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65488432|NCT04640168|Glucocorticoids|glucocorticoids|mesh-ancestor
65488433|NCT04640168|Hormones|hormones|mesh-ancestor
65488434|NCT04640168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65488435|NCT04640168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65488436|NCT04640168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488437|NCT04640168|Antimetabolites|antimetabolites|mesh-ancestor
65488438|NCT04640168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488457|NCT03951402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488458|NCT03951402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488459|NCT03951402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488460|NCT03951402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65488461|NCT03951402|Contraceptive Agents|contraceptive agents|mesh-ancestor
65488462|NCT03951402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65488463|NCT03951402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488464|NCT03951402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65488465|NCT03951402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65488466|NCT03951402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65488467|NCT03951402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65488468|NCT03951402|Narcotics|narcotics|mesh-ancestor
65488469|NCT03951402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65488470|NCT03951402|Analgesics|analgesics|mesh-ancestor
65488471|NCT03951402|Sensory System Agents|sensory system agents|mesh-ancestor
65488472|NCT03951402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65488473|NCT03951402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65488474|NCT03951402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65488475|NCT03951402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65488476|NCT03951402|Adrenergic Agents|adrenergic agents|mesh-ancestor
65488477|NCT03951402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65488478|NCT01100736|Bosentan|bosentan|mesh-list
65488479|NCT01100736|Sitaxsentan|sitaxsentan|mesh-list
65488480|NCT01100736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65488481|NCT01100736|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64872204|NCT01851278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723940|NCT04302350|Nitrous Oxide|nitrous oxide|mesh-list
64723941|NCT04302350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64723942|NCT04302350|Anesthetics, General|anesthetics, general|mesh-ancestor
64723943|NCT04302350|Anesthetics|anesthetics|mesh-ancestor
64331522|NCT05320887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64500063|NCT05238012|Antimetabolites|antimetabolites|mesh-ancestor
64500064|NCT05238012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500065|NCT05238012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64500066|NCT05238012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64500067|NCT05238012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500068|NCT01441882|Dasatinib|dasatinib|mesh-list
64500069|NCT01441882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500070|NCT01441882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64500071|NCT01441882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500072|NCT01441882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500073|NCT01484626|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64500074|NCT01484626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64500075|NCT01484626|Alkylating Agents|alkylating agents|mesh-ancestor
64500076|NCT01484626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500077|NCT01484626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488482|NCT01100736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488483|NCT01584726|Magnesium Sulfate|magnesium sulfate|mesh-list
65488484|NCT01584726|Analgesics|analgesics|mesh-ancestor
65488485|NCT01584726|Sensory System Agents|sensory system agents|mesh-ancestor
65488486|NCT01584726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65488487|NCT01584726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488488|NCT01584726|Anesthetics|anesthetics|mesh-ancestor
65488489|NCT01584726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65488490|NCT01584726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65488491|NCT01584726|Anticonvulsants|anticonvulsants|mesh-ancestor
65488492|NCT01584726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65488493|NCT01584726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65488494|NCT01584726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488495|NCT01584726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65488496|NCT01584726|Tocolytic Agents|tocolytic agents|mesh-ancestor
65488497|NCT01584726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65488498|NCT01584804|Antitussive Agents|antitussive agents|mesh-list
65488499|NCT01584804|Respiratory System Agents|respiratory system agents|mesh-ancestor
65488500|NCT01105494|Epoetin Alfa|epoetin alfa|mesh-list
65488501|NCT01105494|Hematinics|hematinics|mesh-ancestor
65488502|NCT03949686|Bupivacaine|bupivacaine|mesh-list
65488503|NCT03949686|Anesthetics, Local|anesthetics, local|mesh-ancestor
65488504|NCT03949686|Anesthetics|anesthetics|mesh-ancestor
65488505|NCT03949686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65488506|NCT03949686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488507|NCT03949686|Sensory System Agents|sensory system agents|mesh-ancestor
65488508|NCT03949686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65488509|NCT03949842|Fluticasone|fluticasone|mesh-list
65488511|NCT03949842|Adrenergic Agents|adrenergic agents|mesh-list
65488512|NCT03949842|Cholinergic Agents|cholinergic agents|mesh-list
65488513|NCT03949842|Muscarinic Antagonists|muscarinic antagonists|mesh-list
65488514|NCT03949842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65488524|NCT03949842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488525|NCT03949842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65488526|NCT01102608|Ifosfamide|ifosfamide|mesh-list
65488527|NCT01102608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65488528|NCT01102608|Alkylating Agents|alkylating agents|mesh-ancestor
65488529|NCT01102608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488530|NCT01102608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488531|NCT01102686|Leucovorin|leucovorin|mesh-list
65488532|NCT01102686|Pyrimethamine|pyrimethamine|mesh-list
65488533|NCT01102686|Antidotes|antidotes|mesh-ancestor
65488534|NCT01102686|Protective Agents|protective agents|mesh-ancestor
65488535|NCT01102686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488536|NCT01102686|Vitamin B Complex|vitamin b complex|mesh-ancestor
65488537|NCT01102686|Vitamins|vitamins|mesh-ancestor
65488538|NCT01102686|Micronutrients|micronutrients|mesh-ancestor
65488539|NCT01102686|Antimalarials|antimalarials|mesh-ancestor
65488540|NCT01102686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65488541|NCT01102686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65488542|NCT01102686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65488543|NCT01102686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65488544|NCT01102686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488545|NCT01102686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488546|NCT03949374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65488547|NCT03949374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65488548|NCT03949374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65488549|NCT03949374|Antimetabolites|antimetabolites|mesh-ancestor
65488550|NCT03949374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488551|NCT03949374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65488552|NCT03949374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65488553|NCT03949374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488554|NCT05626140|Diclofenac|diclofenac|mesh-list
65488555|NCT05626140|Lacosamide|lacosamide|mesh-list
65488566|NCT05626140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488567|NCT05626140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488568|NCT05626140|Anticonvulsants|anticonvulsants|mesh-ancestor
65488569|NCT05626140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65488570|NCT05626140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65488571|NCT05626140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65488572|NCT05626140|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65488573|NCT05626140|Narcotics|narcotics|mesh-ancestor
65488574|NCT05626140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65488575|NCT05626140|Antitussive Agents|antitussive agents|mesh-ancestor
65488576|NCT05626140|Respiratory System Agents|respiratory system agents|mesh-ancestor
65488577|NCT04878042|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65488578|NCT04878042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65488579|NCT04878042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65488580|NCT04813614|Lidocaine|lidocaine|mesh-list
65488581|NCT04813614|Anesthetics, Local|anesthetics, local|mesh-ancestor
65488582|NCT04813614|Anesthetics|anesthetics|mesh-ancestor
65488583|NCT04813614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65488584|NCT04813614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500078|NCT01545700|Dexamethasone|dexamethasone|mesh-list
64500088|NCT01545700|Hormones|hormones|mesh-ancestor
64500089|NCT01545700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64500090|NCT01545700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64500091|NCT01545700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500092|NCT01545700|Protease Inhibitors|protease inhibitors|mesh-ancestor
64500093|NCT01545700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500094|NCT01545700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500095|NCT01486810|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64500096|NCT01486810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64500097|NCT01486810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500098|NCT01486810|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64500099|NCT01486810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64500100|NCT01486810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64500101|NCT01486810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500103|NCT01486810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64500104|NCT01443442|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64500105|NCT01443442|Bepotastine besilate|bepotastine besilate|mesh-list
64500106|NCT01443442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64500107|NCT01444924|Bupivacaine|bupivacaine|mesh-list
64500108|NCT01444924|Anesthetics, Local|anesthetics, local|mesh-ancestor
64500109|NCT01444924|Anesthetics|anesthetics|mesh-ancestor
64500110|NCT01444924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64500111|NCT01444924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500112|NCT01444924|Sensory System Agents|sensory system agents|mesh-ancestor
64500113|NCT01444924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500114|NCT01546402|Dexamethasone|dexamethasone|mesh-list
64419285|NCT05155033|Aldesleukin|aldesleukin|mesh-list
64500125|NCT01546402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64500128|NCT01546402|Protease Inhibitors|protease inhibitors|mesh-ancestor
64500129|NCT01546402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500130|NCT01546402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500131|NCT03389490|Insulin|insulin|mesh-list
64500132|NCT03389490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65488585|NCT04813614|Sensory System Agents|sensory system agents|mesh-ancestor
65488586|NCT04813614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65488587|NCT04813614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65488588|NCT04813614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65488589|NCT04813614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65488590|NCT04813614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65488591|NCT04813614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488592|NCT01106118|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65488593|NCT01106118|Vasodilator Agents|vasodilator agents|mesh-ancestor
65488594|NCT01106118|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65488595|NCT01106118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65488596|NCT01106118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488597|NCT01106118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488598|NCT01106118|Urological Agents|urological agents|mesh-ancestor
65488599|NCT00234065|Aspirin|aspirin|mesh-list
65488600|NCT00234065|Cilostazol|cilostazol|mesh-list
65488601|NCT00234065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65488602|NCT00234065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65488603|NCT00234065|Analgesics|analgesics|mesh-ancestor
65488604|NCT00234065|Sensory System Agents|sensory system agents|mesh-ancestor
65488605|NCT00234065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65488606|NCT00234065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488607|NCT00234065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65488615|NCT00234065|Antipyretics|antipyretics|mesh-ancestor
65488633|NCT04660812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65488634|NCT04660812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488635|NCT04660812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65488636|NCT04660812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65488637|NCT04660812|Growth Substances|growth substances|mesh-ancestor
65488638|NCT04660812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488639|NCT04660812|Growth Inhibitors|growth inhibitors|mesh-ancestor
65488640|NCT00233987|Cyclophosphamide|cyclophosphamide|mesh-list
65488641|NCT00233987|Melphalan|melphalan|mesh-list
65488642|NCT00233987|Carmustine|carmustine|mesh-list
65488643|NCT00233987|Etoposide|etoposide|mesh-list
65488644|NCT00233987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65488645|NCT00233987|Immunologic Factors|immunologic factors|mesh-ancestor
65488646|NCT00233987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488647|NCT00233987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65488648|NCT00233987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65488650|NCT00233987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488651|NCT00233987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488652|NCT00233987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65488653|NCT00233987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64331527|NCT05316831|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64331529|NCT05316831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331530|NCT05308056|Anesthetics|anesthetics|mesh-list
64331531|NCT05308056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64331532|NCT05308056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331545|NCT05276284|Atezolizumab|atezolizumab|mesh-list
64723944|NCT04302350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64723945|NCT04302350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723946|NCT04302350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64723947|NCT04302350|Analgesics|analgesics|mesh-ancestor
64723948|NCT04302350|Sensory System Agents|sensory system agents|mesh-ancestor
64723949|NCT04302350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64723951|NCT00584935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64723952|NCT00584935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723953|NCT00584935|Immunologic Factors|immunologic factors|mesh-ancestor
64723954|NCT00584935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723955|NCT00584935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64723956|NCT04295486|Aspirin|aspirin|mesh-list
64723957|NCT04295486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64723958|NCT04295486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64723959|NCT04295486|Analgesics|analgesics|mesh-ancestor
64723960|NCT04295486|Sensory System Agents|sensory system agents|mesh-ancestor
64723961|NCT04295486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500133|NCT03389490|Insulin Glargine|insulin glargine|mesh-list
64500134|NCT03389490|Insulin, Isophane|insulin, isophane|mesh-list
64500135|NCT03389490|Isophane Insulin, Human|isophane insulin, human|mesh-list
64500136|NCT03389490|Isophane insulin, beef|isophane insulin, beef|mesh-list
64500137|NCT03389490|Protamines|protamines|mesh-list
64500138|NCT03389490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64500139|NCT03389490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500140|NCT03389490|Heparin Antagonists|heparin antagonists|mesh-ancestor
64500141|NCT03389490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500142|NCT03389490|Coagulants|coagulants|mesh-ancestor
64500143|NCT03994146|Remifentanil|remifentanil|mesh-list
65488654|NCT00233987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65488655|NCT00233987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65488656|NCT00233987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488657|NCT01108926|Tenofovir|tenofovir|mesh-list
65488658|NCT01108926|Emtricitabine|emtricitabine|mesh-list
65488659|NCT01108926|Efavirenz|efavirenz|mesh-list
65488660|NCT01108926|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65488661|NCT01108926|Antiviral Agents|antiviral agents|mesh-ancestor
65488662|NCT01108926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65488663|NCT01108926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65488664|NCT01108926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65488665|NCT01108926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488666|NCT01108926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488667|NCT01108926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65488668|NCT01108926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65488669|NCT01108926|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65488670|NCT01108926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65488671|NCT01108926|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65488672|NCT01108926|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65488673|NCT01108926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65488674|NCT01108926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65488675|NCT05321394|Ritonavir|ritonavir|mesh-list
65488676|NCT05321394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65488677|NCT05321394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65488678|NCT05321394|Protease Inhibitors|protease inhibitors|mesh-ancestor
65488679|NCT05321394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488680|NCT05321394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488681|NCT05321394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64500144|NCT03994146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64500145|NCT03994146|Narcotics|narcotics|mesh-ancestor
64500146|NCT03994146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64500159|NCT01445626|Autonomic Agents|autonomic agents|mesh-ancestor
64500160|NCT01445626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64723962|NCT04295486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723963|NCT04295486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64723964|NCT04295486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64723965|NCT04295486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64723966|NCT04295486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64723967|NCT04295486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723975|NCT00000289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500161|NCT01445626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500162|NCT01445626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64500163|NCT01445626|Glucocorticoids|glucocorticoids|mesh-ancestor
64500164|NCT01445626|Hormones|hormones|mesh-ancestor
65488682|NCT05321394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65488683|NCT05321394|Antiviral Agents|antiviral agents|mesh-ancestor
65488684|NCT05321394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65488685|NCT05321394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65488686|NCT05321394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65488687|NCT04623242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65488688|NCT04623242|Immunologic Factors|immunologic factors|mesh-ancestor
65488689|NCT04623242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488690|NCT00233363|Rebamipide|rebamipide|mesh-list
65488691|NCT00233363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65488692|NCT00233363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65488693|NCT00233363|Antioxidants|antioxidants|mesh-ancestor
65488694|NCT00233363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488695|NCT00233363|Protective Agents|protective agents|mesh-ancestor
65488696|NCT00233363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488697|NCT00233363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488698|NCT01147666|Epoetin Alfa|epoetin alfa|mesh-list
65488699|NCT01147666|Hematinics|hematinics|mesh-ancestor
65488700|NCT01073111|Sirolimus|sirolimus|mesh-list
65488701|NCT01073111|Everolimus|everolimus|mesh-list
65488702|NCT01073111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488703|NCT01073111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65488704|NCT01073111|Immunologic Factors|immunologic factors|mesh-ancestor
65488705|NCT01073111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488706|NCT01073111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65488707|NCT01073111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64500165|NCT01445626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64500166|NCT01445626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64500167|NCT01445626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500168|NCT02744742|Cyclophosphamide|cyclophosphamide|mesh-list
64500169|NCT02744742|Busulfan|busulfan|mesh-list
64500170|NCT02744742|Decitabine|decitabine|mesh-list
64500171|NCT02744742|Lenograstim|lenograstim|mesh-list
64500172|NCT02744742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64500173|NCT02744742|Immunologic Factors|immunologic factors|mesh-ancestor
64500174|NCT02744742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500175|NCT02744742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64500176|NCT02744742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64500177|NCT02744742|Alkylating Agents|alkylating agents|mesh-ancestor
64500178|NCT02744742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500179|NCT02744742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500180|NCT02744742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64500181|NCT02744742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64500182|NCT02744742|Antimetabolites|antimetabolites|mesh-ancestor
64500183|NCT02744742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500184|NCT02744742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64500185|NCT03389412|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64500186|NCT03389412|Hemostatics|hemostatics|mesh-ancestor
64500187|NCT03389412|Coagulants|coagulants|mesh-ancestor
64500188|NCT03389412|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65488708|NCT01073111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65488709|NCT01073111|Antifungal Agents|antifungal agents|mesh-ancestor
65488710|NCT01325987|Vitamin D|vitamin d|mesh-list
65488711|NCT01325987|Ergocalciferols|ergocalciferols|mesh-list
65488712|NCT01325987|Cholecalciferol|cholecalciferol|mesh-list
65488713|NCT01325987|Vitamins|vitamins|mesh-list
65488714|NCT01325987|Micronutrients|micronutrients|mesh-ancestor
65488715|NCT01325987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488716|NCT01325987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65488717|NCT01325987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65488718|NCT00256295|Gemcitabine|gemcitabine|mesh-list
65488719|NCT00256295|Oxaliplatin|oxaliplatin|mesh-list
65488720|NCT00256295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65488721|NCT00256295|Antimetabolites|antimetabolites|mesh-ancestor
65488722|NCT00256295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488723|NCT00256295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488725|NCT00256295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65488726|NCT00256295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488727|NCT00256295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65488728|NCT00256295|Immunologic Factors|immunologic factors|mesh-ancestor
65488729|NCT00256295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488730|NCT04410562|Hydroxychloroquine|hydroxychloroquine|mesh-list
65488731|NCT04410562|Antimalarials|antimalarials|mesh-ancestor
65488732|NCT04410562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65488733|NCT04410562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65488734|NCT04410562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65488735|NCT04410562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488736|NCT04410562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488737|NCT04410562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65488738|NCT01109160|Azithromycin|azithromycin|mesh-list
65488739|NCT01109160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65488740|NCT01109160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65488741|NCT01363336|Nifedipine|nifedipine|mesh-list
65488742|NCT01363336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65488743|NCT01363336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65488744|NCT01363336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488747|NCT01363336|Vasodilator Agents|vasodilator agents|mesh-ancestor
65488748|NCT01363336|Tocolytic Agents|tocolytic agents|mesh-ancestor
65488749|NCT01363336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65488750|NCT01363414|Hyaluronic Acid|hyaluronic acid|mesh-list
65488751|NCT01363414|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65488752|NCT01363414|Immunologic Factors|immunologic factors|mesh-ancestor
65488753|NCT01363414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488754|NCT01363414|Viscosupplements|viscosupplements|mesh-ancestor
65488755|NCT01363414|Protective Agents|protective agents|mesh-ancestor
65488756|NCT02223520|Chlorhexidine|chlorhexidine|mesh-list
65488757|NCT02223520|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65488758|NCT02223520|Mupirocin|mupirocin|mesh-list
65488759|NCT02223520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65488760|NCT02223520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65488761|NCT02223520|Disinfectants|disinfectants|mesh-ancestor
65488762|NCT02223520|Dermatologic Agents|dermatologic agents|mesh-ancestor
65488763|NCT02223520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65488764|NCT02223520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65488765|NCT02223520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488766|NCT02223520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488767|NCT01356472|Imipenem|imipenem|mesh-list
65488768|NCT01356472|Cilastatin|cilastatin|mesh-list
65488769|NCT01356472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65488770|NCT01356472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65488771|NCT01356472|Protease Inhibitors|protease inhibitors|mesh-ancestor
65488772|NCT01356472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488773|NCT01356472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488774|NCT02122198|Leuprolide|leuprolide|mesh-list
65488775|NCT02122198|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65488776|NCT02122198|Medroxyprogesterone|medroxyprogesterone|mesh-list
65488777|NCT02122198|Estradiol|estradiol|mesh-list
65488778|NCT02122198|Estrogens|estrogens|mesh-ancestor
65488779|NCT02122198|Hormones|hormones|mesh-ancestor
65488780|NCT02122198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65488781|NCT02122198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488782|NCT02122198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64500189|NCT03389412|Natriuretic Agents|natriuretic agents|mesh-ancestor
64500190|NCT03389412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500191|NCT03125772|Paclitaxel|paclitaxel|mesh-list
64500192|NCT03125772|Everolimus|everolimus|mesh-list
64500193|NCT03125772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65488783|NCT02122198|Contraceptive Agents|contraceptive agents|mesh-ancestor
65488784|NCT02122198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65488785|NCT02122198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65488786|NCT02122198|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65488787|NCT02122198|Fertility Agents|fertility agents|mesh-ancestor
65488788|NCT02122198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65488789|NCT02122198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488790|NCT02122198|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65488791|NCT02122198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65488792|NCT02122198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65488793|NCT02122198|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65488794|NCT01363570|Ranibizumab|ranibizumab|mesh-list
65488795|NCT01363570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65488796|NCT01363570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65488797|NCT01363570|Growth Substances|growth substances|mesh-ancestor
65488798|NCT01363570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488799|NCT01363570|Growth Inhibitors|growth inhibitors|mesh-ancestor
65488800|NCT01363570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488801|NCT04608500|Minocycline|minocycline|mesh-list
65488802|NCT04608500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65488803|NCT04608500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65488804|NCT01363648|Choline|choline|mesh-list
65488805|NCT01363648|Lipotropic Agents|lipotropic agents|mesh-ancestor
65488806|NCT01363648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65488807|NCT01363648|Antimetabolites|antimetabolites|mesh-ancestor
65488808|NCT01363648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488809|NCT01363648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65488810|NCT01363648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65488811|NCT01363648|Nootropic Agents|nootropic agents|mesh-ancestor
65488812|NCT01107054|Moxifloxacin|moxifloxacin|mesh-list
65488813|NCT01107054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65488814|NCT01107054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65488815|NCT01107054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65488816|NCT01107054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64500194|NCT03125772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500195|NCT03125772|Tubulin Modulators|tubulin modulators|mesh-ancestor
64500196|NCT03125772|Antimitotic Agents|antimitotic agents|mesh-ancestor
64500197|NCT03125772|Mitosis Modulators|mitosis modulators|mesh-ancestor
64500198|NCT03125772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500199|NCT03125772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64500200|NCT03125772|Immunologic Factors|immunologic factors|mesh-ancestor
64500201|NCT03125772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488817|NCT01107054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488818|NCT01107054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488819|NCT01107054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488820|NCT03944070|Ranibizumab|ranibizumab|mesh-list
65488821|NCT03944070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65488822|NCT03944070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65488823|NCT03944070|Growth Substances|growth substances|mesh-ancestor
65488824|NCT03944070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488825|NCT03944070|Growth Inhibitors|growth inhibitors|mesh-ancestor
65488826|NCT03944070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488827|NCT03764462|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65488828|NCT03764462|AD 101|ad 101|mesh-list
65488829|NCT03764462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65488830|NCT03764462|Hormone Antagonists|hormone antagonists|mesh-ancestor
65488831|NCT03764462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65488832|NCT03764462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488833|NCT03764462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65488834|NCT03764462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65488835|NCT03764462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65488836|NCT03764462|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65488837|NCT03764462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488838|NCT03764462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65488839|NCT03764462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65488840|NCT03764462|Antiviral Agents|antiviral agents|mesh-ancestor
65488841|NCT03764462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65488842|NCT05460416|Aspirin|aspirin|mesh-list
65488843|NCT05460416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65488844|NCT05460416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65488845|NCT05460416|Analgesics|analgesics|mesh-ancestor
65488846|NCT05460416|Sensory System Agents|sensory system agents|mesh-ancestor
65488847|NCT05460416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65488848|NCT05460416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488849|NCT05460416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65488850|NCT05460416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65488851|NCT05460416|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65488853|NCT05460416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488854|NCT05460416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65488855|NCT05460416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65488856|NCT05460416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488857|NCT05460416|Antipyretics|antipyretics|mesh-ancestor
65488858|NCT01364194|Bupivacaine|bupivacaine|mesh-list
65488859|NCT01364194|Anesthetics, Local|anesthetics, local|mesh-ancestor
65488860|NCT01364194|Anesthetics|anesthetics|mesh-ancestor
65488861|NCT01364194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65488862|NCT01364194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488863|NCT01364194|Sensory System Agents|sensory system agents|mesh-ancestor
65488864|NCT01364194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65488865|NCT04575038|Brequinar|brequinar|mesh-list
65488866|NCT04575038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488867|NCT04575038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488868|NCT04575038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488869|NCT04575038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65488870|NCT04575038|Immunologic Factors|immunologic factors|mesh-ancestor
65238457|NCT00996593|Iodine|iodine|mesh-list
65488871|NCT04575038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488873|NCT03066622|Antiemetics|antiemetics|mesh-ancestor
65488906|NCT05323214|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65488907|NCT05323214|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65488908|NCT05323214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65488909|NCT05323214|Adrenergic Agents|adrenergic agents|mesh-ancestor
65488910|NCT05323214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65488911|NCT05323214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488912|NCT05323214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65488913|NCT05323214|Narcotics|narcotics|mesh-ancestor
65488914|NCT05323214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65488915|NCT05323214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65488916|NCT05323214|Anesthetics, General|anesthetics, general|mesh-ancestor
65488917|NCT01936480|Moxifloxacin|moxifloxacin|mesh-list
65488918|NCT01936480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65488919|NCT01936480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65488920|NCT01936480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65488921|NCT01936480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65488922|NCT01936480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488923|NCT01936480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488924|NCT01936480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488925|NCT05366816|Sunitinib|sunitinib|mesh-list
65488926|NCT05366816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488927|NCT05366816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64872647|NCT01854489|Leprostatic Agents|leprostatic agents|mesh-ancestor
64500202|NCT01447888|Morphine|morphine|mesh-list
64500203|NCT01447888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64500205|NCT01447888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64500206|NCT01447888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500207|NCT01447888|Analgesics|analgesics|mesh-ancestor
64331560|NCT05244226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64331561|NCT05244226|Narcotics|narcotics|mesh-ancestor
64331562|NCT05244226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64331563|NCT05244226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331564|NCT05244226|Analgesics|analgesics|mesh-ancestor
64331565|NCT05244226|Sensory System Agents|sensory system agents|mesh-ancestor
64331566|NCT05244226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64723976|NCT00000289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723977|NCT00000289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64723978|NCT00000289|Antipruritics|antipruritics|mesh-ancestor
64723979|NCT00000289|Dermatologic Agents|dermatologic agents|mesh-ancestor
64723980|NCT00000289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64723981|NCT00000289|Serotonin Agents|serotonin agents|mesh-ancestor
64723982|NCT00000289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723983|NCT00000289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723984|NCT00000289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64723989|NCT00000295|Progesterone|progesterone|mesh-list
64723990|NCT00000295|Progestins|progestins|mesh-ancestor
64723991|NCT00000295|Hormones|hormones|mesh-ancestor
64723992|NCT00000295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64723993|NCT00000295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723994|NCT00000733|Ribavirin|ribavirin|mesh-list
64723995|NCT00000733|Antimetabolites|antimetabolites|mesh-ancestor
65488928|NCT05366816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65488929|NCT05366816|Growth Substances|growth substances|mesh-ancestor
65488930|NCT05366816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488931|NCT05366816|Growth Inhibitors|growth inhibitors|mesh-ancestor
65488932|NCT05366816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65488933|NCT05366816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488934|NCT05366816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488935|NCT02060188|Nivolumab|nivolumab|mesh-list
65488936|NCT02060188|Ipilimumab|ipilimumab|mesh-list
65488937|NCT02060188|Daratumumab|daratumumab|mesh-list
65488938|NCT02060188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65488939|NCT02060188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488940|NCT02060188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65488941|NCT02060188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488942|NCT01356862|Pasireotide|pasireotide|mesh-list
65488943|NCT01356862|Hormones|hormones|mesh-ancestor
65488944|NCT01356862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65488945|NCT01356862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488946|NCT03763760|Dexamethasone|dexamethasone|mesh-list
65488947|NCT03763760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65488948|NCT03763760|Antiemetics|antiemetics|mesh-ancestor
65488949|NCT03763760|Autonomic Agents|autonomic agents|mesh-ancestor
65488950|NCT03763760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65488951|NCT03763760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488952|NCT03763760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65488953|NCT03763760|Glucocorticoids|glucocorticoids|mesh-ancestor
65488954|NCT03763760|Hormones|hormones|mesh-ancestor
65488955|NCT03763760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65488956|NCT03763760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65488957|NCT03763760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488958|NCT04501952|Remdesivir|remdesivir|mesh-list
65488959|NCT04501952|Antimetabolites|antimetabolites|mesh-ancestor
65488960|NCT04501952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488961|NCT04501952|Antiviral Agents|antiviral agents|mesh-ancestor
65488962|NCT04501952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64723996|NCT00000733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723997|NCT00000733|Antiviral Agents|antiviral agents|mesh-ancestor
65488963|NCT00321100|Bevacizumab|bevacizumab|mesh-list
65488964|NCT00321100|Cetuximab|cetuximab|mesh-list
65488965|NCT00321100|Capecitabine|capecitabine|mesh-list
65488966|NCT00321100|Oxaliplatin|oxaliplatin|mesh-list
65488967|NCT00321100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65488968|NCT00321100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488969|NCT00321100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65488970|NCT00321100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65488971|NCT00321100|Growth Substances|growth substances|mesh-ancestor
65488972|NCT00321100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65488973|NCT00321100|Growth Inhibitors|growth inhibitors|mesh-ancestor
65488974|NCT00321100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65488975|NCT00321100|Antimetabolites|antimetabolites|mesh-ancestor
65488976|NCT00321100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488977|NCT02930122|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65488978|NCT02930122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65488979|NCT01365598|Primaquine|primaquine|mesh-list
65488980|NCT01365598|Antimalarials|antimalarials|mesh-ancestor
65488981|NCT01365598|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65488982|NCT01365598|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65488983|NCT01365598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65488984|NCT01365676|Hypericin|hypericin|mesh-list
65488985|NCT01365676|Antidepressive Agents|antidepressive agents|mesh-ancestor
65488986|NCT01365676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65488987|NCT01365676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65488988|NCT01365676|Antiviral Agents|antiviral agents|mesh-ancestor
65488989|NCT01365676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65488990|NCT01365676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65488991|NCT01365676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65488992|NCT01365676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65488993|NCT01365676|Immunologic Factors|immunologic factors|mesh-ancestor
65489009|NCT00070018|Vincristine|vincristine|mesh-list
65489010|NCT00070018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65489011|NCT00070018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65489012|NCT00070018|Immunologic Factors|immunologic factors|mesh-ancestor
65489013|NCT00070018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489014|NCT00070018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65489015|NCT00070018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65489016|NCT00070018|Alkylating Agents|alkylating agents|mesh-ancestor
65489017|NCT00070018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489018|NCT00070018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489019|NCT00070018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65489020|NCT00070018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65489021|NCT00070018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65489022|NCT00070018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65489023|NCT00070018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65489024|NCT00070018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489025|NCT00070018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65489026|NCT00070018|Glucocorticoids|glucocorticoids|mesh-ancestor
65489027|NCT00070018|Hormones|hormones|mesh-ancestor
65489028|NCT00070018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65489029|NCT00070018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65489030|NCT00070018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65489031|NCT00070018|Tubulin Modulators|tubulin modulators|mesh-ancestor
65489032|NCT00070018|Antimitotic Agents|antimitotic agents|mesh-ancestor
65489033|NCT00070018|Mitosis Modulators|mitosis modulators|mesh-ancestor
65489034|NCT03991988|Montelukast|montelukast|mesh-list
65489035|NCT03991988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65489036|NCT03991988|Respiratory System Agents|respiratory system agents|mesh-ancestor
65489037|NCT03991988|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65489038|NCT03991988|Hormone Antagonists|hormone antagonists|mesh-ancestor
65489039|NCT03991988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65489044|NCT01073189|Fenoldopam|fenoldopam|mesh-list
65489048|NCT01073189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489049|NCT01073189|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65489050|NCT01073189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65489051|NCT01073189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489052|NCT01073189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65489053|NCT01073189|Vasodilator Agents|vasodilator agents|mesh-ancestor
65489054|NCT01073189|Dopamine Agonists|dopamine agonists|mesh-ancestor
65489055|NCT01073189|Dopamine Agents|dopamine agents|mesh-ancestor
65489056|NCT01073189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65489057|NCT03750656|Hyoscyamine|hyoscyamine|mesh-list
65489058|NCT03750656|Tamsulosin|tamsulosin|mesh-list
65489059|NCT03750656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65489060|NCT03750656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65489061|NCT03750656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65489062|NCT03750656|Adrenergic Agents|adrenergic agents|mesh-ancestor
65489063|NCT03750656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65489064|NCT03750656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489065|NCT03750656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489066|NCT03750656|Urological Agents|urological agents|mesh-ancestor
65489067|NCT03750656|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65489068|NCT03750656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65489069|NCT03750656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65489070|NCT03750656|Autonomic Agents|autonomic agents|mesh-ancestor
65489071|NCT03750656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65489072|NCT03750656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65489073|NCT03750656|Respiratory System Agents|respiratory system agents|mesh-ancestor
65489074|NCT03750656|Mydriatics|mydriatics|mesh-ancestor
65489075|NCT03750656|Parasympatholytics|parasympatholytics|mesh-ancestor
65489076|NCT03750656|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64723998|NCT00000733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64723999|NCT04246723|Ritonavir|ritonavir|mesh-list
64724000|NCT04246723|Sofosbuvir|sofosbuvir|mesh-list
64724001|NCT04246723|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64724002|NCT04246723|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64500208|NCT01447888|Sensory System Agents|sensory system agents|mesh-ancestor
64500209|NCT01447888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500210|NCT03389256|Apatinib|apatinib|mesh-list
64500211|NCT03389256|Gefitinib|gefitinib|mesh-list
64500212|NCT03389256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500213|NCT03389256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64500226|NCT01490788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64500228|NCT01490788|Analgesics|analgesics|mesh-ancestor
64331595|NCT05221840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64331596|NCT05221840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489077|NCT03750656|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65489078|NCT03750656|Cholinergic Agents|cholinergic agents|mesh-ancestor
65489079|NCT00229931|Triamcinolone|triamcinolone|mesh-list
65489080|NCT00229931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65489081|NCT00229931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65489082|NCT00229931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65489083|NCT00229931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65489084|NCT00229931|Glucocorticoids|glucocorticoids|mesh-ancestor
65489085|NCT00229931|Hormones|hormones|mesh-ancestor
65489086|NCT00229931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65489087|NCT00229931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489088|NCT00229931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65489089|NCT00229931|Immunologic Factors|immunologic factors|mesh-ancestor
65489090|NCT00229931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489091|NCT00229931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489092|NCT03752294|Dabigatran|dabigatran|mesh-list
65489093|NCT03752294|Antithrombins|antithrombins|mesh-ancestor
65489094|NCT03752294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65489095|NCT03752294|Protease Inhibitors|protease inhibitors|mesh-ancestor
65489096|NCT03752294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489097|NCT03752294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489098|NCT03752294|Anticoagulants|anticoagulants|mesh-ancestor
65489099|NCT03135028|Cytarabine|cytarabine|mesh-list
65489100|NCT03135028|Daunorubicin|daunorubicin|mesh-list
65489101|NCT03135028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64872817|NCT01855555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64331597|NCT05179356|Dapagliflozin|dapagliflozin|mesh-list
64331598|NCT05179356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64331599|NCT05179356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724003|NCT04246723|Protease Inhibitors|protease inhibitors|mesh-ancestor
64724004|NCT04246723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724005|NCT04246723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724006|NCT04246723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64724007|NCT04246723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64724008|NCT04246723|Antiviral Agents|antiviral agents|mesh-ancestor
64724009|NCT04246723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724010|NCT04246723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64724011|NCT04246723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64724013|NCT00000301|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64724014|NCT00000301|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64724015|NCT00000301|Antiviral Agents|antiviral agents|mesh-ancestor
64724016|NCT00000301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724017|NCT00000301|Dopamine Agents|dopamine agents|mesh-ancestor
64724018|NCT00000301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64724019|NCT00000301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724020|NCT00000301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331600|NCT05179356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65489102|NCT03135028|Antimetabolites|antimetabolites|mesh-ancestor
65489103|NCT03135028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489104|NCT03135028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489105|NCT03135028|Antiviral Agents|antiviral agents|mesh-ancestor
65489106|NCT03135028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65489107|NCT03135028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65489108|NCT03135028|Immunologic Factors|immunologic factors|mesh-ancestor
65489109|NCT03135028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489110|NCT03135028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65489111|NCT03135028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65489112|NCT03135028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65489113|NCT03135028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489114|NCT03752138|Decitabine|decitabine|mesh-list
65489115|NCT03752138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65489116|NCT03752138|Antimetabolites|antimetabolites|mesh-ancestor
65489117|NCT03752138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489118|NCT03752138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489119|NCT03752138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489120|NCT01370434|Dexamethasone|dexamethasone|mesh-list
65489121|NCT01370434|Doxorubicin|doxorubicin|mesh-list
65489122|NCT01370434|Vincristine|vincristine|mesh-list
65489123|NCT01370434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65489124|NCT01370434|Antiemetics|antiemetics|mesh-ancestor
65489125|NCT01370434|Autonomic Agents|autonomic agents|mesh-ancestor
65489126|NCT01370434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65489127|NCT01370434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489128|NCT01370434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65489129|NCT01370434|Glucocorticoids|glucocorticoids|mesh-ancestor
65489130|NCT01370434|Hormones|hormones|mesh-ancestor
65489131|NCT01370434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65489132|NCT01370434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65489133|NCT01370434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489134|NCT01370434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489135|NCT01370434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489136|NCT01370434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64500229|NCT01490788|Sensory System Agents|sensory system agents|mesh-ancestor
64500230|NCT01490788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64500231|NCT01490788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65489137|NCT01370434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65489138|NCT01370434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65489139|NCT01370434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65489140|NCT01370434|Tubulin Modulators|tubulin modulators|mesh-ancestor
65489141|NCT01370434|Antimitotic Agents|antimitotic agents|mesh-ancestor
65489142|NCT01370434|Mitosis Modulators|mitosis modulators|mesh-ancestor
65489143|NCT05190952|Dexamethasone|dexamethasone|mesh-list
65489144|NCT05190952|Ketamine|ketamine|mesh-list
65489145|NCT05190952|Bupivacaine|bupivacaine|mesh-list
65489146|NCT05190952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65489147|NCT05190952|Antiemetics|antiemetics|mesh-ancestor
65489148|NCT05190952|Autonomic Agents|autonomic agents|mesh-ancestor
65489149|NCT05190952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65489150|NCT05190952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489151|NCT05190952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65489152|NCT05190952|Glucocorticoids|glucocorticoids|mesh-ancestor
65489153|NCT05190952|Hormones|hormones|mesh-ancestor
65489154|NCT05190952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65489155|NCT05190952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65489156|NCT05190952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489157|NCT05190952|Anesthetics, Local|anesthetics, local|mesh-ancestor
65489158|NCT05190952|Anesthetics|anesthetics|mesh-ancestor
65489159|NCT05190952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65489160|NCT05190952|Sensory System Agents|sensory system agents|mesh-ancestor
65489161|NCT05190952|Analgesics|analgesics|mesh-ancestor
65489162|NCT05190952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65489163|NCT05190952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65489164|NCT05190952|Anesthetics, General|anesthetics, general|mesh-ancestor
65489165|NCT05190952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65489166|NCT05190952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65489167|NCT05190952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65489168|NCT05190952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489169|NCT03972683|Atropine|atropine|mesh-list
65489170|NCT03972683|Adenosine|adenosine|mesh-list
65489171|NCT03972683|Nitroprusside|nitroprusside|mesh-list
64500232|NCT01490788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64500233|NCT01490788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500234|NCT01490788|Adrenergic Agents|adrenergic agents|mesh-ancestor
64500235|NCT01490788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64500236|NCT02520180|Everolimus|everolimus|mesh-list
65489173|NCT03972683|Oxymetazoline|oxymetazoline|mesh-list
65489174|NCT03972683|Acetylcholine|acetylcholine|mesh-list
65489175|NCT03972683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65489176|NCT03972683|Mydriatics|mydriatics|mesh-ancestor
65489177|NCT03972683|Autonomic Agents|autonomic agents|mesh-ancestor
65489178|NCT03972683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65489179|NCT03972683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489180|NCT03972683|Sympathomimetics|sympathomimetics|mesh-ancestor
65489181|NCT03972683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65489182|NCT03972683|Nasal Decongestants|nasal decongestants|mesh-ancestor
65489183|NCT03972683|Respiratory System Agents|respiratory system agents|mesh-ancestor
65489184|NCT03972683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65489185|NCT03972683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65489186|NCT03972683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65489187|NCT03972683|Adrenergic Agents|adrenergic agents|mesh-ancestor
65489188|NCT03972683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65489189|NCT03972683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489190|NCT03972683|Protective Agents|protective agents|mesh-ancestor
65489191|NCT03972683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65489192|NCT03972683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65489193|NCT03972683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65489194|NCT03972683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65489195|NCT03972683|Parasympatholytics|parasympatholytics|mesh-ancestor
65489196|NCT03972683|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65489197|NCT03972683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65489198|NCT03972683|Cholinergic Agents|cholinergic agents|mesh-ancestor
65489199|NCT03972683|Analgesics|analgesics|mesh-ancestor
65489200|NCT03972683|Sensory System Agents|sensory system agents|mesh-ancestor
65489201|NCT03972683|Vasodilator Agents|vasodilator agents|mesh-ancestor
65489202|NCT03972683|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65489220|NCT00227591|Glucocorticoids|glucocorticoids|mesh-ancestor
65489221|NCT00227591|Hormones|hormones|mesh-ancestor
65489222|NCT00227591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65489223|NCT00227591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489224|NCT00227591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65489225|NCT00227591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489226|NCT00227591|Immunologic Factors|immunologic factors|mesh-ancestor
65489227|NCT00227591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65489228|NCT00227591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65489229|NCT00227591|Growth Substances|growth substances|mesh-ancestor
65489230|NCT00227591|Growth Inhibitors|growth inhibitors|mesh-ancestor
65489231|NCT01358344|Pantoprazole|pantoprazole|mesh-list
65489232|NCT01358344|Vorapaxar|vorapaxar|mesh-list
65489233|NCT01358344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65489234|NCT01358344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65489235|NCT01358344|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65489236|NCT01358344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489237|NCT01358344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489238|NCT01358344|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65489239|NCT01366300|Lidocaine|lidocaine|mesh-list
65489240|NCT01366300|Propofol|propofol|mesh-list
65489241|NCT01366300|Anesthetics, Local|anesthetics, local|mesh-ancestor
65489242|NCT01366300|Anesthetics|anesthetics|mesh-ancestor
65489243|NCT01366300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65489244|NCT01366300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500237|NCT02520180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500238|NCT02520180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64500239|NCT02520180|Immunologic Factors|immunologic factors|mesh-ancestor
64500240|NCT02520180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500241|NCT03391050|Dabrafenib|dabrafenib|mesh-list
64500242|NCT03391050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500243|NCT03391050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64500244|NCT03391050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500245|NCT03391050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500246|NCT03397992|Dialysis Solutions|dialysis solutions|mesh-list
64500247|NCT03397992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64500248|NCT03390972|Dexmedetomidine|dexmedetomidine|mesh-list
64500249|NCT03390972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64419337|NCT02378961|Velpatasvir|velpatasvir|mesh-list
64724025|NCT00000307|Naltrexone|naltrexone|mesh-list
64724026|NCT00000307|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64724027|NCT00000307|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64724028|NCT00000307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500250|NCT03390972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64500251|NCT03390972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500252|NCT03390972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64500253|NCT03390972|Analgesics|analgesics|mesh-ancestor
64500254|NCT03390972|Sensory System Agents|sensory system agents|mesh-ancestor
64500256|NCT03390972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64500257|NCT03390972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65489245|NCT01366300|Sensory System Agents|sensory system agents|mesh-ancestor
65489246|NCT01366300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65238767|NCT00929708|AZD-3199|azd-3199|mesh-list
65489247|NCT01366300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65489248|NCT01366300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65489249|NCT01366300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65489250|NCT01366300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65489251|NCT01366300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489252|NCT01366300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65489253|NCT01366300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65489254|NCT01366300|Anesthetics, General|anesthetics, general|mesh-ancestor
65489255|NCT00226811|Sunitinib|sunitinib|mesh-list
65489256|NCT00226811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489257|NCT00226811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65489258|NCT00226811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65489259|NCT00226811|Growth Substances|growth substances|mesh-ancestor
65489260|NCT00226811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872982|NCT01856374|Antimetabolites|antimetabolites|mesh-ancestor
64500258|NCT03390972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64500259|NCT03390972|Adrenergic Agents|adrenergic agents|mesh-ancestor
64500260|NCT03390972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64500261|NCT03390972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500262|NCT01550224|Temozolomide|temozolomide|mesh-list
64500263|NCT01550224|Vorinostat|vorinostat|mesh-list
64500264|NCT01550224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64500265|NCT01550224|Alkylating Agents|alkylating agents|mesh-ancestor
64500266|NCT01550224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500267|NCT01550224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500268|NCT01550224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64500269|NCT01550224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500270|NCT01491022|4-Aminopyridine|4-aminopyridine|mesh-list
64500271|NCT01491022|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64500272|NCT01491022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64500281|NCT00782184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500282|NCT00782184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64500283|NCT00782184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64500284|NCT00782184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500286|NCT03397914|Polymyxins|polymyxins|mesh-list
64500287|NCT03397914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64500288|NCT03397914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64500289|NCT01450306|Cycloserine|cycloserine|mesh-list
64500290|NCT01450306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64500291|NCT01450306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64500292|NCT01450306|Renal Agents|renal agents|mesh-ancestor
64500293|NCT01450306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64500294|NCT01450306|Antitubercular Agents|antitubercular agents|mesh-ancestor
64500295|NCT01450306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64500296|NCT01450306|Antimetabolites|antimetabolites|mesh-ancestor
64500297|NCT01450306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500298|NCT03126708|Paclitaxel|paclitaxel|mesh-list
64500299|NCT03126708|Cetuximab|cetuximab|mesh-list
64500300|NCT03126708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64500301|NCT03126708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500302|NCT03126708|Tubulin Modulators|tubulin modulators|mesh-ancestor
64500303|NCT03126708|Antimitotic Agents|antimitotic agents|mesh-ancestor
65489261|NCT00226811|Growth Inhibitors|growth inhibitors|mesh-ancestor
65489262|NCT00226811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65489263|NCT00226811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489264|NCT00226811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489265|NCT02951052|Rilpivirine|rilpivirine|mesh-list
65489266|NCT02951052|Cabotegravir|cabotegravir|mesh-list
65489267|NCT02951052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65489268|NCT02951052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65489269|NCT02951052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489270|NCT02951052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489271|NCT02951052|Antiviral Agents|antiviral agents|mesh-ancestor
65489272|NCT02951052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65489273|NCT02951052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65489274|NCT02951052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65489275|NCT02951052|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65489276|NCT02951052|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65489277|NCT03936218|Goserelin|goserelin|mesh-list
65489278|NCT03936218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65489279|NCT03936218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489280|NCT05261516|Magnesium Sulfate|magnesium sulfate|mesh-list
65489281|NCT05261516|Analgesics|analgesics|mesh-ancestor
65489282|NCT05261516|Sensory System Agents|sensory system agents|mesh-ancestor
65489283|NCT05261516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65489284|NCT05261516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489285|NCT05261516|Anesthetics|anesthetics|mesh-ancestor
65489286|NCT05261516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65489287|NCT05261516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65489288|NCT05261516|Anticonvulsants|anticonvulsants|mesh-ancestor
65489289|NCT05261516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65489290|NCT05261516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65489293|NCT05261516|Tocolytic Agents|tocolytic agents|mesh-ancestor
65489304|NCT03691376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65489305|NCT03691376|Alkylating Agents|alkylating agents|mesh-ancestor
65489306|NCT03691376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489307|NCT03691376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489308|NCT03691376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65489309|NCT03691376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65489310|NCT03691376|Immunologic Factors|immunologic factors|mesh-ancestor
65489311|NCT03691376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489312|NCT03691376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65489313|NCT03691376|Analgesics|analgesics|mesh-ancestor
65489314|NCT03691376|Sensory System Agents|sensory system agents|mesh-ancestor
65489315|NCT03691376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65489316|NCT03691376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65489317|NCT03691376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65489318|NCT03691376|Antiviral Agents|antiviral agents|mesh-ancestor
65489319|NCT03691376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65489320|NCT01371058|Clopidogrel|clopidogrel|mesh-list
65238847|NCT00789763|Sorafenib|sorafenib|mesh-list
65489321|NCT01371058|Policosanol|policosanol|mesh-list
65489322|NCT01371058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65489323|NCT01371058|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65489324|NCT01371058|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65489325|NCT01371058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65489326|NCT01371058|Purinergic Agents|purinergic agents|mesh-ancestor
65489327|NCT01371058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64500304|NCT03126708|Mitosis Modulators|mitosis modulators|mesh-ancestor
64500305|NCT03126708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500306|NCT03126708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64500307|NCT03390738|Nivolumab|nivolumab|mesh-list
64500308|NCT03390738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64500309|NCT03390738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500310|NCT03390738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64500311|NCT03390738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500312|NCT03390582|Methimazole|methimazole|mesh-list
64500313|NCT03390582|Antithyroid Agents|antithyroid agents|mesh-ancestor
64500314|NCT03390582|Hormone Antagonists|hormone antagonists|mesh-ancestor
64500315|NCT03390582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64724029|NCT00000307|Sensory System Agents|sensory system agents|mesh-ancestor
64724030|NCT00000307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64724031|NCT00000313|Fenfluramine|fenfluramine|mesh-list
64724032|NCT00000313|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64724033|NCT00000313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64724035|NCT00000313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724036|NCT00000313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64724037|NCT00000313|Serotonin Agents|serotonin agents|mesh-ancestor
64724038|NCT00000313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724039|NCT00000319|Buprenorphine|buprenorphine|mesh-list
64724040|NCT00000319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65489328|NCT01371058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489329|NCT01371058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489330|NCT01371058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65489331|NCT01371058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65489332|NCT01371058|Antimetabolites|antimetabolites|mesh-ancestor
65489333|NCT01371058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65489334|NCT01105338|Lycopene|lycopene|mesh-list
65489335|NCT01105338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65489336|NCT01105338|Antioxidants|antioxidants|mesh-ancestor
65489337|NCT01105338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489338|NCT01105338|Protective Agents|protective agents|mesh-ancestor
65489339|NCT01105338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489340|NCT01105338|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65489341|NCT01105338|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65489342|NCT01105338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489343|NCT03747614|Fluorometholone|fluorometholone|mesh-list
65489344|NCT03747614|Tacrolimus|tacrolimus|mesh-list
65489345|NCT03747614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65489346|NCT03747614|Immunologic Factors|immunologic factors|mesh-ancestor
65489347|NCT03747614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489348|NCT03747614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65489349|NCT03747614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489350|NCT03747614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489351|NCT03747614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65489352|NCT03747614|Glucocorticoids|glucocorticoids|mesh-ancestor
65489353|NCT03747614|Hormones|hormones|mesh-ancestor
65489354|NCT03747614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65489355|NCT03747614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65489356|NCT05347004|BI 425809|bi 425809|mesh-list
65489357|NCT05347004|Nootropic Agents|nootropic agents|mesh-ancestor
65489358|NCT05171166|Leucovorin|leucovorin|mesh-list
65489359|NCT05171166|Fluorouracil|fluorouracil|mesh-list
65489360|NCT05171166|Oxaliplatin|oxaliplatin|mesh-list
65489361|NCT05171166|Chlorotrianisene|chlorotrianisene|mesh-list
65489362|NCT05171166|Antimetabolites|antimetabolites|mesh-ancestor
64724041|NCT00000319|Narcotics|narcotics|mesh-ancestor
65489368|NCT05171166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489369|NCT05171166|Antidotes|antidotes|mesh-ancestor
65489370|NCT05171166|Protective Agents|protective agents|mesh-ancestor
65489371|NCT05171166|Vitamin B Complex|vitamin b complex|mesh-ancestor
65489372|NCT05171166|Vitamins|vitamins|mesh-ancestor
65489373|NCT05171166|Micronutrients|micronutrients|mesh-ancestor
65489374|NCT05171166|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65489375|NCT05171166|Estrogens|estrogens|mesh-ancestor
65489376|NCT05171166|Hormones|hormones|mesh-ancestor
65489377|NCT05171166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65489378|NCT05171166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65489379|NCT04353596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65489380|NCT04353596|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65489381|NCT04353596|Protease Inhibitors|protease inhibitors|mesh-ancestor
65489382|NCT04353596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489383|NCT04353596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489384|NCT05190562|Zinc Sulfate|zinc sulfate|mesh-list
65489385|NCT05190562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489386|NCT05190562|Astringents|astringents|mesh-ancestor
65489387|NCT05190562|Dermatologic Agents|dermatologic agents|mesh-ancestor
65489388|NCT01366378|Methylnaltrexone|methylnaltrexone|mesh-list
65489389|NCT01366378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65489390|NCT01366378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489391|NCT01366378|Sensory System Agents|sensory system agents|mesh-ancestor
65489392|NCT01366378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65489393|NCT03747536|Bromides|bromides|mesh-list
65489394|NCT03747536|Ipratropium|ipratropium|mesh-list
65489395|NCT03747536|Anticonvulsants|anticonvulsants|mesh-ancestor
65489415|NCT04734080|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65489416|NCT04734080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65489417|NCT04734080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489418|NCT04734080|Hormones|hormones|mesh-ancestor
65489419|NCT04734080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65489420|NCT01358500|Fentanyl|fentanyl|mesh-list
65489421|NCT01358500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65489422|NCT01358500|Narcotics|narcotics|mesh-ancestor
65489423|NCT01358500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65489424|NCT01358500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489425|NCT01358500|Analgesics|analgesics|mesh-ancestor
65489426|NCT01358500|Sensory System Agents|sensory system agents|mesh-ancestor
65489427|NCT01358500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65489428|NCT01358500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65489429|NCT01358500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65489430|NCT01358500|Anesthetics, General|anesthetics, general|mesh-ancestor
65489431|NCT01358500|Anesthetics|anesthetics|mesh-ancestor
65489432|NCT03724942|Brexpiprazole|brexpiprazole|mesh-list
65489433|NCT03724942|Serotonin Agents|serotonin agents|mesh-ancestor
65489434|NCT03724942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65489435|NCT03724942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489436|NCT03724942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489437|NCT03724942|Dopamine Agonists|dopamine agonists|mesh-ancestor
65489438|NCT03724942|Dopamine Agents|dopamine agents|mesh-ancestor
65489439|NCT01208766|Dexamethasone|dexamethasone|mesh-list
65489440|NCT01208766|Prednisone|prednisone|mesh-list
65489441|NCT01208766|Lenalidomide|lenalidomide|mesh-list
65489442|NCT01208766|Bortezomib|bortezomib|mesh-list
65489443|NCT01208766|Melphalan|melphalan|mesh-list
65489444|NCT01208766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64724042|NCT00000319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64724043|NCT00000319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724044|NCT00000319|Analgesics|analgesics|mesh-ancestor
64724045|NCT00000319|Sensory System Agents|sensory system agents|mesh-ancestor
64724046|NCT00000319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64724047|NCT00000319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64724048|NCT00000325|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64724049|NCT00000325|Hormones|hormones|mesh-ancestor
64331617|NCT05144698|Sirolimus|sirolimus|mesh-list
64500316|NCT03390582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500317|NCT03385356|Vitamin D|vitamin d|mesh-list
64500318|NCT03385356|Vitamins|vitamins|mesh-ancestor
64500319|NCT03385356|Micronutrients|micronutrients|mesh-ancestor
64500320|NCT03385356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500321|NCT03385356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64500322|NCT03388866|Immunologic Factors|immunologic factors|mesh-list
64500323|NCT03388866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489445|NCT01208766|Antiemetics|antiemetics|mesh-ancestor
65489446|NCT01208766|Autonomic Agents|autonomic agents|mesh-ancestor
65489447|NCT01208766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65489448|NCT01208766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489449|NCT01208766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65489450|NCT01208766|Glucocorticoids|glucocorticoids|mesh-ancestor
65489451|NCT01208766|Hormones|hormones|mesh-ancestor
65489452|NCT01208766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65489453|NCT01208766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65489454|NCT01208766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489455|NCT01208766|Immunologic Factors|immunologic factors|mesh-ancestor
65489456|NCT01208766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65489457|NCT01208766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65489458|NCT01208766|Growth Substances|growth substances|mesh-ancestor
65489459|NCT01208766|Growth Inhibitors|growth inhibitors|mesh-ancestor
65489460|NCT01208766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65489461|NCT01208766|Alkylating Agents|alkylating agents|mesh-ancestor
65489462|NCT01208766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489463|NCT01208766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65489464|NCT01208766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65489465|NCT03751514|Azithromycin|azithromycin|mesh-list
64500324|NCT01873170|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64500325|NCT01873170|Contraceptive Agents|contraceptive agents|mesh-list
64500326|NCT01873170|Levonorgestrel|levonorgestrel|mesh-list
64500327|NCT01873170|Etonogestrel|etonogestrel|mesh-list
64500328|NCT01873170|Desogestrel|desogestrel|mesh-list
64500329|NCT01873170|Contraceptives, Oral|contraceptives, oral|mesh-list
64500330|NCT01873170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64500331|NCT01873170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64500332|NCT01873170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500333|NCT01873170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64500334|NCT01873170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64500335|NCT01873170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64500336|NCT01873170|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64500347|NCT03125694|Incretins|incretins|mesh-ancestor
64500348|NCT03125694|Hormones|hormones|mesh-ancestor
64500349|NCT03125694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64500350|NCT03125694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64500351|NCT03125694|Protease Inhibitors|protease inhibitors|mesh-ancestor
64500352|NCT03125694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500353|NCT03125694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500354|NCT02731638|Voriconazole|voriconazole|mesh-list
64500356|NCT02731638|Antifungal Agents|antifungal agents|mesh-ancestor
64500357|NCT02731638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724050|NCT00000325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64724051|NCT00000325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724052|NCT04181203|Leuprolide|leuprolide|mesh-list
64724053|NCT04181203|Goserelin|goserelin|mesh-list
64724054|NCT04181203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64724055|NCT04181203|Hormones|hormones|mesh-list
64724056|NCT04181203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65489466|NCT03751514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65489467|NCT03751514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65489468|NCT03615664|Gemcitabine|gemcitabine|mesh-list
65489469|NCT03615664|Dexamethasone|dexamethasone|mesh-list
65489470|NCT03615664|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65239001|NCT00676845|Olmesartan|olmesartan|mesh-list
65489471|NCT03615664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65489472|NCT03615664|Antiemetics|antiemetics|mesh-ancestor
65489473|NCT03615664|Autonomic Agents|autonomic agents|mesh-ancestor
65489474|NCT03615664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65489475|NCT03615664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489476|NCT03615664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65489477|NCT03615664|Glucocorticoids|glucocorticoids|mesh-ancestor
65489478|NCT03615664|Hormones|hormones|mesh-ancestor
65489479|NCT03615664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65489480|NCT03615664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65489481|NCT03615664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489482|NCT03615664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65489483|NCT03615664|Antimetabolites|antimetabolites|mesh-ancestor
65489484|NCT03615664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489485|NCT03615664|Antiviral Agents|antiviral agents|mesh-ancestor
65489486|NCT03615664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65489487|NCT03615664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489488|NCT03615664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64724057|NCT04181203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724058|NCT04181203|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64724059|NCT04181203|Fertility Agents|fertility agents|mesh-ancestor
64724060|NCT04181203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64724061|NCT04181203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64724062|NCT04181203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64724063|NCT04181203|Luteolytic Agents|luteolytic agents|mesh-ancestor
64724064|NCT04181203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64500358|NCT02731638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64500359|NCT02731638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64500360|NCT02731638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500361|NCT02731638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500362|NCT02731638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64500363|NCT02731638|Hormone Antagonists|hormone antagonists|mesh-ancestor
64500364|NCT02731638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64500365|NCT02731638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500366|NCT02731638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64500374|NCT01451632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500375|NCT01451632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500376|NCT01451632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64500377|NCT01491958|Methotrexate|methotrexate|mesh-list
64500378|NCT01491958|Atorvastatin|atorvastatin|mesh-list
64500379|NCT01491958|Tacrolimus|tacrolimus|mesh-list
64500380|NCT01491958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64500381|NCT01491958|Abortifacient Agents|abortifacient agents|mesh-ancestor
65489489|NCT03615664|Immunologic Factors|immunologic factors|mesh-ancestor
65489490|NCT03615664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65489491|NCT03615664|Alkylating Agents|alkylating agents|mesh-ancestor
65489492|NCT03513250|Scopolamine|scopolamine|mesh-list
65489493|NCT03513250|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65489494|NCT03513250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65489495|NCT03513250|Antiemetics|antiemetics|mesh-ancestor
65489496|NCT03513250|Autonomic Agents|autonomic agents|mesh-ancestor
65489497|NCT03513250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65489498|NCT03513250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489499|NCT03513250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65489500|NCT03513250|Mydriatics|mydriatics|mesh-ancestor
65489501|NCT03513250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65489502|NCT03513250|Cholinergic Agents|cholinergic agents|mesh-ancestor
65489503|NCT03513250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65489504|NCT03513250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489505|NCT03513250|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65489506|NCT03513250|Parasympatholytics|parasympatholytics|mesh-ancestor
65489507|NCT01358812|Panitumumab|panitumumab|mesh-list
65489508|NCT01358812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65489509|NCT01358812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489510|NCT01107522|Temozolomide|temozolomide|mesh-list
65489511|NCT01107522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65489512|NCT01107522|Alkylating Agents|alkylating agents|mesh-ancestor
65489513|NCT01107522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489514|NCT01107522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500382|NCT01491958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64500383|NCT01491958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500384|NCT01491958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64500385|NCT01491958|Antimetabolites|antimetabolites|mesh-ancestor
64500386|NCT01491958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500387|NCT01491958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500388|NCT01491958|Dermatologic Agents|dermatologic agents|mesh-ancestor
64500389|NCT01491958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500390|NCT01491958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64500391|NCT01491958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64500392|NCT01491958|Immunologic Factors|immunologic factors|mesh-ancestor
64500393|NCT01491958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64500394|NCT01491958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64500395|NCT01491958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64500396|NCT01491958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64500397|NCT01491958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64500398|NCT01491958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64500399|NCT01491958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64724065|NCT04181203|Contraceptive Agents|contraceptive agents|mesh-ancestor
64724066|NCT04181203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64724067|NCT03521102|Acetaminophen|acetaminophen|mesh-list
64724068|NCT03521102|Hydromorphone|hydromorphone|mesh-list
65489515|NCT01371448|Paroxetine|paroxetine|mesh-list
65489516|NCT01371448|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65489517|NCT01371448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65489518|NCT01371448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65489519|NCT01371448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489520|NCT01371448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65489521|NCT01371448|Serotonin Agents|serotonin agents|mesh-ancestor
65489522|NCT01371448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489523|NCT01371448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65489524|NCT01371448|Antidepressive Agents|antidepressive agents|mesh-ancestor
65489525|NCT01371448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65489526|NCT01371448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65489527|NCT01371448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65489528|NCT01371448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489529|NCT01371526|Cosyntropin|cosyntropin|mesh-list
65489530|NCT01371526|Hormones|hormones|mesh-ancestor
65489531|NCT01371526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65489532|NCT01371526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489533|NCT03943992|Esomeprazole|esomeprazole|mesh-list
65489534|NCT03943992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65489535|NCT03943992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65489536|NCT03943992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65489537|NCT03943992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489538|NCT03943992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489539|NCT01371604|Ribavirin|ribavirin|mesh-list
65489540|NCT01371604|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65489541|NCT01371604|Antimetabolites|antimetabolites|mesh-ancestor
65489542|NCT01371604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489543|NCT01371604|Antiviral Agents|antiviral agents|mesh-ancestor
65489544|NCT01371604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65489545|NCT01371682|Ropinirole|ropinirole|mesh-list
65489546|NCT01371682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64873224|NCT01857596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64724069|NCT03521102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64724070|NCT03521102|Analgesics|analgesics|mesh-ancestor
64724071|NCT03521102|Sensory System Agents|sensory system agents|mesh-ancestor
64724072|NCT03521102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64724073|NCT03521102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724074|NCT03521102|Antipyretics|antipyretics|mesh-ancestor
65489547|NCT01371682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65489548|NCT01371682|Dopamine Agonists|dopamine agonists|mesh-ancestor
65489549|NCT01371682|Dopamine Agents|dopamine agents|mesh-ancestor
65489550|NCT01371682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65489551|NCT01371682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489552|NCT01371682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489553|NCT01107756|Lenograstim|lenograstim|mesh-list
65489554|NCT01107756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65489555|NCT01107756|Immunologic Factors|immunologic factors|mesh-ancestor
65489556|NCT01107756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489557|NCT03127384|Lidocaine|lidocaine|mesh-list
65489558|NCT03127384|Anesthetics, Local|anesthetics, local|mesh-ancestor
65489559|NCT03127384|Anesthetics|anesthetics|mesh-ancestor
65489560|NCT03127384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65489561|NCT03127384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489562|NCT03127384|Sensory System Agents|sensory system agents|mesh-ancestor
65489563|NCT03127384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65489564|NCT03127384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65489565|NCT03127384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65489566|NCT03127384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65489567|NCT03127384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65489568|NCT03127384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489569|NCT01111656|Interferons|interferons|mesh-list
65489570|NCT01111656|Interferon-beta|interferon-beta|mesh-list
65489571|NCT01111656|Atorvastatin|atorvastatin|mesh-list
65489572|NCT01111656|Interferon beta-1b|interferon beta-1b|mesh-list
65489573|NCT01111656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489574|NCT01111656|Antiviral Agents|antiviral agents|mesh-ancestor
65489575|NCT01111656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65489576|NCT01111656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65489577|NCT01111656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65489578|NCT01111656|Antimetabolites|antimetabolites|mesh-ancestor
65489579|NCT01111656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489587|NCT02819752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65489588|NCT02819752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489589|NCT02567578|YH12852|yh12852|mesh-list
65489590|NCT02567578|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65489591|NCT02567578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65489656|NCT00745134|Analgesics|analgesics|mesh-ancestor
65489657|NCT00745134|Sensory System Agents|sensory system agents|mesh-ancestor
65489658|NCT00745134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65489659|NCT00745134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489660|NCT00745134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65489661|NCT00745134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65489662|NCT00745134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489663|NCT01111968|Vaccines|vaccines|mesh-list
65489664|NCT01111968|Immunologic Factors|immunologic factors|mesh-ancestor
65489665|NCT01111968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489666|NCT04398134|Entecavir|entecavir|mesh-list
65489667|NCT04398134|Antiviral Agents|antiviral agents|mesh-ancestor
65489668|NCT04398134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65489669|NCT04281342|Moxifloxacin|moxifloxacin|mesh-list
65489670|NCT04281342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65489671|NCT04281342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65489672|NCT04281342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65489673|NCT04281342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65489674|NCT04281342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489675|NCT04281342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489676|NCT04281342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489677|NCT04253262|Rucaparib|rucaparib|mesh-list
65489678|NCT04253262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65489679|NCT04253262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489680|NCT04253262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489681|NCT04253262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489682|NCT01108146|Hydrocortisone|hydrocortisone|mesh-list
65489683|NCT01108146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65489684|NCT01108146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65489685|NCT01108146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65489686|NCT01108146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65489687|NCT01108302|Oxytocin|oxytocin|mesh-list
65489688|NCT01108302|Oxytocics|oxytocics|mesh-ancestor
65489689|NCT01108302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65489690|NCT01108302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489691|NCT03122860|Lorecivivint|lorecivivint|mesh-list
65489692|NCT03122860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65489694|NCT01319188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65489695|NCT01319188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65489696|NCT01319188|Growth Substances|growth substances|mesh-ancestor
65489697|NCT01319188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489698|NCT01319188|Growth Inhibitors|growth inhibitors|mesh-ancestor
65489699|NCT01319188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489701|NCT05167084|Metyrapone|metyrapone|mesh-list
65489702|NCT05167084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65489703|NCT05167084|Antimetabolites|antimetabolites|mesh-ancestor
65489704|NCT05167084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489705|NCT05167084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489706|NCT00867178|Vitamin A|vitamin a|mesh-list
65489707|NCT00867178|Cyclophosphamide|cyclophosphamide|mesh-list
65489708|NCT00867178|Thiotepa|thiotepa|mesh-list
65489709|NCT00867178|Cisplatin|cisplatin|mesh-list
65489710|NCT00867178|Carboplatin|carboplatin|mesh-list
65489711|NCT00867178|Etoposide|etoposide|mesh-list
65489712|NCT00867178|Vincristine|vincristine|mesh-list
65489713|NCT00867178|Vorinostat|vorinostat|mesh-list
65489714|NCT00867178|Tretinoin|tretinoin|mesh-list
65489715|NCT00867178|Etoposide phosphate|etoposide phosphate|mesh-list
65489716|NCT00867178|Isotretinoin|isotretinoin|mesh-list
65489717|NCT00867178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65489718|NCT00867178|Immunologic Factors|immunologic factors|mesh-ancestor
65489719|NCT00867178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489720|NCT00867178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65489721|NCT00867178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65489722|NCT00867178|Alkylating Agents|alkylating agents|mesh-ancestor
65489723|NCT00867178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489724|NCT00867178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489725|NCT00867178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65489726|NCT00867178|Vitamins|vitamins|mesh-ancestor
65489727|NCT00867178|Micronutrients|micronutrients|mesh-ancestor
65489728|NCT00867178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64724075|NCT03521102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64724076|NCT03521102|Narcotics|narcotics|mesh-ancestor
64724077|NCT03521102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64724078|NCT00000763|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
64331647|NCT05092360|Antimitotic Agents|antimitotic agents|mesh-ancestor
64331648|NCT05092360|Mitosis Modulators|mitosis modulators|mesh-ancestor
64500400|NCT01492582|Vaccines|vaccines|mesh-list
64500413|NCT01495858|Sensory System Agents|sensory system agents|mesh-ancestor
64500414|NCT01495858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500415|NCT01495858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489729|NCT00867178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65489730|NCT00867178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65489731|NCT00867178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489732|NCT00867178|Tubulin Modulators|tubulin modulators|mesh-ancestor
65489733|NCT00867178|Antimitotic Agents|antimitotic agents|mesh-ancestor
65489734|NCT00867178|Mitosis Modulators|mitosis modulators|mesh-ancestor
65489735|NCT00867178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65489736|NCT00867178|Keratolytic Agents|keratolytic agents|mesh-ancestor
65489737|NCT00867178|Dermatologic Agents|dermatologic agents|mesh-ancestor
65489738|NCT03945396|Calcium Carbonate|calcium carbonate|mesh-list
65489739|NCT03945396|Antacids|antacids|mesh-ancestor
65489740|NCT03945396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489741|NCT03945396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65489742|NCT01109784|Clopidogrel|clopidogrel|mesh-list
65489743|NCT01109784|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65489744|NCT01109784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65489745|NCT01109784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65489746|NCT01109784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65489747|NCT01109784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65489748|NCT01109784|Purinergic Agents|purinergic agents|mesh-ancestor
65489749|NCT01109784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65489750|NCT01109784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489751|NCT01109784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489752|NCT01328340|Methamphetamine|methamphetamine|mesh-list
65489753|NCT01328340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65489754|NCT01328340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489755|NCT01328340|Sympathomimetics|sympathomimetics|mesh-ancestor
65489756|NCT01328340|Autonomic Agents|autonomic agents|mesh-ancestor
65489757|NCT01328340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65489758|NCT01328340|Dopamine Agents|dopamine agents|mesh-ancestor
65489759|NCT01328340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65489760|NCT01328340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489761|NCT01328340|Adrenergic Agents|adrenergic agents|mesh-ancestor
65489762|NCT01328340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65489767|NCT03796728|Anesthetics, Local|anesthetics, local|mesh-ancestor
65489768|NCT03796728|Anesthetics|anesthetics|mesh-ancestor
65489769|NCT03796728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65489770|NCT03796728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489771|NCT03796728|Sensory System Agents|sensory system agents|mesh-ancestor
65489772|NCT03796728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65489773|NCT03796728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65489774|NCT03796728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65489775|NCT03796728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65489776|NCT03796728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65489777|NCT03796728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489778|NCT00352534|Dactinomycin|dactinomycin|mesh-list
65489779|NCT00352534|Cactinomycin|cactinomycin|mesh-list
65489780|NCT00352534|Doxorubicin|doxorubicin|mesh-list
65489781|NCT00352534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65489782|NCT00352534|Vincristine|vincristine|mesh-list
65489783|NCT00352534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65489784|NCT00352534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489785|NCT00352534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65489786|NCT00352534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65489787|NCT00352534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489788|NCT00352534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489789|NCT00352534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65489790|NCT00352534|Tubulin Modulators|tubulin modulators|mesh-ancestor
65489791|NCT00352534|Antimitotic Agents|antimitotic agents|mesh-ancestor
65489792|NCT00352534|Mitosis Modulators|mitosis modulators|mesh-ancestor
65489793|NCT00352534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65489794|NCT00352534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65489795|NCT00352534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65489810|NCT03749642|Analgesics|analgesics|mesh-ancestor
65489811|NCT03749642|Sensory System Agents|sensory system agents|mesh-ancestor
65489812|NCT03749642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65489813|NCT03749642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489814|NCT03749642|Anticonvulsants|anticonvulsants|mesh-ancestor
65489815|NCT03749642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65489816|NCT03749642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65489817|NCT03749642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65489818|NCT03749642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65489819|NCT03749642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65489820|NCT03749642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65489821|NCT03749642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65489822|NCT03749642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489823|NCT03749642|Antimanic Agents|antimanic agents|mesh-ancestor
65489824|NCT03749642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65489825|NCT03749642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65489826|NCT03749642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65489827|NCT03749642|Serotonin Agents|serotonin agents|mesh-ancestor
65489828|NCT03749642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65489829|NCT03749642|Antidepressive Agents|antidepressive agents|mesh-ancestor
65489830|NCT03751358|Anesthetics|anesthetics|mesh-list
65489831|NCT03751358|Anesthetics, Local|anesthetics, local|mesh-list
65489832|NCT03751358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65489833|NCT03751358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489834|NCT03751358|Sensory System Agents|sensory system agents|mesh-ancestor
65489860|NCT02529774|Autonomic Agents|autonomic agents|mesh-ancestor
65489861|NCT02529774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65489862|NCT02529774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489863|NCT02529774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65489864|NCT02529774|Glucocorticoids|glucocorticoids|mesh-ancestor
65489865|NCT02529774|Hormones|hormones|mesh-ancestor
65489866|NCT02529774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65489867|NCT02529774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65489868|NCT02529774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489869|NCT02529774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65489870|NCT02529774|Antimetabolites|antimetabolites|mesh-ancestor
65489871|NCT02529774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489872|NCT02529774|Antidotes|antidotes|mesh-ancestor
65489873|NCT02529774|Protective Agents|protective agents|mesh-ancestor
65489874|NCT02529774|Vitamin B Complex|vitamin b complex|mesh-ancestor
65489875|NCT02529774|Vitamins|vitamins|mesh-ancestor
65489876|NCT02529774|Micronutrients|micronutrients|mesh-ancestor
65489877|NCT02529774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65489878|NCT02529774|Immunologic Factors|immunologic factors|mesh-ancestor
65489879|NCT02529774|Anticoagulants|anticoagulants|mesh-ancestor
65489880|NCT02529774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65489881|NCT02529774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65489882|NCT04459598|Efavirenz|efavirenz|mesh-list
65489883|NCT04459598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65489884|NCT04459598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65489885|NCT04459598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489886|NCT04459598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489887|NCT04459598|Antiviral Agents|antiviral agents|mesh-ancestor
65489888|NCT04459598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65489889|NCT04459598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65489890|NCT04459598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65489891|NCT04459598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65489892|NCT04459598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64873500|NCT01858610|Diuretics|diuretics|mesh-ancestor
64500416|NCT01495858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64500417|NCT01495858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64500418|NCT01495858|Gout Suppressants|gout suppressants|mesh-ancestor
64500419|NCT01495858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64500420|NCT01495858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489893|NCT04459598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65489894|NCT04459598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65489895|NCT03942354|Moxifloxacin|moxifloxacin|mesh-list
65489896|NCT03942354|Linezolid|linezolid|mesh-list
65489897|NCT03942354|Bedaquiline|bedaquiline|mesh-list
65489898|NCT03942354|Clofazimine|clofazimine|mesh-list
65489899|NCT03942354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65489900|NCT03942354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65489901|NCT03942354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65489902|NCT03942354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65489903|NCT03942354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489904|NCT03942354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489905|NCT03942354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489906|NCT03942354|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65489907|NCT03942354|Antitubercular Agents|antitubercular agents|mesh-ancestor
65489908|NCT03942354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65489909|NCT03942354|Leprostatic Agents|leprostatic agents|mesh-ancestor
65489910|NCT05165992|Fentanyl|fentanyl|mesh-list
65489911|NCT05165992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65489912|NCT05165992|Narcotics|narcotics|mesh-ancestor
65489913|NCT05165992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65489914|NCT05165992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489915|NCT05165992|Analgesics|analgesics|mesh-ancestor
65489916|NCT05165992|Sensory System Agents|sensory system agents|mesh-ancestor
65489917|NCT05165992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65489918|NCT05165992|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65489919|NCT05165992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65489920|NCT05165992|Anesthetics, General|anesthetics, general|mesh-ancestor
65489921|NCT05165992|Anesthetics|anesthetics|mesh-ancestor
65489922|NCT01359202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65489923|NCT01367548|Methylnaltrexone|methylnaltrexone|mesh-list
65489924|NCT01367548|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65489925|NCT01367548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489928|NCT01367626|Letrozole|letrozole|mesh-list
65489935|NCT01367626|Hormone Antagonists|hormone antagonists|mesh-ancestor
65489936|NCT01367626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65489937|NCT01367626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489938|NCT01112748|Lidocaine|lidocaine|mesh-list
65489939|NCT01112748|Anesthetics, Local|anesthetics, local|mesh-ancestor
65489940|NCT01112748|Anesthetics|anesthetics|mesh-ancestor
65489941|NCT01112748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65489942|NCT01112748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489943|NCT01112748|Sensory System Agents|sensory system agents|mesh-ancestor
65489944|NCT01112748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65489945|NCT01112748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65489946|NCT01112748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65489947|NCT01112748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65489948|NCT01112748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65489949|NCT01112748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489950|NCT05192902|Anesthetics|anesthetics|mesh-list
65489951|NCT05192902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65489952|NCT05192902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489953|NCT01211808|Diltiazem|diltiazem|mesh-list
65489954|NCT01211808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65489955|NCT01211808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65489956|NCT01211808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65489957|NCT01211808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489958|NCT01211808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65489959|NCT01211808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489960|NCT01211808|Vasodilator Agents|vasodilator agents|mesh-ancestor
65489961|NCT01209858|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65489962|NCT01209858|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
65489963|NCT01209858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65489964|NCT01209858|Contraceptive Agents|contraceptive agents|mesh-ancestor
65489965|NCT01209858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65489966|NCT01209858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873570|NCT01858909|Melatonin|melatonin|mesh-list
65489970|NCT01209858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65489971|NCT01209858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65489972|NCT01209858|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
65489973|NCT01209858|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65489974|NCT01209858|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65489975|NCT05191888|Amoxicillin|amoxicillin|mesh-list
65489976|NCT05191888|Metronidazole|metronidazole|mesh-list
65489977|NCT05191888|Clarithromycin|clarithromycin|mesh-list
65489978|NCT05191888|Rabeprazole|rabeprazole|mesh-list
65489979|NCT05191888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65489980|NCT05191888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65489981|NCT05191888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65489982|NCT05191888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65489983|NCT05191888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65489984|NCT05191888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65489985|NCT05191888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489986|NCT05191888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65489987|NCT05191888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65489988|NCT05191888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65489989|NCT05191888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65489990|NCT05191888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65489991|NCT01112826|Capecitabine|capecitabine|mesh-list
65489992|NCT01112826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65489993|NCT01112826|Antimetabolites|antimetabolites|mesh-ancestor
65489994|NCT01112826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65489995|NCT01112826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65489996|NCT01210014|Zinc Sulfate|zinc sulfate|mesh-list
65489997|NCT01210014|Astringents|astringents|mesh-ancestor
65489998|NCT01210014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65489999|NCT01210014|Dermatologic Agents|dermatologic agents|mesh-ancestor
65490000|NCT05118256|Pirfenidone|pirfenidone|mesh-list
65490001|NCT05118256|Analgesics|analgesics|mesh-ancestor
65490002|NCT05118256|Sensory System Agents|sensory system agents|mesh-ancestor
65490003|NCT05118256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500421|NCT01495858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500422|NCT01497496|Methylprednisolone|methylprednisolone|mesh-list
64500423|NCT01497496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64500424|NCT01497496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64500425|NCT01497496|Prednisolone|prednisolone|mesh-list
65490004|NCT05118256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490005|NCT05118256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65490006|NCT05118256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65490007|NCT05118256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65490008|NCT05118256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65490009|NCT05118256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490010|NCT01114542|Insulin|insulin|mesh-list
65490011|NCT01114542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65490012|NCT01114542|Insulin Glargine|insulin glargine|mesh-list
65490013|NCT01114542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65490014|NCT01114542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490015|NCT02529540|Methamphetamine|methamphetamine|mesh-list
65490016|NCT02529540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65490017|NCT02529540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490018|NCT02529540|Sympathomimetics|sympathomimetics|mesh-ancestor
65490019|NCT02529540|Autonomic Agents|autonomic agents|mesh-ancestor
65490020|NCT02529540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490021|NCT02529540|Dopamine Agents|dopamine agents|mesh-ancestor
65490022|NCT02529540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65490023|NCT02529540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490024|NCT02529540|Adrenergic Agents|adrenergic agents|mesh-ancestor
65490025|NCT02529540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65490026|NCT02529540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65490027|NCT02529540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65490028|NCT02529540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65490029|NCT03941886|Aspirin|aspirin|mesh-list
65490030|NCT03941886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65490031|NCT03941886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65490032|NCT03941886|Analgesics|analgesics|mesh-ancestor
65490033|NCT03941886|Sensory System Agents|sensory system agents|mesh-ancestor
65490034|NCT03941886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490035|NCT03941886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490036|NCT03941886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65490037|NCT03941886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65490038|NCT03941886|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65490041|NCT03941886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65490042|NCT03941886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65490043|NCT03941886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490044|NCT03941886|Antipyretics|antipyretics|mesh-ancestor
65490045|NCT01359436|Antibodies|antibodies|mesh-list
65490046|NCT01359436|Immunologic Factors|immunologic factors|mesh-ancestor
65490047|NCT01359436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490048|NCT01359514|Pregabalin|pregabalin|mesh-list
65490049|NCT01359514|Calcium Channel Blockers|calcium channel blockers|mesh-list
65490050|NCT01359514|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65490051|NCT01359514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65490052|NCT01359514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490053|NCT01359514|Analgesics|analgesics|mesh-ancestor
65490054|NCT01359514|Sensory System Agents|sensory system agents|mesh-ancestor
65490055|NCT01359514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490056|NCT01359514|Anticonvulsants|anticonvulsants|mesh-ancestor
65490057|NCT01359514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65490058|NCT01359514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490059|NCT01359514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65490060|NCT01359514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65490061|NCT01359514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65490062|NCT01359514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65490063|NCT01359514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65490064|NCT01359514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65490065|NCT01359514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65490066|NCT01359514|Antidepressive Agents|antidepressive agents|mesh-ancestor
65490067|NCT01359514|Dopamine Agents|dopamine agents|mesh-ancestor
65490068|NCT01368016|Nicotine|nicotine|mesh-list
65490069|NCT01368016|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65490085|NCT03634852|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65490086|NCT03634852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65490087|NCT03634852|Antiemetics|antiemetics|mesh-ancestor
65490088|NCT03634852|Autonomic Agents|autonomic agents|mesh-ancestor
65490089|NCT03634852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490090|NCT03634852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490091|NCT03634852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65490092|NCT03634852|Glucocorticoids|glucocorticoids|mesh-ancestor
65490093|NCT03634852|Hormones|hormones|mesh-ancestor
65490094|NCT03634852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65490095|NCT03634852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65490096|NCT03634852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490097|NCT03634852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65490098|NCT03634852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65490099|NCT03634852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65490100|NCT03634852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65490101|NCT03634852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490102|NCT03634852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490103|NCT03634852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65490104|NCT03634852|Contraceptive Agents|contraceptive agents|mesh-ancestor
65490105|NCT03634852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65490106|NCT03634852|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65490137|NCT01372306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490138|NCT01372306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490139|NCT01372306|Cholinergic Agents|cholinergic agents|mesh-ancestor
65490140|NCT01372306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65490141|NCT01372306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490142|NCT01372306|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65490143|NCT01372306|Autonomic Agents|autonomic agents|mesh-ancestor
65490144|NCT01372306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490145|NCT01372306|Nootropic Agents|nootropic agents|mesh-ancestor
65490146|NCT01114854|Topiramate|topiramate|mesh-list
65490147|NCT01114854|Anticonvulsants|anticonvulsants|mesh-ancestor
65490148|NCT01114854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65490149|NCT01114854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490150|NCT01359670|Sildenafil Citrate|sildenafil citrate|mesh-list
65490151|NCT01359670|Tadalafil|tadalafil|mesh-list
65490152|NCT01359670|Vasodilator Agents|vasodilator agents|mesh-ancestor
65490153|NCT01359670|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65490154|NCT01359670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65490155|NCT01359670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490156|NCT01359670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490157|NCT01359670|Urological Agents|urological agents|mesh-ancestor
65490158|NCT05188768|Mitogens|mitogens|mesh-list
65490159|NCT05188768|Mitosis Modulators|mitosis modulators|mesh-ancestor
65490160|NCT05188768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490161|NCT01368328|Chromium|chromium|mesh-list
65490162|NCT01368328|Niacin|niacin|mesh-list
65490163|NCT01368328|Trace Elements|trace elements|mesh-ancestor
65490164|NCT01368328|Micronutrients|micronutrients|mesh-ancestor
65490165|NCT01368328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490166|NCT01368328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65490167|NCT01368328|Antimetabolites|antimetabolites|mesh-ancestor
65490168|NCT01368328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490169|NCT01368328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65490170|NCT01368328|Vasodilator Agents|vasodilator agents|mesh-ancestor
65490171|NCT01368328|Vitamin B Complex|vitamin b complex|mesh-ancestor
65490172|NCT01368328|Vitamins|vitamins|mesh-ancestor
65490179|NCT01110642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490180|NCT01110642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65490181|NCT01110642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65490182|NCT01110642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490183|NCT02929498|Azacitidine|azacitidine|mesh-list
65490184|NCT02929498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65490185|NCT02929498|Antimetabolites|antimetabolites|mesh-ancestor
65490186|NCT02929498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490187|NCT02929498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490188|NCT02929498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490189|NCT01359826|Milnacipran|milnacipran|mesh-list
65490190|NCT01359826|Levomilnacipran|levomilnacipran|mesh-list
65490191|NCT01359826|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65490192|NCT01359826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65490193|NCT01359826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65490194|NCT01359826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490195|NCT01359826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65490196|NCT01359826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490197|NCT01359826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65490198|NCT01359826|Analgesics|analgesics|mesh-ancestor
65490199|NCT01359826|Sensory System Agents|sensory system agents|mesh-ancestor
65490200|NCT01359826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490201|NCT01359826|Antidepressive Agents|antidepressive agents|mesh-ancestor
65490202|NCT01359826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65490203|NCT03792672|Ketamine|ketamine|mesh-list
65490204|NCT03792672|Analgesics|analgesics|mesh-ancestor
65490205|NCT03792672|Sensory System Agents|sensory system agents|mesh-ancestor
65490206|NCT03792672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490207|NCT03792672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490209|NCT03792672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65239732|NCT00685347|Tocolytic Agents|tocolytic agents|mesh-ancestor
65490220|NCT01372540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490221|NCT01372540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490222|NCT01113138|Magnesium Sulfate|magnesium sulfate|mesh-list
65490223|NCT01113138|Analgesics|analgesics|mesh-ancestor
65490224|NCT01113138|Sensory System Agents|sensory system agents|mesh-ancestor
65490225|NCT01113138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490226|NCT01113138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490227|NCT01113138|Anesthetics|anesthetics|mesh-ancestor
65490228|NCT01113138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65490229|NCT01113138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65490230|NCT01113138|Anticonvulsants|anticonvulsants|mesh-ancestor
65490231|NCT01113138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65490232|NCT01113138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65490233|NCT01113138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490234|NCT01113138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65490235|NCT01113138|Tocolytic Agents|tocolytic agents|mesh-ancestor
65490236|NCT01113138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65490237|NCT01115322|Nicotinic Acids|nicotinic acids|mesh-list
65490238|NCT01115322|Tazarotene|tazarotene|mesh-list
65490239|NCT01115322|Dermatologic Agents|dermatologic agents|mesh-ancestor
65490240|NCT01115322|Keratolytic Agents|keratolytic agents|mesh-ancestor
65490241|NCT01115322|Vitamin B Complex|vitamin b complex|mesh-ancestor
65490242|NCT01115322|Vitamins|vitamins|mesh-ancestor
65490243|NCT01115322|Micronutrients|micronutrients|mesh-ancestor
65490244|NCT01115322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490245|NCT01111188|Bortezomib|bortezomib|mesh-list
65490246|NCT01111188|Palbociclib|palbociclib|mesh-list
65490247|NCT01111188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490248|NCT01111188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65490249|NCT01111188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490250|NCT01111188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490262|NCT01360060|Sensory System Agents|sensory system agents|mesh-ancestor
65490263|NCT01360060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490264|NCT01360060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490265|NCT01360060|Anesthetics|anesthetics|mesh-ancestor
65490266|NCT01360060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65490267|NCT01360060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65490268|NCT01360060|Anticonvulsants|anticonvulsants|mesh-ancestor
65490269|NCT01360060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65490270|NCT01360060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65490271|NCT01360060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490272|NCT01360060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65490273|NCT01360060|Tocolytic Agents|tocolytic agents|mesh-ancestor
65490274|NCT01360060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65490275|NCT01210638|Oxymorphone|oxymorphone|mesh-list
65490276|NCT01210638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65490277|NCT01210638|Narcotics|narcotics|mesh-ancestor
65490278|NCT01210638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65490279|NCT01210638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490280|NCT01210638|Analgesics|analgesics|mesh-ancestor
65490281|NCT01210638|Sensory System Agents|sensory system agents|mesh-ancestor
65490282|NCT01210638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490283|NCT01210638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65490284|NCT03120676|Atezolizumab|atezolizumab|mesh-list
65490285|NCT03120676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490286|NCT01115478|Vitamin A|vitamin a|mesh-list
65490287|NCT01115478|Vitamins|vitamins|mesh-ancestor
65490288|NCT01115478|Micronutrients|micronutrients|mesh-ancestor
65490289|NCT01115478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490290|NCT01111422|Acetylcysteine|acetylcysteine|mesh-list
65490291|NCT01111422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65490292|NCT01111422|Antiviral Agents|antiviral agents|mesh-ancestor
65490293|NCT01111422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65490294|NCT01111422|Expectorants|expectorants|mesh-ancestor
65490295|NCT01111422|Respiratory System Agents|respiratory system agents|mesh-ancestor
65490305|NCT01213368|Dronedarone|dronedarone|mesh-list
65490306|NCT01213368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65490307|NCT01369186|Morphine|morphine|mesh-list
65490308|NCT01369186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65490309|NCT01369186|Narcotics|narcotics|mesh-ancestor
65490310|NCT01369186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65490311|NCT01369186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490312|NCT01369186|Analgesics|analgesics|mesh-ancestor
65490313|NCT01369186|Sensory System Agents|sensory system agents|mesh-ancestor
65490314|NCT01369186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490315|NCT01115712|Pioglitazone|pioglitazone|mesh-list
65490316|NCT01115712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65490317|NCT01115712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490318|NCT01117662|Rituximab|rituximab|mesh-list
65490319|NCT01117662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65490320|NCT01117662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490321|NCT01117662|Immunologic Factors|immunologic factors|mesh-ancestor
65490322|NCT01117662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490323|NCT01117662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65490324|NCT01319266|Hydrocodone|hydrocodone|mesh-list
65490325|NCT01319266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65490326|NCT01319266|Narcotics|narcotics|mesh-ancestor
65490327|NCT01319266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65490328|NCT01319266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490329|NCT01319266|Analgesics|analgesics|mesh-ancestor
65490330|NCT01319266|Sensory System Agents|sensory system agents|mesh-ancestor
65490331|NCT01319266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490332|NCT01319266|Antitussive Agents|antitussive agents|mesh-ancestor
65490333|NCT01319266|Respiratory System Agents|respiratory system agents|mesh-ancestor
65490334|NCT01115946|Enalapril|enalapril|mesh-list
65490335|NCT01115946|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65490336|NCT01115946|Protease Inhibitors|protease inhibitors|mesh-ancestor
65490337|NCT01115946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490338|NCT01115946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490339|NCT01115946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65490340|NCT01113372|Clopidogrel|clopidogrel|mesh-list
65490341|NCT01113372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65490343|NCT01113372|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65490344|NCT01113372|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65490345|NCT01113372|Purinergic Agents|purinergic agents|mesh-ancestor
65490346|NCT01113372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65490347|NCT01113372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490348|NCT01113372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490349|NCT03120520|Plecanatide|plecanatide|mesh-list
65490350|NCT03120520|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65490351|NCT03120520|Enzyme Activators|enzyme activators|mesh-ancestor
65490352|NCT03120520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490353|NCT03120520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65490354|NCT03941340|Aflutinib|aflutinib|mesh-list
65490355|NCT03941340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65490356|NCT03941340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490357|NCT03941340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490358|NCT01372930|Etanercept|etanercept|mesh-list
65490359|NCT01372930|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65490360|NCT01372930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65490361|NCT01372930|Analgesics|analgesics|mesh-ancestor
65490362|NCT01372930|Sensory System Agents|sensory system agents|mesh-ancestor
65490363|NCT01372930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490364|NCT01372930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490365|NCT01372930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65490366|NCT01372930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65490367|NCT01372930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65490368|NCT01372930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65490369|NCT01372930|Immunologic Factors|immunologic factors|mesh-ancestor
65490371|NCT01328652|Lansoprazole|lansoprazole|mesh-list
65490372|NCT01328652|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65490373|NCT01328652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490387|NCT01116180|Giapreza|giapreza|mesh-list
65490388|NCT01116180|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65490389|NCT01116180|Angiotensinogen|angiotensinogen|mesh-list
65490390|NCT01116180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65490391|NCT01116180|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65490392|NCT01116180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490393|NCT01116180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65490394|NCT01116180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65490395|NCT01116180|Protease Inhibitors|protease inhibitors|mesh-ancestor
65490396|NCT01116180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490397|NCT05067166|Ansuvimab|ansuvimab|mesh-list
65490398|NCT05067166|Antiviral Agents|antiviral agents|mesh-ancestor
65490399|NCT05067166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65490400|NCT01113528|Aspirin|aspirin|mesh-list
65490401|NCT01113528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65490402|NCT01113528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65490403|NCT01113528|Analgesics|analgesics|mesh-ancestor
65490404|NCT01113528|Sensory System Agents|sensory system agents|mesh-ancestor
65490405|NCT01113528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490406|NCT01113528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490407|NCT01113528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65490408|NCT01113528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65490409|NCT01113528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65490410|NCT01113528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65490411|NCT01113528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490412|NCT01113528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65490413|NCT01113528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65490414|NCT01113528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490415|NCT01113528|Antipyretics|antipyretics|mesh-ancestor
65490416|NCT01369576|Zopiclone|zopiclone|mesh-list
65490417|NCT01369576|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65490420|NCT01113762|Cimetidine|cimetidine|mesh-list
65490429|NCT01113762|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65490430|NCT01113762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65490431|NCT01113762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490432|NCT01212666|Ropivacaine|ropivacaine|mesh-list
65490433|NCT01212666|Anesthetics, Local|anesthetics, local|mesh-ancestor
65490434|NCT01212666|Anesthetics|anesthetics|mesh-ancestor
65490435|NCT01212666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65490436|NCT01212666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490437|NCT01212666|Sensory System Agents|sensory system agents|mesh-ancestor
65490438|NCT01212666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490439|NCT01116336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65490440|NCT01116336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490441|NCT01116336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65490442|NCT01116336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239964|NCT00797485|Antidotes|antidotes|mesh-ancestor
65490443|NCT01116336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490445|NCT01213680|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65490446|NCT01213680|Hematinics|hematinics|mesh-ancestor
65490447|NCT03937518|Strontium ranelate|strontium ranelate|mesh-list
65490448|NCT03937518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65490449|NCT03937518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490450|NCT01211496|Methamphetamine|methamphetamine|mesh-list
65490451|NCT01211496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65490452|NCT01211496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490453|NCT01211496|Sympathomimetics|sympathomimetics|mesh-ancestor
65490454|NCT01211496|Autonomic Agents|autonomic agents|mesh-ancestor
65490455|NCT01211496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490456|NCT01211496|Dopamine Agents|dopamine agents|mesh-ancestor
65490457|NCT01211496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65490458|NCT01211496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490470|NCT01118286|Vasodilator Agents|vasodilator agents|mesh-ancestor
65490471|NCT01118286|Tocolytic Agents|tocolytic agents|mesh-ancestor
65490472|NCT01118286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65490473|NCT01585350|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65490474|NCT01585350|Freund's Adjuvant|freund's adjuvant|mesh-list
65490475|NCT01585350|Poly ICLC|poly iclc|mesh-list
65490476|NCT01585350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65490477|NCT01585350|Immunologic Factors|immunologic factors|mesh-ancestor
65490478|NCT01585350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490479|NCT01585350|Interferon Inducers|interferon inducers|mesh-ancestor
65490480|NCT03936036|Linagliptin|linagliptin|mesh-list
65490481|NCT03936036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65490482|NCT03936036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490483|NCT03936036|Incretins|incretins|mesh-ancestor
65490484|NCT03936036|Hormones|hormones|mesh-ancestor
65490485|NCT03936036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65490486|NCT03936036|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65490487|NCT03936036|Protease Inhibitors|protease inhibitors|mesh-ancestor
65490488|NCT03936036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490489|NCT03936036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490490|NCT01118598|Nicotinic Acids|nicotinic acids|mesh-list
65490491|NCT01118598|Niacin|niacin|mesh-list
65490492|NCT01118598|Niacinamide|niacinamide|mesh-list
65490493|NCT01118598|Vitamin B Complex|vitamin b complex|mesh-ancestor
65490494|NCT01118598|Vitamins|vitamins|mesh-ancestor
65490495|NCT01118598|Micronutrients|micronutrients|mesh-ancestor
65490496|NCT01118598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490497|NCT01118598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65490498|NCT01118598|Antimetabolites|antimetabolites|mesh-ancestor
65490499|NCT01118598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490502|NCT01216020|Cisplatin|cisplatin|mesh-list
65240032|NCT00688077|Katacalcin|katacalcin|mesh-list
65490517|NCT03939624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490518|NCT03939624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65490519|NCT03939624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490520|NCT01119144|Calcium, Dietary|calcium, dietary|mesh-list
65490521|NCT01119144|Calcium|calcium|mesh-list
65490522|NCT01119144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65490523|NCT01119144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490524|NCT01119144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65490525|NCT01117038|Amlodipine|amlodipine|mesh-list
65490526|NCT01117038|Enalapril|enalapril|mesh-list
65490533|NCT01117038|Vasodilator Agents|vasodilator agents|mesh-ancestor
65490581|NCT01117116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65490582|NCT01117116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65490583|NCT01117116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65490584|NCT01117116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65490585|NCT01117116|Adrenergic Agents|adrenergic agents|mesh-ancestor
65490586|NCT01117116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65490587|NCT01117116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490588|NCT01216488|Lidocaine|lidocaine|mesh-list
65490589|NCT01216488|Anesthetics, Local|anesthetics, local|mesh-ancestor
65490590|NCT01216488|Anesthetics|anesthetics|mesh-ancestor
65490591|NCT01216488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65490592|NCT01216488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490593|NCT01216488|Sensory System Agents|sensory system agents|mesh-ancestor
65490594|NCT01216488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490595|NCT01216488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65490596|NCT01216488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65490597|NCT01216488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65490598|NCT01216488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65490599|NCT01216488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490600|NCT01122342|Methyltestosterone|methyltestosterone|mesh-list
65490601|NCT01122342|Testosterone|testosterone|mesh-list
65490602|NCT01122342|Testosterone undecanoate|testosterone undecanoate|mesh-list
65490605|NCT01122342|Androgens|androgens|mesh-ancestor
65490631|NCT03963414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65490632|NCT03963414|Immunologic Factors|immunologic factors|mesh-ancestor
65490633|NCT03963414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490634|NCT01216644|Leucovorin|leucovorin|mesh-list
65490635|NCT01216644|Docetaxel|docetaxel|mesh-list
65490636|NCT01216644|Fluorouracil|fluorouracil|mesh-list
65490637|NCT01216644|Oxaliplatin|oxaliplatin|mesh-list
65490638|NCT01216644|Epirubicin|epirubicin|mesh-list
65490639|NCT01216644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490640|NCT01216644|Tubulin Modulators|tubulin modulators|mesh-ancestor
65490641|NCT01216644|Antimitotic Agents|antimitotic agents|mesh-ancestor
65490642|NCT01216644|Mitosis Modulators|mitosis modulators|mesh-ancestor
65490643|NCT01216644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490644|NCT01216644|Antimetabolites|antimetabolites|mesh-ancestor
65490645|NCT01216644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65490693|NCT01214226|Vasodilator Agents|vasodilator agents|mesh-ancestor
65490694|NCT01214226|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65490695|NCT01214226|Antioxidants|antioxidants|mesh-ancestor
65490696|NCT01360372|Methylnaltrexone|methylnaltrexone|mesh-list
65490697|NCT01360372|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65490698|NCT01360372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490699|NCT01360372|Sensory System Agents|sensory system agents|mesh-ancestor
65490700|NCT01360372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490701|NCT01219062|Morphine|morphine|mesh-list
65490761|NCT01216878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65490762|NCT01216878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65490763|NCT01216878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490764|NCT04624984|Gemcitabine|gemcitabine|mesh-list
65490765|NCT04624984|Doxorubicin|doxorubicin|mesh-list
65490766|NCT04624984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65490767|NCT04624984|Vinorelbine|vinorelbine|mesh-list
65490768|NCT04624984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65490769|NCT04624984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65490770|NCT04624984|Antimetabolites|antimetabolites|mesh-ancestor
65490771|NCT04624984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490772|NCT04624984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490773|NCT04624984|Antiviral Agents|antiviral agents|mesh-ancestor
65490774|NCT04624984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65490775|NCT04624984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65490776|NCT04624984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65490777|NCT04624984|Immunologic Factors|immunologic factors|mesh-ancestor
65490778|NCT04624984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490779|NCT04624984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65490816|NCT01217034|Hormones|hormones|mesh-ancestor
65490817|NCT01217034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65490818|NCT01217034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490819|NCT01217034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65490820|NCT01373554|Oltipraz|oltipraz|mesh-list
65490821|NCT01373554|Antiviral Agents|antiviral agents|mesh-ancestor
65490822|NCT01373554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65490823|NCT01373554|Schistosomicides|schistosomicides|mesh-ancestor
65490824|NCT01373554|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65490825|NCT01373554|Anthelmintics|anthelmintics|mesh-ancestor
65490826|NCT01373554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65490827|NCT01373554|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65490828|NCT01373554|Protective Agents|protective agents|mesh-ancestor
65490829|NCT01373554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490830|NCT01373554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490831|NCT01373554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65490844|NCT01373632|Sirolimus|sirolimus|mesh-list
65490873|NCT01214772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65490874|NCT01214772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65490875|NCT01214772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490876|NCT01125150|Metformin|metformin|mesh-list
65490877|NCT01125150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65490878|NCT01125150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490879|NCT01373710|Trastuzumab|trastuzumab|mesh-list
65490880|NCT01373710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65490881|NCT01373710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490882|NCT03935256|Paclitaxel|paclitaxel|mesh-list
65490883|NCT03935256|Carboplatin|carboplatin|mesh-list
65490884|NCT03935256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65490885|NCT03935256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65490886|NCT03935256|Tubulin Modulators|tubulin modulators|mesh-ancestor
65490887|NCT03935256|Antimitotic Agents|antimitotic agents|mesh-ancestor
65490888|NCT03935256|Mitosis Modulators|mitosis modulators|mesh-ancestor
65490889|NCT03935256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490890|NCT03869866|Vaccines|vaccines|mesh-list
65490891|NCT03869866|Immunologic Factors|immunologic factors|mesh-ancestor
65490892|NCT03869866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490893|NCT03783702|Acetaminophen|acetaminophen|mesh-list
65490894|NCT03783702|Ibuprofen|ibuprofen|mesh-list
65490895|NCT03783702|Oxycodone|oxycodone|mesh-list
65490896|NCT03783702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65490897|NCT03783702|Analgesics|analgesics|mesh-ancestor
65490898|NCT03783702|Sensory System Agents|sensory system agents|mesh-ancestor
65490899|NCT03783702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490921|NCT01121016|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65490922|NCT01121016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65490923|NCT01121016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490924|NCT03575572|Colchicine|colchicine|mesh-list
65490925|NCT03575572|Gout Suppressants|gout suppressants|mesh-ancestor
65490926|NCT03575572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65490927|NCT03575572|Tubulin Modulators|tubulin modulators|mesh-ancestor
65490928|NCT03575572|Antimitotic Agents|antimitotic agents|mesh-ancestor
65490929|NCT03575572|Mitosis Modulators|mitosis modulators|mesh-ancestor
65490930|NCT03575572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65490985|NCT01219764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65490986|NCT01219764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65490987|NCT01219764|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65490988|NCT01219764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65490989|NCT01219764|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65490990|NCT03936426|Copper|copper|mesh-list
65490991|NCT03936426|Trace Elements|trace elements|mesh-ancestor
65490992|NCT03936426|Micronutrients|micronutrients|mesh-ancestor
65490993|NCT03936426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490994|NCT01217970|Ibudilast|ibudilast|mesh-list
65490995|NCT01217970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65490996|NCT01217970|Autonomic Agents|autonomic agents|mesh-ancestor
65490997|NCT01217970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65490998|NCT01217970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65490999|NCT01217970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65491000|NCT01217970|Respiratory System Agents|respiratory system agents|mesh-ancestor
65491001|NCT01217970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65491002|NCT01217970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491004|NCT01217970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65491041|NCT03116152|Tubulin Modulators|tubulin modulators|mesh-ancestor
65491042|NCT03116152|Antimitotic Agents|antimitotic agents|mesh-ancestor
65491043|NCT03116152|Mitosis Modulators|mitosis modulators|mesh-ancestor
65491044|NCT03116152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491045|NCT03116152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65491046|NCT03116152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65491047|NCT03116152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491049|NCT01123278|Androgens|androgens|mesh-ancestor
65491050|NCT01123278|Hormones|hormones|mesh-ancestor
65491051|NCT01123278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65491052|NCT01123278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491053|NCT01219920|Leucovorin|leucovorin|mesh-list
65491054|NCT01219920|Irinotecan|irinotecan|mesh-list
65491055|NCT01219920|Antidotes|antidotes|mesh-ancestor
65491056|NCT01219920|Protective Agents|protective agents|mesh-ancestor
65491057|NCT01219920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491058|NCT01219920|Vitamin B Complex|vitamin b complex|mesh-ancestor
65491059|NCT01219920|Vitamins|vitamins|mesh-ancestor
65491060|NCT01219920|Micronutrients|micronutrients|mesh-ancestor
65491061|NCT01219920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491062|NCT01219920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491063|NCT01219920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65491064|NCT01219920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65491093|NCT01220154|Growth Substances|growth substances|mesh-ancestor
65491094|NCT01220154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491095|NCT01220154|Growth Inhibitors|growth inhibitors|mesh-ancestor
65491096|NCT01182766|Topiramate|topiramate|mesh-list
65491097|NCT01182766|Anticonvulsants|anticonvulsants|mesh-ancestor
65491098|NCT01182766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65491099|NCT01182766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491100|NCT01220232|Lamivudine|lamivudine|mesh-list
65491101|NCT01220232|Abacavir|abacavir|mesh-list
65491102|NCT01220232|Dideoxynucleosides|dideoxynucleosides|mesh-list
65491103|NCT01220232|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65491104|NCT01220232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65491105|NCT01220232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491106|NCT01220232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491107|NCT01220232|Antiviral Agents|antiviral agents|mesh-ancestor
65491108|NCT01220232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65491109|NCT01220232|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65491110|NCT01220232|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65491111|NCT01220232|Antimetabolites|antimetabolites|mesh-ancestor
65491112|NCT01126008|Docetaxel|docetaxel|mesh-list
65491113|NCT01126008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491114|NCT01126008|Tubulin Modulators|tubulin modulators|mesh-ancestor
65491115|NCT01126008|Antimitotic Agents|antimitotic agents|mesh-ancestor
65491116|NCT01126008|Mitosis Modulators|mitosis modulators|mesh-ancestor
65491117|NCT01126008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491118|NCT03934710|Serotonin|serotonin|mesh-list
65491119|NCT03934710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-list
65491120|NCT03934710|Serotonin Agents|serotonin agents|mesh-ancestor
65491121|NCT03934710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65491123|NCT03934710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491124|NCT05169424|Fluticasone|fluticasone|mesh-list
65491125|NCT05169424|Xhance|xhance|mesh-list
65491126|NCT05169424|Tiotropium Bromide|tiotropium bromide|mesh-list
65491139|NCT05169424|Cholinergic Agents|cholinergic agents|mesh-ancestor
65491140|NCT05169424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65491141|NCT05169424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491142|NCT03117010|Dexamethasone|dexamethasone|mesh-list
65491143|NCT03117010|Etoposide|etoposide|mesh-list
65491144|NCT03117010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65491145|NCT03117010|Antiemetics|antiemetics|mesh-ancestor
65491146|NCT03117010|Autonomic Agents|autonomic agents|mesh-ancestor
65491147|NCT03117010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65491148|NCT03117010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491149|NCT03117010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65491150|NCT03117010|Glucocorticoids|glucocorticoids|mesh-ancestor
65491151|NCT03117010|Hormones|hormones|mesh-ancestor
65491152|NCT03117010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65491153|NCT03117010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65491154|NCT03117010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491155|NCT03117010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491156|NCT03117010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491157|NCT03117010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65491158|NCT03117010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65491159|NCT03117010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65491160|NCT01123824|Clopidogrel|clopidogrel|mesh-list
65491161|NCT01123824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65491162|NCT01123824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65491163|NCT01123824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65491164|NCT01123824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65491165|NCT01123824|Purinergic Agents|purinergic agents|mesh-ancestor
65491166|NCT01123824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65491167|NCT01123824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491168|NCT01123824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491169|NCT01126086|Otamixaban|otamixaban|mesh-list
65491170|NCT01126086|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65491171|NCT01126086|Antithrombins|antithrombins|mesh-ancestor
65491172|NCT01126086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65491173|NCT01126086|Protease Inhibitors|protease inhibitors|mesh-ancestor
65491174|NCT01126086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491175|NCT01126086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491176|NCT01126086|Anticoagulants|anticoagulants|mesh-ancestor
65491177|NCT03009838|Letrozole|letrozole|mesh-list
65491178|NCT03009838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491179|NCT03009838|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65491180|NCT03009838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65491181|NCT03009838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491182|NCT03009838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491183|NCT03009838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65491184|NCT03009838|Hormone Antagonists|hormone antagonists|mesh-ancestor
65491185|NCT03009838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65491186|NCT03009838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491187|NCT01124058|Heparin|heparin|mesh-list
65491188|NCT01124058|Calcium heparin|calcium heparin|mesh-list
65491189|NCT01124058|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65491190|NCT01124058|Tinzaparin|tinzaparin|mesh-list
65491191|NCT01124058|Dalteparin|dalteparin|mesh-list
65491192|NCT01124058|Warfarin|warfarin|mesh-list
65491193|NCT01124058|Anticoagulants|anticoagulants|mesh-ancestor
65491194|NCT01124058|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65491195|NCT01124058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65491196|NCT01124058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491197|NCT01375972|Gemcitabine|gemcitabine|mesh-list
65491198|NCT01375972|Cisplatin|cisplatin|mesh-list
65491199|NCT01375972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491200|NCT01375972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65491201|NCT01375972|Antimetabolites|antimetabolites|mesh-ancestor
65491202|NCT01375972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491203|NCT01375972|Antiviral Agents|antiviral agents|mesh-ancestor
65491204|NCT01375972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65491219|NCT01220622|Vasodilator Agents|vasodilator agents|mesh-ancestor
65491220|NCT05123170|Lidocaine|lidocaine|mesh-list
65491221|NCT05123170|Dexmedetomidine|dexmedetomidine|mesh-list
65491222|NCT05123170|Anesthetics, Local|anesthetics, local|mesh-ancestor
65491223|NCT05123170|Anesthetics|anesthetics|mesh-ancestor
65491224|NCT05123170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65491225|NCT05123170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491226|NCT05123170|Sensory System Agents|sensory system agents|mesh-ancestor
65491227|NCT05123170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65491228|NCT05123170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65491229|NCT05123170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65491230|NCT05123170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65491231|NCT05123170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65491232|NCT05123170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491233|NCT05123170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65491234|NCT05123170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65491235|NCT05123170|Analgesics|analgesics|mesh-ancestor
65491241|NCT01215708|Tamsulosin|tamsulosin|mesh-list
65491274|NCT01376128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491275|NCT01376128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65491276|NCT01376128|Serotonin Agents|serotonin agents|mesh-ancestor
65491277|NCT01376128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491278|NCT01376128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65491279|NCT01376128|Antidepressive Agents|antidepressive agents|mesh-ancestor
65491280|NCT01376128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65491281|NCT01376128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65491282|NCT01376128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65491283|NCT01376128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491284|NCT01376206|Fluticasone|fluticasone|mesh-list
65491285|NCT01376206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65491286|NCT01376206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65491287|NCT01376206|Autonomic Agents|autonomic agents|mesh-ancestor
65491288|NCT01376206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65491289|NCT01376206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491290|NCT01376206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65491291|NCT01376206|Respiratory System Agents|respiratory system agents|mesh-ancestor
65491292|NCT01376206|Dermatologic Agents|dermatologic agents|mesh-ancestor
65491293|NCT01376206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65491294|NCT01073501|Pregabalin|pregabalin|mesh-list
65491295|NCT01073501|Analgesics|analgesics|mesh-ancestor
65491296|NCT01073501|Sensory System Agents|sensory system agents|mesh-ancestor
65491297|NCT01073501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65491308|NCT05005312|Ritonavir|ritonavir|mesh-list
65491322|NCT01222182|Pravastatin|pravastatin|mesh-list
65491323|NCT01222182|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65491324|NCT01222182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65491325|NCT01222182|Antimetabolites|antimetabolites|mesh-ancestor
65491326|NCT01222182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491327|NCT01222182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65491328|NCT01222182|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65491329|NCT01222182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491330|NCT01218750|Bevacizumab|bevacizumab|mesh-list
65491331|NCT01218750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65491332|NCT01218750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491333|NCT01218750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65491335|NCT01218750|Growth Substances|growth substances|mesh-ancestor
65491382|NCT01073579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491383|NCT01073579|GABA Agents|gaba agents|mesh-ancestor
65491384|NCT01073579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65491385|NCT01073579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491386|NCT00221195|Thrombin|thrombin|mesh-list
65491387|NCT00221195|Hemostatics|hemostatics|mesh-ancestor
65491388|NCT00221195|Coagulants|coagulants|mesh-ancestor
65491389|NCT04646590|Vaccines|vaccines|mesh-list
65491390|NCT04646590|Immunologic Factors|immunologic factors|mesh-ancestor
65491391|NCT04646590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491392|NCT03931668|Maleic acid|maleic acid|mesh-list
65491393|NCT03931668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491394|NCT03931668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491395|NCT00220805|Immunoglobulins|immunoglobulins|mesh-list
65491396|NCT00220805|Antibodies|antibodies|mesh-list
65491397|NCT00220805|gamma-Globulins|gamma-globulins|mesh-list
65491398|NCT00220805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65491399|NCT00220805|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65491400|NCT00220805|Immunoglobulin G|immunoglobulin g|mesh-list
65491401|NCT00220805|Immunologic Factors|immunologic factors|mesh-ancestor
65491402|NCT00220805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491403|NCT00220727|Immunoglobulins|immunoglobulins|mesh-list
65491404|NCT00220727|Antibodies|antibodies|mesh-list
65491405|NCT00220727|gamma-Globulins|gamma-globulins|mesh-list
65491408|NCT00220727|Immunoglobulin G|immunoglobulin g|mesh-list
65491435|NCT01221402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65491436|NCT01221402|Vasodilator Agents|vasodilator agents|mesh-ancestor
65491437|NCT01221402|Vitamin B Complex|vitamin b complex|mesh-ancestor
65491438|NCT01221402|Vitamins|vitamins|mesh-ancestor
65491439|NCT01221402|Micronutrients|micronutrients|mesh-ancestor
65491440|NCT01221402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491441|NCT04214860|Azacitidine|azacitidine|mesh-list
65491442|NCT04214860|Venetoclax|venetoclax|mesh-list
65491443|NCT04214860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65491444|NCT04214860|Antimetabolites|antimetabolites|mesh-ancestor
65491445|NCT04214860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491446|NCT04214860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491447|NCT04214860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491448|NCT01127490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65491449|NCT01127490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65491450|NCT01127490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65491451|NCT01127490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65491452|NCT01127490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491453|NCT01127490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65491454|NCT01127490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491455|NCT01127490|Analgesics|analgesics|mesh-ancestor
65491487|NCT00252239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65491488|NCT00252239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491489|NCT01127022|Choline|choline|mesh-list
65491490|NCT01127022|Lipotropic Agents|lipotropic agents|mesh-ancestor
65491491|NCT01127022|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65491492|NCT01127022|Antimetabolites|antimetabolites|mesh-ancestor
65491493|NCT01127022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491494|NCT01127022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65491495|NCT01127022|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65491496|NCT01127022|Nootropic Agents|nootropic agents|mesh-ancestor
65491497|NCT01221558|Lycopene|lycopene|mesh-list
65491498|NCT01221558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65491499|NCT01221558|Antioxidants|antioxidants|mesh-ancestor
65491500|NCT01221558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491501|NCT01221558|Protective Agents|protective agents|mesh-ancestor
65491502|NCT01221558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491503|NCT01221558|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65491504|NCT01221558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65491505|NCT01221558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491506|NCT01221636|Abatacept|abatacept|mesh-list
65491507|NCT01221636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65491508|NCT01221636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491509|NCT01221636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491510|NCT01221636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65491511|NCT01221636|Immunologic Factors|immunologic factors|mesh-ancestor
65491512|NCT01221636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491513|NCT01221636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65491533|NCT01127568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65491534|NCT01127568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65491535|NCT01127568|Vasodilator Agents|vasodilator agents|mesh-ancestor
65491536|NCT03932292|Calcium|calcium|mesh-list
65491537|NCT03932292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65491538|NCT03932292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491539|NCT01127100|Fentanyl|fentanyl|mesh-list
65491540|NCT01127100|Gabapentin|gabapentin|mesh-list
65491541|NCT01127100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65491542|NCT01127100|Narcotics|narcotics|mesh-ancestor
65491543|NCT01127100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65491544|NCT01127100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491545|NCT01127100|Analgesics|analgesics|mesh-ancestor
65491546|NCT01127100|Sensory System Agents|sensory system agents|mesh-ancestor
65491547|NCT01127100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65491548|NCT01127100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65491549|NCT01127100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65491550|NCT01127100|Anesthetics, General|anesthetics, general|mesh-ancestor
65491551|NCT01127100|Anesthetics|anesthetics|mesh-ancestor
65491552|NCT01127100|Anticonvulsants|anticonvulsants|mesh-ancestor
65491553|NCT01127100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65491554|NCT01127100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65491555|NCT01127100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65491556|NCT01127100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65491557|NCT01127100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65491558|NCT01127100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65491560|NCT01127100|Antimanic Agents|antimanic agents|mesh-ancestor
65491579|NCT01221792|Vasodilator Agents|vasodilator agents|mesh-ancestor
65491580|NCT01221792|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65491581|NCT01221792|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65491582|NCT03932526|Apatinib|apatinib|mesh-list
65491583|NCT03932526|Vinorelbine|vinorelbine|mesh-list
65491584|NCT03932526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491585|NCT03932526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65491586|NCT03932526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491587|NCT03932526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491588|NCT03932526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65491589|NCT03932526|Tubulin Modulators|tubulin modulators|mesh-ancestor
65491590|NCT03932526|Antimitotic Agents|antimitotic agents|mesh-ancestor
65491591|NCT03932526|Mitosis Modulators|mitosis modulators|mesh-ancestor
65491592|NCT01127724|Vitamins|vitamins|mesh-list
65491593|NCT01127724|Vitamin B 12|vitamin b 12|mesh-list
65491594|NCT01127724|Hydroxocobalamin|hydroxocobalamin|mesh-list
65491595|NCT01127724|Vitamin B Complex|vitamin b complex|mesh-list
65491596|NCT01127724|Micronutrients|micronutrients|mesh-ancestor
65491597|NCT01127724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491598|NCT01127724|Hematinics|hematinics|mesh-ancestor
65491599|NCT03103906|Sunscreening Agents|sunscreening agents|mesh-list
65491600|NCT03103906|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65491601|NCT03103906|Protective Agents|protective agents|mesh-ancestor
65491602|NCT03103906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491603|NCT03103906|Dermatologic Agents|dermatologic agents|mesh-ancestor
65491604|NCT05675098|Methylphenidate|methylphenidate|mesh-list
65491605|NCT05675098|Modafinil|modafinil|mesh-list
65491606|NCT05675098|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65491607|NCT05675098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491626|NCT01223820|Capsaicin|capsaicin|mesh-list
65491627|NCT01223820|Antipruritics|antipruritics|mesh-ancestor
65491628|NCT01223820|Dermatologic Agents|dermatologic agents|mesh-ancestor
65491629|NCT01223820|Sensory System Agents|sensory system agents|mesh-ancestor
65491630|NCT01223820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65491631|NCT01223820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491632|NCT01131234|Cediranib|cediranib|mesh-list
65491633|NCT01131234|R04929097|r04929097|mesh-list
65491634|NCT01131234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491635|NCT01131234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491636|NCT01131234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491637|NCT01131234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65491638|NCT01129596|Donepezil|donepezil|mesh-list
65491639|NCT01129596|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65491640|NCT01129596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491641|NCT01129596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491642|NCT01129596|Cholinergic Agents|cholinergic agents|mesh-ancestor
65491643|NCT01129596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65491644|NCT01129596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491645|NCT01129596|Nootropic Agents|nootropic agents|mesh-ancestor
65491646|NCT04680598|Antiviral Agents|antiviral agents|mesh-list
65491647|NCT04680598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65491648|NCT01127880|Clindamycin|clindamycin|mesh-list
65491649|NCT01127880|Clindamycin palmitate|clindamycin palmitate|mesh-list
65491650|NCT01127880|Clindamycin phosphate|clindamycin phosphate|mesh-list
65491651|NCT01127880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65491652|NCT01127880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65491653|NCT01127880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65491654|NCT01127880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491655|NCT01127880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491671|NCT01129830|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65491672|NCT01129830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65491673|NCT01129830|Immunologic Factors|immunologic factors|mesh-ancestor
65491674|NCT01129830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491675|NCT01228422|Interferons|interferons|mesh-list
65491676|NCT01228422|Interferon-alpha|interferon-alpha|mesh-list
65491677|NCT01228422|Interferon alpha-2|interferon alpha-2|mesh-list
65491678|NCT01228422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491679|NCT01228422|Antiviral Agents|antiviral agents|mesh-ancestor
65491680|NCT01228422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65491681|NCT01228422|Immunologic Factors|immunologic factors|mesh-ancestor
65491682|NCT01228422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491683|NCT01319422|Pomalidomide|pomalidomide|mesh-list
65491684|NCT01319422|Immunologic Factors|immunologic factors|mesh-ancestor
65491685|NCT01319422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491686|NCT01319422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65491687|NCT01319422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65491688|NCT01319422|Growth Substances|growth substances|mesh-ancestor
65491689|NCT01319422|Growth Inhibitors|growth inhibitors|mesh-ancestor
65491690|NCT01319422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491691|NCT01227174|Propofol|propofol|mesh-list
65491692|NCT01227174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65491693|NCT01227174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65491694|NCT01227174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491695|NCT01227174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65491696|NCT01227174|Anesthetics, General|anesthetics, general|mesh-ancestor
65491697|NCT01227174|Anesthetics|anesthetics|mesh-ancestor
65491698|NCT05615974|Rituximab|rituximab|mesh-list
65491700|NCT05615974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491719|NCT01224366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491720|NCT01224366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65491721|NCT01224366|Protease Inhibitors|protease inhibitors|mesh-ancestor
65491722|NCT01224366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491723|NCT01224366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491724|NCT05415826|Dexamethasone|dexamethasone|mesh-list
65491725|NCT05415826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65491726|NCT05415826|Antiemetics|antiemetics|mesh-ancestor
65491727|NCT05415826|Autonomic Agents|autonomic agents|mesh-ancestor
65491728|NCT05415826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65491729|NCT05415826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491730|NCT05415826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65491731|NCT05415826|Glucocorticoids|glucocorticoids|mesh-ancestor
65491732|NCT05415826|Hormones|hormones|mesh-ancestor
65491733|NCT05415826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65491734|NCT05415826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65491735|NCT05415826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491736|NCT05415748|Tamsulosin|tamsulosin|mesh-list
65491737|NCT05415748|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65491738|NCT05415748|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65491739|NCT05415748|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65491740|NCT05415748|Adrenergic Agents|adrenergic agents|mesh-ancestor
65491741|NCT05415748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65491742|NCT05415748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491743|NCT05415748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491744|NCT05415748|Urological Agents|urological agents|mesh-ancestor
65491745|NCT03774576|Itraconazole|itraconazole|mesh-list
65491746|NCT03774576|Antifungal Agents|antifungal agents|mesh-ancestor
65491761|NCT05415436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65491762|NCT05415436|Anesthetics, General|anesthetics, general|mesh-ancestor
65491763|NCT05415436|Anesthetics|anesthetics|mesh-ancestor
65491764|NCT01227408|Paclitaxel|paclitaxel|mesh-list
65491765|NCT01227408|Cyclophosphamide|cyclophosphamide|mesh-list
65491766|NCT01227408|Doxorubicin|doxorubicin|mesh-list
65491767|NCT01227408|Capecitabine|capecitabine|mesh-list
65491768|NCT01227408|Methotrexate|methotrexate|mesh-list
65491769|NCT01227408|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
65491770|NCT01227408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65491771|NCT01227408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491772|NCT01227408|Tubulin Modulators|tubulin modulators|mesh-ancestor
65491773|NCT01227408|Antimitotic Agents|antimitotic agents|mesh-ancestor
65491774|NCT01227408|Mitosis Modulators|mitosis modulators|mesh-ancestor
65491775|NCT01227408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491776|NCT01227408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65491777|NCT01227408|Immunologic Factors|immunologic factors|mesh-ancestor
65491778|NCT01227408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491779|NCT01227408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65491780|NCT01227408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65491781|NCT01227408|Alkylating Agents|alkylating agents|mesh-ancestor
65491782|NCT01227408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65491783|NCT01227408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65491784|NCT01227408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65491785|NCT01227408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65491811|NCT02927938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65491812|NCT02927938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65491813|NCT02927938|Immunologic Factors|immunologic factors|mesh-ancestor
65491814|NCT02927938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491815|NCT05370820|Tranexamic Acid|tranexamic acid|mesh-list
65491816|NCT05370820|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65491817|NCT05370820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65491818|NCT05370820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491819|NCT05370820|Hemostatics|hemostatics|mesh-ancestor
65491820|NCT05370820|Coagulants|coagulants|mesh-ancestor
65491821|NCT03923166|Capecitabine|capecitabine|mesh-list
65491822|NCT03923166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65491823|NCT03923166|Antimetabolites|antimetabolites|mesh-ancestor
65491824|NCT03923166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491825|NCT03923166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491826|NCT01224756|Tinoridine|tinoridine|mesh-list
65491827|NCT01224756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65491828|NCT01224756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65491829|NCT01224756|Analgesics|analgesics|mesh-ancestor
65491830|NCT01224756|Sensory System Agents|sensory system agents|mesh-ancestor
65491831|NCT01224756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65491832|NCT01224756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491834|NCT01224756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65491862|NCT03175978|Antimetabolites|antimetabolites|mesh-ancestor
65491863|NCT03175978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491864|NCT03175978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491865|NCT03175978|Dermatologic Agents|dermatologic agents|mesh-ancestor
65491866|NCT03175978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491867|NCT03175978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65491868|NCT03175978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65491869|NCT03175978|Immunologic Factors|immunologic factors|mesh-ancestor
65491870|NCT03175978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65491871|NCT03175978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65491873|NCT03923010|Antifungal Agents|antifungal agents|mesh-ancestor
65491874|NCT03923010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65491875|NCT03923010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65491876|NCT03923010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65491877|NCT03923010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491878|NCT03923010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491879|NCT03923010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65491880|NCT03923010|Hormone Antagonists|hormone antagonists|mesh-ancestor
65491881|NCT03923010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65491882|NCT03923010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491883|NCT03923010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65491884|NCT01227798|Interferons|interferons|mesh-list
65491885|NCT01227798|Interferon alfacon-1|interferon alfacon-1|mesh-list
65491886|NCT01227798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491887|NCT01227798|Antiviral Agents|antiviral agents|mesh-ancestor
65491888|NCT01227798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65491889|NCT01130376|Aldesleukin|aldesleukin|mesh-list
65491890|NCT01130376|Interleukin-2|interleukin-2|mesh-list
65491891|NCT01130376|Hormones|hormones|mesh-list
65491906|NCT03740178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65491907|NCT03740178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491908|NCT03740178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491909|NCT03740178|Cholinergic Agents|cholinergic agents|mesh-ancestor
65491910|NCT03740178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65491911|NCT03740178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491912|NCT03740178|Nootropic Agents|nootropic agents|mesh-ancestor
65491913|NCT01131468|Acetylcysteine|acetylcysteine|mesh-list
65491914|NCT01131468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65491915|NCT01131468|Antiviral Agents|antiviral agents|mesh-ancestor
65491916|NCT01131468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65491917|NCT01131468|Expectorants|expectorants|mesh-ancestor
65491918|NCT01131468|Respiratory System Agents|respiratory system agents|mesh-ancestor
65491919|NCT01131468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65491920|NCT01131468|Antioxidants|antioxidants|mesh-ancestor
65491921|NCT01131468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491922|NCT01131468|Protective Agents|protective agents|mesh-ancestor
65491923|NCT01131468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491924|NCT01131468|Antidotes|antidotes|mesh-ancestor
65491925|NCT01225224|Peficitinib|peficitinib|mesh-list
65491926|NCT01225224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65491927|NCT01225224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491928|NCT01225224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65491929|NCT01225224|Immunologic Factors|immunologic factors|mesh-ancestor
65491930|NCT01225224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65491931|NCT01131546|Amlodipine|amlodipine|mesh-list
65491932|NCT01131546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65491954|NCT01229046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491955|NCT01229046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65491956|NCT03921684|Capecitabine|capecitabine|mesh-list
65491957|NCT03921684|Nivolumab|nivolumab|mesh-list
65491958|NCT03921684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65491959|NCT03921684|Antimetabolites|antimetabolites|mesh-ancestor
65491960|NCT03921684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491961|NCT03921684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491962|NCT03921684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65491963|NCT03921684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65491964|NCT03929094|Gemcitabine|gemcitabine|mesh-list
65491965|NCT03929094|Paclitaxel|paclitaxel|mesh-list
65491966|NCT03929094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65491967|NCT03929094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65491968|NCT03929094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65491969|NCT03929094|Tubulin Modulators|tubulin modulators|mesh-ancestor
65491970|NCT03929094|Antimitotic Agents|antimitotic agents|mesh-ancestor
65491971|NCT03929094|Mitosis Modulators|mitosis modulators|mesh-ancestor
65491972|NCT03929094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65491973|NCT03929094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65491974|NCT03929094|Antimetabolites|antimetabolites|mesh-ancestor
65491975|NCT03929094|Antiviral Agents|antiviral agents|mesh-ancestor
65491976|NCT03929094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492005|NCT03925818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492006|NCT03925818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492007|NCT03925818|Antacids|antacids|mesh-ancestor
65492008|NCT03925818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65492009|NCT03925740|Listerine|listerine|mesh-list
65241551|NCT04980222|Glucocorticoids|glucocorticoids|mesh-ancestor
65492010|NCT03925740|Fluorides|fluorides|mesh-list
65492011|NCT03925740|Sodium Fluoride|sodium fluoride|mesh-list
65492012|NCT03925740|Cariostatic Agents|cariostatic agents|mesh-ancestor
65492013|NCT03925740|Protective Agents|protective agents|mesh-ancestor
65492014|NCT03925740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492015|NCT03925740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65492016|NCT03925740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492017|NCT01130688|Zileuton|zileuton|mesh-list
65492018|NCT01130688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65492019|NCT01130688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65492020|NCT01130688|Analgesics|analgesics|mesh-ancestor
65492021|NCT01130688|Sensory System Agents|sensory system agents|mesh-ancestor
65492022|NCT01130688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65492023|NCT01130688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492024|NCT01130688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65492025|NCT01130688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65492026|NCT01130688|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65492027|NCT01130688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492028|NCT01130688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492029|NCT01130688|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65492030|NCT01130688|Hormone Antagonists|hormone antagonists|mesh-ancestor
65492031|NCT01130688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65492032|NCT03925662|Mebendazole|mebendazole|mesh-list
65492033|NCT03925662|Piperazine|piperazine|mesh-list
65492034|NCT03925662|Piperazine citrate|piperazine citrate|mesh-list
65492035|NCT03925662|Bevacizumab|bevacizumab|mesh-list
65492036|NCT03925662|DMP 777|dmp 777|mesh-list
65492037|NCT03925662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65492045|NCT03925662|Anthelmintics|anthelmintics|mesh-ancestor
65492046|NCT03925662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65492047|NCT03925662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492048|NCT03925662|Tubulin Modulators|tubulin modulators|mesh-ancestor
65492049|NCT03925662|Antimitotic Agents|antimitotic agents|mesh-ancestor
65492050|NCT03925662|Mitosis Modulators|mitosis modulators|mesh-ancestor
65492051|NCT03925662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492052|NCT03925662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492053|NCT01229202|Bevacizumab|bevacizumab|mesh-list
65492054|NCT01229202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65492055|NCT01229202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65492056|NCT01229202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65492057|NCT01229202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65492058|NCT01229202|Growth Substances|growth substances|mesh-ancestor
65492059|NCT01229202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492060|NCT01229202|Growth Inhibitors|growth inhibitors|mesh-ancestor
65492061|NCT01229280|Darifenacin|darifenacin|mesh-list
65492062|NCT01229280|Muscarinic Antagonists|muscarinic antagonists|mesh-list
65492063|NCT01229280|Cholinergic Agents|cholinergic agents|mesh-list
65492064|NCT01229280|Cholinergic Antagonists|cholinergic antagonists|mesh-list
65492065|NCT01229280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65492066|NCT01229280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492067|NCT01229280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492068|NCT01229280|Urological Agents|urological agents|mesh-ancestor
65492069|NCT01131780|Ibuprofen|ibuprofen|mesh-list
65492070|NCT01131780|Pseudoephedrine|pseudoephedrine|mesh-list
65492071|NCT01131780|Ephedrine|ephedrine|mesh-list
65492072|NCT01131780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65492073|NCT01131780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65492074|NCT01131780|Analgesics|analgesics|mesh-ancestor
65492088|NCT01131780|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65492089|NCT01131780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65492090|NCT01131780|Sympathomimetics|sympathomimetics|mesh-ancestor
65492091|NCT01131780|Adrenergic Agents|adrenergic agents|mesh-ancestor
65492092|NCT01131780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65492093|NCT01130922|Moxifloxacin|moxifloxacin|mesh-list
65492094|NCT01130922|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65492095|NCT01130922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65492096|NCT01130922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492097|NCT01130922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65492098|NCT01130922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65492099|NCT01130922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492100|NCT01130922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492101|NCT01130922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65492102|NCT01130922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65492103|NCT01130922|Contraceptive Agents|contraceptive agents|mesh-ancestor
65492104|NCT01130922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65492105|NCT01130922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492106|NCT01130922|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65492107|NCT01130922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65492108|NCT01130922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65492109|NCT01131000|Ibuprofen|ibuprofen|mesh-list
65492110|NCT01131000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65492111|NCT01131000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65492112|NCT01131000|Analgesics|analgesics|mesh-ancestor
65492113|NCT01131000|Sensory System Agents|sensory system agents|mesh-ancestor
65492114|NCT01131000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65492115|NCT01131000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492116|NCT01131000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65492121|NCT01132170|Valproic Acid|valproic acid|mesh-list
65492130|NCT01132170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65492131|NCT01132170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65492132|NCT03925428|Entinostat|entinostat|mesh-list
65492133|NCT03925428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65492134|NCT03925428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65492135|NCT03925428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492136|NCT03925428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492137|NCT03920514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65492138|NCT03920514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65492139|NCT03920514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492140|NCT03919812|Cholecalciferol|cholecalciferol|mesh-list
65492141|NCT03919812|Vitamin D|vitamin d|mesh-list
65492142|NCT03919812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65492143|NCT03919812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492144|NCT03919812|Vitamins|vitamins|mesh-ancestor
65492145|NCT03919812|Micronutrients|micronutrients|mesh-ancestor
65492146|NCT03919812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65492147|NCT03919656|Dapagliflozin|dapagliflozin|mesh-list
65492148|NCT03919656|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65492149|NCT03919656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492150|NCT03919656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65492152|NCT01132248|Mefloquine|mefloquine|mesh-list
65492181|NCT01231854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492182|NCT01231854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65492183|NCT01231854|Immunologic Factors|immunologic factors|mesh-ancestor
65492184|NCT01231854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492185|NCT01231854|Antifungal Agents|antifungal agents|mesh-ancestor
65492186|NCT01231854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492187|NCT01231854|Dermatologic Agents|dermatologic agents|mesh-ancestor
65492188|NCT01231854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65492189|NCT01231854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65492190|NCT01231854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65492191|NCT01132638|Esomeprazole|esomeprazole|mesh-list
65492192|NCT01132638|Pantoprazole|pantoprazole|mesh-list
65492193|NCT01132638|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65492194|NCT01132638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65492195|NCT01132638|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65492196|NCT01132638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492197|NCT01132638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492198|NCT05402124|Aspirin|aspirin|mesh-list
65492199|NCT05402124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65492200|NCT05402124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65492201|NCT05402124|Analgesics|analgesics|mesh-ancestor
65492202|NCT05402124|Sensory System Agents|sensory system agents|mesh-ancestor
65492203|NCT05402124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65492204|NCT05402124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492205|NCT05402124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65492206|NCT05402124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65492207|NCT05402124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65492208|NCT05402124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65492227|NCT01134432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65492228|NCT01134432|Glucocorticoids|glucocorticoids|mesh-ancestor
65492229|NCT01134432|Hormones|hormones|mesh-ancestor
65492230|NCT01134432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65492231|NCT01134432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65492232|NCT01134432|Antiemetics|antiemetics|mesh-ancestor
65492233|NCT01134432|Autonomic Agents|autonomic agents|mesh-ancestor
65492234|NCT01134432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65241821|NCT04530565|Mesna|mesna|mesh-list
65492235|NCT01134432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65492236|NCT01134432|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65492237|NCT01134432|Protective Agents|protective agents|mesh-ancestor
65492238|NCT01232010|Mirodenafil|mirodenafil|mesh-list
65492289|NCT01137942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65492290|NCT01137942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65492291|NCT01137942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65492292|NCT01137942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65492293|NCT01137942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492294|NCT01137942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492295|NCT01137942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65492296|NCT01137942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65492297|NCT01233492|Mannitol|mannitol|mesh-list
65492298|NCT01233492|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65492299|NCT01233492|Diuretics|diuretics|mesh-ancestor
65492300|NCT01233492|Natriuretic Agents|natriuretic agents|mesh-ancestor
65492301|NCT01233492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492302|NCT01135056|Sorafenib|sorafenib|mesh-list
65492349|NCT01138488|Insulin|insulin|mesh-list
65492350|NCT01138488|Insulin Aspart|insulin aspart|mesh-list
65492351|NCT01138488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65492352|NCT01138488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492353|NCT01135680|Moxifloxacin|moxifloxacin|mesh-list
65492354|NCT01135680|Glycerol|glycerol|mesh-list
65492355|NCT01135680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65492356|NCT01135680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492357|NCT01135680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65492358|NCT01135680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65492359|NCT01135680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492360|NCT01135680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492361|NCT01135680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65492362|NCT01135680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492363|NCT01135680|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65492364|NCT01135680|Protective Agents|protective agents|mesh-ancestor
65492365|NCT01135758|Ketamine|ketamine|mesh-list
65492366|NCT01135758|Analgesics|analgesics|mesh-ancestor
65492367|NCT01135758|Sensory System Agents|sensory system agents|mesh-ancestor
65492368|NCT01135758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65492369|NCT01135758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492370|NCT01135758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65492371|NCT01135758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65492372|NCT01135758|Anesthetics, General|anesthetics, general|mesh-ancestor
65492373|NCT01135758|Anesthetics|anesthetics|mesh-ancestor
65492374|NCT01135758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65492375|NCT01135758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65492376|NCT01135758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65492396|NCT03768726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65492397|NCT03768726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65492398|NCT03768726|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65492399|NCT03768726|Dopamine Agents|dopamine agents|mesh-ancestor
65492400|NCT01138956|Acetylcysteine|acetylcysteine|mesh-list
65492401|NCT01138956|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65492402|NCT01138956|Antiviral Agents|antiviral agents|mesh-ancestor
65492403|NCT01138956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492404|NCT01138956|Expectorants|expectorants|mesh-ancestor
65492405|NCT01138956|Respiratory System Agents|respiratory system agents|mesh-ancestor
65492406|NCT01138956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65492407|NCT01138956|Antioxidants|antioxidants|mesh-ancestor
65492408|NCT01138956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492409|NCT01138956|Protective Agents|protective agents|mesh-ancestor
65492410|NCT01138956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492456|NCT01133496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492457|NCT01232400|Esmolol|esmolol|mesh-list
65492458|NCT01232400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65492459|NCT01232400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65492460|NCT01232400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65492461|NCT01232400|Adrenergic Agents|adrenergic agents|mesh-ancestor
65492462|NCT01232400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65492463|NCT01232400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492464|NCT01232400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492465|NCT02528760|Erythromycin|erythromycin|mesh-list
65492466|NCT02528760|Erythromycin Estolate|erythromycin estolate|mesh-list
65492467|NCT02528760|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65492468|NCT02528760|Erythromycin stearate|erythromycin stearate|mesh-list
65492469|NCT02528760|Metoclopramide|metoclopramide|mesh-list
65492470|NCT02528760|Antiemetics|antiemetics|mesh-ancestor
65492471|NCT02528760|Autonomic Agents|autonomic agents|mesh-ancestor
65492472|NCT02528760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65492473|NCT02528760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492474|NCT02528760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65492475|NCT02528760|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65492476|NCT02528760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65492477|NCT02528760|Dopamine Agents|dopamine agents|mesh-ancestor
65492478|NCT02528760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65492479|NCT02528760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492480|NCT02528760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65492481|NCT02528760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492482|NCT02528760|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65492483|NCT02528760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492484|NCT05594472|Gentamicins|gentamicins|mesh-list
65492485|NCT05594472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65492486|NCT05594472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492499|NCT01136850|Chloroquine|chloroquine|mesh-list
65492500|NCT01136850|Pyrimethamine|pyrimethamine|mesh-list
65492501|NCT01136850|Sulfadoxine|sulfadoxine|mesh-list
65492502|NCT01136850|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65492503|NCT01136850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65492504|NCT01136850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492505|NCT01136850|Amebicides|amebicides|mesh-ancestor
65492506|NCT01136850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65492507|NCT01136850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65492508|NCT01136850|Antimalarials|antimalarials|mesh-ancestor
65492509|NCT01136850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65492510|NCT01136850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65492511|NCT01136850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492512|NCT01136850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492513|NCT01136850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65492514|NCT01136850|Renal Agents|renal agents|mesh-ancestor
65492515|NCT05088252|Propofol|propofol|mesh-list
65492516|NCT05088252|Desflurane|desflurane|mesh-list
65492517|NCT05088252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65492518|NCT05088252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65492519|NCT05088252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492520|NCT05088252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65492521|NCT05088252|Anesthetics, General|anesthetics, general|mesh-ancestor
65492522|NCT05088252|Anesthetics|anesthetics|mesh-ancestor
65492523|NCT05088252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65492524|NCT01234116|Tenofovir|tenofovir|mesh-list
65492525|NCT01234116|Emtricitabine|emtricitabine|mesh-list
65492526|NCT01234116|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65492527|NCT01234116|Antiviral Agents|antiviral agents|mesh-ancestor
65492528|NCT01234116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492546|NCT01137084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65492547|NCT01137084|Prednisolone|prednisolone|mesh-list
65492548|NCT01137084|Prednisolone acetate|prednisolone acetate|mesh-list
65492549|NCT01137084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65492550|NCT01137084|Prednisolone phosphate|prednisolone phosphate|mesh-list
65492551|NCT01137084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65492552|NCT01137084|Antiemetics|antiemetics|mesh-ancestor
65492553|NCT01137084|Autonomic Agents|autonomic agents|mesh-ancestor
65492554|NCT01137084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65492555|NCT01137084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492556|NCT01137084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65492557|NCT01137084|Glucocorticoids|glucocorticoids|mesh-ancestor
65492558|NCT01137084|Hormones|hormones|mesh-ancestor
65492559|NCT01137084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65492560|NCT01137084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65492561|NCT01137084|Protective Agents|protective agents|mesh-ancestor
65492562|NCT01137084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65492563|NCT01137084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65492564|NCT01133886|Decitabine|decitabine|mesh-list
65492565|NCT01133886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65492566|NCT01133886|Antimetabolites|antimetabolites|mesh-ancestor
65492567|NCT01133886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492568|NCT01133886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65492569|NCT01133886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492570|NCT03917082|Tamoxifen|tamoxifen|mesh-list
65492571|NCT03917082|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65492572|NCT03917082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492573|NCT03917082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65492574|NCT03917082|Hormone Antagonists|hormone antagonists|mesh-ancestor
65492575|NCT03917082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65492576|NCT03917082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492588|NCT01140126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65492589|NCT01140126|Antiviral Agents|antiviral agents|mesh-ancestor
65492590|NCT01140126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492591|NCT01231074|Metformin|metformin|mesh-list
65492592|NCT01231074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65492593|NCT01231074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492594|NCT03917394|Iron|iron|mesh-list
65492595|NCT03917394|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65492596|NCT03917394|Trace Elements|trace elements|mesh-ancestor
65492597|NCT03917394|Micronutrients|micronutrients|mesh-ancestor
65492598|NCT03917394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492599|NCT03917394|Hematinics|hematinics|mesh-ancestor
65492600|NCT03769896|Nabilone|nabilone|mesh-list
65492601|NCT03769896|Antiemetics|antiemetics|mesh-ancestor
65492602|NCT03769896|Autonomic Agents|autonomic agents|mesh-ancestor
65492603|NCT03769896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65492604|NCT03769896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492605|NCT03769896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65492606|NCT03769896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65492607|NCT03769896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65492608|NCT03769896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65492609|NCT03769896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65492610|NCT01234194|Remifentanil|remifentanil|mesh-list
65492611|NCT01234194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65492612|NCT01234194|Narcotics|narcotics|mesh-ancestor
65492613|NCT01234194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65492614|NCT01234194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492639|NCT05485662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492640|NCT01234272|Morphine|morphine|mesh-list
65492641|NCT01234272|Ropivacaine|ropivacaine|mesh-list
65492642|NCT01234272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65492643|NCT01234272|Narcotics|narcotics|mesh-ancestor
65492644|NCT01234272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65492645|NCT01234272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492646|NCT01234272|Analgesics|analgesics|mesh-ancestor
65492647|NCT01234272|Sensory System Agents|sensory system agents|mesh-ancestor
65492648|NCT01234272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65492649|NCT01234272|Anesthetics, Local|anesthetics, local|mesh-ancestor
65492650|NCT01234272|Anesthetics|anesthetics|mesh-ancestor
65492651|NCT01140438|Metformin|metformin|mesh-list
65492652|NCT01140438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65492653|NCT01140438|Repaglinide|repaglinide|mesh-list
65492654|NCT01140438|Insulin, Isophane|insulin, isophane|mesh-list
65492655|NCT01140438|Isophane Insulin, Human|isophane insulin, human|mesh-list
65492656|NCT01140438|Isophane insulin, beef|isophane insulin, beef|mesh-list
65492657|NCT01140438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65492658|NCT01140438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492659|NCT01140438|Incretins|incretins|mesh-ancestor
65492660|NCT01140438|Hormones|hormones|mesh-ancestor
65492697|NCT01231542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65492698|NCT01231542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492699|NCT01231542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492700|NCT01231542|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65492701|NCT01231542|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65492702|NCT01231542|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65492703|NCT01231542|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65492704|NCT01231542|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65492705|NCT01231542|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65492706|NCT01231542|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65492707|NCT01231542|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65492708|NCT01231542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65492709|NCT01231542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65492710|NCT01231542|Antiviral Agents|antiviral agents|mesh-ancestor
65492711|NCT01231698|Esmolol|esmolol|mesh-list
65492712|NCT01231698|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65492713|NCT01231698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65492714|NCT01231698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65492715|NCT01231698|Adrenergic Agents|adrenergic agents|mesh-ancestor
65492716|NCT01231698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65492717|NCT01231698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492718|NCT01231698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492719|NCT01142778|Bevacizumab|bevacizumab|mesh-list
65492720|NCT01142778|Trastuzumab|trastuzumab|mesh-list
65492721|NCT01142778|Docetaxel|docetaxel|mesh-list
65492722|NCT01142778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65492726|NCT01142778|Growth Substances|growth substances|mesh-ancestor
65492741|NCT03739710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65492742|NCT01142934|Chlorhexidine|chlorhexidine|mesh-list
65492743|NCT01142934|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65492744|NCT01142934|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65492745|NCT01142934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492746|NCT01142934|Disinfectants|disinfectants|mesh-ancestor
65492747|NCT01142934|Dermatologic Agents|dermatologic agents|mesh-ancestor
65492748|NCT04722978|Gemcitabine|gemcitabine|mesh-list
65492749|NCT04722978|Moxifloxacin|moxifloxacin|mesh-list
65492750|NCT04722978|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65492751|NCT04722978|Carboplatin|carboplatin|mesh-list
65492752|NCT04722978|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65492753|NCT04722978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65492754|NCT04722978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65492802|NCT03714594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492803|NCT04624776|Methylprednisolone|methylprednisolone|mesh-list
65492804|NCT04624776|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65492805|NCT04624776|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65492806|NCT04624776|Prednisolone|prednisolone|mesh-list
65492807|NCT04624776|Prednisolone acetate|prednisolone acetate|mesh-list
65492808|NCT04624776|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65492809|NCT04624776|Prednisolone phosphate|prednisolone phosphate|mesh-list
65492810|NCT04624776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65492811|NCT04624776|Antiemetics|antiemetics|mesh-ancestor
65492812|NCT04624776|Autonomic Agents|autonomic agents|mesh-ancestor
65492813|NCT04624776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65492814|NCT04624776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492815|NCT04624776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65492816|NCT04624776|Glucocorticoids|glucocorticoids|mesh-ancestor
65492817|NCT04624776|Hormones|hormones|mesh-ancestor
65492818|NCT04624776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65492819|NCT04624776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65492820|NCT04624776|Protective Agents|protective agents|mesh-ancestor
65492821|NCT04624776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65492822|NCT04624776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65492823|NCT01234896|Nicotine|nicotine|mesh-list
65492824|NCT01234896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65492825|NCT01234896|Autonomic Agents|autonomic agents|mesh-ancestor
65492826|NCT01234896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65492827|NCT01234896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492828|NCT01234896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65492829|NCT01234896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65492830|NCT01234896|Cholinergic Agents|cholinergic agents|mesh-ancestor
65492833|NCT01238094|Simvastatin|simvastatin|mesh-list
65492848|NCT01236612|Antimalarials|antimalarials|mesh-ancestor
65492849|NCT01236612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65492850|NCT01236612|Antimetabolites|antimetabolites|mesh-ancestor
65492851|NCT01236612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492852|NCT03633630|Magnesium Oxide|magnesium oxide|mesh-list
65492853|NCT03633630|Antacids|antacids|mesh-ancestor
65492854|NCT03633630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492855|NCT03633630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65492856|NCT01234974|Everolimus|everolimus|mesh-list
65492857|NCT01234974|Pasireotide|pasireotide|mesh-list
65492858|NCT01234974|Somatostatin|somatostatin|mesh-list
65492859|NCT01234974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65492860|NCT01234974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65492861|NCT01234974|Immunologic Factors|immunologic factors|mesh-ancestor
65492862|NCT01234974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492863|NCT01234974|Hormones|hormones|mesh-ancestor
65492864|NCT01234974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65492865|NCT01140984|Methylprednisolone|methylprednisolone|mesh-list
65492866|NCT01140984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65492867|NCT01140984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65492868|NCT01140984|Prednisolone|prednisolone|mesh-list
65492869|NCT01140984|Prednisolone acetate|prednisolone acetate|mesh-list
65492870|NCT01140984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65492871|NCT01140984|Prednisolone phosphate|prednisolone phosphate|mesh-list
65492872|NCT01140984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65492873|NCT01140984|Antiemetics|antiemetics|mesh-ancestor
65492874|NCT01140984|Autonomic Agents|autonomic agents|mesh-ancestor
65492875|NCT01140984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65492876|NCT01140984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492877|NCT01140984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65492878|NCT01140984|Glucocorticoids|glucocorticoids|mesh-ancestor
65492879|NCT01140984|Hormones|hormones|mesh-ancestor
65492880|NCT01140984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65492881|NCT01140984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65492882|NCT01140984|Protective Agents|protective agents|mesh-ancestor
65492883|NCT01140984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65492885|NCT01145430|Doxorubicin|doxorubicin|mesh-list
65492886|NCT01145430|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65492887|NCT01145430|Veliparib|veliparib|mesh-list
65492888|NCT01145430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65492889|NCT01145430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65492890|NCT01145430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65492891|NCT01145430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65492892|NCT01145430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492893|NCT01145430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492894|NCT01145430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65492895|NCT03389724|Captopril|captopril|mesh-list
65492896|NCT03389724|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65492897|NCT03389724|Protease Inhibitors|protease inhibitors|mesh-ancestor
65492898|NCT03389724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492899|NCT03389724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492900|NCT03389724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65492901|NCT01586052|Epoetin Alfa|epoetin alfa|mesh-list
65492902|NCT01586052|Hematinics|hematinics|mesh-ancestor
65492903|NCT03684564|Warfarin|warfarin|mesh-list
65492904|NCT03684564|Rivaroxaban|rivaroxaban|mesh-list
65492905|NCT03684564|Anticoagulants|anticoagulants|mesh-ancestor
65492906|NCT03684564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65492907|NCT03684564|Antithrombins|antithrombins|mesh-ancestor
65492908|NCT03684564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65492909|NCT03684564|Protease Inhibitors|protease inhibitors|mesh-ancestor
65492910|NCT03684564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65242444|NCT03816163|Gemcitabine|gemcitabine|mesh-list
65492911|NCT03684564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492912|NCT05796752|Memantine|memantine|mesh-list
65492913|NCT05796752|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65492914|NCT05796752|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65492915|NCT05796752|Dopamine Agents|dopamine agents|mesh-ancestor
65492929|NCT05796362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65492930|NCT05796362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492931|NCT05796115|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65492932|NCT05796115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65492933|NCT05796115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492934|NCT05796115|Antitubercular Agents|antitubercular agents|mesh-ancestor
65492935|NCT05795946|Vitamin D|vitamin d|mesh-list
65492936|NCT05795946|Vitamins|vitamins|mesh-ancestor
65492937|NCT05795946|Micronutrients|micronutrients|mesh-ancestor
65492938|NCT05795946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492939|NCT05795946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65492940|NCT05795920|Gemcitabine|gemcitabine|mesh-list
65492941|NCT05795920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65492942|NCT05795920|Antimetabolites|antimetabolites|mesh-ancestor
65492943|NCT05795920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492944|NCT05795920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65492945|NCT05795920|Antiviral Agents|antiviral agents|mesh-ancestor
65492946|NCT05795920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65492947|NCT05795920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492948|NCT05795920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65492949|NCT05795920|Immunologic Factors|immunologic factors|mesh-ancestor
65492950|NCT05795920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492951|NCT05795647|Tocopherols|tocopherols|mesh-list
65492952|NCT05795647|Vitamin E|vitamin e|mesh-list
65492953|NCT05795647|Tocotrienols|tocotrienols|mesh-list
65492954|NCT05795647|alpha-Tocopherol|alpha-tocopherol|mesh-list
65492955|NCT05795647|Pentoxifylline|pentoxifylline|mesh-list
65492956|NCT05795647|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65492957|NCT05795647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65492958|NCT05795647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492959|NCT05795647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65492960|NCT05795647|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65492961|NCT05795647|Protective Agents|protective agents|mesh-ancestor
65492962|NCT05795647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492963|NCT05795647|Vasodilator Agents|vasodilator agents|mesh-ancestor
64500426|NCT01497496|Prednisolone acetate|prednisolone acetate|mesh-list
64500429|NCT01497496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64500430|NCT01497496|Prednisolone phosphate|prednisolone phosphate|mesh-list
64500431|NCT01497496|Immunologic Factors|immunologic factors|mesh-ancestor
64500432|NCT01497496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419368|NCT05523037|Anesthetics, General|anesthetics, general|mesh-ancestor
65492964|NCT05795647|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65492965|NCT05795647|Antioxidants|antioxidants|mesh-ancestor
65492966|NCT05795647|Vitamins|vitamins|mesh-ancestor
65492967|NCT05795647|Micronutrients|micronutrients|mesh-ancestor
65492968|NCT05795517|Ezetimibe|ezetimibe|mesh-list
65492969|NCT05795517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65492970|NCT05795517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65492971|NCT05795517|Antimetabolites|antimetabolites|mesh-ancestor
65492972|NCT05795517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492973|NCT05795517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65492974|NCT05795504|Vitamin D|vitamin d|mesh-list
65492975|NCT05795504|Calcium|calcium|mesh-list
65492976|NCT05795504|Vitamins|vitamins|mesh-ancestor
65492977|NCT05795504|Micronutrients|micronutrients|mesh-ancestor
65492978|NCT05795504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492979|NCT05795504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65492980|NCT05795504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65492981|NCT05795478|Pregabalin|pregabalin|mesh-list
65492982|NCT05795478|Oxycodone|oxycodone|mesh-list
65492983|NCT05795478|Analgesics|analgesics|mesh-ancestor
65492984|NCT05795478|Sensory System Agents|sensory system agents|mesh-ancestor
65492985|NCT05795478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65492986|NCT05795478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65492987|NCT05795478|Anticonvulsants|anticonvulsants|mesh-ancestor
65492988|NCT05795478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65492989|NCT05795478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65492990|NCT05795478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65492991|NCT05795478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65492992|NCT05795478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65493011|NCT05795309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65493012|NCT05795309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493013|NCT05795283|Dexetimide|dexetimide|mesh-list
65493014|NCT05795283|Citalopram|citalopram|mesh-list
65493015|NCT05795283|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65493016|NCT05795283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65493017|NCT05795283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65493018|NCT05795283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493019|NCT05795283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65493020|NCT05795283|Serotonin Agents|serotonin agents|mesh-ancestor
65493021|NCT05795283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493022|NCT05795283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65493023|NCT05795283|Antidepressive Agents|antidepressive agents|mesh-ancestor
65493024|NCT05795283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65493025|NCT05795283|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65493026|NCT05795283|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65493027|NCT05795283|Parasympatholytics|parasympatholytics|mesh-ancestor
65493028|NCT05795283|Autonomic Agents|autonomic agents|mesh-ancestor
65493029|NCT05795283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65493030|NCT05795283|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65493031|NCT05795283|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65493032|NCT05795283|Cholinergic Agents|cholinergic agents|mesh-ancestor
65493033|NCT05795244|Nivolumab|nivolumab|mesh-list
65493034|NCT05795244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65493035|NCT05795244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493036|NCT05795244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65493037|NCT05795244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493038|NCT05795101|Trastuzumab|trastuzumab|mesh-list
65493058|NCT05794997|Adrenergic Agents|adrenergic agents|mesh-ancestor
65493059|NCT05794997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65493060|NCT05794997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493061|NCT05794997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493062|NCT05794997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65493063|NCT05794997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65493064|NCT05794997|Vasodilator Agents|vasodilator agents|mesh-ancestor
65493065|NCT05794997|Antioxidants|antioxidants|mesh-ancestor
65493066|NCT05794997|Protective Agents|protective agents|mesh-ancestor
65493067|NCT05794997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65493068|NCT05794997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65493069|NCT05794997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65493070|NCT05794997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65493071|NCT05794997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65493072|NCT05794997|Sympatholytics|sympatholytics|mesh-ancestor
65493117|NCT05794581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65493118|NCT05794555|Lactulose|lactulose|mesh-list
65493119|NCT05794555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65493120|NCT05794477|Paclitaxel|paclitaxel|mesh-list
65493121|NCT05794477|Carboplatin|carboplatin|mesh-list
65493190|NCT05702359|Micronutrients|micronutrients|mesh-ancestor
65493191|NCT05702359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493192|NCT05702359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65493193|NCT05702359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65493194|NCT05700630|Vorinostat|vorinostat|mesh-list
65493195|NCT05700630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493196|NCT05700630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65493197|NCT05700630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493198|NCT05700630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493199|NCT05690503|Ketamine|ketamine|mesh-list
65493200|NCT05690503|Analgesics|analgesics|mesh-ancestor
65493201|NCT05690503|Sensory System Agents|sensory system agents|mesh-ancestor
65493202|NCT05690503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65493203|NCT05690503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493204|NCT05690503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65493205|NCT05690503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65493206|NCT05690503|Anesthetics, General|anesthetics, general|mesh-ancestor
65493207|NCT05690503|Anesthetics|anesthetics|mesh-ancestor
65493208|NCT05690503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65493209|NCT05690503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65493242|NCT05663515|Incretins|incretins|mesh-ancestor
65493243|NCT05663515|Hormones|hormones|mesh-ancestor
65493244|NCT05663515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65493245|NCT05660967|Lenalidomide|lenalidomide|mesh-list
65493246|NCT05660967|Immunologic Factors|immunologic factors|mesh-ancestor
65493247|NCT05660967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493248|NCT05660967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65493249|NCT05660967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65493250|NCT05660967|Growth Substances|growth substances|mesh-ancestor
65493251|NCT05660967|Growth Inhibitors|growth inhibitors|mesh-ancestor
65493252|NCT05660967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493253|NCT05656742|Vitamin D|vitamin d|mesh-list
65493254|NCT05656742|Vitamins|vitamins|mesh-ancestor
65493255|NCT05656742|Micronutrients|micronutrients|mesh-ancestor
65493256|NCT05656742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493257|NCT05656742|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65493258|NCT05624606|Vaccines|vaccines|mesh-list
65493259|NCT05624606|Immunologic Factors|immunologic factors|mesh-ancestor
65493260|NCT05624606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493261|NCT05608070|Oxytocin|oxytocin|mesh-list
65493262|NCT05608070|Oxytocics|oxytocics|mesh-ancestor
65493299|NCT05477459|Serotonin Agents|serotonin agents|mesh-ancestor
65493300|NCT05477459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65493301|NCT05477459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493302|NCT05477459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65493303|NCT05426486|Carboplatin|carboplatin|mesh-list
65493305|NCT05426486|Trastuzumab|trastuzumab|mesh-list
65493306|NCT05426486|Pertuzumab|pertuzumab|mesh-list
65493307|NCT05426486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493308|NCT05426486|Tubulin Modulators|tubulin modulators|mesh-ancestor
65493309|NCT05426486|Antimitotic Agents|antimitotic agents|mesh-ancestor
65493310|NCT05426486|Mitosis Modulators|mitosis modulators|mesh-ancestor
65493311|NCT05426486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493312|NCT05426486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65493313|NCT05399290|Doxycycline|doxycycline|mesh-list
65493314|NCT05399290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65493315|NCT05399290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65493316|NCT05399290|Antimalarials|antimalarials|mesh-ancestor
65493317|NCT05399290|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65493318|NCT05399290|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65493319|NCT05389852|Dexmedetomidine|dexmedetomidine|mesh-list
65493320|NCT05389852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65493321|NCT05389852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65493322|NCT05389852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493323|NCT05389852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65493324|NCT05389852|Analgesics|analgesics|mesh-ancestor
65493325|NCT05389852|Sensory System Agents|sensory system agents|mesh-ancestor
65493326|NCT05389852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65493327|NCT05389852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65493328|NCT05389852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65493346|NCT05383495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65493347|NCT05383495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493348|NCT05383495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65493349|NCT05383495|Analgesics|analgesics|mesh-ancestor
65493350|NCT05383495|Sensory System Agents|sensory system agents|mesh-ancestor
65493351|NCT05383495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65493352|NCT05383495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65493353|NCT05383495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65493354|NCT05383495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65493355|NCT05383495|Adrenergic Agents|adrenergic agents|mesh-ancestor
65493356|NCT05383495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65493357|NCT05383495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493358|NCT05383495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65493359|NCT05383495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65493360|NCT05383495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65493361|NCT05383495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65493362|NCT05383495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65493363|NCT05383495|Anesthetics, General|anesthetics, general|mesh-ancestor
65493364|NCT05383495|Anesthetics|anesthetics|mesh-ancestor
65493365|NCT05383495|GABA Modulators|gaba modulators|mesh-ancestor
65493366|NCT05383495|GABA Agents|gaba agents|mesh-ancestor
65493367|NCT05383495|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65493368|NCT05352828|Nivolumab|nivolumab|mesh-list
65493369|NCT05352828|Fludarabine|fludarabine|mesh-list
65493370|NCT05352828|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65493371|NCT05352828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65493372|NCT05352828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493373|NCT05352828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65493374|NCT05352828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493375|NCT05352828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65493376|NCT05352828|Alkylating Agents|alkylating agents|mesh-ancestor
65493378|NCT05318469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65493379|NCT05318469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65493380|NCT05318248|Clonidine|clonidine|mesh-list
65493381|NCT05318248|Analgesics|analgesics|mesh-ancestor
65493382|NCT05318248|Sensory System Agents|sensory system agents|mesh-ancestor
65493385|NCT05318248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65493386|NCT05318248|Sympatholytics|sympatholytics|mesh-ancestor
65493387|NCT05318248|Autonomic Agents|autonomic agents|mesh-ancestor
65493388|NCT05318248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65493389|NCT05318248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65493390|NCT05318248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65493391|NCT05318248|Adrenergic Agents|adrenergic agents|mesh-ancestor
65493392|NCT05318248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65493393|NCT05318248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493394|NCT05294965|Fenoterol|fenoterol|mesh-list
65493395|NCT05294965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65493396|NCT05294965|Autonomic Agents|autonomic agents|mesh-ancestor
65493397|NCT05294965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65493398|NCT05294965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493399|NCT05294965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65493400|NCT05294965|Respiratory System Agents|respiratory system agents|mesh-ancestor
65493401|NCT05294965|Sympathomimetics|sympathomimetics|mesh-ancestor
65493402|NCT05294965|Tocolytic Agents|tocolytic agents|mesh-ancestor
65493403|NCT05294965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65493404|NCT05294965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65493405|NCT05294965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65493406|NCT05294965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65493407|NCT05294965|Adrenergic Agents|adrenergic agents|mesh-ancestor
65493408|NCT05294965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65493409|NCT05294965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493410|NCT05290493|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
65493411|NCT05290493|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
65493412|NCT05290493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493413|NCT05290493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493414|NCT05287256|Dronabinol|dronabinol|mesh-list
65493415|NCT05287256|Hallucinogens|hallucinogens|mesh-ancestor
65493425|NCT05287256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493426|NCT05287256|Hormones|hormones|mesh-ancestor
65493427|NCT05287256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65493428|NCT05269355|Dacarbazine|dacarbazine|mesh-list
65493429|NCT05269355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65493430|NCT05269355|Alkylating Agents|alkylating agents|mesh-ancestor
65493431|NCT05269355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493432|NCT05269355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493433|NCT05252390|Olaparib|olaparib|mesh-list
65493434|NCT05252390|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65493435|NCT05252390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493436|NCT05252390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493437|NCT05252390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493438|NCT05219266|Midostaurin|midostaurin|mesh-list
65493439|NCT05219266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493440|NCT05219266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65493441|NCT05219266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493442|NCT05219266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493443|NCT05204862|Antibodies|antibodies|mesh-list
65493444|NCT05204862|Immunologic Factors|immunologic factors|mesh-ancestor
65493445|NCT05204862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493446|NCT05195918|Pirfenidone|pirfenidone|mesh-list
65493447|NCT05195918|Nintedanib|nintedanib|mesh-list
65493448|NCT05195918|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65493449|NCT05195918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493450|NCT05195918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65493451|NCT05195918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493452|NCT05195918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493453|NCT05195918|Analgesics|analgesics|mesh-ancestor
65493454|NCT05195918|Sensory System Agents|sensory system agents|mesh-ancestor
65493455|NCT05195918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65493465|NCT05195918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65493466|NCT05193851|Ricolinostat|ricolinostat|mesh-list
65493467|NCT05193851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493468|NCT05193851|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65493469|NCT05193851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493470|NCT05193851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493471|NCT05193318|Ketamine|ketamine|mesh-list
65493472|NCT05193318|Analgesics|analgesics|mesh-ancestor
65493473|NCT05193318|Sensory System Agents|sensory system agents|mesh-ancestor
65493474|NCT05193318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65493475|NCT05193318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493476|NCT05193318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65493477|NCT05193318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65493478|NCT05193318|Anesthetics, General|anesthetics, general|mesh-ancestor
65493479|NCT05193318|Anesthetics|anesthetics|mesh-ancestor
65493480|NCT05193318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65493481|NCT05193318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65493482|NCT05193318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65493483|NCT05193318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65493519|NCT05113251|Tubulin Modulators|tubulin modulators|mesh-ancestor
65493520|NCT05113251|Antimitotic Agents|antimitotic agents|mesh-ancestor
65493521|NCT05113251|Mitosis Modulators|mitosis modulators|mesh-ancestor
65493522|NCT05113251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493523|NCT05113251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65493524|NCT05113251|Immunologic Factors|immunologic factors|mesh-ancestor
65493525|NCT05113251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493526|NCT05113251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65493527|NCT05113251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65493528|NCT05113251|Alkylating Agents|alkylating agents|mesh-ancestor
65493529|NCT05113251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65493530|NCT05113251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65493531|NCT05113251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65493532|NCT05113251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65493533|NCT05113251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493534|NCT05113251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65493535|NCT05112666|Rivaroxaban|rivaroxaban|mesh-list
65493546|NCT05047211|Dextrans|dextrans|mesh-list
65493575|NCT05046132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493576|NCT05046132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493577|NCT05043090|Durvalumab|durvalumab|mesh-list
65493578|NCT05043090|Sunitinib|sunitinib|mesh-list
65493579|NCT05043090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65493580|NCT05043090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493581|NCT05043090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65493582|NCT05043090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65493583|NCT05043090|Growth Substances|growth substances|mesh-ancestor
65493584|NCT05043090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493585|NCT05043090|Growth Inhibitors|growth inhibitors|mesh-ancestor
65493587|NCT05043090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493640|NCT04630769|Analgesics|analgesics|mesh-ancestor
65493641|NCT04630769|Sensory System Agents|sensory system agents|mesh-ancestor
65493642|NCT04630769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65493643|NCT04630769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493644|NCT04622007|Pembrolizumab|pembrolizumab|mesh-list
65493645|NCT04622007|Pemetrexed|pemetrexed|mesh-list
65493646|NCT04622007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65493647|NCT04622007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493648|NCT04622007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493649|NCT04622007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493650|NCT04622007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65493651|NCT04622007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65493652|NCT04606446|Letrozole|letrozole|mesh-list
65493653|NCT04606446|Fulvestrant|fulvestrant|mesh-list
65493654|NCT04606446|Palbociclib|palbociclib|mesh-list
65493655|NCT04606446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493656|NCT04606446|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65493657|NCT04606446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65493658|NCT04606446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493659|NCT04606446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493660|NCT04606446|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65493661|NCT04606446|Hormone Antagonists|hormone antagonists|mesh-ancestor
65493662|NCT04606446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65493663|NCT04606446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493664|NCT04606446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65493665|NCT04606446|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65493666|NCT04606446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65493667|NCT04565236|Factor VIII|factor viii|mesh-list
65493668|NCT04565236|Coagulants|coagulants|mesh-ancestor
65493669|NCT04559139|Gemcitabine|gemcitabine|mesh-list
65493670|NCT04559139|Cisplatin|cisplatin|mesh-list
65493671|NCT04559139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493672|NCT04559139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65493673|NCT04559139|Antimetabolites|antimetabolites|mesh-ancestor
65493675|NCT04559139|Antiviral Agents|antiviral agents|mesh-ancestor
65493679|NCT04559139|Immunologic Factors|immunologic factors|mesh-ancestor
65493680|NCT04559139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493681|NCT04550377|Cannabidiol|cannabidiol|mesh-list
65493682|NCT04550377|Anticonvulsants|anticonvulsants|mesh-ancestor
65493683|NCT04543188|Midazolam|midazolam|mesh-list
65493684|NCT04543188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65493685|NCT04543188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65493686|NCT04543188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65493687|NCT04543188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493688|NCT04543188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65493689|NCT04543188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65493690|NCT04543188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65493691|NCT04543188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65493692|NCT04543188|Anesthetics, General|anesthetics, general|mesh-ancestor
65493693|NCT04543188|Anesthetics|anesthetics|mesh-ancestor
65493694|NCT04543188|GABA Modulators|gaba modulators|mesh-ancestor
65493695|NCT04543188|GABA Agents|gaba agents|mesh-ancestor
65493696|NCT04543188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65493697|NCT04543188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493698|NCT04541589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65493699|NCT04541589|Immunologic Factors|immunologic factors|mesh-ancestor
65493700|NCT04541589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493701|NCT04499950|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
65493702|NCT04499950|Naltrexone|naltrexone|mesh-list
65493703|NCT04499950|Bupropion|bupropion|mesh-list
65493704|NCT04499950|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65493705|NCT04499950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65493706|NCT04499950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493707|NCT04499950|Sensory System Agents|sensory system agents|mesh-ancestor
65493708|NCT04499950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65493709|NCT04499950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65493710|NCT04499950|Antidepressive Agents|antidepressive agents|mesh-ancestor
65493711|NCT04499950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65493712|NCT04499950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65493713|NCT04499950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65493714|NCT04499950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64877219|NCT01884506|Antioxidants|antioxidants|mesh-ancestor
64500451|NCT02208310|Cholecalciferol|cholecalciferol|mesh-list
65493715|NCT04499950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493716|NCT04499950|Dopamine Agents|dopamine agents|mesh-ancestor
65493717|NCT04499950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65493718|NCT04499950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65493719|NCT04499950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65493720|NCT04499950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493721|NCT04499950|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65493722|NCT04477512|Prednisone|prednisone|mesh-list
65493723|NCT04477512|Nivolumab|nivolumab|mesh-list
65493724|NCT04477512|Abiraterone Acetate|abiraterone acetate|mesh-list
65493725|NCT04477512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65493726|NCT04477512|Glucocorticoids|glucocorticoids|mesh-ancestor
65493727|NCT04477512|Hormones|hormones|mesh-ancestor
65493728|NCT04477512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65493729|NCT04477512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493730|NCT04477512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65493731|NCT04477512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493732|NCT04477512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65493733|NCT04477512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65493734|NCT04477512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493740|NCT04459273|FAPI-46|fapi-46|mesh-list
65493767|NCT04349124|Vasodilator Agents|vasodilator agents|mesh-ancestor
65493768|NCT04349124|Tocolytic Agents|tocolytic agents|mesh-ancestor
65493769|NCT04349124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65493770|NCT04348292|Sirolimus|sirolimus|mesh-list
65493771|NCT04348292|Durvalumab|durvalumab|mesh-list
65493772|NCT04348292|Immunoglobulins|immunoglobulins|mesh-list
65493773|NCT04348292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65493774|NCT04348292|Immunoglobulin G|immunoglobulin g|mesh-list
65493775|NCT04348292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65493776|NCT04348292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65493777|NCT04348292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65493778|NCT04348292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493779|NCT04348292|Antifungal Agents|antifungal agents|mesh-ancestor
65493780|NCT04348292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65493781|NCT04348292|Immunologic Factors|immunologic factors|mesh-ancestor
65493782|NCT04348292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493783|NCT04348292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65493784|NCT04316676|Regadenoson|regadenoson|mesh-list
65493785|NCT04316676|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65493786|NCT04316676|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65493787|NCT04316676|Purinergic Agonists|purinergic agonists|mesh-ancestor
65493788|NCT04316676|Purinergic Agents|purinergic agents|mesh-ancestor
65493789|NCT04316676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65493790|NCT04316676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493791|NCT04316676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877307|NCT01884935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877308|NCT01885013|Metformin|metformin|mesh-list
64877309|NCT01885013|Cyclophosphamide|cyclophosphamide|mesh-list
64877310|NCT01885013|Doxorubicin|doxorubicin|mesh-list
64500453|NCT02208310|Micronutrients|micronutrients|mesh-ancestor
64500454|NCT02208310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500455|NCT02208310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64500456|NCT02208310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64500457|NCT01454362|Nicotine|nicotine|mesh-list
64724079|NCT00000763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64463354|NCT01929382|Antiviral Agents|antiviral agents|mesh-ancestor
64724080|NCT00000763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64724081|NCT00000763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64724082|NCT00000763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64724083|NCT00000763|Growth Substances|growth substances|mesh-ancestor
64724084|NCT00000763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724085|NCT00000763|Growth Inhibitors|growth inhibitors|mesh-ancestor
64724086|NCT00380263|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
64724087|NCT00380263|Growth Substances|growth substances|mesh-ancestor
64724088|NCT00380263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724089|NCT00380263|Vasodilator Agents|vasodilator agents|mesh-ancestor
65493792|NCT04291703|Thymoglobulin|thymoglobulin|mesh-list
65493793|NCT04291703|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65493794|NCT04291703|Immunologic Factors|immunologic factors|mesh-ancestor
65493795|NCT04291703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493796|NCT04291703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65493797|NCT04248452|Calcium, Dietary|calcium, dietary|mesh-list
65493798|NCT04248452|Leucovorin|leucovorin|mesh-list
65493799|NCT04248452|Folic Acid|folic acid|mesh-list
65493800|NCT04248452|Fluorouracil|fluorouracil|mesh-list
65493801|NCT04248452|Capecitabine|capecitabine|mesh-list
65493802|NCT04248452|Oxaliplatin|oxaliplatin|mesh-list
65493803|NCT04248452|Calcium|calcium|mesh-list
65493804|NCT04248452|Levoleucovorin|levoleucovorin|mesh-list
65493805|NCT04248452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65493806|NCT04248452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493807|NCT04248452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65493808|NCT04248452|Antimetabolites|antimetabolites|mesh-ancestor
65493809|NCT04248452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493810|NCT04248452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65493811|NCT04248452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493813|NCT04248452|Immunologic Factors|immunologic factors|mesh-ancestor
65012584|NCT04510207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012585|NCT00163137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65012586|NCT00163137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65012587|NCT00163137|Hormone Antagonists|hormone antagonists|mesh-ancestor
65012588|NCT00163137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65012589|NCT00163137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012590|NCT00163137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65012591|NCT00163137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65012592|NCT00163137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65012593|NCT00142883|Pregabalin|pregabalin|mesh-list
65012594|NCT00142883|Analgesics|analgesics|mesh-ancestor
65012595|NCT00142883|Sensory System Agents|sensory system agents|mesh-ancestor
65012596|NCT00142883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65012597|NCT00142883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012598|NCT00142883|Anticonvulsants|anticonvulsants|mesh-ancestor
65012599|NCT00142883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65012600|NCT00142883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65012601|NCT00142883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012602|NCT00142883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65012603|NCT00142883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65012604|NCT00142883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65012605|NCT00142883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65012606|NCT00142883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65012607|NCT04512430|Bevacizumab|bevacizumab|mesh-list
65012608|NCT04512430|Carboplatin|carboplatin|mesh-list
65012609|NCT04512430|Pemetrexed|pemetrexed|mesh-list
65012610|NCT04512430|Atezolizumab|atezolizumab|mesh-list
65012611|NCT04512430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65012622|NCT04517851|Elotuzumab|elotuzumab|mesh-list
65012628|NCT04515238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65012629|NCT04515238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65012630|NCT04515238|Alkylating Agents|alkylating agents|mesh-ancestor
65012631|NCT04515238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012632|NCT04515238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65012633|NCT04515238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65012634|NCT04515238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012635|NCT00142961|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65012636|NCT00142961|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65012637|NCT00142961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65012638|NCT00142961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65012639|NCT00142961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012640|NCT00142961|Adrenergic Agents|adrenergic agents|mesh-ancestor
65012641|NCT00142961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65012642|NCT00142961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012643|NCT00163254|Abciximab|abciximab|mesh-list
65012644|NCT00163254|Anticoagulants|anticoagulants|mesh-ancestor
65012645|NCT00163254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65012646|NCT00143000|Ribavirin|ribavirin|mesh-list
65012647|NCT00143000|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65012648|NCT00143000|Antimetabolites|antimetabolites|mesh-ancestor
65012649|NCT00143000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012650|NCT00143000|Antiviral Agents|antiviral agents|mesh-ancestor
65012651|NCT00143000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65012652|NCT04514029|Dexamethasone|dexamethasone|mesh-list
65012675|NCT02590393|Autonomic Agents|autonomic agents|mesh-ancestor
65012676|NCT02590393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65012677|NCT02590393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012678|NCT02590393|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65012679|NCT02590393|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65012680|NCT02590393|Cholinergic Agents|cholinergic agents|mesh-ancestor
65012681|NCT02590393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65012682|NCT02590393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012683|NCT00506506|Acetylcysteine|acetylcysteine|mesh-list
65012684|NCT00506506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65012685|NCT00506506|Antiviral Agents|antiviral agents|mesh-ancestor
65012686|NCT00506506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65012687|NCT00506506|Expectorants|expectorants|mesh-ancestor
65012688|NCT00506506|Respiratory System Agents|respiratory system agents|mesh-ancestor
65012689|NCT00506506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65012690|NCT00506506|Antioxidants|antioxidants|mesh-ancestor
65012691|NCT00506506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012692|NCT00506506|Protective Agents|protective agents|mesh-ancestor
65012693|NCT00506506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012694|NCT00506506|Antidotes|antidotes|mesh-ancestor
65012695|NCT02594254|Anti-Infective Agents|anti-infective agents|mesh-list
65012696|NCT02594254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65012697|NCT00163332|Ciclesonide|ciclesonide|mesh-list
65012698|NCT00163332|Glucocorticoids|glucocorticoids|mesh-ancestor
65012699|NCT00163332|Hormones|hormones|mesh-ancestor
65012700|NCT00163332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65012701|NCT00163332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012702|NCT00163332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65012703|NCT00163371|Ciclesonide|ciclesonide|mesh-list
65012704|NCT00163371|Glucocorticoids|glucocorticoids|mesh-ancestor
64453738|NCT01436110|Xhance|xhance|mesh-list
65012705|NCT00163371|Hormones|hormones|mesh-ancestor
65066954|NCT00308178|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65012706|NCT00163371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65012707|NCT00163371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012708|NCT00163371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65012710|NCT00143156|Analgesics|analgesics|mesh-ancestor
65012711|NCT00143156|Sensory System Agents|sensory system agents|mesh-ancestor
65012712|NCT00143156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65012713|NCT00143156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012714|NCT00143156|Anticonvulsants|anticonvulsants|mesh-ancestor
65012715|NCT00143156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65012716|NCT00143156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65012717|NCT00143156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012718|NCT00143156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65012719|NCT00143156|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65012720|NCT00143156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65012723|NCT00163410|Ciclesonide|ciclesonide|mesh-list
65012770|NCT00143351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012771|NCT00143351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65012772|NCT00143351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65012773|NCT00143351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65012774|NCT00143351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65012775|NCT00143351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65012776|NCT00143351|Dopamine Agents|dopamine agents|mesh-ancestor
65012777|NCT00163605|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65012778|NCT00163605|Thrombin|thrombin|mesh-list
65012779|NCT00163605|Calcium|calcium|mesh-list
65012780|NCT00163605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65012781|NCT00163605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012782|NCT00163605|Hemostatics|hemostatics|mesh-ancestor
65012783|NCT00163605|Coagulants|coagulants|mesh-ancestor
65012784|NCT02598583|Ravulizumab|ravulizumab|mesh-list
65012785|NCT02598583|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65012786|NCT02598583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65012787|NCT02598583|Immunologic Factors|immunologic factors|mesh-ancestor
65012788|NCT02598583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012789|NCT00143429|Latanoprost|latanoprost|mesh-list
65012790|NCT00143429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65012791|NCT00143429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65012792|NCT02598895|Carboplatin|carboplatin|mesh-list
65012793|NCT02598895|Docetaxel|docetaxel|mesh-list
65012794|NCT02598895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65012821|NCT00155883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65012822|NCT00155883|Immunologic Factors|immunologic factors|mesh-ancestor
65012823|NCT00155883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012824|NCT00155883|Antidotes|antidotes|mesh-ancestor
65012825|NCT00155883|Protective Agents|protective agents|mesh-ancestor
65012826|NCT00155883|Vitamin B Complex|vitamin b complex|mesh-ancestor
65012827|NCT00155883|Vitamins|vitamins|mesh-ancestor
65012828|NCT00155883|Micronutrients|micronutrients|mesh-ancestor
65012829|NCT00506545|Rolapitant|rolapitant|mesh-list
65012830|NCT00506545|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65012831|NCT00506545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65012832|NCT00506545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012833|NCT00506545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012834|NCT05143723|Hormones|hormones|mesh-list
65012835|NCT05143723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65012836|NCT05143723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012837|NCT00143624|Rosiglitazone|rosiglitazone|mesh-list
65012838|NCT00143624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65012839|NCT00143624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012840|NCT05142865|Carboplatin|carboplatin|mesh-list
65012841|NCT05142865|Etoposide|etoposide|mesh-list
65012842|NCT05142865|Apatinib|apatinib|mesh-list
65012843|NCT05142865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65012844|NCT05142865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65012873|NCT00156078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65012874|NCT00156078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65012875|NCT00156078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012876|NCT00156078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65012877|NCT00156078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65012878|NCT00156078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65012879|NCT00156078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65012880|NCT00156078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65012881|NCT00506623|Capecitabine|capecitabine|mesh-list
65012882|NCT00506623|Irinotecan|irinotecan|mesh-list
65012883|NCT00506623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65012884|NCT00506623|Antimetabolites|antimetabolites|mesh-ancestor
65012885|NCT00506623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012886|NCT00506623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65012887|NCT00506623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65012888|NCT00506623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65012889|NCT00506623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012890|NCT00143741|Atorvastatin|atorvastatin|mesh-list
65012891|NCT00143741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65012892|NCT00143741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65012893|NCT00143741|Antimetabolites|antimetabolites|mesh-ancestor
65012894|NCT00143741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012895|NCT00143741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65012896|NCT00143741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65012897|NCT00143741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012898|NCT00143780|Vaccines|vaccines|mesh-list
65012899|NCT00143780|Immunologic Factors|immunologic factors|mesh-ancestor
65012900|NCT00143780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012901|NCT02276365|Pioglitazone|pioglitazone|mesh-list
65012902|NCT02276365|Empagliflozin|empagliflozin|mesh-list
65012916|NCT00143975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65012917|NCT00143975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65012918|NCT00143975|Immunologic Factors|immunologic factors|mesh-ancestor
65012919|NCT00143975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012920|NCT00143975|Analgesics|analgesics|mesh-ancestor
65012921|NCT00143975|Sensory System Agents|sensory system agents|mesh-ancestor
65012922|NCT00143975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65012923|NCT00143975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65012924|NCT00143975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65012925|NCT00143975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012926|NCT00143975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65012927|NCT00156312|Docetaxel|docetaxel|mesh-list
65012928|NCT00156312|Capecitabine|capecitabine|mesh-list
65012935|NCT00156312|Antimetabolites|antimetabolites|mesh-ancestor
65012937|NCT00506701|Vasodilator Agents|vasodilator agents|mesh-ancestor
65012938|NCT00506701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65012939|NCT00506701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65012940|NCT00506701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012941|NCT00506701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012942|NCT00506701|Urological Agents|urological agents|mesh-ancestor
65012944|NCT05147857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65012945|NCT05147857|Abortifacient Agents|abortifacient agents|mesh-ancestor
65012946|NCT05147857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65012947|NCT05147857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012948|NCT05147857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65012949|NCT05147857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65012950|NCT05147857|Oxytocics|oxytocics|mesh-ancestor
65012951|NCT00144053|Paclitaxel|paclitaxel|mesh-list
65012952|NCT00144053|Vindesine|vindesine|mesh-list
65012953|NCT00144053|Carboplatin|carboplatin|mesh-list
65012954|NCT00144053|Irinotecan|irinotecan|mesh-list
65012970|NCT00144209|Benserazide|benserazide|mesh-list
65012971|NCT00144209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65012972|NCT00144209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65012973|NCT00144209|Dopamine Agents|dopamine agents|mesh-ancestor
65012974|NCT00144209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65012975|NCT00144209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012976|NCT00144209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012977|NCT00144209|Antioxidants|antioxidants|mesh-ancestor
65012978|NCT00144209|Protective Agents|protective agents|mesh-ancestor
65012979|NCT00144209|Dopamine Agonists|dopamine agonists|mesh-ancestor
65012980|NCT00144209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012988|NCT05149339|Cholecalciferol|cholecalciferol|mesh-list
65012989|NCT05149339|Vitamin D|vitamin d|mesh-list
65012990|NCT05149339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65012991|NCT05149339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012992|NCT05149339|Vitamins|vitamins|mesh-ancestor
65012993|NCT05149339|Micronutrients|micronutrients|mesh-ancestor
65012994|NCT05149339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65012995|NCT00144248|Nevirapine|nevirapine|mesh-list
65013034|NCT00144326|Cholinergic Agents|cholinergic agents|mesh-ancestor
65013035|NCT00144326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65013036|NCT00144326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013037|NCT00144326|Anticonvulsants|anticonvulsants|mesh-ancestor
65013038|NCT02954692|Metformin|metformin|mesh-list
65013039|NCT02954692|Insulin Glargine|insulin glargine|mesh-list
65013040|NCT02954692|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
65013041|NCT02954692|Meglitinide|meglitinide|mesh-list
65013042|NCT02954692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
65013043|NCT02954692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65013044|NCT02954692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013045|NCT02954692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013046|NCT02954692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013047|NCT00506935|Vigabatrin|vigabatrin|mesh-list
65013048|NCT00506935|Anticonvulsants|anticonvulsants|mesh-ancestor
65013049|NCT00506935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013050|NCT00506935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013051|NCT00506935|GABA Agents|gaba agents|mesh-ancestor
65013052|NCT00506935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65013053|NCT00506935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013054|NCT00144365|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65013055|NCT00144365|Antiviral Agents|antiviral agents|mesh-ancestor
65013056|NCT00144365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013057|NCT00506974|Sodium Oxybate|sodium oxybate|mesh-list
65013058|NCT00506974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65013059|NCT00506974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65013060|NCT00506974|Anesthetics, General|anesthetics, general|mesh-ancestor
65013061|NCT00506974|Anesthetics|anesthetics|mesh-ancestor
65013062|NCT00506974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65013063|NCT00506974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013078|NCT00507091|Leucovorin|leucovorin|mesh-list
65013080|NCT00507091|Irinotecan|irinotecan|mesh-list
64454062|NCT01970462|Incretins|incretins|mesh-ancestor
65013081|NCT00507091|Antimetabolites|antimetabolites|mesh-ancestor
65013082|NCT00507091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013083|NCT00507091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65013084|NCT00507091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013085|NCT00507091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65013086|NCT00507091|Immunologic Factors|immunologic factors|mesh-ancestor
65013087|NCT00507091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013088|NCT00507091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65013089|NCT00507091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65013090|NCT00507091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013091|NCT00507091|Antidotes|antidotes|mesh-ancestor
65013092|NCT00507091|Protective Agents|protective agents|mesh-ancestor
65013093|NCT00507091|Vitamin B Complex|vitamin b complex|mesh-ancestor
65013094|NCT00507091|Vitamins|vitamins|mesh-ancestor
65013095|NCT00507091|Micronutrients|micronutrients|mesh-ancestor
65013097|NCT05148910|Trace Elements|trace elements|mesh-ancestor
65013098|NCT05148910|Micronutrients|micronutrients|mesh-ancestor
65013099|NCT05148910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013100|NCT00148083|Risperidone|risperidone|mesh-list
65013101|NCT00148083|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65013102|NCT00148083|Serotonin Agents|serotonin agents|mesh-ancestor
65013103|NCT00148083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65013104|NCT00148083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013105|NCT00148083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013106|NCT00148083|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65013107|NCT00148083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65013109|NCT00148083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65013128|NCT05148169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013129|NCT00144482|Epoetin Alfa|epoetin alfa|mesh-list
65013130|NCT00144482|Hematinics|hematinics|mesh-ancestor
65013131|NCT05148754|Elsulfavirine|elsulfavirine|mesh-list
65013132|NCT05148754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65013133|NCT05148754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65013134|NCT05148754|Antiviral Agents|antiviral agents|mesh-ancestor
65013135|NCT05148754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013136|NCT00404729|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
65013137|NCT00404729|Nootropic Agents|nootropic agents|mesh-ancestor
65013138|NCT05146687|Bevacizumab|bevacizumab|mesh-list
65013139|NCT05146687|Ranibizumab|ranibizumab|mesh-list
65013140|NCT05146687|Aflibercept|aflibercept|mesh-list
65013141|NCT05146687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65013142|NCT05146687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013143|NCT05146687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65013144|NCT05146687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65013145|NCT05146687|Growth Substances|growth substances|mesh-ancestor
65013146|NCT05146687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013147|NCT05146687|Growth Inhibitors|growth inhibitors|mesh-ancestor
65013148|NCT05141422|Efavirenz|efavirenz|mesh-list
65013149|NCT05141422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65013150|NCT05141422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65013151|NCT05141422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013181|NCT05148637|Anesthetics, General|anesthetics, general|mesh-ancestor
65013182|NCT05148637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65013183|NCT05148637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65013184|NCT00148278|Dobutamine|dobutamine|mesh-list
65013185|NCT00148278|Epinephrine|epinephrine|mesh-list
65013186|NCT00148278|Norepinephrine|norepinephrine|mesh-list
65013187|NCT00148278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65013188|NCT00148278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65013189|NCT00148278|Adrenergic Agents|adrenergic agents|mesh-ancestor
65013190|NCT00148278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65013191|NCT00148278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013192|NCT00148278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013193|NCT00148278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65013194|NCT00148278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65013195|NCT00148278|Autonomic Agents|autonomic agents|mesh-ancestor
65013196|NCT00148278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65013197|NCT00148278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65013198|NCT00148278|Respiratory System Agents|respiratory system agents|mesh-ancestor
65013199|NCT00148278|Mydriatics|mydriatics|mesh-ancestor
65013200|NCT00148278|Sympathomimetics|sympathomimetics|mesh-ancestor
65013201|NCT00148278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65013202|NCT00148278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65013203|NCT00148278|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65013234|NCT05143762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65013264|NCT00148395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013265|NCT00148395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65013266|NCT00148395|Antimetabolites|antimetabolites|mesh-ancestor
65013267|NCT00148395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013268|NCT00148395|Antiviral Agents|antiviral agents|mesh-ancestor
65013269|NCT00148395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013270|NCT00148395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013271|NCT00148395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65013272|NCT00148395|Immunologic Factors|immunologic factors|mesh-ancestor
65013273|NCT00148395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013274|NCT00148395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65013275|NCT00148395|Alkylating Agents|alkylating agents|mesh-ancestor
65013276|NCT00148395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65013277|NCT00148395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65013278|NCT00148395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65013279|NCT00148395|Tubulin Modulators|tubulin modulators|mesh-ancestor
65013280|NCT00148395|Antimitotic Agents|antimitotic agents|mesh-ancestor
65013281|NCT00148395|Mitosis Modulators|mitosis modulators|mesh-ancestor
65013310|NCT02276677|Oxytocin|oxytocin|mesh-list
65013311|NCT02276677|Oxytocics|oxytocics|mesh-ancestor
65013312|NCT02276677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65013313|NCT02276677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013314|NCT05141344|Melatonin|melatonin|mesh-list
65013315|NCT05141344|Antioxidants|antioxidants|mesh-ancestor
65013316|NCT05141344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013317|NCT05141344|Protective Agents|protective agents|mesh-ancestor
65013318|NCT05141344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013319|NCT05141344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65013320|NCT00156858|Busulfan|busulfan|mesh-list
65013329|NCT03451825|Avelumab|avelumab|mesh-list
65013333|NCT03451825|Immunologic Factors|immunologic factors|mesh-ancestor
65013334|NCT03451825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013335|NCT00156897|Orlistat|orlistat|mesh-list
65013336|NCT00156897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013337|NCT00156897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013338|NCT00156897|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65013339|NCT00156897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65013340|NCT03459859|Cytarabine|cytarabine|mesh-list
65013341|NCT03459859|Pevonedistat|pevonedistat|mesh-list
65013342|NCT03459859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65013343|NCT03459859|Antimetabolites|antimetabolites|mesh-ancestor
65013344|NCT03459859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013345|NCT03459859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013346|NCT03459859|Antiviral Agents|antiviral agents|mesh-ancestor
65013347|NCT03459859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013348|NCT03459859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65013349|NCT03459859|Immunologic Factors|immunologic factors|mesh-ancestor
65013350|NCT03459859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013351|NCT03459859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013352|NCT05594459|Analgesics|analgesics|mesh-list
65013353|NCT05594459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013354|NCT05594459|Sensory System Agents|sensory system agents|mesh-ancestor
65013355|NCT05594459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65013356|NCT00507403|Infliximab|infliximab|mesh-list
65013357|NCT00507403|Dermatologic Agents|dermatologic agents|mesh-ancestor
65013358|NCT00507403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65013359|NCT00507403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65013360|NCT00156975|Capecitabine|capecitabine|mesh-list
65013361|NCT00156975|Oxaliplatin|oxaliplatin|mesh-list
65013362|NCT00156975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65013363|NCT00156975|Antimetabolites|antimetabolites|mesh-ancestor
65013364|NCT00156975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013365|NCT00156975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013366|NCT05594381|Oxaliplatin|oxaliplatin|mesh-list
65013367|NCT05594381|Tegafur|tegafur|mesh-list
65013368|NCT05594381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013369|NCT05594381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65013370|NCT05594381|Antimetabolites|antimetabolites|mesh-ancestor
65013371|NCT05594381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013372|NCT00148473|Misoprostol|misoprostol|mesh-list
65013373|NCT00148473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65013374|NCT00148473|Abortifacient Agents|abortifacient agents|mesh-ancestor
65013375|NCT00148473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65013376|NCT00148473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013377|NCT00148473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65013378|NCT00148473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65013379|NCT00148473|Oxytocics|oxytocics|mesh-ancestor
65013380|NCT00507637|Botulinum Toxins|botulinum toxins|mesh-list
65013381|NCT00507637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65013382|NCT00507637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65013383|NCT00507637|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65013384|NCT00507637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65013385|NCT00507637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65013386|NCT00507637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013387|NCT00507637|Cholinergic Agents|cholinergic agents|mesh-ancestor
65013388|NCT00507637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65013389|NCT00507637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013390|NCT00507637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65013391|NCT00507637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65013392|NCT05594342|Dobutamine|dobutamine|mesh-list
65013419|NCT00507793|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65013420|NCT00507793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65013421|NCT00507793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65013422|NCT00507793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013423|NCT00507832|Hydrocortisone|hydrocortisone|mesh-list
65013424|NCT00507832|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65013425|NCT00507832|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65013426|NCT00507832|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65013427|NCT00507832|Pimecrolimus|pimecrolimus|mesh-list
65013428|NCT00507832|Tacrolimus|tacrolimus|mesh-list
65013429|NCT00507832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65013430|NCT00507832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65013431|NCT00507832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65013432|NCT00507832|Analgesics|analgesics|mesh-ancestor
65013433|NCT00507832|Sensory System Agents|sensory system agents|mesh-ancestor
65013434|NCT00507832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65013435|NCT00507832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013436|NCT00507832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65013437|NCT00507832|Dermatologic Agents|dermatologic agents|mesh-ancestor
65013438|NCT00507832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65013439|NCT00507832|Immunologic Factors|immunologic factors|mesh-ancestor
65013440|NCT00507832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65013441|NCT00507832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013442|NCT00507832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013443|NCT00507949|Megestrol|megestrol|mesh-list
65013444|NCT00507949|Megestrol Acetate|megestrol acetate|mesh-list
65013445|NCT00507949|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65013446|NCT00507949|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65013447|NCT00507949|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65013448|NCT00507949|Contraceptive Agents|contraceptive agents|mesh-ancestor
65013449|NCT00507949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65013450|NCT00507949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013451|NCT00507949|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65013459|NCT00148551|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65013460|NCT00148551|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65013461|NCT00148551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65013462|NCT00148551|Glucocorticoids|glucocorticoids|mesh-ancestor
65013463|NCT00148551|Hormones|hormones|mesh-ancestor
65013464|NCT00148551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65013465|NCT00148551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013466|NCT00148551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65013467|NCT00148551|Immunologic Factors|immunologic factors|mesh-ancestor
65013468|NCT00148551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013469|NCT00148551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013470|NCT05594186|Tranexamic Acid|tranexamic acid|mesh-list
65013471|NCT05594186|Contraceptive Agents|contraceptive agents|mesh-list
65013472|NCT05594186|Levonorgestrel|levonorgestrel|mesh-list
65013473|NCT05594186|Contraceptives, Oral|contraceptives, oral|mesh-list
65013474|NCT05594186|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65013475|NCT05594186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65013476|NCT05594186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65013477|NCT05594186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013478|NCT05594186|Hemostatics|hemostatics|mesh-ancestor
65013479|NCT05594186|Coagulants|coagulants|mesh-ancestor
65013480|NCT05594186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65013492|NCT00148590|Memantine|memantine|mesh-list
65013510|NCT00508456|Temozolomide|temozolomide|mesh-list
65013511|NCT00508456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65013512|NCT00508456|Alkylating Agents|alkylating agents|mesh-ancestor
65013513|NCT00508456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013514|NCT00508456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013515|NCT00508495|Acetaminophen|acetaminophen|mesh-list
65013516|NCT00508495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65013517|NCT00508495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65013518|NCT00508495|Analgesics|analgesics|mesh-ancestor
65013519|NCT00508495|Sensory System Agents|sensory system agents|mesh-ancestor
65013520|NCT00508495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65013521|NCT00508495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013522|NCT00508495|Antipyretics|antipyretics|mesh-ancestor
65013523|NCT00508690|Metronidazole|metronidazole|mesh-list
65013524|NCT00508690|Kanamycin|kanamycin|mesh-list
65013525|NCT00508690|Cefmetazole|cefmetazole|mesh-list
65013526|NCT00508690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013527|NCT00508690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65013528|NCT00508690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65013529|NCT00508690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65013530|NCT00508690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65013531|NCT00508690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013532|NCT00508690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013533|NCT00148707|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
65013534|NCT00148707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013535|NCT05591144|Prednisone|prednisone|mesh-list
65493821|NCT04233866|Leucovorin|leucovorin|mesh-list
65493822|NCT04233866|Folic Acid|folic acid|mesh-list
65013536|NCT05591144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64454507|NCT01910402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65013537|NCT05591144|Glucocorticoids|glucocorticoids|mesh-ancestor
65013539|NCT05591144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65013540|NCT05591144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013541|NCT05591144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65013543|NCT02953522|Folic Acid|folic acid|mesh-list
65013551|NCT00148746|Pimecrolimus|pimecrolimus|mesh-list
65013552|NCT00148746|Prednicarbate|prednicarbate|mesh-list
65013553|NCT00148746|Tacrolimus|tacrolimus|mesh-list
65013554|NCT00148746|Cyclosporins|cyclosporins|mesh-list
65013555|NCT00148746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65013556|NCT00148746|Immunologic Factors|immunologic factors|mesh-ancestor
65013557|NCT00148746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013558|NCT00148746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65013559|NCT00148746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013560|NCT00148746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013561|NCT00148746|Antifungal Agents|antifungal agents|mesh-ancestor
65013562|NCT00148746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013563|NCT00148746|Dermatologic Agents|dermatologic agents|mesh-ancestor
65013564|NCT00148746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65013565|NCT00148746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65013566|NCT00148746|Glucocorticoids|glucocorticoids|mesh-ancestor
65013567|NCT00148746|Hormones|hormones|mesh-ancestor
65013568|NCT00148746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65013569|NCT00148746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65013570|NCT00148746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013607|NCT00466609|Clomipramine|clomipramine|mesh-list
65013608|NCT00466609|Antidepressive Agents|antidepressive agents|mesh-ancestor
65013609|NCT00466609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65013610|NCT00466609|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65013611|NCT00466609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65013612|NCT00466609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65013613|NCT00466609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013614|NCT00466609|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65013615|NCT00466609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65013616|NCT00466609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65013617|NCT00466609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013618|NCT00466609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65013619|NCT00466609|Serotonin Agents|serotonin agents|mesh-ancestor
65013620|NCT00466609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65013621|NCT00466609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65013622|NCT00466609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65013623|NCT00466609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013624|NCT00466609|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65013625|NCT00157326|Tadalafil|tadalafil|mesh-list
65013626|NCT00157326|Vasodilator Agents|vasodilator agents|mesh-ancestor
65013627|NCT00157326|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65013658|NCT00466999|Abortifacient Agents|abortifacient agents|mesh-ancestor
65013659|NCT00466999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65013660|NCT00466999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013661|NCT00466999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65013662|NCT00466999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65013663|NCT00466999|Oxytocics|oxytocics|mesh-ancestor
65013664|NCT00467116|Gemcitabine|gemcitabine|mesh-list
65013665|NCT00467116|Cetuximab|cetuximab|mesh-list
65013666|NCT00467116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65013667|NCT00467116|Antimetabolites|antimetabolites|mesh-ancestor
65013668|NCT00467116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013669|NCT00467116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013670|NCT00467116|Antiviral Agents|antiviral agents|mesh-ancestor
65013671|NCT00467116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013672|NCT00467116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013673|NCT00467116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65013674|NCT00467116|Immunologic Factors|immunologic factors|mesh-ancestor
65013675|NCT00467116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013676|NCT00467116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65013677|NCT00157482|Simvastatin|simvastatin|mesh-list
65013678|NCT00157482|Ezetimibe|ezetimibe|mesh-list
65013679|NCT00157482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65013680|NCT00157482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65013681|NCT00157482|Antimetabolites|antimetabolites|mesh-ancestor
65013682|NCT00157482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013683|NCT00157482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65013707|NCT00148902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013708|NCT00148902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65013709|NCT00148902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013710|NCT05507645|Saruplase|saruplase|mesh-list
65013711|NCT05507645|Anticoagulants|anticoagulants|mesh-list
65013712|NCT05507645|Clopidogrel|clopidogrel|mesh-list
65013713|NCT05507645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013714|NCT05507645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65013715|NCT05507645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65013716|NCT05507645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013717|NCT05507645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65013718|NCT05507645|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65013719|NCT05507645|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65013720|NCT05507645|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65013721|NCT05507645|Purinergic Agents|purinergic agents|mesh-ancestor
65013722|NCT05507645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65013723|NCT03271918|Cabergoline|cabergoline|mesh-list
65013764|NCT00467935|Ranibizumab|ranibizumab|mesh-list
65013765|NCT00467935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65013766|NCT00467935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65013767|NCT00467935|Growth Substances|growth substances|mesh-ancestor
65013768|NCT00467935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013769|NCT00467935|Growth Inhibitors|growth inhibitors|mesh-ancestor
65013770|NCT00467935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013771|NCT00149019|Antibodies|antibodies|mesh-list
65013772|NCT00149019|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65013773|NCT00149019|Immunologic Factors|immunologic factors|mesh-ancestor
65013774|NCT00149019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013775|NCT00468091|Atropine|atropine|mesh-list
65013776|NCT00468091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65013777|NCT00468091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65013778|NCT00468091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65013779|NCT00468091|Autonomic Agents|autonomic agents|mesh-ancestor
65013780|NCT00468091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65013781|NCT00468091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013782|NCT00468091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65013783|NCT00468091|Respiratory System Agents|respiratory system agents|mesh-ancestor
65013784|NCT00468091|Mydriatics|mydriatics|mesh-ancestor
65013785|NCT00468091|Parasympatholytics|parasympatholytics|mesh-ancestor
65013786|NCT00468091|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65013787|NCT00468091|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65013788|NCT00468091|Cholinergic Agents|cholinergic agents|mesh-ancestor
65013789|NCT00468091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65013790|NCT00468091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013791|NCT00468364|Insulin|insulin|mesh-list
65013792|NCT00468364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65013793|NCT00468364|Insulin Glargine|insulin glargine|mesh-list
65013813|NCT03271450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65013814|NCT03271450|Protease Inhibitors|protease inhibitors|mesh-ancestor
65013815|NCT03271450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013816|NCT03271450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013817|NCT00468754|Insulin|insulin|mesh-list
65013818|NCT00468754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65013819|NCT00468754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013820|NCT00468871|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
65013821|NCT00468871|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65013822|NCT00468871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65013823|NCT00468871|Glucocorticoids|glucocorticoids|mesh-ancestor
65013824|NCT00468871|Hormones|hormones|mesh-ancestor
65013825|NCT00468871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65013826|NCT00468871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013827|NCT00468871|Immunologic Factors|immunologic factors|mesh-ancestor
65013828|NCT00468988|Travoprost|travoprost|mesh-list
65013829|NCT00468988|Latanoprost|latanoprost|mesh-list
65013830|NCT00468988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65013831|NCT00468988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65013832|NCT00468988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65013833|NCT00149136|Imatinib Mesylate|imatinib mesylate|mesh-list
65013834|NCT00149136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013835|NCT00149136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65013836|NCT00149136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013837|NCT00149136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013838|NCT00469261|Doxycycline|doxycycline|mesh-list
65013839|NCT00469261|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65013840|NCT00469261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64454800|NCT01906346|Dopamine Agents|dopamine agents|mesh-ancestor
65013841|NCT00469261|Antimalarials|antimalarials|mesh-ancestor
65013842|NCT00469261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65013843|NCT00469261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65013844|NCT00469300|Acyclovir|acyclovir|mesh-list
65013845|NCT00469300|Antiviral Agents|antiviral agents|mesh-ancestor
65013856|NCT04697641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65013857|NCT04697641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65013858|NCT04697641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65013859|NCT04697641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65013860|NCT04697641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65013861|NCT04697641|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65013862|NCT04697641|Cholinergic Agents|cholinergic agents|mesh-ancestor
65013863|NCT04697641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65013864|NCT04697641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013865|NCT00469417|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65013866|NCT00469417|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65013867|NCT00469417|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65013868|NCT00469417|Dermatologic Agents|dermatologic agents|mesh-ancestor
65013869|NCT00469495|Anthelmintics|anthelmintics|mesh-list
65013870|NCT00469495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65013871|NCT00469495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013872|NCT00469651|Vaccines|vaccines|mesh-list
65013873|NCT00469651|Immunologic Factors|immunologic factors|mesh-ancestor
65013874|NCT00469651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013875|NCT00149253|Etoricoxib|etoricoxib|mesh-list
65013876|NCT00149253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013877|NCT00149253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65013878|NCT00149253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65013879|NCT00149253|Analgesics|analgesics|mesh-ancestor
65013880|NCT00149253|Sensory System Agents|sensory system agents|mesh-ancestor
65013881|NCT00149253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65013903|NCT00469768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65013904|NCT00469768|Antiviral Agents|antiviral agents|mesh-ancestor
65013905|NCT00469768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013906|NCT00469885|Nicotine|nicotine|mesh-list
65013907|NCT00469885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65013908|NCT00469885|Autonomic Agents|autonomic agents|mesh-ancestor
65013909|NCT00469885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65013910|NCT00469885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013911|NCT00469885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65013912|NCT00469885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65013913|NCT00469885|Cholinergic Agents|cholinergic agents|mesh-ancestor
65013914|NCT00469885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65013915|NCT00469885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013916|NCT00469924|Caffeine|caffeine|mesh-list
65013917|NCT00469924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64469119|NCT05819632|Curcumin|curcumin|mesh-list
65013918|NCT00469924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013919|NCT00469924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65013920|NCT00469924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013921|NCT00469924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013922|NCT00469924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65013923|NCT00469924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65013924|NCT00469924|Purinergic Agents|purinergic agents|mesh-ancestor
65013925|NCT00469924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65013926|NCT00157677|Fibrin fragment D|fibrin fragment d|mesh-list
65013952|NCT00157716|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
65013953|NCT00157716|Vitamin B Complex|vitamin b complex|mesh-ancestor
65013954|NCT00157716|Vitamins|vitamins|mesh-ancestor
65013955|NCT00157716|Micronutrients|micronutrients|mesh-ancestor
65013956|NCT00157716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013957|NCT00470197|Cytarabine|cytarabine|mesh-list
65013958|NCT00470197|Mitoxantrone|mitoxantrone|mesh-list
65013959|NCT00470197|Alvocidib|alvocidib|mesh-list
65013960|NCT00470197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65013961|NCT00470197|Antimetabolites|antimetabolites|mesh-ancestor
65013962|NCT00470197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013963|NCT00470197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65013964|NCT00470197|Antiviral Agents|antiviral agents|mesh-ancestor
65013965|NCT00470197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65013966|NCT00470197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65013967|NCT00470197|Immunologic Factors|immunologic factors|mesh-ancestor
65013968|NCT00470197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65013969|NCT00470197|Analgesics|analgesics|mesh-ancestor
65013970|NCT00470197|Sensory System Agents|sensory system agents|mesh-ancestor
65013971|NCT00470197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65013972|NCT00470197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65013973|NCT00470197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65013974|NCT00470197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65013975|NCT00470197|Growth Inhibitors|growth inhibitors|mesh-ancestor
65013976|NCT00470197|Growth Substances|growth substances|mesh-ancestor
65013977|NCT00470197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65013978|NCT00470314|N-Methylaspartate|n-methylaspartate|mesh-list
65013979|NCT00470314|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
65013980|NCT00470314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65013984|NCT00149292|Olanzapine|olanzapine|mesh-list
65013997|NCT00149292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65013998|NCT00149292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65013999|NCT00149292|Serotonin Agents|serotonin agents|mesh-ancestor
65014000|NCT00470353|Cholecalciferol|cholecalciferol|mesh-list
65014002|NCT00470353|Calcium Carbonate|calcium carbonate|mesh-list
65014003|NCT00470353|Calcium|calcium|mesh-list
65014004|NCT00470353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65014005|NCT00470353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014006|NCT00470353|Vitamins|vitamins|mesh-ancestor
65014007|NCT00470353|Micronutrients|micronutrients|mesh-ancestor
65014008|NCT00470353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65014009|NCT00470353|Antacids|antacids|mesh-ancestor
65014010|NCT00470353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014011|NCT00470353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65014012|NCT05391893|Diltiazem|diltiazem|mesh-list
65014013|NCT05391893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65014014|NCT05391893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65014015|NCT05391893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65014016|NCT05391893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014019|NCT05391893|Vasodilator Agents|vasodilator agents|mesh-ancestor
65014053|NCT00470743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014054|NCT00470743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014055|NCT00470743|Gout Suppressants|gout suppressants|mesh-ancestor
65014056|NCT00470743|Tocolytic Agents|tocolytic agents|mesh-ancestor
65014057|NCT00470743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65014058|NCT00470821|Melatonin|melatonin|mesh-list
65014059|NCT00470821|Antioxidants|antioxidants|mesh-ancestor
65014060|NCT00470821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014061|NCT00470821|Protective Agents|protective agents|mesh-ancestor
65014062|NCT00470821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014063|NCT00470821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65014064|NCT00335920|Dexamethasone|dexamethasone|mesh-list
65014065|NCT00335920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65014066|NCT00335920|Antiemetics|antiemetics|mesh-ancestor
65014067|NCT00335920|Autonomic Agents|autonomic agents|mesh-ancestor
65014068|NCT00335920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65014069|NCT00335920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014070|NCT00335920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65014072|NCT00335920|Hormones|hormones|mesh-ancestor
65014073|NCT00335920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65014074|NCT00335920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65014075|NCT00335920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014076|NCT00335998|Cisplatin|cisplatin|mesh-list
65014077|NCT00335998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014078|NCT00470977|Ranibizumab|ranibizumab|mesh-list
65014079|NCT00470977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65014080|NCT00470977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65014081|NCT00470977|Growth Substances|growth substances|mesh-ancestor
65014100|NCT00471055|Dermatologic Agents|dermatologic agents|mesh-ancestor
65014101|NCT00471055|Sensory System Agents|sensory system agents|mesh-ancestor
65014102|NCT00471055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65014103|NCT00471055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014104|NCT00471094|Lansoprazole|lansoprazole|mesh-list
65014105|NCT00471094|Dexlansoprazole|dexlansoprazole|mesh-list
65014106|NCT00471094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65014107|NCT00471094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65014108|NCT00471094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65014109|NCT00471094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014110|NCT00471094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014111|NCT00157872|Naproxen|naproxen|mesh-list
65014112|NCT00157872|Rofecoxib|rofecoxib|mesh-list
65014113|NCT00157872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65014114|NCT00157872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65014115|NCT00157872|Analgesics|analgesics|mesh-ancestor
65014116|NCT00157872|Sensory System Agents|sensory system agents|mesh-ancestor
65014117|NCT00157872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65014118|NCT00157872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014119|NCT00157872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65014153|NCT00158028|Serotonin Agents|serotonin agents|mesh-ancestor
65014154|NCT00158028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65014155|NCT00158028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014156|NCT00158028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014157|NCT00158028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65014158|NCT00158028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65014159|NCT00158028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65014160|NCT00158028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65014161|NCT00158028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65014162|NCT00158028|Dopamine Agents|dopamine agents|mesh-ancestor
65014163|NCT00471406|Verteporfin|verteporfin|mesh-list
65014164|NCT00471406|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65014165|NCT00471406|Dermatologic Agents|dermatologic agents|mesh-ancestor
65014166|NCT00149565|Interferon alpha-2|interferon alpha-2|mesh-list
65014167|NCT00149565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014168|NCT00149565|Antiviral Agents|antiviral agents|mesh-ancestor
65014169|NCT00149565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65014170|NCT00471484|Interferons|interferons|mesh-list
65014171|NCT00471484|Interferon-alpha|interferon-alpha|mesh-list
65014172|NCT00471484|Interferon alpha-2|interferon alpha-2|mesh-list
65014173|NCT00471484|Doxorubicin|doxorubicin|mesh-list
65014174|NCT00471484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65014175|NCT00471484|Fluorouracil|fluorouracil|mesh-list
65014176|NCT00471484|Oxaliplatin|oxaliplatin|mesh-list
65014177|NCT00471484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64878871|NCT01902342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878872|NCT01902342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878873|NCT01902342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878874|NCT01902446|Chlorhexidine|chlorhexidine|mesh-list
64878875|NCT01902446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64724090|NCT00380263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64331662|NCT05092360|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64500458|NCT01454362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64500459|NCT01454362|Autonomic Agents|autonomic agents|mesh-ancestor
64500460|NCT01454362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500461|NCT01454362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500462|NCT01454362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64500463|NCT01454362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64500464|NCT01454362|Cholinergic Agents|cholinergic agents|mesh-ancestor
64500465|NCT01454362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64500466|NCT01454362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500467|NCT01497808|Ipilimumab|ipilimumab|mesh-list
64500480|NCT01498588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500482|NCT01498588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64500483|NCT01498588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64500484|NCT01498588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65014178|NCT00471484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014179|NCT00471484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65014180|NCT00471484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65014181|NCT00471484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014182|NCT00471484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014183|NCT00471484|Antimetabolites|antimetabolites|mesh-ancestor
65014184|NCT00471484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65014185|NCT00471484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65014186|NCT00471484|Immunologic Factors|immunologic factors|mesh-ancestor
65014187|NCT00471484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014188|NCT00471484|Antiviral Agents|antiviral agents|mesh-ancestor
65014189|NCT00471484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65014190|NCT00471523|Metformin|metformin|mesh-list
65014191|NCT00471523|Clomiphene|clomiphene|mesh-list
65014192|NCT00471523|Enclomiphene|enclomiphene|mesh-list
65014193|NCT00471523|Zuclomiphene|zuclomiphene|mesh-list
65014194|NCT00471523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65014195|NCT00471523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014196|NCT00471523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65014197|NCT00471523|Hormone Antagonists|hormone antagonists|mesh-ancestor
65014198|NCT00471523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65014199|NCT00471523|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65014200|NCT00471523|Fertility Agents|fertility agents|mesh-ancestor
65014201|NCT00471523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65014202|NCT00471523|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65014203|NCT00471523|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65014207|NCT00471640|Dexamethasone|dexamethasone|mesh-list
65014223|NCT00471679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014224|NCT00149604|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65014225|NCT00149604|Estrogens|estrogens|mesh-list
65014226|NCT00149604|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65014227|NCT00149604|Hormones|hormones|mesh-ancestor
65014228|NCT00149604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65014229|NCT00149604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014230|NCT00149604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65014231|NCT00149604|Hormone Antagonists|hormone antagonists|mesh-ancestor
65014232|NCT00149604|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65014233|NCT00149604|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65014234|NCT00149604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65014235|NCT05281406|Carboplatin|carboplatin|mesh-list
65014236|NCT05281406|Pemetrexed|pemetrexed|mesh-list
65014237|NCT05281406|Osimertinib|osimertinib|mesh-list
65014238|NCT05281406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014239|NCT05281406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014240|NCT05281406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014241|NCT05281406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65014242|NCT05281406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65014243|NCT05281406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65014244|NCT00471952|Caffeine|caffeine|mesh-list
65014245|NCT00471952|Rizatriptan|rizatriptan|mesh-list
65014246|NCT00471952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65014247|NCT00471952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014248|NCT00471952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65014249|NCT00471952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014250|NCT00471952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014251|NCT00471952|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65014252|NCT00471952|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65014265|NCT00471991|Contraceptive Agents|contraceptive agents|mesh-ancestor
65014266|NCT00471991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65014267|NCT00471991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65014268|NCT00471991|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65014269|NCT00471991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65014270|NCT00471991|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65014271|NCT00471991|Hormone Antagonists|hormone antagonists|mesh-ancestor
65014272|NCT00471991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65014273|NCT00471991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014274|NCT00472108|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65014275|NCT00472108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65014276|NCT00472108|Dermatologic Agents|dermatologic agents|mesh-ancestor
65014277|NCT00336310|Repaglinide|repaglinide|mesh-list
65014278|NCT00336310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65014279|NCT00336310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014280|NCT00336349|Botulinum Toxins|botulinum toxins|mesh-list
65014281|NCT00336349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65014282|NCT00336349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65014283|NCT00336349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65014284|NCT00336349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65014285|NCT00336349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014286|NCT00336349|Cholinergic Agents|cholinergic agents|mesh-ancestor
65014287|NCT00336349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65014288|NCT00336349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014289|NCT00336349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65014290|NCT00336349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65014291|NCT00472225|Rituximab|rituximab|mesh-list
65014312|NCT00424151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65014313|NCT00424151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014314|NCT00424151|Immunologic Factors|immunologic factors|mesh-ancestor
65014315|NCT00424151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014316|NCT00424151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65014317|NCT00472810|Mitomycins|mitomycins|mesh-list
65014318|NCT00472810|Mitomycin|mitomycin|mesh-list
65014319|NCT00472810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65014320|NCT00472810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014321|NCT00472810|Alkylating Agents|alkylating agents|mesh-ancestor
65014322|NCT00472810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014323|NCT00472810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65014324|NCT00472810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014325|NCT00337051|Propofol|propofol|mesh-list
65014326|NCT00337051|Sevoflurane|sevoflurane|mesh-list
65014327|NCT00337051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65014328|NCT00337051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65014330|NCT00337051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65493825|NCT04233866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64469570|NCT05814627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65014363|NCT00337246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014364|NCT00337246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65014365|NCT00337246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65014366|NCT00337246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65014367|NCT00337246|Antimetabolites|antimetabolites|mesh-ancestor
65014368|NCT00337246|Analgesics|analgesics|mesh-ancestor
65014369|NCT00337246|Sensory System Agents|sensory system agents|mesh-ancestor
65014370|NCT00337246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65014371|NCT00337246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65014372|NCT00337246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65014373|NCT00337246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014374|NCT00158301|Fluoxetine|fluoxetine|mesh-list
65014375|NCT00158301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65014376|NCT00158301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65014377|NCT00158301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65014378|NCT00158301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014379|NCT00158301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65014380|NCT00158301|Serotonin Agents|serotonin agents|mesh-ancestor
65014381|NCT00158301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014382|NCT00158301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65014383|NCT00158301|Antidepressive Agents|antidepressive agents|mesh-ancestor
65014384|NCT00158301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65014385|NCT00158301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65014386|NCT00158301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65014387|NCT00158301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014388|NCT00473005|Capecitabine|capecitabine|mesh-list
65014405|NCT00473239|Vitamins|vitamins|mesh-ancestor
65014406|NCT00473239|Micronutrients|micronutrients|mesh-ancestor
65014407|NCT00473239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014408|NCT00473239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65014409|NCT00473239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65014410|NCT00149916|Mycophenolic Acid|mycophenolic acid|mesh-list
65014411|NCT00149916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65014412|NCT00149916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014413|NCT00149916|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65014414|NCT00149916|Antitubercular Agents|antitubercular agents|mesh-ancestor
65014415|NCT00149916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65014416|NCT00149916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65014417|NCT00149916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014418|NCT00149916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014419|NCT00337441|Epoetin Alfa|epoetin alfa|mesh-list
65014420|NCT00337441|Hematinics|hematinics|mesh-ancestor
65014421|NCT05183048|Panitumumab|panitumumab|mesh-list
65014422|NCT05183048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65014423|NCT05183048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014424|NCT00337519|Alemtuzumab|alemtuzumab|mesh-list
65014425|NCT00337519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65014426|NCT00337519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014458|NCT00158457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65014459|NCT00158457|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65014460|NCT00158457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65014461|NCT00158457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65014462|NCT00158457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65014463|NCT00509158|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65014464|NCT00509158|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65014465|NCT00509158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65014468|NCT00509158|Antacids|antacids|mesh-ancestor
65014524|NCT00337792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65014525|NCT00337792|GABA Modulators|gaba modulators|mesh-ancestor
65014526|NCT00337792|GABA Agents|gaba agents|mesh-ancestor
65014527|NCT00337792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65014528|NCT00337792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014529|NCT00337792|Anticonvulsants|anticonvulsants|mesh-ancestor
65014530|NCT00337792|Antiemetics|antiemetics|mesh-ancestor
65014531|NCT00337792|Autonomic Agents|autonomic agents|mesh-ancestor
65014532|NCT00337792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65014533|NCT00509353|Irinotecan|irinotecan|mesh-list
65014534|NCT00509353|Vincristine|vincristine|mesh-list
65014535|NCT00509353|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65014536|NCT00509353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65014537|NCT00509353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65014538|NCT00509353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014588|NCT00509470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65014589|NCT00509470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65014590|NCT00509470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014591|NCT00509470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65014592|NCT00509470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014593|NCT00509470|Vasodilator Agents|vasodilator agents|mesh-ancestor
65014595|NCT00509470|Natriuretic Agents|natriuretic agents|mesh-ancestor
65014596|NCT00509470|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65014597|NCT00509470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65014598|NCT00509470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65014599|NCT00405158|Acetaminophen|acetaminophen|mesh-list
65014600|NCT00405158|Antipyretics|antipyretics|mesh-list
65014601|NCT00405158|Penicillins|penicillins|mesh-list
65014602|NCT00405158|Floxacillin|floxacillin|mesh-list
65014603|NCT00405158|Cefadroxil|cefadroxil|mesh-list
65014604|NCT00405158|Oxytocin|oxytocin|mesh-list
65014605|NCT00405158|Oxytocics|oxytocics|mesh-ancestor
65014606|NCT00405158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65014607|NCT00405158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014608|NCT00405158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65014609|NCT00405158|Analgesics|analgesics|mesh-ancestor
65014610|NCT00405158|Sensory System Agents|sensory system agents|mesh-ancestor
65014611|NCT00405158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65014612|NCT00405158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65014613|NCT00405158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65014614|NCT00150072|Imatinib Mesylate|imatinib mesylate|mesh-list
65014615|NCT00150072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014616|NCT00150072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65014617|NCT00150072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014618|NCT00150072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014619|NCT02953366|Mometasone Furoate|mometasone furoate|mesh-list
65014620|NCT02953366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65014621|NCT02953366|Dermatologic Agents|dermatologic agents|mesh-ancestor
65014622|NCT02953366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65014623|NCT00150111|Rituximab|rituximab|mesh-list
65014624|NCT00150111|Methimazole|methimazole|mesh-list
65014625|NCT00150111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65014626|NCT00150111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014627|NCT00150111|Immunologic Factors|immunologic factors|mesh-ancestor
65014628|NCT00150111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014629|NCT00150111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65014630|NCT00150111|Antithyroid Agents|antithyroid agents|mesh-ancestor
65014631|NCT00150111|Hormone Antagonists|hormone antagonists|mesh-ancestor
65014632|NCT00150111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65014633|NCT02953210|Dexamethasone|dexamethasone|mesh-list
65014634|NCT02953210|Ketorolac|ketorolac|mesh-list
65014635|NCT02953210|Lidocaine|lidocaine|mesh-list
65014636|NCT02953210|Clonidine|clonidine|mesh-list
65014637|NCT02953210|Fentanyl|fentanyl|mesh-list
65014638|NCT02953210|Midazolam|midazolam|mesh-list
65014639|NCT02953210|Ketamine|ketamine|mesh-list
65014640|NCT02953210|Ondansetron|ondansetron|mesh-list
65014641|NCT02953210|Bupivacaine|bupivacaine|mesh-list
65014642|NCT02953210|Propofol|propofol|mesh-list
65014643|NCT02953210|Isoflurane|isoflurane|mesh-list
65014644|NCT02953210|Ranitidine|ranitidine|mesh-list
65014645|NCT02953210|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65014646|NCT02953210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65014647|NCT02953210|Rocuronium|rocuronium|mesh-list
65014648|NCT02953210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65014649|NCT02953210|Antiemetics|antiemetics|mesh-ancestor
65014650|NCT02953210|Autonomic Agents|autonomic agents|mesh-ancestor
65014651|NCT02953210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65014652|NCT02953210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014653|NCT02953210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65014654|NCT02953210|Glucocorticoids|glucocorticoids|mesh-ancestor
65014655|NCT02953210|Hormones|hormones|mesh-ancestor
65014656|NCT02953210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65014657|NCT02953210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65014658|NCT02953210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014659|NCT02953210|Anesthetics, Local|anesthetics, local|mesh-ancestor
65014660|NCT02953210|Anesthetics|anesthetics|mesh-ancestor
65014661|NCT02953210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65014662|NCT02953210|Sensory System Agents|sensory system agents|mesh-ancestor
65014663|NCT02953210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64500485|NCT01498588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64500486|NCT01498588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500488|NCT01498744|Clindamycin palmitate|clindamycin palmitate|mesh-list
64500489|NCT01498744|Clindamycin phosphate|clindamycin phosphate|mesh-list
65014664|NCT02953210|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65014665|NCT02953210|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65014666|NCT02953210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65014667|NCT02953210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014668|NCT02953210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65014669|NCT02953210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65014670|NCT02953210|Anesthetics, General|anesthetics, general|mesh-ancestor
65014671|NCT02953210|Analgesics|analgesics|mesh-ancestor
65014672|NCT02953210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65014673|NCT02953210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65014674|NCT02953210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65014675|NCT02953210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65014676|NCT02953210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65014677|NCT02953210|Narcotics|narcotics|mesh-ancestor
65014678|NCT02953210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65014679|NCT02953210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65014721|NCT00509860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65014722|NCT00509860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65014723|NCT00509860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014724|NCT00509860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014725|NCT00509860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014726|NCT00509938|Lactoferrin|lactoferrin|mesh-list
65014727|NCT00509938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65014728|NCT00337948|Epoetin Alfa|epoetin alfa|mesh-list
65014729|NCT00337948|Hematinics|hematinics|mesh-ancestor
65014730|NCT02958215|Phenylephrine|phenylephrine|mesh-list
65014731|NCT02958215|Oxymetazoline|oxymetazoline|mesh-list
65014732|NCT02958215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65014733|NCT02958215|Mydriatics|mydriatics|mesh-ancestor
65014734|NCT02958215|Autonomic Agents|autonomic agents|mesh-ancestor
65014735|NCT02958215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65014736|NCT02958215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014737|NCT02958215|Sympathomimetics|sympathomimetics|mesh-ancestor
65014738|NCT02958215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65014739|NCT02958215|Nasal Decongestants|nasal decongestants|mesh-ancestor
65014740|NCT02958215|Respiratory System Agents|respiratory system agents|mesh-ancestor
65014741|NCT02958215|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65014742|NCT02958215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65014743|NCT02958215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65014744|NCT02958215|Adrenergic Agents|adrenergic agents|mesh-ancestor
65014745|NCT02958215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65014746|NCT02958215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014747|NCT02958215|Protective Agents|protective agents|mesh-ancestor
65014748|NCT00158574|Pyrimethamine|pyrimethamine|mesh-list
65014749|NCT00158574|Sulfadoxine|sulfadoxine|mesh-list
65014750|NCT00158574|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65014751|NCT00158574|Dapsone|dapsone|mesh-list
65014752|NCT00158574|Mefloquine|mefloquine|mesh-list
65014753|NCT00158574|Chlorproguanil|chlorproguanil|mesh-list
65014754|NCT00158574|Proguanil|proguanil|mesh-list
65014755|NCT00158574|Antimalarials|antimalarials|mesh-ancestor
65014756|NCT00158574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65014762|NCT00158574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65014763|NCT00158574|Renal Agents|renal agents|mesh-ancestor
65014764|NCT00158574|Leprostatic Agents|leprostatic agents|mesh-ancestor
65014765|NCT00158574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65014766|NCT00158574|Antimetabolites|antimetabolites|mesh-ancestor
65014767|NCT00338221|Glycine|glycine|mesh-list
65014768|NCT00338221|Glycine Agents|glycine agents|mesh-ancestor
65014769|NCT00338221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65014770|NCT00338221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014771|NCT00338221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014772|NCT00338299|Epoetin Alfa|epoetin alfa|mesh-list
65014773|NCT00338299|Hematinics|hematinics|mesh-ancestor
65014774|NCT00510016|Clonidine|clonidine|mesh-list
65014775|NCT00510016|Analgesics|analgesics|mesh-ancestor
65014776|NCT00510016|Sensory System Agents|sensory system agents|mesh-ancestor
65014777|NCT00510016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65014778|NCT00510016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014779|NCT00510016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65014780|NCT00510016|Sympatholytics|sympatholytics|mesh-ancestor
65014781|NCT00510016|Autonomic Agents|autonomic agents|mesh-ancestor
65014782|NCT00510016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65014788|NCT00150228|Varenicline|varenicline|mesh-list
64470027|NCT05586360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64470028|NCT05586360|Antimetabolites|antimetabolites|mesh-ancestor
64470029|NCT05586360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470030|NCT05586360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64470032|NCT05586360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014810|NCT00338494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014811|NCT02953015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65014813|NCT02953015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65014814|NCT02953015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65014815|NCT02953015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014816|NCT02953015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65014817|NCT02953015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65014818|NCT02953015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014819|NCT02953015|Cholinergic Agents|cholinergic agents|mesh-ancestor
65014820|NCT02953015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65014863|NCT00420901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65014864|NCT00420901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65014865|NCT00420901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455853|NCT01789203|Ciprofloxacin|ciprofloxacin|mesh-list
64470101|NCT05547542|Carfentanil|carfentanil|mesh-list
64470102|NCT05547542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64470103|NCT05547542|Narcotics|narcotics|mesh-ancestor
64470104|NCT05547542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64470105|NCT05547542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470106|NCT05547542|Analgesics|analgesics|mesh-ancestor
64470107|NCT05547542|Sensory System Agents|sensory system agents|mesh-ancestor
64470108|NCT05547542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64470109|NCT05545670|Allopurinol|allopurinol|mesh-list
64470110|NCT05545670|Antimetabolites|antimetabolites|mesh-ancestor
64470111|NCT05545670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470112|NCT05545670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470113|NCT05545670|Gout Suppressants|gout suppressants|mesh-ancestor
64470114|NCT05545670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64470115|NCT05545670|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64470116|NCT05545670|Antioxidants|antioxidants|mesh-ancestor
65014900|NCT00339118|Cyclophosphamide|cyclophosphamide|mesh-list
65014901|NCT00339118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65014902|NCT00339118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014903|NCT00339118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65014904|NCT00339118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65014905|NCT00339118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65014906|NCT00339118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014907|NCT00339118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65014908|NCT00339118|Immunologic Factors|immunologic factors|mesh-ancestor
65014909|NCT00339118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014910|NCT00339118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65014911|NCT00339118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65014912|NCT00339118|Alkylating Agents|alkylating agents|mesh-ancestor
65014913|NCT00339118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65014914|NCT00339157|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65014915|NCT00339157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65014916|NCT00339196|Azacitidine|azacitidine|mesh-list
65014957|NCT00150423|Sensory System Agents|sensory system agents|mesh-ancestor
65014958|NCT00150423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65014959|NCT00150423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014960|NCT00150423|Anticonvulsants|anticonvulsants|mesh-ancestor
65014961|NCT00150423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65014962|NCT00150423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65014963|NCT00150423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65014964|NCT00150423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65014965|NCT00150423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65014966|NCT00150423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65014967|NCT00150423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65014968|NCT00150423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65014969|NCT04988282|Methylprednisolone|methylprednisolone|mesh-list
65014970|NCT04988282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65014971|NCT04988282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65014972|NCT04988282|Prednisolone|prednisolone|mesh-list
65014973|NCT04988282|Prednisolone acetate|prednisolone acetate|mesh-list
65014974|NCT04988282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65014975|NCT04988282|Prednisolone phosphate|prednisolone phosphate|mesh-list
65014976|NCT04988282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65014977|NCT04988282|Antiemetics|antiemetics|mesh-ancestor
65014978|NCT04988282|Autonomic Agents|autonomic agents|mesh-ancestor
65014979|NCT04988282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65014980|NCT04988282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014981|NCT04988282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65014982|NCT04988282|Glucocorticoids|glucocorticoids|mesh-ancestor
65014983|NCT04988282|Hormones|hormones|mesh-ancestor
65014984|NCT04988282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65014985|NCT04988282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65014986|NCT04988282|Protective Agents|protective agents|mesh-ancestor
65014987|NCT04988282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65014988|NCT04988282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65014998|NCT04981067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65014999|NCT04981067|Sensory System Agents|sensory system agents|mesh-ancestor
65015000|NCT04981067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65015001|NCT00510367|Cyclophosphamide|cyclophosphamide|mesh-list
65015002|NCT00510367|Doxorubicin|doxorubicin|mesh-list
65015003|NCT00510367|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65015004|NCT00510367|Fluorouracil|fluorouracil|mesh-list
65015005|NCT00510367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64470249|NCT05453903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64470250|NCT05453903|Immunologic Factors|immunologic factors|mesh-ancestor
64470251|NCT05453903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470252|NCT05453903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470253|NCT05453903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64470254|NCT05453903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64470255|NCT05453903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64470256|NCT05450562|Cemiplimab|cemiplimab|mesh-list
64470258|NCT05450562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015007|NCT00510367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015008|NCT00510367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65015009|NCT00510367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65493826|NCT04233866|Fluorouracil|fluorouracil|mesh-list
65493827|NCT04233866|Irinotecan|irinotecan|mesh-list
65015010|NCT00510367|Alkylating Agents|alkylating agents|mesh-ancestor
65015011|NCT00510367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015012|NCT00510367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015013|NCT00510367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65015014|NCT00510367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65015015|NCT00510367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65015016|NCT00510367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65015017|NCT00510367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015018|NCT00510367|Antimetabolites|antimetabolites|mesh-ancestor
65015019|NCT00510367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65015020|NCT00158847|Fluticasone|fluticasone|mesh-list
65015021|NCT00158847|Xhance|xhance|mesh-list
65015022|NCT00158847|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65015023|NCT00158847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65015024|NCT00158847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65015025|NCT00158847|Autonomic Agents|autonomic agents|mesh-ancestor
65015027|NCT00158847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015028|NCT00158847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65015029|NCT00158847|Respiratory System Agents|respiratory system agents|mesh-ancestor
65015030|NCT00158847|Dermatologic Agents|dermatologic agents|mesh-ancestor
65015031|NCT00158847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65015032|NCT00158847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65015033|NCT00158847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65015034|NCT00158847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65015035|NCT00158847|Adrenergic Agents|adrenergic agents|mesh-ancestor
65015036|NCT00158847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65015037|NCT00158847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015038|NCT00339586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65015039|NCT00339586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015040|NCT00339586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65015041|NCT00339586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015042|NCT00339586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015043|NCT00158886|Topotecan|topotecan|mesh-list
65015044|NCT00158886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65015045|NCT00158886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65015046|NCT00158886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015047|NCT00158886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015048|NCT00158886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015049|NCT00510406|Tamsulosin|tamsulosin|mesh-list
65015050|NCT00510406|Solifenacin Succinate|solifenacin succinate|mesh-list
65015051|NCT00510406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65015052|NCT00510406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65015053|NCT00510406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65015054|NCT00510406|Adrenergic Agents|adrenergic agents|mesh-ancestor
65015055|NCT00510406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65015056|NCT00510406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015057|NCT00510406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015058|NCT00510406|Urological Agents|urological agents|mesh-ancestor
64500501|NCT01498978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500503|NCT01498978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64500504|NCT01498978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500505|NCT01458418|Montelukast|montelukast|mesh-list
64500506|NCT01458418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64500507|NCT01458418|Respiratory System Agents|respiratory system agents|mesh-ancestor
64500508|NCT01458418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65015059|NCT00510406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65015060|NCT00510406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65015061|NCT00510406|Cholinergic Agents|cholinergic agents|mesh-ancestor
65015062|NCT00165555|Sodium thiosulfate|sodium thiosulfate|mesh-list
65015063|NCT00165555|Antidotes|antidotes|mesh-ancestor
65015064|NCT00165555|Protective Agents|protective agents|mesh-ancestor
65015065|NCT00165555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015066|NCT00165555|Antioxidants|antioxidants|mesh-ancestor
65015067|NCT00165555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015068|NCT00165555|Antitubercular Agents|antitubercular agents|mesh-ancestor
65015069|NCT00165555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65015070|NCT00165555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65015071|NCT00165555|Chelating Agents|chelating agents|mesh-ancestor
65015072|NCT00165555|Sequestering Agents|sequestering agents|mesh-ancestor
65015073|NCT00150579|Amphetamine|amphetamine|mesh-list
65015074|NCT00150579|Dextroamphetamine|dextroamphetamine|mesh-list
65015075|NCT00150579|Adderall|adderall|mesh-list
65015076|NCT00150579|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65015077|NCT00150579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015078|NCT00150579|Sympathomimetics|sympathomimetics|mesh-ancestor
65015079|NCT00150579|Autonomic Agents|autonomic agents|mesh-ancestor
65015080|NCT00150579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65015082|NCT00150579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65015083|NCT00150579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493828|NCT04233866|Calcium|calcium|mesh-list
65015084|NCT00150579|Adrenergic Agents|adrenergic agents|mesh-ancestor
65015085|NCT00150579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65015086|NCT00150579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65015087|NCT00150579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65015088|NCT00150579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65015089|NCT00511732|Insulin|insulin|mesh-list
65015090|NCT00511732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65015091|NCT00511732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015092|NCT00510445|Imetelstat|imetelstat|mesh-list
65015100|NCT00150657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65015101|NCT00150657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015102|NCT00150657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65015103|NCT00150657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65015104|NCT00150657|Growth Substances|growth substances|mesh-ancestor
65015105|NCT00150657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015106|NCT00150657|Growth Inhibitors|growth inhibitors|mesh-ancestor
65015107|NCT00150657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65015108|NCT00150657|Antimetabolites|antimetabolites|mesh-ancestor
65015109|NCT00150657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015110|NCT00150657|Antiviral Agents|antiviral agents|mesh-ancestor
65015111|NCT00150657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65015112|NCT00150657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015113|NCT00150657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65015114|NCT00150657|Immunologic Factors|immunologic factors|mesh-ancestor
65015115|NCT00511771|Tegaserod|tegaserod|mesh-list
65015116|NCT00511771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65015117|NCT00511771|Serotonin Agents|serotonin agents|mesh-ancestor
65015118|NCT00511771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65015119|NCT00511771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015120|NCT00511771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015121|NCT00165594|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
65015122|NCT00165594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015123|NCT00165594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65015124|NCT00165594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015125|NCT00165594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015126|NCT00511849|Paclitaxel|paclitaxel|mesh-list
65015127|NCT00511849|Carboplatin|carboplatin|mesh-list
65015128|NCT00511849|Sunitinib|sunitinib|mesh-list
65015142|NCT00510640|Sunitinib|sunitinib|mesh-list
65015143|NCT00510640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015144|NCT00510640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65015145|NCT00510640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65015146|NCT00510640|Growth Substances|growth substances|mesh-ancestor
65015147|NCT00510640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015148|NCT00510640|Growth Inhibitors|growth inhibitors|mesh-ancestor
65015149|NCT00510640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65015150|NCT00510640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015151|NCT00510640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015152|NCT00150696|Risedronic Acid|risedronic acid|mesh-list
65015153|NCT00150696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65015154|NCT00150696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65015155|NCT00150696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015156|NCT00150696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65015157|NCT00150696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015158|NCT00150696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65015160|NCT00165633|Menatetrenone|menatetrenone|mesh-list
65015161|NCT00165633|Hemostatics|hemostatics|mesh-ancestor
65015162|NCT00165633|Coagulants|coagulants|mesh-ancestor
65015163|NCT00165633|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65015164|NCT00165633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65015195|NCT00165750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015196|NCT00165750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015197|NCT00165750|Cholinergic Agents|cholinergic agents|mesh-ancestor
65015198|NCT00165750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65015199|NCT00165750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015200|NCT00165750|Nootropic Agents|nootropic agents|mesh-ancestor
65015201|NCT00511225|Cholecalciferol|cholecalciferol|mesh-list
65015202|NCT00511225|Vitamin D|vitamin d|mesh-list
65015203|NCT00511225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65015204|NCT00511225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015205|NCT00511225|Vitamins|vitamins|mesh-ancestor
65015206|NCT00511225|Micronutrients|micronutrients|mesh-ancestor
65015207|NCT00511225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65015208|NCT00150774|Levetiracetam|levetiracetam|mesh-list
65015209|NCT00150774|Anticonvulsants|anticonvulsants|mesh-ancestor
65015210|NCT00150774|Nootropic Agents|nootropic agents|mesh-ancestor
65015211|NCT04864067|Leucovorin|leucovorin|mesh-list
65015212|NCT04864067|Capecitabine|capecitabine|mesh-list
65015213|NCT04864067|Oxaliplatin|oxaliplatin|mesh-list
65015214|NCT04864067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65015215|NCT04864067|Antimetabolites|antimetabolites|mesh-ancestor
65015216|NCT04864067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015217|NCT04864067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015218|NCT04864067|Antidotes|antidotes|mesh-ancestor
65015219|NCT04864067|Protective Agents|protective agents|mesh-ancestor
65015220|NCT04864067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015221|NCT04864067|Vitamin B Complex|vitamin b complex|mesh-ancestor
65015222|NCT04864067|Vitamins|vitamins|mesh-ancestor
65015223|NCT04864067|Micronutrients|micronutrients|mesh-ancestor
65015224|NCT00511303|Imatinib Mesylate|imatinib mesylate|mesh-list
65015225|NCT00511303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015226|NCT00511303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65015229|NCT00165828|Zonisamide|zonisamide|mesh-list
65015239|NCT00511498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65015240|NCT00511498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015241|NCT00511498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015242|NCT00511498|Urological Agents|urological agents|mesh-ancestor
65015244|NCT00511576|Mocetinostat|mocetinostat|mesh-list
65015245|NCT00511576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015246|NCT00511576|Tubulin Modulators|tubulin modulators|mesh-ancestor
65015247|NCT00511576|Antimitotic Agents|antimitotic agents|mesh-ancestor
65015248|NCT00511576|Mitosis Modulators|mitosis modulators|mesh-ancestor
65015249|NCT00511576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015250|NCT00511576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65015251|NCT00511576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015252|NCT00511654|Midazolam|midazolam|mesh-list
65015253|NCT00511654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65015254|NCT00511654|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65015255|NCT00511654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65015256|NCT00511654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015257|NCT00511654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65015258|NCT00511654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65015259|NCT00511654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65015260|NCT00511654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65015261|NCT00511654|Anesthetics, General|anesthetics, general|mesh-ancestor
65015262|NCT00511654|Anesthetics|anesthetics|mesh-ancestor
65015263|NCT00511654|GABA Modulators|gaba modulators|mesh-ancestor
65015264|NCT00511654|GABA Agents|gaba agents|mesh-ancestor
65015265|NCT00511654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65015266|NCT00511654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015267|NCT04799249|Gemcitabine|gemcitabine|mesh-list
65015268|NCT04799249|Carboplatin|carboplatin|mesh-list
65015269|NCT04799249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015270|NCT04799249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65015283|NCT02952235|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65015284|NCT02952235|Protective Agents|protective agents|mesh-ancestor
65015285|NCT02952235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015286|NCT02952235|Dermatologic Agents|dermatologic agents|mesh-ancestor
65015287|NCT00165867|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
65015288|NCT00165867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015289|NCT00165867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65015290|NCT00165867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015291|NCT00165867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015292|NCT02951806|Fentanyl|fentanyl|mesh-list
64470552|NCT05220748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64470553|NCT05220748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470565|NCT05209984|Topiramate|topiramate|mesh-list
64470566|NCT05209984|Sibutramine|sibutramine|mesh-list
64470567|NCT05209984|Anticonvulsants|anticonvulsants|mesh-ancestor
64470568|NCT05209984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64470569|NCT05209984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470570|NCT05209984|Antidepressive Agents|antidepressive agents|mesh-ancestor
64470571|NCT05209984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64470572|NCT05209984|Appetite Depressants|appetite depressants|mesh-ancestor
64470573|NCT05209984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65015325|NCT00512980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65015326|NCT00512980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65015327|NCT00512980|Tubulin Modulators|tubulin modulators|mesh-ancestor
65015328|NCT00512980|Antimitotic Agents|antimitotic agents|mesh-ancestor
65015329|NCT00512980|Mitosis Modulators|mitosis modulators|mesh-ancestor
65015330|NCT00150891|Cyclosporine|cyclosporine|mesh-list
65015331|NCT00150891|Mycophenolic Acid|mycophenolic acid|mesh-list
65015332|NCT00150891|Azathioprine|azathioprine|mesh-list
65015333|NCT00150891|Tacrolimus|tacrolimus|mesh-list
65015334|NCT00150891|Cyclosporins|cyclosporins|mesh-list
65015335|NCT00150891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65015336|NCT00150891|Immunologic Factors|immunologic factors|mesh-ancestor
65015337|NCT00150891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015338|NCT00150891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65015339|NCT00150891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015340|NCT00150891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015341|NCT00150891|Antifungal Agents|antifungal agents|mesh-ancestor
65015342|NCT00150891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65015343|NCT00150891|Dermatologic Agents|dermatologic agents|mesh-ancestor
65015344|NCT00150891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65015345|NCT00150891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65015346|NCT00150891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015347|NCT00150891|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65015348|NCT00150891|Antitubercular Agents|antitubercular agents|mesh-ancestor
65015349|NCT00150891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65015350|NCT00150891|Antimetabolites|antimetabolites|mesh-ancestor
65015351|NCT00150891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65015352|NCT00513058|Vinorelbine|vinorelbine|mesh-list
65015353|NCT00513058|Lapatinib|lapatinib|mesh-list
65015354|NCT00513058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65015370|NCT02951962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65015371|NCT02951962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015372|NCT02951962|Vasodilator Agents|vasodilator agents|mesh-ancestor
65015373|NCT02951962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65015374|NCT02951962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65015376|NCT02951962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65015377|NCT02951962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65015378|NCT02951962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015379|NCT02951962|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65015380|NCT02951962|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65015381|NCT00513253|Lapatinib|lapatinib|mesh-list
65015382|NCT00513253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015383|NCT00513253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65015384|NCT00513253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015385|NCT00513253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015386|NCT00513487|Fluticasone|fluticasone|mesh-list
65015387|NCT00513487|Methacholine Chloride|methacholine chloride|mesh-list
65015388|NCT00513487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65015389|NCT00513487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65015390|NCT00513487|Autonomic Agents|autonomic agents|mesh-ancestor
65015424|NCT00513643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015425|NCT00151008|Bexarotene|bexarotene|mesh-list
65015426|NCT00151008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015427|NCT00513877|Bortezomib|bortezomib|mesh-list
65015428|NCT00513877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015429|NCT04695613|Magnesium Sulfate|magnesium sulfate|mesh-list
65015430|NCT04695613|Analgesics|analgesics|mesh-ancestor
65015431|NCT04695613|Sensory System Agents|sensory system agents|mesh-ancestor
65015432|NCT04695613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65015433|NCT04695613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015434|NCT04695613|Anesthetics|anesthetics|mesh-ancestor
65015435|NCT04695613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65015436|NCT04695613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65015437|NCT04695613|Anticonvulsants|anticonvulsants|mesh-ancestor
65015438|NCT04695613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65015439|NCT04695613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65015440|NCT04695613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015441|NCT04695613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65015442|NCT04695613|Tocolytic Agents|tocolytic agents|mesh-ancestor
65015444|NCT00151047|Docetaxel|docetaxel|mesh-list
65015445|NCT00151047|Capecitabine|capecitabine|mesh-list
65015446|NCT00151047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015447|NCT00151047|Tubulin Modulators|tubulin modulators|mesh-ancestor
65015448|NCT00151047|Antimitotic Agents|antimitotic agents|mesh-ancestor
65015450|NCT00151047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015451|NCT00151047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65015452|NCT00151047|Antimetabolites|antimetabolites|mesh-ancestor
65015453|NCT00513955|Prednisolone|prednisolone|mesh-list
65015454|NCT00513955|Cyclophosphamide|cyclophosphamide|mesh-list
65015455|NCT00513955|Doxorubicin|doxorubicin|mesh-list
65015456|NCT00513955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65015457|NCT00513955|Vincristine|vincristine|mesh-list
65015458|NCT00513955|Bortezomib|bortezomib|mesh-list
65015459|NCT00513955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65015460|NCT00513955|Immunologic Factors|immunologic factors|mesh-ancestor
65015461|NCT00513955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015462|NCT00513955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65015463|NCT00513955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65015464|NCT00513955|Alkylating Agents|alkylating agents|mesh-ancestor
65015465|NCT00513955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015466|NCT00513955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015467|NCT00513955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65015468|NCT00513955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65015469|NCT00513955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65015470|NCT00513955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65015471|NCT00513955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015472|NCT00513955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65015473|NCT00513955|Tubulin Modulators|tubulin modulators|mesh-ancestor
65015474|NCT00513955|Antimitotic Agents|antimitotic agents|mesh-ancestor
65015475|NCT00513955|Mitosis Modulators|mitosis modulators|mesh-ancestor
65015476|NCT00513955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65015477|NCT00513955|Glucocorticoids|glucocorticoids|mesh-ancestor
65015478|NCT00513955|Hormones|hormones|mesh-ancestor
65015479|NCT00513955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65015480|NCT00513955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65015481|NCT00513994|Nitroglycerin|nitroglycerin|mesh-list
65015482|NCT00513994|Vasodilator Agents|vasodilator agents|mesh-ancestor
65015483|NCT00514072|Vaccines|vaccines|mesh-list
65015484|NCT00514072|BCG Vaccine|bcg vaccine|mesh-list
65015485|NCT00514072|Immunologic Factors|immunologic factors|mesh-ancestor
65015486|NCT00514072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015487|NCT00514072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65015488|NCT00514111|Interferons|interferons|mesh-list
65015489|NCT00514111|Ribavirin|ribavirin|mesh-list
65015490|NCT00514111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015491|NCT00514111|Antiviral Agents|antiviral agents|mesh-ancestor
65015492|NCT00514111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65015493|NCT00514111|Antimetabolites|antimetabolites|mesh-ancestor
65015494|NCT00514111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015495|NCT00151086|Vinorelbine|vinorelbine|mesh-list
65015496|NCT00151086|Estramustine|estramustine|mesh-list
65015506|NCT00514228|Sunitinib|sunitinib|mesh-list
65015507|NCT00514228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015508|NCT00514228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65015509|NCT00514228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65015510|NCT00514228|Growth Substances|growth substances|mesh-ancestor
65015511|NCT00514228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015512|NCT00514228|Growth Inhibitors|growth inhibitors|mesh-ancestor
65015513|NCT00514228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65015514|NCT00514228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015515|NCT00514228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015516|NCT00151125|Oprelvekin|oprelvekin|mesh-list
65015517|NCT00151125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015518|NCT00514618|Misoprostol|misoprostol|mesh-list
65015519|NCT00514618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65015520|NCT00514618|Abortifacient Agents|abortifacient agents|mesh-ancestor
65015521|NCT00514618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65015522|NCT00514618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015523|NCT00514618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65015524|NCT00514618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65015525|NCT00514618|Oxytocics|oxytocics|mesh-ancestor
65015526|NCT00514657|Mitogens|mitogens|mesh-list
65015527|NCT00514657|Mitosis Modulators|mitosis modulators|mesh-ancestor
65015528|NCT00514657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015529|NCT00514774|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65015530|NCT00514774|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65015531|NCT00514774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65015532|NCT02951260|Metformin|metformin|mesh-list
65015533|NCT02951260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65015534|NCT02951260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015535|NCT02951299|Pentoxifylline|pentoxifylline|mesh-list
65015536|NCT02951299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65015537|NCT02951299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015538|NCT02951299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015539|NCT02951299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65015540|NCT02951299|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65015545|NCT02951299|Antioxidants|antioxidants|mesh-ancestor
65015546|NCT00514891|Vitamin A|vitamin a|mesh-list
65015547|NCT00514891|Vitamins|vitamins|mesh-ancestor
65015548|NCT00514891|Micronutrients|micronutrients|mesh-ancestor
65015549|NCT00514891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015550|NCT00514969|Imatinib Mesylate|imatinib mesylate|mesh-list
65015551|NCT00514969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015552|NCT00514969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65015553|NCT00514969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015554|NCT00514969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015555|NCT02950948|Progesterone|progesterone|mesh-list
65015556|NCT02950948|Progestins|progestins|mesh-ancestor
65015557|NCT02950948|Hormones|hormones|mesh-ancestor
65015558|NCT02950948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65015559|NCT02950948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015560|NCT00515320|Fluoxetine|fluoxetine|mesh-list
65015561|NCT00515320|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65015562|NCT00515320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65015563|NCT00515320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65015564|NCT00515320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015565|NCT00515320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65015566|NCT00515320|Serotonin Agents|serotonin agents|mesh-ancestor
65015567|NCT00515320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015568|NCT00515320|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65015569|NCT00515320|Antidepressive Agents|antidepressive agents|mesh-ancestor
65015570|NCT00515320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65015571|NCT00515320|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65015572|NCT00515320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64500509|NCT01458418|Hormone Antagonists|hormone antagonists|mesh-ancestor
64500510|NCT01458418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64500511|NCT01458418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500512|NCT01458418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64500513|NCT01458418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64500514|NCT01458418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500515|NCT01557322|Etanercept|etanercept|mesh-list
64724091|NCT00380263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724092|NCT00000769|Interleukin-4|interleukin-4|mesh-list
64724093|NCT00000769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64724094|NCT00000769|Immunologic Factors|immunologic factors|mesh-ancestor
64500516|NCT01557322|Methotrexate|methotrexate|mesh-list
64500517|NCT01557322|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64500518|NCT01557322|Abortifacient Agents|abortifacient agents|mesh-ancestor
64500519|NCT01557322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64500520|NCT01557322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015573|NCT00515320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015574|NCT00515359|Propofol|propofol|mesh-list
65015575|NCT00515359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65015576|NCT00515359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65015577|NCT00515359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015578|NCT00515359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65015579|NCT00515359|Anesthetics, General|anesthetics, general|mesh-ancestor
65015580|NCT00515359|Anesthetics|anesthetics|mesh-ancestor
65015581|NCT00515554|Rituximab|rituximab|mesh-list
65015582|NCT00515554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65015583|NCT00515554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015584|NCT00515554|Immunologic Factors|immunologic factors|mesh-ancestor
65015585|NCT00515554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456599|NCT03025282|Betamethasone|betamethasone|mesh-list
64470892|NCT04950764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470893|NCT04950764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64470894|NCT04948892|Anesthetics|anesthetics|mesh-list
64470895|NCT04948892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64470896|NCT04948892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470903|NCT04943341|Hormones|hormones|mesh-ancestor
65015586|NCT00515554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65015587|NCT00151203|Clarithromycin|clarithromycin|mesh-list
65015588|NCT00151203|Dexamethasone|dexamethasone|mesh-list
65015589|NCT00151203|Lenalidomide|lenalidomide|mesh-list
65015590|NCT00151203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65015591|NCT00151203|Antiemetics|antiemetics|mesh-ancestor
65015592|NCT00151203|Autonomic Agents|autonomic agents|mesh-ancestor
65015593|NCT00151203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65015594|NCT00151203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015595|NCT00151203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65015597|NCT00151203|Hormones|hormones|mesh-ancestor
65015598|NCT00151203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65015610|NCT00151203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015611|NCT00151203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65015612|NCT00151203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65015613|NCT04620200|Nivolumab|nivolumab|mesh-list
65015614|NCT04620200|Ipilimumab|ipilimumab|mesh-list
65015615|NCT04620200|Immunologic Factors|immunologic factors|mesh-list
65015616|NCT04620200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65015617|NCT04620200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015618|NCT04620200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65015619|NCT04620200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015620|NCT04620200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015621|NCT00515593|Hormones|hormones|mesh-list
65015622|NCT00515593|Parathyroid Hormone|parathyroid hormone|mesh-list
65015623|NCT00515593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65015624|NCT00515593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015625|NCT00515593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65015626|NCT00515788|Cytarabine|cytarabine|mesh-list
65015627|NCT00515788|Temozolomide|temozolomide|mesh-list
65015628|NCT00515788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65015629|NCT00515788|Antimetabolites|antimetabolites|mesh-ancestor
65015630|NCT00515788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015631|NCT00515788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015632|NCT00515788|Antiviral Agents|antiviral agents|mesh-ancestor
65015633|NCT00515788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65015634|NCT00515788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65015635|NCT00515788|Immunologic Factors|immunologic factors|mesh-ancestor
65015636|NCT00515788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015637|NCT00515788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65015639|NCT02950870|Ritonavir|ritonavir|mesh-list
65015652|NCT02950870|Antimetabolites|antimetabolites|mesh-ancestor
65015653|NCT00515866|Gemcitabine|gemcitabine|mesh-list
65015654|NCT00515866|Olaparib|olaparib|mesh-list
65015655|NCT00515866|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65015656|NCT00515866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65015657|NCT00515866|Antimetabolites|antimetabolites|mesh-ancestor
65015658|NCT00515866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015659|NCT00515866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015660|NCT00515866|Antiviral Agents|antiviral agents|mesh-ancestor
65015661|NCT00515866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65015662|NCT00515866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015663|NCT00515866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65015664|NCT00515866|Immunologic Factors|immunologic factors|mesh-ancestor
64889180|NCT01965353|Bortezomib|bortezomib|mesh-list
65015665|NCT00515866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015666|NCT00515905|Propofol|propofol|mesh-list
65015667|NCT00515905|Sevoflurane|sevoflurane|mesh-list
65015668|NCT00515905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65015669|NCT00515905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65015670|NCT00515905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015671|NCT00515905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65015672|NCT00515905|Anesthetics, General|anesthetics, general|mesh-ancestor
65015673|NCT00515905|Anesthetics|anesthetics|mesh-ancestor
65015674|NCT00515905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65015675|NCT00515905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65015676|NCT00515944|Botulinum Toxins|botulinum toxins|mesh-list
65015677|NCT00515944|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65015678|NCT00515944|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65015679|NCT00515944|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65015680|NCT00515944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65015687|NCT00151242|Cytarabine|cytarabine|mesh-list
65015696|NCT00151242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015697|NCT00151242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65015698|NCT00151242|Antimetabolites|antimetabolites|mesh-ancestor
65015699|NCT00151242|Antiviral Agents|antiviral agents|mesh-ancestor
65015700|NCT00151242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65015701|NCT00151242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65015702|NCT00151242|Immunologic Factors|immunologic factors|mesh-ancestor
65015703|NCT00151242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015704|NCT00151242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65015705|NCT00151242|Keratolytic Agents|keratolytic agents|mesh-ancestor
65015706|NCT00151242|Dermatologic Agents|dermatologic agents|mesh-ancestor
65015707|NCT00516100|Pemetrexed|pemetrexed|mesh-list
65015708|NCT00516100|Bortezomib|bortezomib|mesh-list
65015709|NCT00516100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015710|NCT00516100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64456743|NCT01774929|Fentanyl|fentanyl|mesh-list
64471089|NCT04780204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64471090|NCT04780204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471091|NCT04780204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64471092|NCT04780204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64471093|NCT04763564|Liraglutide|liraglutide|mesh-list
64471096|NCT04763564|Incretins|incretins|mesh-ancestor
65015726|NCT00166413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015727|NCT02950441|Niacinamide|niacinamide|mesh-list
65015729|NCT02950441|Nicotinic Acids|nicotinic acids|mesh-list
65015730|NCT02950441|Vitamin B Complex|vitamin b complex|mesh-ancestor
65015731|NCT02950441|Vitamins|vitamins|mesh-ancestor
65015732|NCT02950441|Micronutrients|micronutrients|mesh-ancestor
65015733|NCT02950441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015734|NCT02950441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65015735|NCT02950441|Antimetabolites|antimetabolites|mesh-ancestor
65015736|NCT02950441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015737|NCT02950441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65015738|NCT02950441|Vasodilator Agents|vasodilator agents|mesh-ancestor
65015739|NCT02950246|Chlorhexidine|chlorhexidine|mesh-list
65015740|NCT02950246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65015741|NCT02950246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65015742|NCT02950246|Disinfectants|disinfectants|mesh-ancestor
65015743|NCT02950168|Edoxaban|edoxaban|mesh-list
65015788|NCT00516802|Alkylating Agents|alkylating agents|mesh-ancestor
65015789|NCT02949895|Etoposide|etoposide|mesh-list
65015790|NCT02949895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015791|NCT02949895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65015792|NCT02949895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65015793|NCT02949895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65015794|NCT02949895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015795|NCT02949895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015796|NCT02949583|Chlorhexidine|chlorhexidine|mesh-list
65015797|NCT02949583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65015798|NCT02949583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65015799|NCT02949583|Disinfectants|disinfectants|mesh-ancestor
65015800|NCT00516841|Volociximab|volociximab|mesh-list
65015801|NCT00516841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65015802|NCT00516841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65015803|NCT00516841|Growth Substances|growth substances|mesh-ancestor
65015804|NCT00516841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015805|NCT00516841|Growth Inhibitors|growth inhibitors|mesh-ancestor
65015806|NCT00516841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015807|NCT00516880|Rosiglitazone|rosiglitazone|mesh-list
65015808|NCT00516880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65015809|NCT00516880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015810|NCT04694677|Misoprostol|misoprostol|mesh-list
65015811|NCT04694677|Tranexamic Acid|tranexamic acid|mesh-list
65015812|NCT04694677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65015813|NCT04694677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65015814|NCT04694677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015815|NCT04694677|Hemostatics|hemostatics|mesh-ancestor
65015816|NCT04694677|Coagulants|coagulants|mesh-ancestor
65015817|NCT04694677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65015818|NCT04694677|Abortifacient Agents|abortifacient agents|mesh-ancestor
65015819|NCT04694677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65015820|NCT04694677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015821|NCT04694677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65015822|NCT04694677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65015823|NCT04694677|Oxytocics|oxytocics|mesh-ancestor
65015824|NCT00516958|Levofloxacin|levofloxacin|mesh-list
65015825|NCT00516958|Ofloxacin|ofloxacin|mesh-list
65015826|NCT00516958|Sodium Hypochlorite|sodium hypochlorite|mesh-list
65015827|NCT00516958|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65015828|NCT00516958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65015829|NCT00516958|Renal Agents|renal agents|mesh-ancestor
65015830|NCT00516958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65015831|NCT00516958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65015832|NCT00516958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65015833|NCT00516958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015834|NCT00516958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015835|NCT00516958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015836|NCT00516958|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65015837|NCT00516958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65015838|NCT00516958|Disinfectants|disinfectants|mesh-ancestor
65015839|NCT00517114|Rabeprazole|rabeprazole|mesh-list
65015840|NCT00517114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65015841|NCT00517114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65015842|NCT00517114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65015843|NCT00517114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65015844|NCT00517114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015879|NCT00517582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65015880|NCT00517582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65015881|NCT00517582|Analgesics|analgesics|mesh-ancestor
65015882|NCT00517582|Sensory System Agents|sensory system agents|mesh-ancestor
65015883|NCT00517582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65015884|NCT00517582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015885|NCT00517582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65015886|NCT00517582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65015887|NCT00517582|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
65015888|NCT00517582|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
65015889|NCT00517582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015890|NCT00517582|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65015891|NCT00517582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65015892|NCT00517582|Immunologic Factors|immunologic factors|mesh-ancestor
65015893|NCT00517621|Paclitaxel|paclitaxel|mesh-list
65015894|NCT00517621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65015895|NCT00517621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015896|NCT00517621|Tubulin Modulators|tubulin modulators|mesh-ancestor
65015933|NCT00518245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65015934|NCT00518245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015936|NCT02957903|Anesthetics, Local|anesthetics, local|mesh-ancestor
65015937|NCT02957903|Anesthetics|anesthetics|mesh-ancestor
65015938|NCT02957903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65015939|NCT02957903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015940|NCT02957903|Sensory System Agents|sensory system agents|mesh-ancestor
65015941|NCT02957903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65015942|NCT00518479|Amlodipine|amlodipine|mesh-list
65015943|NCT00518479|Valsartan|valsartan|mesh-list
65015944|NCT00518479|Moxonidine|moxonidine|mesh-list
65015945|NCT00518479|Bendroflumethiazide|bendroflumethiazide|mesh-list
65015946|NCT00518479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65015947|NCT00518479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65015948|NCT00518479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65015949|NCT00518479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65015950|NCT00518479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65015951|NCT00518479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015952|NCT00518479|Vasodilator Agents|vasodilator agents|mesh-ancestor
65015953|NCT00518479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65015954|NCT00518479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65015956|NCT00518479|Natriuretic Agents|natriuretic agents|mesh-ancestor
65015957|NCT00518479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65015958|NCT00166725|Octreotide|octreotide|mesh-list
65015959|NCT00166725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65015960|NCT00166725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65015961|NCT00166725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015979|NCT00151632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65015980|NCT00151632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65015981|NCT02949232|Prednisolone|prednisolone|mesh-list
65015982|NCT02949232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65015983|NCT02949232|Glucocorticoids|glucocorticoids|mesh-ancestor
65015984|NCT02949232|Hormones|hormones|mesh-ancestor
65015985|NCT02949232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65015986|NCT02949232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015987|NCT02949232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65015988|NCT02949232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65015989|NCT00518908|Sevoflurane|sevoflurane|mesh-list
65015990|NCT00518908|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65015991|NCT00518908|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65015992|NCT00518908|Anesthetics, General|anesthetics, general|mesh-ancestor
65015993|NCT00518908|Anesthetics|anesthetics|mesh-ancestor
65015994|NCT00518908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65015995|NCT00518908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65015996|NCT00518947|Verapamil|verapamil|mesh-list
65015997|NCT00518947|Lithium Carbonate|lithium carbonate|mesh-list
65015998|NCT00518947|Antidepressive Agents|antidepressive agents|mesh-ancestor
65015999|NCT00518947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65016000|NCT00518947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016001|NCT00518947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016002|NCT00518947|Antimanic Agents|antimanic agents|mesh-ancestor
65016003|NCT00518947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65016004|NCT00518947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65016005|NCT00518947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016006|NCT00518947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65016007|NCT00518947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65016008|NCT00518947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65016009|NCT00518947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65016010|NCT00518947|Vasodilator Agents|vasodilator agents|mesh-ancestor
65016011|NCT02949466|Triamcinolone|triamcinolone|mesh-list
65016012|NCT02949466|Hyaluronic Acid|hyaluronic acid|mesh-list
65016018|NCT02949466|Immunologic Factors|immunologic factors|mesh-ancestor
65016019|NCT02949466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65016020|NCT02949466|Viscosupplements|viscosupplements|mesh-ancestor
65016021|NCT02949466|Protective Agents|protective agents|mesh-ancestor
65016022|NCT00151710|Pioglitazone|pioglitazone|mesh-list
65016023|NCT00151710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65016024|NCT00151710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016025|NCT00519181|Valproic Acid|valproic acid|mesh-list
65016026|NCT00519181|Anticonvulsants|anticonvulsants|mesh-ancestor
65016027|NCT00519181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016028|NCT00519181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016029|NCT00519181|GABA Agents|gaba agents|mesh-ancestor
65016030|NCT00519181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65016031|NCT00519181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016032|NCT00519181|Antimanic Agents|antimanic agents|mesh-ancestor
65016033|NCT00519181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65016034|NCT00519181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65016035|NCT00519181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65016036|NCT00166803|Rosiglitazone|rosiglitazone|mesh-list
65016037|NCT00166803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65016038|NCT00166803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016039|NCT02949310|Nefopam|nefopam|mesh-list
65016040|NCT02949310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65016041|NCT02949310|Analgesics|analgesics|mesh-ancestor
65016042|NCT02949310|Sensory System Agents|sensory system agents|mesh-ancestor
65016043|NCT02949310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65016044|NCT02949310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016045|NCT02949349|Mycophenolic Acid|mycophenolic acid|mesh-list
65016046|NCT02949349|Prednisolone|prednisolone|mesh-list
65016047|NCT02949349|Azathioprine|azathioprine|mesh-list
65016048|NCT02949349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65016049|NCT02949349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016050|NCT02949349|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64471555|NCT04373785|Temozolomide|temozolomide|mesh-list
64471556|NCT04373785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64471557|NCT04373785|Alkylating Agents|alkylating agents|mesh-ancestor
64471558|NCT04373785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471559|NCT04373785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471560|NCT04313712|Ibogaine|ibogaine|mesh-list
64471561|NCT04313712|Hallucinogens|hallucinogens|mesh-ancestor
64471562|NCT04313712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471563|NCT04313712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64471564|NCT04313712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64471565|NCT04313712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64471566|NCT04313712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64471567|NCT04313712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471568|NCT04312997|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
64471569|NCT04312997|Respiratory System Agents|respiratory system agents|mesh-ancestor
64471570|NCT04310995|Nicorandil|nicorandil|mesh-list
64471571|NCT04310995|Diltiazem|diltiazem|mesh-list
64471573|NCT04310995|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64471574|NCT04310995|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64471575|NCT04310995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64471576|NCT04310995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64471577|NCT04310995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65016056|NCT02949349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65016057|NCT02949349|Glucocorticoids|glucocorticoids|mesh-ancestor
65016058|NCT02949349|Hormones|hormones|mesh-ancestor
65016059|NCT02949349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65016060|NCT02949349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016061|NCT02949349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65016062|NCT02949349|Antimetabolites|antimetabolites|mesh-ancestor
65016063|NCT02949349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65016064|NCT02949349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65016065|NCT02949349|Immunologic Factors|immunologic factors|mesh-ancestor
65016066|NCT02949349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65016067|NCT00166842|Cyclosporine|cyclosporine|mesh-list
65016068|NCT00166842|Sirolimus|sirolimus|mesh-list
65016069|NCT00166842|Tacrolimus|tacrolimus|mesh-list
65016072|NCT00166842|Immunologic Factors|immunologic factors|mesh-ancestor
65016073|NCT00166842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016074|NCT00166842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65016075|NCT00166842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016076|NCT00166842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016077|NCT00166842|Antifungal Agents|antifungal agents|mesh-ancestor
65016078|NCT00166842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65016079|NCT00166842|Dermatologic Agents|dermatologic agents|mesh-ancestor
65016080|NCT00166842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65016081|NCT00166842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65016082|NCT00166842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65016083|NCT00166842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016084|NCT02949193|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65016085|NCT02949193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65016086|NCT02949193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016087|NCT02949193|Incretins|incretins|mesh-ancestor
65016088|NCT02949193|Hormones|hormones|mesh-ancestor
65016089|NCT02949193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65016090|NCT02949193|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65016091|NCT02949193|Protease Inhibitors|protease inhibitors|mesh-ancestor
65016092|NCT02949193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016093|NCT02949193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016094|NCT00519259|Lobeline|lobeline|mesh-list
65016095|NCT00519259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65016096|NCT00519259|Autonomic Agents|autonomic agents|mesh-ancestor
65016097|NCT00519259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65016098|NCT00519259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016099|NCT00519259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65016100|NCT00519259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65016101|NCT00519259|Cholinergic Agents|cholinergic agents|mesh-ancestor
65016102|NCT00519259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65016103|NCT00519259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016104|NCT00519259|Respiratory System Agents|respiratory system agents|mesh-ancestor
65016111|NCT00519298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016112|NCT00519298|Nootropic Agents|nootropic agents|mesh-ancestor
65016113|NCT00519337|Ascorbic Acid|ascorbic acid|mesh-list
65016114|NCT00519337|Vitamins|vitamins|mesh-ancestor
65016115|NCT00519337|Micronutrients|micronutrients|mesh-ancestor
65016116|NCT00519337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016117|NCT00519337|Antioxidants|antioxidants|mesh-ancestor
65016118|NCT00519337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016119|NCT00519337|Protective Agents|protective agents|mesh-ancestor
65016120|NCT00151749|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65016121|NCT00151749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65016122|NCT00151749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65016123|NCT00151749|Antimetabolites|antimetabolites|mesh-ancestor
65016124|NCT00151749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016125|NCT00151749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65016126|NCT00166881|Docetaxel|docetaxel|mesh-list
65016127|NCT00166881|Irinotecan|irinotecan|mesh-list
65016128|NCT00166881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016129|NCT00166881|Tubulin Modulators|tubulin modulators|mesh-ancestor
65016130|NCT00166881|Antimitotic Agents|antimitotic agents|mesh-ancestor
64471628|NCT04275180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016131|NCT00166881|Mitosis Modulators|mitosis modulators|mesh-ancestor
65016132|NCT00166881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016133|NCT00166881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65016134|NCT00166881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65016135|NCT00166881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016159|NCT00519688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016160|NCT02948920|Ephedrine|ephedrine|mesh-list
65016161|NCT02948920|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65016162|NCT02948920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016163|NCT02948920|Sympathomimetics|sympathomimetics|mesh-ancestor
65016164|NCT02948920|Autonomic Agents|autonomic agents|mesh-ancestor
65016165|NCT02948920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65016166|NCT02948920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65016167|NCT02948920|Adrenergic Agents|adrenergic agents|mesh-ancestor
65016168|NCT02948920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65016169|NCT02948920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016170|NCT00151827|Losartan|losartan|mesh-list
65016171|NCT00151827|Olmesartan|olmesartan|mesh-list
65016172|NCT00151827|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65016173|NCT00151827|Furosemide|furosemide|mesh-list
65016174|NCT00151827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65016175|NCT00151827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65016176|NCT00151827|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65016177|NCT00151827|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65016178|NCT00151827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016179|NCT00151827|Diuretics|diuretics|mesh-ancestor
65016180|NCT00151827|Natriuretic Agents|natriuretic agents|mesh-ancestor
65016181|NCT00151827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016182|NCT00151827|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65016183|NCT00151827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65016195|NCT04457180|Apatinib|apatinib|mesh-list
65016196|NCT04457180|Bupropion|bupropion|mesh-list
65016197|NCT04457180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016198|NCT04457180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65016199|NCT04457180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016200|NCT04457180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016201|NCT04457180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65016202|NCT04457180|Antidepressive Agents|antidepressive agents|mesh-ancestor
65016203|NCT04457180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65016204|NCT04457180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65016205|NCT04457180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65016206|NCT04457180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65016207|NCT04457180|Dopamine Agents|dopamine agents|mesh-ancestor
65016208|NCT04457180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65016209|NCT04457180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016210|NCT04457180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65016211|NCT04457180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65016212|NCT04457180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65016213|NCT00520000|Carboplatin|carboplatin|mesh-list
65016214|NCT00520000|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65016216|NCT00520000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016217|NCT00520000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65016218|NCT00520000|Tubulin Modulators|tubulin modulators|mesh-ancestor
64471787|NCT04117178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471788|NCT04117178|Nootropic Agents|nootropic agents|mesh-ancestor
64471789|NCT04117178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64471790|NCT04117178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64471791|NCT04117178|Dopamine Agents|dopamine agents|mesh-ancestor
64471792|NCT04117178|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64471793|NCT04117178|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64471794|NCT04099836|Bevacizumab|bevacizumab|mesh-list
64471795|NCT04099836|Atezolizumab|atezolizumab|mesh-list
64471796|NCT04099836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64471797|NCT04099836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471798|NCT04099836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64471799|NCT04099836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64471801|NCT04099836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471802|NCT04099836|Growth Inhibitors|growth inhibitors|mesh-ancestor
64471803|NCT04094961|Dexamethasone|dexamethasone|mesh-list
64471804|NCT04094961|Dexamethasone acetate|dexamethasone acetate|mesh-list
64471805|NCT04094961|Pomalidomide|pomalidomide|mesh-list
64471806|NCT04094961|Ixazomib|ixazomib|mesh-list
64471808|NCT04094961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65016239|NCT00520507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65016240|NCT00520507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65016241|NCT00520507|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65016242|NCT00520507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65016243|NCT00520507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65016244|NCT00520507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016245|NCT00520507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65016246|NCT00520507|Serotonin Agents|serotonin agents|mesh-ancestor
65016247|NCT04694404|Oxaliplatin|oxaliplatin|mesh-list
65016248|NCT04694404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016249|NCT00151983|Methylphenidate|methylphenidate|mesh-list
65016250|NCT00151983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65016251|NCT00151983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016252|NCT00151983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65016253|NCT00151983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65016254|NCT00151983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64500521|NCT01557322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64500522|NCT01557322|Antimetabolites|antimetabolites|mesh-ancestor
65016255|NCT00151983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016256|NCT00151983|Dopamine Agents|dopamine agents|mesh-ancestor
65016257|NCT00151983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65016259|NCT00520585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65016260|NCT00520585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65016261|NCT00520585|Antimetabolites|antimetabolites|mesh-ancestor
65016262|NCT00520585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016263|NCT00520585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65016264|NCT00520585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65016265|NCT00520585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016266|NCT00152022|Amphetamine|amphetamine|mesh-list
65016267|NCT00152022|Dextroamphetamine|dextroamphetamine|mesh-list
65016268|NCT00152022|Adderall|adderall|mesh-list
65016269|NCT00152022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65016270|NCT00152022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016271|NCT00152022|Sympathomimetics|sympathomimetics|mesh-ancestor
65016272|NCT00152022|Autonomic Agents|autonomic agents|mesh-ancestor
65016273|NCT00152022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65016274|NCT00152022|Dopamine Agents|dopamine agents|mesh-ancestor
65016275|NCT00152022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65016276|NCT00152022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016277|NCT00152022|Adrenergic Agents|adrenergic agents|mesh-ancestor
64471864|NCT04053634|Benralizumab|benralizumab|mesh-list
64471865|NCT04053634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64471866|NCT04053634|Respiratory System Agents|respiratory system agents|mesh-ancestor
64471867|NCT04025216|Cyclophosphamide|cyclophosphamide|mesh-list
64471868|NCT04025216|Fludarabine|fludarabine|mesh-list
64471869|NCT04025216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64471870|NCT04025216|Immunologic Factors|immunologic factors|mesh-ancestor
64471871|NCT04025216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471872|NCT04025216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64471873|NCT04025216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64471874|NCT04025216|Alkylating Agents|alkylating agents|mesh-ancestor
64471875|NCT04025216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471881|NCT03991936|Triamcinolone|triamcinolone|mesh-list
64471882|NCT03991936|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64471883|NCT03991936|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64471884|NCT03991936|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64471885|NCT03991936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64471886|NCT03991936|Glucocorticoids|glucocorticoids|mesh-ancestor
64471887|NCT03991936|Hormones|hormones|mesh-ancestor
64471888|NCT03991936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64471889|NCT03991936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471890|NCT03991936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64471891|NCT03991936|Immunologic Factors|immunologic factors|mesh-ancestor
64471892|NCT03991936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64471893|NCT03991936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471933|NCT03982082|Coal Tar|coal tar|mesh-list
64471934|NCT03982082|Keratolytic Agents|keratolytic agents|mesh-ancestor
65016278|NCT00152022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65016279|NCT00152022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65016280|NCT00152022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65016281|NCT00152022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65016282|NCT00520819|Antioxidants|antioxidants|mesh-list
65016283|NCT00520819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016284|NCT00520819|Protective Agents|protective agents|mesh-ancestor
65016285|NCT00520819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016286|NCT00520897|Raltegravir Potassium|raltegravir potassium|mesh-list
65016287|NCT00520897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65016288|NCT00520897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65016289|NCT00520897|Antiviral Agents|antiviral agents|mesh-ancestor
65016290|NCT00520897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65016291|NCT00520897|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65016292|NCT00520897|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65016293|NCT00520897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016294|NCT00520897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016303|NCT00521092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016304|NCT00521092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016305|NCT00521131|Levocetirizine|levocetirizine|mesh-list
65016306|NCT00521131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65016307|NCT00521131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65016308|NCT00521131|Histamine Antagonists|histamine antagonists|mesh-ancestor
65016309|NCT00521131|Histamine Agents|histamine agents|mesh-ancestor
65016310|NCT00521131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65016311|NCT00521131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016312|NCT00521131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016313|NCT04694092|Landiolol|landiolol|mesh-list
65016314|NCT04694092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65016315|NCT04694092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65016316|NCT04694092|Adrenergic Agents|adrenergic agents|mesh-ancestor
65016317|NCT04694092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65016318|NCT04694092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016319|NCT04694092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016320|NCT04694092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65016321|NCT00521170|Levocetirizine|levocetirizine|mesh-list
65016322|NCT00521170|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65016323|NCT00521170|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65016324|NCT00521170|Histamine Antagonists|histamine antagonists|mesh-ancestor
65016325|NCT00521170|Histamine Agents|histamine agents|mesh-ancestor
65016326|NCT00521170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65016328|NCT00521170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457489|NCT01853072|Nepafenac|nepafenac|mesh-list
65016350|NCT00167154|Dopamine Agents|dopamine agents|mesh-ancestor
65016352|NCT00521482|Temozolomide|temozolomide|mesh-list
65016353|NCT00521482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65016354|NCT00521482|Alkylating Agents|alkylating agents|mesh-ancestor
65016355|NCT00521482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016356|NCT00521482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016357|NCT00521482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65016358|NCT00521482|Immunologic Factors|immunologic factors|mesh-ancestor
65016359|NCT00521482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016360|NCT00521482|Leprostatic Agents|leprostatic agents|mesh-ancestor
65016361|NCT00521482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65016362|NCT00521482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65016363|NCT00521482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65016364|NCT00521482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65016365|NCT00521482|Growth Substances|growth substances|mesh-ancestor
65016366|NCT00521482|Growth Inhibitors|growth inhibitors|mesh-ancestor
65016367|NCT00521521|Docetaxel|docetaxel|mesh-list
65016368|NCT00521521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016369|NCT00521521|Tubulin Modulators|tubulin modulators|mesh-ancestor
65016370|NCT00521521|Antimitotic Agents|antimitotic agents|mesh-ancestor
65016371|NCT00521521|Mitosis Modulators|mitosis modulators|mesh-ancestor
65016372|NCT00521521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016373|NCT00152100|Alemtuzumab|alemtuzumab|mesh-list
65016374|NCT00152100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65016375|NCT00152100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016376|NCT00521950|Mercaptopurine|mercaptopurine|mesh-list
65016377|NCT00521950|Azathioprine|azathioprine|mesh-list
65016378|NCT00521950|Antimetabolites|antimetabolites|mesh-ancestor
65016379|NCT00521950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016380|NCT00521950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65016381|NCT00521950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016382|NCT00521950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65016391|NCT00522184|Analgesics|analgesics|mesh-ancestor
65016392|NCT00522184|Sensory System Agents|sensory system agents|mesh-ancestor
65016393|NCT00522184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65016394|NCT00522184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016395|NCT00522184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65016396|NCT00522184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65016397|NCT00522184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65016398|NCT00522184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65016399|NCT00522184|Immunologic Factors|immunologic factors|mesh-ancestor
65016400|NCT03458923|Diclofenac|diclofenac|mesh-list
65016401|NCT03458923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65016402|NCT03458923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65016403|NCT03458923|Ranibizumab|ranibizumab|mesh-list
65016404|NCT03458923|Endothelial Growth Factors|endothelial growth factors|mesh-list
65016405|NCT03458923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65016406|NCT03458923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65016407|NCT03458923|Growth Substances|growth substances|mesh-ancestor
65016408|NCT03458923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016409|NCT03458923|Growth Inhibitors|growth inhibitors|mesh-ancestor
65016410|NCT03458923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016411|NCT03458923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016412|NCT03458923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65016413|NCT03458923|Analgesics|analgesics|mesh-ancestor
65016414|NCT03458923|Sensory System Agents|sensory system agents|mesh-ancestor
65016415|NCT03458923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64881293|NCT01917708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881294|NCT01917708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64500523|NCT01557322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500524|NCT01557322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500525|NCT01557322|Dermatologic Agents|dermatologic agents|mesh-ancestor
64500526|NCT01557322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500527|NCT01557322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64500542|NCT01459588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64500543|NCT01459588|Laxatives|laxatives|mesh-ancestor
64500544|NCT01459588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64500545|NCT01501162|Ethanol|ethanol|mesh-list
64500546|NCT01501162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64500547|NCT01501162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64500548|NCT01501162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64500549|NCT01501162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500550|NCT01557868|Hyaluronic Acid|hyaluronic acid|mesh-list
64500552|NCT01557868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64500553|NCT01557868|Immunologic Factors|immunologic factors|mesh-ancestor
64500554|NCT01557868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500555|NCT01557868|Viscosupplements|viscosupplements|mesh-ancestor
64500556|NCT01557868|Protective Agents|protective agents|mesh-ancestor
64500557|NCT02208466|Fluoxetine|fluoxetine|mesh-list
65016416|NCT03458923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65016417|NCT03458923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65016418|NCT03458923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016419|NCT04186013|Atezolizumab|atezolizumab|mesh-list
65016420|NCT04186013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016421|NCT00152139|Antibodies|antibodies|mesh-list
65016422|NCT00152139|Immunologic Factors|immunologic factors|mesh-ancestor
65016423|NCT00152139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016424|NCT04725162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65016425|NCT04725162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65016426|NCT04725162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016427|NCT00405431|Lubricant Eye Drops|lubricant eye drops|mesh-list
65016428|NCT00405431|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65016429|NCT00405431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65016430|NCT00167232|Naltrexone|naltrexone|mesh-list
65016431|NCT00167232|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65016432|NCT00167232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65016433|NCT00167232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016434|NCT00167232|Sensory System Agents|sensory system agents|mesh-ancestor
65016435|NCT00167232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65016436|NCT00522886|Cetuximab|cetuximab|mesh-list
65016437|NCT00522886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65016438|NCT00522886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016439|NCT04083560|Hydroxocobalamin|hydroxocobalamin|mesh-list
65016440|NCT04083560|Vitamin B 12|vitamin b 12|mesh-list
65016441|NCT04083560|Hematinics|hematinics|mesh-ancestor
65016442|NCT04083560|Vitamin B Complex|vitamin b complex|mesh-ancestor
65016443|NCT04083560|Vitamins|vitamins|mesh-ancestor
65016444|NCT04083560|Micronutrients|micronutrients|mesh-ancestor
65016445|NCT04083560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016464|NCT00152178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016465|NCT00152178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65016466|NCT00152178|Antimetabolites|antimetabolites|mesh-ancestor
65016467|NCT00152178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65016468|NCT00152178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65016469|NCT00152178|Abortifacient Agents|abortifacient agents|mesh-ancestor
65016470|NCT00152178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65016471|NCT00152178|Dermatologic Agents|dermatologic agents|mesh-ancestor
65016472|NCT00152178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016473|NCT00152178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65016474|NCT00152178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65016475|NCT00152178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65016476|NCT00152178|Hormone Antagonists|hormone antagonists|mesh-ancestor
64472090|NCT03807765|Nivolumab|nivolumab|mesh-list
64472091|NCT03807765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64472092|NCT03807765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472093|NCT03807765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64472094|NCT03807765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472095|NCT03804944|Pembrolizumab|pembrolizumab|mesh-list
64472096|NCT03804944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64472097|NCT03804944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472098|NCT03794999|Benralizumab|benralizumab|mesh-list
64472099|NCT03794999|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64472101|NCT03790111|Gemcitabine|gemcitabine|mesh-list
65016489|NCT00523120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65016490|NCT00523120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65016491|NCT00523120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65016492|NCT00523120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016493|NCT00523120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016495|NCT00523159|Immunologic Factors|immunologic factors|mesh-ancestor
65016496|NCT00523159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016497|NCT04693897|Solifenacin Succinate|solifenacin succinate|mesh-list
65016498|NCT04693897|Mirabegron|mirabegron|mesh-list
65016499|NCT04693897|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65016500|NCT04693897|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65016501|NCT04693897|Cholinergic Agents|cholinergic agents|mesh-ancestor
65016502|NCT04693897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65016503|NCT04693897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016504|NCT04693897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016505|NCT04693897|Urological Agents|urological agents|mesh-ancestor
65016506|NCT04693897|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65016507|NCT04693897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65016508|NCT04693897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65016509|NCT04693897|Adrenergic Agents|adrenergic agents|mesh-ancestor
65016510|NCT00424242|Pemetrexed|pemetrexed|mesh-list
65016511|NCT00424242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016512|NCT00424242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016513|NCT00424242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016514|NCT00424242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65016515|NCT00424242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65016516|NCT04726553|Mycophenolic Acid|mycophenolic acid|mesh-list
65016517|NCT04726553|Antimalarials|antimalarials|mesh-list
65016535|NCT04726553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65016536|NCT04726553|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65016537|NCT04726553|Antitubercular Agents|antitubercular agents|mesh-ancestor
65016538|NCT04726553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65016539|NCT04726553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65016540|NCT04726553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65016541|NCT04726553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65016542|NCT02947945|Reslizumab|reslizumab|mesh-list
65016543|NCT02947945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65016544|NCT02947945|Respiratory System Agents|respiratory system agents|mesh-ancestor
65016545|NCT02948101|Cyclophosphamide|cyclophosphamide|mesh-list
65016546|NCT02948101|Antibodies|antibodies|mesh-list
65016547|NCT02948101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65016548|NCT02948101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65016549|NCT02948101|Immunologic Factors|immunologic factors|mesh-ancestor
64457713|NCT03792958|Vorolanib|vorolanib|mesh-list
65016550|NCT02948101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016551|NCT02948101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65016552|NCT02948101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65016553|NCT02948101|Alkylating Agents|alkylating agents|mesh-ancestor
65016554|NCT02948101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016555|NCT02948101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016556|NCT02948101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65016558|NCT02952157|Anesthetics, Local|anesthetics, local|mesh-ancestor
65016559|NCT02952157|Anesthetics|anesthetics|mesh-ancestor
65016560|NCT02952157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65016561|NCT02952157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016562|NCT02952157|Sensory System Agents|sensory system agents|mesh-ancestor
65016563|NCT02952157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65016564|NCT02952157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65016565|NCT02952157|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65016579|NCT02951728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65016580|NCT02951728|Alkylating Agents|alkylating agents|mesh-ancestor
65016581|NCT02951728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016582|NCT02951728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016583|NCT02951728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65016584|NCT02951728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65016585|NCT02951728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65016586|NCT02951728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65016587|NCT02951728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65016588|NCT02951728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016589|NCT02951728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65016590|NCT02951728|Glucocorticoids|glucocorticoids|mesh-ancestor
65016591|NCT02951728|Hormones|hormones|mesh-ancestor
65016592|NCT02951728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64472233|NCT03629327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64472234|NCT03629327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64472235|NCT03629327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64472236|NCT03629327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472237|NCT03629327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64472238|NCT03629327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64472239|NCT03629327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472240|NCT03629327|Antipyretics|antipyretics|mesh-ancestor
64472241|NCT03628209|Nivolumab|nivolumab|mesh-list
64472242|NCT03628209|Azacitidine|azacitidine|mesh-list
64472243|NCT03628209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64472244|NCT03628209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472245|NCT03628209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64472246|NCT03628209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472247|NCT03628209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64472248|NCT03628209|Antimetabolites|antimetabolites|mesh-ancestor
64472249|NCT03628209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472250|NCT03618641|Nivolumab|nivolumab|mesh-list
64472258|NCT03617718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472259|NCT03617718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472260|NCT03610061|Durvalumab|durvalumab|mesh-list
65016593|NCT02951728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65016594|NCT02951728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65016595|NCT02951728|Tubulin Modulators|tubulin modulators|mesh-ancestor
65016596|NCT02951728|Antimitotic Agents|antimitotic agents|mesh-ancestor
65016597|NCT02951728|Mitosis Modulators|mitosis modulators|mesh-ancestor
65016598|NCT02951728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65016599|NCT02951728|Antimetabolites|antimetabolites|mesh-ancestor
65016600|NCT04726046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65016601|NCT04726046|Cefotetan|cefotetan|mesh-list
65016602|NCT04726046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65016603|NCT00523354|Infliximab|infliximab|mesh-list
65016604|NCT00523354|Dermatologic Agents|dermatologic agents|mesh-ancestor
65016605|NCT00523354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65016606|NCT00523354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65016607|NCT00523393|Insulin|insulin|mesh-list
65016608|NCT00523393|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65016609|NCT00523393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65016646|NCT00167583|Cyclosporins|cyclosporins|mesh-list
65016647|NCT00167583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016648|NCT00167583|Antiviral Agents|antiviral agents|mesh-ancestor
65016649|NCT00167583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65016650|NCT00167583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016651|NCT00167583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016652|NCT00167583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65016653|NCT00167583|Immunologic Factors|immunologic factors|mesh-ancestor
65016654|NCT00167583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016655|NCT00167583|Antifungal Agents|antifungal agents|mesh-ancestor
65016656|NCT00167583|Dermatologic Agents|dermatologic agents|mesh-ancestor
65016657|NCT00167583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65016658|NCT00167583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65016659|NCT03943511|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65016660|NCT03943511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65016661|NCT00172809|Interferons|interferons|mesh-list
65016662|NCT00172809|Interferon-alpha|interferon-alpha|mesh-list
65016663|NCT00172809|Interferon alpha-2|interferon alpha-2|mesh-list
65016664|NCT00172809|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65016665|NCT00172809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016666|NCT00172809|Antiviral Agents|antiviral agents|mesh-ancestor
65016667|NCT00172809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65016668|NCT00172809|Immunologic Factors|immunologic factors|mesh-ancestor
65016669|NCT00172809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016670|NCT04696120|Apixaban|apixaban|mesh-list
65016671|NCT04696120|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65016672|NCT04696120|Antithrombins|antithrombins|mesh-ancestor
65016673|NCT04696120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65016674|NCT04696120|Protease Inhibitors|protease inhibitors|mesh-ancestor
65016675|NCT04696120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016676|NCT04696120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016677|NCT04696120|Anticoagulants|anticoagulants|mesh-ancestor
65016678|NCT00512395|Fentanyl|fentanyl|mesh-list
65016679|NCT00512395|Ropivacaine|ropivacaine|mesh-list
65016680|NCT00512395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65016681|NCT00512395|Narcotics|narcotics|mesh-ancestor
65016684|NCT00512395|Analgesics|analgesics|mesh-ancestor
65016687|NCT00512395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65016688|NCT00512395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65016689|NCT00512395|Anesthetics, General|anesthetics, general|mesh-ancestor
65016690|NCT00512395|Anesthetics|anesthetics|mesh-ancestor
65016691|NCT00512395|Anesthetics, Local|anesthetics, local|mesh-ancestor
65016692|NCT00512473|Hormones|hormones|mesh-list
65016693|NCT00512473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65016694|NCT00512473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016695|NCT00524095|Fluticasone|fluticasone|mesh-list
65016697|NCT00524095|Azithromycin|azithromycin|mesh-list
65016698|NCT00524095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65016699|NCT00524095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65016700|NCT00524095|Autonomic Agents|autonomic agents|mesh-ancestor
65016701|NCT00524095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65016702|NCT00524095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016703|NCT00524095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65016704|NCT00524095|Respiratory System Agents|respiratory system agents|mesh-ancestor
65016705|NCT00524095|Dermatologic Agents|dermatologic agents|mesh-ancestor
65016706|NCT00524095|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65016707|NCT00524095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65016708|NCT00524095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65016709|NCT00512629|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65016710|NCT00512629|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65016711|NCT00512629|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65016712|NCT00512629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65016713|NCT00512668|Sirolimus|sirolimus|mesh-list
65016714|NCT00512668|Leuprolide|leuprolide|mesh-list
65016715|NCT00512668|Goserelin|goserelin|mesh-list
65016716|NCT00512668|Flutamide|flutamide|mesh-list
65016717|NCT00512668|Bicalutamide|bicalutamide|mesh-list
65016718|NCT00512668|Nilutamide|nilutamide|mesh-list
65016733|NCT00512668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65016734|NCT00167739|Pyrimethamine|pyrimethamine|mesh-list
65016735|NCT00167739|Sulfadoxine|sulfadoxine|mesh-list
65016736|NCT00167739|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65016737|NCT00167739|Quinine|quinine|mesh-list
65016738|NCT00167739|Antimalarials|antimalarials|mesh-ancestor
65016739|NCT00167739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65016740|NCT00167739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64472386|NCT03451487|Analgesics|analgesics|mesh-ancestor
64472387|NCT03451487|Sensory System Agents|sensory system agents|mesh-ancestor
64472388|NCT03451487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64472389|NCT03451487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472390|NCT03451487|Antipyretics|antipyretics|mesh-ancestor
64472391|NCT03410030|Ascorbic Acid|ascorbic acid|mesh-list
64472392|NCT03410030|Gemcitabine|gemcitabine|mesh-list
65016741|NCT00167739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65016743|NCT00167739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016744|NCT00167739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016745|NCT00167739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65016746|NCT00167739|Renal Agents|renal agents|mesh-ancestor
65016747|NCT00167739|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65016748|NCT00167739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016749|NCT00167739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65016750|NCT00167739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65016751|NCT00167739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65016752|NCT00167739|Analgesics|analgesics|mesh-ancestor
65016753|NCT00167739|Sensory System Agents|sensory system agents|mesh-ancestor
65016754|NCT00524251|Esomeprazole|esomeprazole|mesh-list
65016774|NCT00525889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65016775|NCT00525889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65016776|NCT00525889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016777|NCT00525889|Antifungal Agents|antifungal agents|mesh-ancestor
65016778|NCT00525889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65016779|NCT00525889|Immunologic Factors|immunologic factors|mesh-ancestor
65016780|NCT00525889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016781|NCT00524524|Beta-lapachone|beta-lapachone|mesh-list
65016782|NCT00524524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65016783|NCT00524524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65016784|NCT00524524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65016785|NCT00524524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016786|NCT00524524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016787|NCT00524524|Antiviral Agents|antiviral agents|mesh-ancestor
65016788|NCT03879122|Docetaxel|docetaxel|mesh-list
65016789|NCT03879122|Nivolumab|nivolumab|mesh-list
65016790|NCT03879122|Ipilimumab|ipilimumab|mesh-list
65016791|NCT03879122|Androgens|androgens|mesh-list
65016792|NCT03879122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016793|NCT03879122|Tubulin Modulators|tubulin modulators|mesh-ancestor
65016794|NCT03879122|Antimitotic Agents|antimitotic agents|mesh-ancestor
65016795|NCT03879122|Mitosis Modulators|mitosis modulators|mesh-ancestor
65016796|NCT03879122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016797|NCT03879122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65016798|NCT03879122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65016799|NCT03879122|Hormones|hormones|mesh-ancestor
64472468|NCT03263481|Secretin|secretin|mesh-list
64472469|NCT03263481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64472470|NCT03263481|Hormones|hormones|mesh-ancestor
64472471|NCT03263481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64472472|NCT03263481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016801|NCT03879122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016802|NCT00525928|Varenicline|varenicline|mesh-list
65016803|NCT00525928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65016804|NCT00525928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65016805|NCT00525928|Cholinergic Agents|cholinergic agents|mesh-ancestor
65016806|NCT00525928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65016807|NCT00525928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016808|NCT00525928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016809|NCT00167817|Aripiprazole|aripiprazole|mesh-list
65016810|NCT00167817|Antidepressive Agents|antidepressive agents|mesh-ancestor
65016811|NCT00167817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65016812|NCT00167817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65016813|NCT00167817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65016814|NCT00167817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65016815|NCT00167817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016816|NCT00167817|Dopamine Agonists|dopamine agonists|mesh-ancestor
65016817|NCT00167817|Dopamine Agents|dopamine agents|mesh-ancestor
65016818|NCT00167817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65016819|NCT00167817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016820|NCT00167817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65016821|NCT00167817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65016823|NCT00167817|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65016824|NCT00167817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65016825|NCT00167817|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65016848|NCT04723563|Anticoagulants|anticoagulants|mesh-ancestor
65016849|NCT04723563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65016850|NCT04723563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65016851|NCT04723563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016852|NCT00525967|Acetaminophen|acetaminophen|mesh-list
65016853|NCT00525967|Methadone|methadone|mesh-list
65016854|NCT00525967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65016855|NCT00525967|Analgesics|analgesics|mesh-ancestor
65016856|NCT00525967|Sensory System Agents|sensory system agents|mesh-ancestor
65016857|NCT00525967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65016858|NCT00525967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016859|NCT00525967|Antipyretics|antipyretics|mesh-ancestor
65016860|NCT00525967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65016861|NCT00525967|Narcotics|narcotics|mesh-ancestor
65016862|NCT00525967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65016863|NCT00525967|Antitussive Agents|antitussive agents|mesh-ancestor
65016864|NCT00525967|Respiratory System Agents|respiratory system agents|mesh-ancestor
65016865|NCT00167856|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65016866|NCT00167856|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65016867|NCT00167856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65016868|NCT00167856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65016869|NCT00167856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016870|NCT00167856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65016871|NCT00167856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016872|NCT00167856|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65016873|NCT00167856|Antidepressive Agents|antidepressive agents|mesh-ancestor
65016874|NCT00167856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65016875|NCT00526006|Esomeprazole|esomeprazole|mesh-list
65016876|NCT00526006|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65016877|NCT00526006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65016878|NCT00526006|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65016879|NCT00526006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016880|NCT00526006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016881|NCT03681275|Tofacitinib|tofacitinib|mesh-list
65016883|NCT03681275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65016884|NCT03681275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016885|NCT02946814|Listerine|listerine|mesh-list
65016886|NCT02946814|Sodium Fluoride|sodium fluoride|mesh-list
65016887|NCT02946814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65016888|NCT02946814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65016889|NCT02946814|Cariostatic Agents|cariostatic agents|mesh-ancestor
65016890|NCT02946814|Protective Agents|protective agents|mesh-ancestor
65016891|NCT02946814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016892|NCT00524836|Levocetirizine|levocetirizine|mesh-list
64890621|NCT01975129|Oxytocin|oxytocin|mesh-list
65016893|NCT00524836|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65016894|NCT00524836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65016895|NCT00524836|Histamine Antagonists|histamine antagonists|mesh-ancestor
65016896|NCT00524836|Histamine Agents|histamine agents|mesh-ancestor
65016897|NCT00524836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65016898|NCT00524836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016899|NCT00524836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016900|NCT00524875|Bevacizumab|bevacizumab|mesh-list
65016901|NCT00524875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65016902|NCT00524875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65016903|NCT00524875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65016904|NCT00524875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65016905|NCT00524875|Growth Substances|growth substances|mesh-ancestor
65016906|NCT00524875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016907|NCT00524875|Growth Inhibitors|growth inhibitors|mesh-ancestor
65016908|NCT00524914|Apomorphine|apomorphine|mesh-list
65016909|NCT00524914|Emetics|emetics|mesh-ancestor
65016910|NCT00524914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016911|NCT00524914|Autonomic Agents|autonomic agents|mesh-ancestor
65016918|NCT02957864|Tenofovir|tenofovir|mesh-list
65016925|NCT02957864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016926|NCT02957864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65016927|NCT02957864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65016928|NCT00168012|Immunoglobulins|immunoglobulins|mesh-list
65016929|NCT00168012|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65016930|NCT00168012|Antibodies|antibodies|mesh-list
65016931|NCT00168012|Immunologic Factors|immunologic factors|mesh-ancestor
65016932|NCT00168012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016933|NCT03585452|Dexmedetomidine|dexmedetomidine|mesh-list
65016934|NCT03585452|Propofol|propofol|mesh-list
65016935|NCT03585452|Anesthetics|anesthetics|mesh-ancestor
65016936|NCT03585452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65016937|NCT03585452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016938|NCT03585452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65016939|NCT03585452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65016940|NCT03585452|Anesthetics, General|anesthetics, general|mesh-ancestor
65016941|NCT03585452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65016942|NCT03585452|Analgesics|analgesics|mesh-ancestor
65016943|NCT03585452|Sensory System Agents|sensory system agents|mesh-ancestor
65016944|NCT03585452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65016945|NCT03585452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65016946|NCT03585452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65016947|NCT03585452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65016948|NCT03585452|Adrenergic Agents|adrenergic agents|mesh-ancestor
65016949|NCT03585452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65016950|NCT03585452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016951|NCT02947672|Dexamethasone|dexamethasone|mesh-list
65016952|NCT02947672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65016953|NCT02947672|Antiemetics|antiemetics|mesh-ancestor
65016954|NCT02947672|Autonomic Agents|autonomic agents|mesh-ancestor
65016955|NCT02947672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65016956|NCT02947672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016966|NCT03539627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65016967|NCT02946268|Ropivacaine|ropivacaine|mesh-list
65016968|NCT02946268|Anesthetics, Local|anesthetics, local|mesh-ancestor
65016969|NCT02946268|Anesthetics|anesthetics|mesh-ancestor
65016970|NCT02946268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65016971|NCT02946268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016972|NCT02946268|Sensory System Agents|sensory system agents|mesh-ancestor
65016973|NCT02946268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65016974|NCT00168051|Factor VIII|factor viii|mesh-list
65016975|NCT00168051|Coagulants|coagulants|mesh-ancestor
65016976|NCT00526318|Cyclophosphamide|cyclophosphamide|mesh-list
65016977|NCT00526318|Melphalan|melphalan|mesh-list
65016978|NCT00526318|Ifosfamide|ifosfamide|mesh-list
65016979|NCT00526318|Dacarbazine|dacarbazine|mesh-list
65016980|NCT00526318|Carboplatin|carboplatin|mesh-list
65016981|NCT00526318|Doxorubicin|doxorubicin|mesh-list
65016982|NCT00526318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65016983|NCT00526318|Etoposide|etoposide|mesh-list
65016984|NCT00526318|Vincristine|vincristine|mesh-list
65016985|NCT00526318|Topotecan|topotecan|mesh-list
65016986|NCT00526318|Etoposide phosphate|etoposide phosphate|mesh-list
65016987|NCT00526318|Vindesine|vindesine|mesh-list
65016988|NCT00526318|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65016989|NCT00526318|Isotretinoin|isotretinoin|mesh-list
65016990|NCT00526318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65016991|NCT00526318|Immunologic Factors|immunologic factors|mesh-ancestor
65016992|NCT00526318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65016993|NCT00526318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65016994|NCT00526318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65016995|NCT00526318|Alkylating Agents|alkylating agents|mesh-ancestor
65016996|NCT00526318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472702|NCT02981628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64472703|NCT02981628|Immunologic Factors|immunologic factors|mesh-ancestor
64472704|NCT02981628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472705|NCT02981628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64472706|NCT02981628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64472707|NCT02981628|Alkylating Agents|alkylating agents|mesh-ancestor
64472709|NCT02981628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017014|NCT04693312|Prednisolone acetate|prednisolone acetate|mesh-list
65017015|NCT04693312|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65017016|NCT04693312|Prednisolone phosphate|prednisolone phosphate|mesh-list
65017017|NCT04693312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65017018|NCT04693312|Antiemetics|antiemetics|mesh-ancestor
65017019|NCT04693312|Autonomic Agents|autonomic agents|mesh-ancestor
65017020|NCT04693312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65017021|NCT04693312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017022|NCT04693312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65017023|NCT04693312|Glucocorticoids|glucocorticoids|mesh-ancestor
65017024|NCT04693312|Hormones|hormones|mesh-ancestor
65017025|NCT04693312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65017026|NCT04693312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65017027|NCT04693312|Protective Agents|protective agents|mesh-ancestor
65017028|NCT04693312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65017029|NCT04693312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017030|NCT00168090|Factor VIII|factor viii|mesh-list
65017031|NCT00168090|Coagulants|coagulants|mesh-ancestor
65017032|NCT00525382|Levocetirizine|levocetirizine|mesh-list
65017033|NCT00525382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65017034|NCT00525382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65017036|NCT00525382|Histamine Agents|histamine agents|mesh-ancestor
65017053|NCT00525577|Antimetabolites|antimetabolites|mesh-ancestor
65017054|NCT00525577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017055|NCT00525577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65017056|NCT00525577|Antioxidants|antioxidants|mesh-ancestor
65017057|NCT00525577|Protective Agents|protective agents|mesh-ancestor
65017058|NCT00525577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017059|NCT03186755|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
65017060|NCT03186755|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65017061|NCT03186755|Hyaluronic Acid|hyaluronic acid|mesh-list
65017062|NCT03186755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65017063|NCT03186755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65017064|NCT03186755|Immunologic Factors|immunologic factors|mesh-ancestor
65017065|NCT03186755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017066|NCT03186755|Viscosupplements|viscosupplements|mesh-ancestor
65017067|NCT03186755|Protective Agents|protective agents|mesh-ancestor
65017068|NCT03186755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65017069|NCT03186755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65017070|NCT03186755|Analgesics|analgesics|mesh-ancestor
65017071|NCT03186755|Sensory System Agents|sensory system agents|mesh-ancestor
65017072|NCT03186755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65017073|NCT03186755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65017074|NCT03186755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65017075|NCT03186755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65017076|NCT03186755|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65017077|NCT03186755|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65017078|NCT03186755|Histamine Antagonists|histamine antagonists|mesh-ancestor
65017079|NCT03186755|Histamine Agents|histamine agents|mesh-ancestor
65017080|NCT03186755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65017081|NCT03186755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017082|NCT00525616|Rituximab|rituximab|mesh-list
65017083|NCT00525616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65017092|NCT00525694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017093|NCT00525694|Sensory System Agents|sensory system agents|mesh-ancestor
65017094|NCT00525694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65017095|NCT00525694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65017096|NCT00525694|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65017097|NCT00525694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65017098|NCT00525694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65017099|NCT00525694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017100|NCT00525694|Dopamine Agents|dopamine agents|mesh-ancestor
65017101|NCT00525694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65017102|NCT02947243|Morphine|morphine|mesh-list
65017103|NCT02947243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65017104|NCT02947243|Narcotics|narcotics|mesh-ancestor
65017105|NCT02947243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65017106|NCT02947243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017107|NCT02947243|Analgesics|analgesics|mesh-ancestor
65017108|NCT02947243|Sensory System Agents|sensory system agents|mesh-ancestor
65017109|NCT02947243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65017110|NCT02946970|Quinine|quinine|mesh-list
65017111|NCT02946970|Antimalarials|antimalarials|mesh-ancestor
65017112|NCT02946970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65017113|NCT02946970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65017114|NCT02946970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65017115|NCT02946970|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65017142|NCT00527059|Simendan|simendan|mesh-list
65017143|NCT00527059|Spironolactone|spironolactone|mesh-list
65017144|NCT00527059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65017145|NCT00527059|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65017146|NCT00527059|Hormone Antagonists|hormone antagonists|mesh-ancestor
65017147|NCT00527059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65017148|NCT00527059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017149|NCT00527059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65017150|NCT00527059|Diuretics|diuretics|mesh-ancestor
65017151|NCT00527059|Natriuretic Agents|natriuretic agents|mesh-ancestor
65017152|NCT00527059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65017153|NCT00527059|Adrenergic Agents|adrenergic agents|mesh-ancestor
65017154|NCT00527059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65017155|NCT00527059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458394|NCT04020016|Nalbuphine|nalbuphine|mesh-list
64472869|NCT02444429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64472870|NCT02444429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64472871|NCT02444429|Prednisolone|prednisolone|mesh-list
64472872|NCT02444429|Prednisolone acetate|prednisolone acetate|mesh-list
65017156|NCT00527059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65017157|NCT00527059|Vasodilator Agents|vasodilator agents|mesh-ancestor
65017158|NCT00527059|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65017159|NCT00527059|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65017160|NCT00527059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017161|NCT00527059|Protective Agents|protective agents|mesh-ancestor
65017162|NCT03156452|Mycophenolic Acid|mycophenolic acid|mesh-list
65017163|NCT03156452|Prednisolone|prednisolone|mesh-list
65017164|NCT03156452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65017165|NCT03156452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017166|NCT03156452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65017167|NCT03156452|Antitubercular Agents|antitubercular agents|mesh-ancestor
65017168|NCT03156452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65017179|NCT00525772|Glucocorticoids|glucocorticoids|mesh-ancestor
65017180|NCT00525772|Hormones|hormones|mesh-ancestor
65017181|NCT00525772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65017182|NCT00525772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017183|NCT00525772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65017184|NCT02945956|Entecavir|entecavir|mesh-list
65017185|NCT02945956|Antiviral Agents|antiviral agents|mesh-ancestor
65017186|NCT02945956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65017187|NCT03122639|Atorvastatin|atorvastatin|mesh-list
65017188|NCT03122639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65017189|NCT03122639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65017190|NCT03122639|Antimetabolites|antimetabolites|mesh-ancestor
65017191|NCT03122639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017192|NCT03122639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65017193|NCT03122639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65017194|NCT03122639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017195|NCT00527137|Darbepoetin alfa|darbepoetin alfa|mesh-list
65017196|NCT00527137|Hematinics|hematinics|mesh-ancestor
65017197|NCT02945839|Topiramate|topiramate|mesh-list
65017198|NCT02945839|Anticonvulsants|anticonvulsants|mesh-ancestor
65017199|NCT02945839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65017200|NCT02945839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017201|NCT02957786|Varenicline|varenicline|mesh-list
65017202|NCT02957786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65017203|NCT02957786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65017204|NCT02957786|Cholinergic Agents|cholinergic agents|mesh-ancestor
65017205|NCT02957786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65017206|NCT02957786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017207|NCT02957786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017208|NCT00407394|Amoxicillin|amoxicillin|mesh-list
65017209|NCT00407394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65017210|NCT00407394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65017211|NCT03109964|Hemostatics|hemostatics|mesh-list
65017212|NCT03109964|Surgiflo|surgiflo|mesh-list
65017213|NCT03109964|Coagulants|coagulants|mesh-ancestor
65017221|NCT00407433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65017222|NCT00407433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017223|NCT00407433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65017224|NCT00407433|Immunologic Factors|immunologic factors|mesh-ancestor
65017225|NCT00407433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017226|NCT00516412|Everolimus|everolimus|mesh-list
65017227|NCT00516412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017228|NCT00516412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65017229|NCT00516412|Immunologic Factors|immunologic factors|mesh-ancestor
65017230|NCT00516412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017231|NCT03058835|Tenofovir|tenofovir|mesh-list
64458472|NCT04020718|Nicotine|nicotine|mesh-list
65017232|NCT03058835|Emtricitabine|emtricitabine|mesh-list
65017233|NCT03058835|Antiviral Agents|antiviral agents|mesh-ancestor
65017234|NCT03058835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65017235|NCT03058835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65017236|NCT03058835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65017237|NCT03058835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017238|NCT03058835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017239|NCT03058835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65017240|NCT03058835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65017241|NCT00516490|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65017242|NCT00516490|Luteolytic Agents|luteolytic agents|mesh-ancestor
65017243|NCT00516490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65017244|NCT00516490|Contraceptive Agents|contraceptive agents|mesh-ancestor
65017245|NCT00516490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65017246|NCT00516490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017247|NCT00516490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65017248|NCT00516490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65017249|NCT00516490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017250|NCT00516607|Temozolomide|temozolomide|mesh-list
65017251|NCT00516607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65017252|NCT00516607|Alkylating Agents|alkylating agents|mesh-ancestor
65017261|NCT00173667|Vasodilator Agents|vasodilator agents|mesh-ancestor
65017262|NCT00173667|Tocolytic Agents|tocolytic agents|mesh-ancestor
65017263|NCT00173667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65017264|NCT00516685|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65017265|NCT00516685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65017266|NCT00516685|Immunologic Factors|immunologic factors|mesh-ancestor
65017267|NCT00516685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017268|NCT03016871|Carboplatin|carboplatin|mesh-list
65017269|NCT03016871|Nivolumab|nivolumab|mesh-list
65017270|NCT03016871|Etoposide|etoposide|mesh-list
65017271|NCT03016871|Etoposide phosphate|etoposide phosphate|mesh-list
65017272|NCT03016871|Ifosfamide|ifosfamide|mesh-list
65017273|NCT03016871|Isophosphamide mustard|isophosphamide mustard|mesh-list
65017274|NCT03016871|Podophyllotoxin|podophyllotoxin|mesh-list
65017275|NCT03016871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017276|NCT03016871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65017277|NCT03016871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65017278|NCT03016871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017279|NCT03016871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65017280|NCT03016871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65017281|NCT03016871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65017282|NCT03016871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017283|NCT03016871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65017284|NCT03016871|Alkylating Agents|alkylating agents|mesh-ancestor
65017285|NCT03016871|Keratolytic Agents|keratolytic agents|mesh-ancestor
65017286|NCT03016871|Dermatologic Agents|dermatologic agents|mesh-ancestor
65017287|NCT03016871|Tubulin Modulators|tubulin modulators|mesh-ancestor
65017288|NCT03016871|Antimitotic Agents|antimitotic agents|mesh-ancestor
65017289|NCT03016871|Mitosis Modulators|mitosis modulators|mesh-ancestor
65017290|NCT03458689|Analgesics|analgesics|mesh-list
65017291|NCT03458689|Sensory System Agents|sensory system agents|mesh-ancestor
65017292|NCT03458689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65017293|NCT03458689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017294|NCT00527215|Darbepoetin alfa|darbepoetin alfa|mesh-list
65017295|NCT00527215|Hematinics|hematinics|mesh-ancestor
65017296|NCT00173745|Botulinum Toxins|botulinum toxins|mesh-list
64882254|NCT01932372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500558|NCT02208466|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64500559|NCT02208466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65017297|NCT00173745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65017298|NCT00173745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65017299|NCT00173745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65017300|NCT00173745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65017301|NCT00173745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017302|NCT00173745|Cholinergic Agents|cholinergic agents|mesh-ancestor
65017303|NCT00173745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65017304|NCT00173745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473016|NCT01726582|Vitamin B Complex|vitamin b complex|mesh-ancestor
65017306|NCT00173745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65017307|NCT02945644|Trazodone|trazodone|mesh-list
65017308|NCT02945644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65017309|NCT02945644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65017310|NCT02945644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65017311|NCT02945644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017312|NCT02945644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65017313|NCT02945644|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65017314|NCT02945644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65017315|NCT02945644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65017316|NCT02945644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017317|NCT02945644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65017318|NCT02945644|Serotonin Agents|serotonin agents|mesh-ancestor
65017319|NCT02945644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65017320|NCT02945644|Antidepressive Agents|antidepressive agents|mesh-ancestor
65017321|NCT02460887|Gemcitabine|gemcitabine|mesh-list
65017344|NCT02945527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65017345|NCT02945527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017346|NCT02945527|Anticonvulsants|anticonvulsants|mesh-ancestor
65017347|NCT02945527|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65017348|NCT02945527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017349|NCT02945527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017350|NCT02945527|Diuretics|diuretics|mesh-ancestor
65017351|NCT02945527|Natriuretic Agents|natriuretic agents|mesh-ancestor
65017352|NCT00168363|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65017353|NCT00168363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65017354|NCT00168363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65017355|NCT00168363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65017356|NCT00168363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65017357|NCT00168363|Adrenergic Agents|adrenergic agents|mesh-ancestor
65017358|NCT00168363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65017359|NCT00168363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017360|NCT00168363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017361|NCT02448095|Ponatinib|ponatinib|mesh-list
65017362|NCT02448095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017363|NCT02448095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65017364|NCT02448095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017365|NCT02448095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017366|NCT00168402|Botulinum Toxins|botulinum toxins|mesh-list
65017367|NCT00168402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65017368|NCT00168402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65017369|NCT00168402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65017370|NCT00168402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65017371|NCT00168402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017372|NCT00168402|Cholinergic Agents|cholinergic agents|mesh-ancestor
65017373|NCT00168402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65017374|NCT00168402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017375|NCT00168402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65017382|NCT00529594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65017383|NCT00529594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017384|NCT00529594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65017385|NCT00529594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65017386|NCT00529594|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65017387|NCT00529594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65017388|NCT00529594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017389|NCT00529594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017390|NCT00173862|Gemcitabine|gemcitabine|mesh-list
65017391|NCT00173862|Ifosfamide|ifosfamide|mesh-list
65017392|NCT00173862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65017393|NCT00173862|Antimetabolites|antimetabolites|mesh-ancestor
65017394|NCT00173862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017395|NCT00173862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017396|NCT00173862|Antiviral Agents|antiviral agents|mesh-ancestor
65017397|NCT00173862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65017398|NCT00173862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017399|NCT00173862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65017400|NCT00173862|Immunologic Factors|immunologic factors|mesh-ancestor
65017401|NCT00173862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017402|NCT00173862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65017403|NCT00173862|Alkylating Agents|alkylating agents|mesh-ancestor
65017405|NCT00529750|Irbesartan|irbesartan|mesh-list
65017406|NCT00529750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65017407|NCT00529750|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65017408|NCT00529750|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65017409|NCT00529750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017410|NCT00529750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65017411|NCT00529750|Sympatholytics|sympatholytics|mesh-ancestor
65017412|NCT00529750|Autonomic Agents|autonomic agents|mesh-ancestor
65017413|NCT00529750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65017424|NCT00529867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65017425|NCT00529867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65017426|NCT00529867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65017427|NCT00168441|Botulinum Toxins|botulinum toxins|mesh-list
65017428|NCT00168441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65017429|NCT00168441|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65017430|NCT00168441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65017431|NCT00168441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65017432|NCT00168441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017433|NCT00168441|Cholinergic Agents|cholinergic agents|mesh-ancestor
65017434|NCT00168441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65017435|NCT00168441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017436|NCT00168441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65017437|NCT00168441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65017438|NCT00168480|Botulinum Toxins|botulinum toxins|mesh-list
65017439|NCT00168480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65017440|NCT00168480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65017481|NCT00527683|Vigabatrin|vigabatrin|mesh-list
65017482|NCT00527683|Anticonvulsants|anticonvulsants|mesh-ancestor
65017483|NCT00527683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017484|NCT00527683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017485|NCT00527683|GABA Agents|gaba agents|mesh-ancestor
65017486|NCT00527683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65017487|NCT00527683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017488|NCT00173901|Ceftazidime|ceftazidime|mesh-list
65017489|NCT00173901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65017490|NCT00173901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65017491|NCT00527761|Cisplatin|cisplatin|mesh-list
65017492|NCT00527761|Docetaxel|docetaxel|mesh-list
65017493|NCT00527761|Temozolomide|temozolomide|mesh-list
65017494|NCT00527761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017495|NCT00527761|Tubulin Modulators|tubulin modulators|mesh-ancestor
65017496|NCT00527761|Antimitotic Agents|antimitotic agents|mesh-ancestor
65017497|NCT00527761|Mitosis Modulators|mitosis modulators|mesh-ancestor
65017541|NCT00144677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65017542|NCT00144677|Immunologic Factors|immunologic factors|mesh-ancestor
65017543|NCT00144677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017544|NCT00144677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65017545|NCT00144677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017546|NCT00144677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017547|NCT00144677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65017548|NCT00144677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65017549|NCT00144677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65017550|NCT00144677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017551|NCT00144677|Antifungal Agents|antifungal agents|mesh-ancestor
65017553|NCT00531076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65017554|NCT00531076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017555|NCT00531076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65017556|NCT00531076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65017557|NCT00531076|Growth Substances|growth substances|mesh-ancestor
65017558|NCT00531076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017559|NCT00531076|Growth Inhibitors|growth inhibitors|mesh-ancestor
65017560|NCT00531115|Cetuximab|cetuximab|mesh-list
65017561|NCT00531115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65017562|NCT00531115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017563|NCT00144716|Insect Repellents|insect repellents|mesh-list
65017564|NCT00144716|Protective Agents|protective agents|mesh-ancestor
65017591|NCT00531310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65017592|NCT00531310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65017593|NCT00407862|Losartan|losartan|mesh-list
65017594|NCT00407862|Telmisartan|telmisartan|mesh-list
65017595|NCT00407862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65017596|NCT00407862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65017597|NCT00407862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65017598|NCT00407862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65017599|NCT00407862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017600|NCT00527995|Sildenafil Citrate|sildenafil citrate|mesh-list
65017601|NCT00527995|Vasodilator Agents|vasodilator agents|mesh-ancestor
65017602|NCT00527995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65017603|NCT00527995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65017604|NCT00527995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017605|NCT00527995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017606|NCT00527995|Urological Agents|urological agents|mesh-ancestor
65017608|NCT00144833|Lopinavir|lopinavir|mesh-list
65017609|NCT00144833|Fosamprenavir|fosamprenavir|mesh-list
65017610|NCT00144833|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65017611|NCT00144833|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65017612|NCT00144833|Protease Inhibitors|protease inhibitors|mesh-ancestor
65017613|NCT00144833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017615|NCT00144833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65017643|NCT02945020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017644|NCT02945020|Anticoagulants|anticoagulants|mesh-ancestor
65017645|NCT02945020|Antiviral Agents|antiviral agents|mesh-ancestor
65017646|NCT02945020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65017647|NCT00528073|Rifaximin|rifaximin|mesh-list
65017648|NCT00528073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65017649|NCT00528073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65017650|NCT00528073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65017651|NCT00528151|Curcumin|curcumin|mesh-list
65017652|NCT00528151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65017653|NCT00528151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65017654|NCT00528151|Analgesics|analgesics|mesh-ancestor
65017655|NCT00528151|Sensory System Agents|sensory system agents|mesh-ancestor
65017656|NCT00528151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65017657|NCT00528151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017658|NCT00528151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65017659|NCT00528151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65017660|NCT00528151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017661|NCT00528151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017662|NCT00528151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017663|NCT00144911|Fluticasone|fluticasone|mesh-list
65017664|NCT00144911|Xhance|xhance|mesh-list
65017665|NCT00144911|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65017666|NCT00144911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65017667|NCT00144911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65017668|NCT00144911|Autonomic Agents|autonomic agents|mesh-ancestor
65017669|NCT00144911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65017670|NCT00144911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017671|NCT00144911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65017672|NCT00144911|Respiratory System Agents|respiratory system agents|mesh-ancestor
65017673|NCT00144911|Dermatologic Agents|dermatologic agents|mesh-ancestor
65017674|NCT00144911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65017675|NCT00144911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65017685|NCT00528385|Spironolactone|spironolactone|mesh-list
65017686|NCT00528385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65017687|NCT00528385|Hormone Antagonists|hormone antagonists|mesh-ancestor
65017688|NCT00528385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65017689|NCT00528385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017690|NCT00528385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65017691|NCT00528385|Diuretics|diuretics|mesh-ancestor
65017692|NCT00528385|Natriuretic Agents|natriuretic agents|mesh-ancestor
65017693|NCT02944981|Gabapentin|gabapentin|mesh-list
65017694|NCT02944981|Analgesics|analgesics|mesh-ancestor
65017695|NCT02944981|Sensory System Agents|sensory system agents|mesh-ancestor
65017696|NCT02944981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65017697|NCT02944981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017698|NCT02944981|Anticonvulsants|anticonvulsants|mesh-ancestor
65017699|NCT02944981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65017700|NCT02944981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65017701|NCT02944981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65017702|NCT02944981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65017703|NCT02944981|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65017704|NCT02944981|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65017705|NCT02944981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65017706|NCT02944981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017707|NCT02944981|Antimanic Agents|antimanic agents|mesh-ancestor
65017709|NCT00168636|Vitamins|vitamins|mesh-ancestor
65017710|NCT00168636|Micronutrients|micronutrients|mesh-ancestor
65017711|NCT00168636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017733|NCT00528502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017734|NCT00528619|Carboplatin|carboplatin|mesh-list
65017735|NCT00528619|Pemetrexed|pemetrexed|mesh-list
65017736|NCT00528619|Sunitinib|sunitinib|mesh-list
65017737|NCT00528619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017738|NCT00528619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017739|NCT00528619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017740|NCT00528619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65017741|NCT00528619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65017742|NCT00528619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65017743|NCT00528619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65017744|NCT00528619|Growth Substances|growth substances|mesh-ancestor
65017745|NCT00528619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017746|NCT00528619|Growth Inhibitors|growth inhibitors|mesh-ancestor
65017747|NCT00528619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65017748|NCT00168714|Interferons|interferons|mesh-list
65017749|NCT00168714|Interferon-beta|interferon-beta|mesh-list
65017750|NCT00168714|Interferon beta-1a|interferon beta-1a|mesh-list
65017751|NCT00168714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017752|NCT00168714|Antiviral Agents|antiviral agents|mesh-ancestor
65017753|NCT00168714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65017754|NCT00168714|Immunologic Factors|immunologic factors|mesh-ancestor
65017755|NCT00168714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017756|NCT00168714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65017757|NCT00528658|Acetaminophen|acetaminophen|mesh-list
65017758|NCT00528658|Ibuprofen|ibuprofen|mesh-list
65017759|NCT00528658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65017761|NCT00528658|Analgesics|analgesics|mesh-ancestor
65017781|NCT00528892|Raltegravir Potassium|raltegravir potassium|mesh-list
65017782|NCT00528892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65017783|NCT00528892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65017784|NCT00528892|Antiviral Agents|antiviral agents|mesh-ancestor
65017785|NCT00528892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65017786|NCT00528892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65017787|NCT00528892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65017788|NCT00528892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017789|NCT00528892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017790|NCT00531349|Propofol|propofol|mesh-list
65017791|NCT00531349|Sevoflurane|sevoflurane|mesh-list
65017792|NCT00531349|Anesthetics|anesthetics|mesh-ancestor
65017793|NCT00531349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65017794|NCT00531349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017795|NCT00531349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65017796|NCT00531349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65017797|NCT00531349|Anesthetics, General|anesthetics, general|mesh-ancestor
65017798|NCT00531349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65017799|NCT00531349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65017800|NCT00531466|Tolperisone|tolperisone|mesh-list
65017801|NCT00531466|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65017802|NCT00531466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017803|NCT00531466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65017804|NCT00531466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65017805|NCT00168792|Tenecteplase|tenecteplase|mesh-list
65017806|NCT00168792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65017807|NCT00168792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65017808|NCT00168792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017809|NCT00531544|Sunitinib|sunitinib|mesh-list
65017810|NCT00531544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017827|NCT00145184|Micronutrients|micronutrients|mesh-ancestor
65017828|NCT00145184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017829|NCT02944357|Gemcitabine|gemcitabine|mesh-list
65017830|NCT02944357|Cisplatin|cisplatin|mesh-list
65017831|NCT02944357|Vaccines|vaccines|mesh-list
65017832|NCT02944357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017833|NCT02944357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65017834|NCT02944357|Antimetabolites|antimetabolites|mesh-ancestor
65017835|NCT02944357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017836|NCT02944357|Antiviral Agents|antiviral agents|mesh-ancestor
65017837|NCT02944357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65017838|NCT02944357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017839|NCT02944357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65017840|NCT02944357|Immunologic Factors|immunologic factors|mesh-ancestor
65017842|NCT02944396|Paclitaxel|paclitaxel|mesh-list
65017886|NCT00145301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65017887|NCT00145301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65017888|NCT00145301|Analgesics|analgesics|mesh-ancestor
65017889|NCT00145301|Sensory System Agents|sensory system agents|mesh-ancestor
65017890|NCT00145301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65017891|NCT00145301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017892|NCT00145301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65017893|NCT00145301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65017894|NCT00168870|Gemcitabine|gemcitabine|mesh-list
65017895|NCT00168870|Treosulfan|treosulfan|mesh-list
65017896|NCT00168870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65017897|NCT00168870|Antimetabolites|antimetabolites|mesh-ancestor
65017898|NCT00168870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017899|NCT00168870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65017900|NCT00168870|Antiviral Agents|antiviral agents|mesh-ancestor
65017901|NCT00168870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65017902|NCT00168870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017903|NCT00168870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65017904|NCT00168870|Immunologic Factors|immunologic factors|mesh-ancestor
65017905|NCT00168870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017906|NCT00168870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65017907|NCT00168870|Alkylating Agents|alkylating agents|mesh-ancestor
65017939|NCT00168948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65017940|NCT00168948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65017941|NCT00168948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65017942|NCT00168948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017943|NCT00168948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017944|NCT00530413|Phenobarbital|phenobarbital|mesh-list
65017945|NCT00530413|Anticonvulsants|anticonvulsants|mesh-ancestor
65017946|NCT00530413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65017947|NCT00530413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65017948|NCT00530413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017949|NCT00530413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65017950|NCT00530413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65017951|NCT00530413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65017952|NCT00530413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017953|NCT00530413|GABA Modulators|gaba modulators|mesh-ancestor
65017954|NCT00530413|GABA Agents|gaba agents|mesh-ancestor
65017955|NCT00530413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65017956|NCT00530413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65017957|NCT00530413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65017958|NCT00174330|Amlodipine|amlodipine|mesh-list
65017959|NCT00174330|Atorvastatin|atorvastatin|mesh-list
65017960|NCT00174330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65017961|NCT00174330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65017962|NCT00174330|Antimetabolites|antimetabolites|mesh-ancestor
65017963|NCT00174330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017964|NCT00174330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65017965|NCT00174330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65017966|NCT00174330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65017967|NCT00174330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65017968|NCT00174330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65017980|NCT00531895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65017981|NCT00531895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65017982|NCT00531895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65017983|NCT00531895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65017984|NCT00531895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65017985|NCT00531895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017986|NCT00531895|Analgesics|analgesics|mesh-ancestor
65017987|NCT00531895|Sensory System Agents|sensory system agents|mesh-ancestor
65017988|NCT00531895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65017989|NCT00531895|Antidepressive Agents|antidepressive agents|mesh-ancestor
65017990|NCT00531895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65017991|NCT00531895|Dopamine Agents|dopamine agents|mesh-ancestor
65017992|NCT02942914|Insulin Glargine|insulin glargine|mesh-list
65017993|NCT02942914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65017994|NCT02942914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65017995|NCT00169026|Antipsychotic Agents|antipsychotic agents|mesh-list
65017996|NCT00169026|Clozapine|clozapine|mesh-list
65017997|NCT00169026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65017998|NCT00169026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65017999|NCT00169026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018000|NCT00169026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65018001|NCT00169026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65018002|NCT00169026|Serotonin Agents|serotonin agents|mesh-ancestor
65018003|NCT00169026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65018004|NCT00169026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018005|NCT00169026|GABA Antagonists|gaba antagonists|mesh-ancestor
65018006|NCT00169026|GABA Agents|gaba agents|mesh-ancestor
64882981|NCT01936532|Hormones|hormones|mesh-ancestor
64500560|NCT02208466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64419381|NCT05122741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64419382|NCT05122741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64500564|NCT02208466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500565|NCT02208466|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64500567|NCT02208466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64500568|NCT02208466|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64500569|NCT02208466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64500570|NCT02208466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500571|NCT02209948|Temozolomide|temozolomide|mesh-list
64500572|NCT02209948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64500573|NCT02209948|Alkylating Agents|alkylating agents|mesh-ancestor
64500574|NCT02209948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500576|NCT02981212|Mycophenolic Acid|mycophenolic acid|mesh-list
64500577|NCT02981212|Prednisolone|prednisolone|mesh-list
64500578|NCT02981212|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64500579|NCT02981212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65018007|NCT00145613|Antibodies|antibodies|mesh-list
65018008|NCT00145613|Immunologic Factors|immunologic factors|mesh-ancestor
65018009|NCT00145613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018010|NCT00531973|Doxorubicin|doxorubicin|mesh-list
65018011|NCT00531973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65018012|NCT00531973|Epirubicin|epirubicin|mesh-list
65018013|NCT00531973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65018014|NCT00531973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018015|NCT00531973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65018016|NCT00531973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65018017|NCT00531973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018018|NCT00531973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018019|NCT00145652|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65018020|NCT00145652|Hematinics|hematinics|mesh-ancestor
65018021|NCT00174486|Tadalafil|tadalafil|mesh-list
65018022|NCT00174486|Vasodilator Agents|vasodilator agents|mesh-ancestor
65018023|NCT00174486|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65018024|NCT00174486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65018025|NCT00174486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018026|NCT00174486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018027|NCT00174486|Urological Agents|urological agents|mesh-ancestor
65018028|NCT00145691|Oxcarbazepine|oxcarbazepine|mesh-list
65018029|NCT00145691|Anticonvulsants|anticonvulsants|mesh-ancestor
65018030|NCT00145691|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65018031|NCT00145691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65018032|NCT00145691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65018033|NCT00145691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018034|NCT00145691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65018035|NCT00145691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65018036|NCT05319340|Anticoagulants|anticoagulants|mesh-list
65018037|NCT05319301|Melatonin|melatonin|mesh-list
65018038|NCT05319301|Antioxidants|antioxidants|mesh-ancestor
65018039|NCT05319301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018040|NCT05319301|Protective Agents|protective agents|mesh-ancestor
65018041|NCT05319301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500580|NCT02981212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500581|NCT02981212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64500582|NCT02981212|Antitubercular Agents|antitubercular agents|mesh-ancestor
64500583|NCT02981212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64500584|NCT02981212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65018042|NCT05319301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65018043|NCT00169065|Olanzapine|olanzapine|mesh-list
65018044|NCT00169065|Clozapine|clozapine|mesh-list
65018045|NCT00169065|Antiemetics|antiemetics|mesh-ancestor
65018046|NCT00169065|Autonomic Agents|autonomic agents|mesh-ancestor
65018047|NCT00169065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65018048|NCT00169065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018049|NCT00169065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65018050|NCT00169065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65018051|NCT00169065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65018052|NCT00169065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65018053|NCT00169065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65018054|NCT00169065|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65018055|NCT00169065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65018056|NCT00169065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65018057|NCT00169065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018058|NCT00169065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65018059|NCT00169065|Serotonin Agents|serotonin agents|mesh-ancestor
65018060|NCT00169065|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65018061|NCT00169065|GABA Antagonists|gaba antagonists|mesh-ancestor
65018062|NCT00169065|GABA Agents|gaba agents|mesh-ancestor
65018063|NCT00145730|Ibuprofen|ibuprofen|mesh-list
64883052|NCT01937169|Levodopa|levodopa|mesh-list
64500585|NCT02981212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500586|NCT02981212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500601|NCT01563406|Chlorhexidine|chlorhexidine|mesh-list
64500602|NCT01563406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64500603|NCT01563406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64500604|NCT01563406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64500605|NCT01563406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500606|NCT01563406|Disinfectants|disinfectants|mesh-ancestor
64500607|NCT01468012|Levodopa|levodopa|mesh-list
64500608|NCT01468012|Carbidopa|carbidopa|mesh-list
64500609|NCT01468012|Entacapone|entacapone|mesh-list
64724095|NCT00000769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724096|NCT00000769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64724097|NCT00000769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64724098|NCT05440591|Metformin|metformin|mesh-list
64500610|NCT01468012|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64500611|NCT01468012|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64500612|NCT01468012|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64500613|NCT01468012|Dopamine Agents|dopamine agents|mesh-ancestor
64500614|NCT01468012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64500615|NCT01468012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500616|NCT01468012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500617|NCT01468012|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64500618|NCT01468012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500619|NCT01468012|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64500620|NCT01468012|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64500621|NCT01468012|Immunologic Factors|immunologic factors|mesh-ancestor
64500623|NCT01468558|Ketoconazole|ketoconazole|mesh-list
64500624|NCT01468558|Antifungal Agents|antifungal agents|mesh-ancestor
64500625|NCT01468558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65018064|NCT00145730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65018065|NCT00145730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65018066|NCT00145730|Analgesics|analgesics|mesh-ancestor
65018067|NCT00145730|Sensory System Agents|sensory system agents|mesh-ancestor
65018068|NCT00145730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65018069|NCT00145730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018070|NCT00145730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65018071|NCT00145730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65018072|NCT00145730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65018073|NCT00145730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018074|NCT00145730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018075|NCT00169143|Rituximab|rituximab|mesh-list
65018076|NCT00169143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65018077|NCT00169143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018078|NCT00169143|Immunologic Factors|immunologic factors|mesh-ancestor
65018079|NCT00169143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018080|NCT00169143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65018081|NCT02942680|Aspirin|aspirin|mesh-list
65018082|NCT02942680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65018083|NCT02942680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65018084|NCT02942680|Analgesics|analgesics|mesh-ancestor
65018085|NCT02942680|Sensory System Agents|sensory system agents|mesh-ancestor
65018086|NCT02942680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65018087|NCT02942680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018088|NCT02942680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65018089|NCT02942680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65018090|NCT02942680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65018091|NCT02942680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65018092|NCT02942680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018093|NCT02942680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65018106|NCT02276911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65018107|NCT02276911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65018108|NCT02276911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65018109|NCT02276911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018110|NCT02276911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018111|NCT00145847|Naltrexone|naltrexone|mesh-list
65018112|NCT00145847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65018113|NCT00145847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65018114|NCT00145847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018115|NCT00145847|Sensory System Agents|sensory system agents|mesh-ancestor
65018116|NCT00145847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65018117|NCT00169182|Nicotinic Acids|nicotinic acids|mesh-list
65018118|NCT00169182|Niacin|niacin|mesh-list
65018119|NCT00169182|Docetaxel|docetaxel|mesh-list
65018120|NCT00169182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018121|NCT00169182|Tubulin Modulators|tubulin modulators|mesh-ancestor
65018122|NCT00169182|Antimitotic Agents|antimitotic agents|mesh-ancestor
65018123|NCT00169182|Mitosis Modulators|mitosis modulators|mesh-ancestor
65018124|NCT00169182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018125|NCT00169182|Vitamin B Complex|vitamin b complex|mesh-ancestor
65018126|NCT00169182|Vitamins|vitamins|mesh-ancestor
65018127|NCT00169182|Micronutrients|micronutrients|mesh-ancestor
65018128|NCT00169182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018129|NCT00169182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65018130|NCT00169182|Antimetabolites|antimetabolites|mesh-ancestor
65018131|NCT00169182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65018132|NCT00169182|Vasodilator Agents|vasodilator agents|mesh-ancestor
64500626|NCT01468558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64500627|NCT01468558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64500628|NCT01468558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500629|NCT01468558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500630|NCT01468558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64500631|NCT01468558|Hormone Antagonists|hormone antagonists|mesh-ancestor
64500632|NCT01468558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64500633|NCT01468558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500634|NCT01468558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64500635|NCT03730662|Insulin Glargine|insulin glargine|mesh-list
64500636|NCT03730662|Tirzepatide|tirzepatide|mesh-list
64500637|NCT03730662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64500638|NCT03730662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500639|NCT03730662|Incretins|incretins|mesh-ancestor
64500640|NCT03730662|Hormones|hormones|mesh-ancestor
64419410|NCT02340975|Durvalumab|durvalumab|mesh-list
64500657|NCT01470118|Lubricant Eye Drops|lubricant eye drops|mesh-list
64500660|NCT01470118|Plasma Substitutes|plasma substitutes|mesh-ancestor
64500661|NCT01470118|Blood Substitutes|blood substitutes|mesh-ancestor
64500662|NCT01470118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64500663|NCT01470118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64500664|NCT01470118|Analgesics|analgesics|mesh-ancestor
65018133|NCT02944825|Ciprofloxacin|ciprofloxacin|mesh-list
65018134|NCT02944825|Trimethoprim|trimethoprim|mesh-list
65018135|NCT02944825|Sulfamethoxazole|sulfamethoxazole|mesh-list
65018136|NCT02944825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65018137|NCT02944825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65018138|NCT02944825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65018139|NCT02944825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65018140|NCT02944825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64883136|NCT01937611|Anesthetics|anesthetics|mesh-ancestor
64883137|NCT01937611|GABA Modulators|gaba modulators|mesh-ancestor
64500665|NCT01470118|Sensory System Agents|sensory system agents|mesh-ancestor
64500666|NCT01470118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500667|NCT01470118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500668|NCT01470118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64500669|NCT01470118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64500670|NCT01470118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64500671|NCT01470118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64500672|NCT01470118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64500673|NCT01470118|Histamine Antagonists|histamine antagonists|mesh-ancestor
64500674|NCT01470118|Histamine Agents|histamine agents|mesh-ancestor
64500675|NCT01470118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64500676|NCT01470118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500677|NCT03390036|Triamcinolone|triamcinolone|mesh-list
64500678|NCT03390036|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64500679|NCT03390036|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64500680|NCT03390036|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64500681|NCT03390036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64500682|NCT03390036|Glucocorticoids|glucocorticoids|mesh-ancestor
64500683|NCT03390036|Hormones|hormones|mesh-ancestor
64331685|NCT04969133|Sensory System Agents|sensory system agents|mesh-ancestor
64331686|NCT04969133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64331696|NCT04919629|Bevacizumab|bevacizumab|mesh-list
64724099|NCT05440591|Dapagliflozin|dapagliflozin|mesh-list
64724100|NCT05440591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64724101|NCT05440591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724102|NCT05440591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64724103|NCT05440591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724104|NCT04099303|Vaccines|vaccines|mesh-list
64724105|NCT04099303|Immunologic Factors|immunologic factors|mesh-ancestor
64724106|NCT04099303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724107|NCT00379951|Ertapenem|ertapenem|mesh-list
64724108|NCT00379951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64724109|NCT00379951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724110|NCT00000337|Selegiline|selegiline|mesh-list
64724111|NCT00000337|Antidepressive Agents|antidepressive agents|mesh-ancestor
64724112|NCT00000337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64724113|NCT00000337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64500684|NCT03390036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64500685|NCT03390036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500686|NCT03390036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64500687|NCT03390036|Immunologic Factors|immunologic factors|mesh-ancestor
64500688|NCT03390036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500689|NCT03390036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500690|NCT01470196|Dexamethasone|dexamethasone|mesh-list
64500691|NCT01470196|Rituximab|rituximab|mesh-list
64500692|NCT01470196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64500693|NCT01470196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500694|NCT01470196|Immunologic Factors|immunologic factors|mesh-ancestor
64500696|NCT01470196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64500697|NCT01470196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64500699|NCT01470196|Autonomic Agents|autonomic agents|mesh-ancestor
64500700|NCT01470196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500701|NCT01470196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64500702|NCT01470196|Glucocorticoids|glucocorticoids|mesh-ancestor
64500703|NCT01470196|Hormones|hormones|mesh-ancestor
64500704|NCT01470196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65018141|NCT02944825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018142|NCT02944825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018143|NCT02944825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65018144|NCT02944825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65018145|NCT02944825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65018146|NCT02944825|Renal Agents|renal agents|mesh-ancestor
65018147|NCT02944825|Antimalarials|antimalarials|mesh-ancestor
65018148|NCT02944825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65018149|NCT02944825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65018150|NCT02944825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65018151|NCT02944825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65018152|NCT02944825|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65018153|NCT02942758|Pioglitazone|pioglitazone|mesh-list
65018154|NCT02942758|Azacitidine|azacitidine|mesh-list
65018155|NCT02942758|Tretinoin|tretinoin|mesh-list
65018156|NCT02942758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65018157|NCT02942758|Antimetabolites|antimetabolites|mesh-ancestor
65018158|NCT02942758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018159|NCT02942758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018160|NCT02942758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018161|NCT02942758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65018162|NCT02942758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018163|NCT02942758|Keratolytic Agents|keratolytic agents|mesh-ancestor
65018164|NCT02942758|Dermatologic Agents|dermatologic agents|mesh-ancestor
64500705|NCT01470196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64500706|NCT03389958|Copper|copper|mesh-list
64500707|NCT03389958|Trace Elements|trace elements|mesh-ancestor
64500708|NCT03389958|Micronutrients|micronutrients|mesh-ancestor
64500723|NCT04446234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64724114|NCT00000337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64724115|NCT00000337|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64724116|NCT00000337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724117|NCT00000337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724118|NCT00000337|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64724119|NCT00000337|Protective Agents|protective agents|mesh-ancestor
64724120|NCT00000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724121|NCT00000781|Zidovudine|zidovudine|mesh-list
64724122|NCT00000781|Nevirapine|nevirapine|mesh-list
64724123|NCT00000781|Didanosine|didanosine|mesh-list
64724124|NCT00000781|Zalcitabine|zalcitabine|mesh-list
64724125|NCT00000781|Antimetabolites|antimetabolites|mesh-ancestor
64500724|NCT04446234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64500725|NCT04446234|Dopamine Agents|dopamine agents|mesh-ancestor
64500726|NCT04446234|Antidepressive Agents|antidepressive agents|mesh-ancestor
64500727|NCT04446234|Dopamine Agonists|dopamine agonists|mesh-ancestor
64500728|NCT04446234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64500729|NCT04446234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64500730|NCT04446234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64500731|NCT04446234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64500732|NCT04446234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64500733|NCT01511068|Sargramostim|sargramostim|mesh-list
64500734|NCT01511068|Immunologic Factors|immunologic factors|mesh-ancestor
65018165|NCT00145886|Parathyroid Hormone|parathyroid hormone|mesh-list
65018166|NCT00145886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018167|NCT00145886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65018168|NCT00174603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65018169|NCT00174603|Antidepressive Agents|antidepressive agents|mesh-ancestor
65018170|NCT00174603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65018171|NCT00174603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65018172|NCT00174603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65018173|NCT00174603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65018174|NCT00174603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018175|NCT02942563|Capecitabine|capecitabine|mesh-list
65018176|NCT02942563|Oxaliplatin|oxaliplatin|mesh-list
65018177|NCT02942563|Irinotecan|irinotecan|mesh-list
65018178|NCT02942563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65018179|NCT02942563|Antimetabolites|antimetabolites|mesh-ancestor
65018180|NCT02942563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018181|NCT02942563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018182|NCT02942563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65018183|NCT02942563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65018184|NCT02942563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018185|NCT00145925|Gliclazide|gliclazide|mesh-list
65018186|NCT00145925|Perindopril|perindopril|mesh-list
65018187|NCT00145925|Indapamide|indapamide|mesh-list
64883168|NCT01937754|Vasodilator Agents|vasodilator agents|mesh-ancestor
64500735|NCT01511068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500736|NCT03613506|Captopril|captopril|mesh-list
64500737|NCT03613506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64500738|NCT03613506|Protease Inhibitors|protease inhibitors|mesh-ancestor
64500739|NCT03613506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500740|NCT03613506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500741|NCT03613506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64500742|NCT01565902|Siponimod|siponimod|mesh-list
64500743|NCT01565902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64500744|NCT01565902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500745|NCT01565902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64500746|NCT01565902|Immunologic Factors|immunologic factors|mesh-ancestor
64500747|NCT01565902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500748|NCT01566448|Ketamine|ketamine|mesh-list
64500749|NCT01566448|Analgesics|analgesics|mesh-ancestor
64500750|NCT01566448|Sensory System Agents|sensory system agents|mesh-ancestor
64500751|NCT01566448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500752|NCT01566448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500753|NCT01566448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64500754|NCT01566448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64500755|NCT01566448|Anesthetics, General|anesthetics, general|mesh-ancestor
64500756|NCT01566448|Anesthetics|anesthetics|mesh-ancestor
64500757|NCT01566448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64500758|NCT01566448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64500759|NCT01566448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64500760|NCT01566448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65018188|NCT00145925|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
65018189|NCT00145925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65018190|NCT00145925|Protease Inhibitors|protease inhibitors|mesh-ancestor
65018191|NCT00145925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018192|NCT00145925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018193|NCT00145925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65018194|NCT00145925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65018195|NCT00145925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018196|NCT00145925|Diuretics|diuretics|mesh-ancestor
64500761|NCT01566448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500762|NCT05565976|Aspirin|aspirin|mesh-list
64500763|NCT05565976|Insulin|insulin|mesh-list
64500764|NCT05565976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64500765|NCT05565976|Insulin Glargine|insulin glargine|mesh-list
64500766|NCT05565976|Dapagliflozin|dapagliflozin|mesh-list
64500767|NCT05565976|Insulin Lispro|insulin lispro|mesh-list
64500786|NCT05565976|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64500787|NCT05565976|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64500788|NCT05565976|Purinergic Agents|purinergic agents|mesh-ancestor
64500789|NCT05565976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64500790|NCT05565976|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64419415|NCT02340975|Immunologic Factors|immunologic factors|mesh-ancestor
64724128|NCT00000781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64724130|NCT00000781|Antiviral Agents|antiviral agents|mesh-ancestor
64724131|NCT00000781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724132|NCT00000781|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64945676|NCT05329766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945677|NCT05329766|Antidotes|antidotes|mesh-ancestor
64945678|NCT05329766|Protective Agents|protective agents|mesh-ancestor
64945679|NCT05329766|Vitamin B Complex|vitamin b complex|mesh-ancestor
64945680|NCT05329766|Vitamins|vitamins|mesh-ancestor
64945681|NCT05329766|Micronutrients|micronutrients|mesh-ancestor
64945682|NCT05313243|Pembrolizumab|pembrolizumab|mesh-list
64500792|NCT05565976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64500793|NCT05565976|Analgesics|analgesics|mesh-ancestor
64500794|NCT05565976|Sensory System Agents|sensory system agents|mesh-ancestor
64500795|NCT05565976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500796|NCT05565976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64500797|NCT05565976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64500798|NCT05565976|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64500799|NCT05565976|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64500800|NCT05565976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64500801|NCT05565976|Antipyretics|antipyretics|mesh-ancestor
64500802|NCT01566526|Dexamethasone|dexamethasone|mesh-list
64500803|NCT01566526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64500804|NCT01566526|Antiemetics|antiemetics|mesh-ancestor
64500805|NCT01566526|Autonomic Agents|autonomic agents|mesh-ancestor
64500806|NCT01566526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500807|NCT01566526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500808|NCT01566526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64500809|NCT01566526|Glucocorticoids|glucocorticoids|mesh-ancestor
64500810|NCT01566526|Hormones|hormones|mesh-ancestor
64500811|NCT01566526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64500812|NCT01566526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64500813|NCT01566526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500814|NCT01566838|Bupivacaine|bupivacaine|mesh-list
64500815|NCT01566838|Anesthetics, Local|anesthetics, local|mesh-ancestor
64500835|NCT05565664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500836|NCT05565664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64500837|NCT05565664|Anticonvulsants|anticonvulsants|mesh-ancestor
64500838|NCT05565664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64500839|NCT05565664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64500840|NCT05565664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64500841|NCT05565664|Tocolytic Agents|tocolytic agents|mesh-ancestor
64500842|NCT05565664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64500844|NCT03125616|Immunologic Factors|immunologic factors|mesh-ancestor
65018197|NCT00145925|Natriuretic Agents|natriuretic agents|mesh-ancestor
65018198|NCT00145925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65018199|NCT00145925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65018200|NCT00169221|Gefitinib|gefitinib|mesh-list
64473931|NCT00273754|Caffeine|caffeine|mesh-list
65018201|NCT00169221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018202|NCT00169221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65018203|NCT00169221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018204|NCT00169221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018206|NCT00529360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65018207|NCT00529360|Antimetabolites|antimetabolites|mesh-ancestor
65018208|NCT00529360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018209|NCT00529360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018210|NCT00174642|Insulin|insulin|mesh-list
65018211|NCT00174642|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65018212|NCT00174642|Metformin|metformin|mesh-list
65018213|NCT00174642|Insulin Glargine|insulin glargine|mesh-list
65018214|NCT00174642|Insulin glulisine|insulin glulisine|mesh-list
65018215|NCT00174642|Secretagogues|secretagogues|mesh-list
65018216|NCT00174642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65018217|NCT00174642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018218|NCT00174681|Insulin Glargine|insulin glargine|mesh-list
65018219|NCT00174681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65018220|NCT00174681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018221|NCT03458416|Cannabidiol|cannabidiol|mesh-list
65018222|NCT03458416|Anticonvulsants|anticonvulsants|mesh-ancestor
65018223|NCT00146042|Erythromycin|erythromycin|mesh-list
65018224|NCT00146042|Erythromycin Estolate|erythromycin estolate|mesh-list
65018225|NCT00146042|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65018226|NCT00146042|Erythromycin stearate|erythromycin stearate|mesh-list
65018227|NCT00146042|Docetaxel|docetaxel|mesh-list
65018228|NCT00146042|Trastuzumab|trastuzumab|mesh-list
65018229|NCT00146042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018230|NCT00146042|Tubulin Modulators|tubulin modulators|mesh-ancestor
65018231|NCT00146042|Antimitotic Agents|antimitotic agents|mesh-ancestor
64500845|NCT03125616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500846|NCT01568008|Bimatoprost|bimatoprost|mesh-list
64500847|NCT01568008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64500848|NCT01568008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64500849|NCT01568008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64500850|NCT05658120|Epinephrine|epinephrine|mesh-list
64500851|NCT05658120|Racepinephrine|racepinephrine|mesh-list
64500852|NCT05658120|Norepinephrine|norepinephrine|mesh-list
64500853|NCT05658120|Epinephryl borate|epinephryl borate|mesh-list
65018232|NCT00146042|Mitosis Modulators|mitosis modulators|mesh-ancestor
65018233|NCT00146042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018234|NCT00146042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65018235|NCT00146042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65018236|NCT00146042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65018237|NCT00146042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65018238|NCT00146042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65018239|NCT00146042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018240|NCT00169299|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65018241|NCT00169299|Medroxyprogesterone|medroxyprogesterone|mesh-list
65018242|NCT00169299|Estrogens|estrogens|mesh-list
65018243|NCT00169299|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65018244|NCT00169299|Hormones|hormones|mesh-ancestor
65018245|NCT00169299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65018246|NCT00169299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018247|NCT00169299|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65018248|NCT00169299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65018249|NCT00169299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65018250|NCT00169299|Contraceptive Agents|contraceptive agents|mesh-ancestor
65018251|NCT00169299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65018252|NCT00169299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65018253|NCT00169299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65018254|NCT00169299|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65018255|NCT00169299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65018256|NCT00169299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018257|NCT02942602|Atorvastatin|atorvastatin|mesh-list
65018258|NCT02942602|Ezetimibe|ezetimibe|mesh-list
65018259|NCT02942602|Cholestyramine Resin|cholestyramine resin|mesh-list
65018260|NCT02942602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65018261|NCT02942602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65018262|NCT02942602|Antimetabolites|antimetabolites|mesh-ancestor
65018263|NCT02942602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018271|NCT02942329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018272|NCT00174720|Ciclesonide|ciclesonide|mesh-list
65018273|NCT00174720|Glucocorticoids|glucocorticoids|mesh-ancestor
65018274|NCT00174720|Hormones|hormones|mesh-ancestor
65018275|NCT00174720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65018276|NCT00174720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018277|NCT00174720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65018278|NCT05318794|Doxorubicin|doxorubicin|mesh-list
65018279|NCT05318794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018280|NCT05318794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65018281|NCT05318794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65018282|NCT05318794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65018283|NCT05318794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018284|NCT05318794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018286|NCT02942212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65018287|NCT02942212|Autonomic Agents|autonomic agents|mesh-ancestor
65018288|NCT02942212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65018289|NCT02942212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018290|NCT02942212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65018291|NCT02942212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64883279|NCT01938456|Docetaxel|docetaxel|mesh-list
64500854|NCT05658120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64500855|NCT05658120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64500856|NCT05658120|Adrenergic Agents|adrenergic agents|mesh-ancestor
64500857|NCT05658120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64500858|NCT05658120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500859|NCT05658120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945683|NCT05313243|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64500860|NCT05658120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64500861|NCT05658120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64500862|NCT05658120|Autonomic Agents|autonomic agents|mesh-ancestor
64500863|NCT05658120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500864|NCT05658120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64724133|NCT00000781|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64724134|NCT00000781|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64724135|NCT00000781|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64724137|NCT00000349|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
64724138|NCT00000349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64724139|NCT00000349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64724140|NCT00000349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64724141|NCT00000349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724142|NCT00000349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64724143|NCT00000349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64724144|NCT00000349|Dopamine Agents|dopamine agents|mesh-ancestor
64724145|NCT00000349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64724146|NCT00000349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724147|NCT00000805|Ganciclovir|ganciclovir|mesh-list
64724148|NCT00000805|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64724149|NCT00000805|Antiviral Agents|antiviral agents|mesh-ancestor
64724150|NCT00000805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724151|NCT00000805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64500865|NCT05658120|Respiratory System Agents|respiratory system agents|mesh-ancestor
65018292|NCT02942212|Cholinergic Agents|cholinergic agents|mesh-ancestor
65018293|NCT02942212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65018294|NCT02942212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018295|NCT00146120|Etoposide|etoposide|mesh-list
65018296|NCT00146120|Idarubicin|idarubicin|mesh-list
65018297|NCT00146120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65018298|NCT00146120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018299|NCT00146120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64500866|NCT05658120|Mydriatics|mydriatics|mesh-ancestor
64500867|NCT05658120|Sympathomimetics|sympathomimetics|mesh-ancestor
64500868|NCT05658120|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64500869|NCT01514734|Timolol|timolol|mesh-list
64500870|NCT01514734|Brinzolamide|brinzolamide|mesh-list
64500885|NCT01515046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500887|NCT01515046|Antiviral Agents|antiviral agents|mesh-ancestor
64500888|NCT01515046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64500889|NCT01515046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500890|NCT01515046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64500891|NCT01515046|Immunologic Factors|immunologic factors|mesh-ancestor
64500892|NCT01515046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500893|NCT01515046|Antioxidants|antioxidants|mesh-ancestor
64500894|NCT01515046|Protective Agents|protective agents|mesh-ancestor
64500895|NCT01515046|Vitamins|vitamins|mesh-ancestor
64500896|NCT01515046|Micronutrients|micronutrients|mesh-ancestor
64500897|NCT01568944|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64500898|NCT01568944|Lansoprazole|lansoprazole|mesh-list
64500899|NCT01568944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64500900|NCT01568944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64500901|NCT01568944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64500902|NCT01568944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64500903|NCT01568944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500904|NCT01568944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500905|NCT05565274|Pentazocine|pentazocine|mesh-list
64500906|NCT05565274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64500907|NCT05565274|Narcotics|narcotics|mesh-ancestor
64500908|NCT05565274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64500909|NCT05565274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500910|NCT05565274|Analgesics|analgesics|mesh-ancestor
64500911|NCT05565274|Sensory System Agents|sensory system agents|mesh-ancestor
64500912|NCT05565274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500913|NCT05565274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64500914|NCT05565274|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64500915|NCT05173584|Albuterol|albuterol|mesh-list
64500916|NCT05173584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64500917|NCT05173584|Autonomic Agents|autonomic agents|mesh-ancestor
64500918|NCT05173584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64724152|NCT00000805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724153|NCT00000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724154|NCT04270682|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
64724155|NCT04270682|Cathartics|cathartics|mesh-ancestor
64724156|NCT04270682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64724158|NCT00000355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64724159|NCT00000355|Narcotics|narcotics|mesh-ancestor
64724160|NCT00000355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64724161|NCT00000355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724162|NCT00000355|Analgesics|analgesics|mesh-ancestor
64724163|NCT00000355|Sensory System Agents|sensory system agents|mesh-ancestor
64724164|NCT00000355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500919|NCT05173584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500920|NCT05173584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64500921|NCT05173584|Respiratory System Agents|respiratory system agents|mesh-ancestor
64500922|NCT05173584|Tocolytic Agents|tocolytic agents|mesh-ancestor
64500923|NCT05173584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64500924|NCT05173584|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64500925|NCT05173584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64500926|NCT05173584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64500929|NCT05173584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500930|NCT04671030|Glycopyrrolate|glycopyrrolate|mesh-list
65018300|NCT00146120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65018301|NCT00146120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018302|NCT00146120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018303|NCT00146120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65018305|NCT00146159|Analgesics|analgesics|mesh-ancestor
65018306|NCT00146159|Sensory System Agents|sensory system agents|mesh-ancestor
65018307|NCT00146159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65018308|NCT00146159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018309|NCT00146159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018310|NCT00146159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65018311|NCT00146159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65018312|NCT00146159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018313|NCT00146159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018314|NCT02276989|Riboflavin|riboflavin|mesh-list
65018315|NCT02276989|Quinine|quinine|mesh-list
65018316|NCT02276989|Acetazolamide|acetazolamide|mesh-list
65018317|NCT02276989|Vitamins|vitamins|mesh-ancestor
65018318|NCT02276989|Micronutrients|micronutrients|mesh-ancestor
65018319|NCT02276989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018320|NCT02276989|Vitamin B Complex|vitamin b complex|mesh-ancestor
65018321|NCT02276989|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65018322|NCT02276989|Dermatologic Agents|dermatologic agents|mesh-ancestor
65018323|NCT02276989|Anticonvulsants|anticonvulsants|mesh-ancestor
65018324|NCT02276989|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65018325|NCT02276989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018326|NCT02276989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018327|NCT02276989|Diuretics|diuretics|mesh-ancestor
65018328|NCT02276989|Natriuretic Agents|natriuretic agents|mesh-ancestor
64500939|NCT04671030|Autonomic Agents|autonomic agents|mesh-ancestor
64500940|NCT04671030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500941|NCT04671030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64500942|NCT04671030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64500943|NCT04671030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64500944|NCT04660890|Moxifloxacin|moxifloxacin|mesh-list
64500945|NCT04660890|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64500946|NCT04660890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64500947|NCT04660890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64500948|NCT04660890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64500949|NCT04660890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64500950|NCT04660890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500951|NCT04660890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500952|NCT04660890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500953|NCT04660890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64500954|NCT04660890|Contraceptive Agents|contraceptive agents|mesh-ancestor
64500955|NCT04660890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64500956|NCT04660890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018329|NCT02276989|Antimalarials|antimalarials|mesh-ancestor
65018330|NCT02276989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65018331|NCT02276989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65018332|NCT02276989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65018333|NCT02276989|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65018334|NCT02276989|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65018335|NCT02276989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65018336|NCT02276989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65018337|NCT02276989|Analgesics|analgesics|mesh-ancestor
65018338|NCT02276989|Sensory System Agents|sensory system agents|mesh-ancestor
65018339|NCT00174759|Clopidogrel|clopidogrel|mesh-list
65018340|NCT00174759|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65018341|NCT00174759|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65018342|NCT00174759|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65018343|NCT00174759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65018344|NCT00174759|Purinergic Agents|purinergic agents|mesh-ancestor
65018345|NCT00174759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65018346|NCT00174759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018347|NCT00174759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018348|NCT00146237|Phenytoin|phenytoin|mesh-list
65018349|NCT00146237|Anticonvulsants|anticonvulsants|mesh-ancestor
65018350|NCT00146237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65018351|NCT00146237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65018352|NCT00146237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65018353|NCT00146237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018354|NCT00146237|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65018355|NCT00146237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65018356|NCT02277067|Misoprostol|misoprostol|mesh-list
65018358|NCT02277067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65018359|NCT02277067|Abortifacient Agents|abortifacient agents|mesh-ancestor
65018360|NCT02277067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65018361|NCT02277067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018362|NCT02277067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65018363|NCT02277067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65018364|NCT02277067|Oxytocics|oxytocics|mesh-ancestor
65018365|NCT00146276|Gemcitabine|gemcitabine|mesh-list
65018366|NCT00146276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65018367|NCT00146276|Antimetabolites|antimetabolites|mesh-ancestor
65018368|NCT00146276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018369|NCT00146276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018370|NCT00146276|Antiviral Agents|antiviral agents|mesh-ancestor
65018371|NCT00146276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65018372|NCT00146276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018373|NCT00146276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65018374|NCT00146276|Immunologic Factors|immunologic factors|mesh-ancestor
65018375|NCT00146276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018376|NCT00174798|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65018377|NCT00174798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65018378|NCT00174798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65018379|NCT00174798|Cholinergic Agents|cholinergic agents|mesh-ancestor
65018380|NCT00174798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65018381|NCT00174798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018382|NCT00174798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018383|NCT00174798|Urological Agents|urological agents|mesh-ancestor
65018384|NCT02940808|Caffeine|caffeine|mesh-list
64500957|NCT04660890|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64500958|NCT04660890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64500959|NCT04660890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64500961|NCT04632264|Oxytocics|oxytocics|mesh-ancestor
64500962|NCT04632264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64500963|NCT04632264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500964|NCT04607928|Pirfenidone|pirfenidone|mesh-list
64500965|NCT04607928|Analgesics|analgesics|mesh-ancestor
64500966|NCT04607928|Sensory System Agents|sensory system agents|mesh-ancestor
64500967|NCT04607928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500968|NCT04607928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500969|NCT04607928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64500970|NCT04607928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64500971|NCT04607928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64500972|NCT04607928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64500973|NCT04607928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500974|NCT03380442|Ketamine|ketamine|mesh-list
64500975|NCT03380442|Psilocybin|psilocybin|mesh-list
64500976|NCT03380442|Analgesics|analgesics|mesh-ancestor
64500977|NCT03380442|Sensory System Agents|sensory system agents|mesh-ancestor
64724165|NCT00000355|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64724166|NCT04022785|Azacitidine|azacitidine|mesh-list
64724167|NCT04022785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64724168|NCT04022785|Antimetabolites|antimetabolites|mesh-ancestor
64724169|NCT04022785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724170|NCT04022785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500978|NCT03380442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500979|NCT03380442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500980|NCT03380442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64500981|NCT03380442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64500982|NCT03380442|Anesthetics, General|anesthetics, general|mesh-ancestor
64500983|NCT03380442|Anesthetics|anesthetics|mesh-ancestor
64500984|NCT03380442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64500985|NCT03380442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64500986|NCT03380442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64500987|NCT03380442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65018385|NCT02940808|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65018386|NCT02940808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018387|NCT02940808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65018388|NCT02940808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018389|NCT02940808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018390|NCT02940808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65018391|NCT02940808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65018392|NCT02940808|Purinergic Agents|purinergic agents|mesh-ancestor
65018393|NCT02940808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65018394|NCT00169416|Valacyclovir|valacyclovir|mesh-list
65018395|NCT00169416|Antiviral Agents|antiviral agents|mesh-ancestor
65018396|NCT00169416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65018397|NCT00174876|Aripiprazole|aripiprazole|mesh-list
65018398|NCT00174876|Antidepressive Agents|antidepressive agents|mesh-ancestor
65018399|NCT00174876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65018400|NCT00174876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65018401|NCT00174876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65018402|NCT00174876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65018403|NCT00174876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018404|NCT00174876|Dopamine Agonists|dopamine agonists|mesh-ancestor
65018405|NCT00174876|Dopamine Agents|dopamine agents|mesh-ancestor
65018406|NCT00174876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65018407|NCT00174876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018408|NCT00174876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65018409|NCT00174876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65018410|NCT00174876|Serotonin Agents|serotonin agents|mesh-ancestor
65018411|NCT00174876|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65018412|NCT00174876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65018428|NCT02940379|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65018429|NCT02940379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65018430|NCT02940379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65018431|NCT02940379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65018432|NCT02940379|Anesthetics, General|anesthetics, general|mesh-ancestor
65018434|NCT02940379|GABA Modulators|gaba modulators|mesh-ancestor
65018435|NCT02940379|GABA Agents|gaba agents|mesh-ancestor
65018436|NCT02940379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65018437|NCT02940379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018438|NCT02940379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65018439|NCT02940379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65018440|NCT02940379|Sympatholytics|sympatholytics|mesh-ancestor
65018441|NCT02940379|Autonomic Agents|autonomic agents|mesh-ancestor
65018442|NCT02940379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65018443|NCT02940379|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65018444|NCT02940379|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65018445|NCT02940379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65018446|NCT02940379|Adrenergic Agents|adrenergic agents|mesh-ancestor
65018447|NCT02940379|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65018448|NCT02940379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65018449|NCT00146549|Paclitaxel|paclitaxel|mesh-list
65018450|NCT00146549|Vinorelbine|vinorelbine|mesh-list
65018451|NCT00146549|Docetaxel|docetaxel|mesh-list
65018452|NCT00146549|Trastuzumab|trastuzumab|mesh-list
65018453|NCT00146549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65018454|NCT00146549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018455|NCT00146549|Tubulin Modulators|tubulin modulators|mesh-ancestor
65018478|NCT00146588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018479|NCT00146588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65018480|NCT00146588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65018481|NCT00146588|Alkylating Agents|alkylating agents|mesh-ancestor
65018482|NCT00146588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018483|NCT00146588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018484|NCT00146588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65018485|NCT00146588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65018486|NCT00146588|Antimetabolites|antimetabolites|mesh-ancestor
65018487|NCT00146588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65018488|NCT00146588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65018489|NCT00146588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65018490|NCT00146588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018491|NCT00175032|Aspirin|aspirin|mesh-list
65018492|NCT00175032|Celecoxib|celecoxib|mesh-list
65018493|NCT00175032|Naproxen|naproxen|mesh-list
65018494|NCT00175032|Lansoprazole|lansoprazole|mesh-list
65018495|NCT00175032|Dexlansoprazole|dexlansoprazole|mesh-list
65018496|NCT00175032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65018497|NCT00175032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65018498|NCT00175032|Analgesics|analgesics|mesh-ancestor
65018499|NCT00175032|Sensory System Agents|sensory system agents|mesh-ancestor
65018500|NCT00175032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65018501|NCT00175032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018502|NCT00175032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65018503|NCT00175032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65018504|NCT00175032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64883485|NCT01939561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64500988|NCT03380442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500989|NCT03380442|Hallucinogens|hallucinogens|mesh-ancestor
64500990|NCT03380442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64500991|NCT05172570|Gabapentin|gabapentin|mesh-list
64500992|NCT05172570|Analgesics|analgesics|mesh-ancestor
64500993|NCT05172570|Sensory System Agents|sensory system agents|mesh-ancestor
64500994|NCT05172570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64501019|NCT03386838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64501020|NCT03386838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64501021|NCT03386838|Immunologic Factors|immunologic factors|mesh-ancestor
64501022|NCT03386838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501023|NCT03386838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64501024|NCT03386838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64419422|NCT02392377|Calcium|calcium|mesh-list
64501033|NCT01570036|Molgramostim|molgramostim|mesh-list
64501034|NCT01570036|Sargramostim|sargramostim|mesh-list
64501035|NCT01570036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64501036|NCT01570036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501037|NCT01570036|Immunologic Factors|immunologic factors|mesh-ancestor
65018505|NCT00175032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65018506|NCT00175032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018507|NCT00175032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65018508|NCT00175032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65018509|NCT00175032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018510|NCT00175032|Antipyretics|antipyretics|mesh-ancestor
65018511|NCT00175032|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65018512|NCT00175032|Gout Suppressants|gout suppressants|mesh-ancestor
65018513|NCT00175032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65018514|NCT00175032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65018515|NCT00175032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65018516|NCT00146627|Eflornithine|eflornithine|mesh-list
65018517|NCT00146627|Nifurtimox|nifurtimox|mesh-list
65018518|NCT00146627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018519|NCT00146627|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65018520|NCT00146627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64501038|NCT01570036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501039|NCT01516684|Lidocaine|lidocaine|mesh-list
64501040|NCT01516684|Fentanyl|fentanyl|mesh-list
64501041|NCT01516684|Anesthetics, Local|anesthetics, local|mesh-list
64501042|NCT01516684|Prilocaine|prilocaine|mesh-list
64501043|NCT01516684|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64501052|NCT01516684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64501053|NCT01516684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64501054|NCT01516684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501055|NCT01516684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64501056|NCT01516684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64501057|NCT01516684|Anesthetics, General|anesthetics, general|mesh-ancestor
64501058|NCT01516684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64501060|NCT01516684|Analgesics|analgesics|mesh-ancestor
64501061|NCT01516684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64501062|NCT01516684|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64501063|NCT01517074|Sirolimus|sirolimus|mesh-list
64501064|NCT01517074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64501065|NCT01517074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501066|NCT01517074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64501067|NCT01517074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501068|NCT01517074|Antifungal Agents|antifungal agents|mesh-ancestor
64501069|NCT01517074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64501070|NCT01517074|Immunologic Factors|immunologic factors|mesh-ancestor
64501071|NCT01517074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501072|NCT01570348|Mycophenolic Acid|mycophenolic acid|mesh-list
64501073|NCT01570348|Cyclophosphamide|cyclophosphamide|mesh-list
64501074|NCT01570348|Fludarabine|fludarabine|mesh-list
64724171|NCT04022785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724172|NCT00000361|Methotrexate|methotrexate|mesh-list
64724173|NCT00000361|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64724174|NCT00000361|Abortifacient Agents|abortifacient agents|mesh-ancestor
64724175|NCT00000361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64724176|NCT00000361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724177|NCT00000361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64501075|NCT01570348|Fludarabine phosphate|fludarabine phosphate|mesh-list
64501077|NCT01570348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64501078|NCT01570348|Immunologic Factors|immunologic factors|mesh-ancestor
64501079|NCT01570348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501080|NCT01570348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64501081|NCT01570348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64501082|NCT01570348|Alkylating Agents|alkylating agents|mesh-ancestor
64501083|NCT01570348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501084|NCT01570348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018521|NCT00146627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65018522|NCT00146627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65018523|NCT00146627|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
65018524|NCT00146627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018525|NCT00146627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018526|NCT00169533|Lapatinib|lapatinib|mesh-list
65018527|NCT00169533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493830|NCT04233866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65018528|NCT00169533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65018529|NCT00169533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018530|NCT00169533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018531|NCT00424229|Lenalidomide|lenalidomide|mesh-list
65018532|NCT00424229|Immunologic Factors|immunologic factors|mesh-ancestor
65018533|NCT00424229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018534|NCT00424229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65018535|NCT00424229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65018536|NCT00424229|Growth Substances|growth substances|mesh-ancestor
65018537|NCT00424229|Growth Inhibitors|growth inhibitors|mesh-ancestor
65018538|NCT00424229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018539|NCT02944123|Clopidogrel|clopidogrel|mesh-list
65018540|NCT02944123|Ticagrelor|ticagrelor|mesh-list
65018541|NCT02944123|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65018542|NCT02944123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65018543|NCT02944123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65018544|NCT02944123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64883528|NCT01939691|Analgesics|analgesics|mesh-ancestor
64501085|NCT01570348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64945686|NCT05301023|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64945687|NCT05301023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64501086|NCT01570348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64501088|NCT01570348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64501089|NCT01570348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501090|NCT01570348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64501091|NCT01570348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64501092|NCT01570348|Antitubercular Agents|antitubercular agents|mesh-ancestor
64501093|NCT01570348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64501094|NCT01570348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501096|NCT03383406|Methotrexate|methotrexate|mesh-list
64501097|NCT03383406|Etoposide|etoposide|mesh-list
64501101|NCT03383406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64501102|NCT03383406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501103|NCT03383406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64501104|NCT03383406|Antimetabolites|antimetabolites|mesh-ancestor
64501105|NCT03383406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501106|NCT03383406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501107|NCT03383406|Dermatologic Agents|dermatologic agents|mesh-ancestor
64501108|NCT03383406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501109|NCT03383406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65018545|NCT02944123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65018546|NCT02944123|Purinergic Agents|purinergic agents|mesh-ancestor
65018547|NCT02944123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65018548|NCT02944123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018549|NCT02944123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018550|NCT02944045|Methylprednisolone|methylprednisolone|mesh-list
65018551|NCT02944045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65018552|NCT02944045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65018553|NCT02944045|Prednisolone|prednisolone|mesh-list
65018554|NCT02944045|Prednisolone acetate|prednisolone acetate|mesh-list
65018555|NCT02944045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65018556|NCT02944045|Prednisolone phosphate|prednisolone phosphate|mesh-list
65018557|NCT02944045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65018558|NCT02944045|Antiemetics|antiemetics|mesh-ancestor
65018559|NCT02944045|Autonomic Agents|autonomic agents|mesh-ancestor
65018560|NCT02944045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65018561|NCT02944045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018562|NCT02944045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65018563|NCT02944045|Glucocorticoids|glucocorticoids|mesh-ancestor
65018564|NCT02944045|Hormones|hormones|mesh-ancestor
65018565|NCT02944045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65018566|NCT02944045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65018567|NCT02944045|Protective Agents|protective agents|mesh-ancestor
65018568|NCT02944045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65018569|NCT02944045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018570|NCT00169572|Dexamethasone|dexamethasone|mesh-list
65018571|NCT00169572|Ondansetron|ondansetron|mesh-list
65018572|NCT00169572|Aprepitant|aprepitant|mesh-list
65018573|NCT00169572|Fosaprepitant|fosaprepitant|mesh-list
65018574|NCT00169572|Casopitant|casopitant|mesh-list
65018575|NCT00169572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64474313|NCT02501434|Heparin|heparin|mesh-list
65018576|NCT00169572|Antiemetics|antiemetics|mesh-ancestor
65018577|NCT00169572|Autonomic Agents|autonomic agents|mesh-ancestor
65018578|NCT00169572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65018579|NCT00169572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018585|NCT00169572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018586|NCT00169572|Antipruritics|antipruritics|mesh-ancestor
65018587|NCT00169572|Dermatologic Agents|dermatologic agents|mesh-ancestor
65018588|NCT00169572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65018589|NCT00169572|Serotonin Agents|serotonin agents|mesh-ancestor
65018590|NCT00169572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65018591|NCT00169572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018592|NCT00169572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65018593|NCT00169572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65018594|NCT00169572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64501110|NCT03383406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64501122|NCT04445922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64501123|NCT04445922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501124|NCT04445922|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64501125|NCT04445922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64501126|NCT04445922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501127|NCT04445922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501128|NCT04445922|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64501129|NCT04445922|Hormone Antagonists|hormone antagonists|mesh-ancestor
64501130|NCT04445922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64501131|NCT04445922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501132|NCT03383328|Prednisolone|prednisolone|mesh-list
64501133|NCT03383328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64501134|NCT03383328|Methylprednisolone|methylprednisolone|mesh-list
64501135|NCT03383328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64501136|NCT03383328|Prednisolone acetate|prednisolone acetate|mesh-list
64501137|NCT03383328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64501138|NCT03383328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64501139|NCT03383328|Prednisolone phosphate|prednisolone phosphate|mesh-list
64501140|NCT03383328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64501141|NCT03383328|Glucocorticoids|glucocorticoids|mesh-ancestor
64501143|NCT03383328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64501144|NCT03383328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501145|NCT03383328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64724178|NCT00000361|Antimetabolites|antimetabolites|mesh-ancestor
64724179|NCT00000361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724180|NCT00000361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501146|NCT03383328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501147|NCT03383328|Antiemetics|antiemetics|mesh-ancestor
64501148|NCT03383328|Autonomic Agents|autonomic agents|mesh-ancestor
64501149|NCT03383328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64501150|NCT03383328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64501151|NCT03383328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64501152|NCT03383328|Protective Agents|protective agents|mesh-ancestor
64501153|NCT03383328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64501154|NCT03383328|Analgesics|analgesics|mesh-ancestor
64501155|NCT03383328|Sensory System Agents|sensory system agents|mesh-ancestor
64501156|NCT03383328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64501157|NCT01573702|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64945688|NCT05301023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501158|NCT01573702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501159|NCT01573702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64501160|NCT01573702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501161|NCT01573702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501162|NCT03093246|Aspirin|aspirin|mesh-list
64501163|NCT03093246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64501164|NCT03093246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64501165|NCT03093246|Analgesics|analgesics|mesh-ancestor
64501166|NCT03093246|Sensory System Agents|sensory system agents|mesh-ancestor
64501167|NCT03093246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64501168|NCT03093246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501169|NCT03093246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65018595|NCT00169572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65018596|NCT00169572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65018597|NCT00169572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65018598|NCT00146783|Pyrimethamine|pyrimethamine|mesh-list
65018599|NCT00146783|Sulfadoxine|sulfadoxine|mesh-list
65018600|NCT00146783|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65018601|NCT00146783|Amodiaquine|amodiaquine|mesh-list
65018602|NCT00146783|Antimalarials|antimalarials|mesh-ancestor
65018604|NCT00146783|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65018605|NCT00146783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65018606|NCT00146783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65018607|NCT00146783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018608|NCT00146783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018609|NCT00146783|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65018610|NCT00146783|Renal Agents|renal agents|mesh-ancestor
65018611|NCT00169611|Methylphenidate|methylphenidate|mesh-list
65018612|NCT00169611|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65018613|NCT00169611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018614|NCT00169611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65018615|NCT00169611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65018616|NCT00169611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65018617|NCT00169611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018618|NCT00169611|Dopamine Agents|dopamine agents|mesh-ancestor
65018619|NCT00169611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65018620|NCT02943655|Mefenamic Acid|mefenamic acid|mesh-list
65018621|NCT02943655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65018622|NCT02943655|Contraceptive Agents|contraceptive agents|mesh-list
65018623|NCT02943655|Medroxyprogesterone|medroxyprogesterone|mesh-list
65018624|NCT02943655|Progesterone|progesterone|mesh-list
65018625|NCT02943655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65018626|NCT02943655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018627|NCT02943655|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65018628|NCT02943655|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64501170|NCT03093246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64501171|NCT03093246|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64501195|NCT02968446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501196|NCT02968446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64419432|NCT02392377|Antimetabolites|antimetabolites|mesh-ancestor
64501212|NCT03383094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501213|NCT03383094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64501214|NCT03378726|Micronutrients|micronutrients|mesh-list
65018629|NCT02943655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65018630|NCT02943655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65018631|NCT02943655|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65018632|NCT02943655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65018633|NCT02943655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65018634|NCT02943655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018635|NCT02943655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65018636|NCT02943655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65018637|NCT02943655|Analgesics|analgesics|mesh-ancestor
65018638|NCT02943655|Sensory System Agents|sensory system agents|mesh-ancestor
65018639|NCT02943655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65018640|NCT02943655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65018641|NCT02943655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65018642|NCT02943655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65018643|NCT02943655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018644|NCT02943655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018645|NCT02943655|Progestins|progestins|mesh-ancestor
65018646|NCT02943655|Hormones|hormones|mesh-ancestor
65018647|NCT02943655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65018648|NCT05085067|Hyaluronic Acid|hyaluronic acid|mesh-list
65018649|NCT05085067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65018650|NCT05085067|Immunologic Factors|immunologic factors|mesh-ancestor
65018651|NCT05085067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018652|NCT05085067|Viscosupplements|viscosupplements|mesh-ancestor
65018653|NCT05085067|Protective Agents|protective agents|mesh-ancestor
65018654|NCT00175227|Furosemide|furosemide|mesh-list
64883633|NCT01940250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64883634|NCT01940250|Tocolytic Agents|tocolytic agents|mesh-ancestor
64501215|NCT03378726|Trace Elements|trace elements|mesh-list
64501216|NCT03378726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501217|NCT05137938|Ketamine|ketamine|mesh-list
64501218|NCT05137938|Analgesics|analgesics|mesh-ancestor
64501219|NCT05137938|Sensory System Agents|sensory system agents|mesh-ancestor
64501221|NCT05137938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501222|NCT05137938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64501223|NCT05137938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64501224|NCT05137938|Anesthetics, General|anesthetics, general|mesh-ancestor
64501225|NCT05137938|Anesthetics|anesthetics|mesh-ancestor
64501241|NCT01576276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64501242|NCT01576276|Analgesics|analgesics|mesh-ancestor
64501243|NCT01576276|Sensory System Agents|sensory system agents|mesh-ancestor
64501244|NCT01576276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64501245|NCT01576276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501246|NCT01576276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64501247|NCT01576276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65018655|NCT00175227|Mannitol|mannitol|mesh-list
65018656|NCT00175227|Diuretics|diuretics|mesh-ancestor
65018657|NCT00175227|Natriuretic Agents|natriuretic agents|mesh-ancestor
65018658|NCT00175227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018659|NCT00175227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65018660|NCT00175227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65018661|NCT00175227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018662|NCT00175227|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65018663|NCT02940262|Edetic Acid|edetic acid|mesh-list
65018664|NCT02940262|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65018665|NCT02940262|Chelating Agents|chelating agents|mesh-ancestor
65018666|NCT02940262|Sequestering Agents|sequestering agents|mesh-ancestor
65018667|NCT02940262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501248|NCT01576276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64501249|NCT01576276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501250|NCT01576276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501251|NCT01576588|Rituximab|rituximab|mesh-list
64501252|NCT01576588|Glucocorticoids|glucocorticoids|mesh-list
64724181|NCT00000361|Dermatologic Agents|dermatologic agents|mesh-ancestor
64724182|NCT00000361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724183|NCT00000361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64724184|NCT00000361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64724185|NCT00000361|Immunologic Factors|immunologic factors|mesh-ancestor
64724186|NCT00000361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64724187|NCT00000361|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64724189|NCT00000811|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64724190|NCT00000811|Trimethoprim|trimethoprim|mesh-list
64724191|NCT00000811|Sulfamethoxazole|sulfamethoxazole|mesh-list
64724192|NCT00000811|Atovaquone|atovaquone|mesh-list
64724193|NCT00000811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64331762|NCT04887467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64501253|NCT01576588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64501254|NCT01576588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501255|NCT01576588|Immunologic Factors|immunologic factors|mesh-ancestor
64501256|NCT01576588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501257|NCT01576588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64501258|NCT01576588|Hormones|hormones|mesh-ancestor
64501259|NCT01576588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64501278|NCT03007810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501280|NCT01578772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64501297|NCT02346630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501298|NCT02346630|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64501299|NCT02346630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501301|NCT03385668|Analgesics|analgesics|mesh-ancestor
64501302|NCT03385668|Sensory System Agents|sensory system agents|mesh-ancestor
64501303|NCT03385668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64501304|NCT03385668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501305|NCT03385668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64501306|NCT03385668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64501307|NCT03385668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64501308|NCT03385668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64501309|NCT03385668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501311|NCT04947072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64501312|NCT04947072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501314|NCT04942158|Zinc Oxide|zinc oxide|mesh-list
64501315|NCT04942158|Dermatologic Agents|dermatologic agents|mesh-ancestor
64501316|NCT04942158|Sunscreening Agents|sunscreening agents|mesh-ancestor
64501317|NCT04942158|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64501318|NCT04942158|Protective Agents|protective agents|mesh-ancestor
65018668|NCT02940262|Anticoagulants|anticoagulants|mesh-ancestor
65018669|NCT02940262|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65018670|NCT02940262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65018671|NCT00146900|Citalopram|citalopram|mesh-list
65018672|NCT00146900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65018673|NCT00146900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65018674|NCT00146900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64892412|NCT01988649|Oxytocin|oxytocin|mesh-list
65018675|NCT00146900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018676|NCT00146900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65018677|NCT00146900|Serotonin Agents|serotonin agents|mesh-ancestor
65018678|NCT00146900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018679|NCT00146900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65018680|NCT00146900|Antidepressive Agents|antidepressive agents|mesh-ancestor
65018681|NCT00146900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65018682|NCT02939482|Triamcinolone|triamcinolone|mesh-list
65018683|NCT02939482|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65018684|NCT02939482|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65018685|NCT02939482|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65018686|NCT02939482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64724194|NCT00000811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724195|NCT00000811|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64724196|NCT00000811|Renal Agents|renal agents|mesh-ancestor
64724197|NCT00000811|Antimalarials|antimalarials|mesh-ancestor
64724198|NCT00000811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64724199|NCT00000811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64724200|NCT00000811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64501319|NCT04942158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501320|NCT04942158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501321|NCT03382470|Anti-Infective Agents|anti-infective agents|mesh-list
64501322|NCT03382470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64501323|NCT03387774|Urinastatin|urinastatin|mesh-list
64501324|NCT03387774|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64501325|NCT03387774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64501326|NCT03387774|Protease Inhibitors|protease inhibitors|mesh-ancestor
64501327|NCT03387774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501328|NCT03387774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501329|NCT03382314|Cholecalciferol|cholecalciferol|mesh-list
64501336|NCT03382314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64501337|NCT03382314|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64501338|NCT03382314|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64501339|NCT03382314|Hormone Antagonists|hormone antagonists|mesh-ancestor
64501340|NCT03382314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64501342|NCT03124524|Drospirenone|drospirenone|mesh-list
64501364|NCT03124524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64501365|NCT03124524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501366|NCT03377400|Cisplatin|cisplatin|mesh-list
64501367|NCT03377400|Durvalumab|durvalumab|mesh-list
64501368|NCT03377400|Tremelimumab|tremelimumab|mesh-list
64501369|NCT03377400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501370|NCT03377400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64501372|NCT01803269|Camptothecin|camptothecin|mesh-list
64501373|NCT01803269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64501374|NCT01803269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64501375|NCT01803269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018687|NCT02939482|Glucocorticoids|glucocorticoids|mesh-ancestor
65018688|NCT02939482|Hormones|hormones|mesh-ancestor
65018689|NCT02939482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65018690|NCT02939482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018691|NCT02939482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65018692|NCT02939482|Immunologic Factors|immunologic factors|mesh-ancestor
65018693|NCT02939482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018694|NCT02939482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018695|NCT00175266|Alemtuzumab|alemtuzumab|mesh-list
65018696|NCT00175266|Infliximab|infliximab|mesh-list
65018697|NCT00175266|Dermatologic Agents|dermatologic agents|mesh-ancestor
65018698|NCT00175266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65018699|NCT00175266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65018700|NCT00175266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65018701|NCT00175266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018702|NCT05013892|Memantine|memantine|mesh-list
65018703|NCT05013892|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65018704|NCT05013892|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65018705|NCT05013892|Dopamine Agents|dopamine agents|mesh-ancestor
65018706|NCT05013892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65018707|NCT05013892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018708|NCT05013892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018709|NCT05013892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64501376|NCT01803269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501377|NCT01803269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501378|NCT01803269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64501379|NCT01802879|Panobinostat|panobinostat|mesh-list
64501380|NCT01802879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501381|NCT01802879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64501382|NCT01802879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501383|NCT01802879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501384|NCT01825577|Methylphenidate|methylphenidate|mesh-list
64484613|NCT01905436|Ivermectin|ivermectin|mesh-list
64501385|NCT01825577|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64501387|NCT01825577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64501388|NCT01825577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64501389|NCT01825577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64501390|NCT01825577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501391|NCT01825577|Dopamine Agents|dopamine agents|mesh-ancestor
64501392|NCT01825577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64501394|NCT03375138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64501395|NCT03375138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501405|NCT03124680|Analgesics|analgesics|mesh-ancestor
64501406|NCT03124680|Sensory System Agents|sensory system agents|mesh-ancestor
64501407|NCT03124680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64501408|NCT03374670|Aflibercept|aflibercept|mesh-list
64501409|NCT03374670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64501410|NCT03374670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65018710|NCT05013892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65018711|NCT02939248|Morphine|morphine|mesh-list
65018712|NCT02939248|Naloxone|naloxone|mesh-list
65018713|NCT02939248|Ticagrelor|ticagrelor|mesh-list
65018714|NCT02939248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65018715|NCT02939248|Narcotics|narcotics|mesh-ancestor
65018716|NCT02939248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65018717|NCT02939248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018718|NCT02939248|Analgesics|analgesics|mesh-ancestor
65018719|NCT02939248|Sensory System Agents|sensory system agents|mesh-ancestor
65018720|NCT02939248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65018721|NCT02939248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65018722|NCT02939248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65018723|NCT02939248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65018724|NCT02939248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65018725|NCT02939248|Purinergic Agents|purinergic agents|mesh-ancestor
65018726|NCT02939248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65018727|NCT02939248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883715|NCT01940978|Methylphenidate|methylphenidate|mesh-list
64724201|NCT00000811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724202|NCT00000811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724203|NCT00000811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64724204|NCT00000811|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64501411|NCT03374670|Growth Substances|growth substances|mesh-ancestor
64501412|NCT03374670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501413|NCT03374670|Growth Inhibitors|growth inhibitors|mesh-ancestor
64501414|NCT03374670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501415|NCT02963610|Pembrolizumab|pembrolizumab|mesh-list
64501416|NCT02963610|Lenalidomide|lenalidomide|mesh-list
64501417|NCT02963610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64501418|NCT02963610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501419|NCT02963610|Immunologic Factors|immunologic factors|mesh-ancestor
64501420|NCT02963610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501421|NCT02963610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64501422|NCT02963610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64501423|NCT02963610|Growth Substances|growth substances|mesh-ancestor
64501424|NCT02963610|Growth Inhibitors|growth inhibitors|mesh-ancestor
64501425|NCT03376932|Albuterol|albuterol|mesh-list
64501432|NCT03376932|Respiratory System Agents|respiratory system agents|mesh-ancestor
64501433|NCT03376932|Parasympatholytics|parasympatholytics|mesh-ancestor
64501434|NCT03376932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64501435|NCT03376932|Cholinergic Agents|cholinergic agents|mesh-ancestor
64501436|NCT03376932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64501437|NCT03376932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501438|NCT03376932|Tocolytic Agents|tocolytic agents|mesh-ancestor
64501439|NCT03376932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64501440|NCT03376932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64501442|NCT03376932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64501443|NCT03376932|Adrenergic Agents|adrenergic agents|mesh-ancestor
64501444|NCT03007342|Amoxicillin|amoxicillin|mesh-list
64501445|NCT03007342|Clavulanic Acid|clavulanic acid|mesh-list
64501446|NCT03007342|Clavulanic Acids|clavulanic acids|mesh-list
64501447|NCT03007342|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64501448|NCT03007342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64501449|NCT03007342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501450|NCT03007342|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65018728|NCT02939248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65018729|NCT02938975|Permethrin|permethrin|mesh-list
65018730|NCT02938975|Insect Repellents|insect repellents|mesh-list
65018731|NCT02938975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018732|NCT02938975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018733|NCT02938975|Protective Agents|protective agents|mesh-ancestor
65018734|NCT02938975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018735|NCT02939092|Chlorhexidine|chlorhexidine|mesh-list
65018736|NCT02939092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65018737|NCT02939092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65018738|NCT02939092|Disinfectants|disinfectants|mesh-ancestor
65018739|NCT00175305|Octreotide|octreotide|mesh-list
65018740|NCT00175305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65018741|NCT00175305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65018742|NCT00175305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018743|NCT02938741|Thymoglobulin|thymoglobulin|mesh-list
64883733|NCT01941004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64501451|NCT03007342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501452|NCT03007342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501453|NCT03376854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
64501454|NCT03376854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64501455|NCT03376854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64501456|NCT03376854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501457|NCT01579162|Cholic Acids|cholic acids|mesh-list
64501458|NCT01579162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64501460|NCT03007654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64501461|NCT03007654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64501462|NCT03007654|Antimetabolites|antimetabolites|mesh-ancestor
64501479|NCT03374514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64501481|NCT01526356|Sirolimus|sirolimus|mesh-list
64501482|NCT01526356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64501483|NCT01526356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501484|NCT01526356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64501485|NCT01526356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501486|NCT01526356|Antifungal Agents|antifungal agents|mesh-ancestor
64501487|NCT01526356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64501488|NCT01526356|Immunologic Factors|immunologic factors|mesh-ancestor
64501489|NCT01526356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501490|NCT02903160|Prednisone|prednisone|mesh-list
64501491|NCT02903160|Carboplatin|carboplatin|mesh-list
64501492|NCT02903160|Abiraterone Acetate|abiraterone acetate|mesh-list
64501493|NCT02903160|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64501494|NCT02903160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501495|NCT02903160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64501496|NCT02903160|Glucocorticoids|glucocorticoids|mesh-ancestor
64724205|NCT00000811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64724206|NCT00000373|Olanzapine|olanzapine|mesh-list
64724207|NCT00000373|Fluoxetine|fluoxetine|mesh-list
64724208|NCT00000373|Antiemetics|antiemetics|mesh-ancestor
64724209|NCT00000373|Autonomic Agents|autonomic agents|mesh-ancestor
64724210|NCT00000373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64724211|NCT00000373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724212|NCT00000373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64724213|NCT00000373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64724214|NCT00000373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64331783|NCT04846335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64331784|NCT04846335|Antimalarials|antimalarials|mesh-ancestor
64501497|NCT02903160|Hormones|hormones|mesh-ancestor
64501498|NCT02903160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64501499|NCT02903160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018744|NCT02938741|Immunologic Factors|immunologic factors|mesh-ancestor
65018745|NCT02938741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018746|NCT02938741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65018747|NCT00407589|Besifloxacin|besifloxacin|mesh-list
65018748|NCT00407589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65018749|NCT00407589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65018750|NCT00407589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65018751|NCT00407589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65018752|NCT00407589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018753|NCT00407589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018754|NCT00407589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018755|NCT02938546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65018756|NCT02938546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65018757|NCT02938546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018758|NCT00175383|Hormones|hormones|mesh-list
65018759|NCT00175383|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65018760|NCT00175383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65018761|NCT00175383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018762|NCT02938468|Dexamethasone|dexamethasone|mesh-list
65018763|NCT02938468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65018764|NCT02938468|Antiemetics|antiemetics|mesh-ancestor
65018765|NCT02938468|Autonomic Agents|autonomic agents|mesh-ancestor
65018766|NCT02938468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64883748|NCT01941134|Estrogens|estrogens|mesh-ancestor
64501500|NCT02903160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64501501|NCT02903160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64501502|NCT02903160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501508|NCT03376464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64501509|NCT03376464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501510|NCT03376464|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64501511|NCT03376464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64501512|NCT03376464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501513|NCT03376464|Cholinergic Agents|cholinergic agents|mesh-ancestor
64501514|NCT03376464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64501515|NCT03374280|Cisplatin|cisplatin|mesh-list
64501516|NCT03374280|Pemetrexed|pemetrexed|mesh-list
64501517|NCT03374280|Gefitinib|gefitinib|mesh-list
64501518|NCT03374280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501519|NCT03374280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501520|NCT03374280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501536|NCT03381066|Mitosis Modulators|mitosis modulators|mesh-ancestor
64501537|NCT03381066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64501539|NCT03630666|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64501540|NCT03630666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64501541|NCT03630666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501542|NCT03375996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64501544|NCT03375996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64501545|NCT03375996|Mydriatics|mydriatics|mesh-ancestor
64501546|NCT03375996|Autonomic Agents|autonomic agents|mesh-ancestor
65018767|NCT02938468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018768|NCT02938468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65018769|NCT02938468|Glucocorticoids|glucocorticoids|mesh-ancestor
65018770|NCT02938468|Hormones|hormones|mesh-ancestor
65018771|NCT02938468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65018772|NCT02938468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65018773|NCT02938468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018774|NCT02938507|Solabegron|solabegron|mesh-list
65018775|NCT02938507|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65018776|NCT02938507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65018777|NCT02938507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65018778|NCT02938507|Adrenergic Agents|adrenergic agents|mesh-ancestor
65018779|NCT02938507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65018780|NCT02938507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018781|NCT02938507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018782|NCT04836910|Metformin|metformin|mesh-list
65018783|NCT04836910|Contraceptive Agents|contraceptive agents|mesh-list
65018784|NCT04836910|Contraceptives, Oral|contraceptives, oral|mesh-list
65018785|NCT04836910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65018786|NCT04836910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65018787|NCT04836910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018788|NCT04836910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65018789|NCT04836910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65018790|NCT00169728|Vaccines|vaccines|mesh-list
65018791|NCT00169728|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65018792|NCT00169728|Immunologic Factors|immunologic factors|mesh-ancestor
65018793|NCT00169728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018794|NCT00147524|Quinapril|quinapril|mesh-list
65018795|NCT00147524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64501547|NCT03375996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64501548|NCT03375996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501549|NCT03375996|Parasympatholytics|parasympatholytics|mesh-ancestor
64501550|NCT03375996|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64501551|NCT03375996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64501552|NCT03375996|Cholinergic Agents|cholinergic agents|mesh-ancestor
64501553|NCT03375996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64501554|NCT03375996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501555|NCT01580410|Oxaliplatin|oxaliplatin|mesh-list
64501556|NCT01580410|Mitomycins|mitomycins|mesh-list
64501557|NCT01580410|Mitomycin|mitomycin|mesh-list
64501558|NCT01580410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501559|NCT01580410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64501560|NCT01580410|Alkylating Agents|alkylating agents|mesh-ancestor
65018796|NCT00147524|Protease Inhibitors|protease inhibitors|mesh-ancestor
65018797|NCT00147524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018798|NCT00147524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018799|NCT00147524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65018800|NCT00147563|Eplerenone|eplerenone|mesh-list
65018801|NCT00147563|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65018802|NCT00147563|Hormone Antagonists|hormone antagonists|mesh-ancestor
65018803|NCT00147563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65018804|NCT00147563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018805|NCT00147563|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65018806|NCT00147563|Diuretics|diuretics|mesh-ancestor
65018807|NCT00147563|Natriuretic Agents|natriuretic agents|mesh-ancestor
65018808|NCT00147563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65018809|NCT02938273|Cetuximab|cetuximab|mesh-list
65018810|NCT02938273|Avelumab|avelumab|mesh-list
65018811|NCT02938273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65018812|NCT02938273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018813|NCT00147602|Atorvastatin|atorvastatin|mesh-list
65018814|NCT00147602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65018815|NCT00147602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64883804|NCT01941329|Ranibizumab|ranibizumab|mesh-list
64501561|NCT01580410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501562|NCT01580410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64501563|NCT01580410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724215|NCT00000373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64724216|NCT00000373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64724217|NCT00000373|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64724218|NCT00000373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64724219|NCT00000373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64724220|NCT00000373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724221|NCT00000373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64724222|NCT00000373|Serotonin Agents|serotonin agents|mesh-ancestor
64724223|NCT00000373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64724224|NCT00000373|Antidepressive Agents|antidepressive agents|mesh-ancestor
64724225|NCT00000373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64724226|NCT00000373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64724227|NCT00000373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724229|NCT00000823|Didanosine|didanosine|mesh-list
64724230|NCT00000823|Antimetabolites|antimetabolites|mesh-ancestor
64331794|NCT04817241|Decitabine|decitabine|mesh-list
64501564|NCT02606136|Mitogens|mitogens|mesh-list
64501565|NCT02606136|Mitosis Modulators|mitosis modulators|mesh-ancestor
64501566|NCT02606136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501567|NCT01581658|Empagliflozin|empagliflozin|mesh-list
64501568|NCT01581658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64501569|NCT01581658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501570|NCT01581658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64501577|NCT01530178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64501578|NCT01530178|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64501579|NCT01530178|Protease Inhibitors|protease inhibitors|mesh-ancestor
64501596|NCT03006874|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65018816|NCT00147602|Antimetabolites|antimetabolites|mesh-ancestor
65018817|NCT00147602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018818|NCT00147602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65018819|NCT00147602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65018820|NCT00147602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018821|NCT02941744|Nivolumab|nivolumab|mesh-list
65493831|NCT04233866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018822|NCT02941744|Ipilimumab|ipilimumab|mesh-list
65018823|NCT02941744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65018824|NCT02941744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883823|NCT01941576|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64501597|NCT03006874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501598|NCT03006874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501599|NCT01581970|Cyclophosphamide|cyclophosphamide|mesh-list
64501600|NCT01581970|Cetuximab|cetuximab|mesh-list
64501601|NCT01581970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64501602|NCT01581970|Immunologic Factors|immunologic factors|mesh-ancestor
64501603|NCT01581970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501604|NCT01581970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64501605|NCT01581970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64501606|NCT01581970|Alkylating Agents|alkylating agents|mesh-ancestor
64501607|NCT01581970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501608|NCT01581970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501609|NCT01581970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64501610|NCT01581970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64501611|NCT01583686|Aldesleukin|aldesleukin|mesh-list
64501612|NCT01583686|Cyclophosphamide|cyclophosphamide|mesh-list
64501613|NCT01583686|Fludarabine|fludarabine|mesh-list
64501614|NCT01583686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64501615|NCT01583686|Immunologic Factors|immunologic factors|mesh-ancestor
64501616|NCT01583686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501617|NCT01583686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64501618|NCT01583686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64724231|NCT00000823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724232|NCT00000823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64724233|NCT00000823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64501619|NCT01583686|Alkylating Agents|alkylating agents|mesh-ancestor
64501620|NCT01583686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501621|NCT01583686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501622|NCT01583686|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64501623|NCT01583686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64501624|NCT01583686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64501625|NCT01583686|Antiviral Agents|antiviral agents|mesh-ancestor
64501626|NCT01583686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501627|NCT01532128|Opicapone|opicapone|mesh-list
64501628|NCT01532128|Rasagiline|rasagiline|mesh-list
64501629|NCT01532128|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64501630|NCT01532128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501631|NCT01532128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501632|NCT01532128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64501633|NCT01532128|Protective Agents|protective agents|mesh-ancestor
64501634|NCT01532128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501635|NCT01532128|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64501636|NCT01532128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64501645|NCT01584544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64501646|NCT01584544|Antimetabolites|antimetabolites|mesh-ancestor
64501647|NCT01584544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501648|NCT01584544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501649|NCT03006952|Losartan|losartan|mesh-list
64501650|NCT03006952|Pentoxifylline|pentoxifylline|mesh-list
64501651|NCT03006952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64501652|NCT03006952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65018825|NCT02941744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65018826|NCT02941744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018827|NCT02941822|Ambroxol|ambroxol|mesh-list
65018828|NCT02941822|Expectorants|expectorants|mesh-ancestor
65018829|NCT02941822|Respiratory System Agents|respiratory system agents|mesh-ancestor
65018830|NCT02941510|Budesonide|budesonide|mesh-list
65018831|NCT02941510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65018832|NCT02941510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65018833|NCT02941510|Autonomic Agents|autonomic agents|mesh-ancestor
65018834|NCT02941510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65018835|NCT02941510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018836|NCT02941510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65018837|NCT02941510|Respiratory System Agents|respiratory system agents|mesh-ancestor
65018838|NCT02941510|Glucocorticoids|glucocorticoids|mesh-ancestor
65018839|NCT02941510|Hormones|hormones|mesh-ancestor
65018840|NCT02941510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65018841|NCT00147680|Paclitaxel|paclitaxel|mesh-list
65018842|NCT00147680|Carboplatin|carboplatin|mesh-list
65018843|NCT00147680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65018844|NCT00147680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018845|NCT00147680|Tubulin Modulators|tubulin modulators|mesh-ancestor
65018846|NCT00147680|Antimitotic Agents|antimitotic agents|mesh-ancestor
65018847|NCT00147680|Mitosis Modulators|mitosis modulators|mesh-ancestor
65018848|NCT00147680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018849|NCT02940184|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65018850|NCT02940184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65018851|NCT02940184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018852|NCT02940184|Incretins|incretins|mesh-ancestor
65018853|NCT02940184|Hormones|hormones|mesh-ancestor
64501653|NCT03006952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64501654|NCT03006952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64501655|NCT03006952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501656|NCT03006952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64501657|NCT03006952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501658|NCT03006952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64501665|NCT01802333|Cytarabine|cytarabine|mesh-list
64501666|NCT01802333|Daunorubicin|daunorubicin|mesh-list
64945691|NCT05299073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64945692|NCT05299073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945693|NCT05298696|Cilostazol|cilostazol|mesh-list
64945694|NCT05298696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64945695|NCT05298696|Autonomic Agents|autonomic agents|mesh-ancestor
64945696|NCT05298696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64945697|NCT05298696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945698|NCT05298696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64945699|NCT05298696|Respiratory System Agents|respiratory system agents|mesh-ancestor
65018854|NCT02940184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65018855|NCT02940184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65018856|NCT02940184|Protease Inhibitors|protease inhibitors|mesh-ancestor
65018857|NCT02940184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018858|NCT02940184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018859|NCT03458143|Ketamine|ketamine|mesh-list
65018860|NCT03458143|Remifentanil|remifentanil|mesh-list
65018861|NCT03458143|Analgesics|analgesics|mesh-ancestor
65018862|NCT03458143|Sensory System Agents|sensory system agents|mesh-ancestor
64883864|NCT01941888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64945700|NCT05298696|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64945701|NCT05298696|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64945702|NCT05298696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945703|NCT05298696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64945704|NCT05298696|Vasodilator Agents|vasodilator agents|mesh-ancestor
64501667|NCT01802333|Vorinostat|vorinostat|mesh-list
64501668|NCT01802333|Idarubicin|idarubicin|mesh-list
64501669|NCT01802333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64501670|NCT01802333|Antimetabolites|antimetabolites|mesh-ancestor
64501671|NCT01802333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501672|NCT01802333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501673|NCT01802333|Antiviral Agents|antiviral agents|mesh-ancestor
64501674|NCT01802333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501675|NCT01802333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64501676|NCT01802333|Immunologic Factors|immunologic factors|mesh-ancestor
64501677|NCT01802333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501678|NCT01802333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64724234|NCT00000823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724235|NCT00000823|Antiviral Agents|antiviral agents|mesh-ancestor
64724236|NCT00000823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724237|NCT00000823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64724238|NCT00000823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64501679|NCT01802333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64501680|NCT01802333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64501681|NCT01802333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501682|NCT01802333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64501684|NCT01585324|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64501685|NCT01585324|Antimetabolites|antimetabolites|mesh-ancestor
64501686|NCT01585324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501687|NCT01585324|Antiviral Agents|antiviral agents|mesh-ancestor
64501688|NCT01585324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501689|NCT01586962|Acetaminophen|acetaminophen|mesh-list
64501705|NCT01586962|Sympathomimetics|sympathomimetics|mesh-ancestor
64501706|NCT01586962|Adrenergic Agents|adrenergic agents|mesh-ancestor
64501707|NCT01586962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64501708|NCT01586962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501709|NCT03006250|Sevoflurane|sevoflurane|mesh-list
64501710|NCT03006250|Desflurane|desflurane|mesh-list
64501711|NCT03006250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64501712|NCT03006250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64501713|NCT03006250|Anesthetics, General|anesthetics, general|mesh-ancestor
64501714|NCT03006250|Anesthetics|anesthetics|mesh-ancestor
64501715|NCT03006250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64501716|NCT03006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501717|NCT01824875|Capecitabine|capecitabine|mesh-list
64501718|NCT01824875|Temozolomide|temozolomide|mesh-list
64501719|NCT01824875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64501720|NCT01824875|Antimetabolites|antimetabolites|mesh-ancestor
64501721|NCT01824875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501722|NCT01824875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501723|NCT01824875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64501724|NCT01824875|Alkylating Agents|alkylating agents|mesh-ancestor
64501725|NCT04129437|Ibuprofen|ibuprofen|mesh-list
64501726|NCT04129437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65018863|NCT03458143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65018864|NCT03458143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018865|NCT03458143|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65018866|NCT03458143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65018867|NCT03458143|Anesthetics, General|anesthetics, general|mesh-ancestor
65018868|NCT03458143|Anesthetics|anesthetics|mesh-ancestor
65018869|NCT03458143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65018870|NCT03458143|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65018871|NCT03458143|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65018872|NCT03458143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65018873|NCT03458143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018874|NCT03458143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65018875|NCT03458143|Narcotics|narcotics|mesh-ancestor
65018876|NCT02941315|Captopril|captopril|mesh-list
65018877|NCT02941315|Spironolactone|spironolactone|mesh-list
65018878|NCT02941315|Furosemide|furosemide|mesh-list
65018879|NCT02941315|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64883873|NCT01941901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883877|NCT01941914|Calcium, Dietary|calcium, dietary|mesh-list
64501727|NCT04129437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64501729|NCT04129437|Sensory System Agents|sensory system agents|mesh-ancestor
64501730|NCT04129437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64501731|NCT04129437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501732|NCT04129437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64501733|NCT04129437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64501734|NCT04129437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64501735|NCT04129437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501736|NCT04129437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501737|NCT04588259|Insulin|insulin|mesh-list
64501738|NCT04588259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64501739|NCT04588259|Insulin Aspart|insulin aspart|mesh-list
64501741|NCT04588259|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64501743|NCT04588259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501744|NCT01801475|Ondansetron|ondansetron|mesh-list
64945705|NCT05298696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64501745|NCT01801475|Antiemetics|antiemetics|mesh-ancestor
64501746|NCT01801475|Autonomic Agents|autonomic agents|mesh-ancestor
64501747|NCT01801475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64501748|NCT01801475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501749|NCT01801475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64501750|NCT01801475|Antipruritics|antipruritics|mesh-ancestor
64501751|NCT01801475|Dermatologic Agents|dermatologic agents|mesh-ancestor
64501763|NCT03063021|Antiviral Agents|antiviral agents|mesh-ancestor
64501764|NCT03063021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501766|NCT03063021|Respiratory System Agents|respiratory system agents|mesh-ancestor
64501767|NCT03063021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64501768|NCT03063021|Antioxidants|antioxidants|mesh-ancestor
64501769|NCT03063021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501770|NCT03063021|Protective Agents|protective agents|mesh-ancestor
64501771|NCT03063021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724240|NCT00000379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64724241|NCT00000379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64724242|NCT00000379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64724243|NCT00000379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018880|NCT02941315|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65018881|NCT02941315|Hormone Antagonists|hormone antagonists|mesh-ancestor
65018882|NCT02941315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65018883|NCT02941315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018884|NCT02941315|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65018885|NCT02941315|Diuretics|diuretics|mesh-ancestor
65018886|NCT02941315|Natriuretic Agents|natriuretic agents|mesh-ancestor
65018887|NCT02941315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65018888|NCT02941315|Adrenergic Agents|adrenergic agents|mesh-ancestor
65018889|NCT02941315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65018890|NCT02941315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018891|NCT02941315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65018892|NCT02941315|Protease Inhibitors|protease inhibitors|mesh-ancestor
65018893|NCT02941315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018894|NCT02941315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64883890|NCT01941953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65222853|NCT03181035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222854|NCT00775138|Amikacin|amikacin|mesh-list
65222855|NCT00775138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65222856|NCT00775138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65222857|NCT03236805|Ketamine|ketamine|mesh-list
65222858|NCT03236805|Morphine|morphine|mesh-list
65222859|NCT03236805|Analgesics|analgesics|mesh-ancestor
65222860|NCT03236805|Sensory System Agents|sensory system agents|mesh-ancestor
65222861|NCT03236805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65222862|NCT03236805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222863|NCT03236805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65222864|NCT03236805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65222865|NCT03236805|Anesthetics, General|anesthetics, general|mesh-ancestor
65222866|NCT03236805|Anesthetics|anesthetics|mesh-ancestor
65222867|NCT03236805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65222868|NCT03236805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65222869|NCT03236805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65222883|NCT02698995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222884|NCT02698995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65222885|NCT02698995|Glucocorticoids|glucocorticoids|mesh-ancestor
65222886|NCT02698995|Hormones|hormones|mesh-ancestor
65222887|NCT02698995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65222888|NCT02698995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64865631|NCT01786538|Vitamins|vitamins|mesh-ancestor
65222889|NCT02698995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65222890|NCT02698995|Anesthetics, Local|anesthetics, local|mesh-ancestor
65222891|NCT02698995|Anesthetics|anesthetics|mesh-ancestor
65222892|NCT02698995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65222893|NCT02698995|Sensory System Agents|sensory system agents|mesh-ancestor
65222894|NCT02698995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65222895|NCT02698995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65222896|NCT02698995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65222897|NCT02698995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65222898|NCT02698995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222899|NCT02698995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65222900|NCT02698995|Narcotics|narcotics|mesh-ancestor
65222901|NCT02698995|Analgesics|analgesics|mesh-ancestor
65222902|NCT02698995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65222903|NCT02698995|Antipyretics|antipyretics|mesh-ancestor
65222904|NCT00920101|Atorvastatin|atorvastatin|mesh-list
65018895|NCT02941315|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65018896|NCT02941315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65018898|NCT02941198|Trace Elements|trace elements|mesh-ancestor
65018899|NCT02941198|Micronutrients|micronutrients|mesh-ancestor
65018900|NCT02941198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018901|NCT00147719|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65018902|NCT00147719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65018903|NCT00147719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65018904|NCT00147719|Antimetabolites|antimetabolites|mesh-ancestor
65018905|NCT00147719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018906|NCT00147719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65018907|NCT05273671|Dexmedetomidine|dexmedetomidine|mesh-list
65018908|NCT05273671|Nalbuphine|nalbuphine|mesh-list
65018909|NCT05273671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65018910|NCT05273671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65018911|NCT05273671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018912|NCT05273671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65018913|NCT05273671|Analgesics|analgesics|mesh-ancestor
65018914|NCT05273671|Sensory System Agents|sensory system agents|mesh-ancestor
65018915|NCT05273671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65018916|NCT05273671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65018917|NCT05273671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65018918|NCT05273671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65018919|NCT05273671|Adrenergic Agents|adrenergic agents|mesh-ancestor
65222905|NCT00920101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65222906|NCT00920101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65222907|NCT00920101|Antimetabolites|antimetabolites|mesh-ancestor
65222908|NCT00920101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222909|NCT00920101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65222910|NCT00920101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65222911|NCT00920101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222912|NCT00616785|Irinotecan|irinotecan|mesh-list
65222913|NCT00616785|Etoposide|etoposide|mesh-list
65222914|NCT00616785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65222915|NCT00616785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65222916|NCT00616785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65222917|NCT00616785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222918|NCT00616785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222919|NCT00616785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65222920|NCT00616785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65222921|NCT00616005|Irinotecan|irinotecan|mesh-list
65222922|NCT00616005|Temozolomide|temozolomide|mesh-list
65222923|NCT00616005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65222924|NCT00616005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65222925|NCT00616005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222926|NCT00616005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222927|NCT00616005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65222928|NCT00616005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65018920|NCT05273671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65018921|NCT05273671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018922|NCT05273671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65018923|NCT05273671|Narcotics|narcotics|mesh-ancestor
65018924|NCT00147758|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65018925|NCT00147758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65018926|NCT00147758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65018927|NCT00147758|Antimetabolites|antimetabolites|mesh-ancestor
65018928|NCT00147758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018929|NCT00147758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65018930|NCT02931526|Tigecycline|tigecycline|mesh-list
65018931|NCT02931526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65018932|NCT02931526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65018933|NCT02931526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65018934|NCT02931526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018935|NCT02931526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018936|NCT00169845|Tocopherols|tocopherols|mesh-list
65018937|NCT00169845|Vitamin E|vitamin e|mesh-list
65018938|NCT00169845|alpha-Tocopherol|alpha-tocopherol|mesh-list
65018939|NCT00169845|Beta Carotene|beta carotene|mesh-list
65018940|NCT00169845|Carotenoids|carotenoids|mesh-list
65018941|NCT00169845|Antioxidants|antioxidants|mesh-ancestor
65018942|NCT00169845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018943|NCT00169845|Protective Agents|protective agents|mesh-ancestor
65018944|NCT00169845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018945|NCT00169845|Vitamins|vitamins|mesh-ancestor
65018946|NCT00169845|Micronutrients|micronutrients|mesh-ancestor
65018948|NCT00147836|Insulin|insulin|mesh-list
65018949|NCT00147836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65018950|NCT00147836|Metformin|metformin|mesh-list
65018951|NCT00147836|Gliclazide|gliclazide|mesh-list
65018952|NCT00147836|Isophane Insulin, Human|isophane insulin, human|mesh-list
65018953|NCT00147836|Insulin, Isophane|insulin, isophane|mesh-list
65018954|NCT00147836|Isophane insulin, beef|isophane insulin, beef|mesh-list
64883932|NCT01942174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65222929|NCT00616005|Alkylating Agents|alkylating agents|mesh-ancestor
65222930|NCT02698527|Lidocaine|lidocaine|mesh-list
65222931|NCT02698527|Anesthetics, Local|anesthetics, local|mesh-ancestor
65222932|NCT02698527|Anesthetics|anesthetics|mesh-ancestor
65222950|NCT02586649|Bromides|bromides|mesh-list
65222951|NCT02586649|Tiotropium Bromide|tiotropium bromide|mesh-list
65222952|NCT02586649|Cholinergic Antagonists|cholinergic antagonists|mesh-list
65222953|NCT02586649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65222954|NCT02586649|Autonomic Agents|autonomic agents|mesh-ancestor
65018955|NCT00147836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65018956|NCT00147836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018957|NCT02931136|Huperzine A|huperzine a|mesh-list
65018958|NCT02931136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65018959|NCT02931136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018960|NCT02931136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018961|NCT02931136|Cholinergic Agents|cholinergic agents|mesh-ancestor
65018962|NCT02931136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65018963|NCT02931136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018964|NCT02931136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65018965|NCT02931136|Protective Agents|protective agents|mesh-ancestor
65018966|NCT02931175|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65018967|NCT02931175|Hormones|hormones|mesh-ancestor
65018968|NCT02931175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65018969|NCT02931175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018970|NCT00147875|Gemcitabine|gemcitabine|mesh-list
65018971|NCT00147875|Prednisone|prednisone|mesh-list
65018972|NCT00147875|Doxorubicin|doxorubicin|mesh-list
65018973|NCT00147875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65018974|NCT00147875|Vinblastine|vinblastine|mesh-list
65018975|NCT00147875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65222955|NCT02586649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65222956|NCT02586649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222957|NCT02586649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65222958|NCT02586649|Respiratory System Agents|respiratory system agents|mesh-ancestor
65222959|NCT02586649|Parasympatholytics|parasympatholytics|mesh-ancestor
65222960|NCT02586649|Cholinergic Agents|cholinergic agents|mesh-ancestor
65222961|NCT02586649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65222962|NCT02586649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222963|NCT02586649|Anticonvulsants|anticonvulsants|mesh-ancestor
65222964|NCT04213833|Lidocaine|lidocaine|mesh-list
65222965|NCT04213833|Dexmedetomidine|dexmedetomidine|mesh-list
65222966|NCT04213833|Propofol|propofol|mesh-list
65222967|NCT04213833|Anesthetics, Local|anesthetics, local|mesh-ancestor
65222968|NCT04213833|Anesthetics|anesthetics|mesh-ancestor
65222969|NCT04213833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65222970|NCT04213833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222971|NCT04213833|Sensory System Agents|sensory system agents|mesh-ancestor
65222972|NCT04213833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65222973|NCT04213833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65222974|NCT04213833|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65222975|NCT04213833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65222976|NCT04213833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65222977|NCT04213833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222978|NCT04213833|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65222979|NCT04213833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65222980|NCT04213833|Anesthetics, General|anesthetics, general|mesh-ancestor
65222981|NCT04213833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65222982|NCT04213833|Analgesics|analgesics|mesh-ancestor
65222983|NCT04213833|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65222984|NCT04213833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65222985|NCT04213833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65222986|NCT04213833|Adrenergic Agents|adrenergic agents|mesh-ancestor
65018976|NCT00147875|Antimetabolites|antimetabolites|mesh-ancestor
65018977|NCT00147875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65018978|NCT00147875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65018979|NCT00147875|Antiviral Agents|antiviral agents|mesh-ancestor
65018980|NCT00147875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65018981|NCT00147875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65018982|NCT00147875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65018983|NCT00147875|Immunologic Factors|immunologic factors|mesh-ancestor
65018984|NCT00147875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65018985|NCT00147875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65018986|NCT00147875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65018987|NCT00147875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65018988|NCT00147875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65018989|NCT00147875|Glucocorticoids|glucocorticoids|mesh-ancestor
65018991|NCT00147875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65018992|NCT00147875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65018993|NCT00147875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65018994|NCT00147875|Tubulin Modulators|tubulin modulators|mesh-ancestor
65018995|NCT00147875|Antimitotic Agents|antimitotic agents|mesh-ancestor
65018996|NCT00147875|Mitosis Modulators|mitosis modulators|mesh-ancestor
64883984|NCT01942304|Calcium|calcium|mesh-list
65222990|NCT04605991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222992|NCT00783796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65222993|NCT00783796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65222994|NCT00783796|Immunologic Factors|immunologic factors|mesh-ancestor
65222995|NCT00783796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222996|NCT00637065|Bosentan|bosentan|mesh-list
65222997|NCT00637065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65222998|NCT00637065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65222999|NCT00637065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223000|NCT00616863|Oxcarbazepine|oxcarbazepine|mesh-list
65223001|NCT00616863|Anticonvulsants|anticonvulsants|mesh-ancestor
65223002|NCT00616863|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65223003|NCT00616863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65223004|NCT00616863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65223005|NCT00616863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223006|NCT00616863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65223007|NCT00616863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65223008|NCT04947553|Dextromethorphan|dextromethorphan|mesh-list
65223009|NCT04947553|Bupropion|bupropion|mesh-list
65223010|NCT04947553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65223011|NCT04947553|Antidepressive Agents|antidepressive agents|mesh-ancestor
65223012|NCT04947553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65223013|NCT04947553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65223014|NCT04947553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65223015|NCT04947553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65223016|NCT04947553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223017|NCT04947553|Dopamine Agents|dopamine agents|mesh-ancestor
65223018|NCT04947553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65223019|NCT04947553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223020|NCT04947553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65018997|NCT00169923|Rosiglitazone|rosiglitazone|mesh-list
65018998|NCT00169923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65018999|NCT00169923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019000|NCT00147914|Amoxicillin|amoxicillin|mesh-list
65019001|NCT00147914|Clavulanic Acid|clavulanic acid|mesh-list
65019002|NCT00147914|Clavulanic Acids|clavulanic acids|mesh-list
65019003|NCT00147914|Cefdinir|cefdinir|mesh-list
65019004|NCT00147914|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65019005|NCT00147914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65019006|NCT00147914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65019007|NCT00147914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65019008|NCT00147914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019009|NCT00147914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019010|NCT00147953|Rituximab|rituximab|mesh-list
65019011|NCT00147953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65019012|NCT00147953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019013|NCT00147953|Immunologic Factors|immunologic factors|mesh-ancestor
65019014|NCT00147953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019015|NCT00147953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65223021|NCT04947553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65223022|NCT04947553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223023|NCT04947553|Antitussive Agents|antitussive agents|mesh-ancestor
65223024|NCT04947553|Respiratory System Agents|respiratory system agents|mesh-ancestor
65223025|NCT04947553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65223026|NCT04947553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65223027|NCT02787369|Idelalisib|idelalisib|mesh-list
65223028|NCT02787369|Ricolinostat|ricolinostat|mesh-list
65223029|NCT02787369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223030|NCT02787369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223031|NCT02787369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223032|NCT02787369|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65223033|NCT05300451|Daratumumab|daratumumab|mesh-list
65223034|NCT05300451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223035|NCT02714205|Nitroglycerin|nitroglycerin|mesh-list
65223036|NCT02714205|Vasodilator Agents|vasodilator agents|mesh-ancestor
65223037|NCT00617253|Sunitinib|sunitinib|mesh-list
65223038|NCT00617253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223039|NCT00617253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65223040|NCT00617253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65223041|NCT00617253|Growth Substances|growth substances|mesh-ancestor
65223042|NCT00617253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223043|NCT00617253|Growth Inhibitors|growth inhibitors|mesh-ancestor
65223044|NCT00617253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65223045|NCT00617253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223046|NCT00617253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223047|NCT02585947|Tenofovir|tenofovir|mesh-list
65223048|NCT02585947|Antiviral Agents|antiviral agents|mesh-ancestor
65223049|NCT02585947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65223050|NCT02585947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65223051|NCT02585947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65223052|NCT02585947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223053|NCT02585947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223054|NCT02585947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65223055|NCT02585947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65223056|NCT02607891|Cannabidiol|cannabidiol|mesh-list
65223062|NCT04079725|Mitomycins|mitomycins|mesh-list
65019016|NCT02930551|Lidocaine|lidocaine|mesh-list
65019017|NCT02930551|Anesthetics, Local|anesthetics, local|mesh-ancestor
65019018|NCT02930551|Anesthetics|anesthetics|mesh-ancestor
65019019|NCT02930551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65019020|NCT02930551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019021|NCT02930551|Sensory System Agents|sensory system agents|mesh-ancestor
65019022|NCT02930551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65019023|NCT02930551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65019024|NCT02930551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65019025|NCT02930551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65019026|NCT02930551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65019027|NCT02930551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019028|NCT00175617|Minoxidil|minoxidil|mesh-list
65019029|NCT00175617|Spironolactone|spironolactone|mesh-list
65019030|NCT00175617|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65019031|NCT00175617|Hormone Antagonists|hormone antagonists|mesh-ancestor
65019032|NCT00175617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65019033|NCT00175617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019034|NCT00175617|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65019035|NCT00175617|Diuretics|diuretics|mesh-ancestor
65019036|NCT00175617|Natriuretic Agents|natriuretic agents|mesh-ancestor
65019037|NCT00175617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65019038|NCT00175617|Vasodilator Agents|vasodilator agents|mesh-ancestor
65019039|NCT02930707|Magnesium Sulfate|magnesium sulfate|mesh-list
65019040|NCT02930707|Bupivacaine|bupivacaine|mesh-list
65019041|NCT02930707|Anesthetics, Local|anesthetics, local|mesh-ancestor
65019042|NCT02930707|Anesthetics|anesthetics|mesh-ancestor
65223063|NCT04079725|Mitomycin|mitomycin|mesh-list
65223064|NCT04079725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65223065|NCT04079725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223066|NCT04079725|Alkylating Agents|alkylating agents|mesh-ancestor
65223067|NCT04079725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223068|NCT04079725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65223069|NCT04079725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223070|NCT00783718|Vedolizumab|vedolizumab|mesh-list
65223071|NCT00783718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65223072|NCT04213287|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65223073|NCT04213287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223074|NCT04213287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65223075|NCT04213287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65223076|NCT04213287|Analgesics|analgesics|mesh-ancestor
65223077|NCT04213287|Sensory System Agents|sensory system agents|mesh-ancestor
65223078|NCT04213287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65223079|NCT04213287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65223080|NCT04213287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65223081|NCT02585791|Glycerol|glycerol|mesh-list
65223082|NCT02585791|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65223083|NCT02585791|Protective Agents|protective agents|mesh-ancestor
65019043|NCT02930707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65019044|NCT02930707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019045|NCT02930707|Sensory System Agents|sensory system agents|mesh-ancestor
65019046|NCT02930707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65019047|NCT02930707|Analgesics|analgesics|mesh-ancestor
65019048|NCT02930707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65019049|NCT02930707|Anticonvulsants|anticonvulsants|mesh-ancestor
65019050|NCT02930707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65019051|NCT02930707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65019052|NCT02930707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019053|NCT02930707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65019054|NCT02930707|Tocolytic Agents|tocolytic agents|mesh-ancestor
65019055|NCT02930707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65019056|NCT00148031|Interferons|interferons|mesh-list
65019058|NCT00148031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019059|NCT00148031|Antiviral Agents|antiviral agents|mesh-ancestor
65019060|NCT00148031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65223084|NCT02585791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223085|NCT04913389|Acetazolamide|acetazolamide|mesh-list
65223086|NCT04913389|Anticonvulsants|anticonvulsants|mesh-ancestor
65223087|NCT04913389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65223088|NCT04913389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223089|NCT04913389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223090|NCT04913389|Diuretics|diuretics|mesh-ancestor
65223091|NCT04913389|Natriuretic Agents|natriuretic agents|mesh-ancestor
65223092|NCT04913389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223093|NCT04904965|Propofol|propofol|mesh-list
65223094|NCT04904965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65223095|NCT04904965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65223096|NCT04904965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223097|NCT04904965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65223098|NCT04904965|Anesthetics, General|anesthetics, general|mesh-ancestor
65223099|NCT04904965|Anesthetics|anesthetics|mesh-ancestor
65223100|NCT00617565|Insulin|insulin|mesh-list
65223101|NCT00617565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65223102|NCT00617565|Insulin Aspart|insulin aspart|mesh-list
65223103|NCT00617565|Biphasic Insulins|biphasic insulins|mesh-list
65223104|NCT00617565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65223105|NCT00617565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223106|NCT04079413|Insulin|insulin|mesh-list
65223107|NCT04079413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65223108|NCT04079413|Insulin Aspart|insulin aspart|mesh-list
65223109|NCT04079413|Insulin, Long-Acting|insulin, long-acting|mesh-list
65223110|NCT04079413|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65223111|NCT04079413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65223112|NCT04079413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223113|NCT00915460|Interferons|interferons|mesh-list
65223114|NCT00915460|Interferon-beta|interferon-beta|mesh-list
65223115|NCT00915460|Interferon beta-1a|interferon beta-1a|mesh-list
65223116|NCT00915460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223117|NCT00915460|Antiviral Agents|antiviral agents|mesh-ancestor
65223118|NCT00915460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65223119|NCT00915460|Immunologic Factors|immunologic factors|mesh-ancestor
65223120|NCT00915460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223121|NCT00915460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65223122|NCT00617643|Nevirapine|nevirapine|mesh-list
65223123|NCT00617643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65223124|NCT00617643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65019061|NCT00148031|Antimetabolites|antimetabolites|mesh-ancestor
65019062|NCT00148031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019063|NCT02930473|Psychotropic Drugs|psychotropic drugs|mesh-list
65019064|NCT02930434|Vitamin D|vitamin d|mesh-list
65019065|NCT02930434|Cholecalciferol|cholecalciferol|mesh-list
65019066|NCT02930434|Vitamins|vitamins|mesh-ancestor
65019067|NCT02930434|Micronutrients|micronutrients|mesh-ancestor
65019068|NCT02930434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019069|NCT02930434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65019070|NCT02930434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65019071|NCT00148070|Erythromycin|erythromycin|mesh-list
65019072|NCT00148070|Erythromycin Estolate|erythromycin estolate|mesh-list
65019073|NCT00148070|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65019074|NCT00148070|Erythromycin stearate|erythromycin stearate|mesh-list
65019075|NCT00148070|Docetaxel|docetaxel|mesh-list
65019076|NCT00148070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019077|NCT00148070|Tubulin Modulators|tubulin modulators|mesh-ancestor
65019078|NCT00148070|Antimitotic Agents|antimitotic agents|mesh-ancestor
65019079|NCT00148070|Mitosis Modulators|mitosis modulators|mesh-ancestor
65223125|NCT00617643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223126|NCT00617643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223127|NCT00617643|Antiviral Agents|antiviral agents|mesh-ancestor
65223131|NCT00617643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65223132|NCT00617643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65223133|NCT04566133|Hydroxychloroquine|hydroxychloroquine|mesh-list
65223134|NCT04566133|Trametinib|trametinib|mesh-list
65223135|NCT04566133|Antimalarials|antimalarials|mesh-ancestor
65223136|NCT04566133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65223137|NCT04566133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65223138|NCT04566133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65223139|NCT04566133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223140|NCT04566133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223141|NCT04566133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65223142|NCT04566133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223143|NCT04566133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65223144|NCT02584075|Metformin|metformin|mesh-list
65223145|NCT02584075|Exenatide|exenatide|mesh-list
65223146|NCT02584075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65223147|NCT02584075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223148|NCT02584075|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65223149|NCT02584075|Incretins|incretins|mesh-ancestor
65223151|NCT02584075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65223152|NCT02585479|Oxaliplatin|oxaliplatin|mesh-list
65223153|NCT02585479|Ethiodized Oil|ethiodized oil|mesh-list
65223154|NCT02585479|Pirarubicin|pirarubicin|mesh-list
65223155|NCT02585479|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
65223156|NCT02585479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223157|NCT02585479|Hemostatics|hemostatics|mesh-ancestor
65223158|NCT02585479|Coagulants|coagulants|mesh-ancestor
65223159|NCT00583453|Celecoxib|celecoxib|mesh-list
65223160|NCT00583453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65223161|NCT00583453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65223162|NCT00583453|Analgesics|analgesics|mesh-ancestor
65223163|NCT00583453|Sensory System Agents|sensory system agents|mesh-ancestor
65223164|NCT00583453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65223165|NCT00583453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223166|NCT00583453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65223167|NCT00583453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65223168|NCT00583453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65019080|NCT00148070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019081|NCT00148070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65019082|NCT00148070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65019083|NCT00148070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65019084|NCT00148070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65019085|NCT00148070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019086|NCT00175695|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
65019087|NCT00175695|Protein C|protein c|mesh-list
65019088|NCT00175695|Anticoagulants|anticoagulants|mesh-ancestor
65019089|NCT00175695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65019090|NCT00175695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65019091|NCT00175695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019092|NCT00175695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65019093|NCT02930317|Factor VIII|factor viii|mesh-list
65019094|NCT02930317|Coagulants|coagulants|mesh-ancestor
65019095|NCT00148148|Amphotericin B|amphotericin b|mesh-list
65019096|NCT00148148|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65019097|NCT00148148|Caspofungin|caspofungin|mesh-list
65019098|NCT00148148|Amebicides|amebicides|mesh-ancestor
65019100|NCT00148148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65019101|NCT00148148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65019102|NCT00148148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65019103|NCT00148148|Antifungal Agents|antifungal agents|mesh-ancestor
65019104|NCT00148148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223169|NCT00583453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65223170|NCT00583453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223171|NCT00583453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223172|NCT02584231|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65223173|NCT02584231|Hemostatics|hemostatics|mesh-ancestor
65223174|NCT02584231|Coagulants|coagulants|mesh-ancestor
65223175|NCT02584231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65223176|NCT02584231|Natriuretic Agents|natriuretic agents|mesh-ancestor
65223177|NCT02584231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223178|NCT04630873|Botulinum Toxins|botulinum toxins|mesh-list
65223179|NCT04630873|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65223180|NCT04630873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65223181|NCT04630873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223182|NCT04630873|Cholinergic Agents|cholinergic agents|mesh-ancestor
65223183|NCT04630873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65223184|NCT04630873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223185|NCT02584153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65223186|NCT02584153|Hemostatics|hemostatics|mesh-ancestor
65223187|NCT02584153|Coagulants|coagulants|mesh-ancestor
65223188|NCT02585401|Aflibercept|aflibercept|mesh-list
65223189|NCT02585401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64865931|NCT01789086|Liraglutide|liraglutide|mesh-list
65223190|NCT02585401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65223191|NCT02585401|Growth Substances|growth substances|mesh-ancestor
65223192|NCT02585401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223194|NCT02585401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223195|NCT04874311|Doxorubicin|doxorubicin|mesh-list
65223196|NCT04874311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65019105|NCT00148148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019106|NCT00170001|Esomeprazole|esomeprazole|mesh-list
65019107|NCT00170001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65019108|NCT00170001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65019109|NCT00170001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65019110|NCT00170001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019111|NCT00170001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019112|NCT00148265|Triamcinolone|triamcinolone|mesh-list
65019113|NCT00148265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65019114|NCT00148265|Glucocorticoids|glucocorticoids|mesh-ancestor
65019115|NCT00148265|Hormones|hormones|mesh-ancestor
65019116|NCT00148265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65019117|NCT00148265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019118|NCT02929693|Gefitinib|gefitinib|mesh-list
65019119|NCT02929693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019120|NCT02929693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65019121|NCT02929693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019122|NCT02929693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019123|NCT00175734|Chrysarobin|chrysarobin|mesh-list
65019124|NCT00175734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65019125|NCT00175734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65019126|NCT00175734|Analgesics|analgesics|mesh-ancestor
65223197|NCT04874311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223198|NCT04874311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65223199|NCT04874311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65223200|NCT04874311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223201|NCT04874311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223202|NCT04873453|Cannabidiol|cannabidiol|mesh-list
65223209|NCT04080349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223210|NCT04080349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65223211|NCT04080349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65223212|NCT04080349|Oxytocics|oxytocics|mesh-ancestor
65223213|NCT04624243|Risperidone|risperidone|mesh-list
65223214|NCT04624243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65223215|NCT04624243|Serotonin Agents|serotonin agents|mesh-ancestor
65223216|NCT04624243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65223217|NCT04624243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223218|NCT04624243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223219|NCT04624243|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65223220|NCT04624243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65223221|NCT04624243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65223222|NCT04624243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65223229|NCT02585011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65223230|NCT02585011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223231|NCT02585011|Sensory System Agents|sensory system agents|mesh-ancestor
65223232|NCT02585011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65223233|NCT02585011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65223234|NCT02585011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65223235|NCT02585011|Adrenergic Agents|adrenergic agents|mesh-ancestor
65223236|NCT02585011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65019127|NCT00175734|Sensory System Agents|sensory system agents|mesh-ancestor
65019128|NCT00175734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65019129|NCT00175734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019130|NCT00175734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65019131|NCT00175734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65019132|NCT00148382|Cetilistat|cetilistat|mesh-list
65019133|NCT00148382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019134|NCT00148382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019135|NCT00148382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65019136|NCT00148382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65019137|NCT00148421|Epoetin Alfa|epoetin alfa|mesh-list
65223237|NCT02585011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223238|NCT02585011|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65223239|NCT02585011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65223240|NCT02585011|Autonomic Agents|autonomic agents|mesh-ancestor
65223241|NCT02585011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65223242|NCT02585011|Respiratory System Agents|respiratory system agents|mesh-ancestor
65223243|NCT02585011|Mydriatics|mydriatics|mesh-ancestor
65223244|NCT02585011|Sympathomimetics|sympathomimetics|mesh-ancestor
65223245|NCT02585011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65223246|NCT04858009|Paclitaxel|paclitaxel|mesh-list
65223247|NCT04858009|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65223248|NCT04858009|Cisplatin|cisplatin|mesh-list
65223249|NCT04858009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65223250|NCT04858009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223251|NCT04858009|Tubulin Modulators|tubulin modulators|mesh-ancestor
65223252|NCT04858009|Antimitotic Agents|antimitotic agents|mesh-ancestor
65223253|NCT04858009|Mitosis Modulators|mitosis modulators|mesh-ancestor
65223254|NCT04858009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223260|NCT00920725|Insulin|insulin|mesh-list
65223261|NCT00920725|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65223262|NCT00920725|Insulin Aspart|insulin aspart|mesh-list
65223263|NCT00920725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65223264|NCT00920725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223265|NCT04524871|Bevacizumab|bevacizumab|mesh-list
64866004|NCT01789385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65223266|NCT04524871|Atezolizumab|atezolizumab|mesh-list
65223267|NCT04524871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65223268|NCT04524871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223269|NCT04524871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65223270|NCT04524871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65223271|NCT04524871|Growth Substances|growth substances|mesh-ancestor
65223272|NCT04524871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223273|NCT04524871|Growth Inhibitors|growth inhibitors|mesh-ancestor
65223274|NCT02583451|Lemborexant|lemborexant|mesh-list
65223275|NCT02583451|Zopiclone|zopiclone|mesh-list
65223276|NCT02583451|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65223277|NCT02583451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65223278|NCT02583451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223279|NCT02583451|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65223280|NCT02583451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65223281|NCT02583451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65223282|NCT02583451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223289|NCT05435911|Anesthetics, General|anesthetics, general|mesh-ancestor
65223290|NCT05435911|Anesthetics|anesthetics|mesh-ancestor
65223291|NCT05435911|Antidotes|antidotes|mesh-ancestor
65223292|NCT05435911|Protective Agents|protective agents|mesh-ancestor
65223293|NCT05435911|GABA Modulators|gaba modulators|mesh-ancestor
65223294|NCT05435911|GABA Agents|gaba agents|mesh-ancestor
65223295|NCT05435911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65223296|NCT05435911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223297|NCT04472299|Ropivacaine|ropivacaine|mesh-list
65223298|NCT04472299|Anesthetics, Local|anesthetics, local|mesh-ancestor
65223299|NCT04472299|Anesthetics|anesthetics|mesh-ancestor
65223300|NCT04472299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65019138|NCT00148421|Darbepoetin alfa|darbepoetin alfa|mesh-list
65019139|NCT00148421|Hematinics|hematinics|mesh-ancestor
65019140|NCT02929888|Aspirin|aspirin|mesh-list
65019141|NCT02929888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65019142|NCT02929888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65019143|NCT02929888|Analgesics|analgesics|mesh-ancestor
65019144|NCT02929888|Sensory System Agents|sensory system agents|mesh-ancestor
65019145|NCT02929888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65019146|NCT02929888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223301|NCT04472299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223302|NCT04472299|Sensory System Agents|sensory system agents|mesh-ancestor
65223303|NCT04472299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65223304|NCT02583685|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65223305|NCT02583685|Interferon-alpha|interferon-alpha|mesh-list
65223306|NCT02583685|Ribavirin|ribavirin|mesh-list
65223307|NCT02583685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
65223308|NCT02583685|Simeprevir|simeprevir|mesh-list
65223309|NCT02583685|Antiviral Agents|antiviral agents|mesh-ancestor
65223310|NCT02583685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65223311|NCT02583685|Immunologic Factors|immunologic factors|mesh-ancestor
65223312|NCT02583685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223313|NCT02583685|Antimetabolites|antimetabolites|mesh-ancestor
65223314|NCT02583685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223315|NCT02583685|Protease Inhibitors|protease inhibitors|mesh-ancestor
65223316|NCT02583685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223317|NCT04606771|Osimertinib|osimertinib|mesh-list
65223318|NCT04606771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223319|NCT04606771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65223320|NCT04606771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223321|NCT04606771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223322|NCT04504123|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65223323|NCT04504123|Doxycycline|doxycycline|mesh-list
65223324|NCT04504123|Tetracycline|tetracycline|mesh-list
65223325|NCT04504123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65223326|NCT04504123|Antimalarials|antimalarials|mesh-ancestor
65223327|NCT04504123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65223328|NCT04504123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65223329|NCT04504123|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65223330|NCT04504123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223331|NCT04504123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223332|NCT02584543|Vaccines|vaccines|mesh-list
65223333|NCT02584543|Immunologic Factors|immunologic factors|mesh-ancestor
65223334|NCT02584543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223335|NCT04077853|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
65223336|NCT04077853|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
65223337|NCT04077853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65223338|NCT04077853|Hormone Antagonists|hormone antagonists|mesh-ancestor
65223339|NCT04077853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65223340|NCT04077853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223341|NCT04077853|Progestins|progestins|mesh-ancestor
64866090|NCT01789892|Prednisolone|prednisolone|mesh-list
65223342|NCT04077853|Hormones|hormones|mesh-ancestor
65223343|NCT04502407|Cisplatin|cisplatin|mesh-list
65223344|NCT04502407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223345|NCT00583219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65223346|NCT00583219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65223347|NCT00583219|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
65223348|NCT00583219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65223349|NCT00583219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65223350|NCT00583219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223351|NCT00583219|Cholinergic Agents|cholinergic agents|mesh-ancestor
65223352|NCT00583219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65223355|NCT00583219|Protective Agents|protective agents|mesh-ancestor
65223356|NCT00583219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65223357|NCT00583219|Antioxidants|antioxidants|mesh-ancestor
65223358|NCT00583219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65223359|NCT00583219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65019147|NCT02929888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65019148|NCT02929888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65019149|NCT02929888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65019150|NCT02929888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65019151|NCT02929888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019152|NCT02929888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65019153|NCT02929888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65019154|NCT02929888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019155|NCT02929888|Antipyretics|antipyretics|mesh-ancestor
65019156|NCT04689412|Resveratrol|resveratrol|mesh-list
65019157|NCT04689412|Antioxidants|antioxidants|mesh-ancestor
65019158|NCT04689412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019159|NCT04689412|Protective Agents|protective agents|mesh-ancestor
65019160|NCT04689412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019161|NCT04689412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884143|NCT01943487|Cholinergic Agents|cholinergic agents|mesh-ancestor
65223360|NCT04501939|Venetoclax|venetoclax|mesh-list
65223361|NCT04501939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223362|NCT05674669|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
65223363|NCT05674669|Hallucinogens|hallucinogens|mesh-ancestor
65223364|NCT05674669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223365|NCT05674669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65223366|NCT05674669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65223367|NCT05674669|Serotonin Agents|serotonin agents|mesh-ancestor
65223368|NCT05674669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65223369|NCT05674669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223370|NCT05674669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65223371|NCT04332211|Pseudoephedrine|pseudoephedrine|mesh-list
65223372|NCT04332211|Ephedrine|ephedrine|mesh-list
65223373|NCT04332211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65223375|NCT04332211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65223376|NCT04332211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223377|NCT04332211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65223378|NCT04332211|Respiratory System Agents|respiratory system agents|mesh-ancestor
65223379|NCT04332211|Nasal Decongestants|nasal decongestants|mesh-ancestor
65223380|NCT04332211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65223381|NCT04332211|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65223382|NCT04332211|Sympathomimetics|sympathomimetics|mesh-ancestor
65223383|NCT04332211|Adrenergic Agents|adrenergic agents|mesh-ancestor
65223384|NCT04332211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65223385|NCT04332211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223386|NCT04116073|Antibodies|antibodies|mesh-list
65223387|NCT04116073|Immunologic Factors|immunologic factors|mesh-ancestor
65223388|NCT04116073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223389|NCT02581501|Gemcitabine|gemcitabine|mesh-list
65223390|NCT02581501|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65223391|NCT02581501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65223392|NCT02581501|Antimetabolites|antimetabolites|mesh-ancestor
65223393|NCT02581501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223394|NCT02581501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223395|NCT02581501|Antiviral Agents|antiviral agents|mesh-ancestor
65223396|NCT02581501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65223397|NCT02581501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223398|NCT02581501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65223399|NCT02581501|Immunologic Factors|immunologic factors|mesh-ancestor
65223400|NCT02581501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223401|NCT01072175|Trametinib|trametinib|mesh-list
65223402|NCT01072175|Dabrafenib|dabrafenib|mesh-list
65223403|NCT01072175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019162|NCT04689412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65019163|NCT00148460|Tenecteplase|tenecteplase|mesh-list
65019164|NCT00148460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65019165|NCT00148460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65019166|NCT00148460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019167|NCT00170196|Prednisone|prednisone|mesh-list
65019168|NCT00170196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65019169|NCT00170196|Glucocorticoids|glucocorticoids|mesh-ancestor
65019170|NCT00170196|Hormones|hormones|mesh-ancestor
65019171|NCT00170196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65019172|NCT00170196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019173|NCT00170196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65019174|NCT00170196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019175|NCT02929459|Vitamins|vitamins|mesh-list
65019176|NCT02929459|Riboflavin|riboflavin|mesh-list
65019177|NCT02929459|Vitamin B Complex|vitamin b complex|mesh-list
65019178|NCT02929459|Micronutrients|micronutrients|mesh-ancestor
65019179|NCT02929459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019180|NCT02929459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65019181|NCT02929459|Dermatologic Agents|dermatologic agents|mesh-ancestor
65019182|NCT02929576|Paclitaxel|paclitaxel|mesh-list
65019183|NCT02929576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65019184|NCT02929576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019185|NCT02929576|Tubulin Modulators|tubulin modulators|mesh-ancestor
65019186|NCT02929576|Antimitotic Agents|antimitotic agents|mesh-ancestor
64884166|NCT01943630|Antiviral Agents|antiviral agents|mesh-ancestor
65223404|NCT01072175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65223405|NCT01072175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223406|NCT01072175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223407|NCT04078711|Losartan|losartan|mesh-list
65223408|NCT04078711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65223409|NCT04078711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65223410|NCT04078711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65223411|NCT04078711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65223412|NCT04078711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223413|NCT05290129|Oxytocin|oxytocin|mesh-list
65223414|NCT05290129|Oxytocics|oxytocics|mesh-ancestor
65223415|NCT05290129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65223416|NCT05290129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223417|NCT04304573|Calcium|calcium|mesh-list
65223418|NCT04304573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65223419|NCT04304573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223420|NCT04667117|Ofatumumab|ofatumumab|mesh-list
65223421|NCT04667117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223422|NCT04426669|Aldesleukin|aldesleukin|mesh-list
65223423|NCT04426669|Cyclophosphamide|cyclophosphamide|mesh-list
65223424|NCT04426669|Fludarabine|fludarabine|mesh-list
65223425|NCT04426669|Interleukin-2|interleukin-2|mesh-list
65223426|NCT04426669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65223427|NCT04426669|Immunologic Factors|immunologic factors|mesh-ancestor
64884184|NCT01943812|Estrogens|estrogens|mesh-ancestor
65019187|NCT02929576|Mitosis Modulators|mitosis modulators|mesh-ancestor
65019188|NCT02929576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019189|NCT00175812|Tretinoin|tretinoin|mesh-list
65019190|NCT00175812|Theophylline|theophylline|mesh-list
65019191|NCT00175812|Valproic Acid|valproic acid|mesh-list
65019192|NCT00175812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019193|NCT00175812|Keratolytic Agents|keratolytic agents|mesh-ancestor
65019194|NCT00175812|Dermatologic Agents|dermatologic agents|mesh-ancestor
65019195|NCT00175812|Anticonvulsants|anticonvulsants|mesh-ancestor
65019196|NCT00175812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019197|NCT00175812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019198|NCT00175812|GABA Agents|gaba agents|mesh-ancestor
65019199|NCT00175812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65019200|NCT00175812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019201|NCT00175812|Antimanic Agents|antimanic agents|mesh-ancestor
65019202|NCT00175812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65019203|NCT00175812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65223434|NCT04426669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65223435|NCT04426669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65223437|NCT04426669|Sensory System Agents|sensory system agents|mesh-ancestor
65223438|NCT04426669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65223439|NCT04426669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65223440|NCT04426669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65223441|NCT04426669|Antiviral Agents|antiviral agents|mesh-ancestor
65223442|NCT04426669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65223443|NCT02874989|Dasatinib|dasatinib|mesh-list
65223444|NCT02874989|Quercetin|quercetin|mesh-list
65223445|NCT02874989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223446|NCT02874989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65223447|NCT02874989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223448|NCT02874989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223450|NCT02874989|Protective Agents|protective agents|mesh-ancestor
65223451|NCT02874989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223452|NCT01071317|Naproxen|naproxen|mesh-list
65223453|NCT01071317|Sumatriptan|sumatriptan|mesh-list
65223454|NCT01071317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65223455|NCT01071317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65223456|NCT01071317|Analgesics|analgesics|mesh-ancestor
65223457|NCT01071317|Sensory System Agents|sensory system agents|mesh-ancestor
65223458|NCT01071317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65223459|NCT01071317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223460|NCT01071317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65223461|NCT01071317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65223462|NCT01071317|Gout Suppressants|gout suppressants|mesh-ancestor
65223463|NCT01071317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65223464|NCT01071317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223465|NCT01071317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223466|NCT01071317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65223467|NCT01071317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65223468|NCT01071317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65223469|NCT01071317|Serotonin Agents|serotonin agents|mesh-ancestor
65223470|NCT01071317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65223471|NCT00783094|Tadalafil|tadalafil|mesh-list
65223472|NCT00783094|Vasodilator Agents|vasodilator agents|mesh-ancestor
65223473|NCT00783094|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65223474|NCT00783094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65223475|NCT00783094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019204|NCT00175812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65019205|NCT00175812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65019206|NCT00175812|Autonomic Agents|autonomic agents|mesh-ancestor
65019207|NCT00175812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65019208|NCT00175812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65019209|NCT00175812|Respiratory System Agents|respiratory system agents|mesh-ancestor
65019210|NCT00175812|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65019211|NCT00175812|Vasodilator Agents|vasodilator agents|mesh-ancestor
65019212|NCT00175812|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65019213|NCT00175812|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65019214|NCT00175812|Purinergic Agents|purinergic agents|mesh-ancestor
65019215|NCT00148499|Benzocaine|benzocaine|mesh-list
65019216|NCT00148499|Ambroxol|ambroxol|mesh-list
65019217|NCT00148499|Anesthetics, Local|anesthetics, local|mesh-ancestor
65019218|NCT00148499|Anesthetics|anesthetics|mesh-ancestor
65019219|NCT00148499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65019220|NCT00148499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223476|NCT00783094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223477|NCT00783094|Urological Agents|urological agents|mesh-ancestor
65223478|NCT04076527|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65223479|NCT04076527|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65223480|NCT04076527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65223481|NCT00790582|Lithium Carbonate|lithium carbonate|mesh-list
65223482|NCT00790582|Antidepressive Agents|antidepressive agents|mesh-ancestor
65223483|NCT00790582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65223484|NCT00790582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223485|NCT00790582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223486|NCT00790582|Antimanic Agents|antimanic agents|mesh-ancestor
65223487|NCT00790582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65223488|NCT00790582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65223489|NCT00790582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223490|NCT05568550|Pembrolizumab|pembrolizumab|mesh-list
65223491|NCT05568550|Olaparib|olaparib|mesh-list
65223492|NCT05568550|Androgens|androgens|mesh-list
65223493|NCT05568550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65223494|NCT05568550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223495|NCT05568550|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65223504|NCT02583217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65223505|NCT02583217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65223506|NCT02583217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223507|NCT02583217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65223509|NCT02583217|Anesthetics|anesthetics|mesh-ancestor
65223510|NCT02583217|Analgesics|analgesics|mesh-ancestor
65223511|NCT02583217|Sensory System Agents|sensory system agents|mesh-ancestor
65223512|NCT02583217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65223513|NCT02583217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65223514|NCT02583217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65223515|NCT02583217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65223516|NCT02583217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65223517|NCT02583217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223518|NCT02583217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65223519|NCT02583217|Narcotics|narcotics|mesh-ancestor
65223520|NCT00774046|Cytarabine|cytarabine|mesh-list
65223521|NCT00774046|Etoposide|etoposide|mesh-list
65223522|NCT00774046|Mitoxantrone|mitoxantrone|mesh-list
65223523|NCT00774046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65223524|NCT00774046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223525|NCT00774046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65019221|NCT00148499|Sensory System Agents|sensory system agents|mesh-ancestor
65019222|NCT00148499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65019223|NCT00148499|Expectorants|expectorants|mesh-ancestor
65019224|NCT00148499|Respiratory System Agents|respiratory system agents|mesh-ancestor
65019225|NCT04283578|Oxytocin|oxytocin|mesh-list
65019226|NCT04283578|Oxytocics|oxytocics|mesh-ancestor
65019227|NCT04283578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65019228|NCT04283578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019229|NCT03457597|Pioglitazone|pioglitazone|mesh-list
65019230|NCT03457597|Tolbutamide|tolbutamide|mesh-list
65019231|NCT03457597|Metoprolol|metoprolol|mesh-list
65019232|NCT03457597|Midazolam|midazolam|mesh-list
65019233|NCT03457597|Omeprazole|omeprazole|mesh-list
65019234|NCT03457597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65019235|NCT03457597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65019236|NCT03457597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65019237|NCT03457597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736794|NCT00608465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65223526|NCT00774046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65223527|NCT00774046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223528|NCT00774046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223529|NCT00774046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65223530|NCT00774046|Antimetabolites|antimetabolites|mesh-ancestor
65223531|NCT00774046|Antiviral Agents|antiviral agents|mesh-ancestor
65223532|NCT00774046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65223533|NCT00774046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65223534|NCT00774046|Immunologic Factors|immunologic factors|mesh-ancestor
65223535|NCT00774046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223536|NCT00774046|Analgesics|analgesics|mesh-ancestor
65223537|NCT00774046|Sensory System Agents|sensory system agents|mesh-ancestor
65223538|NCT00774046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65223539|NCT01046903|Dalteparin|dalteparin|mesh-list
65223540|NCT01046903|Tinzaparin|tinzaparin|mesh-list
65223541|NCT01046903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65223542|NCT01046903|Anticoagulants|anticoagulants|mesh-ancestor
65223543|NCT01046903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65223544|NCT01046903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65223545|NCT01046903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223546|NCT02581423|Capecitabine|capecitabine|mesh-list
65223547|NCT02581423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65223548|NCT02581423|Antimetabolites|antimetabolites|mesh-ancestor
65223549|NCT02581423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223550|NCT02581423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223551|NCT04102072|Dobutamine|dobutamine|mesh-list
65223552|NCT04102072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65223553|NCT04102072|Sympathomimetics|sympathomimetics|mesh-ancestor
65223554|NCT04102072|Autonomic Agents|autonomic agents|mesh-ancestor
65223555|NCT04102072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65223556|NCT04102072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223557|NCT04102072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65223558|NCT04102072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65223559|NCT04102072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65223560|NCT04102072|Adrenergic Agents|adrenergic agents|mesh-ancestor
65223561|NCT04102072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65223566|NCT02875457|Etoposide phosphate|etoposide phosphate|mesh-list
65223567|NCT02875457|Apatinib|apatinib|mesh-list
64866301|NCT01796808|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65223568|NCT02875457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223569|NCT02875457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65019238|NCT03457597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65019239|NCT03457597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65019240|NCT03457597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65019241|NCT03457597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65019242|NCT03457597|Anesthetics, General|anesthetics, general|mesh-ancestor
65019243|NCT03457597|Anesthetics|anesthetics|mesh-ancestor
65019244|NCT03457597|GABA Modulators|gaba modulators|mesh-ancestor
65019245|NCT03457597|GABA Agents|gaba agents|mesh-ancestor
65019246|NCT03457597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65019247|NCT03457597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019248|NCT03457597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65019249|NCT03457597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65019250|NCT03457597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65019251|NCT03457597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65019252|NCT03457597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019253|NCT03457597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65019254|NCT03457597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65019255|NCT03457597|Sympatholytics|sympatholytics|mesh-ancestor
65019256|NCT03457597|Autonomic Agents|autonomic agents|mesh-ancestor
64736812|NCT00379457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64736813|NCT00379457|Etoposide|etoposide|mesh-list
65223570|NCT02875457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65223571|NCT02875457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65223572|NCT02875457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223573|NCT02875457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223574|NCT02875457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65223575|NCT00773968|Epoetin Alfa|epoetin alfa|mesh-list
65223576|NCT00773968|Hematinics|hematinics|mesh-ancestor
65223577|NCT04060381|Ibuprofen|ibuprofen|mesh-list
65223578|NCT04060381|Dopamine|dopamine|mesh-list
65223579|NCT04060381|Epinephrine|epinephrine|mesh-list
65223580|NCT04060381|Norepinephrine|norepinephrine|mesh-list
65223581|NCT04060381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65223582|NCT04060381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65223583|NCT04060381|Analgesics|analgesics|mesh-ancestor
65223584|NCT04060381|Sensory System Agents|sensory system agents|mesh-ancestor
65223585|NCT04060381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65223586|NCT04060381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223587|NCT04060381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65223588|NCT04060381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65223589|NCT04060381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65223590|NCT04060381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223591|NCT04060381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223592|NCT04060381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65223593|NCT04060381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65223594|NCT04060381|Adrenergic Agents|adrenergic agents|mesh-ancestor
65223595|NCT04060381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65223596|NCT04060381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65223597|NCT04060381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65223598|NCT04060381|Autonomic Agents|autonomic agents|mesh-ancestor
65223599|NCT04060381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65223600|NCT04060381|Respiratory System Agents|respiratory system agents|mesh-ancestor
65223601|NCT04060381|Mydriatics|mydriatics|mesh-ancestor
65223602|NCT04060381|Sympathomimetics|sympathomimetics|mesh-ancestor
65223603|NCT04060381|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65223604|NCT04060381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65223605|NCT04060381|Dopamine Agents|dopamine agents|mesh-ancestor
65019257|NCT03457597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65019258|NCT03457597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65019259|NCT03457597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65019260|NCT03457597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65019261|NCT03457597|Adrenergic Agents|adrenergic agents|mesh-ancestor
65019262|NCT02929147|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65019263|NCT02929147|Morphine|morphine|mesh-list
65019264|NCT02929147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65019265|NCT02929147|Narcotics|narcotics|mesh-ancestor
65019266|NCT02929147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65019267|NCT02929147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019268|NCT02929147|Analgesics|analgesics|mesh-ancestor
65019269|NCT02929147|Sensory System Agents|sensory system agents|mesh-ancestor
65019270|NCT02929147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65019271|NCT02929147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65019272|NCT02929147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65019273|NCT02929147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65019274|NCT02929147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65019275|NCT00175890|Levetiracetam|levetiracetam|mesh-list
65019276|NCT00175890|Anticonvulsants|anticonvulsants|mesh-ancestor
65019277|NCT00175890|Nootropic Agents|nootropic agents|mesh-ancestor
65019278|NCT00148616|Memantine|memantine|mesh-list
65223606|NCT04060381|Protective Agents|protective agents|mesh-ancestor
65223607|NCT00782626|Everolimus|everolimus|mesh-list
65223608|NCT00782626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223609|NCT00782626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65223610|NCT00782626|Immunologic Factors|immunologic factors|mesh-ancestor
65223611|NCT00782626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223612|NCT04076371|Olanzapine|olanzapine|mesh-list
65223613|NCT04076371|Risperidone|risperidone|mesh-list
65223614|NCT04076371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65223615|NCT04076371|Ziprasidone|ziprasidone|mesh-list
65223616|NCT04076371|Sertraline|sertraline|mesh-list
65223617|NCT04076371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65223618|NCT04076371|Serotonin Agents|serotonin agents|mesh-ancestor
65223619|NCT04076371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65223620|NCT04076371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223621|NCT04076371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223622|NCT04076371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65223623|NCT04076371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65223624|NCT04076371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65223625|NCT04076371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65223626|NCT04076371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65223627|NCT04076371|Dopamine Agents|dopamine agents|mesh-ancestor
65223628|NCT04076371|Antiemetics|antiemetics|mesh-ancestor
65223629|NCT04076371|Autonomic Agents|autonomic agents|mesh-ancestor
65223630|NCT04076371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65223631|NCT04076371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65223632|NCT04076371|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65223633|NCT04076371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65223634|NCT04076371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65223638|NCT03977467|Atezolizumab|atezolizumab|mesh-list
65223639|NCT03977467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223640|NCT01071083|Interferons|interferons|mesh-list
65223641|NCT01071083|Interferon-beta|interferon-beta|mesh-list
65223642|NCT01071083|Interferon beta-1a|interferon beta-1a|mesh-list
65019279|NCT00148616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65019280|NCT00148616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65019281|NCT00148616|Dopamine Agents|dopamine agents|mesh-ancestor
65019282|NCT00148616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65019283|NCT00148616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019284|NCT00148616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019285|NCT00148616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65019286|NCT00148616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65019287|NCT00175929|Brivaracetam|brivaracetam|mesh-list
65019288|NCT00175929|Anticonvulsants|anticonvulsants|mesh-ancestor
65019289|NCT02928679|Liraglutide|liraglutide|mesh-list
65019290|NCT02928679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65019291|NCT02928679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019292|NCT02928679|Incretins|incretins|mesh-ancestor
65019293|NCT02928679|Hormones|hormones|mesh-ancestor
65019294|NCT02928679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65019295|NCT02928601|Ondansetron|ondansetron|mesh-list
64736851|NCT01629329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65223643|NCT01071083|Methylprednisolone|methylprednisolone|mesh-list
65223644|NCT01071083|Glatiramer Acetate|glatiramer acetate|mesh-list
65223645|NCT01071083|Natalizumab|natalizumab|mesh-list
65223646|NCT01071083|(T,G)-A-L|(t,g)-a-l|mesh-list
65223647|NCT01071083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223648|NCT01071083|Antiviral Agents|antiviral agents|mesh-ancestor
65223649|NCT01071083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65223650|NCT01071083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65223651|NCT01071083|Antiemetics|antiemetics|mesh-ancestor
65223652|NCT01071083|Autonomic Agents|autonomic agents|mesh-ancestor
65223653|NCT01071083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65223654|NCT01071083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223655|NCT01071083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65223656|NCT01071083|Glucocorticoids|glucocorticoids|mesh-ancestor
65223657|NCT01071083|Hormones|hormones|mesh-ancestor
65223658|NCT01071083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65223659|NCT01071083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65223660|NCT01071083|Protective Agents|protective agents|mesh-ancestor
65223661|NCT01071083|Immunologic Factors|immunologic factors|mesh-ancestor
65223662|NCT01071083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65223663|NCT01071083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65223664|NCT01071083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65223665|NCT03973333|Atezolizumab|atezolizumab|mesh-list
65223666|NCT03973333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223667|NCT03968341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65223668|NCT03968341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65223669|NCT04078399|Interferons|interferons|mesh-list
65223670|NCT04078399|Azacitidine|azacitidine|mesh-list
65223671|NCT04078399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223672|NCT04078399|Antiviral Agents|antiviral agents|mesh-ancestor
65223673|NCT04078399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65223674|NCT04078399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65223675|NCT04078399|Antimetabolites|antimetabolites|mesh-ancestor
65223676|NCT04078399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223678|NCT05393791|Abiraterone Acetate|abiraterone acetate|mesh-list
65223679|NCT05393791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223680|NCT05393791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65223681|NCT05393791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223682|NCT05393791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223683|NCT05393791|Hormone Antagonists|hormone antagonists|mesh-ancestor
65019296|NCT02928601|Antiemetics|antiemetics|mesh-ancestor
65019297|NCT02928601|Autonomic Agents|autonomic agents|mesh-ancestor
65019298|NCT02928601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65019299|NCT02928601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019300|NCT02928601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65019301|NCT02928601|Antipruritics|antipruritics|mesh-ancestor
65019302|NCT02928601|Dermatologic Agents|dermatologic agents|mesh-ancestor
65019303|NCT02928601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65019304|NCT02928601|Serotonin Agents|serotonin agents|mesh-ancestor
65019305|NCT02928601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65019306|NCT02928601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019307|NCT02928601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65019308|NCT02928601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65019309|NCT02928601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65019310|NCT02928601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65019311|NCT02928601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65223684|NCT05393791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65223685|NCT05393791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223686|NCT05393791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65223687|NCT05189509|Plasminogen|plasminogen|mesh-list
65223688|NCT05189509|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65223689|NCT05189509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65223690|NCT05189509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65223691|NCT05189509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223692|NCT03897751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65223693|NCT01010126|Sirolimus|sirolimus|mesh-list
65223694|NCT01010126|Bevacizumab|bevacizumab|mesh-list
65223695|NCT01010126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65223696|NCT01010126|Endothelial Growth Factors|endothelial growth factors|mesh-list
65223697|NCT01010126|Antibodies|antibodies|mesh-list
65223698|NCT01010126|Immunoglobulins|immunoglobulins|mesh-list
65223699|NCT01010126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65223700|NCT01010126|Immunoglobulin G|immunoglobulin g|mesh-list
65223701|NCT01010126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223702|NCT01010126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65223703|NCT01010126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65223704|NCT01010126|Growth Substances|growth substances|mesh-ancestor
65223705|NCT01010126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223706|NCT01010126|Growth Inhibitors|growth inhibitors|mesh-ancestor
65223707|NCT01010126|Immunologic Factors|immunologic factors|mesh-ancestor
65223708|NCT01010126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65223714|NCT03897127|Daunorubicin|daunorubicin|mesh-list
65223715|NCT03897127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65223716|NCT03897127|Antimetabolites|antimetabolites|mesh-ancestor
65223717|NCT03897127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223718|NCT03897127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223719|NCT03897127|Antiviral Agents|antiviral agents|mesh-ancestor
65223720|NCT03897127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64866452|NCT01800435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65223721|NCT03897127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65223722|NCT03897127|Immunologic Factors|immunologic factors|mesh-ancestor
65223723|NCT03897127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223724|NCT03897127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65223725|NCT03897127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65223726|NCT03897127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65223727|NCT03897127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223728|NCT04076137|Decitabine|decitabine|mesh-list
65223729|NCT04076137|Antibodies|antibodies|mesh-list
65223730|NCT04076137|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65019312|NCT02928328|Lidocaine|lidocaine|mesh-list
65019313|NCT02928328|Lorazepam|lorazepam|mesh-list
65019314|NCT02928328|Capsaicin|capsaicin|mesh-list
65019315|NCT02928328|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
65019316|NCT02928328|Butyric Acid|butyric acid|mesh-list
65019317|NCT02928328|Anesthetics, Local|anesthetics, local|mesh-ancestor
65019318|NCT02928328|Anesthetics|anesthetics|mesh-ancestor
65019319|NCT02928328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65019320|NCT02928328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019321|NCT02928328|Sensory System Agents|sensory system agents|mesh-ancestor
65019322|NCT02928328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348985|NCT01378429|Hormones|hormones|mesh-ancestor
65223731|NCT04076137|Immunologic Factors|immunologic factors|mesh-ancestor
65223732|NCT04076137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223733|NCT04076137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65223734|NCT04076137|Antimetabolites|antimetabolites|mesh-ancestor
65223735|NCT04076137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223736|NCT04076137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223737|NCT04076137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223738|NCT03879577|Tamoxifen|tamoxifen|mesh-list
65223739|NCT03879577|Docetaxel|docetaxel|mesh-list
65223740|NCT03879577|Trastuzumab|trastuzumab|mesh-list
65223741|NCT03879577|Letrozole|letrozole|mesh-list
65223742|NCT03879577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223743|NCT03879577|Tubulin Modulators|tubulin modulators|mesh-ancestor
65223744|NCT03879577|Antimitotic Agents|antimitotic agents|mesh-ancestor
65223745|NCT03879577|Mitosis Modulators|mitosis modulators|mesh-ancestor
65223746|NCT03879577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223747|NCT03879577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65223748|NCT03879577|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65223749|NCT03879577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65223750|NCT03879577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223751|NCT03879577|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65223752|NCT03879577|Hormone Antagonists|hormone antagonists|mesh-ancestor
65223753|NCT03879577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65223754|NCT03879577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223755|NCT03879577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65223756|NCT03879577|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65223757|NCT03879577|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65223758|NCT03879577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65223759|NCT03141177|Nivolumab|nivolumab|mesh-list
65223760|NCT03141177|Ipilimumab|ipilimumab|mesh-list
65223761|NCT03141177|Sunitinib|sunitinib|mesh-list
65223762|NCT03141177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65223763|NCT03141177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223764|NCT03141177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65223765|NCT03141177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223766|NCT03141177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65223767|NCT03141177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65223768|NCT03141177|Growth Substances|growth substances|mesh-ancestor
65223769|NCT03141177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223770|NCT03141177|Growth Inhibitors|growth inhibitors|mesh-ancestor
65223771|NCT03141177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65223772|NCT03141177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223773|NCT03862495|Azithromycin|azithromycin|mesh-list
65223774|NCT03862495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65223775|NCT03862495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65223776|NCT00617799|Aldesleukin|aldesleukin|mesh-list
65223777|NCT00617799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223778|NCT00617799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65223783|NCT00617877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65223784|NCT00617877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65223785|NCT00617877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65223786|NCT00617877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65019323|NCT02928328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65019324|NCT02928328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65019325|NCT02928328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65019326|NCT02928328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65019327|NCT02928328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019328|NCT02928328|Antipruritics|antipruritics|mesh-ancestor
65019329|NCT02928328|Dermatologic Agents|dermatologic agents|mesh-ancestor
65019330|NCT02928328|Anticonvulsants|anticonvulsants|mesh-ancestor
65019331|NCT02928328|Antiemetics|antiemetics|mesh-ancestor
65019332|NCT02928328|Autonomic Agents|autonomic agents|mesh-ancestor
65019333|NCT02928328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65019334|NCT02928328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65019335|NCT02928328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65019336|NCT02928328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65019337|NCT02928328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65019338|NCT02928328|GABA Modulators|gaba modulators|mesh-ancestor
65019339|NCT02928328|GABA Agents|gaba agents|mesh-ancestor
65019340|NCT02928328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65019341|NCT02928328|Histamine Antagonists|histamine antagonists|mesh-ancestor
65019342|NCT02928328|Histamine Agents|histamine agents|mesh-ancestor
65019343|NCT00148694|Cisplatin|cisplatin|mesh-list
65019344|NCT00148694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019345|NCT00148772|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65019346|NCT00148772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019347|NCT00148772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65019348|NCT00148772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019349|NCT00148772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223787|NCT00617877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65223788|NCT00617877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223789|NCT00617877|Diuretics|diuretics|mesh-ancestor
65223790|NCT00617877|Natriuretic Agents|natriuretic agents|mesh-ancestor
65223791|NCT00617877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223792|NCT00617877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65223793|NCT00617877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65223794|NCT00617955|Aprotinin|aprotinin|mesh-list
65223795|NCT00617955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223796|NCT00617955|Hemostatics|hemostatics|mesh-ancestor
65223797|NCT00617955|Coagulants|coagulants|mesh-ancestor
65223798|NCT00617955|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65223799|NCT00617955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65223800|NCT00617955|Protease Inhibitors|protease inhibitors|mesh-ancestor
65223801|NCT00617955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223802|NCT03834883|Ibutilide|ibutilide|mesh-list
65223803|NCT03834883|Progesterone|progesterone|mesh-list
65223804|NCT03834883|Progestins|progestins|mesh-ancestor
65223805|NCT03834883|Hormones|hormones|mesh-ancestor
65223806|NCT03834883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65223807|NCT03834883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223808|NCT03834883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65019350|NCT00176046|Viscum album peptide|viscum album peptide|mesh-list
65019351|NCT00176046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019352|NCT00176046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65019353|NCT00176046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65019354|NCT00176046|Antiviral Agents|antiviral agents|mesh-ancestor
65019355|NCT00176046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65019356|NCT02927587|Propofol|propofol|mesh-list
65019357|NCT02927587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65019358|NCT02927587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65019359|NCT02927587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019360|NCT02927587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65019361|NCT02927587|Anesthetics, General|anesthetics, general|mesh-ancestor
65019362|NCT02927587|Anesthetics|anesthetics|mesh-ancestor
65223809|NCT02582437|Analgesics, Opioid|analgesics, opioid|mesh-list
65223810|NCT02582437|Narcotics|narcotics|mesh-ancestor
65223811|NCT02582437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65223812|NCT02582437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223813|NCT02582437|Analgesics|analgesics|mesh-ancestor
65223814|NCT02582437|Sensory System Agents|sensory system agents|mesh-ancestor
65223815|NCT02582437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65223816|NCT05674201|Dexmedetomidine|dexmedetomidine|mesh-list
65223817|NCT05674201|Remifentanil|remifentanil|mesh-list
65223818|NCT05674201|Propofol|propofol|mesh-list
65223819|NCT05674201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65223820|NCT05674201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65223821|NCT05674201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223822|NCT05674201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65223823|NCT05674201|Anesthetics, General|anesthetics, general|mesh-ancestor
65223824|NCT05674201|Anesthetics|anesthetics|mesh-ancestor
65223825|NCT05674201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65223826|NCT05674201|Analgesics|analgesics|mesh-ancestor
65223827|NCT05674201|Sensory System Agents|sensory system agents|mesh-ancestor
65223828|NCT05674201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65223829|NCT05674201|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65223830|NCT05674201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65223831|NCT05674201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65223832|NCT05674201|Adrenergic Agents|adrenergic agents|mesh-ancestor
65223833|NCT05674201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65223834|NCT05674201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223835|NCT05674201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65223836|NCT05674201|Narcotics|narcotics|mesh-ancestor
65223837|NCT01070303|Adalimumab|adalimumab|mesh-list
65223838|NCT01070303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65223839|NCT01070303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65223840|NCT00618111|Granisetron|granisetron|mesh-list
65223841|NCT00618111|Antiemetics|antiemetics|mesh-ancestor
65223842|NCT00618111|Autonomic Agents|autonomic agents|mesh-ancestor
65223843|NCT00618111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65223844|NCT00618111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223845|NCT00618111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65223846|NCT00618111|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65223847|NCT00618111|Serotonin Agents|serotonin agents|mesh-ancestor
65223848|NCT00618111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65223849|NCT00618111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223850|NCT01009814|Ritonavir|ritonavir|mesh-list
65223851|NCT01009814|Fostemsavir|fostemsavir|mesh-list
65223853|NCT01009814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65223854|NCT01009814|Protease Inhibitors|protease inhibitors|mesh-ancestor
65223855|NCT01009814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223856|NCT01009814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223857|NCT01009814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65223858|NCT01009814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65223859|NCT01009814|Antiviral Agents|antiviral agents|mesh-ancestor
65223860|NCT01009814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65019363|NCT00148850|Pioglitazone|pioglitazone|mesh-list
65019364|NCT00148850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65019365|NCT00148850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019367|NCT02927353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65019368|NCT02927353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65019369|NCT02927509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
65019370|NCT02927509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65019371|NCT02927509|Adrenergic Agents|adrenergic agents|mesh-ancestor
65019372|NCT02927509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65019373|NCT02927509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019374|NCT02927509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019375|NCT02926885|Liver Extracts|liver extracts|mesh-list
65019376|NCT02926885|Hematinics|hematinics|mesh-ancestor
65019377|NCT02926846|Vancomycin|vancomycin|mesh-list
65019378|NCT02926846|Gentamicins|gentamicins|mesh-list
65019379|NCT02926846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64736931|NCT00000737|Analgesics|analgesics|mesh-ancestor
65223861|NCT01009814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65223862|NCT01009814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65223863|NCT01009814|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65223864|NCT01009814|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65223865|NCT03824587|Calcium, Dietary|calcium, dietary|mesh-list
65223866|NCT03824587|Calcium Carbonate|calcium carbonate|mesh-list
65223867|NCT03824587|Calcium|calcium|mesh-list
65223868|NCT03824587|Sevelamer|sevelamer|mesh-list
65223869|NCT03824587|Calcium acetate|calcium acetate|mesh-list
65223870|NCT03824587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65223871|NCT03824587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223872|NCT03824587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65223873|NCT03824587|Chelating Agents|chelating agents|mesh-ancestor
65223874|NCT03824587|Sequestering Agents|sequestering agents|mesh-ancestor
65223875|NCT03824587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223876|NCT03824587|Antacids|antacids|mesh-ancestor
65223877|NCT03824587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65223878|NCT00773734|Thalidomide|thalidomide|mesh-list
65223879|NCT00773734|Apremilast|apremilast|mesh-list
65223880|NCT00773734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65223881|NCT00773734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65223882|NCT00773734|Analgesics|analgesics|mesh-ancestor
65223883|NCT00773734|Sensory System Agents|sensory system agents|mesh-ancestor
65223884|NCT00773734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65223885|NCT00773734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223886|NCT00773734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65223887|NCT00773734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65223888|NCT00773734|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65223889|NCT00773734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65223890|NCT00773734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223891|NCT00773734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223892|NCT00773734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65223893|NCT00773734|Immunologic Factors|immunologic factors|mesh-ancestor
65223894|NCT00773734|Leprostatic Agents|leprostatic agents|mesh-ancestor
65223895|NCT00773734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65223896|NCT00773734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65223897|NCT00773734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65223898|NCT00773734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65223899|NCT00773734|Growth Substances|growth substances|mesh-ancestor
65223900|NCT00773734|Growth Inhibitors|growth inhibitors|mesh-ancestor
65223901|NCT00773734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223902|NCT02280525|Cytarabine|cytarabine|mesh-list
65019380|NCT02926846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65019381|NCT02926846|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65019382|NCT02926846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019383|NCT02926846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019384|NCT02926183|Gemcitabine|gemcitabine|mesh-list
65019385|NCT02926183|Paclitaxel|paclitaxel|mesh-list
65019386|NCT02926183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65019387|NCT02926183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019388|NCT02926183|Tubulin Modulators|tubulin modulators|mesh-ancestor
65019389|NCT02926183|Antimitotic Agents|antimitotic agents|mesh-ancestor
65019390|NCT02926183|Mitosis Modulators|mitosis modulators|mesh-ancestor
65019391|NCT02926183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019392|NCT02926183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65019393|NCT02926183|Antimetabolites|antimetabolites|mesh-ancestor
65019394|NCT02926183|Antiviral Agents|antiviral agents|mesh-ancestor
65019395|NCT02926183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65019396|NCT02926183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019397|NCT02926183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65223903|NCT02280525|Cyclophosphamide|cyclophosphamide|mesh-list
65223904|NCT02280525|Rituximab|rituximab|mesh-list
65223905|NCT02280525|Fludarabine|fludarabine|mesh-list
65223906|NCT02280525|Fludarabine phosphate|fludarabine phosphate|mesh-list
65223907|NCT02280525|Lenalidomide|lenalidomide|mesh-list
65223908|NCT02280525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65223909|NCT02280525|Immunologic Factors|immunologic factors|mesh-ancestor
65223910|NCT02280525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223911|NCT02280525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65223912|NCT02280525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65223913|NCT02280525|Alkylating Agents|alkylating agents|mesh-ancestor
65223914|NCT02280525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223915|NCT02280525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223916|NCT02280525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65223917|NCT02280525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65223918|NCT02280525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65223919|NCT02280525|Antimetabolites|antimetabolites|mesh-ancestor
65223920|NCT02280525|Antiviral Agents|antiviral agents|mesh-ancestor
65223921|NCT02280525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65223922|NCT02280525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65223923|NCT02280525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65223924|NCT02280525|Growth Substances|growth substances|mesh-ancestor
65223925|NCT02280525|Growth Inhibitors|growth inhibitors|mesh-ancestor
65223926|NCT04297202|Apatinib|apatinib|mesh-list
65223930|NCT04297202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223931|NCT02691897|Melatonin|melatonin|mesh-list
65223932|NCT02691897|Antioxidants|antioxidants|mesh-ancestor
65223933|NCT02691897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223934|NCT02691897|Protective Agents|protective agents|mesh-ancestor
65223935|NCT02691897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223936|NCT02691897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65223937|NCT03067155|Antiviral Agents|antiviral agents|mesh-list
65223938|NCT03067155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65223939|NCT01009580|Insulin|insulin|mesh-list
65223940|NCT01009580|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65223941|NCT01009580|Insulin Aspart|insulin aspart|mesh-list
65223942|NCT01009580|Insulin, Long-Acting|insulin, long-acting|mesh-list
65223943|NCT01009580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65223944|NCT01009580|Biphasic Insulins|biphasic insulins|mesh-list
65019398|NCT02926183|Immunologic Factors|immunologic factors|mesh-ancestor
65019399|NCT02926183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019400|NCT02925832|Bupivacaine|bupivacaine|mesh-list
65019401|NCT02925832|Ropivacaine|ropivacaine|mesh-list
65019402|NCT02925832|Anesthetics, Local|anesthetics, local|mesh-list
64475122|NCT01458951|Tofacitinib|tofacitinib|mesh-list
65019403|NCT02925832|Proxymetacaine|proxymetacaine|mesh-list
65019404|NCT02925832|Anesthetics|anesthetics|mesh-list
65019405|NCT02925832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65019406|NCT02925832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019407|NCT02925832|Sensory System Agents|sensory system agents|mesh-ancestor
65019408|NCT02925832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65019409|NCT00170430|Fluconazole|fluconazole|mesh-list
65019410|NCT00170430|Antifungal Agents|antifungal agents|mesh-ancestor
65019411|NCT00170430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65019412|NCT00170430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65019413|NCT00170430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65019414|NCT00170430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019415|NCT00170430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019416|NCT00170430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65019417|NCT00170430|Hormone Antagonists|hormone antagonists|mesh-ancestor
65019418|NCT00170430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65019419|NCT00170430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019420|NCT00170430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65019421|NCT00170430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65019422|NCT00149084|Amoxicillin|amoxicillin|mesh-list
65019423|NCT00149084|Clarithromycin|clarithromycin|mesh-list
65019424|NCT00149084|Lansoprazole|lansoprazole|mesh-list
65019425|NCT00149084|Dexlansoprazole|dexlansoprazole|mesh-list
65019426|NCT00149084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65019427|NCT00149084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64736962|NCT00528437|Immunologic Factors|immunologic factors|mesh-ancestor
65223945|NCT01009580|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65223946|NCT01009580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65223947|NCT01009580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223948|NCT01009346|Cisplatin|cisplatin|mesh-list
65223949|NCT01009346|Carboplatin|carboplatin|mesh-list
65223950|NCT01009346|Cetuximab|cetuximab|mesh-list
65223951|NCT01009346|Everolimus|everolimus|mesh-list
65223952|NCT01009346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223953|NCT01009346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65223954|NCT01009346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65019428|NCT00149084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65019429|NCT00149084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019430|NCT00149084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019431|NCT00149084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65019432|NCT00149084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65019433|NCT00149084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65019434|NCT00149084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65019435|NCT00149084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65019436|NCT00170469|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65019437|NCT00170469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65019438|NCT00170469|Immunologic Factors|immunologic factors|mesh-ancestor
65019439|NCT00170469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019440|NCT00170469|Antacids|antacids|mesh-ancestor
65019441|NCT00170469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019442|NCT00170469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65019443|NCT00149123|Hydrocortisone|hydrocortisone|mesh-list
65019444|NCT00149123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65019445|NCT00149162|Aldesleukin|aldesleukin|mesh-list
65019446|NCT00149162|Interleukin-2|interleukin-2|mesh-list
65019447|NCT00149162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019448|NCT00149162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65019449|NCT00149162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65019450|NCT00149162|Antiviral Agents|antiviral agents|mesh-ancestor
65019451|NCT00149162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65019452|NCT00149162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65019453|NCT00149162|Analgesics|analgesics|mesh-ancestor
65019454|NCT00149162|Sensory System Agents|sensory system agents|mesh-ancestor
65019455|NCT00149162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65019456|NCT00149162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019473|NCT02925559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019474|NCT00149240|Botulinum Toxins|botulinum toxins|mesh-list
65019475|NCT00149240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65019476|NCT00149240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65019477|NCT00149240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65019478|NCT00149240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64475197|NCT02076321|Antipyretics|antipyretics|mesh-ancestor
65019479|NCT00149240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019480|NCT00149240|Cholinergic Agents|cholinergic agents|mesh-ancestor
65019481|NCT00149240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65019482|NCT00149240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019483|NCT00149240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65019484|NCT00149240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65019485|NCT02925247|Anticoagulants|anticoagulants|mesh-list
65019486|NCT00170664|Paclitaxel|paclitaxel|mesh-list
65019487|NCT00170664|Carboplatin|carboplatin|mesh-list
65019488|NCT00170664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65019489|NCT00170664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64737040|NCT00374543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65223955|NCT01009346|Immunologic Factors|immunologic factors|mesh-ancestor
65223956|NCT01009346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223957|NCT04101682|Bupivacaine|bupivacaine|mesh-list
65223958|NCT04101682|Anesthetics, Local|anesthetics, local|mesh-ancestor
65223959|NCT04101682|Anesthetics|anesthetics|mesh-ancestor
65223960|NCT04101682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65223961|NCT04101682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223962|NCT04101682|Sensory System Agents|sensory system agents|mesh-ancestor
65223963|NCT04101682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65223964|NCT01001702|Aripiprazole|aripiprazole|mesh-list
65223965|NCT01001702|Antidepressive Agents|antidepressive agents|mesh-ancestor
65223966|NCT01001702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65223967|NCT01001702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65223968|NCT01001702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65223969|NCT01001702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65223970|NCT01001702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223971|NCT01001702|Dopamine Agonists|dopamine agonists|mesh-ancestor
65223972|NCT01001702|Dopamine Agents|dopamine agents|mesh-ancestor
65223973|NCT01001702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65223974|NCT01001702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223975|NCT01001702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65223976|NCT01001702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65223978|NCT01001702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65223979|NCT01001702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65223980|NCT01001702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65223981|NCT01001702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65223982|NCT02602210|Hydrocortisone|hydrocortisone|mesh-list
65223983|NCT02602210|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65223984|NCT02602210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65223985|NCT00618345|Everolimus|everolimus|mesh-list
65223986|NCT00618345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223987|NCT00618345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65223988|NCT00618345|Immunologic Factors|immunologic factors|mesh-ancestor
65223989|NCT00618345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223990|NCT02601898|Thioctic Acid|thioctic acid|mesh-list
65223991|NCT02601898|Progesterone|progesterone|mesh-list
65223992|NCT02601898|Progestins|progestins|mesh-ancestor
65019490|NCT00170664|Tubulin Modulators|tubulin modulators|mesh-ancestor
65019491|NCT00170664|Antimitotic Agents|antimitotic agents|mesh-ancestor
65019492|NCT00170664|Mitosis Modulators|mitosis modulators|mesh-ancestor
65019493|NCT00170664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019494|NCT04725617|Varenicline|varenicline|mesh-list
65019495|NCT04725617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65019496|NCT04725617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65019497|NCT04725617|Cholinergic Agents|cholinergic agents|mesh-ancestor
65019498|NCT04725617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65019499|NCT04725617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019500|NCT04725617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019501|NCT03539614|Prazosin|prazosin|mesh-list
65019502|NCT03539614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64737059|NCT00299195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65223993|NCT02601898|Hormones|hormones|mesh-ancestor
65223994|NCT02601898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65223995|NCT02601898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223996|NCT02601898|Antioxidants|antioxidants|mesh-ancestor
65223997|NCT02601898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223998|NCT02601898|Protective Agents|protective agents|mesh-ancestor
65223999|NCT02601898|Vitamin B Complex|vitamin b complex|mesh-ancestor
65224010|NCT00618423|Anesthetics|anesthetics|mesh-ancestor
65224011|NCT00618423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65224012|NCT00618423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65224013|NCT00618423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65224014|NCT00618423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65224015|NCT00618423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224016|NCT04101760|Lenograstim|lenograstim|mesh-list
65224017|NCT04101760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65224018|NCT04101760|Immunologic Factors|immunologic factors|mesh-ancestor
65224019|NCT04101760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224020|NCT00616551|Octreotide|octreotide|mesh-list
65224021|NCT00616551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65224022|NCT00616551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64866755|NCT01802814|Epratuzumab|epratuzumab|mesh-list
65224023|NCT00616551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224024|NCT04478942|Misoprostol|misoprostol|mesh-list
65224025|NCT04478942|Oxytocin|oxytocin|mesh-list
65224026|NCT04478942|Oxytocics|oxytocics|mesh-ancestor
65224027|NCT04478942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65224028|NCT04478942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224029|NCT04478942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65224030|NCT04478942|Abortifacient Agents|abortifacient agents|mesh-ancestor
65224031|NCT04478942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65224032|NCT04478942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65224033|NCT04214145|Phenylephrine|phenylephrine|mesh-list
65224034|NCT04214145|Vasopressins|vasopressins|mesh-list
65224035|NCT04214145|Arginine Vasopressin|arginine vasopressin|mesh-list
65224036|NCT04214145|Oxymetazoline|oxymetazoline|mesh-list
65224037|NCT04214145|Norepinephrine|norepinephrine|mesh-list
65224038|NCT04214145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65224039|NCT04214145|Mydriatics|mydriatics|mesh-ancestor
65224040|NCT04214145|Autonomic Agents|autonomic agents|mesh-ancestor
65224041|NCT04214145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65224042|NCT04214145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224043|NCT04214145|Sympathomimetics|sympathomimetics|mesh-ancestor
65224044|NCT04214145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65224045|NCT04214145|Nasal Decongestants|nasal decongestants|mesh-ancestor
65224046|NCT04214145|Respiratory System Agents|respiratory system agents|mesh-ancestor
65224047|NCT04214145|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65224048|NCT04214145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65224049|NCT04214145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65019503|NCT03539614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65019504|NCT03539614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65019505|NCT03539614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65019506|NCT03539614|Adrenergic Agents|adrenergic agents|mesh-ancestor
65019507|NCT03539614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65019508|NCT03539614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019509|NCT03539614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019510|NCT00170742|Octreotide|octreotide|mesh-list
65019511|NCT00170742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65019512|NCT00170742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65019513|NCT00170742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019514|NCT02917525|Vitamin K|vitamin k|mesh-list
65019515|NCT02917525|Vitamin K 2|vitamin k 2|mesh-list
65019516|NCT02917525|Vitamins|vitamins|mesh-ancestor
65019517|NCT02917525|Micronutrients|micronutrients|mesh-ancestor
64737078|NCT01351415|Growth Substances|growth substances|mesh-ancestor
65224050|NCT04214145|Adrenergic Agents|adrenergic agents|mesh-ancestor
65224051|NCT04214145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64514697|NCT01751087|Hormone Antagonists|hormone antagonists|mesh-ancestor
64554985|NCT03405207|Vitamins|vitamins|mesh-ancestor
64554986|NCT03405207|Micronutrients|micronutrients|mesh-ancestor
64554987|NCT03405207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554988|NCT03405207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64554989|NCT03405207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64554990|NCT04197323|Alprostadil|alprostadil|mesh-list
64555114|NCT04192643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555116|NCT04192643|Coagulants|coagulants|mesh-ancestor
64555117|NCT03753659|Pembrolizumab|pembrolizumab|mesh-list
64555118|NCT03753659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64555119|NCT03753659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555172|NCT04190927|Progestins|progestins|mesh-ancestor
64555256|NCT05016180|Anesthetics, Local|anesthetics, local|mesh-ancestor
64555257|NCT05016180|Anesthetics|anesthetics|mesh-ancestor
64320370|NCT05519072|Cephalexin|cephalexin|mesh-list
64555258|NCT05016180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64555260|NCT05016180|Sensory System Agents|sensory system agents|mesh-ancestor
64555261|NCT05016180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64555262|NCT03023501|Gabapentin|gabapentin|mesh-list
64555305|NCT04195139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555306|NCT04195139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64555307|NCT04195139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555308|NCT04195139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64555309|NCT04195139|Alkylating Agents|alkylating agents|mesh-ancestor
64555310|NCT05021250|Ethiodized Oil|ethiodized oil|mesh-list
64555311|NCT05021250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555312|NCT00919503|Cyclosporine|cyclosporine|mesh-list
64555313|NCT00919503|Mycophenolic Acid|mycophenolic acid|mesh-list
64555314|NCT00919503|Methotrexate|methotrexate|mesh-list
64555317|NCT00919503|Treosulfan|treosulfan|mesh-list
64555318|NCT00919503|Busulfan|busulfan|mesh-list
64555319|NCT00919503|Tacrolimus|tacrolimus|mesh-list
64555320|NCT00919503|Cyclosporins|cyclosporins|mesh-list
64555321|NCT00919503|Thymoglobulin|thymoglobulin|mesh-list
64555322|NCT00919503|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64555323|NCT00919503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64555324|NCT00919503|Abortifacient Agents|abortifacient agents|mesh-ancestor
64555357|NCT02979665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555358|NCT02979665|Growth Inhibitors|growth inhibitors|mesh-ancestor
64555359|NCT02979665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555361|NCT03092076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64555362|NCT03092076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65019518|NCT02917525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019519|NCT02917525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65019520|NCT02917525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65019521|NCT02917525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019522|NCT02917525|Hemostatics|hemostatics|mesh-ancestor
65019523|NCT02917525|Coagulants|coagulants|mesh-ancestor
65019524|NCT00170781|Lumiracoxib|lumiracoxib|mesh-list
65019525|NCT00170781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65019526|NCT00170781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65019527|NCT00170781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019528|NCT00170781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019529|NCT00170781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65019530|NCT00170781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65019531|NCT00170781|Analgesics|analgesics|mesh-ancestor
65019532|NCT00170781|Sensory System Agents|sensory system agents|mesh-ancestor
65019533|NCT00170781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64555363|NCT03092076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64555364|NCT03092076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64555365|NCT03092076|Purinergic Agents|purinergic agents|mesh-ancestor
64555366|NCT03092076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64555367|NCT03092076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555399|NCT03403101|Oxaliplatin|oxaliplatin|mesh-list
64555400|NCT03403101|Irinotecan|irinotecan|mesh-list
64555401|NCT03403101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555402|NCT03403101|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64555403|NCT03403101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64555404|NCT03403101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555405|NCT03403101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555406|NCT00211757|Valproic Acid|valproic acid|mesh-list
64320493|NCT04766996|Propofol|propofol|mesh-list
64555513|NCT03402087|BMS-986165|bms-986165|mesh-list
64555514|NCT03402087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64555515|NCT03402087|Abortifacient Agents|abortifacient agents|mesh-ancestor
64555516|NCT03402087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64555517|NCT03402087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555518|NCT03402087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64320606|NCT02187679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64484491|NCT01976507|Dabigatran|dabigatran|mesh-list
64484493|NCT01976507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64484494|NCT01976507|Protease Inhibitors|protease inhibitors|mesh-ancestor
64484495|NCT01976507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484496|NCT01976507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484499|NCT01964963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64484500|NCT01964963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484501|NCT01964963|Incretins|incretins|mesh-ancestor
64484502|NCT01964963|Hormones|hormones|mesh-ancestor
64484503|NCT01964963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64484504|NCT01964963|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64484505|NCT01964963|Protease Inhibitors|protease inhibitors|mesh-ancestor
64484506|NCT01964963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484507|NCT01964963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484508|NCT01974323|Dapsone|dapsone|mesh-list
64484509|NCT01974323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64484510|NCT01974323|Antimalarials|antimalarials|mesh-ancestor
64484511|NCT01974323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64484512|NCT01974323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64484520|NCT01973387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019534|NCT00170781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019535|NCT00170781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65019536|NCT00170781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65019537|NCT00170820|Everolimus|everolimus|mesh-list
65019538|NCT00170820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019539|NCT00170820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64484522|NCT01973387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484549|NCT04383418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484550|NCT04383418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64555519|NCT03402087|Antimetabolites|antimetabolites|mesh-ancestor
64555520|NCT03402087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555521|NCT03402087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555522|NCT03402087|Dermatologic Agents|dermatologic agents|mesh-ancestor
64555523|NCT03402087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555524|NCT03402087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64555525|NCT03402087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64320617|NCT05507606|Pemetrexed|pemetrexed|mesh-list
64484551|NCT04383418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64484552|NCT04383418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64484554|NCT04383418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64484572|NCT03839134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64484573|NCT03839134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64484574|NCT03839134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484575|NCT03839134|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64484576|NCT03839134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64484577|NCT03839134|Adrenergic Agents|adrenergic agents|mesh-ancestor
64484579|NCT03839134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64484580|NCT03839134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64484581|NCT03839134|Autonomic Agents|autonomic agents|mesh-ancestor
64484582|NCT03839134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64484590|NCT03906526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64484591|NCT03906526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484593|NCT03088930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555530|NCT03402087|Protective Agents|protective agents|mesh-ancestor
64484604|NCT02152696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484605|NCT02152696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64484606|NCT02152696|Dermatologic Agents|dermatologic agents|mesh-ancestor
64484607|NCT02152696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484657|NCT01972841|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64484658|NCT01972841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64484659|NCT01972841|Cholinergic Agents|cholinergic agents|mesh-ancestor
64484660|NCT01972841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64484661|NCT01972841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484662|NCT01972841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484663|NCT01972841|Urological Agents|urological agents|mesh-ancestor
64484664|NCT01972841|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64484665|NCT01972841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64484666|NCT01972841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64484667|NCT01972841|Adrenergic Agents|adrenergic agents|mesh-ancestor
64484668|NCT01774903|Fentanyl|fentanyl|mesh-list
64484669|NCT01774903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64484670|NCT01774903|Narcotics|narcotics|mesh-ancestor
64484671|NCT01774903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64484672|NCT01774903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484673|NCT01774903|Analgesics|analgesics|mesh-ancestor
64484674|NCT01774903|Sensory System Agents|sensory system agents|mesh-ancestor
64484675|NCT01774903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484676|NCT01774903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64484677|NCT01774903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64484678|NCT01774903|Anesthetics, General|anesthetics, general|mesh-ancestor
64484714|NCT01747915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64484715|NCT01747915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484716|NCT01747915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64484717|NCT01747915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64484742|NCT01971203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484743|NCT01970501|Metoprolol|metoprolol|mesh-list
64484744|NCT01970501|Bucindolol|bucindolol|mesh-list
64484748|NCT01970501|Autonomic Agents|autonomic agents|mesh-ancestor
65344947|NCT00864214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65344948|NCT00864214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344949|NCT00864214|Estrogens|estrogens|mesh-ancestor
65344950|NCT00872482|Nimotuzumab|nimotuzumab|mesh-list
65344951|NCT00872482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65344952|NCT00872482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344953|NCT00428389|Rivastigmine|rivastigmine|mesh-list
65344954|NCT00428389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65344955|NCT00428389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344956|NCT00428389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344957|NCT00428389|Cholinergic Agents|cholinergic agents|mesh-ancestor
65344958|NCT00428389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65344959|NCT00428389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344960|NCT00428389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65344961|NCT00428389|Protective Agents|protective agents|mesh-ancestor
65344962|NCT00616642|Rosiglitazone|rosiglitazone|mesh-list
65344963|NCT00616642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65344964|NCT00616642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344965|NCT02568488|Metformin|metformin|mesh-list
64484749|NCT01970501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484750|NCT01970501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484751|NCT01970501|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64484752|NCT01970501|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64555531|NCT03402087|Vitamin B Complex|vitamin b complex|mesh-ancestor
64555532|NCT03402087|Vitamins|vitamins|mesh-ancestor
64555533|NCT03402087|Micronutrients|micronutrients|mesh-ancestor
64555534|NCT03402087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64555535|NCT04020263|Simendan|simendan|mesh-list
64555536|NCT04020263|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64555537|NCT04020263|Vasodilator Agents|vasodilator agents|mesh-ancestor
64555538|NCT04020263|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64484753|NCT01970501|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64484754|NCT01970501|Adrenergic Agents|adrenergic agents|mesh-ancestor
64484755|NCT01970501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64484756|NCT01970501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484757|NCT01970501|Sympathomimetics|sympathomimetics|mesh-ancestor
64484758|NCT01970501|Vasodilator Agents|vasodilator agents|mesh-ancestor
64484759|NCT01970501|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64484760|NCT01970501|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64484761|NCT01969799|Amikacin|amikacin|mesh-list
64484762|NCT01969799|Fosfomycin|fosfomycin|mesh-list
64484763|NCT01969799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64484764|NCT01969799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64484765|NCT01969721|Fluticasone|fluticasone|mesh-list
64484767|NCT01969721|Tiotropium Bromide|tiotropium bromide|mesh-list
64484768|NCT01969721|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64484769|NCT01969721|Olodaterol|olodaterol|mesh-list
64484770|NCT01969721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64484804|NCT01968707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64484805|NCT01968707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64484806|NCT01968707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484807|NCT01968707|Disinfectants|disinfectants|mesh-ancestor
64484808|NCT01968707|Dermatologic Agents|dermatologic agents|mesh-ancestor
64484809|NCT01746901|Naltrexone|naltrexone|mesh-list
64484810|NCT01746901|Oxycodone|oxycodone|mesh-list
64484811|NCT01746901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65344966|NCT02568488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65344967|NCT02568488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344968|NCT01324063|Cytarabine|cytarabine|mesh-list
65344969|NCT01324063|Daunorubicin|daunorubicin|mesh-list
65344970|NCT01324063|Amsacrine|amsacrine|mesh-list
65344971|NCT01324063|Sargramostim|sargramostim|mesh-list
65344972|NCT01324063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65344973|NCT01324063|Antimetabolites|antimetabolites|mesh-ancestor
65344974|NCT01324063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344975|NCT01324063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65344976|NCT01324063|Antiviral Agents|antiviral agents|mesh-ancestor
65344977|NCT01324063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65344978|NCT01324063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65344979|NCT01324063|Immunologic Factors|immunologic factors|mesh-ancestor
65344980|NCT01324063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344981|NCT01324063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65344982|NCT01324063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65344983|NCT01324063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65344984|NCT01324063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344985|NCT00864448|Ramipril|ramipril|mesh-list
65344986|NCT00864448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65344987|NCT00864448|Protease Inhibitors|protease inhibitors|mesh-ancestor
65344988|NCT00864448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65344989|NCT00864448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65344990|NCT00864448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65344991|NCT00406315|Ziprasidone|ziprasidone|mesh-list
65344992|NCT00406315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65344993|NCT00406315|Serotonin Agents|serotonin agents|mesh-ancestor
65344994|NCT00406315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65344995|NCT00406315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484812|NCT01746901|Narcotics|narcotics|mesh-ancestor
64484813|NCT01746901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64484885|NCT00803062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64484886|NCT00803062|Topotecan|topotecan|mesh-list
64484887|NCT00803062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64484888|NCT00803062|Endothelial Growth Factors|endothelial growth factors|mesh-list
64484889|NCT00803062|Antibodies|antibodies|mesh-list
64484890|NCT00803062|Immunoglobulins|immunoglobulins|mesh-list
64484891|NCT00803062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64484892|NCT00803062|Immunoglobulin G|immunoglobulin g|mesh-list
64484893|NCT00803062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64484921|NCT01703845|Autonomic Agents|autonomic agents|mesh-ancestor
64484922|NCT01703845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484923|NCT01703845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484924|NCT01703845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65344996|NCT00406315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65344997|NCT00406315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65344998|NCT00406315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65344999|NCT00406315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65345000|NCT00406315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65345001|NCT00406315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65345002|NCT00406315|Dopamine Agents|dopamine agents|mesh-ancestor
65345003|NCT00872716|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65345004|NCT00872716|Antidepressive Agents|antidepressive agents|mesh-ancestor
65345005|NCT00872716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65345006|NCT00872716|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65345007|NCT00872716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65345008|NCT00872716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65345009|NCT00872716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345010|NCT00864526|Ibuprofen|ibuprofen|mesh-list
65345011|NCT00864526|Oxycodone|oxycodone|mesh-list
65345012|NCT00864526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64737159|NCT00240227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64484925|NCT01703845|Respiratory System Agents|respiratory system agents|mesh-ancestor
64484926|NCT01703845|Parasympatholytics|parasympatholytics|mesh-ancestor
64484927|NCT01703845|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64484928|NCT01703845|Cholinergic Agents|cholinergic agents|mesh-ancestor
64484929|NCT01703845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64484930|NCT01703845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484931|NCT01724359|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64484932|NCT01724359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64484933|NCT01724359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64484934|NCT01724359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64484935|NCT01724359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484936|NCT01724359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64484937|NCT01724359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64484938|NCT01724359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64484965|NCT00823966|Antiviral Agents|antiviral agents|mesh-ancestor
64484966|NCT00823966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64484967|NCT00823966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64484968|NCT00823966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64484972|NCT01702987|Simvastatin|simvastatin|mesh-list
64555539|NCT04020263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64555540|NCT04020263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555541|NCT04020263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555542|NCT04020263|Protective Agents|protective agents|mesh-ancestor
64555543|NCT04020263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555544|NCT05013060|Butyric Acid|butyric acid|mesh-list
64555545|NCT05013060|Histamine Antagonists|histamine antagonists|mesh-ancestor
64484973|NCT01702987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64484974|NCT01702987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64484975|NCT01702987|Antimetabolites|antimetabolites|mesh-ancestor
64484976|NCT01702987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484977|NCT01702987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64484978|NCT01702987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64484979|NCT01702987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484980|NCT01702987|Micronutrients|micronutrients|mesh-ancestor
64484981|NCT01702987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484984|NCT00824044|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64484987|NCT00824044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484989|NCT00824044|Serotonin Agents|serotonin agents|mesh-ancestor
65345013|NCT00864526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65345014|NCT00864526|Analgesics|analgesics|mesh-ancestor
65345015|NCT00864526|Sensory System Agents|sensory system agents|mesh-ancestor
65345016|NCT00864526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65345017|NCT00864526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345018|NCT00864526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65345019|NCT00864526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65345020|NCT00864526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65345021|NCT00864526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345022|NCT00864526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345023|NCT00864526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65345024|NCT00864526|Narcotics|narcotics|mesh-ancestor
65345025|NCT00864526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65345026|NCT00864604|Nabumetone|nabumetone|mesh-list
65345027|NCT00864604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65345028|NCT00864604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65345029|NCT00864604|Analgesics|analgesics|mesh-ancestor
65345030|NCT00864604|Sensory System Agents|sensory system agents|mesh-ancestor
65345031|NCT00864604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65345032|NCT00864604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345033|NCT00864604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65345034|NCT00864604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65345035|NCT00864604|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65345036|NCT00864604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65345037|NCT00864604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345038|NCT00864604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345039|NCT04064138|Anesthetics|anesthetics|mesh-list
65345040|NCT04064138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65345041|NCT04064138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345042|NCT01323751|Ricolinostat|ricolinostat|mesh-list
65345043|NCT01323751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65345044|NCT01323751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64484990|NCT00824044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484991|NCT00824044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64484992|NCT00824044|Antidepressive Agents|antidepressive agents|mesh-ancestor
64484993|NCT00824044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64484994|NCT01702519|Nicotine|nicotine|mesh-list
64484995|NCT01702519|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64484996|NCT01702519|Autonomic Agents|autonomic agents|mesh-ancestor
64484997|NCT01702519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484998|NCT01702519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345045|NCT01323751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345046|NCT01323751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345047|NCT00711594|Afatinib|afatinib|mesh-list
65345048|NCT00711594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65345049|NCT00711594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65345050|NCT00711594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345051|NCT00711594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345052|NCT00864760|Gabapentin|gabapentin|mesh-list
65345053|NCT00864760|Analgesics|analgesics|mesh-ancestor
65345054|NCT00864760|Sensory System Agents|sensory system agents|mesh-ancestor
65345055|NCT00864760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65345056|NCT00864760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345057|NCT00864760|Anticonvulsants|anticonvulsants|mesh-ancestor
65345058|NCT00864760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65345059|NCT00864760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65345060|NCT00864760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65345061|NCT00864760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65345062|NCT00864760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65345063|NCT00864760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65345064|NCT00864760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65345065|NCT00864760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345066|NCT00864760|Antimanic Agents|antimanic agents|mesh-ancestor
65345067|NCT03743662|Bevacizumab|bevacizumab|mesh-list
65345068|NCT03743662|Nivolumab|nivolumab|mesh-list
65345069|NCT03743662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65345070|NCT03743662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65345071|NCT03743662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65345072|NCT03743662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65345073|NCT03743662|Growth Substances|growth substances|mesh-ancestor
65345074|NCT03743662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345075|NCT03743662|Growth Inhibitors|growth inhibitors|mesh-ancestor
65345076|NCT03743662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65345077|NCT03743662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484999|NCT01702519|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64485000|NCT01702519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64485001|NCT01702519|Cholinergic Agents|cholinergic agents|mesh-ancestor
64485002|NCT01702519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64485003|NCT01702519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485004|NCT01739335|Mifepristone|mifepristone|mesh-list
64485005|NCT01739335|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65345078|NCT00710762|Nintedanib|nintedanib|mesh-list
65345079|NCT00710762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65345080|NCT00710762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65345081|NCT00710762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345082|NCT00710762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345083|NCT00736814|Gemcitabine|gemcitabine|mesh-list
65345084|NCT00736814|Carboplatin|carboplatin|mesh-list
65345085|NCT00736814|Docetaxel|docetaxel|mesh-list
65345086|NCT00736814|Vinorelbine|vinorelbine|mesh-list
65345087|NCT00736814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65345088|NCT00736814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65345089|NCT00736814|Antimetabolites|antimetabolites|mesh-ancestor
65345090|NCT00736814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345091|NCT00736814|Antiviral Agents|antiviral agents|mesh-ancestor
65345092|NCT00736814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65345093|NCT00736814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345094|NCT00736814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65345095|NCT00736814|Immunologic Factors|immunologic factors|mesh-ancestor
64737244|NCT04941833|Desogestrel|desogestrel|mesh-list
64485006|NCT01739335|Abortifacient Agents|abortifacient agents|mesh-ancestor
64485007|NCT01739335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64485008|NCT01739335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485009|NCT01739335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64485010|NCT01739335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64485011|NCT01739335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64485012|NCT01739335|Contraceptive Agents|contraceptive agents|mesh-ancestor
64485013|NCT01739335|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64485014|NCT01739335|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64485015|NCT01739335|Hormone Antagonists|hormone antagonists|mesh-ancestor
64485016|NCT01739335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64485017|NCT01739335|Luteolytic Agents|luteolytic agents|mesh-ancestor
64485018|NCT01739335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64485019|NCT01739335|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64485020|NCT00824746|Gefitinib|gefitinib|mesh-list
64485021|NCT00824746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485022|NCT00824746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64485023|NCT00824746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485024|NCT00824746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485026|NCT01722097|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64485027|NCT01722097|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64485028|NCT01722097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64485029|NCT01722097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64485030|NCT01722097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485031|NCT00824824|Timolol|timolol|mesh-list
64485032|NCT00824824|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64485033|NCT00824824|Dorzolamide|dorzolamide|mesh-list
64555546|NCT05013060|Histamine Agents|histamine agents|mesh-ancestor
64555547|NCT05013060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64555548|NCT05013060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555552|NCT05008068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64555553|NCT05008068|Antimetabolites|antimetabolites|mesh-ancestor
64485034|NCT00824824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64485035|NCT00824824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64485036|NCT00824824|Adrenergic Agents|adrenergic agents|mesh-ancestor
64485037|NCT00824824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65345096|NCT00736814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345097|NCT00736814|Tubulin Modulators|tubulin modulators|mesh-ancestor
65345098|NCT00736814|Antimitotic Agents|antimitotic agents|mesh-ancestor
65345099|NCT00736814|Mitosis Modulators|mitosis modulators|mesh-ancestor
65345100|NCT00736814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65345101|NCT04063904|Misoprostol|misoprostol|mesh-list
65345102|NCT04063904|Mifepristone|mifepristone|mesh-list
65345103|NCT04063904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65345104|NCT04063904|Abortifacient Agents|abortifacient agents|mesh-ancestor
65345105|NCT04063904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65345106|NCT04063904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345107|NCT04063904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65345108|NCT04063904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65345109|NCT04063904|Oxytocics|oxytocics|mesh-ancestor
65345110|NCT04063904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65345111|NCT04063904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65345112|NCT04063904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65345113|NCT04063904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65345114|NCT04063904|Contraceptive Agents|contraceptive agents|mesh-ancestor
65345115|NCT04063904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65345116|NCT04063904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65345117|NCT04063904|Hormone Antagonists|hormone antagonists|mesh-ancestor
65019540|NCT00170820|Immunologic Factors|immunologic factors|mesh-ancestor
64485038|NCT00824824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485039|NCT00824824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485040|NCT00824824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64485041|NCT00824824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64485042|NCT00824824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64485043|NCT00824824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64485045|NCT00824824|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64485046|NCT00824824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485068|NCT00825370|Analgesics|analgesics|mesh-ancestor
64485069|NCT00825370|Sensory System Agents|sensory system agents|mesh-ancestor
64485070|NCT00825370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64485071|NCT01721317|Ezogabine|ezogabine|mesh-list
64485072|NCT01721317|Anticonvulsants|anticonvulsants|mesh-ancestor
64485073|NCT01721317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64485074|NCT01721317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485075|NCT05014438|Branebrutinib|branebrutinib|mesh-list
64485076|NCT05014438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64485077|NCT05014438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485078|NCT05014438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485079|NCT00828412|Desonide|desonide|mesh-list
64485080|NCT00828412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64485081|NCT01959035|Aripiprazole|aripiprazole|mesh-list
64485082|NCT01959035|Antidepressive Agents|antidepressive agents|mesh-ancestor
64485083|NCT01959035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64485084|NCT01959035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64485085|NCT01959035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64485086|NCT01959035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65345118|NCT04063904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65345119|NCT04063904|Luteolytic Agents|luteolytic agents|mesh-ancestor
65345120|NCT04063904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65345121|NCT04063904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65345122|NCT00573430|Candesartan|candesartan|mesh-list
65345123|NCT00573430|Candesartan cilexetil|candesartan cilexetil|mesh-list
65345124|NCT00573430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65345125|NCT00573430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65345126|NCT00573430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65345127|NCT00573430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345128|NCT00711516|Modafinil|modafinil|mesh-list
65345129|NCT00711516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65345130|NCT00711516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345131|NCT00711516|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64737290|NCT00000887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485087|NCT01959035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485088|NCT01959035|Dopamine Agonists|dopamine agonists|mesh-ancestor
64485089|NCT01959035|Dopamine Agents|dopamine agents|mesh-ancestor
64485090|NCT01959035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64485091|NCT01959035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485092|NCT01959035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64485093|NCT01959035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64485094|NCT01959035|Serotonin Agents|serotonin agents|mesh-ancestor
64485095|NCT01959035|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64485116|NCT01737931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64485117|NCT01737931|Antiemetics|antiemetics|mesh-ancestor
64485118|NCT01737931|Autonomic Agents|autonomic agents|mesh-ancestor
64485119|NCT01737931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64485120|NCT01737931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485121|NCT01737931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64485122|NCT01737931|Glucocorticoids|glucocorticoids|mesh-ancestor
64485124|NCT01737931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64485125|NCT01737931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64485126|NCT01737931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485127|NCT01737931|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64485128|NCT01737931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64485129|NCT01737931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64485130|NCT01737931|Anesthetics, Local|anesthetics, local|mesh-ancestor
64485131|NCT01737931|Anesthetics|anesthetics|mesh-ancestor
64485132|NCT01737931|Sensory System Agents|sensory system agents|mesh-ancestor
64485133|NCT01737931|Histamine Agents|histamine agents|mesh-ancestor
64555554|NCT05008068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555555|NCT05008068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64555556|NCT05008068|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64555557|NCT05008068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555558|NCT00925119|Atenolol|atenolol|mesh-list
64485134|NCT01737931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64485135|NCT01737931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485136|NCT01737931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64485142|NCT01958489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64485143|NCT01958489|Antimetabolites|antimetabolites|mesh-ancestor
64485144|NCT01958489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485145|NCT01958489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64485146|NCT01958489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65345132|NCT00711516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65345133|NCT00711516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65345134|NCT00711516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345135|NCT00864838|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65345136|NCT00864838|Acetazolamide|acetazolamide|mesh-list
65345137|NCT00864838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65345138|NCT00864838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65345139|NCT00864838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65345140|NCT00864838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65345141|NCT00864838|Adrenergic Agents|adrenergic agents|mesh-ancestor
65345142|NCT00864838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65345143|NCT00864838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345144|NCT00864838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345145|NCT00864838|Anticonvulsants|anticonvulsants|mesh-ancestor
65345146|NCT00864838|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65345147|NCT00864838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345148|NCT00864838|Diuretics|diuretics|mesh-ancestor
65345149|NCT00864838|Natriuretic Agents|natriuretic agents|mesh-ancestor
65345150|NCT04039516|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65345151|NCT04039516|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65345152|NCT04039516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345153|NCT00615550|Progesterone|progesterone|mesh-list
65345154|NCT00615550|Progestins|progestins|mesh-ancestor
65345155|NCT00615550|Hormones|hormones|mesh-ancestor
65345156|NCT00615550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65345157|NCT00615550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485147|NCT01958489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485148|NCT01700179|Ribavirin|ribavirin|mesh-list
64485149|NCT01700179|Antimetabolites|antimetabolites|mesh-ancestor
64485150|NCT01700179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485151|NCT01700179|Antiviral Agents|antiviral agents|mesh-ancestor
64485176|NCT01720225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485177|NCT04548661|Povidone-Iodine|povidone-iodine|mesh-list
64485179|NCT04548661|Plasma Substitutes|plasma substitutes|mesh-ancestor
64485180|NCT04548661|Blood Substitutes|blood substitutes|mesh-ancestor
64485181|NCT04548661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64485182|NCT04548661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64485183|NCT01943435|Acetaminophen|acetaminophen|mesh-list
64485184|NCT01943435|Ibuprofen|ibuprofen|mesh-list
64485185|NCT01943435|Celecoxib|celecoxib|mesh-list
64485186|NCT01943435|Diclofenac|diclofenac|mesh-list
64485187|NCT01943435|Gabapentin|gabapentin|mesh-list
64485188|NCT01943435|Tramadol|tramadol|mesh-list
64485189|NCT01943435|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64485190|NCT01943435|Analgesics|analgesics|mesh-list
64485191|NCT01943435|Mirtazapine|mirtazapine|mesh-list
64485192|NCT01943435|Trazodone|trazodone|mesh-list
64485193|NCT01943435|Sertraline|sertraline|mesh-list
64485194|NCT01943435|Nortriptyline|nortriptyline|mesh-list
64485195|NCT01943435|Antidepressive Agents|antidepressive agents|mesh-list
65345158|NCT00186888|Cyclophosphamide|cyclophosphamide|mesh-list
65345159|NCT00186888|Carboplatin|carboplatin|mesh-list
65345160|NCT00186888|Doxorubicin|doxorubicin|mesh-list
65345161|NCT00186888|Etoposide|etoposide|mesh-list
65345162|NCT00186888|Etoposide phosphate|etoposide phosphate|mesh-list
65345163|NCT00186888|Vincristine|vincristine|mesh-list
65345164|NCT00186888|Topotecan|topotecan|mesh-list
65345165|NCT00186888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65345166|NCT00186888|Immunologic Factors|immunologic factors|mesh-ancestor
65345167|NCT00186888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345168|NCT00186888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65345169|NCT00186888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65345170|NCT00186888|Alkylating Agents|alkylating agents|mesh-ancestor
65345171|NCT00186888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345172|NCT00186888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65345173|NCT00186888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65345174|NCT00186888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65345175|NCT00186888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65345176|NCT00186888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65345177|NCT00186888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345178|NCT00186888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65345179|NCT00186888|Tubulin Modulators|tubulin modulators|mesh-ancestor
65345180|NCT00186888|Antimitotic Agents|antimitotic agents|mesh-ancestor
65345181|NCT00186888|Mitosis Modulators|mitosis modulators|mesh-ancestor
65345182|NCT00186888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65345183|NCT00736164|Selenium|selenium|mesh-list
65345184|NCT00736164|Antioxidants|antioxidants|mesh-ancestor
65019541|NCT00170820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485197|NCT01943435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64485198|NCT01943435|Sensory System Agents|sensory system agents|mesh-ancestor
64485199|NCT01943435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64485200|NCT01943435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485201|NCT01943435|Antipyretics|antipyretics|mesh-ancestor
64485202|NCT01943435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64485203|NCT01943435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64485204|NCT01943435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64485205|NCT01943435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64485260|NCT00807586|Glucocorticoids|glucocorticoids|mesh-ancestor
64485261|NCT00807586|Hormones|hormones|mesh-ancestor
64485262|NCT00807586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64485263|NCT00807586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485264|NCT00807586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64485265|NCT00807586|Protective Agents|protective agents|mesh-ancestor
64485266|NCT00807586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64485281|NCT01941095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64485282|NCT01941095|Abortifacient Agents|abortifacient agents|mesh-ancestor
64485283|NCT01941095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65345185|NCT00736164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345186|NCT00736164|Protective Agents|protective agents|mesh-ancestor
65345187|NCT00736164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345188|NCT00736164|Trace Elements|trace elements|mesh-ancestor
65345189|NCT00736164|Micronutrients|micronutrients|mesh-ancestor
65345190|NCT00739830|Sirolimus|sirolimus|mesh-list
65345191|NCT00739830|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65345192|NCT00739830|Megestrol|megestrol|mesh-list
65345193|NCT00739830|Megestrol Acetate|megestrol acetate|mesh-list
65345194|NCT00739830|Medroxyprogesterone|medroxyprogesterone|mesh-list
65345195|NCT00739830|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65345196|NCT00739830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65345197|NCT00739830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65345198|NCT00739830|Contraceptive Agents|contraceptive agents|mesh-ancestor
65345199|NCT00739830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65345200|NCT00739830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345201|NCT00739830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65345202|NCT00739830|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65345203|NCT00739830|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65345204|NCT00739830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65345205|NCT00739830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65345206|NCT00739830|Appetite Stimulants|appetite stimulants|mesh-ancestor
64485284|NCT01941095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485285|NCT01941095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64485286|NCT01941095|Antimetabolites|antimetabolites|mesh-ancestor
64485287|NCT01941095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485288|NCT01941095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485289|NCT01941095|Dermatologic Agents|dermatologic agents|mesh-ancestor
64485290|NCT01941095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555559|NCT00925119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64555560|NCT00925119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64555561|NCT00925119|Sympatholytics|sympatholytics|mesh-ancestor
64555562|NCT00925119|Autonomic Agents|autonomic agents|mesh-ancestor
64555563|NCT00925119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64555564|NCT00925119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485291|NCT01941095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64485292|NCT01941095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64485293|NCT01941095|Immunologic Factors|immunologic factors|mesh-ancestor
64485294|NCT01941095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64485295|NCT01941095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64485296|NCT01941095|Antimalarials|antimalarials|mesh-ancestor
64485297|NCT01941095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64485300|NCT01941095|Amebicides|amebicides|mesh-ancestor
64485301|NCT01941095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64485302|NCT01941095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64485303|NCT01941095|Analgesics|analgesics|mesh-ancestor
64485304|NCT01941095|Sensory System Agents|sensory system agents|mesh-ancestor
64485305|NCT01941095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64485306|NCT01941095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64485307|NCT01941095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64485308|NCT00831766|Cytarabine|cytarabine|mesh-list
64485309|NCT00831766|Lenalidomide|lenalidomide|mesh-list
64485310|NCT00831766|Idarubicin|idarubicin|mesh-list
65345207|NCT00739830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65345208|NCT00739830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65345209|NCT00739830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65345210|NCT00739830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65345211|NCT00739830|Antifungal Agents|antifungal agents|mesh-ancestor
65345212|NCT00739830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65345213|NCT00739830|Immunologic Factors|immunologic factors|mesh-ancestor
65345214|NCT00577382|Sunitinib|sunitinib|mesh-list
65345215|NCT00577382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65345216|NCT00577382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65345217|NCT00577382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65345218|NCT00577382|Growth Substances|growth substances|mesh-ancestor
65345219|NCT00577382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345220|NCT00577382|Growth Inhibitors|growth inhibitors|mesh-ancestor
65345221|NCT00577382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65345222|NCT00577382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345223|NCT00577382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345224|NCT00733434|Alprostadil|alprostadil|mesh-list
65345225|NCT00733434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65345226|NCT00733434|Vasodilator Agents|vasodilator agents|mesh-ancestor
65345227|NCT00733434|Urological Agents|urological agents|mesh-ancestor
65345228|NCT00736320|Vincristine|vincristine|mesh-list
65345229|NCT00736320|Doxorubicin|doxorubicin|mesh-list
65345230|NCT00736320|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65345231|NCT00736320|Dacarbazine|dacarbazine|mesh-list
65345232|NCT00736320|Bleomycin|bleomycin|mesh-list
65019542|NCT02917018|Dexmedetomidine|dexmedetomidine|mesh-list
64485311|NCT00831766|Antineoplastic Agents|antineoplastic agents|mesh-list
64485312|NCT00831766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64485313|NCT00831766|Antimetabolites|antimetabolites|mesh-ancestor
64485314|NCT00831766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485315|NCT00831766|Antiviral Agents|antiviral agents|mesh-ancestor
64485316|NCT00831766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64485317|NCT00831766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64485318|NCT00831766|Immunologic Factors|immunologic factors|mesh-ancestor
64485319|NCT00831766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485320|NCT00831766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64485321|NCT00831766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64485322|NCT00831766|Growth Substances|growth substances|mesh-ancestor
64485323|NCT00831766|Growth Inhibitors|growth inhibitors|mesh-ancestor
64485324|NCT00831766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64485325|NCT00831766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64485326|NCT00831766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64485327|NCT00831766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485328|NCT01957709|Interferons|interferons|mesh-list
64485329|NCT01957709|Interferon-gamma|interferon-gamma|mesh-list
64485357|NCT00844090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485358|NCT00844090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64485359|NCT00844090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65345233|NCT00736320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65345234|NCT00736320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65345235|NCT00736320|Tubulin Modulators|tubulin modulators|mesh-ancestor
65345236|NCT00736320|Antimitotic Agents|antimitotic agents|mesh-ancestor
65345237|NCT00736320|Mitosis Modulators|mitosis modulators|mesh-ancestor
65345238|NCT00736320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345239|NCT00736320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65345240|NCT00736320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65345241|NCT00736320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65345242|NCT00736320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345243|NCT00736320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65345244|NCT00736320|Alkylating Agents|alkylating agents|mesh-ancestor
65345245|NCT04065282|Capecitabine|capecitabine|mesh-list
65345246|NCT04065282|Oxaliplatin|oxaliplatin|mesh-list
64737409|NCT00000209|Analgesics|analgesics|mesh-ancestor
64485360|NCT00844090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64485361|NCT00844090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485362|NCT00844090|Dopamine Agents|dopamine agents|mesh-ancestor
64485363|NCT00844090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64485364|NCT00844714|Rituximab|rituximab|mesh-list
64485365|NCT00844714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64485366|NCT00844714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485367|NCT00844714|Immunologic Factors|immunologic factors|mesh-ancestor
64485368|NCT00844714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485369|NCT00844714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64485370|NCT00834652|Metformin|metformin|mesh-list
64485371|NCT00834652|Sertraline|sertraline|mesh-list
64485372|NCT00834652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64485373|NCT00834652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485374|NCT00834652|Antidepressive Agents|antidepressive agents|mesh-ancestor
64485375|NCT00834652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64485376|NCT00834652|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64485400|NCT00835198|Tretinoin|tretinoin|mesh-list
64485401|NCT00835198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485402|NCT00835198|Keratolytic Agents|keratolytic agents|mesh-ancestor
64485403|NCT00835198|Dermatologic Agents|dermatologic agents|mesh-ancestor
64485404|NCT00835198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64555565|NCT00925119|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64555566|NCT00925119|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64555567|NCT00925119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64555568|NCT00925119|Adrenergic Agents|adrenergic agents|mesh-ancestor
64555569|NCT00925119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64555570|NCT00925119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485405|NCT00835198|Antimalarials|antimalarials|mesh-ancestor
64485406|NCT00835198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64485407|NCT00835198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64485408|NCT00835198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64485409|NCT00835198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485410|NCT00835198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485411|NCT00835198|Leprostatic Agents|leprostatic agents|mesh-ancestor
64485412|NCT00835198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64485413|NCT00835510|Butenafine|butenafine|mesh-list
64485414|NCT00835510|Clotrimazole|clotrimazole|mesh-list
64485415|NCT00835510|Antifungal Agents|antifungal agents|mesh-ancestor
64485417|NCT00835510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64485418|NCT00835510|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64485419|NCT00835510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64485421|NCT00835510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485422|NCT00835510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65345247|NCT04065282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65345248|NCT04065282|Antimetabolites|antimetabolites|mesh-ancestor
65345249|NCT04065282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345250|NCT04065282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65345251|NCT00873262|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65345252|NCT00873262|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65345253|NCT00873262|Estropipate|estropipate|mesh-list
65345254|NCT00873262|Estradiol|estradiol|mesh-list
65345255|NCT00873262|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65345256|NCT00873262|Estrone|estrone|mesh-list
65345257|NCT00873262|Progesterone|progesterone|mesh-list
65345258|NCT00873262|Estrogens|estrogens|mesh-ancestor
65345259|NCT00873262|Hormones|hormones|mesh-ancestor
65345260|NCT00873262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65345261|NCT00873262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345262|NCT00873262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65345263|NCT00873262|Contraceptive Agents|contraceptive agents|mesh-ancestor
65345264|NCT00873262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64485423|NCT00835510|Hormone Antagonists|hormone antagonists|mesh-ancestor
64485424|NCT00835510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64485425|NCT00835510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485426|NCT00835900|Varenicline|varenicline|mesh-list
64485427|NCT00835900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64485463|NCT03856216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64485464|NCT03856216|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64485465|NCT03856216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64485466|NCT03856216|Alkylating Agents|alkylating agents|mesh-ancestor
64485467|NCT03856216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64485500|NCT03770260|Ixazomib|ixazomib|mesh-list
64485501|NCT03770260|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64485502|NCT03770260|Pevonedistat|pevonedistat|mesh-list
64485503|NCT03770260|Glycine|glycine|mesh-list
64485504|NCT03770260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485505|NCT03770260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485506|NCT03770260|Protease Inhibitors|protease inhibitors|mesh-ancestor
64485507|NCT03770260|Glycine Agents|glycine agents|mesh-ancestor
64485508|NCT03770260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64485509|NCT03770260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485510|NCT00838162|Ritonavir|ritonavir|mesh-list
64485526|NCT00841204|Analgesics|analgesics|mesh-ancestor
64485527|NCT00841204|Sensory System Agents|sensory system agents|mesh-ancestor
64485528|NCT00841204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64485529|NCT00841204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485530|NCT00841204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64485531|NCT00841204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64485532|NCT00841204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485533|NCT00841204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64485534|NCT00841204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485535|NCT00841204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485537|NCT00853840|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
64485538|NCT00853840|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64485539|NCT00853840|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64485540|NCT00853840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485541|NCT00853840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64485542|NCT00853840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64485543|NCT00853840|Antiviral Agents|antiviral agents|mesh-ancestor
64485544|NCT00853840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65345265|NCT00873262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65345266|NCT00873262|Progestins|progestins|mesh-ancestor
65345267|NCT00739986|Semapimod|semapimod|mesh-list
65345268|NCT00739986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65345269|NCT00739986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65345270|NCT00739986|Analgesics|analgesics|mesh-ancestor
65345271|NCT00739986|Sensory System Agents|sensory system agents|mesh-ancestor
65345272|NCT00739986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65345273|NCT00739986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345274|NCT00739986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65345275|NCT00739986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65345276|NCT00739986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65345277|NCT00739986|Immunologic Factors|immunologic factors|mesh-ancestor
65345278|NCT00736970|Sirolimus|sirolimus|mesh-list
65345279|NCT00736970|Trastuzumab|trastuzumab|mesh-list
65345280|NCT00736970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65345281|NCT00736970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65345282|NCT00736970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65345283|NCT00736970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65345284|NCT00736970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64737443|NCT00000227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64485545|NCT00853840|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64555572|NCT04020809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555573|NCT04027751|Tropisetron|tropisetron|mesh-list
64555574|NCT04027751|Antiemetics|antiemetics|mesh-ancestor
64555575|NCT04027751|Autonomic Agents|autonomic agents|mesh-ancestor
64555576|NCT04027751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64555577|NCT04027751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555578|NCT04027751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64485546|NCT00853840|Vasodilator Agents|vasodilator agents|mesh-ancestor
64485547|NCT00853840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64485548|NCT00853840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64485549|NCT00853840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485550|NCT00853840|Urological Agents|urological agents|mesh-ancestor
64485551|NCT00841828|Cyclophosphamide|cyclophosphamide|mesh-list
64485553|NCT00841828|Trastuzumab|trastuzumab|mesh-list
64485554|NCT00841828|Epirubicin|epirubicin|mesh-list
64485555|NCT00841828|Lapatinib|lapatinib|mesh-list
64485556|NCT00841828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64485557|NCT00841828|Immunologic Factors|immunologic factors|mesh-ancestor
64485558|NCT00841828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485559|NCT00841828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64485560|NCT00841828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64485561|NCT00841828|Alkylating Agents|alkylating agents|mesh-ancestor
64485562|NCT00841828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485563|NCT00841828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485564|NCT00841828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64485565|NCT00841828|Tubulin Modulators|tubulin modulators|mesh-ancestor
64485598|NCT00856024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485600|NCT00856024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64485601|NCT00856414|Botulinum Toxins|botulinum toxins|mesh-list
64485602|NCT00856414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64485603|NCT00856414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64485604|NCT00856414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64485605|NCT00856414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65345285|NCT00736970|Antifungal Agents|antifungal agents|mesh-ancestor
65345286|NCT00736970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65345287|NCT00736970|Immunologic Factors|immunologic factors|mesh-ancestor
65345288|NCT00736970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345289|NCT00873340|Interferons|interferons|mesh-list
65345290|NCT00873340|Interferon beta-1b|interferon beta-1b|mesh-list
65345291|NCT00873340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65345292|NCT00873340|Antiviral Agents|antiviral agents|mesh-ancestor
65345293|NCT00873340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65345294|NCT00873340|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65345295|NCT00873340|Immunologic Factors|immunologic factors|mesh-ancestor
65345296|NCT00873340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345297|NCT00740064|Lamivudine|lamivudine|mesh-list
65345298|NCT00740064|Abacavir|abacavir|mesh-list
65345299|NCT00740064|Raltegravir Potassium|raltegravir potassium|mesh-list
65345300|NCT00740064|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65345301|NCT00740064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65345302|NCT00740064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345303|NCT00740064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345304|NCT00740064|Antiviral Agents|antiviral agents|mesh-ancestor
65345305|NCT00740064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65345306|NCT00740064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65345307|NCT00740064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65345308|NCT00740064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65345309|NCT00740064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65345310|NCT00614926|Modafinil|modafinil|mesh-list
64737462|NCT00000245|Desipramine|desipramine|mesh-list
64485606|NCT00856414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485607|NCT00856414|Cholinergic Agents|cholinergic agents|mesh-ancestor
64485608|NCT00856414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64485643|NCT02453620|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
64485644|NCT02453620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64485645|NCT02453620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485646|NCT02453620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64485647|NCT02453620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485648|NCT02453620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485671|NCT04351438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64485672|NCT04351438|Chelating Agents|chelating agents|mesh-ancestor
64485673|NCT04351438|Sequestering Agents|sequestering agents|mesh-ancestor
64485674|NCT04351438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485675|NCT04351438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64485676|NCT04351438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64485677|NCT00890656|Dexamethasone|dexamethasone|mesh-list
64485678|NCT00890656|Cyclophosphamide|cyclophosphamide|mesh-list
64485679|NCT00890656|Doxorubicin|doxorubicin|mesh-list
64485680|NCT00890656|Methotrexate|methotrexate|mesh-list
64485681|NCT00890656|Vincristine|vincristine|mesh-list
64485682|NCT00890656|Asparaginase|asparaginase|mesh-list
64485683|NCT00890656|Pegaspargase|pegaspargase|mesh-list
64485684|NCT00890656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65345311|NCT00614926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65345312|NCT00614926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345313|NCT00614926|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65345314|NCT00614926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65345315|NCT00614926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65345316|NCT00614926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345317|NCT00873496|Hydroxychloroquine|hydroxychloroquine|mesh-list
65345318|NCT00873496|Antimalarials|antimalarials|mesh-ancestor
65345319|NCT00873496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65345320|NCT00873496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65345321|NCT00873496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65345322|NCT00873496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345323|NCT00873496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345324|NCT00873496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65345325|NCT00879892|Xenon|xenon|mesh-list
65345326|NCT00879892|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65345327|NCT00879892|Anesthetics, General|anesthetics, general|mesh-ancestor
65345328|NCT00879892|Anesthetics|anesthetics|mesh-ancestor
65345329|NCT00879892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65345330|NCT00879892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345331|NCT00095784|Decitabine|decitabine|mesh-list
65345332|NCT00095784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65345333|NCT00095784|Antimetabolites|antimetabolites|mesh-ancestor
65345334|NCT00095784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345335|NCT00095784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65345336|NCT00095784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485685|NCT00890656|Immunologic Factors|immunologic factors|mesh-ancestor
64485686|NCT00890656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485687|NCT00890656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64485688|NCT00890656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64485689|NCT00890656|Alkylating Agents|alkylating agents|mesh-ancestor
64485690|NCT00890656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555579|NCT04027751|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64555580|NCT04027751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64555581|NCT04027751|Serotonin Agents|serotonin agents|mesh-ancestor
64555582|NCT04027751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64485691|NCT00890656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485692|NCT00890656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64485693|NCT00890656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64485694|NCT00890656|Antiemetics|antiemetics|mesh-ancestor
64485695|NCT00890656|Autonomic Agents|autonomic agents|mesh-ancestor
64485696|NCT00890656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64485697|NCT00890656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64485698|NCT00890656|Glucocorticoids|glucocorticoids|mesh-ancestor
64485699|NCT00890656|Hormones|hormones|mesh-ancestor
64485700|NCT00890656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65345337|NCT00740142|Lactulose|lactulose|mesh-list
65345338|NCT00740142|N-Methylaspartate|n-methylaspartate|mesh-list
65345339|NCT00740142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65345340|NCT00740142|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
65345341|NCT00740142|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65345342|NCT00740142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65345343|NCT00740142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345344|NCT00740142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345345|NCT00873652|Vaccines|vaccines|mesh-list
65345346|NCT00873652|Immunologic Factors|immunologic factors|mesh-ancestor
65345347|NCT00873652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345348|NCT00423319|Enoxaparin|enoxaparin|mesh-list
65345349|NCT00423319|Enoxaparin sodium|enoxaparin sodium|mesh-list
65345350|NCT00423319|Apixaban|apixaban|mesh-list
65345351|NCT00423319|Anticoagulants|anticoagulants|mesh-ancestor
65345352|NCT00423319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65345353|NCT00423319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65345354|NCT00423319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345355|NCT00423319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65345356|NCT00423319|Antithrombins|antithrombins|mesh-ancestor
65345357|NCT00423319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65345358|NCT00423319|Protease Inhibitors|protease inhibitors|mesh-ancestor
65345359|NCT00423319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345360|NCT05224492|Sulforaphane|sulforaphane|mesh-list
65345361|NCT05224492|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65345362|NCT05224492|Protective Agents|protective agents|mesh-ancestor
65345363|NCT05224492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485701|NCT00890656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64485702|NCT00890656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485716|NCT00890656|Antimitotic Agents|antimitotic agents|mesh-ancestor
64485717|NCT00890656|Mitosis Modulators|mitosis modulators|mesh-ancestor
64485718|NCT00814138|Methotrexate|methotrexate|mesh-list
64485719|NCT00814138|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64485720|NCT00814138|Abortifacient Agents|abortifacient agents|mesh-ancestor
64485721|NCT00814138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64485722|NCT00814138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485723|NCT00814138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64485724|NCT00814138|Antimetabolites|antimetabolites|mesh-ancestor
64485725|NCT00814138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485726|NCT00814138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485727|NCT00814138|Dermatologic Agents|dermatologic agents|mesh-ancestor
64485728|NCT00814138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485729|NCT00814138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64485730|NCT00814138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64485731|NCT00814138|Immunologic Factors|immunologic factors|mesh-ancestor
64485732|NCT00814138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64485736|NCT00860938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64485737|NCT00860938|Autonomic Agents|autonomic agents|mesh-ancestor
64485738|NCT00860938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65345364|NCT05224492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65345365|NCT00733668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65345366|NCT00733668|Antidepressive Agents|antidepressive agents|mesh-ancestor
65345367|NCT00733668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65345368|NCT00733668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65345369|NCT00733668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65345370|NCT00733668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65345371|NCT00733668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345372|NCT04039126|Iodine|iodine|mesh-list
65345373|NCT04039126|Cadexomer iodine|cadexomer iodine|mesh-list
65345374|NCT04039126|Povidone-Iodine|povidone-iodine|mesh-list
65345375|NCT04039126|Tetracycline|tetracycline|mesh-list
65345376|NCT04039126|Povidone|povidone|mesh-list
65345377|NCT04039126|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65345378|NCT04039126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65345379|NCT04039126|Trace Elements|trace elements|mesh-ancestor
65345380|NCT04039126|Micronutrients|micronutrients|mesh-ancestor
65345381|NCT04039126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345382|NCT04039126|Plasma Substitutes|plasma substitutes|mesh-ancestor
65345383|NCT04039126|Blood Substitutes|blood substitutes|mesh-ancestor
65345384|NCT04039126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65345385|NCT04039126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65345386|NCT04039126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345387|NCT04039126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345388|NCT00873808|Zoledronic Acid|zoledronic acid|mesh-list
65345389|NCT00873808|Ibandronic Acid|ibandronic acid|mesh-list
65345390|NCT00873808|Clodronic Acid|clodronic acid|mesh-list
65345391|NCT00873808|Tetracycline|tetracycline|mesh-list
65345392|NCT00873808|Demeclocycline|demeclocycline|mesh-list
65345393|NCT00873808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65345394|NCT00873808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345395|NCT00873808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65345396|NCT00873808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65345397|NCT00873808|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65345407|NCT00873886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345408|NCT00880282|Sirolimus|sirolimus|mesh-list
65345409|NCT00880282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65345410|NCT00880282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65345411|NCT00880282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65345412|NCT00880282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65345413|NCT00880282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65345414|NCT00880282|Antifungal Agents|antifungal agents|mesh-ancestor
65345415|NCT00880282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65345416|NCT00880282|Immunologic Factors|immunologic factors|mesh-ancestor
65345417|NCT00880282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345418|NCT00879268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65345419|NCT00874042|Gemcitabine|gemcitabine|mesh-list
65345420|NCT00874042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65345421|NCT00874042|Antimetabolites|antimetabolites|mesh-ancestor
65345422|NCT00874042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345423|NCT00874042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65345424|NCT00874042|Antiviral Agents|antiviral agents|mesh-ancestor
65345425|NCT00874042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65345426|NCT00874042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345427|NCT00874042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65345428|NCT00874042|Immunologic Factors|immunologic factors|mesh-ancestor
65345429|NCT00874042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345430|NCT00736866|Acetylcysteine|acetylcysteine|mesh-list
65345431|NCT00736866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65345432|NCT00736866|Antiviral Agents|antiviral agents|mesh-ancestor
65345433|NCT00736866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65345434|NCT00736866|Expectorants|expectorants|mesh-ancestor
65345435|NCT00736866|Respiratory System Agents|respiratory system agents|mesh-ancestor
65345436|NCT00736866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65345437|NCT00736866|Antioxidants|antioxidants|mesh-ancestor
65345438|NCT00736866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345439|NCT00736866|Protective Agents|protective agents|mesh-ancestor
65345440|NCT00736866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345441|NCT00736866|Antidotes|antidotes|mesh-ancestor
65345442|NCT00879424|Vitamin D|vitamin d|mesh-list
65345443|NCT00879424|Cholecalciferol|cholecalciferol|mesh-list
65345444|NCT00879424|Vitamins|vitamins|mesh-ancestor
65345445|NCT00879424|Micronutrients|micronutrients|mesh-ancestor
65345446|NCT00879424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345447|NCT00879424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65345448|NCT00879424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65345449|NCT00710684|Donepezil|donepezil|mesh-list
65345450|NCT00710684|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65345451|NCT00710684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345452|NCT00710684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345453|NCT00710684|Cholinergic Agents|cholinergic agents|mesh-ancestor
65345454|NCT00710684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65345455|NCT00710684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345456|NCT00710684|Nootropic Agents|nootropic agents|mesh-ancestor
65345457|NCT00710606|NuvaRing|nuvaring|mesh-list
65345458|NCT00710606|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65345459|NCT00710606|Desogestrel|desogestrel|mesh-list
64737615|NCT00000275|Dopamine Agents|dopamine agents|mesh-ancestor
64485739|NCT00860938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485740|NCT00860938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64485741|NCT00860938|Respiratory System Agents|respiratory system agents|mesh-ancestor
64485742|NCT00860938|Glucocorticoids|glucocorticoids|mesh-ancestor
64485743|NCT00860938|Hormones|hormones|mesh-ancestor
64485744|NCT00860938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64485745|NCT01719757|Oxycodone|oxycodone|mesh-list
64485746|NCT01719757|Naloxone|naloxone|mesh-list
64485747|NCT01719757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64485748|NCT01719757|Narcotics|narcotics|mesh-ancestor
64485749|NCT01719757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64485750|NCT01719757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485751|NCT01719757|Analgesics|analgesics|mesh-ancestor
64485752|NCT01719757|Sensory System Agents|sensory system agents|mesh-ancestor
64485753|NCT01719757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64485754|NCT01719757|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64485755|NCT01718509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64485756|NCT01718509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64485757|NCT01718509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485758|NCT01718509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64485759|NCT01718509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64485760|NCT01718509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64485792|NCT01857934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64485793|NCT01857934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64485794|NCT01857934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485795|NCT01857934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64485796|NCT01857934|Tubulin Modulators|tubulin modulators|mesh-ancestor
64485797|NCT01857934|Antimitotic Agents|antimitotic agents|mesh-ancestor
64485798|NCT01857934|Mitosis Modulators|mitosis modulators|mesh-ancestor
64485799|NCT01857934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64555583|NCT04027751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555585|NCT05018988|Ergocalciferols|ergocalciferols|mesh-list
64555586|NCT05018988|Cholecalciferol|cholecalciferol|mesh-list
64555587|NCT05018988|Vitamins|vitamins|mesh-list
64555588|NCT05018988|Micronutrients|micronutrients|mesh-ancestor
64555589|NCT05018988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555590|NCT05018988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64485800|NCT01857934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64485801|NCT01857934|Analgesics|analgesics|mesh-ancestor
64485802|NCT01857934|Sensory System Agents|sensory system agents|mesh-ancestor
64485803|NCT01857934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64485804|NCT01857934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64485805|NCT01857934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64485806|NCT01857934|Antiviral Agents|antiviral agents|mesh-ancestor
64485807|NCT01857934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65345460|NCT00710606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65345461|NCT00710606|Contraceptive Agents|contraceptive agents|mesh-ancestor
65345462|NCT00710606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65345463|NCT00710606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345464|NCT00710606|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65345465|NCT00710606|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65345466|NCT00710606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65345467|NCT00710606|Estrogens|estrogens|mesh-ancestor
65345468|NCT00710606|Hormones|hormones|mesh-ancestor
65345469|NCT00710606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65066812|NCT00272636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65345470|NCT00710606|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65345471|NCT00710606|Progestins|progestins|mesh-ancestor
65345472|NCT00713544|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
65345473|NCT00713544|Etanercept|etanercept|mesh-list
65345474|NCT00713544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65345475|NCT00713544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65345476|NCT00713544|Analgesics|analgesics|mesh-ancestor
65345477|NCT00713544|Sensory System Agents|sensory system agents|mesh-ancestor
65345478|NCT00713544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65345479|NCT00713544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345480|NCT00713544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64485808|NCT01857934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64485809|NCT01857934|Anticonvulsants|anticonvulsants|mesh-ancestor
64485810|NCT01857934|Nootropic Agents|nootropic agents|mesh-ancestor
64485811|NCT01857934|Dermatologic Agents|dermatologic agents|mesh-ancestor
64485812|NCT00862810|Vaccines|vaccines|mesh-list
64485813|NCT00862810|Immunologic Factors|immunologic factors|mesh-ancestor
64485845|NCT01681849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64485846|NCT01681849|Antidepressive Agents|antidepressive agents|mesh-ancestor
64485848|NCT01681849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64485849|NCT01681849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64485850|NCT01681849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485851|NCT00863356|Hemostatics|hemostatics|mesh-list
64485853|NCT00863356|Coagulants|coagulants|mesh-ancestor
64485854|NCT00863356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64485855|NCT00863356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64485856|NCT00863356|Antimetabolites|antimetabolites|mesh-ancestor
64485886|NCT01718353|Antimitotic Agents|antimitotic agents|mesh-ancestor
64485887|NCT01718353|Mitosis Modulators|mitosis modulators|mesh-ancestor
64485888|NCT01718353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485889|NCT01718353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64485890|NCT01718353|Glucocorticoids|glucocorticoids|mesh-ancestor
64485891|NCT01718353|Hormones|hormones|mesh-ancestor
64485892|NCT01718353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64485894|NCT01718353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64485895|NCT01716715|Paclitaxel|paclitaxel|mesh-list
64485896|NCT01716715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64485897|NCT01716715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65345481|NCT00713544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65345482|NCT00713544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65345483|NCT00713544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65345484|NCT00713544|Immunologic Factors|immunologic factors|mesh-ancestor
65345485|NCT00713544|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65345486|NCT00713544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345487|NCT00713544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65345488|NCT00713544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65345489|NCT00713544|Antiviral Agents|antiviral agents|mesh-ancestor
65345490|NCT00713544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65345491|NCT00737126|Folic Acid|folic acid|mesh-list
65345492|NCT00737126|Hematinics|hematinics|mesh-ancestor
65345493|NCT00737126|Vitamin B Complex|vitamin b complex|mesh-ancestor
65345494|NCT00737126|Vitamins|vitamins|mesh-ancestor
65345495|NCT00737126|Micronutrients|micronutrients|mesh-ancestor
65345496|NCT00737126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345497|NCT04063046|Anesthetics|anesthetics|mesh-list
65345498|NCT04063046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64485898|NCT01716715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485899|NCT01716715|Tubulin Modulators|tubulin modulators|mesh-ancestor
64485922|NCT01935947|Irinotecan|irinotecan|mesh-list
64485923|NCT01935947|Pemetrexed|pemetrexed|mesh-list
64485924|NCT01935947|Camptothecin|camptothecin|mesh-list
64485925|NCT01935947|Entinostat|entinostat|mesh-list
64485926|NCT01935947|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
64485927|NCT01935947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64485928|NCT01935947|Antimetabolites|antimetabolites|mesh-ancestor
64485929|NCT01935947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485930|NCT01935947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485931|NCT01935947|Antiviral Agents|antiviral agents|mesh-ancestor
64485932|NCT01935947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64485933|NCT01935947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485934|NCT01935947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64485935|NCT01935947|Immunologic Factors|immunologic factors|mesh-ancestor
64485936|NCT01935947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485937|NCT01935947|Tubulin Modulators|tubulin modulators|mesh-ancestor
64485938|NCT01935947|Antimitotic Agents|antimitotic agents|mesh-ancestor
64485940|NCT01935947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64485941|NCT01935947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64485942|NCT01935947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64485943|NCT01935947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64485944|NCT01935947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64485945|NCT02986321|Budesonide|budesonide|mesh-list
64485946|NCT02986321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64555591|NCT05018988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64555592|NCT04028765|Misoprostol|misoprostol|mesh-list
64555593|NCT04028765|Oxytocin|oxytocin|mesh-list
64555594|NCT04028765|Oxytocics|oxytocics|mesh-ancestor
64555595|NCT04028765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64555596|NCT04028765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555597|NCT04028765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64555598|NCT04028765|Abortifacient Agents|abortifacient agents|mesh-ancestor
64320681|NCT03536065|Narcotics|narcotics|mesh-ancestor
64320683|NCT03536065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485947|NCT02986321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64485948|NCT02986321|Autonomic Agents|autonomic agents|mesh-ancestor
64485949|NCT02986321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64485950|NCT02986321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485951|NCT02986321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65345499|NCT04063046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345500|NCT05529056|Atropine|atropine|mesh-list
65345501|NCT05529056|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65345502|NCT05529056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65345503|NCT05529056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65345504|NCT05529056|Autonomic Agents|autonomic agents|mesh-ancestor
65345505|NCT05529056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65345506|NCT05529056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345507|NCT05529056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65345508|NCT05529056|Respiratory System Agents|respiratory system agents|mesh-ancestor
65345509|NCT05529056|Mydriatics|mydriatics|mesh-ancestor
65345510|NCT05529056|Parasympatholytics|parasympatholytics|mesh-ancestor
65345511|NCT05529056|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65345512|NCT05529056|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65345513|NCT05529056|Cholinergic Agents|cholinergic agents|mesh-ancestor
65345514|NCT05529056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65345515|NCT05529056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345516|NCT00740922|Becaplermin|becaplermin|mesh-list
65345517|NCT00740922|Anticoagulants|anticoagulants|mesh-ancestor
65345518|NCT00740922|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
64737676|NCT00000293|Nefazodone|nefazodone|mesh-list
64485952|NCT02986321|Respiratory System Agents|respiratory system agents|mesh-ancestor
64485953|NCT02986321|Glucocorticoids|glucocorticoids|mesh-ancestor
64485954|NCT02986321|Hormones|hormones|mesh-ancestor
64485962|NCT01951157|Antimetabolites|antimetabolites|mesh-ancestor
64485963|NCT01951157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485964|NCT01951157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485965|NCT01951157|Antiviral Agents|antiviral agents|mesh-ancestor
64485966|NCT01951157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64485967|NCT01951157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485968|NCT01951157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64485969|NCT01951157|Immunologic Factors|immunologic factors|mesh-ancestor
64485970|NCT01951157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485971|NCT01951157|Tubulin Modulators|tubulin modulators|mesh-ancestor
64485972|NCT01951157|Antimitotic Agents|antimitotic agents|mesh-ancestor
64485973|NCT01951157|Mitosis Modulators|mitosis modulators|mesh-ancestor
64485974|NCT01363349|Risperidone|risperidone|mesh-list
64485975|NCT01363349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64485976|NCT01363349|Serotonin Agents|serotonin agents|mesh-ancestor
64485977|NCT01363349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64485978|NCT01363349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485979|NCT01363349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485980|NCT01363349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64485981|NCT01363349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64485982|NCT01363349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64485983|NCT01363349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64485984|NCT01363349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64485985|NCT01363349|Dopamine Agents|dopamine agents|mesh-ancestor
64485986|NCT00818272|Infliximab|infliximab|mesh-list
64485990|NCT00868348|Ketorolac|ketorolac|mesh-list
64485991|NCT00868348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64485992|NCT00868348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64485993|NCT00868348|Analgesics|analgesics|mesh-ancestor
64485994|NCT00868348|Sensory System Agents|sensory system agents|mesh-ancestor
64485995|NCT00868348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64485996|NCT00868348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345519|NCT00740922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65345520|NCT00740922|Growth Substances|growth substances|mesh-ancestor
65345521|NCT00740922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345522|NCT05523440|Bevacizumab|bevacizumab|mesh-list
65345523|NCT05523440|Niraparib|niraparib|mesh-list
65345524|NCT05523440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65345525|NCT05523440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65345526|NCT05523440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65345527|NCT05523440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65345528|NCT05523440|Growth Substances|growth substances|mesh-ancestor
64737689|NCT00001091|Ritonavir|ritonavir|mesh-list
64485997|NCT00868348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64485998|NCT00868348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64485999|NCT00868348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64486000|NCT00868348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486001|NCT00868348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486002|NCT01933919|Fluvoxamine|fluvoxamine|mesh-list
64486003|NCT01933919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486004|NCT01933919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486005|NCT01933919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64486006|NCT01933919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64486007|NCT01933919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64486008|NCT01933919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555599|NCT04028765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64555600|NCT04028765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64555601|NCT02241759|Moxifloxacin|moxifloxacin|mesh-list
64555602|NCT02241759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64486009|NCT01933919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64486010|NCT01933919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64486011|NCT01933919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64486012|NCT01933919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64486013|NCT01933919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64486014|NCT01933919|Serotonin Agents|serotonin agents|mesh-ancestor
64486015|NCT01933919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64486016|NCT01933919|Antidepressive Agents|antidepressive agents|mesh-ancestor
64486029|NCT01933217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486030|NCT01933217|Dopamine Agents|dopamine agents|mesh-ancestor
64486031|NCT01933217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64486032|NCT01949051|Levocabastine|levocabastine|mesh-list
64486033|NCT01949051|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64486034|NCT01949051|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64486035|NCT01949051|Histamine Antagonists|histamine antagonists|mesh-ancestor
64486036|NCT01949051|Histamine Agents|histamine agents|mesh-ancestor
64486037|NCT01949051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64486038|NCT01949051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486039|NCT01949051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486040|NCT01692301|Amlodipine|amlodipine|mesh-list
64486041|NCT01692301|Valsartan|valsartan|mesh-list
64486042|NCT01692301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64486043|NCT01692301|Olmesartan|olmesartan|mesh-list
64486044|NCT01692301|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64486045|NCT01692301|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64486046|NCT01692301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64486047|NCT01692301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64486048|NCT01692301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64486049|NCT01692301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486050|NCT01692301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64486051|NCT01692301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486052|NCT01692301|Vasodilator Agents|vasodilator agents|mesh-ancestor
64486053|NCT01692301|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64486054|NCT01692301|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64486055|NCT01692301|Diuretics|diuretics|mesh-ancestor
65345529|NCT05523440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345530|NCT05523440|Growth Inhibitors|growth inhibitors|mesh-ancestor
65345531|NCT05523440|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65345532|NCT05523440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345533|NCT05523440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345534|NCT00741078|Amlodipine|amlodipine|mesh-list
65345535|NCT00741078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65345536|NCT00741078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65345537|NCT00741078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64349786|NCT02252536|Gabapentin|gabapentin|mesh-list
64486056|NCT01692301|Natriuretic Agents|natriuretic agents|mesh-ancestor
64486057|NCT01692301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64486058|NCT01592773|Memantine|memantine|mesh-list
64486059|NCT01592773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64486060|NCT01592773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64486061|NCT01592773|Dopamine Agents|dopamine agents|mesh-ancestor
64486062|NCT01592773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64486063|NCT01592773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486064|NCT01592773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486070|NCT04124965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486071|NCT01592695|Ethanol|ethanol|mesh-list
64486072|NCT01592695|Bupropion|bupropion|mesh-list
64486073|NCT01592695|Nicotine|nicotine|mesh-list
64486074|NCT01592695|Varenicline|varenicline|mesh-list
64486093|NCT01592695|Dopamine Agents|dopamine agents|mesh-ancestor
64486094|NCT01592695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64486095|NCT01592695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64486096|NCT01592695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486098|NCT01929863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64486099|NCT01929863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486100|NCT01714609|Sorafenib|sorafenib|mesh-list
64486101|NCT01714609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486102|NCT01714609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64486103|NCT01714609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555603|NCT02241759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64555604|NCT02241759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64555605|NCT02241759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64555606|NCT02241759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555607|NCT02241759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555608|NCT02241759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555609|NCT04434144|Azithromycin|azithromycin|mesh-list
64486104|NCT01714609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486105|NCT04553263|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
64486107|NCT04553263|Bupropion|bupropion|mesh-list
64486108|NCT04553263|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64486109|NCT04553263|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64486110|NCT04553263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486111|NCT04553263|Sensory System Agents|sensory system agents|mesh-ancestor
64486112|NCT04553263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64486113|NCT04553263|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64486114|NCT04553263|Antidepressive Agents|antidepressive agents|mesh-ancestor
64486115|NCT04553263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64486116|NCT04553263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64486117|NCT04553263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64486118|NCT04553263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64486119|NCT04553263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486120|NCT04553263|Dopamine Agents|dopamine agents|mesh-ancestor
64486121|NCT04553263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64486122|NCT04553263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64486123|NCT04553263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64486124|NCT04553263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486125|NCT04553263|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65345538|NCT00741078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345539|NCT00741078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65345540|NCT00741078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345541|NCT00741078|Vasodilator Agents|vasodilator agents|mesh-ancestor
65345542|NCT02568800|Cefepime|cefepime|mesh-list
65345543|NCT02568800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65345544|NCT02568800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65345546|NCT00741234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65345547|NCT00741234|Antimetabolites|antimetabolites|mesh-ancestor
64486138|NCT04768075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486139|NCT04768075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486140|NCT04768075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64486141|NCT04768075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64486142|NCT01592383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64486143|NCT01592383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486144|NCT01592383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64486145|NCT01592383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486146|NCT01592383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486147|NCT01929317|Ropinirole|ropinirole|mesh-list
64486148|NCT01929317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64486149|NCT01929317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64486150|NCT01929317|Dopamine Agonists|dopamine agonists|mesh-ancestor
64486151|NCT01929317|Dopamine Agents|dopamine agents|mesh-ancestor
64486152|NCT01929317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64486153|NCT01929317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486154|NCT01929317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486156|NCT01711879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64486157|NCT01711879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64486161|NCT01711879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486162|NCT00869206|Zoledronic Acid|zoledronic acid|mesh-list
64486163|NCT00869206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64486164|NCT00869206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486165|NCT01689649|Topiramate|topiramate|mesh-list
64486166|NCT01689649|Anticonvulsants|anticonvulsants|mesh-ancestor
64486167|NCT01689649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64486168|NCT01689649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486169|NCT01929083|Ibutilide|ibutilide|mesh-list
64486170|NCT01929083|Progesterone|progesterone|mesh-list
64486171|NCT01929083|Progestins|progestins|mesh-ancestor
64486172|NCT01929083|Hormones|hormones|mesh-ancestor
64555610|NCT04434144|Doxycycline|doxycycline|mesh-list
64555611|NCT04434144|Hydroxychloroquine|hydroxychloroquine|mesh-list
64555612|NCT04434144|Ivermectin|ivermectin|mesh-list
64555613|NCT04434144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64555614|NCT04434144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64555615|NCT04434144|Antimalarials|antimalarials|mesh-ancestor
64555616|NCT04434144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64555617|NCT04434144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64486173|NCT01929083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64486174|NCT01929083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486175|NCT01929083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64486176|NCT01688635|Insulin Glargine|insulin glargine|mesh-list
64486177|NCT01688635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64486178|NCT01688635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486179|NCT00891436|Fluticasone|fluticasone|mesh-list
64486181|NCT00891436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64486182|NCT00891436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64486183|NCT00891436|Autonomic Agents|autonomic agents|mesh-ancestor
64486184|NCT00891436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64486185|NCT00891436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486186|NCT00891436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64486187|NCT00891436|Respiratory System Agents|respiratory system agents|mesh-ancestor
64486188|NCT00891436|Dermatologic Agents|dermatologic agents|mesh-ancestor
64486195|NCT01711645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486197|NCT00820534|Penciclovir|penciclovir|mesh-list
65345548|NCT00741234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345549|NCT00741234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65345550|NCT00741234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345551|NCT00713258|Alendronate|alendronate|mesh-list
65345552|NCT00713258|Hormones|hormones|mesh-list
65345553|NCT00713258|Parathyroid Hormone|parathyroid hormone|mesh-list
65345554|NCT00713258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65345555|NCT00713258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345556|NCT00713258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65345557|NCT00713258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65345558|NCT00710034|Nicotine|nicotine|mesh-list
65345559|NCT00710034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65345560|NCT00710034|Autonomic Agents|autonomic agents|mesh-ancestor
65345561|NCT00710034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65345562|NCT00710034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345563|NCT00710034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65345564|NCT00710034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65345565|NCT00710034|Cholinergic Agents|cholinergic agents|mesh-ancestor
65345566|NCT00710034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65345567|NCT00710034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345568|NCT02567942|Propofol|propofol|mesh-list
65345569|NCT02567942|Sevoflurane|sevoflurane|mesh-list
65345570|NCT02567942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64486198|NCT00820534|Antiviral Agents|antiviral agents|mesh-ancestor
64486199|NCT00820534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64486200|NCT01590433|Exenatide|exenatide|mesh-list
64486201|NCT01590433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64486202|NCT01590433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486203|NCT01590433|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64486204|NCT01590433|Incretins|incretins|mesh-ancestor
64486205|NCT01590433|Hormones|hormones|mesh-ancestor
64486206|NCT01590433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64486207|NCT00820612|Indomethacin|indomethacin|mesh-list
64486208|NCT00820612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64486209|NCT00820612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64486210|NCT00820612|Analgesics|analgesics|mesh-ancestor
64486211|NCT00820612|Sensory System Agents|sensory system agents|mesh-ancestor
64486212|NCT00820612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64486213|NCT00820612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486214|NCT00820612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64486215|NCT00820612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64486216|NCT00820612|Gout Suppressants|gout suppressants|mesh-ancestor
64486217|NCT00820612|Tocolytic Agents|tocolytic agents|mesh-ancestor
64486218|NCT00820612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64486219|NCT00820612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64486220|NCT00820612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486221|NCT00820612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486222|NCT01928927|Telmisartan|telmisartan|mesh-list
64486223|NCT01928927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64486224|NCT01928927|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65345571|NCT02567942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65345572|NCT02567942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345573|NCT02567942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65345574|NCT02567942|Anesthetics, General|anesthetics, general|mesh-ancestor
65345575|NCT02567942|Anesthetics|anesthetics|mesh-ancestor
65345576|NCT02567942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65345577|NCT02567942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65345578|NCT00414973|Teriparatide|teriparatide|mesh-list
65345579|NCT00414973|Calcitonin|calcitonin|mesh-list
65345580|NCT00414973|Salmon calcitonin|salmon calcitonin|mesh-list
65345581|NCT00414973|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
65345582|NCT00414973|Katacalcin|katacalcin|mesh-list
65345583|NCT00414973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65345584|NCT00414973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345585|NCT00414973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65345586|NCT00414973|Vasodilator Agents|vasodilator agents|mesh-ancestor
65345587|NCT00423085|Rivastigmine|rivastigmine|mesh-list
65345588|NCT00423085|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65345589|NCT00423085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345590|NCT00423085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345591|NCT00423085|Cholinergic Agents|cholinergic agents|mesh-ancestor
65345592|NCT00423085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65345593|NCT00423085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345594|NCT00423085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64737740|NCT00000317|Risperidone|risperidone|mesh-list
64486225|NCT01928927|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64486226|NCT01928927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486227|NCT00871624|Dexmedetomidine|dexmedetomidine|mesh-list
64486228|NCT00871624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64486229|NCT00871624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64486230|NCT00871624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486234|NCT00871624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64486235|NCT00871624|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64486236|NCT00871624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64555618|NCT04434144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555619|NCT04434144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555620|NCT04434144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64555621|NCT04957914|Insulin Glargine|insulin glargine|mesh-list
64555622|NCT04957914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64555623|NCT04957914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555624|NCT04957758|Varenicline|varenicline|mesh-list
64486246|NCT01710709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64486247|NCT01710709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486248|NCT01710709|Dopamine Agonists|dopamine agonists|mesh-ancestor
64486249|NCT01710709|Dopamine Agents|dopamine agents|mesh-ancestor
64486250|NCT01710709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64486251|NCT01710709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345595|NCT00423085|Protective Agents|protective agents|mesh-ancestor
65345596|NCT00414661|Tofacitinib|tofacitinib|mesh-list
65345597|NCT00414661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65345598|NCT00414661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345599|NCT00414661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345600|NCT01608451|Cholecalciferol|cholecalciferol|mesh-list
65345601|NCT01608451|Vitamin D|vitamin d|mesh-list
65345602|NCT01608451|Progesterone|progesterone|mesh-list
65345603|NCT01608451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65345604|NCT01608451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345605|NCT01608451|Vitamins|vitamins|mesh-ancestor
65345606|NCT01608451|Micronutrients|micronutrients|mesh-ancestor
65345607|NCT01608451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65345608|NCT01608451|Progestins|progestins|mesh-ancestor
65345609|NCT01608451|Hormones|hormones|mesh-ancestor
65345610|NCT01608451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65345611|NCT00405067|Ezetimibe|ezetimibe|mesh-list
65345612|NCT00405067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65345613|NCT00405067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65345614|NCT00405067|Antimetabolites|antimetabolites|mesh-ancestor
64737767|NCT00001133|Ritonavir|ritonavir|mesh-list
64486252|NCT01710709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64486253|NCT01710709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64486254|NCT01710709|Serotonin Agents|serotonin agents|mesh-ancestor
64486255|NCT01710709|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64486256|NCT01710709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64486257|NCT01710709|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64486258|NCT01710709|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64486260|NCT05317546|Anticonvulsants|anticonvulsants|mesh-ancestor
64486261|NCT01709695|Guanfacine|guanfacine|mesh-list
64486262|NCT01709695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64486263|NCT01709695|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64486264|NCT01709695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64486265|NCT01709695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64486266|NCT01709695|Adrenergic Agents|adrenergic agents|mesh-ancestor
64486267|NCT01709695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64486268|NCT01709695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486269|NCT01709695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486270|NCT05236504|Melatonin|melatonin|mesh-list
64486271|NCT05236504|Antioxidants|antioxidants|mesh-ancestor
64486272|NCT05236504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486273|NCT05236504|Protective Agents|protective agents|mesh-ancestor
64486274|NCT05236504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486275|NCT05236504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64486276|NCT01685983|Prednisolone|prednisolone|mesh-list
64486277|NCT01685983|Abiraterone Acetate|abiraterone acetate|mesh-list
64486278|NCT01685983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64486279|NCT01685983|Glucocorticoids|glucocorticoids|mesh-ancestor
64486280|NCT01685983|Hormones|hormones|mesh-ancestor
64486281|NCT01685983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64486282|NCT01685983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486283|NCT01685983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64486284|NCT01685983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486285|NCT01685983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64486286|NCT01685983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345615|NCT00405067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345616|NCT00405067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65345617|NCT00708708|Etanercept|etanercept|mesh-list
65345618|NCT00708708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65345619|NCT00708708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65345620|NCT00708708|Analgesics|analgesics|mesh-ancestor
65345621|NCT00708708|Sensory System Agents|sensory system agents|mesh-ancestor
65345622|NCT00708708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65345623|NCT00708708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345624|NCT00708708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65345625|NCT00708708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65345626|NCT00708708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65345627|NCT00708708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65345628|NCT00708708|Immunologic Factors|immunologic factors|mesh-ancestor
65345629|NCT00404755|Citalopram|citalopram|mesh-list
65345630|NCT00404755|Bupropion|bupropion|mesh-list
65345631|NCT00404755|Imipramine|imipramine|mesh-list
65345632|NCT00404755|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65345633|NCT00404755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65345634|NCT00404755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64737783|NCT00000329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486287|NCT01685983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486288|NCT01685983|Hormone Antagonists|hormone antagonists|mesh-ancestor
64486289|NCT01685983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64486290|NCT02151448|Interferons|interferons|mesh-list
64486291|NCT02151448|Interferon-alpha|interferon-alpha|mesh-list
64486292|NCT02151448|Interferon alpha-2|interferon alpha-2|mesh-list
64486293|NCT02151448|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
64486294|NCT02151448|Celecoxib|celecoxib|mesh-list
64486295|NCT02151448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486296|NCT02151448|Antiviral Agents|antiviral agents|mesh-ancestor
64486297|NCT02151448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64486298|NCT02151448|Immunologic Factors|immunologic factors|mesh-ancestor
64486299|NCT02151448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486315|NCT00875212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486316|NCT00875212|Cariostatic Agents|cariostatic agents|mesh-ancestor
64486317|NCT00875212|Protective Agents|protective agents|mesh-ancestor
64486318|NCT00875836|Buspirone|buspirone|mesh-list
64486319|NCT00875836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64486320|NCT00875836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64555625|NCT04957758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64555626|NCT04957758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64555627|NCT04957758|Cholinergic Agents|cholinergic agents|mesh-ancestor
64555628|NCT04957758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64555629|NCT04957758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486321|NCT00875836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64486322|NCT00875836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486323|NCT00875836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64486324|NCT00875836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64486325|NCT00875836|Serotonin Agents|serotonin agents|mesh-ancestor
64486326|NCT00875836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64486327|NCT00875836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486328|NCT00891982|Clindamycin, tretinoin drug combination|clindamycin, tretinoin drug combination|mesh-list
65345635|NCT00404755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345636|NCT00404755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65345637|NCT00404755|Serotonin Agents|serotonin agents|mesh-ancestor
65345638|NCT00404755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345639|NCT00404755|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65345640|NCT00404755|Antidepressive Agents|antidepressive agents|mesh-ancestor
65345641|NCT00404755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65345642|NCT00404755|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65345643|NCT00404755|Dopamine Agents|dopamine agents|mesh-ancestor
65345644|NCT00404755|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65345645|NCT00404755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65345646|NCT00404755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345647|NCT00404755|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65345648|NCT00404755|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65345649|NCT00404755|Adrenergic Agents|adrenergic agents|mesh-ancestor
65345650|NCT03904381|Fluorouracil|fluorouracil|mesh-list
65345651|NCT03904381|Antimetabolites|antimetabolites|mesh-ancestor
65345652|NCT03904381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345653|NCT03904381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65345654|NCT03904381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486329|NCT00891982|Dermatologic Agents|dermatologic agents|mesh-ancestor
64486330|NCT05312398|Irinotecan|irinotecan|mesh-list
64486331|NCT05312398|Cetuximab|cetuximab|mesh-list
64486332|NCT05312398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64486333|NCT05312398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64486334|NCT05312398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486335|NCT05312398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486336|NCT05312398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486337|NCT05312398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64486338|NCT01685203|Ribavirin|ribavirin|mesh-list
64486339|NCT01685203|Antimetabolites|antimetabolites|mesh-ancestor
64486340|NCT01685203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486341|NCT01685203|Antiviral Agents|antiviral agents|mesh-ancestor
64486342|NCT01685203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64486343|NCT01928771|Benralizumab|benralizumab|mesh-list
64486344|NCT01928771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64486345|NCT01928771|Respiratory System Agents|respiratory system agents|mesh-ancestor
64486346|NCT01589653|Insulin|insulin|mesh-list
64486347|NCT01589653|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64486348|NCT01589653|Insulin Aspart|insulin aspart|mesh-list
64486349|NCT01589653|Insulin, Long-Acting|insulin, long-acting|mesh-list
64486350|NCT01589653|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64486351|NCT01589653|Biphasic Insulins|biphasic insulins|mesh-list
64486352|NCT01589653|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64486353|NCT01589653|Insulin, Isophane|insulin, isophane|mesh-list
64486354|NCT01589653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64486355|NCT01589653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486356|NCT01928615|Trastuzumab|trastuzumab|mesh-list
64486357|NCT01928615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64486358|NCT01928615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64486377|NCT01589497|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65345655|NCT03904381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65345656|NCT03904381|Immunologic Factors|immunologic factors|mesh-ancestor
65345657|NCT03904381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345658|NCT05740566|Topotecan|topotecan|mesh-list
65345659|NCT05740566|Amrubicin|amrubicin|mesh-list
65345660|NCT05740566|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65345661|NCT05740566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65345662|NCT05740566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345663|NCT05740566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345664|NCT05740566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65345665|NCT00737256|Aripiprazole|aripiprazole|mesh-list
65345666|NCT00737256|Perphenazine|perphenazine|mesh-list
65345667|NCT00737256|Antidepressive Agents|antidepressive agents|mesh-ancestor
65345668|NCT00737256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65345669|NCT00737256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65345670|NCT00737256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65345671|NCT00737256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65345672|NCT00737256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345673|NCT00737256|Dopamine Agonists|dopamine agonists|mesh-ancestor
65345674|NCT00737256|Dopamine Agents|dopamine agents|mesh-ancestor
65345675|NCT00737256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65345676|NCT00737256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345677|NCT00737256|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64737825|NCT00001193|Immunologic Factors|immunologic factors|mesh-ancestor
64486378|NCT01589497|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64486379|NCT01589497|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64486380|NCT01589497|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64486381|NCT01589497|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64486382|NCT01589497|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64486383|NCT01589497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64486384|NCT01589497|Antimetabolites|antimetabolites|mesh-ancestor
64486385|NCT01589497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64486387|NCT01928381|Analgesics|analgesics|mesh-ancestor
64486388|NCT01928381|Sensory System Agents|sensory system agents|mesh-ancestor
64486389|NCT01928381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64486390|NCT01928381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486391|NCT01928381|Anticonvulsants|anticonvulsants|mesh-ancestor
64486392|NCT01928381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64486393|NCT01928381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64486394|NCT01928381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486395|NCT01928381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64486396|NCT01928381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64486397|NCT01928381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64486398|NCT01928381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64486399|NCT01928381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64486400|NCT01928225|Vaccines|vaccines|mesh-list
64486401|NCT01928225|Immunologic Factors|immunologic factors|mesh-ancestor
64555630|NCT04957758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555631|NCT04027283|Erythritol|erythritol|mesh-list
64555632|NCT04027283|Vasodilator Agents|vasodilator agents|mesh-ancestor
65345678|NCT00737256|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65345679|NCT00737256|Serotonin Agents|serotonin agents|mesh-ancestor
65345680|NCT00737256|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65345681|NCT00737256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65345682|NCT00737256|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65345683|NCT00737256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65345684|NCT00614614|Vaccines|vaccines|mesh-list
65345685|NCT00614614|Immunologic Factors|immunologic factors|mesh-ancestor
65345686|NCT00614614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345687|NCT00713310|Mesalamine|mesalamine|mesh-list
65345688|NCT00713310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65345689|NCT00713310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65345690|NCT00713310|Analgesics|analgesics|mesh-ancestor
65345691|NCT00713310|Sensory System Agents|sensory system agents|mesh-ancestor
65345692|NCT00713310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65345693|NCT00713310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345694|NCT00713310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65345695|NCT00713310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65345696|NCT05740488|Hormones|hormones|mesh-list
65345697|NCT05740488|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65345698|NCT05740488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65345699|NCT05740488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345700|NCT05742126|Heparin|heparin|mesh-list
65345701|NCT05742126|Calcium heparin|calcium heparin|mesh-list
65345702|NCT05742126|Anticoagulants|anticoagulants|mesh-ancestor
65345703|NCT05742126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65345704|NCT05742126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65345705|NCT05742126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345706|NCT00882856|Bisoprolol|bisoprolol|mesh-list
65345707|NCT00882856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65345708|NCT00882856|Sympatholytics|sympatholytics|mesh-ancestor
65345709|NCT00882856|Autonomic Agents|autonomic agents|mesh-ancestor
64737849|NCT00001865|Daclizumab|daclizumab|mesh-list
64555633|NCT04028141|Ketamine|ketamine|mesh-list
64555634|NCT04028141|Propofol|propofol|mesh-list
64555635|NCT04028141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64486402|NCT01928225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486403|NCT01927757|Etanercept|etanercept|mesh-list
64486404|NCT01927757|Methotrexate|methotrexate|mesh-list
64486405|NCT01927757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64486406|NCT01927757|Abortifacient Agents|abortifacient agents|mesh-ancestor
64486407|NCT01927757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64486408|NCT01927757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345710|NCT00882856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65345711|NCT00882856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345712|NCT00882856|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65345713|NCT00882856|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65345714|NCT00882856|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65345715|NCT00882856|Adrenergic Agents|adrenergic agents|mesh-ancestor
65345716|NCT00882856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65345717|NCT00882856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345718|NCT00880672|Dutasteride|dutasteride|mesh-list
65345719|NCT00880672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65345720|NCT00880672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65345721|NCT00880672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345722|NCT00880672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345723|NCT00880672|Hormone Antagonists|hormone antagonists|mesh-ancestor
65345724|NCT00880672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65345725|NCT00880672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486409|NCT01927757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64486410|NCT01927757|Antimetabolites|antimetabolites|mesh-ancestor
64486411|NCT01927757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486412|NCT01927757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486413|NCT01927757|Dermatologic Agents|dermatologic agents|mesh-ancestor
64486414|NCT01927757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486415|NCT01927757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64486439|NCT01913639|Vitamin B Complex|vitamin b complex|mesh-ancestor
64486440|NCT01913639|Vitamins|vitamins|mesh-ancestor
64486441|NCT01913639|Micronutrients|micronutrients|mesh-ancestor
64486442|NCT01913483|Heparin|heparin|mesh-list
64486443|NCT01913483|Calcium heparin|calcium heparin|mesh-list
64486444|NCT01913483|Bivalirudin|bivalirudin|mesh-list
64486445|NCT01913483|Anticoagulants|anticoagulants|mesh-ancestor
64486446|NCT01913483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64486447|NCT01913483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64486448|NCT01913483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486449|NCT01913483|Antithrombins|antithrombins|mesh-ancestor
64486450|NCT01913483|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64486451|NCT01913483|Protease Inhibitors|protease inhibitors|mesh-ancestor
64486452|NCT01913483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486453|NCT01913405|Factor VIII|factor viii|mesh-list
64486454|NCT01913405|BAX 855|bax 855|mesh-list
64486455|NCT01913405|Coagulants|coagulants|mesh-ancestor
64486456|NCT01927055|Mannitol|mannitol|mesh-list
64486457|NCT01927055|Droxidopa|droxidopa|mesh-list
64486458|NCT01927055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64486459|NCT01927055|Diuretics|diuretics|mesh-ancestor
64486460|NCT01927055|Natriuretic Agents|natriuretic agents|mesh-ancestor
64486461|NCT01927055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486462|NCT01927055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64486463|NCT01927055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64486464|NCT01913327|Risperidone|risperidone|mesh-list
64486465|NCT01913327|Aripiprazole|aripiprazole|mesh-list
64486466|NCT01913327|Modafinil|modafinil|mesh-list
64486467|NCT01913327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64486468|NCT01913327|Serotonin Agents|serotonin agents|mesh-ancestor
64486469|NCT01913327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64486487|NCT01913327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64486488|NCT01912781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64486490|NCT01911845|Antimetabolites|antimetabolites|mesh-ancestor
64486491|NCT01911845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345726|NCT00737724|Efavirenz|efavirenz|mesh-list
65345727|NCT00737724|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65345728|NCT00737724|Isoniazid|isoniazid|mesh-list
65345729|NCT00737724|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65345730|NCT00737724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65345731|NCT00737724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345732|NCT00737724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345733|NCT00737724|Antiviral Agents|antiviral agents|mesh-ancestor
64737895|NCT00001889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64486492|NCT01911845|Antiviral Agents|antiviral agents|mesh-ancestor
64486493|NCT01911845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64486494|NCT01925183|Interferons|interferons|mesh-list
64486495|NCT01925183|Ribavirin|ribavirin|mesh-list
64486496|NCT01925183|Interferon-alpha|interferon-alpha|mesh-list
64486497|NCT01925183|Interferon alpha-2|interferon alpha-2|mesh-list
64486498|NCT01925183|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64486499|NCT01925183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486500|NCT01925183|Antiviral Agents|antiviral agents|mesh-ancestor
64486501|NCT01925183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64486502|NCT01925183|Antimetabolites|antimetabolites|mesh-ancestor
64486503|NCT01925183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486504|NCT01925183|Immunologic Factors|immunologic factors|mesh-ancestor
64486505|NCT01925183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486506|NCT01910519|Vaccines|vaccines|mesh-list
64486507|NCT01910519|Immunologic Factors|immunologic factors|mesh-ancestor
64486508|NCT01910519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555637|NCT04028141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555638|NCT04028141|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64555639|NCT04028141|Anesthetics, General|anesthetics, general|mesh-ancestor
64555640|NCT04028141|Anesthetics|anesthetics|mesh-ancestor
64555641|NCT04028141|Analgesics|analgesics|mesh-ancestor
64555642|NCT04028141|Sensory System Agents|sensory system agents|mesh-ancestor
64555643|NCT04028141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64486509|NCT01910441|Metformin|metformin|mesh-list
64486510|NCT01910441|Glimepiride|glimepiride|mesh-list
64486511|NCT01910441|Vildagliptin|vildagliptin|mesh-list
64486512|NCT01910441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64486513|NCT01910441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486519|NCT01910441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486520|NCT01910441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486522|NCT01923467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64486523|NCT01923467|Autonomic Agents|autonomic agents|mesh-ancestor
64486533|NCT01908803|Ciprofloxacin|ciprofloxacin|mesh-list
64486534|NCT01908803|Dexamethasone|dexamethasone|mesh-list
64486535|NCT01908803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64486536|NCT01908803|Antiemetics|antiemetics|mesh-ancestor
64486537|NCT01908803|Autonomic Agents|autonomic agents|mesh-ancestor
64486538|NCT01908803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64486539|NCT01908803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486540|NCT01908803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64486541|NCT01908803|Glucocorticoids|glucocorticoids|mesh-ancestor
64486543|NCT01908803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64486544|NCT01908803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64486545|NCT01908803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486546|NCT01908803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64486547|NCT01908803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64486548|NCT01908803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64486549|NCT01908803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64486550|NCT01908803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486551|NCT01908803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486552|NCT01908803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64486553|NCT01908803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64486554|NCT01908101|Halichondrin B|halichondrin b|mesh-list
64486555|NCT01908101|Tubulin Modulators|tubulin modulators|mesh-ancestor
64486556|NCT01908101|Antimitotic Agents|antimitotic agents|mesh-ancestor
64486557|NCT01908101|Mitosis Modulators|mitosis modulators|mesh-ancestor
65345734|NCT00737724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65345735|NCT00737724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65345736|NCT00737724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65345737|NCT00737724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65345738|NCT00737724|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65345739|NCT00737724|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65345740|NCT00737724|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65345741|NCT00737724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64486558|NCT01908101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486559|NCT01908101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486560|NCT01588951|Cytarabine|cytarabine|mesh-list
64486561|NCT01588951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64486562|NCT01588951|Antimetabolites|antimetabolites|mesh-ancestor
64486563|NCT01588951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486564|NCT01588951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486565|NCT01588951|Antiviral Agents|antiviral agents|mesh-ancestor
64486566|NCT01588951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64486567|NCT01588951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64486568|NCT01588951|Immunologic Factors|immunologic factors|mesh-ancestor
64486569|NCT01588951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486570|NCT01588405|Treprostinil|treprostinil|mesh-list
64486571|NCT01588405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64486572|NCT01923311|Elvitegravir|elvitegravir|mesh-list
64486573|NCT01923311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64486574|NCT01923311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64486575|NCT01923311|Antiviral Agents|antiviral agents|mesh-ancestor
64486576|NCT01923311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64486577|NCT01923311|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64555644|NCT04028141|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64555645|NCT04028141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64555646|NCT04028141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64555647|NCT04028141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64555648|NCT04028141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555649|NCT03401541|Vitamin D|vitamin d|mesh-list
64555650|NCT03401541|Calcifediol|calcifediol|mesh-list
64555651|NCT03401541|Ergocalciferols|ergocalciferols|mesh-list
64555653|NCT03401541|Micronutrients|micronutrients|mesh-ancestor
64555654|NCT03401541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486578|NCT01923311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486579|NCT01923311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486580|NCT01603615|Botulinum Toxins|botulinum toxins|mesh-list
64486581|NCT01603615|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64486582|NCT01603615|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64486583|NCT01603615|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64486615|NCT01904903|Mitosis Modulators|mitosis modulators|mesh-ancestor
64486616|NCT01904903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486618|NCT01921205|Anticonvulsants|anticonvulsants|mesh-ancestor
64486619|NCT01921205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64486620|NCT01921205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64486621|NCT01921205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64486622|NCT01921205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486623|NCT01920893|Mometasone Furoate|mometasone furoate|mesh-list
64486624|NCT01920893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64486625|NCT01920893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64486626|NCT01920893|Dermatologic Agents|dermatologic agents|mesh-ancestor
64486627|NCT01920893|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64486628|NCT01920893|Immunologic Factors|immunologic factors|mesh-ancestor
64486629|NCT01920893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486630|NCT01709305|Metformin|metformin|mesh-list
64486631|NCT01709305|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64486640|NCT01709305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64486642|NCT01709305|Protease Inhibitors|protease inhibitors|mesh-ancestor
64486643|NCT01709305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724244|NCT00000379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65345742|NCT00737724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65345743|NCT00737724|Antitubercular Agents|antitubercular agents|mesh-ancestor
65345744|NCT00737724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65345745|NCT00737724|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65345746|NCT00737724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65345747|NCT00737724|Antimetabolites|antimetabolites|mesh-ancestor
65345748|NCT00737724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65345749|NCT00880828|Acetaminophen|acetaminophen|mesh-list
65345750|NCT00880828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65345751|NCT00880828|Analgesics|analgesics|mesh-ancestor
65345752|NCT00880828|Sensory System Agents|sensory system agents|mesh-ancestor
65345753|NCT00880828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65345754|NCT00880828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345755|NCT00880828|Antipyretics|antipyretics|mesh-ancestor
65345756|NCT00712920|Azelastine|azelastine|mesh-list
65345757|NCT00712920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65345758|NCT00712920|Autonomic Agents|autonomic agents|mesh-ancestor
65345759|NCT00712920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737912|NCT00001901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64486644|NCT01709305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486645|NCT01709305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64486646|NCT01709305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64486647|NCT01709305|Immunologic Factors|immunologic factors|mesh-ancestor
64486648|NCT01709305|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64486649|NCT01684423|Rivaroxaban|rivaroxaban|mesh-list
64486650|NCT01684423|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64486651|NCT01684423|Antithrombins|antithrombins|mesh-ancestor
64486652|NCT01684423|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64486653|NCT01684423|Protease Inhibitors|protease inhibitors|mesh-ancestor
64486654|NCT01684423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486655|NCT01684423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486656|NCT01684423|Anticoagulants|anticoagulants|mesh-ancestor
64486657|NCT01709227|Furosemide|furosemide|mesh-list
64486658|NCT01709227|Diuretics|diuretics|mesh-ancestor
64486659|NCT01709227|Natriuretic Agents|natriuretic agents|mesh-ancestor
64486660|NCT01709227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486661|NCT01709227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64486662|NCT01709227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64486663|NCT01709227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486664|NCT00879034|Zoledronic Acid|zoledronic acid|mesh-list
64486665|NCT00879034|Pravastatin|pravastatin|mesh-list
64486666|NCT00879034|Lonafarnib|lonafarnib|mesh-list
64555655|NCT03401541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64555656|NCT03401541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64555658|NCT03953261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64486667|NCT00879034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64486668|NCT00879034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486669|NCT00879034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64486670|NCT00879034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64486671|NCT00879034|Antimetabolites|antimetabolites|mesh-ancestor
64486672|NCT00879034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486673|NCT00879034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64486674|NCT00879034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64486675|NCT00879034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486676|NCT04088890|Cyclophosphamide|cyclophosphamide|mesh-list
64486677|NCT04088890|Fludarabine|fludarabine|mesh-list
65345760|NCT00712920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345761|NCT00712920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65345762|NCT00712920|Respiratory System Agents|respiratory system agents|mesh-ancestor
65345763|NCT00712920|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65345764|NCT00712920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345765|NCT00712920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345766|NCT00712920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65345767|NCT00712920|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65345768|NCT00712920|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65345769|NCT00712920|Histamine Antagonists|histamine antagonists|mesh-ancestor
65345770|NCT00712920|Histamine Agents|histamine agents|mesh-ancestor
65345771|NCT00712920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65345772|NCT00874744|Triamcinolone|triamcinolone|mesh-list
65345773|NCT00874744|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65345774|NCT00874744|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65345775|NCT00874744|Bevacizumab|bevacizumab|mesh-list
65345776|NCT00874744|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65345777|NCT00874744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65345778|NCT00874744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65345779|NCT00874744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65345780|NCT00874744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65345781|NCT00874744|Growth Substances|growth substances|mesh-ancestor
65345811|NCT05736744|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65345812|NCT05736744|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65345813|NCT05736744|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65345814|NCT05736744|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65345815|NCT05736744|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65345816|NCT05736744|Cholinergic Agents|cholinergic agents|mesh-ancestor
65345817|NCT05736744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65345818|NCT00920868|Bevacizumab|bevacizumab|mesh-list
65345819|NCT00920868|Capecitabine|capecitabine|mesh-list
65345820|NCT00920868|Oxaliplatin|oxaliplatin|mesh-list
65345821|NCT00920868|Dasatinib|dasatinib|mesh-list
65345822|NCT00920868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65345823|NCT00920868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65345824|NCT00920868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65345825|NCT00920868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65345826|NCT00920868|Growth Substances|growth substances|mesh-ancestor
65345827|NCT00920868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345828|NCT00920868|Growth Inhibitors|growth inhibitors|mesh-ancestor
65345829|NCT00920868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65345830|NCT00920868|Antimetabolites|antimetabolites|mesh-ancestor
65345831|NCT00920868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345832|NCT00920868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65345833|NCT00920868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345834|NCT05741814|Propofol|propofol|mesh-list
65345835|NCT05741814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65345836|NCT05741814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65345837|NCT05741814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345838|NCT05741814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65345839|NCT05741814|Anesthetics, General|anesthetics, general|mesh-ancestor
65345840|NCT05741814|Anesthetics|anesthetics|mesh-ancestor
65345841|NCT04721626|Chlorhexidine|chlorhexidine|mesh-list
64737988|NCT04331327|Mitogens|mitogens|mesh-list
64486678|NCT04088890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64486679|NCT04088890|Immunologic Factors|immunologic factors|mesh-ancestor
64486680|NCT04088890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486681|NCT04088890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64486682|NCT04088890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64486683|NCT04088890|Alkylating Agents|alkylating agents|mesh-ancestor
64486684|NCT04088890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486685|NCT04088890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486689|NCT00879190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64486690|NCT00879190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64486691|NCT00879190|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64486692|NCT00879190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345842|NCT04721626|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65345843|NCT04721626|Povidone-Iodine|povidone-iodine|mesh-list
65345844|NCT04721626|Tetracycline|tetracycline|mesh-list
65345845|NCT04721626|Doxycycline|doxycycline|mesh-list
65345846|NCT04721626|Povidone|povidone|mesh-list
65345847|NCT04721626|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65345848|NCT04721626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65345849|NCT04721626|Disinfectants|disinfectants|mesh-ancestor
65345850|NCT04721626|Dermatologic Agents|dermatologic agents|mesh-ancestor
65345851|NCT04721626|Plasma Substitutes|plasma substitutes|mesh-ancestor
65345852|NCT04721626|Blood Substitutes|blood substitutes|mesh-ancestor
65345853|NCT04721626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65345854|NCT04721626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65345855|NCT04721626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486693|NCT00879190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486694|NCT01903811|Dexamethasone|dexamethasone|mesh-list
64486695|NCT01903811|Dexamethasone acetate|dexamethasone acetate|mesh-list
64486696|NCT01903811|Ichthammol|ichthammol|mesh-list
64486697|NCT01903811|BB 1101|bb 1101|mesh-list
64486698|NCT01903811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64486719|NCT01709149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64486720|NCT01709149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486721|NCT01709149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486722|NCT01709149|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64486723|NCT01709149|Protective Agents|protective agents|mesh-ancestor
64486725|NCT05214196|Povidone|povidone|mesh-list
64486726|NCT05214196|Plasma Substitutes|plasma substitutes|mesh-ancestor
64486727|NCT05214196|Blood Substitutes|blood substitutes|mesh-ancestor
64486728|NCT05214196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64486729|NCT05214196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64486730|NCT05311228|Azithromycin|azithromycin|mesh-list
64486731|NCT05311228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64486732|NCT05311228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64486733|NCT04382014|Curcumin|curcumin|mesh-list
64486734|NCT04382014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64486735|NCT04382014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64486736|NCT04382014|Analgesics|analgesics|mesh-ancestor
64486737|NCT04382014|Sensory System Agents|sensory system agents|mesh-ancestor
64486738|NCT04382014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64486739|NCT04382014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486740|NCT04382014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64486741|NCT04382014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64486742|NCT04382014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486743|NCT04382014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486744|NCT04382014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486745|NCT00892606|Morphine|morphine|mesh-list
64486746|NCT00892606|Methadone|methadone|mesh-list
64486747|NCT00892606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64486748|NCT00892606|Narcotics|narcotics|mesh-ancestor
64486749|NCT00892606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64486750|NCT00892606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486751|NCT00892606|Analgesics|analgesics|mesh-ancestor
64555659|NCT03953261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64555660|NCT03953261|Analgesics|analgesics|mesh-ancestor
64555661|NCT03953261|Sensory System Agents|sensory system agents|mesh-ancestor
64555662|NCT03953261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64320740|NCT02188537|Nelfinavir|nelfinavir|mesh-list
64486764|NCT04416035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486765|NCT04416035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64486766|NCT04416035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64486767|NCT04416035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64486768|NCT04416035|Growth Substances|growth substances|mesh-ancestor
64486769|NCT04416035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486770|NCT04416035|Growth Inhibitors|growth inhibitors|mesh-ancestor
65345856|NCT04721626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345857|NCT04721626|Antimalarials|antimalarials|mesh-ancestor
65345858|NCT04721626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65345859|NCT04721626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65345860|NCT00881140|Mifepristone|mifepristone|mesh-list
65345861|NCT00881140|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65345862|NCT00881140|Abortifacient Agents|abortifacient agents|mesh-ancestor
65345863|NCT00881140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65345864|NCT00881140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345865|NCT00881140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65345866|NCT00881140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65345867|NCT00881140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65345868|NCT00881140|Contraceptive Agents|contraceptive agents|mesh-ancestor
65345869|NCT00881140|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65345870|NCT00881140|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65345871|NCT00881140|Hormone Antagonists|hormone antagonists|mesh-ancestor
65345872|NCT00881140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65345873|NCT00881140|Luteolytic Agents|luteolytic agents|mesh-ancestor
65345874|NCT00881140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65345875|NCT00881140|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65345876|NCT05733078|Vitamins|vitamins|mesh-list
65345877|NCT05733078|Ascorbic Acid|ascorbic acid|mesh-list
65345878|NCT05733078|Micronutrients|micronutrients|mesh-ancestor
65345879|NCT05733078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345880|NCT05733078|Antioxidants|antioxidants|mesh-ancestor
65345881|NCT05733078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345882|NCT05733078|Protective Agents|protective agents|mesh-ancestor
65345883|NCT00874978|Lenalidomide|lenalidomide|mesh-list
65345884|NCT00874978|Immunologic Factors|immunologic factors|mesh-ancestor
65345885|NCT00874978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345886|NCT00874978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65345898|NCT05728632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65345899|NCT05728632|Adrenergic Agents|adrenergic agents|mesh-ancestor
65345900|NCT05728632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65345901|NCT05728632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345902|NCT05728632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345903|NCT05741658|Dapagliflozin|dapagliflozin|mesh-list
65345904|NCT05741658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65345905|NCT05741658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345906|NCT05741658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65345907|NCT05741658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345908|NCT05741502|Olanzapine|olanzapine|mesh-list
65345909|NCT05741502|Risperidone|risperidone|mesh-list
65345910|NCT05741502|Aripiprazole|aripiprazole|mesh-list
65345911|NCT05741502|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65345912|NCT05741502|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65345913|NCT05741502|Ziprasidone|ziprasidone|mesh-list
65345914|NCT05741502|Antipsychotic Agents|antipsychotic agents|mesh-list
65345915|NCT05741502|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65345916|NCT05741502|Clozapine|clozapine|mesh-list
65345917|NCT05741502|Cariprazine|cariprazine|mesh-list
65345918|NCT05741502|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65345919|NCT05741502|Serotonin Agents|serotonin agents|mesh-ancestor
65345920|NCT05741502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65345921|NCT05741502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345922|NCT05741502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345923|NCT05741502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65345924|NCT05741502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65345925|NCT05741502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65345926|NCT05741502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65345927|NCT05741502|Dopamine Agents|dopamine agents|mesh-ancestor
65345928|NCT05741502|Antiemetics|antiemetics|mesh-ancestor
65345929|NCT05741502|Autonomic Agents|autonomic agents|mesh-ancestor
65345930|NCT05741502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65345931|NCT05741502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64486772|NCT04381858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64486774|NCT04381858|Immunologic Factors|immunologic factors|mesh-ancestor
64486775|NCT04381858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486776|NCT01903031|Ritonavir|ritonavir|mesh-list
64486777|NCT01903031|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64486778|NCT01903031|Tenofovir|tenofovir|mesh-list
64486779|NCT01903031|Efavirenz|efavirenz|mesh-list
64486780|NCT01903031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
64486781|NCT01903031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65345932|NCT05741502|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65345933|NCT05741502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65345934|NCT05741502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65345935|NCT05741502|Antidepressive Agents|antidepressive agents|mesh-ancestor
65345936|NCT05741502|Dopamine Agonists|dopamine agonists|mesh-ancestor
65345937|NCT05741502|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65345938|NCT05741502|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65345939|NCT05741502|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65345940|NCT05741502|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65345941|NCT05741502|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65345942|NCT05741502|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65345943|NCT05741502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65345944|NCT05741502|Adrenergic Agents|adrenergic agents|mesh-ancestor
65345945|NCT05741502|GABA Antagonists|gaba antagonists|mesh-ancestor
64486782|NCT01903031|Etonogestrel|etonogestrel|mesh-list
64486783|NCT01903031|NuvaRing|nuvaring|mesh-list
64486784|NCT01903031|Estradiol|estradiol|mesh-list
64486785|NCT01903031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64486786|NCT01903031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64486787|NCT01903031|Protease Inhibitors|protease inhibitors|mesh-ancestor
64486788|NCT01903031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486789|NCT01903031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486790|NCT01903031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64486791|NCT01903031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64486792|NCT01903031|Antiviral Agents|antiviral agents|mesh-ancestor
64486796|NCT01903031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64486797|NCT01903031|Estrogens|estrogens|mesh-ancestor
64486799|NCT01903031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64486800|NCT01903031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486801|NCT01903031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64486802|NCT01903031|Contraceptive Agents|contraceptive agents|mesh-ancestor
64486803|NCT01903031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64486804|NCT01903031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64486805|NCT01903031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64486806|NCT01903031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64486807|NCT01903031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64486808|NCT01903031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64486809|NCT01903031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64486810|NCT01903031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64486811|NCT01903031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64486812|NCT00883168|Fluticasone|fluticasone|mesh-list
64486814|NCT00883168|Azelastine|azelastine|mesh-list
64486815|NCT00883168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64486816|NCT00883168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64486821|NCT00883168|Respiratory System Agents|respiratory system agents|mesh-ancestor
64486822|NCT00883168|Dermatologic Agents|dermatologic agents|mesh-ancestor
64486823|NCT00883168|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64486824|NCT00883168|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64486825|NCT00883168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486826|NCT00883168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486827|NCT00883168|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64486828|NCT00883168|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64486829|NCT00883168|Histamine Antagonists|histamine antagonists|mesh-ancestor
64486830|NCT00883168|Histamine Agents|histamine agents|mesh-ancestor
64486831|NCT00883168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64486832|NCT01616693|Zinc|zinc|mesh-list
64486833|NCT01616693|Vaccines|vaccines|mesh-list
64486834|NCT01616693|Immunologic Factors|immunologic factors|mesh-ancestor
64738098|NCT00000629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65345946|NCT05741502|GABA Agents|gaba agents|mesh-ancestor
65345947|NCT00710424|Nabiximols|nabiximols|mesh-list
65345948|NCT00710424|Analgesics|analgesics|mesh-ancestor
65345949|NCT00710424|Sensory System Agents|sensory system agents|mesh-ancestor
65345950|NCT00710424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65345951|NCT00710424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345952|NCT00612586|Leucovorin|leucovorin|mesh-list
65345953|NCT00612586|Bevacizumab|bevacizumab|mesh-list
65345954|NCT00612586|Fluorouracil|fluorouracil|mesh-list
65345955|NCT00612586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65345956|NCT00612586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65345957|NCT00612586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65345958|NCT00612586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65345959|NCT00612586|Growth Substances|growth substances|mesh-ancestor
65345960|NCT00612586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345961|NCT00612586|Growth Inhibitors|growth inhibitors|mesh-ancestor
65345962|NCT00612586|Antimetabolites|antimetabolites|mesh-ancestor
65345963|NCT00612586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345964|NCT00612586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65345965|NCT00612586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65345966|NCT00612586|Immunologic Factors|immunologic factors|mesh-ancestor
65345967|NCT00612586|Antidotes|antidotes|mesh-ancestor
65345968|NCT00612586|Protective Agents|protective agents|mesh-ancestor
65345969|NCT00612586|Vitamin B Complex|vitamin b complex|mesh-ancestor
65345970|NCT00612586|Vitamins|vitamins|mesh-ancestor
65345971|NCT00612586|Micronutrients|micronutrients|mesh-ancestor
65345972|NCT00883870|Plasma-lyte 148|plasma-lyte 148|mesh-list
64555663|NCT03953261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555664|NCT03953261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64555665|NCT03953261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64555666|NCT03953261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555667|NCT03953261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555668|NCT03953261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555669|NCT02242149|Diacetylrhein|diacetylrhein|mesh-list
64555670|NCT02242149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64555671|NCT03022565|Vorinostat|vorinostat|mesh-list
64486835|NCT01616693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486836|NCT01616693|Trace Elements|trace elements|mesh-ancestor
64486837|NCT01616693|Micronutrients|micronutrients|mesh-ancestor
64486838|NCT00893074|Dronabinol|dronabinol|mesh-list
64486839|NCT00893074|Hallucinogens|hallucinogens|mesh-ancestor
64486840|NCT00893074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486841|NCT00893074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64486842|NCT00893074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64486843|NCT00893074|Analgesics|analgesics|mesh-ancestor
64486844|NCT00893074|Sensory System Agents|sensory system agents|mesh-ancestor
64486845|NCT00893074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64486846|NCT00893074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64486847|NCT00893074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65345973|NCT00883870|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65345974|NCT00883870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65345975|NCT00614380|Amlodipine|amlodipine|mesh-list
65345976|NCT00614380|Telmisartan|telmisartan|mesh-list
65345977|NCT00614380|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
65345978|NCT00614380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65345979|NCT00614380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65345980|NCT00614380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65345981|NCT00614380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65345982|NCT00614380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65345983|NCT00614380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345984|NCT00614380|Vasodilator Agents|vasodilator agents|mesh-ancestor
65345985|NCT00614380|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65345986|NCT00614380|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65345987|NCT00738192|Fentanyl|fentanyl|mesh-list
65345988|NCT00738192|Sufentanil|sufentanil|mesh-list
65345989|NCT00738192|Dsuvia|dsuvia|mesh-list
65345990|NCT00738192|Butorphanol|butorphanol|mesh-list
65345991|NCT00738192|Citric Acid|citric acid|mesh-list
65095782|NCT00511719|Insulin|insulin|mesh-list
65345992|NCT00738192|Sodium Citrate|sodium citrate|mesh-list
65345993|NCT00738192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65345994|NCT00738192|Narcotics|narcotics|mesh-ancestor
65345995|NCT00738192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65345996|NCT00738192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65345997|NCT00738192|Analgesics|analgesics|mesh-ancestor
65345998|NCT00738192|Sensory System Agents|sensory system agents|mesh-ancestor
65345999|NCT00738192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65346000|NCT00738192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65346001|NCT00738192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65346002|NCT00738192|Anesthetics, General|anesthetics, general|mesh-ancestor
65346003|NCT00738192|Anesthetics|anesthetics|mesh-ancestor
64738144|NCT00000659|Zidovudine|zidovudine|mesh-list
64486848|NCT00893074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64486849|NCT00893074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486850|NCT00893074|Hormones|hormones|mesh-ancestor
64486851|NCT00893074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64486852|NCT00885742|Fibrinolysin|fibrinolysin|mesh-list
64486853|NCT00885742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64486854|NCT00885742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64486855|NCT00885742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486856|NCT00887458|Itraconazole|itraconazole|mesh-list
64486857|NCT00887458|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
64486858|NCT00887458|Antifungal Agents|antifungal agents|mesh-ancestor
65346004|NCT00738192|Anticoagulants|anticoagulants|mesh-ancestor
65346005|NCT00738192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65346006|NCT00738192|Chelating Agents|chelating agents|mesh-ancestor
65346007|NCT00738192|Sequestering Agents|sequestering agents|mesh-ancestor
65346008|NCT00738192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346009|NCT00738192|Antitussive Agents|antitussive agents|mesh-ancestor
65346010|NCT00738192|Respiratory System Agents|respiratory system agents|mesh-ancestor
65346011|NCT00738192|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65346012|NCT05500170|Niacinamide|niacinamide|mesh-list
65346014|NCT05500170|Nicotinic Acids|nicotinic acids|mesh-list
65346015|NCT05500170|Vitamins|vitamins|mesh-ancestor
65346016|NCT05500170|Micronutrients|micronutrients|mesh-ancestor
65346017|NCT05500170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346018|NCT05500170|Vitamin B Complex|vitamin b complex|mesh-ancestor
65346019|NCT05500170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65346020|NCT05500170|Antimetabolites|antimetabolites|mesh-ancestor
65346021|NCT05500170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346022|NCT05500170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65346023|NCT05500170|Vasodilator Agents|vasodilator agents|mesh-ancestor
65346024|NCT00884104|Solifenacin Succinate|solifenacin succinate|mesh-list
64738170|NCT00002021|Foscarnet|foscarnet|mesh-list
64486859|NCT00887458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64486860|NCT00887458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64486861|NCT00887458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64486862|NCT00887458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486863|NCT00887458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486864|NCT00887458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64486865|NCT00887458|Hormone Antagonists|hormone antagonists|mesh-ancestor
64486866|NCT00887458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64486867|NCT00887458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486868|NCT00887458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64486869|NCT03397966|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64486870|NCT03397966|Natriuretic Agents|natriuretic agents|mesh-ancestor
64486871|NCT03397966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486872|NCT03216304|Calcium, Dietary|calcium, dietary|mesh-list
64486873|NCT03216304|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64486874|NCT03216304|Calcium|calcium|mesh-list
64486875|NCT03216304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64486876|NCT03216304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486877|NCT03216304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64486878|NCT03216304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64486879|NCT03216304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64486880|NCT03216304|Antimetabolites|antimetabolites|mesh-ancestor
64486881|NCT03216304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486882|NCT03216304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64486904|NCT00888628|Analgesics|analgesics|mesh-ancestor
64486905|NCT00888628|Sensory System Agents|sensory system agents|mesh-ancestor
64486906|NCT00888628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64486907|NCT00888628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486908|NCT00888628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64486909|NCT00888628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64486910|NCT00888628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64555672|NCT03022565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555673|NCT03022565|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65346025|NCT00884104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65346026|NCT00884104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65346027|NCT00884104|Cholinergic Agents|cholinergic agents|mesh-ancestor
65346028|NCT00884104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65346029|NCT00884104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346030|NCT00884104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346031|NCT00884104|Urological Agents|urological agents|mesh-ancestor
65346032|NCT04140214|Carbocysteine|carbocysteine|mesh-list
65346033|NCT04140214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65346034|NCT04140214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65346035|NCT04140214|Expectorants|expectorants|mesh-ancestor
65346036|NCT04140214|Respiratory System Agents|respiratory system agents|mesh-ancestor
65346037|NCT00612508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65346038|NCT00612508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65346039|NCT00612508|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65346040|NCT00612508|Etonogestrel|etonogestrel|mesh-list
65346041|NCT00612508|Desogestrel|desogestrel|mesh-list
65346042|NCT00612508|NuvaRing|nuvaring|mesh-list
65346043|NCT00612508|Estradiol|estradiol|mesh-list
65346044|NCT00612508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65346045|NCT00612508|Estrogens|estrogens|mesh-ancestor
65346046|NCT00612508|Hormones|hormones|mesh-ancestor
64555674|NCT03022565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555675|NCT03022565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555676|NCT03079050|Dexlansoprazole|dexlansoprazole|mesh-list
64486911|NCT00888628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64486912|NCT00888628|Immunologic Factors|immunologic factors|mesh-ancestor
64486913|NCT03837886|Calcium Carbonate|calcium carbonate|mesh-list
64486915|NCT03837886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64486916|NCT03837886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486917|NCT03837886|Antacids|antacids|mesh-ancestor
64486918|NCT03837886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486919|NCT03837886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64486920|NCT03219970|Osimertinib|osimertinib|mesh-list
64486921|NCT03219970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486922|NCT03219970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64486923|NCT03219970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486924|NCT03219970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486925|NCT03175432|Bevacizumab|bevacizumab|mesh-list
64486926|NCT03175432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64486927|NCT03175432|Atezolizumab|atezolizumab|mesh-list
64486928|NCT03175432|Endothelial Growth Factors|endothelial growth factors|mesh-list
64486929|NCT03175432|Antibodies|antibodies|mesh-list
64486930|NCT03175432|Immunoglobulins|immunoglobulins|mesh-list
64486931|NCT03175432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64486932|NCT03175432|Immunoglobulin G|immunoglobulin g|mesh-list
64486933|NCT03175432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486934|NCT03175432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64486935|NCT03175432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64486936|NCT03175432|Growth Substances|growth substances|mesh-ancestor
64486937|NCT03175432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486938|NCT03175432|Growth Inhibitors|growth inhibitors|mesh-ancestor
64486939|NCT03175432|Immunologic Factors|immunologic factors|mesh-ancestor
64486947|NCT03219580|Fluorouracil|fluorouracil|mesh-list
64486948|NCT03219580|Antimetabolites|antimetabolites|mesh-ancestor
64486949|NCT03219580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346047|NCT00612508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65346048|NCT00612508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346049|NCT00612508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65346050|NCT00612508|Contraceptive Agents|contraceptive agents|mesh-ancestor
65346051|NCT00612508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65346052|NCT00612508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65346053|NCT00612508|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65346054|NCT00612508|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65346055|NCT00612508|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65346056|NCT00612508|Progestins|progestins|mesh-ancestor
65346057|NCT00881218|Regadenoson|regadenoson|mesh-list
65346058|NCT00881218|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65346059|NCT00881218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64738193|NCT00000695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64486950|NCT03219580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64486951|NCT03219580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486952|NCT03219580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64486953|NCT03219580|Immunologic Factors|immunologic factors|mesh-ancestor
64486954|NCT03219580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486955|NCT03215446|Anesthetics|anesthetics|mesh-list
64486958|NCT03215446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64486959|NCT03215446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486960|NCT03215446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64486961|NCT03215446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64486962|NCT03215446|Anesthetics, General|anesthetics, general|mesh-ancestor
64486964|NCT03215446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64486965|NCT00896038|Aprepitant|aprepitant|mesh-list
64486966|NCT00896038|Antiemetics|antiemetics|mesh-ancestor
64486967|NCT00896038|Autonomic Agents|autonomic agents|mesh-ancestor
64486968|NCT00896038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64486969|NCT00896038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486970|NCT00896038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64486971|NCT00896038|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64486972|NCT00896038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64486973|NCT00896038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486974|NCT02804074|Antihypertensive Agents|antihypertensive agents|mesh-list
64486975|NCT04381234|Citric Acid|citric acid|mesh-list
64486976|NCT04381234|Sodium Citrate|sodium citrate|mesh-list
64486977|NCT04381234|Dialysis Solutions|dialysis solutions|mesh-list
64486978|NCT04381234|Anticoagulants|anticoagulants|mesh-ancestor
64486979|NCT04381234|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64486980|NCT04381234|Chelating Agents|chelating agents|mesh-ancestor
64486981|NCT04381234|Sequestering Agents|sequestering agents|mesh-ancestor
64486982|NCT04381234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486983|NCT04381234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64555678|NCT03079050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64555679|NCT03079050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64555680|NCT03079050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64555681|NCT03079050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555682|NCT03079050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555683|NCT03834129|Dexmedetomidine|dexmedetomidine|mesh-list
64486985|NCT03215056|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64486986|NCT03215056|Anesthetics, General|anesthetics, general|mesh-ancestor
64486987|NCT03215056|Anesthetics|anesthetics|mesh-ancestor
64486988|NCT03215056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64486989|NCT03215056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486990|NCT01616459|Vaccines|vaccines|mesh-list
64486991|NCT01616459|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65346060|NCT00881218|Purinergic Agonists|purinergic agonists|mesh-ancestor
65346061|NCT00881218|Purinergic Agents|purinergic agents|mesh-ancestor
65346062|NCT00881218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65346063|NCT00881218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346064|NCT00881218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346065|NCT00613834|Lidocaine|lidocaine|mesh-list
65346066|NCT00613834|Anesthetics, Local|anesthetics, local|mesh-ancestor
65346067|NCT00613834|Anesthetics|anesthetics|mesh-ancestor
65346068|NCT00613834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65346069|NCT00613834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346070|NCT00613834|Sensory System Agents|sensory system agents|mesh-ancestor
65346071|NCT00613834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65346072|NCT00613834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65346073|NCT00613834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65346074|NCT00613834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65346075|NCT00613834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65346076|NCT00613834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346077|NCT00875368|Maraviroc|maraviroc|mesh-list
64486992|NCT01616459|Immunologic Factors|immunologic factors|mesh-ancestor
64486993|NCT01616459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486994|NCT03218254|Methylphenidate|methylphenidate|mesh-list
64486995|NCT03218254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64486996|NCT03218254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486997|NCT03218254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64486998|NCT03218254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64486999|NCT03218254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64487000|NCT03218254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487001|NCT03218254|Dopamine Agents|dopamine agents|mesh-ancestor
64487002|NCT03218254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64487003|NCT01919801|Icatibant|icatibant|mesh-list
64487004|NCT01919801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64487005|NCT01919801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64487006|NCT01919801|Analgesics|analgesics|mesh-ancestor
64487007|NCT01919801|Sensory System Agents|sensory system agents|mesh-ancestor
64487019|NCT01919723|Eptifibatide|eptifibatide|mesh-list
64487020|NCT01919723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64487021|NCT01919723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64487022|NCT01919723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64487023|NCT01919723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64487024|NCT01919723|Purinergic Agents|purinergic agents|mesh-ancestor
64487025|NCT01919723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64487026|NCT01919723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487027|NCT01919723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487028|NCT01919489|Insulin Glargine|insulin glargine|mesh-list
64487029|NCT01919489|Liraglutide|liraglutide|mesh-list
64487030|NCT01919489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64487031|NCT01919489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487032|NCT01919489|Incretins|incretins|mesh-ancestor
64487033|NCT01919489|Hormones|hormones|mesh-ancestor
64487034|NCT01919489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64487036|NCT01919411|Clavulanic Acid|clavulanic acid|mesh-list
64487037|NCT01919411|Clavulanic Acids|clavulanic acids|mesh-list
64487042|NCT01919411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65346078|NCT00875368|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65346079|NCT00875368|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65346080|NCT00875368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346081|NCT00875368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65346082|NCT00875368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65346083|NCT00875368|Antiviral Agents|antiviral agents|mesh-ancestor
65346084|NCT00875368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65346085|NCT00875368|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65346086|NCT04012138|Insulin|insulin|mesh-list
64738229|NCT00002033|Zidovudine|zidovudine|mesh-list
64487043|NCT01919411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487045|NCT01901393|Ketorolac|ketorolac|mesh-list
64487046|NCT01901393|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64487047|NCT01901393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64487048|NCT01901393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64487049|NCT01901393|Analgesics|analgesics|mesh-ancestor
64487050|NCT01901393|Sensory System Agents|sensory system agents|mesh-ancestor
64487051|NCT01901393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64487052|NCT01901393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487053|NCT01901393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64487054|NCT01901393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64487055|NCT01901393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64487056|NCT01901393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555684|NCT03834129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64555685|NCT03834129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64555686|NCT03834129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555687|NCT03834129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64555688|NCT03834129|Analgesics|analgesics|mesh-ancestor
64555689|NCT03834129|Sensory System Agents|sensory system agents|mesh-ancestor
64487057|NCT01901393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487058|NCT01890707|Anesthetics|anesthetics|mesh-list
64487059|NCT01890707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64487060|NCT01890707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487061|NCT01890473|Abatacept|abatacept|mesh-list
64487062|NCT01890473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64487063|NCT01890473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487064|NCT01890473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487065|NCT01890473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64487066|NCT01890473|Immunologic Factors|immunologic factors|mesh-ancestor
64487067|NCT01890473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487068|NCT01890473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64487094|NCT01889069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64487096|NCT01889069|Antimitotic Agents|antimitotic agents|mesh-ancestor
64487097|NCT01889069|Mitosis Modulators|mitosis modulators|mesh-ancestor
64487098|NCT00898222|Aspirin|aspirin|mesh-list
64487099|NCT00898222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64487100|NCT00898222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64487101|NCT00898222|Analgesics|analgesics|mesh-ancestor
64487102|NCT00898222|Sensory System Agents|sensory system agents|mesh-ancestor
64487103|NCT00898222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64487104|NCT00898222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487105|NCT00898222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64487106|NCT00898222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64487107|NCT00898222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64487108|NCT00898222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64487110|NCT00898222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64487111|NCT00898222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64487112|NCT00898222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487113|NCT00898222|Antipyretics|antipyretics|mesh-ancestor
64487114|NCT01830556|Cetuximab|cetuximab|mesh-list
64487115|NCT01830556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64487116|NCT01830556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487118|NCT03214354|Alemtuzumab|alemtuzumab|mesh-list
64487119|NCT03214354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64724245|NCT00000379|Serotonin Agents|serotonin agents|mesh-ancestor
65346087|NCT04012138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65346088|NCT04012138|Insulin Aspart|insulin aspart|mesh-list
65346089|NCT04012138|Albuterol|albuterol|mesh-list
65346090|NCT04012138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65346091|NCT04012138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346092|NCT04012138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65346093|NCT04012138|Autonomic Agents|autonomic agents|mesh-ancestor
65346094|NCT04012138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65346095|NCT04012138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65346096|NCT04012138|Respiratory System Agents|respiratory system agents|mesh-ancestor
65346097|NCT04012138|Tocolytic Agents|tocolytic agents|mesh-ancestor
65346098|NCT04012138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65346099|NCT04012138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65346100|NCT04012138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65346101|NCT04012138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65346102|NCT04012138|Adrenergic Agents|adrenergic agents|mesh-ancestor
65346103|NCT04012138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65346104|NCT04012138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346105|NCT03912298|Analgesics, Opioid|analgesics, opioid|mesh-list
65346106|NCT03912298|Narcotics|narcotics|mesh-ancestor
65346107|NCT03912298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65346108|NCT03912298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346109|NCT03912298|Analgesics|analgesics|mesh-ancestor
65346110|NCT03912298|Sensory System Agents|sensory system agents|mesh-ancestor
65346111|NCT03912298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65346113|NCT02543710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346114|NCT00884260|Levonorgestrel|levonorgestrel|mesh-list
65346115|NCT00884260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64487154|NCT03213964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487155|NCT03217474|Ganciclovir|ganciclovir|mesh-list
64487156|NCT03217474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64487157|NCT03217474|Antiviral Agents|antiviral agents|mesh-ancestor
64487158|NCT03217474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64487170|NCT03213886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487171|NCT03213886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64487172|NCT03217084|Fluorides|fluorides|mesh-list
64487173|NCT03217084|Fluorides, Topical|fluorides, topical|mesh-list
64487174|NCT03217084|Cariostatic Agents|cariostatic agents|mesh-ancestor
64487175|NCT03217084|Protective Agents|protective agents|mesh-ancestor
64487179|NCT00899470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64487180|NCT00899470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487181|NCT00899470|Incretins|incretins|mesh-ancestor
64487182|NCT00899470|Hormones|hormones|mesh-ancestor
64487183|NCT00899470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64487184|NCT00899470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64487186|NCT00899470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65346116|NCT00884260|Contraceptive Agents|contraceptive agents|mesh-ancestor
65346117|NCT00884260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65346118|NCT00884260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346119|NCT00884260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65346120|NCT00884260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65346121|NCT00884260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65346122|NCT00881296|Gemcitabine|gemcitabine|mesh-list
65346123|NCT00881296|Carboplatin|carboplatin|mesh-list
64487187|NCT00899470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487189|NCT01738646|Vorinostat|vorinostat|mesh-list
64487190|NCT01738646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64487191|NCT01738646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487192|NCT01738646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64487193|NCT01738646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64555690|NCT03834129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64555691|NCT03834129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64555692|NCT03834129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64555694|NCT03834129|Adrenergic Agents|adrenergic agents|mesh-ancestor
64320770|NCT02188615|Vinorelbine|vinorelbine|mesh-list
64487194|NCT01738646|Growth Substances|growth substances|mesh-ancestor
64487195|NCT01738646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487196|NCT01738646|Growth Inhibitors|growth inhibitors|mesh-ancestor
64487197|NCT01738646|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64487198|NCT01738646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487199|NCT01738646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487201|NCT00904618|Anesthetics, Local|anesthetics, local|mesh-ancestor
64487202|NCT00904618|Anesthetics|anesthetics|mesh-ancestor
64487203|NCT00904618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64487204|NCT00904618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487205|NCT00904618|Sensory System Agents|sensory system agents|mesh-ancestor
64487206|NCT00904618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64487207|NCT00904618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64487208|NCT00904618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64487209|NCT00904618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64487210|NCT00904618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64487211|NCT00904618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487212|NCT01839370|Pramlintide|pramlintide|mesh-list
64487213|NCT01839370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64487214|NCT01839370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487215|NCT00907426|Bimatoprost|bimatoprost|mesh-list
64487216|NCT00907426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64487217|NCT00907426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64487218|NCT01832662|Caffeine|caffeine|mesh-list
64487219|NCT01832662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64487220|NCT01832662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487221|NCT01832662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64487222|NCT01832662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487223|NCT01832662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487224|NCT01832662|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64487245|NCT01832896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64487246|NCT01832896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64487248|NCT01830400|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64487249|NCT01830400|Anticonvulsants|anticonvulsants|mesh-ancestor
64487250|NCT01830400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64487251|NCT01830400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64487252|NCT01830400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64487253|NCT01830400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487254|NCT01830478|Rituximab|rituximab|mesh-list
64487255|NCT01830478|Lenalidomide|lenalidomide|mesh-list
64487256|NCT01830478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64487257|NCT01830478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487259|NCT01830478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487260|NCT01830478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64487261|NCT01830478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65346124|NCT00881296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346125|NCT00881296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65346126|NCT00881296|Antimetabolites|antimetabolites|mesh-ancestor
65346127|NCT00881296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346128|NCT00881296|Antiviral Agents|antiviral agents|mesh-ancestor
65346129|NCT00881296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65346130|NCT00881296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65346131|NCT00881296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65346132|NCT00881296|Immunologic Factors|immunologic factors|mesh-ancestor
65346133|NCT00881296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346134|NCT00613366|Misoprostol|misoprostol|mesh-list
65346135|NCT00613366|Magnesium Oxide|magnesium oxide|mesh-list
65346136|NCT00613366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65346137|NCT00613366|Abortifacient Agents|abortifacient agents|mesh-ancestor
65346138|NCT00613366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65346139|NCT00613366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346140|NCT00613366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65346141|NCT00613366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65346142|NCT00613366|Oxytocics|oxytocics|mesh-ancestor
65346143|NCT00613366|Antacids|antacids|mesh-ancestor
64738269|NCT00002045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487262|NCT01830478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64487264|NCT01830478|Growth Inhibitors|growth inhibitors|mesh-ancestor
64487265|NCT01838200|Isoniazid|isoniazid|mesh-list
64487266|NCT01838200|Ipilimumab|ipilimumab|mesh-list
64487269|NCT01838200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487270|NCT01838200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64487271|NCT01838200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487272|NCT01838200|Antitubercular Agents|antitubercular agents|mesh-ancestor
64487273|NCT01838200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64487274|NCT01838200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64487275|NCT01838200|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64487276|NCT01838200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64555695|NCT03834129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64555696|NCT03834129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555697|NCT05001204|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
64555698|NCT05001204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64555699|NCT05001204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555701|NCT03022409|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64555702|NCT03022409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555703|NCT03022409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555704|NCT03022409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555705|NCT03833895|Phenylephrine|phenylephrine|mesh-list
64555706|NCT03833895|Oxymetazoline|oxymetazoline|mesh-list
64555707|NCT03833895|Norepinephrine|norepinephrine|mesh-list
64555708|NCT03833895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64555709|NCT03833895|Mydriatics|mydriatics|mesh-ancestor
64555710|NCT03833895|Autonomic Agents|autonomic agents|mesh-ancestor
64555711|NCT03833895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64555712|NCT03833895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555713|NCT03833895|Sympathomimetics|sympathomimetics|mesh-ancestor
64555714|NCT03833895|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64555715|NCT03833895|Nasal Decongestants|nasal decongestants|mesh-ancestor
64320777|NCT02188771|Hyaluronic Acid|hyaluronic acid|mesh-list
65346144|NCT00613366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346146|NCT00612352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65346147|NCT00612352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65346148|NCT00612352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65346149|NCT00612352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346150|NCT00884416|Sorafenib|sorafenib|mesh-list
65346151|NCT00884416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346152|NCT00884416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65346153|NCT00884416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738289|NCT00002057|Antifungal Agents|antifungal agents|mesh-ancestor
64487277|NCT01838200|Antimetabolites|antimetabolites|mesh-ancestor
64487278|NCT01838200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64487279|NCT01838200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64487295|NCT01720108|Protease Inhibitors|protease inhibitors|mesh-ancestor
64487296|NCT01720108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487297|NCT01720108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487298|NCT01720108|Anticoagulants|anticoagulants|mesh-ancestor
64487299|NCT04380220|Protein C|protein c|mesh-list
64487300|NCT04380220|Antithrombins|antithrombins|mesh-list
64487301|NCT04380220|Protein S|protein s|mesh-list
64487302|NCT04380220|Factor VIII|factor viii|mesh-list
64487303|NCT04380220|Complement C3|complement c3|mesh-list
64487304|NCT04380220|Coagulants|coagulants|mesh-ancestor
64487305|NCT04380220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64487306|NCT04380220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487307|NCT04380220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64487308|NCT04380220|Protease Inhibitors|protease inhibitors|mesh-ancestor
64487309|NCT04380220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487310|NCT04380220|Anticoagulants|anticoagulants|mesh-ancestor
64487311|NCT04380220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64487312|NCT04380220|Immunologic Factors|immunologic factors|mesh-ancestor
64487313|NCT04380220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487314|NCT01671813|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64487315|NCT01671813|Immunoconjugates|immunoconjugates|mesh-list
64487316|NCT01671813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64487317|NCT01671813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487318|NCT01671813|Immunologic Factors|immunologic factors|mesh-ancestor
64487319|NCT01671813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487320|NCT01671891|Capecitabine|capecitabine|mesh-list
64487321|NCT01671891|Oxaliplatin|oxaliplatin|mesh-list
64487322|NCT01671891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64487323|NCT01671891|Antimetabolites|antimetabolites|mesh-ancestor
64555716|NCT03833895|Respiratory System Agents|respiratory system agents|mesh-ancestor
64555717|NCT03833895|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64555718|NCT03833895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64555719|NCT03833895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64555720|NCT03833895|Adrenergic Agents|adrenergic agents|mesh-ancestor
64555721|NCT03833895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64555722|NCT03833895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487324|NCT01671891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487325|NCT01671891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487336|NCT04405323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64487337|NCT04405323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64487338|NCT04405323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487339|NCT04405323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487340|NCT04405323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64487362|NCT00911326|Anticoagulants|anticoagulants|mesh-ancestor
64487363|NCT00911326|Plasma Substitutes|plasma substitutes|mesh-ancestor
64487364|NCT00911326|Blood Substitutes|blood substitutes|mesh-ancestor
64487365|NCT00911326|Chelating Agents|chelating agents|mesh-ancestor
64487366|NCT00911326|Sequestering Agents|sequestering agents|mesh-ancestor
64487367|NCT00911326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487368|NCT00911326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64487369|NCT01833676|Sevoflurane|sevoflurane|mesh-list
65346154|NCT00884416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346155|NCT00884494|Insulin|insulin|mesh-list
65346156|NCT00884494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65346157|NCT00884494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346158|NCT00881686|Adenosine|adenosine|mesh-list
65346159|NCT00881686|Analgesics|analgesics|mesh-ancestor
65346160|NCT00881686|Sensory System Agents|sensory system agents|mesh-ancestor
65346161|NCT00881686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65346162|NCT00881686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346163|NCT00881686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64487370|NCT01833676|Desflurane|desflurane|mesh-list
64487371|NCT01833676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64487372|NCT01833676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64487373|NCT01833676|Anesthetics, General|anesthetics, general|mesh-ancestor
64487374|NCT01833676|Anesthetics|anesthetics|mesh-ancestor
64487375|NCT01833676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64487376|NCT01833676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487377|NCT04380376|Melphalan|melphalan|mesh-list
64487378|NCT04380376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64487379|NCT04380376|Alkylating Agents|alkylating agents|mesh-ancestor
64487380|NCT04380376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487381|NCT04380376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487382|NCT04380376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64487383|NCT04380376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64487384|NCT04380376|Immunologic Factors|immunologic factors|mesh-ancestor
64487385|NCT04380376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487386|NCT04380298|Ketorolac|ketorolac|mesh-list
64487387|NCT04380298|Epinephrine|epinephrine|mesh-list
64487388|NCT04380298|Ropivacaine|ropivacaine|mesh-list
64487389|NCT04380298|Anesthetics, Local|anesthetics, local|mesh-ancestor
64487390|NCT04380298|Anesthetics|anesthetics|mesh-ancestor
64487391|NCT04380298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64487392|NCT04380298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487393|NCT04380298|Sensory System Agents|sensory system agents|mesh-ancestor
64487399|NCT04380298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487400|NCT04380298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64487401|NCT04380298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64487402|NCT04380298|Autonomic Agents|autonomic agents|mesh-ancestor
64487403|NCT04380298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64487404|NCT04380298|Respiratory System Agents|respiratory system agents|mesh-ancestor
64487405|NCT04380298|Mydriatics|mydriatics|mesh-ancestor
64487406|NCT04380298|Sympathomimetics|sympathomimetics|mesh-ancestor
64487407|NCT04380298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64487409|NCT04380298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64555723|NCT03833895|Protective Agents|protective agents|mesh-ancestor
64511897|NCT04939597|Memantine|memantine|mesh-list
64555724|NCT02242227|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64555725|NCT02242227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64555726|NCT02242227|Autonomic Agents|autonomic agents|mesh-ancestor
64555727|NCT02242227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64555728|NCT02242227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487410|NCT04380298|Analgesics|analgesics|mesh-ancestor
64487411|NCT04380298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64487412|NCT04380298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64487414|NCT04380298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487415|NCT04164849|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64487416|NCT04164849|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64487417|NCT04164849|Dermatologic Agents|dermatologic agents|mesh-ancestor
64487418|NCT05384691|Luspatercept|luspatercept|mesh-list
64487419|NCT05384691|Hematinics|hematinics|mesh-ancestor
64487420|NCT03210610|Colchicine|colchicine|mesh-list
64487421|NCT03210610|Gout Suppressants|gout suppressants|mesh-ancestor
64487422|NCT03210610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64487423|NCT03210610|Tubulin Modulators|tubulin modulators|mesh-ancestor
64487424|NCT03210610|Antimitotic Agents|antimitotic agents|mesh-ancestor
64487425|NCT03210610|Mitosis Modulators|mitosis modulators|mesh-ancestor
64487426|NCT03210610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346164|NCT00881686|Vasodilator Agents|vasodilator agents|mesh-ancestor
65346165|NCT00881686|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65346166|NCT00881686|Purinergic Agonists|purinergic agonists|mesh-ancestor
65346167|NCT00881686|Purinergic Agents|purinergic agents|mesh-ancestor
65346168|NCT00881686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65346169|NCT00881686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346170|NCT00885508|Lenalidomide|lenalidomide|mesh-list
65346171|NCT00885508|Immunologic Factors|immunologic factors|mesh-ancestor
65346172|NCT00885508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346173|NCT00885508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64738306|NCT00002303|Epoetin Alfa|epoetin alfa|mesh-list
64487427|NCT03210610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487428|NCT03152955|Sufentanil|sufentanil|mesh-list
64487429|NCT03152955|Ketamine|ketamine|mesh-list
64487430|NCT03152955|Ondansetron|ondansetron|mesh-list
64487431|NCT03152955|Analgesics|analgesics|mesh-ancestor
64487432|NCT03152955|Sensory System Agents|sensory system agents|mesh-ancestor
64487433|NCT03152955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64487434|NCT03152955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487435|NCT03152955|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64487436|NCT03152955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64487437|NCT03152955|Anesthetics, General|anesthetics, general|mesh-ancestor
64487438|NCT03152955|Anesthetics|anesthetics|mesh-ancestor
64487439|NCT03152955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64487440|NCT03152955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64487441|NCT03152955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64487442|NCT03152955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64487443|NCT03152955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487444|NCT03152955|Antiemetics|antiemetics|mesh-ancestor
64487445|NCT03152955|Autonomic Agents|autonomic agents|mesh-ancestor
64487446|NCT03152955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64487447|NCT03152955|Antipruritics|antipruritics|mesh-ancestor
64487448|NCT03152955|Dermatologic Agents|dermatologic agents|mesh-ancestor
64487449|NCT03152955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64487450|NCT03152955|Serotonin Agents|serotonin agents|mesh-ancestor
64487451|NCT03152955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64487452|NCT03152955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64487453|NCT03152955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64487454|NCT03152955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64487455|NCT03152955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64487456|NCT03152955|Narcotics|narcotics|mesh-ancestor
64487457|NCT03152955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64487458|NCT01676493|Codeine|codeine|mesh-list
64487459|NCT01676493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64487460|NCT01676493|Narcotics|narcotics|mesh-ancestor
64487461|NCT01676493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64487462|NCT01676493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487463|NCT01676493|Analgesics|analgesics|mesh-ancestor
64487464|NCT01676493|Sensory System Agents|sensory system agents|mesh-ancestor
64487465|NCT01676493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64487466|NCT01676493|Antitussive Agents|antitussive agents|mesh-ancestor
64487477|NCT03210532|Amlodipine|amlodipine|mesh-list
64487478|NCT03210532|Telmisartan|telmisartan|mesh-list
64487479|NCT03210532|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
64487480|NCT03210532|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64487481|NCT03210532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64487482|NCT03210532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64487483|NCT03210532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64555729|NCT02242227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64555730|NCT02242227|Respiratory System Agents|respiratory system agents|mesh-ancestor
64555731|NCT02242227|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64555732|NCT02242227|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64555733|NCT02242227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64555734|NCT02242227|Adrenergic Agents|adrenergic agents|mesh-ancestor
64555735|NCT02242227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65346174|NCT00885508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65346175|NCT00885508|Growth Substances|growth substances|mesh-ancestor
65346176|NCT00885508|Growth Inhibitors|growth inhibitors|mesh-ancestor
65346177|NCT00885508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346178|NCT02543086|Piperaquine|piperaquine|mesh-list
65346179|NCT02543086|Antimalarials|antimalarials|mesh-ancestor
65346180|NCT02543086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65346181|NCT02543086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65346182|NCT02543086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64555736|NCT02242227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555738|NCT03950609|Lenvatinib|lenvatinib|mesh-list
64555739|NCT03950609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555740|NCT03950609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64555741|NCT03950609|Immunologic Factors|immunologic factors|mesh-ancestor
64555742|NCT03950609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555743|NCT03950609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64555744|NCT03950609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320808|NCT04270747|Growth Substances|growth substances|mesh-ancestor
64487486|NCT03210532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487488|NCT03210532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64487489|NCT03210532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64487490|NCT03210532|Antimetabolites|antimetabolites|mesh-ancestor
64487491|NCT03210532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64487492|NCT03210532|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64487493|NCT03210532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487494|NCT03210532|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64487495|NCT03210532|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64487496|NCT03152565|Avelumab|avelumab|mesh-list
64487497|NCT03152565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64487498|NCT03152565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487499|NCT03210064|Fluorouracil|fluorouracil|mesh-list
64487500|NCT03210064|Apatinib|apatinib|mesh-list
64487501|NCT03210064|Antimetabolites|antimetabolites|mesh-ancestor
64487502|NCT03210064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487503|NCT03210064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64487504|NCT03210064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487505|NCT03210064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64487506|NCT03210064|Immunologic Factors|immunologic factors|mesh-ancestor
64487507|NCT03210064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487508|NCT03210064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64487509|NCT03210064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487510|NCT03215524|Thalidomide|thalidomide|mesh-list
64487511|NCT03215524|Dexamethasone|dexamethasone|mesh-list
64487512|NCT03215524|Dexamethasone acetate|dexamethasone acetate|mesh-list
64487513|NCT03215524|Cyclophosphamide|cyclophosphamide|mesh-list
64487514|NCT03215524|Daratumumab|daratumumab|mesh-list
64487515|NCT03215524|Pomalidomide|pomalidomide|mesh-list
64487516|NCT03215524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64487517|NCT03215524|BB 1101|bb 1101|mesh-list
64487518|NCT03215524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64487519|NCT03215524|Immunologic Factors|immunologic factors|mesh-ancestor
64487520|NCT03215524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487521|NCT03215524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64487522|NCT03215524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64487523|NCT03215524|Alkylating Agents|alkylating agents|mesh-ancestor
64555745|NCT03950609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555746|NCT05000892|Paclitaxel|paclitaxel|mesh-list
64555747|NCT05000892|Carboplatin|carboplatin|mesh-list
64555748|NCT05000892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64555749|NCT05000892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555750|NCT05000892|Tubulin Modulators|tubulin modulators|mesh-ancestor
64555751|NCT05000892|Antimitotic Agents|antimitotic agents|mesh-ancestor
64555752|NCT05000892|Mitosis Modulators|mitosis modulators|mesh-ancestor
64555753|NCT05000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320825|NCT02562716|Mitosis Modulators|mitosis modulators|mesh-ancestor
64487524|NCT03215524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487525|NCT03215524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346183|NCT00885586|Gabapentin|gabapentin|mesh-list
65346184|NCT00885586|Analgesics|analgesics|mesh-ancestor
65346185|NCT00885586|Sensory System Agents|sensory system agents|mesh-ancestor
65346186|NCT00885586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65346187|NCT00885586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346188|NCT00885586|Anticonvulsants|anticonvulsants|mesh-ancestor
65346189|NCT00885586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65346190|NCT00885586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65346191|NCT00885586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65346192|NCT00885586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65346193|NCT00885586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65346194|NCT00885586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64487526|NCT03215524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64487527|NCT03215524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64487528|NCT03215524|Antiemetics|antiemetics|mesh-ancestor
64487529|NCT03215524|Autonomic Agents|autonomic agents|mesh-ancestor
64487540|NCT03215524|Growth Substances|growth substances|mesh-ancestor
64487541|NCT03215524|Growth Inhibitors|growth inhibitors|mesh-ancestor
64487542|NCT03215524|Leprostatic Agents|leprostatic agents|mesh-ancestor
64487543|NCT03215524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64487544|NCT03215524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64487545|NCT05372991|Atropine|atropine|mesh-list
64487546|NCT05372991|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64487547|NCT05372991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64487548|NCT05372991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64487549|NCT05372991|Autonomic Agents|autonomic agents|mesh-ancestor
64487550|NCT05372991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64487551|NCT05372991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487552|NCT05372991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64487553|NCT05372991|Respiratory System Agents|respiratory system agents|mesh-ancestor
64487554|NCT05372991|Mydriatics|mydriatics|mesh-ancestor
64487555|NCT05372991|Parasympatholytics|parasympatholytics|mesh-ancestor
64487560|NCT05372991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487561|NCT01672593|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64487562|NCT01672593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64487563|NCT03594435|Ibudilast|ibudilast|mesh-list
64487564|NCT03594435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64487565|NCT03594435|Autonomic Agents|autonomic agents|mesh-ancestor
64487566|NCT03594435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64487567|NCT03594435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487568|NCT03594435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64487569|NCT03594435|Respiratory System Agents|respiratory system agents|mesh-ancestor
64487570|NCT03594435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64487571|NCT03594435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487572|NCT03594435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487573|NCT03594435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64487574|NCT03594435|Vasodilator Agents|vasodilator agents|mesh-ancestor
64487576|NCT01722448|Lipotropic Agents|lipotropic agents|mesh-ancestor
64487577|NCT01722448|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64487578|NCT01722448|Antimetabolites|antimetabolites|mesh-ancestor
64487579|NCT01722448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487580|NCT01722448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64487581|NCT01722448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64487582|NCT01722448|Nootropic Agents|nootropic agents|mesh-ancestor
64487583|NCT01834768|Eplerenone|eplerenone|mesh-list
64487584|NCT01834768|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64487585|NCT01834768|Hormone Antagonists|hormone antagonists|mesh-ancestor
64487586|NCT01834768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64555754|NCT02703623|Prednisone|prednisone|mesh-list
64555755|NCT02703623|Cortisone|cortisone|mesh-list
64555756|NCT02703623|Carboplatin|carboplatin|mesh-list
64555757|NCT02703623|Ipilimumab|ipilimumab|mesh-list
64487587|NCT01834768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487588|NCT01834768|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65346195|NCT00885586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65346196|NCT00885586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346197|NCT00885586|Antimanic Agents|antimanic agents|mesh-ancestor
65346198|NCT02542930|Thymalfasin|thymalfasin|mesh-list
65346199|NCT02542930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65346200|NCT02542930|Immunologic Factors|immunologic factors|mesh-ancestor
65346201|NCT02542930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346202|NCT00881764|Anesthetics|anesthetics|mesh-list
65346203|NCT00881764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65346204|NCT00881764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346205|NCT04038034|Coenzyme Q10|coenzyme q10|mesh-list
65346206|NCT04038034|Vitamins|vitamins|mesh-ancestor
64487589|NCT01834768|Diuretics|diuretics|mesh-ancestor
64487590|NCT01834768|Natriuretic Agents|natriuretic agents|mesh-ancestor
64487591|NCT01834768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64487592|NCT01672671|Paclitaxel|paclitaxel|mesh-list
64487619|NCT01835236|Paclitaxel|paclitaxel|mesh-list
64487620|NCT01835236|Vinorelbine|vinorelbine|mesh-list
64487621|NCT01835236|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64487622|NCT01835236|Trastuzumab|trastuzumab|mesh-list
64487623|NCT01835236|Pertuzumab|pertuzumab|mesh-list
64487624|NCT01835236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64487625|NCT01835236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487626|NCT01835236|Tubulin Modulators|tubulin modulators|mesh-ancestor
64487627|NCT01835236|Antimitotic Agents|antimitotic agents|mesh-ancestor
64487628|NCT01835236|Mitosis Modulators|mitosis modulators|mesh-ancestor
64487629|NCT01835236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487630|NCT01835236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64487631|NCT03152409|Aspirin|aspirin|mesh-list
64487632|NCT03152409|Salicylic Acid|salicylic acid|mesh-list
64487633|NCT03152409|Salicylates|salicylates|mesh-list
64487634|NCT03152409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64487635|NCT03152409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64487636|NCT03152409|Analgesics|analgesics|mesh-ancestor
64487637|NCT03152409|Sensory System Agents|sensory system agents|mesh-ancestor
64487638|NCT03152409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64487639|NCT03152409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487640|NCT03152409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64487659|NCT01830322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64487660|NCT01830322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487661|NCT01830322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64487662|NCT01830322|Immunologic Factors|immunologic factors|mesh-ancestor
64487663|NCT01830322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487664|NCT01835314|Stiripentol|stiripentol|mesh-list
64487665|NCT01835314|Anticonvulsants|anticonvulsants|mesh-ancestor
64487666|NCT01725802|Levodopa|levodopa|mesh-list
64487667|NCT01725802|Carbidopa|carbidopa|mesh-list
64487668|NCT01725802|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64487669|NCT01725802|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64487673|NCT01725802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487674|NCT01725802|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64487676|NCT01706198|Fluticasone|fluticasone|mesh-list
64487678|NCT01706198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64487679|NCT01706198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64487680|NCT01706198|Autonomic Agents|autonomic agents|mesh-ancestor
64487681|NCT01706198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64487682|NCT01706198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487683|NCT01706198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64487684|NCT01706198|Respiratory System Agents|respiratory system agents|mesh-ancestor
64487685|NCT01706198|Dermatologic Agents|dermatologic agents|mesh-ancestor
64487686|NCT01706198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64487687|NCT04378972|Vitamin D|vitamin d|mesh-list
64487688|NCT04378972|Cholecalciferol|cholecalciferol|mesh-list
64487689|NCT04378972|Curcumin|curcumin|mesh-list
64487690|NCT04378972|Tramiprosate|tramiprosate|mesh-list
64487691|NCT04378972|Vitamins|vitamins|mesh-ancestor
64487692|NCT04378972|Micronutrients|micronutrients|mesh-ancestor
65346207|NCT04038034|Micronutrients|micronutrients|mesh-ancestor
65346208|NCT04038034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346209|NCT04037878|Tramadol|tramadol|mesh-list
65346210|NCT04037878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65346211|NCT04037878|Narcotics|narcotics|mesh-ancestor
65346212|NCT04037878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65346213|NCT04037878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346214|NCT04037878|Analgesics|analgesics|mesh-ancestor
65346215|NCT04037878|Sensory System Agents|sensory system agents|mesh-ancestor
65346216|NCT04037878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65346217|NCT02542852|Ritonavir|ritonavir|mesh-list
65346218|NCT02542852|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65346219|NCT02542852|Dolutegravir|dolutegravir|mesh-list
65346220|NCT02542852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65346221|NCT02542852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65346223|NCT02542852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65346224|NCT02542852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346225|NCT02542852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65346226|NCT02542852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65346227|NCT02542852|Antiviral Agents|antiviral agents|mesh-ancestor
65346265|NCT00885820|Tacrolimus|tacrolimus|mesh-list
65346266|NCT00885820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65346267|NCT00885820|Glucocorticoids|glucocorticoids|mesh-ancestor
65346268|NCT00885820|Hormones|hormones|mesh-ancestor
65346269|NCT00885820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65346270|NCT00885820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346271|NCT00885820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65346272|NCT00885820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346273|NCT00885820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65346274|NCT00885820|Immunologic Factors|immunologic factors|mesh-ancestor
65346275|NCT00885820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65346276|NCT00885820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65346277|NCT00885820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346278|NCT00885820|Antiemetics|antiemetics|mesh-ancestor
65346279|NCT00885820|Autonomic Agents|autonomic agents|mesh-ancestor
65346280|NCT00885820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65346281|NCT00885820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65346282|NCT00885820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65346283|NCT00885820|Protective Agents|protective agents|mesh-ancestor
65346321|NCT00810381|Nitroglycerin|nitroglycerin|mesh-list
65346322|NCT00810381|Vasodilator Agents|vasodilator agents|mesh-ancestor
65346323|NCT00810381|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65346324|NCT00810381|Diuretics|diuretics|mesh-ancestor
65346325|NCT00810381|Natriuretic Agents|natriuretic agents|mesh-ancestor
65346326|NCT00810381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346327|NCT00810381|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65346328|NCT00810381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346329|NCT00810381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65346330|NCT00800319|ALKS-33|alks-33|mesh-list
65346331|NCT00800319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65346332|NCT00800319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346333|NCT00800319|Sensory System Agents|sensory system agents|mesh-ancestor
65346334|NCT00800319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65346335|NCT00813501|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65346336|NCT00813501|Immunologic Factors|immunologic factors|mesh-ancestor
65346337|NCT00813501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346338|NCT00800475|Gemfibrozil|gemfibrozil|mesh-list
65346339|NCT00800475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65346340|NCT00800475|Antimetabolites|antimetabolites|mesh-ancestor
65346341|NCT00800475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346342|NCT00800475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65346343|NCT00800475|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65346344|NCT00800475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65346345|NCT00800475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65346346|NCT00810849|Prednisolone|prednisolone|mesh-list
65346347|NCT00810849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65346348|NCT00810849|Glucocorticoids|glucocorticoids|mesh-ancestor
65346349|NCT00810849|Hormones|hormones|mesh-ancestor
65346354|NCT00811005|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
65346366|NCT00813735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65346367|NCT00813735|Serotonin Agents|serotonin agents|mesh-ancestor
65346368|NCT00813735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096165|NCT01244984|Fluticasone|fluticasone|mesh-list
65346369|NCT00813735|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65346370|NCT00813735|Antidepressive Agents|antidepressive agents|mesh-ancestor
65346371|NCT00813735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65346372|NCT00813735|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65346373|NCT00813735|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65346374|NCT00813735|Parasympatholytics|parasympatholytics|mesh-ancestor
65346375|NCT00813735|Autonomic Agents|autonomic agents|mesh-ancestor
65346376|NCT00813735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65346377|NCT00813735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65346378|NCT00813735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65346379|NCT00813735|Cholinergic Agents|cholinergic agents|mesh-ancestor
65346380|NCT00813735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65346381|NCT00813735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65346383|NCT00811083|Antidotes|antidotes|mesh-ancestor
65346384|NCT00811083|Protective Agents|protective agents|mesh-ancestor
65346385|NCT00811083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346386|NCT00811083|Chelating Agents|chelating agents|mesh-ancestor
64738500|NCT00002357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64487693|NCT04378972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487694|NCT04378972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64487695|NCT04378972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64487704|NCT04378972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487705|NCT04378972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487706|NCT04378972|Anticonvulsants|anticonvulsants|mesh-ancestor
64487707|NCT04378972|GABA Agonists|gaba agonists|mesh-ancestor
64487708|NCT04378972|GABA Agents|gaba agents|mesh-ancestor
64555758|NCT02703623|Abiraterone Acetate|abiraterone acetate|mesh-list
64555759|NCT02703623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555760|NCT02703623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64487709|NCT04378972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64487710|NCT01723150|Ciprofloxacin|ciprofloxacin|mesh-list
64487711|NCT01723150|Ceftriaxone|ceftriaxone|mesh-list
64487712|NCT01723150|Ertapenem|ertapenem|mesh-list
64487713|NCT01723150|Trimethoprim|trimethoprim|mesh-list
64487714|NCT01723150|Sulfamethoxazole|sulfamethoxazole|mesh-list
64487715|NCT01723150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64487716|NCT01723150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64487717|NCT01723150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64487718|NCT01723150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64487719|NCT01723150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487720|NCT01723150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487721|NCT01723150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487722|NCT01723150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64487723|NCT01723150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64487724|NCT01723150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64487726|NCT01723150|Antimalarials|antimalarials|mesh-ancestor
64487727|NCT01723150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64487728|NCT01723150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64487729|NCT01723150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65346387|NCT00811083|Sequestering Agents|sequestering agents|mesh-ancestor
65346388|NCT00811083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346389|NCT00642759|Paclitaxel|paclitaxel|mesh-list
65346390|NCT00642759|Bevacizumab|bevacizumab|mesh-list
65346391|NCT00642759|Carboplatin|carboplatin|mesh-list
65346392|NCT00642759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65346393|NCT00642759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346394|NCT00642759|Tubulin Modulators|tubulin modulators|mesh-ancestor
65346395|NCT00642759|Antimitotic Agents|antimitotic agents|mesh-ancestor
65346396|NCT00642759|Mitosis Modulators|mitosis modulators|mesh-ancestor
65346397|NCT00642759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346398|NCT00642759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65346399|NCT00642759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65346400|NCT00642759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65346401|NCT00642759|Growth Substances|growth substances|mesh-ancestor
65346402|NCT00642759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346403|NCT00642759|Growth Inhibitors|growth inhibitors|mesh-ancestor
65346404|NCT00813891|Ranibizumab|ranibizumab|mesh-list
65346405|NCT00813891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65346406|NCT00813891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65346407|NCT00813891|Growth Substances|growth substances|mesh-ancestor
65346408|NCT00813891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346409|NCT00813891|Growth Inhibitors|growth inhibitors|mesh-ancestor
65346410|NCT00813891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346411|NCT00817557|Loteprednol Etabonate|loteprednol etabonate|mesh-list
65346412|NCT00817557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65346413|NCT00611026|Fesoterodine|fesoterodine|mesh-list
65346414|NCT00611026|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65346415|NCT00611026|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65346416|NCT00611026|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65346417|NCT00611026|Cholinergic Agents|cholinergic agents|mesh-ancestor
64487730|NCT01723150|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64487731|NCT01723150|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64487732|NCT01835938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64487733|NCT01835938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487734|NCT01835938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64487735|NCT01835938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487736|NCT01835938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487737|NCT01836016|Fluticasone|fluticasone|mesh-list
64487738|NCT01836016|Xhance|xhance|mesh-list
64487739|NCT01836016|Albuterol|albuterol|mesh-list
64487740|NCT01836016|Formoterol Fumarate|formoterol fumarate|mesh-list
64487741|NCT01836016|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64487742|NCT01836016|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64487743|NCT01836016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65346418|NCT00611026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65346419|NCT00611026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346420|NCT00611026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346421|NCT00611026|Urological Agents|urological agents|mesh-ancestor
65346422|NCT02552589|Fluorides|fluorides|mesh-list
65346423|NCT02552589|Fluorophosphate|fluorophosphate|mesh-list
65346424|NCT02552589|Cariostatic Agents|cariostatic agents|mesh-ancestor
65346425|NCT02552589|Protective Agents|protective agents|mesh-ancestor
65346426|NCT02552589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346427|NCT00811239|Antivenins|antivenins|mesh-list
65346428|NCT00811239|Immunologic Factors|immunologic factors|mesh-ancestor
65346429|NCT00811239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346430|NCT00814047|Yohimbine|yohimbine|mesh-list
65346431|NCT00814047|Mydriatics|mydriatics|mesh-ancestor
65346432|NCT00814047|Autonomic Agents|autonomic agents|mesh-ancestor
65346433|NCT00814047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65346434|NCT00814047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346435|NCT00814047|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65346436|NCT00814047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65346437|NCT00814047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65346438|NCT00814047|Adrenergic Agents|adrenergic agents|mesh-ancestor
65346439|NCT00814047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65346440|NCT00814047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346441|NCT00814047|Urological Agents|urological agents|mesh-ancestor
65346442|NCT00814125|Tamoxifen|tamoxifen|mesh-list
65346443|NCT00814125|Anastrozole|anastrozole|mesh-list
64738558|NCT00002129|Vesnarinone|vesnarinone|mesh-list
64487744|NCT01836016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64487745|NCT01836016|Autonomic Agents|autonomic agents|mesh-ancestor
64487746|NCT01836016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64487747|NCT01836016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487748|NCT01836016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64487756|NCT01836016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64487757|NCT01836016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487758|NCT01836016|Tocolytic Agents|tocolytic agents|mesh-ancestor
64487759|NCT01836016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64487760|NCT01836016|Glucocorticoids|glucocorticoids|mesh-ancestor
64487761|NCT01836016|Hormones|hormones|mesh-ancestor
64487782|NCT01836328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64487783|NCT01836328|Antitussive Agents|antitussive agents|mesh-ancestor
64487784|NCT01836328|Respiratory System Agents|respiratory system agents|mesh-ancestor
64487785|NCT01836406|Ketorolac|ketorolac|mesh-list
64487786|NCT01836406|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64487787|NCT01836406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64487788|NCT01836406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64487789|NCT01836406|Analgesics|analgesics|mesh-ancestor
64487790|NCT01836406|Sensory System Agents|sensory system agents|mesh-ancestor
64487791|NCT01836406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65096239|NCT00514995|Sodium Oxybate|sodium oxybate|mesh-list
65346444|NCT00814125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65346445|NCT00814125|Hormone Antagonists|hormone antagonists|mesh-ancestor
65346446|NCT00814125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65346447|NCT00814125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346448|NCT00814125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65346449|NCT00814125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346450|NCT00814125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65346451|NCT00814125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65346452|NCT00814125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65346453|NCT00814125|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65346454|NCT00814125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65346455|NCT00814125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65346456|NCT00814125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346457|NCT00817713|Ivermectin|ivermectin|mesh-list
65346458|NCT00817713|Albendazole|albendazole|mesh-list
65346459|NCT00817713|Praziquantel|praziquantel|mesh-list
65346460|NCT00817713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65346461|NCT00817713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65346462|NCT00817713|Anthelmintics|anthelmintics|mesh-ancestor
65346463|NCT00817713|Anticestodal Agents|anticestodal agents|mesh-ancestor
65346464|NCT00817713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65346465|NCT00817713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65346466|NCT00817713|Tubulin Modulators|tubulin modulators|mesh-ancestor
65346467|NCT00817713|Antimitotic Agents|antimitotic agents|mesh-ancestor
65346468|NCT00817713|Mitosis Modulators|mitosis modulators|mesh-ancestor
65346469|NCT00817713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487792|NCT01836406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487793|NCT01836406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64487794|NCT01836406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64487795|NCT01836406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64487796|NCT01836406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555761|NCT02703623|Glucocorticoids|glucocorticoids|mesh-ancestor
64555762|NCT02703623|Hormones|hormones|mesh-ancestor
64555763|NCT02703623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64555764|NCT02703623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555765|NCT02703623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64487797|NCT01836406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487798|NCT01836484|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64487799|NCT01836484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64487800|NCT01836484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487802|NCT01726816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64487803|NCT01726816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64487804|NCT01726816|Antimetabolites|antimetabolites|mesh-ancestor
64724246|NCT00000379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346470|NCT00817713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346471|NCT00422383|Rituximab|rituximab|mesh-list
65346472|NCT00422383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65346473|NCT00422383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346474|NCT00422383|Immunologic Factors|immunologic factors|mesh-ancestor
65346475|NCT00422383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346476|NCT00422383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65346477|NCT00814281|Montelukast|montelukast|mesh-list
65346478|NCT00814281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65346479|NCT00814281|Respiratory System Agents|respiratory system agents|mesh-ancestor
65346480|NCT00814281|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65346481|NCT00814281|Hormone Antagonists|hormone antagonists|mesh-ancestor
65346482|NCT00814281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65346483|NCT00814281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346484|NCT00814281|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65346485|NCT00814281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65346486|NCT00814281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346487|NCT00814359|Benzydamine|benzydamine|mesh-list
65346488|NCT00814359|Sucralfate|sucralfate|mesh-list
65346489|NCT00814359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65346490|NCT00814359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65346491|NCT00814359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65346492|NCT00612040|Insulin|insulin|mesh-list
65346493|NCT00612040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65346494|NCT00612040|Insulin Glargine|insulin glargine|mesh-list
65346495|NCT00612040|Insulin Aspart|insulin aspart|mesh-list
65346496|NCT00612040|Insulin, Long-Acting|insulin, long-acting|mesh-list
65346497|NCT00612040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65346498|NCT00612040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346499|NCT00422227|Hydroxychloroquine|hydroxychloroquine|mesh-list
65346500|NCT00422227|Sulfasalazine|sulfasalazine|mesh-list
65346501|NCT00422227|Etanercept|etanercept|mesh-list
65346502|NCT00422227|Methotrexate|methotrexate|mesh-list
65346503|NCT00422227|Leflunomide|leflunomide|mesh-list
64738613|NCT00002381|Nevirapine|nevirapine|mesh-list
64487805|NCT01726816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487806|NCT01726816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64487807|NCT01726816|Antioxidants|antioxidants|mesh-ancestor
64487808|NCT01726816|Protective Agents|protective agents|mesh-ancestor
64487809|NCT01726816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487810|NCT00915538|Budesonide|budesonide|mesh-list
64487811|NCT00915538|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65346504|NCT00422227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65346505|NCT00422227|Abortifacient Agents|abortifacient agents|mesh-ancestor
65346506|NCT00422227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65346507|NCT00422227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346508|NCT00422227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65346509|NCT00422227|Antimetabolites|antimetabolites|mesh-ancestor
65346510|NCT00422227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346511|NCT00422227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346512|NCT00422227|Dermatologic Agents|dermatologic agents|mesh-ancestor
65346513|NCT00422227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65346514|NCT00422227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65346515|NCT00422227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65346516|NCT00422227|Immunologic Factors|immunologic factors|mesh-ancestor
65346517|NCT00422227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65346518|NCT00422227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65346520|NCT00422227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65346521|NCT00422227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65346522|NCT00422227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65346523|NCT00422227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65346524|NCT00422227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65346525|NCT00422227|Analgesics|analgesics|mesh-ancestor
65346526|NCT00422227|Sensory System Agents|sensory system agents|mesh-ancestor
64487812|NCT00915538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64487813|NCT00915538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64487814|NCT00915538|Autonomic Agents|autonomic agents|mesh-ancestor
64487815|NCT00915538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64487830|NCT01724086|Antiviral Agents|antiviral agents|mesh-ancestor
64487831|NCT01724086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64487832|NCT01724086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64487833|NCT01724086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64487834|NCT01724086|Protease Inhibitors|protease inhibitors|mesh-ancestor
64487835|NCT01724086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487836|NCT01724086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487837|NCT01724086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64487838|NCT01724086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64487839|NCT01724086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64487840|NCT01724086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64487841|NCT01724086|Antimetabolites|antimetabolites|mesh-ancestor
64487842|NCT01724086|Immunologic Factors|immunologic factors|mesh-ancestor
64487843|NCT01724086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487844|NCT00913510|Cholinergic Antagonists|cholinergic antagonists|mesh-list
64487846|NCT00913510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64487847|NCT00913510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487848|NCT00913510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487850|NCT01727050|Hemostatics|hemostatics|mesh-ancestor
64487851|NCT01727050|Coagulants|coagulants|mesh-ancestor
64487852|NCT03836638|Botulinum Toxins|botulinum toxins|mesh-list
64487853|NCT03836638|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64487854|NCT03836638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64487855|NCT03836638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487856|NCT03836638|Cholinergic Agents|cholinergic agents|mesh-ancestor
65346527|NCT00422227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65346528|NCT00422227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65346529|NCT00422227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65346530|NCT00811785|Copper|copper|mesh-list
65346531|NCT00811785|Trace Elements|trace elements|mesh-ancestor
65346532|NCT00811785|Micronutrients|micronutrients|mesh-ancestor
65346533|NCT00811785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346534|NCT00814515|Cyclosporine|cyclosporine|mesh-list
65346535|NCT00814515|Cyclosporins|cyclosporins|mesh-list
65346536|NCT00814515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65346537|NCT00814515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346538|NCT00814515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65346539|NCT00814515|Immunologic Factors|immunologic factors|mesh-ancestor
65346540|NCT00814515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346541|NCT00814515|Antifungal Agents|antifungal agents|mesh-ancestor
65346542|NCT00814515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65346543|NCT00814515|Dermatologic Agents|dermatologic agents|mesh-ancestor
65346544|NCT00814515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65346545|NCT00814515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65346546|NCT00814593|Carmustine|carmustine|mesh-list
65346547|NCT00814593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65346548|NCT00814593|Alkylating Agents|alkylating agents|mesh-ancestor
65346549|NCT00814593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346550|NCT00814593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346551|NCT00421993|Adapalene|adapalene|mesh-list
65346552|NCT00421993|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
65346553|NCT00421993|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65346554|NCT00421993|Dermatologic Agents|dermatologic agents|mesh-ancestor
65346555|NCT00421993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65346556|NCT00421993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65346557|NCT00421993|Analgesics|analgesics|mesh-ancestor
65346558|NCT00421993|Sensory System Agents|sensory system agents|mesh-ancestor
65346559|NCT00421993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65346560|NCT00421993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346561|NCT00421993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64738685|NCT00002405|Amprenavir|amprenavir|mesh-list
64487857|NCT03836638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64487858|NCT03836638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487859|NCT01837108|Eplerenone|eplerenone|mesh-list
65346562|NCT00421993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65346563|NCT00884884|Topiramate|topiramate|mesh-list
65346564|NCT00884884|Aripiprazole|aripiprazole|mesh-list
65346565|NCT00884884|Antidepressive Agents|antidepressive agents|mesh-ancestor
65346566|NCT00884884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65346567|NCT00884884|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65346568|NCT00884884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65346569|NCT00884884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65346570|NCT00884884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346571|NCT00884884|Dopamine Agonists|dopamine agonists|mesh-ancestor
65346572|NCT00884884|Dopamine Agents|dopamine agents|mesh-ancestor
65346573|NCT00884884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65346574|NCT00884884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346575|NCT00884884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65346576|NCT00884884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65346577|NCT00884884|Serotonin Agents|serotonin agents|mesh-ancestor
65346578|NCT00884884|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65346579|NCT00884884|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65346580|NCT00884884|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65346581|NCT00884884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65346582|NCT00884884|Anticonvulsants|anticonvulsants|mesh-ancestor
65346583|NCT00884884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65346584|NCT01037725|Oxazolidinones|oxazolidinones|mesh-list
65346585|NCT01037725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65346586|NCT01037725|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64487860|NCT01837108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64487861|NCT01837108|Hormone Antagonists|hormone antagonists|mesh-ancestor
64487862|NCT01837108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64487863|NCT01837108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487864|NCT01837108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64487865|NCT01837108|Diuretics|diuretics|mesh-ancestor
64487866|NCT01837108|Natriuretic Agents|natriuretic agents|mesh-ancestor
64487867|NCT01837108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64487868|NCT01724554|Aflibercept|aflibercept|mesh-list
64487869|NCT01724554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64487870|NCT01724554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64555766|NCT02703623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64555767|NCT02703623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64555768|NCT02703623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555769|NCT02703623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64555770|NCT02703623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487871|NCT01724554|Growth Substances|growth substances|mesh-ancestor
64487872|NCT01724554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487873|NCT01724554|Growth Inhibitors|growth inhibitors|mesh-ancestor
64487874|NCT01724554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487875|NCT01724788|Furosemide|furosemide|mesh-list
64487888|NCT01837498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487889|NCT01837498|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65346587|NCT01037725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65346588|NCT01037725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346589|NCT02551029|Capsaicin|capsaicin|mesh-list
65346590|NCT02551029|Antipruritics|antipruritics|mesh-ancestor
65346591|NCT02551029|Dermatologic Agents|dermatologic agents|mesh-ancestor
65346592|NCT02551029|Sensory System Agents|sensory system agents|mesh-ancestor
65346593|NCT02551029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65346594|NCT02551029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346595|NCT00812019|Vaccines|vaccines|mesh-list
65346596|NCT00812019|MF59 oil emulsion|mf59 oil emulsion|mesh-list
65346597|NCT00812019|Immunologic Factors|immunologic factors|mesh-ancestor
65346598|NCT00812019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346599|NCT00812019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65346600|NCT00413959|Dexamethasone|dexamethasone|mesh-list
65346601|NCT00413959|Cyclophosphamide|cyclophosphamide|mesh-list
65346602|NCT00413959|Rituximab|rituximab|mesh-list
65346603|NCT00413959|Bortezomib|bortezomib|mesh-list
65346604|NCT00413959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65346605|NCT00413959|Immunologic Factors|immunologic factors|mesh-ancestor
65346606|NCT00413959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346607|NCT00413959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65346608|NCT00413959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65346609|NCT00413959|Alkylating Agents|alkylating agents|mesh-ancestor
65346610|NCT00413959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346611|NCT00413959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346612|NCT00413959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65346613|NCT00413959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65346614|NCT00413959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65346615|NCT00413959|Antiemetics|antiemetics|mesh-ancestor
65346616|NCT00413959|Autonomic Agents|autonomic agents|mesh-ancestor
65346617|NCT00413959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65346618|NCT00413959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65346619|NCT00413959|Glucocorticoids|glucocorticoids|mesh-ancestor
65346629|NCT00814905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65346630|NCT00814905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65346631|NCT00814905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65346632|NCT00814905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346633|NCT00611884|Insulin|insulin|mesh-list
65346634|NCT00611884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65346635|NCT00611884|Metformin|metformin|mesh-list
65346636|NCT00611884|Insulin Glargine|insulin glargine|mesh-list
65346637|NCT00611884|Insulin, Long-Acting|insulin, long-acting|mesh-list
65346638|NCT00611884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65346639|NCT00611884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346640|NCT00611806|Folic Acid|folic acid|mesh-list
65346641|NCT00611806|Vitamin B 12|vitamin b 12|mesh-list
65346642|NCT00611806|Hematinics|hematinics|mesh-ancestor
65346643|NCT00611806|Vitamin B Complex|vitamin b complex|mesh-ancestor
65346644|NCT00611806|Vitamins|vitamins|mesh-ancestor
65346645|NCT00611806|Micronutrients|micronutrients|mesh-ancestor
65346646|NCT00611806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346647|NCT00413413|Amlodipine|amlodipine|mesh-list
65346648|NCT00413413|Valsartan|valsartan|mesh-list
65346649|NCT00413413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65346650|NCT00413413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65346651|NCT00413413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65346652|NCT00413413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346653|NCT00413413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65346654|NCT00413413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346655|NCT00413413|Vasodilator Agents|vasodilator agents|mesh-ancestor
65346656|NCT00413413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65346657|NCT00413413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64487890|NCT01837498|Autonomic Agents|autonomic agents|mesh-ancestor
64487891|NCT01837498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64487892|NCT01705574|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64487893|NCT01705574|Antiviral Agents|antiviral agents|mesh-ancestor
64487894|NCT01705574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64487895|NCT01705574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64487896|NCT01705574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64487898|NCT01837576|Dermatologic Agents|dermatologic agents|mesh-ancestor
64487899|NCT01737710|Vaccines|vaccines|mesh-list
64487900|NCT01737710|Immunologic Factors|immunologic factors|mesh-ancestor
64487901|NCT01737710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487902|NCT01837810|Ibuprofen|ibuprofen|mesh-list
64487903|NCT01837810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64487904|NCT01837810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64487905|NCT01837810|Analgesics|analgesics|mesh-ancestor
64487906|NCT01837810|Sensory System Agents|sensory system agents|mesh-ancestor
64487907|NCT01837810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65346658|NCT00886132|Sunitinib|sunitinib|mesh-list
65346659|NCT00886132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346660|NCT00886132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65346661|NCT00886132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65346662|NCT00886132|Growth Substances|growth substances|mesh-ancestor
65346663|NCT00886132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346664|NCT00886132|Growth Inhibitors|growth inhibitors|mesh-ancestor
65346665|NCT00886132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65346666|NCT00886132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65346667|NCT00886132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346668|NCT01040455|Lansoprazole|lansoprazole|mesh-list
65346669|NCT01040455|Dexlansoprazole|dexlansoprazole|mesh-list
65346670|NCT01040455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65346671|NCT01040455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65346672|NCT01040455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65346673|NCT01040455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65346674|NCT01040455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346676|NCT01041235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346677|NCT01041235|Tubulin Modulators|tubulin modulators|mesh-ancestor
65346678|NCT01041235|Antimitotic Agents|antimitotic agents|mesh-ancestor
65346679|NCT01041235|Mitosis Modulators|mitosis modulators|mesh-ancestor
65346680|NCT01041235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346681|NCT01041313|Memantine|memantine|mesh-list
65346682|NCT01041313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64487908|NCT01837810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487909|NCT01837810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64487910|NCT01837810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64487911|NCT01837810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64487912|NCT01837810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487913|NCT01837810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487914|NCT01725100|Trametinib|trametinib|mesh-list
64487915|NCT01725100|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
64487916|NCT01725100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487917|NCT01725100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64487918|NCT01725100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487919|NCT01725100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487920|NCT01725100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64487921|NCT01725100|Protective Agents|protective agents|mesh-ancestor
64487922|NCT01725100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487923|NCT01725100|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64487929|NCT01725412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487930|NCT01725490|Metformin|metformin|mesh-list
64487931|NCT01725490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64487932|NCT01725490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487933|NCT04553666|Vitamins|vitamins|mesh-list
64487934|NCT04553666|Ascorbic Acid|ascorbic acid|mesh-list
64487935|NCT04553666|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
64487936|NCT04553666|Micronutrients|micronutrients|mesh-ancestor
64487964|NCT01838434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64487965|NCT01838434|Growth Substances|growth substances|mesh-ancestor
65346683|NCT01041313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65346684|NCT01041313|Dopamine Agents|dopamine agents|mesh-ancestor
65346685|NCT01041313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65346686|NCT01041313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346687|NCT01041313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346688|NCT01041313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65346689|NCT01041313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65346690|NCT00610714|Paclitaxel|paclitaxel|mesh-list
65346691|NCT00610714|Carboplatin|carboplatin|mesh-list
65346692|NCT00610714|Saracatinib|saracatinib|mesh-list
65346693|NCT00610714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65346694|NCT00610714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346695|NCT00610714|Tubulin Modulators|tubulin modulators|mesh-ancestor
65346696|NCT00610714|Antimitotic Agents|antimitotic agents|mesh-ancestor
65346697|NCT00610714|Mitosis Modulators|mitosis modulators|mesh-ancestor
65346698|NCT00610714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346699|NCT00610714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65346700|NCT00403585|Adefovir|adefovir|mesh-list
65346701|NCT00403585|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65346708|NCT00645411|Vaccines|vaccines|mesh-list
65346738|NCT00402727|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65346739|NCT00402727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65346740|NCT00402727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65346741|NCT00402727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65346742|NCT00402727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65346743|NCT00402727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096536|NCT00506051|Pemetrexed|pemetrexed|mesh-list
65346744|NCT00402727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346745|NCT00402727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346746|NCT00402727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65346747|NCT00402727|Contraceptive Agents|contraceptive agents|mesh-ancestor
65346748|NCT00402727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65346749|NCT00402727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346750|NCT00402727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65346751|NCT00402727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65346752|NCT00402727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65346753|NCT00402727|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65346754|NCT00923494|Ropivacaine|ropivacaine|mesh-list
65346755|NCT00923494|Anesthetics, Local|anesthetics, local|mesh-ancestor
65346756|NCT00923494|Anesthetics|anesthetics|mesh-ancestor
64487966|NCT01838434|Growth Inhibitors|growth inhibitors|mesh-ancestor
64487967|NCT01838434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487968|NCT01838434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487969|NCT01838434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487970|NCT01838668|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64487971|NCT01838668|Dermatologic Agents|dermatologic agents|mesh-ancestor
64487972|NCT01838668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64487973|NCT01838668|Immunologic Factors|immunologic factors|mesh-ancestor
64555771|NCT02703623|Hormone Antagonists|hormone antagonists|mesh-ancestor
64555772|NCT02703623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64555773|NCT04372407|Itraconazole|itraconazole|mesh-list
64555774|NCT04372407|Antifungal Agents|antifungal agents|mesh-ancestor
64555775|NCT04372407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64555776|NCT04372407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64487974|NCT01838668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487975|NCT04377646|Zinc|zinc|mesh-list
64487976|NCT04377646|Hydroxychloroquine|hydroxychloroquine|mesh-list
64487977|NCT04377646|Antimalarials|antimalarials|mesh-ancestor
64487978|NCT04377646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64487979|NCT04377646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64487980|NCT04377646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64487997|NCT01682720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64487998|NCT01838902|Primaquine|primaquine|mesh-list
64487999|NCT01838902|Antimalarials|antimalarials|mesh-ancestor
64488000|NCT01838902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64488001|NCT01838902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64488002|NCT01838902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64488003|NCT01714544|Clocortolone pivalate|clocortolone pivalate|mesh-list
64488004|NCT01714544|Glucocorticoids|glucocorticoids|mesh-ancestor
64488005|NCT01714544|Hormones|hormones|mesh-ancestor
64488006|NCT01714544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64488007|NCT01714544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488008|NCT03409432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64488009|NCT03409432|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64488010|NCT03409432|Lenalidomide|lenalidomide|mesh-list
65346757|NCT00923494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65346758|NCT00923494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346759|NCT00923494|Sensory System Agents|sensory system agents|mesh-ancestor
65346760|NCT00923494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65346761|NCT00888784|Propranolol|propranolol|mesh-list
65346762|NCT00888784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65346763|NCT00888784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65346764|NCT00888784|Adrenergic Agents|adrenergic agents|mesh-ancestor
65346765|NCT00888784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65346766|NCT00888784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346767|NCT00888784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346768|NCT00888784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65346769|NCT00888784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65346770|NCT00888784|Vasodilator Agents|vasodilator agents|mesh-ancestor
65346771|NCT00886678|Carboplatin|carboplatin|mesh-list
65346773|NCT00886678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346774|NCT00886678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65346775|NCT00886678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346776|NCT00886678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65346777|NCT00886678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65346778|NCT00402337|Linaclotide|linaclotide|mesh-list
65346779|NCT00402337|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65346780|NCT00402337|Enzyme Activators|enzyme activators|mesh-ancestor
65346791|NCT00888862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65346805|NCT00650091|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65346806|NCT00650091|Antiviral Agents|antiviral agents|mesh-ancestor
65346807|NCT00650091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65346808|NCT00650091|Expectorants|expectorants|mesh-ancestor
65346809|NCT00650091|Respiratory System Agents|respiratory system agents|mesh-ancestor
65346810|NCT00650091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65346811|NCT00650091|Antioxidants|antioxidants|mesh-ancestor
65346812|NCT00650091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346813|NCT00650091|Protective Agents|protective agents|mesh-ancestor
65346814|NCT00650091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346815|NCT00650091|Antidotes|antidotes|mesh-ancestor
65346816|NCT00889018|Carboplatin|carboplatin|mesh-list
65346817|NCT00889018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346818|NCT00889096|Propranolol|propranolol|mesh-list
65346819|NCT00889096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65346820|NCT00889096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65346821|NCT00889096|Adrenergic Agents|adrenergic agents|mesh-ancestor
65346822|NCT00889096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65346823|NCT00889096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346824|NCT00889096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346825|NCT00889096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65346826|NCT00889096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65346827|NCT00889096|Vasodilator Agents|vasodilator agents|mesh-ancestor
65346828|NCT00818103|Interferons|interferons|mesh-list
65346829|NCT00818103|Atorvastatin|atorvastatin|mesh-list
65346830|NCT00818103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346831|NCT00818103|Antiviral Agents|antiviral agents|mesh-ancestor
65346832|NCT00818103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64488011|NCT03409432|Antibodies|antibodies|mesh-list
64488012|NCT03409432|Immunoglobulins|immunoglobulins|mesh-list
64488013|NCT03409432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64488014|NCT03409432|Immunoconjugates|immunoconjugates|mesh-list
64488015|NCT03409432|Immunologic Factors|immunologic factors|mesh-ancestor
64488016|NCT03409432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488017|NCT03409432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64488018|NCT03409432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64488019|NCT03409432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64488020|NCT03409432|Growth Substances|growth substances|mesh-ancestor
64488021|NCT03409432|Growth Inhibitors|growth inhibitors|mesh-ancestor
64488022|NCT01703858|Pantoprazole|pantoprazole|mesh-list
64488023|NCT01703858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64488024|NCT01703858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64488025|NCT01703858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64488026|NCT01703858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488027|NCT01703858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488029|NCT01729468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64488030|NCT01729468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64488031|NCT01729468|Analgesics|analgesics|mesh-ancestor
65346833|NCT00818103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65346834|NCT00818103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65346835|NCT00818103|Antimetabolites|antimetabolites|mesh-ancestor
65346836|NCT00818103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346837|NCT00818103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65346838|NCT00818103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65346839|NCT00818103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65346840|NCT00642369|Haloperidol|haloperidol|mesh-list
65346841|NCT00642369|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65346842|NCT00642369|Haloperidol decanoate|haloperidol decanoate|mesh-list
65346843|NCT00642369|Antidepressive Agents|antidepressive agents|mesh-ancestor
65346844|NCT00642369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65346845|NCT00642369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65346846|NCT00642369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65346847|NCT00642369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65346848|NCT00642369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346849|NCT00642369|Antiemetics|antiemetics|mesh-ancestor
65346850|NCT00642369|Autonomic Agents|autonomic agents|mesh-ancestor
65346851|NCT00642369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65346852|NCT00642369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65346853|NCT00642369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65346854|NCT00642369|Dopamine Agents|dopamine agents|mesh-ancestor
65346855|NCT00642369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65346856|NCT00642369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346857|NCT00642369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64488032|NCT01729468|Sensory System Agents|sensory system agents|mesh-ancestor
64488033|NCT01729468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64488034|NCT01729468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488035|NCT01729468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64488039|NCT01729468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488056|NCT01714310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64488058|NCT01714310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64488059|NCT01714310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64488060|NCT01714310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64488061|NCT01714310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488062|NCT01714310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64488063|NCT01714310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64488064|NCT01714310|Dopamine Agents|dopamine agents|mesh-ancestor
64488065|NCT03408574|Mecamylamine|mecamylamine|mesh-list
64488066|NCT03408574|Nicotine|nicotine|mesh-list
64488067|NCT03408574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64555777|NCT04372407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64555778|NCT04372407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555779|NCT04372407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555780|NCT04372407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64555781|NCT04372407|Hormone Antagonists|hormone antagonists|mesh-ancestor
65346858|NCT01154335|Everolimus|everolimus|mesh-list
65346859|NCT01154335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346860|NCT01154335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65346861|NCT01154335|Immunologic Factors|immunologic factors|mesh-ancestor
65346862|NCT01154335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346863|NCT00889642|Lidocaine|lidocaine|mesh-list
65346864|NCT00889642|Epinephrine|epinephrine|mesh-list
65346865|NCT00889642|Racepinephrine|racepinephrine|mesh-list
65346866|NCT00889642|Epinephryl borate|epinephryl borate|mesh-list
65346867|NCT00889642|Anesthetics, Local|anesthetics, local|mesh-ancestor
65346868|NCT00889642|Anesthetics|anesthetics|mesh-ancestor
65346869|NCT00889642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65346870|NCT00889642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346871|NCT00889642|Sensory System Agents|sensory system agents|mesh-ancestor
65346872|NCT00889642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65346873|NCT00889642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65346874|NCT00889642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65346875|NCT00889642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65346876|NCT00889642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65346877|NCT00889642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346878|NCT00889642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65346879|NCT00889642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65346880|NCT00889642|Adrenergic Agents|adrenergic agents|mesh-ancestor
65346881|NCT00889642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65346882|NCT00889642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65346883|NCT00889642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65346884|NCT00889642|Autonomic Agents|autonomic agents|mesh-ancestor
65346885|NCT00889642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65346886|NCT00889642|Respiratory System Agents|respiratory system agents|mesh-ancestor
65346887|NCT00889642|Mydriatics|mydriatics|mesh-ancestor
65346888|NCT00889642|Sympathomimetics|sympathomimetics|mesh-ancestor
65346889|NCT00889642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64555782|NCT04372407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64555783|NCT04372407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555784|NCT04372407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64555785|NCT02242383|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64488068|NCT03408574|Autonomic Agents|autonomic agents|mesh-ancestor
64488069|NCT03408574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64488070|NCT03408574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488071|NCT03408574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64488072|NCT03408574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64488073|NCT03408574|Cholinergic Agents|cholinergic agents|mesh-ancestor
65346890|NCT02541526|Mirtazapine|mirtazapine|mesh-list
65346891|NCT02541526|Antidepressive Agents|antidepressive agents|mesh-ancestor
65346892|NCT02541526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65346893|NCT02541526|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65346894|NCT02541526|Histamine Antagonists|histamine antagonists|mesh-ancestor
65346896|NCT02541526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65346897|NCT02541526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346898|NCT02541526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346899|NCT02541526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65346900|NCT02541526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65346901|NCT02541526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65346902|NCT02541526|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65346903|NCT02541526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65346904|NCT02541526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65346905|NCT02541526|Adrenergic Agents|adrenergic agents|mesh-ancestor
65346906|NCT02541526|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65346907|NCT02541526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65346908|NCT02541526|Serotonin Agents|serotonin agents|mesh-ancestor
65346909|NCT02541526|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65346910|NCT01037959|Norfloxacin|norfloxacin|mesh-list
65346911|NCT01037959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65346912|NCT01037959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65346913|NCT01037959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65346914|NCT01037959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65346915|NCT01037959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65346916|NCT01037959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346917|NCT01037959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346918|NCT01037959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65346919|NCT01037959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65346920|NCT01038037|Carboplatin|carboplatin|mesh-list
65346921|NCT01038037|Vinorelbine|vinorelbine|mesh-list
65346922|NCT01038037|Panitumumab|panitumumab|mesh-list
65346923|NCT01038037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346929|NCT01038037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65346930|NCT00645099|Olanzapine|olanzapine|mesh-list
65346931|NCT00645099|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65346932|NCT00645099|Antiemetics|antiemetics|mesh-ancestor
65346933|NCT00645099|Autonomic Agents|autonomic agents|mesh-ancestor
65346934|NCT00645099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65346935|NCT00645099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346936|NCT00645099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65346937|NCT00645099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65346938|NCT00645099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65346939|NCT00645099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65346940|NCT00645099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65346941|NCT00645099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65346942|NCT00645099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65346943|NCT00645099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65346944|NCT00645099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346945|NCT00645099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65346946|NCT00645099|Serotonin Agents|serotonin agents|mesh-ancestor
65346947|NCT00645099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65346948|NCT00645099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65346949|NCT00645099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65346950|NCT00645099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65346951|NCT00645099|Dopamine Agents|dopamine agents|mesh-ancestor
65346952|NCT04401982|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65346953|NCT04401982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65346954|NCT01038349|Methotrexate|methotrexate|mesh-list
65346955|NCT01038349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65346956|NCT01038349|Abortifacient Agents|abortifacient agents|mesh-ancestor
65346957|NCT01038349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64488074|NCT03408574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64488075|NCT03408574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488076|NCT03408574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64488077|NCT03408574|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
64488078|NCT03408574|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64488079|NCT03408574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64488080|NCT01728064|Ubiquinone|ubiquinone|mesh-list
64488081|NCT01728064|Micronutrients|micronutrients|mesh-ancestor
64488082|NCT01728064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488083|NCT03405142|Panitumumab|panitumumab|mesh-list
64488084|NCT03405142|Diethylenetriamine|diethylenetriamine|mesh-list
64488085|NCT03405142|Dextrans|dextrans|mesh-list
64488086|NCT03405142|Edetic Acid|edetic acid|mesh-list
64488087|NCT03405142|Pentetic Acid|pentetic acid|mesh-list
64488088|NCT03405142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64488089|NCT03405142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64488090|NCT03405142|Anticoagulants|anticoagulants|mesh-ancestor
65346958|NCT01038349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346959|NCT01038349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65346960|NCT01038349|Antimetabolites|antimetabolites|mesh-ancestor
65346961|NCT01038349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346962|NCT01038349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346963|NCT01038349|Dermatologic Agents|dermatologic agents|mesh-ancestor
65346964|NCT01038349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096757|NCT00516672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65346965|NCT01038349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65346966|NCT01038349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65346967|NCT01038349|Immunologic Factors|immunologic factors|mesh-ancestor
65346968|NCT01038349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65346969|NCT01038349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65346970|NCT00887770|Moxifloxacin|moxifloxacin|mesh-list
65346971|NCT00887770|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
65346972|NCT00887770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65346973|NCT00887770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65346974|NCT00887770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65346975|NCT00887770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65346976|NCT00887770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65346977|NCT00887770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346978|NCT00887770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346979|NCT00887770|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64488091|NCT03405142|Plasma Substitutes|plasma substitutes|mesh-ancestor
64488092|NCT03405142|Blood Substitutes|blood substitutes|mesh-ancestor
64488093|NCT03405142|Antidotes|antidotes|mesh-ancestor
64488094|NCT03405142|Protective Agents|protective agents|mesh-ancestor
64488095|NCT03405142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488096|NCT03405142|Chelating Agents|chelating agents|mesh-ancestor
64488121|NCT01681472|Protective Agents|protective agents|mesh-ancestor
64488122|NCT01681472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488123|NCT01681472|Vitamin B Complex|vitamin b complex|mesh-ancestor
64488124|NCT01681472|Vitamins|vitamins|mesh-ancestor
64488125|NCT01681472|Micronutrients|micronutrients|mesh-ancestor
64488126|NCT00915928|Perindopril|perindopril|mesh-list
64488127|NCT00915928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64488128|NCT00915928|Protease Inhibitors|protease inhibitors|mesh-ancestor
64488129|NCT00915928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488130|NCT00915928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488131|NCT00915928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64488132|NCT03407404|Midazolam|midazolam|mesh-list
64488133|NCT03407404|Ketamine|ketamine|mesh-list
64488134|NCT03407404|Morphine|morphine|mesh-list
64488135|NCT03407404|Analgesics|analgesics|mesh-ancestor
64488136|NCT03407404|Sensory System Agents|sensory system agents|mesh-ancestor
64488137|NCT03407404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64488138|NCT03407404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488140|NCT03407404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64488142|NCT03407404|Anesthetics|anesthetics|mesh-ancestor
65346980|NCT00887770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65346981|NCT00887770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65346982|NCT00887770|Antiviral Agents|antiviral agents|mesh-ancestor
65346983|NCT01038505|Sirolimus|sirolimus|mesh-list
65346984|NCT01038505|Mycophenolic Acid|mycophenolic acid|mesh-list
65346985|NCT01038505|Tacrolimus|tacrolimus|mesh-list
65346986|NCT01038505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65346987|NCT01038505|Immunologic Factors|immunologic factors|mesh-ancestor
65346988|NCT01038505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65346989|NCT01038505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65346990|NCT01038505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65346991|NCT01038505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65346992|NCT01038505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65346993|NCT01038505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65346994|NCT01038505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65346995|NCT01038505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65346996|NCT01038505|Antifungal Agents|antifungal agents|mesh-ancestor
65346997|NCT01038505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65346998|NCT01038505|Antitubercular Agents|antitubercular agents|mesh-ancestor
65346999|NCT01038583|Aspirin|aspirin|mesh-list
65347000|NCT01038583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65347001|NCT01038583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65347002|NCT01038583|Analgesics|analgesics|mesh-ancestor
65347003|NCT01038583|Sensory System Agents|sensory system agents|mesh-ancestor
65347004|NCT01038583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65347005|NCT01038583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347006|NCT01038583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65347007|NCT01038583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65347008|NCT01038583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65347009|NCT01038583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65347010|NCT01038583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347011|NCT01038583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65347012|NCT01038583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64488143|NCT03407404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64488144|NCT03407404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64555787|NCT02242383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64555788|NCT02242383|Diuretics|diuretics|mesh-ancestor
64555789|NCT02242383|Natriuretic Agents|natriuretic agents|mesh-ancestor
64555790|NCT02242383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555791|NCT02242383|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64555792|NCT02242383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65347013|NCT01038583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347014|NCT01038583|Antipyretics|antipyretics|mesh-ancestor
65347015|NCT02551107|Nitric Oxide|nitric oxide|mesh-list
65347016|NCT02551107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65347017|NCT02551107|Autonomic Agents|autonomic agents|mesh-ancestor
65347018|NCT02551107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65347019|NCT02551107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347020|NCT02551107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65347021|NCT02551107|Respiratory System Agents|respiratory system agents|mesh-ancestor
65347022|NCT02551107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65347023|NCT02551107|Antioxidants|antioxidants|mesh-ancestor
65347024|NCT02551107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347025|NCT02551107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65347026|NCT02551107|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65347027|NCT02551107|Vasodilator Agents|vasodilator agents|mesh-ancestor
65347028|NCT02551107|Gasotransmitters|gasotransmitters|mesh-ancestor
65347029|NCT02551107|Protective Agents|protective agents|mesh-ancestor
65347030|NCT01038661|Docetaxel|docetaxel|mesh-list
65347031|NCT01038661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347032|NCT01038661|Tubulin Modulators|tubulin modulators|mesh-ancestor
65347033|NCT01038661|Antimitotic Agents|antimitotic agents|mesh-ancestor
65347034|NCT01038661|Mitosis Modulators|mitosis modulators|mesh-ancestor
65347035|NCT01038661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347036|NCT01038817|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
65096855|NCT02949765|Iron|iron|mesh-list
65347037|NCT01038817|Cariostatic Agents|cariostatic agents|mesh-ancestor
65347038|NCT01038817|Protective Agents|protective agents|mesh-ancestor
65347039|NCT01038817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347040|NCT00420511|Metformin|metformin|mesh-list
65347041|NCT00420511|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65347042|NCT00420511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65347043|NCT00420511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347044|NCT00420511|Incretins|incretins|mesh-ancestor
65347045|NCT00420511|Hormones|hormones|mesh-ancestor
65347046|NCT00420511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65347047|NCT00420511|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64320865|NCT03534895|GABA Modulators|gaba modulators|mesh-ancestor
64488145|NCT03407404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64488146|NCT03407404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65347048|NCT00420511|Protease Inhibitors|protease inhibitors|mesh-ancestor
65347049|NCT00420511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347050|NCT00420511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347051|NCT01038895|Ramipril|ramipril|mesh-list
65347052|NCT01038895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65347053|NCT01038895|Protease Inhibitors|protease inhibitors|mesh-ancestor
65347054|NCT01038895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347055|NCT01038895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347056|NCT01038895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65347057|NCT00420199|Abatacept|abatacept|mesh-list
65347058|NCT00420199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65347059|NCT00420199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347060|NCT00420199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347061|NCT00420199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65347062|NCT00420199|Immunologic Factors|immunologic factors|mesh-ancestor
65347063|NCT00420199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347064|NCT00420199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64488147|NCT03407404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488148|NCT03407404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64488173|NCT03830086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64488174|NCT03830086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64488175|NCT03830086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64488176|NCT03830086|GABA Modulators|gaba modulators|mesh-ancestor
64488177|NCT03830086|GABA Agents|gaba agents|mesh-ancestor
64488178|NCT03830086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64488179|NCT03830086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488180|NCT03830086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64488181|NCT03830086|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64488182|NCT03830086|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64488183|NCT03830086|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64488184|NCT03830086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64488185|NCT03830086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64488186|NCT03830086|Narcotics|narcotics|mesh-ancestor
64488187|NCT03830086|Analgesics|analgesics|mesh-ancestor
64488189|NCT02240212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64488190|NCT02240212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64488191|NCT02240212|Tubulin Modulators|tubulin modulators|mesh-ancestor
64488192|NCT02240212|Antimitotic Agents|antimitotic agents|mesh-ancestor
64488193|NCT02240212|Mitosis Modulators|mitosis modulators|mesh-ancestor
64488194|NCT02240212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488195|NCT01047436|Artemether|artemether|mesh-list
64488196|NCT01047436|Quinine|quinine|mesh-list
64488197|NCT01047436|Antimalarials|antimalarials|mesh-ancestor
64488198|NCT01047436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64488199|NCT01047436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64488200|NCT01047436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64488201|NCT01047436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64488202|NCT01047436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488234|NCT03406546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64488235|NCT03406546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488236|NCT03406546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64488237|NCT03406546|Analgesics|analgesics|mesh-ancestor
64488238|NCT03406546|Sensory System Agents|sensory system agents|mesh-ancestor
64488239|NCT03406546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64488240|NCT03406546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64488241|NCT03406546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65347065|NCT00649389|Amlodipine|amlodipine|mesh-list
65347066|NCT00649389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65347067|NCT00649389|Olmesartan|olmesartan|mesh-list
65347068|NCT00649389|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65347069|NCT00649389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65347070|NCT00649389|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65347071|NCT00649389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65347072|NCT00649389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347073|NCT00649389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65347074|NCT00649389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347075|NCT00649389|Vasodilator Agents|vasodilator agents|mesh-ancestor
65347076|NCT00649389|Diuretics|diuretics|mesh-ancestor
65347077|NCT00649389|Natriuretic Agents|natriuretic agents|mesh-ancestor
65347078|NCT00649389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65347079|NCT00649389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65347080|NCT00649389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65347081|NCT00402103|Amlodipine|amlodipine|mesh-list
65347082|NCT00402103|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65347083|NCT00402103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65347084|NCT00402103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65347119|NCT00641667|Analgesics|analgesics|mesh-ancestor
65347120|NCT00641667|Sensory System Agents|sensory system agents|mesh-ancestor
65347121|NCT00641667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65347122|NCT00641667|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65347123|NCT00641667|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65347124|NCT00641667|Anesthetics, General|anesthetics, general|mesh-ancestor
65347125|NCT00641667|Anesthetics|anesthetics|mesh-ancestor
65347126|NCT00704184|Interferons|interferons|mesh-list
65347127|NCT00704184|Ribavirin|ribavirin|mesh-list
65347128|NCT00704184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347129|NCT00704184|Antiviral Agents|antiviral agents|mesh-ancestor
65347130|NCT00704184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65347131|NCT00704184|Antimetabolites|antimetabolites|mesh-ancestor
65347132|NCT00704184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347133|NCT00641043|Pioglitazone|pioglitazone|mesh-list
65347134|NCT00641043|Linagliptin|linagliptin|mesh-list
65347135|NCT00641043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65347136|NCT00641043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347137|NCT00641043|Incretins|incretins|mesh-ancestor
65347138|NCT00641043|Hormones|hormones|mesh-ancestor
65347139|NCT00641043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65347140|NCT00641043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65347141|NCT00641043|Protease Inhibitors|protease inhibitors|mesh-ancestor
65347142|NCT00641043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347143|NCT00641043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347144|NCT02567916|Propofol|propofol|mesh-list
65347145|NCT02567916|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65347146|NCT02567916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64488242|NCT03406546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64488243|NCT03406546|Adrenergic Agents|adrenergic agents|mesh-ancestor
64488244|NCT03406546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64488245|NCT03406546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488246|NCT03406546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64488276|NCT02982694|Growth Substances|growth substances|mesh-ancestor
64488277|NCT02982694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488278|NCT02982694|Growth Inhibitors|growth inhibitors|mesh-ancestor
64488280|NCT01712984|Vaccines|vaccines|mesh-list
64488281|NCT01712984|Immunologic Factors|immunologic factors|mesh-ancestor
64488282|NCT01712984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488283|NCT01712984|Antifungal Agents|antifungal agents|mesh-ancestor
64488284|NCT01712984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64488285|NCT01712984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64488286|NCT01712984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64488287|NCT01712984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488288|NCT01712984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488289|NCT01712984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65347147|NCT02567916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347148|NCT02567916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65347149|NCT02567916|Anesthetics, General|anesthetics, general|mesh-ancestor
65347150|NCT02567916|Anesthetics|anesthetics|mesh-ancestor
65347151|NCT00402025|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
65347152|NCT00402025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65347153|NCT00402025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347154|NCT00609622|Bevacizumab|bevacizumab|mesh-list
65347155|NCT00609622|Sunitinib|sunitinib|mesh-list
65347156|NCT00609622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65347157|NCT00609622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347158|NCT00609622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65347159|NCT00609622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65347160|NCT00609622|Growth Substances|growth substances|mesh-ancestor
65347161|NCT00609622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347162|NCT00609622|Growth Inhibitors|growth inhibitors|mesh-ancestor
65347163|NCT00609622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65347164|NCT00609622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347165|NCT00609622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347166|NCT00818415|Naproxen|naproxen|mesh-list
65347167|NCT00818415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65347168|NCT00818415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65347169|NCT00818415|Analgesics|analgesics|mesh-ancestor
65347170|NCT00818415|Sensory System Agents|sensory system agents|mesh-ancestor
65347171|NCT00818415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65347172|NCT00818415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347173|NCT00818415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64488320|NCT01712516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64488321|NCT01712516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488322|NCT01712516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488324|NCT01040728|Olodaterol|olodaterol|mesh-list
64488325|NCT01040728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64488326|NCT01040728|Autonomic Agents|autonomic agents|mesh-ancestor
64488327|NCT01040728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64488328|NCT01040728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488329|NCT01040728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64488330|NCT01040728|Respiratory System Agents|respiratory system agents|mesh-ancestor
64488331|NCT01040728|Parasympatholytics|parasympatholytics|mesh-ancestor
64488332|NCT01040728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64488333|NCT01040728|Cholinergic Agents|cholinergic agents|mesh-ancestor
64488334|NCT01040728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64488335|NCT01040728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488336|NCT01593020|Paclitaxel|paclitaxel|mesh-list
64488337|NCT01593020|Cyclophosphamide|cyclophosphamide|mesh-list
64488338|NCT01593020|Doxorubicin|doxorubicin|mesh-list
64488339|NCT01593020|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65347174|NCT00818415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65347175|NCT00818415|Gout Suppressants|gout suppressants|mesh-ancestor
65347176|NCT00818415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65347177|NCT00818415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347178|NCT00818415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347179|NCT00815841|Methylphenidate|methylphenidate|mesh-list
65347180|NCT00815841|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65347181|NCT00815841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347182|NCT00815841|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65347183|NCT00815841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65347184|NCT00815841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65347185|NCT00815841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347186|NCT00815841|Dopamine Agents|dopamine agents|mesh-ancestor
65347187|NCT00815841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65347188|NCT03897192|Bevacizumab|bevacizumab|mesh-list
65347189|NCT03897192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65347190|NCT03897192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347191|NCT03897192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65347192|NCT03897192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65347193|NCT03897192|Growth Substances|growth substances|mesh-ancestor
65347194|NCT03897192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347195|NCT03897192|Growth Inhibitors|growth inhibitors|mesh-ancestor
65347196|NCT02567214|Glycopyrrolate|glycopyrrolate|mesh-list
65347197|NCT02567214|Tiotropium Bromide|tiotropium bromide|mesh-list
65347198|NCT02567214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65347199|NCT02567214|Autonomic Agents|autonomic agents|mesh-ancestor
65347200|NCT02567214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64739316|NCT00002555|Trace Elements|trace elements|mesh-ancestor
64488340|NCT01593020|Fluorouracil|fluorouracil|mesh-list
64488341|NCT01593020|Epirubicin|epirubicin|mesh-list
64488342|NCT01593020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64488343|NCT01593020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64488352|NCT01593020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64488354|NCT01593020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64488355|NCT01593020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64488356|NCT01593020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64488357|NCT01593020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64488358|NCT01593020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488359|NCT01593020|Antimetabolites|antimetabolites|mesh-ancestor
64488360|NCT01593020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64488361|NCT01040260|Nicotine|nicotine|mesh-list
64488362|NCT01040260|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64488363|NCT01040260|Autonomic Agents|autonomic agents|mesh-ancestor
64488364|NCT01040260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64488365|NCT01040260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347201|NCT02567214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347202|NCT02567214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65347203|NCT02567214|Respiratory System Agents|respiratory system agents|mesh-ancestor
65347204|NCT02567214|Parasympatholytics|parasympatholytics|mesh-ancestor
65347205|NCT02567214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65347206|NCT02567214|Cholinergic Agents|cholinergic agents|mesh-ancestor
65347207|NCT02567214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65347208|NCT02567214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347209|NCT02567214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65347210|NCT02567214|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65347211|NCT00890110|Sunitinib|sunitinib|mesh-list
65347212|NCT00890110|Vaccines|vaccines|mesh-list
65347213|NCT00890110|Immunologic Factors|immunologic factors|mesh-ancestor
65347214|NCT00890110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347215|NCT00890110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347216|NCT00890110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65347217|NCT00890110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65347218|NCT00890110|Growth Substances|growth substances|mesh-ancestor
65347219|NCT00890110|Growth Inhibitors|growth inhibitors|mesh-ancestor
65347220|NCT00890110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65347221|NCT00890110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347222|NCT00890110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488366|NCT01040260|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64488367|NCT01040260|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64488368|NCT01040260|Cholinergic Agents|cholinergic agents|mesh-ancestor
64488369|NCT01040260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64488370|NCT01040260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488371|NCT01046422|Metformin|metformin|mesh-list
64488372|NCT01046422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64488373|NCT01046422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488374|NCT03405376|Aflibercept|aflibercept|mesh-list
64488375|NCT03405376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64488376|NCT03405376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64488377|NCT03405376|Growth Substances|growth substances|mesh-ancestor
64488378|NCT03405376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488379|NCT03405376|Growth Inhibitors|growth inhibitors|mesh-ancestor
64488380|NCT03405376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64488382|NCT02241460|Anesthetics, Local|anesthetics, local|mesh-ancestor
64488386|NCT02241460|Sensory System Agents|sensory system agents|mesh-ancestor
64555797|NCT04366089|Hydroxychloroquine|hydroxychloroquine|mesh-list
64555798|NCT04366089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64555799|NCT04366089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64555800|NCT04366089|Antimalarials|antimalarials|mesh-ancestor
64555801|NCT04366089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64555802|NCT04366089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64555803|NCT04366089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320874|NCT03535753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488387|NCT02241460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64488388|NCT02241460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64488389|NCT02241460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64488390|NCT02241460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64488391|NCT02241460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65347223|NCT02566824|Methylphenidate|methylphenidate|mesh-list
65347224|NCT02566824|Amphetamine|amphetamine|mesh-list
65347225|NCT02566824|Adderall|adderall|mesh-list
65347226|NCT02566824|Dextroamphetamine|dextroamphetamine|mesh-list
65347227|NCT02566824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65347228|NCT02566824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347229|NCT02566824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65347230|NCT02566824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65347231|NCT02566824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65347232|NCT02566824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347233|NCT02566824|Dopamine Agents|dopamine agents|mesh-ancestor
65347234|NCT02566824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65347235|NCT02566824|Sympathomimetics|sympathomimetics|mesh-ancestor
65347236|NCT02566824|Autonomic Agents|autonomic agents|mesh-ancestor
65347237|NCT02566824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65347238|NCT02566824|Adrenergic Agents|adrenergic agents|mesh-ancestor
65347239|NCT02566824|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65347240|NCT00890188|Thalidomide|thalidomide|mesh-list
65347241|NCT00890188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65347242|NCT00890188|Immunologic Factors|immunologic factors|mesh-ancestor
65347243|NCT00890188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347244|NCT00890188|Leprostatic Agents|leprostatic agents|mesh-ancestor
65347245|NCT00890188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65347246|NCT00890188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65347247|NCT00890188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65347248|NCT00890188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65347249|NCT00890188|Growth Substances|growth substances|mesh-ancestor
65347250|NCT00890188|Growth Inhibitors|growth inhibitors|mesh-ancestor
65347251|NCT00890188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347252|NCT05388942|Nitrous Oxide|nitrous oxide|mesh-list
65347253|NCT05388942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65347254|NCT05388942|Anesthetics, General|anesthetics, general|mesh-ancestor
65347255|NCT05388942|Anesthetics|anesthetics|mesh-ancestor
65347256|NCT05388942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65347257|NCT05388942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347263|NCT04037566|Fludarabine|fludarabine|mesh-list
65347264|NCT04037566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65347265|NCT04037566|Immunologic Factors|immunologic factors|mesh-ancestor
65347266|NCT04037566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347267|NCT04037566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65347268|NCT04037566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65347269|NCT04037566|Alkylating Agents|alkylating agents|mesh-ancestor
65347270|NCT04037566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347271|NCT04037566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347272|NCT04037566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65347273|NCT00888082|Goserelin|goserelin|mesh-list
65347274|NCT00888082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65347275|NCT00888082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347276|NCT00627705|Acetylcysteine|acetylcysteine|mesh-list
65347277|NCT00627705|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65347278|NCT00627705|Antiviral Agents|antiviral agents|mesh-ancestor
65347279|NCT00627705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65347280|NCT00627705|Expectorants|expectorants|mesh-ancestor
65347281|NCT00627705|Respiratory System Agents|respiratory system agents|mesh-ancestor
65347282|NCT00627705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65347283|NCT00627705|Antioxidants|antioxidants|mesh-ancestor
65347284|NCT00627705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347285|NCT00627705|Protective Agents|protective agents|mesh-ancestor
64739404|NCT00002621|Interferons|interferons|mesh-list
64488392|NCT02241460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488393|NCT01712204|Febuxostat|febuxostat|mesh-list
64488394|NCT01712204|Gout Suppressants|gout suppressants|mesh-ancestor
64488395|NCT01712204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64488396|NCT01592864|Fluorides|fluorides|mesh-list
64488397|NCT01592864|Tin Fluorides|tin fluorides|mesh-list
64488398|NCT01592864|Fluorophosphate|fluorophosphate|mesh-list
64488399|NCT01592864|Cariostatic Agents|cariostatic agents|mesh-ancestor
64488400|NCT01592864|Protective Agents|protective agents|mesh-ancestor
64488401|NCT01592864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488402|NCT01592786|Memantine|memantine|mesh-list
64488403|NCT01592786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64488404|NCT01592786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64488405|NCT01592786|Dopamine Agents|dopamine agents|mesh-ancestor
64488406|NCT01592786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64488407|NCT01592786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488408|NCT01592786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488428|NCT01592708|Anesthetics, General|anesthetics, general|mesh-ancestor
64488429|NCT01592708|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64488430|NCT01592708|Narcotics|narcotics|mesh-ancestor
64488431|NCT01592708|Analgesics|analgesics|mesh-ancestor
64488432|NCT01592708|Sensory System Agents|sensory system agents|mesh-ancestor
64488433|NCT01592708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64488434|NCT01592708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64488435|NCT01592708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64488436|NCT01592708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64488437|NCT01592708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64488438|NCT01592708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65347286|NCT00627705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347287|NCT00627705|Antidotes|antidotes|mesh-ancestor
65347288|NCT00610168|Vaccines|vaccines|mesh-list
65347289|NCT00610168|Immunologic Factors|immunologic factors|mesh-ancestor
65347290|NCT00610168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347291|NCT00921102|Atropine|atropine|mesh-list
65347292|NCT00921102|Morphine|morphine|mesh-list
65347293|NCT00921102|Bupivacaine|bupivacaine|mesh-list
65347294|NCT00921102|Anesthetics, Local|anesthetics, local|mesh-list
65347295|NCT00921102|Anesthetics|anesthetics|mesh-list
65347296|NCT00921102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65347297|NCT00921102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347298|NCT00921102|Sensory System Agents|sensory system agents|mesh-ancestor
65347299|NCT00921102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65347300|NCT00921102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65347301|NCT00921102|Narcotics|narcotics|mesh-ancestor
65347302|NCT00921102|Analgesics|analgesics|mesh-ancestor
65347303|NCT00921102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65347304|NCT00921102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65347305|NCT00921102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64488439|NCT01592708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64488440|NCT01592708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488441|NCT01592708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488442|NCT01592708|Autonomic Agents|autonomic agents|mesh-ancestor
64488443|NCT01592708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64488444|NCT01592708|Antipruritics|antipruritics|mesh-ancestor
64488445|NCT01592708|Dermatologic Agents|dermatologic agents|mesh-ancestor
64488446|NCT01592708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64488447|NCT01592708|Serotonin Agents|serotonin agents|mesh-ancestor
64488448|NCT01592708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64488449|NCT01592708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64488450|NCT01592708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64488451|NCT01592708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64488452|NCT01592708|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64488453|NCT01592708|Antitussive Agents|antitussive agents|mesh-ancestor
64488454|NCT01592708|Respiratory System Agents|respiratory system agents|mesh-ancestor
64488455|NCT01592708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64488456|NCT01592708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64488457|NCT01592708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64488459|NCT01592708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64488460|NCT01592708|Cholinergic Agents|cholinergic agents|mesh-ancestor
64488461|NCT01592708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64488462|NCT01592708|Glucocorticoids|glucocorticoids|mesh-ancestor
64488464|NCT01592708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64488465|NCT01592708|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64555804|NCT04366089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555805|NCT04366089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64555808|NCT03079830|Narcotics|narcotics|mesh-ancestor
64555809|NCT03079830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64555810|NCT03079830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555811|NCT03079830|Analgesics|analgesics|mesh-ancestor
64488466|NCT01592708|Protective Agents|protective agents|mesh-ancestor
64488467|NCT01592708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64488468|NCT01592708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64488497|NCT01702532|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64488498|NCT01702532|Autonomic Agents|autonomic agents|mesh-ancestor
64488499|NCT01702532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65347306|NCT00921102|Autonomic Agents|autonomic agents|mesh-ancestor
65347307|NCT00921102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65347308|NCT00921102|Respiratory System Agents|respiratory system agents|mesh-ancestor
65347309|NCT00921102|Mydriatics|mydriatics|mesh-ancestor
65347310|NCT00921102|Parasympatholytics|parasympatholytics|mesh-ancestor
65347311|NCT00921102|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65347312|NCT00921102|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65347313|NCT00921102|Cholinergic Agents|cholinergic agents|mesh-ancestor
65347314|NCT00921102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65347315|NCT00921102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347316|NCT00890500|Sirolimus|sirolimus|mesh-list
65347317|NCT00890500|Fludarabine|fludarabine|mesh-list
65347318|NCT00890500|Melphalan|melphalan|mesh-list
65347319|NCT00890500|Tacrolimus|tacrolimus|mesh-list
65347320|NCT00890500|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65347321|NCT00890500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347322|NCT00890500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347323|NCT00890500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65347324|NCT00890500|Immunologic Factors|immunologic factors|mesh-ancestor
65347325|NCT00890500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347326|NCT00890500|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65347327|NCT00890500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347328|NCT00890500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65347329|NCT00890500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65347330|NCT00890500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65097135|NCT00518583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347331|NCT00890500|Antifungal Agents|antifungal agents|mesh-ancestor
65347332|NCT00890500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65347333|NCT00890500|Alkylating Agents|alkylating agents|mesh-ancestor
65347352|NCT04061772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65347353|NCT04061772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65347354|NCT04061772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65347355|NCT04061772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65347356|NCT04061772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65347357|NCT04061772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347358|NCT04061772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65347359|NCT00644787|Fentanyl|fentanyl|mesh-list
65347360|NCT00644787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65347361|NCT00644787|Narcotics|narcotics|mesh-ancestor
65347362|NCT00644787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65347363|NCT00644787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347364|NCT00644787|Analgesics|analgesics|mesh-ancestor
65347365|NCT00644787|Sensory System Agents|sensory system agents|mesh-ancestor
65347366|NCT00644787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65347367|NCT00644787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65347368|NCT00644787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65347369|NCT00644787|Anesthetics, General|anesthetics, general|mesh-ancestor
65347370|NCT00644787|Anesthetics|anesthetics|mesh-ancestor
65347371|NCT00821301|Fluphenazine|fluphenazine|mesh-list
65347372|NCT00821301|Fluphenazine depot|fluphenazine depot|mesh-list
65347373|NCT00821301|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
65347374|NCT00821301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65347375|NCT00821301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65347376|NCT00821301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65347377|NCT00821301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347383|NCT00699348|Epoetin Alfa|epoetin alfa|mesh-list
65347400|NCT03667690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65347401|NCT03667690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347402|NCT03667690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347403|NCT03667690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65347404|NCT03667690|Hormone Antagonists|hormone antagonists|mesh-ancestor
65347405|NCT03667690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65347406|NCT03667690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347407|NCT03667690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65347408|NCT03667690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65347409|NCT00821535|Maraviroc|maraviroc|mesh-list
65347410|NCT00821535|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65347411|NCT00821535|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65347412|NCT00821535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347413|NCT00821535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65347414|NCT00821535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65347415|NCT00821535|Antiviral Agents|antiviral agents|mesh-ancestor
65347416|NCT00821535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65347417|NCT00821535|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65347418|NCT04062006|Aldesleukin|aldesleukin|mesh-list
65347419|NCT04062006|Interleukin-2|interleukin-2|mesh-list
65347420|NCT04062006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347421|NCT04062006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65347422|NCT04062006|Analgesics|analgesics|mesh-ancestor
65347423|NCT04062006|Sensory System Agents|sensory system agents|mesh-ancestor
65347424|NCT04062006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65347425|NCT04062006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488500|NCT01702532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488501|NCT01702532|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64488502|NCT01702532|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64488503|NCT01702532|Cholinergic Agents|cholinergic agents|mesh-ancestor
64488504|NCT01702532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64488505|NCT01702532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488506|NCT02241616|Entecavir|entecavir|mesh-list
64488507|NCT02241616|Antiviral Agents|antiviral agents|mesh-ancestor
64488508|NCT02241616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64488509|NCT03400306|Paclitaxel|paclitaxel|mesh-list
64488510|NCT03400306|Carboplatin|carboplatin|mesh-list
64488511|NCT03400306|Veliparib|veliparib|mesh-list
64488512|NCT03400306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64488513|NCT03400306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64488514|NCT03400306|Tubulin Modulators|tubulin modulators|mesh-ancestor
64488515|NCT03400306|Antimitotic Agents|antimitotic agents|mesh-ancestor
64488516|NCT03400306|Mitosis Modulators|mitosis modulators|mesh-ancestor
64488539|NCT03404908|Anesthetics, Local|anesthetics, local|mesh-ancestor
64488540|NCT03404908|Anesthetics|anesthetics|mesh-ancestor
64488541|NCT03404908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64488542|NCT03404908|Antipyretics|antipyretics|mesh-ancestor
65347426|NCT04062006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65347427|NCT04062006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65347428|NCT04062006|Antiviral Agents|antiviral agents|mesh-ancestor
65347429|NCT04062006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65347430|NCT04872582|Bevacizumab|bevacizumab|mesh-list
65347431|NCT04872582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65347432|NCT04872582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65347433|NCT04872582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347434|NCT04872582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65347435|NCT04872582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65347436|NCT04872582|Growth Substances|growth substances|mesh-ancestor
65347437|NCT04872582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347438|NCT04872582|Growth Inhibitors|growth inhibitors|mesh-ancestor
65347439|NCT04872582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347440|NCT04061538|Zinc|zinc|mesh-list
65347441|NCT04061538|Zinc Sulfate|zinc sulfate|mesh-list
65347442|NCT04061538|Trace Elements|trace elements|mesh-ancestor
65347443|NCT04061538|Micronutrients|micronutrients|mesh-ancestor
65347444|NCT04061538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347445|NCT04061538|Astringents|astringents|mesh-ancestor
65347446|NCT04061538|Dermatologic Agents|dermatologic agents|mesh-ancestor
65347447|NCT04351620|Hydroxychloroquine|hydroxychloroquine|mesh-list
65347448|NCT04351620|Antimalarials|antimalarials|mesh-ancestor
65347449|NCT04351620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65347450|NCT04351620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65347451|NCT04351620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65347452|NCT04351620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347453|NCT04351620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347454|NCT04351620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65347455|NCT00888394|Imidacloprid|imidacloprid|mesh-list
65347456|NCT00888394|Cholinergic Agents|cholinergic agents|mesh-ancestor
65347457|NCT00888394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65019543|NCT02917018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64488543|NCT03404908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64488544|NCT03404908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64488545|NCT03404908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64488546|NCT03404908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64488547|NCT03404908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488548|NCT03404908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488549|NCT01702298|Metformin|metformin|mesh-list
64488550|NCT01702298|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64488551|NCT01702298|Simvastatin|simvastatin|mesh-list
64488552|NCT01702298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64488553|NCT01702298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347458|NCT00888394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347459|NCT00888394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347460|NCT02541760|Mometasone Furoate|mometasone furoate|mesh-list
65347461|NCT02541760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65347462|NCT02541760|Dermatologic Agents|dermatologic agents|mesh-ancestor
65347463|NCT02541760|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65347464|NCT00627393|Anti-Infective Agents|anti-infective agents|mesh-list
65347465|NCT00627393|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65347466|NCT00627393|Dexamethasone|dexamethasone|mesh-list
65347467|NCT00627393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65347468|NCT00627393|Antiemetics|antiemetics|mesh-ancestor
65347469|NCT00627393|Autonomic Agents|autonomic agents|mesh-ancestor
65347470|NCT00627393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65347471|NCT00627393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347472|NCT00627393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65347473|NCT00627393|Glucocorticoids|glucocorticoids|mesh-ancestor
65347474|NCT00627393|Hormones|hormones|mesh-ancestor
65347475|NCT00627393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65347476|NCT00627393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65347477|NCT00627393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347478|NCT00577122|Cyclophosphamide|cyclophosphamide|mesh-list
65347479|NCT00577122|Methotrexate|methotrexate|mesh-list
65347480|NCT00577122|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64739603|NCT00002717|Paclitaxel|paclitaxel|mesh-list
64488554|NCT01702298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64488555|NCT01702298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64488556|NCT01702298|Antimetabolites|antimetabolites|mesh-ancestor
64488557|NCT01702298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488558|NCT01702298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64488559|NCT01702298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64488560|NCT01702298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488561|NCT01702298|Incretins|incretins|mesh-ancestor
64488562|NCT01702298|Hormones|hormones|mesh-ancestor
64488563|NCT01702298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64488564|NCT01702298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64488565|NCT01702298|Protease Inhibitors|protease inhibitors|mesh-ancestor
64488566|NCT03404752|Lenograstim|lenograstim|mesh-list
64488567|NCT03404752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64488568|NCT03404752|Immunologic Factors|immunologic factors|mesh-ancestor
64488569|NCT03404752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488570|NCT03401710|Epoetin Alfa|epoetin alfa|mesh-list
64488591|NCT01701362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488592|NCT01701362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64488593|NCT01701362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64488594|NCT01701362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64555812|NCT03079830|Sensory System Agents|sensory system agents|mesh-ancestor
64555813|NCT03079830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64555814|NCT02242695|Clotrimazole|clotrimazole|mesh-list
64555815|NCT02242695|Dequalinium|dequalinium|mesh-list
64555816|NCT02242695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65347481|NCT00577122|Medroxyprogesterone|medroxyprogesterone|mesh-list
65347482|NCT00577122|Progesterone|progesterone|mesh-list
65097281|NCT00520338|Celecoxib|celecoxib|mesh-list
65347483|NCT00577122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65347484|NCT00577122|Immunologic Factors|immunologic factors|mesh-ancestor
65347485|NCT00577122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347486|NCT00577122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65347487|NCT00577122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65347488|NCT00577122|Alkylating Agents|alkylating agents|mesh-ancestor
65347489|NCT00577122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347490|NCT00577122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347491|NCT00577122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65347492|NCT00577122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65347493|NCT00577122|Abortifacient Agents|abortifacient agents|mesh-ancestor
65347494|NCT00577122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65347496|NCT00577122|Antimetabolites|antimetabolites|mesh-ancestor
65347535|NCT00696774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65347536|NCT00696774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347537|NCT00696774|Analgesics|analgesics|mesh-ancestor
65347538|NCT00696774|Sensory System Agents|sensory system agents|mesh-ancestor
65347539|NCT00696774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65347540|NCT00696774|Antidepressive Agents|antidepressive agents|mesh-ancestor
65347541|NCT00696774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65347542|NCT00696774|Dopamine Agents|dopamine agents|mesh-ancestor
65347543|NCT00608842|Deoxycholic Acid|deoxycholic acid|mesh-list
65347544|NCT00608842|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65347545|NCT00608842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65347546|NCT00626925|Topiramate|topiramate|mesh-list
65347547|NCT00626925|Anticonvulsants|anticonvulsants|mesh-ancestor
65347548|NCT00626925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65347549|NCT00626925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347550|NCT00816543|Docetaxel|docetaxel|mesh-list
65347551|NCT00816543|Oxaliplatin|oxaliplatin|mesh-list
65347552|NCT00816543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347553|NCT00816543|Tubulin Modulators|tubulin modulators|mesh-ancestor
65347554|NCT00816543|Antimitotic Agents|antimitotic agents|mesh-ancestor
65347555|NCT00816543|Mitosis Modulators|mitosis modulators|mesh-ancestor
65347556|NCT00816543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347557|NCT00698646|Valsartan|valsartan|mesh-list
65347558|NCT00698646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65347559|NCT00698646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65347560|NCT00698646|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65347561|NCT00698646|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65347562|NCT00698646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347563|NCT00698646|Diuretics|diuretics|mesh-ancestor
65347564|NCT00698646|Natriuretic Agents|natriuretic agents|mesh-ancestor
65347565|NCT00698646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739685|NCT00002759|GABA Agents|gaba agents|mesh-ancestor
64555817|NCT02242695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64555818|NCT02242695|Antifungal Agents|antifungal agents|mesh-ancestor
64555819|NCT02242695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64320888|NCT03535519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64488598|NCT00919126|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64488600|NCT00919126|Anesthetics|anesthetics|mesh-ancestor
64488601|NCT00919126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64488602|NCT00919126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488603|NCT01710800|Esomeprazole|esomeprazole|mesh-list
64488604|NCT01710800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64488605|NCT01710800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64488606|NCT01710800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65347566|NCT00698646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65347567|NCT00698646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65347568|NCT04625907|Dactinomycin|dactinomycin|mesh-list
65347569|NCT04625907|Cyclophosphamide|cyclophosphamide|mesh-list
65347570|NCT04625907|Temozolomide|temozolomide|mesh-list
65347571|NCT04625907|Ifosfamide|ifosfamide|mesh-list
65347572|NCT04625907|Doxorubicin|doxorubicin|mesh-list
65347573|NCT04625907|Irinotecan|irinotecan|mesh-list
65347574|NCT04625907|Vincristine|vincristine|mesh-list
65347575|NCT04625907|Vinorelbine|vinorelbine|mesh-list
65347576|NCT04625907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65347577|NCT04625907|Immunologic Factors|immunologic factors|mesh-ancestor
65347578|NCT04625907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347579|NCT04625907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65347580|NCT04625907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65347581|NCT04625907|Alkylating Agents|alkylating agents|mesh-ancestor
65347582|NCT04625907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347583|NCT04625907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347598|NCT02565888|Ritonavir|ritonavir|mesh-list
65347624|NCT00822315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347625|NCT00822315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347626|NCT00822315|Antiviral Agents|antiviral agents|mesh-ancestor
65347627|NCT00822315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65347628|NCT00822315|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65347629|NCT00822315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65347630|NCT00822315|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65347631|NCT00822315|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65347632|NCT00822315|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65347633|NCT00822315|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65347634|NCT00822315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65347635|NCT00822315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65347636|NCT00822315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65347637|NCT00822315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65347638|NCT00696696|Gemcitabine|gemcitabine|mesh-list
65347639|NCT00696696|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65347640|NCT00696696|Sorafenib|sorafenib|mesh-list
65347641|NCT00696696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65347642|NCT00696696|Antimetabolites|antimetabolites|mesh-ancestor
65347643|NCT00696696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347644|NCT00696696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347645|NCT00696696|Antiviral Agents|antiviral agents|mesh-ancestor
65347646|NCT00696696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739775|NCT00381953|Interferons|interferons|mesh-list
64488607|NCT01710800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488608|NCT01710800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488609|NCT01710020|Tofacitinib|tofacitinib|mesh-list
64488610|NCT01710020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64488611|NCT01710020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488612|NCT01710020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488614|NCT02982850|Warfarin|warfarin|mesh-list
64488615|NCT02982850|Dabigatran|dabigatran|mesh-list
64488616|NCT02982850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64488617|NCT02982850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64488618|NCT02982850|Analgesics|analgesics|mesh-ancestor
64488619|NCT02982850|Sensory System Agents|sensory system agents|mesh-ancestor
64488620|NCT02982850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64488621|NCT02982850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488622|NCT02982850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64488623|NCT02982850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64488624|NCT02982850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64488653|NCT02242240|Parasympatholytics|parasympatholytics|mesh-ancestor
64488654|NCT02242240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64488655|NCT02242240|Cholinergic Agents|cholinergic agents|mesh-ancestor
64488656|NCT03403972|Vancomycin|vancomycin|mesh-list
64488657|NCT03403972|Simvastatin|simvastatin|mesh-list
64488658|NCT03403972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64488659|NCT03403972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64488660|NCT03403972|Antimetabolites|antimetabolites|mesh-ancestor
65347647|NCT00696696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347648|NCT00696696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65347649|NCT00696696|Immunologic Factors|immunologic factors|mesh-ancestor
65347650|NCT00696696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347651|NCT00696696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65347652|NCT00822393|Busulfan|busulfan|mesh-list
65347653|NCT00822393|Treosulfan|treosulfan|mesh-list
65347654|NCT00822393|Alkylating Agents|alkylating agents|mesh-ancestor
65347655|NCT00822393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347656|NCT00822393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65347657|NCT00822393|Immunologic Factors|immunologic factors|mesh-ancestor
65347658|NCT00822393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347659|NCT00822393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65347660|NCT00822393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347661|NCT00822393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65347662|NCT00819195|Glatiramer Acetate|glatiramer acetate|mesh-list
65347663|NCT00819195|(T,G)-A-L|(t,g)-a-l|mesh-list
65347664|NCT00819195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65347665|NCT00819195|Immunologic Factors|immunologic factors|mesh-ancestor
65347666|NCT00819195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347667|NCT00819195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65347668|NCT00819195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65347669|NCT00892918|Moxifloxacin|moxifloxacin|mesh-list
65347670|NCT00892918|Gatifloxacin|gatifloxacin|mesh-list
65347671|NCT00892918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65347672|NCT00892918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65347673|NCT00892918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65347674|NCT00892918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65347675|NCT00892918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65347676|NCT00892918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65347677|NCT00892918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347678|NCT00892918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347679|NCT00892918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347680|NCT00892996|Dexamethasone|dexamethasone|mesh-list
65347681|NCT00892996|Dexamethasone acetate|dexamethasone acetate|mesh-list
65347687|NCT00892996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347688|NCT00892996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65347689|NCT00892996|Glucocorticoids|glucocorticoids|mesh-ancestor
65347690|NCT00892996|Hormones|hormones|mesh-ancestor
65347691|NCT00892996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65347692|NCT00892996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65347693|NCT00892996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347694|NCT00892996|Protease Inhibitors|protease inhibitors|mesh-ancestor
65347695|NCT00892996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347696|NCT00892996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347697|NCT00891670|Aspirin|aspirin|mesh-list
65347698|NCT00891670|Cilostazol|cilostazol|mesh-list
65347699|NCT00891670|Clopidogrel|clopidogrel|mesh-list
65347700|NCT00891670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65347701|NCT00891670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65347702|NCT00891670|Analgesics|analgesics|mesh-ancestor
65347703|NCT00891670|Sensory System Agents|sensory system agents|mesh-ancestor
65347704|NCT00891670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65347705|NCT00891670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347706|NCT00891670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65347707|NCT00891670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65097495|NCT05144945|Vaccines|vaccines|mesh-list
65347708|NCT00891670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65347709|NCT00891670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65347710|NCT00891670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347711|NCT00891670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65347712|NCT00891670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64488661|NCT03403972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488662|NCT03403972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64488663|NCT03403972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64488664|NCT03403972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488665|NCT03403972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64488666|NCT03403972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64488667|NCT02242318|Valsartan|valsartan|mesh-list
64488668|NCT02242318|Telmisartan|telmisartan|mesh-list
64488669|NCT02242318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64488670|NCT02242318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64488687|NCT01700192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64488688|NCT01700192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64488689|NCT01700192|Respiratory System Agents|respiratory system agents|mesh-ancestor
64488690|NCT01700192|Mydriatics|mydriatics|mesh-ancestor
64488691|NCT01700192|Sympathomimetics|sympathomimetics|mesh-ancestor
64488692|NCT01700192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64488693|NCT01700192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64555820|NCT02242695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65347713|NCT00891670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347714|NCT00891670|Antipyretics|antipyretics|mesh-ancestor
65347715|NCT00891670|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65347716|NCT00891670|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65347717|NCT00891670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65347718|NCT00891670|Purinergic Agents|purinergic agents|mesh-ancestor
65347719|NCT00891670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65347720|NCT00891670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65347721|NCT00891670|Autonomic Agents|autonomic agents|mesh-ancestor
65347722|NCT00891670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65347723|NCT00891670|Respiratory System Agents|respiratory system agents|mesh-ancestor
65347724|NCT00891670|Vasodilator Agents|vasodilator agents|mesh-ancestor
65347725|NCT00891670|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65347726|NCT00891670|Protective Agents|protective agents|mesh-ancestor
65347727|NCT00891670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65347728|NCT00891670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65347729|NCT00699192|Amlodipine|amlodipine|mesh-list
65347730|NCT00699192|Valsartan|valsartan|mesh-list
65347731|NCT00699192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65347732|NCT00699192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65347733|NCT00699192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65347734|NCT00699192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347735|NCT00699192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65347736|NCT00699192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347737|NCT00699192|Vasodilator Agents|vasodilator agents|mesh-ancestor
65347738|NCT00699192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65347739|NCT00699192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65347740|NCT00921180|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65347741|NCT00921180|Interferon-alpha|interferon-alpha|mesh-list
65347742|NCT00921180|Entecavir|entecavir|mesh-list
65347743|NCT00921180|Antiviral Agents|antiviral agents|mesh-ancestor
65347744|NCT00921180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65347745|NCT00921180|Immunologic Factors|immunologic factors|mesh-ancestor
65347746|NCT00921180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347747|NCT04161066|Psilocybin|psilocybin|mesh-list
64555821|NCT02242695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555822|NCT02242695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555823|NCT02242695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64555824|NCT02242695|Hormone Antagonists|hormone antagonists|mesh-ancestor
64488694|NCT01700192|Dermatologic Agents|dermatologic agents|mesh-ancestor
65347748|NCT04161066|Hallucinogens|hallucinogens|mesh-ancestor
65347749|NCT04161066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347750|NCT04161066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65347751|NCT04671810|Eculizumab|eculizumab|mesh-list
65347752|NCT04671810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65347753|NCT04671810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65347754|NCT04671810|Immunologic Factors|immunologic factors|mesh-ancestor
65347755|NCT04671810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347756|NCT00893542|Mycophenolic Acid|mycophenolic acid|mesh-list
65347757|NCT00893542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65347758|NCT00893542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347759|NCT00893542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65347760|NCT00893542|Antitubercular Agents|antitubercular agents|mesh-ancestor
65347761|NCT00893542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65347762|NCT00893542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65347763|NCT00893542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347764|NCT00893542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347765|NCT04668144|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65347766|NCT04668144|Cangrelor|cangrelor|mesh-list
65347767|NCT04668144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65347768|NCT04668144|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65347769|NCT04668144|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65347770|NCT04668144|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65347771|NCT04668144|Purinergic Agents|purinergic agents|mesh-ancestor
65347772|NCT04668144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65347773|NCT04668144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347774|NCT04668144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347775|NCT00401245|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65347776|NCT00401245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65347777|NCT00401245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64488695|NCT01700192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64488696|NCT01700192|Antipruritics|antipruritics|mesh-ancestor
64488697|NCT01700192|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64488698|NCT01700192|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64488699|NCT01700192|Histamine Antagonists|histamine antagonists|mesh-ancestor
64488700|NCT01700192|Histamine Agents|histamine agents|mesh-ancestor
64488701|NCT01700192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64488702|NCT01700192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64488703|NCT01700192|Analgesics|analgesics|mesh-ancestor
64488704|NCT01700192|Sensory System Agents|sensory system agents|mesh-ancestor
64488705|NCT01700192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64739929|NCT05215691|Morphine|morphine|mesh-list
65347778|NCT00401245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65347779|NCT00401245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347780|NCT00401245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65347781|NCT00401245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347782|NCT00401245|Antidepressive Agents|antidepressive agents|mesh-ancestor
65347783|NCT00401245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65347784|NCT04661280|Donepezil|donepezil|mesh-list
65347785|NCT04661280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65347786|NCT04661280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347787|NCT04661280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347788|NCT04661280|Cholinergic Agents|cholinergic agents|mesh-ancestor
65347789|NCT04661280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65347790|NCT04661280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347791|NCT04661280|Nootropic Agents|nootropic agents|mesh-ancestor
65347792|NCT00696384|Antihypertensive Agents|antihypertensive agents|mesh-list
65347793|NCT00696384|Chlorthalidone|chlorthalidone|mesh-list
65347794|NCT00696384|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65347795|NCT00696384|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65347796|NCT00696384|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64488706|NCT01700192|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64488712|NCT02242396|Natriuretic Agents|natriuretic agents|mesh-ancestor
64488713|NCT02242396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488714|NCT02242396|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64488715|NCT02242396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64488716|NCT02242396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488717|NCT02242396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64488718|NCT02242396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64488719|NCT02242474|Adalimumab|adalimumab|mesh-list
64488720|NCT02242474|Etanercept|etanercept|mesh-list
64488721|NCT02242474|Golimumab|golimumab|mesh-list
64488722|NCT02242474|Infliximab|infliximab|mesh-list
64488723|NCT02242474|Certolizumab Pegol|certolizumab pegol|mesh-list
64488724|NCT02242474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64488725|NCT02242474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64488726|NCT02242474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64488727|NCT02242474|Dermatologic Agents|dermatologic agents|mesh-ancestor
64488752|NCT04878315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64488754|NCT04878315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488755|NCT04878315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488756|NCT04878315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64488757|NCT04374604|Mitogens|mitogens|mesh-list
64488758|NCT04374604|Mitosis Modulators|mitosis modulators|mesh-ancestor
64488759|NCT04374604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488760|NCT02242864|Telmisartan|telmisartan|mesh-list
64488761|NCT02242864|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
64488762|NCT02242864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64488763|NCT02242864|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64488764|NCT02242864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64488765|NCT02242864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488766|NCT02242864|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65347797|NCT00696384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347798|NCT00696384|Diuretics|diuretics|mesh-ancestor
65347799|NCT00696384|Natriuretic Agents|natriuretic agents|mesh-ancestor
65347800|NCT00696384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347801|NCT00696384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65347802|NCT00696384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65347803|NCT01041625|Apremilast|apremilast|mesh-list
65347804|NCT01041625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65347805|NCT01041625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65347806|NCT01041625|Analgesics|analgesics|mesh-ancestor
65347807|NCT01041625|Sensory System Agents|sensory system agents|mesh-ancestor
65347808|NCT01041625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65347809|NCT01041625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347810|NCT01041625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65347811|NCT01041625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65347812|NCT01041625|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65347813|NCT01041625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65347814|NCT01041625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347815|NCT01041625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347816|NCT02566356|Oxytocin|oxytocin|mesh-list
64488767|NCT02242864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64488768|NCT02242864|Diuretics|diuretics|mesh-ancestor
64488769|NCT02242864|Natriuretic Agents|natriuretic agents|mesh-ancestor
64488770|NCT02242864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488771|NCT01709708|Bupivacaine|bupivacaine|mesh-list
64488772|NCT01709708|Anesthetics, Local|anesthetics, local|mesh-ancestor
64488773|NCT01709708|Anesthetics|anesthetics|mesh-ancestor
64488820|NCT02243254|Ibuprofen|ibuprofen|mesh-list
64488821|NCT02243254|Remifentanil|remifentanil|mesh-list
64488822|NCT02243254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64488823|NCT02243254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64488824|NCT02243254|Analgesics|analgesics|mesh-ancestor
64488825|NCT02243254|Sensory System Agents|sensory system agents|mesh-ancestor
64555825|NCT02242695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64555826|NCT02242695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555827|NCT04999800|Pembrolizumab|pembrolizumab|mesh-list
64555828|NCT04999800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64555829|NCT04999800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555830|NCT02242851|Telmisartan|telmisartan|mesh-list
64555831|NCT02242851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64555832|NCT02242851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64555833|NCT02242851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64555834|NCT02242851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555835|NCT04999878|Gemcitabine|gemcitabine|mesh-list
64488826|NCT02243254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64488827|NCT02243254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488828|NCT02243254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64488829|NCT02243254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64488830|NCT02243254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64488831|NCT02243254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488832|NCT02243254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488833|NCT02243254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64488834|NCT02243254|Narcotics|narcotics|mesh-ancestor
65347817|NCT02566356|Oxytocics|oxytocics|mesh-ancestor
65347818|NCT02566356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65347819|NCT02566356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347820|NCT00892450|Oxybutynin|oxybutynin|mesh-list
65347821|NCT00892450|Darifenacin|darifenacin|mesh-list
65347822|NCT00892450|Parasympatholytics|parasympatholytics|mesh-ancestor
65347823|NCT00892450|Autonomic Agents|autonomic agents|mesh-ancestor
65347824|NCT00892450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65347825|NCT00892450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347826|NCT00892450|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65347827|NCT00892450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65347828|NCT00892450|Cholinergic Agents|cholinergic agents|mesh-ancestor
65347829|NCT00892450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65347830|NCT00892450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347831|NCT00892450|Urological Agents|urological agents|mesh-ancestor
65347832|NCT01566565|Theophylline|theophylline|mesh-list
65347833|NCT01566565|Bambuterol|bambuterol|mesh-list
65347834|NCT01566565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65347835|NCT01566565|Autonomic Agents|autonomic agents|mesh-ancestor
65347836|NCT01566565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65347837|NCT01566565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347838|NCT01566565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65347839|NCT01566565|Respiratory System Agents|respiratory system agents|mesh-ancestor
65347840|NCT01566565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65347841|NCT01566565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347842|NCT01566565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347843|NCT01566565|Vasodilator Agents|vasodilator agents|mesh-ancestor
64739970|NCT05406713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64488837|NCT03402880|Immunoglobulins|immunoglobulins|mesh-list
64488838|NCT03402880|Immunoglobulin G|immunoglobulin g|mesh-list
64488839|NCT03402880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64488840|NCT03402880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64488841|NCT03402880|Immunologic Factors|immunologic factors|mesh-ancestor
64488842|NCT03402880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488844|NCT01673997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64488845|NCT01673997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64488846|NCT01673997|Sympatholytics|sympatholytics|mesh-ancestor
64488847|NCT01673997|Autonomic Agents|autonomic agents|mesh-ancestor
64488848|NCT01673997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64488849|NCT01673997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488850|NCT01673997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64488851|NCT01673997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64488852|NCT01673997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64488853|NCT01673997|Adrenergic Agents|adrenergic agents|mesh-ancestor
64488854|NCT01673997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64488855|NCT01673997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488856|NCT04373824|Ivermectin|ivermectin|mesh-list
65347844|NCT01566565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65347845|NCT01566565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65347846|NCT01566565|Purinergic Agents|purinergic agents|mesh-ancestor
65347847|NCT01566565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65347848|NCT01039363|Cytarabine|cytarabine|mesh-list
65347849|NCT01039363|Vorinostat|vorinostat|mesh-list
65347850|NCT01039363|Idarubicin|idarubicin|mesh-list
65347851|NCT01039363|Gemtuzumab|gemtuzumab|mesh-list
65347852|NCT01039363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65347853|NCT01039363|Antimetabolites|antimetabolites|mesh-ancestor
65347854|NCT01039363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347855|NCT01039363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097646|NCT00523185|GABA Modulators|gaba modulators|mesh-ancestor
65347856|NCT01039363|Antiviral Agents|antiviral agents|mesh-ancestor
65347857|NCT01039363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65347858|NCT01039363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65347859|NCT01039363|Immunologic Factors|immunologic factors|mesh-ancestor
65347860|NCT01039363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347861|NCT01039363|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65347862|NCT01039363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347863|NCT01039363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65347864|NCT01039363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65347865|NCT01039363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65347866|NCT01039363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65347867|NCT01039441|Bupivacaine|bupivacaine|mesh-list
65347868|NCT01039441|Anesthetics, Local|anesthetics, local|mesh-ancestor
65347869|NCT01039441|Anesthetics|anesthetics|mesh-ancestor
65347870|NCT01039441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65347871|NCT01039441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347872|NCT01039441|Sensory System Agents|sensory system agents|mesh-ancestor
65347873|NCT01039441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65347874|NCT01034917|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65347876|NCT01034917|Antiviral Agents|antiviral agents|mesh-ancestor
65347877|NCT01034917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65347878|NCT01034917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65347882|NCT00816699|Anesthetics|anesthetics|mesh-list
65347883|NCT00816699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65347884|NCT00816699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347885|NCT00822549|Morphine|morphine|mesh-list
65347886|NCT00822549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65347887|NCT00822549|Narcotics|narcotics|mesh-ancestor
65347888|NCT00822549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65347889|NCT00822549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347890|NCT00822549|Analgesics|analgesics|mesh-ancestor
65347891|NCT00822549|Sensory System Agents|sensory system agents|mesh-ancestor
65347892|NCT00822549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65347893|NCT00819351|Asparaginase|asparaginase|mesh-list
65347894|NCT00819351|Pegaspargase|pegaspargase|mesh-list
65347895|NCT00819351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347896|NCT00699998|Aspirin|aspirin|mesh-list
65347897|NCT00699998|Clopidogrel|clopidogrel|mesh-list
65347898|NCT00699998|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65347899|NCT00699998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65347900|NCT00699998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65347901|NCT00699998|Analgesics|analgesics|mesh-ancestor
65347902|NCT00699998|Sensory System Agents|sensory system agents|mesh-ancestor
65347903|NCT00699998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65347904|NCT00699998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347905|NCT00699998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65347906|NCT00699998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65347907|NCT00699998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65347908|NCT00699998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65347909|NCT00699998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488857|NCT04373824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64488858|NCT04373824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64488859|NCT01676571|Vortioxetine|vortioxetine|mesh-list
64488860|NCT01676571|Antidepressive Agents|antidepressive agents|mesh-ancestor
64488861|NCT01676571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64488862|NCT01676571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64488863|NCT01676571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64488864|NCT01676571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64488865|NCT01676571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488866|NCT01676571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64488867|NCT01676571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64488868|NCT01676571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64488869|NCT01676571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488870|NCT01676571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64488871|NCT01676571|Serotonin Agents|serotonin agents|mesh-ancestor
64488888|NCT02077959|Lenalidomide|lenalidomide|mesh-list
64488889|NCT02077959|Pidilizumab|pidilizumab|mesh-list
64488890|NCT02077959|Immunologic Factors|immunologic factors|mesh-ancestor
64555836|NCT04999878|Dexamethasone|dexamethasone|mesh-list
64555838|NCT04999878|Cisplatin|cisplatin|mesh-list
64555839|NCT04999878|Pegaspargase|pegaspargase|mesh-list
65347910|NCT00699998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65347911|NCT00699998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65347912|NCT00699998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347913|NCT00699998|Antipyretics|antipyretics|mesh-ancestor
65347914|NCT00699998|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65347915|NCT00699998|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65347916|NCT00699998|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65347917|NCT00699998|Purinergic Agents|purinergic agents|mesh-ancestor
65347918|NCT00699998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65347919|NCT00696072|Letrozole|letrozole|mesh-list
65347920|NCT00696072|Dasatinib|dasatinib|mesh-list
65347921|NCT00696072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347922|NCT00696072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65347923|NCT00696072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65347924|NCT00696072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65347925|NCT00696072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347926|NCT00696072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65347927|NCT00696072|Hormone Antagonists|hormone antagonists|mesh-ancestor
64740065|NCT05312255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64555840|NCT04999878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64555841|NCT04999878|Antiemetics|antiemetics|mesh-ancestor
64555842|NCT04999878|Autonomic Agents|autonomic agents|mesh-ancestor
64555843|NCT04999878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64488891|NCT02077959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488892|NCT02077959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64488894|NCT02077959|Growth Substances|growth substances|mesh-ancestor
64488895|NCT02077959|Growth Inhibitors|growth inhibitors|mesh-ancestor
64488896|NCT02077959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64488897|NCT02077959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64488898|NCT04548518|Vaccines|vaccines|mesh-list
64488899|NCT04548518|Immunologic Factors|immunologic factors|mesh-ancestor
64488900|NCT04548518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488901|NCT01699022|CycloProvera|cycloprovera|mesh-list
64488902|NCT01699022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64488903|NCT01699022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64488913|NCT01670175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64488914|NCT01670175|Immunologic Factors|immunologic factors|mesh-ancestor
64488915|NCT01670175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488916|NCT01670175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64488917|NCT01670175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64488918|NCT01670175|Alkylating Agents|alkylating agents|mesh-ancestor
64488919|NCT01670175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488920|NCT01670175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64488921|NCT01670175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64488922|NCT01670175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64488923|NCT01670175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64488924|NCT01670175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64488925|NCT01670175|Antifungal Agents|antifungal agents|mesh-ancestor
64488926|NCT01670175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64488967|NCT01988883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64488981|NCT04373356|Sodium Fluoride|sodium fluoride|mesh-list
64488982|NCT04373356|Fluorides, Topical|fluorides, topical|mesh-list
64488983|NCT04373356|Cariostatic Agents|cariostatic agents|mesh-ancestor
64488984|NCT04373356|Protective Agents|protective agents|mesh-ancestor
64488985|NCT04373356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347928|NCT00696072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65066813|NCT00272636|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65347929|NCT00696072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347930|NCT00696072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65347931|NCT00816855|Docetaxel|docetaxel|mesh-list
65347932|NCT00816855|Fluorouracil|fluorouracil|mesh-list
65347933|NCT00816855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65347934|NCT00816855|Tubulin Modulators|tubulin modulators|mesh-ancestor
64488986|NCT04373356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64488987|NCT04373356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64488988|NCT01745757|Paclitaxel|paclitaxel|mesh-list
64488989|NCT01745757|Bevacizumab|bevacizumab|mesh-list
64488990|NCT01745757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64488991|NCT01745757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64488992|NCT01745757|Tubulin Modulators|tubulin modulators|mesh-ancestor
64555844|NCT04999878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555845|NCT04999878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64555846|NCT04999878|Glucocorticoids|glucocorticoids|mesh-ancestor
64555848|NCT04999878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64555849|NCT04999878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64555850|NCT04999878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320915|NCT04291508|Analgesics|analgesics|mesh-ancestor
64488993|NCT01745757|Antimitotic Agents|antimitotic agents|mesh-ancestor
64488994|NCT01745757|Mitosis Modulators|mitosis modulators|mesh-ancestor
64488995|NCT01745757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488996|NCT01745757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64488998|NCT01745757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64488999|NCT01745757|Growth Substances|growth substances|mesh-ancestor
64489000|NCT01745757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489001|NCT01745757|Growth Inhibitors|growth inhibitors|mesh-ancestor
64489002|NCT01709162|Ipilimumab|ipilimumab|mesh-list
64489003|NCT01709162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64489004|NCT01709162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489024|NCT01698554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64489025|NCT01698554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64489026|NCT04404855|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64489027|NCT04404855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64489028|NCT00895791|Umirolimus|umirolimus|mesh-list
64489029|NCT00895791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64489030|NCT00895791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64489031|NCT00895791|Immunologic Factors|immunologic factors|mesh-ancestor
64489032|NCT00895791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489033|NCT01698320|Albuterol|albuterol|mesh-list
64489034|NCT01698320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64489035|NCT01698320|Autonomic Agents|autonomic agents|mesh-ancestor
64489036|NCT01698320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64489037|NCT01698320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489038|NCT01698320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64489039|NCT01698320|Respiratory System Agents|respiratory system agents|mesh-ancestor
64489040|NCT01698320|Tocolytic Agents|tocolytic agents|mesh-ancestor
64489041|NCT01698320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64489042|NCT01698320|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64489043|NCT01698320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64489044|NCT01698320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64489045|NCT01698320|Adrenergic Agents|adrenergic agents|mesh-ancestor
64489046|NCT01698320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64489047|NCT01698320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489048|NCT03401476|Morphine|morphine|mesh-list
64489049|NCT03401476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64489050|NCT03401476|Narcotics|narcotics|mesh-ancestor
64489051|NCT03401476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64489052|NCT03401476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489053|NCT03401476|Analgesics|analgesics|mesh-ancestor
64489054|NCT03401476|Sensory System Agents|sensory system agents|mesh-ancestor
64489055|NCT03401476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64489056|NCT01674777|Ipragliflozin|ipragliflozin|mesh-list
65347935|NCT00816855|Antimitotic Agents|antimitotic agents|mesh-ancestor
65347936|NCT00816855|Mitosis Modulators|mitosis modulators|mesh-ancestor
65347937|NCT00816855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65347938|NCT00816855|Antimetabolites|antimetabolites|mesh-ancestor
65347939|NCT00816855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65347940|NCT00816855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65347941|NCT00816855|Immunologic Factors|immunologic factors|mesh-ancestor
65347942|NCT00816855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65347943|NCT00822783|Omalizumab|omalizumab|mesh-list
65347944|NCT00822783|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65347945|NCT00822783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65347946|NCT00822783|Respiratory System Agents|respiratory system agents|mesh-ancestor
65347947|NCT00634647|Prednisone|prednisone|mesh-list
65347948|NCT00634647|Satraplatin|satraplatin|mesh-list
65347949|NCT00634647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65347950|NCT00634647|Glucocorticoids|glucocorticoids|mesh-ancestor
65347994|NCT00817011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65347995|NCT00817011|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65347996|NCT00817011|Serotonin Agents|serotonin agents|mesh-ancestor
65347997|NCT00817011|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65347998|NCT00817011|Histamine Antagonists|histamine antagonists|mesh-ancestor
65347999|NCT00817011|Histamine Agents|histamine agents|mesh-ancestor
65348000|NCT00817011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65348001|NCT00817011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65348002|NCT00817011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65348003|NCT00817011|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65348004|NCT00817011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65348005|NCT00817011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65348006|NCT00817011|Adrenergic Agents|adrenergic agents|mesh-ancestor
65348007|NCT00817011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65348008|NCT00817011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65348009|NCT00817011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65348010|NCT00817011|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65348011|NCT00817011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65348012|NCT00697788|Dexmedetomidine|dexmedetomidine|mesh-list
65348013|NCT00697788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65348014|NCT00697788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65348015|NCT00697788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348043|NCT04062890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348044|NCT00817245|Amoxicillin|amoxicillin|mesh-list
65348045|NCT00817245|Metronidazole|metronidazole|mesh-list
65348046|NCT00817245|Omeprazole|omeprazole|mesh-list
65348047|NCT00817245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65348048|NCT00817245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65348049|NCT00817245|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65348050|NCT00817245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65348051|NCT00817245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65348052|NCT00817245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65348053|NCT00817245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65348054|NCT00817245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348055|NCT00817245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348056|NCT02550483|Beta Carotene|beta carotene|mesh-list
65348057|NCT02550483|Lycopene|lycopene|mesh-list
65348058|NCT02550483|Carotenoids|carotenoids|mesh-list
65348059|NCT02550483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65348060|NCT02550483|Antioxidants|antioxidants|mesh-ancestor
65348061|NCT02550483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348062|NCT02550483|Protective Agents|protective agents|mesh-ancestor
65348063|NCT02550483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348064|NCT02550483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65348065|NCT02550483|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65348066|NCT02550483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348067|NCT02550483|Provitamins|provitamins|mesh-ancestor
65348068|NCT02550483|Vitamins|vitamins|mesh-ancestor
65348069|NCT02550483|Micronutrients|micronutrients|mesh-ancestor
65348070|NCT04608318|Venetoclax|venetoclax|mesh-list
65348071|NCT04608318|Obinutuzumab|obinutuzumab|mesh-list
65348072|NCT04608318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348073|NCT04608318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65348074|NCT04063358|Ranibizumab|ranibizumab|mesh-list
65348075|NCT04063358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65348076|NCT04063358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65348077|NCT04063358|Growth Substances|growth substances|mesh-ancestor
64740199|NCT04509791|Immunologic Factors|immunologic factors|mesh-ancestor
64489057|NCT01674777|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64489058|NCT01674777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489059|NCT01674777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64489060|NCT01674777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489061|NCT03876717|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65348078|NCT04063358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348079|NCT04063358|Growth Inhibitors|growth inhibitors|mesh-ancestor
65348080|NCT04063358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348082|NCT00631917|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65348083|NCT00631917|Protease Inhibitors|protease inhibitors|mesh-ancestor
65348084|NCT00631917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348085|NCT00631917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348086|NCT00631917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65348087|NCT00419341|Immunoglobulins|immunoglobulins|mesh-list
65348088|NCT00419341|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65348089|NCT00419341|Antibodies|antibodies|mesh-list
65348090|NCT00419341|Immunologic Factors|immunologic factors|mesh-ancestor
65348091|NCT00419341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348092|NCT00694122|Insulin Glargine|insulin glargine|mesh-list
65348093|NCT00694122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65348094|NCT00694122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348095|NCT03922620|Bupivacaine|bupivacaine|mesh-list
65348096|NCT03922620|Anesthetics, Local|anesthetics, local|mesh-ancestor
65348097|NCT03922620|Anesthetics|anesthetics|mesh-ancestor
65348098|NCT03922620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65348099|NCT03922620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348100|NCT03922620|Sensory System Agents|sensory system agents|mesh-ancestor
65348101|NCT03922620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65348102|NCT00419263|Peramivir|peramivir|mesh-list
65348103|NCT00419263|Antiviral Agents|antiviral agents|mesh-ancestor
65348104|NCT00419263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65348105|NCT00419263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348106|NCT00419263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348107|NCT01034995|Citalopram|citalopram|mesh-list
65348108|NCT01034995|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65348109|NCT01034995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65348110|NCT01034995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65348111|NCT01034995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348112|NCT01034995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65348113|NCT01034995|Serotonin Agents|serotonin agents|mesh-ancestor
64489062|NCT03876717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64489063|NCT03876717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64489064|NCT03876717|Antimetabolites|antimetabolites|mesh-ancestor
65348114|NCT01034995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348115|NCT01034995|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65348116|NCT01034995|Antidepressive Agents|antidepressive agents|mesh-ancestor
65348117|NCT01034995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65348118|NCT00921414|Rituximab|rituximab|mesh-list
65348119|NCT00921414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65348120|NCT00921414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348121|NCT00921414|Immunologic Factors|immunologic factors|mesh-ancestor
65348122|NCT00921414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348123|NCT00921414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65348124|NCT04060914|Clopidogrel|clopidogrel|mesh-list
65348125|NCT04060914|Ticagrelor|ticagrelor|mesh-list
65348126|NCT04060914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65348127|NCT04060914|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65348128|NCT04060914|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65348129|NCT04060914|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65348130|NCT04060914|Purinergic Agents|purinergic agents|mesh-ancestor
65348131|NCT04060914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65348132|NCT04060914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555851|NCT04999878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64555853|NCT04999878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555854|NCT04999878|Antiviral Agents|antiviral agents|mesh-ancestor
64555855|NCT04999878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64555856|NCT04999878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555857|NCT04999878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64489081|NCT00924352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489082|NCT00924352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489083|NCT01674933|Listerine|listerine|mesh-list
64489084|NCT01674933|Fluorides|fluorides|mesh-list
64489085|NCT01674933|Fluorides, Topical|fluorides, topical|mesh-list
64489086|NCT01674933|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
64489087|NCT01674933|Sodium Fluoride|sodium fluoride|mesh-list
64489088|NCT01674933|Cariostatic Agents|cariostatic agents|mesh-ancestor
64489089|NCT01674933|Protective Agents|protective agents|mesh-ancestor
64489090|NCT01674933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489091|NCT01674933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64489092|NCT01674933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64489093|NCT04373044|Hydroxychloroquine|hydroxychloroquine|mesh-list
64489094|NCT04373044|Antimalarials|antimalarials|mesh-ancestor
64489095|NCT04373044|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64489096|NCT04373044|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64489097|NCT04373044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64489098|NCT04373044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489099|NCT04373044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489101|NCT01675089|Zoledronic Acid|zoledronic acid|mesh-list
64489102|NCT01675089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64489103|NCT01675089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489104|NCT01697696|Glycopyrrolate|glycopyrrolate|mesh-list
64489105|NCT01697696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64489106|NCT01697696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64489107|NCT01697696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64489108|NCT01697696|Cholinergic Agents|cholinergic agents|mesh-ancestor
64489109|NCT01697696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64489110|NCT01697696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348133|NCT04060914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348134|NCT03894696|Antiviral Agents|antiviral agents|mesh-list
65348135|NCT03894696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65348136|NCT00399763|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65348137|NCT00399763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65348138|NCT00399763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65348139|NCT00399763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65348140|NCT00399763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348141|NCT00399763|Adrenergic Agents|adrenergic agents|mesh-ancestor
65348142|NCT00399763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65348143|NCT00399763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348144|NCT05324904|Vitamin D|vitamin d|mesh-list
65348145|NCT05324904|Acyclovir|acyclovir|mesh-list
65348146|NCT05324904|Vitamins|vitamins|mesh-ancestor
65348147|NCT05324904|Micronutrients|micronutrients|mesh-ancestor
65348148|NCT05324904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348149|NCT05324904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65348150|NCT05324904|Antiviral Agents|antiviral agents|mesh-ancestor
65348151|NCT05324904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65348152|NCT02085265|Telmisartan|telmisartan|mesh-list
65348153|NCT02085265|Perindopril|perindopril|mesh-list
65348154|NCT02085265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65348155|NCT02085265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65348156|NCT02085265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65348157|NCT02085265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348158|NCT02085265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65348159|NCT02085265|Protease Inhibitors|protease inhibitors|mesh-ancestor
65348160|NCT02085265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348161|NCT00699842|Lenalidomide|lenalidomide|mesh-list
64489111|NCT01697696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489112|NCT01569152|Methotrexate|methotrexate|mesh-list
64489113|NCT01569152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64489114|NCT01569152|Abortifacient Agents|abortifacient agents|mesh-ancestor
64489115|NCT01569152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64489116|NCT01569152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489117|NCT01569152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64489118|NCT01569152|Antimetabolites|antimetabolites|mesh-ancestor
64489119|NCT01569152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489120|NCT01569152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489121|NCT01569152|Dermatologic Agents|dermatologic agents|mesh-ancestor
64489122|NCT01569152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489123|NCT01569152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64489131|NCT01675557|Vitamins|vitamins|mesh-list
64489132|NCT01675557|Micronutrients|micronutrients|mesh-ancestor
64489133|NCT01675557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348162|NCT00699842|Immunologic Factors|immunologic factors|mesh-ancestor
65348163|NCT00699842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348164|NCT00699842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65348165|NCT00699842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65348166|NCT00699842|Growth Substances|growth substances|mesh-ancestor
65348167|NCT00699842|Growth Inhibitors|growth inhibitors|mesh-ancestor
65348168|NCT00699842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348169|NCT00399529|Cyclophosphamide|cyclophosphamide|mesh-list
65348170|NCT00399529|Trastuzumab|trastuzumab|mesh-list
65348171|NCT00399529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65348172|NCT00399529|Immunologic Factors|immunologic factors|mesh-ancestor
65348173|NCT00399529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348174|NCT00399529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65348175|NCT00399529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65348176|NCT00399529|Alkylating Agents|alkylating agents|mesh-ancestor
65348177|NCT00399529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348178|NCT00399529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348179|NCT00399529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65348180|NCT00399529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65348181|NCT05403086|Ketamine|ketamine|mesh-list
65348182|NCT05403086|Psilocybin|psilocybin|mesh-list
65348183|NCT05403086|Hallucinogens|hallucinogens|mesh-list
65348184|NCT05403086|Analgesics|analgesics|mesh-ancestor
64489134|NCT01675557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64489135|NCT01675557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64489136|NCT01675947|Sirolimus|sirolimus|mesh-list
64489137|NCT01675947|Lidocaine|lidocaine|mesh-list
64489138|NCT01675947|Anesthetics, Local|anesthetics, local|mesh-ancestor
64489139|NCT01675947|Anesthetics|anesthetics|mesh-ancestor
64489140|NCT01675947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64489141|NCT01675947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489142|NCT01675947|Sensory System Agents|sensory system agents|mesh-ancestor
64489143|NCT01675947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64489144|NCT01675947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64489145|NCT01675947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64489146|NCT01675947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64555858|NCT04999878|Immunologic Factors|immunologic factors|mesh-ancestor
64555859|NCT04999878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64555860|NCT04999878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64555861|NCT04999878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64489147|NCT01675947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64489148|NCT01675947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489149|NCT01675947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64489150|NCT01675947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64489151|NCT01675947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64489152|NCT01675947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489153|NCT01675947|Antifungal Agents|antifungal agents|mesh-ancestor
64489154|NCT01675947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64489155|NCT01675947|Immunologic Factors|immunologic factors|mesh-ancestor
64489156|NCT03840915|Gemcitabine|gemcitabine|mesh-list
64489157|NCT03840915|Paclitaxel|paclitaxel|mesh-list
64489158|NCT03840915|Docetaxel|docetaxel|mesh-list
64489159|NCT03840915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65348185|NCT05403086|Sensory System Agents|sensory system agents|mesh-ancestor
65348186|NCT05403086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65348187|NCT05403086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348188|NCT05403086|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65348189|NCT05403086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65348190|NCT05403086|Anesthetics, General|anesthetics, general|mesh-ancestor
65348191|NCT05403086|Anesthetics|anesthetics|mesh-ancestor
65348192|NCT05403086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65348193|NCT05403086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65348194|NCT05403086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65348195|NCT05403086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65348196|NCT05403086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348197|NCT05403086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65348198|NCT00712712|Acetaminophen|acetaminophen|mesh-list
65348199|NCT00712712|Morphine|morphine|mesh-list
65348200|NCT00712712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65348201|NCT00712712|Narcotics|narcotics|mesh-ancestor
65348202|NCT00712712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65348203|NCT00712712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348204|NCT00712712|Analgesics|analgesics|mesh-ancestor
65348205|NCT00712712|Sensory System Agents|sensory system agents|mesh-ancestor
65348206|NCT00712712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65348207|NCT00712712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65348208|NCT00712712|Antipyretics|antipyretics|mesh-ancestor
65348209|NCT00411151|Sunitinib|sunitinib|mesh-list
65348210|NCT00411151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348211|NCT00411151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65348213|NCT00411151|Growth Substances|growth substances|mesh-ancestor
65348232|NCT03592576|Navitoclax|navitoclax|mesh-list
65348233|NCT03592576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348234|NCT04035850|Vortioxetine|vortioxetine|mesh-list
65348235|NCT04035850|Antidepressive Agents|antidepressive agents|mesh-ancestor
65348236|NCT04035850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65348237|NCT04035850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65348238|NCT04035850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65348239|NCT04035850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65348240|NCT04035850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348241|NCT04035850|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65348242|NCT04035850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65348243|NCT04035850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64489160|NCT03840915|Carboplatin|carboplatin|mesh-list
64489161|NCT03840915|Pemetrexed|pemetrexed|mesh-list
64489162|NCT03840915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64489163|NCT03840915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489164|NCT03840915|Tubulin Modulators|tubulin modulators|mesh-ancestor
64489165|NCT03840915|Antimitotic Agents|antimitotic agents|mesh-ancestor
64489166|NCT03840915|Mitosis Modulators|mitosis modulators|mesh-ancestor
64489167|NCT03840915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489168|NCT03840915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64489169|NCT03840915|Antimetabolites|antimetabolites|mesh-ancestor
64489170|NCT03840915|Antiviral Agents|antiviral agents|mesh-ancestor
64489171|NCT03840915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64489172|NCT03840915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489173|NCT03840915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64489174|NCT03840915|Immunologic Factors|immunologic factors|mesh-ancestor
64489175|NCT03840915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489176|NCT03840915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64489179|NCT03748953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489180|NCT03748953|Protease Inhibitors|protease inhibitors|mesh-ancestor
64489181|NCT03748953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489182|NCT03748953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489183|NCT01567826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64489185|NCT01567826|Simvastatin|simvastatin|mesh-list
64489186|NCT01567826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64489187|NCT01567826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64489188|NCT01567826|Antimetabolites|antimetabolites|mesh-ancestor
64489202|NCT03653247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489203|NCT03653247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64489204|NCT03653247|Immunologic Factors|immunologic factors|mesh-ancestor
64489205|NCT03653247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489206|NCT03653247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64489207|NCT03653247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489208|NCT03653247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64489209|NCT03653247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64489210|NCT03653247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64489211|NCT03653247|Antiviral Agents|antiviral agents|mesh-ancestor
64489212|NCT03653247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64489213|NCT04124432|Nicotine|nicotine|mesh-list
64489214|NCT04124432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64489215|NCT04124432|Autonomic Agents|autonomic agents|mesh-ancestor
64489216|NCT04124432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64489217|NCT04124432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489218|NCT04124432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64489219|NCT04124432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64489220|NCT04124432|Cholinergic Agents|cholinergic agents|mesh-ancestor
64489221|NCT04124432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64489222|NCT04124432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489223|NCT03742245|Olaparib|olaparib|mesh-list
64489224|NCT03742245|Vorinostat|vorinostat|mesh-list
64489225|NCT03742245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64489226|NCT03742245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348244|NCT04035850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348245|NCT04035850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65348246|NCT04035850|Serotonin Agents|serotonin agents|mesh-ancestor
65348247|NCT04035850|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65348248|NCT04035850|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65348249|NCT04035850|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65348250|NCT04035850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65348251|NCT00699608|Zopiclone|zopiclone|mesh-list
65348252|NCT00699608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65348253|NCT00699608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65348254|NCT00699608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348255|NCT00895570|Modafinil|modafinil|mesh-list
65348256|NCT00895570|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65348257|NCT00895570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348258|NCT00895570|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64740414|NCT00002951|Fluorouracil|fluorouracil|mesh-list
64555863|NCT02242929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64555864|NCT02242929|Immunologic Factors|immunologic factors|mesh-ancestor
64555865|NCT02242929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555866|NCT02242929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555867|NCT02242929|Interferon Inducers|interferon inducers|mesh-ancestor
64555868|NCT04457856|Plonmarlimab|plonmarlimab|mesh-list
64555869|NCT04457856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64555870|NCT04457856|Antiviral Agents|antiviral agents|mesh-ancestor
64489227|NCT03742245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489228|NCT03742245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489229|NCT03742245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64489230|NCT03643107|Prednisolone|prednisolone|mesh-list
64489231|NCT03643107|Irofulven|irofulven|mesh-list
64489232|NCT03643107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64489233|NCT03643107|Glucocorticoids|glucocorticoids|mesh-ancestor
64489234|NCT03643107|Hormones|hormones|mesh-ancestor
64489235|NCT03643107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64489236|NCT03643107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489237|NCT03643107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64489238|NCT03643107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489239|NCT03643107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64489240|NCT03643107|Alkylating Agents|alkylating agents|mesh-ancestor
64489241|NCT03643107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489242|NCT02083107|Misoprostol|misoprostol|mesh-list
64489243|NCT02083107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64489244|NCT02083107|Abortifacient Agents|abortifacient agents|mesh-ancestor
64489245|NCT02083107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64489246|NCT02083107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489262|NCT04372732|Autoantibodies|autoantibodies|mesh-list
64489263|NCT04372732|Immunologic Factors|immunologic factors|mesh-ancestor
64489264|NCT04372732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489265|NCT02245126|Lidocaine|lidocaine|mesh-list
64489266|NCT02245126|Bupivacaine|bupivacaine|mesh-list
64489267|NCT02245126|Anesthetics, Local|anesthetics, local|mesh-ancestor
64489268|NCT02245126|Anesthetics|anesthetics|mesh-ancestor
64489269|NCT02245126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64489272|NCT02245126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64489274|NCT02245126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64489275|NCT02245126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64489276|NCT02245126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65348259|NCT00895570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65348260|NCT00895570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65348261|NCT00895570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348262|NCT00895648|Pemetrexed|pemetrexed|mesh-list
65348263|NCT00895648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348264|NCT00895648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348265|NCT00895648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348266|NCT00895648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65348267|NCT00895648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65348268|NCT00893854|Triamcinolone|triamcinolone|mesh-list
65348269|NCT00893854|Diclofenac|diclofenac|mesh-list
65348270|NCT00893854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65348271|NCT00893854|Glucocorticoids|glucocorticoids|mesh-ancestor
65348272|NCT00893854|Hormones|hormones|mesh-ancestor
65348273|NCT00893854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65348274|NCT00893854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348275|NCT00893854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348276|NCT00893854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348277|NCT00893854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65348278|NCT00893854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64740416|NCT00002951|Antimetabolites|antimetabolites|mesh-ancestor
64489277|NCT02245126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489278|NCT03728673|Dexetimide|dexetimide|mesh-list
64489279|NCT03728673|Citalopram|citalopram|mesh-list
64489280|NCT03728673|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64489281|NCT03728673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64489282|NCT03728673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64489283|NCT03728673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489284|NCT03728673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64489285|NCT03728673|Serotonin Agents|serotonin agents|mesh-ancestor
64489286|NCT03728673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489287|NCT03728673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64489288|NCT03728673|Antidepressive Agents|antidepressive agents|mesh-ancestor
64489289|NCT03728673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64489290|NCT03728673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64489291|NCT03728673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64489292|NCT03728673|Parasympatholytics|parasympatholytics|mesh-ancestor
64489293|NCT03728673|Autonomic Agents|autonomic agents|mesh-ancestor
64489294|NCT03728673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64489295|NCT03728673|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64489296|NCT03728673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64489297|NCT03728673|Cholinergic Agents|cholinergic agents|mesh-ancestor
64555871|NCT04457856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64555872|NCT05006898|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64555873|NCT05006898|Oxymetazoline|oxymetazoline|mesh-list
64555874|NCT05006898|Pilocarpine|pilocarpine|mesh-list
64555875|NCT05006898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64555876|NCT05006898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64489298|NCT04372342|Remifentanil|remifentanil|mesh-list
64489299|NCT04372342|Nalbuphine|nalbuphine|mesh-list
64489300|NCT04372342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65348279|NCT00893854|Analgesics|analgesics|mesh-ancestor
65348280|NCT00893854|Sensory System Agents|sensory system agents|mesh-ancestor
65348281|NCT00893854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65348282|NCT00893854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65348283|NCT00893854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65348284|NCT00895804|Pindolol|pindolol|mesh-list
65348285|NCT00895804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65348286|NCT00895804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65348287|NCT00895804|Adrenergic Agents|adrenergic agents|mesh-ancestor
65348288|NCT00895804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65348289|NCT00895804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348290|NCT00895804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348291|NCT00895804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65348292|NCT00895804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65348293|NCT00895804|Serotonin Agents|serotonin agents|mesh-ancestor
64489301|NCT04372342|Narcotics|narcotics|mesh-ancestor
64489302|NCT04372342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64489303|NCT04372342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489304|NCT04372342|Analgesics|analgesics|mesh-ancestor
64489305|NCT04372342|Sensory System Agents|sensory system agents|mesh-ancestor
64489306|NCT04372342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64489333|NCT02244112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64489334|NCT02244112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64489335|NCT02244112|Anesthetics, General|anesthetics, general|mesh-ancestor
64489337|NCT02244112|GABA Modulators|gaba modulators|mesh-ancestor
64489338|NCT02244112|GABA Agents|gaba agents|mesh-ancestor
64489339|NCT02244112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64489340|NCT02244112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489341|NCT03721653|Leucovorin|leucovorin|mesh-list
64489342|NCT03721653|Bevacizumab|bevacizumab|mesh-list
64489343|NCT03721653|Fluorouracil|fluorouracil|mesh-list
64489344|NCT03721653|Oxaliplatin|oxaliplatin|mesh-list
64489345|NCT03721653|Irinotecan|irinotecan|mesh-list
64489346|NCT03721653|Atezolizumab|atezolizumab|mesh-list
64489347|NCT03721653|Levoleucovorin|levoleucovorin|mesh-list
64489348|NCT03721653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64489349|NCT03721653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489350|NCT03721653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64489351|NCT03721653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64489352|NCT03721653|Growth Substances|growth substances|mesh-ancestor
64489353|NCT03721653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489354|NCT03721653|Growth Inhibitors|growth inhibitors|mesh-ancestor
64489355|NCT03721653|Antimetabolites|antimetabolites|mesh-ancestor
64489356|NCT03721653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489368|NCT02244190|Ritonavir|ritonavir|mesh-list
64489369|NCT02244190|Tipranavir|tipranavir|mesh-list
64489370|NCT02244190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64489371|NCT02244190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64489372|NCT02244190|Protease Inhibitors|protease inhibitors|mesh-ancestor
64489374|NCT02244190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489375|NCT02244190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64489379|NCT02244190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64489380|NCT02244190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64489382|NCT00926380|Teriparatide|teriparatide|mesh-list
64489383|NCT00926380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64489384|NCT00926380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489385|NCT00926380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64489386|NCT02244268|Tamsulosin|tamsulosin|mesh-list
64489387|NCT02244268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64489388|NCT02244268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65348294|NCT00895804|Vasodilator Agents|vasodilator agents|mesh-ancestor
65348295|NCT00895882|Interferons|interferons|mesh-list
65348296|NCT00895882|Ribavirin|ribavirin|mesh-list
65348297|NCT00895882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348298|NCT00895882|Antiviral Agents|antiviral agents|mesh-ancestor
65348299|NCT00895882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65348300|NCT00895882|Antimetabolites|antimetabolites|mesh-ancestor
65348301|NCT00895882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348302|NCT00706706|Sunitinib|sunitinib|mesh-list
65348303|NCT00706706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348304|NCT00706706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65348305|NCT00706706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65348306|NCT00706706|Growth Substances|growth substances|mesh-ancestor
65348307|NCT00706706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348308|NCT00706706|Growth Inhibitors|growth inhibitors|mesh-ancestor
65348309|NCT00706706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65348310|NCT00706706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348311|NCT00706706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348312|NCT00894010|Carbamazepine|carbamazepine|mesh-list
65348313|NCT00894010|Levetiracetam|levetiracetam|mesh-list
65348314|NCT00894010|Anticonvulsants|anticonvulsants|mesh-ancestor
65348315|NCT00894010|Nootropic Agents|nootropic agents|mesh-ancestor
64740472|NCT00002987|Hormones|hormones|mesh-ancestor
64489389|NCT02244268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64489390|NCT02244268|Adrenergic Agents|adrenergic agents|mesh-ancestor
64489391|NCT02244268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64489392|NCT02244268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489393|NCT02244268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489394|NCT02244268|Urological Agents|urological agents|mesh-ancestor
64489395|NCT03823131|Pembrolizumab|pembrolizumab|mesh-list
64489396|NCT03823131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64489397|NCT03823131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489398|NCT03630315|Bevacizumab|bevacizumab|mesh-list
64489399|NCT03630315|Ranibizumab|ranibizumab|mesh-list
64489400|NCT03630315|Aflibercept|aflibercept|mesh-list
64555877|NCT05006898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64555878|NCT05006898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64555879|NCT05006898|Adrenergic Agents|adrenergic agents|mesh-ancestor
64555880|NCT05006898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64555881|NCT05006898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555882|NCT05006898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555883|NCT05006898|Sympathomimetics|sympathomimetics|mesh-ancestor
64489401|NCT03630315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64489402|NCT03630315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489403|NCT03630315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64489404|NCT03630315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64489405|NCT03630315|Growth Substances|growth substances|mesh-ancestor
64489406|NCT03630315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489407|NCT03630315|Growth Inhibitors|growth inhibitors|mesh-ancestor
64489408|NCT00929344|Pregabalin|pregabalin|mesh-list
64489409|NCT00929344|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64489410|NCT00929344|Analgesics|analgesics|mesh-ancestor
64489411|NCT00929344|Sensory System Agents|sensory system agents|mesh-ancestor
64489412|NCT00929344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65348316|NCT00894010|Antimanic Agents|antimanic agents|mesh-ancestor
65348317|NCT00894010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65348318|NCT00894010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65348319|NCT00894010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348320|NCT00894010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65348321|NCT00894010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65348322|NCT00894010|Analgesics|analgesics|mesh-ancestor
65348323|NCT00894010|Sensory System Agents|sensory system agents|mesh-ancestor
65348324|NCT00894010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65348325|NCT00894010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65348326|NCT00894010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65348327|NCT00894010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348328|NCT00894010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65348329|NCT00894010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65348330|NCT00895960|Temozolomide|temozolomide|mesh-list
65348332|NCT00895960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65348333|NCT00895960|Alkylating Agents|alkylating agents|mesh-ancestor
65348334|NCT00895960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348335|NCT00895960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348336|NCT00895960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65348337|NCT00895960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348338|NCT00894088|Mycophenolic Acid|mycophenolic acid|mesh-list
65348339|NCT00894088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65348340|NCT00894088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489413|NCT00929344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489414|NCT00929344|Anticonvulsants|anticonvulsants|mesh-ancestor
64489415|NCT00929344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64489416|NCT00929344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64489417|NCT00929344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489418|NCT00929344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64489419|NCT00929344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64489420|NCT00929344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64489421|NCT00929344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64489422|NCT00929344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64489439|NCT04371874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64489440|NCT04371874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489441|NCT04371874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64489442|NCT04371874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64489443|NCT04371874|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64489444|NCT04371874|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64489445|NCT04371874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489446|NCT04371874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64489447|NCT04371874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64489448|NCT04371874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489449|NCT04371874|Antipyretics|antipyretics|mesh-ancestor
64489450|NCT04371874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64489451|NCT04371874|Diuretics|diuretics|mesh-ancestor
64489452|NCT04371874|Natriuretic Agents|natriuretic agents|mesh-ancestor
65348341|NCT00894088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65348342|NCT00894088|Antitubercular Agents|antitubercular agents|mesh-ancestor
65348343|NCT00894088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65348344|NCT00894088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65348345|NCT00894088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348346|NCT00894088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348347|NCT03818178|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65348348|NCT03818178|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65348349|NCT03818178|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65348350|NCT03818178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65348351|NCT00921128|Muscimol|muscimol|mesh-list
65348352|NCT00921128|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65348353|NCT00921128|GABA Agonists|gaba agonists|mesh-ancestor
65348354|NCT00921128|GABA Agents|gaba agents|mesh-ancestor
65348355|NCT00921128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65348356|NCT00921128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348357|NCT00921128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348358|NCT05508776|Moxifloxacin|moxifloxacin|mesh-list
65348359|NCT05508776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65348360|NCT05508776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65348361|NCT05508776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65348362|NCT05508776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65348363|NCT05508776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348364|NCT05508776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348365|NCT05508776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348366|NCT00896428|Gallopamil|gallopamil|mesh-list
65348367|NCT00896428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65348368|NCT00896428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65348369|NCT00896428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348370|NCT00896428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65348371|NCT00896428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348372|NCT02962050|Capsaicin|capsaicin|mesh-list
65348373|NCT02962050|Antipruritics|antipruritics|mesh-ancestor
65348374|NCT02962050|Dermatologic Agents|dermatologic agents|mesh-ancestor
65348379|NCT04486716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348380|NCT00410605|Dexamethasone|dexamethasone|mesh-list
65348381|NCT00410605|Bevacizumab|bevacizumab|mesh-list
65348382|NCT00410605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65348383|NCT00410605|Lenalidomide|lenalidomide|mesh-list
65348384|NCT00410605|Antibodies|antibodies|mesh-list
65348385|NCT00410605|Immunoglobulins|immunoglobulins|mesh-list
65348386|NCT00410605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65348387|NCT00410605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348388|NCT00410605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65348389|NCT00410605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65348390|NCT00410605|Growth Substances|growth substances|mesh-ancestor
65348391|NCT00410605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348392|NCT00410605|Growth Inhibitors|growth inhibitors|mesh-ancestor
65348393|NCT00410605|Immunologic Factors|immunologic factors|mesh-ancestor
65348394|NCT00410605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65348395|NCT00410605|Antiemetics|antiemetics|mesh-ancestor
65348396|NCT00410605|Autonomic Agents|autonomic agents|mesh-ancestor
65348397|NCT00410605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64489453|NCT04371874|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64489454|NCT04371874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64489457|NCT04371874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64489458|NCT04371874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64489459|NCT04371874|Vasodilator Agents|vasodilator agents|mesh-ancestor
64489460|NCT03629613|Antioxidants|antioxidants|mesh-list
64489461|NCT03629613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489462|NCT03629613|Protective Agents|protective agents|mesh-ancestor
64489463|NCT03629613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489465|NCT03629223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489466|NCT03720717|Baclofen|baclofen|mesh-list
64489467|NCT03720717|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64489468|NCT03720717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489469|NCT03720717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64489470|NCT03720717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64489471|NCT03720717|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64489472|NCT03720717|GABA Agonists|gaba agonists|mesh-ancestor
64489473|NCT03720717|GABA Agents|gaba agents|mesh-ancestor
64489474|NCT03720717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64489475|NCT03720717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555884|NCT05006898|Autonomic Agents|autonomic agents|mesh-ancestor
64555885|NCT05006898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64555886|NCT05006898|Nasal Decongestants|nasal decongestants|mesh-ancestor
64555887|NCT05006898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64555888|NCT05006898|Respiratory System Agents|respiratory system agents|mesh-ancestor
64555890|NCT05006898|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64555891|NCT05006898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64489476|NCT04376554|Amoxicillin|amoxicillin|mesh-list
64489477|NCT04376554|Clavulanic Acid|clavulanic acid|mesh-list
64489478|NCT04376554|Clavulanic Acids|clavulanic acids|mesh-list
64489479|NCT04376554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64489480|NCT04376554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64489507|NCT00929578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64489508|NCT00929578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64489509|NCT00929578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489510|NCT00929578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64489511|NCT00929578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64489512|NCT00929578|Dopamine Agents|dopamine agents|mesh-ancestor
64489513|NCT00929578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65348398|NCT00410605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65348399|NCT00410605|Glucocorticoids|glucocorticoids|mesh-ancestor
65348400|NCT00410605|Hormones|hormones|mesh-ancestor
65348401|NCT00410605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65348402|NCT00410605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65348403|NCT00742638|Valproic Acid|valproic acid|mesh-list
65348404|NCT00742638|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65348405|NCT00742638|Antidepressive Agents|antidepressive agents|mesh-ancestor
65348406|NCT00742638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65348407|NCT00742638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65348408|NCT00742638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65348409|NCT00742638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65348410|NCT00742638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348411|NCT00742638|Anticonvulsants|anticonvulsants|mesh-ancestor
65348412|NCT00742638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348413|NCT00742638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348414|NCT00742638|GABA Agents|gaba agents|mesh-ancestor
65348415|NCT00742638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65348416|NCT00742638|Antimanic Agents|antimanic agents|mesh-ancestor
64489514|NCT00929578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489515|NCT03615105|Cyclophosphamide|cyclophosphamide|mesh-list
64489517|NCT03615105|Busulfan|busulfan|mesh-list
64489518|NCT03615105|Thiotepa|thiotepa|mesh-list
64489519|NCT03615105|Rituximab|rituximab|mesh-list
64489520|NCT03615105|Fludarabine|fludarabine|mesh-list
64489521|NCT03615105|Clofarabine|clofarabine|mesh-list
64489522|NCT03615105|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64489523|NCT03615105|Thymoglobulin|thymoglobulin|mesh-list
64489524|NCT03615105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64489525|NCT03615105|Immunologic Factors|immunologic factors|mesh-ancestor
64489526|NCT03615105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489527|NCT03615105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64489528|NCT03615105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64489529|NCT03615105|Alkylating Agents|alkylating agents|mesh-ancestor
64489530|NCT03615105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489531|NCT03615105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489552|NCT03716739|Hormones|hormones|mesh-ancestor
64489553|NCT03716739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64489554|NCT03716739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489555|NCT03716739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64489556|NCT03716739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489557|NCT03716739|Anabolic Agents|anabolic agents|mesh-ancestor
64489558|NCT04763265|Botulinum Toxins|botulinum toxins|mesh-list
64489559|NCT04763265|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64489560|NCT04763265|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64489561|NCT04763265|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64489562|NCT04763265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64489563|NCT04763265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489564|NCT04763265|Cholinergic Agents|cholinergic agents|mesh-ancestor
64489565|NCT04763265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64489566|NCT04763265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489567|NCT04763265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64489570|NCT00004143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64489571|NCT00004143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489573|NCT03705429|Docetaxel|docetaxel|mesh-list
65348417|NCT00418717|Etanercept|etanercept|mesh-list
65348418|NCT00418717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65348419|NCT00418717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65348420|NCT00418717|Analgesics|analgesics|mesh-ancestor
65348421|NCT00418717|Sensory System Agents|sensory system agents|mesh-ancestor
65348422|NCT00418717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65348423|NCT00418717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348424|NCT00418717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65348425|NCT00418717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65348426|NCT00418717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65348427|NCT00418717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65348428|NCT00418717|Immunologic Factors|immunologic factors|mesh-ancestor
65348429|NCT00572572|Aprepitant|aprepitant|mesh-list
65348430|NCT00572572|Antiemetics|antiemetics|mesh-ancestor
64352657|NCT03645603|Dexmedetomidine|dexmedetomidine|mesh-list
65348431|NCT00572572|Autonomic Agents|autonomic agents|mesh-ancestor
65348432|NCT00572572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65348433|NCT00572572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348434|NCT00572572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65348435|NCT00572572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65348436|NCT00572572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65348437|NCT00572572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348438|NCT00897130|Azacitidine|azacitidine|mesh-list
65348439|NCT00897130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65348440|NCT00897130|Antimetabolites|antimetabolites|mesh-ancestor
65348441|NCT00897130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348442|NCT00897130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348443|NCT00897130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348444|NCT00398047|Mitogens|mitogens|mesh-list
65348445|NCT00398047|Mitosis Modulators|mitosis modulators|mesh-ancestor
65348446|NCT00398047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348447|NCT00631371|Interferons|interferons|mesh-list
65348448|NCT00631371|Interferon-alpha|interferon-alpha|mesh-list
65348449|NCT00631371|Sirolimus|sirolimus|mesh-list
65348456|NCT00631371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348457|NCT00631371|Growth Inhibitors|growth inhibitors|mesh-ancestor
65348458|NCT00631371|Antiviral Agents|antiviral agents|mesh-ancestor
65348459|NCT00631371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65348460|NCT00631371|Immunologic Factors|immunologic factors|mesh-ancestor
65348461|NCT00631371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65348462|NCT00631371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65348463|NCT00631371|Antifungal Agents|antifungal agents|mesh-ancestor
65348464|NCT00631371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65348466|NCT00409747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65348467|NCT00409747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65348468|NCT04016740|Dexmedetomidine|dexmedetomidine|mesh-list
65348469|NCT04016740|Ketamine|ketamine|mesh-list
65348470|NCT04016740|Remifentanil|remifentanil|mesh-list
65348471|NCT04016740|Propofol|propofol|mesh-list
65348472|NCT04016740|Ropivacaine|ropivacaine|mesh-list
65348473|NCT04016740|Sevoflurane|sevoflurane|mesh-list
65348474|NCT04016740|Rocuronium|rocuronium|mesh-list
65348475|NCT04016740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65348476|NCT04016740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65348477|NCT04016740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348478|NCT04016740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65348479|NCT04016740|Anesthetics, General|anesthetics, general|mesh-ancestor
65348480|NCT04016740|Anesthetics|anesthetics|mesh-ancestor
65348481|NCT04016740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65348482|NCT04016740|Analgesics|analgesics|mesh-ancestor
65348483|NCT04016740|Sensory System Agents|sensory system agents|mesh-ancestor
65348484|NCT04016740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64740601|NCT00003041|NSC 366140|nsc 366140|mesh-list
65348505|NCT02540512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65348506|NCT02540512|Analgesics|analgesics|mesh-ancestor
65348507|NCT02540512|Sensory System Agents|sensory system agents|mesh-ancestor
65348508|NCT02540512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65348509|NCT02540512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348510|NCT02540512|Antipyretics|antipyretics|mesh-ancestor
65348511|NCT02540512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65348512|NCT02540512|Narcotics|narcotics|mesh-ancestor
65348513|NCT02540512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65348514|NCT02540512|Antitussive Agents|antitussive agents|mesh-ancestor
65348515|NCT02540512|Respiratory System Agents|respiratory system agents|mesh-ancestor
65348516|NCT02540512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65348517|NCT02540512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65348518|NCT02540512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65348519|NCT00897520|Interferons|interferons|mesh-list
65348520|NCT00897520|Interferon-alpha|interferon-alpha|mesh-list
65348521|NCT00897520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348522|NCT00897520|Antiviral Agents|antiviral agents|mesh-ancestor
65348523|NCT00897520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65348524|NCT00897520|Immunologic Factors|immunologic factors|mesh-ancestor
65348525|NCT00897520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348526|NCT00894634|Brompheniramine|brompheniramine|mesh-list
65348527|NCT00894634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348558|NCT00823875|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65348559|NCT00823875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65348560|NCT00823875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348561|NCT00823875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65348562|NCT00823875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65348563|NCT00823875|Antimetabolites|antimetabolites|mesh-ancestor
65348564|NCT00823875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65348565|NCT00823875|Antioxidants|antioxidants|mesh-ancestor
65348566|NCT00397189|Melatonin|melatonin|mesh-list
65348567|NCT00397189|Antioxidants|antioxidants|mesh-ancestor
65348568|NCT00397189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348569|NCT00397189|Protective Agents|protective agents|mesh-ancestor
65348570|NCT00397189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348571|NCT00397189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65348572|NCT00824109|Anti-Infective Agents|anti-infective agents|mesh-list
65348573|NCT00824109|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65348574|NCT01035619|Moxidectin|moxidectin|mesh-list
65348575|NCT01035619|Anthelmintics|anthelmintics|mesh-ancestor
65348576|NCT01035619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65348577|NCT01035619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65348578|NCT01035619|Antinematodal Agents|antinematodal agents|mesh-ancestor
65348579|NCT04044651|Nivolumab|nivolumab|mesh-list
65348580|NCT04044651|Lenvatinib|lenvatinib|mesh-list
65348581|NCT04044651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65348582|NCT04044651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348583|NCT04044651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65348584|NCT04044651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348585|NCT04044651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65348606|NCT04044417|Sensory System Agents|sensory system agents|mesh-ancestor
65348607|NCT04044417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65348608|NCT04044417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348609|NCT04044417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65348610|NCT04044417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65348611|NCT04044417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348612|NCT00397033|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65348613|NCT00397033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65348614|NCT00397033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65348615|NCT00397033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65348616|NCT00397033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348617|NCT00397033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65348618|NCT00397033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65348619|NCT00397033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65348620|NCT00397033|Serotonin Agents|serotonin agents|mesh-ancestor
65348621|NCT00397033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65348622|NCT00397033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348623|NCT00397033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65348624|NCT00397033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65348625|NCT00397033|Dopamine Agents|dopamine agents|mesh-ancestor
65348626|NCT00820053|Epirubicin|epirubicin|mesh-list
65348627|NCT00820053|Ethiodized Oil|ethiodized oil|mesh-list
65348628|NCT00820053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65348629|NCT00820053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348630|NCT00820053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65348631|NCT00820053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65348632|NCT00820053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348652|NCT00699374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348653|NCT00699374|Growth Inhibitors|growth inhibitors|mesh-ancestor
65348654|NCT00898534|Chrysarobin|chrysarobin|mesh-list
65348655|NCT00898534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65348656|NCT00898534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65348657|NCT00898534|Analgesics|analgesics|mesh-ancestor
65348658|NCT00898534|Sensory System Agents|sensory system agents|mesh-ancestor
65348659|NCT00898534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65348660|NCT00898534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348661|NCT00898534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65348662|NCT00898534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65348663|NCT00606892|Nicotine|nicotine|mesh-list
65348664|NCT00606892|Varenicline|varenicline|mesh-list
65348665|NCT00606892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65348666|NCT00606892|Autonomic Agents|autonomic agents|mesh-ancestor
65348667|NCT00606892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65348668|NCT00606892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348669|NCT00606892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65348670|NCT00606892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65348671|NCT00606892|Cholinergic Agents|cholinergic agents|mesh-ancestor
65348672|NCT00606892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65348673|NCT00606892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348674|NCT04667078|Cangrelor|cangrelor|mesh-list
65348675|NCT04667078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65348676|NCT04667078|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65348702|NCT01042717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65348703|NCT03648385|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65348704|NCT03648385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65348705|NCT03648385|Immunologic Factors|immunologic factors|mesh-ancestor
65348706|NCT03648385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348707|NCT00898846|Tegafur|tegafur|mesh-list
65348708|NCT00898846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65348709|NCT00898846|Antimetabolites|antimetabolites|mesh-ancestor
65348710|NCT00898846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348711|NCT00898846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348712|NCT00826371|Ranibizumab|ranibizumab|mesh-list
65348713|NCT00826371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65348714|NCT00826371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65348715|NCT00826371|Growth Substances|growth substances|mesh-ancestor
65348716|NCT00826371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348717|NCT00826371|Growth Inhibitors|growth inhibitors|mesh-ancestor
65348718|NCT00826371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348719|NCT02540824|Apatinib|apatinib|mesh-list
65348720|NCT02540824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348721|NCT02540824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65348722|NCT02540824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348723|NCT02540824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348724|NCT00826527|Solifenacin Succinate|solifenacin succinate|mesh-list
65348752|NCT02550717|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65348753|NCT02550717|Purinergic Agents|purinergic agents|mesh-ancestor
65348754|NCT02550717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65348755|NCT02550249|Nivolumab|nivolumab|mesh-list
65348756|NCT02550249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65348757|NCT02550249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348758|NCT02550249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65348759|NCT02550249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348760|NCT00824811|Fluorometholone|fluorometholone|mesh-list
65348761|NCT00824811|Cyclosporine|cyclosporine|mesh-list
65348762|NCT00824811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65348763|NCT00824811|Lubricant Eye Drops|lubricant eye drops|mesh-list
65348764|NCT00824811|Cyclosporins|cyclosporins|mesh-list
65348765|NCT00824811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348766|NCT00824811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348767|NCT00824811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65348768|NCT00824811|Immunologic Factors|immunologic factors|mesh-ancestor
65348769|NCT00824811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348770|NCT00824811|Antifungal Agents|antifungal agents|mesh-ancestor
65348771|NCT00824811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65348772|NCT00824811|Dermatologic Agents|dermatologic agents|mesh-ancestor
65348773|NCT00824811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65348774|NCT00824811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65348775|NCT00824811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65348776|NCT00824811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65348777|NCT00824811|Glucocorticoids|glucocorticoids|mesh-ancestor
65348778|NCT00824811|Hormones|hormones|mesh-ancestor
65348779|NCT00824811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65348780|NCT00824811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65348781|NCT00606580|Paromomycin|paromomycin|mesh-list
65348782|NCT00606580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65348783|NCT00606580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65348784|NCT00606580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65348794|NCT02550327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348795|NCT02550327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65348796|NCT02550327|Antimetabolites|antimetabolites|mesh-ancestor
65348797|NCT02550327|Antiviral Agents|antiviral agents|mesh-ancestor
65348798|NCT02550327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65348799|NCT02550327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348800|NCT02550327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65348801|NCT02550327|Immunologic Factors|immunologic factors|mesh-ancestor
65348802|NCT02550327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348803|NCT02550327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65348804|NCT00825045|Risperidone|risperidone|mesh-list
65348805|NCT00825045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65348806|NCT00825045|Serotonin Agents|serotonin agents|mesh-ancestor
65348807|NCT00825045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65348808|NCT00825045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348809|NCT00825045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348810|NCT00825045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65348811|NCT00825045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65348812|NCT00825045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65348813|NCT00825045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65348814|NCT00825045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65348815|NCT00825045|Dopamine Agents|dopamine agents|mesh-ancestor
65348816|NCT00625131|Bupropion|bupropion|mesh-list
65348817|NCT00625131|Nicotine|nicotine|mesh-list
65348818|NCT00625131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65348819|NCT00625131|Autonomic Agents|autonomic agents|mesh-ancestor
65348820|NCT00625131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65348821|NCT00625131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348822|NCT00625131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65348823|NCT00625131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65348824|NCT00625131|Cholinergic Agents|cholinergic agents|mesh-ancestor
65348825|NCT00625131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65348826|NCT00625131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348827|NCT00625131|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65348828|NCT00625131|Antidepressive Agents|antidepressive agents|mesh-ancestor
65348829|NCT00625131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64489574|NCT03705429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64489575|NCT03705429|Cyclophosphamide|cyclophosphamide|mesh-list
65348830|NCT00625131|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65348831|NCT00625131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65348832|NCT00625131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65348833|NCT00625131|Dopamine Agents|dopamine agents|mesh-ancestor
65348834|NCT00625131|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65348835|NCT00625131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65348836|NCT00625131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348837|NCT00606502|Vitamins|vitamins|mesh-list
65348838|NCT00606502|Folic Acid|folic acid|mesh-list
65348839|NCT00606502|Vitamin B 12|vitamin b 12|mesh-list
65348840|NCT00606502|Vitamin B Complex|vitamin b complex|mesh-list
65348841|NCT00606502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65348842|NCT00606502|10-deazaaminopterin|10-deazaaminopterin|mesh-list
65348843|NCT00606502|Micronutrients|micronutrients|mesh-ancestor
65348844|NCT00606502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348845|NCT00606502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348846|NCT00606502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65348847|NCT00606502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348848|NCT00606502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348849|NCT00606502|Hematinics|hematinics|mesh-ancestor
65348850|NCT00606502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65348851|NCT00825123|Metoprolol|metoprolol|mesh-list
65348852|NCT00825123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65348853|NCT00825123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65348854|NCT00825123|Sympatholytics|sympatholytics|mesh-ancestor
65348855|NCT00825123|Autonomic Agents|autonomic agents|mesh-ancestor
65348856|NCT00825123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65348857|NCT00825123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348858|NCT00825123|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65348859|NCT00825123|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65348860|NCT00825123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65348861|NCT00825123|Adrenergic Agents|adrenergic agents|mesh-ancestor
65348862|NCT00825123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65348864|NCT00826839|Leuprolide|leuprolide|mesh-list
65348870|NCT00826839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348871|NCT00826839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65348872|NCT00826839|Fertility Agents|fertility agents|mesh-ancestor
65348873|NCT00826839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65348874|NCT00826839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348875|NCT00826839|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65348876|NCT00826839|Hormone Antagonists|hormone antagonists|mesh-ancestor
65348877|NCT00826839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65348878|NCT04017988|Ethanol|ethanol|mesh-list
65348879|NCT04017988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65348880|NCT04017988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65348881|NCT04017988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65348882|NCT04017988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348883|NCT00825201|Paclitaxel|paclitaxel|mesh-list
65348884|NCT00825201|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65348885|NCT00825201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65348886|NCT00825201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348887|NCT00825201|Tubulin Modulators|tubulin modulators|mesh-ancestor
65348888|NCT00825201|Antimitotic Agents|antimitotic agents|mesh-ancestor
65348889|NCT00825201|Mitosis Modulators|mitosis modulators|mesh-ancestor
65348890|NCT00825201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348891|NCT00820911|Cyclosporine|cyclosporine|mesh-list
65348892|NCT00820911|Everolimus|everolimus|mesh-list
65348893|NCT00820911|Cyclosporins|cyclosporins|mesh-list
65348894|NCT00820911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348895|NCT00820911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348896|NCT00820911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65348897|NCT00820911|Immunologic Factors|immunologic factors|mesh-ancestor
65348898|NCT00820911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348899|NCT00820911|Antifungal Agents|antifungal agents|mesh-ancestor
65348900|NCT00820911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65348901|NCT00820911|Dermatologic Agents|dermatologic agents|mesh-ancestor
65348902|NCT00820911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65348903|NCT00820911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65348904|NCT00820911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741034|NCT00002819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489576|NCT03705429|Trastuzumab|trastuzumab|mesh-list
65348906|NCT00605722|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65348907|NCT00605722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65348908|NCT00605722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348909|NCT00605722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65348910|NCT00605722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65348911|NCT00605722|Growth Substances|growth substances|mesh-ancestor
65348912|NCT00605722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348913|NCT00605722|Growth Inhibitors|growth inhibitors|mesh-ancestor
65348914|NCT00605722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65348915|NCT00605722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348916|NCT00605722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348917|NCT00882076|Etoposide|etoposide|mesh-list
65348918|NCT00882076|Mitoxantrone|mitoxantrone|mesh-list
65348919|NCT00882076|Etoposide phosphate|etoposide phosphate|mesh-list
65348920|NCT00882076|Clofarabine|clofarabine|mesh-list
65348921|NCT00882076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65348922|NCT00882076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348923|NCT00882076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65348924|NCT00882076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65348925|NCT00882076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65348926|NCT00882076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348927|NCT00882076|Analgesics|analgesics|mesh-ancestor
65348958|NCT03417154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65348959|NCT03417154|Alkylating Agents|alkylating agents|mesh-ancestor
65348960|NCT03417154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348961|NCT03417154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348962|NCT03417154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65348963|NCT03417154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65348964|NCT03417154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65348965|NCT00900172|Paclitaxel|paclitaxel|mesh-list
65348966|NCT00900172|Bevacizumab|bevacizumab|mesh-list
65348967|NCT00900172|Carboplatin|carboplatin|mesh-list
65348968|NCT00900172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65348969|NCT00900172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65348970|NCT00900172|Tubulin Modulators|tubulin modulators|mesh-ancestor
65348971|NCT00900172|Antimitotic Agents|antimitotic agents|mesh-ancestor
65348972|NCT00900172|Mitosis Modulators|mitosis modulators|mesh-ancestor
65348973|NCT00900172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65348974|NCT00900172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65348975|NCT00900172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65348976|NCT00900172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65348977|NCT00900172|Growth Substances|growth substances|mesh-ancestor
65098766|NCT00528255|Oxytocics|oxytocics|mesh-ancestor
65348978|NCT00900172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348980|NCT00605566|Cyclophosphamide|cyclophosphamide|mesh-list
65348981|NCT00605566|Sorafenib|sorafenib|mesh-list
65348982|NCT00605566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65348983|NCT00605566|Immunologic Factors|immunologic factors|mesh-ancestor
65348984|NCT00605566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65348985|NCT00605566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65348986|NCT00605566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65348987|NCT00605566|Alkylating Agents|alkylating agents|mesh-ancestor
65349001|NCT00882388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349002|NCT00882388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65349003|NCT00882388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65349004|NCT00882388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65349005|NCT00882388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65349006|NCT00882388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349007|NCT00882388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65349008|NCT00882388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65349009|NCT00882388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349010|NCT00882388|Antipyretics|antipyretics|mesh-ancestor
65349011|NCT00882388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65349017|NCT00396877|Clopidogrel|clopidogrel|mesh-list
65349062|NCT00408499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349063|NCT00837369|Regadenoson|regadenoson|mesh-list
65349064|NCT00837369|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65349065|NCT00837369|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65349066|NCT00837369|Purinergic Agonists|purinergic agonists|mesh-ancestor
65349067|NCT00837369|Purinergic Agents|purinergic agents|mesh-ancestor
65349068|NCT00837369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65349069|NCT00837369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349070|NCT00837369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349071|NCT00900874|Albuterol|albuterol|mesh-list
65349072|NCT00900874|Formoterol Fumarate|formoterol fumarate|mesh-list
65349073|NCT00900874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65349074|NCT00900874|Autonomic Agents|autonomic agents|mesh-ancestor
65349075|NCT00900874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349076|NCT00900874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349085|NCT00900874|Tocolytic Agents|tocolytic agents|mesh-ancestor
65349118|NCT02549469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65349119|NCT02549469|Analgesics|analgesics|mesh-ancestor
65349120|NCT02549469|Sensory System Agents|sensory system agents|mesh-ancestor
65349121|NCT02549469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349122|NCT02549469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349123|NCT02549469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65349124|NCT02549469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65349125|NCT02549469|Gout Suppressants|gout suppressants|mesh-ancestor
65349126|NCT02549469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65349127|NCT02549469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349128|NCT02549469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349129|NCT02548533|Lidocaine|lidocaine|mesh-list
65349130|NCT02548533|Epinephrine|epinephrine|mesh-list
65349131|NCT02548533|Prilocaine|prilocaine|mesh-list
65349132|NCT02548533|Carticaine|carticaine|mesh-list
65349133|NCT02548533|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65349134|NCT02548533|Anesthetics, Local|anesthetics, local|mesh-ancestor
65349135|NCT02548533|Anesthetics|anesthetics|mesh-ancestor
65349136|NCT02548533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65349137|NCT02548533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349138|NCT02548533|Sensory System Agents|sensory system agents|mesh-ancestor
65349139|NCT02548533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349140|NCT02548533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65349141|NCT02548533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65349142|NCT02548533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65349143|NCT02548533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65349144|NCT02548533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349145|NCT02548533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65349146|NCT02548533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65349147|NCT02548533|Adrenergic Agents|adrenergic agents|mesh-ancestor
65349148|NCT02548533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65349149|NCT02548533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65349150|NCT02548533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65349151|NCT02548533|Autonomic Agents|autonomic agents|mesh-ancestor
65349152|NCT02548533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64741305|NCT02972723|Metformin|metformin|mesh-list
64489577|NCT03705429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64489578|NCT03705429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65349153|NCT02548533|Respiratory System Agents|respiratory system agents|mesh-ancestor
65349154|NCT02548533|Mydriatics|mydriatics|mesh-ancestor
65349155|NCT02548533|Sympathomimetics|sympathomimetics|mesh-ancestor
65349156|NCT02548533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65349157|NCT02548533|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65349158|NCT02549391|Cinacalcet|cinacalcet|mesh-list
65349159|NCT02549391|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65349160|NCT02549391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349161|NCT02549391|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65349162|NCT02549391|Hormone Antagonists|hormone antagonists|mesh-ancestor
65349163|NCT02549391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65349164|NCT02538172|Valganciclovir|valganciclovir|mesh-list
65349165|NCT02538172|Antiviral Agents|antiviral agents|mesh-ancestor
65349166|NCT02538172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65349167|NCT00837837|Chlorpheniramine|chlorpheniramine|mesh-list
65349168|NCT00837837|Antipruritics|antipruritics|mesh-ancestor
65349169|NCT00837837|Dermatologic Agents|dermatologic agents|mesh-ancestor
65349170|NCT00837837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65349171|NCT00837837|Histamine Antagonists|histamine antagonists|mesh-ancestor
65349172|NCT00837837|Histamine Agents|histamine agents|mesh-ancestor
65349173|NCT00837837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65349174|NCT00837837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349175|NCT00837837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349176|NCT00837837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65349177|NCT00908674|Cyproterone Acetate|cyproterone acetate|mesh-list
65349178|NCT00908674|Cyproterone|cyproterone|mesh-list
65349179|NCT00908674|Androgen Antagonists|androgen antagonists|mesh-ancestor
65349180|NCT00908674|Hormone Antagonists|hormone antagonists|mesh-ancestor
65349181|NCT00908674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65349182|NCT00908674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349183|NCT00908674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65349184|NCT00908674|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65349185|NCT00908674|Contraceptive Agents|contraceptive agents|mesh-ancestor
64489579|NCT03705429|Tubulin Modulators|tubulin modulators|mesh-ancestor
64489580|NCT03705429|Antimitotic Agents|antimitotic agents|mesh-ancestor
64555893|NCT02243241|Moxifloxacin|moxifloxacin|mesh-list
64555894|NCT02243241|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64555895|NCT02243241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64320961|NCT05502380|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64489581|NCT03705429|Mitosis Modulators|mitosis modulators|mesh-ancestor
65349186|NCT00908674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65349187|NCT00621777|Varenicline|varenicline|mesh-list
65349188|NCT00621777|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65349189|NCT00621777|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65349190|NCT00621777|Cholinergic Agents|cholinergic agents|mesh-ancestor
65349191|NCT00621777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65349192|NCT00621777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349193|NCT00621777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349194|NCT02538718|Ritodrine|ritodrine|mesh-list
65349195|NCT02538718|Sympathomimetics|sympathomimetics|mesh-ancestor
65349196|NCT02538718|Autonomic Agents|autonomic agents|mesh-ancestor
65349197|NCT02538718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349198|NCT02538718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349199|NCT02538718|Tocolytic Agents|tocolytic agents|mesh-ancestor
65098987|NCT01356966|Vitamins|vitamins|mesh-ancestor
65349200|NCT02538718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65349201|NCT02538718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65349202|NCT02538718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65349203|NCT02538718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65349204|NCT02538718|Adrenergic Agents|adrenergic agents|mesh-ancestor
65349205|NCT02538718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65349206|NCT02538718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349207|NCT00902512|Sildenafil Citrate|sildenafil citrate|mesh-list
65349208|NCT00902512|Vasodilator Agents|vasodilator agents|mesh-ancestor
65349209|NCT00902512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64741374|NCT00003587|Paclitaxel|paclitaxel|mesh-list
64489582|NCT03705429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489591|NCT04370782|Azithromycin|azithromycin|mesh-list
64489592|NCT04370782|Doxycycline|doxycycline|mesh-list
64489593|NCT04370782|Hydroxychloroquine|hydroxychloroquine|mesh-list
64489594|NCT04370782|Zinc Sulfate|zinc sulfate|mesh-list
64489595|NCT04370782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64489596|NCT04370782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64489597|NCT04370782|Antimalarials|antimalarials|mesh-ancestor
64489598|NCT04370782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64489599|NCT04370782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64489600|NCT04370782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489601|NCT04370782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489602|NCT04370782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64489603|NCT04370782|Astringents|astringents|mesh-ancestor
64489604|NCT04370782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489605|NCT04370782|Dermatologic Agents|dermatologic agents|mesh-ancestor
64489606|NCT03604653|Cisplatin|cisplatin|mesh-list
64489607|NCT03604653|Doxorubicin|doxorubicin|mesh-list
64489608|NCT03604653|Mitomycins|mitomycins|mesh-list
64489609|NCT03604653|Mitomycin|mitomycin|mesh-list
64489610|NCT03604653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489611|NCT03604653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64489612|NCT03604653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64489613|NCT03604653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65349210|NCT00902512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65349211|NCT00902512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349212|NCT00902512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349213|NCT00902512|Urological Agents|urological agents|mesh-ancestor
65349214|NCT00827307|Tamoxifen|tamoxifen|mesh-list
65349215|NCT00827307|Goserelin|goserelin|mesh-list
65349216|NCT00827307|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65349217|NCT00827307|Hormone Antagonists|hormone antagonists|mesh-ancestor
65349218|NCT00827307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65349219|NCT00827307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349220|NCT00827307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65349221|NCT00827307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65349222|NCT00827307|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65349223|NCT00827307|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65349224|NCT00827307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65349225|NCT00837915|Loratadine|loratadine|mesh-list
65349226|NCT00837915|Pseudoephedrine|pseudoephedrine|mesh-list
65349227|NCT00837915|Ephedrine|ephedrine|mesh-list
65349228|NCT00837915|Antipruritics|antipruritics|mesh-ancestor
65349229|NCT00837915|Dermatologic Agents|dermatologic agents|mesh-ancestor
65349230|NCT00837915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65349231|NCT00837915|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65349232|NCT00837915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65349233|NCT00837915|Histamine Antagonists|histamine antagonists|mesh-ancestor
65349234|NCT00837915|Histamine Agents|histamine agents|mesh-ancestor
65349235|NCT00837915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65349236|NCT00837915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349237|NCT00837915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349238|NCT00837915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65349239|NCT00837915|Autonomic Agents|autonomic agents|mesh-ancestor
65349240|NCT00837915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349241|NCT00837915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65349242|NCT00837915|Respiratory System Agents|respiratory system agents|mesh-ancestor
65349243|NCT00837915|Nasal Decongestants|nasal decongestants|mesh-ancestor
65349248|NCT00908986|Rituximab|rituximab|mesh-list
65349249|NCT00908986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65349250|NCT00908986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65349251|NCT00908986|Immunologic Factors|immunologic factors|mesh-ancestor
65349252|NCT00908986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349253|NCT00908986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65349254|NCT00909142|Clodronic Acid|clodronic acid|mesh-list
65349255|NCT00909142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65349256|NCT00909142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349257|NCT00838071|Immunoglobulins|immunoglobulins|mesh-list
65349258|NCT00838071|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65349259|NCT00838071|Antibodies|antibodies|mesh-list
65349260|NCT00838071|Immunologic Factors|immunologic factors|mesh-ancestor
65349261|NCT00838071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349262|NCT02547519|Insulin|insulin|mesh-list
65349263|NCT02547519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65349264|NCT02547519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349265|NCT00909454|Vitamin D|vitamin d|mesh-list
65349266|NCT00909454|Ergocalciferols|ergocalciferols|mesh-list
65349267|NCT00909454|Cholecalciferol|cholecalciferol|mesh-list
64489614|NCT03604653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489615|NCT03604653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489616|NCT03604653|Alkylating Agents|alkylating agents|mesh-ancestor
64489617|NCT03604653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64489618|NCT04376086|Anesthetics|anesthetics|mesh-list
64489619|NCT04376086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64489620|NCT04376086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489621|NCT03703167|Rituximab|rituximab|mesh-list
64489622|NCT03703167|Lenalidomide|lenalidomide|mesh-list
64489623|NCT03703167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64489624|NCT03703167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489625|NCT03703167|Immunologic Factors|immunologic factors|mesh-ancestor
64489626|NCT03703167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489627|NCT03703167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64489628|NCT03703167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64489629|NCT03703167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64489630|NCT03703167|Growth Substances|growth substances|mesh-ancestor
64489631|NCT03703167|Growth Inhibitors|growth inhibitors|mesh-ancestor
64489632|NCT04375852|Autoantibodies|autoantibodies|mesh-list
64489633|NCT04375852|Immunologic Factors|immunologic factors|mesh-ancestor
64489634|NCT04375852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489636|NCT04364464|Enzyme Activators|enzyme activators|mesh-ancestor
64489637|NCT04364464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489638|NCT03600441|Abexinostat|abexinostat|mesh-list
64489639|NCT03600441|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64489640|NCT03600441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489641|NCT03600441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489642|NCT01592240|Bococizumab|bococizumab|mesh-list
64489643|NCT01592240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64489644|NCT01592240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64489645|NCT01592240|Antimetabolites|antimetabolites|mesh-ancestor
64489646|NCT01592240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489667|NCT03692325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64489668|NCT03692325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489670|NCT04357522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64555896|NCT02243241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65349268|NCT00909454|Vitamins|vitamins|mesh-list
65349269|NCT00909454|Micronutrients|micronutrients|mesh-ancestor
65349270|NCT00909454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349271|NCT00909454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65349272|NCT00909454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65349273|NCT04035070|Clindamycin|clindamycin|mesh-list
65349274|NCT04035070|Clindamycin palmitate|clindamycin palmitate|mesh-list
65349276|NCT04035070|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65349277|NCT04035070|Sodium Hypochlorite|sodium hypochlorite|mesh-list
65349278|NCT04035070|Eusol|eusol|mesh-list
65349279|NCT04035070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65349280|NCT04035070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65349281|NCT04035070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65349282|NCT04035070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349283|NCT04035070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349284|NCT04035070|Disinfectants|disinfectants|mesh-ancestor
65349285|NCT04035070|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65349286|NCT00408421|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65349287|NCT00408421|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65349288|NCT00408421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64741437|NCT00003215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64555897|NCT02243241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64555898|NCT02243241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64489671|NCT04357522|Immunologic Factors|immunologic factors|mesh-ancestor
64489672|NCT04357522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489673|NCT03801369|Durvalumab|durvalumab|mesh-list
64489674|NCT03801369|Olaparib|olaparib|mesh-list
64489675|NCT03801369|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64489676|NCT03801369|Immunoglobulins|immunoglobulins|mesh-list
64489677|NCT03801369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64489678|NCT03801369|Immunoglobulin G|immunoglobulin g|mesh-list
64489679|NCT03801369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64489680|NCT03801369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489681|NCT03801369|Immunologic Factors|immunologic factors|mesh-ancestor
64489682|NCT03801369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489683|NCT03801369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489684|NCT03801369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489685|NCT00005901|Pamidronate|pamidronate|mesh-list
64489686|NCT00005901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64489687|NCT00005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489688|NCT04369534|Clopidogrel|clopidogrel|mesh-list
64489689|NCT04369534|Ticagrelor|ticagrelor|mesh-list
64489690|NCT04369534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64489691|NCT04369534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64489692|NCT04369534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64489693|NCT04369534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64489694|NCT04369534|Purinergic Agents|purinergic agents|mesh-ancestor
64489695|NCT04369534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64489696|NCT04369534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489697|NCT04369534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489698|NCT04363762|Salicylic Acid|salicylic acid|mesh-list
65349289|NCT00408421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65349290|NCT00408421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349291|NCT00408421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65349292|NCT00408421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349293|NCT00408421|Analgesics|analgesics|mesh-ancestor
65349294|NCT00408421|Sensory System Agents|sensory system agents|mesh-ancestor
65349295|NCT00408421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349296|NCT00408421|Antidepressive Agents|antidepressive agents|mesh-ancestor
65349297|NCT00408421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65349298|NCT00408421|Dopamine Agents|dopamine agents|mesh-ancestor
65349299|NCT00604786|Omalizumab|omalizumab|mesh-list
65349300|NCT00604786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65349301|NCT00604786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65349302|NCT00604786|Respiratory System Agents|respiratory system agents|mesh-ancestor
65349303|NCT01042873|Dobutamine|dobutamine|mesh-list
65349304|NCT01042873|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65349305|NCT01042873|Sympathomimetics|sympathomimetics|mesh-ancestor
65349306|NCT01042873|Autonomic Agents|autonomic agents|mesh-ancestor
65349307|NCT01042873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349308|NCT01042873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489699|NCT04363762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64489700|NCT04363762|Antifungal Agents|antifungal agents|mesh-ancestor
64489701|NCT04363762|Keratolytic Agents|keratolytic agents|mesh-ancestor
64489702|NCT04363762|Dermatologic Agents|dermatologic agents|mesh-ancestor
64489703|NCT03685773|Niacin|niacin|mesh-list
64489704|NCT03685773|Nicotinic Acids|nicotinic acids|mesh-list
64489705|NCT03685773|Niacinamide|niacinamide|mesh-list
64489706|NCT03685773|Diazoxide|diazoxide|mesh-list
64489707|NCT03685773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64489708|NCT03685773|Antimetabolites|antimetabolites|mesh-ancestor
64489715|NCT03685773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489716|NCT03685773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64489718|NCT04363450|Antimalarials|antimalarials|mesh-ancestor
64489719|NCT04363450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64489720|NCT04363450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64489721|NCT04363450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64489722|NCT04363450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489723|NCT04363450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489724|NCT04363450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64489725|NCT03685149|Flecainide|flecainide|mesh-list
64489726|NCT03685149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64489727|NCT03685149|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64489728|NCT03685149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64489729|NCT03685149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64489730|NCT03685149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489731|NCT04370080|Fluorides|fluorides|mesh-list
64489732|NCT04370080|Cariostatic Agents|cariostatic agents|mesh-ancestor
64489733|NCT04370080|Protective Agents|protective agents|mesh-ancestor
64489734|NCT04370080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489735|NCT01591616|Lidocaine|lidocaine|mesh-list
64489736|NCT01591616|Prilocaine|prilocaine|mesh-list
64489737|NCT01591616|Anesthetics, Local|anesthetics, local|mesh-ancestor
64489738|NCT01591616|Anesthetics|anesthetics|mesh-ancestor
64489742|NCT01591616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64489743|NCT01591616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64489744|NCT01591616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64555900|NCT02243241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349309|NCT01042873|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65349310|NCT01042873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65349311|NCT01042873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65349312|NCT01042873|Adrenergic Agents|adrenergic agents|mesh-ancestor
65349313|NCT01042873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65349314|NCT01042873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349315|NCT01042873|Protective Agents|protective agents|mesh-ancestor
65349316|NCT01042951|Vaccines|vaccines|mesh-list
65349317|NCT01042951|Immunologic Factors|immunologic factors|mesh-ancestor
65349318|NCT01042951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349319|NCT01037023|Topotecan|topotecan|mesh-list
65349320|NCT01037023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65349321|NCT01037023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65349322|NCT01037023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349323|NCT01037023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349324|NCT01037023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65349325|NCT00604708|Vaccines|vaccines|mesh-list
65349326|NCT00604708|Immunologic Factors|immunologic factors|mesh-ancestor
65349327|NCT00604708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349328|NCT00909688|BLI-489|bli-489|mesh-list
65349329|NCT00909688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65349330|NCT00909688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349331|NCT00909688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349332|NCT00909688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65349333|NCT00909688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64555901|NCT02243241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555902|NCT02243241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64555903|NCT02243241|Contraceptive Agents|contraceptive agents|mesh-ancestor
64555904|NCT02243241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64555905|NCT02243241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555906|NCT02243241|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64489745|NCT01591616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64489746|NCT01591616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64489747|NCT01591616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489748|NCT00938314|Epoetin Alfa|epoetin alfa|mesh-list
64489749|NCT00938314|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64489750|NCT00938314|Hematinics|hematinics|mesh-ancestor
64489751|NCT00938314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64489752|NCT00938314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489753|NCT03587961|Ivacaftor|ivacaftor|mesh-list
64489754|NCT03587961|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64489755|NCT03587961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64489756|NCT03587961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489757|NCT04370392|Anesthetics|anesthetics|mesh-list
64489758|NCT04370392|Anesthetics, Local|anesthetics, local|mesh-list
64489759|NCT04370392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64489760|NCT04370392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349334|NCT00903214|Riluzole|riluzole|mesh-list
65349335|NCT00903214|Anticonvulsants|anticonvulsants|mesh-ancestor
65349336|NCT00903214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65349337|NCT00903214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65349338|NCT00903214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65349339|NCT00903214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349340|NCT00903214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349341|NCT00903214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65349342|NCT00903214|Protective Agents|protective agents|mesh-ancestor
65349343|NCT04034836|Parecoxib|parecoxib|mesh-list
65349344|NCT04034836|Ropivacaine|ropivacaine|mesh-list
65349345|NCT04034836|Anesthetics, Local|anesthetics, local|mesh-ancestor
65349346|NCT04034836|Anesthetics|anesthetics|mesh-ancestor
65349347|NCT04034836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65099141|NCT00513188|Levoleucovorin|levoleucovorin|mesh-list
65349348|NCT04034836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349349|NCT04034836|Sensory System Agents|sensory system agents|mesh-ancestor
65349350|NCT04034836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349351|NCT04034836|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65349352|NCT04034836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65349353|NCT04034836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349354|NCT04034836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349355|NCT04034836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65349356|NCT04034836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65349357|NCT04034836|Analgesics|analgesics|mesh-ancestor
65349358|NCT04034836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65349359|NCT04034836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65349360|NCT00407797|Pregabalin|pregabalin|mesh-list
65349361|NCT00407797|Analgesics|analgesics|mesh-ancestor
65349362|NCT00407797|Sensory System Agents|sensory system agents|mesh-ancestor
65349363|NCT00407797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349375|NCT00903292|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65349376|NCT00903292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65349377|NCT00903292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349378|NCT00903292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349379|NCT00903292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65349380|NCT00903292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65349381|NCT00903292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65349382|NCT00903838|Pramipexole|pramipexole|mesh-list
65349383|NCT00903838|Antioxidants|antioxidants|mesh-ancestor
65349384|NCT00903838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349385|NCT00903838|Protective Agents|protective agents|mesh-ancestor
65349386|NCT00903838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349387|NCT00903838|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65349388|NCT00903838|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65349389|NCT00903838|Dopamine Agonists|dopamine agonists|mesh-ancestor
65349390|NCT00903838|Dopamine Agents|dopamine agents|mesh-ancestor
64489761|NCT04370392|Sensory System Agents|sensory system agents|mesh-ancestor
64489762|NCT04370392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64489763|NCT03797001|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64489764|NCT03797001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64489765|NCT04369222|Acetaminophen|acetaminophen|mesh-list
64489766|NCT04369222|Aspirin|aspirin|mesh-list
64489767|NCT04369222|Salicylic Acid|salicylic acid|mesh-list
64489768|NCT04369222|Salicylates|salicylates|mesh-list
64489769|NCT04369222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64489770|NCT04369222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64489771|NCT04369222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64489772|NCT04369222|Analgesics|analgesics|mesh-ancestor
64489773|NCT04369222|Sensory System Agents|sensory system agents|mesh-ancestor
64489784|NCT04369222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489786|NCT04369222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64489787|NCT04369222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64489788|NCT03584373|Acetaminophen|acetaminophen|mesh-list
64489789|NCT03584373|Ketorolac|ketorolac|mesh-list
64489790|NCT03584373|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64489791|NCT03584373|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64489792|NCT03584373|Oxycodone|oxycodone|mesh-list
64489793|NCT03584373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64489794|NCT03584373|Analgesics|analgesics|mesh-ancestor
64489795|NCT03584373|Sensory System Agents|sensory system agents|mesh-ancestor
64489796|NCT03584373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64489797|NCT03584373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489798|NCT03584373|Antipyretics|antipyretics|mesh-ancestor
64489799|NCT03584373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64489800|NCT03584373|Narcotics|narcotics|mesh-ancestor
64489801|NCT03584373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64489802|NCT03584373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64489803|NCT03584373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64489804|NCT03584373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64489805|NCT03584373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64489806|NCT03584373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489807|NCT03584373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489808|NCT01591460|Ribavirin|ribavirin|mesh-list
64489809|NCT01591460|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64489810|NCT01591460|Interferon-alpha|interferon-alpha|mesh-list
64489811|NCT01591460|Antimetabolites|antimetabolites|mesh-ancestor
64555907|NCT02243241|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64489812|NCT01591460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349391|NCT00903838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65349392|NCT00924430|Simvastatin|simvastatin|mesh-list
65349393|NCT00924430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65349394|NCT00924430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65349395|NCT00924430|Antimetabolites|antimetabolites|mesh-ancestor
65349396|NCT00924430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349397|NCT00924430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65349398|NCT00924430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65349399|NCT00924430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349400|NCT00924586|Landiolol|landiolol|mesh-list
65349401|NCT00924586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65349402|NCT00924586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65349403|NCT00924586|Adrenergic Agents|adrenergic agents|mesh-ancestor
65349404|NCT00924586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65349405|NCT00924586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349406|NCT00924586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349407|NCT00924586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65349408|NCT00903994|Ketoprofen|ketoprofen|mesh-list
65349409|NCT00903994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65349410|NCT00903994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65349411|NCT00903994|Analgesics|analgesics|mesh-ancestor
65349412|NCT00903994|Sensory System Agents|sensory system agents|mesh-ancestor
65349413|NCT00903994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349414|NCT00903994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349415|NCT00903994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65349416|NCT00903994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65349417|NCT00903994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65349418|NCT00903994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349419|NCT00903994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099226|NCT00515892|Antibodies|antibodies|mesh-list
65349420|NCT00924742|Tazobactam|tazobactam|mesh-list
65349421|NCT00924742|Piperacillin|piperacillin|mesh-list
65349422|NCT00924742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65349423|NCT00924742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64741575|NCT00004037|Docetaxel|docetaxel|mesh-list
64489813|NCT01591460|Antiviral Agents|antiviral agents|mesh-ancestor
64489814|NCT01591460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64489815|NCT01591460|Immunologic Factors|immunologic factors|mesh-ancestor
64489816|NCT01591460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489817|NCT04363216|Ascorbic Acid|ascorbic acid|mesh-list
64489818|NCT04363216|Vitamins|vitamins|mesh-ancestor
65349424|NCT00924742|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65349425|NCT00924742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349426|NCT00924742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349427|NCT05014282|Nicotine|nicotine|mesh-list
65349428|NCT05014282|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65349429|NCT05014282|Autonomic Agents|autonomic agents|mesh-ancestor
65349430|NCT05014282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349431|NCT05014282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349432|NCT05014282|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65349433|NCT05014282|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65349434|NCT05014282|Cholinergic Agents|cholinergic agents|mesh-ancestor
65349435|NCT05014282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65349436|NCT05014282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349437|NCT00407563|Paclitaxel|paclitaxel|mesh-list
65349438|NCT00407563|Bevacizumab|bevacizumab|mesh-list
65349439|NCT00407563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65349440|NCT00407563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65349441|NCT00407563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65349442|NCT00407563|Tubulin Modulators|tubulin modulators|mesh-ancestor
65349478|NCT00623103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65349479|NCT00623103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349480|NCT00623103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65349481|NCT00623103|Protective Agents|protective agents|mesh-ancestor
65349482|NCT01043341|Vaccines|vaccines|mesh-list
65349483|NCT01043341|Immunologic Factors|immunologic factors|mesh-ancestor
65349484|NCT01043341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349485|NCT01043419|Xenon|xenon|mesh-list
65349486|NCT01043419|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65349487|NCT01043419|Anesthetics, General|anesthetics, general|mesh-ancestor
65349488|NCT01043419|Anesthetics|anesthetics|mesh-ancestor
65349489|NCT01043419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65349490|NCT01043419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349491|NCT01037335|Morphine|morphine|mesh-list
65349492|NCT01037335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65349493|NCT01037335|Narcotics|narcotics|mesh-ancestor
65349494|NCT01037335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65349495|NCT01037335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349496|NCT01037335|Analgesics|analgesics|mesh-ancestor
65349497|NCT01037335|Sensory System Agents|sensory system agents|mesh-ancestor
65349498|NCT01037335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349499|NCT04015492|Factor VIII|factor viii|mesh-list
65349500|NCT04015492|BAX 855|bax 855|mesh-list
65349501|NCT04015492|Coagulants|coagulants|mesh-ancestor
64489819|NCT04363216|Micronutrients|micronutrients|mesh-ancestor
64489820|NCT04363216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489821|NCT04363216|Antioxidants|antioxidants|mesh-ancestor
64489822|NCT04363216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489823|NCT04363216|Protective Agents|protective agents|mesh-ancestor
64489824|NCT03678675|Ketorolac|ketorolac|mesh-list
64489825|NCT03678675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64489826|NCT03678675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64489827|NCT03678675|Analgesics|analgesics|mesh-ancestor
64489828|NCT03678675|Sensory System Agents|sensory system agents|mesh-ancestor
64489829|NCT03678675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64489830|NCT03678675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489831|NCT03678675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64489832|NCT03678675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64489833|NCT03678675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64489834|NCT03678675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489835|NCT03678675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489836|NCT04363060|Amoxicillin|amoxicillin|mesh-list
64489837|NCT04363060|Azithromycin|azithromycin|mesh-list
64489844|NCT04363060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489845|NCT04363060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489846|NCT01591382|Ketamine|ketamine|mesh-list
64489847|NCT01591382|Hydromorphone|hydromorphone|mesh-list
64489848|NCT01591382|Analgesics|analgesics|mesh-ancestor
64489849|NCT01591382|Sensory System Agents|sensory system agents|mesh-ancestor
64489850|NCT01591382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64489851|NCT01591382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489852|NCT01591382|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64489853|NCT01591382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64489854|NCT01591382|Anesthetics, General|anesthetics, general|mesh-ancestor
65349502|NCT00904462|Lidocaine|lidocaine|mesh-list
65349503|NCT00904462|Anesthetics, Local|anesthetics, local|mesh-ancestor
65349504|NCT00904462|Anesthetics|anesthetics|mesh-ancestor
65349505|NCT00904462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65349506|NCT00904462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349507|NCT00904462|Sensory System Agents|sensory system agents|mesh-ancestor
65349508|NCT00904462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349509|NCT00904462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65349510|NCT00904462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65349511|NCT00904462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65349512|NCT00904462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65349513|NCT00904462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349514|NCT00396565|Olanzapine|olanzapine|mesh-list
65349515|NCT00396565|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64489855|NCT01591382|Anesthetics|anesthetics|mesh-ancestor
64489856|NCT01591382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64489857|NCT01591382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64489858|NCT01591382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64489859|NCT01591382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64489860|NCT01591382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489861|NCT01591382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64489862|NCT01591382|Narcotics|narcotics|mesh-ancestor
64489864|NCT03677817|Anesthetics, Local|anesthetics, local|mesh-ancestor
64489865|NCT03677817|Anesthetics|anesthetics|mesh-ancestor
64489866|NCT03677817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64489867|NCT03677817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489868|NCT03677817|Sensory System Agents|sensory system agents|mesh-ancestor
64489869|NCT03677817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64489870|NCT03677817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64489871|NCT03677817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64489872|NCT03677817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64489873|NCT03677817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64489874|NCT03677817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489875|NCT00931996|Antipsychotic Agents|antipsychotic agents|mesh-list
64489876|NCT00931996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64489877|NCT00931996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64489878|NCT00931996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489879|NCT00931996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64489880|NCT04348305|Hydrocortisone|hydrocortisone|mesh-list
64489881|NCT04348305|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64489882|NCT04348305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64489883|NCT00928174|Fluorides|fluorides|mesh-list
64489884|NCT00928174|Cariostatic Agents|cariostatic agents|mesh-ancestor
64489885|NCT00928174|Protective Agents|protective agents|mesh-ancestor
64489886|NCT00928174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555911|NCT03076320|Dermatologic Agents|dermatologic agents|mesh-ancestor
64555912|NCT03076320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64489887|NCT01696214|Fluticasone|fluticasone|mesh-list
64489889|NCT01696214|Theophylline|theophylline|mesh-list
64489890|NCT01696214|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64489891|NCT01696214|Ipratropium|ipratropium|mesh-list
64489892|NCT01696214|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64489893|NCT01696214|Montelukast|montelukast|mesh-list
64489894|NCT01696214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64489895|NCT01696214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64489896|NCT01696214|Autonomic Agents|autonomic agents|mesh-ancestor
64489897|NCT01696214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64489898|NCT01696214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489899|NCT01696214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65349516|NCT00396565|Antiemetics|antiemetics|mesh-ancestor
65349517|NCT00396565|Autonomic Agents|autonomic agents|mesh-ancestor
65349518|NCT00396565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349519|NCT00396565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349520|NCT00396565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65349521|NCT00396565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65349522|NCT00396565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65349523|NCT00396565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65349524|NCT00396565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65349525|NCT00396565|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65349526|NCT00396565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65349527|NCT00396565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65349528|NCT00396565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349529|NCT00396565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65349530|NCT00396565|Serotonin Agents|serotonin agents|mesh-ancestor
65349531|NCT00396565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65349532|NCT00396565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65349533|NCT00396565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65349534|NCT00396565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65349535|NCT00396565|Dopamine Agents|dopamine agents|mesh-ancestor
65349536|NCT00904540|Lidocaine|lidocaine|mesh-list
65349537|NCT00904540|Anesthetics, Local|anesthetics, local|mesh-ancestor
65349538|NCT00904540|Anesthetics|anesthetics|mesh-ancestor
64489900|NCT01696214|Respiratory System Agents|respiratory system agents|mesh-ancestor
64489901|NCT01696214|Dermatologic Agents|dermatologic agents|mesh-ancestor
64489902|NCT01696214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64489903|NCT01696214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64489904|NCT01696214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64489905|NCT01696214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64489906|NCT01696214|Adrenergic Agents|adrenergic agents|mesh-ancestor
64489907|NCT01696214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64489927|NCT03794037|Progestins|progestins|mesh-ancestor
64489928|NCT03794037|Hormones|hormones|mesh-ancestor
64489929|NCT03794037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64489930|NCT03794037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489931|NCT03794037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64489932|NCT03794037|Respiratory System Agents|respiratory system agents|mesh-ancestor
64489933|NCT03794037|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64489934|NCT03794037|Hormone Antagonists|hormone antagonists|mesh-ancestor
64489935|NCT03794037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64489936|NCT03794037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64489937|NCT03794037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489938|NCT04356508|Nivolumab|nivolumab|mesh-list
64489939|NCT04356508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64489940|NCT04356508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489941|NCT04356508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64489942|NCT04356508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489943|NCT04368598|Acetylcysteine|acetylcysteine|mesh-list
64489944|NCT04368598|Dexamethasone|dexamethasone|mesh-list
64489945|NCT04368598|Dexamethasone acetate|dexamethasone acetate|mesh-list
65349539|NCT00904540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65349540|NCT00904540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349541|NCT00904540|Sensory System Agents|sensory system agents|mesh-ancestor
65349542|NCT00904540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349543|NCT00904540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65349544|NCT00904540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65349545|NCT00904540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65349546|NCT00904540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65349547|NCT00904540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349548|NCT00906880|Eflornithine|eflornithine|mesh-list
65349549|NCT00906880|Nifurtimox|nifurtimox|mesh-list
65349550|NCT00906880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65349551|NCT00906880|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65349552|NCT00906880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65349553|NCT00906880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65349554|NCT00906880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65349555|NCT00906880|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
65349556|NCT00906880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349557|NCT00906880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349558|NCT00904852|Bevacizumab|bevacizumab|mesh-list
65349559|NCT00904852|Temozolomide|temozolomide|mesh-list
65349560|NCT00904852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65349561|NCT00904852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65349562|NCT00904852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65349563|NCT00904852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65349564|NCT00904852|Growth Substances|growth substances|mesh-ancestor
65349565|NCT00904852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349566|NCT00904852|Growth Inhibitors|growth inhibitors|mesh-ancestor
65349567|NCT00904852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65349568|NCT00904852|Alkylating Agents|alkylating agents|mesh-ancestor
65099371|NCT00530556|GABA Agonists|gaba agonists|mesh-ancestor
65349569|NCT00904852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489946|NCT04368598|BB 1101|bb 1101|mesh-list
64489947|NCT04368598|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64489948|NCT04368598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64489949|NCT04368598|Antiemetics|antiemetics|mesh-ancestor
64489950|NCT04368598|Autonomic Agents|autonomic agents|mesh-ancestor
64489951|NCT04368598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64489952|NCT04368598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349570|NCT00394771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65349571|NCT00394771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65349572|NCT00394771|Levonorgestrel|levonorgestrel|mesh-list
65349573|NCT00394771|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65349575|NCT00394771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65349576|NCT00394771|Estrogens|estrogens|mesh-ancestor
65349577|NCT00394771|Hormones|hormones|mesh-ancestor
65349578|NCT00394771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65349579|NCT00394771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349580|NCT00394771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65349581|NCT00394771|Contraceptive Agents|contraceptive agents|mesh-ancestor
65349582|NCT00394771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65349583|NCT00394771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65349584|NCT00394771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65349585|NCT00394771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65349586|NCT00394771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65349587|NCT00396409|Omalizumab|omalizumab|mesh-list
65349588|NCT00396409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65349589|NCT00396409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65349590|NCT00396409|Respiratory System Agents|respiratory system agents|mesh-ancestor
65349591|NCT03653832|Clonidine|clonidine|mesh-list
65349592|NCT03653832|Dexmedetomidine|dexmedetomidine|mesh-list
65349593|NCT03653832|Propofol|propofol|mesh-list
65349594|NCT03653832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65349595|NCT03653832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65349596|NCT03653832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349597|NCT03653832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65349598|NCT03653832|Anesthetics, General|anesthetics, general|mesh-ancestor
65349619|NCT04034524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65349620|NCT04034524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65349621|NCT04034524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349622|NCT00925912|Bupivacaine|bupivacaine|mesh-list
65349623|NCT00925912|Anesthetics, Local|anesthetics, local|mesh-ancestor
65349624|NCT00925912|Anesthetics|anesthetics|mesh-ancestor
65349625|NCT00925912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65349626|NCT00925912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349627|NCT00925912|Sensory System Agents|sensory system agents|mesh-ancestor
65349628|NCT00925912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349629|NCT00695136|Donepezil|donepezil|mesh-list
65349630|NCT00695136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65349631|NCT00695136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349632|NCT00695136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349633|NCT00695136|Cholinergic Agents|cholinergic agents|mesh-ancestor
65349634|NCT00695136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65349635|NCT00695136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349636|NCT00695136|Nootropic Agents|nootropic agents|mesh-ancestor
65349637|NCT00921570|Amlodipine|amlodipine|mesh-list
65349638|NCT00921570|Valsartan|valsartan|mesh-list
65349639|NCT00921570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65349640|NCT00921570|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65349641|NCT00921570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65349642|NCT00921570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349643|NCT00921570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65099446|NCT00530868|Bevacizumab|bevacizumab|mesh-list
65349644|NCT00921570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741807|NCT00004163|Trastuzumab|trastuzumab|mesh-list
64489953|NCT04368598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64489954|NCT04368598|Glucocorticoids|glucocorticoids|mesh-ancestor
64489955|NCT04368598|Hormones|hormones|mesh-ancestor
64489956|NCT04368598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64489957|NCT04368598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64489958|NCT04368598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489959|NCT04368598|Protease Inhibitors|protease inhibitors|mesh-ancestor
64489960|NCT04368598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489961|NCT04368598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489982|NCT05347641|Dermatologic Agents|dermatologic agents|mesh-ancestor
64489983|NCT05347641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489984|NCT05347641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64489985|NCT05347641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64489986|NCT05347641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64555916|NCT03076320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64555917|NCT03076320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555918|NCT03076320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65349645|NCT00921570|Vasodilator Agents|vasodilator agents|mesh-ancestor
65349646|NCT00921570|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65349647|NCT00921570|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65349648|NCT02710890|Lacosamide|lacosamide|mesh-list
65349649|NCT02710890|Anticonvulsants|anticonvulsants|mesh-ancestor
65349650|NCT02710890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65349651|NCT02710890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65349652|NCT02710890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65349653|NCT02710890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349654|NCT00605176|Imiquimod|imiquimod|mesh-list
65349655|NCT00605176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65349656|NCT00605176|Immunologic Factors|immunologic factors|mesh-ancestor
65349657|NCT00605176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349658|NCT00605176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65349659|NCT00605176|Interferon Inducers|interferon inducers|mesh-ancestor
64555919|NCT03076320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64489987|NCT05347641|Antiviral Agents|antiviral agents|mesh-ancestor
64489988|NCT05347641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64489989|NCT01696058|Tiotropium Bromide|tiotropium bromide|mesh-list
64489991|NCT01696058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64489993|NCT01696058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64489994|NCT01696058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489995|NCT01696058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64489996|NCT01696058|Respiratory System Agents|respiratory system agents|mesh-ancestor
64489997|NCT01696058|Parasympatholytics|parasympatholytics|mesh-ancestor
64489998|NCT01696058|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64489999|NCT01696058|Cholinergic Agents|cholinergic agents|mesh-ancestor
64490000|NCT01696058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64490001|NCT01696058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490003|NCT04368520|Ergocalciferols|ergocalciferols|mesh-list
64490004|NCT04368520|Cholecalciferol|cholecalciferol|mesh-list
64490005|NCT04368520|Vitamins|vitamins|mesh-list
64490006|NCT04368520|Micronutrients|micronutrients|mesh-ancestor
64490007|NCT04368520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490008|NCT04368520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64490009|NCT04368520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64490010|NCT03790137|Fenfluramine|fenfluramine|mesh-list
64490011|NCT03790137|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64490012|NCT03790137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64490013|NCT03790137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64490036|NCT03580317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490038|NCT03580317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64490039|NCT04362124|BCG Vaccine|bcg vaccine|mesh-list
64490040|NCT04362124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64490041|NCT04362124|Immunologic Factors|immunologic factors|mesh-ancestor
64490042|NCT04362124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490043|NCT04356118|Methotrexate|methotrexate|mesh-list
64490044|NCT04356118|Endostatins|endostatins|mesh-list
64490045|NCT04356118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64490046|NCT04356118|Abortifacient Agents|abortifacient agents|mesh-ancestor
64490047|NCT04356118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64490048|NCT04356118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490049|NCT04356118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64490050|NCT04356118|Antimetabolites|antimetabolites|mesh-ancestor
64490051|NCT04356118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490052|NCT04356118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490053|NCT04356118|Dermatologic Agents|dermatologic agents|mesh-ancestor
64490054|NCT04356118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349660|NCT00743028|Navitoclax|navitoclax|mesh-list
65349661|NCT00743028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65349662|NCT00926302|Levetiracetam|levetiracetam|mesh-list
65349663|NCT00926302|Anticonvulsants|anticonvulsants|mesh-ancestor
65349664|NCT00926302|Nootropic Agents|nootropic agents|mesh-ancestor
65349665|NCT00907036|Cyclosporine|cyclosporine|mesh-list
65349666|NCT00907036|Fludarabine|fludarabine|mesh-list
65349667|NCT00907036|Fludarabine phosphate|fludarabine phosphate|mesh-list
65349668|NCT00907036|Melphalan|melphalan|mesh-list
65349669|NCT00907036|Alemtuzumab|alemtuzumab|mesh-list
65349670|NCT00907036|Cyclosporins|cyclosporins|mesh-list
65349671|NCT00907036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65349672|NCT00907036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65349673|NCT00907036|Antimetabolites|antimetabolites|mesh-ancestor
65349674|NCT00907036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349675|NCT00907036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65349676|NCT00907036|Immunologic Factors|immunologic factors|mesh-ancestor
65349677|NCT00907036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349678|NCT00907036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349679|NCT00907036|Antifungal Agents|antifungal agents|mesh-ancestor
65349680|NCT00907036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65349681|NCT00907036|Dermatologic Agents|dermatologic agents|mesh-ancestor
65349682|NCT00907036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65349683|NCT00907036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65349684|NCT00907036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65349685|NCT00907036|Alkylating Agents|alkylating agents|mesh-ancestor
65349686|NCT00907036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65349687|NCT00907036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64490055|NCT04356118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64490056|NCT04356118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64490057|NCT04356118|Immunologic Factors|immunologic factors|mesh-ancestor
64490058|NCT04356118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64490059|NCT04356118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64490060|NCT04356118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64490061|NCT04356118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64490074|NCT04355962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64490076|NCT04355962|Anesthetics, General|anesthetics, general|mesh-ancestor
64490077|NCT04355962|Anesthetics|anesthetics|mesh-ancestor
64490078|NCT04355962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64490079|NCT04355962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490080|NCT00705081|Ezetimibe|ezetimibe|mesh-list
64490081|NCT00705081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64490082|NCT00705081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64490083|NCT00705081|Antimetabolites|antimetabolites|mesh-ancestor
64490084|NCT00705081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490085|NCT00705081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64490086|NCT00704769|Desloratadine|desloratadine|mesh-list
64555921|NCT04365309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64555923|NCT04365309|Analgesics|analgesics|mesh-ancestor
65349688|NCT00926614|Pioglitazone|pioglitazone|mesh-list
65349689|NCT00926614|Atorvastatin|atorvastatin|mesh-list
65349690|NCT00926614|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65349691|NCT00926614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65349692|NCT00926614|Antimetabolites|antimetabolites|mesh-ancestor
65349693|NCT00926614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349694|NCT00926614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65349695|NCT00926614|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65349696|NCT00926614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349697|NCT00926614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65349698|NCT00926614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349699|NCT00907114|Ketorolac|ketorolac|mesh-list
65349700|NCT00907114|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65349701|NCT00907114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65349702|NCT00907114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65349703|NCT00907114|Analgesics|analgesics|mesh-ancestor
65349704|NCT00907114|Sensory System Agents|sensory system agents|mesh-ancestor
65349705|NCT00907114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349706|NCT00907114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349707|NCT00907114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65349708|NCT00907114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65349709|NCT00907114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65349710|NCT00907114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349711|NCT00907114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349712|NCT02564094|Epoetin Alfa|epoetin alfa|mesh-list
65349713|NCT02564094|Hematinics|hematinics|mesh-ancestor
65349714|NCT00745914|Pioglitazone|pioglitazone|mesh-list
65349715|NCT00745914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65349716|NCT00745914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349717|NCT00746070|Spironolactone|spironolactone|mesh-list
65349718|NCT00746070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65349719|NCT00746070|Hormone Antagonists|hormone antagonists|mesh-ancestor
65349720|NCT00746070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65349721|NCT00746070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349722|NCT00746070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64555924|NCT04365309|Sensory System Agents|sensory system agents|mesh-ancestor
64555925|NCT04365309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349723|NCT00746070|Diuretics|diuretics|mesh-ancestor
65349724|NCT00746070|Natriuretic Agents|natriuretic agents|mesh-ancestor
65349725|NCT00396331|Plerixafor|plerixafor|mesh-list
65349726|NCT00396331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65349727|NCT00396331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65349728|NCT00396331|Antiviral Agents|antiviral agents|mesh-ancestor
65349729|NCT00396331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65349730|NCT00927550|Lithium Carbonate|lithium carbonate|mesh-list
65349731|NCT00927550|Antidepressive Agents|antidepressive agents|mesh-ancestor
65349732|NCT00927550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65349733|NCT00927550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349734|NCT00927550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349735|NCT00927550|Antimanic Agents|antimanic agents|mesh-ancestor
65349736|NCT00927550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65349737|NCT00927550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65349738|NCT00927550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349739|NCT00926926|Oxybutynin|oxybutynin|mesh-list
65349740|NCT00926926|Parasympatholytics|parasympatholytics|mesh-ancestor
65349741|NCT00926926|Autonomic Agents|autonomic agents|mesh-ancestor
65349742|NCT00926926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64555926|NCT04365309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555927|NCT04365309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64555928|NCT04365309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64555929|NCT04365309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64555930|NCT04365309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64555931|NCT04365309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555932|NCT04365309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64555933|NCT04365309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64555934|NCT04365309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490088|NCT00704769|Cholinergic Agents|cholinergic agents|mesh-ancestor
64490089|NCT00704769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64490090|NCT00704769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490091|NCT00704769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490092|NCT00704769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64490093|NCT00704769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64490094|NCT00704769|Histamine Antagonists|histamine antagonists|mesh-ancestor
64490095|NCT00704769|Histamine Agents|histamine agents|mesh-ancestor
64490096|NCT00938548|Pregabalin|pregabalin|mesh-list
64490097|NCT00938548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490098|NCT00938548|Analgesics|analgesics|mesh-ancestor
64490099|NCT00938548|Sensory System Agents|sensory system agents|mesh-ancestor
64490100|NCT00938548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64490101|NCT00938548|Anticonvulsants|anticonvulsants|mesh-ancestor
64490102|NCT00938548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64490103|NCT00938548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64490104|NCT00938548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490105|NCT00938548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64490106|NCT00938548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64490107|NCT00938548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64490108|NCT00938548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64490109|NCT00938548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64490110|NCT00932620|Simvastatin|simvastatin|mesh-list
64490111|NCT00932620|Ezetimibe|ezetimibe|mesh-list
64490112|NCT00932620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64490113|NCT00932620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65349743|NCT00926926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349744|NCT00926926|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65349745|NCT00926926|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65349746|NCT00926926|Cholinergic Agents|cholinergic agents|mesh-ancestor
65349747|NCT00926926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65349748|NCT00926926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349749|NCT00926926|Urological Agents|urological agents|mesh-ancestor
65349750|NCT00396253|Tenecteplase|tenecteplase|mesh-list
65349751|NCT00396253|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65349752|NCT00396253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65349753|NCT00396253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349754|NCT00927004|Etoricoxib|etoricoxib|mesh-list
65349755|NCT00927004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65349756|NCT00927004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65349757|NCT00927004|Analgesics|analgesics|mesh-ancestor
65349758|NCT00927004|Sensory System Agents|sensory system agents|mesh-ancestor
65349759|NCT00927004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349760|NCT00927004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349761|NCT00927004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65349762|NCT00927004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65349763|NCT00927004|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65349764|NCT00927004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65349765|NCT00927004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349766|NCT00927004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349767|NCT00931450|Sunitinib|sunitinib|mesh-list
65349768|NCT00931450|Exemestane|exemestane|mesh-list
65349769|NCT00931450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65349770|NCT00931450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65349771|NCT00931450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65349772|NCT00931450|Growth Substances|growth substances|mesh-ancestor
64741922|NCT00003311|Methotrexate|methotrexate|mesh-list
64490114|NCT00932620|Antimetabolites|antimetabolites|mesh-ancestor
64490115|NCT00932620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490116|NCT00932620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64490117|NCT00932620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64490118|NCT00932620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490119|NCT04361188|Anesthetics|anesthetics|mesh-list
64714193|NCT02988050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64555941|NCT04365231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64555942|NCT04365231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64555943|NCT04365231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555944|NCT04365231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349773|NCT00931450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349774|NCT00931450|Growth Inhibitors|growth inhibitors|mesh-ancestor
65349775|NCT00931450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65349776|NCT00931450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349777|NCT00931450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349778|NCT00931450|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65349779|NCT00931450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65349780|NCT00931450|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65349781|NCT00931450|Hormone Antagonists|hormone antagonists|mesh-ancestor
65349782|NCT00931450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65349783|NCT00928330|Trastuzumab|trastuzumab|mesh-list
65349784|NCT00928330|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65349785|NCT00928330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65349786|NCT00928330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65349787|NCT00928330|Tubulin Modulators|tubulin modulators|mesh-ancestor
65349788|NCT00928330|Antimitotic Agents|antimitotic agents|mesh-ancestor
65349789|NCT00928330|Mitosis Modulators|mitosis modulators|mesh-ancestor
65349790|NCT00928330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349791|NCT00928798|Sirolimus|sirolimus|mesh-list
65349792|NCT00928798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65349793|NCT00928798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65349794|NCT00928798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64555945|NCT04365231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64490120|NCT04361188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64490121|NCT04361188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490123|NCT04367818|Anesthetics, Local|anesthetics, local|mesh-list
64490124|NCT04367818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64490125|NCT04367818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490137|NCT04355806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64490138|NCT04355806|Immunologic Factors|immunologic factors|mesh-ancestor
64490139|NCT04355806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490140|NCT04355806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490141|NCT04355806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490142|NCT01677351|Clonidine|clonidine|mesh-list
64490143|NCT01677351|Analgesics|analgesics|mesh-ancestor
64490144|NCT01677351|Sensory System Agents|sensory system agents|mesh-ancestor
64490145|NCT01677351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64490146|NCT01677351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490147|NCT01677351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64490148|NCT01677351|Sympatholytics|sympatholytics|mesh-ancestor
64490149|NCT01677351|Autonomic Agents|autonomic agents|mesh-ancestor
64490150|NCT01677351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64490151|NCT01677351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64490152|NCT01677351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64490153|NCT01677351|Adrenergic Agents|adrenergic agents|mesh-ancestor
64490154|NCT01677351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64490156|NCT00938704|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64490157|NCT00938704|Hyaluronic Acid|hyaluronic acid|mesh-list
64490159|NCT00938704|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64490160|NCT00938704|Immunologic Factors|immunologic factors|mesh-ancestor
65349795|NCT00928798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65349796|NCT00928798|Antifungal Agents|antifungal agents|mesh-ancestor
65349797|NCT00928798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65349798|NCT00928798|Immunologic Factors|immunologic factors|mesh-ancestor
65349799|NCT00928798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349801|NCT00931840|Cetuximab|cetuximab|mesh-list
65349802|NCT00931840|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65349803|NCT00931840|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65349804|NCT00931840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349806|NCT00931840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65349860|NCT00932542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349861|NCT00932542|Sensory System Agents|sensory system agents|mesh-ancestor
65349862|NCT00932542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349863|NCT00932542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65349864|NCT00932542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65349865|NCT00932542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65349866|NCT00932542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65099669|NCT05319834|Analgesics|analgesics|mesh-ancestor
65349867|NCT00932542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349868|NCT00375427|Zoledronic Acid|zoledronic acid|mesh-list
65349869|NCT00375427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65349870|NCT00375427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349871|NCT04014634|Methylprednisolone|methylprednisolone|mesh-list
65349872|NCT04014634|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65349873|NCT04014634|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65349874|NCT04014634|Prednisolone|prednisolone|mesh-list
65349875|NCT04014634|Prednisolone acetate|prednisolone acetate|mesh-list
65349876|NCT04014634|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65349877|NCT04014634|Prednisolone phosphate|prednisolone phosphate|mesh-list
65349878|NCT04014634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65349879|NCT04014634|Antiemetics|antiemetics|mesh-ancestor
65349880|NCT04014634|Autonomic Agents|autonomic agents|mesh-ancestor
65349881|NCT04014634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349882|NCT04014634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349883|NCT04014634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65349884|NCT04014634|Glucocorticoids|glucocorticoids|mesh-ancestor
65349887|NCT04014634|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65349905|NCT01043575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65349906|NCT01043575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65349907|NCT01045837|Prednisolone|prednisolone|mesh-list
65349908|NCT01045837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65349909|NCT01045837|Glucocorticoids|glucocorticoids|mesh-ancestor
65349910|NCT01045837|Hormones|hormones|mesh-ancestor
65349911|NCT01045837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65349912|NCT01045837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349913|NCT01045837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65349914|NCT01045837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65349915|NCT00567268|Gabapentin|gabapentin|mesh-list
65349916|NCT00567268|Analgesics|analgesics|mesh-ancestor
65349917|NCT00567268|Sensory System Agents|sensory system agents|mesh-ancestor
65349918|NCT00567268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349919|NCT00567268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349920|NCT00567268|Anticonvulsants|anticonvulsants|mesh-ancestor
65349921|NCT00567268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65349922|NCT00567268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65349923|NCT00567268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65349924|NCT00567268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65349925|NCT00567268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65349926|NCT00567268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65349927|NCT00567268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65349928|NCT00567268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349929|NCT00567268|Antimanic Agents|antimanic agents|mesh-ancestor
65349930|NCT00907894|Telbivudine|telbivudine|mesh-list
65349931|NCT00907894|Antiviral Agents|antiviral agents|mesh-ancestor
65349932|NCT00907894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65349933|NCT00907894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65349934|NCT00907894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349935|NCT00907894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349936|NCT04014556|Aflibercept|aflibercept|mesh-list
65349937|NCT04014556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65349939|NCT04014556|Growth Substances|growth substances|mesh-ancestor
65349944|NCT00929812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65349945|NCT00929812|Hormones|hormones|mesh-ancestor
65349946|NCT00929812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65349947|NCT00929812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349948|NCT00907972|Vitamin D|vitamin d|mesh-list
65349949|NCT00907972|Ergocalciferols|ergocalciferols|mesh-list
65349950|NCT00907972|Cholecalciferol|cholecalciferol|mesh-list
65349951|NCT00907972|Vitamins|vitamins|mesh-list
65349952|NCT00907972|Micronutrients|micronutrients|mesh-ancestor
65349953|NCT00907972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349954|NCT00907972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65349955|NCT00907972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65349956|NCT03799744|Durvalumab|durvalumab|mesh-list
65349957|NCT03799744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65349958|NCT03799744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65349959|NCT00908050|Botulinum Toxins|botulinum toxins|mesh-list
65349960|NCT00908050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65349961|NCT00908050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65349962|NCT00908050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65349963|NCT00908050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65349964|NCT00908050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349965|NCT00908050|Cholinergic Agents|cholinergic agents|mesh-ancestor
65349966|NCT00908050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65349967|NCT00908050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349968|NCT00908050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65349969|NCT00908050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65349970|NCT00933634|Propafenone|propafenone|mesh-list
65349971|NCT00933634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65349972|NCT00933634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65349973|NCT00933634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65349974|NCT00933634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65349975|NCT00933634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349976|NCT00933790|Rifampin|rifampin|mesh-list
65349977|NCT00933790|Pyrazinamide|pyrazinamide|mesh-list
65349978|NCT00933790|Ethambutol|ethambutol|mesh-list
64742129|NCT00004361|Sodium Citrate|sodium citrate|mesh-list
64490161|NCT00938704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65349979|NCT00933790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65349980|NCT00933790|Antitubercular Agents|antitubercular agents|mesh-ancestor
65349981|NCT00933790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65349982|NCT00933790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65349983|NCT00933790|Leprostatic Agents|leprostatic agents|mesh-ancestor
65349984|NCT00933790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65349985|NCT00933790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65349986|NCT00933790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349987|NCT00933790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65349988|NCT00933790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65349989|NCT00933790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65349990|NCT00933790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65349991|NCT00933790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65349992|NCT00933790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65349993|NCT00566254|Zonisamide|zonisamide|mesh-list
65349994|NCT00566254|Anticonvulsants|anticonvulsants|mesh-ancestor
65349995|NCT00566254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65349996|NCT00566254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65349997|NCT00566254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65349998|NCT00566254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65349999|NCT00566254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350000|NCT00930202|Conivaptan|conivaptan|mesh-list
65350001|NCT00930202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65350002|NCT00930202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350003|NCT00930202|Natriuretic Agents|natriuretic agents|mesh-ancestor
65350004|NCT00930202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350005|NCT00393367|Prednisone|prednisone|mesh-list
64490162|NCT00938704|Viscosupplements|viscosupplements|mesh-ancestor
64490163|NCT00938704|Protective Agents|protective agents|mesh-ancestor
64490164|NCT00938704|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64490165|NCT00938704|Laxatives|laxatives|mesh-ancestor
64490166|NCT00938704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64490167|NCT03666351|Losartan|losartan|mesh-list
64490168|NCT03666351|Amlodipine|amlodipine|mesh-list
64490169|NCT03666351|Chlorthalidone|chlorthalidone|mesh-list
64490170|NCT03666351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64490171|NCT03666351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64490172|NCT03666351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64490173|NCT03666351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490174|NCT03666351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64490175|NCT03666351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490176|NCT03666351|Vasodilator Agents|vasodilator agents|mesh-ancestor
64490177|NCT03666351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65350006|NCT00393367|Methylprednisolone|methylprednisolone|mesh-list
65350007|NCT00393367|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65350008|NCT00393367|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65350009|NCT00393367|Prednisolone|prednisolone|mesh-list
65350010|NCT00393367|Prednisolone acetate|prednisolone acetate|mesh-list
65350011|NCT00393367|Budesonide|budesonide|mesh-list
65350012|NCT00393367|Bromides|bromides|mesh-list
65350013|NCT00393367|Albuterol|albuterol|mesh-list
65350014|NCT00393367|Ipratropium|ipratropium|mesh-list
65350015|NCT00393367|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65350016|NCT00393367|Prednisolone phosphate|prednisolone phosphate|mesh-list
65350017|NCT00393367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65350018|NCT00393367|Glucocorticoids|glucocorticoids|mesh-ancestor
65350019|NCT00393367|Hormones|hormones|mesh-ancestor
65350020|NCT00393367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65350021|NCT00393367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350022|NCT00393367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65350023|NCT00393367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350024|NCT00393367|Antiemetics|antiemetics|mesh-ancestor
65350025|NCT00393367|Autonomic Agents|autonomic agents|mesh-ancestor
65350026|NCT00393367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65350027|NCT00393367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65350028|NCT00393367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65350029|NCT00393367|Protective Agents|protective agents|mesh-ancestor
65350059|NCT00392665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65350060|NCT00392665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350061|NCT00392665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350062|NCT00392665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65350063|NCT00392665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65350064|NCT00392665|Analgesics|analgesics|mesh-ancestor
65350065|NCT00392665|Sensory System Agents|sensory system agents|mesh-ancestor
65350066|NCT00392665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65350067|NCT00392665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65350068|NCT00392665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65350069|NCT00392665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65350070|NCT01043965|Metformin|metformin|mesh-list
65350071|NCT01043965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65350072|NCT01043965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350073|NCT00622869|Everolimus|everolimus|mesh-list
65350074|NCT00622869|Tacrolimus|tacrolimus|mesh-list
64490178|NCT03666351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64490179|NCT03666351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64490180|NCT03666351|Diuretics|diuretics|mesh-ancestor
64490181|NCT03666351|Natriuretic Agents|natriuretic agents|mesh-ancestor
64490182|NCT03666351|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64490183|NCT00928642|Gemcitabine|gemcitabine|mesh-list
64490184|NCT00928642|Imatinib Mesylate|imatinib mesylate|mesh-list
64490185|NCT00928642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64490186|NCT00928642|Antimetabolites|antimetabolites|mesh-ancestor
64490187|NCT00928642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490199|NCT03663543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64555946|NCT02243553|Vitamin K|vitamin k|mesh-list
64555947|NCT02243553|Ritonavir|ritonavir|mesh-list
64555948|NCT02243553|Tipranavir|tipranavir|mesh-list
64555949|NCT02243553|Digoxin|digoxin|mesh-list
64555950|NCT02243553|Midazolam|midazolam|mesh-list
64555951|NCT02243553|Dextromethorphan|dextromethorphan|mesh-list
64555952|NCT02243553|Caffeine|caffeine|mesh-list
64555953|NCT02243553|Omeprazole|omeprazole|mesh-list
64555954|NCT02243553|Warfarin|warfarin|mesh-list
64555955|NCT02243553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64555956|NCT02243553|Vitamins|vitamins|mesh-ancestor
64321020|NCT02195089|Vaccines|vaccines|mesh-list
64490200|NCT03663543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490203|NCT03579615|Insulin|insulin|mesh-list
64490204|NCT03579615|Insulin Aspart|insulin aspart|mesh-list
64490205|NCT03579615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64490206|NCT03579615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490207|NCT03575403|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64490208|NCT03575403|Methylphenidate|methylphenidate|mesh-list
64490209|NCT03575403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64490210|NCT03575403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490211|NCT03575403|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64490212|NCT03575403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64490213|NCT03575403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64490214|NCT03575403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490215|NCT03575403|Dopamine Agents|dopamine agents|mesh-ancestor
64490216|NCT03575403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64490217|NCT03575403|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64490218|NCT03575403|Analgesics|analgesics|mesh-ancestor
64490219|NCT03575403|Sensory System Agents|sensory system agents|mesh-ancestor
64490220|NCT03575403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64490221|NCT03575403|Antidepressive Agents|antidepressive agents|mesh-ancestor
64490222|NCT03575403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64490224|NCT03553875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65350075|NCT00622869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65350076|NCT00622869|Immunologic Factors|immunologic factors|mesh-ancestor
65350077|NCT00622869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350078|NCT00622869|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65350079|NCT00622869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350080|NCT00622869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350081|NCT00622869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350082|NCT00366457|Gemcitabine|gemcitabine|mesh-list
65350083|NCT00366457|Bevacizumab|bevacizumab|mesh-list
65350084|NCT00366457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65350085|NCT00366457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65350086|NCT00366457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350087|NCT00366457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65099895|NCT03458481|Sofosbuvir|sofosbuvir|mesh-list
65350088|NCT00366457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65350089|NCT00366457|Growth Substances|growth substances|mesh-ancestor
65350090|NCT00366457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350091|NCT00366457|Growth Inhibitors|growth inhibitors|mesh-ancestor
65350092|NCT00366457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65350093|NCT00366457|Antimetabolites|antimetabolites|mesh-ancestor
65350094|NCT00366457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350095|NCT00366457|Antiviral Agents|antiviral agents|mesh-ancestor
65350096|NCT00366457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65350097|NCT00366457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350098|NCT00366457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65350099|NCT00366457|Immunologic Factors|immunologic factors|mesh-ancestor
65350100|NCT00366457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65350101|NCT00624819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65350102|NCT00624819|Immunologic Factors|immunologic factors|mesh-ancestor
65350103|NCT00624819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350104|NCT01049347|Amitriptyline|amitriptyline|mesh-list
65350105|NCT01049347|Paroxetine|paroxetine|mesh-list
64490225|NCT03553875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64490226|NCT03553875|Dopamine Agents|dopamine agents|mesh-ancestor
64490227|NCT03553875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64490228|NCT03553875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490229|NCT03553875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490230|NCT03553875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64490233|NCT04355416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64490234|NCT04355416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64490235|NCT04355416|Analgesics|analgesics|mesh-ancestor
65350106|NCT01049347|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65350107|NCT01049347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65350108|NCT01049347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65350109|NCT01049347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350110|NCT01049347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65350111|NCT01049347|Serotonin Agents|serotonin agents|mesh-ancestor
65350112|NCT01049347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350113|NCT01049347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65350114|NCT01049347|Antidepressive Agents|antidepressive agents|mesh-ancestor
65350115|NCT01049347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65350116|NCT01049347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65350117|NCT01049347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65350118|NCT01049347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350119|NCT01049347|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65350163|NCT00838305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350164|NCT00838305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65350165|NCT00838305|Antidepressive Agents|antidepressive agents|mesh-ancestor
65350166|NCT00838305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65350167|NCT00622713|Rivastigmine|rivastigmine|mesh-list
65350168|NCT00622713|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65350169|NCT00622713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350170|NCT00622713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350171|NCT00622713|Cholinergic Agents|cholinergic agents|mesh-ancestor
65350172|NCT00622713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65350173|NCT00622713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350174|NCT00622713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65350175|NCT00622713|Protective Agents|protective agents|mesh-ancestor
65350176|NCT01046227|Vaccines|vaccines|mesh-list
65350177|NCT01046227|Immunologic Factors|immunologic factors|mesh-ancestor
65350178|NCT01046227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350179|NCT00392197|Aripiprazole|aripiprazole|mesh-list
65350180|NCT00392197|Antidepressive Agents|antidepressive agents|mesh-ancestor
65350181|NCT00392197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65350182|NCT00392197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65350183|NCT00392197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65350184|NCT00392197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65350185|NCT00392197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350186|NCT00392197|Dopamine Agonists|dopamine agonists|mesh-ancestor
65350187|NCT00392197|Dopamine Agents|dopamine agents|mesh-ancestor
65350188|NCT00392197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65350189|NCT00392197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350190|NCT00392197|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65350191|NCT00392197|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65350192|NCT00392197|Serotonin Agents|serotonin agents|mesh-ancestor
65350193|NCT00392197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65350194|NCT00392197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65350204|NCT00391807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350205|NCT00391807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65350206|NCT00391807|Contraceptive Agents|contraceptive agents|mesh-ancestor
65350207|NCT00391807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65350208|NCT00391807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65350209|NCT00391807|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65350210|NCT00391807|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65350211|NCT00391807|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65350212|NCT00624585|Dasatinib|dasatinib|mesh-list
65350213|NCT00624585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350214|NCT00624585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65350215|NCT00624585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350216|NCT00624585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350217|NCT01046383|Caseins|caseins|mesh-list
65350218|NCT01046383|Chelating Agents|chelating agents|mesh-ancestor
65350219|NCT01046383|Sequestering Agents|sequestering agents|mesh-ancestor
65350220|NCT01046383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350221|NCT00831597|Rituximab|rituximab|mesh-list
65350222|NCT00831597|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65350223|NCT00831597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65350224|NCT00831597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350225|NCT00831597|Immunologic Factors|immunologic factors|mesh-ancestor
65350226|NCT00831597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350227|NCT00831597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65350228|NCT00831597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65350229|NCT00831597|Alkylating Agents|alkylating agents|mesh-ancestor
65350230|NCT00831597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350231|NCT00622635|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65350232|NCT00622635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65350233|NCT00622635|Autonomic Agents|autonomic agents|mesh-ancestor
65350234|NCT00622635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65350235|NCT00622635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350236|NCT00622635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64490236|NCT04355416|Sensory System Agents|sensory system agents|mesh-ancestor
64490237|NCT04355416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64490238|NCT04355416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490239|NCT04355416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64490240|NCT04355416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64490241|NCT04355416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350237|NCT00622635|Respiratory System Agents|respiratory system agents|mesh-ancestor
65350238|NCT00622635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65350239|NCT00622635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65350240|NCT00622635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65350241|NCT00622635|Adrenergic Agents|adrenergic agents|mesh-ancestor
65350242|NCT00622635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65350243|NCT00622635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350245|NCT00391027|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65350246|NCT00391027|Insulin Glargine|insulin glargine|mesh-list
65350247|NCT00391027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65350248|NCT00391027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350249|NCT00622401|Interleukin-12|interleukin-12|mesh-list
65350250|NCT00622401|Vaccines|vaccines|mesh-list
65350251|NCT00622401|Immunologic Factors|immunologic factors|mesh-ancestor
65350252|NCT00622401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350253|NCT00622401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65350254|NCT00622401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65350255|NCT00622401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65350256|NCT00622401|Growth Substances|growth substances|mesh-ancestor
65350257|NCT00622401|Growth Inhibitors|growth inhibitors|mesh-ancestor
65350258|NCT00622401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350259|NCT04018365|Empagliflozin|empagliflozin|mesh-list
65350260|NCT04018365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65350261|NCT04018365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350262|NCT04018365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65350263|NCT04018365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350264|NCT00828087|Cobalt|cobalt|mesh-list
65350265|NCT00828087|Chromium|chromium|mesh-list
65350266|NCT00828087|Everolimus|everolimus|mesh-list
65350267|NCT00828087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350268|NCT00828087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65350269|NCT00828087|Immunologic Factors|immunologic factors|mesh-ancestor
65350270|NCT00828087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350271|NCT00828087|Trace Elements|trace elements|mesh-ancestor
65350272|NCT00828087|Micronutrients|micronutrients|mesh-ancestor
64490242|NCT04355416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490243|NCT04355416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490245|NCT03777813|Oxaliplatin|oxaliplatin|mesh-list
64490246|NCT03777813|Durvalumab|durvalumab|mesh-list
64490247|NCT03777813|Levoleucovorin|levoleucovorin|mesh-list
64490248|NCT03777813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490249|NCT03777813|Antidotes|antidotes|mesh-ancestor
65350273|NCT00839085|Ascorbic Acid|ascorbic acid|mesh-list
65350274|NCT00839085|Grape Seed Extract|grape seed extract|mesh-list
65350275|NCT00839085|Antioxidants|antioxidants|mesh-ancestor
65350276|NCT00839085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350277|NCT00839085|Protective Agents|protective agents|mesh-ancestor
65350278|NCT00839085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350279|NCT00839085|Vitamins|vitamins|mesh-ancestor
65350280|NCT00839085|Micronutrients|micronutrients|mesh-ancestor
65350281|NCT00839085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65350282|NCT00839085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350283|NCT00839163|Vitamin K|vitamin k|mesh-list
65350284|NCT00839163|Enoxaparin|enoxaparin|mesh-list
65350285|NCT00839163|Rivaroxaban|rivaroxaban|mesh-list
65350286|NCT00839163|Vitamins|vitamins|mesh-ancestor
65350287|NCT00839163|Micronutrients|micronutrients|mesh-ancestor
65350288|NCT00839163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350289|NCT00839163|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65350290|NCT00839163|Antithrombins|antithrombins|mesh-ancestor
65350291|NCT00839163|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65350292|NCT00839163|Protease Inhibitors|protease inhibitors|mesh-ancestor
65350293|NCT00839163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350294|NCT00839163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350295|NCT00839163|Anticoagulants|anticoagulants|mesh-ancestor
65350296|NCT00839163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65350297|NCT00839163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65350298|NCT00839163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65350299|NCT00839163|Hemostatics|hemostatics|mesh-ancestor
65350300|NCT00839163|Coagulants|coagulants|mesh-ancestor
65350301|NCT02549001|Amorolfine|amorolfine|mesh-list
65350302|NCT02549001|Antifungal Agents|antifungal agents|mesh-ancestor
65350303|NCT02549001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65350304|NCT00621543|Copper|copper|mesh-list
65350305|NCT00621543|Levonorgestrel|levonorgestrel|mesh-list
65350306|NCT00621543|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65350319|NCT00623805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350320|NCT00623805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65350321|NCT00623805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65350322|NCT00623805|Growth Substances|growth substances|mesh-ancestor
65350323|NCT00623805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350324|NCT00623805|Growth Inhibitors|growth inhibitors|mesh-ancestor
65350325|NCT00623805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65350326|NCT00623805|Antimetabolites|antimetabolites|mesh-ancestor
65350327|NCT00623805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350328|NCT02548923|Dexmedetomidine|dexmedetomidine|mesh-list
65350330|NCT02548923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65350331|NCT02548923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65350332|NCT02548923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350333|NCT02548923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65350334|NCT02548923|Anesthetics, General|anesthetics, general|mesh-ancestor
65350335|NCT02548923|Anesthetics|anesthetics|mesh-ancestor
65350336|NCT02548923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65350375|NCT00828477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65350376|NCT00828477|Analgesics|analgesics|mesh-ancestor
65350377|NCT00828477|Sensory System Agents|sensory system agents|mesh-ancestor
65350378|NCT00828477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65350379|NCT00828477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350380|NCT00828477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65350381|NCT00828477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65350382|NCT00621309|Rifampin|rifampin|mesh-list
65350383|NCT00621309|Rifamycins|rifamycins|mesh-list
65350384|NCT00621309|Sulforaphane|sulforaphane|mesh-list
65350385|NCT00621309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65350386|NCT00621309|Antitubercular Agents|antitubercular agents|mesh-ancestor
65100199|NCT02939235|Morphine|morphine|mesh-list
65350387|NCT00621309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65350388|NCT00621309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65350389|NCT00621309|Leprostatic Agents|leprostatic agents|mesh-ancestor
65350390|NCT00621309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65350391|NCT00621309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350392|NCT00621309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350393|NCT00621309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65350394|NCT00621309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65350395|NCT00621309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65350396|NCT00621309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65350397|NCT00621309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65350425|NCT00567190|Antimitotic Agents|antimitotic agents|mesh-ancestor
65350426|NCT00567190|Mitosis Modulators|mitosis modulators|mesh-ancestor
65350427|NCT00567190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350428|NCT00567190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65350429|NCT00922389|Lenograstim|lenograstim|mesh-list
65350430|NCT00922389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65350431|NCT00922389|Immunologic Factors|immunologic factors|mesh-ancestor
65350432|NCT00922389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350433|NCT00691938|Decitabine|decitabine|mesh-list
65350434|NCT00691938|Panobinostat|panobinostat|mesh-list
65350435|NCT00691938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65350436|NCT00691938|Antimetabolites|antimetabolites|mesh-ancestor
65350437|NCT00691938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350487|NCT01046461|Serotonin Agents|serotonin agents|mesh-ancestor
65350488|NCT00623727|Factor VIII|factor viii|mesh-list
65350489|NCT00623727|Coagulants|coagulants|mesh-ancestor
65350490|NCT01046539|Buprenorphine|buprenorphine|mesh-list
65350491|NCT01046539|ALKS-33|alks-33|mesh-list
65350492|NCT01046539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65350493|NCT01046539|Narcotics|narcotics|mesh-ancestor
65350494|NCT01046539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65350495|NCT01046539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350496|NCT01046539|Analgesics|analgesics|mesh-ancestor
65350497|NCT01046539|Sensory System Agents|sensory system agents|mesh-ancestor
65350498|NCT01046539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65350499|NCT01046539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65350500|NCT01044199|Vaccines|vaccines|mesh-list
65350501|NCT01044199|Immunologic Factors|immunologic factors|mesh-ancestor
65350502|NCT01044199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350503|NCT00828789|Tenofovir|tenofovir|mesh-list
65350504|NCT00828789|Efavirenz|efavirenz|mesh-list
65350505|NCT00828789|Antiviral Agents|antiviral agents|mesh-ancestor
65350506|NCT00828789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65350507|NCT00828789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65350508|NCT00828789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65350509|NCT00828789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350540|NCT00839787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65350541|NCT00839787|Narcotics|narcotics|mesh-ancestor
65350542|NCT00839787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65350543|NCT00839787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350544|NCT00839787|Analgesics|analgesics|mesh-ancestor
65350545|NCT00839787|Sensory System Agents|sensory system agents|mesh-ancestor
65350546|NCT00839787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65350547|NCT00934258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65350548|NCT00934258|Fenofibrate|fenofibrate|mesh-list
65350549|NCT00934258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65350550|NCT00934258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65350551|NCT00934258|Antimetabolites|antimetabolites|mesh-ancestor
65350552|NCT00934258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350553|NCT00934258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65350554|NCT00934258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65350555|NCT00934258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350556|NCT00372697|Octreotide|octreotide|mesh-list
65350557|NCT00372697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65350558|NCT00372697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65350559|NCT00372697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350560|NCT00934414|Insulin|insulin|mesh-list
65350561|NCT00934414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65350562|NCT00934414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350563|NCT00930514|Rituximab|rituximab|mesh-list
64742732|NCT00005603|Tubulin Modulators|tubulin modulators|mesh-ancestor
64490250|NCT03777813|Protective Agents|protective agents|mesh-ancestor
64490251|NCT03777813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490252|NCT03777813|Vitamin B Complex|vitamin b complex|mesh-ancestor
64490275|NCT03552471|Tubulin Modulators|tubulin modulators|mesh-ancestor
64490276|NCT03552471|Antimitotic Agents|antimitotic agents|mesh-ancestor
64490277|NCT03552471|Mitosis Modulators|mitosis modulators|mesh-ancestor
64490278|NCT04361032|Deferoxamine|deferoxamine|mesh-list
64490279|NCT04361032|Siderophores|siderophores|mesh-ancestor
64490280|NCT04361032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64490281|NCT04361032|Chelating Agents|chelating agents|mesh-ancestor
64555957|NCT02243553|Micronutrients|micronutrients|mesh-ancestor
64555958|NCT02243553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555959|NCT02243553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64555960|NCT02243553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64555961|NCT02243553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64555962|NCT02243553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64555963|NCT02243553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64321030|NCT02031289|Hematinics|hematinics|mesh-ancestor
64321031|NCT02031289|Vitamin B Complex|vitamin b complex|mesh-ancestor
64490282|NCT04361032|Sequestering Agents|sequestering agents|mesh-ancestor
64490283|NCT04361032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490284|NCT00928954|Gabapentin|gabapentin|mesh-list
64490285|NCT00928954|Memantine|memantine|mesh-list
64490286|NCT00928954|Analgesics|analgesics|mesh-ancestor
64490287|NCT00928954|Sensory System Agents|sensory system agents|mesh-ancestor
64490288|NCT00928954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65350564|NCT00930514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65350565|NCT00930514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350566|NCT00930514|Immunologic Factors|immunologic factors|mesh-ancestor
65350567|NCT00930514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350568|NCT00930514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65350569|NCT00936988|Cinacalcet|cinacalcet|mesh-list
65350570|NCT00936988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65350571|NCT00936988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350572|NCT00936988|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65350573|NCT00936988|Hormone Antagonists|hormone antagonists|mesh-ancestor
65350574|NCT00936988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65350575|NCT00934492|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65350576|NCT00934492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65350577|NCT00934492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65350578|NCT00934492|Renal Agents|renal agents|mesh-ancestor
64490289|NCT00928954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490291|NCT00928954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64490292|NCT00928954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64490293|NCT00928954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64490294|NCT00928954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64490295|NCT00928954|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64490296|NCT00928954|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64490297|NCT00928954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64490298|NCT00928954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490299|NCT00928954|Antimanic Agents|antimanic agents|mesh-ancestor
64490300|NCT00928954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64490301|NCT00928954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64490302|NCT00928954|Dopamine Agents|dopamine agents|mesh-ancestor
64490303|NCT04355026|Hydroxychloroquine|hydroxychloroquine|mesh-list
64490305|NCT04355026|Antimalarials|antimalarials|mesh-ancestor
64490306|NCT04355026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64490325|NCT03542175|Rucaparib|rucaparib|mesh-list
64490326|NCT03542175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64490327|NCT03542175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490328|NCT03542175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490329|NCT03542175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490330|NCT04359862|Propofol|propofol|mesh-list
64490331|NCT04359862|Sevoflurane|sevoflurane|mesh-list
64490332|NCT04359862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64490333|NCT04359862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64490334|NCT04359862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490335|NCT04359862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64490336|NCT04359862|Anesthetics, General|anesthetics, general|mesh-ancestor
64490337|NCT04359862|Anesthetics|anesthetics|mesh-ancestor
64490338|NCT04359862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64490342|NCT03568383|Vitamin B 6|vitamin b 6|mesh-list
64490344|NCT03568383|Vitamins|vitamins|mesh-ancestor
64490345|NCT03568383|Micronutrients|micronutrients|mesh-ancestor
64490346|NCT03568383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490347|NCT03568383|Vitamin B Complex|vitamin b complex|mesh-ancestor
64490348|NCT03568383|Antitubercular Agents|antitubercular agents|mesh-ancestor
64490349|NCT03568383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64490350|NCT03568383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64490351|NCT03568383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64490352|NCT03568383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64490353|NCT03568383|Antimetabolites|antimetabolites|mesh-ancestor
64490354|NCT03568383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350579|NCT00934492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65350580|NCT00934492|Antimalarials|antimalarials|mesh-ancestor
65350581|NCT00934492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65350582|NCT00934492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65350583|NCT00934570|Metformin|metformin|mesh-list
65350584|NCT00934570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65350585|NCT00934570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350586|NCT00930670|Esomeprazole|esomeprazole|mesh-list
65350587|NCT00930670|Omeprazole|omeprazole|mesh-list
65350588|NCT00930670|Pantoprazole|pantoprazole|mesh-list
65350589|NCT00930670|Ranitidine|ranitidine|mesh-list
65350590|NCT00930670|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65350591|NCT00930670|Atorvastatin|atorvastatin|mesh-list
65350592|NCT00930670|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65350593|NCT00930670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65350594|NCT00930670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65350595|NCT00930670|Antimetabolites|antimetabolites|mesh-ancestor
65350596|NCT00930670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350597|NCT00930670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65350598|NCT00930670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65350599|NCT00930670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350600|NCT00930670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65350601|NCT00930670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65350602|NCT00930670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65350603|NCT00930670|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65350604|NCT00930670|Histamine Antagonists|histamine antagonists|mesh-ancestor
65350605|NCT00930670|Histamine Agents|histamine agents|mesh-ancestor
65350606|NCT00930670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65350607|NCT00930670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350608|NCT00937144|Sildenafil Citrate|sildenafil citrate|mesh-list
65350626|NCT00937300|Fludarabine phosphate|fludarabine phosphate|mesh-list
65350627|NCT00937300|Interleukin-2|interleukin-2|mesh-list
65350628|NCT00937300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65350629|NCT00937300|Immunologic Factors|immunologic factors|mesh-ancestor
65350630|NCT00937300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350631|NCT00937300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65350632|NCT00937300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65350633|NCT00937300|Alkylating Agents|alkylating agents|mesh-ancestor
65350634|NCT00937300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350635|NCT00937300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350636|NCT00937300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65350637|NCT00937300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65350638|NCT00937300|Antimetabolites|antimetabolites|mesh-ancestor
65350639|NCT00937300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65350640|NCT00937300|Analgesics|analgesics|mesh-ancestor
65350641|NCT00937300|Sensory System Agents|sensory system agents|mesh-ancestor
65350642|NCT00937300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65350643|NCT02226276|Copper|copper|mesh-list
65350644|NCT02226276|Trastuzumab|trastuzumab|mesh-list
65350645|NCT02226276|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65350646|NCT02226276|Maytansine|maytansine|mesh-list
65350680|NCT00931138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350681|NCT00931138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350682|NCT00931138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65350683|NCT00931138|Antimetabolites|antimetabolites|mesh-ancestor
65350684|NCT00931138|Antiviral Agents|antiviral agents|mesh-ancestor
65350685|NCT00931138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65350686|NCT00931138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65350687|NCT00931138|Immunologic Factors|immunologic factors|mesh-ancestor
65350688|NCT00931138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350689|NCT00935194|Oseltamivir|oseltamivir|mesh-list
65350690|NCT00935194|Antiviral Agents|antiviral agents|mesh-ancestor
65350691|NCT00935194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65350692|NCT00935194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350693|NCT00935194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350694|NCT00690378|Imipenem|imipenem|mesh-list
65350695|NCT00690378|Ceftazidime|ceftazidime|mesh-list
65350696|NCT00690378|Avibactam|avibactam|mesh-list
65350697|NCT00690378|Cilastatin|cilastatin|mesh-list
65350698|NCT00690378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65350736|NCT00833079|Immunologic Factors|immunologic factors|mesh-ancestor
65350737|NCT00833079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350738|NCT00833079|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65350739|NCT00833079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350740|NCT00833079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350741|NCT00935506|Aspirin|aspirin|mesh-list
65350742|NCT00935506|Clopidogrel|clopidogrel|mesh-list
65350743|NCT00935506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65350744|NCT00935506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65350745|NCT00935506|Analgesics|analgesics|mesh-ancestor
65350746|NCT00935506|Sensory System Agents|sensory system agents|mesh-ancestor
65350747|NCT00935506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65350748|NCT00935506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350749|NCT00935506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65350750|NCT00935506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65350751|NCT00935506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64490355|NCT03568383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64490356|NCT04366726|Abaloparatide|abaloparatide|mesh-list
64490357|NCT04366726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64490358|NCT04366726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555964|NCT02243553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64555965|NCT02243553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64555966|NCT02243553|Anesthetics, General|anesthetics, general|mesh-ancestor
64555968|NCT02243553|GABA Modulators|gaba modulators|mesh-ancestor
64555969|NCT02243553|GABA Agents|gaba agents|mesh-ancestor
64555970|NCT02243553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64490359|NCT04366960|Enoxaparin|enoxaparin|mesh-list
64490360|NCT04366960|Anticoagulants|anticoagulants|mesh-ancestor
64490361|NCT04366960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64490362|NCT04366960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64490363|NCT04366960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490364|NCT03539445|3-n-butylphthalide|3-n-butylphthalide|mesh-list
64490386|NCT03537495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490387|NCT03537495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490389|NCT04359550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64490390|NCT04359550|Immunologic Factors|immunologic factors|mesh-ancestor
64490391|NCT04359550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490392|NCT02084511|Celecoxib|celecoxib|mesh-list
64490393|NCT02084511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64490394|NCT02084511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64490395|NCT02084511|Analgesics|analgesics|mesh-ancestor
64490396|NCT02084511|Sensory System Agents|sensory system agents|mesh-ancestor
64490397|NCT02084511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64490398|NCT02084511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490399|NCT02084511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64490400|NCT02084511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64490401|NCT02084511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64490402|NCT02084511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64490403|NCT02084511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490404|NCT02084511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490405|NCT00942448|Diclofenac|diclofenac|mesh-list
64490406|NCT00942448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64490407|NCT00942448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64490408|NCT00942448|Analgesics|analgesics|mesh-ancestor
64490409|NCT00942448|Sensory System Agents|sensory system agents|mesh-ancestor
64490410|NCT00942448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64490411|NCT00942448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490412|NCT00942448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64490413|NCT00942448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65350752|NCT00935506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65350753|NCT00935506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350754|NCT00935506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65350755|NCT00935506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65350756|NCT00935506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350757|NCT00935506|Antipyretics|antipyretics|mesh-ancestor
65350758|NCT00935506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65350759|NCT00935506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65350760|NCT00935506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65350761|NCT00935506|Purinergic Agents|purinergic agents|mesh-ancestor
65350762|NCT00935506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65350763|NCT00833157|Ibuprofen|ibuprofen|mesh-list
65350764|NCT00833157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65350765|NCT00833157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65350766|NCT00833157|Analgesics|analgesics|mesh-ancestor
65350767|NCT00833157|Sensory System Agents|sensory system agents|mesh-ancestor
65350768|NCT00833157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65350769|NCT00833157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350770|NCT00833157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65350771|NCT00833157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65350772|NCT00833157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65350773|NCT00833157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350774|NCT00833157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350775|NCT00833235|Lubricant Eye Drops|lubricant eye drops|mesh-list
65350776|NCT00833235|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65350777|NCT00833235|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65350798|NCT00829257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65350799|NCT00829257|Autonomic Agents|autonomic agents|mesh-ancestor
65350800|NCT00829257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65350801|NCT00829257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350802|NCT00829257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65350803|NCT00829257|Respiratory System Agents|respiratory system agents|mesh-ancestor
65350804|NCT00829257|Dermatologic Agents|dermatologic agents|mesh-ancestor
65350805|NCT00829257|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65350806|NCT00829257|Glucocorticoids|glucocorticoids|mesh-ancestor
65350807|NCT00829257|Hormones|hormones|mesh-ancestor
65350808|NCT00829257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65350809|NCT00829257|Sympathomimetics|sympathomimetics|mesh-ancestor
65350810|NCT03978832|Risperidone|risperidone|mesh-list
65350811|NCT03978832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65350812|NCT03978832|Serotonin Agents|serotonin agents|mesh-ancestor
65350813|NCT03978832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65350814|NCT03978832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350815|NCT03978832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350816|NCT03978832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65350817|NCT03978832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65350818|NCT03978832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65350819|NCT03978832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65350820|NCT03978832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65350821|NCT03978832|Dopamine Agents|dopamine agents|mesh-ancestor
65350822|NCT00840333|Levofloxacin|levofloxacin|mesh-list
65350823|NCT00840333|Ofloxacin|ofloxacin|mesh-list
65350824|NCT00840333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65350825|NCT00840333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65350826|NCT00840333|Renal Agents|renal agents|mesh-ancestor
65350827|NCT00840333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65350828|NCT00840333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65350829|NCT00840333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65350830|NCT00840333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350840|NCT00840489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65350841|NCT00840489|Gout Suppressants|gout suppressants|mesh-ancestor
65350842|NCT00840489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65350843|NCT00840489|Tubulin Modulators|tubulin modulators|mesh-ancestor
65350844|NCT00840489|Antimitotic Agents|antimitotic agents|mesh-ancestor
65350845|NCT00840489|Mitosis Modulators|mitosis modulators|mesh-ancestor
65350846|NCT00840489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350848|NCT00743496|Immunologic Factors|immunologic factors|mesh-ancestor
65350849|NCT00743496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350850|NCT00829569|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65350851|NCT00829569|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65350852|NCT00829569|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65350853|NCT00829569|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65350854|NCT00840645|Mirabegron|mirabegron|mesh-list
65350855|NCT00840645|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65350856|NCT00840645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65350857|NCT00840645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65350858|NCT00840645|Adrenergic Agents|adrenergic agents|mesh-ancestor
65350859|NCT00840645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65350860|NCT00840645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350861|NCT00840645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350862|NCT00840645|Urological Agents|urological agents|mesh-ancestor
65350893|NCT00829647|Growth Substances|growth substances|mesh-ancestor
65350894|NCT00829647|Growth Inhibitors|growth inhibitors|mesh-ancestor
65350895|NCT00829647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350896|NCT00829647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65350897|NCT00829647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350898|NCT00829647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350899|NCT00939328|Rituximab|rituximab|mesh-list
65350900|NCT00939328|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65350901|NCT00939328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65350902|NCT00939328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65350903|NCT00939328|Immunologic Factors|immunologic factors|mesh-ancestor
65350904|NCT00939328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350905|NCT00939328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65350906|NCT00939328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65350907|NCT00939328|Alkylating Agents|alkylating agents|mesh-ancestor
65350908|NCT00939328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350909|NCT00829881|Betahistine|betahistine|mesh-list
65350910|NCT00829881|Vasodilator Agents|vasodilator agents|mesh-ancestor
65350911|NCT00829881|Histamine Agonists|histamine agonists|mesh-ancestor
65350916|NCT00840801|Vaccines|vaccines|mesh-list
65350946|NCT00937924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65350947|NCT00937924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350948|NCT00937924|Anesthetics, Local|anesthetics, local|mesh-ancestor
65350949|NCT00937924|Anesthetics|anesthetics|mesh-ancestor
65350950|NCT00937924|Sensory System Agents|sensory system agents|mesh-ancestor
65350951|NCT00937924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65350952|NCT00937924|Antiemetics|antiemetics|mesh-ancestor
65350953|NCT00937924|Autonomic Agents|autonomic agents|mesh-ancestor
65350954|NCT00937924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65350955|NCT00937924|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65350956|NCT00937924|Histamine Antagonists|histamine antagonists|mesh-ancestor
65350957|NCT00937924|Histamine Agents|histamine agents|mesh-ancestor
65350958|NCT00937924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65350959|NCT00937924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350960|NCT00937924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65350961|NCT00937924|Antipruritics|antipruritics|mesh-ancestor
65350962|NCT00937924|Dermatologic Agents|dermatologic agents|mesh-ancestor
65350963|NCT00743886|Mitogens|mitogens|mesh-list
65350964|NCT00743886|Mitosis Modulators|mitosis modulators|mesh-ancestor
65350965|NCT00743886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350966|NCT00830193|Acetylcysteine|acetylcysteine|mesh-list
65350967|NCT00830193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65350968|NCT00830193|Antiviral Agents|antiviral agents|mesh-ancestor
65350969|NCT00830193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65350970|NCT00830193|Expectorants|expectorants|mesh-ancestor
65350971|NCT00830193|Respiratory System Agents|respiratory system agents|mesh-ancestor
65350972|NCT00830193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65350973|NCT00830193|Antioxidants|antioxidants|mesh-ancestor
65350974|NCT00830193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350975|NCT00830193|Protective Agents|protective agents|mesh-ancestor
65350976|NCT00830193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65350977|NCT00830193|Antidotes|antidotes|mesh-ancestor
65350978|NCT00938158|rGLP-1 protein|rglp-1 protein|mesh-list
65350990|NCT00743964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65350991|NCT00743964|Antimetabolites|antimetabolites|mesh-ancestor
65350992|NCT00743964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65350993|NCT00743964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65350994|NCT00743964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65350995|NCT00743964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65350996|NCT00743964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65350997|NCT00830349|Risperidone|risperidone|mesh-list
65350998|NCT00830349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65350999|NCT00830349|Serotonin Agents|serotonin agents|mesh-ancestor
65351000|NCT00830349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65351001|NCT00830349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351002|NCT00830349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351003|NCT00830349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65351004|NCT00830349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65351005|NCT00830349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65351006|NCT00830349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65351007|NCT00830349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65351008|NCT00830349|Dopamine Agents|dopamine agents|mesh-ancestor
65351009|NCT00841113|Goserelin|goserelin|mesh-list
65351010|NCT00841113|Bicalutamide|bicalutamide|mesh-list
65351011|NCT00841113|Abarelix|abarelix|mesh-list
65351012|NCT00841113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65351013|NCT00841113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351014|NCT00841113|Androgen Antagonists|androgen antagonists|mesh-ancestor
65351015|NCT00841113|Hormone Antagonists|hormone antagonists|mesh-ancestor
65351016|NCT00841113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65351017|NCT00841113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351018|NCT00830505|Fluticasone|fluticasone|mesh-list
65351019|NCT00830505|Xhance|xhance|mesh-list
65351020|NCT00830505|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65351021|NCT00830505|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65351022|NCT00830505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65351031|NCT00830505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65351032|NCT00830505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65351033|NCT00830505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65351034|NCT00830505|Adrenergic Agents|adrenergic agents|mesh-ancestor
65351035|NCT00830505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65351036|NCT00830505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351037|NCT00830505|Glucocorticoids|glucocorticoids|mesh-ancestor
65351038|NCT00830505|Hormones|hormones|mesh-ancestor
65351039|NCT00830505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65351040|NCT00830505|Sympathomimetics|sympathomimetics|mesh-ancestor
65351041|NCT00566020|Lamotrigine|lamotrigine|mesh-list
65351042|NCT00566020|Anticonvulsants|anticonvulsants|mesh-ancestor
65351043|NCT00566020|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65351044|NCT00566020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65351045|NCT00566020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351046|NCT00566020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65351047|NCT00566020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351048|NCT00566020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65351049|NCT00566020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65351050|NCT00566020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65351051|NCT00566020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65351052|NCT00566020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65351053|NCT02563782|Mycophenolic Acid|mycophenolic acid|mesh-list
65351054|NCT02563782|Tacrolimus|tacrolimus|mesh-list
65351055|NCT02563782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65351056|NCT02563782|Immunologic Factors|immunologic factors|mesh-ancestor
65100876|NCT02936427|BB 1101|bb 1101|mesh-list
65351077|NCT00843453|Vitamin B Complex|vitamin b complex|mesh-ancestor
65351078|NCT00843453|Vitamins|vitamins|mesh-ancestor
65351079|NCT00843453|Micronutrients|micronutrients|mesh-ancestor
65351080|NCT00843453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351081|NCT00843453|Hematinics|hematinics|mesh-ancestor
65351082|NCT00921726|Oseltamivir|oseltamivir|mesh-list
65351083|NCT00921726|Zanamivir|zanamivir|mesh-list
65351084|NCT00921726|Antiviral Agents|antiviral agents|mesh-ancestor
65351085|NCT00921726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65351086|NCT00921726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351087|NCT00921726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351144|NCT00835029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351145|NCT00835029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351146|NCT00835029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65351147|NCT00835029|Hormone Antagonists|hormone antagonists|mesh-ancestor
65351148|NCT00835029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65351149|NCT00835029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351150|NCT00835029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65351151|NCT00835029|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65351153|NCT00835107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65351154|NCT00835107|Serotonin Agents|serotonin agents|mesh-ancestor
65351155|NCT00835107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65351156|NCT00835107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351158|NCT00835107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65351202|NCT00742248|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65351203|NCT00742248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65351204|NCT00742248|Adrenergic Agents|adrenergic agents|mesh-ancestor
65351205|NCT00742248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65351206|NCT00742248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351207|NCT04249167|Paclitaxel|paclitaxel|mesh-list
65351208|NCT04249167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65351209|NCT04249167|Atezolizumab|atezolizumab|mesh-list
65351210|NCT04249167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65351211|NCT04249167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65351212|NCT04249167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351213|NCT04249167|Tubulin Modulators|tubulin modulators|mesh-ancestor
65351214|NCT04249167|Antimitotic Agents|antimitotic agents|mesh-ancestor
65351215|NCT04249167|Mitosis Modulators|mitosis modulators|mesh-ancestor
65351216|NCT04249167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351217|NCT04249167|Immunologic Factors|immunologic factors|mesh-ancestor
65351218|NCT04249167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351219|NCT00621153|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65351220|NCT00621153|Candesartan|candesartan|mesh-list
65351221|NCT00621153|Candesartan cilexetil|candesartan cilexetil|mesh-list
65351222|NCT00621153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65351223|NCT00621153|Diuretics|diuretics|mesh-ancestor
65351224|NCT00621153|Natriuretic Agents|natriuretic agents|mesh-ancestor
65351231|NCT05447910|Letrozole|letrozole|mesh-list
65351251|NCT00705614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65351252|NCT00705614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65351253|NCT00844155|Oseltamivir|oseltamivir|mesh-list
65351254|NCT00844155|Antiviral Agents|antiviral agents|mesh-ancestor
65351255|NCT00844155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65351256|NCT00844155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351257|NCT00844155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351258|NCT05669924|Methylphenidate|methylphenidate|mesh-list
65351259|NCT05669924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65351260|NCT05669924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351261|NCT05669924|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65351262|NCT05669924|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65351263|NCT05669924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65351264|NCT05669924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351265|NCT05669924|Dopamine Agents|dopamine agents|mesh-ancestor
65351266|NCT05669924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65351267|NCT00844233|Irinotecan|irinotecan|mesh-list
65351268|NCT00844233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65351269|NCT00844233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65351270|NCT00844233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351271|NCT00844233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351272|NCT00844233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351273|NCT00841893|Mechlorethamine|mechlorethamine|mesh-list
65351274|NCT00841893|Alkylating Agents|alkylating agents|mesh-ancestor
65351275|NCT00841893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351276|NCT00841893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65351277|NCT00841893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351278|NCT00844311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65351279|NCT00844311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65351280|NCT00844311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351281|NCT02547597|Atenolol|atenolol|mesh-list
65351282|NCT02547597|Carvedilol|carvedilol|mesh-list
65351283|NCT02547597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65351284|NCT02547597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65351285|NCT02547597|Adrenergic Agents|adrenergic agents|mesh-ancestor
64743431|NCT01917006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65351286|NCT02547597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65351287|NCT02547597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351288|NCT02547597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351289|NCT02547597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65351290|NCT02547597|Antioxidants|antioxidants|mesh-ancestor
65351291|NCT02547597|Protective Agents|protective agents|mesh-ancestor
65351292|NCT02547597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65351293|NCT02547597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65351294|NCT02547597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65351295|NCT02547597|Vasodilator Agents|vasodilator agents|mesh-ancestor
65351296|NCT02547597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65351297|NCT02547597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65351298|NCT02547597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65351299|NCT02547597|Sympatholytics|sympatholytics|mesh-ancestor
65351300|NCT02547597|Autonomic Agents|autonomic agents|mesh-ancestor
65351301|NCT02547597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65351302|NCT02547597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65351303|NCT00842127|Methylphenidate|methylphenidate|mesh-list
65351340|NCT00842205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351341|NCT00842205|Antiviral Agents|antiviral agents|mesh-ancestor
65351342|NCT00842205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65351343|NCT00738296|Simvastatin|simvastatin|mesh-list
65351344|NCT00738296|Ezetimibe|ezetimibe|mesh-list
65351345|NCT00738296|Pravastatin|pravastatin|mesh-list
65351346|NCT00738296|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65351347|NCT00738296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65351348|NCT00738296|Antimetabolites|antimetabolites|mesh-ancestor
65351349|NCT00738296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351350|NCT00738296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65351351|NCT00738296|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65351352|NCT00738296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351353|NCT00836043|Alemtuzumab|alemtuzumab|mesh-list
65351354|NCT00836043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65351355|NCT00836043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351356|NCT02567396|Talazoparib|talazoparib|mesh-list
65351357|NCT02567396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65351358|NCT02567396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351359|NCT02567396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351360|NCT02567396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351361|NCT00738452|Antibodies|antibodies|mesh-list
65351362|NCT00738452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65351363|NCT00738452|Immunologic Factors|immunologic factors|mesh-ancestor
65351364|NCT00738452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351365|NCT05667428|Leuprolide|leuprolide|mesh-list
64490414|NCT00942448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64490415|NCT00942448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490416|NCT00942448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490417|NCT03532581|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64490418|NCT02982148|Methylene Blue|methylene blue|mesh-list
64490449|NCT03557385|Vasodilator Agents|vasodilator agents|mesh-ancestor
64490450|NCT03557385|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64490451|NCT03557385|Purinergic Agonists|purinergic agonists|mesh-ancestor
64490452|NCT03557385|Purinergic Agents|purinergic agents|mesh-ancestor
64490453|NCT03557385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64490454|NCT03557385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490456|NCT04601350|Anesthetics|anesthetics|mesh-list
64490457|NCT04601350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64327375|NCT02165189|Ribavirin|ribavirin|mesh-list
64490463|NCT04601350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64490479|NCT04358614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490481|NCT04358614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64490482|NCT04358614|Antiviral Agents|antiviral agents|mesh-ancestor
64490483|NCT04358614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64490484|NCT04358614|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64490485|NCT04358614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64490486|NCT01670409|Cisplatin|cisplatin|mesh-list
64490487|NCT01670409|Fluorouracil|fluorouracil|mesh-list
65351366|NCT05667428|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65351367|NCT05667428|Fertility Agents|fertility agents|mesh-ancestor
65351368|NCT05667428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65351369|NCT05667428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351370|NCT05667428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65351371|NCT05667428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351372|NCT05664542|Dexmedetomidine|dexmedetomidine|mesh-list
65351373|NCT05664542|Ropivacaine|ropivacaine|mesh-list
65351374|NCT05664542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65351375|NCT05664542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65351376|NCT05664542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351377|NCT05664542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65351378|NCT05664542|Analgesics|analgesics|mesh-ancestor
65351379|NCT05664542|Sensory System Agents|sensory system agents|mesh-ancestor
65351380|NCT05664542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65351381|NCT05664542|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65351382|NCT05664542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65351383|NCT05664542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65351422|NCT00842595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65351423|NCT00842595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65351424|NCT00842595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65351425|NCT00842595|Tubulin Modulators|tubulin modulators|mesh-ancestor
65351426|NCT00842595|Antimitotic Agents|antimitotic agents|mesh-ancestor
65351427|NCT00842595|Mitosis Modulators|mitosis modulators|mesh-ancestor
65351428|NCT00842595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351429|NCT00842595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65351430|NCT00842595|Alkylating Agents|alkylating agents|mesh-ancestor
65351431|NCT00842595|Analgesics|analgesics|mesh-ancestor
65351432|NCT00842595|Sensory System Agents|sensory system agents|mesh-ancestor
65351433|NCT00842595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65351434|NCT00842595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65351435|NCT00842595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65351436|NCT00842595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351437|NCT00938626|Antibodies|antibodies|mesh-list
65351438|NCT00938626|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65351439|NCT00938626|Immunologic Factors|immunologic factors|mesh-ancestor
65351477|NCT04013386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65351478|NCT04013386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65351479|NCT04013386|Serotonin Agents|serotonin agents|mesh-ancestor
65351480|NCT04013386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65351481|NCT00940420|Ribavirin|ribavirin|mesh-list
65351482|NCT00940420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65351483|NCT00940420|Interferon-alpha|interferon-alpha|mesh-list
65351484|NCT00940420|Antimetabolites|antimetabolites|mesh-ancestor
65351485|NCT00940420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351486|NCT00940420|Antiviral Agents|antiviral agents|mesh-ancestor
65351487|NCT00940420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65351488|NCT00940420|Immunologic Factors|immunologic factors|mesh-ancestor
65351489|NCT00940420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351490|NCT00842907|Tretinoin|tretinoin|mesh-list
65351491|NCT00842907|Isotretinoin|isotretinoin|mesh-list
65351492|NCT00842907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351493|NCT00842907|Keratolytic Agents|keratolytic agents|mesh-ancestor
65351494|NCT00842907|Dermatologic Agents|dermatologic agents|mesh-ancestor
65351495|NCT00620373|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
65351496|NCT00620373|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65351497|NCT00620373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351498|NCT00940654|Acetaminophen|acetaminophen|mesh-list
65351499|NCT00940654|Antipyretics|antipyretics|mesh-list
65351500|NCT00940654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65351501|NCT00940654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65351502|NCT00940654|Analgesics|analgesics|mesh-ancestor
65351503|NCT00940654|Sensory System Agents|sensory system agents|mesh-ancestor
65351504|NCT00940654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65351505|NCT00940654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351506|NCT00843063|Pantoprazole|pantoprazole|mesh-list
65351507|NCT00843063|Famotidine|famotidine|mesh-list
65351508|NCT00843063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65351509|NCT00843063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64743659|NCT01862874|Vaccines|vaccines|mesh-list
64555971|NCT02243553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555972|NCT02243553|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64555973|NCT02243553|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64490488|NCT01670409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490489|NCT01670409|Antimetabolites|antimetabolites|mesh-ancestor
64490490|NCT01670409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490491|NCT01670409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64490492|NCT01670409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64490493|NCT01670409|Immunologic Factors|immunologic factors|mesh-ancestor
65351510|NCT00843063|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65351511|NCT00843063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351512|NCT00843063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351513|NCT00843063|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65351514|NCT00843063|Histamine Antagonists|histamine antagonists|mesh-ancestor
65351515|NCT00843063|Histamine Agents|histamine agents|mesh-ancestor
65351516|NCT00843063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65351517|NCT00843063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351518|NCT04013464|Citalopram|citalopram|mesh-list
65351519|NCT04013464|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65351520|NCT04013464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65351521|NCT04013464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65351522|NCT04013464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351523|NCT04013464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65351524|NCT04013464|Serotonin Agents|serotonin agents|mesh-ancestor
65351525|NCT04013464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351526|NCT04013464|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65351527|NCT04013464|Antidepressive Agents|antidepressive agents|mesh-ancestor
65351528|NCT04013464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65351529|NCT04012918|Capecitabine|capecitabine|mesh-list
65351530|NCT04012918|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65351531|NCT04012918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65351532|NCT04012918|Antimetabolites|antimetabolites|mesh-ancestor
65351533|NCT04012918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351534|NCT04012918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351535|NCT04012918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65351536|NCT04012918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351537|NCT04012918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65351553|NCT00836667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65351554|NCT00836667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351555|NCT00836667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65351556|NCT00836667|Serotonin Agents|serotonin agents|mesh-ancestor
65351557|NCT00836667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351558|NCT00845559|Exenatide|exenatide|mesh-list
65351559|NCT00845559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65351560|NCT00845559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351561|NCT00845559|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65351562|NCT00845559|Incretins|incretins|mesh-ancestor
65351563|NCT00845559|Hormones|hormones|mesh-ancestor
65351564|NCT00845559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65351565|NCT00836823|Alfuzosin|alfuzosin|mesh-list
65351566|NCT00836823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65351567|NCT00836823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65351568|NCT00836823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65351569|NCT00836823|Adrenergic Agents|adrenergic agents|mesh-ancestor
65351570|NCT00836823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65351571|NCT00836823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351572|NCT00836823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351573|NCT00836823|Urological Agents|urological agents|mesh-ancestor
65351574|NCT02567240|Carbon Monoxide|carbon monoxide|mesh-list
65351575|NCT02567240|Antimetabolites|antimetabolites|mesh-ancestor
65351576|NCT02567240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351577|NCT02567240|Gasotransmitters|gasotransmitters|mesh-ancestor
65351578|NCT02567240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65351579|NCT02567240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351580|NCT05107778|Entecavir|entecavir|mesh-list
65351581|NCT05107778|Antiviral Agents|antiviral agents|mesh-ancestor
64490494|NCT01670409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490495|NCT04761705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64490496|NCT04761705|Latanoprost|latanoprost|mesh-list
64490497|NCT04761705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64490498|NCT04358770|Clocortolone|clocortolone|mesh-list
64490499|NCT04358770|Fluocortolone|fluocortolone|mesh-list
64490500|NCT04358770|Clocortolone pivalate|clocortolone pivalate|mesh-list
64490501|NCT04358770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64490503|NCT04358770|Hormones|hormones|mesh-ancestor
64490504|NCT04358770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64490505|NCT04358770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490506|NCT03516981|Pembrolizumab|pembrolizumab|mesh-list
64490507|NCT03516981|Lenvatinib|lenvatinib|mesh-list
64490508|NCT03516981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64490509|NCT03516981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490510|NCT03516981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65351582|NCT05107778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65351583|NCT00372619|Cytarabine|cytarabine|mesh-list
65351584|NCT00372619|Methotrexate|methotrexate|mesh-list
65351585|NCT00372619|Clofarabine|clofarabine|mesh-list
65351586|NCT00372619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65351587|NCT00372619|Abortifacient Agents|abortifacient agents|mesh-ancestor
65351588|NCT00372619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65351589|NCT00372619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351590|NCT00372619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65351591|NCT00372619|Antimetabolites|antimetabolites|mesh-ancestor
65351592|NCT00372619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351593|NCT00372619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351594|NCT00372619|Dermatologic Agents|dermatologic agents|mesh-ancestor
65351595|NCT00372619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351596|NCT00372619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65351597|NCT00372619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65351598|NCT00372619|Immunologic Factors|immunologic factors|mesh-ancestor
65351599|NCT00372619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65351600|NCT00372619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65351601|NCT00372619|Antiviral Agents|antiviral agents|mesh-ancestor
65351602|NCT00372619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65351603|NCT00851175|Caffeine|caffeine|mesh-list
65351604|NCT00851175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65351605|NCT00851175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65351606|NCT00851175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65351607|NCT00851175|Antimetabolites|antimetabolites|mesh-ancestor
65351608|NCT00851175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351609|NCT00851175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65351610|NCT00851175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65351611|NCT00851175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351612|NCT00851175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65351613|NCT00851175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351614|NCT00851175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64490511|NCT03516981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490512|NCT03516981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490513|NCT05618470|Botulinum Toxins|botulinum toxins|mesh-list
64490514|NCT05618470|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64490515|NCT05618470|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64490516|NCT05618470|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64490517|NCT05618470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65351615|NCT00851175|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65351616|NCT00851175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65351617|NCT00851175|Purinergic Agents|purinergic agents|mesh-ancestor
65351618|NCT00851175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65351619|NCT04400474|Atezolizumab|atezolizumab|mesh-list
65351620|NCT04400474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351621|NCT02566226|Morphine|morphine|mesh-list
65351622|NCT02566226|Bupivacaine|bupivacaine|mesh-list
65351623|NCT02566226|Anesthetics, Local|anesthetics, local|mesh-ancestor
65351624|NCT02566226|Anesthetics|anesthetics|mesh-ancestor
65351625|NCT02566226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65351626|NCT02566226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351627|NCT02566226|Sensory System Agents|sensory system agents|mesh-ancestor
65351628|NCT02566226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65351629|NCT02566226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65351630|NCT02566226|Narcotics|narcotics|mesh-ancestor
65351631|NCT02566226|Analgesics|analgesics|mesh-ancestor
65351632|NCT00837135|Vaccines|vaccines|mesh-list
65351633|NCT00837135|Immunologic Factors|immunologic factors|mesh-ancestor
65351634|NCT00837135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351635|NCT00562588|Dipyridamole|dipyridamole|mesh-list
65351636|NCT00562588|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
65351637|NCT00562588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65351638|NCT00562588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490518|NCT05618470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490519|NCT05618470|Cholinergic Agents|cholinergic agents|mesh-ancestor
64490520|NCT05618470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64490521|NCT05618470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490522|NCT05618470|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64490557|NCT01670799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490559|NCT02404935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64490560|NCT02404935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490561|NCT04320940|Phenobarbital|phenobarbital|mesh-list
64490562|NCT04320940|Anticonvulsants|anticonvulsants|mesh-ancestor
64490563|NCT04320940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64490573|NCT04320940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64490574|NCT04320940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64490576|NCT03422523|Rituximab|rituximab|mesh-list
64490577|NCT03422523|Oxaliplatin|oxaliplatin|mesh-list
64490578|NCT03422523|Atezolizumab|atezolizumab|mesh-list
64490579|NCT03422523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64490580|NCT03422523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490581|NCT03422523|Immunologic Factors|immunologic factors|mesh-ancestor
64490582|NCT03422523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490583|NCT03422523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64490584|NCT03422523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64490585|NCT03422523|Antimetabolites|antimetabolites|mesh-ancestor
64490587|NCT03422523|Antiviral Agents|antiviral agents|mesh-ancestor
64490588|NCT03422523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64490589|NCT03422523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490590|NCT03422523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64490591|NCT03032536|Tenofovir|tenofovir|mesh-list
64490592|NCT03032536|Entecavir|entecavir|mesh-list
65351639|NCT00562588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351640|NCT00562588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65351641|NCT00562588|Vasodilator Agents|vasodilator agents|mesh-ancestor
65351642|NCT04263038|Rivaroxaban|rivaroxaban|mesh-list
65351643|NCT04263038|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65351644|NCT04263038|Antithrombins|antithrombins|mesh-ancestor
65351645|NCT04263038|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65351646|NCT04263038|Protease Inhibitors|protease inhibitors|mesh-ancestor
65351647|NCT04263038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351648|NCT04263038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351649|NCT04263038|Anticoagulants|anticoagulants|mesh-ancestor
65351650|NCT02546349|Fluticasone|fluticasone|mesh-list
65351651|NCT02546349|Tiotropium Bromide|tiotropium bromide|mesh-list
65351652|NCT02546349|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65351653|NCT02546349|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65351654|NCT02546349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65351655|NCT02546349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65101490|NCT02945163|Tenofovir|tenofovir|mesh-list
65351656|NCT02546349|Autonomic Agents|autonomic agents|mesh-ancestor
65351657|NCT02546349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65351658|NCT02546349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351659|NCT02546349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65351660|NCT02546349|Respiratory System Agents|respiratory system agents|mesh-ancestor
65351661|NCT02546349|Dermatologic Agents|dermatologic agents|mesh-ancestor
65351662|NCT02546349|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65351663|NCT02546349|Parasympatholytics|parasympatholytics|mesh-ancestor
65351664|NCT02546349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65351665|NCT02546349|Cholinergic Agents|cholinergic agents|mesh-ancestor
64490593|NCT03032536|Antiviral Agents|antiviral agents|mesh-ancestor
64490594|NCT03032536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64490595|NCT03032536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64490596|NCT03032536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64490597|NCT03032536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555974|NCT02243553|Protease Inhibitors|protease inhibitors|mesh-ancestor
64555975|NCT02243553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555976|NCT02243553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64555977|NCT02243553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64555978|NCT02243553|Antiviral Agents|antiviral agents|mesh-ancestor
64555979|NCT02243553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64555980|NCT02243553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64555981|NCT02243553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64555982|NCT02243553|Anticoagulants|anticoagulants|mesh-ancestor
64321045|NCT03533803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64490598|NCT03032536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490599|NCT03032536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64490600|NCT03032536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64490601|NCT03420963|Cyclophosphamide|cyclophosphamide|mesh-list
65351666|NCT02546349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65351667|NCT02546349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351668|NCT02546349|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65351669|NCT02546349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65351670|NCT02546349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65351671|NCT02546349|Adrenergic Agents|adrenergic agents|mesh-ancestor
65351672|NCT02546349|Glucocorticoids|glucocorticoids|mesh-ancestor
65351673|NCT02546349|Hormones|hormones|mesh-ancestor
65351674|NCT02546349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65351675|NCT02546349|Sympathomimetics|sympathomimetics|mesh-ancestor
65351676|NCT00851487|Amoxicillin|amoxicillin|mesh-list
65351677|NCT00851487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65351678|NCT00851487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65351679|NCT00372385|Interferons|interferons|mesh-list
65351680|NCT00372385|Ribavirin|ribavirin|mesh-list
65351681|NCT00372385|Interferon-alpha|interferon-alpha|mesh-list
65351682|NCT00372385|Interferon alpha-2|interferon alpha-2|mesh-list
65351683|NCT00372385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65351684|NCT00372385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351685|NCT00372385|Antiviral Agents|antiviral agents|mesh-ancestor
65351686|NCT00372385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65351687|NCT00372385|Antimetabolites|antimetabolites|mesh-ancestor
65351688|NCT00372385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351689|NCT00372385|Immunologic Factors|immunologic factors|mesh-ancestor
65351690|NCT00372385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351691|NCT03830281|Insulin|insulin|mesh-list
65351692|NCT03830281|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65351693|NCT03830281|Insulin Lispro|insulin lispro|mesh-list
65351694|NCT03830281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65351695|NCT03830281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351696|NCT00563368|Topiramate|topiramate|mesh-list
65351697|NCT00563368|Phentermine|phentermine|mesh-list
65351698|NCT00563368|Anticonvulsants|anticonvulsants|mesh-ancestor
65351699|NCT00563368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64743845|NCT01871532|Hormones|hormones|mesh-ancestor
64490603|NCT03420963|Etoposide phosphate|etoposide phosphate|mesh-list
64490604|NCT03420963|Podophyllotoxin|podophyllotoxin|mesh-list
64490605|NCT03420963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64490606|NCT03420963|Immunologic Factors|immunologic factors|mesh-ancestor
64490607|NCT03420963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490608|NCT03420963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64490609|NCT03420963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64490610|NCT03420963|Alkylating Agents|alkylating agents|mesh-ancestor
65351700|NCT00563368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351701|NCT00563368|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65351702|NCT00563368|Appetite Depressants|appetite depressants|mesh-ancestor
65351703|NCT00563368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65351704|NCT00563368|Sympathomimetics|sympathomimetics|mesh-ancestor
65351705|NCT00563368|Autonomic Agents|autonomic agents|mesh-ancestor
65351706|NCT00563368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65351707|NCT00563368|Adrenergic Agents|adrenergic agents|mesh-ancestor
65351708|NCT00563368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65351709|NCT00563368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351710|NCT00390013|Gabapentin|gabapentin|mesh-list
65351711|NCT00390013|Analgesics|analgesics|mesh-ancestor
65351712|NCT00390013|Sensory System Agents|sensory system agents|mesh-ancestor
65351713|NCT00390013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65351714|NCT00390013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351715|NCT00390013|Anticonvulsants|anticonvulsants|mesh-ancestor
65351716|NCT00390013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65351717|NCT00390013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65351718|NCT00390013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65351719|NCT00390013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65351720|NCT00390013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65351721|NCT00390013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65351722|NCT00390013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65351723|NCT00390013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351724|NCT00390013|Antimanic Agents|antimanic agents|mesh-ancestor
64490611|NCT03420963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490612|NCT03420963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490613|NCT03420963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64490614|NCT03420963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64490615|NCT03420963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64490616|NCT03420963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64490617|NCT03420963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490618|NCT03420963|Keratolytic Agents|keratolytic agents|mesh-ancestor
64490619|NCT03420963|Dermatologic Agents|dermatologic agents|mesh-ancestor
64490620|NCT03420963|Tubulin Modulators|tubulin modulators|mesh-ancestor
64490621|NCT03420963|Antimitotic Agents|antimitotic agents|mesh-ancestor
64490622|NCT03420963|Mitosis Modulators|mitosis modulators|mesh-ancestor
64490623|NCT03032614|Carboplatin|carboplatin|mesh-list
64490624|NCT03032614|Veliparib|veliparib|mesh-list
64490625|NCT03032614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490626|NCT03032614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64490627|NCT03032614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490634|NCT03032458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64490635|NCT03032458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490637|NCT03032458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64490638|NCT03032458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64490639|NCT03032458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64490640|NCT03032458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65351725|NCT00562120|Fexofenadine|fexofenadine|mesh-list
65351726|NCT00562120|Terfenadine|terfenadine|mesh-list
65351727|NCT00562120|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65351728|NCT00562120|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65351729|NCT00562120|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65351730|NCT00562120|Histamine Antagonists|histamine antagonists|mesh-ancestor
65351731|NCT00562120|Histamine Agents|histamine agents|mesh-ancestor
65351732|NCT00562120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65351733|NCT00562120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351734|NCT00562120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351735|NCT00561730|Pantoprazole|pantoprazole|mesh-list
65351736|NCT00561730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65351737|NCT00561730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65351738|NCT00561730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65351739|NCT00561730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351740|NCT00561730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351741|NCT00697112|Sirolimus|sirolimus|mesh-list
65351742|NCT00697112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65351743|NCT00697112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65351744|NCT00697112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65351745|NCT00697112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351746|NCT00697112|Antifungal Agents|antifungal agents|mesh-ancestor
65351747|NCT00697112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65351748|NCT00697112|Immunologic Factors|immunologic factors|mesh-ancestor
65351749|NCT00697112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351750|NCT00621855|Dabigatran|dabigatran|mesh-list
65351751|NCT00621855|Antithrombins|antithrombins|mesh-ancestor
65351752|NCT00621855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65351753|NCT00621855|Protease Inhibitors|protease inhibitors|mesh-ancestor
65351754|NCT00621855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351755|NCT00621855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351756|NCT00621855|Anticoagulants|anticoagulants|mesh-ancestor
65351757|NCT00851565|Infliximab|infliximab|mesh-list
64490641|NCT03032458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64490642|NCT03032458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490643|NCT03032458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64490644|NCT03032458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64490645|NCT03032458|Analgesics|analgesics|mesh-ancestor
64490646|NCT03032458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64490647|NCT03032458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64490648|NCT03032458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64490649|NCT03032458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490650|NCT03032458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65351758|NCT00851565|Antibodies|antibodies|mesh-list
65351759|NCT00851565|Immunologic Factors|immunologic factors|mesh-ancestor
65351760|NCT00851565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351761|NCT00851565|Dermatologic Agents|dermatologic agents|mesh-ancestor
65351762|NCT00851565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65351763|NCT00851565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65351764|NCT04222088|Chloroquine|chloroquine|mesh-list
65351765|NCT04222088|Lumefantrine|lumefantrine|mesh-list
65351766|NCT04222088|Primaquine|primaquine|mesh-list
65351767|NCT04222088|Amebicides|amebicides|mesh-ancestor
65351768|NCT04222088|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65351769|NCT04222088|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65351770|NCT04222088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65351771|NCT04222088|Antimalarials|antimalarials|mesh-ancestor
65351772|NCT04222088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65351773|NCT00561574|Mirtazapine|mirtazapine|mesh-list
65351774|NCT00561574|Antidepressive Agents|antidepressive agents|mesh-ancestor
65351775|NCT00561574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65351776|NCT00561574|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65351777|NCT00561574|Histamine Antagonists|histamine antagonists|mesh-ancestor
65351778|NCT00561574|Histamine Agents|histamine agents|mesh-ancestor
65351779|NCT00561574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65351780|NCT00561574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351781|NCT00561574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351782|NCT00561574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65351783|NCT00561574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65351784|NCT00561574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65351785|NCT00561574|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65351786|NCT00561574|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65351787|NCT00561574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65351788|NCT00561574|Adrenergic Agents|adrenergic agents|mesh-ancestor
65351804|NCT02563704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65351805|NCT02563704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65351806|NCT02563704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351807|NCT02563704|Antiviral Agents|antiviral agents|mesh-ancestor
65351808|NCT02563704|Schistosomicides|schistosomicides|mesh-ancestor
65351809|NCT02563704|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65351810|NCT02563704|Anthelmintics|anthelmintics|mesh-ancestor
65351811|NCT02563704|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65351812|NCT02563704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351813|NCT02563704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65351814|NCT02563704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65351815|NCT02563704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65351816|NCT02563704|Analgesics|analgesics|mesh-ancestor
65351817|NCT02563704|Sensory System Agents|sensory system agents|mesh-ancestor
65351818|NCT00848523|Panobinostat|panobinostat|mesh-list
65351819|NCT00848523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351820|NCT00848523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65351821|NCT00848523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351822|NCT00848523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351823|NCT05604170|Ganaxolone|ganaxolone|mesh-list
65351824|NCT05604170|Neurosteroids|neurosteroids|mesh-ancestor
65351825|NCT05604170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65351826|NCT05604170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351827|NCT05604170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351828|NCT05604170|GABA Modulators|gaba modulators|mesh-ancestor
65351829|NCT05604170|GABA Agents|gaba agents|mesh-ancestor
65351830|NCT00742404|Dexamethasone|dexamethasone|mesh-list
65351831|NCT00742404|Doxorubicin|doxorubicin|mesh-list
65351832|NCT00742404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65351833|NCT00742404|Bortezomib|bortezomib|mesh-list
65351850|NCT05602064|Acetaminophen|acetaminophen|mesh-list
65351851|NCT05602064|Ibuprofen|ibuprofen|mesh-list
65351852|NCT05602064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65351853|NCT05602064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65351854|NCT05602064|Analgesics|analgesics|mesh-ancestor
65351855|NCT05602064|Sensory System Agents|sensory system agents|mesh-ancestor
65351856|NCT05602064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65351857|NCT05602064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351858|NCT05602064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65351859|NCT05602064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64744021|NCT01832766|Dronabinol|dronabinol|mesh-list
64490651|NCT03032458|Narcotics|narcotics|mesh-ancestor
64490652|NCT03032458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64490653|NCT02245438|Ritonavir|ritonavir|mesh-list
64490654|NCT02245438|Tipranavir|tipranavir|mesh-list
64490655|NCT02245438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64490656|NCT02245438|Norethindrone|norethindrone|mesh-list
64490657|NCT02245438|Norethindrone Acetate|norethindrone acetate|mesh-list
64555984|NCT02243553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64555985|NCT02243553|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64555986|NCT02243553|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64490660|NCT02245438|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64490661|NCT02245438|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64490662|NCT02245438|Protease Inhibitors|protease inhibitors|mesh-ancestor
64490663|NCT02245438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490664|NCT02245438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490665|NCT02245438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64490666|NCT02245438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64490667|NCT02245438|Antiviral Agents|antiviral agents|mesh-ancestor
64490668|NCT02245438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64490669|NCT02245438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64490670|NCT02245438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64490671|NCT02245438|Estrogens|estrogens|mesh-ancestor
64490672|NCT02245438|Hormones|hormones|mesh-ancestor
64490673|NCT02245438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64490674|NCT02245438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490675|NCT02245438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64490676|NCT02245438|Contraceptive Agents|contraceptive agents|mesh-ancestor
64490677|NCT02245438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64490678|NCT02245438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64490679|NCT02245438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64490680|NCT02245438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64490681|NCT02245438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64490682|NCT02245438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64490683|NCT03087669|Norepinephrine|norepinephrine|mesh-list
64490684|NCT03087669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64490685|NCT03087669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64490686|NCT03087669|Adrenergic Agents|adrenergic agents|mesh-ancestor
64490687|NCT03087669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64490688|NCT03087669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490689|NCT03087669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490690|NCT03087669|Sympathomimetics|sympathomimetics|mesh-ancestor
64490691|NCT03087669|Autonomic Agents|autonomic agents|mesh-ancestor
64490692|NCT03087669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64490693|NCT03087669|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64490694|NCT00939952|Ertapenem|ertapenem|mesh-list
64490695|NCT00939952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64490718|NCT03456687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490719|NCT03456687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64490720|NCT03456687|Incretins|incretins|mesh-ancestor
64490721|NCT03456687|Hormones|hormones|mesh-ancestor
64490722|NCT03456687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64490723|NCT03456687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64490724|NCT00948298|Vitamin D|vitamin d|mesh-list
64490725|NCT00948298|Vitamins|vitamins|mesh-ancestor
64490726|NCT00948298|Micronutrients|micronutrients|mesh-ancestor
65351860|NCT05602064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65351861|NCT05602064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351862|NCT05602064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351863|NCT05602064|Antipyretics|antipyretics|mesh-ancestor
65351864|NCT00744666|Prednisolone|prednisolone|mesh-list
65351865|NCT00744666|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65351866|NCT00744666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65351867|NCT00744666|Glucocorticoids|glucocorticoids|mesh-ancestor
65351868|NCT00744666|Hormones|hormones|mesh-ancestor
65351869|NCT00744666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65351870|NCT00744666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351871|NCT00744666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65351872|NCT00744666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351873|NCT00744666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65351874|NCT04013620|Abatacept|abatacept|mesh-list
65351875|NCT04013620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65351876|NCT04013620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351877|NCT04013620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65351878|NCT04013620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65351879|NCT04013620|Immunologic Factors|immunologic factors|mesh-ancestor
65351880|NCT04013620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351881|NCT04013620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65351882|NCT00749112|Rituximab|rituximab|mesh-list
65351883|NCT00749112|Alemtuzumab|alemtuzumab|mesh-list
65351884|NCT00749112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65351889|NCT00848679|Lidocaine|lidocaine|mesh-list
65351907|NCT04012606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351908|NCT04012606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351909|NCT05565560|Apremilast|apremilast|mesh-list
65351910|NCT05565560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65351911|NCT05565560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65351912|NCT05565560|Analgesics|analgesics|mesh-ancestor
65351913|NCT05565560|Sensory System Agents|sensory system agents|mesh-ancestor
65351914|NCT05565560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65351915|NCT05565560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351916|NCT05565560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65351917|NCT05565560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65351918|NCT05565560|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65351919|NCT05565560|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65351920|NCT05565560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65351921|NCT05565560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351922|NCT02545959|Methylprednisolone|methylprednisolone|mesh-list
65351923|NCT02545959|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65351924|NCT02545959|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65351925|NCT02545959|Prednisolone|prednisolone|mesh-list
65351926|NCT02545959|Prednisolone acetate|prednisolone acetate|mesh-list
65351927|NCT02545959|Rituximab|rituximab|mesh-list
65351928|NCT02545959|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65351936|NCT02545959|Antiemetics|antiemetics|mesh-ancestor
65351957|NCT00689052|Pramipexole|pramipexole|mesh-list
65351958|NCT00689052|Antioxidants|antioxidants|mesh-ancestor
65351959|NCT00689052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351960|NCT00689052|Protective Agents|protective agents|mesh-ancestor
65351961|NCT00689052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351962|NCT00689052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65351963|NCT00689052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65351964|NCT00689052|Dopamine Agonists|dopamine agonists|mesh-ancestor
65351965|NCT00689052|Dopamine Agents|dopamine agents|mesh-ancestor
65351966|NCT00689052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65351967|NCT04012450|Anesthetics|anesthetics|mesh-list
65351968|NCT04012450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65351969|NCT04012450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351970|NCT00945022|Anesthetics|anesthetics|mesh-list
65351971|NCT00945022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65351972|NCT00945022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351973|NCT02565212|Montelukast|montelukast|mesh-list
65351974|NCT02565212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65351975|NCT02565212|Respiratory System Agents|respiratory system agents|mesh-ancestor
64744132|NCT01802580|Glucocorticoids|glucocorticoids|mesh-ancestor
64490727|NCT00948298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490728|NCT00948298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64490729|NCT00948610|Infliximab|infliximab|mesh-list
64490730|NCT00948610|Dermatologic Agents|dermatologic agents|mesh-ancestor
64490731|NCT00948610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64490732|NCT00948610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64490733|NCT03031834|Quinapril|quinapril|mesh-list
64490734|NCT03031834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64490735|NCT03031834|Protease Inhibitors|protease inhibitors|mesh-ancestor
64490736|NCT03031834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490737|NCT03031834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490738|NCT03031834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64490739|NCT00944554|Varenicline|varenicline|mesh-list
64490740|NCT00944554|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64490741|NCT00944554|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64490742|NCT00944554|Cholinergic Agents|cholinergic agents|mesh-ancestor
64490743|NCT00944554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64490744|NCT00944554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555987|NCT02243553|Purinergic Agents|purinergic agents|mesh-ancestor
64555988|NCT02243553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64555989|NCT02243553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64555992|NCT02243553|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64555993|NCT02243553|Protective Agents|protective agents|mesh-ancestor
64555994|NCT02243553|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64555995|NCT02243553|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64555996|NCT02243553|Hemostatics|hemostatics|mesh-ancestor
64555997|NCT02243553|Coagulants|coagulants|mesh-ancestor
64555998|NCT02243553|Antitussive Agents|antitussive agents|mesh-ancestor
64555999|NCT02243553|Respiratory System Agents|respiratory system agents|mesh-ancestor
64556000|NCT02243553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64556001|NCT02243553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64556002|NCT00922233|Levonorgestrel|levonorgestrel|mesh-list
64556003|NCT00922233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64556004|NCT00922233|Contraceptive Agents|contraceptive agents|mesh-ancestor
64556005|NCT00922233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64321066|NCT02195557|Hylan|hylan|mesh-list
65351976|NCT02565212|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65351977|NCT02565212|Hormone Antagonists|hormone antagonists|mesh-ancestor
65351978|NCT02565212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65351979|NCT02565212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351980|NCT02565212|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65351981|NCT02565212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65351982|NCT02565212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65351983|NCT00747708|Lenograstim|lenograstim|mesh-list
65351984|NCT00747708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65351985|NCT00747708|Immunologic Factors|immunologic factors|mesh-ancestor
65351986|NCT00747708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351987|NCT00560950|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65351988|NCT00560950|Immunologic Factors|immunologic factors|mesh-ancestor
65351989|NCT00560950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351990|NCT02562144|Lidocaine|lidocaine|mesh-list
65351991|NCT02562144|Anesthetics, Local|anesthetics, local|mesh-ancestor
65351992|NCT02562144|Anesthetics|anesthetics|mesh-ancestor
65351993|NCT02562144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65351994|NCT02562144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65351995|NCT02562144|Sensory System Agents|sensory system agents|mesh-ancestor
65351996|NCT02562144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65351997|NCT02562144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65351998|NCT02562144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65351999|NCT02562144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65352000|NCT02562144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65352001|NCT02562144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352002|NCT02562300|Misoprostol|misoprostol|mesh-list
65352003|NCT02562300|Oxytocin|oxytocin|mesh-list
65352004|NCT02562300|Oxytocics|oxytocics|mesh-ancestor
65352005|NCT02562300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65352006|NCT02562300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352007|NCT02562300|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64490745|NCT00944554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490746|NCT03031756|Glycine|glycine|mesh-list
64490747|NCT03031756|Glycine Agents|glycine agents|mesh-ancestor
64490748|NCT03031756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64490757|NCT00944710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490758|NCT00944710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64490759|NCT00944710|Respiratory System Agents|respiratory system agents|mesh-ancestor
65352008|NCT02562300|Abortifacient Agents|abortifacient agents|mesh-ancestor
65352009|NCT02562300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65352010|NCT02562300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65352011|NCT00945178|Naproxen|naproxen|mesh-list
65352012|NCT00945178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65352013|NCT00945178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65352014|NCT00945178|Analgesics|analgesics|mesh-ancestor
65352015|NCT00945178|Sensory System Agents|sensory system agents|mesh-ancestor
65352016|NCT00945178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65352017|NCT00945178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352018|NCT00945178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65352019|NCT00945178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65352020|NCT00945178|Gout Suppressants|gout suppressants|mesh-ancestor
65352021|NCT00945178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65352022|NCT00945178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352023|NCT00945178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352024|NCT00749346|Pemetrexed|pemetrexed|mesh-list
65352025|NCT00749346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352026|NCT00749346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352027|NCT00749346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352028|NCT00749346|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65352029|NCT00749346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65352030|NCT02562690|Thrombin|thrombin|mesh-list
65352031|NCT02562690|Hemostatics|hemostatics|mesh-ancestor
65352032|NCT02562690|Coagulants|coagulants|mesh-ancestor
64490760|NCT00944710|Mydriatics|mydriatics|mesh-ancestor
64490761|NCT00944710|Parasympatholytics|parasympatholytics|mesh-ancestor
64490762|NCT00944710|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64490763|NCT00944710|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64490764|NCT00944710|Cholinergic Agents|cholinergic agents|mesh-ancestor
64490765|NCT00944710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64490766|NCT00944710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490767|NCT00949078|Omalizumab|omalizumab|mesh-list
64490768|NCT00949078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64490769|NCT00949078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64490770|NCT00949078|Respiratory System Agents|respiratory system agents|mesh-ancestor
64490771|NCT00945256|Nitroprusside|nitroprusside|mesh-list
64490772|NCT00945256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64490773|NCT00945256|Vasodilator Agents|vasodilator agents|mesh-ancestor
64490774|NCT00945256|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64490775|NCT00945256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490776|NCT03854032|Nivolumab|nivolumab|mesh-list
64490777|NCT03854032|Linrodostat|linrodostat|mesh-list
64490778|NCT03854032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64490779|NCT03854032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490780|NCT03854032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64490781|NCT03854032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490782|NCT03854032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490783|NCT03031444|Leucovorin|leucovorin|mesh-list
64490784|NCT03031444|Cetuximab|cetuximab|mesh-list
65352033|NCT00576758|Rituximab|rituximab|mesh-list
65352034|NCT00576758|Obinutuzumab|obinutuzumab|mesh-list
65352035|NCT00576758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65352036|NCT00576758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352037|NCT00576758|Immunologic Factors|immunologic factors|mesh-ancestor
65352038|NCT00576758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352039|NCT00576758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65352040|NCT00923676|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65352041|NCT00923676|Fenofibrate|fenofibrate|mesh-list
65352042|NCT00923676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65352043|NCT00923676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65352044|NCT00923676|Antimetabolites|antimetabolites|mesh-ancestor
65352045|NCT00923676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352046|NCT00923676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65352047|NCT00923676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65352048|NCT00923676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352049|NCT00921284|Dexmedetomidine|dexmedetomidine|mesh-list
65352090|NCT00950404|Vasodilator Agents|vasodilator agents|mesh-ancestor
65352091|NCT00950404|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65352092|NCT00950404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65352093|NCT00950404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352094|NCT00950404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352095|NCT00950404|Urological Agents|urological agents|mesh-ancestor
65352096|NCT00749814|Melatonin|melatonin|mesh-list
65352097|NCT00749814|Antioxidants|antioxidants|mesh-ancestor
65352098|NCT00749814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352099|NCT00749814|Protective Agents|protective agents|mesh-ancestor
65352100|NCT00749814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352101|NCT00749814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65352102|NCT00748176|Anesthetics|anesthetics|mesh-list
65352103|NCT00748176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65352104|NCT00748176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352105|NCT00619359|Dexamethasone|dexamethasone|mesh-list
65352106|NCT00619359|Dexamethasone acetate|dexamethasone acetate|mesh-list
65352107|NCT00619359|Ondansetron|ondansetron|mesh-list
65352108|NCT00619359|Aprepitant|aprepitant|mesh-list
65352109|NCT00619359|Fosaprepitant|fosaprepitant|mesh-list
65352110|NCT00619359|BB 1101|bb 1101|mesh-list
65352111|NCT00619359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65352112|NCT00619359|Antiemetics|antiemetics|mesh-ancestor
65352118|NCT00619359|Hormones|hormones|mesh-ancestor
65352142|NCT00848991|Anesthetics, General|anesthetics, general|mesh-ancestor
65352143|NCT00848991|Anesthetics|anesthetics|mesh-ancestor
65352144|NCT00848991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65352145|NCT00848991|Analgesics|analgesics|mesh-ancestor
65352146|NCT00848991|Sensory System Agents|sensory system agents|mesh-ancestor
65352147|NCT00848991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65352148|NCT00848991|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65352149|NCT00848991|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65352150|NCT00848991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65352151|NCT00848991|Adrenergic Agents|adrenergic agents|mesh-ancestor
65352152|NCT00848991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65352153|NCT00848991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352154|NCT00950794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65352155|NCT00950794|Tulobuterol|tulobuterol|mesh-list
65352156|NCT00950794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65352157|NCT00950794|Autonomic Agents|autonomic agents|mesh-ancestor
65352158|NCT00950794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65352159|NCT00950794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352160|NCT00950794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65352161|NCT00950794|Respiratory System Agents|respiratory system agents|mesh-ancestor
65352162|NCT00950794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65352163|NCT00950794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65352164|NCT00950794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65352165|NCT00950794|Adrenergic Agents|adrenergic agents|mesh-ancestor
65352166|NCT00950794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65352167|NCT00950794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352168|NCT00852189|Folic Acid|folic acid|mesh-list
65352169|NCT00852189|Vitamin B Complex|vitamin b complex|mesh-list
64490785|NCT03031444|Fluorouracil|fluorouracil|mesh-list
64490786|NCT03031444|Oxaliplatin|oxaliplatin|mesh-list
64490787|NCT03031444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64490788|NCT03031444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556006|NCT00922233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556007|NCT00922233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64556008|NCT00922233|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64556009|NCT00922233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64556010|NCT05006664|Prednisone|prednisone|mesh-list
64556011|NCT05006664|Cyclophosphamide|cyclophosphamide|mesh-list
64556012|NCT05006664|Doxorubicin|doxorubicin|mesh-list
64556013|NCT05006664|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64484222|NCT01751113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556014|NCT05006664|Etoposide|etoposide|mesh-list
64490789|NCT03031444|Antimetabolites|antimetabolites|mesh-ancestor
64490790|NCT03031444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490791|NCT03031444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64490792|NCT03031444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64490793|NCT03031444|Immunologic Factors|immunologic factors|mesh-ancestor
65352170|NCT00852189|Vinca Alkaloids|vinca alkaloids|mesh-list
65352171|NCT00852189|Hematinics|hematinics|mesh-ancestor
65352172|NCT00852189|Vitamins|vitamins|mesh-ancestor
65352173|NCT00852189|Micronutrients|micronutrients|mesh-ancestor
65352174|NCT00852189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352175|NCT00852189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352176|NCT00852189|Tubulin Modulators|tubulin modulators|mesh-ancestor
65352177|NCT00852189|Antimitotic Agents|antimitotic agents|mesh-ancestor
65352178|NCT00852189|Mitosis Modulators|mitosis modulators|mesh-ancestor
65352179|NCT00852189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352180|NCT00951106|Pyrimethamine|pyrimethamine|mesh-list
65352181|NCT00951106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65352182|NCT00951106|Antimalarials|antimalarials|mesh-ancestor
65352183|NCT00951106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65352184|NCT00951106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65352185|NCT00951106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65352186|NCT00951106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65352187|NCT00951106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352188|NCT00951106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352189|NCT00372229|Valganciclovir|valganciclovir|mesh-list
65352190|NCT00372229|Ganciclovir|ganciclovir|mesh-list
65352191|NCT00372229|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65352192|NCT00372229|Antiviral Agents|antiviral agents|mesh-ancestor
65352193|NCT00372229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65352194|NCT00372229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65352195|NCT00372229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352196|NCT00372229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352197|NCT05301010|Docetaxel|docetaxel|mesh-list
65352198|NCT05301010|Trastuzumab|trastuzumab|mesh-list
65352199|NCT05301010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352200|NCT05301010|Tubulin Modulators|tubulin modulators|mesh-ancestor
65352201|NCT05301010|Antimitotic Agents|antimitotic agents|mesh-ancestor
65352202|NCT05301010|Mitosis Modulators|mitosis modulators|mesh-ancestor
64744348|NCT01838616|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64490794|NCT03031444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490795|NCT03031444|Antidotes|antidotes|mesh-ancestor
64490796|NCT03031444|Protective Agents|protective agents|mesh-ancestor
64490797|NCT03031444|Vitamin B Complex|vitamin b complex|mesh-ancestor
64490798|NCT03031444|Vitamins|vitamins|mesh-ancestor
64490799|NCT03031444|Micronutrients|micronutrients|mesh-ancestor
64490800|NCT03031054|Hyaluronic Acid|hyaluronic acid|mesh-list
64490801|NCT03031054|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64490805|NCT03031054|Protective Agents|protective agents|mesh-ancestor
64490806|NCT00945334|Rifaximin|rifaximin|mesh-list
64490807|NCT00945334|Neomycin|neomycin|mesh-list
65352203|NCT05301010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352204|NCT05301010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65352205|NCT00855699|Acamprosate|acamprosate|mesh-list
65352206|NCT00855699|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65352207|NCT00855777|Ibuprofen|ibuprofen|mesh-list
65352208|NCT00855777|Etoricoxib|etoricoxib|mesh-list
65352209|NCT00855777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65352210|NCT00855777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65352211|NCT00855777|Analgesics|analgesics|mesh-ancestor
65352212|NCT00855777|Sensory System Agents|sensory system agents|mesh-ancestor
65352213|NCT00855777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65352214|NCT00855777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352215|NCT00855777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65352216|NCT00855777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65352217|NCT00855777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65352218|NCT00855777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352219|NCT00855777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352220|NCT00855777|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65352221|NCT04012294|Allopurinol|allopurinol|mesh-list
65352222|NCT04012294|Antimetabolites|antimetabolites|mesh-ancestor
65352223|NCT04012294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352224|NCT04012294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352225|NCT04012294|Gout Suppressants|gout suppressants|mesh-ancestor
65352226|NCT04012294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65352227|NCT04012294|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65352228|NCT04012294|Antioxidants|antioxidants|mesh-ancestor
65352229|NCT04012294|Protective Agents|protective agents|mesh-ancestor
65352230|NCT04012294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352231|NCT00849459|Interleukin-12|interleukin-12|mesh-list
65352232|NCT00849459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65352233|NCT00849459|Immunologic Factors|immunologic factors|mesh-ancestor
65352234|NCT00849459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744420|NCT01793688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352245|NCT00852423|Artesunate|artesunate|mesh-list
65352246|NCT00852423|Lumefantrine|lumefantrine|mesh-list
65352247|NCT00852423|Artemether|artemether|mesh-list
65352248|NCT00852423|Piperaquine|piperaquine|mesh-list
65352249|NCT00852423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65352250|NCT00852423|Amodiaquine|amodiaquine|mesh-list
65352251|NCT00852423|Artenimol|artenimol|mesh-list
65352252|NCT00852423|Mefloquine|mefloquine|mesh-list
65352253|NCT00852423|Antimalarials|antimalarials|mesh-ancestor
65352254|NCT00852423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65352255|NCT00852423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65352256|NCT00852423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65352257|NCT00852423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352258|NCT00852423|Antiviral Agents|antiviral agents|mesh-ancestor
65352259|NCT00852423|Schistosomicides|schistosomicides|mesh-ancestor
64490808|NCT00945334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64490809|NCT00945334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64490810|NCT00945334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64490811|NCT00945334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64490812|NCT00945334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490813|NCT00945334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490814|NCT03656536|Gemcitabine|gemcitabine|mesh-list
64490815|NCT03656536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490836|NCT05153590|Hormones|hormones|mesh-ancestor
64490837|NCT05153590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64490838|NCT03490864|Melatonin|melatonin|mesh-list
64490839|NCT03490864|Antioxidants|antioxidants|mesh-ancestor
64490840|NCT03490864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490841|NCT03490864|Protective Agents|protective agents|mesh-ancestor
64490842|NCT03490864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490843|NCT03490864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64490844|NCT04402203|Favipiravir|favipiravir|mesh-list
64490845|NCT04402203|Antiviral Agents|antiviral agents|mesh-ancestor
64490846|NCT04402203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64490847|NCT05100862|Rituximab|rituximab|mesh-list
64490848|NCT05100862|Obinutuzumab|obinutuzumab|mesh-list
64490849|NCT05100862|Lenalidomide|lenalidomide|mesh-list
64490850|NCT05100862|Zanubrutinib|zanubrutinib|mesh-list
64490851|NCT05100862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64490852|NCT05100862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490853|NCT05100862|Immunologic Factors|immunologic factors|mesh-ancestor
64490854|NCT05100862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490855|NCT05100862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64490856|NCT05100862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64490857|NCT05100862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64490858|NCT05100862|Growth Substances|growth substances|mesh-ancestor
64490859|NCT05100862|Growth Inhibitors|growth inhibitors|mesh-ancestor
64490860|NCT05100862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64490861|NCT05100862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490862|NCT05100862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490863|NCT03455829|Osimertinib|osimertinib|mesh-list
64744432|NCT01792830|Metformin|metformin|mesh-list
65352260|NCT00852423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65352261|NCT00852423|Anthelmintics|anthelmintics|mesh-ancestor
65352262|NCT00941824|Mycophenolic Acid|mycophenolic acid|mesh-list
65352263|NCT00941824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65352264|NCT00941824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352265|NCT00941824|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65352266|NCT00941824|Antitubercular Agents|antitubercular agents|mesh-ancestor
65352267|NCT00941824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65352268|NCT00941824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65352269|NCT00941824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352270|NCT00941824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352272|NCT00849537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65352273|NCT00849537|Glucocorticoids|glucocorticoids|mesh-ancestor
65352274|NCT00849537|Hormones|hormones|mesh-ancestor
65352275|NCT00849537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65352276|NCT00849537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352277|NCT01049815|Calcium Carbonate|calcium carbonate|mesh-list
65352278|NCT01049815|Calcium|calcium|mesh-list
65352279|NCT01049815|Sevelamer|sevelamer|mesh-list
64744433|NCT01792830|Insulin Glargine|insulin glargine|mesh-list
64490864|NCT03455829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556015|NCT05006664|Etoposide phosphate|etoposide phosphate|mesh-list
64556016|NCT05006664|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64556017|NCT05006664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64556018|NCT05006664|Immunologic Factors|immunologic factors|mesh-ancestor
64556019|NCT05006664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556020|NCT05006664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64556021|NCT05006664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64490865|NCT03455829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64490866|NCT03455829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490867|NCT03455829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490868|NCT03030976|Cyclophosphamide|cyclophosphamide|mesh-list
64490890|NCT00949234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64490891|NCT00949234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64490892|NCT00949234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64490893|NCT00949234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64490894|NCT00949234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64490896|NCT03090880|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64490898|NCT03090880|Anticoagulants|anticoagulants|mesh-ancestor
64490899|NCT03090880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64490900|NCT03090880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64490901|NCT03090880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490902|NCT05099848|Leucovorin|leucovorin|mesh-list
64490903|NCT05099848|Fluorouracil|fluorouracil|mesh-list
64490904|NCT05099848|Oxaliplatin|oxaliplatin|mesh-list
64490905|NCT05099848|Apatinib|apatinib|mesh-list
64490906|NCT05099848|Antimetabolites|antimetabolites|mesh-ancestor
64490907|NCT05099848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490908|NCT05099848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64490909|NCT05099848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490912|NCT05099848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490914|NCT05099848|Protective Agents|protective agents|mesh-ancestor
64490915|NCT05099848|Vitamin B Complex|vitamin b complex|mesh-ancestor
65352280|NCT01049815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65352281|NCT01049815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352282|NCT01049815|Antacids|antacids|mesh-ancestor
65352283|NCT01049815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352284|NCT01049815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65352285|NCT01049815|Chelating Agents|chelating agents|mesh-ancestor
65352286|NCT01049815|Sequestering Agents|sequestering agents|mesh-ancestor
65352287|NCT00849615|Leucovorin|leucovorin|mesh-list
65352288|NCT00849615|Folic Acid|folic acid|mesh-list
65352289|NCT00849615|Docetaxel|docetaxel|mesh-list
65352290|NCT00849615|Fluorouracil|fluorouracil|mesh-list
65352291|NCT00849615|Oxaliplatin|oxaliplatin|mesh-list
65352292|NCT00849615|Levoleucovorin|levoleucovorin|mesh-list
65352293|NCT00849615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352294|NCT00849615|Tubulin Modulators|tubulin modulators|mesh-ancestor
65352295|NCT00849615|Antimitotic Agents|antimitotic agents|mesh-ancestor
65352296|NCT00849615|Mitosis Modulators|mitosis modulators|mesh-ancestor
65352297|NCT00849615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352298|NCT00849615|Antimetabolites|antimetabolites|mesh-ancestor
65352299|NCT00849615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65352300|NCT00849615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65352301|NCT00849615|Immunologic Factors|immunologic factors|mesh-ancestor
65352302|NCT00849615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352303|NCT00849615|Antidotes|antidotes|mesh-ancestor
65352304|NCT00849615|Protective Agents|protective agents|mesh-ancestor
65352305|NCT00849615|Vitamin B Complex|vitamin b complex|mesh-ancestor
65352306|NCT00849615|Vitamins|vitamins|mesh-ancestor
65352307|NCT00849615|Micronutrients|micronutrients|mesh-ancestor
65352308|NCT00849615|Hematinics|hematinics|mesh-ancestor
64490916|NCT05099848|Vitamins|vitamins|mesh-ancestor
64490917|NCT05099848|Micronutrients|micronutrients|mesh-ancestor
64490918|NCT05099848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64490919|NCT05099848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490920|NCT05097976|Methylprednisolone|methylprednisolone|mesh-list
64490921|NCT05097976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64490922|NCT05097976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64490923|NCT05097976|Prednisolone|prednisolone|mesh-list
64490924|NCT05097976|Prednisolone acetate|prednisolone acetate|mesh-list
64490955|NCT00941668|Protective Agents|protective agents|mesh-ancestor
64490956|NCT00941668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490957|NCT00941668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64490958|NCT00941668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64490959|NCT00941668|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64490960|NCT00941668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64490961|NCT00941668|Antimetabolites|antimetabolites|mesh-ancestor
64490962|NCT00941668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490963|NCT00941668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64490966|NCT01597414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64490967|NCT01597414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352309|NCT00946036|Sertraline|sertraline|mesh-list
65352310|NCT00946036|Antidepressive Agents|antidepressive agents|mesh-ancestor
65352311|NCT00946036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65352312|NCT00946036|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65352313|NCT00946036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65352314|NCT00946036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65352315|NCT00946036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352316|NCT00946036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65352317|NCT00946036|Serotonin Agents|serotonin agents|mesh-ancestor
65352318|NCT00946036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352319|NCT00688740|Cyclophosphamide|cyclophosphamide|mesh-list
65352320|NCT00688740|Docetaxel|docetaxel|mesh-list
65352321|NCT00688740|Doxorubicin|doxorubicin|mesh-list
65352322|NCT00688740|Fluorouracil|fluorouracil|mesh-list
65352323|NCT00688740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65352324|NCT00688740|Immunologic Factors|immunologic factors|mesh-ancestor
65352325|NCT00688740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352326|NCT00688740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65352327|NCT00688740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65352328|NCT00688740|Alkylating Agents|alkylating agents|mesh-ancestor
65352329|NCT00688740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352330|NCT00688740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352331|NCT00688740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64490968|NCT04984330|Dexamethasone|dexamethasone|mesh-list
64490969|NCT04984330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64490970|NCT04984330|Antiemetics|antiemetics|mesh-ancestor
64490993|NCT03035578|Analgesics|analgesics|mesh-ancestor
64490994|NCT03035578|Sensory System Agents|sensory system agents|mesh-ancestor
64490995|NCT03035578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64490996|NCT04933942|Lomustine|lomustine|mesh-list
64490997|NCT04933942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64490998|NCT04933942|Alkylating Agents|alkylating agents|mesh-ancestor
64490999|NCT04933942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491000|NCT04933942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491001|NCT00089583|Ritonavir|ritonavir|mesh-list
64491002|NCT00089583|Fosamprenavir|fosamprenavir|mesh-list
64556022|NCT05006664|Alkylating Agents|alkylating agents|mesh-ancestor
64556023|NCT05006664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556024|NCT05006664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556025|NCT05006664|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64556026|NCT05006664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64556027|NCT05006664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64556028|NCT05006664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64491003|NCT00089583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64491004|NCT00089583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64491005|NCT00089583|Protease Inhibitors|protease inhibitors|mesh-ancestor
64491006|NCT00089583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491007|NCT00089583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491008|NCT00089583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64491009|NCT00089583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64491010|NCT00089583|Antiviral Agents|antiviral agents|mesh-ancestor
64491011|NCT00089583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65352332|NCT00688740|Tubulin Modulators|tubulin modulators|mesh-ancestor
65352333|NCT00688740|Antimitotic Agents|antimitotic agents|mesh-ancestor
65352334|NCT00688740|Mitosis Modulators|mitosis modulators|mesh-ancestor
65352335|NCT00688740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65352336|NCT00688740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65352337|NCT00688740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65352338|NCT00688740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352339|NCT00688740|Antimetabolites|antimetabolites|mesh-ancestor
65352340|NCT00688740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65352341|NCT05323058|Benzydamine|benzydamine|mesh-list
65352342|NCT05323058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65352343|NCT01046773|Cholecalciferol|cholecalciferol|mesh-list
65352344|NCT01046773|Vitamin D|vitamin d|mesh-list
65352345|NCT01046773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65352346|NCT01046773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352347|NCT01046773|Vitamins|vitamins|mesh-ancestor
65352348|NCT01046773|Micronutrients|micronutrients|mesh-ancestor
65352349|NCT01046773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65352350|NCT00850005|Immunoglobulins|immunoglobulins|mesh-list
65352351|NCT00850005|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65352352|NCT00850005|Antibodies|antibodies|mesh-list
65352353|NCT00850005|gamma-Globulins|gamma-globulins|mesh-list
65352354|NCT00850005|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65352355|NCT00850005|Immunologic Factors|immunologic factors|mesh-ancestor
65352356|NCT00850005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352357|NCT00852579|Azithromycin|azithromycin|mesh-list
65352358|NCT00852579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65352359|NCT00852579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65352360|NCT00942136|Dolutegravir|dolutegravir|mesh-list
65352361|NCT00942136|Omeprazole|omeprazole|mesh-list
65352362|NCT00942136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65352363|NCT00942136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65352364|NCT00942136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65352365|NCT00942136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744504|NCT01790568|Antimetabolites|antimetabolites|mesh-ancestor
64491012|NCT00089583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64491013|NCT00089583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64491014|NCT03029494|Ascorbic Acid|ascorbic acid|mesh-list
64491015|NCT03029494|Vitamins|vitamins|mesh-ancestor
64491016|NCT03029494|Micronutrients|micronutrients|mesh-ancestor
64491017|NCT03029494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491018|NCT03029494|Antioxidants|antioxidants|mesh-ancestor
64491019|NCT03029494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352366|NCT00942136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352367|NCT00942136|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65352368|NCT00942136|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65352369|NCT00942136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65352370|NCT00942136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65352371|NCT00942136|Antiviral Agents|antiviral agents|mesh-ancestor
65352372|NCT00942136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65352373|NCT04228965|Varenicline|varenicline|mesh-list
65352374|NCT04228965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65352375|NCT04228965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65352376|NCT04228965|Cholinergic Agents|cholinergic agents|mesh-ancestor
65352377|NCT04228965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65352378|NCT04228965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352379|NCT04228965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352380|NCT05300932|Cyclophosphamide|cyclophosphamide|mesh-list
65352381|NCT05300932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65352382|NCT05300932|Immunologic Factors|immunologic factors|mesh-ancestor
65352383|NCT05300932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352384|NCT05300932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65352385|NCT05300932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65352386|NCT05300932|Alkylating Agents|alkylating agents|mesh-ancestor
65352387|NCT05300932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352388|NCT05300932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352389|NCT05300932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65352390|NCT00942214|Natalizumab|natalizumab|mesh-list
65352391|NCT00942214|Immunologic Factors|immunologic factors|mesh-ancestor
65352392|NCT00942214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352393|NCT00850161|Insulin|insulin|mesh-list
65352394|NCT00850161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65352395|NCT00850161|Insulin Aspart|insulin aspart|mesh-list
65352396|NCT00850161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65352397|NCT00850161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352398|NCT00951574|Nadroparin|nadroparin|mesh-list
64491020|NCT03029494|Protective Agents|protective agents|mesh-ancestor
64491021|NCT04402047|Diclofenac|diclofenac|mesh-list
64491022|NCT04402047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64491041|NCT03017248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64491042|NCT03017248|Anesthetics, General|anesthetics, general|mesh-ancestor
64491043|NCT03017248|Anesthetics|anesthetics|mesh-ancestor
64491044|NCT03017248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64491045|NCT03017248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64491046|NCT03017248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64491047|NCT03017248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65352399|NCT00951574|Calcium|calcium|mesh-list
65352400|NCT00951574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65352401|NCT00951574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352402|NCT00951574|Anticoagulants|anticoagulants|mesh-ancestor
65352403|NCT00951574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65352404|NCT00951574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65352405|NCT00951574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352406|NCT00686790|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65352407|NCT00686790|Interferon-alpha|interferon-alpha|mesh-list
65352408|NCT00686790|Antiviral Agents|antiviral agents|mesh-ancestor
65352409|NCT00686790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65352410|NCT00686790|Immunologic Factors|immunologic factors|mesh-ancestor
65352411|NCT00686790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352412|NCT00856089|Retapamulin|retapamulin|mesh-list
65102253|NCT00531674|Vitamins|vitamins|mesh-ancestor
65352413|NCT00856089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65352414|NCT00856089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65352415|NCT00686712|Insulin|insulin|mesh-list
65352416|NCT00686712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65352417|NCT00686712|Insulin Glargine|insulin glargine|mesh-list
64491048|NCT03017248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491049|NCT03017248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64491050|NCT03017248|Narcotics|narcotics|mesh-ancestor
64491051|NCT00088881|Prednisone|prednisone|mesh-list
64491052|NCT00088881|Cyclophosphamide|cyclophosphamide|mesh-list
64491053|NCT00088881|Rituximab|rituximab|mesh-list
64491054|NCT00088881|Doxorubicin|doxorubicin|mesh-list
64491055|NCT00088881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64491056|NCT00088881|Vincristine|vincristine|mesh-list
64491057|NCT00088881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64491058|NCT00088881|Immunologic Factors|immunologic factors|mesh-ancestor
64491059|NCT00088881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491060|NCT00088881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64491061|NCT00088881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64491062|NCT00088881|Alkylating Agents|alkylating agents|mesh-ancestor
64491063|NCT00088881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491064|NCT00088881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491065|NCT00088881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64491066|NCT00088881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64491067|NCT00088881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64491068|NCT00088881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64491069|NCT00088881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64491070|NCT00088881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491071|NCT00088881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64491072|NCT00088881|Glucocorticoids|glucocorticoids|mesh-ancestor
64491073|NCT00088881|Hormones|hormones|mesh-ancestor
64491074|NCT00088881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64491075|NCT00088881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64491076|NCT00088881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64491077|NCT00088881|Tubulin Modulators|tubulin modulators|mesh-ancestor
64491078|NCT00088881|Antimitotic Agents|antimitotic agents|mesh-ancestor
64556030|NCT05006664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64556032|NCT05006664|Hormones|hormones|mesh-ancestor
64556033|NCT05006664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64556034|NCT05006664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64491079|NCT00088881|Mitosis Modulators|mitosis modulators|mesh-ancestor
65352418|NCT00686712|Insulin, Isophane|insulin, isophane|mesh-list
65352419|NCT00686712|Isophane Insulin, Human|isophane insulin, human|mesh-list
65352420|NCT00686712|Isophane insulin, beef|isophane insulin, beef|mesh-list
65352421|NCT00686712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65352422|NCT00686712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352423|NCT00748644|Rituximab|rituximab|mesh-list
65352424|NCT00748644|Azathioprine|azathioprine|mesh-list
65352425|NCT00748644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65352426|NCT00748644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352427|NCT00748644|Immunologic Factors|immunologic factors|mesh-ancestor
65352428|NCT00748644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352429|NCT00748644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65352430|NCT00748644|Antimetabolites|antimetabolites|mesh-ancestor
65352431|NCT00748644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352432|NCT00748644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65352433|NCT00748644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65352434|NCT00686634|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65352435|NCT00686634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65352436|NCT00686634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352437|NCT00686634|Incretins|incretins|mesh-ancestor
65352438|NCT00686634|Hormones|hormones|mesh-ancestor
65352439|NCT00686634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65352447|NCT00560404|Epoetin Alfa|epoetin alfa|mesh-list
65352470|NCT00619983|Donepezil|donepezil|mesh-list
65352471|NCT00619983|Analgesics|analgesics|mesh-ancestor
65352472|NCT00619983|Sensory System Agents|sensory system agents|mesh-ancestor
65352473|NCT00619983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65352474|NCT00619983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352475|NCT00619983|Anticonvulsants|anticonvulsants|mesh-ancestor
65352476|NCT00619983|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65352477|NCT00619983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65352478|NCT00619983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65352479|NCT00619983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65352480|NCT00619983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65352481|NCT00619983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65352482|NCT00619983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65352483|NCT00619983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352484|NCT00619983|Antimanic Agents|antimanic agents|mesh-ancestor
65352485|NCT00619983|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65352486|NCT00619983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65352487|NCT00619983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65352488|NCT00619983|Antidepressive Agents|antidepressive agents|mesh-ancestor
65352489|NCT00619983|Dopamine Agents|dopamine agents|mesh-ancestor
65102306|NCT00531791|Prednisone|prednisone|mesh-list
65352490|NCT00619983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65352491|NCT00619983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352492|NCT00619983|Cholinergic Agents|cholinergic agents|mesh-ancestor
65352493|NCT00619983|Nootropic Agents|nootropic agents|mesh-ancestor
65352494|NCT00942682|Sorafenib|sorafenib|mesh-list
65352495|NCT00942682|Everolimus|everolimus|mesh-list
65352496|NCT00942682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352497|NCT00942682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65352498|NCT00942682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352499|NCT00942682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352500|NCT00942682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65352501|NCT00942682|Immunologic Factors|immunologic factors|mesh-ancestor
65352502|NCT00942682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352508|NCT04144023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352509|NCT00853983|Saracatinib|saracatinib|mesh-list
65352510|NCT00853983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352511|NCT00853983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352512|NCT00853983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352513|NCT00750048|Acetaminophen|acetaminophen|mesh-list
65352514|NCT00750048|Naloxone|naloxone|mesh-list
65352515|NCT00750048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65352516|NCT00750048|Analgesics|analgesics|mesh-ancestor
65352517|NCT00750048|Sensory System Agents|sensory system agents|mesh-ancestor
65352518|NCT00750048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65352519|NCT00750048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352520|NCT00750048|Antipyretics|antipyretics|mesh-ancestor
65352521|NCT00750048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65352522|NCT00942838|Cisplatin|cisplatin|mesh-list
65352523|NCT00942838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352524|NCT04057014|Amoxicillin|amoxicillin|mesh-list
65352525|NCT04057014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65352526|NCT04057014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65352527|NCT00364351|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65352528|NCT00364351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352529|NCT00364351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65352530|NCT00364351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352531|NCT00364351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352532|NCT05279872|Zanubrutinib|zanubrutinib|mesh-list
65352533|NCT05279872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352534|NCT05279872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65352535|NCT05279872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352536|NCT05279872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491091|NCT03017404|Immunologic Factors|immunologic factors|mesh-ancestor
64491092|NCT03017404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491093|NCT03017404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64491094|NCT03017404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64491095|NCT03017404|Alkylating Agents|alkylating agents|mesh-ancestor
64491096|NCT03017404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491097|NCT03017404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491098|NCT03017404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64491099|NCT03017404|Tubulin Modulators|tubulin modulators|mesh-ancestor
64491100|NCT03017404|Antimitotic Agents|antimitotic agents|mesh-ancestor
64491101|NCT03017404|Mitosis Modulators|mitosis modulators|mesh-ancestor
64491102|NCT03017404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64491103|NCT03017404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64491104|NCT03017404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64491105|NCT03017404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491106|NCT00953212|Ascorbic Acid|ascorbic acid|mesh-list
64491107|NCT00953212|Amiodarone|amiodarone|mesh-list
65352537|NCT00854139|Cyclosporine|cyclosporine|mesh-list
65352538|NCT00854139|Cyclophosphamide|cyclophosphamide|mesh-list
65352539|NCT00854139|Cyclosporins|cyclosporins|mesh-list
65352540|NCT00854139|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65352541|NCT00854139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65352542|NCT00854139|Immunologic Factors|immunologic factors|mesh-ancestor
65352543|NCT00854139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352544|NCT00854139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65352545|NCT00854139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65352546|NCT00854139|Alkylating Agents|alkylating agents|mesh-ancestor
65352547|NCT00854139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352548|NCT00854139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352549|NCT00854139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65352550|NCT00854139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352551|NCT00854139|Antifungal Agents|antifungal agents|mesh-ancestor
65352552|NCT00854139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65352553|NCT00854139|Dermatologic Agents|dermatologic agents|mesh-ancestor
65352554|NCT00854139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65352555|NCT00755820|Cycloserine|cycloserine|mesh-list
65352556|NCT00755820|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65352557|NCT00755820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65352558|NCT00755820|Renal Agents|renal agents|mesh-ancestor
65352559|NCT00755820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65352560|NCT00755820|Antitubercular Agents|antitubercular agents|mesh-ancestor
65352561|NCT00755820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65352562|NCT00755820|Antimetabolites|antimetabolites|mesh-ancestor
65352563|NCT00755820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352564|NCT00752154|Curcumin|curcumin|mesh-list
65352565|NCT00752154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65352566|NCT00752154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65352568|NCT00752154|Sensory System Agents|sensory system agents|mesh-ancestor
65352569|NCT00752154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65352580|NCT00943228|Antitubercular Agents|antitubercular agents|mesh-ancestor
65352581|NCT00943228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65352582|NCT00943228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65352583|NCT00943228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352584|NCT00943228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352585|NCT00755898|Amantadine|amantadine|mesh-list
65352586|NCT00755898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65352587|NCT00755898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65352588|NCT00755898|Antiviral Agents|antiviral agents|mesh-ancestor
65352589|NCT00755898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65352590|NCT00755898|Dopamine Agents|dopamine agents|mesh-ancestor
65352591|NCT00755898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65352592|NCT00755898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352593|NCT00755898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352594|NCT00755898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65352595|NCT00755898|Analgesics|analgesics|mesh-ancestor
65352596|NCT00755898|Sensory System Agents|sensory system agents|mesh-ancestor
65352597|NCT00755898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65352598|NCT00750126|Fludarabine|fludarabine|mesh-list
65352599|NCT00750126|Busulfan|busulfan|mesh-list
65352600|NCT00750126|Thymoglobulin|thymoglobulin|mesh-list
65352601|NCT00750126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352602|NCT00750126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491108|NCT00953212|Metoprolol|metoprolol|mesh-list
64491109|NCT00953212|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64491110|NCT00953212|Vitamins|vitamins|mesh-ancestor
64491111|NCT00953212|Micronutrients|micronutrients|mesh-ancestor
64491112|NCT00953212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491113|NCT00953212|Antioxidants|antioxidants|mesh-ancestor
64491114|NCT00953212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491115|NCT00953212|Protective Agents|protective agents|mesh-ancestor
64491116|NCT00953212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64491117|NCT00953212|Adrenergic Agents|adrenergic agents|mesh-ancestor
64491118|NCT00953212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64491119|NCT00953212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64491120|NCT00953212|Vasodilator Agents|vasodilator agents|mesh-ancestor
64491121|NCT00953212|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64491122|NCT00953212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64491123|NCT00953212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64491124|NCT00953212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64491125|NCT00953212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64491126|NCT00953212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491127|NCT00953212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64491128|NCT00953212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64491131|NCT00953212|Sympatholytics|sympatholytics|mesh-ancestor
64491132|NCT00953212|Autonomic Agents|autonomic agents|mesh-ancestor
64491133|NCT00953212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64491134|NCT00953212|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64491135|NCT03034408|Mannitol|mannitol|mesh-list
64491136|NCT03034408|Baclofen|baclofen|mesh-list
64491137|NCT03034408|Nalmefene|nalmefene|mesh-list
64491138|NCT03034408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65352603|NCT00750126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65352604|NCT00750126|Immunologic Factors|immunologic factors|mesh-ancestor
65352605|NCT00750126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352606|NCT00750126|Alkylating Agents|alkylating agents|mesh-ancestor
65352607|NCT00750126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65352608|NCT00750126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65352609|NCT00755976|Sulindac|sulindac|mesh-list
65352610|NCT00755976|Epirubicin|epirubicin|mesh-list
65352611|NCT00755976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65352612|NCT00755976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352613|NCT00755976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65352614|NCT00755976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65352615|NCT00755976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352616|NCT00755976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352617|NCT00755976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64744764|NCT01809132|Zinc|zinc|mesh-list
64491139|NCT03034408|Diuretics|diuretics|mesh-ancestor
64491140|NCT03034408|Natriuretic Agents|natriuretic agents|mesh-ancestor
64491141|NCT03034408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491142|NCT03034408|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64491143|NCT03034408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64491144|NCT03034408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64491145|NCT03034408|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64491146|NCT03034408|GABA Agonists|gaba agonists|mesh-ancestor
64491147|NCT03034408|GABA Agents|gaba agents|mesh-ancestor
64491160|NCT03023020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64491161|NCT03023020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64491162|NCT03023020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64491163|NCT03023020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64491164|NCT03023020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491165|NCT03023020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64556035|NCT05006664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64556036|NCT05006664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64556038|NCT04346901|Antithyroid Agents|antithyroid agents|mesh-ancestor
64556039|NCT04346901|Hormone Antagonists|hormone antagonists|mesh-ancestor
64321107|NCT02198443|Cobicistat|cobicistat|mesh-list
64491166|NCT03023020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491168|NCT00087555|Sodium Oxybate|sodium oxybate|mesh-list
64491169|NCT00087555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64491170|NCT00087555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64491171|NCT00087555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64491172|NCT00087555|Anesthetics, General|anesthetics, general|mesh-ancestor
64491173|NCT00087555|Anesthetics|anesthetics|mesh-ancestor
64491174|NCT00087555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64491175|NCT00087555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491176|NCT03022318|Levodopa|levodopa|mesh-list
64491177|NCT03022318|Carbidopa|carbidopa|mesh-list
64491178|NCT03022318|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64491179|NCT03022318|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64491180|NCT03022318|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64491181|NCT03022318|Dopamine Agents|dopamine agents|mesh-ancestor
64491182|NCT03022318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64491183|NCT03022318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491184|NCT03022318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491185|NCT03022318|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64491186|NCT03022318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491187|NCT03022318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64491188|NCT03022318|Immunologic Factors|immunologic factors|mesh-ancestor
64491189|NCT03022318|Dopamine Agonists|dopamine agonists|mesh-ancestor
65352618|NCT00755976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65352619|NCT00755976|Analgesics|analgesics|mesh-ancestor
65352620|NCT00755976|Sensory System Agents|sensory system agents|mesh-ancestor
65352621|NCT00755976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65352622|NCT00755976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352623|NCT00755976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65352624|NCT00755976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65352625|NCT00755976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65352626|NCT00752310|Darunavir|darunavir|mesh-list
65352627|NCT00752310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65352628|NCT00752310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65352629|NCT00752310|Protease Inhibitors|protease inhibitors|mesh-ancestor
65352630|NCT00752310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744781|NCT01809132|Glucocorticoids|glucocorticoids|mesh-ancestor
64491190|NCT01677897|Metformin|metformin|mesh-list
64491191|NCT01677897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64491192|NCT01677897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491193|NCT03483363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64491195|NCT03483363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64491196|NCT03483363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64491197|NCT03483363|Antitubercular Agents|antitubercular agents|mesh-ancestor
64491198|NCT03483363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64491199|NCT03086733|Metformin|metformin|mesh-list
64491200|NCT03086733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64491201|NCT03086733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491202|NCT00086619|Parathyroid Hormone|parathyroid hormone|mesh-list
64491203|NCT00086619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491204|NCT00086619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64491205|NCT00085917|Interferons|interferons|mesh-list
64491206|NCT00085917|Ribavirin|ribavirin|mesh-list
64491207|NCT00085917|Interferon-alpha|interferon-alpha|mesh-list
64491208|NCT00085917|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64491209|NCT00085917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491227|NCT01678365|Gentamicins|gentamicins|mesh-list
64491228|NCT01678365|Ceftriaxone|ceftriaxone|mesh-list
64491229|NCT01678365|Ampicillin|ampicillin|mesh-list
64491231|NCT01678365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64491232|NCT01678365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64491233|NCT01678365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64491234|NCT01678365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64491235|NCT01678365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491236|NCT01678365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491237|NCT00946270|Thalidomide|thalidomide|mesh-list
64491238|NCT00946270|Prednisone|prednisone|mesh-list
64491239|NCT00946270|Pomalidomide|pomalidomide|mesh-list
64491240|NCT00946270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64491241|NCT00946270|Glucocorticoids|glucocorticoids|mesh-ancestor
64491242|NCT00946270|Hormones|hormones|mesh-ancestor
64491243|NCT00946270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64491244|NCT00946270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491245|NCT00946270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64491246|NCT00946270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491247|NCT00946270|Immunologic Factors|immunologic factors|mesh-ancestor
64491248|NCT00946270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64556040|NCT04346901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64556041|NCT04346901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556042|NCT02244021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64556043|NCT02244021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64556044|NCT02244021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556045|NCT04364607|Neostigmine|neostigmine|mesh-list
64556046|NCT04364607|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64321111|NCT02198443|Protease Inhibitors|protease inhibitors|mesh-ancestor
64321112|NCT02198443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352631|NCT00752310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352632|NCT00752310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65352633|NCT00752310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65352634|NCT00752310|Antiviral Agents|antiviral agents|mesh-ancestor
65352635|NCT00752310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65352636|NCT00943462|Temozolomide|temozolomide|mesh-list
65352637|NCT00943462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65352638|NCT00943462|Alkylating Agents|alkylating agents|mesh-ancestor
65352639|NCT00943462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102455|NCT02942420|Bucillamine|bucillamine|mesh-list
65352640|NCT00943462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352642|NCT02560974|Oxaliplatin|oxaliplatin|mesh-list
64491249|NCT00946270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64491250|NCT00946270|Growth Substances|growth substances|mesh-ancestor
64491251|NCT00946270|Growth Inhibitors|growth inhibitors|mesh-ancestor
64491252|NCT00946270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64491253|NCT00946270|Leprostatic Agents|leprostatic agents|mesh-ancestor
64491254|NCT00946270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64491255|NCT00946270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64491256|NCT03021616|Moxifloxacin|moxifloxacin|mesh-list
64491257|NCT03021616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64491258|NCT03021616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64491259|NCT03021616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64491260|NCT03021616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64491261|NCT03021616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491262|NCT03021616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491263|NCT03021616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491264|NCT03021694|Caseins|caseins|mesh-list
64491265|NCT03021694|Chelating Agents|chelating agents|mesh-ancestor
64491266|NCT03021694|Sequestering Agents|sequestering agents|mesh-ancestor
64491267|NCT03021694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491268|NCT00956254|Fentanyl|fentanyl|mesh-list
64491286|NCT01678599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64491287|NCT01678599|Immunologic Factors|immunologic factors|mesh-ancestor
64491288|NCT01678599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491289|NCT01678599|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64491290|NCT01678599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64491291|NCT01678599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64491292|NCT01678599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64491294|NCT03019822|Dextroamphetamine|dextroamphetamine|mesh-list
64491295|NCT03019822|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
64491296|NCT03019822|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
64491297|NCT03019822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64491298|NCT03019822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491299|NCT03019822|Sympathomimetics|sympathomimetics|mesh-ancestor
64491300|NCT03019822|Autonomic Agents|autonomic agents|mesh-ancestor
64491301|NCT03019822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64491302|NCT03019822|Dopamine Agents|dopamine agents|mesh-ancestor
64491303|NCT03019822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64491304|NCT03019822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491305|NCT03019822|Adrenergic Agents|adrenergic agents|mesh-ancestor
64491306|NCT03019822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64491307|NCT03019822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64491308|NCT03019822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64491309|NCT03019822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64491310|NCT03019822|Hallucinogens|hallucinogens|mesh-ancestor
64491311|NCT03019822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64491316|NCT01678677|Immunologic Factors|immunologic factors|mesh-ancestor
64491317|NCT01678677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491319|NCT00946348|Hallucinogens|hallucinogens|mesh-ancestor
64491320|NCT00946348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491321|NCT00946348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65352643|NCT02560974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65352644|NCT02560974|Antimetabolites|antimetabolites|mesh-ancestor
65352645|NCT02560974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352646|NCT02560974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352647|NCT00854451|Amoxicillin|amoxicillin|mesh-list
65352648|NCT00854451|Omeprazole|omeprazole|mesh-list
65352649|NCT00854451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65352650|NCT00854451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65352651|NCT00854451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65352652|NCT00854451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65352653|NCT00854451|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65352654|NCT00854451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352655|NCT00854451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352656|NCT00854529|Bevacizumab|bevacizumab|mesh-list
65352657|NCT00854529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65352658|NCT00854529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352659|NCT00854529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65352660|NCT00854529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65352661|NCT00854529|Growth Substances|growth substances|mesh-ancestor
65352698|NCT00943540|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65352699|NCT00943540|Protease Inhibitors|protease inhibitors|mesh-ancestor
65352700|NCT00861627|Paclitaxel|paclitaxel|mesh-list
65352701|NCT00861627|Carboplatin|carboplatin|mesh-list
65352702|NCT00861627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65352703|NCT00861627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352704|NCT00861627|Tubulin Modulators|tubulin modulators|mesh-ancestor
65352705|NCT00861627|Antimitotic Agents|antimitotic agents|mesh-ancestor
65352706|NCT00861627|Mitosis Modulators|mitosis modulators|mesh-ancestor
65352707|NCT00861627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352708|NCT00943930|Dronabinol|dronabinol|mesh-list
65352709|NCT00943930|Amphetamine|amphetamine|mesh-list
65352710|NCT00943930|Dextroamphetamine|dextroamphetamine|mesh-list
65352711|NCT00943930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64491322|NCT00946348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64491323|NCT00946348|Analgesics|analgesics|mesh-ancestor
64556047|NCT04364607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556048|NCT04364607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556049|NCT04364607|Cholinergic Agents|cholinergic agents|mesh-ancestor
64556050|NCT04364607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64556051|NCT04364607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556052|NCT04364607|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64556053|NCT04364607|Autonomic Agents|autonomic agents|mesh-ancestor
64556054|NCT04364607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556055|NCT04364451|Asparaginase|asparaginase|mesh-list
64556056|NCT04364451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556057|NCT02245269|Ritonavir|ritonavir|mesh-list
64491324|NCT00946348|Sensory System Agents|sensory system agents|mesh-ancestor
64491325|NCT00946348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64491326|NCT00946348|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64491332|NCT00081159|Zoledronic Acid|zoledronic acid|mesh-list
64491333|NCT00081159|Doxorubicin|doxorubicin|mesh-list
64491334|NCT00081159|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64491335|NCT00081159|Leuprolide|leuprolide|mesh-list
64491336|NCT00081159|Goserelin|goserelin|mesh-list
64491337|NCT00081159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64491338|NCT00081159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491339|NCT00081159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64491340|NCT00081159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64491341|NCT00081159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491342|NCT00081159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491343|NCT00081159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64491344|NCT00081159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491345|NCT00081159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64491346|NCT00081159|Fertility Agents|fertility agents|mesh-ancestor
64491347|NCT00081159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64491348|NCT00081159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64491349|NCT03033472|Clindamycin|clindamycin|mesh-list
64491350|NCT03033472|Clindamycin palmitate|clindamycin palmitate|mesh-list
64491351|NCT03033472|Clindamycin phosphate|clindamycin phosphate|mesh-list
64491352|NCT03033472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64491353|NCT03033472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64491354|NCT03033472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64491355|NCT03033472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491356|NCT03033472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491357|NCT02981836|Vaccines|vaccines|mesh-list
64491358|NCT02981836|Immunologic Factors|immunologic factors|mesh-ancestor
64491359|NCT02981836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491360|NCT03033160|Estradiol|estradiol|mesh-list
64491361|NCT03033160|Estrogens|estrogens|mesh-ancestor
64491362|NCT03033160|Hormones|hormones|mesh-ancestor
64491363|NCT03033160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65352712|NCT00943930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102535|NCT02920047|Amlodipine|amlodipine|mesh-list
65352713|NCT00943930|Sympathomimetics|sympathomimetics|mesh-ancestor
65352714|NCT00943930|Autonomic Agents|autonomic agents|mesh-ancestor
65352715|NCT00943930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65352716|NCT00943930|Dopamine Agents|dopamine agents|mesh-ancestor
65352717|NCT00943930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65352718|NCT00943930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352719|NCT00943930|Adrenergic Agents|adrenergic agents|mesh-ancestor
65352720|NCT00943930|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65352721|NCT00943930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65352722|NCT00943930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65352723|NCT00943930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65352724|NCT00943930|Hallucinogens|hallucinogens|mesh-ancestor
65352725|NCT00943930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65352726|NCT00943930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65352727|NCT00943930|Analgesics|analgesics|mesh-ancestor
65352728|NCT00943930|Sensory System Agents|sensory system agents|mesh-ancestor
65352729|NCT00943930|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65352730|NCT00943930|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65352733|NCT00854763|Olmesartan|olmesartan|mesh-list
65352763|NCT02807467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65352764|NCT02807467|Adrenergic Agents|adrenergic agents|mesh-ancestor
65352765|NCT02807467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65352766|NCT02807467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352767|NCT00861783|Oxaliplatin|oxaliplatin|mesh-list
65352768|NCT00861783|Irinotecan|irinotecan|mesh-list
65352769|NCT00861783|Camptothecin|camptothecin|mesh-list
65352770|NCT00861783|ON 01910|on 01910|mesh-list
65352771|NCT00861783|Glycine|glycine|mesh-list
65352772|NCT00861783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352773|NCT00861783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65352774|NCT00861783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65352775|NCT00861783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352776|NCT00861783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352777|NCT00861783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65352778|NCT00861783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65352779|NCT00861783|Glycine Agents|glycine agents|mesh-ancestor
65352780|NCT00861783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65352781|NCT00861783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352782|NCT00947128|Ondansetron|ondansetron|mesh-list
65352783|NCT00947128|Antiemetics|antiemetics|mesh-ancestor
65352784|NCT00947128|Autonomic Agents|autonomic agents|mesh-ancestor
65352785|NCT00947128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64744931|NCT04562532|Sirolimus|sirolimus|mesh-list
64491364|NCT03033160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491365|NCT00958282|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64491366|NCT00958282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64491367|NCT00958282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491368|NCT00958282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64491369|NCT00958282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64491370|NCT00958282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64491371|NCT00958282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491372|NCT00958282|Dopamine Agents|dopamine agents|mesh-ancestor
64491373|NCT00958282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64491374|NCT03033316|Dexamethasone|dexamethasone|mesh-list
64491375|NCT03033316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64491376|NCT03033316|Antiemetics|antiemetics|mesh-ancestor
64491377|NCT03033316|Autonomic Agents|autonomic agents|mesh-ancestor
64491378|NCT03033316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556063|NCT02245269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556064|NCT02245269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64556065|NCT02245269|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64556066|NCT02245269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556067|NCT02245269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64321129|NCT03533179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491379|NCT03033316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491380|NCT03033316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64491381|NCT03033316|Glucocorticoids|glucocorticoids|mesh-ancestor
64491382|NCT03033316|Hormones|hormones|mesh-ancestor
64491383|NCT03033316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65352786|NCT00947128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352787|NCT00947128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65352788|NCT00947128|Antipruritics|antipruritics|mesh-ancestor
65352789|NCT00947128|Dermatologic Agents|dermatologic agents|mesh-ancestor
65352790|NCT00947128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65352791|NCT00947128|Serotonin Agents|serotonin agents|mesh-ancestor
65352792|NCT00947128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65352793|NCT00947128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352794|NCT00947128|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65352795|NCT00947128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65352796|NCT00947128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65352797|NCT00947128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65352798|NCT00947128|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65352799|NCT00861861|Atorvastatin|atorvastatin|mesh-list
65352800|NCT00861861|Pitavastatin|pitavastatin|mesh-list
65352801|NCT00861861|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65352802|NCT00861861|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65352803|NCT00861861|Antimetabolites|antimetabolites|mesh-ancestor
65352804|NCT00861861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352805|NCT00861861|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65352806|NCT00861861|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65352807|NCT00861861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491385|NCT03033316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491386|NCT03032848|Estrogens|estrogens|mesh-list
64491387|NCT03032848|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64491388|NCT03032848|Hormones|hormones|mesh-ancestor
64491389|NCT03032848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64491390|NCT03032848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491391|NCT00080223|Pirfenidone|pirfenidone|mesh-list
64491392|NCT00080223|Analgesics|analgesics|mesh-ancestor
64491393|NCT00080223|Sensory System Agents|sensory system agents|mesh-ancestor
64491415|NCT00959764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64491416|NCT00959764|Vasodilator Agents|vasodilator agents|mesh-ancestor
64491417|NCT01005706|Mycophenolic Acid|mycophenolic acid|mesh-list
64491418|NCT01005706|Sirolimus|sirolimus|mesh-list
64491419|NCT01005706|Tacrolimus|tacrolimus|mesh-list
64491420|NCT01005706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64491421|NCT01005706|Immunologic Factors|immunologic factors|mesh-ancestor
64491422|NCT01005706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491423|NCT01005706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64491424|NCT01005706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491425|NCT01005706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491426|NCT01005706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64491427|NCT01005706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491428|NCT01005706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64491429|NCT01005706|Antitubercular Agents|antitubercular agents|mesh-ancestor
64491430|NCT01005706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64491431|NCT01005706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64491432|NCT01005706|Antifungal Agents|antifungal agents|mesh-ancestor
64491433|NCT03085485|Ivacaftor|ivacaftor|mesh-list
64491434|NCT03085485|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64491435|NCT03085485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64491436|NCT03085485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352808|NCT00686166|Capecitabine|capecitabine|mesh-list
65352809|NCT00686166|Oxaliplatin|oxaliplatin|mesh-list
65352810|NCT00686166|Cetuximab|cetuximab|mesh-list
65352811|NCT00686166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65352812|NCT00686166|Antimetabolites|antimetabolites|mesh-ancestor
65352813|NCT00686166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352814|NCT00686166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352815|NCT00686166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65352816|NCT03963375|Cladribine|cladribine|mesh-list
65352817|NCT03963375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352818|NCT03963375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65352819|NCT03963375|Immunologic Factors|immunologic factors|mesh-ancestor
65352820|NCT03963375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352821|NCT04280536|Trifluridine|trifluridine|mesh-list
65352822|NCT04280536|Antimetabolites|antimetabolites|mesh-ancestor
65352823|NCT04280536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352824|NCT04280536|Antiviral Agents|antiviral agents|mesh-ancestor
65352825|NCT04280536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65352826|NCT00944242|Sertraline|sertraline|mesh-list
65352827|NCT00944242|Antidepressive Agents|antidepressive agents|mesh-ancestor
65352828|NCT00944242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65352829|NCT00944242|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65352830|NCT00944242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65352831|NCT00944242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65352832|NCT00944242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491437|NCT01679691|Anesthetics|anesthetics|mesh-list
64491438|NCT01679691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64491439|NCT01679691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491440|NCT03470805|Olaparib|olaparib|mesh-list
64491441|NCT03470805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64491442|NCT03470805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491443|NCT03470805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491444|NCT03470805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491445|NCT04278573|Vitamin D|vitamin d|mesh-list
64491446|NCT04278573|Cholecalciferol|cholecalciferol|mesh-list
64491464|NCT03084549|Anesthetics|anesthetics|mesh-ancestor
64491465|NCT03084549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64491466|NCT03084549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491467|NCT03084549|Sensory System Agents|sensory system agents|mesh-ancestor
64491468|NCT03084549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556068|NCT02245269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64556069|NCT02245269|Protease Inhibitors|protease inhibitors|mesh-ancestor
64556071|NCT02245269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64556072|NCT02245269|Antiviral Agents|antiviral agents|mesh-ancestor
64556073|NCT02245269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64556074|NCT02245269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64321140|NCT05261971|Etodolac|etodolac|mesh-list
64491469|NCT03082521|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64491470|NCT03082521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65352833|NCT00944242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65352834|NCT00944242|Serotonin Agents|serotonin agents|mesh-ancestor
65352835|NCT00944242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352836|NCT00363649|Interferons|interferons|mesh-list
65352837|NCT00363649|Interferon-alpha|interferon-alpha|mesh-list
65352838|NCT00363649|Sargramostim|sargramostim|mesh-list
65352839|NCT00363649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352840|NCT00363649|Antiviral Agents|antiviral agents|mesh-ancestor
65352841|NCT00363649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65352842|NCT00363649|Immunologic Factors|immunologic factors|mesh-ancestor
65352843|NCT00363649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352844|NCT00855153|Cycloserine|cycloserine|mesh-list
65352845|NCT00855153|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65352846|NCT00855153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65352847|NCT00855153|Renal Agents|renal agents|mesh-ancestor
65352848|NCT00855153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65352849|NCT00855153|Antitubercular Agents|antitubercular agents|mesh-ancestor
65352850|NCT00855153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65352851|NCT00855153|Antimetabolites|antimetabolites|mesh-ancestor
65352852|NCT00855153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352853|NCT00952978|Omeprazole|omeprazole|mesh-list
65352854|NCT00952978|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64491471|NCT03085719|Pembrolizumab|pembrolizumab|mesh-list
64491486|NCT03080805|Lapatinib|lapatinib|mesh-list
64491487|NCT03080805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64491488|NCT03080805|Antimetabolites|antimetabolites|mesh-ancestor
64491489|NCT03080805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491490|NCT03080805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491491|NCT03080805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64491492|NCT03080805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491493|NCT03019120|Vitamin D|vitamin d|mesh-list
64491494|NCT03019120|Vitamins|vitamins|mesh-ancestor
64491495|NCT03019120|Micronutrients|micronutrients|mesh-ancestor
64491496|NCT03019120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491497|NCT03019120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64491498|NCT00960622|Tenofovir|tenofovir|mesh-list
64491499|NCT00960622|Lamivudine|lamivudine|mesh-list
64491500|NCT00960622|Zidovudine|zidovudine|mesh-list
64491501|NCT00960622|Emtricitabine|emtricitabine|mesh-list
64586286|NCT00322439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64491519|NCT03430947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491520|NCT00960778|Nicotine|nicotine|mesh-list
64491521|NCT00960778|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64491522|NCT00960778|Autonomic Agents|autonomic agents|mesh-ancestor
64491523|NCT00960778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64491524|NCT00960778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491525|NCT00960778|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64491526|NCT00960778|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64491527|NCT00960778|Cholinergic Agents|cholinergic agents|mesh-ancestor
64491528|NCT00960778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64491529|NCT00960778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491530|NCT03080181|Pasireotide|pasireotide|mesh-list
64491531|NCT03080181|Hormones|hormones|mesh-ancestor
64491532|NCT03080181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64491533|NCT03080181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352855|NCT00952978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65352856|NCT00952978|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65352857|NCT00952978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352858|NCT00952978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352859|NCT00861939|Bupropion|bupropion|mesh-list
65352860|NCT00861939|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65352861|NCT00861939|Antidepressive Agents|antidepressive agents|mesh-ancestor
65352862|NCT00861939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65352863|NCT00861939|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65102683|NCT05302388|Hormones|hormones|mesh-ancestor
65352864|NCT00861939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65352865|NCT00861939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65352866|NCT00861939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352867|NCT00861939|Dopamine Agents|dopamine agents|mesh-ancestor
65352868|NCT00861939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65352869|NCT00861939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352870|NCT00861939|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65352871|NCT00861939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65352872|NCT00861939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352873|NCT00953134|Folic Acid|folic acid|mesh-list
65352874|NCT00953134|Micronutrients|micronutrients|mesh-list
65352875|NCT00953134|Ferrous fumarate|ferrous fumarate|mesh-list
64491534|NCT03088293|Cyclophosphamide|cyclophosphamide|mesh-list
64491535|NCT03088293|Infliximab|infliximab|mesh-list
64491536|NCT03088293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64491537|NCT03088293|Immunologic Factors|immunologic factors|mesh-ancestor
64491538|NCT03088293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491539|NCT03088293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64491540|NCT03088293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64491541|NCT03088293|Alkylating Agents|alkylating agents|mesh-ancestor
64491542|NCT03088293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491543|NCT03088293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556075|NCT02245269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64556077|NCT04364139|Amlodipine|amlodipine|mesh-list
64556078|NCT04364139|Ramipril|ramipril|mesh-list
64556079|NCT04364139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64556080|NCT04364139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64491556|NCT01008280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491584|NCT01009918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64491585|NCT01009918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64491586|NCT01009918|Adrenergic Agents|adrenergic agents|mesh-ancestor
64491587|NCT01009918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64491588|NCT01009918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491589|NCT01009918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491590|NCT01009918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64491591|NCT01009918|Antioxidants|antioxidants|mesh-ancestor
64491592|NCT01009918|Protective Agents|protective agents|mesh-ancestor
64491593|NCT01009918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64491594|NCT01009918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64491595|NCT01009918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65352876|NCT00953134|Trace Elements|trace elements|mesh-list
65352877|NCT00953134|Hematinics|hematinics|mesh-ancestor
65352878|NCT00953134|Vitamin B Complex|vitamin b complex|mesh-ancestor
65352879|NCT00953134|Vitamins|vitamins|mesh-ancestor
65352880|NCT00953134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352881|NCT00944398|Vitamins|vitamins|mesh-list
65352882|NCT00944398|Zinc|zinc|mesh-list
65352883|NCT00944398|Vitamin B Complex|vitamin b complex|mesh-list
65352884|NCT00944398|Zinc Sulfate|zinc sulfate|mesh-list
65352885|NCT00944398|Micronutrients|micronutrients|mesh-ancestor
65352886|NCT00944398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352887|NCT00944398|Trace Elements|trace elements|mesh-ancestor
65352888|NCT00944398|Astringents|astringents|mesh-ancestor
65352889|NCT00944398|Dermatologic Agents|dermatologic agents|mesh-ancestor
65352890|NCT00855387|Pancrelipase|pancrelipase|mesh-list
65352891|NCT00855387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65352892|NCT00947596|Atropine|atropine|mesh-list
65352893|NCT00947596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64491596|NCT01009918|Vasodilator Agents|vasodilator agents|mesh-ancestor
64491597|NCT01009918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64491598|NCT01009918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64491599|NCT01009918|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64491600|NCT01009918|Protease Inhibitors|protease inhibitors|mesh-ancestor
64491601|NCT01009918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491603|NCT04401657|Adenosine|adenosine|mesh-list
64491604|NCT04401657|Analgesics|analgesics|mesh-ancestor
64491624|NCT03083613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491625|NCT03083613|Tubulin Modulators|tubulin modulators|mesh-ancestor
64491626|NCT03083613|Antimitotic Agents|antimitotic agents|mesh-ancestor
64491627|NCT03083613|Mitosis Modulators|mitosis modulators|mesh-ancestor
64491628|NCT03083613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491629|NCT03083613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64491631|NCT03083613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64491632|NCT03083613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491634|NCT00963508|Malathion|malathion|mesh-list
64491635|NCT00963508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491636|NCT00963508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491637|NCT00963508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64491638|NCT00963508|Cholinergic Agents|cholinergic agents|mesh-ancestor
64491639|NCT00963508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64491640|NCT00963508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491641|NCT03088371|Lidocaine|lidocaine|mesh-list
64491642|NCT03088371|Bupivacaine|bupivacaine|mesh-list
64491643|NCT03088371|Anesthetics, Local|anesthetics, local|mesh-ancestor
64491644|NCT03088371|Anesthetics|anesthetics|mesh-ancestor
64491645|NCT03088371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64491646|NCT03088371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556084|NCT04364139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556085|NCT04364139|Vasodilator Agents|vasodilator agents|mesh-ancestor
64556086|NCT04364139|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64556087|NCT04364139|Sympatholytics|sympatholytics|mesh-ancestor
64556088|NCT04364139|Autonomic Agents|autonomic agents|mesh-ancestor
64556089|NCT04364139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556090|NCT04364139|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64556091|NCT04364139|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64556092|NCT04364139|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64321153|NCT02201563|Minocycline|minocycline|mesh-list
64491648|NCT03088371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64491649|NCT03088371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64491650|NCT03088371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64491651|NCT03088371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65352894|NCT00947596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65352895|NCT00947596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65352896|NCT00947596|Autonomic Agents|autonomic agents|mesh-ancestor
65352897|NCT00947596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65352898|NCT00947596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352899|NCT00947596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65352900|NCT00947596|Respiratory System Agents|respiratory system agents|mesh-ancestor
65352901|NCT00947596|Mydriatics|mydriatics|mesh-ancestor
65352902|NCT00947596|Parasympatholytics|parasympatholytics|mesh-ancestor
65352903|NCT00947596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65352904|NCT00947596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65352905|NCT00947596|Cholinergic Agents|cholinergic agents|mesh-ancestor
65352906|NCT00947596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65352907|NCT00947596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352908|NCT00865059|Gabapentin|gabapentin|mesh-list
65352909|NCT00865059|Analgesics|analgesics|mesh-ancestor
65352910|NCT00865059|Sensory System Agents|sensory system agents|mesh-ancestor
65352911|NCT00865059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65352912|NCT00865059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352913|NCT00865059|Anticonvulsants|anticonvulsants|mesh-ancestor
65352914|NCT00865059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65352915|NCT00865059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65352916|NCT00865059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65352917|NCT00865059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65352918|NCT00865059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65352919|NCT00865059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65352920|NCT00865059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64745060|NCT01755702|Antipyretics|antipyretics|mesh-ancestor
64491652|NCT03088371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64491653|NCT03088371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491654|NCT03083691|Nivolumab|nivolumab|mesh-list
64491655|NCT03083691|Ipilimumab|ipilimumab|mesh-list
64491656|NCT03083691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64491657|NCT03083691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491658|NCT03083691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64491676|NCT01010932|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
64491678|NCT01010932|Sequestering Agents|sequestering agents|mesh-ancestor
64491679|NCT01010932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491680|NCT03018652|Immunoglobulins|immunoglobulins|mesh-list
64491681|NCT03018652|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64491682|NCT03018652|Antibodies|antibodies|mesh-list
64491683|NCT03018652|gamma-Globulins|gamma-globulins|mesh-list
64491684|NCT03018652|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64491685|NCT03018652|Immunologic Factors|immunologic factors|mesh-ancestor
64491686|NCT03018652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491687|NCT03387579|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65352921|NCT00865059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352922|NCT00865059|Antimanic Agents|antimanic agents|mesh-ancestor
65352923|NCT00865137|Tacrolimus|tacrolimus|mesh-list
65352924|NCT00865137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65352925|NCT00865137|Immunologic Factors|immunologic factors|mesh-ancestor
65352926|NCT00865137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352927|NCT00865137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65352928|NCT00865137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352929|NCT00865137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491688|NCT03387579|SMOFlipid|smoflipid|mesh-list
64491689|NCT03387579|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64491690|NCT03387579|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64491691|NCT03387579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64491692|NCT01012336|Dexamethasone|dexamethasone|mesh-list
64491693|NCT01012336|Aprepitant|aprepitant|mesh-list
64491694|NCT01012336|Ramosetron|ramosetron|mesh-list
64491695|NCT01012336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64491696|NCT01012336|Antiemetics|antiemetics|mesh-ancestor
64491697|NCT01012336|Autonomic Agents|autonomic agents|mesh-ancestor
64491698|NCT01012336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64491699|NCT01012336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491700|NCT01012336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64491701|NCT01012336|Glucocorticoids|glucocorticoids|mesh-ancestor
64491702|NCT01012336|Hormones|hormones|mesh-ancestor
64491703|NCT01012336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64491704|NCT01012336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64491705|NCT01012336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491706|NCT01012336|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64491707|NCT01012336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64491708|NCT01012336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491709|NCT01012336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64491710|NCT01012336|Serotonin Agents|serotonin agents|mesh-ancestor
64491712|NCT03387501|Mitosis Modulators|mitosis modulators|mesh-ancestor
64491720|NCT01012492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491721|NCT01012492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64491722|NCT05688345|Dexmedetomidine|dexmedetomidine|mesh-list
64491724|NCT05688345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64556093|NCT04364139|Adrenergic Agents|adrenergic agents|mesh-ancestor
64556094|NCT04364139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64556095|NCT04364139|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64556096|NCT04364139|Protease Inhibitors|protease inhibitors|mesh-ancestor
64556097|NCT04364139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556098|NCT02244255|Tamsulosin|tamsulosin|mesh-list
64556099|NCT02244255|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64321163|NCT02201641|Calcium|calcium|mesh-list
64491725|NCT05688345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64491739|NCT05688345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491741|NCT03083457|Anesthetics, General|anesthetics, general|mesh-list
64491742|NCT03083457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64491743|NCT03083457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491744|NCT04401345|Glycopyrrolate|glycopyrrolate|mesh-list
64491746|NCT04401345|Anticonvulsants|anticonvulsants|mesh-ancestor
64491747|NCT04401345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64491748|NCT04401345|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64491749|NCT04401345|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64491750|NCT04401345|Cholinergic Agents|cholinergic agents|mesh-ancestor
64491751|NCT04401345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64491752|NCT04401345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491753|NCT04401345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491754|NCT01015534|Temozolomide|temozolomide|mesh-list
64491755|NCT01015534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64491756|NCT01015534|Alkylating Agents|alkylating agents|mesh-ancestor
64491757|NCT01015534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491758|NCT01015534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65352930|NCT00862095|Topiramate|topiramate|mesh-list
65352931|NCT00862095|Propranolol|propranolol|mesh-list
65352932|NCT00862095|Amitriptyline|amitriptyline|mesh-list
65352933|NCT00862095|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65352934|NCT00862095|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65352935|NCT00862095|Adrenergic Agents|adrenergic agents|mesh-ancestor
65352936|NCT00862095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65352937|NCT00862095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352938|NCT00862095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352939|NCT00862095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65352940|NCT00862095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65352942|NCT00862095|Anticonvulsants|anticonvulsants|mesh-ancestor
65352943|NCT00862095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65352944|NCT00862095|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65352945|NCT00862095|Antidepressive Agents|antidepressive agents|mesh-ancestor
65352946|NCT00862095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65352947|NCT00862095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65352948|NCT00862095|Analgesics|analgesics|mesh-ancestor
65352949|NCT00862095|Sensory System Agents|sensory system agents|mesh-ancestor
65352950|NCT00862095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65352951|NCT00862095|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65352952|NCT00862095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65352953|NCT00862095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65352954|NCT04054128|Heparin|heparin|mesh-list
65352955|NCT04054128|Calcium heparin|calcium heparin|mesh-list
65352956|NCT04054128|Anticoagulants|anticoagulants|mesh-ancestor
65352957|NCT04054128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65352958|NCT04054128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64745091|NCT01708902|Incretins|incretins|mesh-ancestor
64491759|NCT00968890|Vaccines|vaccines|mesh-list
64491760|NCT00968890|Immunologic Factors|immunologic factors|mesh-ancestor
64491761|NCT00968890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491762|NCT00970216|Telbivudine|telbivudine|mesh-list
64491763|NCT00970216|Antiviral Agents|antiviral agents|mesh-ancestor
64491764|NCT00970216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64491765|NCT00970216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64491766|NCT00970216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491767|NCT00970216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491768|NCT00971620|Botulinum Toxins|botulinum toxins|mesh-list
64491769|NCT00971620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64491770|NCT00971620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64491771|NCT00971620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64491772|NCT00971620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64491773|NCT00971620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491774|NCT00971620|Cholinergic Agents|cholinergic agents|mesh-ancestor
64491775|NCT00971620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65352959|NCT04054128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352960|NCT00865215|Propranolol|propranolol|mesh-list
65352961|NCT00865215|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65352962|NCT00865215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65352963|NCT00865215|Adrenergic Agents|adrenergic agents|mesh-ancestor
65352964|NCT00865215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65352965|NCT00865215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352966|NCT00865215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352967|NCT00865215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65352968|NCT00865215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65352969|NCT00865215|Vasodilator Agents|vasodilator agents|mesh-ancestor
65352970|NCT00865371|Bupropion|bupropion|mesh-list
65352971|NCT00865371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65352972|NCT00865371|Antidepressive Agents|antidepressive agents|mesh-ancestor
65352973|NCT00865371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65352974|NCT00865371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65352975|NCT00865371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65352976|NCT00865371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65352977|NCT00865371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65352978|NCT00865371|Dopamine Agents|dopamine agents|mesh-ancestor
65352979|NCT00865371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65352980|NCT00865371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352981|NCT00865371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65352982|NCT00865371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65352983|NCT00865371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65352984|NCT00865449|Spironolactone|spironolactone|mesh-list
65352985|NCT00865449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65352986|NCT00865449|Hormone Antagonists|hormone antagonists|mesh-ancestor
65352987|NCT00865449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65352988|NCT00865449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352989|NCT00865449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65352990|NCT00865449|Diuretics|diuretics|mesh-ancestor
64745121|NCT01755234|Propofol|propofol|mesh-list
64491776|NCT00971620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491777|NCT00971620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64491778|NCT00971620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64491789|NCT01884922|Mitosis Modulators|mitosis modulators|mesh-ancestor
65352991|NCT00865449|Natriuretic Agents|natriuretic agents|mesh-ancestor
65352992|NCT00858195|Indomethacin|indomethacin|mesh-list
65352993|NCT00858195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65352994|NCT00858195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65352995|NCT00858195|Analgesics|analgesics|mesh-ancestor
65352996|NCT00858195|Sensory System Agents|sensory system agents|mesh-ancestor
65352997|NCT00858195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65352998|NCT00858195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65352999|NCT00858195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65353000|NCT00858195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65353001|NCT00858195|Gout Suppressants|gout suppressants|mesh-ancestor
65353002|NCT00858195|Tocolytic Agents|tocolytic agents|mesh-ancestor
65353003|NCT00858195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65353004|NCT00858195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65353005|NCT00858195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353006|NCT00858195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353007|NCT00618813|Cyclophosphamide|cyclophosphamide|mesh-list
65353008|NCT00618813|Ifosfamide|ifosfamide|mesh-list
65353009|NCT00618813|Doxorubicin|doxorubicin|mesh-list
64491790|NCT01884922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491791|NCT05687409|Entecavir|entecavir|mesh-list
64491792|NCT05687409|Lactulose|lactulose|mesh-list
64491793|NCT05687409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64556100|NCT02244255|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64556101|NCT02244255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64556102|NCT02244255|Adrenergic Agents|adrenergic agents|mesh-ancestor
64491844|NCT00812032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491845|NCT00812032|Antipyretics|antipyretics|mesh-ancestor
64491846|NCT05687253|Bromides|bromides|mesh-list
64491847|NCT05687253|Rocuronium|rocuronium|mesh-list
64491848|NCT05687253|Anticonvulsants|anticonvulsants|mesh-ancestor
64491849|NCT05687253|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64491850|NCT05687253|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64491851|NCT05687253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64491852|NCT05687253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64491853|NCT05687253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491854|NCT02159872|Homoharringtonine|homoharringtonine|mesh-list
64491855|NCT02159872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64491856|NCT02159872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491857|NCT02159872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64491858|NCT02159872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491859|NCT02159872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491860|NCT00417664|Midazolam|midazolam|mesh-list
64491861|NCT00417664|Dexmedetomidine|dexmedetomidine|mesh-list
64491862|NCT00417664|Propofol|propofol|mesh-list
64491863|NCT00417664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64491864|NCT00417664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64491865|NCT00417664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491866|NCT00417664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64491867|NCT00417664|Anesthetics, General|anesthetics, general|mesh-ancestor
64491869|NCT00417664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64491870|NCT00417664|Analgesics|analgesics|mesh-ancestor
64491871|NCT00417664|Sensory System Agents|sensory system agents|mesh-ancestor
64491872|NCT00417664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64491873|NCT00417664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64491874|NCT00417664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64491875|NCT00417664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65353010|NCT00618813|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65353011|NCT00618813|Etoposide|etoposide|mesh-list
65353012|NCT00618813|Vincristine|vincristine|mesh-list
65353013|NCT00618813|Etoposide phosphate|etoposide phosphate|mesh-list
65353014|NCT00618813|Topotecan|topotecan|mesh-list
65353015|NCT00618813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65353016|NCT00618813|Immunologic Factors|immunologic factors|mesh-ancestor
65353017|NCT00618813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353018|NCT00618813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65353019|NCT00618813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65353020|NCT00618813|Alkylating Agents|alkylating agents|mesh-ancestor
65353021|NCT00618813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353022|NCT00618813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353023|NCT00618813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65353024|NCT00618813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64745173|NCT01730118|Mitogens|mitogens|mesh-list
64491876|NCT00417664|Adrenergic Agents|adrenergic agents|mesh-ancestor
64491877|NCT00417664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64491878|NCT00417664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491879|NCT00417664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64491880|NCT00417664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64491881|NCT00417664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64491882|NCT00417664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64491907|NCT01021618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64491908|NCT01021618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491909|NCT01021618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491910|NCT01021618|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64491911|NCT01021618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491912|NCT01021618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64491913|NCT01021618|Vasodilator Agents|vasodilator agents|mesh-ancestor
64491914|NCT03082053|Capecitabine|capecitabine|mesh-list
64491915|NCT03082053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64491916|NCT03082053|Antimetabolites|antimetabolites|mesh-ancestor
64491917|NCT03082053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491918|NCT03082053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491920|NCT03358563|Bicalutamide|bicalutamide|mesh-list
64491921|NCT03358563|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64491922|NCT03358563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491923|NCT03358563|Tubulin Modulators|tubulin modulators|mesh-ancestor
64491924|NCT03358563|Antimitotic Agents|antimitotic agents|mesh-ancestor
64556116|NCT00923949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64556117|NCT00923949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556118|NCT04376541|Fentanyl|fentanyl|mesh-list
64556119|NCT04376541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64491925|NCT03358563|Mitosis Modulators|mitosis modulators|mesh-ancestor
64491926|NCT03358563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491927|NCT03358563|Androgen Antagonists|androgen antagonists|mesh-ancestor
64491928|NCT03358563|Hormone Antagonists|hormone antagonists|mesh-ancestor
64491929|NCT03358563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64491930|NCT03358563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491931|NCT03358563|Hematinics|hematinics|mesh-ancestor
64491941|NCT01018420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491942|NCT01018420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491943|NCT01018420|Gout Suppressants|gout suppressants|mesh-ancestor
64491944|NCT01018420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64491950|NCT00974350|Anesthetics|anesthetics|mesh-ancestor
64491951|NCT00974350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64491952|NCT00974350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353025|NCT00618813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65353026|NCT00618813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65353027|NCT00618813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353028|NCT00618813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65353029|NCT00618813|Tubulin Modulators|tubulin modulators|mesh-ancestor
65353030|NCT00618813|Antimitotic Agents|antimitotic agents|mesh-ancestor
65353031|NCT00618813|Mitosis Modulators|mitosis modulators|mesh-ancestor
65353032|NCT00618813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65353033|NCT00554788|Cyclophosphamide|cyclophosphamide|mesh-list
65353034|NCT00554788|Thiotepa|thiotepa|mesh-list
65353035|NCT00554788|Cisplatin|cisplatin|mesh-list
65353036|NCT00554788|Carboplatin|carboplatin|mesh-list
65353037|NCT00554788|Etoposide|etoposide|mesh-list
65353038|NCT00554788|Vincristine|vincristine|mesh-list
65353039|NCT00554788|Etoposide phosphate|etoposide phosphate|mesh-list
65353040|NCT00554788|Podophyllotoxin|podophyllotoxin|mesh-list
65353041|NCT00554788|Lenograstim|lenograstim|mesh-list
65353042|NCT00554788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65353043|NCT00554788|Immunologic Factors|immunologic factors|mesh-ancestor
65353044|NCT00554788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353045|NCT00554788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65353046|NCT00554788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65353047|NCT00554788|Alkylating Agents|alkylating agents|mesh-ancestor
65353048|NCT00554788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353049|NCT00554788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353050|NCT00554788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65353051|NCT00554788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65353052|NCT00554788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65353053|NCT00554788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65353054|NCT00554788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353055|NCT00554788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65353056|NCT00554788|Tubulin Modulators|tubulin modulators|mesh-ancestor
65353057|NCT00554788|Antimitotic Agents|antimitotic agents|mesh-ancestor
65353058|NCT00554788|Mitosis Modulators|mitosis modulators|mesh-ancestor
65353059|NCT00554788|Keratolytic Agents|keratolytic agents|mesh-ancestor
64745187|NCT01706328|Xhance|xhance|mesh-list
64491953|NCT00974350|Sensory System Agents|sensory system agents|mesh-ancestor
64491954|NCT00974350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64491955|NCT05395702|Interferons|interferons|mesh-list
64491956|NCT05395702|Interferon-gamma|interferon-gamma|mesh-list
64491957|NCT05395702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491958|NCT05395702|Antiviral Agents|antiviral agents|mesh-ancestor
64491959|NCT05395702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65353060|NCT00554788|Dermatologic Agents|dermatologic agents|mesh-ancestor
65353061|NCT00858429|Capecitabine|capecitabine|mesh-list
65353062|NCT00858429|Doxifluridine|doxifluridine|mesh-list
65353063|NCT00858429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65353064|NCT00858429|Antimetabolites|antimetabolites|mesh-ancestor
65353065|NCT00858429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353066|NCT00858429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353067|NCT00858429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65353068|NCT00858429|Immunologic Factors|immunologic factors|mesh-ancestor
65353069|NCT00858429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353070|NCT00858429|Appetite Stimulants|appetite stimulants|mesh-ancestor
65353071|NCT00858429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65353072|NCT02566928|Chlorhexidine|chlorhexidine|mesh-list
65353073|NCT02566928|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65353074|NCT02566928|Bacitracin|bacitracin|mesh-list
65353075|NCT02566928|Mupirocin|mupirocin|mesh-list
65353076|NCT02566928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65353077|NCT02566928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65353078|NCT02566928|Disinfectants|disinfectants|mesh-ancestor
65353079|NCT02566928|Dermatologic Agents|dermatologic agents|mesh-ancestor
64745224|NCT01729728|Tapentadol|tapentadol|mesh-list
64491960|NCT01023178|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64491961|NCT01023178|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64491962|NCT01023178|Estradiol|estradiol|mesh-list
64491963|NCT01023178|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64491964|NCT01023178|Estrogens|estrogens|mesh-list
64491965|NCT01023178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64491966|NCT01023178|Progesterone|progesterone|mesh-list
64491967|NCT01023178|Hormones|hormones|mesh-ancestor
64491968|NCT01023178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64491969|NCT01023178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491970|NCT01023178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64491971|NCT01023178|Contraceptive Agents|contraceptive agents|mesh-ancestor
64491972|NCT01023178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64491973|NCT01023178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64491974|NCT01023178|Progestins|progestins|mesh-ancestor
64491975|NCT03373851|Sufentanil|sufentanil|mesh-list
64491977|NCT03373851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64491978|NCT03373851|Narcotics|narcotics|mesh-ancestor
64491979|NCT03373851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64491980|NCT03373851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491981|NCT03373851|Analgesics|analgesics|mesh-ancestor
64491982|NCT03373851|Sensory System Agents|sensory system agents|mesh-ancestor
64491983|NCT03373851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64491984|NCT03373851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64491985|NCT03373851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64491986|NCT03373851|Anesthetics, General|anesthetics, general|mesh-ancestor
64491987|NCT03373851|Anesthetics|anesthetics|mesh-ancestor
64491988|NCT05623995|Evolocumab|evolocumab|mesh-list
64491989|NCT05623995|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
64491990|NCT05623995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64492009|NCT01023724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492011|NCT00974818|Mitomycin|mitomycin|mesh-list
64492012|NCT00974818|BCG Vaccine|bcg vaccine|mesh-list
64492013|NCT00974818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64492014|NCT00974818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492015|NCT00974818|Alkylating Agents|alkylating agents|mesh-ancestor
65353080|NCT02566928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65353081|NCT02566928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65353082|NCT02566928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353083|NCT02566928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353084|NCT00865605|Clobetasol|clobetasol|mesh-list
65353085|NCT00865605|Halobetasol|halobetasol|mesh-list
65353086|NCT00865605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65353087|NCT00865605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65353088|NCT00865605|Glucocorticoids|glucocorticoids|mesh-ancestor
65353089|NCT00865605|Hormones|hormones|mesh-ancestor
65353090|NCT00865605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65102910|NCT02910570|Incretins|incretins|mesh-ancestor
65353091|NCT00865605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353092|NCT00956644|Amlodipine|amlodipine|mesh-list
64492016|NCT00974818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492017|NCT00974818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64492018|NCT00974818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556120|NCT04376541|Narcotics|narcotics|mesh-ancestor
64556121|NCT04376541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64556122|NCT04376541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556123|NCT04376541|Analgesics|analgesics|mesh-ancestor
64556124|NCT04376541|Sensory System Agents|sensory system agents|mesh-ancestor
64492019|NCT00974818|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64492020|NCT00974818|Immunologic Factors|immunologic factors|mesh-ancestor
64492021|NCT00974818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492022|NCT03371667|Methotrexate|methotrexate|mesh-list
64492023|NCT03371667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64492024|NCT03371667|Abortifacient Agents|abortifacient agents|mesh-ancestor
64492025|NCT03371667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64492026|NCT03371667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492027|NCT03371667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64492028|NCT03371667|Antimetabolites|antimetabolites|mesh-ancestor
64492029|NCT03371667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492030|NCT03371667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492041|NCT01024738|Fluorides|fluorides|mesh-list
64492042|NCT01024738|Cariostatic Agents|cariostatic agents|mesh-ancestor
64492043|NCT01024738|Protective Agents|protective agents|mesh-ancestor
64492044|NCT01024738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492045|NCT01024738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64492116|NCT00979732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64492117|NCT00979732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492118|NCT00979732|Antioxidants|antioxidants|mesh-ancestor
64492119|NCT00979732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492120|NCT00979732|Protective Agents|protective agents|mesh-ancestor
64492139|NCT05457933|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64492140|NCT05457933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492141|NCT03322995|Fluorouracil|fluorouracil|mesh-list
64492142|NCT03322995|Antimetabolites|antimetabolites|mesh-ancestor
64492143|NCT03322995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492144|NCT03322995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64492145|NCT03322995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492146|NCT03322995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64492147|NCT03322995|Immunologic Factors|immunologic factors|mesh-ancestor
64492148|NCT03322995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492149|NCT03321981|Trastuzumab|trastuzumab|mesh-list
64492150|NCT03321981|Letrozole|letrozole|mesh-list
64492151|NCT03321981|Vinorelbine|vinorelbine|mesh-list
64492152|NCT03321981|Fulvestrant|fulvestrant|mesh-list
64492153|NCT03321981|Exemestane|exemestane|mesh-list
64492154|NCT03321981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65353093|NCT00956644|Irbesartan|irbesartan|mesh-list
65353094|NCT00956644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65353095|NCT00956644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65353096|NCT00956644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65353097|NCT00956644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353098|NCT00956644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65353099|NCT00956644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353100|NCT00956644|Vasodilator Agents|vasodilator agents|mesh-ancestor
65353101|NCT00956644|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65353102|NCT00956644|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65353103|NCT00858663|Everolimus|everolimus|mesh-list
65353104|NCT00858663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353105|NCT00858663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65353106|NCT00858663|Immunologic Factors|immunologic factors|mesh-ancestor
65353107|NCT00858663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353108|NCT02544789|Clofarabine|clofarabine|mesh-list
65353109|NCT02544789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65353110|NCT02544789|Antimetabolites|antimetabolites|mesh-ancestor
65353111|NCT02544789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353112|NCT02544789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353113|NCT02565836|Thrombin|thrombin|mesh-list
65353114|NCT02565836|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
64745249|NCT01728246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492155|NCT03321981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492156|NCT03321981|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64492157|NCT03321981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64492158|NCT03321981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492159|NCT03321981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492160|NCT03321981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64492161|NCT03321981|Hormone Antagonists|hormone antagonists|mesh-ancestor
64492162|NCT03321981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64492163|NCT03321981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492164|NCT03321981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64492165|NCT03321981|Tubulin Modulators|tubulin modulators|mesh-ancestor
64492166|NCT03321981|Antimitotic Agents|antimitotic agents|mesh-ancestor
64492167|NCT03321981|Mitosis Modulators|mitosis modulators|mesh-ancestor
64492168|NCT03321981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64556125|NCT04376541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556126|NCT04376541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64556127|NCT04376541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64556128|NCT04376541|Anesthetics, General|anesthetics, general|mesh-ancestor
64556129|NCT04376541|Anesthetics|anesthetics|mesh-ancestor
64556130|NCT04376307|Anesthetics|anesthetics|mesh-list
64556131|NCT04376307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64556132|NCT04376307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492169|NCT03321981|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64492170|NCT01027000|Sirolimus|sirolimus|mesh-list
64492171|NCT01027000|Cyclophosphamide|cyclophosphamide|mesh-list
65353115|NCT02565836|Hemostatics|hemostatics|mesh-ancestor
65353116|NCT02565836|Coagulants|coagulants|mesh-ancestor
65353117|NCT00865761|Alprazolam|alprazolam|mesh-list
65353118|NCT00865761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65353119|NCT00865761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65353120|NCT00865761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353121|NCT00865761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65353122|NCT00865761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65353123|NCT00865761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65353124|NCT00865761|GABA Modulators|gaba modulators|mesh-ancestor
65353125|NCT00865761|GABA Agents|gaba agents|mesh-ancestor
65353126|NCT00865761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65353127|NCT00865761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353128|NCT00865839|Metformin|metformin|mesh-list
65353129|NCT00865839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65353130|NCT00865839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353131|NCT00865917|Metoprolol|metoprolol|mesh-list
65353132|NCT00865917|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65353133|NCT00865917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65353134|NCT00865917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65353135|NCT00865917|Sympatholytics|sympatholytics|mesh-ancestor
65353136|NCT00865917|Autonomic Agents|autonomic agents|mesh-ancestor
65353137|NCT00865917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65353138|NCT00865917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353139|NCT00865917|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65353140|NCT00865917|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65353141|NCT00865917|Adrenergic Agents|adrenergic agents|mesh-ancestor
65353142|NCT00865917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65353143|NCT00865917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353144|NCT00696410|Zinc|zinc|mesh-list
65353145|NCT00696410|Trace Elements|trace elements|mesh-ancestor
64492172|NCT01027000|Busulfan|busulfan|mesh-list
64492173|NCT01027000|Rituximab|rituximab|mesh-list
64492174|NCT01027000|Methotrexate|methotrexate|mesh-list
64492175|NCT01027000|Fludarabine|fludarabine|mesh-list
64492207|NCT01027468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64492208|NCT01027468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492209|NCT01027468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64492210|NCT01027468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64492211|NCT01027468|Growth Substances|growth substances|mesh-ancestor
64492212|NCT01027468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492213|NCT01027468|Growth Inhibitors|growth inhibitors|mesh-ancestor
64492214|NCT05237349|Oxaliplatin|oxaliplatin|mesh-list
64492215|NCT05237349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492216|NCT04278807|Anesthetics|anesthetics|mesh-list
64492217|NCT04278807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64492218|NCT04278807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353146|NCT00696410|Micronutrients|micronutrients|mesh-ancestor
65353147|NCT00696410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353148|NCT00858897|Insulin|insulin|mesh-list
65353149|NCT00858897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65353150|NCT00858897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65353151|NCT00858897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353152|NCT00683904|Carboplatin|carboplatin|mesh-list
65353153|NCT00683904|Epothilones|epothilones|mesh-list
65353154|NCT00683904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353155|NCT00683904|Tubulin Modulators|tubulin modulators|mesh-ancestor
65353156|NCT00683904|Antimitotic Agents|antimitotic agents|mesh-ancestor
65353157|NCT00683904|Mitosis Modulators|mitosis modulators|mesh-ancestor
65353158|NCT00683904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353159|NCT00862329|Caseins|caseins|mesh-list
65353160|NCT00862329|Chelating Agents|chelating agents|mesh-ancestor
65353161|NCT00862329|Sequestering Agents|sequestering agents|mesh-ancestor
65353162|NCT00862329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353163|NCT00866073|Decitabine|decitabine|mesh-list
64492219|NCT03344211|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64492220|NCT03344211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492221|NCT03274401|Anticoagulants|anticoagulants|mesh-list
64492223|NCT05086107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64492224|NCT05086107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64492225|NCT05086107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64492226|NCT05086107|Antitubercular Agents|antitubercular agents|mesh-ancestor
64492227|NCT01029730|Rituximab|rituximab|mesh-list
64492228|NCT01029730|Bortezomib|bortezomib|mesh-list
64492248|NCT05066997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492249|NCT05066997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64492250|NCT05066997|Glucocorticoids|glucocorticoids|mesh-ancestor
64492251|NCT05066997|Hormones|hormones|mesh-ancestor
64492252|NCT05066997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64492253|NCT05066997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64492254|NCT05066997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492255|NCT05066997|Protease Inhibitors|protease inhibitors|mesh-ancestor
64492256|NCT05066997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492257|NCT05066997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492258|NCT05025033|Paclitaxel|paclitaxel|mesh-list
64492259|NCT05025033|Irinotecan|irinotecan|mesh-list
64492260|NCT05025033|Apatinib|apatinib|mesh-list
64492261|NCT05025033|Antibodies|antibodies|mesh-list
64492262|NCT05025033|Immunoglobulins|immunoglobulins|mesh-list
64492263|NCT05025033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64492264|NCT05025033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492265|NCT05025033|Tubulin Modulators|tubulin modulators|mesh-ancestor
64492266|NCT05025033|Antimitotic Agents|antimitotic agents|mesh-ancestor
64492267|NCT05025033|Mitosis Modulators|mitosis modulators|mesh-ancestor
64492268|NCT05025033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492269|NCT05025033|Immunologic Factors|immunologic factors|mesh-ancestor
64492270|NCT05025033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556133|NCT02244489|Capecitabine|capecitabine|mesh-list
64556134|NCT02244489|Oxaliplatin|oxaliplatin|mesh-list
64556135|NCT02244489|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
64556136|NCT02244489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64556137|NCT02244489|Antimetabolites|antimetabolites|mesh-ancestor
64556138|NCT02244489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492271|NCT05025033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64492272|NCT05025033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65353164|NCT00866073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65353165|NCT00866073|Antimetabolites|antimetabolites|mesh-ancestor
65353166|NCT00866073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353168|NCT00866073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353169|NCT00752466|Topiramate|topiramate|mesh-list
65353170|NCT00752466|Flunarizine|flunarizine|mesh-list
65353171|NCT00752466|Anticonvulsants|anticonvulsants|mesh-ancestor
65353172|NCT00752466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65353173|NCT00752466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353174|NCT00752466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65353175|NCT00752466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65353176|NCT00752466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353177|NCT00752466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65353178|NCT00752466|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65353179|NCT00752466|Histamine Antagonists|histamine antagonists|mesh-ancestor
65353180|NCT00752466|Histamine Agents|histamine agents|mesh-ancestor
65353181|NCT00752466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65353182|NCT00752466|Vasodilator Agents|vasodilator agents|mesh-ancestor
65353183|NCT00957190|Timolol|timolol|mesh-list
65353184|NCT00957190|Dorzolamide|dorzolamide|mesh-list
65353185|NCT00957190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65353186|NCT00957190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65353187|NCT00957190|Adrenergic Agents|adrenergic agents|mesh-ancestor
65353188|NCT00957190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65353189|NCT00957190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353190|NCT00957190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353191|NCT00957190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65353192|NCT00957190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65353193|NCT00957190|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65353194|NCT00957190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353195|NCT00866229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65353196|NCT00866229|Simvastatin|simvastatin|mesh-list
65353197|NCT00866229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65353198|NCT00866229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64492273|NCT05025033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492274|NCT05025033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64492275|NCT00980746|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64492276|NCT00980746|Anticonvulsants|anticonvulsants|mesh-ancestor
64492277|NCT00980746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64492281|NCT00981214|Pancrelipase|pancrelipase|mesh-list
64492282|NCT00981214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65353199|NCT00866229|Antimetabolites|antimetabolites|mesh-ancestor
65353200|NCT00866229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353201|NCT00866229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65353202|NCT00866229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65353203|NCT00866229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353204|NCT00953914|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
65353205|NCT00953914|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65353206|NCT00953914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353207|NCT00953914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353208|NCT00953914|Cholinergic Agents|cholinergic agents|mesh-ancestor
65353209|NCT00953914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65353210|NCT00953914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353211|NCT00948220|Ribavirin|ribavirin|mesh-list
65353212|NCT00948220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65353213|NCT00948220|Antimetabolites|antimetabolites|mesh-ancestor
65353214|NCT00948220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353215|NCT00948220|Antiviral Agents|antiviral agents|mesh-ancestor
65353216|NCT00948220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65353217|NCT00756990|Naltrexone|naltrexone|mesh-list
65353218|NCT00756990|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65353219|NCT00756990|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65353223|NCT00957346|Misoprostol|misoprostol|mesh-list
65353250|NCT00751062|Timolol|timolol|mesh-list
65353251|NCT00751062|Latanoprost|latanoprost|mesh-list
65353252|NCT00751062|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65353253|NCT00751062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65353254|NCT00751062|Adrenergic Agents|adrenergic agents|mesh-ancestor
65353255|NCT00751062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65353256|NCT00751062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353257|NCT00751062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353258|NCT00751062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65353259|NCT00751062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65353260|NCT00751062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65353261|NCT00751062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65353262|NCT04030052|Factor VIII|factor viii|mesh-list
65353263|NCT04030052|Coagulants|coagulants|mesh-ancestor
65353264|NCT00751374|Gentamicins|gentamicins|mesh-list
65353265|NCT00751374|Mupirocin|mupirocin|mesh-list
65353266|NCT00751374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65353267|NCT00751374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65353268|NCT00751374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65353269|NCT00751374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353270|NCT00751374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353271|NCT00954304|Loperamide|loperamide|mesh-list
65353272|NCT00954304|Antidiarrheals|antidiarrheals|mesh-list
65353273|NCT00954304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65353274|NCT00363415|Carboplatin|carboplatin|mesh-list
65353275|NCT00363415|Etoposide|etoposide|mesh-list
65353276|NCT00363415|Pemetrexed|pemetrexed|mesh-list
65353277|NCT00363415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353278|NCT00363415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65353279|NCT00363415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65353280|NCT00363415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65353281|NCT00363415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353282|NCT00363415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353283|NCT00363415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65353284|NCT00363415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65353285|NCT00757380|Diminazene aceturate|diminazene aceturate|mesh-list
65353290|NCT00752934|Baclofen|baclofen|mesh-list
65353291|NCT00752934|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65353292|NCT00752934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353293|NCT00752934|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65353294|NCT00752934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65353295|NCT00752934|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65353296|NCT00752934|GABA Agonists|gaba agonists|mesh-ancestor
65353297|NCT00752934|GABA Agents|gaba agents|mesh-ancestor
65353298|NCT00752934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65353299|NCT00752934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353300|NCT00696020|Bromides|bromides|mesh-list
65353301|NCT00696020|Tiotropium Bromide|tiotropium bromide|mesh-list
65353302|NCT00696020|Olodaterol|olodaterol|mesh-list
65353303|NCT00696020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65353304|NCT00696020|Autonomic Agents|autonomic agents|mesh-ancestor
65353305|NCT00696020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65353306|NCT00696020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353307|NCT00696020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65353308|NCT00696020|Respiratory System Agents|respiratory system agents|mesh-ancestor
65353309|NCT00696020|Parasympatholytics|parasympatholytics|mesh-ancestor
65353310|NCT00696020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65353311|NCT00696020|Cholinergic Agents|cholinergic agents|mesh-ancestor
65353312|NCT00696020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65353313|NCT00696020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353314|NCT00696020|Anticonvulsants|anticonvulsants|mesh-ancestor
65103147|NCT02909712|Renal Agents|renal agents|mesh-ancestor
65353315|NCT00576576|Atorvastatin|atorvastatin|mesh-list
65353316|NCT00576576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65353317|NCT00576576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65353318|NCT00576576|Antimetabolites|antimetabolites|mesh-ancestor
65353319|NCT00576576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353320|NCT00576576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65353321|NCT00576576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65353322|NCT00576576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353323|NCT00751764|Moxidectin|moxidectin|mesh-list
64492283|NCT05415657|Denosumab|denosumab|mesh-list
64492315|NCT01032694|Azithromycin|azithromycin|mesh-list
64492316|NCT01032694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64492317|NCT01032694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64492318|NCT04957095|Levodopa|levodopa|mesh-list
64492319|NCT04957095|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64492320|NCT04957095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65353324|NCT00751764|Anthelmintics|anthelmintics|mesh-ancestor
65353325|NCT00751764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65353326|NCT00751764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65353327|NCT00751764|Antinematodal Agents|antinematodal agents|mesh-ancestor
65353328|NCT00757458|Propofol|propofol|mesh-list
65353329|NCT00757458|Edetic Acid|edetic acid|mesh-list
65353330|NCT00757458|Pentetic Acid|pentetic acid|mesh-list
65353331|NCT00757458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65353332|NCT00757458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65353333|NCT00757458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353334|NCT00757458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65353335|NCT00757458|Anesthetics, General|anesthetics, general|mesh-ancestor
65353336|NCT00757458|Anesthetics|anesthetics|mesh-ancestor
65353337|NCT00757458|Anticoagulants|anticoagulants|mesh-ancestor
65353338|NCT00757458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65353339|NCT00757458|Chelating Agents|chelating agents|mesh-ancestor
65353340|NCT00757458|Sequestering Agents|sequestering agents|mesh-ancestor
65353341|NCT00757458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353342|NCT00757458|Antidotes|antidotes|mesh-ancestor
65353343|NCT00757458|Protective Agents|protective agents|mesh-ancestor
65353344|NCT00757458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65353345|NCT00923247|Bortezomib|bortezomib|mesh-list
65353346|NCT00923247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353347|NCT02866136|Carboplatin|carboplatin|mesh-list
65353348|NCT02866136|Etoposide|etoposide|mesh-list
65353349|NCT02866136|Etoposide phosphate|etoposide phosphate|mesh-list
65353350|NCT02866136|Melphalan|melphalan|mesh-list
65353351|NCT02866136|Vincristine|vincristine|mesh-list
65353352|NCT02866136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353353|NCT02866136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65353354|NCT02866136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64745480|NCT01721070|Ketoconazole|ketoconazole|mesh-list
64492322|NCT04957095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64492323|NCT04957095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492324|NCT04957095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492325|NCT01032850|Capecitabine|capecitabine|mesh-list
64492326|NCT01032850|Sorafenib|sorafenib|mesh-list
64492341|NCT00983242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492342|NCT00983242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64492343|NCT00983242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64492344|NCT00983242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64492345|NCT00983242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64492346|NCT00983242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492347|NCT00983242|Vasodilator Agents|vasodilator agents|mesh-ancestor
64492348|NCT00984334|Naloxone|naloxone|mesh-list
64492349|NCT00984334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64492350|NCT00984334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492351|NCT00984334|Sensory System Agents|sensory system agents|mesh-ancestor
65353355|NCT02866136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65353356|NCT02866136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353357|NCT02866136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353358|NCT02866136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65353359|NCT02866136|Alkylating Agents|alkylating agents|mesh-ancestor
65353360|NCT02866136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65353361|NCT02866136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65353362|NCT02866136|Immunologic Factors|immunologic factors|mesh-ancestor
65353363|NCT02866136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353364|NCT02866136|Tubulin Modulators|tubulin modulators|mesh-ancestor
65353365|NCT02866136|Antimitotic Agents|antimitotic agents|mesh-ancestor
65353366|NCT02866136|Mitosis Modulators|mitosis modulators|mesh-ancestor
65353367|NCT00757692|Bicalutamide|bicalutamide|mesh-list
65353368|NCT00757692|Androgen Antagonists|androgen antagonists|mesh-ancestor
65353369|NCT00757692|Hormone Antagonists|hormone antagonists|mesh-ancestor
65353370|NCT00757692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65353371|NCT00757692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353372|NCT00757692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353373|NCT00753168|Timolol|timolol|mesh-list
65353374|NCT00753168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65353375|NCT00753168|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65353376|NCT00753168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353377|NCT00753168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65353378|NCT00753168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65353379|NCT00753168|Adrenergic Agents|adrenergic agents|mesh-ancestor
64492352|NCT00984334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64492354|NCT02168062|Goserelin|goserelin|mesh-list
64492355|NCT02168062|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64492356|NCT02168062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64492357|NCT02168062|Fertility Agents|fertility agents|mesh-ancestor
64492358|NCT02168062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64492359|NCT02168062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492360|NCT02168062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64492361|NCT02168062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492362|NCT02168062|Luteolytic Agents|luteolytic agents|mesh-ancestor
64492363|NCT02168062|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64492364|NCT02168062|Contraceptive Agents|contraceptive agents|mesh-ancestor
64492365|NCT02168062|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64492366|NCT01888367|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64492367|NCT01888367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64492368|NCT05343117|Palbociclib|palbociclib|mesh-list
64492369|NCT05343117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492370|NCT05343117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64492371|NCT05343117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492372|NCT05343117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492373|NCT01898195|Varenicline|varenicline|mesh-list
64492374|NCT01898195|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64492375|NCT01898195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64492376|NCT01898195|Cholinergic Agents|cholinergic agents|mesh-ancestor
65353380|NCT00753168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65353381|NCT00753168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353382|NCT00753168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65353383|NCT00753168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65353384|NCT02565602|Vitamin D|vitamin d|mesh-list
65353385|NCT02565602|Cholecalciferol|cholecalciferol|mesh-list
65353386|NCT02565602|Vitamins|vitamins|mesh-ancestor
65353387|NCT02565602|Micronutrients|micronutrients|mesh-ancestor
65353388|NCT02565602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353389|NCT02565602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65353390|NCT02565602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65353391|NCT00866463|Sildenafil Citrate|sildenafil citrate|mesh-list
65353392|NCT00866463|Vasodilator Agents|vasodilator agents|mesh-ancestor
65353393|NCT00866463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65353394|NCT00866463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65353395|NCT00866463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353396|NCT00866463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353397|NCT00866463|Urological Agents|urological agents|mesh-ancestor
65353399|NCT00695864|Antiemetics|antiemetics|mesh-ancestor
65353400|NCT00695864|Autonomic Agents|autonomic agents|mesh-ancestor
65353401|NCT00695864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65353402|NCT00695864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353403|NCT00695864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65353404|NCT00695864|Antipruritics|antipruritics|mesh-ancestor
65353405|NCT00695864|Dermatologic Agents|dermatologic agents|mesh-ancestor
65353406|NCT00695864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65353430|NCT05325008|gamma-Globulins|gamma-globulins|mesh-list
65353431|NCT05325008|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65353432|NCT05325008|Immunologic Factors|immunologic factors|mesh-ancestor
65353433|NCT05325008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353434|NCT00684762|Cilostazol|cilostazol|mesh-list
65353435|NCT00684762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65353436|NCT00684762|Autonomic Agents|autonomic agents|mesh-ancestor
65353437|NCT00684762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65353438|NCT00684762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353439|NCT00684762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65353440|NCT00684762|Respiratory System Agents|respiratory system agents|mesh-ancestor
65353441|NCT00684762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65353442|NCT00684762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65353443|NCT00684762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353444|NCT00684762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65353445|NCT00684762|Vasodilator Agents|vasodilator agents|mesh-ancestor
65353446|NCT00684762|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65353447|NCT00684762|Protective Agents|protective agents|mesh-ancestor
65353448|NCT00684762|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65353449|NCT00684762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65353454|NCT00695786|Rituximab|rituximab|mesh-list
65353484|NCT00683592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353485|NCT00683592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65353486|NCT00683592|Serotonin Agents|serotonin agents|mesh-ancestor
65353487|NCT00683592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353488|NCT00683592|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65353489|NCT00683592|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65353490|NCT00695396|Epoetin Alfa|epoetin alfa|mesh-list
65353491|NCT00695396|Hematinics|hematinics|mesh-ancestor
65353492|NCT00753402|Epinephrine|epinephrine|mesh-list
64492377|NCT01898195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64556139|NCT02244489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556140|NCT02244489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64556141|NCT02244489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556142|NCT02244567|Metformin|metformin|mesh-list
64556143|NCT02244567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556144|NCT02244567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64556145|NCT04376073|Niraparib|niraparib|mesh-list
64556146|NCT04376073|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64556147|NCT04376073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556148|NCT04376073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321204|NCT02206789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64492378|NCT01898195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492379|NCT01898195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492380|NCT01897727|Spironolactone|spironolactone|mesh-list
64492381|NCT01897727|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64492382|NCT01897727|Hormone Antagonists|hormone antagonists|mesh-ancestor
64492383|NCT01897727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64492384|NCT01897727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492385|NCT01897727|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64492395|NCT01897493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492396|NCT01897493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64492397|NCT01897493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64492399|NCT01897493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64492401|NCT01887353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64492402|NCT01887353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64492403|NCT01887353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492404|NCT00988156|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64492405|NCT00988156|Anticonvulsants|anticonvulsants|mesh-ancestor
64492406|NCT00988156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64492407|NCT00988156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64492408|NCT00988156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64492409|NCT00988156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492410|NCT02160730|Roscovitine|roscovitine|mesh-list
64492411|NCT02160730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492412|NCT02160730|Antiviral Agents|antiviral agents|mesh-ancestor
64492413|NCT02160730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64492414|NCT02160730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64492415|NCT02160730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492416|NCT02160730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492417|NCT03329313|Dialysis Solutions|dialysis solutions|mesh-list
64492418|NCT03329313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64492420|NCT01896869|Folfirinox|folfirinox|mesh-list
64492421|NCT01896869|Vaccines|vaccines|mesh-list
64492422|NCT01896869|Immunologic Factors|immunologic factors|mesh-ancestor
64492423|NCT01896869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492424|NCT01896869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64492425|NCT01896869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492426|NCT01896869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64492427|NCT01896869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492428|NCT03329001|Niraparib|niraparib|mesh-list
64492429|NCT03329001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64492430|NCT03329001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353493|NCT00753402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65353494|NCT00753402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65353495|NCT00753402|Adrenergic Agents|adrenergic agents|mesh-ancestor
65353496|NCT00753402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65353497|NCT00753402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353498|NCT00753402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353499|NCT00753402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65353500|NCT00753402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65353501|NCT00753402|Autonomic Agents|autonomic agents|mesh-ancestor
65353502|NCT00753402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65353503|NCT00753402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65353504|NCT00753402|Respiratory System Agents|respiratory system agents|mesh-ancestor
65353505|NCT00753402|Mydriatics|mydriatics|mesh-ancestor
65353506|NCT00753402|Sympathomimetics|sympathomimetics|mesh-ancestor
65353507|NCT00753402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65353508|NCT05434884|Salicylic Acid|salicylic acid|mesh-list
65353509|NCT05434884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65353510|NCT05434884|Antifungal Agents|antifungal agents|mesh-ancestor
65353511|NCT05434884|Keratolytic Agents|keratolytic agents|mesh-ancestor
65353512|NCT05434884|Dermatologic Agents|dermatologic agents|mesh-ancestor
65353513|NCT00758004|Atorvastatin|atorvastatin|mesh-list
65353514|NCT00758004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65353515|NCT00758004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64492431|NCT03329001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492432|NCT03329001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492433|NCT01896557|Omeprazole|omeprazole|mesh-list
64492434|NCT01896557|Ranitidine|ranitidine|mesh-list
64492435|NCT01896557|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
64492436|NCT01896557|Clopidogrel|clopidogrel|mesh-list
64556149|NCT04376073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556150|NCT04999176|Enoxaparin|enoxaparin|mesh-list
64556151|NCT04999176|Rivaroxaban|rivaroxaban|mesh-list
64556152|NCT04999176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64556153|NCT04999176|Antithrombins|antithrombins|mesh-ancestor
64556154|NCT04999176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64556155|NCT04999176|Protease Inhibitors|protease inhibitors|mesh-ancestor
64556156|NCT04999176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556157|NCT04999176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556158|NCT04999176|Anticoagulants|anticoagulants|mesh-ancestor
64556159|NCT04999176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64556160|NCT04999176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64556161|NCT04363203|Azithromycin|azithromycin|mesh-list
64556162|NCT04363203|Hydroxychloroquine|hydroxychloroquine|mesh-list
64556163|NCT04363203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64556164|NCT04363203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64556166|NCT04363203|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64556167|NCT04363203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64556168|NCT04363203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492437|NCT01896557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
64492438|NCT01896557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64492439|NCT01896557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64492440|NCT01896557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64492441|NCT01896557|Purinergic Agents|purinergic agents|mesh-ancestor
65353516|NCT00758004|Antimetabolites|antimetabolites|mesh-ancestor
65353517|NCT00758004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353518|NCT00758004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65353519|NCT00758004|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65353520|NCT00758004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353521|NCT05388006|Durvalumab|durvalumab|mesh-list
65353522|NCT05388006|Venetoclax|venetoclax|mesh-list
65353523|NCT05388006|Acalabrutinib|acalabrutinib|mesh-list
65353524|NCT05388006|Immunoglobulins|immunoglobulins|mesh-list
65353525|NCT05388006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65353526|NCT05388006|Immunoglobulin G|immunoglobulin g|mesh-list
65353527|NCT05388006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65353528|NCT05388006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353529|NCT05388006|Immunologic Factors|immunologic factors|mesh-ancestor
65353530|NCT05388006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353531|NCT02656706|Nivolumab|nivolumab|mesh-list
65353532|NCT02656706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65353533|NCT02656706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353534|NCT02656706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65353535|NCT02656706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353536|NCT04049916|Artesunate|artesunate|mesh-list
64492442|NCT01896557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64492443|NCT01896557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492444|NCT01896557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492445|NCT01896557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64492446|NCT01896557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64492447|NCT01896557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64492463|NCT03262779|Nivolumab|nivolumab|mesh-list
64492464|NCT03262779|Ipilimumab|ipilimumab|mesh-list
64492465|NCT03262779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64492469|NCT03245541|Durvalumab|durvalumab|mesh-list
64492470|NCT03245541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64492471|NCT03245541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492472|NCT05022394|Nivolumab|nivolumab|mesh-list
64492473|NCT05022394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64492474|NCT05022394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492475|NCT05022394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64492476|NCT05022394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492477|NCT01895777|Dabigatran|dabigatran|mesh-list
64492478|NCT01895777|Antithrombins|antithrombins|mesh-ancestor
64492479|NCT01895777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64492480|NCT01895777|Protease Inhibitors|protease inhibitors|mesh-ancestor
64492481|NCT01895777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492482|NCT01895777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492483|NCT01895777|Anticoagulants|anticoagulants|mesh-ancestor
64492484|NCT00992602|Cytarabine|cytarabine|mesh-list
64492485|NCT00992602|Methotrexate|methotrexate|mesh-list
64492486|NCT00992602|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64492487|NCT00992602|Abortifacient Agents|abortifacient agents|mesh-ancestor
64512345|NCT04504825|Bortezomib|bortezomib|mesh-list
64556169|NCT04363203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556170|NCT04363203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64556171|NCT04363359|Vaccines|vaccines|mesh-list
64556172|NCT04363359|Immunologic Factors|immunologic factors|mesh-ancestor
64556173|NCT04363359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353537|NCT04049916|Piperaquine|piperaquine|mesh-list
65353538|NCT04049916|Primaquine|primaquine|mesh-list
65353539|NCT04049916|Artenimol|artenimol|mesh-list
65353540|NCT04049916|Pyronaridine|pyronaridine|mesh-list
65353541|NCT04049916|Antimalarials|antimalarials|mesh-ancestor
65353542|NCT04049916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65353543|NCT04049916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65353544|NCT04049916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65353545|NCT04049916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353546|NCT04049916|Antiviral Agents|antiviral agents|mesh-ancestor
65353547|NCT04049916|Schistosomicides|schistosomicides|mesh-ancestor
65353548|NCT04049916|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65353549|NCT04049916|Anthelmintics|anthelmintics|mesh-ancestor
65353550|NCT00753558|Gentamicins|gentamicins|mesh-list
65353551|NCT00753558|Polymyxins|polymyxins|mesh-list
65353552|NCT00753558|Colistin|colistin|mesh-list
65353553|NCT00753558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65353554|NCT00753558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65353555|NCT00753558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65353556|NCT00753558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353557|NCT00753558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353558|NCT00753792|Methylprednisolone|methylprednisolone|mesh-list
65353559|NCT00753792|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65353560|NCT00753792|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65353561|NCT00753792|Prednisolone|prednisolone|mesh-list
65353562|NCT00753792|Prednisolone acetate|prednisolone acetate|mesh-list
65353563|NCT00753792|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65353564|NCT00753792|Prednisolone phosphate|prednisolone phosphate|mesh-list
64745696|NCT01694706|Omeprazole|omeprazole|mesh-list
64556174|NCT02244879|Resveratrol|resveratrol|mesh-list
64556175|NCT02244879|Antioxidants|antioxidants|mesh-ancestor
64556176|NCT02244879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556177|NCT02244879|Protective Agents|protective agents|mesh-ancestor
64556178|NCT02244879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321235|NCT02199223|Panitumumab|panitumumab|mesh-list
64492488|NCT00992602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64492489|NCT00992602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492490|NCT00992602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64492491|NCT00992602|Antimetabolites|antimetabolites|mesh-ancestor
64492492|NCT00992602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492494|NCT00992602|Dermatologic Agents|dermatologic agents|mesh-ancestor
64492495|NCT00992602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492496|NCT00992602|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64492497|NCT00992602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64492498|NCT00992602|Immunologic Factors|immunologic factors|mesh-ancestor
64492499|NCT00992602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64492500|NCT00992602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64492501|NCT00992602|Antiviral Agents|antiviral agents|mesh-ancestor
64492502|NCT00992602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64492503|NCT00993226|Bupivacaine|bupivacaine|mesh-list
64492504|NCT00993226|Anesthetics, Local|anesthetics, local|mesh-ancestor
64492505|NCT00993226|Anesthetics|anesthetics|mesh-ancestor
65353565|NCT00753792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65353566|NCT00753792|Antiemetics|antiemetics|mesh-ancestor
65353567|NCT00753792|Autonomic Agents|autonomic agents|mesh-ancestor
65353568|NCT00753792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65353569|NCT00753792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353570|NCT00753792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65353571|NCT00753792|Glucocorticoids|glucocorticoids|mesh-ancestor
65353572|NCT00753792|Hormones|hormones|mesh-ancestor
65353573|NCT00753792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65353574|NCT00753792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65353575|NCT00753792|Protective Agents|protective agents|mesh-ancestor
65353576|NCT00753792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65353577|NCT00753792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353578|NCT00575094|Tigecycline|tigecycline|mesh-list
65353579|NCT00575094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65353580|NCT00575094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65353581|NCT00575094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65353582|NCT00575094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353583|NCT00575094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353584|NCT00553696|Sunitinib|sunitinib|mesh-list
65353585|NCT00553696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353586|NCT00553696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65353587|NCT00553696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65353588|NCT00553696|Growth Substances|growth substances|mesh-ancestor
65353589|NCT00553696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353590|NCT00553696|Growth Inhibitors|growth inhibitors|mesh-ancestor
65353591|NCT00553696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65353592|NCT00553696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353597|NCT00958204|Fluoxetine|fluoxetine|mesh-list
65353608|NCT00958204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65353609|NCT00958204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65353610|NCT00958204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353611|NCT00617409|Paclitaxel|paclitaxel|mesh-list
65353612|NCT00617409|Tretinoin|tretinoin|mesh-list
65353613|NCT00617409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65353614|NCT00617409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353615|NCT00617409|Tubulin Modulators|tubulin modulators|mesh-ancestor
65353616|NCT00617409|Antimitotic Agents|antimitotic agents|mesh-ancestor
65353617|NCT00617409|Mitosis Modulators|mitosis modulators|mesh-ancestor
65353618|NCT00617409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353619|NCT00617409|Keratolytic Agents|keratolytic agents|mesh-ancestor
65353620|NCT00617409|Dermatologic Agents|dermatologic agents|mesh-ancestor
65353621|NCT00695318|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
65353622|NCT00695318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65353623|NCT00695318|Glucocorticoids|glucocorticoids|mesh-ancestor
64745758|NCT01682460|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64745759|NCT01682460|Lubricant Eye Drops|lubricant eye drops|mesh-list
64492529|NCT00995722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492530|NCT00995722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64492531|NCT00995722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492533|NCT04434040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492534|NCT00996346|Sirolimus|sirolimus|mesh-list
64492535|NCT00996346|Irinotecan|irinotecan|mesh-list
64492536|NCT00996346|Complement Factor H|complement factor h|mesh-list
64492537|NCT00996346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64492538|NCT00996346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64492539|NCT00996346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492540|NCT00996346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492541|NCT00996346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492542|NCT00996346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64492543|NCT00996346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64492544|NCT00996346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64492545|NCT00996346|Antifungal Agents|antifungal agents|mesh-ancestor
64492546|NCT00996346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64492547|NCT00996346|Immunologic Factors|immunologic factors|mesh-ancestor
64492548|NCT00996346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492549|NCT00996346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64492550|NCT03016468|Treprostinil|treprostinil|mesh-list
64492553|NCT00997204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64492561|NCT00997204|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
64492562|NCT00997204|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
64492563|NCT00997204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492564|NCT00997204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64492565|NCT00997204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64492566|NCT00997204|Immunologic Factors|immunologic factors|mesh-ancestor
64492568|NCT04263610|Dermatologic Agents|dermatologic agents|mesh-ancestor
64556179|NCT02244879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556180|NCT02244879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64556181|NCT04362735|Vedolizumab|vedolizumab|mesh-list
64556182|NCT04362735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64556183|NCT04375995|Nitric Oxide|nitric oxide|mesh-list
64556184|NCT04375995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64556185|NCT04375995|Autonomic Agents|autonomic agents|mesh-ancestor
64556186|NCT04375995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64492569|NCT04263610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65353624|NCT00695318|Hormones|hormones|mesh-ancestor
65353625|NCT00695318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65353626|NCT00695318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353627|NCT00754104|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65353628|NCT00754104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353629|NCT00754104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65353630|NCT00754104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353631|NCT00754104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353632|NCT00386425|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
65353633|NCT00386425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64492570|NCT04263610|Immunologic Factors|immunologic factors|mesh-ancestor
64492571|NCT04263610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492572|NCT04225390|Dacarbazine|dacarbazine|mesh-list
64492573|NCT04225390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64492574|NCT04225390|Alkylating Agents|alkylating agents|mesh-ancestor
64492575|NCT04225390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492576|NCT04225390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492577|NCT00997672|Lithium Carbonate|lithium carbonate|mesh-list
64492578|NCT00997672|Antidepressive Agents|antidepressive agents|mesh-ancestor
64492579|NCT00997672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64492580|NCT00997672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492581|NCT00997672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492582|NCT00997672|Antimanic Agents|antimanic agents|mesh-ancestor
64492583|NCT00997672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64492584|NCT00997672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64492585|NCT00997672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492586|NCT04101838|Vaccines|vaccines|mesh-list
64492587|NCT04101838|Immunologic Factors|immunologic factors|mesh-ancestor
64492588|NCT04101838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492589|NCT04606797|Nicotine|nicotine|mesh-list
64492590|NCT04606797|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64492591|NCT04606797|Autonomic Agents|autonomic agents|mesh-ancestor
64492592|NCT04606797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64492593|NCT04606797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492594|NCT04606797|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64492595|NCT04606797|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64492596|NCT04606797|Cholinergic Agents|cholinergic agents|mesh-ancestor
64492597|NCT04606797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64492598|NCT04606797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492599|NCT02164240|Sunitinib|sunitinib|mesh-list
64492600|NCT02164240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492601|NCT02164240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64492602|NCT02164240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64492603|NCT02164240|Growth Substances|growth substances|mesh-ancestor
64492604|NCT02164240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492605|NCT02164240|Growth Inhibitors|growth inhibitors|mesh-ancestor
64492606|NCT02164240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64492607|NCT02164240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492608|NCT02164240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492609|NCT02169466|Opicapone|opicapone|mesh-list
64492610|NCT02169466|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
64492611|NCT02169466|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64492612|NCT02169466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492613|NCT02169466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492614|NCT02169466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64492615|NCT02169466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64492616|NCT02169466|Dopamine Agents|dopamine agents|mesh-ancestor
64492617|NCT02169466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64492618|NCT02169466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492619|NCT01001806|Ketorolac|ketorolac|mesh-list
64492639|NCT04021264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492640|NCT04021264|Sensory System Agents|sensory system agents|mesh-ancestor
65353634|NCT03529448|Temozolomide|temozolomide|mesh-list
65353635|NCT03529448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65353636|NCT03529448|Alkylating Agents|alkylating agents|mesh-ancestor
65353637|NCT03529448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353638|NCT03529448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353639|NCT05396898|Tacrolimus|tacrolimus|mesh-list
65353640|NCT05396898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65353641|NCT05396898|Immunologic Factors|immunologic factors|mesh-ancestor
65353642|NCT05396898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353643|NCT05396898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65353644|NCT05396898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353645|NCT05396898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353646|NCT00694304|Vortioxetine|vortioxetine|mesh-list
65353647|NCT00694304|Antidepressive Agents|antidepressive agents|mesh-ancestor
65353648|NCT00694304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65353649|NCT00694304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65353650|NCT00694304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65353651|NCT00694304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65353652|NCT00694304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353653|NCT00694304|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65353654|NCT00694304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65353655|NCT00694304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64745785|NCT01681992|Vaccines|vaccines|mesh-list
64492641|NCT04021264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64492644|NCT04021264|Analgesics|analgesics|mesh-ancestor
64492645|NCT04021264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64556187|NCT04375995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556188|NCT04375995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64556189|NCT04375995|Respiratory System Agents|respiratory system agents|mesh-ancestor
64556190|NCT04375995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64556191|NCT04375995|Antioxidants|antioxidants|mesh-ancestor
64556192|NCT04375995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556193|NCT04375995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64556194|NCT04375995|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64556195|NCT04375995|Vasodilator Agents|vasodilator agents|mesh-ancestor
64556196|NCT04375995|Gasotransmitters|gasotransmitters|mesh-ancestor
64556197|NCT04375995|Protective Agents|protective agents|mesh-ancestor
64556198|NCT04993014|Trastuzumab|trastuzumab|mesh-list
64556199|NCT04993014|Pertuzumab|pertuzumab|mesh-list
64556200|NCT04993014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64321255|NCT02202889|Calcium|calcium|mesh-list
64492646|NCT04021264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64492647|NCT04021264|Anesthetics, General|anesthetics, general|mesh-ancestor
64492648|NCT03233139|Gemcitabine|gemcitabine|mesh-list
64492649|NCT03233139|Paclitaxel|paclitaxel|mesh-list
64492650|NCT03233139|Pemetrexed|pemetrexed|mesh-list
64492651|NCT03233139|Ipilimumab|ipilimumab|mesh-list
64492652|NCT03233139|Cemiplimab|cemiplimab|mesh-list
64492653|NCT03233139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64492654|NCT03233139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492655|NCT03233139|Tubulin Modulators|tubulin modulators|mesh-ancestor
64492656|NCT03233139|Antimitotic Agents|antimitotic agents|mesh-ancestor
64492657|NCT03233139|Mitosis Modulators|mitosis modulators|mesh-ancestor
65353656|NCT00694304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353657|NCT00694304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65353658|NCT00694304|Serotonin Agents|serotonin agents|mesh-ancestor
65353659|NCT00694304|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65353660|NCT00694304|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65353661|NCT00694304|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65353662|NCT00694304|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65353663|NCT00866853|Simeprevir|simeprevir|mesh-list
65353664|NCT00866853|Antiviral Agents|antiviral agents|mesh-ancestor
65353665|NCT00866853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65353666|NCT00866853|Protease Inhibitors|protease inhibitors|mesh-ancestor
65353667|NCT00866853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353668|NCT00866853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353669|NCT04685876|Bupivacaine|bupivacaine|mesh-list
64492658|NCT03233139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492659|NCT03233139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64492660|NCT03233139|Antimetabolites|antimetabolites|mesh-ancestor
64492661|NCT03233139|Antiviral Agents|antiviral agents|mesh-ancestor
64492662|NCT03233139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64492663|NCT03233139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492664|NCT03233139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64492665|NCT03233139|Immunologic Factors|immunologic factors|mesh-ancestor
64492666|NCT03233139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492667|NCT03233139|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64492668|NCT03233139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64492669|NCT03233139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64492670|NCT03233139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64492671|NCT04763343|Ketamine|ketamine|mesh-list
64492672|NCT04763343|Analgesics|analgesics|mesh-ancestor
64492673|NCT04763343|Sensory System Agents|sensory system agents|mesh-ancestor
64492674|NCT04763343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64492675|NCT04763343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492676|NCT04763343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64492694|NCT04757571|Antidepressive Agents|antidepressive agents|mesh-ancestor
64492695|NCT04757571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64492696|NCT04757571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64492697|NCT04757571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64492698|NCT04757571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492699|NCT03232593|Atezolizumab|atezolizumab|mesh-list
64492700|NCT03232593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492701|NCT04746183|Ritonavir|ritonavir|mesh-list
64492702|NCT04746183|Nitazoxanide|nitazoxanide|mesh-list
64492703|NCT04746183|Favipiravir|favipiravir|mesh-list
64492704|NCT04746183|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64492705|NCT04746183|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64492706|NCT04746183|Protease Inhibitors|protease inhibitors|mesh-ancestor
64492707|NCT04746183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556201|NCT04993014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556202|NCT05005494|Magnesium Sulfate|magnesium sulfate|mesh-list
64556203|NCT05005494|Analgesics|analgesics|mesh-ancestor
64556204|NCT05005494|Sensory System Agents|sensory system agents|mesh-ancestor
64556205|NCT05005494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556206|NCT05005494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556207|NCT05005494|Anesthetics|anesthetics|mesh-ancestor
64556208|NCT05005494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64492708|NCT04746183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492709|NCT04746183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64492710|NCT04746183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64492711|NCT04746183|Antiviral Agents|antiviral agents|mesh-ancestor
64492712|NCT04746183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65353670|NCT04685876|Anesthetics, Local|anesthetics, local|mesh-ancestor
65353671|NCT04685876|Anesthetics|anesthetics|mesh-ancestor
65353672|NCT04685876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65353673|NCT04685876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353674|NCT04685876|Sensory System Agents|sensory system agents|mesh-ancestor
65353675|NCT04685876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65353676|NCT00682890|Metformin|metformin|mesh-list
65353677|NCT00682890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65353678|NCT00682890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353679|NCT02565368|Metformin|metformin|mesh-list
65353680|NCT02565368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65353681|NCT02565368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353682|NCT03992365|Bisacodyl|bisacodyl|mesh-list
65353683|NCT03992365|Sodium sulfate|sodium sulfate|mesh-list
65353684|NCT03992365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65353685|NCT03992365|Cathartics|cathartics|mesh-ancestor
65353686|NCT03992365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65353687|NCT03992365|Laxatives|laxatives|mesh-ancestor
65353688|NCT00921804|Risperidone|risperidone|mesh-list
65353689|NCT00921804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64745838|NCT01568112|Aspirin|aspirin|mesh-list
64492713|NCT04746183|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64492714|NCT04746183|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64492716|NCT01895309|Etanercept|etanercept|mesh-list
64492717|NCT01895309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64492718|NCT01895309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64492719|NCT01895309|Analgesics|analgesics|mesh-ancestor
64492720|NCT01895309|Sensory System Agents|sensory system agents|mesh-ancestor
64492721|NCT01895309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64492722|NCT01895309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492723|NCT01895309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64492724|NCT01895309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64492725|NCT01895309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64492726|NCT01895309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64492727|NCT01895309|Immunologic Factors|immunologic factors|mesh-ancestor
64492728|NCT04614311|Triamcinolone|triamcinolone|mesh-list
64492729|NCT04614311|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64492735|NCT04614311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64492736|NCT04614311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492737|NCT04614311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64492738|NCT04614311|Immunologic Factors|immunologic factors|mesh-ancestor
64492739|NCT04614311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492740|NCT04614311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492741|NCT03681639|Cobalt|cobalt|mesh-list
64492742|NCT03681639|Chromium|chromium|mesh-list
64492743|NCT03681639|Trace Elements|trace elements|mesh-ancestor
64492744|NCT03681639|Micronutrients|micronutrients|mesh-ancestor
64492745|NCT03681639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492746|NCT03285321|Nivolumab|nivolumab|mesh-list
64492747|NCT03285321|Ipilimumab|ipilimumab|mesh-list
64492748|NCT03285321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64492749|NCT03285321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492750|NCT03285321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64492751|NCT03285321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492752|NCT03284463|Glyburide|glyburide|mesh-list
64492753|NCT03284463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64492754|NCT03284463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353690|NCT00921804|Serotonin Agents|serotonin agents|mesh-ancestor
65353691|NCT00921804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65353692|NCT00921804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103530|NCT02934035|Analgesics|analgesics|mesh-ancestor
65353693|NCT00921804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353694|NCT00921804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65353695|NCT00921804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65353696|NCT00921804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65353697|NCT00921804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65353698|NCT00921804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65353700|NCT04011280|Varenicline|varenicline|mesh-list
65353701|NCT04011280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65353702|NCT04011280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65353703|NCT04011280|Cholinergic Agents|cholinergic agents|mesh-ancestor
65353704|NCT04011280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65353705|NCT04011280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353706|NCT04011280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353707|NCT00859911|Micronutrients|micronutrients|mesh-list
65353708|NCT00859911|Trace Elements|trace elements|mesh-list
65353709|NCT00859911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353710|NCT00698516|Bevacizumab|bevacizumab|mesh-list
65353711|NCT00698516|Topotecan|topotecan|mesh-list
65353712|NCT00698516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65353713|NCT00698516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353714|NCT00698516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65353715|NCT00698516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65353716|NCT00698516|Growth Substances|growth substances|mesh-ancestor
65353717|NCT00698516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353718|NCT00698516|Growth Inhibitors|growth inhibitors|mesh-ancestor
65353719|NCT00698516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65353720|NCT00698516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65353721|NCT00698516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353722|NCT00698516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353723|NCT00679302|Trimethoprim|trimethoprim|mesh-list
65353724|NCT00679302|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64745842|NCT01568112|Analgesics|analgesics|mesh-ancestor
64492755|NCT05066698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65353725|NCT00679302|Sulfamethoxazole|sulfamethoxazole|mesh-list
65353726|NCT00679302|Simethicone|simethicone|mesh-list
65353727|NCT00679302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65353728|NCT00679302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65353729|NCT00679302|Renal Agents|renal agents|mesh-ancestor
65353730|NCT00679302|Antimalarials|antimalarials|mesh-ancestor
65353731|NCT00679302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65353732|NCT00679302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65353733|NCT00679302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65353734|NCT00679302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353735|NCT00679302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353736|NCT00679302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65353737|NCT00679302|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65353738|NCT00679302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65353739|NCT00679302|Antifoaming Agents|antifoaming agents|mesh-ancestor
65353740|NCT00679302|Emollients|emollients|mesh-ancestor
65353741|NCT00679302|Dermatologic Agents|dermatologic agents|mesh-ancestor
65353742|NCT00679302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65353743|NCT04011124|Rifampin|rifampin|mesh-list
65353744|NCT04011124|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65353745|NCT04011124|Antitubercular Agents|antitubercular agents|mesh-ancestor
65353746|NCT04011124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65353747|NCT04011124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65353748|NCT04011124|Leprostatic Agents|leprostatic agents|mesh-ancestor
65353749|NCT04011124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65353750|NCT04011124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353751|NCT04011124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353752|NCT04011124|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65353753|NCT04011124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64492756|NCT05066698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64492758|NCT04323748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64492759|NCT04323748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492760|NCT04323748|Immunologic Factors|immunologic factors|mesh-ancestor
64492761|NCT04323748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492762|NCT04323748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64492763|NCT04704999|Chloroquine|chloroquine|mesh-list
64492764|NCT04704999|Lumefantrine|lumefantrine|mesh-list
64492765|NCT04704999|Artemether|artemether|mesh-list
64492766|NCT04704999|Tafenoquine|tafenoquine|mesh-list
64492768|NCT04704999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64492769|NCT04704999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64492770|NCT04704999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64492771|NCT04704999|Antimalarials|antimalarials|mesh-ancestor
64492772|NCT04704999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64492773|NCT04197310|Nivolumab|nivolumab|mesh-list
64492774|NCT04197310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64556209|NCT05005494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65353754|NCT04011124|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65353755|NCT04011124|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65353756|NCT04011124|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65353757|NCT04011124|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65353758|NCT00862875|Insulin|insulin|mesh-list
65353759|NCT00862875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65353760|NCT00862875|Insulin Detemir|insulin detemir|mesh-list
65353761|NCT00862875|Insulin, Long-Acting|insulin, long-acting|mesh-list
65353762|NCT00862875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65353763|NCT00862875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353764|NCT02544165|Caffeine|caffeine|mesh-list
65353765|NCT02544165|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65103600|NCT02934945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65353766|NCT02544165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353767|NCT02544165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65353768|NCT02544165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353769|NCT02544165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353770|NCT02544165|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65353771|NCT02544165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65353772|NCT02544165|Purinergic Agents|purinergic agents|mesh-ancestor
65353773|NCT02544165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65353774|NCT05343156|Dexamethasone|dexamethasone|mesh-list
65353775|NCT05343156|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65353776|NCT05343156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65353777|NCT05343156|Antiemetics|antiemetics|mesh-ancestor
65353778|NCT05343156|Autonomic Agents|autonomic agents|mesh-ancestor
64745906|NCT01603602|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64556210|NCT05005494|Anticonvulsants|anticonvulsants|mesh-ancestor
64556211|NCT05005494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64556212|NCT05005494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64556213|NCT05005494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556214|NCT05005494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64556215|NCT05005494|Tocolytic Agents|tocolytic agents|mesh-ancestor
64556216|NCT05005494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64556217|NCT04025567|Vancomycin|vancomycin|mesh-list
64556218|NCT04025567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64556219|NCT04025567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64556220|NCT03074994|Anesthetics|anesthetics|mesh-list
64556221|NCT03074994|Anesthetics, Local|anesthetics, local|mesh-list
64556222|NCT03074994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64321275|NCT03532867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321276|NCT02207959|Proflavine|proflavine|mesh-list
64321277|NCT02207959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64321278|NCT02207959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64321279|NCT02567552|Progesterone|progesterone|mesh-list
64321280|NCT02567552|Progestins|progestins|mesh-ancestor
64492781|NCT05320731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65353779|NCT05343156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65353780|NCT05343156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353781|NCT05343156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65353782|NCT05343156|Glucocorticoids|glucocorticoids|mesh-ancestor
65353783|NCT05343156|Hormones|hormones|mesh-ancestor
65353784|NCT05343156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65353785|NCT05343156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65353786|NCT05343156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353787|NCT05343156|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65353788|NCT00955162|Buprenorphine|buprenorphine|mesh-list
65353789|NCT00955162|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65353790|NCT00955162|Naloxone|naloxone|mesh-list
65353791|NCT00955162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65353792|NCT00955162|Narcotics|narcotics|mesh-ancestor
65353793|NCT00955162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65353794|NCT00955162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353795|NCT00955162|Analgesics|analgesics|mesh-ancestor
65353796|NCT00955162|Sensory System Agents|sensory system agents|mesh-ancestor
65353797|NCT00955162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65353798|NCT00955162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65353799|NCT00949546|Etanercept|etanercept|mesh-list
65353800|NCT00949546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65353801|NCT00949546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65353802|NCT00949546|Analgesics|analgesics|mesh-ancestor
65353803|NCT00949546|Sensory System Agents|sensory system agents|mesh-ancestor
65353804|NCT00949546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65353805|NCT00949546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353806|NCT00949546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65353807|NCT00949546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65353808|NCT00949546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65353809|NCT00949546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64492782|NCT05320731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492783|NCT05320731|Sensory System Agents|sensory system agents|mesh-ancestor
64492784|NCT05320731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64492785|NCT05320731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64492786|NCT05320731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64492787|NCT05320731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64492788|NCT05320731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64492789|NCT05320731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492791|NCT02808364|Immunologic Factors|immunologic factors|mesh-ancestor
64492792|NCT02808364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492793|NCT02709616|Vaccines|vaccines|mesh-list
64492794|NCT02709616|Immunologic Factors|immunologic factors|mesh-ancestor
65353810|NCT00949546|Immunologic Factors|immunologic factors|mesh-ancestor
65353811|NCT05291364|Ethanol|ethanol|mesh-list
65353812|NCT05291364|Dexmedetomidine|dexmedetomidine|mesh-list
65353813|NCT05291364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65353814|NCT05291364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65353815|NCT05291364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353816|NCT05291364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65353817|NCT05291364|Analgesics|analgesics|mesh-ancestor
65353818|NCT05291364|Sensory System Agents|sensory system agents|mesh-ancestor
65353819|NCT05291364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65353820|NCT05291364|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65353821|NCT05291364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65353822|NCT05291364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65353823|NCT05291364|Adrenergic Agents|adrenergic agents|mesh-ancestor
65353824|NCT05291364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65353825|NCT05291364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353826|NCT05291364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65353827|NCT05291364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65353828|NCT00949624|Docetaxel|docetaxel|mesh-list
65353829|NCT00949624|Axitinib|axitinib|mesh-list
65353830|NCT00949624|Crenolanib|crenolanib|mesh-list
65353831|NCT00949624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353832|NCT00949624|Tubulin Modulators|tubulin modulators|mesh-ancestor
65353833|NCT00949624|Antimitotic Agents|antimitotic agents|mesh-ancestor
65353834|NCT00949624|Mitosis Modulators|mitosis modulators|mesh-ancestor
65353835|NCT00949624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745965|NCT01565850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492795|NCT02709616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492796|NCT04534881|Progesterone|progesterone|mesh-list
64492797|NCT04534881|Progestins|progestins|mesh-ancestor
64492798|NCT04534881|Hormones|hormones|mesh-ancestor
64492799|NCT04534881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64492800|NCT04534881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492801|NCT04817956|Trastuzumab|trastuzumab|mesh-list
64492802|NCT04817956|Pertuzumab|pertuzumab|mesh-list
64492803|NCT04817956|Atezolizumab|atezolizumab|mesh-list
64492804|NCT04817956|Vemurafenib|vemurafenib|mesh-list
64492829|NCT04667949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492830|NCT04667949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64492831|NCT04667949|Immunologic Factors|immunologic factors|mesh-ancestor
64492832|NCT04667949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556223|NCT03074994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556224|NCT03074994|Sensory System Agents|sensory system agents|mesh-ancestor
64556225|NCT03074994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556226|NCT04025177|Indomethacin|indomethacin|mesh-list
64556227|NCT04025177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64556228|NCT04025177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64556229|NCT04025177|Analgesics|analgesics|mesh-ancestor
64746001|NCT04410354|Remdesivir|remdesivir|mesh-list
65353836|NCT00949624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65353837|NCT00949624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353838|NCT04019379|Calcium, Dietary|calcium, dietary|mesh-list
65353839|NCT04019379|Calcium|calcium|mesh-list
65353840|NCT04019379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65353841|NCT04019379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353842|NCT04019379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65353843|NCT05351788|Carboplatin|carboplatin|mesh-list
65353844|NCT05351788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353845|NCT04005339|Leucovorin|leucovorin|mesh-list
65353846|NCT04005339|Fluorouracil|fluorouracil|mesh-list
65353847|NCT04005339|Irinotecan|irinotecan|mesh-list
65353848|NCT04005339|Antimetabolites|antimetabolites|mesh-ancestor
65353849|NCT04005339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353850|NCT04005339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65353851|NCT04005339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353852|NCT04005339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65353853|NCT04005339|Immunologic Factors|immunologic factors|mesh-ancestor
65353854|NCT04005339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353855|NCT04005339|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65353856|NCT04005339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65353857|NCT04005339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353858|NCT04005339|Antidotes|antidotes|mesh-ancestor
65353859|NCT04005339|Protective Agents|protective agents|mesh-ancestor
65353860|NCT04005339|Vitamin B Complex|vitamin b complex|mesh-ancestor
65353861|NCT04005339|Vitamins|vitamins|mesh-ancestor
65353862|NCT04005339|Micronutrients|micronutrients|mesh-ancestor
65353863|NCT00949780|Chloral Hydrate|chloral hydrate|mesh-list
65353864|NCT00949780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65353865|NCT00949780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65353866|NCT00949780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353867|NCT02544243|Gemcitabine|gemcitabine|mesh-list
65353868|NCT02544243|Vinorelbine|vinorelbine|mesh-list
65353869|NCT02544243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556230|NCT04025177|Sensory System Agents|sensory system agents|mesh-ancestor
64556231|NCT04025177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556232|NCT04025177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556233|NCT04025177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64556234|NCT04025177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64556235|NCT04025177|Gout Suppressants|gout suppressants|mesh-ancestor
64556236|NCT04025177|Tocolytic Agents|tocolytic agents|mesh-ancestor
65353870|NCT02544243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65353871|NCT02544243|Antimetabolites|antimetabolites|mesh-ancestor
65353872|NCT02544243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353873|NCT02544243|Antiviral Agents|antiviral agents|mesh-ancestor
65353874|NCT02544243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65353875|NCT02544243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353876|NCT02544243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65353877|NCT02544243|Immunologic Factors|immunologic factors|mesh-ancestor
65353878|NCT02544243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353879|NCT02544243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65353880|NCT02544243|Tubulin Modulators|tubulin modulators|mesh-ancestor
64556237|NCT04025177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64321291|NCT02208427|Antimetabolites|antimetabolites|mesh-ancestor
64321293|NCT02208427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64492833|NCT05306223|Levofloxacin|levofloxacin|mesh-list
64492834|NCT05306223|Ofloxacin|ofloxacin|mesh-list
64492835|NCT05306223|Cycloserine|cycloserine|mesh-list
64492836|NCT05306223|Linezolid|linezolid|mesh-list
64492837|NCT05306223|Pyrazinamide|pyrazinamide|mesh-list
64492838|NCT05306223|Bedaquiline|bedaquiline|mesh-list
64492839|NCT05306223|Clofazimine|clofazimine|mesh-list
64492840|NCT05306223|Prothionamide|prothionamide|mesh-list
64492841|NCT05306223|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64492842|NCT05306223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64492843|NCT05306223|Renal Agents|renal agents|mesh-ancestor
64492844|NCT05306223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64492845|NCT05306223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64492846|NCT05306223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64492847|NCT05306223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492848|NCT05306223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492849|NCT05306223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492850|NCT05306223|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64492864|NCT03016000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64492865|NCT03016000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64492869|NCT03016000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492870|NCT04130152|Letrozole|letrozole|mesh-list
64492871|NCT04130152|Palbociclib|palbociclib|mesh-list
64492872|NCT04130152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492873|NCT04130152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64492874|NCT04130152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64492875|NCT04130152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492876|NCT04130152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492877|NCT04130152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64492878|NCT04130152|Hormone Antagonists|hormone antagonists|mesh-ancestor
64492879|NCT04130152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64492880|NCT04130152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492881|NCT04130152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64492882|NCT03254589|Sulfasalazine|sulfasalazine|mesh-list
64492883|NCT03254589|Methotrexate|methotrexate|mesh-list
64556238|NCT04025177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64556239|NCT04025177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556240|NCT04025177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714194|NCT02988050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64556241|NCT04358055|Hyaluronic Acid|hyaluronic acid|mesh-list
64556242|NCT04358055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64556243|NCT04358055|Immunologic Factors|immunologic factors|mesh-ancestor
64492884|NCT03254589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64492885|NCT03254589|Abortifacient Agents|abortifacient agents|mesh-ancestor
64492886|NCT03254589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64492887|NCT03254589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492888|NCT03254589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64492889|NCT03254589|Antimetabolites|antimetabolites|mesh-ancestor
64492890|NCT03254589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353881|NCT02544243|Antimitotic Agents|antimitotic agents|mesh-ancestor
65353882|NCT02544243|Mitosis Modulators|mitosis modulators|mesh-ancestor
65353883|NCT04011670|Caffeine|caffeine|mesh-list
65353884|NCT04011670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65353885|NCT04011670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353886|NCT04011670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65353887|NCT04011670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353888|NCT04011670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353889|NCT04011670|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65353890|NCT04011670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65353891|NCT04011670|Purinergic Agents|purinergic agents|mesh-ancestor
65353892|NCT04011670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65353893|NCT01581073|Darbepoetin alfa|darbepoetin alfa|mesh-list
64492891|NCT03254589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492892|NCT03254589|Dermatologic Agents|dermatologic agents|mesh-ancestor
64492893|NCT03254589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492894|NCT03254589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64492895|NCT03254589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64492896|NCT03254589|Immunologic Factors|immunologic factors|mesh-ancestor
64492897|NCT03254589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64492898|NCT03254589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64492899|NCT03254589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64492900|NCT03254589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64492901|NCT03254589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64492902|NCT03254589|Analgesics|analgesics|mesh-ancestor
64492903|NCT03254589|Sensory System Agents|sensory system agents|mesh-ancestor
64492904|NCT03254589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64492905|NCT03254589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64492906|NCT03254589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64492908|NCT04399395|Bupropion|bupropion|mesh-list
64492909|NCT04399395|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64492910|NCT04399395|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64492911|NCT04399395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492917|NCT04399395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64492918|NCT04399395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64492919|NCT04399395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64492920|NCT04399395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492922|NCT04399395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64492923|NCT04399395|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64492924|NCT04399395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64492925|NCT04399395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492926|NCT04613453|Midazolam|midazolam|mesh-list
64492927|NCT04613453|Ketamine|ketamine|mesh-list
64492928|NCT04613453|Analgesics|analgesics|mesh-ancestor
64492929|NCT04613453|Sensory System Agents|sensory system agents|mesh-ancestor
64492930|NCT04613453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64492931|NCT04613453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492932|NCT04613453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64492933|NCT04613453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64492934|NCT04613453|Anesthetics, General|anesthetics, general|mesh-ancestor
64492936|NCT04613453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64492944|NCT04613453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64492945|NCT04613453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64492946|NCT04613453|GABA Modulators|gaba modulators|mesh-ancestor
64492947|NCT04613453|GABA Agents|gaba agents|mesh-ancestor
64492948|NCT02000596|Trastuzumab|trastuzumab|mesh-list
64492949|NCT02000596|Pertuzumab|pertuzumab|mesh-list
64492950|NCT02000596|Fulvestrant|fulvestrant|mesh-list
64492951|NCT02000596|Anastrozole|anastrozole|mesh-list
64556244|NCT04358055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556245|NCT04358055|Viscosupplements|viscosupplements|mesh-ancestor
64556246|NCT04358055|Protective Agents|protective agents|mesh-ancestor
65353894|NCT01581073|Hematinics|hematinics|mesh-ancestor
65353895|NCT00742820|Calcium, Dietary|calcium, dietary|mesh-list
65353896|NCT00742820|Calcium|calcium|mesh-list
65353897|NCT00742820|Calcium acetate|calcium acetate|mesh-list
65353898|NCT00742820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65353899|NCT00742820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353900|NCT00742820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65353901|NCT00742820|Chelating Agents|chelating agents|mesh-ancestor
65353902|NCT00742820|Sequestering Agents|sequestering agents|mesh-ancestor
65353903|NCT00742820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353904|NCT01324843|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65353905|NCT01324843|Anesthetics, Local|anesthetics, local|mesh-ancestor
65353906|NCT01324843|Anesthetics|anesthetics|mesh-ancestor
65353907|NCT01324843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65353908|NCT01324843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353909|NCT01324843|Sensory System Agents|sensory system agents|mesh-ancestor
65353910|NCT01324843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65353911|NCT01324843|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65353912|NCT00742976|Insulin|insulin|mesh-list
65353913|NCT00742976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65353914|NCT00742976|Insulin Detemir|insulin detemir|mesh-list
65103749|NCT02932007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65353915|NCT00742976|Isophane Insulin, Human|isophane insulin, human|mesh-list
65353916|NCT00742976|Insulin, Isophane|insulin, isophane|mesh-list
65353917|NCT00742976|Isophane insulin, beef|isophane insulin, beef|mesh-list
65353918|NCT00742976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65353919|NCT00742976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353920|NCT00571662|Cyclosporine|cyclosporine|mesh-list
65353921|NCT00571662|Mycophenolic Acid|mycophenolic acid|mesh-list
64556247|NCT04147325|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64556248|NCT04147325|Antiviral Agents|antiviral agents|mesh-ancestor
64556249|NCT04147325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64556250|NCT02985281|Ribavirin|ribavirin|mesh-list
64556251|NCT02985281|Sofosbuvir|sofosbuvir|mesh-list
64556252|NCT02985281|Antimetabolites|antimetabolites|mesh-ancestor
64556253|NCT02985281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556254|NCT02985281|Antiviral Agents|antiviral agents|mesh-ancestor
64492952|NCT02000596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64492953|NCT02000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492954|NCT02000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64492955|NCT02000596|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64492956|NCT02000596|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64492957|NCT02000596|Hormone Antagonists|hormone antagonists|mesh-ancestor
64492958|NCT02000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64492959|NCT02000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492960|NCT02000596|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64492961|NCT02000596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65353922|NCT00571662|Pentostatin|pentostatin|mesh-list
65353923|NCT00571662|Cyclosporins|cyclosporins|mesh-list
65353924|NCT00571662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65353925|NCT00571662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353926|NCT00571662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65353927|NCT00571662|Immunologic Factors|immunologic factors|mesh-ancestor
65353928|NCT00571662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353929|NCT00571662|Antifungal Agents|antifungal agents|mesh-ancestor
65353930|NCT00571662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65353931|NCT00571662|Dermatologic Agents|dermatologic agents|mesh-ancestor
65353932|NCT00571662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65353933|NCT00571662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65353934|NCT00571662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65353935|NCT00571662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353936|NCT00571662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65353937|NCT00571662|Antitubercular Agents|antitubercular agents|mesh-ancestor
65353938|NCT00571662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65353939|NCT00571662|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65353940|NCT00955240|Fluorouracil|fluorouracil|mesh-list
65353941|NCT00955240|Cetuximab|cetuximab|mesh-list
65353942|NCT00955240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353943|NCT00955240|Antimetabolites|antimetabolites|mesh-ancestor
65353944|NCT00955240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353945|NCT00955240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65353946|NCT00955240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65353947|NCT00955240|Immunologic Factors|immunologic factors|mesh-ancestor
65353948|NCT00955240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353949|NCT00955240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64492962|NCT02000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492963|NCT02000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492964|NCT03223779|Trifluridine|trifluridine|mesh-list
64492965|NCT03223779|Antimetabolites|antimetabolites|mesh-ancestor
64492966|NCT03223779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492967|NCT03223779|Antiviral Agents|antiviral agents|mesh-ancestor
64492968|NCT03223779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64492969|NCT05168865|Letrozole|letrozole|mesh-list
64492970|NCT05168865|Estradiol|estradiol|mesh-list
64492971|NCT05168865|Progesterone|progesterone|mesh-list
64492972|NCT05168865|Estrogens|estrogens|mesh-ancestor
64492973|NCT05168865|Hormones|hormones|mesh-ancestor
64492974|NCT05168865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64492975|NCT05168865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492976|NCT05168865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492977|NCT05168865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64492978|NCT05168865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64492979|NCT05168865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586287|NCT00322439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65353950|NCT03387085|Leucovorin|leucovorin|mesh-list
65353951|NCT03387085|Paclitaxel|paclitaxel|mesh-list
65353952|NCT03387085|Cyclophosphamide|cyclophosphamide|mesh-list
65353953|NCT03387085|Bevacizumab|bevacizumab|mesh-list
65353954|NCT03387085|Fluorouracil|fluorouracil|mesh-list
65353955|NCT03387085|Capecitabine|capecitabine|mesh-list
65353956|NCT03387085|Avelumab|avelumab|mesh-list
65353957|NCT03387085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65353958|NCT03387085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65353959|NCT03387085|Tubulin Modulators|tubulin modulators|mesh-ancestor
65353960|NCT03387085|Antimitotic Agents|antimitotic agents|mesh-ancestor
65353961|NCT03387085|Mitosis Modulators|mitosis modulators|mesh-ancestor
65353962|NCT03387085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65353963|NCT03387085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65353964|NCT03387085|Immunologic Factors|immunologic factors|mesh-ancestor
65353965|NCT03387085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65353966|NCT03387085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65353967|NCT03387085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65353968|NCT03387085|Alkylating Agents|alkylating agents|mesh-ancestor
65353969|NCT03387085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65353970|NCT03387085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65353971|NCT03387085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65353972|NCT03387085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65353973|NCT03387085|Growth Substances|growth substances|mesh-ancestor
65353974|NCT03387085|Growth Inhibitors|growth inhibitors|mesh-ancestor
65353975|NCT03387085|Antimetabolites|antimetabolites|mesh-ancestor
65353976|NCT03387085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65354001|NCT00860223|Protective Agents|protective agents|mesh-ancestor
65354002|NCT00860223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354003|NCT00698204|Celecoxib|celecoxib|mesh-list
65354004|NCT00698204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65354005|NCT00698204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65354006|NCT00698204|Analgesics|analgesics|mesh-ancestor
65354007|NCT00698204|Sensory System Agents|sensory system agents|mesh-ancestor
65354008|NCT00698204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65354009|NCT00698204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354010|NCT00698204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65354011|NCT00698204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65354012|NCT00698204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65354013|NCT00698204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65354014|NCT00698204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354015|NCT00698204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354016|NCT00549718|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65354017|NCT00549718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65354018|NCT00549718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65354019|NCT00549718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65354020|NCT00549718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354021|NCT00549718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65354022|NCT00549718|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65354023|NCT00549718|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65354024|NCT00549718|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65354025|NCT00549718|Adrenergic Agents|adrenergic agents|mesh-ancestor
65354026|NCT00549718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354027|NCT00549718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354028|NCT00549718|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65354029|NCT00549718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64492990|NCT01882985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492992|NCT01882985|Antioxidants|antioxidants|mesh-ancestor
64492993|NCT01882985|Protective Agents|protective agents|mesh-ancestor
64492994|NCT01882985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492995|NCT01882985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64492996|NCT01882985|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64492997|NCT02166346|4-Aminopyridine|4-aminopyridine|mesh-list
64492998|NCT02166346|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64492999|NCT02166346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64493000|NCT02166346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493001|NCT04460235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64493002|NCT04460235|Immunologic Factors|immunologic factors|mesh-ancestor
65354030|NCT00549718|Serotonin Agents|serotonin agents|mesh-ancestor
65354031|NCT00549718|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65354032|NCT00549718|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65354033|NCT00549718|Dopamine Agents|dopamine agents|mesh-ancestor
65354034|NCT00863187|Rituximab|rituximab|mesh-list
65354035|NCT00863187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65354036|NCT00863187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65354037|NCT00863187|Immunologic Factors|immunologic factors|mesh-ancestor
65354038|NCT00863187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354039|NCT00863187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65354040|NCT00754884|Calcitonin|calcitonin|mesh-list
65354041|NCT00754884|Salmon calcitonin|salmon calcitonin|mesh-list
65354042|NCT00754884|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
65354043|NCT00754884|Glycerol|glycerol|mesh-list
65354044|NCT00754884|Katacalcin|katacalcin|mesh-list
65354045|NCT00754884|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65354046|NCT00754884|Protective Agents|protective agents|mesh-ancestor
65354047|NCT00754884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354048|NCT00754884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65354049|NCT00754884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65354050|NCT00754884|Vasodilator Agents|vasodilator agents|mesh-ancestor
65354051|NCT00371761|Interferons|interferons|mesh-list
65354052|NCT00371761|Interferon-alpha|interferon-alpha|mesh-list
65354053|NCT00371761|Interferon alpha-2|interferon alpha-2|mesh-list
65354054|NCT00371761|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65354055|NCT00371761|Adefovir|adefovir|mesh-list
65354056|NCT00371761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65354057|NCT00371761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493003|NCT04460235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493005|NCT03015922|Pomalidomide|pomalidomide|mesh-list
64493006|NCT03015922|Immunologic Factors|immunologic factors|mesh-ancestor
64493007|NCT03015922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493008|NCT03015922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64493009|NCT03015922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64493010|NCT03015922|Growth Substances|growth substances|mesh-ancestor
64493011|NCT03015922|Growth Inhibitors|growth inhibitors|mesh-ancestor
64493012|NCT03015922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493014|NCT01893827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64493015|NCT01893827|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64556255|NCT02985281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64556256|NCT00927849|Nitroglycerin|nitroglycerin|mesh-list
64556257|NCT00927849|Botulinum Toxins|botulinum toxins|mesh-list
64556258|NCT00927849|Glycerol|glycerol|mesh-list
64556259|NCT00927849|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64556260|NCT00927849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64556261|NCT00927849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556262|NCT00927849|Cholinergic Agents|cholinergic agents|mesh-ancestor
64556263|NCT00927849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64556264|NCT00927849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321326|NCT02208505|Narcotics|narcotics|mesh-ancestor
65354058|NCT00371761|Antiviral Agents|antiviral agents|mesh-ancestor
65354059|NCT00371761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65354060|NCT00371761|Immunologic Factors|immunologic factors|mesh-ancestor
65354061|NCT00371761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354062|NCT00371761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65354063|NCT00371761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65354064|NCT00371761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354065|NCT00371761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103898|NCT04137770|Analgesics|analgesics|mesh-ancestor
65354066|NCT00754962|Protriptyline|protriptyline|mesh-list
65354067|NCT00754962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65354068|NCT00754962|Antidepressive Agents|antidepressive agents|mesh-ancestor
65354069|NCT00754962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65354070|NCT00754962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65354071|NCT00754962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65354072|NCT00754962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64746201|NCT01582854|Protective Agents|protective agents|mesh-ancestor
64493016|NCT01893827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493017|NCT01893827|Sensory System Agents|sensory system agents|mesh-ancestor
64493018|NCT01893827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64493019|NCT01882907|Pioglitazone|pioglitazone|mesh-list
64493020|NCT01882907|Vildagliptin|vildagliptin|mesh-list
64493021|NCT01882907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64493022|NCT01882907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493023|NCT01882907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64493024|NCT01882907|Protease Inhibitors|protease inhibitors|mesh-ancestor
64493025|NCT01882907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493026|NCT01882907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493027|NCT01051570|Prednisone|prednisone|mesh-list
64493028|NCT01051570|Carboplatin|carboplatin|mesh-list
64493029|NCT01051570|Everolimus|everolimus|mesh-list
64493030|NCT01051570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493031|NCT01051570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64493032|NCT01051570|Glucocorticoids|glucocorticoids|mesh-ancestor
64493033|NCT01051570|Hormones|hormones|mesh-ancestor
64493034|NCT01051570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64493035|NCT01051570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493036|NCT01051570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64493037|NCT01051570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64493038|NCT01051570|Immunologic Factors|immunologic factors|mesh-ancestor
64493039|NCT01893281|Methyltestosterone|methyltestosterone|mesh-list
64493040|NCT01893281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64493041|NCT01893281|Testosterone|testosterone|mesh-list
64493042|NCT01893281|Testosterone undecanoate|testosterone undecanoate|mesh-list
64493043|NCT01893281|Testosterone enanthate|testosterone enanthate|mesh-list
64493044|NCT01893281|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64493045|NCT01893281|Androgens|androgens|mesh-ancestor
64493070|NCT04415567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493072|NCT05256537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64493073|NCT05256537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493074|NCT05256537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64493075|NCT05256537|Antitubercular Agents|antitubercular agents|mesh-ancestor
64493076|NCT05256537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64493077|NCT05256537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64493078|NCT05256537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493079|NCT05256537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493080|NCT03280251|Methylphenidate|methylphenidate|mesh-list
65354073|NCT00754962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354074|NCT00754962|Adrenergic Agents|adrenergic agents|mesh-ancestor
65354075|NCT00754962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354076|NCT00754962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354077|NCT00868023|Formoterol Fumarate|formoterol fumarate|mesh-list
65354078|NCT00868023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65354079|NCT00868023|Autonomic Agents|autonomic agents|mesh-ancestor
65354080|NCT00868023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65354081|NCT00868023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354082|NCT00868023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65354083|NCT00868023|Respiratory System Agents|respiratory system agents|mesh-ancestor
65354084|NCT00868023|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65354085|NCT00868023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65354086|NCT00868023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65354087|NCT00868023|Adrenergic Agents|adrenergic agents|mesh-ancestor
65354088|NCT00868023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354089|NCT00868023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354090|NCT05300386|Citalopram|citalopram|mesh-list
65354091|NCT05300386|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65354092|NCT05300386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65354093|NCT05300386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65354094|NCT05300386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354095|NCT05300386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354096|NCT05300386|Serotonin Agents|serotonin agents|mesh-ancestor
65354097|NCT05300386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354098|NCT05300386|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65354099|NCT05300386|Antidepressive Agents|antidepressive agents|mesh-ancestor
64493081|NCT03280251|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64493082|NCT03280251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493083|NCT03280251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64493084|NCT03280251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64493085|NCT03280251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64493086|NCT03280251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493087|NCT03280251|Dopamine Agents|dopamine agents|mesh-ancestor
64493088|NCT03280251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64493090|NCT01882829|Dextromethorphan|dextromethorphan|mesh-list
64493091|NCT01882829|Antitussive Agents|antitussive agents|mesh-ancestor
64493092|NCT01882829|Respiratory System Agents|respiratory system agents|mesh-ancestor
64556266|NCT00927849|Protective Agents|protective agents|mesh-ancestor
64556267|NCT00927849|Vasodilator Agents|vasodilator agents|mesh-ancestor
64556269|NCT04149587|Dermatologic Agents|dermatologic agents|mesh-ancestor
64556270|NCT04992468|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64556271|NCT04992468|Hormones|hormones|mesh-ancestor
65354100|NCT05300386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65354101|NCT00863499|Methylphenidate|methylphenidate|mesh-list
65354102|NCT00863499|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65354103|NCT00863499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354104|NCT00863499|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65354105|NCT00863499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65354106|NCT00863499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65354107|NCT00863499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354108|NCT00863499|Dopamine Agents|dopamine agents|mesh-ancestor
65354109|NCT00863499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354110|NCT00755118|Leucovorin|leucovorin|mesh-list
65354111|NCT00755118|Bevacizumab|bevacizumab|mesh-list
65354112|NCT00755118|Cetuximab|cetuximab|mesh-list
65354113|NCT00755118|Fluorouracil|fluorouracil|mesh-list
65354114|NCT00755118|Oxaliplatin|oxaliplatin|mesh-list
65354115|NCT00755118|Irinotecan|irinotecan|mesh-list
64556272|NCT04992468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64556273|NCT04992468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556274|NCT02985125|Everolimus|everolimus|mesh-list
64556275|NCT02985125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556276|NCT02985125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64556277|NCT02985125|Immunologic Factors|immunologic factors|mesh-ancestor
64556278|NCT02985125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556279|NCT04912596|Albuterol|albuterol|mesh-list
64556280|NCT04912596|Procaterol|procaterol|mesh-list
64556281|NCT04912596|Methacholine Chloride|methacholine chloride|mesh-list
64556282|NCT04912596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64556283|NCT04912596|Autonomic Agents|autonomic agents|mesh-ancestor
64556284|NCT04912596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556285|NCT04912596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556286|NCT04912596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64556287|NCT04912596|Respiratory System Agents|respiratory system agents|mesh-ancestor
64556288|NCT04912596|Tocolytic Agents|tocolytic agents|mesh-ancestor
64556289|NCT04912596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64556290|NCT04912596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64556291|NCT04912596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64556292|NCT04912596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64493110|NCT01882829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64493111|NCT01882829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64493112|NCT01882829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64493113|NCT01882829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64493114|NCT01882829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64493115|NCT04760301|Tranexamic Acid|tranexamic acid|mesh-list
64493116|NCT04760301|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64493117|NCT04760301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64493118|NCT04760301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493119|NCT04760301|Hemostatics|hemostatics|mesh-ancestor
64493120|NCT04760301|Coagulants|coagulants|mesh-ancestor
64493121|NCT04392375|Nifedipine|nifedipine|mesh-list
64493122|NCT04392375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64493123|NCT04392375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64493124|NCT04392375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493125|NCT04392375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64493126|NCT04392375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556293|NCT04912596|Adrenergic Agents|adrenergic agents|mesh-ancestor
64556294|NCT04912596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64556295|NCT04912596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556297|NCT04912596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65354116|NCT00755118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65354117|NCT00755118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65354118|NCT00755118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65354119|NCT00755118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65354120|NCT00755118|Growth Substances|growth substances|mesh-ancestor
65354121|NCT00755118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354122|NCT00755118|Growth Inhibitors|growth inhibitors|mesh-ancestor
65354123|NCT00755118|Antimetabolites|antimetabolites|mesh-ancestor
65354124|NCT00755118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354125|NCT00755118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65354126|NCT00755118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65354127|NCT00755118|Immunologic Factors|immunologic factors|mesh-ancestor
65354128|NCT00755118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65354131|NCT00755118|Antidotes|antidotes|mesh-ancestor
65354177|NCT00868413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65354178|NCT00868413|Immunologic Factors|immunologic factors|mesh-ancestor
65354179|NCT00868413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354180|NCT00868413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65354181|NCT00868413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65354182|NCT00868413|Alkylating Agents|alkylating agents|mesh-ancestor
65354183|NCT00868413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354184|NCT00868413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65354185|NCT00868413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65354186|NCT00868413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65354187|NCT03897348|Lacosamide|lacosamide|mesh-list
65354188|NCT03897348|Anticonvulsants|anticonvulsants|mesh-ancestor
65354189|NCT03897348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65354190|NCT03897348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65354191|NCT03897348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65354192|NCT03897348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354193|NCT04010578|Vitamin D|vitamin d|mesh-list
65354194|NCT04010578|Cholecalciferol|cholecalciferol|mesh-list
65354195|NCT04010578|Vitamins|vitamins|mesh-ancestor
65354196|NCT04010578|Micronutrients|micronutrients|mesh-ancestor
65354197|NCT04010578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354198|NCT04010578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65354199|NCT04010578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65354200|NCT00868491|Cisplatin|cisplatin|mesh-list
65354201|NCT00868491|Docetaxel|docetaxel|mesh-list
65354202|NCT00868491|Fluorouracil|fluorouracil|mesh-list
65354203|NCT00868491|Cetuximab|cetuximab|mesh-list
64556298|NCT04912596|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
64556299|NCT04912596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64556300|NCT04912596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64556301|NCT04912596|Cholinergic Agents|cholinergic agents|mesh-ancestor
64556302|NCT04912596|Sympathomimetics|sympathomimetics|mesh-ancestor
64493127|NCT04392375|Vasodilator Agents|vasodilator agents|mesh-ancestor
64493129|NCT04392375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64493130|NCT01054768|Thioctic Acid|thioctic acid|mesh-list
64493131|NCT01054768|Acetylcarnitine|acetylcarnitine|mesh-list
64493132|NCT01054768|Antioxidants|antioxidants|mesh-ancestor
64493133|NCT01054768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493134|NCT01054768|Protective Agents|protective agents|mesh-ancestor
64493135|NCT01054768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493136|NCT01054768|Vitamin B Complex|vitamin b complex|mesh-ancestor
64493137|NCT01054768|Vitamins|vitamins|mesh-ancestor
64493138|NCT01054768|Micronutrients|micronutrients|mesh-ancestor
64493139|NCT01054768|Nootropic Agents|nootropic agents|mesh-ancestor
64493140|NCT04387617|Cannabidiol|cannabidiol|mesh-list
64493141|NCT04387617|Anticonvulsants|anticonvulsants|mesh-ancestor
64493142|NCT01055704|Naltrexone|naltrexone|mesh-list
64493143|NCT01055704|Codeine|codeine|mesh-list
64493144|NCT01055704|Methylnaltrexone|methylnaltrexone|mesh-list
64493145|NCT01055704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65354204|NCT00868491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65354205|NCT00868491|Tubulin Modulators|tubulin modulators|mesh-ancestor
65354206|NCT00868491|Antimitotic Agents|antimitotic agents|mesh-ancestor
65354207|NCT00868491|Mitosis Modulators|mitosis modulators|mesh-ancestor
65354208|NCT00868491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354209|NCT00868491|Antimetabolites|antimetabolites|mesh-ancestor
65354210|NCT00868491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65354211|NCT00868491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65354212|NCT00868491|Immunologic Factors|immunologic factors|mesh-ancestor
65354213|NCT00868491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354214|NCT00868491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65354215|NCT00955630|Ranibizumab|ranibizumab|mesh-list
65354216|NCT00955630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65354217|NCT00955630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65354218|NCT00955630|Growth Substances|growth substances|mesh-ancestor
65354219|NCT00955630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354220|NCT00955630|Growth Inhibitors|growth inhibitors|mesh-ancestor
65354221|NCT00955630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65354222|NCT00868569|Leucovorin|leucovorin|mesh-list
65354223|NCT00868569|Fluorouracil|fluorouracil|mesh-list
65354224|NCT00868569|Oxaliplatin|oxaliplatin|mesh-list
65354225|NCT00868569|Antimetabolites|antimetabolites|mesh-ancestor
65354226|NCT00868569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354227|NCT00868569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65354228|NCT00868569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65354253|NCT00549562|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65354254|NCT00549562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65354255|NCT00549562|Dopamine Agents|dopamine agents|mesh-ancestor
65354256|NCT00860925|Clonidine|clonidine|mesh-list
65354257|NCT00860925|Analgesics|analgesics|mesh-ancestor
65354258|NCT00860925|Sensory System Agents|sensory system agents|mesh-ancestor
65354259|NCT00860925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65354260|NCT00860925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354261|NCT00860925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65354262|NCT00860925|Sympatholytics|sympatholytics|mesh-ancestor
65354263|NCT00860925|Autonomic Agents|autonomic agents|mesh-ancestor
65354264|NCT00860925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65354265|NCT00860925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65354266|NCT00860925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65354267|NCT00860925|Adrenergic Agents|adrenergic agents|mesh-ancestor
65354268|NCT00860925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354269|NCT00860925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354270|NCT04237012|Dexamethasone|dexamethasone|mesh-list
65354271|NCT04237012|Lubricant Eye Drops|lubricant eye drops|mesh-list
65354272|NCT04237012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65354273|NCT04237012|Antiemetics|antiemetics|mesh-ancestor
65354274|NCT04237012|Autonomic Agents|autonomic agents|mesh-ancestor
65354275|NCT04237012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65354276|NCT04237012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354277|NCT04237012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65354278|NCT04237012|Glucocorticoids|glucocorticoids|mesh-ancestor
65354279|NCT04237012|Hormones|hormones|mesh-ancestor
65354280|NCT04237012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65354281|NCT04237012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65354282|NCT04237012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65354283|NCT04237012|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65354284|NCT04237012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65354285|NCT00863889|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65354286|NCT00863889|Methylprednisolone|methylprednisolone|mesh-list
65354287|NCT00863889|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65354288|NCT00863889|Prednisolone|prednisolone|mesh-list
65354289|NCT00863889|Prednisolone acetate|prednisolone acetate|mesh-list
65354290|NCT00863889|Lidocaine|lidocaine|mesh-list
64493146|NCT01055704|Narcotics|narcotics|mesh-ancestor
65354291|NCT00863889|Bupivacaine|bupivacaine|mesh-list
65354292|NCT00863889|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65354293|NCT00863889|Prednisolone phosphate|prednisolone phosphate|mesh-list
65354294|NCT00863889|Anesthetics, Local|anesthetics, local|mesh-ancestor
65354295|NCT00863889|Anesthetics|anesthetics|mesh-ancestor
65354296|NCT00863889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65354297|NCT00863889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354298|NCT00863889|Sensory System Agents|sensory system agents|mesh-ancestor
65354299|NCT00863889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65354300|NCT00863889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65354301|NCT00863889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65354302|NCT00863889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65354303|NCT00863889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65354304|NCT00863889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354305|NCT00863889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65354306|NCT00863889|Antiemetics|antiemetics|mesh-ancestor
65354307|NCT00863889|Autonomic Agents|autonomic agents|mesh-ancestor
65354308|NCT00863889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65354309|NCT00863889|Glucocorticoids|glucocorticoids|mesh-ancestor
65354310|NCT00863889|Hormones|hormones|mesh-ancestor
65354311|NCT00863889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65354312|NCT00863889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65354313|NCT00863889|Protective Agents|protective agents|mesh-ancestor
65354314|NCT00863889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65354315|NCT00863889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65354316|NCT00677352|Sertraline|sertraline|mesh-list
65354317|NCT00677352|Paroxetine|paroxetine|mesh-list
65354318|NCT00677352|Antidepressive Agents|antidepressive agents|mesh-ancestor
65354319|NCT00677352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65354320|NCT00677352|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65354321|NCT00677352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65354325|NCT00677352|Serotonin Agents|serotonin agents|mesh-ancestor
65354332|NCT00864045|Sertindole|sertindole|mesh-list
65354333|NCT00864045|Antiemetics|antiemetics|mesh-ancestor
65354334|NCT00864045|Autonomic Agents|autonomic agents|mesh-ancestor
65354335|NCT00864045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65354336|NCT00864045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354337|NCT00864045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65354338|NCT00864045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65354339|NCT00864045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65354340|NCT00864045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65354341|NCT00864045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65354342|NCT00864045|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65354343|NCT00864045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65354344|NCT00864045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65354345|NCT00864045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354346|NCT00864045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354347|NCT00864045|Serotonin Agents|serotonin agents|mesh-ancestor
65354348|NCT00755508|Gabapentin|gabapentin|mesh-list
65354349|NCT00755508|Analgesics|analgesics|mesh-ancestor
65354350|NCT00755508|Sensory System Agents|sensory system agents|mesh-ancestor
65354351|NCT00755508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65354352|NCT00755508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354353|NCT00755508|Anticonvulsants|anticonvulsants|mesh-ancestor
65354354|NCT00755508|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65354355|NCT00755508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65354356|NCT00755508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65354357|NCT00755508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65354358|NCT00755508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65354359|NCT00755508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65354360|NCT00755508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354361|NCT00755508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354362|NCT00755508|Antimanic Agents|antimanic agents|mesh-ancestor
65354363|NCT03680352|Cefepime|cefepime|mesh-list
65354364|NCT03680352|Enmetazobactam|enmetazobactam|mesh-list
65354365|NCT03680352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65354371|NCT00864201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65354372|NCT00864201|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65354373|NCT00864201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354374|NCT00864279|Cetirizine|cetirizine|mesh-list
65354375|NCT00864279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65354376|NCT00864279|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65354377|NCT00864279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65354378|NCT00864279|Histamine Antagonists|histamine antagonists|mesh-ancestor
65354379|NCT00864279|Histamine Agents|histamine agents|mesh-ancestor
65354380|NCT00864279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354381|NCT00864279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354382|NCT00864279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354383|NCT02559648|Denosumab|denosumab|mesh-list
65354384|NCT02559648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65354385|NCT02559648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354386|NCT00864357|Ibuprofen|ibuprofen|mesh-list
65354387|NCT00864357|Oxycodone|oxycodone|mesh-list
65354388|NCT00864357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65354389|NCT00864357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65354390|NCT00864357|Analgesics|analgesics|mesh-ancestor
65354391|NCT00864357|Sensory System Agents|sensory system agents|mesh-ancestor
65354392|NCT00864357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64746516|NCT01524978|Vemurafenib|vemurafenib|mesh-list
64493147|NCT01055704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64493148|NCT01055704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493175|NCT04400019|Antimalarials|antimalarials|mesh-ancestor
64493176|NCT04400019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64493177|NCT04400019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64493178|NCT04400019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64493179|NCT04400019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493180|NCT04400019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493181|NCT04400019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64493182|NCT05225805|Lefamulin|lefamulin|mesh-list
64493183|NCT05225805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64493184|NCT05225805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64493185|NCT03915405|Avelumab|avelumab|mesh-list
64493186|NCT03915405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64493187|NCT03915405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493188|NCT04351581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64493189|NCT04351581|Protease Inhibitors|protease inhibitors|mesh-ancestor
64493190|NCT04351581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493191|NCT04351581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493192|NCT04344873|Abatacept|abatacept|mesh-list
64493193|NCT04344873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64493194|NCT04344873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493195|NCT04344873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493221|NCT03870399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64493223|NCT03867201|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64493224|NCT03867201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493225|NCT03867201|Analgesics|analgesics|mesh-ancestor
65354393|NCT00864357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354394|NCT00864357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65354395|NCT00864357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65354396|NCT00864357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65354397|NCT00864357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354398|NCT00864357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354399|NCT00864357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65354400|NCT00864357|Narcotics|narcotics|mesh-ancestor
65354401|NCT00864357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65354402|NCT00864435|Carvedilol|carvedilol|mesh-list
65354403|NCT00864435|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65354404|NCT00864435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65354405|NCT00864435|Adrenergic Agents|adrenergic agents|mesh-ancestor
65354406|NCT00864435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354407|NCT00864435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354408|NCT00864435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354409|NCT00864435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65354410|NCT00864435|Antioxidants|antioxidants|mesh-ancestor
65354411|NCT00864435|Protective Agents|protective agents|mesh-ancestor
65354412|NCT00864435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65354413|NCT00864435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65354414|NCT00864435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65354415|NCT00864435|Vasodilator Agents|vasodilator agents|mesh-ancestor
65354416|NCT00864435|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65354417|NCT00864435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65354418|NCT00755664|Vitamins|vitamins|mesh-list
65354419|NCT00755664|Vitamin B Complex|vitamin b complex|mesh-list
65354420|NCT00755664|Micronutrients|micronutrients|mesh-ancestor
65354421|NCT00755664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354422|NCT00956098|Oltipraz|oltipraz|mesh-list
65354423|NCT00956098|Antiviral Agents|antiviral agents|mesh-ancestor
65354424|NCT00956098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65354425|NCT00956098|Schistosomicides|schistosomicides|mesh-ancestor
65354426|NCT00956098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65354427|NCT00956098|Anthelmintics|anthelmintics|mesh-ancestor
65354428|NCT00956098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64493226|NCT03867201|Sensory System Agents|sensory system agents|mesh-ancestor
64493227|NCT03867201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65354429|NCT00956098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65354430|NCT00956098|Protective Agents|protective agents|mesh-ancestor
65354431|NCT00956098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354432|NCT00956098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65354433|NCT00956098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65354434|NCT00956098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65354435|NCT00956098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354436|NCT00956098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354437|NCT00864591|Adenosine|adenosine|mesh-list
65104274|NCT02920931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354438|NCT00864591|Analgesics|analgesics|mesh-ancestor
65354439|NCT00864591|Sensory System Agents|sensory system agents|mesh-ancestor
65354440|NCT00864591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65354441|NCT00864591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354442|NCT00864591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65354443|NCT00864591|Vasodilator Agents|vasodilator agents|mesh-ancestor
65354444|NCT00864591|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65354445|NCT00864591|Purinergic Agonists|purinergic agonists|mesh-ancestor
65354446|NCT00864591|Purinergic Agents|purinergic agents|mesh-ancestor
65354447|NCT00864591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354448|NCT00864591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354449|NCT05350384|Methylprednisolone|methylprednisolone|mesh-list
65354450|NCT05350384|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65354451|NCT05350384|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65354453|NCT05350384|Prednisolone acetate|prednisolone acetate|mesh-list
65354454|NCT05350384|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65354455|NCT05350384|Prednisolone phosphate|prednisolone phosphate|mesh-list
65354456|NCT05350384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65354457|NCT05350384|Antiemetics|antiemetics|mesh-ancestor
65354458|NCT05350384|Autonomic Agents|autonomic agents|mesh-ancestor
64493228|NCT03867201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493230|NCT04333407|Omeprazole|omeprazole|mesh-list
64493231|NCT04333407|Rivaroxaban|rivaroxaban|mesh-list
64493232|NCT04333407|Clopidogrel|clopidogrel|mesh-list
64493233|NCT04333407|Atorvastatin|atorvastatin|mesh-list
64493234|NCT04333407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64493235|NCT04333407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64493236|NCT04333407|Analgesics|analgesics|mesh-ancestor
64556303|NCT00936741|Mifepristone|mifepristone|mesh-list
64556304|NCT00936741|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64556305|NCT00936741|Abortifacient Agents|abortifacient agents|mesh-ancestor
64556306|NCT00936741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64556307|NCT00936741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556308|NCT00936741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65354459|NCT05350384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65354460|NCT05350384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354461|NCT05350384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65354462|NCT05350384|Glucocorticoids|glucocorticoids|mesh-ancestor
65354463|NCT05350384|Hormones|hormones|mesh-ancestor
65354464|NCT05350384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65354465|NCT05350384|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65354466|NCT05350384|Protective Agents|protective agents|mesh-ancestor
65354467|NCT05350384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65354468|NCT05350384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65354469|NCT00870441|Valacyclovir|valacyclovir|mesh-list
65354470|NCT00870441|Antiviral Agents|antiviral agents|mesh-ancestor
65354471|NCT00870441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65354472|NCT04079452|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65354473|NCT04079452|Antiviral Agents|antiviral agents|mesh-ancestor
65354474|NCT04079452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65354475|NCT04079452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65354476|NCT04079452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65354477|NCT04079452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354478|NCT04079452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556309|NCT00936741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64556310|NCT00936741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64556311|NCT00936741|Contraceptive Agents|contraceptive agents|mesh-ancestor
64556312|NCT00936741|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64556313|NCT00936741|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64556314|NCT00936741|Hormone Antagonists|hormone antagonists|mesh-ancestor
64321376|NCT05508152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64493237|NCT04333407|Sensory System Agents|sensory system agents|mesh-ancestor
64493238|NCT04333407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64493239|NCT04333407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493240|NCT04333407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64493241|NCT04333407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64493242|NCT04333407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64493243|NCT04333407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64493244|NCT04333407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493255|NCT04333407|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64493256|NCT04333407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64493257|NCT04333407|Purinergic Agents|purinergic agents|mesh-ancestor
64493258|NCT04333407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64493259|NCT04333407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64493260|NCT04333407|Antithrombins|antithrombins|mesh-ancestor
64493261|NCT04333407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64493262|NCT04333407|Protease Inhibitors|protease inhibitors|mesh-ancestor
64493263|NCT04333407|Anticoagulants|anticoagulants|mesh-ancestor
64493264|NCT04333407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64493265|NCT04333407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64493266|NCT04333407|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64493267|NCT04398927|Folfirinox|folfirinox|mesh-list
64493268|NCT04398927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493269|NCT01059682|Dalcetrapib|dalcetrapib|mesh-list
64493270|NCT01059682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64493273|NCT01059682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493274|NCT01059682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65354479|NCT04079452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65354480|NCT04079452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65354481|NCT00864669|Metformin|metformin|mesh-list
65354482|NCT00864669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65354483|NCT00864669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354484|NCT00864747|Propranolol|propranolol|mesh-list
65354485|NCT00864747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65354486|NCT00864747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65354487|NCT00864747|Adrenergic Agents|adrenergic agents|mesh-ancestor
65354488|NCT00864747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354489|NCT00864747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354490|NCT00864747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354491|NCT00864747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65354492|NCT00864747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65354493|NCT00864747|Vasodilator Agents|vasodilator agents|mesh-ancestor
65354494|NCT05279716|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65354495|NCT05279716|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65354496|NCT02559102|Dexmedetomidine|dexmedetomidine|mesh-list
65354497|NCT02559102|Anesthetics|anesthetics|mesh-list
65354498|NCT02559102|Sevoflurane|sevoflurane|mesh-list
65354499|NCT02559102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65354500|NCT02559102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354501|NCT02559102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65354502|NCT02559102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65354503|NCT02559102|Analgesics|analgesics|mesh-ancestor
65354504|NCT02559102|Sensory System Agents|sensory system agents|mesh-ancestor
65354505|NCT02559102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65354506|NCT02559102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64493276|NCT04399083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64493277|NCT04399083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493278|NCT04399083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64493279|NCT04399083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493280|NCT04399083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493281|NCT04399083|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64493282|NCT04399083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64493283|NCT04399083|Purinergic Agents|purinergic agents|mesh-ancestor
64493284|NCT04399083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64493286|NCT01892345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64493287|NCT01892345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64493288|NCT01892345|Immunologic Factors|immunologic factors|mesh-ancestor
64493289|NCT01892345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493290|NCT01059994|Sildenafil Citrate|sildenafil citrate|mesh-list
64493291|NCT01059994|Vasodilator Agents|vasodilator agents|mesh-ancestor
64493292|NCT01059994|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64556315|NCT00936741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65354507|NCT02559102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65354508|NCT02559102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65354509|NCT02559102|Adrenergic Agents|adrenergic agents|mesh-ancestor
65354510|NCT02559102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354511|NCT02559102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104397|NCT00623857|Zinc|zinc|mesh-list
65354512|NCT02559102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65354513|NCT02559102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65354514|NCT02559102|Anesthetics, General|anesthetics, general|mesh-ancestor
65354515|NCT05348668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65354516|NCT05348668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354517|NCT05348668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65354518|NCT00864825|Allopurinol|allopurinol|mesh-list
65354519|NCT00864825|Antimetabolites|antimetabolites|mesh-ancestor
65354520|NCT00864825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354521|NCT00864825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354522|NCT00864825|Gout Suppressants|gout suppressants|mesh-ancestor
65354523|NCT00864825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65354524|NCT00864825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65354525|NCT00864825|Antioxidants|antioxidants|mesh-ancestor
65354526|NCT00864825|Protective Agents|protective agents|mesh-ancestor
65354527|NCT00864825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556316|NCT00936741|Luteolytic Agents|luteolytic agents|mesh-ancestor
64556317|NCT00936741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64556318|NCT00936741|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64556319|NCT04024865|Domperidone|domperidone|mesh-list
64556320|NCT04024865|Antiemetics|antiemetics|mesh-ancestor
64556321|NCT04024865|Autonomic Agents|autonomic agents|mesh-ancestor
64556322|NCT04024865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556323|NCT04024865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556324|NCT04024865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64493293|NCT01059994|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64493294|NCT01059994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493295|NCT01059994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493296|NCT01059994|Urological Agents|urological agents|mesh-ancestor
64493297|NCT03819465|Gemcitabine|gemcitabine|mesh-list
64493299|NCT03819465|Carboplatin|carboplatin|mesh-list
64493300|NCT03819465|Pemetrexed|pemetrexed|mesh-list
64493301|NCT03819465|Durvalumab|durvalumab|mesh-list
64493302|NCT03819465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64493303|NCT03819465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493304|NCT03819465|Tubulin Modulators|tubulin modulators|mesh-ancestor
64493305|NCT03819465|Antimitotic Agents|antimitotic agents|mesh-ancestor
64493306|NCT03819465|Mitosis Modulators|mitosis modulators|mesh-ancestor
64493307|NCT03819465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493321|NCT01111318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493322|NCT01111318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64493323|NCT01111318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493324|NCT05165433|Pembrolizumab|pembrolizumab|mesh-list
64493325|NCT05165433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64493326|NCT05165433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493327|NCT01892189|Ketamine|ketamine|mesh-list
65354529|NCT00956176|Antiviral Agents|antiviral agents|mesh-ancestor
65354530|NCT00956176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65354531|NCT00956176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354532|NCT00956176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354533|NCT00864981|Bupropion|bupropion|mesh-list
65354534|NCT00864981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65354535|NCT00864981|Antidepressive Agents|antidepressive agents|mesh-ancestor
65354536|NCT00864981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65354537|NCT00864981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65354538|NCT00864981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65354539|NCT00864981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65354540|NCT00864981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354541|NCT00864981|Dopamine Agents|dopamine agents|mesh-ancestor
65354542|NCT00864981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354543|NCT00864981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354544|NCT00864981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65354545|NCT00864981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65354546|NCT00864981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354547|NCT00371683|Enoxaparin|enoxaparin|mesh-list
64493328|NCT01892189|Analgesics|analgesics|mesh-ancestor
64493329|NCT01892189|Sensory System Agents|sensory system agents|mesh-ancestor
64493330|NCT01892189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64493331|NCT01892189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493332|NCT01892189|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64493333|NCT01892189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64493334|NCT01892189|Anesthetics, General|anesthetics, general|mesh-ancestor
64493335|NCT01892189|Anesthetics|anesthetics|mesh-ancestor
64493336|NCT01892189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64493337|NCT01892189|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64493338|NCT01892189|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64493339|NCT01892189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64493340|NCT01892189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493341|NCT01062568|Dexamethasone|dexamethasone|mesh-list
64493344|NCT01062568|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64493346|NCT01062568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64493347|NCT01062568|Antiemetics|antiemetics|mesh-ancestor
64493348|NCT01062568|Autonomic Agents|autonomic agents|mesh-ancestor
64493349|NCT01062568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64493351|NCT01062568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64493352|NCT01062568|Glucocorticoids|glucocorticoids|mesh-ancestor
64493353|NCT01062568|Hormones|hormones|mesh-ancestor
64493354|NCT01062568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64493355|NCT01062568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64493356|NCT01062568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493357|NCT01062568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64493358|NCT01062568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493359|NCT05155137|Amlodipine|amlodipine|mesh-list
64493360|NCT05155137|Valsartan|valsartan|mesh-list
64556325|NCT04024865|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64556326|NCT04024865|Dopamine Agents|dopamine agents|mesh-ancestor
64556327|NCT04024865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64556328|NCT04024865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556329|NCT04024241|Cytarabine|cytarabine|mesh-list
65354548|NCT00371683|Apixaban|apixaban|mesh-list
65354549|NCT00371683|Anticoagulants|anticoagulants|mesh-ancestor
65354550|NCT00371683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65354551|NCT00371683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65354552|NCT00371683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354553|NCT00371683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65354554|NCT00371683|Antithrombins|antithrombins|mesh-ancestor
65354555|NCT00371683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65354556|NCT00371683|Protease Inhibitors|protease inhibitors|mesh-ancestor
65354557|NCT00371683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354558|NCT00876135|Albuterol|albuterol|mesh-list
65354559|NCT00876135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65354560|NCT00876135|Autonomic Agents|autonomic agents|mesh-ancestor
65354561|NCT00876135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65354562|NCT00876135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354563|NCT00876135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65354564|NCT00876135|Respiratory System Agents|respiratory system agents|mesh-ancestor
65354565|NCT00876135|Tocolytic Agents|tocolytic agents|mesh-ancestor
65354566|NCT00876135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65354567|NCT00876135|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65354568|NCT00876135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65354569|NCT00876135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65354570|NCT00876135|Adrenergic Agents|adrenergic agents|mesh-ancestor
65354571|NCT00876135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354572|NCT00876135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354573|NCT04039815|Ascorbic Acid|ascorbic acid|mesh-list
64556330|NCT04024241|Mitoxantrone|mitoxantrone|mesh-list
64556331|NCT04024241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64556332|NCT04024241|Antimetabolites|antimetabolites|mesh-ancestor
64556333|NCT04024241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556334|NCT04024241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556335|NCT04024241|Antiviral Agents|antiviral agents|mesh-ancestor
64556336|NCT04024241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64556337|NCT04024241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64556338|NCT04024241|Immunologic Factors|immunologic factors|mesh-ancestor
64493361|NCT05155137|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64493362|NCT05155137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64493363|NCT05155137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64493364|NCT05155137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64493365|NCT05155137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493366|NCT05155137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64493367|NCT05155137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493368|NCT05155137|Vasodilator Agents|vasodilator agents|mesh-ancestor
64493369|NCT05155137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64493386|NCT01064362|PENTA|penta|mesh-list
64493387|NCT01064362|Fondaparinux|fondaparinux|mesh-list
64493388|NCT01064362|Anticoagulants|anticoagulants|mesh-ancestor
64493389|NCT01064362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65354574|NCT04039815|Thiamine|thiamine|mesh-list
65354575|NCT04039815|Hydrocortisone|hydrocortisone|mesh-list
65354576|NCT04039815|Vitamins|vitamins|mesh-ancestor
65354577|NCT04039815|Micronutrients|micronutrients|mesh-ancestor
65354578|NCT04039815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354579|NCT04039815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65354580|NCT04039815|Vitamin B Complex|vitamin b complex|mesh-ancestor
65354581|NCT04039815|Antioxidants|antioxidants|mesh-ancestor
65354582|NCT04039815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354583|NCT04039815|Protective Agents|protective agents|mesh-ancestor
65354584|NCT00870987|Vaccines|vaccines|mesh-list
65354585|NCT00870987|Immunologic Factors|immunologic factors|mesh-ancestor
65354586|NCT00870987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354587|NCT00871065|Sildenafil Citrate|sildenafil citrate|mesh-list
65354588|NCT00871065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354589|NCT00871065|Vasodilator Agents|vasodilator agents|mesh-ancestor
65354590|NCT00871065|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64746725|NCT01519674|Hormones|hormones|mesh-ancestor
64493390|NCT01064362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64493391|NCT01064362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493392|NCT01064362|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64493393|NCT01064362|Antithrombins|antithrombins|mesh-ancestor
64493394|NCT01064362|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64493395|NCT01064362|Protease Inhibitors|protease inhibitors|mesh-ancestor
64493396|NCT01064362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493397|NCT03646461|Nivolumab|nivolumab|mesh-list
64493398|NCT03646461|Cetuximab|cetuximab|mesh-list
64493399|NCT03646461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64493400|NCT03646461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493401|NCT03646461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64493402|NCT03646461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493403|NCT01880957|Lamotrigine|lamotrigine|mesh-list
64493404|NCT01880957|Lithium Carbonate|lithium carbonate|mesh-list
64493405|NCT01880957|Antidepressive Agents|antidepressive agents|mesh-ancestor
64493406|NCT01880957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64493407|NCT01880957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493408|NCT01880957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493409|NCT01880957|Antimanic Agents|antimanic agents|mesh-ancestor
64493410|NCT01880957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64493411|NCT01880957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64493412|NCT01880957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493413|NCT01880957|Anticonvulsants|anticonvulsants|mesh-ancestor
64493414|NCT01880957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64493415|NCT01880957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64493416|NCT01880957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64493417|NCT01880957|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64493424|NCT01064830|Immunologic Factors|immunologic factors|mesh-ancestor
64493425|NCT01064830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493426|NCT01064830|Antifungal Agents|antifungal agents|mesh-ancestor
64493427|NCT01064830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64493428|NCT01064830|Dermatologic Agents|dermatologic agents|mesh-ancestor
64556339|NCT04024241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556341|NCT04024241|Sensory System Agents|sensory system agents|mesh-ancestor
64493434|NCT01890785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64493435|NCT01890785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64493436|NCT01890785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64493437|NCT01890785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354591|NCT00871065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65354592|NCT00871065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354593|NCT00871065|Urological Agents|urological agents|mesh-ancestor
65354595|NCT00962026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65354596|NCT05212012|Methadone|methadone|mesh-list
65354597|NCT05212012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65354598|NCT05212012|Narcotics|narcotics|mesh-ancestor
65354599|NCT05212012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65354600|NCT05212012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354601|NCT05212012|Analgesics|analgesics|mesh-ancestor
65354602|NCT05212012|Sensory System Agents|sensory system agents|mesh-ancestor
65354603|NCT05212012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65354604|NCT05212012|Antitussive Agents|antitussive agents|mesh-ancestor
65354605|NCT05212012|Respiratory System Agents|respiratory system agents|mesh-ancestor
65354606|NCT00616239|Salicylic Acid|salicylic acid|mesh-list
65354607|NCT00616239|Salicylates|salicylates|mesh-list
65354608|NCT00616239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65354609|NCT00616239|Antifungal Agents|antifungal agents|mesh-ancestor
65354610|NCT00616239|Keratolytic Agents|keratolytic agents|mesh-ancestor
65354611|NCT00616239|Dermatologic Agents|dermatologic agents|mesh-ancestor
65354612|NCT00616239|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65354613|NCT00616239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65354614|NCT00616239|Analgesics|analgesics|mesh-ancestor
65354615|NCT00616239|Sensory System Agents|sensory system agents|mesh-ancestor
65354616|NCT00616239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65354617|NCT00616239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354618|NCT00616239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65354619|NCT00616239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65354620|NCT00616239|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65354621|NCT00616239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354622|NCT00616239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354623|NCT00547534|Rituximab|rituximab|mesh-list
65354624|NCT00547534|Bortezomib|bortezomib|mesh-list
65354625|NCT00547534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64493438|NCT01890785|Dopamine Agents|dopamine agents|mesh-ancestor
64493439|NCT01890785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64493440|NCT04616963|Tenofovir|tenofovir|mesh-list
64493441|NCT04616963|Emtricitabine|emtricitabine|mesh-list
64493456|NCT04398771|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64493457|NCT04398771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64493458|NCT04398771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64493459|NCT04398771|Antimetabolites|antimetabolites|mesh-ancestor
65354626|NCT00547534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65354627|NCT00547534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65354628|NCT00547534|Immunologic Factors|immunologic factors|mesh-ancestor
65354629|NCT00547534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354630|NCT00547534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65354631|NCT00547534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65354632|NCT00547534|Alkylating Agents|alkylating agents|mesh-ancestor
65354633|NCT00547534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354634|NCT00871455|Baclofen|baclofen|mesh-list
65354635|NCT00871455|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65354636|NCT00871455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354637|NCT00871455|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65354638|NCT00871455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65354639|NCT00871455|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65354640|NCT00871455|GABA Agonists|gaba agonists|mesh-ancestor
65354641|NCT00871455|GABA Agents|gaba agents|mesh-ancestor
65354642|NCT00871455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354643|NCT00871455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354644|NCT00871533|Interferon-alpha|interferon-alpha|mesh-list
65354645|NCT00871533|Interferon alpha-2|interferon alpha-2|mesh-list
65354646|NCT00871533|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65354647|NCT00871533|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65354648|NCT00871533|Antiviral Agents|antiviral agents|mesh-ancestor
65354649|NCT00871533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65354650|NCT00871533|Immunologic Factors|immunologic factors|mesh-ancestor
65354651|NCT00871533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354652|NCT00871533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65354653|NCT00877149|Telbivudine|telbivudine|mesh-list
65354654|NCT00877149|Antiviral Agents|antiviral agents|mesh-ancestor
65354655|NCT00877149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65354656|NCT00877149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65354657|NCT00877149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354658|NCT00877149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354659|NCT02968108|Ustekinumab|ustekinumab|mesh-list
65354660|NCT02968108|Dermatologic Agents|dermatologic agents|mesh-ancestor
65104509|NCT01279447|Bupivacaine|bupivacaine|mesh-list
64493460|NCT04398771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493461|NCT04398771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65354661|NCT00877227|Leucovorin|leucovorin|mesh-list
65354662|NCT00877227|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
65354663|NCT00877227|Levoleucovorin|levoleucovorin|mesh-list
65354664|NCT00877227|Antidotes|antidotes|mesh-ancestor
65354665|NCT00877227|Protective Agents|protective agents|mesh-ancestor
65354666|NCT00877227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354667|NCT00877227|Vitamin B Complex|vitamin b complex|mesh-ancestor
65354669|NCT00877227|Micronutrients|micronutrients|mesh-ancestor
65354670|NCT00871767|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
65354671|NCT00871767|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65354672|NCT00871767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354673|NCT00871767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65354674|NCT00871767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65354675|NCT00871767|Antiviral Agents|antiviral agents|mesh-ancestor
65354676|NCT00871767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64746804|NCT01484496|Belimumab|belimumab|mesh-list
64493462|NCT04398771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64493463|NCT04398771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493464|NCT04398771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64493465|NCT04398771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64493466|NCT04398771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64493467|NCT01863953|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64493468|NCT01863953|Bimatoprost|bimatoprost|mesh-list
64493469|NCT01863953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64493470|NCT01863953|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64493471|NCT01863953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64493472|NCT01863953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64493473|NCT01863953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64493474|NCT01863953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64493475|NCT01863953|Adrenergic Agents|adrenergic agents|mesh-ancestor
64493476|NCT01863953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64493477|NCT01863953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493478|NCT01863953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493479|NCT01068964|Timolol|timolol|mesh-list
64493488|NCT01068964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493489|NCT01068964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64493490|NCT01068964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64493491|NCT03217162|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64493492|NCT03217162|Respiratory System Agents|respiratory system agents|mesh-ancestor
64493494|NCT05111145|Elexacaftor|elexacaftor|mesh-list
64493495|NCT05111145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64493496|NCT05111145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64493497|NCT05111145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493498|NCT02984475|Metformin|metformin|mesh-list
64556346|NCT04024163|Benzonidazole|benzonidazole|mesh-list
64556347|NCT04024163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64556348|NCT04024163|Immunologic Factors|immunologic factors|mesh-ancestor
64556349|NCT04024163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556350|NCT04024163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64556351|NCT04024163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64556352|NCT04024163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64321428|NCT04714112|Hormones|hormones|mesh-ancestor
64493499|NCT02984475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64493500|NCT02984475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493503|NCT01069354|Anesthetics|anesthetics|mesh-ancestor
64493504|NCT01069354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64746817|NCT01462344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354677|NCT00384397|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65354678|NCT00384397|Immunologic Factors|immunologic factors|mesh-ancestor
65354679|NCT00384397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354680|NCT05119894|Brexpiprazole|brexpiprazole|mesh-list
65354681|NCT05119894|Serotonin Agents|serotonin agents|mesh-ancestor
65354682|NCT05119894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354683|NCT05119894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354684|NCT05119894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354685|NCT05119894|Dopamine Agonists|dopamine agonists|mesh-ancestor
65354686|NCT05119894|Dopamine Agents|dopamine agents|mesh-ancestor
65354687|NCT00877539|Fluticasone|fluticasone|mesh-list
65354688|NCT00877539|Xhance|xhance|mesh-list
65354689|NCT00877539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65354690|NCT00877539|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65354691|NCT00877539|Autonomic Agents|autonomic agents|mesh-ancestor
65354692|NCT00877539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65354693|NCT00877539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354694|NCT00877539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65354695|NCT00877539|Respiratory System Agents|respiratory system agents|mesh-ancestor
65354696|NCT00877539|Dermatologic Agents|dermatologic agents|mesh-ancestor
65354697|NCT00877539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65354698|NCT00872235|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64493505|NCT01069354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493506|NCT01069354|Sensory System Agents|sensory system agents|mesh-ancestor
64493507|NCT01069354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64493508|NCT01069354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64493509|NCT01069354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64493510|NCT01069354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64493511|NCT01069354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64493512|NCT01069354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493513|NCT03080974|Nivolumab|nivolumab|mesh-list
64493514|NCT03080974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64493515|NCT03080974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493516|NCT03080974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64493517|NCT03080974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493519|NCT01069510|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64493520|NCT01069510|Hormone Antagonists|hormone antagonists|mesh-ancestor
64493521|NCT01069510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64493522|NCT01069510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493523|NCT01069510|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64493524|NCT01069510|Diuretics|diuretics|mesh-ancestor
64493525|NCT01069510|Natriuretic Agents|natriuretic agents|mesh-ancestor
64493526|NCT04278495|Losartan|losartan|mesh-list
64493527|NCT04278495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64493528|NCT04278495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64493529|NCT04278495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64493530|NCT04278495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64493531|NCT04278495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354699|NCT00872235|Quinapril|quinapril|mesh-list
65354700|NCT00872235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65354701|NCT00872235|Diuretics|diuretics|mesh-ancestor
65354702|NCT00872235|Natriuretic Agents|natriuretic agents|mesh-ancestor
65354703|NCT00872235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354704|NCT00872235|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65354705|NCT00872235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65354706|NCT00872235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354707|NCT00872235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65354708|NCT00872235|Protease Inhibitors|protease inhibitors|mesh-ancestor
65354709|NCT00872235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354710|NCT00872469|Tranexamic Acid|tranexamic acid|mesh-list
65354711|NCT00872469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65354712|NCT00872469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65354713|NCT00872469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354714|NCT00872469|Hemostatics|hemostatics|mesh-ancestor
65354715|NCT00872469|Coagulants|coagulants|mesh-ancestor
65354716|NCT00872625|Cyclophosphamide|cyclophosphamide|mesh-list
65354717|NCT00872625|Docetaxel|docetaxel|mesh-list
65354718|NCT00872625|Fluorouracil|fluorouracil|mesh-list
65354719|NCT00872625|Epirubicin|epirubicin|mesh-list
65354720|NCT00872625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65354721|NCT00872625|Immunologic Factors|immunologic factors|mesh-ancestor
65354722|NCT00872625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354723|NCT00872625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65354724|NCT00872625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65354725|NCT00872625|Alkylating Agents|alkylating agents|mesh-ancestor
65354726|NCT00872625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354727|NCT00872625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65354728|NCT00872625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65354729|NCT00872625|Tubulin Modulators|tubulin modulators|mesh-ancestor
65354730|NCT00872625|Antimitotic Agents|antimitotic agents|mesh-ancestor
65354731|NCT00872625|Mitosis Modulators|mitosis modulators|mesh-ancestor
65354742|NCT00872781|Natriuretic Agents|natriuretic agents|mesh-ancestor
65354743|NCT00872781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354744|NCT00872781|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65354745|NCT00872781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65354746|NCT00872781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354747|NCT00872781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65354748|NCT00872781|Protease Inhibitors|protease inhibitors|mesh-ancestor
65354749|NCT00872781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354750|NCT00384085|Insulin|insulin|mesh-list
65354751|NCT00384085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65354752|NCT00384085|Insulin Glargine|insulin glargine|mesh-list
65354753|NCT00384085|Insulin glulisine|insulin glulisine|mesh-list
65354754|NCT00384085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65354755|NCT00384085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354756|NCT00361231|Gemcitabine|gemcitabine|mesh-list
65354757|NCT00361231|Bevacizumab|bevacizumab|mesh-list
65354758|NCT00361231|Oxaliplatin|oxaliplatin|mesh-list
65354759|NCT00361231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65354760|NCT00361231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65354761|NCT00361231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65354762|NCT00361231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65354763|NCT00361231|Growth Substances|growth substances|mesh-ancestor
65354764|NCT00361231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493532|NCT04276545|Midazolam|midazolam|mesh-list
64493533|NCT04276545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64493534|NCT04276545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64493535|NCT04276545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64493536|NCT04276545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493537|NCT04276545|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64493538|NCT04276545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64493539|NCT04276545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64493540|NCT04276545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64493541|NCT04276545|Anesthetics, General|anesthetics, general|mesh-ancestor
64493552|NCT01117948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64493553|NCT01117948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493555|NCT01117948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64493556|NCT03602157|Fludarabine|fludarabine|mesh-list
64493557|NCT03602157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64493558|NCT03602157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493559|NCT03602157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493560|NCT03602157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64493561|NCT03602157|Alkylating Agents|alkylating agents|mesh-ancestor
64493562|NCT03014440|Cannabidiol|cannabidiol|mesh-list
64493563|NCT03014440|Anticonvulsants|anticonvulsants|mesh-ancestor
64493564|NCT03013036|Fentanyl|fentanyl|mesh-list
64493565|NCT03013036|Midazolam|midazolam|mesh-list
64493566|NCT03013036|Propofol|propofol|mesh-list
64493567|NCT03013036|Sevoflurane|sevoflurane|mesh-list
64556353|NCT04024163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64556354|NCT04996290|Ropivacaine|ropivacaine|mesh-list
64556355|NCT04996290|Anesthetics, Local|anesthetics, local|mesh-ancestor
64556356|NCT04996290|Anesthetics|anesthetics|mesh-ancestor
65354765|NCT00361231|Growth Inhibitors|growth inhibitors|mesh-ancestor
65354766|NCT00361231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65354767|NCT00361231|Antimetabolites|antimetabolites|mesh-ancestor
65354768|NCT00361231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354769|NCT00361231|Antiviral Agents|antiviral agents|mesh-ancestor
65354770|NCT00361231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65354771|NCT00361231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354772|NCT00361231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65354773|NCT00361231|Immunologic Factors|immunologic factors|mesh-ancestor
65354774|NCT00676650|Prednisone|prednisone|mesh-list
65354775|NCT00676650|Sunitinib|sunitinib|mesh-list
65354776|NCT00676650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65354777|NCT00676650|Glucocorticoids|glucocorticoids|mesh-ancestor
65354778|NCT00676650|Hormones|hormones|mesh-ancestor
65354779|NCT00676650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65354780|NCT00676650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354781|NCT00676650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65354782|NCT00676650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65354783|NCT00676650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65354784|NCT00676650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65354785|NCT00676650|Growth Substances|growth substances|mesh-ancestor
65354786|NCT00676650|Growth Inhibitors|growth inhibitors|mesh-ancestor
65354787|NCT00676650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65354788|NCT00676650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354789|NCT00676650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354790|NCT01045369|Etravirine|etravirine|mesh-list
65354791|NCT01045369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65354792|NCT01045369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65354793|NCT01045369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354794|NCT01045369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354795|NCT01045369|Antiviral Agents|antiviral agents|mesh-ancestor
64556357|NCT04996290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64493568|NCT03013036|Rocuronium|rocuronium|mesh-list
64493569|NCT03013036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64493570|NCT03013036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64493571|NCT03013036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493572|NCT03013036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64493573|NCT03013036|Anesthetics, General|anesthetics, general|mesh-ancestor
64493574|NCT03013036|Anesthetics|anesthetics|mesh-ancestor
64493575|NCT03013036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64493576|NCT03013036|Narcotics|narcotics|mesh-ancestor
64493577|NCT03013036|Analgesics|analgesics|mesh-ancestor
64493578|NCT03013036|Sensory System Agents|sensory system agents|mesh-ancestor
65354796|NCT01045369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65354797|NCT00615459|Tiotropium Bromide|tiotropium bromide|mesh-list
65354798|NCT00615459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65354799|NCT00615459|Autonomic Agents|autonomic agents|mesh-ancestor
65354800|NCT00615459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65354801|NCT00615459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354802|NCT00615459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65354803|NCT00615459|Respiratory System Agents|respiratory system agents|mesh-ancestor
65354804|NCT00615459|Parasympatholytics|parasympatholytics|mesh-ancestor
65354805|NCT00615459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65354806|NCT00615459|Cholinergic Agents|cholinergic agents|mesh-ancestor
65354807|NCT00615459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354808|NCT00615459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354809|NCT03839511|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65354810|NCT03839511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354812|NCT00383149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65354813|NCT00383149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65354814|NCT00878631|Dextrans|dextrans|mesh-list
65354815|NCT00878631|Anticoagulants|anticoagulants|mesh-ancestor
65354816|NCT00878631|Plasma Substitutes|plasma substitutes|mesh-ancestor
65354817|NCT00878631|Blood Substitutes|blood substitutes|mesh-ancestor
65354818|NCT00382993|Naproxen|naproxen|mesh-list
65354819|NCT00382993|Sumatriptan|sumatriptan|mesh-list
65354820|NCT00382993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65354821|NCT00382993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65354822|NCT00382993|Analgesics|analgesics|mesh-ancestor
65354823|NCT00382993|Sensory System Agents|sensory system agents|mesh-ancestor
65354824|NCT00382993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65354825|NCT00382993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354826|NCT00382993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65354827|NCT00382993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65354828|NCT00382993|Gout Suppressants|gout suppressants|mesh-ancestor
64746940|NCT01460628|Modafinil|modafinil|mesh-list
64493579|NCT03013036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64493580|NCT03013036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64493586|NCT03013036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64493587|NCT03013036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493588|NCT03013036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64493589|NCT03013036|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64493590|NCT03013036|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64493591|NCT03013036|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65354829|NCT00382993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65354830|NCT00382993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354831|NCT00382993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354832|NCT00382993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65354833|NCT00382993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65354834|NCT00382993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65354835|NCT00382993|Serotonin Agents|serotonin agents|mesh-ancestor
65354836|NCT00382993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354837|NCT00760968|Methotrexate|methotrexate|mesh-list
65354838|NCT00760968|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65354839|NCT00760968|Abortifacient Agents|abortifacient agents|mesh-ancestor
65354840|NCT00760968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65354841|NCT00760968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354842|NCT00760968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65354843|NCT00760968|Antimetabolites|antimetabolites|mesh-ancestor
65354844|NCT00760968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354845|NCT00760968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65354846|NCT00760968|Dermatologic Agents|dermatologic agents|mesh-ancestor
65354847|NCT00760968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354848|NCT00760968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65354849|NCT00760968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65354850|NCT00760968|Immunologic Factors|immunologic factors|mesh-ancestor
65354851|NCT00760968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65354879|NCT00873483|Estrogens|estrogens|mesh-ancestor
65354880|NCT00873483|Hormones|hormones|mesh-ancestor
65354881|NCT00873483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65354882|NCT00873483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65354883|NCT00873483|Progestins|progestins|mesh-ancestor
65104728|NCT02918591|Empagliflozin|empagliflozin|mesh-list
65354884|NCT00873483|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65354886|NCT01050517|Albendazole|albendazole|mesh-list
65354887|NCT01050517|Praziquantel|praziquantel|mesh-list
65354888|NCT01050517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65354889|NCT01050517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65354890|NCT01050517|Anthelmintics|anthelmintics|mesh-ancestor
65354891|NCT01050517|Anticestodal Agents|anticestodal agents|mesh-ancestor
65354892|NCT01050517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65354893|NCT01050517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65354894|NCT01050517|Tubulin Modulators|tubulin modulators|mesh-ancestor
65354895|NCT01050517|Antimitotic Agents|antimitotic agents|mesh-ancestor
65354896|NCT01050517|Mitosis Modulators|mitosis modulators|mesh-ancestor
65354897|NCT01050517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354898|NCT01050517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65354899|NCT02534467|Montelukast|montelukast|mesh-list
65354900|NCT02534467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65354901|NCT02534467|Respiratory System Agents|respiratory system agents|mesh-ancestor
65354902|NCT02534467|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65354903|NCT02534467|Hormone Antagonists|hormone antagonists|mesh-ancestor
65354904|NCT02534467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65354905|NCT02534467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354906|NCT02534467|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65354907|NCT02534467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65354909|NCT01050595|Naltrexone|naltrexone|mesh-list
64747059|NCT01454934|Antiviral Agents|antiviral agents|mesh-ancestor
65354922|NCT00878943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65354923|NCT00878943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354924|NCT00878943|Urological Agents|urological agents|mesh-ancestor
65354925|NCT00873639|Insulin|insulin|mesh-list
65354926|NCT00873639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65354927|NCT00873639|Insulin Aspart|insulin aspart|mesh-list
65354928|NCT00873639|Insulin Detemir|insulin detemir|mesh-list
65354929|NCT00873639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65354930|NCT00873639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354931|NCT00879021|Pregabalin|pregabalin|mesh-list
65354932|NCT00879021|Analgesics|analgesics|mesh-ancestor
65354933|NCT00879021|Sensory System Agents|sensory system agents|mesh-ancestor
65354934|NCT00879021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65354935|NCT00879021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354936|NCT00879021|Anticonvulsants|anticonvulsants|mesh-ancestor
65354937|NCT00879021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65354938|NCT00879021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65354939|NCT00879021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354940|NCT00879021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65354941|NCT00879021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65354942|NCT00879021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65354943|NCT00879021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65354944|NCT00879021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65354945|NCT00879099|Timolol|timolol|mesh-list
65354946|NCT00879099|Paroxetine|paroxetine|mesh-list
65354947|NCT00879099|Maleic acid|maleic acid|mesh-list
65354948|NCT00879099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354949|NCT00879099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354950|NCT00879099|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65354951|NCT00879099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65354952|NCT00879099|Adrenergic Agents|adrenergic agents|mesh-ancestor
65354953|NCT00879099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354954|NCT00879099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354955|NCT00879099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65354956|NCT00879099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65354957|NCT00879099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65104802|NCT05467709|Midazolam|midazolam|mesh-list
65354958|NCT00879099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65354959|NCT00879099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65354961|NCT00879099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65354962|NCT00879099|Antidepressive Agents|antidepressive agents|mesh-ancestor
65354963|NCT00879099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65354964|NCT00879099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65354965|NCT00879099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65354966|NCT00369655|Aflibercept|aflibercept|mesh-list
65354967|NCT00369655|Endothelial Growth Factors|endothelial growth factors|mesh-list
65354968|NCT00369655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65354969|NCT00369655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65354970|NCT00369655|Growth Substances|growth substances|mesh-ancestor
65354971|NCT00369655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354972|NCT00369655|Growth Inhibitors|growth inhibitors|mesh-ancestor
65354973|NCT00369655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65354974|NCT00879177|Varenicline|varenicline|mesh-list
65354975|NCT00879177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65354976|NCT00879177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65354977|NCT00879177|Cholinergic Agents|cholinergic agents|mesh-ancestor
65354978|NCT00879177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65354979|NCT00879177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65354980|NCT00879177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354981|NCT00676338|Metformin|metformin|mesh-list
65354982|NCT00676338|Pioglitazone|pioglitazone|mesh-list
65354983|NCT00676338|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65354984|NCT00676338|Exenatide|exenatide|mesh-list
65354985|NCT00676338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65354986|NCT00676338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65354987|NCT00676338|Incretins|incretins|mesh-ancestor
65354988|NCT00676338|Hormones|hormones|mesh-ancestor
65354989|NCT00676338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65354990|NCT00676338|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65354991|NCT00676338|Protease Inhibitors|protease inhibitors|mesh-ancestor
65354992|NCT00676338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65354995|NCT02534623|Fentanyl|fentanyl|mesh-list
65354998|NCT02534623|Propofol|propofol|mesh-list
65354999|NCT02534623|Sevoflurane|sevoflurane|mesh-list
65355000|NCT02534623|Anesthetics, Local|anesthetics, local|mesh-ancestor
65355001|NCT02534623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65355002|NCT02534623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355003|NCT02534623|Sensory System Agents|sensory system agents|mesh-ancestor
65355004|NCT02534623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65355005|NCT02534623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65355006|NCT02534623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65355007|NCT02534623|Anesthetics, General|anesthetics, general|mesh-ancestor
65355008|NCT02534623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65355009|NCT02534623|Narcotics|narcotics|mesh-ancestor
65355010|NCT02534623|Analgesics|analgesics|mesh-ancestor
65355011|NCT02534623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65355012|NCT02534623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65355013|NCT02534623|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65355014|NCT00873795|Aripiprazole|aripiprazole|mesh-list
65355015|NCT00873795|Sertraline|sertraline|mesh-list
65355016|NCT00873795|Antidepressive Agents|antidepressive agents|mesh-ancestor
65355017|NCT00873795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65355018|NCT00873795|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65355019|NCT00873795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65355020|NCT00873795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65355021|NCT00873795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355022|NCT00873795|Dopamine Agonists|dopamine agonists|mesh-ancestor
65355023|NCT00873795|Dopamine Agents|dopamine agents|mesh-ancestor
65355024|NCT00873795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65355025|NCT00873795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355026|NCT00873795|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65355027|NCT00873795|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65355028|NCT00873795|Serotonin Agents|serotonin agents|mesh-ancestor
64493592|NCT03013036|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64493593|NCT01071538|Buprenorphine|buprenorphine|mesh-list
64493594|NCT01071538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64493595|NCT01071538|Narcotics|narcotics|mesh-ancestor
64493596|NCT01071538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64493597|NCT01071538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493598|NCT01071538|Analgesics|analgesics|mesh-ancestor
64493599|NCT01071538|Sensory System Agents|sensory system agents|mesh-ancestor
64493600|NCT01071538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64493601|NCT01071538|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64493603|NCT04352686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64493604|NCT04352686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64493605|NCT04352686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65355029|NCT00873795|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65355030|NCT00873795|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65355031|NCT00873795|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65355032|NCT00873795|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65355033|NCT00873795|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65355034|NCT00873795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65355035|NCT00873795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65355036|NCT00873951|Caseins|caseins|mesh-list
65355037|NCT00873951|Chelating Agents|chelating agents|mesh-ancestor
65355038|NCT00873951|Sequestering Agents|sequestering agents|mesh-ancestor
65355039|NCT00873951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355040|NCT00874107|Paclitaxel|paclitaxel|mesh-list
65355041|NCT00874107|Bevacizumab|bevacizumab|mesh-list
65355042|NCT00874107|Carboplatin|carboplatin|mesh-list
65355043|NCT00874107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65355044|NCT00874107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355045|NCT00874107|Tubulin Modulators|tubulin modulators|mesh-ancestor
65355046|NCT00874107|Antimitotic Agents|antimitotic agents|mesh-ancestor
65355047|NCT00874107|Mitosis Modulators|mitosis modulators|mesh-ancestor
65355048|NCT00874107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355049|NCT00874107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65355050|NCT00874107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65355051|NCT00874107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65355052|NCT00874107|Growth Substances|growth substances|mesh-ancestor
65355053|NCT00874107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355054|NCT00874107|Growth Inhibitors|growth inhibitors|mesh-ancestor
65355055|NCT00761358|Z 338|z 338|mesh-list
65355056|NCT00761358|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65355057|NCT00761358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355058|NCT00761358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355059|NCT00761358|Cholinergic Agents|cholinergic agents|mesh-ancestor
65355071|NCT00874419|Antimetabolites|antimetabolites|mesh-ancestor
65355072|NCT00874419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355073|NCT00874419|Antiviral Agents|antiviral agents|mesh-ancestor
65355074|NCT00874419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65355075|NCT00874419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355076|NCT00874419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65355077|NCT00874419|Immunologic Factors|immunologic factors|mesh-ancestor
65355078|NCT00874419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355079|NCT00874419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65355080|NCT00381043|Acamprosate|acamprosate|mesh-list
65355081|NCT00381043|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65355082|NCT01050985|Sirolimus|sirolimus|mesh-list
65355083|NCT01050985|Capecitabine|capecitabine|mesh-list
65355084|NCT01050985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65355085|NCT01050985|Antimetabolites|antimetabolites|mesh-ancestor
65355086|NCT01050985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355087|NCT01050985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355088|NCT01050985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65355089|NCT01050985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65355090|NCT01050985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65355091|NCT01050985|Antifungal Agents|antifungal agents|mesh-ancestor
65355092|NCT01050985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65355093|NCT01050985|Immunologic Factors|immunologic factors|mesh-ancestor
65355094|NCT01050985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355095|NCT00614991|Ritonavir|ritonavir|mesh-list
65355096|NCT00614991|Fosamprenavir|fosamprenavir|mesh-list
65355097|NCT00614991|Raltegravir Potassium|raltegravir potassium|mesh-list
65355098|NCT00614991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65355099|NCT00614991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65355100|NCT00614991|Protease Inhibitors|protease inhibitors|mesh-ancestor
65355101|NCT00614991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493606|NCT04352686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493607|NCT04352686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64493619|NCT02287311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64493620|NCT02287311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64493621|NCT02287311|Alkylating Agents|alkylating agents|mesh-ancestor
64493622|NCT02287311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493623|NCT02287311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493624|NCT02287311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64493625|NCT02172742|Digoxin|digoxin|mesh-list
64493626|NCT02172742|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64493627|NCT02172742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64493628|NCT02172742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64493629|NCT02172742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355102|NCT00614991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355103|NCT00614991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65355104|NCT00614991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65355105|NCT00614991|Antiviral Agents|antiviral agents|mesh-ancestor
65355106|NCT00614991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65355107|NCT00614991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65104953|NCT00532415|Triamcinolone|triamcinolone|mesh-list
65355108|NCT00614991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65355109|NCT00614991|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65355110|NCT00614991|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65355111|NCT00874575|Vitamin D|vitamin d|mesh-list
65355112|NCT00874575|Ergocalciferols|ergocalciferols|mesh-list
65355113|NCT00874575|Cholecalciferol|cholecalciferol|mesh-list
65355114|NCT00874575|Vitamins|vitamins|mesh-list
65355115|NCT00874575|Micronutrients|micronutrients|mesh-ancestor
65355116|NCT00874575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355117|NCT00874575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65355118|NCT00874575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65355119|NCT03083808|Pembrolizumab|pembrolizumab|mesh-list
65355120|NCT03083808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65355121|NCT03083808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355122|NCT00874653|Levonorgestrel|levonorgestrel|mesh-list
65355123|NCT00874653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65355124|NCT00874653|Contraceptive Agents|contraceptive agents|mesh-ancestor
65355125|NCT00874653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65355126|NCT00874653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355127|NCT00874653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65355149|NCT00874809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355150|NCT04376268|Chlorhexidine|chlorhexidine|mesh-list
65355151|NCT04376268|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65355152|NCT04376268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65355153|NCT04376268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65355154|NCT04376268|Disinfectants|disinfectants|mesh-ancestor
65355155|NCT04376268|Dermatologic Agents|dermatologic agents|mesh-ancestor
65355156|NCT00875355|Temozolomide|temozolomide|mesh-list
65355157|NCT00875355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65355158|NCT00875355|Alkylating Agents|alkylating agents|mesh-ancestor
65355159|NCT00875355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355160|NCT00875355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355161|NCT00678288|Interferons|interferons|mesh-list
65355162|NCT00678288|Sorafenib|sorafenib|mesh-list
65355163|NCT00678288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355164|NCT00678288|Antiviral Agents|antiviral agents|mesh-ancestor
65355165|NCT00678288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65355166|NCT00678288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65355167|NCT00678288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355168|NCT00678288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355169|NCT00880815|Rituximab|rituximab|mesh-list
65355170|NCT00880815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65355171|NCT00880815|Methotrexate|methotrexate|mesh-list
65355172|NCT00880815|Fludarabine|fludarabine|mesh-list
65355173|NCT00880815|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65355174|NCT00880815|Antibodies|antibodies|mesh-list
65355175|NCT00880815|Immunoglobulins|immunoglobulins|mesh-list
65355176|NCT00880815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65355177|NCT00880815|Lenograstim|lenograstim|mesh-list
65355178|NCT00880815|Tacrolimus|tacrolimus|mesh-list
65355179|NCT00880815|Thymoglobulin|thymoglobulin|mesh-list
65355180|NCT00880815|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65355181|NCT00880815|Immunologic Factors|immunologic factors|mesh-ancestor
65355184|NCT00880815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65355193|NCT00880815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65355194|NCT00880815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65355195|NCT00880815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65355196|NCT00880815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65355197|NCT00880815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65355198|NCT00880815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65355199|NCT00880815|Alkylating Agents|alkylating agents|mesh-ancestor
65355200|NCT00369343|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65355201|NCT00369343|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65355202|NCT00369343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65355203|NCT00369343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65355204|NCT00369343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355205|NCT00369343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65355206|NCT00369343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355207|NCT00369343|Antidepressive Agents|antidepressive agents|mesh-ancestor
65355208|NCT00369343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65355209|NCT00881049|Imatinib Mesylate|imatinib mesylate|mesh-list
65355210|NCT00881049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355211|NCT00881049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65355212|NCT00881049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355213|NCT00881049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355214|NCT00881127|Cetirizine|cetirizine|mesh-list
65355215|NCT00881127|Pseudoephedrine|pseudoephedrine|mesh-list
65355216|NCT00881127|Ephedrine|ephedrine|mesh-list
65355217|NCT00881127|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65355218|NCT00881127|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65355219|NCT00881127|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65355237|NCT00369265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65355238|NCT00369265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65355239|NCT00369265|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65355240|NCT00369265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355241|NCT00369265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355242|NCT00875745|Sorafenib|sorafenib|mesh-list
65355243|NCT00875745|Vorinostat|vorinostat|mesh-list
65355244|NCT00875745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355245|NCT00875745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65355246|NCT00875745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355247|NCT00875745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355248|NCT00875745|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65355249|NCT00368875|Paclitaxel|paclitaxel|mesh-list
65355250|NCT00368875|Bevacizumab|bevacizumab|mesh-list
65355251|NCT00368875|Vorinostat|vorinostat|mesh-list
65355252|NCT00368875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65355253|NCT00368875|Antibodies|antibodies|mesh-list
65355254|NCT00368875|Immunoglobulins|immunoglobulins|mesh-list
65355255|NCT00368875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65355256|NCT00368875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65355257|NCT00368875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355258|NCT00368875|Tubulin Modulators|tubulin modulators|mesh-ancestor
65355270|NCT00614055|Insulin|insulin|mesh-list
65355290|NCT00613821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355291|NCT00882765|Genistein|genistein|mesh-list
65355292|NCT00882765|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65355293|NCT00882765|Protective Agents|protective agents|mesh-ancestor
65355294|NCT00882765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355295|NCT00882765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355296|NCT00882765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65355297|NCT00882765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355298|NCT00882765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355299|NCT00882765|Phytoestrogens|phytoestrogens|mesh-ancestor
65355300|NCT00882765|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65355351|NCT00881673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65355352|NCT00881673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65355353|NCT00881673|Antiemetics|antiemetics|mesh-ancestor
65355354|NCT00881673|Autonomic Agents|autonomic agents|mesh-ancestor
65355355|NCT00881673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65355356|NCT00881673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355357|NCT00881673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65355358|NCT00881673|Glucocorticoids|glucocorticoids|mesh-ancestor
65355359|NCT00881673|Hormones|hormones|mesh-ancestor
65355360|NCT00881673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65355361|NCT00881673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65355362|NCT00881673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355363|NCT04638465|Cisplatin|cisplatin|mesh-list
65355364|NCT04638465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355365|NCT00881907|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65355366|NCT00881907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65355367|NCT00881907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65355368|NCT00881907|Antitubercular Agents|antitubercular agents|mesh-ancestor
65355369|NCT04487925|Hormones|hormones|mesh-list
65355370|NCT04487925|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65355371|NCT04487925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65355372|NCT04487925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355373|NCT00547300|Metoprolol|metoprolol|mesh-list
65355374|NCT00547300|Nebivolol|nebivolol|mesh-list
65355375|NCT00547300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65355376|NCT00547300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65355377|NCT00547300|Sympatholytics|sympatholytics|mesh-ancestor
65355378|NCT00547300|Autonomic Agents|autonomic agents|mesh-ancestor
65355379|NCT00547300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65355380|NCT00547300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355381|NCT00547300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65355382|NCT00547300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65355383|NCT00547300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65355384|NCT00547300|Adrenergic Agents|adrenergic agents|mesh-ancestor
65355385|NCT00547300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65355386|NCT00547300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355387|NCT00547300|Vasodilator Agents|vasodilator agents|mesh-ancestor
65355388|NCT00547300|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65355389|NCT00547300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65355390|NCT00547300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65355391|NCT00612807|Tranylcypromine|tranylcypromine|mesh-list
65355392|NCT00612807|Bupropion|bupropion|mesh-list
65355393|NCT00612807|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65355394|NCT00612807|Sertraline|sertraline|mesh-list
65355395|NCT00612807|Nortriptyline|nortriptyline|mesh-list
65355396|NCT00612807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65355397|NCT00612807|Antidepressive Agents|antidepressive agents|mesh-ancestor
65355398|NCT00612807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65355399|NCT00612807|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65355400|NCT00612807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65355401|NCT00612807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65355402|NCT00612807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355403|NCT00612807|Dopamine Agents|dopamine agents|mesh-ancestor
65355404|NCT00612807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65355405|NCT00612807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355406|NCT00612807|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65355407|NCT00612807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65355408|NCT00612807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355409|NCT00612807|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65355410|NCT00612807|Serotonin Agents|serotonin agents|mesh-ancestor
65355411|NCT00612807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65355412|NCT00612807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65355413|NCT00612807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65355414|NCT00612807|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65355415|NCT00612807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65355416|NCT00612807|Adrenergic Agents|adrenergic agents|mesh-ancestor
65355417|NCT00612807|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65355418|NCT00612807|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65355419|NCT00958750|Minoxidil|minoxidil|mesh-list
65355422|NCT00958906|Infliximab|infliximab|mesh-list
65355426|NCT00959062|Clonidine|clonidine|mesh-list
65355427|NCT00959062|Analgesics|analgesics|mesh-ancestor
65355428|NCT00959062|Sensory System Agents|sensory system agents|mesh-ancestor
65355429|NCT00959062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65355430|NCT00959062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355431|NCT00959062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65355432|NCT00959062|Sympatholytics|sympatholytics|mesh-ancestor
65355433|NCT00959062|Autonomic Agents|autonomic agents|mesh-ancestor
65355434|NCT00959062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65355435|NCT00959062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65355436|NCT00959062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65355437|NCT00959062|Adrenergic Agents|adrenergic agents|mesh-ancestor
65355438|NCT00959062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65355439|NCT00959062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355440|NCT00963040|Oxytocin|oxytocin|mesh-list
65355441|NCT00963040|Oxytocics|oxytocics|mesh-ancestor
65355442|NCT00963040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65355443|NCT00963040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355444|NCT04038411|Etoposide|etoposide|mesh-list
65355445|NCT04038411|Lenalidomide|lenalidomide|mesh-list
65355446|NCT04038411|Antibodies|antibodies|mesh-list
65355447|NCT04038411|Immunologic Factors|immunologic factors|mesh-ancestor
65355448|NCT04038411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355449|NCT04038411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65355450|NCT04038411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355451|NCT04038411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65355452|NCT04038411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65355453|NCT04038411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355454|NCT04038411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355455|NCT04038411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65355456|NCT04038411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65355457|NCT04038411|Growth Substances|growth substances|mesh-ancestor
65355458|NCT04038411|Growth Inhibitors|growth inhibitors|mesh-ancestor
65355459|NCT04155424|Eculizumab|eculizumab|mesh-list
64493630|NCT02172742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493631|NCT02172742|Protective Agents|protective agents|mesh-ancestor
64493632|NCT02172742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493633|NCT02172742|Anticonvulsants|anticonvulsants|mesh-ancestor
64493634|NCT02172742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64493635|NCT02172742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65355460|NCT04155424|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65355461|NCT04155424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65355462|NCT04155424|Immunologic Factors|immunologic factors|mesh-ancestor
65355463|NCT04155424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355464|NCT00882375|Nicotine|nicotine|mesh-list
65355465|NCT00882375|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65355466|NCT00882375|Autonomic Agents|autonomic agents|mesh-ancestor
65355467|NCT00882375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65355468|NCT00882375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355469|NCT00882375|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65355470|NCT00882375|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65355471|NCT00882375|Cholinergic Agents|cholinergic agents|mesh-ancestor
65355472|NCT00882375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65355473|NCT00882375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355474|NCT00882453|Interferons|interferons|mesh-list
65355475|NCT00882453|Interferon-beta|interferon-beta|mesh-list
65355476|NCT00882453|Interferon beta-1b|interferon beta-1b|mesh-list
65355477|NCT00882453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355478|NCT00882453|Antiviral Agents|antiviral agents|mesh-ancestor
65355479|NCT00882453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64747648|NCT01420536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65355516|NCT00678210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65355517|NCT00678210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355518|NCT00678210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355519|NCT00611715|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65355520|NCT00611715|Letrozole|letrozole|mesh-list
65355521|NCT00611715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355522|NCT00611715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65355523|NCT00611715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355524|NCT00611715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355525|NCT00611715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65355526|NCT00611715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65355527|NCT00611715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65355528|NCT00611715|Hormone Antagonists|hormone antagonists|mesh-ancestor
65355529|NCT00611715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65355530|NCT00611715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355531|NCT04722718|Paclitaxel|paclitaxel|mesh-list
65355532|NCT04722718|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65355533|NCT04722718|Carboplatin|carboplatin|mesh-list
65355534|NCT04722718|Apatinib|apatinib|mesh-list
65355535|NCT04722718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65355536|NCT04722718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355537|NCT04722718|Tubulin Modulators|tubulin modulators|mesh-ancestor
65355538|NCT04722718|Antimitotic Agents|antimitotic agents|mesh-ancestor
65355539|NCT04722718|Mitosis Modulators|mitosis modulators|mesh-ancestor
65355540|NCT04722718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355541|NCT04722718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65355542|NCT04722718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355543|NCT00761670|Risperidone|risperidone|mesh-list
65355544|NCT00761670|Amisulpride|amisulpride|mesh-list
64747652|NCT01467492|Interferons|interferons|mesh-list
64493636|NCT02172742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64493637|NCT01075204|Clarithromycin|clarithromycin|mesh-list
64493638|NCT01075204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64493639|NCT01075204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64493640|NCT01075204|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64493641|NCT01075204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493642|NCT01075204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556358|NCT04996290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556359|NCT04996290|Sensory System Agents|sensory system agents|mesh-ancestor
64556360|NCT04996290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556361|NCT04023617|Docetaxel|docetaxel|mesh-list
65355545|NCT00761670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65355546|NCT00761670|Serotonin Agents|serotonin agents|mesh-ancestor
65355547|NCT00761670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65355548|NCT00761670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355549|NCT00761670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355550|NCT00761670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65355551|NCT00761670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65355552|NCT00761670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65355553|NCT00761670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65355554|NCT00761670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65355555|NCT00761670|Dopamine Agents|dopamine agents|mesh-ancestor
65355556|NCT00761670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65105403|NCT01270828|Pregabalin|pregabalin|mesh-list
65355557|NCT00761670|Antidepressive Agents|antidepressive agents|mesh-ancestor
65355558|NCT00963664|Interferons|interferons|mesh-list
65355559|NCT00963664|Interferon-alpha|interferon-alpha|mesh-list
65355560|NCT00963664|Interferon alpha-2|interferon alpha-2|mesh-list
65355561|NCT00963664|Lovastatin|lovastatin|mesh-list
65355562|NCT00963664|L 647318|l 647318|mesh-list
65355563|NCT00963664|Dihydromevinolin|dihydromevinolin|mesh-list
65355564|NCT00963664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355565|NCT00963664|Antiviral Agents|antiviral agents|mesh-ancestor
65355566|NCT00963664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65355567|NCT00963664|Immunologic Factors|immunologic factors|mesh-ancestor
65355568|NCT00963664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355569|NCT00963664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65355570|NCT00963664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65355571|NCT00963664|Antimetabolites|antimetabolites|mesh-ancestor
65355572|NCT00963664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355573|NCT00963664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65355574|NCT00963664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65355576|NCT00611559|PENTA|penta|mesh-list
65355588|NCT00761904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65355589|NCT00761904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355590|NCT00761904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65355591|NCT00761904|Diuretics|diuretics|mesh-ancestor
65355592|NCT00761904|Natriuretic Agents|natriuretic agents|mesh-ancestor
65355593|NCT00761904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355594|NCT00761904|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65355595|NCT00761904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65355596|NCT00963976|Enalapril|enalapril|mesh-list
65355597|NCT00963976|Hydralazine|hydralazine|mesh-list
65355598|NCT00963976|Labetalol|labetalol|mesh-list
65355599|NCT00963976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65355600|NCT00963976|Protease Inhibitors|protease inhibitors|mesh-ancestor
65355601|NCT00963976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355602|NCT00963976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355603|NCT00963976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65355604|NCT00963976|Vasodilator Agents|vasodilator agents|mesh-ancestor
65355605|NCT00963976|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65355606|NCT00963976|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65355607|NCT00963976|Adrenergic Agents|adrenergic agents|mesh-ancestor
65355608|NCT00963976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65355609|NCT00963976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355610|NCT00963976|Sympathomimetics|sympathomimetics|mesh-ancestor
65355611|NCT00963976|Autonomic Agents|autonomic agents|mesh-ancestor
65355612|NCT00963976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65355613|NCT00963976|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65355614|NCT00963976|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65355615|NCT02558868|Oxaliplatin|oxaliplatin|mesh-list
64556362|NCT04023617|Nivolumab|nivolumab|mesh-list
64556363|NCT04023617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556364|NCT04023617|Tubulin Modulators|tubulin modulators|mesh-ancestor
64321435|NCT02199613|Darunavir|darunavir|mesh-list
64493643|NCT01075204|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64493644|NCT01075204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64493645|NCT01120834|Azacitidine|azacitidine|mesh-list
64493646|NCT01120834|Vorinostat|vorinostat|mesh-list
64493647|NCT01120834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64493648|NCT01120834|Antimetabolites|antimetabolites|mesh-ancestor
64493649|NCT01120834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493650|NCT01120834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493651|NCT01120834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493652|NCT01120834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64493653|NCT01122160|Omeprazole|omeprazole|mesh-list
64493654|NCT01122160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64493656|NCT01122160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64493657|NCT01122160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355616|NCT02558868|Irinotecan|irinotecan|mesh-list
65355617|NCT02558868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355618|NCT02558868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65355619|NCT02558868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65355620|NCT02558868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355621|NCT02558868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355622|NCT00611247|Temozolomide|temozolomide|mesh-list
65355623|NCT00611247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65355624|NCT00611247|Alkylating Agents|alkylating agents|mesh-ancestor
65355625|NCT00611247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355626|NCT00611247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355627|NCT00883935|Ritonavir|ritonavir|mesh-list
65355628|NCT00883935|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65355629|NCT00883935|Dolutegravir|dolutegravir|mesh-list
65355630|NCT00883935|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65355631|NCT00883935|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65355632|NCT00883935|Protease Inhibitors|protease inhibitors|mesh-ancestor
65355633|NCT00883935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355634|NCT00883935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355635|NCT00883935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64747752|NCT03815448|Antimetabolites|antimetabolites|mesh-ancestor
64493658|NCT01122160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493659|NCT02623816|Omeprazole|omeprazole|mesh-list
64493660|NCT02623816|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64493661|NCT02623816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64493662|NCT02623816|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64493663|NCT02623816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493664|NCT02623816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493665|NCT01122238|Nicotine|nicotine|mesh-list
64493666|NCT01122238|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64493667|NCT01122238|Autonomic Agents|autonomic agents|mesh-ancestor
64493668|NCT01122238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64493693|NCT03187353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64493694|NCT03187353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64493695|NCT03187353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493696|NCT03187353|Dopamine Agents|dopamine agents|mesh-ancestor
64493697|NCT03187353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64493698|NCT03186729|Fibrinolytic Agents|fibrinolytic agents|mesh-list
64493699|NCT03186729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64493700|NCT03186729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493701|NCT02393625|Nivolumab|nivolumab|mesh-list
64493702|NCT02393625|Ceritinib|ceritinib|mesh-list
64493703|NCT02393625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64493704|NCT02393625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493705|NCT02393625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64493706|NCT02393625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493707|NCT02393625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64493708|NCT02393625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493709|NCT02399943|Panitumumab|panitumumab|mesh-list
64493710|NCT02399943|Trametinib|trametinib|mesh-list
64493711|NCT02399943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64493712|NCT02399943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355636|NCT00883935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65355637|NCT00883935|Antiviral Agents|antiviral agents|mesh-ancestor
65355638|NCT00883935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65355639|NCT00883935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65355640|NCT00883935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65355641|NCT00883935|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65355642|NCT00883935|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65355644|NCT00675948|Analgesics|analgesics|mesh-ancestor
65355645|NCT00675948|Sensory System Agents|sensory system agents|mesh-ancestor
65355646|NCT00675948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65355647|NCT00675948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355648|NCT00885885|Panitumumab|panitumumab|mesh-list
65355649|NCT00885885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65355650|NCT00885885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355651|NCT00610935|Peramivir|peramivir|mesh-list
65355652|NCT00610935|Antiviral Agents|antiviral agents|mesh-ancestor
65355653|NCT00610935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65355654|NCT00610935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355655|NCT00610935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355656|NCT02303028|Topotecan|topotecan|mesh-list
65355657|NCT02303028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65355658|NCT02303028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65355659|NCT02303028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355660|NCT02303028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493713|NCT02399943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64493714|NCT02399943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493715|NCT02399943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493744|NCT04397913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493745|NCT04397913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493746|NCT02176486|Ixazomib|ixazomib|mesh-list
64493747|NCT02176486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493748|NCT02176486|Protease Inhibitors|protease inhibitors|mesh-ancestor
64493749|NCT02176486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493750|NCT02176486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493751|NCT01124188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64556365|NCT04023617|Antimitotic Agents|antimitotic agents|mesh-ancestor
64556366|NCT04023617|Mitosis Modulators|mitosis modulators|mesh-ancestor
64556367|NCT04023617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556368|NCT04023617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64493752|NCT01124188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64493753|NCT01124188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64493754|NCT01124188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64493755|NCT01124188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493756|NCT01124188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64493757|NCT01124188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493758|NCT01124188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64493759|NCT01124188|Antidepressive Agents|antidepressive agents|mesh-ancestor
65355661|NCT02303028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355662|NCT02287818|Febuxostat|febuxostat|mesh-list
65355663|NCT02287818|Gout Suppressants|gout suppressants|mesh-ancestor
65355664|NCT02287818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65355665|NCT00762060|Anesthetics|anesthetics|mesh-list
65355666|NCT00762060|Anesthetics, Local|anesthetics, local|mesh-list
65355667|NCT00762060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65355668|NCT00762060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355669|NCT00762060|Sensory System Agents|sensory system agents|mesh-ancestor
65355670|NCT00762060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65355671|NCT00610857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65355672|NCT00610857|Antibodies|antibodies|mesh-list
65355673|NCT00610857|Immunoglobulins|immunoglobulins|mesh-list
65355674|NCT00610857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65355675|NCT00610857|Immunologic Factors|immunologic factors|mesh-ancestor
65355676|NCT00610857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355677|NCT00610857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355678|NCT00672984|Moxifloxacin|moxifloxacin|mesh-list
65355679|NCT00672984|Guanfacine|guanfacine|mesh-list
65355680|NCT00672984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65355681|NCT00672984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65355682|NCT00672984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65355716|NCT00886275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355717|NCT00886275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65355718|NCT00886275|Analgesics|analgesics|mesh-ancestor
65355719|NCT00886275|Sensory System Agents|sensory system agents|mesh-ancestor
65355720|NCT00886275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65355721|NCT00886275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65355722|NCT00886275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65355723|NCT00886275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65355724|NCT00886275|Adrenergic Agents|adrenergic agents|mesh-ancestor
65355725|NCT00886275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65355726|NCT00886275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355727|NCT00886275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65355728|NCT00886275|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65355729|NCT00886275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65355730|NCT00886275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65355731|NCT00886275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65355732|NCT00886275|Anesthetics, General|anesthetics, general|mesh-ancestor
65355733|NCT00886275|Anesthetics|anesthetics|mesh-ancestor
65355734|NCT00886275|GABA Modulators|gaba modulators|mesh-ancestor
65355735|NCT00886275|GABA Agents|gaba agents|mesh-ancestor
65355736|NCT04017897|Pembrolizumab|pembrolizumab|mesh-list
65355737|NCT04017897|Nivolumab|nivolumab|mesh-list
65355738|NCT04017897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64747852|NCT01390584|Hormones|hormones|mesh-ancestor
64493760|NCT01124188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64493761|NCT03013114|Bortezomib|bortezomib|mesh-list
64586288|NCT00322439|Analgesics|analgesics|mesh-ancestor
64493776|NCT02393937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64493777|NCT02393937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64493778|NCT00632853|Carboplatin|carboplatin|mesh-list
64493779|NCT00632853|Etoposide|etoposide|mesh-list
64493780|NCT00632853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493781|NCT00632853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64493782|NCT00632853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64493783|NCT00632853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64493784|NCT00632853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493785|NCT00632853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493786|NCT01877915|Rivaroxaban|rivaroxaban|mesh-list
64493791|NCT01877915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493792|NCT01877915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493793|NCT01877915|Anticoagulants|anticoagulants|mesh-ancestor
64493794|NCT04397601|Bevacizumab|bevacizumab|mesh-list
64493795|NCT04397601|Aflibercept|aflibercept|mesh-list
64493796|NCT04397601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64493797|NCT04397601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493798|NCT04397601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64493799|NCT04397601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64493800|NCT04397601|Growth Substances|growth substances|mesh-ancestor
64493801|NCT04397601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493802|NCT04397601|Growth Inhibitors|growth inhibitors|mesh-ancestor
64493803|NCT02870829|Vitamin K 2|vitamin k 2|mesh-list
64493804|NCT02870829|Vitamin K|vitamin k|mesh-list
64493805|NCT02870829|Vitamin MK 7|vitamin mk 7|mesh-list
65355739|NCT04017897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355740|NCT04017897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65355741|NCT04017897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355742|NCT02542137|Thymalfasin|thymalfasin|mesh-list
65355743|NCT02542137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65355744|NCT02542137|Immunologic Factors|immunologic factors|mesh-ancestor
65355745|NCT02542137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355746|NCT00886509|Lenograstim|lenograstim|mesh-list
65355747|NCT00886509|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65355748|NCT00886509|Immunologic Factors|immunologic factors|mesh-ancestor
65355749|NCT00886509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355750|NCT02543385|Ketamine|ketamine|mesh-list
65355751|NCT02543385|Esketamine|esketamine|mesh-list
65355752|NCT02543385|Analgesics|analgesics|mesh-ancestor
65355753|NCT02543385|Sensory System Agents|sensory system agents|mesh-ancestor
65355754|NCT02543385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65355755|NCT02543385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355756|NCT02543385|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65355757|NCT02543385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65355758|NCT02543385|Anesthetics, General|anesthetics, general|mesh-ancestor
65355759|NCT02543385|Anesthetics|anesthetics|mesh-ancestor
65355760|NCT02543385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64747861|NCT01408914|Rifampin|rifampin|mesh-list
64493806|NCT02870829|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64493807|NCT02870829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64493808|NCT02870829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493809|NCT02870829|Hemostatics|hemostatics|mesh-ancestor
64493810|NCT02870829|Coagulants|coagulants|mesh-ancestor
64493811|NCT02870829|Vitamins|vitamins|mesh-ancestor
64493812|NCT02870829|Micronutrients|micronutrients|mesh-ancestor
64493813|NCT02870829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493814|NCT01876823|Memantine|memantine|mesh-list
64493815|NCT01876823|Citalopram|citalopram|mesh-list
64493816|NCT01876823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64493817|NCT01876823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64493818|NCT01876823|Dopamine Agents|dopamine agents|mesh-ancestor
64493819|NCT01876823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64493820|NCT01876823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493821|NCT01876823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493822|NCT01876823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64493823|NCT01876823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64493831|NCT01876511|Pembrolizumab|pembrolizumab|mesh-list
64493832|NCT01876511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64493833|NCT01876511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493834|NCT01993719|Vidarabine|vidarabine|mesh-list
64493835|NCT01993719|Aldesleukin|aldesleukin|mesh-list
64493836|NCT01993719|Cyclophosphamide|cyclophosphamide|mesh-list
64493837|NCT01993719|Pembrolizumab|pembrolizumab|mesh-list
64493838|NCT01993719|Fludarabine|fludarabine|mesh-list
64556369|NCT04023617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64556370|NCT04023149|Aldesleukin|aldesleukin|mesh-list
64556371|NCT04023149|Interleukin-2|interleukin-2|mesh-list
64556372|NCT04023149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556373|NCT04023149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64556374|NCT04023149|Analgesics|analgesics|mesh-ancestor
65355761|NCT02543385|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65355762|NCT02543385|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65355763|NCT02543385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65355764|NCT02543385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355765|NCT02543385|Antidepressive Agents|antidepressive agents|mesh-ancestor
65355766|NCT02543385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65355767|NCT00884481|Natalizumab|natalizumab|mesh-list
65355768|NCT00884481|Immunologic Factors|immunologic factors|mesh-ancestor
65355769|NCT00884481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355770|NCT02543229|Ranibizumab|ranibizumab|mesh-list
65355771|NCT02543229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65355772|NCT02543229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65355773|NCT02543229|Growth Substances|growth substances|mesh-ancestor
65355774|NCT02543229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355775|NCT02543229|Growth Inhibitors|growth inhibitors|mesh-ancestor
65355776|NCT02543229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355777|NCT02543073|Glucocorticoids|glucocorticoids|mesh-list
65355778|NCT02543073|Hormones|hormones|mesh-ancestor
65355779|NCT02543073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65355780|NCT02543073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355781|NCT00546364|Docetaxel|docetaxel|mesh-list
65355782|NCT00546364|Capecitabine|capecitabine|mesh-list
65355783|NCT00546364|Epothilones|epothilones|mesh-list
65355784|NCT00546364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355785|NCT00546364|Tubulin Modulators|tubulin modulators|mesh-ancestor
65355786|NCT00546364|Antimitotic Agents|antimitotic agents|mesh-ancestor
65355787|NCT00546364|Mitosis Modulators|mitosis modulators|mesh-ancestor
65355788|NCT00546364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359927|NCT04505917|Oxytocics|oxytocics|mesh-ancestor
64359928|NCT04505683|Ertapenem|ertapenem|mesh-list
64556375|NCT04023149|Sensory System Agents|sensory system agents|mesh-ancestor
64493839|NCT01993719|Fludarabine phosphate|fludarabine phosphate|mesh-list
64493840|NCT01993719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64493841|NCT01993719|Immunologic Factors|immunologic factors|mesh-ancestor
64493842|NCT01993719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493843|NCT01993719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64493844|NCT01993719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64493845|NCT01993719|Alkylating Agents|alkylating agents|mesh-ancestor
64493846|NCT01993719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493847|NCT01993719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493848|NCT01993719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64493849|NCT01993719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64493850|NCT01993719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64493851|NCT01993719|Antimetabolites|antimetabolites|mesh-ancestor
65355789|NCT00546364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65355790|NCT00546364|Antimetabolites|antimetabolites|mesh-ancestor
65355792|NCT00887211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65355793|NCT00887211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65355794|NCT00887211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65355795|NCT00887211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355796|NCT00887211|Antifungal Agents|antifungal agents|mesh-ancestor
65355797|NCT00887211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65355798|NCT00887211|Immunologic Factors|immunologic factors|mesh-ancestor
65355799|NCT00887211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355800|NCT00887367|Ethanol|ethanol|mesh-list
65355801|NCT00887367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65355802|NCT00887367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65355803|NCT00887367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65355804|NCT00887367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355805|NCT00964288|Lidocaine|lidocaine|mesh-list
65355806|NCT00964288|Anesthetics, Local|anesthetics, local|mesh-ancestor
65355807|NCT00964288|Anesthetics|anesthetics|mesh-ancestor
65355808|NCT00964288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65355809|NCT00964288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355810|NCT00964288|Sensory System Agents|sensory system agents|mesh-ancestor
65355811|NCT00964288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65355812|NCT00964288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65355813|NCT00964288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65355814|NCT00964288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65355815|NCT00964288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65355816|NCT00964288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355817|NCT00964756|Ganciclovir|ganciclovir|mesh-list
65355835|NCT00612105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355836|NCT04017741|Methylprednisolone|methylprednisolone|mesh-list
65355837|NCT04017741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65355838|NCT04017741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65355839|NCT04017741|Prednisolone|prednisolone|mesh-list
65355840|NCT04017741|Prednisolone acetate|prednisolone acetate|mesh-list
65355841|NCT04017741|Lidocaine|lidocaine|mesh-list
65355842|NCT04017741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65355843|NCT04017741|Prednisolone phosphate|prednisolone phosphate|mesh-list
65355844|NCT04017741|Anesthetics, Local|anesthetics, local|mesh-ancestor
65355845|NCT04017741|Anesthetics|anesthetics|mesh-ancestor
65355846|NCT04017741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65355847|NCT04017741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355848|NCT04017741|Sensory System Agents|sensory system agents|mesh-ancestor
65355849|NCT04017741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65355850|NCT04017741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65355851|NCT04017741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65355852|NCT04017741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65355853|NCT04017741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65355854|NCT04017741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355855|NCT04017741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65355856|NCT04017741|Antiemetics|antiemetics|mesh-ancestor
65355857|NCT04017741|Autonomic Agents|autonomic agents|mesh-ancestor
65355858|NCT04017741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65355859|NCT04017741|Glucocorticoids|glucocorticoids|mesh-ancestor
65355860|NCT04017741|Hormones|hormones|mesh-ancestor
65355861|NCT04017741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65355862|NCT04017741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65355863|NCT04017741|Protective Agents|protective agents|mesh-ancestor
65355864|NCT04017741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65355865|NCT04017741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355866|NCT00546052|Losartan|losartan|mesh-list
65355867|NCT00546052|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65355868|NCT00546052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65355873|NCT00546052|Diuretics|diuretics|mesh-ancestor
65355874|NCT00546052|Natriuretic Agents|natriuretic agents|mesh-ancestor
65355875|NCT00546052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355876|NCT00546052|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65355877|NCT00546052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65355878|NCT00887601|Donepezil|donepezil|mesh-list
65355879|NCT00887601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65355880|NCT00887601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355881|NCT00887601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355882|NCT00887601|Cholinergic Agents|cholinergic agents|mesh-ancestor
65355883|NCT00887601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65355884|NCT00887601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355885|NCT00887601|Nootropic Agents|nootropic agents|mesh-ancestor
65355886|NCT02542839|Botulinum Toxins|botulinum toxins|mesh-list
65355887|NCT02542839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65355888|NCT02542839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65355889|NCT02542839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355890|NCT02542839|Cholinergic Agents|cholinergic agents|mesh-ancestor
65355891|NCT02542839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65355892|NCT02542839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355893|NCT00887757|Gemcitabine|gemcitabine|mesh-list
65355894|NCT00887757|Navitoclax|navitoclax|mesh-list
65355895|NCT00887757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65355896|NCT00887757|Antimetabolites|antimetabolites|mesh-ancestor
65355897|NCT00887757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355898|NCT00887757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355899|NCT00887757|Antiviral Agents|antiviral agents|mesh-ancestor
65355901|NCT00887757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355917|NCT04392921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65355918|NCT00673920|Methotrexate|methotrexate|mesh-list
65355919|NCT00673920|Ocrelizumab|ocrelizumab|mesh-list
65355920|NCT00673920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65355921|NCT00673920|Abortifacient Agents|abortifacient agents|mesh-ancestor
65355922|NCT00673920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65355923|NCT00673920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355924|NCT00673920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65355925|NCT00673920|Antimetabolites|antimetabolites|mesh-ancestor
65355926|NCT00673920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355927|NCT00673920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355928|NCT00673920|Dermatologic Agents|dermatologic agents|mesh-ancestor
65355929|NCT00673920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355931|NCT00673920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65355932|NCT00673920|Immunologic Factors|immunologic factors|mesh-ancestor
65355933|NCT00673920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65355934|NCT00673920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65355935|NCT00959686|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65355936|NCT00959686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65355937|NCT00959686|Alkylating Agents|alkylating agents|mesh-ancestor
65355938|NCT00959686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355939|NCT00959686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355940|NCT00379795|Ranibizumab|ranibizumab|mesh-list
65355941|NCT00379795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65355942|NCT00379795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65355943|NCT00379795|Growth Substances|growth substances|mesh-ancestor
65355944|NCT00379795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355945|NCT00379795|Growth Inhibitors|growth inhibitors|mesh-ancestor
65355963|NCT00765024|Antimitotic Agents|antimitotic agents|mesh-ancestor
65355964|NCT00765024|Mitosis Modulators|mitosis modulators|mesh-ancestor
65355965|NCT00765024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355966|NCT00765024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355967|NCT02557932|Bismuth|bismuth|mesh-list
65355968|NCT02557932|Antacids|antacids|mesh-ancestor
65355969|NCT02557932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355970|NCT02557932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65355971|NCT00960232|Cholecalciferol|cholecalciferol|mesh-list
65355972|NCT00960232|Vitamin D|vitamin d|mesh-list
65355973|NCT00960232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65355974|NCT00960232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355975|NCT00960232|Vitamins|vitamins|mesh-ancestor
65355976|NCT00960232|Micronutrients|micronutrients|mesh-ancestor
65355977|NCT00960232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65355978|NCT04577014|Gemcitabine|gemcitabine|mesh-list
65355979|NCT04577014|Docetaxel|docetaxel|mesh-list
65355980|NCT04577014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65355981|NCT04577014|Antimetabolites|antimetabolites|mesh-ancestor
65355982|NCT04577014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65355983|NCT04577014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65355984|NCT04577014|Antiviral Agents|antiviral agents|mesh-ancestor
65355985|NCT04577014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65355986|NCT04577014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65355987|NCT04577014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65355988|NCT04577014|Immunologic Factors|immunologic factors|mesh-ancestor
65355989|NCT04577014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65355990|NCT04577014|Tubulin Modulators|tubulin modulators|mesh-ancestor
65355991|NCT04577014|Antimitotic Agents|antimitotic agents|mesh-ancestor
65356009|NCT00960310|Hormone Antagonists|hormone antagonists|mesh-ancestor
65356010|NCT00960310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65356011|NCT00960310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356012|NCT00960310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356013|NCT00610155|Pregabalin|pregabalin|mesh-list
65356014|NCT00610155|Tramadol|tramadol|mesh-list
65356015|NCT00610155|Analgesics|analgesics|mesh-ancestor
65356016|NCT00610155|Sensory System Agents|sensory system agents|mesh-ancestor
65356017|NCT00610155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65356018|NCT00610155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356019|NCT00610155|Anticonvulsants|anticonvulsants|mesh-ancestor
65356020|NCT00610155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65356021|NCT00610155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65356022|NCT00610155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356023|NCT00610155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65356024|NCT00610155|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65356025|NCT00610155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65356026|NCT00610155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65356027|NCT00610155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65356028|NCT00610155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65356029|NCT00610155|Narcotics|narcotics|mesh-ancestor
65356030|NCT00759018|Remestemcel-l|remestemcel-l|mesh-list
65356031|NCT00759018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65356032|NCT00759018|Antiviral Agents|antiviral agents|mesh-ancestor
65356033|NCT00759018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65356034|NCT00960544|Capecitabine|capecitabine|mesh-list
65356035|NCT00960544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64493852|NCT01993719|Antiviral Agents|antiviral agents|mesh-ancestor
64493853|NCT01993719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64493854|NCT01993719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64493855|NCT01993719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64493856|NCT02758665|Venetoclax|venetoclax|mesh-list
64493857|NCT02758665|Obinutuzumab|obinutuzumab|mesh-list
64493858|NCT02758665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493859|NCT02758665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64493860|NCT03182673|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64493862|NCT03182673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493864|NCT02647203|Fluorides|fluorides|mesh-list
64493865|NCT02647203|Cariostatic Agents|cariostatic agents|mesh-ancestor
64493866|NCT02647203|Protective Agents|protective agents|mesh-ancestor
64493867|NCT02647203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493868|NCT00638157|Gentamicins|gentamicins|mesh-list
64493869|NCT00638157|Daptomycin|daptomycin|mesh-list
64493870|NCT00638157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64493871|NCT00638157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64493872|NCT00638157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64493873|NCT00638157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356036|NCT00960544|Antimetabolites|antimetabolites|mesh-ancestor
65356037|NCT00960544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356038|NCT00960544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356039|NCT04488952|Anesthetics|anesthetics|mesh-list
65356040|NCT04488952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65356041|NCT04488952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356042|NCT00888303|Dexamethasone|dexamethasone|mesh-list
65356043|NCT00888303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65356044|NCT00888303|Antiemetics|antiemetics|mesh-ancestor
65356045|NCT00888303|Autonomic Agents|autonomic agents|mesh-ancestor
65356046|NCT00888303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65356047|NCT00888303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356048|NCT00888303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65356049|NCT00888303|Glucocorticoids|glucocorticoids|mesh-ancestor
65356050|NCT00888303|Hormones|hormones|mesh-ancestor
65356051|NCT00888303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65356052|NCT00888303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65356053|NCT00888303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356054|NCT00967642|Insulin|insulin|mesh-list
65356055|NCT00967642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65356056|NCT00967642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356057|NCT00674700|Immunologic Factors|immunologic factors|mesh-list
65356058|NCT00674700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356059|NCT00762918|Vitamin D|vitamin d|mesh-list
65356060|NCT00762918|Cholecalciferol|cholecalciferol|mesh-list
65356061|NCT00762918|Vitamins|vitamins|mesh-ancestor
65356062|NCT00762918|Micronutrients|micronutrients|mesh-ancestor
65356063|NCT00762918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356064|NCT00762918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65356065|NCT00762918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65356066|NCT00546910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65356067|NCT00546910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65356068|NCT00546910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65356069|NCT00546910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65019544|NCT02917018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64493874|NCT00638157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493875|NCT02530437|Paclitaxel|paclitaxel|mesh-list
65356070|NCT00546910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356071|NCT00546910|Adrenergic Agents|adrenergic agents|mesh-ancestor
65356072|NCT00546910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65356073|NCT00546910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356074|NCT00759720|Glyburide|glyburide|mesh-list
65356075|NCT00759720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65356076|NCT00759720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356077|NCT00379639|Gemcitabine|gemcitabine|mesh-list
65356078|NCT00379639|Romidepsin|romidepsin|mesh-list
65105932|NCT00595972|Endostar protein|endostar protein|mesh-list
65356079|NCT00379639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65356080|NCT00379639|Antimetabolites|antimetabolites|mesh-ancestor
65356109|NCT00609765|Hormones|hormones|mesh-ancestor
65356133|NCT01051219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65356134|NCT01051219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65356135|NCT01051219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65356136|NCT01051219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356137|NCT00961324|Insulin|insulin|mesh-list
65356138|NCT00961324|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65356139|NCT00961324|Insulin Glargine|insulin glargine|mesh-list
65356140|NCT00961324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65356141|NCT00961324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356142|NCT00766350|Amitriptyline|amitriptyline|mesh-list
65356143|NCT00766350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65356144|NCT00766350|Antidepressive Agents|antidepressive agents|mesh-ancestor
65356145|NCT00766350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65356146|NCT00766350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65356147|NCT00766350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65356148|NCT00766350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65356149|NCT00766350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356150|NCT00766350|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65356151|NCT00766350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65356161|NCT00889161|Curcumin|curcumin|mesh-list
65356186|NCT00760032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65356187|NCT00760032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65356188|NCT00760032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65356189|NCT00760032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356190|NCT00760032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356191|NCT00760032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356192|NCT00760032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65356193|NCT00760032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65356194|NCT00961480|Metformin|metformin|mesh-list
65356195|NCT00961480|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65356196|NCT00961480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65356197|NCT00961480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356198|NCT00961480|Incretins|incretins|mesh-ancestor
65356199|NCT00961480|Hormones|hormones|mesh-ancestor
65356200|NCT00961480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65356201|NCT00961480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65356202|NCT00961480|Protease Inhibitors|protease inhibitors|mesh-ancestor
65356203|NCT00961480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356204|NCT00961480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356205|NCT00766662|Pyrimethamine|pyrimethamine|mesh-list
65356206|NCT00766662|Sulfadoxine|sulfadoxine|mesh-list
65356207|NCT00766662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65356208|NCT00766662|Antimalarials|antimalarials|mesh-ancestor
65356209|NCT00766662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65356210|NCT00766662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65356211|NCT00766662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65356212|NCT00766662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65356213|NCT00766662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356214|NCT00766662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356215|NCT00766662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65356216|NCT00766662|Renal Agents|renal agents|mesh-ancestor
65356217|NCT00965926|Mirabegron|mirabegron|mesh-list
65106081|NCT05312866|Anesthetics, General|anesthetics, general|mesh-ancestor
65356227|NCT00966004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65356228|NCT00966004|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65356229|NCT00966004|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65356230|NCT00966004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65356231|NCT00966004|Adrenergic Agents|adrenergic agents|mesh-ancestor
65356232|NCT00966004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65356233|NCT00966004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356234|NCT00966004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356235|NCT00966004|Urological Agents|urological agents|mesh-ancestor
65356236|NCT00966004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65356237|NCT00966004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65356238|NCT00966004|Cholinergic Agents|cholinergic agents|mesh-ancestor
65356239|NCT00966082|Propranolol|propranolol|mesh-list
65356240|NCT00966082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65356241|NCT00966082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65356242|NCT00966082|Adrenergic Agents|adrenergic agents|mesh-ancestor
65356243|NCT00966082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65356244|NCT00966082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356245|NCT00966082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356246|NCT00966082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65356247|NCT00966082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65356248|NCT00966082|Vasodilator Agents|vasodilator agents|mesh-ancestor
65356249|NCT00889629|Vitamin D|vitamin d|mesh-list
65356250|NCT00889629|Cholecalciferol|cholecalciferol|mesh-list
65356251|NCT00889629|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
65356252|NCT00889629|Ergocalciferols|ergocalciferols|mesh-list
65356274|NCT00966160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65356275|NCT00966160|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65356276|NCT00966160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65356277|NCT00966160|Antimetabolites|antimetabolites|mesh-ancestor
65356278|NCT00966160|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65356279|NCT00966160|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65356280|NCT00966160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65356281|NCT00966160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65356282|NCT00966160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65356283|NCT00766818|Lopinavir|lopinavir|mesh-list
65356284|NCT00766818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65356285|NCT00766818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65356286|NCT00766818|Protease Inhibitors|protease inhibitors|mesh-ancestor
65356287|NCT00766818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356288|NCT00766818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356289|NCT00766818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65356290|NCT00766818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65356291|NCT00766818|Antiviral Agents|antiviral agents|mesh-ancestor
65356292|NCT00766818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65356293|NCT00766818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65356294|NCT00766818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65356295|NCT00966316|Aspirin|aspirin|mesh-list
65356296|NCT00966316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65356297|NCT00966316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65356298|NCT00966316|Analgesics|analgesics|mesh-ancestor
65356299|NCT00966316|Sensory System Agents|sensory system agents|mesh-ancestor
65356300|NCT00966316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65356301|NCT00966316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356302|NCT00966316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65356303|NCT00966316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65356304|NCT00966316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65356305|NCT00966316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64493876|NCT02530437|Carboplatin|carboplatin|mesh-list
64493877|NCT02530437|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64493878|NCT02530437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64493879|NCT02530437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493880|NCT02530437|Tubulin Modulators|tubulin modulators|mesh-ancestor
64493881|NCT02530437|Antimitotic Agents|antimitotic agents|mesh-ancestor
64493882|NCT02530437|Mitosis Modulators|mitosis modulators|mesh-ancestor
64493883|NCT02530437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356306|NCT00966316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356307|NCT00966316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65356308|NCT00966316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65356309|NCT00966316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356311|NCT00892827|Rituximab|rituximab|mesh-list
65356312|NCT00892827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65356313|NCT00892827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356314|NCT00892827|Immunologic Factors|immunologic factors|mesh-ancestor
65356315|NCT00892827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356316|NCT00892827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65356317|NCT00766896|Aspirin|aspirin|mesh-list
65356318|NCT00766896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65356319|NCT00766896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65356320|NCT00766896|Analgesics|analgesics|mesh-ancestor
65356321|NCT00766896|Sensory System Agents|sensory system agents|mesh-ancestor
65356366|NCT00973882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65356367|NCT00973882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65356368|NCT00973882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356369|NCT00973882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356370|NCT02558088|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65356371|NCT02558088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65356372|NCT02558088|Autonomic Agents|autonomic agents|mesh-ancestor
65106228|NCT00598429|Alprostadil|alprostadil|mesh-list
65356373|NCT02558088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65356374|NCT02558088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356375|NCT02558088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65356376|NCT02558088|Respiratory System Agents|respiratory system agents|mesh-ancestor
65356377|NCT02558088|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65356378|NCT02558088|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65356379|NCT02558088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65356380|NCT02558088|Adrenergic Agents|adrenergic agents|mesh-ancestor
65356381|NCT02558088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65356382|NCT02558088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356383|NCT05279482|Methylprednisolone|methylprednisolone|mesh-list
65356384|NCT05279482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65356385|NCT05279482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65356386|NCT05279482|Prednisolone|prednisolone|mesh-list
65356387|NCT05279482|Prednisolone acetate|prednisolone acetate|mesh-list
65356388|NCT05279482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65356389|NCT05279482|Prednisolone phosphate|prednisolone phosphate|mesh-list
65356390|NCT05279482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65356391|NCT05279482|Antiemetics|antiemetics|mesh-ancestor
65356392|NCT05279482|Autonomic Agents|autonomic agents|mesh-ancestor
65356411|NCT00890175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65356412|NCT00890175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356413|NCT00966472|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65356414|NCT00966472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65356415|NCT00966472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356416|NCT00966472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65356417|NCT00966472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356418|NCT00966472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356419|NCT00966472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65356420|NCT00966472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65356421|NCT00966472|Antimetabolites|antimetabolites|mesh-ancestor
65356422|NCT00966472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65356423|NCT00966472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65356424|NCT00890253|Mycophenolic Acid|mycophenolic acid|mesh-list
65356425|NCT00890253|Prednisone|prednisone|mesh-list
65356426|NCT00890253|Prednisolone|prednisolone|mesh-list
65356427|NCT00890253|Everolimus|everolimus|mesh-list
65356428|NCT00890253|Basiliximab|basiliximab|mesh-list
65356429|NCT00890253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65356430|NCT00890253|Glucocorticoids|glucocorticoids|mesh-ancestor
65356431|NCT00890253|Hormones|hormones|mesh-ancestor
65356432|NCT00890253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65356433|NCT00890253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356434|NCT00890253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65356435|NCT00890253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356436|NCT00890253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65356437|NCT00890253|Immunologic Factors|immunologic factors|mesh-ancestor
65356438|NCT00890253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65356439|NCT00890253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65356440|NCT00890253|Antitubercular Agents|antitubercular agents|mesh-ancestor
65356441|NCT00890253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65356442|NCT00890253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65356443|NCT00890253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356444|NCT00890253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356445|NCT00674154|Vitamin D|vitamin d|mesh-list
65356446|NCT00674154|Cholecalciferol|cholecalciferol|mesh-list
64493884|NCT00637377|Ranibizumab|ranibizumab|mesh-list
64493885|NCT00637377|Aflibercept|aflibercept|mesh-list
64493886|NCT00637377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65356447|NCT00674154|Vitamins|vitamins|mesh-ancestor
65356448|NCT00674154|Micronutrients|micronutrients|mesh-ancestor
65356449|NCT00674154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356450|NCT00674154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65356451|NCT00674154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65356452|NCT00967954|Hormones|hormones|mesh-list
65356453|NCT00967954|Androgen Antagonists|androgen antagonists|mesh-list
65356454|NCT00967954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65356455|NCT00967954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356456|NCT00967954|Hormone Antagonists|hormone antagonists|mesh-ancestor
65356457|NCT00767286|Cobalt|cobalt|mesh-list
65356458|NCT00767286|Goserelin|goserelin|mesh-list
65356459|NCT00767286|Flutamide|flutamide|mesh-list
65356460|NCT00767286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65356461|NCT00767286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356462|NCT00767286|Trace Elements|trace elements|mesh-ancestor
65356463|NCT00767286|Micronutrients|micronutrients|mesh-ancestor
65356464|NCT00767286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356465|NCT00767286|Androgen Antagonists|androgen antagonists|mesh-ancestor
65356466|NCT00767286|Hormone Antagonists|hormone antagonists|mesh-ancestor
65356467|NCT00767286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65356468|NCT00968110|Omalizumab|omalizumab|mesh-list
65356469|NCT00968110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65356470|NCT00968110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65356471|NCT00968110|Respiratory System Agents|respiratory system agents|mesh-ancestor
65356472|NCT00608517|Methylprednisolone|methylprednisolone|mesh-list
65356473|NCT00608517|Cyclophosphamide|cyclophosphamide|mesh-list
65356474|NCT00608517|Fludarabine|fludarabine|mesh-list
65356475|NCT00608517|Fludarabine phosphate|fludarabine phosphate|mesh-list
65356476|NCT00608517|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65356477|NCT00608517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65356478|NCT00608517|Immunologic Factors|immunologic factors|mesh-ancestor
65356479|NCT00608517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356480|NCT00608517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65356481|NCT00608517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65356482|NCT00608517|Alkylating Agents|alkylating agents|mesh-ancestor
65356486|NCT00608517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65356487|NCT00608517|Antimetabolites|antimetabolites|mesh-ancestor
65356488|NCT00608517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65356489|NCT00608517|Antiemetics|antiemetics|mesh-ancestor
65356490|NCT00608517|Autonomic Agents|autonomic agents|mesh-ancestor
65356491|NCT00608517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65356492|NCT00608517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65356493|NCT00608517|Glucocorticoids|glucocorticoids|mesh-ancestor
65356494|NCT00608517|Hormones|hormones|mesh-ancestor
65356495|NCT00608517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65356496|NCT00608517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65356497|NCT00608517|Protective Agents|protective agents|mesh-ancestor
65356498|NCT00966706|Gemcitabine|gemcitabine|mesh-list
65356499|NCT00966706|Docetaxel|docetaxel|mesh-list
65356500|NCT00966706|Capecitabine|capecitabine|mesh-list
65356501|NCT00966706|Epirubicin|epirubicin|mesh-list
65356502|NCT00966706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356503|NCT00966706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65356504|NCT00966706|Antimetabolites|antimetabolites|mesh-ancestor
65356505|NCT00966706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356506|NCT00966706|Antiviral Agents|antiviral agents|mesh-ancestor
65356507|NCT00966706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65356508|NCT00966706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356509|NCT00966706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65356510|NCT00966706|Immunologic Factors|immunologic factors|mesh-ancestor
65356511|NCT00966706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356512|NCT00966706|Tubulin Modulators|tubulin modulators|mesh-ancestor
65356534|NCT00893061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65356535|NCT00974272|Exenatide|exenatide|mesh-list
65356536|NCT00974272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65356537|NCT00974272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356538|NCT00974272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65356539|NCT00974272|Incretins|incretins|mesh-ancestor
65356540|NCT00974272|Hormones|hormones|mesh-ancestor
65356541|NCT00974272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65356542|NCT00974428|Wobenzym|wobenzym|mesh-list
65356543|NCT00974428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65356544|NCT00974428|Immunologic Factors|immunologic factors|mesh-ancestor
65356545|NCT00974428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356546|NCT00974584|Paclitaxel|paclitaxel|mesh-list
65356547|NCT00974584|Bevacizumab|bevacizumab|mesh-list
65356548|NCT00974584|Carboplatin|carboplatin|mesh-list
65356549|NCT00974584|Pemetrexed|pemetrexed|mesh-list
65356550|NCT00974584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65356551|NCT00974584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356552|NCT00974584|Tubulin Modulators|tubulin modulators|mesh-ancestor
65356553|NCT00974584|Antimitotic Agents|antimitotic agents|mesh-ancestor
65356554|NCT00974584|Mitosis Modulators|mitosis modulators|mesh-ancestor
65356555|NCT00974584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356556|NCT00974584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65356557|NCT00974584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65356558|NCT00974584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65356559|NCT00974584|Growth Substances|growth substances|mesh-ancestor
65356560|NCT00974584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356561|NCT00974584|Growth Inhibitors|growth inhibitors|mesh-ancestor
65356562|NCT00974584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356563|NCT00974584|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65356564|NCT00974584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65356565|NCT00608205|Fluorouracil|fluorouracil|mesh-list
65356566|NCT00608205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356567|NCT00608205|Antimetabolites|antimetabolites|mesh-ancestor
65356568|NCT00608205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356574|NCT00974740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65356575|NCT00974740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65356576|NCT00974740|Antimetabolites|antimetabolites|mesh-ancestor
65356577|NCT00974740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356578|NCT00974740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65356579|NCT00974740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65356580|NCT00974740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356581|NCT00967096|Rifaximin|rifaximin|mesh-list
65356582|NCT00967096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65356583|NCT00967096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65356584|NCT00967096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65356585|NCT05227300|Lidocaine|lidocaine|mesh-list
65356586|NCT05227300|Epinephrine|epinephrine|mesh-list
65356587|NCT05227300|Anesthetics, Local|anesthetics, local|mesh-ancestor
65356634|NCT00890643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356635|NCT00893217|Interferons|interferons|mesh-list
65356636|NCT00893217|Interferon-beta|interferon-beta|mesh-list
65356637|NCT00893217|Interferon beta-1b|interferon beta-1b|mesh-list
65356638|NCT00893217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356639|NCT00893217|Antiviral Agents|antiviral agents|mesh-ancestor
65356640|NCT00893217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65356641|NCT00893217|Immunologic Factors|immunologic factors|mesh-ancestor
65356642|NCT00893217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356643|NCT00893217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65356644|NCT00767598|Sildenafil Citrate|sildenafil citrate|mesh-list
65356645|NCT00767598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65356646|NCT00767598|Udenafil|udenafil|mesh-list
65356647|NCT00767598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
65356648|NCT00767598|Vasodilator Agents|vasodilator agents|mesh-ancestor
65356649|NCT00767598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65356650|NCT00767598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356651|NCT00767598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356652|NCT00767598|Urological Agents|urological agents|mesh-ancestor
65356653|NCT00670800|Metformin|metformin|mesh-list
65356654|NCT00670800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65356655|NCT00670800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356656|NCT00764166|Docetaxel|docetaxel|mesh-list
65356657|NCT00764166|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65356658|NCT00764166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356659|NCT00764166|Tubulin Modulators|tubulin modulators|mesh-ancestor
65356660|NCT00764166|Antimitotic Agents|antimitotic agents|mesh-ancestor
65356661|NCT00764166|Mitosis Modulators|mitosis modulators|mesh-ancestor
65356663|NCT00764166|Hormones|hormones|mesh-ancestor
65356679|NCT02557542|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65356680|NCT02557542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65356681|NCT00767754|Paroxetine|paroxetine|mesh-list
65356682|NCT00767754|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65356683|NCT00767754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65356684|NCT00767754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65356685|NCT00767754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356686|NCT00767754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65356687|NCT00767754|Serotonin Agents|serotonin agents|mesh-ancestor
65356688|NCT00767754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356689|NCT00767754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65356690|NCT00767754|Antidepressive Agents|antidepressive agents|mesh-ancestor
65356691|NCT00767754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65356692|NCT00767754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65356693|NCT00767754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65356694|NCT00767754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356695|NCT00764244|Triamcinolone|triamcinolone|mesh-list
65356701|NCT00764244|Hormones|hormones|mesh-ancestor
65356735|NCT05208190|Serotonin Agents|serotonin agents|mesh-ancestor
65356736|NCT05208190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65356737|NCT05208190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356738|NCT05208190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356739|NCT05208190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65356740|NCT05208190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65356741|NCT05208190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65356742|NCT05208190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65356743|NCT05208190|GABA Antagonists|gaba antagonists|mesh-ancestor
65356744|NCT05208190|GABA Agents|gaba agents|mesh-ancestor
65356745|NCT00609609|Methylprednisolone|methylprednisolone|mesh-list
65356746|NCT00609609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65356747|NCT00609609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65356748|NCT00609609|Prednisolone|prednisolone|mesh-list
65356749|NCT00609609|Prednisolone acetate|prednisolone acetate|mesh-list
65356750|NCT00609609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65356751|NCT00609609|Prednisolone phosphate|prednisolone phosphate|mesh-list
65356752|NCT00609609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65356753|NCT00609609|Antiemetics|antiemetics|mesh-ancestor
65356754|NCT00609609|Autonomic Agents|autonomic agents|mesh-ancestor
65356755|NCT00609609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65356756|NCT00609609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356757|NCT00609609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65356758|NCT00609609|Glucocorticoids|glucocorticoids|mesh-ancestor
65356759|NCT00609609|Hormones|hormones|mesh-ancestor
65356760|NCT00609609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65356761|NCT00609609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65356762|NCT00609609|Protective Agents|protective agents|mesh-ancestor
65356763|NCT00609609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65356764|NCT00609609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356765|NCT00673452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65356766|NCT00673452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65356767|NCT00673452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65356768|NCT00673452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65356769|NCT00673452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356771|NCT00673452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356772|NCT00673452|Analgesics|analgesics|mesh-ancestor
65356773|NCT00673452|Sensory System Agents|sensory system agents|mesh-ancestor
65356774|NCT00673452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65356775|NCT00673452|Antidepressive Agents|antidepressive agents|mesh-ancestor
65356776|NCT00673452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65356777|NCT00673452|Dopamine Agents|dopamine agents|mesh-ancestor
65356778|NCT00967174|Nicotine|nicotine|mesh-list
65356779|NCT00967174|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65356780|NCT00967174|Autonomic Agents|autonomic agents|mesh-ancestor
65356781|NCT00967174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65356782|NCT00967174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356783|NCT00967174|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65356784|NCT00967174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65356785|NCT00967174|Cholinergic Agents|cholinergic agents|mesh-ancestor
65356786|NCT00967174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65356787|NCT00967174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356788|NCT00967252|Atorvastatin|atorvastatin|mesh-list
65356789|NCT00967252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65356790|NCT00967252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65356791|NCT00967252|Antimetabolites|antimetabolites|mesh-ancestor
65356793|NCT00967252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65356823|NCT00891033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356824|NCT00770952|Pioglitazone|pioglitazone|mesh-list
65356825|NCT00770952|Glimepiride|glimepiride|mesh-list
65356826|NCT00770952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65356827|NCT00770952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356828|NCT00770952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65356829|NCT00770952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65356830|NCT00770952|Immunologic Factors|immunologic factors|mesh-ancestor
65356831|NCT00764556|Insulin|insulin|mesh-list
65356832|NCT00764556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65356833|NCT00764556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356834|NCT00968578|Methylprednisolone|methylprednisolone|mesh-list
65356835|NCT00968578|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65356836|NCT00968578|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65356837|NCT00968578|Prednisolone|prednisolone|mesh-list
65356838|NCT00968578|Prednisolone acetate|prednisolone acetate|mesh-list
65356839|NCT00968578|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65356840|NCT00968578|Prednisolone phosphate|prednisolone phosphate|mesh-list
65356841|NCT00968578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65356842|NCT00968578|Antiemetics|antiemetics|mesh-ancestor
65356878|NCT00545584|Protease Inhibitors|protease inhibitors|mesh-ancestor
65356879|NCT00545584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356880|NCT00545584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356881|NCT00378703|Sirolimus|sirolimus|mesh-list
65356882|NCT00378703|Bevacizumab|bevacizumab|mesh-list
65356883|NCT00378703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65356884|NCT00378703|Sorafenib|sorafenib|mesh-list
65356885|NCT00378703|Endothelial Growth Factors|endothelial growth factors|mesh-list
65356886|NCT00378703|Antibodies|antibodies|mesh-list
65356887|NCT00378703|Immunoglobulins|immunoglobulins|mesh-list
65356888|NCT00378703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65356889|NCT00378703|Immunoglobulin G|immunoglobulin g|mesh-list
65356890|NCT00378703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356891|NCT00378703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65356892|NCT00378703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65356893|NCT00378703|Growth Substances|growth substances|mesh-ancestor
65356894|NCT00378703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356895|NCT00378703|Growth Inhibitors|growth inhibitors|mesh-ancestor
65356896|NCT00378703|Immunologic Factors|immunologic factors|mesh-ancestor
65356897|NCT00378703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65356898|NCT00378703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356899|NCT00378703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356900|NCT00378703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65356901|NCT00378703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65356902|NCT00378703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65356928|NCT04035382|Oxytocics|oxytocics|mesh-ancestor
65356929|NCT04035382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65356930|NCT04035382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356931|NCT04035382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65356932|NCT04035382|Abortifacient Agents|abortifacient agents|mesh-ancestor
65356933|NCT04035382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65356934|NCT04035382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65356935|NCT02541045|Metadoxine|metadoxine|mesh-list
65356936|NCT02541045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65356937|NCT00891579|Pemetrexed|pemetrexed|mesh-list
65356938|NCT00891579|Gefitinib|gefitinib|mesh-list
65356939|NCT00891579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356940|NCT00891579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65356941|NCT00891579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356942|NCT00891579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65356943|NCT00891579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65356944|NCT00891579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65356945|NCT00968734|Cholecalciferol|cholecalciferol|mesh-list
65356946|NCT00968734|Vitamin D|vitamin d|mesh-list
65356947|NCT00968734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65356948|NCT00968734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356949|NCT00968734|Vitamins|vitamins|mesh-ancestor
65356950|NCT00968734|Micronutrients|micronutrients|mesh-ancestor
65356951|NCT00968734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65356952|NCT03620643|Fulvestrant|fulvestrant|mesh-list
65356953|NCT03620643|Crizotinib|crizotinib|mesh-list
65356954|NCT03620643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65356955|NCT03620643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356956|NCT03620643|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65356957|NCT03620643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65356958|NCT03620643|Hormone Antagonists|hormone antagonists|mesh-ancestor
65356971|NCT04008316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356972|NCT00893607|Methoxamine|methoxamine|mesh-list
65356973|NCT00893607|Sympathomimetics|sympathomimetics|mesh-ancestor
65356974|NCT00893607|Autonomic Agents|autonomic agents|mesh-ancestor
65356975|NCT00893607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65356976|NCT00893607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65356977|NCT00893607|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65356978|NCT00893607|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65356979|NCT00893607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65356980|NCT00893607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65356981|NCT00893607|Adrenergic Agents|adrenergic agents|mesh-ancestor
65356982|NCT00893607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65356983|NCT00893607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65356984|NCT00969046|Epothilone B|epothilone b|mesh-list
65356985|NCT00969046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65356986|NCT00969046|Tubulin Modulators|tubulin modulators|mesh-ancestor
65356987|NCT00969046|Antimitotic Agents|antimitotic agents|mesh-ancestor
65356990|NCT05008354|Pyridoxine|pyridoxine|mesh-list
65357029|NCT00975910|Anesthetics|anesthetics|mesh-ancestor
65357030|NCT00975910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65357031|NCT00975910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357032|NCT00975910|Sensory System Agents|sensory system agents|mesh-ancestor
65357033|NCT00975910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65357034|NCT00975910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65357035|NCT00975910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65357036|NCT00975910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65357037|NCT00975910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65357038|NCT00975910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357039|NCT03617913|Cisplatin|cisplatin|mesh-list
65357040|NCT03617913|Fluorouracil|fluorouracil|mesh-list
65357041|NCT03617913|Mitomycins|mitomycins|mesh-list
65357042|NCT03617913|Mitomycin|mitomycin|mesh-list
65357043|NCT03617913|Avelumab|avelumab|mesh-list
65357044|NCT03617913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65357045|NCT03617913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357046|NCT03617913|Antimetabolites|antimetabolites|mesh-ancestor
65357047|NCT03617913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357048|NCT03617913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65357049|NCT03617913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65357050|NCT03617913|Immunologic Factors|immunologic factors|mesh-ancestor
65357051|NCT03617913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357052|NCT03617913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65357053|NCT03617913|Alkylating Agents|alkylating agents|mesh-ancestor
65357054|NCT03617913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65357055|NCT03617913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357056|NCT03617913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65357057|NCT00975988|Lapatinib|lapatinib|mesh-list
65357058|NCT00975988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357059|NCT00975988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65357060|NCT00975988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357061|NCT00975988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357069|NCT03557619|Levonorgestrel|levonorgestrel|mesh-list
65357070|NCT03557619|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65357071|NCT03557619|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65357072|NCT03557619|Estradiol|estradiol|mesh-list
65357073|NCT03557619|Estrogens|estrogens|mesh-ancestor
65357074|NCT03557619|Hormones|hormones|mesh-ancestor
65357075|NCT03557619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65357076|NCT03557619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357077|NCT03557619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65357078|NCT03557619|Contraceptive Agents|contraceptive agents|mesh-ancestor
65357079|NCT03557619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65357080|NCT03557619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65357081|NCT03557619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357082|NCT03557619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65357083|NCT03557619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65357084|NCT03557619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65357086|NCT00969592|Insulin|insulin|mesh-list
65357128|NCT00979966|Growth Inhibitors|growth inhibitors|mesh-ancestor
65357129|NCT00979966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65357130|NCT00979966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357131|NCT00979966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357132|NCT00979966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65357133|NCT00979966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65357134|NCT00979966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65357135|NCT00979966|Antifungal Agents|antifungal agents|mesh-ancestor
65357136|NCT00979966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65357137|NCT00979966|Immunologic Factors|immunologic factors|mesh-ancestor
65357138|NCT00969904|Acetylcysteine|acetylcysteine|mesh-list
65357139|NCT00969904|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65357140|NCT00969904|Antiviral Agents|antiviral agents|mesh-ancestor
65357141|NCT00969904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65357142|NCT00969904|Expectorants|expectorants|mesh-ancestor
65357143|NCT00969904|Respiratory System Agents|respiratory system agents|mesh-ancestor
65357144|NCT00969904|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65357145|NCT00969904|Antioxidants|antioxidants|mesh-ancestor
65357146|NCT00969904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357147|NCT00969904|Protective Agents|protective agents|mesh-ancestor
65357148|NCT00969904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357149|NCT00969904|Antidotes|antidotes|mesh-ancestor
65357150|NCT00976690|Mesalamine|mesalamine|mesh-list
65357151|NCT00976690|Azathioprine|azathioprine|mesh-list
65357152|NCT00976690|Antimetabolites|antimetabolites|mesh-ancestor
65357157|NCT00976690|Immunologic Factors|immunologic factors|mesh-ancestor
65357178|NCT00608985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65357179|NCT00608985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357180|NCT00608985|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65357181|NCT00608985|GABA Agonists|gaba agonists|mesh-ancestor
65357182|NCT00608985|GABA Agents|gaba agents|mesh-ancestor
65357183|NCT00608985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65357184|NCT00608985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357185|NCT00969982|Misoprostol|misoprostol|mesh-list
65357186|NCT00969982|Mifepristone|mifepristone|mesh-list
65357187|NCT00969982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65357188|NCT00969982|Abortifacient Agents|abortifacient agents|mesh-ancestor
65357189|NCT00969982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65357190|NCT00969982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357191|NCT00969982|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65357192|NCT00969982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65357235|NCT00892125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65357236|NCT00980356|Vildagliptin|vildagliptin|mesh-list
65357237|NCT00980356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65357238|NCT00980356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357239|NCT00980356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65357240|NCT00980356|Protease Inhibitors|protease inhibitors|mesh-ancestor
65357241|NCT00980356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357242|NCT00980356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357243|NCT00368251|Brivaracetam|brivaracetam|mesh-list
65357244|NCT00368251|Anticonvulsants|anticonvulsants|mesh-ancestor
65357245|NCT00893841|Pramipexole|pramipexole|mesh-list
65357246|NCT00893841|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65357247|NCT00893841|Antidepressive Agents|antidepressive agents|mesh-ancestor
65357248|NCT00893841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65357249|NCT00893841|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65357250|NCT00893841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65357251|NCT00893841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65357252|NCT00893841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357253|NCT00893841|Antioxidants|antioxidants|mesh-ancestor
65357254|NCT00893841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357255|NCT00893841|Protective Agents|protective agents|mesh-ancestor
65357256|NCT00893841|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65357257|NCT00893841|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65357258|NCT00893841|Dopamine Agonists|dopamine agonists|mesh-ancestor
65357259|NCT00893841|Dopamine Agents|dopamine agents|mesh-ancestor
65357260|NCT00893841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65357261|NCT00378079|Methadone|methadone|mesh-list
65357262|NCT00378079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65357283|NCT00970450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65357284|NCT00970450|Serotonin Agents|serotonin agents|mesh-ancestor
65357285|NCT00970450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65357286|NCT00970450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357287|NCT00970528|Acarbose|acarbose|mesh-list
65357288|NCT00970528|Voglibose|voglibose|mesh-list
65357289|NCT00970528|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65357290|NCT00970528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357291|NCT00970528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357292|NCT00970528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65357293|NCT00970528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357294|NCT00970762|Rocuronium|rocuronium|mesh-list
65357295|NCT00970762|Vecuronium Bromide|vecuronium bromide|mesh-list
65357296|NCT00970762|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65357297|NCT00970762|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65357298|NCT00970762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65357299|NCT00970762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65357300|NCT00970762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357301|NCT00970762|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65357302|NCT00970762|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65357303|NCT00970762|Cholinergic Agents|cholinergic agents|mesh-ancestor
65357304|NCT00970762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65357305|NCT00970762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357306|NCT00978172|Artesunate|artesunate|mesh-list
65357307|NCT00978172|Mefloquine|mefloquine|mesh-list
65357308|NCT00978172|Antimalarials|antimalarials|mesh-ancestor
65357313|NCT00978172|Antiviral Agents|antiviral agents|mesh-ancestor
65357332|NCT00608907|Antiemetics|antiemetics|mesh-ancestor
65357333|NCT00608907|Autonomic Agents|autonomic agents|mesh-ancestor
65357334|NCT00608907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65357335|NCT00608907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357336|NCT00608907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65357337|NCT00608907|Glucocorticoids|glucocorticoids|mesh-ancestor
65357338|NCT00608907|Hormones|hormones|mesh-ancestor
65357339|NCT00608907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65357340|NCT00608907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65357341|NCT00608907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357342|NCT00608907|Protease Inhibitors|protease inhibitors|mesh-ancestor
65357343|NCT00608907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357344|NCT00608907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357345|NCT00608907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65357346|NCT00608907|Antitubercular Agents|antitubercular agents|mesh-ancestor
65357347|NCT00608907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65357348|NCT00608907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65357349|NCT00608907|Leprostatic Agents|leprostatic agents|mesh-ancestor
65357350|NCT00608907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65357351|NCT00608907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65357352|NCT00608907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65357353|NCT00608907|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65357354|NCT00608907|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65357355|NCT00608907|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65357356|NCT00608907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65357358|NCT00970996|Interferon-alpha|interferon-alpha|mesh-list
65357359|NCT00970996|Interferon alpha-2|interferon alpha-2|mesh-list
65357360|NCT00970996|Paclitaxel|paclitaxel|mesh-list
65357361|NCT00970996|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65357362|NCT00970996|Cisplatin|cisplatin|mesh-list
65357363|NCT00970996|Temozolomide|temozolomide|mesh-list
65357364|NCT00970996|Interleukin-2|interleukin-2|mesh-list
65357365|NCT00970996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65357366|NCT00970996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357372|NCT00970996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65357373|NCT00970996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65357374|NCT00970996|Alkylating Agents|alkylating agents|mesh-ancestor
65357375|NCT00970996|Immunologic Factors|immunologic factors|mesh-ancestor
65357376|NCT00970996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357377|NCT00970996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65357378|NCT00970996|Analgesics|analgesics|mesh-ancestor
65357379|NCT00970996|Sensory System Agents|sensory system agents|mesh-ancestor
65357380|NCT00970996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65357381|NCT00869193|Grape Seed Extract|grape seed extract|mesh-list
65357382|NCT00869193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65357383|NCT00869193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357384|NCT00869193|Antioxidants|antioxidants|mesh-ancestor
65357385|NCT00869193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357386|NCT00869193|Protective Agents|protective agents|mesh-ancestor
65357387|NCT00869193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357388|NCT04009018|Anesthetics|anesthetics|mesh-list
65357389|NCT04009018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65357390|NCT04009018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357391|NCT00869271|Leucovorin|leucovorin|mesh-list
65357392|NCT00869271|Fluorouracil|fluorouracil|mesh-list
65357393|NCT00869271|Oxaliplatin|oxaliplatin|mesh-list
65357394|NCT00869271|Antimetabolites|antimetabolites|mesh-ancestor
65357395|NCT00869271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357396|NCT00869271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65357397|NCT00869271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357398|NCT00869271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65357399|NCT00869271|Immunologic Factors|immunologic factors|mesh-ancestor
65357400|NCT00869271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357418|NCT00893919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65357419|NCT00893919|Antitubercular Agents|antitubercular agents|mesh-ancestor
65107265|NCT02605421|Cyclophosphamide|cyclophosphamide|mesh-list
65357420|NCT00893919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65357421|NCT00893919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65357422|NCT00893919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357423|NCT00893919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357424|NCT00978328|Oxycodone|oxycodone|mesh-list
65357425|NCT00978328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65357426|NCT00978328|Narcotics|narcotics|mesh-ancestor
65357427|NCT00978328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65357428|NCT00978328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357429|NCT00978328|Analgesics|analgesics|mesh-ancestor
65357430|NCT00978328|Sensory System Agents|sensory system agents|mesh-ancestor
65357431|NCT00978328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65357432|NCT00892359|Anidulafungin|anidulafungin|mesh-list
65357433|NCT00892359|Antifungal Agents|antifungal agents|mesh-ancestor
65357434|NCT00892359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65357435|NCT01051531|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65357436|NCT01051531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65357437|NCT01051531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65357438|NCT01051531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65357439|NCT01051531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357440|NCT01051531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65357441|NCT01051531|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65357442|NCT01051531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65357443|NCT01051531|Serotonin Agents|serotonin agents|mesh-ancestor
65357444|NCT01051531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65357445|NCT01051531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357447|NCT01051531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65357461|NCT00545272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65357462|NCT00545272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357463|NCT00545272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65357464|NCT00545272|Respiratory System Agents|respiratory system agents|mesh-ancestor
65357465|NCT00545272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65357466|NCT00545272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65357467|NCT00545272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65357468|NCT00545272|Adrenergic Agents|adrenergic agents|mesh-ancestor
65357469|NCT00545272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65357470|NCT00545272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357471|NCT00377455|Bosentan|bosentan|mesh-list
65357472|NCT00377455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65357473|NCT00377455|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65357474|NCT00377455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357475|NCT00895557|Varenicline|varenicline|mesh-list
65357476|NCT00895557|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65357477|NCT00895557|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65357478|NCT00895557|Cholinergic Agents|cholinergic agents|mesh-ancestor
65357479|NCT00895557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65357480|NCT00895557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357481|NCT00895557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357482|NCT00869973|Dexamethasone|dexamethasone|mesh-list
65357510|NCT04008784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357511|NCT01051687|Botulinum Toxins|botulinum toxins|mesh-list
65357512|NCT01051687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65357513|NCT01051687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65357514|NCT01051687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65357515|NCT01051687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65357516|NCT01051687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357517|NCT01051687|Cholinergic Agents|cholinergic agents|mesh-ancestor
65357518|NCT01051687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65357519|NCT01051687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357520|NCT01051687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65357521|NCT01051687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65357522|NCT00978718|Selenium|selenium|mesh-list
65357523|NCT00978718|Antioxidants|antioxidants|mesh-ancestor
65357524|NCT00978718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357525|NCT00978718|Protective Agents|protective agents|mesh-ancestor
65357526|NCT00978718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357527|NCT00978718|Trace Elements|trace elements|mesh-ancestor
65357528|NCT00978718|Micronutrients|micronutrients|mesh-ancestor
65357529|NCT00895713|Immunoglobulins|immunoglobulins|mesh-list
65357530|NCT00895713|Antibodies|antibodies|mesh-list
65357531|NCT00895713|gamma-Globulins|gamma-globulins|mesh-list
65357532|NCT00895713|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65357533|NCT00895713|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65357534|NCT00895713|Immunologic Factors|immunologic factors|mesh-ancestor
65357535|NCT00895713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357536|NCT01051765|Irinotecan|irinotecan|mesh-list
65357537|NCT01051765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357538|NCT01051765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65357539|NCT01051765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65357545|NCT00978796|Incretins|incretins|mesh-ancestor
65357553|NCT00894231|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65357554|NCT00894231|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65357555|NCT00894231|Histamine Antagonists|histamine antagonists|mesh-ancestor
65357556|NCT00894231|Histamine Agents|histamine agents|mesh-ancestor
65357557|NCT00894231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65357558|NCT00894231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357559|NCT00894231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357560|NCT00377299|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
65357561|NCT00377299|Nootropic Agents|nootropic agents|mesh-ancestor
65357562|NCT03472365|Capecitabine|capecitabine|mesh-list
65357563|NCT03472365|Oxaliplatin|oxaliplatin|mesh-list
65357564|NCT03472365|Apatinib|apatinib|mesh-list
65357565|NCT03472365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65357566|NCT03472365|Antimetabolites|antimetabolites|mesh-ancestor
65357567|NCT03472365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357568|NCT03472365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357569|NCT03472365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65357570|NCT03472365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357571|NCT00894621|Norepinephrine|norepinephrine|mesh-list
65357572|NCT00894621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65357573|NCT00894621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65357574|NCT00894621|Adrenergic Agents|adrenergic agents|mesh-ancestor
65357575|NCT00894621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65357576|NCT00894621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357602|NCT05178628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65357603|NCT05178628|Antimetabolites|antimetabolites|mesh-ancestor
65357604|NCT05178628|Antiviral Agents|antiviral agents|mesh-ancestor
65357605|NCT05178628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65357606|NCT05178628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357607|NCT05178628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65357608|NCT05178628|Immunologic Factors|immunologic factors|mesh-ancestor
65357609|NCT05178628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357610|NCT05178628|Anticoagulants|anticoagulants|mesh-ancestor
65357611|NCT05178628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65357612|NCT05178628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65357613|NCT00896571|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65357614|NCT00896571|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65357615|NCT00896571|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65357616|NCT00896571|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65357617|NCT00896571|Contraceptive Agents|contraceptive agents|mesh-ancestor
65357618|NCT00896571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65357619|NCT00896571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357621|NCT00896571|Estrogens|estrogens|mesh-ancestor
65357659|NCT00901407|Paroxetine|paroxetine|mesh-list
65357660|NCT00901407|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65357661|NCT00901407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65357662|NCT00901407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65357663|NCT00901407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357664|NCT00901407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65357665|NCT00901407|Serotonin Agents|serotonin agents|mesh-ancestor
65357666|NCT00901407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357667|NCT00901407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65357668|NCT00901407|Antidepressive Agents|antidepressive agents|mesh-ancestor
65357669|NCT00901407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65357670|NCT00901407|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65357671|NCT00901407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65357672|NCT00901407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357673|NCT00901407|Anticonvulsants|anticonvulsants|mesh-ancestor
65357674|NCT00901407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65357675|NCT00901407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65357676|NCT00901407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65357677|NCT00901407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65357678|NCT00901407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65357679|NCT00901407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65357680|NCT00984724|Nicotine|nicotine|mesh-list
65357681|NCT00984724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65357682|NCT00984724|Autonomic Agents|autonomic agents|mesh-ancestor
65357683|NCT00984724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65357684|NCT00984724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357685|NCT00984724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65357686|NCT00984724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65357704|NCT02539641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65357705|NCT02539641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357706|NCT00544882|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65357707|NCT00544882|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65357708|NCT00544882|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65357709|NCT00544882|Desogestrel|desogestrel|mesh-list
65357710|NCT00544882|Oviol|oviol|mesh-list
65357711|NCT00544882|Estradiol|estradiol|mesh-list
65357712|NCT00544882|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65357713|NCT00544882|Estrogens|estrogens|mesh-ancestor
65357714|NCT00544882|Hormones|hormones|mesh-ancestor
65357715|NCT00544882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65357716|NCT00544882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357717|NCT00544882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65357718|NCT00544882|Contraceptive Agents|contraceptive agents|mesh-ancestor
65357719|NCT00544882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65357720|NCT00544882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65357721|NCT00544882|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65357722|NCT00544882|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65357723|NCT00544882|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65357725|NCT00544882|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65357726|NCT04035603|Cycloserine|cycloserine|mesh-list
65357727|NCT04035603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65357755|NCT00901875|Naloxone|naloxone|mesh-list
65357756|NCT00901875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65357757|NCT00901875|Narcotics|narcotics|mesh-ancestor
65357758|NCT00901875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65357759|NCT00901875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357760|NCT00901875|Analgesics|analgesics|mesh-ancestor
65357761|NCT00901875|Sensory System Agents|sensory system agents|mesh-ancestor
65357762|NCT00901875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65357763|NCT00901875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65357764|NCT00972946|Dextrans|dextrans|mesh-list
65357765|NCT00972946|Anticoagulants|anticoagulants|mesh-ancestor
65357766|NCT00972946|Plasma Substitutes|plasma substitutes|mesh-ancestor
65357767|NCT00972946|Blood Substitutes|blood substitutes|mesh-ancestor
65357768|NCT00606177|Aripiprazole|aripiprazole|mesh-list
65357769|NCT00606177|Antidepressive Agents|antidepressive agents|mesh-ancestor
65357770|NCT00606177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65357771|NCT00606177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65357772|NCT00606177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65357773|NCT00606177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65357774|NCT00606177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357811|NCT00359281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65357812|NCT00359281|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65357813|NCT00359281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357814|NCT00359281|Vasodilator Agents|vasodilator agents|mesh-ancestor
65357815|NCT00359281|Vitamin B Complex|vitamin b complex|mesh-ancestor
65357816|NCT00359281|Vitamins|vitamins|mesh-ancestor
65357817|NCT00359281|Micronutrients|micronutrients|mesh-ancestor
65357818|NCT00359281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357819|NCT00359281|Antitussive Agents|antitussive agents|mesh-ancestor
65357820|NCT00359281|Respiratory System Agents|respiratory system agents|mesh-ancestor
65357821|NCT00359281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65357822|NCT00359281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65357823|NCT00359281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65357824|NCT00902031|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
65357825|NCT00902031|Sennosides|sennosides|mesh-list
65357826|NCT00902031|Senna Extract|senna extract|mesh-list
65357827|NCT00902031|Antidiarrheals|antidiarrheals|mesh-ancestor
65357828|NCT00902031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65357829|NCT00902031|Laxatives|laxatives|mesh-ancestor
65357830|NCT00902031|Cathartics|cathartics|mesh-ancestor
65357831|NCT00985348|Levetiracetam|levetiracetam|mesh-list
65357832|NCT00985348|Anticonvulsants|anticonvulsants|mesh-ancestor
65357833|NCT00985348|Nootropic Agents|nootropic agents|mesh-ancestor
65357834|NCT03990961|Pembrolizumab|pembrolizumab|mesh-list
65357835|NCT03990961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65357837|NCT00973336|Vitamin D|vitamin d|mesh-list
65357864|NCT00988078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357865|NCT00895089|Moxifloxacin|moxifloxacin|mesh-list
65357866|NCT00895089|Ceftriaxone|ceftriaxone|mesh-list
65357867|NCT00895089|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65357868|NCT00895089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65357869|NCT00895089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65357870|NCT00895089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65357871|NCT00895089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65357872|NCT00895089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357873|NCT00895089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357874|NCT00895089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65357875|NCT00895089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65357876|NCT00895089|Contraceptive Agents|contraceptive agents|mesh-ancestor
65357877|NCT00895089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65357878|NCT00895089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357879|NCT00895089|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65357880|NCT00895089|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65357881|NCT00895089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65357882|NCT00982540|Caspofungin|caspofungin|mesh-list
65357883|NCT00982540|Antifungal Agents|antifungal agents|mesh-list
65357884|NCT00982540|Clotrimazole|clotrimazole|mesh-list
65357886|NCT00982540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65357887|NCT00982540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357888|NCT00982540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357889|NCT00982540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65357890|NCT00982540|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65357891|NCT00982540|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65357892|NCT00982540|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65357893|NCT00982540|Hormone Antagonists|hormone antagonists|mesh-ancestor
65357894|NCT00982540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65357904|NCT00366535|Analgesics|analgesics|mesh-ancestor
65357905|NCT00366535|Sensory System Agents|sensory system agents|mesh-ancestor
65357906|NCT00366535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65357907|NCT00366535|Anticonvulsants|anticonvulsants|mesh-ancestor
65357908|NCT00982618|Lidocaine|lidocaine|mesh-list
65357909|NCT00982618|Morphine|morphine|mesh-list
65357910|NCT00982618|Anesthetics, Local|anesthetics, local|mesh-list
65357911|NCT00982618|Anesthetics|anesthetics|mesh-list
65357914|NCT00982618|Sensory System Agents|sensory system agents|mesh-ancestor
65357971|NCT00350545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65357972|NCT00350545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65357973|NCT00350545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65357974|NCT00350545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65357975|NCT00350545|Antifungal Agents|antifungal agents|mesh-ancestor
65357976|NCT00350545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65357977|NCT00350545|Dermatologic Agents|dermatologic agents|mesh-ancestor
65357978|NCT04006054|Midazolam|midazolam|mesh-list
65357979|NCT04006054|Dexmedetomidine|dexmedetomidine|mesh-list
65357980|NCT04006054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65357981|NCT04006054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65357982|NCT04006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65357983|NCT04006054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65357984|NCT04006054|Analgesics|analgesics|mesh-ancestor
65357985|NCT04006054|Sensory System Agents|sensory system agents|mesh-ancestor
65357986|NCT04006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65357987|NCT04006054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65357988|NCT04006054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65357989|NCT04006054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65357999|NCT04006054|Anesthetics|anesthetics|mesh-ancestor
65358026|NCT01052389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358027|NCT01052389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65358028|NCT01052389|Serotonin Agents|serotonin agents|mesh-ancestor
65358029|NCT01052389|Antidepressive Agents|antidepressive agents|mesh-ancestor
65358030|NCT01052389|Dopamine Agonists|dopamine agonists|mesh-ancestor
65358031|NCT01052389|Dopamine Agents|dopamine agents|mesh-ancestor
65358032|NCT01052389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65358033|NCT01052389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65358034|NCT01052389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65358035|NCT01052389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65358036|NCT01052389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65358037|NCT01052389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65358038|NCT01052389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65358040|NCT00895323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65358041|NCT00895323|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65358042|NCT00895323|Immunologic Factors|immunologic factors|mesh-ancestor
65358043|NCT00895323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358044|NCT00349921|Adenosine|adenosine|mesh-list
65358045|NCT00349921|Clonidine|clonidine|mesh-list
65358046|NCT00349921|Analgesics|analgesics|mesh-ancestor
65358047|NCT00349921|Sensory System Agents|sensory system agents|mesh-ancestor
65358081|NCT01052623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65358082|NCT01052623|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65358083|NCT01052623|Analgesics|analgesics|mesh-ancestor
65358084|NCT01052623|Sensory System Agents|sensory system agents|mesh-ancestor
65358085|NCT01052623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65358086|NCT01052623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65358087|NCT01052623|Sympatholytics|sympatholytics|mesh-ancestor
65358088|NCT01052623|Autonomic Agents|autonomic agents|mesh-ancestor
65358089|NCT01052623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65358090|NCT01052623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65358091|NCT01052623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65358092|NCT01052623|Adrenergic Agents|adrenergic agents|mesh-ancestor
65358093|NCT01052623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65358094|NCT01052623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358095|NCT00902811|Artesunate|artesunate|mesh-list
65358096|NCT00902811|Amodiaquine|amodiaquine|mesh-list
65358097|NCT00902811|Antimalarials|antimalarials|mesh-ancestor
65358098|NCT00902811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65358099|NCT00902811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65358100|NCT00902811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65358101|NCT00902811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358102|NCT00902811|Antiviral Agents|antiviral agents|mesh-ancestor
65358103|NCT00902811|Schistosomicides|schistosomicides|mesh-ancestor
65358104|NCT00902811|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65358105|NCT00902811|Anthelmintics|anthelmintics|mesh-ancestor
65358106|NCT00898287|Gemcitabine|gemcitabine|mesh-list
65358107|NCT00898287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65358108|NCT00898287|Antimetabolites|antimetabolites|mesh-ancestor
65358109|NCT00898287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358110|NCT00898287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358111|NCT00898287|Antiviral Agents|antiviral agents|mesh-ancestor
65358112|NCT00898287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65358113|NCT00898287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358114|NCT00898287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65358123|NCT04034823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358124|NCT04034823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65358125|NCT00606021|Pemetrexed|pemetrexed|mesh-list
65358126|NCT00606021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358127|NCT00606021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358128|NCT00606021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358129|NCT00606021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65358130|NCT00606021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65358131|NCT00337675|Montelukast|montelukast|mesh-list
65358132|NCT00337675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65358133|NCT00337675|Respiratory System Agents|respiratory system agents|mesh-ancestor
65358134|NCT00337675|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65358135|NCT00337675|Hormone Antagonists|hormone antagonists|mesh-ancestor
65358136|NCT00337675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65358137|NCT00337675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358138|NCT00337675|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65358139|NCT00337675|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65358140|NCT00337675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358141|NCT00902967|Atorvastatin|atorvastatin|mesh-list
65358142|NCT00902967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65358143|NCT00902967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65358144|NCT00902967|Antimetabolites|antimetabolites|mesh-ancestor
65358145|NCT00902967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358168|NCT00337285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65358169|NCT04035525|Coenzyme Q10|coenzyme q10|mesh-list
65358170|NCT04035525|Ubiquinone|ubiquinone|mesh-list
65358171|NCT04035525|Vitamins|vitamins|mesh-ancestor
65358172|NCT04035525|Micronutrients|micronutrients|mesh-ancestor
65358173|NCT04035525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358174|NCT00905853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
65358175|NCT00905853|Amiodarone|amiodarone|mesh-list
65358176|NCT00905853|Vasodilator Agents|vasodilator agents|mesh-ancestor
65358177|NCT00905853|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65358178|NCT00905853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65358179|NCT00905853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358180|NCT00905853|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65358181|NCT00905853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65358182|NCT00905853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65358183|NCT00905853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358184|NCT00905853|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65358185|NCT00905853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65358186|NCT00905853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65358187|NCT00905931|Lycopene|lycopene|mesh-list
65358188|NCT00905931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65358189|NCT00905931|Antioxidants|antioxidants|mesh-ancestor
65358190|NCT00905931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358191|NCT00905931|Protective Agents|protective agents|mesh-ancestor
65358192|NCT00905931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358193|NCT00905931|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65358194|NCT00905931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65358196|NCT04035135|Immunoglobulins|immunoglobulins|mesh-list
65358214|NCT00605865|Serotonin Agents|serotonin agents|mesh-ancestor
65358215|NCT00605865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358216|NCT00922467|Esmolol|esmolol|mesh-list
65358217|NCT00922467|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65358218|NCT00922467|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65358219|NCT00922467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65358220|NCT00922467|Adrenergic Agents|adrenergic agents|mesh-ancestor
65358221|NCT00922467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65358279|NCT00604695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65358280|NCT00604695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358281|NCT01055821|Interferons|interferons|mesh-list
65358282|NCT01055821|Ribavirin|ribavirin|mesh-list
65358283|NCT01055821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358284|NCT01055821|Antiviral Agents|antiviral agents|mesh-ancestor
65358285|NCT01055821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65358286|NCT01055821|Antimetabolites|antimetabolites|mesh-ancestor
65358287|NCT01055821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358288|NCT00904293|Warfarin|warfarin|mesh-list
65358289|NCT00904293|Anticoagulants|anticoagulants|mesh-ancestor
65358290|NCT00904449|Oxymorphone|oxymorphone|mesh-list
65358291|NCT00904449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65358292|NCT00904449|Narcotics|narcotics|mesh-ancestor
65358293|NCT00904449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65358294|NCT00904449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358295|NCT00904449|Analgesics|analgesics|mesh-ancestor
65358296|NCT00904449|Sensory System Agents|sensory system agents|mesh-ancestor
65358297|NCT00904449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65358298|NCT00904449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65358299|NCT00348595|Lenalidomide|lenalidomide|mesh-list
65358300|NCT00348595|Immunologic Factors|immunologic factors|mesh-ancestor
65358301|NCT00348595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358302|NCT00348595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65358303|NCT00348595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65358304|NCT00348595|Growth Substances|growth substances|mesh-ancestor
65358307|NCT02538939|Sodium thiosulfate|sodium thiosulfate|mesh-list
65358327|NCT00904605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65358328|NCT00904605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65358329|NCT00904605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358330|NCT00904605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358331|NCT00905073|Cyclosporine|cyclosporine|mesh-list
65358332|NCT00905073|Methotrexate|methotrexate|mesh-list
65358333|NCT00905073|Cyclosporins|cyclosporins|mesh-list
65358334|NCT00905073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65358335|NCT00905073|Abortifacient Agents|abortifacient agents|mesh-ancestor
65358336|NCT00905073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65358337|NCT00905073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358338|NCT00905073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65358339|NCT00905073|Antimetabolites|antimetabolites|mesh-ancestor
65358340|NCT00905073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358341|NCT00905073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358342|NCT00905073|Dermatologic Agents|dermatologic agents|mesh-ancestor
65358343|NCT00905073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358344|NCT00905073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65358345|NCT00905073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65358346|NCT00905073|Immunologic Factors|immunologic factors|mesh-ancestor
65358347|NCT00905073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65358348|NCT00905073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65358349|NCT00905073|Antifungal Agents|antifungal agents|mesh-ancestor
65358350|NCT00905073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65358351|NCT00905073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65358352|NCT00905229|Vitamins|vitamins|mesh-list
65358353|NCT00905229|Vitamin K|vitamin k|mesh-list
65358354|NCT00905229|Vitamin K 1|vitamin k 1|mesh-list
65358355|NCT00905229|Micronutrients|micronutrients|mesh-ancestor
65358356|NCT00905229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358357|NCT00905229|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65358358|NCT00905229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65358360|NCT00905229|Hemostatics|hemostatics|mesh-ancestor
65358368|NCT00905541|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65358369|NCT00905541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358370|NCT00348283|Adalimumab|adalimumab|mesh-list
65358371|NCT00348283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65358372|NCT00348283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65358373|NCT00336895|Mycophenolic Acid|mycophenolic acid|mesh-list
65358374|NCT00336895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65358375|NCT00336895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358376|NCT00336895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65358377|NCT00336895|Antitubercular Agents|antitubercular agents|mesh-ancestor
65358378|NCT00336895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65358379|NCT00336895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65358380|NCT00336895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358381|NCT00336895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358382|NCT00336583|Cytarabine|cytarabine|mesh-list
65358383|NCT00336583|Methylprednisolone|methylprednisolone|mesh-list
65358384|NCT00336583|Oxaliplatin|oxaliplatin|mesh-list
65358385|NCT00336583|Etoposide|etoposide|mesh-list
65358386|NCT00336583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358387|NCT00336583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65358388|NCT00336583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65358389|NCT00336583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65358390|NCT00336583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358391|NCT00336583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358392|NCT00336583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65358393|NCT00336583|Antimetabolites|antimetabolites|mesh-ancestor
65358394|NCT00336583|Antiviral Agents|antiviral agents|mesh-ancestor
65358395|NCT00336583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65358396|NCT00336583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65358397|NCT00336583|Immunologic Factors|immunologic factors|mesh-ancestor
65358398|NCT00336583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358399|NCT00336583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65358401|NCT00336583|Autonomic Agents|autonomic agents|mesh-ancestor
65358402|NCT00336583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65358403|NCT00336583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65358404|NCT00336583|Glucocorticoids|glucocorticoids|mesh-ancestor
65358405|NCT00336583|Hormones|hormones|mesh-ancestor
65019547|NCT02917018|Analgesics|analgesics|mesh-ancestor
65358406|NCT00336583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65358407|NCT00336583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65358408|NCT00336583|Protective Agents|protective agents|mesh-ancestor
65358409|NCT00336505|Clarithromycin|clarithromycin|mesh-list
65358410|NCT00336505|Cethromycin|cethromycin|mesh-list
65358411|NCT00336505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65358412|NCT00336505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65358413|NCT00336505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65358414|NCT00336505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358415|NCT00336505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358416|NCT00336505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65358417|NCT00336505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65358418|NCT00357877|Chlorhexidine|chlorhexidine|mesh-list
65358419|NCT00357877|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65358420|NCT00357877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65358421|NCT00357877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65358422|NCT00357877|Disinfectants|disinfectants|mesh-ancestor
65358423|NCT00357877|Dermatologic Agents|dermatologic agents|mesh-ancestor
65358424|NCT03987529|Propofol|propofol|mesh-list
65358425|NCT03987529|Sevoflurane|sevoflurane|mesh-list
65358426|NCT03987529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65358427|NCT03987529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65358428|NCT03987529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358457|NCT01059955|Dexamethasone|dexamethasone|mesh-list
65358458|NCT01059955|Dexamethasone acetate|dexamethasone acetate|mesh-list
65358459|NCT01059955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65358460|NCT01059955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65358461|NCT01059955|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65358462|NCT01059955|BB 1101|bb 1101|mesh-list
65358463|NCT01059955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65358464|NCT01059955|Antiemetics|antiemetics|mesh-ancestor
65358466|NCT01059955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65358467|NCT01059955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358468|NCT01059955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65358469|NCT01059955|Glucocorticoids|glucocorticoids|mesh-ancestor
65358470|NCT01059955|Hormones|hormones|mesh-ancestor
65358471|NCT01059955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65358472|NCT01059955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65358473|NCT01059955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358474|NCT01059955|Protease Inhibitors|protease inhibitors|mesh-ancestor
65358475|NCT01059955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358476|NCT01059955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358477|NCT01060189|Tranexamic Acid|tranexamic acid|mesh-list
65358478|NCT01060189|Urinastatin|urinastatin|mesh-list
65358479|NCT01060189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65358480|NCT01060189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65358481|NCT01060189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358482|NCT01060189|Hemostatics|hemostatics|mesh-ancestor
65358483|NCT01060189|Coagulants|coagulants|mesh-ancestor
65358484|NCT01060189|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65358485|NCT01060189|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65358486|NCT01060189|Protease Inhibitors|protease inhibitors|mesh-ancestor
65358487|NCT01060189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358488|NCT01060267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65358489|NCT01060267|Erythromycin|erythromycin|mesh-list
65358490|NCT01060267|Erythromycin Estolate|erythromycin estolate|mesh-list
65358491|NCT01060267|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65358500|NCT01060423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65358501|NCT01060423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65358502|NCT01060423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358503|NCT01060423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358504|NCT01060423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358505|NCT01060423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65358506|NCT01060501|Leucovorin|leucovorin|mesh-list
65358507|NCT01060501|Folic Acid|folic acid|mesh-list
65358508|NCT01060501|Interferons|interferons|mesh-list
65358509|NCT01060501|Interferon-alpha|interferon-alpha|mesh-list
65358510|NCT01060501|Levoleucovorin|levoleucovorin|mesh-list
65358511|NCT01060501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358512|NCT01060501|Antiviral Agents|antiviral agents|mesh-ancestor
65358513|NCT01060501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65358514|NCT01060501|Immunologic Factors|immunologic factors|mesh-ancestor
65358515|NCT01060501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358516|NCT01060501|Antidotes|antidotes|mesh-ancestor
65358517|NCT01060501|Protective Agents|protective agents|mesh-ancestor
65358518|NCT01060501|Vitamin B Complex|vitamin b complex|mesh-ancestor
65358519|NCT01060501|Vitamins|vitamins|mesh-ancestor
65358520|NCT01060501|Micronutrients|micronutrients|mesh-ancestor
65358521|NCT01060501|Hematinics|hematinics|mesh-ancestor
65358522|NCT00671658|Cytarabine|cytarabine|mesh-list
65358523|NCT00671658|Dexamethasone|dexamethasone|mesh-list
65358524|NCT00671658|Methylprednisolone|methylprednisolone|mesh-list
65358525|NCT00671658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65358526|NCT00671658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65358527|NCT00671658|Prednisolone|prednisolone|mesh-list
65358528|NCT00671658|Prednisolone acetate|prednisolone acetate|mesh-list
65358529|NCT00671658|Cyclophosphamide|cyclophosphamide|mesh-list
65358530|NCT00671658|Rituximab|rituximab|mesh-list
65358550|NCT00671658|Autonomic Agents|autonomic agents|mesh-ancestor
65358551|NCT00671658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65358552|NCT00671658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65358553|NCT00671658|Glucocorticoids|glucocorticoids|mesh-ancestor
65358554|NCT00671658|Hormones|hormones|mesh-ancestor
65358555|NCT00671658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65358556|NCT00671658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65358557|NCT00671658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65358558|NCT00671658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65358615|NCT04048200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65358616|NCT04048200|Adrenergic Agents|adrenergic agents|mesh-ancestor
65358617|NCT04048200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65108468|NCT00547443|Paclitaxel|paclitaxel|mesh-list
65358618|NCT04048200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358619|NCT04048200|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65358620|NCT04048200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65358621|NCT04048200|Anesthetics, General|anesthetics, general|mesh-ancestor
65358622|NCT04048200|Anesthetics|anesthetics|mesh-ancestor
65358623|NCT04048200|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65358624|NCT04048200|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65358625|NCT04048200|Narcotics|narcotics|mesh-ancestor
65358626|NCT04048200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65358627|NCT04034589|Fulvestrant|fulvestrant|mesh-list
65358628|NCT04034589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65358639|NCT00906867|Miotics|miotics|mesh-ancestor
65358672|NCT00775086|Estrogens|estrogens|mesh-ancestor
65358673|NCT00775086|Hormones|hormones|mesh-ancestor
65358674|NCT00775086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65358675|NCT00775086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358676|NCT00775086|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65358677|NCT00775086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65358678|NCT00775086|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65358679|NCT00775086|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65358680|NCT00775086|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65358681|NCT02557854|Doxorubicin|doxorubicin|mesh-list
65358682|NCT02557854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65358683|NCT02557854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65358684|NCT02557854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358685|NCT02557854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65358686|NCT02557854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65358687|NCT02557854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358689|NCT02557386|Levobupivacaine|levobupivacaine|mesh-list
65358730|NCT00775164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358731|NCT00771420|Mavrilimumab|mavrilimumab|mesh-list
65358732|NCT00771420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65358733|NCT00771420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65358734|NCT00771420|Immunologic Factors|immunologic factors|mesh-ancestor
65358735|NCT00771420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358736|NCT04767256|Dexamethasone|dexamethasone|mesh-list
65358737|NCT04767256|Dexmedetomidine|dexmedetomidine|mesh-list
65358738|NCT04767256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65358739|NCT04767256|Antiemetics|antiemetics|mesh-ancestor
65358740|NCT04767256|Autonomic Agents|autonomic agents|mesh-ancestor
65358741|NCT04767256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65358742|NCT04767256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358743|NCT04767256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65358744|NCT04767256|Glucocorticoids|glucocorticoids|mesh-ancestor
65358745|NCT04767256|Hormones|hormones|mesh-ancestor
65358746|NCT04767256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65358747|NCT04767256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65358748|NCT04767256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358785|NCT00988780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65358786|NCT00988780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65358787|NCT00988780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65358788|NCT00988780|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65358789|NCT00988780|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65358790|NCT00988780|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65358791|NCT00988780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65358792|NCT00988780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65358793|NCT00988780|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65358794|NCT00988780|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65358795|NCT00988780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65358796|NCT00988780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65358797|NCT00775242|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65358798|NCT00775242|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65358799|NCT00775242|Estradiol|estradiol|mesh-list
65358800|NCT00775242|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65358801|NCT00775242|Estrogens|estrogens|mesh-list
65358802|NCT00775242|Progesterone|progesterone|mesh-list
65358803|NCT00775242|Progestins|progestins|mesh-list
65358804|NCT00775242|Hormones|hormones|mesh-ancestor
65358805|NCT00775242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65358806|NCT00775242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358808|NCT00775242|Contraceptive Agents|contraceptive agents|mesh-ancestor
65358836|NCT00333775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358837|NCT03860428|Acetaminophen|acetaminophen|mesh-list
65358838|NCT03860428|Ibuprofen|ibuprofen|mesh-list
65358839|NCT03860428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
65358840|NCT03860428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65358841|NCT03860428|Analgesics|analgesics|mesh-ancestor
65358842|NCT03860428|Sensory System Agents|sensory system agents|mesh-ancestor
65358843|NCT03860428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65358844|NCT03860428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358845|NCT03860428|Antipyretics|antipyretics|mesh-ancestor
65358846|NCT03860428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65358847|NCT03860428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65358848|NCT03860428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65358849|NCT03860428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358850|NCT03860428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358851|NCT00771888|Lanreotide|lanreotide|mesh-list
65358852|NCT00771888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358853|NCT00605475|Metformin|metformin|mesh-list
65358854|NCT00605475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65358855|NCT00605475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358856|NCT00986596|Vitamin D|vitamin d|mesh-list
65358891|NCT00908661|Hemostatics|hemostatics|mesh-ancestor
65358892|NCT00908661|Coagulants|coagulants|mesh-ancestor
65358893|NCT00983398|Sodium thiosulfate|sodium thiosulfate|mesh-list
65358894|NCT00983398|Carboplatin|carboplatin|mesh-list
65358895|NCT00983398|Melphalan|melphalan|mesh-list
65358896|NCT00983398|Mechlorethamine|mechlorethamine|mesh-list
65358897|NCT00983398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65358898|NCT00983398|Mannitol|mannitol|mesh-list
65358899|NCT00983398|Antidotes|antidotes|mesh-list
65358900|NCT00983398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65358901|NCT00983398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65358902|NCT00983398|Alkylating Agents|alkylating agents|mesh-ancestor
65358903|NCT00983398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358904|NCT00983398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65358905|NCT00983398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65358906|NCT00983398|Immunologic Factors|immunologic factors|mesh-ancestor
65358907|NCT00983398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358908|NCT00983398|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65358909|NCT00983398|Diuretics|diuretics|mesh-ancestor
65358910|NCT00983398|Natriuretic Agents|natriuretic agents|mesh-ancestor
65358911|NCT00983398|Protective Agents|protective agents|mesh-ancestor
65358912|NCT00983398|Antioxidants|antioxidants|mesh-ancestor
65358913|NCT00983398|Antitubercular Agents|antitubercular agents|mesh-ancestor
65358914|NCT00983398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65358915|NCT00983398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65358916|NCT00983398|Chelating Agents|chelating agents|mesh-ancestor
65358917|NCT00983398|Sequestering Agents|sequestering agents|mesh-ancestor
65358918|NCT00333229|Zoledronic Acid|zoledronic acid|mesh-list
65358919|NCT00333229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65358920|NCT00333229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358922|NCT00769548|Flutamide|flutamide|mesh-list
65358939|NCT05277675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65358940|NCT05277675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65358941|NCT03984409|Potassium Citrate|potassium citrate|mesh-list
65358942|NCT03984409|Diuretics|diuretics|mesh-ancestor
65358943|NCT03984409|Natriuretic Agents|natriuretic agents|mesh-ancestor
65358944|NCT03984409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65358945|NCT03984409|Expectorants|expectorants|mesh-ancestor
65358946|NCT03984409|Respiratory System Agents|respiratory system agents|mesh-ancestor
65358947|NCT00983554|Anastrozole|anastrozole|mesh-list
65358948|NCT00983554|Testosterone|testosterone|mesh-list
65358949|NCT00983554|Dutasteride|dutasteride|mesh-list
65358950|NCT00983554|Androgens|androgens|mesh-ancestor
65358951|NCT00983554|Hormones|hormones|mesh-ancestor
65358958|NCT00983554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359002|NCT00332839|Cyclosporine|cyclosporine|mesh-list
65359003|NCT00332839|Mycophenolic Acid|mycophenolic acid|mesh-list
65359004|NCT00332839|Everolimus|everolimus|mesh-list
65359005|NCT00332839|Tacrolimus|tacrolimus|mesh-list
65359006|NCT00332839|Cyclosporins|cyclosporins|mesh-list
65359007|NCT00332839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65359008|NCT00332839|Immunologic Factors|immunologic factors|mesh-ancestor
65359009|NCT00332839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359010|NCT00332839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65359011|NCT00332839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359012|NCT00332839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359013|NCT00332839|Antifungal Agents|antifungal agents|mesh-ancestor
65359014|NCT00332839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65359015|NCT00332839|Dermatologic Agents|dermatologic agents|mesh-ancestor
65359016|NCT00332839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65359017|NCT00332839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359018|NCT00332839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65359019|NCT00332839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65359020|NCT00332839|Antitubercular Agents|antitubercular agents|mesh-ancestor
65359021|NCT00332839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65359022|NCT00927147|Cetuximab|cetuximab|mesh-list
65359023|NCT00927147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65359024|NCT00927147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359025|NCT05712616|Strontium ranelate|strontium ranelate|mesh-list
65359054|NCT00983944|Prednisone|prednisone|mesh-list
65359055|NCT00983944|Cyclophosphamide|cyclophosphamide|mesh-list
65359056|NCT00983944|Rituximab|rituximab|mesh-list
65359057|NCT00983944|Doxorubicin|doxorubicin|mesh-list
65359058|NCT00983944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65359059|NCT00983944|Etoposide|etoposide|mesh-list
65359060|NCT00983944|Vincristine|vincristine|mesh-list
65359061|NCT00983944|Bleomycin|bleomycin|mesh-list
65359062|NCT00983944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65359063|NCT00983944|Immunologic Factors|immunologic factors|mesh-ancestor
65359064|NCT00983944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359065|NCT00983944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65359066|NCT00983944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65359067|NCT00983944|Alkylating Agents|alkylating agents|mesh-ancestor
65359068|NCT00983944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359069|NCT00983944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359070|NCT00983944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65359071|NCT00983944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65359072|NCT00983944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65359073|NCT00983944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65359074|NCT00983944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65359075|NCT00983944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359076|NCT00983944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65359077|NCT00983944|Glucocorticoids|glucocorticoids|mesh-ancestor
65359078|NCT00983944|Hormones|hormones|mesh-ancestor
65359079|NCT00983944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65359080|NCT00983944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65359081|NCT00983944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65359082|NCT00983944|Tubulin Modulators|tubulin modulators|mesh-ancestor
65359083|NCT00983944|Antimitotic Agents|antimitotic agents|mesh-ancestor
65359084|NCT00983944|Mitosis Modulators|mitosis modulators|mesh-ancestor
65359085|NCT00927537|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65359086|NCT00927537|Telmisartan|telmisartan|mesh-list
65359096|NCT02538003|Delpazolid|delpazolid|mesh-list
65359097|NCT02538003|Oxazolidinones|oxazolidinones|mesh-list
65359098|NCT02538003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65359099|NCT02538003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65359100|NCT02538003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65359101|NCT02538003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359102|NCT02538003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359103|NCT00909129|Interferons|interferons|mesh-list
65359104|NCT00909129|Ribavirin|ribavirin|mesh-list
65359105|NCT00909129|Interferon-alpha|interferon-alpha|mesh-list
65359106|NCT00909129|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65359107|NCT00909129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359108|NCT00909129|Antiviral Agents|antiviral agents|mesh-ancestor
65359109|NCT00909129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65359110|NCT00909129|Antimetabolites|antimetabolites|mesh-ancestor
65359111|NCT00909129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359112|NCT00909129|Immunologic Factors|immunologic factors|mesh-ancestor
65359113|NCT00909129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359114|NCT01053325|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65359115|NCT01053325|Antimalarials|antimalarials|mesh-ancestor
65359116|NCT01053325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65359117|NCT01053325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65359118|NCT01053325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65359119|NCT01053325|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65359120|NCT01053325|Renal Agents|renal agents|mesh-ancestor
65359121|NCT01053325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65359122|NCT01053403|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65359123|NCT01053403|Hallucinogens|hallucinogens|mesh-ancestor
65359124|NCT01053403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359126|NCT01053403|Serotonin Agents|serotonin agents|mesh-ancestor
65359141|NCT03990103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65359142|NCT03990103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359143|NCT03990103|Tubulin Modulators|tubulin modulators|mesh-ancestor
65359144|NCT03990103|Antimitotic Agents|antimitotic agents|mesh-ancestor
65359145|NCT03990103|Mitosis Modulators|mitosis modulators|mesh-ancestor
65359146|NCT03990103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359147|NCT03990103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65359148|NCT03990103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65359149|NCT03990103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65359150|NCT03990103|Growth Substances|growth substances|mesh-ancestor
65359151|NCT03990103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359152|NCT03990103|Growth Inhibitors|growth inhibitors|mesh-ancestor
65359153|NCT03990103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65359154|NCT03990103|Antimetabolites|antimetabolites|mesh-ancestor
65359156|NCT00927693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65359157|NCT00927693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359158|NCT00987220|Donepezil|donepezil|mesh-list
65359159|NCT00987220|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65359160|NCT00987220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359161|NCT00987220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359162|NCT00987220|Cholinergic Agents|cholinergic agents|mesh-ancestor
65359163|NCT00987220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65359164|NCT00987220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359165|NCT00987220|Nootropic Agents|nootropic agents|mesh-ancestor
65359166|NCT01581151|Dexamethasone|dexamethasone|mesh-list
65359167|NCT01581151|Ranibizumab|ranibizumab|mesh-list
65359168|NCT01581151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65359169|NCT01581151|Antiemetics|antiemetics|mesh-ancestor
65359170|NCT01581151|Autonomic Agents|autonomic agents|mesh-ancestor
65359171|NCT01581151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65359172|NCT01581151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359173|NCT01581151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65359182|NCT01581151|Growth Inhibitors|growth inhibitors|mesh-ancestor
65359183|NCT01053481|Vitamin D|vitamin d|mesh-list
65359184|NCT01053481|Vitamins|vitamins|mesh-ancestor
65359185|NCT01053481|Micronutrients|micronutrients|mesh-ancestor
65359186|NCT01053481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359187|NCT01053481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65359188|NCT00927771|Azelaic acid|azelaic acid|mesh-list
65359189|NCT00927771|Hydroquinone|hydroquinone|mesh-list
65359190|NCT00927771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359191|NCT00927771|Dermatologic Agents|dermatologic agents|mesh-ancestor
65359192|NCT00927771|Antioxidants|antioxidants|mesh-ancestor
65359193|NCT00927771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359194|NCT00927771|Protective Agents|protective agents|mesh-ancestor
65359195|NCT00927771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359196|NCT00927771|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65359197|NCT01053559|Certolizumab Pegol|certolizumab pegol|mesh-list
65359198|NCT01053559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65359199|NCT01053559|Immunologic Factors|immunologic factors|mesh-ancestor
65359200|NCT01053559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359201|NCT01053559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65359202|NCT01053637|Acetaminophen|acetaminophen|mesh-list
65359204|NCT01053637|Hydrocodone|hydrocodone|mesh-list
65359237|NCT00909519|Gout Suppressants|gout suppressants|mesh-ancestor
65359238|NCT00909519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65359239|NCT00909519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359240|NCT00909519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359241|NCT00909519|Diuretics|diuretics|mesh-ancestor
65359308|NCT00987376|Lipotropic Agents|lipotropic agents|mesh-ancestor
65359309|NCT00987376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65359310|NCT00987376|Antimetabolites|antimetabolites|mesh-ancestor
65359311|NCT00987376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359312|NCT00987376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65359313|NCT00987376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65359314|NCT00987376|Nootropic Agents|nootropic agents|mesh-ancestor
65359378|NCT00987766|Oxaliplatin|oxaliplatin|mesh-list
65359379|NCT00987766|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65359380|NCT00987766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65359381|NCT00987766|Antimetabolites|antimetabolites|mesh-ancestor
65359382|NCT00987766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359383|NCT00987766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359384|NCT00987766|Antiviral Agents|antiviral agents|mesh-ancestor
65359385|NCT00987766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65359386|NCT00987766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359387|NCT00987766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65359388|NCT00987766|Immunologic Factors|immunologic factors|mesh-ancestor
65359440|NCT03986905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65359441|NCT03986905|Cholinergic Agents|cholinergic agents|mesh-ancestor
65359442|NCT03986905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65359443|NCT03986905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359444|NCT03986905|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65359445|NCT03986905|Parasympatholytics|parasympatholytics|mesh-ancestor
65359447|NCT04864444|Primaquine|primaquine|mesh-list
65359448|NCT04864444|Artenimol|artenimol|mesh-list
65359449|NCT04864444|Antimalarials|antimalarials|mesh-ancestor
65359450|NCT04864444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65359451|NCT04864444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65359452|NCT04864444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65359453|NCT00329797|Vitamin D|vitamin d|mesh-list
65359454|NCT00329797|Zoledronic Acid|zoledronic acid|mesh-list
65359455|NCT00329797|Calcium|calcium|mesh-list
65359456|NCT00329797|Vitamins|vitamins|mesh-ancestor
65359457|NCT00329797|Micronutrients|micronutrients|mesh-ancestor
65359458|NCT00329797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359459|NCT00329797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65359498|NCT03983551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65359499|NCT03983551|Protease Inhibitors|protease inhibitors|mesh-ancestor
65359500|NCT03983551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359501|NCT03983551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359502|NCT03983551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65359503|NCT03983551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359504|NCT05709574|Tadalafil|tadalafil|mesh-list
65359505|NCT05709574|Vasodilator Agents|vasodilator agents|mesh-ancestor
65359506|NCT05709574|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65359507|NCT05709574|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65359508|NCT05709574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359509|NCT05709574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359510|NCT05709574|Urological Agents|urological agents|mesh-ancestor
65359511|NCT05546242|Dolutegravir|dolutegravir|mesh-list
65359512|NCT05546242|Cabotegravir|cabotegravir|mesh-list
65359513|NCT05546242|Rilpivirine|rilpivirine|mesh-list
65359514|NCT05546242|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65359515|NCT05546242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65359516|NCT05546242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65359517|NCT05546242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359524|NCT04690504|Melatonin|melatonin|mesh-list
65359553|NCT04613830|Tramadol|tramadol|mesh-list
65359554|NCT04613830|Bupivacaine|bupivacaine|mesh-list
65359555|NCT04613830|Anesthetics, Local|anesthetics, local|mesh-ancestor
65359556|NCT04613830|Anesthetics|anesthetics|mesh-ancestor
65359557|NCT04613830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65359558|NCT04613830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359559|NCT04613830|Sensory System Agents|sensory system agents|mesh-ancestor
65359560|NCT04613830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65359561|NCT04613830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65359562|NCT04613830|Narcotics|narcotics|mesh-ancestor
65359563|NCT04613830|Analgesics|analgesics|mesh-ancestor
65359564|NCT00689936|Thalidomide|thalidomide|mesh-list
65359565|NCT00689936|Dexamethasone|dexamethasone|mesh-list
65359566|NCT00689936|Dexamethasone acetate|dexamethasone acetate|mesh-list
65359567|NCT00689936|Prednisone|prednisone|mesh-list
65359568|NCT00689936|Lenalidomide|lenalidomide|mesh-list
65359569|NCT00689936|Melphalan|melphalan|mesh-list
65359570|NCT00689936|BB 1101|bb 1101|mesh-list
65359572|NCT00689936|Antiemetics|antiemetics|mesh-ancestor
65359617|NCT01563718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359618|NCT01563718|Sensory System Agents|sensory system agents|mesh-ancestor
65359619|NCT01563718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65359620|NCT05655598|Palbociclib|palbociclib|mesh-list
65359621|NCT05655598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359622|NCT05655598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65359623|NCT05655598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359624|NCT05655598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359625|NCT05473234|Amoxicillin|amoxicillin|mesh-list
65359626|NCT05473234|Azithromycin|azithromycin|mesh-list
65359627|NCT05473234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65359628|NCT05473234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65359629|NCT04500418|Cenicriviroc|cenicriviroc|mesh-list
65359630|NCT04500418|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65359631|NCT04500418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359632|NCT04500418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65359633|NCT04500418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65359634|NCT04500418|Antiviral Agents|antiviral agents|mesh-ancestor
65359635|NCT04500418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65359636|NCT00671034|Cytarabine|cytarabine|mesh-list
65359637|NCT00671034|Dexamethasone|dexamethasone|mesh-list
65359638|NCT00671034|Dexamethasone acetate|dexamethasone acetate|mesh-list
65359639|NCT00671034|Prednisone|prednisone|mesh-list
65359640|NCT00671034|Cortisone|cortisone|mesh-list
65359641|NCT00671034|Cyclophosphamide|cyclophosphamide|mesh-list
65359642|NCT00671034|Doxorubicin|doxorubicin|mesh-list
65359643|NCT00671034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65359644|NCT00671034|Methotrexate|methotrexate|mesh-list
65359645|NCT00671034|Vincristine|vincristine|mesh-list
65359646|NCT00671034|Daunorubicin|daunorubicin|mesh-list
65359647|NCT00671034|Asparaginase|asparaginase|mesh-list
65359648|NCT00671034|Mercaptopurine|mercaptopurine|mesh-list
65359649|NCT00671034|Pegaspargase|pegaspargase|mesh-list
65359650|NCT00671034|Thioguanine|thioguanine|mesh-list
65359651|NCT00671034|BB 1101|bb 1101|mesh-list
65359663|NCT00671034|Antiemetics|antiemetics|mesh-ancestor
65359664|NCT00671034|Autonomic Agents|autonomic agents|mesh-ancestor
65359665|NCT00671034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65359666|NCT00671034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65359667|NCT00671034|Glucocorticoids|glucocorticoids|mesh-ancestor
65359668|NCT00671034|Hormones|hormones|mesh-ancestor
65359669|NCT00671034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65359670|NCT00671034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65359671|NCT00671034|Protease Inhibitors|protease inhibitors|mesh-ancestor
65359672|NCT00671034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359673|NCT00671034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65359674|NCT00671034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65359675|NCT00671034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65359676|NCT00671034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65359677|NCT00671034|Abortifacient Agents|abortifacient agents|mesh-ancestor
65109517|NCT00551109|SA 4503|sa 4503|mesh-list
65359678|NCT00671034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65359679|NCT00671034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65359680|NCT00671034|Antimetabolites|antimetabolites|mesh-ancestor
65359681|NCT00671034|Dermatologic Agents|dermatologic agents|mesh-ancestor
65359682|NCT00671034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65359683|NCT00671034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65359684|NCT00671034|Antiviral Agents|antiviral agents|mesh-ancestor
65359714|NCT04425070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65359715|NCT04425070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65359716|NCT04425070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65359717|NCT04425070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65359718|NCT04425070|Alkylating Agents|alkylating agents|mesh-ancestor
65359719|NCT04607954|Durvalumab|durvalumab|mesh-list
65359720|NCT04607954|Immunoglobulins|immunoglobulins|mesh-list
65359721|NCT04607954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65359722|NCT04607954|Immunoglobulin G|immunoglobulin g|mesh-list
65359723|NCT04607954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65359724|NCT04607954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359725|NCT04607954|Immunologic Factors|immunologic factors|mesh-ancestor
65359726|NCT04607954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359727|NCT00743678|Cetuximab|cetuximab|mesh-list
65359728|NCT00743678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65359729|NCT00743678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359730|NCT02679508|Lansoprazole|lansoprazole|mesh-list
65359731|NCT02679508|Dexlansoprazole|dexlansoprazole|mesh-list
65359732|NCT02679508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65359733|NCT02679508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65359734|NCT02679508|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65359735|NCT02679508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359736|NCT02679508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359737|NCT00775632|Cyclosporine|cyclosporine|mesh-list
65359738|NCT00775632|Methotrexate|methotrexate|mesh-list
65359739|NCT00775632|Alemtuzumab|alemtuzumab|mesh-list
65359740|NCT00775632|Cyclosporins|cyclosporins|mesh-list
65359741|NCT00775632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65359742|NCT00775632|Abortifacient Agents|abortifacient agents|mesh-ancestor
65359743|NCT00775632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65359744|NCT00775632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359745|NCT00775632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65359746|NCT00775632|Antimetabolites|antimetabolites|mesh-ancestor
65359756|NCT00775632|Antifungal Agents|antifungal agents|mesh-ancestor
65359757|NCT00775632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65359758|NCT00775632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65359759|NCT00775632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65359761|NCT00772356|Insulin|insulin|mesh-list
65359762|NCT00772356|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65359763|NCT00772356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65359764|NCT00772356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359765|NCT04321330|Atezolizumab|atezolizumab|mesh-list
65359766|NCT04321330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359767|NCT04394182|Ritonavir|ritonavir|mesh-list
65359768|NCT04394182|Lopinavir|lopinavir|mesh-list
65359769|NCT04394182|Azithromycin|azithromycin|mesh-list
65359770|NCT04394182|Hydroxychloroquine|hydroxychloroquine|mesh-list
65359771|NCT04394182|Tazobactam|tazobactam|mesh-list
65359772|NCT04394182|Piperacillin|piperacillin|mesh-list
65359773|NCT04394182|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65359774|NCT04394182|Heparin|heparin|mesh-list
65359775|NCT04394182|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65359776|NCT04394182|Tinzaparin|tinzaparin|mesh-list
65359777|NCT04394182|Dalteparin|dalteparin|mesh-list
65359778|NCT04394182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65359779|NCT04394182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65359780|NCT04394182|Protease Inhibitors|protease inhibitors|mesh-ancestor
65359781|NCT04394182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359782|NCT04394182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359783|NCT04394182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65359784|NCT04394182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65359785|NCT04394182|Antiviral Agents|antiviral agents|mesh-ancestor
65359786|NCT04394182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65359789|NCT04394182|Anticoagulants|anticoagulants|mesh-ancestor
65359806|NCT05325580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359807|NCT05325580|Anesthetics|anesthetics|mesh-ancestor
65359808|NCT05325580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65359809|NCT05325580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65359810|NCT05325580|Anticonvulsants|anticonvulsants|mesh-ancestor
65359811|NCT05325580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65359812|NCT05325580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65359813|NCT05325580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359814|NCT05325580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65359815|NCT05325580|Tocolytic Agents|tocolytic agents|mesh-ancestor
65359816|NCT05325580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65359817|NCT00539734|Ranibizumab|ranibizumab|mesh-list
65359818|NCT00539734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65359819|NCT00539734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65359820|NCT00539734|Growth Substances|growth substances|mesh-ancestor
65359821|NCT00539734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359822|NCT00539734|Growth Inhibitors|growth inhibitors|mesh-ancestor
65359823|NCT00539734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359824|NCT04004572|Pegaspargase|pegaspargase|mesh-list
65359825|NCT04004572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359826|NCT04050436|Cemiplimab|cemiplimab|mesh-list
65359829|NCT01093976|Dronabinol|dronabinol|mesh-list
65359858|NCT04008628|Anesthetics, General|anesthetics, general|mesh-ancestor
65359859|NCT04008628|Anesthetics|anesthetics|mesh-ancestor
65359860|NCT04008628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65359861|NCT04008628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359862|NCT04008628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65359863|NCT04008628|Analgesics|analgesics|mesh-ancestor
65359864|NCT04008628|Sensory System Agents|sensory system agents|mesh-ancestor
65359865|NCT04008628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65359866|NCT00743834|Fluvoxamine|fluvoxamine|mesh-list
65359867|NCT00743834|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65359868|NCT00743834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65359869|NCT00743834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65359870|NCT00743834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359871|NCT00743834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65359872|NCT00743834|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65359873|NCT00743834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65359874|NCT00743834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65359875|NCT00743834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359876|NCT00743834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65359877|NCT00743834|Serotonin Agents|serotonin agents|mesh-ancestor
65359878|NCT00743834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65359879|NCT00743834|Antidepressive Agents|antidepressive agents|mesh-ancestor
65359880|NCT00743834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65359881|NCT00743834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65359882|NCT00743834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359883|NCT00743834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65359884|NCT00743912|Rifaximin|rifaximin|mesh-list
65359885|NCT00743912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65359886|NCT00743912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65359901|NCT00329641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65359902|NCT00329641|Tubulin Modulators|tubulin modulators|mesh-ancestor
65359903|NCT00329641|Antimitotic Agents|antimitotic agents|mesh-ancestor
65359904|NCT00329641|Mitosis Modulators|mitosis modulators|mesh-ancestor
65359905|NCT00329641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359906|NCT00329641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65359907|NCT00329641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65359908|NCT02533219|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
65359910|NCT02533219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65359911|NCT02533219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359912|NCT02533219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359913|NCT00743990|Camphor|camphor|mesh-list
65359914|NCT00743990|Menthol|menthol|mesh-list
65359915|NCT00743990|Petrolatum|petrolatum|mesh-list
65359916|NCT00743990|Antipruritics|antipruritics|mesh-ancestor
65359917|NCT00743990|Dermatologic Agents|dermatologic agents|mesh-ancestor
65359918|NCT00743990|Emollients|emollients|mesh-ancestor
65359919|NCT00743990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65359920|NCT00743990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65359921|NCT00329407|Topiramate|topiramate|mesh-list
65359922|NCT00329407|Anticonvulsants|anticonvulsants|mesh-ancestor
65359923|NCT00329407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65359924|NCT00329407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359925|NCT01056757|Ribavirin|ribavirin|mesh-list
65359926|NCT01056757|Antimetabolites|antimetabolites|mesh-ancestor
65359927|NCT01056757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359928|NCT01056757|Antiviral Agents|antiviral agents|mesh-ancestor
65359929|NCT01056757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65359930|NCT01056835|Epoprostenol|epoprostenol|mesh-list
65359931|NCT01056835|Tezosentan|tezosentan|mesh-list
65359932|NCT01056835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65359934|NCT01056835|Vasodilator Agents|vasodilator agents|mesh-ancestor
65359947|NCT02538393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65359948|NCT00924963|Lidocaine|lidocaine|mesh-list
65359949|NCT00924963|Anesthetics, Local|anesthetics, local|mesh-ancestor
65359950|NCT00924963|Anesthetics|anesthetics|mesh-ancestor
65359951|NCT00924963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65359952|NCT00924963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65359953|NCT00924963|Sensory System Agents|sensory system agents|mesh-ancestor
65359954|NCT00924963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65359955|NCT00924963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65359956|NCT00924963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65360008|NCT00779376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65360009|NCT00779376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65360010|NCT00779376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360011|NCT00779376|Antiviral Agents|antiviral agents|mesh-ancestor
65360012|NCT00779376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65360013|NCT00779376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65360014|NCT00779376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65360015|NCT00779454|Gemcitabine|gemcitabine|mesh-list
65360016|NCT00779454|Capecitabine|capecitabine|mesh-list
65360017|NCT00779454|Oxaliplatin|oxaliplatin|mesh-list
65360018|NCT00779454|Panitumumab|panitumumab|mesh-list
65360019|NCT00779454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65360020|NCT00779454|Antimetabolites|antimetabolites|mesh-ancestor
65360021|NCT00779454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360022|NCT00779454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360023|NCT00779454|Antiviral Agents|antiviral agents|mesh-ancestor
65360024|NCT00779454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65360025|NCT00779454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360030|NCT00773058|Hydrocortisone|hydrocortisone|mesh-list
65360065|NCT00779922|Lenalidomide|lenalidomide|mesh-list
65360066|NCT00779922|Immunologic Factors|immunologic factors|mesh-ancestor
65360067|NCT00779922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360068|NCT00779922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65360069|NCT00779922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65360070|NCT00779922|Growth Substances|growth substances|mesh-ancestor
65360071|NCT00779922|Growth Inhibitors|growth inhibitors|mesh-ancestor
65360072|NCT00779922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360073|NCT00776646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65360074|NCT00776646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65360075|NCT00776646|Diuretics|diuretics|mesh-ancestor
65360076|NCT00776646|Natriuretic Agents|natriuretic agents|mesh-ancestor
65360077|NCT00776646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360078|NCT00776646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65360079|NCT00776646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65360080|NCT00776646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360082|NCT00776724|Epirubicin|epirubicin|mesh-list
65360083|NCT00776724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360084|NCT00776724|Tubulin Modulators|tubulin modulators|mesh-ancestor
65360085|NCT00776724|Antimitotic Agents|antimitotic agents|mesh-ancestor
65360086|NCT00776724|Mitosis Modulators|mitosis modulators|mesh-ancestor
65360087|NCT00776724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360088|NCT00776724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65360089|NCT00776724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65360090|NCT00776724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65360091|NCT00776724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360092|NCT00776802|Dexamethasone|dexamethasone|mesh-list
65360093|NCT00776802|Etoposide|etoposide|mesh-list
65360094|NCT00776802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65360095|NCT00776802|Antiemetics|antiemetics|mesh-ancestor
65360109|NCT00776802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360110|NCT00773916|Methylphenidate|methylphenidate|mesh-list
65360111|NCT00773916|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65360112|NCT00773916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360113|NCT00773916|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65360114|NCT00773916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65360115|NCT00773916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65360116|NCT00773916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360117|NCT00773916|Dopamine Agents|dopamine agents|mesh-ancestor
65360118|NCT00773916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65360119|NCT00774072|Tobramycin|tobramycin|mesh-list
65360120|NCT00774072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65360121|NCT00774072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65360122|NCT00780780|Triamcinolone|triamcinolone|mesh-list
65360123|NCT00780780|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65360124|NCT00780780|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65360125|NCT00780780|Nepafenac|nepafenac|mesh-list
65360126|NCT00780780|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65360127|NCT00780780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65360128|NCT00780780|Glucocorticoids|glucocorticoids|mesh-ancestor
65360129|NCT00780780|Hormones|hormones|mesh-ancestor
65360130|NCT00780780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65360131|NCT00780780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360132|NCT00780780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65360133|NCT00780780|Immunologic Factors|immunologic factors|mesh-ancestor
65360134|NCT00780780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360135|NCT00780780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360136|NCT00780780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65360137|NCT00780780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65360138|NCT00780780|Analgesics|analgesics|mesh-ancestor
65360139|NCT00780780|Sensory System Agents|sensory system agents|mesh-ancestor
65360141|NCT00780780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65360149|NCT00669396|Levonorgestrel|levonorgestrel|mesh-list
65360150|NCT00669396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65360151|NCT00669396|Contraceptive Agents|contraceptive agents|mesh-ancestor
65360152|NCT00669396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65360153|NCT00669396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360154|NCT00669396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65360155|NCT00669396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65360156|NCT00669396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65360157|NCT00669396|Trace Elements|trace elements|mesh-ancestor
65360158|NCT00669396|Micronutrients|micronutrients|mesh-ancestor
65360159|NCT00774462|Rituximab|rituximab|mesh-list
65360160|NCT00774462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65360161|NCT00774462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360162|NCT00774462|Immunologic Factors|immunologic factors|mesh-ancestor
65360163|NCT00774462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360164|NCT00774462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65360165|NCT00669318|Rituximab|rituximab|mesh-list
65360166|NCT00669318|Alemtuzumab|alemtuzumab|mesh-list
65360167|NCT00669318|Pentostatin|pentostatin|mesh-list
65360168|NCT00669318|Sargramostim|sargramostim|mesh-list
65360169|NCT00669318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65360205|NCT00669162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360206|NCT00669162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65360207|NCT00669162|Fertility Agents|fertility agents|mesh-ancestor
65360208|NCT00669162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65360209|NCT00669162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360210|NCT00669162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65360211|NCT00669162|Androgen Antagonists|androgen antagonists|mesh-ancestor
65360212|NCT00669162|Hormone Antagonists|hormone antagonists|mesh-ancestor
65360213|NCT00669162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65360214|NCT00774696|Clarithromycin|clarithromycin|mesh-list
65360215|NCT00774696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65360216|NCT00774696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65360217|NCT00774696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65360218|NCT00774696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360219|NCT00774696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360220|NCT00774696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65360221|NCT00774696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65360222|NCT02556060|Lamotrigine|lamotrigine|mesh-list
65360223|NCT02556060|Anticonvulsants|anticonvulsants|mesh-ancestor
65360224|NCT02556060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65360225|NCT02556060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65360226|NCT02556060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360228|NCT02556060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360255|NCT00400946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65360256|NCT00400946|Immunologic Factors|immunologic factors|mesh-ancestor
65360257|NCT00400946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360258|NCT00400946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65360259|NCT00400946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65360260|NCT00400946|Alkylating Agents|alkylating agents|mesh-ancestor
65360261|NCT00400946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360262|NCT00400946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360263|NCT00400946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65360264|NCT00400946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65360265|NCT00400946|Antiemetics|antiemetics|mesh-ancestor
65360266|NCT00400946|Autonomic Agents|autonomic agents|mesh-ancestor
65360267|NCT00400946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65360268|NCT00400946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65360269|NCT00400946|Glucocorticoids|glucocorticoids|mesh-ancestor
65360270|NCT00400946|Hormones|hormones|mesh-ancestor
65360271|NCT00400946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65360272|NCT00400946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65360273|NCT00400946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65360274|NCT00400946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65360275|NCT00400946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65360276|NCT00400946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360277|NCT00400946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65360278|NCT00400946|Abortifacient Agents|abortifacient agents|mesh-ancestor
65360279|NCT00400946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65360280|NCT00400946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65360281|NCT00400946|Antimetabolites|antimetabolites|mesh-ancestor
65360282|NCT00400946|Dermatologic Agents|dermatologic agents|mesh-ancestor
65360291|NCT00400946|Vitamins|vitamins|mesh-ancestor
65360300|NCT00354770|Antiviral Agents|antiviral agents|mesh-ancestor
65360301|NCT00354770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65360302|NCT00354770|Expectorants|expectorants|mesh-ancestor
65360303|NCT00354770|Respiratory System Agents|respiratory system agents|mesh-ancestor
65360304|NCT00354770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65360305|NCT00354770|Antioxidants|antioxidants|mesh-ancestor
65360306|NCT00354770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360307|NCT00354770|Protective Agents|protective agents|mesh-ancestor
65360308|NCT00354770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360309|NCT00354770|Antidotes|antidotes|mesh-ancestor
65360310|NCT00744224|Exenatide|exenatide|mesh-list
65360311|NCT00744224|Prednisolone|prednisolone|mesh-list
65360312|NCT00744224|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65360313|NCT00744224|Methylprednisolone|methylprednisolone|mesh-list
65360314|NCT00744224|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65360315|NCT00744224|Prednisolone acetate|prednisolone acetate|mesh-list
65360316|NCT00744224|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65360317|NCT00744224|Prednisolone phosphate|prednisolone phosphate|mesh-list
65360318|NCT00744224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65360319|NCT00744224|Glucocorticoids|glucocorticoids|mesh-ancestor
65360320|NCT00744224|Hormones|hormones|mesh-ancestor
65360321|NCT00744224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65360322|NCT00744224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360323|NCT00744224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65360324|NCT00744224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360325|NCT00744224|Antiemetics|antiemetics|mesh-ancestor
65360326|NCT00744224|Autonomic Agents|autonomic agents|mesh-ancestor
65360327|NCT00744224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65360328|NCT00744224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65360329|NCT00744224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65360330|NCT00744224|Protective Agents|protective agents|mesh-ancestor
65360331|NCT00744224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65360332|NCT00744224|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65360335|NCT00744302|Calcium|calcium|mesh-list
65360344|NCT00666588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65360345|NCT00666588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360346|NCT00666588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65360347|NCT00666588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65360348|NCT00666588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360349|NCT00666588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360350|NCT00666588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65360351|NCT00666588|Antimetabolites|antimetabolites|mesh-ancestor
65360352|NCT00666588|Antiviral Agents|antiviral agents|mesh-ancestor
65360353|NCT00666588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65360354|NCT00666588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65360355|NCT00666588|Immunologic Factors|immunologic factors|mesh-ancestor
65360406|NCT00603915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360407|NCT00603915|Antiviral Agents|antiviral agents|mesh-ancestor
65360408|NCT00603915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65360409|NCT00603915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360410|NCT00603915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65360411|NCT00603915|Immunologic Factors|immunologic factors|mesh-ancestor
65360412|NCT00603915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360413|NCT00603915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65360414|NCT00929487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65360415|NCT00925977|Insulin|insulin|mesh-list
65360416|NCT00925977|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65360417|NCT00925977|Insulin Glargine|insulin glargine|mesh-list
65360418|NCT00925977|Insulin glulisine|insulin glulisine|mesh-list
65360419|NCT00925977|Isophane Insulin, Human|isophane insulin, human|mesh-list
65360420|NCT00925977|Insulin, Isophane|insulin, isophane|mesh-list
65360421|NCT00925977|Isophane insulin, beef|isophane insulin, beef|mesh-list
65360422|NCT00925977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65360423|NCT00925977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360424|NCT00926055|Simvastatin|simvastatin|mesh-list
65360425|NCT00926055|Ezetimibe|ezetimibe|mesh-list
65360426|NCT00926055|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
65360427|NCT00926055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65360428|NCT00926055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65360429|NCT00926055|Antimetabolites|antimetabolites|mesh-ancestor
65360430|NCT00926055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360431|NCT00926055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65360454|NCT00690794|Travoprost|travoprost|mesh-list
65360455|NCT00690794|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65360456|NCT00690794|Latanoprost|latanoprost|mesh-list
65360457|NCT00690794|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65360458|NCT00690794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65360459|NCT00666276|Linezolid|linezolid|mesh-list
65360460|NCT00666276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65360461|NCT00666276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65360462|NCT00666276|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65360463|NCT00666276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360464|NCT00666276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360465|NCT00567255|Naltrexone|naltrexone|mesh-list
65360466|NCT00567255|Bupropion|bupropion|mesh-list
65360467|NCT00567255|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65360468|NCT00567255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65360469|NCT00567255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360470|NCT00567255|Sensory System Agents|sensory system agents|mesh-ancestor
65360471|NCT00567255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65360472|NCT00567255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65360473|NCT00567255|Antidepressive Agents|antidepressive agents|mesh-ancestor
65360474|NCT00567255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65360475|NCT00567255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65360476|NCT00567255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65360477|NCT00567255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65360478|NCT00567255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360479|NCT00567255|Dopamine Agents|dopamine agents|mesh-ancestor
65360480|NCT00567255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65360481|NCT00567255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65360482|NCT00567255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65360483|NCT00567255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360484|NCT00746174|Rosiglitazone|rosiglitazone|mesh-list
65360485|NCT00746174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65360486|NCT00746174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360487|NCT00784446|Bevacizumab|bevacizumab|mesh-list
65360488|NCT00784446|Capecitabine|capecitabine|mesh-list
65360489|NCT00784446|Oxaliplatin|oxaliplatin|mesh-list
65360493|NCT00784446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65360494|NCT00784446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65360495|NCT00784446|Growth Substances|growth substances|mesh-ancestor
65360496|NCT00784446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360497|NCT00784446|Growth Inhibitors|growth inhibitors|mesh-ancestor
65360498|NCT00784446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65360499|NCT00784446|Antimetabolites|antimetabolites|mesh-ancestor
65360500|NCT00784446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360501|NCT00784446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65360502|NCT00784446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360503|NCT00744536|Lenalidomide|lenalidomide|mesh-list
65360504|NCT00744536|Melphalan|melphalan|mesh-list
65360505|NCT00744536|Immunologic Factors|immunologic factors|mesh-ancestor
65360506|NCT00744536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360507|NCT00744536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65360508|NCT00744536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65360509|NCT00744536|Growth Substances|growth substances|mesh-ancestor
65360510|NCT00744536|Growth Inhibitors|growth inhibitors|mesh-ancestor
65360511|NCT00744536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360512|NCT00744536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65360513|NCT00744536|Alkylating Agents|alkylating agents|mesh-ancestor
65360514|NCT00744536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360515|NCT00744536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65360516|NCT00744536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65360541|NCT00784680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65360542|NCT00784680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65360543|NCT00784680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65360544|NCT00784680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360545|NCT00784680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360546|NCT00908271|Dapagliflozin|dapagliflozin|mesh-list
65360547|NCT00908271|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65360548|NCT00908271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360549|NCT00908271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65360550|NCT00908271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360551|NCT02556840|Insulin|insulin|mesh-list
65360552|NCT02556840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65360553|NCT02556840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360554|NCT00929877|Ketoprofen|ketoprofen|mesh-list
65360555|NCT00929877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65360556|NCT00929877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65360557|NCT00929877|Analgesics|analgesics|mesh-ancestor
65360558|NCT00929877|Sensory System Agents|sensory system agents|mesh-ancestor
65360559|NCT00929877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65360560|NCT00929877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360561|NCT00929877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65360562|NCT00929877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65360563|NCT00929877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65360564|NCT00929877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360565|NCT00929877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360566|NCT00741884|Varenicline|varenicline|mesh-list
65360567|NCT00741884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65360573|NCT00931437|Vitamin K|vitamin k|mesh-list
65360586|NCT00742040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360587|NCT00742040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65360589|NCT00926757|Antiviral Agents|antiviral agents|mesh-ancestor
65360590|NCT00926757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65360591|NCT00782106|Immunoglobulins|immunoglobulins|mesh-list
65360592|NCT00782106|Antibodies|antibodies|mesh-list
65360593|NCT00782106|gamma-Globulins|gamma-globulins|mesh-list
65360594|NCT00782106|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65360595|NCT00782106|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65360596|NCT00782106|Immunoglobulin G|immunoglobulin g|mesh-list
65360597|NCT00782106|Immunologic Factors|immunologic factors|mesh-ancestor
65360598|NCT00782106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360599|NCT00929955|Ondansetron|ondansetron|mesh-list
65360600|NCT00929955|Simvastatin|simvastatin|mesh-list
65360601|NCT00929955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65360649|NCT05450978|Lamotrigine|lamotrigine|mesh-list
65360650|NCT05450978|Levetiracetam|levetiracetam|mesh-list
65360651|NCT05450978|Anticonvulsants|anticonvulsants|mesh-list
65360652|NCT05450978|Nootropic Agents|nootropic agents|mesh-ancestor
65360653|NCT05450978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65360654|NCT05450978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65360655|NCT05450978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360656|NCT05450978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65360657|NCT05450978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360658|NCT05450978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65360659|NCT05450978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65360660|NCT05450978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65360661|NCT05450978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65360662|NCT05450978|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65360664|NCT04060550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65360665|NCT04060550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65360666|NCT04060550|Respiratory System Agents|respiratory system agents|mesh-ancestor
65360667|NCT00921674|Ivermectin|ivermectin|mesh-list
65360668|NCT00921674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65360669|NCT00921674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65360670|NCT00667446|Leuprolide|leuprolide|mesh-list
65360704|NCT00778128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65360705|NCT00778128|Antimetabolites|antimetabolites|mesh-ancestor
65360706|NCT00778128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360707|NCT00778128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360708|NCT00778128|Antiviral Agents|antiviral agents|mesh-ancestor
65360709|NCT00778128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65360710|NCT00778128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360711|NCT00778128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65360712|NCT00778128|Immunologic Factors|immunologic factors|mesh-ancestor
65360713|NCT00778128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360714|NCT00778284|Amoxicillin|amoxicillin|mesh-list
65360715|NCT00778284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65360716|NCT00778284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65360717|NCT00749138|Tamoxifen|tamoxifen|mesh-list
65360718|NCT00749138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65360719|NCT00749138|Hormone Antagonists|hormone antagonists|mesh-ancestor
65360720|NCT00749138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65360721|NCT00749138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360722|NCT00749138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65360757|NCT00785382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360758|NCT00785382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65360759|NCT00785382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65360760|NCT00785382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65360761|NCT00785382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65360762|NCT00785382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65360763|NCT00667368|Metronidazole|metronidazole|mesh-list
65360764|NCT00667368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65360765|NCT00667368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65360766|NCT00667368|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65360767|NCT00667368|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65360768|NCT00785460|Benphothiamine|benphothiamine|mesh-list
65360769|NCT00785460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65360770|NCT00785460|Immunologic Factors|immunologic factors|mesh-ancestor
65360771|NCT00785460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360819|NCT00666198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65360820|NCT00666198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360821|NCT00666198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360822|NCT00666198|Urological Agents|urological agents|mesh-ancestor
65360823|NCT00778596|Prednisolone|prednisolone|mesh-list
65360824|NCT00778596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65360825|NCT00778596|Glucocorticoids|glucocorticoids|mesh-ancestor
65360826|NCT00778596|Hormones|hormones|mesh-ancestor
65360827|NCT00778596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65360828|NCT00778596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360829|NCT00778596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65360830|NCT00778596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360831|NCT00778674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65360832|NCT00778674|Benazepril|benazepril|mesh-list
65360833|NCT00778674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65360834|NCT00778674|Diuretics|diuretics|mesh-ancestor
65360835|NCT00778674|Natriuretic Agents|natriuretic agents|mesh-ancestor
65360836|NCT00778674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360837|NCT00778674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65360838|NCT00778674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65360839|NCT00778674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360840|NCT00778674|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65360841|NCT00778674|Protease Inhibitors|protease inhibitors|mesh-ancestor
65360842|NCT00778674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360843|NCT00778752|Lenalidomide|lenalidomide|mesh-list
65360844|NCT00778752|Immunologic Factors|immunologic factors|mesh-ancestor
65360845|NCT00778752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360846|NCT00778752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65360847|NCT00778752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65360848|NCT00778752|Growth Substances|growth substances|mesh-ancestor
65360862|NCT00926835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360863|NCT00926835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65360864|NCT00926835|Serotonin Agents|serotonin agents|mesh-ancestor
65360865|NCT00926835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360866|NCT00926835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65360867|NCT00926835|Antidepressive Agents|antidepressive agents|mesh-ancestor
65360868|NCT00926835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65360869|NCT00926835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65360870|NCT00926835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65360871|NCT00926835|Parasympatholytics|parasympatholytics|mesh-ancestor
65360872|NCT00926835|Autonomic Agents|autonomic agents|mesh-ancestor
65360873|NCT00926835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65360874|NCT00926835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65360921|NCT00664560|Sensory System Agents|sensory system agents|mesh-ancestor
65360922|NCT00664560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65360923|NCT00664560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360924|NCT00664560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65360925|NCT00664560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65360926|NCT00664560|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65360927|NCT00664560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65360928|NCT00664560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360929|NCT00664560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360930|NCT00664560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65360931|NCT00783042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65360932|NCT00783042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65360933|NCT00783042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65360934|NCT00783042|Antimetabolites|antimetabolites|mesh-ancestor
65360935|NCT00783042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65360936|NCT00783042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65360977|NCT00937131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65360978|NCT00937131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360979|NCT00937131|Immunologic Factors|immunologic factors|mesh-ancestor
65360980|NCT00937131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360981|NCT00937131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65360982|NCT00778908|Cisplatin|cisplatin|mesh-list
65360983|NCT00778908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360984|NCT02561468|Nefopam|nefopam|mesh-list
65360985|NCT02561468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65360986|NCT02561468|Analgesics|analgesics|mesh-ancestor
65360987|NCT02561468|Sensory System Agents|sensory system agents|mesh-ancestor
65360988|NCT02561468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65360989|NCT02561468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360990|NCT02555748|Sunitinib|sunitinib|mesh-list
65360991|NCT02555748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65360992|NCT02555748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65360993|NCT02555748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65360994|NCT02555748|Growth Substances|growth substances|mesh-ancestor
65360995|NCT02555748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65360996|NCT02555748|Growth Inhibitors|growth inhibitors|mesh-ancestor
65360997|NCT02555748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65360998|NCT02555748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65360999|NCT02555748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361000|NCT00930345|Sunitinib|sunitinib|mesh-list
65361001|NCT00930345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361026|NCT00686972|Glucagon|glucagon|mesh-list
65361027|NCT00686972|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65361028|NCT00686972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65361029|NCT00686972|Hormones|hormones|mesh-ancestor
65361030|NCT00686972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65361031|NCT00686972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361032|NCT00686972|Incretins|incretins|mesh-ancestor
65361033|NCT00665652|Lenalidomide|lenalidomide|mesh-list
65361034|NCT00665652|Immunologic Factors|immunologic factors|mesh-ancestor
65361035|NCT00665652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361036|NCT00665652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65361037|NCT00665652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65361038|NCT00665652|Growth Substances|growth substances|mesh-ancestor
65361039|NCT00665652|Growth Inhibitors|growth inhibitors|mesh-ancestor
65361040|NCT00665652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361041|NCT00752024|Hemostatics|hemostatics|mesh-list
65361042|NCT00752024|Coagulants|coagulants|mesh-ancestor
65361043|NCT00937677|Natalizumab|natalizumab|mesh-list
65361044|NCT00937677|Immunologic Factors|immunologic factors|mesh-ancestor
65361045|NCT00937677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361046|NCT00786240|Fesoterodine|fesoterodine|mesh-list
65361047|NCT00786240|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65361048|NCT00786240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65361049|NCT00786240|Cholinergic Agents|cholinergic agents|mesh-ancestor
65361050|NCT00786240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65361051|NCT00786240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361052|NCT00786240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361053|NCT00786240|Urological Agents|urological agents|mesh-ancestor
65361054|NCT04498923|Dexamethasone|dexamethasone|mesh-list
65361055|NCT04498923|Epinephrine|epinephrine|mesh-list
65361056|NCT04498923|Bupivacaine|bupivacaine|mesh-list
65361057|NCT04498923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65361058|NCT04498923|Antiemetics|antiemetics|mesh-ancestor
65361059|NCT04498923|Autonomic Agents|autonomic agents|mesh-ancestor
65361070|NCT04498923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65361071|NCT04498923|Sensory System Agents|sensory system agents|mesh-ancestor
65361072|NCT04498923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65361073|NCT04498923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65361074|NCT04498923|Adrenergic Agents|adrenergic agents|mesh-ancestor
65361075|NCT04498923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65361076|NCT04498923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361077|NCT04498923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65361078|NCT04498923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65361079|NCT04498923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65361080|NCT04498923|Respiratory System Agents|respiratory system agents|mesh-ancestor
65361081|NCT04498923|Mydriatics|mydriatics|mesh-ancestor
65361082|NCT04498923|Sympathomimetics|sympathomimetics|mesh-ancestor
65361083|NCT04498923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65361084|NCT00779064|Rivaroxaban|rivaroxaban|mesh-list
65361085|NCT00779064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65361086|NCT00779064|Antithrombins|antithrombins|mesh-ancestor
65361088|NCT00779064|Protease Inhibitors|protease inhibitors|mesh-ancestor
65361125|NCT00566631|Dopamine Agents|dopamine agents|mesh-ancestor
65361126|NCT00937911|Darexaban|darexaban|mesh-list
65361127|NCT00937911|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65361128|NCT00937911|Antithrombins|antithrombins|mesh-ancestor
65361129|NCT00937911|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65361130|NCT00937911|Protease Inhibitors|protease inhibitors|mesh-ancestor
65361131|NCT00937911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361132|NCT00937911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361133|NCT00937911|Anticoagulants|anticoagulants|mesh-ancestor
65361134|NCT00930891|Bevacizumab|bevacizumab|mesh-list
65361135|NCT00930891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65361136|NCT00930891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361137|NCT00930891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65361138|NCT00930891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65361139|NCT00930891|Growth Substances|growth substances|mesh-ancestor
65361140|NCT00930891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361141|NCT00930891|Growth Inhibitors|growth inhibitors|mesh-ancestor
65361142|NCT00938379|Insect Repellents|insect repellents|mesh-list
65361143|NCT00938379|Protective Agents|protective agents|mesh-ancestor
65361144|NCT00938379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361145|NCT00661830|Gemcitabine|gemcitabine|mesh-list
65361146|NCT00661830|Sorafenib|sorafenib|mesh-list
65361147|NCT00661830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65361148|NCT00661830|Antimetabolites|antimetabolites|mesh-ancestor
65361149|NCT00661830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361150|NCT00661830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361151|NCT00661830|Antiviral Agents|antiviral agents|mesh-ancestor
65361152|NCT00661830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65361153|NCT00661830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361154|NCT00661830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65361155|NCT00661830|Immunologic Factors|immunologic factors|mesh-ancestor
65361156|NCT00661830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361157|NCT00661830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65361158|NCT00932529|Olanzapine|olanzapine|mesh-list
65361159|NCT00932529|Risperidone|risperidone|mesh-list
65361165|NCT00932529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361166|NCT00932529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361167|NCT00932529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65361168|NCT00932529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65361169|NCT00932529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65361170|NCT00932529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65361171|NCT00932529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65361172|NCT00932529|Dopamine Agents|dopamine agents|mesh-ancestor
65361173|NCT00932529|Antiemetics|antiemetics|mesh-ancestor
65361174|NCT00932529|Autonomic Agents|autonomic agents|mesh-ancestor
65361175|NCT00932529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65361176|NCT00932529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65361177|NCT00932529|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65361178|NCT00932529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65361179|NCT00932529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65361180|NCT00932529|Antidepressive Agents|antidepressive agents|mesh-ancestor
65361181|NCT00783744|Insulin|insulin|mesh-list
65361182|NCT00783744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65361183|NCT00783744|Metformin|metformin|mesh-list
65361184|NCT00783744|Insulin Glargine|insulin glargine|mesh-list
65361185|NCT00783744|Glimepiride|glimepiride|mesh-list
65361186|NCT00783744|Isophane Insulin, Human|isophane insulin, human|mesh-list
65361187|NCT00783744|Insulin, Isophane|insulin, isophane|mesh-list
65361188|NCT00783744|Isophane insulin, beef|isophane insulin, beef|mesh-list
65361189|NCT00783744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65361190|NCT00783744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361191|NCT00783744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65361192|NCT00783744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65361193|NCT00783744|Immunologic Factors|immunologic factors|mesh-ancestor
65361195|NCT00932685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65361196|NCT00932685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65361197|NCT00932685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65361209|NCT00931125|Ranibizumab|ranibizumab|mesh-list
65361210|NCT00931125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65361211|NCT00931125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65361212|NCT00931125|Growth Substances|growth substances|mesh-ancestor
65361213|NCT00931125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361214|NCT00931125|Growth Inhibitors|growth inhibitors|mesh-ancestor
65361215|NCT00931125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361216|NCT00932763|Amlodipine|amlodipine|mesh-list
65361217|NCT00932763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65361218|NCT00932763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65361219|NCT00932763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65361220|NCT00932763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361221|NCT00932763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65361222|NCT00932763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361223|NCT00932763|Vasodilator Agents|vasodilator agents|mesh-ancestor
65361224|NCT00786396|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65361225|NCT00786396|Antiviral Agents|antiviral agents|mesh-ancestor
65361226|NCT00786396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65361227|NCT00783900|Metoprolol|metoprolol|mesh-list
65361228|NCT00783900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65361229|NCT00783900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65361230|NCT00783900|Sympatholytics|sympatholytics|mesh-ancestor
65361231|NCT00783900|Autonomic Agents|autonomic agents|mesh-ancestor
65361232|NCT00783900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65361240|NCT00938613|Budesonide|budesonide|mesh-list
65361258|NCT00786552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361259|NCT00786552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111079|NCT03818685|Nivolumab|nivolumab|mesh-list
65361260|NCT00786552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65361261|NCT00786552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65361262|NCT04047186|Nivolumab|nivolumab|mesh-list
65361263|NCT04047186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65361264|NCT04047186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361265|NCT04047186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65361266|NCT04047186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361267|NCT00931203|Celecoxib|celecoxib|mesh-list
65361268|NCT00931203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65361270|NCT00931203|Analgesics|analgesics|mesh-ancestor
65361317|NCT00931281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65361318|NCT04014855|Lactoferrin|lactoferrin|mesh-list
65361319|NCT04014855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65361320|NCT03401320|Letrozole|letrozole|mesh-list
65361321|NCT03401320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361322|NCT03401320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65361323|NCT03401320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65361324|NCT03401320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361325|NCT03401320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361326|NCT03401320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65361327|NCT03401320|Hormone Antagonists|hormone antagonists|mesh-ancestor
65361328|NCT03401320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65361329|NCT03401320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361330|NCT00571922|Acamprosate|acamprosate|mesh-list
65361331|NCT00571922|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65361332|NCT00933231|Mycophenolic Acid|mycophenolic acid|mesh-list
65361333|NCT00933231|Prednisone|prednisone|mesh-list
65361334|NCT00933231|Methylprednisolone|methylprednisolone|mesh-list
65361335|NCT00933231|Ramipril|ramipril|mesh-list
65361336|NCT00933231|Irbesartan|irbesartan|mesh-list
65361337|NCT00933231|Tacrolimus|tacrolimus|mesh-list
65361338|NCT00933231|Basiliximab|basiliximab|mesh-list
65361340|NCT00933231|Glucocorticoids|glucocorticoids|mesh-ancestor
65361371|NCT03489525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361372|NCT00752180|Insulin|insulin|mesh-list
65361373|NCT00752180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65361374|NCT00752180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65361375|NCT00752180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361376|NCT00784290|Orantinib|orantinib|mesh-list
65361377|NCT00784290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65361378|NCT00784290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361379|NCT00784290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361380|NCT00752414|Levofloxacin|levofloxacin|mesh-list
65361381|NCT00752414|Ofloxacin|ofloxacin|mesh-list
65361382|NCT00752414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65361383|NCT00752414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65361384|NCT00752414|Renal Agents|renal agents|mesh-ancestor
65361385|NCT00752414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65361386|NCT00752414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65361387|NCT00752414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65361388|NCT00752414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361389|NCT00752414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361390|NCT00752414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361391|NCT00752414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65361392|NCT00752414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65361393|NCT04059224|Trametinib|trametinib|mesh-list
65361394|NCT04059224|Dabrafenib|dabrafenib|mesh-list
65361395|NCT04059224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361396|NCT04059224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65361397|NCT04059224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361398|NCT04059224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361399|NCT00686894|Infliximab|infliximab|mesh-list
65361400|NCT00686894|Dermatologic Agents|dermatologic agents|mesh-ancestor
65361401|NCT00686894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65361402|NCT00686894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65361403|NCT00328627|Pioglitazone|pioglitazone|mesh-list
65361404|NCT00328627|Alogliptin|alogliptin|mesh-list
65361405|NCT00328627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65361408|NCT00328627|Hormones|hormones|mesh-ancestor
65361411|NCT00328627|Protease Inhibitors|protease inhibitors|mesh-ancestor
65361412|NCT00328627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361413|NCT00328627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361414|NCT03374956|Liraglutide|liraglutide|mesh-list
65361415|NCT03374956|Topiramate|topiramate|mesh-list
65361416|NCT03374956|Phentermine|phentermine|mesh-list
65361417|NCT03374956|Naltrexone|naltrexone|mesh-list
65361418|NCT03374956|Bupropion|bupropion|mesh-list
65361419|NCT03374956|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65361420|NCT03374956|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65361421|NCT03374956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361422|NCT03374956|Sensory System Agents|sensory system agents|mesh-ancestor
65361423|NCT03374956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65361424|NCT03374956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65361425|NCT03374956|Incretins|incretins|mesh-ancestor
65361426|NCT03374956|Hormones|hormones|mesh-ancestor
65361427|NCT03374956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65361428|NCT03374956|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65361429|NCT03374956|Antidepressive Agents|antidepressive agents|mesh-ancestor
65361430|NCT03374956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65361431|NCT03374956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65361432|NCT03374956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65361433|NCT03374956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65361434|NCT03374956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361435|NCT03374956|Dopamine Agents|dopamine agents|mesh-ancestor
65361436|NCT03374956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65361437|NCT03374956|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65361438|NCT03374956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65361456|NCT00663858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65361457|NCT05223400|Clindamycin|clindamycin|mesh-list
65361458|NCT05223400|Clindamycin palmitate|clindamycin palmitate|mesh-list
65361459|NCT05223400|Clindamycin phosphate|clindamycin phosphate|mesh-list
65361460|NCT05223400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65361461|NCT05223400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65361462|NCT05223400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65361463|NCT05223400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361464|NCT05223400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361465|NCT00790608|Nitric Oxide|nitric oxide|mesh-list
65361466|NCT00790608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65361467|NCT00790608|Autonomic Agents|autonomic agents|mesh-ancestor
65361468|NCT00790608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65361469|NCT00790608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361470|NCT00790608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65361471|NCT00790608|Respiratory System Agents|respiratory system agents|mesh-ancestor
65361472|NCT00790608|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65361473|NCT00790608|Antioxidants|antioxidants|mesh-ancestor
65361474|NCT00790608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361475|NCT00790608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65361476|NCT00790608|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65361477|NCT00790608|Vasodilator Agents|vasodilator agents|mesh-ancestor
65361478|NCT00790608|Gasotransmitters|gasotransmitters|mesh-ancestor
65361479|NCT00790608|Protective Agents|protective agents|mesh-ancestor
65361480|NCT00749450|Fluorouracil|fluorouracil|mesh-list
65361481|NCT00749450|Capecitabine|capecitabine|mesh-list
65361482|NCT00749450|Oxaliplatin|oxaliplatin|mesh-list
65361483|NCT00749450|Antimetabolites|antimetabolites|mesh-ancestor
65361484|NCT00749450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361500|NCT02561936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65361501|NCT02561936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65361502|NCT02561936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361503|NCT02561936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361504|NCT02561936|Antiviral Agents|antiviral agents|mesh-ancestor
65361505|NCT02561936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65361506|NCT02561936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65361507|NCT02561936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65361508|NCT00752648|Simeprevir|simeprevir|mesh-list
65361509|NCT00752648|Antiviral Agents|antiviral agents|mesh-ancestor
65361510|NCT00752648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65361511|NCT00752648|Protease Inhibitors|protease inhibitors|mesh-ancestor
65361512|NCT00752648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361513|NCT00752648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361514|NCT00790920|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
65361515|NCT00790920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65361516|NCT00790920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65361517|NCT00790920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361518|NCT00752882|Ceftazidime|ceftazidime|mesh-list
65361519|NCT00752882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65361520|NCT00752882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65361521|NCT01060735|Vitamin D|vitamin d|mesh-list
65361522|NCT01060735|Vitamins|vitamins|mesh-ancestor
65361523|NCT01060735|Micronutrients|micronutrients|mesh-ancestor
65361524|NCT01060735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361525|NCT01060735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65361526|NCT02555358|Docetaxel|docetaxel|mesh-list
65361527|NCT02555358|Capecitabine|capecitabine|mesh-list
65361528|NCT02555358|Oxaliplatin|oxaliplatin|mesh-list
65361529|NCT02555358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361530|NCT02555358|Tubulin Modulators|tubulin modulators|mesh-ancestor
64753711|NCT04124094|Protective Agents|protective agents|mesh-ancestor
64753718|NCT03033576|Nivolumab|nivolumab|mesh-list
64753719|NCT03033576|Ipilimumab|ipilimumab|mesh-list
64753720|NCT03033576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64753721|NCT03033576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753722|NCT03033576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65361543|NCT00787410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361544|NCT03989557|Aspirin|aspirin|mesh-list
65361545|NCT03989557|Clopidogrel|clopidogrel|mesh-list
65361602|NCT00663702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65361603|NCT00663702|Immunologic Factors|immunologic factors|mesh-ancestor
65361604|NCT00663702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361605|NCT00663702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65361606|NCT02022592|Midazolam|midazolam|mesh-list
65361607|NCT02022592|Lormetazepam|lormetazepam|mesh-list
65361608|NCT02022592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65361609|NCT02022592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65361610|NCT02022592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65361611|NCT02022592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361612|NCT02022592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65361613|NCT02022592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65361614|NCT02022592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65361615|NCT02022592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65361616|NCT02022592|Anesthetics, General|anesthetics, general|mesh-ancestor
65361617|NCT02022592|Anesthetics|anesthetics|mesh-ancestor
65361618|NCT02022592|GABA Modulators|gaba modulators|mesh-ancestor
65361619|NCT02022592|GABA Agents|gaba agents|mesh-ancestor
65361620|NCT02022592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65361621|NCT02022592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361622|NCT00683618|Atorvastatin|atorvastatin|mesh-list
65361657|NCT03816358|Mitosis Modulators|mitosis modulators|mesh-ancestor
65361658|NCT00795678|Gemcitabine|gemcitabine|mesh-list
65361659|NCT00795678|Paclitaxel|paclitaxel|mesh-list
65361660|NCT00795678|Vinorelbine|vinorelbine|mesh-list
65361661|NCT00795678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65361662|NCT00795678|Cyclophosphamide|cyclophosphamide|mesh-list
65361663|NCT00795678|Doxorubicin|doxorubicin|mesh-list
65361664|NCT00795678|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65361665|NCT00795678|Capecitabine|capecitabine|mesh-list
65361666|NCT00795678|Trastuzumab|trastuzumab|mesh-list
65361667|NCT00795678|Lapatinib|lapatinib|mesh-list
65361668|NCT00795678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65361669|NCT00795678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361670|NCT00795678|Tubulin Modulators|tubulin modulators|mesh-ancestor
65361671|NCT00795678|Antimitotic Agents|antimitotic agents|mesh-ancestor
65361672|NCT00795678|Mitosis Modulators|mitosis modulators|mesh-ancestor
65361673|NCT00795678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361674|NCT00795678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65361675|NCT00795678|Immunologic Factors|immunologic factors|mesh-ancestor
65361676|NCT00795678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361677|NCT00795678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65361678|NCT00795678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65361679|NCT00795678|Alkylating Agents|alkylating agents|mesh-ancestor
65361680|NCT00795678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65361681|NCT00795678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65361682|NCT00795678|Antimetabolites|antimetabolites|mesh-ancestor
65361683|NCT00795678|Antiviral Agents|antiviral agents|mesh-ancestor
65361684|NCT00795678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65361685|NCT00795678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361686|NCT00795678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65361687|NCT00795678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65361691|NCT00753038|Paclitaxel|paclitaxel|mesh-list
65361703|NCT00795756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65361704|NCT00795756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361705|NCT00795756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65361706|NCT00795756|Antimetabolites|antimetabolites|mesh-ancestor
65361707|NCT00795756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361708|NCT00795756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361709|NCT00795756|Dermatologic Agents|dermatologic agents|mesh-ancestor
65361710|NCT00795756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361711|NCT00795756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65361712|NCT00795756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65361713|NCT00795756|Immunologic Factors|immunologic factors|mesh-ancestor
65361714|NCT00795756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65361715|NCT00795756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65361716|NCT00795756|Antiviral Agents|antiviral agents|mesh-ancestor
65361717|NCT00795756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65361718|NCT04058522|Triamcinolone|triamcinolone|mesh-list
65361719|NCT04058522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65361720|NCT04058522|Glucocorticoids|glucocorticoids|mesh-ancestor
65361721|NCT04058522|Hormones|hormones|mesh-ancestor
65361722|NCT04058522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65361723|NCT04058522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361724|NCT00791232|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65361725|NCT00791232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65361726|NCT00791232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65361727|NCT00791232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65361728|NCT00791232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361729|NCT00791232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65361730|NCT00791232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65361731|NCT00791232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65361732|NCT00791232|Serotonin Agents|serotonin agents|mesh-ancestor
65361733|NCT00791232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64753913|NCT04394598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64753914|NCT04394598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64753921|NCT05602428|Anesthetics|anesthetics|mesh-list
65361745|NCT01563952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65361746|NCT01563952|Immunologic Factors|immunologic factors|mesh-ancestor
65361747|NCT01563952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361748|NCT01563952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65361749|NCT00795912|Atorvastatin|atorvastatin|mesh-list
65361750|NCT00795912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65361751|NCT00795912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65361752|NCT00795912|Antimetabolites|antimetabolites|mesh-ancestor
65361753|NCT00795912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361754|NCT00795912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65361755|NCT00795912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65361756|NCT00795912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361757|NCT00788034|Vortioxetine|vortioxetine|mesh-list
65361758|NCT00788034|Antidepressive Agents|antidepressive agents|mesh-ancestor
65361759|NCT00788034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65361760|NCT00788034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65361761|NCT00788034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65361762|NCT00788034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65361763|NCT00788034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361764|NCT00788034|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65361765|NCT00788034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65361766|NCT00788034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65361767|NCT00788034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361788|NCT00688064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65361790|NCT00688064|Sensory System Agents|sensory system agents|mesh-ancestor
65361791|NCT00688064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65361792|NCT00688064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361793|NCT00688064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65361794|NCT00688064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65361795|NCT00688064|Dermatologic Agents|dermatologic agents|mesh-ancestor
65361796|NCT00788112|Vorinostat|vorinostat|mesh-list
65361797|NCT00788112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361798|NCT00788112|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65361799|NCT00788112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361800|NCT00788112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361801|NCT03112174|Venetoclax|venetoclax|mesh-list
65361802|NCT03112174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361803|NCT00749918|Vitamin D|vitamin d|mesh-list
65361804|NCT00749918|Cholecalciferol|cholecalciferol|mesh-list
65361805|NCT00749918|Vitamins|vitamins|mesh-ancestor
65361806|NCT00749918|Micronutrients|micronutrients|mesh-ancestor
65361807|NCT00749918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361808|NCT00749918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65361809|NCT00749918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65361810|NCT04058132|Sildenafil Citrate|sildenafil citrate|mesh-list
65361811|NCT04058132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361812|NCT04058132|Vasodilator Agents|vasodilator agents|mesh-ancestor
65361813|NCT04058132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65361814|NCT04058132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65361815|NCT04058132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361816|NCT04058132|Urological Agents|urological agents|mesh-ancestor
65361817|NCT00791544|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65361818|NCT00791544|Sorafenib|sorafenib|mesh-list
65361834|NCT05171686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361835|NCT05171686|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65361836|NCT00990028|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65361837|NCT00990028|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65361838|NCT00990028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65361839|NCT00990028|Antimetabolites|antimetabolites|mesh-ancestor
65361840|NCT00990028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361841|NCT00990028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65361842|NCT00990028|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65361843|NCT00990028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361844|NCT00663234|Atorvastatin|atorvastatin|mesh-list
65361845|NCT00663234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65361846|NCT00663234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65361847|NCT00663234|Antimetabolites|antimetabolites|mesh-ancestor
65361848|NCT00663234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361849|NCT00663234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65361850|NCT00663234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65361851|NCT00663234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361852|NCT00683384|Etanercept|etanercept|mesh-list
65361853|NCT00683384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65361854|NCT00683384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65361855|NCT00683384|Analgesics|analgesics|mesh-ancestor
65361856|NCT00683384|Sensory System Agents|sensory system agents|mesh-ancestor
65361857|NCT00683384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65361858|NCT00683384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361859|NCT00683384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65361860|NCT00683384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65361861|NCT00683384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65361862|NCT00683384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65361863|NCT00683384|Immunologic Factors|immunologic factors|mesh-ancestor
65361864|NCT00753740|Camptothecin|camptothecin|mesh-list
65361865|NCT00753740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65361872|NCT00326911|Bevacizumab|bevacizumab|mesh-list
65361873|NCT00326911|Cetuximab|cetuximab|mesh-list
65361874|NCT00326911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65361875|NCT00326911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361876|NCT00326911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65361877|NCT00326911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65361878|NCT00326911|Growth Substances|growth substances|mesh-ancestor
65361879|NCT00326911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361880|NCT00326911|Growth Inhibitors|growth inhibitors|mesh-ancestor
65361881|NCT00326911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65361882|NCT00326911|Antimetabolites|antimetabolites|mesh-ancestor
65361883|NCT00326911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361884|NCT00326911|Antiviral Agents|antiviral agents|mesh-ancestor
65361885|NCT00326911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65361886|NCT00326911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65361887|NCT00326911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65361888|NCT00326911|Immunologic Factors|immunologic factors|mesh-ancestor
65361889|NCT00791622|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65361890|NCT00791622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65361891|NCT00791622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65361892|NCT00791622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65361893|NCT00791622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361894|NCT00791622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65361895|NCT00791622|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65361896|NCT00791622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65361897|NCT00791622|Serotonin Agents|serotonin agents|mesh-ancestor
65361898|NCT00791622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65361899|NCT00791622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361900|NCT00791622|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65361901|NCT00791622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65361902|NCT00791622|Dopamine Agents|dopamine agents|mesh-ancestor
65361903|NCT00747110|Budesonide|budesonide|mesh-list
65361914|NCT00747110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65361915|NCT00747110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65361916|NCT00747110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65361917|NCT00747110|Analgesics|analgesics|mesh-ancestor
65361918|NCT00747110|Sensory System Agents|sensory system agents|mesh-ancestor
65361919|NCT00747110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65361920|NCT00796458|Docetaxel|docetaxel|mesh-list
65361921|NCT00796458|Hormones|hormones|mesh-list
65361922|NCT00796458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361923|NCT00796458|Tubulin Modulators|tubulin modulators|mesh-ancestor
65361924|NCT00796458|Antimitotic Agents|antimitotic agents|mesh-ancestor
65361925|NCT00796458|Mitosis Modulators|mitosis modulators|mesh-ancestor
65361926|NCT00796458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361927|NCT00796458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65361928|NCT00796458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361929|NCT04046016|Paclitaxel|paclitaxel|mesh-list
65361930|NCT04046016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65361931|NCT04046016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361932|NCT04046016|Tubulin Modulators|tubulin modulators|mesh-ancestor
65361933|NCT04046016|Antimitotic Agents|antimitotic agents|mesh-ancestor
65361934|NCT04046016|Mitosis Modulators|mitosis modulators|mesh-ancestor
65361935|NCT04046016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361936|NCT01057615|Ascorbic Acid|ascorbic acid|mesh-list
65361937|NCT01057615|Vitamins|vitamins|mesh-ancestor
65361963|NCT00791856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65361964|NCT00791856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361965|NCT00791856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65361966|NCT00791856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361967|NCT00791856|Anabolic Agents|anabolic agents|mesh-ancestor
65361968|NCT00796692|Heparin|heparin|mesh-list
65361969|NCT00796692|Calcium heparin|calcium heparin|mesh-list
65361970|NCT00796692|Nadroparin|nadroparin|mesh-list
65361971|NCT00796692|Anticoagulants|anticoagulants|mesh-ancestor
65361972|NCT00796692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65361973|NCT00796692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65361974|NCT00796692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65361975|NCT00540436|Ambrisentan|ambrisentan|mesh-list
65361976|NCT00540436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65361977|NCT00788580|Sirolimus|sirolimus|mesh-list
65361978|NCT00788580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65361979|NCT00788580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65361980|NCT00788580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65361981|NCT00788580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65361982|NCT00788580|Antifungal Agents|antifungal agents|mesh-ancestor
65361983|NCT00788580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65361984|NCT00788580|Immunologic Factors|immunologic factors|mesh-ancestor
65361985|NCT00788580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65361986|NCT00792012|Temozolomide|temozolomide|mesh-list
65361988|NCT00792012|Alkylating Agents|alkylating agents|mesh-ancestor
65362014|NCT02562950|GABA Modulators|gaba modulators|mesh-ancestor
65362015|NCT02562950|GABA Agents|gaba agents|mesh-ancestor
65362016|NCT02562950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65362017|NCT02562950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362018|NCT00792168|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65362019|NCT00792168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65362020|NCT00792168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65362021|NCT00792168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65362022|NCT00792168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362023|NCT00792168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65362024|NCT00792168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362025|NCT00792168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65362026|NCT00792168|Antidepressive Agents|antidepressive agents|mesh-ancestor
65362027|NCT00792168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65362028|NCT00687440|Docetaxel|docetaxel|mesh-list
65362029|NCT00687440|Doxorubicin|doxorubicin|mesh-list
65362030|NCT00687440|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65362031|NCT00687440|Trastuzumab|trastuzumab|mesh-list
65362032|NCT00687440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362033|NCT00687440|Tubulin Modulators|tubulin modulators|mesh-ancestor
65362034|NCT00687440|Antimitotic Agents|antimitotic agents|mesh-ancestor
65362035|NCT00687440|Mitosis Modulators|mitosis modulators|mesh-ancestor
65362036|NCT00687440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362037|NCT00687440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65362038|NCT00687440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65362039|NCT00687440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65362060|NCT00990496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65362061|NCT00990496|Alkylating Agents|alkylating agents|mesh-ancestor
65362131|NCT00792324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362132|NCT00792324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362133|NCT00792324|Antiviral Agents|antiviral agents|mesh-ancestor
65362134|NCT00792324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65362135|NCT00792324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65362136|NCT00792324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65362137|NCT00792324|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65362138|NCT00792324|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65362139|NCT00792324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65362140|NCT00792324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65362141|NCT00990808|Atorvastatin|atorvastatin|mesh-list
65362142|NCT00990808|Anacetrapib|anacetrapib|mesh-list
65362143|NCT00990808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65362144|NCT00990808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65362145|NCT00990808|Antimetabolites|antimetabolites|mesh-ancestor
65362146|NCT00990808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362147|NCT00990808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65362148|NCT00990808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65362149|NCT00990808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362150|NCT00797160|Propofol|propofol|mesh-list
65362184|NCT00681824|Aprotinin|aprotinin|mesh-list
65362185|NCT00681824|Hemostatics|hemostatics|mesh-ancestor
65362186|NCT00681824|Coagulants|coagulants|mesh-ancestor
65362187|NCT00681824|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65362188|NCT00681824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65362189|NCT00681824|Protease Inhibitors|protease inhibitors|mesh-ancestor
65362190|NCT00681824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362191|NCT00681824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362192|NCT00797472|Bleomycin|bleomycin|mesh-list
65362193|NCT00797472|Dacarbazine|dacarbazine|mesh-list
65362194|NCT00797472|Vinblastine|vinblastine|mesh-list
65362195|NCT00797472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65362196|NCT00797472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362197|NCT00797472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362198|NCT00797472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65362199|NCT00797472|Alkylating Agents|alkylating agents|mesh-ancestor
65362200|NCT00797472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65362201|NCT00797472|Tubulin Modulators|tubulin modulators|mesh-ancestor
65362202|NCT00797472|Antimitotic Agents|antimitotic agents|mesh-ancestor
65362203|NCT00797472|Mitosis Modulators|mitosis modulators|mesh-ancestor
65362204|NCT00681668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65362205|NCT00681668|Antidepressive Agents|antidepressive agents|mesh-ancestor
65362206|NCT00681668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65362207|NCT00681668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65362208|NCT00681668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65362209|NCT00681668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65362210|NCT00681668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362211|NCT00539188|Acetylcysteine|acetylcysteine|mesh-list
65362212|NCT00539188|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65362213|NCT00539188|Antiviral Agents|antiviral agents|mesh-ancestor
65362214|NCT00539188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65362229|NCT00681590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65362230|NCT00681590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65362231|NCT05359432|Empagliflozin|empagliflozin|mesh-list
65362232|NCT05359432|Vildagliptin|vildagliptin|mesh-list
65362233|NCT05359432|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65362234|NCT05359432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362235|NCT05359432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65362236|NCT05359432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362237|NCT05359432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65362238|NCT05359432|Protease Inhibitors|protease inhibitors|mesh-ancestor
65362239|NCT05359432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362240|NCT00755456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65362242|NCT00755534|Oxaliplatin|oxaliplatin|mesh-list
65362291|NCT00685802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362292|NCT00685802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65362293|NCT00685802|Vasodilator Agents|vasodilator agents|mesh-ancestor
65362294|NCT00685802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65362295|NCT00685802|Protective Agents|protective agents|mesh-ancestor
65362296|NCT00685802|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65362297|NCT00685802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65362298|NCT00685802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362299|NCT01054651|Artesunate|artesunate|mesh-list
65362300|NCT01054651|Pyrimethamine|pyrimethamine|mesh-list
65362301|NCT01054651|Sulfalene|sulfalene|mesh-list
65362302|NCT01054651|Praziquantel|praziquantel|mesh-list
65362303|NCT01054651|Antimalarials|antimalarials|mesh-ancestor
65362304|NCT01054651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65362305|NCT01054651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65362306|NCT01054651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65362307|NCT01054651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362308|NCT01054651|Antiviral Agents|antiviral agents|mesh-ancestor
65362309|NCT01054651|Schistosomicides|schistosomicides|mesh-ancestor
65362310|NCT01054651|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65362311|NCT01054651|Anthelmintics|anthelmintics|mesh-ancestor
65362313|NCT01054651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362346|NCT03827473|Ascorbic Acid|ascorbic acid|mesh-list
65362347|NCT03827473|Prednisone|prednisone|mesh-list
65362348|NCT03827473|Cortisone|cortisone|mesh-list
65362349|NCT03827473|Docetaxel|docetaxel|mesh-list
65362350|NCT03827473|Abiraterone Acetate|abiraterone acetate|mesh-list
65362351|NCT03827473|Methyltestosterone|methyltestosterone|mesh-list
65362352|NCT03827473|Hormones|hormones|mesh-list
65362353|NCT03827473|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65362354|NCT03827473|Androgens|androgens|mesh-list
65362355|NCT03827473|Androgen Antagonists|androgen antagonists|mesh-list
65362356|NCT03827473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362357|NCT03827473|Tubulin Modulators|tubulin modulators|mesh-ancestor
65362358|NCT03827473|Antimitotic Agents|antimitotic agents|mesh-ancestor
65362359|NCT03827473|Mitosis Modulators|mitosis modulators|mesh-ancestor
65362360|NCT03827473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362361|NCT03827473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65362362|NCT03827473|Glucocorticoids|glucocorticoids|mesh-ancestor
65362363|NCT03827473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65362364|NCT03827473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362365|NCT03827473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65362366|NCT03827473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65362367|NCT03827473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362368|NCT03827473|Hormone Antagonists|hormone antagonists|mesh-ancestor
65362369|NCT03827473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65362370|NCT03827473|Antioxidants|antioxidants|mesh-ancestor
65362371|NCT03827473|Protective Agents|protective agents|mesh-ancestor
65362372|NCT03827473|Vitamins|vitamins|mesh-ancestor
65362373|NCT03827473|Micronutrients|micronutrients|mesh-ancestor
65362374|NCT03827473|Estrogens|estrogens|mesh-ancestor
65362375|NCT03827473|Anabolic Agents|anabolic agents|mesh-ancestor
65362376|NCT00800592|Sildenafil Citrate|sildenafil citrate|mesh-list
64754559|NCT03823248|Folic Acid|folic acid|mesh-list
65362392|NCT00797784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65362393|NCT00797784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65362394|NCT00797784|Immunologic Factors|immunologic factors|mesh-ancestor
65362395|NCT00747968|Exenatide|exenatide|mesh-list
65362396|NCT00747968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65362397|NCT00747968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362398|NCT00747968|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65362399|NCT00747968|Incretins|incretins|mesh-ancestor
65362400|NCT00747968|Hormones|hormones|mesh-ancestor
65362401|NCT00747968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65362402|NCT00755924|Acetic Acid|acetic acid|mesh-list
65362403|NCT00755924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65362404|NCT00755924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65362405|NCT00800748|Ribavirin|ribavirin|mesh-list
65362406|NCT00800748|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65362407|NCT00800748|Antimetabolites|antimetabolites|mesh-ancestor
65362408|NCT00800748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362409|NCT00800748|Antiviral Agents|antiviral agents|mesh-ancestor
65362410|NCT00800748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65362411|NCT05426174|Vaccines|vaccines|mesh-list
65362412|NCT05426174|Immunologic Factors|immunologic factors|mesh-ancestor
65362413|NCT05426174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362414|NCT00798252|Paclitaxel|paclitaxel|mesh-list
65362415|NCT00798252|Docetaxel|docetaxel|mesh-list
65362416|NCT00798252|Doxorubicin|doxorubicin|mesh-list
65362417|NCT00798252|Capecitabine|capecitabine|mesh-list
65362418|NCT00798252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65362419|NCT00798252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362420|NCT00798252|Tubulin Modulators|tubulin modulators|mesh-ancestor
65362421|NCT00798252|Antimitotic Agents|antimitotic agents|mesh-ancestor
65362422|NCT00798252|Mitosis Modulators|mitosis modulators|mesh-ancestor
65362423|NCT00798252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362424|NCT00798252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65362425|NCT00798252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65362426|NCT00798252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65362427|NCT00798252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362428|NCT00798252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65362430|NCT00748046|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65362431|NCT00748046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362432|NCT00326209|Mesalamine|mesalamine|mesh-list
65362433|NCT00326209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65362434|NCT00326209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65362435|NCT00326209|Analgesics|analgesics|mesh-ancestor
65362436|NCT00326209|Sensory System Agents|sensory system agents|mesh-ancestor
65362437|NCT00326209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65362438|NCT00326209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362439|NCT00326209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65362440|NCT00326209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65362441|NCT00537940|Pregabalin|pregabalin|mesh-list
65362442|NCT00537940|Gabapentin|gabapentin|mesh-list
65362443|NCT00537940|Analgesics|analgesics|mesh-ancestor
65362444|NCT00537940|Sensory System Agents|sensory system agents|mesh-ancestor
65362445|NCT00537940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65362446|NCT00537940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362447|NCT00537940|Anticonvulsants|anticonvulsants|mesh-ancestor
65362448|NCT00537940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65362449|NCT00537940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65362450|NCT00537940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362451|NCT00537940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65362452|NCT00537940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65362453|NCT00537940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65362454|NCT00537940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65362455|NCT00537940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65362456|NCT00537940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65362457|NCT00537940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65362458|NCT00537940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65362459|NCT00537940|Antimanic Agents|antimanic agents|mesh-ancestor
65362473|NCT00748202|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
65362474|NCT00748202|Immunologic Factors|immunologic factors|mesh-ancestor
65362475|NCT00748202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362476|NCT00748202|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65362477|NCT00748202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65362478|NCT00325897|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65362479|NCT00325897|Azithromycin|azithromycin|mesh-list
65362480|NCT00325897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65362481|NCT00800826|Dexmedetomidine|dexmedetomidine|mesh-list
65362482|NCT00800826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65362483|NCT00800826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65362484|NCT00800826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362485|NCT00800826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65362486|NCT00800826|Analgesics|analgesics|mesh-ancestor
65362487|NCT00800826|Sensory System Agents|sensory system agents|mesh-ancestor
65362488|NCT00800826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65362489|NCT00800826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65362490|NCT00800826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65362491|NCT00800826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65362492|NCT00800826|Adrenergic Agents|adrenergic agents|mesh-ancestor
65362493|NCT00800826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65362494|NCT00800826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362495|NCT03989089|Pembrolizumab|pembrolizumab|mesh-list
65362496|NCT03989089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65362497|NCT03989089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362498|NCT00793338|Sildenafil Citrate|sildenafil citrate|mesh-list
65362499|NCT00793338|Vasodilator Agents|vasodilator agents|mesh-ancestor
65362500|NCT00793338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65362501|NCT00793338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65362502|NCT00793338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362503|NCT00793338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362504|NCT00793338|Urological Agents|urological agents|mesh-ancestor
65362505|NCT05406856|Cisplatin|cisplatin|mesh-list
65362507|NCT00344773|Gefitinib|gefitinib|mesh-list
65362511|NCT00344773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362512|NCT02554344|Curcumin|curcumin|mesh-list
65362513|NCT02554344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65362514|NCT02554344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65362515|NCT02554344|Analgesics|analgesics|mesh-ancestor
65362516|NCT02554344|Sensory System Agents|sensory system agents|mesh-ancestor
65362517|NCT02554344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65362518|NCT02554344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362519|NCT02554344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65362520|NCT02554344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65362521|NCT02554344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362522|NCT02554344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362523|NCT02554344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362524|NCT01055041|Budesonide|budesonide|mesh-list
65362525|NCT01055041|Doxofylline|doxofylline|mesh-list
65362526|NCT01055041|Montelukast|montelukast|mesh-list
65362527|NCT01055041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65362528|NCT01055041|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65362529|NCT01055041|Autonomic Agents|autonomic agents|mesh-ancestor
65362565|NCT00748436|Histamine Agents|histamine agents|mesh-ancestor
65362566|NCT00748436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65362567|NCT00748436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362568|NCT00748436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362569|NCT00756860|Sevelamer|sevelamer|mesh-list
65362570|NCT00756860|Chelating Agents|chelating agents|mesh-ancestor
65362571|NCT00756860|Sequestering Agents|sequestering agents|mesh-ancestor
65362572|NCT00756860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362573|NCT00757016|Triamcinolone|triamcinolone|mesh-list
65362574|NCT00757016|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65362575|NCT00757016|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65362576|NCT00757016|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65362577|NCT00757016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65362578|NCT00757016|Glucocorticoids|glucocorticoids|mesh-ancestor
65362579|NCT00757016|Hormones|hormones|mesh-ancestor
65362580|NCT00757016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65362581|NCT00757016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362582|NCT00757016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65362583|NCT00757016|Immunologic Factors|immunologic factors|mesh-ancestor
65362584|NCT00757016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362585|NCT00757016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362586|NCT00687362|Infliximab|infliximab|mesh-list
65362587|NCT00687362|Dermatologic Agents|dermatologic agents|mesh-ancestor
65362588|NCT00687362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65362589|NCT00687362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65362590|NCT00757250|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
65362591|NCT00757250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65362592|NCT00757250|Vasodilator Agents|vasodilator agents|mesh-ancestor
65362593|NCT00751478|Naltrexone|naltrexone|mesh-list
65362610|NCT00751556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362611|NCT00751556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65362612|NCT00751556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65362613|NCT00751556|Gout Suppressants|gout suppressants|mesh-ancestor
65362614|NCT00751556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65362615|NCT00751556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362616|NCT00751556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362617|NCT00660816|Docetaxel|docetaxel|mesh-list
65362618|NCT00660816|Pemetrexed|pemetrexed|mesh-list
65362619|NCT00660816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65362620|NCT00660816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362621|NCT00660816|Tubulin Modulators|tubulin modulators|mesh-ancestor
65362622|NCT00660816|Antimitotic Agents|antimitotic agents|mesh-ancestor
65362623|NCT00660816|Mitosis Modulators|mitosis modulators|mesh-ancestor
65362624|NCT00660816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362625|NCT00660816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362626|NCT00660816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65362627|NCT00660816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65362628|NCT00660816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65362629|NCT00685334|Olanzapine|olanzapine|mesh-list
65362630|NCT00685334|Aripiprazole|aripiprazole|mesh-list
65362631|NCT00685334|Antiemetics|antiemetics|mesh-ancestor
65362632|NCT00685334|Autonomic Agents|autonomic agents|mesh-ancestor
65362633|NCT00685334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65362634|NCT00685334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362659|NCT00801294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362660|NCT00801294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362661|NCT04013919|Insulin|insulin|mesh-list
65362662|NCT04013919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65362663|NCT04013919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65362664|NCT04013919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362665|NCT00344461|Tenofovir|tenofovir|mesh-list
65362666|NCT00344461|Nevirapine|nevirapine|mesh-list
65362667|NCT00344461|Antiviral Agents|antiviral agents|mesh-ancestor
65362668|NCT00344461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65362669|NCT00344461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65362670|NCT00344461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65362671|NCT00344461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362672|NCT00344461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362673|NCT00344461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65362674|NCT00344461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65362675|NCT00344461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65362676|NCT00344461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65362677|NCT00685178|Topiramate|topiramate|mesh-list
65362678|NCT00685178|Anticonvulsants|anticonvulsants|mesh-ancestor
65362679|NCT00685178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65362680|NCT00685178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362681|NCT00537394|Raltegravir Potassium|raltegravir potassium|mesh-list
65362682|NCT00537394|Maraviroc|maraviroc|mesh-list
65362683|NCT00537394|Darunavir|darunavir|mesh-list
65362684|NCT00537394|Tipranavir|tipranavir|mesh-list
65362685|NCT00537394|Enfuvirtide|enfuvirtide|mesh-list
65362686|NCT00537394|Etravirine|etravirine|mesh-list
65362687|NCT00537394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65362688|NCT00537394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65362689|NCT00537394|Antiviral Agents|antiviral agents|mesh-ancestor
65362690|NCT00537394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65362691|NCT00537394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65362703|NCT00933309|Metformin|metformin|mesh-list
65362704|NCT00933309|Rosiglitazone|rosiglitazone|mesh-list
65362705|NCT00933309|Exemestane|exemestane|mesh-list
65362706|NCT00933309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65362707|NCT00933309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362708|NCT00933309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362709|NCT00933309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65362710|NCT00933309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65362711|NCT00933309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362712|NCT00933309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362713|NCT00933309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65362714|NCT00933309|Hormone Antagonists|hormone antagonists|mesh-ancestor
65362715|NCT00933309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65362716|NCT00352885|Citalopram|citalopram|mesh-list
65362717|NCT00352885|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65362718|NCT00352885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65362719|NCT00352885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65362720|NCT00352885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362721|NCT00352885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65362722|NCT00352885|Serotonin Agents|serotonin agents|mesh-ancestor
65362723|NCT00352885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362724|NCT00352885|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65362725|NCT00352885|Antidepressive Agents|antidepressive agents|mesh-ancestor
65362726|NCT00352885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65362727|NCT00933387|Paclitaxel|paclitaxel|mesh-list
65362728|NCT00933387|Cetuximab|cetuximab|mesh-list
65362729|NCT00933387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65362730|NCT00933387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362731|NCT00933387|Tubulin Modulators|tubulin modulators|mesh-ancestor
65362732|NCT00933387|Antimitotic Agents|antimitotic agents|mesh-ancestor
65362746|NCT02560766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362747|NCT02560766|Anticonvulsants|anticonvulsants|mesh-ancestor
65362748|NCT02560766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65362749|NCT02560766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65362750|NCT02560766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65362751|NCT02560766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65362752|NCT02560766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65362753|NCT02560766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65362754|NCT02560766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65362755|NCT02560766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362756|NCT02560766|Antimanic Agents|antimanic agents|mesh-ancestor
65362757|NCT00933465|Loperamide|loperamide|mesh-list
65362758|NCT00933465|Antidiarrheals|antidiarrheals|mesh-list
65362759|NCT00933465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65362760|NCT00757874|Clobetasol|clobetasol|mesh-list
65362761|NCT00757874|Tacrolimus|tacrolimus|mesh-list
65362762|NCT00757874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65362763|NCT00757874|Immunologic Factors|immunologic factors|mesh-ancestor
65362764|NCT00757874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362765|NCT00757874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65112582|NCT00558818|Clevudine|clevudine|mesh-list
65362766|NCT00757874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362767|NCT00757874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362768|NCT00757874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65362769|NCT00757874|Glucocorticoids|glucocorticoids|mesh-ancestor
65362770|NCT00757874|Hormones|hormones|mesh-ancestor
65362771|NCT00757874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65362772|NCT05359354|Vaccines|vaccines|mesh-list
65362773|NCT05359354|Immunologic Factors|immunologic factors|mesh-ancestor
65362774|NCT05359354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362775|NCT00344305|Vaccines|vaccines|mesh-list
65362776|NCT00344305|Immunologic Factors|immunologic factors|mesh-ancestor
65362777|NCT00344305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362778|NCT00933777|Everolimus|everolimus|mesh-list
65362779|NCT00933777|Sorafenib|sorafenib|mesh-list
65362780|NCT00933777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362785|NCT00933777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362786|NCT00933777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362787|NCT00801450|Triamcinolone|triamcinolone|mesh-list
65362788|NCT00801450|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65362789|NCT00801450|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65362790|NCT00801450|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65362791|NCT00801450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65362792|NCT00801450|Glucocorticoids|glucocorticoids|mesh-ancestor
65362793|NCT00801450|Hormones|hormones|mesh-ancestor
65362794|NCT00801450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65362795|NCT00801450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362796|NCT00801450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65362797|NCT00801450|Immunologic Factors|immunologic factors|mesh-ancestor
65362798|NCT00801450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362799|NCT00801450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362800|NCT00801528|Diclofenac|diclofenac|mesh-list
65362801|NCT00801528|Ropivacaine|ropivacaine|mesh-list
65362802|NCT00801528|Anesthetics, Local|anesthetics, local|mesh-ancestor
65362803|NCT00801528|Anesthetics|anesthetics|mesh-ancestor
65362804|NCT00801528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65362805|NCT00801528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362806|NCT00801528|Sensory System Agents|sensory system agents|mesh-ancestor
65362807|NCT00801528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65362808|NCT00801528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65362809|NCT00801528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65362810|NCT00801528|Analgesics|analgesics|mesh-ancestor
65362811|NCT00801528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65362831|NCT04003402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362832|NCT00576056|Sorafenib|sorafenib|mesh-list
65362833|NCT00576056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362834|NCT00576056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65362835|NCT00576056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362836|NCT00576056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362837|NCT05360602|Thioctic Acid|thioctic acid|mesh-list
65362838|NCT05360602|Antioxidants|antioxidants|mesh-ancestor
65362839|NCT05360602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112658|NCT04643483|Immunologic Factors|immunologic factors|mesh-ancestor
65362840|NCT05360602|Protective Agents|protective agents|mesh-ancestor
65362841|NCT05360602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362842|NCT05360602|Vitamin B Complex|vitamin b complex|mesh-ancestor
65362843|NCT05360602|Vitamins|vitamins|mesh-ancestor
65362844|NCT05360602|Micronutrients|micronutrients|mesh-ancestor
65362845|NCT00991744|Cytarabine|cytarabine|mesh-list
65362846|NCT00991744|Cortisone|cortisone|mesh-list
65362847|NCT00991744|Prednisolone|prednisolone|mesh-list
65362848|NCT00991744|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65362849|NCT00991744|Methylprednisolone|methylprednisolone|mesh-list
65362850|NCT00991744|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65362885|NCT00989404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362886|NCT00758030|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65362887|NCT00758030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65362888|NCT00758030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65362889|NCT00758030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65362890|NCT00758030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362891|NCT00758030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65362892|NCT00758030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65362893|NCT00758030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65362894|NCT00758030|Serotonin Agents|serotonin agents|mesh-ancestor
65362895|NCT00758030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65362896|NCT00758030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362897|NCT00758030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65362898|NCT00758030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65362899|NCT00758030|Dopamine Agents|dopamine agents|mesh-ancestor
65362900|NCT00991822|Timolol|timolol|mesh-list
65362901|NCT00991822|Dorzolamide|dorzolamide|mesh-list
65362902|NCT00991822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65362903|NCT00991822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65362904|NCT00991822|Adrenergic Agents|adrenergic agents|mesh-ancestor
65362905|NCT00991822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65362906|NCT00991822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362912|NCT00798954|Sirolimus|sirolimus|mesh-list
65362935|NCT00934167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65362936|NCT00934167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362937|NCT00801606|Zinc|zinc|mesh-list
65362938|NCT00801606|Trace Elements|trace elements|mesh-list
65362939|NCT00801606|Micronutrients|micronutrients|mesh-list
65362940|NCT00801606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362941|NCT00934245|Vaccines|vaccines|mesh-list
65362942|NCT00934245|Immunologic Factors|immunologic factors|mesh-ancestor
65362943|NCT00934245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362944|NCT02560688|Clopidogrel|clopidogrel|mesh-list
65362945|NCT02560688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65362946|NCT02560688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65362947|NCT02560688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65362948|NCT02560688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65362949|NCT02560688|Purinergic Agents|purinergic agents|mesh-ancestor
65362950|NCT02560688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65362951|NCT02560688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362952|NCT02560688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362953|NCT00939549|Cyclophosphamide|cyclophosphamide|mesh-list
65362954|NCT00939549|Glatiramer Acetate|glatiramer acetate|mesh-list
65362955|NCT00939549|(T,G)-A-L|(t,g)-a-l|mesh-list
65362956|NCT00939549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65362957|NCT00939549|Immunologic Factors|immunologic factors|mesh-ancestor
65362958|NCT00939549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362959|NCT00939549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65362960|NCT00939549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65362961|NCT00939549|Alkylating Agents|alkylating agents|mesh-ancestor
65362962|NCT00939549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362963|NCT00939549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65362964|NCT00939549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65362965|NCT00939549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65362966|NCT00934323|Metformin|metformin|mesh-list
65362977|NCT00934479|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65362978|NCT00934479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65362979|NCT00934479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362980|NCT00658632|Esomeprazole|esomeprazole|mesh-list
65362981|NCT00658632|Rabeprazole|rabeprazole|mesh-list
65362982|NCT00658632|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65362983|NCT00658632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65362984|NCT00658632|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65362985|NCT00658632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65362986|NCT00658632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65362987|NCT00677534|Vitamin D|vitamin d|mesh-list
65362988|NCT00677534|Cholecalciferol|cholecalciferol|mesh-list
65362989|NCT00677534|Ergocalciferols|ergocalciferols|mesh-list
65362990|NCT00677534|Vitamins|vitamins|mesh-ancestor
65362991|NCT00677534|Micronutrients|micronutrients|mesh-ancestor
65112810|NCT04640285|Menthol|menthol|mesh-list
65362992|NCT00677534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65362993|NCT00677534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65362994|NCT00677534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65362995|NCT00989716|Antihypertensive Agents|antihypertensive agents|mesh-list
65362996|NCT00989716|Nitroglycerin|nitroglycerin|mesh-list
65362997|NCT00989716|Vasodilator Agents|vasodilator agents|mesh-ancestor
65362998|NCT00660348|Morphine|morphine|mesh-list
65362999|NCT00660348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65363000|NCT00660348|Narcotics|narcotics|mesh-ancestor
65363001|NCT00660348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65363002|NCT00660348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363003|NCT00660348|Analgesics|analgesics|mesh-ancestor
65363004|NCT00660348|Sensory System Agents|sensory system agents|mesh-ancestor
65363024|NCT00801918|Immunologic Factors|immunologic factors|mesh-ancestor
65363025|NCT00801918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363026|NCT00801918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65363027|NCT00801918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65363028|NCT00801918|Alkylating Agents|alkylating agents|mesh-ancestor
65363029|NCT00801918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363030|NCT00801918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363031|NCT00801918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65363032|NCT00801918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65363033|NCT00801918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65363034|NCT00801918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65363035|NCT00801918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363036|NCT00801918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65363037|NCT00801918|Analgesics|analgesics|mesh-ancestor
65363038|NCT00801918|Sensory System Agents|sensory system agents|mesh-ancestor
65363039|NCT00801918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65363040|NCT00799188|Everolimus|everolimus|mesh-list
65363041|NCT00799188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363042|NCT00799188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65363043|NCT00799188|Immunologic Factors|immunologic factors|mesh-ancestor
65363044|NCT00799188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363045|NCT00571688|Risperidone|risperidone|mesh-list
65363046|NCT00571688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65363047|NCT00571688|Serotonin Agents|serotonin agents|mesh-ancestor
65363051|NCT00571688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65363072|NCT04837716|Immunoglobulins|immunoglobulins|mesh-list
65363073|NCT04837716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65363074|NCT04837716|Immunoglobulin G|immunoglobulin g|mesh-list
65363075|NCT04837716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363076|NCT04837716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65363077|NCT04837716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65363078|NCT04837716|Growth Substances|growth substances|mesh-ancestor
65363079|NCT04837716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363080|NCT04837716|Growth Inhibitors|growth inhibitors|mesh-ancestor
65363081|NCT04837716|Immunologic Factors|immunologic factors|mesh-ancestor
65363082|NCT04837716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363083|NCT04837716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363084|NCT04837716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65363085|NCT04837716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65363086|NCT04837716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65363087|NCT00343291|Paclitaxel|paclitaxel|mesh-list
65363088|NCT00343291|Bevacizumab|bevacizumab|mesh-list
65363089|NCT00343291|Carboplatin|carboplatin|mesh-list
65363090|NCT00343291|Cetuximab|cetuximab|mesh-list
65363091|NCT00343291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65363092|NCT00343291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363093|NCT00343291|Tubulin Modulators|tubulin modulators|mesh-ancestor
65363094|NCT00343291|Antimitotic Agents|antimitotic agents|mesh-ancestor
65363095|NCT00343291|Mitosis Modulators|mitosis modulators|mesh-ancestor
65363096|NCT00343291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363097|NCT00343291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65363098|NCT00343291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65363099|NCT00343291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65363100|NCT00343291|Growth Substances|growth substances|mesh-ancestor
65363101|NCT00343291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363102|NCT00343291|Growth Inhibitors|growth inhibitors|mesh-ancestor
65363103|NCT05407870|Propofol|propofol|mesh-list
65363115|NCT03988231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363116|NCT05407636|Aflibercept|aflibercept|mesh-list
65363117|NCT05407636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65363118|NCT05407636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65363119|NCT05407636|Growth Substances|growth substances|mesh-ancestor
65363120|NCT05407636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363121|NCT05407636|Growth Inhibitors|growth inhibitors|mesh-ancestor
65363122|NCT05407636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363123|NCT00658788|Calcitriol|calcitriol|mesh-list
65363124|NCT00658788|Clobetasol|clobetasol|mesh-list
65363125|NCT00658788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65363126|NCT00658788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363127|NCT00658788|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65363128|NCT00658788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65363129|NCT00658788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363130|NCT00658788|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65363131|NCT00658788|Vitamins|vitamins|mesh-ancestor
65363132|NCT00658788|Micronutrients|micronutrients|mesh-ancestor
65363133|NCT00658788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65363169|NCT05590312|Anesthetics|anesthetics|mesh-list
65363170|NCT05590312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65363171|NCT05590312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363172|NCT00802230|Terbutaline|terbutaline|mesh-list
65363173|NCT00802230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65363174|NCT00802230|Autonomic Agents|autonomic agents|mesh-ancestor
65363175|NCT00802230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65363176|NCT00802230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363177|NCT00802230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65363178|NCT00802230|Respiratory System Agents|respiratory system agents|mesh-ancestor
65363179|NCT00802230|Sympathomimetics|sympathomimetics|mesh-ancestor
65363180|NCT00802230|Tocolytic Agents|tocolytic agents|mesh-ancestor
65363181|NCT00802230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65363182|NCT00802230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65363183|NCT00802230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65363184|NCT00802230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65363185|NCT00802230|Adrenergic Agents|adrenergic agents|mesh-ancestor
65363186|NCT00802230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65363227|NCT00562965|Mitosis Modulators|mitosis modulators|mesh-ancestor
65363228|NCT00562965|Analgesics|analgesics|mesh-ancestor
65363229|NCT00562965|Sensory System Agents|sensory system agents|mesh-ancestor
65363230|NCT00562965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65363231|NCT00562965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65363232|NCT00562965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363233|NCT00562965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65363234|NCT05406934|Infliximab|infliximab|mesh-list
65363235|NCT05406934|Dermatologic Agents|dermatologic agents|mesh-ancestor
65363236|NCT05406934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65363237|NCT05406934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65363238|NCT00794898|Infliximab|infliximab|mesh-list
65363239|NCT00794898|Dermatologic Agents|dermatologic agents|mesh-ancestor
65363240|NCT00794898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65363241|NCT00794898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65363242|NCT00800280|Cimetidine|cimetidine|mesh-list
65363243|NCT00800280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65363244|NCT00800280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65363245|NCT00800280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65363246|NCT00800280|Histamine Antagonists|histamine antagonists|mesh-ancestor
65363247|NCT00800280|Histamine Agents|histamine agents|mesh-ancestor
65363248|NCT00800280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65363249|NCT00800280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363250|NCT00800280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363251|NCT00800280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65363252|NCT00800280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65363253|NCT00800280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363274|NCT01057849|Olanzapine|olanzapine|mesh-list
65363275|NCT01057849|Risperidone|risperidone|mesh-list
65363276|NCT01057849|Aripiprazole|aripiprazole|mesh-list
65363277|NCT01057849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65363278|NCT01057849|Serotonin Agents|serotonin agents|mesh-ancestor
65363279|NCT01057849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65363280|NCT01057849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363281|NCT01057849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363282|NCT01057849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65363283|NCT01057849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65363284|NCT01057849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65363285|NCT01057849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65363286|NCT01057849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65363287|NCT01057849|Dopamine Agents|dopamine agents|mesh-ancestor
65363288|NCT01057849|Antiemetics|antiemetics|mesh-ancestor
65363289|NCT01057849|Autonomic Agents|autonomic agents|mesh-ancestor
65363290|NCT01057849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65363291|NCT01057849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65363292|NCT01057849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65363293|NCT01057849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65363294|NCT01057849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65363295|NCT01057849|Antidepressive Agents|antidepressive agents|mesh-ancestor
65363296|NCT01057849|Dopamine Agonists|dopamine agonists|mesh-ancestor
65363297|NCT01057849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65363298|NCT01057849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65363299|NCT01057849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65363300|NCT01057849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65363301|NCT00794976|Dexamethasone|dexamethasone|mesh-list
65363302|NCT00794976|Dexamethasone acetate|dexamethasone acetate|mesh-list
65363303|NCT00794976|BB 1101|bb 1101|mesh-list
65363304|NCT00794976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65363305|NCT00794976|Antiemetics|antiemetics|mesh-ancestor
65363306|NCT00794976|Autonomic Agents|autonomic agents|mesh-ancestor
65363307|NCT00794976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65363314|NCT00794976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363315|NCT00794976|Protease Inhibitors|protease inhibitors|mesh-ancestor
65363316|NCT00794976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363317|NCT00794976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363318|NCT00939939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65363319|NCT00939939|Glimepiride|glimepiride|mesh-list
65363320|NCT00939939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65363321|NCT00939939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363322|NCT00939939|Incretins|incretins|mesh-ancestor
65363323|NCT00939939|Hormones|hormones|mesh-ancestor
65363324|NCT00939939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65363325|NCT00939939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65363326|NCT00939939|Protease Inhibitors|protease inhibitors|mesh-ancestor
65363327|NCT00939939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363328|NCT00939939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363329|NCT00939939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65363330|NCT00939939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65363331|NCT00939939|Immunologic Factors|immunologic factors|mesh-ancestor
65363332|NCT00537082|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65363333|NCT00537082|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65363334|NCT00537082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363335|NCT00537082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65363336|NCT00537082|Immunologic Factors|immunologic factors|mesh-ancestor
65363337|NCT00537082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363338|NCT00805662|Oxytocin|oxytocin|mesh-list
65363339|NCT00805662|Oxytocics|oxytocics|mesh-ancestor
65363340|NCT00805662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65363341|NCT00805662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363342|NCT00803166|Clobetasol|clobetasol|mesh-list
65363343|NCT00803166|Halobetasol|halobetasol|mesh-list
65363344|NCT00803166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65363345|NCT00803166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65363354|NCT00324961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65363355|NCT00324961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65363356|NCT00324961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363357|NCT00324961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363358|NCT00941109|Decitabine|decitabine|mesh-list
65363359|NCT00941109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65363360|NCT00941109|Antimetabolites|antimetabolites|mesh-ancestor
65363361|NCT00941109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363362|NCT00941109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363363|NCT00941109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363364|NCT00935415|Montelukast|montelukast|mesh-list
65363365|NCT00935415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65363366|NCT00935415|Respiratory System Agents|respiratory system agents|mesh-ancestor
65363367|NCT00935415|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65363368|NCT00935415|Hormone Antagonists|hormone antagonists|mesh-ancestor
65363369|NCT00935415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65363370|NCT00935415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363371|NCT00935415|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65363372|NCT00935415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65363375|NCT00935571|Propofol|propofol|mesh-list
65363407|NCT03983239|Rifampin|rifampin|mesh-list
65363408|NCT03983239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65363409|NCT03983239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65363410|NCT03983239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363411|NCT03983239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363412|NCT03983239|Antiviral Agents|antiviral agents|mesh-ancestor
65363413|NCT03983239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65363414|NCT03983239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65363415|NCT03983239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65363416|NCT03983239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65363417|NCT03983239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65363418|NCT03983239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65363419|NCT03983239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65363420|NCT03983239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65363421|NCT03983239|Antitubercular Agents|antitubercular agents|mesh-ancestor
65363422|NCT03983239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65363423|NCT03983239|Leprostatic Agents|leprostatic agents|mesh-ancestor
65363424|NCT03983239|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65363425|NCT03983239|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65363426|NCT03983239|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65363427|NCT00935805|Insulin|insulin|mesh-list
65363428|NCT00935805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65363429|NCT00935805|Metformin|metformin|mesh-list
65363430|NCT00935805|Insulin, Isophane|insulin, isophane|mesh-list
65363431|NCT00935805|Isophane Insulin, Human|isophane insulin, human|mesh-list
65363432|NCT00935805|Isophane insulin, beef|isophane insulin, beef|mesh-list
65363433|NCT00935805|Glyburide|glyburide|mesh-list
65363434|NCT00935805|Propranolol|propranolol|mesh-list
65363435|NCT00935805|Amlodipine|amlodipine|mesh-list
65363436|NCT00935805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65363437|NCT00935805|Captopril|captopril|mesh-list
65363438|NCT00935805|Diuretics|diuretics|mesh-list
65363439|NCT00935805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65363440|NCT00935805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363448|NCT00935805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65363449|NCT00935805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65363450|NCT00935805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65363451|NCT00935805|Adrenergic Agents|adrenergic agents|mesh-ancestor
65363452|NCT00935805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65363453|NCT00935805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65363454|NCT00935805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65363455|NCT00935805|Protease Inhibitors|protease inhibitors|mesh-ancestor
65363456|NCT00935805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363457|NCT00935961|Docetaxel|docetaxel|mesh-list
65363458|NCT00935961|Everolimus|everolimus|mesh-list
65363459|NCT00935961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363460|NCT00935961|Tubulin Modulators|tubulin modulators|mesh-ancestor
65363461|NCT00935961|Antimitotic Agents|antimitotic agents|mesh-ancestor
65363462|NCT00935961|Mitosis Modulators|mitosis modulators|mesh-ancestor
65363463|NCT00935961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363464|NCT00935961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65363465|NCT00935961|Immunologic Factors|immunologic factors|mesh-ancestor
65363466|NCT00935961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363467|NCT01055431|Iron|iron|mesh-list
65363468|NCT01055431|Trace Elements|trace elements|mesh-ancestor
65363469|NCT01055431|Micronutrients|micronutrients|mesh-ancestor
65363470|NCT01055431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363471|NCT00803556|Paclitaxel|paclitaxel|mesh-list
65363472|NCT00803556|Trastuzumab|trastuzumab|mesh-list
65363473|NCT00803556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65363474|NCT00803556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363475|NCT00803556|Tubulin Modulators|tubulin modulators|mesh-ancestor
65363476|NCT00803556|Antimitotic Agents|antimitotic agents|mesh-ancestor
65363477|NCT00803556|Mitosis Modulators|mitosis modulators|mesh-ancestor
65363495|NCT00936195|Antiviral Agents|antiviral agents|mesh-ancestor
65363496|NCT00936195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65363497|NCT00936195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65363498|NCT00936195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65363499|NCT00936195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65363500|NCT00936195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65363501|NCT00936195|Antimetabolites|antimetabolites|mesh-ancestor
65363502|NCT00936195|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65363503|NCT00936195|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65363504|NCT00936195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65363505|NCT00936195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65363506|NCT00936195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65363507|NCT00680186|Warfarin|warfarin|mesh-list
65363508|NCT00680186|Dabigatran|dabigatran|mesh-list
65363509|NCT00680186|Anticoagulants|anticoagulants|mesh-ancestor
65363510|NCT00680186|Antithrombins|antithrombins|mesh-ancestor
65363511|NCT00680186|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65363512|NCT00680186|Protease Inhibitors|protease inhibitors|mesh-ancestor
65363513|NCT00680186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363514|NCT00680186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363515|NCT00936429|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65363516|NCT00936429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65363517|NCT00936429|Immunologic Factors|immunologic factors|mesh-ancestor
65363518|NCT00936429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363519|NCT00936429|Antacids|antacids|mesh-ancestor
65363520|NCT00936429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363521|NCT00936429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65363522|NCT00656292|Simvastatin|simvastatin|mesh-list
65363538|NCT00944541|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65363539|NCT00944541|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65363540|NCT00944541|Antiviral Agents|antiviral agents|mesh-ancestor
65363541|NCT00944541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65363542|NCT00944541|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65363543|NCT00944619|Insulin|insulin|mesh-list
65363544|NCT00944619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65363545|NCT00944619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363546|NCT00323869|Gemcitabine|gemcitabine|mesh-list
65363547|NCT00323869|Bevacizumab|bevacizumab|mesh-list
65363548|NCT00323869|Carboplatin|carboplatin|mesh-list
65363549|NCT00323869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65363550|NCT00323869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363551|NCT00323869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65363552|NCT00323869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65363553|NCT00323869|Growth Substances|growth substances|mesh-ancestor
65363554|NCT00323869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363555|NCT00323869|Growth Inhibitors|growth inhibitors|mesh-ancestor
65363556|NCT00323869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65363557|NCT00323869|Antimetabolites|antimetabolites|mesh-ancestor
65363558|NCT00323869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363559|NCT00323869|Antiviral Agents|antiviral agents|mesh-ancestor
65363560|NCT00323869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65363561|NCT00323869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363564|NCT00323557|Molgramostim|molgramostim|mesh-list
65363587|NCT00323479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65363588|NCT00323479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363589|NCT00352105|Fluorouracil|fluorouracil|mesh-list
65363590|NCT00352105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363591|NCT00352105|Antimetabolites|antimetabolites|mesh-ancestor
65363592|NCT00352105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363593|NCT00352105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65363594|NCT00352105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65363595|NCT00352105|Immunologic Factors|immunologic factors|mesh-ancestor
65363596|NCT00352105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363597|NCT03988075|Acetaminophen|acetaminophen|mesh-list
65363599|NCT03988075|Hydrocodone|hydrocodone|mesh-list
65363600|NCT03988075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65363601|NCT03988075|Analgesics|analgesics|mesh-ancestor
65363602|NCT03988075|Sensory System Agents|sensory system agents|mesh-ancestor
65363603|NCT03988075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65363604|NCT03988075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363605|NCT03988075|Antipyretics|antipyretics|mesh-ancestor
65363606|NCT03988075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65363607|NCT03988075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65363608|NCT03988075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65363609|NCT03988075|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65363610|NCT03988075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363611|NCT03988075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363612|NCT03988075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65363613|NCT03988075|Narcotics|narcotics|mesh-ancestor
65363614|NCT03988075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65363615|NCT03988075|Antitussive Agents|antitussive agents|mesh-ancestor
65363616|NCT03988075|Respiratory System Agents|respiratory system agents|mesh-ancestor
65363617|NCT00944853|Zinc|zinc|mesh-list
65363618|NCT00944853|Trace Elements|trace elements|mesh-ancestor
65363619|NCT00944853|Micronutrients|micronutrients|mesh-ancestor
65363620|NCT00944853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363629|NCT00350779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65363630|NCT00350779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363631|NCT00350779|Incretins|incretins|mesh-ancestor
65363632|NCT00350779|Hormones|hormones|mesh-ancestor
65363633|NCT00350779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65363634|NCT00350779|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65363635|NCT00350779|Protease Inhibitors|protease inhibitors|mesh-ancestor
65363636|NCT00350779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363637|NCT00350779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363638|NCT00656136|Afatinib|afatinib|mesh-list
65363639|NCT00656136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363640|NCT00656136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65363641|NCT00656136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363642|NCT00656136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363643|NCT00676520|Everolimus|everolimus|mesh-list
65363644|NCT00676520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363645|NCT00676520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65363646|NCT00676520|Immunologic Factors|immunologic factors|mesh-ancestor
65363647|NCT00676520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363648|NCT02559908|Hyaluronic Acid|hyaluronic acid|mesh-list
65363649|NCT02559908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65363650|NCT02559908|Immunologic Factors|immunologic factors|mesh-ancestor
65363651|NCT02559908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363652|NCT02559908|Viscosupplements|viscosupplements|mesh-ancestor
65363653|NCT02559908|Protective Agents|protective agents|mesh-ancestor
65363654|NCT00322621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65363655|NCT00322621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65363656|NCT00322621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65363657|NCT00322621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65363658|NCT00322621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363659|NCT00322621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65363670|NCT00809718|Raltegravir Potassium|raltegravir potassium|mesh-list
65363671|NCT00809718|Rifapentine|rifapentine|mesh-list
65363672|NCT00809718|Rifampin|rifampin|mesh-list
65363673|NCT00809718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65363674|NCT00809718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65363675|NCT00809718|Antiviral Agents|antiviral agents|mesh-ancestor
65363676|NCT00809718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65363677|NCT00809718|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65363678|NCT00809718|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65363679|NCT00809718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363680|NCT00809718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363681|NCT00809718|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65363682|NCT00809718|Antitubercular Agents|antitubercular agents|mesh-ancestor
65363683|NCT00809718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65363684|NCT00809718|Leprostatic Agents|leprostatic agents|mesh-ancestor
65363685|NCT00809718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65363686|NCT00809718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65363687|NCT00809718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65363688|NCT00809718|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65363689|NCT00809718|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65363690|NCT00809718|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65363691|NCT00809718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65363692|NCT05427266|Bupivacaine|bupivacaine|mesh-list
65363693|NCT05427266|Anesthetics, Local|anesthetics, local|mesh-ancestor
65363694|NCT05427266|Anesthetics|anesthetics|mesh-ancestor
65363695|NCT05427266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65363696|NCT05427266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363697|NCT05427266|Sensory System Agents|sensory system agents|mesh-ancestor
65363698|NCT05427266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65363699|NCT00575042|Fenofibrate|fenofibrate|mesh-list
65363700|NCT00575042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65363711|NCT00656058|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65363712|NCT00656058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65363713|NCT00656058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363714|NCT00537316|Azathioprine|azathioprine|mesh-list
65363715|NCT00537316|Infliximab|infliximab|mesh-list
65363716|NCT00537316|Dermatologic Agents|dermatologic agents|mesh-ancestor
65363717|NCT00537316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65363718|NCT00537316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65363719|NCT00537316|Antimetabolites|antimetabolites|mesh-ancestor
65363720|NCT00537316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363721|NCT00537316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65363722|NCT00537316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363723|NCT00537316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65363724|NCT00537316|Immunologic Factors|immunologic factors|mesh-ancestor
65363725|NCT00537316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363726|NCT00803868|Varenicline|varenicline|mesh-list
65363727|NCT00803868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65363728|NCT00803868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65363729|NCT00803868|Cholinergic Agents|cholinergic agents|mesh-ancestor
65363730|NCT00803868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65363731|NCT00803868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363732|NCT00803868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363733|NCT00655980|Folic Acid|folic acid|mesh-list
65363734|NCT00655980|Vitamin B 12|vitamin b 12|mesh-list
65363735|NCT00655980|Hydroxocobalamin|hydroxocobalamin|mesh-list
65363736|NCT00655980|Nitrous Oxide|nitrous oxide|mesh-list
65363737|NCT00655980|Vitamins|vitamins|mesh-ancestor
65113573|NCT00446069|Morphine|morphine|mesh-list
65363738|NCT00655980|Micronutrients|micronutrients|mesh-ancestor
65363739|NCT00655980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363740|NCT00655980|Hematinics|hematinics|mesh-ancestor
65363741|NCT00655980|Vitamin B Complex|vitamin b complex|mesh-ancestor
65363754|NCT01063621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65363755|NCT01063621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65363756|NCT01063621|Dopamine Agonists|dopamine agonists|mesh-ancestor
65363757|NCT01063621|Dopamine Agents|dopamine agents|mesh-ancestor
65363758|NCT01063621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65363759|NCT01063621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363760|NCT02533141|Simvastatin|simvastatin|mesh-list
65363761|NCT02533141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65363762|NCT02533141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65363763|NCT02533141|Antimetabolites|antimetabolites|mesh-ancestor
65363764|NCT02533141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363765|NCT02533141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65363766|NCT02533141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65363767|NCT02533141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363768|NCT00809796|Pentamidine|pentamidine|mesh-list
65363769|NCT00809796|Antifungal Agents|antifungal agents|mesh-ancestor
65363770|NCT00809796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65363771|NCT00809796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65363772|NCT00809796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65363773|NCT00809796|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65363774|NCT05589454|Calcium, Dietary|calcium, dietary|mesh-list
65363775|NCT05589454|Atorvastatin|atorvastatin|mesh-list
65363776|NCT05589454|Calcium|calcium|mesh-list
65363777|NCT05589454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65363778|NCT05589454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363779|NCT05589454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65363780|NCT05589454|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65363781|NCT05589454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65363782|NCT05589454|Antimetabolites|antimetabolites|mesh-ancestor
65363783|NCT05589454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363784|NCT05589454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65363785|NCT05589454|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65363786|NCT05589454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363787|NCT00803946|Ibuprofen|ibuprofen|mesh-list
65363788|NCT00803946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65363789|NCT00803946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64493887|NCT00637377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64493888|NCT00637377|Growth Substances|growth substances|mesh-ancestor
65363790|NCT00803946|Analgesics|analgesics|mesh-ancestor
65363791|NCT00803946|Sensory System Agents|sensory system agents|mesh-ancestor
65363792|NCT00803946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65363793|NCT00803946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363794|NCT00803946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65363795|NCT00803946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65363796|NCT00803946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65363797|NCT00803946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363798|NCT00803946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363799|NCT00676130|Trimethoprim|trimethoprim|mesh-list
65363800|NCT00676130|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65363801|NCT00676130|Sulfamethoxazole|sulfamethoxazole|mesh-list
65363802|NCT00676130|Cephalexin|cephalexin|mesh-list
65363803|NCT00676130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65363804|NCT00676130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65363805|NCT00676130|Renal Agents|renal agents|mesh-ancestor
65363806|NCT00676130|Antimalarials|antimalarials|mesh-ancestor
65363807|NCT00676130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65363808|NCT00676130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65363809|NCT00676130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65363810|NCT00676130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363811|NCT00676130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363812|NCT00676130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65363813|NCT00676130|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65363814|NCT00676130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65363815|NCT00676130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65363816|NCT00809874|Caseins|caseins|mesh-list
65363826|NCT02560376|Exenatide|exenatide|mesh-list
65363836|NCT00535288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65363837|NCT00535288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65363838|NCT00535288|Histamine Antagonists|histamine antagonists|mesh-ancestor
65363839|NCT00535288|Histamine Agents|histamine agents|mesh-ancestor
65363840|NCT00535288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65363841|NCT00535288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363842|NCT00535288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65363843|NCT00535288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65363844|NCT00535288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65363845|NCT00535288|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65363846|NCT00535288|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65363847|NCT00535288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65363848|NCT00535288|Adrenergic Agents|adrenergic agents|mesh-ancestor
65363849|NCT00535288|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65363850|NCT00535288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65363851|NCT00535288|Serotonin Agents|serotonin agents|mesh-ancestor
65363852|NCT00535288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65363853|NCT00921830|Ibuprofen|ibuprofen|mesh-list
65363854|NCT00921830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65363855|NCT00921830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65363856|NCT00921830|Analgesics|analgesics|mesh-ancestor
65363857|NCT00921830|Sensory System Agents|sensory system agents|mesh-ancestor
65363858|NCT00921830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65363859|NCT00921830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363860|NCT00921830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65363884|NCT02783300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363885|NCT02783300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066814|NCT00272636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65363886|NCT00675506|Hormones|hormones|mesh-list
65363887|NCT00675506|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
65363888|NCT00675506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65363889|NCT00675506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363890|NCT05435378|Vitamins|vitamins|mesh-list
65363891|NCT05435378|Folic Acid|folic acid|mesh-list
65363892|NCT05435378|Niacinamide|niacinamide|mesh-list
65363893|NCT05435378|Vitamin B Complex|vitamin b complex|mesh-list
65363894|NCT05435378|Micronutrients|micronutrients|mesh-ancestor
65363895|NCT05435378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363896|NCT05435378|Hematinics|hematinics|mesh-ancestor
65363897|NCT05589220|Nicotine|nicotine|mesh-list
65363898|NCT05589220|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65363899|NCT05589220|Autonomic Agents|autonomic agents|mesh-ancestor
65363900|NCT05589220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65363901|NCT05589220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363902|NCT05589220|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65363903|NCT05589220|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65363904|NCT05589220|Cholinergic Agents|cholinergic agents|mesh-ancestor
65363905|NCT05589220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65363906|NCT05589220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363907|NCT03895840|Triamcinolone|triamcinolone|mesh-list
65363933|NCT00309907|Antiemetics|antiemetics|mesh-ancestor
65363934|NCT00309907|Autonomic Agents|autonomic agents|mesh-ancestor
65363935|NCT00309907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65363936|NCT00309907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363937|NCT00309907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65363938|NCT00309907|Glucocorticoids|glucocorticoids|mesh-ancestor
65363939|NCT00309907|Hormones|hormones|mesh-ancestor
65363940|NCT00309907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65363941|NCT00309907|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65363942|NCT00309907|Protective Agents|protective agents|mesh-ancestor
65363943|NCT00309907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65363944|NCT00309907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363945|NCT00309907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65363946|NCT00309907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65363947|NCT00309907|Analgesics|analgesics|mesh-ancestor
65363948|NCT00309907|Sensory System Agents|sensory system agents|mesh-ancestor
65363949|NCT00309907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65363950|NCT00309907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65363951|NCT00309907|Immunologic Factors|immunologic factors|mesh-ancestor
65363952|NCT00655824|Ofatumumab|ofatumumab|mesh-list
65363953|NCT00655824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65363954|NCT03985969|Indomethacin|indomethacin|mesh-list
65363955|NCT03985969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65363956|NCT03985969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65363957|NCT03985969|Analgesics|analgesics|mesh-ancestor
65363958|NCT03985969|Sensory System Agents|sensory system agents|mesh-ancestor
65363959|NCT03985969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65363960|NCT03985969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363961|NCT03985969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65363963|NCT03985969|Gout Suppressants|gout suppressants|mesh-ancestor
65363964|NCT03985969|Tocolytic Agents|tocolytic agents|mesh-ancestor
65363978|NCT00575588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65363979|NCT00575588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363980|NCT00575588|Incretins|incretins|mesh-ancestor
65363981|NCT00575588|Hormones|hormones|mesh-ancestor
65363982|NCT00575588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65363983|NCT00575588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65363984|NCT00575588|Protease Inhibitors|protease inhibitors|mesh-ancestor
65363985|NCT00575588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65363986|NCT00575588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363987|NCT01058317|Propranolol|propranolol|mesh-list
65363988|NCT01058317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65363989|NCT01058317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65363990|NCT01058317|Adrenergic Agents|adrenergic agents|mesh-ancestor
65363991|NCT01058317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65363992|NCT01058317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65363993|NCT01058317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65363994|NCT01058317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65363996|NCT01058317|Vasodilator Agents|vasodilator agents|mesh-ancestor
65364034|NCT00758732|Tubulin Modulators|tubulin modulators|mesh-ancestor
65364035|NCT00758732|Antimitotic Agents|antimitotic agents|mesh-ancestor
65364036|NCT00758732|Mitosis Modulators|mitosis modulators|mesh-ancestor
65364037|NCT00758732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364038|NCT00758732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65364039|NCT00758732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65364040|NCT00758732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65364041|NCT00758732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364042|NCT02559674|Gemcitabine|gemcitabine|mesh-list
65364044|NCT02559674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65364045|NCT02559674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364046|NCT02559674|Tubulin Modulators|tubulin modulators|mesh-ancestor
65364047|NCT02559674|Antimitotic Agents|antimitotic agents|mesh-ancestor
65364048|NCT02559674|Mitosis Modulators|mitosis modulators|mesh-ancestor
65364049|NCT02559674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364050|NCT02559674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65364051|NCT02559674|Antimetabolites|antimetabolites|mesh-ancestor
65364052|NCT02559674|Antiviral Agents|antiviral agents|mesh-ancestor
65364053|NCT02559674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65364054|NCT02559674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364055|NCT02559674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65364056|NCT02559674|Immunologic Factors|immunologic factors|mesh-ancestor
65364057|NCT02559674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364058|NCT00761540|Liraglutide|liraglutide|mesh-list
65364059|NCT00761540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65364060|NCT00761540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364061|NCT00761540|Incretins|incretins|mesh-ancestor
65364062|NCT00761540|Hormones|hormones|mesh-ancestor
65364063|NCT00761540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65364064|NCT00759122|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65364077|NCT00759200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364078|NCT00759200|Antiviral Agents|antiviral agents|mesh-ancestor
65364079|NCT00759200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65364080|NCT00759200|Immunologic Factors|immunologic factors|mesh-ancestor
65364081|NCT00759200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364082|NCT02558816|Obinutuzumab|obinutuzumab|mesh-list
65364083|NCT02558816|Venetoclax|venetoclax|mesh-list
65364084|NCT02558816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65364085|NCT02558816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364086|NCT01299753|Propranolol|propranolol|mesh-list
65364087|NCT01299753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65364088|NCT01299753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65364089|NCT01299753|Adrenergic Agents|adrenergic agents|mesh-ancestor
65364090|NCT01299753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65364091|NCT01299753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364092|NCT01299753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364093|NCT01299753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65364094|NCT01299753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65364095|NCT01299753|Vasodilator Agents|vasodilator agents|mesh-ancestor
65364096|NCT02559440|Mometasone Furoate|mometasone furoate|mesh-list
65364097|NCT02559440|Phenylephrine|phenylephrine|mesh-list
65364098|NCT02559440|Oxymetazoline|oxymetazoline|mesh-list
65364099|NCT02559440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65364100|NCT02559440|Dermatologic Agents|dermatologic agents|mesh-ancestor
65364101|NCT02559440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65364102|NCT02559440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65364103|NCT02559440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65364104|NCT02559440|Adrenergic Agents|adrenergic agents|mesh-ancestor
65364105|NCT02559440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65364106|NCT02559440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364107|NCT02559440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364108|NCT02559440|Sympathomimetics|sympathomimetics|mesh-ancestor
65364109|NCT02559440|Autonomic Agents|autonomic agents|mesh-ancestor
65364115|NCT02559440|Mydriatics|mydriatics|mesh-ancestor
65364119|NCT00674570|Hydrocortisone|hydrocortisone|mesh-list
65364120|NCT00674570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65364121|NCT00674570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65364122|NCT00674570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65364123|NCT00674570|Renal Agents|renal agents|mesh-ancestor
65364124|NCT00674570|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65364125|NCT00674570|Antitubercular Agents|antitubercular agents|mesh-ancestor
65364126|NCT00674570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65364127|NCT00674570|Antimetabolites|antimetabolites|mesh-ancestor
65364128|NCT00674570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364129|NCT00940563|Imatinib Mesylate|imatinib mesylate|mesh-list
65364130|NCT00940563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364131|NCT00940563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65364132|NCT00940563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364133|NCT00940563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364134|NCT00761852|Ruboxistaurin|ruboxistaurin|mesh-list
65364135|NCT00761852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364136|NCT00761852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364137|NCT00940719|Vitamin D|vitamin d|mesh-list
65364138|NCT00940719|Cholecalciferol|cholecalciferol|mesh-list
65364139|NCT00940719|Vitamins|vitamins|mesh-ancestor
65364140|NCT00940719|Micronutrients|micronutrients|mesh-ancestor
65364141|NCT00940719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364142|NCT00940719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65364143|NCT00940719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65364144|NCT00940953|Azelastine|azelastine|mesh-list
65364145|NCT00940953|Budesonide|budesonide|mesh-list
65364146|NCT00940953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65364147|NCT00940953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65364148|NCT00940953|Autonomic Agents|autonomic agents|mesh-ancestor
65364163|NCT00940953|Histamine Agents|histamine agents|mesh-ancestor
65364164|NCT00940953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65364165|NCT00759824|Cyclophosphamide|cyclophosphamide|mesh-list
65364166|NCT00759824|Doxorubicin|doxorubicin|mesh-list
65364167|NCT00759824|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65364168|NCT00759824|Vindesine|vindesine|mesh-list
65364169|NCT00759824|Valproic Acid|valproic acid|mesh-list
65364170|NCT00759824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65364171|NCT00759824|Immunologic Factors|immunologic factors|mesh-ancestor
65364172|NCT00759824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364173|NCT00759824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65364174|NCT00759824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65364175|NCT00759824|Alkylating Agents|alkylating agents|mesh-ancestor
65364176|NCT00759824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364177|NCT00759824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364178|NCT00759824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65364179|NCT00759824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65364180|NCT00759824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65364181|NCT00759824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65364182|NCT00759824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364183|NCT00759824|Anticonvulsants|anticonvulsants|mesh-ancestor
65364184|NCT00759824|GABA Agents|gaba agents|mesh-ancestor
65114039|NCT00448643|Cisplatin|cisplatin|mesh-list
65364215|NCT00762632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364216|NCT00322387|Plerixafor|plerixafor|mesh-list
65364217|NCT00322387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65364218|NCT00322387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65364219|NCT00322387|Antiviral Agents|antiviral agents|mesh-ancestor
65364220|NCT00322387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65364221|NCT00561015|Ribavirin|ribavirin|mesh-list
65364222|NCT00561015|Interferon alpha-2|interferon alpha-2|mesh-list
65364223|NCT00561015|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65364224|NCT00561015|Antimetabolites|antimetabolites|mesh-ancestor
65364225|NCT00561015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364226|NCT00561015|Antiviral Agents|antiviral agents|mesh-ancestor
65364227|NCT00561015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65364228|NCT00561015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364229|NCT04012047|Cromakalim|cromakalim|mesh-list
65364230|NCT04012047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65364231|NCT04012047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65364232|NCT04012047|Autonomic Agents|autonomic agents|mesh-ancestor
65364233|NCT04012047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65364234|NCT04012047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364235|NCT04012047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65364236|NCT04012047|Respiratory System Agents|respiratory system agents|mesh-ancestor
65364237|NCT04012047|Parasympatholytics|parasympatholytics|mesh-ancestor
65364238|NCT04012047|Vasodilator Agents|vasodilator agents|mesh-ancestor
65364239|NCT00941265|Levodopa|levodopa|mesh-list
65364240|NCT00941265|Benserazide|benserazide|mesh-list
65364241|NCT00941265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65364242|NCT00941265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65364243|NCT00941265|Dopamine Agents|dopamine agents|mesh-ancestor
65364244|NCT00941265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65364245|NCT00941265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364246|NCT00941265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364248|NCT00941343|Alfuzosin|alfuzosin|mesh-list
65364259|NCT00561795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65114110|NCT05468359|Sorafenib|sorafenib|mesh-list
65364260|NCT00561795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364261|NCT00561795|Tubulin Modulators|tubulin modulators|mesh-ancestor
65364262|NCT00561795|Antimitotic Agents|antimitotic agents|mesh-ancestor
65364263|NCT00561795|Mitosis Modulators|mitosis modulators|mesh-ancestor
65364264|NCT00561795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364265|NCT00652626|Azacitidine|azacitidine|mesh-list
65364266|NCT00652626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65364267|NCT00652626|Antimetabolites|antimetabolites|mesh-ancestor
65364268|NCT00652626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364269|NCT00652626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364270|NCT00652626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364271|NCT00560703|Doxycycline|doxycycline|mesh-list
65364272|NCT00560703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65364273|NCT00560703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65364274|NCT00560703|Antimalarials|antimalarials|mesh-ancestor
65364275|NCT00560703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65364276|NCT00560703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65364277|NCT00308737|Insulin|insulin|mesh-list
65364278|NCT00308737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65364279|NCT00308737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364280|NCT04711902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65364281|NCT04711902|Immunologic Factors|immunologic factors|mesh-ancestor
65364282|NCT04711902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364283|NCT00941499|Leucovorin|leucovorin|mesh-list
65364284|NCT00941499|Bevacizumab|bevacizumab|mesh-list
65364285|NCT00941499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65364286|NCT00941499|Cetuximab|cetuximab|mesh-list
65364287|NCT00941499|Fluorouracil|fluorouracil|mesh-list
65364288|NCT00941499|Oxaliplatin|oxaliplatin|mesh-list
65364289|NCT00941499|Antibodies|antibodies|mesh-list
65364303|NCT00941499|Antidotes|antidotes|mesh-ancestor
65364304|NCT00941499|Protective Agents|protective agents|mesh-ancestor
65364305|NCT00941499|Vitamin B Complex|vitamin b complex|mesh-ancestor
65364306|NCT00941499|Vitamins|vitamins|mesh-ancestor
65364307|NCT00941499|Micronutrients|micronutrients|mesh-ancestor
65364308|NCT04752384|Buprenorphine|buprenorphine|mesh-list
65364309|NCT04752384|Tramadol|tramadol|mesh-list
65364310|NCT04752384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65364311|NCT04752384|Narcotics|narcotics|mesh-ancestor
65364312|NCT04752384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65364313|NCT04752384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364314|NCT04752384|Analgesics|analgesics|mesh-ancestor
65364315|NCT04752384|Sensory System Agents|sensory system agents|mesh-ancestor
65364316|NCT04752384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65364317|NCT04752384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65364318|NCT04743804|Ravulizumab|ravulizumab|mesh-list
65364319|NCT04743804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65364320|NCT04743804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65364321|NCT04743804|Immunologic Factors|immunologic factors|mesh-ancestor
65364322|NCT04743804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364323|NCT00945789|Nitric Oxide|nitric oxide|mesh-list
65364324|NCT00945789|Epoetin Alfa|epoetin alfa|mesh-list
65364325|NCT00945789|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65364326|NCT00945789|Autonomic Agents|autonomic agents|mesh-ancestor
65364327|NCT00945789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65364328|NCT00945789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364354|NCT02553018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364355|NCT02553018|Dermatologic Agents|dermatologic agents|mesh-ancestor
65364356|NCT02553018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364357|NCT02553018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65364358|NCT02553018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65364359|NCT02553018|Immunologic Factors|immunologic factors|mesh-ancestor
65364360|NCT02553018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65364361|NCT02553018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65364362|NCT00941967|Gemcitabine|gemcitabine|mesh-list
65364363|NCT00941967|Oxaliplatin|oxaliplatin|mesh-list
65364364|NCT00941967|Sorafenib|sorafenib|mesh-list
65364365|NCT00941967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65364366|NCT00941967|Antimetabolites|antimetabolites|mesh-ancestor
65364367|NCT00941967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364368|NCT00941967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364369|NCT00941967|Antiviral Agents|antiviral agents|mesh-ancestor
65364370|NCT00941967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65364371|NCT00941967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364412|NCT00950391|Tacrolimus|tacrolimus|mesh-list
65364413|NCT00950391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65364414|NCT00950391|Immunologic Factors|immunologic factors|mesh-ancestor
65364415|NCT00950391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364416|NCT00950391|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65364417|NCT00950391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364418|NCT00950391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364419|NCT00804336|Everolimus|everolimus|mesh-list
65364420|NCT00804336|Pasireotide|pasireotide|mesh-list
65364421|NCT00804336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364422|NCT00804336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65364423|NCT00804336|Immunologic Factors|immunologic factors|mesh-ancestor
65364424|NCT00804336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364425|NCT00804336|Hormones|hormones|mesh-ancestor
65364426|NCT00804336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65364427|NCT00942201|Dexamethasone|dexamethasone|mesh-list
65364428|NCT00942201|Dexamethasone acetate|dexamethasone acetate|mesh-list
65364429|NCT00942201|BB 1101|bb 1101|mesh-list
65364430|NCT00942201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65364431|NCT00942201|Antiemetics|antiemetics|mesh-ancestor
65364432|NCT00942201|Autonomic Agents|autonomic agents|mesh-ancestor
65364433|NCT00942201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65364434|NCT00942201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364435|NCT00942201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65364436|NCT00942201|Glucocorticoids|glucocorticoids|mesh-ancestor
65364437|NCT00942201|Hormones|hormones|mesh-ancestor
65364438|NCT00942201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65364439|NCT00942201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65364440|NCT00942201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364441|NCT00942201|Protease Inhibitors|protease inhibitors|mesh-ancestor
65364444|NCT00942435|Darexaban|darexaban|mesh-list
65364457|NCT00950625|Anesthetics|anesthetics|mesh-ancestor
65364458|NCT00950625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65364459|NCT00950625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364460|NCT00950625|Sensory System Agents|sensory system agents|mesh-ancestor
65364461|NCT00950625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65364462|NCT00950625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65364463|NCT00950625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65364464|NCT00950625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65364465|NCT00950625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65364466|NCT00950625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364467|NCT00942591|Interferons|interferons|mesh-list
65364468|NCT00942591|Interferon-beta|interferon-beta|mesh-list
65364469|NCT00942591|Atorvastatin|atorvastatin|mesh-list
65364470|NCT00942591|Interferon beta-1b|interferon beta-1b|mesh-list
65364471|NCT00942591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364472|NCT00942591|Antiviral Agents|antiviral agents|mesh-ancestor
65364473|NCT00942591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65364474|NCT00942591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65364475|NCT00942591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65364476|NCT00942591|Antimetabolites|antimetabolites|mesh-ancestor
65364477|NCT00942591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364478|NCT00942591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65364479|NCT00942591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65364480|NCT00942591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364481|NCT00942591|Immunologic Factors|immunologic factors|mesh-ancestor
65364482|NCT00942591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364483|NCT00942591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65364484|NCT00946335|Temozolomide|temozolomide|mesh-list
65364485|NCT00946335|Veliparib|veliparib|mesh-list
65364486|NCT00946335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65364487|NCT00946335|Alkylating Agents|alkylating agents|mesh-ancestor
65364495|NCT00762944|Cimetidine|cimetidine|mesh-list
65364498|NCT00762944|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65364499|NCT00762944|Histamine Antagonists|histamine antagonists|mesh-ancestor
65364500|NCT00762944|Histamine Agents|histamine agents|mesh-ancestor
65364501|NCT00762944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65364502|NCT00762944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364503|NCT00762944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364504|NCT00762944|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65364505|NCT00762944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65364506|NCT00762944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364507|NCT00760448|Insulin|insulin|mesh-list
65364508|NCT00760448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65364509|NCT00760448|Insulin Detemir|insulin detemir|mesh-list
65364510|NCT00760448|Isophane Insulin, Human|isophane insulin, human|mesh-list
65364511|NCT00760448|Insulin, Isophane|insulin, isophane|mesh-list
65364512|NCT00760448|Isophane insulin, beef|isophane insulin, beef|mesh-list
65364513|NCT00760448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65364514|NCT00760448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364515|NCT00763178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65364516|NCT00763178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65364517|NCT00763178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65364518|NCT00763178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65364519|NCT00763178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364520|NCT00763178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65364521|NCT00763178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364522|NCT00763178|Analgesics|analgesics|mesh-ancestor
65364523|NCT00763178|Sensory System Agents|sensory system agents|mesh-ancestor
65364525|NCT00763178|Antidepressive Agents|antidepressive agents|mesh-ancestor
65364544|NCT00658320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364545|NCT00658320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364546|NCT00658320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65364547|NCT00658320|Immunologic Factors|immunologic factors|mesh-ancestor
65364548|NCT00658320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364549|NCT00658320|Antifungal Agents|antifungal agents|mesh-ancestor
65364550|NCT00658320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65364551|NCT00658320|Dermatologic Agents|dermatologic agents|mesh-ancestor
65364552|NCT00658320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65364553|NCT00658320|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65364554|NCT00658320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364555|NCT00658320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65364556|NCT00658320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65364557|NCT00658320|Antitubercular Agents|antitubercular agents|mesh-ancestor
65364558|NCT00658320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65364559|NCT02558270|Dapagliflozin|dapagliflozin|mesh-list
65364560|NCT02558270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65364561|NCT02558270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364562|NCT02558270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65364563|NCT02558270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364564|NCT00763568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65364565|NCT00763568|Nitazoxanide|nitazoxanide|mesh-list
65364566|NCT00763568|Antiviral Agents|antiviral agents|mesh-ancestor
65364567|NCT00763568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65364568|NCT00763568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65364569|NCT00806754|Ciclesonide|ciclesonide|mesh-list
65364570|NCT00806754|Azelastine|azelastine|mesh-list
65364571|NCT00806754|Glucocorticoids|glucocorticoids|mesh-ancestor
65364572|NCT00806754|Hormones|hormones|mesh-ancestor
65364573|NCT00806754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65364574|NCT00806754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364575|NCT00806754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65364576|NCT00806754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65364577|NCT00806754|Autonomic Agents|autonomic agents|mesh-ancestor
65364583|NCT00806754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364584|NCT00806754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65364585|NCT00806754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65364586|NCT00806754|Histamine Antagonists|histamine antagonists|mesh-ancestor
65364587|NCT00806754|Histamine Agents|histamine agents|mesh-ancestor
65364588|NCT00806754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65364589|NCT00764816|Caseins|caseins|mesh-list
65364590|NCT00764816|Chelating Agents|chelating agents|mesh-ancestor
65364591|NCT00764816|Sequestering Agents|sequestering agents|mesh-ancestor
65364592|NCT00764816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364593|NCT00322153|Memantine|memantine|mesh-list
65364594|NCT00322153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65364595|NCT00322153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65364596|NCT00322153|Dopamine Agents|dopamine agents|mesh-ancestor
65364597|NCT00322153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65364598|NCT00322153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364599|NCT00322153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364600|NCT00322153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65364601|NCT00322153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65364602|NCT00806910|Conivaptan|conivaptan|mesh-list
65364603|NCT00806910|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65364604|NCT00806910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364605|NCT00806910|Natriuretic Agents|natriuretic agents|mesh-ancestor
65364630|NCT00807222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65364631|NCT00807222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364632|NCT00807222|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65364700|NCT00763646|Tubulin Modulators|tubulin modulators|mesh-ancestor
65364701|NCT00763646|Antimitotic Agents|antimitotic agents|mesh-ancestor
65364702|NCT00763646|Mitosis Modulators|mitosis modulators|mesh-ancestor
65364703|NCT00763646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364704|NCT00763880|Lidocaine|lidocaine|mesh-list
65364705|NCT00763880|Anesthetics, Local|anesthetics, local|mesh-ancestor
65364706|NCT00763880|Anesthetics|anesthetics|mesh-ancestor
65364707|NCT00763880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65364708|NCT00763880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364709|NCT00763880|Sensory System Agents|sensory system agents|mesh-ancestor
65364710|NCT00763880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65364711|NCT00763880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65364712|NCT00763880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65364713|NCT00763880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65364714|NCT00763880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65364715|NCT00763880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364716|NCT00657150|Enoxaparin|enoxaparin|mesh-list
65364717|NCT00657150|Dabigatran|dabigatran|mesh-list
65364718|NCT00657150|Anticoagulants|anticoagulants|mesh-ancestor
65364719|NCT00657150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65364720|NCT00657150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65364721|NCT00657150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364722|NCT00657150|Antithrombins|antithrombins|mesh-ancestor
65364723|NCT00657150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65364724|NCT00657150|Protease Inhibitors|protease inhibitors|mesh-ancestor
65364725|NCT00657150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364726|NCT00770354|Letrozole|letrozole|mesh-list
65364727|NCT00770354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364728|NCT00770354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65364729|NCT00770354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65364736|NCT00670748|Aldesleukin|aldesleukin|mesh-list
65364743|NCT00670748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65364744|NCT00670748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65364745|NCT00670748|Alkylating Agents|alkylating agents|mesh-ancestor
65364746|NCT00670748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364747|NCT00670748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364748|NCT00670748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65364749|NCT00670748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65364750|NCT00670748|Antimetabolites|antimetabolites|mesh-ancestor
65364751|NCT00670748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65364752|NCT00670748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65364753|NCT00670748|Antiviral Agents|antiviral agents|mesh-ancestor
65364754|NCT00670748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65364755|NCT00646776|Ritonavir|ritonavir|mesh-list
65364756|NCT00646776|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65364757|NCT00646776|Rifabutin|rifabutin|mesh-list
65364758|NCT00646776|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65364759|NCT00646776|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65364760|NCT00646776|Protease Inhibitors|protease inhibitors|mesh-ancestor
65364761|NCT00646776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364763|NCT00646776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65364797|NCT00770666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364798|NCT00764036|Artesunate|artesunate|mesh-list
65364799|NCT00764036|Antimalarials|antimalarials|mesh-ancestor
65364800|NCT00764036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65364801|NCT00764036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65364802|NCT00764036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65364803|NCT00764036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364804|NCT00764036|Antiviral Agents|antiviral agents|mesh-ancestor
65364805|NCT00764036|Schistosomicides|schistosomicides|mesh-ancestor
65364806|NCT00764036|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65364807|NCT00764036|Anthelmintics|anthelmintics|mesh-ancestor
65364808|NCT00764114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65364809|NCT00764114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65364810|NCT00811200|Triamcinolone|triamcinolone|mesh-list
65364811|NCT00811200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65364812|NCT00811200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65364813|NCT00811200|Ranibizumab|ranibizumab|mesh-list
65364814|NCT00811200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65364815|NCT00811200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65364816|NCT00811200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65364817|NCT00811200|Growth Substances|growth substances|mesh-ancestor
65364818|NCT00811200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364819|NCT00811200|Growth Inhibitors|growth inhibitors|mesh-ancestor
65364850|NCT00766064|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65364851|NCT00766064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65364852|NCT00766064|Serotonin Agents|serotonin agents|mesh-ancestor
65364853|NCT00766064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65364854|NCT00766064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364855|NCT00766064|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65364856|NCT00766064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65364857|NCT00766064|Dopamine Agents|dopamine agents|mesh-ancestor
65364858|NCT00770744|Olanzapine|olanzapine|mesh-list
65066815|NCT00272636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364859|NCT00770744|Antiemetics|antiemetics|mesh-ancestor
65364860|NCT00770744|Autonomic Agents|autonomic agents|mesh-ancestor
65364861|NCT00770744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65364862|NCT00770744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364863|NCT00770744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65364864|NCT00770744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65364865|NCT00770744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65364866|NCT00770744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65364867|NCT00770744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65364868|NCT00770744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65364869|NCT00770744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65364870|NCT00770744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65364871|NCT00770744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364898|NCT00766220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65364899|NCT00766220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65364900|NCT00770978|Ceftobiprole|ceftobiprole|mesh-list
65364901|NCT00770978|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
65364902|NCT00770978|Cephalosporins|cephalosporins|mesh-list
65364903|NCT00770978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65364904|NCT00770978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65364905|NCT00764426|Ethanol|ethanol|mesh-list
65364906|NCT00764426|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65364907|NCT00764426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65364908|NCT00764426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65364909|NCT00764426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364910|NCT02558036|Pyrithione zinc|pyrithione zinc|mesh-list
65364911|NCT02558036|Keratolytic Agents|keratolytic agents|mesh-ancestor
65364912|NCT02558036|Dermatologic Agents|dermatologic agents|mesh-ancestor
65364959|NCT04048070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65364960|NCT04048070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364961|NCT04048070|Analgesics|analgesics|mesh-ancestor
65364962|NCT04048070|Sensory System Agents|sensory system agents|mesh-ancestor
65364963|NCT04048070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65364964|NCT04048070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65364965|NCT04048070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65364966|NCT04048070|Anesthetics, General|anesthetics, general|mesh-ancestor
65364967|NCT04048070|Anesthetics|anesthetics|mesh-ancestor
65364968|NCT04048070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65364969|NCT04048070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65364970|NCT04048070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65364971|NCT04048070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65364972|NCT04048070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65364973|NCT04048070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364974|NCT04048070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364975|NCT00571064|Donepezil|donepezil|mesh-list
65364976|NCT00571064|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65364977|NCT00571064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65364978|NCT00571064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65364979|NCT00571064|Cholinergic Agents|cholinergic agents|mesh-ancestor
65364980|NCT00571064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65364981|NCT00571064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65364982|NCT00571064|Nootropic Agents|nootropic agents|mesh-ancestor
65364983|NCT00811980|Vancomycin|vancomycin|mesh-list
65364984|NCT00811980|Linezolid|linezolid|mesh-list
65364985|NCT00811980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65365005|NCT00813774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65365006|NCT00813774|Immunologic Factors|immunologic factors|mesh-ancestor
65114842|NCT02927522|Donepezil|donepezil|mesh-list
65365007|NCT00813774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365008|NCT00813774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65365010|NCT02557490|Raltitrexed|raltitrexed|mesh-list
65365011|NCT02557490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365012|NCT02557490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65365013|NCT02557490|Antimetabolites|antimetabolites|mesh-ancestor
65365014|NCT02557490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365015|NCT02557490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65365016|NCT02557490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365017|NCT02551848|Botulinum Toxins|botulinum toxins|mesh-list
65365018|NCT02551848|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65365019|NCT02551848|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65365020|NCT02551848|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65365021|NCT02551848|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65365022|NCT02551848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65365023|NCT02551848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365024|NCT02551848|Cholinergic Agents|cholinergic agents|mesh-ancestor
65365025|NCT02551848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65365026|NCT02551848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365027|NCT02551848|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65365028|NCT02551848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65365029|NCT00807534|Bromides|bromides|mesh-list
65365030|NCT00807534|Ipratropium|ipratropium|mesh-list
65365031|NCT00807534|Anticonvulsants|anticonvulsants|mesh-ancestor
65365032|NCT00807534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65365033|NCT00807534|Autonomic Agents|autonomic agents|mesh-ancestor
65365034|NCT00807534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65365042|NCT05589064|Vitamin D|vitamin d|mesh-list
65365049|NCT00807690|Tacrolimus|tacrolimus|mesh-list
65365050|NCT00807690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65365051|NCT00807690|Immunologic Factors|immunologic factors|mesh-ancestor
65365052|NCT00807690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365053|NCT00807690|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65365054|NCT00807690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365055|NCT00807690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365056|NCT05355844|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65365057|NCT05355844|Dermatologic Agents|dermatologic agents|mesh-ancestor
65365058|NCT00814008|Insulin|insulin|mesh-list
65365059|NCT00814008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65365060|NCT00814008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365061|NCT00814086|Paclitaxel|paclitaxel|mesh-list
65365062|NCT00814086|Cisplatin|cisplatin|mesh-list
65365063|NCT00814086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65365064|NCT00814086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365065|NCT00814086|Tubulin Modulators|tubulin modulators|mesh-ancestor
65365066|NCT00814086|Antimitotic Agents|antimitotic agents|mesh-ancestor
65365067|NCT00814086|Mitosis Modulators|mitosis modulators|mesh-ancestor
65365068|NCT00814086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365069|NCT00669110|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65365070|NCT00669110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65365071|NCT00669110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65365072|NCT00669110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65365073|NCT00669110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365074|NCT00669110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65365075|NCT00669110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365076|NCT00669110|Antidepressive Agents|antidepressive agents|mesh-ancestor
65365095|NCT00654732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65365096|NCT00654732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365097|NCT00654732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365098|NCT00654732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65365099|NCT00654732|Alkylating Agents|alkylating agents|mesh-ancestor
65365100|NCT00654732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65365101|NCT00654732|Tubulin Modulators|tubulin modulators|mesh-ancestor
65365102|NCT00654732|Antimitotic Agents|antimitotic agents|mesh-ancestor
65365103|NCT00654732|Mitosis Modulators|mitosis modulators|mesh-ancestor
65365104|NCT00771368|Nitric Oxide|nitric oxide|mesh-list
65365105|NCT00771368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65365106|NCT00771368|Autonomic Agents|autonomic agents|mesh-ancestor
65365107|NCT00771368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65365108|NCT00771368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365109|NCT00771368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65365110|NCT00771368|Respiratory System Agents|respiratory system agents|mesh-ancestor
65365111|NCT00771368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65365112|NCT00771368|Antioxidants|antioxidants|mesh-ancestor
65365113|NCT00771368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365114|NCT00771368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65365115|NCT00771368|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65365116|NCT00771368|Vasodilator Agents|vasodilator agents|mesh-ancestor
65365117|NCT00771368|Gasotransmitters|gasotransmitters|mesh-ancestor
65365118|NCT00771368|Protective Agents|protective agents|mesh-ancestor
65365119|NCT00771524|Ceftobiprole|ceftobiprole|mesh-list
65365120|NCT00771524|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
65365121|NCT00771524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65365122|NCT00771524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65365123|NCT00771680|Insulin|insulin|mesh-list
65365124|NCT00771680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65365125|NCT00771680|Insulin Aspart|insulin aspart|mesh-list
65365126|NCT00771680|Insulin, Long-Acting|insulin, long-acting|mesh-list
65365127|NCT00771680|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65365128|NCT00771680|Insulin Detemir|insulin detemir|mesh-list
65365129|NCT00771680|Biphasic Insulins|biphasic insulins|mesh-list
65365130|NCT00771680|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65365131|NCT00771680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65365132|NCT00771680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365133|NCT00767468|Sorafenib|sorafenib|mesh-list
65365134|NCT00767468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365135|NCT00767468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65365136|NCT00767468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365137|NCT00767468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365138|NCT00669032|Hyaluronic Acid|hyaluronic acid|mesh-list
65365139|NCT00669032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65365140|NCT00669032|Immunologic Factors|immunologic factors|mesh-ancestor
65365141|NCT00669032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365142|NCT00669032|Viscosupplements|viscosupplements|mesh-ancestor
65365143|NCT00669032|Protective Agents|protective agents|mesh-ancestor
65365144|NCT00775580|Atenolol|atenolol|mesh-list
65365145|NCT00775580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65365146|NCT00775580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65365147|NCT00775580|Sympatholytics|sympatholytics|mesh-ancestor
65365148|NCT00775580|Autonomic Agents|autonomic agents|mesh-ancestor
65365149|NCT00775580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65365150|NCT00775580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365151|NCT00775580|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65365152|NCT00775580|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65365153|NCT00775580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65365154|NCT00775580|Adrenergic Agents|adrenergic agents|mesh-ancestor
65365155|NCT00775580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65365156|NCT00775580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365157|NCT00767546|Botulinum Toxins|botulinum toxins|mesh-list
65365158|NCT00767546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65365159|NCT00767546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65365160|NCT00767546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365161|NCT00767546|Cholinergic Agents|cholinergic agents|mesh-ancestor
65365174|NCT00670046|Valproic Acid|valproic acid|mesh-list
65365175|NCT00670046|Anticonvulsants|anticonvulsants|mesh-ancestor
65365176|NCT00670046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365177|NCT00670046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365178|NCT00670046|GABA Agents|gaba agents|mesh-ancestor
65365179|NCT00670046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65365180|NCT00670046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365181|NCT00670046|Antimanic Agents|antimanic agents|mesh-ancestor
65365182|NCT00670046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65365183|NCT00670046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65365184|NCT00670046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65365185|NCT00321919|Epoetin Alfa|epoetin alfa|mesh-list
65365186|NCT00321919|Hematinics|hematinics|mesh-ancestor
65365187|NCT00812214|Eszopiclone|eszopiclone|mesh-list
65365188|NCT00812214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65365189|NCT00812214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65365190|NCT00812214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365191|NCT00560391|Dexamethasone|dexamethasone|mesh-list
65365192|NCT00560391|Dexamethasone acetate|dexamethasone acetate|mesh-list
65365193|NCT00560391|Lenalidomide|lenalidomide|mesh-list
65365194|NCT00560391|Dasatinib|dasatinib|mesh-list
65365195|NCT00560391|BB 1101|bb 1101|mesh-list
65365196|NCT00560391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65365228|NCT04047914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65365229|NCT04047914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365230|NCT04047914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365231|NCT00537238|Pregabalin|pregabalin|mesh-list
65365232|NCT00537238|Levetiracetam|levetiracetam|mesh-list
65365234|NCT00537238|Sensory System Agents|sensory system agents|mesh-ancestor
65365235|NCT00537238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65365236|NCT00537238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365237|NCT00537238|Anticonvulsants|anticonvulsants|mesh-ancestor
65365238|NCT00537238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65365239|NCT00537238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65365240|NCT00537238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365241|NCT00537238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65365242|NCT00537238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65365243|NCT00537238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65365244|NCT00537238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65365285|NCT00946491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65365286|NCT00946491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65365287|NCT00946491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65365288|NCT00946491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65365289|NCT00946491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65365290|NCT00946491|Dopamine Agents|dopamine agents|mesh-ancestor
65365291|NCT00946491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65365292|NCT00946491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365293|NCT00946491|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65365294|NCT05355610|Gentamicins|gentamicins|mesh-list
65365295|NCT05355610|Dexamethasone|dexamethasone|mesh-list
65365296|NCT05355610|Dexamethasone acetate|dexamethasone acetate|mesh-list
65365297|NCT05355610|BB 1101|bb 1101|mesh-list
65365298|NCT05355610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65365299|NCT05355610|Antiemetics|antiemetics|mesh-ancestor
65365300|NCT05355610|Autonomic Agents|autonomic agents|mesh-ancestor
65365301|NCT05355610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65365302|NCT05355610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365303|NCT05355610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65365304|NCT05355610|Glucocorticoids|glucocorticoids|mesh-ancestor
65365305|NCT05355610|Hormones|hormones|mesh-ancestor
65365306|NCT05355610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65365307|NCT05355610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65365308|NCT05355610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365309|NCT05355610|Protease Inhibitors|protease inhibitors|mesh-ancestor
65365310|NCT05355610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365311|NCT05355610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365312|NCT05355610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65365313|NCT05355610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65365314|NCT05355610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65365316|NCT00552669|Paclitaxel|paclitaxel|mesh-list
65365317|NCT00552669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65365318|NCT00552669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365319|NCT00552669|Tubulin Modulators|tubulin modulators|mesh-ancestor
65365320|NCT00552669|Antimitotic Agents|antimitotic agents|mesh-ancestor
64757481|NCT00118404|Fluoxetine|fluoxetine|mesh-list
65365324|NCT00552669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65365325|NCT00552669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65365326|NCT00552669|Antifungal Agents|antifungal agents|mesh-ancestor
65365327|NCT00552669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65365328|NCT00552669|Immunologic Factors|immunologic factors|mesh-ancestor
65365329|NCT00552669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365330|NCT00943059|Acipimox|acipimox|mesh-list
65365331|NCT00943059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65365332|NCT00943059|Antimetabolites|antimetabolites|mesh-ancestor
65365333|NCT00943059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365334|NCT00943059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65365335|NCT00943137|Fluorouracil|fluorouracil|mesh-list
65365336|NCT00943137|Antimetabolites|antimetabolites|mesh-ancestor
65365337|NCT00943137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365338|NCT00943137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65365339|NCT00943137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365340|NCT00943137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65365341|NCT00943137|Immunologic Factors|immunologic factors|mesh-ancestor
65365342|NCT00943137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365343|NCT00772616|Sufentanil|sufentanil|mesh-list
65365344|NCT00772616|Remifentanil|remifentanil|mesh-list
65365345|NCT00772616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65365346|NCT00772616|Narcotics|narcotics|mesh-ancestor
65365376|NCT05406622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65365377|NCT05406622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65365378|NCT05406622|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65365379|NCT05406622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365380|NCT05406622|Antifungal Agents|antifungal agents|mesh-ancestor
65365381|NCT05406622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65365382|NCT05406622|Immunologic Factors|immunologic factors|mesh-ancestor
65365383|NCT05406622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365384|NCT00776282|Loratadine|loratadine|mesh-list
65365385|NCT00776282|Antipruritics|antipruritics|mesh-ancestor
65365386|NCT00776282|Dermatologic Agents|dermatologic agents|mesh-ancestor
65365387|NCT00776282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65365388|NCT00776282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65365389|NCT00776282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65365390|NCT00776282|Histamine Antagonists|histamine antagonists|mesh-ancestor
65365391|NCT00776282|Histamine Agents|histamine agents|mesh-ancestor
65365392|NCT00776282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65365393|NCT00776282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365394|NCT00776282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365395|NCT00943293|Fludarabine|fludarabine|mesh-list
65365396|NCT00943293|Melphalan|melphalan|mesh-list
65365397|NCT00943293|Alemtuzumab|alemtuzumab|mesh-list
65365398|NCT00943293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365407|NCT00776360|Oxytocin|oxytocin|mesh-list
65365428|NCT00772694|Sorafenib|sorafenib|mesh-list
65365429|NCT00772694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365430|NCT00772694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65365431|NCT00772694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365432|NCT00772694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365433|NCT00776438|Vaccines|vaccines|mesh-list
65365434|NCT00776438|Immunologic Factors|immunologic factors|mesh-ancestor
65365435|NCT00776438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365436|NCT00943449|Sorafenib|sorafenib|mesh-list
65365437|NCT00943449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365438|NCT00943449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65365439|NCT00943449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365440|NCT00943449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365441|NCT00952029|Leucovorin|leucovorin|mesh-list
65365442|NCT00952029|Bevacizumab|bevacizumab|mesh-list
65365443|NCT00952029|Fluorouracil|fluorouracil|mesh-list
65365444|NCT00952029|Irinotecan|irinotecan|mesh-list
65365445|NCT00952029|Calcium|calcium|mesh-list
65365446|NCT00952029|Levoleucovorin|levoleucovorin|mesh-list
65365447|NCT00952029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65365448|NCT00952029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365449|NCT00952029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65365450|NCT00952029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65365451|NCT00952029|Growth Substances|growth substances|mesh-ancestor
65365452|NCT00952029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365453|NCT00952029|Growth Inhibitors|growth inhibitors|mesh-ancestor
65365454|NCT00952029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65365455|NCT00952029|Antimetabolites|antimetabolites|mesh-ancestor
65365477|NCT00776516|Mirabegron|mirabegron|mesh-list
65365478|NCT00776516|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65365479|NCT00776516|Antitubercular Agents|antitubercular agents|mesh-ancestor
65365480|NCT00776516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65365481|NCT00776516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65365482|NCT00776516|Leprostatic Agents|leprostatic agents|mesh-ancestor
65365483|NCT00776516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65365484|NCT00776516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365485|NCT00776516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365486|NCT00776516|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65365487|NCT00776516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65365488|NCT00776516|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65365489|NCT00776516|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65365490|NCT00776516|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65365491|NCT00776516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65365492|NCT00776516|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65365493|NCT00776516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65365494|NCT00776516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65365495|NCT00776516|Adrenergic Agents|adrenergic agents|mesh-ancestor
65365496|NCT00776516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65365497|NCT00776516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365498|NCT00776516|Urological Agents|urological agents|mesh-ancestor
65365499|NCT00768638|Atorvastatin|atorvastatin|mesh-list
65365525|NCT00535132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65365526|NCT00535132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65365527|NCT00535132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65365528|NCT00535132|Dopamine Agents|dopamine agents|mesh-ancestor
65365529|NCT00535132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65365530|NCT00535132|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65365531|NCT00570908|Capecitabine|capecitabine|mesh-list
65365532|NCT00570908|Sunitinib|sunitinib|mesh-list
65365533|NCT00570908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65365535|NCT00570908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365536|NCT00570908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365537|NCT00570908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65365538|NCT00570908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65365539|NCT00570908|Growth Substances|growth substances|mesh-ancestor
65365540|NCT00570908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365541|NCT00570908|Growth Inhibitors|growth inhibitors|mesh-ancestor
65365542|NCT00570908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65365543|NCT00570908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365544|NCT00781391|Warfarin|warfarin|mesh-list
65365545|NCT00781391|Edoxaban|edoxaban|mesh-list
65365546|NCT00781391|Anticoagulants|anticoagulants|mesh-ancestor
65365547|NCT00781391|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65365548|NCT00781391|Antithrombins|antithrombins|mesh-ancestor
65365549|NCT00781391|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65365550|NCT00781391|Protease Inhibitors|protease inhibitors|mesh-ancestor
65365551|NCT00781391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365552|NCT00781391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365553|NCT00773084|Lisinopril|lisinopril|mesh-list
65365554|NCT00773084|Spironolactone|spironolactone|mesh-list
65365555|NCT00773084|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65365556|NCT00773084|Hormone Antagonists|hormone antagonists|mesh-ancestor
65365557|NCT00773084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65365558|NCT00773084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365560|NCT00773084|Diuretics|diuretics|mesh-ancestor
65365565|NCT00773084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365566|NCT00773084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65365567|NCT00773084|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65365568|NCT00773084|Protective Agents|protective agents|mesh-ancestor
65365569|NCT00534976|Montelukast|montelukast|mesh-list
65365570|NCT00534976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65365571|NCT00534976|Respiratory System Agents|respiratory system agents|mesh-ancestor
65365572|NCT00534976|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65365573|NCT00534976|Hormone Antagonists|hormone antagonists|mesh-ancestor
65365574|NCT00534976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65365575|NCT00534976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365576|NCT00534976|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65365577|NCT00534976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65365578|NCT00534976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365579|NCT00773162|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65365580|NCT00773162|Antidepressive Agents|antidepressive agents|mesh-ancestor
65365581|NCT00773162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65365582|NCT00773162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65365583|NCT00773162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65365584|NCT00773162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65365585|NCT00773162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365586|NCT00776828|Cilostazol|cilostazol|mesh-list
65365587|NCT00776828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65365588|NCT00776828|Autonomic Agents|autonomic agents|mesh-ancestor
65365589|NCT00776828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65365590|NCT00776828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365591|NCT00776828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65365592|NCT00776828|Respiratory System Agents|respiratory system agents|mesh-ancestor
65365593|NCT00776828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65365594|NCT00776828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65365605|NCT01063933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65365606|NCT01063933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365607|NCT01063933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365609|NCT02556866|Rituximab|rituximab|mesh-list
65365610|NCT02556866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65365611|NCT02556866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365612|NCT02556866|Immunologic Factors|immunologic factors|mesh-ancestor
65365613|NCT02556866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365614|NCT02556866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65365615|NCT02556866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65365616|NCT02556866|Glucocorticoids|glucocorticoids|mesh-ancestor
65365617|NCT02556866|Hormones|hormones|mesh-ancestor
65365618|NCT02556866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65365619|NCT02556866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65365620|NCT00308113|Ubiquinone|ubiquinone|mesh-list
65365621|NCT00308113|Coenzyme Q10|coenzyme q10|mesh-list
65365622|NCT00308113|Prednisone|prednisone|mesh-list
65365623|NCT00308113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65365624|NCT00308113|Glucocorticoids|glucocorticoids|mesh-ancestor
65365625|NCT00308113|Hormones|hormones|mesh-ancestor
65365626|NCT00308113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65365659|NCT00777218|Topiramate|topiramate|mesh-list
65365660|NCT00777218|Propranolol|propranolol|mesh-list
65365661|NCT00777218|Zonisamide|zonisamide|mesh-list
65365662|NCT00777218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65365663|NCT00777218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65365664|NCT00777218|Adrenergic Agents|adrenergic agents|mesh-ancestor
65365665|NCT00777218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65365666|NCT00777218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365667|NCT00777218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365668|NCT00777218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65365669|NCT00777218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65365670|NCT00777218|Vasodilator Agents|vasodilator agents|mesh-ancestor
65365671|NCT00777218|Anticonvulsants|anticonvulsants|mesh-ancestor
65365672|NCT00777218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65365673|NCT00777218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65365674|NCT00777218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65365675|NCT00777218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65365676|NCT04047758|Letrozole|letrozole|mesh-list
65365677|NCT04047758|Palbociclib|palbociclib|mesh-list
65365678|NCT04047758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365679|NCT04047758|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65365680|NCT04047758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65365681|NCT04047758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365683|NCT04047758|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65365709|NCT00671060|Abortifacient Agents|abortifacient agents|mesh-ancestor
65365710|NCT00671060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65365711|NCT00671060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365712|NCT00671060|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65365713|NCT00671060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65365714|NCT00671060|Oxytocics|oxytocics|mesh-ancestor
65365715|NCT05354986|Povidone|povidone|mesh-list
65365716|NCT05354986|Plasma Substitutes|plasma substitutes|mesh-ancestor
65365717|NCT05354986|Blood Substitutes|blood substitutes|mesh-ancestor
65365718|NCT00773552|Solifenacin Succinate|solifenacin succinate|mesh-list
65365719|NCT00773552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65365720|NCT00773552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65365721|NCT00773552|Cholinergic Agents|cholinergic agents|mesh-ancestor
65365722|NCT00773552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65365723|NCT00773552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365724|NCT00773552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365725|NCT00773552|Urological Agents|urological agents|mesh-ancestor
65365726|NCT04002700|Haloperidol|haloperidol|mesh-list
65365727|NCT04002700|Haloperidol decanoate|haloperidol decanoate|mesh-list
65365728|NCT04002700|Antipsychotic Agents|antipsychotic agents|mesh-list
65365729|NCT04002700|Antiemetics|antiemetics|mesh-ancestor
65365730|NCT04002700|Autonomic Agents|autonomic agents|mesh-ancestor
65365731|NCT04002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65365732|NCT04002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365733|NCT04002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65365734|NCT04002700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65365758|NCT05297123|Arsenic Trioxide|arsenic trioxide|mesh-list
65365759|NCT05297123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365760|NCT05297123|Keratolytic Agents|keratolytic agents|mesh-ancestor
65365761|NCT05297123|Dermatologic Agents|dermatologic agents|mesh-ancestor
65365762|NCT00654420|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65365763|NCT00654420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365764|NCT00654420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65365765|NCT00654420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365766|NCT00654420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365767|NCT00773630|Cilostazol|cilostazol|mesh-list
65365768|NCT00773630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65365769|NCT00773630|Autonomic Agents|autonomic agents|mesh-ancestor
65365770|NCT00773630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65365771|NCT00773630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365772|NCT00773630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65365773|NCT00773630|Respiratory System Agents|respiratory system agents|mesh-ancestor
65365774|NCT00773630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65365816|NCT00307489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365817|NCT00307489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65365818|NCT00307489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65365819|NCT00812292|Rilpivirine|rilpivirine|mesh-list
65365820|NCT00812292|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65365821|NCT00812292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65365822|NCT00812292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365823|NCT00812292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365824|NCT00812292|Antiviral Agents|antiviral agents|mesh-ancestor
65365825|NCT00812292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65365826|NCT00812292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65365827|NCT00812292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65365828|NCT00812370|Bivalirudin|bivalirudin|mesh-list
65365829|NCT00812370|Antithrombins|antithrombins|mesh-ancestor
65365830|NCT00812370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65365831|NCT00812370|Protease Inhibitors|protease inhibitors|mesh-ancestor
65365832|NCT00812370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65365833|NCT00812370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365835|NCT00645840|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65365836|NCT00645840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65365837|NCT00773708|Raltegravir Potassium|raltegravir potassium|mesh-list
65365838|NCT00773708|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65365839|NCT00773708|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65365840|NCT00773708|Antiviral Agents|antiviral agents|mesh-ancestor
65365841|NCT00773708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65365846|NCT00762359|Lansoprazole|lansoprazole|mesh-list
65365865|NCT00770042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365866|NCT00770042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65365867|NCT00770042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65365868|NCT00770042|Antiviral Agents|antiviral agents|mesh-ancestor
65365869|NCT00770042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65365870|NCT00770042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65365871|NCT00770042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65365872|NCT00770042|Antifungal Agents|antifungal agents|mesh-ancestor
65365873|NCT00770042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65365874|NCT00770042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65365875|NCT00770042|Hormone Antagonists|hormone antagonists|mesh-ancestor
65365876|NCT00770042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65365877|NCT00770042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365878|NCT00654186|Lenalidomide|lenalidomide|mesh-list
65365879|NCT00654186|Immunologic Factors|immunologic factors|mesh-ancestor
65365880|NCT00654186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365881|NCT00654186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65365882|NCT00654186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65365883|NCT00654186|Growth Substances|growth substances|mesh-ancestor
65365884|NCT00654186|Growth Inhibitors|growth inhibitors|mesh-ancestor
65365885|NCT00654186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365886|NCT03275818|Paclitaxel|paclitaxel|mesh-list
65365887|NCT03275818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65365888|NCT03275818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365889|NCT03275818|Tubulin Modulators|tubulin modulators|mesh-ancestor
65365890|NCT03275818|Antimitotic Agents|antimitotic agents|mesh-ancestor
65365891|NCT03275818|Mitosis Modulators|mitosis modulators|mesh-ancestor
65365892|NCT03275818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365893|NCT03979105|Ketamine|ketamine|mesh-list
65365894|NCT03979105|Analgesics|analgesics|mesh-ancestor
65365895|NCT03979105|Sensory System Agents|sensory system agents|mesh-ancestor
65365896|NCT03979105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65365899|NCT03979105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65365904|NCT03979105|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65365905|NCT03979105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65365906|NCT03979105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365907|NCT00774020|Zoledronic Acid|zoledronic acid|mesh-list
65365908|NCT00774020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65365909|NCT00774020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365910|NCT04100447|Tranexamic Acid|tranexamic acid|mesh-list
65365911|NCT04100447|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65365912|NCT04100447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65365913|NCT04100447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365915|NCT04100447|Coagulants|coagulants|mesh-ancestor
65365916|NCT03274804|Maraviroc|maraviroc|mesh-list
65365917|NCT03274804|Pembrolizumab|pembrolizumab|mesh-list
65365918|NCT03274804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65365919|NCT03274804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365920|NCT03274804|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65365921|NCT03274804|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65365922|NCT03274804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365923|NCT03274804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65365924|NCT03274804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65365925|NCT03274804|Antiviral Agents|antiviral agents|mesh-ancestor
65365926|NCT03274804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65365927|NCT03274804|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65365928|NCT00761891|Aspirin|aspirin|mesh-list
65365929|NCT00761891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65365930|NCT00761891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65365931|NCT00761891|Analgesics|analgesics|mesh-ancestor
65365952|NCT00321685|Endothelial Growth Factors|endothelial growth factors|mesh-list
65365953|NCT00321685|Antibodies|antibodies|mesh-list
65365954|NCT00321685|Immunoglobulins|immunoglobulins|mesh-list
65365955|NCT00321685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65365956|NCT00321685|Immunoglobulin G|immunoglobulin g|mesh-list
65365957|NCT00321685|Calcium|calcium|mesh-list
65365958|NCT00321685|Levoleucovorin|levoleucovorin|mesh-list
65365959|NCT00321685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365960|NCT00321685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65365961|NCT00321685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65365962|NCT00321685|Growth Substances|growth substances|mesh-ancestor
65365963|NCT00321685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365964|NCT00321685|Growth Inhibitors|growth inhibitors|mesh-ancestor
65365965|NCT00321685|Immunologic Factors|immunologic factors|mesh-ancestor
65365966|NCT00321685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65365967|NCT00321685|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65365968|NCT00321685|Antimetabolites|antimetabolites|mesh-ancestor
65365969|NCT00321685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65365970|NCT00321685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65365971|NCT00321685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65365972|NCT00321685|Antidotes|antidotes|mesh-ancestor
65365973|NCT00321685|Protective Agents|protective agents|mesh-ancestor
65365974|NCT00321685|Vitamin B Complex|vitamin b complex|mesh-ancestor
65365975|NCT00321685|Vitamins|vitamins|mesh-ancestor
65365976|NCT00321685|Micronutrients|micronutrients|mesh-ancestor
65365977|NCT00321685|Hematinics|hematinics|mesh-ancestor
65365978|NCT00777998|Ferrous fumarate|ferrous fumarate|mesh-list
65365979|NCT00777998|Thalidomide|thalidomide|mesh-list
65365980|NCT00777998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65365981|NCT00777998|Immunologic Factors|immunologic factors|mesh-ancestor
65365982|NCT00777998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365983|NCT00777998|Leprostatic Agents|leprostatic agents|mesh-ancestor
65365984|NCT00777998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65365985|NCT00777998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65365986|NCT00777998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65365987|NCT00777998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65365988|NCT00777998|Growth Substances|growth substances|mesh-ancestor
64758146|NCT00352794|Lenalidomide|lenalidomide|mesh-list
64493889|NCT00637377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65365989|NCT00777998|Growth Inhibitors|growth inhibitors|mesh-ancestor
65365990|NCT00777998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65365991|NCT00777998|Trace Elements|trace elements|mesh-ancestor
65365992|NCT00777998|Micronutrients|micronutrients|mesh-ancestor
65365993|NCT05348200|Clobetasol|clobetasol|mesh-list
65365994|NCT05348200|Lidocaine|lidocaine|mesh-list
65365995|NCT05348200|Halobetasol|halobetasol|mesh-list
65365996|NCT05348200|Anesthetics, Local|anesthetics, local|mesh-ancestor
65365997|NCT05348200|Anesthetics|anesthetics|mesh-ancestor
65365998|NCT05348200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65365999|NCT05348200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366000|NCT05348200|Sensory System Agents|sensory system agents|mesh-ancestor
65366001|NCT05348200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65366002|NCT05348200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65366003|NCT05348200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65366004|NCT05348200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65366005|NCT05348200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65366006|NCT05348200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366007|NCT05348200|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65366008|NCT05348200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65366009|NCT05348200|Glucocorticoids|glucocorticoids|mesh-ancestor
65366010|NCT05348200|Hormones|hormones|mesh-ancestor
65366041|NCT00774488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65366042|NCT00774488|Incretins|incretins|mesh-ancestor
65366043|NCT00774488|Hormones|hormones|mesh-ancestor
65366044|NCT00774488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65366045|NCT00774488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366046|NCT01066195|Pemetrexed|pemetrexed|mesh-list
65366047|NCT01066195|Gefitinib|gefitinib|mesh-list
65366048|NCT01066195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366049|NCT01066195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366050|NCT01066195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366051|NCT01066195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65366052|NCT01066195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65366053|NCT01066195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65366054|NCT00774644|Clarithromycin|clarithromycin|mesh-list
65115896|NCT02910206|Propofol|propofol|mesh-list
65366055|NCT00774644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65366056|NCT00774644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65366057|NCT00774644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65366058|NCT00774644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366059|NCT00774644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366060|NCT00774644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65366061|NCT00774644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65366062|NCT05123092|Morphine|morphine|mesh-list
65366063|NCT05123092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65366064|NCT05123092|Narcotics|narcotics|mesh-ancestor
65366065|NCT05123092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65366066|NCT05123092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366067|NCT05123092|Analgesics|analgesics|mesh-ancestor
65366068|NCT05123092|Sensory System Agents|sensory system agents|mesh-ancestor
65366084|NCT00667394|Growth Substances|growth substances|mesh-ancestor
65366085|NCT00667394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366086|NCT00667394|Growth Inhibitors|growth inhibitors|mesh-ancestor
65366087|NCT05357326|Atropine|atropine|mesh-list
65366088|NCT05357326|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65366089|NCT05357326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65366090|NCT05357326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65366091|NCT05357326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65366092|NCT05357326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65366093|NCT05357326|Autonomic Agents|autonomic agents|mesh-ancestor
65366094|NCT05357326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65366095|NCT05357326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366096|NCT05357326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65366097|NCT05357326|Respiratory System Agents|respiratory system agents|mesh-ancestor
65366098|NCT05357326|Mydriatics|mydriatics|mesh-ancestor
65366099|NCT05357326|Parasympatholytics|parasympatholytics|mesh-ancestor
65366100|NCT05357326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65366101|NCT05357326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65366102|NCT05357326|Cholinergic Agents|cholinergic agents|mesh-ancestor
65366103|NCT05357326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65366104|NCT05357326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366105|NCT00778466|Metformin|metformin|mesh-list
65366106|NCT00778466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65366107|NCT00778466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366108|NCT00761735|Ribavirin|ribavirin|mesh-list
65366109|NCT00761735|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65366110|NCT00761735|Antimetabolites|antimetabolites|mesh-ancestor
65366111|NCT00761735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366112|NCT00761735|Antiviral Agents|antiviral agents|mesh-ancestor
65366113|NCT00761735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65366129|NCT04001374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65366130|NCT04001374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65366131|NCT04001374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65366132|NCT04001374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65366133|NCT04001374|Purinergic Agents|purinergic agents|mesh-ancestor
65366134|NCT04001374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65366135|NCT04001374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366136|NCT04001374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366137|NCT02556320|Anticonvulsants|anticonvulsants|mesh-list
65366138|NCT05265910|Loratadine|loratadine|mesh-list
65366139|NCT05265910|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
65366140|NCT05265910|Dextrans|dextrans|mesh-list
65366141|NCT05265910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65366142|NCT05265910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65366143|NCT05265910|Antipruritics|antipruritics|mesh-ancestor
65366144|NCT05265910|Dermatologic Agents|dermatologic agents|mesh-ancestor
65366145|NCT05265910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65366146|NCT05265910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65366147|NCT05265910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65366148|NCT05265910|Histamine Antagonists|histamine antagonists|mesh-ancestor
65366149|NCT05265910|Histamine Agents|histamine agents|mesh-ancestor
65366150|NCT05265910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65366151|NCT05265910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366152|NCT05265910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366154|NCT05265910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65366177|NCT00645528|Insulin|insulin|mesh-list
65366178|NCT00645528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65366179|NCT00645528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366180|NCT00812448|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65366181|NCT00812448|Antioxidants|antioxidants|mesh-ancestor
65366182|NCT00812448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366183|NCT00812448|Protective Agents|protective agents|mesh-ancestor
65366184|NCT00812448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366185|NCT00812448|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65366186|NCT00812448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65366187|NCT00812448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366188|NCT00812448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65366189|NCT00295633|Metformin|metformin|mesh-list
65366190|NCT00295633|Pioglitazone|pioglitazone|mesh-list
65366191|NCT00295633|Rosiglitazone|rosiglitazone|mesh-list
65366192|NCT00295633|Saxagliptin|saxagliptin|mesh-list
65366193|NCT00295633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65366194|NCT00295633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366195|NCT00295633|Incretins|incretins|mesh-ancestor
65366196|NCT00295633|Hormones|hormones|mesh-ancestor
65366197|NCT00295633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65366199|NCT00295633|Protease Inhibitors|protease inhibitors|mesh-ancestor
65366231|NCT00812682|Respiratory System Agents|respiratory system agents|mesh-ancestor
65366232|NCT00768989|Ritonavir|ritonavir|mesh-list
65366233|NCT00768989|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65366234|NCT00768989|Tenofovir|tenofovir|mesh-list
65366235|NCT00768989|Emtricitabine|emtricitabine|mesh-list
65366236|NCT00768989|Raltegravir Potassium|raltegravir potassium|mesh-list
65366237|NCT00768989|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65366238|NCT00768989|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65366239|NCT00768989|Protease Inhibitors|protease inhibitors|mesh-ancestor
65366240|NCT00768989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366241|NCT00768989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366242|NCT00768989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65366243|NCT00768989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65366244|NCT00768989|Antiviral Agents|antiviral agents|mesh-ancestor
65366245|NCT00768989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65366246|NCT00768989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65366247|NCT00768989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65366248|NCT00768989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65366249|NCT00768989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65366250|NCT00768989|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65366251|NCT00768989|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65366252|NCT00779714|Cytarabine|cytarabine|mesh-list
65366253|NCT00779714|Paclitaxel|paclitaxel|mesh-list
65366254|NCT00779714|Cisplatin|cisplatin|mesh-list
65366255|NCT00779714|Dacarbazine|dacarbazine|mesh-list
65366256|NCT00779714|Treosulfan|treosulfan|mesh-list
65366257|NCT00779714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65366258|NCT00779714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366259|NCT00779714|Tubulin Modulators|tubulin modulators|mesh-ancestor
65366260|NCT00779714|Antimitotic Agents|antimitotic agents|mesh-ancestor
65366261|NCT00779714|Mitosis Modulators|mitosis modulators|mesh-ancestor
65366262|NCT00779714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366263|NCT00779714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65366264|NCT00779714|Antimetabolites|antimetabolites|mesh-ancestor
65366265|NCT00779714|Antiviral Agents|antiviral agents|mesh-ancestor
65366272|NCT00812760|Levodopa|levodopa|mesh-list
65366273|NCT00812760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65366274|NCT00812760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65366275|NCT00812760|Dopamine Agents|dopamine agents|mesh-ancestor
65366276|NCT00812760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65366277|NCT00812760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366278|NCT00812760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366279|NCT00814944|Sirolimus|sirolimus|mesh-list
65366280|NCT00814944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65366281|NCT00814944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65366282|NCT00814944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65366283|NCT00814944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366284|NCT00814944|Antifungal Agents|antifungal agents|mesh-ancestor
65366285|NCT00814944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65366286|NCT00814944|Immunologic Factors|immunologic factors|mesh-ancestor
65366287|NCT00814944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366289|NCT00779792|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65366290|NCT00779792|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65366291|NCT00779792|Clobetasol|clobetasol|mesh-list
65366292|NCT00779792|Mineral Oil|mineral oil|mesh-list
65366293|NCT00779792|Tacrolimus|tacrolimus|mesh-list
65366294|NCT00779792|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65366295|NCT00779792|Glycerol|glycerol|mesh-list
65366296|NCT00779792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65366297|NCT00779792|Immunologic Factors|immunologic factors|mesh-ancestor
65366298|NCT00779792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366299|NCT00779792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65366300|NCT00779792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366301|NCT00779792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366302|NCT00779792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65366303|NCT00779792|Glucocorticoids|glucocorticoids|mesh-ancestor
65366304|NCT00779792|Hormones|hormones|mesh-ancestor
65366305|NCT00779792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65366306|NCT00779792|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65366307|NCT00779792|Protective Agents|protective agents|mesh-ancestor
65366308|NCT00779792|Emollients|emollients|mesh-ancestor
65366313|NCT00992134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65366314|NCT00992134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366315|NCT00992134|Immunologic Factors|immunologic factors|mesh-ancestor
65366316|NCT00992134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366317|NCT00992134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65366318|NCT00992134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65366319|NCT00992134|Antimetabolites|antimetabolites|mesh-ancestor
65366320|NCT00992134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366321|NCT00992134|Antiviral Agents|antiviral agents|mesh-ancestor
65366322|NCT00992134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65366323|NCT00992134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65366324|NCT00992134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65366325|NCT00992134|Alkylating Agents|alkylating agents|mesh-ancestor
65366326|NCT02551536|Fexofenadine|fexofenadine|mesh-list
65366327|NCT02551536|Montelukast|montelukast|mesh-list
65366328|NCT02551536|Levocetirizine|levocetirizine|mesh-list
65366329|NCT02551536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65366330|NCT02551536|Respiratory System Agents|respiratory system agents|mesh-ancestor
65366331|NCT02551536|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65366332|NCT02551536|Hormone Antagonists|hormone antagonists|mesh-ancestor
65366333|NCT02551536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65366334|NCT02551536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366335|NCT02551536|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65366336|NCT02551536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65366337|NCT02551536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366338|NCT02551536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65366339|NCT02551536|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65366340|NCT02551536|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65366341|NCT02551536|Histamine Antagonists|histamine antagonists|mesh-ancestor
65366342|NCT02551536|Histamine Agents|histamine agents|mesh-ancestor
65366355|NCT00815022|Analgesics|analgesics|mesh-ancestor
65366356|NCT00815022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65366357|NCT00815022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65366359|NCT02315326|Rituximab|rituximab|mesh-list
65366360|NCT02315326|Methotrexate|methotrexate|mesh-list
65366361|NCT02315326|Procarbazine|procarbazine|mesh-list
65366362|NCT02315326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65366363|NCT02315326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366364|NCT02315326|Immunologic Factors|immunologic factors|mesh-ancestor
65366365|NCT02315326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366366|NCT02315326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65366367|NCT02315326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65366368|NCT02315326|Abortifacient Agents|abortifacient agents|mesh-ancestor
65366369|NCT02315326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65366370|NCT02315326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65366371|NCT02315326|Antimetabolites|antimetabolites|mesh-ancestor
65366372|NCT02315326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366373|NCT02315326|Dermatologic Agents|dermatologic agents|mesh-ancestor
65366374|NCT02315326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366375|NCT02315326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65366376|NCT02315326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65366377|NCT02315326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65366378|NCT00774722|Metronidazole|metronidazole|mesh-list
65366379|NCT00774722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65366380|NCT00774722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65366381|NCT00774722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65366382|NCT00774722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65366383|NCT00808392|Vaccines|vaccines|mesh-list
65366384|NCT00808392|Immunologic Factors|immunologic factors|mesh-ancestor
65366385|NCT00808392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366386|NCT04045548|Dinoprostone|dinoprostone|mesh-list
65366387|NCT04045548|Oxytocics|oxytocics|mesh-ancestor
65366388|NCT04045548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65366399|NCT00780104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366400|NCT00780104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65366401|NCT00780104|Antimetabolites|antimetabolites|mesh-ancestor
65366402|NCT00780104|Antiviral Agents|antiviral agents|mesh-ancestor
65366403|NCT00780104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65366404|NCT00780104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65366405|NCT00780104|Immunologic Factors|immunologic factors|mesh-ancestor
65366406|NCT00780104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366407|NCT00780104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65366408|NCT00780104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65366409|NCT00780104|Antifungal Agents|antifungal agents|mesh-ancestor
65366410|NCT00780104|Analgesics|analgesics|mesh-ancestor
65366411|NCT00780104|Sensory System Agents|sensory system agents|mesh-ancestor
65366413|NCT04047680|Ritonavir|ritonavir|mesh-list
65366461|NCT00812994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65366462|NCT00812994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366463|NCT00812994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65366464|NCT00812994|Serotonin Agents|serotonin agents|mesh-ancestor
65366465|NCT00812994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366466|NCT00812994|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65366467|NCT00812994|Antidepressive Agents|antidepressive agents|mesh-ancestor
65366468|NCT00812994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65366469|NCT00784394|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
65366470|NCT00784394|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65366471|NCT00784394|Protective Agents|protective agents|mesh-ancestor
65366472|NCT00784394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366525|NCT03978559|Antimalarials|antimalarials|mesh-ancestor
65366526|NCT03978559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65366527|NCT03978559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65366528|NCT03978559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65366529|NCT03978559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366530|NCT03978559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366531|NCT03978559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65366532|NCT03978559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65366533|NCT03978559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65366534|NCT03978559|Antifungal Agents|antifungal agents|mesh-ancestor
65366535|NCT00813072|Docetaxel|docetaxel|mesh-list
65366536|NCT00813072|Irinotecan|irinotecan|mesh-list
65366537|NCT00813072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366538|NCT00813072|Tubulin Modulators|tubulin modulators|mesh-ancestor
65366539|NCT00813072|Antimitotic Agents|antimitotic agents|mesh-ancestor
65366540|NCT00813072|Mitosis Modulators|mitosis modulators|mesh-ancestor
65366541|NCT00813072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366542|NCT00813072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65366543|NCT00813072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65366544|NCT00813072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366545|NCT00813228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65366546|NCT00813228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65366547|NCT00813228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366576|NCT00815568|Fludarabine|fludarabine|mesh-list
65366577|NCT00815568|Fludarabine phosphate|fludarabine phosphate|mesh-list
65366578|NCT00815568|Busulfan|busulfan|mesh-list
65366579|NCT00815568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366580|NCT00815568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65366581|NCT00815568|Antimetabolites|antimetabolites|mesh-ancestor
65366582|NCT00815568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116431|NCT01780428|Antipyretics|antipyretics|mesh-ancestor
65366583|NCT00815568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65366584|NCT00815568|Immunologic Factors|immunologic factors|mesh-ancestor
65366585|NCT00815568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366586|NCT00815568|Alkylating Agents|alkylating agents|mesh-ancestor
65366587|NCT00815568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65366588|NCT00815568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65366589|NCT00815646|Sildenafil Citrate|sildenafil citrate|mesh-list
65366590|NCT00815646|Vasodilator Agents|vasodilator agents|mesh-ancestor
65366591|NCT00815646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65366592|NCT00815646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65366593|NCT00815646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366594|NCT00815646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366595|NCT00815646|Urological Agents|urological agents|mesh-ancestor
65366596|NCT01066351|Epoetin Alfa|epoetin alfa|mesh-list
65366597|NCT01066351|Hematinics|hematinics|mesh-ancestor
65366598|NCT00809016|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65366599|NCT00809016|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65366600|NCT00809016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366601|NCT00661778|Bevacizumab|bevacizumab|mesh-list
65366602|NCT00661778|Docetaxel|docetaxel|mesh-list
65366603|NCT00661778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65366604|NCT00661778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366605|NCT00661778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65366614|NCT01062139|Cetirizine|cetirizine|mesh-list
65366617|NCT01062139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65366618|NCT01062139|Histamine Antagonists|histamine antagonists|mesh-ancestor
65366619|NCT01062139|Histamine Agents|histamine agents|mesh-ancestor
65366620|NCT01062139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65366621|NCT01062139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366622|NCT01062139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366623|NCT01062139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65366624|NCT00780650|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65366625|NCT00780650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65366626|NCT00780650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65366627|NCT00780650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65366628|NCT00780650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366629|NCT00780650|Adrenergic Agents|adrenergic agents|mesh-ancestor
65366630|NCT00780650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65366631|NCT00780650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366632|NCT00653328|Doxorubicin|doxorubicin|mesh-list
65366633|NCT00653328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65366634|NCT00653328|Atrasentan|atrasentan|mesh-list
65366635|NCT00653328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65366636|NCT00653328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366637|NCT00653328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65366638|NCT00653328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65366639|NCT00653328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366640|NCT00653328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366641|NCT00653328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65366642|NCT00653328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65366643|NCT01664182|Bevacizumab|bevacizumab|mesh-list
65366644|NCT01664182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65366645|NCT01664182|Sunitinib|sunitinib|mesh-list
65366660|NCT01664182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65366661|NCT01664182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366662|NCT01664182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366664|NCT00780728|Vasodilator Agents|vasodilator agents|mesh-ancestor
65366665|NCT00780728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65366666|NCT00780728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65366667|NCT00780728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366668|NCT00780728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366669|NCT00780728|Urological Agents|urological agents|mesh-ancestor
65366670|NCT00809172|Cyclosporine|cyclosporine|mesh-list
65366671|NCT00809172|Methotrexate|methotrexate|mesh-list
65366672|NCT00809172|Cyclosporins|cyclosporins|mesh-list
65366673|NCT00809172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65366674|NCT00809172|Abortifacient Agents|abortifacient agents|mesh-ancestor
65366675|NCT00809172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65366676|NCT00809172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366677|NCT00809172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65366678|NCT00809172|Antimetabolites|antimetabolites|mesh-ancestor
65366679|NCT00809172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366680|NCT00809172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366681|NCT00809172|Dermatologic Agents|dermatologic agents|mesh-ancestor
65366682|NCT00809172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366683|NCT00809172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65366684|NCT00809172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65366685|NCT00809172|Immunologic Factors|immunologic factors|mesh-ancestor
65366686|NCT00809172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65366687|NCT00809172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65366705|NCT00784862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366706|NCT00784940|Tamoxifen|tamoxifen|mesh-list
65366707|NCT00784940|Anastrozole|anastrozole|mesh-list
65366708|NCT00784940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65366709|NCT00784940|Hormone Antagonists|hormone antagonists|mesh-ancestor
65366710|NCT00784940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65366711|NCT00784940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366712|NCT00784940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65366713|NCT00784940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366714|NCT00784940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65366715|NCT00784940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65366716|NCT00784940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65366717|NCT00784940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65366718|NCT00784940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65366719|NCT00784940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366720|NCT00784940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366721|NCT00790244|Doxorubicin|doxorubicin|mesh-list
65366722|NCT00790244|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65366723|NCT00790244|Ifosfamide|ifosfamide|mesh-list
65366724|NCT00790244|Isophosphamide mustard|isophosphamide mustard|mesh-list
65366725|NCT00790244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65366726|NCT00790244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366727|NCT00790244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65366728|NCT00790244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65366729|NCT00790244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366730|NCT00790244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366731|NCT00790244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65366732|NCT00790244|Alkylating Agents|alkylating agents|mesh-ancestor
65366733|NCT00785018|Complement C1s|complement c1s|mesh-list
65366734|NCT00785018|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
65366735|NCT00785018|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
65366736|NCT00785018|Immunologic Factors|immunologic factors|mesh-ancestor
65366740|NCT00534352|Ritonavir|ritonavir|mesh-list
65366744|NCT00534352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65366745|NCT00534352|Protease Inhibitors|protease inhibitors|mesh-ancestor
65366746|NCT00534352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366747|NCT00534352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366748|NCT00534352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65366749|NCT00534352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65366750|NCT00534352|Antiviral Agents|antiviral agents|mesh-ancestor
65366751|NCT00534352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65366752|NCT00534352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65366753|NCT00534352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65366754|NCT00534352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65366755|NCT00534352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65366756|NCT00642174|Clopidogrel|clopidogrel|mesh-list
65366757|NCT00642174|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65366758|NCT00642174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65366759|NCT00642174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65366760|NCT00642174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65366761|NCT00642174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65366762|NCT00642174|Purinergic Agents|purinergic agents|mesh-ancestor
65366763|NCT00642174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65366764|NCT00642174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366765|NCT00642174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366766|NCT02550444|Clonidine|clonidine|mesh-list
65366767|NCT02550444|Analgesics|analgesics|mesh-ancestor
65366768|NCT02550444|Sensory System Agents|sensory system agents|mesh-ancestor
65366771|NCT02550444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65366790|NCT00665366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65366791|NCT00665366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366792|NCT00665366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65366793|NCT00665366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65366794|NCT00665366|Serotonin Agents|serotonin agents|mesh-ancestor
65366795|NCT00665366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65366796|NCT00665366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65366797|NCT00665366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65366798|NCT00665366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65366799|NCT00665366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366800|NCT00665366|Antimanic Agents|antimanic agents|mesh-ancestor
65366801|NCT00665366|Anticonvulsants|anticonvulsants|mesh-ancestor
65366802|NCT00665366|GABA Agents|gaba agents|mesh-ancestor
65366803|NCT00775684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65366804|NCT00775684|Exenatide|exenatide|mesh-list
65366805|NCT00775684|Glimepiride|glimepiride|mesh-list
65366806|NCT00775684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65366807|NCT00775684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366808|NCT00775684|Incretins|incretins|mesh-ancestor
65366809|NCT00775684|Hormones|hormones|mesh-ancestor
65366810|NCT00775684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65366811|NCT00775684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65366812|NCT00775684|Protease Inhibitors|protease inhibitors|mesh-ancestor
65366813|NCT00775684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366814|NCT00775684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366815|NCT00775684|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65366816|NCT00775684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65366817|NCT00775684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65366818|NCT00775684|Immunologic Factors|immunologic factors|mesh-ancestor
65366819|NCT02556008|Cannabidiol|cannabidiol|mesh-list
65366820|NCT02556008|Anticonvulsants|anticonvulsants|mesh-ancestor
65366821|NCT00992524|Misoprostol|misoprostol|mesh-list
65366822|NCT00992524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65366831|NCT00642018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366832|NCT00642018|Tubulin Modulators|tubulin modulators|mesh-ancestor
65366833|NCT00642018|Antimitotic Agents|antimitotic agents|mesh-ancestor
65366834|NCT00642018|Mitosis Modulators|mitosis modulators|mesh-ancestor
65366835|NCT00642018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366836|NCT00642018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65366837|NCT00642018|Glucocorticoids|glucocorticoids|mesh-ancestor
65366838|NCT00642018|Hormones|hormones|mesh-ancestor
65366839|NCT00642018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65366840|NCT00642018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366841|NCT00642018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65366842|NCT00532948|Capecitabine|capecitabine|mesh-list
65366843|NCT00532948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65366844|NCT00532948|Antimetabolites|antimetabolites|mesh-ancestor
65366845|NCT00532948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366846|NCT00532948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366847|NCT00998920|Equol|equol|mesh-list
65366848|NCT00998920|Phytoestrogens|phytoestrogens|mesh-ancestor
65366849|NCT00998920|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65366888|NCT00992914|Anesthetics, Local|anesthetics, local|mesh-ancestor
65366889|NCT00992914|Anesthetics|anesthetics|mesh-ancestor
65366890|NCT00992914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65366891|NCT00992914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366892|NCT00992914|Sensory System Agents|sensory system agents|mesh-ancestor
65366893|NCT00992914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65366894|NCT00992914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65366895|NCT00992914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65366896|NCT00992914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65366897|NCT00992914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65366898|NCT00992914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366899|NCT00999232|Erythromycin|erythromycin|mesh-list
65366900|NCT00999232|Erythromycin Estolate|erythromycin estolate|mesh-list
65366901|NCT00999232|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65366902|NCT00999232|Erythromycin stearate|erythromycin stearate|mesh-list
65366903|NCT00999232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65366904|NCT00999232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65366905|NCT00999232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65366906|NCT00999232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65366907|NCT00999232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366908|NCT00999232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366909|NCT00993070|Capsaicin|capsaicin|mesh-list
65366910|NCT00993070|Antipruritics|antipruritics|mesh-ancestor
65366911|NCT00993070|Dermatologic Agents|dermatologic agents|mesh-ancestor
65366912|NCT00993070|Sensory System Agents|sensory system agents|mesh-ancestor
65366913|NCT00993070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65366914|NCT00993070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366915|NCT00993304|Liraglutide|liraglutide|mesh-list
65366916|NCT00993304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65366917|NCT00993304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366918|NCT00993304|Incretins|incretins|mesh-ancestor
65366919|NCT00993304|Hormones|hormones|mesh-ancestor
65366921|NCT05189002|Dalteparin|dalteparin|mesh-list
65366928|NCT00644358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65366929|NCT00644358|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65366930|NCT00644358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65366931|NCT00644358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65366932|NCT00644358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366933|NCT00644358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65366934|NCT00644358|Serotonin Agents|serotonin agents|mesh-ancestor
65366935|NCT00644358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366936|NCT00644358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65366937|NCT00644358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65366938|NCT00993694|Dapsone|dapsone|mesh-list
65366939|NCT00993694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65366940|NCT00993694|Antimalarials|antimalarials|mesh-ancestor
65366941|NCT00993694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65366942|NCT00993694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65366943|NCT00993694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65366944|NCT00993694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366945|NCT00993694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366946|NCT00993694|Leprostatic Agents|leprostatic agents|mesh-ancestor
65366947|NCT00993694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65366948|NCT00640926|Radezolid|radezolid|mesh-list
65366949|NCT00640926|Oxazolidinones|oxazolidinones|mesh-list
65366950|NCT00640926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65366951|NCT00640926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65366952|NCT00640926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65366953|NCT00640926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65366954|NCT00640926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366955|NCT00821496|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65366956|NCT00821496|Norethindrone|norethindrone|mesh-list
65366972|NCT02550912|Vitamin D|vitamin d|mesh-list
65366973|NCT02550912|Ergocalciferols|ergocalciferols|mesh-list
65366974|NCT02550912|Cholecalciferol|cholecalciferol|mesh-list
65366975|NCT02550912|Vitamins|vitamins|mesh-list
65366976|NCT02550912|Micronutrients|micronutrients|mesh-ancestor
65366977|NCT02550912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366978|NCT02550912|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65366979|NCT02550912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65366980|NCT00999700|Cisplatin|cisplatin|mesh-list
65366981|NCT00999700|Docetaxel|docetaxel|mesh-list
65366982|NCT00999700|Fluorouracil|fluorouracil|mesh-list
65366983|NCT00999700|Cetuximab|cetuximab|mesh-list
65366984|NCT00999700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65366985|NCT00999700|Tubulin Modulators|tubulin modulators|mesh-ancestor
65366986|NCT00999700|Antimitotic Agents|antimitotic agents|mesh-ancestor
65366987|NCT00999700|Mitosis Modulators|mitosis modulators|mesh-ancestor
65366988|NCT00999700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65366989|NCT00999700|Antimetabolites|antimetabolites|mesh-ancestor
65366990|NCT00999700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65366991|NCT00999700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65366992|NCT00999700|Immunologic Factors|immunologic factors|mesh-ancestor
65366993|NCT00999700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65366994|NCT00999700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65366995|NCT00818298|Ziprasidone|ziprasidone|mesh-list
65366996|NCT00818298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65366997|NCT00818298|Serotonin Agents|serotonin agents|mesh-ancestor
65366998|NCT00818298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65366999|NCT00818298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367000|NCT00818298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367001|NCT00818298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65367007|NCT00821574|Valsartan|valsartan|mesh-list
65367017|NCT00821574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65367018|NCT00995800|Fluticasone|fluticasone|mesh-list
65367019|NCT00995800|Xhance|xhance|mesh-list
65367020|NCT00995800|Formoterol Fumarate|formoterol fumarate|mesh-list
65367021|NCT00995800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65367022|NCT00995800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65367023|NCT00995800|Autonomic Agents|autonomic agents|mesh-ancestor
65367024|NCT00995800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65367025|NCT00995800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367026|NCT00995800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65367027|NCT00995800|Respiratory System Agents|respiratory system agents|mesh-ancestor
65367028|NCT00995800|Dermatologic Agents|dermatologic agents|mesh-ancestor
65367029|NCT00995800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65367030|NCT00995800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65367031|NCT00995800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65367032|NCT00995800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65367033|NCT00995800|Adrenergic Agents|adrenergic agents|mesh-ancestor
65367034|NCT00995800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65367035|NCT00995800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367036|NCT00821652|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65367037|NCT00821652|Freund's Adjuvant|freund's adjuvant|mesh-list
65367038|NCT00821652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65367039|NCT00821652|Immunologic Factors|immunologic factors|mesh-ancestor
65367040|NCT00821652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367041|NCT00319501|Diazepam|diazepam|mesh-list
65367042|NCT00319501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65367043|NCT00319501|Anticonvulsants|anticonvulsants|mesh-ancestor
65367044|NCT00319501|Antiemetics|antiemetics|mesh-ancestor
65367045|NCT00319501|Autonomic Agents|autonomic agents|mesh-ancestor
65367046|NCT00319501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65367058|NCT00319501|Anesthetics|anesthetics|mesh-ancestor
65367062|NCT00319501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367063|NCT00994006|Magnesium citrate|magnesium citrate|mesh-list
65367064|NCT00994006|Magnesium Oxide|magnesium oxide|mesh-list
65367065|NCT00994006|Levulinic acid|levulinic acid|mesh-list
65367066|NCT00994006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367067|NCT00994006|Cathartics|cathartics|mesh-ancestor
65367068|NCT00994006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65367069|NCT00994006|Antacids|antacids|mesh-ancestor
65367070|NCT00994006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367071|NCT00818610|Amoxicillin|amoxicillin|mesh-list
65367072|NCT00818610|Clarithromycin|clarithromycin|mesh-list
65367073|NCT00818610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65367074|NCT00818610|Cefuroxime|cefuroxime|mesh-list
65367075|NCT00818610|Cefuroxime axetil|cefuroxime axetil|mesh-list
65367076|NCT00818610|Lactams|lactams|mesh-list
65367077|NCT00818610|beta-Lactams|beta-lactams|mesh-list
65367078|NCT00818610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65367079|NCT00818610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65367080|NCT00818610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65367081|NCT00818610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367082|NCT00818610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367083|NCT00818610|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65367084|NCT00818610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65367085|NCT00818610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65367086|NCT00761579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65367087|NCT00761579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65367088|NCT00761579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65367089|NCT00761579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65367090|NCT00761579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367091|NCT00761579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65367092|NCT00761579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65367093|NCT00761579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65367094|NCT00761579|Serotonin Agents|serotonin agents|mesh-ancestor
65367099|NCT00761579|Dopamine Agents|dopamine agents|mesh-ancestor
65367102|NCT00627042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367103|NCT00627042|Immunologic Factors|immunologic factors|mesh-ancestor
65367104|NCT00627042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367105|NCT00319111|Bosentan|bosentan|mesh-list
65367106|NCT00319111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65367107|NCT00319111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65367108|NCT00319111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367109|NCT00994396|Vitamin D|vitamin d|mesh-list
65367110|NCT00994396|Cholecalciferol|cholecalciferol|mesh-list
65367111|NCT00994396|Vitamins|vitamins|mesh-ancestor
65367112|NCT00994396|Micronutrients|micronutrients|mesh-ancestor
65367113|NCT00994396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367114|NCT00994396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65367115|NCT00994396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65367116|NCT00816426|Moxifloxacin|moxifloxacin|mesh-list
65367117|NCT00816426|Rifampin|rifampin|mesh-list
65367118|NCT00816426|Isoniazid|isoniazid|mesh-list
65367119|NCT00816426|Pyrazinamide|pyrazinamide|mesh-list
65367120|NCT00816426|Kanamycin|kanamycin|mesh-list
65367121|NCT00816426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65367122|NCT00816426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65367123|NCT00816426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65367124|NCT00816426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65367125|NCT00816426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367126|NCT00816426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367127|NCT00816426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367128|NCT00816426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65367150|NCT00996190|Sympathomimetics|sympathomimetics|mesh-ancestor
65367151|NCT00996190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65367152|NCT00996190|Nasal Decongestants|nasal decongestants|mesh-ancestor
65367153|NCT00996190|Respiratory System Agents|respiratory system agents|mesh-ancestor
65367154|NCT00996190|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65367155|NCT00996190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65367156|NCT00996190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65367157|NCT00996190|Adrenergic Agents|adrenergic agents|mesh-ancestor
65367158|NCT00996190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65367159|NCT00996190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367160|NCT00996190|Protective Agents|protective agents|mesh-ancestor
65367161|NCT00640224|Rosiglitazone|rosiglitazone|mesh-list
65367162|NCT00640224|Drospirenone|drospirenone|mesh-list
65367163|NCT00640224|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65367164|NCT00640224|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65367165|NCT00640224|Estradiol|estradiol|mesh-list
65367166|NCT00640224|Estrogens|estrogens|mesh-ancestor
65367167|NCT00640224|Hormones|hormones|mesh-ancestor
65367168|NCT00640224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65367169|NCT00640224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367170|NCT00640224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65367171|NCT00640224|Contraceptive Agents|contraceptive agents|mesh-ancestor
65367172|NCT00640224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65367173|NCT00640224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65367174|NCT00640224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65367175|NCT00640224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65367198|NCT01001260|Aspirin|aspirin|mesh-list
65367199|NCT01001260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65367200|NCT01001260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65367201|NCT01001260|Analgesics|analgesics|mesh-ancestor
65367202|NCT01001260|Sensory System Agents|sensory system agents|mesh-ancestor
65367203|NCT01001260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65367204|NCT01001260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367205|NCT01001260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65367206|NCT01001260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65367207|NCT01001260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65367208|NCT01001260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65367209|NCT01001260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367210|NCT01001260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65367211|NCT01001260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65367212|NCT01001260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367213|NCT01001260|Antipyretics|antipyretics|mesh-ancestor
65367214|NCT00996424|Acetylcysteine|acetylcysteine|mesh-list
65367215|NCT00996424|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65367216|NCT00996424|Antiviral Agents|antiviral agents|mesh-ancestor
65367217|NCT00996424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65367218|NCT00996424|Expectorants|expectorants|mesh-ancestor
65367219|NCT00996424|Respiratory System Agents|respiratory system agents|mesh-ancestor
65367220|NCT00996424|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65367221|NCT00996424|Antioxidants|antioxidants|mesh-ancestor
65367222|NCT00996424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367223|NCT00996424|Protective Agents|protective agents|mesh-ancestor
65367224|NCT00996424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367225|NCT00996424|Antidotes|antidotes|mesh-ancestor
65367226|NCT05220280|Imatinib Mesylate|imatinib mesylate|mesh-list
65367227|NCT05220280|Infliximab|infliximab|mesh-list
65367228|NCT05220280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367229|NCT05220280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65367241|NCT00318643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65367243|NCT00994708|Esomeprazole|esomeprazole|mesh-list
65367314|NCT01003054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65367315|NCT01003054|Immunologic Factors|immunologic factors|mesh-ancestor
65367316|NCT01003054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367317|NCT01003054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65367318|NCT01003054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65367319|NCT01003054|Alkylating Agents|alkylating agents|mesh-ancestor
65367320|NCT01003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367321|NCT01003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367322|NCT01003054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65367323|NCT01003054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65367324|NCT01003054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367325|NCT01004068|Clomiphene|clomiphene|mesh-list
65367326|NCT01004068|Enclomiphene|enclomiphene|mesh-list
65367327|NCT01004068|Zuclomiphene|zuclomiphene|mesh-list
65367328|NCT01004068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65367329|NCT01004068|Hormone Antagonists|hormone antagonists|mesh-ancestor
65367330|NCT01004068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65367331|NCT01004068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367332|NCT01004068|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65367333|NCT01004068|Fertility Agents|fertility agents|mesh-ancestor
65367334|NCT01004068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65367335|NCT01004068|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65367336|NCT01004068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65367337|NCT01004224|Infigratinib|infigratinib|mesh-list
65367338|NCT01004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367339|NCT00530920|Ritonavir|ritonavir|mesh-list
65367340|NCT00530920|Tipranavir|tipranavir|mesh-list
65367341|NCT00530920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65367342|NCT00530920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65367343|NCT00530920|Protease Inhibitors|protease inhibitors|mesh-ancestor
65367344|NCT00530920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367345|NCT00530920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367356|NCT01003522|Anesthetics, General|anesthetics, general|mesh-list
65367357|NCT01003522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65367358|NCT01003522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367359|NCT01003678|Clofarabine|clofarabine|mesh-list
65367360|NCT01003678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65367361|NCT01003678|Antimetabolites|antimetabolites|mesh-ancestor
65367362|NCT01003678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367363|NCT01003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367364|NCT01004692|Salicylic Acid|salicylic acid|mesh-list
65367365|NCT01004692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65367366|NCT01004692|Antifungal Agents|antifungal agents|mesh-ancestor
65367367|NCT01004692|Keratolytic Agents|keratolytic agents|mesh-ancestor
65367368|NCT01004692|Dermatologic Agents|dermatologic agents|mesh-ancestor
65367369|NCT04000126|Lidocaine|lidocaine|mesh-list
65367370|NCT04000126|Anesthetics, Local|anesthetics, local|mesh-ancestor
65367371|NCT04000126|Anesthetics|anesthetics|mesh-ancestor
65367372|NCT04000126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65367373|NCT04000126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367374|NCT04000126|Sensory System Agents|sensory system agents|mesh-ancestor
65367375|NCT04000126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65367376|NCT04000126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65367377|NCT04000126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65367378|NCT04000126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65367379|NCT04000126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65367381|NCT01008982|Belimumab|belimumab|mesh-list
65367404|NCT01005238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367405|NCT01005238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367406|NCT01005238|Antiviral Agents|antiviral agents|mesh-ancestor
65367407|NCT01005238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65367408|NCT01005238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65367409|NCT01005238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65117265|NCT00535418|Letrozole|letrozole|mesh-list
65367410|NCT01005472|Temozolomide|temozolomide|mesh-list
65367411|NCT01005472|Sunitinib|sunitinib|mesh-list
65367412|NCT01005472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65367413|NCT01005472|Alkylating Agents|alkylating agents|mesh-ancestor
65367414|NCT01005472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367415|NCT01005472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367416|NCT01005472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65367417|NCT01005472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65367418|NCT01005472|Growth Substances|growth substances|mesh-ancestor
65367419|NCT01005472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367420|NCT01005472|Growth Inhibitors|growth inhibitors|mesh-ancestor
65367421|NCT01005472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65367422|NCT01005472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367423|NCT01005550|Ropivacaine|ropivacaine|mesh-list
65367424|NCT01005550|Anesthetics, Local|anesthetics, local|mesh-ancestor
65367425|NCT01005550|Anesthetics|anesthetics|mesh-ancestor
65367426|NCT01005550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65367427|NCT01005550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367428|NCT01005550|Sensory System Agents|sensory system agents|mesh-ancestor
65367429|NCT01005550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65367430|NCT03999580|Vitamin D|vitamin d|mesh-list
65367431|NCT03999580|Cholecalciferol|cholecalciferol|mesh-list
65367432|NCT03999580|Vitamins|vitamins|mesh-ancestor
65367433|NCT03999580|Micronutrients|micronutrients|mesh-ancestor
65367448|NCT00530842|Tiotropium Bromide|tiotropium bromide|mesh-list
65367449|NCT00530842|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65367450|NCT00530842|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65367451|NCT00530842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65367452|NCT00530842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65367453|NCT00530842|Autonomic Agents|autonomic agents|mesh-ancestor
65367454|NCT00530842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65367455|NCT00530842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367456|NCT00530842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65367457|NCT00530842|Respiratory System Agents|respiratory system agents|mesh-ancestor
65367458|NCT00530842|Dermatologic Agents|dermatologic agents|mesh-ancestor
65367459|NCT00530842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65367460|NCT00530842|Parasympatholytics|parasympatholytics|mesh-ancestor
65367461|NCT00530842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65367462|NCT00530842|Cholinergic Agents|cholinergic agents|mesh-ancestor
65367463|NCT00530842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65367464|NCT00530842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367465|NCT00530842|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65367466|NCT00530842|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65367467|NCT00530842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65367468|NCT00530842|Adrenergic Agents|adrenergic agents|mesh-ancestor
65367500|NCT05733364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367501|NCT01006720|Neostigmine|neostigmine|mesh-list
65367502|NCT01006720|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65367503|NCT01006720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367504|NCT01006720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367505|NCT01006720|Cholinergic Agents|cholinergic agents|mesh-ancestor
65367506|NCT01006720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65367507|NCT01006720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367508|NCT01006720|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65367509|NCT01006720|Autonomic Agents|autonomic agents|mesh-ancestor
65367510|NCT01006720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65367511|NCT01006798|Vaccines|vaccines|mesh-list
65367512|NCT01006798|Immunologic Factors|immunologic factors|mesh-ancestor
65367513|NCT01006798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367514|NCT01006876|Warfarin|warfarin|mesh-list
65367515|NCT01006876|Anticoagulants|anticoagulants|mesh-ancestor
65367516|NCT03882424|Bevacizumab|bevacizumab|mesh-list
65367517|NCT03882424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65367518|NCT03882424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367519|NCT03882424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65367520|NCT03882424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65367521|NCT03882424|Growth Substances|growth substances|mesh-ancestor
65367522|NCT03882424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367523|NCT03882424|Growth Inhibitors|growth inhibitors|mesh-ancestor
65367524|NCT03879772|Mometasone Furoate|mometasone furoate|mesh-list
65367525|NCT03879772|Chlorpheniramine|chlorpheniramine|mesh-list
65367549|NCT05732506|Anticoagulants|anticoagulants|mesh-ancestor
65367550|NCT01007500|Dexamethasone|dexamethasone|mesh-list
65367551|NCT01007500|Ondansetron|ondansetron|mesh-list
65367552|NCT01007500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65367553|NCT01007500|Antiemetics|antiemetics|mesh-ancestor
65367554|NCT01007500|Autonomic Agents|autonomic agents|mesh-ancestor
65367555|NCT01007500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65367556|NCT01007500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367557|NCT01007500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65367558|NCT01007500|Glucocorticoids|glucocorticoids|mesh-ancestor
65367559|NCT01007500|Hormones|hormones|mesh-ancestor
65367560|NCT01007500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65367561|NCT01007500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65367562|NCT01007500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367563|NCT01007500|Antipruritics|antipruritics|mesh-ancestor
65367564|NCT01007500|Dermatologic Agents|dermatologic agents|mesh-ancestor
65367565|NCT01007500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65367566|NCT01007500|Serotonin Agents|serotonin agents|mesh-ancestor
65367567|NCT01007500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65367568|NCT01007500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367569|NCT01007500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65367570|NCT01007500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65367571|NCT01007500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65367572|NCT01007500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65367573|NCT01007500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65367574|NCT01007578|Paclitaxel|paclitaxel|mesh-list
65367576|NCT01007578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367597|NCT05129722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65367598|NCT05129722|Diuretics|diuretics|mesh-ancestor
65367599|NCT05129722|Natriuretic Agents|natriuretic agents|mesh-ancestor
65367600|NCT05129722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65367601|NCT05129722|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65367602|NCT05129722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65367603|NCT00642954|Dexamethasone|dexamethasone|mesh-list
65367604|NCT00642954|Lenalidomide|lenalidomide|mesh-list
65367605|NCT00642954|Vorinostat|vorinostat|mesh-list
65367606|NCT00642954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65367607|NCT00642954|Antiemetics|antiemetics|mesh-ancestor
65367608|NCT00642954|Autonomic Agents|autonomic agents|mesh-ancestor
65367609|NCT00642954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65367610|NCT00642954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367611|NCT00642954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65367612|NCT00642954|Glucocorticoids|glucocorticoids|mesh-ancestor
65367613|NCT00642954|Hormones|hormones|mesh-ancestor
65367614|NCT00642954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65367615|NCT00642954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65367616|NCT00642954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367617|NCT00642954|Immunologic Factors|immunologic factors|mesh-ancestor
65367618|NCT00642954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65367619|NCT00642954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65367620|NCT00642954|Growth Substances|growth substances|mesh-ancestor
65367621|NCT00642954|Growth Inhibitors|growth inhibitors|mesh-ancestor
65367622|NCT00642954|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65367623|NCT00642954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367624|NCT00642954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367625|NCT00816660|Factor VIII|factor viii|mesh-list
65367626|NCT00816660|Coagulants|coagulants|mesh-ancestor
65367627|NCT00819000|Interferon-beta|interferon-beta|mesh-list
65367628|NCT00819000|Glatiramer Acetate|glatiramer acetate|mesh-list
65367629|NCT00819000|Interferon beta-1b|interferon beta-1b|mesh-list
65367630|NCT00819000|(T,G)-A-L|(t,g)-a-l|mesh-list
65367631|NCT00819000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65367632|NCT00819000|Immunologic Factors|immunologic factors|mesh-ancestor
65367633|NCT00819000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367634|NCT00819000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64493890|NCT00637377|Growth Inhibitors|growth inhibitors|mesh-ancestor
65367635|NCT00819000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65367636|NCT00819000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367637|NCT00819000|Antiviral Agents|antiviral agents|mesh-ancestor
65367638|NCT00819000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65367639|NCT00640146|Bromides|bromides|mesh-list
65367640|NCT00640146|Methylnaltrexone|methylnaltrexone|mesh-list
65367641|NCT00640146|Anticonvulsants|anticonvulsants|mesh-ancestor
65367642|NCT00640146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65367643|NCT00640146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367644|NCT00640146|Sensory System Agents|sensory system agents|mesh-ancestor
65367645|NCT00640146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65367646|NCT00819078|Bupropion|bupropion|mesh-list
65367647|NCT00819078|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65367648|NCT00819078|Antidepressive Agents|antidepressive agents|mesh-ancestor
65367649|NCT00819078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65367650|NCT00819078|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65367651|NCT00819078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65367652|NCT00819078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65367653|NCT00819078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367654|NCT00819078|Dopamine Agents|dopamine agents|mesh-ancestor
65367655|NCT00819078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65367656|NCT00819078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367657|NCT00819078|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65367658|NCT00819078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65367685|NCT00761267|Anidulafungin|anidulafungin|mesh-list
65367686|NCT00761267|Antifungal Agents|antifungal agents|mesh-ancestor
65367687|NCT00761267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65367688|NCT00761267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65367689|NCT00761267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65367690|NCT00761267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367691|NCT00761267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367692|NCT00761267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65367693|NCT00761267|Hormone Antagonists|hormone antagonists|mesh-ancestor
65367694|NCT00761267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65367695|NCT00761267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367696|NCT00761267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65367697|NCT00761267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65367698|NCT00303667|Vidarabine|vidarabine|mesh-list
65367699|NCT00303667|Aldesleukin|aldesleukin|mesh-list
65367700|NCT00303667|Cyclosporine|cyclosporine|mesh-list
65367701|NCT00303667|Cyclophosphamide|cyclophosphamide|mesh-list
65367702|NCT00303667|Fludarabine|fludarabine|mesh-list
65367703|NCT00303667|Fludarabine phosphate|fludarabine phosphate|mesh-list
65367704|NCT00303667|Interleukin-2|interleukin-2|mesh-list
65367705|NCT00303667|Cyclosporins|cyclosporins|mesh-list
65367706|NCT00303667|Thymoglobulin|thymoglobulin|mesh-list
65367707|NCT00303667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65367708|NCT00303667|Immunologic Factors|immunologic factors|mesh-ancestor
65367709|NCT00303667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367710|NCT00303667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65367711|NCT00303667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65367712|NCT00303667|Alkylating Agents|alkylating agents|mesh-ancestor
65367713|NCT00303667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367714|NCT00303667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367715|NCT00303667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65367728|NCT00303667|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65367729|NCT00303667|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65367730|NCT00761189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65367731|NCT00761189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65367732|NCT00761189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65367733|NCT00761189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65367734|NCT00761189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367735|NCT00761189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65367736|NCT00761189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65367737|NCT00761189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65367738|NCT00761189|Serotonin Agents|serotonin agents|mesh-ancestor
65367739|NCT00761189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65367740|NCT00761189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367741|NCT00761189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65367742|NCT00761189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65367743|NCT00761189|Dopamine Agents|dopamine agents|mesh-ancestor
65367744|NCT01008358|Tremelimumab|tremelimumab|mesh-list
65367745|NCT01008358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367746|NCT01008592|Levocetirizine|levocetirizine|mesh-list
65367747|NCT01008592|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65367748|NCT01008592|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65367749|NCT01008592|Histamine Antagonists|histamine antagonists|mesh-ancestor
65367750|NCT01008592|Histamine Agents|histamine agents|mesh-ancestor
65367751|NCT01008592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65367752|NCT01008592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367753|NCT01008592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367754|NCT01062529|Somatostatin|somatostatin|mesh-list
65367755|NCT01062529|Hormones|hormones|mesh-ancestor
65367756|NCT01062529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65367757|NCT01062529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367758|NCT00760877|Imatinib Mesylate|imatinib mesylate|mesh-list
65367759|NCT00760877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367769|NCT00302731|Estrogens|estrogens|mesh-list
65367770|NCT00302731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65367771|NCT00302731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367772|NCT00302731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65367773|NCT00302731|Contraceptive Agents|contraceptive agents|mesh-ancestor
65367774|NCT00302731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65367775|NCT00302731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65367776|NCT00302731|Progestins|progestins|mesh-ancestor
65367777|NCT00780143|Cytarabine|cytarabine|mesh-list
65367778|NCT00780143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65367779|NCT00780143|Antimetabolites|antimetabolites|mesh-ancestor
65367780|NCT00780143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367781|NCT00780143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367782|NCT00780143|Antiviral Agents|antiviral agents|mesh-ancestor
65367783|NCT00780143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65367784|NCT00780143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65367785|NCT00780143|Immunologic Factors|immunologic factors|mesh-ancestor
65367786|NCT00780143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367787|NCT01007968|Panobinostat|panobinostat|mesh-list
65367788|NCT01007968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367789|NCT01007968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65367790|NCT01007968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367791|NCT01007968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367793|NCT00779909|Cholecalciferol|cholecalciferol|mesh-list
65367794|NCT00779909|Vitamins|vitamins|mesh-ancestor
65367795|NCT00779909|Micronutrients|micronutrients|mesh-ancestor
65367796|NCT00779909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367797|NCT00779909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65367798|NCT00779909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65367799|NCT05559112|Vitamin D|vitamin d|mesh-list
65367800|NCT05559112|Vitamins|vitamins|mesh-ancestor
65367801|NCT05559112|Micronutrients|micronutrients|mesh-ancestor
65367812|NCT00302107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367813|NCT00302107|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65367814|NCT00302107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65367815|NCT00302107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65367816|NCT00302107|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65367817|NCT00302107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65367818|NCT00302107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65367819|NCT00302107|Adrenergic Agents|adrenergic agents|mesh-ancestor
65367820|NCT00302107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65367821|NCT00302107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65367822|NCT00302107|Serotonin Agents|serotonin agents|mesh-ancestor
65367823|NCT00302107|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65367824|NCT02602301|Oxytocin|oxytocin|mesh-list
65367825|NCT02602301|Oxytocics|oxytocics|mesh-ancestor
65367826|NCT02602301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65367827|NCT02602301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367828|NCT00316225|Pemetrexed|pemetrexed|mesh-list
65367829|NCT00316225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367830|NCT00316225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367831|NCT00316225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367832|NCT00316225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65367833|NCT00316225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65367834|NCT00586625|Bepotastine besilate|bepotastine besilate|mesh-list
65367835|NCT00586625|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65367836|NCT00636168|Ipilimumab|ipilimumab|mesh-list
65367837|NCT00636168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65367838|NCT00636168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367839|NCT00636168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65367840|NCT00636168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367841|NCT00759941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65367842|NCT00759941|Latanoprost|latanoprost|mesh-list
65367843|NCT00759941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65367844|NCT00759941|Brinzolamide|brinzolamide|mesh-list
65367852|NCT00315445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65367853|NCT00315445|Analgesics|analgesics|mesh-ancestor
65367854|NCT00315445|Sensory System Agents|sensory system agents|mesh-ancestor
65367855|NCT00315445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65367856|NCT00315445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367857|NCT00315445|Antipyretics|antipyretics|mesh-ancestor
65367858|NCT00315445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65367859|NCT00315445|Narcotics|narcotics|mesh-ancestor
65367860|NCT00315445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65367861|NCT00315445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65367862|NCT00315445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65367863|NCT00315445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65367864|NCT00315445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65367865|NCT03687736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65367866|NCT03687736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65367867|NCT03687736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65367868|NCT03687736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65367869|NCT03687736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367870|NCT03687736|Cholinergic Agents|cholinergic agents|mesh-ancestor
65367871|NCT03687736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65367872|NCT03687736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367873|NCT03687736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65367874|NCT03687736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65367875|NCT00779675|Infliximab|infliximab|mesh-list
65367876|NCT00779675|Dermatologic Agents|dermatologic agents|mesh-ancestor
65367902|NCT05774639|Respiratory System Agents|respiratory system agents|mesh-ancestor
65367903|NCT05774626|Contraceptive Agents|contraceptive agents|mesh-list
65367904|NCT05774626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65367905|NCT05774626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367906|NCT05774574|Cannabidiol|cannabidiol|mesh-list
65367907|NCT05774574|Anticonvulsants|anticonvulsants|mesh-ancestor
65367908|NCT05774275|Doxorubicin|doxorubicin|mesh-list
65367909|NCT05774275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65367910|NCT05774275|Antibodies|antibodies|mesh-list
65367911|NCT05774275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65367912|NCT05774275|Immunologic Factors|immunologic factors|mesh-ancestor
65367913|NCT05774275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367914|NCT05774275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65367915|NCT05774275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65367916|NCT05774275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65367917|NCT05774275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65367918|NCT05774275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65367919|NCT05774275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367920|NCT05774249|Bupivacaine|bupivacaine|mesh-list
65367921|NCT05774249|Anesthetics, Local|anesthetics, local|mesh-ancestor
65367922|NCT05774249|Anesthetics|anesthetics|mesh-ancestor
65367923|NCT05774249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65367924|NCT05774249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367925|NCT05774249|Sensory System Agents|sensory system agents|mesh-ancestor
65367926|NCT05774249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65367927|NCT05774028|Gemcitabine|gemcitabine|mesh-list
65367928|NCT05774028|Dexamethasone|dexamethasone|mesh-list
65367929|NCT05774028|Etoposide|etoposide|mesh-list
65367930|NCT05774028|Mitoxantrone|mitoxantrone|mesh-list
65367931|NCT05774028|Pegaspargase|pegaspargase|mesh-list
65367949|NCT05774028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65367950|NCT05774028|Immunologic Factors|immunologic factors|mesh-ancestor
65367951|NCT05774028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65367952|NCT05774028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65367953|NCT05774028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65367954|NCT05774028|Analgesics|analgesics|mesh-ancestor
65367955|NCT05774028|Sensory System Agents|sensory system agents|mesh-ancestor
65367956|NCT05774015|Magnesium Oxide|magnesium oxide|mesh-list
65367957|NCT05774015|Antacids|antacids|mesh-ancestor
65367958|NCT05774015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367959|NCT05774015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65367960|NCT05773989|Clopidogrel|clopidogrel|mesh-list
65367961|NCT05773989|Ticagrelor|ticagrelor|mesh-list
65367962|NCT05773989|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65367963|NCT05773989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367964|NCT05773989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367965|NCT05773989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65367966|NCT05773989|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65367967|NCT05773989|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65367968|NCT05773989|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65367969|NCT05773989|Purinergic Agents|purinergic agents|mesh-ancestor
65367970|NCT05773989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65367971|NCT05773911|Chitosan|chitosan|mesh-list
65367972|NCT05773911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65367973|NCT05773911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65367974|NCT05773911|Antimetabolites|antimetabolites|mesh-ancestor
65367975|NCT05773911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65367976|NCT05773911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65367977|NCT05773911|Chelating Agents|chelating agents|mesh-ancestor
65367994|NCT05773807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65367995|NCT05773807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65367996|NCT05773807|Anesthetics, General|anesthetics, general|mesh-ancestor
65367997|NCT05773807|Anesthetics|anesthetics|mesh-ancestor
65367998|NCT05773664|Dexamethasone|dexamethasone|mesh-list
65367999|NCT05773664|Dexamethasone acetate|dexamethasone acetate|mesh-list
65368000|NCT05773664|Ichthammol|ichthammol|mesh-list
65368001|NCT05773664|BB 1101|bb 1101|mesh-list
65368002|NCT05773664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65368003|NCT05773664|Antiemetics|antiemetics|mesh-ancestor
65368004|NCT05773664|Autonomic Agents|autonomic agents|mesh-ancestor
65368005|NCT05773664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65368006|NCT05773664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368007|NCT05773664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65368008|NCT05773664|Glucocorticoids|glucocorticoids|mesh-ancestor
65368009|NCT05773664|Hormones|hormones|mesh-ancestor
65368010|NCT05773664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65368011|NCT05773664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65368012|NCT05773664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368013|NCT05773664|Protease Inhibitors|protease inhibitors|mesh-ancestor
65368014|NCT05773664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368015|NCT05773664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368016|NCT05773664|Dermatologic Agents|dermatologic agents|mesh-ancestor
65368017|NCT05773326|Sirolimus|sirolimus|mesh-list
65368018|NCT05773326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65368019|NCT05773326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65368020|NCT05773326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65368021|NCT05773326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368022|NCT05773326|Antifungal Agents|antifungal agents|mesh-ancestor
65368023|NCT05773326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65368024|NCT05773326|Immunologic Factors|immunologic factors|mesh-ancestor
65368025|NCT05773326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368026|NCT05773183|Testosterone|testosterone|mesh-list
65368027|NCT05773183|Androgens|androgens|mesh-ancestor
65368028|NCT05773183|Hormones|hormones|mesh-ancestor
65368029|NCT05773183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65368034|NCT05773092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368035|NCT05773092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368036|NCT05769868|Esmolol|esmolol|mesh-list
65368037|NCT05769868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65368038|NCT05769868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65368039|NCT05769868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65368040|NCT05769868|Adrenergic Agents|adrenergic agents|mesh-ancestor
65368041|NCT05769868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65368042|NCT05769868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368043|NCT05769868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368044|NCT05767398|Zanubrutinib|zanubrutinib|mesh-list
65368045|NCT05767398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368046|NCT05767398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65368047|NCT05767398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368048|NCT05767398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368049|NCT05742438|Lidocaine|lidocaine|mesh-list
65368050|NCT05742438|Dexmedetomidine|dexmedetomidine|mesh-list
65368051|NCT05742438|Morphine|morphine|mesh-list
65368052|NCT05742438|Anesthetics, Local|anesthetics, local|mesh-ancestor
65368091|NCT05695027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368092|NCT05695027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65368093|NCT05695027|Antimetabolites|antimetabolites|mesh-ancestor
65368094|NCT05695027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368095|NCT05695027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65368096|NCT05695027|Vasodilator Agents|vasodilator agents|mesh-ancestor
65368097|NCT05679024|Apixaban|apixaban|mesh-list
65368098|NCT05679024|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65368099|NCT05679024|Antithrombins|antithrombins|mesh-ancestor
65368100|NCT05679024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65368101|NCT05679024|Protease Inhibitors|protease inhibitors|mesh-ancestor
65368102|NCT05679024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368103|NCT05679024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368104|NCT05679024|Anticoagulants|anticoagulants|mesh-ancestor
65368105|NCT05667922|Tacrolimus|tacrolimus|mesh-list
65368106|NCT05667922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65368107|NCT05667922|Immunologic Factors|immunologic factors|mesh-ancestor
65368108|NCT05667922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368109|NCT05667922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65368110|NCT05667922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368111|NCT05667922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368112|NCT05667909|Rituximab|rituximab|mesh-list
65368113|NCT05667909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65368114|NCT05667909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368115|NCT05667909|Immunologic Factors|immunologic factors|mesh-ancestor
65368116|NCT05667909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368117|NCT05667909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65368118|NCT05667896|Tacrolimus|tacrolimus|mesh-list
65368119|NCT05667896|Glucocorticoids|glucocorticoids|mesh-list
65368120|NCT05667896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65368121|NCT05667896|Immunologic Factors|immunologic factors|mesh-ancestor
65368122|NCT05667896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368133|NCT05667883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65368134|NCT05667883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65368135|NCT05667883|Alkylating Agents|alkylating agents|mesh-ancestor
65368136|NCT05667883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368137|NCT05667883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368138|NCT05667883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65368139|NCT05667883|Hormones|hormones|mesh-ancestor
65368140|NCT05667883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65368141|NCT05667805|Thrombin|thrombin|mesh-list
65368142|NCT05667805|Hemostatics|hemostatics|mesh-ancestor
65368143|NCT05667805|Coagulants|coagulants|mesh-ancestor
65368144|NCT05660746|Infliximab|infliximab|mesh-list
65368145|NCT05660746|Dermatologic Agents|dermatologic agents|mesh-ancestor
65368146|NCT05660746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65368193|NCT05554978|Landiolol|landiolol|mesh-list
65368194|NCT05554978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65368195|NCT05554978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65368196|NCT05554978|Adrenergic Agents|adrenergic agents|mesh-ancestor
65368197|NCT05554978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65368198|NCT05554978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368199|NCT05554978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368200|NCT05554978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65368201|NCT05554627|Aripiprazole|aripiprazole|mesh-list
65368202|NCT05554627|Esketamine|esketamine|mesh-list
65368203|NCT05554627|Antidepressive Agents|antidepressive agents|mesh-ancestor
65368204|NCT05554627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65368205|NCT05554627|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65368206|NCT05554627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65368207|NCT05554627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65368208|NCT05554627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368209|NCT05554627|Dopamine Agonists|dopamine agonists|mesh-ancestor
65368210|NCT05554627|Dopamine Agents|dopamine agents|mesh-ancestor
65368211|NCT05554627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65368212|NCT05554627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368213|NCT05554627|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65368214|NCT05554627|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65368215|NCT05554627|Serotonin Agents|serotonin agents|mesh-ancestor
65368216|NCT05554627|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65368217|NCT05554627|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65368218|NCT05554627|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65368219|NCT05554627|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65368220|NCT05546866|Osimertinib|osimertinib|mesh-list
65368221|NCT05546866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368222|NCT05546866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65368223|NCT05546866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368224|NCT05546866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368225|NCT05545969|Pembrolizumab|pembrolizumab|mesh-list
65368226|NCT05545969|Lenvatinib|lenvatinib|mesh-list
65368232|NCT05543642|Vaccines|vaccines|mesh-list
65368233|NCT05543642|Immunologic Factors|immunologic factors|mesh-ancestor
65368234|NCT05543642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368235|NCT05525247|Gemcitabine|gemcitabine|mesh-list
65368236|NCT05525247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65368237|NCT05525247|Antimetabolites|antimetabolites|mesh-ancestor
65368238|NCT05525247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368239|NCT05525247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368240|NCT05525247|Antiviral Agents|antiviral agents|mesh-ancestor
65368241|NCT05525247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65368242|NCT05525247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368243|NCT05525247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65368244|NCT05525247|Immunologic Factors|immunologic factors|mesh-ancestor
65368245|NCT05525247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368246|NCT05494697|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
65368247|NCT05494697|Antiviral Agents|antiviral agents|mesh-ancestor
65368248|NCT05494697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65368250|NCT05476770|Dexamethasone|dexamethasone|mesh-list
65368251|NCT05476770|Hydrocortisone|hydrocortisone|mesh-list
65368252|NCT05476770|Methotrexate|methotrexate|mesh-list
65368253|NCT05476770|Fludarabine|fludarabine|mesh-list
65368254|NCT05476770|Vincristine|vincristine|mesh-list
65368255|NCT05476770|Azacitidine|azacitidine|mesh-list
65368256|NCT05476770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65368257|NCT05476770|Antiemetics|antiemetics|mesh-ancestor
65368258|NCT05476770|Autonomic Agents|autonomic agents|mesh-ancestor
65368259|NCT05476770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65368260|NCT05476770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368261|NCT05476770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65368262|NCT05476770|Glucocorticoids|glucocorticoids|mesh-ancestor
65368263|NCT05476770|Hormones|hormones|mesh-ancestor
65368264|NCT05476770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65368265|NCT05476770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65368266|NCT05476770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368267|NCT05476770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65368274|NCT05476770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368275|NCT05476770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65368276|NCT05476770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65368277|NCT05476770|Immunologic Factors|immunologic factors|mesh-ancestor
65368278|NCT05476770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65368279|NCT05476770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65368280|NCT05476770|Antiviral Agents|antiviral agents|mesh-ancestor
65368281|NCT05476770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65368282|NCT05476770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65368283|NCT05476770|Tubulin Modulators|tubulin modulators|mesh-ancestor
65368284|NCT05476770|Antimitotic Agents|antimitotic agents|mesh-ancestor
65368285|NCT05476770|Mitosis Modulators|mitosis modulators|mesh-ancestor
65368286|NCT05475678|Carboplatin|carboplatin|mesh-list
65368287|NCT05475678|Docetaxel|docetaxel|mesh-list
65368288|NCT05475678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368289|NCT05475678|Tubulin Modulators|tubulin modulators|mesh-ancestor
65368290|NCT05475678|Antimitotic Agents|antimitotic agents|mesh-ancestor
65368291|NCT05475678|Mitosis Modulators|mitosis modulators|mesh-ancestor
65368292|NCT05475678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368293|NCT05438888|Warfarin|warfarin|mesh-list
65368294|NCT05438888|Apixaban|apixaban|mesh-list
65368295|NCT05438888|Anticoagulants|anticoagulants|mesh-ancestor
65368296|NCT05438888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65368297|NCT05438888|Antithrombins|antithrombins|mesh-ancestor
65368298|NCT05438888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65368325|NCT05351736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65368326|NCT05351736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368327|NCT05351736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65368328|NCT05351736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65368329|NCT05351736|Serotonin Agents|serotonin agents|mesh-ancestor
65368330|NCT05351736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65368331|NCT05351736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65368332|NCT05351736|Dopamine Agents|dopamine agents|mesh-ancestor
65368334|NCT05335928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65368335|NCT05335928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368336|NCT05335928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368337|NCT05335928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65368338|NCT05335928|Immunologic Factors|immunologic factors|mesh-ancestor
65368339|NCT05335928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368340|NCT05335928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65368341|NCT05325281|Thioctic Acid|thioctic acid|mesh-list
65368342|NCT05325281|Gemcitabine|gemcitabine|mesh-list
65368343|NCT05325281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65368344|NCT05325281|Antimetabolites|antimetabolites|mesh-ancestor
65368345|NCT05325281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368346|NCT05325281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368347|NCT05325281|Antiviral Agents|antiviral agents|mesh-ancestor
65368348|NCT05325281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65368349|NCT05325281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368350|NCT05325281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65368351|NCT05325281|Immunologic Factors|immunologic factors|mesh-ancestor
65368352|NCT05325281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368353|NCT05325281|Antioxidants|antioxidants|mesh-ancestor
65368354|NCT05325281|Protective Agents|protective agents|mesh-ancestor
65368355|NCT05325281|Vitamin B Complex|vitamin b complex|mesh-ancestor
65368356|NCT05325281|Vitamins|vitamins|mesh-ancestor
65368357|NCT05325281|Micronutrients|micronutrients|mesh-ancestor
65368358|NCT05319561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65368359|NCT05319561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65368366|NCT05303064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65368367|NCT05303064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65368368|NCT05303064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65368369|NCT05303064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65368370|NCT05303064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65368371|NCT05303064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65368372|NCT05303064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65368373|NCT05303064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368374|NCT05303064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65368375|NCT05303064|Serotonin Agents|serotonin agents|mesh-ancestor
65368376|NCT05282108|Imatinib Mesylate|imatinib mesylate|mesh-list
65368377|NCT05282108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368378|NCT05282108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65368379|NCT05282108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368380|NCT05282108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368381|NCT05260008|Epinephrine|epinephrine|mesh-list
65368382|NCT05260008|Bupivacaine|bupivacaine|mesh-list
65368383|NCT05260008|Anesthetics, Local|anesthetics, local|mesh-ancestor
65368384|NCT05260008|Anesthetics|anesthetics|mesh-ancestor
65368385|NCT05260008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65118237|NCT00543218|Katacalcin|katacalcin|mesh-list
65368386|NCT05260008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368387|NCT05260008|Sensory System Agents|sensory system agents|mesh-ancestor
65368388|NCT05260008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65368389|NCT05260008|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65368390|NCT05260008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65368391|NCT05260008|Adrenergic Agents|adrenergic agents|mesh-ancestor
65368392|NCT05260008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65368393|NCT05260008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368394|NCT05260008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65368395|NCT05260008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65368397|NCT05260008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65368398|NCT05260008|Respiratory System Agents|respiratory system agents|mesh-ancestor
65368399|NCT05260008|Mydriatics|mydriatics|mesh-ancestor
65368400|NCT05260008|Sympathomimetics|sympathomimetics|mesh-ancestor
65368401|NCT05260008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64493905|NCT05307718|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
65368402|NCT05255276|Itraconazole|itraconazole|mesh-list
65368403|NCT05255276|Rifampin|rifampin|mesh-list
65368404|NCT05255276|Antifungal Agents|antifungal agents|mesh-ancestor
65368405|NCT05255276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65368406|NCT05255276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65368407|NCT05255276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65368408|NCT05255276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368409|NCT05255276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368410|NCT05255276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65368411|NCT05255276|Hormone Antagonists|hormone antagonists|mesh-ancestor
65368412|NCT05255276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65368413|NCT05255276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368414|NCT05255276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65368415|NCT05255276|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65368416|NCT05255276|Antitubercular Agents|antitubercular agents|mesh-ancestor
65368417|NCT05255276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65368418|NCT05255276|Leprostatic Agents|leprostatic agents|mesh-ancestor
65368419|NCT05255276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65368420|NCT05255276|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65368421|NCT05255276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65368452|NCT05241873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65368453|NCT05227716|Magnesium Sulfate|magnesium sulfate|mesh-list
65368454|NCT05227716|Analgesics|analgesics|mesh-ancestor
65368455|NCT05227716|Sensory System Agents|sensory system agents|mesh-ancestor
65368456|NCT05227716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65118310|NCT00543608|Vancomycin|vancomycin|mesh-list
65368457|NCT05227716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368458|NCT05227716|Anesthetics|anesthetics|mesh-ancestor
65368459|NCT05227716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65368460|NCT05227716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65368461|NCT05227716|Anticonvulsants|anticonvulsants|mesh-ancestor
65368462|NCT05227716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65368463|NCT05227716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65368464|NCT05227716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368465|NCT05227716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65368466|NCT05227716|Tocolytic Agents|tocolytic agents|mesh-ancestor
65368467|NCT05227716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65368468|NCT05201248|Prednisone|prednisone|mesh-list
65368469|NCT05201248|Cyclophosphamide|cyclophosphamide|mesh-list
65368470|NCT05201248|Rituximab|rituximab|mesh-list
65368471|NCT05201248|Doxorubicin|doxorubicin|mesh-list
65368472|NCT05201248|Vincristine|vincristine|mesh-list
65368473|NCT05201248|Lenalidomide|lenalidomide|mesh-list
65368474|NCT05201248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65368475|NCT05201248|Immunologic Factors|immunologic factors|mesh-ancestor
65368501|NCT05195996|Propranolol|propranolol|mesh-list
65368502|NCT05195996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65368503|NCT05195996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65368504|NCT05195996|Adrenergic Agents|adrenergic agents|mesh-ancestor
65368505|NCT05195996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65368506|NCT05195996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368507|NCT05195996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368508|NCT05195996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65368509|NCT05195996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65368510|NCT05195996|Vasodilator Agents|vasodilator agents|mesh-ancestor
65368511|NCT05194397|Niacinamide|niacinamide|mesh-list
65368512|NCT05194397|Niacin|niacin|mesh-list
65368513|NCT05194397|Nicotinic Acids|nicotinic acids|mesh-list
65368514|NCT05194397|Vitamin B Complex|vitamin b complex|mesh-ancestor
65368515|NCT05194397|Vitamins|vitamins|mesh-ancestor
65368516|NCT05194397|Micronutrients|micronutrients|mesh-ancestor
65368517|NCT05194397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368518|NCT05194397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65368519|NCT05194397|Antimetabolites|antimetabolites|mesh-ancestor
65368520|NCT05194397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368521|NCT05194397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65368522|NCT05194397|Vasodilator Agents|vasodilator agents|mesh-ancestor
65368523|NCT05101564|Tamoxifen|tamoxifen|mesh-list
65368524|NCT05101564|Fulvestrant|fulvestrant|mesh-list
65368525|NCT05101564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65368526|NCT05101564|Hormone Antagonists|hormone antagonists|mesh-ancestor
65368527|NCT05101564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65368528|NCT05101564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368529|NCT05101564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65368530|NCT05101564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118385|NCT04638816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65368531|NCT05101564|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65368542|NCT05073484|Immunoglobulins|immunoglobulins|mesh-list
65368543|NCT05073484|Immunologic Factors|immunologic factors|mesh-ancestor
65368544|NCT05073484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368545|NCT05071014|Pembrolizumab|pembrolizumab|mesh-list
65368546|NCT05071014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65368547|NCT05071014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368548|NCT05038228|Vitamin K|vitamin k|mesh-list
65368549|NCT05038228|Rivaroxaban|rivaroxaban|mesh-list
65368550|NCT05038228|Apixaban|apixaban|mesh-list
65368551|NCT05038228|Dabigatran|dabigatran|mesh-list
65368552|NCT05038228|Vitamins|vitamins|mesh-ancestor
65368553|NCT05038228|Micronutrients|micronutrients|mesh-ancestor
65368554|NCT05038228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368555|NCT05038228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65368556|NCT05038228|Antithrombins|antithrombins|mesh-ancestor
65368557|NCT05038228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65368558|NCT05038228|Protease Inhibitors|protease inhibitors|mesh-ancestor
65368559|NCT05038228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368560|NCT05038228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368561|NCT05038228|Anticoagulants|anticoagulants|mesh-ancestor
65368562|NCT05038228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65368563|NCT05038228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65368564|NCT05038228|Hemostatics|hemostatics|mesh-ancestor
65368565|NCT05038228|Coagulants|coagulants|mesh-ancestor
65368566|NCT05025865|Hyaluronic Acid|hyaluronic acid|mesh-list
65368567|NCT05025865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65368568|NCT05025865|Immunologic Factors|immunologic factors|mesh-ancestor
65368594|NCT04994990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65368595|NCT04994990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65368596|NCT04994990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65368597|NCT04994990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65368598|NCT04994990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368599|NCT04994990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65368600|NCT04994990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65368601|NCT04994990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368602|NCT04994990|Cholinergic Agents|cholinergic agents|mesh-ancestor
65368603|NCT04994990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65368604|NCT04976855|Buprenorphine|buprenorphine|mesh-list
65368605|NCT04976855|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65368606|NCT04976855|Naloxone|naloxone|mesh-list
65368607|NCT04976855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65368609|NCT04976855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65368610|NCT04976855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368611|NCT04976855|Analgesics|analgesics|mesh-ancestor
65368612|NCT04976855|Sensory System Agents|sensory system agents|mesh-ancestor
65368613|NCT04976855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65368614|NCT04976855|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65368615|NCT04974216|Rituximab|rituximab|mesh-list
65368616|NCT04974216|Lenalidomide|lenalidomide|mesh-list
65368617|NCT04974216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65368618|NCT04974216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368619|NCT04974216|Immunologic Factors|immunologic factors|mesh-ancestor
65368620|NCT04974216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368621|NCT04974216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65368643|NCT04924699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368644|NCT04907539|Denosumab|denosumab|mesh-list
65368645|NCT04907539|Nivolumab|nivolumab|mesh-list
65368646|NCT04907539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65368647|NCT04907539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368648|NCT04907539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65368649|NCT04907539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368650|NCT04907539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65368651|NCT04907539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368652|NCT04907227|Dexamethasone|dexamethasone|mesh-list
65368653|NCT04907227|Prednisone|prednisone|mesh-list
65368654|NCT04907227|Docetaxel|docetaxel|mesh-list
65368655|NCT04907227|Pembrolizumab|pembrolizumab|mesh-list
65368656|NCT04907227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65368657|NCT04907227|Antiemetics|antiemetics|mesh-ancestor
65368658|NCT04907227|Autonomic Agents|autonomic agents|mesh-ancestor
65368659|NCT04907227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65368660|NCT04907227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368661|NCT04907227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65368662|NCT04907227|Glucocorticoids|glucocorticoids|mesh-ancestor
65368663|NCT04907227|Hormones|hormones|mesh-ancestor
65368664|NCT04907227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65368665|NCT04907227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65368666|NCT04907227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368667|NCT04907227|Tubulin Modulators|tubulin modulators|mesh-ancestor
65368668|NCT04907227|Antimitotic Agents|antimitotic agents|mesh-ancestor
65368669|NCT04907227|Mitosis Modulators|mitosis modulators|mesh-ancestor
65368671|NCT04907227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65368689|NCT04877288|Cyclosporins|cyclosporins|mesh-list
65368690|NCT04877288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65368691|NCT04877288|Immunologic Factors|immunologic factors|mesh-ancestor
65368692|NCT04877288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368693|NCT04877288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65368694|NCT04877288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368695|NCT04877288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368696|NCT04877288|Antifungal Agents|antifungal agents|mesh-ancestor
65368697|NCT04877288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65368698|NCT04877288|Dermatologic Agents|dermatologic agents|mesh-ancestor
65368699|NCT04877288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65368700|NCT04877288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65368701|NCT04877288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368702|NCT04877288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65368703|NCT04877288|Antitubercular Agents|antitubercular agents|mesh-ancestor
65368704|NCT04877288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65368705|NCT04877288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65368706|NCT04873583|Methylprednisolone|methylprednisolone|mesh-list
65368707|NCT04873583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65368708|NCT04873583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65368709|NCT04873583|Prednisolone|prednisolone|mesh-list
65368710|NCT04873583|Prednisolone acetate|prednisolone acetate|mesh-list
65368711|NCT04873583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65368712|NCT04873583|Prednisolone phosphate|prednisolone phosphate|mesh-list
65368713|NCT04873583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65368714|NCT04873583|Antiemetics|antiemetics|mesh-ancestor
65368715|NCT04873583|Autonomic Agents|autonomic agents|mesh-ancestor
65368716|NCT04873583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65368717|NCT04873583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368718|NCT04873583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65368719|NCT04873583|Glucocorticoids|glucocorticoids|mesh-ancestor
65368720|NCT04873583|Hormones|hormones|mesh-ancestor
65368721|NCT04873583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65368722|NCT04873583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65368723|NCT04873583|Protective Agents|protective agents|mesh-ancestor
65368727|NCT04843566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65368728|NCT04830397|Timolol|timolol|mesh-list
65368729|NCT04830397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368730|NCT04830397|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65368731|NCT04830397|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65368732|NCT04830397|Adrenergic Agents|adrenergic agents|mesh-ancestor
65368733|NCT04830397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65368734|NCT04830397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368735|NCT04830397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65368736|NCT04830397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65368737|NCT04815876|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65368738|NCT04815876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65368739|NCT04802590|Venetoclax|venetoclax|mesh-list
65368740|NCT04802590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368741|NCT04776993|Methimazole|methimazole|mesh-list
65368742|NCT04776993|Antithyroid Agents|antithyroid agents|mesh-ancestor
65368743|NCT04776993|Hormone Antagonists|hormone antagonists|mesh-ancestor
65368745|NCT04776993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368786|NCT04652544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368787|NCT04652544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65368788|NCT04652544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65368789|NCT04652076|Paclitaxel|paclitaxel|mesh-list
65368790|NCT04652076|Carboplatin|carboplatin|mesh-list
65368791|NCT04652076|Pembrolizumab|pembrolizumab|mesh-list
65368792|NCT04652076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65368793|NCT04652076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368794|NCT04652076|Tubulin Modulators|tubulin modulators|mesh-ancestor
65368795|NCT04652076|Antimitotic Agents|antimitotic agents|mesh-ancestor
65368796|NCT04652076|Mitosis Modulators|mitosis modulators|mesh-ancestor
65368797|NCT04652076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368798|NCT04652076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65368799|NCT04632069|Acetylcysteine|acetylcysteine|mesh-list
65368849|NCT04547907|Tubulin Modulators|tubulin modulators|mesh-ancestor
65368850|NCT04547907|Antimitotic Agents|antimitotic agents|mesh-ancestor
65368851|NCT04547907|Mitosis Modulators|mitosis modulators|mesh-ancestor
65368852|NCT04547907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368853|NCT04547907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65368854|NCT04545944|Midazolam|midazolam|mesh-list
65368855|NCT04545944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65368856|NCT04545944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65368857|NCT04545944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65368858|NCT04545944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368859|NCT04545944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65368860|NCT04545944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65368861|NCT04545944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65368862|NCT04545944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65368863|NCT04545944|Anesthetics, General|anesthetics, general|mesh-ancestor
65368864|NCT04545944|Anesthetics|anesthetics|mesh-ancestor
65368865|NCT04545944|GABA Modulators|gaba modulators|mesh-ancestor
65368866|NCT04545944|GABA Agents|gaba agents|mesh-ancestor
65368867|NCT04545944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65368868|NCT04545944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368869|NCT04522804|Psilocybin|psilocybin|mesh-list
65368870|NCT04522804|Hallucinogens|hallucinogens|mesh-ancestor
65368871|NCT04522804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368872|NCT04522804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65368873|NCT04460937|Adavosertib|adavosertib|mesh-list
65368874|NCT04460937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368876|NCT04454203|Anesthetics|anesthetics|mesh-list
65368897|NCT04439110|Mitosis Modulators|mitosis modulators|mesh-ancestor
65368898|NCT04439110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368899|NCT04439110|Immunologic Factors|immunologic factors|mesh-ancestor
65368900|NCT04439110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368901|NCT04429555|Ibudilast|ibudilast|mesh-list
65368902|NCT04429555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65368903|NCT04429555|Autonomic Agents|autonomic agents|mesh-ancestor
65368904|NCT04429555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65368905|NCT04429555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368906|NCT04429555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65368907|NCT04429555|Respiratory System Agents|respiratory system agents|mesh-ancestor
65368908|NCT04429555|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65368909|NCT04429555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368910|NCT04429555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118769|NCT05822752|Sorafenib|sorafenib|mesh-list
65368911|NCT04429555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65368912|NCT04429555|Vasodilator Agents|vasodilator agents|mesh-ancestor
65368913|NCT04424303|Tofacitinib|tofacitinib|mesh-list
65368914|NCT04424303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65368915|NCT04424303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65368916|NCT04424303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65368917|NCT04393285|Letrozole|letrozole|mesh-list
65368918|NCT04393285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65368945|NCT04379596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65368946|NCT04374799|Heparin|heparin|mesh-list
64761231|NCT05765825|Carboplatin|carboplatin|mesh-list
64761232|NCT05765825|Etoposide|etoposide|mesh-list
64761233|NCT05765825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369019|NCT04252742|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65369020|NCT04252742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369021|NCT04252742|Analgesics|analgesics|mesh-ancestor
65369022|NCT04252742|Sensory System Agents|sensory system agents|mesh-ancestor
65369023|NCT04252742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65369024|NCT04252742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369025|NCT04212013|Rituximab|rituximab|mesh-list
65369026|NCT04212013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65369027|NCT04212013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369028|NCT04212013|Immunologic Factors|immunologic factors|mesh-ancestor
65369029|NCT04212013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369030|NCT04212013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65369031|NCT04207086|Pembrolizumab|pembrolizumab|mesh-list
65369032|NCT04207086|Lenvatinib|lenvatinib|mesh-list
65369033|NCT04207086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65369034|NCT04207086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369035|NCT04207086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65369036|NCT04207086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369037|NCT04207086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369066|NCT04192955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65369067|NCT04192955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65369068|NCT04192955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65369069|NCT04192955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369070|NCT04192955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369071|NCT04118010|Vitamin D|vitamin d|mesh-list
65369072|NCT04118010|Ergocalciferols|ergocalciferols|mesh-list
65369073|NCT04118010|Cholecalciferol|cholecalciferol|mesh-list
65369074|NCT04118010|Vitamins|vitamins|mesh-list
65369075|NCT04118010|Micronutrients|micronutrients|mesh-ancestor
65369076|NCT04118010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369077|NCT04118010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65369078|NCT04118010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65369079|NCT04113863|Anastrozole|anastrozole|mesh-list
65369080|NCT04113863|Tretinoin|tretinoin|mesh-list
65369081|NCT04113863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65369082|NCT04113863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369083|NCT04113863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65369084|NCT04113863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65369085|NCT04113863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369086|NCT04113863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369087|NCT04113863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65369088|NCT04113863|Hormone Antagonists|hormone antagonists|mesh-ancestor
65369089|NCT04113863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65369090|NCT04113863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369091|NCT04113863|Keratolytic Agents|keratolytic agents|mesh-ancestor
65369092|NCT04113863|Dermatologic Agents|dermatologic agents|mesh-ancestor
65369093|NCT04053491|Anesthetics|anesthetics|mesh-list
65369094|NCT04053491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65369095|NCT04053491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369096|NCT04041232|Glycerol|glycerol|mesh-list
65369097|NCT04041232|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65369098|NCT04041232|Protective Agents|protective agents|mesh-ancestor
65369099|NCT04041232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369100|NCT04030000|Paclitaxel|paclitaxel|mesh-list
65369104|NCT04030000|Tubulin Modulators|tubulin modulators|mesh-ancestor
65369105|NCT04030000|Antimitotic Agents|antimitotic agents|mesh-ancestor
65369106|NCT04030000|Mitosis Modulators|mitosis modulators|mesh-ancestor
65369107|NCT04030000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369108|NCT04010539|Azithromycin|azithromycin|mesh-list
65369109|NCT04010539|Ceftriaxone|ceftriaxone|mesh-list
65369110|NCT04010539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65369111|NCT04010539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65369112|NCT03957590|Paclitaxel|paclitaxel|mesh-list
65369113|NCT03957590|Cisplatin|cisplatin|mesh-list
65369114|NCT03957590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65369115|NCT03957590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369116|NCT03957590|Tubulin Modulators|tubulin modulators|mesh-ancestor
65369117|NCT03957590|Antimitotic Agents|antimitotic agents|mesh-ancestor
65369118|NCT03957590|Mitosis Modulators|mitosis modulators|mesh-ancestor
65369119|NCT03957590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369120|NCT03952637|Sirolimus|sirolimus|mesh-list
65369121|NCT03952637|Prednisone|prednisone|mesh-list
65369122|NCT03952637|Methylprednisolone|methylprednisolone|mesh-list
65369123|NCT03952637|Rituximab|rituximab|mesh-list
65369124|NCT03952637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65369125|NCT03952637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369126|NCT03952637|Immunologic Factors|immunologic factors|mesh-ancestor
65369127|NCT03952637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369128|NCT03952637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65369129|NCT03952637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65369130|NCT03952637|Glucocorticoids|glucocorticoids|mesh-ancestor
65369131|NCT03952637|Hormones|hormones|mesh-ancestor
65369132|NCT03952637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65369133|NCT03952637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65369150|NCT03921866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369151|NCT03921866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65369152|NCT03921866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369153|NCT03921866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369154|NCT03919955|Oxybutynin|oxybutynin|mesh-list
65369155|NCT03919955|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65369156|NCT03919955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65369157|NCT03919955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65369158|NCT03919955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65369159|NCT03919955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369160|NCT03919955|Adrenergic Agents|adrenergic agents|mesh-ancestor
65369161|NCT03919955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65369162|NCT03919955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369163|NCT03919955|Parasympatholytics|parasympatholytics|mesh-ancestor
65369211|NCT03864042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65369212|NCT03864042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65369213|NCT03864042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65369214|NCT03864042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65369215|NCT03864042|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65369216|NCT03864042|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65369217|NCT03864042|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65369218|NCT03864042|Purinergic Agents|purinergic agents|mesh-ancestor
65369219|NCT03864042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65369220|NCT03864042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65369221|NCT03864042|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65369222|NCT03864042|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65369223|NCT03864042|Antidepressive Agents|antidepressive agents|mesh-ancestor
65369224|NCT03864042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65369225|NCT03864042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65369226|NCT03864042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65369227|NCT03864042|Dopamine Agents|dopamine agents|mesh-ancestor
65369228|NCT03864042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65369229|NCT03864042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65369261|NCT03656081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65369262|NCT03656081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65369263|NCT03656081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65369264|NCT03656081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369265|NCT03656081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369331|NCT03599635|Anesthetics|anesthetics|mesh-ancestor
65369332|NCT03599635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65369333|NCT03599635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369334|NCT03599635|Sensory System Agents|sensory system agents|mesh-ancestor
65369335|NCT03599635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65369336|NCT03581292|Temozolomide|temozolomide|mesh-list
65369337|NCT03581292|Veliparib|veliparib|mesh-list
65369338|NCT03581292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65369339|NCT03581292|Alkylating Agents|alkylating agents|mesh-ancestor
65369340|NCT03581292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369341|NCT03581292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369342|NCT03581292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65369343|NCT03581292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369344|NCT03573700|Cyclophosphamide|cyclophosphamide|mesh-list
65369345|NCT03573700|Fludarabine|fludarabine|mesh-list
65369355|NCT03573024|Azacitidine|azacitidine|mesh-list
65369389|NCT03496610|Anesthetics, Local|anesthetics, local|mesh-ancestor
65369390|NCT03496610|Anesthetics|anesthetics|mesh-ancestor
65369391|NCT03496610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65369392|NCT03496610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369393|NCT03496610|Sensory System Agents|sensory system agents|mesh-ancestor
65369394|NCT03496610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65369395|NCT03449485|Chlorprothixene|chlorprothixene|mesh-list
65369396|NCT03449485|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65369397|NCT03449485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65369398|NCT03449485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65369399|NCT03449485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369400|NCT03449485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65369401|NCT03449485|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65369402|NCT03449485|Dopamine Agents|dopamine agents|mesh-ancestor
65369403|NCT03449485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65369404|NCT03449485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369405|NCT03448783|Apixaban|apixaban|mesh-list
65369406|NCT03448783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65369407|NCT03448783|Antithrombins|antithrombins|mesh-ancestor
65369408|NCT03448783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65369409|NCT03448783|Protease Inhibitors|protease inhibitors|mesh-ancestor
65369410|NCT03448783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369411|NCT03448783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369412|NCT03448783|Anticoagulants|anticoagulants|mesh-ancestor
65369413|NCT03434730|Cyclosporine|cyclosporine|mesh-list
65369414|NCT03434730|Mycophenolic Acid|mycophenolic acid|mesh-list
65369415|NCT03434730|Lenograstim|lenograstim|mesh-list
65369416|NCT03434730|Cyclosporins|cyclosporins|mesh-list
65369436|NCT03418649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65119281|NCT05139017|Antimetabolites|antimetabolites|mesh-ancestor
65369437|NCT03418649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369438|NCT03418649|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65369439|NCT03418649|Diuretics|diuretics|mesh-ancestor
65369440|NCT03418649|Natriuretic Agents|natriuretic agents|mesh-ancestor
65369441|NCT03418649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65369443|NCT03406897|Cholecalciferol|cholecalciferol|mesh-list
65369444|NCT03406897|Vitamins|vitamins|mesh-ancestor
65369445|NCT03406897|Micronutrients|micronutrients|mesh-ancestor
65369446|NCT03406897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369447|NCT03406897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65369448|NCT03406897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65369449|NCT03375307|Olaparib|olaparib|mesh-list
65369450|NCT03375307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65369451|NCT03375307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369495|NCT03124355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65369496|NCT03124355|Nootropic Agents|nootropic agents|mesh-ancestor
65369497|NCT03122652|Teriflunomide|teriflunomide|mesh-list
65369498|NCT03122652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65369499|NCT03122652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65369500|NCT03122652|Analgesics|analgesics|mesh-ancestor
65369501|NCT03122652|Sensory System Agents|sensory system agents|mesh-ancestor
65369502|NCT03122652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65369503|NCT03122652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369504|NCT03122652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65369505|NCT03122652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65369506|NCT03122652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65369507|NCT03122652|Immunologic Factors|immunologic factors|mesh-ancestor
65369508|NCT03011268|Adalimumab|adalimumab|mesh-list
65369509|NCT03011268|Golimumab|golimumab|mesh-list
65369510|NCT03011268|Infliximab|infliximab|mesh-list
65369511|NCT03011268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65369512|NCT03011268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65369513|NCT03011268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65369514|NCT03011268|Dermatologic Agents|dermatologic agents|mesh-ancestor
65369515|NCT03011268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65369516|NCT03011268|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65369517|NCT03011268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65369518|NCT03011268|Immunologic Factors|immunologic factors|mesh-ancestor
65369519|NCT03011268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369520|NCT02964559|Pembrolizumab|pembrolizumab|mesh-list
65369521|NCT02964559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65369522|NCT02964559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369523|NCT02944578|Curcumin|curcumin|mesh-list
65369524|NCT02944578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65369542|NCT02889523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369543|NCT02889523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65369544|NCT02889523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65369545|NCT02889523|Alkylating Agents|alkylating agents|mesh-ancestor
65369546|NCT02889523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369547|NCT02889523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369548|NCT02889523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65369549|NCT02889523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65369550|NCT02889523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65369551|NCT02889523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65369552|NCT02889523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65369553|NCT02889523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369554|NCT02889523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65369555|NCT02889523|Tubulin Modulators|tubulin modulators|mesh-ancestor
65369556|NCT02889523|Antimitotic Agents|antimitotic agents|mesh-ancestor
65369557|NCT02889523|Mitosis Modulators|mitosis modulators|mesh-ancestor
65369558|NCT02889523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65369559|NCT02889523|Glucocorticoids|glucocorticoids|mesh-ancestor
65369560|NCT02889523|Hormones|hormones|mesh-ancestor
65369561|NCT02889523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65369562|NCT02889523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65369563|NCT02771626|Nivolumab|nivolumab|mesh-list
65369564|NCT02771626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65369565|NCT02771626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369566|NCT02771626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65369567|NCT02771626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369568|NCT02628067|Pembrolizumab|pembrolizumab|mesh-list
65369569|NCT02628067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65369570|NCT02628067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369571|NCT02616302|Dexlansoprazole|dexlansoprazole|mesh-list
65369578|NCT02546661|Durvalumab|durvalumab|mesh-list
65369583|NCT02546661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65369584|NCT02546661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369585|NCT02546661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369586|NCT02469753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65119426|NCT04949256|Paclitaxel|paclitaxel|mesh-list
65369587|NCT02469753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65369588|NCT02469753|Analgesics|analgesics|mesh-ancestor
65369589|NCT02469753|Sensory System Agents|sensory system agents|mesh-ancestor
65369590|NCT02469753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65369591|NCT02469753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369592|NCT02469753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65369593|NCT02469753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65369594|NCT02375204|Paclitaxel|paclitaxel|mesh-list
65369595|NCT02375204|Etoposide|etoposide|mesh-list
65369596|NCT02375204|Carboplatin|carboplatin|mesh-list
65369597|NCT02375204|Ifosfamide|ifosfamide|mesh-list
65369598|NCT02375204|Etoposide phosphate|etoposide phosphate|mesh-list
65369599|NCT02375204|Lenograstim|lenograstim|mesh-list
65369600|NCT02375204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65369601|NCT02375204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369602|NCT02375204|Tubulin Modulators|tubulin modulators|mesh-ancestor
65369603|NCT02375204|Antimitotic Agents|antimitotic agents|mesh-ancestor
65369604|NCT02375204|Mitosis Modulators|mitosis modulators|mesh-ancestor
65369605|NCT02375204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369606|NCT02375204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65369607|NCT02375204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65369608|NCT02375204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369609|NCT02375204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65369610|NCT02375204|Immunologic Factors|immunologic factors|mesh-ancestor
65369611|NCT02375204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369614|NCT02374242|Nivolumab|nivolumab|mesh-list
65369626|NCT02370329|Antiviral Agents|antiviral agents|mesh-ancestor
65369627|NCT02370329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65369628|NCT02370329|Immunologic Factors|immunologic factors|mesh-ancestor
65369629|NCT02370329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369630|NCT02314988|Tranexamic Acid|tranexamic acid|mesh-list
65369631|NCT02314988|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65369632|NCT02314988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65369633|NCT02314988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369634|NCT02314988|Hemostatics|hemostatics|mesh-ancestor
65369635|NCT02314988|Coagulants|coagulants|mesh-ancestor
65369636|NCT02272790|Gemcitabine|gemcitabine|mesh-list
65369637|NCT02272790|Paclitaxel|paclitaxel|mesh-list
65369638|NCT02272790|Carboplatin|carboplatin|mesh-list
65369639|NCT02272790|Adavosertib|adavosertib|mesh-list
65369640|NCT02272790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65369641|NCT02272790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369642|NCT02272790|Tubulin Modulators|tubulin modulators|mesh-ancestor
65369643|NCT02272790|Antimitotic Agents|antimitotic agents|mesh-ancestor
65369644|NCT02272790|Mitosis Modulators|mitosis modulators|mesh-ancestor
65369645|NCT02272790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369646|NCT02272790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65369647|NCT02272790|Antimetabolites|antimetabolites|mesh-ancestor
65369648|NCT02272790|Antiviral Agents|antiviral agents|mesh-ancestor
65369649|NCT02272790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65369650|NCT02272790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369651|NCT02272790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65369677|NCT01582776|Immunologic Factors|immunologic factors|mesh-ancestor
65369678|NCT01582776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369679|NCT01582776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65369680|NCT01582776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65369681|NCT01582776|Growth Substances|growth substances|mesh-ancestor
65369682|NCT01582776|Growth Inhibitors|growth inhibitors|mesh-ancestor
65369683|NCT01582776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369684|NCT01582776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65369685|NCT01566695|Azacitidine|azacitidine|mesh-list
65369686|NCT01566695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65369687|NCT01566695|Antimetabolites|antimetabolites|mesh-ancestor
65369688|NCT01566695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369689|NCT01566695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369690|NCT01566695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369691|NCT01464164|Prednisone|prednisone|mesh-list
65369692|NCT01464164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65369693|NCT01464164|Glucocorticoids|glucocorticoids|mesh-ancestor
65369694|NCT01464164|Hormones|hormones|mesh-ancestor
65369695|NCT01464164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65369696|NCT01464164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369697|NCT01464164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65369698|NCT01464164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369699|NCT01377389|Ipilimumab|ipilimumab|mesh-list
65369700|NCT01377389|Leuprolide|leuprolide|mesh-list
65369701|NCT01377389|Goserelin|goserelin|mesh-list
65369702|NCT01377389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65369703|NCT01377389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369704|NCT01377389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65369705|NCT01377389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369720|NCT01194271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369721|NCT01194271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65369722|NCT01119508|Temozolomide|temozolomide|mesh-list
65369723|NCT01119508|Ipilimumab|ipilimumab|mesh-list
65369724|NCT01119508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65369725|NCT01119508|Alkylating Agents|alkylating agents|mesh-ancestor
65369726|NCT01119508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369727|NCT01119508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369728|NCT01119508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65369729|NCT01119508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65369730|NCT00769379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65369731|NCT00769379|Trastuzumab|trastuzumab|mesh-list
65369732|NCT00769379|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
65369733|NCT00769379|Antibodies|antibodies|mesh-list
65369734|NCT00769379|Immunoglobulins|immunoglobulins|mesh-list
65369735|NCT00769379|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65369736|NCT00769379|Immunologic Factors|immunologic factors|mesh-ancestor
65119586|NCT04778410|Cytarabine|cytarabine|mesh-list
65369737|NCT00769379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369738|NCT00769379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369739|NCT00602459|Cyclophosphamide|cyclophosphamide|mesh-list
65369740|NCT00602459|Rituximab|rituximab|mesh-list
65369741|NCT00602459|Fludarabine|fludarabine|mesh-list
65369742|NCT00602459|Fludarabine phosphate|fludarabine phosphate|mesh-list
65369743|NCT00602459|Lenalidomide|lenalidomide|mesh-list
65369744|NCT00602459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65369745|NCT00602459|Antibodies|antibodies|mesh-list
65369746|NCT00602459|Immunoglobulins|immunoglobulins|mesh-list
65369747|NCT00602459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65369748|NCT00602459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65369749|NCT00602459|Immunologic Factors|immunologic factors|mesh-ancestor
65369765|NCT00199069|Prednisolone|prednisolone|mesh-list
65369766|NCT00199069|Cyclophosphamide|cyclophosphamide|mesh-list
65369767|NCT00199069|Ifosfamide|ifosfamide|mesh-list
65369768|NCT00199069|Methotrexate|methotrexate|mesh-list
65369769|NCT00199069|Vincristine|vincristine|mesh-list
65369770|NCT00199069|Doxorubicin|doxorubicin|mesh-list
65369771|NCT00199069|Daunorubicin|daunorubicin|mesh-list
65369772|NCT00199069|Asparaginase|asparaginase|mesh-list
65369773|NCT00199069|Mitoxantrone|mitoxantrone|mesh-list
65369774|NCT00199069|Mercaptopurine|mercaptopurine|mesh-list
65369775|NCT00199069|Thioguanine|thioguanine|mesh-list
65369776|NCT00199069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65369777|NCT00199069|Immunologic Factors|immunologic factors|mesh-ancestor
65369778|NCT00199069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369779|NCT00199069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65369780|NCT00199069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65369781|NCT00199069|Alkylating Agents|alkylating agents|mesh-ancestor
65369782|NCT00199069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369783|NCT00199069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369784|NCT00199069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65369785|NCT00199069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65369786|NCT00199069|Antiemetics|antiemetics|mesh-ancestor
65369787|NCT00199069|Autonomic Agents|autonomic agents|mesh-ancestor
65369788|NCT00199069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65369789|NCT00199069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65369790|NCT00199069|Glucocorticoids|glucocorticoids|mesh-ancestor
65369791|NCT00199069|Hormones|hormones|mesh-ancestor
65369793|NCT00199069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65369815|NCT00199043|Rasburicase|rasburicase|mesh-list
65369816|NCT00199043|Antimetabolites|antimetabolites|mesh-ancestor
65369817|NCT00199043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369818|NCT00199043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369819|NCT00199043|Gout Suppressants|gout suppressants|mesh-ancestor
65369820|NCT00199043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65369821|NCT00199043|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65369822|NCT00199043|Antioxidants|antioxidants|mesh-ancestor
65369823|NCT00199043|Protective Agents|protective agents|mesh-ancestor
65369824|NCT00199043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369825|NCT02601989|Tadalafil|tadalafil|mesh-list
65369826|NCT02601989|Vasodilator Agents|vasodilator agents|mesh-ancestor
65369827|NCT02601989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65369828|NCT02601989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65369829|NCT02601989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369830|NCT02601989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369831|NCT02601989|Urological Agents|urological agents|mesh-ancestor
65369832|NCT01067053|Bevacizumab|bevacizumab|mesh-list
65369873|NCT01067365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65369874|NCT01067365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369875|NCT01067365|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65369876|NCT01067365|Fertility Agents|fertility agents|mesh-ancestor
65369877|NCT01067365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65369878|NCT01067365|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65369879|NCT01067365|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65369880|NCT00568776|Inositol|inositol|mesh-list
65369881|NCT00568776|Vitamin B Complex|vitamin b complex|mesh-ancestor
65369882|NCT00568776|Vitamins|vitamins|mesh-ancestor
65369883|NCT00568776|Micronutrients|micronutrients|mesh-ancestor
65369884|NCT00568776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369885|NCT01067443|Amphotericin B|amphotericin b|mesh-list
65369886|NCT01067443|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65369887|NCT01067443|Miltefosine|miltefosine|mesh-list
65369888|NCT01067443|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
65369889|NCT01067443|Amebicides|amebicides|mesh-ancestor
65369890|NCT01067443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65369891|NCT01067443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65369893|NCT01067443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65369894|NCT01067443|Antifungal Agents|antifungal agents|mesh-ancestor
65369895|NCT01067443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65369896|NCT01067443|Schistosomicides|schistosomicides|mesh-ancestor
65369897|NCT01067443|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65369898|NCT01067443|Anthelmintics|anthelmintics|mesh-ancestor
65369899|NCT01065259|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65369900|NCT01065259|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65369901|NCT01065259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65369920|NCT00816816|Antimitotic Agents|antimitotic agents|mesh-ancestor
65369921|NCT00816816|Mitosis Modulators|mitosis modulators|mesh-ancestor
65369922|NCT00816816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369923|NCT00816816|Antimetabolites|antimetabolites|mesh-ancestor
65369924|NCT00816816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65369925|NCT00816816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65369926|NCT00816816|Immunologic Factors|immunologic factors|mesh-ancestor
65369927|NCT00816816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369928|NCT00816894|Olanzapine|olanzapine|mesh-list
65369929|NCT00816894|Antiemetics|antiemetics|mesh-ancestor
65369930|NCT00816894|Autonomic Agents|autonomic agents|mesh-ancestor
65369931|NCT00816894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65369932|NCT00816894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369933|NCT00816894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65369934|NCT00816894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65369935|NCT00816894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65369936|NCT00816894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65369937|NCT00816894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65369938|NCT00816894|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65369939|NCT00816894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65369940|NCT00816894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65369941|NCT00816894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369942|NCT00816894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65369943|NCT00816894|Serotonin Agents|serotonin agents|mesh-ancestor
65369944|NCT00635154|Dexamethasone|dexamethasone|mesh-list
65369945|NCT00635154|Dexamethasone acetate|dexamethasone acetate|mesh-list
65369946|NCT00635154|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65369947|NCT00635154|BB 1101|bb 1101|mesh-list
65369948|NCT00635154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65369949|NCT00635154|Antiemetics|antiemetics|mesh-ancestor
65369950|NCT00635154|Autonomic Agents|autonomic agents|mesh-ancestor
65369951|NCT00635154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65369952|NCT00635154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369953|NCT00635154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65369959|NCT00635154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65369960|NCT00635154|Protease Inhibitors|protease inhibitors|mesh-ancestor
65369961|NCT00635154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65369962|NCT00635154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369963|NCT00822744|Citalopram|citalopram|mesh-list
65369964|NCT00822744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65369965|NCT00822744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65369966|NCT00822744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65369967|NCT00822744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65369968|NCT00822744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65369969|NCT00822744|Serotonin Agents|serotonin agents|mesh-ancestor
65369970|NCT00822744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65369971|NCT00822744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65369972|NCT00822744|Antidepressive Agents|antidepressive agents|mesh-ancestor
65369973|NCT00822744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65369974|NCT00819468|Teduglutide|teduglutide|mesh-list
65369975|NCT00819468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65370015|NCT00756275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370016|NCT00756275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370017|NCT00756275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65370018|NCT00756275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65370019|NCT00756275|Cholinergic Agents|cholinergic agents|mesh-ancestor
65370020|NCT00756275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65370021|NCT00756275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370022|NCT04096547|Rivaroxaban|rivaroxaban|mesh-list
65370023|NCT04096547|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65370024|NCT04096547|Antithrombins|antithrombins|mesh-ancestor
65370025|NCT04096547|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65370026|NCT04096547|Protease Inhibitors|protease inhibitors|mesh-ancestor
65370027|NCT04096547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370028|NCT04096547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370029|NCT04096547|Anticoagulants|anticoagulants|mesh-ancestor
65370030|NCT00298831|Rocuronium|rocuronium|mesh-list
65370031|NCT00298831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65370032|NCT00298831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65370033|NCT00298831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65370034|NCT00298831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370035|NCT00298831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370036|NCT00758069|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65370037|NCT00758069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65370038|NCT00758069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370039|NCT00758069|Incretins|incretins|mesh-ancestor
65370040|NCT00758069|Hormones|hormones|mesh-ancestor
65370041|NCT00758069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65370043|NCT00758069|Protease Inhibitors|protease inhibitors|mesh-ancestor
65370060|NCT01067677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370061|NCT01067677|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65370062|NCT01067677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65370063|NCT01067677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65370064|NCT01067677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65370065|NCT01067677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65370066|NCT01067677|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65370067|NCT01067677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65370068|NCT01067677|Anesthetics, Local|anesthetics, local|mesh-ancestor
65370069|NCT01067677|Anesthetics|anesthetics|mesh-ancestor
65370070|NCT01067677|Sensory System Agents|sensory system agents|mesh-ancestor
65370071|NCT01067677|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65370072|NCT01067677|Histamine Antagonists|histamine antagonists|mesh-ancestor
65370073|NCT01067677|Histamine Agents|histamine agents|mesh-ancestor
65370074|NCT01067677|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65370075|NCT01067677|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65370076|NCT01067677|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65370077|NCT01067677|Dopamine Agents|dopamine agents|mesh-ancestor
65370078|NCT03979651|Hydroxychloroquine|hydroxychloroquine|mesh-list
65370079|NCT03979651|Trametinib|trametinib|mesh-list
65370080|NCT03979651|Antimalarials|antimalarials|mesh-ancestor
65370081|NCT03979651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65370082|NCT03979651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65370083|NCT03979651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65370084|NCT03979651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370085|NCT03979651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370086|NCT03979651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65370087|NCT03979651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65370088|NCT03979651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65370089|NCT02600741|Droperidol|droperidol|mesh-list
65370090|NCT02600741|Haloperidol|haloperidol|mesh-list
65370091|NCT02600741|Pimozide|pimozide|mesh-list
65370092|NCT02600741|Olanzapine|olanzapine|mesh-list
65370093|NCT02600741|Prochlorperazine|prochlorperazine|mesh-list
65370094|NCT02600741|Chlorpromazine|chlorpromazine|mesh-list
65370095|NCT02600741|Trifluoperazine|trifluoperazine|mesh-list
65370104|NCT02600741|Iloperidone|iloperidone|mesh-list
65370105|NCT02600741|Perphenazine|perphenazine|mesh-list
65370106|NCT02600741|Fluphenazine|fluphenazine|mesh-list
65370107|NCT02600741|Fluphenazine depot|fluphenazine depot|mesh-list
65370108|NCT02600741|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
65370109|NCT02600741|Thioridazine|thioridazine|mesh-list
65370110|NCT02600741|Thiothixene|thiothixene|mesh-list
65370111|NCT02600741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65370112|NCT02600741|Serotonin Agents|serotonin agents|mesh-ancestor
65370113|NCT02600741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65370114|NCT02600741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370115|NCT02600741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370116|NCT02600741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65370117|NCT02600741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65370118|NCT02600741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65370119|NCT02600741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65370120|NCT02600741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65370121|NCT02600741|Dopamine Agents|dopamine agents|mesh-ancestor
65370123|NCT02600741|Autonomic Agents|autonomic agents|mesh-ancestor
65370124|NCT02600741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370125|NCT02600741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65370126|NCT02600741|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65370136|NCT02600741|GABA Antagonists|gaba antagonists|mesh-ancestor
65370158|NCT01065727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65370159|NCT01065727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65370160|NCT01065727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65370161|NCT01065727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370230|NCT04840888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65370231|NCT04840888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65370232|NCT04840888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65370233|NCT04840888|Hormone Antagonists|hormone antagonists|mesh-ancestor
65370234|NCT04840888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65370235|NCT04840888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370236|NCT04840888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65370237|NCT04840888|Anticonvulsants|anticonvulsants|mesh-ancestor
65370238|NCT04840888|Antimanic Agents|antimanic agents|mesh-ancestor
65370239|NCT04840888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65370240|NCT04840888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65370241|NCT04840888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65370242|NCT04840888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65370243|NCT04840888|Analgesics|analgesics|mesh-ancestor
65370244|NCT04840888|Sensory System Agents|sensory system agents|mesh-ancestor
65370245|NCT04840888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370246|NCT04840888|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65370247|NCT04840888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65370248|NCT04840888|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65370249|NCT04840888|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65370250|NCT00755807|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65370251|NCT00755807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65370264|NCT05372224|Vitamin D|vitamin d|mesh-list
65370277|NCT00631410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65370278|NCT00631410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370279|NCT00631410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370280|NCT05301712|Naloxone|naloxone|mesh-list
65370281|NCT05301712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65370282|NCT05301712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370283|NCT05301712|Sensory System Agents|sensory system agents|mesh-ancestor
65370284|NCT05301712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370285|NCT00817284|Bevacizumab|bevacizumab|mesh-list
65370286|NCT00817284|Irinotecan|irinotecan|mesh-list
65370287|NCT00817284|Temozolomide|temozolomide|mesh-list
65370288|NCT00817284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65370289|NCT00817284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65370290|NCT00817284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65370291|NCT00817284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65370292|NCT00817284|Growth Substances|growth substances|mesh-ancestor
65370293|NCT00817284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370294|NCT00817284|Growth Inhibitors|growth inhibitors|mesh-ancestor
65370295|NCT00817284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65370296|NCT00817284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65370297|NCT00817284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370298|NCT00817284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370299|NCT00817284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65370300|NCT00817284|Alkylating Agents|alkylating agents|mesh-ancestor
65370301|NCT04096157|Isavuconazole|isavuconazole|mesh-list
65370302|NCT04096157|Antifungal Agents|antifungal agents|mesh-ancestor
65370303|NCT04096157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65370304|NCT00823290|Sorafenib|sorafenib|mesh-list
65370305|NCT00823290|Panobinostat|panobinostat|mesh-list
65370306|NCT00823290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65370307|NCT00823290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65370308|NCT00823290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370311|NCT00755417|Gabapentin|gabapentin|mesh-list
65370319|NCT00755417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65370320|NCT00755417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65370321|NCT00755417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65370322|NCT00755417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65370323|NCT00755417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65370324|NCT00755417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370325|NCT00755417|Antimanic Agents|antimanic agents|mesh-ancestor
65370326|NCT00777803|Botulinum Toxins|botulinum toxins|mesh-list
65370327|NCT00777803|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65370328|NCT00777803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65370329|NCT00777803|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65370330|NCT00777803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65370331|NCT00777803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65370332|NCT00777803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370333|NCT00777803|Cholinergic Agents|cholinergic agents|mesh-ancestor
65370334|NCT00777803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65370335|NCT00777803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370336|NCT00777803|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65370337|NCT00777803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370338|NCT00825864|Dexamethasone|dexamethasone|mesh-list
65370339|NCT00825864|Diclofenac|diclofenac|mesh-list
65370340|NCT00825864|Dexamethasone acetate|dexamethasone acetate|mesh-list
65370341|NCT00825864|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65120155|NCT03266783|Antithrombins|antithrombins|mesh-ancestor
65370368|NCT00527332|Morphine|morphine|mesh-list
65370369|NCT00527332|Bupivacaine|bupivacaine|mesh-list
65370370|NCT00527332|Propofol|propofol|mesh-list
65370371|NCT00527332|Anesthetics, Local|anesthetics, local|mesh-ancestor
65370372|NCT00527332|Anesthetics|anesthetics|mesh-ancestor
65370373|NCT00527332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65370374|NCT00527332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370375|NCT00527332|Sensory System Agents|sensory system agents|mesh-ancestor
65370376|NCT00527332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370377|NCT00527332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65370378|NCT00527332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65370379|NCT00527332|Anesthetics, General|anesthetics, general|mesh-ancestor
65370380|NCT00527332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65370381|NCT00527332|Narcotics|narcotics|mesh-ancestor
65370382|NCT00527332|Analgesics|analgesics|mesh-ancestor
65370383|NCT00527332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65370384|NCT00820092|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
65370385|NCT00820092|Hormones|hormones|mesh-ancestor
65370386|NCT00820092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65370387|NCT00820092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370388|NCT00823602|Buserelin|buserelin|mesh-list
65370389|NCT00823602|Ganirelix|ganirelix|mesh-list
65370390|NCT00823602|Hormone Antagonists|hormone antagonists|mesh-ancestor
65370391|NCT00823602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65370392|NCT00823602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370393|NCT00823602|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65370394|NCT00823602|Fertility Agents|fertility agents|mesh-ancestor
65370395|NCT00823602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65370396|NCT00820326|Dolasetron|dolasetron|mesh-list
65370415|NCT00629772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65370416|NCT00526630|Methylphenidate|methylphenidate|mesh-list
65370417|NCT00526630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65370418|NCT00526630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370419|NCT00526630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65370420|NCT00526630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65370421|NCT00526630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65370422|NCT00526630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370423|NCT00526630|Dopamine Agents|dopamine agents|mesh-ancestor
65370424|NCT00526630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65370425|NCT00755183|Methyltestosterone|methyltestosterone|mesh-list
65370426|NCT00755183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65370427|NCT00755183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65370428|NCT00755183|Testosterone|testosterone|mesh-list
65370429|NCT00755183|Testosterone undecanoate|testosterone undecanoate|mesh-list
65370430|NCT00755183|Testosterone enanthate|testosterone enanthate|mesh-list
65370431|NCT00755183|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65370432|NCT00755183|Androgens|androgens|mesh-ancestor
65370433|NCT00755183|Hormones|hormones|mesh-ancestor
65370434|NCT00755183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65370435|NCT00755183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370436|NCT00755183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65370437|NCT00755183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65370438|NCT00755183|Anabolic Agents|anabolic agents|mesh-ancestor
65370465|NCT00754793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65370466|NCT00754793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65370467|NCT00754793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370468|NCT00754793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65370469|NCT00754793|Serotonin Agents|serotonin agents|mesh-ancestor
65370470|NCT00754793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370471|NCT00754793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65370472|NCT00754793|Antidepressive Agents|antidepressive agents|mesh-ancestor
65370473|NCT00754793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65370474|NCT00754793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65370475|NCT00754793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65370476|NCT00754793|Parasympatholytics|parasympatholytics|mesh-ancestor
65370525|NCT00826644|Etoposide|etoposide|mesh-list
65370526|NCT00826644|Belotecan|belotecan|mesh-list
65370527|NCT00826644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65370528|NCT00826644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65370529|NCT00826644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65370530|NCT00826644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65370531|NCT00826644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370532|NCT00826644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370533|NCT00826644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65370534|NCT00826722|Levetiracetam|levetiracetam|mesh-list
65370535|NCT00826722|Anticonvulsants|anticonvulsants|mesh-ancestor
65370536|NCT00826722|Nootropic Agents|nootropic agents|mesh-ancestor
65370537|NCT04922944|Vaccines|vaccines|mesh-list
65370538|NCT04922944|Immunologic Factors|immunologic factors|mesh-ancestor
65370539|NCT04922944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370540|NCT05198050|Letrozole|letrozole|mesh-list
65370541|NCT05198050|Alprostadil|alprostadil|mesh-list
65370542|NCT05198050|Misoprostol|misoprostol|mesh-list
65370544|NCT05198050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65370582|NCT00628758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370583|NCT00628758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370584|NCT00628758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65370585|NCT00628758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65370586|NCT00628758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65370587|NCT00628758|Adrenergic Agents|adrenergic agents|mesh-ancestor
65370588|NCT00628758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65370589|NCT00628758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370590|NCT00821028|Paclitaxel|paclitaxel|mesh-list
65370591|NCT00821028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65370592|NCT00821028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65370593|NCT00821028|Tubulin Modulators|tubulin modulators|mesh-ancestor
65370594|NCT00821028|Antimitotic Agents|antimitotic agents|mesh-ancestor
65370595|NCT00821028|Mitosis Modulators|mitosis modulators|mesh-ancestor
65370596|NCT00821028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370597|NCT00827034|Warfarin|warfarin|mesh-list
65370598|NCT00827034|Anticoagulants|anticoagulants|mesh-ancestor
65370599|NCT02600585|Vaccines|vaccines|mesh-list
65370600|NCT02600585|Immunologic Factors|immunologic factors|mesh-ancestor
65370601|NCT02600585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370602|NCT00525148|Afatinib|afatinib|mesh-list
65370603|NCT00525148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65370604|NCT00525148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65370607|NCT00754325|Dasatinib|dasatinib|mesh-list
65370632|NCT00298363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65370633|NCT00298363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65370634|NCT00298363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370635|NCT00298363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370636|NCT00298363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65370637|NCT00298363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65370638|NCT00821262|Propofol|propofol|mesh-list
65370639|NCT00821262|Sevoflurane|sevoflurane|mesh-list
65370640|NCT00821262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65370641|NCT00821262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65370642|NCT00821262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370643|NCT00821262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65370644|NCT00821262|Anesthetics, General|anesthetics, general|mesh-ancestor
65370645|NCT00821262|Anesthetics|anesthetics|mesh-ancestor
65370646|NCT00821262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65370647|NCT00821262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65370648|NCT00524368|Ritonavir|ritonavir|mesh-list
65370649|NCT00524368|Darunavir|darunavir|mesh-list
65370650|NCT00524368|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65370651|NCT00524368|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65370652|NCT00524368|Protease Inhibitors|protease inhibitors|mesh-ancestor
65370653|NCT00524368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370654|NCT00524368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370655|NCT00524368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65370656|NCT00524368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65370657|NCT00524368|Antiviral Agents|antiviral agents|mesh-ancestor
65370658|NCT00524368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65370659|NCT00524368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65370660|NCT00524368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65370661|NCT00777101|Capecitabine|capecitabine|mesh-list
65370662|NCT00777101|Lapatinib|lapatinib|mesh-list
65370663|NCT00777101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65370664|NCT00777101|Antimetabolites|antimetabolites|mesh-ancestor
64763030|NCT01285817|Analgesics|analgesics|mesh-ancestor
64493906|NCT05307718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64493907|NCT05307718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
64493908|NCT05307718|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
64493909|NCT05307718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64493910|NCT05307718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64493911|NCT05307718|Antimetabolites|antimetabolites|mesh-ancestor
65370665|NCT00777101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370666|NCT00777101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65370667|NCT00777101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65370668|NCT00777101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370669|NCT00830856|Lamivudine|lamivudine|mesh-list
65370670|NCT00830856|Nevirapine|nevirapine|mesh-list
65370671|NCT00830856|Stavudine|stavudine|mesh-list
65370672|NCT00830856|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
65370673|NCT00830856|Fluconazole|fluconazole|mesh-list
65370674|NCT00830856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65370675|NCT00830856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65370676|NCT00830856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370677|NCT00830856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370678|NCT00830856|Antiviral Agents|antiviral agents|mesh-ancestor
65370679|NCT00830856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65370680|NCT00830856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65370681|NCT00830856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65370682|NCT00830856|Antifungal Agents|antifungal agents|mesh-ancestor
65370683|NCT00830856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65370684|NCT00830856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65370685|NCT00830856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65370686|NCT00830856|Hormone Antagonists|hormone antagonists|mesh-ancestor
65370687|NCT00830856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65370688|NCT00830856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370711|NCT00524134|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65370712|NCT00524134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65370713|NCT00524134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65370715|NCT00524134|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65370716|NCT00524134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65370717|NCT00777023|Gabapentin|gabapentin|mesh-list
65370718|NCT00777023|Analgesics|analgesics|mesh-ancestor
65370719|NCT00777023|Sensory System Agents|sensory system agents|mesh-ancestor
65370777|NCT04095455|Anesthetics|anesthetics|mesh-ancestor
65370778|NCT04095455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65370779|NCT04095455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65370780|NCT04095455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65370781|NCT04095455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65370782|NCT04095455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370783|NCT04095299|Capecitabine|capecitabine|mesh-list
65370784|NCT04095299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65120576|NCT00545519|Immunologic Factors|immunologic factors|mesh-ancestor
65370785|NCT04095299|Antimetabolites|antimetabolites|mesh-ancestor
65370786|NCT04095299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370788|NCT00296725|Fluoxetine|fluoxetine|mesh-list
65370789|NCT00296725|Imipramine|imipramine|mesh-list
65370790|NCT00296725|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65370791|NCT00296725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65370792|NCT00296725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65370793|NCT00296725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370794|NCT00296725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65370795|NCT00296725|Serotonin Agents|serotonin agents|mesh-ancestor
65370796|NCT00296725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370797|NCT00296725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65370798|NCT00296725|Antidepressive Agents|antidepressive agents|mesh-ancestor
65370806|NCT00523978|Sotalol|sotalol|mesh-list
65370826|NCT00296647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65370827|NCT00296647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370828|NCT00296647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65370829|NCT00296647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65370830|NCT00296647|Cholinergic Agents|cholinergic agents|mesh-ancestor
65370831|NCT00296647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65370832|NCT00296647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370833|NCT00296647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65370834|NCT00296647|Antidepressive Agents|antidepressive agents|mesh-ancestor
65370835|NCT00296647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65370836|NCT00296647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65370837|NCT00296647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65370838|NCT00296647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65370839|NCT00296647|Dopamine Agents|dopamine agents|mesh-ancestor
65370840|NCT00296647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65370841|NCT00296647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65370842|NCT00296647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370843|NCT00754013|Donepezil|donepezil|mesh-list
65370844|NCT00754013|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65370845|NCT00754013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370846|NCT00754013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370847|NCT00754013|Cholinergic Agents|cholinergic agents|mesh-ancestor
65370848|NCT00754013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65370849|NCT00754013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65370850|NCT00754013|Nootropic Agents|nootropic agents|mesh-ancestor
65370873|NCT03979625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65370874|NCT03979625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65370946|NCT04093271|Antiemetics|antiemetics|mesh-ancestor
65370947|NCT04093271|Autonomic Agents|autonomic agents|mesh-ancestor
65370948|NCT04093271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65370949|NCT04093271|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65370950|NCT04093271|Histamine Antagonists|histamine antagonists|mesh-ancestor
65370951|NCT04093271|Histamine Agents|histamine agents|mesh-ancestor
65370952|NCT04093271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65370953|NCT04093271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370954|NCT04093271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65370955|NCT04093271|Antipruritics|antipruritics|mesh-ancestor
65370956|NCT04093271|Dermatologic Agents|dermatologic agents|mesh-ancestor
65370957|NCT00827580|Eniluracil|eniluracil|mesh-list
65370958|NCT00827580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65370959|NCT00827580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370960|NCT04094909|Paclitaxel|paclitaxel|mesh-list
65370961|NCT04094909|Cisplatin|cisplatin|mesh-list
65370962|NCT04094909|Carboplatin|carboplatin|mesh-list
65370963|NCT04094909|Pembrolizumab|pembrolizumab|mesh-list
65370964|NCT04094909|Pemetrexed|pemetrexed|mesh-list
65370965|NCT04094909|Endostatins|endostatins|mesh-list
65370966|NCT04094909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65370967|NCT04094909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65370968|NCT04094909|Tubulin Modulators|tubulin modulators|mesh-ancestor
65370969|NCT04094909|Antimitotic Agents|antimitotic agents|mesh-ancestor
65370970|NCT04094909|Mitosis Modulators|mitosis modulators|mesh-ancestor
65370971|NCT04094909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65370972|NCT04094909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65370996|NCT00296491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65370997|NCT00296491|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65370998|NCT00296491|Autonomic Agents|autonomic agents|mesh-ancestor
65370999|NCT00296491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65371000|NCT00296491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371001|NCT00296491|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65371002|NCT00296491|Respiratory System Agents|respiratory system agents|mesh-ancestor
65371003|NCT00296491|Dermatologic Agents|dermatologic agents|mesh-ancestor
65371004|NCT00296491|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65371005|NCT00296491|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65371006|NCT00296491|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65371007|NCT00296491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65371008|NCT00296491|Adrenergic Agents|adrenergic agents|mesh-ancestor
65371009|NCT00296491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65371010|NCT00296491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371011|NCT00296491|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65371012|NCT00296491|Hormone Antagonists|hormone antagonists|mesh-ancestor
65371013|NCT00296491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65371014|NCT00296491|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65371015|NCT00296491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65371017|NCT00296491|Hormones|hormones|mesh-ancestor
65371018|NCT00296491|Sympathomimetics|sympathomimetics|mesh-ancestor
65371019|NCT00747617|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65371020|NCT00747617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65371021|NCT00747617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371022|NCT02599493|Rifampin|rifampin|mesh-list
65371043|NCT00296335|Floxuridine|floxuridine|mesh-list
65371044|NCT00296335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371045|NCT00296335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65371046|NCT00296335|Alkylating Agents|alkylating agents|mesh-ancestor
65371047|NCT00296335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371048|NCT00296335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65371049|NCT00296335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371050|NCT00296335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65371051|NCT00296335|Antimetabolites|antimetabolites|mesh-ancestor
65371052|NCT00296335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65371053|NCT00296335|Immunologic Factors|immunologic factors|mesh-ancestor
65371054|NCT00296335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371055|NCT00296335|Appetite Stimulants|appetite stimulants|mesh-ancestor
65371056|NCT00296335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65371057|NCT04094597|Lactoferrin|lactoferrin|mesh-list
65371058|NCT04094597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65371059|NCT01065961|Dexamethasone|dexamethasone|mesh-list
65371060|NCT01065961|Dexamethasone acetate|dexamethasone acetate|mesh-list
65371061|NCT01065961|BB 1101|bb 1101|mesh-list
65371062|NCT01065961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65371063|NCT01065961|Antiemetics|antiemetics|mesh-ancestor
65371064|NCT01065961|Autonomic Agents|autonomic agents|mesh-ancestor
65371065|NCT01065961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65371066|NCT01065961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371093|NCT02600273|Nicotine|nicotine|mesh-list
65371094|NCT02600273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65371095|NCT02600273|Autonomic Agents|autonomic agents|mesh-ancestor
65371096|NCT02600273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65371097|NCT02600273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371098|NCT02600273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65371099|NCT02600273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65371100|NCT02600273|Cholinergic Agents|cholinergic agents|mesh-ancestor
65371101|NCT02600273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65371102|NCT02600273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371103|NCT04219774|Aspirin|aspirin|mesh-list
65371104|NCT04219774|Clopidogrel|clopidogrel|mesh-list
65371105|NCT04219774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65371106|NCT04219774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65371107|NCT04219774|Analgesics|analgesics|mesh-ancestor
65371108|NCT04219774|Sensory System Agents|sensory system agents|mesh-ancestor
65371109|NCT04219774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65371110|NCT04219774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371111|NCT04219774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65371112|NCT04219774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65371113|NCT04219774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65371114|NCT04219774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65371115|NCT04219774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371116|NCT04219774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65371117|NCT04219774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65371118|NCT04219774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371119|NCT04219774|Antipyretics|antipyretics|mesh-ancestor
65371141|NCT04999228|Sensory System Agents|sensory system agents|mesh-ancestor
65371142|NCT04999228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65371143|NCT04999228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371144|NCT04999228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65371145|NCT01564810|Cetuximab|cetuximab|mesh-list
65371146|NCT01564810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65371147|NCT01564810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371148|NCT04092101|Nicotine|nicotine|mesh-list
65371149|NCT04092101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65371150|NCT04092101|Autonomic Agents|autonomic agents|mesh-ancestor
65371151|NCT04092101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65371152|NCT04092101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371153|NCT04092101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65120940|NCT00549146|Adrenergic Agents|adrenergic agents|mesh-ancestor
65371154|NCT04092101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65371155|NCT04092101|Cholinergic Agents|cholinergic agents|mesh-ancestor
65371156|NCT04092101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65371157|NCT04092101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371159|NCT04093895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65371160|NCT04093895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65371161|NCT04093895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371162|NCT00624780|Pregabalin|pregabalin|mesh-list
65371163|NCT00624780|Lorazepam|lorazepam|mesh-list
65371164|NCT00624780|Analgesics|analgesics|mesh-ancestor
65371165|NCT00624780|Sensory System Agents|sensory system agents|mesh-ancestor
65371166|NCT00624780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65371167|NCT00624780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371168|NCT00624780|Anticonvulsants|anticonvulsants|mesh-ancestor
65371169|NCT00624780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65371170|NCT00624780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65371173|NCT00624780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65371185|NCT02599337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371186|NCT02599337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65371187|NCT02599337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371188|NCT02599337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371189|NCT00831636|Cytarabine|cytarabine|mesh-list
65371190|NCT00831636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65371191|NCT00831636|Antimetabolites|antimetabolites|mesh-ancestor
65371192|NCT00831636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371193|NCT00831636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371194|NCT00831636|Antiviral Agents|antiviral agents|mesh-ancestor
65371195|NCT00831636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65371196|NCT00831636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65371197|NCT00831636|Immunologic Factors|immunologic factors|mesh-ancestor
65371198|NCT00831636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371199|NCT00750737|Amphotericin B|amphotericin b|mesh-list
65371200|NCT00750737|Posaconazole|posaconazole|mesh-list
65371201|NCT00750737|Amebicides|amebicides|mesh-ancestor
65371202|NCT00750737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65371203|NCT00750737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65371204|NCT00750737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65371239|NCT02597699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65371240|NCT02597699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65371241|NCT02597699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371242|NCT02597699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65371243|NCT02597699|Narcotics|narcotics|mesh-ancestor
65371244|NCT02597699|Analgesics|analgesics|mesh-ancestor
65371245|NCT02597699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65371246|NCT02597699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65371247|NCT02597699|Anesthetics, General|anesthetics, general|mesh-ancestor
65371248|NCT02574910|Abiraterone Acetate|abiraterone acetate|mesh-list
65371249|NCT02574910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371250|NCT02574910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65371251|NCT02574910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371252|NCT02574910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371253|NCT02574910|Hormone Antagonists|hormone antagonists|mesh-ancestor
65371254|NCT02574910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65371255|NCT02574910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371256|NCT02574910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65371257|NCT00744653|Bleomycin|bleomycin|mesh-list
65371258|NCT00744653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65371259|NCT00744653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371260|NCT00998218|Ranolazine|ranolazine|mesh-list
65371261|NCT00998218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65371262|NCT00998218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65371287|NCT00311311|Antifungal Agents|antifungal agents|mesh-ancestor
65371288|NCT04089605|Dexamethasone|dexamethasone|mesh-list
65371289|NCT04089605|Dexamethasone acetate|dexamethasone acetate|mesh-list
65371290|NCT04089605|Ranibizumab|ranibizumab|mesh-list
65371291|NCT04089605|BB 1101|bb 1101|mesh-list
65371292|NCT04089605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65371293|NCT04089605|Antiemetics|antiemetics|mesh-ancestor
65371294|NCT04089605|Autonomic Agents|autonomic agents|mesh-ancestor
65371295|NCT04089605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65371296|NCT04089605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371297|NCT04089605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65371298|NCT04089605|Glucocorticoids|glucocorticoids|mesh-ancestor
65371299|NCT04089605|Hormones|hormones|mesh-ancestor
65371300|NCT04089605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65371301|NCT04089605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65371302|NCT04089605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371303|NCT04089605|Protease Inhibitors|protease inhibitors|mesh-ancestor
65371304|NCT04089605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371305|NCT04089605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371306|NCT04089605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65371307|NCT04089605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65371308|NCT04089605|Growth Substances|growth substances|mesh-ancestor
65371309|NCT04089605|Growth Inhibitors|growth inhibitors|mesh-ancestor
65371310|NCT00521404|Gemcitabine|gemcitabine|mesh-list
65371312|NCT00521404|Immunologic Factors|immunologic factors|mesh-ancestor
65371313|NCT00521404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371314|NCT00521404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65371315|NCT00521404|Antimetabolites|antimetabolites|mesh-ancestor
65371317|NCT00521404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371334|NCT00311155|Natriuretic Agents|natriuretic agents|mesh-ancestor
65371335|NCT00311155|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65371336|NCT00311155|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65371337|NCT00311155|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65371338|NCT03981601|Lovastatin|lovastatin|mesh-list
65371339|NCT03981601|L 647318|l 647318|mesh-list
65371340|NCT03981601|Dihydromevinolin|dihydromevinolin|mesh-list
65371341|NCT03981601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65371342|NCT03981601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65371343|NCT03981601|Antimetabolites|antimetabolites|mesh-ancestor
65371344|NCT03981601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371345|NCT03981601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65371346|NCT03981601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65371347|NCT03981601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371348|NCT00274651|Belinostat|belinostat|mesh-list
65371349|NCT00274651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371350|NCT00274651|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65371351|NCT00274651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371390|NCT01068847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65371391|NCT01068847|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65371392|NCT01068847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65371393|NCT01068847|Renal Agents|renal agents|mesh-ancestor
65371394|NCT01068847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65371395|NCT01068847|Antitubercular Agents|antitubercular agents|mesh-ancestor
65371396|NCT01068847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65371397|NCT01068847|Antimetabolites|antimetabolites|mesh-ancestor
65371398|NCT01068847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65371399|NCT01068847|Analgesics|analgesics|mesh-ancestor
65371400|NCT01068847|Anticonvulsants|anticonvulsants|mesh-ancestor
65371401|NCT01068847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65371402|NCT01068847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65371403|NCT01068847|Parasympatholytics|parasympatholytics|mesh-ancestor
65371404|NCT01068847|Autonomic Agents|autonomic agents|mesh-ancestor
65371405|NCT01068847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65371406|NCT01068847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65371407|NCT01068847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65371408|NCT01068847|Adrenergic Agents|adrenergic agents|mesh-ancestor
65371409|NCT01068847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65371410|NCT00827892|Pioglitazone|pioglitazone|mesh-list
65371411|NCT00827892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65371412|NCT00827892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371413|NCT01070875|Heparin|heparin|mesh-list
65371414|NCT01070875|Calcium heparin|calcium heparin|mesh-list
65371415|NCT01070875|Anticoagulants|anticoagulants|mesh-ancestor
65371441|NCT00521014|Sargramostim|sargramostim|mesh-list
65371442|NCT00521014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65371443|NCT00521014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371444|NCT00521014|Immunologic Factors|immunologic factors|mesh-ancestor
65371445|NCT00521014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371446|NCT00521014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65371447|NCT00521014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65371448|NCT00521014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65371449|NCT00521014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65371450|NCT00521014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371451|NCT00521014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371452|NCT00521014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65371453|NCT00521014|Antimetabolites|antimetabolites|mesh-ancestor
65371454|NCT00521014|Antiviral Agents|antiviral agents|mesh-ancestor
65371455|NCT00521014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65371456|NCT00521014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65371457|NCT00521014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65371458|NCT00521014|Alkylating Agents|alkylating agents|mesh-ancestor
65371459|NCT00521014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65371460|NCT00825552|Risperidone|risperidone|mesh-list
65371461|NCT00825552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65371462|NCT00825552|Serotonin Agents|serotonin agents|mesh-ancestor
65371463|NCT00825552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65371464|NCT00825552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371465|NCT00825552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371466|NCT00825552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65371467|NCT00825552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65371468|NCT00825552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65371469|NCT00825552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65371484|NCT00291577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65371485|NCT00291577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371486|NCT00520936|Pemetrexed|pemetrexed|mesh-list
65371487|NCT00520936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371488|NCT00520936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371489|NCT00520936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371490|NCT00520936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65371491|NCT00520936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65371492|NCT02549430|Letrozole|letrozole|mesh-list
65371493|NCT02549430|Fulvestrant|fulvestrant|mesh-list
65371494|NCT02549430|Palbociclib|palbociclib|mesh-list
65371495|NCT02549430|Anastrozole|anastrozole|mesh-list
65371496|NCT02549430|Exemestane|exemestane|mesh-list
65371497|NCT02549430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371498|NCT02549430|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65371499|NCT02549430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65371500|NCT02549430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371501|NCT02549430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371502|NCT02549430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65371503|NCT02549430|Hormone Antagonists|hormone antagonists|mesh-ancestor
65371504|NCT02549430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65371505|NCT02549430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371506|NCT02549430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65371507|NCT02549430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65371508|NCT02549430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65371509|NCT00943839|Sunitinib|sunitinib|mesh-list
65371510|NCT00943839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371511|NCT00943839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65371530|NCT00952497|Antimetabolites|antimetabolites|mesh-ancestor
65371531|NCT00952497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371532|NCT00828282|Simvastatin|simvastatin|mesh-list
65371533|NCT00828282|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65371534|NCT00828282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65371535|NCT00828282|Antimetabolites|antimetabolites|mesh-ancestor
65371536|NCT00828282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371537|NCT00828282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65371538|NCT00828282|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65371539|NCT00828282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371540|NCT00952575|Immunoglobulins|immunoglobulins|mesh-list
65371541|NCT00952575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65371542|NCT00952575|Antibodies|antibodies|mesh-list
65371543|NCT00952575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65371544|NCT00952575|gamma-Globulins|gamma-globulins|mesh-list
65371545|NCT00952575|Immunologic Factors|immunologic factors|mesh-ancestor
65371546|NCT00952575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371547|NCT03865732|Pregnanolone|pregnanolone|mesh-list
65371548|NCT03865732|Ganaxolone|ganaxolone|mesh-list
65371549|NCT03865732|Neurosteroids|neurosteroids|mesh-ancestor
65371550|NCT03865732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65371551|NCT03865732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371552|NCT03865732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371553|NCT03865732|GABA Modulators|gaba modulators|mesh-ancestor
65371554|NCT03865732|GABA Agents|gaba agents|mesh-ancestor
65371555|NCT03865732|Anesthetics|anesthetics|mesh-ancestor
65371556|NCT03865732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65371557|NCT00944307|Raltegravir Potassium|raltegravir potassium|mesh-list
65371558|NCT00944307|Antacids|antacids|mesh-list
65371560|NCT00944307|TEMPO|tempo|mesh-list
65371561|NCT00944307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65371575|NCT00944385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65371576|NCT00944385|Protease Inhibitors|protease inhibitors|mesh-ancestor
65371577|NCT00944385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371578|NCT00944385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371579|NCT00953355|Metformin|metformin|mesh-list
65371580|NCT00953355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65371581|NCT00953355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371582|NCT00944463|Gemcitabine|gemcitabine|mesh-list
65371583|NCT00944463|Simvastatin|simvastatin|mesh-list
65371584|NCT00944463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65371585|NCT00944463|Antimetabolites|antimetabolites|mesh-ancestor
65371586|NCT00944463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371587|NCT00944463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371588|NCT00944463|Antiviral Agents|antiviral agents|mesh-ancestor
65371589|NCT00944463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65371590|NCT00944463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371591|NCT00944463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65371592|NCT00944463|Immunologic Factors|immunologic factors|mesh-ancestor
65371593|NCT00944463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371594|NCT00944463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65371595|NCT00944463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65371596|NCT00944463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65371597|NCT00944463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65371598|NCT00956397|Rifaximin|rifaximin|mesh-list
65371599|NCT00956397|Lactulose|lactulose|mesh-list
65371600|NCT00956397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65371601|NCT00956397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65371602|NCT00956397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65371603|NCT05300373|Adenosine|adenosine|mesh-list
65371604|NCT05300373|Analgesics|analgesics|mesh-ancestor
65121394|NCT05172791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65371605|NCT05300373|Sensory System Agents|sensory system agents|mesh-ancestor
65371617|NCT00953589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371618|NCT00953589|Antiviral Agents|antiviral agents|mesh-ancestor
65371619|NCT00953589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65371620|NCT00947739|Camptothecin|camptothecin|mesh-list
65371621|NCT00947739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65371622|NCT00947739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371623|NCT00947739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65371624|NCT00947739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65371625|NCT00947739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371626|NCT00947739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371627|NCT00956787|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
65371628|NCT00956787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65371629|NCT00956787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371630|NCT00947895|Methylprednisolone|methylprednisolone|mesh-list
65371631|NCT00947895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65371632|NCT00947895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65371633|NCT00947895|Prednisolone|prednisolone|mesh-list
65371634|NCT00947895|Prednisolone acetate|prednisolone acetate|mesh-list
65371635|NCT00947895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65371636|NCT00947895|Prednisolone phosphate|prednisolone phosphate|mesh-list
65371637|NCT00947895|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65371638|NCT00947895|Hormones|hormones|mesh-ancestor
65371639|NCT00947895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65371640|NCT00947895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371641|NCT00947895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65371642|NCT00947895|Antiemetics|antiemetics|mesh-ancestor
65371643|NCT00947895|Autonomic Agents|autonomic agents|mesh-ancestor
65371644|NCT00947895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65371645|NCT00947895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65371646|NCT00947895|Glucocorticoids|glucocorticoids|mesh-ancestor
65371647|NCT00947895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65371648|NCT00947895|Protective Agents|protective agents|mesh-ancestor
65371649|NCT00947895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64493912|NCT05307718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556376|NCT04023149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556377|NCT04023149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556378|NCT04023149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64556379|NCT04023149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64556380|NCT04023149|Antiviral Agents|antiviral agents|mesh-ancestor
65371650|NCT00947895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371651|NCT00623766|Dexamethasone|dexamethasone|mesh-list
65371652|NCT00623766|Prednisone|prednisone|mesh-list
65371653|NCT00623766|Methylprednisolone|methylprednisolone|mesh-list
65371654|NCT00623766|Prednisolone|prednisolone|mesh-list
65371655|NCT00623766|Triamcinolone|triamcinolone|mesh-list
65371656|NCT00623766|Hydrocortisone|hydrocortisone|mesh-list
65371657|NCT00623766|Betamethasone|betamethasone|mesh-list
65371658|NCT00623766|Fludrocortisone|fludrocortisone|mesh-list
65371659|NCT00623766|Ipilimumab|ipilimumab|mesh-list
65371660|NCT00623766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65371661|NCT00623766|Antiemetics|antiemetics|mesh-ancestor
65371662|NCT00623766|Autonomic Agents|autonomic agents|mesh-ancestor
65371663|NCT00623766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65371664|NCT00623766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371665|NCT00623766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65371666|NCT00623766|Glucocorticoids|glucocorticoids|mesh-ancestor
65371667|NCT00623766|Hormones|hormones|mesh-ancestor
65371668|NCT00623766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65371669|NCT00623766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65371670|NCT00623766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371671|NCT00623766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65371672|NCT00623766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65371673|NCT00623766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371674|NCT00623766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65371675|NCT00623766|Protective Agents|protective agents|mesh-ancestor
65371676|NCT00623766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65371699|NCT00954135|Sorafenib|sorafenib|mesh-list
65371700|NCT00954135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65371701|NCT00954135|Immunologic Factors|immunologic factors|mesh-ancestor
65371702|NCT00954135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371703|NCT00954135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65371704|NCT00954135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65371705|NCT00954135|Alkylating Agents|alkylating agents|mesh-ancestor
65371706|NCT00954135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371707|NCT00954135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371708|NCT00954135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65371709|NCT00954135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65371710|NCT00954135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371711|NCT00832806|Varenicline|varenicline|mesh-list
65371712|NCT00832806|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65371713|NCT00832806|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65371714|NCT00832806|Cholinergic Agents|cholinergic agents|mesh-ancestor
65371715|NCT00832806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65371716|NCT00832806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371717|NCT00832806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371718|NCT00832884|Lacosamide|lacosamide|mesh-list
65371719|NCT00832884|Anticonvulsants|anticonvulsants|mesh-ancestor
65371720|NCT00832884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65371721|NCT00832884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65371722|NCT00832884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65371723|NCT00832884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371747|NCT00957177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65371748|NCT00957177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65371749|NCT00957177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371750|NCT00957177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65371751|NCT00957177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65371752|NCT00957177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65371753|NCT00957177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65371754|NCT00957177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65371755|NCT04337580|Omeprazole|omeprazole|mesh-list
65371756|NCT04337580|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65371757|NCT04337580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65371758|NCT04337580|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65371759|NCT04337580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371760|NCT04337580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371762|NCT00828594|Everolimus|everolimus|mesh-list
65371763|NCT00828594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371764|NCT00828594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65371765|NCT00828594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371766|NCT00828594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371767|NCT00828594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65371768|NCT00828594|Immunologic Factors|immunologic factors|mesh-ancestor
65371769|NCT00828594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371770|NCT00550407|Lamotrigine|lamotrigine|mesh-list
65371797|NCT00954525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371798|NCT00954525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65371799|NCT00954525|Immunologic Factors|immunologic factors|mesh-ancestor
65371800|NCT00954525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65371801|NCT00838032|Haloperidol|haloperidol|mesh-list
65371802|NCT00838032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65371803|NCT00838032|Haloperidol decanoate|haloperidol decanoate|mesh-list
65371804|NCT00838032|Antidepressive Agents|antidepressive agents|mesh-ancestor
65371805|NCT00838032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65371806|NCT00838032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65371807|NCT00838032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65371808|NCT00838032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65371809|NCT00838032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371810|NCT00838032|Antiemetics|antiemetics|mesh-ancestor
65371811|NCT00838032|Autonomic Agents|autonomic agents|mesh-ancestor
65371812|NCT00838032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65371813|NCT00838032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65371814|NCT00838032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65371815|NCT00838032|Dopamine Agents|dopamine agents|mesh-ancestor
65371816|NCT00838032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65371817|NCT00838032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371818|NCT00838032|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65371819|NCT00954603|Haloperidol|haloperidol|mesh-list
65371820|NCT00954603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65371821|NCT00954603|Haloperidol decanoate|haloperidol decanoate|mesh-list
65371822|NCT00954603|Antidepressive Agents|antidepressive agents|mesh-ancestor
65371823|NCT00954603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65371824|NCT00954603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65371825|NCT00954603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65371826|NCT00954603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65371827|NCT00954603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371828|NCT00954603|Antiemetics|antiemetics|mesh-ancestor
65371841|NCT00531934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371842|NCT02548806|Clonidine|clonidine|mesh-list
65371843|NCT02548806|Analgesics|analgesics|mesh-ancestor
65371844|NCT02548806|Sensory System Agents|sensory system agents|mesh-ancestor
65371845|NCT02548806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65371846|NCT02548806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371847|NCT02548806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65371848|NCT02548806|Sympatholytics|sympatholytics|mesh-ancestor
65371849|NCT02548806|Autonomic Agents|autonomic agents|mesh-ancestor
65371850|NCT02548806|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65371851|NCT02548806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65371852|NCT02548806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65371853|NCT02548806|Adrenergic Agents|adrenergic agents|mesh-ancestor
65371854|NCT02548806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65371855|NCT02548806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371856|NCT00549939|Alfuzosin|alfuzosin|mesh-list
65371857|NCT00549939|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65371858|NCT00549939|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65371859|NCT00549939|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65371860|NCT00549939|Adrenergic Agents|adrenergic agents|mesh-ancestor
65371861|NCT00549939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65371862|NCT00549939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371863|NCT00549939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371864|NCT00549939|Urological Agents|urological agents|mesh-ancestor
65371865|NCT00272779|Emtricitabine|emtricitabine|mesh-list
65371866|NCT00272779|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65371887|NCT00957879|Vitamins|vitamins|mesh-ancestor
65371888|NCT00957879|Micronutrients|micronutrients|mesh-ancestor
65371889|NCT00957879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65371890|NCT00838266|Grape Seed Extract|grape seed extract|mesh-list
65371891|NCT00838266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65371892|NCT00838266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371893|NCT00838266|Antioxidants|antioxidants|mesh-ancestor
65371894|NCT00838266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371895|NCT00838266|Protective Agents|protective agents|mesh-ancestor
65371896|NCT00838266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371897|NCT04011033|Cyclophosphamide|cyclophosphamide|mesh-list
65371898|NCT04011033|Interleukin-2|interleukin-2|mesh-list
65371899|NCT04011033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65371900|NCT04011033|Immunologic Factors|immunologic factors|mesh-ancestor
65371901|NCT04011033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371902|NCT04011033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65371903|NCT04011033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65371904|NCT04011033|Alkylating Agents|alkylating agents|mesh-ancestor
65371906|NCT04011033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371942|NCT00958269|Incretins|incretins|mesh-ancestor
65371943|NCT00958269|Hormones|hormones|mesh-ancestor
65371944|NCT00958269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65371945|NCT00958269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65371946|NCT00958269|Protease Inhibitors|protease inhibitors|mesh-ancestor
65371947|NCT00958269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371948|NCT00958269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371949|NCT02547402|CXA-10|cxa-10|mesh-list
65371950|NCT02547402|Simvastatin|simvastatin|mesh-list
65371951|NCT02547402|Ezetimibe|ezetimibe|mesh-list
65371952|NCT02547402|Pravastatin|pravastatin|mesh-list
65371953|NCT02547402|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
65371954|NCT02547402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65371955|NCT02547402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65371956|NCT02547402|Antimetabolites|antimetabolites|mesh-ancestor
65371957|NCT02547402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371958|NCT02547402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65371959|NCT02547402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65371960|NCT02547402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371961|NCT02547402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65371962|NCT01068925|Dolutegravir|dolutegravir|mesh-list
65371963|NCT01068925|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65371964|NCT01068925|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65371965|NCT01068925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371966|NCT01068925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371967|NCT01068925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65371968|NCT01068925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65371969|NCT01068925|Antiviral Agents|antiviral agents|mesh-ancestor
65371970|NCT01068925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65371971|NCT00834600|Amlodipine|amlodipine|mesh-list
65371972|NCT00834600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65371973|NCT00834600|Olmesartan|olmesartan|mesh-list
65371974|NCT00834600|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65371982|NCT00834600|Diuretics|diuretics|mesh-ancestor
65371983|NCT00834600|Natriuretic Agents|natriuretic agents|mesh-ancestor
65371984|NCT00834600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65371985|NCT00834600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65371986|NCT00834600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65371987|NCT00958425|Hyaluronic Acid|hyaluronic acid|mesh-list
65371988|NCT00958425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65371989|NCT00958425|Immunologic Factors|immunologic factors|mesh-ancestor
65371990|NCT00958425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65371991|NCT00958425|Viscosupplements|viscosupplements|mesh-ancestor
65371992|NCT00958425|Protective Agents|protective agents|mesh-ancestor
65371993|NCT02547480|Irinotecan|irinotecan|mesh-list
65371994|NCT02547480|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65371995|NCT02547480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65371996|NCT02547480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65371997|NCT02547480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65371998|NCT02547480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65371999|NCT00838656|Gemcitabine|gemcitabine|mesh-list
65372000|NCT00838656|Paclitaxel|paclitaxel|mesh-list
65372001|NCT00838656|Carboplatin|carboplatin|mesh-list
65372002|NCT00838656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65372003|NCT00838656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372004|NCT00838656|Tubulin Modulators|tubulin modulators|mesh-ancestor
65372005|NCT00838656|Antimitotic Agents|antimitotic agents|mesh-ancestor
65372006|NCT00838656|Mitosis Modulators|mitosis modulators|mesh-ancestor
65372007|NCT00838656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372008|NCT00838656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65372009|NCT00838656|Antimetabolites|antimetabolites|mesh-ancestor
65372010|NCT00838656|Antiviral Agents|antiviral agents|mesh-ancestor
65372011|NCT00838656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65372012|NCT00838656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372013|NCT00838656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65372014|NCT00838656|Immunologic Factors|immunologic factors|mesh-ancestor
65372015|NCT00838656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372016|NCT00829608|Vaccines|vaccines|mesh-list
65372017|NCT00829608|Immunologic Factors|immunologic factors|mesh-ancestor
65372023|NCT00553605|Analgesics|analgesics|mesh-ancestor
65372024|NCT00553605|Sensory System Agents|sensory system agents|mesh-ancestor
65372025|NCT00553605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65372026|NCT00553605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372027|NCT00553605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65372028|NCT00553605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65372029|NCT00553605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65372030|NCT00553605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372031|NCT00553605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372032|NCT00553605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65372033|NCT00838968|Interferons|interferons|mesh-list
65372034|NCT00838968|Interferon-alpha|interferon-alpha|mesh-list
65372035|NCT00838968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372036|NCT00838968|Antiviral Agents|antiviral agents|mesh-ancestor
65372037|NCT00838968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65372038|NCT00838968|Immunologic Factors|immunologic factors|mesh-ancestor
65372039|NCT00838968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372040|NCT04010955|Edoxaban|edoxaban|mesh-list
65372041|NCT04010955|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65372042|NCT04010955|Antithrombins|antithrombins|mesh-ancestor
65372043|NCT04010955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65372044|NCT04010955|Protease Inhibitors|protease inhibitors|mesh-ancestor
65372045|NCT04010955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372046|NCT04010955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372047|NCT04010955|Anticoagulants|anticoagulants|mesh-ancestor
65372048|NCT05352165|Pembrolizumab|pembrolizumab|mesh-list
65372049|NCT05352165|Fluorouracil|fluorouracil|mesh-list
65372050|NCT05352165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65372051|NCT05352165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372052|NCT05352165|Antimetabolites|antimetabolites|mesh-ancestor
65372053|NCT05352165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372054|NCT05352165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65372055|NCT05352165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65372063|NCT00948987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65372064|NCT00948987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372065|NCT00948987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65372066|NCT00948987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65372067|NCT00948987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65372068|NCT00948987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65372069|NCT00948987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372070|NCT00948987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65372071|NCT00948987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65372072|NCT00948987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372073|NCT00948987|Antipyretics|antipyretics|mesh-ancestor
65372074|NCT00744497|Prednisone|prednisone|mesh-list
65372075|NCT00744497|Docetaxel|docetaxel|mesh-list
65372076|NCT00744497|Dasatinib|dasatinib|mesh-list
65372077|NCT00744497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372078|NCT00744497|Tubulin Modulators|tubulin modulators|mesh-ancestor
65372079|NCT00744497|Antimitotic Agents|antimitotic agents|mesh-ancestor
65372080|NCT00744497|Mitosis Modulators|mitosis modulators|mesh-ancestor
65372081|NCT00744497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372082|NCT00744497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65372083|NCT00744497|Glucocorticoids|glucocorticoids|mesh-ancestor
65372084|NCT00744497|Hormones|hormones|mesh-ancestor
65372085|NCT00744497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65372086|NCT00744497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372087|NCT00744497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65372088|NCT00744497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65372089|NCT00744497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372110|NCT00955227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372111|NCT00955227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65372112|NCT00949299|Buprenorphine|buprenorphine|mesh-list
65372113|NCT00949299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65372114|NCT00949299|Narcotics|narcotics|mesh-ancestor
65372115|NCT00949299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65372116|NCT00949299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372117|NCT00949299|Analgesics|analgesics|mesh-ancestor
65372118|NCT00949299|Sensory System Agents|sensory system agents|mesh-ancestor
65372119|NCT00949299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65372120|NCT00949299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65372121|NCT00747149|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65372122|NCT00747149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65372123|NCT00747149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65372124|NCT00747149|Antimetabolites|antimetabolites|mesh-ancestor
65372125|NCT00747149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372126|NCT00747149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65372127|NCT00747149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65372128|NCT00747149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372129|NCT00271609|Bevacizumab|bevacizumab|mesh-list
65372130|NCT00271609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65372131|NCT00271609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372132|NCT00271609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65372133|NCT00271609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65372134|NCT00271609|Growth Substances|growth substances|mesh-ancestor
65372135|NCT00271609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372136|NCT00271609|Growth Inhibitors|growth inhibitors|mesh-ancestor
65372137|NCT00548847|Interferons|interferons|mesh-list
65372138|NCT00548847|Interferon-alpha|interferon-alpha|mesh-list
65372139|NCT00548847|Interferon alpha-2|interferon alpha-2|mesh-list
65372140|NCT00548847|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65372141|NCT00548847|Molgramostim|molgramostim|mesh-list
65372142|NCT00548847|Sargramostim|sargramostim|mesh-list
65372152|NCT00949377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372153|NCT00949377|Sensory System Agents|sensory system agents|mesh-ancestor
65372154|NCT00949377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65372155|NCT00290407|Rituximab|rituximab|mesh-list
65372156|NCT00290407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65372157|NCT00290407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372158|NCT00290407|Immunologic Factors|immunologic factors|mesh-ancestor
65372159|NCT00290407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372160|NCT00290407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65372161|NCT02597387|Mitoxantrone|mitoxantrone|mesh-list
65372162|NCT02597387|Analgesics|analgesics|mesh-ancestor
65372163|NCT02597387|Sensory System Agents|sensory system agents|mesh-ancestor
65372164|NCT02597387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65372165|NCT02597387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372166|NCT02597387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372167|NCT02597387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65372168|NCT02597387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65372169|NCT02597387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372170|NCT02597387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372171|NCT01069081|Cisplatin|cisplatin|mesh-list
65372172|NCT01069081|Docetaxel|docetaxel|mesh-list
65372173|NCT01069081|Esomeprazole|esomeprazole|mesh-list
65372174|NCT01069081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372175|NCT01069081|Tubulin Modulators|tubulin modulators|mesh-ancestor
65372176|NCT01069081|Antimitotic Agents|antimitotic agents|mesh-ancestor
65372177|NCT01069081|Mitosis Modulators|mitosis modulators|mesh-ancestor
65372178|NCT01069081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372179|NCT01069081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65372180|NCT01069081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65372181|NCT01069081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65372182|NCT01069081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372183|NCT00949455|Lapatinib|lapatinib|mesh-list
65372184|NCT00949455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372185|NCT00949455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65372186|NCT00949455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372188|NCT05296161|Ocrelizumab|ocrelizumab|mesh-list
65372191|NCT00955695|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65372192|NCT00955695|Gefitinib|gefitinib|mesh-list
65372193|NCT00955695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372194|NCT00955695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65372195|NCT00955695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372196|NCT00955695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372197|NCT00955773|Everolimus|everolimus|mesh-list
65372198|NCT00955773|Trametinib|trametinib|mesh-list
65372199|NCT00955773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372200|NCT00955773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65372201|NCT00955773|Immunologic Factors|immunologic factors|mesh-ancestor
65372202|NCT00955773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372203|NCT00955773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65372204|NCT00955773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372205|NCT00955773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372206|NCT00549549|Celecoxib|celecoxib|mesh-list
65372207|NCT00549549|Indomethacin|indomethacin|mesh-list
65372208|NCT00549549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65372209|NCT00549549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65372210|NCT00549549|Analgesics|analgesics|mesh-ancestor
65372211|NCT00549549|Sensory System Agents|sensory system agents|mesh-ancestor
65372212|NCT00549549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65372213|NCT00549549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372214|NCT00549549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65372215|NCT00549549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65372216|NCT00549549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65372217|NCT00549549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65372218|NCT00549549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372219|NCT00549549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372220|NCT00549549|Gout Suppressants|gout suppressants|mesh-ancestor
65372221|NCT00549549|Tocolytic Agents|tocolytic agents|mesh-ancestor
65372222|NCT00549549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65372233|NCT00622284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65372234|NCT00622284|Protease Inhibitors|protease inhibitors|mesh-ancestor
65372235|NCT00622284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372236|NCT00622284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372237|NCT00269113|Rituximab|rituximab|mesh-list
65372238|NCT00269113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65372239|NCT00269113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372240|NCT00269113|Immunologic Factors|immunologic factors|mesh-ancestor
65372241|NCT00269113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372242|NCT00269113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65372243|NCT00956007|Cetuximab|cetuximab|mesh-list
65372244|NCT00956007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65372245|NCT00956007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372246|NCT01069159|Propranolol|propranolol|mesh-list
65372247|NCT01069159|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65372248|NCT01069159|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65372249|NCT01069159|Adrenergic Agents|adrenergic agents|mesh-ancestor
65372250|NCT01069159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65372251|NCT01069159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372252|NCT01069159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372253|NCT01069159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65372254|NCT01069159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65372255|NCT01069159|Vasodilator Agents|vasodilator agents|mesh-ancestor
65372256|NCT03975205|Doxorubicin|doxorubicin|mesh-list
65372257|NCT03975205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65372258|NCT03975205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372259|NCT03975205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65372260|NCT03975205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65372261|NCT03975205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372262|NCT03975205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372263|NCT01325779|Heparin|heparin|mesh-list
65372264|NCT01325779|Enoxaparin|enoxaparin|mesh-list
65372275|NCT00956163|Cariostatic Agents|cariostatic agents|mesh-ancestor
65372276|NCT00956163|Protective Agents|protective agents|mesh-ancestor
65372277|NCT00956163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372278|NCT00956163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65372279|NCT00956163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65372280|NCT00956163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65372281|NCT00956163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372282|NCT00956163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65372283|NCT00956319|Estazolam|estazolam|mesh-list
65372284|NCT00956319|Zolpidem|zolpidem|mesh-list
65372285|NCT00956319|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65372286|NCT00956319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65372287|NCT00956319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65372288|NCT00956319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372289|NCT00956319|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65372290|NCT00956319|GABA Agonists|gaba agonists|mesh-ancestor
65372291|NCT00956319|GABA Agents|gaba agents|mesh-ancestor
65372292|NCT00956319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65372293|NCT00956319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372294|NCT00956319|Anticonvulsants|anticonvulsants|mesh-ancestor
65372295|NCT00956319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65372296|NCT00956319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65372297|NCT00956319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65372326|NCT00830466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65372327|NCT00830466|Immunologic Factors|immunologic factors|mesh-ancestor
65372328|NCT00830466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372329|NCT00843570|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65372330|NCT00843570|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65372331|NCT00843570|Nafarelin|nafarelin|mesh-list
65372332|NCT00843570|Estradiol|estradiol|mesh-list
65372333|NCT00843570|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65372334|NCT00843570|Progesterone|progesterone|mesh-list
65372335|NCT00843570|Estrogens|estrogens|mesh-ancestor
65372336|NCT00843570|Hormones|hormones|mesh-ancestor
65372337|NCT00843570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65372338|NCT00843570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372339|NCT00843570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65372340|NCT00843570|Contraceptive Agents|contraceptive agents|mesh-ancestor
65372341|NCT00843570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65372342|NCT00843570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65372343|NCT00843570|Progestins|progestins|mesh-ancestor
65372344|NCT00843570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65372345|NCT00843570|Fertility Agents|fertility agents|mesh-ancestor
65372346|NCT02547870|Rilpivirine|rilpivirine|mesh-list
65372347|NCT02547870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65372348|NCT02547870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65372349|NCT02547870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372350|NCT02547870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372351|NCT02547870|Antiviral Agents|antiviral agents|mesh-ancestor
65372352|NCT02547870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65372353|NCT02547870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65372354|NCT02547870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65372355|NCT00836316|Levobupivacaine|levobupivacaine|mesh-list
65372356|NCT00836316|Anesthetics, Local|anesthetics, local|mesh-ancestor
65372357|NCT00836316|Anesthetics|anesthetics|mesh-ancestor
65372358|NCT00836316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65372359|NCT00836316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372360|NCT00836316|Sensory System Agents|sensory system agents|mesh-ancestor
65372367|NCT04913805|Micronutrients|micronutrients|mesh-ancestor
65372368|NCT04913805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372369|NCT04913805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65372370|NCT04913805|Antimetabolites|antimetabolites|mesh-ancestor
65372371|NCT04913805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372372|NCT04913805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65372373|NCT04913805|Vasodilator Agents|vasodilator agents|mesh-ancestor
65372374|NCT00621504|Clarithromycin|clarithromycin|mesh-list
65372375|NCT00621504|Ceftriaxone|ceftriaxone|mesh-list
65372376|NCT00621504|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
65372377|NCT00621504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65372378|NCT00621504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65372379|NCT00621504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65372380|NCT00621504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372381|NCT00621504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372382|NCT00621504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65372383|NCT00621504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65372384|NCT00548145|Ezetimibe|ezetimibe|mesh-list
65372385|NCT00548145|Pitavastatin|pitavastatin|mesh-list
65372386|NCT00548145|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65372387|NCT00548145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65372388|NCT00548145|Antimetabolites|antimetabolites|mesh-ancestor
65372389|NCT00548145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372390|NCT00548145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65372417|NCT00836628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372418|NCT00836628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65372419|NCT00962637|Citric Acid|citric acid|mesh-list
65372420|NCT00962637|Sodium Citrate|sodium citrate|mesh-list
65372421|NCT00962637|Enclomiphene|enclomiphene|mesh-list
65372422|NCT00962637|Clomiphene|clomiphene|mesh-list
65372423|NCT00962637|Zuclomiphene|zuclomiphene|mesh-list
65372424|NCT00962637|Testosterone|testosterone|mesh-list
65372425|NCT00962637|Anticoagulants|anticoagulants|mesh-ancestor
65372426|NCT00962637|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65372427|NCT00962637|Chelating Agents|chelating agents|mesh-ancestor
65372428|NCT00962637|Sequestering Agents|sequestering agents|mesh-ancestor
65372429|NCT00962637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372430|NCT00962637|Androgens|androgens|mesh-ancestor
65372431|NCT00962637|Hormones|hormones|mesh-ancestor
65372432|NCT00962637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65372433|NCT00962637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372434|NCT00962637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65372435|NCT00962637|Hormone Antagonists|hormone antagonists|mesh-ancestor
65372436|NCT00962637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65372438|NCT00962637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65372439|NCT00962637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65372440|NCT00962637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65372441|NCT00839358|Midodrine|midodrine|mesh-list
65372442|NCT00839358|Sympathomimetics|sympathomimetics|mesh-ancestor
65372443|NCT00839358|Autonomic Agents|autonomic agents|mesh-ancestor
65372444|NCT00839358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65372445|NCT00839358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372446|NCT00839358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65372447|NCT00839358|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65372448|NCT00839358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65372463|NCT00963027|Esomeprazole|esomeprazole|mesh-list
65372464|NCT00963027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65372465|NCT00963027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65372466|NCT00963027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65372467|NCT00963027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372468|NCT00963027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372469|NCT00963027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65372470|NCT04170153|Niraparib|niraparib|mesh-list
65372471|NCT04170153|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65372472|NCT04170153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372473|NCT04170153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372474|NCT04170153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372475|NCT00837174|Bortezomib|bortezomib|mesh-list
65372476|NCT00837174|Vorinostat|vorinostat|mesh-list
65372477|NCT00837174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372478|NCT00837174|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65372479|NCT00837174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372480|NCT00837174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372481|NCT04042974|Dinoprostone|dinoprostone|mesh-list
65372482|NCT04042974|Oxytocics|oxytocics|mesh-ancestor
65372483|NCT04042974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65372484|NCT04042974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372485|NCT00844350|Letrozole|letrozole|mesh-list
65372486|NCT00844350|Oxytocin|oxytocin|mesh-list
65372487|NCT00844350|Clomiphene|clomiphene|mesh-list
65372488|NCT00844350|Enclomiphene|enclomiphene|mesh-list
65372489|NCT00844350|Zuclomiphene|zuclomiphene|mesh-list
65372490|NCT00844350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372491|NCT00844350|Oxytocics|oxytocics|mesh-ancestor
65372492|NCT00844350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65372493|NCT00844350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372494|NCT00844350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372495|NCT00844350|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64764862|NCT02976246|Vitamin K|vitamin k|mesh-list
65372504|NCT00844350|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65372505|NCT00844506|Cyclophosphamide|cyclophosphamide|mesh-list
65372506|NCT00844506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65372507|NCT00844506|Immunologic Factors|immunologic factors|mesh-ancestor
65372508|NCT00844506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372509|NCT00844506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65066816|NCT00272636|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65372510|NCT00844506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65372512|NCT00844506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372513|NCT00844506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372514|NCT00844506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65372515|NCT00839826|Enoxaparin|enoxaparin|mesh-list
65372516|NCT00839826|Rivaroxaban|rivaroxaban|mesh-list
65372517|NCT00839826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65372518|NCT00839826|Antithrombins|antithrombins|mesh-ancestor
65372519|NCT00839826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65372520|NCT00839826|Protease Inhibitors|protease inhibitors|mesh-ancestor
65372521|NCT00839826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372522|NCT00839826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372523|NCT00839826|Anticoagulants|anticoagulants|mesh-ancestor
65372524|NCT00839826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65372525|NCT00839826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65372526|NCT00844662|Sevelamer|sevelamer|mesh-list
65372527|NCT00844662|Chelating Agents|chelating agents|mesh-ancestor
65372528|NCT00844662|Sequestering Agents|sequestering agents|mesh-ancestor
65372529|NCT00844662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372530|NCT04678089|Bortezomib|bortezomib|mesh-list
65372552|NCT05299593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65372553|NCT05299593|Adrenergic Agents|adrenergic agents|mesh-ancestor
65372554|NCT05299593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65372555|NCT05299593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372556|NCT05299593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372557|NCT05299593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65372558|NCT05299593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65372559|NCT00844740|Cinacalcet|cinacalcet|mesh-list
65372560|NCT00844740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65372561|NCT00844740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372562|NCT00844740|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65372563|NCT00844740|Hormone Antagonists|hormone antagonists|mesh-ancestor
65372564|NCT00844740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65372565|NCT00963729|Cyclophosphamide|cyclophosphamide|mesh-list
65372566|NCT00963729|Docetaxel|docetaxel|mesh-list
65372567|NCT00963729|Fluorouracil|fluorouracil|mesh-list
65372568|NCT00963729|Letrozole|letrozole|mesh-list
65372569|NCT00963729|Epirubicin|epirubicin|mesh-list
65372570|NCT00963729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65372571|NCT00963729|Immunologic Factors|immunologic factors|mesh-ancestor
65372572|NCT00963729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372605|NCT00964041|Antimetabolites|antimetabolites|mesh-ancestor
65372606|NCT00964041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372607|NCT04009317|Crizotinib|crizotinib|mesh-list
65372608|NCT04009317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372609|NCT04009317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65372610|NCT04009317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372611|NCT04009317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372612|NCT03641547|Capecitabine|capecitabine|mesh-list
65372613|NCT03641547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372614|NCT03641547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65372615|NCT03641547|Antimetabolites|antimetabolites|mesh-ancestor
65372616|NCT03641547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372617|NCT00851370|Omalizumab|omalizumab|mesh-list
65372618|NCT00851370|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65372619|NCT00851370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65372620|NCT00851370|Respiratory System Agents|respiratory system agents|mesh-ancestor
65372621|NCT00967629|Calcium Carbonate|calcium carbonate|mesh-list
65372622|NCT00967629|Calcium|calcium|mesh-list
65372623|NCT00967629|Sevelamer|sevelamer|mesh-list
65372624|NCT00967629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65372625|NCT00967629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372626|NCT00967629|Antacids|antacids|mesh-ancestor
65372634|NCT00840606|Buspirone|buspirone|mesh-list
65372658|NCT00840684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372659|NCT00840684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65372660|NCT00840684|Alkylating Agents|alkylating agents|mesh-ancestor
65372661|NCT00840684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65372662|NCT00840684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65372663|NCT00840684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65372664|NCT00840684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65372665|NCT00840684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372666|NCT00840684|Analgesics|analgesics|mesh-ancestor
65372667|NCT00840684|Sensory System Agents|sensory system agents|mesh-ancestor
65372668|NCT00840684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65372669|NCT00574080|Cytarabine|cytarabine|mesh-list
65372670|NCT00574080|Thalidomide|thalidomide|mesh-list
65372671|NCT00574080|Dexamethasone|dexamethasone|mesh-list
65372672|NCT00574080|Dexamethasone acetate|dexamethasone acetate|mesh-list
65372673|NCT00574080|Cyclophosphamide|cyclophosphamide|mesh-list
65372674|NCT00574080|Melphalan|melphalan|mesh-list
65372675|NCT00574080|Carmustine|carmustine|mesh-list
65372676|NCT00574080|Cisplatin|cisplatin|mesh-list
65372677|NCT00574080|Etoposide|etoposide|mesh-list
65372678|NCT00574080|Etoposide phosphate|etoposide phosphate|mesh-list
65372679|NCT00574080|Doxorubicin|doxorubicin|mesh-list
65372680|NCT00574080|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65372681|NCT00574080|Bortezomib|bortezomib|mesh-list
65372682|NCT00574080|BB 1101|bb 1101|mesh-list
65372683|NCT00574080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65372684|NCT00574080|Immunologic Factors|immunologic factors|mesh-ancestor
65372685|NCT00574080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372686|NCT00574080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65372687|NCT00574080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65372688|NCT00574080|Alkylating Agents|alkylating agents|mesh-ancestor
65372689|NCT00574080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372693|NCT00574080|Antiemetics|antiemetics|mesh-ancestor
65372704|NCT00574080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65372705|NCT00574080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65372706|NCT00574080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65372707|NCT00574080|Antimetabolites|antimetabolites|mesh-ancestor
65372708|NCT00574080|Antiviral Agents|antiviral agents|mesh-ancestor
65372709|NCT00574080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65372710|NCT00574080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65372711|NCT00574080|Leprostatic Agents|leprostatic agents|mesh-ancestor
65372712|NCT00574080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65372713|NCT00574080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65372714|NCT00574080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65372715|NCT00574080|Growth Substances|growth substances|mesh-ancestor
65372716|NCT00574080|Growth Inhibitors|growth inhibitors|mesh-ancestor
65372717|NCT00845364|Perhexiline|perhexiline|mesh-list
65372718|NCT00845364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65372719|NCT00845364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65372720|NCT00845364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372721|NCT00845364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65372722|NCT00845364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372723|NCT00845364|Vasodilator Agents|vasodilator agents|mesh-ancestor
65372724|NCT00546351|Lacosamide|lacosamide|mesh-list
65372725|NCT00546351|Anticonvulsants|anticonvulsants|mesh-ancestor
65372726|NCT00546351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65372727|NCT00546351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65372728|NCT00546351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65372730|NCT00267865|Leucovorin|leucovorin|mesh-list
65372751|NCT00267865|Vitamin B Complex|vitamin b complex|mesh-ancestor
65372752|NCT00267865|Vitamins|vitamins|mesh-ancestor
65372753|NCT00267865|Micronutrients|micronutrients|mesh-ancestor
65372754|NCT00840918|Lidocaine|lidocaine|mesh-list
65372755|NCT00840918|Anesthetics, Local|anesthetics, local|mesh-ancestor
65372756|NCT00840918|Anesthetics|anesthetics|mesh-ancestor
65372757|NCT00840918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65372758|NCT00840918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372759|NCT00840918|Sensory System Agents|sensory system agents|mesh-ancestor
65372760|NCT00840918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65372761|NCT00840918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65372762|NCT00840918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65372763|NCT00840918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65372764|NCT00840918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65372765|NCT00840918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372766|NCT00546117|Lansoprazole|lansoprazole|mesh-list
65372767|NCT00546117|Dexlansoprazole|dexlansoprazole|mesh-list
65372768|NCT00546117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65372769|NCT00546117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65372770|NCT00546117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65372771|NCT00546117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372772|NCT00546117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372773|NCT01582165|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65372774|NCT01582165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65372775|NCT01582165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65372776|NCT01582165|Antimetabolites|antimetabolites|mesh-ancestor
65372777|NCT01582165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372778|NCT01582165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65372779|NCT01582165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65372780|NCT01582165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372781|NCT00841074|Chlorhexidine|chlorhexidine|mesh-list
65372782|NCT00841074|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65372783|NCT00841074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65372784|NCT00841074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65372785|NCT00841074|Disinfectants|disinfectants|mesh-ancestor
65372790|NCT00967707|Analgesics|analgesics|mesh-ancestor
65372791|NCT00967707|Sensory System Agents|sensory system agents|mesh-ancestor
65372792|NCT00967707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65372793|NCT00967707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372794|NCT00967707|Anticonvulsants|anticonvulsants|mesh-ancestor
65372795|NCT00967707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65372796|NCT00967707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65372797|NCT00967707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65372798|NCT00967707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65372799|NCT00967707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65372800|NCT00967707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65372801|NCT00967707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65372802|NCT00967707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372803|NCT00967707|Antimanic Agents|antimanic agents|mesh-ancestor
65372804|NCT00967707|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65372805|NCT00967707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372806|NCT00967707|Cholinergic Agents|cholinergic agents|mesh-ancestor
65372807|NCT00967707|Nootropic Agents|nootropic agents|mesh-ancestor
65372808|NCT00967707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65372809|NCT00967707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65122598|NCT02885740|Adenosine|adenosine|mesh-list
65372810|NCT00967707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65372811|NCT00967707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65372812|NCT00967707|Antidepressive Agents|antidepressive agents|mesh-ancestor
65372813|NCT00964275|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65372814|NCT00964275|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65372815|NCT00964275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372816|NCT00845598|Fluticasone|fluticasone|mesh-list
65372817|NCT00845598|Xhance|xhance|mesh-list
65372818|NCT00845598|Azelastine|azelastine|mesh-list
65372819|NCT00845598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65372820|NCT00845598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65372821|NCT00845598|Autonomic Agents|autonomic agents|mesh-ancestor
64765179|NCT00578214|GABA Agents|gaba agents|mesh-ancestor
64556381|NCT04023149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64556382|NCT04023305|Sevoflurane|sevoflurane|mesh-list
64493913|NCT05307718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493914|NCT05307718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64493915|NCT05307718|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64493916|NCT05307718|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64493917|NCT05307718|Purinergic Agents|purinergic agents|mesh-ancestor
65372822|NCT00845598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65372823|NCT00845598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372824|NCT00845598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65372825|NCT00845598|Respiratory System Agents|respiratory system agents|mesh-ancestor
65372826|NCT00845598|Dermatologic Agents|dermatologic agents|mesh-ancestor
65372827|NCT00845598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65372828|NCT00845598|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65372829|NCT00845598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372830|NCT00845598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372831|NCT00845598|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65372832|NCT00845598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65372833|NCT00845598|Histamine Antagonists|histamine antagonists|mesh-ancestor
65372834|NCT00845598|Histamine Agents|histamine agents|mesh-ancestor
65372835|NCT00845598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65372836|NCT00251719|Lansoprazole|lansoprazole|mesh-list
65372837|NCT00251719|Dexlansoprazole|dexlansoprazole|mesh-list
65372838|NCT00251719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65372839|NCT00251719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65372840|NCT00251719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65372841|NCT00251719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372842|NCT00251719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372843|NCT00845754|Ketorolac|ketorolac|mesh-list
65372844|NCT00845754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65372845|NCT00845754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65372846|NCT00845754|Analgesics|analgesics|mesh-ancestor
65372847|NCT00845754|Sensory System Agents|sensory system agents|mesh-ancestor
65372848|NCT00845754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65372849|NCT00845754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372850|NCT00845754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65372851|NCT00845754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65372852|NCT00845754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65372864|NCT00841386|Vitamins|vitamins|mesh-ancestor
65372865|NCT00841386|Micronutrients|micronutrients|mesh-ancestor
65372866|NCT00841386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372867|NCT00841386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65372868|NCT00841386|Dermatologic Agents|dermatologic agents|mesh-ancestor
65372869|NCT03952143|Insulin|insulin|mesh-list
65372870|NCT03952143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65372871|NCT03952143|Insulin Glargine|insulin glargine|mesh-list
65372872|NCT03952143|Insulin Lispro|insulin lispro|mesh-list
65372873|NCT03952143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65372874|NCT03952143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372875|NCT00968331|Rituximab|rituximab|mesh-list
65372876|NCT00968331|Lenalidomide|lenalidomide|mesh-list
65372877|NCT00968331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65372878|NCT00968331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372879|NCT00968331|Immunologic Factors|immunologic factors|mesh-ancestor
65372880|NCT00968331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372881|NCT00968331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65372882|NCT00968331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65372883|NCT00968331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65372884|NCT00968331|Growth Substances|growth substances|mesh-ancestor
65372885|NCT00968331|Growth Inhibitors|growth inhibitors|mesh-ancestor
65372886|NCT00852228|Cetuximab|cetuximab|mesh-list
65372888|NCT00852228|Irinotecan|irinotecan|mesh-list
65372889|NCT00852228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65372890|NCT00852228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372891|NCT00852228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65372892|NCT00852228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65372893|NCT00852228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372915|NCT00848562|Vasodilator Agents|vasodilator agents|mesh-ancestor
65372916|NCT00848562|Vitamin B Complex|vitamin b complex|mesh-ancestor
65372917|NCT00848562|Vitamins|vitamins|mesh-ancestor
65372918|NCT00848562|Micronutrients|micronutrients|mesh-ancestor
65372919|NCT00848562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372920|NCT02879409|Insulin|insulin|mesh-list
65372921|NCT02879409|Metformin|metformin|mesh-list
65372922|NCT02879409|Pioglitazone|pioglitazone|mesh-list
65372923|NCT02879409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65372924|NCT02879409|Dapagliflozin|dapagliflozin|mesh-list
65372925|NCT02879409|Liraglutide|liraglutide|mesh-list
65372926|NCT02879409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65372927|NCT02879409|Gliclazide|gliclazide|mesh-list
65372928|NCT02879409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65372929|NCT02879409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372930|NCT02879409|Incretins|incretins|mesh-ancestor
65372931|NCT02879409|Hormones|hormones|mesh-ancestor
65372932|NCT02879409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65372933|NCT02879409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65372934|NCT02879409|Protease Inhibitors|protease inhibitors|mesh-ancestor
65372935|NCT02879409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372936|NCT02879409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372937|NCT02879409|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65372938|NCT02546154|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65372939|NCT02546154|Hematinics|hematinics|mesh-ancestor
65372940|NCT03943095|Fluorides|fluorides|mesh-list
65372941|NCT03943095|Tin Fluorides|tin fluorides|mesh-list
65372942|NCT03943095|Cariostatic Agents|cariostatic agents|mesh-ancestor
65372943|NCT03943095|Protective Agents|protective agents|mesh-ancestor
65372944|NCT03943095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372945|NCT00848640|Sorafenib|sorafenib|mesh-list
65372946|NCT00848640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372947|NCT00848640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65372948|NCT00848640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65372957|NCT00848796|Heparin|heparin|mesh-list
65372960|NCT00848796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65372961|NCT00848796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65372962|NCT00848796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372963|NCT00965289|Rituximab|rituximab|mesh-list
65372964|NCT00965289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65372965|NCT00965289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372966|NCT00965289|Immunologic Factors|immunologic factors|mesh-ancestor
65372967|NCT00965289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65372968|NCT00965289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65372970|NCT04042506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65372971|NCT04042506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65372972|NCT04042506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65372973|NCT04042506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65372974|NCT00251641|Methotrexate|methotrexate|mesh-list
65372975|NCT00251641|Infliximab|infliximab|mesh-list
65372976|NCT00251641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65372977|NCT00251641|Abortifacient Agents|abortifacient agents|mesh-ancestor
65373015|NCT00849030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373016|NCT00849030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65373017|NCT00849030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373018|NCT00849030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65373019|NCT00849030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65373020|NCT00849030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65373021|NCT00849030|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65373022|NCT00849030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65373023|NCT00849030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373024|NCT00849030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373025|NCT00842400|Metformin|metformin|mesh-list
65373026|NCT00842400|Probenecid|probenecid|mesh-list
65373027|NCT00842400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65373028|NCT00842400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373029|NCT00842400|Uricosuric Agents|uricosuric agents|mesh-ancestor
65373030|NCT00842400|Gout Suppressants|gout suppressants|mesh-ancestor
65373031|NCT00842400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65373032|NCT00842400|Renal Agents|renal agents|mesh-ancestor
65373033|NCT00266695|Ruboxistaurin|ruboxistaurin|mesh-list
65373034|NCT00266695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373035|NCT00266695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373036|NCT00849264|Fluorouracil|fluorouracil|mesh-list
65373037|NCT00849264|Endostar protein|endostar protein|mesh-list
65373038|NCT00849264|Antimetabolites|antimetabolites|mesh-ancestor
65122817|NCT05419583|Antipyretics|antipyretics|mesh-ancestor
65373039|NCT00849264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373062|NCT00842556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373063|NCT00842556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373064|NCT00842556|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65373065|NCT00842556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65373066|NCT00842556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65373067|NCT00842556|Immunologic Factors|immunologic factors|mesh-ancestor
65373068|NCT00849966|Celecoxib|celecoxib|mesh-list
65373069|NCT00849966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65373070|NCT00849966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65373071|NCT00849966|Analgesics|analgesics|mesh-ancestor
65373072|NCT00849966|Sensory System Agents|sensory system agents|mesh-ancestor
65373073|NCT00849966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373074|NCT00849966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373075|NCT00849966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65373076|NCT00849966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65373077|NCT00849966|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65373078|NCT00849966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65373079|NCT00849966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373080|NCT00849966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373081|NCT00853008|Cytarabine|cytarabine|mesh-list
65373082|NCT00853008|Dexamethasone|dexamethasone|mesh-list
65373083|NCT00853008|Prednisone|prednisone|mesh-list
65373084|NCT00853008|Hydrocortisone|hydrocortisone|mesh-list
65373085|NCT00853008|Methotrexate|methotrexate|mesh-list
65373086|NCT00853008|Vincristine|vincristine|mesh-list
65373087|NCT00853008|Daunorubicin|daunorubicin|mesh-list
65373088|NCT00853008|Mitoxantrone|mitoxantrone|mesh-list
65373089|NCT00853008|Mercaptopurine|mercaptopurine|mesh-list
65373090|NCT00853008|Teniposide|teniposide|mesh-list
65373091|NCT00853008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65373092|NCT00853008|Antiemetics|antiemetics|mesh-ancestor
65373093|NCT00853008|Autonomic Agents|autonomic agents|mesh-ancestor
65373107|NCT00853008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373108|NCT00853008|Dermatologic Agents|dermatologic agents|mesh-ancestor
65373109|NCT00853008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373110|NCT00853008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65373111|NCT00853008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65373112|NCT00853008|Immunologic Factors|immunologic factors|mesh-ancestor
65122889|NCT00557934|Sympathomimetics|sympathomimetics|mesh-ancestor
65373113|NCT00853008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65373114|NCT00853008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65373115|NCT00853008|Antiviral Agents|antiviral agents|mesh-ancestor
65373116|NCT00853008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65373117|NCT00853008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65373118|NCT00853008|Tubulin Modulators|tubulin modulators|mesh-ancestor
65373119|NCT00853008|Antimitotic Agents|antimitotic agents|mesh-ancestor
65373120|NCT00853008|Mitosis Modulators|mitosis modulators|mesh-ancestor
65373121|NCT00853008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65373122|NCT00853008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65373123|NCT00853008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65373124|NCT00853008|Analgesics|analgesics|mesh-ancestor
65373125|NCT00853008|Sensory System Agents|sensory system agents|mesh-ancestor
65373126|NCT02545530|Clonidine|clonidine|mesh-list
65373127|NCT02545530|Analgesics|analgesics|mesh-ancestor
65373128|NCT02545530|Sensory System Agents|sensory system agents|mesh-ancestor
65373129|NCT02545530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373130|NCT02545530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373131|NCT02545530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65373132|NCT02545530|Sympatholytics|sympatholytics|mesh-ancestor
65373133|NCT02545530|Autonomic Agents|autonomic agents|mesh-ancestor
65373134|NCT02545530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65373135|NCT02545530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65373136|NCT02545530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65373137|NCT02545530|Adrenergic Agents|adrenergic agents|mesh-ancestor
65373138|NCT02545530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65373139|NCT02545530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373146|NCT00853320|Sensory System Agents|sensory system agents|mesh-ancestor
65373147|NCT00853320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373148|NCT00547521|Methotrexate|methotrexate|mesh-list
65373149|NCT00547521|Abatacept|abatacept|mesh-list
65373150|NCT00547521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65373151|NCT00547521|Abortifacient Agents|abortifacient agents|mesh-ancestor
65373152|NCT00547521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65373153|NCT00547521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373154|NCT00547521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65373155|NCT00547521|Antimetabolites|antimetabolites|mesh-ancestor
65373156|NCT00547521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373157|NCT00547521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373158|NCT00547521|Dermatologic Agents|dermatologic agents|mesh-ancestor
65373159|NCT00547521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373160|NCT00547521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65373161|NCT00547521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65373162|NCT00547521|Immunologic Factors|immunologic factors|mesh-ancestor
65373163|NCT00547521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65373164|NCT00547521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65373165|NCT00547521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65373166|NCT00850044|Ritonavir|ritonavir|mesh-list
65373167|NCT00850044|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65373168|NCT00850044|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65373169|NCT00850044|Protease Inhibitors|protease inhibitors|mesh-ancestor
65373170|NCT00850044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373171|NCT00850044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373172|NCT00850044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65373173|NCT00850044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65373178|NCT00266227|Rituximab|rituximab|mesh-list
65373190|NCT00266227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373191|NCT00266227|Dermatologic Agents|dermatologic agents|mesh-ancestor
65373192|NCT00266227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373193|NCT00266227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65373194|NCT00266227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65373195|NCT00266227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65373196|NCT04233216|Islatravir|islatravir|mesh-list
65373197|NCT04233216|Antiviral Agents|antiviral agents|mesh-ancestor
65373198|NCT04233216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65373199|NCT04233216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373200|NCT04233216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373201|NCT04233216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65373202|NCT04233216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65373203|NCT04233216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65373204|NCT00968877|Cholecalciferol|cholecalciferol|mesh-list
65373205|NCT00968877|Vitamin D|vitamin d|mesh-list
65373206|NCT00968877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65373207|NCT00968877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373208|NCT00968877|Vitamins|vitamins|mesh-ancestor
65373209|NCT00968877|Micronutrients|micronutrients|mesh-ancestor
65373210|NCT00968877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65373211|NCT00850122|Cefazolin|cefazolin|mesh-list
65373242|NCT00573768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65373243|NCT00573768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65373244|NCT00573768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65373245|NCT00573768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373246|NCT00573768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373247|NCT00965913|Nicotine|nicotine|mesh-list
65373248|NCT00965913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65373249|NCT00965913|Autonomic Agents|autonomic agents|mesh-ancestor
65373250|NCT00965913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373251|NCT00965913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373252|NCT00965913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65373253|NCT00965913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65373254|NCT00965913|Cholinergic Agents|cholinergic agents|mesh-ancestor
65373255|NCT00965913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65373256|NCT00965913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373257|NCT00853866|Reboxetine|reboxetine|mesh-list
65373258|NCT00853866|Antidepressive Agents|antidepressive agents|mesh-ancestor
65373259|NCT00853866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65373260|NCT00853866|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65373261|NCT00853866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65373262|NCT00853866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65123050|NCT04616313|Xenon|xenon|mesh-list
65373263|NCT00853866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373264|NCT00853866|Adrenergic Agents|adrenergic agents|mesh-ancestor
65373265|NCT00853866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65373266|NCT00853866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373267|NCT00855660|Riociguat|riociguat|mesh-list
65373268|NCT00855660|Enzyme Activators|enzyme activators|mesh-ancestor
65373270|NCT00965991|Metformin|metformin|mesh-list
65373286|NCT02545452|Nonoxynol|nonoxynol|mesh-list
65373287|NCT02545452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65373288|NCT02545452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373289|NCT02545452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65373290|NCT02545452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65373291|NCT02545452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373292|NCT02545452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373293|NCT02545452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65373353|NCT00855972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373354|NCT02544906|Propofol|propofol|mesh-list
65373355|NCT02544906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65373356|NCT02544906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65373357|NCT02544906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373358|NCT02544906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65373359|NCT02544906|Anesthetics, General|anesthetics, general|mesh-ancestor
65373360|NCT02544906|Anesthetics|anesthetics|mesh-ancestor
65373361|NCT00861276|Nicotine|nicotine|mesh-list
65373362|NCT00861276|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65373363|NCT00861276|Autonomic Agents|autonomic agents|mesh-ancestor
65373364|NCT00861276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373365|NCT00861276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373366|NCT00861276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65373367|NCT00861276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65373368|NCT00861276|Cholinergic Agents|cholinergic agents|mesh-ancestor
65373369|NCT00861276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65373370|NCT00861276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373371|NCT02544828|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65373372|NCT02544828|Hematinics|hematinics|mesh-ancestor
65373373|NCT00861510|ON 01910|on 01910|mesh-list
65373374|NCT00861510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373375|NCT00861510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65373376|NCT00861510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373404|NCT00856362|Anthelmintics|anthelmintics|mesh-ancestor
65373405|NCT00856362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65373406|NCT00856362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65373407|NCT00856362|Antinematodal Agents|antinematodal agents|mesh-ancestor
65373408|NCT00854802|Ribavirin|ribavirin|mesh-list
65373409|NCT00854802|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65373410|NCT00854802|Cyclosporine|cyclosporine|mesh-list
65373411|NCT00854802|Antimetabolites|antimetabolites|mesh-ancestor
65373412|NCT00854802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373413|NCT00854802|Antiviral Agents|antiviral agents|mesh-ancestor
65373414|NCT00854802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65373415|NCT00854802|Antifungal Agents|antifungal agents|mesh-ancestor
65373416|NCT00854802|Dermatologic Agents|dermatologic agents|mesh-ancestor
65373417|NCT00854802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373418|NCT00854802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65373419|NCT00854802|Immunologic Factors|immunologic factors|mesh-ancestor
65373420|NCT00854802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373421|NCT00854802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65373422|NCT00854802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65373423|NCT00958503|Thiamphenicol|thiamphenicol|mesh-list
65373424|NCT00958503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65373425|NCT00958503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65373426|NCT04119024|Cyclophosphamide|cyclophosphamide|mesh-list
65373427|NCT04119024|Fludarabine|fludarabine|mesh-list
65373428|NCT04119024|Fludarabine phosphate|fludarabine phosphate|mesh-list
65373429|NCT04119024|Interleukin-2|interleukin-2|mesh-list
65373430|NCT04119024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65373431|NCT04119024|Immunologic Factors|immunologic factors|mesh-ancestor
65373432|NCT04119024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373433|NCT04119024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65373434|NCT04119024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65373435|NCT04119024|Alkylating Agents|alkylating agents|mesh-ancestor
65373436|NCT04119024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373448|NCT00966771|Levonorgestrel|levonorgestrel|mesh-list
65373449|NCT00966771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65373450|NCT00966771|Contraceptive Agents|contraceptive agents|mesh-ancestor
65373451|NCT00966771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65373452|NCT00966771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373453|NCT00966771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65373454|NCT00966771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65373455|NCT00966771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65373456|NCT00966771|Trace Elements|trace elements|mesh-ancestor
65373457|NCT00966771|Micronutrients|micronutrients|mesh-ancestor
65373458|NCT00856596|Sertaconazole|sertaconazole|mesh-list
65373459|NCT00856596|Antifungal Agents|antifungal agents|mesh-ancestor
65373460|NCT00856596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65373461|NCT00855114|Everolimus|everolimus|mesh-list
65373462|NCT00855114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373463|NCT00855114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65373464|NCT00855114|Immunologic Factors|immunologic factors|mesh-ancestor
65373465|NCT00855114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373466|NCT00855270|Hydrocortisone|hydrocortisone|mesh-list
65373467|NCT00855270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65373468|NCT03937479|Tiotropium Bromide|tiotropium bromide|mesh-list
65373469|NCT03937479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65373470|NCT03937479|Autonomic Agents|autonomic agents|mesh-ancestor
65373471|NCT03937479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373472|NCT03937479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373473|NCT03937479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65373474|NCT03937479|Respiratory System Agents|respiratory system agents|mesh-ancestor
65373475|NCT03937479|Parasympatholytics|parasympatholytics|mesh-ancestor
65373497|NCT00970905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65373498|NCT00970905|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65373499|NCT00619476|Gabapentin|gabapentin|mesh-list
65373500|NCT00619476|Analgesics|analgesics|mesh-ancestor
65373501|NCT00619476|Sensory System Agents|sensory system agents|mesh-ancestor
65373502|NCT00619476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373503|NCT00619476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373504|NCT00619476|Anticonvulsants|anticonvulsants|mesh-ancestor
65373505|NCT00619476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65373506|NCT00619476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65373507|NCT00619476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65373508|NCT00619476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65373509|NCT00619476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65373510|NCT00619476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65373511|NCT00619476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65373512|NCT00619476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373513|NCT00619476|Antimanic Agents|antimanic agents|mesh-ancestor
65373514|NCT00973713|Everolimus|everolimus|mesh-list
65373515|NCT00973713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373516|NCT00973713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65373517|NCT00973713|Immunologic Factors|immunologic factors|mesh-ancestor
65373518|NCT00973713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373519|NCT00857142|Oxymorphone|oxymorphone|mesh-list
65373520|NCT00857142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65373521|NCT00857142|Narcotics|narcotics|mesh-ancestor
65373522|NCT00857142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65373523|NCT00857142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373524|NCT00857142|Analgesics|analgesics|mesh-ancestor
65373525|NCT00857142|Sensory System Agents|sensory system agents|mesh-ancestor
65373526|NCT00857142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373527|NCT00857142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65373528|NCT00865176|Eplerenone|eplerenone|mesh-list
65373539|NCT00973869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65373540|NCT00973869|Analgesics|analgesics|mesh-ancestor
65373541|NCT00973869|Sensory System Agents|sensory system agents|mesh-ancestor
65373542|NCT00973869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373543|NCT00973869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373544|NCT00973869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65373545|NCT00973869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65373546|NCT00973869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373547|NCT00973869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373548|NCT00973869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373549|NCT00959439|Naproxen|naproxen|mesh-list
65373550|NCT00959439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65373551|NCT00959439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65373552|NCT00959439|Analgesics|analgesics|mesh-ancestor
65373553|NCT00959439|Sensory System Agents|sensory system agents|mesh-ancestor
65373554|NCT00959439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373555|NCT00959439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373556|NCT00959439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65373557|NCT00959439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65373558|NCT00959439|Gout Suppressants|gout suppressants|mesh-ancestor
65373559|NCT00959439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65373560|NCT00959439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373561|NCT00959439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373562|NCT04041492|Vitamin D|vitamin d|mesh-list
65373563|NCT04041492|Cholecalciferol|cholecalciferol|mesh-list
65373564|NCT04041492|Vitamins|vitamins|mesh-ancestor
65373565|NCT04041492|Micronutrients|micronutrients|mesh-ancestor
65373566|NCT04041492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373567|NCT04041492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65373568|NCT04041492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65373584|NCT00959517|Primaquine|primaquine|mesh-list
65373585|NCT00959517|Sulfadoxine|sulfadoxine|mesh-list
65373586|NCT00959517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65373587|NCT00959517|Antimalarials|antimalarials|mesh-ancestor
65373588|NCT00959517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65373589|NCT00959517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65373590|NCT00959517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65373591|NCT00959517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373592|NCT00959517|Antiviral Agents|antiviral agents|mesh-ancestor
65373593|NCT00959517|Schistosomicides|schistosomicides|mesh-ancestor
65373594|NCT00959517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65373595|NCT00959517|Anthelmintics|anthelmintics|mesh-ancestor
65373596|NCT00959517|Amebicides|amebicides|mesh-ancestor
65373597|NCT00959517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65373598|NCT00959517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65373599|NCT00959517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373600|NCT00959517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373601|NCT00959517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65373602|NCT00959517|Renal Agents|renal agents|mesh-ancestor
65373603|NCT00959595|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65373604|NCT00959595|Anesthetics, Local|anesthetics, local|mesh-ancestor
65373605|NCT00959595|Anesthetics|anesthetics|mesh-ancestor
65373606|NCT00959595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65373607|NCT00959595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373608|NCT00959595|Sensory System Agents|sensory system agents|mesh-ancestor
65373609|NCT00959595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373610|NCT00959595|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65373611|NCT00865410|Bupropion|bupropion|mesh-list
65373612|NCT00865410|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65373613|NCT00865410|Antidepressive Agents|antidepressive agents|mesh-ancestor
65373614|NCT00865410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65373615|NCT00865410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65373616|NCT00865410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65373619|NCT00865410|Dopamine Agents|dopamine agents|mesh-ancestor
65373623|NCT00865410|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65373624|NCT00865410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373625|NCT00974181|Paclitaxel|paclitaxel|mesh-list
65373626|NCT00974181|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65373627|NCT00974181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65373628|NCT00974181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373629|NCT00974181|Tubulin Modulators|tubulin modulators|mesh-ancestor
65373630|NCT00974181|Antimitotic Agents|antimitotic agents|mesh-ancestor
65373631|NCT00974181|Mitosis Modulators|mitosis modulators|mesh-ancestor
65373632|NCT00974181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373633|NCT00971607|Sevoflurane|sevoflurane|mesh-list
65373634|NCT00971607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65373635|NCT00971607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65373636|NCT00971607|Anesthetics, General|anesthetics, general|mesh-ancestor
65373637|NCT00971607|Anesthetics|anesthetics|mesh-ancestor
65373638|NCT00971607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65373639|NCT00971607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373640|NCT00971685|Dexamethasone|dexamethasone|mesh-list
65373641|NCT00971685|Lenalidomide|lenalidomide|mesh-list
65373642|NCT00971685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65373643|NCT00971685|Antiemetics|antiemetics|mesh-ancestor
65373644|NCT00971685|Autonomic Agents|autonomic agents|mesh-ancestor
65373645|NCT00971685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373646|NCT00971685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373647|NCT00971685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65373648|NCT00971685|Glucocorticoids|glucocorticoids|mesh-ancestor
65373649|NCT00971685|Hormones|hormones|mesh-ancestor
65373663|NCT03861052|Hormones|hormones|mesh-ancestor
65373672|NCT00971763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373673|NCT00971763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65373674|NCT00971763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65373675|NCT00971763|Alkylating Agents|alkylating agents|mesh-ancestor
65373676|NCT00971763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373677|NCT00971763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373678|NCT00971763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65373679|NCT00971763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65373680|NCT00971763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65373681|NCT00971763|Antimetabolites|antimetabolites|mesh-ancestor
65373682|NCT00971763|Antiviral Agents|antiviral agents|mesh-ancestor
65373683|NCT00971763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65373684|NCT00971763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373685|NCT00971763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65373686|NCT00971763|Tubulin Modulators|tubulin modulators|mesh-ancestor
65373687|NCT00971763|Antimitotic Agents|antimitotic agents|mesh-ancestor
65373688|NCT00971763|Mitosis Modulators|mitosis modulators|mesh-ancestor
65373689|NCT00971763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65373690|NCT00971763|Glucocorticoids|glucocorticoids|mesh-ancestor
65373691|NCT00971763|Hormones|hormones|mesh-ancestor
65373692|NCT00971763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65373693|NCT00971763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65373694|NCT00781196|Folic Acid|folic acid|mesh-list
65373695|NCT00781196|Hematinics|hematinics|mesh-ancestor
65373696|NCT00781196|Vitamin B Complex|vitamin b complex|mesh-ancestor
65373697|NCT00781196|Vitamins|vitamins|mesh-ancestor
65373698|NCT00781196|Micronutrients|micronutrients|mesh-ancestor
65373699|NCT00781196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373700|NCT00865644|Imiquimod|imiquimod|mesh-list
65373717|NCT02555150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65373718|NCT02555150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373719|NCT02555150|Dopamine Agents|dopamine agents|mesh-ancestor
65373720|NCT02555150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65373721|NCT05279469|Fibrin fragment D|fibrin fragment d|mesh-list
65373722|NCT05279469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65373723|NCT05279469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65373724|NCT05279469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373725|NCT05279469|Hemostatics|hemostatics|mesh-ancestor
65373726|NCT05279469|Coagulants|coagulants|mesh-ancestor
65373727|NCT00790946|Valsartan|valsartan|mesh-list
65373728|NCT00790946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65373729|NCT00790946|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65373730|NCT00790946|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65373731|NCT00790946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373732|NCT05179239|Paclitaxel|paclitaxel|mesh-list
65373733|NCT05179239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65373734|NCT05179239|Cisplatin|cisplatin|mesh-list
65373735|NCT05179239|Carboplatin|carboplatin|mesh-list
65373736|NCT05179239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65373737|NCT05179239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373738|NCT05179239|Tubulin Modulators|tubulin modulators|mesh-ancestor
65373739|NCT05179239|Antimitotic Agents|antimitotic agents|mesh-ancestor
65373740|NCT05179239|Mitosis Modulators|mitosis modulators|mesh-ancestor
65373741|NCT05179239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373742|NCT00972075|Melatonin|melatonin|mesh-list
65373743|NCT00972075|Antioxidants|antioxidants|mesh-ancestor
65373744|NCT00972075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373745|NCT00972075|Protective Agents|protective agents|mesh-ancestor
65373746|NCT00972075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373747|NCT00972075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65373748|NCT00974805|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65373749|NCT00974805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65373750|NCT00974805|Autonomic Agents|autonomic agents|mesh-ancestor
65373755|NCT00974805|Glucocorticoids|glucocorticoids|mesh-ancestor
65373756|NCT00974805|Hormones|hormones|mesh-ancestor
65373757|NCT00974805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65373758|NCT00974805|Sympathomimetics|sympathomimetics|mesh-ancestor
65373759|NCT00781352|Nitrous Oxide|nitrous oxide|mesh-list
65373760|NCT00781352|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65373761|NCT00781352|Anesthetics, General|anesthetics, general|mesh-ancestor
65373762|NCT00781352|Anesthetics|anesthetics|mesh-ancestor
65373763|NCT00781352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65373764|NCT00781352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373765|NCT00781352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65373766|NCT00781352|Analgesics|analgesics|mesh-ancestor
65373767|NCT00781352|Sensory System Agents|sensory system agents|mesh-ancestor
65373768|NCT00781352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373769|NCT00791024|Lidocaine|lidocaine|mesh-list
65373770|NCT00791024|Anesthetics, Local|anesthetics, local|mesh-ancestor
65373771|NCT00791024|Anesthetics|anesthetics|mesh-ancestor
65373772|NCT00791024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65373773|NCT00791024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373774|NCT00791024|Sensory System Agents|sensory system agents|mesh-ancestor
65373775|NCT00791024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373776|NCT00791024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65373777|NCT00791024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65373778|NCT00791024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65373779|NCT00791024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65373780|NCT00791024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373781|NCT03897244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65373782|NCT03897244|Amoxicillin|amoxicillin|mesh-list
65373783|NCT03897244|Metronidazole|metronidazole|mesh-list
65373784|NCT03897244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65373785|NCT03897244|Rabeprazole|rabeprazole|mesh-list
65373786|NCT03897244|Bismuth|bismuth|mesh-list
65373799|NCT00666536|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
65373800|NCT00666536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65373801|NCT00666536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65373802|NCT00666536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65373803|NCT00666536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373804|NCT00666536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65373805|NCT00666536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373806|NCT00666536|Vasodilator Agents|vasodilator agents|mesh-ancestor
65373807|NCT00666536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65373808|NCT00666536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65373809|NCT00519532|Rotigotine|rotigotine|mesh-list
65373810|NCT00519532|Dopamine Agonists|dopamine agonists|mesh-ancestor
65373811|NCT00519532|Dopamine Agents|dopamine agents|mesh-ancestor
65373812|NCT00519532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65373813|NCT00519532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373814|NCT00519532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373815|NCT00666458|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65373816|NCT00666458|Saxagliptin|saxagliptin|mesh-list
65373817|NCT00666458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65373818|NCT00666458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373819|NCT00666458|Incretins|incretins|mesh-ancestor
65373848|NCT00781586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65373849|NCT00781586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373850|NCT00781586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373851|NCT00781586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65373852|NCT00781586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65373853|NCT00781586|Purinergic Agents|purinergic agents|mesh-ancestor
65373854|NCT00781586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65373855|NCT00510952|Insulin|insulin|mesh-list
65373856|NCT00510952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65373857|NCT00510952|Insulin Glargine|insulin glargine|mesh-list
65373858|NCT00510952|Insulin Lispro|insulin lispro|mesh-list
65373859|NCT00510952|Protamines|protamines|mesh-list
65373860|NCT00510952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65373861|NCT00510952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373862|NCT00510952|Heparin Antagonists|heparin antagonists|mesh-ancestor
65373863|NCT00510952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373864|NCT00510952|Coagulants|coagulants|mesh-ancestor
65373865|NCT00617604|Mycophenolic Acid|mycophenolic acid|mesh-list
65373866|NCT00617604|Alefacept|alefacept|mesh-list
65373867|NCT00617604|Tacrolimus|tacrolimus|mesh-list
65373868|NCT00617604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65373869|NCT00617604|Immunologic Factors|immunologic factors|mesh-ancestor
65373870|NCT00617604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373871|NCT00617604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65373872|NCT00617604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373873|NCT00617604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373874|NCT00617604|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65373875|NCT00617604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373876|NCT00617604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65373877|NCT00617604|Antitubercular Agents|antitubercular agents|mesh-ancestor
65373878|NCT00617604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65373893|NCT00781820|Antifungal Agents|antifungal agents|mesh-ancestor
65373894|NCT00781820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65373895|NCT00786110|Paclitaxel|paclitaxel|mesh-list
65373896|NCT00786110|Sorafenib|sorafenib|mesh-list
65373897|NCT00786110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65373898|NCT00786110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65373899|NCT00786110|Tubulin Modulators|tubulin modulators|mesh-ancestor
65373900|NCT00786110|Antimitotic Agents|antimitotic agents|mesh-ancestor
65373901|NCT00786110|Mitosis Modulators|mitosis modulators|mesh-ancestor
65373902|NCT00786110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373903|NCT00786110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65373904|NCT00786110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373905|NCT00791804|Fentanyl|fentanyl|mesh-list
65373906|NCT00791804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65373907|NCT00791804|Narcotics|narcotics|mesh-ancestor
65373908|NCT00791804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65373909|NCT00791804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373910|NCT00791804|Analgesics|analgesics|mesh-ancestor
65373911|NCT00791804|Sensory System Agents|sensory system agents|mesh-ancestor
65373912|NCT00791804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373913|NCT00791804|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65373914|NCT00791804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65373915|NCT00791804|Anesthetics, General|anesthetics, general|mesh-ancestor
65373916|NCT00791804|Anesthetics|anesthetics|mesh-ancestor
65373917|NCT00791960|Dimenhydrinate|dimenhydrinate|mesh-list
65373918|NCT00791960|Antiemetics|antiemetics|mesh-ancestor
65373919|NCT00791960|Autonomic Agents|autonomic agents|mesh-ancestor
65373920|NCT00791960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373921|NCT00791960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373922|NCT00791960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65373923|NCT00791960|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65373924|NCT00791960|Histamine Antagonists|histamine antagonists|mesh-ancestor
65373925|NCT00791960|Histamine Agents|histamine agents|mesh-ancestor
65373928|NCT00792350|Sorafenib|sorafenib|mesh-list
65373936|NCT00792584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65373937|NCT00792584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373938|NCT00792584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373939|NCT00792584|Antiviral Agents|antiviral agents|mesh-ancestor
65373940|NCT00792584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65373941|NCT00792584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65123722|NCT01165021|Hematinics|hematinics|mesh-ancestor
65373942|NCT00792584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65373943|NCT00792584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65373944|NCT00792584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65373945|NCT00792584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65373946|NCT00792584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65373948|NCT00792662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65373949|NCT00792662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373950|NCT00792662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65373951|NCT00792662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65373952|NCT00792662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65373953|NCT00792662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373954|NCT00792662|Dopamine Agents|dopamine agents|mesh-ancestor
65373955|NCT00792662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65373956|NCT00792740|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
65373957|NCT00792740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65373958|NCT00792740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65373959|NCT00792740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65373960|NCT02556086|Sofosbuvir|sofosbuvir|mesh-list
65373961|NCT02556086|Antiviral Agents|antiviral agents|mesh-ancestor
65373962|NCT02556086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65373963|NCT04093752|Insulin Glargine|insulin glargine|mesh-list
65373964|NCT04093752|Tirzepatide|tirzepatide|mesh-list
65373979|NCT02544282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65373980|NCT02544282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65373981|NCT02544282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65373982|NCT02544282|Anesthetics, General|anesthetics, general|mesh-ancestor
65373983|NCT02544282|Anesthetics|anesthetics|mesh-ancestor
65373984|NCT02544282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65373985|NCT02544282|Analgesics|analgesics|mesh-ancestor
65373986|NCT02544282|Sensory System Agents|sensory system agents|mesh-ancestor
65373987|NCT02544282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65373988|NCT02544282|Antipyretics|antipyretics|mesh-ancestor
65373989|NCT02544282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65373990|NCT02544282|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65373991|NCT02544282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65373992|NCT02544282|Narcotics|narcotics|mesh-ancestor
65373993|NCT02544282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65373994|NCT02544282|Anesthetics, Local|anesthetics, local|mesh-ancestor
65373995|NCT02544282|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65373996|NCT02544282|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65373997|NCT02544282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65373998|NCT02544282|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65373999|NCT02544282|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65374000|NCT02544282|Cholinergic Agents|cholinergic agents|mesh-ancestor
65374001|NCT02544282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65374002|NCT02544282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374003|NCT04041648|Treprostinil|treprostinil|mesh-list
65374004|NCT04041648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65374005|NCT04041648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65374006|NCT00666224|Glatiramer Acetate|glatiramer acetate|mesh-list
65374007|NCT00666224|(T,G)-A-L|(t,g)-a-l|mesh-list
65374008|NCT00666224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65374009|NCT00666224|Immunologic Factors|immunologic factors|mesh-ancestor
65374023|NCT00663962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65374024|NCT00663962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65374025|NCT00663962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65374026|NCT00663962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65374028|NCT00858624|Analgesics|analgesics|mesh-ancestor
65374029|NCT00858624|Sensory System Agents|sensory system agents|mesh-ancestor
65374030|NCT00858624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65374031|NCT00858624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374032|NCT00858624|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65374033|NCT00858624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65374034|NCT00858624|Anesthetics, General|anesthetics, general|mesh-ancestor
65374035|NCT00858624|Anesthetics|anesthetics|mesh-ancestor
65374036|NCT00858624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65374037|NCT00858624|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65374038|NCT00858624|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65374039|NCT00858624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65374040|NCT00858624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374041|NCT00960453|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65374042|NCT00960453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65374043|NCT00960453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374044|NCT00960453|Incretins|incretins|mesh-ancestor
65374045|NCT00960453|Hormones|hormones|mesh-ancestor
65374046|NCT00960453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65374047|NCT00960453|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65374048|NCT00960453|Protease Inhibitors|protease inhibitors|mesh-ancestor
65374049|NCT00960453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374071|NCT00972387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374072|NCT00972387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65374073|NCT00972387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65374074|NCT00972387|Alkylating Agents|alkylating agents|mesh-ancestor
65374075|NCT00972387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374076|NCT00972387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374077|NCT00972387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65374078|NCT00972387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65374079|NCT00972387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65374080|NCT00972387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65374081|NCT00972387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374082|NCT00972387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65374083|NCT00972387|Glucocorticoids|glucocorticoids|mesh-ancestor
65374084|NCT00972387|Hormones|hormones|mesh-ancestor
65374085|NCT00972387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65374086|NCT00972387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65374087|NCT00972387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65374088|NCT00972387|Tubulin Modulators|tubulin modulators|mesh-ancestor
65374089|NCT00972387|Antimitotic Agents|antimitotic agents|mesh-ancestor
65374090|NCT00972387|Mitosis Modulators|mitosis modulators|mesh-ancestor
65374091|NCT00744263|Vaccines|vaccines|mesh-list
65374092|NCT00744263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65374093|NCT00744263|Immunologic Factors|immunologic factors|mesh-ancestor
65374094|NCT00744263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374095|NCT00783068|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
65374096|NCT00783068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65374097|NCT00783068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65374098|NCT00783068|Cholinergic Agents|cholinergic agents|mesh-ancestor
65374099|NCT00783068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65374100|NCT00783068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374102|NCT00866736|Dasatinib|dasatinib|mesh-list
65374111|NCT00792818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65374112|NCT00792818|Analgesics|analgesics|mesh-ancestor
65374113|NCT00792818|Sensory System Agents|sensory system agents|mesh-ancestor
65374114|NCT00792818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65374115|NCT00792818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374116|NCT00792818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65374117|NCT00792818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65374118|NCT00792818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65374119|NCT00792818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374120|NCT00792818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374121|NCT00792818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374122|NCT00792818|Antioxidants|antioxidants|mesh-ancestor
65374123|NCT00792818|Protective Agents|protective agents|mesh-ancestor
65374124|NCT00972465|Nimotuzumab|nimotuzumab|mesh-list
65374125|NCT00972465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65374126|NCT00972465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374127|NCT00975351|Tetrahydrofolates|tetrahydrofolates|mesh-list
65374128|NCT00975351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374129|NCT00975351|Vitamin B Complex|vitamin b complex|mesh-ancestor
65374130|NCT00975351|Vitamins|vitamins|mesh-ancestor
65374131|NCT00975351|Micronutrients|micronutrients|mesh-ancestor
65374132|NCT01071187|Varenicline|varenicline|mesh-list
65374133|NCT01071187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65374134|NCT01071187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65374135|NCT01071187|Cholinergic Agents|cholinergic agents|mesh-ancestor
65374136|NCT01071187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65374137|NCT01071187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374138|NCT01071187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374139|NCT00618774|Amlodipine|amlodipine|mesh-list
65374140|NCT00618774|Telmisartan|telmisartan|mesh-list
65374141|NCT00618774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65374142|NCT00618774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65374153|NCT00917345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374154|NCT00917345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374155|NCT00917345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65374156|NCT00793052|Dexamethasone|dexamethasone|mesh-list
65374157|NCT00793052|Etoricoxib|etoricoxib|mesh-list
65374158|NCT00793052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65374159|NCT00793052|Antiemetics|antiemetics|mesh-ancestor
65374160|NCT00793052|Autonomic Agents|autonomic agents|mesh-ancestor
65374161|NCT00793052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65374162|NCT00793052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374163|NCT00793052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65374164|NCT00793052|Glucocorticoids|glucocorticoids|mesh-ancestor
65374165|NCT00793052|Hormones|hormones|mesh-ancestor
65123939|NCT00564213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374166|NCT00793052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65374167|NCT00793052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65374168|NCT00793052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374169|NCT00793052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65374170|NCT00793052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65374171|NCT00793052|Analgesics|analgesics|mesh-ancestor
65374172|NCT00793052|Sensory System Agents|sensory system agents|mesh-ancestor
65374173|NCT00793052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65374174|NCT00793052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65374175|NCT00793052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65374176|NCT00793052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374177|NCT00793052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374178|NCT02555852|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
65374179|NCT02555852|Esomeprazole|esomeprazole|mesh-list
65374180|NCT02555852|Omeprazole|omeprazole|mesh-list
65374181|NCT02555852|Rabeprazole|rabeprazole|mesh-list
65374182|NCT02555852|Pantoprazole|pantoprazole|mesh-list
65374183|NCT02555852|Lansoprazole|lansoprazole|mesh-list
65374184|NCT02555852|Famotidine|famotidine|mesh-list
65374185|NCT02555852|Ranitidine|ranitidine|mesh-list
65374186|NCT02555852|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65374187|NCT02555852|Cimetidine|cimetidine|mesh-list
65374188|NCT02555852|Nizatidine|nizatidine|mesh-list
65374189|NCT02555852|Lafutidine|lafutidine|mesh-list
65374192|NCT02555852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65374193|NCT02555852|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
65374194|NCT02555852|Histamine|histamine|mesh-list
65374195|NCT02555852|Histamine phosphate|histamine phosphate|mesh-list
65374196|NCT02555852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374197|NCT02555852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65374198|NCT02555852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65374199|NCT02555852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374200|NCT02555852|Antacids|antacids|mesh-ancestor
65374201|NCT02555852|Histamine Antagonists|histamine antagonists|mesh-ancestor
65374202|NCT02555852|Histamine Agents|histamine agents|mesh-ancestor
65374203|NCT02555852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65374204|NCT02555852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374205|NCT02555852|Histamine Agonists|histamine agonists|mesh-ancestor
65374206|NCT02555852|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65374207|NCT02555852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65374208|NCT02555852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65374209|NCT04091009|Buprenorphine|buprenorphine|mesh-list
65374210|NCT04091009|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65374211|NCT04091009|Naloxone|naloxone|mesh-list
65374212|NCT04091009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65374213|NCT04091009|Narcotics|narcotics|mesh-ancestor
65374214|NCT04091009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65374215|NCT04091009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374216|NCT04091009|Analgesics|analgesics|mesh-ancestor
65374217|NCT04091009|Sensory System Agents|sensory system agents|mesh-ancestor
65374218|NCT04091009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65374240|NCT02597309|Canagliflozin|canagliflozin|mesh-list
65374241|NCT02597309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65374242|NCT02597309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374243|NCT02597309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65374244|NCT02597309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374245|NCT00863148|Busulfan|busulfan|mesh-list
65374246|NCT00863148|Clofarabine|clofarabine|mesh-list
65374247|NCT00863148|Alkylating Agents|alkylating agents|mesh-ancestor
65374248|NCT00863148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374249|NCT00863148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65374250|NCT00863148|Immunologic Factors|immunologic factors|mesh-ancestor
65374251|NCT00863148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374252|NCT00863148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65374253|NCT00863148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374254|NCT00863148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65374255|NCT00863148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65374256|NCT00863148|Antimetabolites|antimetabolites|mesh-ancestor
65374257|NCT00786734|Pitavastatin|pitavastatin|mesh-list
65374258|NCT00786734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65374259|NCT00786734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65374260|NCT00786734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65374261|NCT00786734|Antimetabolites|antimetabolites|mesh-ancestor
65374262|NCT00786734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374263|NCT00786734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374264|NCT00786734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65374265|NCT00263887|Protease Inhibitors|protease inhibitors|mesh-list
65374286|NCT00661388|Epoetin Alfa|epoetin alfa|mesh-list
65374287|NCT00661388|Hematinics|hematinics|mesh-ancestor
65374288|NCT00972855|Bicalutamide|bicalutamide|mesh-list
65374289|NCT00972855|Androgen Antagonists|androgen antagonists|mesh-ancestor
65374290|NCT00972855|Hormone Antagonists|hormone antagonists|mesh-ancestor
65374291|NCT00972855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65374292|NCT00972855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374293|NCT00972855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374294|NCT00972933|Ipilimumab|ipilimumab|mesh-list
65374295|NCT00972933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65374296|NCT00972933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374297|NCT00972933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65374298|NCT00972933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374299|NCT00263575|Fentanyl|fentanyl|mesh-list
65374300|NCT00263575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65374301|NCT00263575|Narcotics|narcotics|mesh-ancestor
65374302|NCT00263575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65374303|NCT00263575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374304|NCT00263575|Analgesics|analgesics|mesh-ancestor
65374305|NCT00263575|Sensory System Agents|sensory system agents|mesh-ancestor
65374306|NCT00263575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65374307|NCT00263575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65374308|NCT00263575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65374309|NCT00263575|Anesthetics, General|anesthetics, general|mesh-ancestor
65374310|NCT00263575|Anesthetics|anesthetics|mesh-ancestor
65374311|NCT00975663|Tacrolimus|tacrolimus|mesh-list
65374312|NCT00975663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65374313|NCT00975663|Immunologic Factors|immunologic factors|mesh-ancestor
65374314|NCT00975663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374315|NCT00975663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65374316|NCT00975663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374317|NCT00975663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374318|NCT00570128|Donepezil|donepezil|mesh-list
65374328|NCT00960921|Trace Elements|trace elements|mesh-ancestor
65374329|NCT00960921|Micronutrients|micronutrients|mesh-ancestor
65374330|NCT00960921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374331|NCT00960921|Hematinics|hematinics|mesh-ancestor
65374332|NCT00863460|Cytarabine|cytarabine|mesh-list
65374333|NCT00863460|Prednisone|prednisone|mesh-list
65374334|NCT00863460|Cyclophosphamide|cyclophosphamide|mesh-list
65374335|NCT00863460|Busulfan|busulfan|mesh-list
65374336|NCT00863460|Thiotepa|thiotepa|mesh-list
65374337|NCT00863460|Carmustine|carmustine|mesh-list
65374338|NCT00863460|Methotrexate|methotrexate|mesh-list
65374339|NCT00863460|Etoposide|etoposide|mesh-list
65374340|NCT00863460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65374341|NCT00863460|Immunologic Factors|immunologic factors|mesh-ancestor
65374342|NCT00863460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374343|NCT00863460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65374344|NCT00863460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65374345|NCT00863460|Alkylating Agents|alkylating agents|mesh-ancestor
65374346|NCT00863460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374347|NCT00863460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374348|NCT00863460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65374349|NCT00863460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65374350|NCT00863460|Glucocorticoids|glucocorticoids|mesh-ancestor
65374351|NCT00863460|Hormones|hormones|mesh-ancestor
65374352|NCT00863460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65374353|NCT00863460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65374354|NCT00863460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65374355|NCT00863460|Abortifacient Agents|abortifacient agents|mesh-ancestor
65374356|NCT00863460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65374357|NCT00863460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65374358|NCT00863460|Antimetabolites|antimetabolites|mesh-ancestor
65374359|NCT00863460|Dermatologic Agents|dermatologic agents|mesh-ancestor
65374360|NCT00863460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374361|NCT00863460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65374362|NCT00863460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65374363|NCT00863460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64493918|NCT05307718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64493919|NCT05307718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493920|NCT05307718|Antithrombins|antithrombins|mesh-ancestor
64493921|NCT05307718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64493922|NCT05307718|Protease Inhibitors|protease inhibitors|mesh-ancestor
64493923|NCT01033864|Mycophenolic Acid|mycophenolic acid|mesh-list
65374364|NCT00863460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65374365|NCT00863460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65374366|NCT00863460|Antiviral Agents|antiviral agents|mesh-ancestor
65374367|NCT00863460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65374368|NCT00262951|Interferons|interferons|mesh-list
65374369|NCT00262951|Interferon-alpha|interferon-alpha|mesh-list
65374370|NCT00262951|Interferon alpha-2|interferon alpha-2|mesh-list
65374371|NCT00262951|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65374372|NCT00262951|Cisplatin|cisplatin|mesh-list
65374373|NCT00262951|Fluorouracil|fluorouracil|mesh-list
65374374|NCT00262951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374375|NCT00262951|Antimetabolites|antimetabolites|mesh-ancestor
65374376|NCT00262951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374429|NCT02555696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374430|NCT02555696|Tubulin Modulators|tubulin modulators|mesh-ancestor
65374431|NCT02555696|Antimitotic Agents|antimitotic agents|mesh-ancestor
65374432|NCT02555696|Mitosis Modulators|mitosis modulators|mesh-ancestor
65374433|NCT02555696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374434|NCT00961077|Oxaliplatin|oxaliplatin|mesh-list
65374435|NCT00961077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374436|NCT05147493|Dexamethasone|dexamethasone|mesh-list
65374437|NCT05147493|Cyclophosphamide|cyclophosphamide|mesh-list
65374438|NCT05147493|Lenalidomide|lenalidomide|mesh-list
65374439|NCT05147493|Bortezomib|bortezomib|mesh-list
65374440|NCT05147493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65374441|NCT05147493|Immunologic Factors|immunologic factors|mesh-ancestor
65374442|NCT05147493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374443|NCT05147493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65374444|NCT05147493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65374445|NCT05147493|Alkylating Agents|alkylating agents|mesh-ancestor
65374446|NCT05147493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374447|NCT05147493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374448|NCT05147493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65374449|NCT05147493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65374450|NCT05147493|Antiemetics|antiemetics|mesh-ancestor
65374451|NCT05147493|Autonomic Agents|autonomic agents|mesh-ancestor
65374452|NCT05147493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65374453|NCT05147493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65374454|NCT05147493|Glucocorticoids|glucocorticoids|mesh-ancestor
65374455|NCT05147493|Hormones|hormones|mesh-ancestor
65374456|NCT05147493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65374457|NCT05147493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65374458|NCT05147493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65374473|NCT03974425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65374474|NCT03974425|Growth Substances|growth substances|mesh-ancestor
65374475|NCT03974425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374476|NCT03974425|Growth Inhibitors|growth inhibitors|mesh-ancestor
65374477|NCT03974425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374478|NCT00975897|Leucovorin|leucovorin|mesh-list
65374479|NCT00975897|Bevacizumab|bevacizumab|mesh-list
65374480|NCT00975897|Cetuximab|cetuximab|mesh-list
65374481|NCT00975897|Fluorouracil|fluorouracil|mesh-list
65374482|NCT00975897|Oxaliplatin|oxaliplatin|mesh-list
65374483|NCT00975897|Irinotecan|irinotecan|mesh-list
65374484|NCT00975897|Calcium|calcium|mesh-list
65374485|NCT00975897|Levoleucovorin|levoleucovorin|mesh-list
65374486|NCT00975897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65374487|NCT00975897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374488|NCT00975897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65374489|NCT00975897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65374490|NCT00975897|Growth Substances|growth substances|mesh-ancestor
65374491|NCT00975897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374492|NCT00975897|Growth Inhibitors|growth inhibitors|mesh-ancestor
65374493|NCT00975897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65374494|NCT00975897|Antimetabolites|antimetabolites|mesh-ancestor
65374495|NCT00975897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374496|NCT00975897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65374497|NCT00975897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65374498|NCT00975897|Immunologic Factors|immunologic factors|mesh-ancestor
65374499|NCT00975897|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65374500|NCT00975897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65374501|NCT00975897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374502|NCT00975897|Antidotes|antidotes|mesh-ancestor
65374503|NCT00975897|Protective Agents|protective agents|mesh-ancestor
65374504|NCT00975897|Vitamin B Complex|vitamin b complex|mesh-ancestor
65374505|NCT00975897|Vitamins|vitamins|mesh-ancestor
65374506|NCT00975897|Micronutrients|micronutrients|mesh-ancestor
65374507|NCT00867672|Decitabine|decitabine|mesh-list
65374508|NCT00867672|Tretinoin|tretinoin|mesh-list
65374509|NCT00867672|Valproic Acid|valproic acid|mesh-list
65374510|NCT00867672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64493924|NCT01033864|Prednisone|prednisone|mesh-list
64493925|NCT01033864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64493926|NCT01033864|Glucocorticoids|glucocorticoids|mesh-ancestor
65374511|NCT00867672|Antimetabolites|antimetabolites|mesh-ancestor
65374512|NCT00867672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374513|NCT00867672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374514|NCT00867672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374515|NCT00867672|Keratolytic Agents|keratolytic agents|mesh-ancestor
65374516|NCT00867672|Dermatologic Agents|dermatologic agents|mesh-ancestor
65374517|NCT00867672|Anticonvulsants|anticonvulsants|mesh-ancestor
65374518|NCT00867672|GABA Agents|gaba agents|mesh-ancestor
65374519|NCT00867672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65374520|NCT00867672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374521|NCT00867672|Antimanic Agents|antimanic agents|mesh-ancestor
65374522|NCT00867672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65374523|NCT00867672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65374524|NCT00867672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65374525|NCT00783926|Vaccines|vaccines|mesh-list
65374526|NCT00783926|Hemagglutinins|hemagglutinins|mesh-list
65374527|NCT00783926|Immunologic Factors|immunologic factors|mesh-ancestor
65374528|NCT00783926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374529|NCT00783926|Agglutinins|agglutinins|mesh-ancestor
65374530|NCT01071499|Morphine|morphine|mesh-list
65374531|NCT01071499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65374532|NCT01071499|Narcotics|narcotics|mesh-ancestor
65374533|NCT01071499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65374534|NCT01071499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374535|NCT01071499|Analgesics|analgesics|mesh-ancestor
65374536|NCT01071499|Sensory System Agents|sensory system agents|mesh-ancestor
65374537|NCT01071499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65374538|NCT00961155|Formoterol Fumarate|formoterol fumarate|mesh-list
65374539|NCT00961155|Montelukast|montelukast|mesh-list
65374540|NCT00961155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65374541|NCT00961155|Autonomic Agents|autonomic agents|mesh-ancestor
65374556|NCT00961155|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65374557|NCT00260533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65374558|NCT00260533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65374559|NCT00260533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65374560|NCT00260533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65374561|NCT00260533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374562|NCT00260533|Adrenergic Agents|adrenergic agents|mesh-ancestor
65374563|NCT00260533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65374564|NCT00260533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374565|NCT00973245|Warfarin|warfarin|mesh-list
65374566|NCT00973245|Rivaroxaban|rivaroxaban|mesh-list
65374567|NCT00973245|Anticoagulants|anticoagulants|mesh-ancestor
65374568|NCT00973245|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65374569|NCT00973245|Antithrombins|antithrombins|mesh-ancestor
65374570|NCT00973245|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65374571|NCT00973245|Protease Inhibitors|protease inhibitors|mesh-ancestor
65374572|NCT00973245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374573|NCT00973245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374574|NCT00793754|Aspirin|aspirin|mesh-list
65374575|NCT00793754|Atorvastatin|atorvastatin|mesh-list
65374576|NCT00793754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65374577|NCT00793754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65374578|NCT00793754|Analgesics|analgesics|mesh-ancestor
65374579|NCT00793754|Sensory System Agents|sensory system agents|mesh-ancestor
65374580|NCT00793754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65374581|NCT00793754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374582|NCT00793754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64493927|NCT01033864|Hormones|hormones|mesh-ancestor
64493928|NCT01033864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64493929|NCT01033864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493930|NCT01033864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64493931|NCT01033864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493932|NCT01033864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64493933|NCT01033864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64493934|NCT01033864|Antitubercular Agents|antitubercular agents|mesh-ancestor
64493935|NCT01033864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64493936|NCT01033864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64493937|NCT01033864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493938|NCT01033864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493939|NCT01082380|Crizotinib|crizotinib|mesh-list
64493940|NCT01082380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493943|NCT01082380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493944|NCT01083706|Azacitidine|azacitidine|mesh-list
64493945|NCT01083706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64493946|NCT01083706|Antimetabolites|antimetabolites|mesh-ancestor
64493947|NCT01083706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374583|NCT00793754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65374584|NCT00793754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65374585|NCT00793754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65374586|NCT00793754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374587|NCT00793754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65374588|NCT00793754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65374589|NCT00793754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374590|NCT00793754|Antipyretics|antipyretics|mesh-ancestor
65374591|NCT00793754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65374592|NCT00793754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65374593|NCT00793754|Antimetabolites|antimetabolites|mesh-ancestor
65374594|NCT00793754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65374595|NCT00793754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65374596|NCT02596763|Baclofen|baclofen|mesh-list
65374597|NCT02596763|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65374598|NCT02596763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374599|NCT02596763|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65374600|NCT02596763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65374601|NCT02596763|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65374602|NCT02596763|GABA Agonists|gaba agonists|mesh-ancestor
65374603|NCT02596763|GABA Agents|gaba agents|mesh-ancestor
65374604|NCT02596763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65374605|NCT02596763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374606|NCT00973323|Warfarin|warfarin|mesh-list
65374607|NCT00973323|Rivaroxaban|rivaroxaban|mesh-list
65374608|NCT00973323|Anticoagulants|anticoagulants|mesh-ancestor
65374633|NCT00787436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65374634|NCT00787436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65374635|NCT00787436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65374636|NCT00787436|Growth Substances|growth substances|mesh-ancestor
65374637|NCT00787436|Growth Inhibitors|growth inhibitors|mesh-ancestor
65374638|NCT00787436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374639|NCT00787436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65374640|NCT00787436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65374641|NCT00787436|Adrenergic Agents|adrenergic agents|mesh-ancestor
65374642|NCT00787436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65374643|NCT00787436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374644|NCT00787436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65374645|NCT00787436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65374646|NCT00787436|Vasodilator Agents|vasodilator agents|mesh-ancestor
65374647|NCT00787436|Sympatholytics|sympatholytics|mesh-ancestor
65374648|NCT00787436|Autonomic Agents|autonomic agents|mesh-ancestor
65374649|NCT00787436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65374650|NCT03945981|Lamivudine|lamivudine|mesh-list
65374651|NCT03945981|Dolutegravir|dolutegravir|mesh-list
65374652|NCT03945981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65374653|NCT03945981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65374654|NCT03945981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374655|NCT03945981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374656|NCT03945981|Antiviral Agents|antiviral agents|mesh-ancestor
65374657|NCT03945981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65374658|NCT03945981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65374659|NCT03945981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65374660|NCT03945981|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65374661|NCT03945981|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65374662|NCT00784082|Hydroxyurea|hydroxyurea|mesh-list
65374663|NCT00784082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374664|NCT00784082|Antisickling Agents|antisickling agents|mesh-ancestor
65374665|NCT00784082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374666|NCT00784082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374667|NCT00784082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65374668|NCT00979563|Irinotecan|irinotecan|mesh-list
65374669|NCT00979563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65374671|NCT00979563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374672|NCT00979563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374673|NCT00979563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374674|NCT00745901|Drospirenone|drospirenone|mesh-list
65374675|NCT00745901|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65374676|NCT00745901|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65374677|NCT00745901|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65374678|NCT00745901|Norgestimate|norgestimate|mesh-list
65374679|NCT00745901|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65374680|NCT00745901|Estradiol|estradiol|mesh-list
65374681|NCT00745901|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65374682|NCT00745901|Estrogens|estrogens|mesh-ancestor
65374683|NCT00745901|Hormones|hormones|mesh-ancestor
65374684|NCT00745901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65374685|NCT00745901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374686|NCT00745901|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65374687|NCT00745901|Contraceptive Agents|contraceptive agents|mesh-ancestor
65374688|NCT00745901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65374689|NCT00745901|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65374690|NCT00745901|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65374691|NCT00745901|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65374692|NCT00745901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65374693|NCT00745901|Hormone Antagonists|hormone antagonists|mesh-ancestor
65374694|NCT00745901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65374695|NCT00745901|Diuretics|diuretics|mesh-ancestor
65374696|NCT00745901|Natriuretic Agents|natriuretic agents|mesh-ancestor
65374697|NCT00745901|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65124460|NCT00564642|Antioxidants|antioxidants|mesh-ancestor
65374698|NCT00863850|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65374699|NCT00863850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65374709|NCT00860340|Diuretics|diuretics|mesh-ancestor
65374713|NCT00784316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65374714|NCT00784316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65374715|NCT00784316|Sympatholytics|sympatholytics|mesh-ancestor
65374716|NCT00784316|Autonomic Agents|autonomic agents|mesh-ancestor
65374717|NCT00784316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65374718|NCT00784316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374719|NCT00784316|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65374720|NCT00784316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65374721|NCT00784316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65374722|NCT00784316|Adrenergic Agents|adrenergic agents|mesh-ancestor
65374723|NCT00784316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65374724|NCT00784316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374725|NCT00784316|Vasodilator Agents|vasodilator agents|mesh-ancestor
65374726|NCT00784316|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65374727|NCT00784316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65374728|NCT00784316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65374729|NCT00784316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65374730|NCT00784316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65374731|NCT00784316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374732|NCT00784316|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65374733|NCT00784316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65374734|NCT00784316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65374735|NCT00286429|Insulin|insulin|mesh-list
65374736|NCT00286429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65374737|NCT00286429|Alogliptin|alogliptin|mesh-list
65374738|NCT00286429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65374739|NCT00286429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374740|NCT00286429|Incretins|incretins|mesh-ancestor
65374741|NCT00286429|Hormones|hormones|mesh-ancestor
65374742|NCT00286429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65374743|NCT00286429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65374752|NCT00665444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65374753|NCT00665444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374754|NCT00665444|Dopamine Agonists|dopamine agonists|mesh-ancestor
65374755|NCT00665444|Dopamine Agents|dopamine agents|mesh-ancestor
65374756|NCT00665444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65374757|NCT00665444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374758|NCT00665444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65374759|NCT00665444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65374760|NCT00665444|Serotonin Agents|serotonin agents|mesh-ancestor
65374761|NCT00665444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65374762|NCT00665444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65374763|NCT00665444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65374764|NCT00665444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65374765|NCT00864006|Valproic Acid|valproic acid|mesh-list
65374766|NCT00864006|Anticonvulsants|anticonvulsants|mesh-ancestor
65374767|NCT00864006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374810|NCT00795314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65374811|NCT00795314|Anesthetics, General|anesthetics, general|mesh-ancestor
65374812|NCT00795314|Anesthetics|anesthetics|mesh-ancestor
65374813|NCT00795314|Antitussive Agents|antitussive agents|mesh-ancestor
65374814|NCT00795314|Respiratory System Agents|respiratory system agents|mesh-ancestor
65374815|NCT00795314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65374816|NCT03926169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65374817|NCT03926169|Immunologic Factors|immunologic factors|mesh-ancestor
65374818|NCT03926169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374819|NCT00864240|Clobetasol|clobetasol|mesh-list
65374820|NCT00864240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65374821|NCT00864240|Glucocorticoids|glucocorticoids|mesh-ancestor
65374822|NCT00864240|Hormones|hormones|mesh-ancestor
65374823|NCT00864240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65374824|NCT00864240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374825|NCT00979641|Docetaxel|docetaxel|mesh-list
65374826|NCT00979641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374827|NCT00979641|Tubulin Modulators|tubulin modulators|mesh-ancestor
65374828|NCT00979641|Antimitotic Agents|antimitotic agents|mesh-ancestor
65374829|NCT00979641|Mitosis Modulators|mitosis modulators|mesh-ancestor
65374830|NCT00979641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374831|NCT00864318|Paclitaxel|paclitaxel|mesh-list
65374832|NCT00864318|Etoposide|etoposide|mesh-list
65374833|NCT00864318|Ifosfamide|ifosfamide|mesh-list
65374834|NCT00864318|Carboplatin|carboplatin|mesh-list
65374835|NCT00864318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65374836|NCT00864318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374837|NCT00864318|Tubulin Modulators|tubulin modulators|mesh-ancestor
65374838|NCT00864318|Antimitotic Agents|antimitotic agents|mesh-ancestor
65374839|NCT00864318|Mitosis Modulators|mitosis modulators|mesh-ancestor
65374840|NCT00864318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374842|NCT00864318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65374854|NCT00788060|Growth Substances|growth substances|mesh-ancestor
65374855|NCT00788060|Growth Inhibitors|growth inhibitors|mesh-ancestor
65374856|NCT00788060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65374857|NCT00788060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374858|NCT00788060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374859|NCT00788138|Vitamin D|vitamin d|mesh-list
65374860|NCT00788138|Cholecalciferol|cholecalciferol|mesh-list
65374861|NCT00788138|Vitamins|vitamins|mesh-ancestor
65374862|NCT00788138|Micronutrients|micronutrients|mesh-ancestor
65374863|NCT00788138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374864|NCT00788138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65374865|NCT00788138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65374866|NCT00864396|Lansoprazole|lansoprazole|mesh-list
65374867|NCT00864396|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65374868|NCT00864396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65374869|NCT00864396|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65374870|NCT00864396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374871|NCT00864396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374872|NCT00745823|Raltegravir Potassium|raltegravir potassium|mesh-list
65374873|NCT00745823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65374874|NCT00745823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65374875|NCT00745823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65374876|NCT00745823|Antiviral Agents|antiviral agents|mesh-ancestor
65374877|NCT00745823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65374878|NCT00745823|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65374879|NCT00745823|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65374880|NCT00745823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374881|NCT00745823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374882|NCT00745823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65374883|NCT00745823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65374884|NCT00961467|Thalidomide|thalidomide|mesh-list
65374896|NCT00961467|Alkylating Agents|alkylating agents|mesh-ancestor
65374897|NCT00961467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374898|NCT00961467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65374899|NCT00961467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65374900|NCT00961467|Immunologic Factors|immunologic factors|mesh-ancestor
65374901|NCT00961467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65374902|NCT00961467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65374903|NCT00961467|Growth Substances|growth substances|mesh-ancestor
65374904|NCT00961467|Growth Inhibitors|growth inhibitors|mesh-ancestor
65374905|NCT00961467|Leprostatic Agents|leprostatic agents|mesh-ancestor
65374906|NCT00961467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65374907|NCT00961467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65374908|NCT00980031|Eplerenone|eplerenone|mesh-list
65374909|NCT00980031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65374910|NCT00980031|Hormone Antagonists|hormone antagonists|mesh-ancestor
65374911|NCT00980031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65374912|NCT00980031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374913|NCT00980031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65374914|NCT00980031|Diuretics|diuretics|mesh-ancestor
65374915|NCT00980031|Natriuretic Agents|natriuretic agents|mesh-ancestor
65374950|NCT00284089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65374951|NCT00284089|Growth Substances|growth substances|mesh-ancestor
65374952|NCT00284089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374953|NCT00284089|Growth Inhibitors|growth inhibitors|mesh-ancestor
65374954|NCT00284089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374955|NCT00984633|Bromides|bromides|mesh-list
65374956|NCT00984633|Propofol|propofol|mesh-list
65374957|NCT00984633|Sevoflurane|sevoflurane|mesh-list
65374958|NCT00984633|Rocuronium|rocuronium|mesh-list
65374959|NCT00984633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65374960|NCT00984633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65374961|NCT00984633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65374962|NCT00984633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65374963|NCT00984633|Anesthetics, General|anesthetics, general|mesh-ancestor
65374964|NCT00984633|Anesthetics|anesthetics|mesh-ancestor
65374965|NCT00984633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65374966|NCT00984633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65374967|NCT00984633|Anticonvulsants|anticonvulsants|mesh-ancestor
65374968|NCT00984633|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65374969|NCT00984633|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65374970|NCT00984633|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65374971|NCT00984633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65374972|NCT00659984|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65374973|NCT00659984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374974|NCT00659984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65374975|NCT00659984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374976|NCT00659984|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65374977|NCT00976755|Everolimus|everolimus|mesh-list
65374978|NCT00976755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65374979|NCT00976755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65374996|NCT00283387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65374997|NCT00283387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65374998|NCT00788294|Tanezumab|tanezumab|mesh-list
65374999|NCT00788294|Analgesics|analgesics|mesh-ancestor
65375000|NCT00788294|Sensory System Agents|sensory system agents|mesh-ancestor
65375001|NCT00788294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65375002|NCT00788294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375003|NCT00795548|Azacitidine|azacitidine|mesh-list
65375004|NCT00795548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65375005|NCT00795548|Antimetabolites|antimetabolites|mesh-ancestor
65375006|NCT00795548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375007|NCT00795548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375008|NCT00795548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375009|NCT00282919|Azithromycin|azithromycin|mesh-list
65375010|NCT00282919|Chloroquine|chloroquine|mesh-list
65375011|NCT00282919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65375012|NCT00282919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65375013|NCT00282919|Amebicides|amebicides|mesh-ancestor
65375014|NCT00282919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65375015|NCT00282919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65375016|NCT00282919|Antimalarials|antimalarials|mesh-ancestor
65375017|NCT00282919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65375018|NCT00984789|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65375019|NCT00984789|Gestodene|gestodene|mesh-list
65375020|NCT00984789|Norelgestromin|norelgestromin|mesh-list
65375021|NCT00984789|Femovan|femovan|mesh-list
65375022|NCT00984789|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65375023|NCT00984789|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65375024|NCT00984789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65375025|NCT00984789|Contraceptive Agents|contraceptive agents|mesh-ancestor
65375026|NCT00984789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65375027|NCT00984789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375028|NCT00984789|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65375029|NCT00984789|Estrogens|estrogens|mesh-ancestor
65375030|NCT00984789|Hormones|hormones|mesh-ancestor
65375032|NCT00984789|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65375037|NCT04046822|Liraglutide|liraglutide|mesh-list
65375038|NCT04046822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65375039|NCT04046822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375040|NCT04046822|Incretins|incretins|mesh-ancestor
65375041|NCT04046822|Hormones|hormones|mesh-ancestor
65375042|NCT04046822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65375043|NCT04007835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65375044|NCT04007835|Gefitinib|gefitinib|mesh-list
65375045|NCT04007835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375046|NCT04007835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65375047|NCT04007835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375048|NCT04007835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375049|NCT00800930|Butyric Acid|butyric acid|mesh-list
65375050|NCT00800930|Histamine Antagonists|histamine antagonists|mesh-ancestor
65375051|NCT00800930|Histamine Agents|histamine agents|mesh-ancestor
65375052|NCT00800930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65375053|NCT00800930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375054|NCT00800930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375055|NCT00868062|Polygeline|polygeline|mesh-list
65375056|NCT00868062|Plasma Substitutes|plasma substitutes|mesh-ancestor
65375057|NCT00868062|Blood Substitutes|blood substitutes|mesh-ancestor
65375058|NCT00742859|Warfarin|warfarin|mesh-list
65375059|NCT00742859|Acenocoumarol|acenocoumarol|mesh-list
65375060|NCT00742859|Betrixaban|betrixaban|mesh-list
65375061|NCT00742859|Anticoagulants|anticoagulants|mesh-ancestor
65375062|NCT00742859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65375063|NCT00742859|Antithrombins|antithrombins|mesh-ancestor
65375064|NCT00742859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65375065|NCT00742859|Protease Inhibitors|protease inhibitors|mesh-ancestor
65375066|NCT00742859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375068|NCT00742781|Vitamin D|vitamin d|mesh-list
65375083|NCT03975283|Anesthetics, Local|anesthetics, local|mesh-ancestor
65375084|NCT03975283|Anesthetics|anesthetics|mesh-ancestor
65375085|NCT03975283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65375086|NCT03975283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375087|NCT03975283|Sensory System Agents|sensory system agents|mesh-ancestor
65375088|NCT03975283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65375089|NCT01070407|Cloricromen|cloricromen|mesh-list
65375090|NCT01070407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65375091|NCT00801086|Ethanol|ethanol|mesh-list
65375092|NCT00801086|Tempol|tempol|mesh-list
65375093|NCT00801086|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65375094|NCT00801086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65375095|NCT00801086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65375096|NCT00801086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375097|NCT00801086|Antioxidants|antioxidants|mesh-ancestor
65375098|NCT00801086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375099|NCT00801086|Protective Agents|protective agents|mesh-ancestor
65375100|NCT00801086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65375101|NCT00801086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375102|NCT00801086|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65375103|NCT00801086|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65375104|NCT00788606|Bevacizumab|bevacizumab|mesh-list
65375105|NCT00788606|Rituximab|rituximab|mesh-list
65375106|NCT00788606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65375107|NCT00788606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375108|NCT00788606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65375109|NCT00788606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65375110|NCT00788606|Growth Substances|growth substances|mesh-ancestor
65375111|NCT00788606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375112|NCT00788606|Growth Inhibitors|growth inhibitors|mesh-ancestor
64767465|NCT00894504|Gemcitabine|gemcitabine|mesh-list
64493948|NCT01083706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493949|NCT01083706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493950|NCT01035346|Ibuprofen|ibuprofen|mesh-list
64493951|NCT01035346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64493966|NCT01035658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64493967|NCT01035658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493968|NCT01035658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64493969|NCT01035658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64493970|NCT01035658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493971|NCT01035658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493972|NCT01037452|Calcium, Dietary|calcium, dietary|mesh-list
64493973|NCT01037452|Lansoprazole|lansoprazole|mesh-list
64493974|NCT01037452|Dexlansoprazole|dexlansoprazole|mesh-list
65375113|NCT00788606|Immunologic Factors|immunologic factors|mesh-ancestor
65375114|NCT00788606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65375115|NCT00795938|Sildenafil Citrate|sildenafil citrate|mesh-list
65375116|NCT00795938|Vasodilator Agents|vasodilator agents|mesh-ancestor
65375117|NCT00795938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65375118|NCT00795938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65375119|NCT00795938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375120|NCT00795938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375121|NCT00795938|Urological Agents|urological agents|mesh-ancestor
65375122|NCT00260065|Decitabine|decitabine|mesh-list
65375123|NCT00260065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65375124|NCT00260065|Antimetabolites|antimetabolites|mesh-ancestor
65375125|NCT00260065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375126|NCT00260065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375127|NCT00260065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375128|NCT01071655|Fluorouracil|fluorouracil|mesh-list
65375129|NCT01071655|Antimetabolites|antimetabolites|mesh-ancestor
65375130|NCT01071655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375131|NCT01071655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65375132|NCT01071655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375133|NCT01071655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65375134|NCT01071655|Immunologic Factors|immunologic factors|mesh-ancestor
65375135|NCT01071655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375136|NCT02531581|Furosemide|furosemide|mesh-list
65375137|NCT02531581|Diuretics|diuretics|mesh-list
65375138|NCT02531581|Natriuretic Agents|natriuretic agents|mesh-ancestor
65375139|NCT02531581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375140|NCT02531581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65375141|NCT02531581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65375142|NCT02531581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375143|NCT04046510|Oxytocin|oxytocin|mesh-list
65375144|NCT04046510|Oxytocics|oxytocics|mesh-ancestor
65375145|NCT04046510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65375146|NCT04046510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375147|NCT00506350|Vaccines|vaccines|mesh-list
65375148|NCT00506350|Immunologic Factors|immunologic factors|mesh-ancestor
65375151|NCT00788840|Insulin, Isophane|insulin, isophane|mesh-list
65375152|NCT00788840|Isophane insulin, beef|isophane insulin, beef|mesh-list
65375153|NCT00788840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65375154|NCT00788840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375155|NCT00742625|Cytarabine|cytarabine|mesh-list
65375156|NCT00742625|Bortezomib|bortezomib|mesh-list
65375157|NCT00742625|Daunorubicin|daunorubicin|mesh-list
65375158|NCT00742625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65375159|NCT00742625|Antimetabolites|antimetabolites|mesh-ancestor
65375160|NCT00742625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375161|NCT00742625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375162|NCT00742625|Antiviral Agents|antiviral agents|mesh-ancestor
65375163|NCT00742625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65375164|NCT00742625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65375165|NCT00742625|Immunologic Factors|immunologic factors|mesh-ancestor
65375166|NCT00742625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375167|NCT00742625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65375168|NCT00742625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65375169|NCT00742625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65375170|NCT00742625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375171|NCT00801788|Oxycodone|oxycodone|mesh-list
65375172|NCT00801788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65375173|NCT00801788|Narcotics|narcotics|mesh-ancestor
65375174|NCT00801788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65375175|NCT00801788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375176|NCT00801788|Analgesics|analgesics|mesh-ancestor
65375177|NCT00801788|Sensory System Agents|sensory system agents|mesh-ancestor
65375178|NCT00801788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65375179|NCT01070485|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65375198|NCT00796250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65375199|NCT00796250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375200|NCT00796250|Antiemetics|antiemetics|mesh-ancestor
65375201|NCT00796250|Autonomic Agents|autonomic agents|mesh-ancestor
65375202|NCT00796250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65375203|NCT00796250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65375204|NCT00796250|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65375205|NCT00796250|Protective Agents|protective agents|mesh-ancestor
65375206|NCT00796250|Dermatologic Agents|dermatologic agents|mesh-ancestor
65375207|NCT00796250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65375208|NCT00796250|Antimetabolites|antimetabolites|mesh-ancestor
65375209|NCT00796250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375210|NCT00796250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65375260|NCT00861120|Doxorubicin|doxorubicin|mesh-list
65375261|NCT00861120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65375262|NCT00861120|Panitumumab|panitumumab|mesh-list
65375263|NCT00861120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65375264|NCT00861120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375265|NCT00861120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65375266|NCT00861120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65375267|NCT00861120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375268|NCT00861120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375269|NCT00861120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65375270|NCT00740051|Glimepiride|glimepiride|mesh-list
65375271|NCT00740051|Linagliptin|linagliptin|mesh-list
65375272|NCT00740051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65375273|NCT00740051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65375274|NCT00740051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375275|NCT00740051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65375276|NCT00740051|Immunologic Factors|immunologic factors|mesh-ancestor
65375277|NCT00740051|Incretins|incretins|mesh-ancestor
65375278|NCT00740051|Hormones|hormones|mesh-ancestor
65375279|NCT00740051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65375280|NCT00740051|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65375281|NCT00740051|Protease Inhibitors|protease inhibitors|mesh-ancestor
65375282|NCT00740051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375283|NCT00740051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375284|NCT00864864|Sunitinib|sunitinib|mesh-list
65375285|NCT00864864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375286|NCT00864864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65375287|NCT00864864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65375288|NCT00864864|Growth Substances|growth substances|mesh-ancestor
65375289|NCT00864864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375290|NCT00864864|Growth Inhibitors|growth inhibitors|mesh-ancestor
65375291|NCT00864864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65375292|NCT00864864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375294|NCT00868764|Granisetron|granisetron|mesh-list
65375299|NCT00868764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65375300|NCT00868764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65375301|NCT00868764|Serotonin Agents|serotonin agents|mesh-ancestor
65375302|NCT00868764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65375303|NCT00868764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375304|NCT00518986|Modafinil|modafinil|mesh-list
65375305|NCT00518986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65375306|NCT00518986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375307|NCT00518986|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65375308|NCT00518986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65375309|NCT00518986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65375310|NCT00518986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375311|NCT00864942|Lenalidomide|lenalidomide|mesh-list
65375312|NCT00864942|Rituximab|rituximab|mesh-list
65375313|NCT00864942|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65375314|NCT00864942|Immunologic Factors|immunologic factors|mesh-ancestor
65375315|NCT00864942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375316|NCT00864942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65375317|NCT00864942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65375318|NCT00864942|Growth Substances|growth substances|mesh-ancestor
65375319|NCT00864942|Growth Inhibitors|growth inhibitors|mesh-ancestor
65375320|NCT00864942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375321|NCT00864942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65375322|NCT00864942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65375323|NCT00864942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65375324|NCT00864942|Alkylating Agents|alkylating agents|mesh-ancestor
65375325|NCT00864942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375326|NCT00870402|Spironolactone|spironolactone|mesh-list
65375327|NCT00870402|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65375328|NCT00870402|Hormone Antagonists|hormone antagonists|mesh-ancestor
65375330|NCT00870402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375339|NCT00742235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65375340|NCT00742235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65375341|NCT00742079|Cycloserine|cycloserine|mesh-list
65375342|NCT00742079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65375343|NCT00742079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65375344|NCT00742079|Renal Agents|renal agents|mesh-ancestor
65375345|NCT00742079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65375346|NCT00742079|Antitubercular Agents|antitubercular agents|mesh-ancestor
65375347|NCT00742079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65375348|NCT00742079|Antimetabolites|antimetabolites|mesh-ancestor
65375349|NCT00742079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375350|NCT04730362|Propofol|propofol|mesh-list
65375351|NCT04730362|Sevoflurane|sevoflurane|mesh-list
65375352|NCT04730362|Anesthetics|anesthetics|mesh-ancestor
65375353|NCT04730362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65375354|NCT04730362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375355|NCT04730362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65375356|NCT04730362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65375357|NCT04730362|Anesthetics, General|anesthetics, general|mesh-ancestor
65375358|NCT04730362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64493975|NCT01037452|Calcium Carbonate|calcium carbonate|mesh-list
64493976|NCT01037452|Magnesium Hydroxide|magnesium hydroxide|mesh-list
64493977|NCT01037452|Calcium|calcium|mesh-list
64493978|NCT01037452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64493979|NCT01037452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493980|NCT01037452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64493981|NCT01037452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64493982|NCT01037452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64493983|NCT01037452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64493984|NCT01037452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493985|NCT01037452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493986|NCT01037452|Antacids|antacids|mesh-ancestor
64493987|NCT03012646|Treprostinil|treprostinil|mesh-list
64556383|NCT04023305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64556384|NCT04023305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64556385|NCT04023305|Anesthetics, General|anesthetics, general|mesh-ancestor
64556386|NCT04023305|Anesthetics|anesthetics|mesh-ancestor
64556387|NCT04023305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64556388|NCT04023305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556389|NCT04149275|Nivolumab|nivolumab|mesh-list
64493988|NCT03012646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64493989|NCT05289856|Avelumab|avelumab|mesh-list
64493990|NCT05289856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64493991|NCT05289856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493992|NCT00636441|Cyclophosphamide|cyclophosphamide|mesh-list
64493993|NCT00636441|Docetaxel|docetaxel|mesh-list
64493994|NCT00636441|Doxorubicin|doxorubicin|mesh-list
64493995|NCT00636441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64493996|NCT00636441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64493997|NCT00636441|Immunologic Factors|immunologic factors|mesh-ancestor
64493998|NCT00636441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493999|NCT00636441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64494000|NCT00636441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64494001|NCT00636441|Alkylating Agents|alkylating agents|mesh-ancestor
65375359|NCT04730362|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65375360|NCT00662792|Tiotropium Bromide|tiotropium bromide|mesh-list
65375361|NCT00662792|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65375362|NCT00662792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65375363|NCT00662792|Autonomic Agents|autonomic agents|mesh-ancestor
65375364|NCT00662792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65375365|NCT00662792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375366|NCT00662792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65375367|NCT00662792|Respiratory System Agents|respiratory system agents|mesh-ancestor
65375368|NCT00662792|Parasympatholytics|parasympatholytics|mesh-ancestor
65375369|NCT00662792|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65375370|NCT00662792|Cholinergic Agents|cholinergic agents|mesh-ancestor
65375371|NCT00662792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65125133|NCT04603794|Disinfectants|disinfectants|mesh-ancestor
65375372|NCT00662792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375373|NCT00662792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65375374|NCT00662792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65375375|NCT00662792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65375376|NCT00662792|Adrenergic Agents|adrenergic agents|mesh-ancestor
65375377|NCT00870480|Finasteride|finasteride|mesh-list
65375378|NCT00870480|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65375379|NCT00870480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65375380|NCT00870480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375381|NCT00870480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375382|NCT00870480|Hormone Antagonists|hormone antagonists|mesh-ancestor
65375383|NCT00870480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65375384|NCT00870480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375385|NCT00870480|Urological Agents|urological agents|mesh-ancestor
65375386|NCT00870558|Ethiodized Oil|ethiodized oil|mesh-list
65375387|NCT00870558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375388|NCT01565278|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65375389|NCT01565278|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65375390|NCT01565278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65375395|NCT00616902|Vitamins|vitamins|mesh-ancestor
65375396|NCT00616902|Micronutrients|micronutrients|mesh-ancestor
65375397|NCT00616902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65375398|NCT00801944|Solifenacin Succinate|solifenacin succinate|mesh-list
65375399|NCT00801944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65375400|NCT00801944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65375401|NCT00801944|Cholinergic Agents|cholinergic agents|mesh-ancestor
65375402|NCT00801944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65375403|NCT00801944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375404|NCT00801944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375405|NCT00801944|Urological Agents|urological agents|mesh-ancestor
65375406|NCT00870636|Bevacizumab|bevacizumab|mesh-list
65375407|NCT00870636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65375408|NCT00870636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375409|NCT00870636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65375410|NCT00870636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65375411|NCT00870636|Growth Substances|growth substances|mesh-ancestor
65375412|NCT00870636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375413|NCT00870636|Growth Inhibitors|growth inhibitors|mesh-ancestor
65375414|NCT00741611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
65375415|NCT00870714|Ketoconazole|ketoconazole|mesh-list
65375416|NCT00870714|Docetaxel|docetaxel|mesh-list
65375417|NCT00870714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375436|NCT02598011|Flucytosine|flucytosine|mesh-list
65375449|NCT00869310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65375450|NCT00869310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375451|NCT00869310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65375452|NCT00869310|Glucocorticoids|glucocorticoids|mesh-ancestor
65375453|NCT00869310|Hormones|hormones|mesh-ancestor
65375454|NCT00869310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65375455|NCT00869310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65375456|NCT00869310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375457|NCT00869310|Protease Inhibitors|protease inhibitors|mesh-ancestor
65375458|NCT00869310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375459|NCT00869310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375460|NCT00869310|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65375461|NCT00869310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65375462|NCT00869310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65375463|NCT00869310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65375464|NCT00869310|Dopamine Agents|dopamine agents|mesh-ancestor
65375465|NCT00662558|Celecoxib|celecoxib|mesh-list
65375466|NCT00662558|Tramadol|tramadol|mesh-list
65375467|NCT00662558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65375468|NCT00662558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65375469|NCT00662558|Analgesics|analgesics|mesh-ancestor
65375470|NCT00662558|Sensory System Agents|sensory system agents|mesh-ancestor
65375471|NCT00662558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65375472|NCT00662558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375473|NCT00662558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65375474|NCT00662558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65375475|NCT00662558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65375476|NCT00662558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65375477|NCT00662558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375478|NCT00662558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375479|NCT00662558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65375480|NCT00662558|Narcotics|narcotics|mesh-ancestor
65375489|NCT00869856|Epoetin Alfa|epoetin alfa|mesh-list
65375490|NCT00869856|Hematinics|hematinics|mesh-ancestor
65375491|NCT00802334|Ritonavir|ritonavir|mesh-list
65375492|NCT00802334|Lopinavir|lopinavir|mesh-list
65375493|NCT00802334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65375494|NCT00802334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65375495|NCT00802334|Protease Inhibitors|protease inhibitors|mesh-ancestor
65375496|NCT00802334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375497|NCT00802334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375498|NCT00802334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65375499|NCT00802334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65375500|NCT00802334|Antiviral Agents|antiviral agents|mesh-ancestor
65375501|NCT00802334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65375502|NCT00802334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65375503|NCT00802334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65375504|NCT00796640|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65375505|NCT00796640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65375506|NCT00796640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65375507|NCT00796640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65375508|NCT00796640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375509|NCT00796640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65375510|NCT00796640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65375511|NCT00796640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65375512|NCT00796640|Serotonin Agents|serotonin agents|mesh-ancestor
65375513|NCT00796640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65375514|NCT00796640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375515|NCT00796640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65375516|NCT00796640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65375517|NCT00796640|Dopamine Agents|dopamine agents|mesh-ancestor
65375518|NCT00796796|Sirolimus|sirolimus|mesh-list
65375519|NCT00796796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65375520|NCT00796796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65375521|NCT00796796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65375522|NCT00796796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375523|NCT00796796|Antifungal Agents|antifungal agents|mesh-ancestor
64494002|NCT00636441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494003|NCT00636441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494004|NCT00636441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64494005|NCT00636441|Tubulin Modulators|tubulin modulators|mesh-ancestor
65375524|NCT00796796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65375525|NCT00796796|Immunologic Factors|immunologic factors|mesh-ancestor
65375526|NCT00796796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375527|NCT03794076|Cromolyn Sodium|cromolyn sodium|mesh-list
65375528|NCT03794076|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
65375529|NCT03794076|Immunologic Factors|immunologic factors|mesh-ancestor
65375530|NCT03794076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375531|NCT03794076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65375532|NCT03794076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65375533|NCT03794076|Respiratory System Agents|respiratory system agents|mesh-ancestor
65375535|NCT00739973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65375536|NCT00739973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65375537|NCT00739973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65375538|NCT00739973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375539|NCT00739973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65375540|NCT00739973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375541|NCT00739973|Vasodilator Agents|vasodilator agents|mesh-ancestor
65375542|NCT00802568|Fludarabine|fludarabine|mesh-list
65375543|NCT00802568|Fludarabine phosphate|fludarabine phosphate|mesh-list
65375544|NCT00802568|Busulfan|busulfan|mesh-list
65375545|NCT00802568|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65375546|NCT00802568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375547|NCT00802568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65375548|NCT00802568|Antimetabolites|antimetabolites|mesh-ancestor
65375549|NCT00802568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375550|NCT00802568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65375551|NCT00802568|Immunologic Factors|immunologic factors|mesh-ancestor
65375552|NCT00802568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375553|NCT00802568|Alkylating Agents|alkylating agents|mesh-ancestor
65375554|NCT00802568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65375556|NCT00802802|Efavirenz|efavirenz|mesh-list
65375566|NCT00802802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65375567|NCT00802802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65375568|NCT00802802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65375569|NCT00802802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65375570|NCT00802802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65375571|NCT00802802|Antitubercular Agents|antitubercular agents|mesh-ancestor
65375572|NCT00802802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65375573|NCT00802802|Leprostatic Agents|leprostatic agents|mesh-ancestor
65375574|NCT00802802|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65375575|NCT00802802|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65375576|NCT00802802|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65375577|NCT00802958|Clobetasol|clobetasol|mesh-list
65375578|NCT00802958|Halobetasol|halobetasol|mesh-list
65375579|NCT00802958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65375580|NCT00802958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65375581|NCT00802958|Glucocorticoids|glucocorticoids|mesh-ancestor
65375582|NCT00802958|Hormones|hormones|mesh-ancestor
65375625|NCT00789308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375626|NCT00789308|Antifungal Agents|antifungal agents|mesh-ancestor
65375627|NCT00789308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65375628|NCT00789308|Dermatologic Agents|dermatologic agents|mesh-ancestor
65375629|NCT00789308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65375630|NCT00789308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65375631|NCT00789308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375632|NCT00789308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65375633|NCT00789308|Antitubercular Agents|antitubercular agents|mesh-ancestor
65375634|NCT00789308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65375635|NCT00789308|Anticoagulants|anticoagulants|mesh-ancestor
65375636|NCT00789308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65375637|NCT00789308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65375638|NCT00789308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65375639|NCT00789308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65375640|NCT00789308|Analgesics|analgesics|mesh-ancestor
65375641|NCT00789308|Sensory System Agents|sensory system agents|mesh-ancestor
65375642|NCT00789308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65375643|NCT00789308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65375644|NCT00789308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65375645|NCT00789308|Plasma Substitutes|plasma substitutes|mesh-ancestor
65375646|NCT00789308|Blood Substitutes|blood substitutes|mesh-ancestor
65375678|NCT00727415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65375679|NCT00727415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65375680|NCT00727415|Alkylating Agents|alkylating agents|mesh-ancestor
65375681|NCT00727415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375682|NCT00727415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375683|NCT00727415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65375684|NCT00727415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65375685|NCT00727415|Antimetabolites|antimetabolites|mesh-ancestor
65375686|NCT00727415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65375687|NCT00727415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65375688|NCT00727415|Growth Substances|growth substances|mesh-ancestor
65375689|NCT00727415|Growth Inhibitors|growth inhibitors|mesh-ancestor
65375690|NCT00803192|Famotidine|famotidine|mesh-list
65375691|NCT00803192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65375692|NCT00803192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65375693|NCT00803192|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65375694|NCT00803192|Histamine Antagonists|histamine antagonists|mesh-ancestor
65375695|NCT00803192|Histamine Agents|histamine agents|mesh-ancestor
65375696|NCT00803192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65375697|NCT00803192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375698|NCT00803192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375699|NCT00544557|Etanercept|etanercept|mesh-list
65375700|NCT00544557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65375701|NCT00544557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65375702|NCT00544557|Analgesics|analgesics|mesh-ancestor
65375703|NCT00544557|Sensory System Agents|sensory system agents|mesh-ancestor
65375704|NCT00544557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65375705|NCT00544557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375706|NCT00544557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65375707|NCT00544557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65375708|NCT00544557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65375720|NCT00877110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375721|NCT00877110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375722|NCT00877110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65375723|NCT00877110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65375724|NCT00877110|Tubulin Modulators|tubulin modulators|mesh-ancestor
65375725|NCT00877110|Antimitotic Agents|antimitotic agents|mesh-ancestor
65375726|NCT00877110|Mitosis Modulators|mitosis modulators|mesh-ancestor
65375727|NCT00877110|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65375728|NCT00877110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65375729|NCT00877110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375730|NCT00727259|Ribavirin|ribavirin|mesh-list
65375731|NCT00727259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65375732|NCT00727259|Antimetabolites|antimetabolites|mesh-ancestor
65375733|NCT00727259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375734|NCT00727259|Antiviral Agents|antiviral agents|mesh-ancestor
65375735|NCT00727259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65375736|NCT00789386|Midazolam|midazolam|mesh-list
65375737|NCT00789386|Remifentanil|remifentanil|mesh-list
65375738|NCT00789386|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65375739|NCT00789386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65375740|NCT00789386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65375741|NCT00789386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375742|NCT00789386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65375743|NCT00789386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65375744|NCT00789386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65375771|NCT00797030|Cyclosporine|cyclosporine|mesh-list
65375772|NCT00797030|Cyclosporins|cyclosporins|mesh-list
65375773|NCT00797030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375774|NCT00797030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375775|NCT00797030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65375776|NCT00797030|Immunologic Factors|immunologic factors|mesh-ancestor
65375777|NCT00797030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375778|NCT00797030|Antifungal Agents|antifungal agents|mesh-ancestor
65375779|NCT00797030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65375780|NCT00797030|Dermatologic Agents|dermatologic agents|mesh-ancestor
65375781|NCT00797030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65375782|NCT00797030|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65375783|NCT00977145|Interferon-gamma|interferon-gamma|mesh-list
65375784|NCT00977145|Antiviral Agents|antiviral agents|mesh-ancestor
65375785|NCT00977145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65375786|NCT00918047|Oxcarbazepine|oxcarbazepine|mesh-list
65375787|NCT00918047|Anticonvulsants|anticonvulsants|mesh-ancestor
65375788|NCT00918047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65375789|NCT00918047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65375790|NCT00918047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65375791|NCT00918047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375792|NCT00918047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65375793|NCT00918047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65375794|NCT00877266|Mepivacaine|mepivacaine|mesh-list
65375795|NCT00877266|Anesthetics, Local|anesthetics, local|mesh-ancestor
65375796|NCT00877266|Anesthetics|anesthetics|mesh-ancestor
65375797|NCT00877266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65375798|NCT00877266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375799|NCT00877266|Sensory System Agents|sensory system agents|mesh-ancestor
65375800|NCT00877266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65375801|NCT02553824|Topiramate|topiramate|mesh-list
65375802|NCT02553824|Phentermine|phentermine|mesh-list
65375803|NCT02553824|Anticonvulsants|anticonvulsants|mesh-ancestor
65375804|NCT02553824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64494006|NCT00636441|Antimitotic Agents|antimitotic agents|mesh-ancestor
64494007|NCT00636441|Mitosis Modulators|mitosis modulators|mesh-ancestor
64494008|NCT00636441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64494009|NCT00636441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64494010|NCT00636441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64494011|NCT00636441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494039|NCT01090180|Dexamethasone|dexamethasone|mesh-list
65375805|NCT02553824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375806|NCT02553824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65375807|NCT02553824|Appetite Depressants|appetite depressants|mesh-ancestor
65375808|NCT02553824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65375809|NCT02553824|Sympathomimetics|sympathomimetics|mesh-ancestor
65375810|NCT02553824|Autonomic Agents|autonomic agents|mesh-ancestor
65375811|NCT02553824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65375812|NCT02553824|Adrenergic Agents|adrenergic agents|mesh-ancestor
65375813|NCT02553824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65375814|NCT02553824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375815|NCT04039854|Propofol|propofol|mesh-list
65375816|NCT04039854|Sevoflurane|sevoflurane|mesh-list
65375817|NCT04039854|Desflurane|desflurane|mesh-list
65375818|NCT04039854|Isoflurane|isoflurane|mesh-list
65375819|NCT04039854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65375820|NCT04039854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65375821|NCT04039854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375822|NCT04039854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65375823|NCT04039854|Anesthetics, General|anesthetics, general|mesh-ancestor
65375824|NCT04039854|Anesthetics|anesthetics|mesh-ancestor
65375825|NCT04039854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65375826|NCT04039854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65375827|NCT04045730|Gemcitabine|gemcitabine|mesh-list
65375828|NCT04045730|Paclitaxel|paclitaxel|mesh-list
65375829|NCT04045730|Pembrolizumab|pembrolizumab|mesh-list
65375830|NCT04045730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65375831|NCT04045730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375832|NCT04045730|Tubulin Modulators|tubulin modulators|mesh-ancestor
64494040|NCT01090180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64494041|NCT01090180|Antiemetics|antiemetics|mesh-ancestor
64494042|NCT01090180|Autonomic Agents|autonomic agents|mesh-ancestor
64494043|NCT01090180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64494044|NCT01090180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494045|NCT01090180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64494046|NCT01090180|Glucocorticoids|glucocorticoids|mesh-ancestor
64494048|NCT01090180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64494051|NCT00636207|Montelukast|montelukast|mesh-list
64494052|NCT00636207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64494053|NCT00636207|Respiratory System Agents|respiratory system agents|mesh-ancestor
64494054|NCT00636207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64494055|NCT00636207|Hormone Antagonists|hormone antagonists|mesh-ancestor
64494056|NCT00636207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64494057|NCT00636207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494058|NCT00636207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64494059|NCT00636207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64494080|NCT01092676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64494081|NCT01092676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494082|NCT01092676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375833|NCT04045730|Antimitotic Agents|antimitotic agents|mesh-ancestor
65375834|NCT04045730|Mitosis Modulators|mitosis modulators|mesh-ancestor
65375835|NCT04045730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375836|NCT04045730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65375837|NCT04045730|Antimetabolites|antimetabolites|mesh-ancestor
65375838|NCT04045730|Antiviral Agents|antiviral agents|mesh-ancestor
65375839|NCT04045730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65375840|NCT04045730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65375841|NCT04045730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65375842|NCT04045730|Immunologic Factors|immunologic factors|mesh-ancestor
65375843|NCT04045730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375844|NCT04045730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65375845|NCT00977223|Aprepitant|aprepitant|mesh-list
65375846|NCT00977223|Fosaprepitant|fosaprepitant|mesh-list
65375847|NCT00977223|Antiemetics|antiemetics|mesh-ancestor
65375848|NCT00977223|Autonomic Agents|autonomic agents|mesh-ancestor
65375849|NCT00977223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65375850|NCT00977223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375851|NCT00977223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65375852|NCT00977223|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65375853|NCT00977223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65375854|NCT00977223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375855|NCT03721068|Cyclophosphamide|cyclophosphamide|mesh-list
65375856|NCT03721068|Fludarabine|fludarabine|mesh-list
65375857|NCT03721068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65375881|NCT00977301|Autonomic Agents|autonomic agents|mesh-ancestor
65375882|NCT00977301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65375883|NCT00977301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375884|NCT00977301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65375885|NCT00977301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65375886|NCT00977301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65375887|NCT00977301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65375888|NCT00977301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65375889|NCT00977301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65375890|NCT00977301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65375891|NCT00977301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65375892|NCT00977301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65375893|NCT00977301|Serotonin Agents|serotonin agents|mesh-ancestor
65375894|NCT00735371|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65375895|NCT00735371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65375896|NCT00735371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375897|NCT00735371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65375898|NCT00735371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65375899|NCT00735371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65375900|NCT00735371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375901|NCT00735371|Dopamine Agents|dopamine agents|mesh-ancestor
65375902|NCT00735371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65375903|NCT00518206|Cyclophosphamide|cyclophosphamide|mesh-list
65375904|NCT00518206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65375905|NCT00518206|Immunologic Factors|immunologic factors|mesh-ancestor
65375906|NCT00518206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375907|NCT00518206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65375908|NCT00518206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65375909|NCT00518206|Alkylating Agents|alkylating agents|mesh-ancestor
65375910|NCT00518206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375911|NCT00518206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65375920|NCT00879918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375921|NCT00879918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65375922|NCT00879918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65375923|NCT00879918|Cholinergic Agents|cholinergic agents|mesh-ancestor
65375924|NCT00879918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65375925|NCT00879918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375926|NCT01565590|Dexmedetomidine|dexmedetomidine|mesh-list
65375927|NCT01565590|Propofol|propofol|mesh-list
65375928|NCT01565590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65375929|NCT01565590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65375930|NCT01565590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375931|NCT01565590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65375932|NCT01565590|Anesthetics, General|anesthetics, general|mesh-ancestor
65375933|NCT01565590|Anesthetics|anesthetics|mesh-ancestor
65375934|NCT01565590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65375935|NCT01565590|Analgesics|analgesics|mesh-ancestor
65375936|NCT01565590|Sensory System Agents|sensory system agents|mesh-ancestor
65375937|NCT01565590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65375938|NCT01565590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65375939|NCT01565590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65375940|NCT01565590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65375941|NCT01565590|Adrenergic Agents|adrenergic agents|mesh-ancestor
65375942|NCT01565590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65375943|NCT01565590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375944|NCT00877422|Vitamin D|vitamin d|mesh-list
65375945|NCT00877422|Cholecalciferol|cholecalciferol|mesh-list
65375946|NCT00877422|Vitamins|vitamins|mesh-ancestor
65375947|NCT00877422|Micronutrients|micronutrients|mesh-ancestor
65375948|NCT00877422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375966|NCT00803816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65375967|NCT00803816|Immunologic Factors|immunologic factors|mesh-ancestor
65375968|NCT00803816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375969|NCT00797264|Ketamine|ketamine|mesh-list
65375970|NCT00797264|Morphine|morphine|mesh-list
65375971|NCT00797264|Analgesics|analgesics|mesh-ancestor
65375972|NCT00797264|Sensory System Agents|sensory system agents|mesh-ancestor
65375973|NCT00797264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65375974|NCT00797264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375975|NCT00797264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65375976|NCT00797264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65375977|NCT00797264|Anesthetics, General|anesthetics, general|mesh-ancestor
65375978|NCT00797264|Anesthetics|anesthetics|mesh-ancestor
65375979|NCT00797264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65375980|NCT00797264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65375981|NCT00797264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65375982|NCT00797264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65375983|NCT00797264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65375984|NCT00797264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65375985|NCT00797264|Narcotics|narcotics|mesh-ancestor
65375986|NCT00981201|Celecoxib|celecoxib|mesh-list
65375987|NCT00981201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65375988|NCT00981201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65375989|NCT00981201|Analgesics|analgesics|mesh-ancestor
65375990|NCT00981201|Sensory System Agents|sensory system agents|mesh-ancestor
65375991|NCT00981201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65375992|NCT00981201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65375993|NCT00981201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65376001|NCT05279391|Heparin|heparin|mesh-list
65376012|NCT05279391|Hormones|hormones|mesh-ancestor
65376013|NCT05279391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65376014|NCT05279391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65376015|NCT05279391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376016|NCT05279391|Anticoagulants|anticoagulants|mesh-ancestor
65376017|NCT05279391|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65376018|NCT05279391|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65376019|NCT05279391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376020|NCT05279391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65376021|NCT02595203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65376022|NCT00789620|Lidocaine|lidocaine|mesh-list
65376023|NCT00789620|Anesthetics, Local|anesthetics, local|mesh-ancestor
65376024|NCT00789620|Anesthetics|anesthetics|mesh-ancestor
65376025|NCT00789620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65376026|NCT00789620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376027|NCT00789620|Sensory System Agents|sensory system agents|mesh-ancestor
65376028|NCT00789620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65376029|NCT00789620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65376030|NCT00789620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65376031|NCT00789620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65376032|NCT00789620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65376034|NCT03970265|Meropenem|meropenem|mesh-list
65376061|NCT00797420|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65376062|NCT00797420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65376063|NCT00981513|Vaccines|vaccines|mesh-list
65376064|NCT00981513|Immunologic Factors|immunologic factors|mesh-ancestor
65376065|NCT00981513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376066|NCT00872274|Sumatriptan|sumatriptan|mesh-list
65376067|NCT00872274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65376068|NCT00872274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65376069|NCT00872274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65376070|NCT00872274|Serotonin Agents|serotonin agents|mesh-ancestor
65376071|NCT00872274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65376072|NCT00872274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376073|NCT00872274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376074|NCT00872586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65376075|NCT00872586|Olmesartan|olmesartan|mesh-list
65376076|NCT00872586|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65376077|NCT00872586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65376078|NCT00872586|Diuretics|diuretics|mesh-ancestor
65376079|NCT00872586|Natriuretic Agents|natriuretic agents|mesh-ancestor
65376080|NCT00872586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376081|NCT00872586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65376082|NCT00872586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65376083|NCT00872586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376084|NCT00872586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65376085|NCT00872586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65376086|NCT00726557|Interferons|interferons|mesh-list
65376087|NCT00726557|Ribavirin|ribavirin|mesh-list
65376088|NCT00726557|Interferon-alpha|interferon-alpha|mesh-list
65376089|NCT00726557|Interferon alpha-2|interferon alpha-2|mesh-list
65376090|NCT00726557|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65376091|NCT00726557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376104|NCT00880386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65376105|NCT00880386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65376106|NCT00880386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65376107|NCT00880386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65376108|NCT00880386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376109|NCT00978081|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65376110|NCT00978081|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65376111|NCT00978081|Dermatologic Agents|dermatologic agents|mesh-ancestor
65376112|NCT00804050|Vitamins|vitamins|mesh-list
65376113|NCT00804050|Micronutrients|micronutrients|mesh-ancestor
65376114|NCT00804050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376115|NCT00877734|Baclofen|baclofen|mesh-list
65376116|NCT00877734|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65376117|NCT00877734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376118|NCT00877734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65376119|NCT00877734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125881|NCT01151098|Buprenorphine|buprenorphine|mesh-list
65376120|NCT00877734|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65376121|NCT00877734|GABA Agonists|gaba agonists|mesh-ancestor
65376122|NCT00877734|GABA Agents|gaba agents|mesh-ancestor
65376123|NCT00877734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65376124|NCT00877734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376125|NCT00981591|Iloprost|iloprost|mesh-list
65376126|NCT00981591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65376127|NCT00981591|Vasodilator Agents|vasodilator agents|mesh-ancestor
65376128|NCT00978159|Esomeprazole|esomeprazole|mesh-list
65376129|NCT00978159|Famotidine|famotidine|mesh-list
65376130|NCT00978159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65376131|NCT00978159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65376132|NCT00978159|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65376133|NCT00978159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376134|NCT00978159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376145|NCT00804206|Growth Substances|growth substances|mesh-ancestor
65376146|NCT00804206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376147|NCT00804206|Growth Inhibitors|growth inhibitors|mesh-ancestor
65376148|NCT00877812|Glycine|glycine|mesh-list
65376149|NCT00877812|Glycine Agents|glycine agents|mesh-ancestor
65376150|NCT00877812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65376151|NCT00877812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376152|NCT00877812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376153|NCT00981903|Tinzaparin|tinzaparin|mesh-list
65376154|NCT00981903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65376155|NCT00981903|Dalteparin|dalteparin|mesh-list
65376156|NCT00981903|Anticoagulants|anticoagulants|mesh-ancestor
65376157|NCT00981903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65376158|NCT00981903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65376159|NCT00981903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376160|NCT00738881|Pemetrexed|pemetrexed|mesh-list
65376161|NCT00738881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65376162|NCT00738881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376163|NCT00738881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376164|NCT00738881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376165|NCT00738881|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65376166|NCT00738881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65376167|NCT00738881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65376168|NCT00657020|Nicotine|nicotine|mesh-list
65376169|NCT00657020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65376170|NCT00657020|Autonomic Agents|autonomic agents|mesh-ancestor
65376171|NCT00657020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65376173|NCT00657020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65376191|NCT00872664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376192|NCT05056155|Lubricant Eye Drops|lubricant eye drops|mesh-list
65376193|NCT05056155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65376194|NCT05056155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65376195|NCT00878124|Ubiquinone|ubiquinone|mesh-list
65376196|NCT00878124|Coenzyme Q10|coenzyme q10|mesh-list
65376197|NCT00878124|Micronutrients|micronutrients|mesh-ancestor
65376198|NCT00878124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376199|NCT00878124|Vitamins|vitamins|mesh-ancestor
65376200|NCT00978315|Cholecalciferol|cholecalciferol|mesh-list
65376201|NCT00978315|Vitamin D|vitamin d|mesh-list
65376202|NCT00978315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65376203|NCT00978315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376204|NCT00978315|Vitamins|vitamins|mesh-ancestor
65376205|NCT00978315|Micronutrients|micronutrients|mesh-ancestor
65376206|NCT00978315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65376207|NCT00978393|Liraglutide|liraglutide|mesh-list
65376208|NCT00978393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65376209|NCT00978393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376210|NCT00978393|Incretins|incretins|mesh-ancestor
65376211|NCT00978393|Hormones|hormones|mesh-ancestor
65376212|NCT00978393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65376213|NCT04740996|Pembrolizumab|pembrolizumab|mesh-list
65376214|NCT04740996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65376215|NCT04740996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376216|NCT00872976|Dasatinib|dasatinib|mesh-list
65376217|NCT00872976|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65376218|NCT00872976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376219|NCT00872976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65376239|NCT00544167|Alkylating Agents|alkylating agents|mesh-ancestor
65376240|NCT00544167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65376241|NCT00544167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65376242|NCT00544167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65376243|NCT00544167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65376244|NCT00544167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376245|NCT00544167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65376246|NCT00659438|Bicalutamide|bicalutamide|mesh-list
65376247|NCT00659438|Androgen Antagonists|androgen antagonists|mesh-ancestor
65376248|NCT00659438|Hormone Antagonists|hormone antagonists|mesh-ancestor
65376249|NCT00659438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65376250|NCT00659438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376251|NCT00659438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376252|NCT05225844|Apatinib|apatinib|mesh-list
65376253|NCT05225844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376254|NCT05225844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65376255|NCT05225844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376256|NCT05225844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376257|NCT00878514|Alprazolam|alprazolam|mesh-list
65376258|NCT00878514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65376259|NCT00878514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65376260|NCT00878514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376261|NCT00878514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65376262|NCT00878514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65376263|NCT00878514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65376264|NCT00878514|GABA Modulators|gaba modulators|mesh-ancestor
65376265|NCT00878514|GABA Agents|gaba agents|mesh-ancestor
65376266|NCT00878514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65376267|NCT00878514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376282|NCT00543855|Donepezil|donepezil|mesh-list
65376283|NCT00543855|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65376284|NCT00543855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376285|NCT00543855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376286|NCT00543855|Cholinergic Agents|cholinergic agents|mesh-ancestor
65376287|NCT00543855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65376288|NCT00543855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376289|NCT00543855|Nootropic Agents|nootropic agents|mesh-ancestor
65376290|NCT00797810|Cytarabine|cytarabine|mesh-list
65376291|NCT00797810|Dexamethasone|dexamethasone|mesh-list
65376292|NCT00797810|Prednisone|prednisone|mesh-list
65376293|NCT00797810|Cyclophosphamide|cyclophosphamide|mesh-list
65376294|NCT00797810|Ifosfamide|ifosfamide|mesh-list
65376295|NCT00797810|Rituximab|rituximab|mesh-list
65376296|NCT00797810|Vincristine|vincristine|mesh-list
65376297|NCT00797810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65376298|NCT00797810|Immunologic Factors|immunologic factors|mesh-ancestor
65376299|NCT00797810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376300|NCT00797810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65376301|NCT00797810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65376302|NCT00797810|Alkylating Agents|alkylating agents|mesh-ancestor
65376303|NCT00797810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376304|NCT00797810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376305|NCT00797810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65376306|NCT00797810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65376307|NCT00797810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65376308|NCT00797810|Antiemetics|antiemetics|mesh-ancestor
65376309|NCT00797810|Autonomic Agents|autonomic agents|mesh-ancestor
65376310|NCT00797810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65376311|NCT00797810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65376312|NCT00797810|Glucocorticoids|glucocorticoids|mesh-ancestor
65376313|NCT00797810|Hormones|hormones|mesh-ancestor
65376314|NCT00797810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65376315|NCT00797810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65376316|NCT00797810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64494084|NCT05273320|Nabilone|nabilone|mesh-list
64494085|NCT05273320|Antiemetics|antiemetics|mesh-ancestor
64494086|NCT05273320|Autonomic Agents|autonomic agents|mesh-ancestor
64494087|NCT05273320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64494088|NCT05273320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494089|NCT05273320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64494090|NCT05273320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65376317|NCT00797810|Antimetabolites|antimetabolites|mesh-ancestor
65376318|NCT00797810|Antiviral Agents|antiviral agents|mesh-ancestor
65376319|NCT00797810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65376320|NCT00797810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65376321|NCT00797810|Tubulin Modulators|tubulin modulators|mesh-ancestor
65376322|NCT00797810|Antimitotic Agents|antimitotic agents|mesh-ancestor
65376323|NCT00797810|Mitosis Modulators|mitosis modulators|mesh-ancestor
65376324|NCT00873210|Sunitinib|sunitinib|mesh-list
65376325|NCT00873210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376326|NCT00873210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65376327|NCT00873210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65376328|NCT00873210|Growth Substances|growth substances|mesh-ancestor
65376329|NCT00873210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376330|NCT00873210|Growth Inhibitors|growth inhibitors|mesh-ancestor
65376331|NCT00873210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65376332|NCT00873210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376333|NCT00873210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376334|NCT00978471|Thiotepa|thiotepa|mesh-list
65376335|NCT00978471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65376336|NCT00978471|Alkylating Agents|alkylating agents|mesh-ancestor
65376337|NCT00978471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376338|NCT00978471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376350|NCT00881088|PENTA|penta|mesh-list
64768767|NCT05821517|Methoxyflurane|methoxyflurane|mesh-list
64768768|NCT05821517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64768769|NCT05821517|Anesthetics, General|anesthetics, general|mesh-ancestor
64768770|NCT05821517|Anesthetics|anesthetics|mesh-ancestor
64768771|NCT05821517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64768772|NCT05821517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768773|NCT05821478|Metronidazole|metronidazole|mesh-list
64768774|NCT05821478|Rifampin|rifampin|mesh-list
64768775|NCT05821478|Ceftriaxone|ceftriaxone|mesh-list
64768776|NCT05821478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65376370|NCT00656084|Mitoxantrone|mitoxantrone|mesh-list
65376371|NCT00656084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65376372|NCT00656084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376373|NCT00656084|Immunologic Factors|immunologic factors|mesh-ancestor
65376374|NCT00656084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376375|NCT00656084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65376376|NCT00656084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65376377|NCT00656084|Antimetabolites|antimetabolites|mesh-ancestor
65376378|NCT00656084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376379|NCT00656084|Antiviral Agents|antiviral agents|mesh-ancestor
65376380|NCT00656084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65376381|NCT00656084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376415|NCT05225766|Anesthetics|anesthetics|mesh-ancestor
65376416|NCT05225766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65376417|NCT05225766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376418|NCT05225766|Sensory System Agents|sensory system agents|mesh-ancestor
65376419|NCT05225766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65376420|NCT00804830|Bevacizumab|bevacizumab|mesh-list
65376421|NCT00804830|Doxorubicin|doxorubicin|mesh-list
65376422|NCT00804830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65376423|NCT00804830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376424|NCT00804830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65376425|NCT00804830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65376427|NCT00804830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376428|NCT00804830|Growth Inhibitors|growth inhibitors|mesh-ancestor
65376429|NCT00804830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65376430|NCT00804830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65376431|NCT00804830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65376432|NCT00804830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376433|NCT00804830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376434|NCT00982215|Acetaminophen|acetaminophen|mesh-list
65376435|NCT00982215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65376436|NCT00982215|Analgesics|analgesics|mesh-ancestor
65376437|NCT00982215|Sensory System Agents|sensory system agents|mesh-ancestor
65376438|NCT00982215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65376439|NCT00982215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376440|NCT00982215|Antipyretics|antipyretics|mesh-ancestor
65376441|NCT00613938|Oxycodone|oxycodone|mesh-list
65376442|NCT00613938|Tapentadol|tapentadol|mesh-list
65376443|NCT00613938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65376444|NCT00613938|Narcotics|narcotics|mesh-ancestor
65376445|NCT00613938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65376459|NCT00805064|Triamcinolone|triamcinolone|mesh-list
65376460|NCT00805064|Bevacizumab|bevacizumab|mesh-list
65376461|NCT00805064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65376462|NCT00805064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376463|NCT00805064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65376464|NCT00805064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65376465|NCT00805064|Growth Substances|growth substances|mesh-ancestor
65376466|NCT00805064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376467|NCT00805064|Growth Inhibitors|growth inhibitors|mesh-ancestor
65376468|NCT00805064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65376469|NCT00805064|Glucocorticoids|glucocorticoids|mesh-ancestor
65376470|NCT00805064|Hormones|hormones|mesh-ancestor
65376471|NCT00805064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65376472|NCT00655928|Acetylcysteine|acetylcysteine|mesh-list
65376473|NCT00655928|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65376474|NCT00655928|Antiviral Agents|antiviral agents|mesh-ancestor
65376475|NCT00655928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65376476|NCT00655928|Expectorants|expectorants|mesh-ancestor
65376477|NCT00655928|Respiratory System Agents|respiratory system agents|mesh-ancestor
65376478|NCT00655928|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65376479|NCT00655928|Antioxidants|antioxidants|mesh-ancestor
65376480|NCT00655928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376481|NCT00655928|Protective Agents|protective agents|mesh-ancestor
65376482|NCT00655928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376483|NCT00655928|Antidotes|antidotes|mesh-ancestor
65376484|NCT00873756|Bevacizumab|bevacizumab|mesh-list
65376485|NCT00873756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65376486|NCT00873756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376487|NCT00873756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65376488|NCT00873756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65376489|NCT00873756|Growth Substances|growth substances|mesh-ancestor
65376502|NCT00873834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65376503|NCT00873834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65376504|NCT00873834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65376505|NCT00873834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376506|NCT00655850|Gemcitabine|gemcitabine|mesh-list
65376507|NCT00655850|Paclitaxel|paclitaxel|mesh-list
65376508|NCT00655850|Bevacizumab|bevacizumab|mesh-list
65376509|NCT00655850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65376510|NCT00655850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376511|NCT00655850|Tubulin Modulators|tubulin modulators|mesh-ancestor
65376512|NCT00655850|Antimitotic Agents|antimitotic agents|mesh-ancestor
65376513|NCT00655850|Mitosis Modulators|mitosis modulators|mesh-ancestor
65376514|NCT00655850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376515|NCT00655850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65376516|NCT00655850|Antimetabolites|antimetabolites|mesh-ancestor
65376517|NCT00655850|Antiviral Agents|antiviral agents|mesh-ancestor
65376518|NCT00655850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65376519|NCT00655850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376520|NCT00655850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65376521|NCT00655850|Immunologic Factors|immunologic factors|mesh-ancestor
65376522|NCT00655850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376523|NCT00655850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65376524|NCT00655850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65376525|NCT00655850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65376526|NCT00655850|Growth Substances|growth substances|mesh-ancestor
65376527|NCT00655850|Growth Inhibitors|growth inhibitors|mesh-ancestor
65376528|NCT00874068|Palmitic Acid|palmitic acid|mesh-list
65376529|NCT00874068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376530|NCT00874068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376531|NCT00805298|Methylprednisolone|methylprednisolone|mesh-list
65376532|NCT00805298|Epinephrine|epinephrine|mesh-list
65376533|NCT00805298|Racepinephrine|racepinephrine|mesh-list
65376534|NCT00805298|Epinephryl borate|epinephryl borate|mesh-list
65376535|NCT00805298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65376536|NCT00805298|Antiemetics|antiemetics|mesh-ancestor
65376543|NCT00805298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65376544|NCT00805298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65376545|NCT00805298|Protective Agents|protective agents|mesh-ancestor
65376546|NCT00805298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65376547|NCT00805298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65376548|NCT00805298|Adrenergic Agents|adrenergic agents|mesh-ancestor
65376549|NCT00805298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65376550|NCT00805298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376551|NCT00805298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65376552|NCT00805298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65376553|NCT00805298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65376554|NCT00805298|Respiratory System Agents|respiratory system agents|mesh-ancestor
65376555|NCT00805298|Mydriatics|mydriatics|mesh-ancestor
65376556|NCT00805298|Sympathomimetics|sympathomimetics|mesh-ancestor
65376557|NCT00805298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65376558|NCT00881400|Cefprozil|cefprozil|mesh-list
65376559|NCT00881400|Cephalosporins|cephalosporins|mesh-list
65376560|NCT00881400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65376561|NCT00881400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65376562|NCT00246571|Sunitinib|sunitinib|mesh-list
65376563|NCT00246571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376564|NCT00246571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65376565|NCT00246571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65376566|NCT00246571|Growth Substances|growth substances|mesh-ancestor
65376567|NCT00246571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376568|NCT00246571|Growth Inhibitors|growth inhibitors|mesh-ancestor
65376569|NCT00246571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65376570|NCT00246571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376571|NCT00246571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376572|NCT02553044|Vitamin D|vitamin d|mesh-list
65376573|NCT02553044|Cholecalciferol|cholecalciferol|mesh-list
65126328|NCT00563069|Anesthetics|anesthetics|mesh-ancestor
65376575|NCT02553044|Micronutrients|micronutrients|mesh-ancestor
65376576|NCT02553044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376577|NCT02553044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65376582|NCT00545103|Analgesics|analgesics|mesh-ancestor
65376583|NCT00545103|Sensory System Agents|sensory system agents|mesh-ancestor
65376584|NCT00545103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65376585|NCT00545103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376586|NCT00545103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65376587|NCT00545103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65376588|NCT00586157|Methylphenidate|methylphenidate|mesh-list
65376589|NCT00586157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65376590|NCT00586157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376591|NCT00586157|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65376592|NCT00586157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65376593|NCT00586157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65376594|NCT00586157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376595|NCT00586157|Dopamine Agents|dopamine agents|mesh-ancestor
65376596|NCT00586157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65376597|NCT04087421|Glycerol|glycerol|mesh-list
65376598|NCT04087421|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65376599|NCT04087421|Protective Agents|protective agents|mesh-ancestor
65376600|NCT04087421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376601|NCT02552654|Hydrocortisone|hydrocortisone|mesh-list
65376602|NCT02552654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65376603|NCT00809744|Cholecalciferol|cholecalciferol|mesh-list
65376604|NCT00809744|Vitamin D|vitamin d|mesh-list
65376605|NCT00809744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65376606|NCT00809744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376607|NCT00809744|Vitamins|vitamins|mesh-ancestor
65376608|NCT00809744|Micronutrients|micronutrients|mesh-ancestor
65376609|NCT00809744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65376610|NCT00246337|Rizatriptan|rizatriptan|mesh-list
65376626|NCT01581853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65376627|NCT01581853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65376628|NCT01581853|Antiviral Agents|antiviral agents|mesh-ancestor
65376629|NCT01581853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65376630|NCT01581853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65376631|NCT01581853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65376632|NCT01070641|Carvedilol|carvedilol|mesh-list
65376633|NCT01070641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65376634|NCT01070641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65376635|NCT01070641|Adrenergic Agents|adrenergic agents|mesh-ancestor
65376636|NCT01070641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65376637|NCT01070641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376638|NCT01070641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376639|NCT01070641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65376640|NCT01070641|Antioxidants|antioxidants|mesh-ancestor
65376641|NCT01070641|Protective Agents|protective agents|mesh-ancestor
65376642|NCT01070641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65376643|NCT01070641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65376644|NCT01070641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65376645|NCT01070641|Vasodilator Agents|vasodilator agents|mesh-ancestor
65376646|NCT01070641|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65126434|NCT04614194|Letrozole|letrozole|mesh-list
65376647|NCT01070641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65376648|NCT00982449|Fialuridine|fialuridine|mesh-list
65376649|NCT00982449|Antiviral Agents|antiviral agents|mesh-ancestor
65376650|NCT00982449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65376651|NCT00982449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65376652|NCT00982449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376653|NCT00982449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376654|NCT02593721|Ibuprofen|ibuprofen|mesh-list
65376655|NCT02593721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65376656|NCT02593721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65376657|NCT02593721|Analgesics|analgesics|mesh-ancestor
65376658|NCT02593721|Sensory System Agents|sensory system agents|mesh-ancestor
65376659|NCT02593721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65376662|NCT02593721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65376663|NCT02593721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65376664|NCT02593721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376665|NCT02593721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376666|NCT00985647|Lamivudine|lamivudine|mesh-list
65376667|NCT00985647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65376668|NCT00985647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65376669|NCT00985647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376670|NCT00985647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376671|NCT00985647|Antiviral Agents|antiviral agents|mesh-ancestor
65376672|NCT00985647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65376673|NCT00985647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65376674|NCT00985647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65376675|NCT00806468|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65376676|NCT00806468|Hemostatics|hemostatics|mesh-ancestor
65376677|NCT00806468|Coagulants|coagulants|mesh-ancestor
65376678|NCT00806468|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65376679|NCT00806468|Natriuretic Agents|natriuretic agents|mesh-ancestor
65376680|NCT00806468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376681|NCT00982527|Fenoldopam|fenoldopam|mesh-list
65376682|NCT00982527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65376683|NCT00982527|Vasodilator Agents|vasodilator agents|mesh-ancestor
65376684|NCT00982527|Dopamine Agonists|dopamine agonists|mesh-ancestor
65376685|NCT00982527|Dopamine Agents|dopamine agents|mesh-ancestor
65376686|NCT00982527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65376687|NCT00982527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376688|NCT00982527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376689|NCT00798980|Levonorgestrel|levonorgestrel|mesh-list
65376690|NCT00798980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65376691|NCT00798980|Contraceptive Agents|contraceptive agents|mesh-ancestor
64769110|NCT05668286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65376706|NCT00613626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376707|NCT00613626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376708|NCT00725543|Infliximab|infliximab|mesh-list
65376709|NCT00725543|Dermatologic Agents|dermatologic agents|mesh-ancestor
65376710|NCT00725543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65376711|NCT00725543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65376712|NCT00239005|Mycophenolic Acid|mycophenolic acid|mesh-list
65376713|NCT00239005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65376714|NCT00239005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376715|NCT00239005|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65376716|NCT00239005|Antitubercular Agents|antitubercular agents|mesh-ancestor
65376717|NCT00239005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65376718|NCT00239005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65376719|NCT00239005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376720|NCT00239005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376721|NCT00616434|Interferons|interferons|mesh-list
65376722|NCT00616434|Interferon-beta|interferon-beta|mesh-list
65376723|NCT00616434|Interferon beta-1a|interferon beta-1a|mesh-list
65376724|NCT00616434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376725|NCT00616434|Antiviral Agents|antiviral agents|mesh-ancestor
65376726|NCT00616434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65376727|NCT00616434|Immunologic Factors|immunologic factors|mesh-ancestor
65376728|NCT00616434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376729|NCT00616434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65376735|NCT00257725|Methylphenidate|methylphenidate|mesh-list
64769184|NCT05590585|Emollients|emollients|mesh-list
65376752|NCT02593643|Sensory System Agents|sensory system agents|mesh-ancestor
65376753|NCT02593643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65376754|NCT02593643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376755|NCT02593643|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65376756|NCT02593643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65376757|NCT02593643|Anesthetics, General|anesthetics, general|mesh-ancestor
65376758|NCT02593643|Anesthetics|anesthetics|mesh-ancestor
65376759|NCT02593643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65376760|NCT02593643|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65376761|NCT02593643|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65376762|NCT02593643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65376763|NCT02593643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376764|NCT02593643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65376765|NCT02593643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65376766|NCT02593643|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65376767|NCT02593643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65376768|NCT02593643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65376769|NCT02593643|GABA Modulators|gaba modulators|mesh-ancestor
65376770|NCT02593643|GABA Agents|gaba agents|mesh-ancestor
65376771|NCT00881556|Fludarabine|fludarabine|mesh-list
65376772|NCT00881556|Busulfan|busulfan|mesh-list
65376773|NCT00881556|Alemtuzumab|alemtuzumab|mesh-list
65376774|NCT00881556|Lorazepam|lorazepam|mesh-list
65376775|NCT00881556|Tacrolimus|tacrolimus|mesh-list
65376787|NCT00881556|Anticonvulsants|anticonvulsants|mesh-ancestor
65376803|NCT00881634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65376804|NCT00881634|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65376805|NCT00881634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65376806|NCT00881634|Histamine Antagonists|histamine antagonists|mesh-ancestor
65376807|NCT00881634|Histamine Agents|histamine agents|mesh-ancestor
65376808|NCT00881634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65376809|NCT00881634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376810|NCT00881634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376811|NCT00881634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65376812|NCT00881634|Autonomic Agents|autonomic agents|mesh-ancestor
65376813|NCT00881634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65376814|NCT00881634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65376815|NCT00881634|Respiratory System Agents|respiratory system agents|mesh-ancestor
65376816|NCT00881634|Nasal Decongestants|nasal decongestants|mesh-ancestor
65376817|NCT00881634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65376818|NCT00881634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65376819|NCT00881634|Sympathomimetics|sympathomimetics|mesh-ancestor
65376820|NCT00881634|Adrenergic Agents|adrenergic agents|mesh-ancestor
65376821|NCT00878670|Evening primrose oil|evening primrose oil|mesh-list
65376822|NCT00878670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65376823|NCT00878670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65376824|NCT00878670|Analgesics|analgesics|mesh-ancestor
65376825|NCT00878670|Sensory System Agents|sensory system agents|mesh-ancestor
65376826|NCT00878670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65376827|NCT00878670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376828|NCT00878670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65376829|NCT00878670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65376830|NCT00878670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65376831|NCT00878670|Antimetabolites|antimetabolites|mesh-ancestor
65376832|NCT00878670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376833|NCT00878670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65376834|NCT00878670|Dermatologic Agents|dermatologic agents|mesh-ancestor
65376835|NCT00878748|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64494091|NCT05273320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64494092|NCT05273320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64494093|NCT05273320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64494094|NCT05273320|Hallucinogens|hallucinogens|mesh-ancestor
64494095|NCT05273320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64494096|NCT05273320|Analgesics|analgesics|mesh-ancestor
64494097|NCT05273320|Sensory System Agents|sensory system agents|mesh-ancestor
64556390|NCT04149275|Ipilimumab|ipilimumab|mesh-list
65376836|NCT00878748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65376837|NCT00878748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65376838|NCT00878748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65376839|NCT00878748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376840|NCT00878748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65376841|NCT00878748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376842|NCT00878748|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65376843|NCT00878748|Antidepressive Agents|antidepressive agents|mesh-ancestor
65376844|NCT00878748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65376845|NCT00652028|Fentanyl|fentanyl|mesh-list
65376846|NCT00652028|Midazolam|midazolam|mesh-list
65376847|NCT00652028|Dexmedetomidine|dexmedetomidine|mesh-list
65376848|NCT00652028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65376849|NCT00652028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65376850|NCT00652028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376851|NCT00652028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65376852|NCT00652028|Analgesics|analgesics|mesh-ancestor
65376853|NCT00652028|Sensory System Agents|sensory system agents|mesh-ancestor
65376854|NCT00652028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65376855|NCT00652028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65376856|NCT00652028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65376857|NCT00652028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65376858|NCT00652028|Adrenergic Agents|adrenergic agents|mesh-ancestor
65376859|NCT00652028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65376860|NCT00652028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376861|NCT00652028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65376862|NCT00652028|Narcotics|narcotics|mesh-ancestor
65376863|NCT00652028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65376864|NCT00652028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65376865|NCT00652028|Anesthetics, General|anesthetics, general|mesh-ancestor
65376878|NCT00799136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376879|NCT00799136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65376880|NCT00799136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376881|NCT00799136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65376882|NCT00799136|Tubulin Modulators|tubulin modulators|mesh-ancestor
65376883|NCT00799136|Antimitotic Agents|antimitotic agents|mesh-ancestor
65376884|NCT00799136|Mitosis Modulators|mitosis modulators|mesh-ancestor
65376885|NCT00799136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376886|NCT02592395|Folfirinox|folfirinox|mesh-list
65376887|NCT02592395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376888|NCT00799214|Metronidazole|metronidazole|mesh-list
65376889|NCT00799214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65376890|NCT00799214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65376891|NCT00799214|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65376892|NCT00799214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65376893|NCT00733421|Etoricoxib|etoricoxib|mesh-list
65376894|NCT00733421|Tramadol|tramadol|mesh-list
65376895|NCT00733421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65376896|NCT00733421|Narcotics|narcotics|mesh-ancestor
65376897|NCT00733421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65376898|NCT00733421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376899|NCT00733421|Analgesics|analgesics|mesh-ancestor
65376900|NCT00733421|Sensory System Agents|sensory system agents|mesh-ancestor
65376901|NCT00733421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65376902|NCT00733421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65376903|NCT00733421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65376928|NCT00917891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65376929|NCT00917891|Antiviral Agents|antiviral agents|mesh-ancestor
65376930|NCT00917891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65376931|NCT00732875|Methotrexate|methotrexate|mesh-list
65376932|NCT00732875|Infliximab|infliximab|mesh-list
65376933|NCT00732875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65376934|NCT00732875|Abortifacient Agents|abortifacient agents|mesh-ancestor
65376935|NCT00732875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65376936|NCT00732875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376937|NCT00732875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65376938|NCT00732875|Antimetabolites|antimetabolites|mesh-ancestor
65376939|NCT00732875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65376940|NCT00732875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65376941|NCT00732875|Dermatologic Agents|dermatologic agents|mesh-ancestor
65376942|NCT00732875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65376943|NCT00732875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65376944|NCT00732875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65376945|NCT00732875|Immunologic Factors|immunologic factors|mesh-ancestor
65126695|NCT00572637|Delanzomib|delanzomib|mesh-list
65376985|NCT00799448|Isophane Insulin, Human|isophane insulin, human|mesh-list
65376986|NCT00799448|Insulin, Isophane|insulin, isophane|mesh-list
65376987|NCT00799448|Isophane insulin, beef|isophane insulin, beef|mesh-list
65376988|NCT00799448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65376989|NCT00799448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376990|NCT00806936|Insulin|insulin|mesh-list
65376991|NCT00806936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65376992|NCT00806936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65376993|NCT00806936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65376994|NCT00799682|Travoprost|travoprost|mesh-list
65376995|NCT00799682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65376996|NCT00799682|Latanoprost|latanoprost|mesh-list
65376997|NCT00799682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65376998|NCT00799682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65376999|NCT03829020|Metformin|metformin|mesh-list
65377000|NCT03829020|Nelfinavir|nelfinavir|mesh-list
65377001|NCT03829020|Bortezomib|bortezomib|mesh-list
65377002|NCT03829020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65377003|NCT03829020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377004|NCT03829020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65377005|NCT03829020|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65377006|NCT03829020|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65377007|NCT03829020|Protease Inhibitors|protease inhibitors|mesh-ancestor
65377008|NCT03829020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377010|NCT03829020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65377038|NCT00737711|Hematinics|hematinics|mesh-ancestor
65377039|NCT00807326|Simethicone|simethicone|mesh-list
65377040|NCT00807326|Loperamide|loperamide|mesh-list
65377041|NCT00807326|Antidiarrheals|antidiarrheals|mesh-list
65377042|NCT00807326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65377043|NCT00807326|Antifoaming Agents|antifoaming agents|mesh-ancestor
65377044|NCT00807326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377045|NCT00807326|Emollients|emollients|mesh-ancestor
65377046|NCT00807326|Dermatologic Agents|dermatologic agents|mesh-ancestor
65377047|NCT00875082|Montelukast|montelukast|mesh-list
65377048|NCT00875082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65377049|NCT00875082|Respiratory System Agents|respiratory system agents|mesh-ancestor
65377050|NCT00875082|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65377051|NCT00875082|Hormone Antagonists|hormone antagonists|mesh-ancestor
65377098|NCT00811460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377099|NCT00875238|Doxorubicin|doxorubicin|mesh-list
65377100|NCT00875238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65377101|NCT00875238|Trastuzumab|trastuzumab|mesh-list
65377102|NCT00875238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65377103|NCT00875238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65377104|NCT00875238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65377105|NCT00875238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65377106|NCT00875238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377107|NCT00875238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377108|NCT00875238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65377109|NCT00732251|Allopurinol|allopurinol|mesh-list
65377110|NCT00732251|Antimetabolites|antimetabolites|mesh-ancestor
65377111|NCT00732251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377112|NCT00732251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377113|NCT00732251|Gout Suppressants|gout suppressants|mesh-ancestor
65377114|NCT00732251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65377115|NCT00732251|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65377116|NCT00732251|Antioxidants|antioxidants|mesh-ancestor
65377117|NCT00732251|Protective Agents|protective agents|mesh-ancestor
65377118|NCT00732251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377151|NCT00799838|Sensory System Agents|sensory system agents|mesh-ancestor
65377152|NCT00799838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377153|NCT00799838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377154|NCT00799838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65377155|NCT00799838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65377156|NCT00799838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65377157|NCT00799838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377158|NCT00799838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377159|NCT00737477|Epoetin Alfa|epoetin alfa|mesh-list
65377160|NCT00737477|Hematinics|hematinics|mesh-ancestor
65377161|NCT00800150|Fludarabine|fludarabine|mesh-list
65377162|NCT00800150|Fludarabine phosphate|fludarabine phosphate|mesh-list
65377163|NCT00800150|Melphalan|melphalan|mesh-list
65377164|NCT00800150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65377165|NCT00800150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65377166|NCT00800150|Antimetabolites|antimetabolites|mesh-ancestor
65377167|NCT00800150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377168|NCT00800150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65377169|NCT00800150|Immunologic Factors|immunologic factors|mesh-ancestor
65377170|NCT00800150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126920|NCT00573417|Modafinil|modafinil|mesh-list
65377171|NCT00800150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65377172|NCT00800150|Alkylating Agents|alkylating agents|mesh-ancestor
65377173|NCT00800150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65377174|NCT00800306|Simendan|simendan|mesh-list
65377175|NCT00800306|Dobutamine|dobutamine|mesh-list
65377176|NCT00800306|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65377177|NCT00800306|Vasodilator Agents|vasodilator agents|mesh-ancestor
65377178|NCT00800306|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65377192|NCT01581775|Valproic Acid|valproic acid|mesh-list
64769621|NCT05047172|Purinergic Agents|purinergic agents|mesh-ancestor
64769622|NCT05047172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64769623|NCT05047172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64769624|NCT05047172|Antithrombins|antithrombins|mesh-ancestor
64769625|NCT05047172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65377195|NCT01581775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377196|NCT01581775|GABA Agents|gaba agents|mesh-ancestor
65377197|NCT01581775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65377198|NCT01581775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377199|NCT01581775|Antimanic Agents|antimanic agents|mesh-ancestor
65377200|NCT01581775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65377201|NCT01581775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65377202|NCT01581775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65377203|NCT04039152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65377204|NCT04039152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65377205|NCT01072747|Heparin|heparin|mesh-list
65377206|NCT01072747|Calcium heparin|calcium heparin|mesh-list
65377207|NCT01072747|Anticoagulants|anticoagulants|mesh-ancestor
64769675|NCT04908371|Anesthetics|anesthetics|mesh-ancestor
64769678|NCT04908371|Sensory System Agents|sensory system agents|mesh-ancestor
65377248|NCT02592083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65377249|NCT02592083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65377250|NCT02592083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65377251|NCT02592083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65377252|NCT02592083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65377253|NCT02592083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65377255|NCT02592083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377256|NCT02592083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65377257|NCT04589676|Naloxone|naloxone|mesh-list
65377258|NCT04589676|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65377259|NCT04589676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377260|NCT04589676|Sensory System Agents|sensory system agents|mesh-ancestor
65377261|NCT04589676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377262|NCT00724451|Ribavirin|ribavirin|mesh-list
65377263|NCT00724451|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65377264|NCT00724451|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65377265|NCT00724451|Antimetabolites|antimetabolites|mesh-ancestor
65377266|NCT00724451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377267|NCT00724451|Antiviral Agents|antiviral agents|mesh-ancestor
65377268|NCT00724451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65377269|NCT00724373|Ribavirin|ribavirin|mesh-list
65377270|NCT00724373|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65377271|NCT00724373|Antimetabolites|antimetabolites|mesh-ancestor
65377275|NCT02594579|Vitamin D|vitamin d|mesh-list
65377295|NCT00724061|Furocoumarins|furocoumarins|mesh-list
65377296|NCT00724061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65377297|NCT00724061|Antiviral Agents|antiviral agents|mesh-ancestor
65377298|NCT00724061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65377299|NCT00724061|Immunologic Factors|immunologic factors|mesh-ancestor
65377300|NCT00724061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377301|NCT00724061|Dermatologic Agents|dermatologic agents|mesh-ancestor
65377302|NCT00724061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65377303|NCT02594423|Bevacizumab|bevacizumab|mesh-list
65377304|NCT02594423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65377305|NCT02594423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65377306|NCT02594423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65377307|NCT02594423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65377308|NCT02594423|Growth Substances|growth substances|mesh-ancestor
65377309|NCT02594423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377310|NCT02594423|Growth Inhibitors|growth inhibitors|mesh-ancestor
65377311|NCT00882414|Ferric Compounds|ferric compounds|mesh-list
65377312|NCT00882414|Hematinics|hematinics|mesh-ancestor
65377313|NCT02593487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65377314|NCT02593487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65377315|NCT02593487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65377316|NCT02593487|Antimetabolites|antimetabolites|mesh-ancestor
65377317|NCT02593487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377318|NCT02593487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65377319|NCT02593487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65377320|NCT02593487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377321|NCT00875784|Sumatriptan|sumatriptan|mesh-list
65377322|NCT00875784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65377323|NCT00875784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65377324|NCT00875784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65377325|NCT00875784|Serotonin Agents|serotonin agents|mesh-ancestor
65377326|NCT00875784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65377327|NCT00875784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377328|NCT00875784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377329|NCT00731549|Aripiprazole|aripiprazole|mesh-list
65377330|NCT00731549|Antidepressive Agents|antidepressive agents|mesh-ancestor
64556391|NCT04149275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64556392|NCT04149275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65377331|NCT00731549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65377332|NCT00731549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65377333|NCT00731549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65377334|NCT00731549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65377335|NCT00731549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377336|NCT00731549|Dopamine Agonists|dopamine agonists|mesh-ancestor
65377337|NCT00731549|Dopamine Agents|dopamine agents|mesh-ancestor
65377338|NCT00731549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65377339|NCT00731549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377340|NCT00731549|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65377341|NCT00731549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65377342|NCT00731549|Serotonin Agents|serotonin agents|mesh-ancestor
65377343|NCT00731549|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65377344|NCT00731549|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65377345|NCT00731549|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65377346|NCT00731549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65377347|NCT00882570|Cefdinir|cefdinir|mesh-list
65377348|NCT00882570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65377349|NCT00882570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65377350|NCT00882882|Metformin|metformin|mesh-list
65377351|NCT00882882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65377352|NCT00882882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377353|NCT00882960|Fentanyl|fentanyl|mesh-list
65377354|NCT00882960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65377355|NCT00882960|Narcotics|narcotics|mesh-ancestor
65377356|NCT00882960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65377357|NCT00882960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377358|NCT00882960|Analgesics|analgesics|mesh-ancestor
65377359|NCT00882960|Sensory System Agents|sensory system agents|mesh-ancestor
65377360|NCT00882960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377361|NCT00882960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65377375|NCT00888732|Insulin, Long-Acting|insulin, long-acting|mesh-list
65377376|NCT00888732|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65377377|NCT00888732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65377378|NCT00888732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377379|NCT00730925|Paclitaxel|paclitaxel|mesh-list
65377380|NCT00730925|Afatinib|afatinib|mesh-list
65377381|NCT00730925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65377382|NCT00730925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65377383|NCT00730925|Tubulin Modulators|tubulin modulators|mesh-ancestor
65377384|NCT00730925|Antimitotic Agents|antimitotic agents|mesh-ancestor
65377385|NCT00730925|Mitosis Modulators|mitosis modulators|mesh-ancestor
65377386|NCT00730925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377387|NCT00730925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65377388|NCT00730925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377389|NCT00236899|Gemcitabine|gemcitabine|mesh-list
65377390|NCT00236899|Paclitaxel|paclitaxel|mesh-list
65377391|NCT00236899|Docetaxel|docetaxel|mesh-list
65377392|NCT00236899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65377393|NCT00236899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65377394|NCT00236899|Tubulin Modulators|tubulin modulators|mesh-ancestor
65377395|NCT00236899|Antimitotic Agents|antimitotic agents|mesh-ancestor
65377396|NCT00236899|Mitosis Modulators|mitosis modulators|mesh-ancestor
65377397|NCT00236899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377398|NCT00236899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65127153|NCT04595825|Antibodies|antibodies|mesh-list
65377399|NCT00236899|Antimetabolites|antimetabolites|mesh-ancestor
65377400|NCT00236899|Antiviral Agents|antiviral agents|mesh-ancestor
65377401|NCT00236899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65377402|NCT00236899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377403|NCT00236899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65377421|NCT00885690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65377422|NCT00885690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65377423|NCT00885690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65377424|NCT00885690|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65377425|NCT00885690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65377426|NCT00885690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65377427|NCT00885690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377428|NCT00885690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65377429|NCT00885690|Serotonin Agents|serotonin agents|mesh-ancestor
65377430|NCT00888810|Topotecan|topotecan|mesh-list
65377431|NCT00888810|Lapatinib|lapatinib|mesh-list
65377432|NCT00888810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65377433|NCT00888810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65377434|NCT00888810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377435|NCT00888810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377436|NCT00888810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65377437|NCT00888810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65377438|NCT00256243|Paclitaxel|paclitaxel|mesh-list
65377439|NCT00256243|Cyclophosphamide|cyclophosphamide|mesh-list
65377440|NCT00256243|Carboplatin|carboplatin|mesh-list
65377441|NCT00256243|Doxorubicin|doxorubicin|mesh-list
65377442|NCT00256243|Trastuzumab|trastuzumab|mesh-list
65377443|NCT00256243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65377444|NCT00256243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65377445|NCT00256243|Tubulin Modulators|tubulin modulators|mesh-ancestor
65377446|NCT00256243|Antimitotic Agents|antimitotic agents|mesh-ancestor
65377447|NCT00256243|Mitosis Modulators|mitosis modulators|mesh-ancestor
65377448|NCT00256243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377449|NCT00256243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65377450|NCT00256243|Immunologic Factors|immunologic factors|mesh-ancestor
65377451|NCT00256243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377464|NCT00236197|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65377465|NCT00236197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377466|NCT00236197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377467|NCT02541708|Folic Acid|folic acid|mesh-list
65377468|NCT02541708|Hematinics|hematinics|mesh-ancestor
65377469|NCT02541708|Vitamin B Complex|vitamin b complex|mesh-ancestor
65377470|NCT02541708|Vitamins|vitamins|mesh-ancestor
65377471|NCT02541708|Micronutrients|micronutrients|mesh-ancestor
65377472|NCT02541708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377473|NCT03973567|Norepinephrine|norepinephrine|mesh-list
65377474|NCT03973567|Antidepressive Agents|antidepressive agents|mesh-list
65377475|NCT03973567|Serotonin|serotonin|mesh-list
65377476|NCT03973567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65377477|NCT03973567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65377478|NCT03973567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65377479|NCT03973567|Serotonin Agents|serotonin agents|mesh-ancestor
65377480|NCT03973567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65377481|NCT03973567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377482|NCT03973567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377483|NCT03973567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65377484|NCT03973567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65377485|NCT03973567|Adrenergic Agents|adrenergic agents|mesh-ancestor
65377486|NCT03973567|Sympathomimetics|sympathomimetics|mesh-ancestor
65377487|NCT03973567|Autonomic Agents|autonomic agents|mesh-ancestor
65377488|NCT03973567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377489|NCT03973567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65377491|NCT03973567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65377514|NCT03973411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65377515|NCT03973411|Serotonin Agents|serotonin agents|mesh-ancestor
65377516|NCT03973411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65377517|NCT03973411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377518|NCT03973411|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65377519|NCT03973411|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65377520|NCT03973411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65377521|NCT03973411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65377522|NCT03973411|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65377523|NCT00883506|Lisinopril|lisinopril|mesh-list
65377524|NCT00883506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65377525|NCT00883506|Protease Inhibitors|protease inhibitors|mesh-ancestor
65377526|NCT00883506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377527|NCT00883506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377528|NCT00883506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65377529|NCT00883506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65377530|NCT00883506|Protective Agents|protective agents|mesh-ancestor
65377531|NCT00883506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377532|NCT00278395|Vorinostat|vorinostat|mesh-list
65377533|NCT00278395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65377534|NCT00278395|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65377535|NCT00278395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377536|NCT00278395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377537|NCT00889044|Clopidogrel|clopidogrel|mesh-list
65377538|NCT00889044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65377539|NCT00889044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65377561|NCT00883662|Levonorgestrel|levonorgestrel|mesh-list
65377562|NCT00883662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65377563|NCT00883662|Contraceptive Agents|contraceptive agents|mesh-ancestor
65377564|NCT00883662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65377565|NCT00883662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377566|NCT00883662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65377567|NCT00883662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65377568|NCT00883662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65377569|NCT00883818|Azithromycin|azithromycin|mesh-list
65377570|NCT00883818|Doxycycline|doxycycline|mesh-list
65377571|NCT00883818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65377572|NCT00883818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65377573|NCT00883818|Antimalarials|antimalarials|mesh-ancestor
65377574|NCT00883818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65377575|NCT00883818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65377576|NCT00889356|Clindamycin|clindamycin|mesh-list
65377577|NCT00889356|Clindamycin palmitate|clindamycin palmitate|mesh-list
65377578|NCT00889356|Clindamycin phosphate|clindamycin phosphate|mesh-list
65377579|NCT00889356|Amphotericin B|amphotericin b|mesh-list
65377580|NCT00889356|Tetracycline|tetracycline|mesh-list
65377581|NCT00889356|Ketoconazole|ketoconazole|mesh-list
65377582|NCT00889356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65377583|NCT00889356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65377584|NCT00889356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65377585|NCT00889356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65377586|NCT00889356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377587|NCT00889356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377588|NCT00889356|Antifungal Agents|antifungal agents|mesh-ancestor
65377589|NCT00889356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65377590|NCT00889356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65377607|NCT00889434|Micronutrients|micronutrients|mesh-ancestor
65377608|NCT00612534|Sufentanil|sufentanil|mesh-list
65377609|NCT00612534|Dsuvia|dsuvia|mesh-list
65377610|NCT00612534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65377611|NCT00612534|Narcotics|narcotics|mesh-ancestor
65377612|NCT00612534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65377613|NCT00612534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377614|NCT00612534|Analgesics|analgesics|mesh-ancestor
65377615|NCT00612534|Sensory System Agents|sensory system agents|mesh-ancestor
65377616|NCT00612534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377617|NCT00612534|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65377618|NCT00612534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65377619|NCT00612534|Anesthetics, General|anesthetics, general|mesh-ancestor
65377620|NCT00612534|Anesthetics|anesthetics|mesh-ancestor
65377621|NCT02542254|Albuterol|albuterol|mesh-list
65377622|NCT02542254|Ipratropium|ipratropium|mesh-list
65377623|NCT02542254|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65377624|NCT02542254|Autonomic Agents|autonomic agents|mesh-ancestor
65377625|NCT02542254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377626|NCT02542254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377627|NCT02542254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65377628|NCT02542254|Respiratory System Agents|respiratory system agents|mesh-ancestor
65377629|NCT02542254|Tocolytic Agents|tocolytic agents|mesh-ancestor
65377630|NCT02542254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65377631|NCT02542254|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65377632|NCT02542254|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65377633|NCT02542254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65377634|NCT02542254|Adrenergic Agents|adrenergic agents|mesh-ancestor
65377635|NCT02542254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65377636|NCT02542254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377637|NCT02542254|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65377638|NCT02542254|Cholinergic Agents|cholinergic agents|mesh-ancestor
65377639|NCT04179396|Rucaparib|rucaparib|mesh-list
64770129|NCT04257578|Acalabrutinib|acalabrutinib|mesh-list
64556393|NCT04149275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64556394|NCT04149275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556396|NCT04148963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64556397|NCT04148963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64556398|NCT04148963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64556399|NCT04148963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556400|NCT04148963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64556401|NCT04148963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64556402|NCT04148963|Dopamine Agents|dopamine agents|mesh-ancestor
65377640|NCT04179396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65377641|NCT04179396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377642|NCT04179396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377643|NCT04179396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65377644|NCT00889590|Zoledronic Acid|zoledronic acid|mesh-list
65377645|NCT00889590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65377646|NCT00889590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377647|NCT00736853|Acetaminophen|acetaminophen|mesh-list
65377648|NCT00736853|Tramadol|tramadol|mesh-list
65377649|NCT00736853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65377650|NCT00736853|Analgesics|analgesics|mesh-ancestor
65377651|NCT00736853|Sensory System Agents|sensory system agents|mesh-ancestor
65377652|NCT00736853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377653|NCT00736853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377654|NCT00736853|Antipyretics|antipyretics|mesh-ancestor
65377655|NCT00736853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65377656|NCT00736853|Narcotics|narcotics|mesh-ancestor
65377657|NCT00736853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65377658|NCT04037514|Acetaminophen|acetaminophen|mesh-list
65377659|NCT04037514|Ibuprofen|ibuprofen|mesh-list
65377660|NCT04037514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65377661|NCT04037514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65377662|NCT04037514|Analgesics|analgesics|mesh-ancestor
65377663|NCT04037514|Sensory System Agents|sensory system agents|mesh-ancestor
65377664|NCT04037514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377665|NCT04037514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377666|NCT04037514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65377667|NCT04037514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65377669|NCT04037514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377686|NCT00573066|Sensory System Agents|sensory system agents|mesh-ancestor
65377687|NCT00573066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377688|NCT00573066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65377689|NCT00573066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65377690|NCT00573066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65377691|NCT00573066|Adrenergic Agents|adrenergic agents|mesh-ancestor
65377692|NCT00573066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65377693|NCT00573066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377694|NCT02541552|Ropivacaine|ropivacaine|mesh-list
65377695|NCT02541552|Anesthetics, Local|anesthetics, local|mesh-ancestor
65377696|NCT02541552|Anesthetics|anesthetics|mesh-ancestor
65377697|NCT02541552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65377698|NCT02541552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377699|NCT02541552|Sensory System Agents|sensory system agents|mesh-ancestor
65377700|NCT02541552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377701|NCT00886314|Midazolam|midazolam|mesh-list
65377702|NCT00886314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65377703|NCT00886314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65377704|NCT00886314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65377705|NCT00886314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377707|NCT00886314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65377708|NCT00886314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65377709|NCT00886314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65377710|NCT00886314|Anesthetics, General|anesthetics, general|mesh-ancestor
65377711|NCT00886314|Anesthetics|anesthetics|mesh-ancestor
65377712|NCT00886314|GABA Modulators|gaba modulators|mesh-ancestor
65377713|NCT00886314|GABA Agents|gaba agents|mesh-ancestor
65377714|NCT00886314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65377715|NCT00886314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377716|NCT00890214|Epoprostenol|epoprostenol|mesh-list
65377717|NCT00890214|Heparin|heparin|mesh-list
65377718|NCT00890214|Calcium heparin|calcium heparin|mesh-list
65377719|NCT00890214|Tezosentan|tezosentan|mesh-list
65377720|NCT00890214|Anticoagulants|anticoagulants|mesh-ancestor
65377721|NCT00890214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65377722|NCT00890214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65377723|NCT00890214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377726|NCT00890214|Vasodilator Agents|vasodilator agents|mesh-ancestor
65377727|NCT03627468|Bromides|bromides|mesh-list
65377728|NCT03627468|Anticonvulsants|anticonvulsants|mesh-ancestor
65377729|NCT00730691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65377730|NCT00730691|Vortioxetine|vortioxetine|mesh-list
65377731|NCT00730691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65377732|NCT00730691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65377733|NCT00730691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65377734|NCT00730691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377735|NCT00730691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65377736|NCT00730691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377737|NCT00730691|Analgesics|analgesics|mesh-ancestor
65377738|NCT00730691|Sensory System Agents|sensory system agents|mesh-ancestor
65377739|NCT00730691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377740|NCT00730691|Antidepressive Agents|antidepressive agents|mesh-ancestor
65377741|NCT00730691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65377742|NCT00730691|Dopamine Agents|dopamine agents|mesh-ancestor
65377743|NCT00730691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65377744|NCT00730691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65377745|NCT00730691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65377746|NCT00730691|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65377747|NCT00730691|Serotonin Agents|serotonin agents|mesh-ancestor
65377748|NCT00730691|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65377749|NCT00730691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65377750|NCT00730691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65377751|NCT00730691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65377752|NCT00886860|Misoprostol|misoprostol|mesh-list
65377753|NCT00886860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65377754|NCT00886860|Abortifacient Agents|abortifacient agents|mesh-ancestor
65377755|NCT00886860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64770283|NCT04009681|Antibodies|antibodies|mesh-list
64556403|NCT04148963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64556404|NCT04148963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494098|NCT05273320|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64494099|NCT05273320|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64494100|NCT05273320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64494101|NCT05273320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494102|NCT05273320|Hormones|hormones|mesh-ancestor
64586289|NCT00322439|Sensory System Agents|sensory system agents|mesh-ancestor
64494113|NCT01041274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494114|NCT01041274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64494115|NCT01041274|Serotonin Agents|serotonin agents|mesh-ancestor
65377756|NCT00886860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377757|NCT00886860|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65377758|NCT00886860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65377759|NCT00886860|Oxytocics|oxytocics|mesh-ancestor
65377760|NCT00884442|Nifedipine|nifedipine|mesh-list
65377761|NCT00884442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65377762|NCT00884442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65377763|NCT00884442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377764|NCT00884442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65377765|NCT00884442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377766|NCT00884442|Vasodilator Agents|vasodilator agents|mesh-ancestor
65377767|NCT00884442|Tocolytic Agents|tocolytic agents|mesh-ancestor
65377768|NCT00884442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65377769|NCT02543034|Petrolatum|petrolatum|mesh-list
65377770|NCT02543034|Emollients|emollients|mesh-ancestor
65377771|NCT02543034|Dermatologic Agents|dermatologic agents|mesh-ancestor
65377772|NCT00278161|Cyclophosphamide|cyclophosphamide|mesh-list
65377773|NCT00278161|Rituximab|rituximab|mesh-list
65377774|NCT00278161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65377775|NCT00278161|Immunologic Factors|immunologic factors|mesh-ancestor
65377776|NCT00278161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377777|NCT00278161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65127469|NCT00580320|Alkylating Agents|alkylating agents|mesh-ancestor
65377778|NCT00278161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65377779|NCT00278161|Alkylating Agents|alkylating agents|mesh-ancestor
65377780|NCT00278161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377781|NCT00278161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65377782|NCT00278161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65377783|NCT00278161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65377784|NCT02541396|Ketamine|ketamine|mesh-list
65377785|NCT02541396|Oxycodone|oxycodone|mesh-list
65377786|NCT02541396|Analgesics|analgesics|mesh-ancestor
65377787|NCT02541396|Sensory System Agents|sensory system agents|mesh-ancestor
65377788|NCT02541396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377789|NCT02541396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377795|NCT02541396|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65377796|NCT02541396|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65377797|NCT02541396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65377798|NCT02541396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377799|NCT02541396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65377800|NCT02541396|Narcotics|narcotics|mesh-ancestor
65377801|NCT00890604|Acetaminophen|acetaminophen|mesh-list
65377802|NCT00890604|Ibuprofen|ibuprofen|mesh-list
65377803|NCT00890604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65377804|NCT00890604|Analgesics|analgesics|mesh-ancestor
65377805|NCT00890604|Sensory System Agents|sensory system agents|mesh-ancestor
65377806|NCT00890604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377807|NCT00890604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377808|NCT00890604|Antipyretics|antipyretics|mesh-ancestor
65377809|NCT00890604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65377810|NCT00890604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65377811|NCT00890604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65377812|NCT00890604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65377813|NCT00890604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377814|NCT00890604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377815|NCT00255151|Dexlansoprazole|dexlansoprazole|mesh-list
65377816|NCT00255151|Lansoprazole|lansoprazole|mesh-list
65377817|NCT00255151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65377818|NCT00255151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65377819|NCT00255151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65377820|NCT00255151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377821|NCT00255151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377822|NCT03973957|Fentanyl|fentanyl|mesh-list
65377823|NCT03973957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65377824|NCT03973957|Narcotics|narcotics|mesh-ancestor
65377825|NCT03973957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65377827|NCT03973957|Analgesics|analgesics|mesh-ancestor
65377838|NCT00723203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65377839|NCT00723203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65377840|NCT00723203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377841|NCT00723203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377842|NCT00891072|Acetic Acid|acetic acid|mesh-list
65377843|NCT00891072|Paclitaxel|paclitaxel|mesh-list
65377844|NCT00891072|Gossypol acetic acid|gossypol acetic acid|mesh-list
65377845|NCT00891072|Carboplatin|carboplatin|mesh-list
65377846|NCT00891072|Retinol acetate|retinol acetate|mesh-list
65377847|NCT00891072|Gossypol|gossypol|mesh-list
65377848|NCT00891072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65377849|NCT00891072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65377850|NCT00891072|Tubulin Modulators|tubulin modulators|mesh-ancestor
65377851|NCT00891072|Antimitotic Agents|antimitotic agents|mesh-ancestor
65377852|NCT00891072|Mitosis Modulators|mitosis modulators|mesh-ancestor
65377853|NCT00891072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377854|NCT00891072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65377855|NCT00891072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65377856|NCT00891072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65377857|NCT00891072|Immunologic Factors|immunologic factors|mesh-ancestor
65377858|NCT00891072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377859|NCT00891072|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65377860|NCT00891072|Protective Agents|protective agents|mesh-ancestor
65377861|NCT00891072|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65377862|NCT00891072|Contraceptive Agents|contraceptive agents|mesh-ancestor
65377863|NCT00891072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65377888|NCT00233389|Rebamipide|rebamipide|mesh-list
65377889|NCT00233389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65377890|NCT00233389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65377891|NCT00233389|Antioxidants|antioxidants|mesh-ancestor
65377892|NCT00233389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377893|NCT00233389|Protective Agents|protective agents|mesh-ancestor
65377894|NCT00233389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377895|NCT00233389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377896|NCT00891306|Cyclosporine|cyclosporine|mesh-list
65377897|NCT00891306|Mycophenolic Acid|mycophenolic acid|mesh-list
65377898|NCT00891306|Methylprednisolone|methylprednisolone|mesh-list
65377899|NCT00891306|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65377900|NCT00891306|Cyclosporins|cyclosporins|mesh-list
65377901|NCT00891306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377902|NCT00891306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377903|NCT00891306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65377904|NCT00891306|Immunologic Factors|immunologic factors|mesh-ancestor
65377905|NCT00891306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65377906|NCT00891306|Antifungal Agents|antifungal agents|mesh-ancestor
65377907|NCT00891306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65377908|NCT00891306|Dermatologic Agents|dermatologic agents|mesh-ancestor
65377917|NCT00891306|Antiemetics|antiemetics|mesh-ancestor
65377943|NCT00813722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377944|NCT00813722|Vasodilator Agents|vasodilator agents|mesh-ancestor
65377945|NCT00813722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65377946|NCT00813722|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65377947|NCT00813722|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65377948|NCT00813722|Natriuretic Agents|natriuretic agents|mesh-ancestor
65377949|NCT00813722|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65377950|NCT00813722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65377951|NCT00813722|Adrenergic Agents|adrenergic agents|mesh-ancestor
65377952|NCT00813722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65377953|NCT00813722|Sympatholytics|sympatholytics|mesh-ancestor
65377954|NCT00813722|Autonomic Agents|autonomic agents|mesh-ancestor
65377955|NCT00813722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65377956|NCT00813722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65377957|NCT00812318|Cabotegravir|cabotegravir|mesh-list
65377958|NCT00812318|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65377959|NCT00812318|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65377960|NCT00812318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65377961|NCT00812318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65377962|NCT00812318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65377963|NCT00812318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65377964|NCT00812318|Antiviral Agents|antiviral agents|mesh-ancestor
65377972|NCT00812396|Hormones|hormones|mesh-ancestor
65377993|NCT00649220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65377994|NCT00649220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65377995|NCT00812786|Cyclosporine|cyclosporine|mesh-list
65377996|NCT00812786|Mycophenolic Acid|mycophenolic acid|mesh-list
65377997|NCT00812786|Everolimus|everolimus|mesh-list
65377998|NCT00812786|Tacrolimus|tacrolimus|mesh-list
65377999|NCT00812786|Cyclosporins|cyclosporins|mesh-list
65378000|NCT00812786|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65378001|NCT00812786|Immunologic Factors|immunologic factors|mesh-ancestor
65378002|NCT00812786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378003|NCT00812786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65378004|NCT00812786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378005|NCT00812786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378006|NCT00812786|Antifungal Agents|antifungal agents|mesh-ancestor
65378007|NCT00812786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65378008|NCT00812786|Dermatologic Agents|dermatologic agents|mesh-ancestor
65378009|NCT00812786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65378010|NCT00812786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378011|NCT00812786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65378012|NCT00812786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65378013|NCT00812786|Antitubercular Agents|antitubercular agents|mesh-ancestor
65378014|NCT00812786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65378015|NCT00654368|Etanercept|etanercept|mesh-list
65378016|NCT00654368|Methotrexate|methotrexate|mesh-list
65378017|NCT00654368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65378018|NCT00654368|Abortifacient Agents|abortifacient agents|mesh-ancestor
65378019|NCT00654368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65378020|NCT00654368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378021|NCT00654368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65378022|NCT00654368|Antimetabolites|antimetabolites|mesh-ancestor
65378038|NCT00654368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65378039|NCT00812864|Capecitabine|capecitabine|mesh-list
65378040|NCT00812864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65378041|NCT00812864|Antimetabolites|antimetabolites|mesh-ancestor
65378042|NCT00812864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378043|NCT00812864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378044|NCT00808184|Raltegravir Potassium|raltegravir potassium|mesh-list
65378045|NCT00808184|Midazolam|midazolam|mesh-list
65378046|NCT00808184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65378047|NCT00808184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65378048|NCT00808184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65378049|NCT00808184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378050|NCT00808184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65378051|NCT00808184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65378052|NCT00808184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65378053|NCT00808184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65378054|NCT00808184|Anesthetics, General|anesthetics, general|mesh-ancestor
65378055|NCT00808184|Anesthetics|anesthetics|mesh-ancestor
65378056|NCT00808184|GABA Modulators|gaba modulators|mesh-ancestor
65378057|NCT00808184|GABA Agents|gaba agents|mesh-ancestor
65378058|NCT00808184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65378059|NCT00808184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378060|NCT00808184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65378061|NCT00808184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65378062|NCT00808184|Antiviral Agents|antiviral agents|mesh-ancestor
65378063|NCT00808184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65378064|NCT00808184|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65378065|NCT00808184|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65378066|NCT00808184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378067|NCT00647426|Carboplatin|carboplatin|mesh-list
65378068|NCT00647426|Docetaxel|docetaxel|mesh-list
65378069|NCT00647426|Sorafenib|sorafenib|mesh-list
65378070|NCT00647426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378071|NCT00647426|Tubulin Modulators|tubulin modulators|mesh-ancestor
65378072|NCT00647426|Antimitotic Agents|antimitotic agents|mesh-ancestor
64770762|NCT00716066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64770763|NCT00716066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770764|NCT00716066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64770765|NCT00716066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770766|NCT00716066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64770767|NCT00716066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64770768|NCT00716066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64770769|NCT00716066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127742|NCT04586465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65378076|NCT00647426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378077|NCT00647348|Simvastatin|simvastatin|mesh-list
65378078|NCT00647348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65378079|NCT00647348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65378080|NCT00647348|Antimetabolites|antimetabolites|mesh-ancestor
65378081|NCT00647348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378082|NCT00647348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65378083|NCT00647348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65378084|NCT00647348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378085|NCT00647270|Adalimumab|adalimumab|mesh-list
65378086|NCT00647270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65378087|NCT00647270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65378088|NCT00645944|Eszopiclone|eszopiclone|mesh-list
65378089|NCT00645944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65378090|NCT00645944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65378091|NCT00645944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378092|NCT00813332|Docetaxel|docetaxel|mesh-list
65378093|NCT00813332|Endostar protein|endostar protein|mesh-list
65378094|NCT00813332|Endostatins|endostatins|mesh-list
65378095|NCT00813332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378096|NCT00813332|Tubulin Modulators|tubulin modulators|mesh-ancestor
65378111|NCT04708496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65378112|NCT04708496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378113|NCT04708496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378114|NCT04708496|Antiviral Agents|antiviral agents|mesh-ancestor
65378115|NCT04708496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65378116|NCT04708496|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65378117|NCT04708496|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65378118|NCT04708496|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65378119|NCT04708496|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65378120|NCT04708496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65378121|NCT04708496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65378122|NCT04708496|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65378123|NCT04708496|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65378124|NCT04708496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65378125|NCT04708496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65378170|NCT00814268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65378171|NCT00814268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65378172|NCT00814268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65378173|NCT00814268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378174|NCT00814268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65378175|NCT00814268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65378176|NCT00814268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378177|NCT00814268|Antipyretics|antipyretics|mesh-ancestor
65378178|NCT00814268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65378179|NCT00814268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65378180|NCT00814268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65378181|NCT00814268|Purinergic Agents|purinergic agents|mesh-ancestor
65378182|NCT00814268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65378183|NCT00817622|Vitamin E|vitamin e|mesh-list
65378184|NCT00817622|Vitamins|vitamins|mesh-ancestor
65378185|NCT00817622|Micronutrients|micronutrients|mesh-ancestor
65378186|NCT00817622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378187|NCT00817622|Antioxidants|antioxidants|mesh-ancestor
65378188|NCT00817622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378189|NCT00817622|Protective Agents|protective agents|mesh-ancestor
65378190|NCT00808418|Docetaxel|docetaxel|mesh-list
65378191|NCT00808418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378192|NCT00808418|Tubulin Modulators|tubulin modulators|mesh-ancestor
65378193|NCT00808418|Antimitotic Agents|antimitotic agents|mesh-ancestor
65378194|NCT00808418|Mitosis Modulators|mitosis modulators|mesh-ancestor
65378195|NCT00808418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378196|NCT00642668|Epoetin Alfa|epoetin alfa|mesh-list
65378198|NCT00817934|Bisacodyl|bisacodyl|mesh-list
65378218|NCT00645788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378219|NCT00645788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378220|NCT00645788|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65378221|NCT00645788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65378222|NCT00814736|Sildenafil Citrate|sildenafil citrate|mesh-list
65378223|NCT00814736|Vasodilator Agents|vasodilator agents|mesh-ancestor
65378224|NCT00814736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65378225|NCT00814736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65378226|NCT00814736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378227|NCT00814736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378228|NCT00814736|Urological Agents|urological agents|mesh-ancestor
65378229|NCT00818090|Paclitaxel|paclitaxel|mesh-list
65378230|NCT00818090|Cisplatin|cisplatin|mesh-list
65378231|NCT00818090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65378232|NCT00818090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378233|NCT00818090|Tubulin Modulators|tubulin modulators|mesh-ancestor
65378234|NCT00818090|Antimitotic Agents|antimitotic agents|mesh-ancestor
65378235|NCT00818090|Mitosis Modulators|mitosis modulators|mesh-ancestor
65378236|NCT00818090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378237|NCT00642356|Levodopa|levodopa|mesh-list
65378238|NCT00642356|Carbidopa|carbidopa|mesh-list
65378239|NCT00642356|Entacapone|entacapone|mesh-list
65378258|NCT00642278|Hormones|hormones|mesh-ancestor
65378269|NCT00815048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65378270|NCT00815048|Narcotics|narcotics|mesh-ancestor
65378271|NCT00815048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65378272|NCT00815048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378273|NCT00815048|Analgesics|analgesics|mesh-ancestor
65378274|NCT00815048|Sensory System Agents|sensory system agents|mesh-ancestor
65378275|NCT00815048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65378276|NCT00815048|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65378277|NCT00815048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65378278|NCT00815048|Anesthetics, General|anesthetics, general|mesh-ancestor
65378279|NCT00815048|Anesthetics|anesthetics|mesh-ancestor
65378280|NCT00815048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65378281|NCT00815048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65378282|NCT00815048|Autonomic Agents|autonomic agents|mesh-ancestor
65378283|NCT00815048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65378284|NCT00815048|Respiratory System Agents|respiratory system agents|mesh-ancestor
65378285|NCT00815048|Mydriatics|mydriatics|mesh-ancestor
65378286|NCT00815048|Parasympatholytics|parasympatholytics|mesh-ancestor
65378287|NCT00815048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65378288|NCT00815048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65378289|NCT00815048|Cholinergic Agents|cholinergic agents|mesh-ancestor
65378290|NCT00815048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64494116|NCT01041274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494117|NCT01041274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64494118|NCT01041274|Antidepressive Agents|antidepressive agents|mesh-ancestor
64494119|NCT01041274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64494120|NCT00635349|Acetaminophen|acetaminophen|mesh-list
64494122|NCT00635349|Aceclofenac|aceclofenac|mesh-list
64494123|NCT00635349|Tramadol|tramadol|mesh-list
64494124|NCT00635349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64494125|NCT00635349|Analgesics|analgesics|mesh-ancestor
64494126|NCT00635349|Sensory System Agents|sensory system agents|mesh-ancestor
64494127|NCT00635349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64494128|NCT00635349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494129|NCT00635349|Antipyretics|antipyretics|mesh-ancestor
64494130|NCT00635349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64494131|NCT00635349|Narcotics|narcotics|mesh-ancestor
64494132|NCT00635349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64494133|NCT00635349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64494134|NCT00635349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64494135|NCT00635349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64494136|NCT00635349|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64494145|NCT00634803|Analgesics|analgesics|mesh-ancestor
64494146|NCT00634803|Sensory System Agents|sensory system agents|mesh-ancestor
64494147|NCT00634803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64494148|NCT00634803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64494149|NCT01042288|Carboplatin|carboplatin|mesh-list
64494150|NCT01042288|Pemetrexed|pemetrexed|mesh-list
64556405|NCT04022837|Pantoprazole|pantoprazole|mesh-list
64556406|NCT04022837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64556407|NCT04022837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64556408|NCT04022837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64556409|NCT04022837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556410|NCT04022837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556411|NCT04022993|Insulin Glargine|insulin glargine|mesh-list
65378291|NCT00815048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378292|NCT00815048|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
65378293|NCT00815048|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65378294|NCT00815048|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65378295|NCT02551796|Levofloxacin|levofloxacin|mesh-list
65378296|NCT02551796|Ofloxacin|ofloxacin|mesh-list
65378297|NCT02551796|Tobramycin|tobramycin|mesh-list
65378298|NCT02551796|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
65378299|NCT02551796|Dexamethasone|dexamethasone|mesh-list
65378300|NCT02551796|Dexamethasone acetate|dexamethasone acetate|mesh-list
65378301|NCT02551796|BB 1101|bb 1101|mesh-list
65378302|NCT02551796|Hyaluronic Acid|hyaluronic acid|mesh-list
65378303|NCT02551796|Dipivefrin|dipivefrin|mesh-list
65378304|NCT02551796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65378305|NCT02551796|Antiemetics|antiemetics|mesh-ancestor
65378306|NCT02551796|Autonomic Agents|autonomic agents|mesh-ancestor
65378307|NCT02551796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65378308|NCT02551796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378309|NCT02551796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65378310|NCT02551796|Glucocorticoids|glucocorticoids|mesh-ancestor
65378311|NCT02551796|Hormones|hormones|mesh-ancestor
65378335|NCT00723125|Paclitaxel|paclitaxel|mesh-list
65378346|NCT00723125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65378347|NCT00723125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65378348|NCT00723125|Growth Substances|growth substances|mesh-ancestor
65378349|NCT00723125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378350|NCT00723125|Growth Inhibitors|growth inhibitors|mesh-ancestor
65378351|NCT00640562|Risperidone|risperidone|mesh-list
65378352|NCT00640562|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65378353|NCT00640562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65378354|NCT00640562|Serotonin Agents|serotonin agents|mesh-ancestor
65378355|NCT00640562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65378356|NCT00640562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378357|NCT00640562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378358|NCT00640562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65378359|NCT00640562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65378360|NCT00640562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65378361|NCT00640562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65378362|NCT00640562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65378363|NCT00640562|Dopamine Agents|dopamine agents|mesh-ancestor
65378364|NCT00640562|Antidepressive Agents|antidepressive agents|mesh-ancestor
65378365|NCT00815204|Dexamethasone|dexamethasone|mesh-list
65378366|NCT00815204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65378367|NCT00815204|Antiemetics|antiemetics|mesh-ancestor
65378368|NCT00815204|Autonomic Agents|autonomic agents|mesh-ancestor
65378369|NCT00815204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65378370|NCT00815204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378373|NCT00815204|Hormones|hormones|mesh-ancestor
65378395|NCT00585689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65378396|NCT00585689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378397|NCT00585689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65378398|NCT00585689|Immunologic Factors|immunologic factors|mesh-ancestor
65378399|NCT00585689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378400|NCT00653432|Hyaluronic Acid|hyaluronic acid|mesh-list
65378401|NCT00653432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65378402|NCT00653432|Immunologic Factors|immunologic factors|mesh-ancestor
65378403|NCT00653432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378404|NCT00653432|Viscosupplements|viscosupplements|mesh-ancestor
65378405|NCT00653432|Protective Agents|protective agents|mesh-ancestor
65378406|NCT00815282|Vaccines|vaccines|mesh-list
65378407|NCT00815282|Immunologic Factors|immunologic factors|mesh-ancestor
65378408|NCT00815282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378409|NCT02593019|Adavosertib|adavosertib|mesh-list
65378455|NCT00253747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65378456|NCT00252733|Candesartan|candesartan|mesh-list
65378457|NCT00252733|Candesartan cilexetil|candesartan cilexetil|mesh-list
65378458|NCT00252733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65378459|NCT00252733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65378460|NCT00252733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65378461|NCT00252733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378463|NCT03974035|Anesthetics, Local|anesthetics, local|mesh-ancestor
65378464|NCT03974035|Anesthetics|anesthetics|mesh-ancestor
65378465|NCT03974035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65378466|NCT03974035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378467|NCT03974035|Sensory System Agents|sensory system agents|mesh-ancestor
65378468|NCT03974035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65378469|NCT00275821|Ranibizumab|ranibizumab|mesh-list
65378470|NCT00275821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65378471|NCT00275821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65378472|NCT00275821|Growth Substances|growth substances|mesh-ancestor
65378473|NCT00275821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378474|NCT00275821|Growth Inhibitors|growth inhibitors|mesh-ancestor
65378475|NCT00275821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378476|NCT00275509|Mycophenolic Acid|mycophenolic acid|mesh-list
65378477|NCT00275509|Dexamethasone|dexamethasone|mesh-list
65378478|NCT00275509|Prednisone|prednisone|mesh-list
65378479|NCT00275509|Tacrolimus|tacrolimus|mesh-list
65378480|NCT00275509|Thymoglobulin|thymoglobulin|mesh-list
65378481|NCT00275509|Daclizumab|daclizumab|mesh-list
65378482|NCT00275509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65378483|NCT00275509|Antiemetics|antiemetics|mesh-ancestor
65378484|NCT00275509|Autonomic Agents|autonomic agents|mesh-ancestor
65378485|NCT00275509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65378486|NCT00275509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378487|NCT00275509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65378488|NCT00275509|Glucocorticoids|glucocorticoids|mesh-ancestor
65378489|NCT00275509|Hormones|hormones|mesh-ancestor
65378491|NCT00275509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65378497|NCT00275509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378498|NCT00275509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65378499|NCT00275509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65378500|NCT00275509|Antitubercular Agents|antitubercular agents|mesh-ancestor
65378501|NCT00275509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65378502|NCT00275509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65378503|NCT01072045|Prednisone|prednisone|mesh-list
65378504|NCT01072045|Propranolol|propranolol|mesh-list
65378505|NCT01072045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65378506|NCT01072045|Glucocorticoids|glucocorticoids|mesh-ancestor
65378507|NCT01072045|Hormones|hormones|mesh-ancestor
65378508|NCT01072045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65378509|NCT01072045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378510|NCT01072045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65378511|NCT01072045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378512|NCT01072045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65378513|NCT01072045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65378514|NCT01072045|Adrenergic Agents|adrenergic agents|mesh-ancestor
65378515|NCT01072045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65378516|NCT01072045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378517|NCT01072045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65378518|NCT01072045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65378519|NCT01072045|Vasodilator Agents|vasodilator agents|mesh-ancestor
65378520|NCT01073059|Ertapenem|ertapenem|mesh-list
65378521|NCT01073059|Valproic Acid|valproic acid|mesh-list
65378522|NCT01073059|Anticonvulsants|anticonvulsants|mesh-ancestor
65378523|NCT01073059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378524|NCT01073059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378525|NCT01073059|GABA Agents|gaba agents|mesh-ancestor
65378526|NCT01073059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65378527|NCT01073059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378528|NCT01073059|Antimanic Agents|antimanic agents|mesh-ancestor
65378534|NCT00252577|Lithium Carbonate|lithium carbonate|mesh-list
65378538|NCT00252577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378539|NCT00252577|Antimanic Agents|antimanic agents|mesh-ancestor
65378540|NCT00252577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65378541|NCT00252577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65378542|NCT00252577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378543|NCT00252499|Rosiglitazone|rosiglitazone|mesh-list
65378544|NCT00252499|Fenofibrate|fenofibrate|mesh-list
65378545|NCT00252499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65378546|NCT00252499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378547|NCT00252499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65378548|NCT00252499|Antimetabolites|antimetabolites|mesh-ancestor
65378549|NCT00252499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378550|NCT00252499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65378551|NCT00252187|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65378552|NCT00252187|Natriuretic Agents|natriuretic agents|mesh-ancestor
65378553|NCT00252187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378554|NCT00163657|Cyclosporine|cyclosporine|mesh-list
65378555|NCT00163657|Mycophenolic Acid|mycophenolic acid|mesh-list
65378556|NCT00163657|Tacrolimus|tacrolimus|mesh-list
65378557|NCT00163657|Cyclosporins|cyclosporins|mesh-list
65378593|NCT00211081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65378594|NCT00211081|Hormone Antagonists|hormone antagonists|mesh-ancestor
65378595|NCT00211081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65378596|NCT00211081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378597|NCT00211081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65378598|NCT00211081|Diuretics|diuretics|mesh-ancestor
65378599|NCT00211081|Natriuretic Agents|natriuretic agents|mesh-ancestor
65378600|NCT00884676|Sunitinib|sunitinib|mesh-list
65378601|NCT00884676|Epothilone B|epothilone b|mesh-list
65378602|NCT00884676|Epothilones|epothilones|mesh-list
65378603|NCT00884676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378604|NCT00884676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65378605|NCT00884676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65378606|NCT00884676|Growth Substances|growth substances|mesh-ancestor
65378607|NCT00884676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128198|NCT03451695|Morphine|morphine|mesh-list
65378609|NCT00884676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65378610|NCT00884676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378611|NCT00884676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378612|NCT00884676|Tubulin Modulators|tubulin modulators|mesh-ancestor
65378613|NCT00884676|Antimitotic Agents|antimitotic agents|mesh-ancestor
65378614|NCT00884676|Mitosis Modulators|mitosis modulators|mesh-ancestor
65378615|NCT00891384|Lenalidomide|lenalidomide|mesh-list
65378616|NCT00891384|Immunologic Factors|immunologic factors|mesh-ancestor
65378617|NCT00891384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378618|NCT00891384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65378619|NCT00891384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65378620|NCT00891384|Growth Substances|growth substances|mesh-ancestor
65378640|NCT00609336|Immunologic Factors|immunologic factors|mesh-ancestor
65378641|NCT00609336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378642|NCT00609336|Tubulin Modulators|tubulin modulators|mesh-ancestor
65378643|NCT00609336|Antimitotic Agents|antimitotic agents|mesh-ancestor
65378644|NCT00609336|Mitosis Modulators|mitosis modulators|mesh-ancestor
65378645|NCT00612066|Rosiglitazone|rosiglitazone|mesh-list
65378646|NCT00612066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65378647|NCT00612066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378648|NCT02541084|Aflibercept|aflibercept|mesh-list
65378649|NCT02541084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65378650|NCT02541084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65378651|NCT02541084|Growth Substances|growth substances|mesh-ancestor
65378652|NCT02541084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378653|NCT02541084|Growth Inhibitors|growth inhibitors|mesh-ancestor
65378654|NCT02541084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378655|NCT04397406|Fentanyl|fentanyl|mesh-list
65378656|NCT04397406|Dexmedetomidine|dexmedetomidine|mesh-list
65378657|NCT04397406|Levobupivacaine|levobupivacaine|mesh-list
65378658|NCT04397406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65378662|NCT04397406|Analgesics|analgesics|mesh-ancestor
65378697|NCT00891696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378698|NCT00891696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65378699|NCT00891696|Vasodilator Agents|vasodilator agents|mesh-ancestor
65378700|NCT00891696|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65378701|NCT00891696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378702|NCT00640328|Ofatumumab|ofatumumab|mesh-list
65378703|NCT00640328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65378704|NCT00640328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378705|NCT00640328|Immunologic Factors|immunologic factors|mesh-ancestor
65378706|NCT00640328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378707|NCT04036890|Minocycline|minocycline|mesh-list
65378708|NCT04036890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65378709|NCT04036890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65378710|NCT00162097|Efavirenz|efavirenz|mesh-list
65378711|NCT00162097|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65378712|NCT00162097|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65378713|NCT00162097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65378714|NCT00162097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378715|NCT00162097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378716|NCT00162097|Antiviral Agents|antiviral agents|mesh-ancestor
65378717|NCT00162097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65378749|NCT01073761|Ritonavir|ritonavir|mesh-list
65378750|NCT01073761|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65378751|NCT01073761|Darunavir|darunavir|mesh-list
65378752|NCT01073761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65378753|NCT01073761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65378754|NCT01073761|Protease Inhibitors|protease inhibitors|mesh-ancestor
65378755|NCT01073761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378756|NCT01073761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378757|NCT01073761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65378759|NCT01073761|Antiviral Agents|antiviral agents|mesh-ancestor
65378760|NCT01073761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65378761|NCT01073761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65378762|NCT01073761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65378763|NCT00819104|Metoprolol|metoprolol|mesh-list
65378764|NCT00819104|Amlodipine|amlodipine|mesh-list
65378765|NCT00819104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65378766|NCT00819104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65378767|NCT00819104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65378768|NCT00819104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378769|NCT00819104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65378770|NCT00819104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378771|NCT00819104|Vasodilator Agents|vasodilator agents|mesh-ancestor
65378802|NCT00885066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378803|NCT00885066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378804|NCT00885066|Antiviral Agents|antiviral agents|mesh-ancestor
65378805|NCT00885066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65378806|NCT00885066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378807|NCT00885066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65378808|NCT00885066|Immunologic Factors|immunologic factors|mesh-ancestor
65378809|NCT00885066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378810|NCT00885066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65378811|NCT00888108|Docetaxel|docetaxel|mesh-list
65378812|NCT00888108|Navitoclax|navitoclax|mesh-list
65378813|NCT00888108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378814|NCT00888108|Tubulin Modulators|tubulin modulators|mesh-ancestor
65378815|NCT00888108|Antimitotic Agents|antimitotic agents|mesh-ancestor
65378816|NCT00888108|Mitosis Modulators|mitosis modulators|mesh-ancestor
65378817|NCT00888108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378818|NCT00885300|Cloxacillin|cloxacillin|mesh-list
65378819|NCT00885300|Heparin|heparin|mesh-list
65378820|NCT00885300|Anticoagulants|anticoagulants|mesh-ancestor
65378821|NCT00885300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65378822|NCT00885300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65378823|NCT00885300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378824|NCT00885300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65378825|NCT00885300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65378826|NCT00888186|Levodopa|levodopa|mesh-list
65378827|NCT00888186|Carbidopa|carbidopa|mesh-list
65378828|NCT00888186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65378829|NCT00888186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65378830|NCT00888186|Dopamine Agents|dopamine agents|mesh-ancestor
65378831|NCT00888186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65378832|NCT00888186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378833|NCT00888186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378845|NCT00892320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65378846|NCT00892320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378847|NCT00892320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65378848|NCT00892320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65378849|NCT00892320|Dopamine Agents|dopamine agents|mesh-ancestor
65378850|NCT00892398|Ranibizumab|ranibizumab|mesh-list
65378851|NCT00892398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65378852|NCT00892398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65378853|NCT00892398|Growth Substances|growth substances|mesh-ancestor
65378854|NCT00892398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378855|NCT00892398|Growth Inhibitors|growth inhibitors|mesh-ancestor
65378856|NCT00892398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378857|NCT00892476|Calcium, Dietary|calcium, dietary|mesh-list
65378858|NCT00892476|Calcium|calcium|mesh-list
65378859|NCT00892476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65378860|NCT00892476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378861|NCT00892476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65378862|NCT02541786|Rabeprazole|rabeprazole|mesh-list
65378863|NCT02541786|Dexlansoprazole|dexlansoprazole|mesh-list
65378864|NCT02541786|Lansoprazole|lansoprazole|mesh-list
65378865|NCT02541786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65378866|NCT02541786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65378867|NCT02541786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65378868|NCT02541786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378869|NCT02541786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378870|NCT00888342|Ethanol|ethanol|mesh-list
65378871|NCT00888342|Zopiclone|zopiclone|mesh-list
65378872|NCT00888342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65378873|NCT00888342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65378874|NCT00888342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65378875|NCT00888342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378876|NCT00888342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65378877|NCT00608868|Gefitinib|gefitinib|mesh-list
65378878|NCT00608868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378879|NCT00608868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65378880|NCT00608868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378883|NCT00900978|Immunologic Factors|immunologic factors|mesh-ancestor
65378884|NCT00900978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378885|NCT04036500|Estradiol|estradiol|mesh-list
65378886|NCT04036500|Estrogens|estrogens|mesh-ancestor
65378887|NCT04036500|Hormones|hormones|mesh-ancestor
65378888|NCT04036500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65378889|NCT04036500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378890|NCT00895674|Sorafenib|sorafenib|mesh-list
65378891|NCT00895674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378892|NCT00895674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65378893|NCT00895674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378894|NCT00895674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378895|NCT04035330|Etidronic Acid|etidronic acid|mesh-list
65378896|NCT04035330|Sodium Hypochlorite|sodium hypochlorite|mesh-list
65378897|NCT04035330|Eusol|eusol|mesh-list
65378898|NCT04035330|Disinfectants|disinfectants|mesh-ancestor
65378899|NCT04035330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65378900|NCT04035330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65378901|NCT04035330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378902|NCT04035096|Ascorbic Acid|ascorbic acid|mesh-list
65378903|NCT04035096|Antioxidants|antioxidants|mesh-ancestor
65378904|NCT04035096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378905|NCT04035096|Protective Agents|protective agents|mesh-ancestor
65378906|NCT04035096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378907|NCT04035096|Vitamins|vitamins|mesh-ancestor
65378908|NCT04035096|Micronutrients|micronutrients|mesh-ancestor
65378909|NCT00608322|Nitric Oxide|nitric oxide|mesh-list
65378910|NCT00608322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65378917|NCT00608322|Antioxidants|antioxidants|mesh-ancestor
65378931|NCT00608244|Immunologic Factors|immunologic factors|mesh-ancestor
65378932|NCT00608244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378933|NCT00608244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65378934|NCT00608244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65378935|NCT00608244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378936|NCT00893100|Diltiazem|diltiazem|mesh-list
65378937|NCT00893100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65378938|NCT00893100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65378939|NCT00893100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65378940|NCT00893100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378941|NCT00893100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65378942|NCT00893100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378943|NCT00893100|Vasodilator Agents|vasodilator agents|mesh-ancestor
65378944|NCT03324984|Bupivacaine|bupivacaine|mesh-list
65378945|NCT03324984|Chloroprocaine|chloroprocaine|mesh-list
65378946|NCT03324984|Anesthetics, Local|anesthetics, local|mesh-ancestor
65378947|NCT03324984|Anesthetics|anesthetics|mesh-ancestor
65378948|NCT03324984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65378949|NCT03324984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378950|NCT03324984|Sensory System Agents|sensory system agents|mesh-ancestor
65378951|NCT03324984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65378952|NCT00896376|Trastuzumab|trastuzumab|mesh-list
65378953|NCT00896376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65378954|NCT00896376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65378955|NCT00901290|Contraceptive Agents|contraceptive agents|mesh-list
64771601|NCT01177956|Fluorouracil|fluorouracil|mesh-list
64556412|NCT04022993|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64556413|NCT04022993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64556414|NCT04022993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556415|NCT04148885|Paclitaxel|paclitaxel|mesh-list
64556416|NCT04148885|Carboplatin|carboplatin|mesh-list
64556417|NCT04148885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64556418|NCT04148885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64556419|NCT04148885|Tubulin Modulators|tubulin modulators|mesh-ancestor
64556420|NCT04148885|Antimitotic Agents|antimitotic agents|mesh-ancestor
64556421|NCT04148885|Mitosis Modulators|mitosis modulators|mesh-ancestor
64321478|NCT03338647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494151|NCT01042288|Panitumumab|panitumumab|mesh-list
64494152|NCT01042288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494153|NCT01042288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494154|NCT01042288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494155|NCT01042288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64494156|NCT01042288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64494184|NCT04447534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64494186|NCT04447534|Sensory System Agents|sensory system agents|mesh-ancestor
64494187|NCT04447534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65378956|NCT00901290|Contraceptives, Oral|contraceptives, oral|mesh-list
65378957|NCT00901290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65378958|NCT00901290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378959|NCT00901290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65378960|NCT00893256|Risperidone|risperidone|mesh-list
65378961|NCT00893256|Citalopram|citalopram|mesh-list
65378962|NCT00893256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65378963|NCT00893256|Serotonin Agents|serotonin agents|mesh-ancestor
65378964|NCT00893256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65378965|NCT00893256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65378966|NCT00893256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65378967|NCT00893256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65378968|NCT00893256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65378969|NCT00893256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65378970|NCT00893256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65378971|NCT00893256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65378972|NCT00893256|Dopamine Agents|dopamine agents|mesh-ancestor
65378973|NCT00893256|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65378975|NCT00893256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65379012|NCT00893490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379013|NCT00893490|Alkylating Agents|alkylating agents|mesh-ancestor
65379014|NCT00893490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379015|NCT00893490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65379016|NCT00893490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379017|NCT00901758|Nitroglycerin|nitroglycerin|mesh-list
65379018|NCT00901758|Vasodilator Agents|vasodilator agents|mesh-ancestor
65379019|NCT00638690|Prednisone|prednisone|mesh-list
65379020|NCT00638690|Prednisolone|prednisolone|mesh-list
65379021|NCT00638690|Abiraterone Acetate|abiraterone acetate|mesh-list
65379022|NCT00638690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65379023|NCT00638690|Glucocorticoids|glucocorticoids|mesh-ancestor
65379024|NCT00638690|Hormones|hormones|mesh-ancestor
65379025|NCT00638690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65379026|NCT00638690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379027|NCT00638690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65379028|NCT00638690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379029|NCT00638690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65379030|NCT00638690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379031|NCT00638690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379032|NCT00638690|Hormone Antagonists|hormone antagonists|mesh-ancestor
65379067|NCT00893880|Nitric Oxide|nitric oxide|mesh-list
65379068|NCT00893880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65379069|NCT00893880|Autonomic Agents|autonomic agents|mesh-ancestor
65379070|NCT00893880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65379071|NCT00893880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379072|NCT00893880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65379073|NCT00893880|Respiratory System Agents|respiratory system agents|mesh-ancestor
65379074|NCT00893880|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65379075|NCT00893880|Antioxidants|antioxidants|mesh-ancestor
65379076|NCT00893880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379077|NCT00893880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65379078|NCT00893880|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65379079|NCT00893880|Vasodilator Agents|vasodilator agents|mesh-ancestor
65379080|NCT00893880|Gasotransmitters|gasotransmitters|mesh-ancestor
65379081|NCT00893880|Protective Agents|protective agents|mesh-ancestor
65379082|NCT00815594|Bevacizumab|bevacizumab|mesh-list
65379083|NCT00815594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65379084|NCT00815594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379085|NCT00815594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65379086|NCT00815594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65379087|NCT00815594|Growth Substances|growth substances|mesh-ancestor
65379088|NCT00815594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494188|NCT04447534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494189|NCT04447534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64494190|NCT04447534|Filaricides|filaricides|mesh-ancestor
64494191|NCT04447534|Antinematodal Agents|antinematodal agents|mesh-ancestor
64494192|NCT04447534|Anthelmintics|anthelmintics|mesh-ancestor
64494194|NCT01044862|Clomiphene|clomiphene|mesh-list
64494195|NCT01044862|Enclomiphene|enclomiphene|mesh-list
64494196|NCT01044862|Zuclomiphene|zuclomiphene|mesh-list
64494197|NCT01044862|Hormones|hormones|mesh-list
64494198|NCT01044862|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64494199|NCT01044862|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64494206|NCT01044862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64494207|NCT01044862|Hormone Antagonists|hormone antagonists|mesh-ancestor
64494208|NCT01044862|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64494209|NCT01044862|Fertility Agents|fertility agents|mesh-ancestor
64494210|NCT01044862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64494211|NCT01044862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64556422|NCT04148885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556423|NCT04022525|Leflunomide|leflunomide|mesh-list
64556431|NCT04022291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64556432|NCT04022291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556433|NCT03074448|Picosulfate sodium|picosulfate sodium|mesh-list
64556434|NCT03074448|Cathartics|cathartics|mesh-ancestor
64556435|NCT03074448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64556436|NCT04021433|Ketamine|ketamine|mesh-list
64556437|NCT04021433|Analgesics|analgesics|mesh-ancestor
64556438|NCT04021433|Sensory System Agents|sensory system agents|mesh-ancestor
64556439|NCT04021433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321497|NCT03533335|Dental Disinfectants|dental disinfectants|mesh-ancestor
64494212|NCT01044862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64494213|NCT04361656|Lubiprostone|lubiprostone|mesh-list
65379089|NCT00815594|Growth Inhibitors|growth inhibitors|mesh-ancestor
65379090|NCT00897312|Interferons|interferons|mesh-list
65379091|NCT00897312|Ribavirin|ribavirin|mesh-list
65379092|NCT00897312|Interferon-alpha|interferon-alpha|mesh-list
65379093|NCT00897312|Tremelimumab|tremelimumab|mesh-list
65379094|NCT00897312|Infliximab|infliximab|mesh-list
65379095|NCT00897312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379096|NCT00897312|Antiviral Agents|antiviral agents|mesh-ancestor
65379097|NCT00897312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65379098|NCT00897312|Antimetabolites|antimetabolites|mesh-ancestor
65379099|NCT00897312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379100|NCT00897312|Immunologic Factors|immunologic factors|mesh-ancestor
65379101|NCT00897312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771765|NCT01216410|Phenylephrine|phenylephrine|mesh-list
64494214|NCT04361656|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64494215|NCT04361656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64494216|NCT04361656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494217|NCT01047358|Exemestane|exemestane|mesh-list
64494218|NCT01047358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494219|NCT01047358|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64494220|NCT01047358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64494221|NCT01047358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494222|NCT01047358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494223|NCT01047358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64494224|NCT01047358|Hormone Antagonists|hormone antagonists|mesh-ancestor
64494225|NCT01047358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64494226|NCT01047358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494227|NCT01048606|Phytoestrogens|phytoestrogens|mesh-list
64494228|NCT01048606|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64494229|NCT01048606|Estrogens|estrogens|mesh-ancestor
64494231|NCT01048606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64494232|NCT01048606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494233|NCT04224766|Bupivacaine|bupivacaine|mesh-list
64494234|NCT04224766|Anesthetics, Local|anesthetics, local|mesh-ancestor
64494236|NCT04224766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64494237|NCT04224766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494238|NCT04224766|Sensory System Agents|sensory system agents|mesh-ancestor
64494239|NCT04224766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64494240|NCT01772004|Avelumab|avelumab|mesh-list
64494241|NCT01772004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64556440|NCT04021433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556441|NCT04021433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64556442|NCT04021433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64556443|NCT04021433|Anesthetics, General|anesthetics, general|mesh-ancestor
64556444|NCT04021433|Anesthetics|anesthetics|mesh-ancestor
64556445|NCT04021433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64556446|NCT04021433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64321516|NCT02204527|Micronutrients|micronutrients|mesh-ancestor
64321520|NCT02200237|Aluminum phosphate|aluminum phosphate|mesh-list
64494242|NCT01772004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494244|NCT02930044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64494245|NCT02930044|Insulin Glargine|insulin glargine|mesh-list
64494246|NCT02930044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64494247|NCT02930044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494248|NCT03683524|Dolutegravir|dolutegravir|mesh-list
64494249|NCT03683524|Darunavir|darunavir|mesh-list
64494259|NCT03683524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64494260|NCT03683524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64494261|NCT03683524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64494270|NCT02246842|Immunologic Factors|immunologic factors|mesh-ancestor
64494271|NCT02246842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494272|NCT02623426|Dexamethasone|dexamethasone|mesh-list
64494273|NCT02623426|Methotrexate|methotrexate|mesh-list
65379102|NCT00897312|Dermatologic Agents|dermatologic agents|mesh-ancestor
65379103|NCT00897312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65379104|NCT00897312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65379105|NCT02540460|Delpazolid|delpazolid|mesh-list
65379106|NCT02540460|Oxazolidinones|oxazolidinones|mesh-list
65379107|NCT02540460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65379108|NCT02540460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65379109|NCT02540460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65379110|NCT02540460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379111|NCT02540460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379112|NCT00543387|Docetaxel|docetaxel|mesh-list
65379113|NCT00543387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379114|NCT00543387|Tubulin Modulators|tubulin modulators|mesh-ancestor
65379115|NCT00543387|Antimitotic Agents|antimitotic agents|mesh-ancestor
65379116|NCT00543387|Mitosis Modulators|mitosis modulators|mesh-ancestor
65379117|NCT00543387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379118|NCT03455556|Atezolizumab|atezolizumab|mesh-list
65379119|NCT03455556|Maytansine|maytansine|mesh-list
65379120|NCT03455556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65379121|NCT03455556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379122|NCT03455556|Immunologic Factors|immunologic factors|mesh-ancestor
65379123|NCT03455556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379124|NCT03455556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65379125|NCT03455556|Tubulin Modulators|tubulin modulators|mesh-ancestor
65379126|NCT03455556|Antimitotic Agents|antimitotic agents|mesh-ancestor
65379127|NCT03455556|Mitosis Modulators|mitosis modulators|mesh-ancestor
65379128|NCT03455556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379129|NCT04017624|Nicotine|nicotine|mesh-list
65379130|NCT04017624|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65379131|NCT04017624|Autonomic Agents|autonomic agents|mesh-ancestor
65379132|NCT04017624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65379133|NCT04017624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379134|NCT04017624|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64494274|NCT02623426|Ranibizumab|ranibizumab|mesh-list
64494275|NCT02623426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64494276|NCT02623426|Antiemetics|antiemetics|mesh-ancestor
64494277|NCT02623426|Autonomic Agents|autonomic agents|mesh-ancestor
64494278|NCT02623426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64494279|NCT02623426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494280|NCT02623426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64494281|NCT02623426|Glucocorticoids|glucocorticoids|mesh-ancestor
64494282|NCT02623426|Hormones|hormones|mesh-ancestor
65379135|NCT04017624|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65379136|NCT04017624|Cholinergic Agents|cholinergic agents|mesh-ancestor
65379137|NCT04017624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65379138|NCT04017624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379139|NCT00809042|Hydroxyurea|hydroxyurea|mesh-list
65379140|NCT00809042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379141|NCT00809042|Antisickling Agents|antisickling agents|mesh-ancestor
65379142|NCT00809042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379143|NCT00809042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379144|NCT00809042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65379145|NCT00986037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65379146|NCT00986037|Immunologic Factors|immunologic factors|mesh-ancestor
65379147|NCT00986037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379148|NCT00983151|Tramadol|tramadol|mesh-list
65379149|NCT00983151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65379150|NCT00983151|Narcotics|narcotics|mesh-ancestor
65379151|NCT00983151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65379152|NCT00983151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379153|NCT00983151|Analgesics|analgesics|mesh-ancestor
65379154|NCT00983151|Sensory System Agents|sensory system agents|mesh-ancestor
65379155|NCT00983151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65379156|NCT00635570|Moxifloxacin|moxifloxacin|mesh-list
65379157|NCT00635570|NuvaRing|nuvaring|mesh-list
65379158|NCT00635570|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65379159|NCT00635570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65379160|NCT00635570|Contraceptive Agents|contraceptive agents|mesh-ancestor
64494283|NCT02623426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64494284|NCT02623426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64494285|NCT02623426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494286|NCT02623426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64494287|NCT02623426|Abortifacient Agents|abortifacient agents|mesh-ancestor
64494288|NCT02623426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64494289|NCT02623426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64494290|NCT02623426|Antimetabolites|antimetabolites|mesh-ancestor
64494291|NCT02623426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494292|NCT02623426|Dermatologic Agents|dermatologic agents|mesh-ancestor
64494293|NCT02623426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494294|NCT02623426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64494295|NCT02623426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64494296|NCT02623426|Immunologic Factors|immunologic factors|mesh-ancestor
64494297|NCT02623426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64494298|NCT02623426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64494299|NCT02623426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64494300|NCT02623426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64494301|NCT02623426|Growth Substances|growth substances|mesh-ancestor
64494302|NCT02623426|Growth Inhibitors|growth inhibitors|mesh-ancestor
65379161|NCT00635570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65379162|NCT00635570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379163|NCT00635570|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65379164|NCT00635570|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65379165|NCT00635570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65379166|NCT00635570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65379167|NCT00635570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65379168|NCT00635570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65379169|NCT00635570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65379170|NCT00635570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379171|NCT00635570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379172|NCT00635570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379173|NCT00893958|Mycophenolic Acid|mycophenolic acid|mesh-list
65379174|NCT00893958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65379175|NCT00893958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379176|NCT00893958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65379177|NCT00893958|Antitubercular Agents|antitubercular agents|mesh-ancestor
65379178|NCT00893958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65379179|NCT00893958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65379180|NCT00893958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379181|NCT00893958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379182|NCT00986115|Memantine|memantine|mesh-list
65379183|NCT00986115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65379184|NCT00986115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65379185|NCT00986115|Dopamine Agents|dopamine agents|mesh-ancestor
65379186|NCT00986115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64771829|NCT01222260|Alkylating Agents|alkylating agents|mesh-ancestor
64494303|NCT02182492|Clarithromycin|clarithromycin|mesh-list
64494304|NCT02182492|Glucocorticoids|glucocorticoids|mesh-list
64556447|NCT04021433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64556448|NCT04021433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64556449|NCT04021433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556450|NCT04147481|Anesthetics|anesthetics|mesh-list
64556451|NCT04147481|Anesthetics, Local|anesthetics, local|mesh-list
64556452|NCT04147481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64556453|NCT04147481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494305|NCT02182492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64494306|NCT02182492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64494307|NCT02182492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64494308|NCT02182492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494309|NCT02182492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494318|NCT01163656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494319|NCT01165840|Dapsone|dapsone|mesh-list
64494320|NCT01165840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64494321|NCT01165840|Antimalarials|antimalarials|mesh-ancestor
64494323|NCT01165840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65379187|NCT00986115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379188|NCT00986115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379189|NCT00986115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65379190|NCT00986115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65379191|NCT04035876|Apatinib|apatinib|mesh-list
65379192|NCT04035876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379193|NCT04035876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65379194|NCT04035876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379195|NCT04035876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379196|NCT00902070|Rocuronium|rocuronium|mesh-list
65379197|NCT00902070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65379198|NCT00902070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65379199|NCT00902070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65379200|NCT00902070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65379201|NCT00902070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379202|NCT00635492|Insulin|insulin|mesh-list
65379203|NCT00635492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65379204|NCT00635492|Exenatide|exenatide|mesh-list
65379205|NCT00635492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65379206|NCT00635492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379207|NCT00635492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65379208|NCT00635492|Incretins|incretins|mesh-ancestor
65379209|NCT00635492|Hormones|hormones|mesh-ancestor
64771860|NCT01225068|Analgesics|analgesics|mesh-ancestor
64494324|NCT01165840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64494325|NCT01165840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494326|NCT01165840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494338|NCT03535506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494339|NCT01170754|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64494340|NCT01170754|Laxatives|laxatives|mesh-ancestor
64494341|NCT01170754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64494342|NCT01378104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64494343|NCT01378104|Interferon-alpha|interferon-alpha|mesh-list
64494344|NCT01378104|Antiviral Agents|antiviral agents|mesh-ancestor
64494345|NCT01378104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64494346|NCT01378104|Immunologic Factors|immunologic factors|mesh-ancestor
64494348|NCT01131052|Insulin|insulin|mesh-list
64494349|NCT01131052|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64494351|NCT01131052|Insulin glulisine|insulin glulisine|mesh-list
64494352|NCT01131052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64494353|NCT01131052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494354|NCT01379274|Lenalidomide|lenalidomide|mesh-list
64494356|NCT01379274|Immunologic Factors|immunologic factors|mesh-ancestor
64494357|NCT01379274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494358|NCT01379274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64494359|NCT01379274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64494360|NCT01379274|Growth Substances|growth substances|mesh-ancestor
64494361|NCT01379274|Growth Inhibitors|growth inhibitors|mesh-ancestor
64494362|NCT01379274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494363|NCT01379274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64494364|NCT01379274|Antimetabolites|antimetabolites|mesh-ancestor
65128789|NCT00573950|Vasodilator Agents|vasodilator agents|mesh-ancestor
65379210|NCT00635492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65379211|NCT00543309|Milrinone|milrinone|mesh-list
65379212|NCT00543309|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65379213|NCT00543309|Natriuretic Agents|natriuretic agents|mesh-ancestor
65379214|NCT00543309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379215|NCT00543309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65379216|NCT00543309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65379217|NCT00543309|Vasodilator Agents|vasodilator agents|mesh-ancestor
65379218|NCT00543309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65379219|NCT00543309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65379220|NCT00543309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379221|NCT00543309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379222|NCT00543309|Protective Agents|protective agents|mesh-ancestor
65379223|NCT00569582|Mifepristone|mifepristone|mesh-list
65379224|NCT00569582|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65379225|NCT00569582|Abortifacient Agents|abortifacient agents|mesh-ancestor
65379226|NCT00569582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65379227|NCT00569582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379228|NCT00569582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65379229|NCT00569582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65379230|NCT00569582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65379231|NCT00569582|Contraceptive Agents|contraceptive agents|mesh-ancestor
65379232|NCT00569582|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65379233|NCT00569582|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65379234|NCT00569582|Hormone Antagonists|hormone antagonists|mesh-ancestor
65379235|NCT00569582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65379236|NCT00569582|Luteolytic Agents|luteolytic agents|mesh-ancestor
65379237|NCT00569582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64494365|NCT01379274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556454|NCT04147481|Sensory System Agents|sensory system agents|mesh-ancestor
64556455|NCT04147481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556456|NCT04148261|Hydrocortisone|hydrocortisone|mesh-list
64556457|NCT04148261|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64556458|NCT04148261|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64556459|NCT04148261|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64556460|NCT04148261|Epinephrine|epinephrine|mesh-list
64494374|NCT05396742|Immunologic Factors|immunologic factors|mesh-ancestor
64494375|NCT05396742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494376|NCT05389176|Esmolol|esmolol|mesh-list
64494377|NCT05389176|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64494378|NCT05389176|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65379238|NCT00569582|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65379239|NCT00988845|Indole-3-carbinol|indole-3-carbinol|mesh-list
65379240|NCT00988845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65379241|NCT00988845|Protective Agents|protective agents|mesh-ancestor
65379242|NCT00988845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379243|NCT00988845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379244|NCT00983697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65379245|NCT00983697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65379246|NCT00983697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379247|NCT00902460|Midazolam|midazolam|mesh-list
65379248|NCT00902460|Tofacitinib|tofacitinib|mesh-list
65379249|NCT00902460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65379250|NCT00902460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65379251|NCT00902460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65379252|NCT00902460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379253|NCT00902460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65379254|NCT00902460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65379255|NCT00902460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65379294|NCT03667443|Micronutrients|micronutrients|mesh-ancestor
65379295|NCT03667443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379296|NCT00902772|Lorazepam|lorazepam|mesh-list
65379297|NCT00902772|Anticonvulsants|anticonvulsants|mesh-ancestor
65379298|NCT00902772|Antiemetics|antiemetics|mesh-ancestor
65379299|NCT00902772|Autonomic Agents|autonomic agents|mesh-ancestor
65379300|NCT00902772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65379301|NCT00902772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379302|NCT00902772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65379303|NCT00902772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65379304|NCT00902772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65379305|NCT00902772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65379306|NCT00902772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65379307|NCT00902772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65379356|NCT02591771|Racepinephrine|racepinephrine|mesh-list
65379357|NCT02591771|Epinephryl borate|epinephryl borate|mesh-list
65379358|NCT02591771|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65379359|NCT02591771|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65379360|NCT02591771|Adrenergic Agents|adrenergic agents|mesh-ancestor
65379361|NCT02591771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65379362|NCT02591771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379363|NCT02591771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379364|NCT02591771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65379365|NCT02591771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65379366|NCT02591771|Autonomic Agents|autonomic agents|mesh-ancestor
65379367|NCT02591771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65379368|NCT02591771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65379369|NCT02591771|Respiratory System Agents|respiratory system agents|mesh-ancestor
65379370|NCT02591771|Mydriatics|mydriatics|mesh-ancestor
65379416|NCT00898950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65379417|NCT00898950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65379418|NCT00898950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379419|NCT00898950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65379420|NCT00898950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65379421|NCT00898950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379422|NCT00898950|Antipyretics|antipyretics|mesh-ancestor
65379423|NCT00898950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65379424|NCT00898950|Antifungal Agents|antifungal agents|mesh-ancestor
65379425|NCT00898950|Keratolytic Agents|keratolytic agents|mesh-ancestor
65379426|NCT00898950|Dermatologic Agents|dermatologic agents|mesh-ancestor
65379427|NCT03622515|Anesthetics|anesthetics|mesh-list
65379428|NCT03622515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65379429|NCT03622515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379430|NCT05279235|Favipiravir|favipiravir|mesh-list
65379431|NCT05279235|Antiviral Agents|antiviral agents|mesh-ancestor
65379432|NCT05279235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65379433|NCT00229723|Gefitinib|gefitinib|mesh-list
65379434|NCT00229723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379435|NCT00229723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65379436|NCT00229723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379437|NCT00229723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379439|NCT04035798|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65379440|NCT04035798|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65379441|NCT04035798|Dopamine Agents|dopamine agents|mesh-ancestor
65379442|NCT04035798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65379443|NCT04035798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379444|NCT04035798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379447|NCT01075477|Rituximab|rituximab|mesh-list
65379462|NCT01075555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65379463|NCT01075555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65379464|NCT00627926|Interferons|interferons|mesh-list
65379465|NCT00627926|Ribavirin|ribavirin|mesh-list
65379466|NCT00627926|Interferon-alpha|interferon-alpha|mesh-list
65379467|NCT00627926|Interferon alpha-2|interferon alpha-2|mesh-list
65379468|NCT00627926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65379469|NCT00627926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379470|NCT00627926|Antiviral Agents|antiviral agents|mesh-ancestor
65379471|NCT00627926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65379472|NCT00627926|Antimetabolites|antimetabolites|mesh-ancestor
65379473|NCT00627926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379474|NCT00627926|Immunologic Factors|immunologic factors|mesh-ancestor
65379475|NCT00627926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379476|NCT00228553|Modafinil|modafinil|mesh-list
65379477|NCT00228553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65379478|NCT00228553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379479|NCT00228553|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65379480|NCT00228553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65379481|NCT00228553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65379482|NCT00228553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379483|NCT00922506|Doxazosin|doxazosin|mesh-list
65379484|NCT00922506|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65379485|NCT00922506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65379486|NCT00922506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65379487|NCT00922506|Cholinergic Agents|cholinergic agents|mesh-ancestor
65379488|NCT00922506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65379489|NCT00922506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379490|NCT00922506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379491|NCT00922506|Urological Agents|urological agents|mesh-ancestor
64494379|NCT05389176|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64494380|NCT05389176|Adrenergic Agents|adrenergic agents|mesh-ancestor
64494381|NCT05389176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64494382|NCT05389176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494383|NCT05389176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494384|NCT01132846|Dopamine|dopamine|mesh-list
64494385|NCT01132846|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64494386|NCT01132846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64494387|NCT01132846|Sympathomimetics|sympathomimetics|mesh-ancestor
64494388|NCT01132846|Autonomic Agents|autonomic agents|mesh-ancestor
64494389|NCT01132846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64494390|NCT01132846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494391|NCT01132846|Dopamine Agents|dopamine agents|mesh-ancestor
64494392|NCT01132846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65379492|NCT00922506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65379493|NCT00922506|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65379494|NCT00922506|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65379495|NCT00922506|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65379496|NCT00922506|Adrenergic Agents|adrenergic agents|mesh-ancestor
65379497|NCT00816140|Clarithromycin|clarithromycin|mesh-list
65379498|NCT00816140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65379499|NCT00816140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65379500|NCT00816140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65379501|NCT00816140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379502|NCT00816140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379503|NCT00816140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65379504|NCT00816140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65379505|NCT00895128|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65379506|NCT00895128|Dasatinib|dasatinib|mesh-list
65379507|NCT00895128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379508|NCT00895128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65379509|NCT00895128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379510|NCT00895128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379511|NCT00903942|Paclitaxel|paclitaxel|mesh-list
65379512|NCT00903942|Carboplatin|carboplatin|mesh-list
65379513|NCT00903942|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65379514|NCT00903942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65379515|NCT00903942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379516|NCT00903942|Tubulin Modulators|tubulin modulators|mesh-ancestor
65379517|NCT00903942|Antimitotic Agents|antimitotic agents|mesh-ancestor
65379518|NCT00903942|Mitosis Modulators|mitosis modulators|mesh-ancestor
65379519|NCT00903942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494393|NCT01132846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494394|NCT01132846|Protective Agents|protective agents|mesh-ancestor
64494396|NCT01133158|Dexamethasone|dexamethasone|mesh-list
64494398|NCT01133158|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64494408|NCT01133158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64494409|NCT01133158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64494410|NCT01133158|Glucocorticoids|glucocorticoids|mesh-ancestor
64494411|NCT01133158|Hormones|hormones|mesh-ancestor
64494412|NCT01133158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64494413|NCT01133158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64494414|NCT01133158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64494415|NCT01133158|Alkylating Agents|alkylating agents|mesh-ancestor
64494416|NCT01133158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494417|NCT01133158|Analgesics|analgesics|mesh-ancestor
64494418|NCT01133158|Sensory System Agents|sensory system agents|mesh-ancestor
65379520|NCT00904020|Lidocaine|lidocaine|mesh-list
65379521|NCT00904020|Anesthetics, Local|anesthetics, local|mesh-ancestor
65379522|NCT00904020|Anesthetics|anesthetics|mesh-ancestor
65379523|NCT00904020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65379524|NCT00904020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379525|NCT00904020|Sensory System Agents|sensory system agents|mesh-ancestor
65379526|NCT00904020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65379527|NCT00904020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65379528|NCT00904020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65379529|NCT00904020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65379530|NCT00904020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65379531|NCT00904020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379532|NCT00895362|Cetuximab|cetuximab|mesh-list
65379533|NCT00895362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65379534|NCT00895362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65379535|NCT00895362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379536|NCT00895362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65379537|NCT00895362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379538|NCT00895362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379539|NCT00904098|Frovatriptan|frovatriptan|mesh-list
65379540|NCT00904098|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65379541|NCT00904098|Serotonin Agents|serotonin agents|mesh-ancestor
65379542|NCT00904098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65379543|NCT00904098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379544|NCT00904098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379545|NCT00904176|Dapagliflozin|dapagliflozin|mesh-list
65379546|NCT00904176|Digoxin|digoxin|mesh-list
65379547|NCT00904176|Warfarin|warfarin|mesh-list
65379548|NCT00904176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65379549|NCT00904176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379562|NCT02540070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65379563|NCT02540070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65379564|NCT02540070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379565|NCT02540070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65379566|NCT02540070|Analgesics|analgesics|mesh-ancestor
65379567|NCT02540070|Sensory System Agents|sensory system agents|mesh-ancestor
65379568|NCT02540070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65379569|NCT02540070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65379570|NCT02540070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65379571|NCT02540070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65379572|NCT02540070|Adrenergic Agents|adrenergic agents|mesh-ancestor
65379573|NCT02540070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65379574|NCT02540070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379575|NCT02540070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65379576|NCT02540070|Narcotics|narcotics|mesh-ancestor
65379577|NCT02540070|Anesthetics, Local|anesthetics, local|mesh-ancestor
65379578|NCT02540070|Anesthetics|anesthetics|mesh-ancestor
65379579|NCT02540070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65379580|NCT02540070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65379581|NCT02540070|Autonomic Agents|autonomic agents|mesh-ancestor
65379582|NCT02540070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65379583|NCT02540070|Respiratory System Agents|respiratory system agents|mesh-ancestor
65129167|NCT00195663|Methotrexate|methotrexate|mesh-list
65379585|NCT02540070|Sympathomimetics|sympathomimetics|mesh-ancestor
65379586|NCT02540070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65379587|NCT02540070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65379588|NCT02540070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65379589|NCT02540070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65379590|NCT02540070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65379591|NCT02540070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379592|NCT00905814|Axitinib|axitinib|mesh-list
65379593|NCT00905814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379603|NCT00900510|Antimalarials|antimalarials|mesh-ancestor
65379604|NCT00900510|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65379605|NCT00900510|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65379606|NCT00900510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65379607|NCT00900510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379608|NCT00900510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379609|NCT00900510|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65379610|NCT00900510|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65379611|NCT00900510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65379612|NCT00900510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65379613|NCT00160693|Certolizumab Pegol|certolizumab pegol|mesh-list
65379614|NCT00160693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65379615|NCT00160693|Immunologic Factors|immunologic factors|mesh-ancestor
65379616|NCT00160693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379617|NCT00160693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65379618|NCT00906048|Levofloxacin|levofloxacin|mesh-list
65379619|NCT00906048|Ofloxacin|ofloxacin|mesh-list
65379620|NCT00906048|Rifampin|rifampin|mesh-list
65379621|NCT00906048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65379622|NCT00906048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65379623|NCT00906048|Renal Agents|renal agents|mesh-ancestor
65379624|NCT00906048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65379625|NCT00906048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65379626|NCT00906048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65379627|NCT00906048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379628|NCT00906048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379629|NCT00906048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494419|NCT01133158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64494420|NCT01133158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64494421|NCT01133158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494422|NCT05396118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64494424|NCT05396118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494425|NCT04092894|Suvorexant|suvorexant|mesh-list
64494432|NCT04092894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556461|NCT04148261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64556462|NCT04148261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64556463|NCT04148261|Adrenergic Agents|adrenergic agents|mesh-ancestor
64556464|NCT04148261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64556465|NCT04148261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556466|NCT04148261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556467|NCT04148261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64556468|NCT04148261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64556469|NCT04148261|Autonomic Agents|autonomic agents|mesh-ancestor
64556470|NCT04148261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556471|NCT04148261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64321538|NCT01663532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64494434|NCT01134952|Sirolimus|sirolimus|mesh-list
65379630|NCT00906048|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65379631|NCT00906048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65379632|NCT00906048|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65379633|NCT00906048|Antitubercular Agents|antitubercular agents|mesh-ancestor
65379634|NCT00906048|Leprostatic Agents|leprostatic agents|mesh-ancestor
65379635|NCT00906048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65379636|NCT00906048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65379637|NCT00906048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65379638|NCT00906048|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65379639|NCT00906048|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65379640|NCT00906048|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65379641|NCT00906048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65379642|NCT00906126|Misoprostol|misoprostol|mesh-list
65379643|NCT00906126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65379644|NCT00906126|Abortifacient Agents|abortifacient agents|mesh-ancestor
65379645|NCT00906126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65379646|NCT00906126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379647|NCT00906126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65379648|NCT00906126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65379681|NCT00904644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65379682|NCT00904644|Antiviral Agents|antiviral agents|mesh-ancestor
65379683|NCT00904644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65379684|NCT00904644|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65379685|NCT00904644|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65379686|NCT00904644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379687|NCT00904644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379688|NCT00906360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65379689|NCT00906360|Cetuximab|cetuximab|mesh-list
65379690|NCT00906360|Sunitinib|sunitinib|mesh-list
65379691|NCT00906360|Antibodies|antibodies|mesh-list
65379692|NCT00906360|Immunoglobulins|immunoglobulins|mesh-list
65379693|NCT00906360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65379694|NCT00906360|Immunologic Factors|immunologic factors|mesh-ancestor
65379695|NCT00906360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379696|NCT00906360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379697|NCT00906360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65379698|NCT00906360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65379699|NCT00906360|Growth Substances|growth substances|mesh-ancestor
65379700|NCT00906360|Growth Inhibitors|growth inhibitors|mesh-ancestor
65379701|NCT00906360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65379702|NCT00906360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379703|NCT00906360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379704|NCT00643604|Treprostinil|treprostinil|mesh-list
65379705|NCT00643604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65379706|NCT00603798|Imiquimod|imiquimod|mesh-list
65379707|NCT00603798|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65379708|NCT00603798|Immunologic Factors|immunologic factors|mesh-ancestor
65379712|NCT00819572|Antibodies|antibodies|mesh-list
65379729|NCT00629798|Fludarabine|fludarabine|mesh-list
65379730|NCT00629798|Melphalan|melphalan|mesh-list
65379731|NCT00629798|Busulfan|busulfan|mesh-list
65379732|NCT00629798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65129319|NCT00564200|Immunologic Factors|immunologic factors|mesh-ancestor
65379733|NCT00629798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379734|NCT00629798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379735|NCT00629798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65379736|NCT00629798|Immunologic Factors|immunologic factors|mesh-ancestor
65379737|NCT00629798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379738|NCT00629798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65379739|NCT00629798|Alkylating Agents|alkylating agents|mesh-ancestor
65379740|NCT00629798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65379741|NCT00160615|Levetiracetam|levetiracetam|mesh-list
65379742|NCT00160615|Anticonvulsants|anticonvulsants|mesh-ancestor
65379743|NCT00160615|Nootropic Agents|nootropic agents|mesh-ancestor
65379744|NCT00906594|Latanoprost|latanoprost|mesh-list
65379745|NCT00906594|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65379746|NCT00906594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65379747|NCT03970759|Fluorides|fluorides|mesh-list
65379748|NCT03970759|Tin Fluorides|tin fluorides|mesh-list
65379749|NCT03970759|Cariostatic Agents|cariostatic agents|mesh-ancestor
65379750|NCT03970759|Protective Agents|protective agents|mesh-ancestor
65379751|NCT03970759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379752|NCT00905190|Ondansetron|ondansetron|mesh-list
65379753|NCT00905190|Antiemetics|antiemetics|mesh-ancestor
65379754|NCT00905190|Autonomic Agents|autonomic agents|mesh-ancestor
65379755|NCT00905190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65379756|NCT00905190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379757|NCT00905190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64494435|NCT01134952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64494436|NCT01134952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494437|NCT01134952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64494438|NCT01134952|Antitubercular Agents|antitubercular agents|mesh-ancestor
64494439|NCT01134952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64494440|NCT01134952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64494441|NCT01134952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494442|NCT01134952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494443|NCT01134952|Antifungal Agents|antifungal agents|mesh-ancestor
64494444|NCT01134952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64494446|NCT01134952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494447|NCT01175902|Timolol|timolol|mesh-list
64494448|NCT01175902|Dorzolamide|dorzolamide|mesh-list
64494449|NCT01175902|Latanoprost|latanoprost|mesh-list
64494450|NCT01175902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64494451|NCT01175902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64494452|NCT01175902|Adrenergic Agents|adrenergic agents|mesh-ancestor
64494453|NCT01175902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65379758|NCT00905190|Antipruritics|antipruritics|mesh-ancestor
65379759|NCT00905190|Dermatologic Agents|dermatologic agents|mesh-ancestor
65379760|NCT00905190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65379761|NCT00905190|Serotonin Agents|serotonin agents|mesh-ancestor
65379762|NCT00905190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65379763|NCT00905190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379764|NCT00905190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65379765|NCT00905190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65379766|NCT00905190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65379767|NCT00905190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65379768|NCT00905190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65379769|NCT00905502|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65379770|NCT00604500|Mometasone Furoate|mometasone furoate|mesh-list
65379771|NCT00604500|Formoterol Fumarate|formoterol fumarate|mesh-list
65379772|NCT00604500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65379773|NCT00604500|Autonomic Agents|autonomic agents|mesh-ancestor
65379774|NCT00604500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65379775|NCT00604500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379776|NCT00604500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65379777|NCT00604500|Respiratory System Agents|respiratory system agents|mesh-ancestor
65379778|NCT00604500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65379779|NCT00604500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65379780|NCT00604500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65379781|NCT00604500|Adrenergic Agents|adrenergic agents|mesh-ancestor
65379782|NCT00604500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65379783|NCT00604500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379784|NCT00604500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65379785|NCT00604500|Dermatologic Agents|dermatologic agents|mesh-ancestor
65379787|NCT00627458|Vaccines|vaccines|mesh-list
65379803|NCT00819728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65379804|NCT00819728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65379805|NCT00819728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379806|NCT00906828|Levodopa|levodopa|mesh-list
65379807|NCT00906828|Carbidopa|carbidopa|mesh-list
65379808|NCT00906828|Entacapone|entacapone|mesh-list
65066817|NCT00272636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65379809|NCT00906828|Tolcapone|tolcapone|mesh-list
65379810|NCT00906828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65379811|NCT00906828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65379812|NCT00906828|Dopamine Agents|dopamine agents|mesh-ancestor
65379813|NCT00906828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65379814|NCT00906828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379815|NCT00906828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379816|NCT00906828|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65379817|NCT00906828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379818|NCT00906828|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65379819|NCT00819806|Cyclophosphamide|cyclophosphamide|mesh-list
65379820|NCT00819806|Vaccines|vaccines|mesh-list
65379821|NCT00819806|Immunologic Factors|immunologic factors|mesh-ancestor
65379822|NCT00819806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379823|NCT00819806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65379824|NCT00819806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65379825|NCT00819806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65379826|NCT00819806|Alkylating Agents|alkylating agents|mesh-ancestor
65379827|NCT00819806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379828|NCT00819806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379829|NCT00819806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65379830|NCT00909402|Capecitabine|capecitabine|mesh-list
65379831|NCT00909402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379832|NCT00909402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65379833|NCT00909402|Antimetabolites|antimetabolites|mesh-ancestor
65379834|NCT00909402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379835|NCT02537964|Chlorhexidine|chlorhexidine|mesh-list
65379836|NCT02537964|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65379837|NCT02537964|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64772469|NCT01328964|Xhance|xhance|mesh-list
64494465|NCT01135186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65379838|NCT02537964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65379839|NCT02537964|Disinfectants|disinfectants|mesh-ancestor
65379840|NCT02537964|Dermatologic Agents|dermatologic agents|mesh-ancestor
65379841|NCT00821444|Ziprasidone|ziprasidone|mesh-list
65379842|NCT00821444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65379843|NCT00821444|Serotonin Agents|serotonin agents|mesh-ancestor
65379844|NCT00821444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65379845|NCT00821444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379846|NCT00821444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379847|NCT00821444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65379848|NCT00821444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65379849|NCT00821444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65379850|NCT00821444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65379851|NCT00821444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65379852|NCT00821444|Dopamine Agents|dopamine agents|mesh-ancestor
65379853|NCT00819962|Bupivacaine|bupivacaine|mesh-list
65379854|NCT00819962|Anesthetics, Local|anesthetics, local|mesh-ancestor
65379873|NCT00927498|Cytarabine|cytarabine|mesh-list
65379895|NCT00159913|Chelating Agents|chelating agents|mesh-ancestor
65379896|NCT00159913|Sequestering Agents|sequestering agents|mesh-ancestor
65379897|NCT00159913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379898|NCT00159913|Vasodilator Agents|vasodilator agents|mesh-ancestor
65379899|NCT00159913|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65379900|NCT00159913|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65379901|NCT00159913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379902|NCT00159913|Urological Agents|urological agents|mesh-ancestor
65379903|NCT05498259|Rituximab|rituximab|mesh-list
65379904|NCT05498259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65379905|NCT05498259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379906|NCT05498259|Immunologic Factors|immunologic factors|mesh-ancestor
65379907|NCT05498259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379908|NCT05498259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65379956|NCT00927732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65379957|NCT00927732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65379958|NCT00927732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65379959|NCT00927732|Adrenergic Agents|adrenergic agents|mesh-ancestor
65379960|NCT00927732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65379961|NCT00927732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379962|NCT00927732|Antimalarials|antimalarials|mesh-ancestor
65379963|NCT00927732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65379964|NCT00927732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65379965|NCT00927732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64494466|NCT01135186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556472|NCT04148261|Respiratory System Agents|respiratory system agents|mesh-ancestor
64556474|NCT04148261|Sympathomimetics|sympathomimetics|mesh-ancestor
64556475|NCT04148261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64556476|NCT04148261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64556478|NCT03072264|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64494477|NCT01216683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494478|NCT01216683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64494479|NCT01216683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64494480|NCT01216683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64494481|NCT01216683|Growth Substances|growth substances|mesh-ancestor
64494482|NCT01216683|Growth Inhibitors|growth inhibitors|mesh-ancestor
64494483|NCT01216683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64494484|NCT01216683|Alkylating Agents|alkylating agents|mesh-ancestor
64494485|NCT01216683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494487|NCT05376228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64494488|NCT05376228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64494489|NCT05164848|Afatinib|afatinib|mesh-list
64494490|NCT05164848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494491|NCT05164848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64494492|NCT05164848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494493|NCT05164848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494494|NCT05164770|Prednisone|prednisone|mesh-list
64494495|NCT05164770|Zanubrutinib|zanubrutinib|mesh-list
64494496|NCT05164770|Cyclophosphamide|cyclophosphamide|mesh-list
64494497|NCT05164770|Vincristine|vincristine|mesh-list
64494498|NCT05164770|Rituximab|rituximab|mesh-list
64494499|NCT05164770|Doxorubicin|doxorubicin|mesh-list
64494500|NCT05164770|Etoposide|etoposide|mesh-list
64494501|NCT05164770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494502|NCT05164770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64494503|NCT05164770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494504|NCT05164770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494505|NCT05164770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64494506|NCT05164770|Immunologic Factors|immunologic factors|mesh-ancestor
64494507|NCT05164770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494508|NCT05164770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64494509|NCT05164770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64494510|NCT05164770|Alkylating Agents|alkylating agents|mesh-ancestor
64494531|NCT01175980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494540|NCT04246554|Analgesics|analgesics|mesh-ancestor
64494541|NCT04246554|Sensory System Agents|sensory system agents|mesh-ancestor
64494542|NCT04246554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64494543|NCT04246554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494545|NCT04246554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64556479|NCT03072264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64556480|NCT03072264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64556481|NCT03072264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321556|NCT02204683|Aflibercept|aflibercept|mesh-list
64494546|NCT04246554|Narcotics|narcotics|mesh-ancestor
64494547|NCT04246554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64494548|NCT04246554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64494549|NCT04246554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65379966|NCT00927732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379967|NCT00927732|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65379968|NCT00927732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65379969|NCT00927732|Cholinergic Agents|cholinergic agents|mesh-ancestor
65379970|NCT00927732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65379971|NCT00927732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65379972|NCT00927732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65379973|NCT00927732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65379974|NCT00927732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65379975|NCT00227539|Pemetrexed|pemetrexed|mesh-list
65379976|NCT00227539|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65379977|NCT00227539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379978|NCT00227539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65379979|NCT00227539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379980|NCT00227539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65379981|NCT00227539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65379982|NCT00227539|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65379983|NCT02936622|Paclitaxel|paclitaxel|mesh-list
65379984|NCT02936622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65379985|NCT02936622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65379986|NCT02936622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379987|NCT02936622|Tubulin Modulators|tubulin modulators|mesh-ancestor
65379988|NCT02936622|Antimitotic Agents|antimitotic agents|mesh-ancestor
65379989|NCT02936622|Mitosis Modulators|mitosis modulators|mesh-ancestor
65379990|NCT02936622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379991|NCT00927966|Everolimus|everolimus|mesh-list
65379992|NCT00927966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65379993|NCT00927966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65379994|NCT00927966|Immunologic Factors|immunologic factors|mesh-ancestor
65379995|NCT00927966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772625|NCT01340586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64772639|NCT01347060|Xhance|xhance|mesh-list
64494551|NCT04246554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64494578|NCT00634179|Doxorubicin|doxorubicin|mesh-list
64494579|NCT00634179|Vincristine|vincristine|mesh-list
64494581|NCT00634179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64494582|NCT00634179|Immunologic Factors|immunologic factors|mesh-ancestor
64494583|NCT00634179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494584|NCT00634179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64494585|NCT00634179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64494586|NCT00634179|Alkylating Agents|alkylating agents|mesh-ancestor
64494587|NCT00634179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65379996|NCT00227305|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65379997|NCT00227305|Antidepressive Agents|antidepressive agents|mesh-ancestor
65379998|NCT00227305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65379999|NCT00227305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65380000|NCT00227305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65380001|NCT00227305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65380002|NCT00227305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380003|NCT00720941|Sunitinib|sunitinib|mesh-list
65380004|NCT00720941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380005|NCT00720941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65380006|NCT00720941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65380007|NCT00720941|Growth Substances|growth substances|mesh-ancestor
65380008|NCT00720941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380009|NCT00720941|Growth Inhibitors|growth inhibitors|mesh-ancestor
65380010|NCT00720941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65380011|NCT00720941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380012|NCT00720941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380013|NCT00924222|Propofol|propofol|mesh-list
65380014|NCT00924222|Sevoflurane|sevoflurane|mesh-list
65380015|NCT00924222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65380016|NCT00924222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65380019|NCT00924222|Anesthetics, General|anesthetics, general|mesh-ancestor
65380047|NCT05470491|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65380048|NCT03970213|Tranexamic Acid|tranexamic acid|mesh-list
65380049|NCT03970213|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65380050|NCT03970213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65380051|NCT03970213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380052|NCT03970213|Hemostatics|hemostatics|mesh-ancestor
65380053|NCT03970213|Coagulants|coagulants|mesh-ancestor
65380054|NCT00821834|Ticlopidine|ticlopidine|mesh-list
65380055|NCT00821834|Clopidogrel|clopidogrel|mesh-list
65380056|NCT00821834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65380057|NCT00821834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65380058|NCT00821834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65380059|NCT00821834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65380060|NCT00821834|Purinergic Agents|purinergic agents|mesh-ancestor
65380061|NCT00821834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380062|NCT00821834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380063|NCT00821834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380064|NCT00821834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65380065|NCT00821834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65380066|NCT00821834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65380067|NCT00821834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65380068|NCT00821834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380069|NCT04005417|Fluorides|fluorides|mesh-list
65380070|NCT04005417|Tin Fluorides|tin fluorides|mesh-list
65380071|NCT04005417|Cariostatic Agents|cariostatic agents|mesh-ancestor
65380072|NCT04005417|Protective Agents|protective agents|mesh-ancestor
65380073|NCT04005417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380074|NCT01073839|Gemcitabine|gemcitabine|mesh-list
65380075|NCT01073839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380076|NCT01073839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65380077|NCT01073839|Antimetabolites|antimetabolites|mesh-ancestor
65380078|NCT01073839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380079|NCT01073839|Antiviral Agents|antiviral agents|mesh-ancestor
64772710|NCT01363128|Methotrexate|methotrexate|mesh-list
64494588|NCT00634179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494589|NCT00634179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64494590|NCT00634179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64494591|NCT00634179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64494592|NCT00634179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65380080|NCT01073839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65380081|NCT01073839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380082|NCT01073839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65380083|NCT01073839|Immunologic Factors|immunologic factors|mesh-ancestor
65380084|NCT01073839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380085|NCT05698407|Sufentanil|sufentanil|mesh-list
65380086|NCT05698407|Dexmedetomidine|dexmedetomidine|mesh-list
65380087|NCT05698407|Dsuvia|dsuvia|mesh-list
65380088|NCT05698407|Ropivacaine|ropivacaine|mesh-list
65380089|NCT05698407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65380090|NCT05698407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65380091|NCT05698407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380092|NCT05698407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65380093|NCT05698407|Analgesics|analgesics|mesh-ancestor
65380094|NCT05698407|Sensory System Agents|sensory system agents|mesh-ancestor
65380095|NCT05698407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380096|NCT05698407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65380097|NCT05698407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65380098|NCT05698407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65380099|NCT05698407|Adrenergic Agents|adrenergic agents|mesh-ancestor
65380100|NCT05698407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380101|NCT05698407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380132|NCT00987441|Ropivacaine|ropivacaine|mesh-list
65380133|NCT00987441|Anesthetics, Local|anesthetics, local|mesh-ancestor
65380134|NCT00987441|Anesthetics|anesthetics|mesh-ancestor
65380135|NCT00987441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65380136|NCT00987441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380137|NCT00987441|Sensory System Agents|sensory system agents|mesh-ancestor
65380138|NCT00987441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380139|NCT00987441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65380140|NCT00987441|Narcotics|narcotics|mesh-ancestor
65380141|NCT00987441|Analgesics|analgesics|mesh-ancestor
65380142|NCT00987441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65380143|NCT00987441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65380144|NCT00987441|Anesthetics, General|anesthetics, general|mesh-ancestor
65380145|NCT00584987|Fluticasone|fluticasone|mesh-list
65380146|NCT00584987|Xhance|xhance|mesh-list
65380147|NCT00584987|Phenylephrine|phenylephrine|mesh-list
65380148|NCT00584987|Oxymetazoline|oxymetazoline|mesh-list
65380149|NCT00584987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65380150|NCT00584987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65380151|NCT00584987|Autonomic Agents|autonomic agents|mesh-ancestor
65380152|NCT00584987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380153|NCT00584987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380154|NCT00584987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65380155|NCT00584987|Respiratory System Agents|respiratory system agents|mesh-ancestor
65380156|NCT00584987|Dermatologic Agents|dermatologic agents|mesh-ancestor
65380157|NCT00584987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65380158|NCT00584987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65380181|NCT00568958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380182|NCT00568958|Sensory System Agents|sensory system agents|mesh-ancestor
65380183|NCT00568958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380184|NCT00821912|Docetaxel|docetaxel|mesh-list
65380185|NCT00821912|Capecitabine|capecitabine|mesh-list
65380186|NCT00821912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380187|NCT00821912|Tubulin Modulators|tubulin modulators|mesh-ancestor
65380188|NCT00821912|Antimitotic Agents|antimitotic agents|mesh-ancestor
65380189|NCT00821912|Mitosis Modulators|mitosis modulators|mesh-ancestor
65380190|NCT00821912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380191|NCT00821912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65380192|NCT00821912|Antimetabolites|antimetabolites|mesh-ancestor
65380193|NCT00727649|Loperamide|loperamide|mesh-list
65380194|NCT00727649|Antidiarrheals|antidiarrheals|mesh-list
65380195|NCT00727649|Psyllium|psyllium|mesh-list
65380196|NCT00727649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65380197|NCT00727649|Cathartics|cathartics|mesh-ancestor
65380198|NCT04006041|Paclitaxel|paclitaxel|mesh-list
65380199|NCT04006041|Cisplatin|cisplatin|mesh-list
65380200|NCT04006041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65380201|NCT04006041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380202|NCT04006041|Tubulin Modulators|tubulin modulators|mesh-ancestor
65380203|NCT04006041|Antimitotic Agents|antimitotic agents|mesh-ancestor
65380204|NCT04006041|Mitosis Modulators|mitosis modulators|mesh-ancestor
65380205|NCT04006041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380206|NCT00225277|Pioglitazone|pioglitazone|mesh-list
65380207|NCT00225277|Glimepiride|glimepiride|mesh-list
65380208|NCT00225277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65380209|NCT00225277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380210|NCT00225277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65380211|NCT00225277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65380212|NCT00225277|Immunologic Factors|immunologic factors|mesh-ancestor
65380213|NCT00821054|Lapatinib|lapatinib|mesh-list
65380214|NCT00821054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380224|NCT00567996|Respiratory System Agents|respiratory system agents|mesh-ancestor
65380225|NCT00567996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65380226|NCT00567996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65380227|NCT00567996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65380228|NCT00567996|Adrenergic Agents|adrenergic agents|mesh-ancestor
65380229|NCT00567996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380230|NCT00567996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380231|NCT04388319|Zonisamide|zonisamide|mesh-list
65380232|NCT04388319|Bupropion|bupropion|mesh-list
65380233|NCT04388319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65380234|NCT04388319|Antidepressive Agents|antidepressive agents|mesh-ancestor
65380235|NCT04388319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65380236|NCT04388319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65380237|NCT04388319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65380238|NCT04388319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65380239|NCT04388319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380240|NCT04388319|Dopamine Agents|dopamine agents|mesh-ancestor
65380241|NCT04388319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380242|NCT04388319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380243|NCT04388319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65380244|NCT04388319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65380245|NCT04388319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380272|NCT00717275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65380273|NCT00717275|Alkylating Agents|alkylating agents|mesh-ancestor
65380274|NCT00717275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380275|NCT00717275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380277|NCT04006353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65380278|NCT04006353|Antitubercular Agents|antitubercular agents|mesh-ancestor
65380279|NCT04006353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65380280|NCT04006353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65380281|NCT04006353|Leprostatic Agents|leprostatic agents|mesh-ancestor
65380282|NCT04006353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65380283|NCT04006353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380284|NCT04006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380285|NCT04006353|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65380286|NCT04006353|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65380287|NCT04006353|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65380288|NCT04006353|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65380289|NCT04006353|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65380290|NCT04006353|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65380291|NCT01075789|Lidocaine|lidocaine|mesh-list
65380292|NCT01075789|Anesthetics, Local|anesthetics, local|mesh-ancestor
65380293|NCT01075789|Anesthetics|anesthetics|mesh-ancestor
65380294|NCT01075789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65380295|NCT01075789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380296|NCT01075789|Sensory System Agents|sensory system agents|mesh-ancestor
65380297|NCT01075789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380298|NCT01075789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65380299|NCT01075789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65380300|NCT01075789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65380301|NCT01075789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64494593|NCT00634179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64494594|NCT00634179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494608|NCT01178944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494609|NCT01178944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494610|NCT01179490|Prednisolone|prednisolone|mesh-list
64494611|NCT01179490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64494612|NCT01179490|Glucocorticoids|glucocorticoids|mesh-ancestor
64494614|NCT01179490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64494615|NCT01179490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494616|NCT01179490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64494617|NCT01179490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380302|NCT01075789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380303|NCT00826046|Remestemcel-l|remestemcel-l|mesh-list
65380304|NCT00826046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65380305|NCT00826046|Antiviral Agents|antiviral agents|mesh-ancestor
65380306|NCT00826046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65380307|NCT00584909|Paclitaxel|paclitaxel|mesh-list
65380308|NCT00584909|Carboplatin|carboplatin|mesh-list
65380309|NCT00584909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65380310|NCT00584909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380311|NCT00584909|Tubulin Modulators|tubulin modulators|mesh-ancestor
65380312|NCT00584909|Antimitotic Agents|antimitotic agents|mesh-ancestor
65380313|NCT00584909|Mitosis Modulators|mitosis modulators|mesh-ancestor
65380314|NCT00584909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380315|NCT03947099|Ketamine|ketamine|mesh-list
65380316|NCT03947099|Analgesics|analgesics|mesh-ancestor
65380317|NCT03947099|Sensory System Agents|sensory system agents|mesh-ancestor
65380318|NCT03947099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380319|NCT03947099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380320|NCT03947099|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65380321|NCT03947099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65380322|NCT03947099|Anesthetics, General|anesthetics, general|mesh-ancestor
65380323|NCT03947099|Anesthetics|anesthetics|mesh-ancestor
65380324|NCT03947099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65380325|NCT03947099|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65380326|NCT03947099|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65380327|NCT03947099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380328|NCT03947099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380329|NCT05361915|Abivertinib|abivertinib|mesh-list
65380330|NCT05361915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65380331|NCT05361915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380332|NCT05361915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380333|NCT00929058|Bevacizumab|bevacizumab|mesh-list
64494618|NCT01179568|Citalopram|citalopram|mesh-list
64494619|NCT01179568|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64494620|NCT01179568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64494621|NCT01179568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64494622|NCT01179568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494624|NCT01179568|Serotonin Agents|serotonin agents|mesh-ancestor
64494625|NCT01179568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494626|NCT01179568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65380334|NCT00929058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65380335|NCT00929058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380336|NCT00929058|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65380337|NCT00929058|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65380338|NCT00929058|Growth Substances|growth substances|mesh-ancestor
65380339|NCT00929058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380340|NCT00929058|Growth Inhibitors|growth inhibitors|mesh-ancestor
65380341|NCT05346393|Terlipressin|terlipressin|mesh-list
65380342|NCT05346393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65380343|NCT05346393|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65380344|NCT00907452|Thalidomide|thalidomide|mesh-list
65380345|NCT00907452|Dexamethasone|dexamethasone|mesh-list
65380346|NCT00907452|Prednisone|prednisone|mesh-list
65380347|NCT00907452|Lenalidomide|lenalidomide|mesh-list
65380348|NCT00907452|Melphalan|melphalan|mesh-list
65380349|NCT00907452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65380350|NCT00907452|Antiemetics|antiemetics|mesh-ancestor
65380351|NCT00907452|Autonomic Agents|autonomic agents|mesh-ancestor
65380352|NCT00907452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380353|NCT00907452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380354|NCT00907452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65380355|NCT00907452|Glucocorticoids|glucocorticoids|mesh-ancestor
65380356|NCT00907452|Hormones|hormones|mesh-ancestor
65380357|NCT00907452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65380358|NCT00907452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65380359|NCT00907452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380360|NCT00907452|Immunologic Factors|immunologic factors|mesh-ancestor
65380361|NCT00907452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65380362|NCT00907452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65380363|NCT00907452|Growth Substances|growth substances|mesh-ancestor
64494627|NCT01179568|Antidepressive Agents|antidepressive agents|mesh-ancestor
64494628|NCT01179568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64494629|NCT01180036|Cyclosporine|cyclosporine|mesh-list
64494630|NCT01180036|Rituximab|rituximab|mesh-list
64494631|NCT01180036|Cyclosporins|cyclosporins|mesh-list
64494635|NCT01180036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494636|NCT01180036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64494637|NCT01180036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494638|NCT01180036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494639|NCT01180036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64494640|NCT01180036|Antifungal Agents|antifungal agents|mesh-ancestor
64494641|NCT01180036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64556482|NCT03072264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64556483|NCT03072264|Serotonin Agents|serotonin agents|mesh-ancestor
64556484|NCT03072264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556485|NCT03072264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65380364|NCT00907452|Growth Inhibitors|growth inhibitors|mesh-ancestor
65380365|NCT00907452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65380366|NCT00907452|Alkylating Agents|alkylating agents|mesh-ancestor
65380367|NCT00907452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380368|NCT00907452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65380369|NCT00907452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65380370|NCT00907452|Leprostatic Agents|leprostatic agents|mesh-ancestor
65380371|NCT00907452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65380372|NCT00907452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65380373|NCT00717197|Capecitabine|capecitabine|mesh-list
65380374|NCT00717197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65380375|NCT00717197|Antimetabolites|antimetabolites|mesh-ancestor
65380376|NCT00717197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380377|NCT00717197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380378|NCT00925392|Doripenem|doripenem|mesh-list
65380379|NCT00925392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65380380|NCT00925392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65380381|NCT05315271|Ketamine|ketamine|mesh-list
65380382|NCT05315271|Bupivacaine|bupivacaine|mesh-list
65380383|NCT05315271|Anesthetics, Local|anesthetics, local|mesh-ancestor
65380384|NCT05315271|Anesthetics|anesthetics|mesh-ancestor
65380385|NCT05315271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65380386|NCT05315271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380387|NCT05315271|Sensory System Agents|sensory system agents|mesh-ancestor
65380414|NCT05313477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65380415|NCT05313477|Vitamins|vitamins|mesh-ancestor
65380416|NCT05313477|Micronutrients|micronutrients|mesh-ancestor
65380417|NCT05313477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65380418|NCT00224107|Silodosin|silodosin|mesh-list
65380419|NCT00224107|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65380420|NCT00224107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65380421|NCT00224107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65380422|NCT00224107|Adrenergic Agents|adrenergic agents|mesh-ancestor
65380423|NCT00224107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380424|NCT00224107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380425|NCT00224107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380426|NCT00224107|Urological Agents|urological agents|mesh-ancestor
65380427|NCT04696731|Cyclophosphamide|cyclophosphamide|mesh-list
65380428|NCT04696731|Fludarabine|fludarabine|mesh-list
65380429|NCT04696731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65380430|NCT04696731|Immunologic Factors|immunologic factors|mesh-ancestor
65380431|NCT04696731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380432|NCT04696731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65380433|NCT04696731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65380434|NCT04696731|Alkylating Agents|alkylating agents|mesh-ancestor
65380435|NCT04696731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380436|NCT04696731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380437|NCT04696731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65380438|NCT04004871|Paclitaxel|paclitaxel|mesh-list
65380439|NCT04004871|Cisplatin|cisplatin|mesh-list
65380440|NCT04004871|Fluorouracil|fluorouracil|mesh-list
65380441|NCT04004871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65380442|NCT04004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380443|NCT04004871|Tubulin Modulators|tubulin modulators|mesh-ancestor
64773086|NCT01445028|Isotretinoin|isotretinoin|mesh-list
64556486|NCT03072264|Antidepressive Agents|antidepressive agents|mesh-ancestor
64556487|NCT03072264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64556488|NCT03072264|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64321559|NCT02204683|Growth Substances|growth substances|mesh-ancestor
64321560|NCT02204683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494642|NCT01180036|Dermatologic Agents|dermatologic agents|mesh-ancestor
64494643|NCT01180036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64494660|NCT01183312|Protective Agents|protective agents|mesh-ancestor
64494661|NCT01183312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494662|NCT01183312|GABA Modulators|gaba modulators|mesh-ancestor
64494663|NCT01183312|GABA Agents|gaba agents|mesh-ancestor
64494664|NCT01183312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64494665|NCT01183312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380444|NCT04004871|Antimitotic Agents|antimitotic agents|mesh-ancestor
65380445|NCT04004871|Mitosis Modulators|mitosis modulators|mesh-ancestor
65380446|NCT04004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380447|NCT04004871|Antimetabolites|antimetabolites|mesh-ancestor
65380448|NCT04004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65380449|NCT04004871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65380450|NCT04004871|Immunologic Factors|immunologic factors|mesh-ancestor
65380451|NCT04004871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380452|NCT00826358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65380453|NCT00826358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65380454|NCT00826358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65380455|NCT00826358|Antimetabolites|antimetabolites|mesh-ancestor
65380456|NCT00826358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380457|NCT00826358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65380458|NCT00826358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65380459|NCT00826358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380460|NCT00987909|Immunologic Factors|immunologic factors|mesh-list
65380461|NCT00987909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380462|NCT00822380|Iron|iron|mesh-list
65380463|NCT00822380|Trace Elements|trace elements|mesh-list
65380464|NCT00822380|Folic Acid|folic acid|mesh-list
65380465|NCT00822380|Ascorbic Acid|ascorbic acid|mesh-list
65380466|NCT00822380|Micronutrients|micronutrients|mesh-list
65380467|NCT00822380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380468|NCT00822380|Hematinics|hematinics|mesh-ancestor
65380469|NCT00822380|Vitamin B Complex|vitamin b complex|mesh-ancestor
65380470|NCT00822380|Vitamins|vitamins|mesh-ancestor
65380471|NCT00822380|Antioxidants|antioxidants|mesh-ancestor
65380474|NCT00720083|Cisplatin|cisplatin|mesh-list
65380491|NCT00209131|Urological Agents|urological agents|mesh-ancestor
65380492|NCT00907608|Darbepoetin alfa|darbepoetin alfa|mesh-list
65380493|NCT00907608|Hematinics|hematinics|mesh-ancestor
65380494|NCT00224029|Oxybutynin|oxybutynin|mesh-list
65380495|NCT00224029|Parasympatholytics|parasympatholytics|mesh-ancestor
65380496|NCT00224029|Autonomic Agents|autonomic agents|mesh-ancestor
65380497|NCT00224029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380498|NCT00224029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380499|NCT00224029|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65380500|NCT00224029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65380501|NCT00224029|Cholinergic Agents|cholinergic agents|mesh-ancestor
65380502|NCT00224029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380503|NCT00224029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380504|NCT00224029|Urological Agents|urological agents|mesh-ancestor
65380505|NCT00929370|Glycine|glycine|mesh-list
65380506|NCT00929370|Glycine Agents|glycine agents|mesh-ancestor
65380507|NCT00929370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380508|NCT00929370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380548|NCT02538432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380549|NCT02538432|Antiviral Agents|antiviral agents|mesh-ancestor
65380550|NCT02538432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65380551|NCT02538432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380552|NCT02538432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65380553|NCT02538432|Immunologic Factors|immunologic factors|mesh-ancestor
65380554|NCT02538432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380555|NCT00719849|Cyclosporine|cyclosporine|mesh-list
65380556|NCT00719849|Mycophenolic Acid|mycophenolic acid|mesh-list
65380557|NCT00719849|Cyclophosphamide|cyclophosphamide|mesh-list
65380558|NCT00719849|Fludarabine|fludarabine|mesh-list
65380559|NCT00719849|Fludarabine phosphate|fludarabine phosphate|mesh-list
65380560|NCT00719849|Cyclosporins|cyclosporins|mesh-list
65380561|NCT00719849|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65380562|NCT00719849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65380563|NCT00719849|Immunologic Factors|immunologic factors|mesh-ancestor
65380565|NCT00719849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65380608|NCT00826826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65380609|NCT00826826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380610|NCT00826826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65380611|NCT00826826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65380612|NCT00826826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65380613|NCT00826826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380614|NCT00826826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65380615|NCT00826826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65380616|NCT00826826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65380617|NCT02592941|Deflazacort|deflazacort|mesh-list
65380618|NCT02592941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65380619|NCT02592941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65380620|NCT02592941|Immunologic Factors|immunologic factors|mesh-ancestor
65380621|NCT02592941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380622|NCT00822614|Fentanyl|fentanyl|mesh-list
65380623|NCT00822614|Morphine|morphine|mesh-list
65380624|NCT00822614|Oxycodone|oxycodone|mesh-list
65380625|NCT00822614|Hydromorphone|hydromorphone|mesh-list
65380626|NCT00822614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65380627|NCT00822614|Narcotics|narcotics|mesh-ancestor
65380628|NCT00822614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65380629|NCT00822614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380630|NCT00822614|Analgesics|analgesics|mesh-ancestor
65380631|NCT00822614|Sensory System Agents|sensory system agents|mesh-ancestor
65380632|NCT00822614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380633|NCT00822614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65380634|NCT00822614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65380635|NCT00822614|Anesthetics, General|anesthetics, general|mesh-ancestor
65380636|NCT00822614|Anesthetics|anesthetics|mesh-ancestor
65380637|NCT04087967|Cytarabine|cytarabine|mesh-list
65380638|NCT04087967|Decitabine|decitabine|mesh-list
65380639|NCT04087967|Idarubicin|idarubicin|mesh-list
65380640|NCT04087967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65380641|NCT04087967|Antimetabolites|antimetabolites|mesh-ancestor
64494666|NCT03188172|Dexamethasone|dexamethasone|mesh-list
64494667|NCT03188172|Cyclophosphamide|cyclophosphamide|mesh-list
64494668|NCT03188172|Melphalan|melphalan|mesh-list
64494669|NCT03188172|Lenalidomide|lenalidomide|mesh-list
64494670|NCT03188172|Bortezomib|bortezomib|mesh-list
64494671|NCT03188172|Daratumumab|daratumumab|mesh-list
64494672|NCT03188172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64494673|NCT03188172|Immunologic Factors|immunologic factors|mesh-ancestor
64494675|NCT03188172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64494676|NCT03188172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65380642|NCT04087967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380643|NCT04087967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380644|NCT04087967|Antiviral Agents|antiviral agents|mesh-ancestor
65380645|NCT04087967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65380646|NCT04087967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65380647|NCT04087967|Immunologic Factors|immunologic factors|mesh-ancestor
65380648|NCT04087967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380649|NCT04087967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380650|NCT04087967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65380651|NCT04087967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65380652|NCT04087967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65380653|NCT00926016|Pioglitazone|pioglitazone|mesh-list
65380654|NCT00926016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65380655|NCT00926016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380656|NCT04017104|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65380657|NCT04017104|Edotreotide|edotreotide|mesh-list
65380658|NCT04017104|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65380659|NCT04017104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380660|NCT00827138|Rebastinib|rebastinib|mesh-list
65380661|NCT00827138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380662|NCT00827138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65380663|NCT00827138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380664|NCT00827138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380693|NCT00930072|Sympatholytics|sympatholytics|mesh-ancestor
65380694|NCT00930072|Autonomic Agents|autonomic agents|mesh-ancestor
65380695|NCT00930072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65380696|NCT00930072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65380697|NCT00930072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65380698|NCT00930072|Adrenergic Agents|adrenergic agents|mesh-ancestor
65380699|NCT00930072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380700|NCT00930072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380701|NCT00626522|Bromides|bromides|mesh-list
65380702|NCT00626522|Formoterol Fumarate|formoterol fumarate|mesh-list
65380703|NCT00626522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65380704|NCT00626522|Autonomic Agents|autonomic agents|mesh-ancestor
65380705|NCT00626522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380706|NCT00626522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380707|NCT00626522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65380708|NCT00626522|Respiratory System Agents|respiratory system agents|mesh-ancestor
65380709|NCT00626522|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65380710|NCT00626522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65380711|NCT00626522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65380712|NCT00626522|Adrenergic Agents|adrenergic agents|mesh-ancestor
65380713|NCT00626522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64494677|NCT03188172|Alkylating Agents|alkylating agents|mesh-ancestor
64494678|NCT03188172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494679|NCT03188172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494680|NCT03188172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64494681|NCT03188172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64494682|NCT03188172|Antiemetics|antiemetics|mesh-ancestor
64494683|NCT03188172|Autonomic Agents|autonomic agents|mesh-ancestor
64494684|NCT03188172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64494685|NCT03188172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64494686|NCT03188172|Glucocorticoids|glucocorticoids|mesh-ancestor
64494687|NCT03188172|Hormones|hormones|mesh-ancestor
64494688|NCT03188172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64494689|NCT03188172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64494690|NCT03188172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64494691|NCT03188172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64494692|NCT03188172|Growth Substances|growth substances|mesh-ancestor
64494693|NCT03188172|Growth Inhibitors|growth inhibitors|mesh-ancestor
64494694|NCT01184014|Insulin|insulin|mesh-list
64494695|NCT01184014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64494696|NCT01184014|Insulin Glargine|insulin glargine|mesh-list
64494697|NCT01184014|Insulin Lispro|insulin lispro|mesh-list
64494698|NCT01184014|Insulin, Isophane|insulin, isophane|mesh-list
64494699|NCT01184014|Isophane Insulin, Human|isophane insulin, human|mesh-list
64494700|NCT01184014|Isophane insulin, beef|isophane insulin, beef|mesh-list
64494701|NCT01184014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64494702|NCT01184014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494724|NCT05282706|Parasympatholytics|parasympatholytics|mesh-ancestor
64494726|NCT02187016|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64494727|NCT02187016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64494728|NCT05439798|Dexamethasone|dexamethasone|mesh-list
64494730|NCT05439798|Ondansetron|ondansetron|mesh-list
64494731|NCT05439798|Palonosetron|palonosetron|mesh-list
64494732|NCT05439798|BB 1101|bb 1101|mesh-list
65380714|NCT00626522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380716|NCT00926640|Etoposide|etoposide|mesh-list
65380717|NCT00926640|Belinostat|belinostat|mesh-list
65380718|NCT00926640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380719|NCT00926640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65380720|NCT00926640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65380721|NCT00926640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65380722|NCT00926640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380723|NCT00926640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380724|NCT00926640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65380725|NCT00931398|Methylphenidate|methylphenidate|mesh-list
65380726|NCT00931398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65380727|NCT00931398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380728|NCT00931398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65380729|NCT00931398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65380730|NCT00931398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65380731|NCT00931398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380732|NCT00931398|Dopamine Agents|dopamine agents|mesh-ancestor
65380733|NCT00931398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380734|NCT00827216|Erythromycin|erythromycin|mesh-list
65380735|NCT00827216|Erythromycin Estolate|erythromycin estolate|mesh-list
65380766|NCT00926718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65380767|NCT00926718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65380768|NCT00823004|Letrozole|letrozole|mesh-list
65380769|NCT00823004|Contraceptive Agents|contraceptive agents|mesh-list
65380770|NCT00823004|Contraceptives, Oral|contraceptives, oral|mesh-list
65380771|NCT00823004|Buserelin|buserelin|mesh-list
65380772|NCT00823004|Ganirelix|ganirelix|mesh-list
65380773|NCT00823004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380774|NCT00823004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65380775|NCT00823004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65380776|NCT00823004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380777|NCT00823004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380778|NCT00823004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65380779|NCT00823004|Hormone Antagonists|hormone antagonists|mesh-ancestor
65380780|NCT00823004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65380781|NCT00823004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380782|NCT00823004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65380783|NCT00823004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65380822|NCT00930306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65380823|NCT00930306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65380824|NCT00830882|Albuterol|albuterol|mesh-list
65380825|NCT00830882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65380826|NCT00830882|Autonomic Agents|autonomic agents|mesh-ancestor
65380827|NCT00830882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380828|NCT00830882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380829|NCT00830882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65380830|NCT00830882|Respiratory System Agents|respiratory system agents|mesh-ancestor
65380831|NCT00830882|Tocolytic Agents|tocolytic agents|mesh-ancestor
65380832|NCT00830882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65380833|NCT00830882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65380834|NCT00830882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65380835|NCT00830882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65380836|NCT00830882|Adrenergic Agents|adrenergic agents|mesh-ancestor
65380837|NCT00830882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380838|NCT00830882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380839|NCT00823238|Tobramycin|tobramycin|mesh-list
65380840|NCT00823238|Ceftazidime|ceftazidime|mesh-list
65380841|NCT00823238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65380842|NCT00823238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65380843|NCT00931788|Antihypertensive Agents|antihypertensive agents|mesh-list
65380844|NCT00827684|Sirolimus|sirolimus|mesh-list
65380845|NCT00827684|Irinotecan|irinotecan|mesh-list
65380846|NCT00827684|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65380858|NCT00927030|Melatonin|melatonin|mesh-list
65380872|NCT00931866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65380873|NCT00931866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65380874|NCT00931866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380875|NCT00931866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380876|NCT00827840|Risperidone|risperidone|mesh-list
65380877|NCT00827840|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65380878|NCT00827840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65380879|NCT00827840|Serotonin Agents|serotonin agents|mesh-ancestor
65380880|NCT00827840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380881|NCT00827840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380882|NCT00827840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380883|NCT00827840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65380884|NCT00827840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65380885|NCT00827840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65380886|NCT00827840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65380887|NCT00827840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65380888|NCT00827840|Dopamine Agents|dopamine agents|mesh-ancestor
65380889|NCT00827840|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65380890|NCT00827840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65380891|NCT00827996|Adalimumab|adalimumab|mesh-list
65380892|NCT00827996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65380893|NCT00827996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65380894|NCT00936780|Paclitaxel|paclitaxel|mesh-list
65380895|NCT00936780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65380896|NCT00936780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380897|NCT00936780|Tubulin Modulators|tubulin modulators|mesh-ancestor
65380898|NCT00936780|Antimitotic Agents|antimitotic agents|mesh-ancestor
65380899|NCT00936780|Mitosis Modulators|mitosis modulators|mesh-ancestor
64773536|NCT01551888|Adrenergic Agents|adrenergic agents|mesh-ancestor
64494733|NCT05439798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64494734|NCT05439798|Antiemetics|antiemetics|mesh-ancestor
64494735|NCT05439798|Autonomic Agents|autonomic agents|mesh-ancestor
64494736|NCT05439798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64494737|NCT05439798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329915|NCT02371473|Diuretics|diuretics|mesh-ancestor
64494739|NCT05439798|Glucocorticoids|glucocorticoids|mesh-ancestor
64556489|NCT03072264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64556490|NCT03072264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556491|NCT04991064|Titanium dioxide|titanium dioxide|mesh-list
64556492|NCT04991064|Sunscreening Agents|sunscreening agents|mesh-ancestor
64556493|NCT04991064|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64556494|NCT04991064|Protective Agents|protective agents|mesh-ancestor
64556495|NCT04991064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556496|NCT04991064|Dermatologic Agents|dermatologic agents|mesh-ancestor
64556497|NCT04991064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64556498|NCT00928083|Artefenomel|artefenomel|mesh-list
64494740|NCT05439798|Hormones|hormones|mesh-ancestor
65380900|NCT00936780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380901|NCT00823550|Lamivudine|lamivudine|mesh-list
65380902|NCT00823550|Entecavir|entecavir|mesh-list
65380903|NCT00823550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65380904|NCT00823550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65380905|NCT00823550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65380906|NCT00823550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380907|NCT00823550|Antiviral Agents|antiviral agents|mesh-ancestor
65380908|NCT00823550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65380909|NCT00823550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65380910|NCT00823550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65380911|NCT00932100|Heparin|heparin|mesh-list
65380912|NCT00932100|Calcium heparin|calcium heparin|mesh-list
65380913|NCT00932100|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65380914|NCT00932100|Tinzaparin|tinzaparin|mesh-list
65380915|NCT00932100|Dalteparin|dalteparin|mesh-list
65380916|NCT00932100|Anticoagulants|anticoagulants|mesh-ancestor
65380917|NCT00932100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65380918|NCT00932100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65380919|NCT00932100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380920|NCT00828230|Budesonide|budesonide|mesh-list
65380921|NCT00828230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65380955|NCT04469556|Vitamin B Complex|vitamin b complex|mesh-ancestor
65380956|NCT04469556|Vitamins|vitamins|mesh-ancestor
65380957|NCT04469556|Micronutrients|micronutrients|mesh-ancestor
65380958|NCT00937092|Dopamine|dopamine|mesh-list
65380959|NCT00937092|Furosemide|furosemide|mesh-list
65380960|NCT00937092|Diuretics|diuretics|mesh-ancestor
65380961|NCT00937092|Natriuretic Agents|natriuretic agents|mesh-ancestor
65380962|NCT00937092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380963|NCT00937092|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65380964|NCT00937092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65380965|NCT00937092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380966|NCT00937092|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65380967|NCT00937092|Sympathomimetics|sympathomimetics|mesh-ancestor
65380968|NCT00937092|Autonomic Agents|autonomic agents|mesh-ancestor
65380969|NCT00937092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380970|NCT00937092|Dopamine Agents|dopamine agents|mesh-ancestor
65380971|NCT00937092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65380972|NCT00937092|Protective Agents|protective agents|mesh-ancestor
65380973|NCT04124601|Nivolumab|nivolumab|mesh-list
65380974|NCT04124601|Ipilimumab|ipilimumab|mesh-list
65380975|NCT04124601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65380976|NCT04124601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380977|NCT04124601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65380978|NCT04124601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65380979|NCT05046639|Lidocaine|lidocaine|mesh-list
65380980|NCT05046639|Anesthetics, Local|anesthetics, local|mesh-ancestor
65380981|NCT05046639|Anesthetics|anesthetics|mesh-ancestor
65380982|NCT05046639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65380983|NCT05046639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65380984|NCT05046639|Sensory System Agents|sensory system agents|mesh-ancestor
65380985|NCT05046639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65380986|NCT05046639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65380987|NCT05046639|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65380988|NCT05046639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65380989|NCT05046639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65380994|NCT00931008|Docetaxel|docetaxel|mesh-list
65380995|NCT00931008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65380996|NCT00931008|Tubulin Modulators|tubulin modulators|mesh-ancestor
65380997|NCT00931008|Antimitotic Agents|antimitotic agents|mesh-ancestor
65380998|NCT00931008|Mitosis Modulators|mitosis modulators|mesh-ancestor
65380999|NCT00931008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381000|NCT00932802|Moxifloxacin|moxifloxacin|mesh-list
65381001|NCT00932802|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65381002|NCT00932802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65381003|NCT00932802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65381004|NCT00932802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65381005|NCT00932802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65381006|NCT00932802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381007|NCT00932802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381008|NCT00932802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381009|NCT00932802|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65381010|NCT00932802|Contraceptive Agents|contraceptive agents|mesh-ancestor
65381011|NCT00932802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65381012|NCT00932802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381013|NCT00932802|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65381014|NCT00932802|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65381015|NCT00932802|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65381016|NCT00932880|Amlodipine|amlodipine|mesh-list
65381017|NCT00932880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65381018|NCT00932880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65381019|NCT00932880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65381020|NCT00932880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773651|NCT01569126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64494741|NCT05439798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64494742|NCT05439798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64494743|NCT05439798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494744|NCT05439798|Protease Inhibitors|protease inhibitors|mesh-ancestor
64494745|NCT05439798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494746|NCT05439798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494747|NCT05439798|Antipruritics|antipruritics|mesh-ancestor
64494748|NCT05439798|Dermatologic Agents|dermatologic agents|mesh-ancestor
64494749|NCT05439798|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64494751|NCT05439798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64494752|NCT05439798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64494753|NCT05439798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64494754|NCT05439798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64494755|NCT05439798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64494756|NCT05439798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65381021|NCT00932880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65381022|NCT00932880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381023|NCT00932880|Vasodilator Agents|vasodilator agents|mesh-ancestor
65381024|NCT00937482|Cediranib|cediranib|mesh-list
65381025|NCT00937482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381026|NCT00937482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381027|NCT00937482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381028|NCT00937482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65381029|NCT03401853|Rituximab|rituximab|mesh-list
65381030|NCT03401853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65381031|NCT03401853|Pembrolizumab|pembrolizumab|mesh-list
65381032|NCT03401853|Obinutuzumab|obinutuzumab|mesh-list
65381033|NCT03401853|Antibodies|antibodies|mesh-list
65381034|NCT03401853|Immunoglobulins|immunoglobulins|mesh-list
65381035|NCT03401853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65381036|NCT03401853|Immunologic Factors|immunologic factors|mesh-ancestor
65381037|NCT03401853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381038|NCT03401853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381039|NCT03401853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65381040|NCT00931086|Belimumab|belimumab|mesh-list
65381041|NCT00931086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65381075|NCT00831350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65381076|NCT00831350|Growth Substances|growth substances|mesh-ancestor
65381077|NCT00831350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381078|NCT00831350|Growth Inhibitors|growth inhibitors|mesh-ancestor
65381079|NCT00831350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130668|NCT04568772|Atovaquone|atovaquone|mesh-list
65381081|NCT00938184|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65381082|NCT00938184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65381083|NCT00938184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65381084|NCT00938184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381085|NCT00938184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65381086|NCT00938184|Serotonin Agents|serotonin agents|mesh-ancestor
65381087|NCT00938184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381088|NCT00938184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65381089|NCT00938184|Antidepressive Agents|antidepressive agents|mesh-ancestor
65381090|NCT00938184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65381091|NCT00938184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65381092|NCT00938184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65381093|NCT00938184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381094|NCT00938262|Rifampin|rifampin|mesh-list
65381095|NCT00938262|Ketoconazole|ketoconazole|mesh-list
65381096|NCT00938262|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65381097|NCT00938262|Antitubercular Agents|antitubercular agents|mesh-ancestor
65381098|NCT00938262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65381099|NCT00938262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65381100|NCT00938262|Leprostatic Agents|leprostatic agents|mesh-ancestor
65381101|NCT00938262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65381102|NCT00938262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381103|NCT00938262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381104|NCT00938262|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65381105|NCT00938262|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65381106|NCT00938262|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65381107|NCT00938262|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65381108|NCT00938262|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64494757|NCT05439798|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64494758|NCT02188576|Tranexamic Acid|tranexamic acid|mesh-list
65381109|NCT00938262|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65381110|NCT00938262|Antifungal Agents|antifungal agents|mesh-ancestor
65381111|NCT00938262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65381112|NCT00938262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65381113|NCT00938262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65381114|NCT00938262|Hormone Antagonists|hormone antagonists|mesh-ancestor
65381115|NCT00938262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65381116|NCT00938262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381117|NCT00938262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65381118|NCT00933426|Paclitaxel|paclitaxel|mesh-list
65381119|NCT00933426|Lenalidomide|lenalidomide|mesh-list
65381120|NCT00933426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65381121|NCT00933426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381122|NCT00933426|Tubulin Modulators|tubulin modulators|mesh-ancestor
65381123|NCT00933426|Antimitotic Agents|antimitotic agents|mesh-ancestor
65381124|NCT00933426|Mitosis Modulators|mitosis modulators|mesh-ancestor
65381125|NCT00933426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381126|NCT00933426|Immunologic Factors|immunologic factors|mesh-ancestor
65381127|NCT00933426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381128|NCT00933426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65381129|NCT00933426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65381130|NCT00933426|Growth Substances|growth substances|mesh-ancestor
65381131|NCT00933426|Growth Inhibitors|growth inhibitors|mesh-ancestor
65381132|NCT04013958|Ketamine|ketamine|mesh-list
65381133|NCT04013958|Analgesics|analgesics|mesh-ancestor
65381134|NCT04013958|Sensory System Agents|sensory system agents|mesh-ancestor
65381135|NCT04013958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65381136|NCT04013958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381137|NCT04013958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65381138|NCT04013958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65381139|NCT04013958|Anesthetics, General|anesthetics, general|mesh-ancestor
65381140|NCT04013958|Anesthetics|anesthetics|mesh-ancestor
65381141|NCT04013958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64494767|NCT02189122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64494768|NCT02189122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64494769|NCT02189122|Analgesics|analgesics|mesh-ancestor
64494770|NCT02189122|Sensory System Agents|sensory system agents|mesh-ancestor
64494771|NCT02189122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65381142|NCT04013958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65381143|NCT04013958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65381144|NCT04013958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65381145|NCT04013958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381146|NCT00933582|Naproxen|naproxen|mesh-list
65381147|NCT00933582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65381148|NCT00933582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65381149|NCT00933582|Analgesics|analgesics|mesh-ancestor
65381150|NCT00933582|Sensory System Agents|sensory system agents|mesh-ancestor
65381151|NCT00933582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65381152|NCT00933582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381153|NCT00933582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65381154|NCT00933582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65381155|NCT00933582|Gout Suppressants|gout suppressants|mesh-ancestor
65381156|NCT00933582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65381157|NCT00933582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381158|NCT00933582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381160|NCT00938730|Anticoagulants|anticoagulants|mesh-ancestor
65381161|NCT00933816|Fluorouracil|fluorouracil|mesh-list
65381162|NCT00933816|Sorafenib|sorafenib|mesh-list
65381163|NCT00933816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381164|NCT00933816|Antimetabolites|antimetabolites|mesh-ancestor
65381165|NCT00933816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381166|NCT00933816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65381167|NCT00933816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65381168|NCT00933816|Immunologic Factors|immunologic factors|mesh-ancestor
65381169|NCT00933816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494772|NCT02189122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494773|NCT02189122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64494774|NCT02189122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64494775|NCT02189122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64494776|NCT02189122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64494777|NCT02189122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494778|NCT02189122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64494779|NCT02189122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64494780|NCT02189122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322257|NCT02226601|Antiemetics|antiemetics|mesh-ancestor
64322355|NCT02226991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64322707|NCT04163185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64322708|NCT04163185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64322709|NCT04163185|Analgesics|analgesics|mesh-ancestor
64322710|NCT04163185|Sensory System Agents|sensory system agents|mesh-ancestor
64322711|NCT04163185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322958|NCT02255045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322959|NCT02255045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381170|NCT00933816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65381171|NCT00933816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381172|NCT00538785|Palivizumab|palivizumab|mesh-list
65381173|NCT00538785|Antiviral Agents|antiviral agents|mesh-ancestor
65381174|NCT00538785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65381175|NCT03334305|Vaccines|vaccines|mesh-list
65381176|NCT03334305|Immunologic Factors|immunologic factors|mesh-ancestor
65381177|NCT03334305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381178|NCT01563939|Remifentanil|remifentanil|mesh-list
65381179|NCT01563939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65381180|NCT01563939|Narcotics|narcotics|mesh-ancestor
65381181|NCT01563939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65381182|NCT01563939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381183|NCT01563939|Analgesics|analgesics|mesh-ancestor
65381184|NCT01563939|Sensory System Agents|sensory system agents|mesh-ancestor
65381185|NCT01563939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65381186|NCT03287271|Paclitaxel|paclitaxel|mesh-list
65381187|NCT03287271|Carboplatin|carboplatin|mesh-list
65381188|NCT03287271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65381189|NCT03287271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381190|NCT03287271|Tubulin Modulators|tubulin modulators|mesh-ancestor
65381191|NCT03287271|Antimitotic Agents|antimitotic agents|mesh-ancestor
65381192|NCT03287271|Mitosis Modulators|mitosis modulators|mesh-ancestor
65381193|NCT03287271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381194|NCT00990405|Amoxicillin|amoxicillin|mesh-list
65381195|NCT00990405|Clarithromycin|clarithromycin|mesh-list
65381196|NCT00990405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65381197|NCT00990405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65381198|NCT00990405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65381199|NCT00990405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381200|NCT00990405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381201|NCT00990405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65381202|NCT00990405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65381203|NCT00990639|Candesartan|candesartan|mesh-list
65381211|NCT03025035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381212|NCT03025035|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65381213|NCT03025035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381214|NCT03025035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381215|NCT03742947|Hemostatics|hemostatics|mesh-list
65381216|NCT03742947|Coagulants|coagulants|mesh-ancestor
65381217|NCT05359497|Liver Extracts|liver extracts|mesh-list
65381218|NCT05359497|Hematinics|hematinics|mesh-ancestor
65381219|NCT00990795|Cyclosporine|cyclosporine|mesh-list
65381220|NCT00990795|Cyclosporins|cyclosporins|mesh-list
65381221|NCT00990795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381222|NCT00990795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381223|NCT00990795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65381224|NCT00990795|Immunologic Factors|immunologic factors|mesh-ancestor
65381225|NCT00990795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381226|NCT00990795|Antifungal Agents|antifungal agents|mesh-ancestor
65381227|NCT00990795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65381228|NCT00990795|Dermatologic Agents|dermatologic agents|mesh-ancestor
65381229|NCT00990795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65381230|NCT00990795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65381231|NCT00622700|Teriflunomide|teriflunomide|mesh-list
65381232|NCT00622700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65381233|NCT00622700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65381234|NCT00622700|Analgesics|analgesics|mesh-ancestor
65381235|NCT00622700|Sensory System Agents|sensory system agents|mesh-ancestor
65381236|NCT00622700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65381237|NCT00622700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381238|NCT00622700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65381239|NCT00622700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65381240|NCT00622700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64773885|NCT03009240|Decitabine|decitabine|mesh-list
64322960|NCT02255045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64322961|NCT02229799|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64322962|NCT02229799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64323110|NCT02224105|Antiemetics|antiemetics|mesh-ancestor
64323111|NCT02224105|Autonomic Agents|autonomic agents|mesh-ancestor
64323112|NCT02224105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64323113|NCT02224105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64323114|NCT02224105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64323115|NCT02224105|Protective Agents|protective agents|mesh-ancestor
64323116|NCT02156375|Ustekinumab|ustekinumab|mesh-list
64323117|NCT02156375|Dermatologic Agents|dermatologic agents|mesh-ancestor
64323118|NCT04057131|Icatibant|icatibant|mesh-list
64556499|NCT00928083|Antimalarials|antimalarials|mesh-ancestor
64556500|NCT00928083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65381241|NCT00622700|Immunologic Factors|immunologic factors|mesh-ancestor
65381242|NCT00831506|Digoxin|digoxin|mesh-list
65381243|NCT00831506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65381244|NCT00831506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65381245|NCT00831506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381246|NCT00831506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381247|NCT00831506|Protective Agents|protective agents|mesh-ancestor
65381248|NCT00831506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381249|NCT02842359|Irbesartan|irbesartan|mesh-list
65381250|NCT02842359|Atorvastatin|atorvastatin|mesh-list
65381251|NCT02842359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65381252|NCT02842359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65381253|NCT02842359|Antimetabolites|antimetabolites|mesh-ancestor
65381254|NCT02842359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381255|NCT02842359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65381256|NCT02842359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65381257|NCT02842359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381258|NCT02842359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65381259|NCT02842359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65381260|NCT02842359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65381261|NCT02783625|Bortezomib|bortezomib|mesh-list
65381262|NCT02783625|Romidepsin|romidepsin|mesh-list
65381263|NCT02783625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381264|NCT02783625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65381265|NCT00828776|Heparin|heparin|mesh-list
64556501|NCT00928083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64556502|NCT00928083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64556503|NCT04361721|Erenumab|erenumab|mesh-list
64556504|NCT04361721|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64556505|NCT04361721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556506|NCT04361721|Analgesics|analgesics|mesh-ancestor
64323121|NCT04057131|Analgesics|analgesics|mesh-ancestor
64323250|NCT05746065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323251|NCT05746065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323329|NCT04230980|Gabapentin|gabapentin|mesh-list
64323330|NCT04230980|Analgesics|analgesics|mesh-ancestor
64323331|NCT04230980|Sensory System Agents|sensory system agents|mesh-ancestor
64323332|NCT04230980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64323333|NCT04230980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323334|NCT04230980|Anticonvulsants|anticonvulsants|mesh-ancestor
64323335|NCT04230980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64323336|NCT04230980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64323337|NCT04230980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64323338|NCT04230980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64323339|NCT04230980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64323340|NCT04230980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64323749|NCT02259595|Disufenton sodium|disufenton sodium|mesh-list
64323750|NCT02259595|Antiviral Agents|antiviral agents|mesh-ancestor
64323751|NCT02259595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64323753|NCT02259595|Respiratory System Agents|respiratory system agents|mesh-ancestor
65381266|NCT00828776|Calcium heparin|calcium heparin|mesh-list
65381267|NCT00828776|Anticoagulants|anticoagulants|mesh-ancestor
65381268|NCT00828776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65381269|NCT00828776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65381270|NCT00828776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381271|NCT00622466|Paclitaxel|paclitaxel|mesh-list
65381272|NCT00622466|Sorafenib|sorafenib|mesh-list
65381273|NCT00622466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65381274|NCT00622466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381275|NCT00622466|Tubulin Modulators|tubulin modulators|mesh-ancestor
65381276|NCT00622466|Antimitotic Agents|antimitotic agents|mesh-ancestor
65381277|NCT00622466|Mitosis Modulators|mitosis modulators|mesh-ancestor
65381278|NCT00622466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381279|NCT00622466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65381280|NCT00622466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381281|NCT04043858|Midodrine|midodrine|mesh-list
65381282|NCT04043858|Sympathomimetics|sympathomimetics|mesh-ancestor
65381283|NCT04043858|Autonomic Agents|autonomic agents|mesh-ancestor
65381284|NCT04043858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65381285|NCT04043858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381286|NCT04043858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65381287|NCT04043858|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65381288|NCT04043858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65381289|NCT04043858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65381315|NCT00537771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381316|NCT03826563|Melatonin|melatonin|mesh-list
65381317|NCT03826563|Antioxidants|antioxidants|mesh-ancestor
65381318|NCT03826563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381319|NCT03826563|Protective Agents|protective agents|mesh-ancestor
65381320|NCT03826563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381321|NCT03826563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65381322|NCT00823940|Glucagon|glucagon|mesh-list
65381323|NCT00823940|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65381324|NCT00823940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65381325|NCT00823940|Hormones|hormones|mesh-ancestor
65381326|NCT00823940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65381327|NCT00823940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381328|NCT00823940|Incretins|incretins|mesh-ancestor
65381329|NCT00829322|Modafinil|modafinil|mesh-list
65381330|NCT00829322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65381331|NCT00829322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381332|NCT00829322|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65381333|NCT00829322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65381334|NCT00829322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65381335|NCT00829322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381336|NCT00623480|Factor VIII|factor viii|mesh-list
65381337|NCT00623480|Coagulants|coagulants|mesh-ancestor
65381338|NCT02513667|Ceritinib|ceritinib|mesh-list
65381343|NCT03823911|Sofosbuvir|sofosbuvir|mesh-list
65381363|NCT00829634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65381364|NCT00829634|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65381365|NCT04003467|Teriparatide|teriparatide|mesh-list
65381366|NCT04003467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65381367|NCT04003467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381368|NCT04003467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65381369|NCT00832208|Amphotericin B|amphotericin b|mesh-list
65381370|NCT00832208|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65381371|NCT00832208|Amebicides|amebicides|mesh-ancestor
65381372|NCT00832208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65381373|NCT00832208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65381374|NCT00832208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65381375|NCT00832208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65381376|NCT00832208|Antifungal Agents|antifungal agents|mesh-ancestor
65381377|NCT05361057|Cytarabine|cytarabine|mesh-list
65381378|NCT05361057|Azacitidine|azacitidine|mesh-list
65381379|NCT05361057|Daunorubicin|daunorubicin|mesh-list
65381380|NCT05361057|Venetoclax|venetoclax|mesh-list
65381381|NCT05361057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65381382|NCT05361057|Antimetabolites|antimetabolites|mesh-ancestor
65381383|NCT05361057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381384|NCT05361057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381385|NCT05361057|Antiviral Agents|antiviral agents|mesh-ancestor
65381386|NCT05361057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65381388|NCT05361057|Immunologic Factors|immunologic factors|mesh-ancestor
65381414|NCT00832364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65381415|NCT00832364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65381416|NCT00832364|Immunologic Factors|immunologic factors|mesh-ancestor
65381417|NCT00832364|Keratolytic Agents|keratolytic agents|mesh-ancestor
65381418|NCT00832364|Dermatologic Agents|dermatologic agents|mesh-ancestor
65381419|NCT00832442|Metoprolol|metoprolol|mesh-list
65381420|NCT00832442|Carvedilol|carvedilol|mesh-list
65381421|NCT00832442|Nebivolol|nebivolol|mesh-list
65381422|NCT00832442|Bisoprolol|bisoprolol|mesh-list
65381423|NCT00832442|Bucindolol|bucindolol|mesh-list
65381424|NCT00832442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65381425|NCT00832442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65381426|NCT00832442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65381427|NCT00832442|Sympatholytics|sympatholytics|mesh-ancestor
65381428|NCT00832442|Autonomic Agents|autonomic agents|mesh-ancestor
65381429|NCT00832442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65381430|NCT00832442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381431|NCT00832442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65381432|NCT00832442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65381433|NCT00832442|Adrenergic Agents|adrenergic agents|mesh-ancestor
65381434|NCT00832442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65381435|NCT00832442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381436|NCT00832442|Antioxidants|antioxidants|mesh-ancestor
65381437|NCT00832442|Protective Agents|protective agents|mesh-ancestor
65381438|NCT00832442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65381439|NCT00832442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65381440|NCT00832442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65381441|NCT00832442|Vasodilator Agents|vasodilator agents|mesh-ancestor
65381442|NCT00832442|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65381443|NCT00832442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65381444|NCT00832442|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65381445|NCT00832442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65381446|NCT00832442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65381447|NCT00832442|Sympathomimetics|sympathomimetics|mesh-ancestor
65381448|NCT00830414|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65381449|NCT00830414|Medroxyprogesterone|medroxyprogesterone|mesh-list
65381450|NCT00830414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65381451|NCT00830414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65381452|NCT00830414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65381453|NCT00830414|Contraceptive Agents|contraceptive agents|mesh-ancestor
65381454|NCT00830414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65381455|NCT00830414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381456|NCT00830414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65381457|NCT00830414|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65381458|NCT00830414|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65381459|NCT00830414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65381460|NCT00830414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381461|NCT00830492|Clomiphene|clomiphene|mesh-list
65381462|NCT00830492|Enclomiphene|enclomiphene|mesh-list
65381463|NCT00830492|Zuclomiphene|zuclomiphene|mesh-list
65381464|NCT00830492|Buserelin|buserelin|mesh-list
65381465|NCT00830492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65381466|NCT00830492|Hormone Antagonists|hormone antagonists|mesh-ancestor
65381467|NCT00830492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65381468|NCT00830492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381469|NCT00830492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65381470|NCT00830492|Fertility Agents|fertility agents|mesh-ancestor
65381471|NCT00830492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65381472|NCT00830492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65381473|NCT00830492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65381474|NCT00830570|Warfarin|warfarin|mesh-list
65381475|NCT00830570|Anticoagulants|anticoagulants|mesh-ancestor
65381476|NCT00837746|Risedronic Acid|risedronic acid|mesh-list
65381477|NCT00837746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65381478|NCT00837746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65381479|NCT00837746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381480|NCT00837746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65381481|NCT00837746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381482|NCT00837746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65381483|NCT04043702|Topiramate|topiramate|mesh-list
65381484|NCT04043702|Anticonvulsants|anticonvulsants|mesh-ancestor
65381485|NCT04043702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65381491|NCT02550080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65381492|NCT02550080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65381493|NCT02550080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381494|NCT02550080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381495|NCT02550080|Leprostatic Agents|leprostatic agents|mesh-ancestor
65381496|NCT02550080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65381497|NCT02547350|Pirarubicin|pirarubicin|mesh-list
65381498|NCT02547350|Epirubicin|epirubicin|mesh-list
65381499|NCT02547350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381500|NCT02547350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65381501|NCT02547350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65381502|NCT02547350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65381503|NCT02547350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381504|NCT02547350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381505|NCT00838214|Prednisone|prednisone|mesh-list
65381506|NCT00838214|Budesonide|budesonide|mesh-list
65381507|NCT00838214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65381508|NCT00838214|Glucocorticoids|glucocorticoids|mesh-ancestor
65381509|NCT00838214|Hormones|hormones|mesh-ancestor
65381510|NCT00838214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65381547|NCT00833300|Olanzapine|olanzapine|mesh-list
65381548|NCT00833300|Haloperidol decanoate|haloperidol decanoate|mesh-list
65381549|NCT00833300|Antiemetics|antiemetics|mesh-ancestor
65381550|NCT00833300|Autonomic Agents|autonomic agents|mesh-ancestor
65381551|NCT00833300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65381552|NCT00833300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381553|NCT00833300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65381554|NCT00833300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65381555|NCT00833300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65381556|NCT00833300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65381557|NCT00833300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65381558|NCT00833300|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65381559|NCT00833300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65381560|NCT00833300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65381561|NCT00833300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381562|NCT00833300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65381563|NCT00833300|Serotonin Agents|serotonin agents|mesh-ancestor
65381564|NCT00833300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65381565|NCT00833300|Dopamine Agents|dopamine agents|mesh-ancestor
65381566|NCT00833300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65381567|NCT00833378|Ritonavir|ritonavir|mesh-list
65381568|NCT00833378|Lopinavir|lopinavir|mesh-list
65381569|NCT00833378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65381570|NCT00833378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65381571|NCT00833378|Protease Inhibitors|protease inhibitors|mesh-ancestor
65381572|NCT00833378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381573|NCT00833378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381574|NCT00833378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65381575|NCT00833378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65381576|NCT00833378|Antiviral Agents|antiviral agents|mesh-ancestor
65381577|NCT00833378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65381578|NCT00833378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65381579|NCT00833378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65381580|NCT05359341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64774202|NCT01639872|Clozapine|clozapine|mesh-list
64323754|NCT02259595|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64323755|NCT02259595|Antioxidants|antioxidants|mesh-ancestor
64323756|NCT02259595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323757|NCT02259595|Protective Agents|protective agents|mesh-ancestor
65381581|NCT05359341|Empagliflozin|empagliflozin|mesh-list
65381582|NCT05359341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65381583|NCT05359341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65381584|NCT05359341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65381585|NCT05359341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381586|NCT05359341|Incretins|incretins|mesh-ancestor
65381587|NCT05359341|Hormones|hormones|mesh-ancestor
65381588|NCT05359341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65381589|NCT05359341|Protease Inhibitors|protease inhibitors|mesh-ancestor
65381590|NCT05359341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381591|NCT05359341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381592|NCT05398731|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65381593|NCT05398731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65381594|NCT05398731|Adrenergic Agents|adrenergic agents|mesh-ancestor
65381595|NCT05398731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65381598|NCT00838760|Darunavir|darunavir|mesh-list
65381638|NCT00833534|Immunologic Factors|immunologic factors|mesh-ancestor
65381639|NCT00833534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381640|NCT00833534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65381641|NCT00833534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65381642|NCT00833534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65381643|NCT00833534|Growth Substances|growth substances|mesh-ancestor
65381644|NCT00833534|Growth Inhibitors|growth inhibitors|mesh-ancestor
65381645|NCT05591001|Ketamine|ketamine|mesh-list
65381646|NCT05591001|Propofol|propofol|mesh-list
65381647|NCT05591001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65381648|NCT05591001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65381649|NCT05591001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381650|NCT05591001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65381651|NCT05591001|Anesthetics, General|anesthetics, general|mesh-ancestor
65381652|NCT05591001|Anesthetics|anesthetics|mesh-ancestor
65381653|NCT05591001|Analgesics|analgesics|mesh-ancestor
65381654|NCT05591001|Sensory System Agents|sensory system agents|mesh-ancestor
65381655|NCT05591001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65381656|NCT05591001|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65381657|NCT05591001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65381658|NCT05591001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65381659|NCT05591001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65381660|NCT05591001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381661|NCT00517192|Ritonavir|ritonavir|mesh-list
65381662|NCT00517192|Darunavir|darunavir|mesh-list
65381663|NCT00517192|Tipranavir|tipranavir|mesh-list
65381664|NCT00517192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65381665|NCT00517192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65381666|NCT00517192|Protease Inhibitors|protease inhibitors|mesh-ancestor
65381667|NCT00517192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381668|NCT00517192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381669|NCT00517192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65381670|NCT00517192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65381671|NCT00517192|Antiviral Agents|antiviral agents|mesh-ancestor
65381679|NCT00833768|Chelating Agents|chelating agents|mesh-ancestor
65381680|NCT00833768|Sequestering Agents|sequestering agents|mesh-ancestor
65381681|NCT00833768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381682|NCT00510484|Pancrelipase|pancrelipase|mesh-list
65381683|NCT00510484|Pancreatin|pancreatin|mesh-list
65381684|NCT00510484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65381685|NCT00839228|Perhexiline|perhexiline|mesh-list
65381686|NCT00839228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65381687|NCT00839228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65381688|NCT00839228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381689|NCT00839228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65381690|NCT00839228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381691|NCT00839228|Vasodilator Agents|vasodilator agents|mesh-ancestor
65381692|NCT05408481|Hydrocortisone|hydrocortisone|mesh-list
65381693|NCT05408481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65381694|NCT00839462|Pantothenic Acid|pantothenic acid|mesh-list
65381695|NCT00839462|Vitamin B Complex|vitamin b complex|mesh-ancestor
65381696|NCT00839462|Vitamins|vitamins|mesh-ancestor
65381697|NCT00839462|Micronutrients|micronutrients|mesh-ancestor
65381698|NCT00839462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381699|NCT05590221|Cyclophosphamide|cyclophosphamide|mesh-list
65381700|NCT05590221|Fludarabine|fludarabine|mesh-list
65381701|NCT05590221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65381702|NCT05590221|Immunologic Factors|immunologic factors|mesh-ancestor
65381703|NCT05590221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381704|NCT05590221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65381705|NCT05590221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65381706|NCT05590221|Alkylating Agents|alkylating agents|mesh-ancestor
65381707|NCT05590221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381708|NCT05590221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381709|NCT05590221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64323758|NCT02259595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323759|NCT02259595|Antidotes|antidotes|mesh-ancestor
64323760|NCT02804035|Furosemide|furosemide|mesh-list
64323761|NCT02804035|Diuretics|diuretics|mesh-ancestor
64323762|NCT02804035|Natriuretic Agents|natriuretic agents|mesh-ancestor
64323763|NCT02804035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328494|NCT02183441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64328495|NCT02183441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64328496|NCT02183441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328497|NCT02183441|Incretins|incretins|mesh-ancestor
64328499|NCT02183441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64328500|NCT02183441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65381710|NCT05590143|Dapagliflozin|dapagliflozin|mesh-list
65381711|NCT05590143|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65381712|NCT05590143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381713|NCT05590143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65381714|NCT05590143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381715|NCT00622388|Ofatumumab|ofatumumab|mesh-list
65381716|NCT00622388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381717|NCT01156389|Ritonavir|ritonavir|mesh-list
65381718|NCT01156389|Artesunate|artesunate|mesh-list
65381719|NCT01156389|Pyronaridine|pyronaridine|mesh-list
65381720|NCT01156389|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65381721|NCT01156389|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65381722|NCT01156389|Protease Inhibitors|protease inhibitors|mesh-ancestor
65381723|NCT01156389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381724|NCT01156389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381769|NCT00625742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381770|NCT00625742|Antioxidants|antioxidants|mesh-ancestor
65381771|NCT00625742|Protective Agents|protective agents|mesh-ancestor
65381772|NCT00625742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65381773|NCT00625742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65381774|NCT00625742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65381775|NCT00625742|Sympatholytics|sympatholytics|mesh-ancestor
65381776|NCT00625742|Autonomic Agents|autonomic agents|mesh-ancestor
65381777|NCT00625742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65381778|NCT00625742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65381779|NCT00625742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65381780|NCT00625742|Adrenergic Agents|adrenergic agents|mesh-ancestor
65381781|NCT00625742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65381782|NCT05589441|Insulin|insulin|mesh-list
65381783|NCT05589441|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65381784|NCT05589441|Albuterol|albuterol|mesh-list
65381785|NCT05589441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65381786|NCT05589441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381787|NCT05589441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65381788|NCT05589441|Autonomic Agents|autonomic agents|mesh-ancestor
65381789|NCT05589441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65381790|NCT05589441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65381791|NCT05589441|Respiratory System Agents|respiratory system agents|mesh-ancestor
65381792|NCT05589441|Tocolytic Agents|tocolytic agents|mesh-ancestor
65381793|NCT05589441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65381794|NCT05589441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65381795|NCT05589441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65381796|NCT05589441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65381797|NCT05589441|Adrenergic Agents|adrenergic agents|mesh-ancestor
65381798|NCT05589441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65381799|NCT05589441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381800|NCT00825188|Amlodipine|amlodipine|mesh-list
65381801|NCT00825188|Eplerenone|eplerenone|mesh-list
65381809|NCT00825188|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65381810|NCT00825188|Hormone Antagonists|hormone antagonists|mesh-ancestor
65381811|NCT00825188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65381812|NCT00825188|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65381813|NCT00825188|Diuretics|diuretics|mesh-ancestor
65381814|NCT00825188|Natriuretic Agents|natriuretic agents|mesh-ancestor
65381815|NCT05589363|Bupivacaine|bupivacaine|mesh-list
65381816|NCT05589363|Anesthetics, Local|anesthetics, local|mesh-ancestor
65381817|NCT05589363|Anesthetics|anesthetics|mesh-ancestor
65381818|NCT05589363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65381819|NCT05589363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381820|NCT05589363|Sensory System Agents|sensory system agents|mesh-ancestor
65381821|NCT05589363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65381822|NCT00834470|Atropine|atropine|mesh-list
65381823|NCT00834470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65381824|NCT00834470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65381825|NCT00834470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65381826|NCT00834470|Autonomic Agents|autonomic agents|mesh-ancestor
65381827|NCT00834470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65381828|NCT00834470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381829|NCT00834470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64774463|NCT01701414|Bupivacaine|bupivacaine|mesh-list
64328501|NCT02403219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64328502|NCT02403219|Botulinum Toxins|botulinum toxins|mesh-list
64328516|NCT03537287|Hormones|hormones|mesh-ancestor
64328517|NCT03537287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64328518|NCT03537287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328519|NCT02280031|Aspirin|aspirin|mesh-list
64328520|NCT02280031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64328521|NCT02280031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64328522|NCT02280031|Analgesics|analgesics|mesh-ancestor
64328523|NCT02280031|Sensory System Agents|sensory system agents|mesh-ancestor
64328524|NCT02280031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64328525|NCT02280031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328526|NCT02280031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64328527|NCT02280031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64556509|NCT04361721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556510|NCT04361643|Lenalidomide|lenalidomide|mesh-list
64556511|NCT04361643|Immunologic Factors|immunologic factors|mesh-ancestor
64556512|NCT04361643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556513|NCT04361643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64556514|NCT04361643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64328528|NCT02280031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64328529|NCT02280031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64328530|NCT02280031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328531|NCT02280031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64328532|NCT02280031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64328533|NCT02280031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328534|NCT02280031|Antipyretics|antipyretics|mesh-ancestor
64328535|NCT00449605|Metformin|metformin|mesh-list
64328536|NCT00449605|Glimepiride|glimepiride|mesh-list
64328538|NCT00449605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65381830|NCT00834470|Respiratory System Agents|respiratory system agents|mesh-ancestor
65381832|NCT00834470|Parasympatholytics|parasympatholytics|mesh-ancestor
65381833|NCT00834470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65381834|NCT00834470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65381835|NCT00834470|Cholinergic Agents|cholinergic agents|mesh-ancestor
65381836|NCT00834470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65381837|NCT00834470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381838|NCT03997864|Prazosin|prazosin|mesh-list
65381839|NCT03997864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65381840|NCT03997864|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65381841|NCT03997864|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65381842|NCT03997864|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65381843|NCT03997864|Adrenergic Agents|adrenergic agents|mesh-ancestor
65381844|NCT03997864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65381845|NCT03997864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381846|NCT03997864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381847|NCT05407467|Curcumin|curcumin|mesh-list
65381848|NCT05407467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65381849|NCT05407467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65381850|NCT05407467|Analgesics|analgesics|mesh-ancestor
65381851|NCT05407467|Sensory System Agents|sensory system agents|mesh-ancestor
65381852|NCT05407467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65381853|NCT05407467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381854|NCT05407467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65381855|NCT05407467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65381856|NCT05407467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381857|NCT05407467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381858|NCT05407467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381859|NCT01010152|Codeine|codeine|mesh-list
65381860|NCT01010152|Analgesics|analgesics|mesh-ancestor
65381861|NCT01010152|Sensory System Agents|sensory system agents|mesh-ancestor
65381862|NCT01010152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64328539|NCT00449605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328540|NCT00449605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64328541|NCT00449605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64328542|NCT00449605|Immunologic Factors|immunologic factors|mesh-ancestor
64328543|NCT00449605|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64328544|NCT00449605|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
64328545|NCT00449605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64328546|NCT00449605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65381863|NCT01010152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381864|NCT01010152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65381865|NCT01010152|Narcotics|narcotics|mesh-ancestor
65381866|NCT01010152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65381867|NCT01010152|Antitussive Agents|antitussive agents|mesh-ancestor
65381868|NCT01010152|Respiratory System Agents|respiratory system agents|mesh-ancestor
65381869|NCT05407233|Insulin|insulin|mesh-list
65381870|NCT05407233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65381871|NCT05407233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65381872|NCT05407233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381873|NCT02549846|Atorvastatin|atorvastatin|mesh-list
65381874|NCT02549846|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65381875|NCT02549846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65381876|NCT02549846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65381877|NCT02549846|Antimetabolites|antimetabolites|mesh-ancestor
65381878|NCT02549846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381879|NCT02549846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65381880|NCT02549846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65381881|NCT02549846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381882|NCT05407155|Paclitaxel|paclitaxel|mesh-list
65381883|NCT05407155|Bevacizumab|bevacizumab|mesh-list
65381884|NCT05407155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65381885|NCT05407155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381886|NCT05407155|Tubulin Modulators|tubulin modulators|mesh-ancestor
65381887|NCT05407155|Antimitotic Agents|antimitotic agents|mesh-ancestor
64328547|NCT00449605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328548|NCT00449605|Hormones|hormones|mesh-ancestor
64328549|NCT00449605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64328550|NCT02774239|Immunoglobulins|immunoglobulins|mesh-list
64328551|NCT02774239|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64328552|NCT02774239|Antibodies|antibodies|mesh-list
64328662|NCT02184065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328663|NCT02184065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64328664|NCT02184065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64328665|NCT02184065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64328666|NCT02184065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64328667|NCT02184065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328668|NCT02184065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328669|NCT00564421|Epinastine|epinastine|mesh-list
64328670|NCT00564421|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64328671|NCT00564421|Histamine Antagonists|histamine antagonists|mesh-ancestor
64328693|NCT00563563|Sensory System Agents|sensory system agents|mesh-ancestor
64328694|NCT00563563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64328695|NCT00563563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64328696|NCT00563563|Antidepressive Agents|antidepressive agents|mesh-ancestor
64328697|NCT00563563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64328698|NCT00563563|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64328699|NCT00563563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65381888|NCT05407155|Mitosis Modulators|mitosis modulators|mesh-ancestor
65381889|NCT05407155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381890|NCT05407155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65381891|NCT05407155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65381892|NCT05407155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65381893|NCT05407155|Growth Substances|growth substances|mesh-ancestor
65381894|NCT05407155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381895|NCT05407155|Growth Inhibitors|growth inhibitors|mesh-ancestor
65381896|NCT00840242|Nicotine|nicotine|mesh-list
65381897|NCT00840242|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65381898|NCT00840242|Autonomic Agents|autonomic agents|mesh-ancestor
65381899|NCT00840242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65381900|NCT00840242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381901|NCT00840242|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65381902|NCT00840242|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65381903|NCT00840242|Cholinergic Agents|cholinergic agents|mesh-ancestor
65381904|NCT00840242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65381905|NCT00840242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381906|NCT00840398|Buspirone|buspirone|mesh-list
65381907|NCT00840398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65381908|NCT00840398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65381909|NCT00840398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65381910|NCT00840398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381911|NCT00840398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65381912|NCT00840398|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65381913|NCT00840398|Serotonin Agents|serotonin agents|mesh-ancestor
65381914|NCT00840398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65381915|NCT00840398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381932|NCT02548286|Vasodilator Agents|vasodilator agents|mesh-ancestor
65381933|NCT02548286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65381934|NCT02548286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65381935|NCT05360433|Oxycodone|oxycodone|mesh-list
65381936|NCT05360433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65381937|NCT05360433|Narcotics|narcotics|mesh-ancestor
65381938|NCT05360433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65381939|NCT05360433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381940|NCT05360433|Analgesics|analgesics|mesh-ancestor
65381941|NCT05360433|Sensory System Agents|sensory system agents|mesh-ancestor
65381942|NCT05360433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65381943|NCT00834860|Ribavirin|ribavirin|mesh-list
65381944|NCT00834860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65381945|NCT00834860|Antimetabolites|antimetabolites|mesh-ancestor
65381946|NCT00834860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381947|NCT00834860|Antiviral Agents|antiviral agents|mesh-ancestor
65381948|NCT00834860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65381949|NCT04875195|Pembrolizumab|pembrolizumab|mesh-list
65381950|NCT04875195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65381951|NCT04875195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381952|NCT04696575|Lamivudine|lamivudine|mesh-list
65381953|NCT04696575|Carboplatin|carboplatin|mesh-list
65381954|NCT04696575|Etoposide|etoposide|mesh-list
65381955|NCT04696575|Etoposide phosphate|etoposide phosphate|mesh-list
65381956|NCT04696575|Atezolizumab|atezolizumab|mesh-list
65381957|NCT04696575|Podophyllotoxin|podophyllotoxin|mesh-list
65381958|NCT04696575|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65381959|NCT04696575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65381960|NCT04696575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65381961|NCT04696575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65381962|NCT04696575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65381963|NCT04696575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65381964|NCT04696575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65381965|NCT04696575|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65381966|NCT04696575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64774591|NCT05613426|Evolocumab|evolocumab|mesh-list
65381971|NCT04696575|Immunologic Factors|immunologic factors|mesh-ancestor
65381972|NCT04696575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381973|NCT04696575|Keratolytic Agents|keratolytic agents|mesh-ancestor
65381974|NCT04696575|Dermatologic Agents|dermatologic agents|mesh-ancestor
65381975|NCT04696575|Tubulin Modulators|tubulin modulators|mesh-ancestor
65381976|NCT04696575|Antimitotic Agents|antimitotic agents|mesh-ancestor
65381977|NCT04696575|Mitosis Modulators|mitosis modulators|mesh-ancestor
65381979|NCT00825422|Anesthetics, Local|anesthetics, local|mesh-ancestor
65381980|NCT00825422|Anesthetics|anesthetics|mesh-ancestor
65381981|NCT00825422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65381982|NCT00825422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381983|NCT00825422|Sensory System Agents|sensory system agents|mesh-ancestor
65381984|NCT00825422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65381985|NCT00505414|Morphine|morphine|mesh-list
65381986|NCT00505414|Tapentadol|tapentadol|mesh-list
65381987|NCT00505414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65381988|NCT00505414|Narcotics|narcotics|mesh-ancestor
65381989|NCT00505414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65381990|NCT00505414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65381991|NCT00505414|Analgesics|analgesics|mesh-ancestor
65381992|NCT00505414|Sensory System Agents|sensory system agents|mesh-ancestor
65382027|NCT00989469|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65382028|NCT00989469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65382029|NCT00989469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382030|NCT00989469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382031|NCT00989469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382032|NCT00989469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65382033|NCT01010308|Nadolol|nadolol|mesh-list
65382034|NCT01010308|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65382035|NCT01010308|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65382036|NCT01010308|Adrenergic Agents|adrenergic agents|mesh-ancestor
65382037|NCT01010308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65382038|NCT01010308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382039|NCT01010308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382040|NCT01010308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65382041|NCT01010308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65382042|NCT01010308|Sympatholytics|sympatholytics|mesh-ancestor
65382043|NCT01010308|Autonomic Agents|autonomic agents|mesh-ancestor
65382044|NCT01010308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65382045|NCT02548052|Betamethasone|betamethasone|mesh-list
65382046|NCT02548052|Betamethasone Valerate|betamethasone valerate|mesh-list
65382047|NCT02548052|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65382048|NCT02548052|Betamethasone benzoate|betamethasone benzoate|mesh-list
65382049|NCT02548052|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65382050|NCT02548052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65382051|NCT02548052|Glucocorticoids|glucocorticoids|mesh-ancestor
65382052|NCT02548052|Hormones|hormones|mesh-ancestor
65382053|NCT02548052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65382054|NCT02548052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382055|NCT02548052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65382056|NCT02548052|Respiratory System Agents|respiratory system agents|mesh-ancestor
65382057|NCT04590417|Cyproterone Acetate|cyproterone acetate|mesh-list
65382058|NCT04590417|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65382059|NCT04590417|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65382060|NCT04590417|Estradiol|estradiol|mesh-list
65382061|NCT04590417|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65382062|NCT04590417|Cyproterone|cyproterone|mesh-list
65382063|NCT04590417|Estrogens|estrogens|mesh-ancestor
65382064|NCT04590417|Hormones|hormones|mesh-ancestor
65382065|NCT04590417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65382066|NCT04590417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382067|NCT04590417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65382068|NCT04590417|Contraceptive Agents|contraceptive agents|mesh-ancestor
65382069|NCT04590417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65382070|NCT04590417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65382071|NCT04590417|Androgen Antagonists|androgen antagonists|mesh-ancestor
65382072|NCT04590417|Hormone Antagonists|hormone antagonists|mesh-ancestor
65382073|NCT04590417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65382074|NCT04590417|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65382075|NCT00825656|Capsaicin|capsaicin|mesh-list
65382076|NCT00825656|Antipruritics|antipruritics|mesh-ancestor
65382077|NCT00825656|Dermatologic Agents|dermatologic agents|mesh-ancestor
65382078|NCT00825656|Sensory System Agents|sensory system agents|mesh-ancestor
65382079|NCT00825656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65382080|NCT00825656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382081|NCT00989625|Naproxen|naproxen|mesh-list
65382082|NCT00989625|Sumatriptan|sumatriptan|mesh-list
65382083|NCT00989625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65382084|NCT00989625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65382085|NCT00989625|Analgesics|analgesics|mesh-ancestor
65382086|NCT00989625|Sensory System Agents|sensory system agents|mesh-ancestor
65382087|NCT00989625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65382088|NCT00989625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65382089|NCT00989625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65382090|NCT00989625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65382091|NCT00989625|Gout Suppressants|gout suppressants|mesh-ancestor
65382092|NCT00989625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65382093|NCT00989625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65382094|NCT00989625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65382095|NCT00989625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65382096|NCT00989625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65382097|NCT00989625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64822030|NCT01519011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822031|NCT01519011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822032|NCT01519011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822033|NCT01519037|Cinacalcet|cinacalcet|mesh-list
64822034|NCT01519037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64822035|NCT01519037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822036|NCT01519037|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64822037|NCT01519037|Hormone Antagonists|hormone antagonists|mesh-ancestor
64822038|NCT01519037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64822039|NCT01519076|Coal Tar|coal tar|mesh-list
64822040|NCT01519076|Keratolytic Agents|keratolytic agents|mesh-ancestor
64822041|NCT01519076|Dermatologic Agents|dermatologic agents|mesh-ancestor
64822042|NCT01519102|Hormones|hormones|mesh-list
64822043|NCT01519102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64822044|NCT01519102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822045|NCT01519128|Rilpivirine|rilpivirine|mesh-list
64822046|NCT01519128|Digoxin|digoxin|mesh-list
64822047|NCT01519128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64822048|NCT01519128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64822049|NCT01519128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822050|NCT01519128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822051|NCT01519128|Protective Agents|protective agents|mesh-ancestor
64822052|NCT01519128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822053|NCT01519128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64822054|NCT01519128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64822055|NCT01519128|Antiviral Agents|antiviral agents|mesh-ancestor
64822056|NCT01519128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64822084|NCT01519310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64822085|NCT01519310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64822097|NCT01519336|Protease Inhibitors|protease inhibitors|mesh-ancestor
64822098|NCT01519336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822099|NCT01519336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822100|NCT01519336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64822101|NCT01519336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64822102|NCT01519336|Antiviral Agents|antiviral agents|mesh-ancestor
64822103|NCT01519336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64822117|NCT01519401|Contraceptive Agents|contraceptive agents|mesh-ancestor
64822118|NCT01519401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64822119|NCT01519401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64822120|NCT01519401|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64822121|NCT01519401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64822122|NCT01519401|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64822123|NCT01519401|Hormone Antagonists|hormone antagonists|mesh-ancestor
64822124|NCT01519401|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64822125|NCT01519401|Diuretics|diuretics|mesh-ancestor
64822126|NCT01519401|Natriuretic Agents|natriuretic agents|mesh-ancestor
64822127|NCT01519544|Acetazolamide|acetazolamide|mesh-list
64822128|NCT01519544|Temazepam|temazepam|mesh-list
64822129|NCT01519544|Anticonvulsants|anticonvulsants|mesh-ancestor
64822130|NCT01519544|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64822131|NCT01519544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822132|NCT01519544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822133|NCT01519544|Diuretics|diuretics|mesh-ancestor
64822134|NCT01519544|Natriuretic Agents|natriuretic agents|mesh-ancestor
64822135|NCT01519544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822136|NCT01519544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64822137|NCT01519544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64822138|NCT01519544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64822139|NCT01519544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64822140|NCT01519544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64822141|NCT01519544|GABA Modulators|gaba modulators|mesh-ancestor
64330994|NCT05791669|Protective Agents|protective agents|mesh-ancestor
64822152|NCT01519726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64822153|NCT01519726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64822154|NCT01519726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64822155|NCT01519726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64822156|NCT01519726|Anesthetics, General|anesthetics, general|mesh-ancestor
64822157|NCT01519726|Anesthetics|anesthetics|mesh-ancestor
64822158|NCT01519726|GABA Modulators|gaba modulators|mesh-ancestor
64822159|NCT01519726|GABA Agents|gaba agents|mesh-ancestor
64822160|NCT01519726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64822161|NCT01519726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822162|NCT01519752|Oxiconazole|oxiconazole|mesh-list
64822163|NCT01519752|Antifungal Agents|antifungal agents|mesh-ancestor
64822164|NCT01519752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64822165|NCT01519856|Piribedil|piribedil|mesh-list
64822166|NCT01519856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64822167|NCT01519856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64822168|NCT01519856|Dopamine Agonists|dopamine agonists|mesh-ancestor
64822200|NCT01520103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822201|NCT01520103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64822202|NCT01520103|Tubulin Modulators|tubulin modulators|mesh-ancestor
64822203|NCT01520103|Antimitotic Agents|antimitotic agents|mesh-ancestor
64822204|NCT01520103|Mitosis Modulators|mitosis modulators|mesh-ancestor
64822205|NCT01520103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822206|NCT01520116|Timolol|timolol|mesh-list
64822207|NCT01520116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64822208|NCT01520116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64822209|NCT01520116|Adrenergic Agents|adrenergic agents|mesh-ancestor
65494585|NCT01143948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64561052|NCT01118091|Antiviral Agents|antiviral agents|mesh-ancestor
64951967|NCT00028028|Sirolimus|sirolimus|mesh-list
64822246|NCT01520350|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64822247|NCT01520350|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64822248|NCT01520350|Serotonin Agents|serotonin agents|mesh-ancestor
64822249|NCT01520350|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64822250|NCT01520350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64822251|NCT01520350|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64822252|NCT01520350|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64822254|NCT01520389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64822255|NCT01520389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64822256|NCT01520389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64822257|NCT01520389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822258|NCT01520389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822259|NCT01520389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822260|NCT01520389|Immunologic Factors|immunologic factors|mesh-ancestor
64822261|NCT01520389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822262|NCT01520415|Lidocaine|lidocaine|mesh-list
64822280|NCT01520441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64822281|NCT01520441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822282|NCT01520441|Cholinergic Agents|cholinergic agents|mesh-ancestor
64822283|NCT01520441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64822284|NCT01520467|Anastrozole|anastrozole|mesh-list
64822285|NCT01520467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64822286|NCT01520467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822287|NCT01520467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64822288|NCT01520467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64822289|NCT01520467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822290|NCT01520467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822291|NCT01520467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64822292|NCT01520467|Hormone Antagonists|hormone antagonists|mesh-ancestor
64822293|NCT01520467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64822295|NCT01520584|Vitamins|vitamins|mesh-list
64822304|NCT01520753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64822305|NCT01520753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822306|NCT01520766|Methamphetamine|methamphetamine|mesh-list
64822307|NCT01520766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64822308|NCT01520766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822309|NCT01520766|Sympathomimetics|sympathomimetics|mesh-ancestor
64822310|NCT01520766|Autonomic Agents|autonomic agents|mesh-ancestor
64822311|NCT01520766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64822312|NCT01520766|Dopamine Agents|dopamine agents|mesh-ancestor
64822313|NCT01520766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64822314|NCT01520766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822315|NCT01520766|Adrenergic Agents|adrenergic agents|mesh-ancestor
64433453|NCT02021331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822319|NCT01520766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64822320|NCT01520792|Acetaminophen|acetaminophen|mesh-list
64822321|NCT01520792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64822322|NCT01520792|Analgesics|analgesics|mesh-ancestor
65494586|NCT01143948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822323|NCT01520792|Sensory System Agents|sensory system agents|mesh-ancestor
64822324|NCT01520792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64822325|NCT01520792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822326|NCT01520792|Antipyretics|antipyretics|mesh-ancestor
64822327|NCT01520818|Insulin|insulin|mesh-list
64822328|NCT01520818|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64822329|NCT01520818|Insulin Aspart|insulin aspart|mesh-list
64590960|NCT00609739|Hormones|hormones|mesh-ancestor
64822330|NCT01520818|Insulin, Long-Acting|insulin, long-acting|mesh-list
64822331|NCT01520818|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64822332|NCT01520818|Biphasic Insulins|biphasic insulins|mesh-list
64822333|NCT01520818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64822334|NCT01520818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822335|NCT01520831|Insulin|insulin|mesh-list
64822336|NCT01520831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64822337|NCT01520831|Insulin Aspart|insulin aspart|mesh-list
64822338|NCT01520831|Insulin, Long-Acting|insulin, long-acting|mesh-list
64822339|NCT01520831|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64822342|NCT01520831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64822343|NCT01520831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822344|NCT01520896|Ketoconazole|ketoconazole|mesh-list
64822345|NCT01520896|Naloxegol|naloxegol|mesh-list
64822346|NCT01520896|Antifungal Agents|antifungal agents|mesh-ancestor
64822347|NCT01520896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64822348|NCT01520896|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64822349|NCT01520896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64822350|NCT01520896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822351|NCT01520896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822352|NCT01520896|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64822353|NCT01520896|Hormone Antagonists|hormone antagonists|mesh-ancestor
64822354|NCT01520896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64822355|NCT01520896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822356|NCT01520896|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64822357|NCT01520896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64822358|NCT01520896|Sensory System Agents|sensory system agents|mesh-ancestor
64822359|NCT01520896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64822360|NCT01521130|Levetiracetam|levetiracetam|mesh-list
64822361|NCT01521130|Anticonvulsants|anticonvulsants|mesh-ancestor
64822362|NCT01521130|Nootropic Agents|nootropic agents|mesh-ancestor
64822363|NCT01521299|Hydroxyurea|hydroxyurea|mesh-list
64822364|NCT01521299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822365|NCT01521299|Antisickling Agents|antisickling agents|mesh-ancestor
64822366|NCT01521299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822367|NCT01521299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822420|NCT01521572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822421|NCT01521572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64822422|NCT01521572|Respiratory System Agents|respiratory system agents|mesh-ancestor
64822423|NCT01521572|Tocolytic Agents|tocolytic agents|mesh-ancestor
64822424|NCT01521572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64822440|NCT01521767|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64822441|NCT01521767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64822442|NCT01521767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64822443|NCT01521767|Cholinergic Agents|cholinergic agents|mesh-ancestor
64822444|NCT01521767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64822445|NCT01521767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822446|NCT01521767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822447|NCT01521767|Urological Agents|urological agents|mesh-ancestor
64822448|NCT01521793|Retinol acetate|retinol acetate|mesh-list
64822449|NCT01521793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64822450|NCT01521793|Immunologic Factors|immunologic factors|mesh-ancestor
64822451|NCT01521793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822452|NCT01521793|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64822453|NCT01521793|Protective Agents|protective agents|mesh-ancestor
64822454|NCT01521793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822455|NCT01521819|Ranibizumab|ranibizumab|mesh-list
64822456|NCT01521819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64822458|NCT01521819|Growth Substances|growth substances|mesh-ancestor
64822501|NCT01522040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64822502|NCT01522040|Tocolytic Agents|tocolytic agents|mesh-ancestor
64822503|NCT01522040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64822505|NCT01522092|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64822506|NCT01522092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64822507|NCT01522092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64822508|NCT01522092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822509|NCT01522092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64822510|NCT01522092|Serotonin Agents|serotonin agents|mesh-ancestor
64822511|NCT01522092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822512|NCT01522092|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64822513|NCT01522092|Antidepressive Agents|antidepressive agents|mesh-ancestor
64822514|NCT01522092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64822515|NCT01522105|Daptomycin|daptomycin|mesh-list
64822516|NCT01522105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64822517|NCT01522105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64822576|NCT01522612|Micronutrients|micronutrients|mesh-ancestor
64822577|NCT01522612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64822578|NCT01522625|Tenofovir|tenofovir|mesh-list
64822579|NCT01522625|Antiviral Agents|antiviral agents|mesh-ancestor
64822580|NCT01522625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64822581|NCT01522625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64822582|NCT01522625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64822583|NCT01522625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822584|NCT01522625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822585|NCT01522625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64822586|NCT01522625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64822587|NCT01522677|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64822588|NCT01522677|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64822589|NCT01522677|Dermatologic Agents|dermatologic agents|mesh-ancestor
64822590|NCT01522729|Fentanyl|fentanyl|mesh-list
64822591|NCT01522729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64822592|NCT01522729|Narcotics|narcotics|mesh-ancestor
64822593|NCT01522729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64822594|NCT01522729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822595|NCT01522729|Analgesics|analgesics|mesh-ancestor
64822596|NCT01522729|Sensory System Agents|sensory system agents|mesh-ancestor
64822597|NCT01522729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64822609|NCT01522820|Immunologic Factors|immunologic factors|mesh-ancestor
64822610|NCT01522820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822611|NCT01522846|Heparin|heparin|mesh-list
64822612|NCT01522846|Anticoagulants|anticoagulants|mesh-ancestor
64822613|NCT01522846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64822614|NCT01522846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64822635|NCT01522872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494587|NCT01145976|Cyclophosphamide|cyclophosphamide|mesh-list
65494588|NCT01145976|Fludarabine|fludarabine|mesh-list
65494589|NCT01145976|Thymoglobulin|thymoglobulin|mesh-list
64561345|NCT03563729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64822636|NCT01522872|Immunologic Factors|immunologic factors|mesh-ancestor
64822637|NCT01522872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64822638|NCT01522872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64822639|NCT01522872|Growth Substances|growth substances|mesh-ancestor
64822640|NCT01522872|Growth Inhibitors|growth inhibitors|mesh-ancestor
64822641|NCT01522872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64822642|NCT01522872|Alkylating Agents|alkylating agents|mesh-ancestor
64822644|NCT01522989|Oxaliplatin|oxaliplatin|mesh-list
64822645|NCT01522989|Palbociclib|palbociclib|mesh-list
64822646|NCT01522989|Antimetabolites|antimetabolites|mesh-ancestor
64822647|NCT01522989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822648|NCT01522989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64822649|NCT01522989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822650|NCT01522989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64822651|NCT01522989|Immunologic Factors|immunologic factors|mesh-ancestor
64822652|NCT01522989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822653|NCT01522989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64822654|NCT01522989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822656|NCT01523002|Pyronaridine|pyronaridine|mesh-list
64822657|NCT01523002|Metoprolol|metoprolol|mesh-list
64822658|NCT01523002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64822659|NCT01523002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64822660|NCT01523002|Sympatholytics|sympatholytics|mesh-ancestor
64822661|NCT01523002|Autonomic Agents|autonomic agents|mesh-ancestor
64822662|NCT01523002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64822695|NCT01523041|Insulin, Long-Acting|insulin, long-acting|mesh-list
64822696|NCT01523041|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64822697|NCT01523041|Biphasic Insulins|biphasic insulins|mesh-list
64822698|NCT01523041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64822699|NCT01523041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822700|NCT01523054|Metoprolol|metoprolol|mesh-list
64822701|NCT01523054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64822702|NCT01523054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64822703|NCT01523054|Sympatholytics|sympatholytics|mesh-ancestor
64822704|NCT01523054|Autonomic Agents|autonomic agents|mesh-ancestor
64591320|NCT00578071|Antimetabolites|antimetabolites|mesh-ancestor
64822705|NCT01523054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64822706|NCT01523054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822707|NCT01523054|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64822708|NCT01523054|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64822709|NCT01523054|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64822710|NCT01523054|Adrenergic Agents|adrenergic agents|mesh-ancestor
64822711|NCT01523054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64822712|NCT01523054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822713|NCT01523067|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
64822714|NCT01523067|Vasodilator Agents|vasodilator agents|mesh-ancestor
64822715|NCT01523080|Acetaminophen|acetaminophen|mesh-list
64822716|NCT01523080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64822717|NCT01523080|Analgesics|analgesics|mesh-ancestor
64822718|NCT01523080|Sensory System Agents|sensory system agents|mesh-ancestor
64822719|NCT01523080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64822720|NCT01523080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822721|NCT01523080|Antipyretics|antipyretics|mesh-ancestor
64822722|NCT01523093|Ondansetron|ondansetron|mesh-list
65494590|NCT01145976|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64822723|NCT01523093|Antiemetics|antiemetics|mesh-ancestor
64822746|NCT01523119|Dermatologic Agents|dermatologic agents|mesh-ancestor
64337479|NCT01388491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64822757|NCT01523236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64822758|NCT01523236|Dermatologic Agents|dermatologic agents|mesh-ancestor
64822759|NCT01523236|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64822760|NCT01523314|Dexamethasone|dexamethasone|mesh-list
64822761|NCT01523314|Bevacizumab|bevacizumab|mesh-list
64822762|NCT01523314|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64822763|NCT01523314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64822764|NCT01523314|Antiemetics|antiemetics|mesh-ancestor
64822765|NCT01523314|Autonomic Agents|autonomic agents|mesh-ancestor
64822766|NCT01523314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64822767|NCT01523314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822768|NCT01523314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64822769|NCT01523314|Glucocorticoids|glucocorticoids|mesh-ancestor
64822770|NCT01523314|Hormones|hormones|mesh-ancestor
64822771|NCT01523314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64822772|NCT01523314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64822773|NCT01523314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822774|NCT01523314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64822775|NCT01523314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64822776|NCT01523314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64822791|NCT01523379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64822792|NCT01523379|Analgesics|analgesics|mesh-ancestor
64822793|NCT01523379|Sensory System Agents|sensory system agents|mesh-ancestor
64822794|NCT01523379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64822795|NCT01523379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822796|NCT01523379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64822797|NCT01523379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64822798|NCT01523418|Rivaroxaban|rivaroxaban|mesh-list
64822799|NCT01523418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64822800|NCT01523418|Antithrombins|antithrombins|mesh-ancestor
64822801|NCT01523418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64822802|NCT01523418|Protease Inhibitors|protease inhibitors|mesh-ancestor
64822812|NCT01523431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822813|NCT01523431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64822814|NCT01523431|Immunologic Factors|immunologic factors|mesh-ancestor
64822815|NCT01523431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822816|NCT01523431|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64822817|NCT01523431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64822818|NCT01523431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822819|NCT01523431|Antidotes|antidotes|mesh-ancestor
64822820|NCT01523431|Protective Agents|protective agents|mesh-ancestor
64822821|NCT01523431|Vitamin B Complex|vitamin b complex|mesh-ancestor
64822822|NCT01523431|Vitamins|vitamins|mesh-ancestor
64822823|NCT01523431|Micronutrients|micronutrients|mesh-ancestor
64822824|NCT01523483|Progesterone|progesterone|mesh-list
64822825|NCT01523483|Progestins|progestins|mesh-ancestor
64822826|NCT01523483|Hormones|hormones|mesh-ancestor
64822827|NCT01523483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64822828|NCT01523483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822829|NCT01523548|Carbon Monoxide|carbon monoxide|mesh-list
64822830|NCT01523548|Antimetabolites|antimetabolites|mesh-ancestor
64822831|NCT01523548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822832|NCT01523548|Gasotransmitters|gasotransmitters|mesh-ancestor
64822833|NCT01523548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64822834|NCT01523548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822835|NCT01523574|Calcium, Dietary|calcium, dietary|mesh-list
64822836|NCT01523574|Vitamin E|vitamin e|mesh-list
64822837|NCT01523574|Oxaliplatin|oxaliplatin|mesh-list
65494591|NCT01145976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64822838|NCT01523574|Magnesium Sulfate|magnesium sulfate|mesh-list
64822839|NCT01523574|Calcium|calcium|mesh-list
64822840|NCT01523574|Vitamins|vitamins|mesh-ancestor
64822870|NCT01523678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822871|NCT01523847|Doxorubicin|doxorubicin|mesh-list
64822872|NCT01523847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64822873|NCT01523847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822878|NCT01523860|Rituximab|rituximab|mesh-list
64822883|NCT01523860|Immunologic Factors|immunologic factors|mesh-ancestor
64822884|NCT01523860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822885|NCT01523860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64434034|NCT01815736|Antiviral Agents|antiviral agents|mesh-ancestor
64822900|NCT01524068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64822901|NCT01524081|Amoxicillin|amoxicillin|mesh-list
64822902|NCT01524081|Metronidazole|metronidazole|mesh-list
64822903|NCT01524081|Clavulanic Acids|clavulanic acids|mesh-list
64822904|NCT01524081|Clavulanic Acid|clavulanic acid|mesh-list
64822906|NCT01524081|Cefuroxime axetil|cefuroxime axetil|mesh-list
64822907|NCT01524081|Fluconazole|fluconazole|mesh-list
64822908|NCT01524081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64822909|NCT01524081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64822910|NCT01524081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64822911|NCT01524081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64822912|NCT01524081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64822913|NCT01524081|Antifungal Agents|antifungal agents|mesh-ancestor
64822914|NCT01524081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64822915|NCT01524081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64822916|NCT01524081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822917|NCT01524081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822918|NCT01524081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64822919|NCT01524081|Hormone Antagonists|hormone antagonists|mesh-ancestor
64822920|NCT01524081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64822921|NCT01524081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822922|NCT01524081|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64822924|NCT01524081|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64822944|NCT01524237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434077|NCT01815424|Tofacitinib|tofacitinib|mesh-list
64822953|NCT01524237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64822954|NCT01524237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822955|NCT01524315|Vitamins|vitamins|mesh-list
64822956|NCT01524315|Thiamine|thiamine|mesh-list
64822957|NCT01524315|Vitamin B Complex|vitamin b complex|mesh-list
64822958|NCT01524315|Micronutrients|micronutrients|mesh-ancestor
64822959|NCT01524315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822960|NCT01524354|Anesthetics|anesthetics|mesh-list
64822961|NCT01524354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64822962|NCT01524354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822963|NCT01524367|Dexmedetomidine|dexmedetomidine|mesh-list
64822964|NCT01524367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64822965|NCT01524367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64822966|NCT01524367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822967|NCT01524367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64822968|NCT01524367|Analgesics|analgesics|mesh-ancestor
64822969|NCT01524367|Sensory System Agents|sensory system agents|mesh-ancestor
64822970|NCT01524367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64822971|NCT01524367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64822972|NCT01524367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64822973|NCT01524367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64822974|NCT01524367|Adrenergic Agents|adrenergic agents|mesh-ancestor
64822975|NCT01524367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64822976|NCT01524367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822977|NCT01524432|Clotrimazole|clotrimazole|mesh-list
64822978|NCT01524432|Miconazole|miconazole|mesh-list
64822979|NCT01524432|Antifungal Agents|antifungal agents|mesh-list
64822980|NCT01524432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64822981|NCT01524432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64822982|NCT01524432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64822983|NCT01524432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64822984|NCT01524432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822989|NCT01524432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822990|NCT01524432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64822991|NCT01524432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64822992|NCT01524445|Bortezomib|bortezomib|mesh-list
64822993|NCT01524445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822994|NCT01524497|Trazodone|trazodone|mesh-list
64822995|NCT01524497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64822996|NCT01524497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64822997|NCT01524497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64822998|NCT01524497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822999|NCT01524497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64823000|NCT01524497|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64823001|NCT01524497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64823002|NCT01524497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64823003|NCT01524497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823004|NCT01524497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64823005|NCT01524497|Serotonin Agents|serotonin agents|mesh-ancestor
64823006|NCT01524497|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64823007|NCT01524497|Antidepressive Agents|antidepressive agents|mesh-ancestor
64823008|NCT01524575|Gemcitabine|gemcitabine|mesh-list
64823022|NCT01524601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64823023|NCT01524601|Antimetabolites|antimetabolites|mesh-ancestor
64823024|NCT01524601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823025|NCT01524601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64823026|NCT01524601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64823027|NCT01524601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64823047|NCT01524705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64823048|NCT01524731|Dexamethasone|dexamethasone|mesh-list
64823049|NCT01524731|Dexamethasone acetate|dexamethasone acetate|mesh-list
64823050|NCT01524731|BB 1101|bb 1101|mesh-list
64823051|NCT01524731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64823052|NCT01524731|Antiemetics|antiemetics|mesh-ancestor
64823053|NCT01524731|Autonomic Agents|autonomic agents|mesh-ancestor
64823054|NCT01524731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64823055|NCT01524731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823056|NCT01524731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64823057|NCT01524731|Glucocorticoids|glucocorticoids|mesh-ancestor
64823058|NCT01524731|Hormones|hormones|mesh-ancestor
64823059|NCT01524731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64823060|NCT01524731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64823061|NCT01524731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823062|NCT01524731|Protease Inhibitors|protease inhibitors|mesh-ancestor
64823063|NCT01524731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64823064|NCT01524731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823065|NCT01524744|Pimecrolimus|pimecrolimus|mesh-list
64823066|NCT01524744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64823067|NCT01524744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64823068|NCT01524744|Analgesics|analgesics|mesh-ancestor
64823069|NCT01524744|Sensory System Agents|sensory system agents|mesh-ancestor
64823070|NCT01524744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64823077|NCT01524744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64823078|NCT01524744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64823079|NCT01524744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823080|NCT01524757|Pantoprazole|pantoprazole|mesh-list
64823081|NCT01524757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64823082|NCT01524757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64823083|NCT01524757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64823094|NCT01524809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823095|NCT01524861|Thioctic Acid|thioctic acid|mesh-list
64823096|NCT01524861|Acetylcarnitine|acetylcarnitine|mesh-list
64823097|NCT01524861|Antioxidants|antioxidants|mesh-ancestor
64823098|NCT01524861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823099|NCT01524861|Protective Agents|protective agents|mesh-ancestor
64823100|NCT01524861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823101|NCT01524861|Vitamin B Complex|vitamin b complex|mesh-ancestor
64823102|NCT01524861|Vitamins|vitamins|mesh-ancestor
64823103|NCT01524861|Micronutrients|micronutrients|mesh-ancestor
64823104|NCT01524861|Nootropic Agents|nootropic agents|mesh-ancestor
64823105|NCT01524874|Vitamin D|vitamin d|mesh-list
64823106|NCT01524874|Ergocalciferols|ergocalciferols|mesh-list
64823107|NCT01524874|Cholecalciferol|cholecalciferol|mesh-list
64823108|NCT01524874|Calcitriol|calcitriol|mesh-list
64823109|NCT01524874|Vitamins|vitamins|mesh-list
64823110|NCT01524874|Micronutrients|micronutrients|mesh-ancestor
64823111|NCT01524874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823112|NCT01524874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64823113|NCT01524874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64823114|NCT01524874|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64823115|NCT01524874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64823116|NCT01524874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823117|NCT01524874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64823118|NCT01524939|Immunoglobulins|immunoglobulins|mesh-list
64823119|NCT01524939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64823120|NCT01524939|Antibodies|antibodies|mesh-list
64823146|NCT01525394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64823147|NCT01525394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64823148|NCT01525394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64823149|NCT01525394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64823150|NCT01525394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64823151|NCT01525394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823152|NCT01525394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823153|NCT01525394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64823154|NCT01525537|Sufentanil|sufentanil|mesh-list
64823156|NCT01525537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64823157|NCT01525537|Narcotics|narcotics|mesh-ancestor
64823158|NCT01525537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64823159|NCT01525537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823160|NCT01525537|Analgesics|analgesics|mesh-ancestor
64823161|NCT01525537|Sensory System Agents|sensory system agents|mesh-ancestor
64823162|NCT01525537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64823163|NCT01525537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64823164|NCT01525537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64823165|NCT01525537|Anesthetics, General|anesthetics, general|mesh-ancestor
64823166|NCT01525537|Anesthetics|anesthetics|mesh-ancestor
64823167|NCT01525680|Hydrocortisone|hydrocortisone|mesh-list
64823168|NCT01525680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64823169|NCT01525706|Ethanol|ethanol|mesh-list
64823170|NCT01525706|Paclitaxel|paclitaxel|mesh-list
64823171|NCT01525706|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64823172|NCT01525706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64823173|NCT01525706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823174|NCT01525706|Tubulin Modulators|tubulin modulators|mesh-ancestor
64823175|NCT01525706|Antimitotic Agents|antimitotic agents|mesh-ancestor
64823176|NCT01525706|Mitosis Modulators|mitosis modulators|mesh-ancestor
64823177|NCT01525706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823178|NCT01525706|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64823179|NCT01525706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64823189|NCT01525771|Capecitabine|capecitabine|mesh-list
64823190|NCT01525771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823191|NCT01525771|Tubulin Modulators|tubulin modulators|mesh-ancestor
64823192|NCT01525771|Antimitotic Agents|antimitotic agents|mesh-ancestor
64823193|NCT01525771|Mitosis Modulators|mitosis modulators|mesh-ancestor
64823194|NCT01525771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823195|NCT01525771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64823196|NCT01525771|Antimetabolites|antimetabolites|mesh-ancestor
64823197|NCT01525823|Metformin|metformin|mesh-list
64823198|NCT01525823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64823199|NCT01525823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823200|NCT01525836|Rituximab|rituximab|mesh-list
64823201|NCT01525836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64823202|NCT01525836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823203|NCT01525836|Immunologic Factors|immunologic factors|mesh-ancestor
64823204|NCT01525836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823205|NCT01525836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64823206|NCT01525888|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65494592|NCT01145976|Immunologic Factors|immunologic factors|mesh-ancestor
65494593|NCT01145976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823234|NCT01526070|Growth Inhibitors|growth inhibitors|mesh-ancestor
64823235|NCT01526070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823237|NCT01526083|Warfarin|warfarin|mesh-list
64823238|NCT01526083|Anticoagulants|anticoagulants|mesh-ancestor
64823239|NCT01526083|Anticonvulsants|anticonvulsants|mesh-ancestor
64823240|NCT01526083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64823241|NCT01526083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64823242|NCT01526083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64823243|NCT01526083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823259|NCT01526122|Aspirin|aspirin|mesh-list
64823260|NCT01526122|Clopidogrel|clopidogrel|mesh-list
64823261|NCT01526122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64823262|NCT01526122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64823263|NCT01526122|Analgesics|analgesics|mesh-ancestor
64823302|NCT01526161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64823303|NCT01526161|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64823304|NCT01526161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64591920|NCT01670318|Chromium|chromium|mesh-list
64823306|NCT01526174|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64823307|NCT01526174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64823308|NCT01526174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64823332|NCT01526317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64823333|NCT01526317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64823334|NCT01526369|Paclitaxel|paclitaxel|mesh-list
64823335|NCT01526369|Trastuzumab|trastuzumab|mesh-list
64823336|NCT01526369|Lapatinib|lapatinib|mesh-list
64823337|NCT01526369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64823338|NCT01526369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823339|NCT01526369|Tubulin Modulators|tubulin modulators|mesh-ancestor
64823340|NCT01526369|Antimitotic Agents|antimitotic agents|mesh-ancestor
64823341|NCT01526369|Mitosis Modulators|mitosis modulators|mesh-ancestor
64823342|NCT01526369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823343|NCT01526369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64823344|NCT01526369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64823345|NCT01526369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64823346|NCT01526395|Propofol|propofol|mesh-list
64823347|NCT01526395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65494594|NCT01145976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65494595|NCT01145976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64472774|NCT02790710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64823376|NCT01526525|Acetaminophen|acetaminophen|mesh-list
64823377|NCT01526525|Parecoxib|parecoxib|mesh-list
64823378|NCT01526525|Ketamine|ketamine|mesh-list
64823379|NCT01526525|Morphine|morphine|mesh-list
64823380|NCT01526525|Tramadol|tramadol|mesh-list
64823381|NCT01526525|Analgesics|analgesics|mesh-ancestor
64945449|NCT05619627|Anesthetics, General|anesthetics, general|mesh-list
64823382|NCT01526525|Sensory System Agents|sensory system agents|mesh-ancestor
64823383|NCT01526525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64823384|NCT01526525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823385|NCT01526525|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64823386|NCT01526525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64823387|NCT01526525|Anesthetics, General|anesthetics, general|mesh-ancestor
64823388|NCT01526525|Anesthetics|anesthetics|mesh-ancestor
64823389|NCT01526525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64823390|NCT01526525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64823391|NCT01526525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64823392|NCT01526525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64823393|NCT01526525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823394|NCT01526525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64823395|NCT01526525|Narcotics|narcotics|mesh-ancestor
64823396|NCT01526525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64823397|NCT01526525|Antipyretics|antipyretics|mesh-ancestor
64823398|NCT01526525|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64823399|NCT01526525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64823400|NCT01526525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64823401|NCT01526525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64823402|NCT01526525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64823403|NCT01526525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64823404|NCT01526564|Acetylcarnitine|acetylcarnitine|mesh-list
64823405|NCT01526564|Vitamin B Complex|vitamin b complex|mesh-ancestor
64823406|NCT01526564|Vitamins|vitamins|mesh-ancestor
64823407|NCT01526564|Micronutrients|micronutrients|mesh-ancestor
64823408|NCT01526564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823409|NCT01526564|Nootropic Agents|nootropic agents|mesh-ancestor
64823410|NCT01526616|Metformin|metformin|mesh-list
64823411|NCT01526616|Spironolactone|spironolactone|mesh-list
64823412|NCT01526616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64823415|NCT01526616|Hormone Antagonists|hormone antagonists|mesh-ancestor
64823416|NCT01526616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64823417|NCT01526616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64823418|NCT01526616|Diuretics|diuretics|mesh-ancestor
64823419|NCT01526616|Natriuretic Agents|natriuretic agents|mesh-ancestor
64823420|NCT01526694|Thalidomide|thalidomide|mesh-list
64823421|NCT01526694|Dexamethasone|dexamethasone|mesh-list
64823422|NCT01526694|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64823423|NCT01526694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64823424|NCT01526694|Antiemetics|antiemetics|mesh-ancestor
64823425|NCT01526694|Autonomic Agents|autonomic agents|mesh-ancestor
64434561|NCT02420717|Antiemetics|antiemetics|mesh-ancestor
64823460|NCT01526850|Immunologic Factors|immunologic factors|mesh-ancestor
64823461|NCT01526850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823462|NCT01526850|Antifungal Agents|antifungal agents|mesh-ancestor
64823463|NCT01526850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494596|NCT01145976|Alkylating Agents|alkylating agents|mesh-ancestor
64823464|NCT01526850|Dermatologic Agents|dermatologic agents|mesh-ancestor
64823465|NCT01526850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64823476|NCT01526941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64823477|NCT01526941|Insulin Aspart|insulin aspart|mesh-list
64823478|NCT01526941|Insulin, Long-Acting|insulin, long-acting|mesh-list
64823479|NCT01526941|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64823480|NCT01526941|Biphasic Insulins|biphasic insulins|mesh-list
64823481|NCT01526941|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64823482|NCT01526941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64823483|NCT01526941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823503|NCT01527019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64823504|NCT01527032|Thalidomide|thalidomide|mesh-list
64823505|NCT01527032|Dexamethasone|dexamethasone|mesh-list
64823506|NCT01527032|Melphalan|melphalan|mesh-list
64823507|NCT01527032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64823508|NCT01527032|Antiemetics|antiemetics|mesh-ancestor
64823509|NCT01527032|Autonomic Agents|autonomic agents|mesh-ancestor
64823510|NCT01527032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64823511|NCT01527032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823512|NCT01527032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64823513|NCT01527032|Glucocorticoids|glucocorticoids|mesh-ancestor
64823514|NCT01527032|Hormones|hormones|mesh-ancestor
64823515|NCT01527032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64823516|NCT01527032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64823517|NCT01527032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823518|NCT01527032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64823519|NCT01527032|Alkylating Agents|alkylating agents|mesh-ancestor
64823520|NCT01527032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823521|NCT01527032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64823522|NCT01527032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64823523|NCT01527032|Immunologic Factors|immunologic factors|mesh-ancestor
64823524|NCT01527032|Leprostatic Agents|leprostatic agents|mesh-ancestor
64823525|NCT01527032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64823526|NCT01527032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64823527|NCT01527032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64592143|NCT01672112|Analgesics|analgesics|mesh-ancestor
64823541|NCT01527279|Histamine Antagonists|histamine antagonists|mesh-ancestor
64823542|NCT01527279|Histamine Agents|histamine agents|mesh-ancestor
64823543|NCT01527279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64823544|NCT01527279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823545|NCT01527279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823546|NCT01527279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64823547|NCT01527305|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64823548|NCT01527305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64823553|NCT01527305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64823554|NCT01527305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64823555|NCT01527305|Serotonin Agents|serotonin agents|mesh-ancestor
64823556|NCT01527305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64823557|NCT01527305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823559|NCT01527305|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64823560|NCT01527305|Dopamine Agents|dopamine agents|mesh-ancestor
64823561|NCT01527318|Clofibric Acid|clofibric acid|mesh-list
64823562|NCT01527318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64823563|NCT01527318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64823564|NCT01527318|Antimetabolites|antimetabolites|mesh-ancestor
64823565|NCT01527318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823566|NCT01527318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64823567|NCT01527422|Prednisone|prednisone|mesh-list
64823568|NCT01527422|Cyclophosphamide|cyclophosphamide|mesh-list
64823569|NCT01527422|Doxorubicin|doxorubicin|mesh-list
64823570|NCT01527422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64823571|NCT01527422|Vincristine|vincristine|mesh-list
64823572|NCT01527422|Sargramostim|sargramostim|mesh-list
64823573|NCT01527422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64823574|NCT01527422|Immunologic Factors|immunologic factors|mesh-ancestor
64823575|NCT01527422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823576|NCT01527422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64823577|NCT01527422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64823578|NCT01527422|Alkylating Agents|alkylating agents|mesh-ancestor
64823579|NCT01527422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823580|NCT01527422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823581|NCT01527422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64823582|NCT01527422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64823583|NCT01527422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64823584|NCT01527422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64823585|NCT01527422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951968|NCT00028028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64951969|NCT00028028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951970|NCT00028028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64951971|NCT00028028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951972|NCT00028028|Antifungal Agents|antifungal agents|mesh-ancestor
64951973|NCT00028028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951974|NCT00028028|Immunologic Factors|immunologic factors|mesh-ancestor
64951975|NCT00028028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951976|NCT00028106|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64951977|NCT00028106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823586|NCT01527422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64823587|NCT01527422|Glucocorticoids|glucocorticoids|mesh-ancestor
64823588|NCT01527422|Hormones|hormones|mesh-ancestor
64434726|NCT01624467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823606|NCT01527474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823608|NCT01527474|Serotonin Agents|serotonin agents|mesh-ancestor
64823609|NCT01527474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823610|NCT01527474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64823611|NCT01527474|Antidepressive Agents|antidepressive agents|mesh-ancestor
64823612|NCT01527474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64823613|NCT01527539|Insulin Aspart|insulin aspart|mesh-list
64823614|NCT01527539|Biphasic Insulins|biphasic insulins|mesh-list
64823615|NCT01527539|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64823616|NCT01527539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64823617|NCT01527539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823618|NCT01527552|Insulin Aspart|insulin aspart|mesh-list
64823619|NCT01527552|Biphasic Insulins|biphasic insulins|mesh-list
64823620|NCT01527552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64823622|NCT01527565|Insulin Aspart|insulin aspart|mesh-list
64823656|NCT01527734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64823657|NCT01527734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823658|NCT01527786|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64823659|NCT01527786|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64823660|NCT01527786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64823661|NCT01527786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64823662|NCT01527786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823663|NCT01527786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64823664|NCT01527786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823665|NCT01527786|Antidepressive Agents|antidepressive agents|mesh-ancestor
64823666|NCT01527786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64823668|NCT01527864|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64823669|NCT01527864|Carboplatin|carboplatin|mesh-list
64823670|NCT01527864|Endostatins|endostatins|mesh-list
64823671|NCT01527864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64823672|NCT01527864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823673|NCT01527864|Tubulin Modulators|tubulin modulators|mesh-ancestor
64823674|NCT01527864|Antimitotic Agents|antimitotic agents|mesh-ancestor
64823675|NCT01527864|Mitosis Modulators|mitosis modulators|mesh-ancestor
64823676|NCT01527864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823677|NCT01527864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64823678|NCT01527864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64823682|NCT01527890|Fentanyl|fentanyl|mesh-list
64823706|NCT01527903|GABA Modulators|gaba modulators|mesh-ancestor
64823707|NCT01527903|GABA Agents|gaba agents|mesh-ancestor
64823708|NCT01527903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64823709|NCT01527903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823714|NCT01527968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823715|NCT01527968|Hemostatics|hemostatics|mesh-ancestor
64823716|NCT01527968|Coagulants|coagulants|mesh-ancestor
64823717|NCT01527994|Aprepitant|aprepitant|mesh-list
64823718|NCT01527994|Antiemetics|antiemetics|mesh-ancestor
64823719|NCT01527994|Autonomic Agents|autonomic agents|mesh-ancestor
64823720|NCT01527994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64823721|NCT01527994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823722|NCT01527994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64823723|NCT01527994|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64823724|NCT01527994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64823725|NCT01527994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823726|NCT01528007|Naltrexone|naltrexone|mesh-list
64823727|NCT01528007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64823728|NCT01528007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64823729|NCT01528007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823730|NCT01528007|Sensory System Agents|sensory system agents|mesh-ancestor
64823731|NCT01528007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64823732|NCT01528137|Lactoferrin|lactoferrin|mesh-list
64823733|NCT01528137|Talactoferrin alfa|talactoferrin alfa|mesh-list
64823734|NCT01528137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64472779|NCT02779855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64823755|NCT01528176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823756|NCT01528176|Vitamins|vitamins|mesh-ancestor
64823757|NCT01528176|Micronutrients|micronutrients|mesh-ancestor
64823758|NCT01528176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64823759|NCT01528371|Midazolam|midazolam|mesh-list
64823760|NCT01528371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64823761|NCT01528371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64823762|NCT01528371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64823763|NCT01528371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823764|NCT01528371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64823765|NCT01528371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64823766|NCT01528371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64823767|NCT01528371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64823768|NCT01528371|Anesthetics, General|anesthetics, general|mesh-ancestor
64823769|NCT01528371|Anesthetics|anesthetics|mesh-ancestor
64823770|NCT01528371|GABA Modulators|gaba modulators|mesh-ancestor
64823771|NCT01528371|GABA Agents|gaba agents|mesh-ancestor
64823772|NCT01528371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64823773|NCT01528371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823774|NCT01528501|Panobinostat|panobinostat|mesh-list
64823775|NCT01528501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823776|NCT01528501|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64823777|NCT01528501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64823778|NCT01528501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823779|NCT01528540|Pregabalin|pregabalin|mesh-list
64823780|NCT01528540|Antioxidants|antioxidants|mesh-list
64823781|NCT01528540|Analgesics|analgesics|mesh-ancestor
64434914|NCT01787188|Meloxicam|meloxicam|mesh-list
64823789|NCT01528540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64823791|NCT01528540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64823792|NCT01528540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64823793|NCT01528540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64823794|NCT01528540|Protective Agents|protective agents|mesh-ancestor
64823795|NCT01528618|Gemcitabine|gemcitabine|mesh-list
64823796|NCT01528618|Cisplatin|cisplatin|mesh-list
64823803|NCT01528618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64823804|NCT01528618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64823805|NCT01528618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64823806|NCT01528618|Immunologic Factors|immunologic factors|mesh-ancestor
64823807|NCT01528618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823808|NCT01528644|Calcium, Dietary|calcium, dietary|mesh-list
64823809|NCT01528644|Iron|iron|mesh-list
64823810|NCT01528644|Ferrous gluconate|ferrous gluconate|mesh-list
64823811|NCT01528644|Calcium|calcium|mesh-list
64823812|NCT01528644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64823813|NCT01528644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823814|NCT01528644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64823815|NCT01528644|Trace Elements|trace elements|mesh-ancestor
65494597|NCT01145976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823816|NCT01528644|Micronutrients|micronutrients|mesh-ancestor
64823817|NCT01528644|Hematinics|hematinics|mesh-ancestor
64823818|NCT01528722|Bupivacaine|bupivacaine|mesh-list
64823819|NCT01528722|Anesthetics, Local|anesthetics, local|mesh-ancestor
64823820|NCT01528722|Anesthetics|anesthetics|mesh-ancestor
64823823|NCT01528722|Sensory System Agents|sensory system agents|mesh-ancestor
64823875|NCT01529125|Nevirapine|nevirapine|mesh-list
64823876|NCT01529125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64823877|NCT01529125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64823878|NCT01529125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64823879|NCT01529125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823880|NCT01529125|Antiviral Agents|antiviral agents|mesh-ancestor
64823881|NCT01529125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64823882|NCT01529125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64823883|NCT01529125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64823884|NCT01529125|Antimetabolites|antimetabolites|mesh-ancestor
64823885|NCT01529125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64823886|NCT01529125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64823887|NCT01529138|Sirolimus|sirolimus|mesh-list
64823888|NCT01529138|Axitinib|axitinib|mesh-list
64823889|NCT01529138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64823890|NCT01529138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64823891|NCT01529138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64823892|NCT01529138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823893|NCT01529138|Antifungal Agents|antifungal agents|mesh-ancestor
64823894|NCT01529138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64823895|NCT01529138|Immunologic Factors|immunologic factors|mesh-ancestor
64823896|NCT01529138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823897|NCT01529138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64823898|NCT01529138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64823899|NCT01529138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823900|NCT01529164|Leucovorin|leucovorin|mesh-list
64823901|NCT01529164|Fluorouracil|fluorouracil|mesh-list
64823902|NCT01529164|Oxaliplatin|oxaliplatin|mesh-list
64823903|NCT01529164|Endostar protein|endostar protein|mesh-list
64823904|NCT01529164|Endostatins|endostatins|mesh-list
64472798|NCT02661035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472799|NCT02661035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823909|NCT01529164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64823910|NCT01529164|Immunologic Factors|immunologic factors|mesh-ancestor
64823911|NCT01529164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823912|NCT01529164|Antidotes|antidotes|mesh-ancestor
64823913|NCT01529164|Protective Agents|protective agents|mesh-ancestor
64823937|NCT01529177|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64823938|NCT01529177|Fertility Agents|fertility agents|mesh-ancestor
64823939|NCT01529177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64823940|NCT01529177|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64823941|NCT01529177|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64823942|NCT01529190|Pregabalin|pregabalin|mesh-list
64823943|NCT01529190|Analgesics|analgesics|mesh-ancestor
64823944|NCT01529190|Sensory System Agents|sensory system agents|mesh-ancestor
64823945|NCT01529190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64823946|NCT01529190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823947|NCT01529190|Anticonvulsants|anticonvulsants|mesh-ancestor
64823948|NCT01529190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64823949|NCT01529190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64823950|NCT01529190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823951|NCT01529190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65494599|NCT01145976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65494600|NCT01238952|Carboplatin|carboplatin|mesh-list
65494601|NCT01238952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494602|NCT05158998|Propofol|propofol|mesh-list
65494603|NCT05158998|Sevoflurane|sevoflurane|mesh-list
65494604|NCT05158998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65494605|NCT05158998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65494606|NCT05158998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494607|NCT05158998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65494608|NCT05158998|Anesthetics, General|anesthetics, general|mesh-ancestor
65494609|NCT05158998|Anesthetics|anesthetics|mesh-ancestor
65494610|NCT05158998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65494611|NCT05158998|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64823992|NCT01529242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64823993|NCT01529242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823994|NCT01529242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64823995|NCT01529242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64823996|NCT01529242|Histamine Antagonists|histamine antagonists|mesh-ancestor
64823997|NCT01529242|Histamine Agents|histamine agents|mesh-ancestor
64823998|NCT01529255|Telbivudine|telbivudine|mesh-list
64823999|NCT01529255|Antiviral Agents|antiviral agents|mesh-ancestor
64824000|NCT01529255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824001|NCT01529255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64824002|NCT01529255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824003|NCT01529255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824004|NCT01529294|Iloperidone|iloperidone|mesh-list
64824005|NCT01529294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64824006|NCT01529294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64824007|NCT01529294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64824008|NCT01529294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824009|NCT01529294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64824010|NCT01529320|Methylprednisolone|methylprednisolone|mesh-list
64824011|NCT01529320|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64824012|NCT01529320|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64824017|NCT01529320|Prednisolone phosphate|prednisolone phosphate|mesh-list
64824018|NCT01529320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64824019|NCT01529320|Antiemetics|antiemetics|mesh-ancestor
64824020|NCT01529320|Autonomic Agents|autonomic agents|mesh-ancestor
64824021|NCT01529320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824022|NCT01529320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824023|NCT01529320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64824024|NCT01529320|Glucocorticoids|glucocorticoids|mesh-ancestor
64824025|NCT01529320|Hormones|hormones|mesh-ancestor
64824026|NCT01529320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64824027|NCT01529320|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64824028|NCT01529320|Protective Agents|protective agents|mesh-ancestor
64435159|NCT01608724|Protease Inhibitors|protease inhibitors|mesh-ancestor
64824035|NCT01529476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64824036|NCT01529476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824037|NCT01529476|Renal Agents|renal agents|mesh-ancestor
64824038|NCT01529476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64824039|NCT01529476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64824040|NCT01529476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64824041|NCT01529476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824042|NCT01529476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824043|NCT01529476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824044|NCT01529476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64824045|NCT01529476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64824046|NCT01529528|Anagliptin|anagliptin|mesh-list
64824054|NCT01529541|Anagliptin|anagliptin|mesh-list
64824068|NCT01529554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824069|NCT01529619|Rivastigmine|rivastigmine|mesh-list
64824070|NCT01529619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64824071|NCT01529619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824072|NCT01529619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824073|NCT01529619|Cholinergic Agents|cholinergic agents|mesh-ancestor
64824074|NCT01529619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64824075|NCT01529619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824076|NCT01529619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64824077|NCT01529619|Protective Agents|protective agents|mesh-ancestor
64824078|NCT01529710|Praziquantel|praziquantel|mesh-list
64824079|NCT01529710|Anthelmintics|anthelmintics|mesh-ancestor
64824080|NCT01529710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64824081|NCT01529710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824082|NCT01529788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64824083|NCT01529788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64824084|NCT01529788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64824085|NCT01529788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824086|NCT01529788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824087|NCT01529788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64824088|NCT01529788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64824089|NCT01529788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824090|NCT01529788|Cholinergic Agents|cholinergic agents|mesh-ancestor
64824091|NCT01529788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64824092|NCT01529892|Methamphetamine|methamphetamine|mesh-list
64824093|NCT01529892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64824094|NCT01529892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824095|NCT01529892|Sympathomimetics|sympathomimetics|mesh-ancestor
64824118|NCT01530022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64824120|NCT01530022|Sensory System Agents|sensory system agents|mesh-ancestor
64824121|NCT01530022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824122|NCT01530022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64824124|NCT01530048|Insulin Aspart|insulin aspart|mesh-list
64824130|NCT01530126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64824131|NCT01530126|Growth Substances|growth substances|mesh-ancestor
64824132|NCT01530126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824133|NCT01530152|Lidocaine|lidocaine|mesh-list
64824134|NCT01530152|Anesthetics, Local|anesthetics, local|mesh-ancestor
64824135|NCT01530152|Anesthetics|anesthetics|mesh-ancestor
64824136|NCT01530152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64824137|NCT01530152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824138|NCT01530152|Sensory System Agents|sensory system agents|mesh-ancestor
64824139|NCT01530152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824140|NCT01530152|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64824141|NCT01530152|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64824142|NCT01530152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64824143|NCT01530152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64824144|NCT01530152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824159|NCT01530230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64824160|NCT01530230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824162|NCT01530295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824163|NCT01530295|Tubulin Modulators|tubulin modulators|mesh-ancestor
64824164|NCT01530295|Antimitotic Agents|antimitotic agents|mesh-ancestor
64824165|NCT01530295|Mitosis Modulators|mitosis modulators|mesh-ancestor
64824166|NCT01530295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824167|NCT01530308|Dopamine|dopamine|mesh-list
64824168|NCT01530308|Haloperidol|haloperidol|mesh-list
64824169|NCT01530308|Haloperidol decanoate|haloperidol decanoate|mesh-list
64824170|NCT01530308|Antipsychotic Agents|antipsychotic agents|mesh-list
64824171|NCT01530308|Dopamine Antagonists|dopamine antagonists|mesh-list
64824172|NCT01530308|Antiemetics|antiemetics|mesh-ancestor
64824173|NCT01530308|Autonomic Agents|autonomic agents|mesh-ancestor
64824174|NCT01530308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824175|NCT01530308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824176|NCT01530308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64824177|NCT01530308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64824178|NCT01530308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64951978|NCT00028106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951979|NCT00028106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951980|NCT00028106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64951981|NCT00056082|Celecoxib|celecoxib|mesh-list
64951982|NCT00056082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64824179|NCT01530308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64824180|NCT01530308|Dopamine Agents|dopamine agents|mesh-ancestor
64824181|NCT01530308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64562538|NCT01222299|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64824182|NCT01530308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824183|NCT01530308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64824184|NCT01530308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64824185|NCT01530308|Sympathomimetics|sympathomimetics|mesh-ancestor
64824186|NCT01530308|Protective Agents|protective agents|mesh-ancestor
64824188|NCT01530386|Anticonvulsants|anticonvulsants|mesh-ancestor
64824189|NCT01530386|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64824190|NCT01530386|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64824191|NCT01530386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64824192|NCT01530386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824193|NCT01530438|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64824194|NCT01530438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64824195|NCT01530438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824196|NCT01530451|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64824197|NCT01530451|Hemostatics|hemostatics|mesh-ancestor
64824198|NCT01530451|Coagulants|coagulants|mesh-ancestor
64824199|NCT01530451|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64824200|NCT01530451|Natriuretic Agents|natriuretic agents|mesh-ancestor
64824201|NCT01530451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824202|NCT01530490|Cabergoline|cabergoline|mesh-list
64824203|NCT01530490|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
64824204|NCT01530490|Plasma Substitutes|plasma substitutes|mesh-ancestor
64824205|NCT01530490|Blood Substitutes|blood substitutes|mesh-ancestor
64824216|NCT01530503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64824217|NCT01530503|Antimetabolites|antimetabolites|mesh-ancestor
64824218|NCT01530503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824219|NCT01530503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824220|NCT01530503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64824221|NCT01530503|Alkylating Agents|alkylating agents|mesh-ancestor
64824228|NCT01530542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824229|NCT01530542|Analgesics|analgesics|mesh-ancestor
64824230|NCT01530542|Sensory System Agents|sensory system agents|mesh-ancestor
64824231|NCT01530542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824232|NCT01530555|Thymoglobulin|thymoglobulin|mesh-list
64824233|NCT01530555|Immunologic Factors|immunologic factors|mesh-ancestor
64824234|NCT01530555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824235|NCT01530555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64824236|NCT01530594|Lenalidomide|lenalidomide|mesh-list
64824237|NCT01530594|Bortezomib|bortezomib|mesh-list
64824238|NCT01530594|Immunologic Factors|immunologic factors|mesh-ancestor
64824239|NCT01530594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824240|NCT01530594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64824241|NCT01530594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64824242|NCT01530594|Growth Substances|growth substances|mesh-ancestor
64824243|NCT01530594|Growth Inhibitors|growth inhibitors|mesh-ancestor
64824244|NCT01530594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824245|NCT01530607|Cyclophosphamide|cyclophosphamide|mesh-list
64824246|NCT01530607|Goserelin|goserelin|mesh-list
64824247|NCT01530607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64824248|NCT01530607|Immunologic Factors|immunologic factors|mesh-ancestor
64824249|NCT01530607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824250|NCT01530607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64824251|NCT01530607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64824252|NCT01530607|Alkylating Agents|alkylating agents|mesh-ancestor
64824253|NCT01530607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824254|NCT01530607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824255|NCT01530607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64824256|NCT01530607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64824257|NCT01530620|Propiverine|propiverine|mesh-list
64824258|NCT01530620|Parasympatholytics|parasympatholytics|mesh-ancestor
64824259|NCT01530620|Autonomic Agents|autonomic agents|mesh-ancestor
64824260|NCT01530620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824262|NCT01530620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64472803|NCT02661035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472804|NCT02661035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64472805|NCT02661035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64472806|NCT02661035|Antitubercular Agents|antitubercular agents|mesh-ancestor
64824265|NCT01530620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64824266|NCT01530620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824267|NCT01530620|Urological Agents|urological agents|mesh-ancestor
64824268|NCT01530698|Vaccines|vaccines|mesh-list
64824269|NCT01530698|Immunologic Factors|immunologic factors|mesh-ancestor
64824270|NCT01530698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824271|NCT01530711|Terlipressin|terlipressin|mesh-list
64824282|NCT01530763|Ceftriaxone|ceftriaxone|mesh-list
64824283|NCT01530763|Clavulanic Acid|clavulanic acid|mesh-list
64824284|NCT01530763|Clavulanic Acids|clavulanic acids|mesh-list
64824285|NCT01530763|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64824286|NCT01530763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64824287|NCT01530763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64824288|NCT01530763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824289|NCT01530763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64824290|NCT01530763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824291|NCT01530763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824292|NCT01530815|Bupivacaine|bupivacaine|mesh-list
64824316|NCT01531049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64824317|NCT01531049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824318|NCT01531114|Ticagrelor|ticagrelor|mesh-list
64824319|NCT01531114|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64824320|NCT01531114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64824321|NCT01531114|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64824322|NCT01531114|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64824323|NCT01531114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64824324|NCT01531114|Purinergic Agents|purinergic agents|mesh-ancestor
64824325|NCT01531114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64824326|NCT01531114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824327|NCT01531114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824328|NCT01531140|Bisacodyl|bisacodyl|mesh-list
64824329|NCT01531140|Senna Extract|senna extract|mesh-list
64824330|NCT01531140|Sennosides|sennosides|mesh-list
64824331|NCT01531140|Cathartics|cathartics|mesh-ancestor
64824332|NCT01531140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64824333|NCT01531140|Laxatives|laxatives|mesh-ancestor
64824334|NCT01531166|Interferons|interferons|mesh-list
64824335|NCT01531166|Interferon-alpha|interferon-alpha|mesh-list
64824345|NCT01531192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824346|NCT01531192|Antifungal Agents|antifungal agents|mesh-ancestor
65494613|NCT02282358|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65494614|NCT02282358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494615|NCT02282358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494616|NCT01144260|Bafetinib|bafetinib|mesh-list
64472811|NCT02661035|Antioxidants|antioxidants|mesh-ancestor
64824358|NCT01531244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824359|NCT01531244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824360|NCT01531244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64824361|NCT01531244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64824362|NCT01531244|Immunologic Factors|immunologic factors|mesh-ancestor
64824363|NCT01531244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824364|NCT01531244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64824365|NCT01531244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824366|NCT01531244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64824367|NCT01531244|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64824368|NCT01531244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824369|NCT01531244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64824371|NCT01531309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64824372|NCT01531309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64824373|NCT01531309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824374|NCT01531322|Vaccines|vaccines|mesh-list
64824375|NCT01531322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64824376|NCT01531322|Immunologic Factors|immunologic factors|mesh-ancestor
64824377|NCT01531322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824378|NCT01531361|Sorafenib|sorafenib|mesh-list
64824379|NCT01531361|Vemurafenib|vemurafenib|mesh-list
64824380|NCT01531361|Crizotinib|crizotinib|mesh-list
64824381|NCT01531361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824382|NCT01531361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64824383|NCT01531361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824384|NCT01531361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824385|NCT01531452|Oxaliplatin|oxaliplatin|mesh-list
64824386|NCT01531452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824387|NCT01531517|Pantothenic Acid|pantothenic acid|mesh-list
64824388|NCT01531517|Propolis|propolis|mesh-list
64824389|NCT01531517|Vitamin B Complex|vitamin b complex|mesh-ancestor
64824390|NCT01531517|Vitamins|vitamins|mesh-ancestor
64824391|NCT01531517|Micronutrients|micronutrients|mesh-ancestor
64824392|NCT01531517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824393|NCT01531517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824399|NCT01531569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64824400|NCT01531569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824401|NCT01531595|Bevacizumab|bevacizumab|mesh-list
64824402|NCT01531595|Oxaliplatin|oxaliplatin|mesh-list
64824403|NCT01531595|Irinotecan|irinotecan|mesh-list
64824404|NCT01531595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64824417|NCT01531647|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64824418|NCT01531647|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64824419|NCT01531647|Protease Inhibitors|protease inhibitors|mesh-ancestor
64824420|NCT01531647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824421|NCT01531647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824422|NCT01531647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65494619|NCT01144260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494620|NCT01239498|Lidocaine|lidocaine|mesh-list
65494621|NCT01239498|Epinephrine|epinephrine|mesh-list
65494622|NCT01239498|Racepinephrine|racepinephrine|mesh-list
65494623|NCT01239498|Anesthetics|anesthetics|mesh-list
65494624|NCT01239498|Epinephryl borate|epinephryl borate|mesh-list
65494625|NCT01239498|Anesthetics, Local|anesthetics, local|mesh-ancestor
64824423|NCT01531647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64824424|NCT01531647|Antiviral Agents|antiviral agents|mesh-ancestor
64824425|NCT01531647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824426|NCT01531647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64824427|NCT01531647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64824428|NCT01531647|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64824429|NCT01531647|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64824452|NCT01531764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64824453|NCT01531764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824454|NCT01531777|Apatinib|apatinib|mesh-list
64824455|NCT01531777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824456|NCT01531777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64824457|NCT01531777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824458|NCT01531777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824459|NCT01531790|Carboplatin|carboplatin|mesh-list
64824460|NCT01531790|Pemetrexed|pemetrexed|mesh-list
64824461|NCT01531790|Endostar protein|endostar protein|mesh-list
64824462|NCT01531790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824463|NCT01531790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824464|NCT01531790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824465|NCT01531790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64824466|NCT01531790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64824472|NCT01531829|Heparin|heparin|mesh-list
64824473|NCT01531829|Plasminogen|plasminogen|mesh-list
64824474|NCT01531829|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64824475|NCT01531829|Tinzaparin|tinzaparin|mesh-list
64824476|NCT01531829|Dalteparin|dalteparin|mesh-list
64824477|NCT01531829|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64824478|NCT01531829|Nadroparin|nadroparin|mesh-list
64824479|NCT01531829|Anticoagulants|anticoagulants|mesh-ancestor
64824480|NCT01531829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64824481|NCT01531829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64824482|NCT01531829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824509|NCT01532115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64824510|NCT01532115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64824511|NCT01532115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824512|NCT01532115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824513|NCT01532115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824514|NCT01532115|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64824515|NCT01532115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64824516|NCT01532115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64824517|NCT01532154|4-Aminopyridine|4-aminopyridine|mesh-list
64824518|NCT01532154|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64824519|NCT01532154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64824520|NCT01532154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824521|NCT01532232|Varenicline|varenicline|mesh-list
64824522|NCT01532232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64824523|NCT01532232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64824524|NCT01532232|Cholinergic Agents|cholinergic agents|mesh-ancestor
64824525|NCT01532232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64824526|NCT01532232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824527|NCT01532232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824528|NCT01532297|Dialysis Solutions|dialysis solutions|mesh-list
64824529|NCT01532297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64824530|NCT01532336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64824531|NCT01532466|Rocuronium|rocuronium|mesh-list
64824532|NCT01532466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64824533|NCT01532466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64824534|NCT01532466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64824535|NCT01532466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824575|NCT01532804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64824576|NCT01532804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824577|NCT01532843|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64824578|NCT01532843|Antiviral Agents|antiviral agents|mesh-ancestor
64824579|NCT01532843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824580|NCT01532856|Thalidomide|thalidomide|mesh-list
64824581|NCT01532856|Dexamethasone|dexamethasone|mesh-list
64824582|NCT01532856|Dexamethasone acetate|dexamethasone acetate|mesh-list
64824583|NCT01532856|Prednisone|prednisone|mesh-list
64824584|NCT01532856|Cyclophosphamide|cyclophosphamide|mesh-list
64824585|NCT01532856|Melphalan|melphalan|mesh-list
64824586|NCT01532856|BB 1101|bb 1101|mesh-list
64824587|NCT01532856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64824588|NCT01532856|Immunologic Factors|immunologic factors|mesh-ancestor
64824589|NCT01532856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824590|NCT01532856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64824591|NCT01532856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64824600|NCT01532856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64824601|NCT01532856|Glucocorticoids|glucocorticoids|mesh-ancestor
64824602|NCT01532856|Hormones|hormones|mesh-ancestor
64824603|NCT01532856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64824604|NCT01532856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64824605|NCT01532856|Protease Inhibitors|protease inhibitors|mesh-ancestor
64824606|NCT01532856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824607|NCT01532856|Leprostatic Agents|leprostatic agents|mesh-ancestor
64472815|NCT02648477|Pembrolizumab|pembrolizumab|mesh-list
64824608|NCT01532856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64824609|NCT01532856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824610|NCT01532856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64824611|NCT01532856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64824612|NCT01532856|Growth Substances|growth substances|mesh-ancestor
64824613|NCT01532856|Growth Inhibitors|growth inhibitors|mesh-ancestor
64824628|NCT01533090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64824629|NCT01533090|Laxatives|laxatives|mesh-ancestor
64824630|NCT01533129|Testosterone|testosterone|mesh-list
64824631|NCT01533129|Androgens|androgens|mesh-ancestor
64824632|NCT01533129|Hormones|hormones|mesh-ancestor
64824633|NCT01533129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64824634|NCT01533129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824635|NCT01533155|Quinidine|quinidine|mesh-list
64824636|NCT01533155|Quinidine gluconate|quinidine gluconate|mesh-list
64824637|NCT01533155|Morphine|morphine|mesh-list
64824638|NCT01533155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64824639|NCT01533155|Narcotics|narcotics|mesh-ancestor
64824640|NCT01533155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64824641|NCT01533155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824642|NCT01533155|Analgesics|analgesics|mesh-ancestor
64824643|NCT01533155|Sensory System Agents|sensory system agents|mesh-ancestor
64824644|NCT01533155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824645|NCT01533155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64824646|NCT01533155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64824647|NCT01533155|Adrenergic Agents|adrenergic agents|mesh-ancestor
64824648|NCT01533155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64824649|NCT01533155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824650|NCT01533155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64824651|NCT01533155|Antimalarials|antimalarials|mesh-ancestor
64824652|NCT01533155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64824653|NCT01533155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64824654|NCT01533155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824655|NCT01533155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824656|NCT01533155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64824658|NCT01533155|Cholinergic Agents|cholinergic agents|mesh-ancestor
64824694|NCT01533272|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64824695|NCT01533272|Protease Inhibitors|protease inhibitors|mesh-ancestor
64824696|NCT01533272|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64824697|NCT01533272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64824698|NCT01533272|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64824699|NCT01533272|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64824700|NCT01533272|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64824701|NCT01533324|Leucovorin|leucovorin|mesh-list
65494626|NCT01239498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64472817|NCT02648477|Anastrozole|anastrozole|mesh-list
64824702|NCT01533324|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
64824703|NCT01533324|Antidotes|antidotes|mesh-ancestor
64824704|NCT01533324|Protective Agents|protective agents|mesh-ancestor
64824705|NCT01533324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824706|NCT01533324|Vitamin B Complex|vitamin b complex|mesh-ancestor
64824707|NCT01533324|Vitamins|vitamins|mesh-ancestor
64824708|NCT01533324|Micronutrients|micronutrients|mesh-ancestor
64824709|NCT01533376|Timolol|timolol|mesh-list
64824710|NCT01533376|Lubricant Eye Drops|lubricant eye drops|mesh-list
64824711|NCT01533376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64824712|NCT01533376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64824713|NCT01533376|Adrenergic Agents|adrenergic agents|mesh-ancestor
64824714|NCT01533376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64435869|NCT02006121|Apomorphine|apomorphine|mesh-list
64824726|NCT01533389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64824727|NCT01533389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824728|NCT01533389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824729|NCT01533389|Urological Agents|urological agents|mesh-ancestor
64824730|NCT01533441|Vitamin K|vitamin k|mesh-list
64824731|NCT01533441|Vitamin K 2|vitamin k 2|mesh-list
64824732|NCT01533441|Vitamin K 1|vitamin k 1|mesh-list
64824733|NCT01533441|Vitamins|vitamins|mesh-ancestor
64824734|NCT01533441|Micronutrients|micronutrients|mesh-ancestor
64824735|NCT01533441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824746|NCT01533545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64824747|NCT01533545|Adrenergic Agents|adrenergic agents|mesh-ancestor
64824748|NCT01533545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64824749|NCT01533545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824750|NCT01533545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824751|NCT01533545|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64824752|NCT01533545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64824753|NCT01533545|Autonomic Agents|autonomic agents|mesh-ancestor
64824754|NCT01533545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824755|NCT01533545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64824756|NCT01533545|Respiratory System Agents|respiratory system agents|mesh-ancestor
64824757|NCT01533545|Mydriatics|mydriatics|mesh-ancestor
64824758|NCT01533545|Sympathomimetics|sympathomimetics|mesh-ancestor
64824759|NCT01533545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64824760|NCT01533545|Anesthetics, Local|anesthetics, local|mesh-ancestor
64824761|NCT01533545|Anesthetics|anesthetics|mesh-ancestor
64824762|NCT01533545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64824763|NCT01533545|Sensory System Agents|sensory system agents|mesh-ancestor
64824764|NCT01533558|Caspofungin|caspofungin|mesh-list
64824765|NCT01533558|Antifungal Agents|antifungal agents|mesh-ancestor
64824766|NCT01533558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824767|NCT01533558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824768|NCT01533558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824769|NCT01533662|Phenylephrine|phenylephrine|mesh-list
64824770|NCT01533662|Oxymetazoline|oxymetazoline|mesh-list
64824771|NCT01533662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64824772|NCT01533662|Mydriatics|mydriatics|mesh-ancestor
64824773|NCT01533662|Autonomic Agents|autonomic agents|mesh-ancestor
64824808|NCT01533740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64824809|NCT01533740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64824810|NCT01533740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824811|NCT01533740|Antidotes|antidotes|mesh-ancestor
64824812|NCT01533740|Protective Agents|protective agents|mesh-ancestor
64824813|NCT01533740|Vitamin B Complex|vitamin b complex|mesh-ancestor
64824814|NCT01533740|Vitamins|vitamins|mesh-ancestor
64824815|NCT01533740|Micronutrients|micronutrients|mesh-ancestor
64824816|NCT01533740|Hematinics|hematinics|mesh-ancestor
64824817|NCT01533818|Amoxicillin|amoxicillin|mesh-list
64824818|NCT01533818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64824819|NCT01533818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824821|NCT01533870|Naloxegol|naloxegol|mesh-list
64824822|NCT01533870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64824823|NCT01533870|Antitubercular Agents|antitubercular agents|mesh-ancestor
64824824|NCT01533870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64824825|NCT01533870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824826|NCT01533870|Leprostatic Agents|leprostatic agents|mesh-ancestor
64824827|NCT01533870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64824828|NCT01533870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824829|NCT01533870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824830|NCT01533870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64824831|NCT01533870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64824832|NCT01533870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64824833|NCT01533870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64824834|NCT01533870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64824835|NCT01533870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64824836|NCT01533870|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64824837|NCT01533870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824838|NCT01533870|Sensory System Agents|sensory system agents|mesh-ancestor
64824862|NCT01534169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64824863|NCT01534169|Glucocorticoids|glucocorticoids|mesh-ancestor
64824866|NCT01534169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64824874|NCT01534312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64824875|NCT01534312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64824876|NCT01534312|Analgesics|analgesics|mesh-ancestor
64824877|NCT01534312|Sensory System Agents|sensory system agents|mesh-ancestor
64824878|NCT01534312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824879|NCT01534312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824880|NCT01534312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64824881|NCT01534312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64824882|NCT01534442|Atropine|atropine|mesh-list
64824883|NCT01534442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64824884|NCT01534442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64824885|NCT01534442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64824886|NCT01534442|Autonomic Agents|autonomic agents|mesh-ancestor
64824887|NCT01534442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824888|NCT01534442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824889|NCT01534442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64824920|NCT01534585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824921|NCT01534702|Cytarabine|cytarabine|mesh-list
64824922|NCT01534702|Clofarabine|clofarabine|mesh-list
64824923|NCT01534702|Idarubicin|idarubicin|mesh-list
64824924|NCT01534702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64824925|NCT01534702|Antimetabolites|antimetabolites|mesh-ancestor
64824926|NCT01534702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824927|NCT01534702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824928|NCT01534702|Antiviral Agents|antiviral agents|mesh-ancestor
64824929|NCT01534702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824949|NCT01534806|Analgesics|analgesics|mesh-ancestor
64824958|NCT01534845|Temozolomide|temozolomide|mesh-list
64824959|NCT01534845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64824960|NCT01534845|Alkylating Agents|alkylating agents|mesh-ancestor
64824961|NCT01534845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824962|NCT01534845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824963|NCT01534858|Polihexanide|polihexanide|mesh-list
64824964|NCT01534858|Betaine|betaine|mesh-list
64824965|NCT01534858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64824966|NCT01534858|Lipotropic Agents|lipotropic agents|mesh-ancestor
64824967|NCT01534858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64824968|NCT01534858|Antimetabolites|antimetabolites|mesh-ancestor
64824969|NCT01534858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824970|NCT01534858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64824971|NCT01534858|Disinfectants|disinfectants|mesh-ancestor
64824972|NCT01534858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824974|NCT01534884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64824975|NCT01534884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824976|NCT01534884|Immunologic Factors|immunologic factors|mesh-ancestor
64824977|NCT01534884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824978|NCT01534884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64824979|NCT01534949|Rituximab|rituximab|mesh-list
64824980|NCT01534949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64824981|NCT01534949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824982|NCT01534949|Immunologic Factors|immunologic factors|mesh-ancestor
64824983|NCT01534949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824984|NCT01534949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64824985|NCT01535027|Alendronate|alendronate|mesh-list
64824986|NCT01535027|Teriparatide|teriparatide|mesh-list
64824987|NCT01535027|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64824988|NCT01535027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64824989|NCT01535027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825016|NCT01535157|Antifungal Agents|antifungal agents|mesh-ancestor
64825017|NCT01535157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64825018|NCT01535157|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64825019|NCT01535157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64825020|NCT01535157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825021|NCT01535157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825022|NCT01535157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64825023|NCT01535157|Hormone Antagonists|hormone antagonists|mesh-ancestor
64825024|NCT01535157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64825025|NCT01535157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825026|NCT01535157|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64825027|NCT01535157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494630|NCT01239498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64825028|NCT01535157|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64825029|NCT01535157|Protective Agents|protective agents|mesh-ancestor
64825030|NCT01535170|Lactoferrin|lactoferrin|mesh-list
64825031|NCT01535170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64825032|NCT01535183|Irinotecan|irinotecan|mesh-list
64825033|NCT01535183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64825034|NCT01535183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64825035|NCT01535183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825036|NCT01535183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825037|NCT01535183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825038|NCT01535417|Celecoxib|celecoxib|mesh-list
64557488|NCT02555007|Mitosis Modulators|mitosis modulators|mesh-ancestor
64825039|NCT01535417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64825040|NCT01535417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64825041|NCT01535417|Analgesics|analgesics|mesh-ancestor
64825042|NCT01535417|Sensory System Agents|sensory system agents|mesh-ancestor
64825043|NCT01535417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64825044|NCT01535417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825045|NCT01535417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64825046|NCT01535417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64825049|NCT01535417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825051|NCT01535469|Fluconazole|fluconazole|mesh-list
64825052|NCT01535469|Antifungal Agents|antifungal agents|mesh-ancestor
64825053|NCT01535469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64825054|NCT01535469|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64825055|NCT01535469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64825073|NCT01535495|Vasodilator Agents|vasodilator agents|mesh-ancestor
64825075|NCT01535547|Tacrolimus|tacrolimus|mesh-list
64825076|NCT01535547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64825077|NCT01535547|Immunologic Factors|immunologic factors|mesh-ancestor
64825078|NCT01535547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825079|NCT01535547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64825080|NCT01535547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825081|NCT01535547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825082|NCT01535547|Antifungal Agents|antifungal agents|mesh-ancestor
64825083|NCT01535547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64825084|NCT01535612|Insulin|insulin|mesh-list
64825085|NCT01535612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64825086|NCT01535612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825087|NCT01535677|Metformin|metformin|mesh-list
64825088|NCT01535677|Dapagliflozin|dapagliflozin|mesh-list
64825130|NCT01535872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825131|NCT01535989|Sirolimus|sirolimus|mesh-list
64825132|NCT01535989|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
64825133|NCT01535989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64825134|NCT01535989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64825135|NCT01535989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64825136|NCT01535989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825137|NCT01535989|Antifungal Agents|antifungal agents|mesh-ancestor
64825138|NCT01535989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64825139|NCT01535989|Immunologic Factors|immunologic factors|mesh-ancestor
64825140|NCT01535989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825141|NCT01535989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64825142|NCT01536002|Propofol|propofol|mesh-list
64825143|NCT01536002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64825144|NCT01536002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64825145|NCT01536002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825146|NCT01536002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64825147|NCT01536002|Anesthetics, General|anesthetics, general|mesh-ancestor
64825148|NCT01536002|Anesthetics|anesthetics|mesh-ancestor
64825149|NCT01536028|Insulin|insulin|mesh-list
64825150|NCT01536028|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64825151|NCT01536028|Insulin Aspart|insulin aspart|mesh-list
64825152|NCT01536028|Insulin, Long-Acting|insulin, long-acting|mesh-list
64825153|NCT01536028|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64825154|NCT01536028|Biphasic Insulins|biphasic insulins|mesh-list
64825155|NCT01536028|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64825156|NCT01536028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64825157|NCT01536028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825158|NCT01536054|Sirolimus|sirolimus|mesh-list
64825159|NCT01536054|Sargramostim|sargramostim|mesh-list
64825160|NCT01536054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64825161|NCT01536054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64825162|NCT01536054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64825172|NCT01536132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64825173|NCT01536132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825174|NCT01536132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825175|NCT01536132|Protective Agents|protective agents|mesh-ancestor
64825176|NCT01536132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825177|NCT01536158|Acetaminophen|acetaminophen|mesh-list
64825178|NCT01536158|Ibuprofen|ibuprofen|mesh-list
64825194|NCT01536223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825195|NCT01536223|Tubulin Modulators|tubulin modulators|mesh-ancestor
64825196|NCT01536223|Antimitotic Agents|antimitotic agents|mesh-ancestor
64825197|NCT01536223|Mitosis Modulators|mitosis modulators|mesh-ancestor
64825198|NCT01536223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825199|NCT01536223|Antimetabolites|antimetabolites|mesh-ancestor
64825271|NCT01536626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64825272|NCT01536626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825273|NCT01536639|Insulin Aspart|insulin aspart|mesh-list
64825274|NCT01536639|Biphasic Insulins|biphasic insulins|mesh-list
64825275|NCT01536639|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64825276|NCT01536639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64825277|NCT01536639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825278|NCT01536652|Insulin Aspart|insulin aspart|mesh-list
64825279|NCT01536652|Biphasic Insulins|biphasic insulins|mesh-list
64825280|NCT01536652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64825281|NCT01536652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64825282|NCT01536652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825283|NCT01536665|Liraglutide|liraglutide|mesh-list
64825284|NCT01536665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64825285|NCT01536665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825286|NCT01536665|Incretins|incretins|mesh-ancestor
64825287|NCT01536665|Hormones|hormones|mesh-ancestor
64825323|NCT01536873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64825324|NCT01536873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64825325|NCT01536873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825326|NCT01536873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825327|NCT01536873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64825343|NCT01537055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825345|NCT01537055|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64825346|NCT01537055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64825347|NCT01537055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64825348|NCT01537055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64825366|NCT01537107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825367|NCT01537107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64825368|NCT01537107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825369|NCT01537146|Ropivacaine|ropivacaine|mesh-list
64825370|NCT01537146|Anesthetics, Local|anesthetics, local|mesh-ancestor
64825371|NCT01537146|Anesthetics|anesthetics|mesh-ancestor
64825372|NCT01537146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64825373|NCT01537146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825374|NCT01537146|Sensory System Agents|sensory system agents|mesh-ancestor
64825375|NCT01537146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64825376|NCT01537250|Levofloxacin|levofloxacin|mesh-list
64825377|NCT01537250|Ofloxacin|ofloxacin|mesh-list
64825378|NCT01537250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64825379|NCT01537250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64825380|NCT01537250|Renal Agents|renal agents|mesh-ancestor
64825381|NCT01537250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64825382|NCT01537250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64825383|NCT01537250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64825384|NCT01537250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825385|NCT01537250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825386|NCT01537250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825387|NCT01537250|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64436535|NCT01962987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64825416|NCT01537601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64825417|NCT01537601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64825418|NCT01537640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64825419|NCT01537640|Immunologic Factors|immunologic factors|mesh-ancestor
64825420|NCT01537640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825421|NCT01537744|Azacitidine|azacitidine|mesh-list
64825422|NCT01537744|Romidepsin|romidepsin|mesh-list
64825423|NCT01537744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64825424|NCT01537744|Antimetabolites|antimetabolites|mesh-ancestor
64825425|NCT01537744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825429|NCT01537770|Lidocaine|lidocaine|mesh-list
64825433|NCT01537770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825434|NCT01537770|Sensory System Agents|sensory system agents|mesh-ancestor
64825435|NCT01537770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64825436|NCT01537770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64825468|NCT01537861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64825469|NCT01537861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64825470|NCT01537861|Glucocorticoids|glucocorticoids|mesh-ancestor
64825471|NCT01537861|Hormones|hormones|mesh-ancestor
64825472|NCT01537861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64825473|NCT01537861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64825474|NCT01537861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64825475|NCT01537861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64825476|NCT01537861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64825477|NCT01537861|Growth Substances|growth substances|mesh-ancestor
64825478|NCT01537861|Growth Inhibitors|growth inhibitors|mesh-ancestor
64825479|NCT01537861|Leprostatic Agents|leprostatic agents|mesh-ancestor
64825480|NCT01537861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64436644|NCT01756456|Mitogens|mitogens|mesh-list
64825491|NCT01538108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825492|NCT01538108|Tubulin Modulators|tubulin modulators|mesh-ancestor
64825493|NCT01538108|Antimitotic Agents|antimitotic agents|mesh-ancestor
64825494|NCT01538108|Mitosis Modulators|mitosis modulators|mesh-ancestor
64825495|NCT01538108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825496|NCT01538225|Nabiximols|nabiximols|mesh-list
64825497|NCT01538225|Analgesics|analgesics|mesh-ancestor
64825501|NCT01538316|Genistein|genistein|mesh-list
64825519|NCT01538329|Antiviral Agents|antiviral agents|mesh-ancestor
64825520|NCT01538329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64825521|NCT01538329|Dopamine Agents|dopamine agents|mesh-ancestor
64825522|NCT01538329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64825523|NCT01538329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825524|NCT01538329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825525|NCT01538329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64825526|NCT01538329|Analgesics|analgesics|mesh-ancestor
64825527|NCT01538329|Sensory System Agents|sensory system agents|mesh-ancestor
64825528|NCT01538329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64825529|NCT01538381|Afatinib|afatinib|mesh-list
64825530|NCT01538381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825531|NCT01538381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64825532|NCT01538381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825533|NCT01538381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825534|NCT01538394|Nicotine|nicotine|mesh-list
64825535|NCT01538394|Varenicline|varenicline|mesh-list
64825536|NCT01538394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64825537|NCT01538394|Autonomic Agents|autonomic agents|mesh-ancestor
64825538|NCT01538394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64825539|NCT01538394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825540|NCT01538394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64825541|NCT01538394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64825542|NCT01538394|Cholinergic Agents|cholinergic agents|mesh-ancestor
64825543|NCT01538394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64825544|NCT01538394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825545|NCT01538446|Clopidogrel|clopidogrel|mesh-list
64825546|NCT01538446|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64825558|NCT01538459|Antiemetics|antiemetics|mesh-ancestor
64825559|NCT01538459|Autonomic Agents|autonomic agents|mesh-ancestor
64825560|NCT01538459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64594182|NCT02996695|Artesunate|artesunate|mesh-list
64825573|NCT01538485|Vitamin D|vitamin d|mesh-list
64825574|NCT01538485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64825575|NCT01538485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825576|NCT01538485|Vitamins|vitamins|mesh-ancestor
64825577|NCT01538485|Micronutrients|micronutrients|mesh-ancestor
64825578|NCT01538485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64825579|NCT01538511|Insulin|insulin|mesh-list
64825580|NCT01538511|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64825581|NCT01538511|Insulin Aspart|insulin aspart|mesh-list
64825582|NCT01538511|Insulin, Long-Acting|insulin, long-acting|mesh-list
64825583|NCT01538511|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64825584|NCT01538511|Biphasic Insulins|biphasic insulins|mesh-list
65494633|NCT01239498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64472824|NCT02648477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825585|NCT01538511|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64825586|NCT01538511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64825587|NCT01538511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825588|NCT01538537|ON 01910|on 01910|mesh-list
64825589|NCT01538537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825590|NCT01538537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64825591|NCT01538537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825592|NCT01538537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825593|NCT01538563|ON 01910|on 01910|mesh-list
64825638|NCT01538693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825639|NCT01538693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64825640|NCT01538693|Antidepressive Agents|antidepressive agents|mesh-ancestor
64825641|NCT01538693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64825642|NCT01538693|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64825643|NCT01538693|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64825644|NCT01538693|Parasympatholytics|parasympatholytics|mesh-ancestor
64825645|NCT01538693|Autonomic Agents|autonomic agents|mesh-ancestor
64825646|NCT01538693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64825647|NCT01538693|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64825648|NCT01538693|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64825649|NCT01538693|Cholinergic Agents|cholinergic agents|mesh-ancestor
64825650|NCT01538693|Antipruritics|antipruritics|mesh-ancestor
64825651|NCT01538693|Dermatologic Agents|dermatologic agents|mesh-ancestor
64825652|NCT01538693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64825653|NCT01538693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64825654|NCT01538693|Histamine Antagonists|histamine antagonists|mesh-ancestor
64825655|NCT01538693|Histamine Agents|histamine agents|mesh-ancestor
64825656|NCT01538693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64825657|NCT01538693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64825658|NCT01538732|Alitretinoin|alitretinoin|mesh-list
64825659|NCT01538732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825660|NCT01538732|Dermatologic Agents|dermatologic agents|mesh-ancestor
64825661|NCT01538771|Darbepoetin alfa|darbepoetin alfa|mesh-list
64825662|NCT01538771|Hematinics|hematinics|mesh-ancestor
64825663|NCT01538797|Ranitidine|ranitidine|mesh-list
64825664|NCT01538797|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
64825665|NCT01538797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64825666|NCT01538797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64825687|NCT01538875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64825688|NCT01538875|Sympathomimetics|sympathomimetics|mesh-ancestor
64825689|NCT01538875|Autonomic Agents|autonomic agents|mesh-ancestor
64825690|NCT01538875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64825691|NCT01538875|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64825692|NCT01538875|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64825693|NCT01538875|Vasodilator Agents|vasodilator agents|mesh-ancestor
64825694|NCT01538901|Imiquimod|imiquimod|mesh-list
64825695|NCT01538901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64825696|NCT01538901|Immunologic Factors|immunologic factors|mesh-ancestor
64825697|NCT01538901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825698|NCT01538901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825699|NCT01538901|Interferon Inducers|interferon inducers|mesh-ancestor
64825700|NCT01538927|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64825701|NCT01538927|Hemostatics|hemostatics|mesh-ancestor
64825702|NCT01538927|Coagulants|coagulants|mesh-ancestor
64825703|NCT01538940|Vaccines|vaccines|mesh-list
64825704|NCT01538940|Immunologic Factors|immunologic factors|mesh-ancestor
64825705|NCT01538940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825771|NCT01539174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64825772|NCT01539174|Tubulin Modulators|tubulin modulators|mesh-ancestor
64825773|NCT01539174|Antimitotic Agents|antimitotic agents|mesh-ancestor
64825774|NCT01539174|Mitosis Modulators|mitosis modulators|mesh-ancestor
64825775|NCT01539265|Silodosin|silodosin|mesh-list
64825776|NCT01539265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64825777|NCT01539265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64825778|NCT01539265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64825779|NCT01539265|Adrenergic Agents|adrenergic agents|mesh-ancestor
64825780|NCT01539265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64563725|NCT01920919|Glucocorticoids|glucocorticoids|mesh-ancestor
64825781|NCT01539265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825782|NCT01539265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825783|NCT01539265|Urological Agents|urological agents|mesh-ancestor
64825784|NCT01539330|Voriconazole|voriconazole|mesh-list
64825785|NCT01539330|Antifungal Agents|antifungal agents|mesh-ancestor
64825786|NCT01539330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64825787|NCT01539330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64436948|NCT05813106|Analgesics|analgesics|mesh-ancestor
64825802|NCT01539408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825803|NCT01539408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64304304|NCT01672736|Dexamethasone|dexamethasone|mesh-list
64951983|NCT00056082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64951984|NCT00056082|Analgesics|analgesics|mesh-ancestor
64951985|NCT00056082|Sensory System Agents|sensory system agents|mesh-ancestor
64951990|NCT00056082|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64951991|NCT00056082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64951992|NCT00056082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951993|NCT00056082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951995|NCT04730973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64951996|NCT04730973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64951997|NCT04730973|Antimetabolites|antimetabolites|mesh-ancestor
64951998|NCT04730973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951999|NCT04730973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64952000|NCT00028418|Clofarabine|clofarabine|mesh-list
64952001|NCT00028418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64952002|NCT00028418|Antimetabolites|antimetabolites|mesh-ancestor
64952003|NCT00028418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952004|NCT00028418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952005|NCT00028496|Metronidazole|metronidazole|mesh-list
64952006|NCT00028496|Molgramostim|molgramostim|mesh-list
64952007|NCT00028496|Vaccines|vaccines|mesh-list
64952008|NCT00028496|Sargramostim|sargramostim|mesh-list
64952009|NCT00028496|Immunologic Factors|immunologic factors|mesh-ancestor
64952010|NCT00028496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952011|NCT00028496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952012|NCT00028496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64952013|NCT00028496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64952014|NCT00028496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64952015|NCT00028496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64952016|NCT00028535|Paclitaxel|paclitaxel|mesh-list
64952017|NCT00028535|Trastuzumab|trastuzumab|mesh-list
64952018|NCT00028535|Interleukin-12|interleukin-12|mesh-list
64952019|NCT00028535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64825804|NCT01539408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64825805|NCT01539408|Oxytocics|oxytocics|mesh-ancestor
64825807|NCT01539473|Tedizolid phosphate|tedizolid phosphate|mesh-list
64825808|NCT01539473|Tyramine|tyramine|mesh-list
64825809|NCT01539473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64825810|NCT01539473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64825811|NCT01539473|Sympathomimetics|sympathomimetics|mesh-ancestor
64825812|NCT01539473|Autonomic Agents|autonomic agents|mesh-ancestor
64825813|NCT01539473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64825814|NCT01539473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825815|NCT01539473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64825816|NCT01539473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64825817|NCT01539473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64825818|NCT01539473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825819|NCT01539473|Adrenergic Agents|adrenergic agents|mesh-ancestor
64825820|NCT01539473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64825821|NCT01539564|Minocycline|minocycline|mesh-list
64825822|NCT01539564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64825823|NCT01539564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64825824|NCT01539577|Dexamethasone|dexamethasone|mesh-list
64825825|NCT01539577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64825826|NCT01539577|Antiemetics|antiemetics|mesh-ancestor
64825827|NCT01539577|Autonomic Agents|autonomic agents|mesh-ancestor
64825828|NCT01539577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64825829|NCT01539577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825830|NCT01539577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64825831|NCT01539577|Glucocorticoids|glucocorticoids|mesh-ancestor
64825832|NCT01539577|Hormones|hormones|mesh-ancestor
64825833|NCT01539577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64825857|NCT01539655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825858|NCT01539655|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64825859|NCT01539655|Histamine Antagonists|histamine antagonists|mesh-ancestor
64825860|NCT01539655|Histamine Agents|histamine agents|mesh-ancestor
64825861|NCT01539655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64825862|NCT01539655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825863|NCT01539681|Sorafenib|sorafenib|mesh-list
64825864|NCT01539681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825865|NCT01539681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64825866|NCT01539681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825867|NCT01539681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825868|NCT01539707|Solifenacin Succinate|solifenacin succinate|mesh-list
64825869|NCT01539707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64825870|NCT01539707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64825871|NCT01539707|Cholinergic Agents|cholinergic agents|mesh-ancestor
64825872|NCT01539707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64825873|NCT01539707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494636|NCT01239498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64563805|NCT05249309|Anesthetics|anesthetics|mesh-ancestor
64825874|NCT01539707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825875|NCT01539707|Urological Agents|urological agents|mesh-ancestor
64825877|NCT01539720|Ulipristal acetate|ulipristal acetate|mesh-list
64825878|NCT01539720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64825879|NCT01539720|Contraceptive Agents|contraceptive agents|mesh-ancestor
64825880|NCT01539720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64825881|NCT01539720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825882|NCT01539720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64825883|NCT01539720|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64825884|NCT01539720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64825885|NCT01539733|Haloperidol|haloperidol|mesh-list
64825886|NCT01539733|Olanzapine|olanzapine|mesh-list
64825887|NCT01539733|Haloperidol decanoate|haloperidol decanoate|mesh-list
64825888|NCT01539733|Antiemetics|antiemetics|mesh-ancestor
64825889|NCT01539733|Autonomic Agents|autonomic agents|mesh-ancestor
64825890|NCT01539733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64825892|NCT01539733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64305192|NCT05069857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825894|NCT01539733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64825895|NCT01539733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64825896|NCT01539733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64825897|NCT01539733|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64825898|NCT01539733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64825899|NCT01539733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64825900|NCT01539733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825901|NCT01539733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64825902|NCT01539733|Serotonin Agents|serotonin agents|mesh-ancestor
64825903|NCT01539733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64825904|NCT01539733|Dopamine Agents|dopamine agents|mesh-ancestor
64825905|NCT01539733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64825906|NCT01539798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64825907|NCT01539902|Cyclophosphamide|cyclophosphamide|mesh-list
64825908|NCT01539902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64825909|NCT01539902|Immunologic Factors|immunologic factors|mesh-ancestor
64825910|NCT01539902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437053|NCT05755334|Ropivacaine|ropivacaine|mesh-list
64825939|NCT01540110|Immunologic Factors|immunologic factors|mesh-ancestor
64825940|NCT01540110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825941|NCT01540110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64825942|NCT01540110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64825943|NCT01540110|Alkylating Agents|alkylating agents|mesh-ancestor
64825944|NCT01540110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825945|NCT01540110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825946|NCT01540110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64825947|NCT01540110|Tubulin Modulators|tubulin modulators|mesh-ancestor
64825948|NCT01540110|Antimitotic Agents|antimitotic agents|mesh-ancestor
64825949|NCT01540110|Mitosis Modulators|mitosis modulators|mesh-ancestor
64825950|NCT01540136|Nedaplatin|nedaplatin|mesh-list
64825951|NCT01540136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825973|NCT01540500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64825974|NCT01540500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825975|NCT01540500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64825976|NCT01540500|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64825977|NCT01540500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64825978|NCT01540500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64825979|NCT01540500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825980|NCT01540500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64825981|NCT01540500|Serotonin Agents|serotonin agents|mesh-ancestor
64825982|NCT01540500|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64825983|NCT01540500|Antidepressive Agents|antidepressive agents|mesh-ancestor
64825984|NCT01540500|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65494637|NCT01239498|Adrenergic Agents|adrenergic agents|mesh-ancestor
64563873|NCT04394143|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64825985|NCT01540500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64825986|NCT01540500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825987|NCT01540500|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64825988|NCT01540526|Axitinib|axitinib|mesh-list
64825989|NCT01540526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825990|NCT01540526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64825991|NCT01540526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825992|NCT01540526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825993|NCT01540591|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64825994|NCT01540591|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64825995|NCT01540591|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64825996|NCT01540591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64825997|NCT01540682|Cetuximab|cetuximab|mesh-list
64825998|NCT01540682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64825999|NCT01540682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64826000|NCT01540708|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64826001|NCT01540708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64826002|NCT01540708|Autonomic Agents|autonomic agents|mesh-ancestor
64826003|NCT01540708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826004|NCT01540708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826005|NCT01540708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64826006|NCT01540708|Respiratory System Agents|respiratory system agents|mesh-ancestor
64826007|NCT01540708|Glucocorticoids|glucocorticoids|mesh-ancestor
64826008|NCT01540708|Hormones|hormones|mesh-ancestor
64945451|NCT05619627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64594675|NCT03086720|Eusol|eusol|mesh-list
64826009|NCT01540708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64826010|NCT01540708|Sympathomimetics|sympathomimetics|mesh-ancestor
64826011|NCT01540721|Acetaminophen|acetaminophen|mesh-list
64826012|NCT01540721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64826013|NCT01540721|Analgesics|analgesics|mesh-ancestor
64826014|NCT01540721|Sensory System Agents|sensory system agents|mesh-ancestor
64826021|NCT01540734|Sensory System Agents|sensory system agents|mesh-ancestor
64826022|NCT01540734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826023|NCT01540734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826024|NCT01540734|Antipyretics|antipyretics|mesh-ancestor
64826025|NCT01540747|Folic Acid|folic acid|mesh-list
64826026|NCT01540747|Vitamin B Complex|vitamin b complex|mesh-list
64826069|NCT01540812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64826070|NCT01540812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64826071|NCT01540812|Tubulin Modulators|tubulin modulators|mesh-ancestor
64826072|NCT01540812|Antimitotic Agents|antimitotic agents|mesh-ancestor
64826073|NCT01540812|Mitosis Modulators|mitosis modulators|mesh-ancestor
64826074|NCT01540812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64826075|NCT01540812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64826076|NCT01540812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64826077|NCT01540812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64826078|NCT01540812|Abortifacient Agents|abortifacient agents|mesh-ancestor
64826079|NCT01540812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64826080|NCT01540812|Dermatologic Agents|dermatologic agents|mesh-ancestor
64826081|NCT01540812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64826082|NCT01540812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64826083|NCT01540812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64594686|NCT00597727|Glycerol|glycerol|mesh-list
64826084|NCT01540877|Anesthetics|anesthetics|mesh-list
64826085|NCT01540877|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64826086|NCT01540877|Anesthetics, Local|anesthetics, local|mesh-list
64826087|NCT01540877|Capsaicin|capsaicin|mesh-list
64826098|NCT01541059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64826099|NCT01541059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826100|NCT01541059|Sensory System Agents|sensory system agents|mesh-ancestor
64826101|NCT01541059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826102|NCT01541072|Lenograstim|lenograstim|mesh-list
64826103|NCT01541072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64826104|NCT01541072|Immunologic Factors|immunologic factors|mesh-ancestor
64826105|NCT01541072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826106|NCT01541085|Ritonavir|ritonavir|mesh-list
64826107|NCT01541085|Darunavir|darunavir|mesh-list
64826108|NCT01541085|Efavirenz|efavirenz|mesh-list
64826109|NCT01541085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64826121|NCT01541085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64826122|NCT01541085|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64826123|NCT01541085|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64826124|NCT01541085|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64826125|NCT01541085|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64826126|NCT01541085|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64826127|NCT01541124|Morphine|morphine|mesh-list
64826128|NCT01541124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64826129|NCT01541124|Narcotics|narcotics|mesh-ancestor
64826130|NCT01541124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64826131|NCT01541124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826132|NCT01541124|Analgesics|analgesics|mesh-ancestor
64826133|NCT01541124|Sensory System Agents|sensory system agents|mesh-ancestor
64826134|NCT01541124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826135|NCT01541137|Diclofenac|diclofenac|mesh-list
64826136|NCT01541137|Parecoxib|parecoxib|mesh-list
64826137|NCT01541137|Valdecoxib|valdecoxib|mesh-list
64826138|NCT01541137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64826139|NCT01541137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64826140|NCT01541137|Analgesics|analgesics|mesh-ancestor
64826141|NCT01541137|Sensory System Agents|sensory system agents|mesh-ancestor
64826142|NCT01541137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826143|NCT01541137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826144|NCT01541137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64826145|NCT01541137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64826146|NCT01541137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64826147|NCT01541137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826148|NCT01541137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826149|NCT01541137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64826150|NCT01541189|Valsartan|valsartan|mesh-list
64826151|NCT01541189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64826152|NCT01541189|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64826153|NCT01541189|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64826166|NCT01541293|Lidocaine|lidocaine|mesh-list
64826171|NCT01541293|Sensory System Agents|sensory system agents|mesh-ancestor
64826172|NCT01541293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826173|NCT01541293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64826174|NCT01541293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64826175|NCT01541293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64826176|NCT01541293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64826177|NCT01541293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826178|NCT01541332|Dexamethasone|dexamethasone|mesh-list
64826179|NCT01541332|Doxorubicin|doxorubicin|mesh-list
64826180|NCT01541332|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64826181|NCT01541332|Pomalidomide|pomalidomide|mesh-list
64826182|NCT01541332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64826183|NCT01541332|Antiemetics|antiemetics|mesh-ancestor
64826184|NCT01541332|Autonomic Agents|autonomic agents|mesh-ancestor
64826185|NCT01541332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826186|NCT01541332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826187|NCT01541332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64826188|NCT01541332|Glucocorticoids|glucocorticoids|mesh-ancestor
64826189|NCT01541332|Hormones|hormones|mesh-ancestor
64826190|NCT01541332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64826191|NCT01541332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64826192|NCT01541332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64826193|NCT01541332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64826194|NCT01541332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64826195|NCT01541332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64826196|NCT01541332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826203|NCT01541436|Capsaicin|capsaicin|mesh-list
64826231|NCT01541475|Dopamine Agents|dopamine agents|mesh-ancestor
64826232|NCT01541475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64826233|NCT01541475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64826234|NCT01541475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826235|NCT01541605|Methylphenidate|methylphenidate|mesh-list
64826236|NCT01541605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64826237|NCT01541605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826238|NCT01541605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64826239|NCT01541605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64826240|NCT01541605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64826241|NCT01541605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826242|NCT01541605|Dopamine Agents|dopamine agents|mesh-ancestor
64826243|NCT01541605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64826244|NCT01541631|Albendazole|albendazole|mesh-list
64826245|NCT01541631|Praziquantel|praziquantel|mesh-list
64472825|NCT02648477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64826246|NCT01541631|Anthelmintics|anthelmintics|mesh-ancestor
64826247|NCT01541631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64826248|NCT01541631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64826249|NCT01541631|Anticestodal Agents|anticestodal agents|mesh-ancestor
64826250|NCT01541631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64826251|NCT01541631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64826252|NCT01541631|Tubulin Modulators|tubulin modulators|mesh-ancestor
64952020|NCT00028535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952021|NCT00028535|Tubulin Modulators|tubulin modulators|mesh-ancestor
64952022|NCT00028535|Antimitotic Agents|antimitotic agents|mesh-ancestor
64952023|NCT00028535|Mitosis Modulators|mitosis modulators|mesh-ancestor
64952024|NCT00028535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952025|NCT00028535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64952026|NCT00028535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64952027|NCT00028535|Immunologic Factors|immunologic factors|mesh-ancestor
64952028|NCT00028535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952029|NCT00028535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64952030|NCT00028535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64952031|NCT00028535|Growth Substances|growth substances|mesh-ancestor
64725733|NCT03805022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64725734|NCT03805022|Ifosfamide|ifosfamide|mesh-list
64952032|NCT00028535|Growth Inhibitors|growth inhibitors|mesh-ancestor
64952034|NCT00056277|Anticonvulsants|anticonvulsants|mesh-ancestor
64952035|NCT00056277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64952036|NCT00056277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64952037|NCT00056277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952038|NCT00056277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64952039|NCT00056277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952040|NCT00056277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64952041|NCT00056277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64952042|NCT00056277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64952043|NCT00056277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64952044|NCT00056277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64952045|NCT00028574|Gabapentin|gabapentin|mesh-list
64826253|NCT01541631|Antimitotic Agents|antimitotic agents|mesh-ancestor
64826254|NCT01541631|Mitosis Modulators|mitosis modulators|mesh-ancestor
64826255|NCT01541631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826256|NCT01541631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64826257|NCT01541670|Antibodies|antibodies|mesh-list
64826258|NCT01541670|Immunologic Factors|immunologic factors|mesh-ancestor
64826259|NCT01541670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826260|NCT01541683|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64826261|NCT01541904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64826262|NCT01541904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64826263|NCT01541943|Losartan|losartan|mesh-list
64826264|NCT01541943|Atorvastatin|atorvastatin|mesh-list
64826265|NCT01541943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64826266|NCT01541943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64826267|NCT01541943|Antimetabolites|antimetabolites|mesh-ancestor
64826268|NCT01541943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826269|NCT01541943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64826270|NCT01541943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64826271|NCT01541943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826272|NCT01541943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64826273|NCT01541943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64826274|NCT01541943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64826295|NCT01542099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826296|NCT01542099|Analgesics|analgesics|mesh-ancestor
64826297|NCT01542099|Sensory System Agents|sensory system agents|mesh-ancestor
64826298|NCT01542099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826302|NCT01542138|Desonide|desonide|mesh-list
64826322|NCT01542190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64826323|NCT01542190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64826324|NCT01542190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826325|NCT01542190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826326|NCT01542242|Liraglutide|liraglutide|mesh-list
64826327|NCT01542242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64826328|NCT01542242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826329|NCT01542242|Incretins|incretins|mesh-ancestor
64826349|NCT01542424|Biphasic Insulins|biphasic insulins|mesh-list
64826350|NCT01542424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64826351|NCT01542424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64826352|NCT01542424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826354|NCT01542437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64826355|NCT01542437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64826356|NCT01542437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826357|NCT01542437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826358|NCT01542450|Insulin|insulin|mesh-list
64826359|NCT01542450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65494639|NCT01239498|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64826360|NCT01542450|Insulin Detemir|insulin detemir|mesh-list
64826361|NCT01542450|Isophane Insulin, Human|isophane insulin, human|mesh-list
64826362|NCT01542450|Insulin, Isophane|insulin, isophane|mesh-list
64826363|NCT01542450|Isophane insulin, beef|isophane insulin, beef|mesh-list
64826364|NCT01542450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64826365|NCT01542450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826366|NCT01542463|Insulin Detemir|insulin detemir|mesh-list
64826367|NCT01542463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64826368|NCT01542463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826369|NCT01542476|Insulin Detemir|insulin detemir|mesh-list
64826370|NCT01542476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64826371|NCT01542476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826372|NCT01542489|Insulin|insulin|mesh-list
64826373|NCT01542489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64826374|NCT01542489|Insulin Aspart|insulin aspart|mesh-list
64307221|NCT04947566|Analgesics|analgesics|mesh-ancestor
64826381|NCT01542697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826382|NCT01542697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826383|NCT01542697|Anesthetics|anesthetics|mesh-ancestor
64826384|NCT01542697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64826385|NCT01542697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64826386|NCT01542697|Anticonvulsants|anticonvulsants|mesh-ancestor
64826402|NCT01542710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64826403|NCT01542710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64826405|NCT01542723|Anticoagulants|anticoagulants|mesh-ancestor
64826406|NCT01542723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64826407|NCT01542723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64826408|NCT01542723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826409|NCT01542762|Nadroparin|nadroparin|mesh-list
64826410|NCT01542762|Anticoagulants|anticoagulants|mesh-ancestor
64826411|NCT01542762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64826412|NCT01542762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64826413|NCT01542762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826414|NCT01542801|Ciprofloxacin|ciprofloxacin|mesh-list
64826415|NCT01542801|Norfloxacin|norfloxacin|mesh-list
64826475|NCT01543321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64826476|NCT01543321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64826477|NCT01543321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64826478|NCT01543321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826479|NCT01543321|Adrenergic Agents|adrenergic agents|mesh-ancestor
64826480|NCT01543321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64826481|NCT01543321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826482|NCT01543347|Temocillin|temocillin|mesh-list
64826483|NCT01543347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64826484|NCT01543347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64826485|NCT01543386|Curcumin|curcumin|mesh-list
64826486|NCT01543386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64826487|NCT01543386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64826488|NCT01543386|Analgesics|analgesics|mesh-ancestor
64826489|NCT01543386|Sensory System Agents|sensory system agents|mesh-ancestor
64826490|NCT01543386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826491|NCT01543386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826492|NCT01543386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64826493|NCT01543386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64826494|NCT01543386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64826495|NCT01543386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826496|NCT01543386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826497|NCT01543399|Tibolone|tibolone|mesh-list
64826514|NCT01543555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64826516|NCT01543555|Antimetabolites|antimetabolites|mesh-ancestor
64826517|NCT01543555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308061|NCT03234153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64826538|NCT01543750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64826539|NCT01543750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826540|NCT01543906|Retinol acetate|retinol acetate|mesh-list
64826541|NCT01543906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64826542|NCT01543906|Immunologic Factors|immunologic factors|mesh-ancestor
64826543|NCT01543906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826544|NCT01543906|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64826545|NCT01543906|Protective Agents|protective agents|mesh-ancestor
64826546|NCT01543906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64826547|NCT01543932|Clopidogrel|clopidogrel|mesh-list
64826548|NCT01543932|Ticagrelor|ticagrelor|mesh-list
64826549|NCT01543932|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64826550|NCT01543932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64826551|NCT01543932|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64826552|NCT01543932|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64437701|NCT05004662|Autonomic Agents|autonomic agents|mesh-ancestor
64826566|NCT01543945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826567|NCT01543945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826568|NCT01543945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64826569|NCT01543945|Glucocorticoids|glucocorticoids|mesh-ancestor
64826570|NCT01543945|Hormones|hormones|mesh-ancestor
64826571|NCT01543945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64826572|NCT01543945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64826573|NCT01543945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64826574|NCT01543945|Protease Inhibitors|protease inhibitors|mesh-ancestor
64826575|NCT01543945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826576|NCT01543945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826577|NCT01543945|Antipruritics|antipruritics|mesh-ancestor
64826578|NCT01543945|Dermatologic Agents|dermatologic agents|mesh-ancestor
64952046|NCT00028574|Analgesics|analgesics|mesh-ancestor
64308318|NCT03220815|Methamphetamine|methamphetamine|mesh-list
64826591|NCT01543971|Lenograstim|lenograstim|mesh-list
64826592|NCT01543971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64826593|NCT01543971|Immunologic Factors|immunologic factors|mesh-ancestor
64826594|NCT01543971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826595|NCT01543971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64826596|NCT01543971|Vasodilator Agents|vasodilator agents|mesh-ancestor
64826597|NCT01544140|Midazolam|midazolam|mesh-list
64826598|NCT01544140|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64826599|NCT01544140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64826600|NCT01544140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64826601|NCT01544140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826602|NCT01544140|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64826603|NCT01544140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64826604|NCT01544140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64826605|NCT01544140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64826606|NCT01544140|Anesthetics, General|anesthetics, general|mesh-ancestor
64826607|NCT01544140|Anesthetics|anesthetics|mesh-ancestor
64826608|NCT01544140|GABA Modulators|gaba modulators|mesh-ancestor
64826609|NCT01544140|GABA Agents|gaba agents|mesh-ancestor
64826610|NCT01544140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64437764|NCT04915612|Calicheamicins|calicheamicins|mesh-list
64437765|NCT04915612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64826630|NCT01544283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64826631|NCT01544283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826632|NCT01544283|Sensory System Agents|sensory system agents|mesh-ancestor
64826633|NCT01544283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826634|NCT01544283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64826635|NCT01544283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64826636|NCT01544283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64826637|NCT01544283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64826638|NCT01544283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826639|NCT01544283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64826640|NCT01544283|Glucocorticoids|glucocorticoids|mesh-ancestor
64826641|NCT01544283|Hormones|hormones|mesh-ancestor
64826646|NCT01544439|Salicylic Acid|salicylic acid|mesh-list
64826647|NCT01544439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64826648|NCT01544439|Antifungal Agents|antifungal agents|mesh-ancestor
64826649|NCT01544439|Keratolytic Agents|keratolytic agents|mesh-ancestor
64826650|NCT01544439|Dermatologic Agents|dermatologic agents|mesh-ancestor
64826651|NCT01544504|Norepinephrine|norepinephrine|mesh-list
64826652|NCT01544504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64826653|NCT01544504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64826654|NCT01544504|Adrenergic Agents|adrenergic agents|mesh-ancestor
64826655|NCT01544504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64826656|NCT01544504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826657|NCT01544504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826658|NCT01544504|Sympathomimetics|sympathomimetics|mesh-ancestor
64826659|NCT01544504|Autonomic Agents|autonomic agents|mesh-ancestor
64826660|NCT01544504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826661|NCT01544504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64826662|NCT01544517|Amoxicillin|amoxicillin|mesh-list
64826663|NCT01544517|Levofloxacin|levofloxacin|mesh-list
64826664|NCT01544517|Ofloxacin|ofloxacin|mesh-list
64826665|NCT01544517|Tinidazole|tinidazole|mesh-list
64826666|NCT01544517|Esomeprazole|esomeprazole|mesh-list
64826667|NCT01544517|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64826668|NCT01544517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64826669|NCT01544517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64437817|NCT04853446|Hormones|hormones|mesh-ancestor
64826681|NCT01544517|Alkylating Agents|alkylating agents|mesh-ancestor
64826682|NCT01544517|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64826683|NCT01544517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64595289|NCT01887171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64826684|NCT01544517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64826686|NCT01544634|Propranolol|propranolol|mesh-list
64826687|NCT01544634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64826688|NCT01544634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64826689|NCT01544634|Adrenergic Agents|adrenergic agents|mesh-ancestor
64308613|NCT02141113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826701|NCT01544634|Respiratory System Agents|respiratory system agents|mesh-ancestor
64826702|NCT01544673|Linezolid|linezolid|mesh-list
64826703|NCT01544673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64826704|NCT01544673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64826705|NCT01544673|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64826706|NCT01544673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826707|NCT01544673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826708|NCT01544725|Ketamine|ketamine|mesh-list
64826709|NCT01544725|Propofol|propofol|mesh-list
64826710|NCT01544725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64826711|NCT01544725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64826712|NCT01544725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826713|NCT01544725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64826714|NCT01544725|Anesthetics, General|anesthetics, general|mesh-ancestor
64826715|NCT01544725|Anesthetics|anesthetics|mesh-ancestor
64826716|NCT01544725|Analgesics|analgesics|mesh-ancestor
64826717|NCT01544725|Sensory System Agents|sensory system agents|mesh-ancestor
64826718|NCT01544725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826719|NCT01544725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64826720|NCT01544725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64826721|NCT01544725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64826722|NCT01544725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64826723|NCT01544725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826724|NCT01544751|Metformin|metformin|mesh-list
64826725|NCT01544751|Atorvastatin|atorvastatin|mesh-list
64826726|NCT01544751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64826756|NCT01544842|Hormones|hormones|mesh-ancestor
64826757|NCT01544842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64826758|NCT01544881|Insulin|insulin|mesh-list
64826759|NCT01544881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64826760|NCT01544881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826761|NCT01544894|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64826762|NCT01544894|Strontium ranelate|strontium ranelate|mesh-list
64826763|NCT01544894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64826764|NCT01544894|Hormone Antagonists|hormone antagonists|mesh-ancestor
64564479|NCT04120519|Thalidomide|thalidomide|mesh-list
64826765|NCT01544894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64826766|NCT01544894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826767|NCT01544894|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64826768|NCT01544894|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64826769|NCT01544894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64826771|NCT01544907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64826772|NCT01544907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64826773|NCT01544907|Tubulin Modulators|tubulin modulators|mesh-ancestor
64826774|NCT01544907|Antimitotic Agents|antimitotic agents|mesh-ancestor
64826775|NCT01544907|Mitosis Modulators|mitosis modulators|mesh-ancestor
64826776|NCT01544907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826777|NCT01544959|Fentanyl|fentanyl|mesh-list
64826778|NCT01544959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64826779|NCT01544959|Esmolol|esmolol|mesh-list
64826780|NCT01544959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64826781|NCT01544959|Narcotics|narcotics|mesh-ancestor
64826782|NCT01544959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64826783|NCT01544959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826784|NCT01544959|Analgesics|analgesics|mesh-ancestor
64826785|NCT01544959|Sensory System Agents|sensory system agents|mesh-ancestor
64826786|NCT01544959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826787|NCT01544959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64826789|NCT01544959|Anesthetics, General|anesthetics, general|mesh-ancestor
64308786|NCT03209427|Morphine|morphine|mesh-list
64826810|NCT01545024|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64826811|NCT01545024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64826812|NCT01545024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826813|NCT01545024|Incretins|incretins|mesh-ancestor
64826814|NCT01545024|Hormones|hormones|mesh-ancestor
64826815|NCT01545024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64826816|NCT01545024|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64826817|NCT01545024|Protease Inhibitors|protease inhibitors|mesh-ancestor
64826818|NCT01545024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826819|NCT01545024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826820|NCT01545284|Acitretin|acitretin|mesh-list
64826821|NCT01545284|Keratolytic Agents|keratolytic agents|mesh-ancestor
64826822|NCT01545284|Dermatologic Agents|dermatologic agents|mesh-ancestor
64826823|NCT01545297|Dexmedetomidine|dexmedetomidine|mesh-list
64826824|NCT01545297|Remifentanil|remifentanil|mesh-list
64826825|NCT01545297|Propofol|propofol|mesh-list
64826826|NCT01545297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64826827|NCT01545297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64826828|NCT01545297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826829|NCT01545297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64826830|NCT01545297|Anesthetics, General|anesthetics, general|mesh-ancestor
64826831|NCT01545297|Anesthetics|anesthetics|mesh-ancestor
64826832|NCT01545297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64826833|NCT01545297|Analgesics|analgesics|mesh-ancestor
64826834|NCT01545297|Sensory System Agents|sensory system agents|mesh-ancestor
64826835|NCT01545297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826836|NCT01545297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64826837|NCT01545297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64826838|NCT01545297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64826839|NCT01545297|Adrenergic Agents|adrenergic agents|mesh-ancestor
64826840|NCT01545297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64826841|NCT01545297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826842|NCT01545297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64826843|NCT01545297|Narcotics|narcotics|mesh-ancestor
64826844|NCT01545427|Imatinib Mesylate|imatinib mesylate|mesh-list
64826845|NCT01545427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952047|NCT00028574|Sensory System Agents|sensory system agents|mesh-ancestor
64826846|NCT01545427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64826847|NCT01545427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826848|NCT01545427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826849|NCT01545440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64826850|NCT01545440|Immunologic Factors|immunologic factors|mesh-ancestor
64826851|NCT01545440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494640|NCT01239498|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64564551|NCT00634517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826853|NCT01545479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64826868|NCT01545778|Sensory System Agents|sensory system agents|mesh-ancestor
64826869|NCT01545778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826870|NCT01545778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64826871|NCT01545778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64826872|NCT01545778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64826873|NCT01545778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826874|NCT01545778|Adrenergic Agents|adrenergic agents|mesh-ancestor
64826875|NCT01545778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64826876|NCT01545791|Insulin Detemir|insulin detemir|mesh-list
64826877|NCT01545791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64826878|NCT01545791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826879|NCT01545804|Lenalidomide|lenalidomide|mesh-list
64826880|NCT01545804|Immunologic Factors|immunologic factors|mesh-ancestor
64826881|NCT01545804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826907|NCT01545947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826908|NCT01545947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64826909|NCT01546051|BCI-838|bci-838|mesh-list
64826910|NCT01546051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64826911|NCT01546051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64826912|NCT01546051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64826913|NCT01546051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826914|NCT01546051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826915|NCT01546090|Alprazolam|alprazolam|mesh-list
64826922|NCT01546090|GABA Modulators|gaba modulators|mesh-ancestor
64826923|NCT01546090|GABA Agents|gaba agents|mesh-ancestor
64826924|NCT01546090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64826925|NCT01546090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826927|NCT01546103|Ergocalciferols|ergocalciferols|mesh-list
64826928|NCT01546103|Cholecalciferol|cholecalciferol|mesh-list
64826929|NCT01546103|Vitamins|vitamins|mesh-list
64826930|NCT01546103|Micronutrients|micronutrients|mesh-ancestor
64826931|NCT01546103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826932|NCT01546103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64826933|NCT01546103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64826934|NCT01546116|Lamivudine|lamivudine|mesh-list
64826935|NCT01546116|Adefovir|adefovir|mesh-list
64826936|NCT01546116|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64826937|NCT01546116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64826938|NCT01546116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64826939|NCT01546116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826940|NCT01546116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826941|NCT01546116|Antiviral Agents|antiviral agents|mesh-ancestor
64826942|NCT01546116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64309268|NCT03197571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64826959|NCT01546597|Metformin|metformin|mesh-list
64826960|NCT01546597|Ranolazine|ranolazine|mesh-list
64826961|NCT01546597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64826962|NCT01546597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826963|NCT01546597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64826964|NCT01546597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64826965|NCT01546597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826966|NCT01546701|Morphine|morphine|mesh-list
64826967|NCT01546701|Buprenorphine|buprenorphine|mesh-list
64826968|NCT01546701|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64826969|NCT01546701|Narcotics|narcotics|mesh-ancestor
64826970|NCT01546701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64826971|NCT01546701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826972|NCT01546701|Analgesics|analgesics|mesh-ancestor
64826973|NCT01546701|Sensory System Agents|sensory system agents|mesh-ancestor
64826974|NCT01546701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826975|NCT01546701|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64826976|NCT01546896|Alprazolam|alprazolam|mesh-list
64826977|NCT01546896|Buspirone|buspirone|mesh-list
64826978|NCT01546896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64826979|NCT01546896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64826980|NCT01546896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826981|NCT01546896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64826982|NCT01546896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64826983|NCT01546896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64826984|NCT01546896|GABA Modulators|gaba modulators|mesh-ancestor
64826985|NCT01546896|GABA Agents|gaba agents|mesh-ancestor
64826986|NCT01546896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64827007|NCT01547104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827008|NCT01547104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64827009|NCT01547104|Immunologic Factors|immunologic factors|mesh-ancestor
64827010|NCT01547104|Incretins|incretins|mesh-ancestor
64827011|NCT01547104|Hormones|hormones|mesh-ancestor
64827012|NCT01547104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64827013|NCT01547104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64827018|NCT01547143|Dexamethasone|dexamethasone|mesh-list
64827019|NCT01547143|Etoposide|etoposide|mesh-list
64827020|NCT01547143|Cyclosporins|cyclosporins|mesh-list
64827021|NCT01547143|gamma-Globulins|gamma-globulins|mesh-list
64827022|NCT01547143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64827023|NCT01547143|Antiemetics|antiemetics|mesh-ancestor
64827024|NCT01547143|Autonomic Agents|autonomic agents|mesh-ancestor
64827025|NCT01547143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827026|NCT01547143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827027|NCT01547143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64827028|NCT01547143|Glucocorticoids|glucocorticoids|mesh-ancestor
64827029|NCT01547143|Hormones|hormones|mesh-ancestor
64827030|NCT01547143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64827031|NCT01547143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64827032|NCT01547143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827033|NCT01547143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827034|NCT01547143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827035|NCT01547143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64827036|NCT01547143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64827037|NCT01547143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64827038|NCT01547143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64827039|NCT01547143|Immunologic Factors|immunologic factors|mesh-ancestor
64827040|NCT01547143|Antifungal Agents|antifungal agents|mesh-ancestor
65494642|NCT01239498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64564720|NCT01921673|Docetaxel|docetaxel|mesh-list
64827041|NCT01547143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64827042|NCT01547143|Dermatologic Agents|dermatologic agents|mesh-ancestor
64438200|NCT04218240|Lofexidine|lofexidine|mesh-list
64827075|NCT01547325|Doxycycline|doxycycline|mesh-list
64827076|NCT01547325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64827077|NCT01547325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64827078|NCT01547325|Antimalarials|antimalarials|mesh-ancestor
64827079|NCT01547325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64827117|NCT01547455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827118|NCT01547494|Vitamins|vitamins|mesh-list
64827119|NCT01547494|Micronutrients|micronutrients|mesh-ancestor
64827120|NCT01547494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827121|NCT01547520|Meperidine|meperidine|mesh-list
64827122|NCT01547520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64827123|NCT01547520|Narcotics|narcotics|mesh-ancestor
64827124|NCT01547520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64827125|NCT01547520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827126|NCT01547520|Analgesics|analgesics|mesh-ancestor
64827127|NCT01547520|Sensory System Agents|sensory system agents|mesh-ancestor
64827128|NCT01547520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827129|NCT01547520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64827130|NCT01547546|GDC-0084|gdc-0084|mesh-list
64827131|NCT01547546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827132|NCT01547546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827133|NCT01547559|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
64827134|NCT01547559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64827135|NCT01547559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64827136|NCT01547559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827148|NCT01548001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64827149|NCT01548001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64827151|NCT01548001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64827152|NCT01548001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64827153|NCT01548027|Anesthetics|anesthetics|mesh-list
64827154|NCT01548027|Anesthetics, Local|anesthetics, local|mesh-list
64827155|NCT01548027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64827156|NCT01548027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827157|NCT01548027|Sensory System Agents|sensory system agents|mesh-ancestor
64827158|NCT01548027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827159|NCT01548066|Valproic Acid|valproic acid|mesh-list
64827160|NCT01548066|Anticonvulsants|anticonvulsants|mesh-ancestor
64827161|NCT01548066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827162|NCT01548066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827170|NCT01548079|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64827171|NCT01548079|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64827172|NCT01548079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64827174|NCT01548118|Immunologic Factors|immunologic factors|mesh-ancestor
64827175|NCT01548118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827176|NCT01548144|Pemetrexed|pemetrexed|mesh-list
64827177|NCT01548144|Crizotinib|crizotinib|mesh-list
64827178|NCT01548144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827179|NCT01548144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827180|NCT01548144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827181|NCT01548144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64827182|NCT01548144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64827183|NCT01548144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64827184|NCT01548157|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64827185|NCT01548157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65494643|NCT01239498|Respiratory System Agents|respiratory system agents|mesh-ancestor
64472827|NCT02648477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64827186|NCT01548157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64827187|NCT01548157|Antimetabolites|antimetabolites|mesh-ancestor
64827188|NCT01548157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827189|NCT01548157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64827190|NCT01548157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64827191|NCT01548157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827192|NCT01548170|Ketoconazole|ketoconazole|mesh-list
64827194|NCT01548170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827195|NCT01548170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64827196|NCT01548170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64827197|NCT01548170|Growth Substances|growth substances|mesh-ancestor
64827198|NCT01548170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827199|NCT01548170|Growth Inhibitors|growth inhibitors|mesh-ancestor
64595814|NCT05735145|Paclitaxel|paclitaxel|mesh-list
64827215|NCT01548209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64827216|NCT01548209|Analgesics|analgesics|mesh-ancestor
64827217|NCT01548209|Sensory System Agents|sensory system agents|mesh-ancestor
64827218|NCT01548209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827219|NCT01548209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64827220|NCT01548209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64827221|NCT01548209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64827222|NCT01548209|Adrenergic Agents|adrenergic agents|mesh-ancestor
64827223|NCT01548209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64827224|NCT01548209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827225|NCT01548235|Insulin Aspart|insulin aspart|mesh-list
64827226|NCT01548235|Biphasic Insulins|biphasic insulins|mesh-list
64827227|NCT01548235|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64827228|NCT01548235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64827229|NCT01548235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827230|NCT01548248|Insulin|insulin|mesh-list
64827231|NCT01548248|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64827232|NCT01548248|Insulin Aspart|insulin aspart|mesh-list
64827233|NCT01548248|Insulin Detemir|insulin detemir|mesh-list
64827234|NCT01548248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64827235|NCT01548248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827236|NCT01548274|Sarpogrelate|sarpogrelate|mesh-list
64827237|NCT01548274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64827238|NCT01548274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64827239|NCT01548274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827240|NCT01548274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64827242|NCT01548274|Serotonin Agents|serotonin agents|mesh-ancestor
65494644|NCT01239498|Mydriatics|mydriatics|mesh-ancestor
64564857|NCT01922765|Amoxicillin|amoxicillin|mesh-list
64827264|NCT01548482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64827265|NCT01548482|Growth Substances|growth substances|mesh-ancestor
64827266|NCT01548482|Growth Inhibitors|growth inhibitors|mesh-ancestor
64827267|NCT01548521|Oxytocin|oxytocin|mesh-list
64827268|NCT01548521|Oxytocics|oxytocics|mesh-ancestor
64827269|NCT01548521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64827270|NCT01548521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827271|NCT01548560|Dapivirine|dapivirine|mesh-list
64827272|NCT01548560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64827273|NCT01548560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64827274|NCT01548560|Antiviral Agents|antiviral agents|mesh-ancestor
64827275|NCT01548560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64827276|NCT01548612|Nitroprusside|nitroprusside|mesh-list
64827277|NCT01548612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64827278|NCT01548612|Vasodilator Agents|vasodilator agents|mesh-ancestor
64827279|NCT01548612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64827280|NCT01548612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827281|NCT01548677|Trastuzumab|trastuzumab|mesh-list
64827282|NCT01548677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64827283|NCT01548677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827284|NCT01548703|BCI-838|bci-838|mesh-list
64827285|NCT01548703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64827286|NCT01548703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64827313|NCT01548859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827314|NCT01548859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64827315|NCT01548859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64827316|NCT01548859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64827317|NCT01548859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64827318|NCT01548859|Anesthetics, General|anesthetics, general|mesh-ancestor
64827319|NCT01548859|Anesthetics|anesthetics|mesh-ancestor
64827320|NCT01548859|GABA Modulators|gaba modulators|mesh-ancestor
64827321|NCT01548859|GABA Agents|gaba agents|mesh-ancestor
64827322|NCT01548859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64827323|NCT01548859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827324|NCT01548859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64827325|NCT01548859|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64827326|NCT01548872|Cardioplegic Solutions|cardioplegic solutions|mesh-list
64827334|NCT01548924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64827335|NCT01548924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827336|NCT01548924|Tubulin Modulators|tubulin modulators|mesh-ancestor
64827337|NCT01548924|Antimitotic Agents|antimitotic agents|mesh-ancestor
64827338|NCT01548924|Mitosis Modulators|mitosis modulators|mesh-ancestor
64827339|NCT01548924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827341|NCT01548950|Sildenafil Citrate|sildenafil citrate|mesh-list
64827342|NCT01548950|Vasodilator Agents|vasodilator agents|mesh-ancestor
64827343|NCT01548950|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64827344|NCT01548950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64827345|NCT01548950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494645|NCT01239498|Sympathomimetics|sympathomimetics|mesh-ancestor
65494646|NCT01239498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64827365|NCT01549093|Growth Substances|growth substances|mesh-ancestor
64827366|NCT01549093|Growth Inhibitors|growth inhibitors|mesh-ancestor
64827367|NCT01549158|Torsemide|torsemide|mesh-list
64827368|NCT01549158|Furosemide|furosemide|mesh-list
64827369|NCT01549158|Diuretics|diuretics|mesh-ancestor
64827370|NCT01549158|Natriuretic Agents|natriuretic agents|mesh-ancestor
64827371|NCT01549158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827372|NCT01549158|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64827373|NCT01549158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64827374|NCT01549158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827375|NCT01549158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64827376|NCT01549171|Iloprost|iloprost|mesh-list
64827377|NCT01549171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64827397|NCT01549418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827398|NCT01549418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64827399|NCT01549418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64827400|NCT01549418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64827401|NCT01549418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64827402|NCT01549418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827403|NCT01549418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64827404|NCT01549418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64827405|NCT01549418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827406|NCT01549418|Antipyretics|antipyretics|mesh-ancestor
64827407|NCT01549431|Dexamethasone|dexamethasone|mesh-list
64827408|NCT01549431|Panobinostat|panobinostat|mesh-list
64827409|NCT01549431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64827410|NCT01549431|Antiemetics|antiemetics|mesh-ancestor
64827411|NCT01549431|Autonomic Agents|autonomic agents|mesh-ancestor
64827412|NCT01549431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827413|NCT01549431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827416|NCT01549431|Hormones|hormones|mesh-ancestor
64310345|NCT04898270|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
64827427|NCT01549496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64827428|NCT01549496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827429|NCT01549496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64827430|NCT01549496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827431|NCT01549496|Vasodilator Agents|vasodilator agents|mesh-ancestor
64827432|NCT01549548|Ponatinib|ponatinib|mesh-list
64827433|NCT01549548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827452|NCT01549691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65494647|NCT00251927|Esomeprazole|esomeprazole|mesh-list
64472829|NCT02648477|Hormone Antagonists|hormone antagonists|mesh-ancestor
64565005|NCT01920737|Abortifacient Agents|abortifacient agents|mesh-ancestor
64827453|NCT01549691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827454|NCT01549691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64827455|NCT01549691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64827456|NCT01549691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64827457|NCT01549691|GABA Modulators|gaba modulators|mesh-ancestor
64827458|NCT01549691|GABA Agents|gaba agents|mesh-ancestor
64827459|NCT01549691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64827460|NCT01549691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827461|NCT01549704|Ropivacaine|ropivacaine|mesh-list
64827462|NCT01549704|Anesthetics, Local|anesthetics, local|mesh-ancestor
64827463|NCT01549704|Anesthetics|anesthetics|mesh-ancestor
64827464|NCT01549704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64827490|NCT01549795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438638|NCT03317496|Gemcitabine|gemcitabine|mesh-list
64827497|NCT01549847|Nootropic Agents|nootropic agents|mesh-ancestor
64827498|NCT01549938|Cholecalciferol|cholecalciferol|mesh-list
64827499|NCT01549938|Vitamin D|vitamin d|mesh-list
64827500|NCT01549938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64827501|NCT01549938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827502|NCT01549938|Vitamins|vitamins|mesh-ancestor
64827503|NCT01549938|Micronutrients|micronutrients|mesh-ancestor
64827504|NCT01549938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64827505|NCT01549990|Sevoflurane|sevoflurane|mesh-list
64827506|NCT01549990|Desflurane|desflurane|mesh-list
64827507|NCT01549990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64827508|NCT01549990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64827509|NCT01549990|Anesthetics, General|anesthetics, general|mesh-ancestor
64827510|NCT01549990|Anesthetics|anesthetics|mesh-ancestor
64827511|NCT01549990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64827512|NCT01549990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827513|NCT01550055|Irinotecan|irinotecan|mesh-list
64827514|NCT01550055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64827515|NCT01550055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64827516|NCT01550055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827517|NCT01550055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827518|NCT01550055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827519|NCT01550107|Allopurinol|allopurinol|mesh-list
64827520|NCT01550107|Antimetabolites|antimetabolites|mesh-ancestor
64827521|NCT01550107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827522|NCT01550107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827523|NCT01550107|Gout Suppressants|gout suppressants|mesh-ancestor
64827524|NCT01550107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64827537|NCT01550146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64827538|NCT01550146|Glucocorticoids|glucocorticoids|mesh-ancestor
64827539|NCT01550146|Hormones|hormones|mesh-ancestor
64827540|NCT01550146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64827541|NCT01550146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64827542|NCT01550146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827543|NCT01550146|Protease Inhibitors|protease inhibitors|mesh-ancestor
64827544|NCT01550146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827545|NCT01550146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827546|NCT01550302|Bupivacaine|bupivacaine|mesh-list
64827547|NCT01550302|Anesthetics, Local|anesthetics, local|mesh-ancestor
64827548|NCT01550302|Anesthetics|anesthetics|mesh-ancestor
64827549|NCT01550302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64827550|NCT01550302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827551|NCT01550302|Sensory System Agents|sensory system agents|mesh-ancestor
64827552|NCT01550302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827553|NCT01550354|Alfentanil|alfentanil|mesh-list
64827554|NCT01550354|Propofol|propofol|mesh-list
64827555|NCT01550354|Rocuronium|rocuronium|mesh-list
64827556|NCT01550354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64827557|NCT01550354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64827558|NCT01550354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827559|NCT01550354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64827560|NCT01550354|Anesthetics, General|anesthetics, general|mesh-ancestor
64827561|NCT01550354|Anesthetics|anesthetics|mesh-ancestor
64827562|NCT01550354|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64827596|NCT01550458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827598|NCT01550640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64827599|NCT01550640|Narcotics|narcotics|mesh-ancestor
64827611|NCT01550770|Propofol|propofol|mesh-list
64827626|NCT01550848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827627|NCT01550848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64827628|NCT01550848|Immunologic Factors|immunologic factors|mesh-ancestor
64827629|NCT01550848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827630|NCT01550900|Metformin|metformin|mesh-list
64827631|NCT01550900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64827632|NCT01550900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827633|NCT01550926|Orlistat|orlistat|mesh-list
64827634|NCT01550926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827635|NCT01550926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827636|NCT01550926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64827637|NCT01550926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64827638|NCT01551069|Hydroxychloroquine|hydroxychloroquine|mesh-list
64827639|NCT01551069|Antimalarials|antimalarials|mesh-ancestor
64827640|NCT01551069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64827641|NCT01551069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64827642|NCT01551069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64827643|NCT01551069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827644|NCT01551069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827645|NCT01551069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64827646|NCT01551147|Montelukast|montelukast|mesh-list
64827647|NCT01551147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65494650|NCT00251927|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65494651|NCT00251927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827648|NCT01551147|Respiratory System Agents|respiratory system agents|mesh-ancestor
64827649|NCT01551147|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64827650|NCT01551147|Hormone Antagonists|hormone antagonists|mesh-ancestor
64827651|NCT01551147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64827652|NCT01551147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827653|NCT01551147|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64827654|NCT01551147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64827655|NCT01551147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438811|NCT02773030|Hormones|hormones|mesh-ancestor
64827679|NCT01551329|Anesthetics|anesthetics|mesh-ancestor
64827680|NCT01551329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64827681|NCT01551329|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64827682|NCT01551329|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64827683|NCT01551329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64827684|NCT01551329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827685|NCT01551368|Nimodipine|nimodipine|mesh-list
64827686|NCT01551368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64827687|NCT01551368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64827688|NCT01551368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64827689|NCT01551368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827690|NCT01551368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64827691|NCT01551368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827692|NCT01551368|Vasodilator Agents|vasodilator agents|mesh-ancestor
64827693|NCT01551394|Gentamicins|gentamicins|mesh-list
64827694|NCT01551394|Meropenem|meropenem|mesh-list
64827695|NCT01551394|Ampicillin|ampicillin|mesh-list
64827764|NCT01551667|Immunologic Factors|immunologic factors|mesh-ancestor
64827765|NCT01551667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827766|NCT01551680|Iniparib|iniparib|mesh-list
64827767|NCT01551680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64827776|NCT01551719|Tigecycline|tigecycline|mesh-list
64827777|NCT01551719|Cephalosporins|cephalosporins|mesh-list
64827778|NCT01551719|Teicoplanin|teicoplanin|mesh-list
64827779|NCT01551719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64827780|NCT01551719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64827781|NCT01551719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827782|NCT01551719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827783|NCT01551797|Acetaminophen|acetaminophen|mesh-list
64827784|NCT01551797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64827785|NCT01551797|Analgesics|analgesics|mesh-ancestor
64827786|NCT01551797|Sensory System Agents|sensory system agents|mesh-ancestor
64827787|NCT01551797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827788|NCT01551797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827789|NCT01551797|Antipyretics|antipyretics|mesh-ancestor
64827790|NCT01551810|Vaccines|vaccines|mesh-list
64827791|NCT01551810|Immunologic Factors|immunologic factors|mesh-ancestor
64827792|NCT01551810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827793|NCT01551823|Vaccines|vaccines|mesh-list
64827794|NCT01551823|Immunologic Factors|immunologic factors|mesh-ancestor
64827795|NCT01551823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827796|NCT01551836|Acetaminophen|acetaminophen|mesh-list
64827797|NCT01551836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64827798|NCT01551836|Analgesics|analgesics|mesh-ancestor
64827799|NCT01551836|Sensory System Agents|sensory system agents|mesh-ancestor
64827800|NCT01551836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827801|NCT01551836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827802|NCT01551836|Antipyretics|antipyretics|mesh-ancestor
64827803|NCT01552005|Saxagliptin|saxagliptin|mesh-list
64827804|NCT01552005|Incretins|incretins|mesh-ancestor
64827805|NCT01552005|Hormones|hormones|mesh-ancestor
64827809|NCT01552005|Protease Inhibitors|protease inhibitors|mesh-ancestor
64311405|NCT02089763|BCT-100|bct-100|mesh-list
64827815|NCT01552018|Hormones|hormones|mesh-ancestor
64827816|NCT01552018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64827817|NCT01552018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827818|NCT01552018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64827820|NCT01552018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827821|NCT01552018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827822|NCT01552018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64827823|NCT01552044|Spironolactone|spironolactone|mesh-list
64827824|NCT01552044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64827825|NCT01552044|Hormone Antagonists|hormone antagonists|mesh-ancestor
64827826|NCT01552044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64827827|NCT01552044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827828|NCT01552044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64827829|NCT01552044|Diuretics|diuretics|mesh-ancestor
64827830|NCT01552044|Natriuretic Agents|natriuretic agents|mesh-ancestor
64827831|NCT01552122|Vitamin D|vitamin d|mesh-list
64827832|NCT01552122|Cholecalciferol|cholecalciferol|mesh-list
64827833|NCT01552122|Alendronate|alendronate|mesh-list
64827834|NCT01552122|Calcium Carbonate|calcium carbonate|mesh-list
64827835|NCT01552122|Calcium|calcium|mesh-list
64827836|NCT01552122|Vitamins|vitamins|mesh-ancestor
64827837|NCT01552122|Micronutrients|micronutrients|mesh-ancestor
64438973|NCT01983462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64827843|NCT01552122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64827844|NCT01552148|Morphine|morphine|mesh-list
64827845|NCT01552148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64827846|NCT01552148|Narcotics|narcotics|mesh-ancestor
64827847|NCT01552148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64827867|NCT01552330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827868|NCT01552330|Antiviral Agents|antiviral agents|mesh-ancestor
64827869|NCT01552330|Schistosomicides|schistosomicides|mesh-ancestor
64827870|NCT01552330|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64827871|NCT01552330|Anthelmintics|anthelmintics|mesh-ancestor
64827872|NCT01552629|Cyclosporine|cyclosporine|mesh-list
64827873|NCT01552629|Cyclosporins|cyclosporins|mesh-list
64827874|NCT01552629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827875|NCT01552629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827876|NCT01552629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64827877|NCT01552629|Immunologic Factors|immunologic factors|mesh-ancestor
64827878|NCT01552629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827879|NCT01552629|Antifungal Agents|antifungal agents|mesh-ancestor
64827880|NCT01552629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64827881|NCT01552629|Dermatologic Agents|dermatologic agents|mesh-ancestor
64827882|NCT01552629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64827883|NCT01552629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64827884|NCT01552668|Fidaxomicin|fidaxomicin|mesh-list
64827885|NCT01552668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64827886|NCT01552668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64827887|NCT01552798|Aspirin|aspirin|mesh-list
64827888|NCT01552798|Acetaminophen|acetaminophen|mesh-list
64827889|NCT01552798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64827890|NCT01552798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64952048|NCT00028574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64952049|NCT00028574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952050|NCT00028574|Anticonvulsants|anticonvulsants|mesh-ancestor
64952051|NCT00028574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64952052|NCT00028574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64952053|NCT00028574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64952054|NCT00028574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64952055|NCT00028574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64952064|NCT00056433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64952065|NCT00056433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952066|NCT00056433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952067|NCT00056433|Urological Agents|urological agents|mesh-ancestor
64952068|NCT00056433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952069|NCT00056433|Antisickling Agents|antisickling agents|mesh-ancestor
64952070|NCT00056433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64952071|NCT00028613|Antibodies|antibodies|mesh-list
64952072|NCT00028613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64952073|NCT00028613|Immunologic Factors|immunologic factors|mesh-ancestor
64952074|NCT00028613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952075|NCT00028652|Interleukin-12|interleukin-12|mesh-list
64952076|NCT00028652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64952077|NCT00028652|Immunologic Factors|immunologic factors|mesh-ancestor
64952078|NCT00028652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952079|NCT00028652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64952080|NCT00028652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64952081|NCT00028652|Growth Substances|growth substances|mesh-ancestor
64952082|NCT00028652|Growth Inhibitors|growth inhibitors|mesh-ancestor
64952083|NCT00028652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952084|NCT00028691|Chlorambucil|chlorambucil|mesh-list
64827891|NCT01552798|Analgesics|analgesics|mesh-ancestor
64827892|NCT01552798|Sensory System Agents|sensory system agents|mesh-ancestor
64827893|NCT01552798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827894|NCT01552798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827895|NCT01552798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64827896|NCT01552798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64827897|NCT01552798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64827898|NCT01552798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64827899|NCT01552798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827900|NCT01552798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64827901|NCT01552798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64827902|NCT01552798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827904|NCT01552837|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64827905|NCT01552837|Antidepressive Agents|antidepressive agents|mesh-ancestor
64827906|NCT01552837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64827907|NCT01552837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64827908|NCT01552837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64827909|NCT01552837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64827925|NCT01552863|Sensory System Agents|sensory system agents|mesh-ancestor
64827926|NCT01552863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827927|NCT01552967|Capecitabine|capecitabine|mesh-list
64827928|NCT01552967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64827929|NCT01552967|Antimetabolites|antimetabolites|mesh-ancestor
64827930|NCT01552967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827931|NCT01552967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827932|NCT01552980|Oxaliplatin|oxaliplatin|mesh-list
64827933|NCT01552980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827934|NCT01552993|Acetaminophen|acetaminophen|mesh-list
64827935|NCT01552993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64827936|NCT01552993|Analgesics|analgesics|mesh-ancestor
64827951|NCT01553019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64827952|NCT01553019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827953|NCT01553019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64827954|NCT01553019|Immunologic Factors|immunologic factors|mesh-ancestor
64827955|NCT01553019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827956|NCT01553123|Ulipristal acetate|ulipristal acetate|mesh-list
64827957|NCT01553123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64827958|NCT01553123|Contraceptive Agents|contraceptive agents|mesh-ancestor
64827959|NCT01553123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64827960|NCT01553123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827961|NCT01553123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64827962|NCT01553357|Dexamethasone|dexamethasone|mesh-list
64827963|NCT01553357|Lenalidomide|lenalidomide|mesh-list
64827964|NCT01553357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64827965|NCT01553357|Antiemetics|antiemetics|mesh-ancestor
64827966|NCT01553357|Autonomic Agents|autonomic agents|mesh-ancestor
64827967|NCT01553357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827968|NCT01553357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827969|NCT01553357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64827970|NCT01553357|Glucocorticoids|glucocorticoids|mesh-ancestor
64827971|NCT01553357|Hormones|hormones|mesh-ancestor
64827990|NCT01553500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64827991|NCT01553617|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
64827992|NCT01553617|Plasma Substitutes|plasma substitutes|mesh-ancestor
64827993|NCT01553617|Blood Substitutes|blood substitutes|mesh-ancestor
64827994|NCT01553721|Udenafil|udenafil|mesh-list
64827995|NCT01553721|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64827996|NCT01553721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64827997|NCT01553721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827998|NCT01553721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828015|NCT01553903|Exemestane|exemestane|mesh-list
64828016|NCT01553903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828017|NCT01553903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64828018|NCT01553903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64828019|NCT01553903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828020|NCT01553903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828021|NCT01553903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64828022|NCT01553903|Hormone Antagonists|hormone antagonists|mesh-ancestor
64828023|NCT01553903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64828024|NCT01553903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828025|NCT01553903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64828051|NCT01554059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828053|NCT01554111|Picosulfate sodium|picosulfate sodium|mesh-list
64828054|NCT01554111|Cathartics|cathartics|mesh-ancestor
64828055|NCT01554111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64828056|NCT01554124|Meropenem|meropenem|mesh-list
64828057|NCT01554124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64828058|NCT01554124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64828059|NCT01554254|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
64828060|NCT01554254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64828061|NCT01554254|Vasodilator Agents|vasodilator agents|mesh-ancestor
64828062|NCT01554345|Vitamin E|vitamin e|mesh-list
64828063|NCT01554345|Selenium|selenium|mesh-list
64828064|NCT01554345|Vitamins|vitamins|mesh-ancestor
64828065|NCT01554345|Micronutrients|micronutrients|mesh-ancestor
64828066|NCT01554345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828067|NCT01554345|Antioxidants|antioxidants|mesh-ancestor
64828068|NCT01554345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828069|NCT01554345|Protective Agents|protective agents|mesh-ancestor
64828070|NCT01554345|Trace Elements|trace elements|mesh-ancestor
64828071|NCT01554397|Cisplatin|cisplatin|mesh-list
64828072|NCT01554397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828100|NCT01554852|Dexamethasone acetate|dexamethasone acetate|mesh-list
64828101|NCT01554852|Cyclophosphamide|cyclophosphamide|mesh-list
64828102|NCT01554852|Melphalan|melphalan|mesh-list
64828103|NCT01554852|Lenalidomide|lenalidomide|mesh-list
64828104|NCT01554852|Bortezomib|bortezomib|mesh-list
64828105|NCT01554852|Vorinostat|vorinostat|mesh-list
64828106|NCT01554852|BB 1101|bb 1101|mesh-list
64828107|NCT01554852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64828108|NCT01554852|Immunologic Factors|immunologic factors|mesh-ancestor
64828109|NCT01554852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828110|NCT01554852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64828111|NCT01554852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64828112|NCT01554852|Alkylating Agents|alkylating agents|mesh-ancestor
64828113|NCT01554852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828114|NCT01554852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828115|NCT01554852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64828116|NCT01554852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64828117|NCT01554852|Antiemetics|antiemetics|mesh-ancestor
64828118|NCT01554852|Autonomic Agents|autonomic agents|mesh-ancestor
64828119|NCT01554852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64828120|NCT01554852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64828121|NCT01554852|Glucocorticoids|glucocorticoids|mesh-ancestor
64828122|NCT01554852|Hormones|hormones|mesh-ancestor
64828123|NCT01554852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64828124|NCT01554852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64828125|NCT01554852|Protease Inhibitors|protease inhibitors|mesh-ancestor
64828126|NCT01554852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828127|NCT01554852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64828128|NCT01554852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64828129|NCT01554852|Growth Substances|growth substances|mesh-ancestor
64828130|NCT01554852|Growth Inhibitors|growth inhibitors|mesh-ancestor
64828131|NCT01554852|Leprostatic Agents|leprostatic agents|mesh-ancestor
64828132|NCT01554852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64828133|NCT01554852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64828147|NCT01554930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64828148|NCT01554930|Protective Agents|protective agents|mesh-ancestor
64952085|NCT00028691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64952086|NCT00028691|Alkylating Agents|alkylating agents|mesh-ancestor
64952087|NCT00028691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952088|NCT00028691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952089|NCT00028730|Cyclophosphamide|cyclophosphamide|mesh-list
64952090|NCT00028730|Thiotepa|thiotepa|mesh-list
64828149|NCT01554930|Immunologic Factors|immunologic factors|mesh-ancestor
64828150|NCT01554930|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64828151|NCT01554930|Diuretics|diuretics|mesh-ancestor
64828152|NCT01554930|Natriuretic Agents|natriuretic agents|mesh-ancestor
64828153|NCT01554969|Capecitabine|capecitabine|mesh-list
64828154|NCT01554969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64828155|NCT01554969|Antimetabolites|antimetabolites|mesh-ancestor
64828156|NCT01554969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828157|NCT01554969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828158|NCT01554995|Linezolid|linezolid|mesh-list
64828159|NCT01554995|Delpazolid|delpazolid|mesh-list
64828160|NCT01554995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64828161|NCT01554995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64828162|NCT01554995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64828163|NCT01554995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828164|NCT01554995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828165|NCT01555008|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
64828166|NCT01555008|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64828167|NCT01555008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828168|NCT01555008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64472833|NCT02604732|Aspirin|aspirin|mesh-list
64565527|NCT03032783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64828169|NCT01555008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828170|NCT01555060|Ferrous gluconate|ferrous gluconate|mesh-list
64828171|NCT01555060|Hematinics|hematinics|mesh-ancestor
64828172|NCT01555099|Budesonide|budesonide|mesh-list
64828173|NCT01555099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64828174|NCT01555099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64828175|NCT01555099|Autonomic Agents|autonomic agents|mesh-ancestor
64828176|NCT01555099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64828177|NCT01555099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828178|NCT01555099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64828179|NCT01555099|Respiratory System Agents|respiratory system agents|mesh-ancestor
64828180|NCT01555099|Glucocorticoids|glucocorticoids|mesh-ancestor
64828181|NCT01555099|Hormones|hormones|mesh-ancestor
64312175|NCT02107391|Goserelin|goserelin|mesh-list
64952091|NCT00028730|Fludarabine|fludarabine|mesh-list
64952092|NCT00028730|Fludarabine phosphate|fludarabine phosphate|mesh-list
64952093|NCT00028730|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64828182|NCT01555099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64828183|NCT01555112|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
64828184|NCT01555112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64828185|NCT01555112|Immunologic Factors|immunologic factors|mesh-ancestor
64828186|NCT01555112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828187|NCT01555112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828188|NCT01555112|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64828189|NCT01555112|Protective Agents|protective agents|mesh-ancestor
64828190|NCT01555112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64828191|NCT01555112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64828192|NCT01555112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828193|NCT01555112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828207|NCT01555216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828208|NCT01555216|Sensory System Agents|sensory system agents|mesh-ancestor
64828209|NCT01555216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64828210|NCT01555398|Fenofibric acid|fenofibric acid|mesh-list
64828211|NCT01555398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64828212|NCT01555398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64828213|NCT01555398|Antimetabolites|antimetabolites|mesh-ancestor
64828214|NCT01555398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828215|NCT01555398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64828216|NCT01555476|Ibuprofen|ibuprofen|mesh-list
64828217|NCT01555476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64828218|NCT01555476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64828219|NCT01555476|Analgesics|analgesics|mesh-ancestor
64828220|NCT01555476|Sensory System Agents|sensory system agents|mesh-ancestor
64828221|NCT01555476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64828222|NCT01555476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828236|NCT01555632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828237|NCT01555632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64828238|NCT01555632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64828239|NCT01555632|Antimetabolites|antimetabolites|mesh-ancestor
64828240|NCT01555632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828241|NCT01555632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64828242|NCT01555632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64828243|NCT01555632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828244|NCT01555658|Heparin|heparin|mesh-list
64828245|NCT01555658|Bivalirudin|bivalirudin|mesh-list
64828246|NCT01555658|Anticoagulants|anticoagulants|mesh-ancestor
64828247|NCT01555658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64828248|NCT01555658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64828249|NCT01555658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828250|NCT01555658|Antithrombins|antithrombins|mesh-ancestor
64828251|NCT01555658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65494652|NCT00251927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472834|NCT02604732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64472835|NCT02604732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64472836|NCT02604732|Analgesics|analgesics|mesh-ancestor
64472837|NCT02604732|Sensory System Agents|sensory system agents|mesh-ancestor
64472838|NCT02604732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312442|NCT03188289|Hemostatics|hemostatics|mesh-ancestor
64952094|NCT00028730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64952095|NCT00028730|Immunologic Factors|immunologic factors|mesh-ancestor
64952096|NCT00028730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952097|NCT00028730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64952098|NCT00028730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64952099|NCT00028730|Alkylating Agents|alkylating agents|mesh-ancestor
64952100|NCT00028730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725740|NCT03805022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64725741|NCT03805022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725742|NCT03805022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725748|NCT00003050|Tamoxifen|tamoxifen|mesh-list
64725749|NCT00003050|Paclitaxel|paclitaxel|mesh-list
64725750|NCT00003050|Cyclophosphamide|cyclophosphamide|mesh-list
64725751|NCT00003050|Doxorubicin|doxorubicin|mesh-list
64725752|NCT00003050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64725753|NCT00003050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64725754|NCT00003050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725755|NCT00003050|Tubulin Modulators|tubulin modulators|mesh-ancestor
64725756|NCT00003050|Antimitotic Agents|antimitotic agents|mesh-ancestor
64725757|NCT00003050|Mitosis Modulators|mitosis modulators|mesh-ancestor
64725758|NCT00003050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725759|NCT00003050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64725760|NCT00003050|Immunologic Factors|immunologic factors|mesh-ancestor
64725761|NCT00003050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725762|NCT00003050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64725763|NCT00003050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64472839|NCT02604732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472840|NCT02604732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64472841|NCT02604732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64472842|NCT02604732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64472843|NCT02604732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64472844|NCT02604732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472845|NCT02604732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64472846|NCT02604732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64828252|NCT01555658|Protease Inhibitors|protease inhibitors|mesh-ancestor
64828253|NCT01555658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828254|NCT01555710|Carboplatin|carboplatin|mesh-list
64828255|NCT01555710|Etoposide|etoposide|mesh-list
64828256|NCT01555710|Isophosphamide mustard|isophosphamide mustard|mesh-list
64828257|NCT01555710|Ifosfamide|ifosfamide|mesh-list
64828258|NCT01555710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439398|NCT04661397|Cobicistat|cobicistat|mesh-list
64828262|NCT01555710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828263|NCT01555710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828264|NCT01555710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64828265|NCT01555710|Alkylating Agents|alkylating agents|mesh-ancestor
64828266|NCT01555788|Pancrelipase|pancrelipase|mesh-list
64828267|NCT01555788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64828268|NCT01555814|Amisulpride|amisulpride|mesh-list
64828269|NCT01555814|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64828270|NCT01555814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64828271|NCT01555814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64828272|NCT01555814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828273|NCT01555814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64828274|NCT01555814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64828275|NCT01555814|Dopamine Agents|dopamine agents|mesh-ancestor
64828276|NCT01555814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64828277|NCT01555814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313021|NCT04833296|Anesthetics, Local|anesthetics, local|mesh-ancestor
64828289|NCT01555879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64828290|NCT01555879|Immunologic Factors|immunologic factors|mesh-ancestor
64828291|NCT01555879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828292|NCT01555879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64828293|NCT01555918|Isavuconazole|isavuconazole|mesh-list
64828294|NCT01555918|Antifungal Agents|antifungal agents|mesh-ancestor
64828295|NCT01555918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64828296|NCT01555970|Acetylcysteine|acetylcysteine|mesh-list
64828297|NCT01555970|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64828298|NCT01555970|Antiviral Agents|antiviral agents|mesh-ancestor
64828299|NCT01555970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64828300|NCT01555970|Expectorants|expectorants|mesh-ancestor
64828301|NCT01555970|Respiratory System Agents|respiratory system agents|mesh-ancestor
64828302|NCT01555970|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65494653|NCT03790800|Urapidil|urapidil|mesh-list
65494654|NCT03790800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65494655|NCT03790800|Vasodilator Agents|vasodilator agents|mesh-ancestor
65494656|NCT03790800|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65494657|NCT03790800|Serotonin Agents|serotonin agents|mesh-ancestor
65494658|NCT03790800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65494659|NCT03790800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494660|NCT03790800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494661|NCT03790800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65494662|NCT03790800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65494663|NCT03790800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65494664|NCT03790800|Adrenergic Agents|adrenergic agents|mesh-ancestor
65494665|NCT03971201|Sorafenib|sorafenib|mesh-list
65494666|NCT03971201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472847|NCT02604732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828303|NCT01555970|Antioxidants|antioxidants|mesh-ancestor
64828304|NCT01555970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828305|NCT01555970|Protective Agents|protective agents|mesh-ancestor
64828316|NCT01556191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64828317|NCT01556191|Fulvestrant|fulvestrant|mesh-list
64828318|NCT01556191|Gefitinib|gefitinib|mesh-list
64828319|NCT01556191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828320|NCT01556191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64828321|NCT01556191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828322|NCT01556191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828323|NCT01556191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64828324|NCT01556191|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64828325|NCT01556191|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64828326|NCT01556191|Hormone Antagonists|hormone antagonists|mesh-ancestor
64828327|NCT01556191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64828328|NCT01556191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828329|NCT01556321|Caffeine|caffeine|mesh-list
64828346|NCT01556334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64828347|NCT01556334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64828349|NCT01556334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828351|NCT01556477|Azacitidine|azacitidine|mesh-list
64828352|NCT01556477|Immunologic Factors|immunologic factors|mesh-ancestor
64828353|NCT01556477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828354|NCT01556477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64828355|NCT01556477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64828356|NCT01556477|Growth Substances|growth substances|mesh-ancestor
64828357|NCT01556477|Growth Inhibitors|growth inhibitors|mesh-ancestor
64828358|NCT01556477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828359|NCT01556477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64828360|NCT01556477|Antimetabolites|antimetabolites|mesh-ancestor
64828361|NCT01556477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828362|NCT01556477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828363|NCT01556529|Unithiol|unithiol|mesh-list
64828364|NCT01556529|Antidotes|antidotes|mesh-ancestor
64828370|NCT01556542|Paclitaxel|paclitaxel|mesh-list
64828375|NCT01556542|Mitosis Modulators|mitosis modulators|mesh-ancestor
64828376|NCT01556542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828377|NCT01556646|Tolvaptan|tolvaptan|mesh-list
64828378|NCT01556646|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64828379|NCT01556646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828380|NCT01556646|Natriuretic Agents|natriuretic agents|mesh-ancestor
64828381|NCT01556646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828382|NCT01556659|Acenocoumarol|acenocoumarol|mesh-list
64828383|NCT01556659|Anticoagulants|anticoagulants|mesh-ancestor
64828384|NCT01556672|Adalimumab|adalimumab|mesh-list
64828385|NCT01556672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64828386|NCT01556672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64828387|NCT01556698|Nitric Oxide|nitric oxide|mesh-list
64828406|NCT01556737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828407|NCT01556737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828408|NCT01556737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64828409|NCT01556737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828410|NCT01556737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494667|NCT03971201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64472848|NCT02604732|Antipyretics|antipyretics|mesh-ancestor
64828411|NCT01556737|Phytoestrogens|phytoestrogens|mesh-ancestor
64828412|NCT01556737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64828413|NCT01556737|Estrogens|estrogens|mesh-ancestor
64828414|NCT01556737|Hormones|hormones|mesh-ancestor
64828415|NCT01556737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64828416|NCT01556815|Sorafenib|sorafenib|mesh-list
64828417|NCT01556815|Chlorotrianisene|chlorotrianisene|mesh-list
64828418|NCT01556815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597005|NCT00670241|Betamethasone|betamethasone|mesh-list
64828419|NCT01556815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64828420|NCT01556815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828421|NCT01556815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828423|NCT01556815|Estrogens|estrogens|mesh-ancestor
64828424|NCT01556815|Hormones|hormones|mesh-ancestor
64828431|NCT01557075|Pravastatin|pravastatin|mesh-list
64828432|NCT01557075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
64828433|NCT01557075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64828434|NCT01557075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64828435|NCT01557075|Antimetabolites|antimetabolites|mesh-ancestor
64828436|NCT01557075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828437|NCT01557075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64828438|NCT01557075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828439|NCT01557114|Ipilimumab|ipilimumab|mesh-list
64828440|NCT01557114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64828441|NCT01557114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828442|NCT01557114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64828443|NCT01557114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828452|NCT01557140|Adrenergic Agents|adrenergic agents|mesh-ancestor
64828453|NCT01557140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64828454|NCT01557140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828455|NCT01557140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828456|NCT01557140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64828457|NCT01557140|Antioxidants|antioxidants|mesh-ancestor
64828458|NCT01557140|Protective Agents|protective agents|mesh-ancestor
64828459|NCT01557140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64828460|NCT01557140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64828461|NCT01557140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64828462|NCT01557140|Vasodilator Agents|vasodilator agents|mesh-ancestor
64828463|NCT01557140|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64828464|NCT01557140|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64828484|NCT01557270|Dexmedetomidine|dexmedetomidine|mesh-list
64828485|NCT01557270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64828486|NCT01557270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64828487|NCT01557270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828488|NCT01557270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64828489|NCT01557270|Analgesics|analgesics|mesh-ancestor
64828490|NCT01557270|Sensory System Agents|sensory system agents|mesh-ancestor
65494668|NCT03971201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472855|NCT02562235|Riociguat|riociguat|mesh-list
64828491|NCT01557270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64828492|NCT01557270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64828493|NCT01557270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64828494|NCT01557270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64828495|NCT01557270|Adrenergic Agents|adrenergic agents|mesh-ancestor
64828496|NCT01557270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64828497|NCT01557270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828498|NCT01557335|Aspirin|aspirin|mesh-list
64828499|NCT01557335|Omeprazole|omeprazole|mesh-list
64828500|NCT01557335|Clopidogrel|clopidogrel|mesh-list
64828501|NCT01557335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64828502|NCT01557335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64828503|NCT01557335|Analgesics|analgesics|mesh-ancestor
64828504|NCT01557335|Sensory System Agents|sensory system agents|mesh-ancestor
64828505|NCT01557335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64828506|NCT01557335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828507|NCT01557335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64828508|NCT01557335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64439652|NCT01939197|Ritonavir|ritonavir|mesh-list
64828514|NCT01557335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828515|NCT01557335|Antipyretics|antipyretics|mesh-ancestor
64828531|NCT01557374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64828532|NCT01557439|Levocetirizine|levocetirizine|mesh-list
64828533|NCT01557439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64828534|NCT01557439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64828535|NCT01557439|Histamine Antagonists|histamine antagonists|mesh-ancestor
64828536|NCT01557439|Histamine Agents|histamine agents|mesh-ancestor
64828537|NCT01557439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64828538|NCT01557439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828539|NCT01557439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828540|NCT01557478|Melatonin|melatonin|mesh-list
64828541|NCT01557478|Antioxidants|antioxidants|mesh-ancestor
64828542|NCT01557478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828596|NCT01557816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828597|NCT01557816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828598|NCT01557829|Silicon|silicon|mesh-list
64828599|NCT01557829|Trace Elements|trace elements|mesh-ancestor
64828600|NCT01557829|Micronutrients|micronutrients|mesh-ancestor
64828601|NCT01557829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828602|NCT01557907|Insulin|insulin|mesh-list
64828603|NCT01557907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64828604|NCT01557907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64828605|NCT01557907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828606|NCT01557985|Bupivacaine|bupivacaine|mesh-list
64828607|NCT01557985|Anesthetics, Local|anesthetics, local|mesh-ancestor
64828608|NCT01557985|Anesthetics|anesthetics|mesh-ancestor
64828609|NCT01557985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64828610|NCT01557985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828611|NCT01557985|Sensory System Agents|sensory system agents|mesh-ancestor
64828612|NCT01557985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64828659|NCT01558245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828660|NCT01558310|Ustekinumab|ustekinumab|mesh-list
64828661|NCT01558310|Dermatologic Agents|dermatologic agents|mesh-ancestor
64828662|NCT01558336|Praziquantel|praziquantel|mesh-list
64828663|NCT01558336|Anthelmintics|anthelmintics|mesh-ancestor
64828664|NCT01558336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64828665|NCT01558336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64828666|NCT01558375|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64828667|NCT01558375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64828668|NCT01558453|Oxaliplatin|oxaliplatin|mesh-list
64828669|NCT01558453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828670|NCT01558466|Sildenafil Citrate|sildenafil citrate|mesh-list
64828671|NCT01558466|Vasodilator Agents|vasodilator agents|mesh-ancestor
64828672|NCT01558466|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64828673|NCT01558466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64828674|NCT01558466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828675|NCT01558466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828676|NCT01558466|Urological Agents|urological agents|mesh-ancestor
64828677|NCT01558622|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
64828678|NCT01558622|Ketoprofen|ketoprofen|mesh-list
64828679|NCT01558622|Meperidine|meperidine|mesh-list
64828680|NCT01558622|Tramadol|tramadol|mesh-list
64828681|NCT01558622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828682|NCT01558622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828683|NCT01558622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64828684|NCT01558622|Narcotics|narcotics|mesh-ancestor
64828685|NCT01558622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64828686|NCT01558622|Analgesics|analgesics|mesh-ancestor
64828687|NCT01558622|Sensory System Agents|sensory system agents|mesh-ancestor
64828688|NCT01558622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64828689|NCT01558622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64828690|NCT01558622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64828691|NCT01558622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64828692|NCT01558622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64828700|NCT01558713|Fentanyl|fentanyl|mesh-list
64828701|NCT01558713|Bupivacaine|bupivacaine|mesh-list
64828702|NCT01558713|Ropivacaine|ropivacaine|mesh-list
64828703|NCT01558713|Levobupivacaine|levobupivacaine|mesh-list
64828704|NCT01558713|Anesthetics, Local|anesthetics, local|mesh-ancestor
64828705|NCT01558713|Anesthetics|anesthetics|mesh-ancestor
64828706|NCT01558713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64828707|NCT01558713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828708|NCT01558713|Sensory System Agents|sensory system agents|mesh-ancestor
64828718|NCT01558830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64828719|NCT01558830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828721|NCT01558869|Oxaliplatin|oxaliplatin|mesh-list
64828722|NCT01558869|Irinotecan|irinotecan|mesh-list
64828723|NCT01558869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64828724|NCT01558869|Antimetabolites|antimetabolites|mesh-ancestor
64828725|NCT01558869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828726|NCT01558869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828727|NCT01558869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64828728|NCT01558869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64828729|NCT01558869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828730|NCT01558934|Lofexidine|lofexidine|mesh-list
64828731|NCT01558934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64828732|NCT01558934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65494671|NCT01236144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65494672|NCT01236144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65494673|NCT01236144|Antiviral Agents|antiviral agents|mesh-ancestor
65494674|NCT01236144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494675|NCT02528526|Inositol|inositol|mesh-list
65494676|NCT02528526|Vitamin B Complex|vitamin b complex|mesh-ancestor
65494677|NCT02528526|Vitamins|vitamins|mesh-ancestor
64566052|NCT05292664|Leucovorin|leucovorin|mesh-list
64828748|NCT01558960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64828749|NCT01558960|Immunologic Factors|immunologic factors|mesh-ancestor
64828750|NCT01558960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828751|NCT01558986|Cefazolin|cefazolin|mesh-list
64828752|NCT01558986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64828753|NCT01558986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64828754|NCT01559025|Vildagliptin|vildagliptin|mesh-list
64828755|NCT01559025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64828756|NCT01559025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64828757|NCT01559025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828758|NCT01559025|Protease Inhibitors|protease inhibitors|mesh-ancestor
64828759|NCT01559025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828760|NCT01559025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828761|NCT01559051|Anesthetics|anesthetics|mesh-list
64828762|NCT01559051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64828763|NCT01559051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828764|NCT01559142|Azathioprine|azathioprine|mesh-list
64828765|NCT01559142|Infliximab|infliximab|mesh-list
64828766|NCT01559142|Dermatologic Agents|dermatologic agents|mesh-ancestor
64828767|NCT01559142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64828768|NCT01559142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64828769|NCT01559142|Antimetabolites|antimetabolites|mesh-ancestor
64828770|NCT01559142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828771|NCT01559142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64828772|NCT01559142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828778|NCT01559272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64828779|NCT01559272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64828780|NCT01559272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828781|NCT01559272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64828782|NCT01559272|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64828783|NCT01559272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64386891|NCT02381717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64828796|NCT01559285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64828797|NCT01559298|Aspirin|aspirin|mesh-list
64828798|NCT01559298|Clopidogrel|clopidogrel|mesh-list
64828799|NCT01559298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64828800|NCT01559298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64828801|NCT01559298|Analgesics|analgesics|mesh-ancestor
64828802|NCT01559298|Sensory System Agents|sensory system agents|mesh-ancestor
64828803|NCT01559298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64828804|NCT01559298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828805|NCT01559298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64828806|NCT01559298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64828807|NCT01559298|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64828808|NCT01559298|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64828809|NCT01559298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494678|NCT02528526|Micronutrients|micronutrients|mesh-ancestor
64828810|NCT01559298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64828811|NCT01559298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64828812|NCT01559298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828813|NCT01559298|Antipyretics|antipyretics|mesh-ancestor
64828814|NCT01559298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64387528|NCT05653817|Mitosis Modulators|mitosis modulators|mesh-ancestor
64828878|NCT01559753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64828879|NCT01559974|Cholecalciferol|cholecalciferol|mesh-list
64828880|NCT01559974|Vitamin D|vitamin d|mesh-list
64828881|NCT01559974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64828882|NCT01559974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828883|NCT01559974|Vitamins|vitamins|mesh-ancestor
64828884|NCT01559974|Micronutrients|micronutrients|mesh-ancestor
64440046|NCT02246647|Mannitol|mannitol|mesh-list
64828920|NCT05570409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828921|NCT05570409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64828922|NCT05570409|Antiemetics|antiemetics|mesh-ancestor
64828923|NCT05570409|Autonomic Agents|autonomic agents|mesh-ancestor
64828924|NCT05570409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64828939|NCT05570084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64828940|NCT05570084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597529|NCT00632411|Nicotine|nicotine|mesh-list
64828941|NCT05570084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828942|NCT05570084|Urological Agents|urological agents|mesh-ancestor
64828943|NCT05569668|Paclitaxel|paclitaxel|mesh-list
64828944|NCT05569668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64828945|NCT05569668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828946|NCT05569668|Tubulin Modulators|tubulin modulators|mesh-ancestor
64828947|NCT05569668|Antimitotic Agents|antimitotic agents|mesh-ancestor
64828948|NCT05569668|Mitosis Modulators|mitosis modulators|mesh-ancestor
64828949|NCT05569668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828950|NCT05569655|Furosemide|furosemide|mesh-list
64828951|NCT05569655|Tolvaptan|tolvaptan|mesh-list
64828952|NCT05569655|Diuretics|diuretics|mesh-ancestor
64828953|NCT05569655|Natriuretic Agents|natriuretic agents|mesh-ancestor
64828954|NCT05569655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828955|NCT05569655|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64828956|NCT05569655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64828957|NCT05569655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828958|NCT05569655|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64828959|NCT05569590|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64828960|NCT05569590|Propolis|propolis|mesh-list
64828961|NCT05569590|Fluorides|fluorides|mesh-list
64828962|NCT05569590|Fluorides, Topical|fluorides, topical|mesh-list
64472877|NCT02444429|Autonomic Agents|autonomic agents|mesh-ancestor
64472878|NCT02444429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64472879|NCT02444429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472880|NCT02444429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64472881|NCT02444429|Glucocorticoids|glucocorticoids|mesh-ancestor
64472883|NCT02444429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64472884|NCT02444429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64472885|NCT02444429|Protective Agents|protective agents|mesh-ancestor
64472886|NCT02444429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64472887|NCT02444429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472888|NCT02388906|Nivolumab|nivolumab|mesh-list
64472889|NCT02388906|Ipilimumab|ipilimumab|mesh-list
64828963|NCT05569590|Cariostatic Agents|cariostatic agents|mesh-ancestor
64828964|NCT05569590|Protective Agents|protective agents|mesh-ancestor
64828965|NCT05569590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828966|NCT05569590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64828967|NCT05569590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64828968|NCT05569577|Estrogens|estrogens|mesh-list
64828969|NCT05569577|Dydrogesterone|dydrogesterone|mesh-list
64828970|NCT05569577|Hormones|hormones|mesh-ancestor
64828971|NCT05569577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64828972|NCT05569577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828973|NCT05569577|Progestins|progestins|mesh-ancestor
64828974|NCT05569031|Lofexidine|lofexidine|mesh-list
64828975|NCT05569031|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64828976|NCT05569031|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64387934|NCT02358161|Immunologic Factors|immunologic factors|mesh-ancestor
64828999|NCT05564741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829000|NCT05564741|Sympathomimetics|sympathomimetics|mesh-ancestor
64829001|NCT05564741|Autonomic Agents|autonomic agents|mesh-ancestor
64829002|NCT05564741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829003|NCT05564741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64829004|NCT05522582|Methotrexate|methotrexate|mesh-list
64829005|NCT05522582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64829006|NCT05522582|Antibodies|antibodies|mesh-list
64829007|NCT05522582|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64829008|NCT05522582|Immunologic Factors|immunologic factors|mesh-ancestor
64829009|NCT05522582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829010|NCT05522582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64829011|NCT05522582|Abortifacient Agents|abortifacient agents|mesh-ancestor
64829012|NCT05522582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64829013|NCT05522582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65494679|NCT02528526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494680|NCT03971279|Dexamethasone|dexamethasone|mesh-list
65494681|NCT03971279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65494682|NCT03971279|Antiemetics|antiemetics|mesh-ancestor
65494683|NCT03971279|Autonomic Agents|autonomic agents|mesh-ancestor
65494684|NCT03971279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65494685|NCT03971279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494686|NCT03971279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65494687|NCT03971279|Glucocorticoids|glucocorticoids|mesh-ancestor
65494688|NCT03971279|Hormones|hormones|mesh-ancestor
65494689|NCT03971279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64388139|NCT02352155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64388140|NCT02352155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829026|NCT05491304|Antiemetics|antiemetics|mesh-ancestor
64829027|NCT05491304|Autonomic Agents|autonomic agents|mesh-ancestor
64829028|NCT05491304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829029|NCT05491304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829030|NCT05491304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64829031|NCT05491304|Glucocorticoids|glucocorticoids|mesh-ancestor
64829032|NCT05491304|Hormones|hormones|mesh-ancestor
64829033|NCT05491304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64829034|NCT05491304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64829035|NCT05491304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829036|NCT05491304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64829037|NCT05491304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64829038|NCT05491304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64829039|NCT05491304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829040|NCT05491304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829041|NCT05461794|Docetaxel|docetaxel|mesh-list
64829042|NCT05461794|Irinotecan|irinotecan|mesh-list
64829043|NCT05461794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829044|NCT05461794|Tubulin Modulators|tubulin modulators|mesh-ancestor
64829045|NCT05461794|Antimitotic Agents|antimitotic agents|mesh-ancestor
64829046|NCT05461794|Mitosis Modulators|mitosis modulators|mesh-ancestor
64829047|NCT05461794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829048|NCT05461794|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64829049|NCT05461794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64829050|NCT05461794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829051|NCT05391555|Remifentanil|remifentanil|mesh-list
64829052|NCT05391555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64829053|NCT05391555|Narcotics|narcotics|mesh-ancestor
64829097|NCT05229965|Codeine|codeine|mesh-list
64829110|NCT05229965|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64829111|NCT05229965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64829112|NCT05229965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829117|NCT05229965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64829119|NCT05219604|Promethazine|promethazine|mesh-list
65494691|NCT03971279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494692|NCT01329744|Mecasermin|mecasermin|mesh-list
65494693|NCT01329744|Growth Substances|growth substances|mesh-ancestor
65494694|NCT01329744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494695|NCT00165503|Sodium thiosulfate|sodium thiosulfate|mesh-list
65494696|NCT00165503|Pemetrexed|pemetrexed|mesh-list
65494697|NCT00165503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494698|NCT00165503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829120|NCT05219604|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64829121|NCT05219604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64829122|NCT05219604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64829123|NCT05219604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829124|NCT05219604|Anesthetics, Local|anesthetics, local|mesh-ancestor
64829125|NCT05219604|Anesthetics|anesthetics|mesh-ancestor
64829126|NCT05219604|Sensory System Agents|sensory system agents|mesh-ancestor
64829127|NCT05219604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829128|NCT05219604|Antiemetics|antiemetics|mesh-ancestor
64829129|NCT05219604|Autonomic Agents|autonomic agents|mesh-ancestor
64829130|NCT05219604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64829131|NCT05219604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64829132|NCT05219604|Histamine Antagonists|histamine antagonists|mesh-ancestor
64829133|NCT05219604|Histamine Agents|histamine agents|mesh-ancestor
64829134|NCT05219604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64829135|NCT05219604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829136|NCT05219604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64829137|NCT05219604|Antipruritics|antipruritics|mesh-ancestor
64829138|NCT05219604|Dermatologic Agents|dermatologic agents|mesh-ancestor
64829139|NCT05166811|Magnesium Sulfate|magnesium sulfate|mesh-list
64829140|NCT05166811|Analgesics|analgesics|mesh-ancestor
64829141|NCT05166811|Sensory System Agents|sensory system agents|mesh-ancestor
64829142|NCT05166811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829143|NCT05166811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390600|NCT02018458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64829146|NCT05166811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64829147|NCT05166811|Anticonvulsants|anticonvulsants|mesh-ancestor
64829148|NCT05166811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64829149|NCT05166811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64829150|NCT05166811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829151|NCT05166811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64829152|NCT05166811|Tocolytic Agents|tocolytic agents|mesh-ancestor
64829153|NCT05166811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64829154|NCT05137080|Dexamethasone|dexamethasone|mesh-list
64829155|NCT05137080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64829156|NCT05137080|Antiemetics|antiemetics|mesh-ancestor
64829157|NCT05137080|Autonomic Agents|autonomic agents|mesh-ancestor
64829158|NCT05137080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829159|NCT05137080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829160|NCT05137080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64829161|NCT05137080|Glucocorticoids|glucocorticoids|mesh-ancestor
64829163|NCT05137080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64829164|NCT05137080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64829165|NCT05137080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829166|NCT04873323|Moxifloxacin|moxifloxacin|mesh-list
64829167|NCT04873323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64829168|NCT04873323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64829169|NCT04873323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64829170|NCT04873323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64829171|NCT04873323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829172|NCT04873323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829173|NCT04873323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829174|NCT04818034|Dapagliflozin|dapagliflozin|mesh-list
64829177|NCT04818034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64390841|NCT05106517|Denosumab|denosumab|mesh-list
64829194|NCT04713358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829195|NCT04713358|Sensory System Agents|sensory system agents|mesh-ancestor
64829196|NCT04713358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829197|NCT04696952|Zopiclone|zopiclone|mesh-list
64829198|NCT04696952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64829199|NCT04696952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64829200|NCT04696952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829201|NCT04599062|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
64829202|NCT04599062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64829203|NCT04599062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829204|NCT04571619|Buprenorphine|buprenorphine|mesh-list
64829205|NCT04571619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64829206|NCT04571619|Narcotics|narcotics|mesh-ancestor
64829207|NCT04571619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64829208|NCT04571619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829209|NCT04571619|Analgesics|analgesics|mesh-ancestor
64829210|NCT04571619|Sensory System Agents|sensory system agents|mesh-ancestor
64829211|NCT04571619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829212|NCT04571619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64829213|NCT04496999|Midostaurin|midostaurin|mesh-list
64829214|NCT04496999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829215|NCT04496999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64829216|NCT04496999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829217|NCT04496999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829218|NCT04492722|Dapagliflozin|dapagliflozin|mesh-list
64829219|NCT04492722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64829220|NCT04492722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829221|NCT04492722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64829222|NCT04492722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829223|NCT04474366|Ropivacaine|ropivacaine|mesh-list
64829225|NCT04474366|Anesthetics|anesthetics|mesh-ancestor
64391292|NCT05736887|Antiviral Agents|antiviral agents|mesh-ancestor
64829234|NCT04464265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64829235|NCT04464265|Anesthetics, General|anesthetics, general|mesh-ancestor
64829236|NCT04464265|Anesthetics|anesthetics|mesh-ancestor
64829237|NCT04437303|Anticoagulants|anticoagulants|mesh-list
64829238|NCT04424511|Azithromycin|azithromycin|mesh-list
64829239|NCT04424511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64829240|NCT04424511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64829241|NCT04421079|Resveratrol|resveratrol|mesh-list
64829242|NCT04421079|Antioxidants|antioxidants|mesh-ancestor
64829243|NCT04421079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829244|NCT04421079|Protective Agents|protective agents|mesh-ancestor
64829245|NCT04421079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829246|NCT04421079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829247|NCT04421079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64829266|NCT04410406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829267|NCT04393506|Apatinib|apatinib|mesh-list
64829268|NCT04393506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64829269|NCT04393506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829270|NCT04393506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64829271|NCT04393506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829272|NCT04393506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829273|NCT04349826|Azithromycin|azithromycin|mesh-list
64829274|NCT04349826|Cefixime|cefixime|mesh-list
64829275|NCT04349826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64829276|NCT04349826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64829277|NCT04340258|Pembrolizumab|pembrolizumab|mesh-list
64829278|NCT04340258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64829279|NCT04340258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829280|NCT04298853|Morphine|morphine|mesh-list
64829281|NCT04298853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64829282|NCT04298853|Narcotics|narcotics|mesh-ancestor
64829283|NCT04298853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64829284|NCT04298853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829285|NCT04298853|Analgesics|analgesics|mesh-ancestor
64829286|NCT04298853|Sensory System Agents|sensory system agents|mesh-ancestor
64829287|NCT04298853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829288|NCT04232683|Tamsulosin|tamsulosin|mesh-list
64829290|NCT04232683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64829291|NCT04232683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64829292|NCT04232683|Adrenergic Agents|adrenergic agents|mesh-ancestor
64566505|NCT04363697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566506|NCT04363697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64566507|NCT04363697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566509|NCT04318405|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
64566510|NCT04318405|Trace Elements|trace elements|mesh-ancestor
64566511|NCT04318405|Micronutrients|micronutrients|mesh-ancestor
64566512|NCT04318405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566513|NCT04318405|Hematinics|hematinics|mesh-ancestor
64566514|NCT04301778|Durvalumab|durvalumab|mesh-list
64566515|NCT04301778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64829293|NCT04232683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64829294|NCT04232683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829295|NCT04232683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829296|NCT04232683|Urological Agents|urological agents|mesh-ancestor
64829297|NCT04227483|Prednisolone|prednisolone|mesh-list
64829298|NCT04227483|Deflazacort|deflazacort|mesh-list
64829299|NCT04227483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64829300|NCT04227483|Glucocorticoids|glucocorticoids|mesh-ancestor
64829301|NCT04227483|Hormones|hormones|mesh-ancestor
64829302|NCT04227483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64829303|NCT04227483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829304|NCT04227483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64829305|NCT04227483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829306|NCT04227483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64829307|NCT04227483|Immunologic Factors|immunologic factors|mesh-ancestor
64829308|NCT04182672|Triamcinolone|triamcinolone|mesh-list
64829328|NCT04101227|Dermatologic Agents|dermatologic agents|mesh-ancestor
64829329|NCT04101227|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64829330|NCT04101227|Serotonin Agents|serotonin agents|mesh-ancestor
64829331|NCT04101227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64829332|NCT04101227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725764|NCT00003050|Alkylating Agents|alkylating agents|mesh-ancestor
64725765|NCT00003050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64725766|NCT00003050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64725767|NCT00003050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64725768|NCT00003050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64829333|NCT04101227|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64829334|NCT04101227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64829335|NCT04101227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64829336|NCT04101227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64829337|NCT04101227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64829338|NCT04066894|Neurotransmitter Agents|neurotransmitter agents|mesh-list
64829339|NCT04066894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829340|NCT04066894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829342|NCT04047004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829343|NCT04047004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64829344|NCT04047004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64829345|NCT04047004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64829346|NCT04047004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829347|NCT04047004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829348|NCT03972280|Antibodies|antibodies|mesh-list
64829349|NCT03972280|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64829350|NCT03972280|Lenograstim|lenograstim|mesh-list
64829351|NCT03972280|Immunologic Factors|immunologic factors|mesh-ancestor
64829352|NCT03972280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829353|NCT03972280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64829354|NCT03893435|Valsartan|valsartan|mesh-list
64829355|NCT03893435|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64829356|NCT03893435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64829357|NCT03893435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64829358|NCT03893435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64829359|NCT03893435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829360|NCT03813121|Midazolam|midazolam|mesh-list
64829361|NCT03813121|Ketamine|ketamine|mesh-list
64829362|NCT03813121|Analgesics|analgesics|mesh-ancestor
64829372|NCT03813121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64829373|NCT03813121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65494700|NCT00165503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64392461|NCT05164367|Atropine|atropine|mesh-list
65494708|NCT00165503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64566589|NCT04031833|Amebicides|amebicides|mesh-ancestor
64566590|NCT04031833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64566591|NCT04031833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64566592|NCT04031833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64566593|NCT04031833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64566594|NCT04031833|Antifungal Agents|antifungal agents|mesh-ancestor
64566595|NCT03975829|Trametinib|trametinib|mesh-list
64566596|NCT03975829|Dabrafenib|dabrafenib|mesh-list
64566597|NCT03975829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566598|NCT03975829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64566599|NCT03975829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566600|NCT03975829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829374|NCT03813121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829375|NCT03813121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64829376|NCT03813121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64829377|NCT03813121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64829378|NCT03813121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64829379|NCT03813121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64829380|NCT03813121|GABA Modulators|gaba modulators|mesh-ancestor
64829381|NCT03813121|GABA Agents|gaba agents|mesh-ancestor
64829382|NCT03782064|Nivolumab|nivolumab|mesh-list
64829383|NCT03782064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64829384|NCT03782064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829385|NCT03782064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64829386|NCT03782064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829387|NCT03710590|Nicotine|nicotine|mesh-list
64829388|NCT03710590|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64829389|NCT03710590|Autonomic Agents|autonomic agents|mesh-ancestor
64829390|NCT03710590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829391|NCT03710590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725769|NCT00003050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725770|NCT00003050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64725771|NCT00003050|Hormone Antagonists|hormone antagonists|mesh-ancestor
64725772|NCT00003050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64725773|NCT00003050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64725777|NCT00002179|Lamivudine|lamivudine|mesh-list
64725778|NCT00002179|Zidovudine|zidovudine|mesh-list
64725779|NCT00002179|Indinavir|indinavir|mesh-list
64725780|NCT00002179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64725781|NCT00002179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64725782|NCT00002179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829392|NCT03710590|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64829393|NCT03710590|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64829394|NCT03710590|Cholinergic Agents|cholinergic agents|mesh-ancestor
64829395|NCT03710590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64829396|NCT03710590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829398|NCT03691714|Durvalumab|durvalumab|mesh-list
64829399|NCT03691714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64829400|NCT03691714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829401|NCT03676725|Lidocaine|lidocaine|mesh-list
64829402|NCT03676725|Anesthetics, Local|anesthetics, local|mesh-ancestor
64829403|NCT03676725|Anesthetics|anesthetics|mesh-ancestor
64829404|NCT03676725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64829405|NCT03676725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829406|NCT03676725|Sensory System Agents|sensory system agents|mesh-ancestor
64829407|NCT03676725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829408|NCT03676725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64829409|NCT03676725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64829410|NCT03676725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64829411|NCT03676725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64829412|NCT03676725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829413|NCT03572049|Itraconazole|itraconazole|mesh-list
64829414|NCT03572049|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
64829415|NCT03572049|Antifungal Agents|antifungal agents|mesh-ancestor
64829416|NCT03572049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64829417|NCT03572049|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64829418|NCT03572049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64829419|NCT03572049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829420|NCT03572049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829421|NCT03572049|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64829422|NCT03572049|Hormone Antagonists|hormone antagonists|mesh-ancestor
64829423|NCT03572049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65494718|NCT01144650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494719|NCT01144650|Leprostatic Agents|leprostatic agents|mesh-ancestor
65494720|NCT01144650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65494721|NCT03971045|Cyclophosphamide|cyclophosphamide|mesh-list
64829424|NCT03572049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829425|NCT03572049|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64829433|NCT03471507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64829434|NCT03471507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64829435|NCT03471507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64829436|NCT03471507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829437|NCT03471507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829438|NCT03470922|Nivolumab|nivolumab|mesh-list
64829439|NCT03470922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64829440|NCT03470922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829441|NCT03470922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64829442|NCT03470922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829443|NCT03468335|Irinotecan|irinotecan|mesh-list
64829444|NCT03468335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64829445|NCT03468335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64829446|NCT03468335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829447|NCT03468335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829448|NCT03468335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829449|NCT03425279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64829450|NCT03425279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829451|NCT03425279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829452|NCT03345810|Gemcitabine|gemcitabine|mesh-list
64829453|NCT03345810|Paclitaxel|paclitaxel|mesh-list
64829454|NCT03345810|Vinorelbine|vinorelbine|mesh-list
64829455|NCT03345810|Carboplatin|carboplatin|mesh-list
64829456|NCT03345810|Durvalumab|durvalumab|mesh-list
64829457|NCT03345810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64829458|NCT03345810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829459|NCT03345810|Tubulin Modulators|tubulin modulators|mesh-ancestor
64829460|NCT03345810|Antimitotic Agents|antimitotic agents|mesh-ancestor
64829461|NCT03345810|Mitosis Modulators|mitosis modulators|mesh-ancestor
64725783|NCT00002179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725784|NCT00002179|Antiviral Agents|antiviral agents|mesh-ancestor
64725785|NCT00002179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64829462|NCT03345810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829463|NCT03345810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64829464|NCT03345810|Antimetabolites|antimetabolites|mesh-ancestor
64829465|NCT03345810|Antiviral Agents|antiviral agents|mesh-ancestor
64829466|NCT03345810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64829467|NCT03345810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829468|NCT03345810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64829469|NCT03345810|Immunologic Factors|immunologic factors|mesh-ancestor
64829470|NCT03345810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829471|NCT03345810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64829472|NCT03280511|Oxaliplatin|oxaliplatin|mesh-list
64829473|NCT03280511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829474|NCT03205423|Gabapentin|gabapentin|mesh-list
64829475|NCT03205423|Analgesics|analgesics|mesh-ancestor
64829476|NCT03205423|Sensory System Agents|sensory system agents|mesh-ancestor
64829477|NCT03205423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829478|NCT03205423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829479|NCT03205423|Anticonvulsants|anticonvulsants|mesh-ancestor
64829480|NCT03205423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64829481|NCT03205423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64829482|NCT03205423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64829483|NCT03205423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64829484|NCT03205423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64829485|NCT03205423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64829486|NCT03205423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64829487|NCT03205423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829488|NCT03205423|Antimanic Agents|antimanic agents|mesh-ancestor
64829489|NCT03104400|Adalimumab|adalimumab|mesh-list
64829490|NCT03104400|Upadacitinib|upadacitinib|mesh-list
64393596|NCT01984294|Ribavirin|ribavirin|mesh-list
64566752|NCT03173248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64566754|NCT03173248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566755|NCT03173248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566756|NCT03173248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566767|NCT03152786|Propranolol|propranolol|mesh-list
64566768|NCT03152786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64566769|NCT03152786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64566770|NCT03152786|Adrenergic Agents|adrenergic agents|mesh-ancestor
64829509|NCT02965716|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
64829510|NCT02965716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64829511|NCT02965716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829512|NCT02918006|Vaccines|vaccines|mesh-list
64829513|NCT02918006|Immunologic Factors|immunologic factors|mesh-ancestor
64829514|NCT02918006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829515|NCT02917772|Nivolumab|nivolumab|mesh-list
64829516|NCT02917772|Ipilimumab|ipilimumab|mesh-list
64829517|NCT02917772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64829518|NCT02917772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829519|NCT02917772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64829520|NCT02917772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829521|NCT02909686|Curcumin|curcumin|mesh-list
64829522|NCT02909686|Resveratrol|resveratrol|mesh-list
64829523|NCT02909686|Pycnogenols|pycnogenols|mesh-list
64829524|NCT02909686|Turmeric extract|turmeric extract|mesh-list
64829525|NCT02909686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64829526|NCT02909686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64829527|NCT02909686|Analgesics|analgesics|mesh-ancestor
64393597|NCT01984294|Antiviral Agents|antiviral agents|mesh-ancestor
64952101|NCT00028730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952102|NCT00028730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64952103|NCT00028730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64952104|NCT00028730|Antimetabolites|antimetabolites|mesh-ancestor
64952105|NCT00028847|Cytarabine|cytarabine|mesh-list
64490885|NCT00949234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952106|NCT00028847|Imatinib Mesylate|imatinib mesylate|mesh-list
64952107|NCT00028847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64503374|NCT05585346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503375|NCT05585346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64503376|NCT05585346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503377|NCT05585346|Antiemetics|antiemetics|mesh-ancestor
64503378|NCT05585346|Autonomic Agents|autonomic agents|mesh-ancestor
64503379|NCT05585346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64503380|NCT05585346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64503381|NCT05585346|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64503382|NCT05585346|Protective Agents|protective agents|mesh-ancestor
64503383|NCT05098704|Clopidogrel|clopidogrel|mesh-list
64503384|NCT05098704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64829528|NCT02909686|Sensory System Agents|sensory system agents|mesh-ancestor
64829529|NCT02909686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829530|NCT02909686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829531|NCT02909686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64829532|NCT02909686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64829533|NCT02909686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829534|NCT02909686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829535|NCT02909686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829536|NCT02909686|Antioxidants|antioxidants|mesh-ancestor
64598124|NCT03028701|Adrenergic Agents|adrenergic agents|mesh-ancestor
64829537|NCT02909686|Protective Agents|protective agents|mesh-ancestor
64829538|NCT02909686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64829540|NCT02909686|Immunologic Factors|immunologic factors|mesh-ancestor
64829541|NCT02713373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64829542|NCT02713373|Pembrolizumab|pembrolizumab|mesh-list
64829543|NCT02713373|Cetuximab|cetuximab|mesh-list
64829544|NCT02713373|Antibodies|antibodies|mesh-list
64829545|NCT02713373|Immunoglobulins|immunoglobulins|mesh-list
64829546|NCT02713373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64829547|NCT02713373|Immunologic Factors|immunologic factors|mesh-ancestor
64829548|NCT02713373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829549|NCT02713373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829550|NCT02686593|Mitoxantrone|mitoxantrone|mesh-list
64829551|NCT02686593|Clofarabine|clofarabine|mesh-list
64829552|NCT02686593|Analgesics|analgesics|mesh-ancestor
64829553|NCT02686593|Sensory System Agents|sensory system agents|mesh-ancestor
64829554|NCT02686593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829555|NCT02686593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829556|NCT02686593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829557|NCT02686593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64829558|NCT02686593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64829559|NCT02686593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829560|NCT02686593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396350|NCT03105661|Tocolytic Agents|tocolytic agents|mesh-ancestor
65494725|NCT03971045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494726|NCT03971045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65494727|NCT03971045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65494728|NCT03971045|Alkylating Agents|alkylating agents|mesh-ancestor
65494729|NCT03971045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472890|NCT02388906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64829583|NCT02553941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829584|NCT02553941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829585|NCT02546492|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64829586|NCT02546492|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64829588|NCT02546492|Hormones|hormones|mesh-ancestor
64829589|NCT02546492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64829590|NCT02546492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829591|NCT02546492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64829592|NCT02546492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829593|NCT02527564|Suvorexant|suvorexant|mesh-list
64829594|NCT02527564|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64829595|NCT02527564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64829596|NCT02527564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64829597|NCT02527564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829598|NCT02527564|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64829599|NCT02527564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64829600|NCT02527564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829601|NCT02339168|Metformin|metformin|mesh-list
64829602|NCT02339168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64829603|NCT02339168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829604|NCT02179749|Mifepristone|mifepristone|mesh-list
64829606|NCT02179749|Abortifacient Agents|abortifacient agents|mesh-ancestor
64397582|NCT03097211|Protective Agents|protective agents|mesh-ancestor
64829617|NCT02179749|Luteolytic Agents|luteolytic agents|mesh-ancestor
64829618|NCT02179749|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64829635|NCT00641186|Sodium Oxybate|sodium oxybate|mesh-list
64829636|NCT00641186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64829637|NCT00641186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64829638|NCT00641186|Anesthetics, General|anesthetics, general|mesh-ancestor
64829639|NCT00641186|Anesthetics|anesthetics|mesh-ancestor
64829640|NCT00641186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64829641|NCT00641186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829642|NCT01561482|Metformin|metformin|mesh-list
64829643|NCT01561482|Simvastatin|simvastatin|mesh-list
64829644|NCT01561482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64829645|NCT01561482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829646|NCT01561482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64829647|NCT01561482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64829648|NCT01561482|Antimetabolites|antimetabolites|mesh-ancestor
64829649|NCT01561482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829650|NCT01561482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64829652|NCT01561482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829702|NCT01564823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829703|NCT01565239|Thrombin|thrombin|mesh-list
64829704|NCT01565239|Hemostatics|hemostatics|mesh-ancestor
64829705|NCT01565239|Coagulants|coagulants|mesh-ancestor
64829706|NCT01565265|Cetrorelix|cetrorelix|mesh-list
64829707|NCT01565265|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64829708|NCT01565265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64829709|NCT01565265|Hormones|hormones|mesh-ancestor
64829710|NCT01565265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64829711|NCT01565265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829712|NCT01565265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64829713|NCT01565265|Fertility Agents|fertility agents|mesh-ancestor
64829714|NCT01565265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64829715|NCT01565265|Hormone Antagonists|hormone antagonists|mesh-ancestor
64829716|NCT01566292|Botulinum Toxins|botulinum toxins|mesh-list
64829717|NCT01566292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64829718|NCT01566292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64829719|NCT01566292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64829720|NCT01566292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64829721|NCT01566292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829722|NCT01566292|Cholinergic Agents|cholinergic agents|mesh-ancestor
64829723|NCT01566292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64829724|NCT01566292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829725|NCT01566292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64829726|NCT01566292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829727|NCT01566422|Vancomycin|vancomycin|mesh-list
64829728|NCT01566422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64829729|NCT01566422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64829730|NCT01566760|Fesoterodine|fesoterodine|mesh-list
64829731|NCT01566760|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64829732|NCT01566760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64829733|NCT01566760|Cholinergic Agents|cholinergic agents|mesh-ancestor
64829749|NCT01567072|Analgesics|analgesics|mesh-ancestor
64829750|NCT01567072|Sensory System Agents|sensory system agents|mesh-ancestor
64829751|NCT01567072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829752|NCT01567072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829753|NCT01567072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64829754|NCT01567072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64829755|NCT01567072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64829756|NCT01567072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829757|NCT01567072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829758|NCT01567423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64829759|NCT01567423|Antimalarials|antimalarials|mesh-ancestor
64598353|NCT02959775|Vaccines|vaccines|mesh-list
64829760|NCT01567423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64829761|NCT01567423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64829762|NCT01567423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64829763|NCT01568632|Imetelstat|imetelstat|mesh-list
64829764|NCT01568632|Motesanib diphosphate|motesanib diphosphate|mesh-list
64829765|NCT01568632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829766|NCT01568632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829767|NCT01568632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64829768|NCT01568645|Imatinib Mesylate|imatinib mesylate|mesh-list
64829769|NCT01568645|Carvedilol|carvedilol|mesh-list
64829770|NCT01568645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829771|NCT01568645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64829772|NCT01568645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829773|NCT01568645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829774|NCT01568645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64829775|NCT01568645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64829776|NCT01568645|Adrenergic Agents|adrenergic agents|mesh-ancestor
64829777|NCT01568645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64829778|NCT01568645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829779|NCT01568645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64829780|NCT01568645|Antioxidants|antioxidants|mesh-ancestor
64503385|NCT05098704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64503386|NCT05098704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64952108|NCT00028847|Antimetabolites|antimetabolites|mesh-ancestor
64952109|NCT00028847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952111|NCT00028847|Antiviral Agents|antiviral agents|mesh-ancestor
64952112|NCT00028847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64952113|NCT00028847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64397763|NCT05052515|Choline|choline|mesh-list
64829781|NCT01568645|Protective Agents|protective agents|mesh-ancestor
64829782|NCT01568645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64829783|NCT01568645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64829784|NCT01568645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64829785|NCT01568645|Vasodilator Agents|vasodilator agents|mesh-ancestor
64829786|NCT01568645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64829787|NCT01568645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64829788|NCT01568684|Citalopram|citalopram|mesh-list
64829789|NCT01568684|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64829790|NCT01568684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64829791|NCT01568684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64829792|NCT01568684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829793|NCT01568684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64829794|NCT01568684|Serotonin Agents|serotonin agents|mesh-ancestor
64829795|NCT01568684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829796|NCT01568684|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64829797|NCT01568684|Antidepressive Agents|antidepressive agents|mesh-ancestor
64829798|NCT01568684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64829799|NCT01569685|Sertraline|sertraline|mesh-list
64829800|NCT01569685|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64829801|NCT01569685|Antidepressive Agents|antidepressive agents|mesh-ancestor
64829817|NCT01570088|Folic Acid|folic acid|mesh-list
64397822|NCT00773695|Alkylating Agents|alkylating agents|mesh-ancestor
64829836|NCT01570504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64829837|NCT01570556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64829838|NCT01570556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64829839|NCT01570569|Losartan|losartan|mesh-list
64829840|NCT01570569|Midazolam|midazolam|mesh-list
64829841|NCT01570569|Dextromethorphan|dextromethorphan|mesh-list
64829842|NCT01570569|Caffeine|caffeine|mesh-list
64829843|NCT01570569|Omeprazole|omeprazole|mesh-list
64829844|NCT01570569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64472891|NCT02388906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829845|NCT01570569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64829846|NCT01570569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64829847|NCT01570569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829848|NCT01570569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64829849|NCT01570569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64829850|NCT01570569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64829851|NCT01570569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64829852|NCT01570569|Anesthetics, General|anesthetics, general|mesh-ancestor
64829853|NCT01570569|Anesthetics|anesthetics|mesh-ancestor
64829854|NCT01570569|GABA Modulators|gaba modulators|mesh-ancestor
64829855|NCT01570569|GABA Agents|gaba agents|mesh-ancestor
64829856|NCT01570569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64829857|NCT01570569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829858|NCT01570569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64829859|NCT01570569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64829860|NCT01570569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64829861|NCT01570569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64829864|NCT01570569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829905|NCT01570660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829906|NCT01570764|Cyclophosphamide|cyclophosphamide|mesh-list
64829907|NCT01570764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64829908|NCT01570764|Immunologic Factors|immunologic factors|mesh-ancestor
64829909|NCT01570764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829910|NCT01570764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64829911|NCT01570764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64829912|NCT01570764|Alkylating Agents|alkylating agents|mesh-ancestor
64829913|NCT01570764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829914|NCT01570764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829915|NCT01570764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64829916|NCT01570790|Fosbretabulin|fosbretabulin|mesh-list
64829917|NCT01570790|Combretastatin|combretastatin|mesh-list
64829918|NCT01570790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64829939|NCT01570959|Antidepressive Agents|antidepressive agents|mesh-ancestor
64829940|NCT01570959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64829941|NCT01570959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64829942|NCT01570959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64829943|NCT01570959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64829944|NCT01570959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829945|NCT01570985|Triamcinolone|triamcinolone|mesh-list
64829946|NCT01570985|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64829947|NCT01570985|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64829948|NCT01570985|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64829949|NCT01570985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64829950|NCT01570985|Glucocorticoids|glucocorticoids|mesh-ancestor
64829951|NCT01570985|Hormones|hormones|mesh-ancestor
64829952|NCT01570985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64829969|NCT01571024|Protective Agents|protective agents|mesh-ancestor
64829970|NCT01571024|Vitamin B Complex|vitamin b complex|mesh-ancestor
64829971|NCT01571024|Vitamins|vitamins|mesh-ancestor
64829972|NCT01571024|Micronutrients|micronutrients|mesh-ancestor
64829973|NCT01571037|Milrinone|milrinone|mesh-list
64829984|NCT01571050|Antacids|antacids|mesh-ancestor
64829985|NCT01571050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829986|NCT01571050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64829987|NCT01571063|Vitamin D|vitamin d|mesh-list
64829988|NCT01571063|Cholecalciferol|cholecalciferol|mesh-list
64829989|NCT01571063|Vitamins|vitamins|mesh-ancestor
64829990|NCT01571063|Micronutrients|micronutrients|mesh-ancestor
64829991|NCT01571063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829992|NCT01571063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64829993|NCT01571063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64829994|NCT01571167|Varenicline|varenicline|mesh-list
64829995|NCT01571167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64829996|NCT01571167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64829997|NCT01571167|Cholinergic Agents|cholinergic agents|mesh-ancestor
64829998|NCT01571167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64829999|NCT01571167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830000|NCT01571167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830001|NCT01571206|Infliximab|infliximab|mesh-list
64830002|NCT01571206|Dermatologic Agents|dermatologic agents|mesh-ancestor
64830003|NCT01571206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64830004|NCT01571206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64830005|NCT01571219|Infliximab|infliximab|mesh-list
64830006|NCT01571219|Dermatologic Agents|dermatologic agents|mesh-ancestor
64830007|NCT01571219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64830008|NCT01571219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64830009|NCT01571323|Misoprostol|misoprostol|mesh-list
64830010|NCT01571323|Oxytocin|oxytocin|mesh-list
64830026|NCT01571414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830027|NCT01571414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64830028|NCT01571414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64830029|NCT01571414|Antiviral Agents|antiviral agents|mesh-ancestor
64830030|NCT01571414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64830031|NCT01571414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64830032|NCT01571414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64830033|NCT01571414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64830034|NCT01571414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64830035|NCT01571414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64830036|NCT01571414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64830045|NCT01571414|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64830046|NCT01571414|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64830048|NCT01571570|Antiviral Agents|antiviral agents|mesh-ancestor
64830049|NCT01571570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64830050|NCT01571570|Protease Inhibitors|protease inhibitors|mesh-ancestor
64830051|NCT01571570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830052|NCT01571570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830053|NCT01571583|Interferons|interferons|mesh-list
65494732|NCT03971045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64567202|NCT04975932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64830054|NCT01571583|Ribavirin|ribavirin|mesh-list
64830055|NCT01571583|Interferon-alpha|interferon-alpha|mesh-list
64830056|NCT01571583|Interferon alpha-2|interferon alpha-2|mesh-list
64830057|NCT01571583|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64830081|NCT01571791|Anesthetics|anesthetics|mesh-ancestor
64830082|NCT01571791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64830083|NCT01571791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830084|NCT01571791|Sensory System Agents|sensory system agents|mesh-ancestor
64830085|NCT01571791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64830086|NCT01571791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64830087|NCT01571791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64830088|NCT01571791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64830089|NCT01571791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64830090|NCT01571791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830091|NCT01571791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64830092|NCT01571791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64830093|NCT01571791|Analgesics|analgesics|mesh-ancestor
64830094|NCT01571791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64830095|NCT01571791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64830096|NCT01571791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64830097|NCT01571791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830098|NCT01571804|Pregabalin|pregabalin|mesh-list
64830099|NCT01571804|Analgesics|analgesics|mesh-ancestor
64830100|NCT01571804|Sensory System Agents|sensory system agents|mesh-ancestor
64830101|NCT01571804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64830102|NCT01571804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830116|NCT01571882|Policosanol|policosanol|mesh-list
64830117|NCT01571882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64830118|NCT01571882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64830119|NCT01571882|Antimetabolites|antimetabolites|mesh-ancestor
64830120|NCT01571882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830121|NCT01571882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64830122|NCT01571882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64830123|NCT01571908|Rocuronium|rocuronium|mesh-list
64830124|NCT01571908|Succinylcholine|succinylcholine|mesh-list
64830127|NCT01571908|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64830134|NCT01571921|Antioxidants|antioxidants|mesh-ancestor
64830135|NCT01571921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830136|NCT01571921|Protective Agents|protective agents|mesh-ancestor
64830137|NCT01571921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830139|NCT01571921|Micronutrients|micronutrients|mesh-ancestor
64830140|NCT01571960|Vaccines|vaccines|mesh-list
64472892|NCT02388906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64830141|NCT01571960|Immunologic Factors|immunologic factors|mesh-ancestor
64830142|NCT01571960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830144|NCT01572012|Antiemetics|antiemetics|mesh-ancestor
64830145|NCT01572012|Autonomic Agents|autonomic agents|mesh-ancestor
64830146|NCT01572012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64830147|NCT01572012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830148|NCT01572012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64830149|NCT01572012|Antipruritics|antipruritics|mesh-ancestor
64830150|NCT01572012|Dermatologic Agents|dermatologic agents|mesh-ancestor
64830151|NCT01572012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64830152|NCT01572012|Serotonin Agents|serotonin agents|mesh-ancestor
64830153|NCT01572012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64830154|NCT01572012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830155|NCT01572012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64830156|NCT01572012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64830157|NCT01572012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64830158|NCT01572012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64830159|NCT01572012|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64830160|NCT01572025|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64830161|NCT01572025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64830162|NCT01572025|Immunologic Factors|immunologic factors|mesh-ancestor
64830163|NCT01572025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830164|NCT01572090|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64830174|NCT01572116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830175|NCT01572116|Sensory System Agents|sensory system agents|mesh-ancestor
64830176|NCT01572116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64830184|NCT01572116|Adrenergic Agents|adrenergic agents|mesh-ancestor
64830185|NCT01572116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64830186|NCT01572116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64830187|NCT01572116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64830188|NCT01572116|Autonomic Agents|autonomic agents|mesh-ancestor
64830189|NCT01572116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64830190|NCT01572116|Respiratory System Agents|respiratory system agents|mesh-ancestor
64830191|NCT01572116|Mydriatics|mydriatics|mesh-ancestor
64830192|NCT01572116|Sympathomimetics|sympathomimetics|mesh-ancestor
64830193|NCT01572116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64830194|NCT01572116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64830195|NCT01572116|Narcotics|narcotics|mesh-ancestor
64830196|NCT01572116|Analgesics|analgesics|mesh-ancestor
64830197|NCT01572116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64830198|NCT01572116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64830199|NCT01572116|Anesthetics, General|anesthetics, general|mesh-ancestor
64830200|NCT01572129|Clopidogrel|clopidogrel|mesh-list
64830201|NCT01572129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64830202|NCT01572129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64830203|NCT01572129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64830204|NCT01572129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64830205|NCT01572129|Purinergic Agents|purinergic agents|mesh-ancestor
64830206|NCT01572129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64830207|NCT01572129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830208|NCT01572129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598797|NCT01967433|Anesthetics|anesthetics|mesh-ancestor
64830209|NCT01572181|Fludarabine|fludarabine|mesh-list
64830210|NCT01572181|Busulfan|busulfan|mesh-list
64830211|NCT01572181|Thymoglobulin|thymoglobulin|mesh-list
64830212|NCT01572181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64830213|NCT01572181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830214|NCT01572181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64830220|NCT01572259|Hormones|hormones|mesh-list
64830223|NCT01572285|Dexamethasone|dexamethasone|mesh-list
64830224|NCT01572285|Dexamethasone acetate|dexamethasone acetate|mesh-list
64830225|NCT01572285|BB 1101|bb 1101|mesh-list
64830226|NCT01572285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64830227|NCT01572285|Antiemetics|antiemetics|mesh-ancestor
64830228|NCT01572285|Autonomic Agents|autonomic agents|mesh-ancestor
64830229|NCT01572285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64830230|NCT01572285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830231|NCT01572285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64830240|NCT01572324|Leucovorin|leucovorin|mesh-list
64830241|NCT01572324|Fluorouracil|fluorouracil|mesh-list
64830242|NCT01572324|Capecitabine|capecitabine|mesh-list
64830243|NCT01572324|Oxaliplatin|oxaliplatin|mesh-list
64830244|NCT01572324|Antimetabolites|antimetabolites|mesh-ancestor
64830245|NCT01572324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830246|NCT01572324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64830247|NCT01572324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64830248|NCT01572324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64830249|NCT01572324|Immunologic Factors|immunologic factors|mesh-ancestor
64830250|NCT01572324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830251|NCT01572324|Antidotes|antidotes|mesh-ancestor
64830252|NCT01572324|Protective Agents|protective agents|mesh-ancestor
64830253|NCT01572324|Vitamin B Complex|vitamin b complex|mesh-ancestor
64830254|NCT01572324|Vitamins|vitamins|mesh-ancestor
64830255|NCT01572324|Micronutrients|micronutrients|mesh-ancestor
64830256|NCT01572350|Triamcinolone|triamcinolone|mesh-list
64830257|NCT01572350|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64830258|NCT01572350|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64830259|NCT01572350|Bevacizumab|bevacizumab|mesh-list
64830270|NCT01572350|Hormones|hormones|mesh-ancestor
64830279|NCT01572363|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64830280|NCT01572363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830281|NCT01572363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830282|NCT01572363|Urological Agents|urological agents|mesh-ancestor
64830283|NCT01572454|Dexmedetomidine|dexmedetomidine|mesh-list
64830284|NCT01572454|Remifentanil|remifentanil|mesh-list
64830285|NCT01572454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64830286|NCT01572454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64830287|NCT01572454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830288|NCT01572454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64830289|NCT01572454|Analgesics|analgesics|mesh-ancestor
64830290|NCT01572454|Sensory System Agents|sensory system agents|mesh-ancestor
64830291|NCT01572454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64830292|NCT01572454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64830293|NCT01572454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64830294|NCT01572454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64830295|NCT01572454|Adrenergic Agents|adrenergic agents|mesh-ancestor
64830296|NCT01572454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64830297|NCT01572454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830304|NCT01572558|Ciprofloxacin|ciprofloxacin|mesh-list
64830305|NCT01572558|Meropenem|meropenem|mesh-list
64830306|NCT01572558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64830307|NCT01572558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64830308|NCT01572558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65494735|NCT00162773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64830309|NCT01572558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64830310|NCT01572558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830311|NCT01572558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830312|NCT01572558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64830313|NCT01572558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64830314|NCT01572558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64830315|NCT01572597|Metronidazole|metronidazole|mesh-list
64830316|NCT01572597|Clarithromycin|clarithromycin|mesh-list
64830317|NCT01572597|Acetylcysteine|acetylcysteine|mesh-list
64830318|NCT01572597|Rabeprazole|rabeprazole|mesh-list
64830322|NCT01572597|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64830323|NCT01572597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64830324|NCT01572597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64830325|NCT01572597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64830326|NCT01572597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830327|NCT01572597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830328|NCT01572597|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64830329|NCT01572597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64830330|NCT01572597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64830331|NCT01572597|Antiviral Agents|antiviral agents|mesh-ancestor
64830332|NCT01572597|Expectorants|expectorants|mesh-ancestor
64830333|NCT01572597|Respiratory System Agents|respiratory system agents|mesh-ancestor
64830334|NCT01572597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64830335|NCT01572597|Antioxidants|antioxidants|mesh-ancestor
64830336|NCT01572597|Protective Agents|protective agents|mesh-ancestor
64830337|NCT01572597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830338|NCT01572623|Clopidogrel|clopidogrel|mesh-list
64830339|NCT01572623|Atorvastatin|atorvastatin|mesh-list
64830340|NCT01572623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64830341|NCT01572623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64830342|NCT01572623|Antimetabolites|antimetabolites|mesh-ancestor
64830343|NCT01572623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830344|NCT01572623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64830345|NCT01572623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64830346|NCT01572623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830347|NCT01572623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64830350|NCT01572623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64830391|NCT01572961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64830392|NCT01572961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830393|NCT01572961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64830394|NCT01572961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64830395|NCT01572961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830396|NCT01572961|Antipyretics|antipyretics|mesh-ancestor
64830398|NCT01573013|Trace Elements|trace elements|mesh-ancestor
64830399|NCT01573013|Micronutrients|micronutrients|mesh-ancestor
64830400|NCT01573013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830401|NCT01573143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64830402|NCT01573143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64830403|NCT01573143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64830404|NCT01573143|Antimetabolites|antimetabolites|mesh-ancestor
64830405|NCT01573143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830406|NCT01573143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64830407|NCT01573143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64830408|NCT01573143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830409|NCT01573286|Glucagon|glucagon|mesh-list
64830410|NCT01573286|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64830411|NCT01573286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64830412|NCT01573286|Hormones|hormones|mesh-ancestor
64830413|NCT01573286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64830414|NCT01573286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830415|NCT01573286|Incretins|incretins|mesh-ancestor
64830416|NCT01573338|Carboplatin|carboplatin|mesh-list
64830417|NCT01573338|Etoposide|etoposide|mesh-list
64830455|NCT01573598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64830456|NCT01573598|Serotonin Agents|serotonin agents|mesh-ancestor
64830457|NCT01573598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830458|NCT01573598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64830459|NCT01573598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64830460|NCT01573637|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64830461|NCT01573637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64830462|NCT01573637|Hormone Antagonists|hormone antagonists|mesh-ancestor
64830463|NCT01573637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64830464|NCT01573637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830465|NCT01573637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64830466|NCT01573637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64830467|NCT01573637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64830468|NCT01573663|Dipropizine|dipropizine|mesh-list
64830469|NCT01573663|Ambroxol|ambroxol|mesh-list
64830470|NCT01573663|Expectorants|expectorants|mesh-ancestor
64830471|NCT01573663|Respiratory System Agents|respiratory system agents|mesh-ancestor
64830472|NCT01573663|Antitussive Agents|antitussive agents|mesh-ancestor
64830473|NCT01573715|Cisatracurium|cisatracurium|mesh-list
64830474|NCT01573715|Atracurium|atracurium|mesh-list
64441628|NCT01740388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64830478|NCT01573715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830479|NCT01573715|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64830480|NCT01573715|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64830481|NCT01573715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64830503|NCT01573806|Incretins|incretins|mesh-ancestor
64830504|NCT01573806|Hormones|hormones|mesh-ancestor
64830505|NCT01573806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64599090|NCT00661583|Ranibizumab|ranibizumab|mesh-list
64830506|NCT01573975|Clarithromycin|clarithromycin|mesh-list
64830507|NCT01573975|Rabeprazole|rabeprazole|mesh-list
64830508|NCT01573975|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64830509|NCT01573975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64830510|NCT01573975|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64830511|NCT01573975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830512|NCT01573975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830513|NCT01573975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64830514|NCT01573975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64830515|NCT01573975|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64830516|NCT01573975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64830517|NCT01573975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64830518|NCT01574014|Hydrocortisone|hydrocortisone|mesh-list
64830519|NCT01574014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64830520|NCT01574027|Vitamin D|vitamin d|mesh-list
64830521|NCT01574027|Cholecalciferol|cholecalciferol|mesh-list
64830522|NCT01574027|Vitamins|vitamins|mesh-ancestor
64830523|NCT01574027|Micronutrients|micronutrients|mesh-ancestor
64830524|NCT01574027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830525|NCT01574027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64830526|NCT01574027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64830527|NCT01574092|Irinotecan|irinotecan|mesh-list
64830528|NCT01574092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64830529|NCT01574092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64830530|NCT01574092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64830531|NCT01574092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830532|NCT01574092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830533|NCT01574131|Fenofibrate|fenofibrate|mesh-list
64830566|NCT01574508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64830567|NCT01574508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830568|NCT01574638|Rifapentine|rifapentine|mesh-list
64830569|NCT01574638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64830570|NCT01574638|Antitubercular Agents|antitubercular agents|mesh-ancestor
64830571|NCT01574638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64830572|NCT01574638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64830573|NCT01574638|Leprostatic Agents|leprostatic agents|mesh-ancestor
64830574|NCT01574742|Minocycline|minocycline|mesh-list
64830575|NCT01574742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64830576|NCT01574742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64830577|NCT01574820|Rosiglitazone|rosiglitazone|mesh-list
64830578|NCT01574820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64830579|NCT01574820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830580|NCT01575158|Citalopram|citalopram|mesh-list
64830581|NCT01575158|Clomipramine|clomipramine|mesh-list
64830582|NCT01575158|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64830583|NCT01575158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64830584|NCT01575158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64830585|NCT01575158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830586|NCT01575158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64830587|NCT01575158|Serotonin Agents|serotonin agents|mesh-ancestor
64830588|NCT01575158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830589|NCT01575158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65494736|NCT00162773|Respiratory System Agents|respiratory system agents|mesh-ancestor
64472898|NCT02318342|Anticoagulants|anticoagulants|mesh-ancestor
64830593|NCT01575236|Chlorhexidine|chlorhexidine|mesh-list
64830639|NCT01575483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830640|NCT01575483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64830641|NCT01575509|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64830642|NCT01575613|Lumefantrine|lumefantrine|mesh-list
64830643|NCT01575613|Artemether|artemether|mesh-list
64830644|NCT01575613|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64830645|NCT01575613|Antimalarials|antimalarials|mesh-ancestor
64830646|NCT01575613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64830647|NCT01575613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64830648|NCT01575613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64830649|NCT01575626|Sevoflurane|sevoflurane|mesh-list
64830650|NCT01575626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64830651|NCT01575626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64830652|NCT01575626|Anesthetics, General|anesthetics, general|mesh-ancestor
64830653|NCT01575626|Anesthetics|anesthetics|mesh-ancestor
64830676|NCT01575678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830678|NCT01575678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830679|NCT01575678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64830680|NCT01575717|Vitamin D|vitamin d|mesh-list
64830681|NCT01575717|Ergocalciferols|ergocalciferols|mesh-list
64830682|NCT01575717|Cholecalciferol|cholecalciferol|mesh-list
64830683|NCT01575717|Vitamins|vitamins|mesh-list
64830684|NCT01575717|Micronutrients|micronutrients|mesh-ancestor
64830685|NCT01575717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830686|NCT01575717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64830687|NCT01575717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64830688|NCT01575782|Chloroquine|chloroquine|mesh-list
64830689|NCT01575782|Amebicides|amebicides|mesh-ancestor
64830690|NCT01575782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64830691|NCT01575782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64830692|NCT01575782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64830693|NCT01575782|Antimalarials|antimalarials|mesh-ancestor
64830694|NCT01575782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64830695|NCT01575795|Ticagrelor|ticagrelor|mesh-list
64830696|NCT01575795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64830697|NCT01575795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64830698|NCT01575795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64952114|NCT00028847|Immunologic Factors|immunologic factors|mesh-ancestor
64398600|NCT02349763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64830699|NCT01575795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64830700|NCT01575795|Purinergic Agents|purinergic agents|mesh-ancestor
64830701|NCT01575795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64830702|NCT01575795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830703|NCT01575795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830717|NCT01576094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830718|NCT01576094|Protective Agents|protective agents|mesh-ancestor
64830719|NCT01576094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830720|NCT01576094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64830722|NCT01576185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64830723|NCT01576185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64830724|NCT01576185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830725|NCT01576185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494737|NCT03970577|Prednisone|prednisone|mesh-list
65494738|NCT03970577|Rituximab|rituximab|mesh-list
64830726|NCT01576263|Ropivacaine|ropivacaine|mesh-list
64830727|NCT01576263|Anesthetics, Local|anesthetics, local|mesh-ancestor
64830728|NCT01576263|Anesthetics|anesthetics|mesh-ancestor
64830729|NCT01576263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64830730|NCT01576263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830731|NCT01576263|Sensory System Agents|sensory system agents|mesh-ancestor
64830732|NCT01576263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64830733|NCT01576315|Itraconazole|itraconazole|mesh-list
64830734|NCT01576315|Voriconazole|voriconazole|mesh-list
64830735|NCT01576315|Antifungal Agents|antifungal agents|mesh-ancestor
64830736|NCT01576315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64830737|NCT01576315|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64830738|NCT01576315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64830739|NCT01576315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830740|NCT01576315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830741|NCT01576315|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64830742|NCT01576315|Hormone Antagonists|hormone antagonists|mesh-ancestor
64830743|NCT01576315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64830744|NCT01576315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398642|NCT04438837|Hydroxychloroquine|hydroxychloroquine|mesh-list
64830746|NCT01576354|4-Aminopyridine|4-aminopyridine|mesh-list
64830747|NCT01576354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64830748|NCT01576354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64830749|NCT01576354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830750|NCT01576419|Celecoxib|celecoxib|mesh-list
64830751|NCT01576419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64830752|NCT01576419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64830753|NCT01576419|Analgesics|analgesics|mesh-ancestor
64830754|NCT01576419|Sensory System Agents|sensory system agents|mesh-ancestor
64830755|NCT01576419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64830756|NCT01576419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830757|NCT01576419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64830758|NCT01576419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64830759|NCT01576419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64830760|NCT01576419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64830761|NCT01576419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830762|NCT01576419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441918|NCT01715896|Golimumab|golimumab|mesh-list
64830780|NCT01576640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64830781|NCT01576640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64830782|NCT01576640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830783|NCT01576640|Dopamine Agents|dopamine agents|mesh-ancestor
64830784|NCT01576640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64830785|NCT01576640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830786|NCT01576640|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64830787|NCT01576640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64830788|NCT01576640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830789|NCT01576679|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64830790|NCT01576679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64830791|NCT01576679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64398643|NCT04438837|Antimalarials|antimalarials|mesh-ancestor
64952115|NCT00028847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952116|NCT00028847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64420634|NCT05487001|Glucocorticoids|glucocorticoids|mesh-ancestor
64952118|NCT00028886|Interferons|interferons|mesh-list
64952119|NCT00028886|Interferon-alpha|interferon-alpha|mesh-list
64952120|NCT00028886|Thalidomide|thalidomide|mesh-list
64952121|NCT00028886|Dexamethasone|dexamethasone|mesh-list
64952122|NCT00028886|Cyclophosphamide|cyclophosphamide|mesh-list
64952124|NCT00028886|Doxorubicin|doxorubicin|mesh-list
64830792|NCT01576679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830793|NCT01576692|Aldesleukin|aldesleukin|mesh-list
64830794|NCT01576692|Antibodies|antibodies|mesh-list
64830795|NCT01576692|Immunoglobulins|immunoglobulins|mesh-list
64830796|NCT01576692|Sargramostim|sargramostim|mesh-list
64830797|NCT01576692|Immunologic Factors|immunologic factors|mesh-ancestor
64830798|NCT01576692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830799|NCT01576692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64830800|NCT01576692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64830801|NCT01576692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64830802|NCT01576692|Antiviral Agents|antiviral agents|mesh-ancestor
64830803|NCT01576692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64830804|NCT01576731|Tenofovir|tenofovir|mesh-list
64830805|NCT01576731|Emtricitabine|emtricitabine|mesh-list
64830806|NCT01576731|Lopinavir|lopinavir|mesh-list
64830807|NCT01576731|Raltegravir Potassium|raltegravir potassium|mesh-list
64830808|NCT01576731|Antiviral Agents|antiviral agents|mesh-ancestor
64830809|NCT01576731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64830810|NCT01576731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64830811|NCT01576731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64830812|NCT01576731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830813|NCT01576731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567807|NCT04951128|Anesthetics|anesthetics|mesh-list
64830814|NCT01576731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64830815|NCT01576731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64830816|NCT01576731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64830848|NCT01577017|Hormone Antagonists|hormone antagonists|mesh-ancestor
64830849|NCT01577017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64830850|NCT01577017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830851|NCT01577043|Racecadotril|racecadotril|mesh-list
64830852|NCT01577043|Antidiarrheals|antidiarrheals|mesh-ancestor
64830853|NCT01577043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64830854|NCT01577043|Protease Inhibitors|protease inhibitors|mesh-ancestor
64830855|NCT01577043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830856|NCT01577043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830857|NCT01577095|Rosiglitazone|rosiglitazone|mesh-list
64830858|NCT01577095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64830859|NCT01577095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830860|NCT01577121|Indomethacin|indomethacin|mesh-list
64830861|NCT01577121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64830862|NCT01577121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64830863|NCT01577121|Analgesics|analgesics|mesh-ancestor
64830864|NCT01577121|Sensory System Agents|sensory system agents|mesh-ancestor
64830865|NCT01577121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64830866|NCT01577121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830867|NCT01577121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64830868|NCT01577121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64830869|NCT01577121|Gout Suppressants|gout suppressants|mesh-ancestor
64830870|NCT01577121|Tocolytic Agents|tocolytic agents|mesh-ancestor
64830871|NCT01577121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64830872|NCT01577121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64830873|NCT01577121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830874|NCT01577121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830875|NCT01577199|Clomiphene|clomiphene|mesh-list
64472900|NCT02134184|Immunologic Factors|immunologic factors|mesh-ancestor
64472901|NCT02134184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830915|NCT01577524|Plasma Substitutes|plasma substitutes|mesh-ancestor
64830916|NCT01577524|Blood Substitutes|blood substitutes|mesh-ancestor
64830917|NCT01577524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64830918|NCT01577524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64830919|NCT01577550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64830920|NCT01577550|Immunologic Factors|immunologic factors|mesh-ancestor
64830921|NCT01577550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830922|NCT01577589|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64830923|NCT01577589|Cephalosporins|cephalosporins|mesh-list
64830924|NCT01577589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64830925|NCT01577589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64830926|NCT01577693|Dutasteride|dutasteride|mesh-list
64830927|NCT01577693|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64830928|NCT01577693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64830929|NCT01577693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830930|NCT01577693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830931|NCT01577693|Hormone Antagonists|hormone antagonists|mesh-ancestor
64830932|NCT01577693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64830933|NCT01577693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830934|NCT01577771|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64830935|NCT01577771|Immunologic Factors|immunologic factors|mesh-ancestor
64830936|NCT01577771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830937|NCT01577849|Vitamin D|vitamin d|mesh-list
64830938|NCT01577849|Cholecalciferol|cholecalciferol|mesh-list
64830939|NCT01577849|Vitamins|vitamins|mesh-ancestor
64830940|NCT01577849|Micronutrients|micronutrients|mesh-ancestor
64830941|NCT01577849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830942|NCT01577849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64830943|NCT01577849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64830944|NCT01577862|Rifampin|rifampin|mesh-list
64830972|NCT01577914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64830973|NCT01577914|Vasodilator Agents|vasodilator agents|mesh-ancestor
64830974|NCT01577914|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64398778|NCT05027243|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64830975|NCT01577914|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64830976|NCT01577940|Ropivacaine|ropivacaine|mesh-list
64830977|NCT01577940|Anesthetics, Local|anesthetics, local|mesh-ancestor
64830978|NCT01577940|Anesthetics|anesthetics|mesh-ancestor
64830979|NCT01577940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64830980|NCT01577940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830981|NCT01577940|Sensory System Agents|sensory system agents|mesh-ancestor
64830982|NCT01577940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64830983|NCT01577992|Levodopa|levodopa|mesh-list
64830984|NCT01577992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64830985|NCT01577992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64830986|NCT01577992|Dopamine Agents|dopamine agents|mesh-ancestor
64830987|NCT01577992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64830988|NCT01577992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831001|NCT01578109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831002|NCT01578109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64831003|NCT01578109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831004|NCT01578109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831005|NCT01578161|Dexmedetomidine|dexmedetomidine|mesh-list
64831006|NCT01578161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64831007|NCT01578161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64831008|NCT01578161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831009|NCT01578161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64952125|NCT00028886|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64952126|NCT00028886|Vincristine|vincristine|mesh-list
64952127|NCT00028886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64952128|NCT00028886|Immunologic Factors|immunologic factors|mesh-ancestor
64952129|NCT00028886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503387|NCT05098704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64503388|NCT05098704|Purinergic Agents|purinergic agents|mesh-ancestor
64503390|NCT05098704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503391|NCT05098704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503392|NCT05584956|Sildenafil Citrate|sildenafil citrate|mesh-list
64952130|NCT00028886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64952131|NCT00028886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64952132|NCT00028886|Alkylating Agents|alkylating agents|mesh-ancestor
64952133|NCT00028886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952134|NCT00028886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952135|NCT00028886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64952136|NCT00028886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64952137|NCT00028886|Antiemetics|antiemetics|mesh-ancestor
64952138|NCT00028886|Autonomic Agents|autonomic agents|mesh-ancestor
64952139|NCT00028886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64952140|NCT00028886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64952141|NCT00028886|Glucocorticoids|glucocorticoids|mesh-ancestor
64952142|NCT00028886|Hormones|hormones|mesh-ancestor
64725786|NCT00002179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64725787|NCT00002179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64725788|NCT00002179|Antimetabolites|antimetabolites|mesh-ancestor
64725789|NCT00002179|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64725790|NCT00002179|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64831010|NCT01578161|Analgesics|analgesics|mesh-ancestor
64831011|NCT01578161|Sensory System Agents|sensory system agents|mesh-ancestor
64831012|NCT01578161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64831013|NCT01578161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64831014|NCT01578161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64831015|NCT01578161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64831016|NCT01578161|Adrenergic Agents|adrenergic agents|mesh-ancestor
64831017|NCT01578161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64831018|NCT01578161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831019|NCT01578174|Dexmedetomidine|dexmedetomidine|mesh-list
64831020|NCT01578174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64831021|NCT01578174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65494740|NCT03970577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494741|NCT03970577|Immunologic Factors|immunologic factors|mesh-ancestor
64472902|NCT02085148|Irinotecan|irinotecan|mesh-list
64831022|NCT01578174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831023|NCT01578174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64831024|NCT01578174|Analgesics|analgesics|mesh-ancestor
64831025|NCT01578174|Sensory System Agents|sensory system agents|mesh-ancestor
64831026|NCT01578174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64831027|NCT01578174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64831028|NCT01578174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64831029|NCT01578174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64831030|NCT01578174|Adrenergic Agents|adrenergic agents|mesh-ancestor
64831031|NCT01578174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64831032|NCT01578174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831033|NCT01578200|Calcium Carbonate|calcium carbonate|mesh-list
64831034|NCT01578200|Calcium|calcium|mesh-list
64831035|NCT01578200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64831036|NCT01578200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831037|NCT01578200|Antacids|antacids|mesh-ancestor
64831038|NCT01578200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831039|NCT01578200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64831040|NCT01578213|Imatinib Mesylate|imatinib mesylate|mesh-list
64831041|NCT01578213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831042|NCT01578213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64333300|NCT05426395|Hematinics|hematinics|mesh-ancestor
64398878|NCT05026229|Antiviral Agents|antiviral agents|mesh-ancestor
64831043|NCT01578213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831044|NCT01578213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831045|NCT01578252|Ondansetron|ondansetron|mesh-list
64831046|NCT01578252|Antiemetics|antiemetics|mesh-ancestor
64831047|NCT01578252|Autonomic Agents|autonomic agents|mesh-ancestor
64831048|NCT01578252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64831049|NCT01578252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831050|NCT01578252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64831056|NCT01578252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831058|NCT01578252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64831059|NCT01578252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64831060|NCT01578252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64831061|NCT01578252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64831062|NCT01578265|Ondansetron|ondansetron|mesh-list
64831063|NCT01578265|Antiemetics|antiemetics|mesh-ancestor
64831064|NCT01578265|Autonomic Agents|autonomic agents|mesh-ancestor
64831065|NCT01578265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64831066|NCT01578265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831067|NCT01578265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64831068|NCT01578265|Antipruritics|antipruritics|mesh-ancestor
64831069|NCT01578265|Dermatologic Agents|dermatologic agents|mesh-ancestor
64831070|NCT01578265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64831071|NCT01578265|Serotonin Agents|serotonin agents|mesh-ancestor
64831072|NCT01578265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64831073|NCT01578265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831074|NCT01578265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64831075|NCT01578265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64831076|NCT01578265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64831077|NCT01578265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64831078|NCT01578265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64831079|NCT01578304|Fesoterodine|fesoterodine|mesh-list
64831080|NCT01578304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64831081|NCT01578304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64831082|NCT01578304|Cholinergic Agents|cholinergic agents|mesh-ancestor
64831083|NCT01578304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64398890|NCT02348905|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64952143|NCT00028886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64831084|NCT01578304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831085|NCT01578304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831086|NCT01578304|Urological Agents|urological agents|mesh-ancestor
64831087|NCT01578343|Dexamethasone|dexamethasone|mesh-list
64831088|NCT01578343|Dexamethasone acetate|dexamethasone acetate|mesh-list
64831089|NCT01578343|Fludarabine|fludarabine|mesh-list
64831090|NCT01578343|Fludarabine phosphate|fludarabine phosphate|mesh-list
64831091|NCT01578343|Mitoxantrone|mitoxantrone|mesh-list
64831092|NCT01578343|Vorinostat|vorinostat|mesh-list
64831093|NCT01578343|BB 1101|bb 1101|mesh-list
64831094|NCT01578343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64831095|NCT01578343|Antiemetics|antiemetics|mesh-ancestor
64831096|NCT01578343|Autonomic Agents|autonomic agents|mesh-ancestor
64831097|NCT01578343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64831098|NCT01578343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831099|NCT01578343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64831100|NCT01578343|Glucocorticoids|glucocorticoids|mesh-ancestor
64831101|NCT01578343|Hormones|hormones|mesh-ancestor
65494742|NCT03970577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472903|NCT02085148|Vincristine|vincristine|mesh-list
64472904|NCT02085148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64831102|NCT01578343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64831103|NCT01578343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64831104|NCT01578343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831105|NCT01578343|Protease Inhibitors|protease inhibitors|mesh-ancestor
64831106|NCT01578343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831107|NCT01578343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831108|NCT01578343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64831109|NCT01578343|Antimetabolites|antimetabolites|mesh-ancestor
64831110|NCT01578343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64831111|NCT01578343|Immunologic Factors|immunologic factors|mesh-ancestor
64831112|NCT01578343|Analgesics|analgesics|mesh-ancestor
64831113|NCT01578343|Sensory System Agents|sensory system agents|mesh-ancestor
64831114|NCT01578343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64831115|NCT01578343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64831116|NCT01578343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64831117|NCT01578434|Calcium, Dietary|calcium, dietary|mesh-list
64952144|NCT00028886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64831118|NCT01578434|Vitamin D|vitamin d|mesh-list
64831119|NCT01578434|Ergocalciferols|ergocalciferols|mesh-list
64831120|NCT01578434|Cholecalciferol|cholecalciferol|mesh-list
64831121|NCT01578434|Vitamins|vitamins|mesh-list
64831122|NCT01578434|Calcium Carbonate|calcium carbonate|mesh-list
64831139|NCT01578447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64831140|NCT01578447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831141|NCT01578447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64831142|NCT01578447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64831143|NCT01578447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64831144|NCT01578473|Vitamin D|vitamin d|mesh-list
64831145|NCT01578473|Ergocalciferols|ergocalciferols|mesh-list
64831146|NCT01578473|Vitamins|vitamins|mesh-list
64831147|NCT01578473|Vitamin E|vitamin e|mesh-list
64831148|NCT01578473|Methyltestosterone|methyltestosterone|mesh-list
64831149|NCT01578473|Testosterone|testosterone|mesh-list
64831150|NCT01578473|Testosterone undecanoate|testosterone undecanoate|mesh-list
64831151|NCT01578473|Testosterone enanthate|testosterone enanthate|mesh-list
64831152|NCT01578473|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64831153|NCT01578473|Micronutrients|micronutrients|mesh-ancestor
64831154|NCT01578473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831155|NCT01578473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64831156|NCT01578473|Androgens|androgens|mesh-ancestor
64831157|NCT01578473|Hormones|hormones|mesh-ancestor
64831158|NCT01578473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64831159|NCT01578473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64831160|NCT01578473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831161|NCT01578473|Anabolic Agents|anabolic agents|mesh-ancestor
64831162|NCT01578473|Antioxidants|antioxidants|mesh-ancestor
64831164|NCT01578473|Protective Agents|protective agents|mesh-ancestor
64831199|NCT01578629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831200|NCT01578629|Antipyretics|antipyretics|mesh-ancestor
64831201|NCT01578629|Antioxidants|antioxidants|mesh-ancestor
64831202|NCT01578629|Protective Agents|protective agents|mesh-ancestor
64831203|NCT01578668|Pemetrexed|pemetrexed|mesh-list
64831204|NCT01578668|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64831205|NCT01578668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831206|NCT01578668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831207|NCT01578668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494743|NCT03970577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65494744|NCT03970577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64568105|NCT04938102|Cholinergic Agents|cholinergic agents|mesh-ancestor
64831208|NCT01578668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64831209|NCT01578668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64831210|NCT01578668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64831211|NCT01578720|Aflibercept|aflibercept|mesh-list
64831212|NCT01578720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64831213|NCT01578720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64831214|NCT01578720|Growth Substances|growth substances|mesh-ancestor
64831215|NCT01578720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831216|NCT01578720|Growth Inhibitors|growth inhibitors|mesh-ancestor
64831217|NCT01578720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831218|NCT01578824|Methacholine Chloride|methacholine chloride|mesh-list
64831219|NCT01578824|Miotics|miotics|mesh-ancestor
64831220|NCT01578824|Autonomic Agents|autonomic agents|mesh-ancestor
64831221|NCT01578824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64831222|NCT01578824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831223|NCT01578824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64831224|NCT01578824|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
64831225|NCT01578824|Respiratory System Agents|respiratory system agents|mesh-ancestor
64831226|NCT01578824|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64831227|NCT01578824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64831228|NCT01578824|Cholinergic Agents|cholinergic agents|mesh-ancestor
64831229|NCT01578824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64399056|NCT05007587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64831237|NCT01578928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831254|NCT01579058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64831255|NCT01579058|Sympatholytics|sympatholytics|mesh-ancestor
64831256|NCT01579058|Autonomic Agents|autonomic agents|mesh-ancestor
64831257|NCT01579058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64831258|NCT01579058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831259|NCT01579058|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64831260|NCT01579058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64831261|NCT01579058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64831262|NCT01579058|Adrenergic Agents|adrenergic agents|mesh-ancestor
64831263|NCT01579058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64831264|NCT01579058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831266|NCT01579110|Prednisone|prednisone|mesh-list
64831267|NCT01579110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64831268|NCT01579110|Glucocorticoids|glucocorticoids|mesh-ancestor
64831269|NCT01579110|Hormones|hormones|mesh-ancestor
64831270|NCT01579110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64831271|NCT01579110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831272|NCT01579110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64831273|NCT01579110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831274|NCT01579110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64831275|NCT01579110|Immunologic Factors|immunologic factors|mesh-ancestor
64831276|NCT01579110|Antinematodal Agents|antinematodal agents|mesh-ancestor
64831277|NCT01579110|Anthelmintics|anthelmintics|mesh-ancestor
64831278|NCT01579110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64831279|NCT01579110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64831280|NCT01579110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64831281|NCT01579149|Plerixafor|plerixafor|mesh-list
64831282|NCT01579149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64831283|NCT01579149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64831284|NCT01579149|Antiviral Agents|antiviral agents|mesh-ancestor
64952145|NCT00028886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64952146|NCT00028886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64952147|NCT00028886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64952148|NCT00028886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952149|NCT00028886|Antiviral Agents|antiviral agents|mesh-ancestor
64952150|NCT00028886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64952151|NCT00028886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64952152|NCT00028886|Tubulin Modulators|tubulin modulators|mesh-ancestor
64952153|NCT00028886|Antimitotic Agents|antimitotic agents|mesh-ancestor
64952154|NCT00028886|Mitosis Modulators|mitosis modulators|mesh-ancestor
64952155|NCT00028886|Leprostatic Agents|leprostatic agents|mesh-ancestor
64831285|NCT01579149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64831286|NCT01579201|Carbetocin|carbetocin|mesh-list
64831287|NCT01579201|Oxytocics|oxytocics|mesh-ancestor
64831288|NCT01579201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64831289|NCT01579201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831290|NCT01579227|Tamoxifen|tamoxifen|mesh-list
64831291|NCT01579227|Tocotrienols|tocotrienols|mesh-list
64831292|NCT01579227|Vitamin E|vitamin e|mesh-list
64831293|NCT01579227|Tocopherols|tocopherols|mesh-list
64831294|NCT01579227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64831295|NCT01579227|Hormone Antagonists|hormone antagonists|mesh-ancestor
64831296|NCT01579227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64831297|NCT01579227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831298|NCT01579227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65494745|NCT03970577|Glucocorticoids|glucocorticoids|mesh-ancestor
64568179|NCT04271839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64831299|NCT01579227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831313|NCT01579279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64831314|NCT01579279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831316|NCT01579279|Sensory System Agents|sensory system agents|mesh-ancestor
64831317|NCT01579279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64831318|NCT01579279|Antidepressive Agents|antidepressive agents|mesh-ancestor
64831319|NCT01579279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64831320|NCT01579279|Dopamine Agents|dopamine agents|mesh-ancestor
64831321|NCT01579383|Sumatriptan|sumatriptan|mesh-list
64831322|NCT01579383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64831323|NCT01579383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64831324|NCT01579383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64831325|NCT01579383|Serotonin Agents|serotonin agents|mesh-ancestor
64831326|NCT01579383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64831327|NCT01579383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831328|NCT01579383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831329|NCT01579448|Vaccines|vaccines|mesh-list
64831330|NCT01579448|Immunologic Factors|immunologic factors|mesh-ancestor
64831331|NCT01579448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831338|NCT01579461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831339|NCT01579461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831340|NCT01579461|Urological Agents|urological agents|mesh-ancestor
64831341|NCT01579500|Botulinum Toxins|botulinum toxins|mesh-list
64831342|NCT01579500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64831343|NCT01579500|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64831344|NCT01579500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64831345|NCT01579500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64831346|NCT01579500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831347|NCT01579500|Cholinergic Agents|cholinergic agents|mesh-ancestor
64831348|NCT01579500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64831349|NCT01579500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831350|NCT01579500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64831351|NCT01579500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64831352|NCT01579539|Methylprednisolone|methylprednisolone|mesh-list
64831353|NCT01579539|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64831354|NCT01579539|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64831355|NCT01579539|Prednisolone|prednisolone|mesh-list
64831356|NCT01579539|Prednisolone acetate|prednisolone acetate|mesh-list
64831357|NCT01579539|Esomeprazole|esomeprazole|mesh-list
64831358|NCT01579539|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64831376|NCT01579539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831377|NCT01579630|Pemetrexed|pemetrexed|mesh-list
64831378|NCT01579630|Gefitinib|gefitinib|mesh-list
64831379|NCT01579630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831380|NCT01579630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831381|NCT01579630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831382|NCT01579630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64831383|NCT01579630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64831384|NCT01579630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64831385|NCT01579695|Tesamorelin|tesamorelin|mesh-list
64831386|NCT01579695|Growth Substances|growth substances|mesh-ancestor
64831395|NCT01579734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64831396|NCT01579734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64831397|NCT01579734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64831398|NCT01579760|Aflibercept|aflibercept|mesh-list
64831399|NCT01579760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64831400|NCT01579760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65494746|NCT03970577|Hormones|hormones|mesh-ancestor
64472905|NCT02085148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64472906|NCT02085148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831401|NCT01579760|Growth Substances|growth substances|mesh-ancestor
64831402|NCT01579760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831403|NCT01579760|Growth Inhibitors|growth inhibitors|mesh-ancestor
64831404|NCT01579760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831406|NCT01579786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64831407|NCT01579786|Analgesics|analgesics|mesh-ancestor
64831408|NCT01579786|Sensory System Agents|sensory system agents|mesh-ancestor
64831409|NCT01579786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64831410|NCT01579786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831411|NCT01579786|Antipyretics|antipyretics|mesh-ancestor
64831412|NCT01579838|Eculizumab|eculizumab|mesh-list
64831413|NCT01579838|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64831414|NCT01579838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64831415|NCT01579838|Immunologic Factors|immunologic factors|mesh-ancestor
64831426|NCT01579890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64831427|NCT01579890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64831429|NCT01579890|Sensory System Agents|sensory system agents|mesh-ancestor
64831430|NCT01579890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64831431|NCT01579890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831432|NCT01579890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64831433|NCT01579890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64831435|NCT01579890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831447|NCT01579994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831448|NCT01579994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64831449|NCT01579994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831450|NCT01579994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831451|NCT01580228|Ofatumumab|ofatumumab|mesh-list
64831452|NCT01580228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831453|NCT01581333|Anti-Infective Agents|anti-infective agents|mesh-list
64831454|NCT01581333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64831455|NCT01581359|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64831456|NCT01581359|Luteolytic Agents|luteolytic agents|mesh-ancestor
64831457|NCT01581359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64831458|NCT01581359|Contraceptive Agents|contraceptive agents|mesh-ancestor
64831459|NCT01581359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64831460|NCT01581359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831461|NCT01581359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64831462|NCT01581359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64831463|NCT01581359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831464|NCT01581476|Quinapril|quinapril|mesh-list
64831465|NCT01581476|Atorvastatin|atorvastatin|mesh-list
64831466|NCT01581476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64831467|NCT01581476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64831468|NCT01581476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64831469|NCT01581476|Antimetabolites|antimetabolites|mesh-ancestor
64831471|NCT01581476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64831519|NCT01583426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831520|NCT01583972|Vitamin A|vitamin a|mesh-list
64831521|NCT01583972|Retinol palmitate|retinol palmitate|mesh-list
64831522|NCT01583972|Vitamins|vitamins|mesh-ancestor
64831523|NCT01583972|Micronutrients|micronutrients|mesh-ancestor
64831524|NCT01583972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831525|NCT01583972|Antioxidants|antioxidants|mesh-ancestor
64831526|NCT01583972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831527|NCT01583972|Protective Agents|protective agents|mesh-ancestor
64831534|NCT01584362|Antinematodal Agents|antinematodal agents|mesh-ancestor
64831536|NCT01584921|Hematinics|hematinics|mesh-ancestor
64831537|NCT01586013|Propofol|propofol|mesh-list
64831538|NCT01586013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64831539|NCT01586013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64831540|NCT01586013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831541|NCT01586013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64831542|NCT01586013|Anesthetics, General|anesthetics, general|mesh-ancestor
64831543|NCT01586013|Anesthetics|anesthetics|mesh-ancestor
64831544|NCT01586845|Cyclosporine|cyclosporine|mesh-list
64831545|NCT01586845|Tacrolimus|tacrolimus|mesh-list
64831546|NCT01586845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64831547|NCT01586845|Immunologic Factors|immunologic factors|mesh-ancestor
64831548|NCT01586845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831549|NCT01586845|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64831550|NCT01586845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831551|NCT01586845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831552|NCT01586845|Antifungal Agents|antifungal agents|mesh-ancestor
64831553|NCT01586845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64831554|NCT01586845|Dermatologic Agents|dermatologic agents|mesh-ancestor
64831555|NCT01586845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64831557|NCT01587339|Zonisamide|zonisamide|mesh-list
64831558|NCT01587339|Lacosamide|lacosamide|mesh-list
64831559|NCT01587339|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64831571|NCT01587339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64831572|NCT01587339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64831573|NCT01587339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64831574|NCT01587339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64831575|NCT01587339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64831576|NCT01587378|Metformin|metformin|mesh-list
64831577|NCT01587378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64831578|NCT01587378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831579|NCT01587482|Paclitaxel|paclitaxel|mesh-list
64831580|NCT01587482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64831581|NCT01587482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831582|NCT01587482|Tubulin Modulators|tubulin modulators|mesh-ancestor
64831583|NCT01587482|Antimitotic Agents|antimitotic agents|mesh-ancestor
64831584|NCT01587482|Mitosis Modulators|mitosis modulators|mesh-ancestor
64831585|NCT01587482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831586|NCT01587625|Oxytocin|oxytocin|mesh-list
64831587|NCT01587625|Oxytocics|oxytocics|mesh-ancestor
64831588|NCT01587625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65494748|NCT03970577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65494749|NCT01073813|Minocycline|minocycline|mesh-list
64831589|NCT01587625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831590|NCT01587820|Cisplatin|cisplatin|mesh-list
64831591|NCT01587820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831592|NCT01587937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64831593|NCT01587937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64831594|NCT01587937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64831595|NCT01587937|Antitubercular Agents|antitubercular agents|mesh-ancestor
64831596|NCT01588171|Enoxaparin|enoxaparin|mesh-list
64831597|NCT01588171|Bemiparin|bemiparin|mesh-list
64952156|NCT00028886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64952157|NCT00028886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64952158|NCT00028886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64952159|NCT00028886|Growth Substances|growth substances|mesh-ancestor
64503393|NCT05584956|Vasodilator Agents|vasodilator agents|mesh-ancestor
64503394|NCT05584956|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64490964|NCT01597414|Trastuzumab|trastuzumab|mesh-list
64952160|NCT00028886|Growth Inhibitors|growth inhibitors|mesh-ancestor
64952161|NCT00028925|Carboplatin|carboplatin|mesh-list
64952162|NCT00028925|Topotecan|topotecan|mesh-list
64952163|NCT00028925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952164|NCT00028925|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64952165|NCT00028925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64952166|NCT00028925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952167|NCT00028925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952168|NCT00398463|polysaccharide-K|polysaccharide-k|mesh-list
64952169|NCT00398463|Tirofiban|tirofiban|mesh-list
64952170|NCT00398463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64952171|NCT00398463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64831598|NCT01588171|Anticoagulants|anticoagulants|mesh-ancestor
64831599|NCT01588171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64442752|NCT02216071|Hormones|hormones|mesh-ancestor
64831621|NCT01589367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64831622|NCT01589367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831623|NCT01589367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831624|NCT01589367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64831625|NCT01589367|Hormone Antagonists|hormone antagonists|mesh-ancestor
64831626|NCT01589367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64831627|NCT01589432|Lidocaine|lidocaine|mesh-list
64831628|NCT01589432|Anesthetics, Local|anesthetics, local|mesh-ancestor
64831629|NCT01589432|Anesthetics|anesthetics|mesh-ancestor
64831630|NCT01589432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64831631|NCT01589432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831632|NCT01589432|Sensory System Agents|sensory system agents|mesh-ancestor
64831633|NCT01589432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64831634|NCT01589432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64831635|NCT01589432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64831636|NCT01589432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64831637|NCT01589432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64831638|NCT01589432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831639|NCT01589614|Erythromycin|erythromycin|mesh-list
64831640|NCT01589614|Erythromycin Estolate|erythromycin estolate|mesh-list
64831641|NCT01589614|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64831642|NCT01589614|Erythromycin stearate|erythromycin stearate|mesh-list
64831643|NCT01589614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64831644|NCT01589614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64831645|NCT01589614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64831646|NCT01589614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64831647|NCT01589614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831648|NCT01589614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831649|NCT01589861|Lapatinib|lapatinib|mesh-list
64399381|NCT02340481|Loperamide|loperamide|mesh-list
64952172|NCT00398463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952173|NCT00398463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64952174|NCT00398463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64952175|NCT00398463|Immunologic Factors|immunologic factors|mesh-ancestor
64952184|NCT00028964|Cyclophosphamide|cyclophosphamide|mesh-list
64952185|NCT00028964|Doxorubicin|doxorubicin|mesh-list
64831650|NCT01589861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831651|NCT01589861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64831676|NCT01590225|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64831677|NCT01590225|Interferon-alpha|interferon-alpha|mesh-list
64831678|NCT01590225|Antimetabolites|antimetabolites|mesh-ancestor
64831679|NCT01590225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831680|NCT01590225|Antiviral Agents|antiviral agents|mesh-ancestor
64831681|NCT01590225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64831682|NCT01590225|Immunologic Factors|immunologic factors|mesh-ancestor
64831683|NCT01590225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831684|NCT01590342|Diclofenac|diclofenac|mesh-list
64831685|NCT01590342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64831686|NCT01590342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64831687|NCT01590342|Analgesics|analgesics|mesh-ancestor
64831688|NCT01590342|Sensory System Agents|sensory system agents|mesh-ancestor
64831689|NCT01590342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64831690|NCT01590342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831691|NCT01590342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64831692|NCT01590342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64831693|NCT01590342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64831694|NCT01590342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831695|NCT01590342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831696|NCT01590537|Copper|copper|mesh-list
64831697|NCT01590537|Levonorgestrel|levonorgestrel|mesh-list
64831698|NCT01590537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64831699|NCT01590537|Contraceptive Agents|contraceptive agents|mesh-ancestor
64831700|NCT01590537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64831701|NCT01590537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831735|NCT01590732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64831736|NCT01590732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831737|NCT01590732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831738|NCT01590732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64831739|NCT01590732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64831740|NCT01590732|Alkylating Agents|alkylating agents|mesh-ancestor
64831741|NCT01590732|Keratolytic Agents|keratolytic agents|mesh-ancestor
64831742|NCT01590732|Dermatologic Agents|dermatologic agents|mesh-ancestor
64831743|NCT01590732|Tubulin Modulators|tubulin modulators|mesh-ancestor
64831744|NCT01590732|Antimitotic Agents|antimitotic agents|mesh-ancestor
64831745|NCT01590732|Mitosis Modulators|mitosis modulators|mesh-ancestor
64831746|NCT01590732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64831747|NCT01590823|Dabigatran|dabigatran|mesh-list
64831748|NCT01590823|Antithrombins|antithrombins|mesh-ancestor
64831749|NCT01590823|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64831750|NCT01590823|Protease Inhibitors|protease inhibitors|mesh-ancestor
64831751|NCT01590823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831752|NCT01590823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831753|NCT01590823|Anticoagulants|anticoagulants|mesh-ancestor
64831754|NCT01590836|Insulin|insulin|mesh-list
64831755|NCT01590836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64831756|NCT01590836|Insulin Aspart|insulin aspart|mesh-list
64952186|NCT00028964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64952195|NCT00028964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64952196|NCT00028964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64952197|NCT00028964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64952198|NCT00028964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64952199|NCT00028964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952200|NCT00423501|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64952202|NCT00423501|Hormones|hormones|mesh-ancestor
64952203|NCT00423501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64952204|NCT00423501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952205|NCT00029003|Gefitinib|gefitinib|mesh-list
64952206|NCT00029003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952207|NCT00029003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64952208|NCT00029003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952209|NCT00029003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952210|NCT00029042|Infliximab|infliximab|mesh-list
64725791|NCT00002179|Protease Inhibitors|protease inhibitors|mesh-ancestor
64725792|NCT00003056|Cyclosporine|cyclosporine|mesh-list
64725793|NCT00003056|Methotrexate|methotrexate|mesh-list
64725794|NCT00003056|Cyclosporins|cyclosporins|mesh-list
64725795|NCT00003056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64725796|NCT00003056|Abortifacient Agents|abortifacient agents|mesh-ancestor
64725797|NCT00003056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64725798|NCT00003056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725799|NCT00003056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64725800|NCT00003056|Antimetabolites|antimetabolites|mesh-ancestor
64952211|NCT00029042|Dermatologic Agents|dermatologic agents|mesh-ancestor
64952212|NCT00029042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64952213|NCT00029042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64952214|NCT00423540|Magnesium Sulfate|magnesium sulfate|mesh-list
64952215|NCT00423540|Analgesics|analgesics|mesh-ancestor
64952216|NCT00423540|Sensory System Agents|sensory system agents|mesh-ancestor
64831757|NCT01590836|Insulin, Long-Acting|insulin, long-acting|mesh-list
64831758|NCT01590836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64831759|NCT01590836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831760|NCT01590849|Contraceptive Agents|contraceptive agents|mesh-list
64831761|NCT01590849|Contraceptives, Oral|contraceptives, oral|mesh-list
64831762|NCT01590849|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64831763|NCT01590849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64831764|NCT01590849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831776|NCT01590966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64831777|NCT01590966|Immunologic Factors|immunologic factors|mesh-ancestor
64831778|NCT01590966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831779|NCT01590966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64831780|NCT01591031|Sevoflurane|sevoflurane|mesh-list
64831781|NCT01591031|Rocuronium|rocuronium|mesh-list
64831782|NCT01591031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64831783|NCT01591031|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64831784|NCT01591031|Anesthetics, General|anesthetics, general|mesh-ancestor
64831786|NCT01591031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64831787|NCT01591031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831788|NCT01591031|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64831789|NCT01591031|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64831790|NCT01591031|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64831791|NCT01591031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64831792|NCT01591070|Tacrolimus|tacrolimus|mesh-list
64831793|NCT01591070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64831794|NCT01591070|Immunologic Factors|immunologic factors|mesh-ancestor
64831795|NCT01591070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831796|NCT01591070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64831797|NCT01591070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831799|NCT01591083|Esomeprazole|esomeprazole|mesh-list
64831811|NCT01591122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831812|NCT01591122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64831813|NCT01591122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831814|NCT01591122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64831815|NCT01591122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831816|NCT01591122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831817|NCT01591122|Hormone Antagonists|hormone antagonists|mesh-ancestor
64831818|NCT01591122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64831819|NCT01591135|Paclitaxel|paclitaxel|mesh-list
64831820|NCT01591135|Fluorouracil|fluorouracil|mesh-list
64831821|NCT01591135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64831822|NCT01591135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831823|NCT01591135|Tubulin Modulators|tubulin modulators|mesh-ancestor
64831824|NCT01591135|Antimitotic Agents|antimitotic agents|mesh-ancestor
64831825|NCT01591135|Mitosis Modulators|mitosis modulators|mesh-ancestor
64831826|NCT01591135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831827|NCT01591135|Antimetabolites|antimetabolites|mesh-ancestor
64831828|NCT01591135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64831843|NCT01591226|Anticoagulants|anticoagulants|mesh-ancestor
64831844|NCT01591226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64831845|NCT01591226|Chelating Agents|chelating agents|mesh-ancestor
64831846|NCT01591226|Sequestering Agents|sequestering agents|mesh-ancestor
64831847|NCT01591226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831848|NCT01591226|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64831849|NCT01591226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831850|NCT01591226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64831851|NCT01591226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831852|NCT01591226|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64831853|NCT01591226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64831854|NCT01591226|Purinergic Agents|purinergic agents|mesh-ancestor
64831867|NCT01591551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831868|NCT01591668|Vesatolimod|vesatolimod|mesh-list
64831869|NCT01591668|Antiviral Agents|antiviral agents|mesh-ancestor
64831870|NCT01591668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64831871|NCT01591759|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64831872|NCT01591759|Nootropic Agents|nootropic agents|mesh-ancestor
64831873|NCT01591850|Ritonavir|ritonavir|mesh-list
64831874|NCT01591850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64831875|NCT01591850|Rifampin|rifampin|mesh-list
64831876|NCT01591850|Ketoconazole|ketoconazole|mesh-list
64831877|NCT01591850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64831878|NCT01591850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64831879|NCT01591850|Protease Inhibitors|protease inhibitors|mesh-ancestor
64831880|NCT01591850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831881|NCT01591850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831882|NCT01591850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64831883|NCT01591850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64831884|NCT01591850|Antiviral Agents|antiviral agents|mesh-ancestor
64831885|NCT01591850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64831886|NCT01591850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64831887|NCT01591850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64831888|NCT01591850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64831889|NCT01591850|Antitubercular Agents|antitubercular agents|mesh-ancestor
64831890|NCT01591850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64831891|NCT01591850|Leprostatic Agents|leprostatic agents|mesh-ancestor
64443041|NCT04787744|Hormone Antagonists|hormone antagonists|mesh-ancestor
64831907|NCT01591889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831908|NCT01591889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64831909|NCT01591889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494750|NCT01073813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65494751|NCT01073813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64568622|NCT02588443|Immunologic Factors|immunologic factors|mesh-ancestor
64831910|NCT01591889|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64952217|NCT00423540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64952218|NCT00423540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952219|NCT00423540|Anesthetics|anesthetics|mesh-ancestor
64952220|NCT00423540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64952221|NCT00423540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64952222|NCT00423540|Anticonvulsants|anticonvulsants|mesh-ancestor
64952223|NCT00423540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64952224|NCT00423540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64952225|NCT00423540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831911|NCT01591889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64831912|NCT01591889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64831913|NCT01591902|Tesamorelin|tesamorelin|mesh-list
64831914|NCT01591902|Growth Substances|growth substances|mesh-ancestor
64831915|NCT01591902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831916|NCT01591980|Pregabalin|pregabalin|mesh-list
64831917|NCT01591980|Analgesics|analgesics|mesh-ancestor
64831918|NCT01591980|Sensory System Agents|sensory system agents|mesh-ancestor
64831919|NCT01591980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64831920|NCT01591980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831921|NCT01591980|Anticonvulsants|anticonvulsants|mesh-ancestor
64831922|NCT01591980|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64831923|NCT01591980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64831924|NCT01591980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831925|NCT01591980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64831926|NCT01591980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64831927|NCT01591980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64831928|NCT01591980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64831929|NCT01591980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64831930|NCT01592019|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
64831932|NCT01592019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64503395|NCT05584956|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64503396|NCT05584956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64503397|NCT05584956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503398|NCT05584956|Urological Agents|urological agents|mesh-ancestor
64503399|NCT01376700|Factor VIII|factor viii|mesh-list
64503400|NCT01376700|Coagulants|coagulants|mesh-ancestor
64503401|NCT01797965|Daclizumab|daclizumab|mesh-list
64503402|NCT01797965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64503403|NCT01797965|Immunologic Factors|immunologic factors|mesh-ancestor
64952226|NCT00423540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64952227|NCT00423540|Tocolytic Agents|tocolytic agents|mesh-ancestor
64952228|NCT00423540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64952229|NCT00029159|Estrogens|estrogens|mesh-list
64952230|NCT00029159|Androgens|androgens|mesh-list
64952231|NCT00029159|Hormones|hormones|mesh-ancestor
64952232|NCT00029159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64952233|NCT00029159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952250|NCT00423696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952251|NCT00423696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64952253|NCT00423696|Immunologic Factors|immunologic factors|mesh-ancestor
64952254|NCT00423696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64952255|NCT00423696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64952256|NCT00423696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952257|NCT00423696|Antidotes|antidotes|mesh-ancestor
64952258|NCT00423696|Protective Agents|protective agents|mesh-ancestor
64952259|NCT00423696|Vitamin B Complex|vitamin b complex|mesh-ancestor
64952260|NCT00423696|Vitamins|vitamins|mesh-ancestor
64952261|NCT00423696|Micronutrients|micronutrients|mesh-ancestor
64952262|NCT00029315|Plasminogen|plasminogen|mesh-list
64952263|NCT00029315|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64952264|NCT00029315|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64952265|NCT00029315|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64831933|NCT01592019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64831934|NCT01592019|Analgesics|analgesics|mesh-ancestor
64831935|NCT01592019|Sensory System Agents|sensory system agents|mesh-ancestor
64831936|NCT01592019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64831937|NCT01592019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831938|NCT01592019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64831939|NCT01592019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64831940|NCT01592019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64831941|NCT01592019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831942|NCT01592019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831943|NCT01592032|Vancomycin|vancomycin|mesh-list
64831944|NCT01592032|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64831945|NCT01592032|Linezolid|linezolid|mesh-list
64831946|NCT01592032|Daptomycin|daptomycin|mesh-list
64831947|NCT01592032|Tigecycline|tigecycline|mesh-list
64831948|NCT01592032|Teicoplanin|teicoplanin|mesh-list
64831952|NCT01592032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64831953|NCT01592032|Anticoagulants|anticoagulants|mesh-ancestor
64831954|NCT01592032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64831955|NCT01592032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64831956|NCT01592032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831957|NCT01592032|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64831958|NCT01592032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831960|NCT01592136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831961|NCT01592136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64831962|NCT01592136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831963|NCT01592136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831964|NCT01592162|Remifentanil|remifentanil|mesh-list
64831965|NCT01592162|Propofol|propofol|mesh-list
64831985|NCT01592201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831986|NCT01592201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64831987|NCT01592201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64831988|NCT01592201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64831989|NCT01592201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64831990|NCT01592201|Dopamine Agents|dopamine agents|mesh-ancestor
64831991|NCT01592201|Antiemetics|antiemetics|mesh-ancestor
64831992|NCT01592201|Autonomic Agents|autonomic agents|mesh-ancestor
64831993|NCT01592201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64831994|NCT01592201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64831995|NCT01592201|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64831996|NCT01592201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64831997|NCT01592201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64831998|NCT01592201|Antidepressive Agents|antidepressive agents|mesh-ancestor
64831999|NCT01592201|Dopamine Agonists|dopamine agonists|mesh-ancestor
64832000|NCT01592201|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64832001|NCT01592201|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64832002|NCT01592201|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64832003|NCT01592201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64600587|NCT01273493|Hormones|hormones|mesh-ancestor
64832004|NCT01592214|Benzocaine|benzocaine|mesh-list
64832005|NCT01592214|Anesthetics, Local|anesthetics, local|mesh-ancestor
64832006|NCT01592214|Anesthetics|anesthetics|mesh-ancestor
64832007|NCT01592214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64832008|NCT01592214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832009|NCT01592214|Sensory System Agents|sensory system agents|mesh-ancestor
64832040|NCT01592305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832041|NCT01592305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64832042|NCT01592305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64832043|NCT01592305|Antiviral Agents|antiviral agents|mesh-ancestor
64832044|NCT01592305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64832045|NCT01592305|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64832046|NCT01592305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64832047|NCT01592305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64832048|NCT01592305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64832049|NCT01592318|Ritonavir|ritonavir|mesh-list
64832050|NCT01592318|Lactams|lactams|mesh-list
64832051|NCT01592318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64832052|NCT01592318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64832053|NCT01592318|Protease Inhibitors|protease inhibitors|mesh-ancestor
64832054|NCT01592318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832055|NCT01592318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832056|NCT01592318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64832057|NCT01592318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64832058|NCT01592318|Antiviral Agents|antiviral agents|mesh-ancestor
64832059|NCT01592318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64832060|NCT01592318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64832061|NCT01592318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64832062|NCT01592318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64832063|NCT01592526|Nicotine|nicotine|mesh-list
64832064|NCT01592526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64832065|NCT01592526|Autonomic Agents|autonomic agents|mesh-ancestor
64832066|NCT01592526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832067|NCT01592526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832068|NCT01592526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64832069|NCT01592526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65494752|NCT03823391|Adalimumab|adalimumab|mesh-list
64472909|NCT02085148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64472910|NCT02085148|Tubulin Modulators|tubulin modulators|mesh-ancestor
64832070|NCT01592526|Cholinergic Agents|cholinergic agents|mesh-ancestor
64832071|NCT01592526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64832073|NCT01592630|Ropivacaine|ropivacaine|mesh-list
64832074|NCT01592630|Anesthetics, Local|anesthetics, local|mesh-ancestor
64832075|NCT01592630|Anesthetics|anesthetics|mesh-ancestor
64832076|NCT01592630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64832077|NCT01592630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832078|NCT01592630|Sensory System Agents|sensory system agents|mesh-ancestor
64832079|NCT01592630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832080|NCT01592981|Cyclophosphamide|cyclophosphamide|mesh-list
64832081|NCT01592981|Rituximab|rituximab|mesh-list
64832082|NCT01592981|Fludarabine|fludarabine|mesh-list
64832083|NCT01592981|Bortezomib|bortezomib|mesh-list
64832084|NCT01592981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64832085|NCT01592981|Immunologic Factors|immunologic factors|mesh-ancestor
64832086|NCT01592981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832087|NCT01592981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64832090|NCT01592981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832092|NCT01592981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64832093|NCT01592981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64832094|NCT01593033|Micronutrients|micronutrients|mesh-list
64832095|NCT01593033|Trace Elements|trace elements|mesh-list
64832096|NCT01593033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832097|NCT01593046|Cabotegravir|cabotegravir|mesh-list
64832098|NCT01593046|Rilpivirine|rilpivirine|mesh-list
64832099|NCT01593046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64832100|NCT01593046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64832101|NCT01593046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832102|NCT01593046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832103|NCT01593046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64832104|NCT01593046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64832105|NCT01593046|Antiviral Agents|antiviral agents|mesh-ancestor
64832125|NCT01593137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64832126|NCT01593137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832127|NCT01593137|Incretins|incretins|mesh-ancestor
64832128|NCT01593137|Hormones|hormones|mesh-ancestor
64832129|NCT01593137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64832130|NCT01593137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64832131|NCT01593137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64832132|NCT01593137|Immunologic Factors|immunologic factors|mesh-ancestor
64832133|NCT01593150|Dabigatran|dabigatran|mesh-list
64832134|NCT01593150|Antithrombins|antithrombins|mesh-ancestor
64832135|NCT01593150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64832136|NCT01593150|Protease Inhibitors|protease inhibitors|mesh-ancestor
64832137|NCT01593150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832138|NCT01593150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832139|NCT01593150|Anticoagulants|anticoagulants|mesh-ancestor
64832140|NCT01593163|Ibuprofen|ibuprofen|mesh-list
64832141|NCT01593163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64832142|NCT01593163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64832143|NCT01593163|Analgesics|analgesics|mesh-ancestor
64832144|NCT01593163|Sensory System Agents|sensory system agents|mesh-ancestor
64832145|NCT01593163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65494753|NCT03823391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65494754|NCT03823391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64472911|NCT02085148|Antimitotic Agents|antimitotic agents|mesh-ancestor
64832146|NCT01593163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832147|NCT01593163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64832148|NCT01593163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64832149|NCT01593163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64832150|NCT01593163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832151|NCT01593163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832152|NCT01593280|Morphine|morphine|mesh-list
64832153|NCT01593280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64832154|NCT01593280|Narcotics|narcotics|mesh-ancestor
64832155|NCT01593280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64832156|NCT01593280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600734|NCT01273727|Dexamethasone|dexamethasone|mesh-list
64399907|NCT05075863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64832184|NCT01593332|Immunologic Factors|immunologic factors|mesh-ancestor
64832185|NCT01593332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832186|NCT01593332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64832187|NCT01593371|Metformin|metformin|mesh-list
64832188|NCT01593371|Pioglitazone|pioglitazone|mesh-list
64832189|NCT01593371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64832190|NCT01593371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832191|NCT01593397|Fentanyl|fentanyl|mesh-list
64832192|NCT01593397|Propofol|propofol|mesh-list
64832193|NCT01593397|Anesthetics|anesthetics|mesh-list
64832194|NCT01593397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64832195|NCT01593397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64832196|NCT01593397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832197|NCT01593397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64832198|NCT01593397|Anesthetics, General|anesthetics, general|mesh-ancestor
64832199|NCT01593397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64832200|NCT01593397|Narcotics|narcotics|mesh-ancestor
64832201|NCT01593397|Analgesics|analgesics|mesh-ancestor
64832202|NCT01593397|Sensory System Agents|sensory system agents|mesh-ancestor
64832203|NCT01593397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832204|NCT01593397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64832205|NCT01593410|Dexamethasone|dexamethasone|mesh-list
64832206|NCT01593410|Lenalidomide|lenalidomide|mesh-list
64832207|NCT01593410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64832208|NCT01593410|Antiemetics|antiemetics|mesh-ancestor
64832209|NCT01593410|Autonomic Agents|autonomic agents|mesh-ancestor
64832210|NCT01593410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832211|NCT01593410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832238|NCT01593566|Anesthetics|anesthetics|mesh-ancestor
64832239|NCT01593566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64832256|NCT01593644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64832257|NCT01593644|Vasodilator Agents|vasodilator agents|mesh-ancestor
64832258|NCT01593644|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64832259|NCT01593644|Purinergic Agonists|purinergic agonists|mesh-ancestor
64832260|NCT01593644|Purinergic Agents|purinergic agents|mesh-ancestor
64832286|NCT01593826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64832287|NCT01593826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64832288|NCT01593826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64832289|NCT01593826|Adrenergic Agents|adrenergic agents|mesh-ancestor
64832290|NCT01593826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64832291|NCT01593826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832292|NCT01593826|Antidotes|antidotes|mesh-ancestor
64832293|NCT01593826|Protective Agents|protective agents|mesh-ancestor
64832294|NCT01593930|Lidocaine|lidocaine|mesh-list
64832295|NCT01593930|Carticaine|carticaine|mesh-list
65494755|NCT00161213|Gemcitabine|gemcitabine|mesh-list
64832296|NCT01593930|Anesthetics, Local|anesthetics, local|mesh-ancestor
64832297|NCT01593930|Anesthetics|anesthetics|mesh-ancestor
64832298|NCT01593930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64832299|NCT01593930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832300|NCT01593930|Sensory System Agents|sensory system agents|mesh-ancestor
64832301|NCT01593930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832302|NCT01593930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64832304|NCT01593930|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64832353|NCT01594177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832354|NCT01594177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64832355|NCT01594177|Immunologic Factors|immunologic factors|mesh-ancestor
64832356|NCT01594177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832357|NCT01594177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64832358|NCT01594177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64832359|NCT01594177|Alkylating Agents|alkylating agents|mesh-ancestor
64832360|NCT01594177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64443522|NCT01709578|Antimetabolites|antimetabolites|mesh-ancestor
64832394|NCT01594346|Tocopherols|tocopherols|mesh-list
64832395|NCT01594346|Tocotrienols|tocotrienols|mesh-list
64832396|NCT01594346|alpha-Tocopherol|alpha-tocopherol|mesh-list
64832397|NCT01594346|Vitamins|vitamins|mesh-ancestor
64832398|NCT01594346|Micronutrients|micronutrients|mesh-ancestor
64832399|NCT01594346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832400|NCT01594346|Antioxidants|antioxidants|mesh-ancestor
64832401|NCT01594346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832402|NCT01594346|Protective Agents|protective agents|mesh-ancestor
64832420|NCT01594502|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64832421|NCT01594502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64832422|NCT01594502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832423|NCT01594502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832424|NCT01594502|Hormone Antagonists|hormone antagonists|mesh-ancestor
64832425|NCT01594502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64832426|NCT01594502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832427|NCT01594619|Diltiazem|diltiazem|mesh-list
64832428|NCT01594619|Naloxegol|naloxegol|mesh-list
64832429|NCT01594619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64832430|NCT01594619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64832431|NCT01594619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64832432|NCT01594619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832441|NCT01594671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64832442|NCT01594671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832443|NCT01594671|Hemostatics|hemostatics|mesh-ancestor
64832444|NCT01594671|Coagulants|coagulants|mesh-ancestor
64832445|NCT01594697|Metformin|metformin|mesh-list
64832446|NCT01594697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64832447|NCT01594697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832448|NCT01594775|Oxytocin|oxytocin|mesh-list
64832449|NCT01594775|Oxytocics|oxytocics|mesh-ancestor
64832450|NCT01594775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64832451|NCT01594775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832452|NCT01594866|Dexetimide|dexetimide|mesh-list
64832453|NCT01594866|Citalopram|citalopram|mesh-list
64832454|NCT01594866|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64832455|NCT01594866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64832456|NCT01594866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64832457|NCT01594866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832458|NCT01594866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64832473|NCT01594879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64832474|NCT01594879|Contraceptive Agents|contraceptive agents|mesh-ancestor
64832475|NCT01594879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64832476|NCT01594879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832477|NCT01594879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64832478|NCT01594879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64832505|NCT01594918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832506|NCT01595009|Everolimus|everolimus|mesh-list
64832507|NCT01595009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64832508|NCT01595009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64832509|NCT01595009|Immunologic Factors|immunologic factors|mesh-ancestor
64832510|NCT01595009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832511|NCT01595022|Contraceptive Agents|contraceptive agents|mesh-list
64832512|NCT01595022|Levonorgestrel|levonorgestrel|mesh-list
64832513|NCT01595022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64832514|NCT01595022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832515|NCT01595022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64832516|NCT01595022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64832517|NCT01595022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64832518|NCT01595022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64832519|NCT01595152|Solifenacin Succinate|solifenacin succinate|mesh-list
64832543|NCT01595399|Respiratory System Agents|respiratory system agents|mesh-ancestor
64832544|NCT01595399|Mydriatics|mydriatics|mesh-ancestor
64832545|NCT01595399|Parasympatholytics|parasympatholytics|mesh-ancestor
64832546|NCT01595399|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65494757|NCT00161213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64569074|NCT02455687|Analgesics|analgesics|mesh-ancestor
64832547|NCT01595399|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64832548|NCT01595399|Cholinergic Agents|cholinergic agents|mesh-ancestor
64832549|NCT01595399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64832550|NCT01595399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832551|NCT01595425|Esomeprazole|esomeprazole|mesh-list
64832586|NCT01595724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64832587|NCT01595724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64832588|NCT01595724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64832589|NCT01595724|Hormone Antagonists|hormone antagonists|mesh-ancestor
64832590|NCT01595724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64832591|NCT01595724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64832592|NCT01595724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64832594|NCT01595737|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64832595|NCT01595737|Vasodilator Agents|vasodilator agents|mesh-ancestor
64832596|NCT01595737|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64832597|NCT01595737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64832598|NCT01595737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832599|NCT01595737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832600|NCT01595737|Protective Agents|protective agents|mesh-ancestor
64832601|NCT01595737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832602|NCT01595763|Fibrin fragment D|fibrin fragment d|mesh-list
64832603|NCT01595763|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64832604|NCT01595763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64832605|NCT01595763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832606|NCT01595763|Hemostatics|hemostatics|mesh-ancestor
64832607|NCT01595763|Coagulants|coagulants|mesh-ancestor
64832608|NCT01595789|Liraglutide|liraglutide|mesh-list
64832609|NCT01595789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64832610|NCT01595789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832611|NCT01595789|Incretins|incretins|mesh-ancestor
64832612|NCT01595789|Hormones|hormones|mesh-ancestor
64832613|NCT01595789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64832614|NCT01595815|Calcium|calcium|mesh-list
64832615|NCT01595815|Ionophores|ionophores|mesh-list
64832616|NCT01595815|Calcium Ionophores|calcium ionophores|mesh-list
64832617|NCT01595815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64832618|NCT01595815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832619|NCT01595815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64832620|NCT01595815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832624|NCT01595828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64832625|NCT01595828|Antimetabolites|antimetabolites|mesh-ancestor
64832626|NCT01595828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832627|NCT01595828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832628|NCT01595828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64832629|NCT01595867|Naltrexone|naltrexone|mesh-list
64832630|NCT01595867|Morphine|morphine|mesh-list
65494758|NCT00161213|Antimetabolites|antimetabolites|mesh-ancestor
64472915|NCT02043678|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64472916|NCT02043678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64832631|NCT01595867|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64832632|NCT01595867|Narcotics|narcotics|mesh-ancestor
64832637|NCT01595867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832691|NCT01596010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64832692|NCT01596010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64832693|NCT01596010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64832694|NCT01596010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64832695|NCT01596075|Cannabidiol|cannabidiol|mesh-list
64832696|NCT01596075|Anticonvulsants|anticonvulsants|mesh-ancestor
64832697|NCT01596114|Tin Fluorides|tin fluorides|mesh-list
64832698|NCT01596114|Cariostatic Agents|cariostatic agents|mesh-ancestor
64832699|NCT01596114|Protective Agents|protective agents|mesh-ancestor
64832700|NCT01596114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832701|NCT01596140|Sirolimus|sirolimus|mesh-list
64832702|NCT01596140|Everolimus|everolimus|mesh-list
64832703|NCT01596140|Vemurafenib|vemurafenib|mesh-list
64832704|NCT01596140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64832705|NCT01596140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64832709|NCT01596140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64832710|NCT01596140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64832711|NCT01596140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64832712|NCT01596140|Antifungal Agents|antifungal agents|mesh-ancestor
65494759|NCT00161213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472917|NCT02043678|Glucocorticoids|glucocorticoids|mesh-ancestor
64832713|NCT01596140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64832714|NCT01596140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832716|NCT01596166|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64832717|NCT01596166|Metoclopramide|metoclopramide|mesh-list
64832718|NCT01596166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64832719|NCT01596166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64832720|NCT01596166|Analgesics|analgesics|mesh-ancestor
64832721|NCT01596166|Sensory System Agents|sensory system agents|mesh-ancestor
64832722|NCT01596166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832724|NCT01596166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64832738|NCT01596218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64832739|NCT01596296|Dinoprostone|dinoprostone|mesh-list
64832740|NCT01596296|Oxytocics|oxytocics|mesh-ancestor
64832741|NCT01596296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64832742|NCT01596296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832743|NCT01596387|Propofol|propofol|mesh-list
64832744|NCT01596387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64832745|NCT01596387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64832746|NCT01596387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832747|NCT01596387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64832748|NCT01596387|Anesthetics, General|anesthetics, general|mesh-ancestor
64832749|NCT01596387|Anesthetics|anesthetics|mesh-ancestor
64832750|NCT01596400|Granisetron|granisetron|mesh-list
64832751|NCT01596400|Antiemetics|antiemetics|mesh-ancestor
64832752|NCT01596400|Autonomic Agents|autonomic agents|mesh-ancestor
64832753|NCT01596400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832754|NCT01596400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832755|NCT01596400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64832756|NCT01596400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64832757|NCT01596400|Serotonin Agents|serotonin agents|mesh-ancestor
64832807|NCT01596647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64832808|NCT01596647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832809|NCT01596647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64832810|NCT01596647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64832811|NCT01596647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64832812|NCT01596647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64832813|NCT01596647|Anesthetics, General|anesthetics, general|mesh-ancestor
64832814|NCT01596647|Anesthetics|anesthetics|mesh-ancestor
64832815|NCT01596647|GABA Modulators|gaba modulators|mesh-ancestor
64832816|NCT01596647|GABA Agents|gaba agents|mesh-ancestor
64832817|NCT01596647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64832818|NCT01596647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832819|NCT01596647|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64832820|NCT01596647|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64832821|NCT01596647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832822|NCT01596647|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64832823|NCT01596647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64832824|NCT01596647|Purinergic Agents|purinergic agents|mesh-ancestor
64832825|NCT01596647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64832826|NCT01596647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64400486|NCT03351439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64833556|NCT05689619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833557|NCT05689463|Immunoglobulins|immunoglobulins|mesh-list
64833558|NCT05689463|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64833559|NCT05689463|Antibodies|antibodies|mesh-list
64444713|NCT02193776|Rifampin|rifampin|mesh-list
64835433|NCT03161353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64835434|NCT03161353|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64835435|NCT03161353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64835436|NCT03161353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835437|NCT03161353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64835438|NCT03161353|Hormone Antagonists|hormone antagonists|mesh-ancestor
64835439|NCT03161353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64835440|NCT03161353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835441|NCT03161353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64835442|NCT03161353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64472918|NCT02043678|Hormones|hormones|mesh-ancestor
64569370|NCT04904406|Lamivudine|lamivudine|mesh-list
64446523|NCT01555138|Autonomic Agents|autonomic agents|mesh-ancestor
64836733|NCT01614535|Narcotics|narcotics|mesh-ancestor
64836734|NCT01614535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64839415|NCT01631513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64839416|NCT01631513|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64839417|NCT01631513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64840119|NCT01636180|Purinergic Agents|purinergic agents|mesh-ancestor
64840120|NCT01636180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64840121|NCT01636180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840122|NCT01636180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840322|NCT01637194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840324|NCT01637194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64840325|NCT01637233|Ritonavir|ritonavir|mesh-list
64840326|NCT01637233|Lopinavir|lopinavir|mesh-list
64840327|NCT01637233|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64840328|NCT01637233|Darunavir|darunavir|mesh-list
64840329|NCT01637233|Fosamprenavir|fosamprenavir|mesh-list
64840330|NCT01637233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
64840331|NCT01637233|Tenofovir|tenofovir|mesh-list
64840332|NCT01637233|Lamivudine|lamivudine|mesh-list
64840333|NCT01637233|Zidovudine|zidovudine|mesh-list
64840334|NCT01637233|Emtricitabine|emtricitabine|mesh-list
64840335|NCT01637233|Maraviroc|maraviroc|mesh-list
64840336|NCT01637233|Abacavir|abacavir|mesh-list
64840337|NCT01637233|Dideoxynucleosides|dideoxynucleosides|mesh-list
64840338|NCT01637233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
64840339|NCT01637233|Protease Inhibitors|protease inhibitors|mesh-list
64840340|NCT01637233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64840362|NCT01637259|Zidovudine|zidovudine|mesh-list
64840363|NCT01637259|Emtricitabine|emtricitabine|mesh-list
64840364|NCT01637259|Maraviroc|maraviroc|mesh-list
64840365|NCT01637259|Abacavir|abacavir|mesh-list
64952266|NCT00029315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952267|NCT00056823|Ranibizumab|ranibizumab|mesh-list
64952268|NCT00056823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64952269|NCT00056823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64725801|NCT00003056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725802|NCT00003056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725803|NCT00003056|Dermatologic Agents|dermatologic agents|mesh-ancestor
64725804|NCT00003056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725805|NCT00003056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64725806|NCT00003056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64725807|NCT00003056|Immunologic Factors|immunologic factors|mesh-ancestor
64952270|NCT00056823|Growth Substances|growth substances|mesh-ancestor
64952271|NCT00056823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952272|NCT00056823|Growth Inhibitors|growth inhibitors|mesh-ancestor
64952273|NCT00056823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952274|NCT00029627|Yohimbine|yohimbine|mesh-list
64952275|NCT00029627|Mydriatics|mydriatics|mesh-ancestor
64952276|NCT00029627|Autonomic Agents|autonomic agents|mesh-ancestor
64952277|NCT00029627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64952278|NCT00029627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952279|NCT00029627|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64840366|NCT01637259|Dideoxynucleosides|dideoxynucleosides|mesh-list
64840367|NCT01637259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
64840368|NCT01637259|Protease Inhibitors|protease inhibitors|mesh-list
64840369|NCT01637259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64840370|NCT01637259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840371|NCT01637259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840372|NCT01637259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64840373|NCT01637259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64840374|NCT01637259|Antiviral Agents|antiviral agents|mesh-ancestor
64840375|NCT01637259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494761|NCT00161213|Antiviral Agents|antiviral agents|mesh-ancestor
65494762|NCT00161213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494763|NCT00161213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569444|NCT04346329|Hydroxychloroquine|hydroxychloroquine|mesh-list
64840376|NCT01637259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64840377|NCT01637259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64840378|NCT01637259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64840379|NCT01637259|Antimetabolites|antimetabolites|mesh-ancestor
64840380|NCT01637259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64840381|NCT01637259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64840382|NCT01637259|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64840384|NCT01637376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840385|NCT01637376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64840386|NCT01637376|Dermatologic Agents|dermatologic agents|mesh-ancestor
64840420|NCT01637545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64840421|NCT01637545|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64840422|NCT01637545|Serotonin Agents|serotonin agents|mesh-ancestor
64840423|NCT01637545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64840424|NCT01637545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840425|NCT01637558|Ritonavir|ritonavir|mesh-list
64840426|NCT01637558|Lopinavir|lopinavir|mesh-list
64840427|NCT01637558|Nevirapine|nevirapine|mesh-list
64840428|NCT01637558|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64840429|NCT01637558|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64840430|NCT01637558|Protease Inhibitors|protease inhibitors|mesh-ancestor
64840431|NCT01637558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840432|NCT01637558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840433|NCT01637558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64840434|NCT01637558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64840435|NCT01637558|Antiviral Agents|antiviral agents|mesh-ancestor
64840436|NCT01637558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64840437|NCT01637558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64840443|NCT01637571|Dexlansoprazole|dexlansoprazole|mesh-list
64840484|NCT01637675|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64840485|NCT01637675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64840486|NCT01637675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840487|NCT01637675|Urological Agents|urological agents|mesh-ancestor
64840488|NCT01637675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64840489|NCT01637675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64840490|NCT01637675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64840491|NCT01637675|Analgesics|analgesics|mesh-ancestor
64840492|NCT01637675|Sensory System Agents|sensory system agents|mesh-ancestor
64840493|NCT01637675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64840494|NCT01637675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840495|NCT01637675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64840496|NCT01637675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64840497|NCT01637675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64840498|NCT01637675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840499|NCT01637675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64840500|NCT01637675|Immunologic Factors|immunologic factors|mesh-ancestor
64840501|NCT01637753|Carmustine|carmustine|mesh-list
64840502|NCT01637753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64840857|NCT01639521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64840858|NCT01639521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64841417|NCT01651520|GABA Modulators|gaba modulators|mesh-ancestor
64841418|NCT01651520|GABA Agents|gaba agents|mesh-ancestor
64841419|NCT01651520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64841420|NCT01651520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841421|NCT01651572|Rocuronium|rocuronium|mesh-list
64841422|NCT01651572|Cisatracurium|cisatracurium|mesh-list
64452343|NCT01839279|Analgesics|analgesics|mesh-ancestor
64841611|NCT01652378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64841612|NCT01652378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64841613|NCT01652417|Methylprednisolone|methylprednisolone|mesh-list
64841614|NCT01652417|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64841975|NCT01654497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842032|NCT01654913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842033|NCT01654913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842034|NCT01654913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64842035|NCT01654913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64842036|NCT01654939|Rifaximin|rifaximin|mesh-list
64842037|NCT01654939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64842038|NCT01654939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64842039|NCT01654939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64842040|NCT01654965|Topotecan|topotecan|mesh-list
64842041|NCT01654965|Lenograstim|lenograstim|mesh-list
64842185|NCT01655628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842186|NCT01655628|Antiviral Agents|antiviral agents|mesh-ancestor
64842187|NCT01655628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64842188|NCT01655628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842189|NCT01655628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64842190|NCT01655628|Immunologic Factors|immunologic factors|mesh-ancestor
64842191|NCT01655628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842646|NCT01657747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64842647|NCT01657747|Cholinergic Agents|cholinergic agents|mesh-ancestor
64842648|NCT01657747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842649|NCT01657747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842650|NCT01657812|Dexmedetomidine|dexmedetomidine|mesh-list
64842651|NCT01657812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64842652|NCT01657812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64842719|NCT01657955|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64842720|NCT01657955|Chlorambucil|chlorambucil|mesh-list
64842721|NCT01657955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64842722|NCT01657955|Alkylating Agents|alkylating agents|mesh-ancestor
64842723|NCT01657955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842724|NCT01657955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842725|NCT01657513|Adalimumab|adalimumab|mesh-list
64842726|NCT01657513|Etanercept|etanercept|mesh-list
64842727|NCT01657513|Infliximab|infliximab|mesh-list
64842728|NCT01657513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64514735|NCT02393157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64842729|NCT01657513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64842730|NCT01657513|Dermatologic Agents|dermatologic agents|mesh-ancestor
64842731|NCT01657513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64842732|NCT01657513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64842733|NCT01657513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64842735|NCT01657513|Sensory System Agents|sensory system agents|mesh-ancestor
64842747|NCT01657981|Anticoagulants|anticoagulants|mesh-ancestor
64842748|NCT01658007|Sirolimus|sirolimus|mesh-list
64842749|NCT01658007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64842750|NCT01658007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64842751|NCT01658007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64842752|NCT01658007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842753|NCT01658007|Antifungal Agents|antifungal agents|mesh-ancestor
64842754|NCT01658007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64842755|NCT01658007|Immunologic Factors|immunologic factors|mesh-ancestor
64842756|NCT01658007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842757|NCT01658033|Leucovorin|leucovorin|mesh-list
64842758|NCT01658033|Oxaliplatin|oxaliplatin|mesh-list
64842759|NCT01658033|Bevacizumab|bevacizumab|mesh-list
64842760|NCT01658033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842761|NCT01658033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64842931|NCT01659099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64842933|NCT01659099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842934|NCT01659099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64842935|NCT01659099|Glucocorticoids|glucocorticoids|mesh-ancestor
64842937|NCT01659099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64842938|NCT01659099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64842939|NCT01659099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64842940|NCT01659099|Tubulin Modulators|tubulin modulators|mesh-ancestor
64843076|NCT01659775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64843077|NCT01659775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843163|NCT01660295|Analgesics|analgesics|mesh-ancestor
64843180|NCT01660386|Saxagliptin|saxagliptin|mesh-list
64843181|NCT01660386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64843182|NCT01660386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843183|NCT01660386|Incretins|incretins|mesh-ancestor
64843184|NCT01660386|Hormones|hormones|mesh-ancestor
64843258|NCT01660854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65494765|NCT00161213|Immunologic Factors|immunologic factors|mesh-ancestor
64569744|NCT01894633|Chloroquine|chloroquine|mesh-list
64843259|NCT01660854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64843260|NCT01660854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64843261|NCT01660854|Antimetabolites|antimetabolites|mesh-ancestor
64843262|NCT01660854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843263|NCT01660867|Dexamethasone|dexamethasone|mesh-list
64843264|NCT01660867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64843265|NCT01660867|Antiemetics|antiemetics|mesh-ancestor
64843266|NCT01660867|Autonomic Agents|autonomic agents|mesh-ancestor
64843267|NCT01660867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843268|NCT01660867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843269|NCT01660867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64843270|NCT01660867|Glucocorticoids|glucocorticoids|mesh-ancestor
64843271|NCT01660867|Hormones|hormones|mesh-ancestor
64843632|NCT01663168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64843633|NCT01663168|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64843634|NCT01663168|Antitubercular Agents|antitubercular agents|mesh-ancestor
64843636|NCT01663441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843637|NCT01663558|Imiquimod|imiquimod|mesh-list
64843638|NCT01663558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64843639|NCT01663558|Immunologic Factors|immunologic factors|mesh-ancestor
64843640|NCT01663558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843641|NCT01663558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843642|NCT01663558|Interferon Inducers|interferon inducers|mesh-ancestor
64843643|NCT01663662|Tolvaptan|tolvaptan|mesh-list
64843644|NCT01663662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64843645|NCT01663662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843646|NCT01663662|Natriuretic Agents|natriuretic agents|mesh-ancestor
64843647|NCT01663662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843650|NCT01663753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843651|NCT01663805|Everolimus|everolimus|mesh-list
64843652|NCT01663805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843653|NCT01663805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64843654|NCT01663805|Immunologic Factors|immunologic factors|mesh-ancestor
64843655|NCT01663805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843656|NCT01663961|Digoxin|digoxin|mesh-list
64843657|NCT01663961|Mirabegron|mirabegron|mesh-list
64843658|NCT01663961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64843659|NCT01663961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64843660|NCT01663961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843661|NCT01663961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843662|NCT01663961|Protective Agents|protective agents|mesh-ancestor
64843663|NCT01663961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843864|NCT01665378|Hematinics|hematinics|mesh-ancestor
64846083|NCT01687751|Anesthetics|anesthetics|mesh-ancestor
64846084|NCT01687751|GABA Modulators|gaba modulators|mesh-ancestor
64846108|NCT01689753|Anticoagulants|anticoagulants|mesh-ancestor
64846109|NCT01689753|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64846110|NCT01689753|Chelating Agents|chelating agents|mesh-ancestor
64846111|NCT01689753|Sequestering Agents|sequestering agents|mesh-ancestor
64846112|NCT01689753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846113|NCT01690039|Fludrocortisone|fludrocortisone|mesh-list
64846115|NCT01690039|Diuretics|diuretics|mesh-ancestor
64846116|NCT01690039|Natriuretic Agents|natriuretic agents|mesh-ancestor
64846117|NCT01690039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846118|NCT01690039|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64846119|NCT01690039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64846120|NCT01690039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846121|NCT01690039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64846122|NCT01690091|Metformin|metformin|mesh-list
64846123|NCT01690091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64846497|NCT01692132|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64846498|NCT01692132|Serotonin Agents|serotonin agents|mesh-ancestor
64846499|NCT01692132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64846500|NCT01692132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846501|NCT01692132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846502|NCT01692210|Dexmedetomidine|dexmedetomidine|mesh-list
64846503|NCT01692210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64846504|NCT01692210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64846505|NCT01692210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846506|NCT01692210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64846507|NCT01692210|Analgesics|analgesics|mesh-ancestor
64846508|NCT01692210|Sensory System Agents|sensory system agents|mesh-ancestor
64846509|NCT01692210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64846510|NCT01692210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64846511|NCT01692210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64846512|NCT01692210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64846513|NCT01692210|Adrenergic Agents|adrenergic agents|mesh-ancestor
64846514|NCT01692210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64846515|NCT01692210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846516|NCT01692457|Golimumab|golimumab|mesh-list
64846517|NCT01692457|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64846518|NCT01692457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64846519|NCT01692457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64846520|NCT01692457|Immunologic Factors|immunologic factors|mesh-ancestor
64846521|NCT01692457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846573|NCT01692834|Dermatologic Agents|dermatologic agents|mesh-ancestor
64846594|NCT01693081|Apomorphine|apomorphine|mesh-list
64846595|NCT01693081|Emetics|emetics|mesh-ancestor
64846596|NCT01693081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846597|NCT01693081|Autonomic Agents|autonomic agents|mesh-ancestor
64846598|NCT01693081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64846599|NCT01693081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64846600|NCT01693081|Dopamine Agonists|dopamine agonists|mesh-ancestor
64846601|NCT01693081|Dopamine Agents|dopamine agents|mesh-ancestor
64846602|NCT01693081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64846603|NCT01693081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846604|NCT01693159|Ethyl 2-cyanoacrylate|ethyl 2-cyanoacrylate|mesh-list
64846605|NCT01693159|Hemostatics|hemostatics|mesh-ancestor
64846606|NCT01693159|Coagulants|coagulants|mesh-ancestor
64846607|NCT01693276|Gemcitabine|gemcitabine|mesh-list
64846608|NCT01693276|Paclitaxel|paclitaxel|mesh-list
64846609|NCT01693276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64846610|NCT01693276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64846611|NCT01693276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846613|NCT01693276|Antimitotic Agents|antimitotic agents|mesh-ancestor
64846680|NCT01693432|Antimitotic Agents|antimitotic agents|mesh-ancestor
64846681|NCT01693432|Mitosis Modulators|mitosis modulators|mesh-ancestor
64846682|NCT01693432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846683|NCT01693445|Oxaliplatin|oxaliplatin|mesh-list
64846684|NCT01693445|Irinotecan|irinotecan|mesh-list
64846685|NCT01693445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846686|NCT01693445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64615166|NCT03127137|Hormones|hormones|mesh-ancestor
64846687|NCT01693445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64846688|NCT01693445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494767|NCT00161213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65494768|NCT01075529|Fluoxetine|fluoxetine|mesh-list
64952280|NCT00029627|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64952281|NCT00029627|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64952282|NCT00029627|Adrenergic Agents|adrenergic agents|mesh-ancestor
64952283|NCT00029627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64952284|NCT00029627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952285|NCT00029627|Urological Agents|urological agents|mesh-ancestor
64952286|NCT02970084|Vitamin K|vitamin k|mesh-list
64952287|NCT02970084|Vitamin K 2|vitamin k 2|mesh-list
64952288|NCT02970084|Vitamins|vitamins|mesh-ancestor
64952289|NCT02970084|Micronutrients|micronutrients|mesh-ancestor
64952290|NCT02970084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952291|NCT02970084|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64952292|NCT02970084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64952293|NCT02970084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952294|NCT02970084|Hemostatics|hemostatics|mesh-ancestor
64952295|NCT02970084|Coagulants|coagulants|mesh-ancestor
64569982|NCT01406223|Dopamine Agents|dopamine agents|mesh-ancestor
64846689|NCT01693445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846690|NCT01693601|Panobinostat|panobinostat|mesh-list
64846691|NCT01693601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846692|NCT01693601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64846782|NCT05288725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64846783|NCT05288725|Immunologic Factors|immunologic factors|mesh-ancestor
64846784|NCT05288673|Ravulizumab|ravulizumab|mesh-list
64846785|NCT05288673|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64846786|NCT05288673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64846787|NCT05288673|Immunologic Factors|immunologic factors|mesh-ancestor
64846788|NCT05288673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846789|NCT05288660|Ravulizumab|ravulizumab|mesh-list
64846790|NCT05288660|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64846791|NCT05288660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64846792|NCT05288660|Immunologic Factors|immunologic factors|mesh-ancestor
64846793|NCT05288660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846794|NCT05288465|Cerebrolysin|cerebrolysin|mesh-list
64846795|NCT05288465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64846829|NCT05288179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846830|NCT05288179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64846831|NCT05288179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64846832|NCT05288179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64846833|NCT05288179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64615318|NCT03001726|Docetaxel|docetaxel|mesh-list
64846834|NCT05288179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846893|NCT05290948|Acetazolamide|acetazolamide|mesh-list
64846894|NCT05290948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64846895|NCT05290948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846896|NCT05290948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64846911|NCT05290935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846912|NCT05290935|Tubulin Modulators|tubulin modulators|mesh-ancestor
64846967|NCT05292742|Pertuzumab|pertuzumab|mesh-list
64846968|NCT05292742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64846969|NCT05292742|Antimetabolites|antimetabolites|mesh-ancestor
64846970|NCT05292742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846971|NCT05292742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846972|NCT05292742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64846973|NCT05292677|Anesthetics|anesthetics|mesh-list
64846974|NCT05292677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64846975|NCT05292677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846976|NCT05292573|Metformin|metformin|mesh-list
64846977|NCT05292573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64846978|NCT05292573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846979|NCT05291910|Paclitaxel|paclitaxel|mesh-list
64846980|NCT05291910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64846981|NCT05291910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64846982|NCT05291910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846983|NCT05291910|Tubulin Modulators|tubulin modulators|mesh-ancestor
64846984|NCT05291910|Antimitotic Agents|antimitotic agents|mesh-ancestor
64846985|NCT05291910|Mitosis Modulators|mitosis modulators|mesh-ancestor
64846987|NCT05291793|Methylprednisolone|methylprednisolone|mesh-list
64847128|NCT05294393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64847129|NCT05294393|Anticonvulsants|anticonvulsants|mesh-ancestor
64847130|NCT05294393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64847131|NCT05294393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64847132|NCT05294393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847133|NCT05294393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64847134|NCT05294393|Tocolytic Agents|tocolytic agents|mesh-ancestor
64847135|NCT05294393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64847136|NCT05293977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64847137|NCT05293977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64847138|NCT05293808|Aspirin|aspirin|mesh-list
64847139|NCT05293808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64847140|NCT05293808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64847141|NCT05293808|Analgesics|analgesics|mesh-ancestor
64847142|NCT05293808|Sensory System Agents|sensory system agents|mesh-ancestor
64847307|NCT05273242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64847308|NCT05273242|Antiviral Agents|antiviral agents|mesh-ancestor
64847309|NCT05273242|Schistosomicides|schistosomicides|mesh-ancestor
64847373|NCT05264896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847374|NCT05264896|Tubulin Modulators|tubulin modulators|mesh-ancestor
64847375|NCT05264896|Antimitotic Agents|antimitotic agents|mesh-ancestor
64847437|NCT05225402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847438|NCT05225402|Sympathomimetics|sympathomimetics|mesh-ancestor
64847439|NCT05225402|Autonomic Agents|autonomic agents|mesh-ancestor
64847440|NCT05225402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64847441|NCT05225402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64847443|NCT05220826|Ethylene|ethylene|mesh-list
64847444|NCT05220826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64847445|NCT05220826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64847446|NCT05220826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64847503|NCT05189444|Natriuretic Agents|natriuretic agents|mesh-ancestor
64847504|NCT05189444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847505|NCT05189444|Expectorants|expectorants|mesh-ancestor
64847506|NCT05189444|Respiratory System Agents|respiratory system agents|mesh-ancestor
64847507|NCT05175274|Colchicine|colchicine|mesh-list
64847508|NCT05175274|Gout Suppressants|gout suppressants|mesh-ancestor
64847509|NCT05175274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64847510|NCT05175274|Tubulin Modulators|tubulin modulators|mesh-ancestor
64847511|NCT05175274|Antimitotic Agents|antimitotic agents|mesh-ancestor
64847512|NCT05175274|Mitosis Modulators|mitosis modulators|mesh-ancestor
64847514|NCT05175274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848546|NCT05801029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848547|NCT05801029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848548|NCT05801029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64848700|NCT05759156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848702|NCT05759156|Coagulants|coagulants|mesh-ancestor
64848703|NCT05756504|Ketorolac|ketorolac|mesh-list
64848704|NCT05756504|Tramadol|tramadol|mesh-list
64848705|NCT05756504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64848706|NCT05756504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64848707|NCT05756504|Analgesics|analgesics|mesh-ancestor
64848708|NCT05756504|Sensory System Agents|sensory system agents|mesh-ancestor
64848709|NCT05756504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64848710|NCT05756504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848711|NCT05756504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64848712|NCT05756504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65494770|NCT01075529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65494771|NCT01075529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64848713|NCT05756504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64848714|NCT05756504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617202|NCT00376012|Leprostatic Agents|leprostatic agents|mesh-ancestor
64848715|NCT05756504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848717|NCT05756504|Narcotics|narcotics|mesh-ancestor
64848718|NCT05756504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64848719|NCT05753644|Ropivacaine|ropivacaine|mesh-list
64848720|NCT05753644|Anesthetics, Local|anesthetics, local|mesh-ancestor
64848894|NCT05537766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64848895|NCT05537766|Alkylating Agents|alkylating agents|mesh-ancestor
64848896|NCT05537766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848897|NCT05537766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849026|NCT05347238|Dopamine Agents|dopamine agents|mesh-ancestor
64849027|NCT05347238|Protective Agents|protective agents|mesh-ancestor
64849028|NCT05345782|Bupivacaine|bupivacaine|mesh-list
64849029|NCT05345782|Anesthetics, Local|anesthetics, local|mesh-ancestor
64849030|NCT05345782|Anesthetics|anesthetics|mesh-ancestor
64849031|NCT05345782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64849032|NCT05345782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849396|NCT04845035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64849397|NCT04845035|Abortifacient Agents|abortifacient agents|mesh-ancestor
64849398|NCT04845035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64849399|NCT04845035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849400|NCT04845035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64849459|NCT04762758|Sensory System Agents|sensory system agents|mesh-ancestor
64849460|NCT04762758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64849461|NCT04762758|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64849462|NCT04762758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64849465|NCT04762758|GABA Agents|gaba agents|mesh-ancestor
64850590|NCT03569475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850591|NCT03569475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64850592|NCT03569475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64850593|NCT03569475|Analgesics|analgesics|mesh-ancestor
64850594|NCT03569475|Sensory System Agents|sensory system agents|mesh-ancestor
64850595|NCT03569475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64850596|NCT03546556|Alovudine|alovudine|mesh-list
64850709|NCT03223974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64850711|NCT03223974|Tubulin Modulators|tubulin modulators|mesh-ancestor
64850712|NCT03223974|Antimitotic Agents|antimitotic agents|mesh-ancestor
64850713|NCT03223974|Mitosis Modulators|mitosis modulators|mesh-ancestor
64850714|NCT03223974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850715|NCT03192046|Carbon Fiber|carbon fiber|mesh-list
64850716|NCT03192046|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64850717|NCT03192046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64850719|NCT03190369|Viscosupplements|viscosupplements|mesh-ancestor
64850720|NCT03190369|Protective Agents|protective agents|mesh-ancestor
64850721|NCT03190369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850722|NCT05438316|Ramipril|ramipril|mesh-list
64401715|NCT02514655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64851001|NCT02663908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64851067|NCT01734512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851068|NCT01555541|Cytarabine|cytarabine|mesh-list
64851069|NCT01555541|Etoposide|etoposide|mesh-list
64851070|NCT01555541|Ofatumumab|ofatumumab|mesh-list
64851071|NCT01555541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64851072|NCT01555541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851073|NCT01555541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64851074|NCT01555541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64851076|NCT01555541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851077|NCT01555541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64851079|NCT01555541|Antiviral Agents|antiviral agents|mesh-ancestor
64851080|NCT01555541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64851081|NCT01555541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64851082|NCT01555541|Immunologic Factors|immunologic factors|mesh-ancestor
64851083|NCT01555541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851084|NCT01398852|Riboflavin|riboflavin|mesh-list
64851085|NCT01398852|Vitamin B Complex|vitamin b complex|mesh-ancestor
64851086|NCT01398852|Vitamins|vitamins|mesh-ancestor
64851367|NCT02654314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851368|NCT02654314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64851369|NCT02626962|Nivolumab|nivolumab|mesh-list
64851370|NCT02626962|Ipilimumab|ipilimumab|mesh-list
64851371|NCT02626962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64851372|NCT02626962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851373|NCT02626962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64851374|NCT02626962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851375|NCT02623998|Metformin|metformin|mesh-list
64851376|NCT02623998|Insulin Glargine|insulin glargine|mesh-list
64851377|NCT02623998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64851378|NCT02623998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64851498|NCT02368301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64851499|NCT02368301|Antiemetics|antiemetics|mesh-ancestor
64851500|NCT02368301|Autonomic Agents|autonomic agents|mesh-ancestor
64851501|NCT02368301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64851502|NCT02368301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851690|NCT02075177|Protective Agents|protective agents|mesh-ancestor
64851691|NCT02050919|Sorafenib|sorafenib|mesh-list
64851692|NCT02050919|Epirubicin|epirubicin|mesh-list
64851693|NCT02050919|Ifosfamide|ifosfamide|mesh-list
64851694|NCT02050919|Isophosphamide mustard|isophosphamide mustard|mesh-list
64851695|NCT02050919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851696|NCT02050919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64851803|NCT01828840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64851804|NCT01828840|Narcotics|narcotics|mesh-ancestor
64952296|NCT00056979|Fludarabine|fludarabine|mesh-list
64952297|NCT00056979|Alemtuzumab|alemtuzumab|mesh-list
64952298|NCT00056979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952299|NCT00056979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64952303|NCT00029822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64491083|NCT03025750|Vaccines|vaccines|mesh-list
64952304|NCT00029822|Adrenergic Agents|adrenergic agents|mesh-ancestor
64503404|NCT01797965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952305|NCT00029822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64952306|NCT00029822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952307|NCT00029822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952308|NCT00029822|Urological Agents|urological agents|mesh-ancestor
64952310|NCT00395681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64952311|NCT00395681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64420644|NCT05475613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952318|NCT00395720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952319|NCT00395759|Lubricant Eye Drops|lubricant eye drops|mesh-list
64952320|NCT00395759|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64952321|NCT00395759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64952322|NCT00395915|Aripiprazole|aripiprazole|mesh-list
64952323|NCT00395915|Antidepressive Agents|antidepressive agents|mesh-ancestor
64952324|NCT00395915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64952325|NCT00395915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64952326|NCT00395915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64952327|NCT00395915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64952328|NCT00395915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952329|NCT00395915|Dopamine Agonists|dopamine agonists|mesh-ancestor
64952330|NCT00395915|Dopamine Agents|dopamine agents|mesh-ancestor
64851805|NCT01828840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64851806|NCT01828840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851807|NCT01828840|Analgesics|analgesics|mesh-ancestor
64851987|NCT01150045|Sensory System Agents|sensory system agents|mesh-ancestor
64851988|NCT01150045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64851989|NCT01150045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64851990|NCT01150045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64852150|NCT00379340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64852151|NCT00379340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852152|NCT00379340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64852153|NCT00379340|Tubulin Modulators|tubulin modulators|mesh-ancestor
64852154|NCT00379340|Antimitotic Agents|antimitotic agents|mesh-ancestor
64852155|NCT00379340|Mitosis Modulators|mitosis modulators|mesh-ancestor
64852320|NCT01695122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64852321|NCT01695122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64852322|NCT01695148|Carotenoids|carotenoids|mesh-list
64852350|NCT01695356|Titanium dioxide|titanium dioxide|mesh-list
64852351|NCT01695356|Avobenzone|avobenzone|mesh-list
64852352|NCT01695356|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
64852353|NCT01695356|Benzophenone|benzophenone|mesh-list
64852354|NCT01695356|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64852355|NCT01695356|Protective Agents|protective agents|mesh-ancestor
64852356|NCT01695356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852357|NCT01695356|Dermatologic Agents|dermatologic agents|mesh-ancestor
64852358|NCT01695356|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64852359|NCT01695460|Cholecalciferol|cholecalciferol|mesh-list
64852360|NCT01695460|Vitamins|vitamins|mesh-list
64852361|NCT01695460|Micronutrients|micronutrients|mesh-ancestor
64852362|NCT01695460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852363|NCT01695460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64852365|NCT01695707|Pioglitazone|pioglitazone|mesh-list
64853248|NCT01701453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64853249|NCT01701453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64853250|NCT01701453|Purinergic Agents|purinergic agents|mesh-ancestor
64853251|NCT01701453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64853436|NCT01702623|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64853437|NCT01702623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64853438|NCT01702636|Tranexamic Acid|tranexamic acid|mesh-list
64853439|NCT01702636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64853440|NCT01702636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64853441|NCT01702636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853442|NCT01702636|Hemostatics|hemostatics|mesh-ancestor
64853443|NCT01702636|Coagulants|coagulants|mesh-ancestor
64853444|NCT01702649|Biapenem|biapenem|mesh-list
64853445|NCT01702649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64853446|NCT01702688|Angiotensin II|angiotensin ii|mesh-list
64853447|NCT01702688|Giapreza|giapreza|mesh-list
64853448|NCT01702688|Angiotensinogen|angiotensinogen|mesh-list
64853449|NCT01702688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64853558|NCT01703351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64853559|NCT01703351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64853560|NCT01703351|Anesthetics, General|anesthetics, general|mesh-ancestor
64853562|NCT01703364|Immunologic Factors|immunologic factors|mesh-ancestor
64853563|NCT01703364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853564|NCT01703364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64853777|NCT01704690|Antimetabolites|antimetabolites|mesh-ancestor
64853778|NCT01704690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64853782|NCT01704703|Panitumumab|panitumumab|mesh-list
64853830|NCT01704794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64853831|NCT01704794|Antimetabolites|antimetabolites|mesh-ancestor
64853832|NCT01704794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853833|NCT01704872|Dinutuximab|dinutuximab|mesh-list
64853834|NCT01704872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853835|NCT01704898|Efavirenz|efavirenz|mesh-list
64853836|NCT01704898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64853837|NCT01704898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64853838|NCT01704898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853839|NCT01704898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853893|NCT01705340|Trastuzumab|trastuzumab|mesh-list
64853894|NCT01705340|Lapatinib|lapatinib|mesh-list
64853895|NCT01705340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64853896|NCT01705340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853897|NCT01705340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64853898|NCT01705340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853899|NCT01705340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853900|NCT01705379|Lactitol|lactitol|mesh-list
64853901|NCT01705379|Cathartics|cathartics|mesh-ancestor
64853902|NCT01705379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64853903|NCT01705392|Bevacizumab|bevacizumab|mesh-list
64853904|NCT01705392|Dacarbazine|dacarbazine|mesh-list
64853905|NCT01705392|Propranolol|propranolol|mesh-list
64853906|NCT01705392|Enalapril|enalapril|mesh-list
64853907|NCT01705392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64853908|NCT01705392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853909|NCT01705392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64853910|NCT01705392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64853911|NCT01705392|Growth Substances|growth substances|mesh-ancestor
64853912|NCT01705392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853913|NCT01705392|Growth Inhibitors|growth inhibitors|mesh-ancestor
64854315|NCT01708369|Oseltamivir|oseltamivir|mesh-list
64854316|NCT01708369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64854317|NCT01708369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64854318|NCT01708369|Analgesics|analgesics|mesh-ancestor
64854319|NCT01708369|Sensory System Agents|sensory system agents|mesh-ancestor
64854321|NCT01708369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854322|NCT01708369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64854323|NCT01708369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64854324|NCT01708369|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64854325|NCT01708369|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64854326|NCT01708369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854327|NCT01708369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64854328|NCT01708369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64854329|NCT01708369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854382|NCT01708707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854384|NCT01708707|Sensory System Agents|sensory system agents|mesh-ancestor
64854529|NCT01709760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854530|NCT01709760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64854531|NCT01709760|Antimetabolites|antimetabolites|mesh-ancestor
64854532|NCT01709760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854533|NCT01709760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854872|NCT01711463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64854873|NCT01711476|Complement Factor H|complement factor h|mesh-list
64854964|NCT01711749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64854965|NCT01711749|Antimetabolites|antimetabolites|mesh-ancestor
64854966|NCT01711749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854967|NCT01711749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64854968|NCT01711749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64854969|NCT01711749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854970|NCT01711814|Peficitinib|peficitinib|mesh-list
64854998|NCT01711931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855015|NCT01712113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64855016|NCT01712113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64855050|NCT01712295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64855051|NCT01712295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855052|NCT01712295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855053|NCT01712295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855083|NCT01712477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64855084|NCT01712477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64855085|NCT01712477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855086|NCT01712477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64855087|NCT01712477|Anesthetics, General|anesthetics, general|mesh-ancestor
64855088|NCT01712477|Anesthetics|anesthetics|mesh-ancestor
64855089|NCT01712477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64855090|NCT01712477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64855091|NCT01712477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64855092|NCT01712477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64855093|NCT01712477|GABA Modulators|gaba modulators|mesh-ancestor
64855094|NCT01712477|GABA Agents|gaba agents|mesh-ancestor
64855095|NCT01712477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64855096|NCT01712477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855097|NCT01712568|Ropinirole|ropinirole|mesh-list
64855098|NCT01712568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64855177|NCT01712997|Iloprost|iloprost|mesh-list
64855178|NCT01712997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64855179|NCT01712997|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64855180|NCT01712997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855181|NCT01712997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64855182|NCT01712997|Vasodilator Agents|vasodilator agents|mesh-ancestor
64855242|NCT01713309|Lenograstim|lenograstim|mesh-list
64855243|NCT01713309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64855244|NCT01713309|Immunologic Factors|immunologic factors|mesh-ancestor
64855245|NCT01713309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855348|NCT01714011|Dopamine Agonists|dopamine agonists|mesh-ancestor
64855349|NCT01714011|Dopamine Agents|dopamine agents|mesh-ancestor
64855350|NCT01714011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64855351|NCT01714011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855352|NCT01714011|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64855353|NCT01714011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64855354|NCT01714011|Serotonin Agents|serotonin agents|mesh-ancestor
64855355|NCT01714011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64623836|NCT00000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472921|NCT02043678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64855357|NCT01714011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64855386|NCT01714089|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64855387|NCT01714089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64855388|NCT01714089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64855443|NCT01714206|Digoxin|digoxin|mesh-list
64855475|NCT01714401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64855476|NCT01714401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64855477|NCT01714401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64855478|NCT01714401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64855479|NCT01714401|Adrenergic Agents|adrenergic agents|mesh-ancestor
64855480|NCT01714401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64855481|NCT01714401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855482|NCT01714414|Lamivudine|lamivudine|mesh-list
64855483|NCT01714414|Zidovudine|zidovudine|mesh-list
64855484|NCT01714414|Efavirenz|efavirenz|mesh-list
64855485|NCT01714414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64855486|NCT01714414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64855487|NCT01714414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855488|NCT01714414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855489|NCT01714414|Antiviral Agents|antiviral agents|mesh-ancestor
64855490|NCT01714414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855491|NCT01714414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64855492|NCT01714414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64855493|NCT01714414|Antimetabolites|antimetabolites|mesh-ancestor
64855494|NCT01714414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64855495|NCT01714414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64855496|NCT01714414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64855497|NCT01714414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64855498|NCT01714414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65494772|NCT01075529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472922|NCT02043678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472923|NCT02029846|Metformin|metformin|mesh-list
64472924|NCT02029846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64472925|NCT02029846|Incretins|incretins|mesh-list
64472926|NCT02029846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64472927|NCT02029846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855507|NCT01714427|Glucocorticoids|glucocorticoids|mesh-ancestor
64855508|NCT01714427|Hormones|hormones|mesh-ancestor
64855633|NCT01715259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855634|NCT01715259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855635|NCT01715259|Hormone Antagonists|hormone antagonists|mesh-ancestor
64855636|NCT01715259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64855637|NCT01715259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855638|NCT01715259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64855639|NCT01715311|Tiotropium Bromide|tiotropium bromide|mesh-list
64855640|NCT01715311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64855641|NCT01715311|Autonomic Agents|autonomic agents|mesh-ancestor
64855642|NCT01715311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64855643|NCT01715311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855644|NCT01715311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64855645|NCT01715311|Respiratory System Agents|respiratory system agents|mesh-ancestor
64855646|NCT01715311|Parasympatholytics|parasympatholytics|mesh-ancestor
64855647|NCT01715311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64855648|NCT01715311|Cholinergic Agents|cholinergic agents|mesh-ancestor
64855649|NCT01715311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65494776|NCT01075529|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65494777|NCT01075529|Antidepressive Agents|antidepressive agents|mesh-ancestor
65494778|NCT01075529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65494779|NCT01075529|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65494780|NCT01075529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64570863|NCT03825809|Anticonvulsants|anticonvulsants|mesh-ancestor
64855763|NCT01715935|Everolimus|everolimus|mesh-list
64855764|NCT01715935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855765|NCT01715935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64855766|NCT01715935|Immunologic Factors|immunologic factors|mesh-ancestor
64855767|NCT01715935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855768|NCT01715987|Tenofovir|tenofovir|mesh-list
64855769|NCT01715987|Entecavir|entecavir|mesh-list
64855770|NCT01715987|Antiviral Agents|antiviral agents|mesh-ancestor
64855771|NCT01715987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855772|NCT01715987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64855773|NCT01715987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64855779|NCT01716260|Primaquine|primaquine|mesh-list
64855886|NCT01716949|Fluorouracil|fluorouracil|mesh-list
64855887|NCT01716949|Capecitabine|capecitabine|mesh-list
64855888|NCT01716949|Oxaliplatin|oxaliplatin|mesh-list
64855889|NCT01716949|Antimetabolites|antimetabolites|mesh-ancestor
64855890|NCT01716949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855891|NCT01716949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64855892|NCT01716949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855893|NCT01716949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64855894|NCT01716949|Immunologic Factors|immunologic factors|mesh-ancestor
64855895|NCT01716949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855896|NCT01717027|Oxycodone|oxycodone|mesh-list
64855897|NCT01717027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64855898|NCT01717027|Narcotics|narcotics|mesh-ancestor
64855899|NCT01717027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64855900|NCT01717027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855901|NCT01717027|Analgesics|analgesics|mesh-ancestor
64855902|NCT01717027|Sensory System Agents|sensory system agents|mesh-ancestor
64855903|NCT01717027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64855904|NCT01717066|Ginsenoside Rg3|ginsenoside rg3|mesh-list
64855905|NCT01717066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64855906|NCT01717066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855907|NCT01717118|Vaccines|vaccines|mesh-list
64855908|NCT01717118|Immunologic Factors|immunologic factors|mesh-ancestor
64472930|NCT02029846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855909|NCT01717118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855910|NCT01717157|Fentanyl|fentanyl|mesh-list
64855911|NCT01717157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64855912|NCT01717157|Narcotics|narcotics|mesh-ancestor
64855913|NCT01717157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64855914|NCT01717157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855915|NCT01717157|Analgesics|analgesics|mesh-ancestor
64855921|NCT01717157|Anesthetics|anesthetics|mesh-ancestor
64855946|NCT01717300|Antimetabolites|antimetabolites|mesh-ancestor
64855947|NCT01717300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855948|NCT01717300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64855949|NCT01717300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855950|NCT01717300|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64624447|NCT00001864|Atropine|atropine|mesh-list
64855951|NCT01717300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855952|NCT01717404|Mexiletine|mexiletine|mesh-list
64855953|NCT01717404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64855954|NCT01717404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64855955|NCT01717404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64855956|NCT01717404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64855957|NCT01717404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855958|NCT01717599|Diclofenac|diclofenac|mesh-list
64855959|NCT01717599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64855960|NCT01717599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64855961|NCT01717599|Analgesics|analgesics|mesh-ancestor
64855962|NCT01717599|Sensory System Agents|sensory system agents|mesh-ancestor
64855963|NCT01717599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64855964|NCT01717599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855965|NCT01717599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64855966|NCT01717599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64855967|NCT01717599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64855968|NCT01717599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855969|NCT01717599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855970|NCT01717612|Thrombin|thrombin|mesh-list
64855971|NCT01717612|Hemostatics|hemostatics|mesh-ancestor
64855972|NCT01717612|Coagulants|coagulants|mesh-ancestor
64855973|NCT01717625|Montelukast|montelukast|mesh-list
64855974|NCT01717625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64855975|NCT01717625|Respiratory System Agents|respiratory system agents|mesh-ancestor
64855976|NCT01717625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64855977|NCT01717625|Hormone Antagonists|hormone antagonists|mesh-ancestor
64856063|NCT01718236|Succinylcholine|succinylcholine|mesh-list
64856069|NCT01718236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856070|NCT01718236|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64856071|NCT01718236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856072|NCT01718236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856073|NCT01718236|Cholinergic Agents|cholinergic agents|mesh-ancestor
64856074|NCT01718236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64856104|NCT01718314|Misoprostol|misoprostol|mesh-list
64856105|NCT01718314|Anesthetics, Local|anesthetics, local|mesh-ancestor
64856106|NCT01718314|Anesthetics|anesthetics|mesh-ancestor
64856107|NCT01718314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64856108|NCT01718314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856109|NCT01718314|Sensory System Agents|sensory system agents|mesh-ancestor
65494781|NCT01075529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494782|NCT01073891|Moxifloxacin|moxifloxacin|mesh-list
64472931|NCT02029846|Hormones|hormones|mesh-ancestor
64514737|NCT02393157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64856110|NCT01718314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64856111|NCT01718314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64856112|NCT01718314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64856113|NCT01718314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64856114|NCT01718314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64856115|NCT01718314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856116|NCT01718314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64856117|NCT01718314|Abortifacient Agents|abortifacient agents|mesh-ancestor
64856118|NCT01718314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64856119|NCT01718314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64856121|NCT01718314|Oxytocics|oxytocics|mesh-ancestor
64856199|NCT01718652|Cyclosporine|cyclosporine|mesh-list
64856200|NCT01718652|Cyclosporins|cyclosporins|mesh-list
64856201|NCT01718652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856202|NCT01718652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856203|NCT01718652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64856204|NCT01718652|Immunologic Factors|immunologic factors|mesh-ancestor
64856205|NCT01718652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856206|NCT01718652|Antifungal Agents|antifungal agents|mesh-ancestor
64856207|NCT01718652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64856208|NCT01718652|Dermatologic Agents|dermatologic agents|mesh-ancestor
64856209|NCT01718652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64856210|NCT01718652|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64856211|NCT01718652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64856212|NCT01718652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64856213|NCT01718678|Melatonin|melatonin|mesh-list
64856292|NCT01719133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856293|NCT01719133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856295|NCT01719159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64856296|NCT01719159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856297|NCT01719159|Immunologic Factors|immunologic factors|mesh-ancestor
64856298|NCT01719159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856299|NCT01719159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64856300|NCT01719185|Vitamin B 12|vitamin b 12|mesh-list
64856301|NCT01719185|Phentermine|phentermine|mesh-list
64856302|NCT01719185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64856303|NCT01719185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856304|NCT01719185|Appetite Depressants|appetite depressants|mesh-ancestor
64856305|NCT01719185|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64856306|NCT01719185|Sympathomimetics|sympathomimetics|mesh-ancestor
64856307|NCT01719185|Autonomic Agents|autonomic agents|mesh-ancestor
64856308|NCT01719185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64856309|NCT01719185|Adrenergic Agents|adrenergic agents|mesh-ancestor
64856310|NCT01719185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64856311|NCT01719185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856312|NCT01719185|Vitamin B Complex|vitamin b complex|mesh-ancestor
64856313|NCT01719185|Vitamins|vitamins|mesh-ancestor
64856316|NCT01719302|Docetaxel|docetaxel|mesh-list
64856317|NCT01719302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64856318|NCT01719302|Antimetabolites|antimetabolites|mesh-ancestor
65494783|NCT01073891|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64472932|NCT02029846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64472933|NCT02025010|Abiraterone Acetate|abiraterone acetate|mesh-list
64472934|NCT02025010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472935|NCT02025010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64856374|NCT01719614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64856375|NCT01719627|Maraviroc|maraviroc|mesh-list
64856376|NCT01719627|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64856377|NCT01719627|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64856378|NCT01719627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856408|NCT01719770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64856409|NCT01719770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856411|NCT01719835|Methylprednisolone|methylprednisolone|mesh-list
64856412|NCT01719835|Prednisolone|prednisolone|mesh-list
64856413|NCT01719835|Cyclophosphamide|cyclophosphamide|mesh-list
64856414|NCT01719835|Doxorubicin|doxorubicin|mesh-list
64856415|NCT01719835|Vincristine|vincristine|mesh-list
64856416|NCT01719835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64856417|NCT01719835|Immunologic Factors|immunologic factors|mesh-ancestor
64856418|NCT01719835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856419|NCT01719835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64856420|NCT01719835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64856421|NCT01719835|Alkylating Agents|alkylating agents|mesh-ancestor
64856442|NCT01719835|Glucocorticoids|glucocorticoids|mesh-ancestor
64856443|NCT01719835|Hormones|hormones|mesh-ancestor
64856444|NCT01719835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64856445|NCT01719835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64856446|NCT01719835|Protective Agents|protective agents|mesh-ancestor
64856447|NCT01719835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64856448|NCT01719926|Indomethacin|indomethacin|mesh-list
64856455|NCT01719926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64856456|NCT01719926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64856457|NCT01719926|Gout Suppressants|gout suppressants|mesh-ancestor
64856458|NCT01719926|Tocolytic Agents|tocolytic agents|mesh-ancestor
64856459|NCT01719926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64856460|NCT01719926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64856461|NCT01719926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856462|NCT01719926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856463|NCT01719952|Oxytocin|oxytocin|mesh-list
64856464|NCT01719952|Carbetocin|carbetocin|mesh-list
64856465|NCT01719952|Oxytocics|oxytocics|mesh-ancestor
64856466|NCT01719952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64856467|NCT01719952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856468|NCT01719978|Epinephrine|epinephrine|mesh-list
64856469|NCT01719978|Racepinephrine|racepinephrine|mesh-list
64856470|NCT01719978|Mepivacaine|mepivacaine|mesh-list
64856471|NCT01719978|Epinephryl borate|epinephryl borate|mesh-list
64856472|NCT01719978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64856473|NCT01719978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64856474|NCT01719978|Adrenergic Agents|adrenergic agents|mesh-ancestor
64856475|NCT01719978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64856503|NCT01720537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856507|NCT01720719|Vitamin E|vitamin e|mesh-list
64856556|NCT01724450|Adrenergic Agents|adrenergic agents|mesh-ancestor
64856557|NCT01724450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64856558|NCT01724450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856559|NCT01724450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856560|NCT01724450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64856707|NCT01730222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64856709|NCT01730222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64856710|NCT01730222|Immunologic Factors|immunologic factors|mesh-ancestor
64856711|NCT01730222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856713|NCT01730287|Calcium|calcium|mesh-list
64856714|NCT01730287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64856715|NCT01730287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856716|NCT01730287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64856717|NCT01730326|Acetaminophen|acetaminophen|mesh-list
64856718|NCT01730326|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
64856719|NCT01730326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64856720|NCT01730326|Analgesics|analgesics|mesh-ancestor
64856721|NCT01730326|Sensory System Agents|sensory system agents|mesh-ancestor
64856722|NCT01730326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64856750|NCT01730508|Immunologic Factors|immunologic factors|mesh-ancestor
65494789|NCT01073891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494790|NCT01073891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494791|NCT01073891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65494792|NCT01073891|Contraceptive Agents|contraceptive agents|mesh-ancestor
65494793|NCT01073891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65494794|NCT01073891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472943|NCT02020694|Ergocalciferols|ergocalciferols|mesh-list
64472944|NCT02020694|Cholecalciferol|cholecalciferol|mesh-list
64571225|NCT02740985|Docetaxel|docetaxel|mesh-list
64856926|NCT01731574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64856961|NCT01731756|Sensory System Agents|sensory system agents|mesh-ancestor
64856962|NCT01731756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857072|NCT01732393|Quercetin|quercetin|mesh-list
64857181|NCT01733485|Analgesics|analgesics|mesh-ancestor
64857182|NCT01733485|Sensory System Agents|sensory system agents|mesh-ancestor
64857183|NCT01733485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857184|NCT01733485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857185|NCT01733485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64857186|NCT01733485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64857187|NCT01733485|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64857218|NCT01733706|Cholinergic Agents|cholinergic agents|mesh-ancestor
64857219|NCT01733706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64857220|NCT01733706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857222|NCT01733823|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64857223|NCT01733823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64857226|NCT01733836|Metformin|metformin|mesh-list
64857391|NCT01735058|Hyaluronic Acid|hyaluronic acid|mesh-list
64857392|NCT01735058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64857393|NCT01735058|Immunologic Factors|immunologic factors|mesh-ancestor
64857394|NCT01735058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857415|NCT01735097|Micronutrients|micronutrients|mesh-ancestor
64857416|NCT01735097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857417|NCT01735097|Antioxidants|antioxidants|mesh-ancestor
64857418|NCT01735097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857419|NCT01735097|Protective Agents|protective agents|mesh-ancestor
64857420|NCT01735123|Caseins|caseins|mesh-list
64857421|NCT01735123|Chelating Agents|chelating agents|mesh-ancestor
64857422|NCT01735123|Sequestering Agents|sequestering agents|mesh-ancestor
64857423|NCT01735123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857424|NCT01735227|Omeprazole|omeprazole|mesh-list
64857425|NCT01735227|Pantoprazole|pantoprazole|mesh-list
64857426|NCT01735227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64857427|NCT01735227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64857428|NCT01735227|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64857429|NCT01735227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857430|NCT01735227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857431|NCT01735240|Ketoconazole|ketoconazole|mesh-list
64857432|NCT01735240|Antifungal Agents|antifungal agents|mesh-ancestor
64857433|NCT01735240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64857434|NCT01735240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64857435|NCT01735240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64857436|NCT01735240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857437|NCT01735240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857470|NCT01735370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64857471|NCT01735370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64857472|NCT01735370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857473|NCT01735370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857474|NCT01735383|Etodolac|etodolac|mesh-list
64857475|NCT01735383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64857476|NCT01735383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64857477|NCT01735383|Analgesics|analgesics|mesh-ancestor
64857478|NCT01735383|Sensory System Agents|sensory system agents|mesh-ancestor
64857479|NCT01735383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857480|NCT01735383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857481|NCT01735383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64857482|NCT01735383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64857483|NCT01735383|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64857484|NCT01735383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64857485|NCT01735383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857486|NCT01735383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857487|NCT01735487|Nicotine|nicotine|mesh-list
64857488|NCT01735487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64857489|NCT01735487|Autonomic Agents|autonomic agents|mesh-ancestor
64857490|NCT01735487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857491|NCT01735487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857492|NCT01735487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64857493|NCT01735487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64857494|NCT01735487|Cholinergic Agents|cholinergic agents|mesh-ancestor
64857495|NCT01735487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64857496|NCT01735487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857497|NCT01735669|Remifentanil|remifentanil|mesh-list
64857498|NCT01735669|Nitrous Oxide|nitrous oxide|mesh-list
64857499|NCT01735669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64857518|NCT01735747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857519|NCT01735747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64857520|NCT01735747|Alkylating Agents|alkylating agents|mesh-ancestor
64857521|NCT01735864|Indirubin|indirubin|mesh-list
64857522|NCT01735864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64857523|NCT01735864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64857524|NCT01735890|Amlodipine|amlodipine|mesh-list
64857525|NCT01735890|Valsartan|valsartan|mesh-list
64857526|NCT01735890|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
64857527|NCT01735890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64857528|NCT01735890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64857529|NCT01735890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64857530|NCT01735890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857546|NCT01736020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64857547|NCT01736020|Analgesics|analgesics|mesh-ancestor
64857548|NCT01736020|Sensory System Agents|sensory system agents|mesh-ancestor
64857549|NCT01736020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857550|NCT01736020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64857586|NCT01736371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857587|NCT01736371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64857588|NCT01736371|Anesthetics, General|anesthetics, general|mesh-ancestor
64857601|NCT01736423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64857602|NCT01736423|Serotonin Agents|serotonin agents|mesh-ancestor
64857603|NCT01736423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64857604|NCT01736423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857605|NCT01736449|Bevacizumab|bevacizumab|mesh-list
64857606|NCT01736449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64857607|NCT01736449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64857608|NCT01736449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64857609|NCT01736449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64857610|NCT01736449|Growth Substances|growth substances|mesh-ancestor
64857611|NCT01736449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857612|NCT01736449|Growth Inhibitors|growth inhibitors|mesh-ancestor
64857613|NCT01736488|Atenolol|atenolol|mesh-list
64857614|NCT01736488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64857615|NCT01736488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64857616|NCT01736488|Sympatholytics|sympatholytics|mesh-ancestor
64857617|NCT01736488|Autonomic Agents|autonomic agents|mesh-ancestor
64857627|NCT01736514|Febuxostat|febuxostat|mesh-list
64857662|NCT01736761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64857663|NCT01736761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64857664|NCT01736761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64857665|NCT01736761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64857666|NCT01736800|Temozolomide|temozolomide|mesh-list
64857667|NCT01736800|Topotecan|topotecan|mesh-list
64857668|NCT01736800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64857669|NCT01736800|Alkylating Agents|alkylating agents|mesh-ancestor
64857670|NCT01736800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857671|NCT01736800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64857672|NCT01736800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64857673|NCT01736800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64857674|NCT01736800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857675|NCT01736813|Maraviroc|maraviroc|mesh-list
64857676|NCT01736813|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64857677|NCT01736813|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64857678|NCT01736813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857679|NCT01736813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64857680|NCT01736813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64857681|NCT01736813|Antiviral Agents|antiviral agents|mesh-ancestor
64857682|NCT01736813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64857683|NCT01736813|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64857684|NCT01736878|Sorafenib|sorafenib|mesh-list
64857685|NCT01736878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64857689|NCT01736891|Rasagiline|rasagiline|mesh-list
64857711|NCT01737112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857712|NCT01737177|Rituximab|rituximab|mesh-list
64857713|NCT01737177|Lenalidomide|lenalidomide|mesh-list
64857714|NCT01737177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64857715|NCT01737177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64857716|NCT01737177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64857731|NCT01737203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64571601|NCT03045510|Decitabine|decitabine|mesh-list
64857732|NCT01737203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857733|NCT01737203|Urological Agents|urological agents|mesh-ancestor
64857734|NCT01737216|Zoledronic Acid|zoledronic acid|mesh-list
64857735|NCT01737216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64857736|NCT01737216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857737|NCT01737294|Capsaicin|capsaicin|mesh-list
64857738|NCT01737294|Antipruritics|antipruritics|mesh-ancestor
64857739|NCT01737294|Dermatologic Agents|dermatologic agents|mesh-ancestor
64857740|NCT01737294|Sensory System Agents|sensory system agents|mesh-ancestor
64857741|NCT01737294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857742|NCT01737294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857743|NCT01737307|Fluorides|fluorides|mesh-list
64857744|NCT01737307|Fluorides, Topical|fluorides, topical|mesh-list
64857745|NCT01737307|Cariostatic Agents|cariostatic agents|mesh-ancestor
64857746|NCT01737307|Protective Agents|protective agents|mesh-ancestor
64857747|NCT01737307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857748|NCT01737320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64857749|NCT01737320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64857750|NCT01737320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64857751|NCT01737320|Antitubercular Agents|antitubercular agents|mesh-ancestor
64857752|NCT01737346|Lomustine|lomustine|mesh-list
64857771|NCT01737411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64857772|NCT01737411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857773|NCT01737411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857774|NCT01737411|Urological Agents|urological agents|mesh-ancestor
64857775|NCT01737541|Fluoxetine|fluoxetine|mesh-list
64857780|NCT01737541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64857781|NCT01737541|Serotonin Agents|serotonin agents|mesh-ancestor
64857782|NCT01737541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857783|NCT01737541|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64857784|NCT01737541|Antidepressive Agents|antidepressive agents|mesh-ancestor
64857785|NCT01737541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64857786|NCT01737541|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64857787|NCT01737541|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64857788|NCT01737541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857790|NCT01737671|Methotrexate|methotrexate|mesh-list
64857791|NCT01737671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64857792|NCT01737671|Abortifacient Agents|abortifacient agents|mesh-ancestor
64857793|NCT01737671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64857794|NCT01737671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857795|NCT01737671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64857796|NCT01737671|Antimetabolites|antimetabolites|mesh-ancestor
64857797|NCT01737671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857798|NCT01737671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64857799|NCT01737671|Dermatologic Agents|dermatologic agents|mesh-ancestor
64857800|NCT01737671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857801|NCT01737671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64857802|NCT01737671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64857820|NCT01738035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64857821|NCT01738035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64857822|NCT01738035|Autonomic Agents|autonomic agents|mesh-ancestor
64857823|NCT01738035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857824|NCT01738035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857825|NCT01738035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64857826|NCT01738035|Respiratory System Agents|respiratory system agents|mesh-ancestor
64857827|NCT01738035|Glucocorticoids|glucocorticoids|mesh-ancestor
64857828|NCT01738035|Hormones|hormones|mesh-ancestor
64857829|NCT01738035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64857830|NCT01738087|Fluticasone|fluticasone|mesh-list
64857831|NCT01738087|Xhance|xhance|mesh-list
64857832|NCT01738087|Formoterol Fumarate|formoterol fumarate|mesh-list
64857833|NCT01738087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64857834|NCT01738087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64857835|NCT01738087|Autonomic Agents|autonomic agents|mesh-ancestor
64857836|NCT01738087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857837|NCT01738087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857838|NCT01738087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64857839|NCT01738087|Respiratory System Agents|respiratory system agents|mesh-ancestor
64857840|NCT01738087|Dermatologic Agents|dermatologic agents|mesh-ancestor
64857841|NCT01738087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64857842|NCT01738087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64857843|NCT01738087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64857844|NCT01738087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64857851|NCT01738100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64857853|NCT01738100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64857854|NCT01738100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403322|NCT05110339|Dexmedetomidine|dexmedetomidine|mesh-list
64857871|NCT01738178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64857872|NCT01738178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64857873|NCT01738178|Purinergic Agents|purinergic agents|mesh-ancestor
64857874|NCT01738178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64857875|NCT01738243|Hyaluronic Acid|hyaluronic acid|mesh-list
64857876|NCT01738243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64857877|NCT01738243|Immunologic Factors|immunologic factors|mesh-ancestor
64857878|NCT01738243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857879|NCT01738243|Viscosupplements|viscosupplements|mesh-ancestor
64857880|NCT01738243|Protective Agents|protective agents|mesh-ancestor
64626410|NCT00000694|Zidovudine|zidovudine|mesh-list
64857881|NCT01738282|Baclofen|baclofen|mesh-list
64857882|NCT01738282|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64857883|NCT01738282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857884|NCT01738282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64857885|NCT01738282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857886|NCT01738282|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64857887|NCT01738282|GABA Agonists|gaba agonists|mesh-ancestor
64857888|NCT01738282|GABA Agents|gaba agents|mesh-ancestor
64857889|NCT01738282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65494799|NCT00209027|Antidepressive Agents|antidepressive agents|mesh-ancestor
64857963|NCT01738815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64857964|NCT01738815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64857966|NCT01738867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64857967|NCT01738867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64857968|NCT01738867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857969|NCT01738867|Sensory System Agents|sensory system agents|mesh-ancestor
64857970|NCT01738867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857971|NCT01738893|Gabapentin|gabapentin|mesh-list
64857972|NCT01738893|Analgesics|analgesics|mesh-ancestor
64857973|NCT01738893|Sensory System Agents|sensory system agents|mesh-ancestor
64857974|NCT01738893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857975|NCT01738893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857976|NCT01738893|Anticonvulsants|anticonvulsants|mesh-ancestor
64857977|NCT01738893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64857978|NCT01738893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64857979|NCT01738893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64857980|NCT01738893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64857981|NCT01738893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64857982|NCT01738893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64857983|NCT01738893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64857984|NCT01738893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857985|NCT01738893|Antimanic Agents|antimanic agents|mesh-ancestor
64857986|NCT01738945|Amlodipine|amlodipine|mesh-list
64857987|NCT01738945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64857988|NCT01738945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64857989|NCT01738945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64857990|NCT01738945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857991|NCT01738945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64857992|NCT01738945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857993|NCT01738945|Vasodilator Agents|vasodilator agents|mesh-ancestor
64857994|NCT01739049|Liraglutide|liraglutide|mesh-list
64857995|NCT01739049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64858005|NCT01739127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64858006|NCT01739127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858007|NCT01739127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858008|NCT01739127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64858009|NCT01739127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64858010|NCT01739127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64858011|NCT01739127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64858012|NCT01739127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64858013|NCT01739127|Dopamine Agents|dopamine agents|mesh-ancestor
64858014|NCT01739127|Antidepressive Agents|antidepressive agents|mesh-ancestor
64858015|NCT01739127|Dopamine Agonists|dopamine agonists|mesh-ancestor
64858016|NCT01739127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64858017|NCT01739127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64858018|NCT01739127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64858019|NCT01739127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64858020|NCT01739192|Bupropion|bupropion|mesh-list
64858027|NCT01739192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858029|NCT01739192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64858030|NCT01739192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858031|NCT01739192|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64858032|NCT01739192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64858033|NCT01739192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858034|NCT01739218|Paclitaxel|paclitaxel|mesh-list
64858035|NCT01739218|Bevacizumab|bevacizumab|mesh-list
64858036|NCT01739218|Carboplatin|carboplatin|mesh-list
64858037|NCT01739218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64858038|NCT01739218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64858039|NCT01739218|Tubulin Modulators|tubulin modulators|mesh-ancestor
64858055|NCT01739439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858056|NCT01739439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64858057|NCT01739439|Antiviral Agents|antiviral agents|mesh-ancestor
64858058|NCT01739439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64858059|NCT01739439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858060|NCT01739439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64858061|NCT01739439|Immunologic Factors|immunologic factors|mesh-ancestor
64858062|NCT01739439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858063|NCT01739504|Anesthetics|anesthetics|mesh-list
64858064|NCT01739504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64858065|NCT01739504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858066|NCT01739556|Aspirin|aspirin|mesh-list
64858124|NCT01739894|Tubulin Modulators|tubulin modulators|mesh-ancestor
64858125|NCT01739894|Antimitotic Agents|antimitotic agents|mesh-ancestor
64858126|NCT01739894|Mitosis Modulators|mitosis modulators|mesh-ancestor
64858127|NCT01739894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858128|NCT01739907|Vitamin D|vitamin d|mesh-list
64858129|NCT01739907|Vitamins|vitamins|mesh-ancestor
64858130|NCT01739907|Micronutrients|micronutrients|mesh-ancestor
64858131|NCT01739907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858132|NCT01739907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64858187|NCT01740336|Paclitaxel|paclitaxel|mesh-list
64858188|NCT01740336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64858189|NCT01740336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64858190|NCT01740336|Tubulin Modulators|tubulin modulators|mesh-ancestor
64858191|NCT01740336|Antimitotic Agents|antimitotic agents|mesh-ancestor
64858192|NCT01740336|Mitosis Modulators|mitosis modulators|mesh-ancestor
64858193|NCT01740336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858194|NCT01740453|Ropivacaine|ropivacaine|mesh-list
64858195|NCT01740453|Anesthetics, Local|anesthetics, local|mesh-ancestor
64858196|NCT01740453|Anesthetics|anesthetics|mesh-ancestor
64858197|NCT01740453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64858198|NCT01740453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858199|NCT01740453|Sensory System Agents|sensory system agents|mesh-ancestor
64858200|NCT01740453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858201|NCT01740518|Ascorbic Acid|ascorbic acid|mesh-list
64858202|NCT01740518|Antioxidants|antioxidants|mesh-ancestor
64858203|NCT01740518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858204|NCT01740518|Protective Agents|protective agents|mesh-ancestor
64858205|NCT01740518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858206|NCT01740518|Vitamins|vitamins|mesh-ancestor
64858207|NCT01740518|Micronutrients|micronutrients|mesh-ancestor
64858208|NCT01740921|Aspirin|aspirin|mesh-list
64858209|NCT01740921|Liraglutide|liraglutide|mesh-list
64858210|NCT01740921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64858211|NCT01740921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64858212|NCT01740921|Analgesics|analgesics|mesh-ancestor
64858213|NCT01740921|Sensory System Agents|sensory system agents|mesh-ancestor
64858214|NCT01740921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858215|NCT01740921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858227|NCT01740921|Hormones|hormones|mesh-ancestor
65494802|NCT00209027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65494803|NCT00209027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65494804|NCT00209027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494805|NCT00209027|Dopamine Agonists|dopamine agonists|mesh-ancestor
65494806|NCT00209027|Dopamine Agents|dopamine agents|mesh-ancestor
64514738|NCT01750697|Rituximab|rituximab|mesh-list
64858236|NCT01740947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64858237|NCT01740947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64858238|NCT01740947|Antifungal Agents|antifungal agents|mesh-ancestor
64858239|NCT01740960|Dronabinol|dronabinol|mesh-list
64858240|NCT01740960|Hallucinogens|hallucinogens|mesh-ancestor
64858241|NCT01740960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858242|NCT01740960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64858243|NCT01740960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64858244|NCT01740960|Analgesics|analgesics|mesh-ancestor
64858245|NCT01740960|Sensory System Agents|sensory system agents|mesh-ancestor
64858246|NCT01740960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858247|NCT01740960|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64858248|NCT01740960|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64858249|NCT01740960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64858250|NCT01740960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858251|NCT01740960|Hormones|hormones|mesh-ancestor
64858252|NCT01740960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64858253|NCT01741038|Cetuximab|cetuximab|mesh-list
64858254|NCT01741038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64858255|NCT01741038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64858256|NCT01741077|Folic Acid|folic acid|mesh-list
64858279|NCT01741181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64858280|NCT01741181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64858281|NCT01741285|Fluticasone|fluticasone|mesh-list
64858282|NCT01741285|Beclomethasone|beclomethasone|mesh-list
64858283|NCT01741285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64858284|NCT01741285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64858285|NCT01741285|Autonomic Agents|autonomic agents|mesh-ancestor
64858286|NCT01741285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858287|NCT01741285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858288|NCT01741285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64858289|NCT01741285|Respiratory System Agents|respiratory system agents|mesh-ancestor
64858290|NCT01741285|Dermatologic Agents|dermatologic agents|mesh-ancestor
64858291|NCT01741285|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64858292|NCT01741285|Glucocorticoids|glucocorticoids|mesh-ancestor
64858293|NCT01741285|Hormones|hormones|mesh-ancestor
64858294|NCT01741285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64858295|NCT01741324|Vitamin D|vitamin d|mesh-list
64858296|NCT01741324|Ergocalciferols|ergocalciferols|mesh-list
64858297|NCT01741324|Cholecalciferol|cholecalciferol|mesh-list
64858298|NCT01741324|Vitamins|vitamins|mesh-list
64858299|NCT01741324|Micronutrients|micronutrients|mesh-ancestor
64858300|NCT01741324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858301|NCT01741324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64858302|NCT01741324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64858303|NCT01741376|Progesterone|progesterone|mesh-list
64858318|NCT01741493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858319|NCT01741493|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64858320|NCT01741493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64858322|NCT01741506|Tinzaparin|tinzaparin|mesh-list
64858323|NCT01741506|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64858324|NCT01741506|Anticoagulants|anticoagulants|mesh-ancestor
64858325|NCT01741506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65494807|NCT00209027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64297424|NCT04478084|Vaccines|vaccines|mesh-list
64626861|NCT00995501|BB 1101|bb 1101|mesh-list
64858333|NCT01741519|Adrenergic Agents|adrenergic agents|mesh-ancestor
64858334|NCT01741519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64858335|NCT01741519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858336|NCT01741519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858337|NCT01741519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64858338|NCT01741558|Riboflavin|riboflavin|mesh-list
64858339|NCT01741558|Methotrexate|methotrexate|mesh-list
64858340|NCT01741558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64858341|NCT01741558|Abortifacient Agents|abortifacient agents|mesh-ancestor
64858342|NCT01741558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64858343|NCT01741558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858344|NCT01741558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64858345|NCT01741558|Antimetabolites|antimetabolites|mesh-ancestor
64858346|NCT01741558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858347|NCT01741558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64858348|NCT01741558|Dermatologic Agents|dermatologic agents|mesh-ancestor
64858349|NCT01741558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858350|NCT01741558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64858351|NCT01741558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64858356|NCT01741558|Vitamins|vitamins|mesh-ancestor
64858426|NCT01742338|Prednisolone|prednisolone|mesh-list
64858427|NCT01742338|Prednisolone acetate|prednisolone acetate|mesh-list
64858428|NCT01742338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64858429|NCT01742338|Prednisolone phosphate|prednisolone phosphate|mesh-list
64858430|NCT01742338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64858431|NCT01742338|Glucocorticoids|glucocorticoids|mesh-ancestor
64858432|NCT01742338|Hormones|hormones|mesh-ancestor
64858433|NCT01742338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64858434|NCT01742338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858435|NCT01742338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64858436|NCT01742338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494808|NCT00209027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472955|NCT02019875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472956|NCT02019875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858437|NCT01742338|Antiemetics|antiemetics|mesh-ancestor
64858438|NCT01742338|Autonomic Agents|autonomic agents|mesh-ancestor
64858439|NCT01742338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858440|NCT01742338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64858441|NCT01742338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64858442|NCT01742338|Protective Agents|protective agents|mesh-ancestor
64858443|NCT01742390|Risperidone|risperidone|mesh-list
64858444|NCT01742390|Aripiprazole|aripiprazole|mesh-list
64858445|NCT01742390|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64858446|NCT01742390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64858447|NCT01742390|Serotonin Agents|serotonin agents|mesh-ancestor
64858448|NCT01742390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64858449|NCT01742390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858450|NCT01742390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858451|NCT01742390|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64858452|NCT01742390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64858453|NCT01742390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64858454|NCT01742390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64858455|NCT01742390|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64858456|NCT01742390|Dopamine Agents|dopamine agents|mesh-ancestor
64858462|NCT01742390|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64858463|NCT01742429|Amoxicillin|amoxicillin|mesh-list
64858464|NCT01742429|Metronidazole|metronidazole|mesh-list
64858465|NCT01742429|Levofloxacin|levofloxacin|mesh-list
64858466|NCT01742429|Ofloxacin|ofloxacin|mesh-list
64858467|NCT01742429|Tetracycline|tetracycline|mesh-list
64858468|NCT01742429|Bismuth|bismuth|mesh-list
64858469|NCT01742429|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
64858470|NCT01742429|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64858471|NCT01742429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64858472|NCT01742429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64858477|NCT01742429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64858478|NCT01742429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64858479|NCT01742429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858480|NCT01742429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858481|NCT01742429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64858482|NCT01742429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64858483|NCT01742429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64858484|NCT01742429|Antacids|antacids|mesh-ancestor
64858485|NCT01742429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64858486|NCT01742429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64858487|NCT01742429|Antidiarrheals|antidiarrheals|mesh-ancestor
64858488|NCT01742533|Hormones|hormones|mesh-list
64858489|NCT01742533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64858491|NCT01742624|Mycophenolic Acid|mycophenolic acid|mesh-list
64858512|NCT01742637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858513|NCT01742637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858514|NCT01742637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64858515|NCT01742637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64858516|NCT01742663|Diclofenac|diclofenac|mesh-list
64858517|NCT01742663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64858518|NCT01742663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64858519|NCT01742663|Analgesics|analgesics|mesh-ancestor
64858520|NCT01742663|Sensory System Agents|sensory system agents|mesh-ancestor
64858521|NCT01742663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858522|NCT01742663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858523|NCT01742663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64858524|NCT01742663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64858525|NCT01742663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64858526|NCT01742663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858527|NCT01742663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858528|NCT01742676|Tacrolimus|tacrolimus|mesh-list
64858529|NCT01742676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64858530|NCT01742676|Immunologic Factors|immunologic factors|mesh-ancestor
64858531|NCT01742676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858532|NCT01742676|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64858571|NCT01742702|Adrenergic Agents|adrenergic agents|mesh-ancestor
64858572|NCT01742702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64858573|NCT01742702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858574|NCT01742702|Vasodilator Agents|vasodilator agents|mesh-ancestor
64858575|NCT01742702|Chelating Agents|chelating agents|mesh-ancestor
64858576|NCT01742702|Sequestering Agents|sequestering agents|mesh-ancestor
64858577|NCT01742702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64858578|NCT01742702|Sympatholytics|sympatholytics|mesh-ancestor
64858579|NCT01742702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64858580|NCT01742702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64858581|NCT01742702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64858582|NCT01742702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64858583|NCT01742767|Pemetrexed|pemetrexed|mesh-list
64858584|NCT01742767|Cisplatin|cisplatin|mesh-list
64858585|NCT01742767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64858586|NCT01742767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494812|NCT00209027|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64858587|NCT01742767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858588|NCT01742767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64472958|NCT02019875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64572359|NCT04783753|Quinidine|quinidine|mesh-list
64858589|NCT01742767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64858590|NCT01742793|Lenalidomide|lenalidomide|mesh-list
64858591|NCT01742793|Romidepsin|romidepsin|mesh-list
64858592|NCT01742793|Immunologic Factors|immunologic factors|mesh-ancestor
64858593|NCT01742793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858594|NCT01742793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64858595|NCT01742793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64858596|NCT01742793|Growth Substances|growth substances|mesh-ancestor
64858597|NCT01742793|Growth Inhibitors|growth inhibitors|mesh-ancestor
64858598|NCT01742793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64858599|NCT01742793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64858600|NCT01742845|Ropivacaine|ropivacaine|mesh-list
64858601|NCT01742845|Anesthetics, Local|anesthetics, local|mesh-ancestor
64858602|NCT01742845|Anesthetics|anesthetics|mesh-ancestor
64404102|NCT04930211|Glucocorticoids|glucocorticoids|mesh-ancestor
64858608|NCT01742988|Venetoclax|venetoclax|mesh-list
64858609|NCT01742988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64858610|NCT01742988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64858611|NCT01742988|Immunologic Factors|immunologic factors|mesh-ancestor
64858612|NCT01742988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858613|NCT01742988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64858614|NCT01743014|Ramipril|ramipril|mesh-list
64858634|NCT01743066|Protective Agents|protective agents|mesh-ancestor
64858635|NCT01743079|Lamivudine|lamivudine|mesh-list
64858636|NCT01743079|Telbivudine|telbivudine|mesh-list
64858637|NCT01743079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64858638|NCT01743079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64858639|NCT01743079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858640|NCT01743079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858641|NCT01743079|Antiviral Agents|antiviral agents|mesh-ancestor
64858642|NCT01743079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64858643|NCT01743079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64858644|NCT01743079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64858645|NCT01743118|Calcipotriene|calcipotriene|mesh-list
64858646|NCT01743118|Dermatologic Agents|dermatologic agents|mesh-ancestor
64858647|NCT01743144|Magnesium Sulfate|magnesium sulfate|mesh-list
64858648|NCT01743144|Analgesics|analgesics|mesh-ancestor
64858649|NCT01743144|Sensory System Agents|sensory system agents|mesh-ancestor
64404160|NCT02680561|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64858686|NCT01743235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65494813|NCT00209027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65494814|NCT00209027|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64472959|NCT02019875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64472960|NCT02019875|Antitubercular Agents|antitubercular agents|mesh-ancestor
64858687|NCT01743235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64858688|NCT01743235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64858689|NCT01743235|Serotonin Agents|serotonin agents|mesh-ancestor
64858690|NCT01743235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64858691|NCT01743235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858692|NCT01743300|Sunitinib|sunitinib|mesh-list
64858745|NCT01743690|Hormones|hormones|mesh-ancestor
64858746|NCT01743690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64858747|NCT01743690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858748|NCT01743690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64858749|NCT01743690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64858750|NCT01743690|Antifungal Agents|antifungal agents|mesh-ancestor
64858751|NCT01743690|Ionophores|ionophores|mesh-ancestor
64858752|NCT01743690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64858753|NCT01743690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858754|NCT01743755|Dexamethasone|dexamethasone|mesh-list
64858755|NCT01743755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64858756|NCT01743755|Antiemetics|antiemetics|mesh-ancestor
64858757|NCT01743755|Autonomic Agents|autonomic agents|mesh-ancestor
64858758|NCT01743755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858759|NCT01743755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494815|NCT00209027|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65494816|NCT00160667|Brivaracetam|brivaracetam|mesh-list
65494817|NCT00160667|Anticonvulsants|anticonvulsants|mesh-ancestor
64572494|NCT04849026|Clozapine|clozapine|mesh-list
64858760|NCT01743755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64858761|NCT01743755|Glucocorticoids|glucocorticoids|mesh-ancestor
64858762|NCT01743755|Hormones|hormones|mesh-ancestor
64858763|NCT01743755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64858764|NCT01743755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64858765|NCT01743755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64858766|NCT01743794|Ropivacaine|ropivacaine|mesh-list
64858767|NCT01743794|Anesthetics, Local|anesthetics, local|mesh-ancestor
64858768|NCT01743794|Anesthetics|anesthetics|mesh-ancestor
64858769|NCT01743794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64858770|NCT01743794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858771|NCT01743794|Sensory System Agents|sensory system agents|mesh-ancestor
64858772|NCT01743794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858773|NCT01743820|Primaquine|primaquine|mesh-list
64858774|NCT01743820|Piperaquine|piperaquine|mesh-list
64858775|NCT01743820|Artenimol|artenimol|mesh-list
64858776|NCT01743820|Antimalarials|antimalarials|mesh-ancestor
64858777|NCT01743820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64858780|NCT01743885|Propranolol|propranolol|mesh-list
64858781|NCT01743885|Acebutolol|acebutolol|mesh-list
64858782|NCT01743885|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64858783|NCT01743885|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64858784|NCT01743885|Adrenergic Agents|adrenergic agents|mesh-ancestor
64858785|NCT01743885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64858786|NCT01743885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858787|NCT01743885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858788|NCT01743885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64858789|NCT01743885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64858849|NCT01744236|Liraglutide|liraglutide|mesh-list
64858850|NCT01744236|Exenatide|exenatide|mesh-list
64858851|NCT01744236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64858852|NCT01744236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858853|NCT01744236|Incretins|incretins|mesh-ancestor
64858854|NCT01744236|Hormones|hormones|mesh-ancestor
64858855|NCT01744236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64858856|NCT01744236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64858857|NCT01744236|Protease Inhibitors|protease inhibitors|mesh-ancestor
64858858|NCT01744236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858859|NCT01744236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627398|NCT00002428|Vaccines|vaccines|mesh-list
64858861|NCT01744249|Axitinib|axitinib|mesh-list
64858862|NCT01744249|Octreotide|octreotide|mesh-list
64858863|NCT01744249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64858864|NCT01744249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64858865|NCT01744249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858866|NCT01744249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858867|NCT01744249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64858868|NCT01744249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64858869|NCT01744262|Anesthetics|anesthetics|mesh-list
64858870|NCT01744262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64858871|NCT01744262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858872|NCT01744288|Clopidogrel|clopidogrel|mesh-list
64858873|NCT01744288|Ticagrelor|ticagrelor|mesh-list
64858874|NCT01744288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64858875|NCT01744288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64858876|NCT01744288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64858877|NCT01744288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64858878|NCT01744288|Purinergic Agents|purinergic agents|mesh-ancestor
64858881|NCT01744288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858894|NCT01744314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858895|NCT01744314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64858896|NCT01744314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64858897|NCT01744314|Gout Suppressants|gout suppressants|mesh-ancestor
64858898|NCT01744314|Tocolytic Agents|tocolytic agents|mesh-ancestor
64858899|NCT01744314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64858900|NCT01744314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64858901|NCT01744366|Goserelin|goserelin|mesh-list
64858902|NCT01744366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64858903|NCT01744366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64858904|NCT01744379|Lesinurad|lesinurad|mesh-list
64858905|NCT01744379|Gout Suppressants|gout suppressants|mesh-ancestor
64858906|NCT01744379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64858907|NCT01744379|Uricosuric Agents|uricosuric agents|mesh-ancestor
64858908|NCT01744379|Renal Agents|renal agents|mesh-ancestor
64858909|NCT01744444|Gabapentin|gabapentin|mesh-list
64858910|NCT01744444|Memantine|memantine|mesh-list
64404476|NCT03954613|Memantine|memantine|mesh-list
64404477|NCT03954613|Donepezil|donepezil|mesh-list
64404478|NCT03954613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64404479|NCT03954613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404480|NCT03954613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404481|NCT03954613|Cholinergic Agents|cholinergic agents|mesh-ancestor
64404482|NCT03954613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64404483|NCT03954613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404484|NCT03954613|Nootropic Agents|nootropic agents|mesh-ancestor
64404485|NCT03954613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64858960|NCT01744873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64858961|NCT01744873|Adrenergic Agents|adrenergic agents|mesh-ancestor
64858962|NCT01744873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64858963|NCT01744873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858964|NCT01744886|Benzocaine|benzocaine|mesh-list
64858965|NCT01744886|Anesthetics, Local|anesthetics, local|mesh-ancestor
64858966|NCT01744886|Anesthetics|anesthetics|mesh-ancestor
64858967|NCT01744886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64858968|NCT01744886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858969|NCT01744886|Sensory System Agents|sensory system agents|mesh-ancestor
64858971|NCT01744626|Rituximab|rituximab|mesh-list
64472964|NCT02019875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64472965|NCT02019875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64472966|NCT02019875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64472967|NCT02019875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64472968|NCT02019875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64472969|NCT01928394|Nivolumab|nivolumab|mesh-list
64472970|NCT01928394|Ipilimumab|ipilimumab|mesh-list
64472971|NCT01928394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64472972|NCT01928394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472973|NCT01928394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64472974|NCT01928394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472975|NCT01907009|Melphalan|melphalan|mesh-list
64472976|NCT01907009|Lenograstim|lenograstim|mesh-list
64472977|NCT01907009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64472978|NCT01907009|Alkylating Agents|alkylating agents|mesh-ancestor
64472979|NCT01907009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472980|NCT01907009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472981|NCT01907009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64572720|NCT05024513|Immunologic Factors|immunologic factors|mesh-ancestor
64858999|NCT01745263|Vitamin D|vitamin d|mesh-list
64859000|NCT01745263|Cholecalciferol|cholecalciferol|mesh-list
64859001|NCT01745263|Vitamins|vitamins|mesh-ancestor
64859002|NCT01745263|Micronutrients|micronutrients|mesh-ancestor
64859003|NCT01745263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859004|NCT01745263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64859005|NCT01745263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64859006|NCT01745302|Gefitinib|gefitinib|mesh-list
64859007|NCT01745302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859008|NCT01745302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64859009|NCT01745302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859011|NCT01745328|Amoxicillin|amoxicillin|mesh-list
64859045|NCT01745575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64859046|NCT01745575|GABA Modulators|gaba modulators|mesh-ancestor
64859047|NCT01745575|GABA Agents|gaba agents|mesh-ancestor
64859048|NCT01745575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64859049|NCT01745575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859051|NCT01745601|Citalopram|citalopram|mesh-list
64859052|NCT01745601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64859053|NCT01745601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65494820|NCT00206375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494821|NCT00160199|Progesterone|progesterone|mesh-list
65494822|NCT00160199|Progestins|progestins|mesh-ancestor
65494823|NCT00160199|Hormones|hormones|mesh-ancestor
65494824|NCT00160199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64404633|NCT03057041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64859092|NCT01745640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64859093|NCT01745640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64859094|NCT01745640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859095|NCT01745640|Immunologic Factors|immunologic factors|mesh-ancestor
64859096|NCT01745640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64859097|NCT01745640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64859098|NCT01745640|Growth Substances|growth substances|mesh-ancestor
64859099|NCT01745640|Growth Inhibitors|growth inhibitors|mesh-ancestor
64859100|NCT01745666|Epinephrine|epinephrine|mesh-list
64859101|NCT01745666|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64859163|NCT01746277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859164|NCT01746277|Tubulin Modulators|tubulin modulators|mesh-ancestor
64859165|NCT01746277|Antimitotic Agents|antimitotic agents|mesh-ancestor
64859166|NCT01746277|Mitosis Modulators|mitosis modulators|mesh-ancestor
64859167|NCT01746277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859168|NCT01746277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859169|NCT01746277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64859170|NCT01746277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64859171|NCT01746277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64859172|NCT01746485|Treprostinil|treprostinil|mesh-list
64859173|NCT01746485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64859174|NCT01746563|Ranibizumab|ranibizumab|mesh-list
64859175|NCT01746563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64859176|NCT01746563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64859177|NCT01746563|Growth Substances|growth substances|mesh-ancestor
64859178|NCT01746563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859179|NCT01746563|Growth Inhibitors|growth inhibitors|mesh-ancestor
64859180|NCT01746563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859181|NCT01746602|Timolol|timolol|mesh-list
64859182|NCT01746602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64859183|NCT01746602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64859184|NCT01746602|Adrenergic Agents|adrenergic agents|mesh-ancestor
64859185|NCT01746602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64859220|NCT01746680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64859221|NCT01746719|Etodolac|etodolac|mesh-list
64859222|NCT01746719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64859223|NCT01746719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64859224|NCT01746719|Analgesics|analgesics|mesh-ancestor
64859225|NCT01746719|Sensory System Agents|sensory system agents|mesh-ancestor
64859226|NCT01746719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64859227|NCT01746719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859228|NCT01746719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64859229|NCT01746719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64859230|NCT01746719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64859231|NCT01746719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64859232|NCT01746719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859233|NCT01746719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859234|NCT01746771|Paclitaxel|paclitaxel|mesh-list
64859235|NCT01746771|Trastuzumab|trastuzumab|mesh-list
64859236|NCT01746771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64859237|NCT01746771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859238|NCT01746771|Tubulin Modulators|tubulin modulators|mesh-ancestor
64859239|NCT01746771|Antimitotic Agents|antimitotic agents|mesh-ancestor
64859240|NCT01746771|Mitosis Modulators|mitosis modulators|mesh-ancestor
64404803|NCT01573429|Hormones|hormones|mesh-ancestor
64724247|NCT00000379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64724248|NCT00000379|Antidepressive Agents|antidepressive agents|mesh-ancestor
64724249|NCT00000379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64724250|NCT00000379|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64724251|NCT00000379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64724252|NCT00000379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724253|NCT00000385|Lithium Carbonate|lithium carbonate|mesh-list
64724254|NCT00000385|Antidepressive Agents|antidepressive agents|mesh-ancestor
64724255|NCT00000385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64724256|NCT00000385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724257|NCT00000385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724258|NCT00000385|Antimanic Agents|antimanic agents|mesh-ancestor
64501772|NCT03063021|Antidotes|antidotes|mesh-ancestor
64501773|NCT02337933|Ursolic acid|ursolic acid|mesh-list
64501774|NCT02337933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501775|NCT02337933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501776|NCT02337933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64501777|NCT02337933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501778|NCT02337933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64501779|NCT02337933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501780|NCT02337933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64501781|NCT02337933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64501782|NCT02337933|Analgesics|analgesics|mesh-ancestor
64501783|NCT02337933|Sensory System Agents|sensory system agents|mesh-ancestor
64501784|NCT02337933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64501785|NCT02337933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501786|NCT02337933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64501787|NCT02337933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64501788|NCT03028857|Choline|choline|mesh-list
64501789|NCT03028857|Lipotropic Agents|lipotropic agents|mesh-ancestor
64859241|NCT01746771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859242|NCT01746771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64859243|NCT01746823|Cyclosporine|cyclosporine|mesh-list
64859244|NCT01746823|Cyclosporins|cyclosporins|mesh-list
64859245|NCT01746823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859246|NCT01746823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859247|NCT01746823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64859248|NCT01746823|Immunologic Factors|immunologic factors|mesh-ancestor
64859249|NCT01746823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859250|NCT01746823|Antifungal Agents|antifungal agents|mesh-ancestor
64859251|NCT01746823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64859252|NCT01746823|Dermatologic Agents|dermatologic agents|mesh-ancestor
64859253|NCT01746823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64859254|NCT01746823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64859255|NCT01746875|Aflibercept|aflibercept|mesh-list
64859256|NCT01746875|Verteporfin|verteporfin|mesh-list
64859257|NCT01746875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64859258|NCT01746875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64859259|NCT01746875|Growth Substances|growth substances|mesh-ancestor
64859260|NCT01746875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859261|NCT01746875|Growth Inhibitors|growth inhibitors|mesh-ancestor
64859262|NCT01746875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859263|NCT01746875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64859264|NCT01746875|Dermatologic Agents|dermatologic agents|mesh-ancestor
64859265|NCT01746992|Prednisone|prednisone|mesh-list
64859266|NCT01746992|Cyclophosphamide|cyclophosphamide|mesh-list
64859267|NCT01746992|Ifosfamide|ifosfamide|mesh-list
64859268|NCT01746992|Doxorubicin|doxorubicin|mesh-list
64859269|NCT01746992|Methotrexate|methotrexate|mesh-list
64859270|NCT01746992|Etoposide|etoposide|mesh-list
64859271|NCT01746992|Vincristine|vincristine|mesh-list
64859272|NCT01746992|Etoposide phosphate|etoposide phosphate|mesh-list
64859273|NCT01746992|Pirarubicin|pirarubicin|mesh-list
64859290|NCT01746992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64859291|NCT01746992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64859292|NCT01746992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64859293|NCT01746992|Abortifacient Agents|abortifacient agents|mesh-ancestor
64404874|NCT03520231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64859296|NCT01746992|Antimetabolites|antimetabolites|mesh-ancestor
64859297|NCT01746992|Dermatologic Agents|dermatologic agents|mesh-ancestor
64859298|NCT01746992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64859299|NCT01746992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64859300|NCT01746992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64859301|NCT01746992|Tubulin Modulators|tubulin modulators|mesh-ancestor
64859302|NCT01746992|Antimitotic Agents|antimitotic agents|mesh-ancestor
64859303|NCT01746992|Mitosis Modulators|mitosis modulators|mesh-ancestor
64859304|NCT01747044|Milnacipran|milnacipran|mesh-list
64859305|NCT01747044|Levomilnacipran|levomilnacipran|mesh-list
64859306|NCT01747044|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64859307|NCT01747044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64859308|NCT01747044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64859309|NCT01747044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859310|NCT01747044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64859311|NCT01747044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859312|NCT01747044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64859313|NCT01747044|Analgesics|analgesics|mesh-ancestor
64859314|NCT01747044|Sensory System Agents|sensory system agents|mesh-ancestor
64472983|NCT01907009|Immunologic Factors|immunologic factors|mesh-ancestor
64572999|NCT01891019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859315|NCT01747044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64859316|NCT01747044|Antidepressive Agents|antidepressive agents|mesh-ancestor
64859317|NCT01747044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64859318|NCT01747083|Metformin|metformin|mesh-list
64859319|NCT01747083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64859320|NCT01747083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859321|NCT01747135|Betadex|betadex|mesh-list
64859322|NCT01747135|Sequestering Agents|sequestering agents|mesh-ancestor
64859323|NCT01747135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859324|NCT01747148|Radavirsen|radavirsen|mesh-list
64859325|NCT01747148|Antiviral Agents|antiviral agents|mesh-ancestor
64859339|NCT01747174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859340|NCT01747174|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64859341|NCT01747174|Vasodilator Agents|vasodilator agents|mesh-ancestor
64859342|NCT01747174|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64859343|NCT01747174|Purinergic Agonists|purinergic agonists|mesh-ancestor
64859344|NCT01747174|Purinergic Agents|purinergic agents|mesh-ancestor
64859345|NCT01747174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64859346|NCT01747174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859347|NCT01747174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64859348|NCT01747174|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64859350|NCT01747226|Cariostatic Agents|cariostatic agents|mesh-ancestor
64859351|NCT01747226|Protective Agents|protective agents|mesh-ancestor
64859352|NCT01747226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859353|NCT01747252|Resveratrol|resveratrol|mesh-list
64859354|NCT01747252|Antioxidants|antioxidants|mesh-ancestor
64859355|NCT01747252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859356|NCT01747252|Protective Agents|protective agents|mesh-ancestor
64859357|NCT01747252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859358|NCT01747252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859359|NCT01747252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64859360|NCT01747278|Trimethoprim|trimethoprim|mesh-list
64859361|NCT01747278|Sulfamethoxazole|sulfamethoxazole|mesh-list
64859362|NCT01747278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64859363|NCT01747278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64859364|NCT01747278|Renal Agents|renal agents|mesh-ancestor
64859365|NCT01747278|Antimalarials|antimalarials|mesh-ancestor
64859374|NCT01747564|Mirabegron|mirabegron|mesh-list
64859386|NCT01747590|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64859387|NCT01747590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859388|NCT01747590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64859389|NCT01747590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859390|NCT01747590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494843|NCT00203021|Immunologic Factors|immunologic factors|mesh-ancestor
65494844|NCT00203021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494845|NCT00203021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64573075|NCT04390061|Antimalarials|antimalarials|mesh-ancestor
64859391|NCT01747590|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64859392|NCT01747590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64859393|NCT01747590|Purinergic Agents|purinergic agents|mesh-ancestor
64859394|NCT01747590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64859395|NCT01747590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64859398|NCT01747590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64859400|NCT01747590|GABA Agents|gaba agents|mesh-ancestor
64859401|NCT01747590|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64859402|NCT01747590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64859403|NCT01747590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64859404|NCT01747590|GABA Modulators|gaba modulators|mesh-ancestor
64859405|NCT01747616|Acetylcysteine|acetylcysteine|mesh-list
64859406|NCT01747616|Chitosan|chitosan|mesh-list
64859407|NCT01747616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64859408|NCT01747616|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64859409|NCT01747616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64859410|NCT01747616|Antiviral Agents|antiviral agents|mesh-ancestor
64859411|NCT01747616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64859412|NCT01747616|Expectorants|expectorants|mesh-ancestor
64859413|NCT01747616|Respiratory System Agents|respiratory system agents|mesh-ancestor
64859414|NCT01747616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64859415|NCT01747616|Antioxidants|antioxidants|mesh-ancestor
64859416|NCT01747616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859417|NCT01747616|Protective Agents|protective agents|mesh-ancestor
64859418|NCT01747616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859419|NCT01747616|Antidotes|antidotes|mesh-ancestor
64859422|NCT01747616|Antimetabolites|antimetabolites|mesh-ancestor
64859424|NCT01747616|Chelating Agents|chelating agents|mesh-ancestor
64859425|NCT01747616|Sequestering Agents|sequestering agents|mesh-ancestor
64859426|NCT01747616|Hemostatics|hemostatics|mesh-ancestor
64859427|NCT01747616|Coagulants|coagulants|mesh-ancestor
64859428|NCT01747642|Sorafenib|sorafenib|mesh-list
64859429|NCT01747642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859430|NCT01747642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64859431|NCT01747642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859432|NCT01747642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859433|NCT01747668|Tocopherols|tocopherols|mesh-list
64859434|NCT01747668|alpha-Tocopherol|alpha-tocopherol|mesh-list
64859435|NCT01747668|Vitamin E|vitamin e|mesh-list
64859436|NCT01747668|Vitamins|vitamins|mesh-ancestor
64859437|NCT01747668|Micronutrients|micronutrients|mesh-ancestor
64859438|NCT01747668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859439|NCT01747668|Antioxidants|antioxidants|mesh-ancestor
64859440|NCT01747668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859441|NCT01747668|Protective Agents|protective agents|mesh-ancestor
64859442|NCT01747707|Docetaxel|docetaxel|mesh-list
64859443|NCT01747707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859444|NCT01747707|Tubulin Modulators|tubulin modulators|mesh-ancestor
64859445|NCT01747707|Antimitotic Agents|antimitotic agents|mesh-ancestor
64859446|NCT01747707|Mitosis Modulators|mitosis modulators|mesh-ancestor
64859447|NCT01747707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859448|NCT01747720|Vitamin D|vitamin d|mesh-list
64859449|NCT01747720|Cholecalciferol|cholecalciferol|mesh-list
64859450|NCT01747720|Vitamins|vitamins|mesh-ancestor
64859451|NCT01747720|Micronutrients|micronutrients|mesh-ancestor
64859452|NCT01747720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859455|NCT01747746|Enoxaparin|enoxaparin|mesh-list
64472984|NCT01907009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573163|NCT05606497|Hormones|hormones|mesh-ancestor
64859472|NCT01747993|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64859495|NCT01748123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859496|NCT01748253|Amlodipine|amlodipine|mesh-list
64859497|NCT01748253|Telmisartan|telmisartan|mesh-list
64859498|NCT01748253|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
64859499|NCT01748253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64859500|NCT01748253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64859501|NCT01748253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64859502|NCT01748253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859503|NCT01748253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64859504|NCT01748253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859505|NCT01748253|Vasodilator Agents|vasodilator agents|mesh-ancestor
64859506|NCT01748253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64859507|NCT01748253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64859508|NCT01748279|Atorvastatin|atorvastatin|mesh-list
64859509|NCT01748279|Formoterol Fumarate|formoterol fumarate|mesh-list
64859510|NCT01748279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64859511|NCT01748279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64859512|NCT01748279|Antimetabolites|antimetabolites|mesh-ancestor
64859513|NCT01748279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859514|NCT01748279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64859515|NCT01748279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64859516|NCT01748279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859517|NCT01748279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64859518|NCT01748279|Autonomic Agents|autonomic agents|mesh-ancestor
64859519|NCT01748279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64859520|NCT01748279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859521|NCT01748279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64859522|NCT01748279|Respiratory System Agents|respiratory system agents|mesh-ancestor
64859533|NCT01748318|Antimalarials|antimalarials|mesh-ancestor
64859541|NCT01748344|Histamine Agents|histamine agents|mesh-ancestor
64859542|NCT01748344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64859543|NCT01748344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859544|NCT01748344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859545|NCT01748370|Vitamin D|vitamin d|mesh-list
64859546|NCT01748370|Ergocalciferols|ergocalciferols|mesh-list
64859547|NCT01748370|Cholecalciferol|cholecalciferol|mesh-list
64859548|NCT01748370|Vitamins|vitamins|mesh-list
64859549|NCT01748370|Micronutrients|micronutrients|mesh-ancestor
64859550|NCT01748370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859551|NCT01748370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64859552|NCT01748370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64859553|NCT01748396|Calcitriol|calcitriol|mesh-list
64859554|NCT01748396|Calcium Carbonate|calcium carbonate|mesh-list
64859555|NCT01748396|Calcium|calcium|mesh-list
64859556|NCT01748396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64859557|NCT01748396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859558|NCT01748396|Antacids|antacids|mesh-ancestor
64859559|NCT01748396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859560|NCT01748396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64859561|NCT01748396|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64859562|NCT01748396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64859563|NCT01748396|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64859564|NCT01748396|Vitamins|vitamins|mesh-ancestor
64859565|NCT01748396|Micronutrients|micronutrients|mesh-ancestor
64859566|NCT01748396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64859567|NCT01748422|Capsaicin|capsaicin|mesh-list
64859568|NCT01748422|Antipruritics|antipruritics|mesh-ancestor
64859586|NCT01748487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859587|NCT01748487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64859588|NCT01748487|Glucocorticoids|glucocorticoids|mesh-ancestor
64859594|NCT01748487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859595|NCT01748487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859596|NCT01748500|Pantoprazole|pantoprazole|mesh-list
64859597|NCT01748500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64859598|NCT01748500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64859599|NCT01748500|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64859600|NCT01748500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859601|NCT01748500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859602|NCT01748526|Canagliflozin|canagliflozin|mesh-list
64859603|NCT01748526|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64859604|NCT01748526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859605|NCT01748526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64859606|NCT01748526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859607|NCT01748539|Brodalumab|brodalumab|mesh-list
64859608|NCT01748539|Dermatologic Agents|dermatologic agents|mesh-ancestor
64859609|NCT01748630|Fentanyl|fentanyl|mesh-list
64859610|NCT01748630|Midazolam|midazolam|mesh-list
64859611|NCT01748630|Dexmedetomidine|dexmedetomidine|mesh-list
64859612|NCT01748630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64859613|NCT01748630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64859614|NCT01748630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859615|NCT01748630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64859616|NCT01748630|Analgesics|analgesics|mesh-ancestor
64859617|NCT01748630|Sensory System Agents|sensory system agents|mesh-ancestor
64859638|NCT01748669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859639|NCT01748669|Protective Agents|protective agents|mesh-ancestor
64859640|NCT01748669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859641|NCT01748669|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64859642|NCT01748669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859643|NCT01748669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64859644|NCT01748669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859645|NCT01748721|Antibodies|antibodies|mesh-list
64859646|NCT01748721|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64859647|NCT01748721|Immunologic Factors|immunologic factors|mesh-ancestor
64859648|NCT01748721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859649|NCT01748747|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64859650|NCT01748747|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64859651|NCT01748747|Immunologic Factors|immunologic factors|mesh-ancestor
65494849|NCT00201851|Hormone Antagonists|hormone antagonists|mesh-ancestor
64859652|NCT01748747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859653|NCT01748773|Capecitabine|capecitabine|mesh-list
64859654|NCT01748773|Oxaliplatin|oxaliplatin|mesh-list
64472985|NCT01907009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64859655|NCT01748773|Trastuzumab|trastuzumab|mesh-list
64859656|NCT01748773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64859657|NCT01748773|Antimetabolites|antimetabolites|mesh-ancestor
64859658|NCT01748773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859661|NCT01748838|Mannitol|mannitol|mesh-list
64859662|NCT01748838|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64859663|NCT01748838|Diuretics|diuretics|mesh-ancestor
64859664|NCT01748838|Natriuretic Agents|natriuretic agents|mesh-ancestor
64859665|NCT01748838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859666|NCT01748929|Albendazole|albendazole|mesh-list
64859667|NCT01748929|Anthelmintics|anthelmintics|mesh-ancestor
64859668|NCT01748929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64859678|NCT01749072|Vinorelbine|vinorelbine|mesh-list
64859683|NCT01749072|Tubulin Modulators|tubulin modulators|mesh-ancestor
64859684|NCT01749072|Antimitotic Agents|antimitotic agents|mesh-ancestor
64628240|NCT04094207|Antioxidants|antioxidants|mesh-ancestor
64859685|NCT01749072|Mitosis Modulators|mitosis modulators|mesh-ancestor
64859686|NCT01749072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859687|NCT01749072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64859688|NCT01749072|Alkylating Agents|alkylating agents|mesh-ancestor
64859689|NCT01749072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64859690|NCT01749072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859691|NCT01749085|Ketoconazole|ketoconazole|mesh-list
64859692|NCT01749085|Antifungal Agents|antifungal agents|mesh-ancestor
64859693|NCT01749085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64859694|NCT01749085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64859695|NCT01749085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64859696|NCT01749085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859697|NCT01749085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859698|NCT01749085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64859699|NCT01749085|Hormone Antagonists|hormone antagonists|mesh-ancestor
64859700|NCT01749085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64859701|NCT01749085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859702|NCT01749085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64859703|NCT01749098|Ketamine|ketamine|mesh-list
64859704|NCT01749098|Analgesics|analgesics|mesh-ancestor
64859705|NCT01749098|Sensory System Agents|sensory system agents|mesh-ancestor
64859706|NCT01749098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64859707|NCT01749098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859708|NCT01749098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64859709|NCT01749098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64859710|NCT01749098|Anesthetics, General|anesthetics, general|mesh-ancestor
64859724|NCT01749111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64859725|NCT01749111|Alkylating Agents|alkylating agents|mesh-ancestor
64859726|NCT01749111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859727|NCT01749111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472986|NCT01882933|Oxaliplatin|oxaliplatin|mesh-list
64472987|NCT01882933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472988|NCT01726582|Leucovorin|leucovorin|mesh-list
64472989|NCT01726582|Gemcitabine|gemcitabine|mesh-list
64472990|NCT01726582|Paclitaxel|paclitaxel|mesh-list
64472991|NCT01726582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64472992|NCT01726582|Fluorouracil|fluorouracil|mesh-list
64472993|NCT01726582|Capecitabine|capecitabine|mesh-list
64472994|NCT01726582|Oxaliplatin|oxaliplatin|mesh-list
64472995|NCT01726582|Irinotecan|irinotecan|mesh-list
64472996|NCT01726582|Cisplatin|cisplatin|mesh-list
64472997|NCT01726582|Folfirinox|folfirinox|mesh-list
64472998|NCT01726582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64472999|NCT01726582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859774|NCT01749319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64859775|NCT01749319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494850|NCT00201851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65494851|NCT00201851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494852|NCT00201851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65494853|NCT00201851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494854|NCT00201851|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65494855|NCT00201851|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65494856|NCT00201851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65494857|NCT01074203|Nitazoxanide|nitazoxanide|mesh-list
65494858|NCT01074203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65494859|NCT01074203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494860|NCT01074281|Enalapril|enalapril|mesh-list
65494861|NCT01074281|Enalaprilat|enalaprilat|mesh-list
65494862|NCT01074281|Nitrendipine|nitrendipine|mesh-list
65494863|NCT01074281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494864|NCT01074281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494865|NCT01074281|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65494866|NCT01074281|Protease Inhibitors|protease inhibitors|mesh-ancestor
64859776|NCT01749319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64859777|NCT01749319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64859778|NCT01749319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64859779|NCT01749319|GABA Agonists|gaba agonists|mesh-ancestor
64859780|NCT01749319|GABA Agents|gaba agents|mesh-ancestor
64859781|NCT01749319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64859782|NCT01749319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859783|NCT01749371|Vitamins|vitamins|mesh-list
64859784|NCT01749371|Vitamin E|vitamin e|mesh-list
64859785|NCT01749371|Tocopherols|tocopherols|mesh-list
64859786|NCT01749371|Tocotrienols|tocotrienols|mesh-list
64859787|NCT01749371|alpha-Tocopherol|alpha-tocopherol|mesh-list
64859788|NCT01749371|Micronutrients|micronutrients|mesh-ancestor
64859790|NCT01749371|Antioxidants|antioxidants|mesh-ancestor
64859812|NCT01749397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859813|NCT01749397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64859814|NCT01749397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859815|NCT01749397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64859816|NCT01749397|Immunologic Factors|immunologic factors|mesh-ancestor
64859817|NCT01749397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859818|NCT01749397|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64859819|NCT01749397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859820|NCT01749423|Botulinum Toxins|botulinum toxins|mesh-list
64859821|NCT01749423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64859822|NCT01749423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64859823|NCT01749423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64859824|NCT01749423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64859825|NCT01749423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859826|NCT01749423|Cholinergic Agents|cholinergic agents|mesh-ancestor
64859827|NCT01749423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64859828|NCT01749423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859829|NCT01749423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64859830|NCT01749423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64859871|NCT01749579|Sensory System Agents|sensory system agents|mesh-ancestor
64859872|NCT01749579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64859873|NCT01749579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64859874|NCT01749579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64859875|NCT01749579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64859876|NCT01749579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64859877|NCT01749579|GABA Modulators|gaba modulators|mesh-ancestor
64859878|NCT01749579|GABA Agents|gaba agents|mesh-ancestor
64859879|NCT01749579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64859880|NCT01749579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859881|NCT01750060|Fentanyl|fentanyl|mesh-list
64859882|NCT01750060|Naltrexone|naltrexone|mesh-list
64859883|NCT01750060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64859884|NCT01750060|Narcotics|narcotics|mesh-ancestor
64859885|NCT01750060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64859886|NCT01750060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859887|NCT01750060|Analgesics|analgesics|mesh-ancestor
64859888|NCT01750060|Sensory System Agents|sensory system agents|mesh-ancestor
64859889|NCT01750060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64859890|NCT01750060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64859891|NCT01750060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64859892|NCT01750060|Anesthetics, General|anesthetics, general|mesh-ancestor
64859893|NCT01750060|Anesthetics|anesthetics|mesh-ancestor
64859894|NCT01750060|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64859895|NCT01750060|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64859896|NCT01750099|Lidocaine|lidocaine|mesh-list
64859897|NCT01750099|Epinephrine|epinephrine|mesh-list
64859898|NCT01750099|Fentanyl|fentanyl|mesh-list
64859899|NCT01750099|Bupivacaine|bupivacaine|mesh-list
64859900|NCT01750099|Anesthetics, Local|anesthetics, local|mesh-ancestor
64859901|NCT01750099|Anesthetics|anesthetics|mesh-ancestor
64859902|NCT01750099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64859903|NCT01750099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859904|NCT01750099|Sensory System Agents|sensory system agents|mesh-ancestor
64405537|NCT04889651|Hormone Antagonists|hormone antagonists|mesh-ancestor
64859914|NCT01750099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64859915|NCT01750099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64859916|NCT01750099|Anesthetics, General|anesthetics, general|mesh-ancestor
64859917|NCT01750099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64859918|NCT01750099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64859919|NCT01750099|Adrenergic Agents|adrenergic agents|mesh-ancestor
64859920|NCT01750099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64859921|NCT01750099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64859922|NCT01750099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64859923|NCT01750099|Autonomic Agents|autonomic agents|mesh-ancestor
64859924|NCT01750099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64859925|NCT01750099|Respiratory System Agents|respiratory system agents|mesh-ancestor
64859926|NCT01750099|Mydriatics|mydriatics|mesh-ancestor
64859927|NCT01750099|Sympathomimetics|sympathomimetics|mesh-ancestor
64859928|NCT01750099|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64859929|NCT01750359|Curcumin|curcumin|mesh-list
64859930|NCT01750359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64859931|NCT01750359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64859932|NCT01750359|Analgesics|analgesics|mesh-ancestor
64859933|NCT01750359|Sensory System Agents|sensory system agents|mesh-ancestor
64859934|NCT01750359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64859939|NCT01750359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859940|NCT01750359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859941|NCT01750385|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64859942|NCT01750385|Cephalosporins|cephalosporins|mesh-list
64859943|NCT01750385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64859944|NCT01750437|Esomeprazole|esomeprazole|mesh-list
64859945|NCT01750437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64859946|NCT01750437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64859947|NCT01750437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64859948|NCT01750437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859961|NCT01750476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64859962|NCT01750476|Contraceptive Agents|contraceptive agents|mesh-ancestor
64859963|NCT01750476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64859964|NCT01750476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859965|NCT01750476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64859966|NCT01750476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64859967|NCT01750476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64859968|NCT01750476|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64859969|NCT01750476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64859970|NCT01750476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859971|NCT01750476|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64859972|NCT01750541|Valproic Acid|valproic acid|mesh-list
64859973|NCT01750541|Haloperidol|haloperidol|mesh-list
64859974|NCT01750541|Haloperidol decanoate|haloperidol decanoate|mesh-list
64859975|NCT01750541|Antiemetics|antiemetics|mesh-ancestor
64859976|NCT01750541|Autonomic Agents|autonomic agents|mesh-ancestor
64859985|NCT01750541|Dopamine Agents|dopamine agents|mesh-ancestor
64860024|NCT01750788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64860025|NCT01750788|Protease Inhibitors|protease inhibitors|mesh-ancestor
64860026|NCT01750788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860027|NCT01750788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860028|NCT01750788|Anticoagulants|anticoagulants|mesh-ancestor
64860029|NCT01750801|Chlorhexidine|chlorhexidine|mesh-list
64860030|NCT01750801|Propolis|propolis|mesh-list
64860031|NCT01750801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64860032|NCT01750801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64473007|NCT01726582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64860033|NCT01750801|Disinfectants|disinfectants|mesh-ancestor
64860034|NCT01750866|Prednisone|prednisone|mesh-list
64860035|NCT01750866|Lenograstim|lenograstim|mesh-list
64860036|NCT01750866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64860037|NCT01750866|Glucocorticoids|glucocorticoids|mesh-ancestor
64860038|NCT01750866|Hormones|hormones|mesh-ancestor
64860040|NCT01750866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860083|NCT01751269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860084|NCT01751269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860085|NCT01751269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64860086|NCT01751269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64860087|NCT01751295|Atorvastatin|atorvastatin|mesh-list
64860088|NCT01751295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64860089|NCT01751295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64860090|NCT01751295|Antimetabolites|antimetabolites|mesh-ancestor
64860091|NCT01751295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860092|NCT01751295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64860093|NCT01751295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64860094|NCT01751295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860095|NCT01751321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64860096|NCT01751321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64860097|NCT01751321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860098|NCT01751321|Incretins|incretins|mesh-ancestor
64860099|NCT01751321|Hormones|hormones|mesh-ancestor
64860100|NCT01751321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64860101|NCT01751321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64860102|NCT01751321|Protease Inhibitors|protease inhibitors|mesh-ancestor
64860103|NCT01751321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860104|NCT01751321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860105|NCT01751347|Lidocaine|lidocaine|mesh-list
65494867|NCT01074281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64860106|NCT01751347|Bupivacaine|bupivacaine|mesh-list
64860107|NCT01751347|Anesthetics, Local|anesthetics, local|mesh-ancestor
64860108|NCT01751347|Anesthetics|anesthetics|mesh-ancestor
64860109|NCT01751347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64860110|NCT01751347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860111|NCT01751347|Sensory System Agents|sensory system agents|mesh-ancestor
64860112|NCT01751347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64860113|NCT01751347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64860114|NCT01751347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64860115|NCT01751347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64860119|NCT01751373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64860120|NCT01751373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64860121|NCT01751373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64860122|NCT01751373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860123|NCT01751373|Cholinergic Agents|cholinergic agents|mesh-ancestor
64860124|NCT01751373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64860125|NCT01751373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860126|NCT01751373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64860127|NCT01751373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64860128|NCT01751425|Imatinib Mesylate|imatinib mesylate|mesh-list
64860129|NCT01751425|Dasatinib|dasatinib|mesh-list
64860130|NCT01751425|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
64860131|NCT01751425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860132|NCT01751425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64860133|NCT01751425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860134|NCT01751425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860135|NCT01751763|Sorafenib|sorafenib|mesh-list
64860136|NCT01751763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860137|NCT01751763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64860138|NCT01751763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860139|NCT01751763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628695|NCT00199082|Hormones|hormones|mesh-ancestor
64860140|NCT01751828|Sertraline|sertraline|mesh-list
64860141|NCT01751828|Antidepressive Agents|antidepressive agents|mesh-ancestor
64860142|NCT01751828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64860143|NCT01751828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64860144|NCT01751828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64860145|NCT01751828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64860156|NCT01751854|Serotonin Agents|serotonin agents|mesh-ancestor
64860160|NCT01751854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64860170|NCT01752075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860171|NCT01752075|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64860172|NCT01752075|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64860173|NCT01752075|Growth Substances|growth substances|mesh-ancestor
64860174|NCT01752075|Growth Inhibitors|growth inhibitors|mesh-ancestor
64860175|NCT01752075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860177|NCT01752153|Deferoxamine|deferoxamine|mesh-list
64860178|NCT01752153|Antioxidants|antioxidants|mesh-ancestor
64860179|NCT01752153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860180|NCT01752153|Protective Agents|protective agents|mesh-ancestor
64860181|NCT01752153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860182|NCT01752153|Siderophores|siderophores|mesh-ancestor
64860183|NCT01752153|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64860184|NCT01752153|Chelating Agents|chelating agents|mesh-ancestor
64860185|NCT01752153|Sequestering Agents|sequestering agents|mesh-ancestor
64860186|NCT01752205|Paclitaxel|paclitaxel|mesh-list
64860187|NCT01752205|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64860188|NCT01752205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64860189|NCT01752205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473008|NCT01726582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860190|NCT01752205|Tubulin Modulators|tubulin modulators|mesh-ancestor
64860191|NCT01752205|Antimitotic Agents|antimitotic agents|mesh-ancestor
64860229|NCT01752517|Tubulin Modulators|tubulin modulators|mesh-ancestor
64860230|NCT01752517|Antimitotic Agents|antimitotic agents|mesh-ancestor
64860231|NCT01752517|Mitosis Modulators|mitosis modulators|mesh-ancestor
64860232|NCT01752517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860233|NCT01752517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64860234|NCT01752517|Alkylating Agents|alkylating agents|mesh-ancestor
64860235|NCT01752543|Conivaptan|conivaptan|mesh-list
64860236|NCT01752543|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64860237|NCT01752543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860238|NCT01752543|Natriuretic Agents|natriuretic agents|mesh-ancestor
64860239|NCT01752543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860240|NCT01752686|Carboplatin|carboplatin|mesh-list
64860241|NCT01752686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860242|NCT01752699|Methadone|methadone|mesh-list
64860243|NCT01752699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64860297|NCT01753128|Antidepressive Agents|antidepressive agents|mesh-ancestor
64860298|NCT01753128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64860299|NCT01753128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64860300|NCT01753128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64860301|NCT01753128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64860302|NCT01753128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860303|NCT01753128|Adrenergic Agents|adrenergic agents|mesh-ancestor
64860304|NCT01753128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64860305|NCT01753128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860306|NCT01753154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64860307|NCT01753349|Botulinum Toxins|botulinum toxins|mesh-list
64860308|NCT01753349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64860309|NCT01753349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64860310|NCT01753349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64860311|NCT01753349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64860312|NCT01753349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860313|NCT01753349|Cholinergic Agents|cholinergic agents|mesh-ancestor
64860314|NCT01753349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64860315|NCT01753349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860316|NCT01753349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64860317|NCT01753349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64860318|NCT01753375|Vitamin D|vitamin d|mesh-list
64860319|NCT01753375|Cholecalciferol|cholecalciferol|mesh-list
64860320|NCT01753375|Vitamins|vitamins|mesh-ancestor
64860321|NCT01753375|Micronutrients|micronutrients|mesh-ancestor
64860322|NCT01753375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860323|NCT01753375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64860355|NCT01753752|Chelating Agents|chelating agents|mesh-ancestor
64860356|NCT01753752|Sequestering Agents|sequestering agents|mesh-ancestor
64860357|NCT01753752|Hemostatics|hemostatics|mesh-ancestor
64860358|NCT01753752|Coagulants|coagulants|mesh-ancestor
64860359|NCT01753882|Citalopram|citalopram|mesh-list
64860360|NCT01753882|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64860361|NCT01753882|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64860362|NCT01753882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65494869|NCT01074281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64860363|NCT01753882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860364|NCT01753882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64860365|NCT01753882|Serotonin Agents|serotonin agents|mesh-ancestor
64860366|NCT01753882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860367|NCT01753882|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64860368|NCT01753882|Antidepressive Agents|antidepressive agents|mesh-ancestor
64860369|NCT01753882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64860370|NCT01754116|Cabotegravir|cabotegravir|mesh-list
64860418|NCT01754324|Antitussive Agents|antitussive agents|mesh-ancestor
64860419|NCT01754324|Respiratory System Agents|respiratory system agents|mesh-ancestor
64860420|NCT01754649|Misoprostol|misoprostol|mesh-list
64860421|NCT01754649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64860422|NCT01754649|Abortifacient Agents|abortifacient agents|mesh-ancestor
64860423|NCT01754649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64860424|NCT01754649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860425|NCT01754649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64860426|NCT01754649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64860427|NCT01754649|Oxytocics|oxytocics|mesh-ancestor
64860428|NCT01754701|Iron|iron|mesh-list
64860429|NCT01754701|Trace Elements|trace elements|mesh-ancestor
64860430|NCT01754701|Micronutrients|micronutrients|mesh-ancestor
64860431|NCT01754701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860432|NCT01754792|Inositol|inositol|mesh-list
64860433|NCT01754792|Vitamin B Complex|vitamin b complex|mesh-ancestor
64860434|NCT01754792|Vitamins|vitamins|mesh-ancestor
64860435|NCT01754792|Micronutrients|micronutrients|mesh-ancestor
64860436|NCT01754792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860437|NCT01754805|Methotrexate|methotrexate|mesh-list
64629004|NCT05271292|Chiauranib|chiauranib|mesh-list
64860486|NCT01754883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860487|NCT01754961|Vitamin D|vitamin d|mesh-list
64860488|NCT01754961|Ergocalciferols|ergocalciferols|mesh-list
64860489|NCT01754961|Cholecalciferol|cholecalciferol|mesh-list
64860490|NCT01754961|Vitamins|vitamins|mesh-list
64860491|NCT01754961|Micronutrients|micronutrients|mesh-ancestor
64860492|NCT01754961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860493|NCT01754961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64860494|NCT01754961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64860495|NCT01754974|Ribavirin|ribavirin|mesh-list
64860496|NCT01754974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64860497|NCT01754974|Antimetabolites|antimetabolites|mesh-ancestor
64860541|NCT01755299|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64860542|NCT01755299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64860543|NCT01755299|Purinergic Agents|purinergic agents|mesh-ancestor
64860544|NCT01755299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64860545|NCT01755338|Methylprednisolone|methylprednisolone|mesh-list
64860546|NCT01755338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64860547|NCT01755338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64860548|NCT01755338|Prednisolone|prednisolone|mesh-list
64860549|NCT01755338|Prednisolone acetate|prednisolone acetate|mesh-list
64860550|NCT01755338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64860551|NCT01755338|Prednisolone phosphate|prednisolone phosphate|mesh-list
64860552|NCT01755338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64860553|NCT01755338|Antiemetics|antiemetics|mesh-ancestor
64860554|NCT01755338|Autonomic Agents|autonomic agents|mesh-ancestor
64860555|NCT01755338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64860556|NCT01755338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860557|NCT01755338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64860558|NCT01755338|Glucocorticoids|glucocorticoids|mesh-ancestor
64860559|NCT01755338|Hormones|hormones|mesh-ancestor
64860560|NCT01755338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64860561|NCT01755338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64860581|NCT01755468|Insulin|insulin|mesh-list
65494879|NCT03100006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65494880|NCT03100006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494881|NCT03099538|Ixekizumab|ixekizumab|mesh-list
65494882|NCT03099538|Dermatologic Agents|dermatologic agents|mesh-ancestor
64574180|NCT02049593|Alkylating Agents|alkylating agents|mesh-ancestor
64860589|NCT01755494|Saxagliptin|saxagliptin|mesh-list
64860590|NCT01755494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64860591|NCT01755494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860592|NCT01755494|Incretins|incretins|mesh-ancestor
64860593|NCT01755494|Hormones|hormones|mesh-ancestor
64860594|NCT01755494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64860595|NCT01755494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64860596|NCT01755494|Protease Inhibitors|protease inhibitors|mesh-ancestor
64860597|NCT01755494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860598|NCT01755494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860599|NCT01755520|Aspirin|aspirin|mesh-list
64860600|NCT01755520|Ticagrelor|ticagrelor|mesh-list
64860602|NCT01755520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64860604|NCT01755520|Sensory System Agents|sensory system agents|mesh-ancestor
64860605|NCT01755520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64860606|NCT01755520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860607|NCT01755520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64860608|NCT01755520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64860609|NCT01755520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64860610|NCT01755520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64860611|NCT01755520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860612|NCT01755520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64860613|NCT01755520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64860614|NCT01755520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860615|NCT01755520|Antipyretics|antipyretics|mesh-ancestor
64860616|NCT01755520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64860617|NCT01755520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64860618|NCT01755520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64860619|NCT01755520|Purinergic Agents|purinergic agents|mesh-ancestor
64406234|NCT05304559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64501790|NCT03028857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64501791|NCT03028857|Antimetabolites|antimetabolites|mesh-ancestor
64860620|NCT01755520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64860621|NCT01755559|Artesunate|artesunate|mesh-list
64860622|NCT01755559|Lumefantrine|lumefantrine|mesh-list
64860623|NCT01755559|Artemether|artemether|mesh-list
64860624|NCT01755559|Piperaquine|piperaquine|mesh-list
64860625|NCT01755559|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64860626|NCT01755559|Amodiaquine|amodiaquine|mesh-list
64860627|NCT01755559|Artenimol|artenimol|mesh-list
64860628|NCT01755559|Antimalarials|antimalarials|mesh-ancestor
64860629|NCT01755559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64860630|NCT01755559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64860631|NCT01755559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64860632|NCT01755559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860633|NCT01755559|Antiviral Agents|antiviral agents|mesh-ancestor
64860634|NCT01755559|Schistosomicides|schistosomicides|mesh-ancestor
64860635|NCT01755559|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64860636|NCT01755559|Anthelmintics|anthelmintics|mesh-ancestor
64860637|NCT01755572|Liraglutide|liraglutide|mesh-list
64860638|NCT01755572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64860639|NCT01755572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860640|NCT01755572|Incretins|incretins|mesh-ancestor
64860641|NCT01755572|Hormones|hormones|mesh-ancestor
64860642|NCT01755572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64860643|NCT01755611|Minocycline|minocycline|mesh-list
64860644|NCT01755611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64860645|NCT01755611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64860646|NCT01755663|Metoprolol|metoprolol|mesh-list
64860647|NCT01755663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64860648|NCT01755663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64860649|NCT01755663|Sympatholytics|sympatholytics|mesh-ancestor
64860650|NCT01755663|Autonomic Agents|autonomic agents|mesh-ancestor
64860659|NCT01755676|Orlistat|orlistat|mesh-list
64406330|NCT04682743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64629251|NCT01049945|Hormones|hormones|mesh-ancestor
64860666|NCT01755728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64860668|NCT01755728|Sensory System Agents|sensory system agents|mesh-ancestor
64860669|NCT01755728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64860670|NCT01755728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860671|NCT01755728|Antipyretics|antipyretics|mesh-ancestor
64860672|NCT01755728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64860673|NCT01755728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64860674|NCT01755728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64860685|NCT01755845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860687|NCT01755871|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64860688|NCT01755871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860689|NCT01755871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64860690|NCT01755871|Immunologic Factors|immunologic factors|mesh-ancestor
64860691|NCT01755871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860692|NCT01755897|Paclitaxel|paclitaxel|mesh-list
64860693|NCT01755897|Cisplatin|cisplatin|mesh-list
64860694|NCT01755897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64860695|NCT01755897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860696|NCT01755897|Tubulin Modulators|tubulin modulators|mesh-ancestor
64860697|NCT01755897|Antimitotic Agents|antimitotic agents|mesh-ancestor
64860698|NCT01755897|Mitosis Modulators|mitosis modulators|mesh-ancestor
64860699|NCT01755897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860700|NCT01755923|Docetaxel|docetaxel|mesh-list
64860701|NCT01755923|Gefitinib|gefitinib|mesh-list
64860702|NCT01755923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860709|NCT01756040|Lactulose|lactulose|mesh-list
64406376|NCT03020875|Acetaminophen|acetaminophen|mesh-list
64860722|NCT01756131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860723|NCT01756131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860724|NCT01756131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64860725|NCT01756131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64860726|NCT01756131|Antiviral Agents|antiviral agents|mesh-ancestor
64860727|NCT01756131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64860728|NCT01756170|Paclitaxel|paclitaxel|mesh-list
64860729|NCT01756170|Cisplatin|cisplatin|mesh-list
64860730|NCT01756170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64860731|NCT01756170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860732|NCT01756170|Tubulin Modulators|tubulin modulators|mesh-ancestor
64860733|NCT01756170|Antimitotic Agents|antimitotic agents|mesh-ancestor
64860734|NCT01756170|Mitosis Modulators|mitosis modulators|mesh-ancestor
64860735|NCT01756170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860736|NCT01756183|Paclitaxel|paclitaxel|mesh-list
64860737|NCT01756183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64860738|NCT01756183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860739|NCT01756183|Tubulin Modulators|tubulin modulators|mesh-ancestor
64860741|NCT01756183|Mitosis Modulators|mitosis modulators|mesh-ancestor
64860742|NCT01756183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860743|NCT01756261|Aflibercept|aflibercept|mesh-list
64860744|NCT01756261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64860745|NCT01756261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64860746|NCT01756261|Growth Substances|growth substances|mesh-ancestor
64860747|NCT01756261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860748|NCT01756261|Growth Inhibitors|growth inhibitors|mesh-ancestor
64860768|NCT01756430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64860769|NCT01756430|Antioxidants|antioxidants|mesh-ancestor
64860770|NCT01756430|Protective Agents|protective agents|mesh-ancestor
64860771|NCT01756430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64860772|NCT01756430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64860773|NCT01756430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64860774|NCT01756430|Vasodilator Agents|vasodilator agents|mesh-ancestor
64860775|NCT01756430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64860776|NCT01756430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64860777|NCT01756443|Lidocaine|lidocaine|mesh-list
64860778|NCT01756443|Epinephrine|epinephrine|mesh-list
64860779|NCT01756443|Racepinephrine|racepinephrine|mesh-list
64860780|NCT01756443|Bupivacaine|bupivacaine|mesh-list
64860781|NCT01756443|Epinephryl borate|epinephryl borate|mesh-list
64860782|NCT01756443|Anesthetics, Local|anesthetics, local|mesh-ancestor
64860783|NCT01756443|Anesthetics|anesthetics|mesh-ancestor
64860784|NCT01756443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64860785|NCT01756443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860786|NCT01756443|Sensory System Agents|sensory system agents|mesh-ancestor
64860787|NCT01756443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64860788|NCT01756443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64860789|NCT01756443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64860790|NCT01756443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64860791|NCT01756443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64860822|NCT01756508|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64860823|NCT01756508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64860824|NCT01756508|Immunologic Factors|immunologic factors|mesh-ancestor
64860825|NCT01756508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860826|NCT01756521|Moxifloxacin|moxifloxacin|mesh-list
64860827|NCT01756521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64860828|NCT01756521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64860829|NCT01756521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64860830|NCT01756521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64860831|NCT01756521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860832|NCT01756521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860833|NCT01756521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860834|NCT01756547|Potassium Citrate|potassium citrate|mesh-list
64860835|NCT01756547|Diuretics|diuretics|mesh-ancestor
64860836|NCT01756547|Natriuretic Agents|natriuretic agents|mesh-ancestor
64860837|NCT01756547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860838|NCT01756547|Expectorants|expectorants|mesh-ancestor
64860839|NCT01756547|Respiratory System Agents|respiratory system agents|mesh-ancestor
64860879|NCT01756781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860880|NCT01756781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64860889|NCT01756781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860890|NCT01756781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860891|NCT01756781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64860892|NCT01756781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860893|NCT01756989|Thalidomide|thalidomide|mesh-list
64860894|NCT01756989|Celecoxib|celecoxib|mesh-list
64860895|NCT01756989|Etoposide|etoposide|mesh-list
64860896|NCT01756989|Etoposide phosphate|etoposide phosphate|mesh-list
64860897|NCT01756989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64860898|NCT01756989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860899|NCT01756989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64860900|NCT01756989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64860901|NCT01756989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860902|NCT01756989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860903|NCT01756989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64860904|NCT01756989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64860905|NCT01756989|Analgesics|analgesics|mesh-ancestor
64860906|NCT01756989|Sensory System Agents|sensory system agents|mesh-ancestor
64860907|NCT01756989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64860908|NCT01756989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860909|NCT01756989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64860910|NCT01756989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64860911|NCT01756989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64473026|NCT01718743|Growth Substances|growth substances|mesh-ancestor
64860912|NCT01756989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64860913|NCT01756989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64860914|NCT01756989|Immunologic Factors|immunologic factors|mesh-ancestor
64860915|NCT01756989|Leprostatic Agents|leprostatic agents|mesh-ancestor
64860916|NCT01756989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64860928|NCT01757015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860929|NCT01757015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860930|NCT01757106|Sevoflurane|sevoflurane|mesh-list
64860931|NCT01757106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64860932|NCT01757106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64860933|NCT01757106|Anesthetics, General|anesthetics, general|mesh-ancestor
64860934|NCT01757106|Anesthetics|anesthetics|mesh-ancestor
64860935|NCT01757106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64860936|NCT01757106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860937|NCT01757236|Vancomycin|vancomycin|mesh-list
64860938|NCT01757236|Rifampin|rifampin|mesh-list
64860939|NCT01757236|Clindamycin|clindamycin|mesh-list
64860940|NCT01757236|Ceftriaxone|ceftriaxone|mesh-list
64860941|NCT01757236|Linezolid|linezolid|mesh-list
64860942|NCT01757236|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64860943|NCT01757236|Fluoroquinolones|fluoroquinolones|mesh-list
64860944|NCT01757236|Trimethoprim|trimethoprim|mesh-list
64860945|NCT01757236|Sulfamethoxazole|sulfamethoxazole|mesh-list
64860946|NCT01757236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64860947|NCT01757236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64860948|NCT01757236|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64860951|NCT01757236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64860953|NCT01757236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860979|NCT01757249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64860980|NCT01757249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64860981|NCT01757249|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
64860982|NCT01757249|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64860983|NCT01757249|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64860984|NCT01757262|Clopidogrel|clopidogrel|mesh-list
65494885|NCT05149768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860985|NCT01757262|Ticagrelor|ticagrelor|mesh-list
64860986|NCT01757262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64860987|NCT01757262|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64860988|NCT01757262|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64860989|NCT01757262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64860990|NCT01757262|Purinergic Agents|purinergic agents|mesh-ancestor
64860991|NCT01757262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64860992|NCT01757262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860993|NCT01757262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860994|NCT01757366|Ginsenoside Rg3|ginsenoside rg3|mesh-list
64860995|NCT01757366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64860996|NCT01757366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860997|NCT01757431|Eculizumab|eculizumab|mesh-list
64860998|NCT01757431|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64860999|NCT01757431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64861000|NCT01757431|Immunologic Factors|immunologic factors|mesh-ancestor
64861001|NCT01757431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861002|NCT01757457|Abciximab|abciximab|mesh-list
64861003|NCT01757457|Anticoagulants|anticoagulants|mesh-ancestor
64861004|NCT01757457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64861005|NCT01757574|Alemtuzumab|alemtuzumab|mesh-list
64861006|NCT01757574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64861007|NCT01757574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861008|NCT01757587|Insulin|insulin|mesh-list
64861045|NCT01757769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861046|NCT01757769|Urological Agents|urological agents|mesh-ancestor
64861047|NCT01757795|Otaplimastat|otaplimastat|mesh-list
64861048|NCT01757795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64861049|NCT01757795|Protective Agents|protective agents|mesh-ancestor
64861050|NCT01757795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861052|NCT01757808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64861053|NCT01757808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64861054|NCT01757808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861055|NCT01757860|Vitamin D|vitamin d|mesh-list
64861056|NCT01757860|Vitamins|vitamins|mesh-ancestor
64861057|NCT01757860|Micronutrients|micronutrients|mesh-ancestor
64861058|NCT01757860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861059|NCT01757860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64861060|NCT01757899|Methylprednisolone|methylprednisolone|mesh-list
64861061|NCT01757899|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64861062|NCT01757899|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64861063|NCT01757899|Prednisolone|prednisolone|mesh-list
64861068|NCT01757899|Antiemetics|antiemetics|mesh-ancestor
64861069|NCT01757899|Autonomic Agents|autonomic agents|mesh-ancestor
64861070|NCT01757899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64861071|NCT01757899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861072|NCT01757899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64861073|NCT01757899|Glucocorticoids|glucocorticoids|mesh-ancestor
64861074|NCT01757899|Hormones|hormones|mesh-ancestor
64861075|NCT01757899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64861076|NCT01757899|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64861077|NCT01757899|Protective Agents|protective agents|mesh-ancestor
64861078|NCT01757899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64861079|NCT01757899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861080|NCT01758029|Methyltestosterone|methyltestosterone|mesh-list
64861081|NCT01758029|Testosterone|testosterone|mesh-list
64861082|NCT01758029|Testosterone undecanoate|testosterone undecanoate|mesh-list
64861083|NCT01758029|Testosterone enanthate|testosterone enanthate|mesh-list
64861084|NCT01758029|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64861085|NCT01758029|Androgens|androgens|mesh-ancestor
64861086|NCT01758029|Hormones|hormones|mesh-ancestor
64861087|NCT01758029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64861088|NCT01758029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861089|NCT01758029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64861090|NCT01758029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861091|NCT01758029|Anabolic Agents|anabolic agents|mesh-ancestor
64861092|NCT01758094|Testosterone|testosterone|mesh-list
64861093|NCT01758094|Androgens|androgens|mesh-ancestor
64861094|NCT01758094|Hormones|hormones|mesh-ancestor
64861095|NCT01758094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64861096|NCT01758094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861097|NCT01758107|Cyclosporine|cyclosporine|mesh-list
64861098|NCT01758107|Cyclosporins|cyclosporins|mesh-list
64861099|NCT01758107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861100|NCT01758107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861101|NCT01758107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64861149|NCT01758198|Abortifacient Agents|abortifacient agents|mesh-ancestor
64861150|NCT01758198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64861151|NCT01758198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861152|NCT01758198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64861153|NCT01758198|Antimetabolites|antimetabolites|mesh-ancestor
64861154|NCT01758198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861155|NCT01758198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861156|NCT01758198|Dermatologic Agents|dermatologic agents|mesh-ancestor
64861157|NCT01758198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861158|NCT01758198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64861159|NCT01758198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64861160|NCT01758198|Immunologic Factors|immunologic factors|mesh-ancestor
64861161|NCT01758198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64861162|NCT01758198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64861163|NCT01758198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64861164|NCT01758263|Metoprolol|metoprolol|mesh-list
64861165|NCT01758263|Nebivolol|nebivolol|mesh-list
64861166|NCT01758263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64861167|NCT01758263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64861168|NCT01758263|Sympatholytics|sympatholytics|mesh-ancestor
64861169|NCT01758263|Autonomic Agents|autonomic agents|mesh-ancestor
64861170|NCT01758263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64473027|NCT01718743|Growth Inhibitors|growth inhibitors|mesh-ancestor
64861171|NCT01758263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861172|NCT01758263|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64861173|NCT01758263|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64861196|NCT01758380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861197|NCT01758393|Prednisone|prednisone|mesh-list
64861198|NCT01758393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64861199|NCT01758393|Glucocorticoids|glucocorticoids|mesh-ancestor
64861200|NCT01758393|Hormones|hormones|mesh-ancestor
64861201|NCT01758393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64861202|NCT01758393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861203|NCT01758393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64861204|NCT01758393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861205|NCT01758471|Acarbose|acarbose|mesh-list
64861213|NCT01758627|Dialysis Solutions|dialysis solutions|mesh-ancestor
64861214|NCT01758627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64861216|NCT01758640|Phenindione|phenindione|mesh-list
64861217|NCT01758640|Anticoagulants|anticoagulants|mesh-ancestor
64861218|NCT01758666|Leucovorin|leucovorin|mesh-list
64861219|NCT01758666|Methotrexate|methotrexate|mesh-list
64861263|NCT01758913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861264|NCT01758913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64861265|NCT01758913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64861266|NCT01758913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64861267|NCT01758913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861268|NCT01758913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861269|NCT01758978|Hydrocodone|hydrocodone|mesh-list
64861270|NCT01758978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64861271|NCT01758978|Narcotics|narcotics|mesh-ancestor
64861272|NCT01758978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64861273|NCT01758978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861274|NCT01758978|Analgesics|analgesics|mesh-ancestor
64861281|NCT01759030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861282|NCT01759030|Immunologic Factors|immunologic factors|mesh-ancestor
64861283|NCT01759030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861284|NCT01759030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64861285|NCT01759108|Rebamipide|rebamipide|mesh-list
64861286|NCT01759108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64861287|NCT01759108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64861288|NCT01759108|Antioxidants|antioxidants|mesh-ancestor
64861289|NCT01759108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861290|NCT01759108|Protective Agents|protective agents|mesh-ancestor
64861291|NCT01759108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861292|NCT01759108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861293|NCT01759394|Maleic acid|maleic acid|mesh-list
64861294|NCT01759394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861295|NCT01759394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861296|NCT01759485|Vitamin D|vitamin d|mesh-list
64861297|NCT01759485|Cholecalciferol|cholecalciferol|mesh-list
64861298|NCT01759485|Vitamins|vitamins|mesh-ancestor
64861299|NCT01759485|Micronutrients|micronutrients|mesh-ancestor
64861300|NCT01759485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861301|NCT01759485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64861311|NCT01759524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64861312|NCT01759524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64861313|NCT01759524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64861314|NCT01759524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64861315|NCT01759524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64861316|NCT01759524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861317|NCT01759524|Analgesics|analgesics|mesh-ancestor
64861318|NCT01759524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64861319|NCT01759524|Sympatholytics|sympatholytics|mesh-ancestor
64861320|NCT01759524|Autonomic Agents|autonomic agents|mesh-ancestor
64861381|NCT01759706|Anesthetics, General|anesthetics, general|mesh-ancestor
64861382|NCT01759706|Anesthetics, Local|anesthetics, local|mesh-ancestor
64861383|NCT01759706|Anticonvulsants|anticonvulsants|mesh-ancestor
64861384|NCT01759706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64861385|NCT01759706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64861386|NCT01759706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64861387|NCT01759706|GABA Modulators|gaba modulators|mesh-ancestor
64861388|NCT01759706|GABA Agents|gaba agents|mesh-ancestor
64861389|NCT01759719|Chromium|chromium|mesh-list
64861390|NCT01759719|Trace Elements|trace elements|mesh-ancestor
64861391|NCT01759719|Micronutrients|micronutrients|mesh-ancestor
64861392|NCT01759719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861393|NCT01759732|Cyclophosphamide|cyclophosphamide|mesh-list
64861394|NCT01759732|Fludarabine|fludarabine|mesh-list
64861395|NCT01759732|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64861396|NCT01759732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64861397|NCT01759732|Immunologic Factors|immunologic factors|mesh-ancestor
64861398|NCT01759732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861399|NCT01759732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64861400|NCT01759732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64861401|NCT01759732|Alkylating Agents|alkylating agents|mesh-ancestor
64861402|NCT01759732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861403|NCT01759732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861404|NCT01759732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64861405|NCT01759771|Vitamin D|vitamin d|mesh-list
64861406|NCT01759771|Cholecalciferol|cholecalciferol|mesh-list
64861407|NCT01759771|Vitamins|vitamins|mesh-ancestor
64861408|NCT01759771|Micronutrients|micronutrients|mesh-ancestor
64861412|NCT01759810|Vaccines|vaccines|mesh-list
64861436|NCT01759875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64861438|NCT01759940|Anesthetics, Local|anesthetics, local|mesh-ancestor
64861439|NCT01759940|Anesthetics|anesthetics|mesh-ancestor
64861440|NCT01759940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64861441|NCT01759940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861442|NCT01759940|Sensory System Agents|sensory system agents|mesh-ancestor
64861443|NCT01759940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64861444|NCT01760018|Desflurane|desflurane|mesh-list
64861445|NCT01760018|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64861446|NCT01760018|Anesthetics, General|anesthetics, general|mesh-ancestor
64861447|NCT01760018|Anesthetics|anesthetics|mesh-ancestor
64861448|NCT01760018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64861449|NCT01760018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861450|NCT01760096|Cyclosporine|cyclosporine|mesh-list
64861451|NCT01760096|Levamisole|levamisole|mesh-list
64861452|NCT01760096|Cyclosporins|cyclosporins|mesh-list
64861453|NCT01760096|Glucocorticoids|glucocorticoids|mesh-list
64861454|NCT01760096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861455|NCT01760096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861456|NCT01760096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64861457|NCT01760096|Immunologic Factors|immunologic factors|mesh-ancestor
64861458|NCT01760096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861495|NCT01760161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861496|NCT01760161|Sensory System Agents|sensory system agents|mesh-ancestor
64861497|NCT01760161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64861499|NCT01760174|Ropivacaine|ropivacaine|mesh-list
64861500|NCT01760174|Anesthetics, Local|anesthetics, local|mesh-ancestor
64861501|NCT01760174|Anesthetics|anesthetics|mesh-ancestor
64861502|NCT01760174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64861503|NCT01760174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494887|NCT00883480|Docetaxel|docetaxel|mesh-list
64473028|NCT01718743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861504|NCT01760174|Sensory System Agents|sensory system agents|mesh-ancestor
64861505|NCT01760174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64861507|NCT01760226|Cyclophosphamide|cyclophosphamide|mesh-list
64861508|NCT01760226|Rituximab|rituximab|mesh-list
64861509|NCT01760226|Doxorubicin|doxorubicin|mesh-list
64861510|NCT01760226|Methotrexate|methotrexate|mesh-list
64861555|NCT01760278|Hormones|hormones|mesh-list
64861556|NCT01760278|Progesterone|progesterone|mesh-list
64861557|NCT01760278|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64861558|NCT01760278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64861559|NCT01760278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861560|NCT01760278|Progestins|progestins|mesh-ancestor
64861561|NCT01760278|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64861562|NCT01760278|Fertility Agents|fertility agents|mesh-ancestor
64861571|NCT01760330|Antipyretics|antipyretics|mesh-ancestor
64861572|NCT01760421|Hydroxychloroquine|hydroxychloroquine|mesh-list
64861573|NCT01760421|Antimalarials|antimalarials|mesh-ancestor
64861574|NCT01760421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64861575|NCT01760421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64861576|NCT01760421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64861577|NCT01760421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861578|NCT01760421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861579|NCT01760421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64861580|NCT01760460|Oxazolidinones|oxazolidinones|mesh-list
64861581|NCT01760460|Anacetrapib|anacetrapib|mesh-list
64861582|NCT01760460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64861583|NCT01760460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64861584|NCT01760460|Antimetabolites|antimetabolites|mesh-ancestor
64861585|NCT01760460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494888|NCT00883480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64861586|NCT01760460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64861587|NCT01760460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64861588|NCT01760460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64861589|NCT01760460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861590|NCT01760564|Miglustat|miglustat|mesh-list
64861591|NCT01760564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861592|NCT01760564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861593|NCT01760564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64861594|NCT01760564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64861595|NCT01760564|Antiviral Agents|antiviral agents|mesh-ancestor
64861604|NCT01760577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64861605|NCT01760577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64861606|NCT01760577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861607|NCT01760577|Cholinergic Agents|cholinergic agents|mesh-ancestor
64861608|NCT01760577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64861609|NCT01760577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861610|NCT01760577|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64861611|NCT01760577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64861612|NCT01760577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64861613|NCT01760577|Immunologic Factors|immunologic factors|mesh-ancestor
64861614|NCT01760577|Viscosupplements|viscosupplements|mesh-ancestor
64861615|NCT01760577|Protective Agents|protective agents|mesh-ancestor
64861616|NCT01760642|Rifampin|rifampin|mesh-list
64861617|NCT01760642|Ketoconazole|ketoconazole|mesh-list
64861618|NCT01760642|Midazolam|midazolam|mesh-list
64861619|NCT01760642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64861666|NCT01760694|Vitamins|vitamins|mesh-ancestor
64861667|NCT01760694|Micronutrients|micronutrients|mesh-ancestor
64861668|NCT01760746|Bevacizumab|bevacizumab|mesh-list
64861669|NCT01760746|Ranibizumab|ranibizumab|mesh-list
64861670|NCT01760746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64861671|NCT01760746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861672|NCT01760746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64861673|NCT01760746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64861674|NCT01760746|Growth Substances|growth substances|mesh-ancestor
64861675|NCT01760746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861676|NCT01760746|Growth Inhibitors|growth inhibitors|mesh-ancestor
64861677|NCT01760798|Teriparatide|teriparatide|mesh-list
64861678|NCT01760798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64861679|NCT01760798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861680|NCT01760798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64861681|NCT01760811|Cetuximab|cetuximab|mesh-list
64861682|NCT01760811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64861683|NCT01760811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861684|NCT01760824|Amoxicillin|amoxicillin|mesh-list
64861685|NCT01760824|Metronidazole|metronidazole|mesh-list
64861686|NCT01760824|Clarithromycin|clarithromycin|mesh-list
64861687|NCT01760824|Tetracycline|tetracycline|mesh-list
64861688|NCT01760824|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
64861689|NCT01760824|Esomeprazole|esomeprazole|mesh-list
64861690|NCT01760824|Bismuth|bismuth|mesh-list
64861691|NCT01760824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64861692|NCT01760824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64861693|NCT01760824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64861694|NCT01760824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64861728|NCT01760980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64861729|NCT01760980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861730|NCT01761071|Diclofenac|diclofenac|mesh-list
64861731|NCT01761071|Ketorolac|ketorolac|mesh-list
64861732|NCT01761071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64861733|NCT01761071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64861734|NCT01761071|Analgesics|analgesics|mesh-ancestor
64861735|NCT01761071|Sensory System Agents|sensory system agents|mesh-ancestor
64861736|NCT01761071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64861737|NCT01761071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861738|NCT01761071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64861739|NCT01761071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64861740|NCT01761071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64861741|NCT01761071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861743|NCT01761110|Buprenorphine|buprenorphine|mesh-list
64407500|NCT05069779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64861791|NCT01761214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861792|NCT01761214|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64861793|NCT01761214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64861794|NCT01761318|Liraglutide|liraglutide|mesh-list
64861795|NCT01761318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64861796|NCT01761318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861797|NCT01761318|Incretins|incretins|mesh-ancestor
64861798|NCT01761318|Hormones|hormones|mesh-ancestor
64945481|NCT05595603|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
64861799|NCT01761318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64861800|NCT01761344|Hydrocortisone|hydrocortisone|mesh-list
64861801|NCT01761344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64861802|NCT01761461|Oxaliplatin|oxaliplatin|mesh-list
64861803|NCT01761461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861804|NCT01761487|Gentamicins|gentamicins|mesh-list
64861805|NCT01761487|Polymyxins|polymyxins|mesh-list
64861806|NCT01761487|Colistin|colistin|mesh-list
64861807|NCT01761487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64861808|NCT01761487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64861809|NCT01761487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64861810|NCT01761487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861811|NCT01761487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861812|NCT01761513|Esomeprazole|esomeprazole|mesh-list
64861813|NCT01761513|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64861814|NCT01761513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64861815|NCT01761513|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64861816|NCT01761513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861817|NCT01761513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861818|NCT01761526|Rotigotine|rotigotine|mesh-list
64861819|NCT01761526|Dopamine Agonists|dopamine agonists|mesh-ancestor
64861820|NCT01761526|Dopamine Agents|dopamine agents|mesh-ancestor
64861821|NCT01761526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64861822|NCT01761526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494892|NCT00883480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494893|NCT00883480|Antiviral Agents|antiviral agents|mesh-ancestor
64473034|NCT01701674|Aldesleukin|aldesleukin|mesh-list
64473035|NCT01701674|Cyclophosphamide|cyclophosphamide|mesh-list
64473036|NCT01701674|Fludarabine|fludarabine|mesh-list
64473037|NCT01701674|Ipilimumab|ipilimumab|mesh-list
64473038|NCT01701674|Interleukin-2|interleukin-2|mesh-list
64473039|NCT01701674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64473040|NCT01701674|Immunologic Factors|immunologic factors|mesh-ancestor
64473041|NCT01701674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473042|NCT01701674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64473043|NCT01701674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64473044|NCT01701674|Alkylating Agents|alkylating agents|mesh-ancestor
64473045|NCT01701674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473046|NCT01701674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473047|NCT01701674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64473048|NCT01701674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64473049|NCT01701674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64473050|NCT01701674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64861849|NCT01761656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64861850|NCT01761656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64861851|NCT01761656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861853|NCT01761669|Vitamins|vitamins|mesh-ancestor
64861854|NCT01761669|Micronutrients|micronutrients|mesh-ancestor
64861855|NCT01761669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861856|NCT01761669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64407608|NCT03101137|Anesthetics, Local|anesthetics, local|mesh-ancestor
64861885|NCT01761994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861886|NCT01761994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64861887|NCT01761994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64861888|NCT01761994|Anticoagulants|anticoagulants|mesh-ancestor
64861889|NCT01761994|Protease Inhibitors|protease inhibitors|mesh-ancestor
64861890|NCT01761994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861891|NCT01761994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861892|NCT01761994|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64861893|NCT01761994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64861894|NCT01761994|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64861895|NCT01761994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64861896|NCT01761994|Immunologic Factors|immunologic factors|mesh-ancestor
64861897|NCT01762046|Metformin|metformin|mesh-list
64861898|NCT01762046|Glipizide|glipizide|mesh-list
65494894|NCT00883480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494895|NCT00883480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494896|NCT00883480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65494897|NCT00883480|Immunologic Factors|immunologic factors|mesh-ancestor
65494898|NCT00883480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494899|NCT00883480|Tubulin Modulators|tubulin modulators|mesh-ancestor
65494900|NCT00883480|Antimitotic Agents|antimitotic agents|mesh-ancestor
65494901|NCT00883480|Mitosis Modulators|mitosis modulators|mesh-ancestor
65494902|NCT00883480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65494903|NCT05418946|Dapagliflozin|dapagliflozin|mesh-list
65494904|NCT05418946|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64861917|NCT01762163|Analgesics|analgesics|mesh-ancestor
64861918|NCT01762163|Sensory System Agents|sensory system agents|mesh-ancestor
64861919|NCT01762163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64861920|NCT01762163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861921|NCT01762163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64861922|NCT01762163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64861923|NCT01762163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64861924|NCT01762163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64861925|NCT01762163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861926|NCT01762163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64861927|NCT01762163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64861928|NCT01762163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861929|NCT01762163|Antipyretics|antipyretics|mesh-ancestor
64861930|NCT01762202|Cyclophosphamide|cyclophosphamide|mesh-list
64861931|NCT01762202|Fludarabine|fludarabine|mesh-list
64861932|NCT01762202|Ofatumumab|ofatumumab|mesh-list
64861933|NCT01762202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64861934|NCT01762202|Immunologic Factors|immunologic factors|mesh-ancestor
64861935|NCT01762202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861936|NCT01762202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64861937|NCT01762202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64861938|NCT01762202|Alkylating Agents|alkylating agents|mesh-ancestor
64861939|NCT01762202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861940|NCT01762202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861941|NCT01762202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64861942|NCT01762306|Folic Acid|folic acid|mesh-list
64861943|NCT01762306|Diclofenac|diclofenac|mesh-list
64861944|NCT01762306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64861945|NCT01762306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64861973|NCT01762332|Remifentanil|remifentanil|mesh-list
64861974|NCT01762332|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64861975|NCT01762332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64861976|NCT01762332|Narcotics|narcotics|mesh-ancestor
64861977|NCT01762332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64861978|NCT01762332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861979|NCT01762332|Analgesics|analgesics|mesh-ancestor
64861980|NCT01762332|Sensory System Agents|sensory system agents|mesh-ancestor
64861981|NCT01762332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64861982|NCT01762332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64861983|NCT01762332|Adrenergic Agents|adrenergic agents|mesh-ancestor
64473052|NCT01701674|Sensory System Agents|sensory system agents|mesh-ancestor
64861984|NCT01762332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64861985|NCT01762332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861987|NCT01762436|Bisoprolol|bisoprolol|mesh-list
64861988|NCT01762436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64861989|NCT01762436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64861990|NCT01762436|Sympatholytics|sympatholytics|mesh-ancestor
64861991|NCT01762436|Autonomic Agents|autonomic agents|mesh-ancestor
64861992|NCT01762436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64861993|NCT01762436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861994|NCT01762436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64861995|NCT01762436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64861996|NCT01762436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64861997|NCT01762436|Adrenergic Agents|adrenergic agents|mesh-ancestor
64861998|NCT01762436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64861999|NCT01762436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862000|NCT01762475|Sildenafil Citrate|sildenafil citrate|mesh-list
64862001|NCT01762475|Vasodilator Agents|vasodilator agents|mesh-ancestor
64862002|NCT01762475|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64862003|NCT01762475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64862004|NCT01762475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862005|NCT01762475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862012|NCT01762540|Calcium|calcium|mesh-list
64862013|NCT01762540|Glucocorticoids|glucocorticoids|mesh-list
64862023|NCT01762644|Cyclosporins|cyclosporins|mesh-list
64862024|NCT01762644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862025|NCT01762644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630596|NCT00003388|Cytarabine|cytarabine|mesh-list
64862026|NCT01762644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64862027|NCT01762644|Immunologic Factors|immunologic factors|mesh-ancestor
64862028|NCT01762644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862029|NCT01762644|Antifungal Agents|antifungal agents|mesh-ancestor
64862030|NCT01762644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64862031|NCT01762644|Dermatologic Agents|dermatologic agents|mesh-ancestor
64862032|NCT01762644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64862033|NCT01762644|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64862034|NCT01762644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64862035|NCT01762644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64862090|NCT01762787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64862091|NCT01762787|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64862092|NCT01762787|Protective Agents|protective agents|mesh-ancestor
64862093|NCT01762826|Inositol|inositol|mesh-list
64862094|NCT01762826|Vitamin B Complex|vitamin b complex|mesh-ancestor
64862095|NCT01762826|Vitamins|vitamins|mesh-ancestor
64862096|NCT01762826|Micronutrients|micronutrients|mesh-ancestor
64862097|NCT01762826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862098|NCT01762839|Moxifloxacin|moxifloxacin|mesh-list
64862099|NCT01762839|Oritavancin|oritavancin|mesh-list
64862100|NCT01762839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64862101|NCT01762839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64862102|NCT01762839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64862103|NCT01762839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64862104|NCT01762839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862105|NCT01762839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862106|NCT01762839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862107|NCT01762852|Belimumab|belimumab|mesh-list
64862108|NCT01762852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64862109|NCT01762852|Immunologic Factors|immunologic factors|mesh-ancestor
64862110|NCT01762852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862111|NCT01762878|Nemiralisib|nemiralisib|mesh-list
64862112|NCT01762878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64862113|NCT01762878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862114|NCT01762878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862115|NCT01762891|Acetaminophen|acetaminophen|mesh-list
64862116|NCT01762891|Celecoxib|celecoxib|mesh-list
64862117|NCT01762891|Rofecoxib|rofecoxib|mesh-list
64862118|NCT01762891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64862119|NCT01762891|Analgesics|analgesics|mesh-ancestor
64862120|NCT01762891|Sensory System Agents|sensory system agents|mesh-ancestor
64862121|NCT01762891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64862122|NCT01762891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862123|NCT01762891|Antipyretics|antipyretics|mesh-ancestor
64862124|NCT01762891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64862125|NCT01762891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64862126|NCT01762891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64862129|NCT01762891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862130|NCT01762891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862131|NCT01762995|Ferrous fumarate|ferrous fumarate|mesh-list
64862132|NCT01762995|Dolutegravir|dolutegravir|mesh-list
64862133|NCT01762995|Calcium Carbonate|calcium carbonate|mesh-list
64862134|NCT01762995|Calcium|calcium|mesh-list
64862135|NCT01762995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64862136|NCT01762995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862137|NCT01762995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64862138|NCT01762995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64862196|NCT01763437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64862197|NCT01763437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862198|NCT01763437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862199|NCT01763450|Bevacizumab|bevacizumab|mesh-list
64862200|NCT01763450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64862201|NCT01763450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862202|NCT01763450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64862203|NCT01763450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64862204|NCT01763450|Growth Substances|growth substances|mesh-ancestor
64862205|NCT01763450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862206|NCT01763450|Growth Inhibitors|growth inhibitors|mesh-ancestor
64862207|NCT01763463|Fluticasone|fluticasone|mesh-list
64862208|NCT01763463|Xhance|xhance|mesh-list
64862209|NCT01763463|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64862210|NCT01763463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64862212|NCT01763463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64862213|NCT01763463|Autonomic Agents|autonomic agents|mesh-ancestor
64862214|NCT01763463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64862215|NCT01763463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862216|NCT01763463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64862217|NCT01763463|Respiratory System Agents|respiratory system agents|mesh-ancestor
64862218|NCT01763463|Dermatologic Agents|dermatologic agents|mesh-ancestor
64862219|NCT01763463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64862220|NCT01763463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64862221|NCT01763463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64862222|NCT01763463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64862223|NCT01763463|Adrenergic Agents|adrenergic agents|mesh-ancestor
64862224|NCT01763463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64862225|NCT01763463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862226|NCT01763463|Glucocorticoids|glucocorticoids|mesh-ancestor
64862227|NCT01763463|Hormones|hormones|mesh-ancestor
64473055|NCT01701674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64862237|NCT01763541|Anastrozole|anastrozole|mesh-list
64862238|NCT01763541|Leuprolide|leuprolide|mesh-list
64862239|NCT01763541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64862240|NCT01763541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862241|NCT01763541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64862242|NCT01763541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64862243|NCT01763541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862244|NCT01763541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862245|NCT01763541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64862246|NCT01763541|Hormone Antagonists|hormone antagonists|mesh-ancestor
64862247|NCT01763541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64862248|NCT01763541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862249|NCT01763541|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64862250|NCT01763541|Fertility Agents|fertility agents|mesh-ancestor
64862251|NCT01763541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64862252|NCT01763658|Dexamethasone|dexamethasone|mesh-list
64862253|NCT01763658|Prednisolone|prednisolone|mesh-list
64862254|NCT01763658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64862255|NCT01763658|Immunoglobulins|immunoglobulins|mesh-list
64862256|NCT01763658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64862257|NCT01763658|gamma-Globulins|gamma-globulins|mesh-list
64862258|NCT01763658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64862259|NCT01763658|Antioxidants|antioxidants|mesh-list
64862260|NCT01763658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64862261|NCT01763658|Antiemetics|antiemetics|mesh-ancestor
64862262|NCT01763658|Autonomic Agents|autonomic agents|mesh-ancestor
64862263|NCT01763658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64862264|NCT01763658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862284|NCT01763749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64862293|NCT01763788|Necitumumab|necitumumab|mesh-list
64862294|NCT01763788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862295|NCT01763788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64862296|NCT01763788|Antimetabolites|antimetabolites|mesh-ancestor
64862297|NCT01763788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862298|NCT01763788|Antiviral Agents|antiviral agents|mesh-ancestor
64862299|NCT01763788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64862300|NCT01763788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862301|NCT01763788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64862302|NCT01763788|Immunologic Factors|immunologic factors|mesh-ancestor
64862303|NCT01763788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862304|NCT01763788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64862305|NCT01764087|Paclitaxel|paclitaxel|mesh-list
64862306|NCT01764087|Tirbanibulin|tirbanibulin|mesh-list
64862307|NCT01764087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64862308|NCT01764087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494913|NCT03097588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64862309|NCT01764087|Tubulin Modulators|tubulin modulators|mesh-ancestor
64862310|NCT01764087|Antimitotic Agents|antimitotic agents|mesh-ancestor
64862311|NCT01764087|Mitosis Modulators|mitosis modulators|mesh-ancestor
64862312|NCT01764087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862313|NCT01764087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862314|NCT01764126|Vaccines|vaccines|mesh-list
64862315|NCT01764126|Immunologic Factors|immunologic factors|mesh-ancestor
64862316|NCT01764126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862317|NCT01764139|Vitamin D|vitamin d|mesh-list
64862318|NCT01764139|Vitamins|vitamins|mesh-ancestor
64862319|NCT01764139|Micronutrients|micronutrients|mesh-ancestor
64862320|NCT01764139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862321|NCT01764139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64862322|NCT01764178|Valsartan|valsartan|mesh-list
64862323|NCT01764178|Pitavastatin|pitavastatin|mesh-list
64862324|NCT01764178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64408041|NCT04821323|Tocolytic Agents|tocolytic agents|mesh-ancestor
64862330|NCT01764178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64862331|NCT01764178|Antimetabolites|antimetabolites|mesh-ancestor
64862332|NCT01764178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862333|NCT01764178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64862334|NCT01764230|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64862335|NCT01764230|Luteolytic Agents|luteolytic agents|mesh-ancestor
64862336|NCT01764230|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64862337|NCT01764230|Contraceptive Agents|contraceptive agents|mesh-ancestor
64862338|NCT01764230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64862339|NCT01764230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862340|NCT01764230|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64862341|NCT01764230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64862342|NCT01764230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862343|NCT01764295|Olmesartan|olmesartan|mesh-list
64862344|NCT01764295|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64862345|NCT01764295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64862346|NCT01764295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64862347|NCT01764295|Antimetabolites|antimetabolites|mesh-ancestor
64862348|NCT01764295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862349|NCT01764295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64862357|NCT01764451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64862358|NCT01764451|Antimetabolites|antimetabolites|mesh-ancestor
64862359|NCT01764451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862360|NCT01764451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64408140|NCT04815395|Oxytocin|oxytocin|mesh-list
64862387|NCT01764750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64862388|NCT01764750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64862389|NCT01764828|Gemcitabine|gemcitabine|mesh-list
64862390|NCT01764828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64862391|NCT01764828|Antimetabolites|antimetabolites|mesh-ancestor
64862392|NCT01764828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862393|NCT01764828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862394|NCT01764828|Antiviral Agents|antiviral agents|mesh-ancestor
64862395|NCT01764828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64862396|NCT01764828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862397|NCT01764828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64862398|NCT01764828|Immunologic Factors|immunologic factors|mesh-ancestor
64862399|NCT01764828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862400|NCT01764867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64862401|NCT01764867|Dexetimide|dexetimide|mesh-list
64862402|NCT01764867|Mirtazapine|mirtazapine|mesh-list
64862403|NCT01764867|Fluvoxamine|fluvoxamine|mesh-list
64862404|NCT01764867|Trazodone|trazodone|mesh-list
64862405|NCT01764867|Citalopram|citalopram|mesh-list
64862406|NCT01764867|Bupropion|bupropion|mesh-list
64862407|NCT01764867|Fluoxetine|fluoxetine|mesh-list
64862408|NCT01764867|Paroxetine|paroxetine|mesh-list
64862409|NCT01764867|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64862410|NCT01764867|Sertraline|sertraline|mesh-list
64862411|NCT01764867|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64862412|NCT01764867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64862413|NCT01764867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64862414|NCT01764867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862415|NCT01764867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64862416|NCT01764867|Serotonin Agents|serotonin agents|mesh-ancestor
64862432|NCT01764867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64862446|NCT01764867|Adrenergic Agents|adrenergic agents|mesh-ancestor
64862447|NCT01764867|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64862448|NCT01764867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64862449|NCT01764867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64862450|NCT01764867|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64862451|NCT01764867|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64862452|NCT01764893|Solifenacin Succinate|solifenacin succinate|mesh-list
64862453|NCT01764893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64862454|NCT01764893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64862455|NCT01764893|Cholinergic Agents|cholinergic agents|mesh-ancestor
64862456|NCT01764893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64862457|NCT01764893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862458|NCT01764893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862459|NCT01764893|Urological Agents|urological agents|mesh-ancestor
64862460|NCT01765010|Cholecalciferol|cholecalciferol|mesh-list
64862461|NCT01765010|Vitamin D|vitamin d|mesh-list
64862462|NCT01765010|Calcitriol|calcitriol|mesh-list
64862463|NCT01765010|Alfacalcidol|alfacalcidol|mesh-list
64862464|NCT01765010|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
64862465|NCT01765010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64862466|NCT01765010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862467|NCT01765010|Vitamins|vitamins|mesh-ancestor
64862468|NCT01765010|Micronutrients|micronutrients|mesh-ancestor
64862469|NCT01765010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64862470|NCT01765010|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64862471|NCT01765010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64862472|NCT01765010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473071|NCT01531582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64473072|NCT01531582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64473073|NCT01531582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473074|NCT01531582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473075|NCT01512888|Busulfan|busulfan|mesh-list
64473076|NCT01512888|Alkylating Agents|alkylating agents|mesh-ancestor
64473077|NCT01512888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473078|NCT01512888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64473079|NCT01512888|Immunologic Factors|immunologic factors|mesh-ancestor
64862481|NCT01765023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862482|NCT01765023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64862483|NCT01765023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64862509|NCT01765374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862510|NCT01765374|Immunologic Factors|immunologic factors|mesh-ancestor
64862511|NCT01765374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862512|NCT01765374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64862514|NCT01765452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64862515|NCT01765452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64862516|NCT01765452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64862517|NCT01765452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64862518|NCT01765452|Purinergic Agents|purinergic agents|mesh-ancestor
64862519|NCT01765452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64862520|NCT01765452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862521|NCT01765452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862522|NCT01765556|Ketoconazole|ketoconazole|mesh-list
64862523|NCT01765556|Vemurafenib|vemurafenib|mesh-list
64862524|NCT01765556|Antifungal Agents|antifungal agents|mesh-ancestor
64862525|NCT01765556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64862526|NCT01765556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64862527|NCT01765556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64862528|NCT01765556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64408370|NCT02640157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64862566|NCT01765829|Pimozide|pimozide|mesh-list
64862567|NCT01765829|Olanzapine|olanzapine|mesh-list
64862568|NCT01765829|Chlorpromazine|chlorpromazine|mesh-list
64862569|NCT01765829|Trifluoperazine|trifluoperazine|mesh-list
64862570|NCT01765829|Risperidone|risperidone|mesh-list
64862571|NCT01765829|Aripiprazole|aripiprazole|mesh-list
64862572|NCT01765829|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64862573|NCT01765829|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64862574|NCT01765829|Ziprasidone|ziprasidone|mesh-list
64862575|NCT01765829|Antipsychotic Agents|antipsychotic agents|mesh-list
64862576|NCT01765829|Clozapine|clozapine|mesh-list
64862577|NCT01765829|Asenapine|asenapine|mesh-list
64862578|NCT01765829|Amisulpride|amisulpride|mesh-list
64862579|NCT01765829|Perphenazine|perphenazine|mesh-list
64862580|NCT01765829|Sertindole|sertindole|mesh-list
64862581|NCT01765829|Sulpiride|sulpiride|mesh-list
64862582|NCT01765829|Clopenthixol|clopenthixol|mesh-list
64862583|NCT01765829|Clothiapine|clothiapine|mesh-list
64862584|NCT01765829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64862585|NCT01765829|Serotonin Agents|serotonin agents|mesh-ancestor
64862586|NCT01765829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64862587|NCT01765829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862588|NCT01765829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473080|NCT01512888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862589|NCT01765829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64862591|NCT01765829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64862620|NCT01765855|Antithrombins|antithrombins|mesh-ancestor
64862621|NCT01765855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64862622|NCT01765855|Protease Inhibitors|protease inhibitors|mesh-ancestor
64862623|NCT01765855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862624|NCT01765855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862625|NCT01765855|Anticoagulants|anticoagulants|mesh-ancestor
64862626|NCT01765868|Betrixaban|betrixaban|mesh-list
64862627|NCT01765868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64862628|NCT01765868|Antithrombins|antithrombins|mesh-ancestor
64862629|NCT01765868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64862630|NCT01765868|Protease Inhibitors|protease inhibitors|mesh-ancestor
64862631|NCT01765868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862632|NCT01765868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862633|NCT01765868|Anticoagulants|anticoagulants|mesh-ancestor
64862634|NCT01765881|Misoprostol|misoprostol|mesh-list
64862635|NCT01765881|Dinoprostone|dinoprostone|mesh-list
64862636|NCT01765881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64862637|NCT01765881|Abortifacient Agents|abortifacient agents|mesh-ancestor
64862638|NCT01765881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64862639|NCT01765881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862640|NCT01765881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64862641|NCT01765881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64862642|NCT01765881|Oxytocics|oxytocics|mesh-ancestor
64862643|NCT01765946|Metformin|metformin|mesh-list
64862644|NCT01765946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64862645|NCT01765946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862646|NCT01766063|Interferons|interferons|mesh-list
64862647|NCT01766063|Interferon-beta|interferon-beta|mesh-list
64862648|NCT01766063|Interferon beta-1b|interferon beta-1b|mesh-list
64862649|NCT01766063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862650|NCT01766063|Antiviral Agents|antiviral agents|mesh-ancestor
64862651|NCT01766063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64862652|NCT01766063|Immunologic Factors|immunologic factors|mesh-ancestor
64862656|NCT01766089|Remifentanil|remifentanil|mesh-list
64862663|NCT01766089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64862664|NCT01766089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65494937|NCT05418244|Ondansetron|ondansetron|mesh-list
64576125|NCT00078715|Yohimbine|yohimbine|mesh-list
64862665|NCT01766089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64862666|NCT01766089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64862667|NCT01766089|Adrenergic Agents|adrenergic agents|mesh-ancestor
64862668|NCT01766089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64862669|NCT01766089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862670|NCT01766089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64862671|NCT01766089|Narcotics|narcotics|mesh-ancestor
64862672|NCT01766154|Tirofiban|tirofiban|mesh-list
64862673|NCT01766154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64862674|NCT01766154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64862675|NCT01766154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862676|NCT01766154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64862677|NCT01766180|Resveratrol|resveratrol|mesh-list
64862678|NCT01766180|Antioxidants|antioxidants|mesh-ancestor
64862679|NCT01766180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862680|NCT01766180|Protective Agents|protective agents|mesh-ancestor
64862681|NCT01766180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862682|NCT01766180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862683|NCT01766180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64862684|NCT01766258|Carbidopa|carbidopa|mesh-list
64862685|NCT01766258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64862723|NCT01766375|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64862724|NCT01766375|Antitubercular Agents|antitubercular agents|mesh-ancestor
64862725|NCT01766375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64862726|NCT01766414|Complement C1s|complement c1s|mesh-list
64862727|NCT01766414|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64862728|NCT01766414|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
64862729|NCT01766414|Immunologic Factors|immunologic factors|mesh-ancestor
64862730|NCT01766414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862731|NCT01766414|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64862732|NCT01766414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64862733|NCT01766518|Mycophenolic Acid|mycophenolic acid|mesh-list
64862734|NCT01766518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64862735|NCT01766518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862736|NCT01766518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64862737|NCT01766518|Antitubercular Agents|antitubercular agents|mesh-ancestor
64862738|NCT01766518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64862739|NCT01766518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64862740|NCT01766518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862741|NCT01766518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862742|NCT01766583|Lenalidomide|lenalidomide|mesh-list
64862743|NCT01766583|Immunologic Factors|immunologic factors|mesh-ancestor
64862744|NCT01766583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862745|NCT01766583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64862747|NCT01766583|Growth Substances|growth substances|mesh-ancestor
64862788|NCT01766960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64862789|NCT01767025|Oxytocin|oxytocin|mesh-list
64862790|NCT01767025|Oxytocics|oxytocics|mesh-ancestor
64862791|NCT01767025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64862792|NCT01767025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862793|NCT01767090|Leuprolide|leuprolide|mesh-list
64862794|NCT01767090|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64862795|NCT01767090|Fertility Agents|fertility agents|mesh-ancestor
64862796|NCT01767090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64862797|NCT01767090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862798|NCT01767090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64862799|NCT01767090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862800|NCT01767259|Valsartan|valsartan|mesh-list
64862801|NCT01767259|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64862820|NCT01767298|Valsartan|valsartan|mesh-list
64862850|NCT01767402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862851|NCT01767428|Acetaminophen|acetaminophen|mesh-list
64862852|NCT01767428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64862853|NCT01767428|Analgesics|analgesics|mesh-ancestor
64862854|NCT01767428|Sensory System Agents|sensory system agents|mesh-ancestor
64862855|NCT01767428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64862856|NCT01767428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862857|NCT01767428|Antipyretics|antipyretics|mesh-ancestor
64862858|NCT01767454|Ipilimumab|ipilimumab|mesh-list
64862859|NCT01767454|Trametinib|trametinib|mesh-list
64862860|NCT01767454|Dabrafenib|dabrafenib|mesh-list
64862861|NCT01767454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64862862|NCT01767454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862863|NCT01767454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64862864|NCT01767454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862865|NCT01767454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64862866|NCT01767454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862867|NCT01767532|Cephalexin|cephalexin|mesh-list
64862868|NCT01767532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64862869|NCT01767532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64862870|NCT01767545|Dexamethasone|dexamethasone|mesh-list
64862871|NCT01767545|Bevacizumab|bevacizumab|mesh-list
64862878|NCT01767545|Growth Inhibitors|growth inhibitors|mesh-ancestor
64862879|NCT01767545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64862880|NCT01767545|Antiemetics|antiemetics|mesh-ancestor
64862881|NCT01767545|Autonomic Agents|autonomic agents|mesh-ancestor
64862882|NCT01767545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64862888|NCT01767571|Cephalexin|cephalexin|mesh-list
64862907|NCT01767623|Vemurafenib|vemurafenib|mesh-list
64862908|NCT01767623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862909|NCT01767623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64862910|NCT01767623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862911|NCT01767623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862912|NCT01767714|Plerixafor|plerixafor|mesh-list
64862913|NCT01767714|Lenograstim|lenograstim|mesh-list
64862914|NCT01767714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64862915|NCT01767714|Immunologic Factors|immunologic factors|mesh-ancestor
64862916|NCT01767714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862917|NCT01767714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64862918|NCT01767714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64862919|NCT01767714|Antiviral Agents|antiviral agents|mesh-ancestor
64862920|NCT01767714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64862921|NCT01767896|Vaccines|vaccines|mesh-list
64862922|NCT01767896|Immunologic Factors|immunologic factors|mesh-ancestor
64862923|NCT01767896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862925|NCT01768039|Vitamins|vitamins|mesh-ancestor
64862972|NCT01768260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64862973|NCT01768260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862974|NCT01768260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64862975|NCT01768260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64862976|NCT01768260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64862977|NCT01768260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64862978|NCT01768260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862979|NCT01768260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64862980|NCT01768260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64862981|NCT01768260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862982|NCT01768260|Antipyretics|antipyretics|mesh-ancestor
64862983|NCT01768273|Midazolam|midazolam|mesh-list
64862984|NCT01768273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64863038|NCT01768351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863039|NCT01768351|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64863040|NCT01768351|Vitamins|vitamins|mesh-ancestor
64863041|NCT01768351|Micronutrients|micronutrients|mesh-ancestor
64863042|NCT01768351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64863043|NCT01768364|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64863044|NCT01768364|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64863045|NCT01768364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863046|NCT01768364|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64863047|NCT01768364|Renal Agents|renal agents|mesh-ancestor
64863048|NCT01768364|Antimalarials|antimalarials|mesh-ancestor
64863049|NCT01768364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64863050|NCT01768364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64863051|NCT01768377|Lidocaine|lidocaine|mesh-list
64863052|NCT01768377|Fentanyl|fentanyl|mesh-list
64863053|NCT01768377|Midazolam|midazolam|mesh-list
64863054|NCT01768377|Anesthetics, Local|anesthetics, local|mesh-ancestor
64863055|NCT01768377|Anesthetics|anesthetics|mesh-ancestor
64863057|NCT01768377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863114|NCT01768663|Hormone Antagonists|hormone antagonists|mesh-ancestor
64863115|NCT01768663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64863116|NCT01768663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863117|NCT01768663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64863118|NCT01768663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64863119|NCT01768663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64863120|NCT01768663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64863121|NCT01768663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863122|NCT01768663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64863123|NCT01768663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64863124|NCT01768663|Antitubercular Agents|antitubercular agents|mesh-ancestor
64863125|NCT01768663|Leprostatic Agents|leprostatic agents|mesh-ancestor
64863449|NCT01770132|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64863450|NCT01770171|Paclitaxel|paclitaxel|mesh-list
64863451|NCT01770171|Bevacizumab|bevacizumab|mesh-list
64863452|NCT01770171|Carboplatin|carboplatin|mesh-list
64863453|NCT01770171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64863454|NCT01770171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863455|NCT01770171|Tubulin Modulators|tubulin modulators|mesh-ancestor
64863456|NCT01770171|Antimitotic Agents|antimitotic agents|mesh-ancestor
64863457|NCT01770171|Mitosis Modulators|mitosis modulators|mesh-ancestor
64863458|NCT01770171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863459|NCT01770171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64863515|NCT01770470|Chitosan|chitosan|mesh-list
64863533|NCT01770600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64863534|NCT01770600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64863535|NCT01770600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64863536|NCT01770600|Dopamine Agents|dopamine agents|mesh-ancestor
64863537|NCT01770769|Cloxacillin|cloxacillin|mesh-list
64863538|NCT01770769|Cephalothin|cephalothin|mesh-list
64863539|NCT01770769|Dalteparin|dalteparin|mesh-list
64863540|NCT01770769|Tinzaparin|tinzaparin|mesh-list
64863541|NCT01770769|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64863542|NCT01770769|Anticoagulants|anticoagulants|mesh-ancestor
64863543|NCT01770769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64863544|NCT01770769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64863545|NCT01770769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863546|NCT01770769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64863547|NCT01770769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863548|NCT01770795|Gemcitabine|gemcitabine|mesh-list
64863549|NCT01770795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64863550|NCT01770795|Antimetabolites|antimetabolites|mesh-ancestor
64863700|NCT01771874|Adrenergic Agents|adrenergic agents|mesh-ancestor
64863701|NCT01771978|Diltiazem|diltiazem|mesh-list
64863702|NCT01771978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64863703|NCT01771978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64863704|NCT01771978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64863705|NCT01771978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863706|NCT01771978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64863707|NCT01771978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863708|NCT01771978|Vasodilator Agents|vasodilator agents|mesh-ancestor
64863709|NCT01772056|Fluticasone|fluticasone|mesh-list
64863710|NCT01772056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64863711|NCT01772056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64863712|NCT01772056|Autonomic Agents|autonomic agents|mesh-ancestor
64863713|NCT01772056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64863714|NCT01772056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863715|NCT01772056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64863716|NCT01772056|Respiratory System Agents|respiratory system agents|mesh-ancestor
64863717|NCT01772056|Dermatologic Agents|dermatologic agents|mesh-ancestor
64863718|NCT01772056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64863719|NCT01772212|Terbinafine|terbinafine|mesh-list
64864066|NCT01774838|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64864067|NCT01774838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64864068|NCT01774838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64864069|NCT01774838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64864070|NCT01774838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64864071|NCT01774838|Purinergic Agents|purinergic agents|mesh-ancestor
64864072|NCT01774838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64864073|NCT01774838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864074|NCT01774838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864075|NCT01774864|Udenafil|udenafil|mesh-list
64864076|NCT01774864|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64864077|NCT01774864|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64864078|NCT01774864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64864232|NCT01776671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64864233|NCT01776671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64473087|NCT01493453|Immunologic Factors|immunologic factors|mesh-ancestor
64864279|NCT01777100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64864280|NCT01777100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64864281|NCT01777100|Anesthetics, General|anesthetics, general|mesh-ancestor
64864282|NCT01777100|Anesthetics|anesthetics|mesh-ancestor
64864283|NCT01777347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64864284|NCT01777464|Histamine|histamine|mesh-list
64864285|NCT01777464|Histamine Agonists|histamine agonists|mesh-ancestor
64864286|NCT01777464|Histamine Agents|histamine agents|mesh-ancestor
64864287|NCT01777464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64864288|NCT01777464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864321|NCT01777685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864322|NCT01777685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64864323|NCT01777685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64864324|NCT01777685|Dopamine Agents|dopamine agents|mesh-ancestor
64864325|NCT01777685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64864326|NCT01777685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864327|NCT01777685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64864328|NCT01777685|Antidepressive Agents|antidepressive agents|mesh-ancestor
64864402|NCT01778218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864404|NCT01778218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64864405|NCT01778244|Metformin|metformin|mesh-list
64864406|NCT01778244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64864407|NCT01778244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864408|NCT01778283|Dialysis Solutions|dialysis solutions|mesh-list
64864409|NCT01778283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64864410|NCT01778309|Acetylcysteine|acetylcysteine|mesh-list
64864411|NCT01778309|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64864412|NCT01778309|Antiviral Agents|antiviral agents|mesh-ancestor
64864413|NCT01778309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64864428|NCT01778413|Emtricitabine|emtricitabine|mesh-list
64864429|NCT01778413|Efavirenz|efavirenz|mesh-list
64864430|NCT01778413|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64864431|NCT01778413|Antiviral Agents|antiviral agents|mesh-ancestor
64864432|NCT01778413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64864433|NCT01778413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64864434|NCT01778413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64864435|NCT01778413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64864436|NCT01778413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864437|NCT01778413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64864438|NCT01778413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64864439|NCT01778413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64864440|NCT01778413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64864441|NCT01778413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64864442|NCT01778413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64864443|NCT01778413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64864444|NCT01778413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64864445|NCT01778647|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
64864446|NCT01778647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864447|NCT01778686|Pindolol|pindolol|mesh-list
64864448|NCT01778686|Citalopram|citalopram|mesh-list
64864545|NCT01779401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64864546|NCT01779401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64864547|NCT01779401|Antipyretics|antipyretics|mesh-ancestor
64864548|NCT01779401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64864549|NCT01779401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64864550|NCT01779401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64864551|NCT01779401|Purinergic Agents|purinergic agents|mesh-ancestor
65494947|NCT05418244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64864552|NCT01779401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64864553|NCT01779401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64864554|NCT01779401|Autonomic Agents|autonomic agents|mesh-ancestor
64864608|NCT01779687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64864609|NCT01779687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64864612|NCT01779687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64864613|NCT01779687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64864615|NCT01779830|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64864616|NCT01779830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64864617|NCT01779830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64864618|NCT01779830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864619|NCT01779830|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64864620|NCT01779830|GABA Agonists|gaba agonists|mesh-ancestor
64864621|NCT01779830|GABA Agents|gaba agents|mesh-ancestor
64864622|NCT01779830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64864623|NCT01779830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864624|NCT01779843|Cytarabine|cytarabine|mesh-list
64864803|NCT01780753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64864804|NCT01780753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64864805|NCT01780753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64864806|NCT01780883|Melatonin|melatonin|mesh-list
64864807|NCT01780883|Antioxidants|antioxidants|mesh-ancestor
64864808|NCT01780883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864810|NCT01780883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864811|NCT01780883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64864812|NCT01780909|Paromomycin|paromomycin|mesh-list
64864813|NCT01780909|Domperidone|domperidone|mesh-list
64864814|NCT01780909|Loperamide|loperamide|mesh-list
64864815|NCT01780909|Antidiarrheals|antidiarrheals|mesh-list
64864816|NCT01780909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64864817|NCT01780909|Antiemetics|antiemetics|mesh-ancestor
64864818|NCT01780909|Autonomic Agents|autonomic agents|mesh-ancestor
64864819|NCT01780909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64864820|NCT01780909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864821|NCT01780909|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64864822|NCT01780909|Dopamine Agents|dopamine agents|mesh-ancestor
64864823|NCT01780909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64864824|NCT01780909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864825|NCT01780909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64864826|NCT01780909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64864827|NCT01780909|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64864828|NCT01780909|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64864829|NCT01780948|Everolimus|everolimus|mesh-list
64864830|NCT01780948|Atorvastatin|atorvastatin|mesh-list
64864831|NCT01780948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64864832|NCT01780948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64864833|NCT01780948|Antimetabolites|antimetabolites|mesh-ancestor
64864834|NCT01780948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864835|NCT01780948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64864836|NCT01780948|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64864837|NCT01780948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64864838|NCT01780948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409395|NCT03074773|Dexamethasone|dexamethasone|mesh-list
64864845|NCT01781273|Ethanol|ethanol|mesh-list
64864846|NCT01781273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64864847|NCT01781273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64864848|NCT01781273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64864849|NCT01781273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864850|NCT01781377|Metoclopramide|metoclopramide|mesh-list
64864851|NCT01781377|Propofol|propofol|mesh-list
64864852|NCT01781377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64864853|NCT01781377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64864854|NCT01781377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864855|NCT01781377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64864856|NCT01781377|Anesthetics, General|anesthetics, general|mesh-ancestor
64864857|NCT01781377|Anesthetics|anesthetics|mesh-ancestor
64864858|NCT01781377|Antiemetics|antiemetics|mesh-ancestor
64864859|NCT01781377|Autonomic Agents|autonomic agents|mesh-ancestor
64864860|NCT01781377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64864861|NCT01781377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64864862|NCT01781377|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64864900|NCT01781702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864901|NCT01781871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64864903|NCT01781871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864904|NCT01781884|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
64864905|NCT01781884|GABA Agents|gaba agents|mesh-ancestor
64864906|NCT01781884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64864907|NCT01781884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864908|NCT01781884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864909|NCT01781897|Mosapride|mosapride|mesh-list
64864910|NCT01781897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64864911|NCT01781897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64864912|NCT01781897|Serotonin Agents|serotonin agents|mesh-ancestor
64864913|NCT01781897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64864919|NCT01781936|Hormones|hormones|mesh-ancestor
64473090|NCT01493453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64473091|NCT01493453|Alkylating Agents|alkylating agents|mesh-ancestor
64473092|NCT01493453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473093|NCT01493453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473094|NCT01493453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64864920|NCT01781936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64864921|NCT01781936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864923|NCT01781988|Carboplatin|carboplatin|mesh-list
64864924|NCT01781988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64864925|NCT01781988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64864926|NCT01781988|Antimetabolites|antimetabolites|mesh-ancestor
64864927|NCT01781988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864928|NCT01781988|Antiviral Agents|antiviral agents|mesh-ancestor
64864929|NCT01781988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64864930|NCT01781988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64864931|NCT01781988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64864932|NCT01781988|Immunologic Factors|immunologic factors|mesh-ancestor
64864933|NCT01781988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864934|NCT01782001|Vitamins|vitamins|mesh-list
64864935|NCT01782001|Vitamin A|vitamin a|mesh-list
64864936|NCT01782001|Retinol palmitate|retinol palmitate|mesh-list
64864974|NCT01782508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64864975|NCT01782508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865027|NCT01782781|Respiratory System Agents|respiratory system agents|mesh-ancestor
64865028|NCT01782781|Mydriatics|mydriatics|mesh-ancestor
64865029|NCT01782781|Sympathomimetics|sympathomimetics|mesh-ancestor
64865030|NCT01782781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64865031|NCT01782846|Codeine|codeine|mesh-list
64865032|NCT01782846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64865033|NCT01782846|Narcotics|narcotics|mesh-ancestor
64865034|NCT01782846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64865035|NCT01782846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865036|NCT01782846|Analgesics|analgesics|mesh-ancestor
64865192|NCT01784107|Ifosfamide|ifosfamide|mesh-list
64865283|NCT01784549|Vinorelbine|vinorelbine|mesh-list
64865284|NCT01784549|Gefitinib|gefitinib|mesh-list
64865285|NCT01784549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865286|NCT01784549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64865287|NCT01784549|Antimetabolites|antimetabolites|mesh-ancestor
64865288|NCT01784549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865289|NCT01784549|Antiviral Agents|antiviral agents|mesh-ancestor
64865290|NCT01784549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64865291|NCT01784549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865292|NCT01784549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64865293|NCT01784549|Immunologic Factors|immunologic factors|mesh-ancestor
64865294|NCT01784549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865295|NCT01784549|Tubulin Modulators|tubulin modulators|mesh-ancestor
64865296|NCT01784549|Antimitotic Agents|antimitotic agents|mesh-ancestor
64865297|NCT01784549|Mitosis Modulators|mitosis modulators|mesh-ancestor
64865298|NCT01784549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64865299|NCT01784549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64865333|NCT01784978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865334|NCT01785004|Vitamin D|vitamin d|mesh-list
64865335|NCT01785004|Cholecalciferol|cholecalciferol|mesh-list
64865336|NCT01785004|Vitamins|vitamins|mesh-ancestor
64865337|NCT01785004|Micronutrients|micronutrients|mesh-ancestor
64865338|NCT01785004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865339|NCT01785004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64865340|NCT01785004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64409534|NCT04807829|Nabilone|nabilone|mesh-list
64865358|NCT01785043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64865359|NCT01785043|Protease Inhibitors|protease inhibitors|mesh-ancestor
64865360|NCT01785043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865361|NCT01785043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865362|NCT01785056|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64865363|NCT01785056|Immunologic Factors|immunologic factors|mesh-ancestor
64865364|NCT01785056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865365|NCT01785108|Vitamin D|vitamin d|mesh-list
64865366|NCT01785108|Ibuprofen|ibuprofen|mesh-list
64865367|NCT01785108|Aluminum sulfate|aluminum sulfate|mesh-list
64865368|NCT01785108|Vitamins|vitamins|mesh-ancestor
64865369|NCT01785108|Micronutrients|micronutrients|mesh-ancestor
64865370|NCT01785108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865371|NCT01785108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64865372|NCT01785108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64865373|NCT01785108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64865374|NCT01785108|Analgesics|analgesics|mesh-ancestor
64865375|NCT01785108|Sensory System Agents|sensory system agents|mesh-ancestor
64865376|NCT01785108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865377|NCT01785108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64865378|NCT01785108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64865379|NCT01785108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64865380|NCT01785108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865381|NCT01785108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865382|NCT01785108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64865383|NCT01785108|Immunologic Factors|immunologic factors|mesh-ancestor
64865384|NCT01785290|Haloperidol|haloperidol|mesh-list
64865385|NCT01785290|Haloperidol decanoate|haloperidol decanoate|mesh-list
64865386|NCT01785290|Antiemetics|antiemetics|mesh-ancestor
64865387|NCT01785290|Autonomic Agents|autonomic agents|mesh-ancestor
64865390|NCT01785290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64865487|NCT01785836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865488|NCT01785836|Leprostatic Agents|leprostatic agents|mesh-ancestor
64865489|NCT01785836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64865490|NCT01785862|Ibuprofen|ibuprofen|mesh-list
64865491|NCT01785862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64865492|NCT01785862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64865493|NCT01785862|Analgesics|analgesics|mesh-ancestor
64865494|NCT01785862|Sensory System Agents|sensory system agents|mesh-ancestor
64865495|NCT01785862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865496|NCT01785862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865497|NCT01785862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64865498|NCT01785862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64865499|NCT01785862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64865500|NCT01785862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865501|NCT01785862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473096|NCT01208662|Lenalidomide|lenalidomide|mesh-list
64473097|NCT01208662|Bortezomib|bortezomib|mesh-list
64865502|NCT01785979|Chloroquine|chloroquine|mesh-list
64865503|NCT01785979|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64865504|NCT01785979|Prednisone|prednisone|mesh-list
64865505|NCT01785979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64865589|NCT01786226|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64865590|NCT01786226|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64865591|NCT01786226|Hormone Antagonists|hormone antagonists|mesh-ancestor
64865592|NCT01786226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64865593|NCT01786226|Luteolytic Agents|luteolytic agents|mesh-ancestor
64865594|NCT01786226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64865595|NCT01786226|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64865596|NCT01786382|Midazolam|midazolam|mesh-list
64865597|NCT01786382|Omeprazole|omeprazole|mesh-list
64865743|NCT01787669|Antiemetics|antiemetics|mesh-ancestor
64865797|NCT01788254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64865798|NCT01788254|Narcotics|narcotics|mesh-ancestor
64865799|NCT01788254|Analgesics|analgesics|mesh-ancestor
64865800|NCT01788254|Sensory System Agents|sensory system agents|mesh-ancestor
64865801|NCT01788254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865802|NCT01788254|Antitussive Agents|antitussive agents|mesh-ancestor
64865803|NCT01788254|Respiratory System Agents|respiratory system agents|mesh-ancestor
64865804|NCT01788254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64865805|NCT01788254|Diuretics|diuretics|mesh-ancestor
64865806|NCT01788254|Natriuretic Agents|natriuretic agents|mesh-ancestor
64866233|NCT01796132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64866692|NCT01802593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866693|NCT01802593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866694|NCT01802593|Dermatologic Agents|dermatologic agents|mesh-ancestor
64866695|NCT01802593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866696|NCT01802593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64866697|NCT01802593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64866698|NCT01802593|Immunologic Factors|immunologic factors|mesh-ancestor
64866699|NCT01802593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64866700|NCT01802593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64866701|NCT01802619|Nitric Oxide|nitric oxide|mesh-list
64866702|NCT01802619|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64866703|NCT01802619|Autonomic Agents|autonomic agents|mesh-ancestor
64867040|NCT01805258|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64867041|NCT01805258|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64867042|NCT01805258|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64867043|NCT01805258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64867044|NCT01805258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64867045|NCT01805310|Magnesium citrate|magnesium citrate|mesh-list
64867046|NCT01805310|Cathartics|cathartics|mesh-ancestor
64867047|NCT01805310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64867048|NCT01805388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64867339|NCT01809886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64867340|NCT01809925|Psyllium|psyllium|mesh-list
64867341|NCT01809925|Calcium polycarbophil|calcium polycarbophil|mesh-list
65494955|NCT05418166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65494956|NCT05418166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64867342|NCT01809925|Cathartics|cathartics|mesh-ancestor
64867343|NCT01809925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64867344|NCT01809925|Antidiarrheals|antidiarrheals|mesh-ancestor
64867345|NCT01810185|Naltrexone|naltrexone|mesh-list
64867346|NCT01810185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64867347|NCT01810185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64867484|NCT01810926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64867485|NCT01810926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867486|NCT01810926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64867487|NCT01810926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64867488|NCT01810926|Abortifacient Agents|abortifacient agents|mesh-ancestor
64867489|NCT01810926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64867490|NCT01810926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64867491|NCT01810926|Antimetabolites|antimetabolites|mesh-ancestor
64867492|NCT01810926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867493|NCT01810926|Dermatologic Agents|dermatologic agents|mesh-ancestor
64867494|NCT01810926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867495|NCT01810926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64867496|NCT01810926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64867636|NCT01812122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867637|NCT01812122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64867775|NCT01812954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64867776|NCT01812954|Abortifacient Agents|abortifacient agents|mesh-ancestor
64867777|NCT01812954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64867778|NCT01812954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867779|NCT01812954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64867780|NCT01812954|Antimetabolites|antimetabolites|mesh-ancestor
64867781|NCT01812954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867782|NCT01812954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867783|NCT01812954|Dermatologic Agents|dermatologic agents|mesh-ancestor
64867784|NCT01812954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867785|NCT01812954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64867786|NCT01812954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64867787|NCT01812954|Immunologic Factors|immunologic factors|mesh-ancestor
64867822|NCT01813162|Antifungal Agents|antifungal agents|mesh-ancestor
64867823|NCT01813201|Methyltestosterone|methyltestosterone|mesh-list
64867824|NCT01813201|Testosterone|testosterone|mesh-list
64867825|NCT01813201|Testosterone undecanoate|testosterone undecanoate|mesh-list
64867826|NCT01813201|Testosterone enanthate|testosterone enanthate|mesh-list
64867827|NCT01813201|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64867828|NCT01813201|Androgens|androgens|mesh-ancestor
64867829|NCT01813201|Hormones|hormones|mesh-ancestor
64868008|NCT01814085|Antidepressive Agents|antidepressive agents|mesh-ancestor
64868009|NCT01814085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64868010|NCT01814098|Citalopram|citalopram|mesh-list
64868011|NCT01814098|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64868012|NCT01814098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64868013|NCT01814098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64868014|NCT01814098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868015|NCT01814098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64868016|NCT01814098|Serotonin Agents|serotonin agents|mesh-ancestor
64868017|NCT01814098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868021|NCT01814163|Paclitaxel|paclitaxel|mesh-list
64868028|NCT01814163|Mitosis Modulators|mitosis modulators|mesh-ancestor
64868029|NCT01814163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868030|NCT01814163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64868031|NCT01814163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64868032|NCT01814163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64868033|NCT01814163|Growth Substances|growth substances|mesh-ancestor
64868034|NCT01814163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868035|NCT01814163|Growth Inhibitors|growth inhibitors|mesh-ancestor
64868036|NCT01814189|Promethazine|promethazine|mesh-list
64868037|NCT01814189|Diphenhydramine|diphenhydramine|mesh-list
64868038|NCT01814189|Sumatriptan|sumatriptan|mesh-list
64868039|NCT01814189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64868040|NCT01814189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64868041|NCT01814189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64868042|NCT01814189|Serotonin Agents|serotonin agents|mesh-ancestor
64868043|NCT01814189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64868044|NCT01814189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868045|NCT01814189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868046|NCT01814189|Antipruritics|antipruritics|mesh-ancestor
64868047|NCT01814189|Dermatologic Agents|dermatologic agents|mesh-ancestor
64868048|NCT01814189|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64868049|NCT01814189|Histamine Antagonists|histamine antagonists|mesh-ancestor
64868050|NCT01814189|Histamine Agents|histamine agents|mesh-ancestor
64868051|NCT01814189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64868174|NCT01814709|Itraconazole|itraconazole|mesh-list
64868405|NCT01816412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868407|NCT01816490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64868408|NCT01816490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868409|NCT01816490|Protective Agents|protective agents|mesh-ancestor
64868410|NCT01816490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868411|NCT01816529|Diltiazem|diltiazem|mesh-list
64868412|NCT01816529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64868413|NCT01816529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64868414|NCT01816529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64868415|NCT01816529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868416|NCT01816529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65494957|NCT05418166|Antimetabolites|antimetabolites|mesh-ancestor
64473098|NCT01208662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64868417|NCT01816529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868418|NCT01816529|Vasodilator Agents|vasodilator agents|mesh-ancestor
64868419|NCT01816555|Vitamin D|vitamin d|mesh-list
64868420|NCT01816555|Vitamins|vitamins|mesh-ancestor
64868421|NCT01816555|Micronutrients|micronutrients|mesh-ancestor
64868422|NCT01816555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868423|NCT01816555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64868424|NCT01816581|Morphine|morphine|mesh-list
64868425|NCT01816581|Naloxone|naloxone|mesh-list
64868426|NCT01816581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64868427|NCT01816581|Narcotics|narcotics|mesh-ancestor
64868428|NCT01816581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64868429|NCT01816581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868464|NCT01816659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868465|NCT01816789|Buserelin|buserelin|mesh-list
64868466|NCT01816789|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64868467|NCT01816789|Fertility Agents|fertility agents|mesh-ancestor
64868468|NCT01816789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64868469|NCT01816789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868470|NCT01816958|Ketamine|ketamine|mesh-list
64868471|NCT01816958|Analgesics|analgesics|mesh-ancestor
64868472|NCT01816958|Sensory System Agents|sensory system agents|mesh-ancestor
64868499|NCT01817036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64409844|NCT04796675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64427652|NCT01618162|Liraglutide|liraglutide|mesh-list
64868501|NCT01817153|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64868502|NCT01817153|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64868503|NCT01817153|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64868504|NCT01817153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64868505|NCT01817218|Anti-Infective Agents|anti-infective agents|mesh-list
64868506|NCT01817218|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64868507|NCT01817257|Heparin|heparin|mesh-list
64868508|NCT01817257|Enoxaparin|enoxaparin|mesh-list
64868509|NCT01817257|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64868510|NCT01817257|Tinzaparin|tinzaparin|mesh-list
64868511|NCT01817257|Dalteparin|dalteparin|mesh-list
64868512|NCT01817257|Anticoagulants|anticoagulants|mesh-ancestor
64868513|NCT01817257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64868514|NCT01817257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64868515|NCT01817257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868516|NCT01817283|Triptolide|triptolide|mesh-list
64868517|NCT01817283|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
64868518|NCT01817283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868519|NCT01817283|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64868520|NCT01817283|Contraceptive Agents|contraceptive agents|mesh-ancestor
64868521|NCT01817283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64868575|NCT01817400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868576|NCT01817400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64868577|NCT01817400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64868578|NCT01817400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64868579|NCT01817400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64868580|NCT01817400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868581|NCT01817400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64868582|NCT01817400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64868583|NCT01817400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868584|NCT01817400|Antipyretics|antipyretics|mesh-ancestor
64868585|NCT01817400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64868596|NCT01817439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868597|NCT01817439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64868598|NCT01817439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64868599|NCT01817439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64868600|NCT01817699|Vitamin D|vitamin d|mesh-list
64868601|NCT01817699|Cholecalciferol|cholecalciferol|mesh-list
64868602|NCT01817699|Vitamins|vitamins|mesh-ancestor
64868603|NCT01817699|Micronutrients|micronutrients|mesh-ancestor
65494958|NCT05418166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473099|NCT01208662|Antiemetics|antiemetics|mesh-ancestor
64473100|NCT01208662|Autonomic Agents|autonomic agents|mesh-ancestor
64868604|NCT01817699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868605|NCT01817699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64868606|NCT01817699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64868607|NCT01817803|Metolazone|metolazone|mesh-list
64868608|NCT01817803|Furosemide|furosemide|mesh-list
64868609|NCT01817803|Spironolactone|spironolactone|mesh-list
64868610|NCT01817803|Diuretics|diuretics|mesh-ancestor
64868611|NCT01817803|Natriuretic Agents|natriuretic agents|mesh-ancestor
64868640|NCT01817868|Coagulants|coagulants|mesh-ancestor
64868641|NCT01817894|Eflornithine|eflornithine|mesh-list
64868642|NCT01817894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868643|NCT01817894|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64868644|NCT01817894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64868645|NCT01817894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64868646|NCT01817894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64868647|NCT01817894|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64868648|NCT01817894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868649|NCT01817894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868650|NCT01817972|Azathioprine|azathioprine|mesh-list
64868651|NCT01817972|Certolizumab Pegol|certolizumab pegol|mesh-list
64868652|NCT01817972|Antimetabolites|antimetabolites|mesh-ancestor
64868675|NCT01818648|Incretins|incretins|mesh-ancestor
64868676|NCT01818648|Hormones|hormones|mesh-ancestor
64868677|NCT01818648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64868678|NCT01818713|Doxorubicin|doxorubicin|mesh-list
64868679|NCT01818713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64868681|NCT01818713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868682|NCT01818713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64868683|NCT01818713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64868684|NCT01818713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868685|NCT01818713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868686|NCT01818843|Carbon Monoxide|carbon monoxide|mesh-list
64868687|NCT01818843|Antimetabolites|antimetabolites|mesh-ancestor
64868688|NCT01818843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868689|NCT01818843|Gasotransmitters|gasotransmitters|mesh-ancestor
64868690|NCT01818843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64868691|NCT01818843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868692|NCT01818856|Ritonavir|ritonavir|mesh-list
64868693|NCT01818856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64868694|NCT01818856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64868695|NCT01818856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64868696|NCT01818856|Protease Inhibitors|protease inhibitors|mesh-ancestor
64868697|NCT01818856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868698|NCT01818856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868699|NCT01818856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64868700|NCT01818856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64868812|NCT01819441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64868813|NCT01819441|Perindopril|perindopril|mesh-list
64868814|NCT01819441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64868815|NCT01819441|Diuretics|diuretics|mesh-ancestor
64868816|NCT01819441|Natriuretic Agents|natriuretic agents|mesh-ancestor
64868817|NCT01819441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868818|NCT01819441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64868819|NCT01819441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64868820|NCT01819441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868853|NCT01819779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64868854|NCT01819779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868855|NCT01819779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64868856|NCT01819779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868857|NCT01819779|Vasodilator Agents|vasodilator agents|mesh-ancestor
64501797|NCT03062943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410039|NCT05211609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64410040|NCT05211609|Sympatholytics|sympatholytics|mesh-ancestor
64868858|NCT01819779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64868859|NCT01819779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64868860|NCT01819857|Ondansetron|ondansetron|mesh-list
64868861|NCT01819857|Antiemetics|antiemetics|mesh-ancestor
64868862|NCT01819857|Autonomic Agents|autonomic agents|mesh-ancestor
64868863|NCT01819857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64868943|NCT01820312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868944|NCT01820325|Paclitaxel|paclitaxel|mesh-list
65494959|NCT05418166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65494960|NCT01631214|Alendronate|alendronate|mesh-list
64473101|NCT01208662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64868945|NCT01820325|Carboplatin|carboplatin|mesh-list
64868946|NCT01820325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64868947|NCT01820325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868948|NCT01820325|Tubulin Modulators|tubulin modulators|mesh-ancestor
64868949|NCT01820325|Antimitotic Agents|antimitotic agents|mesh-ancestor
64868950|NCT01820325|Mitosis Modulators|mitosis modulators|mesh-ancestor
64868951|NCT01820325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868952|NCT01820442|Lofexidine|lofexidine|mesh-list
64868953|NCT01820442|Clonidine|clonidine|mesh-list
64868954|NCT01820442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64868955|NCT01820442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64868956|NCT01820442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868957|NCT01820442|Sensory System Agents|sensory system agents|mesh-ancestor
64868974|NCT01820455|Dermatologic Agents|dermatologic agents|mesh-ancestor
64868975|NCT01820455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64868976|NCT01820455|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64868977|NCT01820455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868979|NCT01820624|Tretinoin|tretinoin|mesh-list
64868992|NCT01820767|Ergocalciferols|ergocalciferols|mesh-list
64868993|NCT01820767|Atorvastatin|atorvastatin|mesh-list
64868994|NCT01820767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64868995|NCT01820767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64868996|NCT01820767|Antimetabolites|antimetabolites|mesh-ancestor
64868997|NCT01820767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868998|NCT01820767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64868999|NCT01820767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64869000|NCT01820767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869001|NCT01820767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64869002|NCT01820767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869003|NCT01820767|Vitamins|vitamins|mesh-ancestor
64869004|NCT01820767|Micronutrients|micronutrients|mesh-ancestor
64869005|NCT01820767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64869006|NCT01820793|Cefoxitin|cefoxitin|mesh-list
64869007|NCT01820793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64869008|NCT01820793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64869009|NCT01820832|Cholecalciferol|cholecalciferol|mesh-list
64869010|NCT01820832|Calcitriol|calcitriol|mesh-list
64869011|NCT01820832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64869012|NCT01820832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869013|NCT01820832|Vitamins|vitamins|mesh-ancestor
64869014|NCT01820832|Micronutrients|micronutrients|mesh-ancestor
64869015|NCT01820832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64869016|NCT01820832|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64869047|NCT01820962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869093|NCT01821066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869094|NCT01821170|Methylphenidate|methylphenidate|mesh-list
64869095|NCT01821170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64869096|NCT01821170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869097|NCT01821170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64869098|NCT01821170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64869099|NCT01821170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64869124|NCT01821248|Antiviral Agents|antiviral agents|mesh-ancestor
64869125|NCT01821248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64869126|NCT01821248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869127|NCT01821248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64869128|NCT01821248|Immunologic Factors|immunologic factors|mesh-ancestor
64869129|NCT01821248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869130|NCT01821261|Chlorhexidine|chlorhexidine|mesh-list
64869131|NCT01821261|Fluorides|fluorides|mesh-list
64869132|NCT01821261|Cariostatic Agents|cariostatic agents|mesh-ancestor
64869133|NCT01821261|Protective Agents|protective agents|mesh-ancestor
64869134|NCT01821261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869135|NCT01821261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64869136|NCT01821261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64869137|NCT01821261|Disinfectants|disinfectants|mesh-ancestor
64869138|NCT01821274|Diltiazem|diltiazem|mesh-list
64869139|NCT01821274|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64869140|NCT01821274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64869146|NCT01821404|Atorvastatin|atorvastatin|mesh-list
64869187|NCT01821612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64869188|NCT01821612|Antimetabolites|antimetabolites|mesh-ancestor
64869189|NCT01821612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869190|NCT01821612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869191|NCT01821612|Antiviral Agents|antiviral agents|mesh-ancestor
64869192|NCT01821612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64869193|NCT01821612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869194|NCT01821612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64869195|NCT01821612|Immunologic Factors|immunologic factors|mesh-ancestor
64869196|NCT01821612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869197|NCT01821612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64869198|NCT01821612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64869199|NCT01821612|Antidotes|antidotes|mesh-ancestor
64869200|NCT01821612|Protective Agents|protective agents|mesh-ancestor
64869201|NCT01821612|Vitamin B Complex|vitamin b complex|mesh-ancestor
64869234|NCT01822028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869235|NCT01822028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869236|NCT01822028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64869237|NCT01822028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64869238|NCT01822028|Antiviral Agents|antiviral agents|mesh-ancestor
65494962|NCT01631214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64473102|NCT01208662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869239|NCT01822028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64869240|NCT01822028|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64869241|NCT01822028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64869242|NCT01822028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869244|NCT01822080|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64869245|NCT01822080|Contraceptive Agents|contraceptive agents|mesh-ancestor
64869274|NCT01822405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869275|NCT01822405|Vasodilator Agents|vasodilator agents|mesh-ancestor
64869276|NCT01822405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64869277|NCT01822405|Antioxidants|antioxidants|mesh-ancestor
64869278|NCT01822405|Vitamins|vitamins|mesh-ancestor
64869279|NCT01822405|Micronutrients|micronutrients|mesh-ancestor
64869286|NCT01822431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869287|NCT01822431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869288|NCT01822431|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64869289|NCT01822483|Mycophenolic Acid|mycophenolic acid|mesh-list
64869323|NCT01822639|Enalapril|enalapril|mesh-list
64869324|NCT01822639|Enalaprilat|enalaprilat|mesh-list
64869325|NCT01822639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64869326|NCT01822639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64869327|NCT01822639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64869328|NCT01822639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869329|NCT01822639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64869330|NCT01822639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869379|NCT01822951|Nootropic Agents|nootropic agents|mesh-ancestor
64869380|NCT01822951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64869381|NCT01822951|Protective Agents|protective agents|mesh-ancestor
64869382|NCT01822977|Omeprazole|omeprazole|mesh-list
64869383|NCT01822977|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64869384|NCT01822977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64869385|NCT01822977|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64869386|NCT01822977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869387|NCT01822977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869388|NCT01823029|Epoetin Alfa|epoetin alfa|mesh-list
64869389|NCT01823029|Hematinics|hematinics|mesh-ancestor
64869390|NCT01823042|Azathioprine|azathioprine|mesh-list
64869391|NCT01823042|Antimetabolites|antimetabolites|mesh-ancestor
64869392|NCT01823042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869508|NCT01824225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869509|NCT01824225|Growth Inhibitors|growth inhibitors|mesh-ancestor
64869510|NCT01824225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869511|NCT01824238|Oxazolidinones|oxazolidinones|mesh-list
64869512|NCT01824238|Anacetrapib|anacetrapib|mesh-list
64869513|NCT01824238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64869514|NCT01824238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64869515|NCT01824238|Antimetabolites|antimetabolites|mesh-ancestor
65494963|NCT01631214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494964|NCT01631214|Immunologic Factors|immunologic factors|mesh-ancestor
64869516|NCT01824238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869517|NCT01824238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64869518|NCT01824238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64869519|NCT01824238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64869520|NCT01824238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869522|NCT01824251|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64869523|NCT01824251|gamma-Globulins|gamma-globulins|mesh-list
64869524|NCT01824251|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64869813|NCT01826149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869815|NCT01826149|Anesthetics, General|anesthetics, general|mesh-ancestor
64869816|NCT01826149|Anesthetics|anesthetics|mesh-ancestor
64869817|NCT01826175|Clopidogrel|clopidogrel|mesh-list
64869818|NCT01826175|Ticagrelor|ticagrelor|mesh-list
64869819|NCT01826175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64869820|NCT01826175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64869821|NCT01826175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64869822|NCT01826175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64869823|NCT01826175|Purinergic Agents|purinergic agents|mesh-ancestor
64869824|NCT01826175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64869825|NCT01826175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869826|NCT01826175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869827|NCT01826253|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
64869828|NCT01826253|Plasma Substitutes|plasma substitutes|mesh-ancestor
64869829|NCT01826253|Blood Substitutes|blood substitutes|mesh-ancestor
64869830|NCT01826279|Resveratrol|resveratrol|mesh-list
64869834|NCT01826279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869835|NCT01826279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869836|NCT01826279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64869837|NCT01826396|Irinotecan|irinotecan|mesh-list
64869838|NCT01826396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64869839|NCT01826396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64869840|NCT01826396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869841|NCT01826396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869842|NCT01826396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869843|NCT01826526|Taurolidine|taurolidine|mesh-list
64869844|NCT01826526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64869845|NCT01826526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64869846|NCT01826526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869847|NCT01826747|Progesterone|progesterone|mesh-list
64869882|NCT01827020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64869883|NCT01827020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64869884|NCT01827020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64869885|NCT01827020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869886|NCT01827020|Analgesics|analgesics|mesh-ancestor
64869887|NCT01827020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64869913|NCT01827137|Growth Inhibitors|growth inhibitors|mesh-ancestor
64869914|NCT01827137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869915|NCT01827202|Candesartan|candesartan|mesh-list
64869916|NCT01827202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64869917|NCT01827202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64869918|NCT01827202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64869919|NCT01827202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869920|NCT01827228|HIV Antibodies|hiv antibodies|mesh-list
64869923|NCT01827280|Vildagliptin|vildagliptin|mesh-list
64577744|NCT00193375|Carboplatin|carboplatin|mesh-list
64869937|NCT01827293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869938|NCT01827293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64869966|NCT01827540|Dolutegravir|dolutegravir|mesh-list
64869967|NCT01827540|Cenicriviroc|cenicriviroc|mesh-list
64869968|NCT01827540|Midazolam|midazolam|mesh-list
64869969|NCT01827540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64869970|NCT01827540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64869971|NCT01827540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64869972|NCT01827540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869973|NCT01827540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64869974|NCT01827540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64869975|NCT01827540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64869976|NCT01827540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64869977|NCT01827540|Anesthetics, General|anesthetics, general|mesh-ancestor
64869978|NCT01827540|Anesthetics|anesthetics|mesh-ancestor
64869979|NCT01827540|GABA Modulators|gaba modulators|mesh-ancestor
64869980|NCT01827540|GABA Agents|gaba agents|mesh-ancestor
64869981|NCT01827540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64869982|NCT01827540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869983|NCT01827540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64869984|NCT01827540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64869985|NCT01827540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869986|NCT01827540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64869987|NCT01827540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64869988|NCT01827540|Antiviral Agents|antiviral agents|mesh-ancestor
64870069|NCT01828294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870071|NCT01828346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64870072|NCT01828346|Antimetabolites|antimetabolites|mesh-ancestor
64870073|NCT01828346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870074|NCT01828346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870075|NCT01828346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870076|NCT01828359|Losartan|losartan|mesh-list
64870077|NCT01828359|Amlodipine|amlodipine|mesh-list
64870078|NCT01828359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64870079|NCT01828359|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64870083|NCT01828359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870084|NCT01828359|Vasodilator Agents|vasodilator agents|mesh-ancestor
64870085|NCT01828359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64870086|NCT01828359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64870133|NCT01828489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870134|NCT01828489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870135|NCT01828489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870136|NCT01828489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64870137|NCT01828489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64870138|NCT01828489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870139|NCT01828489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870140|NCT01828606|Monensin|monensin|mesh-list
64870141|NCT01828606|Antifungal Agents|antifungal agents|mesh-ancestor
64870142|NCT01828606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64870143|NCT01828606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64870144|NCT01828606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64870145|NCT01828606|Coccidiostats|coccidiostats|mesh-ancestor
64870146|NCT01828606|Proton Ionophores|proton ionophores|mesh-ancestor
64870147|NCT01828606|Uncoupling Agents|uncoupling agents|mesh-ancestor
64870148|NCT01828606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870149|NCT01828606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870150|NCT01828606|Ionophores|ionophores|mesh-ancestor
64870151|NCT01828606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64870152|NCT01828606|Sodium Ionophores|sodium ionophores|mesh-ancestor
64870153|NCT01828736|Gemcitabine|gemcitabine|mesh-list
64870154|NCT01828736|Cisplatin|cisplatin|mesh-list
64870340|NCT01832311|Sensory System Agents|sensory system agents|mesh-ancestor
64870341|NCT01832311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870387|NCT01834820|Epinephrine|epinephrine|mesh-list
64870388|NCT01834820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64870389|NCT01834820|Antiemetics|antiemetics|mesh-ancestor
64870390|NCT01834820|Autonomic Agents|autonomic agents|mesh-ancestor
64870391|NCT01834820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870392|NCT01834820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870393|NCT01834820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64870394|NCT01834820|Glucocorticoids|glucocorticoids|mesh-ancestor
64870395|NCT01834820|Hormones|hormones|mesh-ancestor
64870396|NCT01834820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64870397|NCT01834820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64870398|NCT01834820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870399|NCT01834820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64870400|NCT01834820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64870401|NCT01834820|Adrenergic Agents|adrenergic agents|mesh-ancestor
64870402|NCT01834820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64870403|NCT01834820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870404|NCT01834820|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64870405|NCT01834820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64870406|NCT01834820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64870466|NCT01837290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64870468|NCT01837290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64870469|NCT01837290|Adrenergic Agents|adrenergic agents|mesh-ancestor
64870470|NCT01837290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64870471|NCT01837290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870472|NCT01837290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64870473|NCT01837290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64870474|NCT01837290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64870475|NCT01837290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64870581|NCT01840449|Lanreotide|lanreotide|mesh-list
64870621|NCT01840813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870622|NCT01840813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64870623|NCT01840813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64870667|NCT01841242|Povidone-Iodine|povidone-iodine|mesh-list
64870668|NCT01841242|Povidone|povidone|mesh-list
64870669|NCT01841242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64870670|NCT01841242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64870671|NCT01841242|Disinfectants|disinfectants|mesh-ancestor
64870672|NCT01841242|Plasma Substitutes|plasma substitutes|mesh-ancestor
64870673|NCT01841242|Blood Substitutes|blood substitutes|mesh-ancestor
64870674|NCT01841294|Lidocaine|lidocaine|mesh-list
64870675|NCT01841294|Anesthetics, Local|anesthetics, local|mesh-ancestor
64870676|NCT01841294|Anesthetics|anesthetics|mesh-ancestor
64870677|NCT01841294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64870678|NCT01841294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870679|NCT01841294|Sensory System Agents|sensory system agents|mesh-ancestor
64870680|NCT01841294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870681|NCT01841294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64870682|NCT01841294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64870683|NCT01841294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64870684|NCT01841294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64870685|NCT01841294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494966|NCT01567774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64870686|NCT01841307|Cromolyn Sodium|cromolyn sodium|mesh-list
64870687|NCT01841307|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
64870688|NCT01841307|Immunologic Factors|immunologic factors|mesh-ancestor
64870752|NCT01841515|Natriuretic Agents|natriuretic agents|mesh-ancestor
64870753|NCT01841515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870831|NCT01842230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870832|NCT01842230|Vasodilator Agents|vasodilator agents|mesh-ancestor
64870833|NCT01842230|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64870834|NCT01842230|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64870835|NCT01842230|Vitamin B Complex|vitamin b complex|mesh-ancestor
64870836|NCT01842230|Vitamins|vitamins|mesh-ancestor
64870837|NCT01842230|Micronutrients|micronutrients|mesh-ancestor
64870838|NCT01842256|Amlodipine|amlodipine|mesh-list
64870839|NCT01842256|Telmisartan|telmisartan|mesh-list
64870840|NCT01842256|Atorvastatin|atorvastatin|mesh-list
64870841|NCT01842256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64870842|NCT01842256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64870843|NCT01842256|Antimetabolites|antimetabolites|mesh-ancestor
64870844|NCT01842256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870845|NCT01842256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64870846|NCT01842256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64870847|NCT01842256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870848|NCT01842256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64870849|NCT01842256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64870850|NCT01842256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64870889|NCT01842516|Oxazolidinones|oxazolidinones|mesh-list
64870890|NCT01842516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64870891|NCT01842516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64870892|NCT01842516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64870893|NCT01842516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870894|NCT01842516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870895|NCT01842529|Botulinum Toxins|botulinum toxins|mesh-list
64870896|NCT01842529|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64870897|NCT01842529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64870898|NCT01842529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870899|NCT01842529|Cholinergic Agents|cholinergic agents|mesh-ancestor
64870900|NCT01842529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64870901|NCT01842529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870903|NCT01842893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64870904|NCT01842893|Narcotics|narcotics|mesh-ancestor
64870905|NCT01842893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64870906|NCT01842893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870907|NCT01842893|Analgesics|analgesics|mesh-ancestor
64870908|NCT01842893|Sensory System Agents|sensory system agents|mesh-ancestor
64870909|NCT01842893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870910|NCT01842893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64870911|NCT01842893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64870912|NCT01842893|Anesthetics, General|anesthetics, general|mesh-ancestor
64870913|NCT01842893|Anesthetics|anesthetics|mesh-ancestor
64870914|NCT01842932|Bromides|bromides|mesh-list
64870915|NCT01842932|Cholinergic Antagonists|cholinergic antagonists|mesh-list
64870916|NCT01842932|Cimetropium|cimetropium|mesh-list
64870917|NCT01842932|Anticonvulsants|anticonvulsants|mesh-ancestor
64870954|NCT01843127|Incretins|incretins|mesh-ancestor
64870955|NCT01843127|Hormones|hormones|mesh-ancestor
64871034|NCT01843452|Mitomycins|mitomycins|mesh-list
64871035|NCT01843452|Mitomycin|mitomycin|mesh-list
64871036|NCT01843452|Panitumumab|panitumumab|mesh-list
64871037|NCT01843452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64871038|NCT01843452|Antimetabolites|antimetabolites|mesh-ancestor
64871039|NCT01843452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871040|NCT01843452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871041|NCT01843452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64871042|NCT01843452|Alkylating Agents|alkylating agents|mesh-ancestor
64871043|NCT01843452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64871044|NCT01843452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871045|NCT01843452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64871046|NCT01843530|Cortisone|cortisone|mesh-list
64871047|NCT01843530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64871048|NCT01843556|Donepezil|donepezil|mesh-list
64871122|NCT01843868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871210|NCT01844427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871211|NCT01844427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64871212|NCT01844427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64871213|NCT01844622|Domperidone|domperidone|mesh-list
64871434|NCT01845532|Anesthetics|anesthetics|mesh-ancestor
64871435|NCT01845532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64871436|NCT01845532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871437|NCT01845532|Sensory System Agents|sensory system agents|mesh-ancestor
64871438|NCT01845532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64871439|NCT01845532|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64871440|NCT01845558|Wobenzym|wobenzym|mesh-list
64871441|NCT01845558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64871442|NCT01845558|Immunologic Factors|immunologic factors|mesh-ancestor
64871443|NCT01845558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871444|NCT01845584|Immunoglobulins|immunoglobulins|mesh-list
64871445|NCT01845584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64871446|NCT01845584|gamma-Globulins|gamma-globulins|mesh-list
64871447|NCT01845584|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64871448|NCT01845584|Immunologic Factors|immunologic factors|mesh-ancestor
64871449|NCT01845584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871450|NCT01845610|Manganese|manganese|mesh-list
64871451|NCT01845610|Trace Elements|trace elements|mesh-ancestor
64871452|NCT01845610|Micronutrients|micronutrients|mesh-ancestor
64871453|NCT01845610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871454|NCT01845675|Temozolomide|temozolomide|mesh-list
64871455|NCT01845675|Dacarbazine|dacarbazine|mesh-list
64871456|NCT01845675|Endostatins|endostatins|mesh-list
64871457|NCT01845675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64871458|NCT01845675|Alkylating Agents|alkylating agents|mesh-ancestor
64871459|NCT01845675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871512|NCT01846117|Estrogens|estrogens|mesh-ancestor
64871545|NCT01846390|Antiemetics|antiemetics|mesh-ancestor
64871546|NCT01846390|Autonomic Agents|autonomic agents|mesh-ancestor
64871547|NCT01846390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64871548|NCT01846390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871549|NCT01846390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64871550|NCT01846390|Glucocorticoids|glucocorticoids|mesh-ancestor
64871551|NCT01846390|Hormones|hormones|mesh-ancestor
64871552|NCT01846390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64871553|NCT01846390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64871554|NCT01846390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871555|NCT01846390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64640146|NCT05334654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64871556|NCT01846390|Antimetabolites|antimetabolites|mesh-ancestor
64871698|NCT01847599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64871699|NCT01847599|Antimetabolites|antimetabolites|mesh-ancestor
64871700|NCT01847599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871701|NCT01847599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871776|NCT01848119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64871777|NCT01848119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871778|NCT01848119|Antimanic Agents|antimanic agents|mesh-ancestor
64871779|NCT01848132|Prednisone|prednisone|mesh-list
64871780|NCT01848132|Cyclophosphamide|cyclophosphamide|mesh-list
64871781|NCT01848132|Rituximab|rituximab|mesh-list
64871782|NCT01848132|Doxorubicin|doxorubicin|mesh-list
64871783|NCT01848132|Vincristine|vincristine|mesh-list
64871784|NCT01848132|Bortezomib|bortezomib|mesh-list
64871785|NCT01848132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64871810|NCT01848197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871811|NCT01848197|Tubulin Modulators|tubulin modulators|mesh-ancestor
64871812|NCT01848197|Antimitotic Agents|antimitotic agents|mesh-ancestor
64871813|NCT01848197|Mitosis Modulators|mitosis modulators|mesh-ancestor
64871815|NCT01848236|Vitamin D|vitamin d|mesh-list
64871824|NCT01848262|Respiratory System Agents|respiratory system agents|mesh-ancestor
64871825|NCT01848301|Acetylcholine|acetylcholine|mesh-list
64871826|NCT01848301|Vasodilator Agents|vasodilator agents|mesh-ancestor
64871827|NCT01848301|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64871828|NCT01848301|Cholinergic Agents|cholinergic agents|mesh-ancestor
64871829|NCT01848301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64871830|NCT01848301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871831|NCT01848301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871832|NCT01848340|Cabotegravir|cabotegravir|mesh-list
64871833|NCT01848340|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64871834|NCT01848340|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64871835|NCT01848340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871836|NCT01848340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871837|NCT01848340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64473103|NCT01208662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64871838|NCT01848340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64871839|NCT01848340|Antiviral Agents|antiviral agents|mesh-ancestor
64871840|NCT01848340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64871841|NCT01848379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64871842|NCT01848379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871843|NCT01848613|Vinorelbine|vinorelbine|mesh-list
64871844|NCT01848613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64871845|NCT01848613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871846|NCT01848613|Tubulin Modulators|tubulin modulators|mesh-ancestor
64871847|NCT01848613|Antimitotic Agents|antimitotic agents|mesh-ancestor
64871848|NCT01848613|Mitosis Modulators|mitosis modulators|mesh-ancestor
64871849|NCT01848613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871850|NCT01848652|Doxorubicin|doxorubicin|mesh-list
64871857|NCT01848665|Indomethacin|indomethacin|mesh-list
64871868|NCT01848665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64871869|NCT01848665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64871870|NCT01848665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871871|NCT01848665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871872|NCT01848691|Carbon Monoxide|carbon monoxide|mesh-list
64871873|NCT01848691|Antimetabolites|antimetabolites|mesh-ancestor
64871874|NCT01848691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871875|NCT01848691|Gasotransmitters|gasotransmitters|mesh-ancestor
64871876|NCT01848691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64871877|NCT01848691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871879|NCT01848743|Lamivudine|lamivudine|mesh-list
64871880|NCT01848743|Antiviral Agents|antiviral agents|mesh-ancestor
64871881|NCT01848743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64871882|NCT01848743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64871943|NCT01849042|Nootropic Agents|nootropic agents|mesh-ancestor
64871945|NCT01849094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64871982|NCT01849666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871983|NCT01849666|Anticoagulants|anticoagulants|mesh-ancestor
64872033|NCT01850095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64872034|NCT01850095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872035|NCT01850095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872036|NCT01850095|Dermatologic Agents|dermatologic agents|mesh-ancestor
64872037|NCT01850121|Infliximab|infliximab|mesh-list
64872038|NCT01850121|Dermatologic Agents|dermatologic agents|mesh-ancestor
64872039|NCT01850121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64872040|NCT01850121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64872041|NCT01850147|Sunitinib|sunitinib|mesh-list
64872042|NCT01850147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872043|NCT01850147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64872044|NCT01850147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64872045|NCT01850147|Growth Substances|growth substances|mesh-ancestor
64410813|NCT01364727|Amrubicin|amrubicin|mesh-list
65494967|NCT01567774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64578199|NCT01490060|Dexamethasone|dexamethasone|mesh-list
64872057|NCT01850160|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
64872058|NCT01850160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64872059|NCT01850160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872060|NCT01850160|Natriuretic Agents|natriuretic agents|mesh-ancestor
64872061|NCT01850160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872062|NCT01850160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64872063|NCT01850160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64872064|NCT01850251|Vitamin D|vitamin d|mesh-list
64872065|NCT01850251|Vitamins|vitamins|mesh-ancestor
64872066|NCT01850251|Micronutrients|micronutrients|mesh-ancestor
64872067|NCT01850251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872068|NCT01850251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64872069|NCT01850277|Amiodarone|amiodarone|mesh-list
64872070|NCT01850277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872071|NCT01850277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64872072|NCT01850277|Vasodilator Agents|vasodilator agents|mesh-ancestor
64872073|NCT01850277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64872074|NCT01850277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64872075|NCT01850277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64872076|NCT01850277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64872077|NCT01850277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64872078|NCT01850277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872079|NCT01850277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64872080|NCT01850277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64872081|NCT01850277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64872082|NCT01850511|Phenylephrine|phenylephrine|mesh-list
64872083|NCT01850511|Oxymetazoline|oxymetazoline|mesh-list
64872084|NCT01850511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64872124|NCT01850680|Immunologic Factors|immunologic factors|mesh-ancestor
64872125|NCT01850680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64872126|NCT01850680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64872128|NCT01850680|Vitamin B Complex|vitamin b complex|mesh-ancestor
64872129|NCT01850680|Vitamins|vitamins|mesh-ancestor
64872130|NCT01850680|Micronutrients|micronutrients|mesh-ancestor
64872131|NCT01850940|Tolvaptan|tolvaptan|mesh-list
64872187|NCT01851265|Olaparib|olaparib|mesh-list
64872188|NCT01851265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64872189|NCT01851265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872190|NCT01851265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872191|NCT01851265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872192|NCT01851278|Triamcinolone|triamcinolone|mesh-list
64872193|NCT01851278|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64872194|NCT01851278|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64872195|NCT01851278|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64872196|NCT01851278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64872197|NCT01851278|Glucocorticoids|glucocorticoids|mesh-ancestor
64872198|NCT01851278|Hormones|hormones|mesh-ancestor
64872199|NCT01851278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64872200|NCT01851278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872201|NCT01851278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64872202|NCT01851278|Immunologic Factors|immunologic factors|mesh-ancestor
64872203|NCT01851278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872262|NCT01851486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872263|NCT01851512|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64872264|NCT01851512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64872265|NCT01851512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872266|NCT01851551|Rituximab|rituximab|mesh-list
64872267|NCT01851551|Vincristine|vincristine|mesh-list
64872268|NCT01851551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64872269|NCT01851551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872270|NCT01851551|Immunologic Factors|immunologic factors|mesh-ancestor
64872309|NCT01851941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872310|NCT01851941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64872311|NCT01851941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872312|NCT01851941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64872313|NCT01851941|Immunologic Factors|immunologic factors|mesh-ancestor
64872356|NCT01852253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64872357|NCT01852253|Disinfectants|disinfectants|mesh-ancestor
64872358|NCT01852253|Dermatologic Agents|dermatologic agents|mesh-ancestor
64872359|NCT01852266|Vaccines|vaccines|mesh-list
64872360|NCT01852266|Immunologic Factors|immunologic factors|mesh-ancestor
64872361|NCT01852266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872362|NCT01852318|Fexofenadine|fexofenadine|mesh-list
64872363|NCT01852318|Pregabalin|pregabalin|mesh-list
64872364|NCT01852318|Analgesics|analgesics|mesh-ancestor
64872365|NCT01852318|Sensory System Agents|sensory system agents|mesh-ancestor
64872366|NCT01852318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64872367|NCT01852318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872368|NCT01852318|Anticonvulsants|anticonvulsants|mesh-ancestor
64872369|NCT01852318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64872370|NCT01852318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64872371|NCT01852318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872372|NCT01852318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64872373|NCT01852318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64872374|NCT01852318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64872375|NCT01852318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64872376|NCT01852318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64872377|NCT01852318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64872378|NCT01852318|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64872379|NCT01852318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64872616|NCT01854424|Dimercaprol|dimercaprol|mesh-list
64872619|NCT01854424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872620|NCT01854463|Vitamin D|vitamin d|mesh-list
64872621|NCT01854463|Cholecalciferol|cholecalciferol|mesh-list
64872622|NCT01854463|Vitamins|vitamins|mesh-ancestor
64872623|NCT01854463|Micronutrients|micronutrients|mesh-ancestor
64872624|NCT01854463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872625|NCT01854463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64872626|NCT01854463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64872627|NCT01854476|Tranexamic Acid|tranexamic acid|mesh-list
64872628|NCT01854476|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64872629|NCT01854476|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64872630|NCT01854476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872631|NCT01854476|Hemostatics|hemostatics|mesh-ancestor
64872632|NCT01854476|Coagulants|coagulants|mesh-ancestor
64872633|NCT01854489|Rifampin|rifampin|mesh-list
64872634|NCT01854489|Buprenorphine|buprenorphine|mesh-list
64872635|NCT01854489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64872636|NCT01854489|Narcotics|narcotics|mesh-ancestor
64872637|NCT01854489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64872638|NCT01854489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872639|NCT01854489|Analgesics|analgesics|mesh-ancestor
64872640|NCT01854489|Sensory System Agents|sensory system agents|mesh-ancestor
64872641|NCT01854489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64872642|NCT01854489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64872643|NCT01854489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64872732|NCT01855009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494969|NCT01567774|Antimetabolites|antimetabolites|mesh-ancestor
64872733|NCT01855009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64872734|NCT01855061|Midazolam|midazolam|mesh-list
64872735|NCT01855061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64872736|NCT01855061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64872737|NCT01855061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64872738|NCT01855061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872739|NCT01855061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64872740|NCT01855061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64872741|NCT01855061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64872742|NCT01855061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64872744|NCT01855061|Anesthetics|anesthetics|mesh-ancestor
64872780|NCT01855321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872781|NCT01855321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64872782|NCT01855321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64872783|NCT01855334|Spironolactone|spironolactone|mesh-list
64872784|NCT01855334|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64872785|NCT01855334|Hormone Antagonists|hormone antagonists|mesh-ancestor
64872786|NCT01855334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64872938|NCT01856127|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
64872939|NCT01856127|Antidepressive Agents|antidepressive agents|mesh-ancestor
64872941|NCT01856127|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64872942|NCT01856127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64872943|NCT01856127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64872944|NCT01856127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872945|NCT01856127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64872946|NCT01856127|Serotonin Agents|serotonin agents|mesh-ancestor
64872947|NCT01856127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872948|NCT01856127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64872949|NCT01856127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64872950|NCT01856166|Sufentanil|sufentanil|mesh-list
64872951|NCT01856166|Levobupivacaine|levobupivacaine|mesh-list
64872952|NCT01856166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64872953|NCT01856166|Narcotics|narcotics|mesh-ancestor
64873020|NCT01856621|Autonomic Agents|autonomic agents|mesh-ancestor
64873021|NCT01856621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64873022|NCT01856621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873023|NCT01856621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64873125|NCT01857141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64873126|NCT01857141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64873127|NCT01857141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64873128|NCT01857141|Adrenergic Agents|adrenergic agents|mesh-ancestor
64873129|NCT01857141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64873130|NCT01857141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873131|NCT01857154|Calcium, Dietary|calcium, dietary|mesh-list
64873132|NCT01857154|Vitamin D|vitamin d|mesh-list
64873133|NCT01857154|Cholecalciferol|cholecalciferol|mesh-list
64873134|NCT01857154|Calcium Carbonate|calcium carbonate|mesh-list
64873135|NCT01857154|Calcium|calcium|mesh-list
64873136|NCT01857154|Vitamins|vitamins|mesh-ancestor
64873137|NCT01857154|Micronutrients|micronutrients|mesh-ancestor
64873138|NCT01857154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873139|NCT01857154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64873140|NCT01857154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64873141|NCT01857154|Antacids|antacids|mesh-ancestor
64873285|NCT01857843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64873286|NCT01857843|Immunologic Factors|immunologic factors|mesh-ancestor
64873287|NCT01857843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473105|NCT01208662|Hormones|hormones|mesh-ancestor
64578423|NCT01660893|Phenylephrine|phenylephrine|mesh-list
64873288|NCT01857843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64873289|NCT01857843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64873290|NCT01857843|Antimetabolites|antimetabolites|mesh-ancestor
64873291|NCT01857843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873297|NCT01857856|Hormone Antagonists|hormone antagonists|mesh-ancestor
64873298|NCT01857856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64873301|NCT01857856|Diuretics|diuretics|mesh-ancestor
64873318|NCT01857921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64873319|NCT01857921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64873320|NCT01857921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873321|NCT01857921|Vasodilator Agents|vasodilator agents|mesh-ancestor
64873322|NCT01857999|Losartan|losartan|mesh-list
64873323|NCT01857999|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64873324|NCT01857999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64873325|NCT01857999|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64873326|NCT01857999|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64873327|NCT01857999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873328|NCT01858025|Fluorouracil|fluorouracil|mesh-list
64873329|NCT01858025|Mitomycins|mitomycins|mesh-list
64873330|NCT01858025|Mitomycin|mitomycin|mesh-list
64873331|NCT01858025|Antimetabolites|antimetabolites|mesh-ancestor
64873332|NCT01858025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873333|NCT01858025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64873334|NCT01858025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873335|NCT01858025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64873336|NCT01858025|Immunologic Factors|immunologic factors|mesh-ancestor
64873337|NCT01858025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873338|NCT01858025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64873339|NCT01858025|Alkylating Agents|alkylating agents|mesh-ancestor
64873340|NCT01858025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64873341|NCT01858025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873342|NCT01858051|Cholecalciferol|cholecalciferol|mesh-list
64873343|NCT01858051|Vitamin D|vitamin d|mesh-list
64873344|NCT01858051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64873345|NCT01858051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873346|NCT01858051|Vitamins|vitamins|mesh-ancestor
64873347|NCT01858051|Micronutrients|micronutrients|mesh-ancestor
64873348|NCT01858051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64873349|NCT01858077|Everolimus|everolimus|mesh-list
64873350|NCT01858077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873351|NCT01858077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64873359|NCT01858090|Fentanyl|fentanyl|mesh-list
64873360|NCT01858090|Sufentanil|sufentanil|mesh-list
64873361|NCT01858090|Meperidine|meperidine|mesh-list
64873362|NCT01858090|Metoclopramide|metoclopramide|mesh-list
64873363|NCT01858090|Propofol|propofol|mesh-list
65494970|NCT01567774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473106|NCT01208662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64873478|NCT01858571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64873479|NCT01858571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64873480|NCT01858571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64873481|NCT01858571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873482|NCT01858571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64873483|NCT01858571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64873484|NCT01858571|Analgesics|analgesics|mesh-ancestor
64873485|NCT01858571|Sensory System Agents|sensory system agents|mesh-ancestor
64873486|NCT01858571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64873487|NCT01858571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64873488|NCT01858571|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64873489|NCT01858571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64873490|NCT01858571|Leprostatic Agents|leprostatic agents|mesh-ancestor
64873491|NCT01858571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64873492|NCT01858571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64873493|NCT01858571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64873494|NCT01858571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64873495|NCT01858571|Growth Substances|growth substances|mesh-ancestor
64873496|NCT01858571|Growth Inhibitors|growth inhibitors|mesh-ancestor
64873497|NCT01858610|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64873498|NCT01858610|Irbesartan|irbesartan|mesh-list
64873499|NCT01858610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64501798|NCT03062943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64873558|NCT01858831|Antimalarials|antimalarials|mesh-ancestor
64873559|NCT01858831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64873560|NCT01858831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64873561|NCT01858831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873562|NCT01858831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873563|NCT01858831|Antimetabolites|antimetabolites|mesh-ancestor
64873564|NCT01858870|Lacosamide|lacosamide|mesh-list
64873565|NCT01858870|Anticonvulsants|anticonvulsants|mesh-ancestor
64873566|NCT01858870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64338297|NCT02268773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64338298|NCT02268773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338299|NCT02268773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64338307|NCT02268773|Antipyretics|antipyretics|mesh-ancestor
64873665|NCT01859728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64873666|NCT01859728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338360|NCT02269319|Linezolid|linezolid|mesh-list
64873697|NCT01860066|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64873698|NCT01860066|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64873699|NCT01860066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64873700|NCT01860066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64873701|NCT01860066|Autonomic Agents|autonomic agents|mesh-ancestor
64873702|NCT01860066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64873703|NCT01860066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873704|NCT01860066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64873705|NCT01860066|Respiratory System Agents|respiratory system agents|mesh-ancestor
64873706|NCT01860066|Dermatologic Agents|dermatologic agents|mesh-ancestor
64873707|NCT01860066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64873708|NCT01860066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64873709|NCT01860066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64873710|NCT01860066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64873711|NCT01860066|Adrenergic Agents|adrenergic agents|mesh-ancestor
64873734|NCT01860144|Growth Inhibitors|growth inhibitors|mesh-ancestor
64873735|NCT01860183|Mycophenolic Acid|mycophenolic acid|mesh-list
64873736|NCT01860183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64873742|NCT01860183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873743|NCT01860183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873744|NCT01860196|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64873745|NCT01860196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64873746|NCT01860196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64873747|NCT01860196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873748|NCT01860196|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64873749|NCT01860196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64873750|NCT01860196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873751|NCT01860196|Cholinergic Agents|cholinergic agents|mesh-ancestor
64873752|NCT01860196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64873753|NCT01860235|Anesthetics|anesthetics|mesh-list
64873754|NCT01860235|Benzocaine|benzocaine|mesh-list
64873755|NCT01860235|Anesthetics, Local|anesthetics, local|mesh-list
64873756|NCT01860235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64873757|NCT01860235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873758|NCT01860235|Sensory System Agents|sensory system agents|mesh-ancestor
64873759|NCT01860235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64873799|NCT01860625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873800|NCT01860625|Cholinergic Agents|cholinergic agents|mesh-ancestor
64873801|NCT01860625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64873802|NCT01860625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873803|NCT01860625|Nootropic Agents|nootropic agents|mesh-ancestor
64873804|NCT01860638|Bevacizumab|bevacizumab|mesh-list
64873805|NCT01860638|Temozolomide|temozolomide|mesh-list
64873806|NCT01860638|Lomustine|lomustine|mesh-list
64873807|NCT01860638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64873808|NCT01860638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873809|NCT01860638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64873840|NCT01860716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64873841|NCT01860729|Anacetrapib|anacetrapib|mesh-list
64873842|NCT01860729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64873843|NCT01860729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64338540|NCT05401214|Hormones|hormones|mesh-ancestor
64338581|NCT01745588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64338582|NCT01745588|Immunologic Factors|immunologic factors|mesh-ancestor
64338583|NCT01745588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64338584|NCT01745588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64338585|NCT01745588|Growth Substances|growth substances|mesh-ancestor
64338586|NCT01745588|Growth Inhibitors|growth inhibitors|mesh-ancestor
64338587|NCT05398874|Acetaminophen|acetaminophen|mesh-list
64338588|NCT05398874|Diclofenac|diclofenac|mesh-list
64338589|NCT05398874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64338590|NCT05398874|Analgesics|analgesics|mesh-ancestor
64338591|NCT05398874|Sensory System Agents|sensory system agents|mesh-ancestor
64873942|NCT01861340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873944|NCT01861340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64873945|NCT01861340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64873946|NCT01861340|Growth Substances|growth substances|mesh-ancestor
64873947|NCT01861340|Growth Inhibitors|growth inhibitors|mesh-ancestor
64873948|NCT01861535|Imiquimod|imiquimod|mesh-list
64873949|NCT01861535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64873950|NCT01861535|Immunologic Factors|immunologic factors|mesh-ancestor
64873951|NCT01861535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873952|NCT01861535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873953|NCT01861535|Interferon Inducers|interferon inducers|mesh-ancestor
64873954|NCT01861561|Cyclophosphamide|cyclophosphamide|mesh-list
64873955|NCT01861561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64338641|NCT05533229|Fentanyl|fentanyl|mesh-list
64873988|NCT01862003|Folic Acid|folic acid|mesh-list
64873989|NCT01862003|Fluorouracil|fluorouracil|mesh-list
64873990|NCT01862003|Irinotecan|irinotecan|mesh-list
64873991|NCT01862003|Levoleucovorin|levoleucovorin|mesh-list
64873992|NCT01862003|Antimetabolites|antimetabolites|mesh-ancestor
64873993|NCT01862003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873994|NCT01862003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64873995|NCT01862003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473107|NCT01208662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64473108|NCT01208662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338739|NCT01660334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338740|NCT01660334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64338741|NCT01660334|Hormone Antagonists|hormone antagonists|mesh-ancestor
64338742|NCT01660334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64338743|NCT01660334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338744|NCT01660334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64338745|NCT01660256|Rebamipide|rebamipide|mesh-list
64874053|NCT01862497|Adrenergic Agents|adrenergic agents|mesh-ancestor
64874054|NCT01862497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64874055|NCT01862497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874056|NCT01862497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874057|NCT01862497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64874058|NCT01862497|Antioxidants|antioxidants|mesh-ancestor
64874059|NCT01862497|Protective Agents|protective agents|mesh-ancestor
64874060|NCT01862497|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64874061|NCT01862497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64874062|NCT01862497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64874063|NCT01862497|Vasodilator Agents|vasodilator agents|mesh-ancestor
64874064|NCT01862497|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64874065|NCT01862497|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64874066|NCT01862523|Capsaicin|capsaicin|mesh-list
64874067|NCT01862523|Antipruritics|antipruritics|mesh-ancestor
64338766|NCT02330367|Abivertinib|abivertinib|mesh-list
64874079|NCT01862835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64874081|NCT01862835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64874102|NCT01862926|Alkylating Agents|alkylating agents|mesh-ancestor
64874103|NCT01862926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874104|NCT01862926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64874105|NCT01862926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64874106|NCT01862926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64874107|NCT01862978|Heparin|heparin|mesh-list
64874108|NCT01862978|Nadroparin|nadroparin|mesh-list
64874109|NCT01862978|Anticoagulants|anticoagulants|mesh-ancestor
64874110|NCT01862978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64874111|NCT01862978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64874112|NCT01862978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874113|NCT01863004|Bortezomib|bortezomib|mesh-list
64874114|NCT01863004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64874115|NCT01863069|Interferons|interferons|mesh-list
64874116|NCT01863069|Interferon-beta|interferon-beta|mesh-list
64874117|NCT01863069|Interferon beta-1a|interferon beta-1a|mesh-list
64874118|NCT01863069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64874119|NCT01863069|Antiviral Agents|antiviral agents|mesh-ancestor
65494972|NCT01567774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65494973|NCT01567774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64874120|NCT01863069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64874121|NCT01863069|Immunologic Factors|immunologic factors|mesh-ancestor
64874122|NCT01863069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874123|NCT01863069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64874124|NCT01863147|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64874126|NCT01863147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64874127|NCT01863147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874128|NCT01863147|Incretins|incretins|mesh-ancestor
64874129|NCT01863147|Hormones|hormones|mesh-ancestor
64874169|NCT01863251|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64874170|NCT01863251|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64874171|NCT01863251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64874172|NCT01863251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64874173|NCT01863251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874174|NCT01863251|Adrenergic Agents|adrenergic agents|mesh-ancestor
64874175|NCT01863251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64874176|NCT01863251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874177|NCT01863277|Melatonin|melatonin|mesh-list
64874178|NCT01863277|Antioxidants|antioxidants|mesh-ancestor
64874179|NCT01863277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874194|NCT01863355|Anesthetics|anesthetics|mesh-ancestor
64874195|NCT01863407|Metronidazole|metronidazole|mesh-list
64874196|NCT01863407|Dexamethasone|dexamethasone|mesh-list
64642771|NCT00439946|Treprostinil|treprostinil|mesh-list
64874198|NCT01863407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64874199|NCT01863407|Antiemetics|antiemetics|mesh-ancestor
64874200|NCT01863407|Autonomic Agents|autonomic agents|mesh-ancestor
64874201|NCT01863407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64874202|NCT01863407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874203|NCT01863407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64874204|NCT01863407|Glucocorticoids|glucocorticoids|mesh-ancestor
64874205|NCT01863407|Hormones|hormones|mesh-ancestor
64874206|NCT01863407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64874207|NCT01863407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64874208|NCT01863407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64874209|NCT01863407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64874210|NCT01863407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64874211|NCT01863407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64874212|NCT01863407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64874213|NCT01863407|Dermatologic Agents|dermatologic agents|mesh-ancestor
64874214|NCT01863459|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64874215|NCT01863459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64411472|NCT05701007|Docetaxel|docetaxel|mesh-list
64874221|NCT01863459|Dopamine Agents|dopamine agents|mesh-ancestor
64874222|NCT01863459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64874223|NCT01863485|Vorolanib|vorolanib|mesh-list
64874224|NCT01863485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64874225|NCT01863485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64874226|NCT01863485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874227|NCT01863511|Tolvaptan|tolvaptan|mesh-list
64874228|NCT01863511|Diuretics|diuretics|mesh-list
64874229|NCT01863511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
64874230|NCT01863511|Natriuretic Agents|natriuretic agents|mesh-ancestor
64874231|NCT01863511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874232|NCT01863511|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64874233|NCT01863511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874234|NCT01863511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64874235|NCT01863589|Adefovir|adefovir|mesh-list
64874236|NCT01863589|Antiviral Agents|antiviral agents|mesh-ancestor
64874237|NCT01863589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64874238|NCT01863589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64338911|NCT00493298|Natalizumab|natalizumab|mesh-list
64874247|NCT01863602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64874248|NCT01863602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874249|NCT01863602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64874250|NCT01863602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64874251|NCT01863602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64874252|NCT01863602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64874253|NCT01863602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64874254|NCT01863615|Isotretinoin|isotretinoin|mesh-list
64874255|NCT01863615|Dermatologic Agents|dermatologic agents|mesh-ancestor
64874256|NCT01863641|Calcitriol|calcitriol|mesh-list
64874257|NCT01863641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64874258|NCT01863641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874259|NCT01863641|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64874260|NCT01863641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64874261|NCT01863641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874262|NCT01863641|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64874265|NCT01863641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64874266|NCT01863654|Montelukast|montelukast|mesh-list
64874267|NCT01863654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64874268|NCT01863654|Respiratory System Agents|respiratory system agents|mesh-ancestor
64874269|NCT01863654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64874270|NCT01863654|Hormone Antagonists|hormone antagonists|mesh-ancestor
64874271|NCT01863654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64874272|NCT01863654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874273|NCT01863654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64874274|NCT01863654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64874275|NCT01863654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874276|NCT01863706|Misoprostol|misoprostol|mesh-list
64874277|NCT01863706|Oxytocin|oxytocin|mesh-list
64874278|NCT01863706|Oxytocics|oxytocics|mesh-ancestor
64874279|NCT01863706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64874280|NCT01863706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874281|NCT01863706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64874282|NCT01863706|Abortifacient Agents|abortifacient agents|mesh-ancestor
64874283|NCT01863706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64874284|NCT01863706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64874285|NCT01863719|Colistin|colistin|mesh-list
64874286|NCT01863719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64874287|NCT01863719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64874288|NCT01863810|Pregabalin|pregabalin|mesh-list
64874289|NCT01863810|Analgesics|analgesics|mesh-ancestor
64411623|NCT05700617|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64874330|NCT01863914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64874331|NCT01863914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64874332|NCT01863914|Antimetabolites|antimetabolites|mesh-ancestor
64874333|NCT01863914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874334|NCT01863914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64874335|NCT01863914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64874336|NCT01863914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64874337|NCT01864057|Thiamine|thiamine|mesh-list
64874338|NCT01864057|Vitamin B Complex|vitamin b complex|mesh-ancestor
64874339|NCT01864057|Vitamins|vitamins|mesh-ancestor
64874340|NCT01864057|Micronutrients|micronutrients|mesh-ancestor
64874341|NCT01864057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874342|NCT01864070|Everolimus|everolimus|mesh-list
64642918|NCT00509288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64874343|NCT01864070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64874344|NCT01864070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64874345|NCT01864070|Immunologic Factors|immunologic factors|mesh-ancestor
64874346|NCT01864070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874347|NCT01864083|Fluorides|fluorides|mesh-list
64874348|NCT01864083|Cariostatic Agents|cariostatic agents|mesh-ancestor
64874349|NCT01864083|Protective Agents|protective agents|mesh-ancestor
64874350|NCT01864083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874351|NCT01864096|Metformin|metformin|mesh-list
64874352|NCT01864096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64874353|NCT01864096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874354|NCT01864161|Iron|iron|mesh-list
64874355|NCT01864161|Trace Elements|trace elements|mesh-ancestor
64874356|NCT01864161|Micronutrients|micronutrients|mesh-ancestor
64874357|NCT01864161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874358|NCT01864187|Dexmedetomidine|dexmedetomidine|mesh-list
64874375|NCT01864213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64874376|NCT01864213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874377|NCT01864213|Sensory System Agents|sensory system agents|mesh-ancestor
64874386|NCT01864551|Lamotrigine|lamotrigine|mesh-list
64874387|NCT01864551|Olanzapine|olanzapine|mesh-list
64874388|NCT01864551|Antiemetics|antiemetics|mesh-ancestor
64874389|NCT01864551|Autonomic Agents|autonomic agents|mesh-ancestor
64874390|NCT01864551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64874391|NCT01864551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874392|NCT01864551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64874393|NCT01864551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64874394|NCT01864551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64874395|NCT01864551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64874396|NCT01864551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64874397|NCT01864551|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64874398|NCT01864551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64874399|NCT01864551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64874400|NCT01864551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874401|NCT01864551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64874402|NCT01864551|Serotonin Agents|serotonin agents|mesh-ancestor
64874403|NCT01864551|Anticonvulsants|anticonvulsants|mesh-ancestor
64874404|NCT01864551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64874405|NCT01864551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64874406|NCT01864551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64874407|NCT01864616|Vitamin D|vitamin d|mesh-list
64874408|NCT01864616|Cholecalciferol|cholecalciferol|mesh-list
64874409|NCT01864616|Vitamins|vitamins|mesh-ancestor
64874410|NCT01864616|Micronutrients|micronutrients|mesh-ancestor
64874411|NCT01864616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874412|NCT01864616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64874413|NCT01864616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64874414|NCT01864655|Saracatinib|saracatinib|mesh-list
64874415|NCT01864655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64874455|NCT01865188|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64874456|NCT01865188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64874457|NCT01865188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64874458|NCT01865188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64874459|NCT01865188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874460|NCT01865188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64874461|NCT01865188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874462|NCT01865188|Vasodilator Agents|vasodilator agents|mesh-ancestor
64874463|NCT01865188|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64874464|NCT01865201|Mannitol|mannitol|mesh-list
64874465|NCT01865201|Edaravone|edaravone|mesh-list
64874477|NCT01865279|Insulin, Long-Acting|insulin, long-acting|mesh-list
64874478|NCT01865279|Isophane Insulin, Human|isophane insulin, human|mesh-list
64874479|NCT01865279|Insulin, Isophane|insulin, isophane|mesh-list
64874480|NCT01865279|Isophane insulin, beef|isophane insulin, beef|mesh-list
64874481|NCT01865279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64874482|NCT01865279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874483|NCT01865292|Insulin|insulin|mesh-list
64874484|NCT01865292|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64874485|NCT01865292|Insulin Glargine|insulin glargine|mesh-list
64874486|NCT01865292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64874487|NCT01865292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874488|NCT01865305|Insulin|insulin|mesh-list
64874489|NCT01865305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64874490|NCT01865305|Insulin Aspart|insulin aspart|mesh-list
64874491|NCT01865305|Insulin, Long-Acting|insulin, long-acting|mesh-list
64874492|NCT01865305|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64874513|NCT01865500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874514|NCT01865500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64874515|NCT01865500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64874516|NCT01865500|Autonomic Agents|autonomic agents|mesh-ancestor
64874517|NCT01865500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64874518|NCT01865500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64874519|NCT01865500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64874520|NCT01865500|Respiratory System Agents|respiratory system agents|mesh-ancestor
64874521|NCT01865630|Etanercept|etanercept|mesh-list
64874522|NCT01865630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64874523|NCT01865630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64874524|NCT01865630|Analgesics|analgesics|mesh-ancestor
64874525|NCT01865630|Sensory System Agents|sensory system agents|mesh-ancestor
64874526|NCT01865630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64874527|NCT01865630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494977|NCT04663750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64579038|NCT00054665|Prednisone|prednisone|mesh-list
64874528|NCT01865630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64874529|NCT01865630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64874530|NCT01865630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64874531|NCT01865630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64874552|NCT01865916|Antioxidants|antioxidants|mesh-ancestor
64874553|NCT01865916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874554|NCT01865916|Protective Agents|protective agents|mesh-ancestor
64874581|NCT01866059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64874582|NCT01866059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64874583|NCT01866241|Misoprostol|misoprostol|mesh-list
64874584|NCT01866241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64874585|NCT01866241|Abortifacient Agents|abortifacient agents|mesh-ancestor
64874586|NCT01866241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64874587|NCT01866241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339262|NCT01658150|Isradipine|isradipine|mesh-list
64874611|NCT01866397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64874613|NCT01866397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874614|NCT01866488|Misoprostol|misoprostol|mesh-list
64874615|NCT01866488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64874616|NCT01866488|Abortifacient Agents|abortifacient agents|mesh-ancestor
64874617|NCT01866488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64874618|NCT01866488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874619|NCT01866488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64874620|NCT01866488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64874621|NCT01866488|Oxytocics|oxytocics|mesh-ancestor
64874622|NCT01866514|Lidocaine|lidocaine|mesh-list
64874623|NCT01866514|Anesthetics, Local|anesthetics, local|mesh-ancestor
64874624|NCT01866514|Anesthetics|anesthetics|mesh-ancestor
64874625|NCT01866514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64874626|NCT01866514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874627|NCT01866514|Sensory System Agents|sensory system agents|mesh-ancestor
64874628|NCT01866514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64874629|NCT01866514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64874630|NCT01866514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64874631|NCT01866514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64874632|NCT01866514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64874633|NCT01866514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874634|NCT01866553|Interferons|interferons|mesh-list
64874635|NCT01866553|Interferon-alpha|interferon-alpha|mesh-list
65494978|NCT04663750|Growth Substances|growth substances|mesh-ancestor
64874678|NCT01867255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64874679|NCT01867255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874680|NCT01867255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64874681|NCT01867255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874682|NCT01867255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64339412|NCT03111615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874747|NCT01867697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874748|NCT01867697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64874750|NCT01867697|Protective Agents|protective agents|mesh-ancestor
64874751|NCT01867697|Vitamin B Complex|vitamin b complex|mesh-ancestor
64874752|NCT01867697|Vitamins|vitamins|mesh-ancestor
64874753|NCT01867697|Micronutrients|micronutrients|mesh-ancestor
64874754|NCT01867697|Hematinics|hematinics|mesh-ancestor
64874755|NCT01867697|Antacids|antacids|mesh-ancestor
64874756|NCT01867697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64874757|NCT01867775|Mirtazapine|mirtazapine|mesh-list
64874758|NCT01867775|Antidepressive Agents|antidepressive agents|mesh-ancestor
64874759|NCT01867775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64874760|NCT01867775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64874761|NCT01867775|Histamine Antagonists|histamine antagonists|mesh-ancestor
64874779|NCT01867866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874780|NCT01867866|Antiviral Agents|antiviral agents|mesh-ancestor
64874781|NCT01867866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64874782|NCT01867892|Leucovorin|leucovorin|mesh-list
64874783|NCT01867892|Gemcitabine|gemcitabine|mesh-list
64874784|NCT01867892|Fluorouracil|fluorouracil|mesh-list
64874785|NCT01867892|Irinotecan|irinotecan|mesh-list
64874786|NCT01867892|Levoleucovorin|levoleucovorin|mesh-list
64874787|NCT01867892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64874788|NCT01867892|Antimetabolites|antimetabolites|mesh-ancestor
64874789|NCT01867892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874790|NCT01867892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64874791|NCT01867892|Antiviral Agents|antiviral agents|mesh-ancestor
64874798|NCT01867892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64874799|NCT01867892|Antidotes|antidotes|mesh-ancestor
64874800|NCT01867892|Protective Agents|protective agents|mesh-ancestor
64874801|NCT01867892|Vitamin B Complex|vitamin b complex|mesh-ancestor
64874802|NCT01867892|Vitamins|vitamins|mesh-ancestor
64874803|NCT01867892|Micronutrients|micronutrients|mesh-ancestor
64874804|NCT01868048|Nabiximols|nabiximols|mesh-list
64874805|NCT01868048|Analgesics|analgesics|mesh-ancestor
64874806|NCT01868048|Sensory System Agents|sensory system agents|mesh-ancestor
64874807|NCT01868048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64874808|NCT01868048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874809|NCT01868113|Fluticasone|fluticasone|mesh-list
64874810|NCT01868113|Xhance|xhance|mesh-list
64874811|NCT01868113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64874812|NCT01868113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64874813|NCT01868113|Autonomic Agents|autonomic agents|mesh-ancestor
64874814|NCT01868113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64874815|NCT01868113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874816|NCT01868113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64874817|NCT01868113|Respiratory System Agents|respiratory system agents|mesh-ancestor
64874818|NCT01868113|Dermatologic Agents|dermatologic agents|mesh-ancestor
64874819|NCT01868113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64874847|NCT01868438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64874848|NCT01868438|Antiviral Agents|antiviral agents|mesh-ancestor
64874849|NCT01868438|Schistosomicides|schistosomicides|mesh-ancestor
64874850|NCT01868438|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64874851|NCT01868438|Anthelmintics|anthelmintics|mesh-ancestor
64874852|NCT01868464|BCG Vaccine|bcg vaccine|mesh-list
64874853|NCT01868464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64874854|NCT01868464|Immunologic Factors|immunologic factors|mesh-ancestor
64874855|NCT01868464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874856|NCT01868529|Insulin|insulin|mesh-list
64874857|NCT01868529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64874858|NCT01868529|Insulin Glargine|insulin glargine|mesh-list
64874859|NCT01868529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64874870|NCT01868568|Insulin Aspart|insulin aspart|mesh-list
64874871|NCT01868568|Insulin, Long-Acting|insulin, long-acting|mesh-list
64874872|NCT01868568|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64874886|NCT01868750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64874887|NCT01868750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64874888|NCT01868750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874889|NCT01868750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64874890|NCT01868750|Vitamins|vitamins|mesh-ancestor
64874891|NCT01868750|Micronutrients|micronutrients|mesh-ancestor
64874892|NCT01868750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64874893|NCT01868802|Ketamine|ketamine|mesh-list
64874894|NCT01868802|Analgesics|analgesics|mesh-ancestor
64874895|NCT01868802|Sensory System Agents|sensory system agents|mesh-ancestor
64874896|NCT01868802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64874897|NCT01868802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874898|NCT01868802|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64874899|NCT01868802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64874900|NCT01868802|Anesthetics, General|anesthetics, general|mesh-ancestor
64874901|NCT01868802|Anesthetics|anesthetics|mesh-ancestor
64874902|NCT01868802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64874903|NCT01868802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64874904|NCT01868802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64874905|NCT01868802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64874906|NCT01868802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874907|NCT01868880|Bisoprolol|bisoprolol|mesh-list
64874908|NCT01868880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64874909|NCT01868880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64874910|NCT01868880|Adrenergic Agents|adrenergic agents|mesh-ancestor
64874911|NCT01868880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64874912|NCT01868880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874913|NCT01868880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874914|NCT01868880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64874915|NCT01868880|Sympatholytics|sympatholytics|mesh-ancestor
64874916|NCT01868880|Autonomic Agents|autonomic agents|mesh-ancestor
64874920|NCT01868906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64874921|NCT01868906|Alkylating Agents|alkylating agents|mesh-ancestor
64874922|NCT01868906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874923|NCT01868906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64874924|NCT01868945|Vitamin D|vitamin d|mesh-list
64874925|NCT01868945|Cholecalciferol|cholecalciferol|mesh-list
64874926|NCT01868945|Calcifediol|calcifediol|mesh-list
64874927|NCT01868945|Vitamins|vitamins|mesh-ancestor
64874928|NCT01868945|Micronutrients|micronutrients|mesh-ancestor
64874929|NCT01868945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874930|NCT01868945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64874931|NCT01868945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64874932|NCT01868984|Paclitaxel|paclitaxel|mesh-list
64874956|NCT01869023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874957|NCT01869023|Antiviral Agents|antiviral agents|mesh-ancestor
64874958|NCT01869023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64874959|NCT01869023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64874960|NCT01869023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64874961|NCT01869023|Immunologic Factors|immunologic factors|mesh-ancestor
64874962|NCT01869023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874963|NCT01869036|Morphine|morphine|mesh-list
64874964|NCT01869036|Anesthetics|anesthetics|mesh-list
64874965|NCT01869036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64874966|NCT01869036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874967|NCT01869036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64874968|NCT01869036|Narcotics|narcotics|mesh-ancestor
64874969|NCT01869036|Analgesics|analgesics|mesh-ancestor
64874970|NCT01869036|Sensory System Agents|sensory system agents|mesh-ancestor
64874971|NCT01869036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64874972|NCT01869205|Ivermectin|ivermectin|mesh-list
64875009|NCT01869569|Sensory System Agents|sensory system agents|mesh-ancestor
64875010|NCT01869569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64875011|NCT01869569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875012|NCT01869569|Anticonvulsants|anticonvulsants|mesh-ancestor
64875013|NCT01869569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64875014|NCT01869569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64875015|NCT01869569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875016|NCT01869569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64875017|NCT01869569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64875018|NCT01869569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64875019|NCT01869569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64875020|NCT01869569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64875021|NCT01869621|Metformin|metformin|mesh-list
64875022|NCT01869621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64875023|NCT01869621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875024|NCT01869673|Anesthetics|anesthetics|mesh-list
64875025|NCT01869673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64875026|NCT01869673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875027|NCT01869751|Prucalopride|prucalopride|mesh-list
64643603|NCT00115700|Rituximab|rituximab|mesh-list
64875029|NCT01869751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64875030|NCT01869751|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64875031|NCT01869751|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64875032|NCT01869751|Serotonin Agents|serotonin agents|mesh-ancestor
64875033|NCT01869751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64875034|NCT01869751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875035|NCT01869751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875036|NCT01869803|Gemtuzumab|gemtuzumab|mesh-list
64875063|NCT01869907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64875064|NCT01869907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64875065|NCT01869907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875068|NCT01869946|Ropivacaine|ropivacaine|mesh-list
64875075|NCT01870011|Anesthetics|anesthetics|mesh-list
64875076|NCT01870011|Propofol|propofol|mesh-list
64875077|NCT01870011|Desflurane|desflurane|mesh-list
64875078|NCT01870011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64875079|NCT01870011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875080|NCT01870011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64875081|NCT01870011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64875082|NCT01870011|Anesthetics, General|anesthetics, general|mesh-ancestor
64875083|NCT01870011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64875111|NCT01870050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875113|NCT01870050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64875114|NCT01870115|Vitamin D|vitamin d|mesh-list
64875115|NCT01870115|Cholecalciferol|cholecalciferol|mesh-list
64875116|NCT01870115|Melatonin|melatonin|mesh-list
64875117|NCT01870115|Vitamins|vitamins|mesh-ancestor
64473112|NCT01208662|Growth Substances|growth substances|mesh-ancestor
64875118|NCT01870115|Micronutrients|micronutrients|mesh-ancestor
64875119|NCT01870115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875120|NCT01870115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64875121|NCT01870115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875122|NCT01870115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64875123|NCT01870115|Antioxidants|antioxidants|mesh-ancestor
64875124|NCT01870115|Protective Agents|protective agents|mesh-ancestor
64875125|NCT01870115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64875126|NCT01870128|Hydroxychloroquine|hydroxychloroquine|mesh-list
64875127|NCT01870128|Sulfasalazine|sulfasalazine|mesh-list
64875128|NCT01870128|Methylprednisolone|methylprednisolone|mesh-list
64875129|NCT01870128|Methotrexate|methotrexate|mesh-list
64875130|NCT01870128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64875131|NCT01870128|Abortifacient Agents|abortifacient agents|mesh-ancestor
64875132|NCT01870128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64875133|NCT01870128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875169|NCT01870219|Ketamine|ketamine|mesh-list
64875172|NCT01870219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
64875173|NCT01870219|Analgesics|analgesics|mesh-ancestor
64875174|NCT01870219|Sensory System Agents|sensory system agents|mesh-ancestor
64875175|NCT01870219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64875176|NCT01870219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875177|NCT01870219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64875178|NCT01870219|Anesthetics, General|anesthetics, general|mesh-ancestor
64339865|NCT00890591|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64875209|NCT01870440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64875210|NCT01870440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64875211|NCT01870440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875212|NCT01870440|Protease Inhibitors|protease inhibitors|mesh-ancestor
64875213|NCT01870440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875214|NCT01870440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875215|NCT01870466|Cilostazol|cilostazol|mesh-list
64875216|NCT01870466|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64875217|NCT01870466|Simvastatin|simvastatin|mesh-list
64875218|NCT01870466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64875219|NCT01870466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64875220|NCT01870466|Antimetabolites|antimetabolites|mesh-ancestor
64875221|NCT01870466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875222|NCT01870466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64875223|NCT01870466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64875250|NCT01870635|Dermatologic Agents|dermatologic agents|mesh-ancestor
64875251|NCT01870635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64875253|NCT01870635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64875254|NCT01870635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875255|NCT01870635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64875256|NCT01870635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64875257|NCT01870635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64875258|NCT01870635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64875259|NCT01870635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64875260|NCT01870648|Ondansetron|ondansetron|mesh-list
64875261|NCT01870648|Antiemetics|antiemetics|mesh-ancestor
64875262|NCT01870648|Autonomic Agents|autonomic agents|mesh-ancestor
64875263|NCT01870648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64412110|NCT03706885|Efavirenz|efavirenz|mesh-list
64875264|NCT01870648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875265|NCT01870648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64875266|NCT01870648|Antipruritics|antipruritics|mesh-ancestor
64875267|NCT01870648|Dermatologic Agents|dermatologic agents|mesh-ancestor
64875268|NCT01870648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64875269|NCT01870648|Serotonin Agents|serotonin agents|mesh-ancestor
64875270|NCT01870648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65494979|NCT04663750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579395|NCT00066677|Docetaxel|docetaxel|mesh-list
64875300|NCT01870895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875301|NCT01870895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64875302|NCT01870895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64875303|NCT01870895|Serotonin Agents|serotonin agents|mesh-ancestor
64875304|NCT01870895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64875305|NCT01870895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875306|NCT01870908|Tacrolimus|tacrolimus|mesh-list
64875307|NCT01870908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64875308|NCT01870908|Immunologic Factors|immunologic factors|mesh-ancestor
64875309|NCT01870908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875310|NCT01870908|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64875311|NCT01870908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875312|NCT01870908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875313|NCT01870986|Adalimumab|adalimumab|mesh-list
64875314|NCT01870986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64875315|NCT01870986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64875339|NCT01871376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64412192|NCT03063541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64875361|NCT01871480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64875362|NCT01871480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340011|NCT05247320|Sympatholytics|sympatholytics|mesh-ancestor
64875384|NCT01871649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64875386|NCT01871662|Interferons|interferons|mesh-list
64875387|NCT01871662|Ribavirin|ribavirin|mesh-list
64875388|NCT01871662|Interferon-alpha|interferon-alpha|mesh-list
64875389|NCT01871662|Interferon alpha-2|interferon alpha-2|mesh-list
64875390|NCT01871662|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64875391|NCT01871662|Silybin|silybin|mesh-list
64875392|NCT01871662|Silymarin|silymarin|mesh-list
64875393|NCT01871662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875394|NCT01871662|Antiviral Agents|antiviral agents|mesh-ancestor
64875395|NCT01871662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64875396|NCT01871662|Antimetabolites|antimetabolites|mesh-ancestor
64875397|NCT01871662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875398|NCT01871662|Immunologic Factors|immunologic factors|mesh-ancestor
64875399|NCT01871662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875400|NCT01871662|Antioxidants|antioxidants|mesh-ancestor
64875401|NCT01871662|Protective Agents|protective agents|mesh-ancestor
64643980|NCT02129426|Midazolam|midazolam|mesh-list
64875402|NCT01871662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64875403|NCT01871675|Rituximab|rituximab|mesh-list
64875404|NCT01871675|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64875405|NCT01871675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64875406|NCT01871675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875407|NCT01871675|Immunologic Factors|immunologic factors|mesh-ancestor
64875408|NCT01871675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875409|NCT01871675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64875410|NCT01871675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64875411|NCT01871675|Alkylating Agents|alkylating agents|mesh-ancestor
64875412|NCT01871675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875452|NCT01871740|Enalapril|enalapril|mesh-list
64875453|NCT01871740|Enalaprilat|enalaprilat|mesh-list
64875454|NCT01871740|Maleic acid|maleic acid|mesh-list
64875455|NCT01871740|Hematinics|hematinics|mesh-ancestor
64875456|NCT01871740|Vitamin B Complex|vitamin b complex|mesh-ancestor
64875457|NCT01871740|Vitamins|vitamins|mesh-ancestor
64875458|NCT01871740|Micronutrients|micronutrients|mesh-ancestor
64875485|NCT01871857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64875487|NCT01871857|Adrenergic Agents|adrenergic agents|mesh-ancestor
64875488|NCT01871857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64875489|NCT01871857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875490|NCT01871857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875491|NCT01871857|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64875492|NCT01871857|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64875493|NCT01871857|Autonomic Agents|autonomic agents|mesh-ancestor
64875494|NCT01871857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64875495|NCT01871857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64875496|NCT01871857|Respiratory System Agents|respiratory system agents|mesh-ancestor
64875497|NCT01871857|Mydriatics|mydriatics|mesh-ancestor
64875498|NCT01871857|Sympathomimetics|sympathomimetics|mesh-ancestor
64875499|NCT01871857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64875500|NCT01871922|Atropine|atropine|mesh-list
64875501|NCT01871922|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64875502|NCT01871922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64875503|NCT01871922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64875504|NCT01871922|Autonomic Agents|autonomic agents|mesh-ancestor
64340157|NCT05209490|Iodine|iodine|mesh-list
64875529|NCT01871961|Methotrexate|methotrexate|mesh-list
64875530|NCT01871961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64875531|NCT01871961|Abortifacient Agents|abortifacient agents|mesh-ancestor
64875532|NCT01871961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64875533|NCT01871961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875534|NCT01871961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64875535|NCT01871961|Antimetabolites|antimetabolites|mesh-ancestor
64875536|NCT01871961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875537|NCT01871961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875538|NCT01871961|Dermatologic Agents|dermatologic agents|mesh-ancestor
64875541|NCT01871961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64875542|NCT01871961|Immunologic Factors|immunologic factors|mesh-ancestor
64875543|NCT01871961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64875544|NCT01871961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64875545|NCT01871974|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64875546|NCT01871974|Antidepressive Agents|antidepressive agents|mesh-ancestor
64875547|NCT01871974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64875548|NCT01871974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64875549|NCT01871974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64875550|NCT01871974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64875551|NCT01871974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644126|NCT01667120|Ketorolac|ketorolac|mesh-list
64875552|NCT01871987|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64875553|NCT01871987|Antidepressive Agents|antidepressive agents|mesh-ancestor
64875554|NCT01871987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64875588|NCT01872403|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64875589|NCT01872403|Carboplatin|carboplatin|mesh-list
64875590|NCT01872403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64875591|NCT01872403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875592|NCT01872403|Tubulin Modulators|tubulin modulators|mesh-ancestor
64875593|NCT01872403|Antimitotic Agents|antimitotic agents|mesh-ancestor
64340253|NCT00854945|ON 01910|on 01910|mesh-list
64875625|NCT01872494|Anesthetics, Local|anesthetics, local|mesh-ancestor
64875626|NCT01872494|Anesthetics|anesthetics|mesh-ancestor
64875627|NCT01872494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64875628|NCT01872494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875629|NCT01872494|Sensory System Agents|sensory system agents|mesh-ancestor
64875630|NCT01872494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64875631|NCT01872494|Antiemetics|antiemetics|mesh-ancestor
64875632|NCT01872494|Autonomic Agents|autonomic agents|mesh-ancestor
64875633|NCT01872494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64875634|NCT01872494|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64875635|NCT01872494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64412333|NCT02474199|Sensory System Agents|sensory system agents|mesh-ancestor
64875679|NCT01872832|Verinurad|verinurad|mesh-list
64875680|NCT01872832|Gout Suppressants|gout suppressants|mesh-ancestor
64875681|NCT01872832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64875682|NCT01872845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64875683|NCT01872845|Pravastatin|pravastatin|mesh-list
64875684|NCT01872845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64340337|NCT00838981|Methadone|methadone|mesh-list
64875706|NCT01872858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875707|NCT01872858|Antipyretics|antipyretics|mesh-ancestor
64875708|NCT01872858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64875709|NCT01872858|Autonomic Agents|autonomic agents|mesh-ancestor
64875710|NCT01872858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64875711|NCT01872858|Respiratory System Agents|respiratory system agents|mesh-ancestor
64875712|NCT01872858|Vasodilator Agents|vasodilator agents|mesh-ancestor
64875713|NCT01872858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64875714|NCT01872858|Protective Agents|protective agents|mesh-ancestor
64875715|NCT01872858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64875716|NCT01872858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64875717|NCT01872871|Acetaminophen|acetaminophen|mesh-list
64875718|NCT01872871|Anesthetics|anesthetics|mesh-list
64875719|NCT01872871|Anesthetics, Local|anesthetics, local|mesh-list
64875720|NCT01872871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64875721|NCT01872871|Analgesics|analgesics|mesh-ancestor
64875722|NCT01872871|Sensory System Agents|sensory system agents|mesh-ancestor
64875723|NCT01872871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64875724|NCT01872871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875725|NCT01872871|Antipyretics|antipyretics|mesh-ancestor
64875726|NCT01872871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64875727|NCT01872884|Remifentanil|remifentanil|mesh-list
64875728|NCT01872884|Sevoflurane|sevoflurane|mesh-list
64875729|NCT01872884|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64875730|NCT01872884|Narcotics|narcotics|mesh-ancestor
64875731|NCT01872884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64875732|NCT01872884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875733|NCT01872884|Analgesics|analgesics|mesh-ancestor
64501799|NCT03062943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501800|NCT03062943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501801|NCT01536886|Betamethasone|betamethasone|mesh-list
64501802|NCT01536886|Calcipotriene|calcipotriene|mesh-list
64501803|NCT01536886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64501804|NCT01536886|Glucocorticoids|glucocorticoids|mesh-ancestor
64724259|NCT00000385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64412386|NCT02448771|Bazedoxifene|bazedoxifene|mesh-list
64875734|NCT01872884|Sensory System Agents|sensory system agents|mesh-ancestor
64875735|NCT01872884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64875764|NCT01872988|Tenofovir|tenofovir|mesh-list
64875765|NCT01872988|Antiviral Agents|antiviral agents|mesh-ancestor
64875766|NCT01872988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64875767|NCT01872988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64875768|NCT01872988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64875769|NCT01872988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875770|NCT01872988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875771|NCT01872988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64875772|NCT01872988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64875773|NCT01873001|Pioglitazone|pioglitazone|mesh-list
64875774|NCT01873001|Abiraterone Acetate|abiraterone acetate|mesh-list
64875775|NCT01873001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64875776|NCT01873001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875777|NCT01873001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875778|NCT01873001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64875779|NCT01873001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340430|NCT05025735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64875792|NCT01873027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64875793|NCT01873027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875794|NCT01873027|Antifungal Agents|antifungal agents|mesh-ancestor
64875795|NCT01873079|Esomeprazole|esomeprazole|mesh-list
64875796|NCT01873079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64875797|NCT01873079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64875798|NCT01873079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64875799|NCT01873079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875800|NCT01873079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412439|NCT03117751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64875815|NCT01873144|Mydriatics|mydriatics|mesh-ancestor
64875816|NCT01873144|Sympathomimetics|sympathomimetics|mesh-ancestor
64875817|NCT01873144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64875818|NCT01873157|Bortezomib|bortezomib|mesh-list
64875819|NCT01873157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875820|NCT01873222|Sirolimus|sirolimus|mesh-list
64875821|NCT01873222|Umirolimus|umirolimus|mesh-list
64875822|NCT01873222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64875823|NCT01873222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64875824|NCT01873222|Immunologic Factors|immunologic factors|mesh-ancestor
64875825|NCT01873222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875826|NCT01873222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64875827|NCT01873222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64875828|NCT01873222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64875829|NCT01873222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875830|NCT01873222|Antifungal Agents|antifungal agents|mesh-ancestor
64875831|NCT01873313|Ropivacaine|ropivacaine|mesh-list
64875832|NCT01873313|Anesthetics, Local|anesthetics, local|mesh-ancestor
64875833|NCT01873313|Anesthetics|anesthetics|mesh-ancestor
64875834|NCT01873313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64875835|NCT01873313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875836|NCT01873313|Sensory System Agents|sensory system agents|mesh-ancestor
64875837|NCT01873313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64875838|NCT01873339|Midazolam|midazolam|mesh-list
64875839|NCT01873339|Darapladib|darapladib|mesh-list
64875840|NCT01873339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64875841|NCT01873339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64875842|NCT01873339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64875843|NCT01873339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875859|NCT01873378|Contraceptive Agents|contraceptive agents|mesh-ancestor
64875874|NCT01873443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875875|NCT01873443|Immunologic Factors|immunologic factors|mesh-ancestor
64875876|NCT01873443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875877|NCT01873443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64875878|NCT01873443|Hematinics|hematinics|mesh-ancestor
64875879|NCT01873443|Vitamin B Complex|vitamin b complex|mesh-ancestor
64875880|NCT01873443|Vitamins|vitamins|mesh-ancestor
64875881|NCT01873443|Micronutrients|micronutrients|mesh-ancestor
64875882|NCT01873573|Triamcinolone|triamcinolone|mesh-list
64875883|NCT01873573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64875884|NCT01873573|Glucocorticoids|glucocorticoids|mesh-ancestor
64875885|NCT01873573|Hormones|hormones|mesh-ancestor
64875886|NCT01873573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64875887|NCT01873573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875888|NCT01873690|Ciprofloxacin|ciprofloxacin|mesh-list
64875889|NCT01873690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64875890|NCT01873690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64875891|NCT01873690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64875892|NCT01873690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64875893|NCT01873690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875894|NCT01873690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494981|NCT04663750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579698|NCT05545800|Insulin|insulin|mesh-list
64875895|NCT01873690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875896|NCT01873690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64875897|NCT01873690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64875898|NCT01873768|Tranexamic Acid|tranexamic acid|mesh-list
64875899|NCT01873768|Aminocaproic Acid|aminocaproic acid|mesh-list
64875900|NCT01873768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64875901|NCT01873768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64875902|NCT01873768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875903|NCT01873768|Hemostatics|hemostatics|mesh-ancestor
64340538|NCT02276560|Paclitaxel|paclitaxel|mesh-list
64875941|NCT01873833|Alkylating Agents|alkylating agents|mesh-ancestor
64875942|NCT01873833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875943|NCT01873833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875944|NCT01873833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64875945|NCT01873833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64875946|NCT01873833|Antimetabolites|antimetabolites|mesh-ancestor
64875947|NCT01873833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64875948|NCT01873833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64875949|NCT01873833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875950|NCT01873885|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
64875966|NCT01874041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64875967|NCT01874041|Antifungal Agents|antifungal agents|mesh-ancestor
64875968|NCT01874041|Keratolytic Agents|keratolytic agents|mesh-ancestor
64875969|NCT01874041|Dermatologic Agents|dermatologic agents|mesh-ancestor
64875970|NCT01874080|Metformin|metformin|mesh-list
64875971|NCT01874080|Saxagliptin|saxagliptin|mesh-list
64875972|NCT01874080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64875973|NCT01874080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875974|NCT01874080|Incretins|incretins|mesh-ancestor
64875975|NCT01874080|Hormones|hormones|mesh-ancestor
64875976|NCT01874080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64875977|NCT01874080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64875978|NCT01874080|Protease Inhibitors|protease inhibitors|mesh-ancestor
64875979|NCT01874080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875980|NCT01874080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875981|NCT01874171|Cetuximab|cetuximab|mesh-list
64875982|NCT01874171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875983|NCT01874171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64875984|NCT01874236|Bupivacaine|bupivacaine|mesh-list
64875985|NCT01874236|Anesthetics, Local|anesthetics, local|mesh-ancestor
64875986|NCT01874236|Anesthetics|anesthetics|mesh-ancestor
64875987|NCT01874236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64875988|NCT01874236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875989|NCT01874236|Sensory System Agents|sensory system agents|mesh-ancestor
64875990|NCT01874236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64412576|NCT02448225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875994|NCT01874314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64875995|NCT01874314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64875996|NCT01874314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875997|NCT01874314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875998|NCT01874314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875999|NCT01874470|Antihypertensive Agents|antihypertensive agents|mesh-list
64876000|NCT01874470|Diuretics|diuretics|mesh-list
64876001|NCT01874470|Natriuretic Agents|natriuretic agents|mesh-ancestor
64876002|NCT01874470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876003|NCT01874561|Moxifloxacin|moxifloxacin|mesh-list
64876004|NCT01874561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64876005|NCT01874561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64876006|NCT01874561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64876007|NCT01874561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64876008|NCT01874561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876009|NCT01874561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494982|NCT04663750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64473113|NCT01208662|Growth Inhibitors|growth inhibitors|mesh-ancestor
64876010|NCT01874561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876045|NCT01874717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876046|NCT01874730|Anesthetics|anesthetics|mesh-list
64876047|NCT01874730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64876048|NCT01874730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876049|NCT01874743|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64876050|NCT01874743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64876051|NCT01874743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64876052|NCT01874743|Antimetabolites|antimetabolites|mesh-ancestor
64876053|NCT01874743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876054|NCT01874743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64340701|NCT00833495|Antiemetics|antiemetics|mesh-ancestor
64876083|NCT01875172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876085|NCT01875172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64876090|NCT01875185|Aspirin|aspirin|mesh-list
64876091|NCT01875185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64876092|NCT01875185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64876093|NCT01875185|Analgesics|analgesics|mesh-ancestor
64876094|NCT01875185|Sensory System Agents|sensory system agents|mesh-ancestor
64876095|NCT01875185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64876096|NCT01875185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876097|NCT01875185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64876098|NCT01875185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64876130|NCT01875263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64876132|NCT01875653|Sargramostim|sargramostim|mesh-list
64876133|NCT01875653|Immunologic Factors|immunologic factors|mesh-ancestor
64876134|NCT01875653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876135|NCT01875653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876136|NCT01875666|Trastuzumab|trastuzumab|mesh-list
64876137|NCT01875666|Pertuzumab|pertuzumab|mesh-list
64876138|NCT01875666|Lapatinib|lapatinib|mesh-list
64876139|NCT01875666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64876140|NCT01875666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876141|NCT01875666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64876167|NCT01875822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876168|NCT01875926|Gontivimab|gontivimab|mesh-list
64876169|NCT01875926|Antiviral Agents|antiviral agents|mesh-ancestor
64876170|NCT01875926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64876171|NCT01875952|Isoniazid|isoniazid|mesh-list
64876172|NCT01875952|Antitubercular Agents|antitubercular agents|mesh-ancestor
64876173|NCT01875952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64876174|NCT01875952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64876175|NCT01875952|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64876176|NCT01875952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64876177|NCT01875952|Antimetabolites|antimetabolites|mesh-ancestor
64876178|NCT01875952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876179|NCT01875952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64876180|NCT01876004|Methotrexate|methotrexate|mesh-list
64876181|NCT01876004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64876182|NCT01876004|Abortifacient Agents|abortifacient agents|mesh-ancestor
64412659|NCT05697185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64876187|NCT01876004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876188|NCT01876004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876189|NCT01876004|Dermatologic Agents|dermatologic agents|mesh-ancestor
64876210|NCT01876121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64876212|NCT01876121|Analgesics|analgesics|mesh-ancestor
64876213|NCT01876121|Sensory System Agents|sensory system agents|mesh-ancestor
64876214|NCT01876121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64876215|NCT01876121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876216|NCT01876121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64876217|NCT01876121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64876218|NCT01876121|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64876219|NCT01876121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65494983|NCT04663750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64473114|NCT00920621|Vitamin D|vitamin d|mesh-list
64579845|NCT01689441|Vitamins|vitamins|mesh-ancestor
64876220|NCT01876121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876221|NCT01876121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876222|NCT01876186|Solifenacin Succinate|solifenacin succinate|mesh-list
64876223|NCT01876186|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64876224|NCT01876186|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64876225|NCT01876186|Cholinergic Agents|cholinergic agents|mesh-ancestor
64876226|NCT01876186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64876227|NCT01876186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876228|NCT01876186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876229|NCT01876186|Urological Agents|urological agents|mesh-ancestor
64876230|NCT01876290|Dexamethasone|dexamethasone|mesh-list
64876231|NCT01876290|Ondansetron|ondansetron|mesh-list
64644800|NCT00612716|Busulfan|busulfan|mesh-list
64876232|NCT01876290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64876233|NCT01876290|Antiemetics|antiemetics|mesh-ancestor
64876234|NCT01876290|Autonomic Agents|autonomic agents|mesh-ancestor
64876235|NCT01876290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64876236|NCT01876290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876242|NCT01876290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876243|NCT01876290|Antipruritics|antipruritics|mesh-ancestor
64876244|NCT01876290|Dermatologic Agents|dermatologic agents|mesh-ancestor
64876273|NCT01876550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64876274|NCT01876550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876275|NCT01876550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64876276|NCT01876550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64876277|NCT01876550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64876278|NCT01876550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876279|NCT01876550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876280|NCT01876563|Vitamin D|vitamin d|mesh-list
64876281|NCT01876563|Vitamins|vitamins|mesh-ancestor
64876282|NCT01876563|Micronutrients|micronutrients|mesh-ancestor
64876283|NCT01876563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876284|NCT01876563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64876285|NCT01876615|Diclofenac|diclofenac|mesh-list
64876286|NCT01876615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64876287|NCT01876615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64876288|NCT01876615|Analgesics|analgesics|mesh-ancestor
64876289|NCT01876615|Sensory System Agents|sensory system agents|mesh-ancestor
64340936|NCT05047094|Pembrolizumab|pembrolizumab|mesh-list
64876303|NCT01876641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876304|NCT01876641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64876305|NCT01876797|Ticagrelor|ticagrelor|mesh-list
64876306|NCT01876797|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64876307|NCT01876797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64876308|NCT01876797|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64876309|NCT01876797|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64876310|NCT01876797|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64876311|NCT01876797|Purinergic Agents|purinergic agents|mesh-ancestor
64876312|NCT01876797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64876314|NCT01876797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876324|NCT01876862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64876325|NCT01876966|Ritonavir|ritonavir|mesh-list
64876326|NCT01876966|Darunavir|darunavir|mesh-list
64876327|NCT01876966|Lumefantrine|lumefantrine|mesh-list
64876328|NCT01876966|Artemether|artemether|mesh-list
64876329|NCT01876966|Etravirine|etravirine|mesh-list
64876330|NCT01876966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64876331|NCT01876966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65494984|NCT04663750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473115|NCT00920621|Ergocalciferols|ergocalciferols|mesh-list
64473116|NCT00920621|Cholecalciferol|cholecalciferol|mesh-list
64876332|NCT01876966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64876333|NCT01876966|Protease Inhibitors|protease inhibitors|mesh-ancestor
64876334|NCT01876966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876335|NCT01876966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876336|NCT01876966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64876337|NCT01876966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64876338|NCT01876966|Antiviral Agents|antiviral agents|mesh-ancestor
64876339|NCT01876966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64876340|NCT01876966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64876341|NCT01876966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64876342|NCT01876966|Antimalarials|antimalarials|mesh-ancestor
64876343|NCT01876966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64876344|NCT01876966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64876345|NCT01876966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64876346|NCT01876966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64876347|NCT01877122|Ibuprofen|ibuprofen|mesh-list
64876348|NCT01877122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64876349|NCT01877122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64876350|NCT01877122|Analgesics|analgesics|mesh-ancestor
64876378|NCT01877512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876379|NCT01877577|Vitamin D|vitamin d|mesh-list
64876380|NCT01877577|Ergocalciferols|ergocalciferols|mesh-list
64876391|NCT01877590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876392|NCT01877590|Vitamin B Complex|vitamin b complex|mesh-ancestor
64876393|NCT01877590|Vitamins|vitamins|mesh-ancestor
64876394|NCT01877590|Micronutrients|micronutrients|mesh-ancestor
64876395|NCT01877746|Prednisone|prednisone|mesh-list
64876432|NCT01877954|Glucocorticoids|glucocorticoids|mesh-ancestor
64876433|NCT01877954|Hormones|hormones|mesh-ancestor
64876461|NCT01878318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876462|NCT01878318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876464|NCT01878318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876465|NCT01878318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64876466|NCT01878318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64876467|NCT01878318|Immunologic Factors|immunologic factors|mesh-ancestor
64876468|NCT01878318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64876469|NCT01878318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64876470|NCT01878357|Primaquine|primaquine|mesh-list
64876471|NCT01878357|Piperaquine|piperaquine|mesh-list
64876472|NCT01878357|Artenimol|artenimol|mesh-list
64876473|NCT01878357|Antimalarials|antimalarials|mesh-ancestor
64876474|NCT01878357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64876475|NCT01878357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64876476|NCT01878357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64876539|NCT01878695|Antidotes|antidotes|mesh-ancestor
64876540|NCT01878708|Dexamethasone|dexamethasone|mesh-list
64876541|NCT01878708|Dexamethasone acetate|dexamethasone acetate|mesh-list
64876542|NCT01878708|Asparaginase|asparaginase|mesh-list
64876543|NCT01878708|Pegaspargase|pegaspargase|mesh-list
64876544|NCT01878708|BB 1101|bb 1101|mesh-list
64876545|NCT01878708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64876595|NCT01879202|Methylphenidate|methylphenidate|mesh-list
64876596|NCT01879202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64876597|NCT01879202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876598|NCT01879202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64876599|NCT01879202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64876600|NCT01879202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64341245|NCT04946864|Palbociclib|palbociclib|mesh-list
64876613|NCT01879358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64876614|NCT01879358|Immunologic Factors|immunologic factors|mesh-ancestor
64876615|NCT01879358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876616|NCT01879423|Lamotrigine|lamotrigine|mesh-list
64876617|NCT01879423|Anticonvulsants|anticonvulsants|mesh-list
64876618|NCT01879423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64876619|NCT01879423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64876620|NCT01879423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876622|NCT01879423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876668|NCT01879748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876669|NCT01879748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876670|NCT01879748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64876671|NCT01879748|Protective Agents|protective agents|mesh-ancestor
64876672|NCT01879748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876673|NCT01879917|Liraglutide|liraglutide|mesh-list
64876674|NCT01879917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64876675|NCT01879917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876676|NCT01879917|Incretins|incretins|mesh-ancestor
64876677|NCT01879917|Hormones|hormones|mesh-ancestor
64473117|NCT00920621|Vitamins|vitamins|mesh-list
64473118|NCT00920621|Micronutrients|micronutrients|mesh-ancestor
64876678|NCT01879917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64876679|NCT01879930|Doxycycline|doxycycline|mesh-list
64876680|NCT01879930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64876681|NCT01879930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64876683|NCT01879930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64876684|NCT01879930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64876685|NCT01880112|Cefazolin|cefazolin|mesh-list
64876686|NCT01880112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64876687|NCT01880112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64876688|NCT01880125|Acetaminophen|acetaminophen|mesh-list
64876689|NCT01880125|Tramadol|tramadol|mesh-list
64876690|NCT01880125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64876691|NCT01880125|Analgesics|analgesics|mesh-ancestor
64876692|NCT01880125|Sensory System Agents|sensory system agents|mesh-ancestor
64876693|NCT01880125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64876694|NCT01880125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876695|NCT01880125|Antipyretics|antipyretics|mesh-ancestor
64876696|NCT01880125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64876697|NCT01880125|Narcotics|narcotics|mesh-ancestor
64876698|NCT01880125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64876699|NCT01880138|Anesthetics|anesthetics|mesh-list
64876700|NCT01880138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64876702|NCT01880216|Enoxaparin|enoxaparin|mesh-list
64876710|NCT01880307|Azathioprine|azathioprine|mesh-list
64876711|NCT01880307|Infliximab|infliximab|mesh-list
64876712|NCT01880307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64876713|NCT01880307|Glucocorticoids|glucocorticoids|mesh-ancestor
64876714|NCT01880307|Hormones|hormones|mesh-ancestor
64876715|NCT01880307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64876716|NCT01880307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876717|NCT01880307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64876718|NCT01880307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876719|NCT01880307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64876720|NCT01880307|Dermatologic Agents|dermatologic agents|mesh-ancestor
64876721|NCT01880307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64876722|NCT01880307|Antimetabolites|antimetabolites|mesh-ancestor
64876723|NCT01880307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876724|NCT01880307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64876725|NCT01880307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64876726|NCT01880307|Immunologic Factors|immunologic factors|mesh-ancestor
64876727|NCT01880346|Vitamin D|vitamin d|mesh-list
64876751|NCT01880385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876752|NCT01880385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64876753|NCT01880385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64876754|NCT01880385|Alkylating Agents|alkylating agents|mesh-ancestor
64876755|NCT01880385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876756|NCT01880385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876757|NCT01880385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64876758|NCT01880385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64876759|NCT01880385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64413028|NCT04970251|Growth Inhibitors|growth inhibitors|mesh-ancestor
64473121|NCT00920621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64473122|NCT00837616|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64473124|NCT00837616|Estradiol|estradiol|mesh-list
64473125|NCT00837616|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64473126|NCT00837616|Estrogens|estrogens|mesh-ancestor
64473127|NCT00837616|Hormones|hormones|mesh-ancestor
64473128|NCT00837616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64473129|NCT00837616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473130|NCT00837616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64473131|NCT00837616|Contraceptive Agents|contraceptive agents|mesh-ancestor
64473132|NCT00837616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64473133|NCT00837616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64473134|NCT00694850|Riociguat|riociguat|mesh-list
64876777|NCT01880463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876778|NCT01880463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64876779|NCT01880463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64876780|NCT01880619|Tamsulosin|tamsulosin|mesh-list
64876781|NCT01880619|Solifenacin Succinate|solifenacin succinate|mesh-list
64876782|NCT01880619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64876783|NCT01880619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64876803|NCT01880775|Bupivacaine|bupivacaine|mesh-list
64876804|NCT01880775|Prilocaine|prilocaine|mesh-list
64876805|NCT01880775|Anesthetics, Local|anesthetics, local|mesh-ancestor
64876806|NCT01880775|Anesthetics|anesthetics|mesh-ancestor
64876807|NCT01880775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64876808|NCT01880775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876809|NCT01880775|Sensory System Agents|sensory system agents|mesh-ancestor
64876810|NCT01880775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64876811|NCT01879241|Rasagiline|rasagiline|mesh-list
64876812|NCT01879241|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64876824|NCT01880931|Sensory System Agents|sensory system agents|mesh-ancestor
64876825|NCT01880931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64876826|NCT01881074|Listerine|listerine|mesh-list
64876827|NCT01881074|Triclosan|triclosan|mesh-list
64876828|NCT01881074|Sodium Fluoride|sodium fluoride|mesh-list
64876829|NCT01881074|Cariostatic Agents|cariostatic agents|mesh-ancestor
64876830|NCT01881074|Protective Agents|protective agents|mesh-ancestor
64876831|NCT01881074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876832|NCT01881074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64876833|NCT01881074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64876834|NCT01881074|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64876835|NCT01881074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64876836|NCT01881074|Antimetabolites|antimetabolites|mesh-ancestor
64876837|NCT01881074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494988|NCT01567930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65494989|NCT01567930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494990|NCT01567930|Antifungal Agents|antifungal agents|mesh-ancestor
65494991|NCT01567930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65494992|NCT01567930|Immunologic Factors|immunologic factors|mesh-ancestor
65494993|NCT01567930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494994|NCT04604548|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
65494995|NCT04604548|Antioxidants|antioxidants|mesh-ancestor
65494996|NCT04604548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494997|NCT04604548|Protective Agents|protective agents|mesh-ancestor
65494998|NCT04604548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494999|NCT01142622|Ropivacaine|ropivacaine|mesh-list
65495000|NCT01142622|Anesthetics, Local|anesthetics, local|mesh-ancestor
65495001|NCT01142622|Anesthetics|anesthetics|mesh-ancestor
65495002|NCT01142622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64876838|NCT01881074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64876839|NCT01881100|Listerine|listerine|mesh-list
64876870|NCT01881919|Quercetin|quercetin|mesh-list
64876871|NCT01881919|Antioxidants|antioxidants|mesh-ancestor
64876872|NCT01881919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413116|NCT04959721|Hormones|hormones|mesh-ancestor
64876879|NCT01881997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64876880|NCT01881997|Narcotics|narcotics|mesh-ancestor
64876881|NCT01881997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64876882|NCT01881997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876883|NCT01881997|Analgesics|analgesics|mesh-ancestor
64876884|NCT01881997|Sensory System Agents|sensory system agents|mesh-ancestor
64876885|NCT01881997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64876886|NCT01881997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64876924|NCT01882296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64876925|NCT01882296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876958|NCT01882530|Nefopam|nefopam|mesh-list
64876959|NCT01882530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64876960|NCT01882530|Narcotics|narcotics|mesh-ancestor
64876961|NCT01882530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64876962|NCT01882530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876963|NCT01882530|Analgesics|analgesics|mesh-ancestor
64876964|NCT01882530|Sensory System Agents|sensory system agents|mesh-ancestor
64876965|NCT01882530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64876966|NCT01882530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64876967|NCT01882530|Antipyretics|antipyretics|mesh-ancestor
64341611|NCT00796289|Clomiphene|clomiphene|mesh-list
64876999|NCT01883102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877001|NCT01883167|Verinurad|verinurad|mesh-list
64877002|NCT01883167|Gout Suppressants|gout suppressants|mesh-ancestor
64877003|NCT01883167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64877004|NCT01883193|Micronutrients|micronutrients|mesh-list
64877048|NCT01883323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64877049|NCT01883323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64877050|NCT01883323|Antiviral Agents|antiviral agents|mesh-ancestor
64877051|NCT01883323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64877053|NCT01883505|Carbidopa|carbidopa|mesh-list
64877054|NCT01883505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64877055|NCT01883505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64877056|NCT01883505|Dopamine Agents|dopamine agents|mesh-ancestor
64877057|NCT01883505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64877058|NCT01883505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877059|NCT01883505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877060|NCT01883505|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64877061|NCT01883505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877062|NCT01883518|Vaccines|vaccines|mesh-list
64877063|NCT01883518|Immunologic Factors|immunologic factors|mesh-ancestor
64341692|NCT00678119|Growth Substances|growth substances|mesh-ancestor
64877082|NCT01883869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877083|NCT01883882|Analgesics, Opioid|analgesics, opioid|mesh-list
64877084|NCT01883882|Narcotics|narcotics|mesh-ancestor
64877085|NCT01883882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64877086|NCT01883882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877087|NCT01883882|Analgesics|analgesics|mesh-ancestor
64877088|NCT01883882|Sensory System Agents|sensory system agents|mesh-ancestor
64877089|NCT01883882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877090|NCT01883921|Immunoglobulins|immunoglobulins|mesh-list
64877091|NCT01883921|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64877092|NCT01883921|Antibodies|antibodies|mesh-list
64877115|NCT01884272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877116|NCT01884272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877117|NCT01884272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64877118|NCT01884272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64877119|NCT01884272|Gout Suppressants|gout suppressants|mesh-ancestor
64877120|NCT01884272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64341745|NCT03484507|Disinfectants|disinfectants|mesh-ancestor
64877128|NCT01884285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64877129|NCT01884285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64877130|NCT01884285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877131|NCT01884285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877132|NCT01884285|Hormone Antagonists|hormone antagonists|mesh-ancestor
64877133|NCT01884285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64877134|NCT01884285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877135|NCT01884285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64877136|NCT01884298|Lidocaine|lidocaine|mesh-list
64877137|NCT01884298|Remifentanil|remifentanil|mesh-list
64877138|NCT01884298|Anesthetics, Local|anesthetics, local|mesh-ancestor
64877139|NCT01884298|Anesthetics|anesthetics|mesh-ancestor
64877140|NCT01884298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64877141|NCT01884298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877142|NCT01884298|Sensory System Agents|sensory system agents|mesh-ancestor
64877143|NCT01884298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877144|NCT01884298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64877145|NCT01884298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64877146|NCT01884298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64877147|NCT01884298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64877148|NCT01884298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877149|NCT01884298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64877150|NCT01884298|Narcotics|narcotics|mesh-ancestor
64877151|NCT01884298|Analgesics|analgesics|mesh-ancestor
64877152|NCT01884402|Ribavirin|ribavirin|mesh-list
64877161|NCT01884428|Gemcitabine|gemcitabine|mesh-list
64877162|NCT01884428|Prednisolone|prednisolone|mesh-list
64580347|NCT00253513|Alkylating Agents|alkylating agents|mesh-ancestor
64877163|NCT01884428|Vinorelbine|vinorelbine|mesh-list
64877164|NCT01884428|Ifosfamide|ifosfamide|mesh-list
64877165|NCT01884428|Panobinostat|panobinostat|mesh-list
64877166|NCT01884428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64877167|NCT01884428|Antimetabolites|antimetabolites|mesh-ancestor
64877168|NCT01884428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877169|NCT01884428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64877170|NCT01884428|Antiviral Agents|antiviral agents|mesh-ancestor
64877171|NCT01884428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64877172|NCT01884428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877173|NCT01884428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64877174|NCT01884428|Immunologic Factors|immunologic factors|mesh-ancestor
64877175|NCT01884428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877176|NCT01884428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64877177|NCT01884428|Glucocorticoids|glucocorticoids|mesh-ancestor
64341815|NCT01352507|Tadalafil|tadalafil|mesh-list
64877212|NCT01884467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877213|NCT01884506|Iron|iron|mesh-list
64877214|NCT01884506|Ascorbic Acid|ascorbic acid|mesh-list
64877215|NCT01884506|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64877216|NCT01884506|Trace Elements|trace elements|mesh-ancestor
64877276|NCT01884857|Adrenergic Agents|adrenergic agents|mesh-ancestor
64877277|NCT01884857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64877278|NCT01884857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877279|NCT01884896|Metoprolol|metoprolol|mesh-list
64877280|NCT01884896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64877281|NCT01884896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64877282|NCT01884896|Sympatholytics|sympatholytics|mesh-ancestor
64877283|NCT01884896|Autonomic Agents|autonomic agents|mesh-ancestor
64877289|NCT01884896|Adrenergic Agents|adrenergic agents|mesh-ancestor
64877297|NCT01884909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877298|NCT01884909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877299|NCT01884909|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64877300|NCT01884909|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64877301|NCT01884909|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64877302|NCT01884909|Adrenergic Agents|adrenergic agents|mesh-ancestor
64877303|NCT01884909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64877304|NCT01884909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877305|NCT01884935|Natalizumab|natalizumab|mesh-list
64877306|NCT01884935|Immunologic Factors|immunologic factors|mesh-ancestor
64877353|NCT01885364|Sensory System Agents|sensory system agents|mesh-ancestor
64877354|NCT01885364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877355|NCT01885364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64877356|NCT01885364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64877357|NCT01885364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64877358|NCT01885364|Adrenergic Agents|adrenergic agents|mesh-ancestor
64877359|NCT01885364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64877360|NCT01885364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877361|NCT01885481|Dexamethasone|dexamethasone|mesh-list
64877362|NCT01885481|Dexamethasone acetate|dexamethasone acetate|mesh-list
64877363|NCT01885481|Betamethasone|betamethasone|mesh-list
64877364|NCT01885481|Betamethasone Valerate|betamethasone valerate|mesh-list
64877365|NCT01885481|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64877366|NCT01885481|Betamethasone benzoate|betamethasone benzoate|mesh-list
64877367|NCT01885481|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64877369|NCT01885481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64877370|NCT01885481|Antiemetics|antiemetics|mesh-ancestor
64877371|NCT01885481|Autonomic Agents|autonomic agents|mesh-ancestor
64877372|NCT01885481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877373|NCT01885481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877374|NCT01885481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65495003|NCT01142622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514739|NCT01750697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64514740|NCT01750697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413361|NCT05587673|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64514744|NCT02127723|Hyaluronic Acid|hyaluronic acid|mesh-list
64877375|NCT01885481|Glucocorticoids|glucocorticoids|mesh-ancestor
64877376|NCT01885481|Hormones|hormones|mesh-ancestor
64877377|NCT01885481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64877378|NCT01885481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64877379|NCT01885481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64877380|NCT01885481|Protease Inhibitors|protease inhibitors|mesh-ancestor
64877381|NCT01885481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877382|NCT01885481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877383|NCT01885481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64877384|NCT01885481|Respiratory System Agents|respiratory system agents|mesh-ancestor
64877385|NCT01885585|Apixaban|apixaban|mesh-list
64877386|NCT01885585|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64877387|NCT01885585|Antithrombins|antithrombins|mesh-ancestor
64877388|NCT01885585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64877418|NCT01885988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64877419|NCT01885988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877420|NCT01885988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877421|NCT01886001|Chlorhexidine|chlorhexidine|mesh-list
64877422|NCT01886001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64877423|NCT01886001|Povidone-Iodine|povidone-iodine|mesh-list
64877425|NCT01886001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64877426|NCT01886001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64877427|NCT01886001|Disinfectants|disinfectants|mesh-ancestor
64877428|NCT01886001|Dermatologic Agents|dermatologic agents|mesh-ancestor
64877429|NCT01886001|Plasma Substitutes|plasma substitutes|mesh-ancestor
64877430|NCT01886001|Blood Substitutes|blood substitutes|mesh-ancestor
64877431|NCT01886014|Oxytocin|oxytocin|mesh-list
64877432|NCT01886014|Oxytocics|oxytocics|mesh-ancestor
64877433|NCT01886014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64877434|NCT01886014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877461|NCT01886196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64877462|NCT01886196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64877465|NCT01886209|Prednisone|prednisone|mesh-list
64877469|NCT01886209|Prednisolone|prednisolone|mesh-list
64877470|NCT01886209|Prednisolone acetate|prednisolone acetate|mesh-list
64877471|NCT01886209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64877472|NCT01886209|Prednisolone phosphate|prednisolone phosphate|mesh-list
64877473|NCT01886209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64877474|NCT01886209|Glucocorticoids|glucocorticoids|mesh-ancestor
64877475|NCT01886209|Hormones|hormones|mesh-ancestor
64877476|NCT01886209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64877477|NCT01886209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877478|NCT01886209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64877479|NCT01886209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64877480|NCT01886209|Antiemetics|antiemetics|mesh-ancestor
64877481|NCT01886209|Autonomic Agents|autonomic agents|mesh-ancestor
64342111|NCT02280629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64877530|NCT01886443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877531|NCT01886443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64877532|NCT01886443|Dermatologic Agents|dermatologic agents|mesh-ancestor
64877533|NCT01886443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64877534|NCT01886443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64877535|NCT01886443|Hematinics|hematinics|mesh-ancestor
64877536|NCT01886443|Vitamins|vitamins|mesh-ancestor
64877537|NCT01886443|Micronutrients|micronutrients|mesh-ancestor
64877538|NCT01886443|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64877539|NCT01886443|Protease Inhibitors|protease inhibitors|mesh-ancestor
64877540|NCT01886443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877541|NCT01886443|Anticoagulants|anticoagulants|mesh-ancestor
65495004|NCT01142622|Sensory System Agents|sensory system agents|mesh-ancestor
65495005|NCT01142622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65495006|NCT01142700|Ribavirin|ribavirin|mesh-list
65495007|NCT01142700|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65495008|NCT01142700|Antimetabolites|antimetabolites|mesh-ancestor
65495009|NCT01142700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514745|NCT02127723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64877542|NCT01886443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64877543|NCT01886443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64877550|NCT01886534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877551|NCT01886560|Doxycycline|doxycycline|mesh-list
64877552|NCT01886560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64877553|NCT01886560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64877554|NCT01886560|Antimalarials|antimalarials|mesh-ancestor
64877555|NCT01886560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64877556|NCT01886560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64877557|NCT01886573|Azacitidine|azacitidine|mesh-list
64877558|NCT01886573|Entinostat|entinostat|mesh-list
64877559|NCT01886573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
64877560|NCT01886573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64877561|NCT01886573|Antimetabolites|antimetabolites|mesh-ancestor
64877562|NCT01886573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877563|NCT01886573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64877564|NCT01886573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877565|NCT01886599|Asunaprevir|asunaprevir|mesh-list
64877566|NCT01886599|Protease Inhibitors|protease inhibitors|mesh-ancestor
64877567|NCT01886599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877653|NCT01887340|Carboplatin|carboplatin|mesh-list
64877654|NCT01887340|Etoposide|etoposide|mesh-list
64877655|NCT01887340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64877656|NCT01887340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64877657|NCT01887340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64877658|NCT01887340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64877659|NCT01887340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877660|NCT01887340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495010|NCT01142700|Antiviral Agents|antiviral agents|mesh-ancestor
64877661|NCT01887379|Furosemide|furosemide|mesh-list
64877662|NCT01887379|Diuretics|diuretics|mesh-ancestor
64877794|NCT01887847|Cholinergic Agents|cholinergic agents|mesh-ancestor
64877795|NCT01887847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64877796|NCT01887847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877797|NCT01887873|Hyaluronic Acid|hyaluronic acid|mesh-list
64877798|NCT01887873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64877799|NCT01887873|Immunologic Factors|immunologic factors|mesh-ancestor
64877800|NCT01887873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877801|NCT01887873|Viscosupplements|viscosupplements|mesh-ancestor
64877802|NCT01887873|Protective Agents|protective agents|mesh-ancestor
64877803|NCT01887951|Tramadol|tramadol|mesh-list
64877804|NCT01887951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64877805|NCT01887951|Narcotics|narcotics|mesh-ancestor
64877806|NCT01887951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64877807|NCT01887951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877808|NCT01887951|Analgesics|analgesics|mesh-ancestor
64877809|NCT01887951|Sensory System Agents|sensory system agents|mesh-ancestor
64877810|NCT01887951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877811|NCT01888042|Everolimus|everolimus|mesh-list
64877812|NCT01888042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64877813|NCT01888042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64877814|NCT01888042|Immunologic Factors|immunologic factors|mesh-ancestor
64877815|NCT01888042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877816|NCT01888107|Risperidone|risperidone|mesh-list
64877817|NCT01888107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64877818|NCT01888107|Serotonin Agents|serotonin agents|mesh-ancestor
64877819|NCT01888107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64877820|NCT01888107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877821|NCT01888107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877897|NCT01888445|Hematinics|hematinics|mesh-ancestor
64877898|NCT01888458|Micafungin|micafungin|mesh-list
64877899|NCT01888458|Antifungal Agents|antifungal agents|mesh-ancestor
64877900|NCT01888458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64877901|NCT01888536|Pregabalin|pregabalin|mesh-list
64877902|NCT01888536|Alprostadil|alprostadil|mesh-list
64877903|NCT01888536|Analgesics|analgesics|mesh-ancestor
64877904|NCT01888536|Sensory System Agents|sensory system agents|mesh-ancestor
64877905|NCT01888536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877906|NCT01888536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877907|NCT01888536|Anticonvulsants|anticonvulsants|mesh-ancestor
64877908|NCT01888536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64877909|NCT01888536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64877910|NCT01888536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877911|NCT01888536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64877912|NCT01888536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64877935|NCT01888575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877936|NCT01888575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64877937|NCT01888575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64877938|NCT01888575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877939|NCT01888575|Antipyretics|antipyretics|mesh-ancestor
64877940|NCT01888718|Fexofenadine|fexofenadine|mesh-list
64877941|NCT01888718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64877942|NCT01888718|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64877943|NCT01888718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64877944|NCT01888718|Histamine Antagonists|histamine antagonists|mesh-ancestor
64877945|NCT01888718|Histamine Agents|histamine agents|mesh-ancestor
64413738|NCT04921111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64877985|NCT01888757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64877987|NCT01888796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64877988|NCT01888796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877989|NCT01888796|Incretins|incretins|mesh-ancestor
64877990|NCT01888796|Hormones|hormones|mesh-ancestor
64877991|NCT01888796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64877992|NCT01888796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64877993|NCT01888796|Protease Inhibitors|protease inhibitors|mesh-ancestor
64877994|NCT01888796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877995|NCT01888796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877996|NCT01888822|Ciprofloxacin|ciprofloxacin|mesh-list
64877997|NCT01888822|Ampicillin|ampicillin|mesh-list
64877998|NCT01888822|Sulbactam|sulbactam|mesh-list
64877999|NCT01888822|Sultamicillin|sultamicillin|mesh-list
64878000|NCT01888822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64878001|NCT01888822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878002|NCT01888822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64878003|NCT01888822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64878004|NCT01888822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878005|NCT01888822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878006|NCT01888822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878007|NCT01888822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64878008|NCT01888822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64878009|NCT01888822|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64878010|NCT01888835|Mirtazapine|mirtazapine|mesh-list
64878122|NCT01889407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64878123|NCT01889407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878124|NCT01889407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878125|NCT01889433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64878126|NCT01889433|Antiviral Agents|antiviral agents|mesh-ancestor
64878127|NCT01889433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878128|NCT01889446|Calcium|calcium|mesh-list
64878129|NCT01889446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64878130|NCT01889446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878131|NCT01889498|Acetazolamide|acetazolamide|mesh-list
64878132|NCT01889498|Anticonvulsants|anticonvulsants|mesh-ancestor
64878133|NCT01889498|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64878134|NCT01889498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878135|NCT01889498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878136|NCT01889498|Diuretics|diuretics|mesh-ancestor
64878137|NCT01889498|Natriuretic Agents|natriuretic agents|mesh-ancestor
64878138|NCT01889498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878139|NCT01889576|Magnesium Oxide|magnesium oxide|mesh-list
64878140|NCT01889576|Antacids|antacids|mesh-ancestor
64342776|NCT02283905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878176|NCT01889771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64878177|NCT01889771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64878178|NCT01889771|Cholinergic Agents|cholinergic agents|mesh-ancestor
64878179|NCT01889771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64878180|NCT01889771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878181|NCT01889810|Vitamin D|vitamin d|mesh-list
65495011|NCT01142700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65495012|NCT01144728|Metformin|metformin|mesh-list
64580794|NCT00018031|Ribavirin|ribavirin|mesh-list
64878205|NCT01889979|Narcotics|narcotics|mesh-ancestor
64878206|NCT01889979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64878207|NCT01889979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878208|NCT01889979|Analgesics|analgesics|mesh-ancestor
64878220|NCT01890538|Histamine Agents|histamine agents|mesh-ancestor
64878221|NCT01890538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64878222|NCT01890538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878223|NCT01890538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64878224|NCT01890538|Protective Agents|protective agents|mesh-ancestor
64878225|NCT01890538|Nootropic Agents|nootropic agents|mesh-ancestor
64878226|NCT01891292|Acetylcysteine|acetylcysteine|mesh-list
64878227|NCT01891292|Enalapril|enalapril|mesh-list
64878228|NCT01891292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64878229|NCT01891292|Antiviral Agents|antiviral agents|mesh-ancestor
64878230|NCT01891292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878231|NCT01891292|Expectorants|expectorants|mesh-ancestor
64878232|NCT01891292|Respiratory System Agents|respiratory system agents|mesh-ancestor
64878233|NCT01891292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64878234|NCT01891292|Antioxidants|antioxidants|mesh-ancestor
64342867|NCT02256982|Immunologic Factors|immunologic factors|mesh-ancestor
64878268|NCT01893229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878270|NCT01893229|Serotonin Agents|serotonin agents|mesh-ancestor
64878271|NCT01893229|Antidepressive Agents|antidepressive agents|mesh-ancestor
64878272|NCT01893229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878273|NCT01893229|Antimanic Agents|antimanic agents|mesh-ancestor
64878274|NCT01893229|Anticonvulsants|anticonvulsants|mesh-ancestor
64878295|NCT01894789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64878296|NCT01894789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64878297|NCT01894789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64878298|NCT01894789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64878299|NCT01894789|Purinergic Agents|purinergic agents|mesh-ancestor
64878300|NCT01894789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64878301|NCT01894789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878302|NCT01894789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878303|NCT01894815|Dexetimide|dexetimide|mesh-list
64878304|NCT01894815|Citalopram|citalopram|mesh-list
64878315|NCT01894815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64878316|NCT01894815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64878317|NCT01894815|Parasympatholytics|parasympatholytics|mesh-ancestor
64878318|NCT01894815|Autonomic Agents|autonomic agents|mesh-ancestor
64878319|NCT01894815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64878320|NCT01894815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64878321|NCT01894815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64878322|NCT01894815|Cholinergic Agents|cholinergic agents|mesh-ancestor
64878323|NCT01895049|Mycophenolic Acid|mycophenolic acid|mesh-list
64878324|NCT01895049|Prednisone|prednisone|mesh-list
64878325|NCT01895049|Everolimus|everolimus|mesh-list
64878326|NCT01895049|Tacrolimus|tacrolimus|mesh-list
64878327|NCT01895049|Thymoglobulin|thymoglobulin|mesh-list
64878328|NCT01895049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64878329|NCT01895049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64878330|NCT01895049|Glucocorticoids|glucocorticoids|mesh-ancestor
64878352|NCT01896622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878354|NCT01896622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64878355|NCT01896622|Antiviral Agents|antiviral agents|mesh-ancestor
65495013|NCT01144728|Glimepiride|glimepiride|mesh-list
64514746|NCT02127723|Immunologic Factors|immunologic factors|mesh-ancestor
64878356|NCT01896622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878357|NCT01896622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64878358|NCT01896622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64878360|NCT01897051|Propranolol|propranolol|mesh-list
64878361|NCT01897051|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64878362|NCT01897051|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64878363|NCT01897051|Adrenergic Agents|adrenergic agents|mesh-ancestor
64878364|NCT01897051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64878365|NCT01897051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878366|NCT01897051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878367|NCT01897051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64878368|NCT01897051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64878378|NCT01897740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878379|NCT01897740|Urological Agents|urological agents|mesh-ancestor
64878380|NCT01897753|Hormones|hormones|mesh-list
64878381|NCT01897753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64878408|NCT01900015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878409|NCT01900015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64878410|NCT01900015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64878411|NCT01900015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64878412|NCT01900015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64878413|NCT01900015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64878414|NCT01900015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64878415|NCT01900015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64878416|NCT01900015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64878417|NCT01900015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64878418|NCT01900015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64878419|NCT01900028|Itraconazole|itraconazole|mesh-list
64878420|NCT01900028|Olaparib|olaparib|mesh-list
64878421|NCT01900028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64878422|NCT01900028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878423|NCT01900028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878424|NCT01900028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878425|NCT01900028|Antifungal Agents|antifungal agents|mesh-ancestor
64878426|NCT01900028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878427|NCT01900028|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64878428|NCT01900028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64878446|NCT01900106|Dideoxynucleosides|dideoxynucleosides|mesh-list
64878447|NCT01900106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64878448|NCT01900106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64878449|NCT01900106|Protease Inhibitors|protease inhibitors|mesh-ancestor
64878450|NCT01900106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878451|NCT01900106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878452|NCT01900106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64878458|NCT01900106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64878459|NCT01900106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64878460|NCT01900106|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64878461|NCT01900106|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64878462|NCT01900106|Antimetabolites|antimetabolites|mesh-ancestor
64878463|NCT01900158|Gemcitabine|gemcitabine|mesh-list
64878465|NCT01900158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878466|NCT01900158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64878467|NCT01900158|Antimetabolites|antimetabolites|mesh-ancestor
64878468|NCT01900158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878469|NCT01900158|Antiviral Agents|antiviral agents|mesh-ancestor
65495014|NCT01144728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64473137|NCT00667199|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64473138|NCT00667199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878470|NCT01900158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878471|NCT01900158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878472|NCT01900158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64878473|NCT01900158|Immunologic Factors|immunologic factors|mesh-ancestor
64878474|NCT01900158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878475|NCT01900197|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
64878476|NCT01900197|Hematinics|hematinics|mesh-ancestor
64878477|NCT01900301|Scopolamine|scopolamine|mesh-list
64878478|NCT01900301|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64878479|NCT01900301|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64878480|NCT01900301|Antiemetics|antiemetics|mesh-ancestor
64878481|NCT01900301|Autonomic Agents|autonomic agents|mesh-ancestor
64878482|NCT01900301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64878483|NCT01900301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878484|NCT01900301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64878485|NCT01900301|Mydriatics|mydriatics|mesh-ancestor
64878530|NCT01900509|Antiemetics|antiemetics|mesh-ancestor
64878531|NCT01900509|Autonomic Agents|autonomic agents|mesh-ancestor
64878532|NCT01900509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64878564|NCT01900639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64878565|NCT01900639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64878566|NCT01900639|Analgesics|analgesics|mesh-ancestor
64878567|NCT01900639|Sensory System Agents|sensory system agents|mesh-ancestor
64878568|NCT01900639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64878569|NCT01900639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878570|NCT01900639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64878571|NCT01900639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64343226|NCT02523313|Nivolumab|nivolumab|mesh-list
64878599|NCT01900717|Micronutrients|micronutrients|mesh-ancestor
64878600|NCT01900795|Ibuprofen|ibuprofen|mesh-list
64878601|NCT01900795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64878602|NCT01900795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64878603|NCT01900795|Analgesics|analgesics|mesh-ancestor
64878604|NCT01900795|Sensory System Agents|sensory system agents|mesh-ancestor
64878605|NCT01900795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64878606|NCT01900795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878607|NCT01900795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64878608|NCT01900795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64878609|NCT01900795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64878610|NCT01900795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878611|NCT01900795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878612|NCT01900847|Ketamine|ketamine|mesh-list
64878613|NCT01900847|Morphine|morphine|mesh-list
64878614|NCT01900847|Analgesics|analgesics|mesh-ancestor
64878615|NCT01900847|Sensory System Agents|sensory system agents|mesh-ancestor
64878616|NCT01900847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64878617|NCT01900847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878618|NCT01900847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64878619|NCT01900847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64878620|NCT01900847|Anesthetics, General|anesthetics, general|mesh-ancestor
64878646|NCT01900938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64414029|NCT03056599|Gemcitabine|gemcitabine|mesh-list
64724260|NCT00000385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64724261|NCT00000385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414066|NCT03056599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64878647|NCT01900938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878648|NCT01900938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64878649|NCT01900938|Anesthetics, General|anesthetics, general|mesh-ancestor
64878650|NCT01900938|Anesthetics|anesthetics|mesh-ancestor
64878651|NCT01900938|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64878652|NCT01900938|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65495015|NCT01144728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495016|NCT01144728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64878653|NCT01900938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64878654|NCT01900938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64878655|NCT01900938|GABA Modulators|gaba modulators|mesh-ancestor
64878656|NCT01900938|GABA Agents|gaba agents|mesh-ancestor
64878657|NCT01900938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64878658|NCT01900938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878659|NCT01900951|Temozolomide|temozolomide|mesh-list
64878660|NCT01900951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64878661|NCT01900951|Alkylating Agents|alkylating agents|mesh-ancestor
64878662|NCT01900951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878663|NCT01900951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878665|NCT01901003|Anticonvulsants|anticonvulsants|mesh-ancestor
64878666|NCT01901003|Antiemetics|antiemetics|mesh-ancestor
64878667|NCT01901003|Autonomic Agents|autonomic agents|mesh-ancestor
64878668|NCT01901003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64878669|NCT01901003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878670|NCT01901003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64343301|NCT04470479|Cholinergic Agents|cholinergic agents|mesh-ancestor
64878699|NCT01901172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64878738|NCT01901484|Anthelmintics|anthelmintics|mesh-ancestor
64878739|NCT01901484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64878740|NCT01901484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878741|NCT01901549|Metoprolol|metoprolol|mesh-list
64878742|NCT01901549|Lisinopril|lisinopril|mesh-list
64878743|NCT01901549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64878744|NCT01901549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64878745|NCT01901549|Sympatholytics|sympatholytics|mesh-ancestor
64878746|NCT01901549|Autonomic Agents|autonomic agents|mesh-ancestor
64878747|NCT01901549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64878748|NCT01901549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878749|NCT01901549|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64878750|NCT01901549|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64878751|NCT01901549|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64878752|NCT01901549|Adrenergic Agents|adrenergic agents|mesh-ancestor
64878753|NCT01901549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64878754|NCT01901549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878755|NCT01901549|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64878756|NCT01901549|Protease Inhibitors|protease inhibitors|mesh-ancestor
64878757|NCT01901549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878758|NCT01901549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64878759|NCT01901549|Protective Agents|protective agents|mesh-ancestor
64878760|NCT01901601|Anesthetics|anesthetics|mesh-list
64878761|NCT01901601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64878762|NCT01901601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878763|NCT01901640|Udenafil|udenafil|mesh-list
64878764|NCT01901640|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64878765|NCT01901640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64878766|NCT01901640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878767|NCT01901640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878768|NCT01901666|Hormones|hormones|mesh-list
64878769|NCT01901666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64878798|NCT01902108|Anesthetics, Local|anesthetics, local|mesh-ancestor
64878799|NCT01902108|Anesthetics|anesthetics|mesh-ancestor
64878800|NCT01902108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64878802|NCT01902108|Sensory System Agents|sensory system agents|mesh-ancestor
64878803|NCT01902108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64878804|NCT01902108|Analgesics|analgesics|mesh-ancestor
64878805|NCT01902108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64878806|NCT01902108|Sympatholytics|sympatholytics|mesh-ancestor
64878807|NCT01902108|Autonomic Agents|autonomic agents|mesh-ancestor
64878808|NCT01902108|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64878809|NCT01902108|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64878810|NCT01902108|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64878811|NCT01902108|Adrenergic Agents|adrenergic agents|mesh-ancestor
64878812|NCT01902108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64878813|NCT01902108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878815|NCT01902121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64343451|NCT00424697|GABA Agents|gaba agents|mesh-ancestor
64878838|NCT01902186|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64878839|NCT01902186|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64878840|NCT01902186|Protease Inhibitors|protease inhibitors|mesh-ancestor
64878841|NCT01902186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878842|NCT01902186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878843|NCT01902186|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64878844|NCT01902186|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64878845|NCT01902186|Antiviral Agents|antiviral agents|mesh-ancestor
64878846|NCT01902186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878847|NCT01902186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64878853|NCT01902225|Doxorubicin|doxorubicin|mesh-list
64878924|NCT01902537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878925|NCT01902537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878926|NCT01902550|Metoprolol|metoprolol|mesh-list
64878927|NCT01902550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64878928|NCT01902550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64878929|NCT01902550|Sympatholytics|sympatholytics|mesh-ancestor
64878930|NCT01902550|Autonomic Agents|autonomic agents|mesh-ancestor
64878931|NCT01902550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64878932|NCT01902550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878933|NCT01902550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64878934|NCT01902550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64878935|NCT01902550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64878936|NCT01902550|Adrenergic Agents|adrenergic agents|mesh-ancestor
64878937|NCT01902550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64878938|NCT01902550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878939|NCT01902641|Rocuronium|rocuronium|mesh-list
64878940|NCT01902641|Succinylcholine|succinylcholine|mesh-list
64343580|NCT00321815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878971|NCT01902862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64878973|NCT01902862|Immunologic Factors|immunologic factors|mesh-ancestor
64878974|NCT01902862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878975|NCT01902862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65495018|NCT01144728|Immunologic Factors|immunologic factors|mesh-ancestor
64581171|NCT04790175|Tolvaptan|tolvaptan|mesh-list
64878976|NCT01902875|Paclitaxel|paclitaxel|mesh-list
64878977|NCT01902875|Cisplatin|cisplatin|mesh-list
64878978|NCT01902875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64878979|NCT01902875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878980|NCT01902875|Tubulin Modulators|tubulin modulators|mesh-ancestor
64878981|NCT01902875|Antimitotic Agents|antimitotic agents|mesh-ancestor
64878982|NCT01902875|Mitosis Modulators|mitosis modulators|mesh-ancestor
64879010|NCT01903070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879012|NCT01903083|Tadalafil|tadalafil|mesh-list
64879013|NCT01903083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64879014|NCT01903083|Antimetabolites|antimetabolites|mesh-ancestor
64879019|NCT01903083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879020|NCT01903083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64879021|NCT01903083|Immunologic Factors|immunologic factors|mesh-ancestor
64879022|NCT01903083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879023|NCT01903083|Vasodilator Agents|vasodilator agents|mesh-ancestor
64879024|NCT01903083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64879025|NCT01903083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64879026|NCT01903083|Urological Agents|urological agents|mesh-ancestor
64879027|NCT01903096|Antidepressive Agents|antidepressive agents|mesh-list
64879028|NCT01903096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64879030|NCT01903109|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64343671|NCT02285309|Enoximone|enoximone|mesh-list
64879048|NCT01903122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879049|NCT01903200|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64879050|NCT01903200|Antidepressive Agents|antidepressive agents|mesh-ancestor
64879051|NCT01903200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64879052|NCT01903200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64879053|NCT01903200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64879054|NCT01903200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64879055|NCT01903200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879056|NCT01903278|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64879057|NCT01903278|Antiviral Agents|antiviral agents|mesh-ancestor
64879058|NCT01903278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879059|NCT01903291|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64879060|NCT01903291|Dermatologic Agents|dermatologic agents|mesh-ancestor
64879061|NCT01903291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64879062|NCT01903291|Immunologic Factors|immunologic factors|mesh-ancestor
64879063|NCT01903291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879070|NCT01903694|Sorafenib|sorafenib|mesh-list
64879083|NCT01903785|Autonomic Agents|autonomic agents|mesh-ancestor
64879084|NCT01903785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64879085|NCT01903785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879086|NCT01903785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64879087|NCT01903785|Respiratory System Agents|respiratory system agents|mesh-ancestor
64879116|NCT01904097|Pregabalin|pregabalin|mesh-list
64879117|NCT01904097|Analgesics|analgesics|mesh-ancestor
64879118|NCT01904097|Sensory System Agents|sensory system agents|mesh-ancestor
64879119|NCT01904097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64879120|NCT01904097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879121|NCT01904097|Anticonvulsants|anticonvulsants|mesh-ancestor
64879122|NCT01904097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64879123|NCT01904097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65495019|NCT01239810|Hyaluronic Acid|hyaluronic acid|mesh-list
64581245|NCT01745055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879124|NCT01904097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879125|NCT01904097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64879126|NCT01904097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64879127|NCT01904097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64879128|NCT01904097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64879129|NCT01904097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64879130|NCT01904110|Cholecalciferol|cholecalciferol|mesh-list
64879131|NCT01904110|Vitamin D|vitamin d|mesh-list
64879153|NCT01904214|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64879154|NCT01904214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879155|NCT01904214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64879156|NCT01904214|Immunologic Factors|immunologic factors|mesh-ancestor
64879157|NCT01904214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879159|NCT01904253|Amrubicin|amrubicin|mesh-list
64879160|NCT01904253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64879161|NCT01904253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64879162|NCT01904253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879172|NCT01904487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879173|NCT01904487|GABA Modulators|gaba modulators|mesh-ancestor
64879174|NCT01904487|GABA Agents|gaba agents|mesh-ancestor
64879175|NCT01904487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64879176|NCT01904487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879177|NCT01904487|Anticonvulsants|anticonvulsants|mesh-ancestor
64879178|NCT01904487|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
64879179|NCT01904487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64879180|NCT01904487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64879181|NCT01904500|Cefazolin|cefazolin|mesh-list
64879182|NCT01904500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64879183|NCT01904500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879184|NCT01904539|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
64879185|NCT01904539|Cathartics|cathartics|mesh-ancestor
64879196|NCT01904643|Cytarabine|cytarabine|mesh-list
64879197|NCT01904643|Etoposide|etoposide|mesh-list
64879198|NCT01904643|Mitoxantrone|mitoxantrone|mesh-list
64879199|NCT01904643|Lenalidomide|lenalidomide|mesh-list
64879200|NCT01904643|Etoposide phosphate|etoposide phosphate|mesh-list
64879201|NCT01904643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64879202|NCT01904643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879203|NCT01904643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64879204|NCT01904643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64879205|NCT01904643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879206|NCT01904643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879207|NCT01904643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64414375|NCT03050905|Ritonavir|ritonavir|mesh-list
64724263|NCT00002894|Carboplatin|carboplatin|mesh-list
64501806|NCT01536886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64501807|NCT01536886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501808|NCT01536886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64501809|NCT01536886|Respiratory System Agents|respiratory system agents|mesh-ancestor
64501810|NCT01536886|Dermatologic Agents|dermatologic agents|mesh-ancestor
64501811|NCT02247310|Interferons|interferons|mesh-list
64501812|NCT02247310|Interferon-beta|interferon-beta|mesh-list
64501813|NCT02247310|Interferon beta-1b|interferon beta-1b|mesh-list
64501814|NCT02247310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501815|NCT02247310|Antiviral Agents|antiviral agents|mesh-ancestor
64501828|NCT05609253|Itraconazole|itraconazole|mesh-list
64501829|NCT05609253|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
64501831|NCT05609253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501832|NCT05609253|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64501833|NCT05609253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64501834|NCT05609253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501835|NCT05609253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501836|NCT05609253|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64501837|NCT05609253|Hormone Antagonists|hormone antagonists|mesh-ancestor
64501838|NCT05609253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64414394|NCT03050827|Cholinergic Agents|cholinergic agents|mesh-ancestor
64879208|NCT01904643|Antimetabolites|antimetabolites|mesh-ancestor
64879209|NCT01904643|Antiviral Agents|antiviral agents|mesh-ancestor
64879210|NCT01904643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879211|NCT01904643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64879212|NCT01904643|Immunologic Factors|immunologic factors|mesh-ancestor
64879213|NCT01904643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879214|NCT01904643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64879215|NCT01904643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64879216|NCT01904643|Growth Substances|growth substances|mesh-ancestor
64879217|NCT01904643|Growth Inhibitors|growth inhibitors|mesh-ancestor
64879218|NCT01904643|Analgesics|analgesics|mesh-ancestor
64879219|NCT01904643|Sensory System Agents|sensory system agents|mesh-ancestor
64879220|NCT01904643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64879221|NCT01904682|ON 01910|on 01910|mesh-list
64879222|NCT01904682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879223|NCT01904682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64879224|NCT01904682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879225|NCT01904682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879226|NCT01904695|Antihypertensive Agents|antihypertensive agents|mesh-list
64879227|NCT01904695|Diuretics|diuretics|mesh-list
64879228|NCT01904695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64879229|NCT01904695|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
65495020|NCT01239810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64879230|NCT01904695|Natriuretic Agents|natriuretic agents|mesh-ancestor
64879231|NCT01904695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879232|NCT01904695|Protease Inhibitors|protease inhibitors|mesh-ancestor
64879233|NCT01904695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879234|NCT01904695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879235|NCT01904695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64879236|NCT01904734|Clomiphene|clomiphene|mesh-list
64879237|NCT01904734|Enclomiphene|enclomiphene|mesh-list
64879238|NCT01904734|Zuclomiphene|zuclomiphene|mesh-list
64879239|NCT01904734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64647799|NCT00243932|Ubiquinone|ubiquinone|mesh-list
64879240|NCT01904734|Hormone Antagonists|hormone antagonists|mesh-ancestor
64879244|NCT01904734|Fertility Agents|fertility agents|mesh-ancestor
64879245|NCT01904734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64879246|NCT01904734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64879247|NCT01904734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64879248|NCT01904747|Palbociclib|palbociclib|mesh-list
64879249|NCT01904747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879250|NCT01904747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64879251|NCT01904747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879265|NCT01904981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879266|NCT01904981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64879267|NCT01904981|Adrenergic Agents|adrenergic agents|mesh-ancestor
64879268|NCT01904981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64879269|NCT01904981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879270|NCT01904981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64879271|NCT01904981|Sympatholytics|sympatholytics|mesh-ancestor
64879272|NCT01904981|Autonomic Agents|autonomic agents|mesh-ancestor
64879273|NCT01904981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64879274|NCT01904981|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64879275|NCT01904994|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64879276|NCT01904994|Antiviral Agents|antiviral agents|mesh-ancestor
64879277|NCT01904994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879278|NCT01905059|Lamivudine|lamivudine|mesh-list
64879279|NCT01905059|Lopinavir|lopinavir|mesh-list
64879280|NCT01905059|Darunavir|darunavir|mesh-list
64879281|NCT01905059|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
64879282|NCT01905059|Protease Inhibitors|protease inhibitors|mesh-list
64879283|NCT01905059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64879284|NCT01905059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64879285|NCT01905059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879286|NCT01905059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879287|NCT01905059|Antiviral Agents|antiviral agents|mesh-ancestor
64879298|NCT01905137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64879299|NCT01905137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879300|NCT01905137|Cholinergic Agents|cholinergic agents|mesh-ancestor
64879301|NCT01905137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64879302|NCT01905137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879303|NCT01905137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64879304|NCT01905137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64879305|NCT01905150|Leucovorin|leucovorin|mesh-list
64879306|NCT01905150|Ascorbic Acid|ascorbic acid|mesh-list
64879307|NCT01905150|Gemcitabine|gemcitabine|mesh-list
64879308|NCT01905150|Fluorouracil|fluorouracil|mesh-list
64879309|NCT01905150|Docetaxel|docetaxel|mesh-list
64879310|NCT01905150|Oxaliplatin|oxaliplatin|mesh-list
64879311|NCT01905150|Irinotecan|irinotecan|mesh-list
64879312|NCT01905150|Mitomycins|mitomycins|mesh-list
64879313|NCT01905150|Mitomycin|mitomycin|mesh-list
64879402|NCT01905904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64879403|NCT01905904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879405|NCT01906073|Morphine|morphine|mesh-list
64879406|NCT01906073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64879407|NCT01906073|Narcotics|narcotics|mesh-ancestor
64879408|NCT01906073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64879409|NCT01906073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879410|NCT01906073|Analgesics|analgesics|mesh-ancestor
64879411|NCT01906073|Sensory System Agents|sensory system agents|mesh-ancestor
64879412|NCT01906073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64879413|NCT01906073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64879414|NCT01906073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64879415|NCT01906073|Anesthetics, General|anesthetics, general|mesh-ancestor
64879416|NCT01906073|Anesthetics|anesthetics|mesh-ancestor
64879417|NCT01906125|Palbociclib|palbociclib|mesh-list
64879418|NCT01906125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879419|NCT01906125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64879420|NCT01906125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879421|NCT01906125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879422|NCT01906216|Sorafenib|sorafenib|mesh-list
64879423|NCT01906216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879424|NCT01906216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64414528|NCT04814875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64879426|NCT01906216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879427|NCT01906242|Chlorhexidine|chlorhexidine|mesh-list
64879428|NCT01906242|Sodium Hypochlorite|sodium hypochlorite|mesh-list
64879429|NCT01906242|Eusol|eusol|mesh-list
64879430|NCT01906242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64879431|NCT01906242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879432|NCT01906242|Disinfectants|disinfectants|mesh-ancestor
64879433|NCT01906294|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64879434|NCT01906294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879435|NCT01906307|Angiotensin II|angiotensin ii|mesh-list
64879436|NCT01906307|Giapreza|giapreza|mesh-list
64879437|NCT01906307|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64879438|NCT01906411|Dopamine|dopamine|mesh-list
64879439|NCT01906411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64879440|NCT01906411|Sympathomimetics|sympathomimetics|mesh-ancestor
64879441|NCT01906411|Autonomic Agents|autonomic agents|mesh-ancestor
64879442|NCT01906411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64879443|NCT01906411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879444|NCT01906411|Dopamine Agents|dopamine agents|mesh-ancestor
64879480|NCT01906762|Morphine|morphine|mesh-list
64879481|NCT01906762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64879482|NCT01906762|Narcotics|narcotics|mesh-ancestor
64879483|NCT01906762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64879484|NCT01906762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879485|NCT01906762|Analgesics|analgesics|mesh-ancestor
64879508|NCT01906814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879509|NCT01906814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879510|NCT01906814|Tubulin Modulators|tubulin modulators|mesh-ancestor
64879511|NCT01906814|Antimitotic Agents|antimitotic agents|mesh-ancestor
64879512|NCT01906814|Mitosis Modulators|mitosis modulators|mesh-ancestor
64879513|NCT01906879|Bismuth|bismuth|mesh-list
64879514|NCT01906879|Antacids|antacids|mesh-ancestor
64879515|NCT01906879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879526|NCT01906944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64879527|NCT01906944|Glucocorticoids|glucocorticoids|mesh-ancestor
64879528|NCT01906944|Hormones|hormones|mesh-ancestor
64879529|NCT01906944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64879530|NCT01906944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64879531|NCT01906944|Immunologic Factors|immunologic factors|mesh-ancestor
64879532|NCT01907048|Rivaroxaban|rivaroxaban|mesh-list
64879533|NCT01907048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64879534|NCT01907048|Antithrombins|antithrombins|mesh-ancestor
64879535|NCT01907048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64879536|NCT01907048|Protease Inhibitors|protease inhibitors|mesh-ancestor
64879537|NCT01907048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879538|NCT01907048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879539|NCT01907048|Anticoagulants|anticoagulants|mesh-ancestor
64879540|NCT01907061|Acetylcysteine|acetylcysteine|mesh-list
64879541|NCT01907061|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64879542|NCT01907061|Antiviral Agents|antiviral agents|mesh-ancestor
64879560|NCT01907165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879561|NCT01907165|Trace Elements|trace elements|mesh-ancestor
64879562|NCT01907165|Micronutrients|micronutrients|mesh-ancestor
64879563|NCT01907165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879564|NCT01907165|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64879565|NCT01907165|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
64879566|NCT01907165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879567|NCT01907204|Methylprednisolone|methylprednisolone|mesh-list
64879568|NCT01907204|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64879569|NCT01907204|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64879570|NCT01907204|Prednisolone|prednisolone|mesh-list
64879571|NCT01907204|Prednisolone acetate|prednisolone acetate|mesh-list
64879572|NCT01907204|Budesonide|budesonide|mesh-list
64879576|NCT01907204|Antiemetics|antiemetics|mesh-ancestor
64879589|NCT01907204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64879590|NCT01907204|Respiratory System Agents|respiratory system agents|mesh-ancestor
64879591|NCT01907230|Entecavir|entecavir|mesh-list
64879592|NCT01907230|Antiviral Agents|antiviral agents|mesh-ancestor
64879593|NCT01907230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879594|NCT01907308|Docetaxel|docetaxel|mesh-list
64879595|NCT01907308|Trebananib|trebananib|mesh-list
64879596|NCT01907308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879597|NCT01907308|Tubulin Modulators|tubulin modulators|mesh-ancestor
64879598|NCT01907308|Antimitotic Agents|antimitotic agents|mesh-ancestor
64879599|NCT01907308|Mitosis Modulators|mitosis modulators|mesh-ancestor
64879600|NCT01907308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879601|NCT01907308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64879602|NCT01907308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64879603|NCT01907308|Growth Substances|growth substances|mesh-ancestor
64879624|NCT01907529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64879625|NCT01907529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64879626|NCT01907529|Alkylating Agents|alkylating agents|mesh-ancestor
64879627|NCT01907529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879628|NCT01907529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879629|NCT01907529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64879630|NCT01907529|Tubulin Modulators|tubulin modulators|mesh-ancestor
64879631|NCT01907529|Antimitotic Agents|antimitotic agents|mesh-ancestor
64879632|NCT01907529|Mitosis Modulators|mitosis modulators|mesh-ancestor
64879633|NCT01907529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64879634|NCT01907529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64879635|NCT01907529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64879636|NCT01907529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879637|NCT01907529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64879638|NCT01907529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64879639|NCT01907529|Growth Substances|growth substances|mesh-ancestor
64879640|NCT01907529|Growth Inhibitors|growth inhibitors|mesh-ancestor
64879641|NCT01907594|Cycloserine|cycloserine|mesh-list
64879642|NCT01907594|Nicotine|nicotine|mesh-list
64879643|NCT01907594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64879650|NCT01907594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64879651|NCT01907594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879652|NCT01907594|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64879653|NCT01907594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879654|NCT01907594|Renal Agents|renal agents|mesh-ancestor
64473141|NCT00460486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64473142|NCT00378105|Dexamethasone|dexamethasone|mesh-list
64879655|NCT01907594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64879656|NCT01907594|Antitubercular Agents|antitubercular agents|mesh-ancestor
64879657|NCT01907594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64879658|NCT01907594|Antimetabolites|antimetabolites|mesh-ancestor
64879659|NCT01907633|Domperidone|domperidone|mesh-list
64879660|NCT01907633|Antiemetics|antiemetics|mesh-ancestor
64879678|NCT01907724|Protease Inhibitors|protease inhibitors|mesh-ancestor
64879679|NCT01907724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879680|NCT01907724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879682|NCT01907776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64879683|NCT01907776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879684|NCT01907802|Dabrafenib|dabrafenib|mesh-list
64879685|NCT01907802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879686|NCT01907802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64879687|NCT01907802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879688|NCT01907802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879689|NCT01907867|Finafloxacin|finafloxacin|mesh-list
64879690|NCT01907867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64879691|NCT01907867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879692|NCT01907867|Renal Agents|renal agents|mesh-ancestor
64879693|NCT01907867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64879694|NCT01907867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64879695|NCT01907867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64879696|NCT01907867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879697|NCT01907867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879707|NCT01907984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64879708|NCT01907984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879709|NCT01907984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64879710|NCT01907984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64879711|NCT01907984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64879712|NCT01907984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64879713|NCT01907984|Anesthetics, General|anesthetics, general|mesh-ancestor
64879714|NCT01907984|Anesthetics|anesthetics|mesh-ancestor
64879715|NCT01907984|GABA Modulators|gaba modulators|mesh-ancestor
64879716|NCT01907984|GABA Agents|gaba agents|mesh-ancestor
64879717|NCT01907984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64879718|NCT01907984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879750|NCT01908075|Sympathomimetics|sympathomimetics|mesh-ancestor
64879751|NCT01908114|Vaccines|vaccines|mesh-list
64879752|NCT01908114|Immunologic Factors|immunologic factors|mesh-ancestor
64879753|NCT01908114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879754|NCT01908257|Lesinurad|lesinurad|mesh-list
64879755|NCT01908257|Ranitidine|ranitidine|mesh-list
64879756|NCT01908257|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
64879757|NCT01908257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64879758|NCT01908257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64879759|NCT01908257|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64879795|NCT01908322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344436|NCT00057473|Carboplatin|carboplatin|mesh-list
64879863|NCT01909037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879864|NCT01909037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64879865|NCT01909037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64879866|NCT01909037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879867|NCT01909037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879868|NCT01909037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879869|NCT01909063|Vitamin D|vitamin d|mesh-list
64879908|NCT01909661|Caseins|caseins|mesh-list
64879915|NCT01909752|Immunologic Factors|immunologic factors|mesh-ancestor
64344553|NCT00002429|Lamivudine|lamivudine|mesh-list
64879938|NCT01909830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64879939|NCT01909830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64879940|NCT01909843|Gontivimab|gontivimab|mesh-list
64879941|NCT01909843|Antiviral Agents|antiviral agents|mesh-ancestor
64879942|NCT01909843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879943|NCT01909856|Dexamethasone|dexamethasone|mesh-list
64879944|NCT01909856|Palonosetron|palonosetron|mesh-list
64879945|NCT01909856|Granisetron|granisetron|mesh-list
64879946|NCT01909856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64879947|NCT01909856|Antiemetics|antiemetics|mesh-ancestor
64879948|NCT01909856|Autonomic Agents|autonomic agents|mesh-ancestor
64879949|NCT01909856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64879950|NCT01909856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879951|NCT01909856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64879952|NCT01909856|Glucocorticoids|glucocorticoids|mesh-ancestor
64879953|NCT01909856|Hormones|hormones|mesh-ancestor
64879954|NCT01909856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64879955|NCT01909856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64879956|NCT01909856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879957|NCT01909856|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64879958|NCT01909856|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64879959|NCT01909856|Serotonin Agents|serotonin agents|mesh-ancestor
64879960|NCT01909856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64879961|NCT01909856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879962|NCT01910077|Tacrolimus|tacrolimus|mesh-list
64879963|NCT01910077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64879964|NCT01910077|Immunologic Factors|immunologic factors|mesh-ancestor
64880043|NCT01910259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64880044|NCT01910259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64880045|NCT01910259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64880046|NCT01910259|Protective Agents|protective agents|mesh-ancestor
64880047|NCT01910259|Diuretics|diuretics|mesh-ancestor
64880048|NCT01910259|Natriuretic Agents|natriuretic agents|mesh-ancestor
64880049|NCT01910259|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
64880050|NCT01910259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64880051|NCT01910259|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64880074|NCT01910363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64880075|NCT01910363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880076|NCT01910363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64880077|NCT01910363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64880078|NCT01910415|Moxifloxacin|moxifloxacin|mesh-list
64880079|NCT01910415|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64880081|NCT01910415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64880082|NCT01910415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64880083|NCT01910415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64880084|NCT01910415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64880085|NCT01910415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880086|NCT01910415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880087|NCT01910415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880088|NCT01910415|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65495023|NCT01239810|Viscosupplements|viscosupplements|mesh-ancestor
65495024|NCT01239810|Protective Agents|protective agents|mesh-ancestor
64880089|NCT01910415|Contraceptive Agents|contraceptive agents|mesh-ancestor
64880090|NCT01910415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64880091|NCT01910415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880092|NCT01910415|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64880093|NCT01910415|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64880094|NCT01910415|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64880097|NCT01910428|Asparaginase|asparaginase|mesh-list
64880103|NCT01910480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64880104|NCT01910480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344733|NCT03531437|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64880133|NCT01910610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880134|NCT01910610|Growth Inhibitors|growth inhibitors|mesh-ancestor
64880135|NCT01910610|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64880136|NCT01910610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64880137|NCT01910610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880138|NCT01910610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880139|NCT01910766|Ubiquinone|ubiquinone|mesh-list
64880140|NCT01910766|Coenzyme Q10|coenzyme q10|mesh-list
64880141|NCT01910766|Clomiphene|clomiphene|mesh-list
64880142|NCT01910766|Enclomiphene|enclomiphene|mesh-list
64880143|NCT01910766|Zuclomiphene|zuclomiphene|mesh-list
64880144|NCT01910766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64880145|NCT01910766|Hormone Antagonists|hormone antagonists|mesh-ancestor
64880146|NCT01910766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64880147|NCT01910766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880148|NCT01910766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64880170|NCT01910870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64880171|NCT01910870|Alkylating Agents|alkylating agents|mesh-ancestor
64880172|NCT01910870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880173|NCT01910870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880174|NCT01910870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64880175|NCT01910883|Finafloxacin|finafloxacin|mesh-list
64880176|NCT01910883|Fluoroquinolones|fluoroquinolones|mesh-list
64880177|NCT01910883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64880178|NCT01910883|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64880179|NCT01910883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64880180|NCT01910883|Renal Agents|renal agents|mesh-ancestor
64880181|NCT01910883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64880182|NCT01910883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64880183|NCT01910883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64880192|NCT01910987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64880193|NCT01910987|Antiemetics|antiemetics|mesh-ancestor
64880194|NCT01910987|Autonomic Agents|autonomic agents|mesh-ancestor
64880195|NCT01910987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64880196|NCT01910987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880197|NCT01910987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64880198|NCT01910987|Glucocorticoids|glucocorticoids|mesh-ancestor
64880199|NCT01910987|Hormones|hormones|mesh-ancestor
64880200|NCT01910987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64880201|NCT01910987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64880272|NCT01911494|Analgesics|analgesics|mesh-ancestor
64880273|NCT01911494|Sensory System Agents|sensory system agents|mesh-ancestor
64880274|NCT01911494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64880275|NCT01911494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880276|NCT01911494|Anesthetics|anesthetics|mesh-ancestor
64880277|NCT01911494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64880278|NCT01911494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64880279|NCT01911494|Anticonvulsants|anticonvulsants|mesh-ancestor
64880280|NCT01911494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64344924|NCT04939649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64880316|NCT01911624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64880317|NCT01911624|Protease Inhibitors|protease inhibitors|mesh-ancestor
64880318|NCT01911624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880319|NCT01911624|Hemostatics|hemostatics|mesh-ancestor
64880320|NCT01911624|Coagulants|coagulants|mesh-ancestor
64880382|NCT01912053|Immunologic Factors|immunologic factors|mesh-ancestor
64880383|NCT01912053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880436|NCT01912534|Valsartan|valsartan|mesh-list
64880437|NCT01912534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64880467|NCT01912677|Vasodilator Agents|vasodilator agents|mesh-ancestor
64880468|NCT01912677|Tocolytic Agents|tocolytic agents|mesh-ancestor
64880469|NCT01912677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64880470|NCT01912677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64880471|NCT01912677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64880472|NCT01912677|Adrenergic Agents|adrenergic agents|mesh-ancestor
64880473|NCT01912677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64880474|NCT01912677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64880475|NCT01912677|Sympathomimetics|sympathomimetics|mesh-ancestor
64880476|NCT01912677|Autonomic Agents|autonomic agents|mesh-ancestor
64880477|NCT01912677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64880478|NCT01912677|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64880479|NCT01912677|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64880480|NCT01912677|Sympatholytics|sympatholytics|mesh-ancestor
64880502|NCT01912755|Adrenergic Agents|adrenergic agents|mesh-ancestor
64880503|NCT01912755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64880504|NCT01912755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64880505|NCT01912755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64880506|NCT01912755|Autonomic Agents|autonomic agents|mesh-ancestor
64880507|NCT01912755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64880508|NCT01912755|Respiratory System Agents|respiratory system agents|mesh-ancestor
64880509|NCT01912755|Mydriatics|mydriatics|mesh-ancestor
64880510|NCT01912755|Sympathomimetics|sympathomimetics|mesh-ancestor
64880511|NCT01912755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64880512|NCT01912820|Quercetin|quercetin|mesh-list
64880513|NCT01912820|Antioxidants|antioxidants|mesh-ancestor
64880514|NCT01912820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880515|NCT01912820|Protective Agents|protective agents|mesh-ancestor
64880516|NCT01912820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880517|NCT01912898|Vitamin D|vitamin d|mesh-list
64880518|NCT01912898|Ergocalciferols|ergocalciferols|mesh-list
64880519|NCT01912898|Cholecalciferol|cholecalciferol|mesh-list
64880520|NCT01912898|Vitamins|vitamins|mesh-list
64880521|NCT01912898|Micronutrients|micronutrients|mesh-ancestor
64880522|NCT01912898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557817|NCT05629494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64501839|NCT05609253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501840|NCT05609253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64501841|NCT01822535|Midodrine|midodrine|mesh-list
64880523|NCT01912898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64880524|NCT01912898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64880525|NCT01912976|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
64880526|NCT01912976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64880527|NCT01912976|Dermatologic Agents|dermatologic agents|mesh-ancestor
64880528|NCT01913002|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
64880529|NCT01913002|Moxifloxacin|moxifloxacin|mesh-list
64880530|NCT01913002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64880531|NCT01913002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64880532|NCT01913002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64473145|NCT00378105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64880533|NCT01913002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64880548|NCT01913015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64880549|NCT01913054|Fentanyl|fentanyl|mesh-list
64880550|NCT01913054|Propofol|propofol|mesh-list
64880551|NCT01913054|Etomidate|etomidate|mesh-list
64880552|NCT01913054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64880553|NCT01913054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64880554|NCT01913054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880555|NCT01913054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64880556|NCT01913054|Anesthetics, General|anesthetics, general|mesh-ancestor
64880557|NCT01913054|Anesthetics|anesthetics|mesh-ancestor
64880558|NCT01913054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64880559|NCT01913054|Narcotics|narcotics|mesh-ancestor
64880560|NCT01913054|Analgesics|analgesics|mesh-ancestor
64880561|NCT01913054|Sensory System Agents|sensory system agents|mesh-ancestor
64880562|NCT01913054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64880563|NCT01913054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64880564|NCT01913106|Valacyclovir|valacyclovir|mesh-list
64880565|NCT01913106|Antiviral Agents|antiviral agents|mesh-ancestor
64880566|NCT01913106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64880567|NCT01913119|Romidepsin|romidepsin|mesh-list
64501842|NCT01822535|Sympathomimetics|sympathomimetics|mesh-ancestor
64501843|NCT01822535|Autonomic Agents|autonomic agents|mesh-ancestor
64501844|NCT01822535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64501845|NCT01822535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501846|NCT01822535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64501847|NCT01822535|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64501848|NCT01822535|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64501849|NCT01822535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64501850|NCT01822535|Adrenergic Agents|adrenergic agents|mesh-ancestor
64880568|NCT01913119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64880569|NCT01913119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880570|NCT01913379|Itraconazole|itraconazole|mesh-list
64880571|NCT01913379|Gemfibrozil|gemfibrozil|mesh-list
64880572|NCT01913379|Antifungal Agents|antifungal agents|mesh-ancestor
64880573|NCT01913379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64880574|NCT01913379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64880575|NCT01913379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64880576|NCT01913379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880577|NCT01913379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880578|NCT01913379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64880579|NCT01913379|Hormone Antagonists|hormone antagonists|mesh-ancestor
64880580|NCT01913379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64880581|NCT01913379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880582|NCT01913379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64880583|NCT01913379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64880584|NCT01913379|Antimetabolites|antimetabolites|mesh-ancestor
64880585|NCT01913379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64880586|NCT01913379|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64880587|NCT01913431|Entecavir|entecavir|mesh-list
64880588|NCT01913431|Antiviral Agents|antiviral agents|mesh-ancestor
64880589|NCT01913431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64880590|NCT01913444|Antithrombins|antithrombins|mesh-list
64880591|NCT01913444|Antithrombin III|antithrombin iii|mesh-list
64880649|NCT01913990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880650|NCT01913990|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64880651|NCT01913990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64880652|NCT01913990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64880653|NCT01913990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64880654|NCT01913990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64880655|NCT01913990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64880657|NCT01914042|Milnacipran|milnacipran|mesh-list
64880666|NCT01914042|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64880667|NCT01914042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64880668|NCT01914042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64880669|NCT01914042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880670|NCT01914042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64880671|NCT01914042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64880672|NCT01914042|Antidepressive Agents|antidepressive agents|mesh-ancestor
64880673|NCT01914042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64880674|NCT01914081|Resveratrol|resveratrol|mesh-list
64880675|NCT01914081|Antioxidants|antioxidants|mesh-ancestor
64880676|NCT01914081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880677|NCT01914081|Protective Agents|protective agents|mesh-ancestor
65495025|NCT01239888|Tibolone|tibolone|mesh-list
65495026|NCT01239888|Oxytocin|oxytocin|mesh-list
64473147|NCT00378105|Autonomic Agents|autonomic agents|mesh-ancestor
64880678|NCT01914081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880679|NCT01914081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880680|NCT01914081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64880681|NCT01914133|Acarbose|acarbose|mesh-list
64345320|NCT04009876|Oxaliplatin|oxaliplatin|mesh-list
64880702|NCT01914250|Sensory System Agents|sensory system agents|mesh-ancestor
64880703|NCT01914250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64880704|NCT01914250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880705|NCT01914250|Anesthetics, Local|anesthetics, local|mesh-ancestor
64880706|NCT01914250|Anesthetics|anesthetics|mesh-ancestor
64880707|NCT01914250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64880708|NCT01914380|Aflibercept|aflibercept|mesh-list
64880709|NCT01914380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64880710|NCT01914380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64880711|NCT01914380|Growth Substances|growth substances|mesh-ancestor
64880712|NCT01914380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880713|NCT01914380|Growth Inhibitors|growth inhibitors|mesh-ancestor
64880715|NCT01914419|Oxytocin|oxytocin|mesh-list
64880724|NCT01914432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880725|NCT01914432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64880726|NCT01914432|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64880727|NCT01914432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880728|NCT01914432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64880729|NCT01914432|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64880730|NCT01914432|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64880731|NCT01914562|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
64880732|NCT01914562|Cathartics|cathartics|mesh-ancestor
64880733|NCT01914562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64880734|NCT01914627|Salicylic Acid|salicylic acid|mesh-list
64880735|NCT01914627|Salicylates|salicylates|mesh-list
64880736|NCT01914627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64880737|NCT01914627|Antifungal Agents|antifungal agents|mesh-ancestor
64345373|NCT02917096|Antiviral Agents|antiviral agents|mesh-ancestor
64880766|NCT01914744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880768|NCT01914744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64880769|NCT01914744|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64880770|NCT01914744|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64880771|NCT01914770|Belimumab|belimumab|mesh-list
64880772|NCT01914770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64880773|NCT01914770|Immunologic Factors|immunologic factors|mesh-ancestor
64880774|NCT01914770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880775|NCT01914822|Methylphenidate|methylphenidate|mesh-list
64880776|NCT01914822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64880777|NCT01914822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880778|NCT01914822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64880779|NCT01914822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64880780|NCT01914822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64880781|NCT01914822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880782|NCT01914822|Dopamine Agents|dopamine agents|mesh-ancestor
64880817|NCT01915069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64880856|NCT01915264|Acarbose|acarbose|mesh-list
64880857|NCT01915264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64880858|NCT01915264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880859|NCT01915264|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64880860|NCT01915264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495027|NCT01239888|Oxytocics|oxytocics|mesh-ancestor
65495028|NCT01239888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64473148|NCT00378105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64880861|NCT01915264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880862|NCT01915277|Dexmedetomidine|dexmedetomidine|mesh-list
64345513|NCT02500706|Insulin|insulin|mesh-list
64880897|NCT01915472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64880899|NCT01915537|Dermatologic Agents|dermatologic agents|mesh-ancestor
64880934|NCT01915901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880936|NCT01915979|Betamethasone|betamethasone|mesh-list
64880937|NCT01915979|Mitogens|mitogens|mesh-list
64880938|NCT01915979|Mitosis Modulators|mitosis modulators|mesh-ancestor
64880939|NCT01915979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880940|NCT01915979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64880966|NCT01916200|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64880967|NCT01916200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64880968|NCT01916200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64880969|NCT01916200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880970|NCT01916200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64880971|NCT01916200|Serotonin Agents|serotonin agents|mesh-ancestor
64880972|NCT01916200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880973|NCT01916200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64880974|NCT01916200|Antidepressive Agents|antidepressive agents|mesh-ancestor
64880979|NCT01916213|Hyaluronic Acid|hyaluronic acid|mesh-list
64881018|NCT01916265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64881019|NCT01916265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881020|NCT01916382|Nitisinone|nitisinone|mesh-list
64881021|NCT01916382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64881022|NCT01916382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881023|NCT01916395|Sumatriptan|sumatriptan|mesh-list
64881024|NCT01916395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64881025|NCT01916395|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64881026|NCT01916395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64881027|NCT01916395|Serotonin Agents|serotonin agents|mesh-ancestor
64881028|NCT01916395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64881029|NCT01916395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881030|NCT01916395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881031|NCT01916408|Wobenzym|wobenzym|mesh-list
64881032|NCT01916408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64881033|NCT01916408|Immunologic Factors|immunologic factors|mesh-ancestor
64881034|NCT01916408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881035|NCT01916447|Bevacizumab|bevacizumab|mesh-list
64881036|NCT01916447|Irinotecan|irinotecan|mesh-list
64881037|NCT01916447|Camptothecin|camptothecin|mesh-list
64345682|NCT02441114|Parasympatholytics|parasympatholytics|mesh-ancestor
64881061|NCT01916642|Sensory System Agents|sensory system agents|mesh-ancestor
64881062|NCT01916642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64881063|NCT01916642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64881064|NCT01916642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64881065|NCT01916642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64881066|NCT01916642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64881067|NCT01916642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881068|NCT01916642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64881069|NCT01916642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64881081|NCT01916785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64881082|NCT01916785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64881083|NCT01916785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881084|NCT01916798|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64881085|NCT01916798|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64881086|NCT01916798|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64345731|NCT04596826|Dronabinol|dronabinol|mesh-list
64881157|NCT01917058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64881158|NCT01917058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881159|NCT01917058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64881160|NCT01917058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64881192|NCT01917149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64881194|NCT01917149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64881195|NCT01917149|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64881196|NCT01917149|Protease Inhibitors|protease inhibitors|mesh-ancestor
64881197|NCT01917149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64881198|NCT01917279|Docetaxel|docetaxel|mesh-list
64881199|NCT01917279|Capecitabine|capecitabine|mesh-list
64881200|NCT01917279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345858|NCT02439320|Lasmiditan|lasmiditan|mesh-list
64881227|NCT01917331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881228|NCT01917331|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64881229|NCT01917331|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64881230|NCT01917331|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64881231|NCT01917331|Cholinergic Agents|cholinergic agents|mesh-ancestor
64881232|NCT01917331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64881234|NCT01917331|Hormones|hormones|mesh-ancestor
64881235|NCT01917331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64881236|NCT01917448|Morphine|morphine|mesh-list
64881237|NCT01917448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64881238|NCT01917448|Narcotics|narcotics|mesh-ancestor
64881239|NCT01917448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64881240|NCT01917448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881241|NCT01917448|Analgesics|analgesics|mesh-ancestor
64881247|NCT01917578|Cyclophosphamide|cyclophosphamide|mesh-list
64881248|NCT01917578|Carboplatin|carboplatin|mesh-list
64881249|NCT01917578|Doxorubicin|doxorubicin|mesh-list
64881250|NCT01917578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64881251|NCT01917578|Fluorouracil|fluorouracil|mesh-list
64881285|NCT01917617|Immunologic Factors|immunologic factors|mesh-ancestor
64881286|NCT01917617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881288|NCT01917708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64881289|NCT01917708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881290|NCT01917708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64881291|NCT01917708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64881292|NCT01917708|Immunologic Factors|immunologic factors|mesh-ancestor
64881347|NCT01918111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64881348|NCT01918111|Vasodilator Agents|vasodilator agents|mesh-ancestor
64881349|NCT01918111|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64881350|NCT01918111|Purinergic Agonists|purinergic agonists|mesh-ancestor
64881351|NCT01918111|Purinergic Agents|purinergic agents|mesh-ancestor
64881352|NCT01918111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64649886|NCT01369745|Dipyridamole|dipyridamole|mesh-list
64881353|NCT01918111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881355|NCT01918124|Cyclophosphamide|cyclophosphamide|mesh-list
64881356|NCT01918124|Cisplatin|cisplatin|mesh-list
64881357|NCT01918124|Carboplatin|carboplatin|mesh-list
64881358|NCT01918124|Doxorubicin|doxorubicin|mesh-list
64881359|NCT01918124|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64881360|NCT01918124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64881361|NCT01918124|Tubulin Modulators|tubulin modulators|mesh-ancestor
64881362|NCT01918124|Antimitotic Agents|antimitotic agents|mesh-ancestor
64881363|NCT01918124|Mitosis Modulators|mitosis modulators|mesh-ancestor
64881364|NCT01918124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346017|NCT00159783|Olanzapine|olanzapine|mesh-list
64881392|NCT01918241|Immunologic Factors|immunologic factors|mesh-ancestor
64881403|NCT01918358|Valsartan|valsartan|mesh-list
64881404|NCT01918358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64881405|NCT01918358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64881406|NCT01918358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64881407|NCT01918358|Antimetabolites|antimetabolites|mesh-ancestor
64881408|NCT01918358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881409|NCT01918358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64881410|NCT01918358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64881411|NCT01918358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64881412|NCT01918358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64881413|NCT01918358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64881414|NCT01918358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64881415|NCT01918384|Arbekacin|arbekacin|mesh-list
64881443|NCT01918514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881445|NCT01918514|Tocolytic Agents|tocolytic agents|mesh-ancestor
64881446|NCT01918514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64881447|NCT01918631|Tenofovir|tenofovir|mesh-list
64881448|NCT01918631|Entecavir|entecavir|mesh-list
64881449|NCT01918631|Antiviral Agents|antiviral agents|mesh-ancestor
64881450|NCT01918631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64881451|NCT01918631|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64881452|NCT01918631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64881453|NCT01918631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64881454|NCT01918631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881455|NCT01918631|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64881456|NCT01918631|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64881457|NCT01918709|Valsartan|valsartan|mesh-list
64881458|NCT01918709|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64881459|NCT01918709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64881460|NCT01918709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64881461|NCT01918709|Antimetabolites|antimetabolites|mesh-ancestor
64881492|NCT01918878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64881493|NCT01918878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64881494|NCT01918878|Growth Substances|growth substances|mesh-ancestor
64881495|NCT01918878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501851|NCT01822535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64501852|NCT01822535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501853|NCT01537666|Vancomycin|vancomycin|mesh-list
64501854|NCT01537666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64881496|NCT01918878|Growth Inhibitors|growth inhibitors|mesh-ancestor
64881497|NCT01918878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64881498|NCT01918904|Sodium thiosulfate|sodium thiosulfate|mesh-list
64881499|NCT01918904|Antidotes|antidotes|mesh-ancestor
64881500|NCT01918904|Protective Agents|protective agents|mesh-ancestor
64881501|NCT01918904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881502|NCT01918904|Antioxidants|antioxidants|mesh-ancestor
64881503|NCT01918904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881538|NCT01919008|Antidepressive Agents|antidepressive agents|mesh-ancestor
64881539|NCT01919008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64881540|NCT01919008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64881541|NCT01919008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64881542|NCT01919008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64881543|NCT01919008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881544|NCT01919047|Mirabegron|mirabegron|mesh-list
64346196|NCT03967288|Bupivacaine|bupivacaine|mesh-list
64881565|NCT01919255|Citric Acid|citric acid|mesh-list
64881566|NCT01919255|Anticoagulants|anticoagulants|mesh-ancestor
64881567|NCT01919255|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64881568|NCT01919255|Chelating Agents|chelating agents|mesh-ancestor
64881569|NCT01919255|Sequestering Agents|sequestering agents|mesh-ancestor
64881570|NCT01919255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881571|NCT01919255|Cathartics|cathartics|mesh-ancestor
64881572|NCT01919255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64881573|NCT01919255|Antacids|antacids|mesh-ancestor
64881574|NCT01919294|Methyltestosterone|methyltestosterone|mesh-list
64881575|NCT01919294|Testosterone|testosterone|mesh-list
65495030|NCT01239888|Androgen Antagonists|androgen antagonists|mesh-ancestor
64582220|NCT04666740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64881576|NCT01919294|Testosterone undecanoate|testosterone undecanoate|mesh-list
64881577|NCT01919294|Testosterone enanthate|testosterone enanthate|mesh-list
64881578|NCT01919294|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64881591|NCT01919424|Methacholine Chloride|methacholine chloride|mesh-list
64881592|NCT01919424|Miotics|miotics|mesh-ancestor
64881593|NCT01919424|Autonomic Agents|autonomic agents|mesh-ancestor
64881594|NCT01919424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64881595|NCT01919424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881596|NCT01919424|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64881597|NCT01919424|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
64881598|NCT01919424|Respiratory System Agents|respiratory system agents|mesh-ancestor
64881599|NCT01919424|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64881636|NCT01919905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881637|NCT01919905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64881638|NCT01919918|Adenosine|adenosine|mesh-list
64881639|NCT01919918|Analgesics|analgesics|mesh-ancestor
64881640|NCT01919918|Sensory System Agents|sensory system agents|mesh-ancestor
64881668|NCT01920074|Vasodilator Agents|vasodilator agents|mesh-ancestor
64881670|NCT01920516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64881671|NCT01920516|Alkylating Agents|alkylating agents|mesh-ancestor
64881672|NCT01920516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881673|NCT01920516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64881674|NCT01920516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64881675|NCT01920516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64881676|NCT01920516|Immunologic Factors|immunologic factors|mesh-ancestor
64881677|NCT01920516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881678|NCT01920984|Bevacizumab|bevacizumab|mesh-list
64881679|NCT01920984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64881680|NCT01920984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64881681|NCT01920984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64881682|NCT01920984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64881714|NCT01921374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64881716|NCT01921374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64881717|NCT01921374|Androgens|androgens|mesh-ancestor
64881718|NCT01921374|Immunologic Factors|immunologic factors|mesh-ancestor
64881719|NCT01921374|Progestins|progestins|mesh-ancestor
64881721|NCT01921374|Analgesics|analgesics|mesh-ancestor
64881726|NCT01921374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881727|NCT01921374|Antioxidants|antioxidants|mesh-ancestor
64881728|NCT01921374|Protective Agents|protective agents|mesh-ancestor
64881729|NCT01921374|Oxytocics|oxytocics|mesh-ancestor
64881730|NCT01921374|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64650264|NCT01499147|Vidarabine|vidarabine|mesh-list
64881731|NCT01921374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64881732|NCT01921972|Memantine|memantine|mesh-list
64881764|NCT01923935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64881765|NCT01923935|Immunologic Factors|immunologic factors|mesh-ancestor
64881766|NCT01923935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881767|NCT01923974|Melatonin|melatonin|mesh-list
64881768|NCT01923974|Antioxidants|antioxidants|mesh-ancestor
64881769|NCT01923974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881770|NCT01923974|Protective Agents|protective agents|mesh-ancestor
64881771|NCT01923974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881772|NCT01923974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64881773|NCT01924013|Vitamin D|vitamin d|mesh-list
64881774|NCT01924013|Cholecalciferol|cholecalciferol|mesh-list
65495031|NCT01239888|Hormone Antagonists|hormone antagonists|mesh-ancestor
64881775|NCT01924013|Vitamins|vitamins|mesh-ancestor
64881776|NCT01924013|Micronutrients|micronutrients|mesh-ancestor
64881777|NCT01924013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881804|NCT01927640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64881805|NCT01927640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881806|NCT01927640|Anesthetics, Local|anesthetics, local|mesh-ancestor
64881807|NCT01927640|Anesthetics|anesthetics|mesh-ancestor
64881808|NCT01927640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64881809|NCT01927640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64881810|NCT01927640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64881811|NCT01927640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64881812|NCT01927640|Dopamine Agents|dopamine agents|mesh-ancestor
64881813|NCT01927679|Vitamin E|vitamin e|mesh-list
64881814|NCT01927679|Antioxidants|antioxidants|mesh-list
64881815|NCT01927679|Vitamins|vitamins|mesh-ancestor
64881816|NCT01927679|Micronutrients|micronutrients|mesh-ancestor
64881817|NCT01927679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881820|NCT01927965|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
64881821|NCT01927965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64881822|NCT01927965|Alkylating Agents|alkylating agents|mesh-ancestor
64881823|NCT01927965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881824|NCT01927965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64881825|NCT01928407|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64881895|NCT01930396|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64881896|NCT01930396|Dalteparin|dalteparin|mesh-list
64881897|NCT01930396|Anticoagulants|anticoagulants|mesh-ancestor
64881898|NCT01930396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64881899|NCT01930396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64881900|NCT01930396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881901|NCT01930461|Immunologic Factors|immunologic factors|mesh-list
64881902|NCT01930461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881903|NCT01930552|Leucovorin|leucovorin|mesh-list
64881904|NCT01930552|Fluorouracil|fluorouracil|mesh-list
64881905|NCT01930552|Irinotecan|irinotecan|mesh-list
64881906|NCT01930552|Aflibercept|aflibercept|mesh-list
64881907|NCT01930552|Antimetabolites|antimetabolites|mesh-ancestor
64346565|NCT02293187|Vitamin D|vitamin d|mesh-list
64881940|NCT01930604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64881941|NCT01930604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881942|NCT01930604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64881943|NCT01930604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64881944|NCT01930604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881945|NCT01930604|Cholinergic Agents|cholinergic agents|mesh-ancestor
64881946|NCT01930604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64881947|NCT01930604|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64881948|NCT01930682|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64881979|NCT01930786|Botulinum Toxins|botulinum toxins|mesh-list
64881991|NCT01930812|Fluorides|fluorides|mesh-list
64881992|NCT01930812|Sodium Fluoride|sodium fluoride|mesh-list
64881993|NCT01930812|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
64882021|NCT01930877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882023|NCT01930916|Antibodies|antibodies|mesh-list
64882024|NCT01930916|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
64882025|NCT01930916|Lupus Coagulation Inhibitor|lupus coagulation inhibitor|mesh-list
64882026|NCT01930916|Immunologic Factors|immunologic factors|mesh-ancestor
64882027|NCT01930916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882028|NCT01930955|Amoxicillin|amoxicillin|mesh-list
64882029|NCT01930955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64882030|NCT01930955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64882031|NCT01931085|Triclabendazole|triclabendazole|mesh-list
64882032|NCT01931085|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64882033|NCT01931085|Anthelmintics|anthelmintics|mesh-ancestor
64650563|NCT00877604|Antiviral Agents|antiviral agents|mesh-ancestor
64882034|NCT01931085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64882035|NCT01931085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64882036|NCT01931098|Topotecan|topotecan|mesh-list
64882037|NCT01931098|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64346685|NCT02299115|Prednisolone|prednisolone|mesh-list
64882071|NCT01931293|Vitamin B Complex|vitamin b complex|mesh-list
64882072|NCT01931293|Vitamins|vitamins|mesh-ancestor
64882073|NCT01931293|Micronutrients|micronutrients|mesh-ancestor
64882074|NCT01931293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882075|NCT01931293|Hematinics|hematinics|mesh-ancestor
64882076|NCT01931306|Afatinib|afatinib|mesh-list
64882077|NCT01931306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882078|NCT01931306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64882079|NCT01931306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882080|NCT01931306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882121|NCT01931514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64882122|NCT01931514|Respiratory System Agents|respiratory system agents|mesh-ancestor
64882123|NCT01931514|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64882124|NCT01931514|Hormone Antagonists|hormone antagonists|mesh-ancestor
64882125|NCT01931514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64882126|NCT01931514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882127|NCT01931514|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64882128|NCT01931514|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64882129|NCT01931514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882130|NCT01931592|Gentamicins|gentamicins|mesh-list
64882131|NCT01931592|Colistin|colistin|mesh-list
64882162|NCT01931683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882164|NCT01931787|Antioxidants|antioxidants|mesh-ancestor
64882165|NCT01931787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882169|NCT01931787|Vitamins|vitamins|mesh-ancestor
64882332|NCT01932580|Fluorouracil|fluorouracil|mesh-list
64882333|NCT01932580|Oxaliplatin|oxaliplatin|mesh-list
64882334|NCT01932580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882335|NCT01932580|Tubulin Modulators|tubulin modulators|mesh-ancestor
64882336|NCT01932580|Antimitotic Agents|antimitotic agents|mesh-ancestor
64882371|NCT01933022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882372|NCT01933022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64882373|NCT01933022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882374|NCT01933061|Paclitaxel|paclitaxel|mesh-list
64882375|NCT01933061|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64347034|NCT04464005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64882408|NCT01933503|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
64882409|NCT01933503|Cathartics|cathartics|mesh-ancestor
64882410|NCT01933503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64882412|NCT01933516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64882413|NCT01933516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882414|NCT01933516|Immunologic Factors|immunologic factors|mesh-ancestor
64882415|NCT01933516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882416|NCT01933516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64882417|NCT01933542|Morphine|morphine|mesh-list
64882418|NCT01933542|Chlorzoxazone|chlorzoxazone|mesh-list
64347075|NCT02303639|Amiodarone|amiodarone|mesh-list
64882437|NCT01933711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882438|NCT01933711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64882439|NCT01933906|Interferons|interferons|mesh-list
64882440|NCT01933906|Interferon-alpha|interferon-alpha|mesh-list
64882441|NCT01933906|Interferon alpha-2|interferon alpha-2|mesh-list
64882468|NCT01934023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64882469|NCT01934023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495032|NCT01239888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65495033|NCT01239888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65495034|NCT01239888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64882470|NCT01934023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882471|NCT01934049|Anesthetics|anesthetics|mesh-list
64882472|NCT01934049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64882473|NCT01934049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882474|NCT01934088|Fentanyl|fentanyl|mesh-list
64882475|NCT01934088|Midazolam|midazolam|mesh-list
64882476|NCT01934088|Propofol|propofol|mesh-list
64882477|NCT01934088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64882478|NCT01934088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64882495|NCT01934088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882497|NCT01934127|Immunologic Factors|immunologic factors|mesh-ancestor
64882498|NCT01934127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882499|NCT01934166|Nalmefene|nalmefene|mesh-list
64882500|NCT01934166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64882501|NCT01934166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882502|NCT01934166|Sensory System Agents|sensory system agents|mesh-ancestor
64882503|NCT01934166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882504|NCT01934361|Carboplatin|carboplatin|mesh-list
64882505|NCT01934361|Lomustine|lomustine|mesh-list
64882506|NCT01934361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882507|NCT01934361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64882508|NCT01934361|Alkylating Agents|alkylating agents|mesh-ancestor
64882509|NCT01934361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882510|NCT01934569|Losartan|losartan|mesh-list
64882511|NCT01934569|Midazolam|midazolam|mesh-list
64882512|NCT01934569|Caffeine|caffeine|mesh-list
64882513|NCT01934569|Omeprazole|omeprazole|mesh-list
64882514|NCT01934569|Pravastatin|pravastatin|mesh-list
64882515|NCT01934569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64882516|NCT01934569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64882521|NCT01934569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64882522|NCT01934569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64882523|NCT01934569|Anesthetics, General|anesthetics, general|mesh-ancestor
64882524|NCT01934569|Anesthetics|anesthetics|mesh-ancestor
64882525|NCT01934569|GABA Modulators|gaba modulators|mesh-ancestor
64882526|NCT01934569|GABA Agents|gaba agents|mesh-ancestor
64882527|NCT01934569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64882528|NCT01934569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882529|NCT01934569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64882530|NCT01934569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64882531|NCT01934569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64882532|NCT01934569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64882533|NCT01934569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64882534|NCT01934569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64882535|NCT01934569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882536|NCT01934569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64882537|NCT01934569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64882538|NCT01934569|Purinergic Agents|purinergic agents|mesh-ancestor
64882539|NCT01934569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64882564|NCT01934712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64882565|NCT01934712|Insulin Aspart|insulin aspart|mesh-list
64882566|NCT01934712|Insulin, Long-Acting|insulin, long-acting|mesh-list
64882567|NCT01934712|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64882568|NCT01934712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64882569|NCT01934712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882570|NCT01934777|Vitamin E|vitamin e|mesh-list
64882571|NCT01934777|Choline|choline|mesh-list
64882572|NCT01934777|Vitamins|vitamins|mesh-ancestor
64882573|NCT01934777|Micronutrients|micronutrients|mesh-ancestor
64882574|NCT01934777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882575|NCT01934777|Antioxidants|antioxidants|mesh-ancestor
64882576|NCT01934777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882580|NCT01934777|Antimetabolites|antimetabolites|mesh-ancestor
64882588|NCT01934816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64882589|NCT01934816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882591|NCT01934816|Hormones|hormones|mesh-ancestor
64882592|NCT01934816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64882616|NCT01934933|Immunologic Factors|immunologic factors|mesh-ancestor
64882617|NCT01935063|Lidocaine|lidocaine|mesh-list
64882618|NCT01935063|Anesthetics, Local|anesthetics, local|mesh-ancestor
64882619|NCT01935063|Anesthetics|anesthetics|mesh-ancestor
64882620|NCT01935063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64882621|NCT01935063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882622|NCT01935063|Sensory System Agents|sensory system agents|mesh-ancestor
64882623|NCT01935063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882624|NCT01935063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64882625|NCT01935063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64882626|NCT01935063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64882627|NCT01935063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64882628|NCT01935063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882629|NCT01935089|Interferons|interferons|mesh-list
64882630|NCT01935089|Interferon-alpha|interferon-alpha|mesh-list
64882631|NCT01935089|Interferon alpha-2|interferon alpha-2|mesh-list
64882632|NCT01935089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64882633|NCT01935089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882634|NCT01935089|Antiviral Agents|antiviral agents|mesh-ancestor
64882635|NCT01935089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64882636|NCT01935089|Immunologic Factors|immunologic factors|mesh-ancestor
64882637|NCT01935089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882638|NCT01935115|Ketamine|ketamine|mesh-list
64882639|NCT01935115|Propofol|propofol|mesh-list
64882640|NCT01935115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64882641|NCT01935115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64882642|NCT01935115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882643|NCT01935115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64882675|NCT01935206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882677|NCT01935310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64882683|NCT01935492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64882684|NCT01935492|Bevacizumab|bevacizumab|mesh-list
64882711|NCT01935505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882712|NCT01935505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882714|NCT01935505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64882715|NCT01935505|Cholinergic Agents|cholinergic agents|mesh-ancestor
64882716|NCT01935505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64882717|NCT01935505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882718|NCT01935505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64882719|NCT01935505|Antidepressive Agents|antidepressive agents|mesh-ancestor
64882720|NCT01935505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64882721|NCT01935505|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64882722|NCT01935505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64882723|NCT01935505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64882725|NCT01935505|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64882726|NCT01935505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64882727|NCT01935505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882728|NCT01935518|Fasudil|fasudil|mesh-list
64882729|NCT01935518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64882730|NCT01935518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64882731|NCT01935518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347375|NCT01603407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882758|NCT01935544|Cholinergic Agents|cholinergic agents|mesh-ancestor
64882759|NCT01935544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64882760|NCT01935544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882761|NCT01935557|Heparin|heparin|mesh-list
64882762|NCT01935557|Calcium heparin|calcium heparin|mesh-list
64882763|NCT01935557|Anticoagulants|anticoagulants|mesh-ancestor
64882764|NCT01935557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64882765|NCT01935557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64882766|NCT01935557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882767|NCT01935596|Ropivacaine|ropivacaine|mesh-list
64882774|NCT01935596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882775|NCT01935648|Ropivacaine|ropivacaine|mesh-list
64882776|NCT01935648|Anesthetics, Local|anesthetics, local|mesh-ancestor
64882777|NCT01935648|Anesthetics|anesthetics|mesh-ancestor
64882778|NCT01935648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64882808|NCT01935713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64882809|NCT01935713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882811|NCT01935804|Pioglitazone|pioglitazone|mesh-list
64882812|NCT01935804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64882813|NCT01935804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882815|NCT01935817|Silybin|silybin|mesh-list
64882816|NCT01935817|Vitamins|vitamins|mesh-ancestor
64882817|NCT01935817|Micronutrients|micronutrients|mesh-ancestor
64882818|NCT01935817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882819|NCT01935817|Antioxidants|antioxidants|mesh-ancestor
64882820|NCT01935817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882821|NCT01935817|Protective Agents|protective agents|mesh-ancestor
64882822|NCT01935817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64882823|NCT01935817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882824|NCT01935830|Ritonavir|ritonavir|mesh-list
64882825|NCT01935830|Efavirenz|efavirenz|mesh-list
64882839|NCT01935830|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64882840|NCT01935830|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64882841|NCT01935830|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64882842|NCT01935830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64882843|NCT01935830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64882844|NCT01935869|Petrolatum|petrolatum|mesh-list
64882845|NCT01935869|Emollients|emollients|mesh-ancestor
64882846|NCT01935869|Dermatologic Agents|dermatologic agents|mesh-ancestor
64882847|NCT01935882|Lumefantrine|lumefantrine|mesh-list
64882848|NCT01935882|Artemether|artemether|mesh-list
64882849|NCT01935882|Primaquine|primaquine|mesh-list
64882862|NCT01935973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882863|NCT01936012|Lisinopril|lisinopril|mesh-list
64882864|NCT01936012|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64882865|NCT01936012|Protease Inhibitors|protease inhibitors|mesh-ancestor
64882866|NCT01936012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882867|NCT01936012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882868|NCT01936012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64882869|NCT01936012|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64882870|NCT01936012|Protective Agents|protective agents|mesh-ancestor
64882871|NCT01936012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882872|NCT01936025|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64882873|NCT01936025|Dextromethorphan|dextromethorphan|mesh-list
64882874|NCT01936025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64882875|NCT01936025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882876|NCT01936025|Incretins|incretins|mesh-ancestor
64882877|NCT01936025|Hormones|hormones|mesh-ancestor
64882878|NCT01936025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64882879|NCT01936025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64882880|NCT01936025|Protease Inhibitors|protease inhibitors|mesh-ancestor
64882881|NCT01936025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882882|NCT01936025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882883|NCT01936025|Antitussive Agents|antitussive agents|mesh-ancestor
64882884|NCT01936025|Respiratory System Agents|respiratory system agents|mesh-ancestor
64882885|NCT01936025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64882908|NCT01936090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882922|NCT01936129|(T,G)-A-L|(t,g)-a-l|mesh-list
64882930|NCT01936220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64882931|NCT01936220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882932|NCT01936220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64882933|NCT01936233|Aspirin|aspirin|mesh-list
64651466|NCT05310344|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64882934|NCT01936233|Lamivudine|lamivudine|mesh-list
64882935|NCT01936233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64882936|NCT01936233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64882969|NCT01936350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882970|NCT01936350|Urological Agents|urological agents|mesh-ancestor
64882971|NCT01936532|Dexamethasone|dexamethasone|mesh-list
64882972|NCT01936532|Lenalidomide|lenalidomide|mesh-list
64882973|NCT01936532|Ixazomib|ixazomib|mesh-list
64882974|NCT01936532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64882975|NCT01936532|Antiemetics|antiemetics|mesh-ancestor
64882976|NCT01936532|Autonomic Agents|autonomic agents|mesh-ancestor
64882977|NCT01936532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882978|NCT01936532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882979|NCT01936532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64882980|NCT01936532|Glucocorticoids|glucocorticoids|mesh-ancestor
64883098|NCT01937442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64883099|NCT01937442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64883100|NCT01937442|Growth Substances|growth substances|mesh-ancestor
64883101|NCT01937442|Growth Inhibitors|growth inhibitors|mesh-ancestor
64883102|NCT01937442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883103|NCT01937494|Benzyl Alcohol|benzyl alcohol|mesh-list
64883104|NCT01937494|Histamine|histamine|mesh-list
64883105|NCT01937494|Histamine Agonists|histamine agonists|mesh-ancestor
64883106|NCT01937494|Histamine Agents|histamine agents|mesh-ancestor
64883430|NCT01939418|Antimetabolites|antimetabolites|mesh-ancestor
64883431|NCT01939418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883432|NCT01939418|Antiviral Agents|antiviral agents|mesh-ancestor
64883433|NCT01939418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64883434|NCT01939418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64883435|NCT01939418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64883436|NCT01939418|Immunologic Factors|immunologic factors|mesh-ancestor
64883437|NCT01939418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883438|NCT01939444|Naloxone|naloxone|mesh-list
64883466|NCT01939509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883467|NCT01939509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64883468|NCT01939509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64883469|NCT01939509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64883470|NCT01939509|Adrenergic Agents|adrenergic agents|mesh-ancestor
64883471|NCT01939509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64883472|NCT01939509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883473|NCT01939522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64883474|NCT01939522|Immunologic Factors|immunologic factors|mesh-ancestor
64883475|NCT01939522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883476|NCT01939561|Lamotrigine|lamotrigine|mesh-list
64883477|NCT01939561|Anticonvulsants|anticonvulsants|mesh-ancestor
64883478|NCT01939561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64883479|NCT01939561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64883480|NCT01939561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883481|NCT01939561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64883482|NCT01939561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883483|NCT01939561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64737036|NCT00374543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64737037|NCT00374543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737038|NCT00374543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737039|NCT00374543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64349121|NCT02322203|Niacin|niacin|mesh-list
64737569|NCT03121001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64737570|NCT03121001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737571|NCT03121001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737572|NCT03121001|Antifungal Agents|antifungal agents|mesh-ancestor
64737574|NCT03055247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64737575|NCT03055247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64737576|NCT03055247|Analgesics|analgesics|mesh-ancestor
64737577|NCT03055247|Sensory System Agents|sensory system agents|mesh-ancestor
64737613|NCT00000275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64737614|NCT00000275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64737950|NCT00000449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737952|NCT00000449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737953|NCT00000455|Naltrexone|naltrexone|mesh-list
64737954|NCT00000455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64737955|NCT00000455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64737956|NCT00000455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737957|NCT00000455|Sensory System Agents|sensory system agents|mesh-ancestor
64737958|NCT00000455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737959|NCT00001307|Capsaicin|capsaicin|mesh-list
64737960|NCT00001307|Antipruritics|antipruritics|mesh-ancestor
64737961|NCT00001307|Dermatologic Agents|dermatologic agents|mesh-ancestor
64737962|NCT00001307|Sensory System Agents|sensory system agents|mesh-ancestor
64737963|NCT00001307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64501855|NCT01537666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501856|NCT01537900|Grazoprevir|grazoprevir|mesh-list
64501857|NCT01537900|Antiviral Agents|antiviral agents|mesh-ancestor
64501858|NCT01537900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501859|NCT01799993|Amikacin|amikacin|mesh-list
64501860|NCT01799993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64501861|NCT01799993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501862|NCT03005860|Fentanyl|fentanyl|mesh-list
64501863|NCT03005860|Propofol|propofol|mesh-list
64501864|NCT03005860|Sevoflurane|sevoflurane|mesh-list
64501865|NCT03005860|Atracurium|atracurium|mesh-list
64501866|NCT03005860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64501867|NCT03005860|Narcotics|narcotics|mesh-ancestor
64501868|NCT03005860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64501869|NCT03005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501870|NCT03005860|Analgesics|analgesics|mesh-ancestor
64427749|NCT02210091|BAX 855|bax 855|mesh-list
64501877|NCT03005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501885|NCT03005860|Cholinergic Agents|cholinergic agents|mesh-ancestor
64501886|NCT03005860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64737964|NCT00001307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737965|NCT04713761|Carboplatin|carboplatin|mesh-list
64737966|NCT04713761|Pemetrexed|pemetrexed|mesh-list
64737967|NCT04713761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64737968|NCT04713761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737969|NCT04713761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737970|NCT04713761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65495035|NCT01239888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64737971|NCT04713761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64737972|NCT00001937|Fluconazole|fluconazole|mesh-list
64737973|NCT00001937|Antifungal Agents|antifungal agents|mesh-ancestor
64737974|NCT00001937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737975|NCT00001937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64737976|NCT00001937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64737977|NCT00001937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737978|NCT00001937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350114|NCT03489239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64350115|NCT03489161|Buprenorphine|buprenorphine|mesh-list
64350116|NCT03489161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64350117|NCT03489161|Narcotics|narcotics|mesh-ancestor
64350118|NCT03489161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64350119|NCT03489161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350120|NCT03489161|Analgesics|analgesics|mesh-ancestor
64350121|NCT03489161|Sensory System Agents|sensory system agents|mesh-ancestor
64350122|NCT03489161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350123|NCT03489161|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64350124|NCT04804709|Panobinostat|panobinostat|mesh-list
64738364|NCT00001577|Immunologic Factors|immunologic factors|mesh-ancestor
64738385|NCT00002093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64738386|NCT00002093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738387|NCT00002093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738388|NCT00002093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64738389|NCT00002093|Tubulin Modulators|tubulin modulators|mesh-ancestor
64738390|NCT00002093|Antimitotic Agents|antimitotic agents|mesh-ancestor
64738391|NCT00002093|Mitosis Modulators|mitosis modulators|mesh-ancestor
64738392|NCT00002099|Didanosine|didanosine|mesh-list
64738393|NCT00002099|Lentinan|lentinan|mesh-list
64738394|NCT00002099|Antimetabolites|antimetabolites|mesh-ancestor
64738395|NCT00002099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738396|NCT00002099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738397|NCT00002099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738398|NCT00002099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738399|NCT00002099|Antiviral Agents|antiviral agents|mesh-ancestor
64738400|NCT00002099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738421|NCT00002333|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64738422|NCT00002333|Protease Inhibitors|protease inhibitors|mesh-ancestor
64738423|NCT00002333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738424|NCT00002333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738425|NCT00002333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738426|NCT00002333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738427|NCT00002333|Antiviral Agents|antiviral agents|mesh-ancestor
64738428|NCT00002333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738429|NCT00002333|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64738430|NCT00002333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64738431|NCT00002333|Antimetabolites|antimetabolites|mesh-ancestor
64738432|NCT00002333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738433|NCT00002333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738434|NCT00002339|Fluconazole|fluconazole|mesh-list
64738444|NCT00002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738445|NCT00002339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64738446|NCT00002339|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64738447|NCT00002105|Doxorubicin|doxorubicin|mesh-list
64738448|NCT00002105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64738450|NCT00002105|Vincristine|vincristine|mesh-list
64738451|NCT00002105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64738452|NCT00002105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738453|NCT00002105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64738454|NCT00002105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64738455|NCT00002105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738456|NCT00002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738486|NCT00002111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64738487|NCT00002351|Indinavir|indinavir|mesh-list
64738488|NCT00002351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64738489|NCT00002351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64738490|NCT00002351|Protease Inhibitors|protease inhibitors|mesh-ancestor
64738491|NCT00002351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738492|NCT00002351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738493|NCT00002351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738494|NCT00002351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738495|NCT00002351|Antiviral Agents|antiviral agents|mesh-ancestor
64738496|NCT00002351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738497|NCT00002357|Zidovudine|zidovudine|mesh-list
64738498|NCT00002357|Antimetabolites|antimetabolites|mesh-ancestor
64738499|NCT00002357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350536|NCT05152511|Vasodilator Agents|vasodilator agents|mesh-ancestor
64738748|NCT02973581|Antipyretics|antipyretics|mesh-ancestor
64738749|NCT02973581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64738750|NCT02973581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64738751|NCT02973581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64738753|NCT00002435|Antimetabolites|antimetabolites|mesh-ancestor
64738754|NCT00002435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738755|NCT00002435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738756|NCT00002435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738829|NCT00002471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501887|NCT03005860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64738830|NCT00002471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64738831|NCT00002471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64738832|NCT00002471|Antiemetics|antiemetics|mesh-ancestor
64738833|NCT00002471|Autonomic Agents|autonomic agents|mesh-ancestor
64738834|NCT00002471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64738835|NCT00002471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64738836|NCT00002471|Glucocorticoids|glucocorticoids|mesh-ancestor
64738837|NCT00002471|Hormones|hormones|mesh-ancestor
64738838|NCT00002471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64738839|NCT00002471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64738840|NCT00002471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64738841|NCT00002471|Abortifacient Agents|abortifacient agents|mesh-ancestor
64738842|NCT00002471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64738843|NCT00002471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64738844|NCT00002471|Antimetabolites|antimetabolites|mesh-ancestor
64738845|NCT00002471|Dermatologic Agents|dermatologic agents|mesh-ancestor
64738846|NCT00002471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738847|NCT00002471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64738848|NCT00002471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738849|NCT00002471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64738850|NCT00002471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64738851|NCT00002471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64738852|NCT00002471|Antiviral Agents|antiviral agents|mesh-ancestor
64738853|NCT00002471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738854|NCT00002471|Antidotes|antidotes|mesh-ancestor
64738855|NCT00002471|Protective Agents|protective agents|mesh-ancestor
64738856|NCT00002471|Vitamin B Complex|vitamin b complex|mesh-ancestor
64738857|NCT00002471|Vitamins|vitamins|mesh-ancestor
64738858|NCT00002471|Micronutrients|micronutrients|mesh-ancestor
64501888|NCT01593592|Amoxicillin|amoxicillin|mesh-list
64501889|NCT01593592|Clarithromycin|clarithromycin|mesh-list
64501891|NCT01593592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64724264|NCT00002894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64724265|NCT00002894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64724266|NCT00002894|Tubulin Modulators|tubulin modulators|mesh-ancestor
64724267|NCT00002894|Antimitotic Agents|antimitotic agents|mesh-ancestor
64724268|NCT00002894|Mitosis Modulators|mitosis modulators|mesh-ancestor
64724269|NCT00002894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724270|NCT00000829|Vaccines|vaccines|mesh-list
64331842|NCT04597190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501892|NCT01593592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501893|NCT01593592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64501894|NCT01593592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64501895|NCT01593592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64501896|NCT01593592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945706|NCT05298696|Protective Agents|protective agents|mesh-ancestor
64738859|NCT00002471|Tubulin Modulators|tubulin modulators|mesh-ancestor
65495036|NCT01239888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64738860|NCT00002471|Antimitotic Agents|antimitotic agents|mesh-ancestor
64738861|NCT00002471|Mitosis Modulators|mitosis modulators|mesh-ancestor
64738862|NCT00002471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64738863|NCT00002471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64738864|NCT00002477|Cyclophosphamide|cyclophosphamide|mesh-list
64738911|NCT00002489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738912|NCT00002489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64738913|NCT00002489|Antidotes|antidotes|mesh-ancestor
64738914|NCT00002489|Protective Agents|protective agents|mesh-ancestor
64738915|NCT00002489|Vitamin B Complex|vitamin b complex|mesh-ancestor
64738917|NCT00002489|Micronutrients|micronutrients|mesh-ancestor
64738918|NCT00002489|Tubulin Modulators|tubulin modulators|mesh-ancestor
64738919|NCT00002489|Antimitotic Agents|antimitotic agents|mesh-ancestor
64738920|NCT00002489|Mitosis Modulators|mitosis modulators|mesh-ancestor
64738921|NCT00002489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64738922|NCT00002489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738923|NCT00002489|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64738924|NCT00002495|Doxorubicin|doxorubicin|mesh-list
64738925|NCT00002495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64738926|NCT00002495|Vinblastine|vinblastine|mesh-list
64738927|NCT00002495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64738928|NCT00002495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738929|NCT00002495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64738930|NCT00002495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64738931|NCT00002495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738932|NCT00002495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738933|NCT00002495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64738934|NCT00002495|Tubulin Modulators|tubulin modulators|mesh-ancestor
64738935|NCT00002495|Antimitotic Agents|antimitotic agents|mesh-ancestor
64738936|NCT00002495|Mitosis Modulators|mitosis modulators|mesh-ancestor
64738937|NCT00002501|Cyclophosphamide|cyclophosphamide|mesh-list
64739057|NCT00002201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64351104|NCT02522221|Warfarin|warfarin|mesh-list
64739228|NCT00002531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64739229|NCT00002531|Immunologic Factors|immunologic factors|mesh-ancestor
64739230|NCT00002531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739231|NCT00002531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64739232|NCT00002531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64739233|NCT00002531|Alkylating Agents|alkylating agents|mesh-ancestor
64739234|NCT00002531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739235|NCT00002531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739236|NCT00002531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64739237|NCT00002531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64739238|NCT00002531|Antiemetics|antiemetics|mesh-ancestor
64739239|NCT00002531|Autonomic Agents|autonomic agents|mesh-ancestor
64478588|NCT04002297|Rituximab|rituximab|mesh-list
64739240|NCT00002531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64739241|NCT00002531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64739242|NCT00002531|Glucocorticoids|glucocorticoids|mesh-ancestor
64739243|NCT00002531|Hormones|hormones|mesh-ancestor
64739244|NCT00002531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64739245|NCT00002531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64739246|NCT00002531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64739247|NCT00002531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64739248|NCT00002531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64739249|NCT00002531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739250|NCT00002531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64739251|NCT00002531|Abortifacient Agents|abortifacient agents|mesh-ancestor
64739252|NCT00002531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64739253|NCT00002531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64739254|NCT00002531|Antimetabolites|antimetabolites|mesh-ancestor
64739255|NCT00002531|Dermatologic Agents|dermatologic agents|mesh-ancestor
64739256|NCT00002531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64739257|NCT00002531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64739400|NCT00002615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64739401|NCT00002615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64739402|NCT00002615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64739403|NCT00002615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739478|NCT00002657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64473155|NCT00378105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739479|NCT00002657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64739480|NCT00002657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64739481|NCT00002657|Abortifacient Agents|abortifacient agents|mesh-ancestor
64739482|NCT00002657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64739483|NCT00002657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64739484|NCT00002657|Antimetabolites|antimetabolites|mesh-ancestor
64739485|NCT00002657|Dermatologic Agents|dermatologic agents|mesh-ancestor
64739486|NCT00002657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64739487|NCT00002657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64739488|NCT00002657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64739489|NCT00002657|Antiviral Agents|antiviral agents|mesh-ancestor
64739490|NCT00002657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739491|NCT00002657|Tubulin Modulators|tubulin modulators|mesh-ancestor
64739492|NCT00002657|Antimitotic Agents|antimitotic agents|mesh-ancestor
64739493|NCT00002657|Mitosis Modulators|mitosis modulators|mesh-ancestor
64739520|NCT05671991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64739521|NCT05671991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739522|NCT00381875|Sargramostim|sargramostim|mesh-list
64739523|NCT00381875|Freund's Adjuvant|freund's adjuvant|mesh-list
64739524|NCT00381875|Immunologic Factors|immunologic factors|mesh-ancestor
64739525|NCT00381875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739658|NCT00002753|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64739659|NCT00002753|Immunologic Factors|immunologic factors|mesh-ancestor
64739660|NCT00002753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739661|NCT00002759|Cyclosporine|cyclosporine|mesh-list
64739662|NCT00002759|Irinotecan|irinotecan|mesh-list
64739663|NCT00002759|Phenobarbital|phenobarbital|mesh-list
64739664|NCT00002759|Cyclosporins|cyclosporins|mesh-list
64739665|NCT00002759|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64739666|NCT00002759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64739667|NCT00002759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739668|NCT00002759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739669|NCT00002759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739670|NCT00002759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64739671|NCT00002759|Immunologic Factors|immunologic factors|mesh-ancestor
64739672|NCT00002759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739673|NCT00002759|Antifungal Agents|antifungal agents|mesh-ancestor
64739674|NCT00002759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739675|NCT00002759|Dermatologic Agents|dermatologic agents|mesh-ancestor
64739676|NCT00002759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64739677|NCT00002759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64739678|NCT00002759|Anticonvulsants|anticonvulsants|mesh-ancestor
64739679|NCT00002759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64739680|NCT00002759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65495037|NCT01239888|Anabolic Agents|anabolic agents|mesh-ancestor
64583184|NCT00226577|Pemetrexed|pemetrexed|mesh-list
64739681|NCT00002759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64739682|NCT00002759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64739683|NCT00002759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64739684|NCT00002759|GABA Modulators|gaba modulators|mesh-ancestor
64739734|NCT00002783|Calcium|calcium|mesh-list
64739735|NCT00002783|Levoleucovorin|levoleucovorin|mesh-list
64739736|NCT00002783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739737|NCT00002783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64739738|NCT00002783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739748|NCT00002783|Micronutrients|micronutrients|mesh-ancestor
64739749|NCT00002789|Cyclosporine|cyclosporine|mesh-list
64739750|NCT00002789|Cyclophosphamide|cyclophosphamide|mesh-list
64739751|NCT00002789|Busulfan|busulfan|mesh-list
64739752|NCT00002789|Methotrexate|methotrexate|mesh-list
64739753|NCT00002789|Cyclosporins|cyclosporins|mesh-list
64739754|NCT00002789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64739755|NCT00002789|Immunologic Factors|immunologic factors|mesh-ancestor
64739756|NCT00002789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739757|NCT00002789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64739758|NCT00002789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64739759|NCT00002789|Alkylating Agents|alkylating agents|mesh-ancestor
64739760|NCT00002789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739761|NCT00002789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739762|NCT00002789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64739763|NCT00002789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64739764|NCT00002789|Abortifacient Agents|abortifacient agents|mesh-ancestor
64739765|NCT00002789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64739766|NCT00002789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64739767|NCT00002789|Antimetabolites|antimetabolites|mesh-ancestor
64739768|NCT00002789|Dermatologic Agents|dermatologic agents|mesh-ancestor
64739769|NCT00002789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739770|NCT00002789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64739771|NCT00002789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64739772|NCT00002789|Antifungal Agents|antifungal agents|mesh-ancestor
64739773|NCT00002789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739830|NCT05749211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739831|NCT05749211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739833|NCT02972957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64739834|NCT02972957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739835|NCT05568095|Leucovorin|leucovorin|mesh-list
64740032|NCT05343455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64740033|NCT05343455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64740035|NCT05343455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64501897|NCT01593592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501898|NCT01593592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64501899|NCT01593592|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64501900|NCT01593592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64501901|NCT03001960|Clopidogrel|clopidogrel|mesh-list
64501902|NCT03001960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64740036|NCT05343455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64352085|NCT03234491|Insulin|insulin|mesh-list
64740108|NCT00382499|Lidocaine|lidocaine|mesh-list
64740109|NCT00382499|Anesthetics, Local|anesthetics, local|mesh-ancestor
64740110|NCT00382499|Anesthetics|anesthetics|mesh-ancestor
64740111|NCT00382499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64740112|NCT00382499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740113|NCT00382499|Sensory System Agents|sensory system agents|mesh-ancestor
64740114|NCT00382499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64740115|NCT00382499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64740116|NCT00382499|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64740117|NCT00382499|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64740118|NCT00382499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64740119|NCT00382499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740120|NCT04330547|Analgesics|analgesics|mesh-list
64740121|NCT04330547|Sensory System Agents|sensory system agents|mesh-ancestor
64740122|NCT04330547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64740123|NCT04330547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740124|NCT00382889|Beclomethasone|beclomethasone|mesh-list
64740125|NCT00382889|Albuterol|albuterol|mesh-list
64740126|NCT00382889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64740127|NCT00382889|Autonomic Agents|autonomic agents|mesh-ancestor
65495038|NCT01239888|Hormones|hormones|mesh-ancestor
65495039|NCT01318486|Heparin|heparin|mesh-list
64740128|NCT00382889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64740129|NCT00382889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740130|NCT00382889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64740131|NCT00382889|Respiratory System Agents|respiratory system agents|mesh-ancestor
64740132|NCT00382889|Tocolytic Agents|tocolytic agents|mesh-ancestor
64740133|NCT00382889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64740149|NCT04482959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64352169|NCT03466775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64740171|NCT04571879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740173|NCT04571879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64740174|NCT04571879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64740175|NCT04571879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64740176|NCT04571879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64740177|NCT04571879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64740178|NCT04571879|Anesthetics, General|anesthetics, general|mesh-ancestor
64740179|NCT04571879|GABA Modulators|gaba modulators|mesh-ancestor
64740180|NCT04571879|GABA Agents|gaba agents|mesh-ancestor
64740181|NCT04571879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64740182|NCT04563533|Vaccines|vaccines|mesh-list
64740183|NCT04563533|Immunologic Factors|immunologic factors|mesh-ancestor
64740184|NCT04563533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740185|NCT05251259|Montelukast|montelukast|mesh-list
64740186|NCT05251259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64740187|NCT05251259|Respiratory System Agents|respiratory system agents|mesh-ancestor
64740188|NCT05251259|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64740189|NCT05251259|Hormone Antagonists|hormone antagonists|mesh-ancestor
64740190|NCT05251259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64740191|NCT05251259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740595|NCT00003035|Hormone Antagonists|hormone antagonists|mesh-ancestor
65495040|NCT01318486|Anticoagulants|anticoagulants|mesh-ancestor
64473156|NCT00378105|Immunologic Factors|immunologic factors|mesh-ancestor
64740596|NCT00003035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64740622|NCT04329611|Antimalarials|antimalarials|mesh-ancestor
64740623|NCT04329611|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64740624|NCT04329611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64740625|NCT04329611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64740626|NCT04329611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740627|NCT04329611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740628|NCT04329611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64740630|NCT00383357|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64740631|NCT00383357|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64740632|NCT00383357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64740633|NCT00383357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740634|NCT00383357|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64740635|NCT00383357|GABA Agonists|gaba agonists|mesh-ancestor
64740636|NCT00383357|GABA Agents|gaba agents|mesh-ancestor
64740637|NCT00383357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64740638|NCT00383357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740639|NCT00003089|Paclitaxel|paclitaxel|mesh-list
64740640|NCT00003089|Carboplatin|carboplatin|mesh-list
64740641|NCT00003089|Amifostine|amifostine|mesh-list
64740642|NCT00003089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64740643|NCT00003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740667|NCT02145143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740669|NCT03713801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64740670|NCT03713801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740671|NCT00003101|Vincristine|vincristine|mesh-list
64740672|NCT00003101|Busulfan|busulfan|mesh-list
64740673|NCT00003101|Thiotepa|thiotepa|mesh-list
64740674|NCT00003101|Lomustine|lomustine|mesh-list
64740675|NCT00003101|Procarbazine|procarbazine|mesh-list
64740676|NCT00003101|Immunologic Factors|immunologic factors|mesh-ancestor
64740683|NCT00003101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740684|NCT00003101|Alkylating Agents|alkylating agents|mesh-ancestor
64480011|NCT04509622|Antiviral Agents|antiviral agents|mesh-ancestor
64740685|NCT00003101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64740686|NCT00003101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64740707|NCT00003107|Growth Substances|growth substances|mesh-ancestor
64740708|NCT00003107|Growth Inhibitors|growth inhibitors|mesh-ancestor
64740709|NCT00003107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740710|NCT00003113|Cyclophosphamide|cyclophosphamide|mesh-list
64740712|NCT00003113|Etoposide|etoposide|mesh-list
64740713|NCT00003113|Procarbazine|procarbazine|mesh-list
64740714|NCT00003113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64740715|NCT00003113|Immunologic Factors|immunologic factors|mesh-ancestor
64352716|NCT03248531|Adalimumab|adalimumab|mesh-list
64740742|NCT01545557|Viscosupplements|viscosupplements|mesh-ancestor
64740743|NCT01545557|Protective Agents|protective agents|mesh-ancestor
64740744|NCT00003119|Cyclophosphamide|cyclophosphamide|mesh-list
64740745|NCT00003119|Carboplatin|carboplatin|mesh-list
64740746|NCT00003119|Doxorubicin|doxorubicin|mesh-list
64740747|NCT00003119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64740748|NCT00003119|Etoposide|etoposide|mesh-list
64740749|NCT00003119|Sargramostim|sargramostim|mesh-list
64740750|NCT00003119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64740751|NCT00003119|Immunologic Factors|immunologic factors|mesh-ancestor
64740752|NCT00003119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740753|NCT00003119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64740754|NCT00003119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64740755|NCT00003119|Alkylating Agents|alkylating agents|mesh-ancestor
64480086|NCT00579280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740802|NCT00003125|Aldesleukin|aldesleukin|mesh-list
64740803|NCT00003125|Vaccines|vaccines|mesh-list
64740804|NCT00003125|Sargramostim|sargramostim|mesh-list
64740805|NCT00003125|Immunologic Factors|immunologic factors|mesh-ancestor
64740806|NCT00003125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740807|NCT00003125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740808|NCT00003125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64740809|NCT00003125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64740836|NCT00003413|Mitosis Modulators|mitosis modulators|mesh-ancestor
64740837|NCT00003413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740838|NCT00003413|Immunologic Factors|immunologic factors|mesh-ancestor
64740839|NCT00003413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740840|NCT00003413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64740841|NCT00003413|Alkylating Agents|alkylating agents|mesh-ancestor
64740842|NCT00003413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64740843|NCT00003413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64740845|NCT00003137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64740846|NCT00003137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64740847|NCT00003137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740848|NCT00003137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740849|NCT00003137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740850|NCT00003419|Antiviral Agents|antiviral agents|mesh-list
64740851|NCT00003419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64740852|NCT00003425|Cyclophosphamide|cyclophosphamide|mesh-list
64740853|NCT00003425|Melphalan|melphalan|mesh-list
64740854|NCT00003425|Amifostine|amifostine|mesh-list
64740855|NCT00003425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64740856|NCT00003425|Immunologic Factors|immunologic factors|mesh-ancestor
64740857|NCT00003425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740858|NCT00003425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64740891|NCT00003143|Amifostine|amifostine|mesh-list
64559481|NCT03018015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559482|NCT03018015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64559483|NCT03018015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64559484|NCT03018015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64559485|NCT03018015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740897|NCT00003431|Immunologic Factors|immunologic factors|mesh-ancestor
64740898|NCT00003431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740899|NCT00003431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64740900|NCT00003431|Protective Agents|protective agents|mesh-ancestor
64740901|NCT00003149|Interleukin-12|interleukin-12|mesh-list
64740902|NCT00003149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64740903|NCT00003149|Immunologic Factors|immunologic factors|mesh-ancestor
64740904|NCT00003149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740905|NCT00003149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64740906|NCT00003149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64740907|NCT00003149|Growth Substances|growth substances|mesh-ancestor
64740908|NCT00003149|Growth Inhibitors|growth inhibitors|mesh-ancestor
64740909|NCT00003149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352929|NCT05184335|RP5063|rp5063|mesh-list
64740945|NCT00003437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64740946|NCT00003437|Abortifacient Agents|abortifacient agents|mesh-ancestor
64740947|NCT00003437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64740948|NCT00003437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64740949|NCT00003437|Antimetabolites|antimetabolites|mesh-ancestor
64740950|NCT00003437|Dermatologic Agents|dermatologic agents|mesh-ancestor
64741029|NCT00002819|Analgesics|analgesics|mesh-ancestor
64741104|NCT00002837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64741105|NCT00002837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64741106|NCT00002837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64741107|NCT00002837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741108|NCT00003461|Antibodies|antibodies|mesh-list
64741109|NCT00003461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64741110|NCT00003461|Immunologic Factors|immunologic factors|mesh-ancestor
64741111|NCT00003461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741112|NCT00003467|Carmustine|carmustine|mesh-list
64741113|NCT00003467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64741114|NCT00003467|Alkylating Agents|alkylating agents|mesh-ancestor
64741115|NCT00003467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741116|NCT00003467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741117|NCT00002849|Interferons|interferons|mesh-list
64741118|NCT00002849|Interferon-alpha|interferon-alpha|mesh-list
64741119|NCT00002849|Dexamethasone|dexamethasone|mesh-list
64741152|NCT00002855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64741153|NCT00002855|Antifungal Agents|antifungal agents|mesh-ancestor
64741154|NCT00002855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64741155|NCT00002855|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64741156|NCT00002855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64741157|NCT00002855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64741158|NCT00002855|Hormone Antagonists|hormone antagonists|mesh-ancestor
64741159|NCT00002855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64741160|NCT00002855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741161|NCT00002855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64741162|NCT00002855|Androgen Antagonists|androgen antagonists|mesh-ancestor
64741180|NCT00003179|Medroxyprogesterone|medroxyprogesterone|mesh-list
64741192|NCT00003539|Paclitaxel|paclitaxel|mesh-list
64741193|NCT00003539|Trastuzumab|trastuzumab|mesh-list
64741194|NCT00003539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64741195|NCT00003539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741196|NCT00003539|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741197|NCT00003539|Antimitotic Agents|antimitotic agents|mesh-ancestor
64473157|NCT00378105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64741198|NCT00003539|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741199|NCT00003539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741200|NCT00003539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64741201|NCT00002879|Cladribine|cladribine|mesh-list
64741202|NCT00002879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741203|NCT00002879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741204|NCT00002879|Immunologic Factors|immunologic factors|mesh-ancestor
64741205|NCT00002879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741206|NCT00003185|Cyclophosphamide|cyclophosphamide|mesh-list
64741207|NCT00003185|Sargramostim|sargramostim|mesh-list
64741208|NCT00003185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741209|NCT00003185|Immunologic Factors|immunologic factors|mesh-ancestor
64741210|NCT00003185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741211|NCT00003185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64741212|NCT00003185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64741213|NCT00003185|Alkylating Agents|alkylating agents|mesh-ancestor
64741214|NCT00003185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741215|NCT00003185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741216|NCT00003185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64741223|NCT00003935|Etoposide|etoposide|mesh-list
64741256|NCT00003569|Paclitaxel|paclitaxel|mesh-list
64741257|NCT00003569|Cisplatin|cisplatin|mesh-list
64741258|NCT00003569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64741259|NCT00003569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741260|NCT00003569|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741261|NCT00003569|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741262|NCT00003569|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741263|NCT00003569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741264|NCT00003953|Tamoxifen|tamoxifen|mesh-list
64741265|NCT00003953|Cyclophosphamide|cyclophosphamide|mesh-list
64741266|NCT00003953|Docetaxel|docetaxel|mesh-list
64741267|NCT00003953|Doxorubicin|doxorubicin|mesh-list
64741268|NCT00003953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64741269|NCT00003953|Fluorouracil|fluorouracil|mesh-list
64741270|NCT00003953|Methotrexate|methotrexate|mesh-list
64741271|NCT00003953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741272|NCT00003953|Immunologic Factors|immunologic factors|mesh-ancestor
64741273|NCT00003953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741274|NCT00003953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64741275|NCT00003953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64741276|NCT00003953|Alkylating Agents|alkylating agents|mesh-ancestor
64741277|NCT00003953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741278|NCT00003953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741279|NCT00003953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64741280|NCT00003953|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741281|NCT00003953|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741282|NCT00003953|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741283|NCT00003953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64741416|NCT00003215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741417|NCT00003215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64741418|NCT00003215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64353431|NCT03433001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741537|NCT00003611|Acitretin|acitretin|mesh-list
65495043|NCT01318486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583634|NCT00290329|Vaccines|vaccines|mesh-list
64741538|NCT00003611|Keratolytic Agents|keratolytic agents|mesh-ancestor
64741545|NCT00003617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64741546|NCT00003617|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64741547|NCT00003617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741548|NCT00003617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741549|NCT00003617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64741620|NCT00004067|Doxorubicin|doxorubicin|mesh-list
64741621|NCT00004067|Trastuzumab|trastuzumab|mesh-list
64741622|NCT00004067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64741623|NCT00004067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64741624|NCT00004067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741625|NCT00004067|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741626|NCT00004067|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741627|NCT00004067|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741628|NCT00004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741629|NCT00004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741630|NCT00004067|Immunologic Factors|immunologic factors|mesh-ancestor
64741631|NCT00004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741632|NCT00004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64741633|NCT00004067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64741634|NCT00004067|Alkylating Agents|alkylating agents|mesh-ancestor
64741635|NCT00004067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64741636|NCT00004067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64741637|NCT00004067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64741638|NCT00004067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64741639|NCT00004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741640|NCT00004067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64741641|NCT00004073|Suramin|suramin|mesh-list
64741642|NCT00004073|Antinematodal Agents|antinematodal agents|mesh-ancestor
64741643|NCT00004073|Anthelmintics|anthelmintics|mesh-ancestor
64741644|NCT00004073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64741645|NCT00004073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64741646|NCT00004073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741779|NCT00003263|Interferons|interferons|mesh-list
64741780|NCT00003263|Interferon-alpha|interferon-alpha|mesh-list
64741781|NCT00003263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741782|NCT00003263|Antiviral Agents|antiviral agents|mesh-ancestor
64741783|NCT00003263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64741784|NCT00003263|Immunologic Factors|immunologic factors|mesh-ancestor
64741785|NCT00003263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741786|NCT00004157|Oprelvekin|oprelvekin|mesh-list
64741787|NCT00004157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741788|NCT00003269|Cyclophosphamide|cyclophosphamide|mesh-list
64741789|NCT00003269|Etoposide|etoposide|mesh-list
64741790|NCT00003269|Sargramostim|sargramostim|mesh-list
64741791|NCT00003269|Amifostine|amifostine|mesh-list
64741792|NCT00003269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741793|NCT00003269|Immunologic Factors|immunologic factors|mesh-ancestor
64741794|NCT00003269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741795|NCT00003269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64741796|NCT00003269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64741797|NCT00003269|Alkylating Agents|alkylating agents|mesh-ancestor
64741798|NCT00003269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741986|NCT00004223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64741987|NCT00004223|Antimetabolites|antimetabolites|mesh-ancestor
64741988|NCT00004223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741989|NCT00004223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741990|NCT00004223|Antiviral Agents|antiviral agents|mesh-ancestor
64741991|NCT00004223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64741992|NCT00004223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495044|NCT03436108|Bisphenol A|bisphenol a|mesh-list
64741993|NCT00004223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741994|NCT00004223|Immunologic Factors|immunologic factors|mesh-ancestor
64741995|NCT00004223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741996|NCT00004223|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741997|NCT00004223|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741998|NCT00004223|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741999|NCT00003323|Flutamide|flutamide|mesh-list
64742000|NCT00003323|Finasteride|finasteride|mesh-list
64742001|NCT00003323|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64559729|NCT00995475|Fluticasone|fluticasone|mesh-list
64742004|NCT00003323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742005|NCT00003323|Hormone Antagonists|hormone antagonists|mesh-ancestor
64742006|NCT00003323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64742007|NCT00003323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742008|NCT00003323|Urological Agents|urological agents|mesh-ancestor
64742009|NCT00003323|Androgen Antagonists|androgen antagonists|mesh-ancestor
64742010|NCT00003323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64742011|NCT00003323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742012|NCT00004229|Endostatins|endostatins|mesh-list
64742013|NCT00004229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742014|NCT00004229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64742015|NCT00004229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64742016|NCT00004229|Growth Substances|growth substances|mesh-ancestor
64742017|NCT00004229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742018|NCT00004229|Growth Inhibitors|growth inhibitors|mesh-ancestor
64742019|NCT00004235|Docetaxel|docetaxel|mesh-list
64742020|NCT00004235|Irinotecan|irinotecan|mesh-list
64742021|NCT00004235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742022|NCT00004235|Tubulin Modulators|tubulin modulators|mesh-ancestor
64742023|NCT00004235|Antimitotic Agents|antimitotic agents|mesh-ancestor
64742024|NCT00004235|Mitosis Modulators|mitosis modulators|mesh-ancestor
64742025|NCT00004235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742026|NCT00004235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64742027|NCT00004235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64742028|NCT00004235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742029|NCT00003335|Cyclosporine|cyclosporine|mesh-list
64742030|NCT00003335|Methylprednisolone|methylprednisolone|mesh-list
64742031|NCT00003335|Melphalan|melphalan|mesh-list
64742032|NCT00003335|Busulfan|busulfan|mesh-list
64742033|NCT00003335|Cyclosporins|cyclosporins|mesh-list
64742034|NCT00003335|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64742035|NCT00003335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742069|NCT00003353|Melphalan|melphalan|mesh-list
64559811|NCT04974060|Sensory System Agents|sensory system agents|mesh-ancestor
64742074|NCT00003353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742075|NCT00003353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742076|NCT00003353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64742077|NCT00003353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64742078|NCT00004265|Paclitaxel|paclitaxel|mesh-list
64742079|NCT00004265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64742080|NCT00004265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742081|NCT00004265|Tubulin Modulators|tubulin modulators|mesh-ancestor
64742082|NCT00004265|Antimitotic Agents|antimitotic agents|mesh-ancestor
64742083|NCT00004265|Mitosis Modulators|mitosis modulators|mesh-ancestor
64742084|NCT00004265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742085|NCT00003365|Curcumin|curcumin|mesh-list
64742086|NCT00003365|Sulindac|sulindac|mesh-list
64742087|NCT00003365|Quercetin|quercetin|mesh-list
64742088|NCT00003365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64742124|NCT00004865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64742125|NCT00004865|Immunologic Factors|immunologic factors|mesh-ancestor
64742126|NCT00004865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742127|NCT00004865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64742128|NCT00004361|Citric Acid|citric acid|mesh-list
64742216|NCT00004901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742217|NCT00004901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64742218|NCT00004433|Pergolide|pergolide|mesh-list
64742219|NCT00004433|Dopamine Agonists|dopamine agonists|mesh-ancestor
64742220|NCT00004433|Dopamine Agents|dopamine agents|mesh-ancestor
64742221|NCT00004433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64742222|NCT00004433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742224|NCT00004913|Leucovorin|leucovorin|mesh-list
64742241|NCT00004913|Protective Agents|protective agents|mesh-ancestor
64742242|NCT00004913|Vitamin B Complex|vitamin b complex|mesh-ancestor
64742243|NCT00004913|Vitamins|vitamins|mesh-ancestor
64742244|NCT00004913|Micronutrients|micronutrients|mesh-ancestor
64742245|NCT00004919|Irinotecan|irinotecan|mesh-list
64742311|NCT00004997|Vitamin B Complex|vitamin b complex|mesh-ancestor
64742313|NCT00004997|Micronutrients|micronutrients|mesh-ancestor
64742314|NCT00005009|Vaccines|vaccines|mesh-list
64742315|NCT00005009|Immunologic Factors|immunologic factors|mesh-ancestor
64742316|NCT00005009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742317|NCT00004583|Ritonavir|ritonavir|mesh-list
64742318|NCT00004583|Lopinavir|lopinavir|mesh-list
64742319|NCT00004583|Nelfinavir|nelfinavir|mesh-list
64742320|NCT00004583|Lamivudine|lamivudine|mesh-list
64742321|NCT00004583|Stavudine|stavudine|mesh-list
64742322|NCT00004583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64742323|NCT00004583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64742324|NCT00004583|Protease Inhibitors|protease inhibitors|mesh-ancestor
64742325|NCT00004583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742326|NCT00004583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742327|NCT00004583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64742328|NCT00004583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64742329|NCT00004583|Antiviral Agents|antiviral agents|mesh-ancestor
64742330|NCT00004583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64742331|NCT00004583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64742332|NCT00004583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64742333|NCT00004583|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64742334|NCT00004583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64742335|NCT00004583|Antimetabolites|antimetabolites|mesh-ancestor
64742336|NCT00005015|Fluoxetine|fluoxetine|mesh-list
64742337|NCT00005015|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64742338|NCT00005015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64742339|NCT00005015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64742341|NCT00005015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64742350|NCT00004637|Vitamin E|vitamin e|mesh-list
64742351|NCT00004637|Vitamins|vitamins|mesh-ancestor
64742352|NCT00004637|Micronutrients|micronutrients|mesh-ancestor
64742353|NCT00004637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742354|NCT00004637|Antioxidants|antioxidants|mesh-ancestor
64742355|NCT00004637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742389|NCT00004685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742391|NCT00004685|Respiratory System Agents|respiratory system agents|mesh-ancestor
64742392|NCT00004685|Tocolytic Agents|tocolytic agents|mesh-ancestor
64742393|NCT00004685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64742394|NCT00004685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64742395|NCT00004685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64742396|NCT00004685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64742397|NCT00004685|Adrenergic Agents|adrenergic agents|mesh-ancestor
64742497|NCT00004787|Immunologic Factors|immunologic factors|mesh-ancestor
64742498|NCT00004787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742500|NCT00005081|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64742501|NCT00005081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64742502|NCT00005081|Alkylating Agents|alkylating agents|mesh-ancestor
64742503|NCT00005081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742504|NCT00005081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742505|NCT00005081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742506|NCT00005087|Paclitaxel|paclitaxel|mesh-list
64742507|NCT00005087|Cisplatin|cisplatin|mesh-list
64354490|NCT03605719|Antiemetics|antiemetics|mesh-ancestor
64742523|NCT00005093|Antiviral Agents|antiviral agents|mesh-ancestor
64742524|NCT00005093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64742525|NCT00005093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742526|NCT00005093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64742527|NCT00005093|Immunologic Factors|immunologic factors|mesh-ancestor
64742528|NCT00005093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742529|NCT00005093|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64742530|NCT00004811|Itraconazole|itraconazole|mesh-list
64742531|NCT00004811|Antifungal Agents|antifungal agents|mesh-ancestor
64742532|NCT00004811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501903|NCT03001960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64501904|NCT03001960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64501905|NCT03001960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64501906|NCT03001960|Purinergic Agents|purinergic agents|mesh-ancestor
64742533|NCT00004811|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64742534|NCT00004811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64742535|NCT00004811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742536|NCT00004811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742537|NCT00004811|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64742538|NCT00004811|Hormone Antagonists|hormone antagonists|mesh-ancestor
64742539|NCT00004811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64742540|NCT00004811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742541|NCT00004811|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64742543|NCT00004817|Valproic Acid|valproic acid|mesh-list
64742544|NCT00004817|Anticonvulsants|anticonvulsants|mesh-ancestor
64742545|NCT00004817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742546|NCT00004817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742547|NCT00004817|GABA Agents|gaba agents|mesh-ancestor
64742548|NCT00004817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64742549|NCT00004817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742550|NCT00004817|Antimanic Agents|antimanic agents|mesh-ancestor
64742551|NCT00004817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64742552|NCT00004817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64742553|NCT00004817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64742554|NCT00004817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64742555|NCT00004817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64742556|NCT00004817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64742557|NCT00004817|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64742558|NCT00004817|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64742559|NCT00005117|Pravastatin|pravastatin|mesh-list
64742560|NCT00005117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64742561|NCT00005117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64742584|NCT00385463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64742599|NCT00005579|Antimitotic Agents|antimitotic agents|mesh-ancestor
64742600|NCT00005579|Mitosis Modulators|mitosis modulators|mesh-ancestor
64742601|NCT00005579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742602|NCT00005585|Leucovorin|leucovorin|mesh-list
64742603|NCT00005585|Cytarabine|cytarabine|mesh-list
64742604|NCT00005585|Dexamethasone|dexamethasone|mesh-list
64742605|NCT00005585|Cyclophosphamide|cyclophosphamide|mesh-list
64742606|NCT00005585|Methotrexate|methotrexate|mesh-list
64742607|NCT00005585|Vincristine|vincristine|mesh-list
64473158|NCT00378105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64742608|NCT00005585|Daunorubicin|daunorubicin|mesh-list
64742609|NCT00005585|Asparaginase|asparaginase|mesh-list
64742610|NCT00005585|Mercaptopurine|mercaptopurine|mesh-list
64742611|NCT00005585|Pegaspargase|pegaspargase|mesh-list
64742612|NCT00005585|Thioguanine|thioguanine|mesh-list
64742613|NCT00005585|Levoleucovorin|levoleucovorin|mesh-list
64354595|NCT03179605|Clobetasol|clobetasol|mesh-list
64742626|NCT00005585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64742627|NCT00005585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64742628|NCT00005585|Glucocorticoids|glucocorticoids|mesh-ancestor
64742630|NCT00005585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64742631|NCT00005585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64742632|NCT00005585|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64742633|NCT00005585|Abortifacient Agents|abortifacient agents|mesh-ancestor
64742634|NCT00005585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64742635|NCT00005585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64742636|NCT00005585|Antimetabolites|antimetabolites|mesh-ancestor
64742637|NCT00005585|Dermatologic Agents|dermatologic agents|mesh-ancestor
64742638|NCT00005585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742639|NCT00005585|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64742640|NCT00005585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64742641|NCT00005585|Antiviral Agents|antiviral agents|mesh-ancestor
64742643|NCT00005585|Antidotes|antidotes|mesh-ancestor
64742656|NCT00005591|Cetuximab|cetuximab|mesh-list
64742657|NCT00005591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64742658|NCT00005591|Antimetabolites|antimetabolites|mesh-ancestor
64742659|NCT00005591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742660|NCT00005591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742661|NCT00005591|Antiviral Agents|antiviral agents|mesh-ancestor
64742662|NCT00005591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64742663|NCT00005591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742664|NCT00005591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64742665|NCT00005591|Immunologic Factors|immunologic factors|mesh-ancestor
64742666|NCT00005591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742667|NCT00005591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64742669|NCT01926444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64742670|NCT01926444|Parasympatholytics|parasympatholytics|mesh-ancestor
64742671|NCT01926444|Autonomic Agents|autonomic agents|mesh-ancestor
64742672|NCT01926444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64742673|NCT01926444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742674|NCT00005597|Temozolomide|temozolomide|mesh-list
64742675|NCT00005597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64742676|NCT00005597|Alkylating Agents|alkylating agents|mesh-ancestor
64742701|NCT00005603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742702|NCT00005603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64742703|NCT00005603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64742704|NCT00005603|Alkylating Agents|alkylating agents|mesh-ancestor
64742705|NCT00005603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742706|NCT00005603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742707|NCT00005603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64742708|NCT00005603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64742709|NCT00005603|Antiemetics|antiemetics|mesh-ancestor
64742722|NCT00005603|Abortifacient Agents|abortifacient agents|mesh-ancestor
64742723|NCT00005603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64742724|NCT00005603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64742725|NCT00005603|Antimetabolites|antimetabolites|mesh-ancestor
64742726|NCT00005603|Dermatologic Agents|dermatologic agents|mesh-ancestor
64742727|NCT00005603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64742728|NCT00005603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64742729|NCT00005603|Antiviral Agents|antiviral agents|mesh-ancestor
64742730|NCT00005603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64742731|NCT00005603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64742798|NCT00005777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742800|NCT00385931|Simvastatin|simvastatin|mesh-list
64742801|NCT00385931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64742802|NCT00385931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64742803|NCT00385931|Antimetabolites|antimetabolites|mesh-ancestor
64742804|NCT00385931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742805|NCT00385931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64742806|NCT00385931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64742807|NCT00385931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742808|NCT00385931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64742809|NCT00385931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64742810|NCT00385931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64742812|NCT00386399|Mitomycin|mitomycin|mesh-list
64742813|NCT00386399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64742814|NCT00386399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742815|NCT00386399|Alkylating Agents|alkylating agents|mesh-ancestor
64354798|NCT03416569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742836|NCT00003653|Leuprolide|leuprolide|mesh-list
64742837|NCT00003653|Goserelin|goserelin|mesh-list
64742838|NCT00003653|Flutamide|flutamide|mesh-list
64742839|NCT00003653|Bicalutamide|bicalutamide|mesh-list
64742840|NCT00003653|Cyproterone Acetate|cyproterone acetate|mesh-list
64742841|NCT00003653|Nilutamide|nilutamide|mesh-list
64742842|NCT00003653|Buserelin|buserelin|mesh-list
64742843|NCT00003653|Cyproterone|cyproterone|mesh-list
64742849|NCT00003653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742850|NCT00003653|Androgen Antagonists|androgen antagonists|mesh-ancestor
64742851|NCT00003653|Hormone Antagonists|hormone antagonists|mesh-ancestor
64742852|NCT00003653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64742853|NCT00003653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64742854|NCT00003653|Contraceptive Agents|contraceptive agents|mesh-ancestor
64742855|NCT00003671|Leucovorin|leucovorin|mesh-list
64742856|NCT00003671|Cytarabine|cytarabine|mesh-list
64742857|NCT00003671|Dexamethasone|dexamethasone|mesh-list
64742858|NCT00003671|Cyclophosphamide|cyclophosphamide|mesh-list
64742859|NCT00003671|Methotrexate|methotrexate|mesh-list
64742860|NCT00003671|Vincristine|vincristine|mesh-list
64742861|NCT00003671|Daunorubicin|daunorubicin|mesh-list
64742862|NCT00003671|Asparaginase|asparaginase|mesh-list
64742863|NCT00003671|Mercaptopurine|mercaptopurine|mesh-list
64742864|NCT00003671|Thioguanine|thioguanine|mesh-list
64742865|NCT00003671|Levoleucovorin|levoleucovorin|mesh-list
64742866|NCT00003671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64742867|NCT00003671|Immunologic Factors|immunologic factors|mesh-ancestor
64742868|NCT00003671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742869|NCT00003671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64742870|NCT00003671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64742871|NCT00003671|Alkylating Agents|alkylating agents|mesh-ancestor
64354843|NCT03420937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64742890|NCT00003671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742891|NCT00003671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64742892|NCT00003671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64742893|NCT00003671|Antiviral Agents|antiviral agents|mesh-ancestor
64742894|NCT00003671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64742895|NCT00003671|Antidotes|antidotes|mesh-ancestor
64742896|NCT00003671|Protective Agents|protective agents|mesh-ancestor
65495047|NCT03436108|Hormones|hormones|mesh-ancestor
64742897|NCT00003671|Vitamin B Complex|vitamin b complex|mesh-ancestor
64742898|NCT00003671|Vitamins|vitamins|mesh-ancestor
64742899|NCT00003671|Micronutrients|micronutrients|mesh-ancestor
64742910|NCT00003677|Antimitotic Agents|antimitotic agents|mesh-ancestor
64742911|NCT00003677|Mitosis Modulators|mitosis modulators|mesh-ancestor
64742912|NCT00003677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742913|NCT00384605|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
64742914|NCT00384605|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64742915|NCT00384605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64742916|NCT00384605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64742917|NCT00384605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742918|NCT00384605|Hormones|hormones|mesh-ancestor
64742919|NCT00384605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64742920|NCT00384605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742921|NCT00003683|Doxorubicin|doxorubicin|mesh-list
64742922|NCT00003683|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64742923|NCT00003683|Ifosfamide|ifosfamide|mesh-list
64742924|NCT00003683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64354901|NCT03420469|Dopamine Agents|dopamine agents|mesh-ancestor
64742968|NCT00003707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742969|NCT00003707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64742970|NCT00003707|Immunologic Factors|immunologic factors|mesh-ancestor
64742971|NCT00003707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742973|NCT00003719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64742974|NCT00003719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64742975|NCT00003719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742976|NCT00003719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742977|NCT00003719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742978|NCT00003725|Valrubicin|valrubicin|mesh-list
64742979|NCT00003725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742980|NCT00003725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64742981|NCT00003725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64742982|NCT00003725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742984|NCT00003731|Temozolomide|temozolomide|mesh-list
64743020|NCT00003797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743021|NCT00003797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64743022|NCT00003797|Immunologic Factors|immunologic factors|mesh-ancestor
64743023|NCT00003797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743024|NCT00003797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64743025|NCT00003803|Gemcitabine|gemcitabine|mesh-list
64743026|NCT00003803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743027|NCT00003803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64743053|NCT00003815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64743054|NCT00003815|Alkylating Agents|alkylating agents|mesh-ancestor
64743055|NCT00003815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743056|NCT00003815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743057|NCT00003815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64743058|NCT00003815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64743059|NCT00003815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64743061|NCT00003815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743123|NCT00003893|Mitoxantrone|mitoxantrone|mesh-list
64743124|NCT00003893|Mitomycins|mitomycins|mesh-list
64743125|NCT00003893|Mitomycin|mitomycin|mesh-list
64743126|NCT00003893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64743127|NCT00003893|Immunologic Factors|immunologic factors|mesh-ancestor
64743128|NCT00003893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743129|NCT00003893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64743130|NCT00003893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64743131|NCT00003893|Alkylating Agents|alkylating agents|mesh-ancestor
64743132|NCT00003893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743133|NCT00003893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743134|NCT00003893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64743135|NCT00003893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64743136|NCT00003893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64743170|NCT00003917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743171|NCT00003917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743172|NCT00003917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743173|NCT00003923|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
64743174|NCT00003923|Trioxsalen|trioxsalen|mesh-list
64743175|NCT00003923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743176|NCT00003923|Dermatologic Agents|dermatologic agents|mesh-ancestor
64743177|NCT00003923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64743178|NCT00003929|Lomustine|lomustine|mesh-list
64743211|NCT02210819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64743212|NCT02210819|Protease Inhibitors|protease inhibitors|mesh-ancestor
64743213|NCT02210819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743214|NCT02210819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743215|NCT02210819|Anticoagulants|anticoagulants|mesh-ancestor
64743217|NCT04564469|Diuretics|diuretics|mesh-ancestor
64743218|NCT04564469|Natriuretic Agents|natriuretic agents|mesh-ancestor
64743219|NCT04564469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355212|NCT00950989|Abortifacient Agents|abortifacient agents|mesh-ancestor
64743236|NCT04568603|Antitussive Agents|antitussive agents|mesh-ancestor
64743242|NCT04568603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64743243|NCT04568603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64743244|NCT04568603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64743246|NCT04563299|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64743247|NCT04563299|Methylprednisolone|methylprednisolone|mesh-list
64743248|NCT04563299|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64743249|NCT04563299|Prednisolone acetate|prednisolone acetate|mesh-list
64743250|NCT04563299|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64743251|NCT04563299|Prednisolone phosphate|prednisolone phosphate|mesh-list
64743252|NCT04563299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64743253|NCT04563299|Glucocorticoids|glucocorticoids|mesh-ancestor
64743254|NCT04563299|Hormones|hormones|mesh-ancestor
64743264|NCT04563299|Protective Agents|protective agents|mesh-ancestor
64482557|NCT01770145|Levodopa|levodopa|mesh-list
64743265|NCT04561817|Paclitaxel|paclitaxel|mesh-list
64743266|NCT04561817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64743267|NCT04561817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743268|NCT04561817|Tubulin Modulators|tubulin modulators|mesh-ancestor
64743269|NCT04561817|Antimitotic Agents|antimitotic agents|mesh-ancestor
64743270|NCT04561817|Mitosis Modulators|mitosis modulators|mesh-ancestor
64743271|NCT04561817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743272|NCT02211833|Pemetrexed|pemetrexed|mesh-list
64743273|NCT02211833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743274|NCT02211833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743275|NCT02211833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743276|NCT02211833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64743277|NCT02211833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64743278|NCT02211443|Antibodies|antibodies|mesh-list
64743288|NCT01597908|Trametinib|trametinib|mesh-list
64743298|NCT01948908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64743299|NCT01948908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743300|NCT01948908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64743301|NCT01948908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64743302|NCT01948908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64743303|NCT01948908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64743304|NCT01948908|Anesthetics, General|anesthetics, general|mesh-ancestor
64743305|NCT01948908|Anesthetics|anesthetics|mesh-ancestor
64743306|NCT01948908|GABA Modulators|gaba modulators|mesh-ancestor
64743307|NCT01948908|GABA Agents|gaba agents|mesh-ancestor
64743308|NCT01948908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64743309|NCT01948908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743310|NCT01925274|Irinotecan|irinotecan|mesh-list
64743311|NCT01925274|Cetuximab|cetuximab|mesh-list
64743312|NCT01925274|Gedatolisib|gedatolisib|mesh-list
64743313|NCT01925274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64743314|NCT01925274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64743315|NCT01925274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743316|NCT01925274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743317|NCT01925274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743318|NCT01925274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64743319|NCT01925274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64743335|NCT01924182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64743336|NCT01924182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743338|NCT01924182|Sensory System Agents|sensory system agents|mesh-ancestor
64743339|NCT01924182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65495049|NCT03436108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584303|NCT01393730|Prednisone|prednisone|mesh-list
64743340|NCT01946880|Mycophenolic Acid|mycophenolic acid|mesh-list
64743341|NCT01946880|Hydroxychloroquine|hydroxychloroquine|mesh-list
64743342|NCT01946880|Chloroquine|chloroquine|mesh-list
64743343|NCT01946880|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64743344|NCT01946880|Prednisone|prednisone|mesh-list
64743353|NCT01946880|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64743354|NCT01946880|Antitubercular Agents|antitubercular agents|mesh-ancestor
64743355|NCT01946880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64743356|NCT01946880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64743357|NCT01946880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743358|NCT01946880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743359|NCT01946880|Antimalarials|antimalarials|mesh-ancestor
64743360|NCT01946880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64743361|NCT01946880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64743362|NCT01946880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64743363|NCT01946880|Amebicides|amebicides|mesh-ancestor
64743364|NCT01946880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64743365|NCT01946880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64743366|NCT01946880|Analgesics|analgesics|mesh-ancestor
64743367|NCT01946880|Sensory System Agents|sensory system agents|mesh-ancestor
64743368|NCT01946880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64743369|NCT01946880|Filaricides|filaricides|mesh-ancestor
64743370|NCT01946880|Antinematodal Agents|antinematodal agents|mesh-ancestor
64743371|NCT01946880|Anthelmintics|anthelmintics|mesh-ancestor
64743372|NCT01972152|Glucagon|glucagon|mesh-list
64743373|NCT01972152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64743374|NCT01972152|Hormones|hormones|mesh-ancestor
64743375|NCT01972152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64743376|NCT01972152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743377|NCT01972074|Memantine|memantine|mesh-list
64743378|NCT01972074|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64743379|NCT01972074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64743380|NCT01972074|Dopamine Agents|dopamine agents|mesh-ancestor
64743403|NCT01918332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743404|NCT01918332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64743405|NCT01918332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64743407|NCT01918332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64743408|NCT01918332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64743416|NCT01922934|Appetite Depressants|appetite depressants|mesh-ancestor
64743417|NCT01922934|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64743418|NCT01922934|Sympathomimetics|sympathomimetics|mesh-ancestor
64743419|NCT01922934|Autonomic Agents|autonomic agents|mesh-ancestor
64743420|NCT01922934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64743421|NCT01922934|Adrenergic Agents|adrenergic agents|mesh-ancestor
64743422|NCT01922934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64743423|NCT01922934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743424|NCT01921140|Olaparib|olaparib|mesh-list
64743425|NCT01921140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64743426|NCT01921140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743427|NCT01921140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743428|NCT01921140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743429|NCT01917006|Botulinum Toxins|botulinum toxins|mesh-list
64743430|NCT01917006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64743485|NCT01620060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64743486|NCT01620060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64743487|NCT01620060|Serotonin Agents|serotonin agents|mesh-ancestor
64743488|NCT01620060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64743489|NCT01620060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64743490|NCT01620060|Dopamine Agents|dopamine agents|mesh-ancestor
64584375|NCT00553059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64743491|NCT01914666|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64743492|NCT01914666|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64743493|NCT01914666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64743494|NCT01914666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64743495|NCT01914666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743496|NCT01914666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64743497|NCT01914666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743499|NCT01914666|Sensory System Agents|sensory system agents|mesh-ancestor
64743512|NCT01912872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64743513|NCT01912872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743514|NCT01912872|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64743515|NCT01912872|Respiratory System Agents|respiratory system agents|mesh-ancestor
64743516|NCT01912872|Glucocorticoids|glucocorticoids|mesh-ancestor
64743517|NCT01912872|Hormones|hormones|mesh-ancestor
64743518|NCT01912872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64743519|NCT01912872|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64355503|NCT02654145|Omalizumab|omalizumab|mesh-list
64743563|NCT01908582|Leprostatic Agents|leprostatic agents|mesh-ancestor
64743564|NCT01908582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64743565|NCT01908582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743566|NCT01908582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743567|NCT01908582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64743568|NCT01908582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64743632|NCT01904760|Adrenergic Agents|adrenergic agents|mesh-ancestor
64743633|NCT01904760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64743634|NCT01904760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743635|NCT01904058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64743636|NCT01904058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64743637|NCT01904058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64743638|NCT01881126|Timolol|timolol|mesh-list
64743639|NCT01881126|Bimatoprost|bimatoprost|mesh-list
64743640|NCT01881126|Travoprost|travoprost|mesh-list
64743641|NCT01881126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743642|NCT01881126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64743643|NCT01881126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64743644|NCT01881126|Adrenergic Agents|adrenergic agents|mesh-ancestor
64743645|NCT01881126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64743646|NCT01881126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743647|NCT01881126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64743648|NCT01881126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64743649|NCT01880736|Insulin|insulin|mesh-list
64743650|NCT01880736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64743651|NCT01880736|Insulin, Long-Acting|insulin, long-acting|mesh-list
64743652|NCT01880736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64743653|NCT01880736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743654|NCT01880424|Linaclotide|linaclotide|mesh-list
64743655|NCT01880424|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64743656|NCT01880424|Enzyme Activators|enzyme activators|mesh-ancestor
64355638|NCT03412513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64743718|NCT01862250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743719|NCT01862250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64743720|NCT01862250|Sympatholytics|sympatholytics|mesh-ancestor
64743721|NCT01862250|Autonomic Agents|autonomic agents|mesh-ancestor
64743722|NCT01862250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64743723|NCT01862250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64743724|NCT01862250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64743725|NCT01862250|Adrenergic Agents|adrenergic agents|mesh-ancestor
64743957|NCT01869192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64743958|NCT01869192|Tubulin Modulators|tubulin modulators|mesh-ancestor
64743959|NCT01869192|Antimitotic Agents|antimitotic agents|mesh-ancestor
64743960|NCT01869192|Mitosis Modulators|mitosis modulators|mesh-ancestor
64743961|NCT01869192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64743962|NCT01869192|Antimetabolites|antimetabolites|mesh-ancestor
64743963|NCT01869192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64743964|NCT01869192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64743965|NCT01869192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64743966|NCT01869192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743967|NCT01851720|Fentanyl|fentanyl|mesh-list
64743968|NCT01851720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64743969|NCT01851720|Narcotics|narcotics|mesh-ancestor
64743970|NCT01851720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64355970|NCT03424135|Dermatologic Agents|dermatologic agents|mesh-ancestor
64744000|NCT01850004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744001|NCT01850004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744002|NCT01867710|Dexamethasone|dexamethasone|mesh-list
64744004|NCT01867710|Abiraterone Acetate|abiraterone acetate|mesh-list
64744005|NCT01867710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64744006|NCT01867710|Antiemetics|antiemetics|mesh-ancestor
64744007|NCT01867710|Autonomic Agents|autonomic agents|mesh-ancestor
64744008|NCT01867710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64744009|NCT01867710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744010|NCT01867710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64744011|NCT01867710|Glucocorticoids|glucocorticoids|mesh-ancestor
64744012|NCT01867710|Hormones|hormones|mesh-ancestor
64744013|NCT01867710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64744014|NCT01867710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64744015|NCT01867710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744016|NCT01867710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64744017|NCT01867710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64356015|NCT02520635|Temozolomide|temozolomide|mesh-list
64744053|NCT01848990|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64744054|NCT01848990|Insulin Aspart|insulin aspart|mesh-list
64744055|NCT01848990|Insulin Lispro|insulin lispro|mesh-list
64744061|NCT01867086|Immunologic Factors|immunologic factors|mesh-ancestor
64744062|NCT01867086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744063|NCT01867086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744064|NCT01848834|Pembrolizumab|pembrolizumab|mesh-list
64744065|NCT01848834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64744066|NCT01848834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744067|NCT04600362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64744068|NCT04600362|Immunologic Factors|immunologic factors|mesh-ancestor
64744069|NCT04600362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744070|NCT01848210|Troxerutin|troxerutin|mesh-list
64744071|NCT01848210|Anticoagulants|anticoagulants|mesh-ancestor
64744072|NCT01830816|Ixazomib|ixazomib|mesh-list
64744073|NCT01830816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744074|NCT01830816|Protease Inhibitors|protease inhibitors|mesh-ancestor
64744075|NCT01830816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744076|NCT01830816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744102|NCT01803282|Antimitotic Agents|antimitotic agents|mesh-ancestor
64744103|NCT01803282|Mitosis Modulators|mitosis modulators|mesh-ancestor
64744104|NCT01803282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744105|NCT01803282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64744106|NCT01803282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64744107|NCT01803282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64744108|NCT01803282|Growth Substances|growth substances|mesh-ancestor
64744109|NCT01803282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744120|NCT01803282|Antidotes|antidotes|mesh-ancestor
64744231|NCT01798992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64744232|NCT01798992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64744233|NCT01798992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64744234|NCT01798992|Adrenergic Agents|adrenergic agents|mesh-ancestor
64744235|NCT01798992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64744236|NCT01798992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744237|NCT01798992|Antioxidants|antioxidants|mesh-ancestor
64744238|NCT01798992|Protective Agents|protective agents|mesh-ancestor
64744239|NCT01798992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64744240|NCT01798992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64744241|NCT01798992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64744242|NCT01798992|Vasodilator Agents|vasodilator agents|mesh-ancestor
64744243|NCT01798992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64744244|NCT01798992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64744245|NCT01798056|Vaccines|vaccines|mesh-list
64744246|NCT01798056|Immunologic Factors|immunologic factors|mesh-ancestor
64584602|NCT01791751|Clomiphene|clomiphene|mesh-list
64744247|NCT01798056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744248|NCT01824342|Denosumab|denosumab|mesh-list
64744249|NCT01824342|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64744250|NCT01824342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744251|NCT01823328|Ketamine|ketamine|mesh-list
64744252|NCT01823328|Etomidate|etomidate|mesh-list
64744253|NCT01823328|Analgesics|analgesics|mesh-ancestor
64744254|NCT01823328|Sensory System Agents|sensory system agents|mesh-ancestor
64744255|NCT01823328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64744256|NCT01823328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744257|NCT01823328|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64744258|NCT01823328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64744259|NCT01823328|Anesthetics, General|anesthetics, general|mesh-ancestor
64744260|NCT01823328|Anesthetics|anesthetics|mesh-ancestor
64744261|NCT01823328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64744262|NCT01823328|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64744263|NCT01823328|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64744264|NCT01823328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64501907|NCT03001960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64501908|NCT03001960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744265|NCT01823328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744266|NCT01823328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64744290|NCT01797120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64744291|NCT01797120|Immunologic Factors|immunologic factors|mesh-ancestor
64744292|NCT01797120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744293|NCT01797120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64744294|NCT01797120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64744295|NCT01797120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64744296|NCT01797120|Hormone Antagonists|hormone antagonists|mesh-ancestor
64744297|NCT01797120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64744298|NCT01796964|Aflibercept|aflibercept|mesh-list
64744299|NCT01796964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64744300|NCT01796964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64744301|NCT01796964|Growth Substances|growth substances|mesh-ancestor
64744302|NCT01796964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744303|NCT01796964|Growth Inhibitors|growth inhibitors|mesh-ancestor
64744304|NCT01796964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473163|NCT00139477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744617|NCT01814046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64744618|NCT01813890|Tapentadol|tapentadol|mesh-list
64744619|NCT01813890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64744620|NCT01813890|Narcotics|narcotics|mesh-ancestor
64744621|NCT01813890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64744622|NCT01813890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744623|NCT01813890|Analgesics|analgesics|mesh-ancestor
64744624|NCT01813890|Sensory System Agents|sensory system agents|mesh-ancestor
64744625|NCT01813890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64744626|NCT01813890|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64744627|NCT01813890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64744628|NCT01813890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64744629|NCT01813890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744665|NCT01811238|Narcotics|narcotics|mesh-ancestor
64744666|NCT01811238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64744667|NCT01811238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744668|NCT01811238|Analgesics|analgesics|mesh-ancestor
64744729|NCT01768572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64744731|NCT01768572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64744732|NCT01768572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64744733|NCT01768572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64744734|NCT01768572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64744735|NCT01768572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64744736|NCT01768572|Analgesics|analgesics|mesh-ancestor
64744737|NCT01768572|Sensory System Agents|sensory system agents|mesh-ancestor
64356755|NCT03398837|Dronabinol|dronabinol|mesh-list
64744840|NCT01782222|Dopamine Agonists|dopamine agonists|mesh-ancestor
64744841|NCT01782222|Dopamine Agents|dopamine agents|mesh-ancestor
64744842|NCT01782222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64744843|NCT01782222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744844|NCT01782222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744845|NCT01807182|Aldesleukin|aldesleukin|mesh-list
64744846|NCT01807182|Cyclophosphamide|cyclophosphamide|mesh-list
64744847|NCT01807182|Fludarabine|fludarabine|mesh-list
64744848|NCT01807182|Fludarabine phosphate|fludarabine phosphate|mesh-list
64744849|NCT01807182|Interleukin-2|interleukin-2|mesh-list
64744850|NCT01807182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64744851|NCT01807182|Immunologic Factors|immunologic factors|mesh-ancestor
64744852|NCT01807182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744853|NCT01807182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64744854|NCT01807182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64744855|NCT01807182|Alkylating Agents|alkylating agents|mesh-ancestor
64744856|NCT01807182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744857|NCT01807182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744858|NCT01807182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64744896|NCT01780662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64744897|NCT01780506|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64745374|NCT01723254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745375|NCT01722162|Bevacizumab|bevacizumab|mesh-list
64745376|NCT01722162|Capecitabine|capecitabine|mesh-list
64745377|NCT01722162|Levocetirizine|levocetirizine|mesh-list
64745378|NCT01722162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64745379|NCT01722162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64745380|NCT01722162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64745381|NCT01722162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64745382|NCT01722162|Growth Substances|growth substances|mesh-ancestor
64745383|NCT01722162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745384|NCT01722162|Growth Inhibitors|growth inhibitors|mesh-ancestor
64745385|NCT01722162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64745386|NCT01722162|Antimetabolites|antimetabolites|mesh-ancestor
64745387|NCT01722162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745388|NCT01722162|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64745389|NCT01722162|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64745390|NCT01722162|Histamine Antagonists|histamine antagonists|mesh-ancestor
64745391|NCT01722162|Histamine Agents|histamine agents|mesh-ancestor
64745392|NCT01722162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64745393|NCT01721772|Nivolumab|nivolumab|mesh-list
64745394|NCT01721772|Dacarbazine|dacarbazine|mesh-list
64745395|NCT01721772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64745396|NCT01721772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64745397|NCT01721772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64745398|NCT01721772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745399|NCT01721772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64745400|NCT01721772|Alkylating Agents|alkylating agents|mesh-ancestor
64745572|NCT01698918|Immunologic Factors|immunologic factors|mesh-ancestor
64745573|NCT01698918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64745574|NCT01698918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64745575|NCT01698918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745576|NCT01698918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745577|NCT01698918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64745578|NCT01698918|Hormone Antagonists|hormone antagonists|mesh-ancestor
64745579|NCT01717638|Vaccines|vaccines|mesh-list
64745580|NCT01717638|Immunologic Factors|immunologic factors|mesh-ancestor
64745602|NCT01744782|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
64745603|NCT01744782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745604|NCT01604850|Sofosbuvir|sofosbuvir|mesh-list
64745605|NCT01604850|Antiviral Agents|antiviral agents|mesh-ancestor
64745606|NCT01604850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64745607|NCT01742286|Ceritinib|ceritinib|mesh-list
64745608|NCT01742286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64745609|NCT01742286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64745610|NCT01742286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745611|NCT01742286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745612|NCT01716234|Posaconazole|posaconazole|mesh-list
64745613|NCT01716234|Antifungal Agents|antifungal agents|mesh-ancestor
64745614|NCT01716234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64745615|NCT01716234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64745616|NCT01716234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64745617|NCT01716234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64745618|NCT01716234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64745619|NCT01716234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64745620|NCT01716234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745621|NCT01716234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745622|NCT01716234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64745623|NCT01716234|Hormone Antagonists|hormone antagonists|mesh-ancestor
64745624|NCT01716234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64745625|NCT01716234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745626|NCT01716156|Ribavirin|ribavirin|mesh-list
64745627|NCT01716156|Grazoprevir|grazoprevir|mesh-list
64745631|NCT01716156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64745632|NCT01739790|Acetylcysteine|acetylcysteine|mesh-list
64745633|NCT01739790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64745634|NCT01739790|Antiviral Agents|antiviral agents|mesh-ancestor
64745741|NCT01737840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64745742|NCT01737840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745744|NCT01711866|Dopamine Agonists|dopamine agonists|mesh-ancestor
64745745|NCT01711866|Dopamine Agents|dopamine agents|mesh-ancestor
64745746|NCT01711866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64745747|NCT01711866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745748|NCT01711866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745749|NCT01691508|Prednisone|prednisone|mesh-list
64745750|NCT01691508|Prednisolone|prednisolone|mesh-list
64745751|NCT01691508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64745752|NCT01691508|Glucocorticoids|glucocorticoids|mesh-ancestor
64745753|NCT01691508|Hormones|hormones|mesh-ancestor
64745754|NCT01691508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64745755|NCT01691508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745756|NCT01691508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64745757|NCT01691508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746125|NCT01585194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64746126|NCT01585194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746127|NCT01585194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64746128|NCT01585194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746129|NCT01560780|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64746130|NCT01560780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64746131|NCT01585038|Efavirenz|efavirenz|mesh-list
64746132|NCT01585038|Rilpivirine|rilpivirine|mesh-list
64746133|NCT01585038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64746134|NCT01585038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64746135|NCT01585038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746136|NCT01585038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746137|NCT01585038|Antiviral Agents|antiviral agents|mesh-ancestor
64501909|NCT03001960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501911|NCT01593670|Interleukin-2|interleukin-2|mesh-list
64501912|NCT01593670|Vorinostat|vorinostat|mesh-list
64501913|NCT01593670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64501914|NCT01593670|Antimetabolites|antimetabolites|mesh-ancestor
64501915|NCT01593670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746138|NCT01585038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64746139|NCT01585038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64746140|NCT01585038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64746141|NCT01585038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64746142|NCT01585038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64746143|NCT01585038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64358141|NCT04445467|Favipiravir|favipiravir|mesh-list
64746277|NCT01534182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746278|NCT01534182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64746279|NCT01534182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746280|NCT01534182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64746281|NCT01534182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64746282|NCT01534182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64746283|NCT01579812|Metformin|metformin|mesh-list
64746284|NCT01579812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64746285|NCT01579812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746286|NCT01579578|Paclitaxel|paclitaxel|mesh-list
64746287|NCT01579578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64746288|NCT01579578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746289|NCT01579578|Tubulin Modulators|tubulin modulators|mesh-ancestor
64746290|NCT01579578|Antimitotic Agents|antimitotic agents|mesh-ancestor
64746291|NCT01579578|Mitosis Modulators|mitosis modulators|mesh-ancestor
64746292|NCT01579578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746293|NCT01578486|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
64746294|NCT01578486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64746295|NCT01578486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64746296|NCT01578486|Analgesics|analgesics|mesh-ancestor
64746297|NCT01578486|Sensory System Agents|sensory system agents|mesh-ancestor
64746298|NCT01578486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64746299|NCT01578486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746302|NCT01555164|Metformin|metformin|mesh-list
64746310|NCT03028428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64746311|NCT03028428|Immunologic Factors|immunologic factors|mesh-ancestor
64746312|NCT03028428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746313|NCT03028428|Viscosupplements|viscosupplements|mesh-ancestor
64746314|NCT03028428|Protective Agents|protective agents|mesh-ancestor
64746315|NCT01578330|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64746316|NCT01578330|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64746317|NCT01578330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746318|NCT01578330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64746319|NCT01578330|Immunologic Factors|immunologic factors|mesh-ancestor
64746320|NCT01578330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746321|NCT01577160|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64746374|NCT01553136|Cholinergic Agents|cholinergic agents|mesh-ancestor
64746375|NCT01553136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64746376|NCT01553136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746377|NCT01553136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746378|NCT01552902|Methylphenidate|methylphenidate|mesh-list
64746379|NCT01552902|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64746380|NCT01552902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64746381|NCT01552902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746382|NCT01552902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64746383|NCT01552902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64746384|NCT01552902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64746385|NCT01552902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746386|NCT01552902|Dopamine Agents|dopamine agents|mesh-ancestor
64746387|NCT01552902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64746388|NCT02072928|Botulinum Toxins|botulinum toxins|mesh-list
64746389|NCT02072928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64746390|NCT02072928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64746391|NCT02072928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64746392|NCT02072928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64746393|NCT02072928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746394|NCT02072928|Cholinergic Agents|cholinergic agents|mesh-ancestor
64746466|NCT01549002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64746467|NCT01549002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64746468|NCT01549002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64746469|NCT01549002|Anesthetics, General|anesthetics, general|mesh-ancestor
64746470|NCT01549002|Anesthetics|anesthetics|mesh-ancestor
64746471|NCT01548768|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
64746472|NCT01548768|Antirheumatic Agents|antirheumatic agents|mesh-list
64746473|NCT01548768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64746509|NCT01547286|Respiratory System Agents|respiratory system agents|mesh-ancestor
64746510|NCT01547286|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64746511|NCT01547286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64746512|NCT01547286|Cholinergic Agents|cholinergic agents|mesh-ancestor
64746513|NCT01547286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64746514|NCT01547286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747055|NCT01454934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64747056|NCT01454934|Antimetabolites|antimetabolites|mesh-ancestor
64747057|NCT01454934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747058|NCT01454934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747127|NCT01453140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64747129|NCT01453140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747130|NCT01453140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359140|NCT04584567|Doxycycline|doxycycline|mesh-list
64747194|NCT01496976|Growth Inhibitors|growth inhibitors|mesh-ancestor
64747195|NCT01496976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747196|NCT01496976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64747197|NCT01496976|Antiemetics|antiemetics|mesh-ancestor
64747198|NCT01496976|Autonomic Agents|autonomic agents|mesh-ancestor
64747199|NCT01496976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64747200|NCT01496976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64747201|NCT01496976|Glucocorticoids|glucocorticoids|mesh-ancestor
64747202|NCT01496976|Hormones|hormones|mesh-ancestor
64747203|NCT01496976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64359218|NCT03353857|Anesthetics|anesthetics|mesh-ancestor
64747259|NCT02985606|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64747260|NCT02985606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64747261|NCT02985606|Purinergic Agents|purinergic agents|mesh-ancestor
64747262|NCT02985606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64747263|NCT01473732|Mycophenolic Acid|mycophenolic acid|mesh-list
64747264|NCT01473732|Everolimus|everolimus|mesh-list
64747265|NCT01473732|Tacrolimus|tacrolimus|mesh-list
64747266|NCT01473732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64747278|NCT01450098|Evacetrapib|evacetrapib|mesh-list
64747317|NCT01492686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747318|NCT01492686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64747319|NCT01492686|Protective Agents|protective agents|mesh-ancestor
64747320|NCT01492686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747321|NCT01449006|Maraviroc|maraviroc|mesh-list
64747350|NCT01447446|Interferon alpha-2|interferon alpha-2|mesh-list
64747351|NCT01447446|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
64747352|NCT01447446|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64747353|NCT01447446|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64747354|NCT01447446|Antimetabolites|antimetabolites|mesh-ancestor
64747355|NCT01447446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747356|NCT01447446|Antiviral Agents|antiviral agents|mesh-ancestor
64747357|NCT01447446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64747358|NCT01447446|Immunologic Factors|immunologic factors|mesh-ancestor
64747359|NCT01447446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747360|NCT01447446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747361|NCT01471782|Blinatumomab|blinatumomab|mesh-list
64747362|NCT01471782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747363|NCT01490580|Atropine|atropine|mesh-list
64747364|NCT01490580|Sufentanil|sufentanil|mesh-list
64747365|NCT01490580|Propofol|propofol|mesh-list
64747366|NCT01490580|Atracurium|atracurium|mesh-list
64747367|NCT01490580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64359374|NCT04038489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64747390|NCT01490580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747391|NCT01490580|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64747392|NCT01490580|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64747393|NCT01490580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64747394|NCT01490580|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64747395|NCT01490190|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64747396|NCT01490190|Etonogestrel|etonogestrel|mesh-list
64747397|NCT01490190|NuvaRing|nuvaring|mesh-list
64747398|NCT01490190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64747399|NCT01490190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64747401|NCT01490190|Contraceptive Agents|contraceptive agents|mesh-ancestor
64747407|NCT01490190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64747408|NCT01446042|Methyltestosterone|methyltestosterone|mesh-list
64747409|NCT01446042|Testosterone|testosterone|mesh-list
64747410|NCT01446042|Testosterone undecanoate|testosterone undecanoate|mesh-list
64747411|NCT01446042|Testosterone enanthate|testosterone enanthate|mesh-list
64747412|NCT01446042|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64747413|NCT01446042|Androgens|androgens|mesh-ancestor
64747414|NCT01446042|Hormones|hormones|mesh-ancestor
64747415|NCT01446042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64747416|NCT01446042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747417|NCT01446042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64747418|NCT01446042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747419|NCT01446042|Anabolic Agents|anabolic agents|mesh-ancestor
64747432|NCT01470612|Tofacitinib|tofacitinib|mesh-list
64747433|NCT01470612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64747434|NCT01470612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747435|NCT01470612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747436|NCT04073316|Warfarin|warfarin|mesh-list
64747437|NCT04073316|Rivaroxaban|rivaroxaban|mesh-list
64747438|NCT04073316|Anticoagulants|anticoagulants|mesh-ancestor
64747439|NCT04073316|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64747440|NCT04073316|Antithrombins|antithrombins|mesh-ancestor
64747441|NCT04073316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64747442|NCT04073316|Protease Inhibitors|protease inhibitors|mesh-ancestor
64747443|NCT04073316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747444|NCT04073316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747445|NCT04089852|Nitrous Oxide|nitrous oxide|mesh-list
64747446|NCT04089852|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64747447|NCT04089852|Anesthetics, General|anesthetics, general|mesh-ancestor
64747448|NCT04089852|Anesthetics|anesthetics|mesh-ancestor
64747449|NCT04089852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64747452|NCT04089852|Analgesics|analgesics|mesh-ancestor
64747462|NCT01440816|Growth Inhibitors|growth inhibitors|mesh-ancestor
64747463|NCT01440816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747464|NCT03026244|Vitamin D|vitamin d|mesh-list
64747465|NCT03026244|Caseins|caseins|mesh-list
64747466|NCT03026244|Vitamins|vitamins|mesh-ancestor
64747467|NCT03026244|Micronutrients|micronutrients|mesh-ancestor
64747468|NCT03026244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747469|NCT03026244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64747470|NCT03026244|Chelating Agents|chelating agents|mesh-ancestor
64747471|NCT03026244|Sequestering Agents|sequestering agents|mesh-ancestor
64747472|NCT03026244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747473|NCT01470144|Epoprostenol|epoprostenol|mesh-list
64747474|NCT01470144|Tezosentan|tezosentan|mesh-list
64747475|NCT01470144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64747476|NCT01470144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64747477|NCT01470144|Vasodilator Agents|vasodilator agents|mesh-ancestor
64747478|NCT01443858|Meclizine|meclizine|mesh-list
64747479|NCT01443858|Nicotine|nicotine|mesh-list
64747480|NCT01443858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64747481|NCT01443858|Autonomic Agents|autonomic agents|mesh-ancestor
64747482|NCT01443858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64747483|NCT01443858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747639|NCT01437540|Respiratory System Agents|respiratory system agents|mesh-ancestor
64747640|NCT01437540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64747641|NCT01437540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64747642|NCT01437540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64747643|NCT01437540|Adrenergic Agents|adrenergic agents|mesh-ancestor
64747644|NCT01437540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64747645|NCT01437540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747646|NCT01437540|Anticonvulsants|anticonvulsants|mesh-ancestor
64747647|NCT01420536|Salicylic Acid|salicylic acid|mesh-list
64747711|NCT01465230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747712|NCT03820830|Palbociclib|palbociclib|mesh-list
64747713|NCT03820830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747714|NCT03820830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64747715|NCT03820830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747716|NCT03820830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747717|NCT01435122|Axitinib|axitinib|mesh-list
64747718|NCT01435122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747719|NCT01435122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64747720|NCT01435122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747721|NCT01435122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747804|NCT01432626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64747805|NCT01391130|Sunitinib|sunitinib|mesh-list
64747806|NCT01391130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747807|NCT01391130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64747809|NCT01391130|Growth Substances|growth substances|mesh-ancestor
64747834|NCT01390584|Podophyllotoxin|podophyllotoxin|mesh-list
64747835|NCT01390584|Procarbazine|procarbazine|mesh-list
64747836|NCT01390584|Imidazole|imidazole|mesh-list
64747837|NCT01390584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64747938|NCT01428882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747940|NCT01428258|Keratolytic Agents|keratolytic agents|mesh-ancestor
64747941|NCT01428258|Dermatologic Agents|dermatologic agents|mesh-ancestor
64747942|NCT03814200|Rifampin|rifampin|mesh-list
64747943|NCT03814200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64747944|NCT03814200|Antitubercular Agents|antitubercular agents|mesh-ancestor
64747945|NCT03814200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64747946|NCT03814200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64747947|NCT03814200|Leprostatic Agents|leprostatic agents|mesh-ancestor
64747948|NCT03814200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64747949|NCT03814200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747950|NCT03814200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747951|NCT03814200|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64747952|NCT03814200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64359958|NCT03347461|Glucocorticoids|glucocorticoids|mesh-ancestor
64747986|NCT01403610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64747988|NCT01403610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747989|NCT01403610|Growth Inhibitors|growth inhibitors|mesh-ancestor
64747990|NCT01403610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64360006|NCT04502641|Docetaxel|docetaxel|mesh-list
64748019|NCT01402284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64748020|NCT01402284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748021|NCT01402284|Immunologic Factors|immunologic factors|mesh-ancestor
64748022|NCT01402284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64748023|NCT01402284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64748024|NCT01402284|Growth Substances|growth substances|mesh-ancestor
64748025|NCT01402284|Growth Inhibitors|growth inhibitors|mesh-ancestor
64748026|NCT01388790|Cetuximab|cetuximab|mesh-list
64748027|NCT01388790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748029|NCT01388478|Pramipexole|pramipexole|mesh-list
64748034|NCT01388478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64748035|NCT01388478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64360042|NCT03955575|Antimetabolites|antimetabolites|mesh-ancestor
64748066|NCT01400412|Protease Inhibitors|protease inhibitors|mesh-ancestor
64748067|NCT01400412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748068|NCT01400412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748069|NCT01400412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64748070|NCT01400412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64748071|NCT01400412|Antiviral Agents|antiviral agents|mesh-ancestor
64748072|NCT01400412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64748073|NCT01400412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64748074|NCT01400412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64748075|NCT01400412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64748076|NCT01400412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64748077|NCT01400412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64748078|NCT01400412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64748079|NCT01400412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64748081|NCT03829410|Onvansertib|onvansertib|mesh-list
64748108|NCT01422720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64748109|NCT01422720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748111|NCT01387932|Ethiodized Oil|ethiodized oil|mesh-list
64748112|NCT01387932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64748113|NCT01387932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748114|NCT01387932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64748115|NCT01387932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64748116|NCT01387932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748117|NCT01387932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748118|NCT04413786|Oxytocin|oxytocin|mesh-list
64748119|NCT04413786|Oxytocics|oxytocics|mesh-ancestor
64748120|NCT04413786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64748205|NCT01384734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748206|NCT01384734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64748207|NCT01384734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64748208|NCT01384734|Antiviral Agents|antiviral agents|mesh-ancestor
64748209|NCT01384734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64748210|NCT01384734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64748211|NCT01384734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64748212|NCT01384734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64748213|NCT01384734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64748214|NCT01384734|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64748215|NCT01384734|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64748216|NCT01384734|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64748217|NCT01384734|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64748218|NCT01396512|Vaccines|vaccines|mesh-list
64748219|NCT01396512|Immunologic Factors|immunologic factors|mesh-ancestor
64748220|NCT01396512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748221|NCT01396434|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64748222|NCT01396434|Immunologic Factors|immunologic factors|mesh-ancestor
64748223|NCT01396434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748224|NCT01383954|Diclofenac|diclofenac|mesh-list
64748225|NCT01383954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64748226|NCT01383954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64748227|NCT01383954|Analgesics|analgesics|mesh-ancestor
64748228|NCT01383954|Sensory System Agents|sensory system agents|mesh-ancestor
64748229|NCT01383954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748231|NCT01383954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64748271|NCT05365074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64748272|NCT05365074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748273|NCT05365074|Sensory System Agents|sensory system agents|mesh-ancestor
64748274|NCT05365074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748275|NCT01383096|Artefenomel|artefenomel|mesh-list
64748276|NCT01383096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64748277|NCT01383096|Antimalarials|antimalarials|mesh-ancestor
64748278|NCT01383096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64748279|NCT01383096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64748280|NCT01383096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64748281|NCT01382940|Acetaminophen|acetaminophen|mesh-list
64748284|NCT01382940|Methotrexate|methotrexate|mesh-list
64748285|NCT01382940|Histamine Antagonists|histamine antagonists|mesh-list
64748286|NCT01382940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
64748287|NCT01382940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64748288|NCT01382940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748393|NCT01394250|Anesthetics, Local|anesthetics, local|mesh-ancestor
64748394|NCT01394250|Anesthetics|anesthetics|mesh-ancestor
64748395|NCT01394250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64748396|NCT01394250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748397|NCT01394250|Sensory System Agents|sensory system agents|mesh-ancestor
64748398|NCT01394250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360404|NCT02506699|Analgesics|analgesics|mesh-list
64748444|NCT00214968|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64748445|NCT00214968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748446|NCT03592212|Albuterol|albuterol|mesh-list
64748447|NCT03592212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64748448|NCT03592212|Autonomic Agents|autonomic agents|mesh-ancestor
64748449|NCT03592212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748450|NCT03592212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748451|NCT03592212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64748452|NCT03592212|Respiratory System Agents|respiratory system agents|mesh-ancestor
64748453|NCT03592212|Tocolytic Agents|tocolytic agents|mesh-ancestor
64748454|NCT03592212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64748455|NCT03592212|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64748456|NCT03592212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64748457|NCT03592212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64748458|NCT03592212|Adrenergic Agents|adrenergic agents|mesh-ancestor
64748459|NCT03592212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64748460|NCT03592212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748483|NCT04263090|ON 01910|on 01910|mesh-list
64748484|NCT04263090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64748485|NCT04263090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748486|NCT04263090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64748487|NCT04263090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748516|NCT03997266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748517|NCT03997266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748518|NCT05630274|Moxifloxacin|moxifloxacin|mesh-list
64748519|NCT05630274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64748520|NCT05630274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64748521|NCT05630274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64748522|NCT05630274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64748523|NCT05630274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748524|NCT05630274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748525|NCT05630274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748526|NCT05632692|Menthol|menthol|mesh-list
64748527|NCT05632692|Antipruritics|antipruritics|mesh-ancestor
64748528|NCT05632692|Dermatologic Agents|dermatologic agents|mesh-ancestor
64748529|NCT03594162|Cyclophosphamide|cyclophosphamide|mesh-list
64748530|NCT03594162|Fludarabine|fludarabine|mesh-list
64748531|NCT03594162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64748532|NCT03594162|Immunologic Factors|immunologic factors|mesh-ancestor
64748533|NCT03594162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748607|NCT04347486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64748608|NCT04347486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748609|NCT04347486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64748637|NCT03597594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748638|NCT03597594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64748639|NCT03597594|Immunologic Factors|immunologic factors|mesh-ancestor
64748640|NCT03597594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748654|NCT05632224|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64748655|NCT05632224|Serotonin Agents|serotonin agents|mesh-ancestor
64748656|NCT05631912|Cyclophosphamide|cyclophosphamide|mesh-list
64748657|NCT05631912|Fludarabine|fludarabine|mesh-list
64748658|NCT05631912|Fludarabine phosphate|fludarabine phosphate|mesh-list
64748659|NCT05631912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64748693|NCT05631678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64748694|NCT05631678|Antitubercular Agents|antitubercular agents|mesh-ancestor
64748695|NCT05631678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64748696|NCT05631678|Leprostatic Agents|leprostatic agents|mesh-ancestor
64748697|NCT05631678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64748710|NCT04008264|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64748711|NCT04008264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64748713|NCT04008264|Autonomic Agents|autonomic agents|mesh-ancestor
64748714|NCT04008264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748715|NCT04008264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748716|NCT04008264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64748717|NCT04008264|Mydriatics|mydriatics|mesh-ancestor
64748718|NCT04008264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65495056|NCT02870218|Autonomic Agents|autonomic agents|mesh-ancestor
65495057|NCT02870218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748719|NCT04008264|Cholinergic Agents|cholinergic agents|mesh-ancestor
64748720|NCT04008264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64748721|NCT04008264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748722|NCT04008264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64748723|NCT04008264|Parasympatholytics|parasympatholytics|mesh-ancestor
64748724|NCT03595254|Nicotine|nicotine|mesh-list
64748725|NCT03595254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64748726|NCT03595254|Autonomic Agents|autonomic agents|mesh-ancestor
64748727|NCT03595254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748728|NCT03595254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748740|NCT03599466|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64748741|NCT03599466|Protective Agents|protective agents|mesh-ancestor
64748742|NCT03599466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748743|NCT03986970|Tenofovir|tenofovir|mesh-list
64748744|NCT03986970|Emtricitabine|emtricitabine|mesh-list
64748745|NCT03986970|Antiviral Agents|antiviral agents|mesh-ancestor
64748746|NCT03986970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64748747|NCT03986970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64748748|NCT03986970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64748749|NCT03986970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748750|NCT03986970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748751|NCT03986970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64748752|NCT03986970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64748753|NCT03594396|Durvalumab|durvalumab|mesh-list
64748754|NCT03594396|Olaparib|olaparib|mesh-list
64748755|NCT03594396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64748756|NCT03594396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360751|NCT02509273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748787|NCT04407078|Neostigmine|neostigmine|mesh-list
64748788|NCT04407078|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64748789|NCT04407078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748790|NCT04407078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748791|NCT04407078|Cholinergic Agents|cholinergic agents|mesh-ancestor
64748792|NCT04407078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64748793|NCT04407078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748794|NCT04407078|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64748795|NCT04407078|Autonomic Agents|autonomic agents|mesh-ancestor
64748796|NCT04407078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748797|NCT00217620|Sorafenib|sorafenib|mesh-list
64748798|NCT00217620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748831|NCT00211536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748832|NCT03596970|Everolimus|everolimus|mesh-list
64748833|NCT03596970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748834|NCT03596970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64748835|NCT03596970|Immunologic Factors|immunologic factors|mesh-ancestor
64748836|NCT03596970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748837|NCT03596892|Cyclophosphamide|cyclophosphamide|mesh-list
64748838|NCT03596892|Busulfan|busulfan|mesh-list
64748839|NCT03596892|Decitabine|decitabine|mesh-list
64748840|NCT03596892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64748841|NCT03596892|Immunologic Factors|immunologic factors|mesh-ancestor
64473173|NCT00082706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64748842|NCT03596892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748843|NCT03596892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64748844|NCT03596892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64748845|NCT03596892|Alkylating Agents|alkylating agents|mesh-ancestor
64748846|NCT03596892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748847|NCT03596892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748848|NCT03596892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64748849|NCT03596892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64748850|NCT03596892|Antimetabolites|antimetabolites|mesh-ancestor
64748851|NCT03596892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748853|NCT03592836|Diuretics|diuretics|mesh-list
64748854|NCT03592836|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
64748855|NCT03592836|Natriuretic Agents|natriuretic agents|mesh-ancestor
64748856|NCT03592836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748857|NCT03592836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64748858|NCT03592836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748859|NCT03596502|Warfarin|warfarin|mesh-list
64748860|NCT03596502|Anticoagulants|anticoagulants|mesh-list
64748861|NCT04197570|Analgesics, Opioid|analgesics, opioid|mesh-list
64748936|NCT04194528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64748937|NCT04194528|Narcotics|narcotics|mesh-ancestor
64748938|NCT04194528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64748939|NCT04194528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64748940|NCT04194528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64748941|NCT04194528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64748942|NCT03023904|Nivolumab|nivolumab|mesh-list
64748943|NCT03023904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64748944|NCT03023904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748945|NCT03023904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64748946|NCT03023904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748947|NCT04196010|Cytarabine|cytarabine|mesh-list
64748948|NCT04196010|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
64748949|NCT04196010|Mitoxantrone|mitoxantrone|mesh-list
64748950|NCT04196010|Cladribine|cladribine|mesh-list
64748951|NCT04196010|Lenograstim|lenograstim|mesh-list
64748952|NCT04196010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64748953|NCT04196010|Antimetabolites|antimetabolites|mesh-ancestor
64748954|NCT04196010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748975|NCT04196400|Respiratory System Agents|respiratory system agents|mesh-ancestor
64748976|NCT03742986|Paclitaxel|paclitaxel|mesh-list
64748977|NCT03742986|Docetaxel|docetaxel|mesh-list
64748978|NCT03742986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64748979|NCT03742986|Cyclophosphamide|cyclophosphamide|mesh-list
64748980|NCT03742986|Doxorubicin|doxorubicin|mesh-list
64748981|NCT03742986|Nivolumab|nivolumab|mesh-list
64748982|NCT03742986|Trastuzumab|trastuzumab|mesh-list
64748983|NCT03742986|Pertuzumab|pertuzumab|mesh-list
64748984|NCT03742986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64748985|NCT03742986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748986|NCT03742986|Tubulin Modulators|tubulin modulators|mesh-ancestor
64748987|NCT03742986|Antimitotic Agents|antimitotic agents|mesh-ancestor
64748988|NCT03742986|Mitosis Modulators|mitosis modulators|mesh-ancestor
64748989|NCT03742986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748990|NCT03742986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64748991|NCT03742986|Immunologic Factors|immunologic factors|mesh-ancestor
64748992|NCT03742986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748995|NCT03742986|Alkylating Agents|alkylating agents|mesh-ancestor
64748996|NCT03742986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65495058|NCT02870218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473174|NCT00082706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585725|NCT01791647|Inositol|inositol|mesh-list
64748997|NCT03742986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64748998|NCT03742986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64748999|NCT03742986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64749000|NCT03742986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749001|NCT03742986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64749002|NCT03742986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64749003|NCT03023436|Fluorouracil|fluorouracil|mesh-list
64749004|NCT03023436|Capecitabine|capecitabine|mesh-list
64749005|NCT03023436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749006|NCT03023436|Antimetabolites|antimetabolites|mesh-ancestor
64749007|NCT03023436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749008|NCT03023436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64749009|NCT03023436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64749010|NCT03023436|Immunologic Factors|immunologic factors|mesh-ancestor
64749011|NCT03023436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749037|NCT04194684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749039|NCT04194294|Anesthetics, Local|anesthetics, local|mesh-ancestor
64749040|NCT04194294|Anesthetics|anesthetics|mesh-ancestor
64749041|NCT04194294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64749042|NCT04194294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749043|NCT04194294|Sensory System Agents|sensory system agents|mesh-ancestor
64749044|NCT04194294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749045|NCT04194294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64749092|NCT04193592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64749093|NCT04193592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64749094|NCT04193592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64749095|NCT04193592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749096|NCT03933384|Tenofovir|tenofovir|mesh-list
64749097|NCT03933384|Entecavir|entecavir|mesh-list
64749098|NCT03933384|Antiviral Agents|antiviral agents|mesh-ancestor
64749099|NCT03933384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64749100|NCT03933384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64749101|NCT03933384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64749102|NCT03933384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749103|NCT03933384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749104|NCT03933384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64749122|NCT04027530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64749123|NCT04027530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749124|NCT04199754|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64749126|NCT03023358|Cyclophosphamide|cyclophosphamide|mesh-list
64749127|NCT03023358|Doxorubicin|doxorubicin|mesh-list
64749128|NCT03023358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64749129|NCT03023358|Vincristine|vincristine|mesh-list
64749130|NCT03023358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64749131|NCT03023358|Immunologic Factors|immunologic factors|mesh-ancestor
64749132|NCT03023358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749133|NCT03023358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64749134|NCT03023358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64749135|NCT03023358|Alkylating Agents|alkylating agents|mesh-ancestor
64749136|NCT03023358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749137|NCT03023358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749138|NCT03023358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64749139|NCT03023358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65495059|NCT02870218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64749145|NCT03023358|Hormones|hormones|mesh-ancestor
64749149|NCT03023358|Tubulin Modulators|tubulin modulators|mesh-ancestor
64749150|NCT03023358|Antimitotic Agents|antimitotic agents|mesh-ancestor
64749151|NCT03023358|Mitosis Modulators|mitosis modulators|mesh-ancestor
64749152|NCT04192812|Leuprolide|leuprolide|mesh-list
64749153|NCT04192812|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64749154|NCT04192812|Fertility Agents|fertility agents|mesh-ancestor
64749155|NCT04192812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64749156|NCT04192812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749157|NCT04192812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64749158|NCT04192812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749159|NCT04407000|Favipiravir|favipiravir|mesh-list
64749160|NCT04407000|Antiviral Agents|antiviral agents|mesh-ancestor
64749161|NCT04407000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64749162|NCT04192656|Methylprednisolone|methylprednisolone|mesh-list
64749196|NCT04192032|Autonomic Agents|autonomic agents|mesh-ancestor
64749197|NCT04192032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749198|NCT04192032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749260|NCT04198662|Sensory System Agents|sensory system agents|mesh-ancestor
64749285|NCT04023630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749287|NCT04023630|Antithrombins|antithrombins|mesh-ancestor
64749288|NCT04023630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64749289|NCT04023630|Protease Inhibitors|protease inhibitors|mesh-ancestor
64749290|NCT04023630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749291|NCT04023630|Anticoagulants|anticoagulants|mesh-ancestor
65495061|NCT02870218|Cholinergic Agents|cholinergic agents|mesh-ancestor
64749292|NCT04147260|Ciprofloxacin|ciprofloxacin|mesh-list
64749293|NCT04147260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64749294|NCT04147260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64749295|NCT04147260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64749296|NCT04147260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64749297|NCT04147260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749298|NCT04147260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749299|NCT04147260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749300|NCT04147260|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64749301|NCT04147260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64749302|NCT04022304|Isophane Insulin, Human|isophane insulin, human|mesh-list
64749303|NCT04022304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64749304|NCT04022304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749305|NCT04020666|Kallikreins|kallikreins|mesh-list
64749306|NCT04020666|Coagulants|coagulants|mesh-ancestor
64749307|NCT04020666|Fertility Agents, Male|fertility agents, male|mesh-ancestor
64749308|NCT04020666|Fertility Agents|fertility agents|mesh-ancestor
64749309|NCT04020666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64749310|NCT04020666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749311|NCT03929640|Acetaminophen|acetaminophen|mesh-list
64749328|NCT04021992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64749329|NCT04021992|Vinorelbine|vinorelbine|mesh-list
64749330|NCT04021992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64749331|NCT04021992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749332|NCT04021992|Immunologic Factors|immunologic factors|mesh-ancestor
64749333|NCT04021992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749334|NCT04021992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64749335|NCT04021992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64749338|NCT04021992|Antiviral Agents|antiviral agents|mesh-ancestor
64749339|NCT04021992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64749341|NCT04021992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64749342|NCT04021992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64749343|NCT04021992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64749344|NCT04021992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64749345|NCT04021992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64749346|NCT04021992|Tubulin Modulators|tubulin modulators|mesh-ancestor
64749347|NCT04021992|Antimitotic Agents|antimitotic agents|mesh-ancestor
64749348|NCT04021992|Mitosis Modulators|mitosis modulators|mesh-ancestor
64749349|NCT03926130|Mirikizumab|mirikizumab|mesh-list
64749350|NCT03926130|Ustekinumab|ustekinumab|mesh-list
64749351|NCT03926130|Dermatologic Agents|dermatologic agents|mesh-ancestor
64749352|NCT03926130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64749353|NCT03926130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64749354|NCT03926130|Analgesics|analgesics|mesh-ancestor
64749355|NCT03926130|Sensory System Agents|sensory system agents|mesh-ancestor
64749356|NCT03926130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749357|NCT03926130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749358|NCT03926130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64749359|NCT03926130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64749360|NCT03926130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64749361|NCT03926130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64749362|NCT04020588|Minocycline|minocycline|mesh-list
64749363|NCT04020588|Celecoxib|celecoxib|mesh-list
64749364|NCT04020588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64749365|NCT04020588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64749366|NCT04020588|Analgesics|analgesics|mesh-ancestor
64749367|NCT04020588|Sensory System Agents|sensory system agents|mesh-ancestor
64749368|NCT04020588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749405|NCT04022226|Anesthetics|anesthetics|mesh-ancestor
64473176|NCT00082706|Immunologic Factors|immunologic factors|mesh-ancestor
64585952|NCT02277249|Digoxin|digoxin|mesh-list
64749411|NCT04029012|Methoxyflurane|methoxyflurane|mesh-list
64749412|NCT04029012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64749413|NCT04029012|Anesthetics, General|anesthetics, general|mesh-ancestor
64749414|NCT04029012|Anesthetics|anesthetics|mesh-ancestor
64749421|NCT05586438|Colistin|colistin|mesh-list
64749422|NCT05586438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64749423|NCT05586438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64749424|NCT04145232|Nivolumab|nivolumab|mesh-list
64749425|NCT04145232|Ipilimumab|ipilimumab|mesh-list
64749426|NCT04145232|Atezolizumab|atezolizumab|mesh-list
64749452|NCT04144218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64749453|NCT04144218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749454|NCT05580822|Tenecteplase|tenecteplase|mesh-list
64749455|NCT05580822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64749456|NCT05580822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64749457|NCT05580822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749458|NCT04024254|Folic Acid|folic acid|mesh-list
64749459|NCT04024254|Hematinics|hematinics|mesh-ancestor
64749460|NCT04024254|Vitamin B Complex|vitamin b complex|mesh-ancestor
64749461|NCT04024254|Vitamins|vitamins|mesh-ancestor
64749462|NCT04024254|Micronutrients|micronutrients|mesh-ancestor
64749463|NCT04024254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749467|NCT04143906|Gemcitabine|gemcitabine|mesh-list
64749468|NCT04143906|Carboplatin|carboplatin|mesh-list
64749469|NCT04143906|Vinorelbine|vinorelbine|mesh-list
64749470|NCT04143906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749471|NCT04143906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64749472|NCT04143906|Antimetabolites|antimetabolites|mesh-ancestor
64749473|NCT04143906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749474|NCT04143906|Antiviral Agents|antiviral agents|mesh-ancestor
64749475|NCT04143906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64749476|NCT04143906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749557|NCT04149678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64749558|NCT04149678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64749559|NCT04149678|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64749561|NCT05581992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64749562|NCT05581992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64749563|NCT05581992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64749564|NCT05581992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749565|NCT05581992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749566|NCT03020940|Cefuroxime|cefuroxime|mesh-list
64518364|NCT02454426|Serotonin Agents|serotonin agents|mesh-ancestor
64749598|NCT03020706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749599|NCT03020706|Anesthetics|anesthetics|mesh-ancestor
64749600|NCT03020706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64749601|NCT03020706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64749602|NCT03020706|Anticonvulsants|anticonvulsants|mesh-ancestor
64749603|NCT03020706|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64749604|NCT03020706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64749605|NCT03020706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749606|NCT03020706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64749607|NCT03020706|Tocolytic Agents|tocolytic agents|mesh-ancestor
64749608|NCT03020706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64749609|NCT03900624|Dexamethasone|dexamethasone|mesh-list
64749610|NCT03900624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64749634|NCT04149132|Gasotransmitters|gasotransmitters|mesh-ancestor
64749635|NCT04149132|Protective Agents|protective agents|mesh-ancestor
64749636|NCT03908892|Tetracycline|tetracycline|mesh-list
64749637|NCT03908892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64749638|NCT03908892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64749639|NCT03908892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64749640|NCT03908892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495062|NCT02870218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64749650|NCT03021330|Daunorubicin|daunorubicin|mesh-list
64749651|NCT03021330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64749652|NCT03021330|Antimetabolites|antimetabolites|mesh-ancestor
64749653|NCT03021330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749654|NCT03021330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749655|NCT03021330|Antiviral Agents|antiviral agents|mesh-ancestor
64749656|NCT03021330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64749657|NCT03021330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64749658|NCT03021330|Immunologic Factors|immunologic factors|mesh-ancestor
64749659|NCT03021330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361644|NCT02488291|Sufentanil|sufentanil|mesh-list
64749690|NCT04148898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64749691|NCT04148898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749692|NCT04148898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749693|NCT04148820|Aspirin|aspirin|mesh-list
64749694|NCT04148820|Perindopril|perindopril|mesh-list
64749695|NCT04148820|Atorvastatin|atorvastatin|mesh-list
64749696|NCT04148820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64749697|NCT04148820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64749698|NCT04148820|Analgesics|analgesics|mesh-ancestor
64749699|NCT04148820|Sensory System Agents|sensory system agents|mesh-ancestor
64749700|NCT04148820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749701|NCT04148820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749702|NCT04148820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64749728|NCT03941730|Contraceptive Agents|contraceptive agents|mesh-ancestor
64749729|NCT03941730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64749730|NCT03941730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64749731|NCT03941496|Azacitidine|azacitidine|mesh-list
64749732|NCT03941496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64749733|NCT03941496|Antimetabolites|antimetabolites|mesh-ancestor
64749749|NCT03580980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64749750|NCT03580980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64749751|NCT03580980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64749752|NCT03580980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64749772|NCT03587220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749773|NCT03587220|Antipruritics|antipruritics|mesh-ancestor
64749774|NCT03587220|Dermatologic Agents|dermatologic agents|mesh-ancestor
64749775|NCT03587220|Histamine Agonists|histamine agonists|mesh-ancestor
64749776|NCT03587220|Histamine Agents|histamine agents|mesh-ancestor
64749777|NCT03587220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64749778|NCT03586908|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64749779|NCT03586908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64749780|NCT04147572|Tiotropium Bromide|tiotropium bromide|mesh-list
64749781|NCT04147572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64749782|NCT04147572|Autonomic Agents|autonomic agents|mesh-ancestor
64749783|NCT04147572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749784|NCT04147572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749785|NCT04147572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64749786|NCT04147572|Respiratory System Agents|respiratory system agents|mesh-ancestor
65495064|NCT02614690|Calpastatin|calpastatin|mesh-list
64749789|NCT04147572|Cholinergic Agents|cholinergic agents|mesh-ancestor
64749790|NCT04147572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64749791|NCT04147572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749792|NCT04147806|Dexamethasone|dexamethasone|mesh-list
64749793|NCT04147806|Tamsulosin|tamsulosin|mesh-list
64749794|NCT04147806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64749795|NCT04147806|Antiemetics|antiemetics|mesh-ancestor
64749796|NCT04147806|Autonomic Agents|autonomic agents|mesh-ancestor
64749797|NCT04147806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749798|NCT04147806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749799|NCT04147806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64749840|NCT03346668|Sensory System Agents|sensory system agents|mesh-ancestor
64749841|NCT03346668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749842|NCT03346668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749843|NCT03346668|Anticonvulsants|anticonvulsants|mesh-ancestor
64749844|NCT03346668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64749845|NCT03346668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64749846|NCT03346668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64749847|NCT03346668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64749848|NCT03346668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64749849|NCT03346668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64749850|NCT03346668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64361824|NCT03321955|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64749878|NCT03589326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64749879|NCT03589326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64749880|NCT03589326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749881|NCT03589326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64749882|NCT03589326|Abortifacient Agents|abortifacient agents|mesh-ancestor
64749883|NCT03589326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64749884|NCT03589326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64749885|NCT03589326|Antimetabolites|antimetabolites|mesh-ancestor
64749886|NCT03589326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749887|NCT03589326|Dermatologic Agents|dermatologic agents|mesh-ancestor
64749888|NCT03589326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749889|NCT03589326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64749890|NCT03589326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64749891|NCT03589326|Immunologic Factors|immunologic factors|mesh-ancestor
64749892|NCT03589326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64749893|NCT03589326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64749894|NCT03589326|Antiviral Agents|antiviral agents|mesh-ancestor
64749895|NCT03589326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64749896|NCT03589326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64749897|NCT03589326|Tubulin Modulators|tubulin modulators|mesh-ancestor
64749898|NCT03589326|Antimitotic Agents|antimitotic agents|mesh-ancestor
64361870|NCT03316339|Analgesics|analgesics|mesh-ancestor
64749922|NCT03585036|Tramadol|tramadol|mesh-list
64749923|NCT03585036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64749924|NCT03585036|Narcotics|narcotics|mesh-ancestor
64749925|NCT03585036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64749926|NCT03585036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749927|NCT03585036|Analgesics|analgesics|mesh-ancestor
64749928|NCT03585036|Sensory System Agents|sensory system agents|mesh-ancestor
64473179|NCT00082706|Protective Agents|protective agents|mesh-ancestor
64749929|NCT03585036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749930|NCT03585036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64749931|NCT03585036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64749932|NCT03585036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64749933|NCT03585036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64749934|NCT03155568|Bupivacaine|bupivacaine|mesh-list
64749935|NCT03155568|Anesthetics, Local|anesthetics, local|mesh-ancestor
64749936|NCT03155568|Anesthetics|anesthetics|mesh-ancestor
64749937|NCT03155568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64749938|NCT03155568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749939|NCT03155568|Sensory System Agents|sensory system agents|mesh-ancestor
64749940|NCT03155568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749941|NCT03159702|Fludarabine|fludarabine|mesh-list
64749942|NCT03159702|Melphalan|melphalan|mesh-list
64749943|NCT03159702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749945|NCT03159702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64749996|NCT03159936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749997|NCT03159936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64749998|NCT03159936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749999|NCT03156816|Colchicine|colchicine|mesh-list
64750000|NCT03156816|Gout Suppressants|gout suppressants|mesh-ancestor
64750001|NCT03156816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64750002|NCT03156816|Tubulin Modulators|tubulin modulators|mesh-ancestor
64750003|NCT03156816|Antimitotic Agents|antimitotic agents|mesh-ancestor
64750004|NCT03156816|Mitosis Modulators|mitosis modulators|mesh-ancestor
64750005|NCT03156816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750006|NCT03156816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750007|NCT03583476|Amoxicillin|amoxicillin|mesh-list
64750008|NCT03583476|Metronidazole|metronidazole|mesh-list
64750009|NCT03583476|Clarithromycin|clarithromycin|mesh-list
64750010|NCT03583476|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64750044|NCT02728050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750045|NCT02728050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64750046|NCT02728050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64750047|NCT02728050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750048|NCT02728050|Analgesics|analgesics|mesh-ancestor
64750049|NCT02728050|Sensory System Agents|sensory system agents|mesh-ancestor
64750050|NCT02728050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64750051|NCT02728050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64750052|NCT02728050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64750060|NCT03159390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750061|NCT03582306|Chlorophyllin|chlorophyllin|mesh-list
64750062|NCT03582306|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64750063|NCT03582306|Protective Agents|protective agents|mesh-ancestor
64750064|NCT03582306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750065|NCT03159234|Epinephrine|epinephrine|mesh-list
64750066|NCT03159234|Racepinephrine|racepinephrine|mesh-list
64750067|NCT03159234|Epinephryl borate|epinephryl borate|mesh-list
64750078|NCT03159234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64750079|NCT03159234|Respiratory System Agents|respiratory system agents|mesh-ancestor
64750080|NCT03159234|Mydriatics|mydriatics|mesh-ancestor
64750081|NCT03159234|Sympathomimetics|sympathomimetics|mesh-ancestor
64750082|NCT03159234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64750083|NCT05701332|Gemcitabine|gemcitabine|mesh-list
64750084|NCT05701332|BCG Vaccine|bcg vaccine|mesh-list
64750085|NCT05701332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64750086|NCT05701332|Antimetabolites|antimetabolites|mesh-ancestor
64750087|NCT05701332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750088|NCT05701332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750089|NCT05701332|Antiviral Agents|antiviral agents|mesh-ancestor
64750090|NCT05701332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64750091|NCT05701332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750092|NCT05701332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64750093|NCT05701332|Immunologic Factors|immunologic factors|mesh-ancestor
64750094|NCT05701332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750095|NCT05701332|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64750096|NCT03581916|JNJ-64326067|jnj-64326067|mesh-list
64750097|NCT03581916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64750098|NCT03581916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750099|NCT05703048|Dexmedetomidine|dexmedetomidine|mesh-list
64750100|NCT05703048|Esmolol|esmolol|mesh-list
64750101|NCT05703048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64750102|NCT05703048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64750103|NCT05703048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750104|NCT05703048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64750105|NCT05703048|Analgesics|analgesics|mesh-ancestor
64750106|NCT05703048|Sensory System Agents|sensory system agents|mesh-ancestor
64750107|NCT05703048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64750108|NCT05703048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64750117|NCT05702970|Vitamin D|vitamin d|mesh-list
64750140|NCT03028740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750142|NCT03028740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64750143|NCT03028740|Antiviral Agents|antiviral agents|mesh-ancestor
64750144|NCT03028740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64750145|NCT03027648|Levonorgestrel|levonorgestrel|mesh-list
64750146|NCT03027648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64750147|NCT03027648|Contraceptive Agents|contraceptive agents|mesh-ancestor
64750148|NCT03027648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64750149|NCT03027648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750150|NCT03027648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64750151|NCT03027648|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64750152|NCT03027648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64750153|NCT01671384|Valproic Acid|valproic acid|mesh-list
64750154|NCT01671384|Anticonvulsants|anticonvulsants|mesh-ancestor
64750155|NCT01671384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750156|NCT01671384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750157|NCT01671384|GABA Agents|gaba agents|mesh-ancestor
64750158|NCT01671384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64750159|NCT01671384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750160|NCT01671384|Antimanic Agents|antimanic agents|mesh-ancestor
65495066|NCT02614690|Protease Inhibitors|protease inhibitors|mesh-ancestor
64473180|NCT00082706|Vitamin B Complex|vitamin b complex|mesh-ancestor
64750161|NCT01671384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64750162|NCT01671384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64750163|NCT01671384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64750164|NCT01671774|Zoledronic Acid|zoledronic acid|mesh-list
64750165|NCT01671774|Interleukin-2|interleukin-2|mesh-list
64750166|NCT01671774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750167|NCT01671774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64750168|NCT01671774|Analgesics|analgesics|mesh-ancestor
64750169|NCT01671774|Sensory System Agents|sensory system agents|mesh-ancestor
64750170|NCT01671774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64750203|NCT04296006|Autonomic Agents|autonomic agents|mesh-ancestor
64750204|NCT04296006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64750205|NCT04296006|Dopamine Agents|dopamine agents|mesh-ancestor
64750206|NCT04296006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64750207|NCT04296006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750208|NCT04296006|Adrenergic Agents|adrenergic agents|mesh-ancestor
64750209|NCT04296006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64750210|NCT04296006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64750211|NCT04296006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64750212|NCT04296006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64750214|NCT01672476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64750215|NCT01672476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64750216|NCT01672476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64750217|NCT01672476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750218|NCT01672554|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64750219|NCT01672554|Antidepressive Agents|antidepressive agents|mesh-ancestor
64750220|NCT01672554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64750221|NCT01672554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64750222|NCT01672554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64750223|NCT01672554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64750224|NCT01672554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750225|NCT05067582|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
64750226|NCT05067582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750308|NCT01674192|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64750309|NCT01674192|Serotonin Agents|serotonin agents|mesh-ancestor
64750310|NCT01674192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64750311|NCT01674192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495067|NCT02614690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750312|NCT01674192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750313|NCT01674270|Bicalutamide|bicalutamide|mesh-list
64750314|NCT01674270|Androgen Antagonists|androgen antagonists|mesh-ancestor
64750341|NCT05353062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64750342|NCT05353062|Respiratory System Agents|respiratory system agents|mesh-ancestor
64750343|NCT05353062|Mydriatics|mydriatics|mesh-ancestor
64750344|NCT05353062|Sympathomimetics|sympathomimetics|mesh-ancestor
64750345|NCT05353062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64750346|NCT05353062|Coagulants|coagulants|mesh-ancestor
64750347|NCT02315898|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64750348|NCT02315898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64750349|NCT02315898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64750350|NCT02315898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750352|NCT03152370|Folic Acid|folic acid|mesh-list
64750353|NCT03152370|Capecitabine|capecitabine|mesh-list
64750354|NCT03152370|Oxaliplatin|oxaliplatin|mesh-list
64750355|NCT03152370|Levoleucovorin|levoleucovorin|mesh-list
64750356|NCT03152370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64750357|NCT03152370|Antimetabolites|antimetabolites|mesh-ancestor
64750358|NCT03152370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750359|NCT03152370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750360|NCT03152370|Antidotes|antidotes|mesh-ancestor
64750370|NCT02187120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750371|NCT02187120|Hemostatics|hemostatics|mesh-ancestor
64750372|NCT02187120|Coagulants|coagulants|mesh-ancestor
64750373|NCT01674738|Bevacizumab|bevacizumab|mesh-list
64750374|NCT01674738|Pemetrexed|pemetrexed|mesh-list
64750375|NCT01674738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64750385|NCT01674738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64750386|NCT01675206|Vitamin K|vitamin k|mesh-list
64750387|NCT01675206|Vitamin K 2|vitamin k 2|mesh-list
64750388|NCT01675206|Vitamins|vitamins|mesh-ancestor
64750389|NCT01675206|Micronutrients|micronutrients|mesh-ancestor
64750390|NCT01675206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519195|NCT02369068|Hormones|hormones|mesh-ancestor
64750391|NCT01675206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64750392|NCT01675206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64750393|NCT01675206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750394|NCT01675206|Hemostatics|hemostatics|mesh-ancestor
64750395|NCT01675206|Coagulants|coagulants|mesh-ancestor
64750397|NCT03150576|Carboplatin|carboplatin|mesh-list
64750398|NCT03150576|Olaparib|olaparib|mesh-list
64750399|NCT03150576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64750400|NCT03150576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750401|NCT03150576|Tubulin Modulators|tubulin modulators|mesh-ancestor
64750402|NCT03150576|Antimitotic Agents|antimitotic agents|mesh-ancestor
64750403|NCT03150576|Mitosis Modulators|mitosis modulators|mesh-ancestor
64750404|NCT03150576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750405|NCT03150576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64750406|NCT03150576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750407|NCT01059786|Rituximab|rituximab|mesh-list
64750408|NCT01059786|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64750409|NCT01059786|Pentostatin|pentostatin|mesh-list
64750410|NCT01059786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64750411|NCT01059786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750412|NCT01059786|Immunologic Factors|immunologic factors|mesh-ancestor
64750413|NCT01059786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750414|NCT01059786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64750415|NCT01059786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64750416|NCT01059786|Alkylating Agents|alkylating agents|mesh-ancestor
64750418|NCT01059786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
64750427|NCT04747080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64750428|NCT04747080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750429|NCT04747080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64750455|NCT01675362|Trace Elements|trace elements|mesh-ancestor
64750456|NCT01675362|Micronutrients|micronutrients|mesh-ancestor
64750457|NCT01675362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64750458|NCT01675362|Vasodilator Agents|vasodilator agents|mesh-ancestor
64750460|NCT01675518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64750461|NCT01675518|Hormone Antagonists|hormone antagonists|mesh-ancestor
64750462|NCT01675518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64750463|NCT01675518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750464|NCT03158532|Nitroglycerin|nitroglycerin|mesh-list
64519271|NCT03230058|Voriconazole|voriconazole|mesh-list
64750465|NCT03158532|Vasodilator Agents|vasodilator agents|mesh-ancestor
64750466|NCT03878316|Oxytocin|oxytocin|mesh-list
64750468|NCT03878316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64750469|NCT03878316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750470|NCT01675986|Pregabalin|pregabalin|mesh-list
64750471|NCT01675986|Hydroxyzine|hydroxyzine|mesh-list
64750472|NCT01675986|Analgesics|analgesics|mesh-ancestor
64750473|NCT01675986|Sensory System Agents|sensory system agents|mesh-ancestor
64750474|NCT01675986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64750475|NCT01675986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750476|NCT01675986|Anticonvulsants|anticonvulsants|mesh-ancestor
64750477|NCT01675986|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64750478|NCT01675986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64750511|NCT03873480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750512|NCT03873480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750585|NCT03748134|Paclitaxel|paclitaxel|mesh-list
64750589|NCT03748134|Tubulin Modulators|tubulin modulators|mesh-ancestor
64750590|NCT03748134|Antimitotic Agents|antimitotic agents|mesh-ancestor
64750591|NCT03748134|Mitosis Modulators|mitosis modulators|mesh-ancestor
64750592|NCT03748134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750593|NCT03748134|Antimetabolites|antimetabolites|mesh-ancestor
64750594|NCT03748134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64750595|NCT03748134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64750596|NCT03748134|Immunologic Factors|immunologic factors|mesh-ancestor
64750597|NCT03748134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750598|NCT03747432|Dexmedetomidine|dexmedetomidine|mesh-list
64750599|NCT03747432|Propofol|propofol|mesh-list
64750600|NCT03747432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64750601|NCT03747432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64750602|NCT03747432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750603|NCT03747432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64750604|NCT03747432|Anesthetics, General|anesthetics, general|mesh-ancestor
64750605|NCT03747432|Anesthetics|anesthetics|mesh-ancestor
64750606|NCT03747432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64750607|NCT03747432|Analgesics|analgesics|mesh-ancestor
64750641|NCT03652974|Anticonvulsants|anticonvulsants|mesh-ancestor
64750642|NCT03652974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750643|NCT03652974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750644|NCT03652974|GABA Agents|gaba agents|mesh-ancestor
64750645|NCT03652974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64750646|NCT03652974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495068|NCT02614690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586554|NCT00387829|Estradiol|estradiol|mesh-list
64750647|NCT03652974|Antimanic Agents|antimanic agents|mesh-ancestor
64750648|NCT03652974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64750676|NCT03727776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64750678|NCT03727776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64750680|NCT03642210|Levonorgestrel|levonorgestrel|mesh-list
64750689|NCT02082678|Antiemetics|antiemetics|mesh-ancestor
64519487|NCT02043652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64750690|NCT02082678|Autonomic Agents|autonomic agents|mesh-ancestor
64750691|NCT02082678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64750692|NCT02082678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750693|NCT02082678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64750704|NCT02082678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64750705|NCT03843528|Azacitidine|azacitidine|mesh-list
64750706|NCT03843528|Vorinostat|vorinostat|mesh-list
64750707|NCT03843528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64750708|NCT03843528|Antimetabolites|antimetabolites|mesh-ancestor
64750709|NCT03843528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750710|NCT03843528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750711|NCT03843528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750712|NCT03843528|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64750713|NCT03843294|Nivolumab|nivolumab|mesh-list
64750714|NCT03843294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64750715|NCT03843294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750716|NCT03843294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64750717|NCT03843294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750718|NCT03834948|Paclitaxel|paclitaxel|mesh-list
64750719|NCT03834948|Pembrolizumab|pembrolizumab|mesh-list
64750720|NCT03834948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64750721|NCT03834948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750722|NCT03834948|Tubulin Modulators|tubulin modulators|mesh-ancestor
64750723|NCT03834948|Antimitotic Agents|antimitotic agents|mesh-ancestor
64750724|NCT03834948|Mitosis Modulators|mitosis modulators|mesh-ancestor
64750725|NCT03834948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750726|NCT03834948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64750744|NCT00003816|Fludarabine phosphate|fludarabine phosphate|mesh-list
64750745|NCT00003816|Etoposide|etoposide|mesh-list
64750746|NCT00003816|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64750747|NCT00003816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64750748|NCT00003816|Immunologic Factors|immunologic factors|mesh-ancestor
64750749|NCT00003816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750750|NCT00003816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64750751|NCT00003816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64750752|NCT00003816|Alkylating Agents|alkylating agents|mesh-ancestor
64750753|NCT00003816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750754|NCT00003816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750755|NCT00003816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64750756|NCT00003816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64750757|NCT00003816|Antimetabolites|antimetabolites|mesh-ancestor
65495069|NCT01442194|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64750758|NCT00003816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64362726|NCT05067153|Heparin|heparin|mesh-list
64750777|NCT03712878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750778|NCT03712878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64750779|NCT03712878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64750780|NCT03712878|Alkylating Agents|alkylating agents|mesh-ancestor
64750781|NCT03712878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750782|NCT03712878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750783|NCT03712878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64750784|NCT03712878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64750785|NCT03712878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750786|NCT03712878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64750787|NCT03712878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64750805|NCT03611556|Fluorouracil|fluorouracil|mesh-list
64750806|NCT03611556|Durvalumab|durvalumab|mesh-list
64750807|NCT03611556|Levoleucovorin|levoleucovorin|mesh-list
64750808|NCT03611556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64750809|NCT03611556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750810|NCT03611556|Tubulin Modulators|tubulin modulators|mesh-ancestor
64750811|NCT03611556|Antimitotic Agents|antimitotic agents|mesh-ancestor
64750812|NCT03611556|Mitosis Modulators|mitosis modulators|mesh-ancestor
64750813|NCT03611556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750814|NCT03611556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64750815|NCT03611556|Antimetabolites|antimetabolites|mesh-ancestor
64750816|NCT03611556|Antiviral Agents|antiviral agents|mesh-ancestor
64750817|NCT03611556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64750818|NCT03611556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750819|NCT03611556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64750820|NCT03611556|Immunologic Factors|immunologic factors|mesh-ancestor
64750838|NCT03609060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64750839|NCT03609060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750841|NCT04762992|Anticoagulants|anticoagulants|mesh-ancestor
64750842|NCT04762992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64750843|NCT04762992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64750844|NCT04762992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750845|NCT03704766|alpha-Defensins|alpha-defensins|mesh-list
64750846|NCT03704766|Defensins|defensins|mesh-list
64750847|NCT03704766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64750848|NCT03826992|Cytarabine|cytarabine|mesh-list
64750849|NCT03826992|Daunorubicin|daunorubicin|mesh-list
64750850|NCT03826992|Venetoclax|venetoclax|mesh-list
64750851|NCT03826992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64750852|NCT03826992|Antimetabolites|antimetabolites|mesh-ancestor
64750853|NCT03826992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750854|NCT03826992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750855|NCT03826992|Antiviral Agents|antiviral agents|mesh-ancestor
64750856|NCT03826992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64750858|NCT03826992|Immunologic Factors|immunologic factors|mesh-ancestor
64750865|NCT00004092|Cyclophosphamide|cyclophosphamide|mesh-list
64750866|NCT00004092|Carboplatin|carboplatin|mesh-list
64750867|NCT00004092|Doxorubicin|doxorubicin|mesh-list
64750868|NCT00004092|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64750869|NCT00004092|Thiotepa|thiotepa|mesh-list
64750870|NCT00004092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64750871|NCT00004092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750872|NCT00004092|Tubulin Modulators|tubulin modulators|mesh-ancestor
64750873|NCT00004092|Antimitotic Agents|antimitotic agents|mesh-ancestor
64750874|NCT00004092|Mitosis Modulators|mitosis modulators|mesh-ancestor
64750875|NCT00004092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750876|NCT00004092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64750877|NCT00004092|Immunologic Factors|immunologic factors|mesh-ancestor
64750878|NCT00004092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750879|NCT00004092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64362847|NCT03029403|Immunologic Factors|immunologic factors|mesh-ancestor
64750897|NCT03602976|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64750898|NCT03602976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64750899|NCT03825198|Dexamethasone|dexamethasone|mesh-list
64750900|NCT03825198|Ketorolac|ketorolac|mesh-list
64750901|NCT03825198|Sufentanil|sufentanil|mesh-list
64750902|NCT03825198|Morphine|morphine|mesh-list
64750903|NCT03825198|Bromides|bromides|mesh-list
64750904|NCT03825198|Propofol|propofol|mesh-list
64750905|NCT03825198|Sevoflurane|sevoflurane|mesh-list
64750906|NCT03825198|Levobupivacaine|levobupivacaine|mesh-list
64750907|NCT03825198|Rocuronium|rocuronium|mesh-list
64750908|NCT03825198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64750909|NCT03825198|Antiemetics|antiemetics|mesh-ancestor
64750910|NCT03825198|Autonomic Agents|autonomic agents|mesh-ancestor
64750911|NCT03825198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64750912|NCT03825198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750913|NCT03825198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64750914|NCT03825198|Glucocorticoids|glucocorticoids|mesh-ancestor
64750915|NCT03825198|Hormones|hormones|mesh-ancestor
64750922|NCT03825198|Anesthetics, General|anesthetics, general|mesh-ancestor
64750926|NCT03825198|Analgesics|analgesics|mesh-ancestor
64750927|NCT03825198|Sensory System Agents|sensory system agents|mesh-ancestor
64750928|NCT03825198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64750929|NCT03825198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64750930|NCT03825198|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64750931|NCT03825198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64750932|NCT03825198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64750933|NCT03825198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64750934|NCT03825198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750935|NCT03825198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750936|NCT03825198|Anticonvulsants|anticonvulsants|mesh-ancestor
64750963|NCT03817320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64750964|NCT03817320|Antiemetics|antiemetics|mesh-ancestor
64750965|NCT03817320|Autonomic Agents|autonomic agents|mesh-ancestor
64750966|NCT03817320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64750967|NCT03817320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750968|NCT03817320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64750969|NCT03817320|Glucocorticoids|glucocorticoids|mesh-ancestor
64750970|NCT03817320|Hormones|hormones|mesh-ancestor
64750971|NCT03817320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64750972|NCT03817320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64750973|NCT03817320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750974|NCT03817320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64750975|NCT03817320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64750976|NCT03817320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64750977|NCT03817320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750978|NCT03817320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750979|NCT03817320|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64750980|NCT03817320|Abortifacient Agents|abortifacient agents|mesh-ancestor
64750981|NCT03817320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64750982|NCT03817320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64751013|NCT03580356|Respiratory System Agents|respiratory system agents|mesh-ancestor
64751014|NCT03575052|Pimavanserin|pimavanserin|mesh-list
64751015|NCT03575052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64751016|NCT03575052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64751017|NCT03575052|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64751018|NCT03575052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64751019|NCT03575052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64751020|NCT03575052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751021|NCT03575052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64751022|NCT03575052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64751023|NCT03575052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64751024|NCT03575052|Serotonin Agents|serotonin agents|mesh-ancestor
64751025|NCT03575052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64751026|NCT03575052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751027|NCT03556020|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
64751028|NCT03556020|Vasodilator Agents|vasodilator agents|mesh-ancestor
64751029|NCT01473108|Eplerenone|eplerenone|mesh-list
64751030|NCT01473108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64751031|NCT01473108|Hormone Antagonists|hormone antagonists|mesh-ancestor
64751032|NCT01473108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64751033|NCT01473108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751034|NCT01473108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64751035|NCT01473108|Diuretics|diuretics|mesh-ancestor
64751036|NCT01473108|Natriuretic Agents|natriuretic agents|mesh-ancestor
64751037|NCT01473108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64751038|NCT01677546|Insulin|insulin|mesh-list
64751039|NCT01677546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64751040|NCT01677546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64751042|NCT04403724|Fentanyl|fentanyl|mesh-list
64751089|NCT03798678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64751090|NCT03798678|Glucocorticoids|glucocorticoids|mesh-ancestor
64751091|NCT03798678|Hormones|hormones|mesh-ancestor
64363066|NCT00705367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64751104|NCT04762134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64751105|NCT03564756|Ascorbic Acid|ascorbic acid|mesh-list
64751106|NCT03564756|Vitamins|vitamins|mesh-ancestor
64751107|NCT03564756|Micronutrients|micronutrients|mesh-ancestor
64751108|NCT03564756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751109|NCT03564756|Antioxidants|antioxidants|mesh-ancestor
64751110|NCT03564756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751111|NCT03564756|Protective Agents|protective agents|mesh-ancestor
64751112|NCT03462966|Rifaximin|rifaximin|mesh-list
64751113|NCT03462966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64751114|NCT03462966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64751115|NCT03462966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64751116|NCT03531762|Tepotinib|tepotinib|mesh-list
64751117|NCT03531762|Omeprazole|omeprazole|mesh-list
64751118|NCT03531762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64751119|NCT03531762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64751120|NCT03531762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64751121|NCT03531762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751122|NCT03531762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751123|NCT03531762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751124|NCT03458598|Analgesics, Opioid|analgesics, opioid|mesh-list
64751125|NCT03458598|Narcotics|narcotics|mesh-ancestor
64751126|NCT03458598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64586858|NCT05287607|Bilirubin|bilirubin|mesh-list
64751127|NCT03458598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751128|NCT03458598|Analgesics|analgesics|mesh-ancestor
64751129|NCT03458598|Sensory System Agents|sensory system agents|mesh-ancestor
64751130|NCT03458598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64751131|NCT03791736|Octreotide|octreotide|mesh-list
64751132|NCT03791736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64751133|NCT03791736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64751134|NCT03791736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751135|NCT03790488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64751136|NCT03790488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501916|NCT01593670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751137|NCT03790488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751138|NCT01679964|Raltegravir Potassium|raltegravir potassium|mesh-list
64751139|NCT01679964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64751140|NCT01679964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64751141|NCT01679964|Antiviral Agents|antiviral agents|mesh-ancestor
64751142|NCT01679964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64751143|NCT01679964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64751144|NCT01679964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64751145|NCT01679964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751146|NCT01679964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519934|NCT01740401|Ipilimumab|ipilimumab|mesh-list
64751147|NCT03524898|Gemcitabine|gemcitabine|mesh-list
64751148|NCT03524898|Paclitaxel|paclitaxel|mesh-list
64751149|NCT03524898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64751150|NCT03524898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751151|NCT03524898|Tubulin Modulators|tubulin modulators|mesh-ancestor
64751152|NCT03524898|Antimitotic Agents|antimitotic agents|mesh-ancestor
64751153|NCT03524898|Mitosis Modulators|mitosis modulators|mesh-ancestor
64751176|NCT03524508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64751178|NCT03522168|Risperidone|risperidone|mesh-list
64751179|NCT03522168|Aripiprazole|aripiprazole|mesh-list
64751180|NCT03522168|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64751181|NCT03522168|Serotonin Agents|serotonin agents|mesh-ancestor
64751182|NCT03522168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64751183|NCT03522168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751184|NCT03522168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751185|NCT03522168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64751186|NCT03522168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64751187|NCT03522168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64751188|NCT03522168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64751189|NCT03522168|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64751190|NCT03522168|Dopamine Agents|dopamine agents|mesh-ancestor
64751191|NCT03522168|Antidepressive Agents|antidepressive agents|mesh-ancestor
64751201|NCT01676844|Potassium phosphate|potassium phosphate|mesh-list
64751202|NCT01676844|Cariostatic Agents|cariostatic agents|mesh-ancestor
64751203|NCT01676844|Protective Agents|protective agents|mesh-ancestor
64363176|NCT02299999|Gemcitabine|gemcitabine|mesh-list
64751235|NCT03779646|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64751236|NCT03779646|Adrenergic Agents|adrenergic agents|mesh-ancestor
64751237|NCT03779646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64751238|NCT03779646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751239|NCT03774732|Paclitaxel|paclitaxel|mesh-list
64751240|NCT03774732|Cisplatin|cisplatin|mesh-list
64751241|NCT03774732|Carboplatin|carboplatin|mesh-list
64751242|NCT03774732|Pembrolizumab|pembrolizumab|mesh-list
64751243|NCT03774732|Pemetrexed|pemetrexed|mesh-list
64751244|NCT03774732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64751245|NCT03774732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363233|NCT00705289|Infliximab|infliximab|mesh-list
64751275|NCT00089778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64751277|NCT00089778|Sensory System Agents|sensory system agents|mesh-ancestor
64751278|NCT00089778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64751279|NCT00089778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751280|NCT00089778|Mitosis Modulators|mitosis modulators|mesh-ancestor
65495070|NCT01442194|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64473184|NCT00004935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64586927|NCT00450073|Vitamin D|vitamin d|mesh-list
64751281|NCT00089778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751282|NCT00089778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64751283|NCT00089778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64751284|NCT00089778|Antiviral Agents|antiviral agents|mesh-ancestor
64751285|NCT00089778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64751286|NCT00089544|Thalidomide|thalidomide|mesh-list
64751287|NCT00089544|Doxorubicin|doxorubicin|mesh-list
64751288|NCT00089544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64751289|NCT00089544|Ifosfamide|ifosfamide|mesh-list
64751290|NCT00089544|Isophosphamide mustard|isophosphamide mustard|mesh-list
64751291|NCT00089544|Dacarbazine|dacarbazine|mesh-list
64751332|NCT00088374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751333|NCT00087594|Ribavirin|ribavirin|mesh-list
64751355|NCT03768960|Daratumumab|daratumumab|mesh-list
64751356|NCT03768960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751357|NCT00087126|Topotecan|topotecan|mesh-list
64751358|NCT00087126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64751359|NCT00087126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64751360|NCT00087126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751361|NCT00087126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751362|NCT00087126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751363|NCT00086346|Cyclosporine|cyclosporine|mesh-list
64751364|NCT00086346|Sirolimus|sirolimus|mesh-list
64751365|NCT00086346|Tacrolimus|tacrolimus|mesh-list
64751366|NCT00086346|Cyclosporins|cyclosporins|mesh-list
64751367|NCT00086346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64751368|NCT00086346|Immunologic Factors|immunologic factors|mesh-ancestor
64751369|NCT00086346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751370|NCT00086346|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64751371|NCT00086346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751372|NCT00086346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751373|NCT00086346|Antifungal Agents|antifungal agents|mesh-ancestor
64751374|NCT00086346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64751375|NCT00086346|Dermatologic Agents|dermatologic agents|mesh-ancestor
64751376|NCT00086346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64751377|NCT00086346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64751378|NCT00086346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64751379|NCT00086346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751380|NCT00085566|Everolimus|everolimus|mesh-list
64751381|NCT00085566|Gefitinib|gefitinib|mesh-list
64751382|NCT00085566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751383|NCT00085566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64751384|NCT00085566|Immunologic Factors|immunologic factors|mesh-ancestor
64751385|NCT00085566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751401|NCT00085098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751402|NCT00085098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64751403|NCT00085098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64751404|NCT00085098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64751405|NCT00085098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64751406|NCT00085098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751407|NCT00085098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64751408|NCT00084864|Calcitriol|calcitriol|mesh-list
64751409|NCT00084864|Dexamethasone|dexamethasone|mesh-list
64751410|NCT00084864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64751411|NCT00084864|Antiemetics|antiemetics|mesh-ancestor
64751412|NCT00084864|Autonomic Agents|autonomic agents|mesh-ancestor
65495071|NCT01442194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495072|NCT01442194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64586989|NCT01421342|Aripiprazole|aripiprazole|mesh-list
64751413|NCT00084864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64751414|NCT00084864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751415|NCT00084864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64751416|NCT00084864|Glucocorticoids|glucocorticoids|mesh-ancestor
64751417|NCT00084864|Hormones|hormones|mesh-ancestor
64751418|NCT00084864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64751419|NCT00084864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64751420|NCT00084864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751421|NCT00084864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64751447|NCT00083226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64751448|NCT00083226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64751449|NCT00083226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751450|NCT00083226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751451|NCT00082758|Interleukin-2|interleukin-2|mesh-list
64751452|NCT00082758|Denileukin diftitox|denileukin diftitox|mesh-list
64751453|NCT00082758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751454|NCT00082758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64751455|NCT00082758|Analgesics|analgesics|mesh-ancestor
64751456|NCT00082758|Sensory System Agents|sensory system agents|mesh-ancestor
64751457|NCT00082758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64751465|NCT03087942|Growth Substances|growth substances|mesh-ancestor
64751466|NCT03087942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751467|NCT01678092|Omalizumab|omalizumab|mesh-list
64751468|NCT01678092|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64751469|NCT01678092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64751470|NCT01678092|Respiratory System Agents|respiratory system agents|mesh-ancestor
64751471|NCT04402320|Midazolam|midazolam|mesh-list
64751472|NCT04402320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64751473|NCT04402320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64751474|NCT04402320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64751475|NCT04402320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751476|NCT04402320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64751477|NCT04402320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64751478|NCT04402320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64751479|NCT04402320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64751480|NCT04402320|Anesthetics, General|anesthetics, general|mesh-ancestor
64751481|NCT04402320|Anesthetics|anesthetics|mesh-ancestor
64751482|NCT04402320|GABA Modulators|gaba modulators|mesh-ancestor
64751483|NCT04402320|GABA Agents|gaba agents|mesh-ancestor
64751484|NCT04402320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64751485|NCT04402320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751486|NCT03436056|Pembrolizumab|pembrolizumab|mesh-list
64751487|NCT03436056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64751495|NCT03088176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751496|NCT03088176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64751497|NCT01678404|Rituximab|rituximab|mesh-list
64751498|NCT01678404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64751499|NCT01678404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751500|NCT01678404|Immunologic Factors|immunologic factors|mesh-ancestor
64751501|NCT01678404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751502|NCT01678404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64751503|NCT03087864|Paclitaxel|paclitaxel|mesh-list
64751504|NCT03087864|Carboplatin|carboplatin|mesh-list
64751505|NCT03087864|Atezolizumab|atezolizumab|mesh-list
64751506|NCT03087864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64751507|NCT03087864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751508|NCT03087864|Tubulin Modulators|tubulin modulators|mesh-ancestor
64751509|NCT03087864|Antimitotic Agents|antimitotic agents|mesh-ancestor
64751510|NCT03087864|Mitosis Modulators|mitosis modulators|mesh-ancestor
64751511|NCT03087864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751512|NCT01678716|Micronutrients|micronutrients|mesh-list
64751513|NCT01678716|Trace Elements|trace elements|mesh-list
64751514|NCT01678716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751515|NCT00081510|Anastrozole|anastrozole|mesh-list
64751516|NCT00081510|Lonafarnib|lonafarnib|mesh-list
64751517|NCT00081510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64751518|NCT00081510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751519|NCT00081510|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64751520|NCT00081510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64751521|NCT00081510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751522|NCT00081510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751523|NCT00081510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64751524|NCT00081510|Hormone Antagonists|hormone antagonists|mesh-ancestor
64751525|NCT00081510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64751549|NCT01679106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751550|NCT01679106|Analgesics|analgesics|mesh-ancestor
64751551|NCT01679106|Sensory System Agents|sensory system agents|mesh-ancestor
64751552|NCT01679106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64751553|NCT01679106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64751554|NCT01679106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64751555|NCT01679106|Anesthetics, General|anesthetics, general|mesh-ancestor
64751556|NCT01679106|Anesthetics|anesthetics|mesh-ancestor
64751557|NCT04403100|Ritonavir|ritonavir|mesh-list
64751558|NCT04403100|Lopinavir|lopinavir|mesh-list
64751559|NCT04403100|Hydroxychloroquine|hydroxychloroquine|mesh-list
64751560|NCT04403100|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64751561|NCT04403100|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64751562|NCT04403100|Protease Inhibitors|protease inhibitors|mesh-ancestor
64751563|NCT04403100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751564|NCT04403100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751565|NCT04403100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64751566|NCT04403100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64751567|NCT04403100|Antiviral Agents|antiviral agents|mesh-ancestor
64751568|NCT04403100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64751569|NCT04403100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64751570|NCT04403100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64751571|NCT04403100|Antimalarials|antimalarials|mesh-ancestor
64751572|NCT04403100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64751573|NCT04403100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64751574|NCT04403100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64751575|NCT03086538|Pemetrexed|pemetrexed|mesh-list
64751576|NCT03086538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64751577|NCT03086538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751578|NCT03086538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751579|NCT03086538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751580|NCT03086538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64751581|NCT03086538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64751582|NCT03086538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64751583|NCT03473730|Daratumumab|daratumumab|mesh-list
64751590|NCT03081858|Mitosis Modulators|mitosis modulators|mesh-ancestor
64751591|NCT03081858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751592|NCT01679340|Oxaliplatin|oxaliplatin|mesh-list
64751610|NCT01679574|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64751611|NCT01679574|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64751613|NCT01679652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64751614|NCT01679652|Vasodilator Agents|vasodilator agents|mesh-ancestor
64751615|NCT01679652|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64751616|NCT01679652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64751617|NCT01679652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64751618|NCT01679652|Adrenergic Agents|adrenergic agents|mesh-ancestor
64751619|NCT01679652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64751620|NCT01679652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751621|NCT01679652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751622|NCT04761744|Nivolumab|nivolumab|mesh-list
64751623|NCT04761744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64751624|NCT04761744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751625|NCT04761744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64751626|NCT04761744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751627|NCT03089658|Avelumab|avelumab|mesh-list
64751628|NCT03089658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64751629|NCT03089658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751630|NCT03417492|Sildenafil Citrate|sildenafil citrate|mesh-list
64751631|NCT03417492|Citric Acid|citric acid|mesh-list
64751632|NCT03417492|Sodium Citrate|sodium citrate|mesh-list
64751633|NCT03417492|Anticoagulants|anticoagulants|mesh-ancestor
64751634|NCT03417492|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64751635|NCT03417492|Chelating Agents|chelating agents|mesh-ancestor
64751636|NCT03417492|Sequestering Agents|sequestering agents|mesh-ancestor
64751637|NCT03417492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751638|NCT03417492|Vasodilator Agents|vasodilator agents|mesh-ancestor
64751639|NCT03417492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64751640|NCT03417492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64751641|NCT03417492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751642|NCT03417492|Urological Agents|urological agents|mesh-ancestor
64751645|NCT03395184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751646|NCT03395184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751647|NCT03080766|Decitabine|decitabine|mesh-list
64751648|NCT03080766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64751649|NCT03080766|Antimetabolites|antimetabolites|mesh-ancestor
64751669|NCT03088254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64751670|NCT03088254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64751671|NCT03088254|Antimetabolites|antimetabolites|mesh-ancestor
64751672|NCT03088254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64751673|NCT03088254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64751674|NCT03088254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751675|NCT03088254|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64751676|NCT03088254|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64751677|NCT05685342|Acetaminophen|acetaminophen|mesh-list
64751678|NCT05685342|Ibuprofen|ibuprofen|mesh-list
64751679|NCT05685342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64751680|NCT05685342|Analgesics|analgesics|mesh-ancestor
64751681|NCT05685342|Sensory System Agents|sensory system agents|mesh-ancestor
64751682|NCT05685342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64751683|NCT05685342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751684|NCT05685342|Antipyretics|antipyretics|mesh-ancestor
64751685|NCT05685342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64751686|NCT05685342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64751687|NCT05685342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64751688|NCT05685342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64751689|NCT05685342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751690|NCT05685342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751691|NCT05684718|Itraconazole|itraconazole|mesh-list
64751692|NCT05684718|Rifabutin|rifabutin|mesh-list
64751693|NCT05684718|Antifungal Agents|antifungal agents|mesh-ancestor
64751694|NCT05684718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64751695|NCT05684718|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64751696|NCT05684718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64751697|NCT05684718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751718|NCT05684484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751719|NCT05684484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64751720|NCT05684484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64751721|NCT05684484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64751722|NCT05684484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751723|NCT05684484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751724|NCT03086382|Lacosamide|lacosamide|mesh-list
64751725|NCT03086382|Anticonvulsants|anticonvulsants|mesh-ancestor
64751726|NCT03086382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64751727|NCT03086382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64751728|NCT03086382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64751729|NCT03086382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751730|NCT03086226|Itraconazole|itraconazole|mesh-list
64751731|NCT03086226|Antifungal Agents|antifungal agents|mesh-ancestor
64751732|NCT03086226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64751733|NCT03086226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64751734|NCT03086226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64751735|NCT03086226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751736|NCT03086226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751737|NCT03086226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64751738|NCT03086226|Hormone Antagonists|hormone antagonists|mesh-ancestor
64751739|NCT03086226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64751740|NCT03086226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751741|NCT03086226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64751742|NCT03085992|Bevacizumab|bevacizumab|mesh-list
64751743|NCT03085992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64751744|NCT03085992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751745|NCT03085992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64751746|NCT03085992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64751747|NCT03085992|Growth Substances|growth substances|mesh-ancestor
64751750|NCT03086070|Omeprazole|omeprazole|mesh-list
64751755|NCT03086070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751756|NCT05688306|Oprelvekin|oprelvekin|mesh-list
64751757|NCT05688306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751789|NCT03359538|Sirolimus|sirolimus|mesh-list
64751790|NCT03359538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64751791|NCT03359538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64751792|NCT03359538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64751793|NCT03359538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751794|NCT03359538|Antifungal Agents|antifungal agents|mesh-ancestor
64751795|NCT03359538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64751796|NCT03359538|Immunologic Factors|immunologic factors|mesh-ancestor
64751797|NCT03359538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751798|NCT05345808|Triamcinolone|triamcinolone|mesh-list
64751799|NCT05345808|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64751800|NCT05345808|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64751824|NCT03085368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751825|NCT03085368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751826|NCT05638932|Tofacitinib|tofacitinib|mesh-list
64751827|NCT05638932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64751828|NCT05638932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751829|NCT05638932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751830|NCT03085290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64751831|NCT03085290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64751832|NCT05687760|Calcium|calcium|mesh-list
64751833|NCT05687760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64751834|NCT05687760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751835|NCT03084978|Anesthetics|anesthetics|mesh-list
64751888|NCT05582538|Mitosis Modulators|mitosis modulators|mesh-ancestor
64751889|NCT05582538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751890|NCT05582538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64751891|NCT03406650|Durvalumab|durvalumab|mesh-list
64751892|NCT03406650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64751893|NCT03406650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751922|NCT05686434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751924|NCT05686356|Bedaquiline|bedaquiline|mesh-list
64751925|NCT05686356|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64751926|NCT05686356|Antiviral Agents|antiviral agents|mesh-ancestor
64751927|NCT05686356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64751928|NCT05686356|Expectorants|expectorants|mesh-ancestor
64751929|NCT05686356|Respiratory System Agents|respiratory system agents|mesh-ancestor
64751930|NCT05686356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64751931|NCT05686356|Antioxidants|antioxidants|mesh-ancestor
64751932|NCT05686356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751933|NCT05686356|Protective Agents|protective agents|mesh-ancestor
64751934|NCT05686356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751935|NCT05686356|Antidotes|antidotes|mesh-ancestor
64751936|NCT05686356|Antitubercular Agents|antitubercular agents|mesh-ancestor
64751937|NCT05686356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64751938|NCT03083184|Ethanol|ethanol|mesh-list
64751939|NCT03083184|Enoxaparin|enoxaparin|mesh-list
64751940|NCT03083184|Anticoagulants|anticoagulants|mesh-ancestor
64363922|NCT02465827|Ropivacaine|ropivacaine|mesh-list
64751962|NCT05512962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751963|NCT05512962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751964|NCT03082092|Methylprednisolone|methylprednisolone|mesh-list
64751965|NCT03082092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64751966|NCT03082092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64751967|NCT03082092|Prednisolone|prednisolone|mesh-list
64751968|NCT03082092|Prednisolone acetate|prednisolone acetate|mesh-list
64751969|NCT03082092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64751970|NCT03082092|Prednisolone phosphate|prednisolone phosphate|mesh-list
64751972|NCT03082092|Antiemetics|antiemetics|mesh-ancestor
64751977|NCT03082092|Glucocorticoids|glucocorticoids|mesh-ancestor
64751978|NCT03082092|Hormones|hormones|mesh-ancestor
64751979|NCT03082092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64751980|NCT03082092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64751981|NCT03082092|Protective Agents|protective agents|mesh-ancestor
64751982|NCT03082092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64751983|NCT03082092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751984|NCT05498220|Gemcitabine|gemcitabine|mesh-list
64751985|NCT05498220|Dexamethasone|dexamethasone|mesh-list
64751986|NCT05498220|Rituximab|rituximab|mesh-list
64751987|NCT05498220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64587365|NCT00410423|Analgesics|analgesics|mesh-ancestor
64751988|NCT05498220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751989|NCT05498220|Immunologic Factors|immunologic factors|mesh-ancestor
64751990|NCT05498220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751991|NCT05498220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64751992|NCT05498220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64752022|NCT04401852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64752024|NCT03318900|Cyclophosphamide|cyclophosphamide|mesh-list
64752025|NCT03318900|Interleukin-2|interleukin-2|mesh-list
64752026|NCT03318900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64752027|NCT03318900|Immunoglobulin G|immunoglobulin g|mesh-list
64752028|NCT03318900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64752029|NCT03318900|Immunologic Factors|immunologic factors|mesh-ancestor
64752099|NCT03081702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64752100|NCT03081702|Hormone Antagonists|hormone antagonists|mesh-ancestor
64752101|NCT03081702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64752102|NCT03081702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752103|NCT03081702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64752105|NCT04399434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64752106|NCT04399434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752107|NCT04760574|Testosterone|testosterone|mesh-list
64752108|NCT04760574|Androgens|androgens|mesh-ancestor
64752109|NCT04760574|Hormones|hormones|mesh-ancestor
64752110|NCT04760574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64752111|NCT04760574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752112|NCT03237390|Gemcitabine|gemcitabine|mesh-list
64752113|NCT03237390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64752114|NCT03237390|Antimetabolites|antimetabolites|mesh-ancestor
64752115|NCT03237390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752116|NCT03237390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752117|NCT03237390|Antiviral Agents|antiviral agents|mesh-ancestor
64752118|NCT03237390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64752119|NCT03237390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752120|NCT03237390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64752121|NCT03237390|Immunologic Factors|immunologic factors|mesh-ancestor
64752122|NCT03237390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752123|NCT03302910|Torsemide|torsemide|mesh-list
64752124|NCT03302910|Furosemide|furosemide|mesh-list
64752125|NCT03302910|Bumetanide|bumetanide|mesh-list
64752126|NCT03302910|Nitroglycerin|nitroglycerin|mesh-list
64752128|NCT03302910|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
64752129|NCT03302910|Natriuretic Agents|natriuretic agents|mesh-ancestor
64752144|NCT03292926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64752145|NCT03292926|Glucocorticoids|glucocorticoids|mesh-ancestor
64752163|NCT04400136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752165|NCT04962126|Obinutuzumab|obinutuzumab|mesh-list
64752166|NCT04962126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64752167|NCT04962126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752168|NCT04962126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64752169|NCT05338086|Vitamin D|vitamin d|mesh-list
64752170|NCT05338086|Denosumab|denosumab|mesh-list
64752171|NCT05338086|Calcium|calcium|mesh-list
64752172|NCT05338086|Vitamins|vitamins|mesh-ancestor
64752173|NCT05338086|Micronutrients|micronutrients|mesh-ancestor
64752174|NCT05338086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752175|NCT05338086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64752176|NCT05338086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64752177|NCT04858854|Sulforaphane|sulforaphane|mesh-list
64752178|NCT04858854|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64752179|NCT04858854|Protective Agents|protective agents|mesh-ancestor
64752180|NCT04858854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752181|NCT04858854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752182|NCT04857840|Firibastat|firibastat|mesh-list
64752183|NCT04857840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64752184|NCT04582968|Capecitabine|capecitabine|mesh-list
64752185|NCT04582968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64752186|NCT04582968|Antimetabolites|antimetabolites|mesh-ancestor
64752187|NCT04582968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752188|NCT04582968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752189|NCT03261570|Digoxin|digoxin|mesh-list
64752190|NCT03261570|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
64752191|NCT03261570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64752192|NCT03261570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64752193|NCT03261570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752194|NCT03261570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752240|NCT04551144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752242|NCT04785924|Imipenem|imipenem|mesh-list
64752243|NCT04785924|Relebactam|relebactam|mesh-list
64752244|NCT04785924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64752245|NCT04785924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64752246|NCT04785924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64752247|NCT04785924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752248|NCT04785924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752249|NCT04774380|Carboplatin|carboplatin|mesh-list
64752250|NCT04774380|Etoposide|etoposide|mesh-list
64752251|NCT04774380|Durvalumab|durvalumab|mesh-list
64752252|NCT04774380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752253|NCT04774380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64752254|NCT04774380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64752296|NCT02084706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64752297|NCT02084706|Lidocaine|lidocaine|mesh-list
64752298|NCT02084706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64752299|NCT02084706|Anesthetics, Local|anesthetics, local|mesh-ancestor
64752300|NCT02084706|Anesthetics|anesthetics|mesh-ancestor
64752301|NCT02084706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64752302|NCT02084706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752303|NCT02084706|Sensory System Agents|sensory system agents|mesh-ancestor
65495075|NCT00468130|Aripiprazole|aripiprazole|mesh-list
64752323|NCT04704024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752324|NCT04704024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752325|NCT04704024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64752326|NCT04704024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64752327|NCT04433988|Pentoxifylline|pentoxifylline|mesh-list
64752328|NCT04433988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64752329|NCT04433988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752330|NCT04433988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752331|NCT04433988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64752332|NCT04433988|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64752333|NCT04433988|Protective Agents|protective agents|mesh-ancestor
64752334|NCT04433988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752335|NCT04433988|Vasodilator Agents|vasodilator agents|mesh-ancestor
64752336|NCT04433988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64752338|NCT04685538|Tetracaine|tetracaine|mesh-list
64752339|NCT04685538|Chloroprocaine|chloroprocaine|mesh-list
64752340|NCT04685538|Anesthetics, Local|anesthetics, local|mesh-ancestor
64752341|NCT04685538|Anesthetics|anesthetics|mesh-ancestor
64752342|NCT04685538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64752343|NCT04685538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752344|NCT04685538|Sensory System Agents|sensory system agents|mesh-ancestor
64752345|NCT04685538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64752346|NCT03252756|Cannabidiol|cannabidiol|mesh-list
64752347|NCT03252756|Anticonvulsants|anticonvulsants|mesh-ancestor
64752348|NCT05121246|Palivizumab|palivizumab|mesh-list
64752349|NCT05121246|Antiviral Agents|antiviral agents|mesh-ancestor
64752350|NCT05121246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64752351|NCT04344678|Sildenafil Citrate|sildenafil citrate|mesh-list
64752352|NCT04344678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752353|NCT04344678|Vasodilator Agents|vasodilator agents|mesh-ancestor
64752354|NCT04344678|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64521137|NCT05039476|Vitamin A|vitamin a|mesh-list
64752355|NCT04344678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64752356|NCT04344678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752357|NCT04344678|Urological Agents|urological agents|mesh-ancestor
64752383|NCT03220776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64752384|NCT03220776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64752385|NCT03220776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64752386|NCT03220776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64752387|NCT03220776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64752388|NCT03220776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64752389|NCT03220776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64752390|NCT03220776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752391|NCT03220776|Antimanic Agents|antimanic agents|mesh-ancestor
64752392|NCT03220776|Antiviral Agents|antiviral agents|mesh-ancestor
64752393|NCT03220776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64752394|NCT03220776|Expectorants|expectorants|mesh-ancestor
64752395|NCT03220776|Respiratory System Agents|respiratory system agents|mesh-ancestor
64752396|NCT03220776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64752397|NCT03220776|Antioxidants|antioxidants|mesh-ancestor
64752398|NCT03220776|Protective Agents|protective agents|mesh-ancestor
64501917|NCT01593670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752399|NCT03220776|Antidotes|antidotes|mesh-ancestor
64752400|NCT03246828|Gliclazide|gliclazide|mesh-list
64752401|NCT03246828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64752402|NCT03246828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752403|NCT04316442|Immunoconjugates|immunoconjugates|mesh-list
64752404|NCT04316442|Immunologic Factors|immunologic factors|mesh-ancestor
64752405|NCT04316442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752406|NCT03918798|Chloroprocaine|chloroprocaine|mesh-list
64752407|NCT03918798|Procaine|procaine|mesh-list
64752438|NCT02008656|Protective Agents|protective agents|mesh-ancestor
64752439|NCT02008656|Vitamin B Complex|vitamin b complex|mesh-ancestor
64752440|NCT02008656|Vitamins|vitamins|mesh-ancestor
64752441|NCT02008656|Micronutrients|micronutrients|mesh-ancestor
64752442|NCT04300140|Nivolumab|nivolumab|mesh-list
64752443|NCT04300140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64752444|NCT04300140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752445|NCT04300140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64752446|NCT04300140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752447|NCT03174132|Lidocaine|lidocaine|mesh-list
64752448|NCT03174132|Hyaluronic Acid|hyaluronic acid|mesh-list
64752449|NCT03174132|Anesthetics, Local|anesthetics, local|mesh-ancestor
64752450|NCT03174132|Anesthetics|anesthetics|mesh-ancestor
64752451|NCT03174132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64752452|NCT03174132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364417|NCT03370367|Tretinoin|tretinoin|mesh-list
64752485|NCT03818802|Nicotinic Acids|nicotinic acids|mesh-list
64473186|NCT00119158|Fluticasone|fluticasone|mesh-list
64473187|NCT00119158|Xhance|xhance|mesh-list
64752486|NCT03818802|Vitamin B Complex|vitamin b complex|mesh-ancestor
64752487|NCT03818802|Vitamins|vitamins|mesh-ancestor
64752488|NCT03818802|Micronutrients|micronutrients|mesh-ancestor
64752490|NCT03818802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64752518|NCT05158062|Paclitaxel|paclitaxel|mesh-list
64752519|NCT05158062|Docetaxel|docetaxel|mesh-list
64752520|NCT05158062|Bevacizumab|bevacizumab|mesh-list
64752521|NCT05158062|Carboplatin|carboplatin|mesh-list
64752522|NCT05158062|Pembrolizumab|pembrolizumab|mesh-list
64752523|NCT05158062|Olaparib|olaparib|mesh-list
64752524|NCT05158062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64752525|NCT05158062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752526|NCT05158062|Tubulin Modulators|tubulin modulators|mesh-ancestor
64752527|NCT05158062|Antimitotic Agents|antimitotic agents|mesh-ancestor
64752528|NCT05158062|Mitosis Modulators|mitosis modulators|mesh-ancestor
64752529|NCT05158062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752530|NCT05158062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64752531|NCT05158062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64752532|NCT05158062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64752533|NCT05158062|Growth Substances|growth substances|mesh-ancestor
64752534|NCT05158062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752535|NCT05158062|Growth Inhibitors|growth inhibitors|mesh-ancestor
64752536|NCT05158062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64752537|NCT05158062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752538|NCT01176474|Nivolumab|nivolumab|mesh-list
64752539|NCT01176474|Ipilimumab|ipilimumab|mesh-list
64752540|NCT01176474|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64752541|NCT01176474|Immunologic Factors|immunologic factors|mesh-ancestor
64752542|NCT01176474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752543|NCT01176474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64752544|NCT01176474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752545|NCT01176474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64752602|NCT04195776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64752603|NCT04195776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64752604|NCT03708588|Ticagrelor|ticagrelor|mesh-list
64752605|NCT03708588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64752606|NCT03708588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65495076|NCT00468130|Antidepressive Agents|antidepressive agents|mesh-ancestor
65495077|NCT00468130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64473188|NCT00119158|Pimecrolimus|pimecrolimus|mesh-list
64752607|NCT03708588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64752608|NCT03708588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64752609|NCT03708588|Purinergic Agents|purinergic agents|mesh-ancestor
64752610|NCT03708588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64752611|NCT03708588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752612|NCT03708588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752613|NCT04130802|Dexamethasone|dexamethasone|mesh-list
64364574|NCT03375671|GABA Modulators|gaba modulators|mesh-ancestor
64752662|NCT03162432|Vitamins|vitamins|mesh-ancestor
64752663|NCT03162432|Micronutrients|micronutrients|mesh-ancestor
64752664|NCT03162432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752665|NCT03162432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64752691|NCT05249478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64752692|NCT05249478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752693|NCT05249478|Sensory System Agents|sensory system agents|mesh-ancestor
64752694|NCT05249478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64752695|NCT05249478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64752696|NCT05249478|Narcotics|narcotics|mesh-ancestor
64752697|NCT05249478|Analgesics|analgesics|mesh-ancestor
64752698|NCT05249478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64752699|NCT05249478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64752700|NCT05249478|Anesthetics, General|anesthetics, general|mesh-ancestor
64752701|NCT05244252|Bupivacaine|bupivacaine|mesh-list
64752702|NCT05244252|Anesthetics, Local|anesthetics, local|mesh-ancestor
64752703|NCT05244252|Anesthetics|anesthetics|mesh-ancestor
64752704|NCT05244252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64752712|NCT03286842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752713|NCT03269994|Tazobactam|tazobactam|mesh-list
64752714|NCT03269994|Piperacillin|piperacillin|mesh-list
64752715|NCT03269994|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64752716|NCT03269994|Cefoxitin|cefoxitin|mesh-list
64752746|NCT04276428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64752747|NCT04276428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752748|NCT05248932|Norepinephrine|norepinephrine|mesh-list
64752749|NCT05248932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64752750|NCT05248932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64752751|NCT05248932|Adrenergic Agents|adrenergic agents|mesh-ancestor
64752752|NCT05248932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64752753|NCT05248932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752754|NCT05248932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752755|NCT05248932|Sympathomimetics|sympathomimetics|mesh-ancestor
64752756|NCT05248932|Autonomic Agents|autonomic agents|mesh-ancestor
64752757|NCT05248932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64752758|NCT05248932|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64752759|NCT03026790|Buprenorphine|buprenorphine|mesh-list
64752760|NCT03026790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64752761|NCT03026790|Naloxone|naloxone|mesh-list
64752762|NCT03026790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64364711|NCT03363425|Lidocaine|lidocaine|mesh-list
64752778|NCT03003546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64752779|NCT03003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752780|NCT03003546|Tubulin Modulators|tubulin modulators|mesh-ancestor
64752781|NCT03003546|Antimitotic Agents|antimitotic agents|mesh-ancestor
64752782|NCT03003546|Mitosis Modulators|mitosis modulators|mesh-ancestor
64752783|NCT03003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752784|NCT03003546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64752785|NCT03003546|Immunologic Factors|immunologic factors|mesh-ancestor
64752786|NCT03003546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752787|NCT03003546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64752788|NCT02395614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64752789|NCT02395614|Gentamicins|gentamicins|mesh-list
64752790|NCT02395614|Cefazolin|cefazolin|mesh-list
64752791|NCT02395614|Bacitracin|bacitracin|mesh-list
64752792|NCT02395614|Chlorhexidine|chlorhexidine|mesh-list
64752793|NCT02395614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64752794|NCT02395614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64752795|NCT02395614|Disinfectants|disinfectants|mesh-ancestor
64752796|NCT02395614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65495078|NCT00468130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64752797|NCT02395614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752798|NCT02395614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752799|NCT04396938|Lamotrigine|lamotrigine|mesh-list
64752800|NCT04396938|Anticonvulsants|anticonvulsants|mesh-ancestor
64752801|NCT04396938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64752802|NCT04396938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64752803|NCT04396938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752804|NCT04396938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64752805|NCT04396938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752806|NCT04396938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64752807|NCT04396938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64752808|NCT04396938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64752809|NCT04396938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64752810|NCT04396938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64752811|NCT00639678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64752812|NCT00639678|Immunologic Factors|immunologic factors|mesh-ancestor
64752813|NCT00639678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752814|NCT02914158|Tamoxifen|tamoxifen|mesh-list
64752815|NCT02914158|Leuprolide|leuprolide|mesh-list
64752816|NCT02914158|Goserelin|goserelin|mesh-list
64752817|NCT02914158|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64752818|NCT02914158|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64752819|NCT02914158|Hormone Antagonists|hormone antagonists|mesh-ancestor
64752820|NCT02914158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64752821|NCT02914158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752857|NCT03136146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752858|NCT03136146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64752859|NCT03136146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64752860|NCT03136146|Antiemetics|antiemetics|mesh-ancestor
64752861|NCT03136146|Autonomic Agents|autonomic agents|mesh-ancestor
64752862|NCT03136146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64752863|NCT03136146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64752864|NCT03136146|Glucocorticoids|glucocorticoids|mesh-ancestor
64752865|NCT03136146|Hormones|hormones|mesh-ancestor
64752866|NCT03136146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64752867|NCT03136146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64752868|NCT03136146|Protease Inhibitors|protease inhibitors|mesh-ancestor
64752869|NCT03136146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752870|NCT03136146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64752871|NCT03136146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64752872|NCT03136146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64752873|NCT03136146|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64752874|NCT03136146|Tubulin Modulators|tubulin modulators|mesh-ancestor
64752875|NCT03136146|Antimitotic Agents|antimitotic agents|mesh-ancestor
64752876|NCT03136146|Mitosis Modulators|mitosis modulators|mesh-ancestor
64752877|NCT03136146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64752878|NCT03136146|Antimetabolites|antimetabolites|mesh-ancestor
64752879|NCT03136146|Keratolytic Agents|keratolytic agents|mesh-ancestor
64752902|NCT05241054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64752903|NCT05241054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64752904|NCT05241054|Anesthetics, General|anesthetics, general|mesh-ancestor
64752905|NCT05241054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64752906|NCT05241054|Narcotics|narcotics|mesh-ancestor
64752907|NCT05241054|Analgesics|analgesics|mesh-ancestor
64752908|NCT05241054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64752922|NCT00638508|Ketorolac|ketorolac|mesh-list
64752924|NCT00638508|Ropivacaine|ropivacaine|mesh-list
64752925|NCT00638508|Anesthetics, Local|anesthetics, local|mesh-ancestor
64752926|NCT00638508|Anesthetics|anesthetics|mesh-ancestor
64752927|NCT00638508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64752928|NCT00638508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752929|NCT00638508|Sensory System Agents|sensory system agents|mesh-ancestor
64752930|NCT00638508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64752931|NCT00638508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64752932|NCT00638508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64752933|NCT00638508|Analgesics|analgesics|mesh-ancestor
64752934|NCT00638508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64752935|NCT00638508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64752936|NCT00638508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64752937|NCT00638508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752952|NCT00637806|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64752954|NCT00637728|Megestrol Acetate|megestrol acetate|mesh-list
64752955|NCT00637728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64752956|NCT00637728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64752957|NCT00637728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64752958|NCT00637728|Contraceptive Agents|contraceptive agents|mesh-ancestor
64752959|NCT00637728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64752960|NCT00637728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752961|NCT00637728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64752962|NCT00637728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64752963|NCT00637728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64752964|NCT00637728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752965|NCT00637728|Appetite Stimulants|appetite stimulants|mesh-ancestor
64752966|NCT00637728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64501918|NCT01593670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64501919|NCT01593670|Analgesics|analgesics|mesh-ancestor
64501920|NCT01593670|Sensory System Agents|sensory system agents|mesh-ancestor
64501921|NCT01593670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64501922|NCT01593670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501923|NCT01593670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64501924|NCT01593748|Gemcitabine|gemcitabine|mesh-list
64501925|NCT01593748|Docetaxel|docetaxel|mesh-list
64501926|NCT01593748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64501927|NCT01593748|Antimetabolites|antimetabolites|mesh-ancestor
64501928|NCT01593748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501929|NCT01593748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501930|NCT01593748|Antiviral Agents|antiviral agents|mesh-ancestor
64501931|NCT01593748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501932|NCT01593748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501933|NCT01593748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64501934|NCT01593748|Immunologic Factors|immunologic factors|mesh-ancestor
64752968|NCT01922466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64752969|NCT01922466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64752970|NCT01922466|Analgesics|analgesics|mesh-ancestor
64752971|NCT01922466|Sensory System Agents|sensory system agents|mesh-ancestor
64752972|NCT01922466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64752973|NCT01922466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752974|NCT01922466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64752975|NCT01922466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64752976|NCT00637572|Megestrol|megestrol|mesh-list
64752977|NCT00637572|Megestrol Acetate|megestrol acetate|mesh-list
64752978|NCT00637572|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64752979|NCT00637572|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64752980|NCT00637572|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64752981|NCT00637572|Contraceptive Agents|contraceptive agents|mesh-ancestor
64752982|NCT00637572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64752983|NCT00637572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752984|NCT00637572|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64752985|NCT00637572|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64752986|NCT00637572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64752987|NCT00637572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752988|NCT00637572|Appetite Stimulants|appetite stimulants|mesh-ancestor
64752989|NCT00637572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64752990|NCT00637416|Lansoprazole|lansoprazole|mesh-list
64752991|NCT00637416|Dexlansoprazole|dexlansoprazole|mesh-list
64752992|NCT00637416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64752993|NCT00637416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64752994|NCT00637416|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64752995|NCT00637416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364922|NCT03361319|Paclitaxel|paclitaxel|mesh-list
64753027|NCT05244954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64753028|NCT05244954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64753029|NCT05244954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64753030|NCT05244954|Antimalarials|antimalarials|mesh-ancestor
64753031|NCT05244954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64753038|NCT01929252|Analgesics|analgesics|mesh-ancestor
64753039|NCT01929252|Sensory System Agents|sensory system agents|mesh-ancestor
64753054|NCT00634920|Prednisolone|prednisolone|mesh-list
64753056|NCT00634920|Cyclosporins|cyclosporins|mesh-list
64753057|NCT00634920|Basiliximab|basiliximab|mesh-list
64753058|NCT00634920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753059|NCT00634920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753060|NCT00634920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64753061|NCT00634920|Immunologic Factors|immunologic factors|mesh-ancestor
64753062|NCT00634920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753063|NCT00634920|Antifungal Agents|antifungal agents|mesh-ancestor
64753064|NCT00634920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64753065|NCT00634920|Dermatologic Agents|dermatologic agents|mesh-ancestor
64753066|NCT00634920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64753067|NCT00634920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64753068|NCT00634920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753069|NCT00634920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64753070|NCT00634920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64753071|NCT00634920|Antitubercular Agents|antitubercular agents|mesh-ancestor
64753072|NCT00634920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64753073|NCT00634920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64753074|NCT00634920|Glucocorticoids|glucocorticoids|mesh-ancestor
64753075|NCT00634920|Hormones|hormones|mesh-ancestor
64753076|NCT00634920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64753077|NCT00634920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64753078|NCT01923012|Vitamin K|vitamin k|mesh-list
64753079|NCT01923012|Vitamin K 2|vitamin k 2|mesh-list
64753080|NCT01923012|Vitamins|vitamins|mesh-ancestor
64753081|NCT01923012|Micronutrients|micronutrients|mesh-ancestor
64753082|NCT01923012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753083|NCT01923012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64753098|NCT01929330|Dutasteride|dutasteride|mesh-list
64753099|NCT01929330|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64753100|NCT01929330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64753101|NCT01929330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753119|NCT04396548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64753120|NCT04396548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64753121|NCT04396548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64753122|NCT04396548|Adrenergic Agents|adrenergic agents|mesh-ancestor
64753123|NCT04396548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64753124|NCT04396548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753125|NCT01929798|Pancrelipase|pancrelipase|mesh-list
64753126|NCT01929798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64753127|NCT00633984|Cycloserine|cycloserine|mesh-list
64753128|NCT00633984|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64753129|NCT00633984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64753130|NCT00633984|Renal Agents|renal agents|mesh-ancestor
64753131|NCT00633984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64753132|NCT00633984|Antitubercular Agents|antitubercular agents|mesh-ancestor
64753133|NCT00633984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64753134|NCT00633984|Antimetabolites|antimetabolites|mesh-ancestor
64753135|NCT00633984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753136|NCT04395612|Niraparib|niraparib|mesh-list
64753137|NCT04395612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64753138|NCT04395612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753139|NCT04395612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753140|NCT04395612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753141|NCT01923558|Donepezil|donepezil|mesh-list
64753142|NCT01923558|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64753143|NCT01923558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753144|NCT01923558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753145|NCT01923558|Cholinergic Agents|cholinergic agents|mesh-ancestor
64753146|NCT01923558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64753147|NCT01923558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753148|NCT01923558|Nootropic Agents|nootropic agents|mesh-ancestor
64753149|NCT01921218|Cyclosporine|cyclosporine|mesh-list
64753154|NCT01921218|Cyclosporins|cyclosporins|mesh-list
64753155|NCT01921218|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
64753156|NCT01921218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64753157|NCT01921218|Glucocorticoids|glucocorticoids|mesh-ancestor
64753158|NCT01921218|Hormones|hormones|mesh-ancestor
64365090|NCT03281941|Antipruritics|antipruritics|mesh-ancestor
64753183|NCT00633750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64753184|NCT00633750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753185|NCT00633750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753186|NCT00633360|Drospirenone|drospirenone|mesh-list
64753187|NCT00633360|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64753188|NCT00633360|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
64753189|NCT00633360|Estradiol|estradiol|mesh-list
64753190|NCT00633360|Estrogens|estrogens|mesh-ancestor
64753191|NCT00633360|Hormones|hormones|mesh-ancestor
64753192|NCT00633360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64753193|NCT00633360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753194|NCT00633360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64753195|NCT00633360|Contraceptive Agents|contraceptive agents|mesh-ancestor
64753196|NCT00633360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64753197|NCT00633360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64753198|NCT00633360|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64753199|NCT00633360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64753200|NCT00633360|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64753201|NCT00633360|Hormone Antagonists|hormone antagonists|mesh-ancestor
64753202|NCT00633360|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64753203|NCT00633360|Diuretics|diuretics|mesh-ancestor
64753204|NCT00633360|Natriuretic Agents|natriuretic agents|mesh-ancestor
64753205|NCT00988260|Ganirelix|ganirelix|mesh-list
64753206|NCT00988260|Hormone Antagonists|hormone antagonists|mesh-ancestor
64753240|NCT01923948|Anticonvulsants|anticonvulsants|mesh-ancestor
64753272|NCT01924104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64753273|NCT01924104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753274|NCT01924104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64753275|NCT01924104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64753276|NCT01924104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64753277|NCT01924104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64753278|NCT01924104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753279|NCT01924104|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64753280|NCT01924104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64753281|NCT01924104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753282|NCT01924104|Antipyretics|antipyretics|mesh-ancestor
64753283|NCT01924104|Anticoagulants|anticoagulants|mesh-ancestor
64753284|NCT00987402|Ethanol|ethanol|mesh-list
64753285|NCT00987402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64753286|NCT00987402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64753287|NCT00987402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64753288|NCT00987402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753289|NCT00630786|Panitumumab|panitumumab|mesh-list
64753290|NCT00630786|Conatumumab|conatumumab|mesh-list
64753291|NCT00630786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64753292|NCT00630786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753293|NCT00630396|Minocycline|minocycline|mesh-list
64753294|NCT00630396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64753295|NCT00630396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64753296|NCT00636480|Chlorhexidine|chlorhexidine|mesh-list
64753297|NCT00636480|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64753298|NCT00636480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64753299|NCT00636480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64753300|NCT00636480|Disinfectants|disinfectants|mesh-ancestor
64753384|NCT00983580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64753385|NCT00983580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64753386|NCT00983580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64753387|NCT00983580|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64753412|NCT00982020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64753413|NCT00982020|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64753414|NCT00982020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64753415|NCT00982020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64753416|NCT00982020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522196|NCT00111657|Rasburicase|rasburicase|mesh-list
64753417|NCT00982020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64753418|NCT00982020|Serotonin Agents|serotonin agents|mesh-ancestor
64753419|NCT01926132|Ascorbic Acid|ascorbic acid|mesh-list
64753420|NCT01926132|Antioxidants|antioxidants|mesh-ancestor
64753421|NCT01926132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753422|NCT01926132|Protective Agents|protective agents|mesh-ancestor
64753423|NCT01926132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753425|NCT01926132|Micronutrients|micronutrients|mesh-ancestor
64753426|NCT01926210|Letrozole|letrozole|mesh-list
64753427|NCT01926210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753428|NCT01926210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64753429|NCT01926210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64753430|NCT01926210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753431|NCT01926210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753432|NCT01926210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64753433|NCT01926210|Hormone Antagonists|hormone antagonists|mesh-ancestor
64753435|NCT01926210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753469|NCT03064854|Antimitotic Agents|antimitotic agents|mesh-ancestor
64753470|NCT03064854|Mitosis Modulators|mitosis modulators|mesh-ancestor
64753471|NCT03064854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473190|NCT00119158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64753472|NCT03064854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64753473|NCT03064854|Antimetabolites|antimetabolites|mesh-ancestor
64753474|NCT03064854|Antiviral Agents|antiviral agents|mesh-ancestor
64753475|NCT03064854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64753476|NCT03064854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753477|NCT03064854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64753478|NCT03064854|Immunologic Factors|immunologic factors|mesh-ancestor
64753479|NCT03064854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753480|NCT03064854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64522266|NCT05513560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522267|NCT05513560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522268|NCT05513560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64522269|NCT05513560|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64522270|NCT05513560|Protective Agents|protective agents|mesh-ancestor
64522271|NCT05513560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522272|NCT05513560|Vasodilator Agents|vasodilator agents|mesh-ancestor
64522273|NCT05513560|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64522274|NCT05513560|Antioxidants|antioxidants|mesh-ancestor
64522275|NCT05513560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64522276|NCT05513560|Autonomic Agents|autonomic agents|mesh-ancestor
64522277|NCT05513560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64753481|NCT03064854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64753482|NCT03064854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64753483|NCT03063606|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
64753522|NCT04395768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753523|NCT04395768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64753524|NCT04395768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753525|NCT04395768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64753526|NCT04395768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64753527|NCT04395768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64753528|NCT04395768|Antimalarials|antimalarials|mesh-ancestor
64753529|NCT04395768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64753530|NCT04395768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64753531|NCT04395768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753532|NCT04395768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64753533|NCT04395768|Antioxidants|antioxidants|mesh-ancestor
64753534|NCT04395768|Protective Agents|protective agents|mesh-ancestor
64753535|NCT04395768|Vitamin B Complex|vitamin b complex|mesh-ancestor
64753536|NCT01927224|Nifurtimox|nifurtimox|mesh-list
64753537|NCT01927224|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64753538|NCT01927224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64753539|NCT01927224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64753540|NCT01927224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64753574|NCT03059940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64753575|NCT03059940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753576|NCT03059940|Antimetabolites|antimetabolites|mesh-ancestor
64753577|NCT03059940|Gasotransmitters|gasotransmitters|mesh-ancestor
64753579|NCT04552782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64753609|NCT01928316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64753610|NCT01928316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753611|NCT01928316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753612|NCT03050736|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
64753657|NCT04554888|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64753658|NCT04554888|Antidepressive Agents|antidepressive agents|mesh-ancestor
64753659|NCT04554888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64753660|NCT04554888|Histamine Antagonists|histamine antagonists|mesh-ancestor
64753661|NCT05601960|Sunscreening Agents|sunscreening agents|mesh-list
64753662|NCT05601960|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64753663|NCT05601960|Protective Agents|protective agents|mesh-ancestor
64753664|NCT05601960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753665|NCT05601960|Dermatologic Agents|dermatologic agents|mesh-ancestor
64753666|NCT05605002|Serotonin|serotonin|mesh-list
64753667|NCT05605002|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64753668|NCT05605002|Serotonin Agents|serotonin agents|mesh-ancestor
64753699|NCT04124094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64753700|NCT04124094|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64753701|NCT04124094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64753702|NCT04124094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64753703|NCT04124094|Adrenergic Agents|adrenergic agents|mesh-ancestor
64753704|NCT04124094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64753705|NCT04124094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753706|NCT04124094|Glucocorticoids|glucocorticoids|mesh-ancestor
64753708|NCT04124094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64753709|NCT04124094|Sympathomimetics|sympathomimetics|mesh-ancestor
64753710|NCT04124094|Antidotes|antidotes|mesh-ancestor
64365670|NCT03350399|Mitogens|mitogens|mesh-list
64753725|NCT04275024|Dermatologic Agents|dermatologic agents|mesh-ancestor
64753753|NCT04760262|Sensory System Agents|sensory system agents|mesh-ancestor
64753754|NCT04760262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64753755|NCT04760262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64753756|NCT04760262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64753757|NCT03047928|Nivolumab|nivolumab|mesh-list
64753758|NCT03047928|Vaccines|vaccines|mesh-list
64753759|NCT03047928|Immunologic Factors|immunologic factors|mesh-ancestor
64753760|NCT03047928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753761|NCT03047928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64753762|NCT03047928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753763|NCT03047928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64753764|NCT03047928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753765|NCT05607810|Aflibercept|aflibercept|mesh-list
64753766|NCT05607810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64473192|NCT00119158|Autonomic Agents|autonomic agents|mesh-ancestor
64473193|NCT00119158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64473194|NCT00119158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473195|NCT00119158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64473196|NCT00119158|Respiratory System Agents|respiratory system agents|mesh-ancestor
64473197|NCT00119158|Dermatologic Agents|dermatologic agents|mesh-ancestor
64473198|NCT00119158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64588257|NCT00217022|Respiratory System Agents|respiratory system agents|mesh-ancestor
64753767|NCT05607810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64753768|NCT05607810|Growth Substances|growth substances|mesh-ancestor
64753770|NCT05607810|Growth Inhibitors|growth inhibitors|mesh-ancestor
64753814|NCT03831126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753815|NCT03831126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64753816|NCT03831126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64753817|NCT03831126|Respiratory System Agents|respiratory system agents|mesh-ancestor
64753818|NCT04073784|Gemcitabine|gemcitabine|mesh-list
64753819|NCT04073784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64753820|NCT04073784|Antimetabolites|antimetabolites|mesh-ancestor
64753821|NCT04073784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753822|NCT04073784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753823|NCT04073784|Antiviral Agents|antiviral agents|mesh-ancestor
64753824|NCT04073784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64753825|NCT04073784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753826|NCT04073784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64753856|NCT04129710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64753858|NCT04129710|Growth Inhibitors|growth inhibitors|mesh-ancestor
64753860|NCT03200808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753861|NCT03200808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753862|NCT04129008|Aspirin|aspirin|mesh-list
64753863|NCT04129008|Indobufen|indobufen|mesh-list
64753864|NCT04129008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64753865|NCT04129008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64753866|NCT04129008|Analgesics|analgesics|mesh-ancestor
64753867|NCT04129008|Sensory System Agents|sensory system agents|mesh-ancestor
64753868|NCT04129008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64753869|NCT04129008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753945|NCT03012360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64753946|NCT03012360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64753947|NCT03012360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753948|NCT03012360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753949|NCT03012360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753950|NCT03012360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64753951|NCT03012360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64753952|NCT03012360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64753953|NCT04120974|Insulin|insulin|mesh-list
64753954|NCT04120974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64753955|NCT04120974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753956|NCT04126668|Vorolanib|vorolanib|mesh-list
64753957|NCT04126668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64753958|NCT04126668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753988|NCT04126044|Growth Inhibitors|growth inhibitors|mesh-ancestor
64753989|NCT04758858|Glucagon|glucagon|mesh-list
64753990|NCT04758858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753991|NCT04758858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64753992|NCT04758858|Hormones|hormones|mesh-ancestor
64753993|NCT04758858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64753994|NCT02975310|Anesthetics|anesthetics|mesh-list
64753995|NCT02975310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64753996|NCT02975310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753997|NCT04394208|Silymarin|silymarin|mesh-list
64753998|NCT04394208|Antioxidants|antioxidants|mesh-ancestor
64753999|NCT04394208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754000|NCT04394208|Protective Agents|protective agents|mesh-ancestor
64754001|NCT04394208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754035|NCT03933306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64754036|NCT03933306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64754037|NCT03933306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754038|NCT03933306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64754040|NCT03933306|Sensory System Agents|sensory system agents|mesh-ancestor
64754073|NCT04393584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754074|NCT04393584|Antidotes|antidotes|mesh-ancestor
64754077|NCT04393584|Vitamin B Complex|vitamin b complex|mesh-ancestor
64754079|NCT04393584|Micronutrients|micronutrients|mesh-ancestor
64754080|NCT02965950|Cyclophosphamide|cyclophosphamide|mesh-list
64754081|NCT02965950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64754082|NCT02965950|Immunologic Factors|immunologic factors|mesh-ancestor
64366039|NCT03434041|Dopamine Agents|dopamine agents|mesh-ancestor
64754109|NCT02921256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64754110|NCT02921256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754111|NCT02921256|Antimetabolites|antimetabolites|mesh-ancestor
64754112|NCT02921256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754113|NCT02921256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64754114|NCT02921256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64754115|NCT02921256|Immunologic Factors|immunologic factors|mesh-ancestor
64754116|NCT02921256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754117|NCT02921256|Antidotes|antidotes|mesh-ancestor
64754118|NCT02921256|Protective Agents|protective agents|mesh-ancestor
64754119|NCT02921256|Vitamin B Complex|vitamin b complex|mesh-ancestor
64754120|NCT02921256|Vitamins|vitamins|mesh-ancestor
64754121|NCT02921256|Micronutrients|micronutrients|mesh-ancestor
64754122|NCT02921256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64754123|NCT02921256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754124|NCT03828084|Decitabine|decitabine|mesh-list
64754125|NCT03828084|Tetrahydrouridine|tetrahydrouridine|mesh-list
64754126|NCT03828084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64754127|NCT03828084|Antimetabolites|antimetabolites|mesh-ancestor
64754128|NCT03828084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754160|NCT02956590|Pitavastatin|pitavastatin|mesh-list
64754174|NCT03820518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64754175|NCT03820518|Vitamins|vitamins|mesh-ancestor
64754176|NCT03820518|Micronutrients|micronutrients|mesh-ancestor
64754177|NCT03820518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64754178|NCT03820206|Tranexamic Acid|tranexamic acid|mesh-list
64754179|NCT03820206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64754180|NCT03820206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64754181|NCT03820206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754182|NCT03820206|Hemostatics|hemostatics|mesh-ancestor
64754210|NCT04392648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64754211|NCT04392648|Alkylating Agents|alkylating agents|mesh-ancestor
64754212|NCT04392648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754213|NCT04392648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754214|NCT04392648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64754215|NCT04392648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64754216|NCT04392648|Antiemetics|antiemetics|mesh-ancestor
64754217|NCT04392648|Autonomic Agents|autonomic agents|mesh-ancestor
64754218|NCT04392648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64754219|NCT04392648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64754220|NCT04392648|Glucocorticoids|glucocorticoids|mesh-ancestor
64754222|NCT04392648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64754223|NCT04392648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64754224|NCT04392648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64754225|NCT04392648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64754226|NCT04392648|Growth Substances|growth substances|mesh-ancestor
64754227|NCT04392648|Growth Inhibitors|growth inhibitors|mesh-ancestor
64523029|NCT02432976|Hormones|hormones|mesh-ancestor
64754229|NCT03826602|Tucatinib|tucatinib|mesh-list
64754230|NCT03826602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64754233|NCT03826602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64754234|NCT03826602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754235|NCT03826602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754245|NCT03820908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754246|NCT02953548|Cannabidiol|cannabidiol|mesh-list
64754247|NCT02953548|Anticonvulsants|anticonvulsants|mesh-ancestor
64754248|NCT03826524|Epinephrine|epinephrine|mesh-list
64754249|NCT03826524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64754250|NCT03826524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64754251|NCT03826524|Adrenergic Agents|adrenergic agents|mesh-ancestor
64754252|NCT03826524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64754253|NCT03826524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754254|NCT03826524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754255|NCT03826524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64754256|NCT03826524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64754257|NCT03826524|Autonomic Agents|autonomic agents|mesh-ancestor
65495089|NCT00468130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64754258|NCT03826524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64754259|NCT03826524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64754260|NCT03826524|Respiratory System Agents|respiratory system agents|mesh-ancestor
64754261|NCT03826524|Mydriatics|mydriatics|mesh-ancestor
64754262|NCT03826524|Sympathomimetics|sympathomimetics|mesh-ancestor
64754263|NCT03826524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64754264|NCT03112044|Sofosbuvir|sofosbuvir|mesh-list
64754265|NCT03112044|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64754266|NCT03112044|Velpatasvir|velpatasvir|mesh-list
64754267|NCT03112044|Antiviral Agents|antiviral agents|mesh-ancestor
64754268|NCT03112044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64754269|NCT02952222|Dexmedetomidine|dexmedetomidine|mesh-list
64754270|NCT02952222|Propofol|propofol|mesh-list
64754271|NCT02952222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64754272|NCT02952222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64754273|NCT02952222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754274|NCT02952222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64754275|NCT02952222|Anesthetics, General|anesthetics, general|mesh-ancestor
64754276|NCT02952222|Anesthetics|anesthetics|mesh-ancestor
64754277|NCT02952222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64754278|NCT02952222|Analgesics|analgesics|mesh-ancestor
64754279|NCT02952222|Sensory System Agents|sensory system agents|mesh-ancestor
64501935|NCT01593748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501936|NCT01593748|Tubulin Modulators|tubulin modulators|mesh-ancestor
64501937|NCT01593748|Antimitotic Agents|antimitotic agents|mesh-ancestor
64501938|NCT01593748|Mitosis Modulators|mitosis modulators|mesh-ancestor
64501964|NCT03005704|Antipyretics|antipyretics|mesh-ancestor
64501965|NCT01595386|Hydrocortisone|hydrocortisone|mesh-list
64754280|NCT02952222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64754281|NCT02952222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64754282|NCT02952222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64754283|NCT02952222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64754284|NCT02952222|Adrenergic Agents|adrenergic agents|mesh-ancestor
64754285|NCT02952222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64754286|NCT02952222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754287|NCT03826368|Cannabidiol|cannabidiol|mesh-list
64754288|NCT03826368|Anticonvulsants|anticonvulsants|mesh-ancestor
64754289|NCT04391478|Milrinone|milrinone|mesh-list
64754290|NCT04391478|Sildenafil Citrate|sildenafil citrate|mesh-list
64754291|NCT04391478|Vasodilator Agents|vasodilator agents|mesh-ancestor
64754292|NCT04391478|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64754293|NCT04391478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64754294|NCT04391478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754295|NCT04391478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754296|NCT04391478|Urological Agents|urological agents|mesh-ancestor
64754297|NCT04391478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64754298|NCT04391478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64754299|NCT04391478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64754300|NCT04391478|Protective Agents|protective agents|mesh-ancestor
64754301|NCT04391478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523102|NCT04594798|Immunologic Factors|immunologic factors|mesh-ancestor
64754302|NCT03828006|Red yeast rice|red yeast rice|mesh-list
64366231|NCT00700999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64754324|NCT04391868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754326|NCT03829332|Pembrolizumab|pembrolizumab|mesh-list
64754346|NCT01450176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64754347|NCT01450176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64754348|NCT01450176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64754349|NCT01450176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64754350|NCT01450176|Analgesics|analgesics|mesh-ancestor
64754351|NCT01450176|Sensory System Agents|sensory system agents|mesh-ancestor
64754352|NCT01450176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64754353|NCT01450176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754354|NCT01450176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64754355|NCT01450176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64754386|NCT02905110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754387|NCT02905110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64754388|NCT02905110|Antimetabolites|antimetabolites|mesh-ancestor
64754389|NCT02905110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754390|NCT02905110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754391|NCT02905110|Dermatologic Agents|dermatologic agents|mesh-ancestor
64754392|NCT02905110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754393|NCT02905110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64754394|NCT02905110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64754395|NCT02905110|Immunologic Factors|immunologic factors|mesh-ancestor
64754396|NCT02905110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64754397|NCT02905110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64754398|NCT02905110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64754412|NCT01450566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754414|NCT02947386|Nimotuzumab|nimotuzumab|mesh-list
64754415|NCT02947386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64754416|NCT02947386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754417|NCT02947386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64754418|NCT02947386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754419|NCT03043014|Misoprostol|misoprostol|mesh-list
64754420|NCT03043014|Mifepristone|mifepristone|mesh-list
64754421|NCT03043014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64754422|NCT03043014|Abortifacient Agents|abortifacient agents|mesh-ancestor
64754428|NCT03043014|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64754429|NCT03043014|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64754430|NCT03043014|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64754431|NCT03043014|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64754432|NCT03043014|Contraceptive Agents|contraceptive agents|mesh-ancestor
64754433|NCT03043014|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64754434|NCT03043014|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64754435|NCT03043014|Hormone Antagonists|hormone antagonists|mesh-ancestor
64754436|NCT03043014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64754437|NCT03043014|Luteolytic Agents|luteolytic agents|mesh-ancestor
64754438|NCT03043014|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64754439|NCT03043014|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64754440|NCT02983344|Fentanyl|fentanyl|mesh-list
64754441|NCT02983344|Ropivacaine|ropivacaine|mesh-list
64754442|NCT02983344|Anesthetics, Local|anesthetics, local|mesh-ancestor
64754443|NCT02983344|Anesthetics|anesthetics|mesh-ancestor
64754444|NCT02983344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64754445|NCT02983344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754446|NCT02983344|Sensory System Agents|sensory system agents|mesh-ancestor
64754447|NCT02983344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64754448|NCT02983344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64754449|NCT02983344|Narcotics|narcotics|mesh-ancestor
64523268|NCT02213068|Abatacept|abatacept|mesh-list
64754450|NCT02983344|Analgesics|analgesics|mesh-ancestor
64754451|NCT02983344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64754452|NCT02983344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64754453|NCT02983344|Anesthetics, General|anesthetics, general|mesh-ancestor
64754454|NCT03824340|Doxycycline|doxycycline|mesh-list
64754455|NCT03824340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64754456|NCT03824340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64754457|NCT03824340|Antimalarials|antimalarials|mesh-ancestor
64754480|NCT03823638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754482|NCT02884908|Analgesics|analgesics|mesh-ancestor
64754483|NCT02884908|Sensory System Agents|sensory system agents|mesh-ancestor
64564651|NCT02983591|Oxytocin|oxytocin|mesh-list
64501966|NCT01595386|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64501967|NCT01595386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64724271|NCT00000829|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64724272|NCT00000829|Immunologic Factors|immunologic factors|mesh-ancestor
64724273|NCT00000829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754484|NCT02884908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64754485|NCT02884908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754486|NCT02884908|Anticonvulsants|anticonvulsants|mesh-ancestor
64754487|NCT02884908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64754488|NCT02884908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64754489|NCT02884908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754490|NCT02884908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64754491|NCT02884908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64588635|NCT03590912|Cetirizine|cetirizine|mesh-list
64754492|NCT02884908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64754493|NCT02884908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64754494|NCT02884908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64754495|NCT01451580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64754496|NCT01451580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64754497|NCT01451580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754498|NCT01451658|Propranolol|propranolol|mesh-list
64754499|NCT01451658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64754500|NCT01451658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64754501|NCT01451658|Adrenergic Agents|adrenergic agents|mesh-ancestor
64754502|NCT01451658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64754503|NCT01451658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754504|NCT01451658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754505|NCT01451658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64754506|NCT01451658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64754507|NCT01451658|Vasodilator Agents|vasodilator agents|mesh-ancestor
64754508|NCT02861898|Cetuximab|cetuximab|mesh-list
64754625|NCT04849650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754626|NCT04849650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64754627|NCT04849650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64754628|NCT04849650|Dopamine Agents|dopamine agents|mesh-ancestor
64754629|NCT04849650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64754630|NCT04849650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754631|NCT04849650|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64754632|NCT04849650|Antidepressive Agents|antidepressive agents|mesh-ancestor
64754633|NCT04272372|Ketoprofen|ketoprofen|mesh-list
64754634|NCT04272372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64366582|NCT03952091|Lenalidomide|lenalidomide|mesh-list
64754669|NCT02439450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64754670|NCT02862132|Vedolizumab|vedolizumab|mesh-list
64754671|NCT02862132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64754672|NCT02859402|Fludarabine|fludarabine|mesh-list
64754673|NCT02859402|Busulfan|busulfan|mesh-list
64366658|NCT03664895|Goserelin|goserelin|mesh-list
64754693|NCT02535312|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64754694|NCT02535312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64754695|NCT01891812|Nitrous Oxide|nitrous oxide|mesh-list
64754696|NCT01891812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64754697|NCT01891812|Anesthetics, General|anesthetics, general|mesh-ancestor
64754698|NCT01891812|Anesthetics|anesthetics|mesh-ancestor
64754699|NCT01891812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64754700|NCT01891812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754701|NCT01891812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64754702|NCT01891812|Analgesics|analgesics|mesh-ancestor
64754724|NCT01892748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754725|NCT01892748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64754726|NCT01892748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64754727|NCT01893060|Chlorhexidine|chlorhexidine|mesh-list
64754728|NCT01893060|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64754729|NCT01893060|Povidone-Iodine|povidone-iodine|mesh-list
64754730|NCT01893060|Povidone|povidone|mesh-list
64754760|NCT01457820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754761|NCT02794428|Eflornithine|eflornithine|mesh-list
64754762|NCT02794428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754763|NCT02794428|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64754764|NCT02794428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64754765|NCT02794428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64754766|NCT02794428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64754767|NCT02794428|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64754768|NCT02794428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754769|NCT02794428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754770|NCT05020782|Belimumab|belimumab|mesh-list
64754771|NCT05020782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64754772|NCT05020782|Immunologic Factors|immunologic factors|mesh-ancestor
64754773|NCT05020782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754774|NCT05022342|Fulvestrant|fulvestrant|mesh-list
64754775|NCT05022342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64754800|NCT01458054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754801|NCT01458054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64754802|NCT01458054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64754803|NCT01458054|Antiviral Agents|antiviral agents|mesh-ancestor
64754804|NCT01458054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64754805|NCT01458054|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64754806|NCT01458054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64754807|NCT01458054|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64754808|NCT01458054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64754809|NCT01458054|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64754811|NCT01893450|Bromocriptine|bromocriptine|mesh-list
64754817|NCT01893450|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64754818|NCT01893450|Protective Agents|protective agents|mesh-ancestor
64754819|NCT01893450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754820|NCT01893450|Vasodilator Agents|vasodilator agents|mesh-ancestor
64754821|NCT01893450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64754822|NCT01893450|Antioxidants|antioxidants|mesh-ancestor
64754823|NCT01893450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64754824|NCT01893450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64366777|NCT03237637|Sympatholytics|sympatholytics|mesh-ancestor
64754856|NCT01458600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64754857|NCT01458600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64754858|NCT01458600|Vasodilator Agents|vasodilator agents|mesh-ancestor
64754859|NCT01458600|Sympatholytics|sympatholytics|mesh-ancestor
64754860|NCT01458600|Autonomic Agents|autonomic agents|mesh-ancestor
64754861|NCT01458600|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64754862|NCT01458600|Antithyroid Agents|antithyroid agents|mesh-ancestor
64754863|NCT01458600|Hormone Antagonists|hormone antagonists|mesh-ancestor
64754864|NCT01458600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64754865|NCT02832570|Sildenafil Citrate|sildenafil citrate|mesh-list
64754866|NCT02832570|Vasodilator Agents|vasodilator agents|mesh-ancestor
64754867|NCT02832570|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64754899|NCT02730546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754900|NCT02730546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65495091|NCT00468130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64473202|NCT00119158|Sensory System Agents|sensory system agents|mesh-ancestor
64754904|NCT02730546|Immunologic Factors|immunologic factors|mesh-ancestor
64754990|NCT01459380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64754991|NCT01459380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64754992|NCT01459380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64754993|NCT01459380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754994|NCT01459380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754995|NCT01459380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64754996|NCT04346004|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
64754997|NCT04346004|Hematinics|hematinics|mesh-ancestor
64754998|NCT02680314|Methotrexate|methotrexate|mesh-list
64754999|NCT02680314|Misoprostol|misoprostol|mesh-list
64755000|NCT02680314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64755020|NCT02707692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755022|NCT02706678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64755023|NCT02706678|Immunologic Factors|immunologic factors|mesh-ancestor
64755024|NCT02706678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755025|NCT02706678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64755026|NCT02706678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755027|NCT02706678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755028|NCT02705196|Gemcitabine|gemcitabine|mesh-list
64755029|NCT02705196|Paclitaxel|paclitaxel|mesh-list
64755030|NCT02705196|Atezolizumab|atezolizumab|mesh-list
64755031|NCT02705196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64755032|NCT02705196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755033|NCT02705196|Tubulin Modulators|tubulin modulators|mesh-ancestor
64755034|NCT02705196|Antimitotic Agents|antimitotic agents|mesh-ancestor
64755035|NCT02705196|Mitosis Modulators|mitosis modulators|mesh-ancestor
64755037|NCT02705196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64755079|NCT02666742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64755080|NCT02666742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64755082|NCT02666742|Antipyretics|antipyretics|mesh-ancestor
65495092|NCT00468130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64473203|NCT00119158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64755083|NCT02666742|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64755084|NCT02666742|Antithrombins|antithrombins|mesh-ancestor
64755085|NCT02666742|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64755086|NCT02666742|Protease Inhibitors|protease inhibitors|mesh-ancestor
64755087|NCT02684292|Pembrolizumab|pembrolizumab|mesh-list
64755088|NCT02684292|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64755089|NCT02684292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64755090|NCT02684292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755091|NCT05586516|Gemcitabine|gemcitabine|mesh-list
64755092|NCT05586516|Paclitaxel|paclitaxel|mesh-list
64755093|NCT05586516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64755094|NCT05586516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755095|NCT05586516|Tubulin Modulators|tubulin modulators|mesh-ancestor
64755096|NCT05586516|Antimitotic Agents|antimitotic agents|mesh-ancestor
64755097|NCT05586516|Mitosis Modulators|mitosis modulators|mesh-ancestor
64755098|NCT05586516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755099|NCT05586516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64755100|NCT05586516|Antimetabolites|antimetabolites|mesh-ancestor
64755101|NCT05586516|Antiviral Agents|antiviral agents|mesh-ancestor
64755102|NCT05586516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64755103|NCT05586516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755104|NCT05586516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64755105|NCT05586516|Immunologic Factors|immunologic factors|mesh-ancestor
64755106|NCT05586516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755138|NCT02359968|Paclitaxel|paclitaxel|mesh-list
64755139|NCT02359968|Fluorouracil|fluorouracil|mesh-list
64755140|NCT02359968|Oxaliplatin|oxaliplatin|mesh-list
64755141|NCT02359968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64755142|NCT02359968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564920|NCT05498129|Micronutrients|micronutrients|mesh-list
64724275|NCT03282344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64724276|NCT03282344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64724277|NCT03282344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64501968|NCT01595854|Dabigatran|dabigatran|mesh-list
64501969|NCT01595854|Ticagrelor|ticagrelor|mesh-list
64501970|NCT01595854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64501971|NCT01595854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64755143|NCT02359968|Tubulin Modulators|tubulin modulators|mesh-ancestor
64755144|NCT02359968|Antimitotic Agents|antimitotic agents|mesh-ancestor
64755145|NCT02359968|Mitosis Modulators|mitosis modulators|mesh-ancestor
64755146|NCT02359968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755147|NCT02359968|Antimetabolites|antimetabolites|mesh-ancestor
64367097|NCT02510963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64755175|NCT02603328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64755177|NCT02603328|Antimetabolites|antimetabolites|mesh-ancestor
64755178|NCT02603328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755179|NCT02603328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64755180|NCT02603328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64755181|NCT02603328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755182|NCT02323698|Caffeine|caffeine|mesh-list
64755183|NCT02323698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64755184|NCT02323698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755185|NCT02323698|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64755186|NCT02323698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755187|NCT02323698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755188|NCT02323698|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64755189|NCT02323698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64755190|NCT02323698|Purinergic Agents|purinergic agents|mesh-ancestor
64755191|NCT02323698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64755192|NCT02598726|Curcumin|curcumin|mesh-list
64755193|NCT02598726|Piperine|piperine|mesh-list
64755218|NCT01451736|Dopamine Agents|dopamine agents|mesh-ancestor
64755219|NCT01451736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64755240|NCT02300922|Immunologic Factors|immunologic factors|mesh-ancestor
64755241|NCT02300922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755242|NCT01453530|Glycopyrrolate|glycopyrrolate|mesh-list
64755243|NCT01453530|Neostigmine|neostigmine|mesh-list
64755275|NCT02983422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64755276|NCT02983422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64755278|NCT05585814|Pembrolizumab|pembrolizumab|mesh-list
64755279|NCT05585814|Capecitabine|capecitabine|mesh-list
64524076|NCT00363376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64755280|NCT05585814|Oxaliplatin|oxaliplatin|mesh-list
64755281|NCT05585814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64755282|NCT05585814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755283|NCT05585814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64367233|NCT02509091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64755304|NCT02013648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64755305|NCT02013648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64755306|NCT02013648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64755307|NCT02013648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755308|NCT02013648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64755309|NCT05585736|Mydriatics|mydriatics|mesh-list
64755310|NCT05585736|Autonomic Agents|autonomic agents|mesh-ancestor
64755311|NCT05585736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64755312|NCT05585736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755313|NCT01989780|Paclitaxel|paclitaxel|mesh-list
64755314|NCT01989780|Bevacizumab|bevacizumab|mesh-list
64755315|NCT01989780|Letrozole|letrozole|mesh-list
64755316|NCT01989780|Fulvestrant|fulvestrant|mesh-list
64755317|NCT01989780|Anastrozole|anastrozole|mesh-list
64755318|NCT01989780|Exemestane|exemestane|mesh-list
64755319|NCT01989780|Goserelin|goserelin|mesh-list
64755320|NCT01989780|Leuprolide|leuprolide|mesh-list
64755321|NCT01989780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64755335|NCT01989780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755336|NCT01989780|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64755337|NCT01989780|Hormone Antagonists|hormone antagonists|mesh-ancestor
64755338|NCT01989780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64755339|NCT01989780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64755358|NCT02549898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64755360|NCT02549898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64755361|NCT02549898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755362|NCT02549898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64755363|NCT02549898|Respiratory System Agents|respiratory system agents|mesh-ancestor
64755364|NCT02549898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64755365|NCT02549898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64755366|NCT02549898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755367|NCT02549898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64755368|NCT02549898|Vasodilator Agents|vasodilator agents|mesh-ancestor
64755369|NCT02549898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64755370|NCT02549898|Protective Agents|protective agents|mesh-ancestor
64755371|NCT02549898|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64755372|NCT02549898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64755373|NCT02549898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755374|NCT02549898|Hematinics|hematinics|mesh-ancestor
64755375|NCT02549898|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64755376|NCT02549898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64755377|NCT02538198|Lenalidomide|lenalidomide|mesh-list
64755378|NCT02538198|Immunologic Factors|immunologic factors|mesh-ancestor
64755379|NCT02538198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755380|NCT02538198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64755381|NCT02538198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64755382|NCT02538198|Growth Substances|growth substances|mesh-ancestor
65495094|NCT05196256|Levobupivacaine|levobupivacaine|mesh-list
64473205|NCT00119158|Immunologic Factors|immunologic factors|mesh-ancestor
64755383|NCT02538198|Growth Inhibitors|growth inhibitors|mesh-ancestor
64755384|NCT02538198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755385|NCT05585580|Paclitaxel|paclitaxel|mesh-list
64755386|NCT05585580|Lenvatinib|lenvatinib|mesh-list
64755390|NCT05585580|Antimitotic Agents|antimitotic agents|mesh-ancestor
64755391|NCT05585580|Mitosis Modulators|mitosis modulators|mesh-ancestor
64755392|NCT05585580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755393|NCT05585580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64755394|NCT05585580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755395|NCT02516670|Vitamins|vitamins|mesh-list
64755396|NCT02516670|Ascorbic Acid|ascorbic acid|mesh-list
64755397|NCT02516670|Docetaxel|docetaxel|mesh-list
64755425|NCT02283996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64755426|NCT02283996|Glucocorticoids|glucocorticoids|mesh-ancestor
64755427|NCT02283996|Hormones|hormones|mesh-ancestor
64755428|NCT02283996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64755429|NCT02283996|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64755430|NCT02283996|Protective Agents|protective agents|mesh-ancestor
64755431|NCT02283996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64755432|NCT02283996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755433|NCT04390152|Ritonavir|ritonavir|mesh-list
64524225|NCT02423980|Glucagon|glucagon|mesh-list
64755434|NCT04390152|Lopinavir|lopinavir|mesh-list
64755435|NCT04390152|Azithromycin|azithromycin|mesh-list
64755436|NCT04390152|Hydroxychloroquine|hydroxychloroquine|mesh-list
64755437|NCT04390152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64755438|NCT04390152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64755439|NCT04390152|Protease Inhibitors|protease inhibitors|mesh-ancestor
64755440|NCT04390152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755441|NCT04390152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755442|NCT04390152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64755443|NCT04390152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64755444|NCT04390152|Antiviral Agents|antiviral agents|mesh-ancestor
64755445|NCT04390152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64367392|NCT02506439|Vitamin D|vitamin d|mesh-list
64755480|NCT01943994|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
64755481|NCT01943994|Nicotine|nicotine|mesh-list
64755482|NCT01943994|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64755526|NCT02153580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64755548|NCT05586126|Sevoflurane|sevoflurane|mesh-list
64755549|NCT05586126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64755550|NCT05586126|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64755551|NCT05586126|Anesthetics, General|anesthetics, general|mesh-ancestor
64755552|NCT05586126|Anesthetics|anesthetics|mesh-ancestor
64755553|NCT05586126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64755554|NCT05586126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755555|NCT01893996|Adalimumab|adalimumab|mesh-list
64755556|NCT01893996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64755557|NCT01893996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64755558|NCT02442180|Methylprednisolone|methylprednisolone|mesh-list
64755559|NCT02442180|Prednisolone|prednisolone|mesh-list
64755560|NCT02442180|Lenograstim|lenograstim|mesh-list
64755561|NCT02442180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64755562|NCT02442180|Immunologic Factors|immunologic factors|mesh-ancestor
64755563|NCT02442180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755564|NCT02442180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64755565|NCT02442180|Antiemetics|antiemetics|mesh-ancestor
64755566|NCT02442180|Autonomic Agents|autonomic agents|mesh-ancestor
64755567|NCT02442180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64755568|NCT02442180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64755569|NCT02442180|Glucocorticoids|glucocorticoids|mesh-ancestor
64755570|NCT02442180|Hormones|hormones|mesh-ancestor
64755571|NCT02442180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65495095|NCT05196256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64473206|NCT00119158|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64755572|NCT02442180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64755574|NCT02442180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64755575|NCT02442180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755576|NCT01924260|Gemcitabine|gemcitabine|mesh-list
64755577|NCT01924260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64755578|NCT01924260|Antimetabolites|antimetabolites|mesh-ancestor
64755652|NCT04757532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64755653|NCT04757532|Hormone Antagonists|hormone antagonists|mesh-ancestor
64755654|NCT04757532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64755655|NCT04757532|Diuretics|diuretics|mesh-ancestor
64755656|NCT04757532|Natriuretic Agents|natriuretic agents|mesh-ancestor
64755657|NCT04757532|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64755659|NCT02069730|Androgen Antagonists|androgen antagonists|mesh-list
64524450|NCT02412150|Dexmedetomidine|dexmedetomidine|mesh-list
64755660|NCT02069730|Hormones|hormones|mesh-ancestor
64755661|NCT02069730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64755662|NCT02069730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755663|NCT02069730|Hormone Antagonists|hormone antagonists|mesh-ancestor
64755664|NCT02068092|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
64755695|NCT02063022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64755697|NCT02063022|Antimitotic Agents|antimitotic agents|mesh-ancestor
64755698|NCT02063022|Mitosis Modulators|mitosis modulators|mesh-ancestor
64755699|NCT02063022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64755700|NCT02063022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64755701|NCT02063022|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64755702|NCT02063022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64755703|NCT01895010|Tropisetron|tropisetron|mesh-list
64755704|NCT01895010|Antiemetics|antiemetics|mesh-ancestor
64755705|NCT01895010|Autonomic Agents|autonomic agents|mesh-ancestor
64755706|NCT01895010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64755707|NCT01895010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755708|NCT01895010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64755709|NCT01895010|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64755710|NCT01895010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64755711|NCT01895010|Serotonin Agents|serotonin agents|mesh-ancestor
64755735|NCT00575718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64755736|NCT00575718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755748|NCT02087748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755749|NCT02087748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64755750|NCT02087748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64755751|NCT02087748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64755752|NCT02087748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755753|NCT02087748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755754|NCT01490502|Vitamin D|vitamin d|mesh-list
64755755|NCT01490502|Cholecalciferol|cholecalciferol|mesh-list
64755756|NCT01490502|Vitamins|vitamins|mesh-ancestor
64755757|NCT01490502|Micronutrients|micronutrients|mesh-ancestor
64755758|NCT01490502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755759|NCT01490502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64367709|NCT03120923|Hormones|hormones|mesh-ancestor
64755795|NCT00273624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65495096|NCT05196256|Narcotics|narcotics|mesh-ancestor
64755796|NCT00273624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64755797|NCT00273624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64755798|NCT00273624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64755799|NCT00273624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367752|NCT03098121|Antiviral Agents|antiviral agents|mesh-ancestor
64755835|NCT00262470|Serotonin Agents|serotonin agents|mesh-ancestor
64755836|NCT00262470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64755837|NCT00262470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64755838|NCT00262470|Dopamine Agents|dopamine agents|mesh-ancestor
64755839|NCT00262470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64755840|NCT00262470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64755841|NCT00262470|Analgesics|analgesics|mesh-ancestor
64755842|NCT00262470|Sensory System Agents|sensory system agents|mesh-ancestor
64755843|NCT00262470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64755875|NCT00262470|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64755880|NCT01851642|Albuterol|albuterol|mesh-list
64755922|NCT01212822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64755923|NCT01212822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64755924|NCT01212822|Growth Substances|growth substances|mesh-ancestor
64755925|NCT01212822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755926|NCT01212822|Growth Inhibitors|growth inhibitors|mesh-ancestor
64755927|NCT01212822|Immunologic Factors|immunologic factors|mesh-ancestor
64755928|NCT01212822|Antimetabolites|antimetabolites|mesh-ancestor
64755929|NCT01212822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755997|NCT04756050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64755998|NCT04756050|Epinephryl borate|epinephryl borate|mesh-list
64755999|NCT04756050|Anesthetics, Local|anesthetics, local|mesh-ancestor
64756000|NCT04756050|Anesthetics|anesthetics|mesh-ancestor
64756001|NCT04756050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64756002|NCT04756050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756003|NCT04756050|Sensory System Agents|sensory system agents|mesh-ancestor
64756004|NCT04756050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64756005|NCT04756050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64756006|NCT04756050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64756007|NCT04756050|Adrenergic Agents|adrenergic agents|mesh-ancestor
64756008|NCT04756050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64756009|NCT04756050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756010|NCT04756050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64756011|NCT04756050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64756012|NCT04756050|Autonomic Agents|autonomic agents|mesh-ancestor
64756013|NCT04756050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64756014|NCT04756050|Respiratory System Agents|respiratory system agents|mesh-ancestor
64756045|NCT00869232|Antiemetics|antiemetics|mesh-ancestor
64473207|NCT00119158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756062|NCT00869232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64756063|NCT00869232|Growth Substances|growth substances|mesh-ancestor
64756064|NCT00869232|Growth Inhibitors|growth inhibitors|mesh-ancestor
64756065|NCT05320692|Apatinib|apatinib|mesh-list
64756089|NCT01763580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64756090|NCT01763580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756092|NCT04780854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64756093|NCT04780854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756094|NCT03969420|Cytarabine|cytarabine|mesh-list
64756095|NCT03969420|Alvocidib|alvocidib|mesh-list
64756096|NCT03969420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64756097|NCT03969420|Antimetabolites|antimetabolites|mesh-ancestor
64756098|NCT03969420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756099|NCT03969420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756100|NCT03969420|Antiviral Agents|antiviral agents|mesh-ancestor
64756101|NCT03969420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64756102|NCT03969420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64756103|NCT03969420|Immunologic Factors|immunologic factors|mesh-ancestor
64756104|NCT03969420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756105|NCT03969420|Growth Inhibitors|growth inhibitors|mesh-ancestor
64756106|NCT03969420|Growth Substances|growth substances|mesh-ancestor
64756107|NCT03969420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64756108|NCT03969420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756109|NCT01740492|Ketamine|ketamine|mesh-list
64756110|NCT01740492|Analgesics|analgesics|mesh-ancestor
64756111|NCT01740492|Sensory System Agents|sensory system agents|mesh-ancestor
64756112|NCT01740492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64756113|NCT01740492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756114|NCT01740492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64756115|NCT01740492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64756145|NCT04779762|Dermatologic Agents|dermatologic agents|mesh-ancestor
64756146|NCT04777968|Fluorides|fluorides|mesh-list
64756157|NCT01722708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64756158|NCT01722708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64756176|NCT04779060|Antiemetics|antiemetics|mesh-ancestor
64756177|NCT04779060|Autonomic Agents|autonomic agents|mesh-ancestor
64756178|NCT04779060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64756179|NCT04779060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756180|NCT04779060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64756181|NCT04779060|Glucocorticoids|glucocorticoids|mesh-ancestor
64756182|NCT04779060|Hormones|hormones|mesh-ancestor
64756183|NCT04779060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64756184|NCT04779060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64756185|NCT04779060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756186|NCT04778514|Contraceptive Agents|contraceptive agents|mesh-list
64756187|NCT04778514|Contraceptives, Oral|contraceptives, oral|mesh-list
64756188|NCT04778514|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64756189|NCT04778514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64756190|NCT04778514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524976|NCT02551744|Histamine|histamine|mesh-list
64756191|NCT04778514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64756192|NCT04777110|Esketamine|esketamine|mesh-list
64756193|NCT04777110|Antidepressive Agents|antidepressive agents|mesh-ancestor
64756194|NCT04777110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64756195|NCT01100892|Insulin Detemir|insulin detemir|mesh-list
64756196|NCT01100892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64756197|NCT01100892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756198|NCT01895400|Cilostazol|cilostazol|mesh-list
64756199|NCT01895400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64756200|NCT01895400|Autonomic Agents|autonomic agents|mesh-ancestor
64756250|NCT03012984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64756251|NCT03012984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756252|NCT03012984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64756253|NCT03012984|Analgesics|analgesics|mesh-ancestor
64756254|NCT03012984|Sensory System Agents|sensory system agents|mesh-ancestor
64756255|NCT03012984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64756256|NCT03012984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64756290|NCT01896960|Anesthetics, General|anesthetics, general|mesh-ancestor
64756340|NCT00056472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756341|NCT00056472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64756343|NCT00056472|Antidepressive Agents|antidepressive agents|mesh-ancestor
64756344|NCT00056550|Antithrombins|antithrombins|mesh-list
64756368|NCT04880850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64756370|NCT04880850|Insulin Aspart|insulin aspart|mesh-list
64756371|NCT04880850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64756372|NCT04880850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756373|NCT02538744|Doxazosin|doxazosin|mesh-list
64756374|NCT02538744|Cocaine|cocaine|mesh-list
64756375|NCT02538744|Modafinil|modafinil|mesh-list
64756376|NCT02538744|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64756377|NCT02538744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756378|NCT02538744|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64756379|NCT02538744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64756380|NCT02538744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64756381|NCT02538744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756382|NCT02538744|Anesthetics, Local|anesthetics, local|mesh-ancestor
64756383|NCT02538744|Anesthetics|anesthetics|mesh-ancestor
64756384|NCT02538744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64756385|NCT02538744|Sensory System Agents|sensory system agents|mesh-ancestor
64756386|NCT02538744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64756387|NCT02538744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64756398|NCT00060528|Metronidazole|metronidazole|mesh-list
64756431|NCT04771026|Glucocorticoids|glucocorticoids|mesh-ancestor
64756433|NCT04771026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64756434|NCT04771026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64756435|NCT04771026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756436|NCT00063570|Gemcitabine|gemcitabine|mesh-list
64756437|NCT00063570|Pemetrexed|pemetrexed|mesh-list
64756438|NCT00063570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64756439|NCT00063570|Antimetabolites|antimetabolites|mesh-ancestor
64756440|NCT00063570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756441|NCT00063570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756442|NCT00063570|Antiviral Agents|antiviral agents|mesh-ancestor
64756474|NCT00064038|Immunologic Factors|immunologic factors|mesh-ancestor
64756475|NCT00064038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64756476|NCT00064038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64756477|NCT00064038|Growth Substances|growth substances|mesh-ancestor
64756478|NCT00064038|Growth Inhibitors|growth inhibitors|mesh-ancestor
64756479|NCT01960530|Dexamethasone|dexamethasone|mesh-list
64756480|NCT01960530|Hydrocortisone|hydrocortisone|mesh-list
64589373|NCT00525733|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64756481|NCT01960530|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64756482|NCT01960530|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64756483|NCT01960530|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64756484|NCT01960530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64756485|NCT01960530|Antiemetics|antiemetics|mesh-ancestor
64756486|NCT01960530|Autonomic Agents|autonomic agents|mesh-ancestor
64756510|NCT00024102|Capecitabine|capecitabine|mesh-list
64756511|NCT00024102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64756512|NCT00024102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756530|NCT00074802|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64756531|NCT00074802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64756532|NCT00074802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756533|NCT02505750|Capecitabine|capecitabine|mesh-list
64756534|NCT02505750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64756552|NCT00030264|Immunologic Factors|immunologic factors|mesh-ancestor
64756553|NCT00030264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64756554|NCT00030264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64756555|NCT00030264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64756556|NCT00030264|Tubulin Modulators|tubulin modulators|mesh-ancestor
64756557|NCT00030264|Antimitotic Agents|antimitotic agents|mesh-ancestor
64756558|NCT00030264|Mitosis Modulators|mitosis modulators|mesh-ancestor
64756559|NCT01897116|Hydroxychloroquine|hydroxychloroquine|mesh-list
64756560|NCT01897116|Vemurafenib|vemurafenib|mesh-list
64756561|NCT01897116|Antimalarials|antimalarials|mesh-ancestor
64756562|NCT01897116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64756563|NCT01897116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64756564|NCT01897116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64756565|NCT01897116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756566|NCT01897116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756630|NCT00038610|Dermatologic Agents|dermatologic agents|mesh-ancestor
64756631|NCT00038610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64756632|NCT00038610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64756633|NCT00038610|Antiviral Agents|antiviral agents|mesh-ancestor
64756634|NCT00038610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64756635|NCT00038610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64756669|NCT00051168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64756671|NCT00083382|Thalidomide|thalidomide|mesh-list
64756672|NCT00083382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64756673|NCT00083382|Immunologic Factors|immunologic factors|mesh-ancestor
64756674|NCT00083382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756675|NCT00083382|Leprostatic Agents|leprostatic agents|mesh-ancestor
64756676|NCT00083382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64756677|NCT00083382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64756678|NCT00083382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64756679|NCT00083382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64756680|NCT00083382|Growth Substances|growth substances|mesh-ancestor
64756710|NCT00168324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756711|NCT00168324|Protease Inhibitors|protease inhibitors|mesh-ancestor
64756712|NCT00168324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756713|NCT00168324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756714|NCT02091882|Aripiprazole|aripiprazole|mesh-list
64756715|NCT02091882|Antidepressive Agents|antidepressive agents|mesh-ancestor
64756716|NCT02091882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64756717|NCT02091882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64756718|NCT02091882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64756719|NCT02091882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64756720|NCT02091882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756721|NCT02091882|Dopamine Agonists|dopamine agonists|mesh-ancestor
64756722|NCT02091882|Dopamine Agents|dopamine agents|mesh-ancestor
64756723|NCT02091882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64756794|NCT00255684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756795|NCT00255684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64756796|NCT00255684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64525582|NCT05745714|Cytarabine|cytarabine|mesh-list
64756797|NCT00255684|Antimetabolites|antimetabolites|mesh-ancestor
64756798|NCT00255684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756799|NCT00255684|Antifungal Agents|antifungal agents|mesh-ancestor
64756800|NCT00255684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64756801|NCT00255684|Dermatologic Agents|dermatologic agents|mesh-ancestor
64756802|NCT00255684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64756803|NCT00255684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64756804|NCT00255684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64756805|NCT00255684|Antitubercular Agents|antitubercular agents|mesh-ancestor
64756806|NCT00255684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64756807|NCT00256776|Thalidomide|thalidomide|mesh-list
64756808|NCT00256776|Dexamethasone|dexamethasone|mesh-list
64756809|NCT00256776|Bortezomib|bortezomib|mesh-list
64756810|NCT00256776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64756811|NCT00256776|Antiemetics|antiemetics|mesh-ancestor
64756812|NCT00256776|Autonomic Agents|autonomic agents|mesh-ancestor
64756813|NCT00256776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64756814|NCT00256776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756815|NCT00256776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64756816|NCT00256776|Glucocorticoids|glucocorticoids|mesh-ancestor
64756819|NCT00256776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65495099|NCT05196256|Analgesics|analgesics|mesh-ancestor
64756821|NCT00256776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64756822|NCT00256776|Immunologic Factors|immunologic factors|mesh-ancestor
64756823|NCT00256776|Leprostatic Agents|leprostatic agents|mesh-ancestor
64756824|NCT00256776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64756825|NCT00256776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64756826|NCT00256776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64756827|NCT00256776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64756828|NCT00256776|Growth Substances|growth substances|mesh-ancestor
64756829|NCT00256776|Growth Inhibitors|growth inhibitors|mesh-ancestor
64756830|NCT00258180|Cyclophosphamide|cyclophosphamide|mesh-list
64756832|NCT00258180|Immunologic Factors|immunologic factors|mesh-ancestor
64756835|NCT00258180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64756836|NCT00258180|Alkylating Agents|alkylating agents|mesh-ancestor
64756837|NCT00258180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756838|NCT00258180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756839|NCT00258180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64756840|NCT00176202|Valproic Acid|valproic acid|mesh-list
64756841|NCT00176202|Anticonvulsants|anticonvulsants|mesh-list
64756842|NCT00176202|Risperidone|risperidone|mesh-list
64756843|NCT00176202|Antipsychotic Agents|antipsychotic agents|mesh-list
64756844|NCT00176202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64756845|NCT00176202|Serotonin Agents|serotonin agents|mesh-ancestor
64756846|NCT00176202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64756847|NCT00176202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756848|NCT00176202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756849|NCT00176202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64756850|NCT00176202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64756851|NCT00176202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64756852|NCT00176202|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64756853|NCT00176202|Dopamine Agents|dopamine agents|mesh-ancestor
64756854|NCT00176202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756855|NCT00176202|GABA Agents|gaba agents|mesh-ancestor
64756856|NCT00176202|Antimanic Agents|antimanic agents|mesh-ancestor
64756857|NCT00176592|Glatiramer Acetate|glatiramer acetate|mesh-list
64756858|NCT00176592|Interferon beta-1b|interferon beta-1b|mesh-list
64756859|NCT00176592|(T,G)-A-L|(t,g)-a-l|mesh-list
64756860|NCT00176592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64756861|NCT00176592|Immunologic Factors|immunologic factors|mesh-ancestor
64756862|NCT00176592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756863|NCT00176592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64756864|NCT00176592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64756865|NCT00176826|Busulfan|busulfan|mesh-list
64756866|NCT00176826|Alkylating Agents|alkylating agents|mesh-ancestor
64756867|NCT00176826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756868|NCT00176826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64756869|NCT00176826|Immunologic Factors|immunologic factors|mesh-ancestor
64756870|NCT00176826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501972|NCT01595854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64501973|NCT01595854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64501974|NCT01595854|Purinergic Agents|purinergic agents|mesh-ancestor
64756871|NCT00176826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64756872|NCT00176826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756873|NCT00176826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64756874|NCT00176904|Cyclophosphamide|cyclophosphamide|mesh-list
64756875|NCT00176904|Busulfan|busulfan|mesh-list
64756876|NCT00176904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64756877|NCT00176904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64756878|NCT00176904|Immunologic Factors|immunologic factors|mesh-ancestor
64756879|NCT00176904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756880|NCT00176904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64756881|NCT00176904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64756882|NCT00176904|Alkylating Agents|alkylating agents|mesh-ancestor
64756883|NCT00176904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756884|NCT00176904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756982|NCT00193596|Antiviral Agents|antiviral agents|mesh-ancestor
64756983|NCT00193596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64756984|NCT00193596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756985|NCT00193596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64756986|NCT00193596|Immunologic Factors|immunologic factors|mesh-ancestor
64756987|NCT00193596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756988|NCT00193596|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64368925|NCT02487953|Nicotine|nicotine|mesh-list
64757010|NCT00194610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757011|NCT00194610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64757012|NCT00194610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64757013|NCT00093756|Paclitaxel|paclitaxel|mesh-list
64757014|NCT00093756|Carboplatin|carboplatin|mesh-list
64757015|NCT00093756|Bortezomib|bortezomib|mesh-list
64757016|NCT00093756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64757017|NCT00093756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757018|NCT00093756|Tubulin Modulators|tubulin modulators|mesh-ancestor
64757019|NCT00093756|Antimitotic Agents|antimitotic agents|mesh-ancestor
64757020|NCT00093756|Mitosis Modulators|mitosis modulators|mesh-ancestor
64757021|NCT00093756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757022|NCT04118556|Sirolimus|sirolimus|mesh-list
64757023|NCT04118556|Etanercept|etanercept|mesh-list
64757024|NCT04118556|Everolimus|everolimus|mesh-list
64757025|NCT04118556|Infliximab|infliximab|mesh-list
64757026|NCT04118556|Vedolizumab|vedolizumab|mesh-list
64757027|NCT04118556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757028|NCT04118556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64757029|NCT04118556|Immunologic Factors|immunologic factors|mesh-ancestor
64757030|NCT04118556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757040|NCT04118556|Analgesics|analgesics|mesh-ancestor
64757072|NCT00195624|Dermatologic Agents|dermatologic agents|mesh-ancestor
64757073|NCT00195624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64757074|NCT00195624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64757075|NCT00195624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64757076|NCT00195624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757078|NCT00195702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64757079|NCT00195702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64757080|NCT00197184|Vaccines|vaccines|mesh-list
64757081|NCT00197184|Immunologic Factors|immunologic factors|mesh-ancestor
64757082|NCT00197184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757083|NCT00098670|Rituximab|rituximab|mesh-list
64757084|NCT00098670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64757085|NCT00098670|Alemtuzumab|alemtuzumab|mesh-list
64757086|NCT00098670|Fludarabine|fludarabine|mesh-list
64757087|NCT00098670|Fludarabine phosphate|fludarabine phosphate|mesh-list
64757088|NCT00098670|Antibodies|antibodies|mesh-list
64757089|NCT00098670|Immunoglobulins|immunoglobulins|mesh-list
64757090|NCT00098670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64757091|NCT00098670|Immunologic Factors|immunologic factors|mesh-ancestor
64757092|NCT00098670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757093|NCT00098670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757108|NCT00201864|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64757109|NCT00201864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64757110|NCT00201864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757112|NCT00202722|Remifentanil|remifentanil|mesh-list
64757139|NCT00208026|Analgesics|analgesics|mesh-ancestor
64757140|NCT00208026|Sensory System Agents|sensory system agents|mesh-ancestor
64757141|NCT00208026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64757142|NCT00208026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757143|NCT00208026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64757144|NCT00208026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64757145|NCT00208026|Dermatologic Agents|dermatologic agents|mesh-ancestor
64757146|NCT00208026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64757147|NCT00208026|Immunologic Factors|immunologic factors|mesh-ancestor
64757148|NCT00208026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64757149|NCT00208026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757150|NCT00208026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757151|NCT00106392|Tacrolimus|tacrolimus|mesh-list
65495100|NCT05196256|Sensory System Agents|sensory system agents|mesh-ancestor
64757180|NCT01899846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64757181|NCT01899846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757182|NCT01899846|Progestins|progestins|mesh-ancestor
64757183|NCT01899846|Hormones|hormones|mesh-ancestor
64757184|NCT00214890|Tenofovir|tenofovir|mesh-list
64757185|NCT00214890|Abacavir|abacavir|mesh-list
64757186|NCT00214890|Antiviral Agents|antiviral agents|mesh-ancestor
64757187|NCT00214890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64757188|NCT00214890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64757189|NCT00214890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64757190|NCT00214890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757191|NCT00214890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757272|NCT00224952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757273|NCT00224952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757274|NCT00224952|GABA Agents|gaba agents|mesh-ancestor
64757275|NCT00224952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64757276|NCT00224952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757277|NCT00224952|Antimanic Agents|antimanic agents|mesh-ancestor
64757278|NCT00224952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64757279|NCT00224952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64757280|NCT00224952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64757281|NCT00224952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64757282|NCT00224952|Analgesics|analgesics|mesh-ancestor
64757283|NCT00224952|Sensory System Agents|sensory system agents|mesh-ancestor
64757284|NCT00224952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64757285|NCT00224952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64757322|NCT00225732|Ibuprofen|ibuprofen|mesh-list
64757323|NCT00225732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64757354|NCT00226590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757355|NCT00226590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64757356|NCT00226590|Antimetabolites|antimetabolites|mesh-ancestor
64757357|NCT00226590|Antiviral Agents|antiviral agents|mesh-ancestor
64757358|NCT00226590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64757359|NCT00226590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757360|NCT00226590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64757361|NCT00226590|Immunologic Factors|immunologic factors|mesh-ancestor
64757362|NCT00226590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757364|NCT00114114|Testosterone|testosterone|mesh-list
64757365|NCT00114114|Androgens|androgens|mesh-ancestor
64757366|NCT00114114|Hormones|hormones|mesh-ancestor
64757388|NCT00227994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64757389|NCT00114504|Simvastatin|simvastatin|mesh-list
64757390|NCT00114504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64757391|NCT00114504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64757392|NCT00114504|Antimetabolites|antimetabolites|mesh-ancestor
64757393|NCT00114504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757394|NCT00114504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64757399|NCT01898676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757400|NCT01898676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757401|NCT01898676|GABA Agents|gaba agents|mesh-ancestor
64757402|NCT01898676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64757403|NCT01898676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757405|NCT01898676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64757406|NCT01898676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64757407|NCT01898676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64757408|NCT00288366|Aripiprazole|aripiprazole|mesh-list
64757409|NCT00288366|Ziprasidone|ziprasidone|mesh-list
64757410|NCT00288366|Antidepressive Agents|antidepressive agents|mesh-ancestor
64757411|NCT00288366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64757412|NCT00288366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64757413|NCT00288366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64757414|NCT00288366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64757415|NCT00288366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757416|NCT00288366|Dopamine Agonists|dopamine agonists|mesh-ancestor
64757417|NCT00288366|Dopamine Agents|dopamine agents|mesh-ancestor
64757418|NCT00288366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64757419|NCT00288366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757438|NCT00290472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64757439|NCT00290472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757440|NCT00290472|Antifungal Agents|antifungal agents|mesh-ancestor
64757441|NCT00290472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64757442|NCT00290472|Immunologic Factors|immunologic factors|mesh-ancestor
64757443|NCT00290472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757444|NCT04752852|Dexamethasone|dexamethasone|mesh-list
64757445|NCT04752852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64757465|NCT01899144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64757466|NCT01899144|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64757467|NCT01899144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64757468|NCT01899144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64757469|NCT01899144|Adrenergic Agents|adrenergic agents|mesh-ancestor
64757470|NCT01899144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64757471|NCT01899144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757472|NCT01899144|Sympathomimetics|sympathomimetics|mesh-ancestor
64757473|NCT00234078|Rebamipide|rebamipide|mesh-list
64757474|NCT00234078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64757475|NCT00234078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64757476|NCT00234078|Antioxidants|antioxidants|mesh-ancestor
64526271|NCT03028909|MEDI8852|medi8852|mesh-list
64757511|NCT00237666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757512|NCT00237666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757513|NCT00237666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64757536|NCT00123162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757538|NCT00123162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64757540|NCT00123162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757598|NCT02100930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757599|NCT02100930|Dermatologic Agents|dermatologic agents|mesh-ancestor
64757600|NCT02100930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757601|NCT02101008|Disulfiram|disulfiram|mesh-list
64757602|NCT02101008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64757603|NCT02101008|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
64757604|NCT02101008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757605|NCT02101008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757606|NCT00241176|Aripiprazole|aripiprazole|mesh-list
64757607|NCT00241176|Antidepressive Agents|antidepressive agents|mesh-ancestor
64757608|NCT00241176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64757609|NCT00241176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64757610|NCT00241176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64757611|NCT00241176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64757612|NCT00241176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757613|NCT00241176|Dopamine Agonists|dopamine agonists|mesh-ancestor
64757614|NCT00241176|Dopamine Agents|dopamine agents|mesh-ancestor
64757615|NCT00241176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64757616|NCT00241176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757617|NCT00241176|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64757645|NCT00242502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64757646|NCT00242502|Growth Substances|growth substances|mesh-ancestor
64757647|NCT00242502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757648|NCT00242502|Growth Inhibitors|growth inhibitors|mesh-ancestor
64757649|NCT00242502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64757650|NCT00242502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757651|NCT00242502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757652|NCT04389060|Grape Seed Extract|grape seed extract|mesh-list
64757653|NCT04389060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64757693|NCT00127218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757694|NCT00127530|4-Aminopyridine|4-aminopyridine|mesh-list
64757695|NCT00127530|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64757696|NCT00127530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65495101|NCT05196256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64757697|NCT00127530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757698|NCT00250926|Dexamethasone|dexamethasone|mesh-list
64526470|NCT01687283|Dermatologic Agents|dermatologic agents|mesh-ancestor
64757700|NCT00250926|Rituximab|rituximab|mesh-list
64757701|NCT00250926|Bortezomib|bortezomib|mesh-list
64757702|NCT00250926|BB 1101|bb 1101|mesh-list
64757703|NCT00250926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64757704|NCT00250926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757705|NCT00250926|Immunologic Factors|immunologic factors|mesh-ancestor
64757706|NCT00250926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757707|NCT00250926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64757708|NCT00250926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64757709|NCT00250926|Antiemetics|antiemetics|mesh-ancestor
64757710|NCT00250926|Autonomic Agents|autonomic agents|mesh-ancestor
64757711|NCT00250926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64757712|NCT00250926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64757713|NCT00250926|Glucocorticoids|glucocorticoids|mesh-ancestor
64757714|NCT00250926|Hormones|hormones|mesh-ancestor
64757715|NCT00250926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64757716|NCT00250926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64757751|NCT00134004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64757752|NCT00134004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64757826|NCT00142506|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64757827|NCT00142506|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64757828|NCT00142506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757829|NCT00142506|Urological Agents|urological agents|mesh-ancestor
64757830|NCT05266794|Selenium|selenium|mesh-list
64757831|NCT05266794|Thioctic Acid|thioctic acid|mesh-list
64757832|NCT05266794|Antioxidants|antioxidants|mesh-ancestor
64757833|NCT05266794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757834|NCT05266794|Protective Agents|protective agents|mesh-ancestor
64757835|NCT05266794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757836|NCT05266794|Trace Elements|trace elements|mesh-ancestor
64757837|NCT05266794|Micronutrients|micronutrients|mesh-ancestor
64757838|NCT05266794|Vitamin B Complex|vitamin b complex|mesh-ancestor
64757839|NCT05266794|Vitamins|vitamins|mesh-ancestor
64757840|NCT00142818|Naltrexone|naltrexone|mesh-list
64757841|NCT00142818|Modafinil|modafinil|mesh-list
64757842|NCT00142818|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64757843|NCT00142818|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64757844|NCT00142818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757845|NCT00142818|Sensory System Agents|sensory system agents|mesh-ancestor
64757846|NCT00142818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64757847|NCT00142818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64757848|NCT00142818|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64757849|NCT00142818|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64757850|NCT00142818|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64757851|NCT00142818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757852|NCT05266716|Methamphetamine|methamphetamine|mesh-list
64369787|NCT03316469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64757895|NCT04528212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757896|NCT04528212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757897|NCT04528212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64757898|NCT04528212|Antimetabolites|antimetabolites|mesh-ancestor
64757899|NCT04528212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64757900|NCT00148668|Carboplatin|carboplatin|mesh-list
64757901|NCT00148668|Docetaxel|docetaxel|mesh-list
64757902|NCT00148668|Trastuzumab|trastuzumab|mesh-list
64757903|NCT00148668|Vinorelbine|vinorelbine|mesh-list
64757904|NCT00148668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757930|NCT00151320|Bortezomib|bortezomib|mesh-list
64757931|NCT00151320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64757932|NCT00151320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757933|NCT00151320|Immunologic Factors|immunologic factors|mesh-ancestor
64757934|NCT00151320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757935|NCT00151320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64757936|NCT00328614|Ascorbic Acid|ascorbic acid|mesh-list
64757937|NCT00328614|Goserelin|goserelin|mesh-list
64757938|NCT00328614|Methyltestosterone|methyltestosterone|mesh-list
64757939|NCT00328614|Bicalutamide|bicalutamide|mesh-list
64757940|NCT00328614|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
64757941|NCT00328614|Androgens|androgens|mesh-list
64757942|NCT00328614|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64757943|NCT00328614|Ethylene|ethylene|mesh-list
64757944|NCT00328614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64757945|NCT00328614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501975|NCT01595854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64501976|NCT01595854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501977|NCT01595854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501978|NCT01595854|Antithrombins|antithrombins|mesh-ancestor
64501979|NCT01595854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64501980|NCT01595854|Protease Inhibitors|protease inhibitors|mesh-ancestor
64501981|NCT01595854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501982|NCT01595854|Anticoagulants|anticoagulants|mesh-ancestor
64501983|NCT01596088|Dexrazoxane|dexrazoxane|mesh-list
64501984|NCT01596088|Razoxane|razoxane|mesh-list
64501985|NCT01596088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501986|NCT01596088|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64501987|NCT01596088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64501988|NCT01596088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64501989|NCT01596088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501990|NCT01596088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501991|NCT01596088|Protective Agents|protective agents|mesh-ancestor
64501992|NCT01596088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501993|NCT01596088|Antimitotic Agents|antimitotic agents|mesh-ancestor
64501994|NCT01596088|Mitosis Modulators|mitosis modulators|mesh-ancestor
64501995|NCT02216422|Ritonavir|ritonavir|mesh-list
64501996|NCT02216422|Ribavirin|ribavirin|mesh-list
64501997|NCT02216422|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64501998|NCT02216422|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64501999|NCT02216422|Protease Inhibitors|protease inhibitors|mesh-ancestor
64502014|NCT03005548|Narcotics|narcotics|mesh-ancestor
64502015|NCT03005548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64502016|NCT03005548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757946|NCT00328614|Hormones|hormones|mesh-ancestor
64757947|NCT00328614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64757948|NCT00328614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757949|NCT00328614|Antioxidants|antioxidants|mesh-ancestor
64757950|NCT00328614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757951|NCT00328614|Protective Agents|protective agents|mesh-ancestor
64757952|NCT00328614|Vitamins|vitamins|mesh-ancestor
64757953|NCT00328614|Micronutrients|micronutrients|mesh-ancestor
64757954|NCT00328614|Estrogens|estrogens|mesh-ancestor
64757972|NCT00328770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757973|NCT04177680|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
64757974|NCT04177680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64757976|NCT00330564|Sunitinib|sunitinib|mesh-list
64757977|NCT00330564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757978|NCT00330564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64757979|NCT00330564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64757980|NCT00330564|Growth Substances|growth substances|mesh-ancestor
64757981|NCT00330564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757982|NCT00330564|Growth Inhibitors|growth inhibitors|mesh-ancestor
64757983|NCT00330564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64757984|NCT00330564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757985|NCT00330564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757986|NCT00330876|Pitavastatin|pitavastatin|mesh-list
64757987|NCT00330876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64757988|NCT00330876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64757989|NCT00330876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64757990|NCT00330876|Antimetabolites|antimetabolites|mesh-ancestor
64757991|NCT00330876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757992|NCT00330876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757993|NCT00330876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64566167|NCT05265299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64502017|NCT03005548|Analgesics|analgesics|mesh-ancestor
64502018|NCT03005548|Sensory System Agents|sensory system agents|mesh-ancestor
64502019|NCT03005548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502020|NCT03373266|Anesthetics|anesthetics|mesh-list
64502021|NCT03373266|Sevoflurane|sevoflurane|mesh-list
64502022|NCT03373266|Isoflurane|isoflurane|mesh-list
64502023|NCT03373266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64502024|NCT03373266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502025|NCT03373266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64502026|NCT03373266|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64757994|NCT00334074|Cytarabine|cytarabine|mesh-list
64757995|NCT00334074|Clofarabine|clofarabine|mesh-list
64757996|NCT00334074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64757997|NCT00334074|Antimetabolites|antimetabolites|mesh-ancestor
64757998|NCT00334074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757999|NCT00334074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758000|NCT00334074|Antiviral Agents|antiviral agents|mesh-ancestor
64758001|NCT00334074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64758003|NCT00334074|Immunologic Factors|immunologic factors|mesh-ancestor
64758004|NCT00334074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758006|NCT00335478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64758007|NCT00335478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64758008|NCT04345926|Propofol|propofol|mesh-list
64758009|NCT04345926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64758140|NCT00351936|Serotonin Agents|serotonin agents|mesh-ancestor
64758141|NCT00351936|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64758142|NCT00351936|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64758143|NCT00351936|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64758144|NCT00351936|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64758203|NCT01794078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758204|NCT01794078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758205|NCT01794078|Vasodilator Agents|vasodilator agents|mesh-ancestor
64758206|NCT01794078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64758207|NCT01794078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64758208|NCT01794078|Purinergic Agents|purinergic agents|mesh-ancestor
64758209|NCT01794078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64758210|NCT01794078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64758211|NCT01794078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64758212|NCT01794078|Protective Agents|protective agents|mesh-ancestor
64758213|NCT01794078|Plant Growth Regulators|plant growth regulators|mesh-ancestor
64758214|NCT01794078|Growth Substances|growth substances|mesh-ancestor
64758215|NCT00354978|Leucovorin|leucovorin|mesh-list
64758216|NCT00354978|Bevacizumab|bevacizumab|mesh-list
64758217|NCT00354978|Fluorouracil|fluorouracil|mesh-list
64758218|NCT00354978|Irinotecan|irinotecan|mesh-list
64758219|NCT00354978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64590199|NCT04148846|Antimanic Agents|antimanic agents|mesh-ancestor
64758220|NCT00354978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758221|NCT00354978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64758222|NCT00354978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64758223|NCT00354978|Growth Substances|growth substances|mesh-ancestor
64758224|NCT00354978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758273|NCT00359736|Vasodilator Agents|vasodilator agents|mesh-ancestor
64758274|NCT00359736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64758275|NCT00359736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64758276|NCT00359736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758277|NCT00359736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758278|NCT00359736|Urological Agents|urological agents|mesh-ancestor
64370242|NCT02478125|Docetaxel|docetaxel|mesh-list
64758308|NCT00360360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758310|NCT01552590|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64758311|NCT01552590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758312|NCT01552590|Natriuretic Agents|natriuretic agents|mesh-ancestor
64758313|NCT01552590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758314|NCT00549978|Cilostazol|cilostazol|mesh-list
64758315|NCT00549978|Probucol|probucol|mesh-list
64758316|NCT00549978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64758317|NCT00549978|Autonomic Agents|autonomic agents|mesh-ancestor
64758318|NCT00549978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64758319|NCT00549978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758320|NCT00549978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64758321|NCT00549978|Respiratory System Agents|respiratory system agents|mesh-ancestor
64758322|NCT00549978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64758350|NCT03983226|Immunologic Factors|immunologic factors|mesh-ancestor
64758351|NCT03983226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758352|NCT03983226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64758353|NCT03983226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64758354|NCT03983226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64758355|NCT03983226|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64758356|NCT00360672|Lenalidomide|lenalidomide|mesh-list
64758357|NCT00360672|Immunologic Factors|immunologic factors|mesh-ancestor
64758358|NCT00360672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758359|NCT00360672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64758360|NCT00360672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64758361|NCT00360672|Growth Substances|growth substances|mesh-ancestor
64758362|NCT00360672|Growth Inhibitors|growth inhibitors|mesh-ancestor
64758363|NCT00360672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758364|NCT00360828|Irinotecan|irinotecan|mesh-list
64758365|NCT00360828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64758366|NCT00360828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64758367|NCT00360828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758368|NCT00360828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758369|NCT00360828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758370|NCT00361140|Fludarabine|fludarabine|mesh-list
64758371|NCT00361140|Fludarabine phosphate|fludarabine phosphate|mesh-list
64758393|NCT00305682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64758394|NCT00305682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64758395|NCT00305682|Immunologic Factors|immunologic factors|mesh-ancestor
64758396|NCT00305682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758397|NCT00305682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64758398|NCT00305682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65495102|NCT05196256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64473210|NCT00119392|Mycophenolic Acid|mycophenolic acid|mesh-list
64758399|NCT00305682|Alkylating Agents|alkylating agents|mesh-ancestor
64758400|NCT00305682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758401|NCT00305682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758402|NCT00305682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64758403|NCT00305682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64758404|NCT00305682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64758405|NCT00305682|Antitubercular Agents|antitubercular agents|mesh-ancestor
64758406|NCT00305682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64758407|NCT00305682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64758408|NCT00305682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758409|NCT00305682|Antifungal Agents|antifungal agents|mesh-ancestor
64758410|NCT00305760|Cyclophosphamide|cyclophosphamide|mesh-list
64758411|NCT00305760|Cetuximab|cetuximab|mesh-list
64758412|NCT00305760|Vaccines|vaccines|mesh-list
64758413|NCT00305760|Immunologic Factors|immunologic factors|mesh-ancestor
64758414|NCT00305760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758415|NCT00305760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64758416|NCT00305760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64758417|NCT00305760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64758418|NCT00305760|Alkylating Agents|alkylating agents|mesh-ancestor
64758425|NCT00309738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64758458|NCT00365274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758459|NCT00365274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64758460|NCT00365274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64758461|NCT00365274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64758462|NCT00365274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64758463|NCT00365274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758498|NCT00314106|Immunologic Factors|immunologic factors|mesh-ancestor
64758499|NCT00314106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758500|NCT00314106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64370450|NCT03197779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64758532|NCT00319644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758533|NCT02448420|Trastuzumab|trastuzumab|mesh-list
64758534|NCT02448420|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64758535|NCT02448420|Palbociclib|palbociclib|mesh-list
64758537|NCT02448420|Immunoconjugates|immunoconjugates|mesh-list
64758538|NCT02448420|Immunologic Factors|immunologic factors|mesh-ancestor
64758539|NCT02448420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758540|NCT02448420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64758541|NCT02448420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758542|NCT02448420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64758543|NCT02448420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758576|NCT02405676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64758578|NCT02405676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64758579|NCT02405676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64758580|NCT02405676|Antimetabolites|antimetabolites|mesh-ancestor
64758581|NCT02405676|Dermatologic Agents|dermatologic agents|mesh-ancestor
64758582|NCT02405676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758583|NCT02405676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64758584|NCT02405676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64758585|NCT02405676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64758601|NCT04751136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758602|NCT04751136|Nootropic Agents|nootropic agents|mesh-ancestor
64758603|NCT00390234|Aflibercept|aflibercept|mesh-list
64758609|NCT00390234|Growth Inhibitors|growth inhibitors|mesh-ancestor
64758610|NCT00390234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758611|NCT00391716|Gabapentin|gabapentin|mesh-list
64758612|NCT00391716|Analgesics|analgesics|mesh-ancestor
64758613|NCT00391716|Sensory System Agents|sensory system agents|mesh-ancestor
64758614|NCT00391716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64758615|NCT00391716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758616|NCT00391716|Anticonvulsants|anticonvulsants|mesh-ancestor
65495103|NCT05196256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64473211|NCT00119392|Rituximab|rituximab|mesh-list
64473212|NCT00119392|Fludarabine|fludarabine|mesh-list
64758617|NCT00391716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64758618|NCT00391716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64758619|NCT00391716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64758620|NCT00391716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64758621|NCT00391716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64758622|NCT00391716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64758623|NCT00391716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64758624|NCT00391716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758625|NCT00391716|Antimanic Agents|antimanic agents|mesh-ancestor
64758626|NCT00392496|Sunitinib|sunitinib|mesh-list
64758627|NCT00392496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758628|NCT00392496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64758629|NCT00392496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64758630|NCT00392496|Growth Substances|growth substances|mesh-ancestor
64758631|NCT00392496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758632|NCT00392496|Growth Inhibitors|growth inhibitors|mesh-ancestor
64758667|NCT00393978|Antidepressive Agents|antidepressive agents|mesh-ancestor
64758668|NCT00393978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64758669|NCT00393978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64758670|NCT00393978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64758671|NCT00393978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64758672|NCT00393978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758674|NCT00393978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64758675|NCT00396006|Protease Inhibitors|protease inhibitors|mesh-list
64758676|NCT00396006|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64758677|NCT00396006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758678|NCT00396006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758679|NCT00396006|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64758680|NCT00396006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64758681|NCT00397020|Valproic Acid|valproic acid|mesh-list
64758682|NCT00397020|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64758683|NCT00397020|Antidepressive Agents|antidepressive agents|mesh-ancestor
64758684|NCT00397020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64758685|NCT00397020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64758686|NCT00397020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64758687|NCT00397020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64758688|NCT00397020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758689|NCT00397020|Anticonvulsants|anticonvulsants|mesh-ancestor
64758690|NCT00397020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758691|NCT00397020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758692|NCT00397020|GABA Agents|gaba agents|mesh-ancestor
64758695|NCT00397878|Saracatinib|saracatinib|mesh-list
64758740|NCT00374244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758741|NCT00374244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64758742|NCT00377832|Acetaminophen|acetaminophen|mesh-list
64758743|NCT00377832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64758744|NCT00377832|Analgesics|analgesics|mesh-ancestor
64758745|NCT00377832|Sensory System Agents|sensory system agents|mesh-ancestor
64527522|NCT01540565|Veliparib|veliparib|mesh-list
64758746|NCT00377832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64758747|NCT00377832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758748|NCT00377832|Antipyretics|antipyretics|mesh-ancestor
64758749|NCT00401778|Everolimus|everolimus|mesh-list
64758750|NCT00401778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758751|NCT00401778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64758752|NCT00401778|Immunologic Factors|immunologic factors|mesh-ancestor
64758753|NCT00401778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758754|NCT00402714|Pentostatin|pentostatin|mesh-list
64758755|NCT00402714|Methoxsalen|methoxsalen|mesh-list
64758756|NCT00402714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758757|NCT00402714|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
64758758|NCT00402714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758759|NCT00402714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758760|NCT00402714|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64758761|NCT00402714|Dermatologic Agents|dermatologic agents|mesh-ancestor
64758762|NCT00405288|Hydrocortisone|hydrocortisone|mesh-list
64758763|NCT00405288|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64758797|NCT00381810|Protective Agents|protective agents|mesh-ancestor
64758798|NCT00381810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64758799|NCT00381810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64758800|NCT00381810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64758801|NCT00381810|Anesthetics, Local|anesthetics, local|mesh-ancestor
64758849|NCT00461292|Botulinum Toxins|botulinum toxins|mesh-list
64758850|NCT00461292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64758851|NCT00461292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64758852|NCT00461292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64370796|NCT02475161|Rabeprazole|rabeprazole|mesh-list
64758881|NCT00382824|Coenzyme Q10|coenzyme q10|mesh-list
64758882|NCT00382824|Micronutrients|micronutrients|mesh-ancestor
64758883|NCT00382824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758885|NCT00462072|Infliximab|infliximab|mesh-list
64758886|NCT00462072|Dermatologic Agents|dermatologic agents|mesh-ancestor
64758887|NCT00462072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64758888|NCT00462072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64758889|NCT00462228|Memantine|memantine|mesh-list
64758890|NCT00462228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64758891|NCT00462228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64758892|NCT00462228|Dopamine Agents|dopamine agents|mesh-ancestor
64758893|NCT00462228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64758894|NCT00462228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473213|NCT00119392|Fludarabine phosphate|fludarabine phosphate|mesh-list
64758895|NCT00462228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758896|NCT00462228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64758897|NCT00462228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64758898|NCT00408564|Gemcitabine|gemcitabine|mesh-list
64758899|NCT00408564|Capecitabine|capecitabine|mesh-list
64758900|NCT00408564|Oxaliplatin|oxaliplatin|mesh-list
64758935|NCT00383448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64758936|NCT00383448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64758938|NCT00384774|Lasmiditan|lasmiditan|mesh-list
64758939|NCT00384774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64758940|NCT00384774|Serotonin Agents|serotonin agents|mesh-ancestor
64758941|NCT00384774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64758968|NCT00464646|Tubulin Modulators|tubulin modulators|mesh-ancestor
64758969|NCT00464646|Antimitotic Agents|antimitotic agents|mesh-ancestor
64758982|NCT00385008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64758983|NCT00385008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758984|NCT00385008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64758985|NCT00385008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64758986|NCT00385008|Gout Suppressants|gout suppressants|mesh-ancestor
64758987|NCT00385008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64758988|NCT00385008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370923|NCT03068247|Analgesics|analgesics|mesh-ancestor
64759023|NCT00385788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64759024|NCT00385788|Dermatologic Agents|dermatologic agents|mesh-ancestor
64759025|NCT00385788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64759026|NCT00385788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64759027|NCT00385788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64759028|NCT00385788|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64759029|NCT00385788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64759050|NCT00412464|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64759052|NCT00412464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759053|NCT00412464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759054|NCT00412464|Anticoagulants|anticoagulants|mesh-ancestor
64759055|NCT00412464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64759056|NCT00412464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64759057|NCT00466752|Sorafenib|sorafenib|mesh-list
64759058|NCT00466752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759084|NCT00413166|Keratolytic Agents|keratolytic agents|mesh-ancestor
64759085|NCT00413166|Dermatologic Agents|dermatologic agents|mesh-ancestor
64371003|NCT02473601|Mivacurium|mivacurium|mesh-list
64759119|NCT00387036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64759120|NCT04388904|Tenofovir|tenofovir|mesh-list
64759121|NCT04388904|Emtricitabine|emtricitabine|mesh-list
64759122|NCT04388904|Darunavir|darunavir|mesh-list
64759123|NCT04388904|Cobicistat|cobicistat|mesh-list
64759124|NCT04388904|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64759125|NCT04388904|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
64759126|NCT04388904|Antiviral Agents|antiviral agents|mesh-ancestor
64759157|NCT00472056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64759158|NCT00472056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64759159|NCT00472056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64759160|NCT00472056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64759161|NCT00472056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759162|NCT00472056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759163|NCT00472056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64759164|NCT00472056|Antimetabolites|antimetabolites|mesh-ancestor
64759165|NCT00472056|Antiviral Agents|antiviral agents|mesh-ancestor
64759166|NCT00472056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64759167|NCT00472056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64759168|NCT00472056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64759169|NCT00472056|Alkylating Agents|alkylating agents|mesh-ancestor
64371102|NCT03847649|Prednisone|prednisone|mesh-list
64759201|NCT03531918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64759202|NCT00389532|Vaccines|vaccines|mesh-list
64759203|NCT00389532|Immunologic Factors|immunologic factors|mesh-ancestor
64759204|NCT00389532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759205|NCT03520686|Paclitaxel|paclitaxel|mesh-list
64759206|NCT03520686|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64759207|NCT03520686|Cisplatin|cisplatin|mesh-list
64759208|NCT03520686|Carboplatin|carboplatin|mesh-list
64759209|NCT03520686|Pembrolizumab|pembrolizumab|mesh-list
64759210|NCT03520686|Pemetrexed|pemetrexed|mesh-list
64759211|NCT03520686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64502027|NCT03373266|Anesthetics, General|anesthetics, general|mesh-ancestor
64502028|NCT02217904|Islatravir|islatravir|mesh-list
64502029|NCT02217904|Antiviral Agents|antiviral agents|mesh-ancestor
64502030|NCT02217904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64502031|NCT02217904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502032|NCT02217904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502033|NCT02217904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64759212|NCT03520686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759213|NCT03520686|Tubulin Modulators|tubulin modulators|mesh-ancestor
64759214|NCT03520686|Antimitotic Agents|antimitotic agents|mesh-ancestor
64759215|NCT03520686|Mitosis Modulators|mitosis modulators|mesh-ancestor
64371141|NCT02767427|Disinfectants|disinfectants|mesh-ancestor
64759245|NCT00477204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64759246|NCT00477204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64759247|NCT00477204|Antimetabolites|antimetabolites|mesh-ancestor
64759248|NCT00477204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759249|NCT00477204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64759250|NCT00477204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64759251|NCT00477204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759252|NCT00528450|Idarubicin|idarubicin|mesh-list
64759253|NCT00528450|Arsenic Trioxide|arsenic trioxide|mesh-list
64759254|NCT00528450|Tretinoin|tretinoin|mesh-list
64759255|NCT00528450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64759256|NCT00528450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759257|NCT00528450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64759258|NCT00528450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64759292|NCT00479154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64759293|NCT00479154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759294|NCT00479154|Cholinergic Agents|cholinergic agents|mesh-ancestor
64759295|NCT00479154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64759296|NCT00479154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759297|NCT00479154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64759325|NCT00425802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64759326|NCT00425802|Antimetabolites|antimetabolites|mesh-ancestor
64759327|NCT00425802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759328|NCT00425802|Antifungal Agents|antifungal agents|mesh-ancestor
64759329|NCT00425802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64759330|NCT00425802|Dermatologic Agents|dermatologic agents|mesh-ancestor
64759331|NCT00425802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64566812|NCT02928224|Vitamins|vitamins|mesh-ancestor
64759340|NCT00530634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759341|NCT00530634|Antiviral Agents|antiviral agents|mesh-ancestor
64759342|NCT00530634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64759343|NCT00530634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759344|NCT00530634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64759345|NCT00530634|Immunologic Factors|immunologic factors|mesh-ancestor
64759371|NCT00486018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64759372|NCT00486018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64759373|NCT00486018|Growth Substances|growth substances|mesh-ancestor
64759374|NCT00486018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759375|NCT00486018|Growth Inhibitors|growth inhibitors|mesh-ancestor
64759376|NCT00486018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759378|NCT00486642|Androgen Antagonists|androgen antagonists|mesh-ancestor
64759379|NCT00486642|Hormone Antagonists|hormone antagonists|mesh-ancestor
64759380|NCT00486642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64759381|NCT00486642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759382|NCT00486642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759383|NCT00428922|Bevacizumab|bevacizumab|mesh-list
64759384|NCT00428922|Trastuzumab|trastuzumab|mesh-list
64759385|NCT00428922|Docetaxel|docetaxel|mesh-list
64759386|NCT00428922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64759387|NCT00428922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759388|NCT00428922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64759389|NCT00428922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64759390|NCT00428922|Growth Substances|growth substances|mesh-ancestor
64759449|NCT00429702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64759450|NCT00429702|Glucocorticoids|glucocorticoids|mesh-ancestor
64759451|NCT00429702|Hormones|hormones|mesh-ancestor
64759452|NCT00429702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64759453|NCT00429702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64759454|NCT00429702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759455|NCT00429702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759456|NCT00429702|Antipruritics|antipruritics|mesh-ancestor
64759457|NCT00429702|Dermatologic Agents|dermatologic agents|mesh-ancestor
64759458|NCT00429702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64759459|NCT00429702|Serotonin Agents|serotonin agents|mesh-ancestor
64759460|NCT00429702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64759461|NCT00429702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64759462|NCT00429702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64759463|NCT00429702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64759464|NCT00429702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64759465|NCT00429702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64759466|NCT00429702|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64759467|NCT00429702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64759468|NCT00429702|Anesthetics, Local|anesthetics, local|mesh-ancestor
64759469|NCT00429702|Anesthetics|anesthetics|mesh-ancestor
64759470|NCT00429702|Sensory System Agents|sensory system agents|mesh-ancestor
64759471|NCT00429702|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64759472|NCT00429702|Histamine Antagonists|histamine antagonists|mesh-ancestor
64759473|NCT00429702|Histamine Agents|histamine agents|mesh-ancestor
64759474|NCT00429702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64759475|NCT00429702|Anticonvulsants|anticonvulsants|mesh-ancestor
64473215|NCT00119392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64759477|NCT00429702|GABA Agents|gaba agents|mesh-ancestor
64759493|NCT00535782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64759494|NCT00535782|Immunologic Factors|immunologic factors|mesh-ancestor
64759495|NCT00535782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64759496|NCT00535782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64759497|NCT00431184|Pentazocine|pentazocine|mesh-list
64759498|NCT00431184|Lorazepam|lorazepam|mesh-list
64759499|NCT00431184|Anticonvulsants|anticonvulsants|mesh-ancestor
64759500|NCT00431184|Antiemetics|antiemetics|mesh-ancestor
64759501|NCT00431184|Autonomic Agents|autonomic agents|mesh-ancestor
64759502|NCT00431184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64759503|NCT00431184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759504|NCT00431184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64528270|NCT01521923|Antimetabolites|antimetabolites|mesh-ancestor
64759505|NCT00431184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64759506|NCT00431184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64759507|NCT00431184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64759508|NCT00431184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64759509|NCT00431184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64759510|NCT00431184|GABA Modulators|gaba modulators|mesh-ancestor
64759511|NCT00431184|GABA Agents|gaba agents|mesh-ancestor
64759544|NCT01796028|Mitosis Modulators|mitosis modulators|mesh-ancestor
64759545|NCT01796028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759546|NCT00491244|Interferons|interferons|mesh-list
64759548|NCT00491244|Interferon-alpha|interferon-alpha|mesh-list
64759549|NCT00491244|Interferon alpha-2|interferon alpha-2|mesh-list
64759550|NCT00491244|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64759592|NCT00539526|Travoprost|travoprost|mesh-list
64759601|NCT01796106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759602|NCT00541242|Bimatoprost|bimatoprost|mesh-list
64759603|NCT00541242|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64759604|NCT00541242|Latanoprost|latanoprost|mesh-list
64759637|NCT00439296|Immunologic Factors|immunologic factors|mesh-ancestor
65495109|NCT01375348|Narcotics|narcotics|mesh-ancestor
65495110|NCT01375348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64473217|NCT00119392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759638|NCT00439296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759639|NCT00439296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64759640|NCT00439296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64759641|NCT00439296|Alkylating Agents|alkylating agents|mesh-ancestor
64759642|NCT00439296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759643|NCT00439296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759644|NCT00439296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64759645|NCT00439296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64759646|NCT00439296|Antiemetics|antiemetics|mesh-ancestor
64759647|NCT00439296|Autonomic Agents|autonomic agents|mesh-ancestor
64759648|NCT00439296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64759649|NCT00439296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64759650|NCT00439296|Glucocorticoids|glucocorticoids|mesh-ancestor
64759672|NCT00439374|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
64759673|NCT00439374|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
64759674|NCT00439374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64759675|NCT00439374|Hormone Antagonists|hormone antagonists|mesh-ancestor
64759676|NCT00439374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64759677|NCT00439374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759698|NCT04750122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759699|NCT04750122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64759700|NCT00443352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64759701|NCT00443352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64759702|NCT00443352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64759703|NCT00443352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64759731|NCT00504504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64759732|NCT00504504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759733|NCT00504504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759734|NCT00504504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64759735|NCT00504504|Alkylating Agents|alkylating agents|mesh-ancestor
64759736|NCT00504504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64759737|NCT00504504|Tubulin Modulators|tubulin modulators|mesh-ancestor
64759738|NCT00504504|Antimitotic Agents|antimitotic agents|mesh-ancestor
64759739|NCT00504504|Mitosis Modulators|mitosis modulators|mesh-ancestor
64759740|NCT00504660|Celecoxib|celecoxib|mesh-list
64759741|NCT00504660|Capecitabine|capecitabine|mesh-list
64759742|NCT00504660|Thioguanine|thioguanine|mesh-list
64759743|NCT00504660|Temozolomide|temozolomide|mesh-list
64759744|NCT00504660|Lomustine|lomustine|mesh-list
64759781|NCT02115048|Letrozole|letrozole|mesh-list
64759800|NCT00546156|Antimitotic Agents|antimitotic agents|mesh-ancestor
64759801|NCT00546156|Mitosis Modulators|mitosis modulators|mesh-ancestor
64759863|NCT00548418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64759864|NCT00548418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759865|NCT00548418|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64759866|NCT00548418|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64759867|NCT00548418|Growth Substances|growth substances|mesh-ancestor
64759868|NCT00548418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759869|NCT00548418|Growth Inhibitors|growth inhibitors|mesh-ancestor
64759870|NCT00548418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64759871|NCT00548418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64759872|NCT00548418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759873|NCT00548418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759875|NCT00511992|Bevacizumab|bevacizumab|mesh-list
64759876|NCT00511992|Cisplatin|cisplatin|mesh-list
64759877|NCT00511992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64759878|NCT00511992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759879|NCT00511992|Tubulin Modulators|tubulin modulators|mesh-ancestor
64759880|NCT00511992|Antimitotic Agents|antimitotic agents|mesh-ancestor
64759881|NCT00511992|Mitosis Modulators|mitosis modulators|mesh-ancestor
64759882|NCT00511992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759883|NCT00511992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64759884|NCT00511992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64759922|NCT00550290|Cefazolin|cefazolin|mesh-list
64760006|NCT00524472|Insulin|insulin|mesh-list
64760007|NCT00524472|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64760008|NCT00524472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64760009|NCT00524472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760010|NCT00555048|Cyclophosphamide|cyclophosphamide|mesh-list
64760011|NCT00555048|Busulfan|busulfan|mesh-list
64760012|NCT00555048|Methotrexate|methotrexate|mesh-list
64760013|NCT00555048|Alemtuzumab|alemtuzumab|mesh-list
64760014|NCT00555048|Tacrolimus|tacrolimus|mesh-list
64760047|NCT00525876|Alemtuzumab|alemtuzumab|mesh-list
65495112|NCT01375348|Analgesics|analgesics|mesh-ancestor
64760048|NCT00525876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64760049|NCT00525876|Immunologic Factors|immunologic factors|mesh-ancestor
64760050|NCT00525876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760051|NCT00525876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64760052|NCT00525876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64760053|NCT00525876|Alkylating Agents|alkylating agents|mesh-ancestor
64371972|NCT03069339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64760077|NCT00556140|Serotonin Agents|serotonin agents|mesh-ancestor
64760078|NCT00556140|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64760079|NCT00556140|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64760080|NCT00556140|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64760081|NCT00556140|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64760084|NCT00527124|Cediranib|cediranib|mesh-list
64760085|NCT00527124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760086|NCT00527124|Tubulin Modulators|tubulin modulators|mesh-ancestor
64760087|NCT00527124|Antimitotic Agents|antimitotic agents|mesh-ancestor
64760088|NCT00527124|Mitosis Modulators|mitosis modulators|mesh-ancestor
64760140|NCT03572790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64760141|NCT03572790|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64760142|NCT03572790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64760143|NCT03572790|Serotonin Agents|serotonin agents|mesh-ancestor
64760144|NCT03572790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64760147|NCT03428802|Pembrolizumab|pembrolizumab|mesh-list
64760324|NCT00565266|Bromides|bromides|mesh-list
64760325|NCT00565266|Tiotropium Bromide|tiotropium bromide|mesh-list
64760326|NCT00565266|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64760327|NCT00565266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64760328|NCT00565266|Autonomic Agents|autonomic agents|mesh-ancestor
64760329|NCT00565266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64760330|NCT00565266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760331|NCT00565266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64760332|NCT00565266|Respiratory System Agents|respiratory system agents|mesh-ancestor
64760333|NCT00565266|Parasympatholytics|parasympatholytics|mesh-ancestor
64760347|NCT00568386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64760348|NCT00568386|Lubricant Eye Drops|lubricant eye drops|mesh-list
64760349|NCT00568386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64760350|NCT01797978|Methylene Blue|methylene blue|mesh-list
64760351|NCT01797978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64760352|NCT01797978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760353|NCT05363202|Fluticasone|fluticasone|mesh-list
64760354|NCT05363202|Xhance|xhance|mesh-list
64760355|NCT05363202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64760356|NCT05363202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64760357|NCT05363202|Autonomic Agents|autonomic agents|mesh-ancestor
64760358|NCT05363202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64760359|NCT05363202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760360|NCT05363202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64760361|NCT05363202|Respiratory System Agents|respiratory system agents|mesh-ancestor
64760362|NCT05363202|Dermatologic Agents|dermatologic agents|mesh-ancestor
64760363|NCT05363202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64760364|NCT05461092|Morphine|morphine|mesh-list
64760365|NCT05461092|Analgesics, Opioid|analgesics, opioid|mesh-list
64760383|NCT02129478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64760384|NCT02129478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64760385|NCT02129478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64760386|NCT02129478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64760387|NCT02129478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64760388|NCT02129478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760389|NCT02129478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64760390|NCT02129478|Serotonin Agents|serotonin agents|mesh-ancestor
64760391|NCT02129556|Pembrolizumab|pembrolizumab|mesh-list
64760392|NCT02129556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64760393|NCT02129556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760394|NCT05362500|Tranylcypromine|tranylcypromine|mesh-list
64760395|NCT05362500|Glycolic acid|glycolic acid|mesh-list
64760431|NCT05355168|Nimotuzumab|nimotuzumab|mesh-list
64760432|NCT05355168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64760433|NCT05355168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760434|NCT05353374|Fusidic Acid|fusidic acid|mesh-list
64760435|NCT05353374|Petrolatum|petrolatum|mesh-list
64760436|NCT05353374|Emollients|emollients|mesh-ancestor
64760437|NCT05353374|Dermatologic Agents|dermatologic agents|mesh-ancestor
64760471|NCT04747236|Gemcitabine|gemcitabine|mesh-list
64760472|NCT04747236|Azacitidine|azacitidine|mesh-list
64760473|NCT04747236|Romidepsin|romidepsin|mesh-list
64760474|NCT04747236|Belinostat|belinostat|mesh-list
64760475|NCT04747236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64760528|NCT03781128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64760529|NCT01798602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64760530|NCT01798602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64760563|NCT03642366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64760564|NCT03642366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760565|NCT03642366|Urological Agents|urological agents|mesh-ancestor
64760566|NCT00604968|Doxorubicin|doxorubicin|mesh-list
64760567|NCT00604968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64760568|NCT00604968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64760625|NCT05194488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760626|NCT05194488|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64760627|NCT05194488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64760628|NCT05175768|Niacinamide|niacinamide|mesh-list
64760630|NCT05175768|Nicotinic Acids|nicotinic acids|mesh-list
64760631|NCT05175768|Vitamin B Complex|vitamin b complex|mesh-ancestor
64760632|NCT05175768|Vitamins|vitamins|mesh-ancestor
64760633|NCT05175768|Micronutrients|micronutrients|mesh-ancestor
64760634|NCT05175768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495115|NCT05195086|Mycophenolic Acid|mycophenolic acid|mesh-list
64591169|NCT00499343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64760635|NCT05175768|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64760636|NCT05175768|Antimetabolites|antimetabolites|mesh-ancestor
64760637|NCT05175768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760638|NCT05175768|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64760639|NCT05175768|Vasodilator Agents|vasodilator agents|mesh-ancestor
64760640|NCT05097846|Amoxicillin|amoxicillin|mesh-list
64760641|NCT05097846|Doxycycline|doxycycline|mesh-list
64760642|NCT05097846|Furazolidone|furazolidone|mesh-list
64760643|NCT05097846|Esomeprazole|esomeprazole|mesh-list
64760645|NCT05097846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64760689|NCT02897700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64760690|NCT02897700|Alkylating Agents|alkylating agents|mesh-ancestor
64760691|NCT02897700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760692|NCT02897700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760693|NCT02897700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64760694|NCT02897700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64760695|NCT02897700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64760696|NCT02897700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64760697|NCT02897700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64760698|NCT02897700|Antimetabolites|antimetabolites|mesh-ancestor
64760699|NCT02897700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64760700|NCT02897700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64760701|NCT02897700|Abortifacient Agents|abortifacient agents|mesh-ancestor
64760702|NCT02897700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64760703|NCT02897700|Dermatologic Agents|dermatologic agents|mesh-ancestor
64760704|NCT02897700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64760705|NCT02897700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64760706|NCT02889666|Gemcitabine|gemcitabine|mesh-list
64760707|NCT02889666|Cisplatin|cisplatin|mesh-list
64760708|NCT02889666|Carboplatin|carboplatin|mesh-list
64760709|NCT02889666|Docetaxel|docetaxel|mesh-list
64760710|NCT02889666|Oxaliplatin|oxaliplatin|mesh-list
64760743|NCT00610428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760745|NCT02446236|Lenalidomide|lenalidomide|mesh-list
64760746|NCT02446236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64760747|NCT02446236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760748|NCT02446236|Immunologic Factors|immunologic factors|mesh-ancestor
64760749|NCT02446236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760750|NCT02446236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64760751|NCT02446236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64760752|NCT02446236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64760753|NCT02446236|Growth Substances|growth substances|mesh-ancestor
64760779|NCT02136420|Histamine Agents|histamine agents|mesh-ancestor
64760780|NCT02136420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64760785|NCT02136420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64760786|NCT02136420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64760787|NCT02136420|Anesthetics, Local|anesthetics, local|mesh-ancestor
64760788|NCT02136420|Anesthetics|anesthetics|mesh-ancestor
64760789|NCT02136420|Sensory System Agents|sensory system agents|mesh-ancestor
64529498|NCT00298155|Androgen Antagonists|androgen antagonists|mesh-ancestor
64760790|NCT02136420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65495116|NCT05195086|Cyclophosphamide|cyclophosphamide|mesh-list
64473221|NCT00119392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64760791|NCT02136420|Antiemetics|antiemetics|mesh-ancestor
64760792|NCT02136420|Autonomic Agents|autonomic agents|mesh-ancestor
64760793|NCT02136420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64760794|NCT02136498|Varenicline|varenicline|mesh-list
64760795|NCT02136498|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64760796|NCT02136498|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64760797|NCT02136498|Cholinergic Agents|cholinergic agents|mesh-ancestor
64760798|NCT02136498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64760799|NCT02136498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760800|NCT02136498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760801|NCT00612222|Aldesleukin|aldesleukin|mesh-list
64760802|NCT00612222|Cyclophosphamide|cyclophosphamide|mesh-list
64760830|NCT01711242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760832|NCT04405908|Aluminum sulfate|aluminum sulfate|mesh-list
64760833|NCT04405908|1018 oligonucleotide|1018 oligonucleotide|mesh-list
64760834|NCT04405908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64760835|NCT04405908|Immunologic Factors|immunologic factors|mesh-ancestor
64760836|NCT04405908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760837|NCT04405908|Antacids|antacids|mesh-ancestor
64760838|NCT04405908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760839|NCT04405908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64760840|NCT04331496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64760882|NCT00614484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760884|NCT04159974|Tremelimumab|tremelimumab|mesh-list
64760885|NCT04159974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64760886|NCT04159974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760887|NCT04142502|Dexmedetomidine|dexmedetomidine|mesh-list
64760888|NCT04142502|Propofol|propofol|mesh-list
64760889|NCT04142502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64760890|NCT04142502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64760891|NCT04142502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760892|NCT04142502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64760893|NCT04142502|Anesthetics, General|anesthetics, general|mesh-ancestor
64760894|NCT04142502|Anesthetics|anesthetics|mesh-ancestor
64760895|NCT04142502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64760896|NCT04142502|Analgesics|analgesics|mesh-ancestor
64760897|NCT04142502|Sensory System Agents|sensory system agents|mesh-ancestor
64760932|NCT00616122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64760934|NCT00616122|Dermatologic Agents|dermatologic agents|mesh-ancestor
64760935|NCT00616122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64760955|NCT00618540|Immunologic Factors|immunologic factors|mesh-ancestor
64760956|NCT00618540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760957|NCT00618540|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64760958|NCT00618540|Alkylating Agents|alkylating agents|mesh-ancestor
64760959|NCT00618540|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64760960|NCT00618540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64760961|NCT03930732|Cholinergic Agents|cholinergic agents|mesh-list
64760962|NCT03930732|Muscarinic Antagonists|muscarinic antagonists|mesh-list
64760963|NCT03930732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64760964|NCT03930732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760965|NCT03930732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760966|NCT03930732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64760967|NCT00570960|Dextrans|dextrans|mesh-list
64760968|NCT00570960|Anticoagulants|anticoagulants|mesh-ancestor
64760976|NCT00571428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760977|NCT00571428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64760978|NCT00571428|Respiratory System Agents|respiratory system agents|mesh-ancestor
64760979|NCT00571428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64760980|NCT00571428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64760981|NCT00571428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64760982|NCT00571428|Adrenergic Agents|adrenergic agents|mesh-ancestor
64760983|NCT00571428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64760984|NCT00571428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760985|NCT00571974|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64760986|NCT00571974|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64760987|NCT00571974|Dermatologic Agents|dermatologic agents|mesh-ancestor
64760988|NCT00574236|Doxorubicin|doxorubicin|mesh-list
64760989|NCT00574236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64760990|NCT00574236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760991|NCT00574236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64760992|NCT00574236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64761007|NCT01168219|Abortifacient Agents|abortifacient agents|mesh-ancestor
64761008|NCT01168219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64761009|NCT01168219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761010|NCT01168219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64761011|NCT01168219|Antimetabolites|antimetabolites|mesh-ancestor
64761012|NCT01168219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761013|NCT01168219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761014|NCT01168219|Dermatologic Agents|dermatologic agents|mesh-ancestor
64761015|NCT01168219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761016|NCT01168219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64761017|NCT01168219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64419523|NCT04411693|Dexamethasone|dexamethasone|mesh-list
64761034|NCT01115569|Hydrocodone|hydrocodone|mesh-list
64761035|NCT01115569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64761036|NCT01115569|Narcotics|narcotics|mesh-ancestor
64761037|NCT01115569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64761038|NCT01115569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761039|NCT01115569|Analgesics|analgesics|mesh-ancestor
64761040|NCT01115569|Sensory System Agents|sensory system agents|mesh-ancestor
64761041|NCT01115569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64761042|NCT01115569|Antitussive Agents|antitussive agents|mesh-ancestor
64761043|NCT01115569|Respiratory System Agents|respiratory system agents|mesh-ancestor
64761044|NCT01107886|Saxagliptin|saxagliptin|mesh-list
64761045|NCT01107886|Incretins|incretins|mesh-ancestor
64761046|NCT01107886|Hormones|hormones|mesh-ancestor
64761047|NCT01107886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64761048|NCT01107886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761049|NCT01107886|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64761050|NCT01107886|Protease Inhibitors|protease inhibitors|mesh-ancestor
64761051|NCT01107886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761052|NCT01107886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372953|NCT03298373|Hormones|hormones|mesh-ancestor
64761081|NCT05766605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761082|NCT05766605|Antimetabolites|antimetabolites|mesh-ancestor
64761083|NCT05766605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64761084|NCT05766605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64761085|NCT05766605|Immunologic Factors|immunologic factors|mesh-ancestor
64761086|NCT05766605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761087|NCT05766605|Antidotes|antidotes|mesh-ancestor
64761088|NCT05766605|Protective Agents|protective agents|mesh-ancestor
64761089|NCT05766605|Vitamin B Complex|vitamin b complex|mesh-ancestor
64473222|NCT00119392|Antimetabolites|antimetabolites|mesh-ancestor
64591393|NCT03589040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64761090|NCT05766605|Vitamins|vitamins|mesh-ancestor
64761091|NCT05766605|Micronutrients|micronutrients|mesh-ancestor
64761092|NCT05766605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64529812|NCT02037126|Promethazine|promethazine|mesh-list
64761093|NCT05766553|Nicotine|nicotine|mesh-list
64761094|NCT05766553|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64761095|NCT05766553|Autonomic Agents|autonomic agents|mesh-ancestor
64761096|NCT05766553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64761097|NCT05766553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761098|NCT05766553|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64761099|NCT05766553|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64761100|NCT05766553|Cholinergic Agents|cholinergic agents|mesh-ancestor
64761101|NCT05766553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64373017|NCT03290963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64761126|NCT05766514|Cytarabine|cytarabine|mesh-list
64761127|NCT05766514|Decitabine|decitabine|mesh-list
64761128|NCT05766514|Venetoclax|venetoclax|mesh-list
64761129|NCT05766514|Cladribine|cladribine|mesh-list
64761130|NCT05766514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64761131|NCT05766514|Antimetabolites|antimetabolites|mesh-ancestor
64761132|NCT05766514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761133|NCT05766514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761134|NCT05766514|Antiviral Agents|antiviral agents|mesh-ancestor
64761135|NCT05766514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64761136|NCT05766514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64761137|NCT05766514|Immunologic Factors|immunologic factors|mesh-ancestor
64761138|NCT05766514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761139|NCT05766514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761140|NCT05766436|Dexmedetomidine|dexmedetomidine|mesh-list
64761141|NCT05766436|Melatonin|melatonin|mesh-list
64761142|NCT05766436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64761143|NCT05766436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64761144|NCT05766436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761145|NCT05766436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64761146|NCT05766436|Analgesics|analgesics|mesh-ancestor
64761147|NCT05766436|Sensory System Agents|sensory system agents|mesh-ancestor
64761163|NCT05766384|Xenon|xenon|mesh-list
64761168|NCT05766384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761169|NCT05766371|Pembrolizumab|pembrolizumab|mesh-list
64761171|NCT05766371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64761172|NCT05766371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761173|NCT05766371|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64761174|NCT05766371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761175|NCT05766345|BCG Vaccine|bcg vaccine|mesh-list
64761176|NCT05766345|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64761177|NCT05766345|Immunologic Factors|immunologic factors|mesh-ancestor
64761178|NCT05766345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761179|NCT05766267|Moxifloxacin|moxifloxacin|mesh-list
64761180|NCT05766267|Rifampin|rifampin|mesh-list
64761181|NCT05766267|Isoniazid|isoniazid|mesh-list
64761182|NCT05766267|Pyrazinamide|pyrazinamide|mesh-list
64761183|NCT05766267|Ethambutol|ethambutol|mesh-list
64761184|NCT05766267|Rifabutin|rifabutin|mesh-list
64761185|NCT05766267|Bedaquiline|bedaquiline|mesh-list
64761186|NCT05766267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64761187|NCT05766267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64761188|NCT05766267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64761189|NCT05766267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65495119|NCT05195086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495120|NCT05195086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64761190|NCT05766267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761191|NCT05766267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761192|NCT05766267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761193|NCT05766267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64761194|NCT05766267|Antitubercular Agents|antitubercular agents|mesh-ancestor
64761195|NCT05766267|Leprostatic Agents|leprostatic agents|mesh-ancestor
64761196|NCT05766267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64761197|NCT05766267|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64761198|NCT05766267|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64761199|NCT05766267|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64761200|NCT05766267|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64761207|NCT05766176|Antibodies|antibodies|mesh-list
64761208|NCT05766176|Immunoglobulins|immunoglobulins|mesh-list
64761209|NCT05766176|Immunologic Factors|immunologic factors|mesh-ancestor
64761210|NCT05766176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761211|NCT05766124|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64761212|NCT05766124|Plasminogen|plasminogen|mesh-list
64761213|NCT05766124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64761214|NCT05766124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64761215|NCT05766124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761216|NCT05766085|Dexamethasone|dexamethasone|mesh-list
64761217|NCT05766085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64761218|NCT05766085|Antiemetics|antiemetics|mesh-ancestor
64761219|NCT05766085|Autonomic Agents|autonomic agents|mesh-ancestor
64761220|NCT05766085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64761221|NCT05766085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761222|NCT05766085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64761223|NCT05766085|Glucocorticoids|glucocorticoids|mesh-ancestor
64761224|NCT05766085|Hormones|hormones|mesh-ancestor
64761225|NCT05766085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64761226|NCT05766085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64761227|NCT05766085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761254|NCT05765682|Anesthetics, Local|anesthetics, local|mesh-ancestor
64761255|NCT05765682|Anesthetics|anesthetics|mesh-ancestor
64761256|NCT05765682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64761257|NCT05765682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761258|NCT05765682|Sensory System Agents|sensory system agents|mesh-ancestor
64761259|NCT05765682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64761260|NCT05765617|Calcitriol|calcitriol|mesh-list
64761261|NCT05765617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64761262|NCT05765617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761263|NCT05765617|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64761310|NCT05765266|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64761312|NCT05765266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64761313|NCT05765266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761344|NCT05764993|Immunoglobulins|immunoglobulins|mesh-list
64761345|NCT05764993|gamma-Globulins|gamma-globulins|mesh-list
64761346|NCT05764993|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64761347|NCT05764993|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64761348|NCT05764993|Immunologic Factors|immunologic factors|mesh-ancestor
64761349|NCT05764993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761350|NCT05764811|Canagliflozin|canagliflozin|mesh-list
64761351|NCT05764811|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64761352|NCT05764811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761353|NCT05764811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64761354|NCT05764811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761355|NCT05764798|Zolpidem|zolpidem|mesh-list
64761356|NCT05764798|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64761357|NCT05764798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64761358|NCT05764798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64761375|NCT05764746|Antiviral Agents|antiviral agents|mesh-ancestor
64761376|NCT05764746|Schistosomicides|schistosomicides|mesh-ancestor
64761377|NCT05764746|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64761378|NCT05764746|Anthelmintics|anthelmintics|mesh-ancestor
64761379|NCT05764707|Acetaminophen|acetaminophen|mesh-list
64761380|NCT05764707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64761381|NCT05764707|Analgesics|analgesics|mesh-ancestor
64761382|NCT05764707|Sensory System Agents|sensory system agents|mesh-ancestor
64761383|NCT05764707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64761384|NCT05764707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761385|NCT05764707|Antipyretics|antipyretics|mesh-ancestor
64761386|NCT05763602|Povidone-Iodine|povidone-iodine|mesh-list
64761387|NCT05763602|Povidone|povidone|mesh-list
64761388|NCT05763602|Plasma Substitutes|plasma substitutes|mesh-ancestor
64761389|NCT05763602|Blood Substitutes|blood substitutes|mesh-ancestor
64761390|NCT05763602|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64761391|NCT05763602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64761392|NCT05757622|Remifentanil|remifentanil|mesh-list
64761393|NCT05757622|Propofol|propofol|mesh-list
64761396|NCT05757622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761397|NCT05757622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64761398|NCT05757622|Anesthetics, General|anesthetics, general|mesh-ancestor
64761399|NCT05757622|Anesthetics|anesthetics|mesh-ancestor
64761400|NCT05757622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64761401|NCT05757622|Narcotics|narcotics|mesh-ancestor
64761402|NCT05757622|Analgesics|analgesics|mesh-ancestor
64761403|NCT05757622|Sensory System Agents|sensory system agents|mesh-ancestor
64761404|NCT05757622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64761405|NCT05746819|Antipyretics|antipyretics|mesh-list
64761406|NCT05746819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761408|NCT05746650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64761409|NCT05746650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761410|NCT05743400|Thymoglobulin|thymoglobulin|mesh-list
64761411|NCT05743400|Immunologic Factors|immunologic factors|mesh-ancestor
64761412|NCT05743400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761413|NCT05743400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64761414|NCT05733689|Paclitaxel|paclitaxel|mesh-list
64761415|NCT05733689|Docetaxel|docetaxel|mesh-list
64761416|NCT05733689|Carboplatin|carboplatin|mesh-list
64761417|NCT05733689|Pembrolizumab|pembrolizumab|mesh-list
64761418|NCT05733689|Nivolumab|nivolumab|mesh-list
64761419|NCT05733689|Irinotecan|irinotecan|mesh-list
64761420|NCT05733689|Folfirinox|folfirinox|mesh-list
64761421|NCT05733689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64761422|NCT05733689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761443|NCT05731726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64761444|NCT05731726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761445|NCT05731726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64761446|NCT05731726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64761447|NCT05731726|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64761448|NCT05731726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64761449|NCT05731726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761451|NCT05715931|Docetaxel|docetaxel|mesh-list
64761452|NCT05715931|Oxaliplatin|oxaliplatin|mesh-list
64761453|NCT05715931|Trastuzumab|trastuzumab|mesh-list
64761454|NCT05715931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761459|NCT05715931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64761460|NCT05715931|Antidotes|antidotes|mesh-ancestor
64761461|NCT05715931|Protective Agents|protective agents|mesh-ancestor
64761462|NCT05715931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761463|NCT05715931|Vitamin B Complex|vitamin b complex|mesh-ancestor
64761464|NCT05715931|Vitamins|vitamins|mesh-ancestor
64761465|NCT05715931|Micronutrients|micronutrients|mesh-ancestor
64761466|NCT05714384|Calcium|calcium|mesh-list
64761467|NCT05714384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64473223|NCT00119392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761468|NCT05714384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761469|NCT05714007|Ferrous succinate|ferrous succinate|mesh-list
64761470|NCT05714007|Hematinics|hematinics|mesh-ancestor
64761471|NCT05708183|Micronutrients|micronutrients|mesh-list
64761472|NCT05708183|Trace Elements|trace elements|mesh-list
64761473|NCT05708183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761474|NCT05705258|Aflibercept|aflibercept|mesh-list
64761475|NCT05705258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64761476|NCT05705258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64761477|NCT05705258|Growth Substances|growth substances|mesh-ancestor
64761484|NCT05687110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761485|NCT05687110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761486|NCT05687110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64761487|NCT05644041|Gemcitabine|gemcitabine|mesh-list
64761488|NCT05644041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64761489|NCT05644041|Antimetabolites|antimetabolites|mesh-ancestor
64761513|NCT05628623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64761514|NCT05628623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64761515|NCT05611905|Probenecid|probenecid|mesh-list
64761516|NCT05611905|Uricosuric Agents|uricosuric agents|mesh-ancestor
64761517|NCT05611905|Gout Suppressants|gout suppressants|mesh-ancestor
64761518|NCT05611905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64761519|NCT05611905|Renal Agents|renal agents|mesh-ancestor
64761520|NCT05594823|Furosemide|furosemide|mesh-list
64761521|NCT05594823|Diuretics|diuretics|mesh-list
64761522|NCT05594823|Natriuretic Agents|natriuretic agents|mesh-ancestor
64761523|NCT05594823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761524|NCT05594823|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64761525|NCT05594823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64761526|NCT05594823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761527|NCT05581797|Psilocybin|psilocybin|mesh-list
64761528|NCT05581797|Hallucinogens|hallucinogens|mesh-ancestor
64761529|NCT05581797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761530|NCT05581797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64761531|NCT05581030|Rituximab|rituximab|mesh-list
64761532|NCT05581030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64761533|NCT05581030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761534|NCT05581030|Immunologic Factors|immunologic factors|mesh-ancestor
64761535|NCT05581030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761536|NCT05581030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64761537|NCT05510544|Plerixafor|plerixafor|mesh-list
64761538|NCT05510544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64761539|NCT05510544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64761540|NCT05510544|Antiviral Agents|antiviral agents|mesh-ancestor
64761541|NCT05510544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64761542|NCT05509699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64761543|NCT05509699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761544|NCT05509699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761545|NCT05500326|Ivermectin|ivermectin|mesh-list
64761546|NCT05500326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64761547|NCT05500326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64761569|NCT05441215|Protease Inhibitors|protease inhibitors|mesh-ancestor
64761570|NCT05441215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761571|NCT05441215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761572|NCT05441215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64761573|NCT05441215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64761574|NCT05441215|Antiviral Agents|antiviral agents|mesh-ancestor
64761575|NCT05441215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64761576|NCT05441215|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64761577|NCT05441215|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64761578|NCT05431777|Avelumab|avelumab|mesh-list
64761579|NCT05431777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64761580|NCT05431777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761581|NCT05372614|Trastuzumab|trastuzumab|mesh-list
64761582|NCT05372614|Camptothecin|camptothecin|mesh-list
64761583|NCT05372614|Maleic acid|maleic acid|mesh-list
64761584|NCT05372614|Immunoconjugates|immunoconjugates|mesh-list
64761585|NCT05372614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64761586|NCT05372614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761587|NCT05372614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761588|NCT05372614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761589|NCT05372614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64761590|NCT05372614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64761591|NCT05372614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64761647|NCT05320380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64761648|NCT05320380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64761649|NCT05303532|Durvalumab|durvalumab|mesh-list
64761650|NCT05303532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64761651|NCT05303532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761652|NCT05297565|Nivolumab|nivolumab|mesh-list
64761653|NCT05297565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64761654|NCT05297565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761671|NCT05259527|Cholecalciferol|cholecalciferol|mesh-list
64761672|NCT05259527|Vitamins|vitamins|mesh-list
64761673|NCT05259527|Micronutrients|micronutrients|mesh-ancestor
64761674|NCT05259527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761675|NCT05259527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64761676|NCT05259527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64761677|NCT05256641|Acalabrutinib|acalabrutinib|mesh-list
64761678|NCT05256641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761679|NCT05198843|Dasatinib|dasatinib|mesh-list
64761680|NCT05198843|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
64761681|NCT05198843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495122|NCT05195086|Alkylating Agents|alkylating agents|mesh-ancestor
64473224|NCT00119392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64317083|NCT02415699|Antidotes|antidotes|mesh-ancestor
64761682|NCT05198843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64761683|NCT05198843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761684|NCT05198843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761685|NCT05198843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64761686|NCT05198843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64761687|NCT05187377|Hormones|hormones|mesh-list
64761688|NCT05187377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64761689|NCT05187377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761690|NCT05177588|Metformin|metformin|mesh-list
64761691|NCT05177588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64761692|NCT05177588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761693|NCT05171660|Bevacizumab|bevacizumab|mesh-list
64761694|NCT05171660|Capecitabine|capecitabine|mesh-list
64761695|NCT05171660|Oxaliplatin|oxaliplatin|mesh-list
64567970|NCT03058224|Acetaminophen|acetaminophen|mesh-list
64502039|NCT05566834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761696|NCT05171660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64761697|NCT05171660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761698|NCT05171660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64761699|NCT05171660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64761700|NCT05171660|Growth Substances|growth substances|mesh-ancestor
64761709|NCT05153239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64761710|NCT05153239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761711|NCT05153239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761712|NCT05153239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761721|NCT05140941|Sofosbuvir|sofosbuvir|mesh-list
64761722|NCT05140941|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64761723|NCT05140941|Velpatasvir|velpatasvir|mesh-list
64761724|NCT05140941|Antiviral Agents|antiviral agents|mesh-ancestor
64761725|NCT05140941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64761726|NCT05133258|Ciprofloxacin|ciprofloxacin|mesh-list
64761727|NCT05133258|Dexamethasone|dexamethasone|mesh-list
64761728|NCT05133258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64761729|NCT05133258|Antiemetics|antiemetics|mesh-ancestor
64761773|NCT05091346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761774|NCT05059873|Prednisone|prednisone|mesh-list
64761775|NCT05059873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64761776|NCT05059873|Glucocorticoids|glucocorticoids|mesh-ancestor
64761778|NCT05059873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64761779|NCT05059873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761780|NCT05059873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64761781|NCT05059873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761782|NCT05055024|Mazindol|mazindol|mesh-list
64761783|NCT05055024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64761784|NCT05055024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761785|NCT05055024|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64761786|NCT05055024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64761787|NCT05055024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64373670|NCT04977843|Dimercaprol|dimercaprol|mesh-list
64761822|NCT04989218|Cisplatin|cisplatin|mesh-list
64761827|NCT04989218|Antimetabolites|antimetabolites|mesh-ancestor
64761828|NCT04989218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761829|NCT04989218|Antiviral Agents|antiviral agents|mesh-ancestor
64761859|NCT04944290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64761860|NCT04944290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64761861|NCT04944290|Adrenergic Agents|adrenergic agents|mesh-ancestor
64761862|NCT04944290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64761863|NCT04944290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761864|NCT04944290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761865|NCT04944290|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64761866|NCT04944290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761867|NCT04937166|Azacitidine|azacitidine|mesh-list
64761868|NCT04937166|Venetoclax|venetoclax|mesh-list
64761869|NCT04937166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64761870|NCT04937166|Antimetabolites|antimetabolites|mesh-ancestor
64373755|NCT03988205|Immunologic Factors|immunologic factors|mesh-ancestor
64761896|NCT04908176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65495123|NCT05195086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495124|NCT05195086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761897|NCT04908176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761898|NCT04898023|Ascorbic Acid|ascorbic acid|mesh-list
64761899|NCT04898023|Antioxidants|antioxidants|mesh-ancestor
64761900|NCT04898023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761901|NCT04898023|Protective Agents|protective agents|mesh-ancestor
64761902|NCT04898023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761903|NCT04898023|Vitamins|vitamins|mesh-ancestor
64761904|NCT04898023|Micronutrients|micronutrients|mesh-ancestor
64761963|NCT04778267|Sensory System Agents|sensory system agents|mesh-ancestor
64761964|NCT04761627|Ustekinumab|ustekinumab|mesh-list
64761965|NCT04761627|Dermatologic Agents|dermatologic agents|mesh-ancestor
64761966|NCT04760691|Tenofovir|tenofovir|mesh-list
64761967|NCT04760691|Emtricitabine|emtricitabine|mesh-list
64761968|NCT04760691|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64761969|NCT04760691|Leuprolide|leuprolide|mesh-list
64761970|NCT04760691|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64761971|NCT04760691|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64761972|NCT04760691|Estradiol|estradiol|mesh-list
64761973|NCT04760691|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64761974|NCT04760691|Estrogens|estrogens|mesh-list
64761975|NCT04760691|Antiviral Agents|antiviral agents|mesh-ancestor
64761976|NCT04760691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64762037|NCT04682366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762038|NCT04682366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762039|NCT04682366|Urological Agents|urological agents|mesh-ancestor
64762040|NCT04666610|Brivaracetam|brivaracetam|mesh-list
64762041|NCT04666610|Anticonvulsants|anticonvulsants|mesh-ancestor
64762042|NCT04656301|Psilocybin|psilocybin|mesh-list
64762043|NCT04656301|Hallucinogens|hallucinogens|mesh-ancestor
64762044|NCT04656301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762045|NCT04656301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64762058|NCT04578756|Cariprazine|cariprazine|mesh-list
64762059|NCT04578756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64762060|NCT04578756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64762061|NCT04578756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64762062|NCT04578756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762063|NCT04578756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64762090|NCT04560972|Dermatologic Agents|dermatologic agents|mesh-ancestor
64762091|NCT04560972|Tubulin Modulators|tubulin modulators|mesh-ancestor
64762092|NCT04560972|Antimitotic Agents|antimitotic agents|mesh-ancestor
64762093|NCT04560972|Mitosis Modulators|mitosis modulators|mesh-ancestor
64762094|NCT04521335|Copper|copper|mesh-list
64762095|NCT04521335|Disulfiram|disulfiram|mesh-list
64762096|NCT04521335|Trace Elements|trace elements|mesh-ancestor
64762104|NCT04515615|Tegafur|tegafur|mesh-list
64762105|NCT04515615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762106|NCT04515615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64762107|NCT04515615|Antimetabolites|antimetabolites|mesh-ancestor
64762108|NCT04515615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762109|NCT04505410|Infliximab|infliximab|mesh-list
64762110|NCT04505410|Ustekinumab|ustekinumab|mesh-list
64473225|NCT00119392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473226|NCT00119392|Antifungal Agents|antifungal agents|mesh-ancestor
64473227|NCT00119392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64473228|NCT00119392|Dermatologic Agents|dermatologic agents|mesh-ancestor
64762111|NCT04505410|Tofacitinib|tofacitinib|mesh-list
64762112|NCT04505410|Dermatologic Agents|dermatologic agents|mesh-ancestor
64762113|NCT04505410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64762130|NCT04477304|Analgesics, Opioid|analgesics, opioid|mesh-list
64762131|NCT04477304|Narcotics|narcotics|mesh-ancestor
64762132|NCT04477304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64762133|NCT04477304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762134|NCT04477304|Analgesics|analgesics|mesh-ancestor
64762135|NCT04477304|Sensory System Agents|sensory system agents|mesh-ancestor
64762136|NCT04477304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64762137|NCT04452747|Dinoprostone|dinoprostone|mesh-list
64762138|NCT04452747|Oxytocics|oxytocics|mesh-ancestor
64762139|NCT04452747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64762140|NCT04452747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762141|NCT04439136|Afatinib|afatinib|mesh-list
64762142|NCT04439136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762143|NCT04439136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64530853|NCT05108688|Histamine Agents|histamine agents|mesh-ancestor
64530854|NCT05108688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64530855|NCT05108688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64530856|NCT05108688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64530857|NCT05108688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64762152|NCT04370301|Melphalan|melphalan|mesh-list
64762153|NCT04370301|Mechlorethamine|mechlorethamine|mesh-list
64762154|NCT04370301|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64762155|NCT04370301|Fludarabine|fludarabine|mesh-list
64762156|NCT04370301|Tacrolimus|tacrolimus|mesh-list
64762157|NCT04370301|Lenograstim|lenograstim|mesh-list
64762158|NCT04370301|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
64762159|NCT04370301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64762160|NCT04370301|Immunologic Factors|immunologic factors|mesh-ancestor
64762161|NCT04370301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762162|NCT04370301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64762191|NCT04329325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762192|NCT04329325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64762193|NCT04329325|Abortifacient Agents|abortifacient agents|mesh-ancestor
64762194|NCT04329325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64762195|NCT04329325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64762196|NCT04329325|Antimetabolites|antimetabolites|mesh-ancestor
64762197|NCT04329325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762198|NCT04329325|Dermatologic Agents|dermatologic agents|mesh-ancestor
64762199|NCT04329325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762200|NCT04329325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64762201|NCT04329325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64762202|NCT04329325|Immunologic Factors|immunologic factors|mesh-ancestor
64762278|NCT04179162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64762279|NCT04179162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762280|NCT04179162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64762281|NCT04179162|Immunologic Factors|immunologic factors|mesh-ancestor
64762282|NCT04179162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762283|NCT04179162|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64762284|NCT04163432|Carboplatin|carboplatin|mesh-list
64762285|NCT04163432|Pemetrexed|pemetrexed|mesh-list
64762286|NCT04163432|Durvalumab|durvalumab|mesh-list
64762287|NCT04163432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762288|NCT04163432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762289|NCT04163432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762290|NCT04163432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64762291|NCT04163432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64762292|NCT04163432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64762293|NCT04151706|Cyclophosphamide|cyclophosphamide|mesh-list
64762294|NCT04151706|Busulfan|busulfan|mesh-list
64762295|NCT04151706|Thiotepa|thiotepa|mesh-list
64762296|NCT04151706|Fludarabine|fludarabine|mesh-list
64762297|NCT04151706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64762298|NCT04151706|Immunologic Factors|immunologic factors|mesh-ancestor
64762299|NCT04151706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762300|NCT04151706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64762301|NCT04151706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64762302|NCT04151706|Alkylating Agents|alkylating agents|mesh-ancestor
64762303|NCT04151706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762304|NCT04151706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374125|NCT03257423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762334|NCT04109482|Immunologic Factors|immunologic factors|mesh-ancestor
64762335|NCT04109482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762336|NCT04109482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64762337|NCT04109482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64762338|NCT04109482|Alkylating Agents|alkylating agents|mesh-ancestor
64531078|NCT04512534|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
64531079|NCT04512534|Immunologic Factors|immunologic factors|mesh-ancestor
64531080|NCT04512534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374184|NCT03062163|Vitamins|vitamins|mesh-ancestor
64762362|NCT04083235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64762363|NCT04083235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762364|NCT04083235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64762365|NCT04083235|Immunologic Factors|immunologic factors|mesh-ancestor
64762366|NCT04083235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762367|NCT04083235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64762391|NCT04028050|Carboplatin|carboplatin|mesh-list
64762393|NCT04028050|Atezolizumab|atezolizumab|mesh-list
64762394|NCT04028050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762395|NCT04028050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64762396|NCT04028050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64762397|NCT04028050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65495128|NCT05195086|Antitubercular Agents|antitubercular agents|mesh-ancestor
65495129|NCT05195086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65495130|NCT05195086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65495131|NCT05195086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495132|NCT05194852|Anesthetics|anesthetics|mesh-list
65495133|NCT05194852|Anesthetics, Local|anesthetics, local|mesh-list
64762398|NCT04028050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762399|NCT04028050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762400|NCT04006119|Cemiplimab|cemiplimab|mesh-list
64762401|NCT04006119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64762402|NCT04006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762403|NCT04004793|Dapagliflozin|dapagliflozin|mesh-list
64762404|NCT04004793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64762405|NCT04004793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762421|NCT04002011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762422|NCT03969446|Pembrolizumab|pembrolizumab|mesh-list
64762423|NCT03969446|Decitabine|decitabine|mesh-list
64762424|NCT03969446|Venetoclax|venetoclax|mesh-list
64762429|NCT03969446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762430|NCT03969446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762431|NCT03903692|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64762432|NCT03903692|Laxatives|laxatives|mesh-ancestor
64762433|NCT03903692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64762434|NCT03884998|Nivolumab|nivolumab|mesh-list
64762435|NCT03884998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64762436|NCT03884998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762437|NCT03884998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64762438|NCT03884998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762439|NCT03831711|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
64762440|NCT03831711|Bombesin|bombesin|mesh-list
64762441|NCT03831711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762442|NCT03831711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64762443|NCT03831711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762444|NCT03831711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64762445|NCT03809624|Pembrolizumab|pembrolizumab|mesh-list
64762446|NCT03809624|Antibodies|antibodies|mesh-list
64762447|NCT03809624|Immunologic Factors|immunologic factors|mesh-ancestor
64762448|NCT03809624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762457|NCT03783026|Apremilast|apremilast|mesh-list
64762474|NCT03775460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64762475|NCT03775460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473235|NCT00218062|Amphetamine|amphetamine|mesh-list
64473236|NCT00218062|Dextroamphetamine|dextroamphetamine|mesh-list
64762476|NCT03775460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64762477|NCT03775460|Antimetabolites|antimetabolites|mesh-ancestor
64762478|NCT03775460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762479|NCT03775460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762480|NCT03775460|Dermatologic Agents|dermatologic agents|mesh-ancestor
64762481|NCT03775460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762482|NCT03775460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64762483|NCT03775460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64762484|NCT03775460|Immunologic Factors|immunologic factors|mesh-ancestor
64762485|NCT03775460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64762486|NCT03775460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64762487|NCT03775460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64762488|NCT03775460|Glucocorticoids|glucocorticoids|mesh-ancestor
64762489|NCT03775460|Hormones|hormones|mesh-ancestor
64762490|NCT03775460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64762491|NCT03775460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64762492|NCT03695380|Atezolizumab|atezolizumab|mesh-list
64762493|NCT03695380|Niraparib|niraparib|mesh-list
64762519|NCT03538691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64762520|NCT03538691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762521|NCT03538691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64762522|NCT03538691|Serotonin Agents|serotonin agents|mesh-ancestor
64762523|NCT03538691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762524|NCT03538691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64762525|NCT03538691|Antidepressive Agents|antidepressive agents|mesh-ancestor
64762526|NCT03538691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64762536|NCT03538691|Analgesics|analgesics|mesh-ancestor
64762539|NCT03538691|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64762540|NCT03538691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64762541|NCT03538691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762542|NCT03538691|Dopamine Agonists|dopamine agonists|mesh-ancestor
64762576|NCT03497676|Antiviral Agents|antiviral agents|mesh-ancestor
64762577|NCT03497676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64762578|NCT03497676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64762579|NCT03497676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64762580|NCT03497676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762581|NCT03497676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762582|NCT03497676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64762583|NCT03497676|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64762584|NCT03497676|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64374437|NCT03252665|Micronutrients|micronutrients|mesh-ancestor
64762611|NCT03419234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64762612|NCT03419234|Glucocorticoids|glucocorticoids|mesh-ancestor
64762613|NCT03419234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64762614|NCT03419234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762615|NCT03419234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64762616|NCT03419234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762617|NCT03419234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64762618|NCT03419234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762619|NCT03419234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762620|NCT03419234|Hormone Antagonists|hormone antagonists|mesh-ancestor
64762621|NCT03419234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64762622|NCT03419234|Antioxidants|antioxidants|mesh-ancestor
64762623|NCT03419234|Protective Agents|protective agents|mesh-ancestor
64762624|NCT03419234|Vitamins|vitamins|mesh-ancestor
64762625|NCT03419234|Micronutrients|micronutrients|mesh-ancestor
64762626|NCT03419234|Estrogens|estrogens|mesh-ancestor
64762627|NCT03419234|Anabolic Agents|anabolic agents|mesh-ancestor
64762628|NCT03330886|Atezolizumab|atezolizumab|mesh-list
64762629|NCT03330886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495134|NCT05194852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64762630|NCT03282916|Valacyclovir|valacyclovir|mesh-list
64762631|NCT03282916|Antiviral Agents|antiviral agents|mesh-ancestor
64568395|NCT02782663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64502040|NCT05566834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762632|NCT03282916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64762633|NCT03282799|Etonogestrel|etonogestrel|mesh-list
64762634|NCT03282799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64762635|NCT03282799|Contraceptive Agents|contraceptive agents|mesh-ancestor
64762636|NCT03282799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64762666|NCT03125928|Atezolizumab|atezolizumab|mesh-list
64762667|NCT03125928|Pertuzumab|pertuzumab|mesh-list
64762668|NCT03125928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64762669|NCT03125928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762670|NCT03125928|Tubulin Modulators|tubulin modulators|mesh-ancestor
64762671|NCT03125928|Antimitotic Agents|antimitotic agents|mesh-ancestor
64762672|NCT03125928|Mitosis Modulators|mitosis modulators|mesh-ancestor
64762673|NCT03125928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762674|NCT03125928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64762675|NCT03085056|Paclitaxel|paclitaxel|mesh-list
64762676|NCT03085056|Trametinib|trametinib|mesh-list
64762677|NCT03085056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64762678|NCT03085056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762679|NCT03085056|Tubulin Modulators|tubulin modulators|mesh-ancestor
64762680|NCT03085056|Antimitotic Agents|antimitotic agents|mesh-ancestor
64762681|NCT03085056|Mitosis Modulators|mitosis modulators|mesh-ancestor
64762682|NCT03085056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762707|NCT02983045|Cisplatin|cisplatin|mesh-list
64762708|NCT02983045|Carboplatin|carboplatin|mesh-list
64762709|NCT02983045|Nivolumab|nivolumab|mesh-list
64762710|NCT02983045|Pemetrexed|pemetrexed|mesh-list
64762711|NCT02983045|Ipilimumab|ipilimumab|mesh-list
64762712|NCT02983045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64762713|NCT02983045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762714|NCT02983045|Tubulin Modulators|tubulin modulators|mesh-ancestor
64762715|NCT02983045|Antimitotic Agents|antimitotic agents|mesh-ancestor
64762737|NCT02894398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64374582|NCT04944069|Bevacizumab|bevacizumab|mesh-list
64762751|NCT02616965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762752|NCT02616965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64762754|NCT02576717|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64762755|NCT02576717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762756|NCT02576717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64762757|NCT02576717|Immunologic Factors|immunologic factors|mesh-ancestor
64762758|NCT02576717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762759|NCT02564263|Paclitaxel|paclitaxel|mesh-list
64762760|NCT02564263|Docetaxel|docetaxel|mesh-list
64762761|NCT02564263|Pembrolizumab|pembrolizumab|mesh-list
64762762|NCT02564263|Irinotecan|irinotecan|mesh-list
64762763|NCT02564263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64762764|NCT02564263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762765|NCT02564263|Tubulin Modulators|tubulin modulators|mesh-ancestor
64762766|NCT02564263|Antimitotic Agents|antimitotic agents|mesh-ancestor
64762767|NCT02564263|Mitosis Modulators|mitosis modulators|mesh-ancestor
64762768|NCT02564263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762769|NCT02564263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64762770|NCT02564263|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64762771|NCT02564263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64762772|NCT02564263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762773|NCT02540018|Paclitaxel|paclitaxel|mesh-list
64762774|NCT02540018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64762804|NCT02301286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64762805|NCT02301286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64762823|NCT02231749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762824|NCT02231749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64762825|NCT02231749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762826|NCT02231749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64762827|NCT02231749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64762828|NCT02231749|Growth Substances|growth substances|mesh-ancestor
64762829|NCT02231749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762830|NCT02231749|Growth Inhibitors|growth inhibitors|mesh-ancestor
64762831|NCT02231749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64762832|NCT02231749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762833|NCT02126969|Carboplatin|carboplatin|mesh-list
64762835|NCT02126969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762836|NCT02126969|Tubulin Modulators|tubulin modulators|mesh-ancestor
64762837|NCT02126969|Antimitotic Agents|antimitotic agents|mesh-ancestor
64762838|NCT02126969|Mitosis Modulators|mitosis modulators|mesh-ancestor
64762839|NCT02126969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762840|NCT02099188|Leucovorin|leucovorin|mesh-list
64762841|NCT02099188|Docetaxel|docetaxel|mesh-list
64762842|NCT02099188|Doxorubicin|doxorubicin|mesh-list
64762843|NCT02099188|Fluorouracil|fluorouracil|mesh-list
64762844|NCT02099188|Etoposide|etoposide|mesh-list
64762845|NCT02099188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64762846|NCT02099188|Ifosfamide|ifosfamide|mesh-list
64762847|NCT02099188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762848|NCT02099188|Tubulin Modulators|tubulin modulators|mesh-ancestor
64762849|NCT02099188|Antimitotic Agents|antimitotic agents|mesh-ancestor
64762850|NCT02099188|Mitosis Modulators|mitosis modulators|mesh-ancestor
64502041|NCT01900002|Sorafenib|sorafenib|mesh-list
64762988|NCT01715285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64762989|NCT01715285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762990|NCT01715285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762991|NCT01715285|Hormone Antagonists|hormone antagonists|mesh-ancestor
64762992|NCT01715285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64762993|NCT01705184|Bevacizumab|bevacizumab|mesh-list
64762994|NCT01705184|Pemetrexed|pemetrexed|mesh-list
64762995|NCT01705184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64762996|NCT01705184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762997|NCT01705184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64762998|NCT01705184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64762999|NCT01705184|Growth Substances|growth substances|mesh-ancestor
64763000|NCT01705184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763001|NCT01705184|Growth Inhibitors|growth inhibitors|mesh-ancestor
64763002|NCT01705184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763003|NCT01705184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763004|NCT01705184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64763005|NCT01705184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64763006|NCT01285817|Celecoxib|celecoxib|mesh-list
64763007|NCT01285817|Cyclophosphamide|cyclophosphamide|mesh-list
64763008|NCT01285817|Methotrexate|methotrexate|mesh-list
64763009|NCT01285817|Vinblastine|vinblastine|mesh-list
64763010|NCT01285817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64763067|NCT01105975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64763068|NCT01105975|Antimetabolites|antimetabolites|mesh-ancestor
64763069|NCT01105975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763070|NCT01105975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64763071|NCT01105975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64763072|NCT01105975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763074|NCT01063517|Olaparib|olaparib|mesh-list
64763075|NCT01063517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64763076|NCT01063517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763077|NCT01063517|Tubulin Modulators|tubulin modulators|mesh-ancestor
64763078|NCT01063517|Antimitotic Agents|antimitotic agents|mesh-ancestor
64763079|NCT01063517|Mitosis Modulators|mitosis modulators|mesh-ancestor
64763080|NCT01063517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724278|NCT03282344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763081|NCT01063517|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64763082|NCT01063517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763083|NCT00819637|Albuterol|albuterol|mesh-list
64763084|NCT00819637|Formoterol Fumarate|formoterol fumarate|mesh-list
64763085|NCT00819637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64763086|NCT00819637|Autonomic Agents|autonomic agents|mesh-ancestor
64763087|NCT00819637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64763088|NCT00819637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374838|NCT02454491|Vasodilator Agents|vasodilator agents|mesh-ancestor
64763096|NCT00819637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763098|NCT00819637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64763099|NCT00651456|Bevacizumab|bevacizumab|mesh-list
64763100|NCT00651456|Cisplatin|cisplatin|mesh-list
64763149|NCT04386876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64763150|NCT04386642|Tranexamic Acid|tranexamic acid|mesh-list
64763151|NCT04386642|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64763152|NCT04386642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64763153|NCT04386642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763154|NCT04386642|Hemostatics|hemostatics|mesh-ancestor
64763155|NCT04386642|Coagulants|coagulants|mesh-ancestor
64763181|NCT04383990|Insulin|insulin|mesh-list
64763182|NCT04383990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64763183|NCT04383990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763184|NCT04381884|Ivermectin|ivermectin|mesh-list
64763185|NCT04381884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64763186|NCT04381884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763187|NCT04381962|Azithromycin|azithromycin|mesh-list
64763188|NCT04381962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64763189|NCT04381962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763190|NCT04381104|Acetaminophen|acetaminophen|mesh-list
64763191|NCT04381104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64763192|NCT04381104|Analgesics|analgesics|mesh-ancestor
64763193|NCT04381104|Sensory System Agents|sensory system agents|mesh-ancestor
64763194|NCT04381104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64763195|NCT04381104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763196|NCT04381104|Antipyretics|antipyretics|mesh-ancestor
64763197|NCT04380402|Atorvastatin|atorvastatin|mesh-list
64763198|NCT04380402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64763199|NCT04380402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64763200|NCT04380402|Antimetabolites|antimetabolites|mesh-ancestor
64763239|NCT04376970|Hormones|hormones|mesh-ancestor
64763248|NCT04377048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763249|NCT04377048|Antiviral Agents|antiviral agents|mesh-ancestor
64763250|NCT04377048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763251|NCT04377048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763252|NCT04377048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64763253|NCT04377048|Immunologic Factors|immunologic factors|mesh-ancestor
64763254|NCT04377048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763256|NCT04377048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64763258|NCT04376814|Lopinavir|lopinavir|mesh-list
64763259|NCT04376814|Hydroxychloroquine|hydroxychloroquine|mesh-list
64763260|NCT04376814|Favipiravir|favipiravir|mesh-list
64763261|NCT04376814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65495135|NCT05194852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473238|NCT00218062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763262|NCT04376814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64763263|NCT04376814|Protease Inhibitors|protease inhibitors|mesh-ancestor
64763264|NCT04376814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763265|NCT04376814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763266|NCT04376814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64763267|NCT04376814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64763268|NCT04376814|Antiviral Agents|antiviral agents|mesh-ancestor
64763269|NCT04376814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763270|NCT04376814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64763271|NCT04376814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64763272|NCT04376814|Antimalarials|antimalarials|mesh-ancestor
64763273|NCT04376814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64763274|NCT04376814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64763275|NCT04376814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763276|NCT04374942|Hydroxychloroquine|hydroxychloroquine|mesh-list
64763277|NCT04374942|Antimalarials|antimalarials|mesh-ancestor
64763293|NCT04374318|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64763294|NCT04374318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64763295|NCT04374318|Adrenergic Agents|adrenergic agents|mesh-ancestor
64763296|NCT04374318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64763297|NCT04374318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763298|NCT04374552|Azithromycin|azithromycin|mesh-list
64763299|NCT04374552|Hydroxychloroquine|hydroxychloroquine|mesh-list
64763300|NCT04374552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64763301|NCT04374552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763302|NCT04374552|Antimalarials|antimalarials|mesh-ancestor
64763303|NCT04374552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64763304|NCT04374552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64763305|NCT04374552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763306|NCT04374552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763307|NCT04374552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763308|NCT04374006|Propolis|propolis|mesh-list
64763309|NCT04374006|Dienogest|dienogest|mesh-list
64763310|NCT04374006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763311|NCT04374006|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64763312|NCT04374006|Contraceptive Agents|contraceptive agents|mesh-ancestor
64763313|NCT04374006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64763314|NCT04374006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763315|NCT04374006|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64763316|NCT04374006|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64763317|NCT04374006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64763318|NCT04374006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64763319|NCT04374006|Hormone Antagonists|hormone antagonists|mesh-ancestor
64763320|NCT04374006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64763321|NCT04374006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64763322|NCT04374006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763361|NCT04368546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763362|NCT04368546|Growth Inhibitors|growth inhibitors|mesh-ancestor
64763363|NCT04368546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64763364|NCT04368546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763365|NCT04368546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763366|NCT04366596|Paclitaxel|paclitaxel|mesh-list
64763367|NCT04366596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64763368|NCT04366596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763369|NCT04366596|Tubulin Modulators|tubulin modulators|mesh-ancestor
64763370|NCT04366596|Antimitotic Agents|antimitotic agents|mesh-ancestor
64763371|NCT04366596|Mitosis Modulators|mitosis modulators|mesh-ancestor
64763372|NCT04366596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763373|NCT04366050|Ramipril|ramipril|mesh-list
64763374|NCT04366050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64375131|NCT03238079|Immunoglobulins|immunoglobulins|mesh-list
64763403|NCT04365270|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64763404|NCT04365270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763405|NCT04365270|Disinfectants|disinfectants|mesh-ancestor
64763406|NCT04365270|Dermatologic Agents|dermatologic agents|mesh-ancestor
64763407|NCT04365270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64763408|NCT04365270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64763409|NCT04365270|Antimetabolites|antimetabolites|mesh-ancestor
64763410|NCT04365270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763411|NCT04365270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64763412|NCT04365270|Chelating Agents|chelating agents|mesh-ancestor
64763413|NCT04365270|Sequestering Agents|sequestering agents|mesh-ancestor
64763414|NCT04365270|Hemostatics|hemostatics|mesh-ancestor
64763415|NCT04365270|Coagulants|coagulants|mesh-ancestor
64763416|NCT04365270|Sunscreening Agents|sunscreening agents|mesh-ancestor
64763417|NCT04365270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64763418|NCT04365270|Protective Agents|protective agents|mesh-ancestor
64763419|NCT04365270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763454|NCT04363866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64763455|NCT04363866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64763456|NCT04363866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763457|NCT04363866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763458|NCT04363866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763459|NCT04363866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763460|NCT04362384|Vitamin E|vitamin e|mesh-list
64763461|NCT04362384|Prednisolone|prednisolone|mesh-list
64763462|NCT04362384|Vitamins|vitamins|mesh-ancestor
64763463|NCT04362384|Micronutrients|micronutrients|mesh-ancestor
64763464|NCT04362384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763465|NCT04362384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64763466|NCT04362384|Glucocorticoids|glucocorticoids|mesh-ancestor
64763467|NCT04362384|Hormones|hormones|mesh-ancestor
64763468|NCT04362384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64763469|NCT04362384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64763470|NCT04362384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763471|NCT04362384|Protective Agents|protective agents|mesh-ancestor
64763472|NCT04362384|Antioxidants|antioxidants|mesh-ancestor
64763473|NCT04362384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763474|NCT04361214|Leflunomide|leflunomide|mesh-list
64763475|NCT04361214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763502|NCT04359966|Ofloxacin|ofloxacin|mesh-list
64763566|NCT04357392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64763567|NCT04357392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64375329|NCT03056625|Vitamin A|vitamin a|mesh-list
64763588|NCT04356222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763589|NCT04356222|Dermatologic Agents|dermatologic agents|mesh-ancestor
64763590|NCT04356222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763591|NCT04356222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64763592|NCT04356222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64763593|NCT04356222|Immunologic Factors|immunologic factors|mesh-ancestor
64763594|NCT04356222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763595|NCT04356222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64763596|NCT04356222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64763597|NCT04356144|Thrombin|thrombin|mesh-list
64763598|NCT04356144|Hemostatics|hemostatics|mesh-ancestor
64763599|NCT04356144|Coagulants|coagulants|mesh-ancestor
64763600|NCT04355598|Lidocaine|lidocaine|mesh-list
64763601|NCT04355598|Nitroglycerin|nitroglycerin|mesh-list
64763602|NCT04355598|Prilocaine|prilocaine|mesh-list
64763603|NCT04355598|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64763604|NCT04355598|Anesthetics, Local|anesthetics, local|mesh-ancestor
64763605|NCT04355598|Anesthetics|anesthetics|mesh-ancestor
64763606|NCT04355598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64763607|NCT04355598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763608|NCT04355598|Sensory System Agents|sensory system agents|mesh-ancestor
64763609|NCT04355598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64763610|NCT04355598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64763611|NCT04355598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64763612|NCT04355598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64763613|NCT04355598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64763615|NCT04355598|Vasodilator Agents|vasodilator agents|mesh-ancestor
64763654|NCT04354662|Protective Agents|protective agents|mesh-ancestor
64763655|NCT04354662|Vitamin B Complex|vitamin b complex|mesh-ancestor
64763656|NCT04354662|Vitamins|vitamins|mesh-ancestor
64763657|NCT04354662|Micronutrients|micronutrients|mesh-ancestor
64763658|NCT04354350|Telmisartan|telmisartan|mesh-list
64763659|NCT04354350|Ramipril|ramipril|mesh-list
64763660|NCT04354350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64763661|NCT04354350|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64763662|NCT04354350|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64763663|NCT04354350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763664|NCT04354350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64763665|NCT04354350|Protease Inhibitors|protease inhibitors|mesh-ancestor
64473239|NCT00218062|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64763666|NCT04354350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763667|NCT04353336|Hydroxychloroquine|hydroxychloroquine|mesh-list
64763668|NCT04353336|Chloroquine|chloroquine|mesh-list
64763669|NCT04353336|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64763670|NCT04353336|Antimalarials|antimalarials|mesh-ancestor
64763671|NCT04353336|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64763702|NCT04352400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64763703|NCT04352400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64763704|NCT04352400|Analgesics|analgesics|mesh-ancestor
64763705|NCT04352400|Sensory System Agents|sensory system agents|mesh-ancestor
64763706|NCT04352400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64763707|NCT04352400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763708|NCT04352400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64763709|NCT04352400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763710|NCT04352400|Anticoagulants|anticoagulants|mesh-ancestor
64763711|NCT04352400|Protease Inhibitors|protease inhibitors|mesh-ancestor
64763712|NCT04352400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763713|NCT04352400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763714|NCT04352400|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64763715|NCT04352400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64763744|NCT04350684|Ritonavir|ritonavir|mesh-list
64763745|NCT04350684|Lopinavir|lopinavir|mesh-list
64763746|NCT04350684|Interferon-beta|interferon-beta|mesh-list
64763747|NCT04350684|Interferon beta-1a|interferon beta-1a|mesh-list
64763748|NCT04350684|Hydroxychloroquine|hydroxychloroquine|mesh-list
64763749|NCT04350684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763750|NCT04350684|Antiviral Agents|antiviral agents|mesh-ancestor
64763751|NCT04350684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763752|NCT04350684|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64763753|NCT04350684|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64763754|NCT04350684|Protease Inhibitors|protease inhibitors|mesh-ancestor
64763755|NCT04350684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763756|NCT04350684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763757|NCT04350684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64763758|NCT04350684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64763759|NCT04350684|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64763760|NCT04350684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64763761|NCT04350684|Antimalarials|antimalarials|mesh-ancestor
64763762|NCT04350684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64763763|NCT04350684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64763764|NCT04350684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763765|NCT04350684|Immunologic Factors|immunologic factors|mesh-ancestor
64763766|NCT04350684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763767|NCT04350684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64763768|NCT04350450|Hydroxychloroquine|hydroxychloroquine|mesh-list
64763769|NCT04350450|Antimalarials|antimalarials|mesh-ancestor
64763770|NCT04350450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64763771|NCT04350450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64763772|NCT04350450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763776|NCT04349592|Azithromycin|azithromycin|mesh-list
65495137|NCT05194852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64763817|NCT04345458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64763818|NCT04345458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763819|NCT04345458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64763820|NCT04345458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763821|NCT04345458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64763822|NCT04345458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64763823|NCT04345458|Immunologic Factors|immunologic factors|mesh-ancestor
64763824|NCT04344756|Heparin|heparin|mesh-list
64763825|NCT04344756|Calcium heparin|calcium heparin|mesh-list
64763826|NCT04344756|Tinzaparin|tinzaparin|mesh-list
64763827|NCT04344756|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64763828|NCT04344756|Dalteparin|dalteparin|mesh-list
64763861|NCT04342650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763862|NCT04342650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64763863|NCT04342650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64532591|NCT01553851|Trametinib|trametinib|mesh-list
64763864|NCT04342650|Analgesics|analgesics|mesh-ancestor
64763865|NCT04342650|Sensory System Agents|sensory system agents|mesh-ancestor
64763866|NCT04342650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64763867|NCT04342650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763868|NCT04342650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64763869|NCT04342650|Filaricides|filaricides|mesh-ancestor
64763870|NCT04342650|Antinematodal Agents|antinematodal agents|mesh-ancestor
64763871|NCT04342650|Anthelmintics|anthelmintics|mesh-ancestor
64763872|NCT04341870|Azithromycin|azithromycin|mesh-list
64763873|NCT04341870|Hydroxychloroquine|hydroxychloroquine|mesh-list
64763902|NCT04341402|Hormone Antagonists|hormone antagonists|mesh-ancestor
64763903|NCT04341402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64763904|NCT04341402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64763905|NCT04341402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64763906|NCT04340544|Hydroxychloroquine|hydroxychloroquine|mesh-list
64763918|NCT04340778|Anesthetics, Local|anesthetics, local|mesh-ancestor
64763919|NCT04340778|Anesthetics|anesthetics|mesh-ancestor
64763951|NCT04340388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64763952|NCT04340388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64763953|NCT04340388|Protease Inhibitors|protease inhibitors|mesh-ancestor
64763954|NCT04340388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64763955|NCT04340388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64763956|NCT04338906|Hydroxychloroquine|hydroxychloroquine|mesh-list
64763958|NCT04338906|Antimalarials|antimalarials|mesh-ancestor
64763959|NCT04338906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64763960|NCT04338906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64763961|NCT04338906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763962|NCT04338906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763963|NCT04338906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763964|NCT04338906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763965|NCT04338906|Protease Inhibitors|protease inhibitors|mesh-ancestor
64375705|NCT04900155|Atorvastatin|atorvastatin|mesh-list
64763997|NCT04337268|Hormones|hormones|mesh-ancestor
64763998|NCT04337268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64763999|NCT04337268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764000|NCT04337268|Incretins|incretins|mesh-ancestor
64764001|NCT04336566|Melatonin|melatonin|mesh-list
64764002|NCT04336566|Antioxidants|antioxidants|mesh-ancestor
64764003|NCT04336566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764004|NCT04336566|Protective Agents|protective agents|mesh-ancestor
64764005|NCT04336566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764006|NCT04336566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64764007|NCT04336488|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64764067|NCT04333992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764068|NCT04333992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64764069|NCT04333992|Anesthetics, General|anesthetics, general|mesh-ancestor
64764070|NCT04333992|Anesthetics|anesthetics|mesh-ancestor
64764071|NCT04333992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64724279|NCT00000403|Doxycycline|doxycycline|mesh-list
64724280|NCT00000403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64724281|NCT00000403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724282|NCT00000403|Antimalarials|antimalarials|mesh-ancestor
64724283|NCT00000403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64724284|NCT00000403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64331864|NCT04529772|Prednisone|prednisone|mesh-list
64502042|NCT01900002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502043|NCT01900002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64764072|NCT04333992|Narcotics|narcotics|mesh-ancestor
64764073|NCT04333992|Analgesics|analgesics|mesh-ancestor
64473240|NCT00218062|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64764074|NCT04333992|Sensory System Agents|sensory system agents|mesh-ancestor
64764075|NCT04333992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764076|NCT04333992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64764077|NCT04333992|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64764078|NCT04332978|Fluticasone|fluticasone|mesh-list
64764079|NCT04332978|Xhance|xhance|mesh-list
64764080|NCT04332978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64764081|NCT04332978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64764082|NCT04332978|Autonomic Agents|autonomic agents|mesh-ancestor
64764083|NCT04332978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764084|NCT04332978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764085|NCT04332978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64764086|NCT04332978|Respiratory System Agents|respiratory system agents|mesh-ancestor
64764087|NCT04332978|Dermatologic Agents|dermatologic agents|mesh-ancestor
64764088|NCT04332978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64375827|NCT04893993|Vitamins|vitamins|mesh-ancestor
64764115|NCT04331418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64764116|NCT04331418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64764117|NCT04331418|Adrenergic Agents|adrenergic agents|mesh-ancestor
64764118|NCT04331418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64764119|NCT04331418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764120|NCT04330872|Aspirin|aspirin|mesh-list
64764121|NCT04330872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64764122|NCT04330872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64764123|NCT04330872|Analgesics|analgesics|mesh-ancestor
64764124|NCT04330872|Sensory System Agents|sensory system agents|mesh-ancestor
64764125|NCT04330872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64945707|NCT05298696|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64502044|NCT01900002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502045|NCT01900002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502047|NCT03005002|Ipilimumab|ipilimumab|mesh-list
64502048|NCT03005002|Tremelimumab|tremelimumab|mesh-list
64502049|NCT03005002|Immunoglobulins|immunoglobulins|mesh-list
64502050|NCT03005002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64502051|NCT03005002|Immunoglobulin G|immunoglobulin g|mesh-list
64502052|NCT03005002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64502053|NCT03005002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502054|NCT03005002|Immunologic Factors|immunologic factors|mesh-ancestor
64502055|NCT03005002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502056|NCT03005002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64502057|NCT03005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502058|NCT03001102|Chlorhexidine|chlorhexidine|mesh-list
64502059|NCT03001102|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64764126|NCT04330872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764127|NCT04330872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64764128|NCT04330872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64764129|NCT04330872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64764130|NCT04330872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64764131|NCT04330872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764132|NCT04330872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64764133|NCT04330872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64764134|NCT04330872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764135|NCT04330872|Antipyretics|antipyretics|mesh-ancestor
64764136|NCT04330326|Sorbitol|sorbitol|mesh-list
64764137|NCT04330326|Cathartics|cathartics|mesh-ancestor
64764162|NCT05508594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64764163|NCT05508594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64764164|NCT05508594|Anesthetics, General|anesthetics, general|mesh-ancestor
64764165|NCT05508594|Anesthetics|anesthetics|mesh-ancestor
64764166|NCT05508594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64484204|NCT01730053|Ezetimibe|ezetimibe|mesh-list
64764167|NCT05508594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64764168|NCT05508594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64764169|NCT05508594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64764170|NCT05508594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764171|NCT05508594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64764172|NCT05508594|Narcotics|narcotics|mesh-ancestor
64764173|NCT05508594|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64764174|NCT05417100|Methadone|methadone|mesh-list
64764175|NCT05417100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64764176|NCT05417100|Narcotics|narcotics|mesh-ancestor
64764177|NCT05417100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64764178|NCT05417100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764179|NCT05417100|Analgesics|analgesics|mesh-ancestor
64764224|NCT01326000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64764225|NCT01326000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764226|NCT03035214|Dexamethasone|dexamethasone|mesh-list
65495138|NCT01375426|Amoxicillin|amoxicillin|mesh-list
64473241|NCT00218062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64592955|NCT03844256|Nivolumab|nivolumab|mesh-list
64764227|NCT03035214|Dexamethasone acetate|dexamethasone acetate|mesh-list
64764228|NCT03035214|BB 1101|bb 1101|mesh-list
64764229|NCT03035214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64764257|NCT03033732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764259|NCT03033732|Sensory System Agents|sensory system agents|mesh-ancestor
64764260|NCT03033732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764261|NCT03033732|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64764262|NCT03033732|Antitussive Agents|antitussive agents|mesh-ancestor
64764263|NCT03033732|Respiratory System Agents|respiratory system agents|mesh-ancestor
64764264|NCT03033264|Dinoprostone|dinoprostone|mesh-list
64764265|NCT03033264|Oxytocics|oxytocics|mesh-ancestor
64764266|NCT03033264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64764267|NCT03033264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764268|NCT03033342|Omeprazole|omeprazole|mesh-list
64764269|NCT03033342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64764270|NCT03033342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64764271|NCT03033342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64764272|NCT03033342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764273|NCT03033342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764274|NCT03032484|Bevacizumab|bevacizumab|mesh-list
64764275|NCT03032484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64764276|NCT03032484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764277|NCT03032484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64764278|NCT03032484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64764296|NCT03030690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764311|NCT03029442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64764312|NCT03029442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764313|NCT03023514|Thioctic Acid|thioctic acid|mesh-list
64764314|NCT03023514|Progesterone|progesterone|mesh-list
64764315|NCT03023514|Progestins|progestins|mesh-ancestor
64764316|NCT03023514|Hormones|hormones|mesh-ancestor
64764317|NCT03023514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64764318|NCT03023514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764319|NCT03023514|Antioxidants|antioxidants|mesh-ancestor
64764320|NCT03023514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764321|NCT03023514|Protective Agents|protective agents|mesh-ancestor
64764322|NCT03023514|Vitamin B Complex|vitamin b complex|mesh-ancestor
64764323|NCT03023514|Vitamins|vitamins|mesh-ancestor
64764324|NCT03023514|Micronutrients|micronutrients|mesh-ancestor
64764325|NCT03019926|Hydroxychloroquine|hydroxychloroquine|mesh-list
64764326|NCT03019926|Antimalarials|antimalarials|mesh-ancestor
64764327|NCT03019926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64764328|NCT03019926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64764329|NCT03019926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64764330|NCT03019926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764333|NCT03019848|Curcumin|curcumin|mesh-list
64764495|NCT03014778|Chlorhexidine|chlorhexidine|mesh-list
64764496|NCT03014778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64764497|NCT03014778|Povidone-Iodine|povidone-iodine|mesh-list
64764499|NCT03014778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64764500|NCT03014778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64764501|NCT03014778|Disinfectants|disinfectants|mesh-ancestor
64764502|NCT03014778|Dermatologic Agents|dermatologic agents|mesh-ancestor
64764503|NCT03014778|Plasma Substitutes|plasma substitutes|mesh-ancestor
64764504|NCT03014778|Blood Substitutes|blood substitutes|mesh-ancestor
64764505|NCT03014076|Trastuzumab|trastuzumab|mesh-list
64376242|NCT03046953|Avelumab|avelumab|mesh-list
64764538|NCT03009006|Calcium, Dietary|calcium, dietary|mesh-list
64764540|NCT03009006|Calcium|calcium|mesh-list
64764541|NCT03009006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64764542|NCT03009006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764543|NCT03009006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64764544|NCT03009006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64764545|NCT03009006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64764546|NCT03009006|Disinfectants|disinfectants|mesh-ancestor
64764547|NCT03008148|Temozolomide|temozolomide|mesh-list
64764583|NCT03006042|Sensory System Agents|sensory system agents|mesh-ancestor
64764584|NCT03006042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764585|NCT03005496|Vitamin D|vitamin d|mesh-list
64764620|NCT03005496|Protective Agents|protective agents|mesh-ancestor
64764621|NCT03005496|Provitamins|provitamins|mesh-ancestor
64764622|NCT03005496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64764623|NCT03005496|Chelating Agents|chelating agents|mesh-ancestor
64764624|NCT03005496|Sequestering Agents|sequestering agents|mesh-ancestor
64764625|NCT03005808|Ropivacaine|ropivacaine|mesh-list
64764626|NCT03005808|Anesthetics, Local|anesthetics, local|mesh-ancestor
64764627|NCT03005808|Anesthetics|anesthetics|mesh-ancestor
64764628|NCT03005808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64764699|NCT03002064|Antimitotic Agents|antimitotic agents|mesh-ancestor
64764700|NCT03002064|Mitosis Modulators|mitosis modulators|mesh-ancestor
64764701|NCT03002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764702|NCT03002064|Antimetabolites|antimetabolites|mesh-ancestor
64764703|NCT03002064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64764704|NCT03002064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64764705|NCT03002064|Immunologic Factors|immunologic factors|mesh-ancestor
64764706|NCT03002064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764707|NCT03001128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65495141|NCT05193838|Allopurinol|allopurinol|mesh-list
64764708|NCT03001128|Antiviral Agents|antiviral agents|mesh-ancestor
64764709|NCT03001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64764710|NCT03000660|Dexamethasone|dexamethasone|mesh-list
64764711|NCT03000660|Venetoclax|venetoclax|mesh-list
64764712|NCT03000660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64764713|NCT03000660|Antiemetics|antiemetics|mesh-ancestor
64764714|NCT03000660|Autonomic Agents|autonomic agents|mesh-ancestor
64764715|NCT03000660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764716|NCT03000660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764717|NCT03000660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64764718|NCT03000660|Glucocorticoids|glucocorticoids|mesh-ancestor
64764719|NCT03000660|Hormones|hormones|mesh-ancestor
64764720|NCT03000660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64764721|NCT03000660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64764722|NCT03000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376463|NCT02613507|Nivolumab|nivolumab|mesh-list
64764756|NCT02989272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64764802|NCT02987244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64764803|NCT02987244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64764804|NCT02987244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64764805|NCT02987244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764806|NCT02987244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64764807|NCT02987244|Tubulin Modulators|tubulin modulators|mesh-ancestor
64764808|NCT02987244|Antimitotic Agents|antimitotic agents|mesh-ancestor
64764809|NCT02987244|Mitosis Modulators|mitosis modulators|mesh-ancestor
64764810|NCT02987166|Pembrolizumab|pembrolizumab|mesh-list
64764841|NCT02978976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64764843|NCT02978976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64764844|NCT02978976|Respiratory System Agents|respiratory system agents|mesh-ancestor
64764845|NCT02979132|Iron|iron|mesh-list
64764846|NCT02979132|Trace Elements|trace elements|mesh-ancestor
64764847|NCT02979132|Micronutrients|micronutrients|mesh-ancestor
64764848|NCT02979132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764849|NCT02978040|Tirofiban|tirofiban|mesh-list
64764850|NCT02978040|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64764851|NCT02978040|Cangrelor|cangrelor|mesh-list
64764852|NCT02978040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64764853|NCT02978040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64764854|NCT02978040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64764888|NCT02975076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64764889|NCT02975076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64764942|NCT02959476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764943|NCT02958852|Letrozole|letrozole|mesh-list
64764944|NCT02958852|Fulvestrant|fulvestrant|mesh-list
64764966|NCT02641782|Isotretinoin|isotretinoin|mesh-list
64764967|NCT02641782|Antibodies|antibodies|mesh-list
64764968|NCT02641782|Sargramostim|sargramostim|mesh-list
64764969|NCT02641782|Immunologic Factors|immunologic factors|mesh-ancestor
64764970|NCT02641782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764971|NCT02641782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764972|NCT02641782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64764973|NCT02641782|Analgesics|analgesics|mesh-ancestor
64764974|NCT02641782|Sensory System Agents|sensory system agents|mesh-ancestor
64764975|NCT02641782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764976|NCT02641782|Keratolytic Agents|keratolytic agents|mesh-ancestor
64764977|NCT02641782|Dermatologic Agents|dermatologic agents|mesh-ancestor
64764978|NCT02641782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64764979|NCT02641782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64764980|NCT02641782|Antiviral Agents|antiviral agents|mesh-ancestor
64764981|NCT02641782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64764982|NCT02641314|Celecoxib|celecoxib|mesh-list
64764983|NCT02641314|Propranolol|propranolol|mesh-list
64764984|NCT02641314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764985|NCT02641314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64764986|NCT02641314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765038|NCT04745286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64765039|NCT04745286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64765040|NCT04745286|Anesthetics, General|anesthetics, general|mesh-ancestor
64765041|NCT04745286|Anesthetics|anesthetics|mesh-ancestor
64765042|NCT04745286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64765043|NCT04745286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64765044|NCT04745286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64765045|NCT04745286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64765046|NCT04745286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495142|NCT05193838|Antimetabolites|antimetabolites|mesh-ancestor
64765047|NCT04745286|Antidepressive Agents|antidepressive agents|mesh-ancestor
64765048|NCT04745286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64765078|NCT04739202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64765079|NCT04739202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765080|NCT04739202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64765081|NCT04739202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64765082|NCT04739202|Growth Substances|growth substances|mesh-ancestor
64765249|NCT03527472|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64765250|NCT03527472|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64765251|NCT03297684|Aflibercept|aflibercept|mesh-list
64765252|NCT03297684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64765253|NCT03297684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64765281|NCT01685424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64765282|NCT01685424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765283|NCT01685424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64765284|NCT01685424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64765285|NCT01685424|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64765286|NCT01685424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64765287|NCT01685424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765288|NCT01685424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765290|NCT01327638|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
64765291|NCT01327638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64765292|NCT01327638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64765293|NCT01327638|Analgesics|analgesics|mesh-ancestor
64765294|NCT01327638|Sensory System Agents|sensory system agents|mesh-ancestor
64765295|NCT01327638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64765296|NCT01327638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765297|NCT01327638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64765298|NCT01327638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64765299|NCT01327638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64765332|NCT00588900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64765333|NCT00589056|Nelfinavir|nelfinavir|mesh-list
64765334|NCT00589056|Etoposide|etoposide|mesh-list
64765335|NCT00589056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765336|NCT00589056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64765337|NCT00589056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64765369|NCT00590772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765370|NCT00592176|Bevacizumab|bevacizumab|mesh-list
64765371|NCT00592176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64765372|NCT00592176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765373|NCT00592176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64765374|NCT00592176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64765375|NCT00592176|Growth Substances|growth substances|mesh-ancestor
64765376|NCT00592176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765377|NCT00592176|Growth Inhibitors|growth inhibitors|mesh-ancestor
64765378|NCT00592488|Acetylcarnitine|acetylcarnitine|mesh-list
64765379|NCT00592488|Vitamin B Complex|vitamin b complex|mesh-ancestor
64765381|NCT00592488|Micronutrients|micronutrients|mesh-ancestor
64765382|NCT00592488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765383|NCT00592488|Nootropic Agents|nootropic agents|mesh-ancestor
64765384|NCT00595530|Ketamine|ketamine|mesh-list
64765385|NCT00595530|Analgesics|analgesics|mesh-ancestor
64765386|NCT00595530|Sensory System Agents|sensory system agents|mesh-ancestor
64765387|NCT00595530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64765388|NCT00595530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765389|NCT00595530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64765390|NCT00595530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64765391|NCT00595530|Anesthetics, General|anesthetics, general|mesh-ancestor
64765392|NCT00595530|Anesthetics|anesthetics|mesh-ancestor
64765393|NCT00595530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64765394|NCT00595530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64765395|NCT00595530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64765396|NCT00595530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64765397|NCT00595530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765398|NCT00596622|Lithium Carbonate|lithium carbonate|mesh-list
64765439|NCT00603018|Serotonin Agents|serotonin agents|mesh-ancestor
64765440|NCT00603018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765441|NCT00603018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64765442|NCT00603018|Antidepressive Agents|antidepressive agents|mesh-ancestor
64765443|NCT00603018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64765444|NCT00603018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64377188|NCT04860531|Betamethasone|betamethasone|mesh-list
64765475|NCT00625404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64765476|NCT00625404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765477|NCT00625404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765478|NCT00625404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64765479|NCT00625404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64765480|NCT00626340|Fluoxetine|fluoxetine|mesh-list
64765481|NCT00626340|Estrogens|estrogens|mesh-list
64765482|NCT00626340|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64765483|NCT00626340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64765484|NCT00626340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64765485|NCT00626340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765486|NCT00626340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64765487|NCT00626340|Serotonin Agents|serotonin agents|mesh-ancestor
64377237|NCT01594827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64765523|NCT00632970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64765601|NCT00645450|Vasodilator Agents|vasodilator agents|mesh-ancestor
64765603|NCT00647400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64765604|NCT00647400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64765605|NCT00648648|Gemcitabine|gemcitabine|mesh-list
64765606|NCT00648648|Carboplatin|carboplatin|mesh-list
64765607|NCT00648648|Adavosertib|adavosertib|mesh-list
64765608|NCT00648648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765609|NCT00648648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64765610|NCT00648648|Antimetabolites|antimetabolites|mesh-ancestor
64765611|NCT00648648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765612|NCT00648648|Antiviral Agents|antiviral agents|mesh-ancestor
64765613|NCT00648648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64765614|NCT00648648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765615|NCT00648648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64765616|NCT00648648|Immunologic Factors|immunologic factors|mesh-ancestor
64765617|NCT00648648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765618|NCT00652314|Thrombin|thrombin|mesh-list
64765619|NCT00652314|Hemostatics|hemostatics|mesh-ancestor
64765620|NCT00652314|Coagulants|coagulants|mesh-ancestor
64765621|NCT00654030|Vaccines|vaccines|mesh-list
64765622|NCT00654030|Immunologic Factors|immunologic factors|mesh-ancestor
64765623|NCT00654030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765624|NCT00656448|Epoetin Alfa|epoetin alfa|mesh-list
64765655|NCT00662298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64765656|NCT00662298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765657|NCT00662298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64765658|NCT00662298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765659|NCT00666666|Acetic Acid|acetic acid|mesh-list
64765660|NCT00666666|Bicalutamide|bicalutamide|mesh-list
64765661|NCT00666666|Gossypol acetic acid|gossypol acetic acid|mesh-list
64765662|NCT00666666|Gossypol|gossypol|mesh-list
64765663|NCT00666666|Hormones|hormones|mesh-list
64765664|NCT00666666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64765683|NCT00666978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64765684|NCT00666978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64765685|NCT00666978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765686|NCT00666978|Dopamine Agents|dopamine agents|mesh-ancestor
64765687|NCT00666978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64765688|NCT00666978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765689|NCT00666978|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64765690|NCT00666978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64765691|NCT00666978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765692|NCT00670956|Betamethasone|betamethasone|mesh-list
64765693|NCT00670956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64765694|NCT00670956|Glucocorticoids|glucocorticoids|mesh-ancestor
64765695|NCT00670956|Hormones|hormones|mesh-ancestor
64765696|NCT00670956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64765697|NCT00670956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765698|NCT00670956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64765699|NCT00670956|Respiratory System Agents|respiratory system agents|mesh-ancestor
64765700|NCT00671502|Carisoprodol|carisoprodol|mesh-list
64765701|NCT00671502|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64765702|NCT00671502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765703|NCT00671502|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64765704|NCT00671502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64765705|NCT00671970|Bevacizumab|bevacizumab|mesh-list
64765706|NCT00671970|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64765707|NCT00671970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64765708|NCT00671970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765709|NCT00671970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64765710|NCT00671970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64765711|NCT00671970|Growth Substances|growth substances|mesh-ancestor
64765712|NCT00671970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765713|NCT00671970|Growth Inhibitors|growth inhibitors|mesh-ancestor
64569715|NCT04891458|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64502070|NCT03000946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64502071|NCT03000946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64502072|NCT03000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502073|NCT03000946|Hormones|hormones|mesh-ancestor
64502074|NCT03000946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64502075|NCT03000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765714|NCT00671970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64765715|NCT00671970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765716|NCT00671970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765717|NCT00672204|Sirolimus|sirolimus|mesh-list
64765718|NCT00672204|Thymoglobulin|thymoglobulin|mesh-list
64765719|NCT00672204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64765720|NCT00672204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64765721|NCT00672204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64765722|NCT00672204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64765723|NCT00672204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765724|NCT00672204|Antifungal Agents|antifungal agents|mesh-ancestor
64765725|NCT00672204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64765726|NCT00672204|Immunologic Factors|immunologic factors|mesh-ancestor
64765727|NCT00672204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765728|NCT00672438|Alfentanil|alfentanil|mesh-list
64765729|NCT00672438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64765730|NCT00672438|Narcotics|narcotics|mesh-ancestor
64765731|NCT00672438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64765732|NCT00672438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765733|NCT00672438|Analgesics|analgesics|mesh-ancestor
64765734|NCT00672438|Sensory System Agents|sensory system agents|mesh-ancestor
64765735|NCT00672438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64377467|NCT03201185|Ramipril|ramipril|mesh-list
64765759|NCT00675792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64765760|NCT00675792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765762|NCT00675792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765763|NCT00675792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765764|NCT00675792|Cholinergic Agents|cholinergic agents|mesh-ancestor
64765765|NCT00675792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64765766|NCT00675792|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64765767|NCT00675792|Autonomic Agents|autonomic agents|mesh-ancestor
64765768|NCT00676806|Cyclophosphamide|cyclophosphamide|mesh-list
64765769|NCT00676806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64765770|NCT00676806|Immunologic Factors|immunologic factors|mesh-ancestor
64765771|NCT00676806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765776|NCT00676806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765777|NCT00676806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64765778|NCT00678834|Tocopherols|tocopherols|mesh-list
64765779|NCT00678834|Vitamin E|vitamin e|mesh-list
64765780|NCT00678834|Tocotrienols|tocotrienols|mesh-list
64765781|NCT00678834|alpha-Tocopherol|alpha-tocopherol|mesh-list
64765782|NCT00678834|Antioxidants|antioxidants|mesh-ancestor
64765783|NCT00678834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765784|NCT00678834|Protective Agents|protective agents|mesh-ancestor
64765785|NCT00678834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765786|NCT00678834|Vitamins|vitamins|mesh-ancestor
64765820|NCT00682734|Histamine Agents|histamine agents|mesh-ancestor
64765821|NCT00682734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64765822|NCT00682734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765823|NCT00682734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64765825|NCT00682734|Dermatologic Agents|dermatologic agents|mesh-ancestor
64765826|NCT00682734|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64765827|NCT00682734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64765828|NCT00682734|Dopamine Agents|dopamine agents|mesh-ancestor
64765829|NCT00683046|Fludarabine|fludarabine|mesh-list
64765830|NCT00683046|Melphalan|melphalan|mesh-list
64765831|NCT00683046|Alemtuzumab|alemtuzumab|mesh-list
64765832|NCT00683046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765859|NCT00690924|Vitamins|vitamins|mesh-ancestor
64765954|NCT00706446|Cholinergic Agents|cholinergic agents|mesh-ancestor
64765955|NCT00706446|Anticonvulsants|anticonvulsants|mesh-ancestor
64765956|NCT00706836|Pregabalin|pregabalin|mesh-list
64765957|NCT00706836|Analgesics|analgesics|mesh-ancestor
64765958|NCT00706836|Sensory System Agents|sensory system agents|mesh-ancestor
64765959|NCT00706836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64765960|NCT00706836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765961|NCT00706836|Anticonvulsants|anticonvulsants|mesh-ancestor
64765962|NCT00706836|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64765963|NCT00706836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64765964|NCT00706836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377712|NCT04854759|Analgesics|analgesics|mesh-ancestor
64765999|NCT00715884|Sirolimus|sirolimus|mesh-list
64766000|NCT00715884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64766001|NCT00715884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64766002|NCT00715884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64766003|NCT00715884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766004|NCT00715884|Antifungal Agents|antifungal agents|mesh-ancestor
64766005|NCT00715884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64766034|NCT00717054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64766035|NCT00717054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766036|NCT00717054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64766037|NCT00717054|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64766038|NCT00717054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64766039|NCT00717054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766040|NCT00717054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64766041|NCT00717054|Mydriatics|mydriatics|mesh-ancestor
64766092|NCT00724464|Antimetabolites|antimetabolites|mesh-ancestor
64766093|NCT00724464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766094|NCT00724464|Immunologic Factors|immunologic factors|mesh-ancestor
64766095|NCT00724464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766096|NCT00726414|Quinine|quinine|mesh-list
64766097|NCT00726414|Antimalarials|antimalarials|mesh-ancestor
64766098|NCT00726414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64766099|NCT00726414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64766133|NCT00728910|Vitamin B Complex|vitamin b complex|mesh-ancestor
64766135|NCT00728910|Micronutrients|micronutrients|mesh-ancestor
64766136|NCT00728910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766138|NCT00729846|Verteporfin|verteporfin|mesh-list
64377889|NCT04365933|Interferons|interferons|mesh-list
64766170|NCT00733278|Copper|copper|mesh-list
64766171|NCT00733278|Contraceptive Agents|contraceptive agents|mesh-list
64766172|NCT00733278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64766173|NCT00733278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766174|NCT00733278|Trace Elements|trace elements|mesh-ancestor
64766175|NCT00733278|Micronutrients|micronutrients|mesh-ancestor
64766176|NCT00733356|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64766177|NCT00733356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64766178|NCT00733356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766179|NCT00733356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64766180|NCT00733356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64766202|NCT00735462|Interferon Inducers|interferon inducers|mesh-ancestor
64766208|NCT00736632|Vitamin D|vitamin d|mesh-list
64713985|NCT03041636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766230|NCT00741468|Caffeine|caffeine|mesh-list
64766231|NCT00741468|Omeprazole|omeprazole|mesh-list
64766232|NCT00741468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64766233|NCT00741468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64766265|NCT00741858|Hormones|hormones|mesh-ancestor
64766266|NCT00741858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64766267|NCT00741858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766268|NCT00741858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64766269|NCT00741858|Contraceptive Agents|contraceptive agents|mesh-ancestor
64766270|NCT00741858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64766271|NCT00741858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64766272|NCT00742872|Mosapride|mosapride|mesh-list
64766273|NCT00742872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766274|NCT00742872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64766275|NCT00742872|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64766276|NCT00742872|Serotonin Agents|serotonin agents|mesh-ancestor
64766310|NCT00745290|Anesthetics|anesthetics|mesh-ancestor
64766311|NCT00745290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64766312|NCT00745290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766313|NCT00745290|Sensory System Agents|sensory system agents|mesh-ancestor
64766314|NCT00745290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64766315|NCT00751530|Raltegravir Potassium|raltegravir potassium|mesh-list
64766316|NCT00751530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64766317|NCT00751530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64766318|NCT00751530|Antiviral Agents|antiviral agents|mesh-ancestor
64766348|NCT00755040|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64766349|NCT00755274|Vaccines|vaccines|mesh-list
64766350|NCT00755274|Immunologic Factors|immunologic factors|mesh-ancestor
64766351|NCT00755274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766352|NCT00756600|Anesthetics|anesthetics|mesh-list
64766394|NCT00759798|Immunologic Factors|immunologic factors|mesh-ancestor
64766395|NCT00759798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766396|NCT00759798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64766397|NCT00759798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64766398|NCT00759798|Alkylating Agents|alkylating agents|mesh-ancestor
64766399|NCT00759798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766400|NCT00759798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766401|NCT00759798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64766402|NCT00759798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64766403|NCT00760578|Pioglitazone|pioglitazone|mesh-list
64766431|NCT00762450|Protective Agents|protective agents|mesh-ancestor
64766432|NCT00762450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766433|NCT00762450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64766434|NCT00762450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64766435|NCT00762450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64766436|NCT00762450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64766438|NCT00762450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766439|NCT00762450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64766440|NCT00762528|Triclosan|triclosan|mesh-list
64766441|NCT00762528|Fluorides|fluorides|mesh-list
64766442|NCT00762528|Fluorophosphate|fluorophosphate|mesh-list
64766443|NCT00762528|Cariostatic Agents|cariostatic agents|mesh-ancestor
64766444|NCT00762528|Protective Agents|protective agents|mesh-ancestor
64766445|NCT00762528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766446|NCT00762528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64766447|NCT00762528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64766448|NCT00762528|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64766449|NCT00762528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64766450|NCT00762528|Antimetabolites|antimetabolites|mesh-ancestor
64766451|NCT00762528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766493|NCT00769392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64766494|NCT00769392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64766527|NCT00784524|Analgesics|analgesics|mesh-ancestor
64766528|NCT00784524|Sensory System Agents|sensory system agents|mesh-ancestor
64766529|NCT00784524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64766530|NCT00784524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766531|NCT00784524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64766532|NCT00784524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64766533|NCT00784524|Antiviral Agents|antiviral agents|mesh-ancestor
64766534|NCT00784524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64766535|NCT00785772|Gabapentin|gabapentin|mesh-list
64766536|NCT00785772|Analgesics|analgesics|mesh-ancestor
64766537|NCT00785772|Sensory System Agents|sensory system agents|mesh-ancestor
64766538|NCT00785772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64766576|NCT00787722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64766603|NCT00788892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766604|NCT00788892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64766605|NCT00788892|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64766606|NCT00788892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64766608|NCT00789672|Levodopa|levodopa|mesh-list
64766609|NCT00789672|Carbidopa|carbidopa|mesh-list
64766610|NCT00789672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64766611|NCT00789672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64766612|NCT00789672|Dopamine Agents|dopamine agents|mesh-ancestor
64766617|NCT00789672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766669|NCT00793650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766670|NCT00795210|Hormones|hormones|mesh-list
64766671|NCT00795210|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
64378399|NCT01667679|Serotonin Agents|serotonin agents|mesh-ancestor
64766703|NCT00796302|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64766704|NCT00796302|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64766705|NCT00796302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64766706|NCT00796302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64766708|NCT00796926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64766709|NCT00798018|Lidocaine|lidocaine|mesh-list
64766710|NCT00798018|Tetracaine|tetracaine|mesh-list
64766711|NCT00798018|Anesthetics, Local|anesthetics, local|mesh-ancestor
64766712|NCT00798018|Anesthetics|anesthetics|mesh-ancestor
65495144|NCT05193838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495145|NCT05193838|Gout Suppressants|gout suppressants|mesh-ancestor
64473246|NCT00218062|Dopamine Agents|dopamine agents|mesh-ancestor
64766713|NCT00798018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64766760|NCT00801684|Respiratory System Agents|respiratory system agents|mesh-ancestor
64766761|NCT00801684|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64766762|NCT00801684|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64766763|NCT00801684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64766764|NCT00801684|Adrenergic Agents|adrenergic agents|mesh-ancestor
64766765|NCT00801684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64766766|NCT00801684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766767|NCT00801684|Luteolytic Agents|luteolytic agents|mesh-ancestor
64766768|NCT00801684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64766769|NCT00801684|Contraceptive Agents|contraceptive agents|mesh-ancestor
64766770|NCT00801684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64766771|NCT00801684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64766772|NCT00801684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64766773|NCT00801684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766775|NCT00803010|Methotrexate|methotrexate|mesh-list
64766776|NCT00803010|Tacrolimus|tacrolimus|mesh-list
64766777|NCT00803010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64766782|NCT00803010|Antimetabolites|antimetabolites|mesh-ancestor
64766783|NCT00803010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766784|NCT00803010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766785|NCT00803010|Dermatologic Agents|dermatologic agents|mesh-ancestor
64766786|NCT00803010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766787|NCT00803010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64766788|NCT00803010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64766789|NCT00803010|Immunologic Factors|immunologic factors|mesh-ancestor
64766790|NCT00803010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64766791|NCT00803010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64766792|NCT00803010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64766793|NCT00803010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64766794|NCT00803010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64766795|NCT00803010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64766796|NCT00803010|Antifungal Agents|antifungal agents|mesh-ancestor
64766797|NCT00803400|Alprazolam|alprazolam|mesh-list
64766798|NCT00803400|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64766799|NCT00803400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64766800|NCT00803400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766801|NCT00803400|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64766802|NCT00803400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64766803|NCT00803400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64766804|NCT00803400|GABA Modulators|gaba modulators|mesh-ancestor
64766930|NCT05209620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766931|NCT05209620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64766932|NCT05209620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64766933|NCT05206812|Durvalumab|durvalumab|mesh-list
64766934|NCT05206812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64766935|NCT05206812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766936|NCT05131152|Cyclosporine|cyclosporine|mesh-list
64766937|NCT05131152|Cyclosporins|cyclosporins|mesh-list
64766938|NCT05131152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766992|NCT00142272|Ciprofloxacin|ciprofloxacin|mesh-list
64766993|NCT00142272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64766994|NCT00142272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64766995|NCT00142272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64766996|NCT00142272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64766997|NCT00142272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766998|NCT00142272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766999|NCT00142272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767000|NCT00142272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64767001|NCT00142272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64767002|NCT00821886|Carboplatin|carboplatin|mesh-list
64767003|NCT00821886|Trastuzumab|trastuzumab|mesh-list
64767004|NCT00821886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767005|NCT00821886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64767006|NCT00821964|Paclitaxel|paclitaxel|mesh-list
64767007|NCT00821964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64767008|NCT00821964|Imiquimod|imiquimod|mesh-list
64767009|NCT00821964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64767010|NCT00821964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767011|NCT00821964|Tubulin Modulators|tubulin modulators|mesh-ancestor
64767012|NCT00821964|Antimitotic Agents|antimitotic agents|mesh-ancestor
64767013|NCT00821964|Mitosis Modulators|mitosis modulators|mesh-ancestor
64378743|NCT04389411|Montelukast|montelukast|mesh-list
64767051|NCT00824460|Chelating Agents|chelating agents|mesh-ancestor
64767052|NCT00824460|Sequestering Agents|sequestering agents|mesh-ancestor
64767084|NCT00830076|Incretins|incretins|mesh-ancestor
64767085|NCT00830076|Hormones|hormones|mesh-ancestor
64502076|NCT03004768|BMS-986165|bms-986165|mesh-list
64767089|NCT00830076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64767090|NCT00830076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767091|NCT00830388|Ketoconazole|ketoconazole|mesh-list
64767092|NCT00830388|Antifungal Agents|antifungal agents|mesh-ancestor
64767093|NCT00830388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64767094|NCT00830388|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64767126|NCT00832338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64767127|NCT00832338|Immunologic Factors|immunologic factors|mesh-ancestor
64767128|NCT00832338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64767129|NCT00832338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64767130|NCT00832338|Alkylating Agents|alkylating agents|mesh-ancestor
64767131|NCT00832338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64767133|NCT00834210|Dapsone|dapsone|mesh-list
64767134|NCT00834210|Tazarotene|tazarotene|mesh-list
64767135|NCT00834210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64767153|NCT00834288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64767154|NCT00834288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767156|NCT00834288|Sensory System Agents|sensory system agents|mesh-ancestor
64767157|NCT00834288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64767158|NCT00834678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64767159|NCT00834678|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64767160|NCT00834678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767161|NCT00834678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64767162|NCT00834678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64767163|NCT00834678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767164|NCT00834678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64767185|NCT00837252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767186|NCT00837252|Hormone Antagonists|hormone antagonists|mesh-ancestor
64767187|NCT00837252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64767188|NCT00837252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767189|NCT00837252|Urological Agents|urological agents|mesh-ancestor
64767190|NCT00839982|Cytarabine|cytarabine|mesh-list
64767191|NCT00839982|Clofarabine|clofarabine|mesh-list
64767192|NCT00839982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64767193|NCT00839982|Antimetabolites|antimetabolites|mesh-ancestor
64767224|NCT00848016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64767225|NCT00848016|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
64767226|NCT00848016|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
64767228|NCT00849810|Nebivolol|nebivolol|mesh-list
64767229|NCT00849810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64767230|NCT00849810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64767231|NCT00849810|Sympatholytics|sympatholytics|mesh-ancestor
64767232|NCT00849810|Autonomic Agents|autonomic agents|mesh-ancestor
64767233|NCT00849810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64767234|NCT00849810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767235|NCT00849810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64767236|NCT00849810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64767237|NCT00849810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64378971|NCT02445599|Analgesics|analgesics|mesh-ancestor
64767268|NCT00868140|Pioglitazone|pioglitazone|mesh-list
64767269|NCT00868140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64767270|NCT00868140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767271|NCT00868374|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64767272|NCT00868374|Antidepressive Agents|antidepressive agents|mesh-ancestor
64767273|NCT00868374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64767274|NCT00868374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64767275|NCT00868374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64767276|NCT00868374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64767277|NCT00868374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767307|NCT00869622|Micronutrients|micronutrients|mesh-ancestor
64767308|NCT00869622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767309|NCT00869622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64767310|NCT00869622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64767311|NCT00869622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64767312|NCT00869622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64767313|NCT00869622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767314|NCT00871260|Regadenoson|regadenoson|mesh-list
64767315|NCT00871260|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64767316|NCT00871260|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64767317|NCT00871260|Purinergic Agonists|purinergic agonists|mesh-ancestor
64767318|NCT00871260|Purinergic Agents|purinergic agents|mesh-ancestor
64767319|NCT00871260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64767320|NCT00871260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767321|NCT00871260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767322|NCT00874614|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64767323|NCT00874614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767324|NCT00874614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64767325|NCT00874614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473247|NCT00218062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64767326|NCT00874614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64767327|NCT00875550|Fentanyl|fentanyl|mesh-list
64767328|NCT00875550|Midazolam|midazolam|mesh-list
64767329|NCT00875550|Dexmedetomidine|dexmedetomidine|mesh-list
64767330|NCT00875550|Morphine|morphine|mesh-list
64767331|NCT00875550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64767332|NCT00875550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64767333|NCT00875550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767363|NCT00878436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64767366|NCT00878826|Anticoagulants|anticoagulants|mesh-ancestor
64767377|NCT00879060|Natriuretic Agents|natriuretic agents|mesh-ancestor
64767378|NCT00882102|Decitabine|decitabine|mesh-list
64767414|NCT00887562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767415|NCT00887562|Protective Agents|protective agents|mesh-ancestor
64767416|NCT00887562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767417|NCT00887562|Micronutrients|micronutrients|mesh-ancestor
64767418|NCT00887640|Diphenhydramine|diphenhydramine|mesh-list
64767419|NCT00887640|Promethazine|promethazine|mesh-list
64767449|NCT00889200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64767451|NCT00892710|Bevacizumab|bevacizumab|mesh-list
64767452|NCT00892710|Carboplatin|carboplatin|mesh-list
64767453|NCT00892710|Pemetrexed|pemetrexed|mesh-list
64767454|NCT00892710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64767455|NCT00892710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767456|NCT00892710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64767457|NCT00892710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64767458|NCT00892710|Growth Substances|growth substances|mesh-ancestor
64767459|NCT00892710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767460|NCT00892710|Growth Inhibitors|growth inhibitors|mesh-ancestor
64767461|NCT00892710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64767463|NCT00892710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64767597|NCT00911742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767598|NCT00911742|Analgesics|analgesics|mesh-ancestor
64767599|NCT00911742|Sensory System Agents|sensory system agents|mesh-ancestor
64767600|NCT00911742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64767601|NCT00912990|Cisatracurium|cisatracurium|mesh-list
64767602|NCT00912990|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64767603|NCT00912990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64767604|NCT00912990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64767605|NCT00912990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767606|NCT00913068|Lidocaine|lidocaine|mesh-list
64767607|NCT00913068|Ropivacaine|ropivacaine|mesh-list
64767608|NCT00913068|Anesthetics, Local|anesthetics, local|mesh-ancestor
64767609|NCT00913068|Anesthetics|anesthetics|mesh-ancestor
64767610|NCT00913068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64767611|NCT00913068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767612|NCT00913068|Sensory System Agents|sensory system agents|mesh-ancestor
64767613|NCT00913068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64767614|NCT00913068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64767615|NCT00913068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64767616|NCT00913068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64767617|NCT00913068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64767618|NCT00913068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767619|NCT00916032|Factor VIII|factor viii|mesh-list
64767620|NCT00916032|Coagulants|coagulants|mesh-ancestor
64767621|NCT00922194|Metformin|metformin|mesh-list
64767622|NCT00922194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64767623|NCT00922194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767624|NCT00923910|Acetaminophen|acetaminophen|mesh-list
64767625|NCT00923910|Diphenhydramine|diphenhydramine|mesh-list
64767626|NCT00923910|Promethazine|promethazine|mesh-list
64767627|NCT00923910|Interleukin-4|interleukin-4|mesh-list
64767628|NCT00923910|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
64767629|NCT00923910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64767674|NCT00925782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64767675|NCT00925782|Alkylating Agents|alkylating agents|mesh-ancestor
64379416|NCT04331691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767711|NCT00928200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64767712|NCT00928200|Antiemetics|antiemetics|mesh-ancestor
64767713|NCT00928200|Autonomic Agents|autonomic agents|mesh-ancestor
64767714|NCT00928200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64767715|NCT00928200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767716|NCT00928200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64767717|NCT00928200|Glucocorticoids|glucocorticoids|mesh-ancestor
64767719|NCT00928200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64767774|NCT00931242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64767775|NCT00931242|Growth Substances|growth substances|mesh-ancestor
64767776|NCT00931242|Growth Inhibitors|growth inhibitors|mesh-ancestor
64767777|NCT00931242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767778|NCT00932022|Trospium chloride|trospium chloride|mesh-list
64767800|NCT00939120|Cholinergic Agents|cholinergic agents|mesh-ancestor
64767801|NCT00939120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64767802|NCT00939120|Urological Agents|urological agents|mesh-ancestor
64767803|NCT00939900|Zoledronic Acid|zoledronic acid|mesh-list
64767804|NCT00939900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64767805|NCT00939900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767806|NCT00943098|Diclofenac|diclofenac|mesh-list
64767807|NCT00943098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64767808|NCT00943098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64767809|NCT00943098|Analgesics|analgesics|mesh-ancestor
64767810|NCT00943098|Sensory System Agents|sensory system agents|mesh-ancestor
64767811|NCT00943098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64767812|NCT00943098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767813|NCT00943098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64767814|NCT00943098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65495149|NCT05193838|Protective Agents|protective agents|mesh-ancestor
64767818|NCT00943800|Vidarabine|vidarabine|mesh-list
64767825|NCT00943800|Thymoglobulin|thymoglobulin|mesh-list
64767826|NCT00943800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767827|NCT00943800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64767828|NCT00943800|Antimetabolites|antimetabolites|mesh-ancestor
64767829|NCT00943800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767830|NCT00943800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64767865|NCT00948090|Etoposide|etoposide|mesh-list
64767866|NCT00948090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64767867|NCT00948090|Immunologic Factors|immunologic factors|mesh-ancestor
64767868|NCT00948090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767869|NCT00948090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64767870|NCT00948090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64767871|NCT00948090|Alkylating Agents|alkylating agents|mesh-ancestor
64379608|NCT02148250|Insulin|insulin|mesh-list
64767936|NCT00973752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64767937|NCT00973752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64767938|NCT00973752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767939|NCT00973752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64767940|NCT00973752|Glucocorticoids|glucocorticoids|mesh-ancestor
64767941|NCT00973752|Hormones|hormones|mesh-ancestor
64767942|NCT00973752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64767943|NCT00973752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767944|NCT00973752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64767945|NCT00973752|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64767964|NCT00974142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64767965|NCT00974142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767966|NCT00974142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64767967|NCT00974142|Immunologic Factors|immunologic factors|mesh-ancestor
64767968|NCT00974142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767969|NCT00974142|Antifungal Agents|antifungal agents|mesh-ancestor
64767982|NCT00974376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64767983|NCT00974376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64767984|NCT00974376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64767985|NCT00974376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64767986|NCT00974376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64767987|NCT00974376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767988|NCT00974376|Antimanic Agents|antimanic agents|mesh-ancestor
64767989|NCT00976248|Everolimus|everolimus|mesh-list
64767990|NCT00976248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767991|NCT00976248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64767992|NCT00976248|Immunologic Factors|immunologic factors|mesh-ancestor
64767993|NCT00976248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767994|NCT00976404|Raltegravir Potassium|raltegravir potassium|mesh-list
64767995|NCT00976404|Maraviroc|maraviroc|mesh-list
64767997|NCT00976404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64767998|NCT00976404|Antiviral Agents|antiviral agents|mesh-ancestor
64767999|NCT00976404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64768000|NCT00976404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64768001|NCT00976404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64768002|NCT00976404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768003|NCT00976404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768055|NCT00987948|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64768056|NCT00989586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64768092|NCT00997620|Autonomic Agents|autonomic agents|mesh-ancestor
64768093|NCT00997620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64768094|NCT00997620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768095|NCT00997620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64768096|NCT00997620|Respiratory System Agents|respiratory system agents|mesh-ancestor
64768097|NCT00997620|Dermatologic Agents|dermatologic agents|mesh-ancestor
64768098|NCT00997620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64768099|NCT00997932|Contraceptive Agents|contraceptive agents|mesh-list
64768100|NCT00997932|Levonorgestrel|levonorgestrel|mesh-list
64768101|NCT00997932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64768126|NCT00999102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768127|NCT00999102|Vasodilator Agents|vasodilator agents|mesh-ancestor
64768128|NCT00999102|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64768129|NCT00999102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64768130|NCT00999102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64768131|NCT01000818|Raltegravir Potassium|raltegravir potassium|mesh-list
64768133|NCT01000818|Famotidine|famotidine|mesh-list
64768134|NCT01000818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64502077|NCT03004768|Dermatologic Agents|dermatologic agents|mesh-ancestor
64502078|NCT03004768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64502079|NCT03004768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502080|NCT03004768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502081|NCT03005236|Tacrolimus|tacrolimus|mesh-list
64502082|NCT03005236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64502083|NCT03005236|Immunologic Factors|immunologic factors|mesh-ancestor
64502084|NCT03005236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502085|NCT03005236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64502086|NCT03005236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502087|NCT03005236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502088|NCT03363204|Salicylic Acid|salicylic acid|mesh-list
64502089|NCT03363204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64502090|NCT03363204|Antifungal Agents|antifungal agents|mesh-ancestor
64502091|NCT03363204|Keratolytic Agents|keratolytic agents|mesh-ancestor
64502092|NCT03363204|Dermatologic Agents|dermatologic agents|mesh-ancestor
64502093|NCT02519010|Amlodipine|amlodipine|mesh-list
64502094|NCT02519010|Valsartan|valsartan|mesh-list
64502095|NCT02519010|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
64502096|NCT02519010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64502097|NCT02519010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64502098|NCT02519010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64502099|NCT02519010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502100|NCT02519010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64502101|NCT02519010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502102|NCT02519010|Vasodilator Agents|vasodilator agents|mesh-ancestor
64502103|NCT02519010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64502104|NCT02519010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64502112|NCT03004612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64502113|NCT03004612|Protease Inhibitors|protease inhibitors|mesh-ancestor
64502114|NCT03004612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502115|NCT03004612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768135|NCT01000818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64768136|NCT01000818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64768137|NCT01000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768138|NCT01000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768139|NCT01000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64768140|NCT01000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64768141|NCT01000818|Antiviral Agents|antiviral agents|mesh-ancestor
64768142|NCT01000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64768143|NCT01000818|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64768144|NCT01000818|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64768145|NCT01000818|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64768146|NCT01000818|Histamine Antagonists|histamine antagonists|mesh-ancestor
64768147|NCT01000818|Histamine Agents|histamine agents|mesh-ancestor
64768148|NCT01000818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64768149|NCT01000818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768150|NCT01001052|Colchicine|colchicine|mesh-list
64768151|NCT01001052|Gout Suppressants|gout suppressants|mesh-ancestor
64768239|NCT01008462|Fludarabine phosphate|fludarabine phosphate|mesh-list
64768240|NCT01008462|Etoposide|etoposide|mesh-list
64768241|NCT01008462|Etoposide phosphate|etoposide phosphate|mesh-list
64768242|NCT01008462|Podophyllotoxin|podophyllotoxin|mesh-list
64768243|NCT01008462|Tacrolimus|tacrolimus|mesh-list
64768244|NCT01008462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64768245|NCT01008462|Immunologic Factors|immunologic factors|mesh-ancestor
65495150|NCT05193838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495151|NCT05193604|Gemcitabine|gemcitabine|mesh-list
65495152|NCT05193604|Paclitaxel|paclitaxel|mesh-list
64473251|NCT00218062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64594393|NCT03087968|Hormones|hormones|mesh-ancestor
64768297|NCT01015170|Antidepressive Agents|antidepressive agents|mesh-ancestor
64768298|NCT01015170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64768299|NCT01015170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64380036|NCT02105116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64768328|NCT01018134|Glucocorticoids|glucocorticoids|mesh-ancestor
64768329|NCT01018134|Hormones|hormones|mesh-ancestor
64768330|NCT01018134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64768331|NCT01018134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768332|NCT01020006|Gemcitabine|gemcitabine|mesh-list
64768333|NCT01020006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64768334|NCT01020006|Antimetabolites|antimetabolites|mesh-ancestor
64768335|NCT01020006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768336|NCT01020006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768337|NCT01020006|Antiviral Agents|antiviral agents|mesh-ancestor
64768338|NCT01020006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64768339|NCT01020006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768340|NCT01020006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64768341|NCT01020006|Immunologic Factors|immunologic factors|mesh-ancestor
64768342|NCT01020006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768343|NCT05395962|Carboplatin|carboplatin|mesh-list
64768374|NCT04147416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768375|NCT04147416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64768376|NCT04147416|Anesthetics, General|anesthetics, general|mesh-ancestor
64768377|NCT04147416|Anesthetics|anesthetics|mesh-ancestor
64570579|NCT04120259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502116|NCT04527042|Rivaroxaban|rivaroxaban|mesh-list
64502117|NCT04527042|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64502118|NCT04527042|Antithrombins|antithrombins|mesh-ancestor
64945708|NCT05298696|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64502119|NCT04527042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64502120|NCT04527042|Protease Inhibitors|protease inhibitors|mesh-ancestor
64502121|NCT04527042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502122|NCT04527042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502123|NCT04527042|Anticoagulants|anticoagulants|mesh-ancestor
64502124|NCT03372486|Bupivacaine|bupivacaine|mesh-list
64502143|NCT05035888|Nasal Decongestants|nasal decongestants|mesh-ancestor
64502144|NCT05035888|Respiratory System Agents|respiratory system agents|mesh-ancestor
64502145|NCT05035888|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64502146|NCT05035888|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64502147|NCT05035888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64502148|NCT05035888|Adrenergic Agents|adrenergic agents|mesh-ancestor
64502149|NCT05035888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64502150|NCT05035888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502151|NCT05035888|Protective Agents|protective agents|mesh-ancestor
64502152|NCT03362814|Ritonavir|ritonavir|mesh-list
64502153|NCT03362814|Ribavirin|ribavirin|mesh-list
64502154|NCT03362814|Lactams|lactams|mesh-list
64502155|NCT03362814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64502156|NCT03362814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64768378|NCT04098432|Nivolumab|nivolumab|mesh-list
64768379|NCT04098432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64768380|NCT04098432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768381|NCT04098432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64768382|NCT04098432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768383|NCT02662062|Pembrolizumab|pembrolizumab|mesh-list
64768384|NCT02662062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768385|NCT02662062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64768386|NCT02406222|Dexamethasone|dexamethasone|mesh-list
64768387|NCT02406222|Cyclophosphamide|cyclophosphamide|mesh-list
64768388|NCT02406222|Pomalidomide|pomalidomide|mesh-list
64768389|NCT02406222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64768390|NCT02406222|Immunologic Factors|immunologic factors|mesh-ancestor
64768413|NCT00458796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768414|NCT01022190|Etoricoxib|etoricoxib|mesh-list
64768415|NCT01022190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64768416|NCT01022190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64768417|NCT01022190|Analgesics|analgesics|mesh-ancestor
64768418|NCT01022190|Sensory System Agents|sensory system agents|mesh-ancestor
64768419|NCT01022190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64768420|NCT01022190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768421|NCT01022190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64768422|NCT01022190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64570606|NCT05256342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64502157|NCT03362814|Protease Inhibitors|protease inhibitors|mesh-ancestor
64502158|NCT03362814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502159|NCT03362814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502160|NCT03362814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64502161|NCT03362814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64502162|NCT03362814|Antiviral Agents|antiviral agents|mesh-ancestor
64502163|NCT03362814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64502164|NCT03362814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64502165|NCT03362814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64502166|NCT03362814|Antimetabolites|antimetabolites|mesh-ancestor
64502167|NCT03362814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64502168|NCT03004066|Daptomycin|daptomycin|mesh-list
64502169|NCT03004066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64502170|NCT03004066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64502171|NCT03362736|Ustekinumab|ustekinumab|mesh-list
64502172|NCT03362736|Dermatologic Agents|dermatologic agents|mesh-ancestor
64502173|NCT03004222|Bupivacaine|bupivacaine|mesh-list
64502174|NCT03004222|Anesthetics, Local|anesthetics, local|mesh-ancestor
64502175|NCT03004222|Anesthetics|anesthetics|mesh-ancestor
64502176|NCT03004222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64502177|NCT03004222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502178|NCT03004222|Sensory System Agents|sensory system agents|mesh-ancestor
64502179|NCT03004222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502180|NCT03000634|Dexamethasone|dexamethasone|mesh-list
64502181|NCT03000634|Lenalidomide|lenalidomide|mesh-list
64502182|NCT03000634|Bortezomib|bortezomib|mesh-list
64502183|NCT03000634|Elotuzumab|elotuzumab|mesh-list
64502184|NCT03000634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64768423|NCT01022190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64768424|NCT01022190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64768425|NCT01022190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768426|NCT01022190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768427|NCT01024686|Vaccines|vaccines|mesh-list
65495153|NCT05193604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65495154|NCT05193604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495155|NCT05193604|Tubulin Modulators|tubulin modulators|mesh-ancestor
64594443|NCT02405078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64768428|NCT01024686|Immunologic Factors|immunologic factors|mesh-ancestor
64768429|NCT01024686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768430|NCT01027806|Montelukast|montelukast|mesh-list
64768431|NCT01027806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64768432|NCT01027806|Respiratory System Agents|respiratory system agents|mesh-ancestor
64768433|NCT01027806|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64768434|NCT01027806|Hormone Antagonists|hormone antagonists|mesh-ancestor
64768435|NCT01027806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64768436|NCT01027806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768437|NCT01027806|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64768438|NCT01027806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64768439|NCT01027806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768472|NCT01029054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768473|NCT01029054|Protease Inhibitors|protease inhibitors|mesh-ancestor
64768474|NCT01029054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768475|NCT01029054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768476|NCT01029054|Immunologic Factors|immunologic factors|mesh-ancestor
64768477|NCT01029054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64768478|NCT01029054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64768479|NCT01029054|Growth Substances|growth substances|mesh-ancestor
64768480|NCT01029054|Growth Inhibitors|growth inhibitors|mesh-ancestor
64768481|NCT01032954|Botulinum Toxins|botulinum toxins|mesh-list
64768523|NCT04780932|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64768525|NCT04316910|Anesthetics, General|anesthetics, general|mesh-list
64380259|NCT05128773|Tamoxifen|tamoxifen|mesh-list
64768553|NCT01034592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64768554|NCT01034592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64768555|NCT01034592|Growth Substances|growth substances|mesh-ancestor
64768556|NCT01034592|Growth Inhibitors|growth inhibitors|mesh-ancestor
64768557|NCT01034592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768559|NCT01037790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768560|NCT01037790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64768561|NCT01037790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768562|NCT01037790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768563|NCT01043094|Pitavastatin|pitavastatin|mesh-list
64768564|NCT01043094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64768565|NCT01043094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64768566|NCT01043094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64768567|NCT01043094|Antimetabolites|antimetabolites|mesh-ancestor
64768568|NCT01043094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570674|NCT04126733|Nivolumab|nivolumab|mesh-list
64502185|NCT03000634|Antiemetics|antiemetics|mesh-ancestor
64724305|NCT00000841|Lamivudine|lamivudine|mesh-list
64724306|NCT00000841|Zidovudine|zidovudine|mesh-list
64724307|NCT00000841|Stavudine|stavudine|mesh-list
64502200|NCT02520102|Sargramostim|sargramostim|mesh-list
64502201|NCT02520102|Immunologic Factors|immunologic factors|mesh-ancestor
64502202|NCT02520102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502203|NCT03000556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64502204|NCT03000556|Hyaluronic Acid|hyaluronic acid|mesh-list
64502211|NCT03371862|Liraglutide|liraglutide|mesh-list
64502212|NCT03371862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64502213|NCT03371862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502214|NCT03371862|Incretins|incretins|mesh-ancestor
64502215|NCT03371862|Hormones|hormones|mesh-ancestor
64502216|NCT03371862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64502217|NCT03368430|Melatonin|melatonin|mesh-list
64502218|NCT03368430|Antioxidants|antioxidants|mesh-ancestor
64502219|NCT03368430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502220|NCT03368430|Protective Agents|protective agents|mesh-ancestor
64502221|NCT03368430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502222|NCT03368430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64502223|NCT03371784|Hydrocortisone|hydrocortisone|mesh-list
64502224|NCT03371784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64502225|NCT03003832|Analgesics, Opioid|analgesics, opioid|mesh-list
64502226|NCT03003832|Analgesics|analgesics|mesh-list
64502227|NCT03003832|Narcotics|narcotics|mesh-ancestor
64502228|NCT03003832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64502229|NCT03003832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502230|NCT03003832|Sensory System Agents|sensory system agents|mesh-ancestor
64502231|NCT03003832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502232|NCT03368352|Melatonin|melatonin|mesh-list
64502233|NCT03368352|Antioxidants|antioxidants|mesh-ancestor
64502234|NCT03368352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502235|NCT03368352|Protective Agents|protective agents|mesh-ancestor
64502236|NCT03368352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502237|NCT03368352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64502238|NCT02248012|Everolimus|everolimus|mesh-list
64502239|NCT02248012|Temozolomide|temozolomide|mesh-list
64768569|NCT01043094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768570|NCT01043094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64768571|NCT01043640|Cyclosporine|cyclosporine|mesh-list
64768600|NCT01044264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64768601|NCT01044264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64768602|NCT01044264|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64768603|NCT01044264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768604|NCT01044264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768605|NCT01044264|Dermatologic Agents|dermatologic agents|mesh-ancestor
64768606|NCT01044966|Temozolomide|temozolomide|mesh-list
64768607|NCT01044966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64768608|NCT01044966|Alkylating Agents|alkylating agents|mesh-ancestor
64768609|NCT01044966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768610|NCT01044966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768611|NCT01045122|Dexmedetomidine|dexmedetomidine|mesh-list
64768612|NCT01045122|Propofol|propofol|mesh-list
64768613|NCT01045122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64768614|NCT01045122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64768615|NCT01045122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768616|NCT01045122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64768617|NCT01045122|Anesthetics, General|anesthetics, general|mesh-ancestor
64768618|NCT01045122|Anesthetics|anesthetics|mesh-ancestor
64768728|NCT05821712|Protective Agents|protective agents|mesh-ancestor
64768729|NCT05821712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768730|NCT05821712|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64768731|NCT05821712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64768835|NCT05821192|Antimetabolites|antimetabolites|mesh-ancestor
64768836|NCT05821192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768837|NCT05821192|Antiviral Agents|antiviral agents|mesh-ancestor
64768838|NCT05821192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64768839|NCT05821192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768840|NCT05821192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64768841|NCT05821153|Aldesleukin|aldesleukin|mesh-list
64768842|NCT05821153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768843|NCT05821153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64768844|NCT05821153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64768877|NCT05821075|Glucocorticoids|glucocorticoids|mesh-ancestor
64768878|NCT05821075|Hormones|hormones|mesh-ancestor
65495156|NCT05193604|Antimitotic Agents|antimitotic agents|mesh-ancestor
65495157|NCT05193604|Mitosis Modulators|mitosis modulators|mesh-ancestor
64768939|NCT05820685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768940|NCT05820685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64768941|NCT05820685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64768942|NCT05820685|Analgesics|analgesics|mesh-ancestor
64768943|NCT05820685|Sensory System Agents|sensory system agents|mesh-ancestor
64380650|NCT02444351|Cholinergic Agents|cholinergic agents|mesh-ancestor
64768977|NCT05817162|Sensory System Agents|sensory system agents|mesh-ancestor
64768978|NCT05817162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64768980|NCT05816746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64768981|NCT05816746|Antimetabolites|antimetabolites|mesh-ancestor
64380689|NCT02600897|Rituximab|rituximab|mesh-list
64769012|NCT05796570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769013|NCT05796570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64769014|NCT05791617|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64769015|NCT05791617|Natriuretic Agents|natriuretic agents|mesh-ancestor
64769016|NCT05791617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769017|NCT05738057|Gemcitabine|gemcitabine|mesh-list
64769018|NCT05738057|Cisplatin|cisplatin|mesh-list
64769019|NCT05738057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769020|NCT05738057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64769021|NCT05738057|Antimetabolites|antimetabolites|mesh-ancestor
64769022|NCT05738057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769023|NCT05738057|Antiviral Agents|antiviral agents|mesh-ancestor
64769024|NCT05738057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64769026|NCT05738057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64769062|NCT05699408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769064|NCT05696782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64769096|NCT05668286|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64769097|NCT05668286|Prilocaine|prilocaine|mesh-list
64769098|NCT05668286|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64769099|NCT05668286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64769100|NCT05668286|Glucocorticoids|glucocorticoids|mesh-ancestor
64769101|NCT05668286|Hormones|hormones|mesh-ancestor
64769102|NCT05668286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64769103|NCT05668286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769104|NCT05668286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64769105|NCT05668286|Immunologic Factors|immunologic factors|mesh-ancestor
64769106|NCT05668286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64769107|NCT05668286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769108|NCT05668286|Anesthetics, Local|anesthetics, local|mesh-ancestor
64769109|NCT05668286|Anesthetics|anesthetics|mesh-ancestor
64380856|NCT01604265|Nabiximols|nabiximols|mesh-list
64769185|NCT05590585|Dermatologic Agents|dermatologic agents|mesh-ancestor
64769186|NCT05581823|Carbamazepine|carbamazepine|mesh-list
64769187|NCT05581823|Anticonvulsants|anticonvulsants|mesh-ancestor
64769188|NCT05581823|Antimanic Agents|antimanic agents|mesh-ancestor
64769189|NCT05581823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64769190|NCT05581823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64769191|NCT05581823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769192|NCT05581823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64769193|NCT05581823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64769194|NCT05581823|Analgesics|analgesics|mesh-ancestor
64769195|NCT05581823|Sensory System Agents|sensory system agents|mesh-ancestor
64769196|NCT05581823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64769197|NCT05581823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64769198|NCT05581823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64769199|NCT05581823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769200|NCT05581823|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64769201|NCT05581823|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64769203|NCT05580003|Midazolam|midazolam|mesh-list
64769204|NCT05580003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64502240|NCT02248012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769205|NCT05580003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64769271|NCT05500599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64769277|NCT05500599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64769278|NCT05500599|Anesthetics, General|anesthetics, general|mesh-ancestor
64769279|NCT05500599|Anesthetics|anesthetics|mesh-ancestor
64769280|NCT05500599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64769281|NCT05500599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64769282|NCT05500599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64769283|NCT05500599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64769284|NCT05500599|GABA Modulators|gaba modulators|mesh-ancestor
64769285|NCT05500599|GABA Agents|gaba agents|mesh-ancestor
64769286|NCT05500599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64380989|NCT03191981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769310|NCT05473715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769311|NCT05473715|Growth Inhibitors|growth inhibitors|mesh-ancestor
64769312|NCT05473715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769314|NCT05471076|Immunologic Factors|immunologic factors|mesh-ancestor
64769315|NCT05471076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769316|NCT05469178|Carboplatin|carboplatin|mesh-list
64769317|NCT05469178|Pembrolizumab|pembrolizumab|mesh-list
64769318|NCT05469178|Pemetrexed|pemetrexed|mesh-list
64769319|NCT05469178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769320|NCT05469178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64769321|NCT05469178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64769322|NCT05469178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769323|NCT05469178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64769324|NCT05469178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64769325|NCT05453396|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
64769326|NCT05453396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64769371|NCT05351502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64769372|NCT05351502|Autonomic Agents|autonomic agents|mesh-ancestor
64769373|NCT05351502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64769374|NCT05351502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769375|NCT05351502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64769376|NCT05351502|Respiratory System Agents|respiratory system agents|mesh-ancestor
64769377|NCT05351502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64769378|NCT05351502|Antioxidants|antioxidants|mesh-ancestor
64769379|NCT05351502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769380|NCT05351502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64769381|NCT05351502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64769382|NCT05351502|Vasodilator Agents|vasodilator agents|mesh-ancestor
64769383|NCT05351502|Gasotransmitters|gasotransmitters|mesh-ancestor
64769384|NCT05351502|Protective Agents|protective agents|mesh-ancestor
64769390|NCT05327296|Propofol|propofol|mesh-list
64769391|NCT05327296|Isoflurane|isoflurane|mesh-list
64769392|NCT05327296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64769393|NCT05327296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64769394|NCT05327296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769395|NCT05327296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64769396|NCT05327296|Anesthetics, General|anesthetics, general|mesh-ancestor
64769397|NCT05327296|Anesthetics|anesthetics|mesh-ancestor
64769398|NCT05327296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64769399|NCT05317000|Nivolumab|nivolumab|mesh-list
64769400|NCT05317000|Azacitidine|azacitidine|mesh-list
64769401|NCT05317000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64769402|NCT05317000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769427|NCT05270863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64502241|NCT02248012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64502242|NCT02248012|Immunologic Factors|immunologic factors|mesh-ancestor
64502243|NCT02248012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502244|NCT02248012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64502245|NCT02248012|Alkylating Agents|alkylating agents|mesh-ancestor
64502246|NCT02248012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502247|NCT03362268|Omeprazole|omeprazole|mesh-list
64502248|NCT03362268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64502256|NCT04523844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64502258|NCT04523844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64502259|NCT04523844|Adrenergic Agents|adrenergic agents|mesh-ancestor
64502260|NCT04523844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64502261|NCT04523844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502263|NCT04523844|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64502264|NCT04523844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502265|NCT03361878|Metformin|metformin|mesh-list
64502266|NCT03361878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64502267|NCT03361878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502268|NCT03361800|Entinostat|entinostat|mesh-list
64769428|NCT05270863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64769429|NCT05270863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64769430|NCT05270863|Adrenergic Agents|adrenergic agents|mesh-ancestor
64769431|NCT05270863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64769432|NCT05270863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769433|NCT05270863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769434|NCT05270863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64769435|NCT05270863|Miotics|miotics|mesh-ancestor
64769436|NCT05270863|Autonomic Agents|autonomic agents|mesh-ancestor
64769437|NCT05270863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64769438|NCT05270863|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64769439|NCT05270863|Cholinergic Agents|cholinergic agents|mesh-ancestor
64769440|NCT05270863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64769441|NCT05270863|Analgesics|analgesics|mesh-ancestor
64769442|NCT05270863|Sensory System Agents|sensory system agents|mesh-ancestor
64769443|NCT05270863|Protective Agents|protective agents|mesh-ancestor
64769444|NCT05237141|Etonogestrel|etonogestrel|mesh-list
64769445|NCT05237141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64769446|NCT05237141|Contraceptive Agents|contraceptive agents|mesh-ancestor
64769447|NCT05237141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64769448|NCT05237141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769449|NCT05237141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64769450|NCT05233098|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
64769451|NCT05233098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64769452|NCT05233098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381139|NCT02435927|Vitamins|vitamins|mesh-ancestor
64769467|NCT05183035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769468|NCT05183035|Antiviral Agents|antiviral agents|mesh-ancestor
64769469|NCT05183035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64769470|NCT05183035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64769471|NCT05183035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64769482|NCT05175547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769483|NCT05137262|Cisplatin|cisplatin|mesh-list
64769484|NCT05137262|Doxorubicin|doxorubicin|mesh-list
64769485|NCT05137262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64769486|NCT05137262|Methotrexate|methotrexate|mesh-list
64769487|NCT05137262|Durvalumab|durvalumab|mesh-list
64769488|NCT05137262|Abiraterone Acetate|abiraterone acetate|mesh-list
64769489|NCT05137262|Vinblastine|vinblastine|mesh-list
64769490|NCT05137262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769491|NCT05137262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64769492|NCT05137262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64769493|NCT05137262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64769494|NCT05137262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64769495|NCT05137262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769496|NCT05137262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64769497|NCT05137262|Abortifacient Agents|abortifacient agents|mesh-ancestor
64769498|NCT05137262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64769499|NCT05137262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769500|NCT05137262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64473253|NCT00121186|Methotrexate|methotrexate|mesh-list
64769501|NCT05137262|Antimetabolites|antimetabolites|mesh-ancestor
64769502|NCT05137262|Dermatologic Agents|dermatologic agents|mesh-ancestor
64769503|NCT05137262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64769504|NCT05137262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64769505|NCT05137262|Immunologic Factors|immunologic factors|mesh-ancestor
64769506|NCT05137262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64769507|NCT05137262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64769509|NCT05137262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64769549|NCT05118672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64769550|NCT05118672|Adrenergic Agents|adrenergic agents|mesh-ancestor
64769551|NCT05118672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64769552|NCT05118672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769553|NCT05118672|Protective Agents|protective agents|mesh-ancestor
64769554|NCT05118672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64769555|NCT05118672|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64769556|NCT05118672|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64769557|NCT05118672|Histamine Antagonists|histamine antagonists|mesh-ancestor
64769558|NCT05118672|Histamine Agents|histamine agents|mesh-ancestor
64769559|NCT05114837|Cyclophosphamide|cyclophosphamide|mesh-list
64769560|NCT05114837|Fludarabine|fludarabine|mesh-list
64769561|NCT05114837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64769562|NCT05114837|Immunologic Factors|immunologic factors|mesh-ancestor
64769563|NCT05114837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769564|NCT05114837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64769565|NCT05114837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64769566|NCT05114837|Alkylating Agents|alkylating agents|mesh-ancestor
64769567|NCT05114837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769606|NCT05047172|Sensory System Agents|sensory system agents|mesh-ancestor
64769607|NCT05047172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64769608|NCT05047172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769609|NCT05047172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64769610|NCT05047172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64769611|NCT05047172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64769612|NCT05047172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65495158|NCT05193604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769655|NCT04971226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769656|NCT04955678|Sorbitol|sorbitol|mesh-list
64769657|NCT04955678|Calcium|calcium|mesh-list
64769658|NCT04955678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64769659|NCT04955678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769660|NCT04955678|Cathartics|cathartics|mesh-ancestor
64769661|NCT04955678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64769662|NCT04924166|Hydrocortisone|hydrocortisone|mesh-list
64769663|NCT04924166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64769664|NCT04915729|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64769665|NCT04915729|Tenecteplase|tenecteplase|mesh-list
64769666|NCT04915729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64769667|NCT04915729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64769668|NCT04915729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769669|NCT04908371|Lidocaine|lidocaine|mesh-list
64769670|NCT04908371|Epinephrine|epinephrine|mesh-list
64769671|NCT04908371|Racepinephrine|racepinephrine|mesh-list
64769672|NCT04908371|Levobupivacaine|levobupivacaine|mesh-list
64769673|NCT04908371|Epinephryl borate|epinephryl borate|mesh-list
64769674|NCT04908371|Anesthetics, Local|anesthetics, local|mesh-ancestor
64769710|NCT04900792|Micronutrients|micronutrients|mesh-ancestor
64769711|NCT04900792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769712|NCT04900792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64769713|NCT04900792|Alkylating Agents|alkylating agents|mesh-ancestor
64502269|NCT03361800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945709|NCT05298696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502270|NCT03361800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64502271|NCT03361800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502272|NCT03361800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502273|NCT02998918|Curcumin|curcumin|mesh-list
64502274|NCT02998918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64502275|NCT02998918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64502276|NCT02998918|Analgesics|analgesics|mesh-ancestor
64724308|NCT00000841|Indinavir|indinavir|mesh-list
64724309|NCT00000841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64724310|NCT00000841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64724311|NCT00000841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724312|NCT00000841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724319|NCT00000841|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64502277|NCT02998918|Sensory System Agents|sensory system agents|mesh-ancestor
64502278|NCT02998918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502280|NCT02998918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64502282|NCT02998918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502283|NCT02998918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502284|NCT02998918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502285|NCT02995642|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
64502286|NCT02995642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502287|NCT02998606|Naloxegol|naloxegol|mesh-list
64769714|NCT04900792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769715|NCT04900792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769716|NCT04900792|Antioxidants|antioxidants|mesh-ancestor
64769717|NCT04900792|Protective Agents|protective agents|mesh-ancestor
64769718|NCT04900792|Hematinics|hematinics|mesh-ancestor
64769719|NCT04900792|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64769720|NCT04900792|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64769721|NCT04897217|Megestrol|megestrol|mesh-list
64769833|NCT04800107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769835|NCT04800107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64769836|NCT04800107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769837|NCT04800107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64769838|NCT04800107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769839|NCT04786574|Tolvaptan|tolvaptan|mesh-list
64769840|NCT04786574|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64769841|NCT04786574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769842|NCT04786574|Natriuretic Agents|natriuretic agents|mesh-ancestor
64769843|NCT04786574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769844|NCT04783857|Progesterone|progesterone|mesh-list
64769845|NCT04783857|Progestins|progestins|mesh-ancestor
64538545|NCT00620061|Lubiprostone|lubiprostone|mesh-list
64769876|NCT04761159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64769883|NCT04761159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64769884|NCT04761159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769893|NCT04721548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64769894|NCT04721548|Vasodilator Agents|vasodilator agents|mesh-ancestor
64769895|NCT04716296|Ketamine|ketamine|mesh-list
64769896|NCT04716296|Analgesics|analgesics|mesh-ancestor
64769897|NCT04716296|Sensory System Agents|sensory system agents|mesh-ancestor
64769898|NCT04716296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64769899|NCT04716296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769900|NCT04716296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64769903|NCT04716296|Anesthetics|anesthetics|mesh-ancestor
64769940|NCT04675931|Antimalarials|antimalarials|mesh-ancestor
64769941|NCT04675931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64769942|NCT04675931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64769943|NCT04675931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64769944|NCT04675931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769945|NCT04675931|Antiviral Agents|antiviral agents|mesh-ancestor
64769946|NCT04675931|Schistosomicides|schistosomicides|mesh-ancestor
64381607|NCT05164653|Valsartan|valsartan|mesh-list
64769974|NCT04652661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64769975|NCT04652661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64769976|NCT04652661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64769977|NCT04652661|Adrenergic Agents|adrenergic agents|mesh-ancestor
64769978|NCT04652661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64769979|NCT04652661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769980|NCT04652661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64769981|NCT04652661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64769982|NCT04652661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64769983|NCT04652661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64769984|NCT04652661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64769985|NCT04652661|Anesthetics, General|anesthetics, general|mesh-ancestor
64769986|NCT04652661|Anesthetics|anesthetics|mesh-ancestor
64769987|NCT04652661|GABA Modulators|gaba modulators|mesh-ancestor
64769988|NCT04652661|GABA Agents|gaba agents|mesh-ancestor
64769989|NCT04623931|Temozolomide|temozolomide|mesh-list
64769990|NCT04623931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64769991|NCT04623931|Alkylating Agents|alkylating agents|mesh-ancestor
64769992|NCT04623931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769993|NCT04623931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381610|NCT05164653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64770020|NCT04573751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64770021|NCT04573751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64502288|NCT02998606|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64502289|NCT02998606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502290|NCT02998606|Sensory System Agents|sensory system agents|mesh-ancestor
64502291|NCT02998606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502292|NCT05365438|Atorvastatin|atorvastatin|mesh-list
64502293|NCT05365438|Ezetimibe|ezetimibe|mesh-list
64502294|NCT05365438|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64502295|NCT05365438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64502296|NCT05365438|Antimetabolites|antimetabolites|mesh-ancestor
64502297|NCT05365438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502298|NCT05365438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64502299|NCT05365438|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64502300|NCT05365438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571119|NCT04877106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64770022|NCT04573751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64770024|NCT04522622|Teriparatide|teriparatide|mesh-list
64770025|NCT04522622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64770026|NCT04522622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770055|NCT04474483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770056|NCT04474483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64770058|NCT04432207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770059|NCT04425447|Anesthetics|anesthetics|mesh-list
64770060|NCT04425447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64770061|NCT04425447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770062|NCT04384367|Naproxen|naproxen|mesh-list
64770063|NCT04384367|Rizatriptan|rizatriptan|mesh-list
64770064|NCT04384367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64770065|NCT04384367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64770066|NCT04384367|Analgesics|analgesics|mesh-ancestor
64770067|NCT04384367|Sensory System Agents|sensory system agents|mesh-ancestor
64770068|NCT04384367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64770069|NCT04384367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770100|NCT04332068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64770101|NCT04332068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64770102|NCT04332068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64770116|NCT04298567|Sensory System Agents|sensory system agents|mesh-ancestor
64770117|NCT04298567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64770118|NCT04298567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770119|NCT04298567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64770120|NCT04298567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64770121|NCT04298567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64770122|NCT04298567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64571124|NCT00981617|ALKS-33|alks-33|mesh-list
64502301|NCT05264506|Estradiol|estradiol|mesh-list
64502302|NCT05264506|Estrogens|estrogens|mesh-ancestor
64502303|NCT05264506|Hormones|hormones|mesh-ancestor
64502304|NCT05264506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64502305|NCT05264506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502306|NCT02248168|Pramipexole|pramipexole|mesh-list
64502307|NCT02248168|Antioxidants|antioxidants|mesh-ancestor
64502308|NCT02248168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502309|NCT02248168|Protective Agents|protective agents|mesh-ancestor
64502310|NCT02248168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502311|NCT02248168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64502312|NCT02248168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64770123|NCT04298567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64770124|NCT04298567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64770125|NCT04298567|Antipyretics|antipyretics|mesh-ancestor
64770126|NCT04298541|Edotreotide|edotreotide|mesh-list
64770127|NCT04298541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64770128|NCT04298541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770212|NCT04148105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64770213|NCT04148105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64770214|NCT04148105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770215|NCT04148105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64770216|NCT04148105|Vasodilator Agents|vasodilator agents|mesh-ancestor
64770217|NCT04148105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64770218|NCT04148105|Protective Agents|protective agents|mesh-ancestor
64770219|NCT04148105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64770220|NCT04148105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64770221|NCT04148105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64770223|NCT04125472|Renal Agents|renal agents|mesh-ancestor
64770224|NCT04094675|Sirolimus|sirolimus|mesh-list
64770225|NCT04094675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64770226|NCT04094675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64770227|NCT04094675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64770228|NCT04094675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770229|NCT04094675|Antifungal Agents|antifungal agents|mesh-ancestor
64770230|NCT04094675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64770382|NCT03781817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64770383|NCT03781817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770494|NCT03429543|Incretins|incretins|mesh-ancestor
64770495|NCT03429543|Hormones|hormones|mesh-ancestor
64770496|NCT03429543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64770497|NCT03429543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64770498|NCT03429543|Protease Inhibitors|protease inhibitors|mesh-ancestor
64770535|NCT03128034|Dermatologic Agents|dermatologic agents|mesh-ancestor
64770536|NCT03128034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64770537|NCT03128034|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64770538|NCT03128034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64770539|NCT03128034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64770540|NCT03128034|Antitubercular Agents|antitubercular agents|mesh-ancestor
64770541|NCT03128034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64770542|NCT03105336|Cyclophosphamide|cyclophosphamide|mesh-list
64770543|NCT03105336|Fludarabine|fludarabine|mesh-list
64770544|NCT03105336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64770545|NCT03105336|Immunologic Factors|immunologic factors|mesh-ancestor
64770546|NCT03105336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770547|NCT03105336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64770548|NCT03105336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64770549|NCT03105336|Alkylating Agents|alkylating agents|mesh-ancestor
64770550|NCT03105336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770551|NCT03105336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770552|NCT03105336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64539195|NCT01437995|Glucocorticoids|glucocorticoids|mesh-ancestor
64770604|NCT02979873|Antifungal Agents|antifungal agents|mesh-ancestor
64770605|NCT02979873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64770606|NCT02979873|Immunologic Factors|immunologic factors|mesh-ancestor
64770607|NCT02979873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770617|NCT02621489|Metformin|metformin|mesh-list
64770618|NCT02621489|Insulin Aspart|insulin aspart|mesh-list
64770619|NCT02621489|Exenatide|exenatide|mesh-list
64770620|NCT02621489|Biguanides|biguanides|mesh-list
64770621|NCT02621489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64770647|NCT02320435|Pertuzumab|pertuzumab|mesh-list
64770648|NCT02320435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64770649|NCT02320435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770665|NCT01995344|Immunologic Factors|immunologic factors|mesh-ancestor
64770666|NCT01995344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770667|NCT01995344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64770668|NCT01995344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64770669|NCT01995344|Alkylating Agents|alkylating agents|mesh-ancestor
64770670|NCT01995344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495159|NCT05193604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64473257|NCT00121186|Tacrolimus|tacrolimus|mesh-list
64770671|NCT01995344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770672|NCT01995344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64770673|NCT01995344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64770703|NCT01591291|Autonomic Agents|autonomic agents|mesh-ancestor
64770704|NCT01591291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64770705|NCT01591291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770706|NCT01591291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64770707|NCT01591291|Antipruritics|antipruritics|mesh-ancestor
64770708|NCT01591291|Dermatologic Agents|dermatologic agents|mesh-ancestor
64770709|NCT01591291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64770710|NCT01591291|Serotonin Agents|serotonin agents|mesh-ancestor
64770711|NCT01591291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64770712|NCT01591291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770713|NCT01591291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64770714|NCT01591291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64770715|NCT01591291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64770716|NCT01591291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64770717|NCT01591291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64770755|NCT00716066|Podophyllotoxin|podophyllotoxin|mesh-list
64770756|NCT00716066|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64770757|NCT00716066|Thymoglobulin|thymoglobulin|mesh-list
64770758|NCT00716066|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64770759|NCT00716066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64770760|NCT00716066|Glucocorticoids|glucocorticoids|mesh-ancestor
64571278|NCT04553003|Antiemetics|antiemetics|mesh-ancestor
64770822|NCT01060020|Urological Agents|urological agents|mesh-ancestor
64770823|NCT01060098|Adalimumab|adalimumab|mesh-list
64770824|NCT01060098|Etanercept|etanercept|mesh-list
64770825|NCT01060098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64770826|NCT01060098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64770827|NCT01060098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64770828|NCT01060098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64770829|NCT01060098|Analgesics|analgesics|mesh-ancestor
64770830|NCT01060098|Sensory System Agents|sensory system agents|mesh-ancestor
64770831|NCT01060098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64770832|NCT01060098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770833|NCT01060098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64770834|NCT01060098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64770835|NCT01060098|Immunologic Factors|immunologic factors|mesh-ancestor
64770836|NCT01061034|Aspirin|aspirin|mesh-list
64770837|NCT01061034|Omeprazole|omeprazole|mesh-list
64770838|NCT01061034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64770839|NCT01061034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64770840|NCT01061034|Analgesics|analgesics|mesh-ancestor
64770841|NCT01061034|Sensory System Agents|sensory system agents|mesh-ancestor
64770842|NCT01061034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64770843|NCT01061034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770844|NCT01061034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64770845|NCT01061034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64770846|NCT01061034|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64770847|NCT01061034|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64770848|NCT01061034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770849|NCT01061034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64770850|NCT01061034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64770851|NCT01061034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64770852|NCT01061034|Antipyretics|antipyretics|mesh-ancestor
64770853|NCT01061034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64502313|NCT02248168|Dopamine Agonists|dopamine agonists|mesh-ancestor
64502314|NCT02248168|Dopamine Agents|dopamine agents|mesh-ancestor
64502327|NCT05672524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64502328|NCT05672524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502329|NCT05672524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502330|NCT03002428|Teriparatide|teriparatide|mesh-list
64502331|NCT03002428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64502332|NCT03002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502333|NCT03002428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64770883|NCT01083732|Antithrombins|antithrombins|mesh-ancestor
64571303|NCT03044184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64770884|NCT01083732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64770885|NCT01083732|Protease Inhibitors|protease inhibitors|mesh-ancestor
64770886|NCT01083732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64770887|NCT01083732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770888|NCT01083732|Anticoagulants|anticoagulants|mesh-ancestor
64770889|NCT01084278|Colchicine|colchicine|mesh-list
64770890|NCT01084278|Gout Suppressants|gout suppressants|mesh-ancestor
65495160|NCT05193604|Antimetabolites|antimetabolites|mesh-ancestor
64595178|NCT01944423|Renal Agents|renal agents|mesh-ancestor
64770891|NCT01084278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64770892|NCT01084278|Tubulin Modulators|tubulin modulators|mesh-ancestor
64770893|NCT01084278|Antimitotic Agents|antimitotic agents|mesh-ancestor
64770894|NCT01084278|Mitosis Modulators|mitosis modulators|mesh-ancestor
64770895|NCT01084278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770896|NCT01084278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770897|NCT01085760|Metronidazole|metronidazole|mesh-list
64770898|NCT01085760|Vancomycin|vancomycin|mesh-list
64770899|NCT01085760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64770900|NCT01085760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64770901|NCT01085760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64770902|NCT01085760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64770903|NCT01090752|Metformin|metformin|mesh-list
64770927|NCT01094574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64770928|NCT01094574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64770929|NCT01094574|Adrenergic Agents|adrenergic agents|mesh-ancestor
64770930|NCT01094574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64502334|NCT04398706|Vaccines|vaccines|mesh-list
64502335|NCT04398706|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64502337|NCT04398706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502342|NCT03371550|Docetaxel|docetaxel|mesh-list
64502343|NCT03371550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64724320|NCT00000841|Protease Inhibitors|protease inhibitors|mesh-ancestor
64724321|NCT04226456|Acetylcysteine|acetylcysteine|mesh-list
64724322|NCT04226456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64724323|NCT04226456|Antiviral Agents|antiviral agents|mesh-ancestor
64724324|NCT04226456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724325|NCT04226456|Expectorants|expectorants|mesh-ancestor
64724326|NCT04226456|Respiratory System Agents|respiratory system agents|mesh-ancestor
64724327|NCT04226456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64502344|NCT03371550|Tubulin Modulators|tubulin modulators|mesh-ancestor
64502345|NCT03371550|Antimitotic Agents|antimitotic agents|mesh-ancestor
64502346|NCT03371550|Mitosis Modulators|mitosis modulators|mesh-ancestor
64502347|NCT03371550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502348|NCT05670028|Antihypertensive Agents|antihypertensive agents|mesh-list
64502356|NCT04861948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64502357|NCT04861948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64502358|NCT04861948|Growth Substances|growth substances|mesh-ancestor
64571327|NCT03047538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770931|NCT01094574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770932|NCT01094574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770933|NCT01094574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64770934|NCT01094574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64770935|NCT01094574|Vasodilator Agents|vasodilator agents|mesh-ancestor
64770936|NCT01094574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64770937|NCT01094574|Narcotics|narcotics|mesh-ancestor
64770938|NCT01094574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64770939|NCT01094574|Analgesics|analgesics|mesh-ancestor
64770940|NCT01094574|Sensory System Agents|sensory system agents|mesh-ancestor
64770941|NCT01094574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64770942|NCT01094574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64770943|NCT01094574|Anesthetics, General|anesthetics, general|mesh-ancestor
64770944|NCT01094574|Anesthetics|anesthetics|mesh-ancestor
64770945|NCT01095510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64770946|NCT01095510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64770947|NCT01095510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64770948|NCT01095510|Immunologic Factors|immunologic factors|mesh-ancestor
64770949|NCT01095510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770950|NCT01096290|Lubiprostone|lubiprostone|mesh-list
64770951|NCT01096290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64770952|NCT01096290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64770953|NCT01096290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770954|NCT01096680|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64770984|NCT01097304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64770986|NCT01097460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64770987|NCT01097460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770988|NCT01098318|Sertraline|sertraline|mesh-list
64770989|NCT01098318|Antidepressive Agents|antidepressive agents|mesh-ancestor
64770990|NCT01098318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64770996|NCT01098318|Serotonin Agents|serotonin agents|mesh-ancestor
64771000|NCT01100112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64771001|NCT01100112|Autonomic Agents|autonomic agents|mesh-ancestor
64771002|NCT01100112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64771003|NCT01100112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771004|NCT01100112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64771005|NCT01100112|Respiratory System Agents|respiratory system agents|mesh-ancestor
64771006|NCT01100112|Glucocorticoids|glucocorticoids|mesh-ancestor
64771007|NCT01100112|Hormones|hormones|mesh-ancestor
64771008|NCT01100112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64771009|NCT01100268|Methylphenidate|methylphenidate|mesh-list
64771010|NCT01100268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64771011|NCT01100268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771012|NCT01100268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64771013|NCT01100268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64771014|NCT01100268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65495161|NCT05193604|Antiviral Agents|antiviral agents|mesh-ancestor
65495162|NCT05193604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65495163|NCT05193604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595244|NCT00603187|Hormone Antagonists|hormone antagonists|mesh-ancestor
64771015|NCT01100268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771016|NCT01100268|Dopamine Agents|dopamine agents|mesh-ancestor
64771044|NCT01103934|Autonomic Agents|autonomic agents|mesh-ancestor
64771045|NCT01103934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64771046|NCT01103934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64771047|NCT01103934|Respiratory System Agents|respiratory system agents|mesh-ancestor
64771048|NCT01103934|Dermatologic Agents|dermatologic agents|mesh-ancestor
64771049|NCT01103934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64771050|NCT01103934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64771051|NCT01105650|Cyclosporine|cyclosporine|mesh-list
64502359|NCT04861948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502360|NCT04861948|Growth Inhibitors|growth inhibitors|mesh-ancestor
64502361|NCT04861948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502362|NCT04861948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502363|NCT04861948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64502364|NCT04861948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64502366|NCT04526028|Palbociclib|palbociclib|mesh-list
64502367|NCT04526028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64502368|NCT04526028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502369|NCT04526028|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64502370|NCT04526028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64502371|NCT04526028|Hormone Antagonists|hormone antagonists|mesh-ancestor
64502372|NCT04526028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64502373|NCT04526028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571400|NCT03820193|Antimanic Agents|antimanic agents|mesh-ancestor
64771052|NCT01105650|Methylprednisolone|methylprednisolone|mesh-list
64771053|NCT01105650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64771054|NCT01105650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64771055|NCT01105650|Prednisolone|prednisolone|mesh-list
64771056|NCT01105650|Prednisolone acetate|prednisolone acetate|mesh-list
64771057|NCT01105650|Cyclophosphamide|cyclophosphamide|mesh-list
64771058|NCT01105650|Fludarabine|fludarabine|mesh-list
64771059|NCT01105650|Interleukin-2|interleukin-2|mesh-list
64771060|NCT01105650|Cyclosporins|cyclosporins|mesh-list
64771061|NCT01105650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64771062|NCT01105650|Prednisolone phosphate|prednisolone phosphate|mesh-list
64771063|NCT01105650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64771064|NCT01105650|Immunologic Factors|immunologic factors|mesh-ancestor
64771065|NCT01105650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771066|NCT01105650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64771067|NCT01105650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64771068|NCT01105650|Alkylating Agents|alkylating agents|mesh-ancestor
64771082|NCT01105650|Glucocorticoids|glucocorticoids|mesh-ancestor
64771083|NCT01105650|Hormones|hormones|mesh-ancestor
64771084|NCT01105650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64771085|NCT01105650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64771086|NCT01105650|Protective Agents|protective agents|mesh-ancestor
64771087|NCT01105650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64771088|NCT01105650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64771089|NCT01105650|Analgesics|analgesics|mesh-ancestor
64771090|NCT01105650|Sensory System Agents|sensory system agents|mesh-ancestor
64771091|NCT01110876|Temozolomide|temozolomide|mesh-list
64771092|NCT01110876|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64502374|NCT04526028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64502375|NCT04526028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502376|NCT04526028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502377|NCT02518698|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64502378|NCT02518698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502386|NCT02247544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64502387|NCT02247544|Alkylating Agents|alkylating agents|mesh-ancestor
64502388|NCT02247544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502389|NCT02247544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502391|NCT03370848|Psyllium|psyllium|mesh-list
64502392|NCT03370848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64502393|NCT03370848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64502394|NCT03370848|Analgesics|analgesics|mesh-ancestor
64502395|NCT03370848|Sensory System Agents|sensory system agents|mesh-ancestor
64502396|NCT03370848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502397|NCT03370848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502398|NCT03370848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64502399|NCT03370848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64771093|NCT01110876|Vorinostat|vorinostat|mesh-list
64771094|NCT01110876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64771095|NCT01110876|Alkylating Agents|alkylating agents|mesh-ancestor
64771096|NCT01110876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771097|NCT01110876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64771098|NCT01110876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64771099|NCT01110876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771100|NCT01110876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64771101|NCT01112358|Cetrorelix|cetrorelix|mesh-list
64771102|NCT01112358|Progesterone|progesterone|mesh-list
64771103|NCT01112358|Progestins|progestins|mesh-ancestor
64771104|NCT01112358|Hormones|hormones|mesh-ancestor
64771105|NCT01112358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64771106|NCT01112358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771107|NCT01112358|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64771108|NCT01112358|Fertility Agents|fertility agents|mesh-ancestor
64771109|NCT01112358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64771110|NCT01112358|Hormone Antagonists|hormone antagonists|mesh-ancestor
64771111|NCT01112670|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64771112|NCT01112670|Atorvastatin|atorvastatin|mesh-list
64771113|NCT01112670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64771114|NCT01112670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64771209|NCT05304546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64771210|NCT05304546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64771211|NCT04974138|Folic Acid|folic acid|mesh-list
64771232|NCT04944654|Antiviral Agents|antiviral agents|mesh-ancestor
64771233|NCT04944654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64771234|NCT04944654|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64771235|NCT04944654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64771236|NCT04944654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771237|NCT04944654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771239|NCT04944654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64771240|NCT04187352|Cisplatin|cisplatin|mesh-list
64771241|NCT04187352|Fluorouracil|fluorouracil|mesh-list
64771242|NCT04187352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64771243|NCT04187352|Antimetabolites|antimetabolites|mesh-ancestor
64771244|NCT04187352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771245|NCT04187352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64571480|NCT01669122|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64502400|NCT03370848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64502401|NCT03370848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64502402|NCT03370848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502403|NCT03370848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64502404|NCT03370848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64502405|NCT03370848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502406|NCT03370848|Antipyretics|antipyretics|mesh-ancestor
64502407|NCT03370848|Cathartics|cathartics|mesh-ancestor
64502408|NCT03370848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64502409|NCT02248792|Methotrexate|methotrexate|mesh-list
64502410|NCT02248792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64502411|NCT02248792|Abortifacient Agents|abortifacient agents|mesh-ancestor
64724329|NCT04226456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724330|NCT04226456|Protective Agents|protective agents|mesh-ancestor
64724331|NCT04226456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502412|NCT02248792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64502413|NCT02248792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502414|NCT02248792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64502415|NCT02248792|Antimetabolites|antimetabolites|mesh-ancestor
64502416|NCT02248792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502417|NCT02248792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502418|NCT02248792|Dermatologic Agents|dermatologic agents|mesh-ancestor
64945710|NCT05287425|Ciprofloxacin|ciprofloxacin|mesh-list
64502419|NCT02248792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502420|NCT02248792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64502427|NCT03367728|Anesthetics|anesthetics|mesh-ancestor
64502428|NCT03367728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64502429|NCT03367728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502430|NCT03367728|Sensory System Agents|sensory system agents|mesh-ancestor
64502431|NCT03367728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502432|NCT02248870|Dexamethasone|dexamethasone|mesh-list
64502433|NCT02248870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64502434|NCT02248870|Antiemetics|antiemetics|mesh-ancestor
64502435|NCT02248870|Autonomic Agents|autonomic agents|mesh-ancestor
64502436|NCT02248870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502437|NCT02248870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502438|NCT02248870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64502439|NCT02248870|Glucocorticoids|glucocorticoids|mesh-ancestor
64502440|NCT02248870|Hormones|hormones|mesh-ancestor
64771246|NCT04187352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64771247|NCT04187352|Immunologic Factors|immunologic factors|mesh-ancestor
64771248|NCT04187352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771249|NCT04142892|Onapristone|onapristone|mesh-list
64771250|NCT04142892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64771251|NCT04142892|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64771252|NCT04142892|Fertility Agents|fertility agents|mesh-ancestor
64771253|NCT04142892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64771254|NCT04142892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771255|NCT04142892|Hormone Antagonists|hormone antagonists|mesh-ancestor
64771256|NCT04142892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64771257|NCT03697356|Dexamethasone|dexamethasone|mesh-list
64771258|NCT03697356|Rituximab|rituximab|mesh-list
64771259|NCT03697356|Lenalidomide|lenalidomide|mesh-list
64771260|NCT03697356|Bortezomib|bortezomib|mesh-list
64771261|NCT03697356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64771262|NCT03697356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64771263|NCT03697356|Immunologic Factors|immunologic factors|mesh-ancestor
64771264|NCT03697356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771265|NCT03697356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64771266|NCT03697356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64771267|NCT03697356|Antiemetics|antiemetics|mesh-ancestor
64771295|NCT00255138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771297|NCT00255138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64771298|NCT00255138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771299|NCT01128192|Pasireotide|pasireotide|mesh-list
64771300|NCT01128192|Hormones|hormones|mesh-ancestor
64771301|NCT01128192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64771302|NCT01128192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771303|NCT01128270|Chloral Hydrate|chloral hydrate|mesh-list
64771304|NCT01128270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64771305|NCT01128270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64771306|NCT01128270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771312|NCT01128972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495168|NCT01375816|Bevacizumab|bevacizumab|mesh-list
64595391|NCT01889667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64771313|NCT01128972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64771334|NCT01130844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64771335|NCT01130844|Analgesics|analgesics|mesh-ancestor
64771336|NCT01130844|Sensory System Agents|sensory system agents|mesh-ancestor
64771337|NCT01130844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64771338|NCT01130844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771339|NCT01130844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64771340|NCT01130844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64771341|NCT01134198|Mifepristone|mifepristone|mesh-list
64771342|NCT01134198|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64771343|NCT01134198|Abortifacient Agents|abortifacient agents|mesh-ancestor
64771344|NCT01134198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64771345|NCT01134198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771346|NCT01134198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64771347|NCT01134198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64771348|NCT01134198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64771349|NCT01134198|Contraceptive Agents|contraceptive agents|mesh-ancestor
64771350|NCT01134198|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64771351|NCT01134198|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64771352|NCT01134198|Hormone Antagonists|hormone antagonists|mesh-ancestor
64771353|NCT01134198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64771354|NCT01134198|Luteolytic Agents|luteolytic agents|mesh-ancestor
64771355|NCT01134198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64771356|NCT01134198|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64771357|NCT01134510|Complement C1s|complement c1s|mesh-list
64771358|NCT01134510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64571581|NCT01451333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64771393|NCT01139190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64771394|NCT01139190|Gout Suppressants|gout suppressants|mesh-ancestor
64771395|NCT01139190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64771396|NCT01139190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771397|NCT01139190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771398|NCT01140360|Imatinib Mesylate|imatinib mesylate|mesh-list
64771399|NCT01140360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64771400|NCT01140360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64771401|NCT01140360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771402|NCT01140360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771404|NCT01142310|Anticonvulsants|anticonvulsants|mesh-ancestor
64771405|NCT01142310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64771406|NCT01142310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64771407|NCT01142310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771408|NCT01142310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64771409|NCT01142310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771410|NCT01142310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64771411|NCT01142310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64771412|NCT01142310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64771413|NCT01142310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64771414|NCT01142310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64771415|NCT01144338|Exenatide|exenatide|mesh-list
64771416|NCT01144338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64771417|NCT01144338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771418|NCT01144338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64502441|NCT02248870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64502452|NCT03361098|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64502454|NCT03361098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502455|NCT03361098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64502456|NCT03361098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502457|NCT03361098|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64502458|NCT03361098|Incretins|incretins|mesh-ancestor
64502459|NCT03361098|Hormones|hormones|mesh-ancestor
64502460|NCT03361098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64502461|NCT03367494|Bromides|bromides|mesh-list
64502462|NCT03367494|Anticonvulsants|anticonvulsants|mesh-ancestor
64502463|NCT05594290|Etoposide|etoposide|mesh-list
64502464|NCT05594290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502465|NCT05594290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64502466|NCT05594290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64502467|NCT05594290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64502468|NCT05594290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502469|NCT05594290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502470|NCT03370380|Aflibercept|aflibercept|mesh-list
64771419|NCT01144338|Incretins|incretins|mesh-ancestor
64771420|NCT01144338|Hormones|hormones|mesh-ancestor
64771421|NCT01144338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64771443|NCT01146834|Cyclophosphamide|cyclophosphamide|mesh-list
64771444|NCT01146834|Bortezomib|bortezomib|mesh-list
64771445|NCT01146834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65495169|NCT01375816|Fluorouracil|fluorouracil|mesh-list
65495170|NCT01375816|Irinotecan|irinotecan|mesh-list
64595466|NCT02991781|Varenicline|varenicline|mesh-list
64771446|NCT01146834|Immunologic Factors|immunologic factors|mesh-ancestor
64771447|NCT01146834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771448|NCT01146834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64771449|NCT01146834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64771450|NCT01146834|Alkylating Agents|alkylating agents|mesh-ancestor
64771451|NCT01146834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771452|NCT01146834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64771453|NCT01146834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64771454|NCT01146834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64771455|NCT01146834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64771456|NCT01146834|Antiviral Agents|antiviral agents|mesh-ancestor
64540093|NCT01412879|Levoleucovorin|levoleucovorin|mesh-list
64771457|NCT01146834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64771458|NCT01147302|Complement C1s|complement c1s|mesh-list
64771459|NCT01147302|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64771460|NCT01147302|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
64771461|NCT01147302|Immunologic Factors|immunologic factors|mesh-ancestor
64771462|NCT01147302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771463|NCT01147302|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64771464|NCT01147302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64771467|NCT01149876|Keratolytic Agents|keratolytic agents|mesh-ancestor
64771513|NCT01163604|Purinergic Agents|purinergic agents|mesh-ancestor
64771514|NCT01163604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64771515|NCT01163604|Antithrombins|antithrombins|mesh-ancestor
64771551|NCT01170390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64771552|NCT01170390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64382964|NCT02046070|Ixazomib|ixazomib|mesh-list
64771580|NCT01175148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64771581|NCT01175148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771582|NCT01175148|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64771584|NCT01175148|Antimetabolites|antimetabolites|mesh-ancestor
64771585|NCT01175148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771586|NCT01175148|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64771587|NCT01175148|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64771588|NCT01175148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771589|NCT01177098|Timolol|timolol|mesh-list
64771590|NCT01177098|Bimatoprost|bimatoprost|mesh-list
64771591|NCT01177098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64771592|NCT01177098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64771593|NCT01177098|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64771594|NCT01177098|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64771595|NCT01177098|Adrenergic Agents|adrenergic agents|mesh-ancestor
64771596|NCT01177098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64771597|NCT01177098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771598|NCT01177098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771643|NCT01188876|Vitamin B 12|vitamin b 12|mesh-list
64771644|NCT01188876|Hydroxocobalamin|hydroxocobalamin|mesh-list
64502471|NCT03370380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64502472|NCT03370380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64502473|NCT03370380|Growth Substances|growth substances|mesh-ancestor
64502474|NCT03370380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502475|NCT03370380|Growth Inhibitors|growth inhibitors|mesh-ancestor
64502476|NCT03370380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502477|NCT04414540|Metformin|metformin|mesh-list
64502478|NCT04414540|Pembrolizumab|pembrolizumab|mesh-list
64502479|NCT04414540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64502480|NCT04414540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502481|NCT04414540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64502482|NCT04414540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502483|NCT05568160|Vasopressins|vasopressins|mesh-list
64502484|NCT05568160|Arginine Vasopressin|arginine vasopressin|mesh-list
64502485|NCT05568160|Norepinephrine|norepinephrine|mesh-list
64502486|NCT05568160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64724332|NCT04226456|Antidotes|antidotes|mesh-ancestor
64724333|NCT00000415|Calcium|calcium|mesh-list
64724334|NCT00000415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64724335|NCT00000415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724336|NCT00000847|polysaccharide-K|polysaccharide-k|mesh-list
64724337|NCT00000847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64724338|NCT00000847|Immunologic Factors|immunologic factors|mesh-ancestor
64571677|NCT00608725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64771645|NCT01188876|Carboplatin|carboplatin|mesh-list
64771646|NCT01188876|Vitamins|vitamins|mesh-ancestor
64771647|NCT01188876|Micronutrients|micronutrients|mesh-ancestor
64771648|NCT01188876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771649|NCT01188876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64771650|NCT01188876|Hematinics|hematinics|mesh-ancestor
64771651|NCT01188876|Vitamin B Complex|vitamin b complex|mesh-ancestor
64771652|NCT01193868|R04929097|r04929097|mesh-list
64771653|NCT01193868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771654|NCT01193868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771655|NCT01195116|Dexmedetomidine|dexmedetomidine|mesh-list
65495171|NCT01375816|Calcium|calcium|mesh-list
64595538|NCT01893879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771656|NCT01195116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64771657|NCT01195116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64771658|NCT01195116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771659|NCT01195116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64771660|NCT01195116|Analgesics|analgesics|mesh-ancestor
64771661|NCT01195116|Sensory System Agents|sensory system agents|mesh-ancestor
64771662|NCT01195116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64771663|NCT01195116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64771664|NCT01195116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64771665|NCT01195116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64771666|NCT01195116|Adrenergic Agents|adrenergic agents|mesh-ancestor
64771667|NCT01195116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64724339|NCT00000847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724340|NCT00000847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64724341|NCT00000847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64724342|NCT00000847|Antiviral Agents|antiviral agents|mesh-ancestor
64724343|NCT00000847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724344|NCT00000847|Interferon Inducers|interferon inducers|mesh-ancestor
64724345|NCT00000847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64419544|NCT02336607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64502487|NCT05568160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64502488|NCT05568160|Adrenergic Agents|adrenergic agents|mesh-ancestor
64502489|NCT05568160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64502490|NCT05568160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502491|NCT05568160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502493|NCT05568160|Autonomic Agents|autonomic agents|mesh-ancestor
64502494|NCT05568160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502495|NCT05568160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64502496|NCT05568160|Hemostatics|hemostatics|mesh-ancestor
64502497|NCT05568160|Coagulants|coagulants|mesh-ancestor
64502498|NCT05568160|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64502499|NCT05568160|Natriuretic Agents|natriuretic agents|mesh-ancestor
64502501|NCT03889912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64502502|NCT03889912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502503|NCT03367182|Paclitaxel|paclitaxel|mesh-list
64502504|NCT03367182|Bevacizumab|bevacizumab|mesh-list
64571704|NCT01896349|Nortriptyline|nortriptyline|mesh-list
64771668|NCT01195116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771669|NCT01197612|Budesonide|budesonide|mesh-list
64771670|NCT01197612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64771671|NCT01197612|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64771672|NCT01197612|Autonomic Agents|autonomic agents|mesh-ancestor
64771673|NCT01197612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64771674|NCT01197612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771675|NCT01197612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64771676|NCT01197612|Respiratory System Agents|respiratory system agents|mesh-ancestor
64771677|NCT01197612|Glucocorticoids|glucocorticoids|mesh-ancestor
64771678|NCT01197612|Hormones|hormones|mesh-ancestor
64771679|NCT01197612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64771703|NCT01205646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64771704|NCT01205646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771705|NCT01206660|Desoximetasone|desoximetasone|mesh-list
64771706|NCT01206660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64771707|NCT01206660|Glucocorticoids|glucocorticoids|mesh-ancestor
64771708|NCT01206660|Hormones|hormones|mesh-ancestor
64771709|NCT01206660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64771710|NCT01206660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771711|NCT01207752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64771712|NCT01207752|Lubricant Eye Drops|lubricant eye drops|mesh-list
64771713|NCT01207752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64771714|NCT01207908|Mecasermin|mecasermin|mesh-list
64771715|NCT01207908|Growth Substances|growth substances|mesh-ancestor
64771716|NCT01207908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771717|NCT01208922|Ciprofloxacin|ciprofloxacin|mesh-list
64771718|NCT01208922|Rifamycins|rifamycins|mesh-list
64771719|NCT01208922|Rifamycin SV|rifamycin sv|mesh-list
64771720|NCT01208922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64771721|NCT01208922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64771722|NCT01208922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64771723|NCT01208922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64502505|NCT03367182|Doxorubicin|doxorubicin|mesh-list
64502506|NCT03367182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64502507|NCT03367182|Topotecan|topotecan|mesh-list
64502515|NCT03367182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64502516|NCT03367182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64502517|NCT03367182|Growth Substances|growth substances|mesh-ancestor
64502518|NCT03367182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502519|NCT03367182|Growth Inhibitors|growth inhibitors|mesh-ancestor
64571734|NCT01896349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64771724|NCT01208922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771725|NCT01208922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771726|NCT01208922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64771727|NCT01208922|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64771728|NCT01208922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64771729|NCT01208922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64771730|NCT01210170|Mometasone Furoate|mometasone furoate|mesh-list
64771731|NCT01210170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64771732|NCT01210170|Dermatologic Agents|dermatologic agents|mesh-ancestor
64771733|NCT01210170|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64771734|NCT01210560|Tolvaptan|tolvaptan|mesh-list
64771925|NCT01236378|Antifungal Agents|antifungal agents|mesh-ancestor
64771926|NCT01236378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64771927|NCT01236378|Immunologic Factors|immunologic factors|mesh-ancestor
64771928|NCT01236378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771929|NCT01236768|Contraceptive Agents|contraceptive agents|mesh-list
64771930|NCT01236768|Contraceptives, Oral|contraceptives, oral|mesh-list
64771931|NCT01236768|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-list
64771932|NCT01236768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64771933|NCT01236768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771934|NCT01236768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64771935|NCT01236768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64771936|NCT01238640|Nicotine|nicotine|mesh-list
64771937|NCT01238640|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64771938|NCT01238640|Autonomic Agents|autonomic agents|mesh-ancestor
64771939|NCT01238640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64771940|NCT01238640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771941|NCT01238640|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65495172|NCT01375816|Levoleucovorin|levoleucovorin|mesh-list
64595620|NCT01276717|Vorinostat|vorinostat|mesh-list
64771942|NCT01238640|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64771943|NCT01238640|Cholinergic Agents|cholinergic agents|mesh-ancestor
64771944|NCT01238640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64502520|NCT03367182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64502521|NCT03367182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64502522|NCT03367182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64502523|NCT03367182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502524|NCT03367182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64502525|NCT05561764|Imipenem|imipenem|mesh-list
64502526|NCT05561764|Relebactam|relebactam|mesh-list
64502527|NCT05561764|Cilastatin|cilastatin|mesh-list
64571767|NCT01659307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64771945|NCT01238640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771946|NCT01244724|Citalopram|citalopram|mesh-list
64571768|NCT01659307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64571769|NCT01659307|Analgesics|analgesics|mesh-ancestor
64571770|NCT01659307|Sensory System Agents|sensory system agents|mesh-ancestor
64571771|NCT01659307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64571772|NCT01659307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571773|NCT01659307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64571774|NCT01659307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64571775|NCT01659307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64571776|NCT01659307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64571777|NCT01659307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571778|NCT01659307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64571779|NCT01659307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64571780|NCT01659307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571781|NCT01659307|Antipyretics|antipyretics|mesh-ancestor
64571782|NCT01594476|Levonorgestrel|levonorgestrel|mesh-list
64771947|NCT01244724|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64771948|NCT01244724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64771949|NCT01244724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64571784|NCT01594476|Contraceptive Agents|contraceptive agents|mesh-ancestor
64571785|NCT01594476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64771990|NCT01250730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64771991|NCT01250730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771992|NCT01250730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771993|NCT01251978|Ranibizumab|ranibizumab|mesh-list
64771994|NCT01251978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64771995|NCT01251978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64771996|NCT01251978|Growth Substances|growth substances|mesh-ancestor
64771997|NCT01251978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771998|NCT01251978|Growth Inhibitors|growth inhibitors|mesh-ancestor
64771999|NCT01251978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64772000|NCT01253460|Cyclophosphamide|cyclophosphamide|mesh-list
64772001|NCT01253460|Rituximab|rituximab|mesh-list
64772002|NCT01253460|Sapacitabine|sapacitabine|mesh-list
64772003|NCT01253460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64772004|NCT01253460|Immunologic Factors|immunologic factors|mesh-ancestor
64772005|NCT01253460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772006|NCT01253460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64772007|NCT01253460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64772008|NCT01253460|Alkylating Agents|alkylating agents|mesh-ancestor
64772009|NCT01253460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772010|NCT01253460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64772011|NCT01253460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64772012|NCT01253460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64772013|NCT01254396|Sildenafil Citrate|sildenafil citrate|mesh-list
64772014|NCT01254396|Vasodilator Agents|vasodilator agents|mesh-ancestor
64772015|NCT01254396|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64772016|NCT01254396|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64772017|NCT01254396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772018|NCT01254396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383427|NCT02409407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64772034|NCT01258374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64571790|NCT04391231|Pentoxifylline|pentoxifylline|mesh-list
64502528|NCT05561764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64502529|NCT05561764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64502530|NCT05561764|Protease Inhibitors|protease inhibitors|mesh-ancestor
64502531|NCT05561764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571813|NCT04872192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772035|NCT01258374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64772036|NCT01258374|Protease Inhibitors|protease inhibitors|mesh-ancestor
64772037|NCT01262118|Tofacitinib|tofacitinib|mesh-list
65495173|NCT01375816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64473258|NCT00121186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64772038|NCT01262118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64772039|NCT01262118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772040|NCT01262118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772042|NCT01263132|Vitamin B 12|vitamin b 12|mesh-list
64772043|NCT01263132|Gabapentin|gabapentin|mesh-list
64772044|NCT01263132|Analgesics|analgesics|mesh-ancestor
64772045|NCT01263132|Sensory System Agents|sensory system agents|mesh-ancestor
64772046|NCT01263132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772047|NCT01263132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772048|NCT01263132|Anticonvulsants|anticonvulsants|mesh-ancestor
64772049|NCT01263132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64772050|NCT01263132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64571814|NCT01624285|Sorafenib|sorafenib|mesh-list
64502532|NCT05561764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724351|NCT00000439|Valproic Acid|valproic acid|mesh-list
64724352|NCT00000439|Anticonvulsants|anticonvulsants|mesh-ancestor
64724353|NCT00000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724354|NCT00000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724355|NCT00000439|GABA Agents|gaba agents|mesh-ancestor
64724356|NCT00000439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64724357|NCT00000439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724358|NCT00000439|Antimanic Agents|antimanic agents|mesh-ancestor
64724359|NCT00000439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64724360|NCT00000439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64724361|NCT00000439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64724362|NCT00002912|Etoposide|etoposide|mesh-list
64724363|NCT00002912|Mitoxantrone|mitoxantrone|mesh-list
64724364|NCT00002912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64724365|NCT00002912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502533|NCT05561764|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64502534|NCT04119180|Midazolam|midazolam|mesh-list
64502535|NCT04119180|Ketamine|ketamine|mesh-list
64502536|NCT04119180|Analgesics|analgesics|mesh-ancestor
64502537|NCT04119180|Sensory System Agents|sensory system agents|mesh-ancestor
64502538|NCT04119180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502539|NCT04119180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502540|NCT04119180|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64502541|NCT04119180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64502542|NCT04119180|Anesthetics, General|anesthetics, general|mesh-ancestor
64502543|NCT04119180|Anesthetics|anesthetics|mesh-ancestor
64502544|NCT04119180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64502545|NCT04119180|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64419576|NCT02573311|Tamsulosin|tamsulosin|mesh-list
64502557|NCT03358212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64502558|NCT03358212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502559|NCT04522050|Gemcitabine|gemcitabine|mesh-list
64502560|NCT04522050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502561|NCT04522050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64502562|NCT04522050|Antimetabolites|antimetabolites|mesh-ancestor
64502563|NCT04522050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571831|NCT01454609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64772051|NCT01263132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64772052|NCT01263132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64772053|NCT01263132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64772054|NCT01263132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64772055|NCT01263132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64772056|NCT01263132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772057|NCT01263132|Antimanic Agents|antimanic agents|mesh-ancestor
64772058|NCT01263132|Vitamin B Complex|vitamin b complex|mesh-ancestor
64772060|NCT01263132|Micronutrients|micronutrients|mesh-ancestor
64772061|NCT01267656|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64772062|NCT01267656|Lubricant Eye Drops|lubricant eye drops|mesh-list
64772063|NCT01267656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64772064|NCT01270542|Bevacizumab|bevacizumab|mesh-list
64772065|NCT01270542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64772066|NCT01270542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64772067|NCT01270542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64772068|NCT01270542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64772069|NCT01270542|Growth Substances|growth substances|mesh-ancestor
64772070|NCT01270542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772071|NCT01270542|Growth Inhibitors|growth inhibitors|mesh-ancestor
64772072|NCT01271244|Citalopram|citalopram|mesh-list
64772073|NCT01271244|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64772074|NCT01271244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64772075|NCT01271244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64772076|NCT01271244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772077|NCT01271244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64772107|NCT01275300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64772108|NCT01275300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772109|NCT01275300|Antipyretics|antipyretics|mesh-ancestor
64772110|NCT01275300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64772111|NCT01275300|Antimetabolites|antimetabolites|mesh-ancestor
64772112|NCT01275300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64772113|NCT01275300|Vasodilator Agents|vasodilator agents|mesh-ancestor
64772114|NCT01275300|Vitamin B Complex|vitamin b complex|mesh-ancestor
64502564|NCT04522050|Antiviral Agents|antiviral agents|mesh-ancestor
64502565|NCT04522050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64502566|NCT04522050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772115|NCT01275300|Vitamins|vitamins|mesh-ancestor
64772116|NCT01275300|Micronutrients|micronutrients|mesh-ancestor
64772117|NCT01276314|Prednisolone|prednisolone|mesh-list
64772118|NCT01276314|Etanercept|etanercept|mesh-list
64772119|NCT01276314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64772120|NCT01276314|Glucocorticoids|glucocorticoids|mesh-ancestor
64772121|NCT01276314|Hormones|hormones|mesh-ancestor
64772122|NCT01276314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64383538|NCT03174041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772212|NCT01294098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64772213|NCT01294098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772215|NCT01294098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772216|NCT01295112|Dexamethasone|dexamethasone|mesh-list
64772217|NCT01295112|Dexamethasone acetate|dexamethasone acetate|mesh-list
64772218|NCT01295112|Bevacizumab|bevacizumab|mesh-list
64772219|NCT01295112|BB 1101|bb 1101|mesh-list
64772220|NCT01295112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64772221|NCT01295112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64772222|NCT01295112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64383641|NCT05518929|Propofol|propofol|mesh-list
64772254|NCT01304082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64502567|NCT04522050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64502568|NCT04522050|Immunologic Factors|immunologic factors|mesh-ancestor
64502569|NCT04522050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502570|NCT03109392|Lidocaine|lidocaine|mesh-list
64502571|NCT03109392|Anesthetics, Local|anesthetics, local|mesh-ancestor
64502572|NCT03109392|Anesthetics|anesthetics|mesh-ancestor
64502573|NCT03109392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64502574|NCT03109392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724366|NCT00002912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64724367|NCT00002912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64724368|NCT00002912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724369|NCT00002912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724371|NCT00002912|Sensory System Agents|sensory system agents|mesh-ancestor
64724372|NCT00002912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64724373|NCT00002912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724374|NCT04183790|Ivacaftor|ivacaftor|mesh-list
64724375|NCT04183790|Elexacaftor|elexacaftor|mesh-list
64724376|NCT04183790|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64724377|NCT04183790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64724378|NCT04183790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724379|NCT00000445|Naltrexone|naltrexone|mesh-list
64724380|NCT00000445|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64463649|NCT02984176|Antifoaming Agents|antifoaming agents|mesh-ancestor
64724381|NCT00000445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64724382|NCT00000445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724383|NCT00000445|Sensory System Agents|sensory system agents|mesh-ancestor
64724384|NCT00000445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64724385|NCT00000451|Naltrexone|naltrexone|mesh-list
64724386|NCT00000451|Sertraline|sertraline|mesh-list
64724387|NCT00000451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64724388|NCT00000451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64724389|NCT00000451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724390|NCT00000451|Sensory System Agents|sensory system agents|mesh-ancestor
64331939|NCT04352777|Fulvestrant|fulvestrant|mesh-list
64502588|NCT03357900|Anesthetics, General|anesthetics, general|mesh-ancestor
64772255|NCT01304082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571883|NCT01456247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571884|NCT01456325|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64772257|NCT01304082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772258|NCT01304082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64772259|NCT01304082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64772260|NCT01304082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65495174|NCT01375816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473259|NCT00121186|Abortifacient Agents|abortifacient agents|mesh-ancestor
64595761|NCT01277731|Prednisolone phosphate|prednisolone phosphate|mesh-list
64772261|NCT01304082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64772262|NCT01304082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772312|NCT01308840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772313|NCT01308840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64772314|NCT01308840|Immunologic Factors|immunologic factors|mesh-ancestor
64772315|NCT01308840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772316|NCT01308840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64772317|NCT01311102|Lidocaine|lidocaine|mesh-list
64772318|NCT01311102|Anesthetics, Local|anesthetics, local|mesh-ancestor
64772319|NCT01311102|Anesthetics|anesthetics|mesh-ancestor
64772320|NCT01311102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64772321|NCT01311102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772322|NCT01311102|Sensory System Agents|sensory system agents|mesh-ancestor
64772323|NCT01311102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772324|NCT01311102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64772325|NCT01311102|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64772326|NCT01311102|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64772327|NCT01311102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64772328|NCT01311102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772329|NCT01312038|Simethicone|simethicone|mesh-list
64772330|NCT01312038|Antifoaming Agents|antifoaming agents|mesh-ancestor
64571899|NCT04866654|Nivolumab|nivolumab|mesh-list
64502589|NCT03357900|Anesthetics|anesthetics|mesh-ancestor
64502590|NCT03357900|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64502591|NCT03357900|Narcotics|narcotics|mesh-ancestor
64502592|NCT03357900|Analgesics|analgesics|mesh-ancestor
64502593|NCT03357900|Sensory System Agents|sensory system agents|mesh-ancestor
64502594|NCT03357900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502595|NCT04525326|Bevacizumab|bevacizumab|mesh-list
64772331|NCT01312038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772332|NCT01312038|Emollients|emollients|mesh-ancestor
64772333|NCT01312038|Dermatologic Agents|dermatologic agents|mesh-ancestor
64772334|NCT01312272|Oxytocin|oxytocin|mesh-list
64772335|NCT01312272|Oxytocics|oxytocics|mesh-ancestor
64772336|NCT01312272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64772337|NCT01312272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772338|NCT01312818|Dexamethasone|dexamethasone|mesh-list
64772339|NCT01312818|Methotrexate|methotrexate|mesh-list
64772340|NCT01312818|Bortezomib|bortezomib|mesh-list
64772341|NCT01312818|Imatinib Mesylate|imatinib mesylate|mesh-list
64772342|NCT01312818|Vorinostat|vorinostat|mesh-list
64772343|NCT01312818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64772344|NCT01312818|Antiemetics|antiemetics|mesh-ancestor
64772371|NCT01313520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64772372|NCT01313520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64772374|NCT01315002|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64772375|NCT01315002|Autonomic Agents|autonomic agents|mesh-ancestor
64772376|NCT01315002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772377|NCT01315002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772378|NCT01315002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64772379|NCT01315002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64772380|NCT01315002|Cholinergic Agents|cholinergic agents|mesh-ancestor
64772381|NCT01315002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64772382|NCT01315002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772383|NCT01315158|Fentanyl|fentanyl|mesh-list
64772384|NCT01315158|Midazolam|midazolam|mesh-list
64772385|NCT01315158|Analgesics, Opioid|analgesics, opioid|mesh-list
64772386|NCT01315158|Propofol|propofol|mesh-list
64772387|NCT01315158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64772388|NCT01315158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64772389|NCT01315158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772390|NCT01315158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64772391|NCT01315158|Anesthetics, General|anesthetics, general|mesh-ancestor
64772451|NCT01328184|Contraceptive Agents|contraceptive agents|mesh-ancestor
64772452|NCT01328184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64772453|NCT01328184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772457|NCT01328184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64772458|NCT01328184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772459|NCT01328184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64772460|NCT01328184|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64772462|NCT01328184|Hormones|hormones|mesh-ancestor
64772463|NCT01328184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64772464|NCT01328184|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64772465|NCT01328184|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
64772519|NCT01331694|Ipratropium|ipratropium|mesh-list
65495175|NCT01375816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65495176|NCT01375816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64772520|NCT01331694|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64772521|NCT01331694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64772522|NCT01331694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64772523|NCT01331694|Autonomic Agents|autonomic agents|mesh-ancestor
64772524|NCT01331694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772525|NCT01331694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772526|NCT01331694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64772527|NCT01331694|Respiratory System Agents|respiratory system agents|mesh-ancestor
64772528|NCT01331694|Dermatologic Agents|dermatologic agents|mesh-ancestor
64772529|NCT01331694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64772530|NCT01331694|Parasympatholytics|parasympatholytics|mesh-ancestor
64772531|NCT01331694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64772532|NCT01331694|Cholinergic Agents|cholinergic agents|mesh-ancestor
64772533|NCT01331694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64772543|NCT01331694|Hormones|hormones|mesh-ancestor
64772554|NCT01333098|Contraceptive Agents|contraceptive agents|mesh-ancestor
64772555|NCT01333098|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64772556|NCT01333098|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64772557|NCT01333098|Hormone Antagonists|hormone antagonists|mesh-ancestor
64383959|NCT04698226|Temazepam|temazepam|mesh-list
64772572|NCT01333488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64772573|NCT01333488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772574|NCT01333488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64772575|NCT01333488|Tocolytic Agents|tocolytic agents|mesh-ancestor
64772576|NCT01333488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64772577|NCT01335204|Bavituximab|bavituximab|mesh-list
64772578|NCT01335204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64772579|NCT01335204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64772580|NCT01335750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64772581|NCT01336296|Mycophenolic Acid|mycophenolic acid|mesh-list
64772582|NCT01336296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64772583|NCT01336296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64772584|NCT01336296|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64772585|NCT01336296|Antitubercular Agents|antitubercular agents|mesh-ancestor
64772586|NCT01336296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64772587|NCT01336296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64772588|NCT01336296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772589|NCT01336296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772590|NCT01337700|Milnacipran|milnacipran|mesh-list
64772591|NCT01337700|Levomilnacipran|levomilnacipran|mesh-list
64772592|NCT01337700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64772593|NCT01337700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64772594|NCT01337700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64772595|NCT01337700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502596|NCT04525326|Cetuximab|cetuximab|mesh-list
64572039|NCT02508311|Respiratory System Agents|respiratory system agents|mesh-ancestor
64572040|NCT02508311|Tocolytic Agents|tocolytic agents|mesh-ancestor
64572041|NCT02508311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64572042|NCT02508311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64772607|NCT01339260|Antiemetics|antiemetics|mesh-ancestor
64772608|NCT01339260|Autonomic Agents|autonomic agents|mesh-ancestor
64772609|NCT01339260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772610|NCT01339260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772611|NCT01339260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64772612|NCT01339260|Glucocorticoids|glucocorticoids|mesh-ancestor
64772613|NCT01339260|Hormones|hormones|mesh-ancestor
64772614|NCT01339260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64384018|NCT02560389|Levodopa|levodopa|mesh-list
64772678|NCT01353144|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64772679|NCT01353144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64772680|NCT01353144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772681|NCT01353144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64772682|NCT01353144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64772683|NCT01353144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772684|NCT01353144|Antipyretics|antipyretics|mesh-ancestor
64772685|NCT01362192|Chlorhexidine|chlorhexidine|mesh-list
64772686|NCT01362192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64772687|NCT01362192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64772688|NCT01362192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64772689|NCT01362192|Disinfectants|disinfectants|mesh-ancestor
64772690|NCT01362192|Dermatologic Agents|dermatologic agents|mesh-ancestor
64772692|NCT01363050|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64772693|NCT01363050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64772694|NCT01363050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64772695|NCT01363050|Analgesics|analgesics|mesh-ancestor
64772696|NCT01363050|Sensory System Agents|sensory system agents|mesh-ancestor
64772704|NCT01363128|Cytarabine|cytarabine|mesh-list
64772708|NCT01363128|Doxorubicin|doxorubicin|mesh-list
64572071|NCT01459211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64772709|NCT01363128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64772765|NCT01371786|Mometasone Furoate|mometasone furoate|mesh-list
64772766|NCT01371786|Ciclesonide|ciclesonide|mesh-list
64772767|NCT01371786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64772768|NCT01371786|Dermatologic Agents|dermatologic agents|mesh-ancestor
64772769|NCT01371786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64772770|NCT01371786|Glucocorticoids|glucocorticoids|mesh-ancestor
64772771|NCT01371786|Hormones|hormones|mesh-ancestor
64772772|NCT01371786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64772773|NCT01371786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772774|NCT01375140|Prednisone|prednisone|mesh-list
64772775|NCT01375140|Lenalidomide|lenalidomide|mesh-list
64772776|NCT01375140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64772777|NCT01375140|Glucocorticoids|glucocorticoids|mesh-ancestor
64772778|NCT01375140|Hormones|hormones|mesh-ancestor
64772779|NCT01375140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64772780|NCT01375140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772781|NCT01375140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64772782|NCT01375140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64772783|NCT01375140|Immunologic Factors|immunologic factors|mesh-ancestor
64772784|NCT01375140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64772785|NCT01375140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64772835|NCT01388946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772836|NCT01390818|Niacinamide|niacinamide|mesh-list
64772837|NCT01390818|Sirolimus|sirolimus|mesh-list
64772839|NCT01390818|Protease Inhibitors|protease inhibitors|mesh-ancestor
64772840|NCT01390818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772841|NCT01390818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772842|NCT01390818|Vitamin B Complex|vitamin b complex|mesh-ancestor
64772843|NCT01390818|Vitamins|vitamins|mesh-ancestor
64772844|NCT01390818|Micronutrients|micronutrients|mesh-ancestor
64772879|NCT01399008|Tubulin Modulators|tubulin modulators|mesh-ancestor
64772880|NCT01399008|Antimitotic Agents|antimitotic agents|mesh-ancestor
64772881|NCT01399008|Mitosis Modulators|mitosis modulators|mesh-ancestor
64772882|NCT01399008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772883|NCT01399008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64772884|NCT01399008|Antimetabolites|antimetabolites|mesh-ancestor
64772885|NCT01399008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772886|NCT01399008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64772887|NCT01399008|Antioxidants|antioxidants|mesh-ancestor
64772888|NCT01399008|Protective Agents|protective agents|mesh-ancestor
64772914|NCT01403376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772915|NCT01403376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772916|NCT01403376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64772917|NCT01403376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64772918|NCT01403376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64772919|NCT01403376|Immunologic Factors|immunologic factors|mesh-ancestor
64772920|NCT01403376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64772921|NCT01404936|Interferons|interferons|mesh-list
64772922|NCT01404936|Interferon-alpha|interferon-alpha|mesh-list
64772923|NCT01404936|Interferon alpha-2|interferon alpha-2|mesh-list
64772924|NCT01404936|Doxorubicin|doxorubicin|mesh-list
64772925|NCT01404936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64772926|NCT01404936|Bleomycin|bleomycin|mesh-list
64772927|NCT01404936|Dacarbazine|dacarbazine|mesh-list
64772928|NCT01404936|Vinblastine|vinblastine|mesh-list
64772929|NCT01404936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64772930|NCT01404936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502597|NCT04525326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64502598|NCT04525326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502607|NCT03357822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502608|NCT03357822|Antiviral Agents|antiviral agents|mesh-ancestor
64502609|NCT03357822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64502610|NCT03357822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64724391|NCT00000451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772931|NCT01404936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64772932|NCT01404936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64772933|NCT01404936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772934|NCT01404936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772935|NCT01404936|Antiviral Agents|antiviral agents|mesh-ancestor
64772936|NCT01404936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64772937|NCT01404936|Immunologic Factors|immunologic factors|mesh-ancestor
64772938|NCT01404936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772939|NCT01404936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64772940|NCT01404936|Alkylating Agents|alkylating agents|mesh-ancestor
64773057|NCT01435824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64773058|NCT01435824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64773059|NCT01436526|Rivaroxaban|rivaroxaban|mesh-list
64773060|NCT01436526|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64773061|NCT01436526|Antithrombins|antithrombins|mesh-ancestor
64773062|NCT01436526|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64773063|NCT01436526|Protease Inhibitors|protease inhibitors|mesh-ancestor
64773064|NCT01436526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773065|NCT01436526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773066|NCT01436526|Anticoagulants|anticoagulants|mesh-ancestor
64773067|NCT01438710|Tacrolimus|tacrolimus|mesh-list
64773068|NCT01438710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64773069|NCT01438710|Immunologic Factors|immunologic factors|mesh-ancestor
64773070|NCT01438710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773071|NCT01438710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64773072|NCT01438710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773073|NCT01438710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473261|NCT00121186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773074|NCT01443546|Leuprolide|leuprolide|mesh-list
64773075|NCT01443546|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64773076|NCT01443546|Fertility Agents|fertility agents|mesh-ancestor
64773144|NCT01463202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64773145|NCT01463202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64773146|NCT01463202|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64773147|NCT01463202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64773148|NCT01463202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773149|NCT01467882|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64773150|NCT01467882|Luteolytic Agents|luteolytic agents|mesh-ancestor
64773151|NCT01467882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64773152|NCT01467882|Contraceptive Agents|contraceptive agents|mesh-ancestor
64773153|NCT01467882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64773154|NCT01467882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773155|NCT01467882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64773156|NCT01467882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64773157|NCT01467882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773175|NCT01474122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773176|NCT01474122|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64773178|NCT01474200|Diuretics|diuretics|mesh-list
64773179|NCT01474200|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
64541827|NCT00704847|Katacalcin|katacalcin|mesh-list
64773180|NCT01474200|Natriuretic Agents|natriuretic agents|mesh-ancestor
64773181|NCT01474200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773182|NCT01474200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64773183|NCT01474200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773184|NCT01474590|Doxycycline|doxycycline|mesh-list
64773185|NCT01474590|Isotretinoin|isotretinoin|mesh-list
64773186|NCT01474590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64773187|NCT01474590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64773188|NCT01474590|Antimalarials|antimalarials|mesh-ancestor
64773189|NCT01474590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64773204|NCT01478256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64572245|NCT01455233|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64773205|NCT01478256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64773206|NCT01478256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64773207|NCT01478256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773208|NCT01478256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773209|NCT01478256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64773210|NCT01478256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64773211|NCT01478256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773212|NCT01479270|Epinephrine|epinephrine|mesh-list
64773213|NCT01479270|Ropivacaine|ropivacaine|mesh-list
64773228|NCT01479270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64773229|NCT01479270|Respiratory System Agents|respiratory system agents|mesh-ancestor
64773231|NCT01479270|Sympathomimetics|sympathomimetics|mesh-ancestor
64773232|NCT01479270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64773233|NCT01479348|Tetrahydrouridine|tetrahydrouridine|mesh-list
65495179|NCT01375816|Growth Inhibitors|growth inhibitors|mesh-ancestor
64773235|NCT01479348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773236|NCT01483560|Metformin|metformin|mesh-list
64773237|NCT01483560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64773238|NCT01483560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773239|NCT01484340|Nicotine|nicotine|mesh-list
64773240|NCT01484340|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64773241|NCT01484340|Autonomic Agents|autonomic agents|mesh-ancestor
64773242|NCT01484340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773243|NCT01484340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773244|NCT01484340|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64773245|NCT01484340|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64773246|NCT01484340|Cholinergic Agents|cholinergic agents|mesh-ancestor
64773247|NCT01484340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64773248|NCT01484340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773249|NCT01485588|Immunoconjugates|immunoconjugates|mesh-list
64773250|NCT01485588|Immunologic Factors|immunologic factors|mesh-ancestor
64773251|NCT01485588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773252|NCT01488318|Cetuximab|cetuximab|mesh-list
64773253|NCT01488318|Dasatinib|dasatinib|mesh-list
64724392|NCT00000451|Antidepressive Agents|antidepressive agents|mesh-ancestor
64724393|NCT00000451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64572278|NCT01455857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64773254|NCT01488318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64773255|NCT01488318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773256|NCT01488318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64773257|NCT01488318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773258|NCT01488318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773259|NCT01495572|Aldesleukin|aldesleukin|mesh-list
64773260|NCT01495572|Cyclophosphamide|cyclophosphamide|mesh-list
64773261|NCT01495572|Fludarabine|fludarabine|mesh-list
64773262|NCT01495572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64773263|NCT01495572|Immunologic Factors|immunologic factors|mesh-ancestor
64773264|NCT01495572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773265|NCT01495572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64773266|NCT01495572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64773267|NCT01495572|Alkylating Agents|alkylating agents|mesh-ancestor
64773268|NCT01495572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773269|NCT01495572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773270|NCT01495572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64773271|NCT01495572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64773272|NCT01495572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64773273|NCT01495572|Antiviral Agents|antiviral agents|mesh-ancestor
64773331|NCT01515540|Anesthetics|anesthetics|mesh-ancestor
64773332|NCT01515540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64773333|NCT01515540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773334|NCT01515540|Sensory System Agents|sensory system agents|mesh-ancestor
64773335|NCT01515540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773336|NCT01515540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64773337|NCT01515540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64773338|NCT01515540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64773339|NCT01515540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64773340|NCT01515540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724394|NCT00000451|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64724395|NCT00000451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64724396|NCT00000451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64724397|NCT00000451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724398|NCT00000451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64724399|NCT00000451|Serotonin Agents|serotonin agents|mesh-ancestor
64724400|NCT00000865|Lamivudine|lamivudine|mesh-list
64724401|NCT00000865|Zidovudine|zidovudine|mesh-list
64724402|NCT00000865|Abacavir|abacavir|mesh-list
64724403|NCT00000865|Stavudine|stavudine|mesh-list
64572311|NCT03043326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64773341|NCT01519284|Levodopa|levodopa|mesh-list
64773342|NCT01519284|Carbidopa|carbidopa|mesh-list
64773343|NCT01519284|Opicapone|opicapone|mesh-list
64773344|NCT01519284|Entacapone|entacapone|mesh-list
64773345|NCT01519284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64773346|NCT01519284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64773347|NCT01519284|Dopamine Agents|dopamine agents|mesh-ancestor
64773348|NCT01519284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64773349|NCT01519284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773350|NCT01519284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773351|NCT01519284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64773352|NCT01519284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773353|NCT01519284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64773354|NCT01520454|Heparin|heparin|mesh-list
64773355|NCT01520454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64773356|NCT01520454|Anticoagulants|anticoagulants|mesh-ancestor
64773401|NCT01526538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64773402|NCT01526538|Antitubercular Agents|antitubercular agents|mesh-ancestor
64773403|NCT01526538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64773404|NCT01526538|Antimetabolites|antimetabolites|mesh-ancestor
64773405|NCT01526538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773406|NCT01529502|Nitric Oxide|nitric oxide|mesh-list
64724404|NCT00000865|Didanosine|didanosine|mesh-list
64724405|NCT00000865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64724406|NCT00000865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64724407|NCT00000865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724408|NCT00000865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502611|NCT03357822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64502612|NCT03357822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502613|NCT03357822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502614|NCT03357822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64502615|NCT03357822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64502616|NCT03359694|Docetaxel|docetaxel|mesh-list
64502617|NCT03359694|Doxorubicin|doxorubicin|mesh-list
64502618|NCT03359694|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64502619|NCT03359694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502620|NCT03359694|Tubulin Modulators|tubulin modulators|mesh-ancestor
64502621|NCT03359694|Antimitotic Agents|antimitotic agents|mesh-ancestor
64502622|NCT03359694|Mitosis Modulators|mitosis modulators|mesh-ancestor
64502623|NCT03359694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502624|NCT03359694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64502625|NCT03359694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64502626|NCT03359694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64502627|NCT03359694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502628|NCT04113382|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64502629|NCT04113382|Laxatives|laxatives|mesh-ancestor
64502630|NCT04113382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64502631|NCT03404596|Nicotine|nicotine|mesh-list
64502632|NCT03404596|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64502633|NCT03404596|Autonomic Agents|autonomic agents|mesh-ancestor
64502634|NCT03404596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773407|NCT01529502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64773408|NCT01529502|Autonomic Agents|autonomic agents|mesh-ancestor
64473262|NCT00121186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64773409|NCT01529502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773410|NCT01529502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773411|NCT01529502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64773412|NCT01529502|Respiratory System Agents|respiratory system agents|mesh-ancestor
64773413|NCT01529502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64773415|NCT01529502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773416|NCT01529502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64773417|NCT01529502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64773418|NCT01529502|Vasodilator Agents|vasodilator agents|mesh-ancestor
64773419|NCT01529502|Gasotransmitters|gasotransmitters|mesh-ancestor
64773420|NCT01529502|Protective Agents|protective agents|mesh-ancestor
64773422|NCT01532700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773423|NCT01533948|Axitinib|axitinib|mesh-list
64773424|NCT01533948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773425|NCT01533948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64773426|NCT01533948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773427|NCT01533948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773428|NCT01534416|Bupivacaine|bupivacaine|mesh-list
64773429|NCT01534416|Anesthetics, Local|anesthetics, local|mesh-ancestor
64773430|NCT01534416|Anesthetics|anesthetics|mesh-ancestor
64502635|NCT03404596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502650|NCT03123276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64502651|NCT03123276|Immunologic Factors|immunologic factors|mesh-ancestor
64502652|NCT03123276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502653|NCT03123276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64502654|NCT02249026|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64502655|NCT02249026|Buprenorphine|buprenorphine|mesh-list
64502656|NCT02249026|Opiate Alkaloids|opiate alkaloids|mesh-list
64502657|NCT02249026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64502658|NCT02249026|Narcotics|narcotics|mesh-ancestor
64502659|NCT02249026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64502660|NCT02249026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502661|NCT02249026|Analgesics|analgesics|mesh-ancestor
64502662|NCT02249026|Sensory System Agents|sensory system agents|mesh-ancestor
64419588|NCT05516251|Topiramate|topiramate|mesh-list
64724415|NCT00000469|Lovastatin|lovastatin|mesh-list
64724416|NCT00000469|L 647318|l 647318|mesh-list
64724417|NCT00000469|Dihydromevinolin|dihydromevinolin|mesh-list
64724418|NCT00000469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64724419|NCT00000469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64724420|NCT00000469|Analgesics|analgesics|mesh-ancestor
64331980|NCT04175912|Carboplatin|carboplatin|mesh-list
64502664|NCT02249026|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64502666|NCT03359070|Clotrimazole|clotrimazole|mesh-list
64502667|NCT03359070|Antifungal Agents|antifungal agents|mesh-ancestor
64502668|NCT03359070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64502669|NCT03359070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64502670|NCT03359070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64502671|NCT03359070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773431|NCT01534416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64773449|NCT01535976|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64773450|NCT01535976|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64773451|NCT01535976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64773452|NCT01535976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773454|NCT01536366|Opicapone|opicapone|mesh-list
64773455|NCT01536366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64773456|NCT01536366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773457|NCT01536366|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64773458|NCT01536366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773459|NCT01536366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773460|NCT01536366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64773461|NCT01536366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64773462|NCT01537926|Acetylcysteine|acetylcysteine|mesh-list
64773463|NCT01537926|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64773464|NCT01537926|Antiviral Agents|antiviral agents|mesh-ancestor
64773465|NCT01537926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64773466|NCT01537926|Expectorants|expectorants|mesh-ancestor
64773467|NCT01537926|Respiratory System Agents|respiratory system agents|mesh-ancestor
64773468|NCT01537926|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64773469|NCT01537926|Antioxidants|antioxidants|mesh-ancestor
64773470|NCT01537926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773471|NCT01537926|Protective Agents|protective agents|mesh-ancestor
64773472|NCT01537926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773473|NCT01537926|Antidotes|antidotes|mesh-ancestor
64773474|NCT01538862|Lenograstim|lenograstim|mesh-list
64773475|NCT01538862|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64773476|NCT01538862|Immunologic Factors|immunologic factors|mesh-ancestor
64773477|NCT01538862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773478|NCT01541358|Listerine|listerine|mesh-list
64773479|NCT01541358|Fluorides|fluorides|mesh-list
64773480|NCT01541358|Sodium Fluoride|sodium fluoride|mesh-list
64502672|NCT03359070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502673|NCT03359070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64502674|NCT03359070|Hormone Antagonists|hormone antagonists|mesh-ancestor
64502675|NCT03359070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64502676|NCT03359070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502677|NCT03359070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64502678|NCT03359070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64502679|NCT03359070|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64502680|NCT03366246|Lidocaine|lidocaine|mesh-list
64773481|NCT01541358|Cariostatic Agents|cariostatic agents|mesh-ancestor
64773482|NCT01541358|Protective Agents|protective agents|mesh-ancestor
64773483|NCT01541358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773484|NCT01541358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64773485|NCT01541358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64773487|NCT01542372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64773488|NCT01542372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64773513|NCT01545336|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64773514|NCT01545336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64773515|NCT01545336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773516|NCT01545336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773517|NCT01545336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64773518|NCT01545336|Hormone Antagonists|hormone antagonists|mesh-ancestor
64773519|NCT01545336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64773520|NCT01545336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773521|NCT01548690|Phenylacetic acid|phenylacetic acid|mesh-list
64773522|NCT01548690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64773523|NCT01548690|Antimetabolites|antimetabolites|mesh-ancestor
65495180|NCT01375816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64473263|NCT00121186|Antimetabolites|antimetabolites|mesh-ancestor
64773524|NCT01548690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773525|NCT01548690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572390|NCT04783753|Antimalarials|antimalarials|mesh-ancestor
64502681|NCT03366246|Prilocaine|prilocaine|mesh-list
64502682|NCT03366246|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64502683|NCT03366246|Anesthetics, Local|anesthetics, local|mesh-ancestor
64502684|NCT03366246|Anesthetics|anesthetics|mesh-ancestor
64502685|NCT03366246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64502686|NCT03366246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502687|NCT03366246|Sensory System Agents|sensory system agents|mesh-ancestor
64502688|NCT03366246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502689|NCT03366246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64502690|NCT03366246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64502691|NCT03366246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64502692|NCT03366246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64502701|NCT01623466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64502702|NCT01623466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64502703|NCT03556384|Temozolomide|temozolomide|mesh-list
64502704|NCT03556384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64502705|NCT03556384|Alkylating Agents|alkylating agents|mesh-ancestor
64502706|NCT03556384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502709|NCT04520646|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64502710|NCT04520646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502711|NCT04520646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64502712|NCT04520646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502713|NCT01624948|Mycophenolic Acid|mycophenolic acid|mesh-list
64572411|NCT01039285|Poractant alfa|poractant alfa|mesh-list
64773526|NCT01551888|Formoterol Fumarate|formoterol fumarate|mesh-list
64773527|NCT01551888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64773528|NCT01551888|Autonomic Agents|autonomic agents|mesh-ancestor
64773529|NCT01551888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773530|NCT01551888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773531|NCT01551888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64773532|NCT01551888|Respiratory System Agents|respiratory system agents|mesh-ancestor
64773533|NCT01551888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64773534|NCT01551888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64773535|NCT01551888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64773584|NCT01559922|Protective Agents|protective agents|mesh-ancestor
64773585|NCT01559922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773586|NCT01560624|Treprostinil|treprostinil|mesh-list
64773587|NCT01560624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64773588|NCT01562886|Rilpivirine|rilpivirine|mesh-list
64773589|NCT01562886|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64773590|NCT01562886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64773591|NCT01562886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773592|NCT01562886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773593|NCT01562886|Antiviral Agents|antiviral agents|mesh-ancestor
64773594|NCT01562886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64773595|NCT01562886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64773596|NCT01562886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64773597|NCT01563198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64773598|NCT01563198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64773599|NCT01563198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773600|NCT01564914|Bevacizumab|bevacizumab|mesh-list
64773601|NCT01564914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64773602|NCT01564914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773603|NCT01564914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64502714|NCT01624948|Everolimus|everolimus|mesh-list
64502715|NCT01624948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502716|NCT01624948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64945714|NCT05287425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64502717|NCT01624948|Immunologic Factors|immunologic factors|mesh-ancestor
64502718|NCT01624948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502719|NCT01624948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64502720|NCT01624948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64502721|NCT01624948|Antitubercular Agents|antitubercular agents|mesh-ancestor
64502722|NCT01624948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64724422|NCT00000469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64724423|NCT00000469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572441|NCT03523975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64773604|NCT01564914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64773605|NCT01564914|Growth Substances|growth substances|mesh-ancestor
64773606|NCT01564914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773607|NCT01564914|Growth Inhibitors|growth inhibitors|mesh-ancestor
64773608|NCT01565538|Pemetrexed|pemetrexed|mesh-list
64773609|NCT01565538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64773610|NCT01565538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773611|NCT01565538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773612|NCT01565538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773613|NCT01565538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64385021|NCT05491785|Oxycodone|oxycodone|mesh-list
64773647|NCT01569126|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64773648|NCT01569126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64773649|NCT01569126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64773650|NCT01569126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773698|NCT01588158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64773699|NCT01588158|Antitussive Agents|antitussive agents|mesh-ancestor
64773700|NCT01588158|Respiratory System Agents|respiratory system agents|mesh-ancestor
64773701|NCT01588158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64773702|NCT01588158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64773703|NCT01588158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64773705|NCT01588470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64773706|NCT01588470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773707|NCT01591746|Botulinum Toxins|botulinum toxins|mesh-list
64773708|NCT01591746|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64773709|NCT01591746|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64724424|NCT00000469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64724425|NCT00000469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64724426|NCT00000469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64724427|NCT00000469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64724435|NCT00000469|Antimetabolites|antimetabolites|mesh-ancestor
64724436|NCT00000469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64724437|NCT00000469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64724438|NCT00000889|Aldesleukin|aldesleukin|mesh-list
64724439|NCT00000889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64724440|NCT00000889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64724441|NCT00000889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64724442|NCT00000889|Antiviral Agents|antiviral agents|mesh-ancestor
64724443|NCT00000889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724444|NCT00000505|Plasminogen|plasminogen|mesh-list
64502723|NCT01624948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64502724|NCT01624948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502725|NCT01624948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502726|NCT04523064|Empagliflozin|empagliflozin|mesh-list
64572469|NCT04857450|Anesthetics, General|anesthetics, general|mesh-ancestor
64773710|NCT01591746|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64773711|NCT01591746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64773712|NCT01591746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773713|NCT01591746|Cholinergic Agents|cholinergic agents|mesh-ancestor
64773714|NCT01591746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64773715|NCT01591746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773716|NCT01591746|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64773717|NCT01591746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773718|NCT05565924|Biguanides|biguanides|mesh-list
64773719|NCT05565924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64773720|NCT05565924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773721|NCT05564832|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64572470|NCT04857450|Anesthetics|anesthetics|mesh-ancestor
64572471|NCT04857450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64572477|NCT01420653|Acetaminophen|acetaminophen|mesh-list
64502727|NCT04523064|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64502728|NCT04523064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502729|NCT04523064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64502730|NCT04523064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502731|NCT04520880|Antibodies|antibodies|mesh-list
64502732|NCT04520880|Immunoglobulins|immunoglobulins|mesh-list
64502733|NCT04520880|Antibodies, Blocking|antibodies, blocking|mesh-list
64502734|NCT04520880|Immunologic Factors|immunologic factors|mesh-ancestor
64502735|NCT04520880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502736|NCT03365466|Aspirin|aspirin|mesh-list
64502737|NCT03365466|Heparin|heparin|mesh-list
64502738|NCT03365466|Calcium heparin|calcium heparin|mesh-list
64502739|NCT03365466|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64502740|NCT03365466|Tinzaparin|tinzaparin|mesh-list
64502741|NCT03365466|Dalteparin|dalteparin|mesh-list
64502742|NCT03365466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64502743|NCT03365466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64502744|NCT03365466|Analgesics|analgesics|mesh-ancestor
64502745|NCT03365466|Sensory System Agents|sensory system agents|mesh-ancestor
64502746|NCT03365466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502747|NCT03365466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502748|NCT03365466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64502749|NCT03365466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64724445|NCT00000505|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64724446|NCT00000505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64724447|NCT00000505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64724448|NCT00000505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724449|NCT00000901|Lamivudine|lamivudine|mesh-list
64724450|NCT00000901|Stavudine|stavudine|mesh-list
64724451|NCT00000901|Indinavir|indinavir|mesh-list
64724452|NCT00000901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64724453|NCT00000901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64724454|NCT00000901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64332012|NCT04077723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64502750|NCT03365466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64502751|NCT03365466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64502752|NCT03365466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502753|NCT03365466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64502754|NCT03365466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64502755|NCT03365466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502756|NCT03365466|Antipyretics|antipyretics|mesh-ancestor
64502757|NCT03365466|Anticoagulants|anticoagulants|mesh-ancestor
64773722|NCT05564832|Pilocarpine|pilocarpine|mesh-list
65495181|NCT01375816|Antimetabolites|antimetabolites|mesh-ancestor
64773723|NCT05564832|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64773724|NCT05564832|Miotics|miotics|mesh-ancestor
64773725|NCT05564832|Autonomic Agents|autonomic agents|mesh-ancestor
64773726|NCT05564832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773727|NCT05564832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773728|NCT05564832|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64773729|NCT05564832|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64773730|NCT05564832|Cholinergic Agents|cholinergic agents|mesh-ancestor
64773731|NCT05564832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64385145|NCT03605901|Narcotics|narcotics|mesh-ancestor
64773864|NCT03729258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773865|NCT03729258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773866|NCT03729258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64773867|NCT03729258|Analgesics|analgesics|mesh-ancestor
64773868|NCT03729258|Sensory System Agents|sensory system agents|mesh-ancestor
64773869|NCT03729258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773870|NCT03355170|Domperidone|domperidone|mesh-list
64773950|NCT04873596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64773951|NCT04873596|Anesthetics, General|anesthetics, general|mesh-ancestor
64773952|NCT04873596|Anesthetics|anesthetics|mesh-ancestor
64773953|NCT04873596|GABA Modulators|gaba modulators|mesh-ancestor
64773954|NCT04873596|GABA Agents|gaba agents|mesh-ancestor
64773955|NCT04868760|Ipilimumab|ipilimumab|mesh-list
64773956|NCT04868760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64773957|NCT04868760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773958|NCT04868760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64774004|NCT03624270|Vitamins|vitamins|mesh-ancestor
64774005|NCT03624270|Micronutrients|micronutrients|mesh-ancestor
64774006|NCT03624270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774007|NCT03498066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64774008|NCT03498066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64774009|NCT03498066|Adrenergic Agents|adrenergic agents|mesh-ancestor
64774010|NCT03498066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64774011|NCT03498066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774012|NCT03498066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774013|NCT03455088|Fluoxetine|fluoxetine|mesh-list
64774014|NCT03455088|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64774015|NCT03455088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64774016|NCT03455088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64774017|NCT03455088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774018|NCT03455088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64774019|NCT03455088|Serotonin Agents|serotonin agents|mesh-ancestor
64774020|NCT03455088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774021|NCT03455088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64774022|NCT03455088|Antidepressive Agents|antidepressive agents|mesh-ancestor
64774023|NCT03455088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64774047|NCT01605942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774048|NCT01605942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774049|NCT01605942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64774050|NCT01605942|Glucocorticoids|glucocorticoids|mesh-ancestor
64385489|NCT05745935|Oxytocics|oxytocics|mesh-ancestor
64774106|NCT01616082|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64774144|NCT01621230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774145|NCT01621230|Sensory System Agents|sensory system agents|mesh-ancestor
64774146|NCT01621230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774147|NCT01621230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64774160|NCT01631682|Propranolol|propranolol|mesh-list
64774161|NCT01631682|Oxytocin|oxytocin|mesh-list
64774162|NCT01631682|Mifepristone|mifepristone|mesh-list
64774163|NCT01631682|Oxytocics|oxytocics|mesh-ancestor
64774164|NCT01631682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64774165|NCT01631682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774166|NCT01631682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64774167|NCT01631682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64774168|NCT01631682|Adrenergic Agents|adrenergic agents|mesh-ancestor
64774169|NCT01631682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64774170|NCT01631682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774171|NCT01631682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64774172|NCT01631682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64774173|NCT01631682|Vasodilator Agents|vasodilator agents|mesh-ancestor
64774174|NCT01631682|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64774175|NCT01631682|Abortifacient Agents|abortifacient agents|mesh-ancestor
64774176|NCT01631682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64774177|NCT01631682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64774178|NCT01631682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64774179|NCT01631682|Contraceptive Agents|contraceptive agents|mesh-ancestor
64774180|NCT01631682|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64572629|NCT02849639|Cholinergic Agents|cholinergic agents|mesh-ancestor
64774251|NCT01641120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774252|NCT01641120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64774253|NCT01643382|Insulin|insulin|mesh-list
64774254|NCT01643382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64774255|NCT01643382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64774256|NCT01643382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774257|NCT01643616|Midazolam|midazolam|mesh-list
64774258|NCT01643616|Ropivacaine|ropivacaine|mesh-list
64774259|NCT01643616|Prilocaine|prilocaine|mesh-list
65495182|NCT01375816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514748|NCT02127723|Viscosupplements|viscosupplements|mesh-ancestor
64774260|NCT01643616|Anesthetics, Local|anesthetics, local|mesh-ancestor
64774261|NCT01643616|Anesthetics|anesthetics|mesh-ancestor
64774262|NCT01643616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64774263|NCT01643616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774264|NCT01643616|Sensory System Agents|sensory system agents|mesh-ancestor
64774265|NCT01643616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774266|NCT01643616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64774267|NCT01643616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64774268|NCT01643616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64774269|NCT01643616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64774270|NCT01643616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64774271|NCT01643616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64774272|NCT01643616|Anesthetics, General|anesthetics, general|mesh-ancestor
64774273|NCT01643616|GABA Modulators|gaba modulators|mesh-ancestor
64774274|NCT01643616|GABA Agents|gaba agents|mesh-ancestor
64774275|NCT01643616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64774276|NCT01643616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774278|NCT01644396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64774279|NCT01644396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64774280|NCT01645098|Dexmedetomidine|dexmedetomidine|mesh-list
64572630|NCT02849639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64572633|NCT02849639|Parasympatholytics|parasympatholytics|mesh-ancestor
64502769|NCT03346252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64502770|NCT03346252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502771|NCT03346252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64502772|NCT03346252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502773|NCT03365388|Hyaluronic Acid|hyaluronic acid|mesh-list
64502781|NCT03123744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64502782|NCT03123744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502783|NCT03123744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774281|NCT01645098|Ketamine|ketamine|mesh-list
64572659|NCT04856124|Anesthetics, General|anesthetics, general|mesh-ancestor
64774282|NCT01645098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64774283|NCT01645098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64774284|NCT01645098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774285|NCT01645098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64774286|NCT01645098|Analgesics|analgesics|mesh-ancestor
64774319|NCT01652040|Anabolic Agents|anabolic agents|mesh-ancestor
64774321|NCT01652976|Fluorouracil|fluorouracil|mesh-list
64774322|NCT01652976|Oxaliplatin|oxaliplatin|mesh-list
64774323|NCT01652976|Dasatinib|dasatinib|mesh-list
64774324|NCT01652976|Antimetabolites|antimetabolites|mesh-ancestor
64774325|NCT01652976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774326|NCT01652976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64774327|NCT01652976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774374|NCT01667796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774375|NCT01667796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64774376|NCT01667796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64774378|NCT01668030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64774379|NCT01668030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64774380|NCT01668030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64774382|NCT01669434|Enalapril|enalapril|mesh-list
64774383|NCT01669434|Enalaprilat|enalaprilat|mesh-list
64774384|NCT01669434|Lisinopril|lisinopril|mesh-list
64774385|NCT01669434|Perindopril|perindopril|mesh-list
64774386|NCT01669434|Benazepril|benazepril|mesh-list
64774387|NCT01669434|Captopril|captopril|mesh-list
64774388|NCT01669434|Quinapril|quinapril|mesh-list
64774389|NCT01669434|Trandolapril|trandolapril|mesh-list
64774390|NCT01669434|Fosinopril|fosinopril|mesh-list
64774391|NCT01669434|Moexipril|moexipril|mesh-list
64774392|NCT01669434|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64774393|NCT01669434|Protease Inhibitors|protease inhibitors|mesh-ancestor
64774394|NCT01669434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64774395|NCT01669434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774396|NCT01669434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64774397|NCT01669434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64774398|NCT01669434|Protective Agents|protective agents|mesh-ancestor
64502784|NCT03358524|Vitamins|vitamins|mesh-list
64502785|NCT03358524|Vitamin E|vitamin e|mesh-list
64502786|NCT03358524|Tocopherols|tocopherols|mesh-list
64502787|NCT03358524|Tocotrienols|tocotrienols|mesh-list
64572695|NCT01422369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64774399|NCT01669434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774400|NCT01678794|Candesartan|candesartan|mesh-list
64774401|NCT01678794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64774402|NCT01678794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64774403|NCT01678794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64774404|NCT01678794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774405|NCT01680900|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
64774406|NCT01680900|Antidepressive Agents|antidepressive agents|mesh-ancestor
64774407|NCT01680900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64774408|NCT01680900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64774409|NCT01680900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64774410|NCT01680900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64774411|NCT01680900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774412|NCT01680900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64774413|NCT01680900|Serotonin Agents|serotonin agents|mesh-ancestor
64774414|NCT01680900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495183|NCT01375816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64774415|NCT01680900|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64774416|NCT01680900|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64774417|NCT01682538|Nitisinone|nitisinone|mesh-list
64774418|NCT01682538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64774419|NCT01682538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774420|NCT01684020|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64774454|NCT01701102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774455|NCT01701102|Analgesics|analgesics|mesh-ancestor
64774456|NCT01701102|Sensory System Agents|sensory system agents|mesh-ancestor
64774461|NCT01701102|Anesthetics|anesthetics|mesh-ancestor
64774582|NCT05683548|Immunologic Factors|immunologic factors|mesh-ancestor
64774583|NCT05683548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774584|NCT05661942|Calcium|calcium|mesh-list
64774585|NCT05661942|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64774586|NCT05661942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774587|NCT05636436|Vaccines|vaccines|mesh-list
64774624|NCT05157360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774625|NCT05157360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64774626|NCT05136066|Peppermint oil|peppermint oil|mesh-list
64774627|NCT05136066|Antiemetics|antiemetics|mesh-ancestor
64774649|NCT04068948|Hydroxyzine|hydroxyzine|mesh-list
64774650|NCT04068948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64774651|NCT04068948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64774652|NCT04068948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64774653|NCT04068948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774654|NCT04068948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64774655|NCT04068948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64774656|NCT04068948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64774657|NCT04068948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64774658|NCT04068948|Anesthetics, General|anesthetics, general|mesh-ancestor
64774659|NCT04068948|Anesthetics|anesthetics|mesh-ancestor
64774660|NCT04068948|GABA Modulators|gaba modulators|mesh-ancestor
64543320|NCT04198363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543321|NCT04198363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64543322|NCT04198363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64572740|NCT04780945|Olaparib|olaparib|mesh-list
64502788|NCT03358524|alpha-Tocopherol|alpha-tocopherol|mesh-list
64502789|NCT03358524|Micronutrients|micronutrients|mesh-ancestor
64502790|NCT03358524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502791|NCT03358524|Antioxidants|antioxidants|mesh-ancestor
64502792|NCT03358524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502794|NCT04444986|Favipiravir|favipiravir|mesh-list
64502795|NCT04444986|Antiviral Agents|antiviral agents|mesh-ancestor
64502796|NCT04444986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64502797|NCT03356730|Vitamin D|vitamin d|mesh-list
64502798|NCT03356730|Vitamins|vitamins|mesh-ancestor
64502799|NCT03356730|Micronutrients|micronutrients|mesh-ancestor
64502800|NCT03356730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502801|NCT03356730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64502802|NCT03364998|Factor VIII|factor viii|mesh-list
64502803|NCT03364998|Coagulants|coagulants|mesh-ancestor
64502804|NCT03587142|Buspirone|buspirone|mesh-list
64502805|NCT03587142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64502806|NCT03587142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64502807|NCT03587142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64502808|NCT03587142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502809|NCT03587142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64502810|NCT03587142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64502811|NCT03587142|Serotonin Agents|serotonin agents|mesh-ancestor
64502812|NCT03587142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64502813|NCT03587142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572762|NCT01427517|Respiratory System Agents|respiratory system agents|mesh-ancestor
64543323|NCT04198363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64543324|NCT04198363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64543325|NCT04198363|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64543326|NCT04198363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543327|NCT04198363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64543328|NCT04198363|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64543329|NCT04198363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64543330|NCT04198363|Antacids|antacids|mesh-ancestor
64543331|NCT04198363|Diuretics|diuretics|mesh-ancestor
64543332|NCT04198363|Natriuretic Agents|natriuretic agents|mesh-ancestor
64543333|NCT04198363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543334|NCT04198363|Expectorants|expectorants|mesh-ancestor
64543335|NCT04198363|Respiratory System Agents|respiratory system agents|mesh-ancestor
64543336|NCT04020133|Epinephrine|epinephrine|mesh-list
64774661|NCT04068948|GABA Agents|gaba agents|mesh-ancestor
64774662|NCT04068948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64774663|NCT04068948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774664|NCT04068948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64774665|NCT04068948|Narcotics|narcotics|mesh-ancestor
64774666|NCT04068948|Analgesics|analgesics|mesh-ancestor
64774730|NCT01721226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774732|NCT01721460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64572763|NCT01427517|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64572764|NCT01427517|Antioxidants|antioxidants|mesh-ancestor
64502814|NCT04509102|Adderall|adderall|mesh-list
64502815|NCT04509102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64724455|NCT00000901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724456|NCT00000901|Antiviral Agents|antiviral agents|mesh-ancestor
64724457|NCT00000901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724458|NCT00000901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64724459|NCT00000901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64724460|NCT00000901|Antimetabolites|antimetabolites|mesh-ancestor
64724461|NCT00000901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64724462|NCT00000901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64724463|NCT00000901|Protease Inhibitors|protease inhibitors|mesh-ancestor
64724464|NCT00000541|Vitamins|vitamins|mesh-list
64724465|NCT00000541|Folic Acid|folic acid|mesh-list
64724466|NCT00000541|Vitamin E|vitamin e|mesh-list
64724467|NCT00000541|Vitamin B 12|vitamin b 12|mesh-list
64724468|NCT00000541|Vitamin B 6|vitamin b 6|mesh-list
64724469|NCT00000541|Pyridoxal|pyridoxal|mesh-list
64724470|NCT00000541|Pyridoxine|pyridoxine|mesh-list
64724471|NCT00000541|Beta Carotene|beta carotene|mesh-list
64724472|NCT00000541|Vitamin B Complex|vitamin b complex|mesh-list
64724473|NCT00000541|Carotenoids|carotenoids|mesh-list
64724474|NCT00000541|Micronutrients|micronutrients|mesh-ancestor
64724475|NCT00000541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502816|NCT04509102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502817|NCT04508946|Thiamine|thiamine|mesh-list
64502818|NCT04508946|Hydrocortisone|hydrocortisone|mesh-list
64502819|NCT04508946|Vitamins|vitamins|mesh-ancestor
64502820|NCT04508946|Micronutrients|micronutrients|mesh-ancestor
64502821|NCT04508946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774733|NCT01721460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64774734|NCT01721460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774735|NCT01721460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64330262|NCT02376075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64330263|NCT02376075|Protease Inhibitors|protease inhibitors|mesh-ancestor
64330264|NCT02376075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330265|NCT02376075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330266|NCT02197637|Vinorelbine|vinorelbine|mesh-list
64330267|NCT02197637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64330268|NCT02197637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330269|NCT02197637|Tubulin Modulators|tubulin modulators|mesh-ancestor
64330270|NCT02197637|Antimitotic Agents|antimitotic agents|mesh-ancestor
64330271|NCT02197637|Mitosis Modulators|mitosis modulators|mesh-ancestor
64330272|NCT02197637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330273|NCT04469413|Acetaminophen|acetaminophen|mesh-list
64330274|NCT04469413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64330275|NCT04469413|Analgesics|analgesics|mesh-ancestor
64330308|NCT02288923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64330986|NCT05791721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64330987|NCT05791721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330988|NCT05791721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330989|NCT05791669|Listerine|listerine|mesh-list
64330990|NCT05791669|Fluorides|fluorides|mesh-list
64330991|NCT05791669|Sodium Fluoride|sodium fluoride|mesh-list
64330992|NCT05791669|Fluorides, Topical|fluorides, topical|mesh-list
64330993|NCT05791669|Cariostatic Agents|cariostatic agents|mesh-ancestor
64331063|NCT05790941|Vasodilator Agents|vasodilator agents|mesh-ancestor
64331064|NCT05790902|Tamsulosin|tamsulosin|mesh-list
64331065|NCT05790902|Silodosin|silodosin|mesh-list
64331066|NCT05790902|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64331067|NCT05790902|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64331068|NCT05790902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64331069|NCT05790902|Adrenergic Agents|adrenergic agents|mesh-ancestor
64331070|NCT05790902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64331073|NCT05790902|Urological Agents|urological agents|mesh-ancestor
64331075|NCT05790720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64332065|NCT04008030|Vitamin B Complex|vitamin b complex|mesh-ancestor
64332067|NCT04008030|Micronutrients|micronutrients|mesh-ancestor
64332068|NCT03977493|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64332069|NCT03977493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64332070|NCT03977493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64332071|NCT03977493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332072|NCT03977493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64332073|NCT03977493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64586290|NCT00322439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64332527|NCT02559180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64332528|NCT02559180|Growth Substances|growth substances|mesh-ancestor
64332529|NCT02559180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335246|NCT05255523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335247|NCT03149679|Cyclophosphamide|cyclophosphamide|mesh-list
64335248|NCT03149679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64335249|NCT03149679|Immunologic Factors|immunologic factors|mesh-ancestor
64335415|NCT04083183|Fludarabine phosphate|fludarabine phosphate|mesh-list
64335416|NCT04083183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64335417|NCT04083183|Thymoglobulin|thymoglobulin|mesh-list
64335453|NCT02342769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64335454|NCT02342769|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64335455|NCT02342769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64335456|NCT03766295|Gemcitabine|gemcitabine|mesh-list
64335457|NCT03766295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64335796|NCT03148509|Bupropion|bupropion|mesh-list
64336018|NCT02340117|Antimitotic Agents|antimitotic agents|mesh-ancestor
64336019|NCT02340117|Mitosis Modulators|mitosis modulators|mesh-ancestor
64336020|NCT02340117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336021|NCT02340117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64336022|NCT02340117|Antimetabolites|antimetabolites|mesh-ancestor
64336023|NCT02340117|Antiviral Agents|antiviral agents|mesh-ancestor
64336024|NCT02340117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64336025|NCT02340117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336026|NCT02340117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64336027|NCT02340117|Immunologic Factors|immunologic factors|mesh-ancestor
64336267|NCT02310295|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64336268|NCT02310295|Bevacizumab|bevacizumab|mesh-list
64336269|NCT02310295|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64336287|NCT05012865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64336288|NCT05012865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336289|NCT05012865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64336290|NCT05012865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336291|NCT05012865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336292|NCT03505489|Mannitol|mannitol|mesh-list
64336293|NCT03505489|Methacholine Chloride|methacholine chloride|mesh-list
64336294|NCT03505489|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64336295|NCT03505489|Diuretics|diuretics|mesh-ancestor
64336296|NCT03505489|Natriuretic Agents|natriuretic agents|mesh-ancestor
64336297|NCT03505489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336298|NCT03505489|Miotics|miotics|mesh-ancestor
64336299|NCT03505489|Autonomic Agents|autonomic agents|mesh-ancestor
64336300|NCT03505489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64336301|NCT03505489|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64336302|NCT03505489|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
64336303|NCT03505489|Respiratory System Agents|respiratory system agents|mesh-ancestor
64336304|NCT03505489|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64336305|NCT03505489|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64336306|NCT03505489|Cholinergic Agents|cholinergic agents|mesh-ancestor
64336309|NCT02310373|Nicotine|nicotine|mesh-list
64336315|NCT02310373|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64336316|NCT02310373|Cholinergic Agents|cholinergic agents|mesh-ancestor
64336317|NCT02310373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64336318|NCT02310373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336319|NCT02338323|Febuxostat|febuxostat|mesh-list
64336320|NCT02338323|Benzbromarone|benzbromarone|mesh-list
64336321|NCT02338323|Gout Suppressants|gout suppressants|mesh-ancestor
64336322|NCT02338323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64336323|NCT02338323|Uricosuric Agents|uricosuric agents|mesh-ancestor
64336324|NCT02338323|Renal Agents|renal agents|mesh-ancestor
64336325|NCT03450343|Azacitidine|azacitidine|mesh-list
64336326|NCT03450343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64336498|NCT03505255|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64336717|NCT02383251|Mitosis Modulators|mitosis modulators|mesh-ancestor
64336718|NCT02383251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336719|NCT02313103|Lofexidine|lofexidine|mesh-list
64336720|NCT02313103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64336721|NCT02313103|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64336722|NCT02313103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336723|NCT02313103|Sensory System Agents|sensory system agents|mesh-ancestor
64336724|NCT02313103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64336725|NCT02313103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64336726|NCT02313103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64336727|NCT02313103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65495184|NCT01375816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64473264|NCT00121186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514751|NCT05586711|Estrogens|estrogens|mesh-ancestor
64336728|NCT02313103|Adrenergic Agents|adrenergic agents|mesh-ancestor
64336729|NCT02313103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64336730|NCT02313103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336731|NCT01959633|Interferons|interferons|mesh-list
64336732|NCT01959633|Vemurafenib|vemurafenib|mesh-list
64336733|NCT01959633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336734|NCT01959633|Antiviral Agents|antiviral agents|mesh-ancestor
64336735|NCT01959633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64336899|NCT02440009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64336900|NCT02440009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336901|NCT02440009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64336903|NCT02318563|Cannabidiol|cannabidiol|mesh-list
64336904|NCT02318563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64336905|NCT02318563|Anticonvulsants|anticonvulsants|mesh-ancestor
64336906|NCT02314195|Serotonin|serotonin|mesh-list
64336907|NCT02314195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
64336908|NCT02314195|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64336909|NCT02314195|Serotonin Agents|serotonin agents|mesh-ancestor
64337471|NCT01388491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64337472|NCT01388491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337473|NCT01388491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64337474|NCT01388491|Contraceptive Agents|contraceptive agents|mesh-ancestor
64337475|NCT01388491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64572952|NCT01890863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502822|NCT04508946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64502833|NCT03364764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64502834|NCT03364764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64502835|NCT03364764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502836|NCT03364764|Antifungal Agents|antifungal agents|mesh-ancestor
64502837|NCT03364764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64502838|NCT03364764|Immunologic Factors|immunologic factors|mesh-ancestor
64502839|NCT03364764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502848|NCT02519400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502849|NCT02519400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64502850|NCT02519400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64502851|NCT02519400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64502852|NCT02519400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502853|NCT02519400|Adrenergic Agents|adrenergic agents|mesh-ancestor
64502854|NCT02519400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64502855|NCT04509258|Acetylcarnitine|acetylcarnitine|mesh-list
64502856|NCT04509258|Acetylcysteine|acetylcysteine|mesh-list
64502857|NCT04509258|Ondansetron|ondansetron|mesh-list
64502858|NCT04509258|Mineral Oil|mineral oil|mesh-list
64502859|NCT04509258|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64502860|NCT04509258|Antiemetics|antiemetics|mesh-ancestor
64502861|NCT04509258|Autonomic Agents|autonomic agents|mesh-ancestor
64502862|NCT04509258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502863|NCT04509258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502864|NCT04509258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64724476|NCT00000541|Antioxidants|antioxidants|mesh-ancestor
64724477|NCT00000541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724478|NCT00000541|Protective Agents|protective agents|mesh-ancestor
64724479|NCT00000541|Hematinics|hematinics|mesh-ancestor
64332112|NCT03816332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332114|NCT03816332|Immunologic Factors|immunologic factors|mesh-ancestor
64332115|NCT03816332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64332116|NCT03816332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724548|NCT02994836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64724549|NCT00000937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64724550|NCT00000937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724551|NCT00000613|Genistein|genistein|mesh-list
64724552|NCT00000613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64724553|NCT00000613|Protective Agents|protective agents|mesh-ancestor
64337476|NCT01388491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64337477|NCT01388491|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64337478|NCT01388491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64337921|NCT02264795|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64337923|NCT02264795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64337924|NCT02264795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337925|NCT02264873|Decitabine|decitabine|mesh-list
64337926|NCT02264873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64337927|NCT02264873|Antimetabolites|antimetabolites|mesh-ancestor
64337959|NCT01660022|Antimalarials|antimalarials|mesh-ancestor
64337960|NCT01660022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64337961|NCT01660022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64337962|NCT01660022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64337963|NCT02265575|Hyaluronic Acid|hyaluronic acid|mesh-list
64337964|NCT02265575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64337965|NCT02265575|Immunologic Factors|immunologic factors|mesh-ancestor
64337966|NCT02265575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337967|NCT02265575|Viscosupplements|viscosupplements|mesh-ancestor
64572972|NCT02950051|Rituximab|rituximab|mesh-list
64724554|NCT00000613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724555|NCT00000613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64724556|NCT00000613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64724557|NCT00000613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724558|NCT00000613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724559|NCT00000613|Phytoestrogens|phytoestrogens|mesh-ancestor
64502865|NCT04509258|Antipruritics|antipruritics|mesh-ancestor
64502866|NCT04509258|Dermatologic Agents|dermatologic agents|mesh-ancestor
64502867|NCT04509258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64502868|NCT04509258|Serotonin Agents|serotonin agents|mesh-ancestor
64502869|NCT04509258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64502870|NCT04509258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502871|NCT04509258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64502872|NCT04509258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65495185|NCT01375816|Immunologic Factors|immunologic factors|mesh-ancestor
65495186|NCT01375816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64473265|NCT00121186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473266|NCT00121186|Dermatologic Agents|dermatologic agents|mesh-ancestor
64502873|NCT04509258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64502874|NCT04509258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64502875|NCT04509258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64502877|NCT04509258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64502879|NCT04509258|Respiratory System Agents|respiratory system agents|mesh-ancestor
64502880|NCT04509258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64502881|NCT04509258|Antioxidants|antioxidants|mesh-ancestor
64502882|NCT04509258|Protective Agents|protective agents|mesh-ancestor
64502883|NCT04509258|Antidotes|antidotes|mesh-ancestor
64502884|NCT04509258|Vitamin B Complex|vitamin b complex|mesh-ancestor
64502885|NCT04509258|Vitamins|vitamins|mesh-ancestor
64502886|NCT04509258|Micronutrients|micronutrients|mesh-ancestor
64502887|NCT04509258|Nootropic Agents|nootropic agents|mesh-ancestor
64502888|NCT04509258|Emollients|emollients|mesh-ancestor
64502889|NCT03364530|Gemcitabine|gemcitabine|mesh-list
64502890|NCT03364530|Oxaliplatin|oxaliplatin|mesh-list
64502911|NCT03364218|Antioxidants|antioxidants|mesh-ancestor
64502912|NCT03364218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502913|NCT03364218|Protective Agents|protective agents|mesh-ancestor
64502914|NCT03364218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502915|NCT03364218|Antidotes|antidotes|mesh-ancestor
64502916|NCT04444284|Vaccines|vaccines|mesh-list
64502917|NCT04444284|Immunologic Factors|immunologic factors|mesh-ancestor
64502918|NCT04444284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332137|NCT03805607|Ketorolac|ketorolac|mesh-list
64724560|NCT00000613|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64724561|NCT00000613|Estrogens|estrogens|mesh-ancestor
64724562|NCT00000613|Hormones|hormones|mesh-ancestor
64724563|NCT00000613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64724564|NCT02909348|Pembrolizumab|pembrolizumab|mesh-list
64724565|NCT02909348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64724566|NCT02909348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64724567|NCT00000949|Aldesleukin|aldesleukin|mesh-list
64724568|NCT00000949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64724569|NCT00000949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64724570|NCT00000949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64724571|NCT00000949|Antiviral Agents|antiviral agents|mesh-ancestor
64724572|NCT00000949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724573|NCT00002936|Etoposide|etoposide|mesh-list
64724574|NCT00002936|Altretamine|altretamine|mesh-list
64502919|NCT03354312|Lidocaine|lidocaine|mesh-list
64502920|NCT03354312|Epinephrine|epinephrine|mesh-list
64502921|NCT03354312|Racepinephrine|racepinephrine|mesh-list
64502922|NCT03354312|Carticaine|carticaine|mesh-list
64502923|NCT03354312|Epinephryl borate|epinephryl borate|mesh-list
64502924|NCT03354312|Anesthetics, Local|anesthetics, local|mesh-ancestor
64502925|NCT03354312|Anesthetics|anesthetics|mesh-ancestor
64502926|NCT03354312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64573040|NCT00750841|Cediranib|cediranib|mesh-list
64502927|NCT03354312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502928|NCT03354312|Sensory System Agents|sensory system agents|mesh-ancestor
64502929|NCT03354312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502930|NCT03354312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64502931|NCT03354312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64502932|NCT03354312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64502933|NCT03354312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64502934|NCT03354312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502935|NCT03354312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64502936|NCT03354312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64502937|NCT03354312|Adrenergic Agents|adrenergic agents|mesh-ancestor
64332138|NCT03805607|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64332139|NCT03805607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64332140|NCT03805607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64332141|NCT03805607|Analgesics|analgesics|mesh-ancestor
64724575|NCT00002936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64724576|NCT00002936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64724577|NCT00002936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64724587|NCT00000649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64724588|NCT00000649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64724590|NCT00000649|Antiviral Agents|antiviral agents|mesh-ancestor
64724591|NCT00000649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724592|NCT00000649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64724593|NCT00000649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64724594|NCT00000649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64724595|NCT00000649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64724596|NCT00000961|Zidovudine|zidovudine|mesh-list
64724597|NCT00000961|Immune Sera|immune sera|mesh-list
64573085|NCT01892813|Varenicline|varenicline|mesh-list
64573086|NCT01892813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65495187|NCT01375816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65495188|NCT01375816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573087|NCT01892813|Autonomic Agents|autonomic agents|mesh-ancestor
64502938|NCT03354312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64502939|NCT03354312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64502940|NCT03354312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64502941|NCT03354312|Autonomic Agents|autonomic agents|mesh-ancestor
64502942|NCT03354312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64502943|NCT03354312|Respiratory System Agents|respiratory system agents|mesh-ancestor
64502945|NCT03354312|Sympathomimetics|sympathomimetics|mesh-ancestor
64502946|NCT03354312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64502948|NCT03363984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64502949|NCT03363984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64502950|NCT03363984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64502951|NCT03363984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502952|NCT03363984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64502953|NCT03363984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64502954|NCT03363984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64502955|NCT03363984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64502956|NCT03363984|Anesthetics, General|anesthetics, general|mesh-ancestor
64502957|NCT03363984|Anesthetics|anesthetics|mesh-ancestor
64502972|NCT03355716|Analgesics|analgesics|mesh-ancestor
64502973|NCT03355716|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64502974|NCT03355716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64724598|NCT00000961|Antimetabolites|antimetabolites|mesh-ancestor
64724599|NCT00000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724600|NCT00000961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64724601|NCT00000961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64724602|NCT00000961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724603|NCT00000961|Antiviral Agents|antiviral agents|mesh-ancestor
64724604|NCT00000961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724605|NCT00000961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64724606|NCT00000961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64724607|NCT00000961|Immunologic Factors|immunologic factors|mesh-ancestor
64724608|NCT00000961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463892|NCT04274920|Calcium|calcium|mesh-list
64724609|NCT04048304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64724610|NCT04048304|Vancomycin|vancomycin|mesh-list
64573116|NCT00716443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64724611|NCT04048304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724612|NCT00000655|Trimethoprim|trimethoprim|mesh-list
64724613|NCT00000655|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64724614|NCT00000655|Atovaquone|atovaquone|mesh-list
64332160|NCT03671018|Immunologic Factors|immunologic factors|mesh-ancestor
64332161|NCT03671018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502975|NCT03355716|Anesthetics, General|anesthetics, general|mesh-ancestor
64502976|NCT03355716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64502977|NCT03355716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64502978|NCT03355716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64502979|NCT03355716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502980|NCT03355716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64502988|NCT04508400|BB 1101|bb 1101|mesh-list
64502989|NCT04508400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64502990|NCT04508400|Antiemetics|antiemetics|mesh-ancestor
64502991|NCT04508400|Autonomic Agents|autonomic agents|mesh-ancestor
64502992|NCT04508400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502993|NCT04508400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502994|NCT04508400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64502995|NCT04508400|Glucocorticoids|glucocorticoids|mesh-ancestor
64502996|NCT04508400|Hormones|hormones|mesh-ancestor
64502997|NCT04508400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64502998|NCT04508400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64502999|NCT04508400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503000|NCT04508400|Protease Inhibitors|protease inhibitors|mesh-ancestor
64503001|NCT04508400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64503002|NCT04508400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503003|NCT04508400|Antipruritics|antipruritics|mesh-ancestor
65495189|NCT01375816|Antidotes|antidotes|mesh-ancestor
65495190|NCT01375816|Protective Agents|protective agents|mesh-ancestor
64573162|NCT05606497|Glucocorticoids|glucocorticoids|mesh-ancestor
64503004|NCT04508400|Dermatologic Agents|dermatologic agents|mesh-ancestor
64503005|NCT04508400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64503006|NCT04508400|Serotonin Agents|serotonin agents|mesh-ancestor
64503007|NCT04508400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64503008|NCT04508400|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64503009|NCT04508400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64503010|NCT04508400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64724616|NCT00000655|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64724617|NCT00000655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724618|NCT00000655|Renal Agents|renal agents|mesh-ancestor
64724619|NCT00000655|Antimalarials|antimalarials|mesh-ancestor
64724620|NCT00000655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64724621|NCT00000655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64503012|NCT04508400|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64503013|NCT04508400|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64503014|NCT03355638|Pyranoprofen|pyranoprofen|mesh-list
64503015|NCT03355638|Aflibercept|aflibercept|mesh-list
64503016|NCT03355638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64503017|NCT03355638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64503018|NCT03355638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64503019|NCT03355638|Growth Substances|growth substances|mesh-ancestor
64503020|NCT03355638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503021|NCT03355638|Growth Inhibitors|growth inhibitors|mesh-ancestor
64503034|NCT01626664|Mogamulizumab|mogamulizumab|mesh-list
64503035|NCT01626664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64503036|NCT01626664|Antimetabolites|antimetabolites|mesh-ancestor
64503037|NCT01626664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503038|NCT01626664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503039|NCT01626664|Antiviral Agents|antiviral agents|mesh-ancestor
64503040|NCT01626664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64503041|NCT01626664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64503042|NCT01626664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64503043|NCT01626664|Immunologic Factors|immunologic factors|mesh-ancestor
64503044|NCT01626664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503045|NCT04515966|Methylprednisolone|methylprednisolone|mesh-list
64503046|NCT04515966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64503047|NCT04515966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64503048|NCT04515966|Prednisolone|prednisolone|mesh-list
64503049|NCT04515966|Prednisolone acetate|prednisolone acetate|mesh-list
64503051|NCT04515966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64473267|NCT00121186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64503052|NCT04515966|Prednisolone phosphate|prednisolone phosphate|mesh-list
64503053|NCT04515966|Anesthetics, Local|anesthetics, local|mesh-ancestor
64503054|NCT04515966|Anesthetics|anesthetics|mesh-ancestor
64503055|NCT04515966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64503056|NCT04515966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503057|NCT04515966|Sensory System Agents|sensory system agents|mesh-ancestor
64503058|NCT04515966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64503059|NCT04515966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64419633|NCT05515939|Insulin|insulin|mesh-list
64503081|NCT03355248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64503083|NCT03355248|Sensory System Agents|sensory system agents|mesh-ancestor
64503084|NCT03355248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64503096|NCT03350334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64724622|NCT00000655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64724623|NCT00000655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724624|NCT00000655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724625|NCT00000655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64724626|NCT00000655|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64724627|NCT00000655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64724628|NCT00000655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64724630|NCT00002948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64724631|NCT00002948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64573244|NCT00053989|Glucocorticoids|glucocorticoids|mesh-ancestor
64724632|NCT00002948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724633|NCT00002948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724634|NCT00002948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64724635|NCT02594293|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64724636|NCT02594293|Antiviral Agents|antiviral agents|mesh-ancestor
64724637|NCT02594293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724638|NCT00000967|Interferons|interferons|mesh-list
64724639|NCT00000967|Interferon-alpha|interferon-alpha|mesh-list
64724640|NCT00000967|Interferon alpha-2|interferon alpha-2|mesh-list
64724641|NCT00000967|Zidovudine|zidovudine|mesh-list
64724642|NCT00000967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64724643|NCT00000967|Antiviral Agents|antiviral agents|mesh-ancestor
64724644|NCT00000967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724645|NCT00000967|Immunologic Factors|immunologic factors|mesh-ancestor
64724646|NCT00000967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724647|NCT00000967|Antimetabolites|antimetabolites|mesh-ancestor
64419634|NCT05515939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64503105|NCT03350334|Dopamine Agents|dopamine agents|mesh-ancestor
64503106|NCT02230696|Fluticasone|fluticasone|mesh-list
64503108|NCT02230696|Azelastine|azelastine|mesh-list
64503109|NCT02230696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64503110|NCT02230696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64503111|NCT02230696|Autonomic Agents|autonomic agents|mesh-ancestor
64503112|NCT02230696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64503113|NCT02230696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503114|NCT02230696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64503115|NCT02230696|Respiratory System Agents|respiratory system agents|mesh-ancestor
64503116|NCT02230696|Dermatologic Agents|dermatologic agents|mesh-ancestor
64503117|NCT02230696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64503118|NCT02230696|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64503119|NCT02230696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64503120|NCT02230696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724648|NCT00000967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724649|NCT00000967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64724650|NCT00000967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64724651|NCT00000967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724652|NCT00000967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64724653|NCT00000967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64724654|NCT00000661|Zidovudine|zidovudine|mesh-list
64724655|NCT00000661|Oxazepam|oxazepam|mesh-list
64724656|NCT00000661|Antimetabolites|antimetabolites|mesh-ancestor
64724657|NCT00000661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724658|NCT00000661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64503121|NCT02230696|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64503122|NCT02230696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64503123|NCT02230696|Histamine Antagonists|histamine antagonists|mesh-ancestor
64503124|NCT02230696|Histamine Agents|histamine agents|mesh-ancestor
64503125|NCT02230696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64503126|NCT03355014|Metformin|metformin|mesh-list
64503127|NCT03355014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64503128|NCT03355014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503129|NCT02231086|Leucovorin|leucovorin|mesh-list
64503130|NCT02231086|Fluorouracil|fluorouracil|mesh-list
64503131|NCT02231086|Capecitabine|capecitabine|mesh-list
64503132|NCT02231086|Oxaliplatin|oxaliplatin|mesh-list
64503133|NCT02231086|Antimetabolites|antimetabolites|mesh-ancestor
64503134|NCT02231086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503135|NCT02231086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64503136|NCT02231086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503137|NCT02231086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64503138|NCT02231086|Immunologic Factors|immunologic factors|mesh-ancestor
64503139|NCT02231086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503140|NCT02231086|Antidotes|antidotes|mesh-ancestor
64503141|NCT02231086|Protective Agents|protective agents|mesh-ancestor
64503142|NCT02231086|Vitamin B Complex|vitamin b complex|mesh-ancestor
64503143|NCT02231086|Vitamins|vitamins|mesh-ancestor
64503144|NCT02231086|Micronutrients|micronutrients|mesh-ancestor
64503145|NCT03353298|Allopurinol|allopurinol|mesh-list
64503146|NCT03353298|Antimetabolites|antimetabolites|mesh-ancestor
64503147|NCT03353298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503148|NCT03353298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64503149|NCT03353298|Gout Suppressants|gout suppressants|mesh-ancestor
64503150|NCT03353298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64503160|NCT02509546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64503161|NCT02509546|Vasodilator Agents|vasodilator agents|mesh-ancestor
64503162|NCT02509546|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64503163|NCT02509546|Purinergic Agonists|purinergic agonists|mesh-ancestor
64503172|NCT03146962|Micronutrients|micronutrients|mesh-ancestor
64503173|NCT03146962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573315|NCT02670707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495191|NCT01375816|Vitamin B Complex|vitamin b complex|mesh-ancestor
65495192|NCT01375816|Vitamins|vitamins|mesh-ancestor
64473268|NCT00121186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64597168|NCT00674219|Memantine|memantine|mesh-list
64503174|NCT03146962|Antioxidants|antioxidants|mesh-ancestor
64503175|NCT03146962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503176|NCT03146962|Protective Agents|protective agents|mesh-ancestor
64503177|NCT03349866|Capecitabine|capecitabine|mesh-list
64503178|NCT03349866|Oxaliplatin|oxaliplatin|mesh-list
64503179|NCT03349866|Apatinib|apatinib|mesh-list
64503180|NCT03349866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64503181|NCT03349866|Antimetabolites|antimetabolites|mesh-ancestor
64724659|NCT00000661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64724660|NCT00000661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724661|NCT00000661|Antiviral Agents|antiviral agents|mesh-ancestor
64724662|NCT00000661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724663|NCT00000661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64724664|NCT00000661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64724665|NCT00000661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64724666|NCT00000661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64724667|NCT00000661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724668|NCT00000661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64724669|NCT00000661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64724670|NCT00000661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64724671|NCT00000661|GABA Modulators|gaba modulators|mesh-ancestor
64724672|NCT00000661|GABA Agents|gaba agents|mesh-ancestor
64724673|NCT00000661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64724674|NCT00000979|Zidovudine|zidovudine|mesh-list
64724675|NCT00000979|Didanosine|didanosine|mesh-list
64724676|NCT00000979|Antimetabolites|antimetabolites|mesh-ancestor
64724677|NCT00000979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724678|NCT00000979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64724679|NCT00000979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64724680|NCT00000979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724681|NCT00000979|Antiviral Agents|antiviral agents|mesh-ancestor
64724682|NCT00000979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724683|NCT00000979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64724684|NCT00000979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64724685|NCT00000991|Zidovudine|zidovudine|mesh-list
64463953|NCT03044314|Vasodilator Agents|vasodilator agents|mesh-ancestor
64724686|NCT00000991|Trimethoprim|trimethoprim|mesh-list
64724687|NCT00000991|Sulfamethoxazole|sulfamethoxazole|mesh-list
64724688|NCT00000991|Dapsone|dapsone|mesh-list
64724689|NCT00000991|Pentamidine|pentamidine|mesh-list
64724690|NCT00000991|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64724691|NCT00000991|Antimetabolites|antimetabolites|mesh-ancestor
64573342|NCT02214615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724692|NCT00000991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503182|NCT03349866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503184|NCT03349866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64503185|NCT03349866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64503186|NCT01631110|Vaccines|vaccines|mesh-list
64503187|NCT01631110|Immunologic Factors|immunologic factors|mesh-ancestor
64503188|NCT01631110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724693|NCT00000991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64724694|NCT00000991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64724695|NCT00000991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724696|NCT00000991|Antiviral Agents|antiviral agents|mesh-ancestor
64724697|NCT00000991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724698|NCT00000991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64724699|NCT00000991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64724700|NCT00000991|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64724701|NCT00000991|Renal Agents|renal agents|mesh-ancestor
64724702|NCT00000991|Antimalarials|antimalarials|mesh-ancestor
64724708|NCT00000991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64724709|NCT00000991|Leprostatic Agents|leprostatic agents|mesh-ancestor
64724710|NCT00000991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64724711|NCT00000991|Antifungal Agents|antifungal agents|mesh-ancestor
64724712|NCT00000991|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64724713|NCT00000673|Ganciclovir|ganciclovir|mesh-list
64503189|NCT01631656|Azelaic acid|azelaic acid|mesh-list
64503190|NCT01631656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503191|NCT01631656|Dermatologic Agents|dermatologic agents|mesh-ancestor
64503193|NCT02989636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64503194|NCT02989636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503195|NCT02989636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64503196|NCT02989636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503197|NCT02985190|Azacitidine|azacitidine|mesh-list
64503198|NCT02985190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64503199|NCT02985190|Antimetabolites|antimetabolites|mesh-ancestor
64503200|NCT02985190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503201|NCT02985190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503202|NCT02985190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64503203|NCT01376310|Gemcitabine|gemcitabine|mesh-list
64503204|NCT01376310|Paclitaxel|paclitaxel|mesh-list
64503205|NCT01376310|Docetaxel|docetaxel|mesh-list
64503206|NCT01376310|Carboplatin|carboplatin|mesh-list
64503207|NCT01376310|Pemetrexed|pemetrexed|mesh-list
64503208|NCT01376310|Everolimus|everolimus|mesh-list
64503209|NCT01376310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64503210|NCT01376310|Trametinib|trametinib|mesh-list
64503211|NCT01376310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64503212|NCT01376310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503213|NCT01376310|Tubulin Modulators|tubulin modulators|mesh-ancestor
64503214|NCT01376310|Antimitotic Agents|antimitotic agents|mesh-ancestor
64503215|NCT01376310|Mitosis Modulators|mitosis modulators|mesh-ancestor
64503216|NCT01376310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503230|NCT01585402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503232|NCT01638052|Bupivacaine|bupivacaine|mesh-list
65495193|NCT01375816|Micronutrients|micronutrients|mesh-ancestor
65495194|NCT03632824|Tranexamic Acid|tranexamic acid|mesh-list
64503233|NCT01638052|Anesthetics, Local|anesthetics, local|mesh-ancestor
64503234|NCT01638052|Anesthetics|anesthetics|mesh-ancestor
64503235|NCT01638052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64503236|NCT01638052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503237|NCT01638052|Sensory System Agents|sensory system agents|mesh-ancestor
64724715|NCT00000673|Antiviral Agents|antiviral agents|mesh-ancestor
64724716|NCT00000673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724717|NCT00000673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64724718|NCT00000673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724719|NCT00000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724720|NCT00000685|Zidovudine|zidovudine|mesh-list
64724721|NCT00000685|Antimetabolites|antimetabolites|mesh-ancestor
64724722|NCT00000685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724723|NCT00000685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64724724|NCT00000685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64724725|NCT00000685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64332282|NCT03218826|Docetaxel|docetaxel|mesh-list
64503238|NCT01638052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64503239|NCT01638052|Analgesics|analgesics|mesh-ancestor
64503240|NCT01638052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64503241|NCT01638052|Sympatholytics|sympatholytics|mesh-ancestor
64503242|NCT01638052|Autonomic Agents|autonomic agents|mesh-ancestor
64503243|NCT01638052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64503244|NCT01638052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64503245|NCT01638052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64503246|NCT01638052|Adrenergic Agents|adrenergic agents|mesh-ancestor
64503247|NCT01638052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64503248|NCT01638052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503249|NCT02518152|Alendronate|alendronate|mesh-list
64419675|NCT05519371|Propofol|propofol|mesh-list
64503258|NCT01229878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64503259|NCT03352674|Insulin|insulin|mesh-list
64503260|NCT03352674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64503261|NCT03352674|Insulin Glargine|insulin glargine|mesh-list
64294828|NCT04495088|Immunologic Factors|immunologic factors|mesh-ancestor
64294829|NCT04495088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294831|NCT04495088|Protective Agents|protective agents|mesh-ancestor
64294832|NCT04495088|Vitamin B Complex|vitamin b complex|mesh-ancestor
64294920|NCT04821141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64294922|NCT04821141|Hormone Antagonists|hormone antagonists|mesh-ancestor
64294923|NCT04821141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64294924|NCT04435652|Paclitaxel|paclitaxel|mesh-list
64294925|NCT04435652|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64294926|NCT04435652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64294927|NCT04435652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294928|NCT04435652|Tubulin Modulators|tubulin modulators|mesh-ancestor
64295370|NCT02805907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295371|NCT02805907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64295372|NCT02477397|Fluticasone|fluticasone|mesh-list
64295373|NCT02477397|Xhance|xhance|mesh-list
64295374|NCT02477397|Budesonide|budesonide|mesh-list
64295375|NCT02477397|Formoterol Fumarate|formoterol fumarate|mesh-list
64295376|NCT02477397|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64295377|NCT02477397|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64295378|NCT02477397|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64295379|NCT02477397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64295380|NCT02477397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64295381|NCT02477397|Autonomic Agents|autonomic agents|mesh-ancestor
64295382|NCT02477397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64295383|NCT02477397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295384|NCT02477397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64295385|NCT02477397|Respiratory System Agents|respiratory system agents|mesh-ancestor
64295386|NCT02477397|Dermatologic Agents|dermatologic agents|mesh-ancestor
64295429|NCT05580861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64295430|NCT05580861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64295431|NCT05580861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64295432|NCT02469831|Rocuronium|rocuronium|mesh-list
64295439|NCT02995005|Antiviral Agents|antiviral agents|mesh-ancestor
64295440|NCT02995005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64295441|NCT02995005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64297037|NCT03103568|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64297038|NCT03103568|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64297039|NCT05654467|Vaccines|vaccines|mesh-list
64297040|NCT05654467|Immunologic Factors|immunologic factors|mesh-ancestor
64297041|NCT05654467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297042|NCT03101072|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64297043|NCT03101072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64297044|NCT03101072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64297045|NCT03101072|Antitubercular Agents|antitubercular agents|mesh-ancestor
64297046|NCT02925195|Vitamin D|vitamin d|mesh-list
64297047|NCT02925195|Cholecalciferol|cholecalciferol|mesh-list
64297048|NCT02925195|Vitamins|vitamins|mesh-ancestor
64297049|NCT02925195|Micronutrients|micronutrients|mesh-ancestor
64297050|NCT02925195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297051|NCT02925195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64297052|NCT02925195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64297082|NCT01499888|Sirolimus|sirolimus|mesh-list
64297083|NCT01499888|Alemtuzumab|alemtuzumab|mesh-list
64297084|NCT01499888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64297085|NCT01499888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65495195|NCT03632824|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65495196|NCT03632824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64597315|NCT04928703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64597316|NCT04928703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597317|NCT04928703|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64297086|NCT01499888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64297087|NCT01499888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297088|NCT01499888|Antifungal Agents|antifungal agents|mesh-ancestor
64297089|NCT01499888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64298256|NCT02077231|Vitamin A|vitamin a|mesh-list
64298259|NCT02077231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573482|NCT02588105|Fluorouracil|fluorouracil|mesh-list
64298260|NCT02077231|Antioxidants|antioxidants|mesh-ancestor
64298261|NCT02077231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298262|NCT02077231|Protective Agents|protective agents|mesh-ancestor
64298263|NCT02077231|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64298264|NCT02077231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64298265|NCT02077309|Linagliptin|linagliptin|mesh-list
64298266|NCT02077309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64298267|NCT02077309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298299|NCT02074189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298301|NCT02074189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64298302|NCT02074189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298303|NCT02074189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64298304|NCT02074189|Immunologic Factors|immunologic factors|mesh-ancestor
64298305|NCT02074189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298306|NCT02463591|Thrombin|thrombin|mesh-list
64298307|NCT02463591|Hemostatics|hemostatics|mesh-ancestor
64298308|NCT02463591|Coagulants|coagulants|mesh-ancestor
64299924|NCT03283059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64299925|NCT03283059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299926|NCT03283059|Nootropic Agents|nootropic agents|mesh-ancestor
64299927|NCT05060588|Valsartan|valsartan|mesh-list
64300339|NCT01652716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64300340|NCT01652716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300341|NCT01652716|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64503262|NCT03352674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64503263|NCT03352674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503264|NCT01639222|Calcium, Dietary|calcium, dietary|mesh-list
64503265|NCT01639222|Vitamin D|vitamin d|mesh-list
64503266|NCT01639222|Cholecalciferol|cholecalciferol|mesh-list
64503267|NCT01639222|Calcium|calcium|mesh-list
64503268|NCT01639222|Vitamins|vitamins|mesh-ancestor
64503269|NCT01639222|Micronutrients|micronutrients|mesh-ancestor
64503270|NCT01639222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503271|NCT01639222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64503272|NCT01639222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64503273|NCT04443270|Chloroquine|chloroquine|mesh-list
64503274|NCT04443270|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64503275|NCT04443270|Amebicides|amebicides|mesh-ancestor
64945715|NCT05287425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64945716|NCT05287425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64945717|NCT05287425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64945733|NCT05276492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64945734|NCT05276492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945735|NCT05261399|Carboplatin|carboplatin|mesh-list
64945736|NCT05261399|Pemetrexed|pemetrexed|mesh-list
64945737|NCT05261399|Osimertinib|osimertinib|mesh-list
64945738|NCT05261399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945739|NCT05261399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300342|NCT01652716|Incretins|incretins|mesh-ancestor
64573508|NCT01488279|BB 1101|bb 1101|mesh-list
64300343|NCT01652716|Hormones|hormones|mesh-ancestor
64300344|NCT01652716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64300345|NCT02459613|Annexin A5|annexin a5|mesh-list
64300346|NCT02459613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300347|NCT02459613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300348|NCT02251249|Acetaminophen|acetaminophen|mesh-list
64300349|NCT02251249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64300424|NCT05023304|Hormones|hormones|mesh-ancestor
64300425|NCT05023304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64300426|NCT05023304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300427|NCT05023304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64300504|NCT05016206|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64300505|NCT05016206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64300506|NCT05016206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64300507|NCT05016206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64300508|NCT05016206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64300509|NCT05016206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300510|NCT05016206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495198|NCT03632824|Hemostatics|hemostatics|mesh-ancestor
64300789|NCT05014100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64300790|NCT05014100|Growth Substances|growth substances|mesh-ancestor
64300791|NCT05014100|Growth Inhibitors|growth inhibitors|mesh-ancestor
64300792|NCT05014100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64300817|NCT02120677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300818|NCT02120677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64300821|NCT02120911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64300822|NCT02120911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64300824|NCT02112487|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64300825|NCT02112487|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64300826|NCT02112487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300827|NCT02112487|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64300828|NCT03094442|Dexamethasone|dexamethasone|mesh-list
64300829|NCT03094442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64300830|NCT03094442|Antiemetics|antiemetics|mesh-ancestor
64300831|NCT03094442|Autonomic Agents|autonomic agents|mesh-ancestor
64300832|NCT03094442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64300833|NCT03094442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301725|NCT02458755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301726|NCT02458755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64302079|NCT02126527|Antifungal Agents|antifungal agents|mesh-ancestor
64302080|NCT02126527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64302081|NCT02126527|Immunologic Factors|immunologic factors|mesh-ancestor
64302082|NCT02126527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302083|NCT02126527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64302084|NCT02133625|Pioglitazone|pioglitazone|mesh-list
64302099|NCT03071822|Asparaginase|asparaginase|mesh-list
64302117|NCT03071822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573605|NCT04839198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64573606|NCT04839198|Autonomic Agents|autonomic agents|mesh-ancestor
64573609|NCT04839198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64302118|NCT03071822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64302119|NCT03071822|Immunologic Factors|immunologic factors|mesh-ancestor
64302120|NCT03071822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64302121|NCT03071822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64302122|NCT03071822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65495200|NCT00911820|Bevacizumab|bevacizumab|mesh-list
65495201|NCT00911820|Cisplatin|cisplatin|mesh-list
65495202|NCT00911820|Docetaxel|docetaxel|mesh-list
64302123|NCT03071822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64302124|NCT03071822|Alkylating Agents|alkylating agents|mesh-ancestor
64302125|NCT04991012|Triamcinolone|triamcinolone|mesh-list
64302126|NCT04991012|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64302127|NCT04991012|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64302128|NCT04991012|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64302129|NCT04991012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64302130|NCT04991012|Glucocorticoids|glucocorticoids|mesh-ancestor
64302131|NCT04991012|Hormones|hormones|mesh-ancestor
64302132|NCT04991012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64302133|NCT04991012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302134|NCT04991012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64302135|NCT04991012|Immunologic Factors|immunologic factors|mesh-ancestor
64302136|NCT04991012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302988|NCT05635370|Pentoxifylline|pentoxifylline|mesh-list
64302989|NCT05635370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64302990|NCT05635370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302991|NCT05635370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302992|NCT05635370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64302993|NCT05635370|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64302994|NCT05635370|Protective Agents|protective agents|mesh-ancestor
64302995|NCT05635370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303596|NCT02248493|Narcotics|narcotics|mesh-ancestor
64945740|NCT05261399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945741|NCT05261399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64724726|NCT00000685|Antiviral Agents|antiviral agents|mesh-ancestor
64573637|NCT01436799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64303597|NCT02248493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64303598|NCT02248493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303599|NCT02248493|Analgesics|analgesics|mesh-ancestor
64303600|NCT02248493|Sensory System Agents|sensory system agents|mesh-ancestor
64303601|NCT02248493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303603|NCT02248493|Antipyretics|antipyretics|mesh-ancestor
64303604|NCT02248493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64303605|NCT02248493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64303606|NCT02248493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64303607|NCT02248493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64303608|NCT02248493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303609|NCT02248493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303610|NCT05577871|Dexmedetomidine|dexmedetomidine|mesh-list
64303611|NCT05577871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64303612|NCT05577871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64303789|NCT03566225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64303994|NCT05730062|Narcotics|narcotics|mesh-ancestor
64303995|NCT05730062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64303996|NCT05730062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303997|NCT05730062|Analgesics|analgesics|mesh-ancestor
64303998|NCT05730062|Sensory System Agents|sensory system agents|mesh-ancestor
64303999|NCT05730062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64304038|NCT04886414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64304039|NCT04886414|Disinfectants|disinfectants|mesh-ancestor
64304040|NCT05633420|Artesunate|artesunate|mesh-list
64304041|NCT05633420|Pyronaridine|pyronaridine|mesh-list
64304042|NCT05633420|Antimalarials|antimalarials|mesh-ancestor
64304043|NCT05633420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64304044|NCT05633420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64304045|NCT05633420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64304046|NCT05633420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304047|NCT05633420|Antiviral Agents|antiviral agents|mesh-ancestor
64304048|NCT05633420|Schistosomicides|schistosomicides|mesh-ancestor
64304049|NCT05633420|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64304050|NCT05633420|Anthelmintics|anthelmintics|mesh-ancestor
64304051|NCT05729594|Bimatoprost|bimatoprost|mesh-list
64573670|NCT02479451|Vasodilator Agents|vasodilator agents|mesh-ancestor
65019555|NCT02917018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019557|NCT00170859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019558|NCT00170859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65019559|NCT00170859|Immunologic Factors|immunologic factors|mesh-ancestor
65019560|NCT00170859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019561|NCT02917057|Exenatide|exenatide|mesh-list
65019562|NCT02917057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65019563|NCT02917057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019564|NCT02917057|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65019565|NCT02917057|Incretins|incretins|mesh-ancestor
65019566|NCT02917057|Hormones|hormones|mesh-ancestor
65019567|NCT02917057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65019568|NCT02916940|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
65019569|NCT02916940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65019570|NCT02916940|Glucocorticoids|glucocorticoids|mesh-ancestor
65019571|NCT02916940|Hormones|hormones|mesh-ancestor
65019572|NCT02916940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65019573|NCT02916940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019574|NCT00170898|Lumiracoxib|lumiracoxib|mesh-list
65019575|NCT00170898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65019576|NCT00170898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65019577|NCT00170898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066955|NCT00308178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019578|NCT00170898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019579|NCT00170898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65019580|NCT00170898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65019582|NCT00170898|Sensory System Agents|sensory system agents|mesh-ancestor
65019583|NCT00170898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65019584|NCT00170898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019585|NCT00170898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65019586|NCT00170898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64573682|NCT02415413|Melphalan|melphalan|mesh-list
64724727|NCT00000685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724728|NCT00000685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64724729|NCT00000685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64724730|NCT00002972|Paclitaxel|paclitaxel|mesh-list
64724731|NCT00002972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64573704|NCT02379377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65019587|NCT02916355|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65019588|NCT02916355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65019589|NCT02916511|Paclitaxel|paclitaxel|mesh-list
65019590|NCT02916511|Carboplatin|carboplatin|mesh-list
65019591|NCT02916511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65019592|NCT02916511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019593|NCT02916511|Tubulin Modulators|tubulin modulators|mesh-ancestor
65019594|NCT02916511|Antimitotic Agents|antimitotic agents|mesh-ancestor
65019595|NCT02916511|Mitosis Modulators|mitosis modulators|mesh-ancestor
65019596|NCT02916511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019597|NCT00170937|Valsartan|valsartan|mesh-list
65019598|NCT00170937|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65019599|NCT00170937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65019600|NCT00170937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65019601|NCT00170937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65019602|NCT00170937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019603|NCT00170937|Diuretics|diuretics|mesh-ancestor
65019604|NCT00170937|Natriuretic Agents|natriuretic agents|mesh-ancestor
65019605|NCT00170937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019606|NCT00170937|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65019607|NCT00170937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65019608|NCT02916238|Fluoxetine|fluoxetine|mesh-list
65019609|NCT02916238|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65019610|NCT02916238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65019611|NCT02916238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65019612|NCT02916238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019613|NCT02916238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65019614|NCT02916238|Serotonin Agents|serotonin agents|mesh-ancestor
65019615|NCT02916238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019616|NCT02916238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65019617|NCT02916238|Antidepressive Agents|antidepressive agents|mesh-ancestor
65019618|NCT02916238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65019619|NCT02916238|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64332288|NCT03182751|Tranexamic Acid|tranexamic acid|mesh-list
65019621|NCT02916238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573740|NCT02607306|Incretins|incretins|mesh-ancestor
65019622|NCT00149708|Hormones|hormones|mesh-list
64475346|NCT00366106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019623|NCT00149708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65019624|NCT00149708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019626|NCT00163761|Vinorelbine|vinorelbine|mesh-list
65019627|NCT00163761|Ifosfamide|ifosfamide|mesh-list
65019628|NCT00163761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65019629|NCT00163761|Antimetabolites|antimetabolites|mesh-ancestor
65019630|NCT00163761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019631|NCT00163761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019632|NCT00163761|Antiviral Agents|antiviral agents|mesh-ancestor
65019633|NCT00163761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65019634|NCT00163761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019635|NCT00163761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65019636|NCT00163761|Immunologic Factors|immunologic factors|mesh-ancestor
65019637|NCT00163761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019638|NCT00163761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65019639|NCT00163761|Tubulin Modulators|tubulin modulators|mesh-ancestor
65019640|NCT00163761|Antimitotic Agents|antimitotic agents|mesh-ancestor
65019644|NCT02916160|Valsartan|valsartan|mesh-list
65019671|NCT00149864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64573791|NCT02298257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65019672|NCT00149864|Antitubercular Agents|antitubercular agents|mesh-ancestor
65019673|NCT00149864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65019674|NCT00149864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65019675|NCT00149864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019676|NCT00149864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019677|NCT00149903|Mycophenolic Acid|mycophenolic acid|mesh-list
65019678|NCT00149903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65019679|NCT00149903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019680|NCT00149903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65019681|NCT00149903|Antitubercular Agents|antitubercular agents|mesh-ancestor
65019682|NCT00149903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65019683|NCT00149903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65019684|NCT00149903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019685|NCT00149903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019686|NCT04688632|Moxifloxacin|moxifloxacin|mesh-list
65019687|NCT04688632|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65019688|NCT04688632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65019689|NCT04688632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65019690|NCT04688632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65019691|NCT04688632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65019692|NCT04688632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019693|NCT04688632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019694|NCT04688632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019695|NCT04688632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65019697|NCT04688632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64945742|NCT05261399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64945743|NCT05261399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64945744|NCT05259722|Alitretinoin|alitretinoin|mesh-list
64945745|NCT05259722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945746|NCT05259722|Dermatologic Agents|dermatologic agents|mesh-ancestor
64945747|NCT05258721|Fluorides|fluorides|mesh-list
64945748|NCT05258721|Cariostatic Agents|cariostatic agents|mesh-ancestor
64945749|NCT05258721|Protective Agents|protective agents|mesh-ancestor
64945750|NCT05258721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945751|NCT05255003|Enoxaparin|enoxaparin|mesh-list
64945752|NCT05255003|Dalteparin|dalteparin|mesh-list
64945753|NCT05255003|Tinzaparin|tinzaparin|mesh-list
64945754|NCT05255003|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64945755|NCT05255003|Anticoagulants|anticoagulants|mesh-ancestor
64945756|NCT05255003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64945757|NCT05255003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64945758|NCT05255003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945759|NCT05232032|Nociceptin|nociceptin|mesh-list
65019698|NCT04688632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019699|NCT04688632|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65019700|NCT04688632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65019701|NCT04688632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65019702|NCT00171015|Valsartan|valsartan|mesh-list
65019703|NCT00171015|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65019704|NCT00171015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65019705|NCT00171015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65019706|NCT00171015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65019707|NCT00171015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019708|NCT00171015|Diuretics|diuretics|mesh-ancestor
65019709|NCT00171015|Natriuretic Agents|natriuretic agents|mesh-ancestor
65019710|NCT00171015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019711|NCT00171015|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65019712|NCT00171015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65019713|NCT05786677|Serotonin|serotonin|mesh-list
65019714|NCT05786677|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65019715|NCT05786677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65019716|NCT05786677|Serotonin Agents|serotonin agents|mesh-ancestor
65019717|NCT05786677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65019718|NCT05786677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019719|NCT05786677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019720|NCT05786677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65019721|NCT05786677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65019722|NCT05786612|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65019723|NCT05786612|Laxatives|laxatives|mesh-ancestor
65019724|NCT05786612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65019725|NCT05786547|Varenicline|varenicline|mesh-list
65019726|NCT05786547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65019727|NCT05786547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65019728|NCT05786547|Cholinergic Agents|cholinergic agents|mesh-ancestor
65019729|NCT05786547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65019731|NCT05786547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019736|NCT05786443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019737|NCT05786443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65019738|NCT05786443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019739|NCT05786430|Carboplatin|carboplatin|mesh-list
65019741|NCT05786430|Lazertinib|lazertinib|mesh-list
65019742|NCT05786430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019743|NCT05786430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019744|NCT05786430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019745|NCT05786430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65019746|NCT05786430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65019747|NCT05786430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65019748|NCT05786417|Calcium Channel Blockers|calcium channel blockers|mesh-list
65019749|NCT05786417|Calcium|calcium|mesh-list
65019750|NCT05786417|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65019751|NCT05786417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65019752|NCT05786417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019753|NCT05786417|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65019754|NCT05786417|Adrenergic Agents|adrenergic agents|mesh-ancestor
65019755|NCT05786417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65019756|NCT05786417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019757|NCT05786417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65019758|NCT05786365|Ketamine|ketamine|mesh-list
65019759|NCT05786365|Analgesics|analgesics|mesh-ancestor
65019760|NCT05786365|Sensory System Agents|sensory system agents|mesh-ancestor
65019761|NCT05786365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65019762|NCT05786365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019763|NCT05786365|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65019764|NCT05786365|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65019765|NCT05786365|Anesthetics, General|anesthetics, general|mesh-ancestor
65019766|NCT05786365|Anesthetics|anesthetics|mesh-ancestor
65019767|NCT05786365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65019768|NCT05786365|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65019769|NCT05786365|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65019770|NCT05786365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64304053|NCT02631746|Nivolumab|nivolumab|mesh-list
64945760|NCT05232032|Vasodilator Agents|vasodilator agents|mesh-ancestor
64945761|NCT05222516|Broncho-Vaxom|broncho-vaxom|mesh-list
64945762|NCT05222516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65019771|NCT05786365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019773|NCT05786339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65019774|NCT05786339|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65019775|NCT05786339|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65019776|NCT05786339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019777|NCT05786040|Rituximab|rituximab|mesh-list
65019778|NCT05786040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65019779|NCT05786040|Antibodies|antibodies|mesh-list
65019780|NCT05786040|Immunoglobulins|immunoglobulins|mesh-list
65019781|NCT05786040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65019782|NCT05786040|Immunologic Factors|immunologic factors|mesh-ancestor
65019783|NCT05786040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019784|NCT05786040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019785|NCT05786040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65019786|NCT05785832|Insulin|insulin|mesh-list
65019787|NCT05785832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65019788|NCT05785832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019789|NCT05785585|Vitamin B 12|vitamin b 12|mesh-list
65019790|NCT05785585|Hydroxocobalamin|hydroxocobalamin|mesh-list
65019791|NCT05785585|Vitamin B Complex|vitamin b complex|mesh-ancestor
65019792|NCT05785585|Vitamins|vitamins|mesh-ancestor
65019793|NCT05785585|Micronutrients|micronutrients|mesh-ancestor
65019794|NCT05785585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019795|NCT05785585|Hematinics|hematinics|mesh-ancestor
65019796|NCT05785442|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65019797|NCT05785442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65019798|NCT05785429|Colchicine|colchicine|mesh-list
65019799|NCT05785429|Gout Suppressants|gout suppressants|mesh-ancestor
65019819|NCT05785377|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65019820|NCT05785377|Autonomic Agents|autonomic agents|mesh-ancestor
65019821|NCT05785325|Bevacizumab|bevacizumab|mesh-list
65019822|NCT05785325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65019823|NCT05785325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019824|NCT05785325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65019825|NCT05785325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65019826|NCT05785325|Growth Substances|growth substances|mesh-ancestor
65019827|NCT05785325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019828|NCT05785325|Growth Inhibitors|growth inhibitors|mesh-ancestor
65019829|NCT05785234|Sufentanil|sufentanil|mesh-list
65019830|NCT05785234|Remifentanil|remifentanil|mesh-list
65019831|NCT05785234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65019832|NCT05785234|Narcotics|narcotics|mesh-ancestor
65019833|NCT05785234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65019834|NCT05785234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019835|NCT05785234|Analgesics|analgesics|mesh-ancestor
65019836|NCT05785234|Sensory System Agents|sensory system agents|mesh-ancestor
65019837|NCT05785234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65019838|NCT05785234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65019839|NCT05785234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65019840|NCT05785234|Anesthetics, General|anesthetics, general|mesh-ancestor
65019841|NCT05785234|Anesthetics|anesthetics|mesh-ancestor
65019842|NCT05785208|Osimertinib|osimertinib|mesh-list
65019843|NCT05785208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019844|NCT05785208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65019845|NCT05785208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019846|NCT05785208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019866|NCT05785065|Antitubercular Agents|antitubercular agents|mesh-ancestor
65019867|NCT05785065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65019868|NCT05785065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65019869|NCT05785065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019870|NCT05785065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019871|NCT05785026|Menthol|menthol|mesh-list
65019872|NCT05785026|Antipruritics|antipruritics|mesh-ancestor
65019873|NCT05785026|Dermatologic Agents|dermatologic agents|mesh-ancestor
65019874|NCT05784987|Rituximab|rituximab|mesh-list
65019875|NCT05784987|Etoposide|etoposide|mesh-list
65019876|NCT05784987|Lenalidomide|lenalidomide|mesh-list
65019877|NCT05784987|Mitoxantrone|mitoxantrone|mesh-list
65019878|NCT05784987|Ifosfamide|ifosfamide|mesh-list
65019879|NCT05784987|Isophosphamide mustard|isophosphamide mustard|mesh-list
65019880|NCT05784987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65019881|NCT05784987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019882|NCT05784987|Immunologic Factors|immunologic factors|mesh-ancestor
65019883|NCT05784987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019884|NCT05784987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65019885|NCT05784987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65019886|NCT05784987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65019887|NCT05784987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65019888|NCT05784987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65019889|NCT05784987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019890|NCT05784987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65019891|NCT05784987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65019892|NCT05784987|Growth Substances|growth substances|mesh-ancestor
65019893|NCT05784987|Growth Inhibitors|growth inhibitors|mesh-ancestor
65019914|NCT05784467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019915|NCT05784467|Adrenergic Agents|adrenergic agents|mesh-ancestor
65019916|NCT05784467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65019917|NCT05784467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65019918|NCT05784467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65019919|NCT05784467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65019920|NCT05782894|Remifentanil|remifentanil|mesh-list
65019922|NCT05782894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65019923|NCT05782894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65019924|NCT05782894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019925|NCT05782894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65019926|NCT05782894|Anesthetics, General|anesthetics, general|mesh-ancestor
65019927|NCT05782894|Anesthetics|anesthetics|mesh-ancestor
65019928|NCT05782894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65019929|NCT05782894|Narcotics|narcotics|mesh-ancestor
65019930|NCT05782894|Analgesics|analgesics|mesh-ancestor
65019931|NCT05782894|Sensory System Agents|sensory system agents|mesh-ancestor
65019932|NCT05782894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65019933|NCT05782712|Adenosine|adenosine|mesh-list
65019934|NCT05782712|Analgesics|analgesics|mesh-ancestor
65019935|NCT05782712|Sensory System Agents|sensory system agents|mesh-ancestor
65019936|NCT05782712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65019937|NCT05782712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019938|NCT05782712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65019939|NCT05782712|Vasodilator Agents|vasodilator agents|mesh-ancestor
65019940|NCT05782712|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65019941|NCT05782712|Purinergic Agonists|purinergic agonists|mesh-ancestor
65019942|NCT05782712|Purinergic Agents|purinergic agents|mesh-ancestor
65019943|NCT05782712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65019944|NCT05782712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019945|NCT05781516|Prednisolone|prednisolone|mesh-list
65019946|NCT05781516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65019947|NCT05781516|Glucocorticoids|glucocorticoids|mesh-ancestor
65019956|NCT05781321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65019957|NCT05781321|Alkylating Agents|alkylating agents|mesh-ancestor
65019958|NCT05781321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019959|NCT05781321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65019960|NCT05781321|Cariostatic Agents|cariostatic agents|mesh-ancestor
65019961|NCT05781321|Protective Agents|protective agents|mesh-ancestor
65019962|NCT05781321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019963|NCT05781321|Dopamine Agents|dopamine agents|mesh-ancestor
65019964|NCT05781321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65019965|NCT05781321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65019966|NCT05781321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65019967|NCT05780437|Remdesivir|remdesivir|mesh-list
65019968|NCT05780437|Antimetabolites|antimetabolites|mesh-ancestor
65019969|NCT05780437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019970|NCT05780437|Antiviral Agents|antiviral agents|mesh-ancestor
65019971|NCT05780437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65019972|NCT05780424|Remdesivir|remdesivir|mesh-list
65019973|NCT05780424|Antimetabolites|antimetabolites|mesh-ancestor
65019974|NCT05780424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65019975|NCT05780424|Antiviral Agents|antiviral agents|mesh-ancestor
65019976|NCT05780424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65019977|NCT05778266|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65019978|NCT05778266|Laxatives|laxatives|mesh-ancestor
65019979|NCT05778266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65019980|NCT05774405|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65019981|NCT05774405|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65019982|NCT05774405|Estradiol|estradiol|mesh-list
65019983|NCT05774405|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65019984|NCT05774405|Estrogens|estrogens|mesh-ancestor
65019985|NCT05774405|Hormones|hormones|mesh-ancestor
65019986|NCT05774405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65019987|NCT05774405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019988|NCT05774405|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65019989|NCT05774405|Contraceptive Agents|contraceptive agents|mesh-ancestor
65019995|NCT05766683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65019996|NCT05766683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65019997|NCT05766683|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65019998|NCT05766683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65019999|NCT05766683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020000|NCT05766683|Cholinergic Agents|cholinergic agents|mesh-ancestor
65020001|NCT05766683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65020002|NCT05764941|Vinorelbine|vinorelbine|mesh-list
65020003|NCT05764941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65020004|NCT05764941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020005|NCT05764941|Tubulin Modulators|tubulin modulators|mesh-ancestor
65020006|NCT05764941|Antimitotic Agents|antimitotic agents|mesh-ancestor
65020007|NCT05764941|Mitosis Modulators|mitosis modulators|mesh-ancestor
65020008|NCT05764941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020010|NCT05757869|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65020011|NCT05757869|Antithrombins|antithrombins|mesh-ancestor
65020012|NCT05757869|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65020013|NCT05757869|Protease Inhibitors|protease inhibitors|mesh-ancestor
65020014|NCT05757869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020015|NCT05757869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020016|NCT05757869|Anticoagulants|anticoagulants|mesh-ancestor
65020017|NCT05750017|Vaccines|vaccines|mesh-list
65020018|NCT05750017|Immunologic Factors|immunologic factors|mesh-ancestor
65020019|NCT05750017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020020|NCT05734105|Sunitinib|sunitinib|mesh-list
65020021|NCT05734105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020022|NCT05734105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64574172|NCT02049593|Talazoparib|talazoparib|mesh-list
65020042|NCT05700422|Cholinergic Agents|cholinergic agents|mesh-ancestor
65020043|NCT05700422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65020044|NCT05700422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020045|NCT05700422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020046|NCT05635110|Rifampin|rifampin|mesh-list
65020047|NCT05635110|Omeprazole|omeprazole|mesh-list
65020048|NCT05635110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65020049|NCT05635110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65020050|NCT05635110|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65020051|NCT05635110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020052|NCT05635110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020053|NCT05635110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65020054|NCT05635110|Antitubercular Agents|antitubercular agents|mesh-ancestor
65020055|NCT05635110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65020056|NCT05635110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65020057|NCT05635110|Leprostatic Agents|leprostatic agents|mesh-ancestor
65020058|NCT05635110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65020059|NCT05635110|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65020060|NCT05635110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65020061|NCT05635110|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65020062|NCT05635110|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65020063|NCT05635110|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65020064|NCT05635110|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65020065|NCT05634577|Pembrolizumab|pembrolizumab|mesh-list
65020066|NCT05634577|Mitotane|mitotane|mesh-list
64503276|NCT04443270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64503277|NCT04443270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64503278|NCT04443270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64503279|NCT04443270|Antimalarials|antimalarials|mesh-ancestor
64484642|NCT01149850|Antibodies|antibodies|mesh-list
64503280|NCT04443270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64945763|NCT05222516|Immunologic Factors|immunologic factors|mesh-ancestor
64419681|NCT05519371|Anesthetics|anesthetics|mesh-ancestor
64945786|NCT05174065|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64945787|NCT05174065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64945788|NCT05174065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945789|NCT05174065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945791|NCT05111717|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64945792|NCT05111717|Anesthetics, General|anesthetics, general|mesh-ancestor
64945793|NCT05111717|Anesthetics|anesthetics|mesh-ancestor
64945794|NCT05111717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64945795|NCT05111717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945796|NCT05105919|Aspirin|aspirin|mesh-list
64945797|NCT05105919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64945798|NCT05105919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64945799|NCT05105919|Analgesics|analgesics|mesh-ancestor
64945800|NCT05105919|Sensory System Agents|sensory system agents|mesh-ancestor
64574197|NCT01449747|Protease Inhibitors|protease inhibitors|mesh-ancestor
65020067|NCT05634577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64574198|NCT01449747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020068|NCT05634577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020069|NCT05634577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65020070|NCT05634369|Gemcitabine|gemcitabine|mesh-list
65020071|NCT05634369|Dexamethasone|dexamethasone|mesh-list
65020072|NCT05634369|Docetaxel|docetaxel|mesh-list
65020073|NCT05634369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65020074|NCT05634369|Antiemetics|antiemetics|mesh-ancestor
65020075|NCT05634369|Autonomic Agents|autonomic agents|mesh-ancestor
65020076|NCT05634369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65020077|NCT05634369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020078|NCT05634369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65020079|NCT05634369|Glucocorticoids|glucocorticoids|mesh-ancestor
65020080|NCT05634369|Hormones|hormones|mesh-ancestor
65020081|NCT05634369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65020082|NCT05634369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65020083|NCT05634369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020084|NCT05634369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020085|NCT05634369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020086|NCT05634369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65020087|NCT05634369|Antimetabolites|antimetabolites|mesh-ancestor
65020088|NCT05634369|Antiviral Agents|antiviral agents|mesh-ancestor
65020089|NCT05634369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65020090|NCT05634369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65020091|NCT05634369|Immunologic Factors|immunologic factors|mesh-ancestor
65020092|NCT05634369|Tubulin Modulators|tubulin modulators|mesh-ancestor
65020093|NCT05634369|Antimitotic Agents|antimitotic agents|mesh-ancestor
64945801|NCT05105919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64945802|NCT05105919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945803|NCT05105919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64945804|NCT05105919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64945805|NCT05105919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64945806|NCT05105919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64945807|NCT05105919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945808|NCT05105919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64945809|NCT05105919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64945810|NCT05105919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724732|NCT00002972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64724733|NCT00002972|Tubulin Modulators|tubulin modulators|mesh-ancestor
64724734|NCT00002972|Antimitotic Agents|antimitotic agents|mesh-ancestor
64724735|NCT00002972|Mitosis Modulators|mitosis modulators|mesh-ancestor
64724736|NCT00002972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724738|NCT00000691|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
65020094|NCT05634369|Mitosis Modulators|mitosis modulators|mesh-ancestor
65020095|NCT05616260|Acetazolamide|acetazolamide|mesh-list
65020096|NCT05616260|Anticonvulsants|anticonvulsants|mesh-ancestor
65020097|NCT05616260|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65020098|NCT05616260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066956|NCT00282360|Trimetazidine|trimetazidine|mesh-list
65020099|NCT05616260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020100|NCT05616260|Diuretics|diuretics|mesh-ancestor
65020101|NCT05616260|Natriuretic Agents|natriuretic agents|mesh-ancestor
65020102|NCT05616260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020103|NCT05611034|Oxaliplatin|oxaliplatin|mesh-list
65020104|NCT05611034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020105|NCT05592509|Vitamins|vitamins|mesh-list
65020106|NCT05592509|Micronutrients|micronutrients|mesh-ancestor
65020107|NCT05592509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020108|NCT05591092|Iodine|iodine|mesh-list
65020109|NCT05591092|Cadexomer iodine|cadexomer iodine|mesh-list
65020110|NCT05591092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65020111|NCT05591092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65020112|NCT05591092|Trace Elements|trace elements|mesh-ancestor
65020113|NCT05591092|Micronutrients|micronutrients|mesh-ancestor
65020114|NCT05591092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020115|NCT05583227|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65020116|NCT05583227|Immunologic Factors|immunologic factors|mesh-ancestor
65020117|NCT05583227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020118|NCT05582213|Anesthetics|anesthetics|mesh-list
65020119|NCT05582213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65020120|NCT05582213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020121|NCT05550597|Fentanyl|fentanyl|mesh-list
65020142|NCT05535764|Interferon-alpha|interferon-alpha|mesh-list
64574271|NCT04836156|Carboplatin|carboplatin|mesh-list
64574272|NCT04836156|Docetaxel|docetaxel|mesh-list
64574273|NCT04836156|Epirubicin|epirubicin|mesh-list
65020143|NCT05535764|Interferon alpha-2|interferon alpha-2|mesh-list
65020144|NCT05535764|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65020145|NCT05535764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020146|NCT05535764|Antiviral Agents|antiviral agents|mesh-ancestor
65020147|NCT05535764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65020148|NCT05535764|Immunologic Factors|immunologic factors|mesh-ancestor
65020149|NCT05535764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020150|NCT05520567|Azacitidine|azacitidine|mesh-list
65020151|NCT05520567|Venetoclax|venetoclax|mesh-list
65020152|NCT05520567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65020153|NCT05520567|Antimetabolites|antimetabolites|mesh-ancestor
65020154|NCT05520567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020155|NCT05520567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020156|NCT05520567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020157|NCT05495269|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65020158|NCT05495269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65020159|NCT05444582|Levonorgestrel|levonorgestrel|mesh-list
65020160|NCT05444582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65020161|NCT05444582|Contraceptive Agents|contraceptive agents|mesh-ancestor
65020162|NCT05444582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65020163|NCT05444582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020164|NCT05444582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65020165|NCT05444582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65020166|NCT05444582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65020167|NCT05413915|Imatinib Mesylate|imatinib mesylate|mesh-list
65020168|NCT05413915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020169|NCT05413915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65020170|NCT05413915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020171|NCT05413915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020172|NCT05355935|Moxifloxacin|moxifloxacin|mesh-list
64574274|NCT04836156|Phenobarbital|phenobarbital|mesh-list
64574275|NCT04836156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64574276|NCT04836156|Immunologic Factors|immunologic factors|mesh-ancestor
64724739|NCT00000691|Antiviral Agents|antiviral agents|mesh-ancestor
64724740|NCT00000691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724741|NCT00000691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65020173|NCT05355935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65020174|NCT05355935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65020175|NCT05355935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65020176|NCT05355935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65020177|NCT05355935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020178|NCT05355935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020179|NCT05355935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020180|NCT05334017|Cocaine|cocaine|mesh-list
65020181|NCT05334017|Xylometazoline|xylometazoline|mesh-list
65020182|NCT05334017|Anesthetics, Local|anesthetics, local|mesh-ancestor
65020183|NCT05334017|Anesthetics|anesthetics|mesh-ancestor
65020184|NCT05334017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65020185|NCT05334017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020186|NCT05334017|Sensory System Agents|sensory system agents|mesh-ancestor
65020187|NCT05334017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65020188|NCT05334017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65020189|NCT05334017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65020190|NCT05334017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65020191|NCT05334017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65020192|NCT05334017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020193|NCT05334017|Dopamine Agents|dopamine agents|mesh-ancestor
65020194|NCT05334017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65020195|NCT05334017|Nasal Decongestants|nasal decongestants|mesh-ancestor
65020196|NCT05334017|Respiratory System Agents|respiratory system agents|mesh-ancestor
65020223|NCT05292339|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65020224|NCT05292339|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65020226|NCT05292339|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65020227|NCT05292339|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65020228|NCT05292339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65020229|NCT05292339|Glucocorticoids|glucocorticoids|mesh-ancestor
65020230|NCT05292339|Hormones|hormones|mesh-ancestor
65020231|NCT05292339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65020232|NCT05292339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020233|NCT05292339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65020234|NCT05292339|Immunologic Factors|immunologic factors|mesh-ancestor
65020235|NCT05292339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020236|NCT05292339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020237|NCT05292339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65020238|NCT05292339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65020239|NCT05292339|Analgesics|analgesics|mesh-ancestor
65020240|NCT05292339|Sensory System Agents|sensory system agents|mesh-ancestor
65020241|NCT05292339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65020242|NCT05292339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65020243|NCT05292339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65020244|NCT05291650|Hyaluronic Acid|hyaluronic acid|mesh-list
65020245|NCT05291650|Glucocorticoids|glucocorticoids|mesh-list
65020246|NCT05291650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65020247|NCT05291650|Immunologic Factors|immunologic factors|mesh-ancestor
65020248|NCT05291650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020249|NCT05291650|Viscosupplements|viscosupplements|mesh-ancestor
65020250|NCT05291650|Protective Agents|protective agents|mesh-ancestor
65020251|NCT05291650|Hormones|hormones|mesh-ancestor
65020252|NCT05291650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65020257|NCT05266469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020258|NCT05266027|Nalbuphine|nalbuphine|mesh-list
65020259|NCT05266027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65020260|NCT05266027|Narcotics|narcotics|mesh-ancestor
65020261|NCT05266027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65020262|NCT05266027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020263|NCT05266027|Analgesics|analgesics|mesh-ancestor
64724742|NCT00000691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65020264|NCT05266027|Sensory System Agents|sensory system agents|mesh-ancestor
65020265|NCT05266027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65020270|NCT05176483|Nivolumab|nivolumab|mesh-list
65020271|NCT05176483|Ipilimumab|ipilimumab|mesh-list
65020272|NCT05176483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65020273|NCT05176483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020274|NCT05176483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65020275|NCT05176483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020276|NCT05159427|Glipizide|glipizide|mesh-list
65020277|NCT05159427|Rifaximin|rifaximin|mesh-list
65020278|NCT05159427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65020279|NCT05159427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65020280|NCT05159427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65020281|NCT05159427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65020282|NCT05159427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020283|NCT05157867|Trypsin Inhibitors|trypsin inhibitors|mesh-list
65020284|NCT05157867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65020285|NCT05157867|Protease Inhibitors|protease inhibitors|mesh-ancestor
65020286|NCT05157867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020287|NCT05157867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020288|NCT05152628|Tacrolimus|tacrolimus|mesh-list
64574383|NCT00156013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64945811|NCT05105919|Antipyretics|antipyretics|mesh-ancestor
64945812|NCT05096195|Calcium, Dietary|calcium, dietary|mesh-list
64945813|NCT05096195|Vitamin D|vitamin d|mesh-list
64945814|NCT05096195|Denosumab|denosumab|mesh-list
64945815|NCT05096195|Calcium|calcium|mesh-list
64945816|NCT05096195|Vitamins|vitamins|mesh-ancestor
64945817|NCT05096195|Micronutrients|micronutrients|mesh-ancestor
64945818|NCT05096195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945819|NCT05096195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64945820|NCT05096195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64945821|NCT05083247|Gemcitabine|gemcitabine|mesh-list
64945822|NCT05083247|Paclitaxel|paclitaxel|mesh-list
64945823|NCT05083247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64945824|NCT05083247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945825|NCT05083247|Tubulin Modulators|tubulin modulators|mesh-ancestor
64945826|NCT05083247|Antimitotic Agents|antimitotic agents|mesh-ancestor
64945827|NCT05083247|Mitosis Modulators|mitosis modulators|mesh-ancestor
64945828|NCT05083247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945835|NCT05083247|Immunologic Factors|immunologic factors|mesh-ancestor
64945843|NCT05077527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64945844|NCT05077527|Alkylating Agents|alkylating agents|mesh-ancestor
64945845|NCT05077527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945846|NCT05077527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945847|NCT05077527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64945848|NCT05070364|Interferons|interferons|mesh-list
64945849|NCT05070364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945850|NCT05070364|Antiviral Agents|antiviral agents|mesh-ancestor
64945851|NCT05070364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64945852|NCT05054439|Paclitaxel|paclitaxel|mesh-list
64945853|NCT05054439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64945854|NCT05054439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945855|NCT05054439|Tubulin Modulators|tubulin modulators|mesh-ancestor
65020289|NCT05152628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65020290|NCT05152628|Immunologic Factors|immunologic factors|mesh-ancestor
65020291|NCT05152628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020292|NCT05152628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65020293|NCT05152628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020294|NCT05152628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020295|NCT05131386|Trabectedin|trabectedin|mesh-list
65020296|NCT05131386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64476027|NCT00381862|Antidotes|antidotes|mesh-ancestor
65020303|NCT05129332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020304|NCT05129332|Antioxidants|antioxidants|mesh-ancestor
65020305|NCT05129332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020306|NCT05129332|Protective Agents|protective agents|mesh-ancestor
65020307|NCT05111262|Budesonide|budesonide|mesh-list
65020308|NCT05111262|Formoterol Fumarate|formoterol fumarate|mesh-list
65020309|NCT05111262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65020310|NCT05111262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65020311|NCT05111262|Autonomic Agents|autonomic agents|mesh-ancestor
65020312|NCT05111262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65020313|NCT05111262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020314|NCT05111262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65020315|NCT05111262|Respiratory System Agents|respiratory system agents|mesh-ancestor
65020316|NCT05111262|Glucocorticoids|glucocorticoids|mesh-ancestor
65020317|NCT05111262|Hormones|hormones|mesh-ancestor
65020318|NCT05111262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65020319|NCT05111262|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65020320|NCT05111262|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65020321|NCT05111262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65020322|NCT05111262|Adrenergic Agents|adrenergic agents|mesh-ancestor
65020323|NCT05111262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65020324|NCT05111262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020325|NCT05094128|Upadacitinib|upadacitinib|mesh-list
65020326|NCT05094128|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65020327|NCT05094128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65020332|NCT05091242|Analgesics|analgesics|mesh-ancestor
65020333|NCT05091242|Sensory System Agents|sensory system agents|mesh-ancestor
65020334|NCT05091242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65020335|NCT05091242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020336|NCT05091242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65020337|NCT05091242|Sympatholytics|sympatholytics|mesh-ancestor
65020338|NCT05091242|Autonomic Agents|autonomic agents|mesh-ancestor
65020339|NCT05091242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65020340|NCT05091242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65020341|NCT05091242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65020342|NCT05091242|Adrenergic Agents|adrenergic agents|mesh-ancestor
65020343|NCT05091242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65020344|NCT05091242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020345|NCT05028140|Pioglitazone|pioglitazone|mesh-list
65020346|NCT05028140|Empagliflozin|empagliflozin|mesh-list
65020347|NCT05028140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65020348|NCT05028140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020349|NCT05028140|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65020350|NCT05028140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020351|NCT05027516|Azithromycin|azithromycin|mesh-list
65020352|NCT05027516|Ceftriaxone|ceftriaxone|mesh-list
65020353|NCT05027516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65020354|NCT05027516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65020361|NCT04992013|Niraparib|niraparib|mesh-list
65020362|NCT04992013|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65020363|NCT04992013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020364|NCT04992013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020365|NCT04992013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020366|NCT04989816|Trastuzumab|trastuzumab|mesh-list
65020367|NCT04989816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65020368|NCT04989816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020369|NCT04969263|Vaccines|vaccines|mesh-list
65020375|NCT04933630|Serotonin|serotonin|mesh-list
65020379|NCT04933630|Adrenergic Agents|adrenergic agents|mesh-ancestor
64574488|NCT01319981|Prednisolone|prednisolone|mesh-list
65020380|NCT04933630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65020381|NCT04933630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020382|NCT04933630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020383|NCT04933630|Sympathomimetics|sympathomimetics|mesh-ancestor
65020384|NCT04933630|Autonomic Agents|autonomic agents|mesh-ancestor
65020385|NCT04933630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65020386|NCT04933630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65020387|NCT04933630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65020388|NCT04933630|Serotonin Agents|serotonin agents|mesh-ancestor
65020389|NCT04933630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65020390|NCT04933630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65020391|NCT04923841|Atropine|atropine|mesh-list
65020392|NCT04923841|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65020393|NCT04923841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65020394|NCT04923841|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65020395|NCT04923841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65020396|NCT04923841|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65020397|NCT04923841|Autonomic Agents|autonomic agents|mesh-ancestor
65020398|NCT04923841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65020399|NCT04923841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020400|NCT04923841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65020401|NCT04923841|Respiratory System Agents|respiratory system agents|mesh-ancestor
65020402|NCT04923841|Mydriatics|mydriatics|mesh-ancestor
65020403|NCT04923841|Parasympatholytics|parasympatholytics|mesh-ancestor
65020404|NCT04923841|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65020405|NCT04923841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65020406|NCT04923841|Cholinergic Agents|cholinergic agents|mesh-ancestor
65020407|NCT04923841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65020408|NCT04923841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020409|NCT04892017|Trametinib|trametinib|mesh-list
65020410|NCT04892017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020411|NCT04892017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65020412|NCT04892017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304054|NCT02631746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64945856|NCT05054439|Antimitotic Agents|antimitotic agents|mesh-ancestor
65020413|NCT04892017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020414|NCT04880863|Docetaxel|docetaxel|mesh-list
65020415|NCT04880863|Obinutuzumab|obinutuzumab|mesh-list
65020416|NCT04880863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020417|NCT04880863|Tubulin Modulators|tubulin modulators|mesh-ancestor
65020418|NCT04880863|Antimitotic Agents|antimitotic agents|mesh-ancestor
65020419|NCT04880863|Mitosis Modulators|mitosis modulators|mesh-ancestor
65020420|NCT04880863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020421|NCT04880863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65020422|NCT04861987|Capecitabine|capecitabine|mesh-list
65020423|NCT04861987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65020424|NCT04861987|Antimetabolites|antimetabolites|mesh-ancestor
65020425|NCT04861987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020426|NCT04861987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020427|NCT04848480|Insulin|insulin|mesh-list
65020428|NCT04848480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65020429|NCT04848480|Insulin Aspart|insulin aspart|mesh-list
65020430|NCT04848480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65020431|NCT04848480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020432|NCT04838808|Rivaroxaban|rivaroxaban|mesh-list
65020433|NCT04838808|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65020434|NCT04838808|Antithrombins|antithrombins|mesh-ancestor
65020435|NCT04838808|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65020436|NCT04838808|Protease Inhibitors|protease inhibitors|mesh-ancestor
65020437|NCT04838808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020438|NCT04838808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020439|NCT04838808|Anticoagulants|anticoagulants|mesh-ancestor
65020440|NCT04836429|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
65020441|NCT04836429|Trioxsalen|trioxsalen|mesh-list
65020442|NCT04836429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020443|NCT04836429|Dermatologic Agents|dermatologic agents|mesh-ancestor
65020457|NCT04792502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65020458|NCT04792502|Growth Substances|growth substances|mesh-ancestor
65020459|NCT04792502|Growth Inhibitors|growth inhibitors|mesh-ancestor
65020460|NCT04792502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020461|NCT04784715|Trastuzumab|trastuzumab|mesh-list
65020462|NCT04784715|Pertuzumab|pertuzumab|mesh-list
65020463|NCT04784715|Taxane|taxane|mesh-list
65020464|NCT04784715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65020465|NCT04784715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020466|NCT04777422|Defibrotide|defibrotide|mesh-list
65020467|NCT04777422|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65020468|NCT04777422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64574566|NCT00066781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020471|NCT04766021|Mirabegron|mirabegron|mesh-list
65020514|NCT04673617|Cyclophosphamide|cyclophosphamide|mesh-list
65020515|NCT04673617|Rituximab|rituximab|mesh-list
65020516|NCT04673617|Fludarabine|fludarabine|mesh-list
65020517|NCT04673617|Interleukin-2|interleukin-2|mesh-list
65020518|NCT04673617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65020519|NCT04673617|Immunologic Factors|immunologic factors|mesh-ancestor
64461800|NCT01970371|Meropenem|meropenem|mesh-list
65020520|NCT04673617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020521|NCT04673617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65020522|NCT04673617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65020523|NCT04673617|Alkylating Agents|alkylating agents|mesh-ancestor
65020524|NCT04673617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020525|NCT04673617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020526|NCT04673617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65020527|NCT04673617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65020528|NCT04673617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65020529|NCT04673617|Analgesics|analgesics|mesh-ancestor
65020530|NCT04673617|Sensory System Agents|sensory system agents|mesh-ancestor
65020531|NCT04673617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65020532|NCT04659811|Pembrolizumab|pembrolizumab|mesh-list
65020533|NCT04659811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65020534|NCT04659811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020536|NCT04610658|Ipilimumab|ipilimumab|mesh-list
65020537|NCT04610658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65020538|NCT04610658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020539|NCT04610658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65020540|NCT04610658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020541|NCT04597437|Zanamivir|zanamivir|mesh-list
65020542|NCT04597437|Antiviral Agents|antiviral agents|mesh-ancestor
65020543|NCT04597437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65020544|NCT04597437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020545|NCT04597437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020556|NCT04595994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020557|NCT04587791|Cannabidiol|cannabidiol|mesh-list
65020558|NCT04587791|Anticonvulsants|anticonvulsants|mesh-ancestor
65020559|NCT04538066|Bryostatin 1|bryostatin 1|mesh-list
65020560|NCT04538066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65020561|NCT04538066|Immunologic Factors|immunologic factors|mesh-ancestor
65020562|NCT04538066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020563|NCT04538066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020564|NCT04532918|Cyclosporine|cyclosporine|mesh-list
65020565|NCT04532918|Rifampin|rifampin|mesh-list
65020566|NCT04532918|Allopurinol|allopurinol|mesh-list
65020567|NCT04532918|Verinurad|verinurad|mesh-list
65020568|NCT04532918|Cyclosporins|cyclosporins|mesh-list
65020569|NCT04532918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020570|NCT04532918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020571|NCT04532918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65020572|NCT04532918|Immunologic Factors|immunologic factors|mesh-ancestor
65020573|NCT04532918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020574|NCT04532918|Antifungal Agents|antifungal agents|mesh-ancestor
65020575|NCT04532918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65020576|NCT04532918|Dermatologic Agents|dermatologic agents|mesh-ancestor
65020577|NCT04532918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65020578|NCT04532918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65020579|NCT04532918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65020580|NCT04532918|Antitubercular Agents|antitubercular agents|mesh-ancestor
65020581|NCT04532918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65020582|NCT04532918|Leprostatic Agents|leprostatic agents|mesh-ancestor
65020583|NCT04532918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65020584|NCT04532918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65020585|NCT04532918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65020586|NCT04532918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65020587|NCT04532918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65020588|NCT04532918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65020589|NCT04532918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65020590|NCT04532918|Antimetabolites|antimetabolites|mesh-ancestor
65020591|NCT04532918|Gout Suppressants|gout suppressants|mesh-ancestor
65020594|NCT04532918|Protective Agents|protective agents|mesh-ancestor
65020596|NCT04511247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65020597|NCT04511247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65020598|NCT04511247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65020599|NCT04511247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020600|NCT04511247|Antifungal Agents|antifungal agents|mesh-ancestor
65020601|NCT04511247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65020602|NCT04511247|Immunologic Factors|immunologic factors|mesh-ancestor
65020603|NCT04511247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020604|NCT04510428|Immunoglobulins|immunoglobulins|mesh-list
65020605|NCT04510428|Antibodies|antibodies|mesh-list
65020606|NCT04510428|gamma-Globulins|gamma-globulins|mesh-list
65020607|NCT04510428|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65020608|NCT04510428|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65020609|NCT04510428|Immunologic Factors|immunologic factors|mesh-ancestor
65020610|NCT04510428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020611|NCT04483466|Methotrexate|methotrexate|mesh-list
65020612|NCT04483466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65020613|NCT04483466|Abortifacient Agents|abortifacient agents|mesh-ancestor
65020614|NCT04483466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65020615|NCT04483466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020616|NCT04483466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65020617|NCT04483466|Antimetabolites|antimetabolites|mesh-ancestor
65020618|NCT04483466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020619|NCT04483466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020620|NCT04483466|Dermatologic Agents|dermatologic agents|mesh-ancestor
65020621|NCT04483466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020622|NCT04483466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65020623|NCT04483466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65020624|NCT04483466|Immunologic Factors|immunologic factors|mesh-ancestor
65020625|NCT04483466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65020626|NCT04483466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65020627|NCT04466475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65020628|NCT04466475|Melphalan|melphalan|mesh-list
65020636|NCT04466475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574734|NCT01896323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65020637|NCT04466475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020638|NCT04466475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65020639|NCT04466475|Alkylating Agents|alkylating agents|mesh-ancestor
65020640|NCT04466475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020641|NCT04466475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65020642|NCT04466475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65020643|NCT04387084|Pembrolizumab|pembrolizumab|mesh-list
65020644|NCT04387084|Nivolumab|nivolumab|mesh-list
65020645|NCT04387084|Durvalumab|durvalumab|mesh-list
65020646|NCT04387084|Avelumab|avelumab|mesh-list
65020647|NCT04387084|Cemiplimab|cemiplimab|mesh-list
65020648|NCT04387084|Atezolizumab|atezolizumab|mesh-list
65020649|NCT04387084|Immunoglobulins|immunoglobulins|mesh-list
65020650|NCT04387084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65020651|NCT04387084|Immunoglobulin G|immunoglobulin g|mesh-list
65020652|NCT04387084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65020653|NCT04387084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020654|NCT04387084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65020655|NCT04387084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020656|NCT04387084|Immunologic Factors|immunologic factors|mesh-ancestor
65020657|NCT04387084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020658|NCT04347798|Hydroxychloroquine|hydroxychloroquine|mesh-list
65020659|NCT04347798|Chloroquine|chloroquine|mesh-list
65020660|NCT04347798|Antimalarials|antimalarials|mesh-ancestor
65020661|NCT04347798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65020662|NCT04347798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64945857|NCT05054439|Mitosis Modulators|mitosis modulators|mesh-ancestor
64945858|NCT05054439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945859|NCT05049603|Atorvastatin|atorvastatin|mesh-list
64945860|NCT05049603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64945861|NCT05049603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64945862|NCT05049603|Antimetabolites|antimetabolites|mesh-ancestor
64945863|NCT05049603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945864|NCT05049603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64945865|NCT05049603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64945866|NCT05049603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945867|NCT05037162|Fibrin fragment D|fibrin fragment d|mesh-list
64945868|NCT05037162|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64945869|NCT05037162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64945870|NCT05037162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724743|NCT00000691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724744|NCT00000691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724746|NCT00002984|Fluorouracil|fluorouracil|mesh-list
64724747|NCT00002984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64724748|NCT00002984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020663|NCT04347798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65020664|NCT04347798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020665|NCT04347798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020666|NCT04347798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65020667|NCT04347798|Amebicides|amebicides|mesh-ancestor
64476404|NCT02110264|Naltrexone|naltrexone|mesh-list
65020668|NCT04335669|Paclitaxel|paclitaxel|mesh-list
65020669|NCT04335669|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65020670|NCT04335669|Cyclophosphamide|cyclophosphamide|mesh-list
65020672|NCT04335669|Pembrolizumab|pembrolizumab|mesh-list
65020673|NCT04335669|Capecitabine|capecitabine|mesh-list
65020674|NCT04335669|Epirubicin|epirubicin|mesh-list
65020675|NCT04335669|Taxane|taxane|mesh-list
65020676|NCT04335669|Antimetabolites|antimetabolites|mesh-list
65020677|NCT04335669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65020678|NCT04335669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020679|NCT04335669|Tubulin Modulators|tubulin modulators|mesh-ancestor
65020680|NCT04335669|Antimitotic Agents|antimitotic agents|mesh-ancestor
65020681|NCT04335669|Mitosis Modulators|mitosis modulators|mesh-ancestor
65020682|NCT04335669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020683|NCT04335669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65020684|NCT04335669|Immunologic Factors|immunologic factors|mesh-ancestor
65020685|NCT04335669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020686|NCT04335669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65020687|NCT04335669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65020688|NCT04335669|Alkylating Agents|alkylating agents|mesh-ancestor
65020689|NCT04335669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65020690|NCT04335669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65020691|NCT04335669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65020692|NCT04335669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65020693|NCT04335669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65020708|NCT04334759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65020709|NCT04332367|Paclitaxel|paclitaxel|mesh-list
65020710|NCT04332367|Carboplatin|carboplatin|mesh-list
65020711|NCT04332367|Ramucirumab|ramucirumab|mesh-list
65020712|NCT04332367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65020713|NCT04332367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020714|NCT04332367|Tubulin Modulators|tubulin modulators|mesh-ancestor
65020715|NCT04332367|Antimitotic Agents|antimitotic agents|mesh-ancestor
65020716|NCT04332367|Mitosis Modulators|mitosis modulators|mesh-ancestor
65020717|NCT04332367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020718|NCT04310176|Bevacizumab|bevacizumab|mesh-list
65020719|NCT04310176|Fluorouracil|fluorouracil|mesh-list
65020720|NCT04310176|Capecitabine|capecitabine|mesh-list
65020721|NCT04310176|Valproic Acid|valproic acid|mesh-list
65020722|NCT04310176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65020723|NCT04310176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020724|NCT04310176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65020725|NCT04310176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65020726|NCT04310176|Growth Substances|growth substances|mesh-ancestor
65020727|NCT04310176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020728|NCT04310176|Growth Inhibitors|growth inhibitors|mesh-ancestor
65020729|NCT04310176|Antimetabolites|antimetabolites|mesh-ancestor
65020730|NCT04310176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020731|NCT04310176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65020732|NCT04310176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65020733|NCT04310176|Immunologic Factors|immunologic factors|mesh-ancestor
65020734|NCT04310176|Anticonvulsants|anticonvulsants|mesh-ancestor
65020735|NCT04310176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020736|NCT04310176|GABA Agents|gaba agents|mesh-ancestor
65020753|NCT04236609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020754|NCT04236609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65020755|NCT04236609|Immunologic Factors|immunologic factors|mesh-ancestor
65020756|NCT04236609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020757|NCT04236609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65020758|NCT04236609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65020759|NCT04236609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65020760|NCT04236609|Antifungal Agents|antifungal agents|mesh-ancestor
65020761|NCT04232657|Denosumab|denosumab|mesh-list
65020762|NCT04232657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65020763|NCT04232657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020764|NCT04209595|Rucaparib|rucaparib|mesh-list
65020765|NCT04209595|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65020766|NCT04209595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020767|NCT04209595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020768|NCT04209595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020769|NCT04187833|Nivolumab|nivolumab|mesh-list
65020770|NCT04187833|Talazoparib|talazoparib|mesh-list
65020771|NCT04187833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65020772|NCT04187833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020773|NCT04187833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65020774|NCT04187833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020775|NCT04187833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65020776|NCT04187833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020777|NCT04173585|Bortezomib|bortezomib|mesh-list
65020778|NCT04173585|Gemtuzumab|gemtuzumab|mesh-list
65020779|NCT04173585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020780|NCT04173585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65020781|NCT04172987|Tirzepatide|tirzepatide|mesh-list
65020782|NCT04172987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65020783|NCT04172987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020784|NCT04172987|Incretins|incretins|mesh-ancestor
65020785|NCT04172987|Hormones|hormones|mesh-ancestor
65020787|NCT04138381|Imatinib Mesylate|imatinib mesylate|mesh-list
65020793|NCT04128501|Venetoclax|venetoclax|mesh-list
65020794|NCT04128501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65020795|NCT04128501|Antimetabolites|antimetabolites|mesh-ancestor
65020796|NCT04128501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020797|NCT04128501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020798|NCT04128501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020799|NCT04127786|Vaccines|vaccines|mesh-list
65020800|NCT04127786|Immunologic Factors|immunologic factors|mesh-ancestor
65020801|NCT04127786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020802|NCT04082780|Rifamycins|rifamycins|mesh-list
65020803|NCT04082780|Rifamycin SV|rifamycin sv|mesh-list
65020804|NCT04082780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65020805|NCT04082780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65020806|NCT04082780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65020807|NCT04077463|Carboplatin|carboplatin|mesh-list
65020808|NCT04077463|Pemetrexed|pemetrexed|mesh-list
65020809|NCT04077463|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
65020810|NCT04077463|Lazertinib|lazertinib|mesh-list
65020811|NCT04077463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020812|NCT04077463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020813|NCT04077463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020814|NCT04077463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65020815|NCT04077463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65020816|NCT04077463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65020817|NCT04077463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65020818|NCT04049331|Methyltestosterone|methyltestosterone|mesh-list
65020843|NCT04015596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020844|NCT04015596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65020845|NCT04015596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65020846|NCT04015596|Gout Suppressants|gout suppressants|mesh-ancestor
65020847|NCT04015596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65020848|NCT04015596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020849|NCT04015596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020850|NCT03985722|Trabectedin|trabectedin|mesh-list
65020851|NCT03985722|Olaratumab|olaratumab|mesh-list
65020852|NCT03985722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65020853|NCT03985722|Alkylating Agents|alkylating agents|mesh-ancestor
65020854|NCT03985722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020855|NCT03985722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020856|NCT03954327|Tenofovir|tenofovir|mesh-list
65020857|NCT03954327|Emtricitabine|emtricitabine|mesh-list
65020858|NCT03954327|Raltegravir Potassium|raltegravir potassium|mesh-list
65020859|NCT03954327|Antiviral Agents|antiviral agents|mesh-ancestor
65020860|NCT03954327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65020861|NCT03954327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65020862|NCT03954327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65020863|NCT03954327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020864|NCT03954327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020865|NCT03954327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65020866|NCT03954327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65020867|NCT03954327|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65020892|NCT03736720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65020893|NCT03736720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020894|NCT03736720|Antidotes|antidotes|mesh-ancestor
65020895|NCT03736720|Protective Agents|protective agents|mesh-ancestor
65020896|NCT03736720|Vitamin B Complex|vitamin b complex|mesh-ancestor
65020897|NCT03736720|Vitamins|vitamins|mesh-ancestor
65020898|NCT03736720|Micronutrients|micronutrients|mesh-ancestor
65020899|NCT03718234|Hydrocortisone|hydrocortisone|mesh-list
65020900|NCT03718234|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65020901|NCT03718234|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65020902|NCT03718234|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65020903|NCT03718234|Glucocorticoids|glucocorticoids|mesh-list
65020904|NCT03718234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65020905|NCT03718234|Hormones|hormones|mesh-ancestor
65020906|NCT03718234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65020907|NCT03718234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020908|NCT03490344|Lenalidomide|lenalidomide|mesh-list
65020909|NCT03490344|Daratumumab|daratumumab|mesh-list
65020910|NCT03490344|Immunologic Factors|immunologic factors|mesh-ancestor
65020911|NCT03490344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020912|NCT03490344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65020913|NCT03490344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65020914|NCT03490344|Growth Substances|growth substances|mesh-ancestor
65020915|NCT03490344|Growth Inhibitors|growth inhibitors|mesh-ancestor
65020917|NCT03473756|Atezolizumab|atezolizumab|mesh-list
65020942|NCT03460353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575043|NCT04826016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575044|NCT04826016|Tubulin Modulators|tubulin modulators|mesh-ancestor
65020943|NCT03460353|Dopamine Agents|dopamine agents|mesh-ancestor
64575045|NCT04826016|Antimitotic Agents|antimitotic agents|mesh-ancestor
65020944|NCT03460353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65020945|NCT03460327|Candesartan|candesartan|mesh-list
65493832|NCT04233866|Tubulin Modulators|tubulin modulators|mesh-ancestor
65020946|NCT03460327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65020947|NCT03460327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65020948|NCT03460327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65020949|NCT03460327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020950|NCT03460314|Buprenorphine|buprenorphine|mesh-list
65020951|NCT03460314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65020952|NCT03460314|Narcotics|narcotics|mesh-ancestor
65020953|NCT03460314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65020954|NCT03460314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020955|NCT03460314|Analgesics|analgesics|mesh-ancestor
65020956|NCT03460314|Sensory System Agents|sensory system agents|mesh-ancestor
65020957|NCT03460314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65020958|NCT03460314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65020959|NCT03460210|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65020960|NCT03460210|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65020961|NCT03460210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65020962|NCT03460210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65020963|NCT03460210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020964|NCT03460210|Adrenergic Agents|adrenergic agents|mesh-ancestor
65020965|NCT03460210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65020966|NCT03460210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020967|NCT03449472|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65020968|NCT03449472|Antidepressive Agents|antidepressive agents|mesh-ancestor
65020969|NCT03449472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65020970|NCT03449472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65020971|NCT03449472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65020972|NCT03449472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64575077|NCT00070135|Immunologic Factors|immunologic factors|mesh-ancestor
65020974|NCT03446001|Methylene Blue|methylene blue|mesh-list
65020975|NCT03446001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65020976|NCT03446001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020977|NCT03440879|Goserelin|goserelin|mesh-list
65020978|NCT03440879|Androgens|androgens|mesh-list
65020979|NCT03440879|Hormones|hormones|mesh-ancestor
65020980|NCT03440879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65020981|NCT03440879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020982|NCT03440879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65020983|NCT03440879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65020984|NCT03433755|Evolocumab|evolocumab|mesh-list
65020985|NCT03433755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65020986|NCT03433755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65020987|NCT03433755|Antimetabolites|antimetabolites|mesh-ancestor
65020988|NCT03433755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65020989|NCT03433755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65020990|NCT03406507|Ravulizumab|ravulizumab|mesh-list
65020991|NCT03406507|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65020992|NCT03406507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65020993|NCT03406507|Immunologic Factors|immunologic factors|mesh-ancestor
65020994|NCT03406507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65020995|NCT03283150|Dexmedetomidine|dexmedetomidine|mesh-list
65020996|NCT03283150|Remifentanil|remifentanil|mesh-list
65020997|NCT03283150|Propofol|propofol|mesh-list
65020998|NCT03283150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65020999|NCT03283150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65021000|NCT03283150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021001|NCT03283150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65021002|NCT03283150|Anesthetics, General|anesthetics, general|mesh-ancestor
65021003|NCT03283150|Anesthetics|anesthetics|mesh-ancestor
65021004|NCT03283150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65021005|NCT03283150|Analgesics|analgesics|mesh-ancestor
64724749|NCT00002984|Tubulin Modulators|tubulin modulators|mesh-ancestor
64724750|NCT00002984|Antimitotic Agents|antimitotic agents|mesh-ancestor
64724751|NCT00002984|Mitosis Modulators|mitosis modulators|mesh-ancestor
64724752|NCT00002984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724753|NCT00002984|Antimetabolites|antimetabolites|mesh-ancestor
64724754|NCT00002984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64724755|NCT00002984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64724756|NCT00002984|Immunologic Factors|immunologic factors|mesh-ancestor
64724757|NCT00002984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724758|NCT02508038|Zoledronic Acid|zoledronic acid|mesh-list
65021006|NCT03283150|Sensory System Agents|sensory system agents|mesh-ancestor
65021007|NCT03283150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65021008|NCT03283150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65021009|NCT03283150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65021010|NCT03283150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65021011|NCT03283150|Adrenergic Agents|adrenergic agents|mesh-ancestor
65021012|NCT03283150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65021013|NCT03283150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021014|NCT03283150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65021015|NCT03283150|Narcotics|narcotics|mesh-ancestor
65021016|NCT03277924|Doxorubicin|doxorubicin|mesh-list
65021017|NCT03277924|Methotrexate|methotrexate|mesh-list
65021018|NCT03277924|Nivolumab|nivolumab|mesh-list
65021019|NCT03277924|Sunitinib|sunitinib|mesh-list
65493833|NCT04233866|Antimitotic Agents|antimitotic agents|mesh-ancestor
65021020|NCT03277924|Epirubicin|epirubicin|mesh-list
65021021|NCT03277924|Ifosfamide|ifosfamide|mesh-list
65021022|NCT03277924|Dacarbazine|dacarbazine|mesh-list
65021023|NCT03277924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021024|NCT03277924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65021025|NCT03277924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65021026|NCT03277924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65021027|NCT03277924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021028|NCT03277924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021056|NCT03239340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021057|NCT03239340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021058|NCT03149770|Naloxone|naloxone|mesh-list
65021059|NCT03149770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65021060|NCT03149770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021061|NCT03149770|Sensory System Agents|sensory system agents|mesh-ancestor
65021062|NCT03149770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65021063|NCT03132675|Pembrolizumab|pembrolizumab|mesh-list
65021064|NCT03132675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65021065|NCT03132675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021066|NCT03127215|Olaparib|olaparib|mesh-list
65021067|NCT03127215|Trabectedin|trabectedin|mesh-list
65021068|NCT03127215|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65021069|NCT03127215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021070|NCT03127215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021071|NCT03127215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021072|NCT03127215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65021073|NCT03127215|Alkylating Agents|alkylating agents|mesh-ancestor
65021074|NCT03110744|Palbociclib|palbociclib|mesh-list
65021075|NCT03110744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021076|NCT03110744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65021077|NCT03110744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021078|NCT03110744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021079|NCT03056040|Eculizumab|eculizumab|mesh-list
65021080|NCT03056040|Ravulizumab|ravulizumab|mesh-list
65021081|NCT03056040|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65021082|NCT03056040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65021083|NCT03056040|Immunologic Factors|immunologic factors|mesh-ancestor
65021084|NCT03056040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021085|NCT02924038|Poly ICLC|poly iclc|mesh-list
65021086|NCT02924038|Interferon Inducers|interferon inducers|mesh-ancestor
65021087|NCT02924038|Immunologic Factors|immunologic factors|mesh-ancestor
65021088|NCT02924038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021097|NCT02873962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021098|NCT02873962|Growth Inhibitors|growth inhibitors|mesh-ancestor
65021099|NCT02873962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65021100|NCT02873962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021101|NCT02873962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65021102|NCT02873962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021103|NCT02726581|Dexamethasone|dexamethasone|mesh-list
65021104|NCT02726581|Nivolumab|nivolumab|mesh-list
65021105|NCT02726581|Pomalidomide|pomalidomide|mesh-list
65021106|NCT02726581|Elotuzumab|elotuzumab|mesh-list
65021107|NCT02726581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65021108|NCT02726581|Antiemetics|antiemetics|mesh-ancestor
65021109|NCT02726581|Autonomic Agents|autonomic agents|mesh-ancestor
65021110|NCT02726581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65021111|NCT02726581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021112|NCT02726581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65021113|NCT02726581|Glucocorticoids|glucocorticoids|mesh-ancestor
65021114|NCT02726581|Hormones|hormones|mesh-ancestor
65021115|NCT02726581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65021116|NCT02726581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65021117|NCT02726581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021118|NCT02726581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65021119|NCT02726581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64575203|NCT01587027|Aminophylline|aminophylline|mesh-list
64724759|NCT02508038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64724760|NCT02508038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724761|NCT00002990|BCG Vaccine|bcg vaccine|mesh-list
64724762|NCT00002990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64464102|NCT03109990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64724763|NCT00002990|Immunologic Factors|immunologic factors|mesh-ancestor
64724764|NCT00002990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724765|NCT00000997|Zalcitabine|zalcitabine|mesh-list
64724766|NCT00000997|Antimetabolites|antimetabolites|mesh-ancestor
64945871|NCT05037162|Hemostatics|hemostatics|mesh-ancestor
64945872|NCT05037162|Coagulants|coagulants|mesh-ancestor
64945873|NCT05024318|Pembrolizumab|pembrolizumab|mesh-list
64945874|NCT05024318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64945875|NCT05024318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945876|NCT05022654|Irinotecan|irinotecan|mesh-list
64945877|NCT05022654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64945878|NCT05022654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64945879|NCT05022654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419699|NCT05514847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64945892|NCT05020457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945893|NCT05020457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64945894|NCT05020457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64945895|NCT05020444|Cyclophosphamide|cyclophosphamide|mesh-list
64724767|NCT00000997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724768|NCT00000997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64724769|NCT00000997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65021120|NCT02726581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021121|NCT02726581|Immunologic Factors|immunologic factors|mesh-ancestor
65021122|NCT02726581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65021123|NCT02726581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65021124|NCT02726581|Growth Substances|growth substances|mesh-ancestor
65021125|NCT02726581|Growth Inhibitors|growth inhibitors|mesh-ancestor
65021126|NCT02700048|Naloxone|naloxone|mesh-list
65021127|NCT02700048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65021128|NCT02700048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021129|NCT02700048|Sensory System Agents|sensory system agents|mesh-ancestor
65021130|NCT02700048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65021131|NCT02535832|Pioglitazone|pioglitazone|mesh-list
65021132|NCT02535832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65021133|NCT02535832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021134|NCT02428985|Riociguat|riociguat|mesh-list
65021135|NCT02428985|Enzyme Activators|enzyme activators|mesh-ancestor
65021136|NCT02428985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021137|NCT02425904|Clofarabine|clofarabine|mesh-list
65021138|NCT02425904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65021139|NCT02425904|Antimetabolites|antimetabolites|mesh-ancestor
65021140|NCT02425904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021141|NCT02425904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021142|NCT02406209|Prednisolone|prednisolone|mesh-list
65021143|NCT02406209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65021144|NCT02406209|Methylprednisolone|methylprednisolone|mesh-list
65021145|NCT02406209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65021146|NCT02406209|Prednisolone acetate|prednisolone acetate|mesh-list
65021147|NCT02406209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65021148|NCT02406209|Prednisolone phosphate|prednisolone phosphate|mesh-list
65021149|NCT02406209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65021150|NCT02406209|Glucocorticoids|glucocorticoids|mesh-ancestor
65021151|NCT02406209|Hormones|hormones|mesh-ancestor
65021152|NCT02406209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64575223|NCT01587027|Diuretics|diuretics|mesh-ancestor
64724770|NCT00000997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724771|NCT00000997|Antiviral Agents|antiviral agents|mesh-ancestor
64724772|NCT00000997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724773|NCT00000997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64724774|NCT00000997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64724776|NCT00000697|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
65021153|NCT02406209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575257|NCT04754789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65021154|NCT02406209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65021155|NCT02406209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021156|NCT02406209|Antiemetics|antiemetics|mesh-ancestor
65021157|NCT02406209|Autonomic Agents|autonomic agents|mesh-ancestor
65021158|NCT02406209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65021159|NCT02406209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65021160|NCT02406209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65021161|NCT02406209|Protective Agents|protective agents|mesh-ancestor
65021162|NCT02296125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65021163|NCT02296125|Gefitinib|gefitinib|mesh-list
65021164|NCT02296125|Osimertinib|osimertinib|mesh-list
65021165|NCT02296125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021166|NCT02296125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65021167|NCT02296125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021168|NCT02296125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021169|NCT02295722|Gemcitabine|gemcitabine|mesh-list
65021170|NCT02295722|Melphalan|melphalan|mesh-list
65021171|NCT02295722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65021172|NCT02295722|Antimetabolites|antimetabolites|mesh-ancestor
65021173|NCT02295722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021174|NCT02295722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021175|NCT02295722|Antiviral Agents|antiviral agents|mesh-ancestor
65021176|NCT02295722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65021177|NCT02295722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021178|NCT02295722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65021179|NCT02295722|Immunologic Factors|immunologic factors|mesh-ancestor
65021180|NCT02295722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021181|NCT02295722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65021182|NCT02295722|Alkylating Agents|alkylating agents|mesh-ancestor
65021183|NCT02295722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65021184|NCT02282059|Sunitinib|sunitinib|mesh-list
65021185|NCT02282059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021186|NCT02282059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65021187|NCT02282059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65021192|NCT02282059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575293|NCT04815408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021193|NCT02282059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021194|NCT02242942|Venetoclax|venetoclax|mesh-list
65021195|NCT02242942|Obinutuzumab|obinutuzumab|mesh-list
65021196|NCT02242942|Chlorambucil|chlorambucil|mesh-list
65021197|NCT02242942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021198|NCT02242942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65021199|NCT02242942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65021200|NCT02242942|Alkylating Agents|alkylating agents|mesh-ancestor
65021201|NCT02242942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021202|NCT02233829|Dopamine|dopamine|mesh-list
65021203|NCT02233829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65021204|NCT02233829|Sympathomimetics|sympathomimetics|mesh-ancestor
65021205|NCT02233829|Autonomic Agents|autonomic agents|mesh-ancestor
65021206|NCT02233829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65021207|NCT02233829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021208|NCT02233829|Dopamine Agents|dopamine agents|mesh-ancestor
65021209|NCT02233829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65021210|NCT02233829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021211|NCT02233829|Protective Agents|protective agents|mesh-ancestor
65021212|NCT01964989|Vaccines|vaccines|mesh-list
65021213|NCT01964989|Immunologic Factors|immunologic factors|mesh-ancestor
65021214|NCT01964989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021215|NCT01711554|Vitamin A|vitamin a|mesh-list
65021216|NCT01711554|Lenalidomide|lenalidomide|mesh-list
65021217|NCT01711554|Tretinoin|tretinoin|mesh-list
65021218|NCT01711554|Dinutuximab|dinutuximab|mesh-list
65021219|NCT01711554|Isotretinoin|isotretinoin|mesh-list
65021220|NCT01711554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65021221|NCT01711554|Vitamins|vitamins|mesh-ancestor
65021222|NCT01711554|Micronutrients|micronutrients|mesh-ancestor
65021223|NCT01711554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021224|NCT01711554|Immunologic Factors|immunologic factors|mesh-ancestor
65021225|NCT01711554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65021226|NCT01711554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64575299|NCT04806906|Cc-486|cc-486|mesh-list
65021231|NCT01711554|Dermatologic Agents|dermatologic agents|mesh-ancestor
65021232|NCT01708941|Interferons|interferons|mesh-list
65021233|NCT01708941|Interferon-alpha|interferon-alpha|mesh-list
65021234|NCT01708941|Interferon alpha-2|interferon alpha-2|mesh-list
65021235|NCT01708941|Ipilimumab|ipilimumab|mesh-list
65021236|NCT01708941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021237|NCT01708941|Antiviral Agents|antiviral agents|mesh-ancestor
65021238|NCT01708941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65021239|NCT01708941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65021240|NCT01708941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65021241|NCT01708941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021242|NCT01708941|Immunologic Factors|immunologic factors|mesh-ancestor
65021243|NCT01708941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021244|NCT01575860|Lenalidomide|lenalidomide|mesh-list
65021245|NCT01575860|Immunologic Factors|immunologic factors|mesh-ancestor
65066957|NCT00282360|Vasodilator Agents|vasodilator agents|mesh-ancestor
65021246|NCT01575860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021247|NCT01575860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65021248|NCT01575860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65021249|NCT01575860|Growth Substances|growth substances|mesh-ancestor
65021250|NCT01575860|Growth Inhibitors|growth inhibitors|mesh-ancestor
65021251|NCT01575860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021252|NCT01416831|Interleukin-2|interleukin-2|mesh-list
65021253|NCT01416831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021254|NCT01416831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65021255|NCT01416831|Analgesics|analgesics|mesh-ancestor
65021256|NCT01416831|Sensory System Agents|sensory system agents|mesh-ancestor
65021257|NCT01416831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65021258|NCT01416831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021259|NCT01386385|Paclitaxel|paclitaxel|mesh-list
65021260|NCT01386385|Carboplatin|carboplatin|mesh-list
65021261|NCT01386385|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65021262|NCT01386385|Veliparib|veliparib|mesh-list
65021264|NCT01386385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021272|NCT01364051|Maleic acid|maleic acid|mesh-list
65021273|NCT01364051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021274|NCT01364051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021276|NCT01364051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65021277|NCT01303341|Sorafenib|sorafenib|mesh-list
65021278|NCT01303341|Riluzole|riluzole|mesh-list
65021279|NCT01303341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021280|NCT01303341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65021281|NCT01303341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021282|NCT01303341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021283|NCT01303341|Anticonvulsants|anticonvulsants|mesh-ancestor
65021284|NCT01303341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65021285|NCT01303341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65021286|NCT01303341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65021287|NCT01303341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021288|NCT01303341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65021289|NCT01303341|Protective Agents|protective agents|mesh-ancestor
65021290|NCT01065454|Riociguat|riociguat|mesh-list
65021291|NCT01065454|Enzyme Activators|enzyme activators|mesh-ancestor
65021292|NCT01065454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021326|NCT00635700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65021327|NCT00635700|Dopamine Agents|dopamine agents|mesh-ancestor
65021329|NCT00582075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65021330|NCT00582075|Alkylating Agents|alkylating agents|mesh-ancestor
65021331|NCT00582075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021332|NCT00582075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021333|NCT00558961|Imatinib Mesylate|imatinib mesylate|mesh-list
65021334|NCT00558961|Chlorambucil|chlorambucil|mesh-list
65021335|NCT00558961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021336|NCT00558961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65021337|NCT00558961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021338|NCT00558961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021339|NCT00558961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65021340|NCT00558961|Alkylating Agents|alkylating agents|mesh-ancestor
65021341|NCT00542451|Paclitaxel|paclitaxel|mesh-list
65021342|NCT00542451|Trastuzumab|trastuzumab|mesh-list
65021343|NCT00542451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65021344|NCT00542451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021345|NCT00542451|Tubulin Modulators|tubulin modulators|mesh-ancestor
65021346|NCT00542451|Antimitotic Agents|antimitotic agents|mesh-ancestor
65021347|NCT00542451|Mitosis Modulators|mitosis modulators|mesh-ancestor
65021348|NCT00542451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021349|NCT00542451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65021350|NCT00392353|Azacitidine|azacitidine|mesh-list
65021351|NCT00392353|Vorinostat|vorinostat|mesh-list
65021352|NCT00392353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65021353|NCT00392353|Antimetabolites|antimetabolites|mesh-ancestor
65021354|NCT00392353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575473|NCT04354428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65021371|NCT00326456|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65021372|NCT00326456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65021373|NCT00326456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021374|NCT00326456|Tubulin Modulators|tubulin modulators|mesh-ancestor
65021375|NCT00326456|Antimitotic Agents|antimitotic agents|mesh-ancestor
65021376|NCT00326456|Mitosis Modulators|mitosis modulators|mesh-ancestor
65021377|NCT00326456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021378|NCT00326456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65021379|NCT00326456|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65021380|NCT00326456|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65021381|NCT00326456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021382|NCT00149942|Mycophenolic Acid|mycophenolic acid|mesh-list
65021383|NCT00149942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65021384|NCT00149942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021385|NCT00149942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65021386|NCT00149942|Antitubercular Agents|antitubercular agents|mesh-ancestor
65021387|NCT00149942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65021388|NCT00149942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65021389|NCT00149942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021390|NCT00149942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021391|NCT00149981|Everolimus|everolimus|mesh-list
65021392|NCT00149981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021393|NCT00149981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64895125|NCT02007330|Lidocaine|lidocaine|mesh-list
65021394|NCT00149981|Immunologic Factors|immunologic factors|mesh-ancestor
65021395|NCT00149981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021397|NCT02915731|Vitamins|vitamins|mesh-ancestor
65021398|NCT02915731|Micronutrients|micronutrients|mesh-ancestor
65021399|NCT02915731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021400|NCT02915809|Vaccines|vaccines|mesh-list
65021401|NCT02915809|Immunologic Factors|immunologic factors|mesh-ancestor
64575474|NCT04354428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64945896|NCT05020444|Fludarabine|fludarabine|mesh-list
64945897|NCT05020444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64503285|NCT04443270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64503286|NCT04443270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503287|NCT04443270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64945911|NCT05012189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945912|NCT05006573|Benralizumab|benralizumab|mesh-list
64945913|NCT05006573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64575505|NCT04817202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021402|NCT02915809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021403|NCT00405860|Mycophenolic Acid|mycophenolic acid|mesh-list
65021404|NCT00405860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65021405|NCT00405860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021406|NCT00405860|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65021407|NCT00405860|Antitubercular Agents|antitubercular agents|mesh-ancestor
65021408|NCT00405860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65021409|NCT00405860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65021410|NCT00405860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021411|NCT00405860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021412|NCT02914678|Fentanyl|fentanyl|mesh-list
65021413|NCT02914678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65021414|NCT02914678|Narcotics|narcotics|mesh-ancestor
65021415|NCT02914678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65021416|NCT02914678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021417|NCT02914678|Analgesics|analgesics|mesh-ancestor
65021418|NCT02914678|Sensory System Agents|sensory system agents|mesh-ancestor
65021419|NCT02914678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65021420|NCT02914678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65021421|NCT02914678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64477146|NCT00513292|Epirubicin|epirubicin|mesh-list
65021423|NCT02914678|Anesthetics|anesthetics|mesh-ancestor
65021424|NCT02914639|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65021425|NCT02914639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65021426|NCT00405977|Magnesium Sulfate|magnesium sulfate|mesh-list
65021427|NCT00405977|Analgesics|analgesics|mesh-ancestor
64945914|NCT05006573|Respiratory System Agents|respiratory system agents|mesh-ancestor
64945915|NCT04954599|Carboplatin|carboplatin|mesh-list
64945916|NCT04954599|Pembrolizumab|pembrolizumab|mesh-list
64945917|NCT04954599|Nivolumab|nivolumab|mesh-list
64945918|NCT04954599|Ipilimumab|ipilimumab|mesh-list
64945919|NCT04954599|Atezolizumab|atezolizumab|mesh-list
64945920|NCT04954599|Durvalumab|durvalumab|mesh-list
64945921|NCT04954599|Avelumab|avelumab|mesh-list
64945922|NCT04954599|Cemiplimab|cemiplimab|mesh-list
64945923|NCT04954599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64945924|NCT04954599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945925|NCT04954599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64945926|NCT04954599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945927|NCT04952610|Etripamil|etripamil|mesh-list
64945928|NCT04952610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64945929|NCT04952610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64945930|NCT04952610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945931|NCT04952610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64945932|NCT04952610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945933|NCT04921189|Ascorbic Acid|ascorbic acid|mesh-list
64945934|NCT04921189|Thiamine|thiamine|mesh-list
64945935|NCT04921189|Hydrocortisone|hydrocortisone|mesh-list
64945936|NCT04921189|Antioxidants|antioxidants|mesh-ancestor
65021428|NCT00405977|Sensory System Agents|sensory system agents|mesh-ancestor
65021429|NCT00405977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65021430|NCT00405977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021431|NCT00405977|Anesthetics|anesthetics|mesh-ancestor
65021432|NCT00405977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65021433|NCT00405977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65021434|NCT00405977|Anticonvulsants|anticonvulsants|mesh-ancestor
65021435|NCT00405977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65021436|NCT00405977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65021437|NCT00405977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021438|NCT00405977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65021439|NCT00405977|Tocolytic Agents|tocolytic agents|mesh-ancestor
65021440|NCT00405977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65021441|NCT00150020|Mycophenolic Acid|mycophenolic acid|mesh-list
65021442|NCT00150020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65021443|NCT00150020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021444|NCT00150020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65021445|NCT00150020|Antitubercular Agents|antitubercular agents|mesh-ancestor
65021446|NCT00150020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65021447|NCT00150020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65021448|NCT00150020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021449|NCT00150020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021450|NCT02914015|Morphine|morphine|mesh-list
65021451|NCT02914015|Ropivacaine|ropivacaine|mesh-list
65021452|NCT02914015|Anesthetics, Local|anesthetics, local|mesh-list
65021453|NCT02914015|Anesthetics|anesthetics|mesh-list
65021454|NCT02914015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65021455|NCT02914015|Narcotics|narcotics|mesh-ancestor
65021456|NCT02914015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65021457|NCT02914015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021458|NCT02914015|Analgesics|analgesics|mesh-ancestor
65021459|NCT02914015|Sensory System Agents|sensory system agents|mesh-ancestor
65021460|NCT02914015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65021461|NCT00171093|Valsartan|valsartan|mesh-list
65021462|NCT00171093|Simvastatin|simvastatin|mesh-list
65021467|NCT00171093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65021468|NCT00171093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65021469|NCT00171093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021470|NCT00171093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65021471|NCT00171093|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65021472|NCT00171093|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65021473|NCT02914054|Dexamethasone|dexamethasone|mesh-list
65021474|NCT02914054|Prednisone|prednisone|mesh-list
65021475|NCT02914054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65021476|NCT02914054|Antiemetics|antiemetics|mesh-ancestor
65021477|NCT02914054|Autonomic Agents|autonomic agents|mesh-ancestor
65021478|NCT02914054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65021479|NCT02914054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021480|NCT02914054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65021481|NCT02914054|Glucocorticoids|glucocorticoids|mesh-ancestor
65021482|NCT02914054|Hormones|hormones|mesh-ancestor
65021483|NCT02914054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65021484|NCT02914054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65021485|NCT02914054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021486|NCT00150059|Pimecrolimus|pimecrolimus|mesh-list
65021487|NCT00150059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65021488|NCT00150059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65021489|NCT00150059|Analgesics|analgesics|mesh-ancestor
65021490|NCT00150059|Sensory System Agents|sensory system agents|mesh-ancestor
65021491|NCT00150059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65021492|NCT00150059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021512|NCT00171132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65021513|NCT00171132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65021514|NCT00171132|Sympatholytics|sympatholytics|mesh-ancestor
65021515|NCT00171132|Autonomic Agents|autonomic agents|mesh-ancestor
65021516|NCT00171132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65021517|NCT00171132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65021518|NCT00171132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65021519|NCT00171132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65021520|NCT00171132|Adrenergic Agents|adrenergic agents|mesh-ancestor
65021521|NCT00171132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65021522|NCT02913859|Androgen Antagonists|androgen antagonists|mesh-list
65021523|NCT02913859|Hormone Antagonists|hormone antagonists|mesh-ancestor
65021524|NCT02913859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65021525|NCT02913859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021526|NCT00150137|Methimazole|methimazole|mesh-list
65021527|NCT00150137|Antithyroid Agents|antithyroid agents|mesh-ancestor
65021528|NCT00150137|Hormone Antagonists|hormone antagonists|mesh-ancestor
65021529|NCT00150137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65021530|NCT00150137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021531|NCT00150215|Olanzapine|olanzapine|mesh-list
65021532|NCT00150215|Antiemetics|antiemetics|mesh-ancestor
65021533|NCT00150215|Autonomic Agents|autonomic agents|mesh-ancestor
65021534|NCT00150215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65021535|NCT00150215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021536|NCT00150215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65021537|NCT00150215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65021538|NCT00150215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65021539|NCT00150215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65021540|NCT00150215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65021541|NCT00150215|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65021542|NCT00150215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65021543|NCT00150215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65021544|NCT00150215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021545|NCT00150215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64575617|NCT04772729|Insulin|insulin|mesh-list
64945937|NCT04921189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945938|NCT04921189|Protective Agents|protective agents|mesh-ancestor
65021546|NCT00150215|Serotonin Agents|serotonin agents|mesh-ancestor
65021547|NCT00171171|Deferasirox|deferasirox|mesh-list
65021548|NCT00171171|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65021549|NCT00171171|Chelating Agents|chelating agents|mesh-ancestor
65021550|NCT00171171|Sequestering Agents|sequestering agents|mesh-ancestor
65021551|NCT00171171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021552|NCT02913430|Tamoxifen|tamoxifen|mesh-list
65021553|NCT02913430|Fulvestrant|fulvestrant|mesh-list
65021554|NCT02913430|Palbociclib|palbociclib|mesh-list
65021555|NCT02913430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65021556|NCT02913430|Hormone Antagonists|hormone antagonists|mesh-ancestor
65021557|NCT02913430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65021558|NCT02913430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021559|NCT02913430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65021560|NCT02913430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021561|NCT02913430|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65021562|NCT02913430|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65021563|NCT02913430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65021564|NCT02913430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65021565|NCT02913430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65021566|NCT02913430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021567|NCT02913430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021568|NCT02913469|Morphine|morphine|mesh-list
65021569|NCT02913469|Metoclopramide|metoclopramide|mesh-list
65021570|NCT02913469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65021571|NCT02913469|Narcotics|narcotics|mesh-ancestor
65021572|NCT02913469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65021573|NCT02913469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021574|NCT02913469|Analgesics|analgesics|mesh-ancestor
65021575|NCT02913469|Sensory System Agents|sensory system agents|mesh-ancestor
65021576|NCT02913469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65021589|NCT00150254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65021590|NCT00150254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021591|NCT00150254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021592|NCT02913508|Vedolizumab|vedolizumab|mesh-list
65021593|NCT02913508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65021594|NCT02913157|Hydroxychloroquine|hydroxychloroquine|mesh-list
65021595|NCT02913157|Antimalarials|antimalarials|mesh-ancestor
65021596|NCT02913157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65021597|NCT02913157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65021598|NCT02913157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65021599|NCT02913157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021600|NCT02913157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021601|NCT02913157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65021602|NCT00150293|Pregabalin|pregabalin|mesh-list
65021603|NCT00150293|Analgesics|analgesics|mesh-ancestor
65021604|NCT00150293|Sensory System Agents|sensory system agents|mesh-ancestor
65021605|NCT00150293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65021606|NCT00150293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021607|NCT00150293|Anticonvulsants|anticonvulsants|mesh-ancestor
65021608|NCT00150293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65021609|NCT00150293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65021610|NCT00150293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575694|NCT00585559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64945939|NCT04921189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945940|NCT04921189|Vitamins|vitamins|mesh-ancestor
64945941|NCT04921189|Micronutrients|micronutrients|mesh-ancestor
64945942|NCT04921189|Vitamin B Complex|vitamin b complex|mesh-ancestor
64945943|NCT04921189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64945944|NCT04908189|Apremilast|apremilast|mesh-list
64945949|NCT04908189|Sensory System Agents|sensory system agents|mesh-ancestor
64945950|NCT04908189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64945951|NCT04908189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945952|NCT04908189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64945953|NCT04908189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64945960|NCT04902911|Antibodies|antibodies|mesh-list
64945961|NCT04902911|Immunoglobulin M|immunoglobulin m|mesh-list
64945962|NCT04902911|Immunologic Factors|immunologic factors|mesh-ancestor
64945963|NCT04902911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945964|NCT04864366|Tenofovir|tenofovir|mesh-list
64945965|NCT04864366|Antiviral Agents|antiviral agents|mesh-ancestor
64945966|NCT04864366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64945967|NCT04864366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64945968|NCT04864366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64724777|NCT00000697|Antiviral Agents|antiviral agents|mesh-ancestor
64724778|NCT00000697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724779|NCT00000697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64724780|NCT00000697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64724781|NCT00000697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724782|NCT00000697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945969|NCT04864366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952331|NCT00395915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64575718|NCT02763137|Dopamine Agonists|dopamine agonists|mesh-ancestor
65021611|NCT00150293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65021612|NCT00150293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65021613|NCT00150293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65021614|NCT00150293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65021615|NCT00150293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65021616|NCT02913118|Amoxicillin|amoxicillin|mesh-list
65021618|NCT02913118|Doxycycline|doxycycline|mesh-list
65021619|NCT02913118|Minocycline|minocycline|mesh-list
65021620|NCT02913118|Cephalosporins|cephalosporins|mesh-list
65021621|NCT02913118|Fluoroquinolones|fluoroquinolones|mesh-list
65021622|NCT02913118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65021623|NCT02913118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65021624|NCT02913118|Antimalarials|antimalarials|mesh-ancestor
65021625|NCT02913118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65021626|NCT02913118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65021627|NCT02913118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65021628|NCT02913118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021629|NCT02913118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021630|NCT00150332|Linezolid|linezolid|mesh-list
65021631|NCT00150332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65021632|NCT00150332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65021633|NCT00150332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65021634|NCT00150332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021635|NCT00150332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021636|NCT00150371|Atorvastatin|atorvastatin|mesh-list
64575719|NCT02763137|Dopamine Agents|dopamine agents|mesh-ancestor
64945970|NCT04864366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945971|NCT04864366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64945972|NCT04864366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64945973|NCT04859296|Dronabinol|dronabinol|mesh-list
64945974|NCT04859296|Hallucinogens|hallucinogens|mesh-ancestor
64945975|NCT04859296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945976|NCT04859296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64945977|NCT04859296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64945978|NCT04859296|Analgesics|analgesics|mesh-ancestor
64945979|NCT04859296|Sensory System Agents|sensory system agents|mesh-ancestor
64945980|NCT04859296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64503288|NCT04443270|Filaricides|filaricides|mesh-ancestor
64503289|NCT04443270|Antinematodal Agents|antinematodal agents|mesh-ancestor
64945981|NCT04859296|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64945982|NCT04859296|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64945983|NCT04859296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64945984|NCT04859296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945986|NCT04859296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64945987|NCT04857684|Bevacizumab|bevacizumab|mesh-list
64945988|NCT04857684|Atezolizumab|atezolizumab|mesh-list
64945989|NCT04857684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65021637|NCT00150371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64575744|NCT00176917|Thymoglobulin|thymoglobulin|mesh-list
64575745|NCT00176917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65021638|NCT00150371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65021639|NCT00150371|Antimetabolites|antimetabolites|mesh-ancestor
65021640|NCT00150371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477372|NCT01426347|Vitamins|vitamins|mesh-ancestor
65021641|NCT00150371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65021642|NCT00150371|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65021643|NCT00150371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021644|NCT02912494|Darbepoetin alfa|darbepoetin alfa|mesh-list
65021645|NCT02912494|Hematinics|hematinics|mesh-ancestor
65021646|NCT00150410|Insulin|insulin|mesh-list
65021647|NCT00150410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65021648|NCT00150410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021649|NCT00171288|Ezetimibe|ezetimibe|mesh-list
65021650|NCT00171288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65021651|NCT00171288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65021652|NCT00171288|Antimetabolites|antimetabolites|mesh-ancestor
65021653|NCT00171288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021654|NCT00171288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65021655|NCT00150449|Pregabalin|pregabalin|mesh-list
65021656|NCT00150449|Analgesics|analgesics|mesh-ancestor
65021657|NCT00150449|Sensory System Agents|sensory system agents|mesh-ancestor
65021658|NCT00150449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65021659|NCT00150449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021660|NCT00150449|Anticonvulsants|anticonvulsants|mesh-ancestor
65021661|NCT00150449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65021662|NCT00150449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65021663|NCT00150449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021664|NCT00150449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65021665|NCT00150449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65021666|NCT00150449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65021667|NCT00150449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65021668|NCT00150449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65021673|NCT02912182|Prednisolone acetate|prednisolone acetate|mesh-list
65021674|NCT02912182|Betamethasone|betamethasone|mesh-list
65021675|NCT02912182|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65021676|NCT02912182|Prednisolone phosphate|prednisolone phosphate|mesh-list
65021677|NCT02912182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65021678|NCT02912182|Glucocorticoids|glucocorticoids|mesh-ancestor
65021679|NCT02912182|Hormones|hormones|mesh-ancestor
65021680|NCT02912182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65021681|NCT02912182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021682|NCT02912182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65021683|NCT02912182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021684|NCT02912182|Antiemetics|antiemetics|mesh-ancestor
65021685|NCT02912182|Autonomic Agents|autonomic agents|mesh-ancestor
65021686|NCT02912182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65021687|NCT02912182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65021688|NCT02912182|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65021689|NCT02912182|Protective Agents|protective agents|mesh-ancestor
65021690|NCT02912182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65066958|NCT00273065|Neosaxitoxin|neosaxitoxin|mesh-list
65493835|NCT04233866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021691|NCT02912182|Respiratory System Agents|respiratory system agents|mesh-ancestor
65021692|NCT02912026|Olorofim|olorofim|mesh-list
65021693|NCT02912026|Antifungal Agents|antifungal agents|mesh-ancestor
65021694|NCT02912026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65021695|NCT02911870|Moxifloxacin|moxifloxacin|mesh-list
65021696|NCT02911870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65021697|NCT02911870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65021698|NCT02911870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65021699|NCT02911870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65021700|NCT02911870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021701|NCT02911870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021702|NCT02911870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021703|NCT02843230|Bevacizumab|bevacizumab|mesh-list
65021704|NCT02843230|Temozolomide|temozolomide|mesh-list
64575823|NCT01520727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021712|NCT02843230|Growth Inhibitors|growth inhibitors|mesh-ancestor
65021713|NCT02843230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65021714|NCT02843230|Alkylating Agents|alkylating agents|mesh-ancestor
65021715|NCT02843230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021716|NCT02712814|Estrogens|estrogens|mesh-list
65021717|NCT02712814|Hormones|hormones|mesh-ancestor
65021718|NCT02712814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65021719|NCT02712814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021721|NCT00150527|Citalopram|citalopram|mesh-list
65021722|NCT00150527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65021723|NCT00150527|Antiemetics|antiemetics|mesh-ancestor
65021724|NCT00150527|Autonomic Agents|autonomic agents|mesh-ancestor
65021725|NCT00150527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65021726|NCT00150527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021727|NCT00150527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65021728|NCT00150527|Glucocorticoids|glucocorticoids|mesh-ancestor
65021729|NCT00150527|Hormones|hormones|mesh-ancestor
65021730|NCT00150527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65021731|NCT00150527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65021732|NCT00150527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021733|NCT00150527|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65021734|NCT00150527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65021735|NCT00150527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65021736|NCT00150527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021737|NCT00150527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65021738|NCT00150527|Serotonin Agents|serotonin agents|mesh-ancestor
65021739|NCT00150527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65021740|NCT00150527|Antidepressive Agents|antidepressive agents|mesh-ancestor
65021741|NCT00150527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65021742|NCT00171327|Valsartan|valsartan|mesh-list
65021743|NCT00171327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65021744|NCT00171327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65021745|NCT00171327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64945990|NCT04857684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945991|NCT04857684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65021746|NCT00171327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021747|NCT02911597|Naltrexone|naltrexone|mesh-list
65021748|NCT02911597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65021749|NCT02911597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65021750|NCT02911597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021751|NCT02911597|Sensory System Agents|sensory system agents|mesh-ancestor
65021752|NCT02911597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65021753|NCT02911480|Oxytocin|oxytocin|mesh-list
65021754|NCT02911480|Oxytocics|oxytocics|mesh-ancestor
65021755|NCT02911480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65021756|NCT02911480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021757|NCT00171366|Amlodipine|amlodipine|mesh-list
65021758|NCT00171366|Benazepril|benazepril|mesh-list
65021759|NCT00171366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65021760|NCT00171366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65021761|NCT00171366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65021762|NCT00171366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021763|NCT00171366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65021764|NCT00171366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021765|NCT00171366|Vasodilator Agents|vasodilator agents|mesh-ancestor
65021766|NCT00171366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65021767|NCT00171366|Protease Inhibitors|protease inhibitors|mesh-ancestor
65021768|NCT00171366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021769|NCT00150605|Carbamazepine|carbamazepine|mesh-list
65021770|NCT00150605|Anticonvulsants|anticonvulsants|mesh-ancestor
65021771|NCT00150605|Antimanic Agents|antimanic agents|mesh-ancestor
65021772|NCT00150605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65021773|NCT00150605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65021774|NCT00150605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021775|NCT00150605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65021776|NCT00150605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65021777|NCT00150605|Analgesics|analgesics|mesh-ancestor
65021778|NCT00150605|Sensory System Agents|sensory system agents|mesh-ancestor
65021779|NCT00150605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65021780|NCT00150605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64575888|NCT03007563|Bilirubin|bilirubin|mesh-list
65021783|NCT00150605|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64575895|NCT05331131|Sensory System Agents|sensory system agents|mesh-ancestor
65021784|NCT00150605|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65021785|NCT02910778|Ticagrelor|ticagrelor|mesh-list
65021786|NCT02910778|Atorvastatin|atorvastatin|mesh-list
65021787|NCT02910778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65021788|NCT02910778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65021789|NCT02910778|Antimetabolites|antimetabolites|mesh-ancestor
65021790|NCT02910778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021791|NCT02910778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65021792|NCT02910778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65021793|NCT02910778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021794|NCT02910778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65021795|NCT02910778|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65021796|NCT02910778|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65021797|NCT02910778|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65021798|NCT02910778|Purinergic Agents|purinergic agents|mesh-ancestor
65021799|NCT02910778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65021800|NCT02910778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021802|NCT00164112|Levofloxacin|levofloxacin|mesh-list
65021803|NCT00164112|Ofloxacin|ofloxacin|mesh-list
65021804|NCT00164112|Telithromycin|telithromycin|mesh-list
65021805|NCT00164112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65021806|NCT00164112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65021807|NCT00164112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65021808|NCT00164112|Renal Agents|renal agents|mesh-ancestor
65021809|NCT00164112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65021810|NCT00164112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65021811|NCT00164112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021812|NCT00164112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021813|NCT00164112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021814|NCT00164112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65021815|NCT00164112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65021816|NCT02910817|Metformin|metformin|mesh-list
65021817|NCT02910817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65021818|NCT02910817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021821|NCT00150722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65021822|NCT00150722|Antimetabolites|antimetabolites|mesh-ancestor
65021823|NCT00150722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021824|NCT00150722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65021825|NCT00150722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65021826|NCT00150722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021827|NCT00150761|Levocetirizine|levocetirizine|mesh-list
65021828|NCT00150761|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65021829|NCT00150761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65021830|NCT00150761|Histamine Antagonists|histamine antagonists|mesh-ancestor
65021831|NCT00150761|Histamine Agents|histamine agents|mesh-ancestor
65021832|NCT00150761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65021833|NCT00150761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021834|NCT00150761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021835|NCT03782740|Melatonin|melatonin|mesh-list
65021836|NCT03782740|Antioxidants|antioxidants|mesh-ancestor
65021837|NCT03782740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021838|NCT03782740|Protective Agents|protective agents|mesh-ancestor
64945992|NCT04857684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64945993|NCT04857684|Growth Substances|growth substances|mesh-ancestor
64945994|NCT04857684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945995|NCT04857684|Growth Inhibitors|growth inhibitors|mesh-ancestor
64945996|NCT04854811|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
64945997|NCT04854811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64945998|NCT04854811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945999|NCT04854811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946000|NCT04846348|Diphenhydramine|diphenhydramine|mesh-list
64946001|NCT04846348|Promethazine|promethazine|mesh-list
64946002|NCT04846348|Salicylates|salicylates|mesh-list
64946003|NCT04846348|Cromolyn Sodium|cromolyn sodium|mesh-list
64946004|NCT04846348|Emollients|emollients|mesh-list
64946005|NCT04846348|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64946006|NCT04846348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64946007|NCT04846348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64946008|NCT04846348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946009|NCT04846348|Anesthetics, Local|anesthetics, local|mesh-ancestor
64946010|NCT04846348|Anesthetics|anesthetics|mesh-ancestor
64946011|NCT04846348|Sensory System Agents|sensory system agents|mesh-ancestor
64946012|NCT04846348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64946013|NCT04846348|Antiemetics|antiemetics|mesh-ancestor
64946014|NCT04846348|Autonomic Agents|autonomic agents|mesh-ancestor
64946019|NCT04846348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64946020|NCT04846348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946033|NCT04846348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64946034|NCT04846348|Respiratory System Agents|respiratory system agents|mesh-ancestor
64724791|NCT00001009|Dextrans|dextrans|mesh-list
64724792|NCT00001009|Anticoagulants|anticoagulants|mesh-ancestor
64724793|NCT00001009|Plasma Substitutes|plasma substitutes|mesh-ancestor
64724794|NCT00001009|Blood Substitutes|blood substitutes|mesh-ancestor
64724795|NCT00000703|Leucovorin|leucovorin|mesh-list
64724796|NCT00000703|Cytarabine|cytarabine|mesh-list
64724797|NCT00000703|Zidovudine|zidovudine|mesh-list
64724798|NCT00000703|Dexamethasone|dexamethasone|mesh-list
64724799|NCT00000703|Cyclophosphamide|cyclophosphamide|mesh-list
64724800|NCT00000703|Doxorubicin|doxorubicin|mesh-list
64724801|NCT00000703|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64724802|NCT00000703|Methotrexate|methotrexate|mesh-list
64724803|NCT00000703|Vincristine|vincristine|mesh-list
65021839|NCT03782740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021840|NCT03782740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65021841|NCT00171483|Tegaserod|tegaserod|mesh-list
65021842|NCT00171483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65021843|NCT00171483|Serotonin Agents|serotonin agents|mesh-ancestor
65021844|NCT00171483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65021845|NCT00171483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021846|NCT00171483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021847|NCT03777904|Iron|iron|mesh-list
65021848|NCT03777904|Trace Elements|trace elements|mesh-ancestor
65021849|NCT03777904|Micronutrients|micronutrients|mesh-ancestor
65021850|NCT03777904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021851|NCT00150839|Mirtazapine|mirtazapine|mesh-list
65021852|NCT00150839|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65021853|NCT00150839|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65021854|NCT00150839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65021855|NCT00150839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65021856|NCT00150839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021857|NCT00150839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65021858|NCT00150839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021859|NCT00150839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65021860|NCT00150839|Antidepressive Agents|antidepressive agents|mesh-ancestor
65021861|NCT00150839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65021862|NCT00150839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64463136|NCT00637000|Buprenorphine|buprenorphine|mesh-list
65021863|NCT00150839|Histamine Antagonists|histamine antagonists|mesh-ancestor
65021864|NCT00150839|Histamine Agents|histamine agents|mesh-ancestor
65021865|NCT00150839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65021874|NCT00150839|Serotonin Agents|serotonin agents|mesh-ancestor
65021880|NCT03732820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021881|NCT03732820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021882|NCT03732820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65021883|NCT03732820|Hormone Antagonists|hormone antagonists|mesh-ancestor
65021884|NCT03732820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65021885|NCT03732820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021886|NCT03732820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65021887|NCT03719092|Vitamins|vitamins|mesh-list
65021888|NCT03719092|Vitamin A|vitamin a|mesh-list
65021889|NCT03719092|Retinol palmitate|retinol palmitate|mesh-list
65021890|NCT03719092|Micronutrients|micronutrients|mesh-ancestor
65021891|NCT03719092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021892|NCT03719092|Antioxidants|antioxidants|mesh-ancestor
65021893|NCT03719092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021894|NCT03719092|Protective Agents|protective agents|mesh-ancestor
65021895|NCT03719092|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65021896|NCT03719092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021897|NCT03669367|Abatacept|abatacept|mesh-list
65021898|NCT03669367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65021899|NCT03669367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021900|NCT03669367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021901|NCT03669367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65021902|NCT03669367|Immunologic Factors|immunologic factors|mesh-ancestor
65021903|NCT03669367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021904|NCT03669367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65021905|NCT00532168|Ritonavir|ritonavir|mesh-list
65021906|NCT00532168|Lopinavir|lopinavir|mesh-list
65021907|NCT00532168|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65021908|NCT00532168|Tenofovir|tenofovir|mesh-list
65021909|NCT00532168|Emtricitabine|emtricitabine|mesh-list
65021910|NCT00532168|Efavirenz|efavirenz|mesh-list
65021911|NCT00532168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65021912|NCT00532168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64576034|NCT04797546|Morphine|morphine|mesh-list
64576035|NCT04797546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65021921|NCT00532168|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65021922|NCT00532168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65021923|NCT00532168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65021924|NCT00532168|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65021925|NCT00532168|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65021926|NCT00532168|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65021927|NCT00532168|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65021928|NCT00532168|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65021929|NCT00532207|Teriparatide|teriparatide|mesh-list
65021930|NCT00532207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65021931|NCT00532207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021932|NCT00532207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65021933|NCT04723836|Riboflavin|riboflavin|mesh-list
65021934|NCT04723836|Vitamins|vitamins|mesh-ancestor
65021935|NCT04723836|Micronutrients|micronutrients|mesh-ancestor
64477670|NCT01421667|Immunologic Factors|immunologic factors|mesh-ancestor
65021936|NCT04723836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021937|NCT04723836|Vitamin B Complex|vitamin b complex|mesh-ancestor
65021938|NCT04723836|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65021939|NCT04723836|Dermatologic Agents|dermatologic agents|mesh-ancestor
65021940|NCT00150995|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
65021941|NCT00150995|Chelating Agents|chelating agents|mesh-ancestor
65021942|NCT00150995|Sequestering Agents|sequestering agents|mesh-ancestor
64576036|NCT04797546|Narcotics|narcotics|mesh-ancestor
64724804|NCT00000703|Bleomycin|bleomycin|mesh-list
64724805|NCT00000703|Allopurinol|allopurinol|mesh-list
64724806|NCT00000703|Levoleucovorin|levoleucovorin|mesh-list
64332335|NCT03092674|Cytarabine|cytarabine|mesh-list
64946035|NCT04844918|Tirzepatide|tirzepatide|mesh-list
64946036|NCT04844918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64946037|NCT04844918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946038|NCT04844918|Incretins|incretins|mesh-ancestor
64946039|NCT04844918|Hormones|hormones|mesh-ancestor
64946040|NCT04844918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64946041|NCT04771520|Piperazine|piperazine|mesh-list
64946042|NCT04771520|Mebendazole|mebendazole|mesh-list
64946043|NCT04771520|Piperazine citrate|piperazine citrate|mesh-list
64946044|NCT04771520|DMP 777|dmp 777|mesh-list
64946045|NCT04771520|Antinematodal Agents|antinematodal agents|mesh-ancestor
64946046|NCT04771520|Anthelmintics|anthelmintics|mesh-ancestor
64946047|NCT04771520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64946048|NCT04771520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64946049|NCT04771520|Tubulin Modulators|tubulin modulators|mesh-ancestor
64946050|NCT04771520|Antimitotic Agents|antimitotic agents|mesh-ancestor
64946051|NCT04771520|Mitosis Modulators|mitosis modulators|mesh-ancestor
64946052|NCT04771520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946053|NCT04771520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946054|NCT04771520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021943|NCT00150995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021944|NCT00150995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021945|NCT00150995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65021946|NCT00150995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65021947|NCT00150995|Growth Substances|growth substances|mesh-ancestor
65021948|NCT00150995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021949|NCT00150995|Growth Inhibitors|growth inhibitors|mesh-ancestor
65021950|NCT00150995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021951|NCT00532246|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65021952|NCT00532246|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65021953|NCT00532246|Hormone Antagonists|hormone antagonists|mesh-ancestor
65021954|NCT00532246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65021955|NCT00532246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021956|NCT00532246|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65021957|NCT00532246|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65021958|NCT00532246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65021959|NCT00532285|Gemcitabine|gemcitabine|mesh-list
65021960|NCT00532285|Paclitaxel|paclitaxel|mesh-list
65021961|NCT00532285|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65021962|NCT00532285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65021963|NCT00532285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021964|NCT00532285|Tubulin Modulators|tubulin modulators|mesh-ancestor
65021965|NCT00532285|Antimitotic Agents|antimitotic agents|mesh-ancestor
65021966|NCT00532285|Mitosis Modulators|mitosis modulators|mesh-ancestor
65021967|NCT00532285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021968|NCT00532285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65021969|NCT00532285|Antimetabolites|antimetabolites|mesh-ancestor
65021976|NCT03138733|Daptomycin|daptomycin|mesh-list
65021986|NCT00151034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65021987|NCT00151034|Tubulin Modulators|tubulin modulators|mesh-ancestor
65021988|NCT00151034|Antimitotic Agents|antimitotic agents|mesh-ancestor
65021989|NCT00151034|Mitosis Modulators|mitosis modulators|mesh-ancestor
65021990|NCT00151034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65021991|NCT00151034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65021992|NCT00151034|Antimetabolites|antimetabolites|mesh-ancestor
65021993|NCT00151034|Antiviral Agents|antiviral agents|mesh-ancestor
65021994|NCT00151034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65021995|NCT00151034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65021996|NCT00151034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65021997|NCT00151034|Immunologic Factors|immunologic factors|mesh-ancestor
65021998|NCT00151034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65021999|NCT00151034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65022000|NCT02817451|Vaccines|vaccines|mesh-list
65022001|NCT02817451|Immunologic Factors|immunologic factors|mesh-ancestor
65022002|NCT02817451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022003|NCT00171522|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65022004|NCT00171522|Tegaserod|tegaserod|mesh-list
65022005|NCT00171522|Laxatives|laxatives|mesh-ancestor
65022006|NCT00171522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65022007|NCT00171522|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65022008|NCT00171522|Serotonin Agents|serotonin agents|mesh-ancestor
65022009|NCT00171522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65022010|NCT00171522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463284|NCT00630994|Decitabine|decitabine|mesh-list
65022012|NCT02716012|Sorafenib|sorafenib|mesh-list
65022013|NCT02716012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65022018|NCT00151073|Docetaxel|docetaxel|mesh-list
65022033|NCT00171561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65022034|NCT00171561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65022035|NCT00171561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022036|NCT00171561|Diuretics|diuretics|mesh-ancestor
65022037|NCT00171561|Natriuretic Agents|natriuretic agents|mesh-ancestor
65022038|NCT00171561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022039|NCT00171561|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65022040|NCT00171561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65022041|NCT00151112|Anesthetics|anesthetics|mesh-list
65022042|NCT00151112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65022043|NCT00151112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022044|NCT00532324|Chlorhexidine|chlorhexidine|mesh-list
65022045|NCT00532324|Mupirocin|mupirocin|mesh-list
65022046|NCT00532324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65022047|NCT00532324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65022048|NCT00532324|Disinfectants|disinfectants|mesh-ancestor
65022049|NCT00532324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65022050|NCT00532324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65022051|NCT00532324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022052|NCT00532324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022053|NCT00171600|Valsartan|valsartan|mesh-list
65022054|NCT00171600|Lisinopril|lisinopril|mesh-list
65493837|NCT04233866|Antimetabolites|antimetabolites|mesh-ancestor
65022055|NCT00171600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65022056|NCT00171600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65022057|NCT00171600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65022058|NCT00171600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022059|NCT00171600|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65022060|NCT00171600|Protease Inhibitors|protease inhibitors|mesh-ancestor
65022061|NCT00171600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022062|NCT00171600|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65022063|NCT00171600|Protective Agents|protective agents|mesh-ancestor
64576193|NCT01533207|Antimetabolites|antimetabolites|mesh-ancestor
65022070|NCT05467384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65022071|NCT05467384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022072|NCT05467384|Vasodilator Agents|vasodilator agents|mesh-ancestor
65022073|NCT05467189|Paclitaxel|paclitaxel|mesh-list
65022074|NCT05467189|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65022075|NCT05467189|Busulfan|busulfan|mesh-list
65022076|NCT05467189|Lapatinib|lapatinib|mesh-list
65022077|NCT05467189|Afatinib|afatinib|mesh-list
65022078|NCT05467189|Crizotinib|crizotinib|mesh-list
65022079|NCT05467189|Ceritinib|ceritinib|mesh-list
65022080|NCT05467189|Antineoplastic Agents|antineoplastic agents|mesh-list
65022081|NCT05467189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65022082|NCT05467189|Tubulin Modulators|tubulin modulators|mesh-ancestor
65022083|NCT05467189|Antimitotic Agents|antimitotic agents|mesh-ancestor
65022084|NCT05467189|Mitosis Modulators|mitosis modulators|mesh-ancestor
65022085|NCT05467189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022086|NCT05467189|Alkylating Agents|alkylating agents|mesh-ancestor
65022087|NCT05467189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65022088|NCT05467189|Immunologic Factors|immunologic factors|mesh-ancestor
65022089|NCT05467189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022090|NCT05467189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65022091|NCT05467189|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65022092|NCT05467189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65022093|NCT05467189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022094|NCT00171639|Zoledronic Acid|zoledronic acid|mesh-list
65022095|NCT00171639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65022096|NCT00171639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022097|NCT05466604|Dexamethasone|dexamethasone|mesh-list
65022098|NCT05466604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65022099|NCT05466604|Antiemetics|antiemetics|mesh-ancestor
65022100|NCT05466604|Autonomic Agents|autonomic agents|mesh-ancestor
65022101|NCT05466604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022102|NCT05466604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022103|NCT05466604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65022104|NCT05466604|Glucocorticoids|glucocorticoids|mesh-ancestor
65022105|NCT05466604|Hormones|hormones|mesh-ancestor
64304055|NCT02631746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503290|NCT04443270|Anthelmintics|anthelmintics|mesh-ancestor
65022106|NCT05466604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65022107|NCT05466604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65022108|NCT05466604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65022109|NCT04723875|Paclitaxel|paclitaxel|mesh-list
65022110|NCT04723875|Docetaxel|docetaxel|mesh-list
65022111|NCT04723875|Carboplatin|carboplatin|mesh-list
65022112|NCT04723875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65022113|NCT04723875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65022114|NCT04723875|Tubulin Modulators|tubulin modulators|mesh-ancestor
65022115|NCT04723875|Antimitotic Agents|antimitotic agents|mesh-ancestor
65022116|NCT04723875|Mitosis Modulators|mitosis modulators|mesh-ancestor
65022117|NCT04723875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022118|NCT05466019|Leucovorin|leucovorin|mesh-list
65022119|NCT05466019|Docetaxel|docetaxel|mesh-list
65022120|NCT05466019|Oxaliplatin|oxaliplatin|mesh-list
65022121|NCT05466019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65022122|NCT05466019|Tubulin Modulators|tubulin modulators|mesh-ancestor
65022123|NCT05466019|Antimitotic Agents|antimitotic agents|mesh-ancestor
65022124|NCT05466019|Mitosis Modulators|mitosis modulators|mesh-ancestor
65022125|NCT05466019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022126|NCT05466019|Antidotes|antidotes|mesh-ancestor
65022127|NCT05466019|Protective Agents|protective agents|mesh-ancestor
65022128|NCT05466019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022129|NCT05466019|Vitamin B Complex|vitamin b complex|mesh-ancestor
65022130|NCT05466019|Vitamins|vitamins|mesh-ancestor
65022131|NCT05466019|Micronutrients|micronutrients|mesh-ancestor
65022132|NCT05465902|Vaccines|vaccines|mesh-list
65022133|NCT05465902|Immunologic Factors|immunologic factors|mesh-ancestor
65022134|NCT05465902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022135|NCT00151346|Fentanyl|fentanyl|mesh-list
65022136|NCT00151346|Bupivacaine|bupivacaine|mesh-list
65022137|NCT00151346|Anesthetics, Local|anesthetics, local|mesh-ancestor
65022138|NCT00151346|Anesthetics|anesthetics|mesh-ancestor
65022139|NCT00151346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65022140|NCT00151346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022141|NCT00151346|Sensory System Agents|sensory system agents|mesh-ancestor
65022142|NCT00151346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022146|NCT00151346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65022147|NCT00151346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65022148|NCT00151346|Anesthetics, General|anesthetics, general|mesh-ancestor
65022149|NCT00164424|Acyclovir|acyclovir|mesh-list
65022150|NCT00164424|Antiviral Agents|antiviral agents|mesh-ancestor
65022151|NCT00164424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65022152|NCT00532519|Citalopram|citalopram|mesh-list
65022153|NCT00532519|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65022154|NCT00532519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65022155|NCT00532519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65022156|NCT00532519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022157|NCT00532519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65022158|NCT00532519|Serotonin Agents|serotonin agents|mesh-ancestor
65022159|NCT00532519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022160|NCT00532519|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64463432|NCT01920334|GABA Agonists|gaba agonists|mesh-ancestor
65022161|NCT00532519|Antidepressive Agents|antidepressive agents|mesh-ancestor
65022162|NCT00532519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65022164|NCT00171678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65022165|NCT00171678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65022166|NCT00171678|Analgesics|analgesics|mesh-ancestor
65022167|NCT00171678|Sensory System Agents|sensory system agents|mesh-ancestor
65022168|NCT00171678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022169|NCT00171678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022170|NCT00171678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65022171|NCT00171678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65022172|NCT00171678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65022173|NCT00171678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022191|NCT00171717|Dermatologic Agents|dermatologic agents|mesh-ancestor
65022192|NCT00171717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65022193|NCT00171717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65022194|NCT00151502|Atorvastatin|atorvastatin|mesh-list
65022195|NCT00151502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65022196|NCT00151502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65022197|NCT00151502|Antimetabolites|antimetabolites|mesh-ancestor
65022198|NCT00151502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022199|NCT00151502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65022200|NCT00151502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65022201|NCT00151502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022202|NCT00164463|Moxifloxacin|moxifloxacin|mesh-list
65022203|NCT00164463|Isoniazid|isoniazid|mesh-list
65022204|NCT00164463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65022205|NCT00164463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65022206|NCT00164463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65022207|NCT00164463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65022208|NCT00164463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022209|NCT00164463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022210|NCT00164463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65022211|NCT00164463|Antitubercular Agents|antitubercular agents|mesh-ancestor
65022212|NCT00164463|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65022213|NCT00164463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65022215|NCT00164463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65022241|NCT00171795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022242|NCT00171795|Cholinergic Agents|cholinergic agents|mesh-ancestor
65022243|NCT00171795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65022244|NCT00171795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022245|NCT00171795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65022246|NCT00171795|Protective Agents|protective agents|mesh-ancestor
65022247|NCT00151541|Dapsone|dapsone|mesh-list
65022248|NCT00151541|Adapalene|adapalene|mesh-list
65022249|NCT00151541|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65022250|NCT00151541|Dermatologic Agents|dermatologic agents|mesh-ancestor
65022251|NCT00151541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65022252|NCT00151541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65022253|NCT00151541|Analgesics|analgesics|mesh-ancestor
65022254|NCT00151541|Sensory System Agents|sensory system agents|mesh-ancestor
65022255|NCT00151541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022256|NCT00151541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022257|NCT00151541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65022258|NCT00151541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65022259|NCT00151541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65022260|NCT00151541|Antimalarials|antimalarials|mesh-ancestor
65022261|NCT00151541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65022262|NCT00151541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65022263|NCT00151541|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65022264|NCT00151541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022265|NCT00151541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022266|NCT00151541|Leprostatic Agents|leprostatic agents|mesh-ancestor
65022267|NCT00151541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65022268|NCT00151580|Ribavirin|ribavirin|mesh-list
65022269|NCT00151580|Antimetabolites|antimetabolites|mesh-ancestor
65022270|NCT00151580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022284|NCT00151619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022285|NCT00151619|Vasodilator Agents|vasodilator agents|mesh-ancestor
65022286|NCT05324761|Pregabalin|pregabalin|mesh-list
65022287|NCT05324761|Gabapentin|gabapentin|mesh-list
65022288|NCT05324761|Analgesics|analgesics|mesh-ancestor
65022289|NCT05324761|Sensory System Agents|sensory system agents|mesh-ancestor
65022290|NCT05324761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022291|NCT05324761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022292|NCT05324761|Anticonvulsants|anticonvulsants|mesh-ancestor
65022293|NCT05324761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65022294|NCT05324761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65022295|NCT05324761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022296|NCT05324761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65022297|NCT05324761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65022298|NCT05324761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65022299|NCT05324761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65022300|NCT05324761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65022301|NCT05324761|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65022302|NCT05324761|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65022303|NCT05324761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65022304|NCT05324761|Antimanic Agents|antimanic agents|mesh-ancestor
65022305|NCT00532675|Lenalidomide|lenalidomide|mesh-list
65022306|NCT00532675|Panobinostat|panobinostat|mesh-list
65022307|NCT00532675|Immunologic Factors|immunologic factors|mesh-ancestor
65022308|NCT00532675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022309|NCT00532675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65022310|NCT00532675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65022311|NCT00532675|Growth Substances|growth substances|mesh-ancestor
65022312|NCT00532675|Growth Inhibitors|growth inhibitors|mesh-ancestor
65022329|NCT05308030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022330|NCT05308030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65022331|NCT05308030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65022332|NCT05308030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022333|NCT05308030|Antipyretics|antipyretics|mesh-ancestor
65022334|NCT05308030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65022335|NCT05308030|Antithrombins|antithrombins|mesh-ancestor
65022336|NCT05308030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65022337|NCT05308030|Protease Inhibitors|protease inhibitors|mesh-ancestor
65022338|NCT05308030|Anticoagulants|anticoagulants|mesh-ancestor
65022339|NCT05293600|Acetazolamide|acetazolamide|mesh-list
65022340|NCT05293600|Eszopiclone|eszopiclone|mesh-list
65022341|NCT05293600|Trazodone|trazodone|mesh-list
65022342|NCT05293600|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65022343|NCT05293600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65022344|NCT05293600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65022345|NCT05293600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65022346|NCT05293600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022347|NCT05293600|Adrenergic Agents|adrenergic agents|mesh-ancestor
65022348|NCT05293600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65022349|NCT05293600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022350|NCT05293600|Anticonvulsants|anticonvulsants|mesh-ancestor
65022351|NCT05293600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65022352|NCT05293600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022353|NCT05293600|Diuretics|diuretics|mesh-ancestor
65022354|NCT05293600|Natriuretic Agents|natriuretic agents|mesh-ancestor
65022355|NCT05293600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65022356|NCT05293600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65493838|NCT04233866|Antiviral Agents|antiviral agents|mesh-ancestor
65022357|NCT05293600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65022358|NCT05293600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65022372|NCT00532714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022373|NCT00532714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65022374|NCT00532714|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65022375|NCT00532714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65022376|NCT00532714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022377|NCT00151736|Etodolac|etodolac|mesh-list
65022378|NCT00151736|Chlorambucil|chlorambucil|mesh-list
65022379|NCT00151736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65022380|NCT00151736|Alkylating Agents|alkylating agents|mesh-ancestor
65022381|NCT00151736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022382|NCT00151736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65022383|NCT00151736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65022384|NCT00151736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65022385|NCT00151736|Analgesics|analgesics|mesh-ancestor
65022386|NCT00151736|Sensory System Agents|sensory system agents|mesh-ancestor
65022387|NCT00151736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022388|NCT00151736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022389|NCT00151736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65022390|NCT00151736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65022391|NCT00151736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65022392|NCT00151736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65022393|NCT00151736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022394|NCT00171990|Famciclovir|famciclovir|mesh-list
65022395|NCT00171990|Antiviral Agents|antiviral agents|mesh-ancestor
65022396|NCT00171990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65022397|NCT00171990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65022398|NCT00171990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022399|NCT00171990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022400|NCT00172029|Zoledronic Acid|zoledronic acid|mesh-list
65022401|NCT00172029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65022402|NCT00172029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022403|NCT00406094|Montelukast|montelukast|mesh-list
65022410|NCT00406094|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65022411|NCT00406094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65022412|NCT00406094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022413|NCT00164736|Ritonavir|ritonavir|mesh-list
65022414|NCT00164736|Lopinavir|lopinavir|mesh-list
65022415|NCT00164736|Lamivudine|lamivudine|mesh-list
65022416|NCT00164736|Zidovudine|zidovudine|mesh-list
65022417|NCT00164736|Nevirapine|nevirapine|mesh-list
65022418|NCT00164736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65022419|NCT00164736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65022420|NCT00164736|Protease Inhibitors|protease inhibitors|mesh-ancestor
65022421|NCT00164736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022422|NCT00164736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022423|NCT00164736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65022424|NCT00164736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65022425|NCT00164736|Antiviral Agents|antiviral agents|mesh-ancestor
65022426|NCT00164736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65022427|NCT00164736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65022428|NCT00164736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65022429|NCT00164736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65493839|NCT04233866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65022430|NCT00164736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65022431|NCT00164736|Antimetabolites|antimetabolites|mesh-ancestor
65022432|NCT00164736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65022433|NCT00164736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65022434|NCT04725383|Amitriptyline|amitriptyline|mesh-list
65022435|NCT04725383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65022436|NCT04725383|Antidepressive Agents|antidepressive agents|mesh-ancestor
65022437|NCT04725383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65022438|NCT04725383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65022439|NCT04725383|Analgesics|analgesics|mesh-ancestor
65022447|NCT04725383|Adrenergic Agents|adrenergic agents|mesh-ancestor
65022451|NCT05177146|Sensory System Agents|sensory system agents|mesh-ancestor
65022452|NCT05177146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022453|NCT05177146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022454|NCT05177146|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65022455|NCT05177146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65022456|NCT05177146|Anesthetics, General|anesthetics, general|mesh-ancestor
64478204|NCT01857583|PENTA|penta|mesh-list
65022457|NCT05177146|Anesthetics|anesthetics|mesh-ancestor
65022458|NCT05177146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65022459|NCT05177146|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65022460|NCT05177146|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65022461|NCT05177146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65022462|NCT05177146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022463|NCT00532909|Bevacizumab|bevacizumab|mesh-list
65022464|NCT00532909|Capecitabine|capecitabine|mesh-list
65022465|NCT00532909|Oxaliplatin|oxaliplatin|mesh-list
65022466|NCT00532909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65022467|NCT00532909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65022468|NCT00532909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65022469|NCT00532909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65022470|NCT00532909|Growth Substances|growth substances|mesh-ancestor
65022471|NCT00532909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022472|NCT00532909|Growth Inhibitors|growth inhibitors|mesh-ancestor
65022473|NCT00532909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65022474|NCT00532909|Antimetabolites|antimetabolites|mesh-ancestor
65022475|NCT00532909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022476|NCT00172068|Vitamin D|vitamin d|mesh-list
65022496|NCT00152048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65022497|NCT00152048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65022498|NCT00152048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65022499|NCT00152048|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
65022500|NCT00152048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65493840|NCT04233866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022501|NCT00152048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022503|NCT05060068|Esketamine|esketamine|mesh-list
65022504|NCT05060068|Analgesics|analgesics|mesh-ancestor
65022505|NCT05060068|Sensory System Agents|sensory system agents|mesh-ancestor
65022506|NCT05060068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022507|NCT05060068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022508|NCT05060068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65022509|NCT05060068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65022510|NCT05060068|Anesthetics, General|anesthetics, general|mesh-ancestor
65022511|NCT05060068|Anesthetics|anesthetics|mesh-ancestor
65022512|NCT05060068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65022513|NCT05060068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65022514|NCT05060068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65022515|NCT05060068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65022516|NCT05060068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022517|NCT05060068|Antidepressive Agents|antidepressive agents|mesh-ancestor
65022518|NCT05060068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65022519|NCT04687111|Valsartan|valsartan|mesh-list
65022520|NCT04687111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65022521|NCT04687111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65022522|NCT04687111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65022523|NCT04687111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65022524|NCT04687111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022525|NCT00164775|Imipramine|imipramine|mesh-list
65022534|NCT00164775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65022535|NCT00164775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022536|NCT00533026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65022537|NCT00533026|Warfarin|warfarin|mesh-list
65022538|NCT00533026|Anticoagulants|anticoagulants|mesh-ancestor
65022539|NCT00533026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65022540|NCT00533026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65022541|NCT00533026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65022542|NCT00533026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022543|NCT00533026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65022544|NCT00533026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022545|NCT00533026|Analgesics|analgesics|mesh-ancestor
65022546|NCT00533026|Sensory System Agents|sensory system agents|mesh-ancestor
65022547|NCT00533026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022548|NCT00533026|Antidepressive Agents|antidepressive agents|mesh-ancestor
65022549|NCT00533026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65022550|NCT00533026|Dopamine Agents|dopamine agents|mesh-ancestor
65022551|NCT00152126|Melphalan|melphalan|mesh-list
65022552|NCT00152126|Busulfan|busulfan|mesh-list
65022553|NCT00152126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65022554|NCT00152126|Alkylating Agents|alkylating agents|mesh-ancestor
65022555|NCT00152126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022556|NCT00152126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65022557|NCT00152126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65022558|NCT00152126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65022559|NCT00152126|Immunologic Factors|immunologic factors|mesh-ancestor
65022560|NCT00152126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022561|NCT05039593|Chlorhexidine|chlorhexidine|mesh-list
65022562|NCT05039593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65022563|NCT05039593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65022564|NCT05039593|Disinfectants|disinfectants|mesh-ancestor
65022565|NCT00425451|Chlorhexidine|chlorhexidine|mesh-list
65022566|NCT00425451|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65022567|NCT00425451|Flurbiprofen|flurbiprofen|mesh-list
65022568|NCT00425451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65022573|NCT00425451|Sensory System Agents|sensory system agents|mesh-ancestor
65022574|NCT00425451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022575|NCT00425451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022576|NCT00425451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65022577|NCT00425451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65022578|NCT00425451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65022579|NCT00425451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65022580|NCT00425451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65022581|NCT00425451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022582|NCT00425451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022583|NCT00152204|Pyrimethamine|pyrimethamine|mesh-list
65022584|NCT00152204|Sulfadoxine|sulfadoxine|mesh-list
65022585|NCT00152204|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65022586|NCT00152204|Antimalarials|antimalarials|mesh-ancestor
65022587|NCT00152204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65022588|NCT00152204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65022589|NCT00152204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65022590|NCT00152204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65022591|NCT00152204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022592|NCT00152204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022593|NCT00152204|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65022594|NCT00152204|Renal Agents|renal agents|mesh-ancestor
65022595|NCT00533065|Donepezil|donepezil|mesh-list
65022596|NCT00533065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65022597|NCT00533065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022598|NCT00533065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576764|NCT02219997|Hormones|hormones|mesh-ancestor
65022618|NCT04922983|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65022619|NCT04922983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65022620|NCT04922983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65022621|NCT04922983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022622|NCT04922983|Cholinergic Agents|cholinergic agents|mesh-ancestor
65022623|NCT04922983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65022624|NCT04922983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022625|NCT04922983|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65022626|NCT04922983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022627|NCT04914247|Selexipag|selexipag|mesh-list
65022628|NCT04914247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65022629|NCT00152360|Orlistat|orlistat|mesh-list
65022630|NCT00152360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022631|NCT00152360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022632|NCT00152360|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65022633|NCT00152360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65022634|NCT00164892|Rofecoxib|rofecoxib|mesh-list
65022635|NCT00164892|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65022636|NCT00164892|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65022637|NCT00164892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022638|NCT00164892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022639|NCT00164892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65022640|NCT00164892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65022641|NCT00164892|Analgesics|analgesics|mesh-ancestor
65022642|NCT00164892|Sensory System Agents|sensory system agents|mesh-ancestor
65022643|NCT00164892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65493841|NCT04233866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65022644|NCT00164892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022645|NCT00164892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65022646|NCT00164892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65022647|NCT00152399|Somatostatin|somatostatin|mesh-list
65022648|NCT00152399|Hormones|hormones|mesh-ancestor
65022649|NCT00152399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65022650|NCT00152399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022651|NCT00164931|Omeprazole|omeprazole|mesh-list
64946055|NCT04769453|Hyaluronic Acid|hyaluronic acid|mesh-list
64946056|NCT04769453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65022652|NCT00164931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65022653|NCT00164931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65022654|NCT00164931|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65022655|NCT00164931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022656|NCT00164931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022657|NCT00152438|Progesterone|progesterone|mesh-list
65022658|NCT00152438|Progestins|progestins|mesh-ancestor
65022659|NCT00152438|Hormones|hormones|mesh-ancestor
65022660|NCT00152438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65022661|NCT00152438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022662|NCT00164970|Vitamin B 12|vitamin b 12|mesh-list
65022663|NCT00164970|Hydroxocobalamin|hydroxocobalamin|mesh-list
65022664|NCT00164970|Vitamins|vitamins|mesh-ancestor
65022665|NCT00164970|Micronutrients|micronutrients|mesh-ancestor
65022666|NCT00164970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022667|NCT00164970|Vitamin B Complex|vitamin b complex|mesh-ancestor
65022668|NCT00164970|Hematinics|hematinics|mesh-ancestor
65022669|NCT02937844|Cyclophosphamide|cyclophosphamide|mesh-list
65022670|NCT02937844|Fludarabine|fludarabine|mesh-list
65022671|NCT02937844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65022672|NCT02937844|Immunologic Factors|immunologic factors|mesh-ancestor
65022673|NCT02937844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022674|NCT02937844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65022675|NCT02937844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64463957|NCT05608642|Lidocaine|lidocaine|mesh-list
65022676|NCT02937844|Alkylating Agents|alkylating agents|mesh-ancestor
65022677|NCT02937844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022678|NCT02937844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65022679|NCT02937844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65022680|NCT02937415|Antioxidants|antioxidants|mesh-list
65022681|NCT02937415|Carbon Monoxide|carbon monoxide|mesh-list
65022682|NCT02937415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022683|NCT02937415|Protective Agents|protective agents|mesh-ancestor
65022693|NCT00152594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022694|NCT00152594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022695|NCT00152594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65022696|NCT00152594|Hormone Antagonists|hormone antagonists|mesh-ancestor
65022697|NCT00152594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65022698|NCT00152594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022699|NCT00152594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65022700|NCT00407199|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65022701|NCT00407199|Antidepressive Agents|antidepressive agents|mesh-ancestor
65022702|NCT00407199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65022703|NCT00407199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65022704|NCT00407199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65022705|NCT00407199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65022706|NCT00407199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022707|NCT04725422|Zoledronic Acid|zoledronic acid|mesh-list
65022708|NCT04725422|Pamidronate|pamidronate|mesh-list
65022709|NCT04725422|Sulfasalazine|sulfasalazine|mesh-list
65022710|NCT04725422|Adalimumab|adalimumab|mesh-list
65022711|NCT04725422|Etanercept|etanercept|mesh-list
65022712|NCT04725422|Golimumab|golimumab|mesh-list
65022713|NCT04725422|Methotrexate|methotrexate|mesh-list
65022714|NCT04725422|Infliximab|infliximab|mesh-list
65022715|NCT04725422|Certolizumab Pegol|certolizumab pegol|mesh-list
65022716|NCT04725422|Leflunomide|leflunomide|mesh-list
65022717|NCT04725422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65022718|NCT04725422|Abortifacient Agents|abortifacient agents|mesh-ancestor
65022719|NCT04725422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65493842|NCT04233866|Immunologic Factors|immunologic factors|mesh-ancestor
65022720|NCT04725422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022737|NCT04725422|Sensory System Agents|sensory system agents|mesh-ancestor
65022738|NCT04725422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022739|NCT04725422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65022740|NCT04725422|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65022741|NCT04725422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65022742|NCT00152633|Losartan|losartan|mesh-list
65022743|NCT00152633|Metoprolol|metoprolol|mesh-list
65022744|NCT00152633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65022745|NCT00152633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65022746|NCT00152633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65022747|NCT00152633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65022748|NCT00152633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022749|NCT00152633|Sympatholytics|sympatholytics|mesh-ancestor
65022750|NCT00152633|Autonomic Agents|autonomic agents|mesh-ancestor
65022751|NCT00152633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022752|NCT00152633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022753|NCT00152633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65022754|NCT00152633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65022755|NCT00152633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65022756|NCT00152633|Adrenergic Agents|adrenergic agents|mesh-ancestor
65022757|NCT00152633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65022758|NCT02937181|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
65022759|NCT02937181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65022760|NCT02937181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65022761|NCT00425490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65022785|NCT02936830|Cariostatic Agents|cariostatic agents|mesh-ancestor
65022786|NCT02936830|Protective Agents|protective agents|mesh-ancestor
65022787|NCT02936830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022788|NCT02936830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65022789|NCT02936830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65022790|NCT02936830|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65022791|NCT00165048|Rofecoxib|rofecoxib|mesh-list
65022792|NCT00165048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65022793|NCT00165048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65022794|NCT00165048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022795|NCT00165048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022796|NCT00165048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65022797|NCT00165048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65022798|NCT00165048|Analgesics|analgesics|mesh-ancestor
65022799|NCT00165048|Sensory System Agents|sensory system agents|mesh-ancestor
65022800|NCT00165048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022801|NCT00165048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022802|NCT00165048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65022803|NCT00165048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65022804|NCT04690270|Sumatriptan|sumatriptan|mesh-list
65022805|NCT04690270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65022806|NCT04690270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65022807|NCT04690270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65022808|NCT04690270|Serotonin Agents|serotonin agents|mesh-ancestor
65022809|NCT04690270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65022810|NCT04690270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022811|NCT04690270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022812|NCT00165087|Doxorubicin|doxorubicin|mesh-list
65022813|NCT00165087|Dexrazoxane|dexrazoxane|mesh-list
65022814|NCT00165087|Asparaginase|asparaginase|mesh-list
65022830|NCT00152750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022831|NCT00152750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022832|NCT00152750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65022833|NCT00152750|Sympatholytics|sympatholytics|mesh-ancestor
65022834|NCT00152750|Autonomic Agents|autonomic agents|mesh-ancestor
65022835|NCT00152750|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65022836|NCT00152750|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65022837|NCT00152750|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65022838|NCT00152750|Adrenergic Agents|adrenergic agents|mesh-ancestor
65022839|NCT00152750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65022840|NCT00152750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022841|NCT02936167|Plasma-lyte 148|plasma-lyte 148|mesh-list
65022842|NCT02936167|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65022843|NCT02936167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65022844|NCT00152828|Celecoxib|celecoxib|mesh-list
65022845|NCT00152828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65022846|NCT00152828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65022847|NCT00152828|Analgesics|analgesics|mesh-ancestor
65022848|NCT00152828|Sensory System Agents|sensory system agents|mesh-ancestor
65022849|NCT00152828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022850|NCT00152828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022851|NCT00152828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65022852|NCT00152828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65022853|NCT00152828|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65022854|NCT00152828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65022855|NCT00152828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022856|NCT00152828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022857|NCT02935933|Dexmedetomidine|dexmedetomidine|mesh-list
65022858|NCT02935933|Morphine|morphine|mesh-list
65022859|NCT02935933|Bupivacaine|bupivacaine|mesh-list
65022860|NCT02935933|Anesthetics, Local|anesthetics, local|mesh-ancestor
65022873|NCT02935933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65022874|NCT02935933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022875|NCT02935933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65022876|NCT02935933|Narcotics|narcotics|mesh-ancestor
65022877|NCT00152867|Dexamethasone|dexamethasone|mesh-list
65022878|NCT00152867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65022879|NCT00152867|Antiemetics|antiemetics|mesh-ancestor
65022880|NCT00152867|Autonomic Agents|autonomic agents|mesh-ancestor
65022881|NCT00152867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022882|NCT00152867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022883|NCT00152867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65022884|NCT00152867|Glucocorticoids|glucocorticoids|mesh-ancestor
65022885|NCT00152867|Hormones|hormones|mesh-ancestor
65022886|NCT00152867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65022887|NCT00152867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65022888|NCT00152867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65022889|NCT02935972|Lidocaine|lidocaine|mesh-list
65022890|NCT02935972|Diazepam|diazepam|mesh-list
65022891|NCT02935972|Anesthetics, Local|anesthetics, local|mesh-ancestor
65022892|NCT02935972|Anesthetics|anesthetics|mesh-ancestor
65022893|NCT02935972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65022894|NCT02935972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022895|NCT02935972|Sensory System Agents|sensory system agents|mesh-ancestor
65022896|NCT02935972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022897|NCT02935972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65022898|NCT02935972|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65022899|NCT02935972|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65022900|NCT02935972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65022901|NCT02935972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022902|NCT02935972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65022917|NCT02935972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65022918|NCT02935855|Warfarin|warfarin|mesh-list
65022919|NCT02935855|Rivaroxaban|rivaroxaban|mesh-list
65022920|NCT02935855|Dabigatran|dabigatran|mesh-list
65022921|NCT02935855|Apixaban|apixaban|mesh-list
65022922|NCT02935855|Edoxaban|edoxaban|mesh-list
65022923|NCT02935855|Anticoagulants|anticoagulants|mesh-ancestor
65022924|NCT02935855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65022925|NCT02935855|Antithrombins|antithrombins|mesh-ancestor
65022926|NCT02935855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65022927|NCT02935855|Protease Inhibitors|protease inhibitors|mesh-ancestor
65022928|NCT02935855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65022929|NCT02935855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022930|NCT02935582|Betamethasone|betamethasone|mesh-list
65022931|NCT02935582|Betamethasone Valerate|betamethasone valerate|mesh-list
65022932|NCT02935582|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65022933|NCT02935582|Betamethasone benzoate|betamethasone benzoate|mesh-list
65022934|NCT02935582|Calcipotriene|calcipotriene|mesh-list
65022935|NCT02935582|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65022936|NCT02935582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65022937|NCT02935582|Glucocorticoids|glucocorticoids|mesh-ancestor
65022938|NCT02935582|Hormones|hormones|mesh-ancestor
65022939|NCT02935582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65022940|NCT02935582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022941|NCT02935582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65022942|NCT02935582|Respiratory System Agents|respiratory system agents|mesh-ancestor
65022943|NCT02935582|Dermatologic Agents|dermatologic agents|mesh-ancestor
65022944|NCT00406172|Bevacizumab|bevacizumab|mesh-list
65022947|NCT00406172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65022966|NCT02935231|Autonomic Agents|autonomic agents|mesh-ancestor
64577113|NCT00083551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65022967|NCT02935231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022968|NCT02935231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022969|NCT02935231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65022970|NCT02935231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65022971|NCT02935231|Cholinergic Agents|cholinergic agents|mesh-ancestor
65022972|NCT02935231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65022973|NCT02935231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022974|NCT00172380|Docetaxel|docetaxel|mesh-list
64478725|NCT01876381|Tolvaptan|tolvaptan|mesh-list
65022975|NCT00172380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65022976|NCT00172380|Tubulin Modulators|tubulin modulators|mesh-ancestor
65022977|NCT00172380|Antimitotic Agents|antimitotic agents|mesh-ancestor
65022978|NCT00172380|Mitosis Modulators|mitosis modulators|mesh-ancestor
65022979|NCT00172380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022980|NCT00152984|Tiotropium Bromide|tiotropium bromide|mesh-list
65022981|NCT00152984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65022982|NCT00152984|Autonomic Agents|autonomic agents|mesh-ancestor
65022983|NCT00152984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65022984|NCT00152984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65022985|NCT00152984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65022986|NCT00152984|Respiratory System Agents|respiratory system agents|mesh-ancestor
65022987|NCT00152984|Parasympatholytics|parasympatholytics|mesh-ancestor
65022988|NCT00152984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65022989|NCT00152984|Cholinergic Agents|cholinergic agents|mesh-ancestor
65022990|NCT00152984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65022991|NCT00152984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65022992|NCT02935075|Tenofovir|tenofovir|mesh-list
65022993|NCT02935075|Lamivudine|lamivudine|mesh-list
65022994|NCT02935075|Efavirenz|efavirenz|mesh-list
65022995|NCT02935075|Antiviral Agents|antiviral agents|mesh-ancestor
65022996|NCT02935075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65022997|NCT02935075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64503291|NCT03349008|Entecavir|entecavir|mesh-list
64946057|NCT04769453|Immunologic Factors|immunologic factors|mesh-ancestor
64946058|NCT04769453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946059|NCT04769453|Viscosupplements|viscosupplements|mesh-ancestor
64946060|NCT04769453|Protective Agents|protective agents|mesh-ancestor
64946061|NCT04765709|Carboplatin|carboplatin|mesh-list
64946062|NCT04765709|Pemetrexed|pemetrexed|mesh-list
64946063|NCT04765709|Durvalumab|durvalumab|mesh-list
65022998|NCT02935075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65022999|NCT02935075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023000|NCT02935075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023001|NCT02935075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65023002|NCT02935075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65023003|NCT02935075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65023004|NCT02935075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65023005|NCT02935075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65023006|NCT02935075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65023007|NCT02935075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65023008|NCT02935075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65023009|NCT02934919|Nalmefene|nalmefene|mesh-list
65023010|NCT02934919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65023011|NCT02934919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023012|NCT02934919|Sensory System Agents|sensory system agents|mesh-ancestor
65023013|NCT02934919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65023014|NCT00172419|Atorvastatin|atorvastatin|mesh-list
65023015|NCT00172419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65023016|NCT00172419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65023017|NCT00172419|Antimetabolites|antimetabolites|mesh-ancestor
65493843|NCT04233866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023018|NCT00172419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023045|NCT02934763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023046|NCT02934763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65023047|NCT02934763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65023048|NCT02934763|Vasodilator Agents|vasodilator agents|mesh-ancestor
64464330|NCT01454440|Eptifibatide|eptifibatide|mesh-list
65023049|NCT04689958|Vitamin D|vitamin d|mesh-list
65023050|NCT04689958|Vitamins|vitamins|mesh-ancestor
65023051|NCT04689958|Micronutrients|micronutrients|mesh-ancestor
65023052|NCT04689958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023053|NCT04689958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65023054|NCT00153140|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65023055|NCT00153140|Laxatives|laxatives|mesh-ancestor
65023056|NCT00153140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65023057|NCT04684420|Metformin|metformin|mesh-list
65023058|NCT04684420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65023059|NCT04684420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023060|NCT02934607|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65023061|NCT02934607|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65023062|NCT02934607|Respiratory System Agents|respiratory system agents|mesh-ancestor
65023063|NCT00153296|Carbamazepine|carbamazepine|mesh-list
65023064|NCT00153296|Anticonvulsants|anticonvulsants|mesh-ancestor
65023065|NCT00153296|Antimanic Agents|antimanic agents|mesh-ancestor
65023066|NCT00153296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65023067|NCT00153296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65023068|NCT00153296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023069|NCT00153296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65023070|NCT00153296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65023071|NCT00153296|Analgesics|analgesics|mesh-ancestor
65023072|NCT00153296|Sensory System Agents|sensory system agents|mesh-ancestor
65023092|NCT02934061|Analgesics|analgesics|mesh-ancestor
65023093|NCT02934061|Sensory System Agents|sensory system agents|mesh-ancestor
65023094|NCT02934061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65023095|NCT02934061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023096|NCT02934061|Anticonvulsants|anticonvulsants|mesh-ancestor
65023097|NCT02934061|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65023098|NCT02934061|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65023099|NCT02934061|Parasympatholytics|parasympatholytics|mesh-ancestor
65023100|NCT02934061|Autonomic Agents|autonomic agents|mesh-ancestor
65023101|NCT02934061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65023102|NCT02934061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65023103|NCT02934061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65023104|NCT02934061|Adrenergic Agents|adrenergic agents|mesh-ancestor
65023105|NCT02934061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65023106|NCT02934061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023107|NCT02934217|Cyclosporine|cyclosporine|mesh-list
65023108|NCT02934217|Cyclosporins|cyclosporins|mesh-list
65023109|NCT02934217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023110|NCT02934217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023111|NCT02934217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65023112|NCT02934217|Immunologic Factors|immunologic factors|mesh-ancestor
65023113|NCT02934217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023114|NCT02934217|Antifungal Agents|antifungal agents|mesh-ancestor
65023115|NCT02934217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65023116|NCT02934217|Dermatologic Agents|dermatologic agents|mesh-ancestor
65023117|NCT02934217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65023140|NCT02933788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65023141|NCT02933788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65023142|NCT02933788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65023143|NCT02933788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023144|NCT02933788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65023145|NCT02933788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65023146|NCT02933788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023147|NCT02933788|Antipyretics|antipyretics|mesh-ancestor
65023148|NCT02933788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65023149|NCT02933788|Autonomic Agents|autonomic agents|mesh-ancestor
65023150|NCT02933788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65023151|NCT02933788|Respiratory System Agents|respiratory system agents|mesh-ancestor
65023152|NCT02933788|Vasodilator Agents|vasodilator agents|mesh-ancestor
65023153|NCT02933788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65023154|NCT02933788|Protective Agents|protective agents|mesh-ancestor
65023155|NCT02933788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65023156|NCT02933788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65023157|NCT00165399|Docetaxel|docetaxel|mesh-list
65023158|NCT00165399|Goserelin|goserelin|mesh-list
65023159|NCT00165399|Bicalutamide|bicalutamide|mesh-list
65023160|NCT00165399|Estramustine|estramustine|mesh-list
65023161|NCT00165399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023162|NCT00165399|Tubulin Modulators|tubulin modulators|mesh-ancestor
65023163|NCT00165399|Antimitotic Agents|antimitotic agents|mesh-ancestor
65023164|NCT00165399|Mitosis Modulators|mitosis modulators|mesh-ancestor
65023165|NCT00165399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023166|NCT00165399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65023167|NCT00165399|Androgen Antagonists|androgen antagonists|mesh-ancestor
65023168|NCT00165399|Hormone Antagonists|hormone antagonists|mesh-ancestor
65023185|NCT02933593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65023186|NCT02933593|Adrenergic Agents|adrenergic agents|mesh-ancestor
65023187|NCT02933593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65023188|NCT02933593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65023189|NCT02933593|Sympathomimetics|sympathomimetics|mesh-ancestor
65023190|NCT02933593|Autonomic Agents|autonomic agents|mesh-ancestor
65023191|NCT02933593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65023192|NCT02933593|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65023193|NCT02933593|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65023194|NCT00153491|Lumefantrine|lumefantrine|mesh-list
65023195|NCT00153491|Artemether|artemether|mesh-list
65023196|NCT00153491|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65023197|NCT00153491|Antimalarials|antimalarials|mesh-ancestor
65023198|NCT00153491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65023199|NCT00153491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65023200|NCT00153491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65023201|NCT02933437|Ajmaline|ajmaline|mesh-list
65023202|NCT02933437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65023203|NCT02933437|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65023204|NCT02933437|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65023205|NCT02933437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65023206|NCT02933437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023207|NCT00153530|Methotrexate|methotrexate|mesh-list
65023208|NCT00153530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65023209|NCT00153530|Abortifacient Agents|abortifacient agents|mesh-ancestor
65023210|NCT00153530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65023213|NCT00153530|Antimetabolites|antimetabolites|mesh-ancestor
65023232|NCT02932930|Anesthetics, Local|anesthetics, local|mesh-ancestor
65023233|NCT02932930|Anesthetics|anesthetics|mesh-ancestor
65023234|NCT02932930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65023235|NCT02932930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023236|NCT02932930|Sensory System Agents|sensory system agents|mesh-ancestor
65023237|NCT02932930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65023238|NCT00165516|Sodium thiosulfate|sodium thiosulfate|mesh-list
65023239|NCT00165516|Antidotes|antidotes|mesh-ancestor
65023240|NCT00165516|Protective Agents|protective agents|mesh-ancestor
65023241|NCT00165516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023242|NCT00165516|Antioxidants|antioxidants|mesh-ancestor
65023243|NCT00165516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023244|NCT00165516|Antitubercular Agents|antitubercular agents|mesh-ancestor
65023245|NCT00165516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65023246|NCT00165516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65023247|NCT00165516|Chelating Agents|chelating agents|mesh-ancestor
65023248|NCT00165516|Sequestering Agents|sequestering agents|mesh-ancestor
65023249|NCT04642378|Insulin|insulin|mesh-list
65023250|NCT04642378|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65023251|NCT04642378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65023252|NCT04642378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023253|NCT00407784|Eplerenone|eplerenone|mesh-list
65023254|NCT00407784|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65023255|NCT00407784|Hormone Antagonists|hormone antagonists|mesh-ancestor
65023256|NCT00407784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65023257|NCT00407784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023258|NCT00407784|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65023259|NCT00407784|Diuretics|diuretics|mesh-ancestor
65023260|NCT00407784|Natriuretic Agents|natriuretic agents|mesh-ancestor
65023261|NCT00407784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65023262|NCT02932774|Cetirizine|cetirizine|mesh-list
65023263|NCT02932774|Loratadine|loratadine|mesh-list
65023264|NCT02932774|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65023273|NCT02932774|Dermatologic Agents|dermatologic agents|mesh-ancestor
65023274|NCT00180063|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
65023275|NCT00180063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023276|NCT00180063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023277|NCT00153725|Aspirin|aspirin|mesh-list
65023278|NCT00153725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65023279|NCT00153725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65023280|NCT00153725|Analgesics|analgesics|mesh-ancestor
65023281|NCT00153725|Sensory System Agents|sensory system agents|mesh-ancestor
65023282|NCT00153725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65023283|NCT00153725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023284|NCT00153725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65023285|NCT00153725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65023286|NCT00153725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65023287|NCT00153725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65023288|NCT00153725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023289|NCT00153725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65023290|NCT00153725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65023291|NCT00153725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023292|NCT00153725|Antipyretics|antipyretics|mesh-ancestor
65023293|NCT00153764|Vitamins|vitamins|mesh-list
65023294|NCT00153764|Micronutrients|micronutrients|mesh-ancestor
65023295|NCT00153764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023296|NCT00180102|Cytarabine|cytarabine|mesh-list
65023297|NCT00180102|Mitoxantrone|mitoxantrone|mesh-list
65023323|NCT00153881|Antimitotic Agents|antimitotic agents|mesh-ancestor
65023324|NCT00153881|Mitosis Modulators|mitosis modulators|mesh-ancestor
65023325|NCT00153881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023326|NCT00153881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65023327|NCT00153881|Antimetabolites|antimetabolites|mesh-ancestor
65023328|NCT00180141|Pimecrolimus|pimecrolimus|mesh-list
65023329|NCT00180141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65023330|NCT00180141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65023331|NCT00180141|Analgesics|analgesics|mesh-ancestor
65023332|NCT00180141|Sensory System Agents|sensory system agents|mesh-ancestor
65023333|NCT00180141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65023334|NCT00180141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023335|NCT00180141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65023336|NCT00180141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65023337|NCT00180141|Dermatologic Agents|dermatologic agents|mesh-ancestor
65023338|NCT00180141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65023339|NCT00180141|Immunologic Factors|immunologic factors|mesh-ancestor
65023340|NCT00180141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65023341|NCT00180141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023342|NCT00180141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023343|NCT02931877|Propofol|propofol|mesh-list
65023344|NCT02931877|Sevoflurane|sevoflurane|mesh-list
65023345|NCT02931877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65023346|NCT02931877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65023347|NCT02931877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464643|NCT01888003|Epoetin Alfa|epoetin alfa|mesh-list
64479101|NCT03950427|Bupropion|bupropion|mesh-list
65023348|NCT02931877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65023349|NCT02931877|Anesthetics, General|anesthetics, general|mesh-ancestor
64577519|NCT00088621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65023367|NCT00153998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65023368|NCT00153998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65023369|NCT00153998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023370|NCT00153998|Antidotes|antidotes|mesh-ancestor
65023371|NCT00153998|Protective Agents|protective agents|mesh-ancestor
65023372|NCT00153998|Vitamin B Complex|vitamin b complex|mesh-ancestor
65023373|NCT00153998|Vitamins|vitamins|mesh-ancestor
65023374|NCT00153998|Micronutrients|micronutrients|mesh-ancestor
65023375|NCT00153998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65023376|NCT00153998|Hematinics|hematinics|mesh-ancestor
65023377|NCT02925130|Albuterol|albuterol|mesh-list
65023378|NCT02925130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65023379|NCT02925130|Autonomic Agents|autonomic agents|mesh-ancestor
65023380|NCT02925130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65023381|NCT02925130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023382|NCT02925130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65023383|NCT02925130|Respiratory System Agents|respiratory system agents|mesh-ancestor
65023384|NCT02925130|Tocolytic Agents|tocolytic agents|mesh-ancestor
65023385|NCT02925130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65023386|NCT02925130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65023387|NCT02925130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65023388|NCT02925130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65023389|NCT02925130|Adrenergic Agents|adrenergic agents|mesh-ancestor
65023390|NCT02925130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65023391|NCT02925130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023393|NCT02924974|Morphine|morphine|mesh-list
65023394|NCT02924974|Anesthetics, Local|anesthetics, local|mesh-ancestor
65023395|NCT02924974|Anesthetics|anesthetics|mesh-ancestor
65023396|NCT02924974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65023397|NCT02924974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023398|NCT02924974|Sensory System Agents|sensory system agents|mesh-ancestor
65023406|NCT02924974|Narcotics|narcotics|mesh-ancestor
65023410|NCT00154037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65023411|NCT00154037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023412|NCT00154037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65023413|NCT00154037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65023414|NCT00154037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65023415|NCT00154037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023416|NCT02924857|Paclitaxel|paclitaxel|mesh-list
65023417|NCT02924857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65023418|NCT02924857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023419|NCT02924857|Tubulin Modulators|tubulin modulators|mesh-ancestor
65023420|NCT02924857|Antimitotic Agents|antimitotic agents|mesh-ancestor
65023421|NCT02924857|Mitosis Modulators|mitosis modulators|mesh-ancestor
65023422|NCT02924857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023423|NCT00154076|Topiramate|topiramate|mesh-list
65023424|NCT00154076|Zonisamide|zonisamide|mesh-list
65023425|NCT00154076|Anticonvulsants|anticonvulsants|mesh-ancestor
65023426|NCT00154076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65023427|NCT00154076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023428|NCT00154076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65023432|NCT00154115|Simendan|simendan|mesh-list
65023462|NCT02924233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65023463|NCT02924233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023464|NCT02924233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65023465|NCT02924233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023466|NCT02923999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65023468|NCT02923999|Immunoglobulins|immunoglobulins|mesh-list
65023469|NCT02923999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65023470|NCT02923999|Immunologic Factors|immunologic factors|mesh-ancestor
65023471|NCT02923999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023472|NCT02923999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023473|NCT00154193|Cyclosporine|cyclosporine|mesh-list
65023474|NCT00154193|Cyclosporins|cyclosporins|mesh-list
65023475|NCT00154193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023476|NCT00154193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023477|NCT00154193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65023478|NCT00154193|Immunologic Factors|immunologic factors|mesh-ancestor
65023479|NCT00154193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023480|NCT00154193|Antifungal Agents|antifungal agents|mesh-ancestor
65023481|NCT00154193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65023482|NCT00154193|Dermatologic Agents|dermatologic agents|mesh-ancestor
65023483|NCT00154193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65023484|NCT00154193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65023485|NCT00154232|Mycophenolic Acid|mycophenolic acid|mesh-list
65023486|NCT00154232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65023487|NCT00154232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023488|NCT00154232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65023489|NCT00154232|Antitubercular Agents|antitubercular agents|mesh-ancestor
65023490|NCT00154232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65023491|NCT00154232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65023492|NCT00154232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023493|NCT00154232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023503|NCT00154349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023504|NCT00187941|Mycophenolic Acid|mycophenolic acid|mesh-list
65023505|NCT00187941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65023506|NCT00187941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023507|NCT00187941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65023508|NCT00187941|Antitubercular Agents|antitubercular agents|mesh-ancestor
65023509|NCT00187941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65023510|NCT00187941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65023511|NCT00187941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023512|NCT00187941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023514|NCT02923687|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65023515|NCT02923687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65023516|NCT02923687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65023517|NCT02923687|Analgesics|analgesics|mesh-ancestor
65023518|NCT02923687|Sensory System Agents|sensory system agents|mesh-ancestor
65023519|NCT02923687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65023520|NCT02923687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023521|NCT02923687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65023522|NCT02923687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65023523|NCT02923687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65023524|NCT02923687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023525|NCT02923687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023526|NCT00154388|Imatinib Mesylate|imatinib mesylate|mesh-list
65023527|NCT00154388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023528|NCT00154388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65023529|NCT00154388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023530|NCT00154388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023531|NCT02923258|Docetaxel|docetaxel|mesh-list
65023532|NCT02923258|Cisplatin|cisplatin|mesh-list
65023546|NCT02923336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65023547|NCT02923336|Vasodilator Agents|vasodilator agents|mesh-ancestor
65023548|NCT02922946|Entinostat|entinostat|mesh-list
65023549|NCT02922946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023550|NCT02922946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65023551|NCT02922946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023552|NCT02922946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023553|NCT02922712|Nimesulide|nimesulide|mesh-list
65023554|NCT02922712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65023555|NCT02922712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65023556|NCT02922712|Analgesics|analgesics|mesh-ancestor
65023557|NCT02922712|Sensory System Agents|sensory system agents|mesh-ancestor
65023558|NCT02922712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65023559|NCT02922712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023560|NCT02922712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65023561|NCT02922712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65023562|NCT02922712|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65023563|NCT02922712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023564|NCT02922712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023565|NCT02922673|Aspirin|aspirin|mesh-list
65023566|NCT02922673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65023567|NCT02922673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65023568|NCT02922673|Analgesics|analgesics|mesh-ancestor
65023569|NCT02922673|Sensory System Agents|sensory system agents|mesh-ancestor
64479332|NCT01870921|Ticagrelor|ticagrelor|mesh-list
65023570|NCT02922673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65023571|NCT02922673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023572|NCT02922673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65023573|NCT02922673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65023580|NCT02922673|Antipyretics|antipyretics|mesh-ancestor
65023589|NCT04705454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65023590|NCT04705454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023591|NCT02922166|SRX246|srx246|mesh-list
65023592|NCT02922166|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65023593|NCT02922166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023594|NCT02922166|Natriuretic Agents|natriuretic agents|mesh-ancestor
65023595|NCT02922166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023596|NCT02922127|Contraceptive Agents|contraceptive agents|mesh-list
65023597|NCT02922127|Ulipristal acetate|ulipristal acetate|mesh-list
65023598|NCT02922127|Contraceptives, Oral|contraceptives, oral|mesh-list
65023599|NCT02922127|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65023600|NCT02922127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65023601|NCT02922127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023602|NCT02922127|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65023603|NCT02922127|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65023604|NCT02921659|Niacinamide|niacinamide|mesh-list
65023605|NCT02921659|Vitamin B Complex|vitamin b complex|mesh-ancestor
65023606|NCT02921659|Vitamins|vitamins|mesh-ancestor
65023607|NCT02921659|Micronutrients|micronutrients|mesh-ancestor
65023608|NCT02921659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023609|NCT04689100|Leucovorin|leucovorin|mesh-list
65023611|NCT04689100|Oxaliplatin|oxaliplatin|mesh-list
65023612|NCT04689100|Irinotecan|irinotecan|mesh-list
65023613|NCT04689100|Calcium|calcium|mesh-list
65023642|NCT00406250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65023643|NCT00406250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023644|NCT00406250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65023645|NCT00406250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65023646|NCT00406250|Growth Substances|growth substances|mesh-ancestor
65023647|NCT00406250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023648|NCT00406250|Growth Inhibitors|growth inhibitors|mesh-ancestor
65023649|NCT00406289|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65023650|NCT00406289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65023651|NCT00406289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023652|NCT02921269|Bevacizumab|bevacizumab|mesh-list
65023653|NCT02921269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65023654|NCT02921269|Atezolizumab|atezolizumab|mesh-list
65023655|NCT02921269|Endothelial Growth Factors|endothelial growth factors|mesh-list
65023656|NCT02921269|Antibodies|antibodies|mesh-list
65023657|NCT02921269|Immunoglobulins|immunoglobulins|mesh-list
65023658|NCT02921269|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65023659|NCT02921269|Immunoglobulin G|immunoglobulin g|mesh-list
65023660|NCT02921269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023661|NCT02921269|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65023662|NCT02921269|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65023663|NCT02921269|Growth Substances|growth substances|mesh-ancestor
65023664|NCT02921269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023665|NCT02921269|Growth Inhibitors|growth inhibitors|mesh-ancestor
65023666|NCT02921269|Immunologic Factors|immunologic factors|mesh-ancestor
65023667|NCT02921191|Lenograstim|lenograstim|mesh-list
65023668|NCT02921191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65023669|NCT02921191|Immunologic Factors|immunologic factors|mesh-ancestor
65023670|NCT02921191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023671|NCT02920801|Metformin|metformin|mesh-list
65023688|NCT00180843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65023689|NCT00180843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023690|NCT00180843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65023691|NCT00180843|Respiratory System Agents|respiratory system agents|mesh-ancestor
65023692|NCT00180843|Tocolytic Agents|tocolytic agents|mesh-ancestor
65023693|NCT00180843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65023694|NCT00180843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65023695|NCT00180843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65023696|NCT00180843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65023697|NCT00180843|Adrenergic Agents|adrenergic agents|mesh-ancestor
65023698|NCT00180843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65023699|NCT00180843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023700|NCT00180843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65023701|NCT00180843|Cholinergic Agents|cholinergic agents|mesh-ancestor
65023702|NCT02920567|Octreotide|octreotide|mesh-list
65023703|NCT02920567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65023704|NCT02920567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65023705|NCT02920567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023706|NCT00180882|Rituximab|rituximab|mesh-list
65023707|NCT00180882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65023708|NCT00180882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023709|NCT00180882|Immunologic Factors|immunologic factors|mesh-ancestor
65023712|NCT00180921|Imatinib Mesylate|imatinib mesylate|mesh-list
65023740|NCT00154661|Protective Agents|protective agents|mesh-ancestor
65023741|NCT00154661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023742|NCT00154661|Vasodilator Agents|vasodilator agents|mesh-ancestor
65023743|NCT00154661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65023744|NCT00154661|Antioxidants|antioxidants|mesh-ancestor
65023745|NCT00180960|Oxaliplatin|oxaliplatin|mesh-list
65023746|NCT00180960|Irinotecan|irinotecan|mesh-list
65023747|NCT00180960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023748|NCT00180960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65023749|NCT00180960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65023750|NCT00180960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023751|NCT00180960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023752|NCT00154700|Folic Acid|folic acid|mesh-list
65023753|NCT00154700|Paclitaxel|paclitaxel|mesh-list
65023754|NCT00154700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65023755|NCT00154700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023756|NCT00154700|Tubulin Modulators|tubulin modulators|mesh-ancestor
65023757|NCT00154700|Antimitotic Agents|antimitotic agents|mesh-ancestor
65023758|NCT00154700|Mitosis Modulators|mitosis modulators|mesh-ancestor
65023759|NCT00154700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023760|NCT00154700|Hematinics|hematinics|mesh-ancestor
65493845|NCT04233866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65023761|NCT00154700|Vitamin B Complex|vitamin b complex|mesh-ancestor
65023762|NCT00154700|Vitamins|vitamins|mesh-ancestor
65023763|NCT00154700|Micronutrients|micronutrients|mesh-ancestor
65023764|NCT00154700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023765|NCT04688983|Imatinib Mesylate|imatinib mesylate|mesh-list
65023766|NCT04688983|Blinatumomab|blinatumomab|mesh-list
65023767|NCT04688983|Ponatinib|ponatinib|mesh-list
65023768|NCT04688983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023769|NCT04688983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65023770|NCT04688983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023772|NCT02920060|Levetiracetam|levetiracetam|mesh-list
65023783|NCT02920060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65023784|NCT02920060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65023785|NCT00154739|Gemcitabine|gemcitabine|mesh-list
65023786|NCT00154739|Epirubicin|epirubicin|mesh-list
65023787|NCT00154739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023788|NCT00154739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65023789|NCT00154739|Antimetabolites|antimetabolites|mesh-ancestor
65023790|NCT00154739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023791|NCT00154739|Antiviral Agents|antiviral agents|mesh-ancestor
65023792|NCT00154739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65023793|NCT00154739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023794|NCT00154739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65023795|NCT00154739|Immunologic Factors|immunologic factors|mesh-ancestor
65023796|NCT00154739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023797|NCT00154739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65023798|NCT00154739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65023799|NCT00154739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65023800|NCT00154778|Leucovorin|leucovorin|mesh-list
65023802|NCT00154778|Protective Agents|protective agents|mesh-ancestor
65023803|NCT00154778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023804|NCT00154778|Vitamin B Complex|vitamin b complex|mesh-ancestor
65023805|NCT00154778|Vitamins|vitamins|mesh-ancestor
65023806|NCT00154778|Micronutrients|micronutrients|mesh-ancestor
65023807|NCT02919202|Listerine|listerine|mesh-list
65023808|NCT02919202|Fluorides|fluorides|mesh-list
65023809|NCT02919202|Sodium Fluoride|sodium fluoride|mesh-list
65023810|NCT02919202|Fluorides, Topical|fluorides, topical|mesh-list
65023811|NCT02919202|Cariostatic Agents|cariostatic agents|mesh-ancestor
65023812|NCT02919202|Protective Agents|protective agents|mesh-ancestor
65023813|NCT02919202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023814|NCT02919202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65023815|NCT02919202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65023816|NCT00154895|Minocycline|minocycline|mesh-list
65023817|NCT00154895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64577980|NCT03086993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65023828|NCT02918812|Sensory System Agents|sensory system agents|mesh-ancestor
65023829|NCT02918812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65023830|NCT02918812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65023831|NCT02918812|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65023832|NCT02918812|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65023833|NCT02918812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65023834|NCT02918812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023835|NCT02918812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65023836|NCT02918812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65023837|NCT02918812|Analgesics|analgesics|mesh-ancestor
65023838|NCT02918812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65023839|NCT02918812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65023840|NCT02918812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65023841|NCT02918812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023842|NCT02918110|Misoprostol|misoprostol|mesh-list
65023843|NCT02918110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65023844|NCT02918110|Abortifacient Agents|abortifacient agents|mesh-ancestor
65023845|NCT02918110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65023846|NCT02918110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023847|NCT02918110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65023848|NCT02918110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65023849|NCT02918110|Oxytocics|oxytocics|mesh-ancestor
65023850|NCT00181272|Azithromycin|azithromycin|mesh-list
65023851|NCT00181272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65023852|NCT00181272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65023853|NCT02910076|Hydroxychloroquine|hydroxychloroquine|mesh-list
65023873|NCT00188565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65023874|NCT00188565|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65023875|NCT00188565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65023876|NCT00188565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465169|NCT04123210|Vitamins|vitamins|mesh-ancestor
65023877|NCT00188565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023878|NCT00155246|Pentoxifylline|pentoxifylline|mesh-list
65023879|NCT00155246|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65023880|NCT00155246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65023881|NCT00155246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023882|NCT00155246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65023883|NCT00155246|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65023884|NCT00155246|Protective Agents|protective agents|mesh-ancestor
65023885|NCT00155246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023886|NCT00155246|Vasodilator Agents|vasodilator agents|mesh-ancestor
65023887|NCT00155246|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65023888|NCT00155246|Antioxidants|antioxidants|mesh-ancestor
65023889|NCT02909413|Sevoflurane|sevoflurane|mesh-list
65023890|NCT02909413|Desflurane|desflurane|mesh-list
65023894|NCT02909413|Anesthetics|anesthetics|mesh-ancestor
65023927|NCT00188604|Trace Elements|trace elements|mesh-ancestor
65023928|NCT00188604|Micronutrients|micronutrients|mesh-ancestor
65023929|NCT00188604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023930|NCT04865029|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65023931|NCT04865029|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65023932|NCT04865029|Estradiol|estradiol|mesh-list
65023933|NCT04865029|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65023934|NCT04865029|Progesterone|progesterone|mesh-list
65023935|NCT04865029|Estrogens|estrogens|mesh-ancestor
65023936|NCT04865029|Hormones|hormones|mesh-ancestor
65023937|NCT04865029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65023938|NCT04865029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023939|NCT04865029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65023940|NCT04865029|Contraceptive Agents|contraceptive agents|mesh-ancestor
65023941|NCT04865029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65023942|NCT04865029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65023943|NCT04865029|Progestins|progestins|mesh-ancestor
65023944|NCT00155402|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65023945|NCT00155402|Hemostatics|hemostatics|mesh-ancestor
65023946|NCT00155402|Coagulants|coagulants|mesh-ancestor
65023947|NCT04808323|Capecitabine|capecitabine|mesh-list
65023948|NCT04808323|Oxaliplatin|oxaliplatin|mesh-list
65023949|NCT04808323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65023950|NCT04808323|Antimetabolites|antimetabolites|mesh-ancestor
65023951|NCT04808323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023952|NCT04808323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023975|NCT00533299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65023976|NCT00533299|GABA Agents|gaba agents|mesh-ancestor
65023977|NCT00533299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65023978|NCT00533299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023979|NCT00533299|Antimanic Agents|antimanic agents|mesh-ancestor
65023980|NCT00533299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65023981|NCT00533299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65023982|NCT00533299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65023983|NCT00533299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65023984|NCT00533299|Vasodilator Agents|vasodilator agents|mesh-ancestor
65023985|NCT04788823|Prednisone|prednisone|mesh-list
65023986|NCT04788823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65023987|NCT04788823|Glucocorticoids|glucocorticoids|mesh-ancestor
65023988|NCT04788823|Hormones|hormones|mesh-ancestor
65023989|NCT04788823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65023990|NCT04788823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493846|NCT04233866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65023991|NCT04788823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65023993|NCT00181584|Zoledronic Acid|zoledronic acid|mesh-list
65023994|NCT00181584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65023995|NCT00181584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65023996|NCT04696042|Lanreotide|lanreotide|mesh-list
65023997|NCT04696042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65023998|NCT00181662|Curcumin|curcumin|mesh-list
65023999|NCT00181662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65024000|NCT00181662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65024001|NCT00181662|Analgesics|analgesics|mesh-ancestor
65024002|NCT00181662|Sensory System Agents|sensory system agents|mesh-ancestor
65024003|NCT00181662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65024004|NCT00181662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024005|NCT00181662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65024006|NCT00181662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65024007|NCT00181662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024008|NCT00181662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024010|NCT00533416|ON 01910|on 01910|mesh-list
65024014|NCT00533416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024015|NCT00155558|Leucovorin|leucovorin|mesh-list
65024016|NCT00155558|Fluorouracil|fluorouracil|mesh-list
65024017|NCT00155558|Antimetabolites|antimetabolites|mesh-ancestor
65024018|NCT00155558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024019|NCT00155558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65024020|NCT00155558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024021|NCT00155558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65024022|NCT00155558|Immunologic Factors|immunologic factors|mesh-ancestor
65024023|NCT00155558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024024|NCT00155558|Antidotes|antidotes|mesh-ancestor
65024025|NCT00155558|Protective Agents|protective agents|mesh-ancestor
65024026|NCT00155558|Vitamin B Complex|vitamin b complex|mesh-ancestor
65024027|NCT00155558|Vitamins|vitamins|mesh-ancestor
65024028|NCT00155558|Micronutrients|micronutrients|mesh-ancestor
65024029|NCT00533455|Gabapentin|gabapentin|mesh-list
65024030|NCT00533455|Analgesics|analgesics|mesh-ancestor
65024031|NCT00533455|Sensory System Agents|sensory system agents|mesh-ancestor
65024032|NCT00533455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65024033|NCT00533455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024034|NCT00533455|Anticonvulsants|anticonvulsants|mesh-ancestor
65024035|NCT00533455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65024036|NCT00533455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65024037|NCT00533455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65024038|NCT00533455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65024039|NCT00533455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65024040|NCT00533455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65024041|NCT00533455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65024042|NCT00533455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024043|NCT00533455|Antimanic Agents|antimanic agents|mesh-ancestor
65024044|NCT00533533|Docetaxel|docetaxel|mesh-list
65024045|NCT00533533|Oxaliplatin|oxaliplatin|mesh-list
65024046|NCT00533533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024047|NCT00533533|Tubulin Modulators|tubulin modulators|mesh-ancestor
65024048|NCT00533533|Antimitotic Agents|antimitotic agents|mesh-ancestor
65024054|NCT00533611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65024055|NCT00533611|Antimetabolites|antimetabolites|mesh-ancestor
65024056|NCT00533611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65024057|NCT00533611|Vasodilator Agents|vasodilator agents|mesh-ancestor
65024058|NCT00533611|Vitamin B Complex|vitamin b complex|mesh-ancestor
65024059|NCT00533611|Vitamins|vitamins|mesh-ancestor
65024060|NCT00533611|Micronutrients|micronutrients|mesh-ancestor
65024061|NCT04575844|Liraglutide|liraglutide|mesh-list
65024062|NCT04575844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65024063|NCT04575844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024064|NCT04575844|Incretins|incretins|mesh-ancestor
65024065|NCT04575844|Hormones|hormones|mesh-ancestor
65066959|NCT00273065|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65024066|NCT04575844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65024115|NCT00533923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024116|NCT00533923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65024117|NCT00533923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65024118|NCT00533923|Alkylating Agents|alkylating agents|mesh-ancestor
65024119|NCT00533923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024120|NCT00533923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024121|NCT00533923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65024122|NCT00533923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024123|NCT00533923|Antifungal Agents|antifungal agents|mesh-ancestor
65024124|NCT00533923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65024125|NCT00533923|Dermatologic Agents|dermatologic agents|mesh-ancestor
65024126|NCT00533923|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65024127|NCT00533923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65024128|NCT00409227|Alfuzosin|alfuzosin|mesh-list
65024129|NCT00409227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
65024130|NCT00409227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65024131|NCT00409227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65024132|NCT00409227|Adrenergic Agents|adrenergic agents|mesh-ancestor
65024133|NCT00409227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65024134|NCT00409227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024135|NCT00409227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024136|NCT00409227|Urological Agents|urological agents|mesh-ancestor
65024137|NCT00533962|Anecortave|anecortave|mesh-list
65024138|NCT00533962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65024139|NCT00533962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65024140|NCT00533962|Growth Substances|growth substances|mesh-ancestor
65024141|NCT00533962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024142|NCT00533962|Growth Inhibitors|growth inhibitors|mesh-ancestor
65024143|NCT00533962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024157|NCT00181818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024158|NCT04462627|Antibodies|antibodies|mesh-list
65024159|NCT04462627|Immunologic Factors|immunologic factors|mesh-ancestor
65024160|NCT04462627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024161|NCT00406601|Sorafenib|sorafenib|mesh-list
65024162|NCT00406601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024163|NCT00406601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65024164|NCT00406601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024165|NCT00406601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024166|NCT00409305|Betahistine|betahistine|mesh-list
65024167|NCT00409305|Vasodilator Agents|vasodilator agents|mesh-ancestor
65024168|NCT00409305|Histamine Agonists|histamine agonists|mesh-ancestor
65024169|NCT00409305|Histamine Agents|histamine agents|mesh-ancestor
65024173|NCT00406679|Acetaminophen|acetaminophen|mesh-list
65024220|NCT00181935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024221|NCT00181935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024222|NCT00181935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65024223|NCT00181935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65024224|NCT00181935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65024225|NCT00181935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65024226|NCT00181935|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65024227|NCT00181935|Dopamine Agents|dopamine agents|mesh-ancestor
65024228|NCT00181935|Antiemetics|antiemetics|mesh-ancestor
65024229|NCT00181935|Autonomic Agents|autonomic agents|mesh-ancestor
65024230|NCT00181935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65024231|NCT00181935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65024232|NCT00181935|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65024233|NCT00181935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65024234|NCT00181935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65024235|NCT00409383|Paclitaxel|paclitaxel|mesh-list
65024236|NCT00409383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65024237|NCT00409383|Temozolomide|temozolomide|mesh-list
65024238|NCT00409383|Oblimersen|oblimersen|mesh-list
65024240|NCT00409383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024275|NCT02500147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65024276|NCT02500147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024277|NCT00182013|Olanzapine|olanzapine|mesh-list
65024278|NCT00182013|Risperidone|risperidone|mesh-list
65024279|NCT00182013|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65024280|NCT00182013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65024281|NCT00182013|Serotonin Agents|serotonin agents|mesh-ancestor
65024282|NCT00182013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65024283|NCT00182013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024284|NCT00182013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024285|NCT00182013|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65024286|NCT00182013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65024287|NCT00182013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65024288|NCT00182013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65024289|NCT00182013|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65024290|NCT00182013|Dopamine Agents|dopamine agents|mesh-ancestor
65024291|NCT00182013|Antiemetics|antiemetics|mesh-ancestor
65024292|NCT00182013|Autonomic Agents|autonomic agents|mesh-ancestor
65024293|NCT00182013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65024294|NCT00182013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65024295|NCT00182013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65024296|NCT00182013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65024297|NCT00182013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65024298|NCT00182013|Antidepressive Agents|antidepressive agents|mesh-ancestor
65024299|NCT00182052|Rosiglitazone|rosiglitazone|mesh-list
65024300|NCT00182052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65024325|NCT02081755|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65024326|NCT02081755|Antitubercular Agents|antitubercular agents|mesh-ancestor
65024327|NCT02081755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65024328|NCT02081755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65024329|NCT02081755|Antimetabolites|antimetabolites|mesh-ancestor
65024330|NCT02081755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65024331|NCT02081755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65024333|NCT01715974|Sargramostim|sargramostim|mesh-list
65024334|NCT01715974|Immunologic Factors|immunologic factors|mesh-ancestor
65024335|NCT01715974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024336|NCT01715974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024337|NCT01413100|Mycophenolic Acid|mycophenolic acid|mesh-list
65024338|NCT01413100|Plerixafor|plerixafor|mesh-list
65024339|NCT01413100|Cyclophosphamide|cyclophosphamide|mesh-list
65024340|NCT01413100|Thymoglobulin|thymoglobulin|mesh-list
65024341|NCT01413100|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65024342|NCT01413100|Lenograstim|lenograstim|mesh-list
65024343|NCT01413100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65024344|NCT01413100|Immunologic Factors|immunologic factors|mesh-ancestor
65024345|NCT01413100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024346|NCT01413100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65024362|NCT05471479|Charcoal|charcoal|mesh-list
65024380|NCT05471050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65024381|NCT05471050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024382|NCT05470972|Ethanol|ethanol|mesh-list
65024383|NCT05470972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65024384|NCT05470972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65024385|NCT05470972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65024386|NCT05470972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024387|NCT04686058|Midazolam|midazolam|mesh-list
65024388|NCT04686058|Meperidine|meperidine|mesh-list
65024389|NCT04686058|Propofol|propofol|mesh-list
65024390|NCT04686058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65024391|NCT04686058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65024392|NCT04686058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024393|NCT04686058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65024394|NCT04686058|Anesthetics, General|anesthetics, general|mesh-ancestor
65024395|NCT04686058|Anesthetics|anesthetics|mesh-ancestor
65024396|NCT04686058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65024397|NCT04686058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65024398|NCT04686058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65024399|NCT04686058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65024400|NCT04686058|GABA Modulators|gaba modulators|mesh-ancestor
64480149|NCT01802437|Fluoxetine|fluoxetine|mesh-list
65024401|NCT04686058|GABA Agents|gaba agents|mesh-ancestor
65024402|NCT04686058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65024403|NCT04686058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024404|NCT04686058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65024406|NCT04686058|Analgesics|analgesics|mesh-ancestor
65024407|NCT04686058|Sensory System Agents|sensory system agents|mesh-ancestor
65024408|NCT04686058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65024409|NCT00156299|Dexamethasone|dexamethasone|mesh-list
65024410|NCT00156299|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
65024411|NCT00156299|Choline|choline|mesh-list
65024412|NCT00156299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65024413|NCT00156299|Antiemetics|antiemetics|mesh-ancestor
65024414|NCT00156299|Autonomic Agents|autonomic agents|mesh-ancestor
65024421|NCT00156299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65024422|NCT00156299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024423|NCT00156299|Lipotropic Agents|lipotropic agents|mesh-ancestor
65024424|NCT00156299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65024425|NCT00156299|Antimetabolites|antimetabolites|mesh-ancestor
65024426|NCT00156299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024427|NCT00156299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65024428|NCT00156299|Nootropic Agents|nootropic agents|mesh-ancestor
65024429|NCT00156299|Analgesics|analgesics|mesh-ancestor
65024430|NCT00156299|Sensory System Agents|sensory system agents|mesh-ancestor
65024431|NCT00156299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65024432|NCT00156299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65024433|NCT00156299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65024434|NCT00535951|Panobinostat|panobinostat|mesh-list
65024435|NCT00535951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024436|NCT00535951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65024437|NCT00535951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024438|NCT00535951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024439|NCT00188955|Sirolimus|sirolimus|mesh-list
65024440|NCT00188955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65024441|NCT00188955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65024442|NCT00188955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65024443|NCT00188955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024444|NCT00188955|Antifungal Agents|antifungal agents|mesh-ancestor
65024445|NCT00188955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65024446|NCT00188955|Immunologic Factors|immunologic factors|mesh-ancestor
65024447|NCT00188955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024448|NCT00536068|Acetaminophen|acetaminophen|mesh-list
65024449|NCT00536068|Aspirin|aspirin|mesh-list
65024450|NCT00536068|Diclofenac|diclofenac|mesh-list
65024451|NCT00536068|Naproxen|naproxen|mesh-list
65024453|NCT00536068|Analgesics|analgesics|mesh-ancestor
64578621|NCT00048737|Antimetabolites|antimetabolites|mesh-ancestor
65024465|NCT00536068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64578622|NCT01604109|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
65024466|NCT00536068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65024467|NCT00536068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65024468|NCT05470582|Vaccines|vaccines|mesh-list
65024469|NCT05470582|Immunologic Factors|immunologic factors|mesh-ancestor
65024470|NCT05470582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024471|NCT00156377|Mupirocin|mupirocin|mesh-list
65024472|NCT00156377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65024473|NCT00156377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65024474|NCT00156377|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64480223|NCT01571128|Tenofovir|tenofovir|mesh-list
65024475|NCT00156377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024476|NCT00156377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024477|NCT00188994|Insulin|insulin|mesh-list
65024478|NCT00188994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65024479|NCT00188994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024480|NCT05469880|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65024481|NCT05469880|Dermatologic Agents|dermatologic agents|mesh-ancestor
65024482|NCT00408525|Donepezil|donepezil|mesh-list
65024483|NCT00408525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65024484|NCT00408525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024485|NCT00408525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024486|NCT00408525|Cholinergic Agents|cholinergic agents|mesh-ancestor
65024487|NCT00408525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65024488|NCT00408525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024489|NCT00408525|Nootropic Agents|nootropic agents|mesh-ancestor
65024490|NCT05469529|Dexmedetomidine|dexmedetomidine|mesh-list
65024491|NCT05469529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65024492|NCT05469529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65024493|NCT05469529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024494|NCT05469529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65024495|NCT05469529|Analgesics|analgesics|mesh-ancestor
65024496|NCT05469529|Sensory System Agents|sensory system agents|mesh-ancestor
65024497|NCT05469529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65024498|NCT05469529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65024501|NCT05469529|Adrenergic Agents|adrenergic agents|mesh-ancestor
65024502|NCT05469529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65024503|NCT05469529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024504|NCT00189033|Psyllium|psyllium|mesh-list
65024505|NCT00189033|Cathartics|cathartics|mesh-ancestor
65024506|NCT00189033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65024507|NCT05469061|Cisplatin|cisplatin|mesh-list
65024508|NCT05469061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024509|NCT05469022|Lazertinib|lazertinib|mesh-list
65024510|NCT05469022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65024511|NCT05469022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024512|NCT05469022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024513|NCT00189072|Gabapentin|gabapentin|mesh-list
65024514|NCT00189072|Analgesics|analgesics|mesh-ancestor
65024515|NCT00189072|Sensory System Agents|sensory system agents|mesh-ancestor
65024516|NCT00189072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65024518|NCT00189072|Anticonvulsants|anticonvulsants|mesh-ancestor
65024558|NCT00536419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65024559|NCT00189150|Mycophenolic Acid|mycophenolic acid|mesh-list
65024560|NCT00189150|Valganciclovir|valganciclovir|mesh-list
65024561|NCT00189150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65024562|NCT00189150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024563|NCT00189150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65024564|NCT00189150|Antitubercular Agents|antitubercular agents|mesh-ancestor
65024565|NCT00189150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65024566|NCT00189150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65024567|NCT00189150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024568|NCT00189150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024569|NCT00189150|Antiviral Agents|antiviral agents|mesh-ancestor
65024570|NCT00156689|Levetiracetam|levetiracetam|mesh-list
65024571|NCT00156689|Anticonvulsants|anticonvulsants|mesh-ancestor
65024572|NCT00156689|Nootropic Agents|nootropic agents|mesh-ancestor
65024573|NCT00536614|Cetuximab|cetuximab|mesh-list
65024574|NCT00536614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65024575|NCT00536614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024576|NCT05468203|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65024577|NCT05468203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024578|NCT05468203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65024579|NCT05468203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024580|NCT05468164|Omeprazole|omeprazole|mesh-list
65024581|NCT05468164|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65024582|NCT05468164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65024583|NCT05468164|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65024584|NCT05468164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024585|NCT05468164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024586|NCT05468047|Ketamine|ketamine|mesh-list
65024587|NCT05468047|Analgesics|analgesics|mesh-ancestor
65024588|NCT05468047|Sensory System Agents|sensory system agents|mesh-ancestor
65024589|NCT05468047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65024590|NCT05468047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024591|NCT05468047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65024592|NCT05468047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65024593|NCT05468047|Anesthetics, General|anesthetics, general|mesh-ancestor
65024594|NCT05468047|Anesthetics|anesthetics|mesh-ancestor
65024595|NCT05468047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65024596|NCT05468047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65024597|NCT05468047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65024598|NCT05468047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65024599|NCT05468047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024600|NCT00182364|Heparin|heparin|mesh-list
65024601|NCT00182364|Calcium heparin|calcium heparin|mesh-list
65024602|NCT00182364|Dalteparin|dalteparin|mesh-list
65024603|NCT00182364|Tinzaparin|tinzaparin|mesh-list
65024604|NCT00182364|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65024605|NCT00182364|Anticoagulants|anticoagulants|mesh-ancestor
65024606|NCT00182364|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65024610|NCT00536653|Vitamin D|vitamin d|mesh-list
65024660|NCT00182442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65024661|NCT00182442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024662|NCT00182442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65024663|NCT00182442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65024664|NCT00182442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65024665|NCT00182442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65024666|NCT00182442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65024667|NCT00182442|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65024668|NCT00182442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65024669|NCT00182442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65024670|NCT00182442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024671|NCT00182442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65024672|NCT00182442|Serotonin Agents|serotonin agents|mesh-ancestor
65024673|NCT00182442|Antidepressive Agents|antidepressive agents|mesh-ancestor
65024674|NCT00536770|Calcitriol|calcitriol|mesh-list
65024675|NCT00536770|Gemcitabine|gemcitabine|mesh-list
65024676|NCT00536770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65024677|NCT00536770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65024678|NCT00536770|Antimetabolites|antimetabolites|mesh-ancestor
65024679|NCT00536770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024680|NCT00536770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024681|NCT00536770|Antiviral Agents|antiviral agents|mesh-ancestor
65024682|NCT00536770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65024683|NCT00536770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024684|NCT00536770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65024685|NCT00536770|Immunologic Factors|immunologic factors|mesh-ancestor
65024686|NCT00536770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024687|NCT00536770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65024688|NCT00536770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65024689|NCT00536770|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65024690|NCT00536770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65024701|NCT04685512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466007|NCT02531308|Metformin|metformin|mesh-list
65024702|NCT04685512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024704|NCT04685512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65024705|NCT00157040|Factor VIII|factor viii|mesh-list
65024706|NCT00157040|Coagulants|coagulants|mesh-ancestor
65024707|NCT00189384|Gentamicins|gentamicins|mesh-list
65024708|NCT00189384|Ceftriaxone|ceftriaxone|mesh-list
65024709|NCT00189384|Penicillins|penicillins|mesh-list
65024710|NCT00189384|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65024711|NCT00189384|Penicillin G Procaine|penicillin g procaine|mesh-list
65024712|NCT00189384|Penicillin G|penicillin g|mesh-list
65024713|NCT00189384|Penicillin G Benzathine|penicillin g benzathine|mesh-list
65024714|NCT00189384|Procaine|procaine|mesh-list
65024715|NCT00189384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65024716|NCT00189384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65024717|NCT00189384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65024721|NCT00189384|Renal Agents|renal agents|mesh-ancestor
65024759|NCT00157235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65024760|NCT00157235|Autonomic Agents|autonomic agents|mesh-ancestor
65024761|NCT00157235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65024762|NCT00157235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024763|NCT00157235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65024764|NCT00157235|Respiratory System Agents|respiratory system agents|mesh-ancestor
65024765|NCT00157235|Parasympatholytics|parasympatholytics|mesh-ancestor
65024766|NCT00157235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65024767|NCT00157235|Cholinergic Agents|cholinergic agents|mesh-ancestor
65024768|NCT00157235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65024769|NCT00157235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024770|NCT00157235|Anticonvulsants|anticonvulsants|mesh-ancestor
65024771|NCT00182520|Topiramate|topiramate|mesh-list
65024772|NCT00182520|Anticonvulsants|anticonvulsants|mesh-ancestor
65024773|NCT00182520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65024774|NCT00182520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024775|NCT00157274|Alemtuzumab|alemtuzumab|mesh-list
65024776|NCT00157274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65024777|NCT00157274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024778|NCT04257487|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
65024779|NCT04257487|Anticoagulants|anticoagulants|mesh-ancestor
65024780|NCT04257487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65024781|NCT04257487|Antimetabolites|antimetabolites|mesh-ancestor
65024782|NCT04257487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024783|NCT04257487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65024784|NCT04257487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65024785|NCT04257487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65024786|NCT04257487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65024787|NCT04257487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024788|NCT00182559|Cyclosporine|cyclosporine|mesh-list
65024789|NCT00182559|Tacrolimus|tacrolimus|mesh-list
65024790|NCT00182559|Cyclosporins|cyclosporins|mesh-list
65024791|NCT00182559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65024792|NCT00182559|Immunologic Factors|immunologic factors|mesh-ancestor
65024799|NCT00182559|Dermatologic Agents|dermatologic agents|mesh-ancestor
65024800|NCT00182559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65024801|NCT00425568|Testosterone|testosterone|mesh-list
65024802|NCT00425568|Androgens|androgens|mesh-ancestor
65024803|NCT00425568|Hormones|hormones|mesh-ancestor
65024804|NCT00425568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65024805|NCT00425568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024806|NCT00157508|Nitroaspirin|nitroaspirin|mesh-list
65024807|NCT00157508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65024808|NCT00157508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65024809|NCT00157508|Analgesics|analgesics|mesh-ancestor
65024810|NCT00157508|Sensory System Agents|sensory system agents|mesh-ancestor
65024811|NCT00157508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65024812|NCT00157508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024813|NCT00157508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65024814|NCT00157508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65024815|NCT00157508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65024816|NCT00157508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65024817|NCT00157508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024818|NCT00157508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65024819|NCT00157508|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65024820|NCT00157508|Protease Inhibitors|protease inhibitors|mesh-ancestor
65024821|NCT00157508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024822|NCT00189618|Aspirin|aspirin|mesh-list
65024823|NCT00189618|Clopidogrel|clopidogrel|mesh-list
65024824|NCT00189618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65024825|NCT00189618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65024826|NCT00189618|Analgesics|analgesics|mesh-ancestor
65024827|NCT00189618|Sensory System Agents|sensory system agents|mesh-ancestor
65024828|NCT00189618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65024829|NCT00189618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024830|NCT00189618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65024831|NCT00189618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65024832|NCT00189618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65024833|NCT00189618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65024835|NCT00189618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65024836|NCT00189618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65024837|NCT00189618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024838|NCT00189618|Antipyretics|antipyretics|mesh-ancestor
65024839|NCT00189618|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65024840|NCT00189618|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65024841|NCT00189618|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65024842|NCT00189618|Purinergic Agents|purinergic agents|mesh-ancestor
65024843|NCT00189618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65024844|NCT00406796|Ranibizumab|ranibizumab|mesh-list
65024845|NCT00406796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65024846|NCT00406796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65024847|NCT00406796|Growth Substances|growth substances|mesh-ancestor
65024848|NCT00406796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024849|NCT00406796|Growth Inhibitors|growth inhibitors|mesh-ancestor
65024850|NCT00406796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024851|NCT00534391|Polymyxins|polymyxins|mesh-list
65024852|NCT00534391|Neomycin|neomycin|mesh-list
65024854|NCT00534391|Gramicidin|gramicidin|mesh-list
65024855|NCT00534391|Lubricant Eye Drops|lubricant eye drops|mesh-list
65024856|NCT00534391|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65024857|NCT00534391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65024858|NCT00534391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65024859|NCT00534391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65024860|NCT00534391|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65024861|NCT00534391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024862|NCT00534391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024863|NCT00534391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65024864|NCT00534508|Tacrolimus|tacrolimus|mesh-list
65024865|NCT00534508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65024866|NCT00534508|Immunologic Factors|immunologic factors|mesh-ancestor
65024867|NCT00534508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024868|NCT00534508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65024881|NCT00182715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024882|NCT00182715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65024883|NCT00182715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024884|NCT00182715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65024885|NCT00182715|Immunologic Factors|immunologic factors|mesh-ancestor
65024886|NCT00182715|Antidotes|antidotes|mesh-ancestor
65024887|NCT00182715|Protective Agents|protective agents|mesh-ancestor
65024888|NCT00182715|Vitamin B Complex|vitamin b complex|mesh-ancestor
65024889|NCT00182715|Vitamins|vitamins|mesh-ancestor
65024890|NCT00182715|Micronutrients|micronutrients|mesh-ancestor
65024891|NCT00182715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65024892|NCT00534586|Ketamine|ketamine|mesh-list
65024893|NCT00534586|Remifentanil|remifentanil|mesh-list
65024894|NCT00534586|Propofol|propofol|mesh-list
65024895|NCT00534586|Sevoflurane|sevoflurane|mesh-list
65024896|NCT00534586|Esketamine|esketamine|mesh-list
65024897|NCT00534586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65024898|NCT00534586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65024899|NCT00534586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024900|NCT00534586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65024901|NCT00534586|Anesthetics, General|anesthetics, general|mesh-ancestor
65024902|NCT00534586|Anesthetics|anesthetics|mesh-ancestor
65024903|NCT00534586|Analgesics|analgesics|mesh-ancestor
65024904|NCT00534586|Sensory System Agents|sensory system agents|mesh-ancestor
65024905|NCT00534586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65024906|NCT00534586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65024907|NCT00534586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65024908|NCT00534586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65024909|NCT00534586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65024910|NCT00534586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024911|NCT00534586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65024912|NCT00534586|Narcotics|narcotics|mesh-ancestor
65024913|NCT00534586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65024914|NCT00534586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64579040|NCT00054665|Doxorubicin|doxorubicin|mesh-list
64946064|NCT04765709|Vinorelbine|vinorelbine|mesh-list
64946065|NCT04765709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64946066|NCT04765709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946067|NCT04765709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946068|NCT04765709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946069|NCT04765709|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64579076|NCT00476190|Vincristine|vincristine|mesh-list
65024915|NCT00534586|Antidepressive Agents|antidepressive agents|mesh-ancestor
65024916|NCT00534586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65024918|NCT00534625|Hydroxyurea|hydroxyurea|mesh-list
65024919|NCT00534625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65024920|NCT00534625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65024921|NCT00534625|Analgesics|analgesics|mesh-ancestor
65024922|NCT00534625|Sensory System Agents|sensory system agents|mesh-ancestor
65024923|NCT00534625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65024924|NCT00534625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024925|NCT00534625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65024926|NCT00534625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65024927|NCT00534625|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65024928|NCT00534625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024929|NCT00534625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024930|NCT00534625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65024931|NCT00534625|Hormone Antagonists|hormone antagonists|mesh-ancestor
65024932|NCT00534625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65024933|NCT00534625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024934|NCT00534625|Antisickling Agents|antisickling agents|mesh-ancestor
65024935|NCT00534625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65024936|NCT00406874|Folic Acid|folic acid|mesh-list
65024937|NCT00406874|Hematinics|hematinics|mesh-ancestor
65024938|NCT00406874|Vitamin B Complex|vitamin b complex|mesh-ancestor
65024939|NCT00406874|Vitamins|vitamins|mesh-ancestor
65024940|NCT00406874|Micronutrients|micronutrients|mesh-ancestor
65024941|NCT00406874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024942|NCT04106830|Mycophenolic Acid|mycophenolic acid|mesh-list
65024943|NCT04106830|Azathioprine|azathioprine|mesh-list
65024944|NCT04106830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024945|NCT04106830|Immunologic Factors|immunologic factors|mesh-ancestor
65024946|NCT04106830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024947|NCT04106830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65024948|NCT04106830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65024949|NCT04106830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65024954|NCT04106830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024955|NCT04106830|Antimetabolites|antimetabolites|mesh-ancestor
65024956|NCT04106830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65024957|NCT04106830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65024958|NCT00189657|Irinotecan|irinotecan|mesh-list
65024959|NCT00189657|Fluorouracil|fluorouracil|mesh-list
65024960|NCT00189657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65024961|NCT00189657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65024962|NCT00189657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024963|NCT00189657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024964|NCT00189657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65024965|NCT00189657|Antimetabolites|antimetabolites|mesh-ancestor
65024966|NCT00189657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65024967|NCT00189657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65024968|NCT00189657|Immunologic Factors|immunologic factors|mesh-ancestor
65024969|NCT00189657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65024970|NCT00406913|Mupirocin|mupirocin|mesh-list
65024971|NCT00406913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65024972|NCT00406913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65024973|NCT00406913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64898729|NCT02022358|Leucovorin|leucovorin|mesh-list
65024974|NCT00406913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65024975|NCT00406913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024976|NCT00406952|Sertraline|sertraline|mesh-list
65024977|NCT00406952|Antidepressive Agents|antidepressive agents|mesh-ancestor
65024978|NCT00406952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65024979|NCT00406952|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65024980|NCT00406952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65024981|NCT00406952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65024982|NCT00406952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024983|NCT00406952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65024984|NCT00406952|Serotonin Agents|serotonin agents|mesh-ancestor
65024994|NCT04090879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65024995|NCT04090879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65024996|NCT00157547|Fluvoxamine|fluvoxamine|mesh-list
65024997|NCT00157547|Citalopram|citalopram|mesh-list
65024998|NCT00157547|Fluoxetine|fluoxetine|mesh-list
65024999|NCT00157547|Paroxetine|paroxetine|mesh-list
65025000|NCT00157547|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65025001|NCT00157547|Sertraline|sertraline|mesh-list
65025002|NCT00157547|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65025003|NCT00157547|Serotonin|serotonin|mesh-list
65025004|NCT00157547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65025005|NCT00157547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65025006|NCT00157547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025007|NCT00157547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65025008|NCT00157547|Serotonin Agents|serotonin agents|mesh-ancestor
65025009|NCT00157547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025010|NCT00157547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65025011|NCT00157547|Antidepressive Agents|antidepressive agents|mesh-ancestor
65025012|NCT00157547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65025013|NCT00157547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65025014|NCT00157547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65025015|NCT00157547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025016|NCT00157547|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65025017|NCT00157547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65025018|NCT00157547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65025019|NCT00157547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65025020|NCT00157547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65025021|NCT00157547|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65025022|NCT00157547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65025023|NCT04061161|Bromides|bromides|mesh-list
65025024|NCT04061161|Tiotropium Bromide|tiotropium bromide|mesh-list
65025025|NCT04061161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65025034|NCT04061161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65025035|NCT04061161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025036|NCT04061161|Anticonvulsants|anticonvulsants|mesh-ancestor
65025037|NCT00157586|Manidipine|manidipine|mesh-list
65025038|NCT00157586|Delapril|delapril|mesh-list
65025039|NCT00157586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65025040|NCT00157586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65025041|NCT00157586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65025042|NCT00157586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025043|NCT00157586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65025044|NCT00157586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025045|NCT00157586|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65493848|NCT04233866|Antidotes|antidotes|mesh-ancestor
65025046|NCT00157586|Protease Inhibitors|protease inhibitors|mesh-ancestor
65025047|NCT00157586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025048|NCT00182871|Testosterone|testosterone|mesh-list
65025049|NCT00182871|Androgens|androgens|mesh-ancestor
65025050|NCT00182871|Hormones|hormones|mesh-ancestor
65025051|NCT00182871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65025052|NCT00182871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025053|NCT00189774|Nateglinide|nateglinide|mesh-list
65025054|NCT00189774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65025055|NCT00189774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025056|NCT04686643|Niacin|niacin|mesh-list
65025057|NCT04686643|Amlodipine|amlodipine|mesh-list
65025083|NCT00534898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025084|NCT03748810|Metformin|metformin|mesh-list
65025085|NCT03748810|Dapagliflozin|dapagliflozin|mesh-list
65025086|NCT03748810|Empagliflozin|empagliflozin|mesh-list
65025087|NCT03748810|Glimepiride|glimepiride|mesh-list
65025088|NCT03748810|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65025089|NCT03748810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65025090|NCT03748810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025091|NCT03748810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65025092|NCT03748810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025093|NCT03748810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65025094|NCT03748810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65025095|NCT03748810|Immunologic Factors|immunologic factors|mesh-ancestor
65025096|NCT03748810|Protease Inhibitors|protease inhibitors|mesh-ancestor
65025097|NCT03748810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025098|NCT00157859|Chloroquine|chloroquine|mesh-list
65025099|NCT00157859|Pyrimethamine|pyrimethamine|mesh-list
65025100|NCT00157859|Sulfadoxine|sulfadoxine|mesh-list
65025101|NCT00157859|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65025102|NCT00157859|Amebicides|amebicides|mesh-ancestor
65025103|NCT00157859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65025104|NCT00157859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65025105|NCT00157859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65025106|NCT00157859|Antimalarials|antimalarials|mesh-ancestor
65025107|NCT00157859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65025108|NCT00157859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65025109|NCT00157859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025110|NCT00157859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025111|NCT00157859|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65025112|NCT00157859|Renal Agents|renal agents|mesh-ancestor
65025113|NCT00157898|Metronidazole|metronidazole|mesh-list
65025114|NCT00157898|Ceftriaxone|ceftriaxone|mesh-list
65025115|NCT00157898|Ertapenem|ertapenem|mesh-list
65025116|NCT00157898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65025117|NCT00157898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65025118|NCT00157898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65025119|NCT00157898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64946070|NCT04765709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64946071|NCT04765709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64946072|NCT04765709|Immunologic Factors|immunologic factors|mesh-ancestor
65025120|NCT03669523|Denosumab|denosumab|mesh-list
65025121|NCT03669523|Nivolumab|nivolumab|mesh-list
65025122|NCT03669523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65025123|NCT03669523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025124|NCT03669523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65025125|NCT03669523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025126|NCT03669523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65025127|NCT03669523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025128|NCT00157976|Tin etiopurpurin|tin etiopurpurin|mesh-list
65025129|NCT00157976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65025130|NCT00157976|Dermatologic Agents|dermatologic agents|mesh-ancestor
65025131|NCT03522961|Nitrofurantoin|nitrofurantoin|mesh-list
65025132|NCT03522961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65025133|NCT03522961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65025134|NCT03522961|Renal Agents|renal agents|mesh-ancestor
65025135|NCT03522961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65025136|NCT00158093|Moxifloxacin|moxifloxacin|mesh-list
65025137|NCT00158093|Atenolol|atenolol|mesh-list
65025138|NCT00158093|Nebivolol|nebivolol|mesh-list
65025139|NCT00158093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65025140|NCT00158093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65025141|NCT00158093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65025142|NCT00158093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65025143|NCT00158093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025144|NCT00158093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025145|NCT00158093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025146|NCT00158093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025147|NCT00158093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65025148|NCT00158093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65025149|NCT00158093|Sympatholytics|sympatholytics|mesh-ancestor
65025150|NCT00158093|Autonomic Agents|autonomic agents|mesh-ancestor
65025151|NCT00158093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65025163|NCT03429946|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65025164|NCT03429946|Hormone Antagonists|hormone antagonists|mesh-ancestor
65025165|NCT03429946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65025166|NCT03429946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025167|NCT03429946|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65025168|NCT03429946|Diuretics|diuretics|mesh-ancestor
65025169|NCT03429946|Natriuretic Agents|natriuretic agents|mesh-ancestor
65025170|NCT00158132|Amantadine|amantadine|mesh-list
65025171|NCT00158132|Propranolol|propranolol|mesh-list
65025172|NCT00158132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65025173|NCT00158132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65025174|NCT00158132|Adrenergic Agents|adrenergic agents|mesh-ancestor
65025175|NCT00158132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65025176|NCT00158132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025177|NCT00158132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025178|NCT00158132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65025179|NCT00158132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65025190|NCT00158171|Folic Acid|folic acid|mesh-list
64579371|NCT01439204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65025220|NCT03358693|Upadacitinib|upadacitinib|mesh-list
65025221|NCT03358693|Ustekinumab|ustekinumab|mesh-list
65025222|NCT03358693|Ixekizumab|ixekizumab|mesh-list
65025223|NCT03358693|Brodalumab|brodalumab|mesh-list
65025224|NCT03358693|Abrocitinib|abrocitinib|mesh-list
65025225|NCT03358693|Dermatologic Agents|dermatologic agents|mesh-ancestor
65025226|NCT03358693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65025227|NCT03358693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65025228|NCT03358693|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65025229|NCT03358693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65025230|NCT03358693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466531|NCT02223208|Glucocorticoids|glucocorticoids|mesh-ancestor
65025231|NCT03358693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025232|NCT00190008|Piracetam|piracetam|mesh-list
65025233|NCT00190008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65025234|NCT00190008|Protective Agents|protective agents|mesh-ancestor
65025235|NCT00190008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025236|NCT00190008|Nootropic Agents|nootropic agents|mesh-ancestor
65025237|NCT00183222|Naltrexone|naltrexone|mesh-list
65025238|NCT00183222|Ondansetron|ondansetron|mesh-list
65025239|NCT00183222|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65025240|NCT00183222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65025241|NCT00183222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025242|NCT00183222|Sensory System Agents|sensory system agents|mesh-ancestor
65025243|NCT00183222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65025244|NCT00183222|Antiemetics|antiemetics|mesh-ancestor
65025245|NCT00183222|Autonomic Agents|autonomic agents|mesh-ancestor
65025246|NCT00183222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65025247|NCT00183222|Antipruritics|antipruritics|mesh-ancestor
65025248|NCT00183222|Dermatologic Agents|dermatologic agents|mesh-ancestor
65025249|NCT00183222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65025250|NCT00183222|Serotonin Agents|serotonin agents|mesh-ancestor
65025251|NCT00183222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65025252|NCT00183222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946073|NCT04765709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946074|NCT04765709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64946075|NCT04765709|Tubulin Modulators|tubulin modulators|mesh-ancestor
64946076|NCT04765709|Antimitotic Agents|antimitotic agents|mesh-ancestor
64946077|NCT04765709|Mitosis Modulators|mitosis modulators|mesh-ancestor
64946078|NCT04752059|Trastuzumab|trastuzumab|mesh-list
64946079|NCT04752059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64946080|NCT04752059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946081|NCT04742699|Lemborexant|lemborexant|mesh-list
64724807|NCT00000703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65025253|NCT00183222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64579404|NCT01615731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65025254|NCT00183222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65025255|NCT00183222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65025256|NCT00183222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65025257|NCT00183222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65025258|NCT00158405|Ritonavir|ritonavir|mesh-list
65025259|NCT00158405|Indinavir|indinavir|mesh-list
65025260|NCT00158405|Lamivudine|lamivudine|mesh-list
65025261|NCT00158405|Zidovudine|zidovudine|mesh-list
65025262|NCT00158405|Efavirenz|efavirenz|mesh-list
65025263|NCT00158405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65025264|NCT00158405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65025265|NCT00158405|Protease Inhibitors|protease inhibitors|mesh-ancestor
65025266|NCT00158405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025267|NCT00158405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025268|NCT00158405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65025269|NCT00158405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65025270|NCT00158405|Antiviral Agents|antiviral agents|mesh-ancestor
65025271|NCT00158405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65025272|NCT00158405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65025273|NCT00158405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65025274|NCT00158405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65025275|NCT00158405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65025276|NCT00158405|Antimetabolites|antimetabolites|mesh-ancestor
65025277|NCT00158405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65066960|NCT00273065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65025278|NCT00158405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65025279|NCT00158405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65025280|NCT00158405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65025281|NCT00158405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65025282|NCT05275738|Niacinamide|niacinamide|mesh-list
65025284|NCT05275738|Nicotinic Acids|nicotinic acids|mesh-list
65025285|NCT05275738|Vitamin B Complex|vitamin b complex|mesh-ancestor
65025286|NCT05275738|Vitamins|vitamins|mesh-ancestor
64724808|NCT00000703|Immunologic Factors|immunologic factors|mesh-ancestor
64724809|NCT00000703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724817|NCT00000703|Antiemetics|antiemetics|mesh-ancestor
64724818|NCT00000703|Autonomic Agents|autonomic agents|mesh-ancestor
64724819|NCT00000703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64724820|NCT00000703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65025287|NCT05275738|Micronutrients|micronutrients|mesh-ancestor
65025288|NCT05275738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025289|NCT05275738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65025290|NCT05275738|Antimetabolites|antimetabolites|mesh-ancestor
65025291|NCT05275738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025292|NCT05275738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65025293|NCT05275738|Vasodilator Agents|vasodilator agents|mesh-ancestor
65025294|NCT00158483|Acyclovir|acyclovir|mesh-list
65025295|NCT00158483|Antiviral Agents|antiviral agents|mesh-ancestor
65025296|NCT00158483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65025297|NCT00158522|Interferons|interferons|mesh-list
65025298|NCT00158522|Interferon-alpha|interferon-alpha|mesh-list
65025299|NCT00158522|Interferon alpha-2|interferon alpha-2|mesh-list
65025300|NCT00158522|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65025301|NCT00158522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025302|NCT00158522|Antiviral Agents|antiviral agents|mesh-ancestor
65025303|NCT00158522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65025304|NCT00158522|Immunologic Factors|immunologic factors|mesh-ancestor
65025305|NCT00158522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025306|NCT00158561|Pyrimethamine|pyrimethamine|mesh-list
65025307|NCT00158561|Sulfadoxine|sulfadoxine|mesh-list
65025308|NCT00158561|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65025309|NCT00158561|Dapsone|dapsone|mesh-list
65025310|NCT00158561|Chlorproguanil|chlorproguanil|mesh-list
65025311|NCT00158561|Antimalarials|antimalarials|mesh-ancestor
65025312|NCT00158561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65025313|NCT00158561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65025314|NCT00158561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65025315|NCT00158561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65025316|NCT00158561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025336|NCT00538174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65025337|NCT00538174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025338|NCT04724486|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65025339|NCT04724486|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65025340|NCT04724486|Cetrorelix|cetrorelix|mesh-list
65025341|NCT04724486|Menotropins|menotropins|mesh-list
65025342|NCT04724486|Luteolytic Agents|luteolytic agents|mesh-ancestor
65025343|NCT04724486|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65025344|NCT04724486|Contraceptive Agents|contraceptive agents|mesh-ancestor
65025345|NCT04724486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65025346|NCT04724486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025347|NCT04724486|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65025348|NCT04724486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65025349|NCT04724486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025350|NCT04724486|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65025351|NCT04724486|Fertility Agents|fertility agents|mesh-ancestor
65025352|NCT04724486|Hormone Antagonists|hormone antagonists|mesh-ancestor
65025353|NCT04724486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65025354|NCT00538330|Tamoxifen|tamoxifen|mesh-list
65025355|NCT00538330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65025356|NCT00538330|Hormone Antagonists|hormone antagonists|mesh-ancestor
65025358|NCT00538330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025387|NCT00538525|Doxorubicin|doxorubicin|mesh-list
65025388|NCT00538525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025389|NCT00538525|Tubulin Modulators|tubulin modulators|mesh-ancestor
65025390|NCT00538525|Antimitotic Agents|antimitotic agents|mesh-ancestor
65025391|NCT00538525|Mitosis Modulators|mitosis modulators|mesh-ancestor
65025392|NCT00538525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025393|NCT00538525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65025394|NCT00538525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65025395|NCT00538525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65025396|NCT00538525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025397|NCT00538564|Tadalafil|tadalafil|mesh-list
65025398|NCT00538564|Vasodilator Agents|vasodilator agents|mesh-ancestor
65025399|NCT00538564|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65025400|NCT00538564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65025401|NCT00538564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025402|NCT00538564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025403|NCT00538564|Urological Agents|urological agents|mesh-ancestor
65025404|NCT00538603|Paclitaxel|paclitaxel|mesh-list
65025405|NCT00538603|Carboplatin|carboplatin|mesh-list
65025406|NCT00538603|Doxorubicin|doxorubicin|mesh-list
65025407|NCT00538603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65025408|NCT00538603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65025409|NCT00538603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025410|NCT00538603|Tubulin Modulators|tubulin modulators|mesh-ancestor
65025411|NCT00538603|Antimitotic Agents|antimitotic agents|mesh-ancestor
65025412|NCT00538603|Mitosis Modulators|mitosis modulators|mesh-ancestor
65025413|NCT00538603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025414|NCT00538603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65025415|NCT00538603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65025416|NCT00538603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65025417|NCT00538603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025418|NCT00158834|Fluticasone|fluticasone|mesh-list
65025430|NCT00158834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65025431|NCT00158834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65025432|NCT00158834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65025433|NCT00158834|Adrenergic Agents|adrenergic agents|mesh-ancestor
65025434|NCT00158834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65025435|NCT00158834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025437|NCT00538720|Ergocalciferols|ergocalciferols|mesh-list
65025438|NCT00538720|Vitamins|vitamins|mesh-ancestor
65025439|NCT00538720|Micronutrients|micronutrients|mesh-ancestor
65025440|NCT00538720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025441|NCT00538720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65025442|NCT00538720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65025443|NCT00536887|Atorvastatin|atorvastatin|mesh-list
65025444|NCT00536887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65025445|NCT00536887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65025446|NCT00536887|Antimetabolites|antimetabolites|mesh-ancestor
65025447|NCT00536887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025448|NCT00536887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65025449|NCT00536887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65025450|NCT00536887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025451|NCT00158873|Fentanyl|fentanyl|mesh-list
65025452|NCT00158873|Midazolam|midazolam|mesh-list
65025453|NCT00158873|Morphine|morphine|mesh-list
65025454|NCT00158873|Remifentanil|remifentanil|mesh-list
65025455|NCT00158873|Lorazepam|lorazepam|mesh-list
65025456|NCT00158873|Propofol|propofol|mesh-list
65025480|NCT00537121|Leucovorin|leucovorin|mesh-list
65025482|NCT00537121|Irinotecan|irinotecan|mesh-list
65025483|NCT00537121|Vorinostat|vorinostat|mesh-list
65025484|NCT00537121|Calcium|calcium|mesh-list
65025485|NCT00537121|Levoleucovorin|levoleucovorin|mesh-list
65025486|NCT00537121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65025487|NCT00537121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025488|NCT00537121|Antimetabolites|antimetabolites|mesh-ancestor
65025489|NCT00537121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025490|NCT00537121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65025491|NCT00537121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025492|NCT00537121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65025493|NCT00537121|Immunologic Factors|immunologic factors|mesh-ancestor
65025494|NCT00537121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65025495|NCT00537121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65025496|NCT00537121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025497|NCT00537121|Antidotes|antidotes|mesh-ancestor
65025498|NCT00537121|Protective Agents|protective agents|mesh-ancestor
65025499|NCT00537121|Vitamin B Complex|vitamin b complex|mesh-ancestor
65025500|NCT00537121|Vitamins|vitamins|mesh-ancestor
65025501|NCT00537121|Micronutrients|micronutrients|mesh-ancestor
65025502|NCT00537121|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65025503|NCT00406991|Aspirin|aspirin|mesh-list
65025504|NCT00406991|Clopidogrel|clopidogrel|mesh-list
65025505|NCT00406991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65025506|NCT00406991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65025507|NCT00406991|Analgesics|analgesics|mesh-ancestor
65025508|NCT00406991|Sensory System Agents|sensory system agents|mesh-ancestor
65025509|NCT00406991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65025510|NCT00406991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025511|NCT00406991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65025512|NCT00406991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65025513|NCT00406991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65025514|NCT00406991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65025516|NCT00406991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65025524|NCT00406991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65025525|NCT05432947|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65025526|NCT05432947|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65025527|NCT05432947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025528|NCT00158990|Sertraline|sertraline|mesh-list
65025529|NCT00158990|Antidepressive Agents|antidepressive agents|mesh-ancestor
65025530|NCT00158990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65025531|NCT00158990|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65025532|NCT00158990|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65025533|NCT00158990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64481268|NCT01799941|Quinidine|quinidine|mesh-list
65025534|NCT00158990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025535|NCT00158990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65025536|NCT00158990|Serotonin Agents|serotonin agents|mesh-ancestor
65025537|NCT00158990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025538|NCT00537355|Histamine|histamine|mesh-list
65025539|NCT00537355|Histamine Agonists|histamine agonists|mesh-ancestor
65025540|NCT00537355|Histamine Agents|histamine agents|mesh-ancestor
65025541|NCT00537355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65025542|NCT00537355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025543|NCT00537355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025545|NCT00183612|Antiemetics|antiemetics|mesh-ancestor
65025546|NCT00183612|Autonomic Agents|autonomic agents|mesh-ancestor
65025547|NCT00183612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65025548|NCT00183612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025549|NCT00183612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65025550|NCT00183612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65025551|NCT00183612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65025552|NCT00183612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65025553|NCT00183612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65025554|NCT00183612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65025555|NCT00183612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64724821|NCT00000703|Glucocorticoids|glucocorticoids|mesh-ancestor
64724822|NCT00000703|Hormones|hormones|mesh-ancestor
64332358|NCT03027388|LB100|lb100|mesh-list
64946082|NCT04742699|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64946083|NCT04742699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64946094|NCT04667104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64946095|NCT04667104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64946096|NCT04667104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946097|NCT04667104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946098|NCT04667104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65025556|NCT00183612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65025557|NCT00183612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025558|NCT00183612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65025559|NCT00183612|Serotonin Agents|serotonin agents|mesh-ancestor
65025560|NCT05381623|Hemostatics|hemostatics|mesh-list
65025561|NCT05381623|Coagulants|coagulants|mesh-ancestor
65025562|NCT00537472|Bupivacaine|bupivacaine|mesh-list
65025563|NCT00537472|Anesthetics|anesthetics|mesh-list
65025564|NCT00537472|Anesthetics, Local|anesthetics, local|mesh-ancestor
65025565|NCT00537472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65025566|NCT00537472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025567|NCT00537472|Sensory System Agents|sensory system agents|mesh-ancestor
65025568|NCT00537472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65025569|NCT00159107|Acamprosate|acamprosate|mesh-list
65025570|NCT00159107|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65025571|NCT00537550|Methotrexate|methotrexate|mesh-list
65025572|NCT00537550|Vincristine|vincristine|mesh-list
65025573|NCT00537550|Asparaginase|asparaginase|mesh-list
65025574|NCT00537550|Daunorubicin|daunorubicin|mesh-list
65025575|NCT00537550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65025576|NCT00537550|Abortifacient Agents|abortifacient agents|mesh-ancestor
65025577|NCT00537550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65025578|NCT00537550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025579|NCT00537550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65025580|NCT00537550|Antimetabolites|antimetabolites|mesh-ancestor
65025581|NCT00537550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025582|NCT00537550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025583|NCT00537550|Dermatologic Agents|dermatologic agents|mesh-ancestor
65025584|NCT00537550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025585|NCT00537550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65025586|NCT00537550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65025587|NCT00537550|Immunologic Factors|immunologic factors|mesh-ancestor
65025588|NCT00537550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65025589|NCT00537550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65025590|NCT00537550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65025591|NCT00537550|Tubulin Modulators|tubulin modulators|mesh-ancestor
65025595|NCT00537550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64579741|NCT05698524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025596|NCT00537550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65025597|NCT00159146|Pindolol|pindolol|mesh-list
65025598|NCT00159146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65025599|NCT00159146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65025600|NCT00159146|Adrenergic Agents|adrenergic agents|mesh-ancestor
65025601|NCT00159146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65025602|NCT00159146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025603|NCT00159146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025604|NCT00159146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65025605|NCT00159146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65025606|NCT00159146|Serotonin Agents|serotonin agents|mesh-ancestor
65025607|NCT00159146|Vasodilator Agents|vasodilator agents|mesh-ancestor
65025608|NCT00537667|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65025609|NCT00537667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65025610|NCT00538876|Decitabine|decitabine|mesh-list
65025611|NCT00538876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65025612|NCT00538876|Antimetabolites|antimetabolites|mesh-ancestor
64481335|NCT02995720|Antimetabolites|antimetabolites|mesh-ancestor
65025613|NCT00538876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025614|NCT00538876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025615|NCT00538876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025616|NCT00538954|Magnesium Oxide|magnesium oxide|mesh-list
65025617|NCT00538954|Antacids|antacids|mesh-ancestor
65025618|NCT00538954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025619|NCT00538954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65025620|NCT00539071|Risperidone|risperidone|mesh-list
65025621|NCT00539071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65025622|NCT00539071|Serotonin Agents|serotonin agents|mesh-ancestor
65025623|NCT00539071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65025637|NCT00183807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025638|NCT00183807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65025639|NCT00183807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65025640|NCT00183807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025641|NCT00183807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025642|NCT00183807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65025643|NCT00183807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65025644|NCT00183807|Analgesics|analgesics|mesh-ancestor
65025645|NCT00183807|Sensory System Agents|sensory system agents|mesh-ancestor
65025646|NCT00183807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65025647|NCT00183807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025648|NCT00183807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65025649|NCT00183807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65025650|NCT00183807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65025651|NCT00183807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65025652|NCT00539773|Interferons|interferons|mesh-list
65025653|NCT00539773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025654|NCT00539773|Antiviral Agents|antiviral agents|mesh-ancestor
65025655|NCT00539773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65493849|NCT04233866|Protective Agents|protective agents|mesh-ancestor
65025656|NCT00409461|Sirolimus|sirolimus|mesh-list
65025657|NCT00409461|Tacrolimus|tacrolimus|mesh-list
65025658|NCT00409461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65025659|NCT00409461|Immunologic Factors|immunologic factors|mesh-ancestor
65025660|NCT00409461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025661|NCT00409461|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65025662|NCT00409461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025663|NCT00409461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025664|NCT00409461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65025665|NCT00409461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65025666|NCT00409461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65025667|NCT00409461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025668|NCT00409461|Antifungal Agents|antifungal agents|mesh-ancestor
65025669|NCT00539890|Insulin|insulin|mesh-list
65025672|NCT00539968|Docetaxel|docetaxel|mesh-list
65025676|NCT00539968|Antimitotic Agents|antimitotic agents|mesh-ancestor
65025677|NCT00539968|Mitosis Modulators|mitosis modulators|mesh-ancestor
65025678|NCT00539968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025679|NCT00539968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025680|NCT00183846|Irinotecan|irinotecan|mesh-list
65025681|NCT00183846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65025682|NCT00183846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65025683|NCT00183846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025684|NCT00183846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025685|NCT00183846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481436|NCT00704938|Aldesleukin|aldesleukin|mesh-list
65025686|NCT00540085|Rocuronium|rocuronium|mesh-list
65025687|NCT00540085|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65025688|NCT00540085|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65025690|NCT00540085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65025691|NCT00540085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025692|NCT00540202|Lumefantrine|lumefantrine|mesh-list
65025693|NCT00540202|Artemether|artemether|mesh-list
65025694|NCT00540202|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65025695|NCT00540202|Quinine|quinine|mesh-list
65025696|NCT00540202|Antimalarials|antimalarials|mesh-ancestor
65025697|NCT00540202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65025698|NCT00540202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65025699|NCT00540202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65025700|NCT00540202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65025701|NCT00540202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025702|NCT00540202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65025703|NCT00540202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65025704|NCT00540202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65025705|NCT00540202|Analgesics|analgesics|mesh-ancestor
65025706|NCT00540202|Sensory System Agents|sensory system agents|mesh-ancestor
65025707|NCT00183885|Mitomycins|mitomycins|mesh-list
65025708|NCT00183885|Mitomycin|mitomycin|mesh-list
65025709|NCT00183885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025710|NCT00183885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65025716|NCT00540241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025717|NCT00540241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025718|NCT00540241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025719|NCT00540241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65025720|NCT00540241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65025721|NCT00159224|Ritonavir|ritonavir|mesh-list
65025722|NCT00159224|Lopinavir|lopinavir|mesh-list
65025723|NCT00159224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65025724|NCT00159224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65025725|NCT00159224|Protease Inhibitors|protease inhibitors|mesh-ancestor
65025726|NCT00159224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025727|NCT00159224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025728|NCT00159224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65025729|NCT00159224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65025730|NCT00159224|Antiviral Agents|antiviral agents|mesh-ancestor
65025731|NCT00159224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65025732|NCT00159224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65025733|NCT00159224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65025734|NCT00540280|Gemcitabine|gemcitabine|mesh-list
65025735|NCT00540280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025736|NCT00540280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65025737|NCT00540280|Antimetabolites|antimetabolites|mesh-ancestor
65025738|NCT00540280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025739|NCT00540280|Antiviral Agents|antiviral agents|mesh-ancestor
65025740|NCT00540280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65025741|NCT00540280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025742|NCT00540280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65025743|NCT00540280|Immunologic Factors|immunologic factors|mesh-ancestor
65025745|NCT00183924|Carboplatin|carboplatin|mesh-list
64579909|NCT05234307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025761|NCT00159302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65025762|NCT00159302|Respiratory System Agents|respiratory system agents|mesh-ancestor
65025763|NCT00159302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65025764|NCT00159302|Antioxidants|antioxidants|mesh-ancestor
65025765|NCT00159302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025766|NCT00159302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65025767|NCT00159302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65025768|NCT00159302|Vasodilator Agents|vasodilator agents|mesh-ancestor
65025769|NCT00159302|Gasotransmitters|gasotransmitters|mesh-ancestor
65025770|NCT00159302|Protective Agents|protective agents|mesh-ancestor
65025771|NCT00540709|Insulin Glargine|insulin glargine|mesh-list
65025772|NCT00540709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65025773|NCT00540709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025774|NCT00540748|Oxytocin|oxytocin|mesh-list
65025775|NCT00540748|Oxytocics|oxytocics|mesh-ancestor
65025776|NCT00540748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65025777|NCT00540748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025778|NCT00540787|Quinidine|quinidine|mesh-list
65025779|NCT00540787|Amiodarone|amiodarone|mesh-list
65025780|NCT00540787|Sotalol|sotalol|mesh-list
65025781|NCT00540787|Flecainide|flecainide|mesh-list
65025782|NCT00540787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
65025783|NCT00540787|Propafenone|propafenone|mesh-list
65025784|NCT00540787|Dofetilide|dofetilide|mesh-list
65025785|NCT00540787|Cifenline|cifenline|mesh-list
65025786|NCT00540787|Calcium Channel Blockers|calcium channel blockers|mesh-list
65025787|NCT00540787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65025788|NCT00540787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025789|NCT00540787|Vasodilator Agents|vasodilator agents|mesh-ancestor
65025790|NCT00540787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65025791|NCT00540787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64304060|NCT04699058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946099|NCT04667104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64946100|NCT04657016|Tirzepatide|tirzepatide|mesh-list
64946101|NCT04657016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64946102|NCT04657016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946103|NCT04657016|Incretins|incretins|mesh-ancestor
64946104|NCT04657016|Hormones|hormones|mesh-ancestor
64946105|NCT04657016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64946106|NCT04654689|Curcumin|curcumin|mesh-list
64946107|NCT04654689|Resveratrol|resveratrol|mesh-list
64946108|NCT04654689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64946109|NCT04654689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64946110|NCT04654689|Analgesics|analgesics|mesh-ancestor
64579936|NCT00238615|Tubulin Modulators|tubulin modulators|mesh-ancestor
65025792|NCT00540787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025793|NCT00540787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65025794|NCT00540787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65025795|NCT00540787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65025796|NCT00540787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025797|NCT00540787|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65025798|NCT00540787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65025799|NCT00540787|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65025800|NCT00540787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65025801|NCT00540787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65025802|NCT00540787|Adrenergic Agents|adrenergic agents|mesh-ancestor
65025803|NCT00540787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65025804|NCT00540787|Sympatholytics|sympatholytics|mesh-ancestor
65025805|NCT00540787|Autonomic Agents|autonomic agents|mesh-ancestor
65025806|NCT00540787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65025807|NCT00540787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65025808|NCT00540787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65025809|NCT00540787|Antimalarials|antimalarials|mesh-ancestor
65025810|NCT00540787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65025811|NCT00540787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65025812|NCT00540787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65025813|NCT00540787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65025814|NCT00540787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65025815|NCT00540787|Cholinergic Agents|cholinergic agents|mesh-ancestor
65025817|NCT00159380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025818|NCT00159380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025819|NCT00540826|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65025820|NCT00540826|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65025821|NCT00540826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65025822|NCT00540826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65025823|NCT00540826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025824|NCT00540826|Adrenergic Agents|adrenergic agents|mesh-ancestor
65025825|NCT00540826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64579937|NCT00238615|Antimitotic Agents|antimitotic agents|mesh-ancestor
65025826|NCT00540826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025827|NCT00540943|Irinotecan|irinotecan|mesh-list
65025828|NCT00540943|Cetuximab|cetuximab|mesh-list
65025829|NCT00540943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65025830|NCT00540943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65025831|NCT00540943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025832|NCT00540943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025833|NCT00540943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025834|NCT00540943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65025835|NCT00159458|Gemcitabine|gemcitabine|mesh-list
65025836|NCT00159458|Oxaliplatin|oxaliplatin|mesh-list
65025837|NCT00159458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65025838|NCT00159458|Antimetabolites|antimetabolites|mesh-ancestor
65025839|NCT00159458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025840|NCT00159458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025841|NCT00159458|Antiviral Agents|antiviral agents|mesh-ancestor
65025842|NCT00159458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65025843|NCT00159458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025844|NCT00159458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65025845|NCT00159458|Immunologic Factors|immunologic factors|mesh-ancestor
65025846|NCT00159458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025847|NCT00541021|Gemcitabine|gemcitabine|mesh-list
65025848|NCT00541021|Sorafenib|sorafenib|mesh-list
65025849|NCT00541021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65025850|NCT00541021|Antimetabolites|antimetabolites|mesh-ancestor
65025851|NCT00541021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025852|NCT00541021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025853|NCT00541021|Antiviral Agents|antiviral agents|mesh-ancestor
65025854|NCT00541021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65025855|NCT00541021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025856|NCT00541021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65025857|NCT00541021|Immunologic Factors|immunologic factors|mesh-ancestor
65025869|NCT00541138|Hormone Antagonists|hormone antagonists|mesh-ancestor
65025870|NCT00541138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65025871|NCT00541138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025872|NCT00541138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65025873|NCT00541138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65025874|NCT00541138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65025875|NCT00541138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65025876|NCT00541177|Atropine|atropine|mesh-list
65025877|NCT00541177|Tropicamide|tropicamide|mesh-list
65025878|NCT00541177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65025879|NCT00541177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65025880|NCT00541177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65025881|NCT00541177|Autonomic Agents|autonomic agents|mesh-ancestor
65025882|NCT00541177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65025893|NCT00541216|Ephedrine|ephedrine|mesh-list
65025928|NCT00541411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65025929|NCT00541411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65025930|NCT00541411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025931|NCT00541411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65025932|NCT00541489|Naproxen|naproxen|mesh-list
65025933|NCT00541489|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
65025934|NCT00541489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65025935|NCT00541489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65025936|NCT00541489|Analgesics|analgesics|mesh-ancestor
65025937|NCT00541489|Sensory System Agents|sensory system agents|mesh-ancestor
65025938|NCT00541489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65025939|NCT00541489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025940|NCT00541489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65025941|NCT00541489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65025942|NCT00541489|Gout Suppressants|gout suppressants|mesh-ancestor
65025943|NCT00541489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65025944|NCT00541489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025945|NCT00541489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025946|NCT00541489|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65025947|NCT00190437|Amoxicillin|amoxicillin|mesh-list
65025948|NCT00190437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65025949|NCT00190437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65025950|NCT00159575|Metformin|metformin|mesh-list
65025951|NCT00159575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65025952|NCT00159575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025953|NCT00541567|Ibipinabant|ibipinabant|mesh-list
65025954|NCT00541567|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65025955|NCT00541567|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65025956|NCT00541567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65493850|NCT04233866|Vitamin B Complex|vitamin b complex|mesh-ancestor
65025957|NCT00541567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025958|NCT00541567|Hormones|hormones|mesh-ancestor
65025960|NCT00541567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025966|NCT00408798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025967|NCT00408798|Cholinergic Agents|cholinergic agents|mesh-ancestor
65025968|NCT00408798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65025969|NCT00408798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025970|NCT00408798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65025971|NCT00408798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65025972|NCT00541723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65025973|NCT00541723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65025974|NCT00541723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65025975|NCT00541723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025976|NCT00541723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65025977|NCT00541723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65025978|NCT00541723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025979|NCT00541723|Cholinergic Agents|cholinergic agents|mesh-ancestor
65025980|NCT00541723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65025981|NCT00159614|Rolofylline|rolofylline|mesh-list
65025982|NCT00159614|Diuretics|diuretics|mesh-ancestor
65025983|NCT00159614|Natriuretic Agents|natriuretic agents|mesh-ancestor
65025984|NCT00159614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65025985|NCT00541840|Sorafenib|sorafenib|mesh-list
65025986|NCT00541840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025987|NCT00541840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65025988|NCT00541840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65025989|NCT00541840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025990|NCT00190476|Docetaxel|docetaxel|mesh-list
65025991|NCT00190476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65025992|NCT00190476|Tubulin Modulators|tubulin modulators|mesh-ancestor
65025993|NCT00190476|Antimitotic Agents|antimitotic agents|mesh-ancestor
65025994|NCT00190476|Mitosis Modulators|mitosis modulators|mesh-ancestor
65025995|NCT00190476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65025996|NCT00159653|Timolol|timolol|mesh-list
65025997|NCT00159653|Latanoprost|latanoprost|mesh-list
65025998|NCT00159653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64580126|NCT00141739|Etanercept|etanercept|mesh-list
65026004|NCT00159653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65026005|NCT00159653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65026006|NCT00159653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65026007|NCT00159653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65026008|NCT00541918|Propofol|propofol|mesh-list
65026009|NCT00541918|Sevoflurane|sevoflurane|mesh-list
65026010|NCT00541918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65026011|NCT00541918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65026012|NCT00541918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026013|NCT00541918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65026014|NCT00541918|Anesthetics, General|anesthetics, general|mesh-ancestor
65026015|NCT00541918|Anesthetics|anesthetics|mesh-ancestor
65026016|NCT00541918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65026017|NCT00541918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65026018|NCT00190515|Leucovorin|leucovorin|mesh-list
65026019|NCT00190515|Levoleucovorin|levoleucovorin|mesh-list
65026020|NCT00190515|Antidotes|antidotes|mesh-ancestor
65026021|NCT00190515|Protective Agents|protective agents|mesh-ancestor
65026022|NCT00190515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026023|NCT00190515|Vitamin B Complex|vitamin b complex|mesh-ancestor
65026024|NCT00190515|Vitamins|vitamins|mesh-ancestor
65026025|NCT00190515|Micronutrients|micronutrients|mesh-ancestor
65026026|NCT00159692|Amlodipine|amlodipine|mesh-list
65026027|NCT00159692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65026028|NCT00159692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65026029|NCT00159692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65066961|NCT00273065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65026030|NCT00159692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026031|NCT00159692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65026032|NCT00159692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026033|NCT00159692|Vasodilator Agents|vasodilator agents|mesh-ancestor
65026035|NCT00542074|Emollients|emollients|mesh-list
65026048|NCT00542152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026049|NCT00542152|Antifungal Agents|antifungal agents|mesh-ancestor
65026050|NCT00542152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65026051|NCT00542152|Dermatologic Agents|dermatologic agents|mesh-ancestor
65026052|NCT00542152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65026053|NCT00542152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65026054|NCT00542152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65026055|NCT00159731|Pregabalin|pregabalin|mesh-list
65026056|NCT00159731|Analgesics|analgesics|mesh-ancestor
65026057|NCT00159731|Sensory System Agents|sensory system agents|mesh-ancestor
65026058|NCT00159731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65026059|NCT00159731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026060|NCT00159731|Anticonvulsants|anticonvulsants|mesh-ancestor
65026061|NCT00159731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65026062|NCT00159731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65026063|NCT00159731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026064|NCT00159731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65026065|NCT00159731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65026066|NCT00159731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65026067|NCT00159731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65026068|NCT00159731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65026069|NCT00408915|Lisuride|lisuride|mesh-list
65026070|NCT00408915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65026071|NCT00408915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65026072|NCT00408915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65026073|NCT00408915|Serotonin Agents|serotonin agents|mesh-ancestor
65026074|NCT00408915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026075|NCT00408915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026076|NCT00408915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026077|NCT00408915|Dopamine Agonists|dopamine agonists|mesh-ancestor
65026078|NCT00408915|Dopamine Agents|dopamine agents|mesh-ancestor
65026079|NCT00542347|Esomeprazole|esomeprazole|mesh-list
65026080|NCT00542347|Omeprazole|omeprazole|mesh-list
65026081|NCT00542347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65026082|NCT00542347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65026083|NCT00542347|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64304061|NCT04626128|Aflibercept|aflibercept|mesh-list
65026085|NCT00542347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026086|NCT00190554|Cisplatin|cisplatin|mesh-list
65026087|NCT00190554|Fluorouracil|fluorouracil|mesh-list
65026088|NCT00190554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026089|NCT00190554|Antimetabolites|antimetabolites|mesh-ancestor
65026090|NCT00190554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026091|NCT00190554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65026092|NCT00190554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65026093|NCT00190554|Immunologic Factors|immunologic factors|mesh-ancestor
65026094|NCT00190554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026095|NCT00159770|Olanzapine|olanzapine|mesh-list
65026096|NCT00159770|Risperidone|risperidone|mesh-list
65026097|NCT00159770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65026098|NCT00159770|Ziprasidone|ziprasidone|mesh-list
65026099|NCT00159770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65026100|NCT00159770|Serotonin Agents|serotonin agents|mesh-ancestor
65026101|NCT00159770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026102|NCT00159770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026103|NCT00159770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899856|NCT02028689|Metformin|metformin|mesh-list
65026104|NCT00159770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65026105|NCT00159770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65026106|NCT00159770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65026107|NCT00159770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65026108|NCT00159770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65026109|NCT00159770|Dopamine Agents|dopamine agents|mesh-ancestor
65026110|NCT00159770|Antiemetics|antiemetics|mesh-ancestor
65026111|NCT00159770|Autonomic Agents|autonomic agents|mesh-ancestor
65026112|NCT00159770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65026113|NCT00159770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65026114|NCT00159770|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65026116|NCT00159770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65026126|NCT00542893|Dacarbazine|dacarbazine|mesh-list
65026128|NCT00542893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65026129|NCT00542893|Alkylating Agents|alkylating agents|mesh-ancestor
65026130|NCT00542893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026131|NCT00542893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026132|NCT00184041|Cytarabine|cytarabine|mesh-list
65026133|NCT00184041|Prednisone|prednisone|mesh-list
65026134|NCT00184041|Methotrexate|methotrexate|mesh-list
65026135|NCT00184041|Cyclophosphamide|cyclophosphamide|mesh-list
65026136|NCT00184041|Vincristine|vincristine|mesh-list
65026137|NCT00184041|Daunorubicin|daunorubicin|mesh-list
65026138|NCT00184041|Asparaginase|asparaginase|mesh-list
65026139|NCT00184041|Mercaptopurine|mercaptopurine|mesh-list
65026140|NCT00184041|Thioguanine|thioguanine|mesh-list
65026141|NCT00184041|Pegaspargase|pegaspargase|mesh-list
65026142|NCT00184041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65026143|NCT00184041|Glucocorticoids|glucocorticoids|mesh-ancestor
65026144|NCT00184041|Hormones|hormones|mesh-ancestor
65026145|NCT00184041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65026146|NCT00184041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026147|NCT00184041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65026148|NCT00184041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026149|NCT00184041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65026150|NCT00184041|Abortifacient Agents|abortifacient agents|mesh-ancestor
65026151|NCT00184041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65026152|NCT00184041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65026153|NCT00184041|Antimetabolites|antimetabolites|mesh-ancestor
65026154|NCT00184041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026155|NCT00184041|Dermatologic Agents|dermatologic agents|mesh-ancestor
65026156|NCT00184041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026157|NCT00184041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65026158|NCT00184041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65026159|NCT00184041|Immunologic Factors|immunologic factors|mesh-ancestor
65026160|NCT00184041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65026169|NCT00184041|Antiviral Agents|antiviral agents|mesh-ancestor
65026170|NCT00184041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65026171|NCT00184041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65026172|NCT00184041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65026173|NCT00184041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65026174|NCT00543049|Sunitinib|sunitinib|mesh-list
65026175|NCT00543049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026176|NCT00543049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65026177|NCT00543049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65026178|NCT00543049|Growth Substances|growth substances|mesh-ancestor
65026179|NCT00543049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026180|NCT00543049|Growth Inhibitors|growth inhibitors|mesh-ancestor
65026181|NCT00543049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65026182|NCT00543049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026183|NCT00543049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026184|NCT04685005|Caffeine|caffeine|mesh-list
65026185|NCT04685005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65026186|NCT04685005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026187|NCT04685005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65026188|NCT04685005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026189|NCT04685005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026190|NCT04685005|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65026191|NCT04685005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65026192|NCT04685005|Purinergic Agents|purinergic agents|mesh-ancestor
65026193|NCT04685005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026194|NCT00190632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65026195|NCT00190632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65026196|NCT00190632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65026197|NCT00190632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65026210|NCT00543166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467505|NCT04783636|Fertility Agents|fertility agents|mesh-ancestor
65026211|NCT00543205|Oblimersen|oblimersen|mesh-list
65026212|NCT00543205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026213|NCT00159809|Sildenafil Citrate|sildenafil citrate|mesh-list
65026214|NCT00159809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026215|NCT00159809|Vasodilator Agents|vasodilator agents|mesh-ancestor
65026216|NCT00159809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65026217|NCT00159809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65026218|NCT00159809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026219|NCT00159809|Urological Agents|urological agents|mesh-ancestor
65026220|NCT00543244|Interferons|interferons|mesh-list
65026221|NCT00543244|Ribavirin|ribavirin|mesh-list
65026222|NCT00543244|Interferon-alpha|interferon-alpha|mesh-list
65026223|NCT00543244|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65026224|NCT00543244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026225|NCT00543244|Antiviral Agents|antiviral agents|mesh-ancestor
65026226|NCT00543244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65026227|NCT00543244|Antimetabolites|antimetabolites|mesh-ancestor
65026228|NCT00543244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026229|NCT00543244|Immunologic Factors|immunologic factors|mesh-ancestor
65026230|NCT00543244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026231|NCT00190710|Gemcitabine|gemcitabine|mesh-list
65026232|NCT00190710|Carboplatin|carboplatin|mesh-list
65026233|NCT00190710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026234|NCT00190710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65026235|NCT00190710|Antimetabolites|antimetabolites|mesh-ancestor
65026236|NCT00190710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026237|NCT00190710|Antiviral Agents|antiviral agents|mesh-ancestor
65026239|NCT00190710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026254|NCT03456661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65026255|NCT03456661|Adrenergic Agents|adrenergic agents|mesh-ancestor
65026256|NCT03456661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026257|NCT03456661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026258|NCT03456661|Anesthetics, Local|anesthetics, local|mesh-ancestor
65026259|NCT03456661|Anesthetics|anesthetics|mesh-ancestor
65026260|NCT03456544|Vancomycin|vancomycin|mesh-list
65026261|NCT03456544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65026262|NCT03456544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65026263|NCT00159887|Sildenafil Citrate|sildenafil citrate|mesh-list
65026264|NCT00159887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026265|NCT00159887|Vasodilator Agents|vasodilator agents|mesh-ancestor
65026266|NCT00159887|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65026267|NCT00159887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65026268|NCT00159887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026269|NCT00159887|Urological Agents|urological agents|mesh-ancestor
65026270|NCT00543361|Metformin|metformin|mesh-list
65026271|NCT00543361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65026272|NCT00543361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026273|NCT00190788|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
65026274|NCT00190788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65026275|NCT00543634|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65026276|NCT00543634|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65026277|NCT00543634|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65026278|NCT00543634|Contraceptive Agents|contraceptive agents|mesh-ancestor
65026279|NCT00543634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65026280|NCT00543634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026281|NCT00543634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64467584|NCT04782310|Dopamine Agents|dopamine agents|mesh-ancestor
65026282|NCT00543634|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65026283|NCT00543634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65026284|NCT00543634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026285|NCT00543634|Estrogens|estrogens|mesh-ancestor
65026293|NCT00184197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026294|NCT00184197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026295|NCT00543829|Tamoxifen|tamoxifen|mesh-list
65026296|NCT00543829|Docetaxel|docetaxel|mesh-list
65026297|NCT00543829|Doxorubicin|doxorubicin|mesh-list
65026298|NCT00543829|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65026299|NCT00543829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026300|NCT00543829|Tubulin Modulators|tubulin modulators|mesh-ancestor
65026301|NCT00543829|Antimitotic Agents|antimitotic agents|mesh-ancestor
65026302|NCT00543829|Mitosis Modulators|mitosis modulators|mesh-ancestor
65026303|NCT00543829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026304|NCT00543829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65026305|NCT00543829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65026306|NCT00543829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65026307|NCT00543829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026308|NCT00543829|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65026309|NCT00543829|Hormone Antagonists|hormone antagonists|mesh-ancestor
65026310|NCT00543829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65026311|NCT00543829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026312|NCT00543829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65026313|NCT00543829|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65026314|NCT00543829|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65026315|NCT00543829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65026316|NCT00190827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65026317|NCT00190827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65026318|NCT00190827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65026338|NCT00544063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026339|NCT00544063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026340|NCT00544180|Risedronic Acid|risedronic acid|mesh-list
65026341|NCT00544180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65026342|NCT00544180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65026343|NCT00544180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026344|NCT00544180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65026345|NCT00544180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026346|NCT00544180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65026347|NCT00544219|Prednisone|prednisone|mesh-list
65026348|NCT00544219|Cyclophosphamide|cyclophosphamide|mesh-list
65026349|NCT00544219|Rituximab|rituximab|mesh-list
65026350|NCT00544219|Doxorubicin|doxorubicin|mesh-list
65026351|NCT00544219|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65026352|NCT00544219|Vincristine|vincristine|mesh-list
65026353|NCT00544219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65026354|NCT00544219|Immunologic Factors|immunologic factors|mesh-ancestor
65026355|NCT00544219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026356|NCT00544219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65026357|NCT00544219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65026358|NCT00544219|Alkylating Agents|alkylating agents|mesh-ancestor
65026359|NCT00544219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026360|NCT00544219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026361|NCT00544219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65026362|NCT00544219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65026363|NCT00544219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65026364|NCT00544219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65026365|NCT00544219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65026366|NCT00544219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026379|NCT00190866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65026380|NCT00190866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026381|NCT00190866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026382|NCT00190866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026383|NCT00190866|Analgesics|analgesics|mesh-ancestor
65026384|NCT00190866|Sensory System Agents|sensory system agents|mesh-ancestor
65026385|NCT00190866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65026386|NCT00190866|Antidepressive Agents|antidepressive agents|mesh-ancestor
65026387|NCT00190866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65026388|NCT00190866|Dopamine Agents|dopamine agents|mesh-ancestor
65026389|NCT00160160|Eprosartan|eprosartan|mesh-list
65026390|NCT00160160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65026391|NCT00160160|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
65026392|NCT00160160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65026393|NCT00160160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026394|NCT00544570|Cyclophosphamide|cyclophosphamide|mesh-list
65026395|NCT00544570|Melphalan|melphalan|mesh-list
65026397|NCT00544570|Etoposide|etoposide|mesh-list
65026398|NCT00544570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64580592|NCT05535738|Xhance|xhance|mesh-list
65026433|NCT00544687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65026434|NCT00544687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65026435|NCT00544687|Antidepressive Agents|antidepressive agents|mesh-ancestor
65026436|NCT00544687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65026437|NCT00544687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65026438|NCT00544687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65026439|NCT00544687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65026440|NCT00544687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026441|NCT00544687|Adrenergic Agents|adrenergic agents|mesh-ancestor
65026442|NCT00544687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026443|NCT00544687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026444|NCT00160238|Betahistine|betahistine|mesh-list
65026445|NCT00160238|Vasodilator Agents|vasodilator agents|mesh-ancestor
65026446|NCT00160238|Histamine Agonists|histamine agonists|mesh-ancestor
65026447|NCT00160238|Histamine Agents|histamine agents|mesh-ancestor
65026448|NCT00160238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026449|NCT00160238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026450|NCT00160238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026451|NCT00544804|Lapatinib|lapatinib|mesh-list
65026452|NCT00544804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026453|NCT00544804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65026454|NCT00544804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026455|NCT00544804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026456|NCT00160277|Moxonidine|moxonidine|mesh-list
65026457|NCT00160277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65026458|NCT02963181|Melatonin|melatonin|mesh-list
65026459|NCT02963181|Yohimbine|yohimbine|mesh-list
65026460|NCT02963181|Antioxidants|antioxidants|mesh-ancestor
65026461|NCT02963181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026462|NCT02963181|Protective Agents|protective agents|mesh-ancestor
65026463|NCT02963181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026464|NCT02963181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65026465|NCT02963181|Mydriatics|mydriatics|mesh-ancestor
65026466|NCT02963181|Autonomic Agents|autonomic agents|mesh-ancestor
65026467|NCT02963181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65026468|NCT02963181|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65026469|NCT02963181|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65026470|NCT02963181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65026471|NCT02963181|Adrenergic Agents|adrenergic agents|mesh-ancestor
65026472|NCT02963181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026473|NCT02963181|Urological Agents|urological agents|mesh-ancestor
65026474|NCT00544999|Cytarabine|cytarabine|mesh-list
65026475|NCT00544999|Everolimus|everolimus|mesh-list
65026476|NCT00544999|Daunorubicin|daunorubicin|mesh-list
65026477|NCT00544999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65026478|NCT00544999|Antimetabolites|antimetabolites|mesh-ancestor
65026479|NCT00544999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026480|NCT00544999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026481|NCT00544999|Antiviral Agents|antiviral agents|mesh-ancestor
65026482|NCT00544999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65026483|NCT00544999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65026484|NCT00544999|Immunologic Factors|immunologic factors|mesh-ancestor
65026485|NCT00544999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026486|NCT00544999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65026487|NCT00544999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65026488|NCT00544999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65026489|NCT00544999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026490|NCT00160316|Estradiol|estradiol|mesh-list
65026491|NCT00160316|Dydrogesterone|dydrogesterone|mesh-list
65026492|NCT00160316|Estrogens|estrogens|mesh-ancestor
65026493|NCT00160316|Hormones|hormones|mesh-ancestor
65026494|NCT00160316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65026495|NCT00160316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026496|NCT00160316|Progestins|progestins|mesh-ancestor
65026497|NCT00545194|Dinoprostone|dinoprostone|mesh-list
65026498|NCT00545194|Oxytocics|oxytocics|mesh-ancestor
65026499|NCT00545194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65026500|NCT00545194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026501|NCT00190944|Teriparatide|teriparatide|mesh-list
65026502|NCT00190944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65026503|NCT00190944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467809|NCT04769908|Lenvatinib|lenvatinib|mesh-list
65026504|NCT00190944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64580640|NCT00262639|Gabapentin|gabapentin|mesh-list
64580667|NCT01062451|Protease Inhibitors|protease inhibitors|mesh-ancestor
65026507|NCT03456466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026508|NCT03456466|Immunologic Factors|immunologic factors|mesh-ancestor
65026509|NCT03456466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026510|NCT03456466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65026511|NCT00160355|Fludarabine|fludarabine|mesh-list
65026512|NCT00160355|Melphalan|melphalan|mesh-list
65026513|NCT00160355|Thiotepa|thiotepa|mesh-list
65026514|NCT00160355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026515|NCT00160355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026516|NCT00160355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65026517|NCT00160355|Immunologic Factors|immunologic factors|mesh-ancestor
65026518|NCT00160355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026519|NCT00160355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65026520|NCT00160355|Alkylating Agents|alkylating agents|mesh-ancestor
65026521|NCT00160355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65026522|NCT00545311|Glycopyrrolate|glycopyrrolate|mesh-list
65026523|NCT00545311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65026524|NCT00545311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65026525|NCT00545311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65026526|NCT00545311|Cholinergic Agents|cholinergic agents|mesh-ancestor
65026527|NCT00545311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026528|NCT00545311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026529|NCT00545311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026530|NCT00160394|Adapalene|adapalene|mesh-list
65026531|NCT00160394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65026532|NCT00160394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65026533|NCT00160394|Analgesics|analgesics|mesh-ancestor
65026534|NCT00160394|Sensory System Agents|sensory system agents|mesh-ancestor
65026535|NCT00160394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65026536|NCT00160394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026537|NCT00160394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65026538|NCT00160394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65026539|NCT00160394|Dermatologic Agents|dermatologic agents|mesh-ancestor
65026540|NCT00191022|Paroxetine|paroxetine|mesh-list
64946111|NCT04654689|Sensory System Agents|sensory system agents|mesh-ancestor
64946112|NCT04654689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64946113|NCT04654689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946114|NCT04654689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64946115|NCT04654689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65026541|NCT00191022|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65026542|NCT00191022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65026543|NCT00191022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65066962|NCT00273065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026544|NCT00191022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026545|NCT00191022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026546|NCT00191022|Serotonin Agents|serotonin agents|mesh-ancestor
65026547|NCT00191022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026548|NCT00191022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65026549|NCT00191022|Antidepressive Agents|antidepressive agents|mesh-ancestor
65026550|NCT00191022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65026551|NCT00191022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65026552|NCT00191022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65026553|NCT00191022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026554|NCT00545389|Mesalamine|mesalamine|mesh-list
65026555|NCT00545389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65026556|NCT00545389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65026557|NCT00545389|Analgesics|analgesics|mesh-ancestor
65026558|NCT00545389|Sensory System Agents|sensory system agents|mesh-ancestor
65026559|NCT00545389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65026560|NCT00545389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026561|NCT00545389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65026562|NCT00545389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65026563|NCT00545467|Aripiprazole|aripiprazole|mesh-list
65026564|NCT00545467|Antidepressive Agents|antidepressive agents|mesh-ancestor
65026565|NCT00545467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65026584|NCT00545935|Artesunate|artesunate|mesh-list
65026585|NCT00545935|Amodiaquine|amodiaquine|mesh-list
65026586|NCT00545935|Antimalarials|antimalarials|mesh-ancestor
65026587|NCT00545935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65026588|NCT00545935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65026589|NCT00545935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65026590|NCT00545935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026591|NCT00545935|Antiviral Agents|antiviral agents|mesh-ancestor
65026592|NCT00545935|Schistosomicides|schistosomicides|mesh-ancestor
65026593|NCT00545935|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65026594|NCT00545935|Anthelmintics|anthelmintics|mesh-ancestor
65026595|NCT00160511|Levetiracetam|levetiracetam|mesh-list
65026596|NCT00160511|Anticonvulsants|anticonvulsants|mesh-ancestor
65026597|NCT00160511|Nootropic Agents|nootropic agents|mesh-ancestor
65026598|NCT00191061|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65026599|NCT00191061|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65026600|NCT00191061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65026601|NCT00191061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65026602|NCT00191061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026603|NCT00191061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026604|NCT00191061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026605|NCT00191061|Analgesics|analgesics|mesh-ancestor
65026606|NCT00191061|Sensory System Agents|sensory system agents|mesh-ancestor
65026607|NCT00191061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65026608|NCT00191061|Antidepressive Agents|antidepressive agents|mesh-ancestor
65026609|NCT00191061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65026610|NCT00191061|Dopamine Agents|dopamine agents|mesh-ancestor
65026611|NCT00160550|Levetiracetam|levetiracetam|mesh-list
65026612|NCT00160550|Anticonvulsants|anticonvulsants|mesh-ancestor
65026613|NCT00160550|Nootropic Agents|nootropic agents|mesh-ancestor
65026614|NCT00160589|Levocetirizine|levocetirizine|mesh-list
65026615|NCT00160589|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65026629|NCT00546130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026630|NCT00546130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65026631|NCT00546130|Immunologic Factors|immunologic factors|mesh-ancestor
65026632|NCT00546130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026633|NCT00546130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65026634|NCT00546130|Antiviral Agents|antiviral agents|mesh-ancestor
65026635|NCT00546130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65026636|NCT00546130|Interferon Inducers|interferon inducers|mesh-ancestor
65026637|NCT00546130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65026638|NCT00546130|Protective Agents|protective agents|mesh-ancestor
65026639|NCT00191178|Insulin|insulin|mesh-list
65026640|NCT00191178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65026641|NCT00191178|Insulin Glargine|insulin glargine|mesh-list
65026642|NCT00191178|Insulin Lispro|insulin lispro|mesh-list
65026643|NCT00191178|Protamines|protamines|mesh-list
65026644|NCT00191178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65026645|NCT00191178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026646|NCT00191178|Heparin Antagonists|heparin antagonists|mesh-ancestor
65026647|NCT00191178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026648|NCT00191178|Coagulants|coagulants|mesh-ancestor
65026649|NCT00546169|Thrombin|thrombin|mesh-list
65026650|NCT00546169|Hemostatics|hemostatics|mesh-ancestor
65026651|NCT00546169|Coagulants|coagulants|mesh-ancestor
65026652|NCT00160628|Levetiracetam|levetiracetam|mesh-list
65026653|NCT00160628|Anticonvulsants|anticonvulsants|mesh-ancestor
65026654|NCT00160628|Nootropic Agents|nootropic agents|mesh-ancestor
65026655|NCT00546286|Timolol|timolol|mesh-list
65026656|NCT00546286|Dorzolamide|dorzolamide|mesh-list
65026657|NCT00546286|Maleic acid|maleic acid|mesh-list
65026658|NCT00546286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026659|NCT00546286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026660|NCT00546286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65026661|NCT00546286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65026662|NCT00546286|Adrenergic Agents|adrenergic agents|mesh-ancestor
65026663|NCT00546286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026668|NCT00546325|Rimonabant|rimonabant|mesh-list
65026671|NCT00546325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65026672|NCT00546325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026673|NCT00546325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026674|NCT00546325|Hormones|hormones|mesh-ancestor
65026675|NCT00546325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65026676|NCT00546325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026677|NCT00546403|Modafinil|modafinil|mesh-list
65026678|NCT00546403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65026679|NCT00546403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026680|NCT00546403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65026681|NCT00546403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65026682|NCT00546403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65026683|NCT00546403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026684|NCT00546442|Metformin|metformin|mesh-list
65026685|NCT00546442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65026686|NCT00546442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026687|NCT00191256|Gemcitabine|gemcitabine|mesh-list
65026688|NCT00191256|Paclitaxel|paclitaxel|mesh-list
65026689|NCT00191256|Carboplatin|carboplatin|mesh-list
65026690|NCT00191256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65026691|NCT00191256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026692|NCT00191256|Tubulin Modulators|tubulin modulators|mesh-ancestor
65026693|NCT00191256|Antimitotic Agents|antimitotic agents|mesh-ancestor
65026694|NCT00191256|Mitosis Modulators|mitosis modulators|mesh-ancestor
65026720|NCT00160745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65026721|NCT00160745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65026722|NCT00160745|Antimetabolites|antimetabolites|mesh-ancestor
65026723|NCT00160745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026724|NCT00160745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65026725|NCT00160745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65026726|NCT00160745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026727|NCT00546676|Telithromycin|telithromycin|mesh-list
65026728|NCT00546676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65026729|NCT00546676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65026730|NCT00546832|Celecoxib|celecoxib|mesh-list
65026731|NCT00546832|Diclofenac|diclofenac|mesh-list
65026732|NCT00546832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65026733|NCT00546832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65026734|NCT00546832|Analgesics|analgesics|mesh-ancestor
65026735|NCT00546832|Sensory System Agents|sensory system agents|mesh-ancestor
65026736|NCT00546832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65026737|NCT00546832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026776|NCT00184626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65026777|NCT00184626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026778|NCT00547417|Tadalafil|tadalafil|mesh-list
65026779|NCT00547417|Vasodilator Agents|vasodilator agents|mesh-ancestor
65026780|NCT00547417|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65026781|NCT00547417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65026782|NCT00547417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026783|NCT00547417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026784|NCT00547417|Urological Agents|urological agents|mesh-ancestor
65026785|NCT00191295|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65026786|NCT00191295|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65026787|NCT00191295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65026788|NCT00191295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65026789|NCT00191295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026790|NCT00191295|Adrenergic Agents|adrenergic agents|mesh-ancestor
65026791|NCT00191295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026792|NCT00191295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026793|NCT00547495|Tadalafil|tadalafil|mesh-list
65026830|NCT00191373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026831|NCT00191373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65026832|NCT00547612|Substance P|substance p|mesh-list
65026833|NCT00547612|Neurokinin A|neurokinin a|mesh-list
65026834|NCT00547612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026835|NCT00547612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026836|NCT00547612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026837|NCT00547768|Fexofenadine|fexofenadine|mesh-list
65026838|NCT00547768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65026839|NCT00547768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65026840|NCT00547768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65026841|NCT00547768|Histamine Antagonists|histamine antagonists|mesh-ancestor
65026842|NCT00547768|Histamine Agents|histamine agents|mesh-ancestor
65026843|NCT00547768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65026844|NCT00547768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026845|NCT00547768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026846|NCT00184665|Insulin|insulin|mesh-list
65026847|NCT00184665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65026848|NCT00184665|Insulin Aspart|insulin aspart|mesh-list
65026849|NCT00184665|Insulin Detemir|insulin detemir|mesh-list
65026850|NCT00184665|Isophane Insulin, Human|isophane insulin, human|mesh-list
65026851|NCT00184665|Insulin, Isophane|insulin, isophane|mesh-list
65026852|NCT00184665|Isophane insulin, beef|isophane insulin, beef|mesh-list
64580998|NCT01729845|Antimetabolites|antimetabolites|mesh-ancestor
64946116|NCT04654689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946117|NCT04654689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946118|NCT04654689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946119|NCT04654689|Antioxidants|antioxidants|mesh-ancestor
64946120|NCT04654689|Protective Agents|protective agents|mesh-ancestor
64946121|NCT04654689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64946122|NCT04634838|Copper|copper|mesh-list
64946123|NCT04634838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64946124|NCT04634838|Trace Elements|trace elements|mesh-ancestor
64946125|NCT04634838|Micronutrients|micronutrients|mesh-ancestor
64503292|NCT03349008|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
64503293|NCT03349008|Antiviral Agents|antiviral agents|mesh-ancestor
64484982|NCT01702987|Vitamins|vitamins|mesh-ancestor
64946126|NCT04634838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946127|NCT04634838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64946128|NCT04629534|Cholecalciferol|cholecalciferol|mesh-list
64946129|NCT04629534|Vitamin D|vitamin d|mesh-list
64946130|NCT04629534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64332365|NCT03020199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64946131|NCT04629534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946132|NCT04629534|Vitamins|vitamins|mesh-ancestor
64946133|NCT04629534|Micronutrients|micronutrients|mesh-ancestor
64946134|NCT04629534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64946135|NCT04616183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64946136|NCT04616183|Cetuximab|cetuximab|mesh-list
64946137|NCT04616183|Antibodies|antibodies|mesh-list
64946138|NCT04616183|Immunoglobulins|immunoglobulins|mesh-list
64946139|NCT04616183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64946140|NCT04616183|Immunologic Factors|immunologic factors|mesh-ancestor
65026853|NCT00184665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65026854|NCT00184665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026855|NCT04983238|Sodium thiosulfate|sodium thiosulfate|mesh-list
65026856|NCT04983238|Trastuzumab|trastuzumab|mesh-list
65026857|NCT04983238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65026858|NCT04983238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026859|NCT04983238|Antidotes|antidotes|mesh-ancestor
65026860|NCT04983238|Protective Agents|protective agents|mesh-ancestor
65026861|NCT04983238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026862|NCT04983238|Antioxidants|antioxidants|mesh-ancestor
65026863|NCT04983238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026864|NCT04983238|Antitubercular Agents|antitubercular agents|mesh-ancestor
65026865|NCT04983238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65026866|NCT04983238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65026867|NCT04983238|Chelating Agents|chelating agents|mesh-ancestor
65026868|NCT04983238|Sequestering Agents|sequestering agents|mesh-ancestor
65026869|NCT04974385|Bupivacaine|bupivacaine|mesh-list
65026870|NCT04974385|Anesthetics, Local|anesthetics, local|mesh-ancestor
65026871|NCT04974385|Anesthetics|anesthetics|mesh-ancestor
65026872|NCT04974385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65026873|NCT04974385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026874|NCT04974385|Sensory System Agents|sensory system agents|mesh-ancestor
65026875|NCT04974385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65026876|NCT00547885|Dihydrocodeine|dihydrocodeine|mesh-list
65026877|NCT00547885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64482614|NCT05701995|BMS-986165|bms-986165|mesh-list
65026878|NCT00547885|Narcotics|narcotics|mesh-ancestor
65026879|NCT00547885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65026880|NCT00547885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65026881|NCT00547885|Analgesics|analgesics|mesh-ancestor
65026882|NCT00547885|Sensory System Agents|sensory system agents|mesh-ancestor
65026883|NCT00547885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65026884|NCT00161018|Risperidone|risperidone|mesh-list
65026895|NCT00161018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65026896|NCT00161018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65026897|NCT00161018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65026898|NCT00161018|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65026899|NCT00161018|Dopamine Agents|dopamine agents|mesh-ancestor
65026900|NCT00161018|Antidepressive Agents|antidepressive agents|mesh-ancestor
65026901|NCT00191412|Pemetrexed|pemetrexed|mesh-list
65026902|NCT00191412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026903|NCT00191412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026904|NCT00191412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026905|NCT00191412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65026906|NCT00191412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65026907|NCT00548002|Levofloxacin|levofloxacin|mesh-list
65026908|NCT00548002|Ofloxacin|ofloxacin|mesh-list
65026909|NCT00548002|Trovafloxacin|trovafloxacin|mesh-list
65026910|NCT00548002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65026911|NCT00548002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65026912|NCT00548002|Renal Agents|renal agents|mesh-ancestor
65026913|NCT00548002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65026914|NCT00548002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65026915|NCT00548002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65026916|NCT00548002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066963|NCT00418704|Docetaxel|docetaxel|mesh-list
65026917|NCT00548002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026918|NCT00548002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65026919|NCT00548002|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65026920|NCT00548002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65026921|NCT00191490|Gemcitabine|gemcitabine|mesh-list
65026922|NCT00191490|Docetaxel|docetaxel|mesh-list
65026940|NCT00548080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026941|NCT00161096|Pantoprazole|pantoprazole|mesh-list
65026942|NCT00161096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65026943|NCT00161096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65026944|NCT00161096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65026945|NCT00161096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65026946|NCT00161096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65026947|NCT00184821|Glyburide|glyburide|mesh-list
65026948|NCT00184821|Adenosine|adenosine|mesh-list
65026949|NCT00184821|Diazoxide|diazoxide|mesh-list
65026950|NCT00184821|Annexin A5|annexin a5|mesh-list
65026951|NCT00184821|Analgesics|analgesics|mesh-ancestor
65026952|NCT00184821|Sensory System Agents|sensory system agents|mesh-ancestor
65027005|NCT00161291|Letrozole|letrozole|mesh-list
65027006|NCT00161291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65027007|NCT00161291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027008|NCT00161291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65027009|NCT00161291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65027010|NCT00161291|Growth Substances|growth substances|mesh-ancestor
65027011|NCT00161291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027012|NCT00161291|Growth Inhibitors|growth inhibitors|mesh-ancestor
65027013|NCT00161291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65027014|NCT00161291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65027015|NCT00161291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027016|NCT00161291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027017|NCT00161291|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65027018|NCT00161291|Hormone Antagonists|hormone antagonists|mesh-ancestor
65027019|NCT00161291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65027020|NCT00548899|Sorafenib|sorafenib|mesh-list
65027021|NCT00548899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946141|NCT04616183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946142|NCT04616183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946143|NCT04602065|Antibodies|antibodies|mesh-list
64946163|NCT04584112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64946164|NCT04584112|Lenograstim|lenograstim|mesh-list
64946165|NCT04584112|Sargramostim|sargramostim|mesh-list
64946166|NCT04584112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64946167|NCT04584112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946168|NCT04584112|Tubulin Modulators|tubulin modulators|mesh-ancestor
64946169|NCT04584112|Antimitotic Agents|antimitotic agents|mesh-ancestor
64946170|NCT04584112|Mitosis Modulators|mitosis modulators|mesh-ancestor
64946171|NCT04584112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946172|NCT04584112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64946173|NCT04584112|Immunologic Factors|immunologic factors|mesh-ancestor
64946174|NCT04584112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946175|NCT04584112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64946176|NCT04584112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64946177|NCT04584112|Alkylating Agents|alkylating agents|mesh-ancestor
64946178|NCT04584112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64946179|NCT04584112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64946180|NCT04584112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64946181|NCT04584112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64946182|NCT04584112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946183|NCT04584112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64946184|NCT04576156|Imetelstat|imetelstat|mesh-list
64946185|NCT04576156|Motesanib diphosphate|motesanib diphosphate|mesh-list
64946186|NCT04576156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946187|NCT04576156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946188|NCT04576156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64946189|NCT04573777|Evolocumab|evolocumab|mesh-list
64946190|NCT04573777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64946191|NCT04573777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64946192|NCT04573777|Antimetabolites|antimetabolites|mesh-ancestor
64946193|NCT04573777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946194|NCT04573777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64946195|NCT04507711|Palonosetron|palonosetron|mesh-list
64946196|NCT04507711|Antiemetics|antiemetics|mesh-ancestor
64946197|NCT04507711|Autonomic Agents|autonomic agents|mesh-ancestor
64946198|NCT04507711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64946199|NCT04507711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027022|NCT00548899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65027023|NCT00548899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027024|NCT00548899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027025|NCT00191568|Gemcitabine|gemcitabine|mesh-list
65027026|NCT00191568|Oxaliplatin|oxaliplatin|mesh-list
65027027|NCT00191568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65027028|NCT00191568|Antimetabolites|antimetabolites|mesh-ancestor
65027029|NCT00191568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027030|NCT00191568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027031|NCT00191568|Antiviral Agents|antiviral agents|mesh-ancestor
65027032|NCT00191568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027033|NCT00191568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027034|NCT00191568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65027035|NCT00191568|Immunologic Factors|immunologic factors|mesh-ancestor
65027036|NCT00191568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027037|NCT00548938|Temozolomide|temozolomide|mesh-list
65027038|NCT00548938|Carmustine|carmustine|mesh-list
65027039|NCT00548938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65027040|NCT00548938|Alkylating Agents|alkylating agents|mesh-ancestor
65027041|NCT00548938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027042|NCT00548938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027074|NCT00191607|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65027075|NCT00191607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65027076|NCT00191607|Antimetabolites|antimetabolites|mesh-ancestor
65027077|NCT00191607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027078|NCT00191607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027079|NCT00191607|Antiviral Agents|antiviral agents|mesh-ancestor
65027080|NCT00191607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027081|NCT00191607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027082|NCT00191607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65027083|NCT00191607|Immunologic Factors|immunologic factors|mesh-ancestor
65027084|NCT00191607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027085|NCT00191607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65027086|NCT00191607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65027087|NCT00191607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65027088|NCT00549289|Cyclosporine|cyclosporine|mesh-list
65027089|NCT00549289|Cyclosporins|cyclosporins|mesh-list
65027090|NCT00549289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027091|NCT00549289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027092|NCT00549289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65027093|NCT00549289|Immunologic Factors|immunologic factors|mesh-ancestor
65027094|NCT00549289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027095|NCT00549289|Antifungal Agents|antifungal agents|mesh-ancestor
65027096|NCT00549289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027097|NCT00549289|Dermatologic Agents|dermatologic agents|mesh-ancestor
65027098|NCT00549289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65027099|NCT00549289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65027100|NCT00184977|Fluticasone|fluticasone|mesh-list
65027101|NCT00184977|Xhance|xhance|mesh-list
65027102|NCT00184977|Acetylcysteine|acetylcysteine|mesh-list
65027103|NCT00184977|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65027104|NCT00184977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65027105|NCT00184977|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65027106|NCT00184977|Autonomic Agents|autonomic agents|mesh-ancestor
65027107|NCT00184977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65027108|NCT00184977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027109|NCT00184977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65027113|NCT00184977|Antiviral Agents|antiviral agents|mesh-ancestor
65027114|NCT00184977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027115|NCT00184977|Expectorants|expectorants|mesh-ancestor
65027116|NCT00184977|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65027117|NCT00184977|Antioxidants|antioxidants|mesh-ancestor
65027118|NCT00184977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027119|NCT00184977|Protective Agents|protective agents|mesh-ancestor
65027120|NCT00184977|Antidotes|antidotes|mesh-ancestor
65027121|NCT03456154|Salicylic Acid|salicylic acid|mesh-list
65027122|NCT03456154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027123|NCT03456154|Antifungal Agents|antifungal agents|mesh-ancestor
65027124|NCT03456154|Keratolytic Agents|keratolytic agents|mesh-ancestor
65027125|NCT03456154|Dermatologic Agents|dermatologic agents|mesh-ancestor
65027126|NCT00161447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65027127|NCT00161447|Medroxyprogesterone|medroxyprogesterone|mesh-list
65027128|NCT00161447|Testosterone|testosterone|mesh-list
65027129|NCT00161447|Acyline|acyline|mesh-list
65027130|NCT00161447|Androgens|androgens|mesh-ancestor
65027131|NCT00161447|Hormones|hormones|mesh-ancestor
65027132|NCT00161447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65027133|NCT00161447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027134|NCT00161447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65027135|NCT00161447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027136|NCT00161447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65027137|NCT00161447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65027138|NCT00161447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64581283|NCT04246359|Interferons|interferons|mesh-list
64946200|NCT04507711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64946201|NCT04507711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64946202|NCT04507711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64485044|NCT00824824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64946203|NCT04507711|Serotonin Agents|serotonin agents|mesh-ancestor
64946204|NCT04507711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64946205|NCT04507711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946206|NCT04499274|Ondansetron|ondansetron|mesh-list
64946207|NCT04499274|Antiemetics|antiemetics|mesh-ancestor
64946208|NCT04499274|Autonomic Agents|autonomic agents|mesh-ancestor
64946209|NCT04499274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64946210|NCT04499274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946211|NCT04499274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64946212|NCT04499274|Antipruritics|antipruritics|mesh-ancestor
64946213|NCT04499274|Dermatologic Agents|dermatologic agents|mesh-ancestor
64946231|NCT04497961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946232|NCT04494425|Paclitaxel|paclitaxel|mesh-list
64332366|NCT03020199|Glucocorticoids|glucocorticoids|mesh-ancestor
64332367|NCT03020199|Hormones|hormones|mesh-ancestor
64332368|NCT03020199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64332369|NCT03020199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332370|NCT03020199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64581308|NCT05192265|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65027139|NCT00161447|Contraceptive Agents|contraceptive agents|mesh-ancestor
65027140|NCT00161447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65027141|NCT00161447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65027142|NCT00161447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65027143|NCT00161447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65027144|NCT00161447|Hormone Antagonists|hormone antagonists|mesh-ancestor
65493853|NCT04233866|Hematinics|hematinics|mesh-ancestor
65027145|NCT00191685|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65027146|NCT00191685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65027147|NCT00191685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65027148|NCT00191685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65027149|NCT00191685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027150|NCT00191685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65027151|NCT00191685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027152|NCT00191685|Analgesics|analgesics|mesh-ancestor
65027153|NCT00191685|Sensory System Agents|sensory system agents|mesh-ancestor
65027154|NCT00191685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65027155|NCT00191685|Antidepressive Agents|antidepressive agents|mesh-ancestor
65027156|NCT00191685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65027157|NCT00191685|Dopamine Agents|dopamine agents|mesh-ancestor
65027158|NCT00161486|Methyltestosterone|methyltestosterone|mesh-list
65027159|NCT00161486|Testosterone|testosterone|mesh-list
64724828|NCT00000703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724829|NCT00000703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64724830|NCT00000703|Abortifacient Agents|abortifacient agents|mesh-ancestor
64724831|NCT00000703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64724832|NCT00000703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64724833|NCT00000703|Antimetabolites|antimetabolites|mesh-ancestor
64724834|NCT00000703|Dermatologic Agents|dermatologic agents|mesh-ancestor
64724835|NCT00000703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64724836|NCT00000703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64724837|NCT00000703|Antiviral Agents|antiviral agents|mesh-ancestor
64724838|NCT00000703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724839|NCT00000703|Antidotes|antidotes|mesh-ancestor
64724840|NCT00000703|Protective Agents|protective agents|mesh-ancestor
64724841|NCT00000703|Vitamin B Complex|vitamin b complex|mesh-ancestor
64724842|NCT00000703|Vitamins|vitamins|mesh-ancestor
64724843|NCT00000703|Micronutrients|micronutrients|mesh-ancestor
64724844|NCT00000703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64724845|NCT00000703|Tubulin Modulators|tubulin modulators|mesh-ancestor
64724846|NCT00000703|Antimitotic Agents|antimitotic agents|mesh-ancestor
64946233|NCT04494425|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64946234|NCT04494425|Capecitabine|capecitabine|mesh-list
64946235|NCT04494425|Trastuzumab|trastuzumab|mesh-list
64946236|NCT04494425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64946237|NCT04494425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946238|NCT04494425|Tubulin Modulators|tubulin modulators|mesh-ancestor
64946239|NCT04494425|Antimitotic Agents|antimitotic agents|mesh-ancestor
64946240|NCT04494425|Mitosis Modulators|mitosis modulators|mesh-ancestor
65027160|NCT00161486|Testosterone undecanoate|testosterone undecanoate|mesh-list
65027161|NCT00161486|Testosterone enanthate|testosterone enanthate|mesh-list
65027162|NCT00161486|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65027163|NCT00161486|Acyline|acyline|mesh-list
65027164|NCT00161486|Androgens|androgens|mesh-ancestor
65027165|NCT00161486|Hormones|hormones|mesh-ancestor
65027166|NCT00161486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65027167|NCT00161486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027168|NCT00161486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65027169|NCT00161486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027170|NCT00161486|Anabolic Agents|anabolic agents|mesh-ancestor
65027171|NCT00161486|Hormone Antagonists|hormone antagonists|mesh-ancestor
65027172|NCT00549874|Rosiglitazone|rosiglitazone|mesh-list
65027173|NCT00549874|Glyburide|glyburide|mesh-list
65027174|NCT00549874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65027175|NCT00549874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027176|NCT00191763|Gemcitabine|gemcitabine|mesh-list
65027177|NCT00191763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027178|NCT00191763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65027179|NCT00191763|Antimetabolites|antimetabolites|mesh-ancestor
65027217|NCT00185094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65027218|NCT00185094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027219|NCT00185094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65027220|NCT00185094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65027221|NCT00185094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65027222|NCT00185094|Adrenergic Agents|adrenergic agents|mesh-ancestor
65027223|NCT00185094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65027224|NCT00550303|Bazedoxifene|bazedoxifene|mesh-list
65027225|NCT00550303|Estrogens|estrogens|mesh-list
65027226|NCT00550303|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65027227|NCT00550303|Hormones|hormones|mesh-ancestor
65027228|NCT00550303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65027229|NCT00550303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027230|NCT00550303|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65027231|NCT00550303|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65027232|NCT00550303|Hormone Antagonists|hormone antagonists|mesh-ancestor
65027233|NCT00550303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65027234|NCT00550342|Rituximab|rituximab|mesh-list
65027235|NCT00550342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65027236|NCT00550342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027237|NCT00550342|Immunologic Factors|immunologic factors|mesh-ancestor
65027238|NCT00550342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027239|NCT00550342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65027240|NCT00161681|Levonorgestrel|levonorgestrel|mesh-list
65027241|NCT00161681|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65027242|NCT00161681|Estradiol|estradiol|mesh-list
65027243|NCT00161681|Estrogens|estrogens|mesh-ancestor
65027244|NCT00161681|Hormones|hormones|mesh-ancestor
65027245|NCT00161681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65027246|NCT00161681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027247|NCT00161681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65027248|NCT00161681|Contraceptive Agents|contraceptive agents|mesh-ancestor
64482983|NCT03153813|Capsaicin|capsaicin|mesh-list
65027258|NCT02963454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65027259|NCT02963454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65027260|NCT02963454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027261|NCT02963454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027262|NCT02963454|Protective Agents|protective agents|mesh-ancestor
65027263|NCT02963454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027264|NCT02963454|Sympathomimetics|sympathomimetics|mesh-ancestor
65027265|NCT02963454|Autonomic Agents|autonomic agents|mesh-ancestor
65027266|NCT02963454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65027267|NCT02963454|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65027268|NCT02963454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65027269|NCT02963454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65027270|NCT02963454|Adrenergic Agents|adrenergic agents|mesh-ancestor
65027271|NCT02963454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65027272|NCT00191802|Teriparatide|teriparatide|mesh-list
65027273|NCT00191802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65027274|NCT00191802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027275|NCT00191802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65027276|NCT00550693|Chlorhexidine|chlorhexidine|mesh-list
65027277|NCT00550693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65027278|NCT00550693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027279|NCT00550693|Disinfectants|disinfectants|mesh-ancestor
65027280|NCT00550810|Sunitinib|sunitinib|mesh-list
65027281|NCT00550810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027282|NCT00550810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65027283|NCT00550810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65027284|NCT00550810|Growth Substances|growth substances|mesh-ancestor
65027285|NCT00550810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027286|NCT00550810|Growth Inhibitors|growth inhibitors|mesh-ancestor
65027287|NCT00550810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64901058|NCT02045940|GSK2881078|gsk2881078|mesh-list
65027298|NCT00191841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65027299|NCT00191841|Immunologic Factors|immunologic factors|mesh-ancestor
65027300|NCT00191841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027301|NCT00550927|Bevacizumab|bevacizumab|mesh-list
65027302|NCT00550927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65027303|NCT00550927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027304|NCT00550927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65027305|NCT00550927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65027306|NCT00550927|Growth Substances|growth substances|mesh-ancestor
65027307|NCT00550927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027308|NCT00550927|Growth Inhibitors|growth inhibitors|mesh-ancestor
65027309|NCT00161720|Protein C|protein c|mesh-list
65027310|NCT00161720|Anticoagulants|anticoagulants|mesh-ancestor
65027311|NCT00161720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65027312|NCT00161720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65027313|NCT00161720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027314|NCT00185133|Amlodipine|amlodipine|mesh-list
65027315|NCT00185133|Olmesartan|olmesartan|mesh-list
65027316|NCT00185133|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65027317|NCT00185133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65027318|NCT00185133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65027319|NCT00185133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65027320|NCT00185133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027321|NCT00185133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65027322|NCT00185133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027323|NCT00185133|Vasodilator Agents|vasodilator agents|mesh-ancestor
65027324|NCT00185133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65027325|NCT00185133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65027326|NCT00551005|Celecoxib|celecoxib|mesh-list
65027327|NCT00551005|Etoposide|etoposide|mesh-list
65027328|NCT00551005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65027329|NCT00551005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027330|NCT00551005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64468654|NCT01469637|Mesalamine|mesalamine|mesh-list
65027331|NCT00551005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65027335|NCT00551005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65027336|NCT00551005|Analgesics|analgesics|mesh-ancestor
65027337|NCT00551005|Sensory System Agents|sensory system agents|mesh-ancestor
65027338|NCT00551005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65027339|NCT00551005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027340|NCT00551005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65027341|NCT00551005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65027342|NCT00551005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65027343|NCT00551005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65027344|NCT00551044|Bicalutamide|bicalutamide|mesh-list
65027345|NCT00551044|Androgen Antagonists|androgen antagonists|mesh-ancestor
65027346|NCT00551044|Hormone Antagonists|hormone antagonists|mesh-ancestor
65027347|NCT00551044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65027348|NCT00551044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027349|NCT00551044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027350|NCT00161759|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65027351|NCT00161759|Thrombin|thrombin|mesh-list
65027352|NCT00161759|Hemostatics|hemostatics|mesh-ancestor
65027353|NCT00161759|Coagulants|coagulants|mesh-ancestor
65027354|NCT00551122|Gemcitabine|gemcitabine|mesh-list
65027355|NCT00551122|Paclitaxel|paclitaxel|mesh-list
65027356|NCT00551122|Ifosfamide|ifosfamide|mesh-list
65027357|NCT00551122|Lenograstim|lenograstim|mesh-list
65027358|NCT00551122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65027359|NCT00551122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027360|NCT00551122|Tubulin Modulators|tubulin modulators|mesh-ancestor
65027361|NCT00551122|Antimitotic Agents|antimitotic agents|mesh-ancestor
65027362|NCT00551122|Mitosis Modulators|mitosis modulators|mesh-ancestor
65027363|NCT00551122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027364|NCT00551122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65027365|NCT00551122|Antimetabolites|antimetabolites|mesh-ancestor
65027366|NCT00551122|Antiviral Agents|antiviral agents|mesh-ancestor
65027367|NCT00551122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027368|NCT00551122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027369|NCT00551122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65027370|NCT00551122|Immunologic Factors|immunologic factors|mesh-ancestor
65027371|NCT00551122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027374|NCT00551122|Alkylating Agents|alkylating agents|mesh-ancestor
64581544|NCT02250807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027376|NCT00551239|Fludarabine|fludarabine|mesh-list
65027377|NCT00551239|Fludarabine phosphate|fludarabine phosphate|mesh-list
65027378|NCT00551239|Pixantrone|pixantrone|mesh-list
65027379|NCT00551239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65027380|NCT00551239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027381|NCT00551239|Immunologic Factors|immunologic factors|mesh-ancestor
65027382|NCT00551239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027383|NCT00551239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65027384|NCT00551239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65027385|NCT00551239|Antimetabolites|antimetabolites|mesh-ancestor
65027386|NCT00551239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027387|NCT00551239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65027388|NCT00551239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65027389|NCT00551239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65027390|NCT00551239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027391|NCT00191880|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65027392|NCT00191880|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65027393|NCT00191880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65027394|NCT00191880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65027395|NCT00191880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946241|NCT04494425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946242|NCT04494425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64946243|NCT04494425|Antimetabolites|antimetabolites|mesh-ancestor
64946244|NCT04494425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64946245|NCT04488159|Leucovorin|leucovorin|mesh-list
64946246|NCT04488159|Fluorouracil|fluorouracil|mesh-list
64724847|NCT00000703|Mitosis Modulators|mitosis modulators|mesh-ancestor
64724848|NCT00000703|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64724849|NCT00000703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64724850|NCT00000703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64724851|NCT00000703|Gout Suppressants|gout suppressants|mesh-ancestor
64724852|NCT00000703|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64724853|NCT00000703|Antioxidants|antioxidants|mesh-ancestor
64724854|NCT00001015|Ribavirin|ribavirin|mesh-list
64724855|NCT00001015|Antimetabolites|antimetabolites|mesh-ancestor
64724856|NCT00001015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946247|NCT04488159|Capecitabine|capecitabine|mesh-list
64946248|NCT04488159|Oxaliplatin|oxaliplatin|mesh-list
64946249|NCT04488159|Antimetabolites|antimetabolites|mesh-ancestor
64946250|NCT04488159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946251|NCT04488159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64946252|NCT04488159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946253|NCT04488159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64946254|NCT04488159|Immunologic Factors|immunologic factors|mesh-ancestor
64946255|NCT04488159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946256|NCT04488159|Antidotes|antidotes|mesh-ancestor
64946257|NCT04488159|Protective Agents|protective agents|mesh-ancestor
64946258|NCT04488159|Vitamin B Complex|vitamin b complex|mesh-ancestor
64946259|NCT04488159|Vitamins|vitamins|mesh-ancestor
65027396|NCT00191880|Adrenergic Agents|adrenergic agents|mesh-ancestor
65027397|NCT00191880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65027398|NCT00191880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027399|NCT00551317|Darapladib|darapladib|mesh-list
65027400|NCT00551317|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
65027401|NCT00551317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027402|NCT00551317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027403|NCT00551356|Insulin Lispro|insulin lispro|mesh-list
65027404|NCT00551356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65027405|NCT00551356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027406|NCT02963337|Remifentanil|remifentanil|mesh-list
65027407|NCT02963337|Bupivacaine|bupivacaine|mesh-list
65027408|NCT02963337|Anesthetics, Local|anesthetics, local|mesh-ancestor
65027409|NCT02963337|Anesthetics|anesthetics|mesh-ancestor
65027410|NCT02963337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65027411|NCT02963337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027412|NCT02963337|Sensory System Agents|sensory system agents|mesh-ancestor
65027413|NCT02963337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65027414|NCT02963337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65027415|NCT02963337|Narcotics|narcotics|mesh-ancestor
65027416|NCT02963337|Analgesics|analgesics|mesh-ancestor
65027417|NCT00191919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65027418|NCT00191919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65027419|NCT00191919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65027420|NCT00191919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65027421|NCT00191919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027422|NCT00191919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65027423|NCT00191919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027424|NCT00191919|Analgesics|analgesics|mesh-ancestor
64581571|NCT00168389|Hormones|hormones|mesh-ancestor
64946260|NCT04488159|Micronutrients|micronutrients|mesh-ancestor
64946261|NCT04449861|Durvalumab|durvalumab|mesh-list
64946262|NCT04449861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64946263|NCT04449861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946264|NCT04435691|Azacitidine|azacitidine|mesh-list
64946265|NCT04435691|Venetoclax|venetoclax|mesh-list
64946266|NCT04435691|Magrolimab|magrolimab|mesh-list
64419791|NCT04812379|Serotonin Agents|serotonin agents|mesh-ancestor
64946287|NCT04321993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
64946288|NCT04321993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64946289|NCT04321993|Antimetabolites|antimetabolites|mesh-ancestor
64946290|NCT04321993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946291|NCT04321993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64946292|NCT04321993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946293|NCT04319627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64946294|NCT04319627|Calcium|calcium|mesh-list
64581598|NCT04592952|Vasodilator Agents|vasodilator agents|mesh-ancestor
65027425|NCT00191919|Sensory System Agents|sensory system agents|mesh-ancestor
65027426|NCT00191919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65027427|NCT00191919|Antidepressive Agents|antidepressive agents|mesh-ancestor
65027428|NCT00191919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65027429|NCT00191919|Dopamine Agents|dopamine agents|mesh-ancestor
65027430|NCT00161837|Vaccines|vaccines|mesh-list
65027431|NCT00161837|Immunologic Factors|immunologic factors|mesh-ancestor
65027432|NCT00161837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027433|NCT00551512|Cisplatin|cisplatin|mesh-list
65027434|NCT00551512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027435|NCT00551590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65027436|NCT00551590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65027437|NCT00551590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027438|NCT00551590|Incretins|incretins|mesh-ancestor
65027439|NCT00551590|Hormones|hormones|mesh-ancestor
65027440|NCT00551590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64946295|NCT04319627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64946296|NCT04319627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946297|NCT04319627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64946298|NCT04319627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64946299|NCT04319627|Antimetabolites|antimetabolites|mesh-ancestor
64946300|NCT04319627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946301|NCT04319627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64946302|NCT04319627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64946303|NCT04319627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946304|NCT04319224|Nivolumab|nivolumab|mesh-list
64946305|NCT04319224|Ipilimumab|ipilimumab|mesh-list
64946306|NCT04319224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64946307|NCT04319224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946308|NCT04319224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64946309|NCT04319224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946310|NCT04315948|Interferons|interferons|mesh-list
64946311|NCT04315948|Ritonavir|ritonavir|mesh-list
64946312|NCT04315948|Lopinavir|lopinavir|mesh-list
64946313|NCT04315948|Interferon-beta|interferon-beta|mesh-list
64946314|NCT04315948|Interferon beta-1a|interferon beta-1a|mesh-list
64946315|NCT04315948|Remdesivir|remdesivir|mesh-list
64946316|NCT04315948|Hydroxychloroquine|hydroxychloroquine|mesh-list
64332402|NCT02959944|Prednisone|prednisone|mesh-list
64332403|NCT02959944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64332404|NCT02959944|Glucocorticoids|glucocorticoids|mesh-ancestor
64332405|NCT02959944|Hormones|hormones|mesh-ancestor
64332406|NCT02959944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64332407|NCT02959944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724857|NCT00001015|Antiviral Agents|antiviral agents|mesh-ancestor
64724858|NCT00001015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724859|NCT00000709|Zidovudine|zidovudine|mesh-list
64724860|NCT00000709|Antimetabolites|antimetabolites|mesh-ancestor
64724861|NCT00000709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724862|NCT00000709|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64724863|NCT00000709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64724864|NCT00000709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724865|NCT00000709|Antiviral Agents|antiviral agents|mesh-ancestor
64724866|NCT00000709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724867|NCT00000709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64724868|NCT00000709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64724869|NCT00001027|Pentamidine|pentamidine|mesh-list
64724870|NCT00001027|Antifungal Agents|antifungal agents|mesh-ancestor
64724871|NCT00001027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027441|NCT00551590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65027442|NCT00551590|Protease Inhibitors|protease inhibitors|mesh-ancestor
65027443|NCT00551590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027444|NCT00551590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027445|NCT00161915|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65027446|NCT00161915|Hemostatics|hemostatics|mesh-ancestor
65027447|NCT00161915|Coagulants|coagulants|mesh-ancestor
65027448|NCT00185172|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65027449|NCT00185172|Olmesartan|olmesartan|mesh-list
65027450|NCT00185172|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65027451|NCT00185172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65027452|NCT00185172|Diuretics|diuretics|mesh-ancestor
65027453|NCT00185172|Natriuretic Agents|natriuretic agents|mesh-ancestor
65027454|NCT00185172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027455|NCT00185172|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65027456|NCT00185172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65027457|NCT00185172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027458|NCT00185172|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65027459|NCT00185172|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65027460|NCT00191997|Olanzapine|olanzapine|mesh-list
65027461|NCT00191997|Antiemetics|antiemetics|mesh-ancestor
65027462|NCT00191997|Autonomic Agents|autonomic agents|mesh-ancestor
65027463|NCT00191997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65027464|NCT00191997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027465|NCT00191997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65027466|NCT00191997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64946317|NCT04315948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946318|NCT04315948|Antiviral Agents|antiviral agents|mesh-ancestor
64946319|NCT04315948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64946320|NCT04315948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64946321|NCT04315948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64946322|NCT04315948|Protease Inhibitors|protease inhibitors|mesh-ancestor
64946323|NCT04315948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946324|NCT04315948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946330|NCT04315948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64946331|NCT04315948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64946332|NCT04315948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64946333|NCT04315948|Immunologic Factors|immunologic factors|mesh-ancestor
64946338|NCT04300127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64946339|NCT04300127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946341|NCT04296305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64946342|NCT04296305|Narcotics|narcotics|mesh-ancestor
64946343|NCT04296305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64946344|NCT04296305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946345|NCT04296305|Analgesics|analgesics|mesh-ancestor
64946346|NCT04296305|Sensory System Agents|sensory system agents|mesh-ancestor
64946347|NCT04296305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64946348|NCT04291105|Cemiplimab|cemiplimab|mesh-list
65027467|NCT00191997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65027468|NCT00191997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65027469|NCT00191997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65027470|NCT00191997|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65027471|NCT00191997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65027472|NCT00191997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65027473|NCT00191997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027474|NCT00191997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65027475|NCT00191997|Serotonin Agents|serotonin agents|mesh-ancestor
65027476|NCT00551824|Mitomycins|mitomycins|mesh-list
65027477|NCT00551824|Mitomycin|mitomycin|mesh-list
65027478|NCT00551824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65027479|NCT00551824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027480|NCT00551824|Alkylating Agents|alkylating agents|mesh-ancestor
65027481|NCT00551824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027482|NCT00551824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65027483|NCT00551824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027485|NCT00185250|Interferon-beta|interferon-beta|mesh-list
65027486|NCT00185250|Interferon beta-1b|interferon beta-1b|mesh-list
65027487|NCT00185250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027488|NCT00185250|Antiviral Agents|antiviral agents|mesh-ancestor
65027489|NCT00185250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027490|NCT00185250|Immunologic Factors|immunologic factors|mesh-ancestor
65027491|NCT00185250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027492|NCT00185250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65027493|NCT00161993|Immunoglobulins|immunoglobulins|mesh-list
65027494|NCT00161993|Antibodies|antibodies|mesh-list
65027495|NCT00161993|gamma-Globulins|gamma-globulins|mesh-list
65027496|NCT00161993|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65027497|NCT00161993|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65027498|NCT00161993|Immunologic Factors|immunologic factors|mesh-ancestor
65027499|NCT00161993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027500|NCT00185328|Estradiol|estradiol|mesh-list
65027501|NCT00185328|Estrogens|estrogens|mesh-ancestor
65027502|NCT00185328|Hormones|hormones|mesh-ancestor
65027503|NCT00185328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64581674|NCT04303026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65027506|NCT00162110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65027507|NCT00162110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027508|NCT00552370|Insulin Glargine|insulin glargine|mesh-list
65027509|NCT00552370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65027510|NCT00552370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027511|NCT00162149|Ritonavir|ritonavir|mesh-list
65027512|NCT00162149|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65027513|NCT00162149|Nevirapine|nevirapine|mesh-list
65027514|NCT00162149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65027515|NCT00162149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65027516|NCT00162149|Protease Inhibitors|protease inhibitors|mesh-ancestor
65027517|NCT00162149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027518|NCT00162149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027519|NCT00162149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65027520|NCT00162149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65027521|NCT00162149|Antiviral Agents|antiviral agents|mesh-ancestor
65027522|NCT00162149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027523|NCT00162149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65027524|NCT00162149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65027525|NCT00162149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65027526|NCT00162149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65027527|NCT00162149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65027528|NCT00162149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65027529|NCT00552526|Anticonvulsants|anticonvulsants|mesh-list
65027531|NCT00162188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65027532|NCT00162188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65027533|NCT00162188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027534|NCT00162188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027535|NCT00162188|Antiviral Agents|antiviral agents|mesh-ancestor
65027536|NCT00162188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027537|NCT00162188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65027538|NCT00162188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64581676|NCT00113321|Decitabine|decitabine|mesh-list
64724872|NCT00001027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64724873|NCT00001027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64724874|NCT00001027|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64724876|NCT00000727|Pyrimethamine|pyrimethamine|mesh-list
65027539|NCT00162188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65027540|NCT00162188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65027541|NCT00162188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65027542|NCT00162188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65027543|NCT00162227|Efavirenz|efavirenz|mesh-list
65027544|NCT00162227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65027545|NCT00162227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65027546|NCT00162227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027547|NCT00162227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027548|NCT00162227|Antiviral Agents|antiviral agents|mesh-ancestor
65027549|NCT00162227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027550|NCT00162227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65027551|NCT00162227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65027552|NCT00162227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64483295|NCT01276756|Ribavirin|ribavirin|mesh-list
65027553|NCT00162227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65027554|NCT00162227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65027555|NCT00162227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65027556|NCT04701580|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65027557|NCT04701580|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65027558|NCT04701580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027559|NCT00552682|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65027560|NCT00552682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65027561|NCT00552682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65027562|NCT00552682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65027581|NCT04609306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65027582|NCT04609306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027583|NCT04684498|Oseltamivir|oseltamivir|mesh-list
65027584|NCT04684498|Antiviral Agents|antiviral agents|mesh-ancestor
65027585|NCT04684498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64901360|NCT02047175|Niacin|niacin|mesh-list
65027586|NCT04684498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027587|NCT04684498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027588|NCT00552799|Penicillins|penicillins|mesh-list
65027589|NCT00552799|Penicillin V|penicillin v|mesh-list
65027590|NCT00552799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65027591|NCT00552799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027593|NCT00409071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65027594|NCT00162305|Dapagliflozin|dapagliflozin|mesh-list
65027595|NCT00162305|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65027596|NCT00162305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027597|NCT00162305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65027598|NCT00162305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027599|NCT04513015|Antioxidants|antioxidants|mesh-list
65027606|NCT04382326|Vaccines|vaccines|mesh-list
65027637|NCT00162422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64581812|NCT05656248|Dermatologic Agents|dermatologic agents|mesh-ancestor
64581813|NCT05656248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027638|NCT00162422|Autonomic Agents|autonomic agents|mesh-ancestor
65027639|NCT00162422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65027640|NCT00162422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027641|NCT00162422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65027642|NCT00162422|Respiratory System Agents|respiratory system agents|mesh-ancestor
65027643|NCT00162422|Tocolytic Agents|tocolytic agents|mesh-ancestor
65027644|NCT00162422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65027645|NCT00162422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65027646|NCT00162422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65027647|NCT00162422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65027648|NCT00162422|Adrenergic Agents|adrenergic agents|mesh-ancestor
65027649|NCT00162422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65027650|NCT00162422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027651|NCT04355143|Colchicine|colchicine|mesh-list
65027652|NCT04355143|Gout Suppressants|gout suppressants|mesh-ancestor
65027653|NCT04355143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65027654|NCT04355143|Tubulin Modulators|tubulin modulators|mesh-ancestor
65027655|NCT04355143|Antimitotic Agents|antimitotic agents|mesh-ancestor
65027656|NCT04355143|Mitosis Modulators|mitosis modulators|mesh-ancestor
65027657|NCT04355143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027658|NCT04355143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027659|NCT00185445|Fludarabine|fludarabine|mesh-list
64901434|NCT00005826|Rubitecan|rubitecan|mesh-list
65027660|NCT00185445|Fludarabine phosphate|fludarabine phosphate|mesh-list
65027661|NCT00185445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64724877|NCT00000727|Sulfadoxine|sulfadoxine|mesh-list
64724878|NCT00000727|Trimethoprim|trimethoprim|mesh-list
64724879|NCT00000727|Sulfamethoxazole|sulfamethoxazole|mesh-list
64724880|NCT00000727|Pentamidine|pentamidine|mesh-list
64724881|NCT00000727|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64724882|NCT00000727|Antimetabolites|antimetabolites|mesh-ancestor
64724883|NCT00000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724884|NCT00000727|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64724885|NCT00000727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64724886|NCT00000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724887|NCT00000727|Antiviral Agents|antiviral agents|mesh-ancestor
64724888|NCT00000727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724889|NCT00000727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64724890|NCT00000727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64724891|NCT00000727|Antimalarials|antimalarials|mesh-ancestor
64724892|NCT00000727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64724893|NCT00000727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64724894|NCT00000727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64724895|NCT00000727|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65027662|NCT00185445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65027663|NCT00185445|Antimetabolites|antimetabolites|mesh-ancestor
65027664|NCT00185445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027665|NCT00185445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65027666|NCT00185445|Immunologic Factors|immunologic factors|mesh-ancestor
65027667|NCT00185445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027668|NCT00552838|Anti-Infective Agents|anti-infective agents|mesh-list
65027669|NCT00552838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65027670|NCT04233034|Verapamil|verapamil|mesh-list
65027671|NCT04233034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65027672|NCT04233034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65027673|NCT04233034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65027674|NCT04233034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027675|NCT04233034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65027676|NCT04233034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027677|NCT04233034|Vasodilator Agents|vasodilator agents|mesh-ancestor
65027678|NCT04202809|Durvalumab|durvalumab|mesh-list
65027679|NCT04202809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65027680|NCT04202809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027681|NCT04187053|Methylene Blue|methylene blue|mesh-list
65027682|NCT04187053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027683|NCT04187053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027684|NCT00162461|Phenytoin|phenytoin|mesh-list
65027711|NCT04095364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581886|NCT00183443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027712|NCT00162656|Cyclophosphamide|cyclophosphamide|mesh-list
65027713|NCT00162656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65027714|NCT00162656|Immunologic Factors|immunologic factors|mesh-ancestor
65027715|NCT00162656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027716|NCT00162656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65027717|NCT00162656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65027718|NCT00162656|Alkylating Agents|alkylating agents|mesh-ancestor
65027719|NCT00162656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027720|NCT00162656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027721|NCT00162656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65027722|NCT00162695|Etoposide|etoposide|mesh-list
65027723|NCT00162695|Vincristine|vincristine|mesh-list
65027724|NCT00162695|Epirubicin|epirubicin|mesh-list
65027725|NCT00162695|Ifosfamide|ifosfamide|mesh-list
65027726|NCT00162695|Carboplatin|carboplatin|mesh-list
65027727|NCT00162695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65027728|NCT00162695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027729|NCT00162695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65027730|NCT00162695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65027731|NCT00162695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027732|NCT00162695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493854|NCT04166318|Fluorouracil|fluorouracil|mesh-list
65027733|NCT00162695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65027734|NCT00162695|Alkylating Agents|alkylating agents|mesh-ancestor
65027735|NCT00162695|Tubulin Modulators|tubulin modulators|mesh-ancestor
65027736|NCT00162695|Antimitotic Agents|antimitotic agents|mesh-ancestor
65027737|NCT00162695|Mitosis Modulators|mitosis modulators|mesh-ancestor
65027738|NCT00162695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65027740|NCT00162734|Ribavirin|ribavirin|mesh-list
64724896|NCT00000727|Renal Agents|renal agents|mesh-ancestor
64724897|NCT00000727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64724898|NCT00000727|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64724899|NCT00000727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64724900|NCT00000727|Antifungal Agents|antifungal agents|mesh-ancestor
64946349|NCT04291105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64946350|NCT04291105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946351|NCT04266236|Ropivacaine|ropivacaine|mesh-list
64946352|NCT04266236|Anesthetics|anesthetics|mesh-ancestor
64946353|NCT04266236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64946354|NCT04266236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946355|NCT04266236|Anesthetics, Local|anesthetics, local|mesh-ancestor
64946356|NCT04266236|Sensory System Agents|sensory system agents|mesh-ancestor
65027741|NCT00162734|Interferon alfacon-1|interferon alfacon-1|mesh-list
65027742|NCT00162734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027743|NCT00162734|Antiviral Agents|antiviral agents|mesh-ancestor
65027744|NCT00162734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027745|NCT00162734|Antimetabolites|antimetabolites|mesh-ancestor
65027746|NCT00162734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027747|NCT00185796|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65027748|NCT00185796|Immunologic Factors|immunologic factors|mesh-ancestor
65027749|NCT00185796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027750|NCT00185796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65027751|NCT00162812|Epirubicin|epirubicin|mesh-list
65027752|NCT00162812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65027753|NCT00162812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027754|NCT00162812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65027755|NCT00162812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65027756|NCT00162812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027757|NCT00162812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027758|NCT00162851|Alemtuzumab|alemtuzumab|mesh-list
65027759|NCT00162851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65027760|NCT00162851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027761|NCT04015414|Varenicline|varenicline|mesh-list
65027762|NCT04015414|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65027763|NCT04015414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65027764|NCT04015414|Cholinergic Agents|cholinergic agents|mesh-ancestor
65027765|NCT04015414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65027766|NCT04015414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027767|NCT04015414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027768|NCT00185835|Gefitinib|gefitinib|mesh-list
65027786|NCT03970330|Norethindrone Acetate|norethindrone acetate|mesh-list
64581960|NCT00041119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64581963|NCT00186875|Cytarabine|cytarabine|mesh-list
65027787|NCT03970330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65027788|NCT03970330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65027789|NCT03970330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027790|NCT03970330|Sensory System Agents|sensory system agents|mesh-ancestor
65027791|NCT03970330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65027792|NCT03970330|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65027793|NCT03970330|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65027794|NCT03970330|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65027795|NCT03970330|Contraceptive Agents|contraceptive agents|mesh-ancestor
65027796|NCT03970330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65027797|NCT03970330|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65027798|NCT03970330|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65027799|NCT03757585|Inositol|inositol|mesh-list
65027800|NCT03757585|Acetylcysteine|acetylcysteine|mesh-list
65027801|NCT03757585|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65027802|NCT03757585|Antiviral Agents|antiviral agents|mesh-ancestor
65027803|NCT03757585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027804|NCT03757585|Expectorants|expectorants|mesh-ancestor
65027805|NCT03757585|Respiratory System Agents|respiratory system agents|mesh-ancestor
65027806|NCT03757585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65027807|NCT03757585|Antioxidants|antioxidants|mesh-ancestor
65027808|NCT03757585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027809|NCT03757585|Protective Agents|protective agents|mesh-ancestor
65027810|NCT03757585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027812|NCT03757585|Vitamin B Complex|vitamin b complex|mesh-ancestor
65027813|NCT03757585|Vitamins|vitamins|mesh-ancestor
65027814|NCT03757585|Micronutrients|micronutrients|mesh-ancestor
65027815|NCT00163046|Gabapentin|gabapentin|mesh-list
65027816|NCT00163046|Analgesics|analgesics|mesh-ancestor
65027817|NCT00163046|Sensory System Agents|sensory system agents|mesh-ancestor
65027818|NCT00163046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65027819|NCT00163046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946357|NCT04266236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64946358|NCT04256343|Deuterium Oxide|deuterium oxide|mesh-list
64946359|NCT04256343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946360|NCT04256343|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64946361|NCT04256343|Protective Agents|protective agents|mesh-ancestor
64946362|NCT04256343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027820|NCT00163046|Anticonvulsants|anticonvulsants|mesh-ancestor
65027821|NCT00163046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65027822|NCT00163046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65027823|NCT00163046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65027824|NCT00163046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65027825|NCT00163046|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65027826|NCT00163046|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65027827|NCT00163046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65027828|NCT00163046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027829|NCT00163046|Antimanic Agents|antimanic agents|mesh-ancestor
65027830|NCT00185952|Nifedipine|nifedipine|mesh-list
65027831|NCT00185952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65027832|NCT00185952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65027833|NCT00185952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027834|NCT00185952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65027835|NCT00185952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027836|NCT00185952|Vasodilator Agents|vasodilator agents|mesh-ancestor
65027837|NCT00185952|Tocolytic Agents|tocolytic agents|mesh-ancestor
65027838|NCT00185952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65027839|NCT03541447|Octreotide|octreotide|mesh-list
65027840|NCT03541447|Tolvaptan|tolvaptan|mesh-list
65027841|NCT03541447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65027842|NCT03541447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65027843|NCT03541447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027844|NCT03541447|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65027846|NCT03541447|Natriuretic Agents|natriuretic agents|mesh-ancestor
65027865|NCT00192621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64582040|NCT04751227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582045|NCT02579772|Acetylcysteine|acetylcysteine|mesh-list
65027866|NCT03516604|Citalopram|citalopram|mesh-list
65027867|NCT03516604|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65027868|NCT03516604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65027869|NCT03516604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65027870|NCT03516604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027871|NCT03516604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65027872|NCT03516604|Serotonin Agents|serotonin agents|mesh-ancestor
65027873|NCT03516604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027874|NCT03516604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65027875|NCT03516604|Antidepressive Agents|antidepressive agents|mesh-ancestor
65027876|NCT03516604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65027877|NCT00185991|Gentamicins|gentamicins|mesh-list
65027878|NCT00185991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65027879|NCT00185991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027880|NCT00185991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65027881|NCT00185991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027882|NCT00185991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027883|NCT03434158|Olaparib|olaparib|mesh-list
65027884|NCT03434158|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65027885|NCT03434158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946363|NCT04243629|Pramlintide|pramlintide|mesh-list
64946364|NCT04243629|Insulin, Short-Acting|insulin, short-acting|mesh-list
64946365|NCT04243629|Pancrelipase|pancrelipase|mesh-list
64946366|NCT04243629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64724901|NCT00000727|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64724902|NCT00000727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64724903|NCT00001039|Clarithromycin|clarithromycin|mesh-list
64724905|NCT00001039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64724906|NCT00001039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724907|NCT00001039|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64419803|NCT04757857|Anticoagulants|anticoagulants|mesh-ancestor
64724911|NCT00001039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64724912|NCT00001039|Antitubercular Agents|antitubercular agents|mesh-ancestor
64724913|NCT00001057|Zidovudine|zidovudine|mesh-list
64724914|NCT00001057|Didanosine|didanosine|mesh-list
64724915|NCT00001057|Antimetabolites|antimetabolites|mesh-ancestor
64724916|NCT00001057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724917|NCT00001057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64724918|NCT00001057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64724919|NCT00001057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724920|NCT00001057|Antiviral Agents|antiviral agents|mesh-ancestor
64724921|NCT00001057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724922|NCT00001057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64724923|NCT00001057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64724924|NCT00002293|Nystatin|nystatin|mesh-list
64724925|NCT00002293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64724926|NCT00002293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027886|NCT03434158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027887|NCT03434158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027888|NCT00163202|Atorvastatin|atorvastatin|mesh-list
65027889|NCT00163202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65027890|NCT00163202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65027891|NCT00163202|Antimetabolites|antimetabolites|mesh-ancestor
65027892|NCT00163202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027893|NCT00163202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65027894|NCT00163202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65027895|NCT00163202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027896|NCT03318952|Lidocaine|lidocaine|mesh-list
65027897|NCT03318952|Anesthetics, Local|anesthetics, local|mesh-list
65027898|NCT03318952|Carticaine|carticaine|mesh-list
65027899|NCT03318952|Anesthetics|anesthetics|mesh-list
65027900|NCT03318952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65027901|NCT03318952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027902|NCT03318952|Sensory System Agents|sensory system agents|mesh-ancestor
65027903|NCT03318952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65027904|NCT03318952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65027905|NCT03318952|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65027906|NCT03318952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65027907|NCT03318952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65027908|NCT03318952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027909|NCT00192660|Ritonavir|ritonavir|mesh-list
65027910|NCT00192660|Nelfinavir|nelfinavir|mesh-list
65027911|NCT00192660|Indinavir|indinavir|mesh-list
65027912|NCT00192660|Saquinavir|saquinavir|mesh-list
65027913|NCT00192660|Amprenavir|amprenavir|mesh-list
65027914|NCT00192660|Tenofovir|tenofovir|mesh-list
65027915|NCT00192660|Lamivudine|lamivudine|mesh-list
65027916|NCT00192660|Zidovudine|zidovudine|mesh-list
65027917|NCT00192660|Nevirapine|nevirapine|mesh-list
65027918|NCT00192660|Abacavir|abacavir|mesh-list
65027919|NCT00192660|Didanosine|didanosine|mesh-list
65027920|NCT00192660|Stavudine|stavudine|mesh-list
65027921|NCT00192660|Tipranavir|tipranavir|mesh-list
65027922|NCT00192660|Enfuvirtide|enfuvirtide|mesh-list
64582099|NCT02989701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65027928|NCT00192660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027929|NCT00192660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65027930|NCT00192660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65027931|NCT00192660|Antiviral Agents|antiviral agents|mesh-ancestor
65027932|NCT00192660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65027933|NCT00192660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65027934|NCT00192660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65027935|NCT00192660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65027936|NCT00192660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65027937|NCT00192660|Antimetabolites|antimetabolites|mesh-ancestor
65027938|NCT00192660|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65027939|NCT00192660|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65027940|NCT00192660|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65027941|NCT00192660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65027942|NCT00192660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65027943|NCT00192660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65027944|NCT00192660|Antitubercular Agents|antitubercular agents|mesh-ancestor
65027945|NCT00192660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65027946|NCT00192660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65027947|NCT00192660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65027948|NCT00163241|Celecoxib|celecoxib|mesh-list
65027949|NCT00163241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65027950|NCT00163241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65027951|NCT00163241|Analgesics|analgesics|mesh-ancestor
65027952|NCT00163241|Sensory System Agents|sensory system agents|mesh-ancestor
65027953|NCT00163241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65027954|NCT00163241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027955|NCT00163241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65027956|NCT00163241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64724927|NCT00002293|Antifungal Agents|antifungal agents|mesh-ancestor
64724928|NCT00002293|Ionophores|ionophores|mesh-ancestor
64724929|NCT00002293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64724930|NCT00002293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946367|NCT04243629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946368|NCT04243629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64946369|NCT04202835|Cyclophosphamide|cyclophosphamide|mesh-list
64946370|NCT04202835|Thymoglobulin|thymoglobulin|mesh-list
64946371|NCT04202835|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64946372|NCT04202835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64946373|NCT04202835|Immunologic Factors|immunologic factors|mesh-ancestor
65027957|NCT00163241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65027958|NCT00163241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65027959|NCT00163241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027960|NCT00163241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027961|NCT03016819|Dacarbazine|dacarbazine|mesh-list
65027962|NCT03016819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65027963|NCT03016819|Alkylating Agents|alkylating agents|mesh-ancestor
65027964|NCT03016819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027965|NCT03016819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027966|NCT02916316|Doxorubicin|doxorubicin|mesh-list
65027967|NCT02916316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65027968|NCT02916316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65027969|NCT02916316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027970|NCT02916316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65027971|NCT02916316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65027972|NCT02916316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65027973|NCT02916316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027974|NCT00186264|Hydrocortisone|hydrocortisone|mesh-list
65027975|NCT00186264|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65027976|NCT00186264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65027977|NCT00186264|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65027978|NCT00186264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65027979|NCT00186264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65027980|NCT00186264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65027981|NCT00186264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65027982|NCT00186264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65027983|NCT00186264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65027984|NCT00186264|Antidepressive Agents|antidepressive agents|mesh-ancestor
65027985|NCT00186264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65027986|NCT02858869|Pembrolizumab|pembrolizumab|mesh-list
64946374|NCT04202835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946375|NCT04202835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64946376|NCT04202835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64946377|NCT04202835|Alkylating Agents|alkylating agents|mesh-ancestor
64946378|NCT04202835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946379|NCT04202835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946380|NCT04202835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64946381|NCT04199026|Sirolimus|sirolimus|mesh-list
64724932|NCT00002299|Interferon-beta|interferon-beta|mesh-list
65027987|NCT02858869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65027988|NCT02858869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65027989|NCT00163319|Ciclesonide|ciclesonide|mesh-list
65027990|NCT00163319|Glucocorticoids|glucocorticoids|mesh-ancestor
65027991|NCT00163319|Hormones|hormones|mesh-ancestor
65027992|NCT00163319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65027993|NCT00163319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582160|NCT00278863|Antimetabolites|antimetabolites|mesh-ancestor
64724933|NCT00002299|Ganciclovir|ganciclovir|mesh-list
64724934|NCT00002299|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64724935|NCT00002299|Interferon beta-1b|interferon beta-1b|mesh-list
64724936|NCT00002299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64724937|NCT00002299|Antiviral Agents|antiviral agents|mesh-ancestor
64724938|NCT00002299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724939|NCT00002299|Immunologic Factors|immunologic factors|mesh-ancestor
64724940|NCT00002299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724941|NCT00002299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64724942|NCT00002299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724943|NCT00002299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724944|NCT00002299|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64724945|NCT00001063|Zidovudine|zidovudine|mesh-list
64724946|NCT00001063|Stavudine|stavudine|mesh-list
64724947|NCT00001063|Didanosine|didanosine|mesh-list
64724948|NCT00001063|Antimetabolites|antimetabolites|mesh-ancestor
64724949|NCT00001063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724950|NCT00001063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64724951|NCT00001063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64724952|NCT00001063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724953|NCT00001063|Antiviral Agents|antiviral agents|mesh-ancestor
64332470|NCT02823002|Lidocaine|lidocaine|mesh-list
64946382|NCT04199026|Doxorubicin|doxorubicin|mesh-list
64946383|NCT04199026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64946384|NCT04199026|Daunorubicin|daunorubicin|mesh-list
64946385|NCT04199026|Irinotecan|irinotecan|mesh-list
64946386|NCT04199026|Vincristine|vincristine|mesh-list
64946387|NCT04199026|Everolimus|everolimus|mesh-list
64946388|NCT04199026|Temozolomide|temozolomide|mesh-list
64946389|NCT04199026|Ifosfamide|ifosfamide|mesh-list
64946390|NCT04199026|Isophosphamide mustard|isophosphamide mustard|mesh-list
64946391|NCT04199026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64946392|NCT04199026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64946393|NCT04199026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419804|NCT04755283|Rivaroxaban|rivaroxaban|mesh-list
64946398|NCT04199026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64946399|NCT04199026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64946400|NCT04199026|Tubulin Modulators|tubulin modulators|mesh-ancestor
64946401|NCT04199026|Antimitotic Agents|antimitotic agents|mesh-ancestor
64946402|NCT04199026|Mitosis Modulators|mitosis modulators|mesh-ancestor
64946403|NCT04199026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64946404|NCT04199026|Immunologic Factors|immunologic factors|mesh-ancestor
64946405|NCT04199026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946406|NCT04199026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64946417|NCT04182997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64946419|NCT04182997|Hormones|hormones|mesh-ancestor
64946420|NCT04182997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64946421|NCT04182997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64946422|NCT04182997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332489|NCT02806687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64332490|NCT02806687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64332491|NCT02806687|Immunologic Factors|immunologic factors|mesh-ancestor
64332492|NCT02806687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332493|NCT02723331|Gemcitabine|gemcitabine|mesh-list
64332494|NCT02723331|Paclitaxel|paclitaxel|mesh-list
64332495|NCT02723331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64332496|NCT02723331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64332497|NCT02723331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332498|NCT02723331|Tubulin Modulators|tubulin modulators|mesh-ancestor
64332499|NCT02723331|Antimitotic Agents|antimitotic agents|mesh-ancestor
64332500|NCT02723331|Mitosis Modulators|mitosis modulators|mesh-ancestor
65027994|NCT00163319|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65027995|NCT02812420|Durvalumab|durvalumab|mesh-list
65027996|NCT02812420|Ipilimumab|ipilimumab|mesh-list
65027997|NCT02812420|Tremelimumab|tremelimumab|mesh-list
65027998|NCT02812420|Immunoglobulins|immunoglobulins|mesh-list
64483728|NCT00786916|Lidocaine|lidocaine|mesh-list
65027999|NCT02812420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65028000|NCT02812420|Immunoglobulin G|immunoglobulin g|mesh-list
65028001|NCT02812420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65028002|NCT02812420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028003|NCT02812420|Immunologic Factors|immunologic factors|mesh-ancestor
65028004|NCT02812420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028005|NCT02812420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65028006|NCT02812420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028007|NCT02556931|Mycophenolic Acid|mycophenolic acid|mesh-list
65028008|NCT02556931|Cyclophosphamide|cyclophosphamide|mesh-list
65028009|NCT02556931|Fludarabine|fludarabine|mesh-list
65028010|NCT02556931|Tacrolimus|tacrolimus|mesh-list
65028011|NCT02556931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65028012|NCT02556931|Immunologic Factors|immunologic factors|mesh-ancestor
65028013|NCT02556931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028014|NCT02556931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65028015|NCT02556931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65028016|NCT02556931|Alkylating Agents|alkylating agents|mesh-ancestor
65028017|NCT02556931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028018|NCT02556931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028019|NCT02556931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65028020|NCT02556931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65028021|NCT02556931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028022|NCT02556931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65028023|NCT02556931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65028024|NCT02556931|Antitubercular Agents|antitubercular agents|mesh-ancestor
65028025|NCT02556931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65028026|NCT02556931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65028027|NCT00163358|Ciclesonide|ciclesonide|mesh-list
65028028|NCT00163358|Glucocorticoids|glucocorticoids|mesh-ancestor
65028029|NCT00163358|Hormones|hormones|mesh-ancestor
65028032|NCT00163358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65028033|NCT00163397|Ciclesonide|ciclesonide|mesh-list
65028034|NCT00163397|Glucocorticoids|glucocorticoids|mesh-ancestor
65028035|NCT00163397|Hormones|hormones|mesh-ancestor
65028036|NCT00163397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65028037|NCT00163397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028038|NCT00163397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65028039|NCT02125786|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65028040|NCT02125786|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65028041|NCT02125786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028042|NCT00163436|Ciclesonide|ciclesonide|mesh-list
65028043|NCT00163436|Glucocorticoids|glucocorticoids|mesh-ancestor
65028044|NCT00163436|Hormones|hormones|mesh-ancestor
65028045|NCT00163436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65028046|NCT00163436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028047|NCT00163436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65028048|NCT00186420|Docetaxel|docetaxel|mesh-list
65028049|NCT00186420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028050|NCT00186420|Tubulin Modulators|tubulin modulators|mesh-ancestor
65028051|NCT00186420|Antimitotic Agents|antimitotic agents|mesh-ancestor
65028052|NCT00186420|Mitosis Modulators|mitosis modulators|mesh-ancestor
65028053|NCT00186420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028054|NCT01628029|Melatonin|melatonin|mesh-list
65028055|NCT01628029|Methylphenidate|methylphenidate|mesh-list
65028056|NCT01628029|Antioxidants|antioxidants|mesh-ancestor
65028057|NCT01628029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028058|NCT01628029|Protective Agents|protective agents|mesh-ancestor
65028059|NCT01628029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028060|NCT01628029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65028061|NCT01628029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65028062|NCT01628029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65028074|NCT00717652|Tretinoin|tretinoin|mesh-list
65028075|NCT00717652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65028076|NCT00717652|Glucocorticoids|glucocorticoids|mesh-ancestor
65028077|NCT00717652|Hormones|hormones|mesh-ancestor
65028078|NCT00717652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65028079|NCT00717652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028080|NCT00717652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028081|NCT00717652|Keratolytic Agents|keratolytic agents|mesh-ancestor
65028082|NCT00717652|Dermatologic Agents|dermatologic agents|mesh-ancestor
65028083|NCT00066040|Chlorhexidine|chlorhexidine|mesh-list
65028084|NCT00066040|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
65028085|NCT00066040|Fluorides|fluorides|mesh-list
65028086|NCT00066040|Fluorides, Topical|fluorides, topical|mesh-list
65028087|NCT00066040|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
65028088|NCT00066040|Cariostatic Agents|cariostatic agents|mesh-ancestor
65028089|NCT00066040|Protective Agents|protective agents|mesh-ancestor
65028090|NCT00066040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028091|NCT00066040|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65028092|NCT00066040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65028093|NCT00066040|Disinfectants|disinfectants|mesh-ancestor
65028094|NCT00163553|Meperidine|meperidine|mesh-list
64724954|NCT00001063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724955|NCT00001063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64724956|NCT00001063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64724957|NCT00002305|Fluconazole|fluconazole|mesh-list
64724958|NCT00002305|Amphotericin B|amphotericin b|mesh-list
64724959|NCT00002305|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64724960|NCT00002305|Flucytosine|flucytosine|mesh-list
64724961|NCT00002305|Antifungal Agents|antifungal agents|mesh-ancestor
64724962|NCT00002305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724963|NCT00002305|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64724981|NCT00002311|Wobenzym|wobenzym|mesh-list
64332531|NCT02559180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332533|NCT02539966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64332534|NCT02539966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64332535|NCT02539966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64332536|NCT02539966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332537|NCT02539966|Antifungal Agents|antifungal agents|mesh-ancestor
64332538|NCT02539966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64332539|NCT02539966|Immunologic Factors|immunologic factors|mesh-ancestor
64332540|NCT02539966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724997|NCT00002317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724998|NCT00002317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64724999|NCT00002317|Antimetabolites|antimetabolites|mesh-ancestor
64725000|NCT00002317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725001|NCT00002317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725002|NCT00002317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64725003|NCT00002317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725004|NCT00001123|Ribavirin|ribavirin|mesh-list
64725005|NCT00001123|Antimetabolites|antimetabolites|mesh-ancestor
64725006|NCT00001123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725007|NCT00001123|Antiviral Agents|antiviral agents|mesh-ancestor
64725008|NCT00001123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725009|NCT00002323|Zidovudine|zidovudine|mesh-list
64725010|NCT00002323|Nevirapine|nevirapine|mesh-list
64725011|NCT00002323|Antimetabolites|antimetabolites|mesh-ancestor
64725012|NCT00002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028095|NCT00163553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65028096|NCT00163553|Narcotics|narcotics|mesh-ancestor
65028097|NCT00163553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65028098|NCT00163553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028099|NCT00163553|Analgesics|analgesics|mesh-ancestor
65028100|NCT00163553|Sensory System Agents|sensory system agents|mesh-ancestor
65028101|NCT00163553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028102|NCT00163553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65028103|NCT00163592|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65028104|NCT00163592|Hemostatics|hemostatics|mesh-ancestor
65028105|NCT00163592|Coagulants|coagulants|mesh-ancestor
65028106|NCT04683445|Pembrolizumab|pembrolizumab|mesh-list
65028107|NCT04683445|Trastuzumab|trastuzumab|mesh-list
65028108|NCT04683445|Pertuzumab|pertuzumab|mesh-list
65028109|NCT04683445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65028110|NCT04683445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028111|NCT00192777|Capecitabine|capecitabine|mesh-list
65028112|NCT00192777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65028113|NCT00192777|Antimetabolites|antimetabolites|mesh-ancestor
65028114|NCT00192777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028115|NCT00192777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028116|NCT00553072|Magnesium Sulfate|magnesium sulfate|mesh-list
65028117|NCT00553072|Analgesics|analgesics|mesh-ancestor
65028118|NCT00553072|Sensory System Agents|sensory system agents|mesh-ancestor
65028119|NCT00553072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028120|NCT00553072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028121|NCT00553072|Anesthetics|anesthetics|mesh-ancestor
65028122|NCT00553072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65028123|NCT00553072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65028124|NCT00553072|Anticonvulsants|anticonvulsants|mesh-ancestor
65028125|NCT00553072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65028126|NCT00553072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64582314|NCT02100007|Topotecan|topotecan|mesh-list
65028139|NCT05808725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65028140|NCT05808725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028141|NCT05808725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65028142|NCT05808725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028143|NCT05808725|Vasodilator Agents|vasodilator agents|mesh-ancestor
65028144|NCT05808608|Axitinib|axitinib|mesh-list
65028145|NCT05808608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028146|NCT05808608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65028147|NCT05808608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028148|NCT05808608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028149|NCT05808387|Resveratrol|resveratrol|mesh-list
65028150|NCT05808387|Antioxidants|antioxidants|mesh-ancestor
65028151|NCT05808387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028152|NCT05808387|Protective Agents|protective agents|mesh-ancestor
65028153|NCT05808387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028154|NCT05808387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028155|NCT05808387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65028156|NCT05808231|Quinine|quinine|mesh-list
65028157|NCT05808231|Antimalarials|antimalarials|mesh-ancestor
65028158|NCT05808231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65028159|NCT05808231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65028160|NCT05808231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65028161|NCT05808231|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65028162|NCT05808231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028163|NCT05808231|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65028164|NCT05808231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028165|NCT05808231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65028166|NCT05808231|Analgesics|analgesics|mesh-ancestor
65028167|NCT05808231|Sensory System Agents|sensory system agents|mesh-ancestor
65028168|NCT05808192|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65028169|NCT05808192|Immunologic Factors|immunologic factors|mesh-ancestor
65028170|NCT05808192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028171|NCT05808049|Antioxidants|antioxidants|mesh-list
64725013|NCT00002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64725014|NCT00002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64725015|NCT00002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725016|NCT00002323|Antiviral Agents|antiviral agents|mesh-ancestor
64419833|NCT05506501|Anesthetics|anesthetics|mesh-list
65028172|NCT05808049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028173|NCT05808049|Protective Agents|protective agents|mesh-ancestor
65028174|NCT05808049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028175|NCT05808010|Hydrotalcite|hydrotalcite|mesh-list
65028176|NCT05808010|Antacids|antacids|mesh-ancestor
65028177|NCT05808010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028178|NCT05808010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65028179|NCT05807945|Ropivacaine|ropivacaine|mesh-list
65493855|NCT04166318|Capecitabine|capecitabine|mesh-list
65028180|NCT05807945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65028181|NCT05807945|Anesthetics, Local|anesthetics, local|mesh-ancestor
65028182|NCT05807945|Anesthetics|anesthetics|mesh-ancestor
65028183|NCT05807945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65028184|NCT05807945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028185|NCT05807945|Sensory System Agents|sensory system agents|mesh-ancestor
65028186|NCT05807945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028187|NCT05807932|Mycophenolic Acid|mycophenolic acid|mesh-list
65028188|NCT05807932|Venetoclax|venetoclax|mesh-list
65028189|NCT05807932|Amsacrine|amsacrine|mesh-list
65028190|NCT05807932|Tacrolimus|tacrolimus|mesh-list
65028191|NCT05807932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65028192|NCT05807932|Immunologic Factors|immunologic factors|mesh-ancestor
65028225|NCT05807711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028226|NCT05807659|Busulfan|busulfan|mesh-list
65028227|NCT05807659|Alkylating Agents|alkylating agents|mesh-ancestor
65028228|NCT05807659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028229|NCT05807659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65028230|NCT05807659|Immunologic Factors|immunologic factors|mesh-ancestor
65028231|NCT05807659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028232|NCT05807659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65028233|NCT05807659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028234|NCT05807659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65028235|NCT05807542|Paclitaxel|paclitaxel|mesh-list
65028236|NCT05807542|Carboplatin|carboplatin|mesh-list
65028237|NCT05807542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65028238|NCT05807542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028239|NCT05807542|Tubulin Modulators|tubulin modulators|mesh-ancestor
65028240|NCT05807542|Antimitotic Agents|antimitotic agents|mesh-ancestor
65028241|NCT05807542|Mitosis Modulators|mitosis modulators|mesh-ancestor
65028242|NCT05807542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028243|NCT05807503|Cerebrolysin|cerebrolysin|mesh-list
65028244|NCT05807503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65028245|NCT05807503|Protective Agents|protective agents|mesh-ancestor
65028246|NCT05807503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028247|NCT05807503|Nootropic Agents|nootropic agents|mesh-ancestor
65028248|NCT05807425|Polidocanol|polidocanol|mesh-list
65028249|NCT05807425|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65028250|NCT05807425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65028251|NCT05807412|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65028273|NCT05807347|Immunologic Factors|immunologic factors|mesh-ancestor
65028274|NCT05807347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028275|NCT05807347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028276|NCT05807347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65028277|NCT05807347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65028278|NCT05807204|Acetylcysteine|acetylcysteine|mesh-list
65028279|NCT05807204|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65028280|NCT05807204|Antiviral Agents|antiviral agents|mesh-ancestor
65028281|NCT05807204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65028282|NCT05807204|Expectorants|expectorants|mesh-ancestor
65028283|NCT05807204|Respiratory System Agents|respiratory system agents|mesh-ancestor
65028284|NCT05807204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65028285|NCT05807204|Antioxidants|antioxidants|mesh-ancestor
65028286|NCT05807204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028287|NCT05807204|Protective Agents|protective agents|mesh-ancestor
65028288|NCT05807204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028289|NCT05807204|Antidotes|antidotes|mesh-ancestor
65028290|NCT05807165|Memantine|memantine|mesh-list
65028291|NCT05807165|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65028292|NCT05807165|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65028293|NCT05807165|Dopamine Agents|dopamine agents|mesh-ancestor
65028294|NCT05807165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65028295|NCT05807165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028296|NCT05807165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028326|NCT05781698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65028327|NCT05781698|Analgesics|analgesics|mesh-ancestor
65028328|NCT05781698|Sensory System Agents|sensory system agents|mesh-ancestor
65028329|NCT05781698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028330|NCT05781698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028331|NCT05781698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65028332|NCT05781698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65028333|NCT05759949|Fulvestrant|fulvestrant|mesh-list
65028334|NCT05759949|Palbociclib|palbociclib|mesh-list
65028335|NCT05759949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65028336|NCT05759949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028337|NCT05759949|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65028338|NCT05759949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65028339|NCT05759949|Hormone Antagonists|hormone antagonists|mesh-ancestor
65028340|NCT05759949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65028341|NCT05759949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028342|NCT05759949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65028343|NCT05759949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028344|NCT05759949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028345|NCT05736861|Ivermectin|ivermectin|mesh-list
65028346|NCT05736861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65028347|NCT05736861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65028348|NCT05709509|Aspirin|aspirin|mesh-list
65028349|NCT05709509|Colchicine|colchicine|mesh-list
65028350|NCT05709509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65028351|NCT05709509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65028352|NCT05709509|Analgesics|analgesics|mesh-ancestor
65028353|NCT05709509|Sensory System Agents|sensory system agents|mesh-ancestor
65028364|NCT05709509|Antipyretics|antipyretics|mesh-ancestor
65028372|NCT05693844|Fludarabine|fludarabine|mesh-list
65028373|NCT05693844|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65028374|NCT05693844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65028375|NCT05693844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028376|NCT05693844|Tubulin Modulators|tubulin modulators|mesh-ancestor
65028377|NCT05693844|Antimitotic Agents|antimitotic agents|mesh-ancestor
65028378|NCT05693844|Mitosis Modulators|mitosis modulators|mesh-ancestor
65028379|NCT05693844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028380|NCT05693844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65028381|NCT05693844|Immunologic Factors|immunologic factors|mesh-ancestor
65028382|NCT05693844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028383|NCT05693844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65028384|NCT05693844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65028385|NCT05693844|Alkylating Agents|alkylating agents|mesh-ancestor
65028386|NCT05693844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65028387|NCT05690698|Haloperidol|haloperidol|mesh-list
65028388|NCT05690698|Haloperidol decanoate|haloperidol decanoate|mesh-list
65028389|NCT05690698|Antiemetics|antiemetics|mesh-ancestor
65028390|NCT05690698|Autonomic Agents|autonomic agents|mesh-ancestor
65028391|NCT05690698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028392|NCT05690698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028393|NCT05690698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65028394|NCT05690698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65028395|NCT05690698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65028396|NCT05690698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65028397|NCT05690698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65028398|NCT05690698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65028399|NCT05690698|Dopamine Agents|dopamine agents|mesh-ancestor
65028400|NCT05690698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65028401|NCT05690698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028402|NCT05690698|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65028403|NCT05674513|Ulipristal acetate|ulipristal acetate|mesh-list
65028404|NCT05674513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65028405|NCT05674513|Contraceptive Agents|contraceptive agents|mesh-ancestor
64902188|NCT05680974|Antibodies|antibodies|mesh-list
65028421|NCT05669482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028422|NCT05669482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65028423|NCT05669482|Immunologic Factors|immunologic factors|mesh-ancestor
65028424|NCT05669482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028425|NCT05644340|Methamphetamine|methamphetamine|mesh-list
65028426|NCT05644340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65028427|NCT05644340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028428|NCT05644340|Sympathomimetics|sympathomimetics|mesh-ancestor
65028429|NCT05644340|Autonomic Agents|autonomic agents|mesh-ancestor
65028430|NCT05644340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028431|NCT05644340|Dopamine Agents|dopamine agents|mesh-ancestor
65028432|NCT05644340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65028433|NCT05644340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028434|NCT05644340|Adrenergic Agents|adrenergic agents|mesh-ancestor
65028435|NCT05644340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65028436|NCT05644340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65028437|NCT05644340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65028438|NCT05644340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65028440|NCT05630872|Dolutegravir|dolutegravir|mesh-list
65028441|NCT05630872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65028442|NCT05630872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65028489|NCT05617118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028490|NCT05617118|Cholinergic Agents|cholinergic agents|mesh-ancestor
65028491|NCT05617118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65028492|NCT05617118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028493|NCT05617118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65028494|NCT05617118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028495|NCT05617118|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65028496|NCT05617118|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65028497|NCT05617118|GABA Agonists|gaba agonists|mesh-ancestor
65028498|NCT05617118|GABA Agents|gaba agents|mesh-ancestor
65028499|NCT05608837|Dexamethasone|dexamethasone|mesh-list
65028500|NCT05608837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65028501|NCT05608837|Antiemetics|antiemetics|mesh-ancestor
65028502|NCT05608837|Autonomic Agents|autonomic agents|mesh-ancestor
65028503|NCT05608837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028504|NCT05608837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028505|NCT05608837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65028506|NCT05608837|Glucocorticoids|glucocorticoids|mesh-ancestor
65028507|NCT05608837|Hormones|hormones|mesh-ancestor
65028508|NCT05608837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65028509|NCT05608837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65028541|NCT05591105|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65028542|NCT05591105|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65028543|NCT05591105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65028544|NCT05591105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65028545|NCT05591105|Narcotics|narcotics|mesh-ancestor
65028546|NCT05591105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65028547|NCT05591105|Antipyretics|antipyretics|mesh-ancestor
65028548|NCT05591105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65028549|NCT05591105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65028550|NCT05591105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65028552|NCT05550662|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65028553|NCT05550662|Anesthetics, General|anesthetics, general|mesh-ancestor
65028554|NCT05550662|Anesthetics|anesthetics|mesh-ancestor
65028555|NCT05550662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65028556|NCT05550662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028557|NCT05546658|Psilocybin|psilocybin|mesh-list
65028558|NCT05546658|Hallucinogens|hallucinogens|mesh-ancestor
65028559|NCT05546658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028560|NCT05546658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65028561|NCT05533697|Pembrolizumab|pembrolizumab|mesh-list
65028562|NCT05533697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65028563|NCT05533697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028564|NCT05526157|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65028565|NCT05526157|Glucagon|glucagon|mesh-list
65028566|NCT05526157|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65028567|NCT05526157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65028568|NCT05526157|Hormones|hormones|mesh-ancestor
65028569|NCT05526157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65028570|NCT05526157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028571|NCT05526157|Incretins|incretins|mesh-ancestor
65028572|NCT05526157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028573|NCT05526157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65028574|NCT05494580|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65028578|NCT05464654|Estrogens|estrogens|mesh-list
65028581|NCT05464654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65028582|NCT05464654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028583|NCT05438602|Ritonavir|ritonavir|mesh-list
65028584|NCT05438602|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65028585|NCT05438602|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65028586|NCT05438602|Protease Inhibitors|protease inhibitors|mesh-ancestor
65028587|NCT05438602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028588|NCT05438602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469908|NCT05629585|Pembrolizumab|pembrolizumab|mesh-list
64513806|NCT01891851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64513807|NCT01891851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64513808|NCT01891851|Antiviral Agents|antiviral agents|mesh-ancestor
64513809|NCT01891851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64513810|NCT01891851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64513811|NCT01891851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64513824|NCT01459419|Antibodies|antibodies|mesh-list
64513825|NCT01459419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64513826|NCT01459419|Immunologic Factors|immunologic factors|mesh-ancestor
64513827|NCT01459419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513828|NCT01892241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65028589|NCT05438602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65028590|NCT05438602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65028591|NCT05438602|Antiviral Agents|antiviral agents|mesh-ancestor
65028592|NCT05438602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65028619|NCT05280704|Anesthetics, Local|anesthetics, local|mesh-ancestor
65028620|NCT05280704|Anesthetics|anesthetics|mesh-ancestor
65028621|NCT05280704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65028622|NCT05280704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028623|NCT05280704|Sensory System Agents|sensory system agents|mesh-ancestor
65028624|NCT05280704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028625|NCT05280704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65028626|NCT05280704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65028627|NCT05280704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65028628|NCT05280704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65028629|NCT05280704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028630|NCT05267873|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65028631|NCT05267873|Vortioxetine|vortioxetine|mesh-list
65028632|NCT05267873|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65028633|NCT05267873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65028634|NCT05267873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65028635|NCT05267873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028636|NCT05267873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65028637|NCT05267873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028638|NCT05267873|Analgesics|analgesics|mesh-ancestor
65028639|NCT05267873|Sensory System Agents|sensory system agents|mesh-ancestor
65028640|NCT05267873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028641|NCT05267873|Antidepressive Agents|antidepressive agents|mesh-ancestor
65028642|NCT05267873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65028643|NCT05267873|Dopamine Agents|dopamine agents|mesh-ancestor
65028644|NCT05267873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65028645|NCT05267873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65028646|NCT05267873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65028647|NCT05267873|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65028648|NCT05267873|Serotonin Agents|serotonin agents|mesh-ancestor
65028659|NCT05232929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028660|NCT05232929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028661|NCT05180097|Gemcitabine|gemcitabine|mesh-list
65028662|NCT05180097|Dexamethasone|dexamethasone|mesh-list
65028663|NCT05180097|Pembrolizumab|pembrolizumab|mesh-list
65028664|NCT05180097|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65028665|NCT05180097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65028666|NCT05180097|Antiemetics|antiemetics|mesh-ancestor
65028667|NCT05180097|Autonomic Agents|autonomic agents|mesh-ancestor
65028668|NCT05180097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028669|NCT05180097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028670|NCT05180097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65028671|NCT05180097|Glucocorticoids|glucocorticoids|mesh-ancestor
65028673|NCT05180097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65028674|NCT05180097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65028675|NCT05180097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028676|NCT05180097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65028677|NCT05180097|Antimetabolites|antimetabolites|mesh-ancestor
65028678|NCT05180097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028679|NCT05180097|Antiviral Agents|antiviral agents|mesh-ancestor
65028680|NCT05180097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65028681|NCT05180097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028682|NCT05180097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65028683|NCT05180097|Immunologic Factors|immunologic factors|mesh-ancestor
65028684|NCT05180097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65028685|NCT05113901|Methylprednisolone|methylprednisolone|mesh-list
65028686|NCT05113901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65028687|NCT05113901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65028688|NCT05113901|Prednisolone|prednisolone|mesh-list
65028689|NCT05113901|Prednisolone acetate|prednisolone acetate|mesh-list
65028690|NCT05113901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65028691|NCT05113901|Prednisolone phosphate|prednisolone phosphate|mesh-list
65028692|NCT05113901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65028693|NCT05113901|Antiemetics|antiemetics|mesh-ancestor
65028701|NCT05113901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65028702|NCT05113901|Protective Agents|protective agents|mesh-ancestor
65028703|NCT05113901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65028704|NCT05113901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028705|NCT05065216|Kallikreins|kallikreins|mesh-list
65028706|NCT05065216|Coagulants|coagulants|mesh-ancestor
65028707|NCT05065216|Fertility Agents, Male|fertility agents, male|mesh-ancestor
65028708|NCT05065216|Fertility Agents|fertility agents|mesh-ancestor
65028709|NCT05065216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65028710|NCT05065216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028711|NCT05024214|Sunitinib|sunitinib|mesh-list
65028712|NCT05024214|Lenvatinib|lenvatinib|mesh-list
65028713|NCT05024214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028714|NCT05024214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65028715|NCT05024214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65028716|NCT05024214|Growth Substances|growth substances|mesh-ancestor
65028717|NCT05024214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028718|NCT05024214|Growth Inhibitors|growth inhibitors|mesh-ancestor
65028719|NCT05024214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65028720|NCT05024214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028721|NCT05024214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028722|NCT05018091|Dexamethasone|dexamethasone|mesh-list
65028723|NCT05018091|Dexamethasone acetate|dexamethasone acetate|mesh-list
65028724|NCT05018091|BB 1101|bb 1101|mesh-list
65028725|NCT05018091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65028726|NCT05018091|Antiemetics|antiemetics|mesh-ancestor
65028727|NCT05018091|Autonomic Agents|autonomic agents|mesh-ancestor
65028728|NCT05018091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028729|NCT05018091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028730|NCT05018091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65028731|NCT05018091|Glucocorticoids|glucocorticoids|mesh-ancestor
65028732|NCT05018091|Hormones|hormones|mesh-ancestor
65028733|NCT05018091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65028734|NCT05018091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65028735|NCT05018091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470057|NCT05567094|Hormones|hormones|mesh-ancestor
65028740|NCT04999644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65028741|NCT04999644|Autonomic Agents|autonomic agents|mesh-ancestor
65028742|NCT04999644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028743|NCT04999644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028744|NCT04999644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65028745|NCT04999644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65028746|NCT04999644|Cholinergic Agents|cholinergic agents|mesh-ancestor
65028747|NCT04999644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65028748|NCT04999644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028749|NCT04977986|Cannabidiol|cannabidiol|mesh-list
65028750|NCT04977986|Anticonvulsants|anticonvulsants|mesh-ancestor
65028751|NCT04962503|Afamelanotide|afamelanotide|mesh-list
65028752|NCT04962503|Dermatologic Agents|dermatologic agents|mesh-ancestor
65028753|NCT04918186|Durvalumab|durvalumab|mesh-list
65028754|NCT04918186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65028755|NCT04918186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028756|NCT04916080|Acetylcysteine|acetylcysteine|mesh-list
65028757|NCT04916080|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65028758|NCT04916080|Antiviral Agents|antiviral agents|mesh-ancestor
65028759|NCT04916080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65028760|NCT04916080|Expectorants|expectorants|mesh-ancestor
65028761|NCT04916080|Respiratory System Agents|respiratory system agents|mesh-ancestor
65028762|NCT04916080|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65028763|NCT04916080|Antioxidants|antioxidants|mesh-ancestor
65028764|NCT04916080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028765|NCT04916080|Protective Agents|protective agents|mesh-ancestor
65028766|NCT04916080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028767|NCT04916080|Antidotes|antidotes|mesh-ancestor
65028790|NCT04880434|Cyclophosphamide|cyclophosphamide|mesh-list
65028791|NCT04880434|Fludarabine|fludarabine|mesh-list
65028792|NCT04880434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65028793|NCT04880434|Immunologic Factors|immunologic factors|mesh-ancestor
65028794|NCT04880434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028795|NCT04880434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65028796|NCT04880434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65028797|NCT04880434|Alkylating Agents|alkylating agents|mesh-ancestor
65028798|NCT04880434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028799|NCT04880434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028800|NCT04880434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65028801|NCT04862975|Tenofovir|tenofovir|mesh-list
65028802|NCT04862975|Emtricitabine|emtricitabine|mesh-list
65028803|NCT04862975|Efavirenz|efavirenz|mesh-list
65028804|NCT04862975|Dolutegravir|dolutegravir|mesh-list
65028805|NCT04862975|Antiviral Agents|antiviral agents|mesh-ancestor
65028806|NCT04862975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65028807|NCT04862975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65028808|NCT04862975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65028809|NCT04862975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028810|NCT04862975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028811|NCT04862975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65028812|NCT04862975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65028813|NCT04862975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65028814|NCT04862975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65028815|NCT04862975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64582990|NCT01442714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028838|NCT04832854|Mitosis Modulators|mitosis modulators|mesh-ancestor
65028839|NCT04832854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028840|NCT04832854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65028841|NCT04832854|Antimetabolites|antimetabolites|mesh-ancestor
65028842|NCT04832854|Antiviral Agents|antiviral agents|mesh-ancestor
65028843|NCT04832854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65028844|NCT04832854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028845|NCT04832854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65028846|NCT04832854|Immunologic Factors|immunologic factors|mesh-ancestor
65028847|NCT04832854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028848|NCT04832854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65028849|NCT04832854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65028851|NCT04826562|Dolutegravir|dolutegravir|mesh-list
65028852|NCT04826562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65028853|NCT04826562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65028854|NCT04826562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65028855|NCT04826562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028856|NCT04826562|Antiviral Agents|antiviral agents|mesh-ancestor
65028857|NCT04826562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65028858|NCT04826562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65028859|NCT04826562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65028860|NCT04826562|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65028888|NCT04716699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514113|NCT02600949|Pembrolizumab|pembrolizumab|mesh-list
64514194|NCT01928290|Antidotes|antidotes|mesh-ancestor
65028889|NCT04716699|Sensory System Agents|sensory system agents|mesh-ancestor
65028890|NCT04716699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028891|NCT04716699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65028892|NCT04716699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65028893|NCT04716699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65028894|NCT04716699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65028895|NCT04716699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028896|NCT04691817|Atezolizumab|atezolizumab|mesh-list
65028897|NCT04691817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65028898|NCT04685980|Morphine|morphine|mesh-list
65028899|NCT04685980|Anesthetics|anesthetics|mesh-list
65028900|NCT04685980|Anesthetics, Local|anesthetics, local|mesh-list
65028901|NCT04685980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65028902|NCT04685980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028903|NCT04685980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65028904|NCT04685980|Narcotics|narcotics|mesh-ancestor
65028905|NCT04685980|Analgesics|analgesics|mesh-ancestor
65028906|NCT04685980|Sensory System Agents|sensory system agents|mesh-ancestor
65028940|NCT04577690|Epinephrine|epinephrine|mesh-list
65028941|NCT04577690|Racepinephrine|racepinephrine|mesh-list
65028942|NCT04577690|Bupivacaine|bupivacaine|mesh-list
65028943|NCT04577690|Epinephryl borate|epinephryl borate|mesh-list
65028944|NCT04577690|Anesthetics, Local|anesthetics, local|mesh-ancestor
65028945|NCT04577690|Anesthetics|anesthetics|mesh-ancestor
65028946|NCT04577690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65028947|NCT04577690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65028948|NCT04577690|Sensory System Agents|sensory system agents|mesh-ancestor
65028949|NCT04577690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65028950|NCT04577690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65028951|NCT04577690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65028952|NCT04577690|Adrenergic Agents|adrenergic agents|mesh-ancestor
65028953|NCT04577690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65028954|NCT04577690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65028955|NCT04577690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65028956|NCT04577690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65028957|NCT04577690|Autonomic Agents|autonomic agents|mesh-ancestor
65028958|NCT04577690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65028959|NCT04577690|Respiratory System Agents|respiratory system agents|mesh-ancestor
65028960|NCT04577690|Mydriatics|mydriatics|mesh-ancestor
65028961|NCT04577690|Sympathomimetics|sympathomimetics|mesh-ancestor
65028962|NCT04577690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65028963|NCT04564547|Islatravir|islatravir|mesh-list
65028964|NCT04564547|Antiviral Agents|antiviral agents|mesh-ancestor
65028993|NCT04531176|Hormones|hormones|mesh-ancestor
65028994|NCT04531176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65028995|NCT04531176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65028996|NCT04531176|Antidepressive Agents|antidepressive agents|mesh-ancestor
65028997|NCT04531176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65028998|NCT04531176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65028999|NCT04531176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65029000|NCT04531176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65029001|NCT04531176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029002|NCT04531176|Dopamine Agents|dopamine agents|mesh-ancestor
65029003|NCT04531176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65029004|NCT04531176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65029005|NCT04531176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65029006|NCT04531176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029007|NCT04531176|Anticonvulsants|anticonvulsants|mesh-ancestor
65029008|NCT04531176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65029009|NCT04531176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65029010|NCT04531176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65029011|NCT04531176|Appetite Depressants|appetite depressants|mesh-ancestor
65029012|NCT04531176|Sympathomimetics|sympathomimetics|mesh-ancestor
65029016|NCT04472767|Ipilimumab|ipilimumab|mesh-list
65029046|NCT04409860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029047|NCT04409860|Tubulin Modulators|tubulin modulators|mesh-ancestor
65029048|NCT04409860|Antimitotic Agents|antimitotic agents|mesh-ancestor
65029049|NCT04409860|Mitosis Modulators|mitosis modulators|mesh-ancestor
65029050|NCT04409860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029051|NCT04380636|Paclitaxel|paclitaxel|mesh-list
65029052|NCT04380636|Etoposide|etoposide|mesh-list
65029053|NCT04380636|Carboplatin|carboplatin|mesh-list
65029054|NCT04380636|Pembrolizumab|pembrolizumab|mesh-list
65029055|NCT04380636|Pemetrexed|pemetrexed|mesh-list
65029056|NCT04380636|Durvalumab|durvalumab|mesh-list
65029057|NCT04380636|Olaparib|olaparib|mesh-list
65029058|NCT04380636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65029059|NCT04380636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029060|NCT04380636|Tubulin Modulators|tubulin modulators|mesh-ancestor
65029061|NCT04380636|Antimitotic Agents|antimitotic agents|mesh-ancestor
65029062|NCT04380636|Mitosis Modulators|mitosis modulators|mesh-ancestor
65029063|NCT04380636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029064|NCT04380636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64514345|NCT02248701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514346|NCT02248701|Hormone Antagonists|hormone antagonists|mesh-ancestor
64514347|NCT02248701|Urological Agents|urological agents|mesh-ancestor
64514348|NCT02283814|Topiramate|topiramate|mesh-list
64514349|NCT02283814|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64514350|NCT02283814|Anticonvulsants|anticonvulsants|mesh-ancestor
64514351|NCT02283814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64514352|NCT02283814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514353|NCT02283814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64514354|NCT02283814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64514355|NCT02283814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64514356|NCT02283814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514357|NCT05739682|Anti-Infective Agents|anti-infective agents|mesh-list
64514358|NCT05739682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65029096|NCT04093167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65029097|NCT04093167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029099|NCT04075110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65029100|NCT04075110|Respiratory System Agents|respiratory system agents|mesh-ancestor
65029101|NCT04075110|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65029102|NCT04075110|Hormone Antagonists|hormone antagonists|mesh-ancestor
65029103|NCT04075110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65029108|NCT04055909|Nangibotide|nangibotide|mesh-list
65029133|NCT03861793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65029134|NCT03861793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029135|NCT03831113|Buprenorphine|buprenorphine|mesh-list
65029136|NCT03831113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65029137|NCT03831113|Narcotics|narcotics|mesh-ancestor
65029138|NCT03831113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65029139|NCT03831113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029140|NCT03831113|Analgesics|analgesics|mesh-ancestor
65029141|NCT03831113|Sensory System Agents|sensory system agents|mesh-ancestor
65029142|NCT03831113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65029143|NCT03831113|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65029144|NCT03816553|Apatinib|apatinib|mesh-list
65029145|NCT03816553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029146|NCT03816553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65029147|NCT03816553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029148|NCT03816553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029149|NCT03760523|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
65029150|NCT03760523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65029151|NCT03760523|Alkylating Agents|alkylating agents|mesh-ancestor
65029186|NCT03648905|Dopamine|dopamine|mesh-list
65029187|NCT03648905|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65029188|NCT03648905|Sympathomimetics|sympathomimetics|mesh-ancestor
65029189|NCT03648905|Autonomic Agents|autonomic agents|mesh-ancestor
65029190|NCT03648905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65029191|NCT03648905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029192|NCT03648905|Dopamine Agents|dopamine agents|mesh-ancestor
65029193|NCT03648905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65029194|NCT03648905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029195|NCT03648905|Protective Agents|protective agents|mesh-ancestor
65029196|NCT03641560|Androgens|androgens|mesh-list
65029197|NCT03641560|Hormones|hormones|mesh-ancestor
65029198|NCT03641560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65029199|NCT03641560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029200|NCT03559647|Atezolizumab|atezolizumab|mesh-list
65029201|NCT03559647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029202|NCT03557918|Tremelimumab|tremelimumab|mesh-list
65029203|NCT03557918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029204|NCT03544099|Pembrolizumab|pembrolizumab|mesh-list
65029205|NCT03544099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65029206|NCT03544099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029207|NCT03528408|Nivolumab|nivolumab|mesh-list
65029208|NCT03528408|Ipilimumab|ipilimumab|mesh-list
65029209|NCT03528408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65029210|NCT03528408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029211|NCT03528408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65029212|NCT03528408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029213|NCT03527108|Nivolumab|nivolumab|mesh-list
65029214|NCT03527108|Ramucirumab|ramucirumab|mesh-list
65029215|NCT03527108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65029216|NCT03527108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029217|NCT03527108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65029218|NCT03527108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029219|NCT03501381|Aldesleukin|aldesleukin|mesh-list
65029220|NCT03501381|Interleukin-2|interleukin-2|mesh-list
65029226|NCT03501381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65029227|NCT03501381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029228|NCT03501381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65029229|NCT03501381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65029230|NCT03501381|Antiviral Agents|antiviral agents|mesh-ancestor
65029231|NCT03501381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65029232|NCT03501381|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65029233|NCT03501381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029234|NCT03501381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029235|NCT03478488|Gemcitabine|gemcitabine|mesh-list
65029236|NCT03478488|Oxaliplatin|oxaliplatin|mesh-list
65029237|NCT03478488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65029238|NCT03478488|Antimetabolites|antimetabolites|mesh-ancestor
65029239|NCT03478488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029240|NCT03478488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029241|NCT03478488|Antiviral Agents|antiviral agents|mesh-ancestor
65029242|NCT03478488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65029243|NCT03478488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029244|NCT03478488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65029245|NCT03478488|Immunologic Factors|immunologic factors|mesh-ancestor
65029246|NCT03478488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029247|NCT03451331|Gemcitabine|gemcitabine|mesh-list
65029248|NCT03451331|Carboplatin|carboplatin|mesh-list
65029249|NCT03451331|Oxaliplatin|oxaliplatin|mesh-list
65029250|NCT03451331|Nivolumab|nivolumab|mesh-list
65029251|NCT03451331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029252|NCT03451331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65029253|NCT03451331|Antimetabolites|antimetabolites|mesh-ancestor
65029254|NCT03451331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029255|NCT03451331|Antiviral Agents|antiviral agents|mesh-ancestor
65029256|NCT03451331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65029257|NCT03451331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029269|NCT03412877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583439|NCT01898819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64583440|NCT01898819|Analgesics|analgesics|mesh-ancestor
65029270|NCT03412877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65029271|NCT03412877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65029272|NCT03412877|Alkylating Agents|alkylating agents|mesh-ancestor
65029273|NCT03412877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029274|NCT03412877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029275|NCT03412877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65029276|NCT03412877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65029277|NCT03412877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65029278|NCT03412877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65029279|NCT03412877|Antiviral Agents|antiviral agents|mesh-ancestor
65029280|NCT03412877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65029281|NCT03406299|Leucovorin|leucovorin|mesh-list
65029282|NCT03406299|Gemcitabine|gemcitabine|mesh-list
65029283|NCT03406299|Oxaliplatin|oxaliplatin|mesh-list
65029284|NCT03406299|Tegafur|tegafur|mesh-list
65029285|NCT03406299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029286|NCT03406299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65029287|NCT03406299|Antimetabolites|antimetabolites|mesh-ancestor
65029288|NCT03406299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029289|NCT03406299|Antiviral Agents|antiviral agents|mesh-ancestor
65029290|NCT03406299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65029291|NCT03406299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029292|NCT03406299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65029293|NCT03406299|Immunologic Factors|immunologic factors|mesh-ancestor
65029294|NCT03406299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029295|NCT03406299|Antidotes|antidotes|mesh-ancestor
65029296|NCT03406299|Protective Agents|protective agents|mesh-ancestor
65029297|NCT03406299|Vitamin B Complex|vitamin b complex|mesh-ancestor
64725021|NCT00002323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64725022|NCT00380965|Nabilone|nabilone|mesh-list
64725023|NCT00380965|Antiemetics|antiemetics|mesh-ancestor
64725024|NCT00380965|Autonomic Agents|autonomic agents|mesh-ancestor
64725025|NCT00380965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64725026|NCT00380965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725027|NCT00380965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64725028|NCT00380965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64725029|NCT00380965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64725030|NCT00380965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64725031|NCT00380965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64725032|NCT00002996|Flecainide|flecainide|mesh-list
64725033|NCT00002996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64503296|NCT03352362|Acetaminophen|acetaminophen|mesh-list
64503297|NCT03352362|Ibuprofen|ibuprofen|mesh-list
65029298|NCT03406299|Vitamins|vitamins|mesh-ancestor
65029299|NCT03406299|Micronutrients|micronutrients|mesh-ancestor
65029300|NCT03404960|Nivolumab|nivolumab|mesh-list
65029301|NCT03404960|Ipilimumab|ipilimumab|mesh-list
65029302|NCT03404960|Niraparib|niraparib|mesh-list
65029303|NCT03404960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65029304|NCT03404960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029305|NCT03404960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65029306|NCT03404960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029307|NCT03404960|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65029308|NCT03404960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029309|NCT03396445|Paclitaxel|paclitaxel|mesh-list
65029310|NCT03396445|Carboplatin|carboplatin|mesh-list
65029311|NCT03396445|Pembrolizumab|pembrolizumab|mesh-list
65029312|NCT03396445|Pemetrexed|pemetrexed|mesh-list
65029313|NCT03396445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65029314|NCT03396445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029315|NCT03396445|Tubulin Modulators|tubulin modulators|mesh-ancestor
64514490|NCT01727141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65029316|NCT03396445|Antimitotic Agents|antimitotic agents|mesh-ancestor
65029317|NCT03396445|Mitosis Modulators|mitosis modulators|mesh-ancestor
65029318|NCT03396445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029319|NCT03396445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65029320|NCT03396445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029324|NCT03385655|Durvalumab|durvalumab|mesh-list
65029351|NCT03330028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65029352|NCT03330028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493857|NCT04166318|Mitomycin|mitomycin|mesh-list
65029353|NCT03330028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65029354|NCT03330028|Glucocorticoids|glucocorticoids|mesh-ancestor
65029355|NCT03330028|Hormones|hormones|mesh-ancestor
65029356|NCT03330028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65029357|NCT03330028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65029358|NCT03330028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65029359|NCT03330028|Alkylating Agents|alkylating agents|mesh-ancestor
65029360|NCT03330028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65029361|NCT03330028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029362|NCT03330028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65029363|NCT03330028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65029364|NCT03330028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65029365|NCT03330028|Anesthetics, Local|anesthetics, local|mesh-ancestor
65029366|NCT03330028|Anesthetics|anesthetics|mesh-ancestor
65029367|NCT03330028|Sensory System Agents|sensory system agents|mesh-ancestor
65029368|NCT03330028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64946431|NCT04134936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946433|NCT04134936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64946434|NCT04134936|Growth Substances|growth substances|mesh-ancestor
64946435|NCT04134936|Growth Inhibitors|growth inhibitors|mesh-ancestor
64946436|NCT04134936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946437|NCT04115111|Durvalumab|durvalumab|mesh-list
64946438|NCT04115111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64946439|NCT04115111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946440|NCT04113109|Icatibant|icatibant|mesh-list
64946441|NCT04113109|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64946442|NCT04113109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64946443|NCT04113109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946444|NCT04113109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64946445|NCT04113109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64946446|NCT04113109|Analgesics|analgesics|mesh-ancestor
64946447|NCT04113109|Sensory System Agents|sensory system agents|mesh-ancestor
64332581|NCT02455557|Temozolomide|temozolomide|mesh-list
64332582|NCT02455557|Sargramostim|sargramostim|mesh-list
64332583|NCT02455557|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64332584|NCT02455557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64332585|NCT02455557|Alkylating Agents|alkylating agents|mesh-ancestor
64332586|NCT02455557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725034|NCT00002996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64419840|NCT05509153|Acetylcysteine|acetylcysteine|mesh-list
64725040|NCT00001135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64725041|NCT00001135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725042|NCT00001135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725043|NCT00001135|Antiviral Agents|antiviral agents|mesh-ancestor
64725044|NCT00001135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725045|NCT00001135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64725046|NCT00001135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64725047|NCT00001135|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64946448|NCT04113109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65029369|NCT03330028|Histamine Antagonists|histamine antagonists|mesh-ancestor
65029370|NCT03330028|Histamine Agents|histamine agents|mesh-ancestor
65029371|NCT03330028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65029372|NCT03330028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65029373|NCT03330028|Antipruritics|antipruritics|mesh-ancestor
65029374|NCT03330028|Dermatologic Agents|dermatologic agents|mesh-ancestor
65029375|NCT03330028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65029376|NCT03330028|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65029377|NCT03324373|Everolimus|everolimus|mesh-list
65029378|NCT03324373|Lenvatinib|lenvatinib|mesh-list
65029379|NCT03324373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029380|NCT03324373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65029381|NCT03324373|Immunologic Factors|immunologic factors|mesh-ancestor
65029382|NCT03324373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029383|NCT03324373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65029384|NCT03324373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029385|NCT03324373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029386|NCT03311555|Docetaxel|docetaxel|mesh-list
65029387|NCT03311555|Androgens|androgens|mesh-list
65029388|NCT03311555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029393|NCT03311555|Hormones|hormones|mesh-ancestor
65029427|NCT03259503|Busulfan|busulfan|mesh-list
65029428|NCT03259503|Olaparib|olaparib|mesh-list
65029429|NCT03259503|Mechlorethamine|mechlorethamine|mesh-list
65029430|NCT03259503|Vorinostat|vorinostat|mesh-list
65029431|NCT03259503|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65029432|NCT03259503|Antibodies|antibodies|mesh-list
65029433|NCT03259503|Immunoglobulins|immunoglobulins|mesh-list
65029434|NCT03259503|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65029435|NCT03259503|Immunologic Factors|immunologic factors|mesh-ancestor
65029436|NCT03259503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029437|NCT03259503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029438|NCT03259503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65029439|NCT03259503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65029440|NCT03259503|Antimetabolites|antimetabolites|mesh-ancestor
65029441|NCT03259503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029442|NCT03259503|Antiviral Agents|antiviral agents|mesh-ancestor
65029443|NCT03259503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65029444|NCT03259503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029445|NCT03259503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65029446|NCT03259503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65029447|NCT03259503|Alkylating Agents|alkylating agents|mesh-ancestor
65029448|NCT03259503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65029449|NCT03259503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65029450|NCT03259503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65029451|NCT03217565|Tedizolid|tedizolid|mesh-list
65029452|NCT03217565|Tedizolid phosphate|tedizolid phosphate|mesh-list
65029453|NCT03217565|Oxazolidinones|oxazolidinones|mesh-list
65029454|NCT03217565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65029455|NCT03217565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65029456|NCT03217565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65029457|NCT03217565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029459|NCT03214562|Cytarabine|cytarabine|mesh-list
64514636|NCT02712801|Nevirapine|nevirapine|mesh-list
65029473|NCT03214562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65029474|NCT03214562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65029475|NCT03214562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65029476|NCT03214562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65029477|NCT03214562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029478|NCT03196180|Fluorouracil|fluorouracil|mesh-list
65029479|NCT03196180|Imiquimod|imiquimod|mesh-list
65029480|NCT03196180|Antimetabolites|antimetabolites|mesh-ancestor
65029481|NCT03196180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029482|NCT03196180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65029483|NCT03196180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029484|NCT03196180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65029485|NCT03196180|Immunologic Factors|immunologic factors|mesh-ancestor
65029486|NCT03196180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029487|NCT03196180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65029488|NCT03196180|Interferon Inducers|interferon inducers|mesh-ancestor
65029489|NCT03162627|Olaparib|olaparib|mesh-list
65029490|NCT03162627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65029491|NCT03162627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029526|NCT02960022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65029527|NCT02960022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029528|NCT02960022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65029529|NCT02960022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029530|NCT02960022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029531|NCT02960022|Hormone Antagonists|hormone antagonists|mesh-ancestor
65029532|NCT02960022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65029533|NCT02853344|Pembrolizumab|pembrolizumab|mesh-list
65029534|NCT02853344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65029535|NCT02853344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029536|NCT02821013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65029537|NCT02821013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029538|NCT02821013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029539|NCT02738229|Valacyclovir|valacyclovir|mesh-list
65029540|NCT02738229|Antiviral Agents|antiviral agents|mesh-ancestor
65029541|NCT02738229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65029542|NCT02675426|Upadacitinib|upadacitinib|mesh-list
65029543|NCT02675426|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
65029544|NCT02675426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65029545|NCT02675426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029546|NCT02675426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029547|NCT02675426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65029548|NCT02579473|Rotigotine|rotigotine|mesh-list
65029549|NCT02579473|Dopamine Agonists|dopamine agonists|mesh-ancestor
64514713|NCT02401503|Alkylating Agents|alkylating agents|mesh-ancestor
65029551|NCT02579473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65029552|NCT02579473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029574|NCT02427620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65029575|NCT02427620|Methotrexate|methotrexate|mesh-list
65029576|NCT02427620|Vincristine|vincristine|mesh-list
65029577|NCT02427620|Daunorubicin|daunorubicin|mesh-list
65029578|NCT02427620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65029579|NCT02427620|Antibodies|antibodies|mesh-list
65029580|NCT02427620|Immunoglobulins|immunoglobulins|mesh-list
65029581|NCT02427620|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65029582|NCT02427620|BB 1101|bb 1101|mesh-list
65029583|NCT02427620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65029584|NCT02427620|Immunologic Factors|immunologic factors|mesh-ancestor
65029585|NCT02427620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493858|NCT04166318|Antimetabolites|antimetabolites|mesh-ancestor
65029586|NCT02427620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65029587|NCT02427620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65029588|NCT02427620|Alkylating Agents|alkylating agents|mesh-ancestor
65029589|NCT02427620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029590|NCT02427620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029591|NCT02427620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65029592|NCT02427620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65029594|NCT02427620|Autonomic Agents|autonomic agents|mesh-ancestor
65029595|NCT02427620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65029596|NCT02427620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65029597|NCT02427620|Glucocorticoids|glucocorticoids|mesh-ancestor
65029598|NCT02427620|Hormones|hormones|mesh-ancestor
65029599|NCT02427620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65029600|NCT02427620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65029601|NCT02427620|Protease Inhibitors|protease inhibitors|mesh-ancestor
65029602|NCT02427620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029603|NCT02427620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65029604|NCT02427620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65029605|NCT02427620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65029617|NCT02427620|Tubulin Modulators|tubulin modulators|mesh-ancestor
65029618|NCT02427620|Antimitotic Agents|antimitotic agents|mesh-ancestor
65029619|NCT02427620|Mitosis Modulators|mitosis modulators|mesh-ancestor
65029620|NCT02415621|Abiraterone Acetate|abiraterone acetate|mesh-list
65029621|NCT02415621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029622|NCT02415621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65029623|NCT02415621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029624|NCT02415621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029625|NCT02415621|Hormone Antagonists|hormone antagonists|mesh-ancestor
65029626|NCT02415621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65029627|NCT02415621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029628|NCT02415621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65029629|NCT02403505|Myeloma Proteins|myeloma proteins|mesh-list
65029630|NCT02403505|Paraproteins|paraproteins|mesh-list
65029631|NCT02403505|BCG Vaccine|bcg vaccine|mesh-list
65029632|NCT02403505|Immunologic Factors|immunologic factors|mesh-ancestor
65029633|NCT02403505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029634|NCT02403505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65029635|NCT02401035|Pantoprazole|pantoprazole|mesh-list
65029636|NCT02401035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65029637|NCT02401035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65029638|NCT02401035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65029639|NCT02401035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029640|NCT02401035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029641|NCT02365766|Gemcitabine|gemcitabine|mesh-list
65029642|NCT02365766|Pembrolizumab|pembrolizumab|mesh-list
65029643|NCT02365766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029644|NCT02365766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65029662|NCT02153944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65029663|NCT02153944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65029664|NCT02153944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029665|NCT02153944|Dopamine Agents|dopamine agents|mesh-ancestor
65029666|NCT02153944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65029667|NCT02153944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65029668|NCT02153944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65029669|NCT02153944|Adrenergic Agents|adrenergic agents|mesh-ancestor
65029670|NCT02153944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65029671|NCT02153944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65029672|NCT02153944|Vasodilator Agents|vasodilator agents|mesh-ancestor
65029673|NCT02152982|Temozolomide|temozolomide|mesh-list
65029674|NCT02152982|Veliparib|veliparib|mesh-list
65029675|NCT02152982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65029676|NCT02152982|Alkylating Agents|alkylating agents|mesh-ancestor
65029677|NCT02152982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029678|NCT02152982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029679|NCT02152982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65029680|NCT02152982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029681|NCT02112916|Calcium, Dietary|calcium, dietary|mesh-list
65029682|NCT02112916|Leucovorin|leucovorin|mesh-list
65029683|NCT02112916|Folic Acid|folic acid|mesh-list
65029684|NCT02112916|Cytarabine|cytarabine|mesh-list
65029685|NCT02112916|Dexamethasone|dexamethasone|mesh-list
65029686|NCT02112916|Dexamethasone acetate|dexamethasone acetate|mesh-list
65029687|NCT02112916|Hydrocortisone|hydrocortisone|mesh-list
65029688|NCT02112916|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65029689|NCT02112916|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65029690|NCT02112916|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65029691|NCT02112916|Cyclophosphamide|cyclophosphamide|mesh-list
65029692|NCT02112916|Ifosfamide|ifosfamide|mesh-list
65029693|NCT02112916|Isophosphamide mustard|isophosphamide mustard|mesh-list
65029694|NCT02112916|Doxorubicin|doxorubicin|mesh-list
65029695|NCT02112916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65029696|NCT02112916|Methotrexate|methotrexate|mesh-list
65029697|NCT02112916|Etoposide|etoposide|mesh-list
65029705|NCT02112916|Pegaspargase|pegaspargase|mesh-list
65029706|NCT02112916|Thioguanine|thioguanine|mesh-list
65029707|NCT02112916|BB 1101|bb 1101|mesh-list
65029708|NCT02112916|Calcium|calcium|mesh-list
65029709|NCT02112916|2-Aminopurine|2-aminopurine|mesh-list
65029710|NCT02112916|Levoleucovorin|levoleucovorin|mesh-list
65029711|NCT02112916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65029712|NCT02112916|Immunologic Factors|immunologic factors|mesh-ancestor
65029713|NCT02112916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029714|NCT02112916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65029715|NCT02112916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65029716|NCT02112916|Alkylating Agents|alkylating agents|mesh-ancestor
65029717|NCT02112916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029718|NCT02112916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029719|NCT02112916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65029720|NCT02112916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65029721|NCT02112916|Antiemetics|antiemetics|mesh-ancestor
65029722|NCT02112916|Autonomic Agents|autonomic agents|mesh-ancestor
65029723|NCT02112916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65029724|NCT02112916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65029725|NCT02112916|Glucocorticoids|glucocorticoids|mesh-ancestor
65029726|NCT02112916|Hormones|hormones|mesh-ancestor
65029727|NCT02112916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65029728|NCT02112916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64946449|NCT04113109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946450|NCT04113109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64946451|NCT04113109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64946452|NCT04113109|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
64946453|NCT04113109|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
64946454|NCT04113109|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64946455|NCT04113109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64946456|NCT04113109|Immunologic Factors|immunologic factors|mesh-ancestor
64946457|NCT04107038|Anesthetics|anesthetics|mesh-list
64946458|NCT04107038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64946459|NCT04107038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946469|NCT04098003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64946488|NCT03982693|Anticoagulants|anticoagulants|mesh-ancestor
64946489|NCT03982693|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64946490|NCT03982693|Chelating Agents|chelating agents|mesh-ancestor
64946491|NCT03982693|Sequestering Agents|sequestering agents|mesh-ancestor
64946492|NCT03982693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946493|NCT03982693|Antidotes|antidotes|mesh-ancestor
64946494|NCT03982693|Protective Agents|protective agents|mesh-ancestor
64946495|NCT03982693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946496|NCT03982693|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64946498|NCT03965195|Immunologic Factors|immunologic factors|mesh-ancestor
64946499|NCT03965195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946500|NCT03942653|Pembrolizumab|pembrolizumab|mesh-list
64946501|NCT03942653|Goserelin|goserelin|mesh-list
64725048|NCT00001135|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64725049|NCT00003002|Sargramostim|sargramostim|mesh-list
64725050|NCT00003002|Immunologic Factors|immunologic factors|mesh-ancestor
65029729|NCT02112916|Protease Inhibitors|protease inhibitors|mesh-ancestor
65029730|NCT02112916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029731|NCT02112916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65029732|NCT02112916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65029733|NCT02112916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65029734|NCT02112916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65029735|NCT02112916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65029736|NCT02112916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65029737|NCT02112916|Abortifacient Agents|abortifacient agents|mesh-ancestor
65029738|NCT02112916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65029739|NCT02112916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65029740|NCT02112916|Antimetabolites|antimetabolites|mesh-ancestor
65029741|NCT02112916|Dermatologic Agents|dermatologic agents|mesh-ancestor
65029742|NCT02112916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65029743|NCT02112916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65029744|NCT02112916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65029745|NCT02112916|Antiviral Agents|antiviral agents|mesh-ancestor
65029746|NCT02112916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65029747|NCT02112916|Antidotes|antidotes|mesh-ancestor
65029748|NCT02112916|Protective Agents|protective agents|mesh-ancestor
65029749|NCT02112916|Vitamin B Complex|vitamin b complex|mesh-ancestor
65029750|NCT02112916|Vitamins|vitamins|mesh-ancestor
65029751|NCT02112916|Micronutrients|micronutrients|mesh-ancestor
65029752|NCT02112916|Tubulin Modulators|tubulin modulators|mesh-ancestor
65029753|NCT02112916|Antimitotic Agents|antimitotic agents|mesh-ancestor
65029754|NCT02112916|Mitosis Modulators|mitosis modulators|mesh-ancestor
65029755|NCT02112916|Hematinics|hematinics|mesh-ancestor
65029756|NCT02112916|Keratolytic Agents|keratolytic agents|mesh-ancestor
65029757|NCT02091960|Trastuzumab|trastuzumab|mesh-list
65029758|NCT02091960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65029759|NCT02091960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029760|NCT02060721|Macitentan|macitentan|mesh-list
65029761|NCT02060721|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65029762|NCT02060721|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65029769|NCT01631617|Sodium Hypochlorite|sodium hypochlorite|mesh-list
65029770|NCT01631617|Eusol|eusol|mesh-list
65029771|NCT01631617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65029772|NCT01631617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65029773|NCT01631617|Antimalarials|antimalarials|mesh-ancestor
65029774|NCT01631617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65029775|NCT01631617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65029776|NCT01631617|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65029777|NCT01631617|Renal Agents|renal agents|mesh-ancestor
65029778|NCT01631617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65029779|NCT01631617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515013|NCT04132648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65029780|NCT01631617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029781|NCT01631617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65029782|NCT01631617|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65029783|NCT01631617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65029784|NCT01631617|Disinfectants|disinfectants|mesh-ancestor
65029785|NCT01553214|Dexamethasone|dexamethasone|mesh-list
65029786|NCT01553214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65029787|NCT01553214|Antiemetics|antiemetics|mesh-ancestor
65029824|NCT01527149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65029825|NCT01527149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65029826|NCT01527149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65029827|NCT01527149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65029828|NCT01527149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65029829|NCT01527149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029830|NCT01527149|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65029831|NCT01527149|Abortifacient Agents|abortifacient agents|mesh-ancestor
65029832|NCT01527149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65029833|NCT01527149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65029834|NCT01527149|Antimetabolites|antimetabolites|mesh-ancestor
65029835|NCT01527149|Dermatologic Agents|dermatologic agents|mesh-ancestor
65029836|NCT01527149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65029837|NCT01527149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65029838|NCT01527149|Antiviral Agents|antiviral agents|mesh-ancestor
65029839|NCT01527149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65029840|NCT01527149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65029841|NCT01527149|Tubulin Modulators|tubulin modulators|mesh-ancestor
65029842|NCT01527149|Antimitotic Agents|antimitotic agents|mesh-ancestor
65029843|NCT01527149|Mitosis Modulators|mitosis modulators|mesh-ancestor
65029844|NCT01527149|Protease Inhibitors|protease inhibitors|mesh-ancestor
65029845|NCT01359956|Interferons|interferons|mesh-list
65029846|NCT01359956|Interferon-alpha|interferon-alpha|mesh-list
65029847|NCT01359956|Interferon alpha-2|interferon alpha-2|mesh-list
65029848|NCT01359956|Dacarbazine|dacarbazine|mesh-list
65029849|NCT01359956|Fotemustine|fotemustine|mesh-list
65029850|NCT01359956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029851|NCT01359956|Antiviral Agents|antiviral agents|mesh-ancestor
65029852|NCT01359956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65029853|NCT01359956|Immunologic Factors|immunologic factors|mesh-ancestor
64583996|NCT01857297|Vaccines|vaccines|mesh-list
64725051|NCT00003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725052|NCT00001891|Dobutamine|dobutamine|mesh-list
64725053|NCT00001891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64725054|NCT00001891|Sympathomimetics|sympathomimetics|mesh-ancestor
64725055|NCT00001891|Autonomic Agents|autonomic agents|mesh-ancestor
64725056|NCT00001891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64725057|NCT00001891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725058|NCT00001891|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64725059|NCT00001891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64725060|NCT00001891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64725061|NCT00001891|Adrenergic Agents|adrenergic agents|mesh-ancestor
64725062|NCT00001891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64946502|NCT03942653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64584017|NCT01859013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65029854|NCT01359956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029855|NCT01359956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65029887|NCT01198067|Immunologic Factors|immunologic factors|mesh-ancestor
65029888|NCT01198067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029889|NCT01198067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65029890|NCT01198067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65029891|NCT01198067|Growth Substances|growth substances|mesh-ancestor
65029892|NCT01198067|Growth Inhibitors|growth inhibitors|mesh-ancestor
65029893|NCT01198067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029894|NCT01196936|Tamoxifen|tamoxifen|mesh-list
65029895|NCT01196936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65029896|NCT01196936|Hormone Antagonists|hormone antagonists|mesh-ancestor
65029897|NCT01196936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65029898|NCT01196936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029899|NCT01196936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65029900|NCT01196936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029901|NCT01196936|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65029902|NCT01196936|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65029903|NCT01196936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65029904|NCT01192568|Oxybutynin|oxybutynin|mesh-list
65029905|NCT01192568|Parasympatholytics|parasympatholytics|mesh-ancestor
65029906|NCT01192568|Autonomic Agents|autonomic agents|mesh-ancestor
65029907|NCT01192568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65029908|NCT01192568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584018|NCT01859013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946503|NCT03942653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503298|NCT03352362|Propacetamol|propacetamol|mesh-list
64485343|NCT04644029|Tenofovir|tenofovir|mesh-list
64503299|NCT03352362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64946504|NCT03942653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64946505|NCT03941262|Pembrolizumab|pembrolizumab|mesh-list
64946507|NCT03941262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64946508|NCT03941262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946509|NCT03928314|Paclitaxel|paclitaxel|mesh-list
64946510|NCT03928314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64946511|NCT03928314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946512|NCT03928314|Tubulin Modulators|tubulin modulators|mesh-ancestor
64946513|NCT03928314|Antimitotic Agents|antimitotic agents|mesh-ancestor
64419846|NCT05509153|Antioxidants|antioxidants|mesh-ancestor
64946519|NCT03878082|Acetaminophen|acetaminophen|mesh-list
64946520|NCT03878082|Propacetamol|propacetamol|mesh-list
64946521|NCT03878082|Analgesics|analgesics|mesh-ancestor
64946522|NCT03878082|Sensory System Agents|sensory system agents|mesh-ancestor
64946523|NCT03878082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64946524|NCT03878082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946525|NCT03878082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65029909|NCT01192568|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65029910|NCT01192568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65029911|NCT01192568|Cholinergic Agents|cholinergic agents|mesh-ancestor
65029912|NCT01192568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65029913|NCT01192568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029914|NCT01192568|Urological Agents|urological agents|mesh-ancestor
65029915|NCT01075971|Buprenorphine|buprenorphine|mesh-list
65029916|NCT01075971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65029917|NCT01075971|Narcotics|narcotics|mesh-ancestor
65029918|NCT01075971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65029919|NCT01075971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029920|NCT01075971|Analgesics|analgesics|mesh-ancestor
65029921|NCT01075971|Sensory System Agents|sensory system agents|mesh-ancestor
65029922|NCT01075971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65029923|NCT01075971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65029925|NCT00775749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65029926|NCT00775749|Autonomic Agents|autonomic agents|mesh-ancestor
65029927|NCT00775749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65029928|NCT00775749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029929|NCT00775749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64471203|NCT04696523|Xenon|xenon|mesh-list
65029932|NCT00775749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65029933|NCT00775749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029936|NCT00576979|Cyclophosphamide|cyclophosphamide|mesh-list
65029937|NCT00576979|Etoposide|etoposide|mesh-list
65029938|NCT00576979|Etoposide phosphate|etoposide phosphate|mesh-list
65029939|NCT00576979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65029940|NCT00576979|Immunologic Factors|immunologic factors|mesh-ancestor
65029959|NCT00324922|Renal Agents|renal agents|mesh-ancestor
65029960|NCT00324922|Antimalarials|antimalarials|mesh-ancestor
65029961|NCT00324922|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65029962|NCT00324922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65029963|NCT00324922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65029964|NCT00324922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65029965|NCT00324922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65029966|NCT00324922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65029967|NCT00324922|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65029968|NCT00324922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65029969|NCT00324805|Gemcitabine|gemcitabine|mesh-list
65029970|NCT00324805|Bevacizumab|bevacizumab|mesh-list
65029971|NCT00324805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65029972|NCT00324805|Cisplatin|cisplatin|mesh-list
65029973|NCT00324805|Docetaxel|docetaxel|mesh-list
65029974|NCT00324805|Pemetrexed|pemetrexed|mesh-list
65029975|NCT00324805|Vinorelbine|vinorelbine|mesh-list
65029976|NCT00324805|Endothelial Growth Factors|endothelial growth factors|mesh-list
65029977|NCT00324805|Antibodies|antibodies|mesh-list
65029978|NCT00324805|Immunoglobulins|immunoglobulins|mesh-list
65029979|NCT00324805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65029980|NCT00324805|Immunoglobulin G|immunoglobulin g|mesh-list
65029981|NCT00324805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65029982|NCT00324805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65029983|NCT00324805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65029984|NCT00324805|Growth Substances|growth substances|mesh-ancestor
65029985|NCT00324805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65029986|NCT00324805|Growth Inhibitors|growth inhibitors|mesh-ancestor
65029987|NCT00324805|Immunologic Factors|immunologic factors|mesh-ancestor
65029988|NCT00324805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65030006|NCT00192855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030007|NCT00407186|Cisplatin|cisplatin|mesh-list
65030008|NCT00407186|Capecitabine|capecitabine|mesh-list
65030009|NCT00407186|Epirubicin|epirubicin|mesh-list
65030010|NCT00407186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030011|NCT00407186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65030012|NCT00407186|Antimetabolites|antimetabolites|mesh-ancestor
65030013|NCT00407186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030014|NCT00407186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65030015|NCT00407186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65030016|NCT00407186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65030017|NCT00407186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030018|NCT00163748|Gemcitabine|gemcitabine|mesh-list
65030019|NCT00163748|Vinorelbine|vinorelbine|mesh-list
65030020|NCT00163748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65030021|NCT00163748|Antimetabolites|antimetabolites|mesh-ancestor
65030022|NCT00163748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030023|NCT00163748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030024|NCT00163748|Antiviral Agents|antiviral agents|mesh-ancestor
65030025|NCT00163748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65030026|NCT00163748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030027|NCT00163748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65030028|NCT00163748|Immunologic Factors|immunologic factors|mesh-ancestor
65030057|NCT00193011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65030058|NCT00193011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65030059|NCT00193089|Docetaxel|docetaxel|mesh-list
65030060|NCT00193089|Trastuzumab|trastuzumab|mesh-list
65030061|NCT00193089|Vinorelbine|vinorelbine|mesh-list
65030062|NCT00193089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030063|NCT00193089|Tubulin Modulators|tubulin modulators|mesh-ancestor
65030064|NCT00193089|Antimitotic Agents|antimitotic agents|mesh-ancestor
65030065|NCT00193089|Mitosis Modulators|mitosis modulators|mesh-ancestor
65030066|NCT00193089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030067|NCT00193089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65030068|NCT00193089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65030069|NCT00193167|Topotecan|topotecan|mesh-list
65030070|NCT00193167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65030071|NCT00193167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65030072|NCT00193167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030073|NCT00193167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030074|NCT00193167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030075|NCT05208307|Dexamethasone|dexamethasone|mesh-list
65030076|NCT05208307|Dexamethasone acetate|dexamethasone acetate|mesh-list
65030077|NCT05208307|Pomalidomide|pomalidomide|mesh-list
65030078|NCT05208307|Ichthammol|ichthammol|mesh-list
65030079|NCT05208307|BB 1101|bb 1101|mesh-list
65030080|NCT05208307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65030081|NCT05208307|Antiemetics|antiemetics|mesh-ancestor
64515238|NCT02042391|Cytarabine|cytarabine|mesh-list
65030083|NCT05208307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65030084|NCT05208307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584236|NCT00334633|Tinidazole|tinidazole|mesh-list
65030105|NCT00193245|Mitosis Modulators|mitosis modulators|mesh-ancestor
65030106|NCT00193245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030107|NCT00193245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65030108|NCT00193245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65030109|NCT00193245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030110|NCT00193284|Carboplatin|carboplatin|mesh-list
65030111|NCT00193284|Docetaxel|docetaxel|mesh-list
65030112|NCT00193284|Fluorouracil|fluorouracil|mesh-list
65030113|NCT00193284|Gefitinib|gefitinib|mesh-list
65030114|NCT00193284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030115|NCT00193284|Tubulin Modulators|tubulin modulators|mesh-ancestor
65030116|NCT00193284|Antimitotic Agents|antimitotic agents|mesh-ancestor
65030117|NCT00193284|Mitosis Modulators|mitosis modulators|mesh-ancestor
65030118|NCT00193284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030119|NCT00193284|Antimetabolites|antimetabolites|mesh-ancestor
65030120|NCT00193284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65030121|NCT00193284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65030122|NCT00193284|Immunologic Factors|immunologic factors|mesh-ancestor
65030123|NCT00193284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030124|NCT00193284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65030125|NCT00193284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030126|NCT00163982|Norfloxacin|norfloxacin|mesh-list
65030127|NCT00163982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65030128|NCT00163982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65030129|NCT00163982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65030130|NCT00163982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64946552|NCT03818737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64946553|NCT03818737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946554|NCT03818737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64946555|NCT03818737|Glucocorticoids|glucocorticoids|mesh-ancestor
64946556|NCT03818737|Hormones|hormones|mesh-ancestor
64946557|NCT03818737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64946558|NCT03818737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64946559|NCT03818737|Protective Agents|protective agents|mesh-ancestor
64946560|NCT03814941|Anesthetics|anesthetics|mesh-list
64946561|NCT03814941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64946562|NCT03814941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946563|NCT03759938|Rivaroxaban|rivaroxaban|mesh-list
64946564|NCT03759938|Apixaban|apixaban|mesh-list
64946565|NCT03759938|Edoxaban|edoxaban|mesh-list
64946566|NCT03759938|Dabigatran|dabigatran|mesh-list
64946567|NCT03759938|Anticoagulants|anticoagulants|mesh-list
64946568|NCT03759938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64946569|NCT03759938|Antithrombins|antithrombins|mesh-ancestor
64946570|NCT03759938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64946571|NCT03759938|Protease Inhibitors|protease inhibitors|mesh-ancestor
64725063|NCT00001891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725064|NCT00001891|Protective Agents|protective agents|mesh-ancestor
64725065|NCT00383864|Interferons|interferons|mesh-list
65030131|NCT00163982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030132|NCT00163982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030133|NCT00163982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030134|NCT00163982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65030135|NCT00163982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65030136|NCT00193323|Gemcitabine|gemcitabine|mesh-list
65030137|NCT00193323|Docetaxel|docetaxel|mesh-list
65030138|NCT00193323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65030139|NCT00193323|Antimetabolites|antimetabolites|mesh-ancestor
65030140|NCT00193323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030141|NCT00193323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030142|NCT00193323|Antiviral Agents|antiviral agents|mesh-ancestor
65030143|NCT00193323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65030144|NCT00193323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030145|NCT00193323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65030146|NCT00193323|Immunologic Factors|immunologic factors|mesh-ancestor
65030147|NCT00193323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030148|NCT00193323|Tubulin Modulators|tubulin modulators|mesh-ancestor
65030149|NCT00193323|Antimitotic Agents|antimitotic agents|mesh-ancestor
65030150|NCT00193323|Mitosis Modulators|mitosis modulators|mesh-ancestor
65030151|NCT05117398|Dalbavancin|dalbavancin|mesh-list
65030152|NCT05117398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65030153|NCT05117398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65030154|NCT00193362|Gemcitabine|gemcitabine|mesh-list
65030155|NCT00193362|Paclitaxel|paclitaxel|mesh-list
65030156|NCT00193362|Vinorelbine|vinorelbine|mesh-list
65030157|NCT00193362|Carboplatin|carboplatin|mesh-list
65030158|NCT00193362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65030159|NCT00193362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030160|NCT00193362|Tubulin Modulators|tubulin modulators|mesh-ancestor
65030161|NCT00193362|Antimitotic Agents|antimitotic agents|mesh-ancestor
65030162|NCT00193362|Mitosis Modulators|mitosis modulators|mesh-ancestor
65030163|NCT00193362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030164|NCT00193362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65030165|NCT00193362|Antimetabolites|antimetabolites|mesh-ancestor
65030166|NCT00193362|Antiviral Agents|antiviral agents|mesh-ancestor
65030167|NCT00193362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65030169|NCT00193362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65030170|NCT00193362|Immunologic Factors|immunologic factors|mesh-ancestor
65030171|NCT00193362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030172|NCT00193401|Topotecan|topotecan|mesh-list
65030173|NCT00193401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65030174|NCT00193401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65030175|NCT00193401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030176|NCT00193401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030177|NCT00193401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030178|NCT00553189|Topotecan|topotecan|mesh-list
65030179|NCT00553189|Veliparib|veliparib|mesh-list
65030180|NCT00553189|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65030181|NCT00553189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65030182|NCT00553189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030183|NCT00553189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030184|NCT00553189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030185|NCT00553189|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65030186|NCT00193440|Rituximab|rituximab|mesh-list
65030187|NCT00193440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65030188|NCT00193440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030189|NCT00193440|Immunologic Factors|immunologic factors|mesh-ancestor
65030190|NCT00193440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030191|NCT00193440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65030192|NCT05077969|Celecoxib|celecoxib|mesh-list
65030193|NCT05077969|Famotidine|famotidine|mesh-list
65030194|NCT05077969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65030195|NCT05077969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65030196|NCT05077969|Analgesics|analgesics|mesh-ancestor
65030197|NCT05077969|Sensory System Agents|sensory system agents|mesh-ancestor
65030198|NCT05077969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65030199|NCT05077969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030200|NCT05077969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65030201|NCT05077969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65030204|NCT05077969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030209|NCT05077969|Histamine Antagonists|histamine antagonists|mesh-ancestor
65030210|NCT05077969|Histamine Agents|histamine agents|mesh-ancestor
65030211|NCT05077969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65030212|NCT05063734|Aflibercept|aflibercept|mesh-list
65030213|NCT05063734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65030214|NCT05063734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65030215|NCT05063734|Growth Substances|growth substances|mesh-ancestor
65030216|NCT05063734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030217|NCT05063734|Growth Inhibitors|growth inhibitors|mesh-ancestor
65030218|NCT05063734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030219|NCT00193518|Arsenic Trioxide|arsenic trioxide|mesh-list
65030220|NCT00193518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030221|NCT00164216|Artesunate|artesunate|mesh-list
65030222|NCT00164216|Mefloquine|mefloquine|mesh-list
65030223|NCT00164216|Antimalarials|antimalarials|mesh-ancestor
65030224|NCT00164216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65030225|NCT00164216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64725066|NCT00383864|Ribavirin|ribavirin|mesh-list
64725067|NCT00383864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725068|NCT00383864|Antiviral Agents|antiviral agents|mesh-ancestor
64725069|NCT00383864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725070|NCT00383864|Antimetabolites|antimetabolites|mesh-ancestor
64725071|NCT00383864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725072|NCT00003008|Ritonavir|ritonavir|mesh-list
64725073|NCT00003008|Nelfinavir|nelfinavir|mesh-list
64725074|NCT00003008|Indinavir|indinavir|mesh-list
64725075|NCT00003008|Saquinavir|saquinavir|mesh-list
64725076|NCT00003008|Paclitaxel|paclitaxel|mesh-list
64725077|NCT00003008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64725078|NCT00003008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725079|NCT00003008|Tubulin Modulators|tubulin modulators|mesh-ancestor
64725080|NCT00003008|Antimitotic Agents|antimitotic agents|mesh-ancestor
64946572|NCT03759938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946573|NCT03759938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946574|NCT03737240|Insulin|insulin|mesh-list
64946575|NCT03737240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64503300|NCT03352362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64946601|NCT03556332|Daratumumab|daratumumab|mesh-list
64946602|NCT03556332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64946603|NCT03556332|Antiemetics|antiemetics|mesh-ancestor
64946604|NCT03556332|Autonomic Agents|autonomic agents|mesh-ancestor
64946605|NCT03556332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64946606|NCT03556332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946607|NCT03556332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64946608|NCT03556332|Glucocorticoids|glucocorticoids|mesh-ancestor
64946609|NCT03556332|Hormones|hormones|mesh-ancestor
64946610|NCT03556332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64946611|NCT03556332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64946612|NCT03556332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946613|NCT03556332|Immunologic Factors|immunologic factors|mesh-ancestor
64946614|NCT03556332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64946615|NCT03556332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64946616|NCT03556332|Growth Substances|growth substances|mesh-ancestor
64946617|NCT03556332|Growth Inhibitors|growth inhibitors|mesh-ancestor
64946621|NCT03547908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946622|NCT03547908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946623|NCT03547908|Antiviral Agents|antiviral agents|mesh-ancestor
64946624|NCT03547908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64946638|NCT03539900|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64946639|NCT03539900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64946640|NCT03539900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64584349|NCT00337987|Tubulin Modulators|tubulin modulators|mesh-ancestor
65030226|NCT00164216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65030227|NCT00164216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030228|NCT00164216|Antiviral Agents|antiviral agents|mesh-ancestor
65030229|NCT00164216|Schistosomicides|schistosomicides|mesh-ancestor
65030230|NCT00164216|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65030231|NCT00164216|Anthelmintics|anthelmintics|mesh-ancestor
65030232|NCT00193557|Bortezomib|bortezomib|mesh-list
65030233|NCT00193557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030234|NCT00164255|Artesunate|artesunate|mesh-list
65030236|NCT00164255|Sulfadoxine|sulfadoxine|mesh-list
65030237|NCT00164255|Antimalarials|antimalarials|mesh-ancestor
65030238|NCT00164255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65030239|NCT00164255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65030240|NCT00164255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65030241|NCT00164255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030242|NCT00164255|Antiviral Agents|antiviral agents|mesh-ancestor
65030243|NCT00164255|Schistosomicides|schistosomicides|mesh-ancestor
65030244|NCT00164255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65030245|NCT00164255|Anthelmintics|anthelmintics|mesh-ancestor
65030246|NCT00164255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65030247|NCT00164255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030248|NCT00164255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030249|NCT00164255|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65030250|NCT00164255|Renal Agents|renal agents|mesh-ancestor
65030251|NCT04683406|Oseltamivir|oseltamivir|mesh-list
65030252|NCT04683406|Antiviral Agents|antiviral agents|mesh-ancestor
65030253|NCT04683406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65030254|NCT04683406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030255|NCT04683406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030256|NCT00409656|Basiliximab|basiliximab|mesh-list
65030257|NCT00409656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65030258|NCT00409656|Immunologic Factors|immunologic factors|mesh-ancestor
65030259|NCT00409656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030260|NCT00409695|Thymoglobulin|thymoglobulin|mesh-list
65030261|NCT00409695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65030262|NCT00409695|Immunologic Factors|immunologic factors|mesh-ancestor
64946641|NCT03539900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946643|NCT03539900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64946644|NCT03539900|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65030263|NCT00409695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584381|NCT00553059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65030264|NCT00409695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65030265|NCT04977232|Citalopram|citalopram|mesh-list
65030266|NCT04977232|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65030267|NCT04977232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65030268|NCT04977232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65030269|NCT04977232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030270|NCT04977232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65030271|NCT04977232|Serotonin Agents|serotonin agents|mesh-ancestor
65030272|NCT04977232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030273|NCT04977232|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65030274|NCT04977232|Antidepressive Agents|antidepressive agents|mesh-ancestor
65030275|NCT04977232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65030276|NCT04974814|Atorvastatin|atorvastatin|mesh-list
65030277|NCT04974814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65030278|NCT04974814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65030279|NCT04974814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65030280|NCT04974814|Antimetabolites|antimetabolites|mesh-ancestor
65030281|NCT04974814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030282|NCT04974814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64946645|NCT03539900|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64946646|NCT03539900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946647|NCT03539900|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64725081|NCT00003008|Mitosis Modulators|mitosis modulators|mesh-ancestor
64725082|NCT00003008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725083|NCT00003008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64725084|NCT00003008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64725085|NCT00003008|Protease Inhibitors|protease inhibitors|mesh-ancestor
64725086|NCT00003008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725087|NCT00003008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64725088|NCT00003008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64725089|NCT00003008|Antiviral Agents|antiviral agents|mesh-ancestor
64725090|NCT00003008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725091|NCT00003008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64725092|NCT00003008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64725093|NCT00001903|Immunoglobulins|immunoglobulins|mesh-list
64725094|NCT00001903|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64725095|NCT00001903|Antibodies|antibodies|mesh-list
64946649|NCT03530683|Azacitidine|azacitidine|mesh-list
64503302|NCT03352362|Sensory System Agents|sensory system agents|mesh-ancestor
64485490|NCT03643744|Analgesics|analgesics|mesh-ancestor
64946650|NCT03530683|Venetoclax|venetoclax|mesh-list
64946651|NCT03530683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64946652|NCT03530683|Antiemetics|antiemetics|mesh-ancestor
64946653|NCT03530683|Autonomic Agents|autonomic agents|mesh-ancestor
64946654|NCT03530683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64946655|NCT03530683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946656|NCT03530683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64946657|NCT03530683|Glucocorticoids|glucocorticoids|mesh-ancestor
64946658|NCT03530683|Hormones|hormones|mesh-ancestor
64946659|NCT03530683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65030283|NCT04974814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65030284|NCT04974814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030285|NCT00164411|Vaccines|vaccines|mesh-list
65030286|NCT00164411|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65030287|NCT00164411|Immunologic Factors|immunologic factors|mesh-ancestor
65030288|NCT00164411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030289|NCT04910815|Rifaximin|rifaximin|mesh-list
65030290|NCT04910815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65030291|NCT04910815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65030292|NCT04910815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65030293|NCT00193635|Mycophenolic Acid|mycophenolic acid|mesh-list
64584402|NCT02015611|Vitamin D|vitamin d|mesh-list
64584403|NCT02015611|Vitamins|vitamins|mesh-ancestor
64946660|NCT03530683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64946661|NCT03530683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946662|NCT03530683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64946663|NCT03530683|Antimetabolites|antimetabolites|mesh-ancestor
64946664|NCT03530683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946665|NCT03530683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946666|NCT03525873|Methylphenidate|methylphenidate|mesh-list
64946667|NCT03525873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64946668|NCT03525873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946669|NCT03525873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64946670|NCT03525873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64946671|NCT03525873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64946672|NCT03525873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946673|NCT03525873|Dopamine Agents|dopamine agents|mesh-ancestor
64946674|NCT03525873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64946675|NCT03493789|Deoxyglucose|deoxyglucose|mesh-list
64946676|NCT03493789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64946677|NCT03493789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64946678|NCT03493789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946679|NCT03493789|Antimetabolites|antimetabolites|mesh-ancestor
64946680|NCT03493789|Antiviral Agents|antiviral agents|mesh-ancestor
64946681|NCT03493789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64946697|NCT03476798|Growth Substances|growth substances|mesh-ancestor
64946704|NCT03456843|Docetaxel|docetaxel|mesh-list
64946705|NCT03456843|Methyltestosterone|methyltestosterone|mesh-list
64725096|NCT00001903|Immunologic Factors|immunologic factors|mesh-ancestor
64725097|NCT00001903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725098|NCT00002335|Emtricitabine|emtricitabine|mesh-list
64725099|NCT00002335|Antiviral Agents|antiviral agents|mesh-ancestor
64725100|NCT00002335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725101|NCT00002335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64725102|NCT00002335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64725103|NCT00002335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725104|NCT00002335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725105|NCT00002335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64725106|NCT00002335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64725107|NCT00002341|Itraconazole|itraconazole|mesh-list
64725108|NCT00002341|Antifungal Agents|antifungal agents|mesh-ancestor
64725109|NCT00002341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725110|NCT00002341|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64725111|NCT00002341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64725112|NCT00002341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725113|NCT00002341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725114|NCT00002341|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64725115|NCT00002341|Hormone Antagonists|hormone antagonists|mesh-ancestor
64332635|NCT02203526|Cytarabine|cytarabine|mesh-list
64946706|NCT03456843|Hormones|hormones|mesh-list
64946707|NCT03456843|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64946708|NCT03456843|Androgens|androgens|mesh-list
65030294|NCT00193635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65030295|NCT00193635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030296|NCT00193635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65030297|NCT00193635|Antitubercular Agents|antitubercular agents|mesh-ancestor
65030298|NCT00193635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65030299|NCT00193635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65030300|NCT00193635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030301|NCT00193635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030302|NCT04902703|Molgramostim|molgramostim|mesh-list
65030303|NCT04902703|Sargramostim|sargramostim|mesh-list
65030304|NCT04902703|Immunologic Factors|immunologic factors|mesh-ancestor
65030305|NCT04902703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030306|NCT04902703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030307|NCT00193674|Dydrogesterone|dydrogesterone|mesh-list
64946709|NCT03456843|Androgen Antagonists|androgen antagonists|mesh-list
64946710|NCT03456843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946711|NCT03456843|Tubulin Modulators|tubulin modulators|mesh-ancestor
64946712|NCT03456843|Antimitotic Agents|antimitotic agents|mesh-ancestor
64946713|NCT03456843|Mitosis Modulators|mitosis modulators|mesh-ancestor
64946714|NCT03456843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946715|NCT03456843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64946716|NCT03456843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946717|NCT03456843|Antioxidants|antioxidants|mesh-ancestor
64946718|NCT03456843|Protective Agents|protective agents|mesh-ancestor
64946719|NCT03456843|Vitamins|vitamins|mesh-ancestor
64946720|NCT03456843|Micronutrients|micronutrients|mesh-ancestor
64946721|NCT03456843|Estrogens|estrogens|mesh-ancestor
64946722|NCT03456843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64946723|NCT03456843|Anabolic Agents|anabolic agents|mesh-ancestor
64946724|NCT03456843|Hormone Antagonists|hormone antagonists|mesh-ancestor
64946725|NCT03432741|Gemcitabine|gemcitabine|mesh-list
64946726|NCT03432741|Deoxyglucose|deoxyglucose|mesh-list
64946727|NCT03432741|Rituximab|rituximab|mesh-list
64946728|NCT03432741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64946729|NCT03432741|Pembrolizumab|pembrolizumab|mesh-list
64946730|NCT03432741|Nivolumab|nivolumab|mesh-list
64946731|NCT03432741|Trastuzumab|trastuzumab|mesh-list
64946732|NCT03432741|Obinutuzumab|obinutuzumab|mesh-list
64946733|NCT03432741|Daratumumab|daratumumab|mesh-list
64946734|NCT03432741|Romidepsin|romidepsin|mesh-list
64946735|NCT03432741|Belinostat|belinostat|mesh-list
64946736|NCT03432741|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
64946737|NCT03432741|Antibodies|antibodies|mesh-list
64946738|NCT03432741|Immunoglobulins|immunoglobulins|mesh-list
64946739|NCT03432741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64946740|NCT03432741|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64946741|NCT03432741|Immunologic Factors|immunologic factors|mesh-ancestor
64332652|NCT02203526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64332653|NCT02203526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64332654|NCT02203526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64332655|NCT02203526|Antiviral Agents|antiviral agents|mesh-ancestor
64332656|NCT02203526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64332657|NCT02203526|Antifungal Agents|antifungal agents|mesh-ancestor
64419883|NCT02336373|Antisickling Agents|antisickling agents|mesh-ancestor
64725117|NCT00002341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725118|NCT00002341|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64725120|NCT00002347|Nevirapine|nevirapine|mesh-list
64725121|NCT00002347|Zalcitabine|zalcitabine|mesh-list
64725122|NCT00002347|Saquinavir|saquinavir|mesh-list
64725123|NCT00002347|Antimetabolites|antimetabolites|mesh-ancestor
64725124|NCT00002347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725125|NCT00002347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64725126|NCT00002347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64725127|NCT00002347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030308|NCT00193674|Progestins|progestins|mesh-ancestor
64584429|NCT01413542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65030309|NCT00193674|Hormones|hormones|mesh-ancestor
64471572|NCT04310995|Isosorbide|isosorbide|mesh-list
65030310|NCT00193674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65030311|NCT00193674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030313|NCT04899778|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65030314|NCT04899778|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65030315|NCT04899778|Contraceptive Agents|contraceptive agents|mesh-list
65030316|NCT04899778|Contraceptives, Oral|contraceptives, oral|mesh-list
65030317|NCT04899778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65030318|NCT04899778|Estradiol|estradiol|mesh-list
65030319|NCT04899778|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65030320|NCT04899778|Trace Elements|trace elements|mesh-ancestor
65030321|NCT04899778|Micronutrients|micronutrients|mesh-ancestor
65030322|NCT04899778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725128|NCT00002347|Antiviral Agents|antiviral agents|mesh-ancestor
64725129|NCT00002347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725130|NCT00002347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64946742|NCT03432741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946743|NCT03432741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946744|NCT03432741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64946745|NCT03432741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64946746|NCT03432741|Antimetabolites|antimetabolites|mesh-ancestor
64946756|NCT03427463|Morphine|morphine|mesh-list
64946757|NCT03427463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64946758|NCT03427463|Narcotics|narcotics|mesh-ancestor
64946759|NCT03427463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64946760|NCT03427463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946761|NCT03427463|Analgesics|analgesics|mesh-ancestor
64946762|NCT03427463|Sensory System Agents|sensory system agents|mesh-ancestor
64946763|NCT03427463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64946764|NCT03399773|Cyclophosphamide|cyclophosphamide|mesh-list
64946765|NCT03399773|Thiotepa|thiotepa|mesh-list
64946766|NCT03399773|Fludarabine|fludarabine|mesh-list
64946767|NCT03399773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64946768|NCT03399773|Immunologic Factors|immunologic factors|mesh-ancestor
64946769|NCT03399773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946770|NCT03399773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64946771|NCT03399773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64946772|NCT03399773|Alkylating Agents|alkylating agents|mesh-ancestor
64946773|NCT03399773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946774|NCT03399773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946775|NCT03399773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64946776|NCT03363867|Bevacizumab|bevacizumab|mesh-list
64946777|NCT03363867|Atezolizumab|atezolizumab|mesh-list
64946778|NCT03363867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64946779|NCT03363867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946780|NCT03363867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64332670|NCT02195895|Calcium, Dietary|calcium, dietary|mesh-list
64332671|NCT02195895|Vitamin D|vitamin d|mesh-list
64332672|NCT02195895|Ergocalciferols|ergocalciferols|mesh-list
64332673|NCT02195895|Cholecalciferol|cholecalciferol|mesh-list
64725131|NCT00002347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64725132|NCT00002347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64725133|NCT00002347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64725134|NCT00002347|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64725135|NCT00002347|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64725136|NCT00002347|Protease Inhibitors|protease inhibitors|mesh-ancestor
64725137|NCT00002347|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64725138|NCT00002347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65030323|NCT04899778|Estrogens|estrogens|mesh-ancestor
64584442|NCT01875159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030324|NCT04899778|Hormones|hormones|mesh-ancestor
65030325|NCT04899778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65030326|NCT04899778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65030327|NCT04899778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65030328|NCT04899778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65030329|NCT00164450|Isoniazid|isoniazid|mesh-list
65030330|NCT00164450|Rifapentine|rifapentine|mesh-list
65030331|NCT00164450|Antitubercular Agents|antitubercular agents|mesh-ancestor
65030332|NCT00164450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65030333|NCT00164450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65030334|NCT00164450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65030335|NCT00164450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65030336|NCT00164450|Antimetabolites|antimetabolites|mesh-ancestor
65030337|NCT00164450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030338|NCT00164450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65030339|NCT00164450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65030340|NCT00164450|Leprostatic Agents|leprostatic agents|mesh-ancestor
65030341|NCT00193869|Dexamethasone|dexamethasone|mesh-list
65030342|NCT00193869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65030343|NCT00193869|Antiemetics|antiemetics|mesh-ancestor
65030344|NCT00193869|Autonomic Agents|autonomic agents|mesh-ancestor
65030345|NCT00193869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65030346|NCT00193869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030347|NCT00193869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65030348|NCT00193869|Glucocorticoids|glucocorticoids|mesh-ancestor
65030349|NCT00193869|Hormones|hormones|mesh-ancestor
65030350|NCT00193869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65030351|NCT00193869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65030352|NCT00193869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030353|NCT04748809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65030354|NCT04743934|Androgens|androgens|mesh-list
65030355|NCT04743934|Hormones|hormones|mesh-ancestor
65030362|NCT00176241|Tubulin Modulators|tubulin modulators|mesh-ancestor
64584480|NCT00342355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584481|NCT00342355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65030363|NCT00176241|Antimitotic Agents|antimitotic agents|mesh-ancestor
65030364|NCT00176241|Mitosis Modulators|mitosis modulators|mesh-ancestor
65030365|NCT00176241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030366|NCT00176241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65030367|NCT00176241|Antimetabolites|antimetabolites|mesh-ancestor
65030368|NCT00176241|Antiviral Agents|antiviral agents|mesh-ancestor
65030369|NCT00176241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65030370|NCT00176241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030371|NCT00176241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65030372|NCT00176241|Immunologic Factors|immunologic factors|mesh-ancestor
65030373|NCT00176241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030374|NCT04742959|Paclitaxel|paclitaxel|mesh-list
65030375|NCT04742959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65030376|NCT04742959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030377|NCT04742959|Tubulin Modulators|tubulin modulators|mesh-ancestor
65030378|NCT04742959|Antimitotic Agents|antimitotic agents|mesh-ancestor
65030379|NCT04742959|Mitosis Modulators|mitosis modulators|mesh-ancestor
65030380|NCT04742959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030381|NCT00164801|Diltiazem|diltiazem|mesh-list
65030382|NCT00164801|Baclofen|baclofen|mesh-list
65030383|NCT00164801|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65030384|NCT00164801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030385|NCT00164801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65030386|NCT00164801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65030387|NCT00164801|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65030388|NCT00164801|GABA Agonists|gaba agonists|mesh-ancestor
65030389|NCT00164801|GABA Agents|gaba agents|mesh-ancestor
65030390|NCT00164801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65030391|NCT00164801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030392|NCT00164801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65030393|NCT00164801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65030394|NCT00164801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65030396|NCT00164801|Vasodilator Agents|vasodilator agents|mesh-ancestor
65030397|NCT00176280|Dexamethasone|dexamethasone|mesh-list
65030398|NCT00176280|Sargramostim|sargramostim|mesh-list
65030399|NCT00176280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65030400|NCT00176280|Antiemetics|antiemetics|mesh-ancestor
65030401|NCT00176280|Autonomic Agents|autonomic agents|mesh-ancestor
65030402|NCT00176280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65030403|NCT00176280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030404|NCT00176280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65030405|NCT00176280|Glucocorticoids|glucocorticoids|mesh-ancestor
65030406|NCT00176280|Hormones|hormones|mesh-ancestor
65030407|NCT00176280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65030408|NCT00176280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65030409|NCT00176280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030410|NCT00176280|Immunologic Factors|immunologic factors|mesh-ancestor
65030411|NCT04723940|Doxycycline|doxycycline|mesh-list
65030412|NCT04723940|Clindamycin|clindamycin|mesh-list
65030413|NCT04723940|Clindamycin palmitate|clindamycin palmitate|mesh-list
65030414|NCT04723940|Clindamycin phosphate|clindamycin phosphate|mesh-list
65030415|NCT04723940|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65030416|NCT04723940|Cefadroxil|cefadroxil|mesh-list
65030417|NCT04723940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65030418|NCT04723940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65030419|NCT04723940|Antimalarials|antimalarials|mesh-ancestor
65030420|NCT04723940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65030421|NCT04723940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65030422|NCT04723940|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65030423|NCT04723940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030424|NCT04723940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030425|NCT04723940|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65030426|NCT04723940|Renal Agents|renal agents|mesh-ancestor
65030427|NCT00164840|Esomeprazole|esomeprazole|mesh-list
65030428|NCT00164840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65030429|NCT00164840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65030430|NCT00164840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65030431|NCT00164840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584514|NCT00552279|Vaccines|vaccines|mesh-list
64725139|NCT00001237|Molgramostim|molgramostim|mesh-list
64725140|NCT00001237|Sargramostim|sargramostim|mesh-list
64725141|NCT00001237|Immunologic Factors|immunologic factors|mesh-ancestor
64725142|NCT00001237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725143|NCT00001237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725144|NCT00001933|Nefiracetam|nefiracetam|mesh-list
65030432|NCT00164840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030433|NCT04641247|Niraparib|niraparib|mesh-list
65030434|NCT04641247|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65030435|NCT04641247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030436|NCT04641247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030437|NCT04641247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030438|NCT04635007|Misoprostol|misoprostol|mesh-list
65030439|NCT04635007|Tranexamic Acid|tranexamic acid|mesh-list
65030440|NCT04635007|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65030441|NCT04635007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65030442|NCT04635007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030443|NCT04635007|Hemostatics|hemostatics|mesh-ancestor
65030444|NCT04635007|Coagulants|coagulants|mesh-ancestor
65030445|NCT04635007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65030446|NCT04635007|Abortifacient Agents|abortifacient agents|mesh-ancestor
65030447|NCT04635007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64584544|NCT05266651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725145|NCT00001933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64725146|NCT00001933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64725147|NCT00001933|Protective Agents|protective agents|mesh-ancestor
64725148|NCT00001933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725149|NCT00001933|Nootropic Agents|nootropic agents|mesh-ancestor
64725150|NCT00001249|Antibodies|antibodies|mesh-list
64725151|NCT00001249|Immunologic Factors|immunologic factors|mesh-ancestor
64725152|NCT00001249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725153|NCT00380575|Conivaptan|conivaptan|mesh-list
64725154|NCT00380575|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64725155|NCT00380575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332674|NCT02195895|Alendronate|alendronate|mesh-list
64946781|NCT03363867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64946782|NCT03363867|Growth Substances|growth substances|mesh-ancestor
64725163|NCT00001963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725164|NCT00001963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64725165|NCT00001963|Respiratory System Agents|respiratory system agents|mesh-ancestor
64725166|NCT00001963|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64946783|NCT03363867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946784|NCT03363867|Growth Inhibitors|growth inhibitors|mesh-ancestor
64946785|NCT03356873|Vitamin D|vitamin d|mesh-list
64946786|NCT03356873|Ergocalciferols|ergocalciferols|mesh-list
64946787|NCT03356873|Cholecalciferol|cholecalciferol|mesh-list
64946788|NCT03356873|Vitamins|vitamins|mesh-list
64946789|NCT03356873|Micronutrients|micronutrients|mesh-ancestor
64946790|NCT03356873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946791|NCT03356873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64946792|NCT03356873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64946793|NCT03308578|Atorvastatin|atorvastatin|mesh-list
64946794|NCT03308578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64946795|NCT03308578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64946796|NCT03308578|Antimetabolites|antimetabolites|mesh-ancestor
64946797|NCT03308578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946798|NCT03308578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64946799|NCT03308578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64946800|NCT03308578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946801|NCT03305341|Molgramostim|molgramostim|mesh-list
64485640|NCT02453620|Nivolumab|nivolumab|mesh-list
64946802|NCT03305341|Sargramostim|sargramostim|mesh-list
64584561|NCT01412060|Cariprazine|cariprazine|mesh-list
65030448|NCT04635007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584562|NCT01412060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65030449|NCT04635007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65030450|NCT04635007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65030451|NCT04635007|Oxytocics|oxytocics|mesh-ancestor
65030452|NCT00194064|Olanzapine|olanzapine|mesh-list
65030453|NCT00194064|Antiemetics|antiemetics|mesh-ancestor
65030454|NCT00194064|Autonomic Agents|autonomic agents|mesh-ancestor
65030455|NCT00194064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65030456|NCT00194064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030457|NCT00194064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65030459|NCT00194064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64515622|NCT03298698|Glucocorticoids|glucocorticoids|mesh-ancestor
65030460|NCT00194064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65030461|NCT00194064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65030462|NCT00194064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65030463|NCT00194064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65030464|NCT00194064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65030465|NCT00194064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030466|NCT00194064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65030467|NCT00194064|Serotonin Agents|serotonin agents|mesh-ancestor
65030468|NCT00164996|Anesthetics|anesthetics|mesh-list
65030469|NCT00164996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65030470|NCT00164996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030471|NCT04418557|Antibodies|antibodies|mesh-list
64584563|NCT01412060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64584564|NCT01412060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64946803|NCT03305341|Immunologic Factors|immunologic factors|mesh-ancestor
64946804|NCT03305341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946805|NCT03305341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946806|NCT03297606|Nivolumab|nivolumab|mesh-list
64946807|NCT03297606|Trastuzumab|trastuzumab|mesh-list
64946808|NCT03297606|Ipilimumab|ipilimumab|mesh-list
64946809|NCT03297606|Pertuzumab|pertuzumab|mesh-list
64946810|NCT03297606|Sunitinib|sunitinib|mesh-list
64946811|NCT03297606|Dasatinib|dasatinib|mesh-list
64946812|NCT03297606|Olaparib|olaparib|mesh-list
64946813|NCT03297606|Palbociclib|palbociclib|mesh-list
64946814|NCT03297606|Axitinib|axitinib|mesh-list
64946825|NCT03297606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64946826|NCT03297606|Growth Substances|growth substances|mesh-ancestor
64946827|NCT03297606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946828|NCT03297606|Growth Inhibitors|growth inhibitors|mesh-ancestor
64946829|NCT03297606|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64946830|NCT03255473|Dexamethasone|dexamethasone|mesh-list
64946831|NCT03255473|Dexamethasone acetate|dexamethasone acetate|mesh-list
64946832|NCT03255473|Prednisone|prednisone|mesh-list
64946833|NCT03255473|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65030472|NCT04418557|Immunologic Factors|immunologic factors|mesh-ancestor
64584583|NCT00345865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030473|NCT04418557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030474|NCT04682782|Esketamine|esketamine|mesh-list
65030475|NCT04682782|Antidepressive Agents|antidepressive agents|mesh-ancestor
65030476|NCT04682782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65030477|NCT04682665|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
65030478|NCT04682665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65030479|NCT04682665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65030480|NCT00165035|Paclitaxel|paclitaxel|mesh-list
65030481|NCT00165035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65030482|NCT00165035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65030483|NCT00165035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030484|NCT00165035|Tubulin Modulators|tubulin modulators|mesh-ancestor
65030485|NCT00165035|Antimitotic Agents|antimitotic agents|mesh-ancestor
65030486|NCT00165035|Mitosis Modulators|mitosis modulators|mesh-ancestor
65030487|NCT00165035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030488|NCT04378933|Methamphetamine|methamphetamine|mesh-list
64584584|NCT00345865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64946834|NCT03255473|BB 1101|bb 1101|mesh-list
64946835|NCT03255473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64946836|NCT03255473|Antiemetics|antiemetics|mesh-ancestor
64946837|NCT03255473|Autonomic Agents|autonomic agents|mesh-ancestor
64946838|NCT03255473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64946839|NCT03255473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946840|NCT03255473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64946841|NCT03255473|Glucocorticoids|glucocorticoids|mesh-ancestor
64946842|NCT03255473|Hormones|hormones|mesh-ancestor
64946843|NCT03255473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64946844|NCT03255473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64946845|NCT03255473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946846|NCT03255473|Protease Inhibitors|protease inhibitors|mesh-ancestor
64946847|NCT03255473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946848|NCT03255473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946849|NCT03217747|Avelumab|avelumab|mesh-list
64946855|NCT03217747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946856|NCT03176277|Venetoclax|venetoclax|mesh-list
64946857|NCT03176277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946858|NCT03173560|Everolimus|everolimus|mesh-list
64946859|NCT03173560|Lenvatinib|lenvatinib|mesh-list
64725168|NCT00001963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725169|NCT00001963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64725170|NCT00001963|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64725171|NCT00001963|Vasodilator Agents|vasodilator agents|mesh-ancestor
64725172|NCT00001963|Gasotransmitters|gasotransmitters|mesh-ancestor
64725173|NCT00001963|Protective Agents|protective agents|mesh-ancestor
64725174|NCT00001963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64725175|NCT00001963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64725176|NCT00001963|Analgesics|analgesics|mesh-ancestor
64725177|NCT00001963|Sensory System Agents|sensory system agents|mesh-ancestor
64725178|NCT00001963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64725179|NCT00001963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64725180|NCT00002377|Valganciclovir|valganciclovir|mesh-list
64725181|NCT00002377|Ganciclovir|ganciclovir|mesh-list
64725182|NCT00002377|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64725183|NCT00002377|Antiviral Agents|antiviral agents|mesh-ancestor
65030489|NCT04378933|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65030490|NCT04378933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030491|NCT04378933|Sympathomimetics|sympathomimetics|mesh-ancestor
65030492|NCT04378933|Autonomic Agents|autonomic agents|mesh-ancestor
65030493|NCT04378933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65030494|NCT04378933|Dopamine Agents|dopamine agents|mesh-ancestor
65030495|NCT04378933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65030496|NCT04378933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030497|NCT04378933|Adrenergic Agents|adrenergic agents|mesh-ancestor
65030498|NCT04378933|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65030499|NCT04378933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65030500|NCT04378933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64725184|NCT00002377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725185|NCT00002377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64725186|NCT00002377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64332705|NCT01970722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946860|NCT03173560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946861|NCT03173560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64946862|NCT03173560|Immunologic Factors|immunologic factors|mesh-ancestor
64946863|NCT03173560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946864|NCT03173560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64946865|NCT03173560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946866|NCT03173560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946867|NCT03098225|Methylprednisolone|methylprednisolone|mesh-list
64946868|NCT03098225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64946869|NCT03098225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64946870|NCT03098225|Prednisolone|prednisolone|mesh-list
64946871|NCT03098225|Prednisolone acetate|prednisolone acetate|mesh-list
64946872|NCT03098225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64946873|NCT03098225|Prednisolone phosphate|prednisolone phosphate|mesh-list
64946874|NCT03098225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64946875|NCT03098225|Antiemetics|antiemetics|mesh-ancestor
64946876|NCT03098225|Autonomic Agents|autonomic agents|mesh-ancestor
64946877|NCT03098225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64946878|NCT03098225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946879|NCT03098225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64946880|NCT03098225|Glucocorticoids|glucocorticoids|mesh-ancestor
64946891|NCT03017131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64946892|NCT03017131|Immunologic Factors|immunologic factors|mesh-ancestor
64946893|NCT03017131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946894|NCT03017131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64946895|NCT03017131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64946896|NCT03017131|Alkylating Agents|alkylating agents|mesh-ancestor
64946897|NCT03017131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946898|NCT03017131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946899|NCT03017131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64946900|NCT03017131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64946901|NCT03017131|Antimetabolites|antimetabolites|mesh-ancestor
64946902|NCT03017131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946903|NCT03017131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64946904|NCT03017131|Analgesics|analgesics|mesh-ancestor
64725187|NCT00002377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725188|NCT00001339|Doxorubicin|doxorubicin|mesh-list
64725189|NCT00001339|Etoposide|etoposide|mesh-list
64725190|NCT00001339|Vincristine|vincristine|mesh-list
64946905|NCT03017131|Sensory System Agents|sensory system agents|mesh-ancestor
64946906|NCT03017131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64946909|NCT03017131|Antiviral Agents|antiviral agents|mesh-ancestor
64946910|NCT03017131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64946912|NCT02990468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946913|NCT02972840|Rituximab|rituximab|mesh-list
65030501|NCT04378933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65030502|NCT04326673|Methyltestosterone|methyltestosterone|mesh-list
65030503|NCT04326673|Testosterone|testosterone|mesh-list
65030504|NCT04326673|Testosterone undecanoate|testosterone undecanoate|mesh-list
65030505|NCT04326673|Testosterone enanthate|testosterone enanthate|mesh-list
65030506|NCT04326673|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65030507|NCT04326673|Androgens|androgens|mesh-ancestor
65030508|NCT04326673|Hormones|hormones|mesh-ancestor
65030509|NCT04326673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65030510|NCT04326673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030511|NCT04326673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65030512|NCT04326673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030513|NCT04326673|Anabolic Agents|anabolic agents|mesh-ancestor
65030514|NCT00165074|Calfactant|calfactant|mesh-list
65030515|NCT00165074|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
65030516|NCT00165074|Respiratory System Agents|respiratory system agents|mesh-ancestor
65030517|NCT04307953|Saracatinib|saracatinib|mesh-list
65030518|NCT04307953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584614|NCT05266261|Cholecalciferol|cholecalciferol|mesh-list
64946914|NCT02972840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64946915|NCT02972840|Acalabrutinib|acalabrutinib|mesh-list
64946916|NCT02972840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64946917|NCT02972840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946918|NCT02972840|Immunologic Factors|immunologic factors|mesh-ancestor
64946919|NCT02972840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946920|NCT02972840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64946921|NCT02972840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64946922|NCT02972840|Alkylating Agents|alkylating agents|mesh-ancestor
64946923|NCT02972840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946924|NCT02940301|Nivolumab|nivolumab|mesh-list
64946925|NCT02940301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64946926|NCT02940301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946927|NCT02940301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64946928|NCT02940301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946929|NCT02927769|Nivolumab|nivolumab|mesh-list
64946930|NCT02927769|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64946931|NCT02927769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64946932|NCT02927769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64946933|NCT02927769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946934|NCT02927769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64946935|NCT02927769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946936|NCT02927769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64946937|NCT02927769|Alkylating Agents|alkylating agents|mesh-ancestor
64946938|NCT02899299|Carboplatin|carboplatin|mesh-list
64946939|NCT02899299|Nivolumab|nivolumab|mesh-list
64946940|NCT02899299|Pemetrexed|pemetrexed|mesh-list
64946941|NCT02899299|Ipilimumab|ipilimumab|mesh-list
64946942|NCT02899299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946943|NCT02899299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64946960|NCT02855944|Tubulin Modulators|tubulin modulators|mesh-ancestor
64946961|NCT02855944|Antimitotic Agents|antimitotic agents|mesh-ancestor
64946962|NCT02855944|Mitosis Modulators|mitosis modulators|mesh-ancestor
64946963|NCT02855944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946964|NCT02855944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64946965|NCT02855944|Antimetabolites|antimetabolites|mesh-ancestor
64946966|NCT02855944|Antiviral Agents|antiviral agents|mesh-ancestor
65030519|NCT04307953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584631|NCT05266105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030520|NCT04307953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030521|NCT04297267|Gemcitabine|gemcitabine|mesh-list
65030522|NCT04297267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030523|NCT04297267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65030524|NCT04297267|Antimetabolites|antimetabolites|mesh-ancestor
65030525|NCT04297267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030526|NCT04297267|Antiviral Agents|antiviral agents|mesh-ancestor
65030527|NCT04297267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65030528|NCT04297267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030529|NCT04297267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65030530|NCT04297267|Immunologic Factors|immunologic factors|mesh-ancestor
65030531|NCT04297267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471800|NCT04099836|Growth Substances|growth substances|mesh-ancestor
65030533|NCT00176475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64946967|NCT02855944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64946968|NCT02855944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946969|NCT02855944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64946970|NCT02855944|Immunologic Factors|immunologic factors|mesh-ancestor
64946971|NCT02855944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946972|NCT02855944|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64946973|NCT02733185|Vitamins|vitamins|mesh-list
64946974|NCT02733185|Edetic Acid|edetic acid|mesh-list
64946975|NCT02733185|Pentetic Acid|pentetic acid|mesh-list
64946976|NCT02733185|Micronutrients|micronutrients|mesh-ancestor
64946977|NCT02733185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946978|NCT02733185|Anticoagulants|anticoagulants|mesh-ancestor
64946979|NCT02733185|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64946980|NCT02733185|Chelating Agents|chelating agents|mesh-ancestor
64946981|NCT02733185|Sequestering Agents|sequestering agents|mesh-ancestor
64946982|NCT02733185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946983|NCT02733185|Antidotes|antidotes|mesh-ancestor
64946984|NCT02733185|Protective Agents|protective agents|mesh-ancestor
64946985|NCT02733185|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64946986|NCT02697448|Propofol|propofol|mesh-list
64946987|NCT02697448|Sevoflurane|sevoflurane|mesh-list
64946988|NCT02697448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64946989|NCT02697448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64725191|NCT00001339|Mitotane|mitotane|mesh-list
64725192|NCT00001339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64725193|NCT00001339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725194|NCT00001339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64725195|NCT00001339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64725196|NCT00001339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946990|NCT02697448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946991|NCT02697448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64947000|NCT02663518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947011|NCT02603848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947012|NCT02603848|Analgesics|analgesics|mesh-ancestor
64947013|NCT02603848|Sensory System Agents|sensory system agents|mesh-ancestor
64947014|NCT02603848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64947015|NCT02603848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64947016|NCT02603848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64947017|NCT02603848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64947018|NCT02603848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64947019|NCT02603848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64947020|NCT02603848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030534|NCT00176475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030535|NCT00176475|Immunologic Factors|immunologic factors|mesh-ancestor
65030536|NCT00176475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030537|NCT00176475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65030538|NCT00165191|Doxorubicin|doxorubicin|mesh-list
65030539|NCT00165191|Fluorouracil|fluorouracil|mesh-list
65030540|NCT00165191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030541|NCT00165191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65030542|NCT00165191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65030543|NCT00165191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65030544|NCT00165191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030545|NCT00165191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030546|NCT00165191|Antimetabolites|antimetabolites|mesh-ancestor
65030547|NCT00165191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65030548|NCT00165191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65030549|NCT00165191|Immunologic Factors|immunologic factors|mesh-ancestor
65030550|NCT00165191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947021|NCT02603848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947022|NCT02519452|Daratumumab|daratumumab|mesh-list
64947023|NCT02519452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947024|NCT02512887|Anesthetics|anesthetics|mesh-list
64947025|NCT02512887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64947026|NCT02512887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947027|NCT02505984|Oxytocin|oxytocin|mesh-list
64947028|NCT02505984|Oxytocics|oxytocics|mesh-ancestor
64947029|NCT02505984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64947030|NCT02505984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947031|NCT02484261|Bortezomib|bortezomib|mesh-list
64947032|NCT02484261|Pravastatin|pravastatin|mesh-list
64947033|NCT02484261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947034|NCT02484261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64947035|NCT02484261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64947036|NCT02484261|Antimetabolites|antimetabolites|mesh-ancestor
64947037|NCT02484261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947038|NCT02484261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64947039|NCT02484261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64947040|NCT02484261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947041|NCT02477696|Acalabrutinib|acalabrutinib|mesh-list
64947042|NCT02477696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947043|NCT02471430|Interferons|interferons|mesh-list
64947044|NCT02471430|Interferon-alpha|interferon-alpha|mesh-list
64947045|NCT02471430|Interferon alpha-2|interferon alpha-2|mesh-list
64947046|NCT02471430|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64947047|NCT02471430|Panobinostat|panobinostat|mesh-list
64947048|NCT02471430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947049|NCT02471430|Antiviral Agents|antiviral agents|mesh-ancestor
64947050|NCT02471430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64947051|NCT02471430|Immunologic Factors|immunologic factors|mesh-ancestor
64947052|NCT02471430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947053|NCT02471430|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64947054|NCT02471430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947055|NCT02471430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947056|NCT02451943|Doxorubicin|doxorubicin|mesh-list
64947057|NCT02451943|Olaratumab|olaratumab|mesh-list
64947058|NCT02451943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64947059|NCT02451943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947060|NCT02451943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64947061|NCT02451943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64947062|NCT02451943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584663|NCT05265793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030552|NCT04224571|Bortezomib|bortezomib|mesh-list
65030553|NCT04224571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65030554|NCT04224571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030555|NCT04224571|Immunologic Factors|immunologic factors|mesh-ancestor
65030556|NCT04224571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030557|NCT04224571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65030558|NCT00176514|Antineoplastic Agents|antineoplastic agents|mesh-list
65030559|NCT00165230|Thalidomide|thalidomide|mesh-list
65030560|NCT00165230|Temozolomide|temozolomide|mesh-list
65030561|NCT00165230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65030562|NCT00165230|Immunologic Factors|immunologic factors|mesh-ancestor
65030563|NCT00165230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030564|NCT00165230|Leprostatic Agents|leprostatic agents|mesh-ancestor
64947063|NCT02451943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725197|NCT00001339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725198|NCT00001339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64725199|NCT00001339|Tubulin Modulators|tubulin modulators|mesh-ancestor
64725200|NCT00001339|Antimitotic Agents|antimitotic agents|mesh-ancestor
64725201|NCT00001339|Mitosis Modulators|mitosis modulators|mesh-ancestor
64419897|NCT02372799|Antidepressive Agents|antidepressive agents|mesh-ancestor
64947079|NCT02409342|Antiviral Agents|antiviral agents|mesh-ancestor
64947080|NCT02409342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64947081|NCT02409342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947082|NCT02409342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64947083|NCT02409342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64947084|NCT02409342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64947085|NCT02399085|Lenalidomide|lenalidomide|mesh-list
64947086|NCT02399085|Immunologic Factors|immunologic factors|mesh-ancestor
64947087|NCT02399085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947088|NCT02399085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64947089|NCT02399085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64947090|NCT02399085|Growth Substances|growth substances|mesh-ancestor
64947091|NCT02399085|Growth Inhibitors|growth inhibitors|mesh-ancestor
64947092|NCT02399085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947093|NCT02255409|Vaccines|vaccines|mesh-list
64947094|NCT02255409|Immunologic Factors|immunologic factors|mesh-ancestor
64947095|NCT02255409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947096|NCT02213757|Estrogens|estrogens|mesh-list
64947097|NCT02213757|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64947098|NCT02213757|Hormones|hormones|mesh-ancestor
64947099|NCT02213757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64947100|NCT02213757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947101|NCT02120404|Esmolol|esmolol|mesh-list
64947102|NCT02120404|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64947103|NCT02120404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64947104|NCT02120404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64485939|NCT01935947|Mitosis Modulators|mitosis modulators|mesh-ancestor
64947105|NCT02120404|Adrenergic Agents|adrenergic agents|mesh-ancestor
64947106|NCT02120404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64947107|NCT02120404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947108|NCT02120404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947109|NCT02117791|Riociguat|riociguat|mesh-list
64947110|NCT02117791|Enzyme Activators|enzyme activators|mesh-ancestor
64947111|NCT02117791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947112|NCT02102243|Insulin|insulin|mesh-list
64947113|NCT02102243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64947114|NCT02102243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64947115|NCT02102243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947116|NCT02079740|Trametinib|trametinib|mesh-list
64584675|NCT04005599|Anticonvulsants|anticonvulsants|mesh-ancestor
65030565|NCT00165230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65030566|NCT00165230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65030567|NCT00165230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65030568|NCT00165230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65030569|NCT00165230|Growth Substances|growth substances|mesh-ancestor
65030570|NCT00165230|Growth Inhibitors|growth inhibitors|mesh-ancestor
65030571|NCT00165230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030572|NCT00165230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65030573|NCT00165230|Alkylating Agents|alkylating agents|mesh-ancestor
65030574|NCT00165230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030575|NCT00176553|Dextromethorphan|dextromethorphan|mesh-list
65030576|NCT00176553|Antitussive Agents|antitussive agents|mesh-ancestor
65030577|NCT00176553|Respiratory System Agents|respiratory system agents|mesh-ancestor
65030578|NCT00176553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65030579|NCT00176553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65030580|NCT00176553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65030581|NCT00176553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030582|NCT00176553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030583|NCT00165308|Tamoxifen|tamoxifen|mesh-list
65030584|NCT00165308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65030585|NCT00165308|Hormone Antagonists|hormone antagonists|mesh-ancestor
64947117|NCT02079740|Navitoclax|navitoclax|mesh-list
64947118|NCT02079740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947119|NCT02079740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64947120|NCT02079740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947121|NCT02079740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947122|NCT01998971|Acetaminophen|acetaminophen|mesh-list
64947123|NCT01998971|Diphenhydramine|diphenhydramine|mesh-list
64947124|NCT01998971|Promethazine|promethazine|mesh-list
64947125|NCT01998971|Thalidomide|thalidomide|mesh-list
64947126|NCT01998971|Dexamethasone|dexamethasone|mesh-list
64947127|NCT01998971|Prednisone|prednisone|mesh-list
64947128|NCT01998971|Lenalidomide|lenalidomide|mesh-list
64947142|NCT01998971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64947143|NCT01998971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64947145|NCT01998971|Immunologic Factors|immunologic factors|mesh-ancestor
64947146|NCT01998971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64947147|NCT01998971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64947148|NCT01998971|Growth Substances|growth substances|mesh-ancestor
64947149|NCT01998971|Growth Inhibitors|growth inhibitors|mesh-ancestor
64947150|NCT01998971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64947151|NCT01998971|Analgesics|analgesics|mesh-ancestor
64725203|NCT00001993|Miglustat|miglustat|mesh-list
64725204|NCT00001993|Zidovudine|zidovudine|mesh-list
64725205|NCT00001993|Antimetabolites|antimetabolites|mesh-ancestor
64725206|NCT00001993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725207|NCT00001993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64725208|NCT00001993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64725209|NCT00001993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725210|NCT00001993|Antiviral Agents|antiviral agents|mesh-ancestor
64725211|NCT00001993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64584696|NCT00330863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65030586|NCT00165308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65030587|NCT00165308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030588|NCT00165308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65030589|NCT00165308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030590|NCT00165308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65030591|NCT00165308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65030592|NCT00165308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65030593|NCT00165347|Vatalanib|vatalanib|mesh-list
65030594|NCT00165347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65030595|NCT00165347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030596|NCT00165347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030597|NCT00176670|Midazolam|midazolam|mesh-list
65030598|NCT00176670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65030599|NCT00176670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65030600|NCT00176670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65030601|NCT00176670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030602|NCT00176670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65030603|NCT00176670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64947154|NCT01998971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64947156|NCT01998971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947157|NCT01998971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64947158|NCT01998971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64947159|NCT01998971|Leprostatic Agents|leprostatic agents|mesh-ancestor
64947160|NCT01998971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64947161|NCT01998971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64947162|NCT01998971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64947163|NCT01998971|Respiratory System Agents|respiratory system agents|mesh-ancestor
64947164|NCT01998971|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64947165|NCT01998971|Hormone Antagonists|hormone antagonists|mesh-ancestor
64947166|NCT01998971|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64947167|NCT01998971|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64947168|NCT01998971|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64947169|NCT01998971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64947170|NCT01998971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64947171|NCT01998971|Anesthetics, Local|anesthetics, local|mesh-ancestor
64947172|NCT01998971|Anesthetics|anesthetics|mesh-ancestor
64947173|NCT01998971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64947174|NCT01998971|Histamine Antagonists|histamine antagonists|mesh-ancestor
64947175|NCT01998971|Histamine Agents|histamine agents|mesh-ancestor
64947176|NCT01998971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64947177|NCT01998971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64947178|NCT01998971|Antipruritics|antipruritics|mesh-ancestor
64947179|NCT01998971|Dermatologic Agents|dermatologic agents|mesh-ancestor
64947180|NCT01969227|Ketamine|ketamine|mesh-list
64947181|NCT01969227|Analgesics|analgesics|mesh-ancestor
64947182|NCT01969227|Sensory System Agents|sensory system agents|mesh-ancestor
64947183|NCT01969227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64947184|NCT01969227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947185|NCT01969227|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64947186|NCT01969227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64947187|NCT01969227|Anesthetics, General|anesthetics, general|mesh-ancestor
64947188|NCT01969227|Anesthetics|anesthetics|mesh-ancestor
65030604|NCT00176670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64584713|NCT01899521|Astringents|astringents|mesh-ancestor
64584714|NCT01899521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471876|NCT04025216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030605|NCT00176670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65030606|NCT00176670|Anesthetics, General|anesthetics, general|mesh-ancestor
65030607|NCT00176670|Anesthetics|anesthetics|mesh-ancestor
65030608|NCT00176670|GABA Modulators|gaba modulators|mesh-ancestor
65030609|NCT00176670|GABA Agents|gaba agents|mesh-ancestor
65030610|NCT00176670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65030611|NCT00176670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030612|NCT00165464|Irinotecan|irinotecan|mesh-list
65030613|NCT00165464|Docetaxel|docetaxel|mesh-list
65030614|NCT00165464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030615|NCT00165464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65030616|NCT00165464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65030617|NCT00165464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030618|NCT00165464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947189|NCT01969227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64947190|NCT01969227|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64947191|NCT01969227|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64947192|NCT01969227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64947202|NCT01709734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947203|NCT01604135|Riboflavin|riboflavin|mesh-list
64947204|NCT01604135|Dextrans|dextrans|mesh-list
64947205|NCT01604135|Vitamin B Complex|vitamin b complex|mesh-ancestor
64947206|NCT01604135|Vitamins|vitamins|mesh-ancestor
64947207|NCT01604135|Micronutrients|micronutrients|mesh-ancestor
64947208|NCT01604135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947209|NCT01604135|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64947210|NCT01604135|Dermatologic Agents|dermatologic agents|mesh-ancestor
64947211|NCT01604135|Anticoagulants|anticoagulants|mesh-ancestor
64947212|NCT01604135|Plasma Substitutes|plasma substitutes|mesh-ancestor
64725215|NCT00001993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64725216|NCT00001993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947213|NCT01604135|Blood Substitutes|blood substitutes|mesh-ancestor
64947214|NCT00644189|Clofarabine|clofarabine|mesh-list
64947215|NCT00644189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64947216|NCT00644189|Antimetabolites|antimetabolites|mesh-ancestor
64947217|NCT00644189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947218|NCT00644189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947219|NCT00630032|Cyclophosphamide|cyclophosphamide|mesh-list
64947220|NCT00630032|Docetaxel|docetaxel|mesh-list
64947221|NCT00630032|Fluorouracil|fluorouracil|mesh-list
64947222|NCT00630032|Epirubicin|epirubicin|mesh-list
64947223|NCT00630032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64947224|NCT00630032|Immunologic Factors|immunologic factors|mesh-ancestor
64947225|NCT00630032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947226|NCT00630032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64947233|NCT00630032|Antimitotic Agents|antimitotic agents|mesh-ancestor
64947234|NCT00630032|Mitosis Modulators|mitosis modulators|mesh-ancestor
64947235|NCT00630032|Antimetabolites|antimetabolites|mesh-ancestor
64947236|NCT00630032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64947237|NCT00630032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64947238|NCT00630032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64947239|NCT00630032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64947240|NCT00630032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947241|NCT00465517|Ganaxolone|ganaxolone|mesh-list
64947242|NCT00465517|Neurosteroids|neurosteroids|mesh-ancestor
65030619|NCT00165464|Tubulin Modulators|tubulin modulators|mesh-ancestor
64584728|NCT05737329|Hormones|hormones|mesh-ancestor
65030620|NCT00165464|Antimitotic Agents|antimitotic agents|mesh-ancestor
65030621|NCT00165464|Mitosis Modulators|mitosis modulators|mesh-ancestor
65030622|NCT04082650|Vitamin D|vitamin d|mesh-list
65030623|NCT04082650|Vitamins|vitamins|mesh-ancestor
65030624|NCT04082650|Micronutrients|micronutrients|mesh-ancestor
65030625|NCT04082650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030626|NCT04082650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65030627|NCT00176787|Capecitabine|capecitabine|mesh-list
65030628|NCT00176787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65030629|NCT00176787|Antimetabolites|antimetabolites|mesh-ancestor
65030630|NCT00176787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030631|NCT00176787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030632|NCT00176943|Imiquimod|imiquimod|mesh-list
65030633|NCT00176943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65030634|NCT00176943|Immunologic Factors|immunologic factors|mesh-ancestor
65030635|NCT00176943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030636|NCT00176943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030637|NCT00176943|Interferon Inducers|interferon inducers|mesh-ancestor
65030638|NCT03978208|Naproxen|naproxen|mesh-list
65030639|NCT03978208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65030640|NCT03978208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65030641|NCT03978208|Analgesics|analgesics|mesh-ancestor
65030642|NCT03978208|Sensory System Agents|sensory system agents|mesh-ancestor
65030643|NCT03978208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65030644|NCT03978208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030645|NCT03978208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65030646|NCT03978208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64584732|NCT05737329|Contraceptive Agents|contraceptive agents|mesh-ancestor
64947243|NCT00465517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64947244|NCT00465517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947245|NCT00465517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947246|NCT00465517|GABA Modulators|gaba modulators|mesh-ancestor
64947247|NCT00465517|GABA Agents|gaba agents|mesh-ancestor
64947248|NCT00289952|Valproic Acid|valproic acid|mesh-list
64947249|NCT00289952|Anticonvulsants|anticonvulsants|mesh-ancestor
64947250|NCT00289952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947251|NCT00289952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947252|NCT00289952|GABA Agents|gaba agents|mesh-ancestor
64947253|NCT00289952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64947254|NCT00289952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947255|NCT00289952|Antimanic Agents|antimanic agents|mesh-ancestor
64947256|NCT00289952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64503305|NCT03352362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64947257|NCT00289952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65030647|NCT03978208|Gout Suppressants|gout suppressants|mesh-ancestor
65030648|NCT03978208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65030649|NCT03978208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030650|NCT03978208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030651|NCT03936829|Cyclophosphamide|cyclophosphamide|mesh-list
65030652|NCT03936829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65030653|NCT03936829|Immunologic Factors|immunologic factors|mesh-ancestor
65030654|NCT03936829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030655|NCT03936829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65030656|NCT03936829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64947269|NCT05772871|Immunologic Factors|immunologic factors|mesh-ancestor
64947270|NCT05772871|Antinematodal Agents|antinematodal agents|mesh-ancestor
64947271|NCT05772871|Anthelmintics|anthelmintics|mesh-ancestor
64947272|NCT05772871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64947273|NCT05772871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64947274|NCT05772871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64947275|NCT05772832|Dexmedetomidine|dexmedetomidine|mesh-list
64947276|NCT05772832|Remifentanil|remifentanil|mesh-list
64947277|NCT05772832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64947278|NCT05772832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64947279|NCT05772832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947280|NCT05772832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64947281|NCT05772832|Analgesics|analgesics|mesh-ancestor
64947282|NCT05772832|Sensory System Agents|sensory system agents|mesh-ancestor
64947283|NCT05772832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64947284|NCT05772832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64947285|NCT05772832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64947286|NCT05772832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64947287|NCT05772832|Adrenergic Agents|adrenergic agents|mesh-ancestor
64947288|NCT05772832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64947289|NCT05772832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947290|NCT05772832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64947291|NCT05772832|Narcotics|narcotics|mesh-ancestor
64947292|NCT05772728|Azacitidine|azacitidine|mesh-list
64947293|NCT05772728|Mitoxantrone|mitoxantrone|mesh-list
64725218|NCT00001999|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64725219|NCT00001999|Immunoglobulins|immunoglobulins|mesh-list
64725220|NCT00001999|Antibodies|antibodies|mesh-list
64725221|NCT00001999|Antiviral Agents|antiviral agents|mesh-ancestor
64725222|NCT00001999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64947294|NCT05772728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64947295|NCT05772728|Antimetabolites|antimetabolites|mesh-ancestor
64947296|NCT05772728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947297|NCT05772728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947298|NCT05772728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947299|NCT05772728|Analgesics|analgesics|mesh-ancestor
64947300|NCT05772728|Sensory System Agents|sensory system agents|mesh-ancestor
64419932|NCT02311881|Antipyretics|antipyretics|mesh-ancestor
64947306|NCT05772676|Antiemetics|antiemetics|mesh-ancestor
64947307|NCT05772676|Autonomic Agents|autonomic agents|mesh-ancestor
64947308|NCT05772676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64947309|NCT05772676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947310|NCT05772676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64947311|NCT05772676|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64947312|NCT05772676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64947313|NCT05772676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947314|NCT05772624|Nivolumab|nivolumab|mesh-list
64947315|NCT05772624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64947316|NCT05772624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947317|NCT05772624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64947318|NCT05772624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947319|NCT05772546|Maleic acid|maleic acid|mesh-list
64947320|NCT05772546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947321|NCT05772546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947322|NCT05772429|Cannabidiol|cannabidiol|mesh-list
65030657|NCT03936829|Alkylating Agents|alkylating agents|mesh-ancestor
64584764|NCT00318409|Antidepressive Agents|antidepressive agents|mesh-ancestor
65030658|NCT03936829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030659|NCT03936829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030660|NCT03936829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65030661|NCT00165659|Donepezil|donepezil|mesh-list
65030662|NCT00165659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65030663|NCT00165659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030664|NCT00165659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030665|NCT00165659|Cholinergic Agents|cholinergic agents|mesh-ancestor
65030666|NCT00165659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65030667|NCT00165659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030668|NCT00165659|Nootropic Agents|nootropic agents|mesh-ancestor
65030669|NCT03935893|Cyclophosphamide|cyclophosphamide|mesh-list
65030670|NCT03935893|Fludarabine|fludarabine|mesh-list
65030671|NCT03935893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64584765|NCT00318409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64947338|NCT05772208|Nimotuzumab|nimotuzumab|mesh-list
64947339|NCT05772208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64947340|NCT05772208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947341|NCT05772156|Methylergonovine|methylergonovine|mesh-list
64947342|NCT05772156|Oxytocics|oxytocics|mesh-ancestor
64947343|NCT05772156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64947344|NCT05772156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947345|NCT05772039|Listerine|listerine|mesh-list
64947346|NCT05772039|Fluorides|fluorides|mesh-list
64947347|NCT05772039|Sodium Fluoride|sodium fluoride|mesh-list
64947348|NCT05772039|Cariostatic Agents|cariostatic agents|mesh-ancestor
64947349|NCT05772039|Protective Agents|protective agents|mesh-ancestor
64947350|NCT05772039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947351|NCT05772039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64947352|NCT05772039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64947353|NCT05772013|Azithromycin|azithromycin|mesh-list
64947354|NCT05772013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64947355|NCT05772013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64947356|NCT05771779|Vaccines|vaccines|mesh-list
64947357|NCT05771779|Immunologic Factors|immunologic factors|mesh-ancestor
64947358|NCT05771779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947359|NCT05771675|Simvastatin|simvastatin|mesh-list
64947360|NCT05771675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64947361|NCT05771675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64947362|NCT05771675|Antimetabolites|antimetabolites|mesh-ancestor
64947363|NCT05771675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947364|NCT05771675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64947365|NCT05771675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64947366|NCT05771675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947367|NCT05771584|Sargramostim|sargramostim|mesh-list
64947368|NCT05771584|Immunologic Factors|immunologic factors|mesh-ancestor
64725223|NCT00001999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64947369|NCT05771584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947370|NCT05771480|Gemcitabine|gemcitabine|mesh-list
64947371|NCT05771480|Paclitaxel|paclitaxel|mesh-list
64947372|NCT05771480|Cisplatin|cisplatin|mesh-list
64947373|NCT05771480|Carboplatin|carboplatin|mesh-list
64947374|NCT05771480|Oxaliplatin|oxaliplatin|mesh-list
64947375|NCT05771480|Durvalumab|durvalumab|mesh-list
64947376|NCT05771480|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64947377|NCT05771480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64947378|NCT05771480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947379|NCT05771480|Tubulin Modulators|tubulin modulators|mesh-ancestor
64584777|NCT00333437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65030672|NCT03935893|Immunologic Factors|immunologic factors|mesh-ancestor
65030673|NCT03935893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030674|NCT03935893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65030675|NCT03935893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65030676|NCT03935893|Alkylating Agents|alkylating agents|mesh-ancestor
65066964|NCT00418704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65030677|NCT03935893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030678|NCT03935893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515843|NCT01999348|Adrenergic Agents|adrenergic agents|mesh-ancestor
65030679|NCT03935893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65030680|NCT00176982|Hydroxychloroquine|hydroxychloroquine|mesh-list
65030681|NCT00176982|Antimalarials|antimalarials|mesh-ancestor
65030682|NCT00176982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65030683|NCT00176982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65030684|NCT00176982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65030685|NCT00176982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030686|NCT00176982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030687|NCT00176982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65030688|NCT03887377|Botulinum Toxins|botulinum toxins|mesh-list
65030689|NCT03887377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65030690|NCT03887377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65030691|NCT03887377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65030692|NCT03887377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030693|NCT03887377|Cholinergic Agents|cholinergic agents|mesh-ancestor
65030694|NCT03887377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65030695|NCT03887377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030696|NCT00165737|Donepezil|donepezil|mesh-list
65030697|NCT00165737|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65030698|NCT00165737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584778|NCT00333437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947380|NCT05771480|Antimitotic Agents|antimitotic agents|mesh-ancestor
64947381|NCT05771480|Mitosis Modulators|mitosis modulators|mesh-ancestor
64947382|NCT05771480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947383|NCT05771480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64947384|NCT05771480|Antimetabolites|antimetabolites|mesh-ancestor
64947385|NCT05771480|Antiviral Agents|antiviral agents|mesh-ancestor
64947406|NCT05771038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64947407|NCT05771038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947409|NCT05771012|Cyclosporins|cyclosporins|mesh-list
64947410|NCT05771012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584807|NCT04971187|Carboplatin|carboplatin|mesh-list
65030699|NCT00165737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030700|NCT00165737|Cholinergic Agents|cholinergic agents|mesh-ancestor
65030701|NCT00165737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65030702|NCT00165737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030703|NCT00165737|Nootropic Agents|nootropic agents|mesh-ancestor
65030704|NCT04682899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65030705|NCT04682899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65030706|NCT04682899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65030707|NCT04682899|Antitubercular Agents|antitubercular agents|mesh-ancestor
65030708|NCT03789916|Aspirin|aspirin|mesh-list
65030709|NCT03789916|Ticagrelor|ticagrelor|mesh-list
65030710|NCT03789916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65030711|NCT03789916|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65030712|NCT03789916|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65030713|NCT03789916|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65030714|NCT03789916|Purinergic Agents|purinergic agents|mesh-ancestor
65030715|NCT03789916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65030716|NCT03789916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030717|NCT03789916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030718|NCT03789916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65030719|NCT03789916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65030720|NCT03789916|Analgesics|analgesics|mesh-ancestor
65030721|NCT03789916|Sensory System Agents|sensory system agents|mesh-ancestor
65030722|NCT03789916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64584808|NCT04971187|Pemetrexed|pemetrexed|mesh-list
64947411|NCT05771012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947412|NCT05771012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64947413|NCT05771012|Immunologic Factors|immunologic factors|mesh-ancestor
64947414|NCT05771012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947415|NCT05771012|Antifungal Agents|antifungal agents|mesh-ancestor
64947416|NCT05771012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64947417|NCT05771012|Dermatologic Agents|dermatologic agents|mesh-ancestor
64947418|NCT05771012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64947419|NCT05771012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64947420|NCT05770960|Codeine|codeine|mesh-list
64947421|NCT05770960|Naloxegol|naloxegol|mesh-list
64947422|NCT05770960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64947423|NCT05770960|Narcotics|narcotics|mesh-ancestor
64947424|NCT05770960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64947425|NCT05770960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947426|NCT05770960|Analgesics|analgesics|mesh-ancestor
64947427|NCT05770960|Sensory System Agents|sensory system agents|mesh-ancestor
64947428|NCT05770960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64947429|NCT05770960|Antitussive Agents|antitussive agents|mesh-ancestor
64947430|NCT05770960|Respiratory System Agents|respiratory system agents|mesh-ancestor
64947431|NCT05770960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64947432|NCT05769946|Hemay005|hemay005|mesh-list
64584832|NCT01392326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65030723|NCT03789916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65030724|NCT03789916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65030725|NCT03789916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65030726|NCT03789916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65030727|NCT03789916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65030728|NCT03789916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030729|NCT03789916|Antipyretics|antipyretics|mesh-ancestor
65030730|NCT00165815|Donepezil|donepezil|mesh-list
65030731|NCT00165815|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65030732|NCT00165815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030733|NCT00165815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030734|NCT00165815|Cholinergic Agents|cholinergic agents|mesh-ancestor
65030735|NCT00165815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65030736|NCT00165815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030737|NCT00165815|Nootropic Agents|nootropic agents|mesh-ancestor
65030738|NCT00177021|Imiquimod|imiquimod|mesh-list
65030739|NCT00177021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65030740|NCT00177021|Immunologic Factors|immunologic factors|mesh-ancestor
65030741|NCT00177021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030742|NCT00177021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030743|NCT00177021|Interferon Inducers|interferon inducers|mesh-ancestor
65030744|NCT03697603|Brexpiprazole|brexpiprazole|mesh-list
65030745|NCT03697603|Serotonin Agents|serotonin agents|mesh-ancestor
64947433|NCT05769946|Dermatologic Agents|dermatologic agents|mesh-ancestor
64947434|NCT05769946|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64947435|NCT05769946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64947436|NCT05769946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947437|NCT05769946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947438|NCT05768282|Prednisolone|prednisolone|mesh-list
64947439|NCT05768282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64947440|NCT05768282|Glucocorticoids|glucocorticoids|mesh-ancestor
64947441|NCT05768282|Hormones|hormones|mesh-ancestor
64947442|NCT05768282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64947443|NCT05768282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947444|NCT05768282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64947445|NCT05768282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947446|NCT05766800|Paclitaxel|paclitaxel|mesh-list
64947462|NCT05766410|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64947463|NCT05766410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947464|NCT05766410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947465|NCT05766410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64947466|NCT05766410|Hormone Antagonists|hormone antagonists|mesh-ancestor
64947467|NCT05766410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64947468|NCT05766410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947469|NCT05766410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64947471|NCT05757011|Anesthetics, Local|anesthetics, local|mesh-ancestor
64725225|NCT00001999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332761|NCT01565499|Paclitaxel|paclitaxel|mesh-list
64947472|NCT05757011|Anesthetics|anesthetics|mesh-ancestor
64947473|NCT05757011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65030746|NCT03697603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65030747|NCT03697603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030748|NCT03697603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030749|NCT03697603|Dopamine Agonists|dopamine agonists|mesh-ancestor
65030750|NCT03697603|Dopamine Agents|dopamine agents|mesh-ancestor
65030751|NCT00165854|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
65030752|NCT00165854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030753|NCT00165854|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65030754|NCT00165854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584852|NCT00320671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64947474|NCT05757011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947475|NCT05757011|Sensory System Agents|sensory system agents|mesh-ancestor
64947476|NCT05757011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64947477|NCT05754996|Nifuroxazide|nifuroxazide|mesh-list
64947478|NCT05754996|Lactulose|lactulose|mesh-list
64947479|NCT05754996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64947480|NCT05754996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64947481|NCT05750875|Loratadine|loratadine|mesh-list
64503309|NCT03352362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947482|NCT05750875|Gabapentin|gabapentin|mesh-list
64947483|NCT05750875|Analgesics|analgesics|mesh-ancestor
64947496|NCT05750875|Antimanic Agents|antimanic agents|mesh-ancestor
64947497|NCT05750875|Antipruritics|antipruritics|mesh-ancestor
64947498|NCT05750875|Dermatologic Agents|dermatologic agents|mesh-ancestor
64947499|NCT05750875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64947500|NCT05750875|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64947501|NCT05750875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64947502|NCT05750875|Histamine Antagonists|histamine antagonists|mesh-ancestor
64947503|NCT05750875|Histamine Agents|histamine agents|mesh-ancestor
64947504|NCT05736562|Vitamins|vitamins|mesh-list
64947523|NCT05724134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947525|NCT05715073|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64947526|NCT05715073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947527|NCT05715073|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64947528|NCT05715073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947529|NCT05715073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947530|NCT05715073|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64947531|NCT05715073|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64947532|NCT05715073|Purinergic Agents|purinergic agents|mesh-ancestor
64947533|NCT05715073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64947534|NCT05702671|Immunoglobulins|immunoglobulins|mesh-list
64947535|NCT05702671|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64947536|NCT05702671|Antibodies|antibodies|mesh-list
64947537|NCT05702671|Immunologic Factors|immunologic factors|mesh-ancestor
64947538|NCT05702671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947539|NCT05702463|Aspirin|aspirin|mesh-list
64947540|NCT05702463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64947541|NCT05702463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64947542|NCT05702463|Analgesics|analgesics|mesh-ancestor
64947543|NCT05702463|Sensory System Agents|sensory system agents|mesh-ancestor
64947544|NCT05702463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64947545|NCT05702463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947546|NCT05702463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64947547|NCT05702463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64947548|NCT05702463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64947549|NCT05702463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64947550|NCT05702463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947551|NCT05702463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64947552|NCT05702463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64947553|NCT05702463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947554|NCT05702463|Antipyretics|antipyretics|mesh-ancestor
64947555|NCT05696795|Abrocitinib|abrocitinib|mesh-list
64947556|NCT05696795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64584863|NCT00320749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030755|NCT00165854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030757|NCT00177060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65030758|NCT00177060|Narcotics|narcotics|mesh-ancestor
65030759|NCT00177060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65030760|NCT00177060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030761|NCT00177060|Analgesics|analgesics|mesh-ancestor
65030762|NCT00177060|Sensory System Agents|sensory system agents|mesh-ancestor
65030763|NCT00177060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65030764|NCT03546361|Pembrolizumab|pembrolizumab|mesh-list
65030765|NCT03546361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65030766|NCT03546361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030767|NCT03421639|Leuprolide|leuprolide|mesh-list
65030768|NCT03421639|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65030769|NCT03421639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65030770|NCT03421639|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65030771|NCT03421639|Fertility Agents|fertility agents|mesh-ancestor
65030772|NCT03421639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65030773|NCT03421639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030774|NCT03421639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64584864|NCT00320749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64947557|NCT05696795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486386|NCT01928381|Pregabalin|pregabalin|mesh-list
64947558|NCT05696795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725226|NCT00001999|Immunologic Factors|immunologic factors|mesh-ancestor
64725227|NCT00001999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725229|NCT00002383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64725230|NCT00002383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64947574|NCT05680584|Melatonin|melatonin|mesh-list
64947575|NCT05680584|Hydroxyzine|hydroxyzine|mesh-list
64947576|NCT05680584|Antioxidants|antioxidants|mesh-ancestor
64947577|NCT05680584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947578|NCT05680584|Protective Agents|protective agents|mesh-ancestor
64947579|NCT05680584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947580|NCT05680584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64947581|NCT05680584|Antipruritics|antipruritics|mesh-ancestor
64947582|NCT05680584|Dermatologic Agents|dermatologic agents|mesh-ancestor
64947583|NCT05680584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64947584|NCT05680584|Histamine Antagonists|histamine antagonists|mesh-ancestor
64947585|NCT05680584|Histamine Agents|histamine agents|mesh-ancestor
64947586|NCT05680584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64947587|NCT05673200|Paclitaxel|paclitaxel|mesh-list
64947588|NCT05673200|Pembrolizumab|pembrolizumab|mesh-list
64947589|NCT05673200|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64947590|NCT05673200|Decitabine|decitabine|mesh-list
64947591|NCT05673200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64947592|NCT05673200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947593|NCT05673200|Tubulin Modulators|tubulin modulators|mesh-ancestor
64947594|NCT05673200|Antimitotic Agents|antimitotic agents|mesh-ancestor
64947595|NCT05673200|Mitosis Modulators|mitosis modulators|mesh-ancestor
64947596|NCT05673200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947597|NCT05673200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64947598|NCT05673200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65030775|NCT03421639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584882|NCT00322309|Mirtazapine|mirtazapine|mesh-list
64584883|NCT00322309|Antidepressive Agents|antidepressive agents|mesh-ancestor
65030776|NCT03421639|Hormones|hormones|mesh-ancestor
65030777|NCT03421639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65030778|NCT03421639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65030779|NCT03421639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030780|NCT03421639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030781|NCT03421639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65030782|NCT03421639|Hormone Antagonists|hormone antagonists|mesh-ancestor
65030783|NCT00177099|Tacrolimus|tacrolimus|mesh-list
65030784|NCT00177099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65030785|NCT00177099|Immunologic Factors|immunologic factors|mesh-ancestor
65030786|NCT00177099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030787|NCT00177099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65030788|NCT00177099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030789|NCT00177099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030790|NCT03413800|Dexamethasone|dexamethasone|mesh-list
65030791|NCT03413800|Lenalidomide|lenalidomide|mesh-list
65030792|NCT03413800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65030793|NCT03413800|Antiemetics|antiemetics|mesh-ancestor
65030794|NCT03413800|Autonomic Agents|autonomic agents|mesh-ancestor
65030795|NCT03413800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65030796|NCT03413800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030797|NCT03413800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65030798|NCT03413800|Glucocorticoids|glucocorticoids|mesh-ancestor
65030799|NCT03413800|Hormones|hormones|mesh-ancestor
65030800|NCT03413800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65030801|NCT03413800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65030802|NCT03413800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030803|NCT03413800|Immunologic Factors|immunologic factors|mesh-ancestor
65030804|NCT03413800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65030805|NCT03413800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65030806|NCT03413800|Growth Substances|growth substances|mesh-ancestor
64584887|NCT00322309|Histamine Agents|histamine agents|mesh-ancestor
64947599|NCT05673200|Antimetabolites|antimetabolites|mesh-ancestor
64947600|NCT05673200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947601|NCT05672173|Cyclophosphamide|cyclophosphamide|mesh-list
64947602|NCT05672173|Nivolumab|nivolumab|mesh-list
64947603|NCT05672173|Fludarabine|fludarabine|mesh-list
64584912|NCT04046744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65030807|NCT03413800|Growth Inhibitors|growth inhibitors|mesh-ancestor
65030808|NCT03354013|Calcium|calcium|mesh-list
65030809|NCT03354013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65030810|NCT03354013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030811|NCT03335839|Plasminogen|plasminogen|mesh-list
65030812|NCT03335839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65030813|NCT03335839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65030814|NCT03335839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65030815|NCT03335839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030816|NCT00166010|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65030817|NCT00166010|Natriuretic Agents|natriuretic agents|mesh-ancestor
65030818|NCT00166010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030819|NCT03104491|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65030820|NCT03104491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65030821|NCT03104491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030822|NCT03104491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65030823|NCT05336812|Venetoclax|venetoclax|mesh-list
65030824|NCT05336812|Obinutuzumab|obinutuzumab|mesh-list
65030825|NCT05336812|Acalabrutinib|acalabrutinib|mesh-list
65030826|NCT05336812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584913|NCT04046744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64947604|NCT05672173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64947605|NCT05672173|Immunologic Factors|immunologic factors|mesh-ancestor
64947606|NCT05672173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947607|NCT05672173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64947608|NCT05672173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64947609|NCT05672173|Alkylating Agents|alkylating agents|mesh-ancestor
64947610|NCT05672173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947611|NCT05672173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947612|NCT05672173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64947613|NCT05672173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64947614|NCT05672173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64947615|NCT05655949|Gemcitabine|gemcitabine|mesh-list
64947616|NCT05655949|Cisplatin|cisplatin|mesh-list
64947617|NCT05655949|Durvalumab|durvalumab|mesh-list
64947618|NCT05655949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947619|NCT05655949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64947620|NCT05655949|Antimetabolites|antimetabolites|mesh-ancestor
64947641|NCT05646992|Antimetabolites|antimetabolites|mesh-ancestor
64947642|NCT05646992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64947643|NCT05646992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947644|NCT05646992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64947646|NCT05637606|Norepinephrine|norepinephrine|mesh-list
64947647|NCT05637606|Ephedrine|ephedrine|mesh-list
64947648|NCT05637606|Pseudoephedrine|pseudoephedrine|mesh-list
64947649|NCT05637606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64947650|NCT05637606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64947651|NCT05637606|Adrenergic Agents|adrenergic agents|mesh-ancestor
64947652|NCT05637606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64947653|NCT05637606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947654|NCT05637606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947655|NCT05637606|Sympathomimetics|sympathomimetics|mesh-ancestor
65030827|NCT05336812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64584932|NCT01431950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65030828|NCT00537862|Mycophenolic Acid|mycophenolic acid|mesh-list
65030829|NCT00537862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65030830|NCT00537862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030831|NCT00537862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65030832|NCT00537862|Antitubercular Agents|antitubercular agents|mesh-ancestor
65030833|NCT00537862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65030834|NCT00537862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65030835|NCT00537862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030836|NCT00537862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030837|NCT00537901|Bevacizumab|bevacizumab|mesh-list
65030838|NCT00537901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65030839|NCT00537901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030840|NCT00537901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65030841|NCT00537901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65030842|NCT00537901|Growth Substances|growth substances|mesh-ancestor
65030843|NCT00537901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030844|NCT00537901|Growth Inhibitors|growth inhibitors|mesh-ancestor
65030845|NCT00166127|Simendan|simendan|mesh-list
65030846|NCT00166127|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65030847|NCT00166127|Vasodilator Agents|vasodilator agents|mesh-ancestor
65030848|NCT00166127|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65030849|NCT00166127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65030850|NCT00166127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030851|NCT00166127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030852|NCT00166127|Protective Agents|protective agents|mesh-ancestor
65030853|NCT00166127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030854|NCT00194649|Miglustat|miglustat|mesh-list
65030855|NCT00194649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030856|NCT00194649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947656|NCT05637606|Autonomic Agents|autonomic agents|mesh-ancestor
64947657|NCT05637606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64725232|NCT00002383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725233|NCT00002383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725234|NCT00002383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64725235|NCT00002383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64725236|NCT00002383|Antiviral Agents|antiviral agents|mesh-ancestor
64947658|NCT05637606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64947659|NCT05637606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64947660|NCT05637606|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65030857|NCT00194649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64584962|NCT00322465|Alkylating Agents|alkylating agents|mesh-ancestor
65030858|NCT00194649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65030859|NCT00194649|Antiviral Agents|antiviral agents|mesh-ancestor
65030860|NCT00194649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65030861|NCT00194649|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65030862|NCT00194649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65030863|NCT00194649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030864|NCT00166244|Mycophenolic Acid|mycophenolic acid|mesh-list
65030865|NCT00166244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65030866|NCT00166244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030867|NCT00166244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65030868|NCT00166244|Antitubercular Agents|antitubercular agents|mesh-ancestor
65030869|NCT00166244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65030870|NCT00166244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64584967|NCT03021993|Nivolumab|nivolumab|mesh-list
64947664|NCT05637606|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64947665|NCT05637606|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64947666|NCT05637606|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64947667|NCT05637606|Protective Agents|protective agents|mesh-ancestor
64947688|NCT05533684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64947689|NCT05533684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64947690|NCT05533684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947691|NCT05533684|Antimanic Agents|antimanic agents|mesh-ancestor
64947692|NCT05533164|Rituximab|rituximab|mesh-list
64947693|NCT05533164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64947694|NCT05533164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947695|NCT05533164|Immunologic Factors|immunologic factors|mesh-ancestor
64947696|NCT05533164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947697|NCT05533164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64947698|NCT05514132|Durvalumab|durvalumab|mesh-list
64947699|NCT05514132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64947700|NCT05514132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64947701|NCT05514132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947702|NCT05514132|Immunologic Factors|immunologic factors|mesh-ancestor
64947703|NCT05514132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947719|NCT05501756|Alemtuzumab|alemtuzumab|mesh-list
64947720|NCT05501756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64947721|NCT05501756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947722|NCT05458479|Fluoxetine|fluoxetine|mesh-list
64947723|NCT05458479|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64947724|NCT05458479|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64947725|NCT05458479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64947726|NCT05458479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947727|NCT05458479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64947728|NCT05458479|Serotonin Agents|serotonin agents|mesh-ancestor
64947729|NCT05458479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947738|NCT05433961|Anesthetics, General|anesthetics, general|mesh-ancestor
64947740|NCT05433961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64947741|NCT05433961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947742|NCT05423769|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64947743|NCT05423769|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64947744|NCT05423769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947745|NCT05423769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64947746|NCT05423769|Immunologic Factors|immunologic factors|mesh-ancestor
64947747|NCT05423769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947748|NCT05408247|Acetylcysteine|acetylcysteine|mesh-list
64947749|NCT05408247|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64584975|NCT00558753|Pregabalin|pregabalin|mesh-list
65030871|NCT00166244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030872|NCT00166244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030873|NCT00177138|Alemtuzumab|alemtuzumab|mesh-list
65030874|NCT00177138|Tacrolimus|tacrolimus|mesh-list
65030875|NCT00177138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65030876|NCT00177138|Immunologic Factors|immunologic factors|mesh-ancestor
65030877|NCT00177138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030878|NCT00177138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65030879|NCT00177138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030880|NCT00177138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030881|NCT00177138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65030882|NCT00177138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030883|NCT05311774|Tramadol|tramadol|mesh-list
65030884|NCT05311774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65030885|NCT05311774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65030886|NCT05311774|Narcotics|narcotics|mesh-ancestor
65030887|NCT05311774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65030888|NCT05311774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030889|NCT05311774|Analgesics|analgesics|mesh-ancestor
65030890|NCT05311774|Sensory System Agents|sensory system agents|mesh-ancestor
65030891|NCT05311774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65030892|NCT05311774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64584976|NCT00558753|Analgesics|analgesics|mesh-ancestor
64947750|NCT05408247|Antiviral Agents|antiviral agents|mesh-ancestor
64947751|NCT05408247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64947752|NCT05408247|Expectorants|expectorants|mesh-ancestor
64947753|NCT05408247|Respiratory System Agents|respiratory system agents|mesh-ancestor
64947754|NCT05408247|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64947755|NCT05408247|Antioxidants|antioxidants|mesh-ancestor
64947756|NCT05408247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947757|NCT05408247|Protective Agents|protective agents|mesh-ancestor
64947758|NCT05408247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947759|NCT05408247|Antidotes|antidotes|mesh-ancestor
64947760|NCT05406401|Prednisone|prednisone|mesh-list
64947761|NCT05406401|Prednisolone|prednisolone|mesh-list
64947762|NCT05406401|Cyclophosphamide|cyclophosphamide|mesh-list
64947763|NCT05406401|Rituximab|rituximab|mesh-list
64725237|NCT00002383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725238|NCT00002383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64725239|NCT00002383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64725240|NCT00002389|Lamivudine|lamivudine|mesh-list
64725241|NCT00002389|Zidovudine|zidovudine|mesh-list
64725242|NCT00002389|Abacavir|abacavir|mesh-list
64947764|NCT05406401|Doxorubicin|doxorubicin|mesh-list
64947765|NCT05406401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64947766|NCT05406401|Immunologic Factors|immunologic factors|mesh-ancestor
64947767|NCT05406401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947768|NCT05406401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64419976|NCT04582669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64947771|NCT05406401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947772|NCT05406401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030893|NCT05311774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65030894|NCT05311774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65030895|NCT05311774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030896|NCT05311774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65030897|NCT05311774|Antidepressive Agents|antidepressive agents|mesh-ancestor
64516082|NCT02006836|Insulin|insulin|mesh-list
65030899|NCT05311774|Dopamine Agents|dopamine agents|mesh-ancestor
65030900|NCT00194727|Capecitabine|capecitabine|mesh-list
65030901|NCT00194727|Vinorelbine|vinorelbine|mesh-list
65030902|NCT00194727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65030903|NCT00194727|Antimetabolites|antimetabolites|mesh-ancestor
65030904|NCT00194727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030905|NCT00194727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030906|NCT00194727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65030907|NCT00194727|Tubulin Modulators|tubulin modulators|mesh-ancestor
65030908|NCT00194727|Antimitotic Agents|antimitotic agents|mesh-ancestor
65030909|NCT00194727|Mitosis Modulators|mitosis modulators|mesh-ancestor
65030910|NCT00166400|Metoprolol|metoprolol|mesh-list
65030911|NCT00166400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65030912|NCT00166400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65030913|NCT00166400|Sympatholytics|sympatholytics|mesh-ancestor
65030914|NCT00166400|Autonomic Agents|autonomic agents|mesh-ancestor
65030915|NCT00166400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65030916|NCT00166400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947773|NCT05406401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64947774|NCT05406401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64947775|NCT05406401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64947776|NCT05406401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64947777|NCT05406401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64947778|NCT05406401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947779|NCT05406401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64503312|NCT01598740|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64947781|NCT05406401|Hormones|hormones|mesh-ancestor
64947782|NCT05406401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64947783|NCT05406401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64947784|NCT05397639|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
64947785|NCT05397639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64947786|NCT05397639|Serotonin Agents|serotonin agents|mesh-ancestor
64947787|NCT05397639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64947788|NCT05397639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947789|NCT05397639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947790|NCT05375942|Infliximab|infliximab|mesh-list
64947791|NCT05375942|Dermatologic Agents|dermatologic agents|mesh-ancestor
64947792|NCT05375942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64947801|NCT05209308|Rituximab|rituximab|mesh-list
64947802|NCT05209308|Venetoclax|venetoclax|mesh-list
64947803|NCT05209308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64947804|NCT05209308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947805|NCT05209308|Immunologic Factors|immunologic factors|mesh-ancestor
65030917|NCT00166400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65030918|NCT00166400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65030919|NCT00166400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65030920|NCT00166400|Adrenergic Agents|adrenergic agents|mesh-ancestor
65030921|NCT00166400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65030922|NCT00166400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030923|NCT02042287|Metronidazole|metronidazole|mesh-list
64947806|NCT05209308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947807|NCT05209308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64947808|NCT05153317|Ivacaftor|ivacaftor|mesh-list
64947809|NCT05153317|Elexacaftor|elexacaftor|mesh-list
64947810|NCT05153317|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64947811|NCT05153317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64947812|NCT05153317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947813|NCT05150015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64947814|NCT05150015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64947815|NCT05148962|Vaccines|vaccines|mesh-list
64947816|NCT05148962|Immunologic Factors|immunologic factors|mesh-ancestor
64947817|NCT05148962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947818|NCT05147805|Treprostinil|treprostinil|mesh-list
64947819|NCT05147805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64947820|NCT05112848|Vaccines|vaccines|mesh-list
64947821|NCT05112848|Immunologic Factors|immunologic factors|mesh-ancestor
64947822|NCT05112848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947823|NCT05053503|Lofexidine|lofexidine|mesh-list
64947824|NCT05053503|Naltrexone|naltrexone|mesh-list
64947825|NCT05053503|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64947826|NCT05053503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64947827|NCT05053503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947828|NCT05053503|Sensory System Agents|sensory system agents|mesh-ancestor
64947829|NCT05053503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64947830|NCT05053503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64947831|NCT05053503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64947832|NCT05053503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64725243|NCT00002389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64725244|NCT00002389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64725245|NCT00002389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725246|NCT00002389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725247|NCT00002389|Antiviral Agents|antiviral agents|mesh-ancestor
64947833|NCT05053503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64947834|NCT05053503|Adrenergic Agents|adrenergic agents|mesh-ancestor
64947835|NCT05053503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64947836|NCT05053503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947837|NCT05050253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64947838|NCT05029622|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64947839|NCT05029622|Luteolytic Agents|luteolytic agents|mesh-ancestor
64947840|NCT05029622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64947845|NCT05029622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64947846|NCT05029622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947848|NCT05010122|Venetoclax|venetoclax|mesh-list
64947849|NCT05010122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64947850|NCT05010122|Antimetabolites|antimetabolites|mesh-ancestor
64947851|NCT05010122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947852|NCT05010122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947853|NCT05010122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947855|NCT05007041|Immunologic Factors|immunologic factors|mesh-ancestor
64947856|NCT05007041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947857|NCT04930653|Mogamulizumab|mogamulizumab|mesh-list
64947858|NCT04930653|Immunoglobulins|immunoglobulins|mesh-list
64947859|NCT04930653|Immunoglobulin G|immunoglobulin g|mesh-list
64947860|NCT04930653|Immunologic Factors|immunologic factors|mesh-ancestor
64947861|NCT04930653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947873|NCT04893096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947874|NCT04893096|Immunologic Factors|immunologic factors|mesh-ancestor
64947875|NCT04893096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947876|NCT04892511|Nitroprusside|nitroprusside|mesh-list
64947877|NCT04892511|Labetalol|labetalol|mesh-list
65030924|NCT02042287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65030925|NCT02042287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65030926|NCT02042287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65030927|NCT02042287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65030928|NCT05296213|Calcium|calcium|mesh-list
65030929|NCT05296213|Fluorides|fluorides|mesh-list
65030930|NCT05296213|Caseins|caseins|mesh-list
65030931|NCT05296213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65030932|NCT05296213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030933|NCT05296213|Cariostatic Agents|cariostatic agents|mesh-ancestor
64947878|NCT04892511|Urapidil|urapidil|mesh-list
64947879|NCT04892511|Phenylephrine|phenylephrine|mesh-list
64947880|NCT04892511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64947881|NCT04892511|Mydriatics|mydriatics|mesh-ancestor
64947882|NCT04892511|Autonomic Agents|autonomic agents|mesh-ancestor
64947883|NCT04892511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64947884|NCT04892511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947885|NCT04892511|Sympathomimetics|sympathomimetics|mesh-ancestor
64947886|NCT04892511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64947887|NCT04892511|Nasal Decongestants|nasal decongestants|mesh-ancestor
64947888|NCT04892511|Respiratory System Agents|respiratory system agents|mesh-ancestor
64947889|NCT04892511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64947890|NCT04892511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64947891|NCT04892511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64947892|NCT04892511|Adrenergic Agents|adrenergic agents|mesh-ancestor
64947893|NCT04892511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64947894|NCT04892511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947895|NCT04892511|Protective Agents|protective agents|mesh-ancestor
64947896|NCT04892511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64947897|NCT04892511|Vasodilator Agents|vasodilator agents|mesh-ancestor
64947898|NCT04892511|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64947899|NCT04892511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64947900|NCT04892511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64947901|NCT04892511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64947902|NCT04892511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64947903|NCT04892511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64947904|NCT04892511|Serotonin Agents|serotonin agents|mesh-ancestor
64947905|NCT04857333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64947906|NCT04857333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64947907|NCT04855695|Venetoclax|venetoclax|mesh-list
64947908|NCT04855695|Obinutuzumab|obinutuzumab|mesh-list
64947909|NCT04855695|Acalabrutinib|acalabrutinib|mesh-list
64725248|NCT00002389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725249|NCT00002389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64725250|NCT00002389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64725251|NCT00002389|Antimetabolites|antimetabolites|mesh-ancestor
64725252|NCT00001357|Interleukin-2|interleukin-2|mesh-list
64947910|NCT04855695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947911|NCT04855695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64947912|NCT04799288|Teriflunomide|teriflunomide|mesh-list
64947913|NCT04799288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64947914|NCT04799288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64947915|NCT04799288|Analgesics|analgesics|mesh-ancestor
64947916|NCT04799288|Sensory System Agents|sensory system agents|mesh-ancestor
64947917|NCT04799288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64947918|NCT04799288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947919|NCT04799288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64947951|NCT04752163|Posaconazole|posaconazole|mesh-list
64947952|NCT04752163|Dexamethasone|dexamethasone|mesh-list
64947953|NCT04752163|Dexamethasone acetate|dexamethasone acetate|mesh-list
64947954|NCT04752163|Prednisone|prednisone|mesh-list
64947955|NCT04752163|Cortisone|cortisone|mesh-list
64947956|NCT04752163|Cyclophosphamide|cyclophosphamide|mesh-list
64947957|NCT04752163|Rituximab|rituximab|mesh-list
64947958|NCT04752163|Methotrexate|methotrexate|mesh-list
64947959|NCT04752163|Vincristine|vincristine|mesh-list
64947960|NCT04752163|Azacitidine|azacitidine|mesh-list
64947961|NCT04752163|Venetoclax|venetoclax|mesh-list
64947962|NCT04752163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64947963|NCT04752163|Antibodies|antibodies|mesh-list
64585037|NCT02107339|Antitussive Agents|antitussive agents|mesh-ancestor
65030934|NCT05296213|Protective Agents|protective agents|mesh-ancestor
65030935|NCT05296213|Chelating Agents|chelating agents|mesh-ancestor
65030936|NCT05296213|Sequestering Agents|sequestering agents|mesh-ancestor
65030937|NCT05296213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030938|NCT00166478|Sulindac sulfone|sulindac sulfone|mesh-list
65030939|NCT00166478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030940|NCT00166478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65030941|NCT00166478|Protective Agents|protective agents|mesh-ancestor
65030942|NCT00166478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030943|NCT00166478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65030944|NCT00166478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030945|NCT00166478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585038|NCT02107339|Respiratory System Agents|respiratory system agents|mesh-ancestor
64947964|NCT04752163|Immunoglobulins|immunoglobulins|mesh-list
64947965|NCT04752163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64947966|NCT04752163|Lenograstim|lenograstim|mesh-list
64947967|NCT04752163|BB 1101|bb 1101|mesh-list
64947968|NCT04752163|Mesna|mesna|mesh-list
64947969|NCT04752163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64947970|NCT04752163|Immunologic Factors|immunologic factors|mesh-ancestor
64947971|NCT04752163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947972|NCT04752163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64947973|NCT04752163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64947974|NCT04752163|Alkylating Agents|alkylating agents|mesh-ancestor
64947975|NCT04752163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947976|NCT04752163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947977|NCT04752163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64947978|NCT04752163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64947979|NCT04752163|Antiemetics|antiemetics|mesh-ancestor
64947980|NCT04752163|Autonomic Agents|autonomic agents|mesh-ancestor
64947981|NCT04752163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64947982|NCT04752163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64947983|NCT04752163|Glucocorticoids|glucocorticoids|mesh-ancestor
64947984|NCT04752163|Hormones|hormones|mesh-ancestor
64947985|NCT04752163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64947986|NCT04752163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64947987|NCT04752163|Protease Inhibitors|protease inhibitors|mesh-ancestor
64947988|NCT04752163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948001|NCT04752163|Protective Agents|protective agents|mesh-ancestor
64948002|NCT04752163|Vitamin B Complex|vitamin b complex|mesh-ancestor
64948003|NCT04752163|Vitamins|vitamins|mesh-ancestor
64948004|NCT04752163|Micronutrients|micronutrients|mesh-ancestor
64948005|NCT04752163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64948006|NCT04752163|Tubulin Modulators|tubulin modulators|mesh-ancestor
64948007|NCT04752163|Antimitotic Agents|antimitotic agents|mesh-ancestor
64948008|NCT04752163|Mitosis Modulators|mitosis modulators|mesh-ancestor
64725253|NCT00001357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725254|NCT00001357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64725255|NCT00001357|Analgesics|analgesics|mesh-ancestor
64725256|NCT00001357|Sensory System Agents|sensory system agents|mesh-ancestor
64948009|NCT04752163|Antifungal Agents|antifungal agents|mesh-ancestor
64419995|NCT02335983|Hormones|hormones|mesh-ancestor
64948020|NCT04735926|Micronutrients|micronutrients|mesh-ancestor
64948021|NCT04735926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948022|NCT04735926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64948023|NCT04720768|Palbociclib|palbociclib|mesh-list
64948024|NCT04720768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948025|NCT04720768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64948026|NCT04720768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948027|NCT04720768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948028|NCT04702256|Mycophenolic Acid|mycophenolic acid|mesh-list
65030946|NCT00166478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65030947|NCT00166478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65030948|NCT00166478|Analgesics|analgesics|mesh-ancestor
65030949|NCT00166478|Sensory System Agents|sensory system agents|mesh-ancestor
65030950|NCT00166478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65030951|NCT00166478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65030952|NCT00166478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65030953|NCT05282875|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65030954|NCT05282875|Immunologic Factors|immunologic factors|mesh-ancestor
65030955|NCT05282875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030956|NCT00194766|Temozolomide|temozolomide|mesh-list
65030957|NCT00194766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65030958|NCT00194766|Alkylating Agents|alkylating agents|mesh-ancestor
65030959|NCT00194766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030960|NCT00194766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030961|NCT00166556|Alemtuzumab|alemtuzumab|mesh-list
65030962|NCT00166556|Tacrolimus|tacrolimus|mesh-list
65030963|NCT00166556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65030964|NCT00166556|Immunologic Factors|immunologic factors|mesh-ancestor
64948029|NCT04702256|Prednisone|prednisone|mesh-list
64948030|NCT04702256|Methylprednisolone|methylprednisolone|mesh-list
64948031|NCT04702256|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64948032|NCT04702256|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64948033|NCT04702256|Prednisolone|prednisolone|mesh-list
64948034|NCT04702256|Prednisolone acetate|prednisolone acetate|mesh-list
64948035|NCT04702256|Obinutuzumab|obinutuzumab|mesh-list
64948036|NCT04702256|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64948037|NCT04702256|Prednisolone phosphate|prednisolone phosphate|mesh-list
64948038|NCT04702256|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
64948039|NCT04702256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64948040|NCT04702256|Glucocorticoids|glucocorticoids|mesh-ancestor
64948041|NCT04702256|Hormones|hormones|mesh-ancestor
64948042|NCT04702256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64948043|NCT04702256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948044|NCT04702256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64948045|NCT04702256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948046|NCT04702256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64948047|NCT04702256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64948048|NCT04702256|Antitubercular Agents|antitubercular agents|mesh-ancestor
64948049|NCT04702256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64948050|NCT04702256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64948051|NCT04702256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948059|NCT04702256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64948060|NCT04702256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64948061|NCT04702256|Histamine Antagonists|histamine antagonists|mesh-ancestor
64948062|NCT04702256|Histamine Agents|histamine agents|mesh-ancestor
64948063|NCT04702256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64948064|NCT04671966|Cetrorelix|cetrorelix|mesh-list
64948065|NCT04671966|Estradiol|estradiol|mesh-list
64948066|NCT04671966|Estrogens|estrogens|mesh-ancestor
64948067|NCT04671966|Hormones|hormones|mesh-ancestor
64948068|NCT04671966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64948069|NCT04671966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948070|NCT04671966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64948071|NCT04671966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64948072|NCT04671966|Fertility Agents|fertility agents|mesh-ancestor
64948073|NCT04671966|Hormone Antagonists|hormone antagonists|mesh-ancestor
65030965|NCT00166556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030966|NCT00166556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65030967|NCT00166556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65030968|NCT00166556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030969|NCT00166556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65030970|NCT00166556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65030972|NCT05276206|Anesthetics, Local|anesthetics, local|mesh-list
64516150|NCT03289338|Antiemetics|antiemetics|mesh-ancestor
65030973|NCT05276206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65030974|NCT05276206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030975|NCT05276206|Sensory System Agents|sensory system agents|mesh-ancestor
65030976|NCT05276206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65030977|NCT00166595|Risperidone|risperidone|mesh-list
65030978|NCT00166595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65030979|NCT00166595|Serotonin Agents|serotonin agents|mesh-ancestor
65030980|NCT00166595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65030981|NCT00166595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65030982|NCT00166595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030983|NCT00166595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65030984|NCT00166595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65030985|NCT00166595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65030986|NCT00166595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64585068|NCT01409564|Cilostazol|cilostazol|mesh-list
64948074|NCT04641702|Atropine|atropine|mesh-list
64948075|NCT04641702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64948076|NCT04641702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64948077|NCT04641702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64948078|NCT04641702|Autonomic Agents|autonomic agents|mesh-ancestor
64948079|NCT04641702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64948080|NCT04641702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948081|NCT04641702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64948082|NCT04641702|Respiratory System Agents|respiratory system agents|mesh-ancestor
64725262|NCT00001381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64725263|NCT00001381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725264|NCT00001381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725265|NCT00001381|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64725266|NCT00001381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64725267|NCT00002011|Methoxsalen|methoxsalen|mesh-list
64725268|NCT00002011|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64725269|NCT00002011|Dermatologic Agents|dermatologic agents|mesh-ancestor
64486963|NCT03215446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64948083|NCT04641702|Mydriatics|mydriatics|mesh-ancestor
64948084|NCT04641702|Parasympatholytics|parasympatholytics|mesh-ancestor
64948085|NCT04641702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64948086|NCT04641702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64948087|NCT04641702|Cholinergic Agents|cholinergic agents|mesh-ancestor
64948088|NCT04641702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64948089|NCT04641702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948090|NCT04629729|Cyclophosphamide|cyclophosphamide|mesh-list
64948091|NCT04629729|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64948092|NCT04629729|Fludarabine|fludarabine|mesh-list
64585093|NCT02009449|Capecitabine|capecitabine|mesh-list
65030987|NCT00166595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65030988|NCT00166595|Dopamine Agents|dopamine agents|mesh-ancestor
65030989|NCT05259631|Propofol|propofol|mesh-list
65030990|NCT05259631|Sevoflurane|sevoflurane|mesh-list
65030991|NCT05259631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65030992|NCT05259631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65030993|NCT05259631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65030994|NCT05259631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65030995|NCT05259631|Anesthetics, General|anesthetics, general|mesh-ancestor
65030996|NCT05259631|Anesthetics|anesthetics|mesh-ancestor
65030997|NCT05259631|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65030998|NCT05259631|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65030999|NCT00408135|Telithromycin|telithromycin|mesh-list
65031000|NCT00408135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65031001|NCT00408135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65031002|NCT00407225|Difluprednate|difluprednate|mesh-list
65031003|NCT00407225|Glucocorticoids|glucocorticoids|mesh-ancestor
64948093|NCT04629729|Interleukin-2|interleukin-2|mesh-list
64948094|NCT04629729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64948095|NCT04629729|Immunologic Factors|immunologic factors|mesh-ancestor
64948096|NCT04629729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948097|NCT04629729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64948098|NCT04629729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64948099|NCT04629729|Alkylating Agents|alkylating agents|mesh-ancestor
64948100|NCT04629729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948101|NCT04629729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948102|NCT04629729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64948103|NCT04629729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64948104|NCT04629729|Analgesics|analgesics|mesh-ancestor
64948105|NCT04629729|Sensory System Agents|sensory system agents|mesh-ancestor
64948106|NCT04629729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64948107|NCT04626479|Pembrolizumab|pembrolizumab|mesh-list
64948108|NCT04626479|Lenvatinib|lenvatinib|mesh-list
64948109|NCT04626479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64948110|NCT04626479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948111|NCT04626479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64948112|NCT04626479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948113|NCT04626479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948114|NCT04624750|Mexiletine|mexiletine|mesh-list
64948115|NCT04624750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64948116|NCT04624750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64948117|NCT04624750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64948139|NCT04603183|Fulvestrant|fulvestrant|mesh-list
64948140|NCT04603183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64948141|NCT04603183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948142|NCT04603183|Tubulin Modulators|tubulin modulators|mesh-ancestor
64948143|NCT04603183|Antimitotic Agents|antimitotic agents|mesh-ancestor
64948144|NCT04603183|Mitosis Modulators|mitosis modulators|mesh-ancestor
64948145|NCT04603183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948146|NCT04603183|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64948147|NCT04603183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64948148|NCT04603183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948149|NCT04603183|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64948150|NCT04603183|Hormone Antagonists|hormone antagonists|mesh-ancestor
64948151|NCT04603183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64948152|NCT04603183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725270|NCT00002017|Interleukin-2|interleukin-2|mesh-list
65031004|NCT00407225|Hormones|hormones|mesh-ancestor
65031005|NCT00407225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65031006|NCT00407225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031007|NCT05124067|Dexamethasone|dexamethasone|mesh-list
65031008|NCT05124067|Dexamethasone acetate|dexamethasone acetate|mesh-list
65031009|NCT05124067|Dexmedetomidine|dexmedetomidine|mesh-list
65031010|NCT05124067|Ondansetron|ondansetron|mesh-list
65031011|NCT05124067|BB 1101|bb 1101|mesh-list
65031012|NCT05124067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65031013|NCT05124067|Antiemetics|antiemetics|mesh-ancestor
64585108|NCT02009449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64585116|NCT02009449|Vitamins|vitamins|mesh-ancestor
64725271|NCT00002017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725272|NCT00002017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64725273|NCT00002017|Analgesics|analgesics|mesh-ancestor
64725274|NCT00002017|Sensory System Agents|sensory system agents|mesh-ancestor
64420009|NCT04578691|Dermatologic Agents|dermatologic agents|mesh-ancestor
64948158|NCT04580134|Serotonin Agents|serotonin agents|mesh-ancestor
64948159|NCT04580134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64948160|NCT04580134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948161|NCT04580134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948162|NCT04580134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64948163|NCT04580134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64948164|NCT04580134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64948165|NCT04580134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64948166|NCT04580134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64948167|NCT04580134|Dopamine Agents|dopamine agents|mesh-ancestor
64948168|NCT04580134|GABA Antagonists|gaba antagonists|mesh-ancestor
64948181|NCT04556773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948182|NCT04556773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64948183|NCT04556773|Antimetabolites|antimetabolites|mesh-ancestor
64948184|NCT04556773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64948185|NCT04556773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64948186|NCT04556773|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64948187|NCT04556773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64948188|NCT04556773|Hormone Antagonists|hormone antagonists|mesh-ancestor
64948189|NCT04556773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64948190|NCT04556773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948191|NCT04556773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64948192|NCT04556773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64948193|NCT04556773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948194|NCT04541108|Pembrolizumab|pembrolizumab|mesh-list
64948195|NCT04541108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64948196|NCT04541108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948197|NCT04529954|Valproic Acid|valproic acid|mesh-list
64948198|NCT04529954|Anticonvulsants|anticonvulsants|mesh-ancestor
64948199|NCT04529954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948200|NCT04529954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948201|NCT04529954|GABA Agents|gaba agents|mesh-ancestor
64948202|NCT04529954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64948203|NCT04529954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948204|NCT04529954|Antimanic Agents|antimanic agents|mesh-ancestor
64948205|NCT04529954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64948206|NCT04529954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64948207|NCT04529954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64948208|NCT04525755|Nicotine|nicotine|mesh-list
64948209|NCT04525755|Varenicline|varenicline|mesh-list
64948210|NCT04525755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64948211|NCT04525755|Autonomic Agents|autonomic agents|mesh-ancestor
64948212|NCT04525755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64948213|NCT04525755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948214|NCT04525755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64948215|NCT04525755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64948216|NCT04525755|Cholinergic Agents|cholinergic agents|mesh-ancestor
64585118|NCT01794091|Eplerenone|eplerenone|mesh-list
65031014|NCT05124067|Autonomic Agents|autonomic agents|mesh-ancestor
65031015|NCT05124067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65031016|NCT05124067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031017|NCT05124067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65031018|NCT05124067|Glucocorticoids|glucocorticoids|mesh-ancestor
65031019|NCT05124067|Hormones|hormones|mesh-ancestor
65031020|NCT05124067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65031021|NCT05124067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65031022|NCT05124067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031023|NCT05124067|Protease Inhibitors|protease inhibitors|mesh-ancestor
65031024|NCT05124067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948217|NCT04525755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64948218|NCT04525755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948219|NCT04512079|Enoxaparin|enoxaparin|mesh-list
64948220|NCT04512079|Apixaban|apixaban|mesh-list
64948221|NCT04512079|Anticoagulants|anticoagulants|mesh-ancestor
64948222|NCT04512079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64948223|NCT04512079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64948224|NCT04512079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948225|NCT04512079|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64948226|NCT04512079|Antithrombins|antithrombins|mesh-ancestor
64948227|NCT04512079|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64948228|NCT04512079|Protease Inhibitors|protease inhibitors|mesh-ancestor
64948229|NCT04512079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948230|NCT04508725|Mitogens|mitogens|mesh-list
64725275|NCT00002017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64725276|NCT00002017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725277|NCT00002023|Zidovudine|zidovudine|mesh-list
64420048|NCT02371629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64948252|NCT04490057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64948253|NCT04490057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64948254|NCT04490057|Dopamine Agents|dopamine agents|mesh-ancestor
64948255|NCT04490057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64948256|NCT04490057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64948257|NCT04490057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948258|NCT04468165|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64948259|NCT04468165|Dermatologic Agents|dermatologic agents|mesh-ancestor
64948260|NCT04468165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64948261|NCT04468165|Immunologic Factors|immunologic factors|mesh-ancestor
64948262|NCT04468165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948263|NCT04437485|Norepinephrine|norepinephrine|mesh-list
64948265|NCT04437485|Antidepressive Agents|antidepressive agents|mesh-list
64948266|NCT04437485|Serotonin|serotonin|mesh-list
64948267|NCT04437485|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
64948268|NCT04437485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64948269|NCT04437485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64948270|NCT04437485|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64948271|NCT04437485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64948272|NCT04437485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64948273|NCT04437485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948274|NCT04437485|Dopamine Agents|dopamine agents|mesh-ancestor
64948275|NCT04437485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64948276|NCT04437485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948277|NCT04437485|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64948278|NCT04437485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64948279|NCT04437485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948280|NCT04437485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64948281|NCT04437485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64948282|NCT04437485|Adrenergic Agents|adrenergic agents|mesh-ancestor
64948283|NCT04437485|Sympathomimetics|sympathomimetics|mesh-ancestor
64948284|NCT04437485|Autonomic Agents|autonomic agents|mesh-ancestor
65031025|NCT05124067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031026|NCT05124067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65031027|NCT05124067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65031028|NCT05124067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65031029|NCT05124067|Analgesics|analgesics|mesh-ancestor
65031030|NCT05124067|Sensory System Agents|sensory system agents|mesh-ancestor
65031031|NCT05124067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65031032|NCT05124067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65031033|NCT05124067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64585128|NCT01794169|Azacitidine|azacitidine|mesh-list
64948285|NCT04437485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64948286|NCT04437485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64948287|NCT04437485|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64948288|NCT04437485|Serotonin Agents|serotonin agents|mesh-ancestor
64948289|NCT04421560|Rituximab|rituximab|mesh-list
64948290|NCT04421560|Pembrolizumab|pembrolizumab|mesh-list
64948291|NCT04421560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64948292|NCT04421560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948293|NCT04421560|Immunologic Factors|immunologic factors|mesh-ancestor
64948294|NCT04421560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487185|NCT00899470|Protease Inhibitors|protease inhibitors|mesh-ancestor
64948304|NCT04410796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64948305|NCT04406649|Dihydroergotamine|dihydroergotamine|mesh-list
64948306|NCT04406649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64948307|NCT04406649|Dopamine Agonists|dopamine agonists|mesh-ancestor
64948308|NCT04406649|Dopamine Agents|dopamine agents|mesh-ancestor
64948309|NCT04406649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64948310|NCT04406649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948311|NCT04406649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725279|NCT00002023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725280|NCT00002023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64725281|NCT00002023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64725282|NCT00002023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725283|NCT00002023|Antiviral Agents|antiviral agents|mesh-ancestor
64725284|NCT00002023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725285|NCT00002023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64725286|NCT00002023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64725287|NCT00002029|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64725288|NCT00002029|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64725289|NCT00002029|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64725290|NCT00002029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64725291|NCT00002035|Zidovudine|zidovudine|mesh-list
64948318|NCT04332341|Niacinamide|niacinamide|mesh-list
64948319|NCT04332341|Niacin|niacin|mesh-list
64948320|NCT04332341|Nicotinic Acids|nicotinic acids|mesh-list
64948321|NCT04332341|Vitamin B Complex|vitamin b complex|mesh-ancestor
64948322|NCT04332341|Vitamins|vitamins|mesh-ancestor
64948323|NCT04332341|Micronutrients|micronutrients|mesh-ancestor
64948324|NCT04332341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948325|NCT04332341|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64948326|NCT04332341|Antimetabolites|antimetabolites|mesh-ancestor
64948327|NCT04332341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948328|NCT04332341|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64948329|NCT04332341|Vasodilator Agents|vasodilator agents|mesh-ancestor
64948330|NCT04323657|Cyclophosphamide|cyclophosphamide|mesh-list
64948331|NCT04323657|Fludarabine|fludarabine|mesh-list
64948332|NCT04323657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64948333|NCT04323657|Immunologic Factors|immunologic factors|mesh-ancestor
64948334|NCT04323657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948335|NCT04323657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64948336|NCT04323657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64948337|NCT04323657|Alkylating Agents|alkylating agents|mesh-ancestor
64948338|NCT04323657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948339|NCT04323657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585137|NCT01794169|Immunologic Factors|immunologic factors|mesh-ancestor
65031034|NCT05124067|Adrenergic Agents|adrenergic agents|mesh-ancestor
65031035|NCT05124067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65031036|NCT05124067|Antipruritics|antipruritics|mesh-ancestor
65031037|NCT05124067|Dermatologic Agents|dermatologic agents|mesh-ancestor
65031038|NCT05124067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65031039|NCT05124067|Serotonin Agents|serotonin agents|mesh-ancestor
65031040|NCT05124067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65031041|NCT05124067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65031042|NCT05124067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65031043|NCT05124067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64948340|NCT04323657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64948341|NCT04318691|Dimercaprol|dimercaprol|mesh-list
64948342|NCT04318691|Chelating Agents|chelating agents|mesh-ancestor
64948343|NCT04318691|Sequestering Agents|sequestering agents|mesh-ancestor
64948344|NCT04318691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948345|NCT04278092|Paclitaxel|paclitaxel|mesh-list
64948346|NCT04278092|Cetuximab|cetuximab|mesh-list
64948347|NCT04278092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64948348|NCT04278092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948349|NCT04278092|Tubulin Modulators|tubulin modulators|mesh-ancestor
64948350|NCT04278092|Antimitotic Agents|antimitotic agents|mesh-ancestor
64948351|NCT04278092|Mitosis Modulators|mitosis modulators|mesh-ancestor
64948352|NCT04278092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948353|NCT04278092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64948354|NCT04240106|Niraparib|niraparib|mesh-list
64948355|NCT04240106|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64948356|NCT04240106|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64948357|NCT04240106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948358|NCT04240106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948359|NCT04240106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948379|NCT04210505|Povidone-Iodine|povidone-iodine|mesh-list
64948380|NCT04210505|Povidone|povidone|mesh-list
64948381|NCT04210505|Plasma Substitutes|plasma substitutes|mesh-ancestor
64948382|NCT04210505|Blood Substitutes|blood substitutes|mesh-ancestor
64948383|NCT04210505|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64725292|NCT00002035|Didanosine|didanosine|mesh-list
64725293|NCT00002035|Antimetabolites|antimetabolites|mesh-ancestor
64420057|NCT02371629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64948386|NCT04201262|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64948387|NCT04201262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64948388|NCT04201262|Immunologic Factors|immunologic factors|mesh-ancestor
64948389|NCT04201262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948390|NCT04189107|Dexamethasone|dexamethasone|mesh-list
64948391|NCT04189107|Dexamethasone acetate|dexamethasone acetate|mesh-list
64948392|NCT04189107|BB 1101|bb 1101|mesh-list
64948393|NCT04189107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64948394|NCT04189107|Antiemetics|antiemetics|mesh-ancestor
64948395|NCT04189107|Autonomic Agents|autonomic agents|mesh-ancestor
64948396|NCT04189107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64948397|NCT04189107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948398|NCT04189107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64948399|NCT04189107|Glucocorticoids|glucocorticoids|mesh-ancestor
64948400|NCT04189107|Hormones|hormones|mesh-ancestor
64948401|NCT04189107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64948402|NCT04189107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64948403|NCT04189107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948404|NCT04189107|Protease Inhibitors|protease inhibitors|mesh-ancestor
64948405|NCT04189107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948406|NCT04189107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948407|NCT04166331|Dobutamine|dobutamine|mesh-list
64948408|NCT04166331|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64948409|NCT04166331|Sympathomimetics|sympathomimetics|mesh-ancestor
64948410|NCT04166331|Autonomic Agents|autonomic agents|mesh-ancestor
64948421|NCT04124991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64948423|NCT04123314|Psilocybin|psilocybin|mesh-list
64948424|NCT04123314|Hallucinogens|hallucinogens|mesh-ancestor
64585145|NCT00396019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65031044|NCT00194883|Hormones|hormones|mesh-list
65031045|NCT00194883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65031046|NCT00194883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031047|NCT02277184|Cisplatin|cisplatin|mesh-list
65031048|NCT02277184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031049|NCT00166829|Mycophenolic Acid|mycophenolic acid|mesh-list
65031050|NCT00166829|Sirolimus|sirolimus|mesh-list
65031051|NCT00166829|Tacrolimus|tacrolimus|mesh-list
65031052|NCT00166829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65031053|NCT00166829|Immunologic Factors|immunologic factors|mesh-ancestor
65031054|NCT00166829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031055|NCT00166829|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65031056|NCT00166829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031057|NCT00166829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031058|NCT00166829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65031059|NCT00166829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031060|NCT00166829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65031061|NCT00166829|Antitubercular Agents|antitubercular agents|mesh-ancestor
65031062|NCT00166829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65031063|NCT00166829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64585146|NCT01390220|Midazolam|midazolam|mesh-list
64948425|NCT04123314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948426|NCT04123314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64948427|NCT04115267|Antineoplastic Agents|antineoplastic agents|mesh-list
64948428|NCT04081389|Interferons|interferons|mesh-list
64948429|NCT04081389|Interferon-alpha|interferon-alpha|mesh-list
64948430|NCT04081389|Interferon alpha-2|interferon alpha-2|mesh-list
64948431|NCT04081389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
64948432|NCT04081389|Celecoxib|celecoxib|mesh-list
64948433|NCT04081389|Paclitaxel|paclitaxel|mesh-list
64948434|NCT04081389|Cyclophosphamide|cyclophosphamide|mesh-list
64948435|NCT04081389|Doxorubicin|doxorubicin|mesh-list
64948436|NCT04081389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64948437|NCT04081389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64948438|NCT04081389|Daunorubicin|daunorubicin|mesh-list
64948439|NCT04081389|Benzenesulfonamide|benzenesulfonamide|mesh-list
64948440|NCT04081389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64948441|NCT04081389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948442|NCT04081389|Tubulin Modulators|tubulin modulators|mesh-ancestor
64948443|NCT04081389|Antimitotic Agents|antimitotic agents|mesh-ancestor
64948444|NCT04081389|Mitosis Modulators|mitosis modulators|mesh-ancestor
64948445|NCT04081389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948446|NCT04081389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64948447|NCT04081389|Immunologic Factors|immunologic factors|mesh-ancestor
64948448|NCT04081389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948449|NCT04081389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64948450|NCT04081389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64948451|NCT04081389|Alkylating Agents|alkylating agents|mesh-ancestor
64948452|NCT04081389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64948453|NCT04081389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64948454|NCT04081389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64948455|NCT04081389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64948457|NCT04081389|Antiviral Agents|antiviral agents|mesh-ancestor
64585166|NCT00357331|Respiratory System Agents|respiratory system agents|mesh-ancestor
65031064|NCT00166829|Antifungal Agents|antifungal agents|mesh-ancestor
65031065|NCT00177333|Doxycycline|doxycycline|mesh-list
65031066|NCT00177333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65031067|NCT00177333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65031068|NCT00177333|Antimalarials|antimalarials|mesh-ancestor
65031069|NCT00177333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65031070|NCT00177333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65031071|NCT05046535|Nicotine|nicotine|mesh-list
65031072|NCT05046535|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65031073|NCT05046535|Autonomic Agents|autonomic agents|mesh-ancestor
65031074|NCT05046535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65031075|NCT05046535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031076|NCT05046535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65031077|NCT05046535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65031078|NCT05046535|Cholinergic Agents|cholinergic agents|mesh-ancestor
65031079|NCT05046535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65031080|NCT05046535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031081|NCT00166868|Neomycin|neomycin|mesh-list
65031082|NCT00166868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65031083|NCT00166868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64948458|NCT04081389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64948459|NCT04081389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64948460|NCT04081389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64948461|NCT04081389|Analgesics|analgesics|mesh-ancestor
64948462|NCT04081389|Sensory System Agents|sensory system agents|mesh-ancestor
64948463|NCT04081389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64725296|NCT00002035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64948467|NCT04081389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64948468|NCT03934567|Abexinostat|abexinostat|mesh-list
64948469|NCT03934567|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64948470|NCT03934567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948471|NCT03934567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948472|NCT03907852|Cyclophosphamide|cyclophosphamide|mesh-list
64948473|NCT03907852|Nivolumab|nivolumab|mesh-list
64948474|NCT03907852|Fludarabine|fludarabine|mesh-list
64948475|NCT03907852|Ipilimumab|ipilimumab|mesh-list
64948476|NCT03907852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64948482|NCT03907852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948483|NCT03907852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948484|NCT03907852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64948485|NCT03907852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64948486|NCT03907852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64948487|NCT03900884|Letrozole|letrozole|mesh-list
64948488|NCT03900884|Venetoclax|venetoclax|mesh-list
64948489|NCT03900884|Palbociclib|palbociclib|mesh-list
64948490|NCT03900884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948491|NCT03900884|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64948492|NCT03900884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64948493|NCT03900884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948494|NCT03900884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948495|NCT03900884|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64948496|NCT03900884|Hormone Antagonists|hormone antagonists|mesh-ancestor
64948497|NCT03900884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65031084|NCT00166868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65031085|NCT00166868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031086|NCT00166868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031087|NCT00194961|Hormones|hormones|mesh-list
65031088|NCT00194961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65031089|NCT00194961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031090|NCT00177372|Misoprostol|misoprostol|mesh-list
65031091|NCT00177372|Mifepristone|mifepristone|mesh-list
65031092|NCT00177372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65031093|NCT00177372|Abortifacient Agents|abortifacient agents|mesh-ancestor
65031094|NCT00177372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65031095|NCT00177372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031096|NCT00177372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65031097|NCT00177372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65031098|NCT00177372|Oxytocics|oxytocics|mesh-ancestor
65031099|NCT00177372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65031100|NCT00177372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65031101|NCT00177372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65031102|NCT00177372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65031103|NCT00177372|Contraceptive Agents|contraceptive agents|mesh-ancestor
65031104|NCT00177372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65031105|NCT00177372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65031106|NCT00177372|Hormone Antagonists|hormone antagonists|mesh-ancestor
64585184|NCT04163107|Hormones|hormones|mesh-ancestor
64585186|NCT04163107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64948498|NCT03900884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948499|NCT03900884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64948500|NCT03872388|Capecitabine|capecitabine|mesh-list
64948501|NCT03872388|Atorvastatin|atorvastatin|mesh-list
64948502|NCT03872388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64948503|NCT03872388|Antimetabolites|antimetabolites|mesh-ancestor
64948504|NCT03872388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948505|NCT03872388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948506|NCT03872388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64948507|NCT03872388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64948508|NCT03872388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64948509|NCT03872388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64948510|NCT03872388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948511|NCT03865940|Lidocaine|lidocaine|mesh-list
64948512|NCT03865940|Guanfacine|guanfacine|mesh-list
64948513|NCT03865940|Anesthetics, Local|anesthetics, local|mesh-ancestor
64948514|NCT03865940|Anesthetics|anesthetics|mesh-ancestor
64948515|NCT03865940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64948516|NCT03865940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948517|NCT03865940|Sensory System Agents|sensory system agents|mesh-ancestor
64948518|NCT03865940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64948519|NCT03865940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65031107|NCT00177372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65031108|NCT00177372|Luteolytic Agents|luteolytic agents|mesh-ancestor
65031109|NCT00177372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65031110|NCT00177372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65031111|NCT00195000|Cytarabine|cytarabine|mesh-list
65031112|NCT00195000|Gemtuzumab|gemtuzumab|mesh-list
65031113|NCT00195000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65031114|NCT00195000|Antimetabolites|antimetabolites|mesh-ancestor
65031115|NCT00195000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031116|NCT00195000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031117|NCT00195000|Antiviral Agents|antiviral agents|mesh-ancestor
65031118|NCT00195000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65031119|NCT00195000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65031120|NCT00195000|Immunologic Factors|immunologic factors|mesh-ancestor
65031122|NCT00195000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65031123|NCT04819399|Catumaxomab|catumaxomab|mesh-list
65031125|NCT00177411|Hormones|hormones|mesh-list
65031126|NCT00177411|Parathyroid Hormone|parathyroid hormone|mesh-list
65031127|NCT00177411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
65031128|NCT00177411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65031129|NCT00177411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031130|NCT00177411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65031131|NCT00195078|Gefitinib|gefitinib|mesh-list
65031132|NCT00195078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031133|NCT00195078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65031134|NCT00195078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031135|NCT00195078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031136|NCT00167141|Contraceptive Agents|contraceptive agents|mesh-list
65031137|NCT00167141|Contraceptive Agents, Male|contraceptive agents, male|mesh-list
65031138|NCT00167141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65031139|NCT00167141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031140|NCT04660045|Acalabrutinib|acalabrutinib|mesh-list
64948520|NCT03865940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64948521|NCT03865940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64948522|NCT03865940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64948523|NCT03865940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948524|NCT03865940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64487334|NCT04405323|Antifungal Agents|antifungal agents|mesh-ancestor
64948526|NCT03865940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64948527|NCT03865940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65031141|NCT04660045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031142|NCT00177528|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65031143|NCT00177528|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65031144|NCT00177528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65031145|NCT00177528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65031146|NCT00177528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031147|NCT00177528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65031148|NCT00177528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031149|NCT00177528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65031150|NCT00177528|Antidepressive Agents|antidepressive agents|mesh-ancestor
65031151|NCT00177528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65031152|NCT04566250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
65031153|NCT04566250|Analgesics|analgesics|mesh-ancestor
65031154|NCT04566250|Sensory System Agents|sensory system agents|mesh-ancestor
65031155|NCT04566250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65031156|NCT04566250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031157|NCT04548583|Remestemcel-l|remestemcel-l|mesh-list
65031158|NCT04548583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65031159|NCT04548583|Antiviral Agents|antiviral agents|mesh-ancestor
65031160|NCT04548583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65031161|NCT00167297|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65031162|NCT00167297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65031163|NCT00167297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65031164|NCT00167297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64948528|NCT03865940|Adrenergic Agents|adrenergic agents|mesh-ancestor
64948529|NCT03865940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64948530|NCT03844997|Palbociclib|palbociclib|mesh-list
64948532|NCT03844997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64948533|NCT03844997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948534|NCT03844997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948536|NCT03840967|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64948537|NCT03840967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948538|NCT03840967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948539|NCT03840967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948540|NCT03826199|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64948541|NCT03826199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64948542|NCT03826199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64948543|NCT03826199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948559|NCT03671811|Contraceptive Agents|contraceptive agents|mesh-ancestor
64948560|NCT03671811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64948561|NCT03671811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948562|NCT03671811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64948563|NCT03671811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64948564|NCT03671811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64585270|NCT00397813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031165|NCT00167297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031166|NCT00167297|Adrenergic Agents|adrenergic agents|mesh-ancestor
65031167|NCT00167297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65031168|NCT00167297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031169|NCT00177567|Lamotrigine|lamotrigine|mesh-list
65031170|NCT00177567|Valproic Acid|valproic acid|mesh-list
65031171|NCT00177567|Olanzapine|olanzapine|mesh-list
65031172|NCT00177567|Risperidone|risperidone|mesh-list
65031173|NCT00177567|Lithium Carbonate|lithium carbonate|mesh-list
65031174|NCT00177567|Mirtazapine|mirtazapine|mesh-list
65031175|NCT00177567|Tranylcypromine|tranylcypromine|mesh-list
65031176|NCT00177567|Bupropion|bupropion|mesh-list
65031177|NCT00177567|Paroxetine|paroxetine|mesh-list
65031178|NCT00177567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65031179|NCT00177567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65031180|NCT00177567|Serotonin Agents|serotonin agents|mesh-ancestor
65031181|NCT00177567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65031182|NCT00177567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031183|NCT00177567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031184|NCT00177567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65031185|NCT00177567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65031186|NCT00177567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65031187|NCT00177567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65031188|NCT00177567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65031189|NCT00177567|Dopamine Agents|dopamine agents|mesh-ancestor
65031190|NCT00177567|Antiemetics|antiemetics|mesh-ancestor
65031191|NCT00177567|Autonomic Agents|autonomic agents|mesh-ancestor
65031192|NCT00177567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65031193|NCT00177567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64948565|NCT03671811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948566|NCT03671811|Appetite Stimulants|appetite stimulants|mesh-ancestor
64948567|NCT03671811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64948568|NCT03668119|Nivolumab|nivolumab|mesh-list
64948569|NCT03668119|Ipilimumab|ipilimumab|mesh-list
64948570|NCT03668119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64948571|NCT03668119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948572|NCT03668119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64948573|NCT03668119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948574|NCT03625388|Dasatinib|dasatinib|mesh-list
64948575|NCT03625388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948576|NCT03625388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64948577|NCT03625388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948578|NCT03625388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948579|NCT03595059|Paclitaxel|paclitaxel|mesh-list
64948580|NCT03595059|Docetaxel|docetaxel|mesh-list
64948581|NCT03595059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64585297|NCT00358579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64585298|NCT00358579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65031194|NCT00177567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65031195|NCT00177567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64585299|NCT00358579|Autonomic Agents|autonomic agents|mesh-ancestor
65031196|NCT00177567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65031197|NCT00177567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65031198|NCT00177567|Antidepressive Agents|antidepressive agents|mesh-ancestor
65031199|NCT00177567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65031200|NCT00177567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65031201|NCT00177567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65031202|NCT00177567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031203|NCT00177567|Antimanic Agents|antimanic agents|mesh-ancestor
65031204|NCT00177567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65031205|NCT00177567|Anticonvulsants|anticonvulsants|mesh-ancestor
65031206|NCT00177567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65031207|NCT00177567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65031208|NCT00177567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65031209|NCT00177567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65031210|NCT00177567|Histamine Antagonists|histamine antagonists|mesh-ancestor
65031211|NCT00177567|Histamine Agents|histamine agents|mesh-ancestor
65031212|NCT00177567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65031213|NCT00177567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65031214|NCT00177567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65031215|NCT00177567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65031216|NCT00177567|Adrenergic Agents|adrenergic agents|mesh-ancestor
65031217|NCT00177567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65031218|NCT00177567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65031219|NCT00177567|GABA Agents|gaba agents|mesh-ancestor
64948582|NCT03595059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948583|NCT03595059|Tubulin Modulators|tubulin modulators|mesh-ancestor
64948584|NCT03595059|Antimitotic Agents|antimitotic agents|mesh-ancestor
64948585|NCT03595059|Mitosis Modulators|mitosis modulators|mesh-ancestor
64948586|NCT03595059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948587|NCT03589729|Cytarabine|cytarabine|mesh-list
64948588|NCT03589729|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
64948589|NCT03589729|Idarubicin|idarubicin|mesh-list
64948590|NCT03589729|Cladribine|cladribine|mesh-list
64948591|NCT03589729|Gemtuzumab|gemtuzumab|mesh-list
64948592|NCT03589729|Dexrazoxane|dexrazoxane|mesh-list
64948593|NCT03589729|Razoxane|razoxane|mesh-list
64948594|NCT03589729|Calicheamicins|calicheamicins|mesh-list
64420094|NCT04411537|Irinotecan|irinotecan|mesh-list
65031220|NCT00177567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64585324|NCT00338039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64585325|NCT00358657|Mycophenolic Acid|mycophenolic acid|mesh-list
65031221|NCT00195156|Valproic Acid|valproic acid|mesh-list
64585326|NCT00358657|Sirolimus|sirolimus|mesh-list
65031222|NCT00195156|Anticonvulsants|anticonvulsants|mesh-ancestor
65031223|NCT00195156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031224|NCT00195156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031225|NCT00195156|GABA Agents|gaba agents|mesh-ancestor
65031226|NCT00195156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65031227|NCT00195156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031228|NCT00195156|Antimanic Agents|antimanic agents|mesh-ancestor
65031229|NCT00195156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65031230|NCT00195156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65031231|NCT00195156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65031232|NCT00167375|Eszopiclone|eszopiclone|mesh-list
65031233|NCT00167375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65031234|NCT00167375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65031235|NCT00167375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031236|NCT00195195|Sirolimus|sirolimus|mesh-list
65031237|NCT00195195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65031238|NCT00195195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65031239|NCT00195195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65031240|NCT00195195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031241|NCT00195195|Antifungal Agents|antifungal agents|mesh-ancestor
64725314|NCT00002047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64725315|NCT00002047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725317|NCT00002047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725318|NCT00002047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64487408|NCT04380298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64948597|NCT03589729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948598|NCT03589729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948599|NCT03589729|Antiviral Agents|antiviral agents|mesh-ancestor
64948600|NCT03589729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64948601|NCT03589729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64948602|NCT03589729|Immunologic Factors|immunologic factors|mesh-ancestor
64948626|NCT03585686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948628|NCT03543969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64948629|NCT03543969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948630|NCT03543969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64948631|NCT03543969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948632|NCT03479307|Ketotifen|ketotifen|mesh-list
64948633|NCT03479307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64948634|NCT03479307|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64948635|NCT03479307|Antipruritics|antipruritics|mesh-ancestor
64948636|NCT03479307|Dermatologic Agents|dermatologic agents|mesh-ancestor
64948637|NCT03479307|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64948638|NCT03479307|Histamine Antagonists|histamine antagonists|mesh-ancestor
64948639|NCT03479307|Histamine Agents|histamine agents|mesh-ancestor
64948640|NCT03479307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64585344|NCT00358657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65031242|NCT00195195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65031243|NCT00195195|Immunologic Factors|immunologic factors|mesh-ancestor
65031244|NCT00195195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031245|NCT04299880|Leucovorin|leucovorin|mesh-list
65031246|NCT04299880|Gemcitabine|gemcitabine|mesh-list
65031247|NCT04299880|Paclitaxel|paclitaxel|mesh-list
65031248|NCT04299880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65031249|NCT04299880|Bevacizumab|bevacizumab|mesh-list
65031250|NCT04299880|Fluorouracil|fluorouracil|mesh-list
65031251|NCT04299880|Nivolumab|nivolumab|mesh-list
65031252|NCT04299880|Irinotecan|irinotecan|mesh-list
65031253|NCT04299880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65031254|NCT04299880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031255|NCT04299880|Tubulin Modulators|tubulin modulators|mesh-ancestor
65031256|NCT04299880|Antimitotic Agents|antimitotic agents|mesh-ancestor
65031257|NCT04299880|Mitosis Modulators|mitosis modulators|mesh-ancestor
65031258|NCT04299880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031259|NCT04299880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65031260|NCT04299880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65031261|NCT04299880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65031262|NCT04299880|Growth Substances|growth substances|mesh-ancestor
64585345|NCT00358657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64948641|NCT03479307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948642|NCT03479307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948643|NCT03479307|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64948644|NCT03467867|Rituximab|rituximab|mesh-list
64948645|NCT03467867|Venetoclax|venetoclax|mesh-list
64948646|NCT03467867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64948647|NCT03467867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948648|NCT03467867|Immunologic Factors|immunologic factors|mesh-ancestor
64948649|NCT03467867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948650|NCT03467867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64948651|NCT03452111|ST 1435|st 1435|mesh-list
64948652|NCT03452111|Testosterone|testosterone|mesh-list
64948653|NCT03452111|Androgens|androgens|mesh-ancestor
64948654|NCT03452111|Hormones|hormones|mesh-ancestor
64948657|NCT03452111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64948659|NCT03452111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64948660|NCT03452111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64948661|NCT03393884|Paclitaxel|paclitaxel|mesh-list
64948662|NCT03393884|Carboplatin|carboplatin|mesh-list
64948663|NCT03393884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64948664|NCT03393884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948665|NCT03393884|Tubulin Modulators|tubulin modulators|mesh-ancestor
64948666|NCT03393884|Antimitotic Agents|antimitotic agents|mesh-ancestor
64948667|NCT03393884|Mitosis Modulators|mitosis modulators|mesh-ancestor
64948668|NCT03393884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503314|NCT01598740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64948669|NCT03390933|Fluoxetine|fluoxetine|mesh-list
64948670|NCT03390933|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64948671|NCT03390933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64948672|NCT03390933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64585364|NCT00340379|Autonomic Agents|autonomic agents|mesh-ancestor
65031263|NCT04299880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031264|NCT04299880|Growth Inhibitors|growth inhibitors|mesh-ancestor
65031265|NCT04299880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65031266|NCT04299880|Antimetabolites|antimetabolites|mesh-ancestor
65031267|NCT04299880|Antiviral Agents|antiviral agents|mesh-ancestor
65031268|NCT04299880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65031269|NCT04299880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031270|NCT04299880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65031271|NCT04299880|Immunologic Factors|immunologic factors|mesh-ancestor
65031272|NCT04299880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65031273|NCT04299880|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65031274|NCT04299880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65031275|NCT04299880|Antidotes|antidotes|mesh-ancestor
65031276|NCT04299880|Protective Agents|protective agents|mesh-ancestor
65031277|NCT04299880|Vitamin B Complex|vitamin b complex|mesh-ancestor
65031278|NCT04299880|Vitamins|vitamins|mesh-ancestor
65031279|NCT04299880|Micronutrients|micronutrients|mesh-ancestor
65031280|NCT00167492|Mycophenolic Acid|mycophenolic acid|mesh-list
65031281|NCT00167492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65031282|NCT00167492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031283|NCT00167492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65031284|NCT00167492|Antitubercular Agents|antitubercular agents|mesh-ancestor
65031285|NCT00167492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64948673|NCT03390933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948674|NCT03390933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64948675|NCT03390933|Serotonin Agents|serotonin agents|mesh-ancestor
64948676|NCT03390933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948677|NCT03390933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64948678|NCT03390933|Antidepressive Agents|antidepressive agents|mesh-ancestor
64948679|NCT03390933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64948680|NCT03390933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64948681|NCT03390933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64948682|NCT03390933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948683|NCT03390504|Docetaxel|docetaxel|mesh-list
64948684|NCT03390504|Pembrolizumab|pembrolizumab|mesh-list
64948685|NCT03390504|Mitogens|mitogens|mesh-list
64725319|NCT00002047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64725320|NCT00002053|Pentamidine|pentamidine|mesh-list
64725321|NCT00002053|Antifungal Agents|antifungal agents|mesh-ancestor
64948691|NCT03390504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64948693|NCT03387787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64948694|NCT03387787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948695|NCT03364036|Cladribine|cladribine|mesh-list
64948696|NCT03364036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948697|NCT03364036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64948698|NCT03364036|Immunologic Factors|immunologic factors|mesh-ancestor
64948699|NCT03364036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948700|NCT03338790|Prednisone|prednisone|mesh-list
64948701|NCT03338790|Docetaxel|docetaxel|mesh-list
64948702|NCT03338790|Nivolumab|nivolumab|mesh-list
64948703|NCT03338790|Rucaparib|rucaparib|mesh-list
64948704|NCT03338790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948705|NCT03338790|Tubulin Modulators|tubulin modulators|mesh-ancestor
64585385|NCT00358735|Enoxaparin|enoxaparin|mesh-list
65031286|NCT00167492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65031287|NCT00167492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031288|NCT00167492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031289|NCT04087096|Zoledronic Acid|zoledronic acid|mesh-list
65031290|NCT04087096|Denosumab|denosumab|mesh-list
65031291|NCT04087096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65031292|NCT04087096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031293|NCT00177684|Amphotericin B|amphotericin b|mesh-list
65031294|NCT00177684|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65031295|NCT00177684|Amebicides|amebicides|mesh-ancestor
65031296|NCT00177684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65031297|NCT00177684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65031298|NCT00177684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65031299|NCT00177684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65031300|NCT00177684|Antifungal Agents|antifungal agents|mesh-ancestor
65031301|NCT00532090|R04929097|r04929097|mesh-list
65031302|NCT00532090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031303|NCT00532090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031304|NCT00195312|Bupivacaine|bupivacaine|mesh-list
65031305|NCT00195312|Anesthetics, Local|anesthetics, local|mesh-ancestor
65031306|NCT00195312|Anesthetics|anesthetics|mesh-ancestor
65031307|NCT00195312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65031308|NCT00195312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031309|NCT00195312|Sensory System Agents|sensory system agents|mesh-ancestor
65031310|NCT00195312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65031311|NCT00167609|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64948706|NCT03338790|Antimitotic Agents|antimitotic agents|mesh-ancestor
64948707|NCT03338790|Mitosis Modulators|mitosis modulators|mesh-ancestor
64948708|NCT03338790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948709|NCT03338790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64948710|NCT03338790|Glucocorticoids|glucocorticoids|mesh-ancestor
64948711|NCT03338790|Hormones|hormones|mesh-ancestor
64948712|NCT03338790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64948713|NCT03338790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948714|NCT03338790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64948715|NCT03338790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64948716|NCT03338790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64948717|NCT03338790|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64948718|NCT03338790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948719|NCT03323463|Carboplatin|carboplatin|mesh-list
64948720|NCT03323463|Fluorouracil|fluorouracil|mesh-list
64948721|NCT03323463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948722|NCT03323463|Antimetabolites|antimetabolites|mesh-ancestor
64948723|NCT03323463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948734|NCT03299660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948735|NCT03299660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65031312|NCT00167609|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64585411|NCT03006276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64585412|NCT03006276|Analgesics|analgesics|mesh-ancestor
65031313|NCT00167609|Immunologic Factors|immunologic factors|mesh-ancestor
64585417|NCT03006276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65031314|NCT00167609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031315|NCT03888079|Anesthetics|anesthetics|mesh-list
65031316|NCT03888079|Anesthetics, Local|anesthetics, local|mesh-list
65031317|NCT03888079|Anesthetics, General|anesthetics, general|mesh-list
65031318|NCT03888079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65031319|NCT03888079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031320|NCT03888079|Sensory System Agents|sensory system agents|mesh-ancestor
65031321|NCT03888079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65031322|NCT00167648|Leuprolide|leuprolide|mesh-list
65031323|NCT00167648|Goserelin|goserelin|mesh-list
65031324|NCT00167648|Estradiol|estradiol|mesh-list
65031325|NCT00167648|Estrogens|estrogens|mesh-ancestor
65031326|NCT00167648|Hormones|hormones|mesh-ancestor
65031327|NCT00167648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65031328|NCT00167648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031329|NCT00167648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65031330|NCT00167648|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65031331|NCT00167648|Fertility Agents|fertility agents|mesh-ancestor
65031332|NCT00167648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65031333|NCT00167648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031334|NCT02906722|Colistin|colistin|mesh-list
65031335|NCT02906722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64948736|NCT03299660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948737|NCT03299660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64948738|NCT03299660|Immunologic Factors|immunologic factors|mesh-ancestor
64948739|NCT03299660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948740|NCT03299660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64948741|NCT03292458|Sodium Oxybate|sodium oxybate|mesh-list
64948742|NCT03292458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64948743|NCT03292458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64948744|NCT03292458|Anesthetics, General|anesthetics, general|mesh-ancestor
64503315|NCT01598740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503316|NCT01598740|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64948746|NCT03292458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64948747|NCT03292458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948748|NCT03243058|Aldesleukin|aldesleukin|mesh-list
64948749|NCT03243058|Interleukin-2|interleukin-2|mesh-list
64948750|NCT03243058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948751|NCT03243058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64948752|NCT03243058|Analgesics|analgesics|mesh-ancestor
64948753|NCT03243058|Sensory System Agents|sensory system agents|mesh-ancestor
64948754|NCT03243058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64948755|NCT03243058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948756|NCT03243058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65031336|NCT02906722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65031337|NCT00167687|Prazosin|prazosin|mesh-list
65031338|NCT00167687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65031339|NCT00167687|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65031340|NCT00167687|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65031341|NCT00167687|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65031342|NCT00167687|Adrenergic Agents|adrenergic agents|mesh-ancestor
65031343|NCT00167687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65031344|NCT00167687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031345|NCT00167687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031346|NCT02906995|Nicotine|nicotine|mesh-list
65031347|NCT02906995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65031348|NCT02906995|Autonomic Agents|autonomic agents|mesh-ancestor
65031349|NCT02906995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65031350|NCT02906995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031351|NCT02906995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65031352|NCT02906995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65031353|NCT02906995|Cholinergic Agents|cholinergic agents|mesh-ancestor
64948757|NCT03243058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64948758|NCT03243058|Antiviral Agents|antiviral agents|mesh-ancestor
64948759|NCT03243058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64948762|NCT03179930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64948763|NCT03179930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948764|NCT03179930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64948765|NCT03179930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948766|NCT03179930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948767|NCT03140358|Atropine|atropine|mesh-list
64948768|NCT03140358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64948769|NCT03140358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64948770|NCT03140358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64948771|NCT03140358|Autonomic Agents|autonomic agents|mesh-ancestor
64948772|NCT03140358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64948773|NCT03140358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948774|NCT03140358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64948775|NCT03140358|Respiratory System Agents|respiratory system agents|mesh-ancestor
64948776|NCT03140358|Mydriatics|mydriatics|mesh-ancestor
64948777|NCT03140358|Parasympatholytics|parasympatholytics|mesh-ancestor
64948778|NCT03140358|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64948779|NCT03140358|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64948780|NCT03140358|Cholinergic Agents|cholinergic agents|mesh-ancestor
64948781|NCT03140358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64948782|NCT03140358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948783|NCT02954536|Pembrolizumab|pembrolizumab|mesh-list
64948784|NCT02954536|Fluorouracil|fluorouracil|mesh-list
64948785|NCT02954536|Capecitabine|capecitabine|mesh-list
64948786|NCT02954536|Oxaliplatin|oxaliplatin|mesh-list
64948787|NCT02954536|Trastuzumab|trastuzumab|mesh-list
64948788|NCT02954536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948789|NCT02954536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64948806|NCT02899611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64948808|NCT02778685|Letrozole|letrozole|mesh-list
64948809|NCT02778685|Fulvestrant|fulvestrant|mesh-list
64948810|NCT02778685|Palbociclib|palbociclib|mesh-list
64948811|NCT02778685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64948812|NCT02778685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948813|NCT02778685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64948814|NCT02778685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64948815|NCT02778685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031354|NCT02906995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65031355|NCT02906995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031356|NCT00195390|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65031357|NCT00195390|Immunologic Factors|immunologic factors|mesh-ancestor
65031358|NCT00195390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031359|NCT02906800|Digoxin|digoxin|mesh-list
65031360|NCT02906800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65031361|NCT02906800|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65031362|NCT02906800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031363|NCT02906800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031364|NCT02906800|Protective Agents|protective agents|mesh-ancestor
65031365|NCT02906800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031366|NCT00195468|Cyclosporine|cyclosporine|mesh-list
65031367|NCT00195468|Cyclosporins|cyclosporins|mesh-list
65031368|NCT00195468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031369|NCT00195468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031370|NCT00195468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65031371|NCT00195468|Immunologic Factors|immunologic factors|mesh-ancestor
64585449|NCT00352001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948816|NCT02778685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948817|NCT02778685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64948818|NCT02778685|Hormone Antagonists|hormone antagonists|mesh-ancestor
64503317|NCT01598740|Diuretics|diuretics|mesh-ancestor
64503318|NCT01598740|Natriuretic Agents|natriuretic agents|mesh-ancestor
64948819|NCT02778685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64948820|NCT02778685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948821|NCT02778685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64948822|NCT02778685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64948823|NCT02778685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64948824|NCT02750202|Vaccines|vaccines|mesh-list
64948825|NCT02750202|Immunologic Factors|immunologic factors|mesh-ancestor
64948826|NCT02750202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948827|NCT02645266|Aflibercept|aflibercept|mesh-list
64948828|NCT02645266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64948829|NCT02645266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64948830|NCT02645266|Growth Substances|growth substances|mesh-ancestor
64948831|NCT02645266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948832|NCT02645266|Growth Inhibitors|growth inhibitors|mesh-ancestor
64948833|NCT02645266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948834|NCT02634294|Interferons|interferons|mesh-list
64948835|NCT02634294|Interferon-alpha|interferon-alpha|mesh-list
64948836|NCT02634294|Interferon alpha-2|interferon alpha-2|mesh-list
64948837|NCT02634294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64948838|NCT02634294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948839|NCT02634294|Antiviral Agents|antiviral agents|mesh-ancestor
64948840|NCT02634294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64948844|NCT02586831|Aldesleukin|aldesleukin|mesh-list
64948845|NCT02586831|Adalimumab|adalimumab|mesh-list
64948846|NCT02586831|Interleukin-2|interleukin-2|mesh-list
64948861|NCT02586831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64948862|NCT02586831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64948864|NCT02586831|Hormones|hormones|mesh-ancestor
64948865|NCT02586831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64948866|NCT02586831|Immunologic Factors|immunologic factors|mesh-ancestor
65031372|NCT00195468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031373|NCT00195468|Antifungal Agents|antifungal agents|mesh-ancestor
65031374|NCT00195468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65031375|NCT00195468|Dermatologic Agents|dermatologic agents|mesh-ancestor
65031376|NCT00195468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65031377|NCT00195468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65031378|NCT00167765|Abciximab|abciximab|mesh-list
65031379|NCT00167765|Anticoagulants|anticoagulants|mesh-ancestor
65031380|NCT00167765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65031381|NCT02906254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65031382|NCT02906254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65031383|NCT00167843|Pyrimethamine|pyrimethamine|mesh-list
65031384|NCT00167843|Sulfadoxine|sulfadoxine|mesh-list
65031385|NCT00167843|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65031386|NCT00167843|Antimalarials|antimalarials|mesh-ancestor
65031387|NCT00167843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65031388|NCT00167843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65031389|NCT00167843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65031390|NCT00167843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65031391|NCT00167843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031392|NCT00167843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031393|NCT00167843|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65031394|NCT00167843|Renal Agents|renal agents|mesh-ancestor
65031395|NCT02906059|Irinotecan|irinotecan|mesh-list
65031396|NCT02906059|Adavosertib|adavosertib|mesh-list
65031397|NCT02906059|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65031398|NCT02906059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65031399|NCT02906059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031400|NCT02906059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031401|NCT02906059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031402|NCT02906176|Voriconazole|voriconazole|mesh-list
65031403|NCT02906176|Antifungal Agents|antifungal agents|mesh-ancestor
65031404|NCT02906176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65031405|NCT02906176|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64585507|NCT00360685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65031412|NCT02906176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031413|NCT02906176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65031414|NCT02905864|Liraglutide|liraglutide|mesh-list
65031415|NCT02905864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65031416|NCT02905864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031417|NCT02905864|Incretins|incretins|mesh-ancestor
65031418|NCT02905864|Hormones|hormones|mesh-ancestor
65031419|NCT02905864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65031420|NCT00167882|Mesalamine|mesalamine|mesh-list
65031421|NCT00167882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65031422|NCT00167882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65031423|NCT00167882|Analgesics|analgesics|mesh-ancestor
65031424|NCT00167882|Sensory System Agents|sensory system agents|mesh-ancestor
65031425|NCT00167882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65031426|NCT00167882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031427|NCT00167882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65031428|NCT00167882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65031429|NCT02905708|Charcoal|charcoal|mesh-list
65031430|NCT02905708|Antidotes|antidotes|mesh-ancestor
65031431|NCT02905708|Protective Agents|protective agents|mesh-ancestor
65031432|NCT02905708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031433|NCT00167921|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65031434|NCT00167921|Estrogens|estrogens|mesh-ancestor
65031435|NCT00167921|Hormones|hormones|mesh-ancestor
65031436|NCT00167921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65031437|NCT00167921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031438|NCT00167960|Tazobactam|tazobactam|mesh-list
65031439|NCT00167960|Piperacillin|piperacillin|mesh-list
65031440|NCT00167960|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65031441|NCT00167960|Lactams|lactams|mesh-list
65031442|NCT00167960|beta-Lactams|beta-lactams|mesh-list
65031443|NCT00167960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64948867|NCT02586831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64948868|NCT02575677|Oxycodone|oxycodone|mesh-list
64948869|NCT02575677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64948870|NCT02575677|Narcotics|narcotics|mesh-ancestor
64948871|NCT02575677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64948872|NCT02575677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948873|NCT02575677|Analgesics|analgesics|mesh-ancestor
64948874|NCT02575677|Sensory System Agents|sensory system agents|mesh-ancestor
64948875|NCT02575677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64948876|NCT02573909|Oxycodone|oxycodone|mesh-list
65031444|NCT00167960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65031445|NCT00167960|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65031446|NCT00167960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031447|NCT00167960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031448|NCT02905513|Contraceptive Agents|contraceptive agents|mesh-list
65031449|NCT02905513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65031450|NCT02905513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031451|NCT00167999|Tazobactam|tazobactam|mesh-list
65031452|NCT00167999|Piperacillin|piperacillin|mesh-list
65031453|NCT00167999|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65031454|NCT00167999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65031455|NCT00167999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65031456|NCT00167999|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65031457|NCT00167999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031458|NCT00167999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031459|NCT00177996|Sertraline|sertraline|mesh-list
65031460|NCT00177996|Antidepressive Agents|antidepressive agents|mesh-ancestor
65031461|NCT00177996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65031462|NCT00177996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65031463|NCT00177996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64585542|NCT00558519|Antiemetics|antiemetics|mesh-ancestor
64948877|NCT02573909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64948878|NCT02573909|Narcotics|narcotics|mesh-ancestor
64948879|NCT02573909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64948880|NCT02573909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948881|NCT02573909|Analgesics|analgesics|mesh-ancestor
64948882|NCT02573909|Sensory System Agents|sensory system agents|mesh-ancestor
64948883|NCT02573909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64948884|NCT02573831|Oxycodone|oxycodone|mesh-list
64948885|NCT02573831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64948886|NCT02573831|Narcotics|narcotics|mesh-ancestor
64948887|NCT02573831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64948888|NCT02573831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948889|NCT02573831|Analgesics|analgesics|mesh-ancestor
64948890|NCT02573831|Sensory System Agents|sensory system agents|mesh-ancestor
64503319|NCT00709098|Iloprost|iloprost|mesh-list
64948891|NCT02573831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64948892|NCT02571881|Oxycodone|oxycodone|mesh-list
64948893|NCT02571881|Naloxone|naloxone|mesh-list
64948894|NCT02571881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64948895|NCT02571881|Narcotics|narcotics|mesh-ancestor
64948896|NCT02571881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64948897|NCT02571881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948898|NCT02571881|Analgesics|analgesics|mesh-ancestor
64948899|NCT02571881|Sensory System Agents|sensory system agents|mesh-ancestor
64948900|NCT02571881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64948901|NCT02571881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64948902|NCT02571179|Fentanyl|fentanyl|mesh-list
64948903|NCT02571179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64948904|NCT02571179|Narcotics|narcotics|mesh-ancestor
64948905|NCT02571179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64948906|NCT02571179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948907|NCT02571179|Analgesics|analgesics|mesh-ancestor
64948908|NCT02571179|Sensory System Agents|sensory system agents|mesh-ancestor
64948925|NCT02511418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65031464|NCT00177996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65031465|NCT00177996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031466|NCT00177996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65031467|NCT00177996|Serotonin Agents|serotonin agents|mesh-ancestor
65031468|NCT00177996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031469|NCT00168077|Thrombin|thrombin|mesh-list
65031470|NCT00168077|Hemostatics|hemostatics|mesh-ancestor
65031471|NCT00168077|Coagulants|coagulants|mesh-ancestor
65031472|NCT00195585|Leucovorin|leucovorin|mesh-list
65031473|NCT00195585|Levoleucovorin|levoleucovorin|mesh-list
65031474|NCT00195585|Antidotes|antidotes|mesh-ancestor
65031475|NCT00195585|Protective Agents|protective agents|mesh-ancestor
65031476|NCT00195585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031477|NCT00195585|Vitamin B Complex|vitamin b complex|mesh-ancestor
65031478|NCT00195585|Vitamins|vitamins|mesh-ancestor
65031479|NCT00195585|Micronutrients|micronutrients|mesh-ancestor
65031480|NCT02905045|Ketoprofen|ketoprofen|mesh-list
65031481|NCT02905045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65031482|NCT02905045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65031483|NCT02905045|Analgesics|analgesics|mesh-ancestor
65031484|NCT02905045|Sensory System Agents|sensory system agents|mesh-ancestor
64585560|NCT00558519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64948926|NCT02511418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64948927|NCT02511418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948928|NCT02278250|Carboplatin|carboplatin|mesh-list
64948929|NCT02278250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948930|NCT02250326|Paclitaxel|paclitaxel|mesh-list
64948931|NCT02250326|Azacitidine|azacitidine|mesh-list
64948932|NCT02250326|Cc-486|cc-486|mesh-list
64948933|NCT02250326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64948934|NCT02250326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948935|NCT02250326|Tubulin Modulators|tubulin modulators|mesh-ancestor
64948936|NCT02250326|Antimitotic Agents|antimitotic agents|mesh-ancestor
64948937|NCT02250326|Mitosis Modulators|mitosis modulators|mesh-ancestor
64725340|NCT00002395|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64725341|NCT00002395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64725342|NCT00002395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64332866|NCT00783367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64948938|NCT02250326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948939|NCT02250326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64948940|NCT02250326|Antimetabolites|antimetabolites|mesh-ancestor
64948941|NCT02250326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948942|NCT02225600|Oxytocin|oxytocin|mesh-list
64948943|NCT02225600|Oxytocics|oxytocics|mesh-ancestor
64948944|NCT02225600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64948945|NCT02225600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948946|NCT02211742|Dapagliflozin|dapagliflozin|mesh-list
64948947|NCT02211742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64948948|NCT02211742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948949|NCT02211742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64948950|NCT02211742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948951|NCT02101905|Lapatinib|lapatinib|mesh-list
64948952|NCT02101905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948953|NCT02101905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64948954|NCT02101905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031485|NCT02905045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64585582|NCT03239015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65031486|NCT02905045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031487|NCT02905045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65031488|NCT02905045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65031489|NCT02905045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65031490|NCT02905045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031491|NCT02905045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031492|NCT02904772|Cyclosporine|cyclosporine|mesh-list
65031493|NCT02904772|Mycophenolic Acid|mycophenolic acid|mesh-list
65031494|NCT02904772|Prednisolone|prednisolone|mesh-list
65031495|NCT02904772|Cyclosporins|cyclosporins|mesh-list
65031496|NCT02904772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066965|NCT00418704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031497|NCT02904772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516677|NCT01230411|Ibuprofen|ibuprofen|mesh-list
65031499|NCT02904772|Immunologic Factors|immunologic factors|mesh-ancestor
65031500|NCT02904772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031501|NCT02904772|Antifungal Agents|antifungal agents|mesh-ancestor
65031502|NCT02904772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65031503|NCT02904772|Dermatologic Agents|dermatologic agents|mesh-ancestor
65031504|NCT02904772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65031505|NCT02904772|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65031506|NCT02904772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65031507|NCT02904772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031508|NCT02904772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65031509|NCT02904772|Antitubercular Agents|antitubercular agents|mesh-ancestor
65031510|NCT02904772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65031511|NCT02904772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65031512|NCT02904772|Glucocorticoids|glucocorticoids|mesh-ancestor
65031513|NCT02904772|Hormones|hormones|mesh-ancestor
64585583|NCT03239015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948955|NCT02101905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948956|NCT02081404|Esomeprazole|esomeprazole|mesh-list
64948957|NCT02081404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64948958|NCT02081404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64948959|NCT02081404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64948960|NCT02081404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948961|NCT02081404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948962|NCT01526603|Carboplatin|carboplatin|mesh-list
64948963|NCT01526603|Etoposide|etoposide|mesh-list
64948964|NCT01526603|Melphalan|melphalan|mesh-list
64948965|NCT01526603|Tretinoin|tretinoin|mesh-list
64948966|NCT01526603|Isotretinoin|isotretinoin|mesh-list
64585611|NCT00558285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65031514|NCT02904772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64585612|NCT00558285|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64585613|NCT00558285|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65031515|NCT02904772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65031516|NCT00195741|Valproic Acid|valproic acid|mesh-list
65031517|NCT00195741|Anticonvulsants|anticonvulsants|mesh-ancestor
65031518|NCT00195741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031519|NCT00195741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031520|NCT00195741|GABA Agents|gaba agents|mesh-ancestor
65031521|NCT00195741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65031522|NCT00195741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031523|NCT00195741|Antimanic Agents|antimanic agents|mesh-ancestor
65031524|NCT00195741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65031525|NCT00195741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65031526|NCT00195741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65031527|NCT00178035|Paroxetine|paroxetine|mesh-list
65031528|NCT00178035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65031529|NCT00178035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65031530|NCT00178035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65031531|NCT00178035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031532|NCT00178035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65031533|NCT00178035|Serotonin Agents|serotonin agents|mesh-ancestor
65031534|NCT00178035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031535|NCT00178035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65031536|NCT00178035|Antidepressive Agents|antidepressive agents|mesh-ancestor
65031537|NCT00178035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65031538|NCT00178035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64585618|NCT01389596|Pregabalin|pregabalin|mesh-list
64948967|NCT01526603|Lenograstim|lenograstim|mesh-list
64948976|NCT01526603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64948977|NCT01526603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64948978|NCT01526603|Immunologic Factors|immunologic factors|mesh-ancestor
64948979|NCT01526603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948980|NCT01526603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64948981|NCT01526603|Keratolytic Agents|keratolytic agents|mesh-ancestor
64948982|NCT01526603|Dermatologic Agents|dermatologic agents|mesh-ancestor
64948983|NCT01407263|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64948984|NCT01407263|Hemostatics|hemostatics|mesh-list
64948985|NCT01407263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64948986|NCT01407263|Coagulants|coagulants|mesh-ancestor
64948987|NCT01194570|Ocrelizumab|ocrelizumab|mesh-list
64948988|NCT01194570|Immunologic Factors|immunologic factors|mesh-ancestor
64585634|NCT00558207|Antimetabolites|antimetabolites|mesh-ancestor
65031539|NCT00178035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65031540|NCT00178035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031541|NCT02904538|Dexamethasone|dexamethasone|mesh-list
65031542|NCT02904538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65031543|NCT02904538|Antiemetics|antiemetics|mesh-ancestor
65031544|NCT02904538|Autonomic Agents|autonomic agents|mesh-ancestor
65031545|NCT02904538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65031546|NCT02904538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031547|NCT02904538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65031548|NCT02904538|Glucocorticoids|glucocorticoids|mesh-ancestor
65031549|NCT02904538|Hormones|hormones|mesh-ancestor
65031550|NCT02904538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65031551|NCT02904538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65031552|NCT02904538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031553|NCT02963103|Tacrolimus|tacrolimus|mesh-list
65031554|NCT02963103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65031555|NCT02963103|Immunologic Factors|immunologic factors|mesh-ancestor
65031556|NCT02963103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031557|NCT02963103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65031558|NCT02963103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031559|NCT02963103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031560|NCT00407264|Fluticasone|fluticasone|mesh-list
65031561|NCT00407264|Xhance|xhance|mesh-list
65031562|NCT00407264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65031563|NCT00407264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64585636|NCT00558207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948989|NCT01194570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948990|NCT01124695|Tamoxifen|tamoxifen|mesh-list
64948991|NCT01124695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64948992|NCT01124695|Hormone Antagonists|hormone antagonists|mesh-ancestor
64948993|NCT01124695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64948994|NCT01124695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948995|NCT01124695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64948996|NCT01124695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948997|NCT01124695|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64948998|NCT01124695|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64948999|NCT01124695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64949000|NCT01013649|Gemcitabine|gemcitabine|mesh-list
64949001|NCT01013649|Fluorouracil|fluorouracil|mesh-list
64949002|NCT01013649|Capecitabine|capecitabine|mesh-list
64949003|NCT01013649|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64949004|NCT01013649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64949005|NCT01013649|Antimetabolites|antimetabolites|mesh-ancestor
64949006|NCT01013649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725343|NCT00002395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725345|NCT00002401|Lamivudine|lamivudine|mesh-list
65031564|NCT00407264|Autonomic Agents|autonomic agents|mesh-ancestor
65031565|NCT00407264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65031566|NCT00407264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031567|NCT00407264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65031568|NCT00407264|Respiratory System Agents|respiratory system agents|mesh-ancestor
65031569|NCT00407264|Dermatologic Agents|dermatologic agents|mesh-ancestor
65031570|NCT00407264|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64516753|NCT02349178|Cyclophosphamide|cyclophosphamide|mesh-list
65031571|NCT02904499|Dabigatran|dabigatran|mesh-list
65031572|NCT02904499|Antithrombins|antithrombins|mesh-ancestor
65031573|NCT02904499|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65031574|NCT02904499|Protease Inhibitors|protease inhibitors|mesh-ancestor
65031575|NCT02904499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031576|NCT02904499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031577|NCT02904499|Anticoagulants|anticoagulants|mesh-ancestor
65031578|NCT00195780|Valproic Acid|valproic acid|mesh-list
65031579|NCT00195780|Anticonvulsants|anticonvulsants|mesh-ancestor
65031580|NCT00195780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031581|NCT00195780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031582|NCT00195780|GABA Agents|gaba agents|mesh-ancestor
65031583|NCT00195780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64725346|NCT00002401|Zidovudine|zidovudine|mesh-list
64420157|NCT05497765|Silybin|silybin|mesh-list
64949009|NCT01013649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949010|NCT01013649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949011|NCT01013649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64949012|NCT01013649|Immunologic Factors|immunologic factors|mesh-ancestor
64949013|NCT01013649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949014|NCT01013649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64949015|NCT00038766|Semapimod|semapimod|mesh-list
64949016|NCT00038766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64949017|NCT00038766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64949018|NCT00038766|Analgesics|analgesics|mesh-ancestor
64949019|NCT00038766|Sensory System Agents|sensory system agents|mesh-ancestor
64949020|NCT00038766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64949021|NCT00038766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949022|NCT00038766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64949023|NCT00038766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64949024|NCT00038766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64949025|NCT00038766|Immunologic Factors|immunologic factors|mesh-ancestor
64949026|NCT00070070|Sargramostim|sargramostim|mesh-list
64949027|NCT00070070|BCG Vaccine|bcg vaccine|mesh-list
64949028|NCT00070070|Immunologic Factors|immunologic factors|mesh-ancestor
64949029|NCT00070070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949030|NCT00070070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64949031|NCT00042315|Vinorelbine|vinorelbine|mesh-list
64949062|NCT00042354|Antimetabolites|antimetabolites|mesh-ancestor
64949063|NCT00042354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949064|NCT00042354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949066|NCT00042393|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64949067|NCT00042393|Antiviral Agents|antiviral agents|mesh-ancestor
64949068|NCT00042393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949069|NCT00042393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64949070|NCT00042393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64949074|NCT00042471|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
64585679|NCT02660411|Anesthetics|anesthetics|mesh-ancestor
64585680|NCT02660411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65031584|NCT00195780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031585|NCT00195780|Antimanic Agents|antimanic agents|mesh-ancestor
65031586|NCT00195780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65031587|NCT00195780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65031588|NCT00195780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65031589|NCT00407342|Alefacept|alefacept|mesh-list
65031590|NCT00407342|Dermatologic Agents|dermatologic agents|mesh-ancestor
65031591|NCT00407342|Immunologic Factors|immunologic factors|mesh-ancestor
65031592|NCT00407342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031593|NCT00553423|Lactulose|lactulose|mesh-list
65031594|NCT00553423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65031595|NCT02904304|Ibuprofen|ibuprofen|mesh-list
65031596|NCT02904304|Phenylephrine|phenylephrine|mesh-list
65031597|NCT02904304|Oxymetazoline|oxymetazoline|mesh-list
65031598|NCT02904304|Desloratadine|desloratadine|mesh-list
65031599|NCT02904304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65031600|NCT02904304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65031601|NCT02904304|Analgesics|analgesics|mesh-ancestor
65031602|NCT02904304|Sensory System Agents|sensory system agents|mesh-ancestor
65031603|NCT02904304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65031604|NCT02904304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031605|NCT02904304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64949075|NCT00042471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64949076|NCT00042471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949077|NCT00042471|Appetite Depressants|appetite depressants|mesh-ancestor
64949078|NCT00042471|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64949079|NCT00042471|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
64949080|NCT00042471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949081|NCT00042549|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64949082|NCT00042549|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64949083|NCT00042549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64949084|NCT00042588|Antibodies|antibodies|mesh-list
64949085|NCT00042588|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64949086|NCT00042588|Immunologic Factors|immunologic factors|mesh-ancestor
64949087|NCT00042588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949088|NCT00038805|Gemtuzumab|gemtuzumab|mesh-list
64949089|NCT00038805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64949090|NCT00038805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949091|NCT00018824|Naltrexone|naltrexone|mesh-list
64949092|NCT00018824|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64949093|NCT00018824|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64949094|NCT00018824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949095|NCT00018824|Sensory System Agents|sensory system agents|mesh-ancestor
64949096|NCT00018824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64949097|NCT00038844|Cyclophosphamide|cyclophosphamide|mesh-list
64949098|NCT00038844|Rituximab|rituximab|mesh-list
64949099|NCT00038844|Fludarabine|fludarabine|mesh-list
64949100|NCT00038844|Fludarabine phosphate|fludarabine phosphate|mesh-list
64949101|NCT00038844|Alemtuzumab|alemtuzumab|mesh-list
64949102|NCT00038844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64949103|NCT00038844|Immunologic Factors|immunologic factors|mesh-ancestor
64949104|NCT00038844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031606|NCT02904304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65031607|NCT02904304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65031608|NCT02904304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031609|NCT02904304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031610|NCT02904304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65031611|NCT02904304|Mydriatics|mydriatics|mesh-ancestor
65031612|NCT02904304|Autonomic Agents|autonomic agents|mesh-ancestor
65031613|NCT02904304|Sympathomimetics|sympathomimetics|mesh-ancestor
65031614|NCT02904304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65031615|NCT02904304|Nasal Decongestants|nasal decongestants|mesh-ancestor
65031616|NCT02904304|Respiratory System Agents|respiratory system agents|mesh-ancestor
65031617|NCT02904304|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65031618|NCT02904304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65031619|NCT02904304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65031620|NCT02904304|Adrenergic Agents|adrenergic agents|mesh-ancestor
65031621|NCT02904304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65031622|NCT02904304|Protective Agents|protective agents|mesh-ancestor
65031623|NCT02904304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65031624|NCT02904304|Cholinergic Agents|cholinergic agents|mesh-ancestor
65031625|NCT02904304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65031626|NCT02904304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65031627|NCT02904304|Histamine Antagonists|histamine antagonists|mesh-ancestor
65031628|NCT02904304|Histamine Agents|histamine agents|mesh-ancestor
65031629|NCT00407459|Bevacizumab|bevacizumab|mesh-list
65031630|NCT00407459|Carboplatin|carboplatin|mesh-list
65031631|NCT00407459|Pemetrexed|pemetrexed|mesh-list
65031632|NCT00407459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65031633|NCT00407459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585702|NCT04528563|Ketorolac|ketorolac|mesh-list
64949105|NCT00038844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64949106|NCT00038844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64949107|NCT00038844|Alkylating Agents|alkylating agents|mesh-ancestor
64725348|NCT00002401|Indinavir|indinavir|mesh-list
64725349|NCT00002401|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64725350|NCT00002401|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64725351|NCT00002401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725352|NCT00002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725353|NCT00002401|Antiviral Agents|antiviral agents|mesh-ancestor
64949112|NCT00038844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64949113|NCT00038844|Antimetabolites|antimetabolites|mesh-ancestor
64949114|NCT00018863|Methylphenidate|methylphenidate|mesh-list
64949115|NCT00018863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64949116|NCT00018863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503324|NCT03348696|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64949117|NCT00018863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64949118|NCT00018863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65031634|NCT00407459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65031635|NCT00407459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65031636|NCT00407459|Growth Substances|growth substances|mesh-ancestor
65031637|NCT00407459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031638|NCT00407459|Growth Inhibitors|growth inhibitors|mesh-ancestor
65031639|NCT00407459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031640|NCT00407459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031641|NCT00407459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65031642|NCT00407459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65031643|NCT02904031|Leucovorin|leucovorin|mesh-list
65031644|NCT02904031|Fluorouracil|fluorouracil|mesh-list
65031645|NCT02904031|Oxaliplatin|oxaliplatin|mesh-list
65031646|NCT02904031|Panitumumab|panitumumab|mesh-list
65031647|NCT02904031|Levoleucovorin|levoleucovorin|mesh-list
65031648|NCT02904031|Antimetabolites|antimetabolites|mesh-ancestor
65031649|NCT02904031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031650|NCT02904031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65031651|NCT02904031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031652|NCT02904031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65031653|NCT02904031|Immunologic Factors|immunologic factors|mesh-ancestor
65031654|NCT02904031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031655|NCT02904031|Antidotes|antidotes|mesh-ancestor
65031656|NCT02904031|Protective Agents|protective agents|mesh-ancestor
65031657|NCT02904031|Vitamin B Complex|vitamin b complex|mesh-ancestor
65031659|NCT02904031|Micronutrients|micronutrients|mesh-ancestor
65031660|NCT02904031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65031661|NCT02904109|Mannitol|mannitol|mesh-list
65031662|NCT02904109|Triflusal|triflusal|mesh-list
65031663|NCT02904109|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65031664|NCT02904109|Diuretics|diuretics|mesh-ancestor
65031665|NCT02904109|Natriuretic Agents|natriuretic agents|mesh-ancestor
65031666|NCT02904109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031668|NCT00178113|Lycopene|lycopene|mesh-list
65031679|NCT02903524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64585772|NCT00365053|Belinostat|belinostat|mesh-list
65031680|NCT02903524|Pirarubicin|pirarubicin|mesh-list
65031681|NCT02903524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65031682|NCT02903524|Immunologic Factors|immunologic factors|mesh-ancestor
65031683|NCT02903524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031684|NCT02903524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65031685|NCT02903524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65031686|NCT02903524|Alkylating Agents|alkylating agents|mesh-ancestor
65031687|NCT02903524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031688|NCT02903524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031689|NCT02903524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65031690|NCT02903524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65031691|NCT02903524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65031692|NCT02903524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65031693|NCT02903524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031694|NCT00168350|Memantine|memantine|mesh-list
65031695|NCT00168350|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65031696|NCT00168350|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65031697|NCT00168350|Dopamine Agents|dopamine agents|mesh-ancestor
65031698|NCT00168350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65031699|NCT00168350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031700|NCT00168350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031701|NCT00168350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65031702|NCT00168350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65031703|NCT02903485|Anesthetics|anesthetics|mesh-list
65031704|NCT02903485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65031705|NCT02903485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031706|NCT02903719|Ropivacaine|ropivacaine|mesh-list
65031707|NCT02903719|Anesthetics, Local|anesthetics, local|mesh-ancestor
64949119|NCT00018863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64949120|NCT00018863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949121|NCT00018863|Dopamine Agents|dopamine agents|mesh-ancestor
64949122|NCT00018863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64949123|NCT00038883|Alemtuzumab|alemtuzumab|mesh-list
64949124|NCT00038883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64949125|NCT00038883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949127|NCT00018902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64949128|NCT00018902|Citalopram|citalopram|mesh-list
64949129|NCT00018902|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64949130|NCT00018902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64949131|NCT00018902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65031708|NCT02903719|Anesthetics|anesthetics|mesh-ancestor
65031709|NCT02903719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65031710|NCT02903719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031711|NCT02903719|Sensory System Agents|sensory system agents|mesh-ancestor
65031712|NCT02903719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65031713|NCT00178269|Docetaxel|docetaxel|mesh-list
65031714|NCT00178269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031715|NCT00178269|Tubulin Modulators|tubulin modulators|mesh-ancestor
65031716|NCT00178269|Antimitotic Agents|antimitotic agents|mesh-ancestor
65031717|NCT00178269|Mitosis Modulators|mitosis modulators|mesh-ancestor
65031718|NCT00178269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031719|NCT02903251|Oxytocin|oxytocin|mesh-list
65031720|NCT02903251|Oxytocics|oxytocics|mesh-ancestor
65031721|NCT02903251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65031723|NCT00168467|Ramipril|ramipril|mesh-list
65031724|NCT00168467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65031725|NCT00168467|Protease Inhibitors|protease inhibitors|mesh-ancestor
65031726|NCT00168467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031727|NCT00168467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031728|NCT00168467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65031729|NCT00195936|Cinacalcet|cinacalcet|mesh-list
65031730|NCT00195936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65031731|NCT00195936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031732|NCT00195936|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65031733|NCT00195936|Hormone Antagonists|hormone antagonists|mesh-ancestor
65031734|NCT00195936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65031735|NCT02902861|Methotrexate|methotrexate|mesh-list
64585801|NCT00365209|Curcumin|curcumin|mesh-list
64949132|NCT00018902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949133|NCT00018902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64949134|NCT00018902|Serotonin Agents|serotonin agents|mesh-ancestor
64949135|NCT00018902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949136|NCT00018902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64949137|NCT00018902|Antidepressive Agents|antidepressive agents|mesh-ancestor
64949138|NCT00018902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64949139|NCT00018902|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64949140|NCT00018902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64949144|NCT00038922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949145|NCT00018941|Aldesleukin|aldesleukin|mesh-list
64949146|NCT00018941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949147|NCT00018941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64949148|NCT00018941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64949149|NCT00018941|Antiviral Agents|antiviral agents|mesh-ancestor
64949150|NCT00018941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949152|NCT00038961|Fondaparinux|fondaparinux|mesh-list
64949153|NCT00038961|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64585825|NCT00409825|Hormones|hormones|mesh-ancestor
65031736|NCT02902861|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65031737|NCT02902861|Abortifacient Agents|abortifacient agents|mesh-ancestor
65031738|NCT02902861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65031739|NCT02902861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031740|NCT02902861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65031741|NCT02902861|Antimetabolites|antimetabolites|mesh-ancestor
65031742|NCT02902861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031743|NCT02902861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031744|NCT02902861|Dermatologic Agents|dermatologic agents|mesh-ancestor
65031745|NCT02902861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031746|NCT02902861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65031747|NCT02902861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65031748|NCT02902861|Immunologic Factors|immunologic factors|mesh-ancestor
65031749|NCT02902861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65031750|NCT02902861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65031751|NCT02903017|Tranexamic Acid|tranexamic acid|mesh-list
65031752|NCT02903017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64949154|NCT00038961|Antithrombins|antithrombins|mesh-ancestor
64949155|NCT00038961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64949156|NCT00038961|Protease Inhibitors|protease inhibitors|mesh-ancestor
64949157|NCT00038961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949158|NCT00038961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949159|NCT00038961|Anticoagulants|anticoagulants|mesh-ancestor
64949160|NCT00038961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64949161|NCT00038961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64949162|NCT00019019|Paclitaxel|paclitaxel|mesh-list
64949163|NCT00019019|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
64949164|NCT00019019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64949165|NCT00019019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949166|NCT00019019|Tubulin Modulators|tubulin modulators|mesh-ancestor
64949167|NCT00019019|Antimitotic Agents|antimitotic agents|mesh-ancestor
64949168|NCT00019019|Mitosis Modulators|mitosis modulators|mesh-ancestor
64949169|NCT00019019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949170|NCT00019019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64949171|NCT00019019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64725354|NCT00002401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725355|NCT00002401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64725356|NCT00002401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64725357|NCT00002401|Antimetabolites|antimetabolites|mesh-ancestor
64725358|NCT00002401|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64725359|NCT00002401|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64725360|NCT00002401|Protease Inhibitors|protease inhibitors|mesh-ancestor
64725361|NCT00002407|Lamivudine|lamivudine|mesh-list
64725370|NCT00002407|Antiviral Agents|antiviral agents|mesh-ancestor
64725371|NCT00002407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725372|NCT00002407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64725373|NCT00002407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64725374|NCT00002407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64725375|NCT00002407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64725377|NCT00002407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64332881|NCT00783367|Growth Substances|growth substances|mesh-ancestor
64949172|NCT00019019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64949173|NCT00019019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949174|NCT00019058|Hydroxyurea|hydroxyurea|mesh-list
64949175|NCT00019058|Pentoxifylline|pentoxifylline|mesh-list
64949176|NCT00019058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031753|NCT02903017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64585842|NCT00411463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64585843|NCT00411463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65031754|NCT02903017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585844|NCT00411463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65031755|NCT02903017|Hemostatics|hemostatics|mesh-ancestor
65031756|NCT02903017|Coagulants|coagulants|mesh-ancestor
65031757|NCT02902744|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
65031758|NCT02902744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65031759|NCT02902744|Glucocorticoids|glucocorticoids|mesh-ancestor
65031760|NCT02902744|Hormones|hormones|mesh-ancestor
65031761|NCT02902744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65031762|NCT02902744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031763|NCT00168584|Vitamin A|vitamin a|mesh-list
65031764|NCT00168584|Vitamins|vitamins|mesh-ancestor
65031765|NCT00168584|Micronutrients|micronutrients|mesh-ancestor
65031766|NCT00168584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031767|NCT02902666|Acetaminophen|acetaminophen|mesh-list
65031768|NCT02902666|Codeine|codeine|mesh-list
65031769|NCT02902666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65031770|NCT02902666|Analgesics|analgesics|mesh-ancestor
65031771|NCT02902666|Sensory System Agents|sensory system agents|mesh-ancestor
64585845|NCT00411463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949177|NCT00019058|Antisickling Agents|antisickling agents|mesh-ancestor
64949178|NCT00019058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949179|NCT00019058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949180|NCT00019058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64949181|NCT00019058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64949182|NCT00019058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64949183|NCT00019058|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64949184|NCT00019058|Protective Agents|protective agents|mesh-ancestor
64949185|NCT00019058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949186|NCT00019058|Vasodilator Agents|vasodilator agents|mesh-ancestor
64949187|NCT00019058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64949188|NCT00019058|Antioxidants|antioxidants|mesh-ancestor
64949189|NCT00039039|Paclitaxel|paclitaxel|mesh-list
64949190|NCT00039039|Carboplatin|carboplatin|mesh-list
64949191|NCT00039039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64949192|NCT00039039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949193|NCT00039039|Tubulin Modulators|tubulin modulators|mesh-ancestor
64949194|NCT00039039|Antimitotic Agents|antimitotic agents|mesh-ancestor
64949195|NCT00039039|Mitosis Modulators|mitosis modulators|mesh-ancestor
64949196|NCT00039039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949197|NCT00019097|Melphalan|melphalan|mesh-list
64949198|NCT00019097|Sargramostim|sargramostim|mesh-list
64949199|NCT00019097|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
64949200|NCT00019097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64725378|NCT00002407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64725379|NCT00002407|Protease Inhibitors|protease inhibitors|mesh-ancestor
64725380|NCT00002413|Emivirine|emivirine|mesh-list
64725381|NCT00002413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64725382|NCT00002413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64725383|NCT00002413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031772|NCT02902666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65031773|NCT02902666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031774|NCT02902666|Antipyretics|antipyretics|mesh-ancestor
65031775|NCT02902666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65031776|NCT02902666|Narcotics|narcotics|mesh-ancestor
65031777|NCT02902666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65031778|NCT02902666|Antitussive Agents|antitussive agents|mesh-ancestor
65031779|NCT02902666|Respiratory System Agents|respiratory system agents|mesh-ancestor
65031780|NCT02902354|Nifedipine|nifedipine|mesh-list
65031781|NCT02902354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65031782|NCT02902354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65031783|NCT02902354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031784|NCT02902354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65031785|NCT02902354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585856|NCT01793077|Leuprolide|leuprolide|mesh-list
64725384|NCT00002413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949201|NCT00019097|Alkylating Agents|alkylating agents|mesh-ancestor
64949202|NCT00019097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949203|NCT00019097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949204|NCT00019097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64949205|NCT00019097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64949206|NCT00019097|Immunologic Factors|immunologic factors|mesh-ancestor
64949207|NCT00019097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949208|NCT00019097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64949209|NCT00019136|Aldesleukin|aldesleukin|mesh-list
64949210|NCT00019136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949211|NCT00019136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64949212|NCT00019136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64949213|NCT00019136|Antiviral Agents|antiviral agents|mesh-ancestor
64949228|NCT00039117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64949229|NCT00039117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64420202|NCT05497063|Pyrimethamine|pyrimethamine|mesh-list
64949249|NCT00039234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64949250|NCT00039234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64949251|NCT00039234|Antiviral Agents|antiviral agents|mesh-ancestor
64949252|NCT00039234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949253|NCT00039234|Histamine Agonists|histamine agonists|mesh-ancestor
64949254|NCT00039234|Histamine Agents|histamine agents|mesh-ancestor
64949255|NCT00039234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64949256|NCT00039234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949257|NCT00039234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949258|NCT00019331|Aldesleukin|aldesleukin|mesh-list
64949259|NCT00019331|Sargramostim|sargramostim|mesh-list
64949260|NCT00019331|Immunologic Factors|immunologic factors|mesh-ancestor
64949261|NCT00019331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949262|NCT00019331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949263|NCT00019331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64949264|NCT00019331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64949265|NCT00019331|Antiviral Agents|antiviral agents|mesh-ancestor
64503326|NCT03348696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64949266|NCT00019331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64503327|NCT03348696|Antiemetics|antiemetics|mesh-ancestor
64503328|NCT03348696|Autonomic Agents|autonomic agents|mesh-ancestor
64949267|NCT00039273|Panitumumab|panitumumab|mesh-list
64949268|NCT00039273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64949269|NCT00039273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949270|NCT00019409|Cytarabine|cytarabine|mesh-list
64949271|NCT00019409|Prednisone|prednisone|mesh-list
64949272|NCT00019409|Hydrocortisone|hydrocortisone|mesh-list
65031786|NCT02902354|Vasodilator Agents|vasodilator agents|mesh-ancestor
65031787|NCT02902354|Tocolytic Agents|tocolytic agents|mesh-ancestor
65031788|NCT02902354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65031789|NCT00168623|Vitamin A|vitamin a|mesh-list
65031790|NCT00168623|Vitamins|vitamins|mesh-ancestor
65031791|NCT00168623|Micronutrients|micronutrients|mesh-ancestor
65031792|NCT00168623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031793|NCT02902315|Vitamins|vitamins|mesh-list
65031794|NCT02902315|Ascorbic Acid|ascorbic acid|mesh-list
65031795|NCT02902315|Tocopherols|tocopherols|mesh-list
65031796|NCT02902315|alpha-Tocopherol|alpha-tocopherol|mesh-list
65031798|NCT02902315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031799|NCT02902315|Antioxidants|antioxidants|mesh-ancestor
65031800|NCT02902315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031801|NCT02902315|Protective Agents|protective agents|mesh-ancestor
65031802|NCT02902432|Endostar protein|endostar protein|mesh-list
65031803|NCT02902432|Endostatins|endostatins|mesh-list
64949273|NCT00019409|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64949274|NCT00019409|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64949291|NCT00019409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64725385|NCT00002413|Antiviral Agents|antiviral agents|mesh-ancestor
64725386|NCT00002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725388|NCT00002419|Abacavir|abacavir|mesh-list
64949292|NCT00019409|Glucocorticoids|glucocorticoids|mesh-ancestor
64949293|NCT00019409|Hormones|hormones|mesh-ancestor
64949294|NCT00019409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64949295|NCT00019409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64949296|NCT00019409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64949297|NCT00019409|Abortifacient Agents|abortifacient agents|mesh-ancestor
64949298|NCT00019409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64949299|NCT00019409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64949300|NCT00019409|Antimetabolites|antimetabolites|mesh-ancestor
64949301|NCT00019409|Dermatologic Agents|dermatologic agents|mesh-ancestor
64949308|NCT00019409|Tubulin Modulators|tubulin modulators|mesh-ancestor
64949309|NCT00019409|Antimitotic Agents|antimitotic agents|mesh-ancestor
64949310|NCT00019409|Mitosis Modulators|mitosis modulators|mesh-ancestor
64949311|NCT00019409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64949312|NCT00019409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64949313|NCT00019409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64949314|NCT00019448|Interleukin-2|interleukin-2|mesh-list
64949315|NCT00019448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949316|NCT00019448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64949317|NCT00019448|Analgesics|analgesics|mesh-ancestor
64949318|NCT00019448|Sensory System Agents|sensory system agents|mesh-ancestor
64949319|NCT00019448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64949320|NCT00019448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949321|NCT00019487|Aldesleukin|aldesleukin|mesh-list
64949322|NCT00019487|Freund's Adjuvant|freund's adjuvant|mesh-list
64949323|NCT00019487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949324|NCT00019487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64949325|NCT00019487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64949326|NCT00019487|Antiviral Agents|antiviral agents|mesh-ancestor
64949327|NCT00019487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949328|NCT00019487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64949329|NCT00019487|Immunologic Factors|immunologic factors|mesh-ancestor
64949330|NCT00019487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949331|NCT00039351|Prednisone|prednisone|mesh-list
64949332|NCT00039351|Cyclophosphamide|cyclophosphamide|mesh-list
64949333|NCT00039351|Vincristine|vincristine|mesh-list
64949334|NCT00039351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64949346|NCT00039351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64949348|NCT00039351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64585884|NCT00365599|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65031804|NCT02902432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65031805|NCT02902432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65031806|NCT02902432|Growth Substances|growth substances|mesh-ancestor
65031807|NCT02902432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031808|NCT02902432|Growth Inhibitors|growth inhibitors|mesh-ancestor
65031809|NCT02902432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031810|NCT00168701|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65031811|NCT00168701|Dermatologic Agents|dermatologic agents|mesh-ancestor
65031812|NCT00168701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65031813|NCT00168701|Immunologic Factors|immunologic factors|mesh-ancestor
65031814|NCT00168701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031815|NCT02902042|Pembrolizumab|pembrolizumab|mesh-list
65031816|NCT02902042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65031817|NCT02902042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031818|NCT00168740|Rituximab|rituximab|mesh-list
65031819|NCT00168740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64585885|NCT00365599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64949349|NCT00039351|Tubulin Modulators|tubulin modulators|mesh-ancestor
64949350|NCT00039351|Antimitotic Agents|antimitotic agents|mesh-ancestor
64949351|NCT00039351|Mitosis Modulators|mitosis modulators|mesh-ancestor
64949352|NCT00019565|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64949353|NCT00019565|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64949354|NCT00019565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949355|NCT00039390|Capecitabine|capecitabine|mesh-list
64949356|NCT00039390|Gefitinib|gefitinib|mesh-list
64949357|NCT00039390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64949358|NCT00039390|Antimetabolites|antimetabolites|mesh-ancestor
64949359|NCT00039390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949360|NCT00039390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949361|NCT00039390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64949362|NCT00039390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949363|NCT00039429|Atrasentan|atrasentan|mesh-list
64949364|NCT00039429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949365|NCT00039429|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64949366|NCT00039429|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64949367|NCT00039429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949368|NCT00019721|Aldesleukin|aldesleukin|mesh-list
64949369|NCT00019721|Freund's Adjuvant|freund's adjuvant|mesh-list
64949370|NCT00019721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949371|NCT00019721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64725390|NCT00002419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64725391|NCT00002419|Amprenavir|amprenavir|mesh-list
64725392|NCT00002419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64725393|NCT00002419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64725394|NCT00002419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64332913|NCT04416451|Immunologic Factors|immunologic factors|mesh-ancestor
64949372|NCT00019721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64949373|NCT00019721|Antiviral Agents|antiviral agents|mesh-ancestor
64949374|NCT00019721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949375|NCT00019721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64949376|NCT00019721|Immunologic Factors|immunologic factors|mesh-ancestor
64949377|NCT00019721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949383|NCT00019760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64949384|NCT00019760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949385|NCT00019760|Antidotes|antidotes|mesh-ancestor
64949386|NCT00019760|Protective Agents|protective agents|mesh-ancestor
64585900|NCT02104739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031820|NCT00168740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031821|NCT00168740|Immunologic Factors|immunologic factors|mesh-ancestor
65031822|NCT00168740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031823|NCT00168740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65031824|NCT00168779|Valsartan|valsartan|mesh-list
65031825|NCT00168779|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65031826|NCT00168779|Telmisartan|telmisartan|mesh-list
65031827|NCT00168779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65031828|NCT00168779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65031829|NCT00168779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65031830|NCT00168779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031831|NCT00168779|Diuretics|diuretics|mesh-ancestor
65031832|NCT00168779|Natriuretic Agents|natriuretic agents|mesh-ancestor
65031833|NCT00168779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585902|NCT00411619|Everolimus|everolimus|mesh-list
64949387|NCT00019760|Vitamin B Complex|vitamin b complex|mesh-ancestor
64949388|NCT00019760|Vitamins|vitamins|mesh-ancestor
64949389|NCT00019760|Micronutrients|micronutrients|mesh-ancestor
64949390|NCT00019760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64949391|NCT00019760|Alkylating Agents|alkylating agents|mesh-ancestor
64949392|NCT00019760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949393|NCT00019760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949394|NCT00019760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64949395|NCT00019760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64949396|NCT00019760|Immunologic Factors|immunologic factors|mesh-ancestor
64949409|NCT00039468|Leprostatic Agents|leprostatic agents|mesh-ancestor
64949410|NCT00039468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64949411|NCT00039468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949412|NCT00039468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64949413|NCT00039468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64503329|NCT03348696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64949414|NCT00039468|Growth Substances|growth substances|mesh-ancestor
64949415|NCT00039468|Growth Inhibitors|growth inhibitors|mesh-ancestor
64503330|NCT03348696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949417|NCT00019838|Fludarabine phosphate|fludarabine phosphate|mesh-list
64949418|NCT00019838|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
64949419|NCT00019838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949420|NCT00019838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64949421|NCT00019838|Antimetabolites|antimetabolites|mesh-ancestor
64949422|NCT00019838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949423|NCT00019838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64949424|NCT00019838|Immunologic Factors|immunologic factors|mesh-ancestor
64949425|NCT00019838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949426|NCT00019838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64949427|NCT00019838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949428|NCT00019916|Aldesleukin|aldesleukin|mesh-list
64949429|NCT00019916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949430|NCT00019916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64949431|NCT00019916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64949432|NCT00019916|Antiviral Agents|antiviral agents|mesh-ancestor
64949433|NCT00019916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949434|NCT00039546|Gemcitabine|gemcitabine|mesh-list
64949435|NCT00039546|Paclitaxel|paclitaxel|mesh-list
64949436|NCT00039546|Cyclophosphamide|cyclophosphamide|mesh-list
64949437|NCT00039546|Epirubicin|epirubicin|mesh-list
64949438|NCT00039546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64949439|NCT00039546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949440|NCT00039546|Tubulin Modulators|tubulin modulators|mesh-ancestor
64949441|NCT00039546|Antimitotic Agents|antimitotic agents|mesh-ancestor
65031834|NCT00168779|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65031835|NCT00168779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65031836|NCT00168857|Losartan|losartan|mesh-list
65031837|NCT00168857|Telmisartan|telmisartan|mesh-list
65031838|NCT00168857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65031839|NCT00168857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65031840|NCT00168857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65031841|NCT00168857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64585913|NCT00412087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64585914|NCT00412087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64585915|NCT00312923|Policosanol|policosanol|mesh-list
64949442|NCT00039546|Mitosis Modulators|mitosis modulators|mesh-ancestor
64949443|NCT00039546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949444|NCT00039546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64949445|NCT00039546|Immunologic Factors|immunologic factors|mesh-ancestor
64949446|NCT00039546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725395|NCT00002419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725396|NCT00002419|Antiviral Agents|antiviral agents|mesh-ancestor
64725397|NCT00002419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725398|NCT00002419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64725399|NCT00002419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64725400|NCT00002419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64725401|NCT00002419|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64725402|NCT00002419|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64725403|NCT00002419|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64725404|NCT00002419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64725405|NCT00002419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64725406|NCT00002419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64725407|NCT00002419|Antitubercular Agents|antitubercular agents|mesh-ancestor
64725408|NCT00002419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64949450|NCT00039546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64949451|NCT00039546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64949452|NCT00039546|Antimetabolites|antimetabolites|mesh-ancestor
64949453|NCT00039546|Antiviral Agents|antiviral agents|mesh-ancestor
64949454|NCT00039546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949455|NCT00039546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949456|NCT00039546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64949457|NCT00039546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64949477|NCT00039663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64949478|NCT00039663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949479|NCT00039663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64949480|NCT00039663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64949481|NCT00039663|Antimetabolites|antimetabolites|mesh-ancestor
64949482|NCT00039663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949483|NCT00039663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64949484|NCT00039663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64949485|NCT00039663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949486|NCT00039663|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64949487|NCT00039663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64949488|NCT00020111|Arsenic Trioxide|arsenic trioxide|mesh-list
64949489|NCT00020111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949490|NCT00020150|Temozolomide|temozolomide|mesh-list
64949491|NCT00020150|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64503331|NCT03348696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64949492|NCT00020150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64949493|NCT00020150|Alkylating Agents|alkylating agents|mesh-ancestor
64949494|NCT00020150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949495|NCT00020150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949496|NCT00020150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949497|NCT00039858|Argatroban|argatroban|mesh-list
64949498|NCT00039858|Antithrombins|antithrombins|mesh-ancestor
64585921|NCT00312923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65031842|NCT00168857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031843|NCT00196131|Morphine|morphine|mesh-list
65031844|NCT00196131|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65031845|NCT00196131|Narcotics|narcotics|mesh-ancestor
65031846|NCT00196131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65031847|NCT00196131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031848|NCT00196131|Analgesics|analgesics|mesh-ancestor
65031849|NCT00196131|Sensory System Agents|sensory system agents|mesh-ancestor
65031850|NCT00196131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65031851|NCT00168896|Carboplatin|carboplatin|mesh-list
65031852|NCT00168896|Irinotecan|irinotecan|mesh-list
65031853|NCT00168896|Etoposide|etoposide|mesh-list
65031854|NCT00168896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031855|NCT00168896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65031856|NCT00168896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65031857|NCT00168896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031858|NCT00168896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031859|NCT00168896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65031860|NCT00168896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65031861|NCT02901418|Immunoglobulins|immunoglobulins|mesh-list
65031862|NCT02901418|Immunologic Factors|immunologic factors|mesh-ancestor
65031863|NCT02901418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031864|NCT02901379|Atorvastatin|atorvastatin|mesh-list
64585922|NCT00412243|Cyclophosphamide|cyclophosphamide|mesh-list
64949499|NCT00039858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64725413|NCT00381511|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64725415|NCT00381511|Dalteparin|dalteparin|mesh-list
64725416|NCT00381511|Anticoagulants|anticoagulants|mesh-ancestor
64725417|NCT00381511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64725418|NCT00381511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64725419|NCT00381511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949500|NCT00039858|Protease Inhibitors|protease inhibitors|mesh-ancestor
64949501|NCT00039858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949502|NCT00039858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949503|NCT00039858|Anticoagulants|anticoagulants|mesh-ancestor
64949504|NCT00039858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64949505|NCT00020189|Aspirin|aspirin|mesh-list
64949506|NCT00020189|Alvocidib|alvocidib|mesh-list
64949507|NCT00020189|Clopidogrel|clopidogrel|mesh-list
64949508|NCT00020189|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64949509|NCT00020189|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64949510|NCT00020189|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64949511|NCT00020189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64949512|NCT00020189|Purinergic Agents|purinergic agents|mesh-ancestor
64949513|NCT00020189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64949523|NCT00020189|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64949524|NCT00020189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64949525|NCT00020189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64949526|NCT00020189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585943|NCT00315341|Narcotics|narcotics|mesh-ancestor
65031865|NCT02901379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64585944|NCT00315341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65031866|NCT02901379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65031867|NCT02901379|Antimetabolites|antimetabolites|mesh-ancestor
65031868|NCT02901379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031869|NCT02901379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65031870|NCT02901379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65031871|NCT02901379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031873|NCT02901106|Dermatologic Agents|dermatologic agents|mesh-ancestor
65031874|NCT02901106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65031875|NCT02901106|Immunologic Factors|immunologic factors|mesh-ancestor
65031876|NCT02901106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031878|NCT02901145|Nivolumab|nivolumab|mesh-list
65031879|NCT02901145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65031880|NCT02901145|Immunologic Factors|immunologic factors|mesh-ancestor
65031881|NCT02901145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031882|NCT02901145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64949527|NCT00020189|Antipyretics|antipyretics|mesh-ancestor
64949528|NCT00020189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949529|NCT00020189|Growth Inhibitors|growth inhibitors|mesh-ancestor
64949530|NCT00020189|Growth Substances|growth substances|mesh-ancestor
64949535|NCT00039975|Diltiazem|diltiazem|mesh-list
64949536|NCT00039975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64949537|NCT00039975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64949538|NCT00039975|Protease Inhibitors|protease inhibitors|mesh-ancestor
64949539|NCT00039975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949540|NCT00039975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949541|NCT00039975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64949542|NCT00039975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64949543|NCT00039975|Antiviral Agents|antiviral agents|mesh-ancestor
64949544|NCT00039975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949545|NCT00039975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64949546|NCT00039975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64949547|NCT00039975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64949548|NCT00039975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64949549|NCT00039975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64949550|NCT00039975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64949551|NCT00039975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949552|NCT00039975|Vasodilator Agents|vasodilator agents|mesh-ancestor
64949553|NCT00020267|Interleukin-2|interleukin-2|mesh-list
64949554|NCT00020267|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64949555|NCT00020267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949556|NCT00020267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64949557|NCT00020267|Analgesics|analgesics|mesh-ancestor
64949558|NCT00020267|Sensory System Agents|sensory system agents|mesh-ancestor
64949559|NCT00020267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64949560|NCT00020267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949561|NCT00020267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64949562|NCT00020267|Immunologic Factors|immunologic factors|mesh-ancestor
64949563|NCT00040014|Exemestane|exemestane|mesh-list
64949564|NCT00040014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949565|NCT00040014|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64488381|NCT02241460|Lidocaine|lidocaine|mesh-list
64949566|NCT00040014|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64949567|NCT00040014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585960|NCT04767542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031883|NCT02901145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65031884|NCT02901145|Alkylating Agents|alkylating agents|mesh-ancestor
65031885|NCT02901145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031886|NCT02901145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031887|NCT02901145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65031888|NCT02901145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65031889|NCT02901145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65031890|NCT02901301|Pembrolizumab|pembrolizumab|mesh-list
65031891|NCT02901301|Capecitabine|capecitabine|mesh-list
65031892|NCT02901301|Trastuzumab|trastuzumab|mesh-list
65031893|NCT02901301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031894|NCT02901301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65031895|NCT02901301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65031896|NCT02901301|Antimetabolites|antimetabolites|mesh-ancestor
65031897|NCT02901301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031898|NCT00169013|Gabapentin|gabapentin|mesh-list
65031899|NCT00169013|Analgesics|analgesics|mesh-ancestor
65031900|NCT00169013|Sensory System Agents|sensory system agents|mesh-ancestor
65031901|NCT00169013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65031902|NCT00169013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031903|NCT00169013|Anticonvulsants|anticonvulsants|mesh-ancestor
65031904|NCT00169013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65031905|NCT00169013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65031906|NCT00169013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65031907|NCT00169013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65031908|NCT00169013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64949568|NCT00040014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949569|NCT00040014|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64949570|NCT00040014|Hormone Antagonists|hormone antagonists|mesh-ancestor
64725420|NCT00002425|Saquinavir|saquinavir|mesh-list
64725421|NCT00002425|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64725422|NCT00002425|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64725423|NCT00002425|Protease Inhibitors|protease inhibitors|mesh-ancestor
64725424|NCT00002425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725425|NCT00002425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725426|NCT00002425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64725427|NCT00002425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64725428|NCT00002425|Antiviral Agents|antiviral agents|mesh-ancestor
64725429|NCT00002425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725430|NCT00002425|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64725431|NCT00002425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64949571|NCT00040014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64949572|NCT00040014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031909|NCT00169013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64585986|NCT01794533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65031910|NCT00169013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65031911|NCT00169013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031912|NCT00169013|Antimanic Agents|antimanic agents|mesh-ancestor
65031913|NCT00169091|Haloperidol|haloperidol|mesh-list
65031914|NCT00169091|Haloperidol decanoate|haloperidol decanoate|mesh-list
65031915|NCT00169091|Clozapine|clozapine|mesh-list
65031916|NCT00169091|Antiemetics|antiemetics|mesh-ancestor
65031917|NCT00169091|Autonomic Agents|autonomic agents|mesh-ancestor
65031918|NCT00169091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65031919|NCT00169091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031920|NCT00169091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65031921|NCT00169091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65031922|NCT00169091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65031923|NCT00169091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65031924|NCT00169091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65031925|NCT00169091|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65031926|NCT00169091|Dopamine Agents|dopamine agents|mesh-ancestor
65031927|NCT00169091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65031928|NCT00169091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031929|NCT00169091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65031930|NCT00169091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65031931|NCT00169091|Serotonin Agents|serotonin agents|mesh-ancestor
65031932|NCT00169091|GABA Antagonists|gaba antagonists|mesh-ancestor
65031933|NCT00169091|GABA Agents|gaba agents|mesh-ancestor
65031934|NCT00169130|Cyclophosphamide|cyclophosphamide|mesh-list
65031935|NCT00169130|Doxorubicin|doxorubicin|mesh-list
64949573|NCT00020345|Gemcitabine|gemcitabine|mesh-list
64949574|NCT00020345|Fluorouracil|fluorouracil|mesh-list
64949575|NCT00020345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64949576|NCT00020345|Antimetabolites|antimetabolites|mesh-ancestor
64949577|NCT00020345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949608|NCT00020501|Leucovorin|leucovorin|mesh-list
64949609|NCT00020501|Fluorouracil|fluorouracil|mesh-list
64949610|NCT00020501|Floxuridine|floxuridine|mesh-list
64949611|NCT00020501|Irinotecan|irinotecan|mesh-list
64949612|NCT00020501|Melphalan|melphalan|mesh-list
64949613|NCT00020501|Calcium|calcium|mesh-list
64949614|NCT00020501|Levoleucovorin|levoleucovorin|mesh-list
64949615|NCT00020501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64949616|NCT00020501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949617|NCT00020501|Antimetabolites|antimetabolites|mesh-ancestor
64949618|NCT00020501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949619|NCT00020501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64949620|NCT00020501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949639|NCT00020540|Protective Agents|protective agents|mesh-ancestor
64949640|NCT00020579|Entinostat|entinostat|mesh-list
64949641|NCT00020579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586012|NCT01730833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031936|NCT00169130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65031937|NCT00169130|Immunologic Factors|immunologic factors|mesh-ancestor
65031938|NCT00169130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031939|NCT00169130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65031940|NCT00169130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65031941|NCT00169130|Alkylating Agents|alkylating agents|mesh-ancestor
65031942|NCT00169130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031943|NCT00169130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031944|NCT00169130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65031945|NCT00169130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64905744|NCT00006343|Cytarabine|cytarabine|mesh-list
65031946|NCT00169130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65031947|NCT00169130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65031948|NCT00169130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031949|NCT00178620|Reteplase|reteplase|mesh-list
65031950|NCT00178620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65031951|NCT00178620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65031952|NCT00178620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031953|NCT00169169|Rituximab|rituximab|mesh-list
65031954|NCT00169169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65031955|NCT00169169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031956|NCT00169169|Immunologic Factors|immunologic factors|mesh-ancestor
65031957|NCT00169169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031958|NCT00169169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65031959|NCT00169208|Rituximab|rituximab|mesh-list
65031960|NCT00169208|Fludarabine|fludarabine|mesh-list
65031961|NCT00169208|Mitoxantrone|mitoxantrone|mesh-list
65031962|NCT00169208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64949642|NCT00020579|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64949643|NCT00020579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949644|NCT00020579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949646|NCT00040209|Apomorphine|apomorphine|mesh-list
64949647|NCT00040209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64949648|NCT00040209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64949649|NCT00040209|Dopamine Agents|dopamine agents|mesh-ancestor
64949650|NCT00040209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64949651|NCT00040209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949652|NCT00040209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949653|NCT00040209|Emetics|emetics|mesh-ancestor
64949654|NCT00040209|Autonomic Agents|autonomic agents|mesh-ancestor
64949655|NCT00040209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64949656|NCT00040209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64949657|NCT00040209|Dopamine Agonists|dopamine agonists|mesh-ancestor
64949658|NCT00040248|Daclizumab|daclizumab|mesh-list
65031963|NCT00169208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031964|NCT00169208|Immunologic Factors|immunologic factors|mesh-ancestor
65031965|NCT00169208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031966|NCT00169208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65031967|NCT00169208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031968|NCT00169208|Analgesics|analgesics|mesh-ancestor
65031969|NCT00169208|Sensory System Agents|sensory system agents|mesh-ancestor
65031970|NCT00169208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65031971|NCT00169208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65031972|NCT00169208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65031973|NCT00169208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031974|NCT00178698|Gemcitabine|gemcitabine|mesh-list
65031975|NCT00178698|Interferons|interferons|mesh-list
65031976|NCT00178698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586045|NCT03636503|Rituximab|rituximab|mesh-list
64949659|NCT00040248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64949660|NCT00040248|Immunologic Factors|immunologic factors|mesh-ancestor
64949661|NCT00040248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949662|NCT00020618|Morphine|morphine|mesh-list
64949663|NCT00020618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64725432|NCT00002431|Chlorhexidine|chlorhexidine|mesh-list
64725433|NCT00002431|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64725434|NCT00002431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64725435|NCT00002431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725436|NCT00002431|Disinfectants|disinfectants|mesh-ancestor
64725437|NCT00002431|Dermatologic Agents|dermatologic agents|mesh-ancestor
64949664|NCT00020618|Narcotics|narcotics|mesh-ancestor
64949665|NCT00020618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64949666|NCT00020618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949667|NCT00020618|Analgesics|analgesics|mesh-ancestor
64949668|NCT00020618|Sensory System Agents|sensory system agents|mesh-ancestor
64949669|NCT00020618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64949670|NCT00020657|Ondansetron|ondansetron|mesh-list
64949671|NCT00020657|Granisetron|granisetron|mesh-list
64949672|NCT00020657|Prochlorperazine|prochlorperazine|mesh-list
64949673|NCT00020657|Dolasetron|dolasetron|mesh-list
64949674|NCT00020657|Antiemetics|antiemetics|mesh-ancestor
64949675|NCT00020657|Autonomic Agents|autonomic agents|mesh-ancestor
64949676|NCT00020657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64949677|NCT00020657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949678|NCT00020657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64949679|NCT00020657|Antipruritics|antipruritics|mesh-ancestor
64949680|NCT00020657|Dermatologic Agents|dermatologic agents|mesh-ancestor
64949681|NCT00020657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64949682|NCT00020657|Serotonin Agents|serotonin agents|mesh-ancestor
64949683|NCT00020657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64949684|NCT00020657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949685|NCT00020657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64949686|NCT00020657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64949687|NCT00020657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64949688|NCT00020657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64949689|NCT00020657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64949690|NCT00020657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64949719|NCT00040482|Alkylating Agents|alkylating agents|mesh-ancestor
64949720|NCT00040482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949721|NCT00040482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949722|NCT00040482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64949724|NCT00020774|Lonafarnib|lonafarnib|mesh-list
64949725|NCT00020774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64949726|NCT00020774|Antimetabolites|antimetabolites|mesh-ancestor
64420324|NCT00609115|Antifungal Agents|antifungal agents|mesh-ancestor
64949734|NCT00020774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949735|NCT00040521|Oprelvekin|oprelvekin|mesh-list
65031977|NCT00178698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64586053|NCT03448159|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64586054|NCT03448159|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65031978|NCT00178698|Antimetabolites|antimetabolites|mesh-ancestor
65031979|NCT00178698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65031980|NCT00178698|Antiviral Agents|antiviral agents|mesh-ancestor
65031981|NCT00178698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65031982|NCT00178698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65031983|NCT00178698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65031984|NCT00178698|Immunologic Factors|immunologic factors|mesh-ancestor
65031985|NCT00178698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031986|NCT00169247|Cetuximab|cetuximab|mesh-list
65031987|NCT00169247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65031988|NCT00169247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65031989|NCT02899702|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65031990|NCT02899702|Immunologic Factors|immunologic factors|mesh-ancestor
65031991|NCT02899702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65031992|NCT02899507|Amoxicillin|amoxicillin|mesh-list
65031993|NCT02899507|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65031994|NCT02899507|Clavulanic Acids|clavulanic acids|mesh-list
65031995|NCT02899507|Clavulanic Acid|clavulanic acid|mesh-list
65031996|NCT02899507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65031997|NCT02899507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65031998|NCT02899507|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65031999|NCT02899507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032000|NCT02899507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032001|NCT00178854|Risperidone|risperidone|mesh-list
65032002|NCT00178854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65032003|NCT00178854|Serotonin Agents|serotonin agents|mesh-ancestor
65032004|NCT00178854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65032005|NCT00178854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949753|NCT00040794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949754|NCT00040794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64949756|NCT00021047|Carboplatin|carboplatin|mesh-list
64949757|NCT00021047|Capecitabine|capecitabine|mesh-list
64949758|NCT00021047|Epirubicin|epirubicin|mesh-list
64949759|NCT00021047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949760|NCT00021047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64949761|NCT00021047|Antimetabolites|antimetabolites|mesh-ancestor
64949762|NCT00021047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949763|NCT00021047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64586081|NCT01792037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65032006|NCT00178854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586082|NCT01792037|Prednisolone|prednisolone|mesh-list
65032007|NCT00178854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65032008|NCT00178854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65032009|NCT00178854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65032010|NCT00178854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65032011|NCT00178854|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65032012|NCT00178854|Dopamine Agents|dopamine agents|mesh-ancestor
65032013|NCT00196365|Levonorgestrel|levonorgestrel|mesh-list
65032014|NCT00196365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65032015|NCT00196365|Contraceptive Agents|contraceptive agents|mesh-ancestor
65032016|NCT00196365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65032017|NCT00196365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032018|NCT00196365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65032019|NCT00196365|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65032020|NCT00196365|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65032022|NCT02898961|Amikacin|amikacin|mesh-list
65032023|NCT02898961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65032024|NCT02898961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032025|NCT02898961|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64517201|NCT01229943|Octreotide|octreotide|mesh-list
65032026|NCT02898961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032027|NCT02898961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032029|NCT00553618|Interleukin-2|interleukin-2|mesh-list
65032030|NCT00553618|Dacarbazine|dacarbazine|mesh-list
65032031|NCT00553618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032032|NCT00553618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65032033|NCT00553618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64949764|NCT00021047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64949765|NCT00021047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64949766|NCT00021047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949767|NCT00021164|Aldesleukin|aldesleukin|mesh-list
64949768|NCT00021164|Freund's Adjuvant|freund's adjuvant|mesh-list
64949769|NCT00021164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949770|NCT00021164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64949771|NCT00021164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64949772|NCT00021164|Antiviral Agents|antiviral agents|mesh-ancestor
64949773|NCT00021164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949774|NCT00021164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64725439|NCT00002077|Antifungal Agents|antifungal agents|mesh-ancestor
64725440|NCT00002077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725441|NCT00002077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64332963|NCT03528421|Fludarabine|fludarabine|mesh-list
64949775|NCT00021164|Immunologic Factors|immunologic factors|mesh-ancestor
64949776|NCT00021164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949777|NCT00040872|Cyclophosphamide|cyclophosphamide|mesh-list
64949778|NCT00040872|Thiotepa|thiotepa|mesh-list
65032034|NCT00553618|Antiviral Agents|antiviral agents|mesh-ancestor
64586107|NCT01792037|Glucocorticoids|glucocorticoids|mesh-ancestor
65032035|NCT00553618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032036|NCT00553618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65032037|NCT00553618|Analgesics|analgesics|mesh-ancestor
65032038|NCT00553618|Sensory System Agents|sensory system agents|mesh-ancestor
65032039|NCT00553618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65032040|NCT00553618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032041|NCT00553618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65032042|NCT00553618|Alkylating Agents|alkylating agents|mesh-ancestor
65032043|NCT00553618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032044|NCT02898376|Tocopherols|tocopherols|mesh-list
65032045|NCT02898376|Vitamin E|vitamin e|mesh-list
65032046|NCT02898376|Tocotrienols|tocotrienols|mesh-list
65032047|NCT02898376|alpha-Tocopherol|alpha-tocopherol|mesh-list
65032048|NCT02898376|Pentoxifylline|pentoxifylline|mesh-list
65032049|NCT02898376|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65032050|NCT02898376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032051|NCT02898376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032052|NCT02898376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65032053|NCT02898376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65032054|NCT02898376|Protective Agents|protective agents|mesh-ancestor
65032055|NCT02898376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032056|NCT02898376|Vasodilator Agents|vasodilator agents|mesh-ancestor
65032057|NCT02898376|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65032058|NCT02898376|Antioxidants|antioxidants|mesh-ancestor
65032059|NCT02898376|Vitamins|vitamins|mesh-ancestor
65032060|NCT02898376|Micronutrients|micronutrients|mesh-ancestor
65032061|NCT00408174|Balsalazide|balsalazide|mesh-list
65032062|NCT00408174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65032063|NCT00408174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65032064|NCT00408174|Analgesics|analgesics|mesh-ancestor
65032065|NCT00408174|Sensory System Agents|sensory system agents|mesh-ancestor
65032066|NCT00408174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65032067|NCT00408174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032071|NCT00169520|Docetaxel|docetaxel|mesh-list
65032073|NCT00169520|Tubulin Modulators|tubulin modulators|mesh-ancestor
65032074|NCT00169520|Antimitotic Agents|antimitotic agents|mesh-ancestor
65032075|NCT00169520|Mitosis Modulators|mitosis modulators|mesh-ancestor
65032076|NCT00169520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032077|NCT02897986|Vinorelbine|vinorelbine|mesh-list
65032078|NCT02897986|Propranolol|propranolol|mesh-list
65032079|NCT02897986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65032080|NCT02897986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032081|NCT02897986|Tubulin Modulators|tubulin modulators|mesh-ancestor
65032082|NCT02897986|Antimitotic Agents|antimitotic agents|mesh-ancestor
65032083|NCT02897986|Mitosis Modulators|mitosis modulators|mesh-ancestor
65032084|NCT02897986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032085|NCT02897986|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65032086|NCT02897986|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65032087|NCT02897986|Adrenergic Agents|adrenergic agents|mesh-ancestor
64949779|NCT00040872|Carboplatin|carboplatin|mesh-list
64949780|NCT00040872|Doxorubicin|doxorubicin|mesh-list
64949781|NCT00040872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64949782|NCT00040872|Etoposide|etoposide|mesh-list
64949783|NCT00040872|Vincristine|vincristine|mesh-list
64949784|NCT00040872|Topotecan|topotecan|mesh-list
64949785|NCT00040872|Isotretinoin|isotretinoin|mesh-list
64949786|NCT00040872|Antibodies|antibodies|mesh-list
64949787|NCT00040872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64949788|NCT00040872|Sargramostim|sargramostim|mesh-list
64949789|NCT00040872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64488613|NCT02982850|Aspirin|aspirin|mesh-list
64949790|NCT00040872|Immunologic Factors|immunologic factors|mesh-ancestor
64949791|NCT00040872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949792|NCT00040872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64949793|NCT00040872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64949794|NCT00040872|Alkylating Agents|alkylating agents|mesh-ancestor
64503332|NCT03348696|Glucocorticoids|glucocorticoids|mesh-ancestor
64949795|NCT00040872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949814|NCT00040950|Rituximab|rituximab|mesh-list
64949815|NCT00040950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64949816|NCT00040950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949817|NCT00040950|Immunologic Factors|immunologic factors|mesh-ancestor
64949818|NCT00040950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949819|NCT00040950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64949820|NCT00040989|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64949821|NCT00040989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949822|NCT00021281|Leucovorin|leucovorin|mesh-list
64949823|NCT00021281|Fluorouracil|fluorouracil|mesh-list
64949824|NCT00021281|Irinotecan|irinotecan|mesh-list
64949825|NCT00021281|Calcium|calcium|mesh-list
64949826|NCT00021281|Levoleucovorin|levoleucovorin|mesh-list
64949827|NCT00021281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64420334|NCT04085887|Panitumumab|panitumumab|mesh-list
64949832|NCT00021281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949833|NCT00021281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64949834|NCT00021281|Immunologic Factors|immunologic factors|mesh-ancestor
64949835|NCT00021281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64949836|NCT00021281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64949837|NCT00021281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949839|NCT00021281|Protective Agents|protective agents|mesh-ancestor
64949840|NCT00021281|Vitamin B Complex|vitamin b complex|mesh-ancestor
64949841|NCT00021281|Vitamins|vitamins|mesh-ancestor
64949842|NCT00021281|Micronutrients|micronutrients|mesh-ancestor
64949843|NCT00041106|Gemcitabine|gemcitabine|mesh-list
64949844|NCT00041106|Gefitinib|gefitinib|mesh-list
64949845|NCT00041106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949846|NCT00041106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64949847|NCT00041106|Antimetabolites|antimetabolites|mesh-ancestor
65032088|NCT02897986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64586158|NCT03855371|Arsenic Trioxide|arsenic trioxide|mesh-list
65032089|NCT02897986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032090|NCT02897986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65032091|NCT02897986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65032092|NCT02897986|Vasodilator Agents|vasodilator agents|mesh-ancestor
65032093|NCT00169559|Fenofibrate|fenofibrate|mesh-list
65032094|NCT00169559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65032095|NCT00169559|Antimetabolites|antimetabolites|mesh-ancestor
65032096|NCT00169559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032097|NCT00169559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65032098|NCT00408213|Mycophenolic Acid|mycophenolic acid|mesh-list
65032099|NCT00408213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65032100|NCT00408213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032101|NCT00408213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65032102|NCT00408213|Antitubercular Agents|antitubercular agents|mesh-ancestor
65032103|NCT00408213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65032104|NCT00408213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032105|NCT00408213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032106|NCT00408213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032107|NCT00408252|Sunitinib|sunitinib|mesh-list
65032108|NCT00408252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032109|NCT00408252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65032110|NCT00408252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65032111|NCT00408252|Growth Substances|growth substances|mesh-ancestor
65032112|NCT00408252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032113|NCT00408252|Growth Inhibitors|growth inhibitors|mesh-ancestor
65032114|NCT00408252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65032115|NCT00408252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586159|NCT03855371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64949848|NCT00041106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949849|NCT00041106|Antiviral Agents|antiviral agents|mesh-ancestor
64949850|NCT00041106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949851|NCT00041106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949852|NCT00041106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64949866|NCT00021320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64503333|NCT03348696|Hormones|hormones|mesh-ancestor
64949868|NCT00021320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949869|NCT00041223|Proanthocyanidin|proanthocyanidin|mesh-list
64949870|NCT00041223|Procyanidin|procyanidin|mesh-list
64503334|NCT03348696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64488753|NCT04878315|Protease Inhibitors|protease inhibitors|mesh-ancestor
64949871|NCT00041223|Antioxidants|antioxidants|mesh-ancestor
64725442|NCT00002077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65032116|NCT00408252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586185|NCT00418951|Voriconazole|voriconazole|mesh-list
65032117|NCT02897869|Amikacin|amikacin|mesh-list
65032118|NCT02897869|Murepavadin|murepavadin|mesh-list
65032119|NCT02897869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65032120|NCT02897869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032121|NCT02897830|Dexamethasone|dexamethasone|mesh-list
65032122|NCT02897830|Lenalidomide|lenalidomide|mesh-list
65032123|NCT02897830|Ixazomib|ixazomib|mesh-list
65032124|NCT02897830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65032125|NCT02897830|Antiemetics|antiemetics|mesh-ancestor
65032126|NCT02897830|Autonomic Agents|autonomic agents|mesh-ancestor
65032127|NCT02897830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65032128|NCT02897830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032129|NCT02897830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65032130|NCT02897830|Glucocorticoids|glucocorticoids|mesh-ancestor
65032131|NCT02897830|Hormones|hormones|mesh-ancestor
65032132|NCT02897830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65032133|NCT02897830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65032134|NCT02897830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032135|NCT02897830|Immunologic Factors|immunologic factors|mesh-ancestor
65032136|NCT02897830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65032137|NCT02897830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64586186|NCT00418951|Amphotericin B|amphotericin b|mesh-list
64725443|NCT00002077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725444|NCT00002077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725445|NCT00002077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64725446|NCT00002077|Hormone Antagonists|hormone antagonists|mesh-ancestor
64332967|NCT03528421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64949872|NCT00041223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949873|NCT00041223|Protective Agents|protective agents|mesh-ancestor
64949874|NCT00041223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949875|NCT00041223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64949876|NCT00041223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64949877|NCT00041223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949878|NCT00021359|Dexamethasone|dexamethasone|mesh-list
64949879|NCT00021359|Isotretinoin|isotretinoin|mesh-list
64949880|NCT00021359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64949881|NCT00021359|Antiemetics|antiemetics|mesh-ancestor
64949882|NCT00021359|Autonomic Agents|autonomic agents|mesh-ancestor
64949883|NCT00021359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64949884|NCT00021359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949885|NCT00021359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64949886|NCT00021359|Glucocorticoids|glucocorticoids|mesh-ancestor
64949888|NCT00021359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64949889|NCT00021359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64949890|NCT00021359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949891|NCT00021359|Dermatologic Agents|dermatologic agents|mesh-ancestor
64949892|NCT00041262|Fluorouracil|fluorouracil|mesh-list
64949893|NCT00041262|Epirubicin|epirubicin|mesh-list
64949894|NCT00041262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949895|NCT00041262|Antimetabolites|antimetabolites|mesh-ancestor
64586205|NCT00363077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032138|NCT02897830|Growth Substances|growth substances|mesh-ancestor
65032139|NCT02897830|Growth Inhibitors|growth inhibitors|mesh-ancestor
65032140|NCT02897830|Protease Inhibitors|protease inhibitors|mesh-ancestor
65032141|NCT02897830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032142|NCT02897830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032143|NCT02897557|Pancrelipase|pancrelipase|mesh-list
65032144|NCT02897557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65032145|NCT02897596|Grazoprevir|grazoprevir|mesh-list
65032146|NCT02897596|Antiviral Agents|antiviral agents|mesh-ancestor
65032147|NCT02897596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032148|NCT04681027|Oxymorphone|oxymorphone|mesh-list
65032149|NCT04681027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65032150|NCT04681027|Narcotics|narcotics|mesh-ancestor
65032151|NCT04681027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65032152|NCT04681027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032153|NCT04681027|Analgesics|analgesics|mesh-ancestor
65032154|NCT04681027|Sensory System Agents|sensory system agents|mesh-ancestor
65032155|NCT04681027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65032156|NCT04681027|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65032157|NCT00408330|Azelaic acid|azelaic acid|mesh-list
65032158|NCT00408330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949896|NCT00041262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949897|NCT00041262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64949898|NCT00041262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64949899|NCT00041262|Immunologic Factors|immunologic factors|mesh-ancestor
64949900|NCT00041262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949901|NCT00041262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64949902|NCT00041262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64949903|NCT00041262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64949932|NCT00021554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949934|NCT00049023|Edotreotide|edotreotide|mesh-list
64949935|NCT00049023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64949936|NCT00049023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64949937|NCT00049023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949938|NCT00049023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64949939|NCT00049023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949940|NCT00021671|Metronidazole|metronidazole|mesh-list
64949941|NCT00021671|Nevirapine|nevirapine|mesh-list
64949942|NCT00021671|Erythromycin|erythromycin|mesh-list
64949943|NCT00021671|Erythromycin Estolate|erythromycin estolate|mesh-list
64949944|NCT00021671|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64503335|NCT03348696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64503336|NCT03348696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503337|NCT03348696|Protease Inhibitors|protease inhibitors|mesh-ancestor
64949945|NCT00021671|Erythromycin stearate|erythromycin stearate|mesh-list
64949946|NCT00021671|Ampicillin|ampicillin|mesh-list
64949947|NCT00021671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949948|NCT00021671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64949949|NCT00021671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64949950|NCT00021671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64949951|NCT00021671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64725447|NCT00002077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64725448|NCT00002077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586224|NCT00421603|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65032159|NCT00408330|Dermatologic Agents|dermatologic agents|mesh-ancestor
65032160|NCT00408369|Pafuramidine|pafuramidine|mesh-list
65032161|NCT00408369|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65032162|NCT00408369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65032163|NCT00408369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65032164|NCT00408369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032165|NCT02897206|Imipenem|imipenem|mesh-list
65032166|NCT02897206|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
65032167|NCT02897206|Cilastatin|cilastatin|mesh-list
65032168|NCT02897206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65032169|NCT02897206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032170|NCT02897206|Protease Inhibitors|protease inhibitors|mesh-ancestor
65032171|NCT02897206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032172|NCT02897206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032173|NCT02897401|Carbon Monoxide|carbon monoxide|mesh-list
64586225|NCT00363779|Cyclosporine|cyclosporine|mesh-list
64725449|NCT00002077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64332972|NCT03528421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64949952|NCT00021671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64949953|NCT00021671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949954|NCT00021671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949955|NCT00021671|Antiviral Agents|antiviral agents|mesh-ancestor
64949956|NCT00021671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64949957|NCT00021671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64949958|NCT00021671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64949959|NCT00021671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64949960|NCT00021671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64949961|NCT00021671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64949962|NCT00049062|Gefitinib|gefitinib|mesh-list
64949963|NCT00049062|Anastrozole|anastrozole|mesh-list
64949964|NCT00049062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949980|NCT00049101|Levoleucovorin|levoleucovorin|mesh-list
64949981|NCT00049101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64949982|NCT00049101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949983|NCT00049101|Antimetabolites|antimetabolites|mesh-ancestor
64949984|NCT00049101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949985|NCT00049101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64949986|NCT00049101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949987|NCT00049101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64949988|NCT00049101|Immunologic Factors|immunologic factors|mesh-ancestor
64949989|NCT00049101|Antidotes|antidotes|mesh-ancestor
64949990|NCT00049101|Protective Agents|protective agents|mesh-ancestor
64949991|NCT00049101|Vitamin B Complex|vitamin b complex|mesh-ancestor
64949992|NCT00049101|Vitamins|vitamins|mesh-ancestor
64949993|NCT00049101|Micronutrients|micronutrients|mesh-ancestor
64949994|NCT00049101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64949995|NCT00049101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949996|NCT00394628|Temozolomide|temozolomide|mesh-list
64949997|NCT00394628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64949998|NCT00394628|Alkylating Agents|alkylating agents|mesh-ancestor
64420355|NCT04279561|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64950007|NCT00049179|Antiviral Agents|antiviral agents|mesh-ancestor
64950008|NCT00049179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950009|NCT00049179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64950010|NCT00049179|Immunologic Factors|immunologic factors|mesh-ancestor
64950011|NCT00049179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950012|NCT00049179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64950013|NCT00394745|Valsartan|valsartan|mesh-list
65032174|NCT02897401|Antimetabolites|antimetabolites|mesh-ancestor
65032175|NCT02897401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032176|NCT02897401|Gasotransmitters|gasotransmitters|mesh-ancestor
65032177|NCT02897401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65032178|NCT02897401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032180|NCT02897011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65032181|NCT02897011|Abortifacient Agents|abortifacient agents|mesh-ancestor
65032182|NCT02897011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65032183|NCT02897011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032184|NCT02897011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65032185|NCT02897011|Antimetabolites|antimetabolites|mesh-ancestor
65032186|NCT02897011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586238|NCT01405820|Immunologic Factors|immunologic factors|mesh-ancestor
64950014|NCT00394745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64950015|NCT00394745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64950016|NCT00394745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64503338|NCT03348696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950017|NCT00394745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950018|NCT00049218|Carboplatin|carboplatin|mesh-list
64950019|NCT00049218|Etoposide|etoposide|mesh-list
64950020|NCT00049218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950021|NCT00049218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64950022|NCT00049218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64950040|NCT00049296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64950041|NCT00049296|Growth Substances|growth substances|mesh-ancestor
64950042|NCT00049296|Growth Inhibitors|growth inhibitors|mesh-ancestor
64950043|NCT00021827|Hormones|hormones|mesh-list
64950044|NCT00021827|Parathyroid Hormone|parathyroid hormone|mesh-list
64950045|NCT00021827|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
64725450|NCT00002077|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64725451|NCT00002089|Azithromycin|azithromycin|mesh-list
64725452|NCT00002089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64725453|NCT00002089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725454|NCT00002095|Ganciclovir|ganciclovir|mesh-list
64725455|NCT00002095|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64725456|NCT00002095|Antiviral Agents|antiviral agents|mesh-ancestor
64725457|NCT00002095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725458|NCT00002095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64950046|NCT00021827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64950047|NCT00021827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950048|NCT00021827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64950049|NCT00049335|Capecitabine|capecitabine|mesh-list
64950050|NCT00049335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64950051|NCT00049335|Antimetabolites|antimetabolites|mesh-ancestor
64950052|NCT00049335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950053|NCT00049335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950054|NCT00049374|Thalidomide|thalidomide|mesh-list
64950055|NCT00049374|Dexamethasone|dexamethasone|mesh-list
64950056|NCT00049374|Oblimersen|oblimersen|mesh-list
64950057|NCT00049374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64950058|NCT00049374|Antiemetics|antiemetics|mesh-ancestor
64950059|NCT00049374|Autonomic Agents|autonomic agents|mesh-ancestor
64950060|NCT00049374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64950061|NCT00049374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950062|NCT00049374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64950063|NCT00049374|Glucocorticoids|glucocorticoids|mesh-ancestor
64950064|NCT00049374|Hormones|hormones|mesh-ancestor
64950065|NCT00049374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64950066|NCT00049374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65032187|NCT02897011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586253|NCT01794767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032188|NCT02897011|Dermatologic Agents|dermatologic agents|mesh-ancestor
65032189|NCT02897011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032190|NCT02897011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65032191|NCT02897011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65032192|NCT02897011|Immunologic Factors|immunologic factors|mesh-ancestor
65032193|NCT02897011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65032194|NCT02897011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65032195|NCT00169832|Rosiglitazone|rosiglitazone|mesh-list
65032196|NCT00169832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65032197|NCT00169832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032198|NCT00196599|Emtricitabine|emtricitabine|mesh-list
65032199|NCT00196599|Efavirenz|efavirenz|mesh-list
65032200|NCT00196599|Didanosine|didanosine|mesh-list
65032201|NCT00196599|Antiviral Agents|antiviral agents|mesh-ancestor
65032202|NCT00196599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032203|NCT00196599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64950067|NCT00049374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950068|NCT00049374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64950069|NCT00049374|Immunologic Factors|immunologic factors|mesh-ancestor
64950070|NCT00049374|Leprostatic Agents|leprostatic agents|mesh-ancestor
64950071|NCT00049374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64950077|NCT00021983|Immunotoxins|immunotoxins|mesh-list
64950078|NCT00021983|Immunologic Factors|immunologic factors|mesh-ancestor
64950079|NCT00021983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950093|NCT00049413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
64950094|NCT00049413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950095|NCT00022022|Docetaxel|docetaxel|mesh-list
64950096|NCT00022022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950097|NCT00022022|Tubulin Modulators|tubulin modulators|mesh-ancestor
64950098|NCT00022022|Antimitotic Agents|antimitotic agents|mesh-ancestor
64950099|NCT00022022|Mitosis Modulators|mitosis modulators|mesh-ancestor
64950100|NCT00022022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950101|NCT00049452|Zoledronic Acid|zoledronic acid|mesh-list
64950102|NCT00049452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64950103|NCT00049452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950104|NCT00022139|Paclitaxel|paclitaxel|mesh-list
64950105|NCT00022139|Carboplatin|carboplatin|mesh-list
64950106|NCT00022139|Fluorouracil|fluorouracil|mesh-list
64950107|NCT00022139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64950108|NCT00022139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950109|NCT00022139|Tubulin Modulators|tubulin modulators|mesh-ancestor
64950110|NCT00022139|Antimitotic Agents|antimitotic agents|mesh-ancestor
64950111|NCT00022139|Mitosis Modulators|mitosis modulators|mesh-ancestor
64950112|NCT00022139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950113|NCT00022139|Antimetabolites|antimetabolites|mesh-ancestor
64950114|NCT00022139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64950115|NCT00022139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64725459|NCT00002095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725460|NCT00002095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725461|NCT00002101|Clarithromycin|clarithromycin|mesh-list
64725462|NCT00002101|Ethambutol|ethambutol|mesh-list
64725463|NCT00002101|Rifabutin|rifabutin|mesh-list
64725464|NCT00002101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64950116|NCT00022139|Immunologic Factors|immunologic factors|mesh-ancestor
64950117|NCT00022139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950118|NCT00049569|Leucovorin|leucovorin|mesh-list
64950119|NCT00049569|Cytarabine|cytarabine|mesh-list
65032204|NCT00196599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65032205|NCT00196599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032206|NCT00196599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032207|NCT00196599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65032208|NCT00196599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65032209|NCT00196599|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65032210|NCT00196599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65032211|NCT00196599|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65032212|NCT00196599|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65032213|NCT00196599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65032214|NCT00196599|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64950120|NCT00049569|Prednisone|prednisone|mesh-list
64950121|NCT00049569|Hydrocortisone|hydrocortisone|mesh-list
64950122|NCT00049569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64950123|NCT00049569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64950124|NCT00049569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64950125|NCT00049569|Cyclophosphamide|cyclophosphamide|mesh-list
64950126|NCT00049569|Doxorubicin|doxorubicin|mesh-list
64950127|NCT00049569|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64950128|NCT00049569|Methotrexate|methotrexate|mesh-list
64950129|NCT00049569|Etoposide|etoposide|mesh-list
64950130|NCT00049569|Vincristine|vincristine|mesh-list
64950131|NCT00049569|Imatinib Mesylate|imatinib mesylate|mesh-list
64950132|NCT00049569|Asparaginase|asparaginase|mesh-list
64950133|NCT00049569|Pegaspargase|pegaspargase|mesh-list
64950134|NCT00049569|Levoleucovorin|levoleucovorin|mesh-list
64950135|NCT00049569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64950136|NCT00049569|Immunologic Factors|immunologic factors|mesh-ancestor
64950137|NCT00049569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950138|NCT00049569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64950139|NCT00049569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64950140|NCT00049569|Alkylating Agents|alkylating agents|mesh-ancestor
64950141|NCT00049569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950142|NCT00049569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950146|NCT00049569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64950147|NCT00049569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950148|NCT00049569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64950149|NCT00049569|Glucocorticoids|glucocorticoids|mesh-ancestor
64950151|NCT00049569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64950152|NCT00049569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64950153|NCT00049569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64950154|NCT00049569|Abortifacient Agents|abortifacient agents|mesh-ancestor
64420375|NCT05489887|Ceritinib|ceritinib|mesh-list
64950160|NCT00049569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64950161|NCT00049569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64950162|NCT00049569|Antiviral Agents|antiviral agents|mesh-ancestor
64950163|NCT00049569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950164|NCT00049569|Antidotes|antidotes|mesh-ancestor
64950165|NCT00049569|Protective Agents|protective agents|mesh-ancestor
64503339|NCT03348696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950166|NCT00049569|Vitamin B Complex|vitamin b complex|mesh-ancestor
64950167|NCT00049569|Vitamins|vitamins|mesh-ancestor
64950168|NCT00049569|Micronutrients|micronutrients|mesh-ancestor
64950169|NCT00049569|Tubulin Modulators|tubulin modulators|mesh-ancestor
64950170|NCT00049569|Antimitotic Agents|antimitotic agents|mesh-ancestor
64950171|NCT00049569|Mitosis Modulators|mitosis modulators|mesh-ancestor
64950172|NCT00049569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64950173|NCT00022178|Cyclophosphamide|cyclophosphamide|mesh-list
64950174|NCT00022178|Doxorubicin|doxorubicin|mesh-list
64950175|NCT00022178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64950176|NCT00022178|Fluorouracil|fluorouracil|mesh-list
64950177|NCT00022178|Vincristine|vincristine|mesh-list
64950178|NCT00022178|Epirubicin|epirubicin|mesh-list
64950179|NCT00022178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65032215|NCT00196599|Antimetabolites|antimetabolites|mesh-ancestor
65032216|NCT00178971|Buspirone|buspirone|mesh-list
65032217|NCT00178971|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65032218|NCT00178971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65032219|NCT00178971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65032220|NCT00178971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032221|NCT00178971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65032222|NCT00178971|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65032223|NCT00178971|Serotonin Agents|serotonin agents|mesh-ancestor
65032224|NCT00178971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65032225|NCT00178971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032226|NCT02896621|Amlodipine|amlodipine|mesh-list
65032227|NCT02896621|Chlorthalidone|chlorthalidone|mesh-list
65032228|NCT02896621|Amiloride|amiloride|mesh-list
65032229|NCT02896621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65032230|NCT02896621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65032231|NCT02896621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65032232|NCT02896621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032233|NCT02896621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65032234|NCT02896621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032235|NCT02896621|Vasodilator Agents|vasodilator agents|mesh-ancestor
65032236|NCT02896621|Diuretics|diuretics|mesh-ancestor
65032237|NCT02896621|Natriuretic Agents|natriuretic agents|mesh-ancestor
65032238|NCT02896621|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65032239|NCT02896621|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65032240|NCT02896621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65032241|NCT02896621|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64950180|NCT00022178|Immunologic Factors|immunologic factors|mesh-ancestor
64950181|NCT00022178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950182|NCT00022178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64950183|NCT00022178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64950184|NCT00022178|Alkylating Agents|alkylating agents|mesh-ancestor
64725465|NCT00002101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725466|NCT00002101|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64725467|NCT00002101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725468|NCT00002101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725469|NCT00002101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64950185|NCT00022178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950186|NCT00022178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950187|NCT00022178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64950188|NCT00022178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64950189|NCT00022178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64950190|NCT00022178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64950191|NCT00022178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950193|NCT00022178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64884226|NCT01944085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032242|NCT02896621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65032243|NCT02896582|Cytarabine|cytarabine|mesh-list
65032244|NCT02896582|Dexamethasone|dexamethasone|mesh-list
65032245|NCT02896582|Etoposide|etoposide|mesh-list
65032246|NCT02896582|Melphalan|melphalan|mesh-list
65032247|NCT02896582|Cisplatin|cisplatin|mesh-list
65032248|NCT02896582|Obinutuzumab|obinutuzumab|mesh-list
65032249|NCT02896582|Carmustine|carmustine|mesh-list
65032250|NCT02896582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65032251|NCT02896582|Antiemetics|antiemetics|mesh-ancestor
65032252|NCT02896582|Autonomic Agents|autonomic agents|mesh-ancestor
65032253|NCT02896582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65032254|NCT02896582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032255|NCT02896582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65032256|NCT02896582|Glucocorticoids|glucocorticoids|mesh-ancestor
65032257|NCT02896582|Hormones|hormones|mesh-ancestor
65032258|NCT02896582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65032259|NCT02896582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65032260|NCT02896582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032261|NCT02896582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64950194|NCT00022178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64950195|NCT00022178|Tubulin Modulators|tubulin modulators|mesh-ancestor
64950196|NCT00022178|Antimitotic Agents|antimitotic agents|mesh-ancestor
64950197|NCT00022178|Mitosis Modulators|mitosis modulators|mesh-ancestor
64950198|NCT00049608|Gemcitabine|gemcitabine|mesh-list
64950199|NCT00049608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64950200|NCT00049608|Antimetabolites|antimetabolites|mesh-ancestor
64950201|NCT00049608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950202|NCT00049608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950203|NCT00049608|Antiviral Agents|antiviral agents|mesh-ancestor
64950204|NCT00049608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950205|NCT00049608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950206|NCT00049608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64950207|NCT00049608|Immunologic Factors|immunologic factors|mesh-ancestor
64950208|NCT00049608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950209|NCT00022217|Paclitaxel|paclitaxel|mesh-list
64950210|NCT00022217|Carboplatin|carboplatin|mesh-list
64950211|NCT00022217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64950212|NCT00022217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950213|NCT00022217|Tubulin Modulators|tubulin modulators|mesh-ancestor
64950216|NCT00022217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950217|NCT00022256|Motexafin gadolinium|motexafin gadolinium|mesh-list
64950218|NCT00022256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950219|NCT00022256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64950220|NCT00022256|Dermatologic Agents|dermatologic agents|mesh-ancestor
64950222|NCT00049725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64950224|NCT00049725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950225|NCT00049764|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
64950226|NCT00049764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950227|NCT00049803|Sodium Oxybate|sodium oxybate|mesh-list
64950228|NCT00049803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64950229|NCT00049803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64950230|NCT00049803|Anesthetics, General|anesthetics, general|mesh-ancestor
64950231|NCT00049803|Anesthetics|anesthetics|mesh-ancestor
64950232|NCT00049803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65032262|NCT02896582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65032263|NCT02896582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65032264|NCT02896582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032265|NCT02896582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032266|NCT02896582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65032267|NCT02896582|Antimetabolites|antimetabolites|mesh-ancestor
65032268|NCT02896582|Antiviral Agents|antiviral agents|mesh-ancestor
65032269|NCT02896582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032270|NCT02896582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65032271|NCT02896582|Immunologic Factors|immunologic factors|mesh-ancestor
65032272|NCT02896582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65032273|NCT02896582|Alkylating Agents|alkylating agents|mesh-ancestor
65032274|NCT02896582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65032275|NCT02896582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65032276|NCT00196638|Interferons|interferons|mesh-list
65032277|NCT00196638|Interferon-alpha|interferon-alpha|mesh-list
65032278|NCT00196638|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65032279|NCT00196638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032280|NCT00196638|Antiviral Agents|antiviral agents|mesh-ancestor
65032281|NCT00196638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032282|NCT00196638|Immunologic Factors|immunologic factors|mesh-ancestor
65032283|NCT00196638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032284|NCT02896270|Valproic Acid|valproic acid|mesh-list
65032285|NCT02896270|Anticonvulsants|anticonvulsants|mesh-ancestor
65032286|NCT02896270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032287|NCT02896270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032288|NCT02896270|GABA Agents|gaba agents|mesh-ancestor
65032289|NCT02896270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64950233|NCT00049803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950235|NCT00397761|Capecitabine|capecitabine|mesh-list
64950236|NCT00397761|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64503340|NCT04506450|Anesthetics|anesthetics|mesh-list
64503341|NCT04506450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64950237|NCT00397761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64950238|NCT00397761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950239|NCT00397761|Tubulin Modulators|tubulin modulators|mesh-ancestor
64950240|NCT00397761|Antimitotic Agents|antimitotic agents|mesh-ancestor
64950241|NCT00397761|Mitosis Modulators|mitosis modulators|mesh-ancestor
64950242|NCT00397761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950243|NCT00397761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64950244|NCT00397761|Antimetabolites|antimetabolites|mesh-ancestor
64950245|NCT00022412|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
64950246|NCT00022412|Vitamins|vitamins|mesh-ancestor
64950247|NCT00022412|Micronutrients|micronutrients|mesh-ancestor
64950248|NCT00022412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725470|NCT00002101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64884270|NCT01944384|Natriuretic Agents|natriuretic agents|mesh-ancestor
65032290|NCT02896270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032291|NCT02896270|Antimanic Agents|antimanic agents|mesh-ancestor
65032292|NCT02896270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65032293|NCT02896270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65032294|NCT02896270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65032295|NCT00196677|Vitamins|vitamins|mesh-list
65032296|NCT00196677|Micronutrients|micronutrients|mesh-ancestor
65032297|NCT00196677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032298|NCT02895958|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
65032299|NCT02895958|Antiviral Agents|antiviral agents|mesh-ancestor
65032300|NCT02895958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032301|NCT00169949|Aripiprazole|aripiprazole|mesh-list
65032302|NCT00169949|Antidepressive Agents|antidepressive agents|mesh-ancestor
65032303|NCT00169949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65032304|NCT00169949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65032305|NCT00169949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65032306|NCT00169949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65032307|NCT00169949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032308|NCT00169949|Dopamine Agonists|dopamine agonists|mesh-ancestor
65032309|NCT00169949|Dopamine Agents|dopamine agents|mesh-ancestor
65032310|NCT00169949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64884271|NCT01944410|Mitogens|mitogens|mesh-list
64884274|NCT01944436|Rivastigmine|rivastigmine|mesh-list
64725471|NCT00002101|Antitubercular Agents|antitubercular agents|mesh-ancestor
64725472|NCT00002101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64725474|NCT02335424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64725475|NCT02335424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725476|NCT00002107|Aldesleukin|aldesleukin|mesh-list
64725477|NCT00002107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725478|NCT00002107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64950249|NCT00022412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64950250|NCT00397800|Cyclophosphamide|cyclophosphamide|mesh-list
64950251|NCT00397800|Rituximab|rituximab|mesh-list
64950252|NCT00397800|Fludarabine|fludarabine|mesh-list
64950253|NCT00397800|Fludarabine phosphate|fludarabine phosphate|mesh-list
64950254|NCT00397800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64950255|NCT00397800|Immunologic Factors|immunologic factors|mesh-ancestor
64950256|NCT00397800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950257|NCT00397800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64950258|NCT00397800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64950259|NCT00397800|Alkylating Agents|alkylating agents|mesh-ancestor
64950260|NCT00397800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950261|NCT00397800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950262|NCT00397800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64950263|NCT00397800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64950264|NCT00397800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64950265|NCT00397800|Antimetabolites|antimetabolites|mesh-ancestor
64950266|NCT00022451|Tipifarnib|tipifarnib|mesh-list
64950267|NCT00022451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950268|NCT00022529|Trastuzumab|trastuzumab|mesh-list
64950269|NCT00022529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64884291|NCT01944618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032311|NCT00169949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032312|NCT00169949|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65032313|NCT00169949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65032314|NCT00169949|Serotonin Agents|serotonin agents|mesh-ancestor
65032315|NCT00169949|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65032316|NCT00169949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65032317|NCT00169949|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65032318|NCT00169949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65032319|NCT00196755|Calcium|calcium|mesh-list
65032320|NCT00196755|Sevelamer|sevelamer|mesh-list
65032321|NCT00196755|Calcium acetate|calcium acetate|mesh-list
65032322|NCT00196755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65032323|NCT00196755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032324|NCT00196755|Chelating Agents|chelating agents|mesh-ancestor
65032325|NCT00196755|Sequestering Agents|sequestering agents|mesh-ancestor
65032326|NCT00196755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032327|NCT00169988|Risperidone|risperidone|mesh-list
64950270|NCT00022529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950271|NCT00022607|Thalidomide|thalidomide|mesh-list
64950272|NCT00022607|Bevacizumab|bevacizumab|mesh-list
64950273|NCT00022607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64950274|NCT00022607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950275|NCT00022607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64950276|NCT00022607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64950277|NCT00022607|Growth Substances|growth substances|mesh-ancestor
64950278|NCT00022607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950279|NCT00022607|Growth Inhibitors|growth inhibitors|mesh-ancestor
64950280|NCT00022607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64950281|NCT00022607|Immunologic Factors|immunologic factors|mesh-ancestor
64950282|NCT00022607|Leprostatic Agents|leprostatic agents|mesh-ancestor
64950283|NCT00022607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64950284|NCT00022607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950285|NCT00049998|Topotecan|topotecan|mesh-list
64950290|NCT00049998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950291|NCT00022646|Gemcitabine|gemcitabine|mesh-list
64950297|NCT00022646|Antiviral Agents|antiviral agents|mesh-ancestor
64950298|NCT00022646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950299|NCT00022646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950300|NCT00022646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64950301|NCT00022646|Immunologic Factors|immunologic factors|mesh-ancestor
64950302|NCT00022646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950303|NCT00022646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64950304|NCT00022646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64950305|NCT00022685|Epratuzumab|epratuzumab|mesh-list
64950306|NCT00022685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64950307|NCT00022685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950308|NCT00022724|Sirolimus|sirolimus|mesh-list
64950309|NCT00022724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64950310|NCT00022724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725479|NCT00002107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64725480|NCT00002107|Antiviral Agents|antiviral agents|mesh-ancestor
64725481|NCT00002107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725482|NCT00002113|Fluconazole|fluconazole|mesh-list
64725483|NCT00002113|Flucytosine|flucytosine|mesh-list
64950311|NCT00022724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64884309|NCT01944683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65032328|NCT00169988|Sertraline|sertraline|mesh-list
64884310|NCT01944683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032329|NCT00169988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65032330|NCT00169988|Serotonin Agents|serotonin agents|mesh-ancestor
65032331|NCT00169988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65032332|NCT00169988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032333|NCT00169988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032334|NCT00169988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65032335|NCT00169988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65032336|NCT00169988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65032337|NCT00169988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65032338|NCT00169988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65032339|NCT00169988|Dopamine Agents|dopamine agents|mesh-ancestor
65032340|NCT00169988|Antidepressive Agents|antidepressive agents|mesh-ancestor
65032341|NCT00169988|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65032342|NCT00169988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65032343|NCT00169988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65032344|NCT02895529|Itraconazole|itraconazole|mesh-list
65032345|NCT02895529|Caspofungin|caspofungin|mesh-list
65032346|NCT02895529|Antifungal Agents|antifungal agents|mesh-ancestor
65032347|NCT02895529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032348|NCT02895529|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65032349|NCT02895529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65032350|NCT02895529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032351|NCT02895529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032352|NCT02895529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65032353|NCT02895529|Hormone Antagonists|hormone antagonists|mesh-ancestor
64950312|NCT00022724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950313|NCT00022724|Antifungal Agents|antifungal agents|mesh-ancestor
64950314|NCT00022724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64950315|NCT00022724|Immunologic Factors|immunologic factors|mesh-ancestor
64950316|NCT00022724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950318|NCT00050154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950319|NCT00022841|Pamidronate|pamidronate|mesh-list
64950320|NCT00022841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64950321|NCT00022841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950322|NCT00022880|Tositumomab I-131|tositumomab i-131|mesh-list
64950323|NCT00022880|Antibodies|antibodies|mesh-list
64950324|NCT00022880|Immunologic Factors|immunologic factors|mesh-ancestor
64950325|NCT00022880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950326|NCT00022880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950327|NCT00050271|Acetylcarnitine|acetylcarnitine|mesh-list
64950328|NCT00050271|Vitamin B Complex|vitamin b complex|mesh-ancestor
64950329|NCT00050271|Vitamins|vitamins|mesh-ancestor
65032354|NCT02895529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65032355|NCT02895529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032356|NCT02895529|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65032357|NCT02895061|Alfacalcidol|alfacalcidol|mesh-list
65032358|NCT02895061|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65032359|NCT02895061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65032360|NCT02895061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032361|NCT02895061|Vitamins|vitamins|mesh-ancestor
65032362|NCT02895061|Micronutrients|micronutrients|mesh-ancestor
65032363|NCT00170183|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65032364|NCT00170183|Natriuretic Agents|natriuretic agents|mesh-ancestor
65032365|NCT00170183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032366|NCT00170222|Doxycycline|doxycycline|mesh-list
65032367|NCT00170222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65032368|NCT00170222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032369|NCT00170222|Antimalarials|antimalarials|mesh-ancestor
65032370|NCT00170222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64884336|NCT01945047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64950330|NCT00050271|Micronutrients|micronutrients|mesh-ancestor
64950331|NCT00050271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950332|NCT00050271|Nootropic Agents|nootropic agents|mesh-ancestor
64950333|NCT00022958|Tositumomab I-131|tositumomab i-131|mesh-list
64950334|NCT00022958|Antibodies|antibodies|mesh-list
64950335|NCT00022958|Immunologic Factors|immunologic factors|mesh-ancestor
64950336|NCT00022958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950337|NCT00022958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950338|NCT00050349|Epothilones|epothilones|mesh-list
64950339|NCT00050349|Epothilone B|epothilone b|mesh-list
64950340|NCT00050349|Tubulin Modulators|tubulin modulators|mesh-ancestor
64950341|NCT00050349|Antimitotic Agents|antimitotic agents|mesh-ancestor
64950342|NCT00050349|Mitosis Modulators|mitosis modulators|mesh-ancestor
64950343|NCT00050349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950344|NCT00050349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950345|NCT00050427|Trabectedin|trabectedin|mesh-list
64950346|NCT00050427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64950347|NCT00050427|Alkylating Agents|alkylating agents|mesh-ancestor
64950348|NCT00050427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950349|NCT00050427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950350|NCT00023153|Adefovir|adefovir|mesh-list
64950351|NCT00023153|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64950352|NCT00023153|Antiviral Agents|antiviral agents|mesh-ancestor
64950353|NCT00023153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950354|NCT00023153|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64950355|NCT00023153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64950356|NCT00023153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950357|NCT00023153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950358|NCT00050505|Vaccines|vaccines|mesh-list
64950368|NCT00050817|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64950374|NCT00023231|Mycophenolic Acid|mycophenolic acid|mesh-list
64950375|NCT00023231|Sirolimus|sirolimus|mesh-list
64950376|NCT00023231|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64950377|NCT00023231|Ganciclovir|ganciclovir|mesh-list
64950378|NCT00023231|Prednisone|prednisone|mesh-list
64950379|NCT00023231|Methylprednisolone|methylprednisolone|mesh-list
64950380|NCT00023231|Atorvastatin|atorvastatin|mesh-list
64950381|NCT00023231|Daclizumab|daclizumab|mesh-list
64950382|NCT00023231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64950383|NCT00023231|Glucocorticoids|glucocorticoids|mesh-ancestor
65032371|NCT00170222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64884353|NCT01945437|Analgesics|analgesics|mesh-ancestor
64884354|NCT01945437|Sensory System Agents|sensory system agents|mesh-ancestor
65032372|NCT02894983|Calpastatin|calpastatin|mesh-list
65032373|NCT02894983|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65032374|NCT02894983|Protease Inhibitors|protease inhibitors|mesh-ancestor
65032375|NCT02894983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032376|NCT02894983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032377|NCT02895022|Lidocaine|lidocaine|mesh-list
65032378|NCT02895022|Anesthetics, Local|anesthetics, local|mesh-ancestor
65032379|NCT02895022|Anesthetics|anesthetics|mesh-ancestor
65032380|NCT02895022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65032381|NCT02895022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032382|NCT02895022|Sensory System Agents|sensory system agents|mesh-ancestor
65032383|NCT02895022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65032384|NCT02895022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65032385|NCT02895022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65032386|NCT02895022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65032387|NCT02895022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65032388|NCT02895022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032389|NCT00409851|Amlodipine|amlodipine|mesh-list
65032390|NCT00409851|Valsartan|valsartan|mesh-list
65032391|NCT00409851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65032392|NCT00409851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65032393|NCT00409851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65032394|NCT00409851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032395|NCT00409851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65032396|NCT00409851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032397|NCT00409851|Vasodilator Agents|vasodilator agents|mesh-ancestor
65032398|NCT00409851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64950384|NCT00023231|Hormones|hormones|mesh-ancestor
64950385|NCT00023231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64950386|NCT00023231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950387|NCT00023231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64725484|NCT00002113|Antifungal Agents|antifungal agents|mesh-ancestor
64725485|NCT00002113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725486|NCT00002113|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64725487|NCT00002113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64725488|NCT00002113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725489|NCT00002113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032399|NCT00409851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65032400|NCT05424445|Misoprostol|misoprostol|mesh-list
65032401|NCT05424445|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65032402|NCT05424445|Abortifacient Agents|abortifacient agents|mesh-ancestor
65032403|NCT05424445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65032404|NCT05424445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032405|NCT05424445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65032406|NCT05424445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65032407|NCT05424445|Oxytocics|oxytocics|mesh-ancestor
65032408|NCT00409890|Scopolamine|scopolamine|mesh-list
65032409|NCT00409890|Bromides|bromides|mesh-list
65032410|NCT00409890|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65032411|NCT00409890|Anticonvulsants|anticonvulsants|mesh-ancestor
65032412|NCT00409890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65032413|NCT00409890|Antiemetics|antiemetics|mesh-ancestor
65032414|NCT00409890|Autonomic Agents|autonomic agents|mesh-ancestor
65032415|NCT00409890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65032416|NCT00409890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032417|NCT00409890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65032418|NCT00409890|Mydriatics|mydriatics|mesh-ancestor
65032419|NCT00409890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65032420|NCT00409890|Cholinergic Agents|cholinergic agents|mesh-ancestor
65032421|NCT00409890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65032422|NCT00409890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032423|NCT00409890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65032424|NCT00409890|Parasympatholytics|parasympatholytics|mesh-ancestor
65032425|NCT05423821|Anesthetics|anesthetics|mesh-list
65032426|NCT05423821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64503342|NCT04506450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950388|NCT00023231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950389|NCT00023231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64950390|NCT00023231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64503343|NCT03352128|Calcium|calcium|mesh-list
64950391|NCT00023231|Antitubercular Agents|antitubercular agents|mesh-ancestor
64950392|NCT00023231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64950393|NCT00023231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950394|NCT00023231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950395|NCT00023231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950396|NCT00023231|Antifungal Agents|antifungal agents|mesh-ancestor
64950397|NCT00023231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64950398|NCT00023231|Immunologic Factors|immunologic factors|mesh-ancestor
64950399|NCT00023231|Antiemetics|antiemetics|mesh-ancestor
64950400|NCT00023231|Autonomic Agents|autonomic agents|mesh-ancestor
64950401|NCT00023231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64950402|NCT00023231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64950403|NCT00023231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64950404|NCT00023231|Protective Agents|protective agents|mesh-ancestor
64950405|NCT00023231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65032427|NCT05423821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884408|NCT01945554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032428|NCT00170378|Enoxaparin|enoxaparin|mesh-list
65032429|NCT00170378|Anticoagulants|anticoagulants|mesh-ancestor
65032430|NCT00170378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65032431|NCT00170378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65032432|NCT00170378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032433|NCT00179244|Bupropion|bupropion|mesh-list
65032434|NCT00179244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65032435|NCT00179244|Antidepressive Agents|antidepressive agents|mesh-ancestor
65032436|NCT00179244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65032437|NCT00179244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65032438|NCT00179244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65032439|NCT00179244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65032440|NCT00179244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032441|NCT00179244|Dopamine Agents|dopamine agents|mesh-ancestor
65032442|NCT00179244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65032443|NCT00179244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032444|NCT00179244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64950406|NCT00023231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64950407|NCT00023231|Antimetabolites|antimetabolites|mesh-ancestor
64950408|NCT00023231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64950409|NCT00023231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64950410|NCT00023231|Antiviral Agents|antiviral agents|mesh-ancestor
64950411|NCT00023231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64950412|NCT00023231|Renal Agents|renal agents|mesh-ancestor
64950413|NCT00023231|Antimalarials|antimalarials|mesh-ancestor
64950414|NCT00023231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64950415|NCT00023231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64950416|NCT00050856|Enfuvirtide|enfuvirtide|mesh-list
64950417|NCT00050856|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64950418|NCT00050856|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64950419|NCT00050856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950420|NCT00050856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64950421|NCT00050856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64950422|NCT00050856|Antiviral Agents|antiviral agents|mesh-ancestor
64950437|NCT00050895|Tenofovir|tenofovir|mesh-list
64950438|NCT00050895|Lamivudine|lamivudine|mesh-list
64950439|NCT00050895|Zidovudine|zidovudine|mesh-list
64950440|NCT00050895|Stavudine|stavudine|mesh-list
64950441|NCT00050895|Efavirenz|efavirenz|mesh-list
64950442|NCT00050895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64950443|NCT00050895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64950444|NCT00050895|Protease Inhibitors|protease inhibitors|mesh-ancestor
64420390|NCT05489731|Osimertinib|osimertinib|mesh-list
64950449|NCT00050895|Antiviral Agents|antiviral agents|mesh-ancestor
64950450|NCT00050895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950451|NCT00050895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64950452|NCT00050895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64950453|NCT00050895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64950454|NCT00050895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64950455|NCT00050895|Antimetabolites|antimetabolites|mesh-ancestor
64950456|NCT00050895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64950457|NCT00050895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65032445|NCT00179244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64884426|NCT01945736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884427|NCT01945736|Analgesics|analgesics|mesh-ancestor
65032446|NCT00179244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032447|NCT05423197|Panitumumab|panitumumab|mesh-list
65032448|NCT05423197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65032449|NCT05423197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032450|NCT00196872|Cyclophosphamide|cyclophosphamide|mesh-list
65032451|NCT00196872|Epirubicin|epirubicin|mesh-list
65032452|NCT00196872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65032453|NCT00196872|Immunologic Factors|immunologic factors|mesh-ancestor
65032454|NCT00196872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032455|NCT00196872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65032456|NCT00196872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65032457|NCT00196872|Alkylating Agents|alkylating agents|mesh-ancestor
65032458|NCT00196872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032459|NCT00196872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032460|NCT00196872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65032461|NCT00196872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65032462|NCT00196872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65032463|NCT00196872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65032464|NCT00196872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032465|NCT05422885|Dasatinib|dasatinib|mesh-list
65032466|NCT05422885|Quercetin|quercetin|mesh-list
64884428|NCT01945736|Sensory System Agents|sensory system agents|mesh-ancestor
64950458|NCT00050895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64950459|NCT00050895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64950460|NCT00050895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64950461|NCT00023387|Isoniazid|isoniazid|mesh-list
64725490|NCT00002113|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64725491|NCT00002113|Hormone Antagonists|hormone antagonists|mesh-ancestor
64725492|NCT00002113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64725493|NCT00002113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725494|NCT00002113|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64725495|NCT00002113|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64725496|NCT00002113|Antimetabolites|antimetabolites|mesh-ancestor
64725497|NCT00002437|Cidofovir|cidofovir|mesh-list
64725498|NCT00002437|Probenecid|probenecid|mesh-list
64725499|NCT00002437|Uricosuric Agents|uricosuric agents|mesh-ancestor
64725500|NCT00002437|Gout Suppressants|gout suppressants|mesh-ancestor
64725501|NCT00002437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64725502|NCT00002437|Renal Agents|renal agents|mesh-ancestor
64725503|NCT00002437|Antiviral Agents|antiviral agents|mesh-ancestor
64725504|NCT00002437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725505|NCT00002437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333014|NCT02207699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64950462|NCT00023387|Rifapentine|rifapentine|mesh-list
64503344|NCT03352128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64503345|NCT03352128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950463|NCT00023387|Rifampin|rifampin|mesh-list
65032467|NCT05422885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64884444|NCT01945801|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65032468|NCT05422885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65032469|NCT05422885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032470|NCT05422885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032472|NCT05422885|Protective Agents|protective agents|mesh-ancestor
65032473|NCT05422885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032474|NCT00170456|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65032475|NCT00170456|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65032476|NCT00170456|Immunologic Factors|immunologic factors|mesh-ancestor
65032477|NCT00170456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032478|NCT00170456|Antacids|antacids|mesh-ancestor
65032479|NCT00170456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032480|NCT00170456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65032481|NCT00179283|Sertraline|sertraline|mesh-list
65032482|NCT00179283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65032483|NCT00179283|Antidepressive Agents|antidepressive agents|mesh-ancestor
65032484|NCT00179283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65032485|NCT00179283|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65032486|NCT00179283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65032487|NCT00179283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65032488|NCT00179283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032489|NCT00179283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65032490|NCT00179283|Serotonin Agents|serotonin agents|mesh-ancestor
65032491|NCT00179283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032492|NCT00179283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65032493|NCT00179283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65032494|NCT05420350|Lamotrigine|lamotrigine|mesh-list
65032495|NCT05420350|Bupropion|bupropion|mesh-list
64950464|NCT00023387|Antitubercular Agents|antitubercular agents|mesh-ancestor
64950465|NCT00023387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64950466|NCT00023387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950467|NCT00023387|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64950468|NCT00023387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64950469|NCT00023387|Antimetabolites|antimetabolites|mesh-ancestor
64950470|NCT00023387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950471|NCT00023387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64950472|NCT00023387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64950473|NCT00023387|Leprostatic Agents|leprostatic agents|mesh-ancestor
64950474|NCT00023387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64950475|NCT00023387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950476|NCT00023387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65032496|NCT05420350|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65032497|NCT05420350|Antidepressive Agents|antidepressive agents|mesh-ancestor
65032498|NCT05420350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65032499|NCT05420350|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65032500|NCT05420350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65032501|NCT05420350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65032502|NCT05420350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032503|NCT05420350|Dopamine Agents|dopamine agents|mesh-ancestor
65032504|NCT05420350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65032505|NCT05420350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032506|NCT05420350|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65032507|NCT05420350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65032508|NCT05420350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032509|NCT05420350|Anticonvulsants|anticonvulsants|mesh-ancestor
65032510|NCT05420350|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65032511|NCT05420350|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65032512|NCT05420350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65032513|NCT05420350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65032514|NCT05420350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65032515|NCT05420350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65032516|NCT03097939|Nivolumab|nivolumab|mesh-list
65032517|NCT03097939|Ipilimumab|ipilimumab|mesh-list
64884473|NCT05410314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950477|NCT00023387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64950478|NCT00023387|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64950479|NCT00023387|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64950480|NCT00023387|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64950487|NCT00050934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950488|NCT00050934|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64950489|NCT00050934|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64950490|NCT00023426|Rifapentine|rifapentine|mesh-list
64950491|NCT00023426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64950492|NCT00023426|Antitubercular Agents|antitubercular agents|mesh-ancestor
64950493|NCT00023426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64950494|NCT00023426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950495|NCT00023426|Leprostatic Agents|leprostatic agents|mesh-ancestor
64950496|NCT00050973|Bexarotene|bexarotene|mesh-list
64950497|NCT00050973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950498|NCT00023504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64950499|NCT00023504|Immunologic Factors|immunologic factors|mesh-ancestor
64725506|NCT00002437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725507|NCT04329650|Methylprednisolone|methylprednisolone|mesh-list
64725508|NCT04329650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64725509|NCT04329650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64725510|NCT04329650|Prednisolone|prednisolone|mesh-list
64725511|NCT04329650|Prednisolone acetate|prednisolone acetate|mesh-list
64950506|NCT00051051|Sensory System Agents|sensory system agents|mesh-ancestor
64884497|NCT05409339|Caffeine|caffeine|mesh-list
65032518|NCT03097939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65032519|NCT03097939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032520|NCT03097939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65032521|NCT03097939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032522|NCT03014635|Botulinum Toxins|botulinum toxins|mesh-list
65032523|NCT03014635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65032524|NCT03014635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65032525|NCT03014635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65032526|NCT03014635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65032527|NCT03014635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032528|NCT03014635|Cholinergic Agents|cholinergic agents|mesh-ancestor
65032529|NCT03014635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65032530|NCT03014635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032531|NCT03014635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65032532|NCT03014635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65032533|NCT00170573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65032534|NCT00170573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65032535|NCT00170573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032536|NCT02885272|Deoxyglucose|deoxyglucose|mesh-list
65032537|NCT02885272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64884500|NCT05409339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64950507|NCT00051051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64950508|NCT00051051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950509|NCT00051051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64950510|NCT00051051|Protective Agents|protective agents|mesh-ancestor
64950511|NCT00051090|Lamivudine|lamivudine|mesh-list
64950512|NCT00051090|Efavirenz|efavirenz|mesh-list
64950513|NCT00051090|Abacavir|abacavir|mesh-list
64950514|NCT00051090|Didanosine|didanosine|mesh-list
64950515|NCT00051090|Telbivudine|telbivudine|mesh-list
64950516|NCT00051090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64950517|NCT00051090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64950518|NCT00051090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950519|NCT00051090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950520|NCT00051090|Antiviral Agents|antiviral agents|mesh-ancestor
64950521|NCT00051090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950522|NCT00051090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64950523|NCT00051090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64950524|NCT00051090|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64950525|NCT00051090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64950526|NCT00051090|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64950527|NCT00051090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64950528|NCT00051090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64950529|NCT00051090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64950530|NCT00051090|Antimetabolites|antimetabolites|mesh-ancestor
64950531|NCT00023621|Celecoxib|celecoxib|mesh-list
64950532|NCT00023621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64950533|NCT00023621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64950534|NCT00023621|Analgesics|analgesics|mesh-ancestor
64950535|NCT00023621|Sensory System Agents|sensory system agents|mesh-ancestor
64884517|NCT05273567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032538|NCT02885272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65032539|NCT02885272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032540|NCT02885272|Antimetabolites|antimetabolites|mesh-ancestor
65032541|NCT02885272|Antiviral Agents|antiviral agents|mesh-ancestor
64906339|NCT00007033|Analgesics|analgesics|mesh-ancestor
65032542|NCT02885272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032543|NCT02793583|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65032544|NCT02793583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65032545|NCT02793583|Alkylating Agents|alkylating agents|mesh-ancestor
64517736|NCT03244956|Trametinib|trametinib|mesh-list
65032546|NCT02793583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032547|NCT02793583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032548|NCT00170612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65032549|NCT00170612|Immunologic Factors|immunologic factors|mesh-ancestor
65032550|NCT00170612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032551|NCT00170690|Treosulfan|treosulfan|mesh-list
65032552|NCT00170690|Busulfan|busulfan|mesh-list
65032553|NCT00170690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65032554|NCT00170690|Alkylating Agents|alkylating agents|mesh-ancestor
65032555|NCT00170690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032556|NCT00170690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032557|NCT00170690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65032558|NCT00170690|Immunologic Factors|immunologic factors|mesh-ancestor
64950536|NCT00023621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64489336|NCT02244112|Anesthetics|anesthetics|mesh-ancestor
64503346|NCT03122730|Epoprostenol|epoprostenol|mesh-list
64950537|NCT00023621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950538|NCT00023621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64950539|NCT00023621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64950540|NCT00023621|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64950541|NCT00023621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64950542|NCT00023621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950543|NCT00023621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950545|NCT00023660|Fluorouracil|fluorouracil|mesh-list
64950546|NCT00023660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950547|NCT00023660|Antimetabolites|antimetabolites|mesh-ancestor
64950550|NCT00023660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64950551|NCT00023660|Immunologic Factors|immunologic factors|mesh-ancestor
64950552|NCT00023660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950553|NCT00023660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64950554|NCT00023660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64950555|NCT00023660|Analgesics|analgesics|mesh-ancestor
64950556|NCT00023660|Sensory System Agents|sensory system agents|mesh-ancestor
64950557|NCT00023660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64950558|NCT00023660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64950559|NCT00023660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64950560|NCT00023660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64884540|NCT05068063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032559|NCT00170690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032560|NCT00170690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65032561|NCT00196989|Pioglitazone|pioglitazone|mesh-list
65032562|NCT00196989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65032563|NCT00196989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032564|NCT00170729|Prednisolone|prednisolone|mesh-list
65032565|NCT00170729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65032566|NCT00170729|Methylprednisolone|methylprednisolone|mesh-list
65032567|NCT00170729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65032568|NCT00170729|Prednisolone acetate|prednisolone acetate|mesh-list
65032569|NCT00170729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65032570|NCT00170729|Prednisolone phosphate|prednisolone phosphate|mesh-list
65032571|NCT00170729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65032572|NCT00170729|Glucocorticoids|glucocorticoids|mesh-ancestor
65032573|NCT00170729|Hormones|hormones|mesh-ancestor
65032574|NCT00170729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65032575|NCT00170729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032576|NCT00170729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64950561|NCT00023660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64950562|NCT00023660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950563|NCT00051285|Enoximone|enoximone|mesh-list
64725516|NCT04329650|Antiemetics|antiemetics|mesh-ancestor
64725517|NCT04329650|Autonomic Agents|autonomic agents|mesh-ancestor
64725518|NCT04329650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64725519|NCT04329650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725520|NCT04329650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64950569|NCT00051285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950570|NCT00051285|Protective Agents|protective agents|mesh-ancestor
64950571|NCT00051285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950572|NCT00023699|Gefitinib|gefitinib|mesh-list
64950573|NCT00023699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950574|NCT00023699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64950575|NCT00023699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950576|NCT00023699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950577|NCT00051441|Benzydamine|benzydamine|mesh-list
64950578|NCT00051441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64950579|NCT00023738|Doxorubicin|doxorubicin|mesh-list
64950580|NCT00023738|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64950581|NCT00023738|Ifosfamide|ifosfamide|mesh-list
64950582|NCT00023738|Dacarbazine|dacarbazine|mesh-list
64950583|NCT00023738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64950584|NCT00023738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950585|NCT00023738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64950586|NCT00023738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64950587|NCT00023738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950588|NCT00023738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950589|NCT00023738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64950590|NCT00023738|Alkylating Agents|alkylating agents|mesh-ancestor
64950591|NCT00397917|Folic Acid|folic acid|mesh-list
64950592|NCT00397917|Hematinics|hematinics|mesh-ancestor
64950593|NCT00397917|Vitamin B Complex|vitamin b complex|mesh-ancestor
64950594|NCT00397917|Vitamins|vitamins|mesh-ancestor
64950595|NCT00397917|Micronutrients|micronutrients|mesh-ancestor
64950596|NCT00397917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950597|NCT00397956|Ertapenem|ertapenem|mesh-list
64884557|NCT04946396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032577|NCT00170729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032578|NCT00170729|Antiemetics|antiemetics|mesh-ancestor
65032579|NCT00170729|Autonomic Agents|autonomic agents|mesh-ancestor
65032580|NCT00170729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65032581|NCT00170729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65032582|NCT00170729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65032583|NCT00170729|Protective Agents|protective agents|mesh-ancestor
65032584|NCT00170768|Oxybutynin|oxybutynin|mesh-list
65032585|NCT00170768|Darifenacin|darifenacin|mesh-list
65032586|NCT00170768|Parasympatholytics|parasympatholytics|mesh-ancestor
65032587|NCT00170768|Autonomic Agents|autonomic agents|mesh-ancestor
64884558|NCT04908657|Sildenafil Citrate|sildenafil citrate|mesh-list
64950598|NCT00397956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64950599|NCT00397956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950600|NCT00023777|Cytarabine|cytarabine|mesh-list
64950601|NCT00023777|Daunorubicin|daunorubicin|mesh-list
64950602|NCT00023777|Sargramostim|sargramostim|mesh-list
64950603|NCT00023777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64950604|NCT00023777|Antimetabolites|antimetabolites|mesh-ancestor
64950605|NCT00023777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950606|NCT00023777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950607|NCT00023777|Antiviral Agents|antiviral agents|mesh-ancestor
64950608|NCT00023777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64503347|NCT03122730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64950609|NCT00023777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64950610|NCT00023777|Immunologic Factors|immunologic factors|mesh-ancestor
64950611|NCT00023777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950612|NCT00023777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64950613|NCT00023777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64950614|NCT00023777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64950615|NCT00023777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950616|NCT00023816|Carbendazim|carbendazim|mesh-list
64950617|NCT00023816|Antinematodal Agents|antinematodal agents|mesh-ancestor
64950618|NCT00023816|Anthelmintics|anthelmintics|mesh-ancestor
64950619|NCT00023816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64950620|NCT00023816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950626|NCT00023855|Doxorubicin|doxorubicin|mesh-list
64950627|NCT00023855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64950628|NCT00023855|Bortezomib|bortezomib|mesh-list
64950629|NCT00023855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64725523|NCT04329650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64725524|NCT04329650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64725525|NCT04329650|Protective Agents|protective agents|mesh-ancestor
64725526|NCT04329650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64333047|NCT01345851|Paclitaxel|paclitaxel|mesh-list
64950634|NCT00023855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950635|NCT00023894|Alvocidib|alvocidib|mesh-list
64950636|NCT00023894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950637|NCT00023894|Growth Inhibitors|growth inhibitors|mesh-ancestor
64950638|NCT00023894|Growth Substances|growth substances|mesh-ancestor
64950639|NCT00023894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950640|NCT00023894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64950641|NCT00023894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950642|NCT00023894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950643|NCT00023933|Antibodies|antibodies|mesh-list
64950644|NCT00023933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64950645|NCT00023933|Immunologic Factors|immunologic factors|mesh-ancestor
64950646|NCT00023933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950647|NCT00051597|Antibodies|antibodies|mesh-list
64950648|NCT00051597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64950649|NCT00051597|Immunologic Factors|immunologic factors|mesh-ancestor
64950650|NCT00051597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950651|NCT00023972|Gemcitabine|gemcitabine|mesh-list
64950652|NCT00023972|Exatecan|exatecan|mesh-list
64884566|NCT04887389|Fluorides|fluorides|mesh-list
65032588|NCT00170768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65032589|NCT00170768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032590|NCT00170768|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65032591|NCT00170768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65032592|NCT00170768|Cholinergic Agents|cholinergic agents|mesh-ancestor
65032593|NCT00170768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65032594|NCT00170768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032595|NCT00170768|Urological Agents|urological agents|mesh-ancestor
65032596|NCT02655562|Montelukast|montelukast|mesh-list
65032597|NCT02655562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65032598|NCT02655562|Respiratory System Agents|respiratory system agents|mesh-ancestor
65032599|NCT02655562|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65032600|NCT02655562|Hormone Antagonists|hormone antagonists|mesh-ancestor
65032601|NCT02655562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65032602|NCT02655562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032603|NCT02655562|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65032604|NCT02655562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65032605|NCT02655562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950653|NCT00023972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64950654|NCT00023972|Antimetabolites|antimetabolites|mesh-ancestor
64950655|NCT00023972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950656|NCT00023972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950657|NCT00023972|Antiviral Agents|antiviral agents|mesh-ancestor
64950658|NCT00023972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950659|NCT00023972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950660|NCT00023972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64950661|NCT00023972|Immunologic Factors|immunologic factors|mesh-ancestor
64950662|NCT00023972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950663|NCT00023972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64950664|NCT00023972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64950665|NCT00024011|Bortezomib|bortezomib|mesh-list
64950666|NCT00024011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950667|NCT00051753|Amoxicillin|amoxicillin|mesh-list
64950668|NCT00051753|Levofloxacin|levofloxacin|mesh-list
64950669|NCT00051753|Ofloxacin|ofloxacin|mesh-list
64950670|NCT00051753|Clavulanic Acid|clavulanic acid|mesh-list
64950671|NCT00051753|Clavulanic Acids|clavulanic acids|mesh-list
64950672|NCT00051753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64950673|NCT00051753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64950674|NCT00051753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950675|NCT00051753|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64950676|NCT00051753|Renal Agents|renal agents|mesh-ancestor
64950677|NCT00051753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64950678|NCT00051753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64950679|NCT00051753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950680|NCT00051753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950681|NCT00051753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950682|NCT00051753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64950683|NCT00051753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64950684|NCT00051753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64950685|NCT00024050|Cyclosporine|cyclosporine|mesh-list
65032606|NCT00170885|Everolimus|everolimus|mesh-list
65032607|NCT00170885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032608|NCT00170885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65032609|NCT00170885|Immunologic Factors|immunologic factors|mesh-ancestor
65032610|NCT00170885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032611|NCT02607748|Listerine|listerine|mesh-list
65032612|NCT02607748|Fluorides|fluorides|mesh-list
65032613|NCT02607748|Sodium Fluoride|sodium fluoride|mesh-list
65032614|NCT02607748|Cariostatic Agents|cariostatic agents|mesh-ancestor
65032615|NCT02607748|Protective Agents|protective agents|mesh-ancestor
65032617|NCT02607748|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65032618|NCT02607748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032619|NCT02502253|Resveratrol|resveratrol|mesh-list
65032620|NCT02502253|Antioxidants|antioxidants|mesh-ancestor
65032621|NCT02502253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032622|NCT02502253|Protective Agents|protective agents|mesh-ancestor
65032623|NCT02502253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032624|NCT02502253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032625|NCT02502253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65032627|NCT00170924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65032628|NCT00170924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65032629|NCT00170924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65032630|NCT00170924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032631|NCT01356940|4-Aminopyridine|4-aminopyridine|mesh-list
65032632|NCT01356940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65032633|NCT01356940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65032634|NCT01356940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950686|NCT00024050|Cyclophosphamide|cyclophosphamide|mesh-list
64489491|NCT03627741|Hormones|hormones|mesh-ancestor
64950687|NCT00024050|Busulfan|busulfan|mesh-list
64950688|NCT00024050|Methotrexate|methotrexate|mesh-list
64950689|NCT00024050|Cyclosporins|cyclosporins|mesh-list
64950690|NCT00024050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64950691|NCT00024050|Immunologic Factors|immunologic factors|mesh-ancestor
64725532|NCT00002443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64950697|NCT00024050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950698|NCT00024050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64950699|NCT00024050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64950700|NCT00024050|Abortifacient Agents|abortifacient agents|mesh-ancestor
64950701|NCT00024050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64950702|NCT00024050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64950703|NCT00024050|Antimetabolites|antimetabolites|mesh-ancestor
64950704|NCT00024050|Dermatologic Agents|dermatologic agents|mesh-ancestor
64950705|NCT00024050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950706|NCT00024050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64950707|NCT00024050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64950708|NCT00024050|Antifungal Agents|antifungal agents|mesh-ancestor
65032635|NCT00170963|Amlodipine|amlodipine|mesh-list
65032636|NCT00170963|Valsartan|valsartan|mesh-list
65032637|NCT00170963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65032638|NCT00170963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65032639|NCT00170963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65032640|NCT00170963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032641|NCT00170963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65032642|NCT00170963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032643|NCT00170963|Vasodilator Agents|vasodilator agents|mesh-ancestor
65032644|NCT00170963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65032645|NCT00170963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65032646|NCT02492776|Omeprazole|omeprazole|mesh-list
65032647|NCT02492776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65032648|NCT02492776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65032649|NCT02492776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65032650|NCT02492776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032651|NCT02492776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032652|NCT00171002|Amlodipine|amlodipine|mesh-list
65032653|NCT00171002|Valsartan|valsartan|mesh-list
65032654|NCT00171002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65032655|NCT00171002|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65032656|NCT00171002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65032657|NCT00171002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032683|NCT05392699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032684|NCT00171080|Valsartan|valsartan|mesh-list
65032685|NCT00171080|Irbesartan|irbesartan|mesh-list
65032686|NCT00171080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65066966|NCT00418704|Tubulin Modulators|tubulin modulators|mesh-ancestor
65032687|NCT00171080|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65032688|NCT00171080|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65032689|NCT00171080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032691|NCT02229877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65032692|NCT02229877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65032693|NCT02229877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65032694|NCT02229877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032695|NCT02229877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032697|NCT00171119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65032698|NCT00171119|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65032699|NCT00171119|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65032700|NCT00171119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032701|NCT02102113|Dronabinol|dronabinol|mesh-list
65032702|NCT02102113|Hallucinogens|hallucinogens|mesh-ancestor
65032703|NCT02102113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032704|NCT02102113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65032705|NCT02102113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65032706|NCT02102113|Analgesics|analgesics|mesh-ancestor
65032707|NCT02102113|Sensory System Agents|sensory system agents|mesh-ancestor
65032708|NCT02102113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65032709|NCT02102113|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65032710|NCT02102113|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65032728|NCT05349448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032729|NCT05349448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65032730|NCT05349448|Analgesics|analgesics|mesh-ancestor
65032731|NCT05349448|Sensory System Agents|sensory system agents|mesh-ancestor
65032732|NCT05349448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65032733|NCT05349448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65032734|NCT05349448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65032735|NCT05349448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65032736|NCT05349448|Adrenergic Agents|adrenergic agents|mesh-ancestor
65032737|NCT05349448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65032738|NCT05349448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032739|NCT05349448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65032740|NCT05349448|Glucocorticoids|glucocorticoids|mesh-ancestor
65032741|NCT05349448|Hormones|hormones|mesh-ancestor
65032742|NCT05349448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65032743|NCT05349448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65032744|NCT05349448|Immunologic Factors|immunologic factors|mesh-ancestor
65032745|NCT05349448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032746|NCT00171353|Valsartan|valsartan|mesh-list
65032747|NCT00171353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65032748|NCT00171353|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65032749|NCT00171353|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64884720|NCT04150614|Dexamethasone|dexamethasone|mesh-list
64950709|NCT00024050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950710|NCT00024050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64950711|NCT00024089|Gefitinib|gefitinib|mesh-list
64950712|NCT00024089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950713|NCT00024089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64950714|NCT00024089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950715|NCT00024089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950716|NCT00051831|Ritonavir|ritonavir|mesh-list
64950717|NCT00051831|Saquinavir|saquinavir|mesh-list
64950718|NCT00051831|Tenofovir|tenofovir|mesh-list
64950719|NCT00051831|Emtricitabine|emtricitabine|mesh-list
64950720|NCT00051831|Enfuvirtide|enfuvirtide|mesh-list
64950721|NCT00051831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64950722|NCT00051831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64950723|NCT00051831|Protease Inhibitors|protease inhibitors|mesh-ancestor
64950724|NCT00051831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950725|NCT00051831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950726|NCT00051831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64950727|NCT00051831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64950728|NCT00051831|Antiviral Agents|antiviral agents|mesh-ancestor
64950729|NCT00051831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950730|NCT00051831|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64950731|NCT00051831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64950732|NCT00051831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64950733|NCT00051831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64950734|NCT00051831|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64950735|NCT00051831|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65032750|NCT00171353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032751|NCT01656343|Abatacept|abatacept|mesh-list
65032752|NCT01656343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
65032753|NCT01656343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65032754|NCT01656343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032755|NCT01656343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032756|NCT01656343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65032757|NCT01656343|Immunologic Factors|immunologic factors|mesh-ancestor
65032758|NCT01656343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032759|NCT01656343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65032760|NCT01656343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032761|NCT01539811|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65032762|NCT01539811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64474078|NCT04079218|Estradiol|estradiol|mesh-list
65032763|NCT01539811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032764|NCT01539811|Antitubercular Agents|antitubercular agents|mesh-ancestor
65032765|NCT00171392|Mycophenolic Acid|mycophenolic acid|mesh-list
65032766|NCT00171392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65032767|NCT00171392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032768|NCT00171392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64950736|NCT00024128|Cyclosporine|cyclosporine|mesh-list
64950737|NCT00024128|Cyclophosphamide|cyclophosphamide|mesh-list
64950738|NCT00024128|Cyclosporins|cyclosporins|mesh-list
64950739|NCT00024128|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64950740|NCT00024128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64950741|NCT00024128|Immunologic Factors|immunologic factors|mesh-ancestor
64950742|NCT00024128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950743|NCT00024128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64950744|NCT00024128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64950745|NCT00024128|Alkylating Agents|alkylating agents|mesh-ancestor
64950746|NCT00024128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950747|NCT00024128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950748|NCT00024128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64950749|NCT00024128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950750|NCT00024128|Antifungal Agents|antifungal agents|mesh-ancestor
64950751|NCT00024128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950752|NCT00024128|Dermatologic Agents|dermatologic agents|mesh-ancestor
64950753|NCT00024128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64950754|NCT00024206|Orantinib|orantinib|mesh-list
64950755|NCT00024206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64333061|NCT03532841|Sensory System Agents|sensory system agents|mesh-ancestor
64333062|NCT03532841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64333073|NCT02199431|Antifungal Agents|antifungal agents|mesh-ancestor
64333074|NCT02199431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64333075|NCT02199431|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64725533|NCT00002443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64725534|NCT00002443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725535|NCT00002443|Antiviral Agents|antiviral agents|mesh-ancestor
64725536|NCT00002443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725537|NCT00002443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64725538|NCT00002443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64725539|NCT00002443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64725540|NCT00002443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64725541|NCT00002443|Protease Inhibitors|protease inhibitors|mesh-ancestor
64725542|NCT00001561|Immunoglobulins|immunoglobulins|mesh-list
65032769|NCT00171392|Antitubercular Agents|antitubercular agents|mesh-ancestor
65032770|NCT00171392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65032771|NCT00171392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032772|NCT00171392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032773|NCT00171392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032774|NCT00171431|Tegaserod|tegaserod|mesh-list
65032775|NCT00171431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65032776|NCT00171431|Serotonin Agents|serotonin agents|mesh-ancestor
65032777|NCT00171431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65032778|NCT00171431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032779|NCT00171431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032780|NCT04679740|Sirolimus|sirolimus|mesh-list
65032781|NCT04679740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65032782|NCT04679740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032783|NCT04679740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65032784|NCT04679740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032785|NCT04679740|Antifungal Agents|antifungal agents|mesh-ancestor
65032786|NCT04679740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65032787|NCT04679740|Immunologic Factors|immunologic factors|mesh-ancestor
65032788|NCT04679740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032789|NCT01330030|Selegiline|selegiline|mesh-list
65032790|NCT01330030|Antidepressive Agents|antidepressive agents|mesh-ancestor
65032791|NCT01330030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65032792|NCT01330030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65032793|NCT01330030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65032794|NCT01330030|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65032795|NCT01330030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032796|NCT01330030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032797|NCT01330030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65032798|NCT01330030|Protective Agents|protective agents|mesh-ancestor
65032799|NCT01330030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725543|NCT00001561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64725544|NCT00001561|Antibodies|antibodies|mesh-list
64725545|NCT00001561|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
64725546|NCT00001561|Immunologic Factors|immunologic factors|mesh-ancestor
64725547|NCT00001561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725548|NCT00002449|Aldesleukin|aldesleukin|mesh-list
64725549|NCT00002449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725550|NCT00002449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64725551|NCT00002449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64725552|NCT00002449|Antiviral Agents|antiviral agents|mesh-ancestor
64950759|NCT00024245|Uricosuric Agents|uricosuric agents|mesh-ancestor
64503348|NCT03122730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64884787|NCT03920007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65032800|NCT00171470|Tegaserod|tegaserod|mesh-list
65032801|NCT00171470|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65032802|NCT00171470|Serotonin Agents|serotonin agents|mesh-ancestor
65032803|NCT00171470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65032804|NCT00171470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032805|NCT00171470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032806|NCT00171509|Cyclosporine|cyclosporine|mesh-list
65032807|NCT00171509|Cyclosporins|cyclosporins|mesh-list
65032808|NCT00171509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032809|NCT00171509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032810|NCT00171509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65032811|NCT00171509|Immunologic Factors|immunologic factors|mesh-ancestor
65032812|NCT00171509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032813|NCT00171509|Antifungal Agents|antifungal agents|mesh-ancestor
65032814|NCT00171509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032815|NCT00171509|Dermatologic Agents|dermatologic agents|mesh-ancestor
65032816|NCT00171509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65032817|NCT00171509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65032818|NCT00179712|Topotecan|topotecan|mesh-list
65032819|NCT00179712|Lenalidomide|lenalidomide|mesh-list
65032820|NCT00179712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65032821|NCT00179712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65032822|NCT00179712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032823|NCT00179712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032824|NCT00179712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032825|NCT00179712|Immunologic Factors|immunologic factors|mesh-ancestor
65032826|NCT00179712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032827|NCT00179712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64950760|NCT00024245|Gout Suppressants|gout suppressants|mesh-ancestor
64503349|NCT04505904|Oxytocin|oxytocin|mesh-list
64503350|NCT04505904|Oxytocics|oxytocics|mesh-ancestor
64950783|NCT00052026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64950784|NCT00052026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64950785|NCT00052026|Vasodilator Agents|vasodilator agents|mesh-ancestor
64950786|NCT00052026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64950787|NCT00052026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64950788|NCT00024323|Cisplatin|cisplatin|mesh-list
64950789|NCT00024323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950790|NCT00024362|BBR 3464|bbr 3464|mesh-list
64950791|NCT00024362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950792|NCT00024401|Paclitaxel|paclitaxel|mesh-list
64950793|NCT00024401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64950794|NCT00024401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950795|NCT00024401|Tubulin Modulators|tubulin modulators|mesh-ancestor
64950796|NCT00024401|Antimitotic Agents|antimitotic agents|mesh-ancestor
65032828|NCT00179712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65032829|NCT00179712|Growth Substances|growth substances|mesh-ancestor
65032830|NCT00179712|Growth Inhibitors|growth inhibitors|mesh-ancestor
64518031|NCT01720667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64518032|NCT01720667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64518033|NCT01720667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518034|NCT01720667|GABA Modulators|gaba modulators|mesh-ancestor
64518035|NCT01720667|GABA Agents|gaba agents|mesh-ancestor
65032831|NCT00611572|Flumazenil|flumazenil|mesh-list
65032832|NCT00611572|Antidotes|antidotes|mesh-ancestor
65032833|NCT00611572|Protective Agents|protective agents|mesh-ancestor
65032834|NCT00611572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032835|NCT00611572|GABA Modulators|gaba modulators|mesh-ancestor
65032837|NCT00611572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65032838|NCT00611572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032839|NCT00197340|Ropivacaine|ropivacaine|mesh-list
65032840|NCT00197340|Anesthetics, Local|anesthetics, local|mesh-ancestor
65032841|NCT00197340|Anesthetics|anesthetics|mesh-ancestor
65032842|NCT00197340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65032843|NCT00197340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032844|NCT00197340|Sensory System Agents|sensory system agents|mesh-ancestor
65032845|NCT00197340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65032846|NCT00171587|Vatalanib|vatalanib|mesh-list
65032847|NCT00171587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65032848|NCT00171587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032849|NCT00171587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032850|NCT05265052|Oxycodone|oxycodone|mesh-list
65032851|NCT05265052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65032852|NCT05265052|Narcotics|narcotics|mesh-ancestor
65032853|NCT05265052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65032854|NCT05265052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032855|NCT05265052|Analgesics|analgesics|mesh-ancestor
65032856|NCT05265052|Sensory System Agents|sensory system agents|mesh-ancestor
65032857|NCT05265052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65032858|NCT00171626|Diclofenac|diclofenac|mesh-list
65032863|NCT00171626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65032864|NCT00171626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032865|NCT00171626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65032866|NCT00171626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65032867|NCT00171626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65032868|NCT00171626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032869|NCT00171626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032870|NCT00171665|Diclofenac|diclofenac|mesh-list
65032871|NCT00171665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65032872|NCT00171665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65032873|NCT00171665|Analgesics|analgesics|mesh-ancestor
65032874|NCT00171665|Sensory System Agents|sensory system agents|mesh-ancestor
65032875|NCT00171665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65032876|NCT00171665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032877|NCT00171665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65032921|NCT05209360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65032922|NCT05209360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032923|NCT00171782|Valsartan|valsartan|mesh-list
65032924|NCT00171782|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65032925|NCT00171782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65032926|NCT00171782|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65032927|NCT00171782|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65032928|NCT00171782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032929|NCT00171782|Diuretics|diuretics|mesh-ancestor
65032930|NCT00171782|Natriuretic Agents|natriuretic agents|mesh-ancestor
65032931|NCT00171782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032932|NCT00171782|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65032933|NCT00171782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65032934|NCT00197379|Roxithromycin|roxithromycin|mesh-list
65032935|NCT00197379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65032936|NCT00197379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032937|NCT05159050|Paclitaxel|paclitaxel|mesh-list
65032938|NCT05159050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65032939|NCT05159050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032940|NCT05159050|Tubulin Modulators|tubulin modulators|mesh-ancestor
65032941|NCT05159050|Antimitotic Agents|antimitotic agents|mesh-ancestor
65032942|NCT05159050|Mitosis Modulators|mitosis modulators|mesh-ancestor
65032943|NCT05159050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032944|NCT00197418|Amoxicillin|amoxicillin|mesh-list
65032945|NCT00197418|Metronidazole|metronidazole|mesh-list
65032946|NCT00197418|Clarithromycin|clarithromycin|mesh-list
65032947|NCT00197418|Rabeprazole|rabeprazole|mesh-list
65032948|NCT00197418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65032949|NCT00197418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032950|NCT00197418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65032964|NCT05103904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032965|NCT00171821|Deferasirox|deferasirox|mesh-list
65032966|NCT00171821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65032967|NCT00171821|Chelating Agents|chelating agents|mesh-ancestor
65032968|NCT00171821|Sequestering Agents|sequestering agents|mesh-ancestor
65032969|NCT00171821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032970|NCT05054023|Piroxicam|piroxicam|mesh-list
65032971|NCT05054023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65032972|NCT05054023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65032973|NCT05054023|Analgesics|analgesics|mesh-ancestor
65032974|NCT05054023|Sensory System Agents|sensory system agents|mesh-ancestor
64884955|NCT01100775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64884956|NCT01100775|Nootropic Agents|nootropic agents|mesh-ancestor
64725553|NCT00002449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725554|NCT00003014|Carboplatin|carboplatin|mesh-list
64725555|NCT00003014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725557|NCT00002125|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
64725558|NCT00002125|Antiviral Agents|antiviral agents|mesh-ancestor
64725559|NCT00002125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725560|NCT00002125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64725561|NCT00002125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64725562|NCT00002125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333076|NCT02199431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64950797|NCT00024401|Mitosis Modulators|mitosis modulators|mesh-ancestor
64950798|NCT00024401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950799|NCT00024440|Cyclophosphamide|cyclophosphamide|mesh-list
64950800|NCT00024440|Fludarabine|fludarabine|mesh-list
64950801|NCT00024440|Fludarabine phosphate|fludarabine phosphate|mesh-list
64950802|NCT00024440|Oblimersen|oblimersen|mesh-list
64950803|NCT00024440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64950804|NCT00024440|Immunologic Factors|immunologic factors|mesh-ancestor
64950805|NCT00024440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950813|NCT00024440|Antimetabolites|antimetabolites|mesh-ancestor
64950820|NCT00024518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950822|NCT00052221|Hematinics|hematinics|mesh-ancestor
64950823|NCT00052299|Cytarabine|cytarabine|mesh-list
64950824|NCT00052299|Etoposide|etoposide|mesh-list
64950825|NCT00052299|Mitoxantrone|mitoxantrone|mesh-list
64950826|NCT00052299|Idarubicin|idarubicin|mesh-list
64950827|NCT00052299|Gemtuzumab|gemtuzumab|mesh-list
64950828|NCT00052299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64950829|NCT00052299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950830|NCT00052299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64950831|NCT00052299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64950832|NCT00052299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950833|NCT00052299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950834|NCT00052299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64489635|NCT04364464|Riociguat|riociguat|mesh-list
64950835|NCT00052299|Antimetabolites|antimetabolites|mesh-ancestor
64950836|NCT00052299|Antiviral Agents|antiviral agents|mesh-ancestor
64503351|NCT04505904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64950837|NCT00052299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950838|NCT00052299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64950839|NCT00052299|Immunologic Factors|immunologic factors|mesh-ancestor
64950840|NCT00052299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950841|NCT00052299|Analgesics|analgesics|mesh-ancestor
64950842|NCT00052299|Sensory System Agents|sensory system agents|mesh-ancestor
64950843|NCT00052299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64950844|NCT00052299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64950845|NCT00052299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64950846|NCT00052338|Gemcitabine|gemcitabine|mesh-list
64950847|NCT00052338|Carboplatin|carboplatin|mesh-list
64950848|NCT00052338|Bortezomib|bortezomib|mesh-list
64884969|NCT05413096|Sensory System Agents|sensory system agents|mesh-ancestor
65032975|NCT05054023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65032976|NCT05054023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032977|NCT05054023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65032978|NCT05054023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65032979|NCT05054023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65032980|NCT05054023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032981|NCT05054023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032982|NCT00171860|Imatinib Mesylate|imatinib mesylate|mesh-list
65032983|NCT00171860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032984|NCT00171860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65032985|NCT00171860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65032986|NCT00171860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032987|NCT00553930|Interferons|interferons|mesh-list
65032988|NCT00553930|Ribavirin|ribavirin|mesh-list
65032989|NCT00553930|Interferon-alpha|interferon-alpha|mesh-list
64884970|NCT05413096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64950849|NCT00052338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950850|NCT00052338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64950851|NCT00052338|Antimetabolites|antimetabolites|mesh-ancestor
64950852|NCT00052338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950853|NCT00052338|Antiviral Agents|antiviral agents|mesh-ancestor
64950854|NCT00052338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950855|NCT00052338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725563|NCT00002125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725564|NCT00001579|Leucovorin|leucovorin|mesh-list
64725565|NCT00001579|Fluorouracil|fluorouracil|mesh-list
64725566|NCT00001579|Eniluracil|eniluracil|mesh-list
64725567|NCT00001579|Antimetabolites|antimetabolites|mesh-ancestor
64725568|NCT00001579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725569|NCT00001579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64725570|NCT00001579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725571|NCT00001579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64725572|NCT00001579|Immunologic Factors|immunologic factors|mesh-ancestor
64725573|NCT00001579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725574|NCT00001579|Antidotes|antidotes|mesh-ancestor
64725575|NCT00001579|Protective Agents|protective agents|mesh-ancestor
64725576|NCT00001579|Vitamin B Complex|vitamin b complex|mesh-ancestor
64725577|NCT00001579|Vitamins|vitamins|mesh-ancestor
64725578|NCT00001579|Micronutrients|micronutrients|mesh-ancestor
64950856|NCT00052338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64950857|NCT00052338|Immunologic Factors|immunologic factors|mesh-ancestor
64950858|NCT00052338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950859|NCT04733066|Teduglutide|teduglutide|mesh-list
64950860|NCT04733066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64950861|NCT04733066|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64950862|NCT04733066|Protective Agents|protective agents|mesh-ancestor
64950871|NCT00052377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64950872|NCT00052377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950873|NCT00052377|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64950874|NCT00052377|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64950875|NCT00052377|Antiviral Agents|antiviral agents|mesh-ancestor
64950876|NCT00052377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950877|NCT00052377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64950878|NCT00052377|Immunologic Factors|immunologic factors|mesh-ancestor
64950879|NCT00052377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64950880|NCT00052377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64950881|NCT00052377|Growth Substances|growth substances|mesh-ancestor
65032990|NCT00553930|Interferon alpha-2|interferon alpha-2|mesh-list
64884982|NCT05412914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64884983|NCT05412914|Anesthetics, General|anesthetics, general|mesh-ancestor
65032991|NCT00553930|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65032992|NCT00553930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65032993|NCT00553930|Antiviral Agents|antiviral agents|mesh-ancestor
65032994|NCT00553930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65032995|NCT00553930|Antimetabolites|antimetabolites|mesh-ancestor
65032996|NCT00553930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65032997|NCT00553930|Immunologic Factors|immunologic factors|mesh-ancestor
65032998|NCT00553930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65032999|NCT00171899|Imatinib Mesylate|imatinib mesylate|mesh-list
65033000|NCT00171899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033001|NCT00171899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65033002|NCT00171899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033003|NCT00171899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033004|NCT05004259|Daratumumab|daratumumab|mesh-list
65033005|NCT05004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033006|NCT00171938|Imatinib Mesylate|imatinib mesylate|mesh-list
65033007|NCT00171938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033008|NCT00171938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65033009|NCT00171938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033010|NCT00171938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033011|NCT00171977|Imatinib Mesylate|imatinib mesylate|mesh-list
64884984|NCT05412914|Anesthetics|anesthetics|mesh-ancestor
64950882|NCT00052377|Growth Inhibitors|growth inhibitors|mesh-ancestor
64950883|NCT00052416|Thalidomide|thalidomide|mesh-list
64950884|NCT00052416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64950885|NCT00052416|Immunologic Factors|immunologic factors|mesh-ancestor
64950890|NCT00052416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64950891|NCT00052416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64950892|NCT00052416|Growth Substances|growth substances|mesh-ancestor
64950893|NCT00052416|Growth Inhibitors|growth inhibitors|mesh-ancestor
64950894|NCT00052416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950895|NCT00052455|Vincristine|vincristine|mesh-list
64950896|NCT00052455|Temozolomide|temozolomide|mesh-list
64950897|NCT00052455|Lomustine|lomustine|mesh-list
64950898|NCT00052455|Procarbazine|procarbazine|mesh-list
64950899|NCT00052455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64950900|NCT00052455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950901|NCT00052455|Tubulin Modulators|tubulin modulators|mesh-ancestor
64950902|NCT00052455|Antimitotic Agents|antimitotic agents|mesh-ancestor
64950903|NCT00052455|Mitosis Modulators|mitosis modulators|mesh-ancestor
64950904|NCT00052455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950905|NCT00052455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64725579|NCT00001579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725580|NCT00003020|Immunotoxins|immunotoxins|mesh-list
64725581|NCT00003020|Immunologic Factors|immunologic factors|mesh-ancestor
64725582|NCT00003020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725583|NCT00002131|Vesnarinone|vesnarinone|mesh-list
64725584|NCT00002131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65033012|NCT00171977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885002|NCT05412472|Avasopasem manganese|avasopasem manganese|mesh-list
65033013|NCT00171977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65033014|NCT00171977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033015|NCT00171977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033016|NCT00197613|Lamivudine|lamivudine|mesh-list
65033017|NCT00197613|Zidovudine|zidovudine|mesh-list
65033018|NCT00197613|Efavirenz|efavirenz|mesh-list
65033019|NCT00197613|Nevirapine|nevirapine|mesh-list
65033020|NCT00197613|Didanosine|didanosine|mesh-list
65033021|NCT00197613|Stavudine|stavudine|mesh-list
65033022|NCT00197613|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65033023|NCT00197613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65033024|NCT00197613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033025|NCT00197613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033026|NCT00197613|Antiviral Agents|antiviral agents|mesh-ancestor
65033027|NCT00197613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65033028|NCT00197613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65033029|NCT00197613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65033030|NCT00197613|Antimetabolites|antimetabolites|mesh-ancestor
65033031|NCT00197613|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65033032|NCT00197613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65033033|NCT00197613|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65033034|NCT00197613|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65033035|NCT00197613|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65033036|NCT00197613|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64885003|NCT05412472|Antioxidants|antioxidants|mesh-ancestor
64725585|NCT00002131|Immunologic Factors|immunologic factors|mesh-ancestor
64725586|NCT00002131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725587|NCT00002131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950906|NCT00052455|Alkylating Agents|alkylating agents|mesh-ancestor
64950907|NCT00052494|Irinotecan|irinotecan|mesh-list
64950908|NCT00052494|Imatinib Mesylate|imatinib mesylate|mesh-list
64950909|NCT00052494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503352|NCT04505904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950910|NCT00052494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64950911|NCT00052494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64950912|NCT00052494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950913|NCT00052494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950914|NCT00052494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64950916|NCT00395174|Agglutinins|agglutinins|mesh-ancestor
64950917|NCT00395174|Immunologic Factors|immunologic factors|mesh-ancestor
64950918|NCT00395174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950919|NCT00395213|Norepinephrine|norepinephrine|mesh-list
64950920|NCT00395213|Serotonin|serotonin|mesh-list
64950921|NCT00395213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
64950922|NCT00395213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64950923|NCT00395213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65033037|NCT02240407|Acetaminophen|acetaminophen|mesh-list
65033038|NCT02240407|Diphenhydramine|diphenhydramine|mesh-list
65033039|NCT02240407|Promethazine|promethazine|mesh-list
65033040|NCT02240407|Sirolimus|sirolimus|mesh-list
65033041|NCT02240407|Rituximab|rituximab|mesh-list
65033042|NCT02240407|Lidocaine|lidocaine|mesh-list
65033043|NCT02240407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65033044|NCT02240407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033045|NCT02240407|Immunologic Factors|immunologic factors|mesh-ancestor
65033046|NCT02240407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033047|NCT02240407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65033048|NCT02240407|Anesthetics, Local|anesthetics, local|mesh-ancestor
65033049|NCT02240407|Anesthetics|anesthetics|mesh-ancestor
65033050|NCT02240407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65033051|NCT02240407|Sensory System Agents|sensory system agents|mesh-ancestor
65033052|NCT02240407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65033053|NCT02240407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65033054|NCT02240407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64474377|NCT00325078|Infliximab|infliximab|mesh-list
65033055|NCT02240407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65033056|NCT02240407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65033057|NCT02240407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033058|NCT02240407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65033059|NCT02240407|Analgesics|analgesics|mesh-ancestor
65033060|NCT02240407|Antipyretics|antipyretics|mesh-ancestor
65033061|NCT02240407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65033062|NCT02240407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65033063|NCT02240407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65033064|NCT02240407|Antifungal Agents|antifungal agents|mesh-ancestor
65033065|NCT02240407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65033066|NCT02240407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64885025|NCT05411900|Cholinergic Agents|cholinergic agents|mesh-ancestor
64950924|NCT00395213|Adrenergic Agents|adrenergic agents|mesh-ancestor
64950925|NCT00395213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64950926|NCT00395213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420527|NCT05485051|Disinfectants|disinfectants|mesh-ancestor
64950937|NCT00052611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64950938|NCT00052611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64950939|NCT00052611|Analgesics|analgesics|mesh-ancestor
64950940|NCT00052611|Sensory System Agents|sensory system agents|mesh-ancestor
64950941|NCT00052611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64950942|NCT00052611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950943|NCT00052611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64950944|NCT00052611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64950945|NCT00052611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65033067|NCT02240407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65033068|NCT02240407|Antiemetics|antiemetics|mesh-ancestor
65033069|NCT02240407|Autonomic Agents|autonomic agents|mesh-ancestor
65033070|NCT02240407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65033071|NCT02240407|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65033072|NCT02240407|Histamine Antagonists|histamine antagonists|mesh-ancestor
65033073|NCT02240407|Histamine Agents|histamine agents|mesh-ancestor
65033074|NCT02240407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65033075|NCT02240407|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65033076|NCT02240407|Antipruritics|antipruritics|mesh-ancestor
65033077|NCT02240407|Dermatologic Agents|dermatologic agents|mesh-ancestor
65033078|NCT00172016|Zoledronic Acid|zoledronic acid|mesh-list
65033079|NCT00172016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65033080|NCT00172016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033081|NCT04958122|Penicillins|penicillins|mesh-list
65033082|NCT04958122|Cefixime|cefixime|mesh-list
65033083|NCT04958122|Penicillin G Benzathine|penicillin g benzathine|mesh-list
65033084|NCT04958122|Penicillin G|penicillin g|mesh-list
65033085|NCT04958122|Penicillin G Procaine|penicillin g procaine|mesh-list
65033086|NCT04958122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65033087|NCT04958122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65033088|NCT00180024|Irbesartan|irbesartan|mesh-list
65033089|NCT00180024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65033090|NCT00180024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65033091|NCT00180024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65033092|NCT00180024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033093|NCT00172055|Zoledronic Acid|zoledronic acid|mesh-list
65033094|NCT00172055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65033095|NCT00172055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033096|NCT04934449|Salicylic Acid|salicylic acid|mesh-list
65033097|NCT04934449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64885099|NCT05303038|Bevacizumab|bevacizumab|mesh-list
65033112|NCT03455179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65033113|NCT03455179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65033114|NCT03455179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65033115|NCT00202293|Olanzapine|olanzapine|mesh-list
65033116|NCT00202293|Chlorpromazine|chlorpromazine|mesh-list
65033117|NCT00202293|Antiemetics|antiemetics|mesh-ancestor
65033118|NCT00202293|Autonomic Agents|autonomic agents|mesh-ancestor
65033119|NCT00202293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65033120|NCT00202293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033121|NCT00202293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65033122|NCT00202293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65033123|NCT00202293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65033124|NCT00202293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65033125|NCT00202293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65033126|NCT00202293|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65033128|NCT00202293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65033129|NCT00202293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033130|NCT00202293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65033131|NCT00202293|Serotonin Agents|serotonin agents|mesh-ancestor
65033132|NCT00202293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65033133|NCT00202293|Dopamine Agents|dopamine agents|mesh-ancestor
65033134|NCT00197730|Folic Acid|folic acid|mesh-list
65033135|NCT00197730|Vitamin B Complex|vitamin b complex|mesh-list
65033136|NCT00197730|Vitamins|vitamins|mesh-ancestor
65033137|NCT00197730|Micronutrients|micronutrients|mesh-ancestor
65033138|NCT00197730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033139|NCT00197730|Hematinics|hematinics|mesh-ancestor
64950946|NCT00052611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64950947|NCT00052611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950948|NCT00052611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950949|NCT00395252|Gemcitabine|gemcitabine|mesh-list
64950950|NCT00395252|Cetuximab|cetuximab|mesh-list
64950951|NCT00395252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64950952|NCT00395252|Antimetabolites|antimetabolites|mesh-ancestor
64950953|NCT00395252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950954|NCT00395252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950955|NCT00395252|Antiviral Agents|antiviral agents|mesh-ancestor
64950956|NCT00395252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950961|NCT00395252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64950962|NCT00052689|Gemcitabine|gemcitabine|mesh-list
64950963|NCT00052689|Bortezomib|bortezomib|mesh-list
64950964|NCT00052689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64950965|NCT00052689|Antimetabolites|antimetabolites|mesh-ancestor
64950966|NCT00052689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725588|NCT00002131|Antiviral Agents|antiviral agents|mesh-ancestor
64725589|NCT00002131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725590|NCT00002131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64885124|NCT05077800|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65033140|NCT00172172|Calcium|calcium|mesh-list
65033141|NCT00172172|Parathyroid Hormone|parathyroid hormone|mesh-list
65033142|NCT00172172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65033143|NCT00172172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033144|NCT02908711|Ropivacaine|ropivacaine|mesh-list
65033145|NCT02908711|Anesthetics, Local|anesthetics, local|mesh-ancestor
65033146|NCT02908711|Anesthetics|anesthetics|mesh-ancestor
65033147|NCT02908711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65033148|NCT02908711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033149|NCT02908711|Sensory System Agents|sensory system agents|mesh-ancestor
65033150|NCT02908711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65033151|NCT04865731|Esomeprazole|esomeprazole|mesh-list
65033152|NCT04865731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65033153|NCT04865731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65033154|NCT04865731|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65033155|NCT04865731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033156|NCT04865731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033157|NCT04681846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65033158|NCT04681846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65033159|NCT02908438|Hormones|hormones|mesh-list
65033160|NCT02908438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64725591|NCT00002131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64725592|NCT00002131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725593|NCT00002131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725594|NCT00002131|Protective Agents|protective agents|mesh-ancestor
64725595|NCT00380887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64950967|NCT00052689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950968|NCT00052689|Antiviral Agents|antiviral agents|mesh-ancestor
64950969|NCT00052689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950970|NCT00052689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950971|NCT00052689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64950972|NCT00052689|Immunologic Factors|immunologic factors|mesh-ancestor
64950973|NCT00052689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950975|NCT00052728|Tipifarnib|tipifarnib|mesh-list
64950976|NCT00052728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64950977|NCT00052728|Hormone Antagonists|hormone antagonists|mesh-ancestor
64950978|NCT00052728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64950979|NCT00052728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950980|NCT00052728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64950981|NCT00052728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950982|NCT00052728|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64950983|NCT00052728|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64503353|NCT03348462|Anthralin|anthralin|mesh-list
64503354|NCT03348462|Dermatologic Agents|dermatologic agents|mesh-ancestor
64950984|NCT00052728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64950985|NCT00395369|Aprotinin|aprotinin|mesh-list
64950992|NCT00395369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950993|NCT00052845|Sulindac sulfone|sulindac sulfone|mesh-list
64950994|NCT00052845|Docetaxel|docetaxel|mesh-list
64950995|NCT00052845|Estramustine|estramustine|mesh-list
64950996|NCT00052845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885145|NCT04917055|Antiemetics|antiemetics|mesh-ancestor
65033161|NCT02908438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033162|NCT04731844|Curcumin|curcumin|mesh-list
65033163|NCT04731844|Piperine|piperine|mesh-list
65033164|NCT04731844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65033165|NCT04731844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65033166|NCT04731844|Analgesics|analgesics|mesh-ancestor
65033167|NCT04731844|Sensory System Agents|sensory system agents|mesh-ancestor
65033168|NCT04731844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65033169|NCT04731844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033170|NCT04731844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65033171|NCT04731844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65033172|NCT04731844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033173|NCT04731844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033174|NCT04731844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033175|NCT04731844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65033176|NCT00172367|Lycopene|lycopene|mesh-list
65033177|NCT00172367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65033178|NCT00172367|Antioxidants|antioxidants|mesh-ancestor
65033179|NCT00172367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033180|NCT00172367|Protective Agents|protective agents|mesh-ancestor
65033181|NCT00172367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033182|NCT00172367|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65033183|NCT00172367|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65033184|NCT00172367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033185|NCT04632316|Cyclophosphamide|cyclophosphamide|mesh-list
65033186|NCT04632316|Fludarabine|fludarabine|mesh-list
65033187|NCT04632316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65033188|NCT04632316|Immunologic Factors|immunologic factors|mesh-ancestor
65033189|NCT04632316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033190|NCT04632316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65033191|NCT04632316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65033192|NCT04632316|Alkylating Agents|alkylating agents|mesh-ancestor
65033193|NCT04632316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033194|NCT04632316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033195|NCT04632316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64950997|NCT00052845|Tubulin Modulators|tubulin modulators|mesh-ancestor
65033196|NCT00197886|Norepinephrine|norepinephrine|mesh-list
65033197|NCT00197886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65033198|NCT00197886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65033199|NCT00197886|Adrenergic Agents|adrenergic agents|mesh-ancestor
65033200|NCT00197886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65033201|NCT00197886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033202|NCT00197886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518403|NCT03240120|Tinzaparin|tinzaparin|mesh-list
65033203|NCT00197886|Sympathomimetics|sympathomimetics|mesh-ancestor
65033204|NCT00197886|Autonomic Agents|autonomic agents|mesh-ancestor
65033205|NCT00197886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65033207|NCT04569877|Molgramostim|molgramostim|mesh-list
65033208|NCT04569877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65033209|NCT04569877|Sargramostim|sargramostim|mesh-list
65033210|NCT04569877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033211|NCT04569877|Immunologic Factors|immunologic factors|mesh-ancestor
65033212|NCT04569877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033213|NCT02908165|Sorafenib|sorafenib|mesh-list
65033214|NCT02908165|Chlorotrianisene|chlorotrianisene|mesh-list
65033215|NCT02908165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033216|NCT02908165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65033217|NCT02908165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033218|NCT02908165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033219|NCT02908165|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65033220|NCT02908165|Estrogens|estrogens|mesh-ancestor
65033221|NCT02908165|Hormones|hormones|mesh-ancestor
65033222|NCT02908165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65033223|NCT02908165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033224|NCT02908165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65033225|NCT04534270|Dapagliflozin|dapagliflozin|mesh-list
65033226|NCT04534270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65033227|NCT04534270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033228|NCT04534270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65033237|NCT00202605|Amphetamine|amphetamine|mesh-list
65033238|NCT00202605|Dextroamphetamine|dextroamphetamine|mesh-list
65033239|NCT00202605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65033240|NCT00202605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033241|NCT00202605|Sympathomimetics|sympathomimetics|mesh-ancestor
65033242|NCT00202605|Autonomic Agents|autonomic agents|mesh-ancestor
65033243|NCT00202605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65033244|NCT00202605|Dopamine Agents|dopamine agents|mesh-ancestor
65033245|NCT00202605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65033246|NCT00202605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033247|NCT00202605|Adrenergic Agents|adrenergic agents|mesh-ancestor
65033248|NCT00202605|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65033249|NCT00202605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65033250|NCT00202605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65033251|NCT00202605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65033252|NCT00198120|Cycloserine|cycloserine|mesh-list
65033253|NCT00198120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65033254|NCT00198120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65033255|NCT00198120|Renal Agents|renal agents|mesh-ancestor
65033256|NCT00198120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64885221|NCT04721821|Tofacitinib|tofacitinib|mesh-list
64950998|NCT00052845|Antimitotic Agents|antimitotic agents|mesh-ancestor
64950999|NCT00052845|Mitosis Modulators|mitosis modulators|mesh-ancestor
64951000|NCT00052845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951001|NCT00052845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64951002|NCT00052845|Alkylating Agents|alkylating agents|mesh-ancestor
64951003|NCT00052845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64951004|NCT00052845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64951005|NCT00052845|Protective Agents|protective agents|mesh-ancestor
64951006|NCT00052845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951007|NCT00052845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64951008|NCT00052845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951009|NCT00052845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64951010|NCT00052845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64951011|NCT00052845|Analgesics|analgesics|mesh-ancestor
64951012|NCT00052845|Sensory System Agents|sensory system agents|mesh-ancestor
64951013|NCT00052845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64951014|NCT00052845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64951015|NCT00052845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64951016|NCT00024986|Tenofovir|tenofovir|mesh-list
64951017|NCT00024986|Antiviral Agents|antiviral agents|mesh-ancestor
64951018|NCT00024986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951019|NCT00024986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64951020|NCT00024986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64951021|NCT00024986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951022|NCT00024986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951023|NCT00024986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64725596|NCT00380887|Estrogens|estrogens|mesh-ancestor
64725597|NCT00380887|Hormones|hormones|mesh-ancestor
64725598|NCT00380887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64725599|NCT00380887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725601|NCT00002461|Carmustine|carmustine|mesh-list
65033257|NCT00198120|Antitubercular Agents|antitubercular agents|mesh-ancestor
65033258|NCT00198120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65033259|NCT00198120|Antimetabolites|antimetabolites|mesh-ancestor
65033260|NCT00198120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033261|NCT00198159|Gefitinib|gefitinib|mesh-list
65033262|NCT00198159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033263|NCT00198159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65033264|NCT00198159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033265|NCT00198159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033266|NCT02907307|Clotrimazole|clotrimazole|mesh-list
65033267|NCT02907307|Miconazole|miconazole|mesh-list
65033268|NCT02907307|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65033269|NCT02907307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65033270|NCT02907307|Antifungal Agents|antifungal agents|mesh-ancestor
65033271|NCT02907307|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65033272|NCT02907307|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65033273|NCT02907307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033274|NCT02907307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033276|NCT02907307|Hormone Antagonists|hormone antagonists|mesh-ancestor
64885243|NCT04609098|Piperaquine|piperaquine|mesh-list
64725602|NCT00002461|Etoposide|etoposide|mesh-list
64725603|NCT00002461|Sargramostim|sargramostim|mesh-list
64725604|NCT00002461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64725605|NCT00002461|Immunologic Factors|immunologic factors|mesh-ancestor
64725606|NCT00002461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725607|NCT00002461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64725608|NCT00002461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64725609|NCT00002461|Alkylating Agents|alkylating agents|mesh-ancestor
64725610|NCT00002461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725611|NCT00002461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951024|NCT00024986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64951025|NCT00052884|Melphalan|melphalan|mesh-list
64951026|NCT00052884|Amifostine|amifostine|mesh-list
64951031|NCT00052884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951032|NCT00052884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951033|NCT00052884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64951034|NCT00052884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951035|NCT00052884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64951036|NCT00052884|Protective Agents|protective agents|mesh-ancestor
64951037|NCT00052923|Cyclophosphamide|cyclophosphamide|mesh-list
64951038|NCT00052923|Carmustine|carmustine|mesh-list
64951039|NCT00052923|Rituximab|rituximab|mesh-list
64951040|NCT00052923|Etoposide|etoposide|mesh-list
64951041|NCT00052923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951042|NCT00052923|Immunologic Factors|immunologic factors|mesh-ancestor
64951043|NCT00052923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951044|NCT00052923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64951045|NCT00052923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64951053|NCT00052923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64951054|NCT00052923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951055|NCT00025064|Prednisolone|prednisolone|mesh-list
64951056|NCT00025064|Doxorubicin|doxorubicin|mesh-list
64503355|NCT04505514|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
64951057|NCT00025064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64489863|NCT03677817|Lidocaine|lidocaine|mesh-list
64951058|NCT00025064|Etoposide|etoposide|mesh-list
64951059|NCT00025064|Vincristine|vincristine|mesh-list
64885261|NCT04493333|Immunologic Factors|immunologic factors|mesh-ancestor
65033277|NCT02907307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65033278|NCT02907307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033279|NCT02907307|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65033280|NCT02907307|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65033282|NCT00553345|Selenium|selenium|mesh-list
65033283|NCT00553345|Vitamins|vitamins|mesh-ancestor
65033284|NCT00553345|Micronutrients|micronutrients|mesh-ancestor
65033285|NCT00553345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033286|NCT00553345|Antioxidants|antioxidants|mesh-ancestor
65033287|NCT00553345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033288|NCT00553345|Protective Agents|protective agents|mesh-ancestor
65033289|NCT00553345|Trace Elements|trace elements|mesh-ancestor
65033290|NCT00202800|Gemcitabine|gemcitabine|mesh-list
65033291|NCT00202800|Etoposide|etoposide|mesh-list
65033292|NCT00202800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65033293|NCT00202800|Antimetabolites|antimetabolites|mesh-ancestor
65033294|NCT00202800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033295|NCT00202800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033296|NCT00202800|Antiviral Agents|antiviral agents|mesh-ancestor
65033297|NCT00202800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65033298|NCT00202800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033299|NCT00202800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951060|NCT00025064|Melphalan|melphalan|mesh-list
64951061|NCT00025064|Ifosfamide|ifosfamide|mesh-list
64951062|NCT00025064|Dacarbazine|dacarbazine|mesh-list
64951063|NCT00025064|Bleomycin|bleomycin|mesh-list
64951064|NCT00025064|Vinblastine|vinblastine|mesh-list
64951065|NCT00025064|Procarbazine|procarbazine|mesh-list
64951066|NCT00025064|Chlorambucil|chlorambucil|mesh-list
64951067|NCT00025064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951068|NCT00025064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64951069|NCT00025064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64951070|NCT00025064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64951071|NCT00025064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951072|NCT00025064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725612|NCT00002461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64725613|NCT00002461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64725614|NCT00002461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64725615|NCT00002461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64725616|NCT00002461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725617|NCT00003026|Bicalutamide|bicalutamide|mesh-list
64333128|NCT02324842|Incretins|incretins|mesh-ancestor
64951073|NCT00025064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64951074|NCT00025064|Tubulin Modulators|tubulin modulators|mesh-ancestor
64951075|NCT00025064|Antimitotic Agents|antimitotic agents|mesh-ancestor
64951076|NCT00025064|Mitosis Modulators|mitosis modulators|mesh-ancestor
64951077|NCT00025064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64951078|NCT00025064|Alkylating Agents|alkylating agents|mesh-ancestor
64951079|NCT00025064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64951080|NCT00025064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951081|NCT00025064|Immunologic Factors|immunologic factors|mesh-ancestor
65033300|NCT00202800|Immunologic Factors|immunologic factors|mesh-ancestor
64885284|NCT04321551|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64885285|NCT04321551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033301|NCT00202800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033302|NCT00202800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65033303|NCT00202800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65033304|NCT00202800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65033305|NCT00407771|Tirofiban|tirofiban|mesh-list
65033306|NCT00407771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65033307|NCT00407771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65033308|NCT00407771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033309|NCT00407771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65033310|NCT00198198|Aripiprazole|aripiprazole|mesh-list
65033311|NCT00198198|Antidepressive Agents|antidepressive agents|mesh-ancestor
65033312|NCT00198198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65033313|NCT00198198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65033314|NCT00198198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65033315|NCT00198198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65033316|NCT00198198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033317|NCT00198198|Dopamine Agonists|dopamine agonists|mesh-ancestor
65033318|NCT00198198|Dopamine Agents|dopamine agents|mesh-ancestor
65033319|NCT00198198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65033320|NCT00198198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033321|NCT00198198|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64885286|NCT04321551|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64951082|NCT00025064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951083|NCT00025064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64951084|NCT00025064|Glucocorticoids|glucocorticoids|mesh-ancestor
64951085|NCT00025064|Hormones|hormones|mesh-ancestor
64951086|NCT00025064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64951087|NCT00025064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64951088|NCT00053001|Thalidomide|thalidomide|mesh-list
64951089|NCT00053001|Epoetin Alfa|epoetin alfa|mesh-list
64951090|NCT00053001|Hematinics|hematinics|mesh-ancestor
64951091|NCT00053001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951092|NCT00053001|Immunologic Factors|immunologic factors|mesh-ancestor
64951093|NCT00053001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951094|NCT00053001|Leprostatic Agents|leprostatic agents|mesh-ancestor
64951095|NCT00053001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64951096|NCT00053001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951097|NCT00053001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64951108|NCT00025103|Etoposide|etoposide|mesh-list
64951109|NCT00025103|Vincristine|vincristine|mesh-list
64951110|NCT00025103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951111|NCT00025103|Immunologic Factors|immunologic factors|mesh-ancestor
64951112|NCT00025103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951113|NCT00025103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64951114|NCT00025103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64885306|NCT04302324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033322|NCT00198198|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65033323|NCT00198198|Serotonin Agents|serotonin agents|mesh-ancestor
65033324|NCT00198198|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65033325|NCT00198198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65033326|NCT00198198|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65033327|NCT00198198|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65033328|NCT02206087|Heparin|heparin|mesh-list
65033329|NCT02206087|Calcium heparin|calcium heparin|mesh-list
65033330|NCT02206087|Anticoagulants|anticoagulants|mesh-ancestor
65033331|NCT02206087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65033332|NCT02206087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65033333|NCT02206087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033334|NCT00198237|Docetaxel|docetaxel|mesh-list
65033335|NCT00198237|Capecitabine|capecitabine|mesh-list
65033336|NCT00198237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033337|NCT00198237|Tubulin Modulators|tubulin modulators|mesh-ancestor
65033338|NCT00198237|Antimitotic Agents|antimitotic agents|mesh-ancestor
65033339|NCT00198237|Mitosis Modulators|mitosis modulators|mesh-ancestor
65033340|NCT00198237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885309|NCT04302324|Hormones|hormones|mesh-ancestor
64951115|NCT00025103|Alkylating Agents|alkylating agents|mesh-ancestor
64420545|NCT05479747|Analgesics|analgesics|mesh-list
64951117|NCT00025103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951118|NCT00025103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64951119|NCT00025103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64951120|NCT00025103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64951121|NCT00025103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64951122|NCT00025103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951123|NCT00025103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64951124|NCT00025103|Tubulin Modulators|tubulin modulators|mesh-ancestor
64951125|NCT00025103|Antimitotic Agents|antimitotic agents|mesh-ancestor
64951126|NCT00025103|Mitosis Modulators|mitosis modulators|mesh-ancestor
64951127|NCT00025103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64951128|NCT00025103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951129|NCT00025103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64951130|NCT00025103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64503356|NCT04505514|Hematinics|hematinics|mesh-ancestor
64503357|NCT04505202|Chlorhexidine|chlorhexidine|mesh-list
64951132|NCT00025142|Fluorouracil|fluorouracil|mesh-list
64951133|NCT00025142|Oxaliplatin|oxaliplatin|mesh-list
64951134|NCT00025142|Gefitinib|gefitinib|mesh-list
64951135|NCT00025142|Calcium|calcium|mesh-list
64951136|NCT00025142|Levoleucovorin|levoleucovorin|mesh-list
64951137|NCT00025142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64951138|NCT00025142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951139|NCT00025142|Antimetabolites|antimetabolites|mesh-ancestor
64951140|NCT00025142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951141|NCT00025142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64951142|NCT00025142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725618|NCT00003026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64725620|NCT00003026|Androgen Antagonists|androgen antagonists|mesh-ancestor
64725621|NCT00003026|Hormone Antagonists|hormone antagonists|mesh-ancestor
64725622|NCT00003026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64725623|NCT00003026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885325|NCT04074460|Propofol|propofol|mesh-list
65033341|NCT00198237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65033342|NCT00198237|Antimetabolites|antimetabolites|mesh-ancestor
65033343|NCT00198354|Gemcitabine|gemcitabine|mesh-list
65033344|NCT00198354|Paclitaxel|paclitaxel|mesh-list
65033345|NCT00198354|Carboplatin|carboplatin|mesh-list
65033346|NCT00198354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65033347|NCT00198354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033348|NCT00198354|Tubulin Modulators|tubulin modulators|mesh-ancestor
65033349|NCT00198354|Antimitotic Agents|antimitotic agents|mesh-ancestor
65033350|NCT00198354|Mitosis Modulators|mitosis modulators|mesh-ancestor
65033351|NCT00198354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033352|NCT00198354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65033354|NCT00198354|Antiviral Agents|antiviral agents|mesh-ancestor
65033355|NCT00198354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65033356|NCT00198354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033357|NCT00198354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65033358|NCT00198354|Immunologic Factors|immunologic factors|mesh-ancestor
65033359|NCT00198354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033360|NCT02158585|Lamotrigine|lamotrigine|mesh-list
65033361|NCT02158585|Anticonvulsants|anticonvulsants|mesh-ancestor
65033362|NCT02158585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64725624|NCT00003026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725625|NCT00003026|Luteolytic Agents|luteolytic agents|mesh-ancestor
64725626|NCT00003026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64725627|NCT00003026|Contraceptive Agents|contraceptive agents|mesh-ancestor
64333133|NCT02295280|Diphenhydramine|diphenhydramine|mesh-list
64951143|NCT00025142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951144|NCT00025142|Immunologic Factors|immunologic factors|mesh-ancestor
64951145|NCT00025142|Antidotes|antidotes|mesh-ancestor
64951146|NCT00025142|Protective Agents|protective agents|mesh-ancestor
64951147|NCT00025142|Vitamin B Complex|vitamin b complex|mesh-ancestor
64951148|NCT00025142|Vitamins|vitamins|mesh-ancestor
64951149|NCT00025142|Micronutrients|micronutrients|mesh-ancestor
64951150|NCT00025142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64951151|NCT00025142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951152|NCT00053118|Carboplatin|carboplatin|mesh-list
64951153|NCT00053118|Etoposide|etoposide|mesh-list
64951154|NCT00053118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951155|NCT00053118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64951156|NCT00053118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64951157|NCT00053118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64951158|NCT00053118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951159|NCT00053118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951160|NCT00025181|Ipilimumab|ipilimumab|mesh-list
64951161|NCT00025181|Freund's Adjuvant|freund's adjuvant|mesh-list
64951162|NCT00025181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64951163|NCT00025181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951165|NCT00025181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951166|NCT00025181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64951167|NCT00025181|Immunologic Factors|immunologic factors|mesh-ancestor
64951168|NCT00025181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951169|NCT00025220|Thalidomide|thalidomide|mesh-list
64951170|NCT00025220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951171|NCT00025220|Immunologic Factors|immunologic factors|mesh-ancestor
65033363|NCT02158585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65033364|NCT02158585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033365|NCT02158585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65033366|NCT02158585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033367|NCT02158585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65033368|NCT02158585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65033369|NCT02158585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65033370|NCT02158585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65033371|NCT02158585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65033372|NCT00202917|Fludarabine|fludarabine|mesh-list
65033373|NCT00202917|Melphalan|melphalan|mesh-list
65033374|NCT00202917|Thiotepa|thiotepa|mesh-list
65033375|NCT00202917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951172|NCT00025220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951173|NCT00025220|Leprostatic Agents|leprostatic agents|mesh-ancestor
64951174|NCT00025220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64951175|NCT00025220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951176|NCT00025220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64951177|NCT00025220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64951178|NCT00025220|Growth Substances|growth substances|mesh-ancestor
64951184|NCT00025298|Paclitaxel|paclitaxel|mesh-list
64951185|NCT00025298|Carboplatin|carboplatin|mesh-list
64951186|NCT00025298|Amifostine|amifostine|mesh-list
64951187|NCT00025298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64951188|NCT00025298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951189|NCT00025298|Tubulin Modulators|tubulin modulators|mesh-ancestor
64951190|NCT00025298|Antimitotic Agents|antimitotic agents|mesh-ancestor
64951191|NCT00025298|Mitosis Modulators|mitosis modulators|mesh-ancestor
64951192|NCT00025298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951193|NCT00025298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64951194|NCT00025298|Protective Agents|protective agents|mesh-ancestor
64951195|NCT00025298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951196|NCT00053196|Mycophenolic Acid|mycophenolic acid|mesh-list
64951197|NCT00053196|Methotrexate|methotrexate|mesh-list
64951198|NCT00053196|Fludarabine phosphate|fludarabine phosphate|mesh-list
64725628|NCT00003026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64725629|NCT00003026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64725630|NCT00003026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64725632|NCT00002143|Keratolytic Agents|keratolytic agents|mesh-ancestor
64725633|NCT00002143|Dermatologic Agents|dermatologic agents|mesh-ancestor
64725634|NCT00002149|Amoxicillin|amoxicillin|mesh-list
64725635|NCT00002149|Clavulanic Acid|clavulanic acid|mesh-list
64725636|NCT00002149|Clavulanic Acids|clavulanic acids|mesh-list
64725637|NCT00002149|Pseudoephedrine|pseudoephedrine|mesh-list
64951199|NCT00053196|Fludarabine|fludarabine|mesh-list
64951200|NCT00053196|Busulfan|busulfan|mesh-list
64951201|NCT00053196|Allopurinol|allopurinol|mesh-list
64951202|NCT00053196|Tacrolimus|tacrolimus|mesh-list
64951203|NCT00053196|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64951204|NCT00053196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64951205|NCT00053196|Abortifacient Agents|abortifacient agents|mesh-ancestor
64951206|NCT00053196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64951207|NCT00053196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951208|NCT00053196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64503358|NCT04505202|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64951209|NCT00053196|Antimetabolites|antimetabolites|mesh-ancestor
64951210|NCT00053196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951211|NCT00053196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951212|NCT00053196|Dermatologic Agents|dermatologic agents|mesh-ancestor
64951213|NCT00053196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951214|NCT00053196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64951215|NCT00053196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951216|NCT00053196|Immunologic Factors|immunologic factors|mesh-ancestor
65033376|NCT00202917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885358|NCT03747042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885359|NCT03747042|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65033377|NCT00202917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65033378|NCT00202917|Immunologic Factors|immunologic factors|mesh-ancestor
65033379|NCT00202917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033380|NCT00202917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65033381|NCT00202917|Alkylating Agents|alkylating agents|mesh-ancestor
65033382|NCT00202917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65033383|NCT00202995|Glatiramer Acetate|glatiramer acetate|mesh-list
65033384|NCT00202995|Interferon beta-1b|interferon beta-1b|mesh-list
65033385|NCT00202995|(T,G)-A-L|(t,g)-a-l|mesh-list
65033386|NCT00202995|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65033387|NCT00202995|Immunologic Factors|immunologic factors|mesh-ancestor
65033388|NCT00202995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951217|NCT00053196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64951218|NCT00053196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64951219|NCT00053196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64951220|NCT00053196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64951221|NCT00053196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64951222|NCT00053196|Antitubercular Agents|antitubercular agents|mesh-ancestor
64951223|NCT00053196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64951224|NCT00053196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951225|NCT00053196|Alkylating Agents|alkylating agents|mesh-ancestor
64951226|NCT00053196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64951227|NCT00053196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64951228|NCT00053196|Gout Suppressants|gout suppressants|mesh-ancestor
64951229|NCT00053196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64951230|NCT00053196|Antioxidants|antioxidants|mesh-ancestor
64951231|NCT00053196|Protective Agents|protective agents|mesh-ancestor
64951232|NCT00025337|Leucovorin|leucovorin|mesh-list
64951233|NCT00025337|Bevacizumab|bevacizumab|mesh-list
64951234|NCT00025337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64951235|NCT00025337|Fluorouracil|fluorouracil|mesh-list
64951236|NCT00025337|Oxaliplatin|oxaliplatin|mesh-list
64951237|NCT00025337|Antibodies|antibodies|mesh-list
64951238|NCT00025337|Immunoglobulins|immunoglobulins|mesh-list
64951253|NCT00025337|Protective Agents|protective agents|mesh-ancestor
64951254|NCT00025337|Vitamin B Complex|vitamin b complex|mesh-ancestor
64951255|NCT00025337|Vitamins|vitamins|mesh-ancestor
64420553|NCT05479357|Oxytocin|oxytocin|mesh-list
64951265|NCT00025454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951266|NCT00025493|Docetaxel|docetaxel|mesh-list
64951267|NCT00025493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951268|NCT00025493|Tubulin Modulators|tubulin modulators|mesh-ancestor
64951269|NCT00025493|Antimitotic Agents|antimitotic agents|mesh-ancestor
64951270|NCT00025493|Mitosis Modulators|mitosis modulators|mesh-ancestor
64725639|NCT00002149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64725640|NCT00002149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725641|NCT00002149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64725642|NCT00002149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725643|NCT00002149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951271|NCT00025493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951272|NCT00025532|Antibodies|antibodies|mesh-list
64951273|NCT00025532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64951274|NCT00025532|Immunologic Factors|immunologic factors|mesh-ancestor
64951275|NCT00025532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951276|NCT00053430|Thalidomide|thalidomide|mesh-list
64951277|NCT00053430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951278|NCT00053430|Immunologic Factors|immunologic factors|mesh-ancestor
64951279|NCT00053430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951280|NCT00053430|Leprostatic Agents|leprostatic agents|mesh-ancestor
64885368|NCT03703102|Dermatologic Agents|dermatologic agents|mesh-ancestor
65033389|NCT00202995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65033390|NCT00202995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65033391|NCT04677868|Methotrexate|methotrexate|mesh-list
65033392|NCT04677868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65033393|NCT04677868|Abortifacient Agents|abortifacient agents|mesh-ancestor
65033394|NCT04677868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65033395|NCT04677868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033396|NCT04677868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65033397|NCT04677868|Antimetabolites|antimetabolites|mesh-ancestor
65033398|NCT04677868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033399|NCT04677868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033400|NCT04677868|Dermatologic Agents|dermatologic agents|mesh-ancestor
65033401|NCT04677868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033402|NCT04677868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65033403|NCT04677868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65033404|NCT04677868|Immunologic Factors|immunologic factors|mesh-ancestor
65033405|NCT04677868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65033406|NCT04677868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65033407|NCT00198393|Gemcitabine|gemcitabine|mesh-list
65033408|NCT00198393|Docetaxel|docetaxel|mesh-list
65033409|NCT00198393|Gefitinib|gefitinib|mesh-list
65033410|NCT00198393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65033411|NCT00198393|Antimetabolites|antimetabolites|mesh-ancestor
65033412|NCT00198393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033413|NCT00198393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033414|NCT00198393|Antiviral Agents|antiviral agents|mesh-ancestor
65033415|NCT00198393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65033416|NCT00198393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033417|NCT00198393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65033418|NCT00198393|Immunologic Factors|immunologic factors|mesh-ancestor
65033419|NCT00198393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033420|NCT00198393|Tubulin Modulators|tubulin modulators|mesh-ancestor
65033421|NCT00198393|Antimitotic Agents|antimitotic agents|mesh-ancestor
65033422|NCT00198393|Mitosis Modulators|mitosis modulators|mesh-ancestor
64951281|NCT00053430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64951282|NCT00053430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951283|NCT00053430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64951284|NCT00053430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64951285|NCT00053430|Growth Substances|growth substances|mesh-ancestor
64885402|NCT03427736|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65033423|NCT00198393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65033424|NCT02103322|Imatinib Mesylate|imatinib mesylate|mesh-list
65033425|NCT02103322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65493859|NCT04166318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033426|NCT02103322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65033427|NCT02103322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033428|NCT02103322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033430|NCT00554827|Folic Acid|folic acid|mesh-list
65033431|NCT00554827|Vitamin B 12|vitamin b 12|mesh-list
65033432|NCT00554827|Vitamin B Complex|vitamin b complex|mesh-list
65033433|NCT00554827|10-deazaaminopterin|10-deazaaminopterin|mesh-list
65033434|NCT00554827|Aminopterin|aminopterin|mesh-list
65033435|NCT00554827|Micronutrients|micronutrients|mesh-ancestor
65033436|NCT00554827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033437|NCT00554827|Hematinics|hematinics|mesh-ancestor
65033438|NCT00554827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65033439|NCT00554827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033440|NCT00554827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033441|NCT00554827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033442|NCT00203034|Rasagiline|rasagiline|mesh-list
65033443|NCT00203034|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65033444|NCT00203034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033445|NCT00203034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490075|NCT04355962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64951286|NCT00053430|Growth Inhibitors|growth inhibitors|mesh-ancestor
64951287|NCT00053430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951289|NCT00025610|Carboplatin|carboplatin|mesh-list
64951290|NCT00025610|Doxorubicin|doxorubicin|mesh-list
64951291|NCT00025610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64951292|NCT00025610|Etoposide|etoposide|mesh-list
64951293|NCT00025610|Vincristine|vincristine|mesh-list
64951294|NCT00025610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951295|NCT00025610|Immunologic Factors|immunologic factors|mesh-ancestor
64951296|NCT00025610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951297|NCT00025610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64951298|NCT00025610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64951299|NCT00025610|Alkylating Agents|alkylating agents|mesh-ancestor
64951300|NCT00025610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951307|NCT00025610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64951309|NCT00025610|Antimitotic Agents|antimitotic agents|mesh-ancestor
64951310|NCT00025610|Mitosis Modulators|mitosis modulators|mesh-ancestor
64951311|NCT00025649|Cyclophosphamide|cyclophosphamide|mesh-list
64951312|NCT00025649|Melphalan|melphalan|mesh-list
64951313|NCT00025649|Busulfan|busulfan|mesh-list
64951314|NCT00025649|Carboplatin|carboplatin|mesh-list
64951315|NCT00025649|Doxorubicin|doxorubicin|mesh-list
64951316|NCT00025649|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64951317|NCT00025649|Etoposide|etoposide|mesh-list
64951318|NCT00025649|Vincristine|vincristine|mesh-list
64951319|NCT00025649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951320|NCT00025649|Immunologic Factors|immunologic factors|mesh-ancestor
64951321|NCT00025649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033446|NCT00203034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65033447|NCT00203034|Protective Agents|protective agents|mesh-ancestor
65033448|NCT00203034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033449|NCT00203073|Mitoxantrone|mitoxantrone|mesh-list
65033450|NCT00203073|Glatiramer Acetate|glatiramer acetate|mesh-list
65033451|NCT00203073|(T,G)-A-L|(t,g)-a-l|mesh-list
65033452|NCT00203073|Analgesics|analgesics|mesh-ancestor
65033453|NCT00203073|Sensory System Agents|sensory system agents|mesh-ancestor
65033454|NCT00203073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65033455|NCT00203073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033456|NCT00203073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033457|NCT00203073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65033458|NCT00203073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65033459|NCT00203073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033460|NCT00203073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033461|NCT00203073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65033462|NCT00203073|Immunologic Factors|immunologic factors|mesh-ancestor
65033463|NCT00203073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65033464|NCT00203073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65033465|NCT00198432|Paclitaxel|paclitaxel|mesh-list
65033466|NCT00198432|Vinorelbine|vinorelbine|mesh-list
65033467|NCT00198432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65033468|NCT00198432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033469|NCT00198432|Tubulin Modulators|tubulin modulators|mesh-ancestor
65033470|NCT00198432|Antimitotic Agents|antimitotic agents|mesh-ancestor
65033471|NCT00198432|Mitosis Modulators|mitosis modulators|mesh-ancestor
65033472|NCT00198432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033473|NCT02072863|Prednisone|prednisone|mesh-list
65033474|NCT02072863|Melphalan|melphalan|mesh-list
65033475|NCT02072863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65033490|NCT02072161|Antimetabolites|antimetabolites|mesh-ancestor
65033491|NCT02072161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033492|NCT02072161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65033493|NCT02072161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033494|NCT02072161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65033495|NCT02072161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033496|NCT00203112|Minocycline|minocycline|mesh-list
65033497|NCT00203112|Glatiramer Acetate|glatiramer acetate|mesh-list
65033498|NCT00203112|(T,G)-A-L|(t,g)-a-l|mesh-list
65033499|NCT00203112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65033500|NCT00203112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65033501|NCT00203112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65033502|NCT00203112|Immunologic Factors|immunologic factors|mesh-ancestor
65033503|NCT00203112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033504|NCT00203112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65033505|NCT00203112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65033506|NCT02057380|Dexamethasone|dexamethasone|mesh-list
65033507|NCT02057380|Paclitaxel|paclitaxel|mesh-list
65033508|NCT02057380|Bortezomib|bortezomib|mesh-list
65033509|NCT02057380|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65033510|NCT02057380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65033511|NCT02057380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033512|NCT02057380|Tubulin Modulators|tubulin modulators|mesh-ancestor
65033513|NCT02057380|Antimitotic Agents|antimitotic agents|mesh-ancestor
65033514|NCT02057380|Mitosis Modulators|mitosis modulators|mesh-ancestor
65033515|NCT02057380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033516|NCT02057380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65033517|NCT02057380|Antiemetics|antiemetics|mesh-ancestor
65033518|NCT02057380|Autonomic Agents|autonomic agents|mesh-ancestor
65033519|NCT02057380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65033520|NCT02057380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033521|NCT02057380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65033522|NCT02057380|Glucocorticoids|glucocorticoids|mesh-ancestor
65033523|NCT02057380|Hormones|hormones|mesh-ancestor
64951322|NCT00025649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64951323|NCT00025649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64951324|NCT00025649|Alkylating Agents|alkylating agents|mesh-ancestor
64951325|NCT00025649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951326|NCT00025649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951331|NCT00025649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951332|NCT00025649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64951333|NCT00025649|Tubulin Modulators|tubulin modulators|mesh-ancestor
64885503|NCT02856698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65033524|NCT02057380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64885504|NCT02856698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033525|NCT02057380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65033526|NCT02057380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65033527|NCT02057380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033528|NCT02052778|Futibatinib|futibatinib|mesh-list
65033529|NCT02052778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033530|NCT02050828|Ranibizumab|ranibizumab|mesh-list
65033531|NCT02050828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65033532|NCT02050828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65033533|NCT02050828|Growth Substances|growth substances|mesh-ancestor
65033534|NCT02050828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033535|NCT02050828|Growth Inhibitors|growth inhibitors|mesh-ancestor
65033536|NCT02050828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951334|NCT00025649|Antimitotic Agents|antimitotic agents|mesh-ancestor
64951335|NCT00025649|Mitosis Modulators|mitosis modulators|mesh-ancestor
64951336|NCT00025688|Paclitaxel|paclitaxel|mesh-list
64951337|NCT00025688|Carboplatin|carboplatin|mesh-list
64951338|NCT00025688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64951339|NCT00025688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951340|NCT00025688|Tubulin Modulators|tubulin modulators|mesh-ancestor
64951341|NCT00025688|Antimitotic Agents|antimitotic agents|mesh-ancestor
64951342|NCT00025688|Mitosis Modulators|mitosis modulators|mesh-ancestor
64725644|NCT00002149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64725645|NCT00002149|Autonomic Agents|autonomic agents|mesh-ancestor
64725646|NCT00002149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64725647|NCT00002149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725648|NCT00002149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64725649|NCT00002149|Respiratory System Agents|respiratory system agents|mesh-ancestor
64725650|NCT00002149|Nasal Decongestants|nasal decongestants|mesh-ancestor
64725651|NCT00002149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64725652|NCT00002149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64725653|NCT00002149|Sympathomimetics|sympathomimetics|mesh-ancestor
64725654|NCT00002149|Adrenergic Agents|adrenergic agents|mesh-ancestor
64951343|NCT00025688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951344|NCT00025727|Ritonavir|ritonavir|mesh-list
64951345|NCT00025727|Lopinavir|lopinavir|mesh-list
64951346|NCT00025727|Fosamprenavir|fosamprenavir|mesh-list
64951347|NCT00025727|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64951348|NCT00025727|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64951349|NCT00025727|Protease Inhibitors|protease inhibitors|mesh-ancestor
64951350|NCT00025727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951351|NCT00025727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951352|NCT00025727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64951353|NCT00025727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64951354|NCT00025727|Antiviral Agents|antiviral agents|mesh-ancestor
64951355|NCT00025727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951356|NCT00025727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64951357|NCT00025727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64951358|NCT00053820|Interferons|interferons|mesh-list
64951359|NCT00053820|Interferon-alpha|interferon-alpha|mesh-list
64951360|NCT00053820|Aldesleukin|aldesleukin|mesh-list
64503359|NCT04505202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64951361|NCT00053820|Fluorouracil|fluorouracil|mesh-list
64951362|NCT00053820|Antimetabolites|antimetabolites|mesh-ancestor
64951363|NCT00053820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503360|NCT04505202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951364|NCT00053820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65033537|NCT02046694|Allopurinol|allopurinol|mesh-list
64885515|NCT02625610|Leucovorin|leucovorin|mesh-list
65033538|NCT02046694|Antimetabolites|antimetabolites|mesh-ancestor
65033539|NCT02046694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033540|NCT02046694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033541|NCT02046694|Gout Suppressants|gout suppressants|mesh-ancestor
65033542|NCT02046694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65033543|NCT02046694|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65033544|NCT02046694|Antioxidants|antioxidants|mesh-ancestor
65033545|NCT02046694|Protective Agents|protective agents|mesh-ancestor
65033546|NCT02046694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033547|NCT00203190|Topiramate|topiramate|mesh-list
65033548|NCT00203190|Anticonvulsants|anticonvulsants|mesh-ancestor
65033549|NCT00203190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65033550|NCT00203190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033551|NCT02019589|Progesterone|progesterone|mesh-list
65033552|NCT02019589|Progestins|progestins|mesh-ancestor
65033553|NCT02019589|Hormones|hormones|mesh-ancestor
65033554|NCT02019589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65033555|NCT02019589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033556|NCT02018926|Azacitidine|azacitidine|mesh-list
64951365|NCT00053820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951366|NCT00053820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951367|NCT00053820|Immunologic Factors|immunologic factors|mesh-ancestor
64951368|NCT00053820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951372|NCT00053820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64951373|NCT04731090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64951374|NCT04731090|Fluoroquinolones|fluoroquinolones|mesh-list
64951375|NCT04731090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64951376|NCT04731090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951377|NCT04731090|Antitubercular Agents|antitubercular agents|mesh-ancestor
64951378|NCT04731090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64951379|NCT04731090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951380|NCT04731090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951381|NCT00053937|Pirfenidone|pirfenidone|mesh-list
64951382|NCT00053937|Analgesics|analgesics|mesh-ancestor
64951383|NCT00053937|Sensory System Agents|sensory system agents|mesh-ancestor
64951384|NCT00053937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64951385|NCT00053937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951386|NCT00053937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64420592|NCT04274179|Anticonvulsants|anticonvulsants|mesh-ancestor
64725657|NCT03868046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725658|NCT03868046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725660|NCT02973295|Antioxidants|antioxidants|mesh-ancestor
64725661|NCT02973295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725662|NCT02973295|Protective Agents|protective agents|mesh-ancestor
64725663|NCT02973295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725664|NCT00003032|Tamoxifen|tamoxifen|mesh-list
64725665|NCT00003032|Cyclophosphamide|cyclophosphamide|mesh-list
64725666|NCT00003032|Mitoxantrone|mitoxantrone|mesh-list
64725667|NCT00003032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64725668|NCT00003032|Immunologic Factors|immunologic factors|mesh-ancestor
64725669|NCT00003032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725670|NCT00003032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64725671|NCT00003032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65033557|NCT02018926|Mocetinostat|mocetinostat|mesh-list
65033558|NCT02018926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65033559|NCT02018926|Antimetabolites|antimetabolites|mesh-ancestor
65033560|NCT02018926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033561|NCT02018926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033562|NCT02018926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033563|NCT02018926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65033564|NCT01989325|Dexamethasone|dexamethasone|mesh-list
65033565|NCT01989325|Filanesib|filanesib|mesh-list
65033566|NCT01989325|Lenograstim|lenograstim|mesh-list
65033567|NCT01989325|Proteasome Inhibitors|proteasome inhibitors|mesh-list
65033568|NCT01989325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65033569|NCT01989325|Antiemetics|antiemetics|mesh-ancestor
65033570|NCT01989325|Autonomic Agents|autonomic agents|mesh-ancestor
65033571|NCT01989325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65033572|NCT01989325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033573|NCT01989325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65033574|NCT01989325|Glucocorticoids|glucocorticoids|mesh-ancestor
65033575|NCT01989325|Hormones|hormones|mesh-ancestor
65033576|NCT01989325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65033577|NCT01989325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65033578|NCT01989325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033579|NCT01989325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65033580|NCT01989325|Immunologic Factors|immunologic factors|mesh-ancestor
65033581|NCT01989325|Protease Inhibitors|protease inhibitors|mesh-ancestor
65033582|NCT01989325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033583|NCT01989325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033584|NCT01989325|Antimitotic Agents|antimitotic agents|mesh-ancestor
65033585|NCT01989325|Mitosis Modulators|mitosis modulators|mesh-ancestor
65033586|NCT01978366|Halofuginone|halofuginone|mesh-list
65033587|NCT01978366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033588|NCT01978366|Coccidiostats|coccidiostats|mesh-ancestor
65033589|NCT01978366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64725672|NCT00003032|Alkylating Agents|alkylating agents|mesh-ancestor
64725673|NCT00003032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725674|NCT00003032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333171|NCT05263505|Antimetabolites|antimetabolites|mesh-ancestor
64951396|NCT00053976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64951397|NCT00053976|Prednisolone phosphate|prednisolone phosphate|mesh-list
64951398|NCT00053976|Daclizumab|daclizumab|mesh-list
64951399|NCT00053976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64951400|NCT00053976|Antiemetics|antiemetics|mesh-ancestor
64951401|NCT00053976|Autonomic Agents|autonomic agents|mesh-ancestor
65033590|NCT01978366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65033591|NCT01978366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65033592|NCT01978366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65033593|NCT01978366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033594|NCT01978366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033595|NCT01978366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65033596|NCT01978366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65033597|NCT01978366|Growth Substances|growth substances|mesh-ancestor
65033598|NCT01978366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033599|NCT01978366|Growth Inhibitors|growth inhibitors|mesh-ancestor
65033600|NCT02962986|Phenylephrine|phenylephrine|mesh-list
65033601|NCT02962986|Oxymetazoline|oxymetazoline|mesh-list
65033602|NCT02962986|Norepinephrine|norepinephrine|mesh-list
65033603|NCT02962986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65033604|NCT02962986|Mydriatics|mydriatics|mesh-ancestor
65033605|NCT02962986|Autonomic Agents|autonomic agents|mesh-ancestor
65033606|NCT02962986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65033607|NCT02962986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033608|NCT02962986|Sympathomimetics|sympathomimetics|mesh-ancestor
65033609|NCT02962986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65033610|NCT02962986|Nasal Decongestants|nasal decongestants|mesh-ancestor
64951402|NCT00053976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64951403|NCT00053976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951404|NCT00053976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64951405|NCT00053976|Glucocorticoids|glucocorticoids|mesh-ancestor
64951406|NCT00053976|Hormones|hormones|mesh-ancestor
64951407|NCT00053976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64951408|NCT00053976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64951409|NCT00053976|Protective Agents|protective agents|mesh-ancestor
64951410|NCT00053976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64951411|NCT00053976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951412|NCT00053976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951413|NCT00053976|Immunologic Factors|immunologic factors|mesh-ancestor
64951414|NCT04733573|Salicylic Acid|salicylic acid|mesh-list
64951415|NCT04733573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951416|NCT04733573|Antifungal Agents|antifungal agents|mesh-ancestor
64951417|NCT04733573|Keratolytic Agents|keratolytic agents|mesh-ancestor
64951418|NCT04733573|Dermatologic Agents|dermatologic agents|mesh-ancestor
64951419|NCT00026039|Estrogens|estrogens|mesh-list
64951420|NCT00026039|Hormones|hormones|mesh-ancestor
64951421|NCT00026039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64951422|NCT00026039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951423|NCT00054054|Docetaxel|docetaxel|mesh-list
64951424|NCT00054054|Fluorouracil|fluorouracil|mesh-list
64951425|NCT00054054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951426|NCT00054054|Tubulin Modulators|tubulin modulators|mesh-ancestor
64951427|NCT00054054|Antimitotic Agents|antimitotic agents|mesh-ancestor
64951428|NCT00054054|Mitosis Modulators|mitosis modulators|mesh-ancestor
64725676|NCT00003032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64725677|NCT00003032|Hormone Antagonists|hormone antagonists|mesh-ancestor
64725678|NCT00003032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64951429|NCT00054054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951430|NCT00054054|Antimetabolites|antimetabolites|mesh-ancestor
64490223|NCT03553875|Memantine|memantine|mesh-list
65033611|NCT02962986|Respiratory System Agents|respiratory system agents|mesh-ancestor
65033612|NCT02962986|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65033613|NCT02962986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65033614|NCT02962986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65033615|NCT02962986|Adrenergic Agents|adrenergic agents|mesh-ancestor
65033616|NCT02962986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65033617|NCT02962986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033618|NCT02962986|Protective Agents|protective agents|mesh-ancestor
65033619|NCT04677361|Pembrolizumab|pembrolizumab|mesh-list
65033620|NCT04677361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65033621|NCT04677361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033622|NCT01968733|Moxifloxacin|moxifloxacin|mesh-list
65033623|NCT01968733|Solithromycin|solithromycin|mesh-list
65033624|NCT01968733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64951431|NCT00054054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64951432|NCT00054054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951433|NCT00054054|Immunologic Factors|immunologic factors|mesh-ancestor
64951445|NCT00398229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64951446|NCT00398229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951448|NCT00026156|Vinorelbine|vinorelbine|mesh-list
64951449|NCT00026156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951450|NCT00026156|Tubulin Modulators|tubulin modulators|mesh-ancestor
64951451|NCT00026156|Antimitotic Agents|antimitotic agents|mesh-ancestor
64951452|NCT00026156|Mitosis Modulators|mitosis modulators|mesh-ancestor
64951453|NCT00026156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951454|NCT00026156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64951455|NCT00054171|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64951456|NCT00054171|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64951457|NCT00054171|Dermatologic Agents|dermatologic agents|mesh-ancestor
64951458|NCT00026195|Irinotecan|irinotecan|mesh-list
64951459|NCT00026195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64951460|NCT00026195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64951461|NCT00026195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951462|NCT00026195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951463|NCT00026195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951464|NCT00054210|Paclitaxel|paclitaxel|mesh-list
64951465|NCT00054210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64951466|NCT00054210|Carboplatin|carboplatin|mesh-list
64951467|NCT00054210|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
64951468|NCT00054210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64951469|NCT00054210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951470|NCT00054210|Tubulin Modulators|tubulin modulators|mesh-ancestor
64951471|NCT00054210|Antimitotic Agents|antimitotic agents|mesh-ancestor
64951472|NCT00054210|Mitosis Modulators|mitosis modulators|mesh-ancestor
64951473|NCT00054210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951474|NCT00026234|Dexamethasone|dexamethasone|mesh-list
64951475|NCT00026234|Capecitabine|capecitabine|mesh-list
64951476|NCT00026234|Oxaliplatin|oxaliplatin|mesh-list
64951477|NCT00026234|Floxuridine|floxuridine|mesh-list
64951478|NCT00026234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64951479|NCT00026234|Antiemetics|antiemetics|mesh-ancestor
64951480|NCT00026234|Autonomic Agents|autonomic agents|mesh-ancestor
64951481|NCT00026234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64951482|NCT00026234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951483|NCT00026234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64951484|NCT00026234|Glucocorticoids|glucocorticoids|mesh-ancestor
64951485|NCT00026234|Hormones|hormones|mesh-ancestor
64951486|NCT00026234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64951487|NCT00026234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64951488|NCT00026234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033625|NCT01968733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64885596|NCT01442246|Fertility Agents|fertility agents|mesh-ancestor
65033626|NCT01968733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65033627|NCT01968733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65033628|NCT01968733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033629|NCT01968733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033630|NCT01968733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033631|NCT00410553|Gemcitabine|gemcitabine|mesh-list
65033632|NCT00410553|Halichondrin B|halichondrin b|mesh-list
65033633|NCT00410553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65033634|NCT00410553|Antimetabolites|antimetabolites|mesh-ancestor
65033635|NCT00410553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033636|NCT00410553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033637|NCT00410553|Antiviral Agents|antiviral agents|mesh-ancestor
65033638|NCT00410553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65033639|NCT00410553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033640|NCT00410553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65033641|NCT00410553|Immunologic Factors|immunologic factors|mesh-ancestor
65033642|NCT00410553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033643|NCT00410553|Tubulin Modulators|tubulin modulators|mesh-ancestor
65033644|NCT00410553|Antimitotic Agents|antimitotic agents|mesh-ancestor
65033645|NCT00410553|Mitosis Modulators|mitosis modulators|mesh-ancestor
65033646|NCT00410592|Esomeprazole|esomeprazole|mesh-list
65033647|NCT00410592|Pantoprazole|pantoprazole|mesh-list
65033648|NCT00410592|Lansoprazole|lansoprazole|mesh-list
65033649|NCT00410592|Dexlansoprazole|dexlansoprazole|mesh-list
65033650|NCT00410592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65033651|NCT00410592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65033652|NCT00410592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65033653|NCT00410592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066967|NCT00418704|Antimitotic Agents|antimitotic agents|mesh-ancestor
65033654|NCT00410592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033656|NCT00410631|Melphalan|melphalan|mesh-list
65033657|NCT00410631|Ifosfamide|ifosfamide|mesh-list
64951489|NCT00026234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64951490|NCT00026234|Antimetabolites|antimetabolites|mesh-ancestor
64951491|NCT00026234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951492|NCT00054288|Gemcitabine|gemcitabine|mesh-list
64951493|NCT00054288|Irinotecan|irinotecan|mesh-list
64951494|NCT00054288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64951495|NCT00054288|Antimetabolites|antimetabolites|mesh-ancestor
64725680|NCT00003032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64725681|NCT00003032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65033658|NCT00410631|Dacarbazine|dacarbazine|mesh-list
65033659|NCT00410631|Carboplatin|carboplatin|mesh-list
65033660|NCT00410631|Doxorubicin|doxorubicin|mesh-list
65033661|NCT00410631|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65033662|NCT00410631|Etoposide|etoposide|mesh-list
65033663|NCT00410631|Vincristine|vincristine|mesh-list
65033664|NCT00410631|Topotecan|topotecan|mesh-list
65033665|NCT00410631|Etoposide phosphate|etoposide phosphate|mesh-list
65033666|NCT00410631|Vindesine|vindesine|mesh-list
65033667|NCT00410631|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65033668|NCT00410631|Isotretinoin|isotretinoin|mesh-list
65033669|NCT00410631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65033670|NCT00410631|Immunologic Factors|immunologic factors|mesh-ancestor
65033671|NCT00410631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033672|NCT00410631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65033673|NCT00410631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65033674|NCT00410631|Alkylating Agents|alkylating agents|mesh-ancestor
65033676|NCT00410631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033719|NCT01887886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65033720|NCT01887886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033721|NCT01887886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033722|NCT01877395|Vaccines|vaccines|mesh-list
65033723|NCT01877395|Immunologic Factors|immunologic factors|mesh-ancestor
65033724|NCT01877395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033725|NCT01874626|Ibuprofen|ibuprofen|mesh-list
65033726|NCT01874626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65033727|NCT01874626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65033728|NCT01874626|Analgesics|analgesics|mesh-ancestor
65033729|NCT01874626|Sensory System Agents|sensory system agents|mesh-ancestor
64907551|NCT00000793|Amitriptyline|amitriptyline|mesh-list
65033730|NCT01874626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65033731|NCT01874626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033732|NCT01874626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65033733|NCT01874626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65033734|NCT01874626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65033735|NCT01874626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033736|NCT01874626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033738|NCT00410748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65033739|NCT00410748|Narcotics|narcotics|mesh-ancestor
65033740|NCT00410748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65033741|NCT00410748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033742|NCT00410748|Analgesics|analgesics|mesh-ancestor
65033743|NCT00410748|Sensory System Agents|sensory system agents|mesh-ancestor
65033744|NCT00410748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65033766|NCT01862224|Immunologic Factors|immunologic factors|mesh-ancestor
65033767|NCT01862224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65033768|NCT01862224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65033769|NCT01859962|Ribavirin|ribavirin|mesh-list
65033770|NCT01859962|Antimetabolites|antimetabolites|mesh-ancestor
65033771|NCT01859962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033772|NCT01859962|Antiviral Agents|antiviral agents|mesh-ancestor
65033773|NCT01859962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65033774|NCT00173888|Gemcitabine|gemcitabine|mesh-list
65033775|NCT00173888|Cisplatin|cisplatin|mesh-list
65033776|NCT00173888|Docetaxel|docetaxel|mesh-list
65033832|NCT00555100|Growth Inhibitors|growth inhibitors|mesh-ancestor
65033833|NCT00555139|Alprazolam|alprazolam|mesh-list
65033834|NCT00555139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65033835|NCT00555139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65033836|NCT00555139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033837|NCT00555139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65033838|NCT00555139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65033839|NCT00555139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65033840|NCT00555139|GABA Modulators|gaba modulators|mesh-ancestor
65033841|NCT00555139|GABA Agents|gaba agents|mesh-ancestor
65033842|NCT00555139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65033843|NCT00555139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65033844|NCT00203463|Topiramate|topiramate|mesh-list
65033845|NCT00203463|Anticonvulsants|anticonvulsants|mesh-ancestor
65033846|NCT00203463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65033847|NCT00203463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033848|NCT00407849|Triamcinolone|triamcinolone|mesh-list
65033849|NCT00407849|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65033850|NCT00407849|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65033851|NCT00407849|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65033852|NCT00407849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65033853|NCT00407849|Glucocorticoids|glucocorticoids|mesh-ancestor
65033854|NCT00407849|Hormones|hormones|mesh-ancestor
65033855|NCT00407849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65033856|NCT00407849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033857|NCT00407849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65033861|NCT00407927|Epinastine|epinastine|mesh-list
65033880|NCT01807546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033881|NCT01807546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65033882|NCT01807546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65033883|NCT01807546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519082|NCT03228030|Thiamine|thiamine|mesh-list
65033884|NCT03454984|Guadecitabine|guadecitabine|mesh-list
65033885|NCT03454984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65033886|NCT01785433|Tiotropium Bromide|tiotropium bromide|mesh-list
65033887|NCT01785433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65033888|NCT01785433|Autonomic Agents|autonomic agents|mesh-ancestor
65033889|NCT01785433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65033890|NCT01785433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65033891|NCT01785433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65033892|NCT01785433|Respiratory System Agents|respiratory system agents|mesh-ancestor
65033893|NCT01785433|Parasympatholytics|parasympatholytics|mesh-ancestor
65033941|NCT01756924|Renal Agents|renal agents|mesh-ancestor
65033942|NCT01756924|Leprostatic Agents|leprostatic agents|mesh-ancestor
65033943|NCT01756924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65033944|NCT01756924|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65033945|NCT01756924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65033946|NCT01756924|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65033947|NCT01756924|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65033948|NCT01756924|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65033949|NCT01756924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65033950|NCT01756924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65033951|NCT01756924|Antimalarials|antimalarials|mesh-ancestor
65033952|NCT01756924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65033953|NCT01756924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65033954|NCT01756339|Moxifloxacin|moxifloxacin|mesh-list
65033955|NCT01756339|Solithromycin|solithromycin|mesh-list
65033956|NCT01756339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65033957|NCT01756339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65033958|NCT01756339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65033999|NCT00174317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65034000|NCT00174317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65034001|NCT00174317|Analgesics|analgesics|mesh-ancestor
65034002|NCT00174317|Sensory System Agents|sensory system agents|mesh-ancestor
65034003|NCT00174317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65034004|NCT00174317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034005|NCT00174317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65034006|NCT00174317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65034007|NCT00174317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65034008|NCT00174317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65034009|NCT00174317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034010|NCT00174317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034011|NCT01737892|Epinephrine|epinephrine|mesh-list
65034012|NCT01737892|Racepinephrine|racepinephrine|mesh-list
65034013|NCT01737892|Epinephryl borate|epinephryl borate|mesh-list
65034014|NCT01737892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65034015|NCT01737892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65034016|NCT01737892|Adrenergic Agents|adrenergic agents|mesh-ancestor
65034017|NCT01737892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65034056|NCT01719016|Purinergic Agents|purinergic agents|mesh-ancestor
65034057|NCT01719016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65034058|NCT01719016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034059|NCT00174356|Paclitaxel|paclitaxel|mesh-list
65034060|NCT00174356|Carboplatin|carboplatin|mesh-list
65034061|NCT00174356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65034062|NCT00174356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034063|NCT00174356|Tubulin Modulators|tubulin modulators|mesh-ancestor
65034064|NCT00174356|Antimitotic Agents|antimitotic agents|mesh-ancestor
65034065|NCT00174356|Mitosis Modulators|mitosis modulators|mesh-ancestor
65034066|NCT00174356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034067|NCT01718158|Ribavirin|ribavirin|mesh-list
65034068|NCT01718158|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65034069|NCT01718158|Antimetabolites|antimetabolites|mesh-ancestor
65034070|NCT01718158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034071|NCT01718158|Antiviral Agents|antiviral agents|mesh-ancestor
65034072|NCT01718158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65034073|NCT00174395|Eletriptan|eletriptan|mesh-list
65034074|NCT00174395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65034075|NCT00174395|Serotonin Agents|serotonin agents|mesh-ancestor
65034076|NCT00174395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65034077|NCT00174395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034078|NCT00174395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034079|NCT00203775|Risperidone|risperidone|mesh-list
65034080|NCT00203775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65034081|NCT00203775|Serotonin Agents|serotonin agents|mesh-ancestor
65034082|NCT00203775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65034103|NCT00555256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65034104|NCT00555256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65034105|NCT00555256|Antifungal Agents|antifungal agents|mesh-ancestor
65034106|NCT00555256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65034107|NCT00555256|Immunologic Factors|immunologic factors|mesh-ancestor
65034108|NCT00174434|Paclitaxel|paclitaxel|mesh-list
65034109|NCT00174434|Sunitinib|sunitinib|mesh-list
64519308|NCT02373124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65034110|NCT00174434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65034111|NCT00174434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034112|NCT00174434|Tubulin Modulators|tubulin modulators|mesh-ancestor
65034113|NCT00174434|Antimitotic Agents|antimitotic agents|mesh-ancestor
65034114|NCT00174434|Mitosis Modulators|mitosis modulators|mesh-ancestor
65034115|NCT00174434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034116|NCT00174434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65034117|NCT00174434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65034118|NCT00174434|Growth Substances|growth substances|mesh-ancestor
65034119|NCT00174434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034120|NCT00174434|Growth Inhibitors|growth inhibitors|mesh-ancestor
65034158|NCT00174512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034159|NCT00174512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034160|NCT00174512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034161|NCT00199017|Cytarabine|cytarabine|mesh-list
65034162|NCT00199017|Dexamethasone|dexamethasone|mesh-list
65034163|NCT00199017|Prednisolone|prednisolone|mesh-list
65034164|NCT00199017|Cyclophosphamide|cyclophosphamide|mesh-list
65034165|NCT00199017|Methotrexate|methotrexate|mesh-list
65034166|NCT00199017|Vincristine|vincristine|mesh-list
65034167|NCT00199017|Doxorubicin|doxorubicin|mesh-list
65034168|NCT00199017|Daunorubicin|daunorubicin|mesh-list
65034169|NCT00199017|Asparaginase|asparaginase|mesh-list
65034170|NCT00199017|Mercaptopurine|mercaptopurine|mesh-list
65034172|NCT00199017|Cladribine|cladribine|mesh-list
65034223|NCT00174551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65034224|NCT00174551|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65034225|NCT00174551|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65034226|NCT00174551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65034227|NCT00174551|Adrenergic Agents|adrenergic agents|mesh-ancestor
65034228|NCT00174551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65034229|NCT00174551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034230|NCT00174551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034231|NCT04676659|Tenecteplase|tenecteplase|mesh-list
65034232|NCT04676659|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65034233|NCT04676659|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65034234|NCT04676659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034235|NCT00174590|Risperidone|risperidone|mesh-list
65034236|NCT00174590|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65034283|NCT02962947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65034284|NCT02962947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65034285|NCT02962947|Adrenergic Agents|adrenergic agents|mesh-ancestor
65034286|NCT02962947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65034287|NCT02962947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034288|NCT02962947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034289|NCT02962947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65034290|NCT02962947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65034291|NCT02962947|Vasodilator Agents|vasodilator agents|mesh-ancestor
65034292|NCT00555334|Lamivudine|lamivudine|mesh-list
65034293|NCT00555334|Entecavir|entecavir|mesh-list
65034294|NCT00555334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65034295|NCT00555334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65034296|NCT00555334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034297|NCT00555334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034298|NCT00555334|Antiviral Agents|antiviral agents|mesh-ancestor
65034302|NCT01640080|Esketamine|esketamine|mesh-list
65034342|NCT00199134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034343|NCT00199134|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65034344|NCT00199134|Hormone Antagonists|hormone antagonists|mesh-ancestor
65034345|NCT00199134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65034346|NCT00199134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034347|NCT00174824|Insulin Glargine|insulin glargine|mesh-list
65034348|NCT00174824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65034349|NCT00174824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034350|NCT00174863|SR 31747|sr 31747|mesh-list
65034351|NCT00174863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034352|NCT00174863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034353|NCT00174863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65034354|NCT00174863|Immunologic Factors|immunologic factors|mesh-ancestor
65034355|NCT00174863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034356|NCT00712582|Cyclophosphamide|cyclophosphamide|mesh-list
65034357|NCT00712582|Ifosfamide|ifosfamide|mesh-list
65034358|NCT00712582|Isophosphamide mustard|isophosphamide mustard|mesh-list
65034359|NCT00712582|Carmustine|carmustine|mesh-list
65034360|NCT00712582|Rituximab|rituximab|mesh-list
65034361|NCT00712582|Carboplatin|carboplatin|mesh-list
65034362|NCT00712582|Etoposide|etoposide|mesh-list
65034363|NCT00712582|Etoposide phosphate|etoposide phosphate|mesh-list
65034364|NCT00712582|Mitoxantrone|mitoxantrone|mesh-list
65034365|NCT00712582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65034366|NCT00712582|Immunologic Factors|immunologic factors|mesh-ancestor
65034367|NCT00712582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034368|NCT00712582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65034369|NCT00712582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65034370|NCT00712582|Alkylating Agents|alkylating agents|mesh-ancestor
65034371|NCT00712582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034387|NCT00174902|Sensory System Agents|sensory system agents|mesh-ancestor
65034388|NCT00174902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65034389|NCT00174902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034390|NCT00174902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65034391|NCT00174902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65034392|NCT00174902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65034393|NCT00174902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65034394|NCT00174902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034395|NCT00174902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65034396|NCT00174902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65034397|NCT00174902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034398|NCT00174902|Antipyretics|antipyretics|mesh-ancestor
65034399|NCT00174902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65034400|NCT00174902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65034401|NCT00174902|Adrenergic Agents|adrenergic agents|mesh-ancestor
65034402|NCT00174902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65034403|NCT00174902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65034404|NCT00174902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65034405|NCT00174902|Vasodilator Agents|vasodilator agents|mesh-ancestor
65034406|NCT00373711|Iodine|iodine|mesh-list
65034407|NCT00373711|Cadexomer iodine|cadexomer iodine|mesh-list
65034408|NCT00373711|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65034440|NCT04676776|Mifepristone|mifepristone|mesh-list
65034441|NCT04676776|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65034442|NCT04676776|Contraceptive Agents|contraceptive agents|mesh-ancestor
65034443|NCT04676776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65034444|NCT04676776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034445|NCT04676776|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65034446|NCT04676776|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65034447|NCT04676776|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65034448|NCT04676776|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65034449|NCT04676776|Abortifacient Agents|abortifacient agents|mesh-ancestor
65034451|NCT04676776|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65034503|NCT00175370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65034504|NCT00175370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65034505|NCT00204243|Naltrexone|naltrexone|mesh-list
65034506|NCT00204243|Methadone|methadone|mesh-list
65034507|NCT00204243|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65034508|NCT00204243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65034509|NCT00204243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034510|NCT00204243|Sensory System Agents|sensory system agents|mesh-ancestor
65034511|NCT00204243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65034512|NCT00204243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65034513|NCT00204243|Narcotics|narcotics|mesh-ancestor
65034514|NCT00204243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65034515|NCT00204243|Analgesics|analgesics|mesh-ancestor
65034516|NCT00204243|Antitussive Agents|antitussive agents|mesh-ancestor
65034517|NCT00204243|Respiratory System Agents|respiratory system agents|mesh-ancestor
65034518|NCT04675372|Midazolam|midazolam|mesh-list
65034519|NCT04675372|Dexmedetomidine|dexmedetomidine|mesh-list
65034520|NCT04675372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65034521|NCT04675372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65034522|NCT04675372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034523|NCT04675372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65034524|NCT04675372|Analgesics|analgesics|mesh-ancestor
65034525|NCT04675372|Sensory System Agents|sensory system agents|mesh-ancestor
65034556|NCT04424602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65243437|NCT00694863|Cosyntropin|cosyntropin|mesh-list
65034557|NCT04395079|Durvalumab|durvalumab|mesh-list
65034558|NCT04395079|Ipilimumab|ipilimumab|mesh-list
65034559|NCT04395079|Tremelimumab|tremelimumab|mesh-list
65034560|NCT04395079|Immunoglobulins|immunoglobulins|mesh-list
65034561|NCT04395079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65034562|NCT04395079|Immunoglobulin G|immunoglobulin g|mesh-list
65034563|NCT04395079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64519757|NCT02404168|Lamotrigine|lamotrigine|mesh-list
65034564|NCT04395079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034565|NCT04395079|Immunologic Factors|immunologic factors|mesh-ancestor
65034566|NCT04395079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034567|NCT04395079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65034568|NCT04395079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034569|NCT00199407|Istradefylline|istradefylline|mesh-list
65034570|NCT00199407|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
65034571|NCT00199407|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65034572|NCT00199407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65034573|NCT00199407|Purinergic Agents|purinergic agents|mesh-ancestor
65034574|NCT00199407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65034575|NCT00199407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034576|NCT00199407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034577|NCT00199446|Istradefylline|istradefylline|mesh-list
65034578|NCT00199446|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
65034579|NCT00199446|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65034580|NCT00199446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65034581|NCT00199446|Purinergic Agents|purinergic agents|mesh-ancestor
65034582|NCT00199446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65034583|NCT00199446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034584|NCT00199446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034585|NCT04306393|Nitric Oxide|nitric oxide|mesh-list
65034586|NCT04306393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65034587|NCT04306393|Autonomic Agents|autonomic agents|mesh-ancestor
65034593|NCT04306393|Antioxidants|antioxidants|mesh-ancestor
65034594|NCT04306393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034595|NCT04306393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65034596|NCT04306393|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65034597|NCT04306393|Vasodilator Agents|vasodilator agents|mesh-ancestor
65034598|NCT04306393|Gasotransmitters|gasotransmitters|mesh-ancestor
65034599|NCT04306393|Protective Agents|protective agents|mesh-ancestor
65034600|NCT00204321|Sirolimus|sirolimus|mesh-list
65034601|NCT00204321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65034602|NCT00204321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65034603|NCT00204321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65034604|NCT00204321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034605|NCT00204321|Antifungal Agents|antifungal agents|mesh-ancestor
65034606|NCT00204321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65034607|NCT00204321|Immunologic Factors|immunologic factors|mesh-ancestor
65034608|NCT00204321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034609|NCT00175565|Fluticasone|fluticasone|mesh-list
65034610|NCT00175565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65034611|NCT00175565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65034612|NCT00175565|Autonomic Agents|autonomic agents|mesh-ancestor
65034617|NCT00175565|Dermatologic Agents|dermatologic agents|mesh-ancestor
65034649|NCT00175643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034650|NCT00175643|Interferon Inducers|interferon inducers|mesh-ancestor
65034651|NCT00204438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65034652|NCT00204438|Desogestrel|desogestrel|mesh-list
65034653|NCT00204438|Estradiol|estradiol|mesh-list
65034654|NCT00204438|Estrogens|estrogens|mesh-ancestor
65034655|NCT00204438|Hormones|hormones|mesh-ancestor
65034656|NCT00204438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65034657|NCT00204438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034658|NCT00204438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65034659|NCT00204438|Contraceptive Agents|contraceptive agents|mesh-ancestor
65034660|NCT00204438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65034661|NCT00204438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65034662|NCT00204438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65034663|NCT00204438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65034664|NCT00204438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65034665|NCT00204438|Progestins|progestins|mesh-ancestor
65034666|NCT00175682|Prazosin|prazosin|mesh-list
65034667|NCT00175682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65034669|NCT00175682|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65034703|NCT04111315|Dipyrone|dipyrone|mesh-list
65034704|NCT04111315|Ibuprofen|ibuprofen|mesh-list
65034705|NCT04111315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65034706|NCT04111315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65243439|NCT00694863|Hormones|hormones|mesh-ancestor
65034707|NCT04111315|Analgesics|analgesics|mesh-ancestor
65034708|NCT04111315|Sensory System Agents|sensory system agents|mesh-ancestor
65034709|NCT04111315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65034710|NCT04111315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034711|NCT04111315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65034769|NCT00175838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65034770|NCT00175838|Analgesics|analgesics|mesh-ancestor
65034771|NCT00175838|Sensory System Agents|sensory system agents|mesh-ancestor
65034772|NCT00175838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65034773|NCT00175838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034774|NCT00175838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65034775|NCT00175838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65034776|NCT00175838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65034777|NCT00175838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65034778|NCT00175838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034779|NCT00175838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65034780|NCT00175838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65034781|NCT00175838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034782|NCT00175838|Antipyretics|antipyretics|mesh-ancestor
65034783|NCT00175838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034784|NCT00175838|Antisickling Agents|antisickling agents|mesh-ancestor
65034830|NCT03374254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65034831|NCT03374254|Immunologic Factors|immunologic factors|mesh-ancestor
65034832|NCT03374254|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65034833|NCT03374254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65034834|NCT03374254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034835|NCT03374254|Antidotes|antidotes|mesh-ancestor
65034836|NCT03374254|Protective Agents|protective agents|mesh-ancestor
65034837|NCT03374254|Vitamin B Complex|vitamin b complex|mesh-ancestor
65034838|NCT03374254|Vitamins|vitamins|mesh-ancestor
65034839|NCT03374254|Micronutrients|micronutrients|mesh-ancestor
65034840|NCT00199758|Gemcitabine|gemcitabine|mesh-list
65034841|NCT00199758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65034842|NCT00199758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65034843|NCT00199758|Antimetabolites|antimetabolites|mesh-ancestor
65034844|NCT00199758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034845|NCT00199758|Antiviral Agents|antiviral agents|mesh-ancestor
65034846|NCT00199758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65034847|NCT00199758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034848|NCT00199758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65034886|NCT03252808|Immunologic Factors|immunologic factors|mesh-ancestor
65034887|NCT03252808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034888|NCT03191461|Adenosine|adenosine|mesh-list
65034889|NCT03191461|Analgesics|analgesics|mesh-ancestor
65034890|NCT03191461|Sensory System Agents|sensory system agents|mesh-ancestor
65034891|NCT03191461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65034892|NCT03191461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034893|NCT03191461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65034894|NCT03191461|Vasodilator Agents|vasodilator agents|mesh-ancestor
65034895|NCT03191461|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65034896|NCT03191461|Purinergic Agonists|purinergic agonists|mesh-ancestor
65034897|NCT03191461|Purinergic Agents|purinergic agents|mesh-ancestor
65034898|NCT03191461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65034899|NCT03191461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034900|NCT00199953|Rabeprazole|rabeprazole|mesh-list
65034901|NCT00199953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65034902|NCT00199953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65034904|NCT00199953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034943|NCT02830360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65034944|NCT02830360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034945|NCT02830360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65034946|NCT02830360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65034947|NCT02830360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65034948|NCT02830360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65034949|NCT02830360|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65034950|NCT02830360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65034951|NCT02830360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65034952|NCT02830360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65034953|NCT02830360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65034954|NCT02830360|Adrenergic Agents|adrenergic agents|mesh-ancestor
65034955|NCT02830360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65034956|NCT02830360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034957|NCT02830360|Sympatholytics|sympatholytics|mesh-ancestor
65034958|NCT02830360|Autonomic Agents|autonomic agents|mesh-ancestor
65034959|NCT02830360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65034960|NCT02827435|Bromides|bromides|mesh-list
65034961|NCT02827435|Rocuronium|rocuronium|mesh-list
65034962|NCT02827435|Anticonvulsants|anticonvulsants|mesh-ancestor
65034963|NCT02827435|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65034964|NCT02827435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65034965|NCT02827435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65034966|NCT02827435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65034967|NCT02827435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034968|NCT00176618|Curcumin|curcumin|mesh-list
65034969|NCT00176618|Sulindac|sulindac|mesh-list
65034970|NCT00176618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65034971|NCT00176618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65034972|NCT00176618|Analgesics|analgesics|mesh-ancestor
65034973|NCT00176618|Sensory System Agents|sensory system agents|mesh-ancestor
65034974|NCT00176618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65034975|NCT00176618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034981|NCT00176618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65034982|NCT02675959|Defibrotide|defibrotide|mesh-list
65034983|NCT02675959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65034984|NCT02675959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65034985|NCT02675959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65034986|NCT02675959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65034987|NCT00410787|Hydromorphone|hydromorphone|mesh-list
65034988|NCT00410787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65034989|NCT00410787|Narcotics|narcotics|mesh-ancestor
65034990|NCT00410787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65034991|NCT00410787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65034992|NCT00410787|Analgesics|analgesics|mesh-ancestor
65034993|NCT00410787|Sensory System Agents|sensory system agents|mesh-ancestor
65034994|NCT00410787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65034995|NCT00554164|Prednisone|prednisone|mesh-list
65034996|NCT00554164|Cyclophosphamide|cyclophosphamide|mesh-list
65034997|NCT00554164|Doxorubicin|doxorubicin|mesh-list
65034998|NCT00554164|Vincristine|vincristine|mesh-list
65034999|NCT00554164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65035000|NCT00554164|Immunologic Factors|immunologic factors|mesh-ancestor
65035001|NCT00554164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035002|NCT00554164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65035003|NCT00554164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65035004|NCT00554164|Alkylating Agents|alkylating agents|mesh-ancestor
65035005|NCT00554164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035006|NCT00554164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035007|NCT00554164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65035008|NCT00554164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65035009|NCT00554164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65035014|NCT00554164|Hormones|hormones|mesh-ancestor
65035026|NCT02572141|Antimetabolites|antimetabolites|mesh-ancestor
65035027|NCT02572141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035028|NCT02572141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65035029|NCT02572141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035030|NCT02572141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65035031|NCT02572141|Immunologic Factors|immunologic factors|mesh-ancestor
65035032|NCT02572141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035033|NCT02572141|Antidotes|antidotes|mesh-ancestor
65035034|NCT02572141|Protective Agents|protective agents|mesh-ancestor
65035035|NCT02572141|Vitamin B Complex|vitamin b complex|mesh-ancestor
65035036|NCT02572141|Vitamins|vitamins|mesh-ancestor
65035094|NCT00176774|Protective Agents|protective agents|mesh-ancestor
65035095|NCT00176774|Vitamin B Complex|vitamin b complex|mesh-ancestor
65035096|NCT00176774|Vitamins|vitamins|mesh-ancestor
65035097|NCT00176774|Micronutrients|micronutrients|mesh-ancestor
65035098|NCT00176774|Chelating Agents|chelating agents|mesh-ancestor
65035099|NCT00176774|Sequestering Agents|sequestering agents|mesh-ancestor
65035100|NCT00176774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65035101|NCT00176774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65035102|NCT00176774|Growth Substances|growth substances|mesh-ancestor
65035103|NCT00176774|Growth Inhibitors|growth inhibitors|mesh-ancestor
65035104|NCT02434744|Metformin|metformin|mesh-list
65035160|NCT00554476|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65035161|NCT00554476|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65035162|NCT00554476|Indomethacin|indomethacin|mesh-list
65035163|NCT00554476|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64476484|NCT04522557|Interferon alpha-2|interferon alpha-2|mesh-list
65035164|NCT00554476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65035165|NCT00554476|Glucocorticoids|glucocorticoids|mesh-ancestor
65035166|NCT00554476|Hormones|hormones|mesh-ancestor
65035167|NCT00554476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65035168|NCT00554476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035169|NCT00554476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65035170|NCT00554476|Immunologic Factors|immunologic factors|mesh-ancestor
65035171|NCT00554476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035172|NCT00554476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035173|NCT00554476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65035174|NCT00554476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65035175|NCT00554476|Analgesics|analgesics|mesh-ancestor
65035176|NCT00554476|Sensory System Agents|sensory system agents|mesh-ancestor
65035177|NCT00554476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65035178|NCT00554476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65035212|NCT00176813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65035213|NCT00176813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65035214|NCT00176813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65035215|NCT00176813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65035216|NCT00176813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65035217|NCT04678531|Tea Tree Oil|tea tree oil|mesh-list
65035218|NCT04678531|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65035219|NCT04678531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65035220|NCT02320708|Acetaminophen|acetaminophen|mesh-list
65035221|NCT02320708|Ibuprofen|ibuprofen|mesh-list
65035222|NCT02320708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65035223|NCT02320708|Analgesics|analgesics|mesh-ancestor
65035224|NCT02320708|Sensory System Agents|sensory system agents|mesh-ancestor
65035235|NCT02309671|Hormones|hormones|mesh-ancestor
65035272|NCT00177008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035273|NCT00177008|Dopamine Agonists|dopamine agonists|mesh-ancestor
65035274|NCT00177008|Dopamine Agents|dopamine agents|mesh-ancestor
65035275|NCT00177008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65035276|NCT00177008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035277|NCT00177008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65035340|NCT02207257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035341|NCT02207257|Anticoagulants|anticoagulants|mesh-ancestor
65035342|NCT00554710|Methylprednisolone|methylprednisolone|mesh-list
65035343|NCT00554710|Budesonide|budesonide|mesh-list
65035344|NCT00554710|Azathioprine|azathioprine|mesh-list
65035345|NCT00554710|Infliximab|infliximab|mesh-list
65035346|NCT00554710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65035347|NCT00554710|Antiemetics|antiemetics|mesh-ancestor
65035348|NCT00554710|Autonomic Agents|autonomic agents|mesh-ancestor
65035349|NCT00554710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65035350|NCT00554710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035351|NCT00554710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65035352|NCT00554710|Glucocorticoids|glucocorticoids|mesh-ancestor
65035353|NCT00554710|Hormones|hormones|mesh-ancestor
65035354|NCT00554710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65035355|NCT00554710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65035356|NCT00554710|Protective Agents|protective agents|mesh-ancestor
65035357|NCT00554710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035358|NCT00554710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65035359|NCT00554710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65035360|NCT00554710|Respiratory System Agents|respiratory system agents|mesh-ancestor
65035361|NCT00554710|Dermatologic Agents|dermatologic agents|mesh-ancestor
65035362|NCT00554710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65035363|NCT00554710|Antimetabolites|antimetabolites|mesh-ancestor
65035364|NCT00554710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035365|NCT00554710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65035366|NCT00554710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65035367|NCT00554710|Immunologic Factors|immunologic factors|mesh-ancestor
65035368|NCT00200187|Anesthetics|anesthetics|mesh-list
65035369|NCT00200187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65035370|NCT00200187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035371|NCT04659109|Glenzocimab|glenzocimab|mesh-list
65035384|NCT04659070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65493861|NCT04166318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520569|NCT02451774|Antioxidants|antioxidants|mesh-ancestor
65035385|NCT04659070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65035386|NCT04659070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65035387|NCT04659070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035388|NCT04659070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65035389|NCT04659070|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65035390|NCT04659070|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65035391|NCT00177281|Belotecan|belotecan|mesh-list
65035392|NCT00177281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65035393|NCT00177281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65035394|NCT00177281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035395|NCT00177281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035396|NCT00177281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035397|NCT00200226|Vitamin B 6|vitamin b 6|mesh-list
65035398|NCT00200226|Pyridoxal|pyridoxal|mesh-list
65035399|NCT00200226|Pyridoxine|pyridoxine|mesh-list
65035401|NCT00200226|Vitamins|vitamins|mesh-ancestor
65035439|NCT00200421|Autonomic Agents|autonomic agents|mesh-ancestor
65035440|NCT00200421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65035441|NCT00200421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035442|NCT00200421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65035443|NCT00200421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65035444|NCT00200421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65035445|NCT00200421|Adrenergic Agents|adrenergic agents|mesh-ancestor
65035446|NCT00200421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65035447|NCT00200421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035448|NCT00200421|Vasodilator Agents|vasodilator agents|mesh-ancestor
65035449|NCT00200421|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65035450|NCT00200421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65035451|NCT00200421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65035452|NCT04656106|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65035453|NCT04656106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65035454|NCT04656106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035455|NCT04656262|Cyclophosphamide|cyclophosphamide|mesh-list
65035456|NCT04656262|Doxorubicin|doxorubicin|mesh-list
65035458|NCT04656262|Immunologic Factors|immunologic factors|mesh-ancestor
65035491|NCT00200538|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65035492|NCT00200538|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65035493|NCT00200538|Dopamine Agents|dopamine agents|mesh-ancestor
65035494|NCT00200538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65035495|NCT00200538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035496|NCT00200538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035497|NCT00200538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65035498|NCT00200538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65035499|NCT00177710|Amphotericin B|amphotericin b|mesh-list
65035500|NCT00177710|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65035501|NCT00177710|Amebicides|amebicides|mesh-ancestor
65035502|NCT00177710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65035503|NCT00177710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65035504|NCT00177710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65035505|NCT00177710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65035506|NCT00177710|Antifungal Agents|antifungal agents|mesh-ancestor
65035507|NCT00177749|Posaconazole|posaconazole|mesh-list
65035508|NCT00177749|Antifungal Agents|antifungal agents|mesh-ancestor
65035509|NCT00177749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65035510|NCT00177749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65035511|NCT00177749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65035512|NCT00177749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65035513|NCT00177749|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65035514|NCT00177749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65035515|NCT00177749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035516|NCT00177749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035517|NCT00177749|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65035518|NCT00177749|Hormone Antagonists|hormone antagonists|mesh-ancestor
65035519|NCT00177749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65035520|NCT00177749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035531|NCT04654819|Anesthetics|anesthetics|mesh-list
65035532|NCT04654819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64476855|NCT00499408|Vitamin D|vitamin d|mesh-list
65035533|NCT04654819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035534|NCT04654741|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65035535|NCT04654741|Medroxyprogesterone|medroxyprogesterone|mesh-list
65035536|NCT04654741|Ganirelix|ganirelix|mesh-list
65035537|NCT04654741|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65035538|NCT04654741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65035539|NCT04654741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65035540|NCT04654741|Contraceptive Agents|contraceptive agents|mesh-ancestor
65035541|NCT04654741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65035542|NCT04654741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035543|NCT04654741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65035544|NCT04654741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65035545|NCT04654741|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65035546|NCT04654741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65035547|NCT04654741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035548|NCT04654741|Hormone Antagonists|hormone antagonists|mesh-ancestor
65035549|NCT04654741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65035582|NCT00200655|Antimetabolites|antimetabolites|mesh-ancestor
65035583|NCT00200655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035584|NCT00200655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65035585|NCT00200655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65035586|NCT00200655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035587|NCT04653493|Cyclophosphamide|cyclophosphamide|mesh-list
65035588|NCT04653493|Fludarabine|fludarabine|mesh-list
65035589|NCT04653493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65035590|NCT04653493|Immunologic Factors|immunologic factors|mesh-ancestor
65035591|NCT04653493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035592|NCT04653493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65035593|NCT04653493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65035594|NCT04653493|Alkylating Agents|alkylating agents|mesh-ancestor
65035595|NCT04653493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035596|NCT04653493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035638|NCT04653415|Prednisolone|prednisolone|mesh-list
65035639|NCT04653415|Prednisolone acetate|prednisolone acetate|mesh-list
65035640|NCT04653415|Gabapentin|gabapentin|mesh-list
65035641|NCT04653415|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65035642|NCT04653415|Prednisolone phosphate|prednisolone phosphate|mesh-list
65035643|NCT04653415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65035644|NCT04653415|Antiemetics|antiemetics|mesh-ancestor
65035645|NCT04653415|Autonomic Agents|autonomic agents|mesh-ancestor
65035646|NCT04653415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65035647|NCT04653415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035704|NCT04652128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65035705|NCT04652128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035706|NCT00205725|Olanzapine|olanzapine|mesh-list
65035707|NCT00205725|Ziprasidone|ziprasidone|mesh-list
65035708|NCT00205725|Antiemetics|antiemetics|mesh-ancestor
65035709|NCT00205725|Autonomic Agents|autonomic agents|mesh-ancestor
65035710|NCT00205725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65035711|NCT00205725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035712|NCT00205725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65035713|NCT00205725|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65035714|NCT00205725|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65035715|NCT00205725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65035716|NCT00205725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65035766|NCT00206154|Budesonide|budesonide|mesh-list
65035767|NCT00206154|Formoterol Fumarate|formoterol fumarate|mesh-list
65035768|NCT00206154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65035769|NCT00206154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65035770|NCT00206154|Autonomic Agents|autonomic agents|mesh-ancestor
65035771|NCT00206154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65035772|NCT00206154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035773|NCT00206154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65035774|NCT00206154|Respiratory System Agents|respiratory system agents|mesh-ancestor
65035775|NCT00206154|Glucocorticoids|glucocorticoids|mesh-ancestor
65035776|NCT00206154|Hormones|hormones|mesh-ancestor
65035777|NCT00206154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65035778|NCT00206154|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65035779|NCT00206154|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65035780|NCT00206154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65035781|NCT00206154|Adrenergic Agents|adrenergic agents|mesh-ancestor
65035782|NCT00206154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65035826|NCT00559858|Vitamin B Complex|vitamin b complex|mesh-ancestor
65035827|NCT00559858|Vitamins|vitamins|mesh-ancestor
65035828|NCT00559858|Micronutrients|micronutrients|mesh-ancestor
64521019|NCT03198702|Cholinergic Agents|cholinergic agents|mesh-ancestor
65035829|NCT00559858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035830|NCT00559975|Vaccines|vaccines|mesh-list
65035831|NCT00559975|Immunologic Factors|immunologic factors|mesh-ancestor
65035832|NCT00559975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035833|NCT00206193|Misoprostol|misoprostol|mesh-list
65035834|NCT00206193|Sulprostone|sulprostone|mesh-list
65035835|NCT00206193|Mifepristone|mifepristone|mesh-list
65035836|NCT00206193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65035837|NCT00206193|Abortifacient Agents|abortifacient agents|mesh-ancestor
65035838|NCT00206193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65035855|NCT04638439|Entecavir|entecavir|mesh-list
65035887|NCT00408278|Mitoxantrone|mitoxantrone|mesh-list
65035888|NCT00408278|Analgesics|analgesics|mesh-ancestor
65035889|NCT00408278|Sensory System Agents|sensory system agents|mesh-ancestor
65035890|NCT00408278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65035891|NCT00408278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035892|NCT00408278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65035893|NCT00408278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65035894|NCT00408278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65035895|NCT00408278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65035896|NCT00408278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65035897|NCT00560092|Magnesium Sulfate|magnesium sulfate|mesh-list
65035946|NCT00560209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65035947|NCT00560209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65035948|NCT04636957|Ciprofloxacin|ciprofloxacin|mesh-list
65035949|NCT04636957|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
65035950|NCT04636957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65035951|NCT04636957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65035952|NCT04636957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65035953|NCT04636957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65036012|NCT00201318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65036013|NCT00201318|Alkylating Agents|alkylating agents|mesh-ancestor
65036014|NCT00201318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036015|NCT00201318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036016|NCT00201318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65036017|NCT00201318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65036018|NCT00201318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65036019|NCT00201318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65036020|NCT00201318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036021|NCT00201318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65036022|NCT00201318|Tubulin Modulators|tubulin modulators|mesh-ancestor
65036023|NCT00201318|Antimitotic Agents|antimitotic agents|mesh-ancestor
65036024|NCT00201318|Mitosis Modulators|mitosis modulators|mesh-ancestor
65036025|NCT00201318|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65036026|NCT00201318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65036027|NCT00201318|Antiviral Agents|antiviral agents|mesh-ancestor
65036028|NCT00201318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65036029|NCT00201318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65036031|NCT00201357|Thalidomide|thalidomide|mesh-list
65036069|NCT00201435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65036070|NCT00201435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036071|NCT00201435|Tubulin Modulators|tubulin modulators|mesh-ancestor
65036072|NCT00201435|Antimitotic Agents|antimitotic agents|mesh-ancestor
65036073|NCT00201435|Mitosis Modulators|mitosis modulators|mesh-ancestor
65036074|NCT00201435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036075|NCT00201435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65036076|NCT00201435|Antimetabolites|antimetabolites|mesh-ancestor
65036077|NCT00560599|Chlorhexidine|chlorhexidine|mesh-list
65036078|NCT00560599|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65036079|NCT00560599|Mupirocin|mupirocin|mesh-list
65036080|NCT00560599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65036081|NCT00560599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65036082|NCT00560599|Disinfectants|disinfectants|mesh-ancestor
65036083|NCT00560599|Dermatologic Agents|dermatologic agents|mesh-ancestor
65036084|NCT00560599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65036085|NCT00560599|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65036086|NCT00560599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036087|NCT00560599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036088|NCT04635553|Praziquantel|praziquantel|mesh-list
65036089|NCT04635553|Anthelmintics|anthelmintics|mesh-ancestor
65036090|NCT04635553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65036091|NCT04635553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65036092|NCT00560638|Loteprednol Etabonate|loteprednol etabonate|mesh-list
65036093|NCT00560638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65036094|NCT04634656|Lidocaine|lidocaine|mesh-list
65036095|NCT04634656|Anesthetics, Local|anesthetics, local|mesh-ancestor
65036116|NCT04633954|Adrenergic Agents|adrenergic agents|mesh-ancestor
65036117|NCT04633954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65036118|NCT04633954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036119|NCT04633954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036120|NCT00201630|Alfuzosin|alfuzosin|mesh-list
65036121|NCT00201630|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65036122|NCT00201630|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65036123|NCT00201630|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65036124|NCT00201630|Adrenergic Agents|adrenergic agents|mesh-ancestor
65036125|NCT00201630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65036126|NCT00201630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036127|NCT00201630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036128|NCT00201630|Urological Agents|urological agents|mesh-ancestor
65036129|NCT00179231|Olanzapine|olanzapine|mesh-list
65036130|NCT00179231|Clozapine|clozapine|mesh-list
65036131|NCT00179231|Antiemetics|antiemetics|mesh-ancestor
65036132|NCT00179231|Autonomic Agents|autonomic agents|mesh-ancestor
65036133|NCT00179231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65036134|NCT00179231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036135|NCT00179231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65036136|NCT00179231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65036137|NCT00179231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65036138|NCT00179231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65036139|NCT00179231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65036140|NCT00179231|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65036141|NCT00179231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65036142|NCT00179231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65036162|NCT00201708|Alkylating Agents|alkylating agents|mesh-ancestor
65036163|NCT00201708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036164|NCT00201708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036165|NCT00201708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65036166|NCT00201708|Tubulin Modulators|tubulin modulators|mesh-ancestor
65036167|NCT00201708|Antimitotic Agents|antimitotic agents|mesh-ancestor
65036168|NCT00201708|Mitosis Modulators|mitosis modulators|mesh-ancestor
65036169|NCT00201708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65036227|NCT04631341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036228|NCT04631341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65036229|NCT04723238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65036230|NCT04723238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65036231|NCT04723238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65036232|NCT04723238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65036233|NCT04723238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036234|NCT04723238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65036235|NCT04723238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036236|NCT04723238|Analgesics|analgesics|mesh-ancestor
65036237|NCT04723238|Sensory System Agents|sensory system agents|mesh-ancestor
65036238|NCT04723238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65036239|NCT04723238|Antidepressive Agents|antidepressive agents|mesh-ancestor
65036240|NCT04723238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65036241|NCT04723238|Dopamine Agents|dopamine agents|mesh-ancestor
65036242|NCT00201786|Pentostatin|pentostatin|mesh-list
65036243|NCT00201786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036244|NCT00201786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65036245|NCT00201786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036246|NCT00201786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036247|NCT04630522|Vitamin D|vitamin d|mesh-list
65036276|NCT00186810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65036277|NCT00186810|Immunologic Factors|immunologic factors|mesh-ancestor
65036278|NCT00186810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036279|NCT00186810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65036280|NCT00186810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65036281|NCT00186810|Alkylating Agents|alkylating agents|mesh-ancestor
65036282|NCT00186810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036283|NCT00186810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036284|NCT00186810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65036285|NCT04630288|Clopidogrel|clopidogrel|mesh-list
65036286|NCT04630288|Ticagrelor|ticagrelor|mesh-list
65036287|NCT04630288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65036288|NCT04630288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65036289|NCT04630288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65036290|NCT04630288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65036291|NCT04630288|Purinergic Agents|purinergic agents|mesh-ancestor
65036292|NCT04630288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65036293|NCT04630288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036294|NCT04630288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036295|NCT00561028|Antibodies|antibodies|mesh-list
65036296|NCT00561028|Immunologic Factors|immunologic factors|mesh-ancestor
65036297|NCT00561028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036298|NCT00561067|Methylprednisolone|methylprednisolone|mesh-list
65036299|NCT00561067|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65036300|NCT00561067|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65036301|NCT00561067|Prednisolone|prednisolone|mesh-list
65036302|NCT00561067|Prednisolone acetate|prednisolone acetate|mesh-list
65036303|NCT00561067|Epoetin Alfa|epoetin alfa|mesh-list
65036322|NCT00561106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65036323|NCT00561106|Glucocorticoids|glucocorticoids|mesh-ancestor
65036324|NCT00561106|Hormones|hormones|mesh-ancestor
65036325|NCT00561106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65036326|NCT00561106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036327|NCT00561106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65036328|NCT00561106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036329|NCT00561106|Antiviral Agents|antiviral agents|mesh-ancestor
65036330|NCT00561106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65036331|NCT00561184|Vaccines|vaccines|mesh-list
65036332|NCT00561184|Immunologic Factors|immunologic factors|mesh-ancestor
65036333|NCT00561184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036334|NCT00186849|Cyclophosphamide|cyclophosphamide|mesh-list
65036335|NCT00186849|Ifosfamide|ifosfamide|mesh-list
65036336|NCT00186849|Carboplatin|carboplatin|mesh-list
65036337|NCT00186849|Doxorubicin|doxorubicin|mesh-list
65036338|NCT00186849|Etoposide|etoposide|mesh-list
65036339|NCT00186849|Topotecan|topotecan|mesh-list
65036340|NCT00186849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65036341|NCT00186849|Immunologic Factors|immunologic factors|mesh-ancestor
65036342|NCT00186849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036343|NCT00186849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65036344|NCT00186849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65036345|NCT00186849|Alkylating Agents|alkylating agents|mesh-ancestor
65036346|NCT00186849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036347|NCT00186849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036373|NCT00186966|Busulfan|busulfan|mesh-list
65036374|NCT00186966|Fludarabine|fludarabine|mesh-list
65036375|NCT00186966|Etoposide|etoposide|mesh-list
65036376|NCT00186966|Daunorubicin|daunorubicin|mesh-list
65036377|NCT00186966|Thioguanine|thioguanine|mesh-list
65036378|NCT00186966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65036379|NCT00186966|Immunologic Factors|immunologic factors|mesh-ancestor
65036380|NCT00186966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036381|NCT00186966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65036382|NCT00186966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65036383|NCT00186966|Alkylating Agents|alkylating agents|mesh-ancestor
65036384|NCT00186966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036385|NCT00186966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036386|NCT00186966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65036387|NCT00186966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65036388|NCT00186966|Antimetabolites|antimetabolites|mesh-ancestor
65036389|NCT00186966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65036390|NCT00186966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65036391|NCT00186966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65036392|NCT00186966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036393|NCT00186966|Antiviral Agents|antiviral agents|mesh-ancestor
65036394|NCT00186966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65036395|NCT00186966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65036396|NCT00180050|Budesonide|budesonide|mesh-list
65036397|NCT00180050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65036398|NCT00180050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65036399|NCT00180050|Autonomic Agents|autonomic agents|mesh-ancestor
65036400|NCT00180050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65036405|NCT00180050|Hormones|hormones|mesh-ancestor
65036420|NCT00180089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036421|NCT00180089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65036422|NCT00180089|Respiratory System Agents|respiratory system agents|mesh-ancestor
65036423|NCT00180089|Glucocorticoids|glucocorticoids|mesh-ancestor
65036424|NCT00180089|Hormones|hormones|mesh-ancestor
65036425|NCT00180089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65036426|NCT00575419|Acetylcysteine|acetylcysteine|mesh-list
64521630|NCT00030147|Estradiol|estradiol|mesh-list
65036427|NCT00575419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65036429|NCT00575419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65036430|NCT00575419|Expectorants|expectorants|mesh-ancestor
65036431|NCT00575419|Respiratory System Agents|respiratory system agents|mesh-ancestor
65036432|NCT00575419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65036433|NCT00575419|Antioxidants|antioxidants|mesh-ancestor
65036434|NCT00575419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036435|NCT00575419|Protective Agents|protective agents|mesh-ancestor
65036436|NCT00575419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036437|NCT00575419|Antidotes|antidotes|mesh-ancestor
65036438|NCT00180128|Cytarabine|cytarabine|mesh-list
65036439|NCT00180128|Daunorubicin|daunorubicin|mesh-list
65036440|NCT00180128|Mitoxantrone|mitoxantrone|mesh-list
65036441|NCT00180128|Idarubicin|idarubicin|mesh-list
65036442|NCT00180128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65036443|NCT00180128|Antimetabolites|antimetabolites|mesh-ancestor
65036444|NCT00180128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036445|NCT00180128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036446|NCT00180128|Antiviral Agents|antiviral agents|mesh-ancestor
65036447|NCT00180128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65036448|NCT00180128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65036455|NCT00180128|Analgesics|analgesics|mesh-ancestor
65036466|NCT00575614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036467|NCT00575848|Glycine|glycine|mesh-list
65036468|NCT00575848|Glycine Agents|glycine agents|mesh-ancestor
65036469|NCT00575848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65036470|NCT00575848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036471|NCT00575848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036472|NCT00576238|Betamethasone|betamethasone|mesh-list
65036473|NCT00576238|Betamethasone Valerate|betamethasone valerate|mesh-list
65036474|NCT00576238|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65036475|NCT00576238|Betamethasone benzoate|betamethasone benzoate|mesh-list
65036476|NCT00576238|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65036477|NCT00576238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65036478|NCT00576238|Glucocorticoids|glucocorticoids|mesh-ancestor
65036479|NCT00576238|Hormones|hormones|mesh-ancestor
65036481|NCT00576238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036524|NCT00576550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036525|NCT00576550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65036526|NCT00576550|Respiratory System Agents|respiratory system agents|mesh-ancestor
65036527|NCT00576706|Misoprostol|misoprostol|mesh-list
65036528|NCT00576706|Rebamipide|rebamipide|mesh-list
65036529|NCT00576706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65036530|NCT00576706|Abortifacient Agents|abortifacient agents|mesh-ancestor
65036531|NCT00576706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65036532|NCT00576706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036533|NCT00576706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65036534|NCT00576706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65036535|NCT00576706|Oxytocics|oxytocics|mesh-ancestor
65036536|NCT00576706|Antioxidants|antioxidants|mesh-ancestor
65036537|NCT00576706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036538|NCT00576706|Protective Agents|protective agents|mesh-ancestor
65036539|NCT00576706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036540|NCT00576784|Pioglitazone|pioglitazone|mesh-list
65036541|NCT00576784|Glimepiride|glimepiride|mesh-list
65036542|NCT00576784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65036543|NCT00576784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036544|NCT00576784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65036545|NCT00576784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65036546|NCT00576784|Immunologic Factors|immunologic factors|mesh-ancestor
65036547|NCT00576862|Insulin Glargine|insulin glargine|mesh-list
65036548|NCT00576862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65036549|NCT00576862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036550|NCT00202020|Aspirin|aspirin|mesh-list
65036551|NCT00202020|Cilostazol|cilostazol|mesh-list
65036552|NCT00202020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65036571|NCT00202020|Vasodilator Agents|vasodilator agents|mesh-ancestor
65036572|NCT00202020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65036574|NCT00202020|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65036575|NCT00202020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65036576|NCT00577018|Prucalopride|prucalopride|mesh-list
65036577|NCT00577018|Laxatives|laxatives|mesh-ancestor
65036578|NCT00577018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65036579|NCT00577018|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65036581|NCT00577018|Serotonin Agents|serotonin agents|mesh-ancestor
65036582|NCT00577018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65036583|NCT00577018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036584|NCT00577018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036585|NCT04578847|Imatinib Mesylate|imatinib mesylate|mesh-list
65036586|NCT04578847|Dasatinib|dasatinib|mesh-list
65036587|NCT04578847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036588|NCT04578847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65036589|NCT04578847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036590|NCT04578847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036591|NCT00577057|Fluorouracil|fluorouracil|mesh-list
65036592|NCT00577057|Capecitabine|capecitabine|mesh-list
65036593|NCT00577057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036594|NCT00577057|Antimetabolites|antimetabolites|mesh-ancestor
65036595|NCT00577057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036596|NCT00577057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65036597|NCT00577057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65036598|NCT00577057|Immunologic Factors|immunologic factors|mesh-ancestor
65036623|NCT00187005|Autonomic Agents|autonomic agents|mesh-ancestor
65036624|NCT00187005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65036625|NCT00187005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65036626|NCT00187005|Glucocorticoids|glucocorticoids|mesh-ancestor
65036627|NCT00187005|Hormones|hormones|mesh-ancestor
65036628|NCT00187005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65036629|NCT00187005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65036630|NCT00187005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65036631|NCT00187005|Abortifacient Agents|abortifacient agents|mesh-ancestor
65036651|NCT00577369|Desflurane|desflurane|mesh-list
65036689|NCT00187083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036690|NCT00187083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65036691|NCT00187083|Abortifacient Agents|abortifacient agents|mesh-ancestor
65036692|NCT00187083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65036694|NCT00187083|Antimetabolites|antimetabolites|mesh-ancestor
65036760|NCT00187122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65036761|NCT00187122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65036762|NCT00187122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65036763|NCT00187122|Abortifacient Agents|abortifacient agents|mesh-ancestor
65036764|NCT00187122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65036765|NCT00187122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65036766|NCT00187122|Antimetabolites|antimetabolites|mesh-ancestor
65036767|NCT00187122|Dermatologic Agents|dermatologic agents|mesh-ancestor
65036768|NCT00187122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036769|NCT00187122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65036770|NCT00187122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65036771|NCT00187122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65036772|NCT00187122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65036773|NCT00187122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65036774|NCT00187122|Antiviral Agents|antiviral agents|mesh-ancestor
65036775|NCT00187122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65036776|NCT00187122|Tubulin Modulators|tubulin modulators|mesh-ancestor
65036777|NCT00187122|Antimitotic Agents|antimitotic agents|mesh-ancestor
65036778|NCT00187122|Mitosis Modulators|mitosis modulators|mesh-ancestor
65036779|NCT00187122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65036780|NCT00180635|Pimagedine|pimagedine|mesh-list
65036781|NCT00180635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036782|NCT00180635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036783|NCT00578266|Cyclophosphamide|cyclophosphamide|mesh-list
65036784|NCT00578266|Alemtuzumab|alemtuzumab|mesh-list
65036785|NCT00578266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65036786|NCT00578266|Immunologic Factors|immunologic factors|mesh-ancestor
65036787|NCT00578266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036788|NCT00578266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64557530|NCT03067974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557531|NCT05104866|Gemcitabine|gemcitabine|mesh-list
64557532|NCT05104866|Capecitabine|capecitabine|mesh-list
65036802|NCT00579085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65036803|NCT00579085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036804|NCT00579085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65036805|NCT00579085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65036806|NCT00579085|Anesthetics, General|anesthetics, general|mesh-ancestor
65036807|NCT00579085|Anesthetics|anesthetics|mesh-ancestor
65036808|NCT00579085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65036809|NCT00579085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65036810|NCT00579085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65036811|NCT00579085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65036812|NCT00579085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036813|NCT00187161|Cytarabine|cytarabine|mesh-list
65036814|NCT00187161|Cyclophosphamide|cyclophosphamide|mesh-list
65036815|NCT00187161|Doxorubicin|doxorubicin|mesh-list
65036816|NCT00187161|Methotrexate|methotrexate|mesh-list
65036855|NCT00579475|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65036856|NCT00579475|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65036857|NCT00579475|Hormone Antagonists|hormone antagonists|mesh-ancestor
65036858|NCT00579475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65036859|NCT00579475|Luteolytic Agents|luteolytic agents|mesh-ancestor
65036860|NCT00579475|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65036861|NCT00579475|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65036862|NCT00579592|Mycophenolic Acid|mycophenolic acid|mesh-list
65036922|NCT00202176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65036923|NCT00202176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036924|NCT00580060|Molgramostim|molgramostim|mesh-list
65036925|NCT00580060|Sargramostim|sargramostim|mesh-list
65036926|NCT00580060|Immunologic Factors|immunologic factors|mesh-ancestor
65036927|NCT00580060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036928|NCT00580060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036929|NCT00180908|Doxorubicin|doxorubicin|mesh-list
65036930|NCT00180908|Etoposide|etoposide|mesh-list
65036931|NCT00180908|Methotrexate|methotrexate|mesh-list
65036932|NCT00180908|Ifosfamide|ifosfamide|mesh-list
65036933|NCT00180908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65036934|NCT00180908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036935|NCT00180908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65036936|NCT00180908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65036937|NCT00180908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036938|NCT00180908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036939|NCT00180908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65036940|NCT00180908|Abortifacient Agents|abortifacient agents|mesh-ancestor
65036941|NCT00180908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65036942|NCT00180908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036970|NCT00581425|Imiquimod|imiquimod|mesh-list
65036974|NCT00581425|Immunologic Factors|immunologic factors|mesh-ancestor
65036975|NCT00581425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65036976|NCT00581425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65036977|NCT00581425|Interferon Inducers|interferon inducers|mesh-ancestor
65036978|NCT00209079|Docetaxel|docetaxel|mesh-list
65036979|NCT00209079|Imatinib Mesylate|imatinib mesylate|mesh-list
65036980|NCT00209079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65036981|NCT00209079|Tubulin Modulators|tubulin modulators|mesh-ancestor
65036982|NCT00209079|Antimitotic Agents|antimitotic agents|mesh-ancestor
65036983|NCT00209079|Mitosis Modulators|mitosis modulators|mesh-ancestor
65036984|NCT00209079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65036985|NCT00209079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65036986|NCT00209079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65036987|NCT04576975|Dexmedetomidine|dexmedetomidine|mesh-list
65036988|NCT04576975|Ketamine|ketamine|mesh-list
65036989|NCT04576975|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65036990|NCT04576975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65036991|NCT04576975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037029|NCT00181025|Immunologic Factors|immunologic factors|mesh-ancestor
65037030|NCT00181025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037032|NCT00209313|Antiviral Agents|antiviral agents|mesh-ancestor
65037033|NCT00209313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65037034|NCT00582634|Docetaxel|docetaxel|mesh-list
65037035|NCT00582634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037036|NCT00582634|Tubulin Modulators|tubulin modulators|mesh-ancestor
65037037|NCT00582634|Antimitotic Agents|antimitotic agents|mesh-ancestor
65037038|NCT00582634|Mitosis Modulators|mitosis modulators|mesh-ancestor
64888992|NCT01964391|Paclitaxel|paclitaxel|mesh-list
65037098|NCT00181298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65037099|NCT00181298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037100|NCT00181298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037101|NCT00181298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65037102|NCT00181298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65037103|NCT00583180|Capsaicin|capsaicin|mesh-list
65037104|NCT00583180|Antipruritics|antipruritics|mesh-ancestor
65037105|NCT00583180|Dermatologic Agents|dermatologic agents|mesh-ancestor
65037106|NCT00583180|Sensory System Agents|sensory system agents|mesh-ancestor
65037107|NCT00583180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65037108|NCT00583180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037109|NCT00583258|Alfuzosin|alfuzosin|mesh-list
65037110|NCT00583258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65037111|NCT00583258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65037112|NCT00583258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65037113|NCT00583258|Adrenergic Agents|adrenergic agents|mesh-ancestor
65037114|NCT00583258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65037115|NCT00583258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037116|NCT00583258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037117|NCT00583258|Urological Agents|urological agents|mesh-ancestor
65037118|NCT00181532|Celecoxib|celecoxib|mesh-list
65037119|NCT00181532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65037120|NCT00181532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65037121|NCT00181532|Analgesics|analgesics|mesh-ancestor
65037122|NCT00181532|Sensory System Agents|sensory system agents|mesh-ancestor
65037123|NCT00181532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65037124|NCT00181532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037125|NCT00181532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65037126|NCT00181532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65037127|NCT00181532|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65037128|NCT00181532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65037129|NCT00181532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037130|NCT00181532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037131|NCT04576390|Ondansetron|ondansetron|mesh-list
65037132|NCT04576390|Palonosetron|palonosetron|mesh-list
64490290|NCT00928954|Anticonvulsants|anticonvulsants|mesh-ancestor
65037133|NCT04576390|Antiemetics|antiemetics|mesh-ancestor
65037134|NCT04576390|Autonomic Agents|autonomic agents|mesh-ancestor
65037135|NCT04576390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65037136|NCT04576390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037137|NCT04576390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65037138|NCT04576390|Antipruritics|antipruritics|mesh-ancestor
65037139|NCT04576390|Dermatologic Agents|dermatologic agents|mesh-ancestor
65037140|NCT04576390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65037141|NCT04576390|Serotonin Agents|serotonin agents|mesh-ancestor
65037142|NCT04576390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65037143|NCT04576390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037144|NCT04576390|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65037145|NCT04576390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65037146|NCT04576390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65037147|NCT04576390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65037148|NCT04576390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65037149|NCT04576390|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65037159|NCT00187707|Gabapentin|gabapentin|mesh-list
65037189|NCT00181688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037190|NCT00181688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65037191|NCT00181688|Hormone Antagonists|hormone antagonists|mesh-ancestor
65037192|NCT00181688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65037193|NCT00181688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037194|NCT00181688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65037195|NCT00209469|Alendronate|alendronate|mesh-list
65037196|NCT00209469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65037197|NCT00209469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037198|NCT00181727|Valproic Acid|valproic acid|mesh-list
65037249|NCT00181922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037250|NCT00181922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037251|NCT00181922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65037252|NCT00181922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65037256|NCT00181922|Dopamine Agents|dopamine agents|mesh-ancestor
65037317|NCT00216411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65037318|NCT00216411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65037319|NCT00216411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037320|NCT00216411|Cholinergic Agents|cholinergic agents|mesh-ancestor
65037321|NCT00216411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65493869|NCT04147494|Edetic Acid|edetic acid|mesh-list
65037322|NCT00216411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037323|NCT00216411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65037324|NCT00216411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65037327|NCT00585091|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65037328|NCT00585091|Mydriatics|mydriatics|mesh-ancestor
65037329|NCT00585091|Autonomic Agents|autonomic agents|mesh-ancestor
65037330|NCT00585091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65037331|NCT00585091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037377|NCT00585754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65037378|NCT00585754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037379|NCT00585754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037380|NCT00209547|Fospropofol|fospropofol|mesh-list
65037381|NCT00209547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65037382|NCT00209547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65037383|NCT00209547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037384|NCT00585871|Metoprolol|metoprolol|mesh-list
65037385|NCT00585871|Clonidine|clonidine|mesh-list
65037386|NCT00585871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65037387|NCT00585871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65037388|NCT00585871|Sympatholytics|sympatholytics|mesh-ancestor
65037389|NCT00585871|Autonomic Agents|autonomic agents|mesh-ancestor
65037395|NCT00585871|Adrenergic Agents|adrenergic agents|mesh-ancestor
65037439|NCT04575415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65037440|NCT04575415|Growth Substances|growth substances|mesh-ancestor
65037441|NCT04575415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037442|NCT04575415|Growth Inhibitors|growth inhibitors|mesh-ancestor
65037443|NCT04575415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65037444|NCT04575415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037445|NCT04575415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037446|NCT00209586|Fospropofol|fospropofol|mesh-list
65037447|NCT00209586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65037448|NCT00209586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65037449|NCT00209586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037450|NCT00209625|Leucovorin|leucovorin|mesh-list
65037451|NCT00209625|Fluorouracil|fluorouracil|mesh-list
65037452|NCT00209625|Irinotecan|irinotecan|mesh-list
65037453|NCT00209625|Antimetabolites|antimetabolites|mesh-ancestor
65037454|NCT00209625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037455|NCT00209625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65037456|NCT00209625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037457|NCT00209625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65037458|NCT00209625|Immunologic Factors|immunologic factors|mesh-ancestor
65037459|NCT00209625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037460|NCT00209625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65037461|NCT00209625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65037462|NCT00209625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037463|NCT00209625|Antidotes|antidotes|mesh-ancestor
65037464|NCT00209625|Protective Agents|protective agents|mesh-ancestor
65037465|NCT00209625|Vitamin B Complex|vitamin b complex|mesh-ancestor
65037484|NCT00182312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037485|NCT00182312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65037486|NCT00182312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037487|NCT00182312|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65037488|NCT00182312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65037489|NCT00182312|Purinergic Agents|purinergic agents|mesh-ancestor
65037490|NCT00182312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65037491|NCT00209664|Irinotecan|irinotecan|mesh-list
65037492|NCT00209664|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65037493|NCT00209664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65037507|NCT00587119|Budesonide|budesonide|mesh-list
65037547|NCT00209703|Vitamin B Complex|vitamin b complex|mesh-ancestor
65037548|NCT00209703|Vitamins|vitamins|mesh-ancestor
65037549|NCT00209703|Micronutrients|micronutrients|mesh-ancestor
65037550|NCT04575103|Antipsychotic Agents|antipsychotic agents|mesh-list
65037551|NCT04575103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65037552|NCT04575103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65037553|NCT04575103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037554|NCT04575103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65037555|NCT00587548|Diethylenetriamine|diethylenetriamine|mesh-list
65037556|NCT00587548|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65037557|NCT00587548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037559|NCT00216606|Anticonvulsants|anticonvulsants|mesh-ancestor
65037560|NCT00216606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65037561|NCT00216606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037562|NCT00587665|Ketamine|ketamine|mesh-list
65037563|NCT00587665|Analgesics|analgesics|mesh-ancestor
65037564|NCT00587665|Sensory System Agents|sensory system agents|mesh-ancestor
65037565|NCT00587665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65037566|NCT00587665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037567|NCT00587665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65037568|NCT00587665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65037569|NCT00587665|Anesthetics, General|anesthetics, general|mesh-ancestor
65037570|NCT00587665|Anesthetics|anesthetics|mesh-ancestor
65037571|NCT00587665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65037598|NCT00216645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65037599|NCT00216645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65037600|NCT00216645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037601|NCT00216645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037602|NCT00588016|Itraconazole|itraconazole|mesh-list
65037603|NCT00588016|Antifungal Agents|antifungal agents|mesh-ancestor
65037604|NCT00588016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65037605|NCT00588016|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65037606|NCT00588016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65037607|NCT00588016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037608|NCT00588016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037609|NCT00588016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65037610|NCT00588016|Hormone Antagonists|hormone antagonists|mesh-ancestor
65037611|NCT00588016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65037612|NCT00588016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037613|NCT00588016|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65037614|NCT00216684|Fentanyl|fentanyl|mesh-list
65037615|NCT00216684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65037616|NCT00216684|Narcotics|narcotics|mesh-ancestor
65037617|NCT00216684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65037618|NCT00216684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037619|NCT00216684|Analgesics|analgesics|mesh-ancestor
65493872|NCT04147494|FAPI-46|fapi-46|mesh-list
65037620|NCT00216684|Sensory System Agents|sensory system agents|mesh-ancestor
65037621|NCT00216684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65037622|NCT00216684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65037623|NCT00216684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65037624|NCT00216684|Anesthetics, General|anesthetics, general|mesh-ancestor
65037625|NCT00216684|Anesthetics|anesthetics|mesh-ancestor
65037641|NCT00182507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65037642|NCT00182507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65037643|NCT00182507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65037644|NCT00182507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65037645|NCT00182507|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65037646|NCT00182507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65037647|NCT00182507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65037648|NCT00182507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037649|NCT00182507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65037650|NCT00182507|Serotonin Agents|serotonin agents|mesh-ancestor
65037651|NCT00209742|Leucovorin|leucovorin|mesh-list
65037652|NCT00209742|polysaccharide-K|polysaccharide-k|mesh-list
65037653|NCT00209742|Tegafur|tegafur|mesh-list
65037654|NCT00209742|Levoleucovorin|levoleucovorin|mesh-list
65037655|NCT00209742|Antidotes|antidotes|mesh-ancestor
65037656|NCT00209742|Protective Agents|protective agents|mesh-ancestor
65037657|NCT00209742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037658|NCT00209742|Vitamin B Complex|vitamin b complex|mesh-ancestor
65037659|NCT00209742|Vitamins|vitamins|mesh-ancestor
65037660|NCT00209742|Micronutrients|micronutrients|mesh-ancestor
65037661|NCT00209742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65037662|NCT00209742|Antimetabolites|antimetabolites|mesh-ancestor
65037663|NCT00209742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037664|NCT00209742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037665|NCT00209742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65037666|NCT00209742|Immunologic Factors|immunologic factors|mesh-ancestor
65037667|NCT00209742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65037668|NCT00209742|Antiviral Agents|antiviral agents|mesh-ancestor
65037669|NCT00209742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65037670|NCT00209742|Interferon Inducers|interferon inducers|mesh-ancestor
65037686|NCT00216723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65037687|NCT00216723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65037688|NCT00216723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65037689|NCT00216723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65037690|NCT00209781|Pyrimethamine|pyrimethamine|mesh-list
65037691|NCT00209781|Sulfadoxine|sulfadoxine|mesh-list
65037692|NCT00209781|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65037693|NCT00209781|Antimalarials|antimalarials|mesh-ancestor
65037694|NCT00209781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65037695|NCT00209781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65493873|NCT04147494|Chelating Agents|chelating agents|mesh-ancestor
65037696|NCT00209781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65037697|NCT00209781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65037698|NCT00209781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65037699|NCT00209781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522943|NCT00361114|Dapsone|dapsone|mesh-list
65037700|NCT00209781|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65037702|NCT00182663|Clarithromycin|clarithromycin|mesh-list
65037703|NCT00182663|Thalidomide|thalidomide|mesh-list
65037704|NCT00182663|Dexamethasone|dexamethasone|mesh-list
65037705|NCT00182663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65037706|NCT00182663|Antiemetics|antiemetics|mesh-ancestor
65037707|NCT00182663|Autonomic Agents|autonomic agents|mesh-ancestor
65037708|NCT00182663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65037709|NCT00182663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037710|NCT00182663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65037711|NCT00182663|Glucocorticoids|glucocorticoids|mesh-ancestor
65037712|NCT00182663|Hormones|hormones|mesh-ancestor
65037713|NCT00182663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65037714|NCT00182663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65037715|NCT00182663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037716|NCT00182663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65037717|NCT00182663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65037718|NCT00182663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65037724|NCT00182663|Immunologic Factors|immunologic factors|mesh-ancestor
65037725|NCT00182663|Leprostatic Agents|leprostatic agents|mesh-ancestor
65037726|NCT00182663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65037727|NCT00182663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65037728|NCT00182663|Growth Substances|growth substances|mesh-ancestor
65037729|NCT00182663|Growth Inhibitors|growth inhibitors|mesh-ancestor
65037730|NCT00216762|Rituximab|rituximab|mesh-list
65037731|NCT00216762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65037745|NCT00588835|Aprepitant|aprepitant|mesh-list
65037790|NCT00209859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65037791|NCT00209859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65037792|NCT00209859|Glucocorticoids|glucocorticoids|mesh-ancestor
65037793|NCT00209859|Hormones|hormones|mesh-ancestor
65037794|NCT00209859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65037795|NCT00209859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65037796|NCT00209859|Respiratory System Agents|respiratory system agents|mesh-ancestor
65037797|NCT00588913|Zoledronic Acid|zoledronic acid|mesh-list
65037798|NCT00588913|Aldesleukin|aldesleukin|mesh-list
65037799|NCT00588913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037843|NCT00589264|Copper|copper|mesh-list
65037855|NCT00182819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037856|NCT00182819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65037857|NCT00216840|Betamethasone|betamethasone|mesh-list
65037858|NCT00216840|Betamethasone Valerate|betamethasone valerate|mesh-list
65037859|NCT00216840|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65037860|NCT00216840|Betamethasone benzoate|betamethasone benzoate|mesh-list
65037861|NCT00216840|Calcipotriene|calcipotriene|mesh-list
65037862|NCT00216840|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65037863|NCT00216840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65037864|NCT00216840|Glucocorticoids|glucocorticoids|mesh-ancestor
65037865|NCT00216840|Hormones|hormones|mesh-ancestor
65037866|NCT00216840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65037867|NCT00216840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037868|NCT00216840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65037869|NCT00216840|Respiratory System Agents|respiratory system agents|mesh-ancestor
65037870|NCT00216840|Dermatologic Agents|dermatologic agents|mesh-ancestor
65037871|NCT00589732|Valsartan|valsartan|mesh-list
65037872|NCT00589732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65037873|NCT00589732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65037874|NCT00589732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65037908|NCT00209937|Analgesics|analgesics|mesh-ancestor
65037909|NCT00209937|Sensory System Agents|sensory system agents|mesh-ancestor
65037910|NCT00209937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65037911|NCT00209937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037912|NCT00209937|Anticonvulsants|anticonvulsants|mesh-ancestor
65037913|NCT00209937|GABA Agonists|gaba agonists|mesh-ancestor
65037914|NCT00209937|GABA Agents|gaba agents|mesh-ancestor
65037915|NCT00209937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65037916|NCT00209937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65037917|NCT00590278|Raltitrexed|raltitrexed|mesh-list
65037975|NCT00590785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65037976|NCT00590785|Immunologic Factors|immunologic factors|mesh-ancestor
65037977|NCT00590785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65037978|NCT00590785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65037980|NCT00590785|Alkylating Agents|alkylating agents|mesh-ancestor
65038043|NCT00210132|Ropivacaine|ropivacaine|mesh-list
65038044|NCT00210132|Anesthetics, Local|anesthetics, local|mesh-ancestor
65038045|NCT00210132|Anesthetics|anesthetics|mesh-ancestor
65038046|NCT00210132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65038047|NCT00210132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038048|NCT00210132|Sensory System Agents|sensory system agents|mesh-ancestor
65038049|NCT00210132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038050|NCT00183404|Olanzapine|olanzapine|mesh-list
65038051|NCT00183404|Antiemetics|antiemetics|mesh-ancestor
65038052|NCT00183404|Autonomic Agents|autonomic agents|mesh-ancestor
65038053|NCT00183404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038054|NCT00183404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038055|NCT00183404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65038104|NCT00476086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038105|NCT00476086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65038106|NCT00476086|Immunologic Factors|immunologic factors|mesh-ancestor
65038107|NCT00476086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038108|NCT00476047|Tositumomab I-131|tositumomab i-131|mesh-list
65038109|NCT00476047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038110|NCT00217191|Ibuprofen|ibuprofen|mesh-list
65038111|NCT00217191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65038171|NCT00412152|Sensory System Agents|sensory system agents|mesh-ancestor
65038172|NCT00412152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038173|NCT02963402|Adalimumab|adalimumab|mesh-list
65038174|NCT02963402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65038175|NCT02963402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65038176|NCT00210327|Bortezomib|bortezomib|mesh-list
65038177|NCT00210327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038178|NCT00425516|Cyclophosphamide|cyclophosphamide|mesh-list
65038179|NCT00425516|Docetaxel|docetaxel|mesh-list
65038180|NCT00425516|Fluorouracil|fluorouracil|mesh-list
65038181|NCT00425516|Epirubicin|epirubicin|mesh-list
65038182|NCT00425516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65038183|NCT00425516|Immunologic Factors|immunologic factors|mesh-ancestor
65038184|NCT00425516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038185|NCT00425516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65038186|NCT00425516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65038187|NCT00425516|Alkylating Agents|alkylating agents|mesh-ancestor
65038188|NCT00425516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038189|NCT00425516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038190|NCT00425516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65038191|NCT00425516|Tubulin Modulators|tubulin modulators|mesh-ancestor
65038227|NCT00408785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038228|NCT00408785|Cholinergic Agents|cholinergic agents|mesh-ancestor
65038229|NCT00408785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65038230|NCT00408785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038231|NCT00408785|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65038232|NCT00408785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038233|NCT00475735|Methylphenidate|methylphenidate|mesh-list
65038234|NCT00475735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65038235|NCT00475735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038236|NCT00475735|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65038237|NCT00475735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65038238|NCT00475735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65038239|NCT00475735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038240|NCT00475735|Dopamine Agents|dopamine agents|mesh-ancestor
65038241|NCT00475735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65038242|NCT00475657|Pemetrexed|pemetrexed|mesh-list
65038243|NCT00475657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038244|NCT00475657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038245|NCT00475657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038246|NCT00475657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65038247|NCT00475657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65038277|NCT00210444|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65038278|NCT00210444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038279|NCT00475306|Diphenhydramine|diphenhydramine|mesh-list
65038280|NCT00475306|Promethazine|promethazine|mesh-list
65038281|NCT00475306|Metoclopramide|metoclopramide|mesh-list
65038282|NCT00475306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65038283|NCT00475306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65038284|NCT00475306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65038285|NCT00475306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038286|NCT00475306|Anesthetics, Local|anesthetics, local|mesh-ancestor
65038287|NCT00475306|Anesthetics|anesthetics|mesh-ancestor
65038288|NCT00475306|Sensory System Agents|sensory system agents|mesh-ancestor
65038339|NCT00184106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65038340|NCT00184106|Antidepressive Agents|antidepressive agents|mesh-ancestor
65038341|NCT00184106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65038342|NCT00184106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65038343|NCT00184106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65038344|NCT00184106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038410|NCT00217503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65038411|NCT00217503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65038412|NCT00217542|Interferons|interferons|mesh-list
65038413|NCT00217542|Interferon-alpha|interferon-alpha|mesh-list
65038414|NCT00217542|Interferon alpha-2|interferon alpha-2|mesh-list
65038415|NCT00217542|Azacitidine|azacitidine|mesh-list
65038416|NCT00217542|Amifostine|amifostine|mesh-list
65038417|NCT00217542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038418|NCT00217542|Antiviral Agents|antiviral agents|mesh-ancestor
65038419|NCT00217542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65038420|NCT00217542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65038421|NCT00217542|Antimetabolites|antimetabolites|mesh-ancestor
65038422|NCT00217542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038423|NCT00217542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038424|NCT00217542|Immunologic Factors|immunologic factors|mesh-ancestor
65038425|NCT00217542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038426|NCT00217542|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65038427|NCT00217542|Protective Agents|protective agents|mesh-ancestor
65038428|NCT00210717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65038429|NCT00210717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65038467|NCT00184574|Insulin Aspart|insulin aspart|mesh-list
65038468|NCT00184574|Biphasic Insulins|biphasic insulins|mesh-list
65038469|NCT00184574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65038470|NCT00184574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038471|NCT00210795|Epoetin Alfa|epoetin alfa|mesh-list
65038472|NCT00210795|Hematinics|hematinics|mesh-ancestor
65038473|NCT00217698|Gemcitabine|gemcitabine|mesh-list
65038474|NCT00217698|Gefitinib|gefitinib|mesh-list
65038475|NCT00217698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038476|NCT00217698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65038486|NCT00184613|Insulin|insulin|mesh-list
65038535|NCT00184847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65038536|NCT00184847|Cholinergic Agents|cholinergic agents|mesh-ancestor
65038537|NCT00184886|Methotrexate|methotrexate|mesh-list
65038538|NCT00184886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65038539|NCT00184886|Abortifacient Agents|abortifacient agents|mesh-ancestor
65038540|NCT00184886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65038541|NCT00184886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038542|NCT00184886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65038543|NCT00184886|Antimetabolites|antimetabolites|mesh-ancestor
65038544|NCT00184886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038545|NCT00184886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038546|NCT00184886|Dermatologic Agents|dermatologic agents|mesh-ancestor
65038547|NCT00184886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038548|NCT00184886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65038549|NCT00184886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65038550|NCT00184886|Immunologic Factors|immunologic factors|mesh-ancestor
65038551|NCT00184886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65038552|NCT00184886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65038553|NCT00217932|Valproic Acid|valproic acid|mesh-list
65038554|NCT00217932|Anticonvulsants|anticonvulsants|mesh-ancestor
65038555|NCT00217932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038556|NCT00217932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038557|NCT00217932|GABA Agents|gaba agents|mesh-ancestor
65038558|NCT00217932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65038559|NCT00217932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038583|NCT00185120|Vasodilator Agents|vasodilator agents|mesh-ancestor
65038584|NCT00185120|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65038585|NCT00185120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65038586|NCT00185120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65038587|NCT00185120|Protease Inhibitors|protease inhibitors|mesh-ancestor
65038588|NCT00185120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038589|NCT00218049|Vanoxerine|vanoxerine|mesh-list
65038590|NCT00218049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65038591|NCT00218049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65038592|NCT00218049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64523831|NCT02414568|Glucocorticoids|glucocorticoids|mesh-ancestor
65038646|NCT00409019|Tenofovir|tenofovir|mesh-list
65038647|NCT00409019|Adefovir|adefovir|mesh-list
65038648|NCT00409019|Telbivudine|telbivudine|mesh-list
65038649|NCT00409019|Antiviral Agents|antiviral agents|mesh-ancestor
65038650|NCT00409019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65038651|NCT00409019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65038652|NCT00409019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65038653|NCT00409019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038654|NCT00409019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038655|NCT00409019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65038656|NCT00409019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65038657|NCT00211146|Epoetin Alfa|epoetin alfa|mesh-list
65038658|NCT00211146|Hematinics|hematinics|mesh-ancestor
65038659|NCT00211224|Riluzole|riluzole|mesh-list
65038660|NCT00211224|Anticonvulsants|anticonvulsants|mesh-ancestor
65038661|NCT00211224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65038662|NCT00211224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65038663|NCT00211224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65038664|NCT00211224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038666|NCT00211224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65038703|NCT00185510|Autonomic Agents|autonomic agents|mesh-ancestor
65038704|NCT00185510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038705|NCT00185510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038706|NCT00185510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65038707|NCT00185510|Glucocorticoids|glucocorticoids|mesh-ancestor
65038708|NCT00185510|Hormones|hormones|mesh-ancestor
65038709|NCT00185510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65038710|NCT00185510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65038711|NCT00185510|Protective Agents|protective agents|mesh-ancestor
65038712|NCT00185510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65038766|NCT00185861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038767|NCT00211380|Aripiprazole|aripiprazole|mesh-list
65038768|NCT00211380|Antidepressive Agents|antidepressive agents|mesh-ancestor
65038769|NCT00211380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65038770|NCT00211380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65038771|NCT00211380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65038772|NCT00211380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65038773|NCT00211380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038774|NCT00211380|Dopamine Agonists|dopamine agonists|mesh-ancestor
65038775|NCT00211380|Dopamine Agents|dopamine agents|mesh-ancestor
65038776|NCT00211380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65038777|NCT00211380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038778|NCT00211380|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65038779|NCT00211380|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65038780|NCT00211380|Serotonin Agents|serotonin agents|mesh-ancestor
65038781|NCT00211380|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65038782|NCT00211380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65038783|NCT00211380|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65038784|NCT00211380|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65038785|NCT00185939|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65038786|NCT00185939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65038787|NCT00185939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65038788|NCT00185939|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65038789|NCT00185939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038790|NCT00185939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038791|NCT00218322|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65038792|NCT00218322|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65038793|NCT00218322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65038794|NCT00218322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65038795|NCT00218322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038806|NCT00218361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65038807|NCT00218517|Selegiline|selegiline|mesh-list
65038808|NCT00218517|Antidepressive Agents|antidepressive agents|mesh-ancestor
65038809|NCT00218517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65038810|NCT00218517|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65038811|NCT00218517|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65038812|NCT00218517|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65038813|NCT00218517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038814|NCT00218517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038815|NCT00218517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65038816|NCT00218517|Protective Agents|protective agents|mesh-ancestor
65038817|NCT00218517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038818|NCT00211419|Triamcinolone|triamcinolone|mesh-list
64524052|NCT02448862|Anesthetics|anesthetics|mesh-ancestor
65038819|NCT00211419|Anecortave|anecortave|mesh-list
65038820|NCT00211419|Verteporfin|verteporfin|mesh-list
65038821|NCT00211419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65038822|NCT00211419|Glucocorticoids|glucocorticoids|mesh-ancestor
65038823|NCT00211419|Hormones|hormones|mesh-ancestor
65038824|NCT00211419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65038825|NCT00211419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038826|NCT00211419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65038827|NCT00211419|Dermatologic Agents|dermatologic agents|mesh-ancestor
65038828|NCT00211419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65038829|NCT00211419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65038830|NCT00211419|Growth Substances|growth substances|mesh-ancestor
65038854|NCT00186797|Cyclophosphamide|cyclophosphamide|mesh-list
65038855|NCT00186797|Fludarabine|fludarabine|mesh-list
65038856|NCT00186797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65038857|NCT00186797|Immunologic Factors|immunologic factors|mesh-ancestor
65038858|NCT00186797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038859|NCT00186797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65038860|NCT00186797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65038861|NCT00186797|Alkylating Agents|alkylating agents|mesh-ancestor
65038862|NCT00186797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038863|NCT00186797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038864|NCT00186797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65038865|NCT00211653|Acetylcysteine|acetylcysteine|mesh-list
65038866|NCT00211653|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65038867|NCT00211653|Antiviral Agents|antiviral agents|mesh-ancestor
65038868|NCT00211653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65038869|NCT00211653|Expectorants|expectorants|mesh-ancestor
65038870|NCT00211653|Respiratory System Agents|respiratory system agents|mesh-ancestor
65038877|NCT00187031|Topotecan|topotecan|mesh-list
65038913|NCT00187070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65038914|NCT00187070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65038915|NCT00187070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65038916|NCT00187070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038917|NCT00187070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65038918|NCT00187070|Abortifacient Agents|abortifacient agents|mesh-ancestor
65038919|NCT00187070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65038920|NCT00187070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65038921|NCT00187070|Antimetabolites|antimetabolites|mesh-ancestor
65038922|NCT00187070|Dermatologic Agents|dermatologic agents|mesh-ancestor
65038923|NCT00187070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65038924|NCT00187070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65038925|NCT00187070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65038926|NCT00187070|Antiviral Agents|antiviral agents|mesh-ancestor
65038927|NCT00187070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65038928|NCT00187070|Tubulin Modulators|tubulin modulators|mesh-ancestor
65038929|NCT00187070|Antimitotic Agents|antimitotic agents|mesh-ancestor
65038930|NCT00187070|Mitosis Modulators|mitosis modulators|mesh-ancestor
65038938|NCT00211848|Ribavirin|ribavirin|mesh-list
65038970|NCT00212043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890855|NCT01976780|Anthelmintics|anthelmintics|mesh-ancestor
65038971|NCT00212043|Antiviral Agents|antiviral agents|mesh-ancestor
65038972|NCT00212043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65038974|NCT00212043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65038975|NCT00212043|Immunologic Factors|immunologic factors|mesh-ancestor
65038976|NCT00212043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038977|NCT00212082|Docetaxel|docetaxel|mesh-list
65038978|NCT00212082|Doxorubicin|doxorubicin|mesh-list
65038979|NCT00212082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65038980|NCT00212082|Tubulin Modulators|tubulin modulators|mesh-ancestor
65038981|NCT00212082|Antimitotic Agents|antimitotic agents|mesh-ancestor
65038982|NCT00212082|Mitosis Modulators|mitosis modulators|mesh-ancestor
65038983|NCT00212082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038984|NCT00212082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65038985|NCT00212082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65038986|NCT00212082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65038987|NCT00212082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038988|NCT00219219|Zoledronic Acid|zoledronic acid|mesh-list
65038989|NCT00219219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65038990|NCT00219219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038991|NCT00187928|Topiramate|topiramate|mesh-list
65038992|NCT00187928|Anticonvulsants|anticonvulsants|mesh-ancestor
65038993|NCT00187928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65038994|NCT00187928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65038995|NCT00212199|Orlistat|orlistat|mesh-list
65038996|NCT00212199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65038997|NCT00212199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65038998|NCT00212199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65038999|NCT00212199|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65039000|NCT00219258|Zoledronic Acid|zoledronic acid|mesh-list
65039001|NCT00219258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65039002|NCT00219258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039003|NCT00188006|Heparin|heparin|mesh-list
65039004|NCT00188006|Anticoagulants|anticoagulants|mesh-ancestor
65039005|NCT00188006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65039008|NCT00188045|Propranolol|propranolol|mesh-list
65039009|NCT00188045|Spironolactone|spironolactone|mesh-list
65039010|NCT00188045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65039011|NCT00188045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65039012|NCT00188045|Adrenergic Agents|adrenergic agents|mesh-ancestor
65039013|NCT00188045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039014|NCT00188045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039015|NCT00188045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039016|NCT00188045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65039017|NCT00188045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65039018|NCT00188045|Vasodilator Agents|vasodilator agents|mesh-ancestor
65039019|NCT00188045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65039020|NCT00188045|Hormone Antagonists|hormone antagonists|mesh-ancestor
65039021|NCT00188045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65039022|NCT00188045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65039023|NCT00188045|Diuretics|diuretics|mesh-ancestor
65039065|NCT00219570|Clindamycin|clindamycin|mesh-list
65039066|NCT00219570|Clindamycin palmitate|clindamycin palmitate|mesh-list
65039067|NCT00219570|Clindamycin phosphate|clindamycin phosphate|mesh-list
65039068|NCT00219570|Nadifloxacin|nadifloxacin|mesh-list
65039069|NCT00219570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65039070|NCT00219570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65039071|NCT00219570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65039072|NCT00219570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039073|NCT00219570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039074|NCT00219570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65039075|NCT00219570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65039076|NCT00219570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039077|NCT00212472|Factor VIII|factor viii|mesh-list
65039078|NCT00212472|Coagulants|coagulants|mesh-ancestor
65039079|NCT00188552|Tocopherols|tocopherols|mesh-list
65039080|NCT00188552|Vitamin E|vitamin e|mesh-list
65039081|NCT00188552|Tocotrienols|tocotrienols|mesh-list
65039082|NCT00188552|alpha-Tocopherol|alpha-tocopherol|mesh-list
65039083|NCT00188552|Pentoxifylline|pentoxifylline|mesh-list
65039084|NCT00188552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65039085|NCT00188552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039086|NCT00188552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039087|NCT00188552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65039088|NCT00188552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65039089|NCT00188552|Protective Agents|protective agents|mesh-ancestor
65039090|NCT00188552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039091|NCT00188552|Vasodilator Agents|vasodilator agents|mesh-ancestor
65039092|NCT00188552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65039093|NCT00188552|Antioxidants|antioxidants|mesh-ancestor
65039094|NCT00188552|Vitamins|vitamins|mesh-ancestor
65039095|NCT00188552|Micronutrients|micronutrients|mesh-ancestor
65039096|NCT00188630|Acetylcysteine|acetylcysteine|mesh-list
65039097|NCT00188630|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65039098|NCT00188630|Antiviral Agents|antiviral agents|mesh-ancestor
65039099|NCT00188630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65039108|NCT00188669|Tocopherols|tocopherols|mesh-list
65039109|NCT00188669|Vitamin E|vitamin e|mesh-list
65039110|NCT00188669|Tocotrienols|tocotrienols|mesh-list
65039111|NCT00188669|alpha-Tocopherol|alpha-tocopherol|mesh-list
65039112|NCT00188669|Pentoxifylline|pentoxifylline|mesh-list
65039113|NCT00188669|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65039114|NCT00188669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039115|NCT00188669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039116|NCT00188669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65039117|NCT00188669|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65039118|NCT00188669|Protective Agents|protective agents|mesh-ancestor
65039119|NCT00188669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039173|NCT00219765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65039174|NCT00219765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65039175|NCT00219765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65039176|NCT00212589|Leucovorin|leucovorin|mesh-list
65039177|NCT00212589|Folic Acid|folic acid|mesh-list
65039178|NCT00212589|Fluorouracil|fluorouracil|mesh-list
65039179|NCT00212589|Capecitabine|capecitabine|mesh-list
65039180|NCT00212589|Levoleucovorin|levoleucovorin|mesh-list
65039181|NCT00212589|Antimetabolites|antimetabolites|mesh-ancestor
65039182|NCT00212589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039183|NCT00212589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65039188|NCT00212589|Antidotes|antidotes|mesh-ancestor
65039237|NCT00188942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65039238|NCT00188942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65039239|NCT00188942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039240|NCT00219882|Turmeric extract|turmeric extract|mesh-list
65039308|NCT00189566|Carboplatin|carboplatin|mesh-list
65039309|NCT00189566|Topotecan|topotecan|mesh-list
65039310|NCT00189566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65039311|NCT00189566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039312|NCT00189566|Tubulin Modulators|tubulin modulators|mesh-ancestor
65039313|NCT00189566|Antimitotic Agents|antimitotic agents|mesh-ancestor
65039314|NCT00189566|Mitosis Modulators|mitosis modulators|mesh-ancestor
65039315|NCT00189566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039316|NCT00189566|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65039317|NCT00189566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65039318|NCT00189566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039319|NCT00220116|Capecitabine|capecitabine|mesh-list
65039320|NCT00220116|Oxaliplatin|oxaliplatin|mesh-list
65039321|NCT00220116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65039369|NCT00189722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65039370|NCT00189722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039371|NCT00189722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039372|NCT00220194|Leuprolide|leuprolide|mesh-list
65039373|NCT00220194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65039374|NCT00220194|Fertility Agents|fertility agents|mesh-ancestor
65039375|NCT00220194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65039376|NCT00220194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039377|NCT00220194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65039378|NCT00220194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039379|NCT00189761|Tacrolimus|tacrolimus|mesh-list
65039380|NCT00189761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65039381|NCT00189761|Immunologic Factors|immunologic factors|mesh-ancestor
65039382|NCT00189761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039383|NCT00189761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65039384|NCT00189761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039385|NCT00189761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039386|NCT00213096|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65039387|NCT00213096|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65039388|NCT00213096|Levonorgestrel|levonorgestrel|mesh-list
65039389|NCT00213096|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65039390|NCT00213096|ST 1435|st 1435|mesh-list
65039391|NCT00213096|Contraceptive Agents|contraceptive agents|mesh-list
65039392|NCT00213096|Contraceptives, Oral|contraceptives, oral|mesh-list
65039419|NCT00220233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039420|NCT00220233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65039421|NCT00220233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039422|NCT00220233|Vasodilator Agents|vasodilator agents|mesh-ancestor
65039424|NCT00220233|Natriuretic Agents|natriuretic agents|mesh-ancestor
65039425|NCT00220233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65039426|NCT00220233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65039427|NCT00220233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65039428|NCT00189839|Tacrolimus|tacrolimus|mesh-list
65039429|NCT00189839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65039430|NCT00189839|Immunologic Factors|immunologic factors|mesh-ancestor
65039431|NCT00189839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039432|NCT00189839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65039433|NCT00189839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039434|NCT00189839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039435|NCT00189878|Methotrexate|methotrexate|mesh-list
65039436|NCT00189878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65039473|NCT00213252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65039474|NCT00213252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039475|NCT00213252|Antiemetics|antiemetics|mesh-ancestor
65039476|NCT00213252|Autonomic Agents|autonomic agents|mesh-ancestor
65039477|NCT00213252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65039478|NCT00213252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65039479|NCT00213252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65039480|NCT00213252|Protective Agents|protective agents|mesh-ancestor
65039481|NCT00213252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65039482|NCT00213252|Respiratory System Agents|respiratory system agents|mesh-ancestor
65039483|NCT00213252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65039484|NCT00213252|Hormone Antagonists|hormone antagonists|mesh-ancestor
65039485|NCT00213252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65039488|NCT00189995|Haloperidol|haloperidol|mesh-list
65039535|NCT00412581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039536|NCT00412581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65039537|NCT00412581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65039538|NCT00412581|Growth Substances|growth substances|mesh-ancestor
65039539|NCT00412581|Growth Inhibitors|growth inhibitors|mesh-ancestor
65039540|NCT00412581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039541|NCT00412581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65039542|NCT00412581|Alkylating Agents|alkylating agents|mesh-ancestor
65039543|NCT00412581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039544|NCT00190151|Ciprofloxacin|ciprofloxacin|mesh-list
65039545|NCT00190151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65039546|NCT00190151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65039547|NCT00190151|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65039548|NCT00190151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65039592|NCT00190307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039593|NCT00190307|Antipyretics|antipyretics|mesh-ancestor
65039594|NCT02963168|Docetaxel|docetaxel|mesh-list
65039595|NCT02963168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039596|NCT02963168|Tubulin Modulators|tubulin modulators|mesh-ancestor
65039597|NCT02963168|Antimitotic Agents|antimitotic agents|mesh-ancestor
65039598|NCT02963168|Mitosis Modulators|mitosis modulators|mesh-ancestor
65039599|NCT02963168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039600|NCT00190424|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
65039601|NCT00190424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65039602|NCT00190424|Immunologic Factors|immunologic factors|mesh-ancestor
65039603|NCT00190424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039604|NCT00190463|Amphotericin B|amphotericin b|mesh-list
65039605|NCT00190463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65039606|NCT00190463|Amebicides|amebicides|mesh-ancestor
65039607|NCT00190463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65039608|NCT00190463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65039609|NCT00190463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65039610|NCT00190463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65039611|NCT00190463|Antifungal Agents|antifungal agents|mesh-ancestor
65039612|NCT00213486|Irinotecan|irinotecan|mesh-list
65039613|NCT00213486|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65039614|NCT00213486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65039615|NCT00213486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039616|NCT00213486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039617|NCT00213486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039618|NCT00190502|Antibodies|antibodies|mesh-list
65039619|NCT00190502|Immunologic Factors|immunologic factors|mesh-ancestor
65039620|NCT00190502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039621|NCT00122837|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65039622|NCT00122837|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65039623|NCT00122837|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65039624|NCT00122837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65039625|NCT00122837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65039629|NCT00122837|Analgesics|analgesics|mesh-ancestor
65039631|NCT00122837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65039632|NCT00122837|Antidepressive Agents|antidepressive agents|mesh-ancestor
65039633|NCT00122837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65039634|NCT00122837|Dopamine Agents|dopamine agents|mesh-ancestor
65039635|NCT00122837|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65039636|NCT00190580|Valsartan|valsartan|mesh-list
65039637|NCT00190580|Antihypertensive Agents|antihypertensive agents|mesh-list
65039638|NCT00190580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65039639|NCT00190580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65039640|NCT00190580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039641|NCT00220506|Modafinil|modafinil|mesh-list
64524876|NCT02407782|Ivermectin|ivermectin|mesh-list
65039643|NCT00220506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039644|NCT00220506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65039645|NCT00220506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65039646|NCT00220506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65039655|NCT00190619|Analgesics|analgesics|mesh-ancestor
65039685|NCT00190736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65039686|NCT00190736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65039687|NCT00190736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039688|NCT00190736|Adrenergic Agents|adrenergic agents|mesh-ancestor
65039689|NCT00190736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039690|NCT00190736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039691|NCT00220584|Donepezil|donepezil|mesh-list
65039692|NCT00220584|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65039693|NCT00220584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039694|NCT00220584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039695|NCT00220584|Cholinergic Agents|cholinergic agents|mesh-ancestor
65039696|NCT00220584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039697|NCT00220584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039698|NCT00220584|Nootropic Agents|nootropic agents|mesh-ancestor
65039699|NCT00190814|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65039700|NCT00190814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65039740|NCT00190892|Antiemetics|antiemetics|mesh-ancestor
65039741|NCT00190892|Autonomic Agents|autonomic agents|mesh-ancestor
65039742|NCT00190892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65039743|NCT00190892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039744|NCT00190892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65039745|NCT00190892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65039746|NCT00190892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65039747|NCT00190892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65039748|NCT00190892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65039749|NCT00190892|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65039750|NCT00190892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65039751|NCT00190892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65039752|NCT00190892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039753|NCT00190892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039754|NCT00190892|Serotonin Agents|serotonin agents|mesh-ancestor
65039755|NCT00190892|Anticonvulsants|anticonvulsants|mesh-ancestor
65039756|NCT00190892|Antimanic Agents|antimanic agents|mesh-ancestor
65039757|NCT00190892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65039758|NCT00190892|Analgesics|analgesics|mesh-ancestor
65039759|NCT00190892|Sensory System Agents|sensory system agents|mesh-ancestor
65039760|NCT00190892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65039761|NCT00190892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65039762|NCT00190892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65039763|NCT00220857|Rabeprazole|rabeprazole|mesh-list
65039764|NCT00220857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65039765|NCT00220857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64891681|NCT01983761|Fludarabine|fludarabine|mesh-list
65039787|NCT00190970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039788|NCT00191009|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65039789|NCT00191009|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65039790|NCT00191009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65039791|NCT00191009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65039792|NCT00191009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039848|NCT00191204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039849|NCT00191204|Analgesics|analgesics|mesh-ancestor
65039850|NCT00191204|Sensory System Agents|sensory system agents|mesh-ancestor
65039851|NCT00191204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65039852|NCT00191204|Antidepressive Agents|antidepressive agents|mesh-ancestor
65039853|NCT00191204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65039854|NCT00191204|Dopamine Agents|dopamine agents|mesh-ancestor
65039855|NCT00123227|Rosiglitazone|rosiglitazone|mesh-list
65039856|NCT00123227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65039858|NCT00191243|Gemcitabine|gemcitabine|mesh-list
65039859|NCT00191243|Docetaxel|docetaxel|mesh-list
65039914|NCT00191399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65039915|NCT00191399|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65039916|NCT00191399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65039917|NCT00191399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65039918|NCT00191399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039919|NCT00191399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65039920|NCT00191399|Serotonin Agents|serotonin agents|mesh-ancestor
65039921|NCT00191399|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65039922|NCT00191399|Antidepressive Agents|antidepressive agents|mesh-ancestor
65039923|NCT00191399|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65039924|NCT00191399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65039925|NCT00191399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039974|NCT00214266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65039975|NCT00214266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65039976|NCT00214266|Antitubercular Agents|antitubercular agents|mesh-ancestor
65039977|NCT00214266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65039978|NCT00214266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65039979|NCT00214266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65039980|NCT00214266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65039981|NCT00221325|Rituximab|rituximab|mesh-list
65039982|NCT00221325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65039983|NCT00221325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65039984|NCT00221325|Immunologic Factors|immunologic factors|mesh-ancestor
65039985|NCT00221325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039986|NCT00221325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65039987|NCT00123461|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
65039988|NCT00123461|Vitamins|vitamins|mesh-ancestor
65039989|NCT00123461|Micronutrients|micronutrients|mesh-ancestor
65039990|NCT00123461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65039991|NCT00123461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65039992|NCT00191516|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65039993|NCT00191516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65039994|NCT00191516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65039995|NCT00191516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65039997|NCT00191516|Adrenergic Agents|adrenergic agents|mesh-ancestor
65040023|NCT00221364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65040024|NCT00123539|Estrogens|estrogens|mesh-list
65040025|NCT00123539|Hormones|hormones|mesh-ancestor
65040026|NCT00123539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65040027|NCT00123539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040028|NCT00191594|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65040029|NCT00191594|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65040030|NCT00191594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65040089|NCT00191633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65040090|NCT00191633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65040091|NCT00191633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040092|NCT00191633|Adrenergic Agents|adrenergic agents|mesh-ancestor
65040093|NCT00191633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65040094|NCT00191633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040095|NCT00221520|Midazolam|midazolam|mesh-list
65040096|NCT00221520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65040097|NCT00221520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65040098|NCT00221520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65040099|NCT00221520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040100|NCT00221520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65040101|NCT00221520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65040102|NCT00221520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65040111|NCT00191672|Paclitaxel|paclitaxel|mesh-list
65040148|NCT00221637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040149|NCT00221637|GABA Agents|gaba agents|mesh-ancestor
65040150|NCT00221637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65040151|NCT00221637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040152|NCT00221637|Antimanic Agents|antimanic agents|mesh-ancestor
65040153|NCT00221637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65040154|NCT00221637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65040156|NCT00123656|Fluticasone|fluticasone|mesh-list
65040157|NCT00123656|Esomeprazole|esomeprazole|mesh-list
65040158|NCT00123656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65040159|NCT00123656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65040160|NCT00123656|Autonomic Agents|autonomic agents|mesh-ancestor
65040161|NCT00123656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65040162|NCT00123656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040163|NCT00123656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65040164|NCT00123656|Respiratory System Agents|respiratory system agents|mesh-ancestor
65040165|NCT00123656|Dermatologic Agents|dermatologic agents|mesh-ancestor
65040166|NCT00123656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65040167|NCT00123656|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65040168|NCT00123656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65040169|NCT00123656|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65040170|NCT00123656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040171|NCT00123656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040172|NCT00214617|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65040180|NCT00191750|Pemetrexed|pemetrexed|mesh-list
65040197|NCT00191828|Antiemetics|antiemetics|mesh-ancestor
65040198|NCT00191828|Autonomic Agents|autonomic agents|mesh-ancestor
65040199|NCT00191828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65040200|NCT00191828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040201|NCT00191828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65040202|NCT00191828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65040203|NCT00191828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65040204|NCT00191828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65040205|NCT00191828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65040206|NCT00191828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65040207|NCT00191828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65040208|NCT00191828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65040210|NCT00191828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65040257|NCT00192062|Gemcitabine|gemcitabine|mesh-list
65040258|NCT00192062|Vinorelbine|vinorelbine|mesh-list
65040259|NCT00192062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65040260|NCT00192062|Antimetabolites|antimetabolites|mesh-ancestor
65040261|NCT00192062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040262|NCT00192062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040263|NCT00192062|Antiviral Agents|antiviral agents|mesh-ancestor
65040264|NCT00192062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65040265|NCT00192062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040266|NCT00192062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65040273|NCT00192101|Gemcitabine|gemcitabine|mesh-list
65040321|NCT00215046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040322|NCT00215046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65040323|NCT00215046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65040324|NCT00215046|Immunologic Factors|immunologic factors|mesh-ancestor
65040325|NCT00215046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65040326|NCT00215046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65040327|NCT00215046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65040328|NCT00215046|Tubulin Modulators|tubulin modulators|mesh-ancestor
65040329|NCT00215046|Antimitotic Agents|antimitotic agents|mesh-ancestor
65040330|NCT00215046|Mitosis Modulators|mitosis modulators|mesh-ancestor
65040331|NCT00474487|Vaccines|vaccines|mesh-list
65040332|NCT00474487|Immunologic Factors|immunologic factors|mesh-ancestor
65040333|NCT00474487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040334|NCT00124124|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65040335|NCT00124124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65040336|NCT00124124|Immunologic Factors|immunologic factors|mesh-ancestor
65040337|NCT00124124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040338|NCT00474253|Rocuronium|rocuronium|mesh-list
65040339|NCT00474253|Succinylcholine|succinylcholine|mesh-list
65040340|NCT00474253|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65040341|NCT00474253|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65040342|NCT00474253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65040343|NCT00474253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65040344|NCT00474253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040345|NCT00474253|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
65040346|NCT00221871|Ketamine|ketamine|mesh-list
65040347|NCT00221871|Analgesics|analgesics|mesh-ancestor
65040348|NCT00221871|Sensory System Agents|sensory system agents|mesh-ancestor
65040349|NCT00221871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65040350|NCT00221871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040351|NCT00221871|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65040364|NCT00474058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040365|NCT00474058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040366|NCT02277730|Phenylephrine|phenylephrine|mesh-list
65040367|NCT02277730|Oxymetazoline|oxymetazoline|mesh-list
65040368|NCT02277730|Ephedrine|ephedrine|mesh-list
65040369|NCT02277730|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65040370|NCT02277730|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65040371|NCT02277730|Mydriatics|mydriatics|mesh-ancestor
65040372|NCT02277730|Autonomic Agents|autonomic agents|mesh-ancestor
65040373|NCT02277730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65040374|NCT02277730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040375|NCT02277730|Sympathomimetics|sympathomimetics|mesh-ancestor
65040376|NCT02277730|Nasal Decongestants|nasal decongestants|mesh-ancestor
65040378|NCT02277730|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65040379|NCT02277730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65040380|NCT02277730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65040381|NCT02277730|Adrenergic Agents|adrenergic agents|mesh-ancestor
65040382|NCT02277730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65040383|NCT02277730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040384|NCT02277730|Protective Agents|protective agents|mesh-ancestor
65040385|NCT02277730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65040386|NCT04571437|Capecitabine|capecitabine|mesh-list
65040387|NCT04571437|Letrozole|letrozole|mesh-list
65040388|NCT04571437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65040415|NCT00215163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65040416|NCT00215163|Serotonin Agents|serotonin agents|mesh-ancestor
65040417|NCT00215163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040418|NCT00215163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65040419|NCT00215163|Antidepressive Agents|antidepressive agents|mesh-ancestor
65040420|NCT00215163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65040421|NCT00215163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65040422|NCT00215163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65040423|NCT00215163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040424|NCT00215202|Gefitinib|gefitinib|mesh-list
65040425|NCT00215202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040426|NCT00215202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65040427|NCT00215202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040428|NCT00215202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040429|NCT00215241|Risperidone|risperidone|mesh-list
65040430|NCT00215241|Sertraline|sertraline|mesh-list
65040431|NCT00215241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65040432|NCT00215241|Serotonin Agents|serotonin agents|mesh-ancestor
65040433|NCT00215241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65040434|NCT00215241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040435|NCT00215241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040436|NCT00215241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65040437|NCT00215241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65040438|NCT00215241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65040439|NCT00215241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65040440|NCT00215241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65040441|NCT00215241|Dopamine Agents|dopamine agents|mesh-ancestor
65040442|NCT00215241|Antidepressive Agents|antidepressive agents|mesh-ancestor
65040446|NCT00124241|Lamivudine|lamivudine|mesh-list
65040460|NCT00124280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040461|NCT00215280|Ivermectin|ivermectin|mesh-list
65040462|NCT00215280|Albendazole|albendazole|mesh-list
65040463|NCT00215280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65040464|NCT00215280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65040465|NCT00215280|Anthelmintics|anthelmintics|mesh-ancestor
65040466|NCT00215280|Anticestodal Agents|anticestodal agents|mesh-ancestor
65040467|NCT00215280|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65040468|NCT00215280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65040469|NCT00215280|Tubulin Modulators|tubulin modulators|mesh-ancestor
65040470|NCT00215280|Antimitotic Agents|antimitotic agents|mesh-ancestor
65040471|NCT00215280|Mitosis Modulators|mitosis modulators|mesh-ancestor
65040472|NCT00215280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040473|NCT00215280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040474|NCT00192413|Vaccines|vaccines|mesh-list
65040475|NCT00192413|Immunologic Factors|immunologic factors|mesh-ancestor
65040476|NCT00192413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040479|NCT00215358|Autonomic Agents|autonomic agents|mesh-ancestor
65040518|NCT00192608|Protease Inhibitors|protease inhibitors|mesh-ancestor
65040519|NCT00192608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040520|NCT00192608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040521|NCT00192608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65040522|NCT00192608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65040523|NCT00192608|Antiviral Agents|antiviral agents|mesh-ancestor
65040524|NCT00192608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65040525|NCT00192608|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65040526|NCT00192608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65040527|NCT00215436|Formoterol Fumarate|formoterol fumarate|mesh-list
65040528|NCT00215436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65040529|NCT00215436|Autonomic Agents|autonomic agents|mesh-ancestor
65040580|NCT00411879|Adrenergic Agents|adrenergic agents|mesh-ancestor
65040581|NCT00411879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65040582|NCT00411879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040583|NCT00411879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040584|NCT00411879|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65040585|NCT00411879|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65040586|NCT00411879|Autonomic Agents|autonomic agents|mesh-ancestor
65040587|NCT00411879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65040588|NCT00411879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65040589|NCT00411879|Respiratory System Agents|respiratory system agents|mesh-ancestor
65040590|NCT00411879|Mydriatics|mydriatics|mesh-ancestor
65040591|NCT00411879|Sympathomimetics|sympathomimetics|mesh-ancestor
65040592|NCT00411879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65040593|NCT00411879|Hemostatics|hemostatics|mesh-ancestor
65040594|NCT00411879|Coagulants|coagulants|mesh-ancestor
65040595|NCT00411879|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65040596|NCT00411879|Natriuretic Agents|natriuretic agents|mesh-ancestor
65040597|NCT00222183|Pimecrolimus|pimecrolimus|mesh-list
65040598|NCT00222183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65040599|NCT00222183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65040633|NCT00192803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65040634|NCT00192803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65040635|NCT00192803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65040636|NCT00192803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040637|NCT00192842|Gemcitabine|gemcitabine|mesh-list
65040651|NCT00192842|Analgesics|analgesics|mesh-ancestor
65040701|NCT00215631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65040702|NCT00215631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040703|NCT00215631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040704|NCT00215631|Urological Agents|urological agents|mesh-ancestor
65040705|NCT00193076|Gemcitabine|gemcitabine|mesh-list
65040706|NCT00193076|Carboplatin|carboplatin|mesh-list
65040707|NCT00193076|Trastuzumab|trastuzumab|mesh-list
65040708|NCT00193076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040709|NCT00193076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65040710|NCT00193076|Antimetabolites|antimetabolites|mesh-ancestor
65040711|NCT00193076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040765|NCT00193232|Tubulin Modulators|tubulin modulators|mesh-ancestor
65040766|NCT00193232|Antimitotic Agents|antimitotic agents|mesh-ancestor
65040767|NCT00193232|Mitosis Modulators|mitosis modulators|mesh-ancestor
65040768|NCT00193232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040769|NCT00222495|Olanzapine|olanzapine|mesh-list
65040770|NCT00222495|Risperidone|risperidone|mesh-list
65040771|NCT00222495|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65040772|NCT00222495|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65040773|NCT00222495|Serotonin Agents|serotonin agents|mesh-ancestor
65040774|NCT00222495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65040775|NCT00222495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040776|NCT00222495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040777|NCT00222495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65040778|NCT00222495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65040779|NCT00222495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65040780|NCT00222495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65040781|NCT00222495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65040782|NCT00222495|Dopamine Agents|dopamine agents|mesh-ancestor
65040783|NCT00222495|Antiemetics|antiemetics|mesh-ancestor
65040784|NCT00222495|Autonomic Agents|autonomic agents|mesh-ancestor
65040785|NCT00222495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65040786|NCT00222495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65040787|NCT00222495|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65040788|NCT00222495|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65040790|NCT00222495|Antidepressive Agents|antidepressive agents|mesh-ancestor
65040815|NCT00193310|Mitosis Modulators|mitosis modulators|mesh-ancestor
65040816|NCT00193310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040817|NCT00193349|Carboplatin|carboplatin|mesh-list
65040818|NCT00193349|Irinotecan|irinotecan|mesh-list
65040819|NCT00193349|Imatinib Mesylate|imatinib mesylate|mesh-list
65040820|NCT00193349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040821|NCT00193349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65040822|NCT00193349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65040823|NCT00193349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65040824|NCT00193349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040881|NCT00193544|Immunologic Factors|immunologic factors|mesh-ancestor
65040882|NCT00193544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040883|NCT00193544|Leprostatic Agents|leprostatic agents|mesh-ancestor
65040884|NCT00193544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65040885|NCT00193544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65040886|NCT00193544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65040887|NCT00193544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65040888|NCT00193544|Growth Substances|growth substances|mesh-ancestor
65040889|NCT00193544|Growth Inhibitors|growth inhibitors|mesh-ancestor
65040890|NCT00193544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65040891|NCT00215865|Ribavirin|ribavirin|mesh-list
65040892|NCT00215865|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65040893|NCT00215865|Antimetabolites|antimetabolites|mesh-ancestor
65040894|NCT00215865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65040895|NCT00215865|Antiviral Agents|antiviral agents|mesh-ancestor
65040896|NCT00215865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65040897|NCT00124358|Buprenorphine|buprenorphine|mesh-list
65040898|NCT00124358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65040899|NCT00124358|Narcotics|narcotics|mesh-ancestor
65040900|NCT00124358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65040901|NCT00124358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65040903|NCT00124358|Sensory System Agents|sensory system agents|mesh-ancestor
65040904|NCT00124358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65040905|NCT00124358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65040906|NCT00193583|Carboplatin|carboplatin|mesh-list
65040907|NCT00193583|Topotecan|topotecan|mesh-list
65040915|NCT00215982|Irinotecan|irinotecan|mesh-list
65040931|NCT00216021|Capecitabine|capecitabine|mesh-list
65040932|NCT00216021|Oxaliplatin|oxaliplatin|mesh-list
65040933|NCT00216021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65040934|NCT00216021|Antimetabolites|antimetabolites|mesh-ancestor
65041001|NCT00124475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041002|NCT00124475|Dermatologic Agents|dermatologic agents|mesh-ancestor
65041003|NCT00409721|Memantine|memantine|mesh-list
65041004|NCT00409721|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65041005|NCT00409721|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65041006|NCT00409721|Dopamine Agents|dopamine agents|mesh-ancestor
65041007|NCT00409721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65041008|NCT00409721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041009|NCT00409721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041010|NCT00409721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65041011|NCT00409721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65041012|NCT00193622|Bevacizumab|bevacizumab|mesh-list
65041013|NCT00193622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65041014|NCT00193622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65041015|NCT00193622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041016|NCT00193622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65041017|NCT00193622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65041018|NCT00193622|Growth Substances|growth substances|mesh-ancestor
65041019|NCT00193622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041020|NCT00193622|Growth Inhibitors|growth inhibitors|mesh-ancestor
65041021|NCT00193622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65041022|NCT00193622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041023|NCT00193622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041050|NCT00193661|Testosterone|testosterone|mesh-list
65041051|NCT00193661|Androgens|androgens|mesh-ancestor
65041052|NCT00193661|Hormones|hormones|mesh-ancestor
65041053|NCT00193661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65041054|NCT00193661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041055|NCT00206232|Spironolactone|spironolactone|mesh-list
65041056|NCT00206232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65041057|NCT00206232|Hormone Antagonists|hormone antagonists|mesh-ancestor
65041058|NCT00206232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65041059|NCT00206232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041060|NCT00206232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65041061|NCT00206232|Diuretics|diuretics|mesh-ancestor
65041062|NCT00206232|Natriuretic Agents|natriuretic agents|mesh-ancestor
65041063|NCT00193700|Testosterone|testosterone|mesh-list
65041064|NCT00193700|Androgens|androgens|mesh-ancestor
65041065|NCT00193700|Hormones|hormones|mesh-ancestor
65041066|NCT00193700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65041067|NCT00193700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041104|NCT00125021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041105|NCT00193856|Zoledronic Acid|zoledronic acid|mesh-list
65041106|NCT00193856|Leuprolide|leuprolide|mesh-list
65041107|NCT00193856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65041108|NCT00193856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041109|NCT00193856|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65041110|NCT00193856|Fertility Agents|fertility agents|mesh-ancestor
65041111|NCT00193856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65041112|NCT00193856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65041113|NCT00193856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041114|NCT00223509|Lamotrigine|lamotrigine|mesh-list
65041115|NCT00223509|Anticonvulsants|anticonvulsants|mesh-ancestor
65041116|NCT00223509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65041117|NCT00223509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65041128|NCT00223548|Mesna|mesna|mesh-list
65041166|NCT00193973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65041167|NCT00193973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65041168|NCT00193973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65041169|NCT00193973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65041170|NCT00223860|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65041171|NCT00223860|Hormones|hormones|mesh-list
65041172|NCT00223860|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65041173|NCT00223860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65041174|NCT00223860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041175|NCT00223860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65041176|NCT00125255|Lidocaine|lidocaine|mesh-list
65041177|NCT00125255|Tetracaine|tetracaine|mesh-list
65041178|NCT00125255|Anesthetics, Local|anesthetics, local|mesh-ancestor
65041179|NCT00125255|Anesthetics|anesthetics|mesh-ancestor
65041180|NCT00125255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65041181|NCT00125255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041182|NCT00125255|Sensory System Agents|sensory system agents|mesh-ancestor
65041183|NCT00125255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65041184|NCT00125255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65041185|NCT00125255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65041186|NCT00125255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65041187|NCT00125255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65041188|NCT00125255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041189|NCT00223938|Ferric gluconate|ferric gluconate|mesh-list
65041190|NCT00223938|Ferric Compounds|ferric compounds|mesh-list
65041191|NCT00223938|Hematinics|hematinics|mesh-ancestor
65041192|NCT00125294|Methadone|methadone|mesh-list
65041193|NCT00125294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65041210|NCT00206466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041211|NCT00206466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65041212|NCT00206466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65041213|NCT00206466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65041214|NCT00206466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041215|NCT00206466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65041216|NCT00206466|Immunologic Factors|immunologic factors|mesh-ancestor
65041217|NCT00206466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041218|NCT00206466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65041219|NCT00206466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65041220|NCT00206466|Alkylating Agents|alkylating agents|mesh-ancestor
65041221|NCT00206466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65041222|NCT00224094|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65041223|NCT00224094|Estrogens|estrogens|mesh-ancestor
65041224|NCT00224094|Hormones|hormones|mesh-ancestor
65041225|NCT00224094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65041226|NCT00224094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041227|NCT00125411|Docetaxel|docetaxel|mesh-list
65041228|NCT00125411|Satraplatin|satraplatin|mesh-list
65041229|NCT00125411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041230|NCT00125411|Tubulin Modulators|tubulin modulators|mesh-ancestor
65041231|NCT00125411|Antimitotic Agents|antimitotic agents|mesh-ancestor
65041232|NCT00125411|Mitosis Modulators|mitosis modulators|mesh-ancestor
65041233|NCT00125411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041234|NCT00206505|Docetaxel|docetaxel|mesh-list
65041235|NCT00206505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041236|NCT00206505|Tubulin Modulators|tubulin modulators|mesh-ancestor
65041237|NCT00206505|Antimitotic Agents|antimitotic agents|mesh-ancestor
65041238|NCT00206505|Mitosis Modulators|mitosis modulators|mesh-ancestor
65041239|NCT00206505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041240|NCT00206544|Tamoxifen|tamoxifen|mesh-list
65041241|NCT00206544|Progesterone|progesterone|mesh-list
65041242|NCT00206544|Progestins|progestins|mesh-ancestor
65041243|NCT00206544|Hormones|hormones|mesh-ancestor
65041245|NCT00206544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041249|NCT00206544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64893171|NCT01994460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65041250|NCT00206544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65041251|NCT00206544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65041252|NCT00206544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65041253|NCT00194324|Miconazole|miconazole|mesh-list
65041254|NCT00194324|Clotrimazole|clotrimazole|mesh-list
65041255|NCT00194324|Antifungal Agents|antifungal agents|mesh-ancestor
65041256|NCT00194324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65041257|NCT00194324|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65041258|NCT00194324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65041259|NCT00194324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041260|NCT00194324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041261|NCT00194324|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65041262|NCT00194324|Hormone Antagonists|hormone antagonists|mesh-ancestor
65041263|NCT00194324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65041264|NCT00194324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041265|NCT00194324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64482628|NCT03584919|Cefuroxime|cefuroxime|mesh-list
64526516|NCT00367978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64526522|NCT00367978|Vasodilator Agents|vasodilator agents|mesh-ancestor
64915159|NCT00387530|Valganciclovir|valganciclovir|mesh-list
65493878|NCT04147494|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65041266|NCT00194324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65041267|NCT00194324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65041268|NCT00206622|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65041269|NCT00206622|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65041270|NCT00206622|Levonorgestrel|levonorgestrel|mesh-list
65041288|NCT00194402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65041289|NCT00194402|Antimetabolites|antimetabolites|mesh-ancestor
65041290|NCT00194402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041291|NCT00194402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65041292|NCT00194402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65041293|NCT00194402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041294|NCT00194402|Vasodilator Agents|vasodilator agents|mesh-ancestor
65041295|NCT00194402|Vitamin B Complex|vitamin b complex|mesh-ancestor
65041296|NCT00194402|Vitamins|vitamins|mesh-ancestor
65041297|NCT00194402|Micronutrients|micronutrients|mesh-ancestor
65041298|NCT00194402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041299|NCT00473512|Dexamethasone|dexamethasone|mesh-list
65041300|NCT00473512|Abiraterone Acetate|abiraterone acetate|mesh-list
65041301|NCT00473512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65041349|NCT00473434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65041350|NCT00473434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65041351|NCT00473434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041352|NCT00473434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65041353|NCT00473434|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65041354|NCT00473434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65041355|NCT00473434|Serotonin Agents|serotonin agents|mesh-ancestor
65041356|NCT00473434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65041357|NCT00473434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041358|NCT00473434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65041359|NCT00473434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65041412|NCT00125645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65041413|NCT00125645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65041414|NCT00125645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041415|NCT00125684|Morphine|morphine|mesh-list
65041416|NCT00125684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65041417|NCT00125684|Narcotics|narcotics|mesh-ancestor
65041418|NCT00125684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65041419|NCT00125684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041421|NCT00125684|Sensory System Agents|sensory system agents|mesh-ancestor
65041422|NCT00125684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65041423|NCT00194597|Sildenafil Citrate|sildenafil citrate|mesh-list
65041424|NCT00194597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041425|NCT00194597|Vasodilator Agents|vasodilator agents|mesh-ancestor
65041426|NCT00194597|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65041472|NCT00224445|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65041473|NCT00224445|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65041474|NCT00224445|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65041475|NCT00224445|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65041476|NCT00224445|Protease Inhibitors|protease inhibitors|mesh-ancestor
65041477|NCT00224445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041478|NCT00224445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041479|NCT00224445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65041480|NCT00224445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65041481|NCT00224445|Antiviral Agents|antiviral agents|mesh-ancestor
65041482|NCT00224445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65041483|NCT00224445|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65041484|NCT00224445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65041485|NCT00224445|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65041486|NCT00224445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65041487|NCT00194753|Paclitaxel|paclitaxel|mesh-list
65041488|NCT00194753|Cyclophosphamide|cyclophosphamide|mesh-list
65041489|NCT00194753|Doxorubicin|doxorubicin|mesh-list
65041490|NCT00194753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65041491|NCT00194753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041492|NCT00194753|Tubulin Modulators|tubulin modulators|mesh-ancestor
65041493|NCT00194753|Antimitotic Agents|antimitotic agents|mesh-ancestor
65041494|NCT00194753|Mitosis Modulators|mitosis modulators|mesh-ancestor
65041495|NCT00194753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041520|NCT00224523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65041521|NCT00472303|Morphine|morphine|mesh-list
65041522|NCT00472303|Tapentadol|tapentadol|mesh-list
65041523|NCT00472303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65041524|NCT00472303|Narcotics|narcotics|mesh-ancestor
65041525|NCT00472303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65041526|NCT00472303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041527|NCT00472303|Analgesics|analgesics|mesh-ancestor
65041528|NCT00472303|Sensory System Agents|sensory system agents|mesh-ancestor
65041529|NCT00472303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65041530|NCT00472303|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65041531|NCT00472303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65041532|NCT00472303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65041533|NCT00472303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041534|NCT00472303|Adrenergic Agents|adrenergic agents|mesh-ancestor
65041535|NCT00472303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65041536|NCT00125996|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65041537|NCT00125996|Hematinics|hematinics|mesh-ancestor
65041538|NCT00206934|Dexetimide|dexetimide|mesh-list
65041539|NCT00206934|Citalopram|citalopram|mesh-list
65041540|NCT00206934|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65041544|NCT00206934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65041572|NCT00194948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65041573|NCT00194948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041574|NCT00194948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65041575|NCT00194948|Serotonin Agents|serotonin agents|mesh-ancestor
65041576|NCT00194948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041577|NCT00194948|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65041578|NCT00194948|Antidepressive Agents|antidepressive agents|mesh-ancestor
65041579|NCT00194948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65041580|NCT00206973|Mannitol|mannitol|mesh-list
65041581|NCT00206973|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65041582|NCT00206973|Diuretics|diuretics|mesh-ancestor
65041583|NCT00206973|Natriuretic Agents|natriuretic agents|mesh-ancestor
65041584|NCT00206973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041585|NCT00471445|Ketamine|ketamine|mesh-list
65041586|NCT00471445|Amitriptyline|amitriptyline|mesh-list
65041587|NCT00471445|Analgesics|analgesics|mesh-ancestor
65041588|NCT00471445|Sensory System Agents|sensory system agents|mesh-ancestor
65041589|NCT00471445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65041590|NCT00471445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041591|NCT00471445|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65041592|NCT00471445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65041593|NCT00471445|Anesthetics, General|anesthetics, general|mesh-ancestor
65041594|NCT00471445|Anesthetics|anesthetics|mesh-ancestor
65041595|NCT00471445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65041596|NCT00471445|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65041597|NCT00471445|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65041598|NCT00471445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65041599|NCT00471445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041600|NCT00471445|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65041601|NCT00471445|Antidepressive Agents|antidepressive agents|mesh-ancestor
65041608|NCT00207051|Cetuximab|cetuximab|mesh-list
65041614|NCT00402467|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65041615|NCT00402467|Antithrombins|antithrombins|mesh-ancestor
65041616|NCT00402467|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65041617|NCT00402467|Protease Inhibitors|protease inhibitors|mesh-ancestor
65041618|NCT00402467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041619|NCT00402467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041620|NCT00402467|Anticoagulants|anticoagulants|mesh-ancestor
65041621|NCT00402467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65041622|NCT00402467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65041623|NCT00224679|Aspirin|aspirin|mesh-list
65041624|NCT00224679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65041625|NCT00224679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65041626|NCT00224679|Analgesics|analgesics|mesh-ancestor
65041627|NCT00224679|Sensory System Agents|sensory system agents|mesh-ancestor
65041675|NCT00195104|Antiviral Agents|antiviral agents|mesh-ancestor
65041676|NCT00195104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65041677|NCT00195104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65041678|NCT00195104|Immunologic Factors|immunologic factors|mesh-ancestor
65041679|NCT00195104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041680|NCT00413088|Bemiparin|bemiparin|mesh-list
65041681|NCT00413088|Anticoagulants|anticoagulants|mesh-ancestor
65041682|NCT00409760|Amlodipine|amlodipine|mesh-list
65041683|NCT00409760|Valsartan|valsartan|mesh-list
65041684|NCT00409760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65041741|NCT00207402|Antimetabolites|antimetabolites|mesh-ancestor
65041742|NCT00207402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041743|NCT00207402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65041744|NCT00207402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041745|NCT00195299|Sirolimus|sirolimus|mesh-list
65041746|NCT00195299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65041747|NCT00195299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65041748|NCT00195299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65041749|NCT00195299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041750|NCT00195299|Antifungal Agents|antifungal agents|mesh-ancestor
65041751|NCT00195299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65041752|NCT00195299|Immunologic Factors|immunologic factors|mesh-ancestor
65041753|NCT00195299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041754|NCT00471328|Sunitinib|sunitinib|mesh-list
65041755|NCT00471328|Imatinib Mesylate|imatinib mesylate|mesh-list
65041756|NCT00471328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041757|NCT00471328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65041758|NCT00471328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65041759|NCT00471328|Growth Substances|growth substances|mesh-ancestor
65041797|NCT00195416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65041798|NCT00195416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65041799|NCT00195416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65041800|NCT00195416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65041801|NCT00195416|Immunologic Factors|immunologic factors|mesh-ancestor
65041802|NCT00195455|Estradiol|estradiol|mesh-list
65041803|NCT00195455|Estrogens|estrogens|mesh-ancestor
65041804|NCT00195455|Hormones|hormones|mesh-ancestor
65041805|NCT00195455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65041806|NCT00195455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041807|NCT00126347|Folic Acid|folic acid|mesh-list
65041808|NCT00126347|Betaine|betaine|mesh-list
65041809|NCT00126347|Hematinics|hematinics|mesh-ancestor
65041810|NCT00126347|Vitamin B Complex|vitamin b complex|mesh-ancestor
65041811|NCT00126347|Vitamins|vitamins|mesh-ancestor
65041812|NCT00126347|Micronutrients|micronutrients|mesh-ancestor
65041813|NCT00126347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041814|NCT00126347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65041815|NCT00126347|Lipotropic Agents|lipotropic agents|mesh-ancestor
65041816|NCT00126347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65041817|NCT00126347|Antimetabolites|antimetabolites|mesh-ancestor
65041818|NCT00126347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041819|NCT00126347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65041820|NCT00225225|Rosiglitazone|rosiglitazone|mesh-list
65041821|NCT00225225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65041822|NCT00225225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041823|NCT00126386|Zoledronic Acid|zoledronic acid|mesh-list
65041824|NCT00126386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65041825|NCT00126386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041826|NCT00225264|Pioglitazone|pioglitazone|mesh-list
65041827|NCT00225264|Glimepiride|glimepiride|mesh-list
65041828|NCT00225264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65041829|NCT00225264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041830|NCT00225264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65041840|NCT00126464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041841|NCT00126464|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65041842|NCT00126464|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65041843|NCT00126464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65041844|NCT00126464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65041845|NCT00195533|Tazobactam|tazobactam|mesh-list
65041846|NCT00195533|Piperacillin|piperacillin|mesh-list
65041847|NCT00195533|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65041848|NCT00195533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65041849|NCT00195533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65041850|NCT00195533|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65041851|NCT00195533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041852|NCT00195533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041853|NCT00207558|Folic Acid|folic acid|mesh-list
65041854|NCT00207558|Hematinics|hematinics|mesh-ancestor
65041855|NCT00207558|Vitamin B Complex|vitamin b complex|mesh-ancestor
65041856|NCT00207558|Vitamins|vitamins|mesh-ancestor
65041857|NCT00207558|Micronutrients|micronutrients|mesh-ancestor
65041858|NCT00207558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041859|NCT00195572|Leucovorin|leucovorin|mesh-list
65041860|NCT00195572|Levoleucovorin|levoleucovorin|mesh-list
65041861|NCT00195572|Antidotes|antidotes|mesh-ancestor
65041896|NCT00470470|Imatinib Mesylate|imatinib mesylate|mesh-list
65041897|NCT00470470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041898|NCT00470470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65041899|NCT00470470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041900|NCT00470470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041901|NCT00195689|Adalimumab|adalimumab|mesh-list
65041902|NCT00195689|Antibodies|antibodies|mesh-list
65041903|NCT00195689|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65041904|NCT00195689|Immunologic Factors|immunologic factors|mesh-ancestor
65041905|NCT00195689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041906|NCT00195689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65041907|NCT00195689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65041908|NCT00470275|Cytarabine|cytarabine|mesh-list
65041909|NCT00470275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65041910|NCT00470275|Antimetabolites|antimetabolites|mesh-ancestor
65041911|NCT00470275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041912|NCT00470275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65041913|NCT00470275|Antiviral Agents|antiviral agents|mesh-ancestor
65041914|NCT00470275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65041915|NCT00470275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65041916|NCT00470275|Immunologic Factors|immunologic factors|mesh-ancestor
65041917|NCT00470275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041951|NCT00195767|Anticonvulsants|anticonvulsants|mesh-ancestor
65041952|NCT00195767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65041953|NCT00195767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65041954|NCT00195767|GABA Agents|gaba agents|mesh-ancestor
65041955|NCT00195767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65041956|NCT00195767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65041957|NCT00195767|Antimanic Agents|antimanic agents|mesh-ancestor
65041958|NCT00195767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65041959|NCT00195767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65041960|NCT00195767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65041961|NCT00207675|Infliximab|infliximab|mesh-list
65041962|NCT00207675|Dermatologic Agents|dermatologic agents|mesh-ancestor
65041963|NCT00207675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65041964|NCT00207675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65041965|NCT00202358|Atenolol|atenolol|mesh-list
65041966|NCT00202358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65041967|NCT00202358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65042009|NCT00202397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042010|NCT00202397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042011|NCT00202397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65042012|NCT00202397|Protective Agents|protective agents|mesh-ancestor
65042013|NCT00478972|Rimonabant|rimonabant|mesh-list
65042014|NCT00478972|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65042015|NCT00478972|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65042016|NCT00478972|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65042017|NCT00478972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042018|NCT00478972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042019|NCT00478972|Hormones|hormones|mesh-ancestor
65042020|NCT00478972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65042021|NCT00478972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042022|NCT00207792|Lenograstim|lenograstim|mesh-list
65042023|NCT00207792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65042024|NCT00207792|Immunologic Factors|immunologic factors|mesh-ancestor
65042066|NCT00202514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042067|NCT00202514|GABA Agents|gaba agents|mesh-ancestor
65042068|NCT00202514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042069|NCT00202514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042070|NCT00202514|Antimanic Agents|antimanic agents|mesh-ancestor
65042071|NCT00202514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65042072|NCT00202514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65042073|NCT00202514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65042074|NCT00207831|Tegafur|tegafur|mesh-list
65042075|NCT00207831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65042076|NCT00207831|Antimetabolites|antimetabolites|mesh-ancestor
65042077|NCT00207831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042078|NCT00207831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65042079|NCT00195923|Clindamycin|clindamycin|mesh-list
65042080|NCT00195923|Clindamycin palmitate|clindamycin palmitate|mesh-list
65042081|NCT00195923|Clindamycin phosphate|clindamycin phosphate|mesh-list
65042082|NCT00195923|Gentamicins|gentamicins|mesh-list
65042083|NCT00195923|Ceftazidime|ceftazidime|mesh-list
65042084|NCT00195923|Ampicillin|ampicillin|mesh-list
65042085|NCT00195923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65042086|NCT00195923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65042087|NCT00195923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65042088|NCT00195923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042118|NCT00411333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042119|NCT00411333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65042120|NCT00411333|Immunologic Factors|immunologic factors|mesh-ancestor
65042121|NCT00411333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042122|NCT00411333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042123|NCT00225849|Aspirin|aspirin|mesh-list
65042124|NCT00225849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65042125|NCT00225849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65042126|NCT00225849|Analgesics|analgesics|mesh-ancestor
65042127|NCT00225849|Sensory System Agents|sensory system agents|mesh-ancestor
65042128|NCT00225849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65042129|NCT00225849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042130|NCT00225849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65042131|NCT00225849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65042180|NCT00226044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042181|NCT00226044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042182|NCT00202982|Glatiramer Acetate|glatiramer acetate|mesh-list
65042184|NCT00202982|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65042185|NCT00202982|Immunologic Factors|immunologic factors|mesh-ancestor
65042186|NCT00202982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042188|NCT00202982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65042249|NCT00208065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042250|NCT00208065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65042251|NCT00208065|Serotonin Agents|serotonin agents|mesh-ancestor
65042253|NCT00203099|Glatiramer Acetate|glatiramer acetate|mesh-list
65042254|NCT00203099|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65042255|NCT00203099|(T,G)-A-L|(t,g)-a-l|mesh-list
65042256|NCT00203099|Antiviral Agents|antiviral agents|mesh-ancestor
65042257|NCT00203099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65042258|NCT00203099|Expectorants|expectorants|mesh-ancestor
65042259|NCT00203099|Respiratory System Agents|respiratory system agents|mesh-ancestor
65042260|NCT00203099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65042261|NCT00203099|Antioxidants|antioxidants|mesh-ancestor
65042262|NCT00203099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042263|NCT00203099|Protective Agents|protective agents|mesh-ancestor
65042264|NCT00203099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042265|NCT00203099|Antidotes|antidotes|mesh-ancestor
65042266|NCT00203099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65042267|NCT00203099|Immunologic Factors|immunologic factors|mesh-ancestor
65042268|NCT00203099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65042269|NCT00203099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65042270|NCT00226200|Omalizumab|omalizumab|mesh-list
65042271|NCT00226200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65042272|NCT00226200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65042273|NCT00226200|Respiratory System Agents|respiratory system agents|mesh-ancestor
65042274|NCT00203138|Rasagiline|rasagiline|mesh-list
65042275|NCT00203138|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65042281|NCT00196547|Montelukast|montelukast|mesh-list
65042298|NCT00208143|Risperidone|risperidone|mesh-list
65042299|NCT00208143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65042300|NCT00208143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65042301|NCT00208143|Serotonin Agents|serotonin agents|mesh-ancestor
65042302|NCT00208143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042303|NCT00208143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042304|NCT00208143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042305|NCT00208143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65042306|NCT00208143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65042307|NCT00208143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65042308|NCT00208143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65042309|NCT00208143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65042310|NCT00208143|Dopamine Agents|dopamine agents|mesh-ancestor
65042311|NCT00208143|Antidepressive Agents|antidepressive agents|mesh-ancestor
65042312|NCT00196586|Interferons|interferons|mesh-list
65042313|NCT00196586|Ribavirin|ribavirin|mesh-list
65042314|NCT00196586|Interferon-alpha|interferon-alpha|mesh-list
65042315|NCT00196586|Interferon alpha-2|interferon alpha-2|mesh-list
65042316|NCT00196586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65042317|NCT00196586|Interleukin-2|interleukin-2|mesh-list
65042318|NCT00196586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65042319|NCT00196586|Antiviral Agents|antiviral agents|mesh-ancestor
65042354|NCT00208182|Risperidone|risperidone|mesh-list
65042355|NCT00208182|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65042356|NCT00208182|Serotonin Agents|serotonin agents|mesh-ancestor
65042357|NCT00208182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042358|NCT00208182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042359|NCT00208182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042360|NCT00208182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65042361|NCT00208182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65042362|NCT00208182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65042363|NCT00208182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65042364|NCT00208182|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65042365|NCT00208182|Dopamine Agents|dopamine agents|mesh-ancestor
65042366|NCT00226395|Oxymorphone|oxymorphone|mesh-list
65042416|NCT00208260|Vitamin B Complex|vitamin b complex|mesh-ancestor
65042417|NCT00208260|Vitamins|vitamins|mesh-ancestor
65042418|NCT00208260|Micronutrients|micronutrients|mesh-ancestor
65042419|NCT00226473|Dacarbazine|dacarbazine|mesh-list
65042420|NCT00226473|Vindesine|vindesine|mesh-list
65042421|NCT00226473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65042422|NCT00226473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65042423|NCT00226473|Alkylating Agents|alkylating agents|mesh-ancestor
65042424|NCT00226473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042425|NCT00226473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65042426|NCT00226473|Tubulin Modulators|tubulin modulators|mesh-ancestor
65042427|NCT00226473|Antimitotic Agents|antimitotic agents|mesh-ancestor
65042428|NCT00226473|Mitosis Modulators|mitosis modulators|mesh-ancestor
65042429|NCT00208299|Adenosine|adenosine|mesh-list
65042430|NCT00208299|Regadenoson|regadenoson|mesh-list
65042431|NCT00208299|Analgesics|analgesics|mesh-ancestor
65042432|NCT00208299|Sensory System Agents|sensory system agents|mesh-ancestor
65042433|NCT00208299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65042434|NCT00208299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042435|NCT00208299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65042436|NCT00208299|Vasodilator Agents|vasodilator agents|mesh-ancestor
65042437|NCT00208299|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65042438|NCT00208299|Purinergic Agonists|purinergic agonists|mesh-ancestor
65042439|NCT00208299|Purinergic Agents|purinergic agents|mesh-ancestor
65042440|NCT00208299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042441|NCT00208299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042442|NCT00208299|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65042443|NCT00196664|Paroxetine|paroxetine|mesh-list
65042444|NCT00196664|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65042445|NCT00196664|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65042457|NCT00196703|Memantine|memantine|mesh-list
65042459|NCT00196703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65042460|NCT00196703|Dopamine Agents|dopamine agents|mesh-ancestor
65042461|NCT00196703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042462|NCT00196703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042463|NCT00196703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042464|NCT00196703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65042465|NCT00196703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65042466|NCT00413322|Fluorouracil|fluorouracil|mesh-list
65042467|NCT00413322|Belinostat|belinostat|mesh-list
65042468|NCT00413322|Antimetabolites|antimetabolites|mesh-ancestor
65042469|NCT00413322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042470|NCT00413322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65042471|NCT00413322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65042472|NCT00413322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65493880|NCT04138706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65042473|NCT00413322|Immunologic Factors|immunologic factors|mesh-ancestor
65042474|NCT00413322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042475|NCT00413322|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65042476|NCT00413322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042477|NCT00413361|Hydroxychloroquine|hydroxychloroquine|mesh-list
65042478|NCT00413361|Antimalarials|antimalarials|mesh-ancestor
65042479|NCT00413361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65042480|NCT00413361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65042481|NCT00413361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65042489|NCT00410657|Prednisolone|prednisolone|mesh-list
65042508|NCT00413439|Isavuconazole|isavuconazole|mesh-list
65042509|NCT00413439|Antifungal Agents|antifungal agents|mesh-ancestor
65042510|NCT00413439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65042511|NCT00196820|Capecitabine|capecitabine|mesh-list
65042512|NCT00196820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65042513|NCT00196820|Antimetabolites|antimetabolites|mesh-ancestor
65042514|NCT00196820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042515|NCT00196820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65042559|NCT00226551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042560|NCT00226551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042561|NCT00226551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042562|NCT00226551|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65042563|NCT00226551|Autonomic Agents|autonomic agents|mesh-ancestor
65042564|NCT00226551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65042565|NCT00226551|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65042566|NCT00226551|Respiratory System Agents|respiratory system agents|mesh-ancestor
65042567|NCT00226551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65042568|NCT00226551|Sympathomimetics|sympathomimetics|mesh-ancestor
65042569|NCT00226551|Protective Agents|protective agents|mesh-ancestor
65042570|NCT00196859|Ibandronic Acid|ibandronic acid|mesh-list
65042571|NCT00196859|Capecitabine|capecitabine|mesh-list
65042572|NCT00196859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65042573|NCT00196859|Antimetabolites|antimetabolites|mesh-ancestor
65042574|NCT00196859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042615|NCT00208572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65042616|NCT00208572|Antidepressive Agents|antidepressive agents|mesh-ancestor
65042617|NCT00208572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65042618|NCT00226707|Pimecrolimus|pimecrolimus|mesh-list
65042619|NCT00226707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65042620|NCT00226707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65042621|NCT00226707|Analgesics|analgesics|mesh-ancestor
65042622|NCT00226707|Sensory System Agents|sensory system agents|mesh-ancestor
65042623|NCT00226707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65042624|NCT00226707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042625|NCT00226707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65042626|NCT00226707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65042627|NCT00226707|Dermatologic Agents|dermatologic agents|mesh-ancestor
65042628|NCT00226707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65042629|NCT00226707|Immunologic Factors|immunologic factors|mesh-ancestor
65042630|NCT00226707|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65042631|NCT00226707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527949|NCT03306264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527950|NCT03306264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527951|NCT04977336|Acetaminophen|acetaminophen|mesh-list
64527952|NCT04977336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64527953|NCT04977336|Analgesics|analgesics|mesh-ancestor
64527957|NCT04977336|Antipyretics|antipyretics|mesh-ancestor
65042664|NCT00203567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65042665|NCT00203567|Analgesics|analgesics|mesh-ancestor
65042666|NCT00203567|Sensory System Agents|sensory system agents|mesh-ancestor
65493882|NCT04064060|Luspatercept|luspatercept|mesh-list
65042667|NCT00203567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65042668|NCT00203567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65042669|NCT00203567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65042670|NCT00203567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042671|NCT00203567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65042672|NCT00203567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65042673|NCT00226746|Gemcitabine|gemcitabine|mesh-list
65042675|NCT00226746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65042676|NCT00226746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65042677|NCT00226746|Tubulin Modulators|tubulin modulators|mesh-ancestor
65042678|NCT00226746|Antimitotic Agents|antimitotic agents|mesh-ancestor
65042679|NCT00226746|Mitosis Modulators|mitosis modulators|mesh-ancestor
65042680|NCT00226746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042681|NCT00226746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65042682|NCT00226746|Antimetabolites|antimetabolites|mesh-ancestor
65042683|NCT00226746|Antiviral Agents|antiviral agents|mesh-ancestor
65042684|NCT00226746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65042685|NCT00226746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042686|NCT00226746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65042687|NCT00226746|Immunologic Factors|immunologic factors|mesh-ancestor
65042690|NCT00203606|Ribavirin|ribavirin|mesh-list
65042703|NCT00203684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65042704|NCT00203684|Respiratory System Agents|respiratory system agents|mesh-ancestor
65042705|NCT00226785|Dexmedetomidine|dexmedetomidine|mesh-list
65042706|NCT00226785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65042707|NCT00226785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65042708|NCT00226785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042709|NCT00226785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65042710|NCT00226785|Analgesics|analgesics|mesh-ancestor
65042711|NCT00226785|Sensory System Agents|sensory system agents|mesh-ancestor
65042712|NCT00226785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65042713|NCT00226785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65042714|NCT00226785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65042715|NCT00226785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65042716|NCT00226785|Adrenergic Agents|adrenergic agents|mesh-ancestor
65042717|NCT00226785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042718|NCT00226785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042719|NCT00197132|Rosiglitazone|rosiglitazone|mesh-list
65042720|NCT00197132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65042721|NCT00197132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042722|NCT00226824|Galantamine|galantamine|mesh-list
65042755|NCT00226902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65042756|NCT00226902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65042757|NCT00203762|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65042758|NCT00203762|Antiviral Agents|antiviral agents|mesh-ancestor
65042759|NCT00203762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65042760|NCT00226980|Thalidomide|thalidomide|mesh-list
65042761|NCT00226980|Capecitabine|capecitabine|mesh-list
65042762|NCT00226980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65042763|NCT00226980|Antimetabolites|antimetabolites|mesh-ancestor
65042764|NCT00226980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042765|NCT00226980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65042766|NCT00226980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65042767|NCT00226980|Immunologic Factors|immunologic factors|mesh-ancestor
65042768|NCT00226980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042769|NCT00226980|Leprostatic Agents|leprostatic agents|mesh-ancestor
65042816|NCT00208923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65042819|NCT00227136|Serotonin Agents|serotonin agents|mesh-ancestor
65042820|NCT00227136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042821|NCT00227136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042822|NCT00227136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042823|NCT00203957|Istradefylline|istradefylline|mesh-list
65042824|NCT00203957|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
65042825|NCT00203957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65042826|NCT00203957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65042827|NCT00203957|Purinergic Agents|purinergic agents|mesh-ancestor
65042828|NCT00203957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65042829|NCT00203957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042830|NCT00203957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042831|NCT00197444|Nedaplatin|nedaplatin|mesh-list
65042832|NCT00197444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65042835|NCT00204074|Estradiol|estradiol|mesh-list
65042875|NCT00227331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65042876|NCT00227331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65042877|NCT00197561|Selenium|selenium|mesh-list
65042878|NCT00197561|Antioxidants|antioxidants|mesh-ancestor
65042879|NCT00197561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042880|NCT00197561|Protective Agents|protective agents|mesh-ancestor
65042881|NCT00197561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042882|NCT00197561|Trace Elements|trace elements|mesh-ancestor
65042883|NCT00197561|Micronutrients|micronutrients|mesh-ancestor
65042943|NCT00204230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65042944|NCT00204230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65042945|NCT00204230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042946|NCT00204269|Testosterone|testosterone|mesh-list
65042947|NCT00204269|Androgens|androgens|mesh-ancestor
65042948|NCT00204269|Hormones|hormones|mesh-ancestor
65042949|NCT00204269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65042950|NCT00204269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042951|NCT00197756|Vitamins|vitamins|mesh-list
65042952|NCT00197756|Vitamin A|vitamin a|mesh-list
65042953|NCT00197756|Retinol palmitate|retinol palmitate|mesh-list
65042954|NCT00197756|Micronutrients|micronutrients|mesh-ancestor
65042955|NCT00197756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042956|NCT00197756|Antioxidants|antioxidants|mesh-ancestor
65042957|NCT00197756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65042958|NCT00197756|Protective Agents|protective agents|mesh-ancestor
65042959|NCT00197756|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65042960|NCT00197756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65042961|NCT00227565|Carboplatin|carboplatin|mesh-list
65042962|NCT00227565|Pemetrexed|pemetrexed|mesh-list
64528256|NCT00267111|Tetracaine|tetracaine|mesh-list
65042963|NCT00227565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65042998|NCT00227682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65042999|NCT00227682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65043000|NCT00227682|Glucocorticoids|glucocorticoids|mesh-ancestor
65043001|NCT00227682|Hormones|hormones|mesh-ancestor
65043002|NCT00227682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65043003|NCT00227682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65043004|NCT00227682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043005|NCT00227682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65043006|NCT00227682|Immunologic Factors|immunologic factors|mesh-ancestor
65043007|NCT00227682|Leprostatic Agents|leprostatic agents|mesh-ancestor
65043008|NCT00227682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65043009|NCT00227682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65043010|NCT00227682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65043011|NCT00227682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65043012|NCT00227682|Growth Substances|growth substances|mesh-ancestor
65043013|NCT00227682|Growth Inhibitors|growth inhibitors|mesh-ancestor
65043014|NCT00227682|Antioxidants|antioxidants|mesh-ancestor
65043015|NCT00227682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043016|NCT00227682|Protective Agents|protective agents|mesh-ancestor
65043017|NCT00227682|Vitamins|vitamins|mesh-ancestor
65043018|NCT00227682|Micronutrients|micronutrients|mesh-ancestor
65043019|NCT00230763|Timolol|timolol|mesh-list
65043020|NCT00230763|Latanoprost|latanoprost|mesh-list
65043021|NCT00230763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65043031|NCT00204386|Topiramate|topiramate|mesh-list
65043050|NCT00197912|Celecoxib|celecoxib|mesh-list
65043051|NCT00197912|Cyclophosphamide|cyclophosphamide|mesh-list
65043052|NCT00197912|Interleukin-2|interleukin-2|mesh-list
65043053|NCT00197912|Immunologic Factors|immunologic factors|mesh-ancestor
65043054|NCT00197912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043055|NCT00197912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65043056|NCT00197912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65043057|NCT00197912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65043058|NCT00197912|Alkylating Agents|alkylating agents|mesh-ancestor
65043059|NCT00197912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043060|NCT00197912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043061|NCT00197912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65043062|NCT00197912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65043063|NCT00197912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65043064|NCT00197912|Analgesics|analgesics|mesh-ancestor
65043065|NCT00197912|Sensory System Agents|sensory system agents|mesh-ancestor
65043066|NCT00197912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65043067|NCT00197912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65043068|NCT00197912|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65043069|NCT00197912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65043070|NCT00197912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043071|NCT02962323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65043072|NCT02962323|Calcium|calcium|mesh-list
65043073|NCT02962323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65043076|NCT02962323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65043099|NCT00204542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043100|NCT00204542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65043101|NCT00204542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65043102|NCT00204542|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65043103|NCT00204542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043104|NCT00204542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043105|NCT00230958|Interferons|interferons|mesh-list
65043106|NCT00230958|Ribavirin|ribavirin|mesh-list
65043107|NCT00230958|Interferon-alpha|interferon-alpha|mesh-list
65043108|NCT00230958|Interferon alpha-2|interferon alpha-2|mesh-list
65043109|NCT00230958|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65043110|NCT00230958|Taribavirin|taribavirin|mesh-list
65043111|NCT00230958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043112|NCT00230958|Antiviral Agents|antiviral agents|mesh-ancestor
65043113|NCT00230958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65043114|NCT00230958|Antimetabolites|antimetabolites|mesh-ancestor
65043115|NCT00230958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043116|NCT00230958|Immunologic Factors|immunologic factors|mesh-ancestor
64917046|NCT00094003|Poly I-C|poly i-c|mesh-list
65043118|NCT00227955|Imipramine|imipramine|mesh-list
65043154|NCT00204581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043155|NCT00204581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65043156|NCT00204581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65043157|NCT00204581|Antiviral Agents|antiviral agents|mesh-ancestor
65043158|NCT00204581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65043159|NCT00231075|Paclitaxel|paclitaxel|mesh-list
65043160|NCT00231075|Carboplatin|carboplatin|mesh-list
65043161|NCT00231075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65043162|NCT00231075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043163|NCT00231075|Tubulin Modulators|tubulin modulators|mesh-ancestor
65043164|NCT00231075|Antimitotic Agents|antimitotic agents|mesh-ancestor
65043165|NCT00231075|Mitosis Modulators|mitosis modulators|mesh-ancestor
65043166|NCT00231075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043167|NCT00198146|Daclizumab|daclizumab|mesh-list
65043168|NCT00198146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65043169|NCT00198146|Immunologic Factors|immunologic factors|mesh-ancestor
65043170|NCT00198146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043171|NCT00204620|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65043172|NCT00204620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65043173|NCT00204620|Alkylating Agents|alkylating agents|mesh-ancestor
65043174|NCT00204620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043175|NCT00204620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043176|NCT02962518|Triamcinolone|triamcinolone|mesh-list
65043177|NCT02962518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65043178|NCT02962518|Glucocorticoids|glucocorticoids|mesh-ancestor
65043179|NCT02962518|Hormones|hormones|mesh-ancestor
65043180|NCT02962518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65043182|NCT00204659|Rituximab|rituximab|mesh-list
65043201|NCT00204737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65043202|NCT00204737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043203|NCT00204737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65043204|NCT00204737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043205|NCT00198380|Gefitinib|gefitinib|mesh-list
65043206|NCT00198380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043207|NCT00198380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65043208|NCT00198380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043209|NCT00198380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043210|NCT00228267|Propofol|propofol|mesh-list
65043211|NCT00228267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65043212|NCT00228267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65043213|NCT00228267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043214|NCT00228267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65043215|NCT00228267|Anesthetics, General|anesthetics, general|mesh-ancestor
65043216|NCT00228267|Anesthetics|anesthetics|mesh-ancestor
65043217|NCT00231348|Nefazodone|nefazodone|mesh-list
65043218|NCT00231348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65043219|NCT00231348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65043220|NCT00231348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65043221|NCT00231348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043222|NCT00231348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65043223|NCT00231348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043224|NCT00231348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65043225|NCT00231348|Antidepressive Agents|antidepressive agents|mesh-ancestor
65043226|NCT00231348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65043227|NCT00231348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65043244|NCT00409994|Sirolimus|sirolimus|mesh-list
65043245|NCT00409994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65043246|NCT00409994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65043247|NCT00409994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65043248|NCT00409994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043249|NCT00409994|Antifungal Agents|antifungal agents|mesh-ancestor
65043250|NCT00409994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65043251|NCT00409994|Immunologic Factors|immunologic factors|mesh-ancestor
65043252|NCT00409994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043253|NCT00410033|Insulin|insulin|mesh-list
65043309|NCT02963324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65043310|NCT00228540|Modafinil|modafinil|mesh-list
65043311|NCT00228540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65043312|NCT00228540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043313|NCT00228540|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65043314|NCT00228540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65043315|NCT00228540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65043316|NCT00228540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043317|NCT00231621|Topiramate|topiramate|mesh-list
65043318|NCT00231621|Anticonvulsants|anticonvulsants|mesh-ancestor
65043319|NCT00231621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65043320|NCT00231621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043321|NCT00474526|Vaccines|vaccines|mesh-list
65043322|NCT00474526|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65043323|NCT00474526|Immunologic Factors|immunologic factors|mesh-ancestor
65043324|NCT00474526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043325|NCT00231660|Topiramate|topiramate|mesh-list
65043326|NCT00231660|Anticonvulsants|anticonvulsants|mesh-ancestor
65043327|NCT00231660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65043328|NCT00231660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043329|NCT00231738|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
65043330|NCT00231738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65043331|NCT00231738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65043361|NCT00199004|Cyclophosphamide|cyclophosphamide|mesh-list
65043362|NCT00199004|Rituximab|rituximab|mesh-list
65043363|NCT00199004|Methotrexate|methotrexate|mesh-list
65043364|NCT00199004|Vincristine|vincristine|mesh-list
65043365|NCT00199004|Doxorubicin|doxorubicin|mesh-list
65043366|NCT00199004|Daunorubicin|daunorubicin|mesh-list
65043367|NCT00199004|Asparaginase|asparaginase|mesh-list
65043368|NCT00199004|Mercaptopurine|mercaptopurine|mesh-list
65043369|NCT00199004|Thioguanine|thioguanine|mesh-list
65043370|NCT00199004|Vindesine|vindesine|mesh-list
65043371|NCT00199004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65043372|NCT00199004|Immunologic Factors|immunologic factors|mesh-ancestor
65043374|NCT00199004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65043427|NCT00228891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043428|NCT00477412|Cytarabine|cytarabine|mesh-list
65043429|NCT00477412|Dexamethasone|dexamethasone|mesh-list
65043430|NCT00477412|Dexamethasone acetate|dexamethasone acetate|mesh-list
65043431|NCT00477412|Cyclophosphamide|cyclophosphamide|mesh-list
65043432|NCT00477412|Rituximab|rituximab|mesh-list
65043433|NCT00477412|Doxorubicin|doxorubicin|mesh-list
65043434|NCT00477412|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65043435|NCT00477412|Methotrexate|methotrexate|mesh-list
65043436|NCT00477412|Vincristine|vincristine|mesh-list
65043437|NCT00477412|Bortezomib|bortezomib|mesh-list
65043438|NCT00477412|Daunorubicin|daunorubicin|mesh-list
65043439|NCT00477412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65043440|NCT00477412|Antibodies|antibodies|mesh-list
65043441|NCT00477412|Immunoglobulins|immunoglobulins|mesh-list
65043442|NCT00477412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65043443|NCT00477412|BB 1101|bb 1101|mesh-list
65043444|NCT00477412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65043445|NCT00477412|Immunologic Factors|immunologic factors|mesh-ancestor
65043446|NCT00477412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043447|NCT00477412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65043448|NCT00477412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65043449|NCT00477412|Alkylating Agents|alkylating agents|mesh-ancestor
65043450|NCT00477412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043451|NCT00477412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043452|NCT00477412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65043453|NCT00477412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65043477|NCT00477412|Tubulin Modulators|tubulin modulators|mesh-ancestor
65043478|NCT00477412|Antimitotic Agents|antimitotic agents|mesh-ancestor
65043479|NCT00477412|Mitosis Modulators|mitosis modulators|mesh-ancestor
65043480|NCT00477412|Protease Inhibitors|protease inhibitors|mesh-ancestor
65043481|NCT00410774|Gemcitabine|gemcitabine|mesh-list
65043482|NCT00410774|Bevacizumab|bevacizumab|mesh-list
65043483|NCT00410774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65043484|NCT00410774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043485|NCT00410774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65043498|NCT00228930|Tamoxifen|tamoxifen|mesh-list
65043542|NCT00232089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043543|NCT00232089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043544|NCT00205166|Caffeine|caffeine|mesh-list
65043545|NCT00205166|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65043546|NCT00205166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043547|NCT00205166|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65043548|NCT00205166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043549|NCT00205166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043550|NCT00205166|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65043551|NCT00205166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65043552|NCT00205166|Purinergic Agents|purinergic agents|mesh-ancestor
65043553|NCT00205166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65043554|NCT00229125|Gabapentin|gabapentin|mesh-list
65043555|NCT00229125|Lorazepam|lorazepam|mesh-list
65043556|NCT00229125|Analgesics|analgesics|mesh-ancestor
65043557|NCT00229125|Sensory System Agents|sensory system agents|mesh-ancestor
65043558|NCT00229125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65043559|NCT00229125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043560|NCT00229125|Anticonvulsants|anticonvulsants|mesh-ancestor
65043561|NCT00229125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65043562|NCT00229125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65043563|NCT00229125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65043564|NCT00229125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65043565|NCT00229125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65043566|NCT00229125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65043567|NCT00229125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65043575|NCT00229125|GABA Agents|gaba agents|mesh-ancestor
65043591|NCT00232167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65043592|NCT00232167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65043593|NCT00232167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043594|NCT00232167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65043595|NCT00232167|Serotonin Agents|serotonin agents|mesh-ancestor
65043596|NCT00232167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043597|NCT00232167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65043598|NCT00232167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65043599|NCT00232167|GABA Modulators|gaba modulators|mesh-ancestor
65043600|NCT00232167|GABA Agents|gaba agents|mesh-ancestor
65043601|NCT00205322|Leucovorin|leucovorin|mesh-list
65043602|NCT00205322|Capecitabine|capecitabine|mesh-list
65043603|NCT00205322|Oxaliplatin|oxaliplatin|mesh-list
65043604|NCT00205322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65043605|NCT00205322|Antimetabolites|antimetabolites|mesh-ancestor
65043606|NCT00205322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043607|NCT00205322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043608|NCT00205322|Antidotes|antidotes|mesh-ancestor
65043609|NCT00205322|Protective Agents|protective agents|mesh-ancestor
65043610|NCT00205322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043611|NCT00205322|Vitamin B Complex|vitamin b complex|mesh-ancestor
65043612|NCT00205322|Vitamins|vitamins|mesh-ancestor
65043613|NCT00205322|Micronutrients|micronutrients|mesh-ancestor
65043614|NCT00232206|Docetaxel|docetaxel|mesh-list
65043615|NCT00232206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043616|NCT00232206|Tubulin Modulators|tubulin modulators|mesh-ancestor
65043617|NCT00232206|Antimitotic Agents|antimitotic agents|mesh-ancestor
65043618|NCT00232206|Mitosis Modulators|mitosis modulators|mesh-ancestor
65043619|NCT00232206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043620|NCT00229242|Diuretics|diuretics|mesh-list
65043621|NCT00229242|Natriuretic Agents|natriuretic agents|mesh-ancestor
65043622|NCT00229242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043623|NCT00232284|Sertraline|sertraline|mesh-list
65043624|NCT00232284|Antidepressive Agents|antidepressive agents|mesh-ancestor
65043625|NCT00232284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65043631|NCT00232284|Serotonin Agents|serotonin agents|mesh-ancestor
65043632|NCT00232284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043633|NCT00205634|Clarithromycin|clarithromycin|mesh-list
65043634|NCT00205634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65043635|NCT00205634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65043636|NCT00205634|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65043637|NCT00205634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043638|NCT00205634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043639|NCT00205634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65043640|NCT00205634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65043641|NCT00232362|Pioglitazone|pioglitazone|mesh-list
65043642|NCT00232362|Rosiglitazone|rosiglitazone|mesh-list
65043643|NCT00232362|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65043644|NCT00232362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043646|NCT00205751|Dexamethasone|dexamethasone|mesh-list
65043647|NCT00205751|Prednisone|prednisone|mesh-list
65043648|NCT00205751|Melphalan|melphalan|mesh-list
65043649|NCT00205751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65043650|NCT00205751|Antiemetics|antiemetics|mesh-ancestor
65043651|NCT00205751|Autonomic Agents|autonomic agents|mesh-ancestor
65043652|NCT00205751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65043653|NCT00205751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043654|NCT00205751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65043655|NCT00205751|Glucocorticoids|glucocorticoids|mesh-ancestor
65043656|NCT00205751|Hormones|hormones|mesh-ancestor
65043657|NCT00205751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65043658|NCT00205751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65043659|NCT00205751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043660|NCT00205751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65043661|NCT00205751|Alkylating Agents|alkylating agents|mesh-ancestor
65043662|NCT00205751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043663|NCT00205751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65043664|NCT00205751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65043672|NCT00205751|Growth Inhibitors|growth inhibitors|mesh-ancestor
65043673|NCT00229476|Sertraline|sertraline|mesh-list
65043674|NCT00229476|Antidepressive Agents|antidepressive agents|mesh-ancestor
65043675|NCT00229476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65043676|NCT00229476|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65043677|NCT00229476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65043678|NCT00229476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65043679|NCT00229476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043680|NCT00229476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65043681|NCT00229476|Serotonin Agents|serotonin agents|mesh-ancestor
65043682|NCT00229476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043683|NCT00205946|Bupropion|bupropion|mesh-list
65043684|NCT00205946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65043685|NCT00205946|Antidepressive Agents|antidepressive agents|mesh-ancestor
65043686|NCT00205946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65043687|NCT00205946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65043688|NCT00205946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65043689|NCT00205946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65043691|NCT00205946|Dopamine Agents|dopamine agents|mesh-ancestor
65043726|NCT00206063|Antithrombins|antithrombins|mesh-ancestor
65043727|NCT00206063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65043728|NCT00206063|Protease Inhibitors|protease inhibitors|mesh-ancestor
65043729|NCT00206063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65043730|NCT00206063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043731|NCT00206063|Anticoagulants|anticoagulants|mesh-ancestor
65043732|NCT00206141|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65043733|NCT00206141|Antidepressive Agents|antidepressive agents|mesh-ancestor
65043734|NCT00206141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65043792|NCT00411047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043794|NCT00411125|Salmon calcitonin|salmon calcitonin|mesh-list
65043795|NCT00411125|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
65043796|NCT00411125|Katacalcin|katacalcin|mesh-list
65043797|NCT00411125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65043798|NCT00411125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043799|NCT00411125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65043801|NCT00411164|Hydromorphone|hydromorphone|mesh-list
65043857|NCT00206453|Tubulin Modulators|tubulin modulators|mesh-ancestor
65043858|NCT00206453|Antimitotic Agents|antimitotic agents|mesh-ancestor
65043859|NCT00206453|Mitosis Modulators|mitosis modulators|mesh-ancestor
65043860|NCT00206453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043861|NCT00206492|Tamoxifen|tamoxifen|mesh-list
65043862|NCT00206492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65043863|NCT00206492|Hormone Antagonists|hormone antagonists|mesh-ancestor
65043864|NCT00206492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65043865|NCT00206492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043866|NCT00206492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65043867|NCT00206492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043868|NCT00206492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65043869|NCT00206492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65043870|NCT00206492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65043915|NCT00206765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64895865|NCT05138068|Serotonin Agents|serotonin agents|mesh-ancestor
65043916|NCT00424710|Ranibizumab|ranibizumab|mesh-list
65043917|NCT00424710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65043918|NCT00424710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65043919|NCT00424710|Growth Substances|growth substances|mesh-ancestor
65043920|NCT00424710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043921|NCT00424710|Growth Inhibitors|growth inhibitors|mesh-ancestor
65043922|NCT00424710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043923|NCT00206960|Risperidone|risperidone|mesh-list
65043924|NCT00206960|Clopenthixol|clopenthixol|mesh-list
65043925|NCT00206960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65043926|NCT00206960|Serotonin Agents|serotonin agents|mesh-ancestor
65043927|NCT00206960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65043928|NCT00206960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043929|NCT00206960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65043930|NCT00206960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65043931|NCT00206960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65043932|NCT00206960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65043933|NCT00206960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65043934|NCT00206960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65043935|NCT00206960|Dopamine Agents|dopamine agents|mesh-ancestor
65043936|NCT00206999|Imipramine|imipramine|mesh-list
65043937|NCT00206999|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65043938|NCT00206999|Antidepressive Agents|antidepressive agents|mesh-ancestor
65043939|NCT00206999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65043940|NCT00206999|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65043941|NCT00206999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65043942|NCT00206999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65043959|NCT00207116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043960|NCT00232908|Enfuvirtide|enfuvirtide|mesh-list
65043961|NCT00232908|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65043962|NCT00232908|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65043963|NCT00232908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65043964|NCT00232908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65043965|NCT00232908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65043966|NCT00232908|Antiviral Agents|antiviral agents|mesh-ancestor
65043967|NCT00232908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65043968|NCT00207155|Cetuximab|cetuximab|mesh-list
65043969|NCT00207155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65043970|NCT00207155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65043971|NCT00232947|Vaccines|vaccines|mesh-list
65043972|NCT00232947|Immunologic Factors|immunologic factors|mesh-ancestor
65043974|NCT00413712|Adenosine|adenosine|mesh-list
65044020|NCT00207428|Carbamazepine|carbamazepine|mesh-list
65044021|NCT00207428|Anticonvulsants|anticonvulsants|mesh-ancestor
65044022|NCT00207428|Antimanic Agents|antimanic agents|mesh-ancestor
65044023|NCT00207428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65044024|NCT00207428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65044025|NCT00207428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044026|NCT00207428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65044027|NCT00207428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65044028|NCT00207428|Analgesics|analgesics|mesh-ancestor
65044029|NCT00207428|Sensory System Agents|sensory system agents|mesh-ancestor
65044030|NCT00207428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044085|NCT00411320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65044086|NCT00411320|Glucocorticoids|glucocorticoids|mesh-ancestor
65044087|NCT00411320|Hormones|hormones|mesh-ancestor
65044088|NCT00411320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65044089|NCT00411320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65044090|NCT00411320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044092|NCT00233337|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65044093|NCT00233337|Antimalarials|antimalarials|mesh-ancestor
65044094|NCT00233337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65044095|NCT00233337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65044096|NCT00233337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65044097|NCT00230490|Adefovir|adefovir|mesh-list
65044099|NCT00230490|Antiviral Agents|antiviral agents|mesh-ancestor
65044100|NCT00230490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65044101|NCT00230490|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65044102|NCT00230490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65044103|NCT00230490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044104|NCT00230490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044105|NCT00230490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65044106|NCT01089556|Pregabalin|pregabalin|mesh-list
65044107|NCT01089556|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65044108|NCT01089556|Analgesics|analgesics|mesh-ancestor
65044109|NCT01089556|Sensory System Agents|sensory system agents|mesh-ancestor
65044136|NCT01089127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044137|NCT01089127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044138|NCT01089127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65044139|NCT01089127|Respiratory System Agents|respiratory system agents|mesh-ancestor
65044140|NCT01089127|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65044141|NCT01089127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65044142|NCT01089127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65044143|NCT01089127|Adrenergic Agents|adrenergic agents|mesh-ancestor
65044144|NCT01089127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044145|NCT01089127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044146|NCT00424580|Montelukast|montelukast|mesh-list
65044147|NCT00424580|Desloratadine|desloratadine|mesh-list
65044148|NCT00424580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65044149|NCT00424580|Respiratory System Agents|respiratory system agents|mesh-ancestor
65044150|NCT00424580|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65044151|NCT00424580|Hormone Antagonists|hormone antagonists|mesh-ancestor
65044152|NCT00424580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65044153|NCT00424580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044154|NCT00424580|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65044155|NCT00424580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65044156|NCT00424580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044157|NCT00424580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65044158|NCT00424580|Cholinergic Agents|cholinergic agents|mesh-ancestor
65044159|NCT00424580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044160|NCT00424580|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64485552|NCT00841828|Docetaxel|docetaxel|mesh-list
65044161|NCT00424580|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65044162|NCT00424580|Histamine Antagonists|histamine antagonists|mesh-ancestor
65044163|NCT00424580|Histamine Agents|histamine agents|mesh-ancestor
65044164|NCT00233532|Verapamil|verapamil|mesh-list
65044165|NCT00233532|Trandolapril|trandolapril|mesh-list
65044166|NCT00233532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65044172|NCT00233532|Vasodilator Agents|vasodilator agents|mesh-ancestor
65044173|NCT00233532|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65044174|NCT00233532|Protease Inhibitors|protease inhibitors|mesh-ancestor
65044175|NCT00233532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044176|NCT00233532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65044177|NCT00233571|Adalimumab|adalimumab|mesh-list
65044178|NCT00233571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65044179|NCT00233571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65044180|NCT00237198|Letrozole|letrozole|mesh-list
65044181|NCT00237198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044182|NCT00237198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65044183|NCT00237198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65044184|NCT00237198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044185|NCT00237198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044186|NCT00237198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65044187|NCT00237198|Hormone Antagonists|hormone antagonists|mesh-ancestor
65044188|NCT00237198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65044189|NCT00237198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044190|NCT00233610|Tamoxifen|tamoxifen|mesh-list
65044191|NCT00233610|Bicalutamide|bicalutamide|mesh-list
65044192|NCT00233610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65044193|NCT00233610|Hormone Antagonists|hormone antagonists|mesh-ancestor
65044194|NCT00233610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65044223|NCT00208169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044224|NCT00208169|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65044225|NCT00208169|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65044226|NCT00208169|Serotonin Agents|serotonin agents|mesh-ancestor
65044227|NCT00208169|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65044228|NCT00208169|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65044229|NCT00208169|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65044230|NCT00208169|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65044231|NCT01087723|Heparin|heparin|mesh-list
65044232|NCT01087723|Bivalirudin|bivalirudin|mesh-list
65044233|NCT01087723|Anticoagulants|anticoagulants|mesh-ancestor
65044234|NCT01087723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65044235|NCT01087723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65044236|NCT01087723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044237|NCT01087723|Antithrombins|antithrombins|mesh-ancestor
65044238|NCT01087723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65044239|NCT01087723|Protease Inhibitors|protease inhibitors|mesh-ancestor
65044240|NCT01087723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044241|NCT00208208|Ziprasidone|ziprasidone|mesh-list
65044242|NCT00208208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65044243|NCT00208208|Serotonin Agents|serotonin agents|mesh-ancestor
65044244|NCT00208208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044245|NCT00208208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044246|NCT00208208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044247|NCT00208208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65044248|NCT00208208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65044249|NCT00208208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65044268|NCT01085734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65044269|NCT01085734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044270|NCT01085734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65044271|NCT01085734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65044272|NCT01085734|Growth Substances|growth substances|mesh-ancestor
65044273|NCT01085734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044274|NCT01085734|Growth Inhibitors|growth inhibitors|mesh-ancestor
65044275|NCT00208403|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
65044276|NCT00208403|Vasodilator Agents|vasodilator agents|mesh-ancestor
65044277|NCT00208403|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65044278|NCT00208403|Protective Agents|protective agents|mesh-ancestor
65044279|NCT00208403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044280|NCT01084603|Nicotine|nicotine|mesh-list
65044281|NCT01084603|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65044282|NCT01084603|Autonomic Agents|autonomic agents|mesh-ancestor
65044283|NCT01084603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044284|NCT01084603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044324|NCT00208520|Sensory System Agents|sensory system agents|mesh-ancestor
65044325|NCT00208520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044326|NCT00208520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65044327|NCT00208520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65044328|NCT00237393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65044329|NCT00237393|Antidepressive Agents|antidepressive agents|mesh-ancestor
65044330|NCT00237393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65044331|NCT00237393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65044332|NCT00237393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65044333|NCT00237393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65044334|NCT00237393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044335|NCT00208559|Ziprasidone|ziprasidone|mesh-list
65044386|NCT00208715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65044387|NCT00208715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044388|NCT00208715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65044389|NCT00208715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65044390|NCT00208715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65044391|NCT00208715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044392|NCT00208793|Calcium, Dietary|calcium, dietary|mesh-list
65044393|NCT00208793|Vitamin D|vitamin d|mesh-list
65044394|NCT00208793|Ergocalciferols|ergocalciferols|mesh-list
65044395|NCT00208793|Cholecalciferol|cholecalciferol|mesh-list
65044396|NCT00208793|Vitamins|vitamins|mesh-list
65044397|NCT00208793|Calcium|calcium|mesh-list
65044398|NCT00208793|Micronutrients|micronutrients|mesh-ancestor
65044399|NCT00208793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044400|NCT00208793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65044401|NCT00208793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65044402|NCT00233883|Enfuvirtide|enfuvirtide|mesh-list
65044403|NCT00233883|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65044442|NCT00234000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044443|NCT00234000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044444|NCT00234117|Rabeprazole|rabeprazole|mesh-list
65044445|NCT00234117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65044446|NCT00234117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65044447|NCT00234117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65044448|NCT00234117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044449|NCT00234117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044450|NCT00209144|Insulin|insulin|mesh-list
65044451|NCT00209144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65044452|NCT00209144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044453|NCT00209222|Cytarabine|cytarabine|mesh-list
65044454|NCT00209222|Dexamethasone|dexamethasone|mesh-list
65044455|NCT00209222|Prednisone|prednisone|mesh-list
64485852|NCT00863356|Chitosan|chitosan|mesh-list
65044456|NCT00209222|Cyclophosphamide|cyclophosphamide|mesh-list
65044457|NCT00209222|Melphalan|melphalan|mesh-list
65044458|NCT00209222|Rituximab|rituximab|mesh-list
65044459|NCT00209222|Doxorubicin|doxorubicin|mesh-list
65044460|NCT00209222|Etoposide|etoposide|mesh-list
65044461|NCT00209222|Vincristine|vincristine|mesh-list
65044462|NCT00209222|Cisplatin|cisplatin|mesh-list
65044463|NCT00209222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65044464|NCT00209222|Immunologic Factors|immunologic factors|mesh-ancestor
65044465|NCT00209222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044466|NCT00209222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65044467|NCT00209222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65044468|NCT00209222|Alkylating Agents|alkylating agents|mesh-ancestor
65044469|NCT00209222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044471|NCT00209222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65044472|NCT00209222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65044473|NCT00209222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65044474|NCT00209222|Antiemetics|antiemetics|mesh-ancestor
65044488|NCT00209222|Antimitotic Agents|antimitotic agents|mesh-ancestor
65044489|NCT00209222|Mitosis Modulators|mitosis modulators|mesh-ancestor
65044490|NCT00209222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65044491|NCT00209222|Antimetabolites|antimetabolites|mesh-ancestor
65044492|NCT00209222|Antiviral Agents|antiviral agents|mesh-ancestor
65044493|NCT00209222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65044494|NCT00234195|Bupropion|bupropion|mesh-list
65044495|NCT00234195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65044496|NCT00234195|Antidepressive Agents|antidepressive agents|mesh-ancestor
65044497|NCT00234195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65044498|NCT00234195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65044499|NCT00234195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65044500|NCT00234195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65044501|NCT00234195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044502|NCT00234195|Dopamine Agents|dopamine agents|mesh-ancestor
65044503|NCT00234195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044504|NCT00234195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044505|NCT00234195|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65044506|NCT00234195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65044507|NCT00234195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044508|NCT00209261|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65044509|NCT00209261|Hemostatics|hemostatics|mesh-ancestor
65044510|NCT00209261|Coagulants|coagulants|mesh-ancestor
65044511|NCT00209261|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65044512|NCT00209261|Natriuretic Agents|natriuretic agents|mesh-ancestor
65044514|NCT00209300|Mesalamine|mesalamine|mesh-list
65044535|NCT00237588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65044536|NCT00237588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65044537|NCT00237588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65044538|NCT00411437|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65044539|NCT00411437|Oxybutynin|oxybutynin|mesh-list
65044540|NCT00411437|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65044541|NCT00411437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65044543|NCT00411437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044544|NCT00411437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044545|NCT00411437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044546|NCT00411437|Urological Agents|urological agents|mesh-ancestor
65044547|NCT00411437|Parasympatholytics|parasympatholytics|mesh-ancestor
65044548|NCT00411437|Autonomic Agents|autonomic agents|mesh-ancestor
65044549|NCT00411437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044550|NCT00234312|Citalopram|citalopram|mesh-list
65044551|NCT00234312|Sertraline|sertraline|mesh-list
65044552|NCT00234312|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65044553|NCT00234312|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65044554|NCT00234312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65044555|NCT00234312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044556|NCT00234312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044557|NCT00234312|Serotonin Agents|serotonin agents|mesh-ancestor
65044558|NCT00234312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044559|NCT00234312|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65044560|NCT00234312|Antidepressive Agents|antidepressive agents|mesh-ancestor
65044561|NCT00234312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65044562|NCT00411515|Mycophenolic Acid|mycophenolic acid|mesh-list
65044563|NCT00411515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65044564|NCT00411515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044565|NCT00411515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65044566|NCT00411515|Antitubercular Agents|antitubercular agents|mesh-ancestor
65044577|NCT00237627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65044578|NCT00237627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044579|NCT00237627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044580|NCT00209495|Dexamethasone|dexamethasone|mesh-list
65044581|NCT00209495|Pregabalin|pregabalin|mesh-list
65044582|NCT00209495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65044583|NCT00209495|Antiemetics|antiemetics|mesh-ancestor
65044646|NCT00234429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65044647|NCT00209651|Irinotecan|irinotecan|mesh-list
65044648|NCT00209651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65044649|NCT00209651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65044650|NCT00209651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044651|NCT00209651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044652|NCT00209651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044653|NCT02961855|Diclofenac|diclofenac|mesh-list
65044654|NCT02961855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65044655|NCT02961855|Lidocaine|lidocaine|mesh-list
65044656|NCT02961855|Anesthetics, Local|anesthetics, local|mesh-ancestor
65044657|NCT02961855|Anesthetics|anesthetics|mesh-ancestor
65044658|NCT02961855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65044659|NCT02961855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044660|NCT02961855|Sensory System Agents|sensory system agents|mesh-ancestor
65044661|NCT02961855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044662|NCT02961855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65044663|NCT02961855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65044664|NCT02961855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65044665|NCT02961855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65044666|NCT02961855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044667|NCT02961855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65044668|NCT02961855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65044669|NCT02961855|Analgesics|analgesics|mesh-ancestor
65044670|NCT02961855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65044671|NCT02961855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65044672|NCT02961855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044673|NCT00209690|Cisplatin|cisplatin|mesh-list
65044674|NCT00209690|Docetaxel|docetaxel|mesh-list
65044691|NCT01081132|Adrenergic Agents|adrenergic agents|mesh-ancestor
65044692|NCT01081132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044693|NCT01081132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044694|NCT01081132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044695|NCT00234468|Gefitinib|gefitinib|mesh-list
65044696|NCT00234468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044697|NCT00234468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65044698|NCT00234468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044699|NCT00234468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044700|NCT01080625|Phenylephrine|phenylephrine|mesh-list
65044701|NCT01080625|Epinephrine|epinephrine|mesh-list
65044702|NCT01080625|Oxymetazoline|oxymetazoline|mesh-list
65044703|NCT01080625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65044704|NCT01080625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65044705|NCT01080625|Adrenergic Agents|adrenergic agents|mesh-ancestor
65044706|NCT01080625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044707|NCT01080625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044708|NCT01080625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044709|NCT01080625|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65044744|NCT01089790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044745|NCT01089790|Incretins|incretins|mesh-ancestor
65044746|NCT01089790|Hormones|hormones|mesh-ancestor
65044747|NCT01089790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65044748|NCT01089790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65044749|NCT01089790|Protease Inhibitors|protease inhibitors|mesh-ancestor
65044750|NCT01089790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044751|NCT01089790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044752|NCT00234507|Botulinum Toxins|botulinum toxins|mesh-list
65044753|NCT00234507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65044754|NCT00234507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65044755|NCT00234507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65044756|NCT00234507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65044757|NCT00234507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044758|NCT00234507|Cholinergic Agents|cholinergic agents|mesh-ancestor
65044759|NCT00234507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044760|NCT00234507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044761|NCT00234507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65044762|NCT00234507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65044764|NCT01084330|Irinotecan|irinotecan|mesh-list
65044765|NCT01084330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044766|NCT01084330|Tubulin Modulators|tubulin modulators|mesh-ancestor
65044767|NCT01084330|Antimitotic Agents|antimitotic agents|mesh-ancestor
65044794|NCT00209846|GABA Agents|gaba agents|mesh-ancestor
65044795|NCT00209846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044796|NCT00209846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044797|NCT01082068|Letrozole|letrozole|mesh-list
65044798|NCT01082068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044799|NCT01082068|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65044800|NCT01082068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65044801|NCT01082068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044802|NCT01082068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044803|NCT01082068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65044804|NCT01082068|Hormone Antagonists|hormone antagonists|mesh-ancestor
65044805|NCT01082068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65044806|NCT01082068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044807|NCT01086748|Risperidone|risperidone|mesh-list
65044808|NCT01086748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65044809|NCT01086748|Serotonin Agents|serotonin agents|mesh-ancestor
65044810|NCT01086748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044811|NCT01086748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044812|NCT01086748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044813|NCT01086748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65044814|NCT01086748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65044816|NCT01086748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65044844|NCT00209885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65044845|NCT00209885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044846|NCT00209885|Analgesics|analgesics|mesh-ancestor
65044847|NCT00209885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65044848|NCT00209885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65044849|NCT00209885|Anesthetics, General|anesthetics, general|mesh-ancestor
65044850|NCT00209885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65044851|NCT00209885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65044852|NCT00209885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044853|NCT00209885|Anticonvulsants|anticonvulsants|mesh-ancestor
65044854|NCT00209885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65044855|NCT00209885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65044856|NCT00209885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65044857|NCT00209885|Antimanic Agents|antimanic agents|mesh-ancestor
65044858|NCT00209885|Antidepressive Agents|antidepressive agents|mesh-ancestor
65044905|NCT02277886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65044906|NCT02277886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044907|NCT00413751|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65044908|NCT00413751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65044909|NCT00413751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65044910|NCT00413751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65044911|NCT00413751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65044912|NCT00413751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65044913|NCT00413751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65044914|NCT00413751|Adrenergic Agents|adrenergic agents|mesh-ancestor
65044915|NCT00413751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65044916|NCT00413751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65044917|NCT00413751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044918|NCT00210041|Gemcitabine|gemcitabine|mesh-list
65044919|NCT00210041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044921|NCT00210041|Antimetabolites|antimetabolites|mesh-ancestor
65044963|NCT04997941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65044964|NCT04997941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65044965|NCT04997941|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65044966|NCT04997941|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65044967|NCT04997941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65044968|NCT00210158|Nitrous Oxide|nitrous oxide|mesh-list
65044969|NCT00210158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65044970|NCT00210158|Anesthetics, General|anesthetics, general|mesh-ancestor
65044971|NCT00210158|Anesthetics|anesthetics|mesh-ancestor
65044972|NCT00210158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65044973|NCT00210158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65044974|NCT00210158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65044975|NCT00210158|Analgesics|analgesics|mesh-ancestor
65044976|NCT00210158|Sensory System Agents|sensory system agents|mesh-ancestor
65044977|NCT00210158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65045022|NCT00210314|Immunologic Factors|immunologic factors|mesh-ancestor
65045023|NCT00210314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65045024|NCT00210314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65045025|NCT00210314|Antiviral Agents|antiviral agents|mesh-ancestor
65045026|NCT00210314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65045027|NCT00237861|Olanzapine|olanzapine|mesh-list
65045028|NCT00237861|Risperidone|risperidone|mesh-list
65045029|NCT00237861|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65045030|NCT00237861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65045031|NCT00237861|Serotonin Agents|serotonin agents|mesh-ancestor
65045032|NCT00237861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65045033|NCT00237861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045034|NCT00237861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045035|NCT00237861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65045036|NCT00237861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65045037|NCT00237861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65045038|NCT00237861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65045039|NCT00237861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65045040|NCT00237861|Dopamine Agents|dopamine agents|mesh-ancestor
65045041|NCT00237861|Antiemetics|antiemetics|mesh-ancestor
65045042|NCT00237861|Autonomic Agents|autonomic agents|mesh-ancestor
65045043|NCT00237861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65045044|NCT00237861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65045045|NCT00237861|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65045046|NCT00237861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65045047|NCT00237861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65045048|NCT00237861|Antidepressive Agents|antidepressive agents|mesh-ancestor
65045049|NCT00210392|Bortezomib|bortezomib|mesh-list
65045050|NCT00210392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045051|NCT00413829|Ranibizumab|ranibizumab|mesh-list
65045052|NCT00413829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65045053|NCT00413829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65045054|NCT00413829|Growth Substances|growth substances|mesh-ancestor
65045055|NCT00413829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045056|NCT00413829|Growth Inhibitors|growth inhibitors|mesh-ancestor
65045057|NCT00413829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897016|NCT02011191|Biotin|biotin|mesh-list
64503369|NCT05585346|Prednisolone phosphate|prednisolone phosphate|mesh-list
64951507|NCT00026273|Fluorouracil|fluorouracil|mesh-list
65045058|NCT02210104|Cyclophosphamide|cyclophosphamide|mesh-list
65045059|NCT02210104|Ipilimumab|ipilimumab|mesh-list
65045060|NCT02210104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65045061|NCT02210104|Immunologic Factors|immunologic factors|mesh-ancestor
65045062|NCT02210104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045063|NCT02210104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65045065|NCT02210104|Alkylating Agents|alkylating agents|mesh-ancestor
65045066|NCT02210104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045067|NCT02210104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045068|NCT02210104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65045069|NCT02210104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65045070|NCT02210104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65045071|NCT02210182|Pentamidine|pentamidine|mesh-list
65045072|NCT02210182|Antifungal Agents|antifungal agents|mesh-ancestor
65045073|NCT02210182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65045120|NCT04570345|Sensory System Agents|sensory system agents|mesh-ancestor
65045121|NCT04570345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65045122|NCT04570345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045123|NCT04570345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65045124|NCT04570345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65045125|NCT04570345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65045126|NCT04570345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65045127|NCT04570345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045128|NCT04570345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65045129|NCT04570345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65045130|NCT04570345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045131|NCT04570345|Antipyretics|antipyretics|mesh-ancestor
65045132|NCT04570345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65045133|NCT04570345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65045134|NCT04570345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65045135|NCT04570345|Purinergic Agents|purinergic agents|mesh-ancestor
65045136|NCT04570345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65045175|NCT00234858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045176|NCT00234858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65045177|NCT00234858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65045178|NCT00234858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65045179|NCT00234858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65045180|NCT00234858|Vasodilator Agents|vasodilator agents|mesh-ancestor
65045181|NCT00234858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65045182|NCT00234858|Protease Inhibitors|protease inhibitors|mesh-ancestor
65045183|NCT00234858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045184|NCT04569838|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65045185|NCT04569838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65045186|NCT04569838|Alkylating Agents|alkylating agents|mesh-ancestor
65045187|NCT04569838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045188|NCT04569838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045189|NCT00210743|Epoetin Alfa|epoetin alfa|mesh-list
65045190|NCT00210743|Hematinics|hematinics|mesh-ancestor
65045191|NCT04569916|Irinotecan|irinotecan|mesh-list
65045192|NCT04569916|Apatinib|apatinib|mesh-list
65045193|NCT04569916|Antibodies|antibodies|mesh-list
65045194|NCT04569916|Immunologic Factors|immunologic factors|mesh-ancestor
65045195|NCT04569916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045196|NCT04569916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65045197|NCT04569916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65045198|NCT04569916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045199|NCT04569916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045200|NCT04569916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045201|NCT04569916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65045202|NCT00210782|Topiramate|topiramate|mesh-list
65045203|NCT00210782|Phenytoin|phenytoin|mesh-list
65045204|NCT00210782|Anticonvulsants|anticonvulsants|mesh-ancestor
65045213|NCT00237900|Leucovorin|leucovorin|mesh-list
65045218|NCT00237900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65045219|NCT00237900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045220|NCT00237900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65045221|NCT00237900|Immunologic Factors|immunologic factors|mesh-ancestor
65045222|NCT00237900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045223|NCT00237900|Antidotes|antidotes|mesh-ancestor
65045224|NCT00237900|Protective Agents|protective agents|mesh-ancestor
65045225|NCT00237900|Vitamin B Complex|vitamin b complex|mesh-ancestor
65045226|NCT00237900|Vitamins|vitamins|mesh-ancestor
65045227|NCT00237900|Micronutrients|micronutrients|mesh-ancestor
65045228|NCT00237900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65045229|NCT00237900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045230|NCT00210821|Topiramate|topiramate|mesh-list
65045231|NCT00210821|Anticonvulsants|anticonvulsants|mesh-ancestor
65045282|NCT00211016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65045283|NCT00211016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65045284|NCT04568161|Cyclophosphamide|cyclophosphamide|mesh-list
65045285|NCT04568161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65045286|NCT04568161|Immunologic Factors|immunologic factors|mesh-ancestor
65045287|NCT04568161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045288|NCT04568161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65045289|NCT04568161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65045290|NCT04568161|Alkylating Agents|alkylating agents|mesh-ancestor
65045291|NCT04568161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045294|NCT00238017|Artesunate|artesunate|mesh-list
65045347|NCT00238173|Alkylating Agents|alkylating agents|mesh-ancestor
64897306|NCT02012920|Seviteronel|seviteronel|mesh-list
65045348|NCT00238173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045349|NCT00238173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045350|NCT00238173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65045351|NCT00238173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65045352|NCT00238173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65045353|NCT00238173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65045354|NCT00238173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045355|NCT00238173|Antiviral Agents|antiviral agents|mesh-ancestor
64530597|NCT05459129|Paclitaxel|paclitaxel|mesh-list
65045356|NCT00238173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65045357|NCT00238173|Expectorants|expectorants|mesh-ancestor
65045410|NCT00238290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045411|NCT00238290|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65045412|NCT00238290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65045413|NCT00238290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045414|NCT00238290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045415|NCT00238290|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65045416|NCT00238290|Hormone Antagonists|hormone antagonists|mesh-ancestor
65045417|NCT00238290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65045418|NCT00238290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045419|NCT00211328|Anecortave|anecortave|mesh-list
65045420|NCT00211328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65045421|NCT00211328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65045422|NCT00211328|Growth Substances|growth substances|mesh-ancestor
65045423|NCT00211328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045424|NCT00211328|Growth Inhibitors|growth inhibitors|mesh-ancestor
65045425|NCT00211328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045426|NCT00238329|Interferons|interferons|mesh-list
65045427|NCT00238329|Interferon-alpha|interferon-alpha|mesh-list
65045468|NCT00238368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65045469|NCT00238368|Alkylating Agents|alkylating agents|mesh-ancestor
65045470|NCT00238368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045471|NCT00238368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045472|NCT00238368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65045473|NCT00238368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65045474|NCT00238368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65045475|NCT00238368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65045479|NCT00238368|Glucocorticoids|glucocorticoids|mesh-ancestor
65045535|NCT00211445|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65045536|NCT00211445|Dermatologic Agents|dermatologic agents|mesh-ancestor
65045537|NCT02894710|Lidocaine|lidocaine|mesh-list
65045538|NCT02894710|Anesthetics, Local|anesthetics, local|mesh-ancestor
65045539|NCT02894710|Anesthetics|anesthetics|mesh-ancestor
65045540|NCT02894710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65045541|NCT02894710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045542|NCT02894710|Sensory System Agents|sensory system agents|mesh-ancestor
65045543|NCT02894710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65045544|NCT02894710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65045600|NCT00238641|Botulinum Toxins|botulinum toxins|mesh-list
65045601|NCT00238641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65045602|NCT00238641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65045603|NCT00238641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65045604|NCT00238641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65045605|NCT00238641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045606|NCT00238641|Cholinergic Agents|cholinergic agents|mesh-ancestor
65045607|NCT00238641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65045608|NCT00238641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045609|NCT00238641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65045610|NCT00238641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65045611|NCT00238641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65045612|NCT05427175|Methotrexate|methotrexate|mesh-list
65045613|NCT05427175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65045614|NCT05427175|Abortifacient Agents|abortifacient agents|mesh-ancestor
65045615|NCT05427175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65045616|NCT05427175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045617|NCT05427175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65045618|NCT05427175|Antimetabolites|antimetabolites|mesh-ancestor
65045619|NCT05427175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045620|NCT05427175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045621|NCT05427175|Dermatologic Agents|dermatologic agents|mesh-ancestor
65045622|NCT05427175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045623|NCT05427175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65045624|NCT05427175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65045625|NCT05427175|Immunologic Factors|immunologic factors|mesh-ancestor
65045626|NCT05427175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65045627|NCT05427175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65045628|NCT00211679|Botulinum Toxins|botulinum toxins|mesh-list
65045629|NCT00211679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65045630|NCT00211679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65045631|NCT00211679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65045640|NCT04680091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045641|NCT04680091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045642|NCT04680091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65045643|NCT04680091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65045644|NCT04680091|Antiviral Agents|antiviral agents|mesh-ancestor
65045645|NCT04680091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65045646|NCT04680091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65045647|NCT04680091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65045648|NCT04680091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65045649|NCT04680091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65045650|NCT04680091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65045651|NCT04680091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65045652|NCT00211718|Botulinum Toxins|botulinum toxins|mesh-list
65045653|NCT00211718|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65045654|NCT00211718|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65045655|NCT00211718|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65045656|NCT00211718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65045657|NCT00211718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045658|NCT00211718|Cholinergic Agents|cholinergic agents|mesh-ancestor
65045659|NCT00211718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64487044|NCT01901393|Ibuprofen|ibuprofen|mesh-list
65045660|NCT00211718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045661|NCT00211718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65045662|NCT00211718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65045663|NCT00238719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65045664|NCT00238719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65045665|NCT00238719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65045680|NCT00211796|GABA Agents|gaba agents|mesh-ancestor
64897638|NCT02014753|Micronutrients|micronutrients|mesh-ancestor
65045681|NCT00211796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65045682|NCT00211796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045683|NCT00211796|Antimanic Agents|antimanic agents|mesh-ancestor
65045684|NCT00211796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65045685|NCT00211796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65045686|NCT00211796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65045687|NCT05426824|Pegaspargase|pegaspargase|mesh-list
65045688|NCT05426824|Asparaginase|asparaginase|mesh-list
65045689|NCT05426824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045690|NCT00238797|Gefitinib|gefitinib|mesh-list
65045691|NCT00238797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045692|NCT00238797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65045693|NCT00238797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045694|NCT00238797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045695|NCT05426044|Metformin|metformin|mesh-list
65045696|NCT05426044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65045697|NCT05426044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045698|NCT05425654|Cyclophosphamide|cyclophosphamide|mesh-list
65045699|NCT05425654|Busulfan|busulfan|mesh-list
65045700|NCT05425654|Carmustine|carmustine|mesh-list
65045701|NCT05425654|Rituximab|rituximab|mesh-list
65045702|NCT05425654|Methotrexate|methotrexate|mesh-list
65045703|NCT05425654|Vincristine|vincristine|mesh-list
65045704|NCT05425654|Lenalidomide|lenalidomide|mesh-list
65045705|NCT05425654|Procarbazine|procarbazine|mesh-list
65045706|NCT05425654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65045707|NCT05425654|Immunologic Factors|immunologic factors|mesh-ancestor
65045708|NCT05425654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045709|NCT05425654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65045710|NCT05425654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65045725|NCT05425654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65045726|NCT05425654|Tubulin Modulators|tubulin modulators|mesh-ancestor
65045727|NCT05425654|Antimitotic Agents|antimitotic agents|mesh-ancestor
65045728|NCT05425654|Mitosis Modulators|mitosis modulators|mesh-ancestor
65045729|NCT05425654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65045730|NCT05425654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65045731|NCT05425654|Growth Substances|growth substances|mesh-ancestor
65045732|NCT05425654|Growth Inhibitors|growth inhibitors|mesh-ancestor
65045733|NCT05425576|Pembrolizumab|pembrolizumab|mesh-list
64487117|NCT03214354|Sirolimus|sirolimus|mesh-list
65045734|NCT05425576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65045789|NCT04721301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65045790|NCT04721301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65045791|NCT04721301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65045792|NCT04721301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65045793|NCT04721301|Antiviral Agents|antiviral agents|mesh-ancestor
65045794|NCT04721301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65045795|NCT04721301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65045796|NCT00238992|Mycophenolic Acid|mycophenolic acid|mesh-list
65045859|NCT00239070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045860|NCT00239070|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65045861|NCT00239070|Antitubercular Agents|antitubercular agents|mesh-ancestor
65045862|NCT00239070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65045863|NCT00239070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65045864|NCT00239070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045865|NCT00239070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045866|NCT00211952|Celecoxib|celecoxib|mesh-list
65045867|NCT00211952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65045868|NCT00211952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65045869|NCT00211952|Analgesics|analgesics|mesh-ancestor
65045870|NCT00211952|Sensory System Agents|sensory system agents|mesh-ancestor
65045922|NCT00212108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65045923|NCT00212108|Analgesics|analgesics|mesh-ancestor
65045924|NCT00212108|Sensory System Agents|sensory system agents|mesh-ancestor
65045925|NCT00212108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65045926|NCT00212108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045927|NCT00212108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65045928|NCT00212108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65045929|NCT00212108|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65045930|NCT00212108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65045931|NCT00212108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045932|NCT00212108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045933|NCT00212108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045934|NCT00212108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65045935|NCT00212186|Selenium|selenium|mesh-list
65045936|NCT00212186|Antioxidants|antioxidants|mesh-ancestor
65045937|NCT00212186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045938|NCT00212186|Protective Agents|protective agents|mesh-ancestor
65045939|NCT00212186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045940|NCT00212186|Trace Elements|trace elements|mesh-ancestor
65045941|NCT00212186|Micronutrients|micronutrients|mesh-ancestor
65045942|NCT00414336|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65045943|NCT00414336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65045946|NCT00414336|Antacids|antacids|mesh-ancestor
65045974|NCT00239304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045975|NCT00239304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045976|NCT00239343|Gefitinib|gefitinib|mesh-list
65045977|NCT00239343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045978|NCT00239343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65045979|NCT00239343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65045980|NCT00239343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65045981|NCT00411593|Bevacizumab|bevacizumab|mesh-list
65045982|NCT00411593|Bortezomib|bortezomib|mesh-list
65045983|NCT00411593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65045984|NCT00411593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65045985|NCT00411593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65045986|NCT00411593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65045987|NCT00411593|Growth Substances|growth substances|mesh-ancestor
65045988|NCT00411593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045989|NCT00411593|Growth Inhibitors|growth inhibitors|mesh-ancestor
65045990|NCT00239382|Meloxicam|meloxicam|mesh-list
65045991|NCT00239382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65045992|NCT00239382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65045993|NCT00239382|Analgesics|analgesics|mesh-ancestor
65045994|NCT00239382|Sensory System Agents|sensory system agents|mesh-ancestor
65045995|NCT00239382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65045996|NCT00239382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65045997|NCT00239382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65045998|NCT00239382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65045999|NCT00239382|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65046000|NCT00239382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65046001|NCT00239382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046002|NCT00239382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046003|NCT00239421|Fluticasone|fluticasone|mesh-list
65046005|NCT00239421|Formoterol Fumarate|formoterol fumarate|mesh-list
65046006|NCT00239421|Tiotropium Bromide|tiotropium bromide|mesh-list
65046007|NCT00239421|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65046015|NCT00239421|Dermatologic Agents|dermatologic agents|mesh-ancestor
65046016|NCT00239421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65046017|NCT00239421|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65046018|NCT00239421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65046019|NCT00239421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65046020|NCT00239421|Adrenergic Agents|adrenergic agents|mesh-ancestor
65046021|NCT00239421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65046022|NCT00239421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046023|NCT00239421|Parasympatholytics|parasympatholytics|mesh-ancestor
65046024|NCT00239421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65046025|NCT00239421|Cholinergic Agents|cholinergic agents|mesh-ancestor
65046026|NCT00239460|Tiotropium Bromide|tiotropium bromide|mesh-list
65046027|NCT00239460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65046028|NCT00239460|Autonomic Agents|autonomic agents|mesh-ancestor
65046029|NCT00239460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65046030|NCT00239460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046031|NCT00239460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65046032|NCT00239460|Respiratory System Agents|respiratory system agents|mesh-ancestor
65046033|NCT00239460|Parasympatholytics|parasympatholytics|mesh-ancestor
65046034|NCT00239460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65046035|NCT00239460|Cholinergic Agents|cholinergic agents|mesh-ancestor
65046036|NCT00239460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65046037|NCT00239460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046038|NCT00239499|Fluticasone|fluticasone|mesh-list
65046039|NCT00239499|Tiotropium Bromide|tiotropium bromide|mesh-list
65046040|NCT00239499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65046041|NCT00239499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65046042|NCT00239499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65046043|NCT00239499|Autonomic Agents|autonomic agents|mesh-ancestor
65046044|NCT00239499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65046045|NCT00239499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65493885|NCT04002934|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65046054|NCT00239499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046055|NCT00239499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65046056|NCT00239499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65046057|NCT00239499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65046058|NCT00239499|Adrenergic Agents|adrenergic agents|mesh-ancestor
65046059|NCT00212615|Capecitabine|capecitabine|mesh-list
65046060|NCT00212615|Oxaliplatin|oxaliplatin|mesh-list
65046061|NCT00212615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65046062|NCT00212615|Antimetabolites|antimetabolites|mesh-ancestor
65046063|NCT00212615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046064|NCT00212615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046065|NCT00222573|Metoprolol|metoprolol|mesh-list
65046066|NCT00222573|Clopidogrel|clopidogrel|mesh-list
65046067|NCT00222573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65046068|NCT00222573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65046069|NCT00222573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65046070|NCT00222573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65046071|NCT00222573|Purinergic Agents|purinergic agents|mesh-ancestor
65046072|NCT00222573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65046073|NCT00222573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046074|NCT00222573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046075|NCT00222573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65046076|NCT00222573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65046077|NCT00222573|Sympatholytics|sympatholytics|mesh-ancestor
65046078|NCT00222573|Autonomic Agents|autonomic agents|mesh-ancestor
65046079|NCT00222573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65046080|NCT00222573|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65046081|NCT00222573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65046082|NCT00222573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65046083|NCT00222573|Adrenergic Agents|adrenergic agents|mesh-ancestor
65046084|NCT00212654|Landiolol|landiolol|mesh-list
65046085|NCT00212654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65046086|NCT00212654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65046093|NCT00239538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65046094|NCT00239538|Telmisartan|telmisartan|mesh-list
65046095|NCT00239538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65046096|NCT00239538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65046097|NCT00239538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65046098|NCT00239538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046099|NCT00239538|Diuretics|diuretics|mesh-ancestor
65046100|NCT00239538|Natriuretic Agents|natriuretic agents|mesh-ancestor
65046101|NCT00239538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046102|NCT00239538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65046103|NCT00239538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65046104|NCT00212810|Topiramate|topiramate|mesh-list
65046105|NCT00212810|Anticonvulsants|anticonvulsants|mesh-ancestor
65046114|NCT00213122|Miglitol|miglitol|mesh-list
65046149|NCT00239889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046150|NCT00239889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65046151|NCT00239889|Vasodilator Agents|vasodilator agents|mesh-ancestor
65046152|NCT00239967|Rimonabant|rimonabant|mesh-list
65046153|NCT00239967|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65046154|NCT00239967|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65046155|NCT00239967|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65046156|NCT00239967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65046157|NCT00239967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046158|NCT00239967|Hormones|hormones|mesh-ancestor
65046159|NCT00239967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65046160|NCT00239967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046161|NCT00223002|Chlorhexidine|chlorhexidine|mesh-list
65046162|NCT00223002|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65046163|NCT00223002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65046164|NCT00223002|Disinfectants|disinfectants|mesh-ancestor
65046165|NCT00213512|Rituximab|rituximab|mesh-list
65046199|NCT00240045|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65046200|NCT00240045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65046201|NCT00240045|Adrenergic Agents|adrenergic agents|mesh-ancestor
65046202|NCT00240045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65046203|NCT00240045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046204|NCT00243672|Atorvastatin|atorvastatin|mesh-list
65046205|NCT00243672|Gemfibrozil|gemfibrozil|mesh-list
65046206|NCT00243672|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65046207|NCT00243672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65046208|NCT00243672|Antimetabolites|antimetabolites|mesh-ancestor
65046209|NCT00243672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046210|NCT00243672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65046211|NCT00243672|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65046212|NCT00243672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046213|NCT00243672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65046214|NCT00243672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65046215|NCT00240084|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65046216|NCT00240084|Natriuretic Agents|natriuretic agents|mesh-ancestor
65046217|NCT00240084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046218|NCT00243711|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65046219|NCT00243711|Glycerol|glycerol|mesh-list
65046220|NCT00243711|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65046221|NCT00243711|Protective Agents|protective agents|mesh-ancestor
65046222|NCT00243711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046247|NCT00240279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046248|NCT00240279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65046249|NCT00240279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65046250|NCT00240279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046251|NCT00243750|Methotrexate|methotrexate|mesh-list
65046252|NCT00243750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65046253|NCT00243750|Abortifacient Agents|abortifacient agents|mesh-ancestor
65046254|NCT00243750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65046255|NCT00243750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046256|NCT00243750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65046257|NCT00243750|Antimetabolites|antimetabolites|mesh-ancestor
65046258|NCT00243750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046259|NCT00243750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046260|NCT00243750|Dermatologic Agents|dermatologic agents|mesh-ancestor
65046261|NCT00243750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046262|NCT00243750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65046263|NCT00243750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65046264|NCT00243750|Immunologic Factors|immunologic factors|mesh-ancestor
65046302|NCT00214214|Alemtuzumab|alemtuzumab|mesh-list
65046303|NCT00214214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65046304|NCT00214214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046305|NCT00214253|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
65046306|NCT00214253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65046307|NCT00214253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046308|NCT00240396|Narcotics|narcotics|mesh-list
65046309|NCT00240396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65046310|NCT00240396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046311|NCT00240396|Analgesics|analgesics|mesh-ancestor
65046312|NCT00240396|Sensory System Agents|sensory system agents|mesh-ancestor
65046313|NCT00240396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65046314|NCT00214331|Azithromycin|azithromycin|mesh-list
65046315|NCT00214331|Ciprofloxacin|ciprofloxacin|mesh-list
65046316|NCT00214331|Gentamicins|gentamicins|mesh-list
65046317|NCT00214331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65046318|NCT00214331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65046319|NCT00214331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65046320|NCT00214331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65046321|NCT00214331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046322|NCT00214331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046323|NCT00214331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046324|NCT00214331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65046325|NCT00214331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65046326|NCT00214331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65046328|NCT00243984|Anticonvulsants|anticonvulsants|mesh-ancestor
65046329|NCT00243984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65046330|NCT00243984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046331|NCT00214370|Fentanyl|fentanyl|mesh-list
65046332|NCT00214370|Propofol|propofol|mesh-list
65046334|NCT00214370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65046335|NCT00214370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046336|NCT00214370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65046337|NCT00214370|Anesthetics, General|anesthetics, general|mesh-ancestor
65046338|NCT00214370|Anesthetics|anesthetics|mesh-ancestor
65046339|NCT00214370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65046340|NCT00214370|Narcotics|narcotics|mesh-ancestor
64951508|NCT00026273|Irinotecan|irinotecan|mesh-list
65046341|NCT00214370|Analgesics|analgesics|mesh-ancestor
65046342|NCT00214370|Sensory System Agents|sensory system agents|mesh-ancestor
65046343|NCT00214370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65046344|NCT00214370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65046345|NCT00240435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65046346|NCT00240435|Tiotropium Bromide|tiotropium bromide|mesh-list
65046347|NCT00240435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65046348|NCT00240435|Autonomic Agents|autonomic agents|mesh-ancestor
65046349|NCT00240435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65046350|NCT00240435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046351|NCT00240435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65046352|NCT00240435|Respiratory System Agents|respiratory system agents|mesh-ancestor
65046353|NCT00240435|Parasympatholytics|parasympatholytics|mesh-ancestor
65046354|NCT00240435|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65046355|NCT00240435|Cholinergic Agents|cholinergic agents|mesh-ancestor
65046356|NCT00240435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65046357|NCT00240435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046358|NCT00244023|Methyltestosterone|methyltestosterone|mesh-list
65046359|NCT00244023|Testosterone|testosterone|mesh-list
65046360|NCT00244023|Testosterone undecanoate|testosterone undecanoate|mesh-list
65046361|NCT00244023|Testosterone enanthate|testosterone enanthate|mesh-list
65046362|NCT00244023|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65046363|NCT00244023|Androgens|androgens|mesh-ancestor
65046364|NCT00244023|Hormones|hormones|mesh-ancestor
64531710|NCT02918864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64531711|NCT02918864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531712|NCT02890368|Interferons|interferons|mesh-list
64531713|NCT02890368|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
64531714|NCT02890368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65046391|NCT00214604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65046392|NCT00214604|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65046393|NCT00214604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046394|NCT00214643|Clindamycin|clindamycin|mesh-list
65046395|NCT00214643|Clindamycin palmitate|clindamycin palmitate|mesh-list
65046396|NCT00214643|Clindamycin phosphate|clindamycin phosphate|mesh-list
65046397|NCT00214643|Fosmidomycin|fosmidomycin|mesh-list
65046398|NCT00214643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65046399|NCT00214643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65046400|NCT00214643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65046401|NCT00214643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046447|NCT00214955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65046448|NCT00214955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65046449|NCT00214955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65046450|NCT00214955|Anesthetics, General|anesthetics, general|mesh-ancestor
65046451|NCT00214955|Anesthetics|anesthetics|mesh-ancestor
65046452|NCT00244179|Interferons|interferons|mesh-list
65046453|NCT00244179|Interferon-gamma|interferon-gamma|mesh-list
65046454|NCT00244179|Infliximab|infliximab|mesh-list
65046455|NCT00244179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046456|NCT00244179|Antiviral Agents|antiviral agents|mesh-ancestor
65046457|NCT00244179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65046458|NCT00244179|Dermatologic Agents|dermatologic agents|mesh-ancestor
65046459|NCT00244179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65046460|NCT00244179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65046461|NCT00214994|Tiagabine|tiagabine|mesh-list
65046462|NCT00214994|Anticonvulsants|anticonvulsants|mesh-ancestor
65046463|NCT00214994|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
65046464|NCT00214994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64898482|NCT02020213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65046505|NCT00215228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65046506|NCT00215228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65046507|NCT00215228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046508|NCT00215228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65046509|NCT00215228|Serotonin Agents|serotonin agents|mesh-ancestor
65046510|NCT00215228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046511|NCT00215228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65046512|NCT00215228|Antidepressive Agents|antidepressive agents|mesh-ancestor
65046513|NCT00215228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65046514|NCT00215228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65046515|NCT00215228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65046516|NCT00215228|Analgesics|analgesics|mesh-ancestor
65046517|NCT00215228|Sensory System Agents|sensory system agents|mesh-ancestor
65046518|NCT00215228|Dopamine Agents|dopamine agents|mesh-ancestor
65046519|NCT00215267|Praziquantel|praziquantel|mesh-list
65046520|NCT00215267|Anthelmintics|anthelmintics|mesh-ancestor
65046521|NCT00215267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65046522|NCT00215267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65046523|NCT00240708|Risperidone|risperidone|mesh-list
65046524|NCT00240708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65046525|NCT00240708|Serotonin Agents|serotonin agents|mesh-ancestor
65046526|NCT00240708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65046527|NCT00240708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046528|NCT00240708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046529|NCT00240708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65046530|NCT00240708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65046531|NCT00240708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65046535|NCT00215345|Celecoxib|celecoxib|mesh-list
65046548|NCT00215345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65046549|NCT00215345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65046550|NCT00215345|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65046551|NCT00215345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65046552|NCT00215345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046553|NCT00240747|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
65046554|NCT00240747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65046555|NCT00240747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65046556|NCT00240747|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65046557|NCT00240747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046558|NCT00240747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046559|NCT00215384|Formoterol Fumarate|formoterol fumarate|mesh-list
65046560|NCT00215384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65046561|NCT00215384|Autonomic Agents|autonomic agents|mesh-ancestor
65046562|NCT00215384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65046563|NCT00215384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046564|NCT00215384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65046565|NCT00215384|Respiratory System Agents|respiratory system agents|mesh-ancestor
65046566|NCT00215384|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65046567|NCT00215384|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65046568|NCT00215384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65046569|NCT00215384|Adrenergic Agents|adrenergic agents|mesh-ancestor
65046570|NCT00215384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65046571|NCT00215384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046572|NCT00215423|Formoterol Fumarate|formoterol fumarate|mesh-list
65046573|NCT00215423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65046593|NCT00215462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898570|NCT02021110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64898571|NCT02021123|Anidulafungin|anidulafungin|mesh-list
65046594|NCT00215501|Fluorouracil|fluorouracil|mesh-list
65046595|NCT00215501|Capecitabine|capecitabine|mesh-list
65046596|NCT00215501|Irinotecan|irinotecan|mesh-list
65046597|NCT00215501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046598|NCT00215501|Antimetabolites|antimetabolites|mesh-ancestor
65046599|NCT00215501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046600|NCT00215501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65046601|NCT00215501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65046602|NCT00215501|Immunologic Factors|immunologic factors|mesh-ancestor
65046603|NCT00215501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046604|NCT00215501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65046605|NCT00215501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65046606|NCT00215501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046607|NCT00240786|Acetaminophen|acetaminophen|mesh-list
65046608|NCT00240786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65046609|NCT00240786|Analgesics|analgesics|mesh-ancestor
65046610|NCT00240786|Sensory System Agents|sensory system agents|mesh-ancestor
65046611|NCT00240786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65046612|NCT00240786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046613|NCT00240786|Antipyretics|antipyretics|mesh-ancestor
65046614|NCT00215579|Risperidone|risperidone|mesh-list
65046615|NCT00215579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65046617|NCT00215579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65046618|NCT00215579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046619|NCT00215579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046626|NCT00556621|Gemcitabine|gemcitabine|mesh-list
65046639|NCT00244452|Fertility Agents|fertility agents|mesh-ancestor
65046640|NCT00244452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65046641|NCT00244452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046642|NCT00244452|Hormone Antagonists|hormone antagonists|mesh-ancestor
65046643|NCT00244452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65046644|NCT00556699|Rituximab|rituximab|mesh-list
65046645|NCT00556699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65046646|NCT00556699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046647|NCT00556699|Immunologic Factors|immunologic factors|mesh-ancestor
65046648|NCT00556699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046649|NCT00556699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65046650|NCT00411866|Ketoconazole|ketoconazole|mesh-list
65046651|NCT00411866|Antifungal Agents|antifungal agents|mesh-ancestor
65046652|NCT00411866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65046653|NCT00411866|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65046654|NCT00411866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65046696|NCT00240825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65046697|NCT00240825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046698|NCT00240825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046699|NCT04666675|Upadacitinib|upadacitinib|mesh-list
65046700|NCT04666675|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64920688|NCT00116896|Cisplatin|cisplatin|mesh-list
65046701|NCT04666675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65046702|NCT04666675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046703|NCT04666675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046704|NCT04666675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65046705|NCT00244530|Nifedipine|nifedipine|mesh-list
65046706|NCT00244530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65046707|NCT00244530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65046708|NCT00244530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046709|NCT00244530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65046710|NCT00244530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046711|NCT00244530|Vasodilator Agents|vasodilator agents|mesh-ancestor
65046712|NCT00244530|Tocolytic Agents|tocolytic agents|mesh-ancestor
65046713|NCT00244530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65046714|NCT00411905|Bortezomib|bortezomib|mesh-list
65046715|NCT00411905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046716|NCT00240864|Acetaminophen|acetaminophen|mesh-list
64898722|NCT02022293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65046746|NCT04666324|Simethicone|simethicone|mesh-list
65046747|NCT04666324|Antifoaming Agents|antifoaming agents|mesh-ancestor
65046748|NCT04666324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046749|NCT04666324|Emollients|emollients|mesh-ancestor
65046750|NCT04666324|Dermatologic Agents|dermatologic agents|mesh-ancestor
65046751|NCT04720833|Vitamin D|vitamin d|mesh-list
65046752|NCT04720833|Calcium|calcium|mesh-list
65046753|NCT04720833|Vitamins|vitamins|mesh-ancestor
65046754|NCT04720833|Micronutrients|micronutrients|mesh-ancestor
65046755|NCT04720833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046756|NCT04720833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65046757|NCT04720833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65046758|NCT00244608|Budesonide|budesonide|mesh-list
65046759|NCT00244608|Terbutaline|terbutaline|mesh-list
65046760|NCT00244608|Formoterol Fumarate|formoterol fumarate|mesh-list
65046761|NCT00244608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65046762|NCT00244608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65046763|NCT00244608|Autonomic Agents|autonomic agents|mesh-ancestor
65046764|NCT00244608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65046766|NCT00244608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65046799|NCT00240942|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65046800|NCT00240942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65046801|NCT00240942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65046802|NCT00240942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046803|NCT00240942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65046804|NCT00240942|Hormone Antagonists|hormone antagonists|mesh-ancestor
65046805|NCT00240942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65046806|NCT00240942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046807|NCT00215891|Interferons|interferons|mesh-list
65046808|NCT00215891|Ribavirin|ribavirin|mesh-list
65046809|NCT00215891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046810|NCT00215891|Antiviral Agents|antiviral agents|mesh-ancestor
65046811|NCT00215891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65046812|NCT00215891|Antimetabolites|antimetabolites|mesh-ancestor
65046813|NCT00215891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046814|NCT02961816|Pyridoxine|pyridoxine|mesh-list
65046815|NCT02961816|Gemcitabine|gemcitabine|mesh-list
65046816|NCT02961816|Dexamethasone|dexamethasone|mesh-list
65046817|NCT02961816|Rituximab|rituximab|mesh-list
65046818|NCT02961816|Melphalan|melphalan|mesh-list
65046819|NCT02961816|Busulfan|busulfan|mesh-list
65046820|NCT02961816|Panobinostat|panobinostat|mesh-list
65046821|NCT02961816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65046832|NCT02961816|Hormones|hormones|mesh-ancestor
65046852|NCT04665232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65046853|NCT04665232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046854|NCT00216008|Docetaxel|docetaxel|mesh-list
65046855|NCT00216008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046856|NCT00216008|Tubulin Modulators|tubulin modulators|mesh-ancestor
65046857|NCT00216008|Antimitotic Agents|antimitotic agents|mesh-ancestor
65046858|NCT00216008|Mitosis Modulators|mitosis modulators|mesh-ancestor
65046859|NCT00216008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046860|NCT04665076|Cyclophosphamide|cyclophosphamide|mesh-list
65046861|NCT04665076|Fludarabine|fludarabine|mesh-list
65046862|NCT04665076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65046863|NCT04665076|Immunologic Factors|immunologic factors|mesh-ancestor
65046871|NCT00241020|Octreotide|octreotide|mesh-list
65046913|NCT04664803|Cefetamet|cefetamet|mesh-list
65046914|NCT04664803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65046915|NCT04664803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65046917|NCT04664725|Bupropion|bupropion|mesh-list
65046918|NCT04664725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65046919|NCT04664725|Antidepressive Agents|antidepressive agents|mesh-ancestor
65046920|NCT04664725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65046921|NCT04664725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65046980|NCT00241215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046981|NCT00241215|Cholinergic Agents|cholinergic agents|mesh-ancestor
65046982|NCT00241215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65046983|NCT00241215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65046984|NCT00216437|Capecitabine|capecitabine|mesh-list
65046985|NCT00216437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65046986|NCT00216437|Antimetabolites|antimetabolites|mesh-ancestor
65046987|NCT00216437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65046988|NCT00216437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65046989|NCT00244920|Squalamine|squalamine|mesh-list
65046990|NCT00244920|Leuprolide|leuprolide|mesh-list
65046991|NCT00244920|Bicalutamide|bicalutamide|mesh-list
65046992|NCT00244920|Hormones|hormones|mesh-list
65046993|NCT00244920|Androgen Antagonists|androgen antagonists|mesh-list
65046995|NCT00244920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047037|NCT00244998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65047038|NCT00244998|Hormone Antagonists|hormone antagonists|mesh-ancestor
65047039|NCT00244998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65047040|NCT00244998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047041|NCT00216554|Risperidone|risperidone|mesh-list
65047042|NCT00216554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65047043|NCT00216554|Serotonin Agents|serotonin agents|mesh-ancestor
65047044|NCT00216554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65047045|NCT00216554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047046|NCT00216554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047047|NCT00216554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65047048|NCT00216554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65047049|NCT00216554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65047050|NCT00216554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65047051|NCT00216554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65047052|NCT00216554|Dopamine Agents|dopamine agents|mesh-ancestor
65047053|NCT00241254|Methylprednisolone|methylprednisolone|mesh-list
65047094|NCT04662736|Tedizolid|tedizolid|mesh-list
65047095|NCT04662736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65047096|NCT04662658|Xenon|xenon|mesh-list
65047097|NCT04662658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65047098|NCT04662658|Anesthetics, General|anesthetics, general|mesh-ancestor
65047099|NCT04662658|Anesthetics|anesthetics|mesh-ancestor
65047100|NCT04662658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65047101|NCT04662658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047102|NCT00216788|Esomeprazole|esomeprazole|mesh-list
65047103|NCT00216788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65047104|NCT00216788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65047105|NCT00216788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65047106|NCT00216788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047107|NCT00216788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047108|NCT00245115|Cyclophosphamide|cyclophosphamide|mesh-list
65047109|NCT00245115|Busulfan|busulfan|mesh-list
65047110|NCT00245115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65047111|NCT00245115|Immunologic Factors|immunologic factors|mesh-ancestor
65047112|NCT00245115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047113|NCT00245115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65047114|NCT00245115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65047115|NCT00245115|Alkylating Agents|alkylating agents|mesh-ancestor
65047148|NCT00241332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65047149|NCT00241332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65047150|NCT00241332|Anesthetics, General|anesthetics, general|mesh-ancestor
65047152|NCT00216866|Dalteparin|dalteparin|mesh-list
65047153|NCT00216866|Tinzaparin|tinzaparin|mesh-list
65047154|NCT00216866|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65047155|NCT00216866|Warfarin|warfarin|mesh-list
65047156|NCT00216866|Anticoagulants|anticoagulants|mesh-ancestor
65047157|NCT00216866|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65047158|NCT00216866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65047159|NCT00216866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047160|NCT00557206|Docetaxel|docetaxel|mesh-list
65047161|NCT00557206|Oxaliplatin|oxaliplatin|mesh-list
65047162|NCT00557206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047163|NCT00557206|Tubulin Modulators|tubulin modulators|mesh-ancestor
65047164|NCT00557206|Antimitotic Agents|antimitotic agents|mesh-ancestor
65047165|NCT00557206|Mitosis Modulators|mitosis modulators|mesh-ancestor
65047166|NCT00557206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047167|NCT00245154|Paclitaxel|paclitaxel|mesh-list
65047168|NCT00245154|Carboplatin|carboplatin|mesh-list
65047169|NCT00245154|Cediranib|cediranib|mesh-list
65047170|NCT00245154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65047171|NCT00245154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047172|NCT00245154|Tubulin Modulators|tubulin modulators|mesh-ancestor
65047173|NCT00245154|Antimitotic Agents|antimitotic agents|mesh-ancestor
65047174|NCT00245154|Mitosis Modulators|mitosis modulators|mesh-ancestor
65047175|NCT00245154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047176|NCT00245154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047177|NCT00245154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65047178|NCT00241371|Clofarabine|clofarabine|mesh-list
65047179|NCT00241371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65047180|NCT00241371|Antimetabolites|antimetabolites|mesh-ancestor
65047181|NCT00241371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047193|NCT04660786|Glucocorticoids|glucocorticoids|mesh-ancestor
65047194|NCT04660786|Hormones|hormones|mesh-ancestor
65047195|NCT04660786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65047196|NCT04660786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65047197|NCT04660786|Immunologic Factors|immunologic factors|mesh-ancestor
65047198|NCT04660786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047199|NCT04660786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047200|NCT00217178|Folic Acid|folic acid|mesh-list
65047201|NCT00217178|Vitamins|vitamins|mesh-ancestor
65047202|NCT00217178|Micronutrients|micronutrients|mesh-ancestor
65047203|NCT00217178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047204|NCT00217178|Hematinics|hematinics|mesh-ancestor
65047205|NCT00217178|Vitamin B Complex|vitamin b complex|mesh-ancestor
65047206|NCT00241449|Tamoxifen|tamoxifen|mesh-list
65047207|NCT00241449|Fulvestrant|fulvestrant|mesh-list
65047208|NCT00241449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65047209|NCT00241449|Hormone Antagonists|hormone antagonists|mesh-ancestor
65047210|NCT00241449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65047211|NCT00241449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047212|NCT00241449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65047213|NCT00241449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047214|NCT00241449|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65047215|NCT00241449|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65047216|NCT00241449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65047242|NCT04659499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047243|NCT00241527|Esomeprazole|esomeprazole|mesh-list
65047244|NCT00241527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65047245|NCT00241527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65047246|NCT00241527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65047247|NCT00241527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047248|NCT00241527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047249|NCT04648813|Bromides|bromides|mesh-list
65047250|NCT04648813|Tiotropium Bromide|tiotropium bromide|mesh-list
65047251|NCT04648813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65047252|NCT04648813|Autonomic Agents|autonomic agents|mesh-ancestor
65047253|NCT04648813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65047254|NCT04648813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047255|NCT04648813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65047256|NCT04648813|Respiratory System Agents|respiratory system agents|mesh-ancestor
65047257|NCT04648813|Parasympatholytics|parasympatholytics|mesh-ancestor
65047262|NCT04648813|Anticonvulsants|anticonvulsants|mesh-ancestor
65047301|NCT00245427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65047302|NCT00245427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65047303|NCT00245427|Antitubercular Agents|antitubercular agents|mesh-ancestor
65047304|NCT00558298|Risperidone|risperidone|mesh-list
65047305|NCT00558298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65047306|NCT00558298|Serotonin Agents|serotonin agents|mesh-ancestor
65047307|NCT00558298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65047308|NCT00558298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047309|NCT00558298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047310|NCT00558298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65047311|NCT00558298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65047312|NCT00558298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65047313|NCT00558298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65047314|NCT00558298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65047315|NCT00558298|Dopamine Agents|dopamine agents|mesh-ancestor
65047316|NCT04647877|Phenytoin|phenytoin|mesh-list
65047317|NCT04647877|Anticonvulsants|anticonvulsants|mesh-ancestor
65047318|NCT04647877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65047319|NCT04647877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65047320|NCT04647877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65047321|NCT04647877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047322|NCT04647877|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65047323|NCT04647877|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65047324|NCT00245505|Mesalamine|mesalamine|mesh-list
65047325|NCT00245505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65047326|NCT00245505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65047327|NCT00245505|Analgesics|analgesics|mesh-ancestor
65047328|NCT00245505|Sensory System Agents|sensory system agents|mesh-ancestor
65047329|NCT00245505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65047330|NCT00245505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047331|NCT00245505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65047332|NCT00245505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65047342|NCT00217373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047343|NCT00217373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047344|NCT00217373|Antiviral Agents|antiviral agents|mesh-ancestor
65047345|NCT00217373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65047346|NCT00217373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65047347|NCT00217373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65047348|NCT00217373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65047349|NCT04647292|Antihypertensive Agents|antihypertensive agents|mesh-list
65047350|NCT00241605|Metformin|metformin|mesh-list
65047351|NCT00241605|Rosiglitazone|rosiglitazone|mesh-list
65047352|NCT00241605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65047353|NCT00241605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047354|NCT00217412|Vorinostat|vorinostat|mesh-list
65047355|NCT00217412|Isotretinoin|isotretinoin|mesh-list
65047356|NCT00217412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047357|NCT00217412|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65047358|NCT00217412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047359|NCT00217412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047360|NCT00217412|Dermatologic Agents|dermatologic agents|mesh-ancestor
65047361|NCT04646824|Pemetrexed|pemetrexed|mesh-list
65047362|NCT04646824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047363|NCT04646824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047364|NCT04646824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047370|NCT00217451|Fosmidomycin|fosmidomycin|mesh-list
65047395|NCT00217529|Mitosis Modulators|mitosis modulators|mesh-ancestor
65047396|NCT00217529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047397|NCT00217529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65047398|NCT00217529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047399|NCT00245661|Temazepam|temazepam|mesh-list
65047400|NCT00245661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65047401|NCT00245661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65047402|NCT00245661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047403|NCT00245661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65047404|NCT00245661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65047405|NCT00245661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65047406|NCT00245661|GABA Modulators|gaba modulators|mesh-ancestor
65047407|NCT00245661|GABA Agents|gaba agents|mesh-ancestor
65047408|NCT00245661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65047456|NCT00558337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047457|NCT00558337|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65047458|NCT00558337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047459|NCT00558337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65047460|NCT00558337|Immunologic Factors|immunologic factors|mesh-ancestor
65047461|NCT00558337|Dopamine Agonists|dopamine agonists|mesh-ancestor
65047462|NCT00558376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65047464|NCT00558376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65047465|NCT00217646|Sorafenib|sorafenib|mesh-list
65047466|NCT00217646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047467|NCT00217646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65047468|NCT00217646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047469|NCT00217646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047470|NCT00558454|Ferrous succinate|ferrous succinate|mesh-list
65047471|NCT00558454|Hematinics|hematinics|mesh-ancestor
65047472|NCT00558493|Clevudine|clevudine|mesh-list
65047473|NCT00558493|Antiviral Agents|antiviral agents|mesh-ancestor
65047474|NCT00558493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65047475|NCT04645303|Triamcinolone|triamcinolone|mesh-list
65047476|NCT04645303|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65047477|NCT04645303|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65047478|NCT04645303|Hyaluronic Acid|hyaluronic acid|mesh-list
65047479|NCT04645303|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65047480|NCT04645303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65047481|NCT04645303|Glucocorticoids|glucocorticoids|mesh-ancestor
65047482|NCT04645303|Hormones|hormones|mesh-ancestor
65047483|NCT04645303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65047484|NCT04645303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047485|NCT04645303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65047486|NCT04645303|Immunologic Factors|immunologic factors|mesh-ancestor
65047487|NCT04645303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047492|NCT04644484|Vaccines|vaccines|mesh-list
65047502|NCT04644250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65047503|NCT04644250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047504|NCT04644250|Tubulin Modulators|tubulin modulators|mesh-ancestor
65047505|NCT04644250|Antimitotic Agents|antimitotic agents|mesh-ancestor
65047506|NCT04644250|Mitosis Modulators|mitosis modulators|mesh-ancestor
65047507|NCT04644250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047508|NCT00245739|Darunavir|darunavir|mesh-list
65047509|NCT00245739|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65047510|NCT00245739|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65047511|NCT00245739|Protease Inhibitors|protease inhibitors|mesh-ancestor
65047512|NCT00245739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047513|NCT00245739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047514|NCT00245739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65047515|NCT00245739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65047516|NCT00245739|Antiviral Agents|antiviral agents|mesh-ancestor
65047517|NCT00245739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65047518|NCT00558883|Acarbose|acarbose|mesh-list
65047519|NCT00558883|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65047520|NCT00558883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047521|NCT00558883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047522|NCT00558883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65047523|NCT00558883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047524|NCT04644094|Dexamethasone|dexamethasone|mesh-list
65047525|NCT04644094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65047526|NCT04644094|Antiemetics|antiemetics|mesh-ancestor
65047527|NCT04644094|Autonomic Agents|autonomic agents|mesh-ancestor
65047528|NCT04644094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65047529|NCT04644094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047530|NCT04644094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65047531|NCT04644094|Glucocorticoids|glucocorticoids|mesh-ancestor
65047533|NCT04644094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65047546|NCT04643821|Respiratory System Agents|respiratory system agents|mesh-ancestor
65047547|NCT04643821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65047548|NCT04643821|Antioxidants|antioxidants|mesh-ancestor
65047549|NCT04643821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047550|NCT04643821|Protective Agents|protective agents|mesh-ancestor
65047551|NCT04643821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047552|NCT04643821|Antidotes|antidotes|mesh-ancestor
65047553|NCT04643821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65047554|NCT04643821|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65047555|NCT04643821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65047556|NCT04643821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65047557|NCT04643821|Vitamins|vitamins|mesh-ancestor
65047558|NCT04643821|Micronutrients|micronutrients|mesh-ancestor
65047559|NCT04643821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65494049|NCT03777436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047607|NCT00245934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65047608|NCT00245934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65047609|NCT00245934|Immunologic Factors|immunologic factors|mesh-ancestor
65047610|NCT00218231|Bupropion|bupropion|mesh-list
65047611|NCT00218231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65047612|NCT00218231|Antidepressive Agents|antidepressive agents|mesh-ancestor
65047613|NCT00218231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65047614|NCT00218231|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65047615|NCT00218231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65047616|NCT00218231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65047617|NCT00218231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047618|NCT00218231|Dopamine Agents|dopamine agents|mesh-ancestor
65047619|NCT00218231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65047620|NCT00218231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047621|NCT00218231|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65047622|NCT00218231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65047623|NCT00218231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047624|NCT00241995|Anticonvulsants|anticonvulsants|mesh-list
65047625|NCT00218309|Hydromorphone|hydromorphone|mesh-list
65047626|NCT00218309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65047627|NCT00218309|Narcotics|narcotics|mesh-ancestor
65047628|NCT00218309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65047629|NCT00218309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047630|NCT00218309|Analgesics|analgesics|mesh-ancestor
65047631|NCT00218309|Sensory System Agents|sensory system agents|mesh-ancestor
65047632|NCT00218309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65047633|NCT00218348|Amphetamine|amphetamine|mesh-list
65047650|NCT00559312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65047651|NCT00559312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65047652|NCT00559312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65047653|NCT00559312|Autonomic Agents|autonomic agents|mesh-ancestor
65047654|NCT00559312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65047655|NCT00559312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047656|NCT00559312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65047657|NCT00559312|Respiratory System Agents|respiratory system agents|mesh-ancestor
65047658|NCT00559312|Dermatologic Agents|dermatologic agents|mesh-ancestor
65047659|NCT00559312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65047660|NCT00559312|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65047711|NCT00218621|Sensory System Agents|sensory system agents|mesh-ancestor
65047712|NCT00218621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65047713|NCT00218621|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65047714|NCT00218621|Antitussive Agents|antitussive agents|mesh-ancestor
65047715|NCT00218621|Respiratory System Agents|respiratory system agents|mesh-ancestor
65047716|NCT00246168|Acetaminophen|acetaminophen|mesh-list
65047717|NCT00246168|Tramadol|tramadol|mesh-list
65047718|NCT00246168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65047719|NCT00246168|Analgesics|analgesics|mesh-ancestor
65047720|NCT00246168|Sensory System Agents|sensory system agents|mesh-ancestor
65047721|NCT00246168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65047722|NCT00246168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047723|NCT00246168|Antipyretics|antipyretics|mesh-ancestor
65047724|NCT00246168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65047725|NCT00246168|Narcotics|narcotics|mesh-ancestor
65047726|NCT00246168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65047727|NCT00218660|Naltrexone|naltrexone|mesh-list
65047728|NCT00218660|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65047729|NCT00218660|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65047730|NCT00218660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047731|NCT00218660|Sensory System Agents|sensory system agents|mesh-ancestor
65047732|NCT00218660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65047733|NCT00559546|Montelukast|montelukast|mesh-list
65047734|NCT00559546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65047735|NCT00559546|Respiratory System Agents|respiratory system agents|mesh-ancestor
65047736|NCT00559546|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65047737|NCT00559546|Hormone Antagonists|hormone antagonists|mesh-ancestor
65047738|NCT00559546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65047739|NCT00559546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047740|NCT00559546|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65047741|NCT00559546|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64533065|NCT00323739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899728|NCT02027961|Dabrafenib|dabrafenib|mesh-list
65047751|NCT00246207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65047753|NCT04639804|Naproxen|naproxen|mesh-list
65047754|NCT04639804|Aceclofenac|aceclofenac|mesh-list
65047755|NCT04639804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65047756|NCT04639804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65047757|NCT04639804|Analgesics|analgesics|mesh-ancestor
65047758|NCT04639804|Sensory System Agents|sensory system agents|mesh-ancestor
65047759|NCT04639804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65047760|NCT04639804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047761|NCT04639804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65047762|NCT04639804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65047763|NCT04639804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65047764|NCT04639804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65047765|NCT04639804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047766|NCT04639804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047767|NCT04639804|Gout Suppressants|gout suppressants|mesh-ancestor
65047768|NCT00218855|Thalidomide|thalidomide|mesh-list
65047769|NCT00218855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65047770|NCT00218855|Immunologic Factors|immunologic factors|mesh-ancestor
65047771|NCT00218855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047772|NCT00218855|Leprostatic Agents|leprostatic agents|mesh-ancestor
65047773|NCT00218855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65047774|NCT00218855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65047775|NCT00218855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65047776|NCT00218855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65047777|NCT00218855|Growth Substances|growth substances|mesh-ancestor
65047778|NCT00218855|Growth Inhibitors|growth inhibitors|mesh-ancestor
65047779|NCT00218855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047780|NCT00246246|Risperidone|risperidone|mesh-list
65047781|NCT00246246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65047782|NCT00246246|Serotonin Agents|serotonin agents|mesh-ancestor
65047783|NCT00246246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65047784|NCT00246246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047785|NCT00246246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047790|NCT00246246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65047791|NCT00246246|Dopamine Agents|dopamine agents|mesh-ancestor
65047792|NCT00242190|Gemcitabine|gemcitabine|mesh-list
65047793|NCT00242190|Oxaliplatin|oxaliplatin|mesh-list
65047794|NCT00242190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65047795|NCT00242190|Antimetabolites|antimetabolites|mesh-ancestor
65047796|NCT00242190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047797|NCT00242190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047798|NCT00242190|Antiviral Agents|antiviral agents|mesh-ancestor
65047799|NCT00242190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65047800|NCT00242190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047801|NCT00242190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65047802|NCT00242190|Immunologic Factors|immunologic factors|mesh-ancestor
65047803|NCT00242190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047804|NCT04628884|Heparin|heparin|mesh-list
65047805|NCT04628884|Anticoagulants|anticoagulants|mesh-ancestor
65047806|NCT04628884|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65047807|NCT04628884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65047808|NCT04628884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047809|NCT00412334|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65047810|NCT00412334|Interferon-alpha|interferon-alpha|mesh-list
65047811|NCT00412334|Ribavirin|ribavirin|mesh-list
65047812|NCT00412334|Antiviral Agents|antiviral agents|mesh-ancestor
65047813|NCT00412334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65047814|NCT00412334|Immunologic Factors|immunologic factors|mesh-ancestor
65047815|NCT00412334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047816|NCT00412334|Antimetabolites|antimetabolites|mesh-ancestor
65047817|NCT00412334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047818|NCT00561379|Rituximab|rituximab|mesh-list
65047819|NCT00561379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65047820|NCT00561379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047835|NCT00561496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65047836|NCT00561496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65047837|NCT00561496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65047838|NCT00561496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047839|NCT00561496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047840|NCT00561496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65047841|NCT00561496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65047842|NCT00246285|Risperidone|risperidone|mesh-list
65047843|NCT00246285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65047844|NCT00246285|Serotonin Agents|serotonin agents|mesh-ancestor
65047845|NCT00246285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65047846|NCT00246285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047847|NCT00246285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047848|NCT00246285|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65047849|NCT00246285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65047850|NCT00246285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65047851|NCT00246285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65047852|NCT00246285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65047853|NCT00246285|Dopamine Agents|dopamine agents|mesh-ancestor
65047854|NCT00242268|Simvastatin|simvastatin|mesh-list
65047888|NCT00561613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65047889|NCT00561613|Contraceptive Agents|contraceptive agents|mesh-ancestor
65047890|NCT00561613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65047891|NCT00561691|Nimotuzumab|nimotuzumab|mesh-list
65047892|NCT00561691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65047893|NCT00561691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047894|NCT04628143|Nafamostat|nafamostat|mesh-list
65047895|NCT04628143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65047896|NCT04628143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65047897|NCT04628143|Analgesics|analgesics|mesh-ancestor
65047898|NCT04628143|Sensory System Agents|sensory system agents|mesh-ancestor
65047899|NCT04628143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64921866|NCT00009750|Paclitaxel|paclitaxel|mesh-list
65494050|NCT03773302|Gemcitabine|gemcitabine|mesh-list
65047900|NCT04628143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047901|NCT04628143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65047902|NCT04628143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65047903|NCT04628143|Anticoagulants|anticoagulants|mesh-ancestor
65047904|NCT04628143|Protease Inhibitors|protease inhibitors|mesh-ancestor
65047905|NCT04628143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047906|NCT04628143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047907|NCT04628143|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65047935|NCT00219323|Omalizumab|omalizumab|mesh-list
65047938|NCT00219323|Respiratory System Agents|respiratory system agents|mesh-ancestor
65047939|NCT00246597|Epoetin Alfa|epoetin alfa|mesh-list
65047940|NCT00246597|Hematinics|hematinics|mesh-ancestor
65047941|NCT04626739|Cyclophosphamide|cyclophosphamide|mesh-list
65047942|NCT04626739|Fludarabine|fludarabine|mesh-list
65047943|NCT04626739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65047944|NCT04626739|Immunologic Factors|immunologic factors|mesh-ancestor
65047945|NCT04626739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047946|NCT04626739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65047947|NCT04626739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65047948|NCT04626739|Alkylating Agents|alkylating agents|mesh-ancestor
65047949|NCT04626739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047950|NCT04626739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65047951|NCT04626739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65047952|NCT00219401|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65047953|NCT00219401|Immunologic Factors|immunologic factors|mesh-ancestor
65047954|NCT00219401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047955|NCT04627129|Itraconazole|itraconazole|mesh-list
65047956|NCT04627129|Antifungal Agents|antifungal agents|mesh-ancestor
65047957|NCT04627129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65047958|NCT04627129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65047959|NCT04627129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65047960|NCT04627129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65047961|NCT04627129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047962|NCT04627129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65047963|NCT04627129|Hormone Antagonists|hormone antagonists|mesh-ancestor
65047965|NCT04627129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65047982|NCT00246675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047983|NCT00219479|Phenytoin|phenytoin|mesh-list
65047984|NCT00219479|Anticonvulsants|anticonvulsants|mesh-ancestor
65047985|NCT00219479|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65047986|NCT00219479|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65047987|NCT00219479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65047988|NCT00219479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65047989|NCT00219479|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65047990|NCT00219479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65047991|NCT04626778|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65047992|NCT04626778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65047993|NCT04626778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65047994|NCT04626973|Ezetimibe|ezetimibe|mesh-list
65047995|NCT04626973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65047996|NCT04626973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65047997|NCT04626973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65047998|NCT04626973|Antimetabolites|antimetabolites|mesh-ancestor
65047999|NCT04626973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048000|NCT04626973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65048001|NCT04626973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048002|NCT00242463|Nandrolone Decanoate|nandrolone decanoate|mesh-list
65048003|NCT00242463|Nandrolone|nandrolone|mesh-list
65048004|NCT00242463|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
65048005|NCT00242463|Testosterone Congeners|testosterone congeners|mesh-list
65048006|NCT00242463|Androgens|androgens|mesh-ancestor
65048028|NCT00561964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65048029|NCT00561964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048030|NCT00219596|Timolol|timolol|mesh-list
65048031|NCT00219596|Latanoprost|latanoprost|mesh-list
65048032|NCT00219596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65048033|NCT00219596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65048034|NCT00219596|Adrenergic Agents|adrenergic agents|mesh-ancestor
65048035|NCT00219596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65048036|NCT00219596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048037|NCT00219596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048038|NCT00219596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65048094|NCT04625179|Hyaluronic Acid|hyaluronic acid|mesh-list
65048095|NCT04625179|Antioxidants|antioxidants|mesh-ancestor
65048096|NCT04625179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048097|NCT04625179|Protective Agents|protective agents|mesh-ancestor
65048098|NCT04625179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048099|NCT04625179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65048100|NCT04625179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65048101|NCT04625179|Immunologic Factors|immunologic factors|mesh-ancestor
65048102|NCT04625179|Viscosupplements|viscosupplements|mesh-ancestor
65048103|NCT02962232|Paclitaxel|paclitaxel|mesh-list
65048104|NCT02962232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65048105|NCT02962232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048106|NCT02962232|Tubulin Modulators|tubulin modulators|mesh-ancestor
65048107|NCT02962232|Antimitotic Agents|antimitotic agents|mesh-ancestor
65048108|NCT02962232|Mitosis Modulators|mitosis modulators|mesh-ancestor
65048109|NCT02962232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048110|NCT00246909|Pantoprazole|pantoprazole|mesh-list
65048111|NCT00246909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65048112|NCT00246909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65048113|NCT00246909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65048114|NCT00246909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048115|NCT00246909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048117|NCT00219869|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65048118|NCT00219869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048119|NCT00219869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048135|NCT04624360|Hormones|hormones|mesh-ancestor
65048142|NCT00219908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64900121|NCT02031692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048143|NCT00219908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048144|NCT00219908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048145|NCT00219908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65048146|NCT00219908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65048147|NCT00219908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048148|NCT00219908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048149|NCT00242736|Esomeprazole|esomeprazole|mesh-list
65048150|NCT00242736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65048151|NCT00242736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65048152|NCT00242736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65048153|NCT00242736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048154|NCT00242736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048155|NCT00242775|Fluticasone|fluticasone|mesh-list
65048156|NCT00242775|Budesonide|budesonide|mesh-list
65048157|NCT00242775|Formoterol Fumarate|formoterol fumarate|mesh-list
65048158|NCT00242775|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65048159|NCT00242775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65048160|NCT00242775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65048161|NCT00242775|Autonomic Agents|autonomic agents|mesh-ancestor
65048162|NCT00242775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65048163|NCT00242775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048164|NCT00242775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65048165|NCT00242775|Respiratory System Agents|respiratory system agents|mesh-ancestor
65048166|NCT00242775|Dermatologic Agents|dermatologic agents|mesh-ancestor
65048167|NCT00242775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65048168|NCT00242775|Glucocorticoids|glucocorticoids|mesh-ancestor
65048187|NCT00562198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65048188|NCT00562198|Dopamine Agents|dopamine agents|mesh-ancestor
65048189|NCT00562198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65048190|NCT00562198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048192|NCT00562198|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65048193|NCT00562198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048194|NCT00562198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65048195|NCT00562198|Immunologic Factors|immunologic factors|mesh-ancestor
65048196|NCT00562198|Dopamine Agonists|dopamine agonists|mesh-ancestor
65048197|NCT00562198|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65048198|NCT00220064|Leucovorin|leucovorin|mesh-list
65048199|NCT00220064|Fluorouracil|fluorouracil|mesh-list
65048201|NCT00220064|Antimetabolites|antimetabolites|mesh-ancestor
65048202|NCT00220064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048203|NCT00220064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65048204|NCT00220064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048205|NCT00220064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65048206|NCT00220064|Immunologic Factors|immunologic factors|mesh-ancestor
65048207|NCT00220064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048208|NCT00220064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65048209|NCT00220064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65048210|NCT00220064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048211|NCT00220064|Antidotes|antidotes|mesh-ancestor
65048212|NCT00220064|Protective Agents|protective agents|mesh-ancestor
65048213|NCT00220064|Vitamin B Complex|vitamin b complex|mesh-ancestor
65048214|NCT00220064|Vitamins|vitamins|mesh-ancestor
65048215|NCT00220064|Micronutrients|micronutrients|mesh-ancestor
65048216|NCT00220103|Capecitabine|capecitabine|mesh-list
65048217|NCT00220103|Epirubicin|epirubicin|mesh-list
65048218|NCT00220103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048219|NCT00220103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65048233|NCT00247026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65048234|NCT00247026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048235|NCT00247026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65048236|NCT00247026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65048237|NCT00247026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048238|NCT00247026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048239|NCT00247026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048240|NCT00247026|Micronutrients|micronutrients|mesh-ancestor
65048241|NCT00247026|Vitamins|vitamins|mesh-ancestor
65048242|NCT01580683|Ascorbic Acid|ascorbic acid|mesh-list
65048243|NCT01580683|Vitamins|vitamins|mesh-ancestor
65048244|NCT01580683|Micronutrients|micronutrients|mesh-ancestor
65048245|NCT01580683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048246|NCT01580683|Antioxidants|antioxidants|mesh-ancestor
65048247|NCT01580683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048248|NCT01580683|Protective Agents|protective agents|mesh-ancestor
65048249|NCT00242814|Amlodipine|amlodipine|mesh-list
65048250|NCT00242814|Telmisartan|telmisartan|mesh-list
65048251|NCT00242814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65048252|NCT00242814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65048253|NCT00242814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65048254|NCT00242814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048255|NCT00242814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65048256|NCT00242814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048257|NCT00242814|Vasodilator Agents|vasodilator agents|mesh-ancestor
65048258|NCT00242814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65048259|NCT00242814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65048260|NCT04623385|Tretinoin|tretinoin|mesh-list
65048277|NCT00220220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65048278|NCT00220220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048279|NCT00220220|Vasodilator Agents|vasodilator agents|mesh-ancestor
65048280|NCT00220220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65048281|NCT00220220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65048282|NCT00242853|Nitric Oxide|nitric oxide|mesh-list
65048283|NCT00242853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65048284|NCT00242853|Autonomic Agents|autonomic agents|mesh-ancestor
65048285|NCT00242853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65048286|NCT00242853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048287|NCT00242853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65048288|NCT00242853|Respiratory System Agents|respiratory system agents|mesh-ancestor
65048289|NCT00242853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65048290|NCT00242853|Antioxidants|antioxidants|mesh-ancestor
65048291|NCT00242853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048292|NCT00242853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65048293|NCT00242853|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65048294|NCT00242853|Vasodilator Agents|vasodilator agents|mesh-ancestor
65048295|NCT00242853|Gasotransmitters|gasotransmitters|mesh-ancestor
65048296|NCT00242853|Protective Agents|protective agents|mesh-ancestor
65048297|NCT00220259|Fluticasone|fluticasone|mesh-list
65048300|NCT00220259|Autonomic Agents|autonomic agents|mesh-ancestor
65048327|NCT04622566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65048328|NCT04622566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048329|NCT04622566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048330|NCT04622488|Diclofenac|diclofenac|mesh-list
65048331|NCT04622488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65048332|NCT04622488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65048333|NCT04622488|Analgesics|analgesics|mesh-ancestor
65048334|NCT04622488|Sensory System Agents|sensory system agents|mesh-ancestor
65048335|NCT04622488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65048336|NCT04622488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048337|NCT04622488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65048338|NCT04622488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65048339|NCT04622488|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65048340|NCT04622488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048341|NCT04622488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048342|NCT00220298|Methyltestosterone|methyltestosterone|mesh-list
65048343|NCT00220298|Testosterone|testosterone|mesh-list
65048344|NCT00220298|Testosterone undecanoate|testosterone undecanoate|mesh-list
65048345|NCT00220298|Testosterone enanthate|testosterone enanthate|mesh-list
65048346|NCT00220298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65048347|NCT00220298|Androgens|androgens|mesh-ancestor
65048349|NCT00220298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65048350|NCT00220298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048351|NCT00220298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65048352|NCT00220298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048353|NCT00220298|Anabolic Agents|anabolic agents|mesh-ancestor
65048354|NCT00220337|Lacosamide|lacosamide|mesh-list
65048355|NCT00220337|Anticonvulsants|anticonvulsants|mesh-ancestor
65048356|NCT00220337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65048357|NCT00220337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65048360|NCT00412412|Trastuzumab|trastuzumab|mesh-list
65048369|NCT04621669|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65048370|NCT04621669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65048371|NCT04621669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65048372|NCT04621669|Antimetabolites|antimetabolites|mesh-ancestor
65048373|NCT04621669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048374|NCT04621669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65048375|NCT04621669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65048376|NCT04621669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048377|NCT04621669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65048378|NCT04621669|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65048379|NCT04621669|Protective Agents|protective agents|mesh-ancestor
65048380|NCT00412646|Etravirine|etravirine|mesh-list
65048381|NCT00412646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65048382|NCT00412646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65048383|NCT00412646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048384|NCT00412646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048385|NCT00412646|Antiviral Agents|antiviral agents|mesh-ancestor
65048386|NCT00412646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65048387|NCT00243009|Cyclosporine|cyclosporine|mesh-list
65048388|NCT00243009|Mycophenolic Acid|mycophenolic acid|mesh-list
65048389|NCT00243009|Fludarabine|fludarabine|mesh-list
65048390|NCT00243009|Fludarabine phosphate|fludarabine phosphate|mesh-list
65048391|NCT00243009|Cyclosporins|cyclosporins|mesh-list
65048392|NCT00243009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048393|NCT00243009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65048394|NCT00243009|Antimetabolites|antimetabolites|mesh-ancestor
65048395|NCT00243009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048396|NCT00243009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65048397|NCT00243009|Immunologic Factors|immunologic factors|mesh-ancestor
65048398|NCT00243009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048399|NCT00243009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048400|NCT00243009|Antifungal Agents|antifungal agents|mesh-ancestor
65048401|NCT00243009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65048409|NCT00562510|Raltegravir Potassium|raltegravir potassium|mesh-list
65048410|NCT00562510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65048411|NCT00562510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65048412|NCT00562510|Antiviral Agents|antiviral agents|mesh-ancestor
65048413|NCT00562510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65048414|NCT00562510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65048415|NCT00562510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65048416|NCT00562510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048417|NCT00562510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048418|NCT04621513|Montelukast|montelukast|mesh-list
65048419|NCT04621513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65048420|NCT04621513|Respiratory System Agents|respiratory system agents|mesh-ancestor
65048421|NCT04621513|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65048422|NCT04621513|Hormone Antagonists|hormone antagonists|mesh-ancestor
65048423|NCT04621513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65494051|NCT03773302|Infigratinib|infigratinib|mesh-list
65048424|NCT04621513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048425|NCT04621513|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65048426|NCT04621513|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65048427|NCT04621513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048428|NCT00220454|Hydrocortisone|hydrocortisone|mesh-list
65048429|NCT00220454|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65048430|NCT00220454|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65048431|NCT00220454|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65048432|NCT00220454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65048433|NCT00562705|Hormones|hormones|mesh-list
65048434|NCT00562705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65048435|NCT00562705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048436|NCT04620967|Insulin|insulin|mesh-list
65048437|NCT04620967|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65048438|NCT04620967|Insulin Aspart|insulin aspart|mesh-list
65048439|NCT04620967|Insulin, Long-Acting|insulin, long-acting|mesh-list
65048440|NCT04620967|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65048441|NCT04620967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64951509|NCT00026273|Calcium|calcium|mesh-list
64951510|NCT00026273|Levoleucovorin|levoleucovorin|mesh-list
64951511|NCT00026273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64951512|NCT00026273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951513|NCT00026273|Antimetabolites|antimetabolites|mesh-ancestor
65048442|NCT04620967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048443|NCT00220493|Methylphenidate|methylphenidate|mesh-list
65048444|NCT00220493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65048445|NCT00220493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048446|NCT00220493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65048447|NCT00220493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65048448|NCT00220493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65048449|NCT00220493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048450|NCT00220493|Dopamine Agents|dopamine agents|mesh-ancestor
65048451|NCT00220493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65048452|NCT04620616|Menthol|menthol|mesh-list
65048453|NCT04620616|Antipruritics|antipruritics|mesh-ancestor
65048454|NCT04620616|Dermatologic Agents|dermatologic agents|mesh-ancestor
65048455|NCT00220532|Folic Acid|folic acid|mesh-list
65048456|NCT00220532|Riboflavin|riboflavin|mesh-list
65048457|NCT00220532|Hematinics|hematinics|mesh-ancestor
65048458|NCT00220532|Vitamin B Complex|vitamin b complex|mesh-ancestor
65048459|NCT00220532|Vitamins|vitamins|mesh-ancestor
65048460|NCT00220532|Micronutrients|micronutrients|mesh-ancestor
65048461|NCT00220532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048462|NCT00220532|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65048463|NCT00220532|Dermatologic Agents|dermatologic agents|mesh-ancestor
65048464|NCT04620772|Cyclophosphamide|cyclophosphamide|mesh-list
65048465|NCT04620772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65048466|NCT04620772|Immunologic Factors|immunologic factors|mesh-ancestor
65048467|NCT04620772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048468|NCT04620772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65048492|NCT00220649|Gemcitabine|gemcitabine|mesh-list
65048493|NCT00220649|Fluorouracil|fluorouracil|mesh-list
65048494|NCT00220649|Oxaliplatin|oxaliplatin|mesh-list
65048495|NCT00220649|Irinotecan|irinotecan|mesh-list
65048496|NCT00220649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65048497|NCT00220649|Antimetabolites|antimetabolites|mesh-ancestor
65048498|NCT00220649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048499|NCT00220649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048500|NCT00220649|Antiviral Agents|antiviral agents|mesh-ancestor
65048502|NCT00220649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048503|NCT00220649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65048504|NCT00220649|Immunologic Factors|immunologic factors|mesh-ancestor
65048505|NCT00220649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048506|NCT00220649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65048507|NCT00220649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65048508|NCT00220649|Antidotes|antidotes|mesh-ancestor
65048509|NCT00220649|Protective Agents|protective agents|mesh-ancestor
65048510|NCT00220649|Vitamin B Complex|vitamin b complex|mesh-ancestor
65048511|NCT00220649|Vitamins|vitamins|mesh-ancestor
65048512|NCT00220649|Micronutrients|micronutrients|mesh-ancestor
65048513|NCT04619758|Emollients|emollients|mesh-list
65048514|NCT04619758|Dermatologic Agents|dermatologic agents|mesh-ancestor
65048515|NCT04619914|Letrozole|letrozole|mesh-list
65048516|NCT04619914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048548|NCT00220844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65048549|NCT00220844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65048550|NCT00220844|Analgesics|analgesics|mesh-ancestor
65048551|NCT00220844|Sensory System Agents|sensory system agents|mesh-ancestor
65048552|NCT00220844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65048553|NCT00220844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048554|NCT00220844|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65048555|NCT00220844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65048556|NCT00220844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65048557|NCT00220844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048558|NCT00220844|Adrenergic Agents|adrenergic agents|mesh-ancestor
65048559|NCT00220844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65048560|NCT00220844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048561|NCT00247494|Mycophenolic Acid|mycophenolic acid|mesh-list
65048562|NCT00247494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65048563|NCT00247494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048564|NCT00247494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65048565|NCT00247494|Antitubercular Agents|antitubercular agents|mesh-ancestor
65048566|NCT00247494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65048567|NCT00247494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65048568|NCT00247494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048569|NCT00247494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048570|NCT04619251|Itraconazole|itraconazole|mesh-list
65048571|NCT04619251|Antifungal Agents|antifungal agents|mesh-ancestor
65048572|NCT04619251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65048573|NCT04619251|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65048575|NCT04619251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048592|NCT00220922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048593|NCT00221000|Methoxsalen|methoxsalen|mesh-list
65048594|NCT00221000|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65048595|NCT00221000|Dermatologic Agents|dermatologic agents|mesh-ancestor
65048596|NCT00243477|Citalopram|citalopram|mesh-list
65048597|NCT00243477|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65048598|NCT00243477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65048599|NCT00243477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65048600|NCT00243477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048601|NCT00243477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65048602|NCT00243477|Serotonin Agents|serotonin agents|mesh-ancestor
65048603|NCT00243477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048604|NCT00243477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65048605|NCT00243477|Antidepressive Agents|antidepressive agents|mesh-ancestor
65048606|NCT00243477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65048607|NCT00221039|Methoxsalen|methoxsalen|mesh-list
65048608|NCT00221039|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65048609|NCT00221039|Dermatologic Agents|dermatologic agents|mesh-ancestor
65048610|NCT00562939|Vaccines|vaccines|mesh-list
65048611|NCT00562939|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65048612|NCT00562939|Immunologic Factors|immunologic factors|mesh-ancestor
65048613|NCT00562939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048643|NCT04617652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65048644|NCT04617652|Anticonvulsants|anticonvulsants|mesh-ancestor
65048645|NCT04617652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65048646|NCT04617652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65048647|NCT04617652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494052|NCT03773302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048648|NCT04617652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65048650|NCT04617652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65048651|NCT00247572|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65048652|NCT00247572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65048653|NCT00247572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048654|NCT00247572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65048655|NCT00247572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65048656|NCT00247572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65048657|NCT00247572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048658|NCT00247572|Dopamine Agents|dopamine agents|mesh-ancestor
65048659|NCT00247572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65048660|NCT00221312|Alendronate|alendronate|mesh-list
65048695|NCT00247650|Hormone Antagonists|hormone antagonists|mesh-ancestor
65048696|NCT00247650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65048697|NCT00247650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048698|NCT00247650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65048699|NCT00221429|Valproic Acid|valproic acid|mesh-list
65048700|NCT00221429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65048701|NCT00221429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048702|NCT00221429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048703|NCT00221429|Antimanic Agents|antimanic agents|mesh-ancestor
65048704|NCT00221429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65048705|NCT00221429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65048706|NCT00221429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048707|NCT00221429|Anticonvulsants|anticonvulsants|mesh-ancestor
64534035|NCT05076942|Cisplatin|cisplatin|mesh-list
65048708|NCT00221429|GABA Agents|gaba agents|mesh-ancestor
65048709|NCT00221429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65048710|NCT00563017|Risperidone|risperidone|mesh-list
65048711|NCT00563017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65048712|NCT00563017|Serotonin Agents|serotonin agents|mesh-ancestor
65048713|NCT00563017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65048714|NCT00563017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048716|NCT00563017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65048746|NCT00221468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65048747|NCT00221468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65048748|NCT00221468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65048749|NCT00221468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048750|NCT00563212|Interferons|interferons|mesh-list
65048751|NCT00563212|Interferon-gamma|interferon-gamma|mesh-list
65048752|NCT00563212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048753|NCT00563212|Antiviral Agents|antiviral agents|mesh-ancestor
65048754|NCT00563212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65048755|NCT00563251|Azithromycin|azithromycin|mesh-list
65048756|NCT00563251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65048757|NCT00563251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65048758|NCT00251082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65048759|NCT00251082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65048761|NCT00251082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65048762|NCT00251082|Dydrogesterone|dydrogesterone|mesh-list
65048763|NCT00251082|Estrogens|estrogens|mesh-ancestor
65048764|NCT00251082|Hormones|hormones|mesh-ancestor
65048765|NCT00251082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65048766|NCT00251082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048767|NCT00251082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65048768|NCT00251082|Contraceptive Agents|contraceptive agents|mesh-ancestor
65048769|NCT00251082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65048770|NCT00251082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65048771|NCT00251082|Progestins|progestins|mesh-ancestor
65048772|NCT00221624|Ribavirin|ribavirin|mesh-list
65048773|NCT00221624|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65048774|NCT00221624|Amantadine|amantadine|mesh-list
65048775|NCT00221624|Antimetabolites|antimetabolites|mesh-ancestor
65048777|NCT00221624|Antiviral Agents|antiviral agents|mesh-ancestor
65048795|NCT04720092|Anticoagulants|anticoagulants|mesh-ancestor
65048796|NCT00221702|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65494053|NCT03773302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65048797|NCT00221702|Antiviral Agents|antiviral agents|mesh-ancestor
65048798|NCT00221702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65048799|NCT04615702|Acetaminophen|acetaminophen|mesh-list
65048800|NCT04615702|Metronidazole|metronidazole|mesh-list
65048801|NCT04615702|Ciprofloxacin|ciprofloxacin|mesh-list
65048802|NCT04615702|Imipenem|imipenem|mesh-list
65048803|NCT04615702|Diclofenac|diclofenac|mesh-list
65048804|NCT04615702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65048805|NCT04615702|Opiate Alkaloids|opiate alkaloids|mesh-list
65048806|NCT04615702|Secretin|secretin|mesh-list
65048807|NCT04615702|Bilirubin|bilirubin|mesh-list
65048808|NCT04615702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048809|NCT04615702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65048810|NCT04615702|Analgesics|analgesics|mesh-ancestor
65048811|NCT04615702|Sensory System Agents|sensory system agents|mesh-ancestor
65048812|NCT04615702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65048813|NCT04615702|Antipyretics|antipyretics|mesh-ancestor
65048814|NCT04615702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65048815|NCT04615702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65048816|NCT04615702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65048817|NCT04615702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65048818|NCT04615702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65048819|NCT04615702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65048820|NCT04615702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65048821|NCT04615702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048829|NCT04615702|Narcotics|narcotics|mesh-ancestor
65048844|NCT04615156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65048845|NCT04615156|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65048846|NCT04614727|Calcium|calcium|mesh-list
65048847|NCT04614727|Fluorides|fluorides|mesh-list
65048848|NCT04614727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65048849|NCT04614727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048850|NCT04614727|Cariostatic Agents|cariostatic agents|mesh-ancestor
65048851|NCT04614727|Protective Agents|protective agents|mesh-ancestor
65048852|NCT04614298|Brodalumab|brodalumab|mesh-list
65048853|NCT04614298|Dermatologic Agents|dermatologic agents|mesh-ancestor
65048854|NCT04614259|Bupivacaine|bupivacaine|mesh-list
65048855|NCT04614259|Anesthetics, Local|anesthetics, local|mesh-ancestor
65048856|NCT04614259|Anesthetics|anesthetics|mesh-ancestor
65048857|NCT04614259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65048858|NCT04614259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048859|NCT04614259|Sensory System Agents|sensory system agents|mesh-ancestor
65048860|NCT04614259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65048861|NCT00412763|Silymarin|silymarin|mesh-list
65048862|NCT00412763|Antioxidants|antioxidants|mesh-ancestor
65048863|NCT00412763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048864|NCT00412763|Protective Agents|protective agents|mesh-ancestor
65048865|NCT00412763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048866|NCT00563446|Darbepoetin alfa|darbepoetin alfa|mesh-list
65048867|NCT00563446|Hematinics|hematinics|mesh-ancestor
65048869|NCT00563485|Terazosin|terazosin|mesh-list
65048870|NCT00563485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65048871|NCT00563485|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65048872|NCT00563485|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65048873|NCT00563485|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65048874|NCT00563485|Adrenergic Agents|adrenergic agents|mesh-ancestor
65048875|NCT00563485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65048876|NCT00563485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048877|NCT00563485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048878|NCT00563485|Urological Agents|urological agents|mesh-ancestor
64900861|NCT02044354|Antimitotic Agents|antimitotic agents|mesh-ancestor
65048887|NCT00412802|Anticoagulants|anticoagulants|mesh-ancestor
65048888|NCT00412802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65048889|NCT00412802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65048890|NCT00412802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048891|NCT00563524|Fezakinumab|fezakinumab|mesh-list
65048892|NCT00563524|Dermatologic Agents|dermatologic agents|mesh-ancestor
65048893|NCT04613869|Hydromorphone|hydromorphone|mesh-list
65048894|NCT04613869|Esketamine|esketamine|mesh-list
65048895|NCT04613869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65048896|NCT04613869|Narcotics|narcotics|mesh-ancestor
65048897|NCT04613869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65048898|NCT04613869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048899|NCT04613869|Analgesics|analgesics|mesh-ancestor
65048900|NCT04613869|Sensory System Agents|sensory system agents|mesh-ancestor
65048901|NCT04613869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65048902|NCT04613869|Antidepressive Agents|antidepressive agents|mesh-ancestor
65048903|NCT04613869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65048904|NCT04613557|Cyclophosphamide|cyclophosphamide|mesh-list
65048905|NCT04613557|Fludarabine|fludarabine|mesh-list
65048906|NCT04613557|Fludarabine phosphate|fludarabine phosphate|mesh-list
65048907|NCT04613557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65048908|NCT04613557|Immunologic Factors|immunologic factors|mesh-ancestor
65048909|NCT04613557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048910|NCT04613557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65048911|NCT04613557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65048912|NCT04613557|Alkylating Agents|alkylating agents|mesh-ancestor
65048913|NCT04613557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048914|NCT04613557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048915|NCT04613557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65048916|NCT04613557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65048917|NCT04613557|Antimetabolites|antimetabolites|mesh-ancestor
65048918|NCT00251355|Gemcitabine|gemcitabine|mesh-list
65048919|NCT00251355|Fluorouracil|fluorouracil|mesh-list
65048920|NCT00251355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65048921|NCT00251355|Antimetabolites|antimetabolites|mesh-ancestor
65048926|NCT00251355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048927|NCT00251355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65048928|NCT00251355|Immunologic Factors|immunologic factors|mesh-ancestor
65048929|NCT00251355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048930|NCT02962388|Anagrelide|anagrelide|mesh-list
65048931|NCT02962388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65048932|NCT02962388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65048933|NCT02962388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048934|NCT02962388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65048935|NCT04613167|Evolocumab|evolocumab|mesh-list
65048936|NCT04613167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65048937|NCT04613167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65048938|NCT04613167|Antimetabolites|antimetabolites|mesh-ancestor
65048939|NCT04613167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048940|NCT04613167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65048941|NCT04613284|Durvalumab|durvalumab|mesh-list
65048942|NCT04613284|Endostar protein|endostar protein|mesh-list
65048943|NCT04613284|Endostatins|endostatins|mesh-list
65048944|NCT04613284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65048945|NCT04613284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048946|NCT04613284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65048947|NCT04613284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65048948|NCT04613284|Growth Substances|growth substances|mesh-ancestor
65048949|NCT04613284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048950|NCT04613284|Growth Inhibitors|growth inhibitors|mesh-ancestor
65048951|NCT00563641|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65048952|NCT00563641|Respiratory System Agents|respiratory system agents|mesh-ancestor
65048953|NCT00248118|Bupropion|bupropion|mesh-list
65048954|NCT00248118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65048955|NCT00248118|Antidepressive Agents|antidepressive agents|mesh-ancestor
65048956|NCT00248118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65048969|NCT04612894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65048970|NCT04612894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048971|NCT04612894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048972|NCT00251394|Rituximab|rituximab|mesh-list
65048973|NCT00251394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65048974|NCT00251394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65048975|NCT00251394|Immunologic Factors|immunologic factors|mesh-ancestor
65048976|NCT00251394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048977|NCT00251394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65048978|NCT00221975|Lamotrigine|lamotrigine|mesh-list
65048979|NCT00221975|Valproic Acid|valproic acid|mesh-list
65048980|NCT00221975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65048981|NCT00221975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65048982|NCT00221975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65048983|NCT00221975|Antimanic Agents|antimanic agents|mesh-ancestor
65048984|NCT00221975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65048985|NCT00221975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65048986|NCT00221975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65048987|NCT00221975|Anticonvulsants|anticonvulsants|mesh-ancestor
65048988|NCT00221975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65048989|NCT00221975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65048990|NCT00221975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65048991|NCT00221975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65048992|NCT00221975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65048993|NCT00221975|GABA Agents|gaba agents|mesh-ancestor
65049018|NCT00251472|Paclitaxel|paclitaxel|mesh-list
65049019|NCT00251472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65049020|NCT00251472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049021|NCT00251472|Tubulin Modulators|tubulin modulators|mesh-ancestor
65049022|NCT00251472|Antimitotic Agents|antimitotic agents|mesh-ancestor
65049023|NCT00251472|Mitosis Modulators|mitosis modulators|mesh-ancestor
64923019|NCT00023725|Semaxinib|semaxinib|mesh-list
65494054|NCT03773302|Antimetabolites|antimetabolites|mesh-ancestor
65049024|NCT00251472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049026|NCT00222053|Thalidomide|thalidomide|mesh-list
65049027|NCT00222053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65049028|NCT00222053|Immunologic Factors|immunologic factors|mesh-ancestor
65049029|NCT00222053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049030|NCT00222053|Leprostatic Agents|leprostatic agents|mesh-ancestor
65049031|NCT00222053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65049032|NCT00222053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65049033|NCT00222053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65049034|NCT00222053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65049035|NCT00222053|Growth Substances|growth substances|mesh-ancestor
65049036|NCT00222053|Growth Inhibitors|growth inhibitors|mesh-ancestor
65049073|NCT00563875|Analgesics|analgesics|mesh-ancestor
65049074|NCT00563875|Sensory System Agents|sensory system agents|mesh-ancestor
65049075|NCT00563875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65049076|NCT00563875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049077|NCT00563875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65049078|NCT00563875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65049079|NCT00563875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65049080|NCT00563875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65049081|NCT00563875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049082|NCT00563875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65049083|NCT00563875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65049084|NCT00563875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490502|NCT04358770|Glucocorticoids|glucocorticoids|mesh-ancestor
65049085|NCT00563875|Antipyretics|antipyretics|mesh-ancestor
65049086|NCT04611685|Parecoxib|parecoxib|mesh-list
65049087|NCT04611685|Loxoprofen|loxoprofen|mesh-list
65049089|NCT04611685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65049090|NCT04611685|Narcotics|narcotics|mesh-ancestor
65049091|NCT04611685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65049092|NCT04611685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049093|NCT04611685|Analgesics|analgesics|mesh-ancestor
65049094|NCT04611685|Sensory System Agents|sensory system agents|mesh-ancestor
65049104|NCT00563914|Amodiaquine|amodiaquine|mesh-list
65049125|NCT00563992|Anticonvulsants|anticonvulsants|mesh-ancestor
65049126|NCT00563992|GABA Agents|gaba agents|mesh-ancestor
65049127|NCT00563992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65049128|NCT00251550|Pemetrexed|pemetrexed|mesh-list
65049129|NCT00251550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049130|NCT00251550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049131|NCT00251550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049132|NCT00251550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65049133|NCT00251550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65049134|NCT04611373|Levamisole|levamisole|mesh-list
65049135|NCT04611373|Acetazolamide|acetazolamide|mesh-list
65049136|NCT04611373|Anticonvulsants|anticonvulsants|mesh-ancestor
65049137|NCT04611373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65049138|NCT04611373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049139|NCT04611373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049140|NCT04611373|Diuretics|diuretics|mesh-ancestor
65049141|NCT04611373|Natriuretic Agents|natriuretic agents|mesh-ancestor
65049142|NCT04611373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049143|NCT04611373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65049144|NCT04611373|Immunologic Factors|immunologic factors|mesh-ancestor
65049145|NCT04611373|Antinematodal Agents|antinematodal agents|mesh-ancestor
65049146|NCT04611373|Anthelmintics|anthelmintics|mesh-ancestor
65049147|NCT04611373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65049148|NCT04611373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65049176|NCT00222443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049177|NCT00222443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049178|NCT04610398|Dexamethasone|dexamethasone|mesh-list
65049179|NCT04610398|Dexamethasone acetate|dexamethasone acetate|mesh-list
65049180|NCT04610398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65049181|NCT04610398|Antiemetics|antiemetics|mesh-ancestor
65049182|NCT04610398|Autonomic Agents|autonomic agents|mesh-ancestor
65049183|NCT04610398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65049184|NCT04610398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049185|NCT04610398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65049186|NCT04610398|Glucocorticoids|glucocorticoids|mesh-ancestor
65049187|NCT04610398|Hormones|hormones|mesh-ancestor
65049188|NCT04610398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65049189|NCT04610398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65049190|NCT04610398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049191|NCT00222482|Valproic Acid|valproic acid|mesh-list
65049192|NCT00222482|Anticonvulsants|anticonvulsants|mesh-ancestor
65049193|NCT00222482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049194|NCT00222482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049195|NCT00222482|GABA Agents|gaba agents|mesh-ancestor
65049196|NCT00222482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65049197|NCT00222482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049198|NCT00222482|Antimanic Agents|antimanic agents|mesh-ancestor
65049199|NCT00222482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65049200|NCT00222482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65049201|NCT00222482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65049202|NCT04610125|Cyclophosphamide|cyclophosphamide|mesh-list
65049223|NCT00222521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049224|NCT04609540|Trastuzumab|trastuzumab|mesh-list
65049225|NCT04609540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65049226|NCT04609540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049227|NCT00564187|Irbesartan|irbesartan|mesh-list
65049228|NCT00564187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65049229|NCT00564187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65049230|NCT00564187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65049231|NCT00564187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049232|NCT04609189|Vitamin D|vitamin d|mesh-list
65049233|NCT04609189|Cholecalciferol|cholecalciferol|mesh-list
65049234|NCT04609189|Calcium Carbonate|calcium carbonate|mesh-list
65049235|NCT04609189|Calcium|calcium|mesh-list
65049236|NCT04609189|Vitamins|vitamins|mesh-ancestor
65049237|NCT04609189|Micronutrients|micronutrients|mesh-ancestor
65049238|NCT04609189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049239|NCT04609189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65049240|NCT04609189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65049241|NCT04609189|Antacids|antacids|mesh-ancestor
65049242|NCT04609189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049243|NCT04609189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65049244|NCT00222677|Aspirin|aspirin|mesh-list
65049245|NCT00222677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65049246|NCT00222677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65049247|NCT00222677|Analgesics|analgesics|mesh-ancestor
65049248|NCT00222677|Sensory System Agents|sensory system agents|mesh-ancestor
65049249|NCT00222677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65049250|NCT00222677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049251|NCT00222677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65049252|NCT00222677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65049253|NCT00222677|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65049258|NCT00222677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049264|NCT00564460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049265|NCT00564460|Hormone Antagonists|hormone antagonists|mesh-ancestor
65049266|NCT00564460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65049267|NCT00564460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049268|NCT00564460|Urological Agents|urological agents|mesh-ancestor
65049269|NCT04609033|Ketamine|ketamine|mesh-list
65049270|NCT04609033|Morphine|morphine|mesh-list
65049271|NCT04609033|Bupivacaine|bupivacaine|mesh-list
65049272|NCT04609033|Anesthetics, Local|anesthetics, local|mesh-ancestor
65049273|NCT04609033|Anesthetics|anesthetics|mesh-ancestor
65049274|NCT04609033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65049275|NCT04609033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049276|NCT04609033|Sensory System Agents|sensory system agents|mesh-ancestor
65049277|NCT04609033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65049278|NCT04609033|Analgesics|analgesics|mesh-ancestor
65049279|NCT04609033|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65049280|NCT04609033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65049281|NCT04609033|Anesthetics, General|anesthetics, general|mesh-ancestor
65049282|NCT04609033|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65049283|NCT04609033|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65049284|NCT04609033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65049285|NCT04609033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049286|NCT04609033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65049287|NCT04609033|Narcotics|narcotics|mesh-ancestor
65049288|NCT00248313|Sirolimus|sirolimus|mesh-list
65049289|NCT00248313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65049311|NCT04608253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65049312|NCT04608253|Nootropic Agents|nootropic agents|mesh-ancestor
65049313|NCT00222833|Aripiprazole|aripiprazole|mesh-list
65049314|NCT00222833|Antidepressive Agents|antidepressive agents|mesh-ancestor
65049315|NCT00222833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65049316|NCT00222833|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65049317|NCT00222833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65049318|NCT00222833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65049319|NCT00222833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049320|NCT00222833|Dopamine Agonists|dopamine agonists|mesh-ancestor
65049321|NCT00222833|Dopamine Agents|dopamine agents|mesh-ancestor
65049322|NCT00222833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65049323|NCT00222833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049324|NCT00222833|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65049326|NCT00222833|Serotonin Agents|serotonin agents|mesh-ancestor
65049327|NCT00222833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65049328|NCT00222833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65049329|NCT00222833|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65049330|NCT00222833|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65049331|NCT00564538|Tacrolimus|tacrolimus|mesh-list
65049332|NCT00564538|Thymoglobulin|thymoglobulin|mesh-list
65049333|NCT00564538|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65049334|NCT00564538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65049335|NCT00564538|Immunologic Factors|immunologic factors|mesh-ancestor
65049336|NCT00564538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049337|NCT00564538|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65049338|NCT00564538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049339|NCT00564538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049340|NCT00251706|Amiodarone|amiodarone|mesh-list
65049341|NCT00251706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65049342|NCT00251706|Vasodilator Agents|vasodilator agents|mesh-ancestor
65049354|NCT00199121|Antimetabolites|antimetabolites|mesh-ancestor
65049355|NCT00199121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049356|NCT00199121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65049357|NCT00199121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65049358|NCT00199121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049359|NCT00199121|Antiviral Agents|antiviral agents|mesh-ancestor
65049360|NCT00199121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65049361|NCT00199121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65049362|NCT00199121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65049363|NCT04607785|Chlorhexidine|chlorhexidine|mesh-list
65049364|NCT04607785|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65049365|NCT04607785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65049366|NCT04607785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65049367|NCT04607785|Disinfectants|disinfectants|mesh-ancestor
65049368|NCT04607785|Dermatologic Agents|dermatologic agents|mesh-ancestor
65049369|NCT00199160|Sorafenib|sorafenib|mesh-list
65049370|NCT00199160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049371|NCT00199160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65049372|NCT00199160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049373|NCT00199160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049374|NCT04607629|Omalizumab|omalizumab|mesh-list
65049375|NCT04607629|Budesonide|budesonide|mesh-list
65049376|NCT04607629|Formoterol Fumarate|formoterol fumarate|mesh-list
65049377|NCT04607629|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65049378|NCT04607629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65049379|NCT04607629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65049380|NCT04607629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65049402|NCT00251784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049403|NCT00251784|Urological Agents|urological agents|mesh-ancestor
65049404|NCT00248430|Aldesleukin|aldesleukin|mesh-list
65049405|NCT00248430|Melphalan|melphalan|mesh-list
65049406|NCT00248430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65049407|NCT00248430|Alkylating Agents|alkylating agents|mesh-ancestor
65049408|NCT00248430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049409|NCT00248430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049410|NCT00248430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65049411|NCT00248430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65049412|NCT00248430|Immunologic Factors|immunologic factors|mesh-ancestor
65049413|NCT00248430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049414|NCT00248430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65049415|NCT00248430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65049416|NCT00248430|Antiviral Agents|antiviral agents|mesh-ancestor
65049417|NCT00248430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65049418|NCT05556356|Acetaminophen|acetaminophen|mesh-list
65049419|NCT05556356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65049420|NCT05556356|Analgesics|analgesics|mesh-ancestor
65049421|NCT05556356|Sensory System Agents|sensory system agents|mesh-ancestor
65049422|NCT05556356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65049424|NCT05556356|Antipyretics|antipyretics|mesh-ancestor
65049455|NCT04606537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049456|NCT04606537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65049457|NCT04606537|Hormone Antagonists|hormone antagonists|mesh-ancestor
65049458|NCT04606537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65049459|NCT04606537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049460|NCT04606537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65049461|NCT04606537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65049462|NCT04606537|Antitubercular Agents|antitubercular agents|mesh-ancestor
65049463|NCT04606537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65049464|NCT04606537|Leprostatic Agents|leprostatic agents|mesh-ancestor
65049465|NCT04606537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65049466|NCT04606537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65049467|NCT04606537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64923482|NCT00025441|Dactinomycin|dactinomycin|mesh-list
65049468|NCT04606537|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65049469|NCT04606537|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65049470|NCT04606537|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65049471|NCT04606537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65049472|NCT00251823|Eptifibatide|eptifibatide|mesh-list
65049505|NCT00251901|Esomeprazole|esomeprazole|mesh-list
65049506|NCT00251901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65049507|NCT00251901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65049508|NCT00251901|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65049509|NCT00251901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049510|NCT00251901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049511|NCT05517278|Anti-Infective Agents|anti-infective agents|mesh-list
65049512|NCT05517278|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65049513|NCT00564772|Ritonavir|ritonavir|mesh-list
65049514|NCT00564772|Lopinavir|lopinavir|mesh-list
65049515|NCT00564772|Raltegravir Potassium|raltegravir potassium|mesh-list
65049516|NCT00564772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65049517|NCT00564772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65049518|NCT00564772|Protease Inhibitors|protease inhibitors|mesh-ancestor
65049519|NCT00564772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049520|NCT00564772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049521|NCT00564772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65049522|NCT00564772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65049523|NCT00564772|Antiviral Agents|antiviral agents|mesh-ancestor
65049524|NCT00564772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65049525|NCT00564772|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65049526|NCT00564772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65049527|NCT00564772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65049528|NCT00564772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65049529|NCT00251940|Glyburide|glyburide|mesh-list
65049530|NCT00251940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65049531|NCT00251940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049532|NCT04604938|Losartan|losartan|mesh-list
65049533|NCT04604938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65049534|NCT04604938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65049535|NCT04604938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65049536|NCT04604938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65049538|NCT00565006|Anacetrapib|anacetrapib|mesh-list
65049548|NCT00565123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65049549|NCT00565123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65049550|NCT00565123|Renal Agents|renal agents|mesh-ancestor
65049551|NCT00565123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65049552|NCT00565123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65049553|NCT00565123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65049554|NCT00565123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049555|NCT00565123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049556|NCT00565123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049557|NCT00565123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65049558|NCT00565123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65049559|NCT04604509|Bupropion|bupropion|mesh-list
65049560|NCT04604509|Nicotine|nicotine|mesh-list
65049561|NCT04604509|Varenicline|varenicline|mesh-list
65049562|NCT04604509|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65049563|NCT04604509|Autonomic Agents|autonomic agents|mesh-ancestor
65049564|NCT04604509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65049565|NCT04604509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049566|NCT04604509|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65049567|NCT04604509|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65049568|NCT04604509|Cholinergic Agents|cholinergic agents|mesh-ancestor
65049569|NCT04604509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65049570|NCT04604509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049571|NCT04604509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65049577|NCT04604509|Dopamine Agents|dopamine agents|mesh-ancestor
65049596|NCT04603729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049597|NCT04603729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65049598|NCT04603729|Glucocorticoids|glucocorticoids|mesh-ancestor
65049599|NCT04603729|Hormones|hormones|mesh-ancestor
65049600|NCT04603729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65049601|NCT04603729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65049602|NCT04603729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049603|NCT04603729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65049604|NCT04603729|Protective Agents|protective agents|mesh-ancestor
65049605|NCT04603924|Niclosamide|niclosamide|mesh-list
65049606|NCT04603924|Anticestodal Agents|anticestodal agents|mesh-ancestor
65049607|NCT04603924|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64491033|NCT03017248|Ketamine|ketamine|mesh-list
65049608|NCT04603924|Anthelmintics|anthelmintics|mesh-ancestor
65049609|NCT04603924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65049610|NCT04603924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65049611|NCT04603924|Antinematodal Agents|antinematodal agents|mesh-ancestor
65049613|NCT04603573|Fluorides|fluorides|mesh-list
65049614|NCT04603573|Sodium Fluoride|sodium fluoride|mesh-list
65049615|NCT04603573|Fluorides, Topical|fluorides, topical|mesh-list
65049654|NCT04603066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65049655|NCT04603066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65049656|NCT05285813|Acetaminophen|acetaminophen|mesh-list
65049657|NCT05285813|Diphenhydramine|diphenhydramine|mesh-list
65049658|NCT05285813|Promethazine|promethazine|mesh-list
65049659|NCT05285813|Dexamethasone|dexamethasone|mesh-list
65049660|NCT05285813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65049661|NCT05285813|Antiemetics|antiemetics|mesh-ancestor
65049662|NCT05285813|Autonomic Agents|autonomic agents|mesh-ancestor
65049663|NCT05285813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65049664|NCT05285813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049665|NCT05285813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65049666|NCT05285813|Glucocorticoids|glucocorticoids|mesh-ancestor
65049667|NCT05285813|Hormones|hormones|mesh-ancestor
65049668|NCT05285813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65049669|NCT05285813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65049670|NCT05285813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049671|NCT05285813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65049672|NCT05285813|Analgesics|analgesics|mesh-ancestor
65049673|NCT05285813|Sensory System Agents|sensory system agents|mesh-ancestor
65049674|NCT05285813|Antipyretics|antipyretics|mesh-ancestor
65049675|NCT05285813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65049676|NCT05285813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65049677|NCT05285813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65049678|NCT05285813|Anesthetics, Local|anesthetics, local|mesh-ancestor
65049707|NCT00565240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049708|NCT00565240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049709|NCT00565240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65049710|NCT00565240|Hormone Antagonists|hormone antagonists|mesh-ancestor
65049711|NCT00565240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65049712|NCT00565240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049713|NCT00565240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65049714|NCT00565240|Contraceptive Agents|contraceptive agents|mesh-ancestor
65049715|NCT00565240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65049716|NCT00565240|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65049717|NCT00565240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65049718|NCT00565240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65049719|NCT00565240|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65049720|NCT00565240|Progestins|progestins|mesh-ancestor
65049721|NCT00565240|Hormones|hormones|mesh-ancestor
65049722|NCT04602247|Fesoterodine|fesoterodine|mesh-list
65049723|NCT04602247|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65049724|NCT04602247|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65049725|NCT04602247|Cholinergic Agents|cholinergic agents|mesh-ancestor
65049726|NCT04602247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65049727|NCT04602247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049728|NCT04602247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049729|NCT04602247|Urological Agents|urological agents|mesh-ancestor
65049730|NCT00252330|Amibegron|amibegron|mesh-list
65049731|NCT00252330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65049732|NCT00252330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65049752|NCT04601701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049753|NCT04601701|Growth Inhibitors|growth inhibitors|mesh-ancestor
65049754|NCT04601701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65049755|NCT04601701|Antiemetics|antiemetics|mesh-ancestor
65049756|NCT04601701|Autonomic Agents|autonomic agents|mesh-ancestor
65049757|NCT04601701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65049758|NCT04601701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65049759|NCT04601701|Glucocorticoids|glucocorticoids|mesh-ancestor
65049760|NCT04601701|Hormones|hormones|mesh-ancestor
65049761|NCT04601701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65049762|NCT04601701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65049763|NCT00252369|Infliximab|infliximab|mesh-list
65049764|NCT00252369|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65049765|NCT00252369|Dermatologic Agents|dermatologic agents|mesh-ancestor
65049766|NCT00252369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65049767|NCT00252369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65049768|NCT00252369|Hemostatics|hemostatics|mesh-ancestor
65049769|NCT00252369|Coagulants|coagulants|mesh-ancestor
65049771|NCT00565318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65049772|NCT00565318|Immunologic Factors|immunologic factors|mesh-ancestor
65049773|NCT00565318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049774|NCT00565318|Chelating Agents|chelating agents|mesh-ancestor
65049775|NCT00565318|Sequestering Agents|sequestering agents|mesh-ancestor
65049776|NCT00565318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049777|NCT05201144|Sildenafil Citrate|sildenafil citrate|mesh-list
65049778|NCT05201144|Vasodilator Agents|vasodilator agents|mesh-ancestor
65049779|NCT05201144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65049780|NCT05201144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65049781|NCT05201144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049782|NCT05201144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049798|NCT00565396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65049799|NCT00565396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65049800|NCT00565396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049801|NCT00565396|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65049802|NCT00565396|Protease Inhibitors|protease inhibitors|mesh-ancestor
65049803|NCT00565396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049804|NCT04601116|Atorvastatin|atorvastatin|mesh-list
65049805|NCT04601116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65049806|NCT04601116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65049807|NCT04601116|Antimetabolites|antimetabolites|mesh-ancestor
65049808|NCT04601116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049809|NCT04601116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65049810|NCT04601116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65049811|NCT04601116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049812|NCT04600648|Insulin|insulin|mesh-list
65049813|NCT04600648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65049814|NCT04600648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049815|NCT00249132|Risperidone|risperidone|mesh-list
65049816|NCT00249132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65049817|NCT00249132|Serotonin Agents|serotonin agents|mesh-ancestor
65049818|NCT00249132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65049819|NCT00249132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049820|NCT00249132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049821|NCT00249132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65049822|NCT00249132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65049823|NCT00249132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65049824|NCT00249132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65049825|NCT00249132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65049843|NCT00414648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64923884|NCT00000461|Niacin|niacin|mesh-list
65049844|NCT00414648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049846|NCT00414648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65049847|NCT00414648|Immunologic Factors|immunologic factors|mesh-ancestor
65049848|NCT00414648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049849|NCT00414687|Iloprost|iloprost|mesh-list
65049850|NCT00414687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65049851|NCT00414687|Vasodilator Agents|vasodilator agents|mesh-ancestor
65049852|NCT04599205|Tranexamic Acid|tranexamic acid|mesh-list
65049853|NCT04599205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65049854|NCT04599205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65049855|NCT04599205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049856|NCT04599205|Hemostatics|hemostatics|mesh-ancestor
65049857|NCT04599205|Coagulants|coagulants|mesh-ancestor
65049858|NCT05070260|Glenzocimab|glenzocimab|mesh-list
65049859|NCT05070260|Anticoagulants|anticoagulants|mesh-ancestor
65049860|NCT04598737|Lithium Carbonate|lithium carbonate|mesh-list
65049861|NCT04598737|Antidepressive Agents|antidepressive agents|mesh-ancestor
65049862|NCT04598737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65049863|NCT04598737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049864|NCT04598737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049865|NCT04598737|Antimanic Agents|antimanic agents|mesh-ancestor
65049869|NCT05055128|Lansoprazole|lansoprazole|mesh-list
65049895|NCT00252603|Cholinergic Agents|cholinergic agents|mesh-ancestor
65049896|NCT00252603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65049897|NCT00252603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049898|NCT00252603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65049899|NCT00252603|Autonomic Agents|autonomic agents|mesh-ancestor
65049900|NCT00252603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65049901|NCT00252603|Nootropic Agents|nootropic agents|mesh-ancestor
65049902|NCT00565630|Moxifloxacin|moxifloxacin|mesh-list
65049903|NCT00565630|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65049904|NCT00565630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65049905|NCT00565630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65049906|NCT00565630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65049907|NCT00565630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65049908|NCT00565630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535234|NCT01505647|Vaccines|vaccines|mesh-list
65049909|NCT00565630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049910|NCT00565630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049911|NCT00565630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65049912|NCT00565630|Contraceptive Agents|contraceptive agents|mesh-ancestor
65049916|NCT00565630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65049948|NCT04598542|Immunologic Factors|immunologic factors|mesh-ancestor
65049949|NCT04598542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049950|NCT04598542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049951|NCT04995263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65049952|NCT04995263|Caffeine|caffeine|mesh-list
65049953|NCT04995263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65049954|NCT04995263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049955|NCT04995263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65049956|NCT04995263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65049957|NCT04995263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049958|NCT04995263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65049959|NCT04995263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65049960|NCT04995263|Purinergic Agents|purinergic agents|mesh-ancestor
65049961|NCT04995263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65049962|NCT04995263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65049963|NCT04598191|Iloprost|iloprost|mesh-list
65049964|NCT04598191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65049965|NCT04598191|Vasodilator Agents|vasodilator agents|mesh-ancestor
65049966|NCT04955366|Abatacept|abatacept|mesh-list
65049967|NCT04955366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65049968|NCT04955366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65049969|NCT04955366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65049970|NCT04955366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65049971|NCT04955366|Immunologic Factors|immunologic factors|mesh-ancestor
65049972|NCT04955366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049995|NCT00565981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65049996|NCT00565981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65049997|NCT04952519|Amantadine|amantadine|mesh-list
65049998|NCT04952519|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65049999|NCT04952519|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65050000|NCT04952519|Antiviral Agents|antiviral agents|mesh-ancestor
65050001|NCT04952519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65050002|NCT04952519|Dopamine Agents|dopamine agents|mesh-ancestor
65050003|NCT04952519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65050004|NCT04952519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050005|NCT04952519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050006|NCT04952519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65050007|NCT04952519|Analgesics|analgesics|mesh-ancestor
65050008|NCT04952519|Sensory System Agents|sensory system agents|mesh-ancestor
65050009|NCT04952519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050010|NCT00414921|Clonidine|clonidine|mesh-list
65050011|NCT00414921|Methylphenidate|methylphenidate|mesh-list
65050012|NCT00414921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65050013|NCT00414921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050051|NCT00249210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65050052|NCT00249210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050053|NCT00249210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050054|NCT00249210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491482|NCT01006252|Antimitotic Agents|antimitotic agents|mesh-ancestor
65050055|NCT00249210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65050056|NCT00249210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65050058|NCT00252798|Carboplatin|carboplatin|mesh-list
65050059|NCT00252798|Gefitinib|gefitinib|mesh-list
65050060|NCT00252798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65050061|NCT00252798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050062|NCT00252798|Tubulin Modulators|tubulin modulators|mesh-ancestor
65050063|NCT00252798|Antimitotic Agents|antimitotic agents|mesh-ancestor
65050064|NCT00252798|Mitosis Modulators|mitosis modulators|mesh-ancestor
65050065|NCT00252798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050066|NCT00252798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65050067|NCT00252798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050069|NCT02961660|Antiviral Agents|antiviral agents|mesh-ancestor
65050070|NCT02961660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65050071|NCT00403013|Anesthetics|anesthetics|mesh-list
65050072|NCT00403013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65050073|NCT00403013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050103|NCT04595929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65050104|NCT04595929|Immunologic Factors|immunologic factors|mesh-ancestor
65050105|NCT04595929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050106|NCT04595929|Antidotes|antidotes|mesh-ancestor
65050107|NCT04595929|Protective Agents|protective agents|mesh-ancestor
65050108|NCT04595929|Vitamin B Complex|vitamin b complex|mesh-ancestor
65050109|NCT04595929|Vitamins|vitamins|mesh-ancestor
65050110|NCT04595929|Micronutrients|micronutrients|mesh-ancestor
65050111|NCT00252954|Levetiracetam|levetiracetam|mesh-list
65050112|NCT00252954|Anticonvulsants|anticonvulsants|mesh-ancestor
65050113|NCT00252954|Nootropic Agents|nootropic agents|mesh-ancestor
65050114|NCT04595812|Misoprostol|misoprostol|mesh-list
65050115|NCT04595812|Hemostatics|hemostatics|mesh-list
65050116|NCT04595812|Oxytocin|oxytocin|mesh-list
65050117|NCT04595812|Carbetocin|carbetocin|mesh-list
65050118|NCT04595812|Oxytocics|oxytocics|mesh-ancestor
65050119|NCT04595812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65050120|NCT04595812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050121|NCT04595812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65050122|NCT04595812|Abortifacient Agents|abortifacient agents|mesh-ancestor
65050123|NCT04595812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65050124|NCT04595812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65050125|NCT04595812|Coagulants|coagulants|mesh-ancestor
65050126|NCT00249366|Lorazepam|lorazepam|mesh-list
65050127|NCT00249366|Anticonvulsants|anticonvulsants|mesh-ancestor
65050128|NCT00249366|Antiemetics|antiemetics|mesh-ancestor
65050129|NCT00249366|Autonomic Agents|autonomic agents|mesh-ancestor
65050130|NCT00249366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050131|NCT00249366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050132|NCT00249366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65050133|NCT00249366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65050134|NCT00249366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65050135|NCT00249366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65050136|NCT00249366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65050137|NCT00249366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65050138|NCT00249366|GABA Modulators|gaba modulators|mesh-ancestor
65050139|NCT00249366|GABA Agents|gaba agents|mesh-ancestor
65050140|NCT00249366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65050142|NCT04635683|Lenalidomide|lenalidomide|mesh-list
65050144|NCT04635683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050145|NCT04635683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65050146|NCT04635683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65050147|NCT04635683|Growth Substances|growth substances|mesh-ancestor
65050148|NCT04635683|Growth Inhibitors|growth inhibitors|mesh-ancestor
65050149|NCT04635683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050150|NCT00249405|Citalopram|citalopram|mesh-list
65050151|NCT00249405|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65050152|NCT00249405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65050153|NCT00249405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65050154|NCT00249405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050155|NCT00249405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65050156|NCT00249405|Serotonin Agents|serotonin agents|mesh-ancestor
65050157|NCT00249405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050158|NCT00249405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65050159|NCT00249405|Antidepressive Agents|antidepressive agents|mesh-ancestor
65050160|NCT00249405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65050161|NCT00566644|Levonorgestrel|levonorgestrel|mesh-list
65050162|NCT00566644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65050163|NCT00566644|Contraceptive Agents|contraceptive agents|mesh-ancestor
65050164|NCT00566644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65050165|NCT00566644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050166|NCT00566644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65050167|NCT00566644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65050168|NCT00566644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65050169|NCT00253110|Haloperidol|haloperidol|mesh-list
65050170|NCT00253110|Risperidone|risperidone|mesh-list
65050171|NCT00253110|Haloperidol decanoate|haloperidol decanoate|mesh-list
65050172|NCT00253110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65050173|NCT00253110|Serotonin Agents|serotonin agents|mesh-ancestor
65050174|NCT00253110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64902125|NCT00006030|Tamoxifen|tamoxifen|mesh-list
65050185|NCT00253110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050186|NCT00253110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65050187|NCT00253110|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65050188|NCT00566683|Meperidine|meperidine|mesh-list
65050189|NCT00566683|Diazepam|diazepam|mesh-list
65050190|NCT00566683|Alfentanil|alfentanil|mesh-list
65050191|NCT00566683|Propofol|propofol|mesh-list
65050192|NCT00566683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65050193|NCT00566683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65050194|NCT00566683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050195|NCT00566683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65050196|NCT00566683|Anesthetics, General|anesthetics, general|mesh-ancestor
65050197|NCT00566683|Anesthetics|anesthetics|mesh-ancestor
65050198|NCT00566683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65050199|NCT00566683|Narcotics|narcotics|mesh-ancestor
65050200|NCT00566683|Analgesics|analgesics|mesh-ancestor
65050201|NCT00566683|Sensory System Agents|sensory system agents|mesh-ancestor
65050202|NCT00566683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050203|NCT00566683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65050204|NCT00566683|Anticonvulsants|anticonvulsants|mesh-ancestor
65050205|NCT00566683|Antiemetics|antiemetics|mesh-ancestor
65050206|NCT00566683|Autonomic Agents|autonomic agents|mesh-ancestor
65050207|NCT00566683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65050208|NCT00566683|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65050209|NCT00566683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65050210|NCT00566683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65050212|NCT00566683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65050213|NCT00566683|GABA Modulators|gaba modulators|mesh-ancestor
65050214|NCT00566683|GABA Agents|gaba agents|mesh-ancestor
65050215|NCT00566683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65050216|NCT00566683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050217|NCT00566761|Triamcinolone|triamcinolone|mesh-list
65050232|NCT00566800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65050233|NCT00566800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050234|NCT00566800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050235|NCT04593706|Dexamethasone|dexamethasone|mesh-list
65050236|NCT04593706|Methylprednisolone|methylprednisolone|mesh-list
65050237|NCT04593706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65050238|NCT04593706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65050239|NCT04593706|Prednisolone|prednisolone|mesh-list
65050240|NCT04593706|Prednisolone acetate|prednisolone acetate|mesh-list
65050241|NCT04593706|Triamcinolone|triamcinolone|mesh-list
65050242|NCT04593706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65050243|NCT04593706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65050244|NCT04593706|Betamethasone|betamethasone|mesh-list
65050245|NCT04593706|Betamethasone Valerate|betamethasone valerate|mesh-list
65050246|NCT04593706|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65050247|NCT04593706|Betamethasone benzoate|betamethasone benzoate|mesh-list
65050248|NCT04593706|Dexamethasone acetate|dexamethasone acetate|mesh-list
65050249|NCT04593706|Betamethasone acetate|betamethasone acetate|mesh-list
65050250|NCT04593706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65050251|NCT04593706|Prednisolone phosphate|prednisolone phosphate|mesh-list
65050252|NCT04593706|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65050253|NCT04593706|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65050254|NCT04593706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65050255|NCT04593706|BB 1101|bb 1101|mesh-list
65050256|NCT04593706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65050257|NCT04593706|Antiemetics|antiemetics|mesh-ancestor
65050258|NCT04593706|Autonomic Agents|autonomic agents|mesh-ancestor
65050259|NCT04593706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050260|NCT04593706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050261|NCT04593706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65050278|NCT04587830|Alkylating Agents|alkylating agents|mesh-ancestor
65050279|NCT04587830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050280|NCT04587830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050281|NCT04593238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65050282|NCT04593238|Calcium|calcium|mesh-list
65050283|NCT04593238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64491711|NCT03387501|Mitogens|mitogens|mesh-list
65050284|NCT04593238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050285|NCT04593238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65050286|NCT04593160|Acetaminophen|acetaminophen|mesh-list
65050287|NCT04593160|Diclofenac|diclofenac|mesh-list
65050288|NCT04593160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65050289|NCT04593160|Analgesics|analgesics|mesh-ancestor
65050290|NCT04593160|Sensory System Agents|sensory system agents|mesh-ancestor
65050291|NCT04593160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050292|NCT04593160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050293|NCT04593160|Antipyretics|antipyretics|mesh-ancestor
65050294|NCT04593160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65050295|NCT04593160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65050296|NCT04593160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65050297|NCT04593160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65050298|NCT04593160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050299|NCT04593160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050300|NCT00253149|Risperidone|risperidone|mesh-list
65050301|NCT00253149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65050302|NCT00253149|Serotonin Agents|serotonin agents|mesh-ancestor
65050325|NCT00249483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65050326|NCT00249483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050327|NCT00249483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65050328|NCT00249483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050329|NCT00249483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65050330|NCT00249483|Antidepressive Agents|antidepressive agents|mesh-ancestor
65050331|NCT00249483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65050332|NCT00567034|Naltrexone|naltrexone|mesh-list
65050333|NCT00567034|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65050334|NCT00567034|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65050335|NCT00567034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050336|NCT00567034|Sensory System Agents|sensory system agents|mesh-ancestor
65050337|NCT00567034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050338|NCT04593043|Warfarin|warfarin|mesh-list
65050339|NCT04593043|Dabigatran|dabigatran|mesh-list
65050340|NCT04593043|Anticoagulants|anticoagulants|mesh-ancestor
65050341|NCT04593043|Antithrombins|antithrombins|mesh-ancestor
65050342|NCT04593043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65050343|NCT04593043|Protease Inhibitors|protease inhibitors|mesh-ancestor
65050344|NCT04593043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050345|NCT04593043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050346|NCT04484363|Azacitidine|azacitidine|mesh-list
65050347|NCT04484363|Pevonedistat|pevonedistat|mesh-list
65050348|NCT04484363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65050374|NCT04591990|Hydrocortisone|hydrocortisone|mesh-list
65050375|NCT04591990|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65050376|NCT04591990|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65050377|NCT04591990|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65050378|NCT04591990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65050379|NCT04438265|Levobupivacaine|levobupivacaine|mesh-list
65050380|NCT04438265|Anesthetics, Local|anesthetics, local|mesh-ancestor
65050381|NCT04438265|Anesthetics|anesthetics|mesh-ancestor
65050382|NCT04438265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65050383|NCT04438265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050384|NCT04438265|Sensory System Agents|sensory system agents|mesh-ancestor
65050385|NCT04438265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050386|NCT04591795|Diclofenac|diclofenac|mesh-list
65050387|NCT04591795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65050388|NCT04591795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65050389|NCT04591795|Analgesics|analgesics|mesh-ancestor
65050390|NCT04591795|Sensory System Agents|sensory system agents|mesh-ancestor
65050391|NCT04591795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050392|NCT04591795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050393|NCT04591795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65050394|NCT04591795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65050395|NCT04591795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65050396|NCT04591795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050398|NCT04591639|Dapagliflozin|dapagliflozin|mesh-list
65050422|NCT04592029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050423|NCT04592029|Growth Inhibitors|growth inhibitors|mesh-ancestor
65050424|NCT04409873|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65050425|NCT04409873|Listerine|listerine|mesh-list
65050426|NCT04409873|Cetylpyridinium|cetylpyridinium|mesh-list
65050427|NCT04409873|Chlorine dioxide|chlorine dioxide|mesh-list
65050428|NCT04409873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65050429|NCT04409873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65050430|NCT04409873|Dental Disinfectants|dental disinfectants|mesh-ancestor
65050431|NCT04409873|Disinfectants|disinfectants|mesh-ancestor
65050432|NCT00253227|Galantamine|galantamine|mesh-list
65050433|NCT00253227|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65050434|NCT00253227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050435|NCT00253227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050436|NCT00253227|Cholinergic Agents|cholinergic agents|mesh-ancestor
65050437|NCT00253227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65050438|NCT00253227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050439|NCT00253227|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65050440|NCT00253227|Autonomic Agents|autonomic agents|mesh-ancestor
65050441|NCT00253227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050442|NCT00253227|Nootropic Agents|nootropic agents|mesh-ancestor
65050444|NCT04591444|Fluorides, Topical|fluorides, topical|mesh-list
65050445|NCT04591444|Cariostatic Agents|cariostatic agents|mesh-ancestor
65050446|NCT04591444|Protective Agents|protective agents|mesh-ancestor
65050447|NCT04591444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050448|NCT04591327|Anesthetics|anesthetics|mesh-list
65050449|NCT04591327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65050450|NCT04591327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050451|NCT04396730|Cannabidiol|cannabidiol|mesh-list
65050452|NCT04396730|Contraceptive Agents|contraceptive agents|mesh-list
65050453|NCT04396730|Contraceptives, Oral|contraceptives, oral|mesh-list
65050454|NCT04396730|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65050467|NCT00253266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65050468|NCT00253266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65050469|NCT00253266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65050470|NCT00253266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050471|NCT00253266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65050472|NCT00253266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65050473|NCT00253305|Terbinafine|terbinafine|mesh-list
65050474|NCT00253305|Naftifine|naftifine|mesh-list
65050475|NCT00253305|Antifungal Agents|antifungal agents|mesh-ancestor
65050476|NCT00253305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65050477|NCT00253305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050478|NCT00253305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050479|NCT04591600|Ivermectin|ivermectin|mesh-list
65050480|NCT04591600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65050481|NCT04591600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65050482|NCT04591405|Vaccines|vaccines|mesh-list
65050483|NCT04591405|Immunologic Factors|immunologic factors|mesh-ancestor
65050484|NCT04591405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050485|NCT04590742|Melatonin|melatonin|mesh-list
65050486|NCT04590742|Antioxidants|antioxidants|mesh-ancestor
65050487|NCT04590742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050488|NCT04590742|Protective Agents|protective agents|mesh-ancestor
65050489|NCT04590742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050490|NCT04590742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65050491|NCT00253344|Docetaxel|docetaxel|mesh-list
65050515|NCT00567463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050516|NCT00567463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050517|NCT00567463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65050518|NCT00567463|Respiratory System Agents|respiratory system agents|mesh-ancestor
65050519|NCT00567463|Dermatologic Agents|dermatologic agents|mesh-ancestor
65050520|NCT00567463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65050521|NCT00253422|Fulvestrant|fulvestrant|mesh-list
65050522|NCT00253422|Anastrozole|anastrozole|mesh-list
65050523|NCT00253422|Exemestane|exemestane|mesh-list
65050524|NCT00253422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65050525|NCT00253422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050526|NCT00253422|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65050527|NCT00253422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65050528|NCT00253422|Hormone Antagonists|hormone antagonists|mesh-ancestor
65050529|NCT00253422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65050530|NCT00253422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050531|NCT00253422|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65050532|NCT00253422|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65050533|NCT00253422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050534|NCT00253422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050535|NCT04590937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65050568|NCT04272242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050569|NCT04272242|Vitamin B Complex|vitamin b complex|mesh-ancestor
65050570|NCT04272242|Antitubercular Agents|antitubercular agents|mesh-ancestor
65050571|NCT04272242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65050572|NCT04272242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65050573|NCT04272242|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65050574|NCT04272242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65050575|NCT04272242|Antimetabolites|antimetabolites|mesh-ancestor
65050576|NCT04272242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050577|NCT04272242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65050578|NCT04272242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65050579|NCT04272242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65050580|NCT04272242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050581|NCT04272242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65050582|NCT04272242|Antiviral Agents|antiviral agents|mesh-ancestor
65050583|NCT04272242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65050584|NCT04272242|Leprostatic Agents|leprostatic agents|mesh-ancestor
65050585|NCT04244552|Doxorubicin|doxorubicin|mesh-list
65050586|NCT04244552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65050587|NCT04244552|Pembrolizumab|pembrolizumab|mesh-list
65050588|NCT04244552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65050589|NCT04244552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050590|NCT04244552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65050591|NCT04244552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65050592|NCT04244552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050593|NCT04244552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050594|NCT04244552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65050595|NCT04590196|Curcumin|curcumin|mesh-list
65050597|NCT04590196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65050598|NCT04590196|Analgesics|analgesics|mesh-ancestor
65050599|NCT04590196|Sensory System Agents|sensory system agents|mesh-ancestor
64902589|NCT03084939|Capecitabine|capecitabine|mesh-list
65050612|NCT00567658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050613|NCT00567697|Ranibizumab|ranibizumab|mesh-list
65050614|NCT00567697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65050615|NCT00567697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65050616|NCT00567697|Growth Substances|growth substances|mesh-ancestor
65050617|NCT00567697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050618|NCT00567697|Growth Inhibitors|growth inhibitors|mesh-ancestor
65050619|NCT00567697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050620|NCT04589494|Morphine|morphine|mesh-list
65050621|NCT04589494|Tramadol|tramadol|mesh-list
65050622|NCT04589494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65050623|NCT04589494|Narcotics|narcotics|mesh-ancestor
65050624|NCT04589494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65050625|NCT04589494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050626|NCT04589494|Analgesics|analgesics|mesh-ancestor
65050627|NCT04589494|Sensory System Agents|sensory system agents|mesh-ancestor
65050628|NCT04589494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050629|NCT04589299|Immunoglobulins|immunoglobulins|mesh-list
65050630|NCT04589299|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65050631|NCT04589299|Antibodies|antibodies|mesh-list
65050632|NCT04589299|Immunologic Factors|immunologic factors|mesh-ancestor
65050633|NCT04589299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050634|NCT00253500|Epirubicin|epirubicin|mesh-list
65050635|NCT00253500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65050636|NCT00253500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050637|NCT00253500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65050638|NCT00253500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65050639|NCT00253500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050640|NCT00253500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050641|NCT04589143|S 20098|s 20098|mesh-list
65050642|NCT04589143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65050643|NCT04589143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65050644|NCT04589143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050645|NCT04588987|Apatinib|apatinib|mesh-list
65050646|NCT04588987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050647|NCT04588987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65050649|NCT04588987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050650|NCT00253539|Tamoxifen|tamoxifen|mesh-list
65050651|NCT00253539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65050652|NCT00253539|Hormone Antagonists|hormone antagonists|mesh-ancestor
65050653|NCT00253539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65050654|NCT00253539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050655|NCT00253539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65050656|NCT00253539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050657|NCT00253539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65050658|NCT00253539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65050659|NCT00253539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65050660|NCT04588636|Salicylic Acid|salicylic acid|mesh-list
65050661|NCT04588636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65050662|NCT04588636|Antifungal Agents|antifungal agents|mesh-ancestor
65050663|NCT04588636|Keratolytic Agents|keratolytic agents|mesh-ancestor
65050664|NCT04588636|Dermatologic Agents|dermatologic agents|mesh-ancestor
65050665|NCT00567775|Insulin|insulin|mesh-list
65050666|NCT00567775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65050667|NCT00567775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65050668|NCT00567775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050669|NCT00567814|Oxazepam|oxazepam|mesh-list
65050671|NCT00567814|Antimetabolites|antimetabolites|mesh-ancestor
65050672|NCT00567814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050673|NCT00567814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050674|NCT00567814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65050675|NCT00567814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65050676|NCT00567814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050677|NCT00567814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65050678|NCT00567814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65050679|NCT00567814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65050680|NCT00567814|GABA Modulators|gaba modulators|mesh-ancestor
65050681|NCT00567814|GABA Agents|gaba agents|mesh-ancestor
65050683|NCT04588441|Adenosine|adenosine|mesh-list
65050691|NCT04588441|Purinergic Agonists|purinergic agonists|mesh-ancestor
65050692|NCT04588441|Purinergic Agents|purinergic agents|mesh-ancestor
65050693|NCT04588441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65050694|NCT04588441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050695|NCT04588090|Cisplatin|cisplatin|mesh-list
65050696|NCT04588090|Paclitaxel|paclitaxel|mesh-list
65050697|NCT04588090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050698|NCT04588090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65050699|NCT04588090|Tubulin Modulators|tubulin modulators|mesh-ancestor
65050700|NCT04588090|Antimitotic Agents|antimitotic agents|mesh-ancestor
65050701|NCT04588090|Mitosis Modulators|mitosis modulators|mesh-ancestor
65050702|NCT04588090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050703|NCT00253578|Sorafenib|sorafenib|mesh-list
65050704|NCT00253578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050705|NCT00253578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65050706|NCT00253578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050707|NCT00253578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050708|NCT04588285|Ambroxol|ambroxol|mesh-list
65050709|NCT04588285|Expectorants|expectorants|mesh-ancestor
65050710|NCT04588285|Respiratory System Agents|respiratory system agents|mesh-ancestor
65050711|NCT04153565|Pembrolizumab|pembrolizumab|mesh-list
65050712|NCT04153565|Pemetrexed|pemetrexed|mesh-list
65050713|NCT04153565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050714|NCT04153565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65050715|NCT04153565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050716|NCT04153565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050717|NCT04153565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65050718|NCT04153565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65050719|NCT04588324|Antineoplastic Agents|antineoplastic agents|mesh-list
65050720|NCT00253617|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
65050721|NCT00253617|Trioxsalen|trioxsalen|mesh-list
65050722|NCT00253617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050734|NCT04587778|Anesthetics|anesthetics|mesh-ancestor
65050735|NCT04587778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65050736|NCT04587778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65050737|NCT04587778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65050738|NCT04587778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65050739|NCT04587778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050740|NCT04587778|Antidepressive Agents|antidepressive agents|mesh-ancestor
65050741|NCT04587778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65050743|NCT04587505|Tramadol|tramadol|mesh-list
65050744|NCT04587505|Anesthetics|anesthetics|mesh-list
65050745|NCT04587505|Ropivacaine|ropivacaine|mesh-list
65050746|NCT04587505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65050747|NCT04587505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050748|NCT04587505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65050749|NCT04587505|Narcotics|narcotics|mesh-ancestor
65050750|NCT04587505|Analgesics|analgesics|mesh-ancestor
65050751|NCT04587505|Sensory System Agents|sensory system agents|mesh-ancestor
65050752|NCT04587505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050753|NCT04587505|Anesthetics, Local|anesthetics, local|mesh-ancestor
65050754|NCT04128683|Bromocriptine|bromocriptine|mesh-list
65050755|NCT04128683|Amisulpride|amisulpride|mesh-list
65050756|NCT04128683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65050757|NCT04128683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65050758|NCT04128683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65050759|NCT04128683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050760|NCT04128683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65050761|NCT04128683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65050762|NCT04128683|Dopamine Agents|dopamine agents|mesh-ancestor
65050767|NCT04128683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65050781|NCT04587115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050782|NCT04587115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65050783|NCT04587115|Serotonin Agents|serotonin agents|mesh-ancestor
65050784|NCT04587115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65050785|NCT04587115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050786|NCT04587115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65050787|NCT04587115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65050788|NCT04587115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65050789|NCT04587115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65050790|NCT04587115|Dopamine Agents|dopamine agents|mesh-ancestor
65050791|NCT00403247|Vitamin B 12|vitamin b 12|mesh-list
65050792|NCT00403247|Hydroxocobalamin|hydroxocobalamin|mesh-list
65050793|NCT00403247|Pyridoxine|pyridoxine|mesh-list
65050794|NCT00403247|Vitamins|vitamins|mesh-ancestor
65050795|NCT00403247|Micronutrients|micronutrients|mesh-ancestor
65050796|NCT00403247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050797|NCT00403247|Vitamin B Complex|vitamin b complex|mesh-ancestor
65050798|NCT00403247|Hematinics|hematinics|mesh-ancestor
65050799|NCT00253773|Acetaminophen|acetaminophen|mesh-list
65050800|NCT00253773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65050801|NCT00253773|Analgesics|analgesics|mesh-ancestor
65050802|NCT00253773|Sensory System Agents|sensory system agents|mesh-ancestor
65050803|NCT00253773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050804|NCT00253773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050805|NCT00253773|Antipyretics|antipyretics|mesh-ancestor
65050806|NCT00403286|Fluticasone|fluticasone|mesh-list
65050807|NCT00403286|Xhance|xhance|mesh-list
65050808|NCT00403286|Formoterol Fumarate|formoterol fumarate|mesh-list
65050809|NCT00403286|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65050810|NCT00403286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65050811|NCT00403286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65050829|NCT04585867|Anesthetics|anesthetics|mesh-ancestor
65050830|NCT04585867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65050831|NCT04585867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050832|NCT04585867|Sensory System Agents|sensory system agents|mesh-ancestor
65050833|NCT04585867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050834|NCT00253851|Heparin|heparin|mesh-list
65050835|NCT00253851|Calcium heparin|calcium heparin|mesh-list
65050836|NCT00253851|Anticoagulants|anticoagulants|mesh-ancestor
65050837|NCT00253851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65050838|NCT00253851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65050839|NCT00253851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050840|NCT00249912|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65050841|NCT00249912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65050842|NCT00249912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65050843|NCT00249912|Antimetabolites|antimetabolites|mesh-ancestor
65050844|NCT00249912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050845|NCT00249912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65050846|NCT00249912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65050847|NCT00249912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050848|NCT04585438|Diclofenac|diclofenac|mesh-list
65050849|NCT04585438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65050850|NCT04585438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65050851|NCT04585438|Analgesics|analgesics|mesh-ancestor
65050852|NCT04585438|Sensory System Agents|sensory system agents|mesh-ancestor
65050853|NCT04585438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050854|NCT04585438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050855|NCT04585438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65050856|NCT04585438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65050857|NCT04585438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65050858|NCT04585438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050859|NCT04585438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050870|NCT00223301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65050871|NCT00223301|Antitubercular Agents|antitubercular agents|mesh-ancestor
65050872|NCT00223301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65050873|NCT00223301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65050874|NCT00223301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050875|NCT00223301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050876|NCT04585321|Diclofenac|diclofenac|mesh-list
65050877|NCT04585321|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
65050878|NCT04585321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65050879|NCT04585321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65050880|NCT04585321|Analgesics|analgesics|mesh-ancestor
65050881|NCT04585321|Sensory System Agents|sensory system agents|mesh-ancestor
65050882|NCT04585321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050883|NCT04585321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050884|NCT04585321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64536158|NCT00480987|Antiviral Agents|antiviral agents|mesh-ancestor
65050885|NCT04585321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65050886|NCT04585321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65050887|NCT04585321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050888|NCT04585321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050889|NCT00412997|Panobinostat|panobinostat|mesh-list
65050890|NCT00412997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050891|NCT00412997|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65050892|NCT00412997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050893|NCT00412997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050894|NCT00253929|Adenosine|adenosine|mesh-list
65050895|NCT00253929|Nitroprusside|nitroprusside|mesh-list
65050896|NCT00253929|Acetylcholine|acetylcholine|mesh-list
65050897|NCT00253929|Caffeine|caffeine|mesh-list
65050898|NCT00253929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65050899|NCT00253929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050900|NCT00253929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65050901|NCT00253929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050902|NCT00253929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050907|NCT00253929|Analgesics|analgesics|mesh-ancestor
65050908|NCT00253929|Sensory System Agents|sensory system agents|mesh-ancestor
65050909|NCT00253929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65050910|NCT00253929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65050911|NCT00253929|Vasodilator Agents|vasodilator agents|mesh-ancestor
65050912|NCT00253929|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65050913|NCT00253929|Purinergic Agonists|purinergic agonists|mesh-ancestor
65050914|NCT00253929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65050915|NCT00253929|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65050916|NCT00253929|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65050917|NCT00253929|Cholinergic Agents|cholinergic agents|mesh-ancestor
65050918|NCT00568048|Bevacizumab|bevacizumab|mesh-list
65050919|NCT00568048|Temozolomide|temozolomide|mesh-list
65050920|NCT00568048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65050921|NCT00568048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050922|NCT00568048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65050923|NCT00568048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65050924|NCT00568048|Growth Substances|growth substances|mesh-ancestor
65050925|NCT00568048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65050926|NCT00568048|Growth Inhibitors|growth inhibitors|mesh-ancestor
65050927|NCT00568048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65050928|NCT00568048|Alkylating Agents|alkylating agents|mesh-ancestor
65050929|NCT00568048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050930|NCT04584580|Heparin|heparin|mesh-list
65050958|NCT00223418|Serotonin Agents|serotonin agents|mesh-ancestor
64492321|NCT04957095|Dopamine Agents|dopamine agents|mesh-ancestor
65050959|NCT00223418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65050961|NCT00223418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65050962|NCT00223418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65050963|NCT04584736|Ezetimibe|ezetimibe|mesh-list
65050964|NCT04584736|Pitavastatin|pitavastatin|mesh-list
65050965|NCT04584736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65050966|NCT04584736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65050967|NCT04584736|Antimetabolites|antimetabolites|mesh-ancestor
65050968|NCT04584736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65050969|NCT04584736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65050970|NCT04584736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65050971|NCT04584736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65050972|NCT00250068|Rubitecan|rubitecan|mesh-list
65050973|NCT00250068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65050974|NCT00250068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65050975|NCT00250068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65050976|NCT00250068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051014|NCT00254007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65051015|NCT00254007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65051016|NCT00254007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051017|NCT00254007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65051018|NCT00254007|Serotonin Agents|serotonin agents|mesh-ancestor
65051019|NCT00254007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051020|NCT00254007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65051021|NCT00254007|Antidepressive Agents|antidepressive agents|mesh-ancestor
65051022|NCT00254007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65051023|NCT00223613|Insulin|insulin|mesh-list
65051024|NCT00223613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65051025|NCT00223613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051026|NCT04583137|Lidocaine|lidocaine|mesh-list
65051027|NCT04583137|Anesthetics, Local|anesthetics, local|mesh-ancestor
65051028|NCT04583137|Anesthetics|anesthetics|mesh-ancestor
65051029|NCT04583137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65051030|NCT04583137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051074|NCT00223691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051075|NCT00223691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051076|NCT00223691|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65051077|NCT00223691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65051078|NCT00223691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65051079|NCT00223691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65051080|NCT00223691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65051081|NCT00223691|Purinergic Agents|purinergic agents|mesh-ancestor
65051082|NCT00223691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65051083|NCT00223691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65051084|NCT00223691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65051085|NCT00223691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65051086|NCT00223691|Dopamine Agents|dopamine agents|mesh-ancestor
65051087|NCT00223691|Anticonvulsants|anticonvulsants|mesh-ancestor
65051088|NCT00223691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65051089|NCT00223691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65051090|NCT00223691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65051091|NCT00223691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65051092|NCT00223691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051093|NCT00223691|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65051094|NCT00223691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65051095|NCT00223691|Adrenergic Agents|adrenergic agents|mesh-ancestor
65051096|NCT00223691|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65051097|NCT00223691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65051122|NCT00223691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65051123|NCT00223691|Protective Agents|protective agents|mesh-ancestor
65051124|NCT00223691|Sympathomimetics|sympathomimetics|mesh-ancestor
65051125|NCT00223691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65051126|NCT00223691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65051127|NCT00223691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65051128|NCT00223691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65051129|NCT00223691|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65051130|NCT00223691|Immunologic Factors|immunologic factors|mesh-ancestor
65051131|NCT00223691|Dopamine Agonists|dopamine agonists|mesh-ancestor
65051132|NCT00223691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65051133|NCT00223691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65051134|NCT00223691|Respiratory System Agents|respiratory system agents|mesh-ancestor
65051135|NCT00223691|Nasal Decongestants|nasal decongestants|mesh-ancestor
65051136|NCT00223691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65051138|NCT00223691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65051139|NCT00223691|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65051140|NCT00223691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65051141|NCT00223691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65051142|NCT00223691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65051143|NCT00223691|Urological Agents|urological agents|mesh-ancestor
65051144|NCT00223691|Antidepressive Agents|antidepressive agents|mesh-ancestor
65051145|NCT00223691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65051146|NCT00223691|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65051147|NCT00223691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65051172|NCT00223769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65051173|NCT00223769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051174|NCT00223769|Anabolic Agents|anabolic agents|mesh-ancestor
65051175|NCT04582084|Etanercept|etanercept|mesh-list
65051176|NCT04582084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65051177|NCT04582084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65051178|NCT04582084|Analgesics|analgesics|mesh-ancestor
65051179|NCT04582084|Sensory System Agents|sensory system agents|mesh-ancestor
65051180|NCT04582084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65051181|NCT04582084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051182|NCT04582084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65051183|NCT04582084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65051184|NCT04582084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65051185|NCT04582084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65051186|NCT04582084|Immunologic Factors|immunologic factors|mesh-ancestor
65051187|NCT00254046|Etravirine|etravirine|mesh-list
65051188|NCT00254046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65051190|NCT00254046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051228|NCT04581265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65051229|NCT04581265|Alkylating Agents|alkylating agents|mesh-ancestor
65051230|NCT04580797|PF-06700841|pf-06700841|mesh-list
65051231|NCT04580797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65051232|NCT04580797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051233|NCT04580797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051234|NCT00568477|Rituximab|rituximab|mesh-list
65051235|NCT00568477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65051236|NCT00568477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051237|NCT00568477|Immunologic Factors|immunologic factors|mesh-ancestor
65051238|NCT00568477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051239|NCT00568477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65051240|NCT00568711|Doxycycline|doxycycline|mesh-list
65051241|NCT00568711|Rifampin|rifampin|mesh-list
65051242|NCT00568711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65051243|NCT00568711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65051244|NCT00568711|Antimalarials|antimalarials|mesh-ancestor
65051245|NCT00568711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65051281|NCT00568789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65051282|NCT00568789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051283|NCT00568789|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65051284|NCT00568789|GABA Agonists|gaba agonists|mesh-ancestor
65051285|NCT00568789|GABA Agents|gaba agents|mesh-ancestor
65051286|NCT00568789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65051287|NCT00568789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051288|NCT00254202|Iloperidone|iloperidone|mesh-list
65051289|NCT00254202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65051290|NCT00254202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65051291|NCT00254202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65051292|NCT00254202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051293|NCT00254202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65051294|NCT00568984|Metformin|metformin|mesh-list
65051295|NCT00568984|Repaglinide|repaglinide|mesh-list
65051296|NCT00568984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65051297|NCT00568984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051298|NCT00254241|Risperidone|risperidone|mesh-list
65051299|NCT00254241|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65051300|NCT00254241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65051301|NCT00254241|Serotonin Agents|serotonin agents|mesh-ancestor
65051302|NCT00254241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65051303|NCT00254241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051333|NCT00224354|Denileukin diftitox|denileukin diftitox|mesh-list
65051334|NCT00224354|Immunotoxins|immunotoxins|mesh-list
65051335|NCT00224354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051336|NCT00224354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65051338|NCT00224354|Sensory System Agents|sensory system agents|mesh-ancestor
65051339|NCT00224354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65051340|NCT00224354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051341|NCT00224354|Immunologic Factors|immunologic factors|mesh-ancestor
65051342|NCT00569296|Aldesleukin|aldesleukin|mesh-list
65051343|NCT00569296|Sargramostim|sargramostim|mesh-list
65051344|NCT00569296|Immunologic Factors|immunologic factors|mesh-ancestor
65051345|NCT00569296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051346|NCT00569296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051347|NCT00569296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65051348|NCT00569296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65051349|NCT00569296|Antiviral Agents|antiviral agents|mesh-ancestor
65051350|NCT00569296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65051351|NCT00569335|Bevacizumab|bevacizumab|mesh-list
65051352|NCT00569335|Irinotecan|irinotecan|mesh-list
65494056|NCT03773302|Antiviral Agents|antiviral agents|mesh-ancestor
65051353|NCT00569335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65051355|NCT00569335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65051356|NCT00569335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65051357|NCT00569335|Growth Substances|growth substances|mesh-ancestor
65051358|NCT00569335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051359|NCT00569335|Growth Inhibitors|growth inhibitors|mesh-ancestor
65051360|NCT00569335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65051361|NCT00569335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65051362|NCT00569335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051363|NCT00569335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051364|NCT00224393|Etanercept|etanercept|mesh-list
65051365|NCT00224393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65051366|NCT00224393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65051367|NCT00224393|Analgesics|analgesics|mesh-ancestor
65051375|NCT00224393|Immunologic Factors|immunologic factors|mesh-ancestor
65051376|NCT00254319|Bevacizumab|bevacizumab|mesh-list
65051377|NCT00254319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65051378|NCT00254319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051379|NCT00254319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65051380|NCT00254319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65051381|NCT00254319|Growth Substances|growth substances|mesh-ancestor
65051382|NCT00254319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051383|NCT00254319|Growth Inhibitors|growth inhibitors|mesh-ancestor
65051384|NCT00569452|Insulin|insulin|mesh-list
65051385|NCT00569452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65051386|NCT00569452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65051387|NCT00569452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051388|NCT00569881|Moxifloxacin|moxifloxacin|mesh-list
65051389|NCT00569881|Gatifloxacin|gatifloxacin|mesh-list
65051390|NCT00569881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65051391|NCT00569881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65051392|NCT00569881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65051393|NCT00569881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65051394|NCT00569881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051395|NCT00569881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051396|NCT00569881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051397|NCT00569881|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65051398|NCT00569881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65051399|NCT00224471|Vaccines|vaccines|mesh-list
65051400|NCT00224471|Immunologic Factors|immunologic factors|mesh-ancestor
65051401|NCT00224471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051423|NCT00224510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051424|NCT00224510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64925430|NCT00032968|Narcotics|narcotics|mesh-ancestor
65051425|NCT00224510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051426|NCT00224510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65051427|NCT00224510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65051428|NCT00224510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65051429|NCT00224510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65051430|NCT00224510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65051431|NCT00570193|Ranibizumab|ranibizumab|mesh-list
65051432|NCT00570193|Verteporfin|verteporfin|mesh-list
65051433|NCT00570193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65051434|NCT00570193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65051435|NCT00570193|Growth Substances|growth substances|mesh-ancestor
65051436|NCT00570193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051437|NCT00570193|Growth Inhibitors|growth inhibitors|mesh-ancestor
65051438|NCT00570193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051439|NCT00570193|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65051440|NCT00570193|Dermatologic Agents|dermatologic agents|mesh-ancestor
65051441|NCT00224549|Amlodipine|amlodipine|mesh-list
65051442|NCT00224549|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65051443|NCT00224549|Irbesartan|irbesartan|mesh-list
65051444|NCT00224549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65051445|NCT00224549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65051446|NCT00224549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65051447|NCT00224549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051469|NCT00254436|Hematinics|hematinics|mesh-ancestor
65051470|NCT00224588|Ketamine|ketamine|mesh-list
65051471|NCT00224588|Analgesics|analgesics|mesh-ancestor
65051472|NCT00224588|Sensory System Agents|sensory system agents|mesh-ancestor
65051473|NCT00224588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65051474|NCT00224588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051475|NCT00224588|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65051476|NCT00224588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65051477|NCT00224588|Anesthetics, General|anesthetics, general|mesh-ancestor
65051478|NCT00224588|Anesthetics|anesthetics|mesh-ancestor
65051479|NCT00224588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65051480|NCT00224588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65051481|NCT00224588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65051482|NCT00224588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65051483|NCT00224588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051484|NCT00570622|Pioglitazone|pioglitazone|mesh-list
65051485|NCT00570622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65051486|NCT00570622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051487|NCT00254475|Valsartan|valsartan|mesh-list
65051488|NCT00254475|Simvastatin|simvastatin|mesh-list
65051489|NCT00254475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65051524|NCT00254553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051525|NCT00254553|Anabolic Agents|anabolic agents|mesh-ancestor
65051526|NCT00571129|Mitomycins|mitomycins|mesh-list
65051527|NCT00571129|Mitomycin|mitomycin|mesh-list
65051528|NCT00571129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65051529|NCT00571129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051530|NCT00571129|Alkylating Agents|alkylating agents|mesh-ancestor
65051531|NCT00571129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051532|NCT00571129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65051533|NCT00571129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051534|NCT03453931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65051535|NCT03453931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65051536|NCT03453931|Glucocorticoids|glucocorticoids|mesh-ancestor
65051537|NCT03453931|Hormones|hormones|mesh-ancestor
65051538|NCT03453931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65051539|NCT03453931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051540|NCT03453931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65051541|NCT03453931|Protective Agents|protective agents|mesh-ancestor
65051542|NCT03453931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65051543|NCT03453931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051544|NCT00571246|Topiramate|topiramate|mesh-list
65051545|NCT00571246|Lamotrigine|lamotrigine|mesh-list
65051546|NCT00571246|Anticonvulsants|anticonvulsants|mesh-ancestor
65051547|NCT00571246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65051549|NCT00571246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65051574|NCT00254670|Naltrexone|naltrexone|mesh-list
65494057|NCT03773302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65051575|NCT00254670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65051576|NCT00254670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65051577|NCT00254670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051578|NCT00254670|Sensory System Agents|sensory system agents|mesh-ancestor
65051579|NCT00254670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65051580|NCT00571558|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65051581|NCT00571558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65051582|NCT00571558|Dermatologic Agents|dermatologic agents|mesh-ancestor
65051583|NCT00571636|Fentanyl|fentanyl|mesh-list
65051584|NCT00571636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65051585|NCT00571636|Narcotics|narcotics|mesh-ancestor
65051586|NCT00571636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65051587|NCT00571636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051588|NCT00571636|Analgesics|analgesics|mesh-ancestor
65051589|NCT00571636|Sensory System Agents|sensory system agents|mesh-ancestor
65051590|NCT00571636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65051591|NCT00571636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65051592|NCT00571636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65051593|NCT00571636|Anesthetics, General|anesthetics, general|mesh-ancestor
65051594|NCT00571636|Anesthetics|anesthetics|mesh-ancestor
65051595|NCT00571675|Prednisone|prednisone|mesh-list
65051596|NCT00571675|Docetaxel|docetaxel|mesh-list
65051597|NCT00571675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051598|NCT00571675|Tubulin Modulators|tubulin modulators|mesh-ancestor
65051599|NCT00571675|Antimitotic Agents|antimitotic agents|mesh-ancestor
65051600|NCT00571675|Mitosis Modulators|mitosis modulators|mesh-ancestor
65051601|NCT00571675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051602|NCT00571675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65051620|NCT00571714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65051621|NCT00571714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65051622|NCT00571753|Isoniazid|isoniazid|mesh-list
65051623|NCT00571753|Antitubercular Agents|antitubercular agents|mesh-ancestor
65051624|NCT00571753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65051625|NCT00571753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65051626|NCT00571753|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65051627|NCT00571753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65051628|NCT00571753|Antimetabolites|antimetabolites|mesh-ancestor
65051629|NCT00571753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051630|NCT00571753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65051631|NCT00254709|Sirolimus|sirolimus|mesh-list
65051632|NCT00254709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65051633|NCT00254709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65051634|NCT00254709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65051635|NCT00254709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051636|NCT00254709|Antifungal Agents|antifungal agents|mesh-ancestor
65051637|NCT00254709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64536903|NCT01541930|Metronidazole|metronidazole|mesh-list
65051638|NCT00254709|Immunologic Factors|immunologic factors|mesh-ancestor
65051639|NCT00254709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051640|NCT00224822|Aripiprazole|aripiprazole|mesh-list
65051641|NCT00224822|Antidepressive Agents|antidepressive agents|mesh-ancestor
65051642|NCT00224822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65051643|NCT00224822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65051644|NCT00224822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65051645|NCT00224822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65051646|NCT00224822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051647|NCT00224822|Dopamine Agonists|dopamine agonists|mesh-ancestor
65051648|NCT00224822|Dopamine Agents|dopamine agents|mesh-ancestor
65051649|NCT00224822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65051662|NCT00571870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051663|NCT00571870|Hormone Antagonists|hormone antagonists|mesh-ancestor
65051664|NCT00571870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65051665|NCT00254748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65051666|NCT00254748|Antidepressive Agents|antidepressive agents|mesh-ancestor
65051667|NCT00254748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65051668|NCT00254748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65051669|NCT00254748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65051670|NCT00254748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65051671|NCT00254748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051672|NCT00572026|Methylphenidate|methylphenidate|mesh-list
65051673|NCT00572026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65051674|NCT00572026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051675|NCT00572026|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65051676|NCT00572026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65051677|NCT00572026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65051678|NCT00572026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051679|NCT00572026|Dopamine Agents|dopamine agents|mesh-ancestor
65051680|NCT00572026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65051681|NCT00572065|Cytarabine|cytarabine|mesh-list
65051682|NCT00572065|Arsenic Trioxide|arsenic trioxide|mesh-list
65051683|NCT00572065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65051684|NCT00572065|Antimetabolites|antimetabolites|mesh-ancestor
65051685|NCT00572065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051686|NCT00572065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051687|NCT00572065|Antiviral Agents|antiviral agents|mesh-ancestor
65051688|NCT00572065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65051692|NCT00234897|Adalimumab|adalimumab|mesh-list
65051706|NCT00234936|Methotrexate|methotrexate|mesh-list
65051707|NCT00234936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65051708|NCT00234936|Abortifacient Agents|abortifacient agents|mesh-ancestor
65051709|NCT00234936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65051710|NCT00234936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051711|NCT00234936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65051712|NCT00234936|Antimetabolites|antimetabolites|mesh-ancestor
65051713|NCT00234936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051714|NCT00234936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051715|NCT00234936|Dermatologic Agents|dermatologic agents|mesh-ancestor
65051716|NCT00234936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051717|NCT00234936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65051718|NCT00234936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65051719|NCT00234936|Immunologic Factors|immunologic factors|mesh-ancestor
65051720|NCT00234936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65051721|NCT00234936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65051722|NCT00234936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65051724|NCT00413075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494058|NCT03773302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051725|NCT00413075|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65051726|NCT00413075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051727|NCT00413075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051728|NCT00572650|Vildagliptin|vildagliptin|mesh-list
65051729|NCT00572650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64903726|NCT00005944|Fluorouracil|fluorouracil|mesh-list
64903727|NCT00005944|Mitomycins|mitomycins|mesh-list
64903728|NCT00005944|Mitomycin|mitomycin|mesh-list
64903729|NCT00005944|Calcium|calcium|mesh-list
64903730|NCT00005944|Levoleucovorin|levoleucovorin|mesh-list
64903731|NCT00005944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65051757|NCT00573001|Tenofovir|tenofovir|mesh-list
65051758|NCT00573001|Zidovudine|zidovudine|mesh-list
65051759|NCT00573001|Emtricitabine|emtricitabine|mesh-list
65051760|NCT00573001|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65051761|NCT00573001|Nevirapine|nevirapine|mesh-list
65051762|NCT00573001|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65051763|NCT00573001|Efavirenz|efavirenz|mesh-list
65051764|NCT00573001|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65051815|NCT00225173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051816|NCT00225173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051817|NCT00225173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65051818|NCT00225173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65051819|NCT00225173|Antimetabolites|antimetabolites|mesh-ancestor
65051820|NCT00225173|Antiviral Agents|antiviral agents|mesh-ancestor
65051821|NCT00225173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65051822|NCT00225173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051823|NCT00225173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65051824|NCT00225173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65051825|NCT00225173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65051826|NCT00225173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65051827|NCT00225173|Glucocorticoids|glucocorticoids|mesh-ancestor
65051828|NCT00225173|Hormones|hormones|mesh-ancestor
65051829|NCT00225173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65051830|NCT00225173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65051831|NCT00225173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65051832|NCT00225173|Tubulin Modulators|tubulin modulators|mesh-ancestor
65051833|NCT00225173|Antimitotic Agents|antimitotic agents|mesh-ancestor
65051834|NCT00225173|Mitosis Modulators|mitosis modulators|mesh-ancestor
65051835|NCT00234975|Ritonavir|ritonavir|mesh-list
65051836|NCT00234975|Lopinavir|lopinavir|mesh-list
65051837|NCT00234975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65051838|NCT00234975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65051839|NCT00234975|Protease Inhibitors|protease inhibitors|mesh-ancestor
65051840|NCT00234975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051841|NCT00234975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051842|NCT00234975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65051843|NCT00234975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65051858|NCT00235014|Protease Inhibitors|protease inhibitors|mesh-ancestor
65051859|NCT00235014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051860|NCT00235014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65051861|NCT00225290|Thalidomide|thalidomide|mesh-list
65051862|NCT00225290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65051863|NCT00225290|Immunologic Factors|immunologic factors|mesh-ancestor
65051864|NCT00225290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051865|NCT00225290|Leprostatic Agents|leprostatic agents|mesh-ancestor
65051866|NCT00225290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65051867|NCT00225290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65051868|NCT00225290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65051869|NCT00225290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65051870|NCT00225290|Growth Substances|growth substances|mesh-ancestor
65051871|NCT00225290|Growth Inhibitors|growth inhibitors|mesh-ancestor
65051872|NCT00225290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051873|NCT00573547|Fluoxetine|fluoxetine|mesh-list
65051874|NCT00573547|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65494059|NCT03773302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65051875|NCT00573547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65051876|NCT00573547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65051877|NCT00573547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051878|NCT00573547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65051879|NCT00573547|Serotonin Agents|serotonin agents|mesh-ancestor
65051880|NCT00573547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051881|NCT00573547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65051882|NCT00573547|Antidepressive Agents|antidepressive agents|mesh-ancestor
65051883|NCT00573547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65051884|NCT00573547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65051885|NCT00573547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65051886|NCT00573547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051887|NCT00573664|Gabapentin|gabapentin|mesh-list
65051888|NCT00573664|Analgesics|analgesics|mesh-ancestor
65051889|NCT00573664|Sensory System Agents|sensory system agents|mesh-ancestor
65051896|NCT00573664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65051897|NCT00573664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65051898|NCT00573664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65051899|NCT00573664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65051900|NCT00573664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051901|NCT00573664|Antimanic Agents|antimanic agents|mesh-ancestor
65051902|NCT00573742|Candesartan|candesartan|mesh-list
65051903|NCT00573742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65051904|NCT00573742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65051905|NCT00573742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65051906|NCT00573742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051907|NCT00254865|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65051908|NCT00254865|Norelgestromin|norelgestromin|mesh-list
65051909|NCT00254865|Contraceptive Agents|contraceptive agents|mesh-list
65051910|NCT00254865|Estradiol|estradiol|mesh-list
65051911|NCT00254865|Estrogens|estrogens|mesh-ancestor
65051912|NCT00254865|Hormones|hormones|mesh-ancestor
65051913|NCT00254865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65051914|NCT00254865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051915|NCT00254865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65051916|NCT00254865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65051917|NCT00254865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65051918|NCT00254865|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65051919|NCT00254865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65051920|NCT00235053|Fluticasone|fluticasone|mesh-list
65051921|NCT00235053|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65051922|NCT00235053|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65051923|NCT00235053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65051924|NCT00235053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65051937|NCT00235053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051938|NCT00235053|Glucocorticoids|glucocorticoids|mesh-ancestor
65051939|NCT00235053|Hormones|hormones|mesh-ancestor
65051940|NCT00235053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65051941|NCT00235053|Sympathomimetics|sympathomimetics|mesh-ancestor
65051942|NCT00574015|Acetaminophen|acetaminophen|mesh-list
65051943|NCT00574015|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65051944|NCT00574015|Hydrocodone|hydrocodone|mesh-list
65051945|NCT00574015|Bupivacaine|bupivacaine|mesh-list
65051946|NCT00574015|Anesthetics, Local|anesthetics, local|mesh-ancestor
65051948|NCT00574015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65051949|NCT00574015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051950|NCT00574015|Sensory System Agents|sensory system agents|mesh-ancestor
65051951|NCT00574015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65051952|NCT00574015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65051953|NCT00574015|Analgesics|analgesics|mesh-ancestor
65051954|NCT00574015|Antipyretics|antipyretics|mesh-ancestor
65051955|NCT00574015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65051956|NCT00574015|Narcotics|narcotics|mesh-ancestor
65051957|NCT00574015|Antitussive Agents|antitussive agents|mesh-ancestor
65051958|NCT00574015|Respiratory System Agents|respiratory system agents|mesh-ancestor
65051959|NCT00574015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65051960|NCT00574015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65051961|NCT00574015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65051962|NCT00225485|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65051963|NCT00225485|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65051964|NCT00225485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65051965|NCT00225485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65051966|NCT00225485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051967|NCT00225485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65051979|NCT00574093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051980|NCT00574093|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65051981|NCT00574093|Dermatologic Agents|dermatologic agents|mesh-ancestor
65051982|NCT00574366|Everolimus|everolimus|mesh-list
65051983|NCT00574366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65051984|NCT00574366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65051985|NCT00574366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65051986|NCT00574366|Immunologic Factors|immunologic factors|mesh-ancestor
65051987|NCT00574366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051988|NCT00574366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65051989|NCT00574366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65051990|NCT00574366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051991|NCT00225524|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65051992|NCT00225524|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65051993|NCT00225524|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65051994|NCT00225524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65051995|NCT00225524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65051996|NCT00225524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65051997|NCT00225524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65051998|NCT00225524|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65051999|NCT00225524|Antidepressive Agents|antidepressive agents|mesh-ancestor
65052000|NCT00225524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65052001|NCT00574483|Quinacrine|quinacrine|mesh-list
65052002|NCT00574483|Anticestodal Agents|anticestodal agents|mesh-ancestor
65052003|NCT00574483|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65052004|NCT00574483|Anthelmintics|anthelmintics|mesh-ancestor
65052005|NCT00574483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65052006|NCT00574483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65052007|NCT00574483|Antimalarials|antimalarials|mesh-ancestor
65052008|NCT00574483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65052013|NCT00235092|Sirolimus|sirolimus|mesh-list
65052020|NCT00235092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052021|NCT00235092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65052022|NCT00235092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65052023|NCT00235092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65052024|NCT00235092|Antifungal Agents|antifungal agents|mesh-ancestor
65052025|NCT00235092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65052026|NCT00235092|Immunologic Factors|immunologic factors|mesh-ancestor
65052027|NCT00235092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052029|NCT00574600|Immunologic Factors|immunologic factors|mesh-ancestor
65052030|NCT00574600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052031|NCT00574639|Alprazolam|alprazolam|mesh-list
65052032|NCT00574639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65052033|NCT00574639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65052034|NCT00574639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052035|NCT00574639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65052036|NCT00574639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65052037|NCT00574639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65052038|NCT00574639|GABA Modulators|gaba modulators|mesh-ancestor
65052039|NCT00574639|GABA Agents|gaba agents|mesh-ancestor
65052040|NCT00574639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65052041|NCT00574639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052042|NCT00255255|Budesonide|budesonide|mesh-list
65052043|NCT00255255|Formoterol Fumarate|formoterol fumarate|mesh-list
65052044|NCT00255255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65052045|NCT00255255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65052046|NCT00255255|Autonomic Agents|autonomic agents|mesh-ancestor
65052047|NCT00255255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65052048|NCT00255255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052049|NCT00255255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65052050|NCT00255255|Respiratory System Agents|respiratory system agents|mesh-ancestor
65052051|NCT00255255|Glucocorticoids|glucocorticoids|mesh-ancestor
65052052|NCT00255255|Hormones|hormones|mesh-ancestor
65052053|NCT00255255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65052054|NCT00255255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65052059|NCT00255255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052060|NCT00574756|Ranolazine|ranolazine|mesh-list
65052061|NCT00574756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65052062|NCT00574756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65052063|NCT00574756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052064|NCT03453346|Ribavirin|ribavirin|mesh-list
65052065|NCT03453346|Sofosbuvir|sofosbuvir|mesh-list
65052066|NCT03453346|Antimetabolites|antimetabolites|mesh-ancestor
65052067|NCT03453346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052068|NCT03453346|Antiviral Agents|antiviral agents|mesh-ancestor
65052069|NCT03453346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65052070|NCT00575068|Galiximab|galiximab|mesh-list
65052071|NCT00575068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65052072|NCT00575068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052073|NCT00575224|Interferons|interferons|mesh-list
65052074|NCT00575224|Ribavirin|ribavirin|mesh-list
65052075|NCT00575224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052076|NCT00575224|Antiviral Agents|antiviral agents|mesh-ancestor
65052080|NCT00225797|Oxymorphone|oxymorphone|mesh-list
65052116|NCT00225914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65052117|NCT00225914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65052118|NCT00225914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65052119|NCT00225914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052120|NCT00225914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65052121|NCT00225914|Serotonin Agents|serotonin agents|mesh-ancestor
65052122|NCT00225914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052123|NCT00225914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65052124|NCT00225914|Antidepressive Agents|antidepressive agents|mesh-ancestor
65052125|NCT00225914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65052126|NCT00225914|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65052127|NCT00225914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65052128|NCT00225914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052129|NCT03451903|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65052130|NCT03451903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65052131|NCT03451903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65052132|NCT03451903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052133|NCT00235248|Aspirin|aspirin|mesh-list
65052134|NCT00235248|Warfarin|warfarin|mesh-list
65052135|NCT00235248|Clopidogrel|clopidogrel|mesh-list
65052136|NCT00235248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65052137|NCT00235248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65052138|NCT00235248|Analgesics|analgesics|mesh-ancestor
65052139|NCT00235248|Sensory System Agents|sensory system agents|mesh-ancestor
65052164|NCT03451435|Respiratory System Agents|respiratory system agents|mesh-ancestor
65052165|NCT03451435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65052166|NCT03451435|Antioxidants|antioxidants|mesh-ancestor
65052167|NCT03451435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052168|NCT03451435|Protective Agents|protective agents|mesh-ancestor
65052169|NCT03451435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052170|NCT03451435|Antidotes|antidotes|mesh-ancestor
65052171|NCT04575064|Remdesivir|remdesivir|mesh-list
65052172|NCT04575064|Antimetabolites|antimetabolites|mesh-ancestor
65052173|NCT04575064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052174|NCT04575064|Antiviral Agents|antiviral agents|mesh-ancestor
65052175|NCT04575064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65052176|NCT03451318|Mometasone Furoate|mometasone furoate|mesh-list
65052177|NCT03451318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65052178|NCT03451318|Dermatologic Agents|dermatologic agents|mesh-ancestor
65052179|NCT03451318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65052180|NCT00255450|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65052181|NCT00255450|Hematinics|hematinics|mesh-ancestor
65052182|NCT00255450|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65052183|NCT00255450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65052184|NCT04573855|Immunoglobulins|immunoglobulins|mesh-list
65052185|NCT04573855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65052186|NCT04573855|Antibodies|antibodies|mesh-list
65052187|NCT04573855|Immunologic Factors|immunologic factors|mesh-ancestor
65052188|NCT04573855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052189|NCT00226109|Spironolactone|spironolactone|mesh-list
65052190|NCT00226109|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65052191|NCT00226109|Hormone Antagonists|hormone antagonists|mesh-ancestor
65052192|NCT00226109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65052193|NCT00226109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052194|NCT00226109|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65052195|NCT00226109|Diuretics|diuretics|mesh-ancestor
65052196|NCT00226109|Natriuretic Agents|natriuretic agents|mesh-ancestor
65052197|NCT04573426|Acetaminophen|acetaminophen|mesh-list
65052205|NCT00235287|Candesartan cilexetil|candesartan cilexetil|mesh-list
65052206|NCT00235287|Enalapril|enalapril|mesh-list
65052207|NCT00235287|Enalaprilat|enalaprilat|mesh-list
65052208|NCT00235287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65052209|NCT00235287|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65052210|NCT00235287|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65052211|NCT00235287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052212|NCT00235287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65052213|NCT00235287|Protease Inhibitors|protease inhibitors|mesh-ancestor
65052214|NCT00235287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052215|NCT00255489|Gefitinib|gefitinib|mesh-list
65052216|NCT00255489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052217|NCT00255489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65052218|NCT00255489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052219|NCT00255489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052220|NCT04573153|Hydroxychloroquine|hydroxychloroquine|mesh-list
65052221|NCT04573153|Sorbitol|sorbitol|mesh-list
65052222|NCT04573153|Antimalarials|antimalarials|mesh-ancestor
65052223|NCT04573153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65052224|NCT04573153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65052225|NCT04573153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65052226|NCT04573153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052227|NCT04573153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052228|NCT04573153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65052229|NCT04573153|Cathartics|cathartics|mesh-ancestor
65052230|NCT04573153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65052231|NCT04573192|Lomustine|lomustine|mesh-list
65052232|NCT04573192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65052233|NCT04573192|Alkylating Agents|alkylating agents|mesh-ancestor
65052234|NCT04573192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052235|NCT04573192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052236|NCT00255528|Metoprolol|metoprolol|mesh-list
65052246|NCT00255528|Adrenergic Agents|adrenergic agents|mesh-ancestor
65052247|NCT00255528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65052248|NCT00255528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052249|NCT04572685|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65052250|NCT04572685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65052251|NCT04572685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65052252|NCT04572685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65052253|NCT04572685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052254|NCT04572685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65052255|NCT04572685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65052256|NCT04572685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65052257|NCT04572685|Serotonin Agents|serotonin agents|mesh-ancestor
65052258|NCT04572685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65052259|NCT04572685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052260|NCT04572685|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65052261|NCT04572685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65052262|NCT04572685|Dopamine Agents|dopamine agents|mesh-ancestor
65052263|NCT04572724|Valsartan|valsartan|mesh-list
65052264|NCT04572724|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65052265|NCT04572724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65052266|NCT04572724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65052267|NCT04572724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65052268|NCT04572724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052269|NCT00255567|Paromomycin|paromomycin|mesh-list
65052270|NCT00255567|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
65052271|NCT00255567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65052272|NCT00255567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65052278|NCT03450967|Durvalumab|durvalumab|mesh-list
65052290|NCT00255606|Glucocorticoids|glucocorticoids|mesh-ancestor
65052291|NCT00255606|Hormones|hormones|mesh-ancestor
65052292|NCT00255606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65052293|NCT00255606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052294|NCT00255606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65052295|NCT00226343|Valproic Acid|valproic acid|mesh-list
65052296|NCT00226343|Anticonvulsants|anticonvulsants|mesh-ancestor
65052297|NCT00226343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052298|NCT00226343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052299|NCT00226343|GABA Agents|gaba agents|mesh-ancestor
65052300|NCT00226343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65052301|NCT00226343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052302|NCT00226343|Antimanic Agents|antimanic agents|mesh-ancestor
65052303|NCT00226343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65052304|NCT00226343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65052305|NCT00226343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65052306|NCT03450499|Ketamine|ketamine|mesh-list
65052307|NCT03450499|Analgesics|analgesics|mesh-ancestor
65052309|NCT03450499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65052310|NCT03450499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052345|NCT00226421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052346|NCT00226421|Analgesics|analgesics|mesh-ancestor
65052347|NCT00226421|Sensory System Agents|sensory system agents|mesh-ancestor
65052348|NCT00226421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65052349|NCT00226421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65052350|NCT04572373|SMOFlipid|smoflipid|mesh-list
65052351|NCT04572373|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65052352|NCT04572373|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65052353|NCT04572373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65052354|NCT03450109|Goserelin|goserelin|mesh-list
65052355|NCT03450109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65052356|NCT03450109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052357|NCT00413387|Budesonide|budesonide|mesh-list
65052358|NCT00413387|Beclomethasone|beclomethasone|mesh-list
65052359|NCT00413387|Formoterol Fumarate|formoterol fumarate|mesh-list
65052360|NCT00413387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65052361|NCT00413387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65052404|NCT02277457|Crizotinib|crizotinib|mesh-list
65052405|NCT02277457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052406|NCT02277457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65052407|NCT02277457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052408|NCT02277457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052409|NCT00255879|Olanzapine|olanzapine|mesh-list
65052410|NCT00255879|Risperidone|risperidone|mesh-list
65052411|NCT00255879|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65052412|NCT00255879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65052413|NCT00255879|Serotonin Agents|serotonin agents|mesh-ancestor
65052414|NCT00255879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65052415|NCT00255879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052416|NCT00255879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052417|NCT00255879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65052418|NCT00255879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65052419|NCT00255879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65052420|NCT00255879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65052421|NCT00255879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65052422|NCT00255879|Dopamine Agents|dopamine agents|mesh-ancestor
65052423|NCT00255879|Antiemetics|antiemetics|mesh-ancestor
65052424|NCT00255879|Autonomic Agents|autonomic agents|mesh-ancestor
65052425|NCT00255879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65052426|NCT00255879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65052427|NCT00255879|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65052455|NCT00226538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65052456|NCT00226538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052457|NCT00226538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65052458|NCT00226538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65052459|NCT00226538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65052460|NCT00226538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052461|NCT00226538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052462|NCT00226538|Antifungal Agents|antifungal agents|mesh-ancestor
65052463|NCT00226538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65052464|NCT00226538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65052465|NCT00226538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65052466|NCT00226538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65052467|NCT00226538|Hormone Antagonists|hormone antagonists|mesh-ancestor
64926553|NCT02971345|Iodine|iodine|mesh-list
65494062|NCT03743636|Niacinamide|niacinamide|mesh-list
65052468|NCT00226538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65052469|NCT00226538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65052470|NCT00226538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65052471|NCT00226538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65052472|NCT00226538|Antitubercular Agents|antitubercular agents|mesh-ancestor
65052473|NCT00226538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65052474|NCT00226538|Leprostatic Agents|leprostatic agents|mesh-ancestor
65052475|NCT00226538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65052476|NCT00226538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65052477|NCT00226538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65052478|NCT00226538|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65052479|NCT00226538|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65052480|NCT00226538|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65052481|NCT00226538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65052491|NCT00255918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65052492|NCT00255918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052493|NCT00255918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052494|NCT00226694|Citalopram|citalopram|mesh-list
65052495|NCT00226694|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65052496|NCT00226694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65052497|NCT00226694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65052498|NCT00226694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052499|NCT00226694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65052500|NCT00226694|Serotonin Agents|serotonin agents|mesh-ancestor
65052501|NCT00226694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052502|NCT00226694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65052503|NCT00226694|Antidepressive Agents|antidepressive agents|mesh-ancestor
65052504|NCT00226694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65052505|NCT00255996|Linezolid|linezolid|mesh-list
65052506|NCT00255996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65052507|NCT00255996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65052508|NCT00255996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65052509|NCT00255996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052510|NCT00255996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052511|NCT00226889|Bosentan|bosentan|mesh-list
65052512|NCT00226889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65052513|NCT00226889|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65052514|NCT00226889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052515|NCT00226967|Octreotide|octreotide|mesh-list
65052519|NCT00199381|Istradefylline|istradefylline|mesh-list
65052536|NCT00227123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65052537|NCT00227123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65052538|NCT00227123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65052539|NCT00227123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65052540|NCT00227123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65052541|NCT00227123|Dopamine Agents|dopamine agents|mesh-ancestor
65052542|NCT00227123|Antidepressive Agents|antidepressive agents|mesh-ancestor
65052543|NCT00235521|Iloprost|iloprost|mesh-list
65052544|NCT00235521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65052545|NCT00235521|Vasodilator Agents|vasodilator agents|mesh-ancestor
65052546|NCT00235560|Sirolimus|sirolimus|mesh-list
65052547|NCT00235560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65052548|NCT00235560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65052549|NCT00235560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65052550|NCT00235560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052551|NCT00235560|Antifungal Agents|antifungal agents|mesh-ancestor
65052552|NCT00235560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65052553|NCT00235560|Immunologic Factors|immunologic factors|mesh-ancestor
65052554|NCT00235560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052555|NCT00227318|Candesartan cilexetil|candesartan cilexetil|mesh-list
65052556|NCT00227318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65052557|NCT00227318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65052558|NCT00227318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65052559|NCT00227318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052560|NCT00227357|Buprenorphine|buprenorphine|mesh-list
65052561|NCT00227357|Methadone|methadone|mesh-list
65052562|NCT00227357|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65052563|NCT00227357|Naloxone|naloxone|mesh-list
65052564|NCT00227357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65052565|NCT00227357|Narcotics|narcotics|mesh-ancestor
65052566|NCT00227357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65052567|NCT00227357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052568|NCT00227357|Analgesics|analgesics|mesh-ancestor
65052569|NCT00227357|Sensory System Agents|sensory system agents|mesh-ancestor
65052574|NCT00198133|Pemetrexed|pemetrexed|mesh-list
65052577|NCT00198133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052578|NCT00198133|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65052579|NCT00198133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65052580|NCT00227474|Vaccines|vaccines|mesh-list
65052581|NCT00227474|Immunologic Factors|immunologic factors|mesh-ancestor
65052582|NCT00227474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052583|NCT00227513|Bortezomib|bortezomib|mesh-list
65052584|NCT00227513|Vorinostat|vorinostat|mesh-list
65052585|NCT00227513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052586|NCT00227513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65052587|NCT00227513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052588|NCT00227513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052589|NCT00227630|Pemetrexed|pemetrexed|mesh-list
65052590|NCT00227630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052591|NCT00227630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052592|NCT00227630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052593|NCT00227630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65052594|NCT00227630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65052595|NCT00256230|Disulfiram|disulfiram|mesh-list
65052596|NCT00256230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65052601|NCT00227669|Docetaxel|docetaxel|mesh-list
65052630|NCT00256269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052631|NCT00197002|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65052632|NCT00197002|Immunologic Factors|immunologic factors|mesh-ancestor
65052633|NCT00197002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052634|NCT00227708|Docetaxel|docetaxel|mesh-list
65052635|NCT00227708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052636|NCT00227708|Tubulin Modulators|tubulin modulators|mesh-ancestor
65052637|NCT00227708|Antimitotic Agents|antimitotic agents|mesh-ancestor
65052638|NCT00227708|Mitosis Modulators|mitosis modulators|mesh-ancestor
65052639|NCT00227708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052640|NCT00235911|Budesonide|budesonide|mesh-list
65052641|NCT00235911|Formoterol Fumarate|formoterol fumarate|mesh-list
65052642|NCT00235911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65052643|NCT00235911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65052644|NCT00235911|Autonomic Agents|autonomic agents|mesh-ancestor
65052645|NCT00235911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65052646|NCT00235911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052647|NCT00235911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65052648|NCT00235911|Respiratory System Agents|respiratory system agents|mesh-ancestor
65052649|NCT00235911|Glucocorticoids|glucocorticoids|mesh-ancestor
65052650|NCT00235911|Hormones|hormones|mesh-ancestor
65052682|NCT00235950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052683|NCT00235950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65052684|NCT00235950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65052685|NCT00235950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65052686|NCT00235950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65052687|NCT00235950|Purinergic Agents|purinergic agents|mesh-ancestor
65052688|NCT00235950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65052689|NCT00235950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052690|NCT00227942|Zolpidem|zolpidem|mesh-list
65052691|NCT00227942|Estrogens|estrogens|mesh-list
65052692|NCT00227942|Hormones|hormones|mesh-ancestor
65052693|NCT00227942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65052694|NCT00227942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052695|NCT00227942|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65052696|NCT00227942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65052697|NCT00227942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65052698|NCT00227942|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65052737|NCT00228020|Cyclosporine|cyclosporine|mesh-list
65052738|NCT00228020|Mycophenolic Acid|mycophenolic acid|mesh-list
65052739|NCT00228020|Prednisone|prednisone|mesh-list
65052740|NCT00228020|Cyclosporins|cyclosporins|mesh-list
65052741|NCT00228020|Basiliximab|basiliximab|mesh-list
65052742|NCT00228020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65052743|NCT00228020|Glucocorticoids|glucocorticoids|mesh-ancestor
65052744|NCT00228020|Hormones|hormones|mesh-ancestor
65052745|NCT00228020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65052746|NCT00228020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052747|NCT00228020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65052748|NCT00228020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052749|NCT00228020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052750|NCT00228020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052751|NCT00228020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65052752|NCT00228020|Immunologic Factors|immunologic factors|mesh-ancestor
65052753|NCT00228020|Antifungal Agents|antifungal agents|mesh-ancestor
65052754|NCT00228020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65052755|NCT00228020|Dermatologic Agents|dermatologic agents|mesh-ancestor
65052756|NCT00228020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65052757|NCT00228020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65052758|NCT00228020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65052759|NCT00228020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65052760|NCT00228020|Antitubercular Agents|antitubercular agents|mesh-ancestor
65052761|NCT00228020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65052762|NCT00236067|Tiagabine|tiagabine|mesh-list
65052786|NCT00236145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65052787|NCT00236145|Narcotics|narcotics|mesh-ancestor
65052788|NCT00236145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65052789|NCT00236145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052790|NCT00236145|Analgesics|analgesics|mesh-ancestor
65052791|NCT00236145|Sensory System Agents|sensory system agents|mesh-ancestor
65052792|NCT00236145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65052793|NCT00236145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65052794|NCT00236145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65052795|NCT00236145|Anesthetics, General|anesthetics, general|mesh-ancestor
65052796|NCT00236145|Anesthetics|anesthetics|mesh-ancestor
65052797|NCT00228254|Vitamin A|vitamin a|mesh-list
65052798|NCT00228254|Vitamins|vitamins|mesh-ancestor
65052799|NCT00228254|Micronutrients|micronutrients|mesh-ancestor
65052800|NCT00228254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052801|NCT00195676|Adalimumab|adalimumab|mesh-list
65052802|NCT00195676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65052803|NCT00195676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65052804|NCT00194077|Aripiprazole|aripiprazole|mesh-list
65052805|NCT00194077|Antidepressive Agents|antidepressive agents|mesh-ancestor
65052806|NCT00194077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65052807|NCT00194077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65052808|NCT00194077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65052809|NCT00194077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65052810|NCT00194077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052811|NCT00194077|Dopamine Agonists|dopamine agonists|mesh-ancestor
65052812|NCT00194077|Dopamine Agents|dopamine agents|mesh-ancestor
65052813|NCT00194077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65052814|NCT00194077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052816|NCT00194077|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65052833|NCT00228410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65052834|NCT00228410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052835|NCT00228410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052836|NCT00193180|Docetaxel|docetaxel|mesh-list
65052837|NCT00193180|Imatinib Mesylate|imatinib mesylate|mesh-list
65052838|NCT00193180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052839|NCT00193180|Tubulin Modulators|tubulin modulators|mesh-ancestor
65052840|NCT00193180|Antimitotic Agents|antimitotic agents|mesh-ancestor
65052841|NCT00193180|Mitosis Modulators|mitosis modulators|mesh-ancestor
65052842|NCT00193180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052843|NCT00193180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65052844|NCT00193180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052845|NCT00193063|Gemcitabine|gemcitabine|mesh-list
65052846|NCT00193063|Trastuzumab|trastuzumab|mesh-list
65052847|NCT00193063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65052848|NCT00193063|Antimetabolites|antimetabolites|mesh-ancestor
65052849|NCT00193063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052850|NCT00193063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052851|NCT00193063|Antiviral Agents|antiviral agents|mesh-ancestor
65052852|NCT00193063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65052888|NCT00228605|Narcotics|narcotics|mesh-ancestor
65052889|NCT00228605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65052890|NCT00228605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052891|NCT00228605|Analgesics|analgesics|mesh-ancestor
65052892|NCT00228605|Sensory System Agents|sensory system agents|mesh-ancestor
65052893|NCT00228605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65052894|NCT00228605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65052895|NCT00228605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65052896|NCT00228605|Anesthetics, General|anesthetics, general|mesh-ancestor
65052897|NCT00228605|Anesthetics|anesthetics|mesh-ancestor
65052898|NCT00191815|Gemcitabine|gemcitabine|mesh-list
65052899|NCT00191815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65052900|NCT00191815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65052901|NCT00191815|Antimetabolites|antimetabolites|mesh-ancestor
65052902|NCT00191815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052903|NCT00191815|Antiviral Agents|antiviral agents|mesh-ancestor
65052904|NCT00191815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65052905|NCT00191815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052906|NCT00191815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65052907|NCT00191815|Immunologic Factors|immunologic factors|mesh-ancestor
65052908|NCT00191815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052909|NCT00191386|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65052910|NCT00191386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65052911|NCT00191386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65052912|NCT00191386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65052913|NCT00191386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052914|NCT00191386|Adrenergic Agents|adrenergic agents|mesh-ancestor
65052934|NCT00191269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65052935|NCT00191269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65052936|NCT00191269|Immunologic Factors|immunologic factors|mesh-ancestor
65052937|NCT00191269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052938|NCT00228878|Insulin|insulin|mesh-list
65052939|NCT00228878|Insulin Aspart|insulin aspart|mesh-list
65052940|NCT00228878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65052941|NCT00228878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65052942|NCT00228995|Epoetin Alfa|epoetin alfa|mesh-list
65052943|NCT00228995|Hematinics|hematinics|mesh-ancestor
65052944|NCT00413946|Epoetin Alfa|epoetin alfa|mesh-list
65052945|NCT00413946|Hematinics|hematinics|mesh-ancestor
65052946|NCT00229112|Tazobactam|tazobactam|mesh-list
65052947|NCT00229112|Piperacillin|piperacillin|mesh-list
65052948|NCT00229112|Ertapenem|ertapenem|mesh-list
65052949|NCT00229112|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65052950|NCT00229112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65052951|NCT00229112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65052952|NCT00229112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65052993|NCT00236223|Dexamethasone|dexamethasone|mesh-list
65052994|NCT00236223|Ketamine|ketamine|mesh-list
65052995|NCT00236223|Gabapentin|gabapentin|mesh-list
65052996|NCT00236223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65052997|NCT00236223|Antiemetics|antiemetics|mesh-ancestor
65052998|NCT00236223|Autonomic Agents|autonomic agents|mesh-ancestor
65052999|NCT00236223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65053000|NCT00236223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053001|NCT00236223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65053002|NCT00236223|Glucocorticoids|glucocorticoids|mesh-ancestor
65053003|NCT00236223|Hormones|hormones|mesh-ancestor
65053004|NCT00236223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65053005|NCT00236223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65053006|NCT00236223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053007|NCT00236223|Analgesics|analgesics|mesh-ancestor
65053008|NCT00236223|Sensory System Agents|sensory system agents|mesh-ancestor
65053009|NCT00236223|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65053010|NCT00236223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65053011|NCT00236223|Anesthetics, General|anesthetics, general|mesh-ancestor
65053012|NCT00236223|Anesthetics|anesthetics|mesh-ancestor
65053013|NCT00236223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65053014|NCT00236223|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65053015|NCT00236223|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65053016|NCT00236223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65053017|NCT00236223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053018|NCT00236223|Anticonvulsants|anticonvulsants|mesh-ancestor
65053019|NCT00236223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65053020|NCT00236223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65053021|NCT00236223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65053022|NCT00236223|Antimanic Agents|antimanic agents|mesh-ancestor
65053023|NCT00229424|Famotidine|famotidine|mesh-list
65053024|NCT00229424|Lafutidine|lafutidine|mesh-list
65053025|NCT00229424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65053026|NCT00229424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65053033|NCT00256932|Alvimopan|alvimopan|mesh-list
65053035|NCT00191152|Gemcitabine|gemcitabine|mesh-list
65053036|NCT00191152|Capecitabine|capecitabine|mesh-list
65053037|NCT00191152|Docetaxel|docetaxel|mesh-list
65053038|NCT00191152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65053039|NCT00191152|Antimetabolites|antimetabolites|mesh-ancestor
65053040|NCT00191152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053041|NCT00191152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053042|NCT00191152|Antiviral Agents|antiviral agents|mesh-ancestor
65053043|NCT00191152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65053044|NCT00191152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053045|NCT00191152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65053046|NCT00191152|Immunologic Factors|immunologic factors|mesh-ancestor
65053047|NCT00191152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053048|NCT00191152|Tubulin Modulators|tubulin modulators|mesh-ancestor
65053049|NCT00191152|Antimitotic Agents|antimitotic agents|mesh-ancestor
65053050|NCT00191152|Mitosis Modulators|mitosis modulators|mesh-ancestor
65053051|NCT00257049|Levofloxacin|levofloxacin|mesh-list
65053052|NCT00257049|Ofloxacin|ofloxacin|mesh-list
65053053|NCT00257049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65053054|NCT00257049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65053055|NCT00257049|Renal Agents|renal agents|mesh-ancestor
64905072|NCT00006942|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65053090|NCT00229697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65053091|NCT00229697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053092|NCT00229697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65053093|NCT00229697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65053094|NCT00229697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65053095|NCT00229697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65053096|NCT00229697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053097|NCT00229697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053098|NCT00236379|Olanzapine|olanzapine|mesh-list
65053099|NCT00236379|Risperidone|risperidone|mesh-list
65053100|NCT00236379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65053101|NCT00236379|Serotonin Agents|serotonin agents|mesh-ancestor
65053102|NCT00236379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65053103|NCT00236379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053104|NCT00236379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053105|NCT00236379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65053106|NCT00236379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65053107|NCT00236379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65053108|NCT00236379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65053109|NCT00236379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65053110|NCT00236379|Dopamine Agents|dopamine agents|mesh-ancestor
65053111|NCT00236379|Antiemetics|antiemetics|mesh-ancestor
65053112|NCT00236379|Autonomic Agents|autonomic agents|mesh-ancestor
65053113|NCT00236379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65053114|NCT00236379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65053115|NCT00236379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65053116|NCT00236379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65053117|NCT00236379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65053118|NCT00229775|Chloroquine|chloroquine|mesh-list
65053119|NCT00229775|Artemether|artemether|mesh-list
65053120|NCT00229775|Pyrimethamine|pyrimethamine|mesh-list
65053121|NCT00229775|Sulfadoxine|sulfadoxine|mesh-list
65053122|NCT00229775|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65053123|NCT00229775|Amebicides|amebicides|mesh-ancestor
65053124|NCT00229775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65053125|NCT00229775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65053127|NCT00229775|Antimalarials|antimalarials|mesh-ancestor
65053128|NCT00229775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65053129|NCT00229775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65053130|NCT00229775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053131|NCT00229775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053132|NCT00229775|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65053133|NCT00229775|Renal Agents|renal agents|mesh-ancestor
65053134|NCT00257127|Vaccines|vaccines|mesh-list
65053135|NCT00257127|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65053136|NCT00257127|Immunologic Factors|immunologic factors|mesh-ancestor
65053137|NCT00257127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053138|NCT00190684|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65053139|NCT00190684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65053140|NCT00190684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65053141|NCT00190684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65053142|NCT00190684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053143|NCT00190684|Adrenergic Agents|adrenergic agents|mesh-ancestor
65494064|NCT03743636|Nicotinic Acids|nicotinic acids|mesh-list
65053144|NCT00190684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65053145|NCT00190684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053146|NCT00236418|Topiramate|topiramate|mesh-list
65053147|NCT00236418|Anticonvulsants|anticonvulsants|mesh-ancestor
65053148|NCT00236418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65053149|NCT00236418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053150|NCT00236457|Risperidone|risperidone|mesh-list
65053151|NCT00236457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65053152|NCT00236457|Serotonin Agents|serotonin agents|mesh-ancestor
65053153|NCT00236457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65053173|NCT00236535|Tramadol|tramadol|mesh-list
65053174|NCT00236535|Hydrocodone|hydrocodone|mesh-list
65053175|NCT00236535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65053176|NCT00236535|Analgesics|analgesics|mesh-ancestor
65053177|NCT00236535|Sensory System Agents|sensory system agents|mesh-ancestor
65053178|NCT00236535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65053179|NCT00236535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053180|NCT00236535|Antipyretics|antipyretics|mesh-ancestor
65053181|NCT00236535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65053182|NCT00236535|Narcotics|narcotics|mesh-ancestor
65053183|NCT00236535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65053184|NCT00236535|Antitussive Agents|antitussive agents|mesh-ancestor
65053185|NCT00236535|Respiratory System Agents|respiratory system agents|mesh-ancestor
65053186|NCT00193219|Leucovorin|leucovorin|mesh-list
65053187|NCT00193219|Bevacizumab|bevacizumab|mesh-list
65053188|NCT00193219|Cetuximab|cetuximab|mesh-list
65053189|NCT00193219|Fluorouracil|fluorouracil|mesh-list
65053190|NCT00193219|Oxaliplatin|oxaliplatin|mesh-list
65053191|NCT00193219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65053192|NCT00193219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053193|NCT00193219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65053194|NCT00193219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65053195|NCT00193219|Growth Substances|growth substances|mesh-ancestor
65053196|NCT00193219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053197|NCT00193219|Growth Inhibitors|growth inhibitors|mesh-ancestor
65053198|NCT00193219|Antimetabolites|antimetabolites|mesh-ancestor
65053199|NCT00193219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053200|NCT00193219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65053201|NCT00193219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65053202|NCT00193219|Immunologic Factors|immunologic factors|mesh-ancestor
65053203|NCT00193219|Antidotes|antidotes|mesh-ancestor
65053204|NCT00193219|Protective Agents|protective agents|mesh-ancestor
65053205|NCT00193219|Vitamin B Complex|vitamin b complex|mesh-ancestor
65053218|NCT00196339|Androgen Antagonists|androgen antagonists|mesh-ancestor
65053219|NCT00196339|Hormone Antagonists|hormone antagonists|mesh-ancestor
65494065|NCT03743636|Resveratrol|resveratrol|mesh-list
65053220|NCT00196339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65053221|NCT00196339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053222|NCT00196339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053223|NCT00196339|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65053224|NCT00196339|Contraceptive Agents|contraceptive agents|mesh-ancestor
65053225|NCT00196339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65053226|NCT00257361|Cycloserine|cycloserine|mesh-list
65053227|NCT00257361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65053228|NCT00257361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65053229|NCT00257361|Renal Agents|renal agents|mesh-ancestor
65053230|NCT00257361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65053231|NCT00257361|Antitubercular Agents|antitubercular agents|mesh-ancestor
65053232|NCT00257361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65053233|NCT00257361|Antimetabolites|antimetabolites|mesh-ancestor
65053234|NCT00257361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053235|NCT00199355|Istradefylline|istradefylline|mesh-list
65053236|NCT00199355|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
65053237|NCT00199355|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65053238|NCT00199355|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65053239|NCT00199355|Purinergic Agents|purinergic agents|mesh-ancestor
65053240|NCT00199355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65053241|NCT00199355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053242|NCT00199355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053264|NCT00236574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65053265|NCT00236574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053266|NCT00236574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053267|NCT00236574|Cholinergic Agents|cholinergic agents|mesh-ancestor
65053268|NCT00236574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65053269|NCT00236574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053270|NCT00236574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65053271|NCT00236574|Autonomic Agents|autonomic agents|mesh-ancestor
65053272|NCT00236574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65053273|NCT00236574|Nootropic Agents|nootropic agents|mesh-ancestor
65053274|NCT00199433|Istradefylline|istradefylline|mesh-list
65053275|NCT00199433|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
65053276|NCT00199433|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65053277|NCT00199433|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65053278|NCT00199433|Purinergic Agents|purinergic agents|mesh-ancestor
65053279|NCT00199433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65053280|NCT00199433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053281|NCT00199433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053282|NCT00199472|Diuretics|diuretics|mesh-list
65053283|NCT00199472|Natriuretic Agents|natriuretic agents|mesh-ancestor
65053284|NCT00199472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053286|NCT00199511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65053287|NCT00199511|Diuretics|diuretics|mesh-ancestor
65053288|NCT00199511|Natriuretic Agents|natriuretic agents|mesh-ancestor
65053289|NCT00199511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053290|NCT00236613|Topiramate|topiramate|mesh-list
65053291|NCT00236613|Anticonvulsants|anticonvulsants|mesh-ancestor
65053292|NCT00236613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65053293|NCT00236613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053308|NCT00257595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65053309|NCT00257595|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65053310|NCT00257595|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65053311|NCT00257595|Histamine Antagonists|histamine antagonists|mesh-ancestor
65053312|NCT00257595|Histamine Agents|histamine agents|mesh-ancestor
65053313|NCT00257595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65053314|NCT00257595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053315|NCT00257595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053316|NCT00199667|Mycophenolic Acid|mycophenolic acid|mesh-list
65053317|NCT00199667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65053318|NCT00199667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053319|NCT00199667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65053320|NCT00199667|Antitubercular Agents|antitubercular agents|mesh-ancestor
65053321|NCT00199667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65053322|NCT00199667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65053323|NCT00199667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053324|NCT00199667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053325|NCT00236691|Topiramate|topiramate|mesh-list
65053326|NCT00236691|Anticonvulsants|anticonvulsants|mesh-ancestor
65053327|NCT00236691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65053328|NCT00236691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053329|NCT00236730|Topiramate|topiramate|mesh-list
65053330|NCT00236730|Anticonvulsants|anticonvulsants|mesh-ancestor
65053331|NCT00236730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65053332|NCT00236730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053333|NCT00199745|Atorvastatin|atorvastatin|mesh-list
65053334|NCT00199745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65053335|NCT00199745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65053336|NCT00199745|Antimetabolites|antimetabolites|mesh-ancestor
65053337|NCT00199745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053338|NCT00199745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65053339|NCT00199745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65053350|NCT00199784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65053351|NCT00199784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053352|NCT00199784|Sympathomimetics|sympathomimetics|mesh-ancestor
65053353|NCT00199784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65053354|NCT00199784|Nasal Decongestants|nasal decongestants|mesh-ancestor
65053355|NCT00199784|Respiratory System Agents|respiratory system agents|mesh-ancestor
65053356|NCT00199784|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65053357|NCT00199784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65053358|NCT00199784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65053359|NCT00199784|Adrenergic Agents|adrenergic agents|mesh-ancestor
65053360|NCT00199784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65053361|NCT00199784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053362|NCT00199784|Protective Agents|protective agents|mesh-ancestor
65053363|NCT00236769|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65053364|NCT00236769|Norelgestromin|norelgestromin|mesh-list
65053365|NCT00236769|Estradiol|estradiol|mesh-list
65053366|NCT00236769|Estrogens|estrogens|mesh-ancestor
65053367|NCT00236769|Hormones|hormones|mesh-ancestor
65053368|NCT00236769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65053369|NCT00236769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053370|NCT00236769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65053371|NCT00236769|Contraceptive Agents|contraceptive agents|mesh-ancestor
65053372|NCT00236769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65053373|NCT00236769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65053374|NCT00236769|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65053376|NCT00415311|Lectins|lectins|mesh-list
65053377|NCT00415311|Agglutinins|agglutinins|mesh-ancestor
65053378|NCT00415311|Immunologic Factors|immunologic factors|mesh-ancestor
65053379|NCT00415311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053380|NCT00415311|Coagulants|coagulants|mesh-ancestor
65053381|NCT00199940|Ziprasidone|ziprasidone|mesh-list
65053382|NCT00199940|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65053383|NCT00199940|Serotonin Agents|serotonin agents|mesh-ancestor
65053392|NCT00199940|Dopamine Agents|dopamine agents|mesh-ancestor
65053393|NCT00236808|Levofloxacin|levofloxacin|mesh-list
65053394|NCT00236808|Ofloxacin|ofloxacin|mesh-list
65053395|NCT00236808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65053396|NCT00236808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65053397|NCT00236808|Renal Agents|renal agents|mesh-ancestor
65053398|NCT00236808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65053399|NCT00236808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65053400|NCT00236808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65053401|NCT00236808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053402|NCT00236808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053403|NCT00236808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053404|NCT00236808|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65053405|NCT00236808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65053406|NCT00199979|Nevirapine|nevirapine|mesh-list
65053407|NCT00199979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65053408|NCT00199979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65053409|NCT00199979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053410|NCT00199979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053411|NCT00199979|Antiviral Agents|antiviral agents|mesh-ancestor
65053412|NCT00199979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65053413|NCT00199979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65053414|NCT00199979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65053415|NCT00199979|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65053416|NCT00199979|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65053417|NCT00257634|Dexamethasone|dexamethasone|mesh-list
65053418|NCT00257634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65053419|NCT00257634|Antiemetics|antiemetics|mesh-ancestor
65053420|NCT00257634|Autonomic Agents|autonomic agents|mesh-ancestor
65053421|NCT00257634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65053422|NCT00257634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053423|NCT00257634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65053434|NCT00410306|Testosterone|testosterone|mesh-list
65053435|NCT00410306|Testosterone undecanoate|testosterone undecanoate|mesh-list
65053436|NCT00410306|Testosterone enanthate|testosterone enanthate|mesh-list
65053437|NCT00410306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65053438|NCT00410306|Androgens|androgens|mesh-ancestor
65053440|NCT00410306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65053441|NCT00410306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053442|NCT00410306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65053443|NCT00410306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053444|NCT00410306|Anabolic Agents|anabolic agents|mesh-ancestor
65053445|NCT00257712|Hormones|hormones|mesh-list
65053446|NCT00257712|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
65053447|NCT00257712|Tesamorelin|tesamorelin|mesh-list
65053448|NCT00257712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65053449|NCT00257712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053450|NCT00257712|Growth Substances|growth substances|mesh-ancestor
65053451|NCT00179647|Dexamethasone|dexamethasone|mesh-list
65053452|NCT00179647|Lenalidomide|lenalidomide|mesh-list
65053453|NCT00179647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65053454|NCT00179647|Antiemetics|antiemetics|mesh-ancestor
65053455|NCT00179647|Autonomic Agents|autonomic agents|mesh-ancestor
65053456|NCT00179647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65053457|NCT00179647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053458|NCT00179647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65053459|NCT00179647|Glucocorticoids|glucocorticoids|mesh-ancestor
65053460|NCT00179647|Hormones|hormones|mesh-ancestor
65053461|NCT00179647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65053462|NCT00179647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64905479|NCT00006211|Nelfinavir|nelfinavir|mesh-list
65053482|NCT00179413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053483|NCT00179413|Antiviral Agents|antiviral agents|mesh-ancestor
65053484|NCT00179413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65053485|NCT00179413|Immunologic Factors|immunologic factors|mesh-ancestor
65053486|NCT00179413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053487|NCT00179413|Gout Suppressants|gout suppressants|mesh-ancestor
65053488|NCT00179413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65053489|NCT00179413|Tubulin Modulators|tubulin modulators|mesh-ancestor
65053490|NCT00179413|Antimitotic Agents|antimitotic agents|mesh-ancestor
65053491|NCT00179413|Mitosis Modulators|mitosis modulators|mesh-ancestor
65053492|NCT00179413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053493|NCT00236886|Topiramate|topiramate|mesh-list
65053494|NCT00236886|Anticonvulsants|anticonvulsants|mesh-ancestor
65053495|NCT00236886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65053496|NCT00236886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053497|NCT00257790|Tobramycin|tobramycin|mesh-list
65053498|NCT00257790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65053499|NCT00257790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65053500|NCT00200174|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65053501|NCT00200174|Exemestane|exemestane|mesh-list
65053502|NCT00200174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053503|NCT00200174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65053504|NCT00200174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65053505|NCT00200174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053506|NCT00200174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053507|NCT00200174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65053508|NCT00200174|Hormone Antagonists|hormone antagonists|mesh-ancestor
65053509|NCT00200174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65053510|NCT00200174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053511|NCT00200174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65053519|NCT00200252|Oxytocin|oxytocin|mesh-list
65053526|NCT00177307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65053527|NCT00177307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053528|NCT00177307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65053529|NCT00177307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65053530|NCT00177307|Growth Substances|growth substances|mesh-ancestor
65053531|NCT00177307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053532|NCT00177307|Growth Inhibitors|growth inhibitors|mesh-ancestor
65053533|NCT00177307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65053534|NCT00177307|Antimetabolites|antimetabolites|mesh-ancestor
65053535|NCT00177307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053536|NCT00257829|Methazolamide|methazolamide|mesh-list
65053537|NCT00257829|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65053538|NCT00257829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053539|NCT00257829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053540|NCT00257829|Diuretics|diuretics|mesh-ancestor
65053541|NCT00257829|Natriuretic Agents|natriuretic agents|mesh-ancestor
65053542|NCT00257829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053543|NCT00176644|Estradiol|estradiol|mesh-list
65053544|NCT00176644|Estrogens|estrogens|mesh-ancestor
65053545|NCT00176644|Hormones|hormones|mesh-ancestor
65053546|NCT00176644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65053547|NCT00176644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053548|NCT02484664|Celecoxib|celecoxib|mesh-list
65053549|NCT02484664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65053550|NCT02484664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65053551|NCT02484664|Analgesics|analgesics|mesh-ancestor
65053552|NCT02484664|Sensory System Agents|sensory system agents|mesh-ancestor
65053553|NCT02484664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65053554|NCT02484664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053568|NCT00257868|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65053569|NCT00257868|Protective Agents|protective agents|mesh-ancestor
65053570|NCT00176605|Cyclophosphamide|cyclophosphamide|mesh-list
65053571|NCT00176605|Etoposide|etoposide|mesh-list
65053572|NCT00176605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65053573|NCT00176605|Immunologic Factors|immunologic factors|mesh-ancestor
65053574|NCT00176605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053575|NCT00176605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65053576|NCT00176605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65053577|NCT00176605|Alkylating Agents|alkylating agents|mesh-ancestor
65053578|NCT00176605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053579|NCT00176605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053580|NCT00176605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65053581|NCT00176605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65053582|NCT00176605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65053583|NCT00176605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64538846|NCT04105946|Narcotics|narcotics|mesh-ancestor
65053584|NCT00176605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053585|NCT00176488|Vinorelbine|vinorelbine|mesh-list
65053586|NCT00176488|Epirubicin|epirubicin|mesh-list
65053587|NCT00176488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65053588|NCT00176488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053589|NCT00176488|Tubulin Modulators|tubulin modulators|mesh-ancestor
65053590|NCT00176488|Antimitotic Agents|antimitotic agents|mesh-ancestor
65053591|NCT00176488|Mitosis Modulators|mitosis modulators|mesh-ancestor
65053592|NCT00176488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053593|NCT00176488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65053594|NCT00176488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65053613|NCT00200447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053614|NCT00200447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053615|NCT00200447|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65053616|NCT00200447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053617|NCT00200447|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65053618|NCT00237120|Imatinib Mesylate|imatinib mesylate|mesh-list
65053619|NCT00237120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053620|NCT00237120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65053621|NCT00237120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053622|NCT00237120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053623|NCT00175825|Brivaracetam|brivaracetam|mesh-list
65053624|NCT00175825|Anticonvulsants|anticonvulsants|mesh-ancestor
65053625|NCT04710329|Ascorbic Acid|ascorbic acid|mesh-list
65053626|NCT04710329|Antioxidants|antioxidants|mesh-ancestor
65053627|NCT04710329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053628|NCT04710329|Protective Agents|protective agents|mesh-ancestor
65053629|NCT04710329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053630|NCT04710329|Vitamins|vitamins|mesh-ancestor
65053631|NCT04710329|Micronutrients|micronutrients|mesh-ancestor
65053632|NCT00200525|Apomorphine|apomorphine|mesh-list
65053633|NCT00200525|Emetics|emetics|mesh-ancestor
65053634|NCT00200525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053635|NCT00200525|Autonomic Agents|autonomic agents|mesh-ancestor
65053636|NCT00200525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65053637|NCT00200525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65053638|NCT00200525|Dopamine Agonists|dopamine agonists|mesh-ancestor
65053639|NCT00200525|Dopamine Agents|dopamine agents|mesh-ancestor
65053640|NCT00200525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65053658|NCT00200564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053659|NCT00174265|Olanzapine|olanzapine|mesh-list
65053661|NCT00174265|Antiemetics|antiemetics|mesh-ancestor
65053662|NCT00174265|Autonomic Agents|autonomic agents|mesh-ancestor
65053663|NCT00174265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65053664|NCT00174265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053665|NCT00174265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65053666|NCT00174265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65053667|NCT00174265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65053668|NCT00174265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65053669|NCT00174265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65053670|NCT00174265|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65053671|NCT00174265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65053672|NCT00174265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65053673|NCT00174265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053674|NCT00174265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65053675|NCT00174265|Serotonin Agents|serotonin agents|mesh-ancestor
65053676|NCT00200603|Calcium|calcium|mesh-list
65053677|NCT00200603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65053678|NCT00200603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053679|NCT00200681|Bortezomib|bortezomib|mesh-list
65053680|NCT00200681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053681|NCT00258063|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65053682|NCT00258063|Norelgestromin|norelgestromin|mesh-list
65053683|NCT00258063|Contraceptive Agents|contraceptive agents|mesh-list
65053684|NCT00258063|Estradiol|estradiol|mesh-list
65053685|NCT00258063|Estrogens|estrogens|mesh-ancestor
65053686|NCT00258063|Hormones|hormones|mesh-ancestor
65053687|NCT00258063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65053688|NCT00258063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053702|NCT00258102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053703|NCT00258102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053704|NCT00258102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053705|NCT00258102|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65053706|NCT00258102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65053707|NCT00265278|Modafinil|modafinil|mesh-list
65053708|NCT00265278|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65053709|NCT00265278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053710|NCT00265278|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65053711|NCT00265278|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65053712|NCT00265278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65053713|NCT00265278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053714|NCT00258258|Zoledronic Acid|zoledronic acid|mesh-list
65053715|NCT00258258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65053716|NCT00258258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053717|NCT00172042|Zoledronic Acid|zoledronic acid|mesh-list
65053718|NCT00172042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65053719|NCT00172042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053720|NCT00258297|Gefitinib|gefitinib|mesh-list
65053721|NCT00258297|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65053722|NCT00258297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053723|NCT00258297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65053724|NCT00258297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053725|NCT00258336|Rituximab|rituximab|mesh-list
65053726|NCT00258336|Immunoglobulins|immunoglobulins|mesh-list
65053727|NCT00258336|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65053728|NCT00258336|Antibodies|antibodies|mesh-list
65053729|NCT00258336|Sargramostim|sargramostim|mesh-list
65053730|NCT00258336|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
65053731|NCT00258336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65053732|NCT00258336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053743|NCT00171925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65053744|NCT00258375|Docetaxel|docetaxel|mesh-list
65053745|NCT00258375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053746|NCT00258375|Tubulin Modulators|tubulin modulators|mesh-ancestor
65053747|NCT00258375|Antimitotic Agents|antimitotic agents|mesh-ancestor
65053748|NCT00258375|Mitosis Modulators|mitosis modulators|mesh-ancestor
65053749|NCT00258375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053750|NCT00201305|Leucovorin|leucovorin|mesh-list
65053752|NCT00201305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65053753|NCT00201305|Antimetabolites|antimetabolites|mesh-ancestor
65053754|NCT00201305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053755|NCT00201305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053756|NCT00201305|Antiviral Agents|antiviral agents|mesh-ancestor
65053757|NCT00201305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65053758|NCT00201305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053759|NCT00201305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65053760|NCT00201305|Immunologic Factors|immunologic factors|mesh-ancestor
65053761|NCT00201305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053762|NCT00201305|Antidotes|antidotes|mesh-ancestor
65053763|NCT00201305|Protective Agents|protective agents|mesh-ancestor
65053764|NCT00201305|Vitamin B Complex|vitamin b complex|mesh-ancestor
65053765|NCT00201305|Vitamins|vitamins|mesh-ancestor
65053766|NCT00201305|Micronutrients|micronutrients|mesh-ancestor
65053767|NCT00265551|Olanzapine|olanzapine|mesh-list
65053768|NCT00265551|Antiemetics|antiemetics|mesh-ancestor
65053769|NCT00265551|Autonomic Agents|autonomic agents|mesh-ancestor
65053770|NCT00265551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65053771|NCT00265551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053772|NCT00265551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65053792|NCT00201422|Amoxicillin|amoxicillin|mesh-list
65053793|NCT00201422|Clarithromycin|clarithromycin|mesh-list
65053794|NCT00201422|Omeprazole|omeprazole|mesh-list
65053795|NCT00201422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65053796|NCT00201422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65053797|NCT00201422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65053798|NCT00201422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65053799|NCT00201422|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65053800|NCT00201422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053801|NCT00201422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053802|NCT00201422|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65053803|NCT00201422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65053804|NCT00201422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65053805|NCT00258609|Botulinum Toxins|botulinum toxins|mesh-list
65053806|NCT00258609|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65053807|NCT00258609|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65053808|NCT00258609|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65053809|NCT00258609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65053810|NCT00258609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053811|NCT00258609|Cholinergic Agents|cholinergic agents|mesh-ancestor
65053812|NCT00258609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65053813|NCT00258609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053814|NCT00258609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65053815|NCT00258609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65053816|NCT00265746|Metformin|metformin|mesh-list
65053817|NCT00265746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65053818|NCT00265746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053819|NCT00201539|Morphine|morphine|mesh-list
65053820|NCT00201539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65053821|NCT00201539|Narcotics|narcotics|mesh-ancestor
65053822|NCT00201539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65053823|NCT00201539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053824|NCT00201539|Analgesics|analgesics|mesh-ancestor
65053825|NCT00201539|Sensory System Agents|sensory system agents|mesh-ancestor
65053827|NCT00265824|Bevacizumab|bevacizumab|mesh-list
65053831|NCT00265824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65053832|NCT00265824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65053833|NCT00265824|Growth Substances|growth substances|mesh-ancestor
65053834|NCT00265824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053835|NCT00265824|Growth Inhibitors|growth inhibitors|mesh-ancestor
65053836|NCT00265824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65053837|NCT00265824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053838|NCT00265824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053839|NCT00201695|Dexamethasone|dexamethasone|mesh-list
65053840|NCT00201695|Doxorubicin|doxorubicin|mesh-list
65053841|NCT00201695|Vincristine|vincristine|mesh-list
65053842|NCT00201695|Arsenic Trioxide|arsenic trioxide|mesh-list
65053843|NCT00201695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65053844|NCT00201695|Antiemetics|antiemetics|mesh-ancestor
65053845|NCT00201695|Autonomic Agents|autonomic agents|mesh-ancestor
65053846|NCT00201695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65053847|NCT00201695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053848|NCT00201695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65053849|NCT00201695|Glucocorticoids|glucocorticoids|mesh-ancestor
65053850|NCT00201695|Hormones|hormones|mesh-ancestor
65053851|NCT00201695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65053852|NCT00201695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65053853|NCT00201695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053854|NCT00201695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65053855|NCT00201695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65053856|NCT00201695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65053857|NCT00201695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053858|NCT00201695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053859|NCT00201695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65053860|NCT00201695|Tubulin Modulators|tubulin modulators|mesh-ancestor
65053873|NCT00410345|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65053874|NCT00410345|Hormone Antagonists|hormone antagonists|mesh-ancestor
65053875|NCT00410345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65053876|NCT00410345|Luteolytic Agents|luteolytic agents|mesh-ancestor
65053877|NCT00410345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65053878|NCT00410345|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65053879|NCT00265863|Mitomycins|mitomycins|mesh-list
65053880|NCT00265863|Mitomycin|mitomycin|mesh-list
65053881|NCT00265863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65053882|NCT00265863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053883|NCT00265863|Alkylating Agents|alkylating agents|mesh-ancestor
65053884|NCT00265863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053885|NCT00265863|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65053886|NCT00265863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053887|NCT00410462|Doxorubicin|doxorubicin|mesh-list
65053888|NCT00410462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65053889|NCT00410462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65053890|NCT00410462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053891|NCT00410462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65053892|NCT00410462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65053893|NCT00410462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053894|NCT00410462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053895|NCT00258765|Zoledronic Acid|zoledronic acid|mesh-list
65053896|NCT00258765|Docetaxel|docetaxel|mesh-list
65053897|NCT00258765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053904|NCT00410540|Morphine|morphine|mesh-list
65053922|NCT00201812|Autonomic Agents|autonomic agents|mesh-ancestor
65053923|NCT00201812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65053924|NCT00201812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053925|NCT00201812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65053926|NCT00201812|Hormones|hormones|mesh-ancestor
65053927|NCT00201812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65053928|NCT00201812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65053929|NCT00201812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053930|NCT00201812|Tubulin Modulators|tubulin modulators|mesh-ancestor
65053931|NCT00201812|Antimitotic Agents|antimitotic agents|mesh-ancestor
65053932|NCT00201812|Mitosis Modulators|mitosis modulators|mesh-ancestor
65053933|NCT00201812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053934|NCT00201812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65053935|NCT00201812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65053936|NCT00201812|Analgesics|analgesics|mesh-ancestor
65053937|NCT00201812|Sensory System Agents|sensory system agents|mesh-ancestor
65053938|NCT00201812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65053939|NCT00201812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65053940|NCT00201812|Immunologic Factors|immunologic factors|mesh-ancestor
65053941|NCT00258843|Vaccines|vaccines|mesh-list
65053942|NCT00258843|Immunologic Factors|immunologic factors|mesh-ancestor
65053943|NCT00258843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053944|NCT04709094|Bupropion|bupropion|mesh-list
65053945|NCT04709094|Warfarin|warfarin|mesh-list
65053946|NCT04709094|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65053972|NCT04709094|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65053973|NCT04709094|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65053974|NCT04709094|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65053975|NCT04709094|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65053976|NCT00171340|Zoledronic Acid|zoledronic acid|mesh-list
65053977|NCT00171340|Letrozole|letrozole|mesh-list
65053978|NCT00171340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65053979|NCT00171340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65053980|NCT00171340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65053981|NCT00171340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65053982|NCT00171340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65053983|NCT00171340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65053984|NCT00171340|Hormone Antagonists|hormone antagonists|mesh-ancestor
65053985|NCT00171340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65053986|NCT00171340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65053987|NCT00171340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65053988|NCT00202007|Risperidone|risperidone|mesh-list
65053989|NCT00202007|Aripiprazole|aripiprazole|mesh-list
65053990|NCT00202007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65053991|NCT00202007|Serotonin Agents|serotonin agents|mesh-ancestor
65054026|NCT00266058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65054027|NCT00266058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65054028|NCT00266058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65054029|NCT00266058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65054030|NCT00266058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65054031|NCT00266058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65054032|NCT00266058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65054033|NCT00266058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65054034|NCT00266058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65054035|NCT00266058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65054037|NCT00266058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65054038|NCT00266058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65054039|NCT00171223|Imatinib Mesylate|imatinib mesylate|mesh-list
65054040|NCT00171223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054041|NCT00171223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65054042|NCT00171223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054043|NCT00171223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054044|NCT00202124|Tryptophan|tryptophan|mesh-list
65054045|NCT00202124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65054046|NCT00202124|Antidepressive Agents|antidepressive agents|mesh-ancestor
65054047|NCT00202124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65054048|NCT00266097|Gemcitabine|gemcitabine|mesh-list
65054049|NCT00266097|Oxaliplatin|oxaliplatin|mesh-list
65054050|NCT00266097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65054075|NCT00202241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65054076|NCT00202241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054077|NCT00266136|Cytarabine|cytarabine|mesh-list
65054078|NCT00266136|Cyclophosphamide|cyclophosphamide|mesh-list
65054079|NCT00266136|Daunorubicin|daunorubicin|mesh-list
65054080|NCT00266136|Thioguanine|thioguanine|mesh-list
65054081|NCT00266136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65054082|NCT00266136|Immunologic Factors|immunologic factors|mesh-ancestor
65054083|NCT00266136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054084|NCT00266136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65054085|NCT00266136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65054086|NCT00266136|Alkylating Agents|alkylating agents|mesh-ancestor
65054087|NCT00266136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054088|NCT00266136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054089|NCT00266136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65054090|NCT00266136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65054091|NCT00266136|Antimetabolites|antimetabolites|mesh-ancestor
65054092|NCT00266136|Antiviral Agents|antiviral agents|mesh-ancestor
65054093|NCT00266136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65054094|NCT00266136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65054095|NCT00266136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65054096|NCT00266136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65054097|NCT00266136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054098|NCT00230594|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65054099|NCT00230594|Hemostatics|hemostatics|mesh-ancestor
65054100|NCT00230594|Coagulants|coagulants|mesh-ancestor
65054101|NCT00230594|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65054102|NCT00230594|Natriuretic Agents|natriuretic agents|mesh-ancestor
65054104|NCT00259077|Omeprazole|omeprazole|mesh-list
65054121|NCT00479674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65054122|NCT00479674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65054123|NCT00479674|Growth Substances|growth substances|mesh-ancestor
65054124|NCT00479674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054125|NCT00479674|Growth Inhibitors|growth inhibitors|mesh-ancestor
65054126|NCT02962310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65054127|NCT02962310|Calcium|calcium|mesh-list
65054128|NCT02962310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65054129|NCT02962310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054130|NCT02962310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65054132|NCT02962310|Antimetabolites|antimetabolites|mesh-ancestor
65054133|NCT02962310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054134|NCT02962310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65054135|NCT02962310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65054136|NCT02962310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054137|NCT00259116|Methocarbamol|methocarbamol|mesh-list
65054138|NCT00259116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65054139|NCT00259116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054140|NCT00259116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65054141|NCT00259116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65054142|NCT00415779|Zoledronic Acid|zoledronic acid|mesh-list
65054143|NCT00415779|Docetaxel|docetaxel|mesh-list
65054144|NCT00415779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054145|NCT00415779|Tubulin Modulators|tubulin modulators|mesh-ancestor
65054146|NCT00415779|Antimitotic Agents|antimitotic agents|mesh-ancestor
65054147|NCT00415779|Mitosis Modulators|mitosis modulators|mesh-ancestor
65054148|NCT00415779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054149|NCT00415779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65054150|NCT00415779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054151|NCT00259155|Rifaximin|rifaximin|mesh-list
65054165|NCT00230789|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65054166|NCT00230789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65054167|NCT00230789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65054168|NCT00230789|Cholinergic Agents|cholinergic agents|mesh-ancestor
65054169|NCT00230789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65054170|NCT00230789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054171|NCT00230789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054172|NCT00230789|Urological Agents|urological agents|mesh-ancestor
65054173|NCT00478777|Dexamethasone|dexamethasone|mesh-list
65054174|NCT00478777|Lenalidomide|lenalidomide|mesh-list
65054175|NCT00478777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65054176|NCT00478777|Antiemetics|antiemetics|mesh-ancestor
65054177|NCT00478777|Autonomic Agents|autonomic agents|mesh-ancestor
65054178|NCT00478777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65054179|NCT00478777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054180|NCT00478777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65054181|NCT00478777|Glucocorticoids|glucocorticoids|mesh-ancestor
64539433|NCT01418209|Contraceptive Agents|contraceptive agents|mesh-ancestor
65054182|NCT00478777|Hormones|hormones|mesh-ancestor
65054183|NCT00478777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65054184|NCT00478777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65054185|NCT00478777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054186|NCT00478777|Immunologic Factors|immunologic factors|mesh-ancestor
65054187|NCT00478777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65054188|NCT00478777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65054189|NCT00478777|Growth Substances|growth substances|mesh-ancestor
65054190|NCT00478777|Growth Inhibitors|growth inhibitors|mesh-ancestor
65054191|NCT00477607|Thioctic Acid|thioctic acid|mesh-list
65054192|NCT00477607|Antioxidants|antioxidants|mesh-ancestor
65054193|NCT00477607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054194|NCT00477607|Protective Agents|protective agents|mesh-ancestor
65054207|NCT00266214|Sensory System Agents|sensory system agents|mesh-ancestor
65054208|NCT00266214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65054209|NCT00266214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65054210|NCT00266214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65054211|NCT00266214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65054212|NCT00266214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65054213|NCT00266214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054214|NCT00266253|Metformin|metformin|mesh-list
65054215|NCT00266253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65054216|NCT00266253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054217|NCT00230984|Methyltestosterone|methyltestosterone|mesh-list
65054218|NCT00230984|Testosterone|testosterone|mesh-list
65054219|NCT00230984|Testosterone undecanoate|testosterone undecanoate|mesh-list
65054220|NCT00230984|Testosterone enanthate|testosterone enanthate|mesh-list
65054221|NCT00230984|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65054222|NCT00230984|Androgens|androgens|mesh-ancestor
65054223|NCT00230984|Hormones|hormones|mesh-ancestor
65054224|NCT00230984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65054225|NCT00230984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054226|NCT00230984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65054227|NCT00230984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054228|NCT00230984|Anabolic Agents|anabolic agents|mesh-ancestor
65054229|NCT00415350|Azithromycin|azithromycin|mesh-list
65054230|NCT00415350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65054231|NCT00415350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65054232|NCT00231023|Triamcinolone|triamcinolone|mesh-list
65054233|NCT00231023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65054234|NCT00231023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65054235|NCT00231023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65054236|NCT00231023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65054237|NCT00231023|Glucocorticoids|glucocorticoids|mesh-ancestor
65054238|NCT00231023|Hormones|hormones|mesh-ancestor
65054241|NCT00231023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65054247|NCT00231101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65054248|NCT00231101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65054249|NCT00231101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65054250|NCT00231101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65054251|NCT00231101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054252|NCT00231140|Thalidomide|thalidomide|mesh-list
65054253|NCT00231140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65054254|NCT00231140|Immunologic Factors|immunologic factors|mesh-ancestor
65054255|NCT00231140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054256|NCT00231140|Leprostatic Agents|leprostatic agents|mesh-ancestor
64484453|NCT01727713|Antidepressive Agents|antidepressive agents|mesh-ancestor
65054258|NCT00231140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65054259|NCT00231140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65054312|NCT00231491|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65054313|NCT00231491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65054314|NCT00231491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054315|NCT00231491|Cholinergic Agents|cholinergic agents|mesh-ancestor
65054316|NCT00231491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65054317|NCT00231491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054318|NCT00231491|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65054319|NCT00231491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65054320|NCT00477490|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65054321|NCT00477490|Hemostatics|hemostatics|mesh-ancestor
65054322|NCT00477490|Coagulants|coagulants|mesh-ancestor
65054323|NCT00477490|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65054324|NCT00477490|Natriuretic Agents|natriuretic agents|mesh-ancestor
65054325|NCT00477490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054326|NCT00231530|Topiramate|topiramate|mesh-list
65054327|NCT00231530|Anticonvulsants|anticonvulsants|mesh-ancestor
65054328|NCT00231530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65054329|NCT00231530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054330|NCT00231569|Mipomersen|mipomersen|mesh-list
65054331|NCT00231569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64539583|NCT04069273|Paclitaxel|paclitaxel|mesh-list
65054332|NCT00231569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65054333|NCT00231569|Antimetabolites|antimetabolites|mesh-ancestor
65054334|NCT00231569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054335|NCT00231569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65054336|NCT00477334|Famciclovir|famciclovir|mesh-list
65054337|NCT00477334|Antiviral Agents|antiviral agents|mesh-ancestor
65054338|NCT00477334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65054339|NCT00477334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65054340|NCT00477334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054341|NCT00477334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054342|NCT00231608|Topiramate|topiramate|mesh-list
65054343|NCT00231608|Anticonvulsants|anticonvulsants|mesh-ancestor
65054344|NCT00231608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65054353|NCT04561336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054355|NCT00259428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65054356|NCT00231647|Topiramate|topiramate|mesh-list
65054357|NCT00231647|Anticonvulsants|anticonvulsants|mesh-ancestor
65054358|NCT00231647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65054359|NCT00231647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054360|NCT04560322|Venetoclax|venetoclax|mesh-list
65054361|NCT04560322|Obinutuzumab|obinutuzumab|mesh-list
65054362|NCT04560322|Acalabrutinib|acalabrutinib|mesh-list
65054363|NCT04560322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054364|NCT04560322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65054365|NCT04560751|Lenvatinib|lenvatinib|mesh-list
65054366|NCT04560751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054367|NCT04560751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65054368|NCT04560751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054369|NCT04560751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054370|NCT00266643|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65054371|NCT00266643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65054372|NCT00266643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65054373|NCT00266643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65054374|NCT00266643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054375|NCT00266643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65054376|NCT00266643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054377|NCT00266643|Analgesics|analgesics|mesh-ancestor
65054378|NCT00266643|Sensory System Agents|sensory system agents|mesh-ancestor
65054379|NCT00266643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65054380|NCT00266643|Antidepressive Agents|antidepressive agents|mesh-ancestor
65054381|NCT00266643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65054382|NCT00266643|Dopamine Agents|dopamine agents|mesh-ancestor
65054383|NCT00231725|Insulin Lispro|insulin lispro|mesh-list
65054384|NCT00231725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65054385|NCT00231725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054386|NCT04560049|Phenol|phenol|mesh-list
65054387|NCT04560049|Silver Nitrate|silver nitrate|mesh-list
65054395|NCT04559425|BB 1101|bb 1101|mesh-list
65054396|NCT04559425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65054397|NCT04559425|Antiemetics|antiemetics|mesh-ancestor
65054398|NCT04559425|Autonomic Agents|autonomic agents|mesh-ancestor
65054399|NCT04559425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65054400|NCT04559425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054401|NCT04559425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65054402|NCT04559425|Glucocorticoids|glucocorticoids|mesh-ancestor
65054403|NCT04559425|Hormones|hormones|mesh-ancestor
65054404|NCT04559425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65054405|NCT04559425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65054406|NCT04559425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054407|NCT04559425|Protease Inhibitors|protease inhibitors|mesh-ancestor
64539658|NCT02074735|Choline|choline|mesh-list
65054408|NCT04559425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054409|NCT04559425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054410|NCT00231764|Daclizumab|daclizumab|mesh-list
65054411|NCT00231764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65054412|NCT00231764|Immunologic Factors|immunologic factors|mesh-ancestor
65054413|NCT00231764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054414|NCT04559308|Metformin|metformin|mesh-list
65054415|NCT04559308|Paclitaxel|paclitaxel|mesh-list
65054416|NCT04559308|Cyclophosphamide|cyclophosphamide|mesh-list
65054417|NCT04559308|Doxorubicin|doxorubicin|mesh-list
65054418|NCT04559308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65054419|NCT04559308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054420|NCT04559308|Tubulin Modulators|tubulin modulators|mesh-ancestor
65054421|NCT04559308|Antimitotic Agents|antimitotic agents|mesh-ancestor
65054422|NCT04559308|Mitosis Modulators|mitosis modulators|mesh-ancestor
65054423|NCT04559308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054424|NCT04559308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65054436|NCT04559113|Methylprednisolone|methylprednisolone|mesh-list
65054439|NCT04559113|Prednisolone|prednisolone|mesh-list
65054440|NCT04559113|Prednisolone acetate|prednisolone acetate|mesh-list
65054441|NCT04559113|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65054442|NCT04559113|Prednisolone phosphate|prednisolone phosphate|mesh-list
65054443|NCT04559113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65054444|NCT04559113|Antiemetics|antiemetics|mesh-ancestor
65054445|NCT04559113|Autonomic Agents|autonomic agents|mesh-ancestor
65054446|NCT04559113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65054447|NCT04559113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054448|NCT04559113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65054449|NCT04559113|Glucocorticoids|glucocorticoids|mesh-ancestor
65054450|NCT04559113|Hormones|hormones|mesh-ancestor
65054451|NCT04559113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65054452|NCT04559113|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65054453|NCT04559113|Protective Agents|protective agents|mesh-ancestor
65054454|NCT04559113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65054455|NCT04559113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054456|NCT00266721|Pancrelipase|pancrelipase|mesh-list
64906479|NCT00008008|Cyclophosphamide|cyclophosphamide|mesh-list
65054496|NCT00266838|Dexamethasone|dexamethasone|mesh-list
65054497|NCT00266838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65054498|NCT00266838|Antiemetics|antiemetics|mesh-ancestor
65054499|NCT00266838|Autonomic Agents|autonomic agents|mesh-ancestor
65054500|NCT00266838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65054501|NCT00266838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054502|NCT00266838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65054503|NCT00266838|Glucocorticoids|glucocorticoids|mesh-ancestor
65054504|NCT00266838|Hormones|hormones|mesh-ancestor
65054505|NCT00266838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65054506|NCT00266838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65054507|NCT00266838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054508|NCT00232037|Tegaserod|tegaserod|mesh-list
65054509|NCT00232037|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65054510|NCT00232037|Serotonin Agents|serotonin agents|mesh-ancestor
65054511|NCT00232037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65054512|NCT00232037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054513|NCT00232037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054514|NCT02212210|Methylprednisolone|methylprednisolone|mesh-list
65054515|NCT02212210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65054516|NCT02212210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65054517|NCT02212210|Prednisolone|prednisolone|mesh-list
65054518|NCT02212210|Prednisolone acetate|prednisolone acetate|mesh-list
65054519|NCT02212210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65054520|NCT02212210|Prednisolone phosphate|prednisolone phosphate|mesh-list
65054521|NCT02212210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65054522|NCT02212210|Antiemetics|antiemetics|mesh-ancestor
65054523|NCT02212210|Autonomic Agents|autonomic agents|mesh-ancestor
65054524|NCT02212210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65054525|NCT02212210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054526|NCT02212210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65054527|NCT02212210|Glucocorticoids|glucocorticoids|mesh-ancestor
65054528|NCT02212210|Hormones|hormones|mesh-ancestor
65054529|NCT02212210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65054530|NCT02212210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65054533|NCT02212210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054534|NCT00232076|Cyclosporine|cyclosporine|mesh-list
65054535|NCT00232076|Cyclosporins|cyclosporins|mesh-list
65054536|NCT00232076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054537|NCT00232076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054538|NCT00232076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65054539|NCT00232076|Immunologic Factors|immunologic factors|mesh-ancestor
65054540|NCT00232076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054541|NCT00232076|Antifungal Agents|antifungal agents|mesh-ancestor
65054542|NCT00232076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65054543|NCT00232076|Dermatologic Agents|dermatologic agents|mesh-ancestor
65054544|NCT00232076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65054545|NCT00232076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65054546|NCT00232115|Pimecrolimus|pimecrolimus|mesh-list
65054547|NCT00232115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65054548|NCT00232115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65054549|NCT00232115|Analgesics|analgesics|mesh-ancestor
65054550|NCT00232115|Sensory System Agents|sensory system agents|mesh-ancestor
65054551|NCT00232115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65054552|NCT00232115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054588|NCT04557475|Analgesics|analgesics|mesh-ancestor
65054589|NCT04557475|Sensory System Agents|sensory system agents|mesh-ancestor
65054590|NCT04557475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65054591|NCT04557475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054592|NCT04557475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65054593|NCT04557475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65054594|NCT04557475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65054595|NCT04557475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65054596|NCT04557475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054597|NCT04557475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65054598|NCT04557475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65054599|NCT04557475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054600|NCT04557475|Antipyretics|antipyretics|mesh-ancestor
65054601|NCT00232271|Enoxaparin|enoxaparin|mesh-list
65054602|NCT00232271|Anticoagulants|anticoagulants|mesh-ancestor
65054603|NCT00232271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65054604|NCT00232271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65054605|NCT00232271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054606|NCT04557397|Itraconazole|itraconazole|mesh-list
65054607|NCT04557397|Rifampin|rifampin|mesh-list
65054608|NCT04557397|Antifungal Agents|antifungal agents|mesh-ancestor
65054609|NCT04557397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65054610|NCT04557397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65054611|NCT04557397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65054612|NCT04557397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054613|NCT04557397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054630|NCT04557202|Tamsulosin|tamsulosin|mesh-list
65054633|NCT04557202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64495983|NCT03438240|Narcotics|narcotics|mesh-ancestor
65054634|NCT04557202|Adrenergic Agents|adrenergic agents|mesh-ancestor
65054635|NCT04557202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65054636|NCT04557202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054637|NCT04557202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054638|NCT04557202|Urological Agents|urological agents|mesh-ancestor
65054639|NCT00232349|Galantamine|galantamine|mesh-list
65054640|NCT00232349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65054641|NCT00232349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054642|NCT00232349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054643|NCT00232349|Cholinergic Agents|cholinergic agents|mesh-ancestor
65054644|NCT00232349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65054645|NCT00232349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054646|NCT00232349|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65054647|NCT00232349|Autonomic Agents|autonomic agents|mesh-ancestor
65054648|NCT00232349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65054649|NCT00232349|Nootropic Agents|nootropic agents|mesh-ancestor
65054650|NCT00259701|Nitroglycerin|nitroglycerin|mesh-list
65054651|NCT00259701|Acetylcholine|acetylcholine|mesh-list
65054652|NCT00259701|Vasodilator Agents|vasodilator agents|mesh-ancestor
65054653|NCT00259701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65054654|NCT00259701|Cholinergic Agents|cholinergic agents|mesh-ancestor
65054655|NCT00259701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65054656|NCT00259701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054657|NCT00259701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054658|NCT04556929|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65054659|NCT04556929|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65054660|NCT04556929|Dermatologic Agents|dermatologic agents|mesh-ancestor
65054662|NCT04566211|Metronidazole|metronidazole|mesh-list
65054663|NCT04566211|Clarithromycin|clarithromycin|mesh-list
65054664|NCT04566211|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
65054665|NCT04566211|Pantoprazole|pantoprazole|mesh-list
65054666|NCT04566211|Bismuth|bismuth|mesh-list
65054667|NCT04566211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65054668|NCT04566211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65054673|NCT04566211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054674|NCT04566211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65054675|NCT04566211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65054676|NCT04566211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65054677|NCT04566211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65054678|NCT04566211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65054679|NCT04566211|Antacids|antacids|mesh-ancestor
65054680|NCT00259779|Prednisolone|prednisolone|mesh-list
65054681|NCT00259779|Budesonide|budesonide|mesh-list
65054682|NCT00259779|Formoterol Fumarate|formoterol fumarate|mesh-list
65054683|NCT00259779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65054684|NCT00259779|Glucocorticoids|glucocorticoids|mesh-ancestor
65054685|NCT00259779|Hormones|hormones|mesh-ancestor
65054686|NCT00259779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65054687|NCT00259779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054688|NCT00259779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65054689|NCT00259779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054690|NCT00259779|Autonomic Agents|autonomic agents|mesh-ancestor
65054691|NCT00259779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65054692|NCT00259779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65054693|NCT00259779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65054694|NCT00259779|Respiratory System Agents|respiratory system agents|mesh-ancestor
65054695|NCT00259779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65054696|NCT00259779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65054697|NCT00259779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65054698|NCT00259779|Adrenergic Agents|adrenergic agents|mesh-ancestor
65054699|NCT00259779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65054700|NCT00259779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054701|NCT02211079|Tolbutamide|tolbutamide|mesh-list
65054702|NCT02211079|Midazolam|midazolam|mesh-list
65054703|NCT02211079|Caffeine|caffeine|mesh-list
65054704|NCT02211079|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65054705|NCT02211079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65054706|NCT02211079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65054707|NCT02211079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906663|NCT05636566|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64951514|NCT00026273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539963|NCT02823990|Nivolumab|nivolumab|mesh-list
65054708|NCT02211079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65054710|NCT02211079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65054711|NCT02211079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65054712|NCT02211079|Anesthetics, General|anesthetics, general|mesh-ancestor
65054713|NCT02211079|Anesthetics|anesthetics|mesh-ancestor
65054714|NCT02211079|GABA Modulators|gaba modulators|mesh-ancestor
65054715|NCT02211079|GABA Agents|gaba agents|mesh-ancestor
65054716|NCT02211079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65054717|NCT02211079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054718|NCT02211079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65054719|NCT02211079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65054720|NCT02211079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054721|NCT02211079|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65054722|NCT02211079|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65054723|NCT02211079|Purinergic Agents|purinergic agents|mesh-ancestor
65054724|NCT02211079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65054725|NCT00232622|Streptokinase|streptokinase|mesh-list
65054726|NCT00232622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65054727|NCT00232622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65054728|NCT00232622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054729|NCT00232661|Tamoxifen|tamoxifen|mesh-list
65054730|NCT00232661|Anastrozole|anastrozole|mesh-list
65054731|NCT00232661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65054732|NCT00232661|Hormone Antagonists|hormone antagonists|mesh-ancestor
65054733|NCT00232661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65054734|NCT00232661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054735|NCT00232661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65054736|NCT00232661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054753|NCT00267267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65054754|NCT00267267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65054755|NCT00267267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054756|NCT04564690|Vitamin E|vitamin e|mesh-list
65054757|NCT04564690|Selenium|selenium|mesh-list
65054758|NCT04564690|Vitamins|vitamins|mesh-ancestor
65054759|NCT04564690|Micronutrients|micronutrients|mesh-ancestor
65054760|NCT04564690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054761|NCT04564690|Antioxidants|antioxidants|mesh-ancestor
65054762|NCT04564690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054763|NCT04564690|Protective Agents|protective agents|mesh-ancestor
65054764|NCT04564690|Trace Elements|trace elements|mesh-ancestor
65054765|NCT00232700|Citalopram|citalopram|mesh-list
65054766|NCT00232700|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65054767|NCT00232700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65054768|NCT00232700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65054769|NCT00232700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054770|NCT00232700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65054771|NCT00232700|Serotonin Agents|serotonin agents|mesh-ancestor
65054772|NCT00232700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054773|NCT00232700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65054774|NCT00232700|Antidepressive Agents|antidepressive agents|mesh-ancestor
65054775|NCT00232700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65054776|NCT04564456|Fluticasone|fluticasone|mesh-list
65054805|NCT04564144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65054806|NCT04564144|Histamine Antagonists|histamine antagonists|mesh-ancestor
65054807|NCT04564144|Histamine Agents|histamine agents|mesh-ancestor
65054808|NCT04564144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65054809|NCT04564144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054810|NCT04564144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65054811|NCT00267306|Visilizumab|visilizumab|mesh-list
65054812|NCT00267306|Immunologic Factors|immunologic factors|mesh-ancestor
65054813|NCT00267306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054814|NCT00259896|Exenatide|exenatide|mesh-list
65054815|NCT00259896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65054816|NCT00259896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054817|NCT00259896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65054818|NCT00259896|Incretins|incretins|mesh-ancestor
65054819|NCT00259896|Hormones|hormones|mesh-ancestor
65054820|NCT00259896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65054821|NCT04721795|Antitubercular Agents|antitubercular agents|mesh-list
65054822|NCT04721795|Atorvastatin|atorvastatin|mesh-list
65054823|NCT04721795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65054824|NCT04721795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65054825|NCT04721795|Antimetabolites|antimetabolites|mesh-ancestor
65054826|NCT04721795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054858|NCT00259935|Topotecan|topotecan|mesh-list
65054859|NCT00259935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65054860|NCT00259935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65054861|NCT00259935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054862|NCT00259935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054863|NCT00259935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054864|NCT00232856|Sirolimus|sirolimus|mesh-list
65054865|NCT00232856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65054866|NCT00232856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65054867|NCT00232856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65054868|NCT00232856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054869|NCT00232856|Antifungal Agents|antifungal agents|mesh-ancestor
65054870|NCT00232856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65054871|NCT00232856|Immunologic Factors|immunologic factors|mesh-ancestor
65054872|NCT00232856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054873|NCT00259974|Rituximab|rituximab|mesh-list
65054874|NCT00259974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65054875|NCT00259974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054876|NCT00259974|Immunologic Factors|immunologic factors|mesh-ancestor
65054878|NCT00259974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65054879|NCT00232895|Propofol|propofol|mesh-list
65054880|NCT00232895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65054881|NCT00232895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65054882|NCT00232895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054883|NCT00232895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65054884|NCT00232895|Anesthetics, General|anesthetics, general|mesh-ancestor
65054885|NCT00232895|Anesthetics|anesthetics|mesh-ancestor
65054886|NCT00232934|Thalidomide|thalidomide|mesh-list
65054887|NCT00232934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65054888|NCT00232934|Immunologic Factors|immunologic factors|mesh-ancestor
65054889|NCT00232934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054890|NCT00232934|Leprostatic Agents|leprostatic agents|mesh-ancestor
65054891|NCT00232934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65054892|NCT00232934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951515|NCT00026273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64951516|NCT00026273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951517|NCT00026273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951518|NCT00026273|Immunologic Factors|immunologic factors|mesh-ancestor
64951519|NCT00026273|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64951520|NCT00026273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64951521|NCT00026273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951522|NCT00026273|Antidotes|antidotes|mesh-ancestor
64906874|NCT00000187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054893|NCT00232934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65054894|NCT00232934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65054895|NCT00232934|Growth Substances|growth substances|mesh-ancestor
65054896|NCT00232934|Growth Inhibitors|growth inhibitors|mesh-ancestor
65054897|NCT00232934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65054898|NCT04673812|Fentanyl|fentanyl|mesh-list
65054899|NCT04673812|Bupivacaine|bupivacaine|mesh-list
65054900|NCT04673812|Naloxone|naloxone|mesh-list
65054901|NCT04673812|Anesthetics, Local|anesthetics, local|mesh-ancestor
65054902|NCT04673812|Anesthetics|anesthetics|mesh-ancestor
65054903|NCT04673812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65054904|NCT04673812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054905|NCT04673812|Sensory System Agents|sensory system agents|mesh-ancestor
65054906|NCT04673812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65054907|NCT04673812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65054908|NCT04673812|Narcotics|narcotics|mesh-ancestor
65054909|NCT04673812|Analgesics|analgesics|mesh-ancestor
65054910|NCT04673812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65054911|NCT04673812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65054912|NCT04673812|Anesthetics, General|anesthetics, general|mesh-ancestor
65054913|NCT04673812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65054914|NCT04673461|Xylometazoline|xylometazoline|mesh-list
65054915|NCT04673461|Nasal Decongestants|nasal decongestants|mesh-ancestor
65054916|NCT04673461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65054917|NCT04673461|Respiratory System Agents|respiratory system agents|mesh-ancestor
65054918|NCT00260052|Epoetin Alfa|epoetin alfa|mesh-list
65054919|NCT00260052|Hematinics|hematinics|mesh-ancestor
65054920|NCT04673500|Lidocaine|lidocaine|mesh-list
65054921|NCT04673500|Propofol|propofol|mesh-list
65054922|NCT04673500|Anesthetics, Local|anesthetics, local|mesh-ancestor
65054923|NCT04673500|Anesthetics|anesthetics|mesh-ancestor
65054924|NCT04673500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65054925|NCT04673500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054926|NCT04673500|Sensory System Agents|sensory system agents|mesh-ancestor
65054927|NCT04673500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65054928|NCT04673500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65054930|NCT04673500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65054932|NCT04673500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054933|NCT04673500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65054934|NCT04673500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65054935|NCT04673500|Anesthetics, General|anesthetics, general|mesh-ancestor
65054936|NCT00233012|Topiramate|topiramate|mesh-list
65054937|NCT00233012|Anticonvulsants|anticonvulsants|mesh-ancestor
65054938|NCT00233012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65054939|NCT00233012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054940|NCT00267540|Cholecalciferol|cholecalciferol|mesh-list
65054941|NCT00267540|Vitamin D|vitamin d|mesh-list
65054942|NCT00267540|Vitamins|vitamins|mesh-ancestor
65054943|NCT00267540|Micronutrients|micronutrients|mesh-ancestor
65054944|NCT00267540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054945|NCT00267540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65054946|NCT00267540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65054947|NCT00233051|Fluticasone|fluticasone|mesh-list
65054948|NCT00233051|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65054949|NCT00233051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65054950|NCT00233051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65054951|NCT00233051|Autonomic Agents|autonomic agents|mesh-ancestor
65054952|NCT00233051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65054953|NCT00233051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65054955|NCT00233051|Respiratory System Agents|respiratory system agents|mesh-ancestor
65054956|NCT00233051|Dermatologic Agents|dermatologic agents|mesh-ancestor
65054957|NCT00233051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65054958|NCT00233051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65054959|NCT00233051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65054964|NCT04672759|Durvalumab|durvalumab|mesh-list
65054981|NCT00260247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65054982|NCT00260247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65054983|NCT00260247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65054984|NCT00260247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054985|NCT00260247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65054986|NCT00260247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65054987|NCT00260247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65054988|NCT04671589|Meropenem|meropenem|mesh-list
65054989|NCT04671589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65054990|NCT04671589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65054991|NCT00260325|Valdecoxib|valdecoxib|mesh-list
65054992|NCT00260325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65054993|NCT00260325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65054994|NCT00260325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65054995|NCT00260325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65054996|NCT00260325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65054997|NCT00260325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65054998|NCT00260325|Analgesics|analgesics|mesh-ancestor
65054999|NCT00260325|Sensory System Agents|sensory system agents|mesh-ancestor
65055000|NCT00260325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65055001|NCT00260325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055002|NCT00260325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65055003|NCT00260325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65055004|NCT04671160|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65055005|NCT04671160|Dalteparin|dalteparin|mesh-list
65055006|NCT04671160|Anticoagulants|anticoagulants|mesh-ancestor
65055007|NCT04671160|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65055008|NCT04671160|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65055009|NCT04671160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055013|NCT00233558|Methotrexate|methotrexate|mesh-list
65055023|NCT00233558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055024|NCT00233558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65055025|NCT00233558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65055026|NCT00233558|Immunologic Factors|immunologic factors|mesh-ancestor
65055027|NCT00233558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65055028|NCT00233558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65055029|NCT00233558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65055030|NCT00233636|Gefitinib|gefitinib|mesh-list
65055031|NCT00233636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055032|NCT00233636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65055033|NCT00233636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055034|NCT00233636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055035|NCT00267657|Reserpine|reserpine|mesh-list
65055036|NCT00267657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65055037|NCT00267657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65055038|NCT00267657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65055039|NCT00267657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65055040|NCT00267657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055041|NCT00267657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65055042|NCT00267657|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65055043|NCT00267657|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65055044|NCT00267657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65055045|NCT00267657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055046|NCT00267657|Adrenergic Agents|adrenergic agents|mesh-ancestor
65055047|NCT00267657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65055048|NCT04670809|Clevidipine|clevidipine|mesh-list
65055049|NCT04670809|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65055050|NCT04670809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65055053|NCT04670809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055067|NCT04670497|Anesthetics, Local|anesthetics, local|mesh-ancestor
65055068|NCT04670497|Anesthetics|anesthetics|mesh-ancestor
65055069|NCT04670497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65055070|NCT04670497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055071|NCT04670497|Sensory System Agents|sensory system agents|mesh-ancestor
65055072|NCT04670497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65055073|NCT04670497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65055074|NCT04670497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65055075|NCT04670497|Adrenergic Agents|adrenergic agents|mesh-ancestor
65055076|NCT04670497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65055077|NCT04670497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055078|NCT04670497|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65055079|NCT04670497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64496446|NCT03435900|Fosfomycin|fosfomycin|mesh-list
65055128|NCT00556192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65055129|NCT00556270|Fentanyl|fentanyl|mesh-list
65055130|NCT00556270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65055131|NCT00556270|Narcotics|narcotics|mesh-ancestor
65055132|NCT00556270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65055133|NCT00556270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055134|NCT00556270|Analgesics|analgesics|mesh-ancestor
65055135|NCT00556270|Sensory System Agents|sensory system agents|mesh-ancestor
65055136|NCT00556270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65055137|NCT00556270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65055138|NCT00556270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65055139|NCT00556270|Anesthetics, General|anesthetics, general|mesh-ancestor
65055140|NCT00556270|Anesthetics|anesthetics|mesh-ancestor
65055141|NCT00260520|Dalteparin|dalteparin|mesh-list
65055142|NCT00260520|Tinzaparin|tinzaparin|mesh-list
65055143|NCT00260520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65055144|NCT00260520|Anticoagulants|anticoagulants|mesh-ancestor
65055145|NCT00260520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65055146|NCT00260520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65055147|NCT00260520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055148|NCT00233909|Gemtuzumab|gemtuzumab|mesh-list
65055149|NCT00233909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65055150|NCT00233909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055151|NCT00267813|Bupropion|bupropion|mesh-list
65055152|NCT00267813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65055153|NCT00267813|Antidepressive Agents|antidepressive agents|mesh-ancestor
65055154|NCT00267813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65055176|NCT00234143|Darbepoetin alfa|darbepoetin alfa|mesh-list
65055177|NCT00234143|Hematinics|hematinics|mesh-ancestor
65055178|NCT00234182|Interferons|interferons|mesh-list
65055179|NCT00234182|Interferon-alpha|interferon-alpha|mesh-list
65055180|NCT00234182|Interferon alpha-2|interferon alpha-2|mesh-list
65055181|NCT00234182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055182|NCT00234182|Antiviral Agents|antiviral agents|mesh-ancestor
65055183|NCT00234182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65055184|NCT00234182|Immunologic Factors|immunologic factors|mesh-ancestor
65055185|NCT00234182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055186|NCT04669990|Remdesivir|remdesivir|mesh-list
65055187|NCT04669990|Antimetabolites|antimetabolites|mesh-ancestor
65055188|NCT04669990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055189|NCT04669990|Antiviral Agents|antiviral agents|mesh-ancestor
65055190|NCT04669990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65055191|NCT00556348|Bevacizumab|bevacizumab|mesh-list
65055192|NCT00556348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65055193|NCT00556348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055194|NCT00556348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65055195|NCT00556348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65055196|NCT00556348|Growth Substances|growth substances|mesh-ancestor
65055197|NCT00556348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055198|NCT00556348|Growth Inhibitors|growth inhibitors|mesh-ancestor
65055199|NCT00556387|Ketamine|ketamine|mesh-list
65055200|NCT00556387|Analgesics|analgesics|mesh-ancestor
65055201|NCT00556387|Sensory System Agents|sensory system agents|mesh-ancestor
65055202|NCT00556387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65055203|NCT00556387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055204|NCT00556387|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65055205|NCT00556387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65055206|NCT00556387|Anesthetics, General|anesthetics, general|mesh-ancestor
65055207|NCT00556387|Anesthetics|anesthetics|mesh-ancestor
65055208|NCT00556387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65055209|NCT00556387|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65055217|NCT04552093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055218|NCT04556110|Perindopril|perindopril|mesh-list
65055219|NCT04556110|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65055220|NCT04556110|Protease Inhibitors|protease inhibitors|mesh-ancestor
65055221|NCT04556110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055222|NCT04556110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055223|NCT04556110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65055224|NCT00234299|Aspirin|aspirin|mesh-list
65055225|NCT00234299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65055226|NCT00234299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65055227|NCT00234299|Analgesics|analgesics|mesh-ancestor
65055228|NCT00234299|Sensory System Agents|sensory system agents|mesh-ancestor
65055229|NCT00234299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65055230|NCT00234299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055231|NCT00234299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65055232|NCT00234299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65055233|NCT00234299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65055234|NCT00234299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65055235|NCT00234299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055236|NCT00234299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65055237|NCT00234299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65055238|NCT00234299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055239|NCT00234299|Antipyretics|antipyretics|mesh-ancestor
65055240|NCT04556032|Ergothioneine|ergothioneine|mesh-list
65055241|NCT04556032|Antioxidants|antioxidants|mesh-ancestor
65055242|NCT04556032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055243|NCT04556032|Protective Agents|protective agents|mesh-ancestor
65055244|NCT04556032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055245|NCT04556071|Bevacizumab|bevacizumab|mesh-list
65055246|NCT04556071|Niraparib|niraparib|mesh-list
65055247|NCT04556071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65055248|NCT04556071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055251|NCT04556071|Growth Substances|growth substances|mesh-ancestor
65055256|NCT04556071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055257|NCT04563871|Osimertinib|osimertinib|mesh-list
65055258|NCT04563871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055259|NCT04563871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65055260|NCT04563871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055261|NCT04563871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055262|NCT00234377|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65055263|NCT00234377|Antidepressive Agents|antidepressive agents|mesh-ancestor
65055264|NCT00234377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65055265|NCT00234377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65055266|NCT00234377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65055267|NCT00234377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65055268|NCT00234377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055269|NCT04563754|Proflavine|proflavine|mesh-list
65055270|NCT04563754|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65055271|NCT04563754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65055272|NCT02211118|Dexmedetomidine|dexmedetomidine|mesh-list
65055273|NCT02211118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65055274|NCT02211118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65055275|NCT02211118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055276|NCT02211118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65055277|NCT02211118|Analgesics|analgesics|mesh-ancestor
65055278|NCT02211118|Sensory System Agents|sensory system agents|mesh-ancestor
65055279|NCT02211118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65055280|NCT02211118|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65055281|NCT02211118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65055282|NCT02211118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65055283|NCT02211118|Adrenergic Agents|adrenergic agents|mesh-ancestor
65055284|NCT02211118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65055285|NCT02211118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055286|NCT00234416|Gemcitabine|gemcitabine|mesh-list
65055287|NCT00234416|Gefitinib|gefitinib|mesh-list
65055288|NCT00234416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65055289|NCT00234416|Antimetabolites|antimetabolites|mesh-ancestor
65055290|NCT00234416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055293|NCT00234416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65055294|NCT00234416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055295|NCT00234416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65055296|NCT00234416|Immunologic Factors|immunologic factors|mesh-ancestor
65055297|NCT00234416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055298|NCT00234416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65055299|NCT00234455|Sirolimus|sirolimus|mesh-list
65055300|NCT00234455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65055301|NCT00234455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65055302|NCT00234455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65055303|NCT00234455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055304|NCT00234455|Antifungal Agents|antifungal agents|mesh-ancestor
64496655|NCT01923831|Analgesics|analgesics|mesh-ancestor
65055305|NCT00234455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65055306|NCT00234455|Immunologic Factors|immunologic factors|mesh-ancestor
65055307|NCT00234455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055309|NCT00234572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055310|NCT00260793|Ropinirole|ropinirole|mesh-list
65055311|NCT00260793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65055312|NCT00260793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65055313|NCT00260793|Dopamine Agonists|dopamine agonists|mesh-ancestor
65055314|NCT00260793|Dopamine Agents|dopamine agents|mesh-ancestor
65055315|NCT00260793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65055316|NCT00260793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055317|NCT00260793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055318|NCT00415935|Methotrexate|methotrexate|mesh-list
65055319|NCT00415935|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65055320|NCT00415935|Abortifacient Agents|abortifacient agents|mesh-ancestor
65055321|NCT00415935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65055322|NCT00415935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055323|NCT00415935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65055324|NCT00415935|Antimetabolites|antimetabolites|mesh-ancestor
65055325|NCT00415935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055326|NCT00415935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055333|NCT00415935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65055334|NCT00413738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
65055335|NCT00413738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65055336|NCT02211391|Caseins|caseins|mesh-list
65055337|NCT02211391|Chelating Agents|chelating agents|mesh-ancestor
65055338|NCT02211391|Sequestering Agents|sequestering agents|mesh-ancestor
65055339|NCT02211391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055340|NCT00234689|Naltrexone|naltrexone|mesh-list
65055341|NCT00234689|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65055342|NCT00234689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65055343|NCT00234689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055344|NCT00234689|Sensory System Agents|sensory system agents|mesh-ancestor
65055345|NCT00234689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65055346|NCT04561960|Fluorides|fluorides|mesh-list
65055347|NCT04561960|Cariostatic Agents|cariostatic agents|mesh-ancestor
65055348|NCT04561960|Protective Agents|protective agents|mesh-ancestor
65055349|NCT04561960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055350|NCT04561921|Magnesium Sulfate|magnesium sulfate|mesh-list
65055351|NCT04561921|Nordefrin|nordefrin|mesh-list
65055352|NCT04561921|Mepivacaine|mepivacaine|mesh-list
65055353|NCT04561921|Analgesics|analgesics|mesh-ancestor
65055354|NCT04561921|Sensory System Agents|sensory system agents|mesh-ancestor
65055355|NCT04561921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65055356|NCT04561921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055357|NCT04561921|Anesthetics|anesthetics|mesh-ancestor
65055358|NCT04561921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65055359|NCT04561921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65055360|NCT04561921|Anticonvulsants|anticonvulsants|mesh-ancestor
65055361|NCT04561921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65055362|NCT04561921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65055379|NCT04561687|Glucocorticoids|glucocorticoids|mesh-ancestor
65055380|NCT04561687|Hormones|hormones|mesh-ancestor
65055381|NCT04561687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65055382|NCT04561687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65055383|NCT04561687|Hormone Antagonists|hormone antagonists|mesh-ancestor
65055384|NCT04561687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65055385|NCT04561687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65055386|NCT04561687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055387|NCT04561687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65055388|NCT04561687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055389|NCT04561687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65055390|NCT04561687|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65055391|NCT04561687|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65055392|NCT04561687|Histamine Antagonists|histamine antagonists|mesh-ancestor
65055393|NCT04561687|Histamine Agents|histamine agents|mesh-ancestor
65055394|NCT04561687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65055395|NCT04561219|Nitazoxanide|nitazoxanide|mesh-list
65055396|NCT04561219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65055397|NCT04561219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65055398|NCT00234845|Adalimumab|adalimumab|mesh-list
65055399|NCT00234845|Methotrexate|methotrexate|mesh-list
65055400|NCT00234845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65055401|NCT00234845|Abortifacient Agents|abortifacient agents|mesh-ancestor
65055402|NCT00234845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65055403|NCT00234845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055404|NCT00234845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65055405|NCT00234845|Antimetabolites|antimetabolites|mesh-ancestor
65055406|NCT00234845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055407|NCT00234845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055408|NCT00234845|Dermatologic Agents|dermatologic agents|mesh-ancestor
65055409|NCT00234845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055421|NCT02211625|Analgesics|analgesics|mesh-ancestor
65055422|NCT02211625|Sensory System Agents|sensory system agents|mesh-ancestor
65055423|NCT02211625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65055424|NCT00234923|Ritonavir|ritonavir|mesh-list
65055425|NCT00234923|Lopinavir|lopinavir|mesh-list
65055426|NCT00234923|Lamivudine|lamivudine|mesh-list
65055427|NCT00234923|Zidovudine|zidovudine|mesh-list
65055428|NCT00234923|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
65055429|NCT00234923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65055430|NCT00234923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65055431|NCT00234923|Protease Inhibitors|protease inhibitors|mesh-ancestor
65055432|NCT00234923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055433|NCT00234923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055434|NCT00234923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65055435|NCT00234923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65055436|NCT00234923|Antiviral Agents|antiviral agents|mesh-ancestor
65055437|NCT00234923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65055438|NCT00234923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65055439|NCT00234923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65055440|NCT00234923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65055441|NCT00234923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65055442|NCT00234923|Antimetabolites|antimetabolites|mesh-ancestor
65055443|NCT02213887|Pantoprazole|pantoprazole|mesh-list
65055444|NCT02213887|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65055445|NCT02213887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65055446|NCT02213887|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65055447|NCT02213887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055448|NCT02213887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055449|NCT00234962|Ritonavir|ritonavir|mesh-list
65055450|NCT00234962|Lopinavir|lopinavir|mesh-list
65055451|NCT00234962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65055462|NCT04551703|Epinephrine|epinephrine|mesh-list
65055466|NCT04551703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65055467|NCT04551703|Adrenergic Agents|adrenergic agents|mesh-ancestor
65055468|NCT04551703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65055469|NCT04551703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055470|NCT04551703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055471|NCT04551703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65055472|NCT04551703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65055473|NCT04551703|Autonomic Agents|autonomic agents|mesh-ancestor
65055474|NCT04551703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65055475|NCT04551703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65055476|NCT04551703|Respiratory System Agents|respiratory system agents|mesh-ancestor
65055477|NCT04551703|Mydriatics|mydriatics|mesh-ancestor
65055478|NCT04551703|Sympathomimetics|sympathomimetics|mesh-ancestor
65055479|NCT04551703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65055480|NCT00235001|Verapamil|verapamil|mesh-list
65055481|NCT00235001|Trandolapril|trandolapril|mesh-list
65055482|NCT00235001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65055483|NCT00235001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65055484|NCT00235001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65055487|NCT00235001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055520|NCT00235079|Antimitotic Agents|antimitotic agents|mesh-ancestor
65055521|NCT00235079|Mitosis Modulators|mitosis modulators|mesh-ancestor
65055522|NCT00235079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055523|NCT00235079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055524|NCT00260988|Dalteparin|dalteparin|mesh-list
65055525|NCT00260988|Tinzaparin|tinzaparin|mesh-list
65055526|NCT00260988|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65055527|NCT00260988|Anticoagulants|anticoagulants|mesh-ancestor
65055528|NCT00260988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65055529|NCT00260988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64540792|NCT00690495|Propofol|propofol|mesh-list
65055530|NCT00260988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055531|NCT00235157|Sirolimus|sirolimus|mesh-list
65055532|NCT00235157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65055533|NCT00235157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65055534|NCT00235157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65055535|NCT00235157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055536|NCT00235157|Antifungal Agents|antifungal agents|mesh-ancestor
65055537|NCT00235157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65055538|NCT00235157|Immunologic Factors|immunologic factors|mesh-ancestor
65055539|NCT00235157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055540|NCT04550338|Tranexamic Acid|tranexamic acid|mesh-list
65055541|NCT04550338|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65055542|NCT04550338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65055543|NCT04550338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055544|NCT04550338|Hemostatics|hemostatics|mesh-ancestor
65055545|NCT04550338|Coagulants|coagulants|mesh-ancestor
65055546|NCT04550611|Immunoglobulins|immunoglobulins|mesh-list
65055547|NCT04550611|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65055548|NCT04550611|Antibodies|antibodies|mesh-list
65055549|NCT04550611|gamma-Globulins|gamma-globulins|mesh-list
65055550|NCT04550611|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65055551|NCT04550611|Immunologic Factors|immunologic factors|mesh-ancestor
65055552|NCT04550611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055555|NCT00261027|Exemestane|exemestane|mesh-list
65055561|NCT00261027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65055562|NCT00261027|Hormone Antagonists|hormone antagonists|mesh-ancestor
65055563|NCT00261027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65055564|NCT00261027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055565|NCT00235235|Gemcitabine|gemcitabine|mesh-list
65055566|NCT00235235|Cyclophosphamide|cyclophosphamide|mesh-list
65055567|NCT00235235|Doxorubicin|doxorubicin|mesh-list
65055568|NCT00235235|Capecitabine|capecitabine|mesh-list
65055569|NCT00235235|Vinorelbine|vinorelbine|mesh-list
65055570|NCT00235235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65055571|NCT00235235|Immunologic Factors|immunologic factors|mesh-ancestor
65055572|NCT00235235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055573|NCT00235235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65055574|NCT00235235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65055575|NCT00235235|Alkylating Agents|alkylating agents|mesh-ancestor
65055576|NCT00235235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055577|NCT00235235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055578|NCT00235235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65055579|NCT00235235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65055580|NCT00235235|Antimetabolites|antimetabolites|mesh-ancestor
65055581|NCT00235235|Antiviral Agents|antiviral agents|mesh-ancestor
65055582|NCT00235235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65055583|NCT00235235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055584|NCT00235235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65055585|NCT00235235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65055586|NCT00235235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65055587|NCT00235235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65055588|NCT00235235|Tubulin Modulators|tubulin modulators|mesh-ancestor
65055589|NCT00235235|Antimitotic Agents|antimitotic agents|mesh-ancestor
65055590|NCT00235235|Mitosis Modulators|mitosis modulators|mesh-ancestor
65055591|NCT00268359|Bevacizumab|bevacizumab|mesh-list
65055592|NCT00268359|Irinotecan|irinotecan|mesh-list
65055594|NCT00268359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055603|NCT00268359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055604|NCT00235274|Secretin|secretin|mesh-list
65055605|NCT00235274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65055606|NCT00235274|Hormones|hormones|mesh-ancestor
65055607|NCT00235274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65055608|NCT00235274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055609|NCT00268398|Leucovorin|leucovorin|mesh-list
65055610|NCT00268398|Folic Acid|folic acid|mesh-list
65055611|NCT00268398|Fluorouracil|fluorouracil|mesh-list
65055612|NCT00268398|Oxaliplatin|oxaliplatin|mesh-list
65055613|NCT00268398|Irinotecan|irinotecan|mesh-list
65055614|NCT00268398|Levoleucovorin|levoleucovorin|mesh-list
65055615|NCT00268398|Antimetabolites|antimetabolites|mesh-ancestor
65055616|NCT00268398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055617|NCT00268398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65055618|NCT00268398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055619|NCT00268398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65055620|NCT00268398|Immunologic Factors|immunologic factors|mesh-ancestor
65055621|NCT00268398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055622|NCT00268398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65055623|NCT00268398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65055624|NCT00268398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055625|NCT00268398|Antidotes|antidotes|mesh-ancestor
65055626|NCT00268398|Protective Agents|protective agents|mesh-ancestor
65055627|NCT00268398|Vitamin B Complex|vitamin b complex|mesh-ancestor
65055628|NCT00268398|Vitamins|vitamins|mesh-ancestor
65055629|NCT00268398|Micronutrients|micronutrients|mesh-ancestor
65055630|NCT00268398|Hematinics|hematinics|mesh-ancestor
65055631|NCT00235313|Nicotine|nicotine|mesh-list
65055632|NCT00235313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65055633|NCT00235313|Autonomic Agents|autonomic agents|mesh-ancestor
65055634|NCT00235313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65055635|NCT00235313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055636|NCT00235313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64907611|NCT00000826|Dapsone|dapsone|mesh-list
64951523|NCT00026273|Protective Agents|protective agents|mesh-ancestor
64951524|NCT00026273|Vitamin B Complex|vitamin b complex|mesh-ancestor
64951525|NCT00026273|Vitamins|vitamins|mesh-ancestor
64951526|NCT00026273|Micronutrients|micronutrients|mesh-ancestor
64951527|NCT00054405|Aldesleukin|aldesleukin|mesh-list
64951528|NCT00054405|Interleukin-2|interleukin-2|mesh-list
64951529|NCT00054405|Interleukin-12|interleukin-12|mesh-list
64951530|NCT00054405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951531|NCT00054405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64951532|NCT00054405|Analgesics|analgesics|mesh-ancestor
65055637|NCT00235313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65055638|NCT00235313|Cholinergic Agents|cholinergic agents|mesh-ancestor
65055639|NCT00235313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65055640|NCT00235313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055641|NCT04549012|Tranexamic Acid|tranexamic acid|mesh-list
65055642|NCT04549012|Oxytocin|oxytocin|mesh-list
65055643|NCT04549012|Oxytocics|oxytocics|mesh-ancestor
65055644|NCT04549012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65055645|NCT04549012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055646|NCT04549012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65055647|NCT04549012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65055648|NCT04549012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055649|NCT04549012|Hemostatics|hemostatics|mesh-ancestor
65055650|NCT04549012|Coagulants|coagulants|mesh-ancestor
65055651|NCT00261105|Telithromycin|telithromycin|mesh-list
65055652|NCT00261105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65055653|NCT00261105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65055654|NCT00235508|Eszopiclone|eszopiclone|mesh-list
65055655|NCT00235508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65055656|NCT00235508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65055657|NCT00235508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055658|NCT00268515|Cyclosporine|cyclosporine|mesh-list
65055659|NCT00268515|Prednisone|prednisone|mesh-list
65055660|NCT00268515|Azathioprine|azathioprine|mesh-list
65055661|NCT00268515|Tacrolimus|tacrolimus|mesh-list
65055662|NCT00268515|Cyclosporins|cyclosporins|mesh-list
65055663|NCT00268515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65055664|NCT00268515|Glucocorticoids|glucocorticoids|mesh-ancestor
65055665|NCT00268515|Hormones|hormones|mesh-ancestor
65055666|NCT00268515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65055667|NCT00268515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055668|NCT00268515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64540939|NCT03147378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055675|NCT00268515|Antifungal Agents|antifungal agents|mesh-ancestor
65055676|NCT00268515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65055677|NCT00268515|Dermatologic Agents|dermatologic agents|mesh-ancestor
65055678|NCT00268515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65055679|NCT00268515|Antimetabolites|antimetabolites|mesh-ancestor
65055680|NCT00268515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65055681|NCT04548700|Prednisone|prednisone|mesh-list
65055682|NCT04548700|Cyclophosphamide|cyclophosphamide|mesh-list
65055683|NCT04548700|Vincristine|vincristine|mesh-list
65055684|NCT04548700|Mitoxantrone|mitoxantrone|mesh-list
65055685|NCT04548700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65055686|NCT04548700|Immunologic Factors|immunologic factors|mesh-ancestor
65055687|NCT04548700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055688|NCT04548700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65055689|NCT04548700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65055690|NCT04548700|Alkylating Agents|alkylating agents|mesh-ancestor
65055691|NCT04548700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055692|NCT04548700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055693|NCT04548700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65055694|NCT04548700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65055695|NCT04548700|Glucocorticoids|glucocorticoids|mesh-ancestor
65055696|NCT04548700|Hormones|hormones|mesh-ancestor
65055697|NCT04548700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65055698|NCT04548700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65055700|NCT04548700|Tubulin Modulators|tubulin modulators|mesh-ancestor
65055722|NCT02212561|Abortifacient Agents|abortifacient agents|mesh-ancestor
65055723|NCT02212561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65055724|NCT02212561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055725|NCT02212561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65055726|NCT02212561|Antimetabolites|antimetabolites|mesh-ancestor
65055727|NCT02212561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055728|NCT02212561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055729|NCT02212561|Dermatologic Agents|dermatologic agents|mesh-ancestor
65055730|NCT02212561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055731|NCT02212561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65055732|NCT02212561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65055733|NCT02212561|Immunologic Factors|immunologic factors|mesh-ancestor
65055734|NCT02212561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65055735|NCT02212561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65055736|NCT02212561|Antiviral Agents|antiviral agents|mesh-ancestor
65055737|NCT02212561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65055738|NCT02212561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65055739|NCT00268554|Dipyridamole|dipyridamole|mesh-list
65055740|NCT00268554|Caffeine|caffeine|mesh-list
65055741|NCT00268554|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65055742|NCT00268554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055743|NCT00268554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65055744|NCT00268554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055745|NCT00268554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055746|NCT00268554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65055747|NCT00268554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65055748|NCT00268554|Purinergic Agents|purinergic agents|mesh-ancestor
65055749|NCT00268554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65055750|NCT00268554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65055752|NCT00268593|Prednisone|prednisone|mesh-list
65055764|NCT00268593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65055765|NCT04555525|Sarecycline|sarecycline|mesh-list
65055766|NCT04555525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65055767|NCT04555525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65055768|NCT04555525|Dermatologic Agents|dermatologic agents|mesh-ancestor
65055769|NCT00261183|Melatonin|melatonin|mesh-list
65055770|NCT00261183|Antioxidants|antioxidants|mesh-ancestor
65055771|NCT00261183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055772|NCT00261183|Protective Agents|protective agents|mesh-ancestor
65055773|NCT00261183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055774|NCT00261183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65055775|NCT00268632|Risedronic Acid|risedronic acid|mesh-list
65055776|NCT00268632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65055777|NCT00268632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65055778|NCT00268632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055779|NCT00268632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65055780|NCT00268632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055781|NCT00268632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65055782|NCT04554979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65055783|NCT04554979|Hydroxychloroquine|hydroxychloroquine|mesh-list
65055784|NCT04554979|Anticoagulants|anticoagulants|mesh-list
65055785|NCT04554979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65055786|NCT04554979|Antimalarials|antimalarials|mesh-ancestor
65055787|NCT04554979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65055814|NCT00268671|Antimitotic Agents|antimitotic agents|mesh-ancestor
65055815|NCT00268671|Mitosis Modulators|mitosis modulators|mesh-ancestor
65055816|NCT00268671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055817|NCT04554433|Ethanol|ethanol|mesh-list
65055818|NCT04554433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65055819|NCT04554433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65055820|NCT04554433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65055821|NCT04554433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055822|NCT04721054|Lidocaine|lidocaine|mesh-list
65055823|NCT04721054|Bupivacaine|bupivacaine|mesh-list
65055824|NCT04721054|Anesthetics|anesthetics|mesh-list
65055825|NCT04721054|Anesthetics, Local|anesthetics, local|mesh-ancestor
65055826|NCT04721054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65055827|NCT04721054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055828|NCT04721054|Sensory System Agents|sensory system agents|mesh-ancestor
65055829|NCT04721054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65055830|NCT04721054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65055831|NCT04721054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65055832|NCT04721054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65055833|NCT04721054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65055834|NCT04721054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055836|NCT02212639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65055837|NCT02212639|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65055838|NCT02212639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055839|NCT02212639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055840|NCT02212639|Protective Agents|protective agents|mesh-ancestor
65055841|NCT02212639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055842|NCT02212756|Metformin|metformin|mesh-list
65055843|NCT02212756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65055844|NCT02212756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055845|NCT02212795|Levofloxacin|levofloxacin|mesh-list
65055846|NCT02212795|Ofloxacin|ofloxacin|mesh-list
65055847|NCT02212795|Fluoroquinolones|fluoroquinolones|mesh-list
65055849|NCT02212795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65055855|NCT02212795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055856|NCT02212795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055857|NCT02212795|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65055858|NCT02212795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65055859|NCT02212795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65055860|NCT00261261|Midazolam|midazolam|mesh-list
65055861|NCT00261261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65055862|NCT00261261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65055863|NCT00261261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65055864|NCT00261261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055865|NCT00261261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65055866|NCT00261261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65055867|NCT00261261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65055868|NCT00261261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65055869|NCT00261261|Anesthetics, General|anesthetics, general|mesh-ancestor
65055870|NCT00261261|Anesthetics|anesthetics|mesh-ancestor
65055871|NCT00261261|GABA Modulators|gaba modulators|mesh-ancestor
65055872|NCT00261261|GABA Agents|gaba agents|mesh-ancestor
65055873|NCT00261261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65055874|NCT00261261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055875|NCT00235820|Adalimumab|adalimumab|mesh-list
65055876|NCT00235820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65055877|NCT00235820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65055878|NCT00268710|Docetaxel|docetaxel|mesh-list
65055879|NCT00268710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055884|NCT00261300|Pantoprazole|pantoprazole|mesh-list
65055903|NCT02212990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055904|NCT00235859|Adalimumab|adalimumab|mesh-list
65055905|NCT00235859|Methotrexate|methotrexate|mesh-list
65055906|NCT00235859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65055907|NCT00235859|Abortifacient Agents|abortifacient agents|mesh-ancestor
65055908|NCT00235859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65055909|NCT00235859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055910|NCT00235859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65055911|NCT00235859|Antimetabolites|antimetabolites|mesh-ancestor
65055912|NCT00235859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055913|NCT00235859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055914|NCT00235859|Dermatologic Agents|dermatologic agents|mesh-ancestor
65055915|NCT00235859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055916|NCT00235859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65055917|NCT00235859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65055918|NCT00235859|Immunologic Factors|immunologic factors|mesh-ancestor
65055919|NCT00235859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65055920|NCT00235859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65055921|NCT00235859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65055923|NCT02213029|Oxytocics|oxytocics|mesh-ancestor
65055958|NCT02213224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055959|NCT02213224|Vasodilator Agents|vasodilator agents|mesh-ancestor
65055960|NCT02213224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65055961|NCT02213224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65055962|NCT02213224|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65055963|NCT02213224|Protease Inhibitors|protease inhibitors|mesh-ancestor
65055964|NCT02213224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055965|NCT00268788|Immunoglobulins|immunoglobulins|mesh-list
65055966|NCT00268788|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65055967|NCT00268788|Antibodies|antibodies|mesh-list
65055968|NCT00268788|gamma-Globulins|gamma-globulins|mesh-list
65055969|NCT00268788|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65055970|NCT00268788|Immunologic Factors|immunologic factors|mesh-ancestor
65055971|NCT00268788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055972|NCT00235937|Anastrozole|anastrozole|mesh-list
65055973|NCT00235937|Goserelin|goserelin|mesh-list
65055974|NCT00235937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65055975|NCT00235937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65055976|NCT00235937|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65055977|NCT00235937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65055978|NCT00235937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65055979|NCT00235937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65055980|NCT00235937|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65055981|NCT00235937|Hormone Antagonists|hormone antagonists|mesh-ancestor
65055982|NCT00235937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65055983|NCT00235937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65055984|NCT00261339|Pantoprazole|pantoprazole|mesh-list
65055985|NCT00261339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65056003|NCT00261378|Doxorubicin|doxorubicin|mesh-list
65056004|NCT00261378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65056005|NCT00261378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65056006|NCT00261378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056007|NCT00261378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65056008|NCT00261378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65056009|NCT00261378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056010|NCT00261378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056011|NCT04553458|Ethanol|ethanol|mesh-list
65056012|NCT04553458|Sorafenib|sorafenib|mesh-list
65056013|NCT04553458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056014|NCT04553458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65056015|NCT04553458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056016|NCT04553458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056017|NCT04553458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65056018|NCT04553458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65056019|NCT04553458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65056020|NCT04553458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056059|NCT02213614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65056060|NCT02213614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056061|NCT02213614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056062|NCT02213614|Antimanic Agents|antimanic agents|mesh-ancestor
65056063|NCT02213614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65056064|NCT02213614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65056065|NCT02213614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056067|NCT02213653|Trace Elements|trace elements|mesh-ancestor
65056068|NCT02213653|Micronutrients|micronutrients|mesh-ancestor
65056069|NCT02213653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056070|NCT04552444|Biapenem|biapenem|mesh-list
65056071|NCT04552444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65056072|NCT00236171|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
65056073|NCT00236171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65056074|NCT04552405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65056075|NCT02213848|Calcium|calcium|mesh-list
65056076|NCT02213848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65056118|NCT00261612|Glucocorticoids|glucocorticoids|mesh-ancestor
65056119|NCT00261612|Hormones|hormones|mesh-ancestor
65056120|NCT00261612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65056121|NCT00261612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65056122|NCT04547764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65056123|NCT04547764|Calcium|calcium|mesh-list
65056124|NCT04547764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65056125|NCT04547764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056126|NCT04547764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65056127|NCT04547608|Propofol|propofol|mesh-list
64541380|NCT05089344|Fertility Agents|fertility agents|mesh-ancestor
65056128|NCT04547608|Rocuronium|rocuronium|mesh-list
65056129|NCT04547608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65056130|NCT04547608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65056131|NCT04547608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056132|NCT04547608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65056133|NCT04547608|Anesthetics, General|anesthetics, general|mesh-ancestor
65056134|NCT04547608|Anesthetics|anesthetics|mesh-ancestor
65056135|NCT04547608|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65056136|NCT04547608|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65056137|NCT04547608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65056138|NCT04547608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65056139|NCT00236249|Lidocaine|lidocaine|mesh-list
65056140|NCT00236249|Anesthetics, Local|anesthetics, local|mesh-ancestor
65056141|NCT00236249|Anesthetics|anesthetics|mesh-ancestor
65056142|NCT00236249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65056143|NCT00236249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056144|NCT00236249|Sensory System Agents|sensory system agents|mesh-ancestor
65056151|NCT00269061|Pioglitazone|pioglitazone|mesh-list
65056162|NCT04547335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056163|NCT04547335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056164|NCT04547335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65056165|NCT04547335|Hormone Antagonists|hormone antagonists|mesh-ancestor
65056166|NCT04547335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65056167|NCT04547335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056168|NCT04547335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65056169|NCT00236288|Bupropion|bupropion|mesh-list
65056170|NCT00236288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65056171|NCT00236288|Antidepressive Agents|antidepressive agents|mesh-ancestor
65056172|NCT00236288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65056173|NCT00236288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65056174|NCT00236288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65056175|NCT00236288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65056176|NCT00236288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056177|NCT00236288|Dopamine Agents|dopamine agents|mesh-ancestor
65056178|NCT00236288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65056179|NCT00236288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056180|NCT00236288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65056181|NCT00236288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65056182|NCT00236288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056212|NCT04547179|Sensory System Agents|sensory system agents|mesh-ancestor
65056213|NCT04547179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65056214|NCT04547179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056215|NCT00236405|Epoetin Alfa|epoetin alfa|mesh-list
65056216|NCT00236405|Hematinics|hematinics|mesh-ancestor
65056217|NCT00236444|Risperidone|risperidone|mesh-list
65056218|NCT00236444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65056219|NCT00236444|Serotonin Agents|serotonin agents|mesh-ancestor
65056220|NCT00236444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65056221|NCT00236444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056222|NCT00236444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056223|NCT00236444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65056224|NCT00236444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65056225|NCT00236444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65056226|NCT00236444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65056227|NCT00236444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65056228|NCT00236444|Dopamine Agents|dopamine agents|mesh-ancestor
65056229|NCT00269217|Niacin|niacin|mesh-list
65056230|NCT00269217|Niacinamide|niacinamide|mesh-list
65056231|NCT00269217|Nicotinic Acids|nicotinic acids|mesh-list
65056232|NCT00269217|Simvastatin|simvastatin|mesh-list
65056233|NCT00269217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65056234|NCT00269217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65056235|NCT00269217|Antimetabolites|antimetabolites|mesh-ancestor
65056236|NCT00269217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056237|NCT00269217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65056238|NCT00269217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65056239|NCT00269217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056260|NCT00236483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65056261|NCT04545970|Sunscreening Agents|sunscreening agents|mesh-list
65056262|NCT04545970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65056263|NCT04545970|Protective Agents|protective agents|mesh-ancestor
65056264|NCT04545970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056265|NCT04545970|Dermatologic Agents|dermatologic agents|mesh-ancestor
65056266|NCT04545931|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65056267|NCT04545931|Hemostatics|hemostatics|mesh-ancestor
65056268|NCT04545931|Coagulants|coagulants|mesh-ancestor
65056269|NCT04545931|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65056270|NCT04545931|Natriuretic Agents|natriuretic agents|mesh-ancestor
65056271|NCT04545931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056272|NCT00236522|Levofloxacin|levofloxacin|mesh-list
65056273|NCT00236522|Ofloxacin|ofloxacin|mesh-list
65056274|NCT00236522|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65056275|NCT00236522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65056276|NCT00236522|Renal Agents|renal agents|mesh-ancestor
65056277|NCT00236522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65056278|NCT00236522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65056279|NCT00236522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65056280|NCT00236522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056281|NCT00236522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056282|NCT00236522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056283|NCT00236522|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65056284|NCT00236522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65056285|NCT00261729|Prazosin|prazosin|mesh-list
65056286|NCT00261729|Paroxetine|paroxetine|mesh-list
65056287|NCT00261729|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65056288|NCT00261729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65056289|NCT00261729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65056290|NCT00261729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056291|NCT00261729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65056292|NCT00261729|Serotonin Agents|serotonin agents|mesh-ancestor
65056295|NCT00261729|Antidepressive Agents|antidepressive agents|mesh-ancestor
65056299|NCT00261729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056300|NCT00261729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65056301|NCT00261729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65056302|NCT00261729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65056303|NCT00261729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65056304|NCT00261729|Adrenergic Agents|adrenergic agents|mesh-ancestor
65056305|NCT00236561|Topiramate|topiramate|mesh-list
65056306|NCT00236561|Propranolol|propranolol|mesh-list
65056307|NCT00236561|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65056308|NCT00236561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65056309|NCT00236561|Adrenergic Agents|adrenergic agents|mesh-ancestor
65056310|NCT00236561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65056311|NCT00236561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056312|NCT00236561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056313|NCT00236561|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65056314|NCT00236561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65056315|NCT00236561|Vasodilator Agents|vasodilator agents|mesh-ancestor
65056316|NCT00236561|Anticonvulsants|anticonvulsants|mesh-ancestor
65056317|NCT00236561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65056318|NCT02215330|Eplerenone|eplerenone|mesh-list
65056319|NCT02215330|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65056320|NCT02215330|Hormone Antagonists|hormone antagonists|mesh-ancestor
65056321|NCT02215330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65056322|NCT02215330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056323|NCT02215330|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65056324|NCT02215330|Diuretics|diuretics|mesh-ancestor
65056325|NCT02215330|Natriuretic Agents|natriuretic agents|mesh-ancestor
65056326|NCT02215330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65056327|NCT02278510|Topotecan|topotecan|mesh-list
65056328|NCT02278510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65056329|NCT02278510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65056330|NCT02278510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056331|NCT02278510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056333|NCT04545892|Capsaicin|capsaicin|mesh-list
65056338|NCT04545892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056339|NCT02214706|Sirolimus|sirolimus|mesh-list
65056340|NCT02214706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65056341|NCT02214706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65056342|NCT02214706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65056343|NCT02214706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056344|NCT02214706|Antifungal Agents|antifungal agents|mesh-ancestor
65056345|NCT02214706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65056346|NCT02214706|Immunologic Factors|immunologic factors|mesh-ancestor
65056347|NCT02214706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056348|NCT00236600|Topiramate|topiramate|mesh-list
65056349|NCT00236600|Anticonvulsants|anticonvulsants|mesh-ancestor
65056350|NCT00236600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65056351|NCT00236600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056352|NCT00236639|Topiramate|topiramate|mesh-list
65056353|NCT00236639|Anticonvulsants|anticonvulsants|mesh-ancestor
65056354|NCT00236639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65056355|NCT00236639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056356|NCT04545463|Psyllium|psyllium|mesh-list
65056357|NCT04545463|Cathartics|cathartics|mesh-ancestor
65056358|NCT04545463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65056359|NCT00236678|Epoetin Alfa|epoetin alfa|mesh-list
65056360|NCT00236678|Hematinics|hematinics|mesh-ancestor
65056361|NCT00269334|Paroxetine|paroxetine|mesh-list
65056362|NCT00269334|Citalopram|citalopram|mesh-list
65056363|NCT00269334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65056364|NCT00269334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65056365|NCT00269334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65056366|NCT00269334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056386|NCT00236717|Valproic Acid|valproic acid|mesh-list
65056387|NCT00236717|Anticonvulsants|anticonvulsants|mesh-ancestor
65056388|NCT00236717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65056389|NCT00236717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056390|NCT00236717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056391|NCT00236717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056392|NCT00236717|GABA Agents|gaba agents|mesh-ancestor
65056393|NCT00236717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65056394|NCT00236717|Antimanic Agents|antimanic agents|mesh-ancestor
65056395|NCT00236717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65056396|NCT00236717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65056397|NCT00236717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65056398|NCT00236717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65056399|NCT00236717|Analgesics|analgesics|mesh-ancestor
65056400|NCT00236717|Sensory System Agents|sensory system agents|mesh-ancestor
65056401|NCT00236717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65056402|NCT00236717|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65056403|NCT00236717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65056404|NCT00236717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65056405|NCT00236717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65056406|NCT04540666|Propofol|propofol|mesh-list
65056407|NCT04540666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65056408|NCT04540666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65056410|NCT04540666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65056437|NCT00236795|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
65056438|NCT00236795|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65056439|NCT00236795|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65056440|NCT04540627|Palivizumab|palivizumab|mesh-list
65056441|NCT04540627|Antiviral Agents|antiviral agents|mesh-ancestor
65056442|NCT04540627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65056443|NCT00236834|Levofloxacin|levofloxacin|mesh-list
65056445|NCT00236834|Imipenem|imipenem|mesh-list
65056446|NCT00236834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65056447|NCT00236834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65056448|NCT00236834|Renal Agents|renal agents|mesh-ancestor
65056449|NCT00236834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65056450|NCT00236834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65056451|NCT00236834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65056452|NCT00236834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056453|NCT00236834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056454|NCT00236834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056455|NCT00236834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65056456|NCT00236834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65056457|NCT00236873|Topiramate|topiramate|mesh-list
65056458|NCT00236873|Anticonvulsants|anticonvulsants|mesh-ancestor
65056459|NCT00236873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64908493|NCT00000252|Nitrous Oxide|nitrous oxide|mesh-list
65056491|NCT00237068|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65056492|NCT00237068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056493|NCT00237068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056494|NCT00269568|Misoprostol|misoprostol|mesh-list
65056495|NCT00269568|Mifepristone|mifepristone|mesh-list
65056496|NCT00269568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65056497|NCT00269568|Abortifacient Agents|abortifacient agents|mesh-ancestor
65056498|NCT00269568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65056499|NCT00269568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056500|NCT00269568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65056501|NCT00269568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65056502|NCT00269568|Oxytocics|oxytocics|mesh-ancestor
65056503|NCT00269568|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65056505|NCT00269568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65056506|NCT00269568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65056507|NCT00269568|Contraceptive Agents|contraceptive agents|mesh-ancestor
65056508|NCT00269568|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65056509|NCT00269568|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65056510|NCT00269568|Hormone Antagonists|hormone antagonists|mesh-ancestor
65056511|NCT00269568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65056512|NCT00269568|Luteolytic Agents|luteolytic agents|mesh-ancestor
65056513|NCT00269568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65056514|NCT00269568|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65056515|NCT00237146|Zoledronic Acid|zoledronic acid|mesh-list
65056516|NCT00237146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65056517|NCT00237146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056518|NCT04544059|Lenalidomide|lenalidomide|mesh-list
65056519|NCT04544059|Immunologic Factors|immunologic factors|mesh-ancestor
65056520|NCT04544059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056534|NCT00237224|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65056535|NCT00237224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65056536|NCT00237224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056537|NCT00237224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056538|NCT00237224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65056539|NCT00237224|Hormone Antagonists|hormone antagonists|mesh-ancestor
65056540|NCT00237224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65056541|NCT00237224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056542|NCT00237263|Entacapone|entacapone|mesh-list
65056543|NCT00237263|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65056544|NCT00237263|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65056545|NCT00237263|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65056546|NCT00237263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056547|NCT00237263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056548|NCT00237302|Topiramate|topiramate|mesh-list
65056549|NCT00237302|Anticonvulsants|anticonvulsants|mesh-ancestor
65056550|NCT00237302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65056551|NCT00237302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056552|NCT00262275|Aspirin|aspirin|mesh-list
65056553|NCT00262275|Clopidogrel|clopidogrel|mesh-list
65056554|NCT00262275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65056555|NCT00262275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65056556|NCT00262275|Analgesics|analgesics|mesh-ancestor
65056557|NCT00262275|Sensory System Agents|sensory system agents|mesh-ancestor
65056558|NCT00262275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65056559|NCT00262275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056560|NCT00262275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65056579|NCT02214979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056580|NCT02214979|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65056581|NCT02214979|Protease Inhibitors|protease inhibitors|mesh-ancestor
65056582|NCT02214979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056583|NCT00237341|Fentanyl|fentanyl|mesh-list
65056584|NCT00237341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65056585|NCT00237341|Narcotics|narcotics|mesh-ancestor
65056586|NCT00237341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65056587|NCT00237341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056588|NCT00237341|Analgesics|analgesics|mesh-ancestor
65056589|NCT00237341|Sensory System Agents|sensory system agents|mesh-ancestor
65056590|NCT00237341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65056591|NCT00237341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65056592|NCT00237341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65056593|NCT00237341|Anesthetics, General|anesthetics, general|mesh-ancestor
65056594|NCT00237341|Anesthetics|anesthetics|mesh-ancestor
65056595|NCT04539301|Anticoagulants|anticoagulants|mesh-list
65056596|NCT00237419|Infliximab|infliximab|mesh-list
65056597|NCT00237419|Dermatologic Agents|dermatologic agents|mesh-ancestor
65056598|NCT00237419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65056599|NCT00237419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65056601|NCT04539106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65056602|NCT04539106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65056603|NCT04539106|Growth Substances|growth substances|mesh-ancestor
65056604|NCT04539106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056605|NCT04539106|Growth Inhibitors|growth inhibitors|mesh-ancestor
65056606|NCT04539106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056607|NCT00237497|Zopiclone|zopiclone|mesh-list
65056608|NCT00237497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65056609|NCT00237497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65056610|NCT00237497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056624|NCT00416169|Autonomic Agents|autonomic agents|mesh-ancestor
65056625|NCT00416169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65056626|NCT00416169|Nootropic Agents|nootropic agents|mesh-ancestor
65056627|NCT00237536|Lonidamine|lonidamine|mesh-list
65056628|NCT00237536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056629|NCT00237536|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
65056630|NCT00237536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056631|NCT00237536|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65056632|NCT00237536|Contraceptive Agents|contraceptive agents|mesh-ancestor
65056633|NCT00237536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65056634|NCT00237536|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65056635|NCT00237536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65056636|NCT00237536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65056637|NCT00237536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65056638|NCT02215720|Sirolimus|sirolimus|mesh-list
65056639|NCT02215720|Cetuximab|cetuximab|mesh-list
65056640|NCT02215720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65056641|NCT02215720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056642|NCT02215720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65056643|NCT02215720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65056644|NCT02215720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65056645|NCT02215720|Antifungal Agents|antifungal agents|mesh-ancestor
65056646|NCT02215720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65056647|NCT02215720|Immunologic Factors|immunologic factors|mesh-ancestor
65056648|NCT02215720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056649|NCT00416208|Bortezomib|bortezomib|mesh-list
65056650|NCT00416208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056651|NCT02215798|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64498009|NCT05603013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056652|NCT02215798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65056653|NCT02215798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65056654|NCT02215798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64908616|NCT03295747|Parasympatholytics|parasympatholytics|mesh-ancestor
64951533|NCT00054405|Sensory System Agents|sensory system agents|mesh-ancestor
64951534|NCT00054405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64951535|NCT00054405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951536|NCT00054405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64951537|NCT00054405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64951538|NCT00054405|Antiviral Agents|antiviral agents|mesh-ancestor
64951539|NCT00054405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951540|NCT00054405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64951541|NCT00054405|Immunologic Factors|immunologic factors|mesh-ancestor
64951542|NCT00054405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65056655|NCT02215798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056656|NCT02215798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65056657|NCT02215798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056658|NCT02215798|Analgesics|analgesics|mesh-ancestor
65056659|NCT02215798|Sensory System Agents|sensory system agents|mesh-ancestor
65056660|NCT02215798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65056661|NCT02215798|Antidepressive Agents|antidepressive agents|mesh-ancestor
65056662|NCT02215798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65056663|NCT02215798|Dopamine Agents|dopamine agents|mesh-ancestor
65056664|NCT02215018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65056665|NCT02215057|Lidocaine|lidocaine|mesh-list
65056666|NCT02215057|Anesthetics|anesthetics|mesh-list
65056667|NCT02215057|Anesthetics, Local|anesthetics, local|mesh-ancestor
65056668|NCT02215057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65056669|NCT02215057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056670|NCT02215057|Sensory System Agents|sensory system agents|mesh-ancestor
65056671|NCT02215057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65056672|NCT02215057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65056673|NCT02215057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65056674|NCT02215057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65056675|NCT02215057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65056676|NCT02215057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056677|NCT00269685|Vasopressins|vasopressins|mesh-list
65056678|NCT00269685|Arginine Vasopressin|arginine vasopressin|mesh-list
65056679|NCT00269685|Hemostatics|hemostatics|mesh-ancestor
65056680|NCT00269685|Coagulants|coagulants|mesh-ancestor
65056681|NCT00269685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65056685|NCT04543123|Citalopram|citalopram|mesh-list
65056701|NCT04539418|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65056702|NCT04539418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65056703|NCT04539418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056704|NCT04539418|Hemostatics|hemostatics|mesh-ancestor
65056705|NCT04539418|Coagulants|coagulants|mesh-ancestor
65056706|NCT00269724|Oxybutynin|oxybutynin|mesh-list
65056707|NCT00269724|Parasympatholytics|parasympatholytics|mesh-ancestor
65056708|NCT00269724|Autonomic Agents|autonomic agents|mesh-ancestor
65056709|NCT00269724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65056710|NCT00269724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056711|NCT00269724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65056712|NCT00269724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65056713|NCT00269724|Cholinergic Agents|cholinergic agents|mesh-ancestor
65056714|NCT00269724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65056715|NCT00269724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056716|NCT00269724|Urological Agents|urological agents|mesh-ancestor
65056717|NCT04710017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65056718|NCT04710017|Tranexamic Acid|tranexamic acid|mesh-list
65056719|NCT04710017|Medroxyprogesterone|medroxyprogesterone|mesh-list
65056720|NCT04710017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65056721|NCT04710017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65056722|NCT04710017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056723|NCT04710017|Hemostatics|hemostatics|mesh-ancestor
65056724|NCT04710017|Coagulants|coagulants|mesh-ancestor
65056725|NCT04710017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65056726|NCT04710017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65056727|NCT04710017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65056728|NCT04710017|Contraceptive Agents|contraceptive agents|mesh-ancestor
65056729|NCT04710017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65056730|NCT04710017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056745|NCT04538521|Micronutrients|micronutrients|mesh-ancestor
65056746|NCT04538521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494067|NCT03743636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056748|NCT00269763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65056749|NCT00269763|Narcotics|narcotics|mesh-ancestor
65056750|NCT00269763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65056751|NCT00269763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056752|NCT00269763|Analgesics|analgesics|mesh-ancestor
65056753|NCT00269763|Sensory System Agents|sensory system agents|mesh-ancestor
65056754|NCT00269763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65056755|NCT00269763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65056756|NCT00269763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65056757|NCT00269763|Anesthetics, General|anesthetics, general|mesh-ancestor
65056758|NCT00269763|Anesthetics|anesthetics|mesh-ancestor
65056759|NCT00237575|Gemcitabine|gemcitabine|mesh-list
65056760|NCT00237575|Sargramostim|sargramostim|mesh-list
65056761|NCT00237575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056762|NCT00237575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65056763|NCT00237575|Antimetabolites|antimetabolites|mesh-ancestor
65056764|NCT00237575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056765|NCT00237575|Antiviral Agents|antiviral agents|mesh-ancestor
65056766|NCT00237575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65056767|NCT00237575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056768|NCT00237575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65056769|NCT00237575|Immunologic Factors|immunologic factors|mesh-ancestor
65056770|NCT00237575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056771|NCT00269802|Methylphenidate|methylphenidate|mesh-list
65056772|NCT00269802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65056773|NCT00269802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056774|NCT00269802|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65056775|NCT00269802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65056776|NCT00269802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65056777|NCT00269802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056778|NCT00269802|Dopamine Agents|dopamine agents|mesh-ancestor
65056779|NCT00269802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64951543|NCT00054405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64951544|NCT00054405|Growth Substances|growth substances|mesh-ancestor
64951545|NCT00054405|Growth Inhibitors|growth inhibitors|mesh-ancestor
64951546|NCT00026351|Rituximab|rituximab|mesh-list
65056780|NCT02215174|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65056781|NCT02215174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65056782|NCT02215174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65056783|NCT02215174|Antimetabolites|antimetabolites|mesh-ancestor
65056784|NCT02215174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056785|NCT02215174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65056786|NCT02215174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65056787|NCT02215174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056788|NCT00237614|Acetylcysteine|acetylcysteine|mesh-list
65056789|NCT00237614|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65056790|NCT00237614|Antiviral Agents|antiviral agents|mesh-ancestor
65056791|NCT00237614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65056792|NCT00237614|Expectorants|expectorants|mesh-ancestor
65056793|NCT00237614|Respiratory System Agents|respiratory system agents|mesh-ancestor
65056794|NCT00237614|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65056795|NCT00237614|Antioxidants|antioxidants|mesh-ancestor
65056796|NCT00237614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056797|NCT00237614|Protective Agents|protective agents|mesh-ancestor
65056798|NCT00237614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056799|NCT00237614|Antidotes|antidotes|mesh-ancestor
65056800|NCT00269841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65056801|NCT00269841|Infliximab|infliximab|mesh-list
65056802|NCT00269841|Antibodies|antibodies|mesh-list
65056803|NCT00269841|Immunoglobulins|immunoglobulins|mesh-list
65056804|NCT00269841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65056805|NCT00269841|Immunologic Factors|immunologic factors|mesh-ancestor
65056806|NCT00269841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056807|NCT00269841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056808|NCT00269841|Dermatologic Agents|dermatologic agents|mesh-ancestor
65056809|NCT00269841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65056810|NCT00269841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65056811|NCT00414128|Mycophenolic Acid|mycophenolic acid|mesh-list
65056823|NCT00414128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65056824|NCT00414128|Antitubercular Agents|antitubercular agents|mesh-ancestor
65056825|NCT00414128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65056826|NCT00414128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65056827|NCT00414128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056828|NCT04538365|Triclosan|triclosan|mesh-list
65056829|NCT04538365|Propranolol|propranolol|mesh-list
65056830|NCT04538365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65056831|NCT04538365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65056832|NCT04538365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65056833|NCT04538365|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65056834|NCT04538365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65056835|NCT04538365|Antimetabolites|antimetabolites|mesh-ancestor
65056836|NCT04538365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056837|NCT04538365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65056838|NCT04538365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65056839|NCT04538365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65056840|NCT04538365|Adrenergic Agents|adrenergic agents|mesh-ancestor
65056841|NCT04538365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65056842|NCT04538365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056843|NCT04538365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65056844|NCT04538365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65056845|NCT04538365|Vasodilator Agents|vasodilator agents|mesh-ancestor
65056846|NCT00414245|Metformin|metformin|mesh-list
65056847|NCT00414245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65056848|NCT00414245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056849|NCT00269880|Heparin|heparin|mesh-list
65056850|NCT00269880|Abciximab|abciximab|mesh-list
65056851|NCT00269880|Anticoagulants|anticoagulants|mesh-ancestor
65056852|NCT00269880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65056853|NCT00269880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65056854|NCT00269880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056855|NCT00269880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65056856|NCT00237653|Valganciclovir|valganciclovir|mesh-list
65056865|NCT02215876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056866|NCT02215876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65056867|NCT02215876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65056868|NCT02215876|Alkylating Agents|alkylating agents|mesh-ancestor
65056869|NCT02215876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056870|NCT02215876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056871|NCT02215876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65056872|NCT02215876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65056873|NCT02215876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65056874|NCT02215876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65056875|NCT02215876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65056876|NCT00269997|Epoetin Alfa|epoetin alfa|mesh-list
65056877|NCT00269997|Hematinics|hematinics|mesh-ancestor
65056878|NCT00237731|Morphine|morphine|mesh-list
65056879|NCT00237731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65056880|NCT00237731|Narcotics|narcotics|mesh-ancestor
65056881|NCT00237731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65056882|NCT00237731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056883|NCT00237731|Analgesics|analgesics|mesh-ancestor
65056884|NCT00237731|Sensory System Agents|sensory system agents|mesh-ancestor
65056885|NCT00237731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65056886|NCT04542226|Bromides|bromides|mesh-list
65056887|NCT04542226|Anticonvulsants|anticonvulsants|mesh-ancestor
65056888|NCT00270036|Epoetin Alfa|epoetin alfa|mesh-list
65056889|NCT00270036|Hematinics|hematinics|mesh-ancestor
65056890|NCT00262392|Pamidronate|pamidronate|mesh-list
65056891|NCT00262392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65056892|NCT00262392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056893|NCT04537780|Montelukast|montelukast|mesh-list
65056894|NCT04537780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65494068|NCT03743636|Protective Agents|protective agents|mesh-ancestor
65056895|NCT04537780|Respiratory System Agents|respiratory system agents|mesh-ancestor
65056906|NCT02215993|Ticagrelor|ticagrelor|mesh-list
65056907|NCT02215993|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65056908|NCT02215993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65056909|NCT02215993|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65056910|NCT02215993|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65056911|NCT02215993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65056912|NCT02215993|Purinergic Agents|purinergic agents|mesh-ancestor
65056913|NCT02215993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65056914|NCT02215993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056915|NCT02215993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056916|NCT02216149|Capecitabine|capecitabine|mesh-list
65056917|NCT02216149|Tegafur|tegafur|mesh-list
65056918|NCT02216149|Oxaliplatin|oxaliplatin|mesh-list
65056919|NCT02216149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65056920|NCT02216149|Antimetabolites|antimetabolites|mesh-ancestor
65056921|NCT02216149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056922|NCT02216149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056923|NCT00238004|Nicotinic Acids|nicotinic acids|mesh-list
65056924|NCT00238004|Niacin|niacin|mesh-list
65056925|NCT00238004|Niacinamide|niacinamide|mesh-list
65056926|NCT00238004|Vitamin B Complex|vitamin b complex|mesh-ancestor
65056927|NCT00238004|Vitamins|vitamins|mesh-ancestor
65056928|NCT00238004|Micronutrients|micronutrients|mesh-ancestor
65056929|NCT00238004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056930|NCT00238004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65056931|NCT00238004|Antimetabolites|antimetabolites|mesh-ancestor
65056932|NCT00238004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056933|NCT00238004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65056934|NCT00238004|Vasodilator Agents|vasodilator agents|mesh-ancestor
65056935|NCT00262548|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65056936|NCT00262548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65056937|NCT00262548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65056949|NCT00415584|Hormone Antagonists|hormone antagonists|mesh-ancestor
65056950|NCT00415584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65056951|NCT04536922|Aldesleukin|aldesleukin|mesh-list
65056952|NCT04536922|Cyclophosphamide|cyclophosphamide|mesh-list
65056953|NCT04536922|Pembrolizumab|pembrolizumab|mesh-list
65056955|NCT04536922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65056956|NCT04536922|Immunologic Factors|immunologic factors|mesh-ancestor
65056957|NCT04536922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056958|NCT04536922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65056959|NCT04536922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65056960|NCT04536922|Alkylating Agents|alkylating agents|mesh-ancestor
65056961|NCT04536922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056962|NCT04536922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65056963|NCT04536922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65056964|NCT04536922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65056965|NCT04536922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65056966|NCT04536922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65056967|NCT04536922|Antiviral Agents|antiviral agents|mesh-ancestor
65056968|NCT04536922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65056969|NCT00238082|Beclomethasone|beclomethasone|mesh-list
65056970|NCT00238082|Norflurane|norflurane|mesh-list
65056971|NCT00238082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65243440|NCT00694863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65056973|NCT00238082|Hormones|hormones|mesh-ancestor
65056974|NCT00238082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65056975|NCT00238082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65056976|NCT00238082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65056978|NCT00238082|Anesthetics|anesthetics|mesh-ancestor
65056995|NCT00238160|Antimetabolites|antimetabolites|mesh-ancestor
65056996|NCT00238160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65056997|NCT00238160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65056998|NCT00238160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65056999|NCT00238160|Immunologic Factors|immunologic factors|mesh-ancestor
65057000|NCT00238160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057001|NCT00415701|Hydrocortisone|hydrocortisone|mesh-list
65057002|NCT00415701|Propofol|propofol|mesh-list
65057003|NCT00415701|Etomidate|etomidate|mesh-list
65057004|NCT00415701|Cosyntropin|cosyntropin|mesh-list
65057005|NCT00415701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65057006|NCT00415701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65057007|NCT00415701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057008|NCT00415701|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65057009|NCT00415701|Anesthetics, General|anesthetics, general|mesh-ancestor
65057010|NCT00415701|Anesthetics|anesthetics|mesh-ancestor
65057011|NCT00415701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65057012|NCT00415701|Hormones|hormones|mesh-ancestor
65057013|NCT00415701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65057014|NCT02961998|Celecoxib|celecoxib|mesh-list
65057015|NCT02961998|Sorafenib|sorafenib|mesh-list
65057016|NCT02961998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057017|NCT02961998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65057018|NCT02961998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057043|NCT00262587|Hormones|hormones|mesh-ancestor
65057045|NCT00262587|Sympathomimetics|sympathomimetics|mesh-ancestor
65057046|NCT00238199|Calcitriol|calcitriol|mesh-list
65057047|NCT00238199|Docetaxel|docetaxel|mesh-list
65057048|NCT00238199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057049|NCT00238199|Tubulin Modulators|tubulin modulators|mesh-ancestor
65057050|NCT00238199|Antimitotic Agents|antimitotic agents|mesh-ancestor
65057051|NCT00238199|Mitosis Modulators|mitosis modulators|mesh-ancestor
65057052|NCT00238199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057053|NCT00238199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65057054|NCT00238199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057055|NCT00238199|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65057056|NCT00238199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65057057|NCT00238199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65057058|NCT00238199|Vitamins|vitamins|mesh-ancestor
65057059|NCT00238199|Micronutrients|micronutrients|mesh-ancestor
65057060|NCT00238199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65057061|NCT04536493|Lidocaine|lidocaine|mesh-list
65057062|NCT04536493|Epinephrine|epinephrine|mesh-list
65057063|NCT04536493|Racepinephrine|racepinephrine|mesh-list
65057064|NCT04536493|Tetracaine|tetracaine|mesh-list
65057065|NCT04536493|Epinephryl borate|epinephryl borate|mesh-list
65057066|NCT04536493|Anesthetics, Local|anesthetics, local|mesh-ancestor
65057067|NCT04536493|Anesthetics|anesthetics|mesh-ancestor
65057068|NCT04536493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65057069|NCT04536493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057070|NCT04536493|Sensory System Agents|sensory system agents|mesh-ancestor
65057071|NCT04536493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65057072|NCT04536493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65057073|NCT04536493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65057074|NCT04536493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65057089|NCT04536181|Prednisone|prednisone|mesh-list
65057091|NCT04536181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65057092|NCT04536181|Glucocorticoids|glucocorticoids|mesh-ancestor
65057093|NCT04536181|Hormones|hormones|mesh-ancestor
65057094|NCT04536181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65057095|NCT04536181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057096|NCT04536181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65057097|NCT04536181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057098|NCT04535869|Sofosbuvir|sofosbuvir|mesh-list
65057099|NCT04535869|Antiviral Agents|antiviral agents|mesh-ancestor
65057100|NCT04535869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65057101|NCT02216227|Iodine|iodine|mesh-list
65057102|NCT02216227|Chlorhexidine|chlorhexidine|mesh-list
65057103|NCT02216227|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64542367|NCT05632549|Biotin|biotin|mesh-list
65057104|NCT02216227|Povidone-Iodine|povidone-iodine|mesh-list
65057105|NCT02216227|Vancomycin|vancomycin|mesh-list
65057106|NCT02216227|Cefazolin|cefazolin|mesh-list
65057107|NCT02216227|Mupirocin|mupirocin|mesh-list
65057108|NCT02216227|Povidone|povidone|mesh-list
65057109|NCT02216227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65057110|NCT02216227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65057111|NCT02216227|Disinfectants|disinfectants|mesh-ancestor
65057112|NCT02216227|Dermatologic Agents|dermatologic agents|mesh-ancestor
65057113|NCT02216227|Trace Elements|trace elements|mesh-ancestor
65057114|NCT02216227|Micronutrients|micronutrients|mesh-ancestor
65057115|NCT02216227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057116|NCT02216227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65057117|NCT02216227|Plasma Substitutes|plasma substitutes|mesh-ancestor
65057118|NCT02216227|Blood Substitutes|blood substitutes|mesh-ancestor
65057119|NCT02216227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65057120|NCT02216227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057121|NCT02216227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057122|NCT00238277|Temozolomide|temozolomide|mesh-list
65057123|NCT00238277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65057134|NCT02216266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057135|NCT02216266|Miotics|miotics|mesh-ancestor
65057136|NCT02216266|Autonomic Agents|autonomic agents|mesh-ancestor
65057137|NCT02216266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65057138|NCT00238316|Letrozole|letrozole|mesh-list
65057139|NCT00238316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057140|NCT00238316|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65057141|NCT00238316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65057142|NCT00238316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057143|NCT00238316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057144|NCT00238316|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65057145|NCT00238316|Hormone Antagonists|hormone antagonists|mesh-ancestor
65057146|NCT00238316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65057147|NCT00238316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057148|NCT04535518|Aspirin|aspirin|mesh-list
65057149|NCT04535518|Infliximab|infliximab|mesh-list
65057150|NCT04535518|Immunoglobulins|immunoglobulins|mesh-list
65057151|NCT04535518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65057152|NCT04535518|gamma-Globulins|gamma-globulins|mesh-list
65057153|NCT04535518|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65057154|NCT04535518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65057155|NCT04535518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65057156|NCT04535518|Analgesics|analgesics|mesh-ancestor
65057157|NCT04535518|Sensory System Agents|sensory system agents|mesh-ancestor
65057158|NCT04535518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65057159|NCT04535518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057160|NCT04535518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65057161|NCT04535518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65057162|NCT04535518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65057180|NCT00262782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498533|NCT01613027|Rituximab|rituximab|mesh-list
65057181|NCT00238394|Cediranib|cediranib|mesh-list
65057182|NCT00238394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057183|NCT00238394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057184|NCT00238394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057185|NCT00238394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65057186|NCT00238472|Nateglinide|nateglinide|mesh-list
65057187|NCT00238472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65057188|NCT00238472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057189|NCT00238628|Bexarotene|bexarotene|mesh-list
65057190|NCT00238628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057191|NCT02216617|Docetaxel|docetaxel|mesh-list
65057192|NCT02216617|Afatinib|afatinib|mesh-list
65057193|NCT02216617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057194|NCT02216617|Tubulin Modulators|tubulin modulators|mesh-ancestor
65057195|NCT02216617|Antimitotic Agents|antimitotic agents|mesh-ancestor
65057196|NCT02216617|Mitosis Modulators|mitosis modulators|mesh-ancestor
65057197|NCT02216617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057198|NCT02216617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65057199|NCT02216617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057200|NCT00262977|Aspirin|aspirin|mesh-list
65057201|NCT00262977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65057202|NCT00262977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65057203|NCT00262977|Analgesics|analgesics|mesh-ancestor
65057204|NCT00262977|Sensory System Agents|sensory system agents|mesh-ancestor
65057231|NCT00238667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65057232|NCT00238667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65057233|NCT00238667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65057234|NCT00238667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65057235|NCT00238667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057236|NCT00238667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65057237|NCT00238667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65057238|NCT00238667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057239|NCT00238667|Antipyretics|antipyretics|mesh-ancestor
65057240|NCT00238667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65057241|NCT00238667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65057242|NCT00238667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65057243|NCT00238667|Purinergic Agents|purinergic agents|mesh-ancestor
65057244|NCT00238667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65057245|NCT00238667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65057246|NCT00238667|Vasodilator Agents|vasodilator agents|mesh-ancestor
65057247|NCT00263016|Docetaxel|docetaxel|mesh-list
65057248|NCT00263016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057249|NCT00263016|Tubulin Modulators|tubulin modulators|mesh-ancestor
65057250|NCT00263016|Antimitotic Agents|antimitotic agents|mesh-ancestor
65057284|NCT04534231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65057285|NCT04534231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057286|NCT00263094|Rofecoxib|rofecoxib|mesh-list
65057287|NCT00263094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65057288|NCT00263094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65057289|NCT00263094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057290|NCT00263094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057291|NCT00263094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65057292|NCT00263094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65057293|NCT00263094|Analgesics|analgesics|mesh-ancestor
65057294|NCT00263094|Sensory System Agents|sensory system agents|mesh-ancestor
65057295|NCT00263094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65057296|NCT00263094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057297|NCT00263094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65057298|NCT00263094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65057299|NCT00238784|Budesonide|budesonide|mesh-list
65057300|NCT00238784|Formoterol Fumarate|formoterol fumarate|mesh-list
65057301|NCT00238784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65057302|NCT00238784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65057303|NCT00238784|Autonomic Agents|autonomic agents|mesh-ancestor
65057304|NCT00238784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65057309|NCT00238784|Hormones|hormones|mesh-ancestor
65057334|NCT04533724|Dopamine Agents|dopamine agents|mesh-ancestor
65057335|NCT04533724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65057336|NCT04533724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057337|NCT04533724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65057338|NCT04533724|Antidepressive Agents|antidepressive agents|mesh-ancestor
65057339|NCT00238901|Basiliximab|basiliximab|mesh-list
65057340|NCT00238901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65057341|NCT00238901|Immunologic Factors|immunologic factors|mesh-ancestor
65057342|NCT00238901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057343|NCT00238940|Mycophenolic Acid|mycophenolic acid|mesh-list
65057344|NCT00238940|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65057345|NCT00238940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057346|NCT00238940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65057347|NCT00238940|Antitubercular Agents|antitubercular agents|mesh-ancestor
65057348|NCT00238940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65057349|NCT00238940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65057351|NCT00238940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057352|NCT00238979|Mycophenolic Acid|mycophenolic acid|mesh-list
65057353|NCT00238979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65057354|NCT00238979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057355|NCT00238979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65057356|NCT00238979|Antitubercular Agents|antitubercular agents|mesh-ancestor
65057357|NCT00238979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65057358|NCT00238979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65057359|NCT00238979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057360|NCT00238979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057361|NCT00239018|Mycophenolic Acid|mycophenolic acid|mesh-list
65057380|NCT00239057|Antitubercular Agents|antitubercular agents|mesh-ancestor
65057381|NCT00239057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65057382|NCT00239057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65057383|NCT00239057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057384|NCT00239057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057385|NCT02217007|Calcium, Dietary|calcium, dietary|mesh-list
65057386|NCT02217007|Acamprosate|acamprosate|mesh-list
65057387|NCT02217007|Calcium|calcium|mesh-list
65057388|NCT02217007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65057389|NCT02217007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057390|NCT02217007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65057391|NCT02217007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65057392|NCT00239096|Losartan|losartan|mesh-list
65057393|NCT00239096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65057394|NCT00239096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65057395|NCT00239096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65057396|NCT00239096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65057397|NCT00239096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057398|NCT04532554|Hormones|hormones|mesh-list
65057431|NCT00239174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057432|NCT00239174|Hormones|hormones|mesh-ancestor
65057433|NCT00239174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65057434|NCT00239174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057435|NCT04531423|Golimumab|golimumab|mesh-list
65057436|NCT04531423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65057437|NCT04531423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65057438|NCT04531423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65057439|NCT04531423|Immunologic Factors|immunologic factors|mesh-ancestor
65057440|NCT04531423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057441|NCT00239252|Interferons|interferons|mesh-list
65057442|NCT00239252|Interferon alfacon-1|interferon alfacon-1|mesh-list
65057443|NCT00239252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057444|NCT00239252|Antiviral Agents|antiviral agents|mesh-ancestor
65057445|NCT00239252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65057446|NCT00263406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65057447|NCT00263406|Protease Inhibitors|protease inhibitors|mesh-ancestor
65057448|NCT00263406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057449|NCT00263406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057450|NCT04531267|Calcium|calcium|mesh-list
65057451|NCT04531267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65057453|NCT04531228|Lenvatinib|lenvatinib|mesh-list
65057482|NCT00414323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057483|NCT00414323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65057484|NCT00414323|Serotonin Agents|serotonin agents|mesh-ancestor
65057485|NCT00414323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057486|NCT00414323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65057487|NCT00414323|Antidepressive Agents|antidepressive agents|mesh-ancestor
65057488|NCT00414323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65057489|NCT00414323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65057490|NCT00414323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65057491|NCT00414323|Analgesics|analgesics|mesh-ancestor
65057492|NCT00414323|Sensory System Agents|sensory system agents|mesh-ancestor
65057493|NCT00414323|Dopamine Agents|dopamine agents|mesh-ancestor
65057494|NCT00263484|Zoledronic Acid|zoledronic acid|mesh-list
65057496|NCT00263484|Dexamethasone|dexamethasone|mesh-list
65057497|NCT00263484|Dexamethasone acetate|dexamethasone acetate|mesh-list
65057498|NCT00263484|BB 1101|bb 1101|mesh-list
65057499|NCT00263484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65057500|NCT00263484|Antiemetics|antiemetics|mesh-ancestor
65057501|NCT00263484|Autonomic Agents|autonomic agents|mesh-ancestor
65057502|NCT00263484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65057503|NCT00263484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057504|NCT00263484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65057505|NCT00263484|Glucocorticoids|glucocorticoids|mesh-ancestor
65057506|NCT00263484|Hormones|hormones|mesh-ancestor
65057507|NCT00263484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65057508|NCT00263484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65057509|NCT00263484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057510|NCT00263484|Protease Inhibitors|protease inhibitors|mesh-ancestor
65057511|NCT00263484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057512|NCT00263484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057513|NCT00263484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65057514|NCT00263484|Immunologic Factors|immunologic factors|mesh-ancestor
65057515|NCT00263484|Leprostatic Agents|leprostatic agents|mesh-ancestor
65057523|NCT02217319|Sevoflurane|sevoflurane|mesh-list
65057524|NCT02217319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65057525|NCT02217319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65057526|NCT02217319|Anesthetics, General|anesthetics, general|mesh-ancestor
65057527|NCT02217319|Anesthetics|anesthetics|mesh-ancestor
65057528|NCT02217319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65057529|NCT02217319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057530|NCT02217514|Midazolam|midazolam|mesh-list
65057531|NCT02217514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65057532|NCT02217514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65057533|NCT02217514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65057534|NCT02217514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057535|NCT02217514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65057536|NCT02217514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65057537|NCT02217514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65057538|NCT02217514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65057539|NCT02217514|Anesthetics, General|anesthetics, general|mesh-ancestor
65057540|NCT02217514|Anesthetics|anesthetics|mesh-ancestor
65057541|NCT02217514|GABA Modulators|gaba modulators|mesh-ancestor
65057542|NCT02217514|GABA Agents|gaba agents|mesh-ancestor
65057543|NCT02217514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65057544|NCT02217514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057545|NCT02217553|Cholecalciferol|cholecalciferol|mesh-list
65057546|NCT02217553|Vitamin D|vitamin d|mesh-list
65057547|NCT02217553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65057548|NCT02217553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057574|NCT02217670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057575|NCT00239291|Gefitinib|gefitinib|mesh-list
65057576|NCT00239291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057577|NCT00239291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65057578|NCT00239291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057579|NCT00239291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057580|NCT02217826|Octreotide|octreotide|mesh-list
65057581|NCT02217826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65057582|NCT02217826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65057583|NCT02217826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057584|NCT00239330|Atorvastatin|atorvastatin|mesh-list
65057585|NCT00239330|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65057586|NCT00239330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65057587|NCT00239330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65057588|NCT00239330|Antimetabolites|antimetabolites|mesh-ancestor
65057589|NCT00239330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057590|NCT00239330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65057591|NCT00239330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65057592|NCT00239330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057593|NCT02218021|Oxycodone|oxycodone|mesh-list
65057594|NCT02218021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65057595|NCT02218021|Narcotics|narcotics|mesh-ancestor
65057596|NCT02218021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65057597|NCT02218021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057598|NCT02218021|Analgesics|analgesics|mesh-ancestor
65057599|NCT02218021|Sensory System Agents|sensory system agents|mesh-ancestor
65057600|NCT02218021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65057621|NCT00239408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65057622|NCT00239408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057623|NCT00239408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65057624|NCT00239408|Respiratory System Agents|respiratory system agents|mesh-ancestor
64498986|NCT01843205|Methamphetamine|methamphetamine|mesh-list
65057625|NCT00239408|Parasympatholytics|parasympatholytics|mesh-ancestor
65057626|NCT00239408|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65057627|NCT00239408|Cholinergic Agents|cholinergic agents|mesh-ancestor
65057686|NCT00239447|Tiotropium Bromide|tiotropium bromide|mesh-list
65057687|NCT00239447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65057688|NCT00239447|Autonomic Agents|autonomic agents|mesh-ancestor
65057689|NCT00239447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65057690|NCT00239447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057691|NCT00239447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65057692|NCT00239447|Respiratory System Agents|respiratory system agents|mesh-ancestor
65057693|NCT00239447|Parasympatholytics|parasympatholytics|mesh-ancestor
65057694|NCT00239447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65057695|NCT00239447|Cholinergic Agents|cholinergic agents|mesh-ancestor
65057696|NCT00239447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65057697|NCT00239447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057698|NCT00263796|Oxytocin|oxytocin|mesh-list
65057699|NCT00263796|Oxytocics|oxytocics|mesh-ancestor
65057700|NCT00263796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65057701|NCT00263796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057702|NCT01642108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65057703|NCT01642108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65057704|NCT01642108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057705|NCT01642108|Incretins|incretins|mesh-ancestor
65057706|NCT01642108|Hormones|hormones|mesh-ancestor
65057707|NCT01642108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65057708|NCT01642108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65057709|NCT01642108|Protease Inhibitors|protease inhibitors|mesh-ancestor
65057710|NCT01642108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057711|NCT01642108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057712|NCT00250185|Acetylcholine|acetylcholine|mesh-list
65057713|NCT00250185|Vasodilator Agents|vasodilator agents|mesh-ancestor
65057714|NCT00250185|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65057715|NCT00250185|Cholinergic Agents|cholinergic agents|mesh-ancestor
65057716|NCT00250185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65243443|NCT00629213|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65057719|NCT00239486|Pramipexole|pramipexole|mesh-list
65057725|NCT00239486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65057726|NCT00239486|Dopamine Agonists|dopamine agonists|mesh-ancestor
65057727|NCT00239486|Dopamine Agents|dopamine agents|mesh-ancestor
65057728|NCT00239486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65057729|NCT01642966|Ticagrelor|ticagrelor|mesh-list
65057730|NCT01642966|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65057731|NCT01642966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65057732|NCT01642966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65057733|NCT01642966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65057734|NCT01642966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65057735|NCT01642966|Purinergic Agents|purinergic agents|mesh-ancestor
65057736|NCT01642966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65057737|NCT01642966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057738|NCT01642966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057739|NCT01643083|Rifaximin|rifaximin|mesh-list
65057740|NCT01643083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65057741|NCT01643083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65057742|NCT01643083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65057743|NCT01643278|Ipilimumab|ipilimumab|mesh-list
65057744|NCT01643278|Dasatinib|dasatinib|mesh-list
65057745|NCT01643278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65057746|NCT01643278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057747|NCT01643278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65057748|NCT01643278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057749|NCT01643278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65057750|NCT01643278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057751|NCT01643629|Minoxidil|minoxidil|mesh-list
65057752|NCT01643629|Finasteride|finasteride|mesh-list
65057753|NCT01643629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65057754|NCT01643629|Vasodilator Agents|vasodilator agents|mesh-ancestor
65057755|NCT01643629|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65057756|NCT01643629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65057757|NCT01643629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057758|NCT01643629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057759|NCT01643629|Hormone Antagonists|hormone antagonists|mesh-ancestor
65057760|NCT01643629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64909723|NCT04004416|Lorazepam|lorazepam|mesh-list
65057761|NCT01643629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057762|NCT01643629|Urological Agents|urological agents|mesh-ancestor
65057763|NCT01644253|Rituximab|rituximab|mesh-list
65057764|NCT01644253|Obinutuzumab|obinutuzumab|mesh-list
65057765|NCT01644253|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65057766|NCT01644253|Idelalisib|idelalisib|mesh-list
65057767|NCT01644253|Immunoglobulin G|immunoglobulin g|mesh-list
65057768|NCT01644253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65057769|NCT01644253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057770|NCT01644253|Immunologic Factors|immunologic factors|mesh-ancestor
65057771|NCT01644253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057772|NCT01644253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65057773|NCT01644253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65057774|NCT01644253|Alkylating Agents|alkylating agents|mesh-ancestor
65057775|NCT01644253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057776|NCT01644253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057777|NCT01644799|Lenalidomide|lenalidomide|mesh-list
65057778|NCT01644799|Idelalisib|idelalisib|mesh-list
65057779|NCT01644799|Immunologic Factors|immunologic factors|mesh-ancestor
65057780|NCT01644799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057781|NCT01644799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65057782|NCT01644799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65057783|NCT01644799|Growth Substances|growth substances|mesh-ancestor
65057784|NCT01644799|Growth Inhibitors|growth inhibitors|mesh-ancestor
65057785|NCT01644799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057786|NCT01644799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057787|NCT01644799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057788|NCT01644838|Promethazine|promethazine|mesh-list
65057789|NCT01644838|Diphenhydramine|diphenhydramine|mesh-list
65057806|NCT01644838|Histamine Antagonists|histamine antagonists|mesh-ancestor
65057807|NCT01644838|Histamine Agents|histamine agents|mesh-ancestor
65057808|NCT01644838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65057809|NCT01644838|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65057810|NCT01644838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65057811|NCT01644838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65057812|NCT01644838|Anesthetics, Local|anesthetics, local|mesh-ancestor
65057813|NCT01644838|Anesthetics|anesthetics|mesh-ancestor
65057814|NCT01644838|Sensory System Agents|sensory system agents|mesh-ancestor
65057815|NCT01644955|Carboplatin|carboplatin|mesh-list
65057816|NCT01644955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057817|NCT01644994|Cisplatin|cisplatin|mesh-list
65057818|NCT01644994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057819|NCT04528888|Methylprednisolone|methylprednisolone|mesh-list
65057820|NCT04528888|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65057821|NCT04528888|Heparin|heparin|mesh-list
65057822|NCT04528888|Enoxaparin|enoxaparin|mesh-list
65057823|NCT04528888|Calcium heparin|calcium heparin|mesh-list
65057824|NCT04528888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65057825|NCT04528888|Antiemetics|antiemetics|mesh-ancestor
65057826|NCT04528888|Autonomic Agents|autonomic agents|mesh-ancestor
65057827|NCT04528888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65057828|NCT04528888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057829|NCT04528888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65057830|NCT04528888|Glucocorticoids|glucocorticoids|mesh-ancestor
65057831|NCT04528888|Hormones|hormones|mesh-ancestor
65057832|NCT04528888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65057833|NCT04528888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65057834|NCT04528888|Protective Agents|protective agents|mesh-ancestor
65057835|NCT04528888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65057836|NCT04528888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057837|NCT04528888|Anticoagulants|anticoagulants|mesh-ancestor
65057838|NCT04528888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65057849|NCT01645384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65057850|NCT01645384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65057851|NCT01645384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057852|NCT00239798|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65057853|NCT00239798|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65057854|NCT00239798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057855|NCT00239798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65057856|NCT00239798|Immunologic Factors|immunologic factors|mesh-ancestor
65057857|NCT00239798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057858|NCT01645423|Atorvastatin|atorvastatin|mesh-list
65057859|NCT01645423|Calcium|calcium|mesh-list
65057860|NCT01645423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65057861|NCT01645423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057862|NCT01645423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65057863|NCT01645423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65057864|NCT01645423|Antimetabolites|antimetabolites|mesh-ancestor
65057865|NCT01645423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057866|NCT01645423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65057867|NCT01645423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65057868|NCT01645423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057869|NCT01645774|Oxymetazoline|oxymetazoline|mesh-list
65057870|NCT01645774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65057871|NCT01645774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65057872|NCT01645774|Adrenergic Agents|adrenergic agents|mesh-ancestor
65057873|NCT01645774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65057874|NCT01645774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057875|NCT01645774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057876|NCT01645774|Sympathomimetics|sympathomimetics|mesh-ancestor
65057890|NCT02961075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057891|NCT01646281|Flecainide|flecainide|mesh-list
65057892|NCT01646281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65057893|NCT01646281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65057894|NCT01646281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65057895|NCT01646281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65057896|NCT01646281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057897|NCT01646554|Oxaliplatin|oxaliplatin|mesh-list
65057898|NCT01646554|Aflibercept|aflibercept|mesh-list
65057899|NCT01646554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057900|NCT01646554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65057901|NCT01646554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65057902|NCT01646554|Growth Substances|growth substances|mesh-ancestor
65057903|NCT01646554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057904|NCT01646554|Growth Inhibitors|growth inhibitors|mesh-ancestor
65057905|NCT00264069|Antipsychotic Agents|antipsychotic agents|mesh-list
65057906|NCT00264069|Antidepressive Agents|antidepressive agents|mesh-list
65057907|NCT00264069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65057908|NCT00264069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65057909|NCT00264069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65057910|NCT00264069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057911|NCT01646788|Paclitaxel|paclitaxel|mesh-list
65057912|NCT01646788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65057913|NCT01646788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65057914|NCT01646788|Tubulin Modulators|tubulin modulators|mesh-ancestor
65057915|NCT01646788|Antimitotic Agents|antimitotic agents|mesh-ancestor
65057916|NCT01646788|Mitosis Modulators|mitosis modulators|mesh-ancestor
65057917|NCT01646788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057918|NCT01647256|Nikkomycin|nikkomycin|mesh-list
65057919|NCT01647256|Antifungal Agents|antifungal agents|mesh-ancestor
65057920|NCT01647256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65057921|NCT01647256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057922|NCT01647256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057930|NCT00239954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057931|NCT00239954|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65057932|NCT00239954|Antidepressive Agents|antidepressive agents|mesh-ancestor
65057933|NCT00239954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65057934|NCT04528927|Azithromycin|azithromycin|mesh-list
65057935|NCT04528927|Doxycycline|doxycycline|mesh-list
65057936|NCT04528927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65057937|NCT04528927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65057938|NCT04528927|Antimalarials|antimalarials|mesh-ancestor
65057939|NCT04528927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65057940|NCT04528927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65057942|NCT04720287|Neostigmine|neostigmine|mesh-list
65057943|NCT04720287|Anesthetics, Local|anesthetics, local|mesh-ancestor
65057944|NCT04720287|Anesthetics|anesthetics|mesh-ancestor
65057945|NCT04720287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65057946|NCT04720287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057947|NCT04720287|Sensory System Agents|sensory system agents|mesh-ancestor
65057948|NCT04720287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65057949|NCT04720287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65057950|NCT04720287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057951|NCT04720287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057952|NCT04720287|Cholinergic Agents|cholinergic agents|mesh-ancestor
65057953|NCT04720287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65057954|NCT04720287|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65057955|NCT04720287|Autonomic Agents|autonomic agents|mesh-ancestor
65057956|NCT00239993|Glatiramer Acetate|glatiramer acetate|mesh-list
65057980|NCT01647529|Ganciclovir|ganciclovir|mesh-list
65057981|NCT01647529|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65057982|NCT01647529|Antiviral Agents|antiviral agents|mesh-ancestor
65057983|NCT01647529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65057984|NCT01647529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65057985|NCT01647529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65057986|NCT01647529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057987|NCT00240032|Cetirizine|cetirizine|mesh-list
65057988|NCT00240032|Glatiramer Acetate|glatiramer acetate|mesh-list
65057989|NCT00240032|(T,G)-A-L|(t,g)-a-l|mesh-list
65057990|NCT00240032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65057991|NCT00240032|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65057992|NCT00240032|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65057993|NCT00240032|Histamine Antagonists|histamine antagonists|mesh-ancestor
65057994|NCT00240032|Histamine Agents|histamine agents|mesh-ancestor
65057995|NCT00240032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65057996|NCT00240032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65057997|NCT00240032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65057999|NCT00240032|Immunologic Factors|immunologic factors|mesh-ancestor
65058000|NCT00240032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65058001|NCT00240032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65058002|NCT00240149|Insulin|insulin|mesh-list
65058003|NCT00240149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65058004|NCT00240149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65058005|NCT00240149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058006|NCT01647646|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65058007|NCT01647646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65058008|NCT01647646|Respiratory System Agents|respiratory system agents|mesh-ancestor
65058009|NCT01647646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65058010|NCT01647646|Autonomic Agents|autonomic agents|mesh-ancestor
65058011|NCT01647646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058012|NCT01647646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058013|NCT01647646|Glucocorticoids|glucocorticoids|mesh-ancestor
65058014|NCT01647646|Hormones|hormones|mesh-ancestor
65058016|NCT01647646|Sympathomimetics|sympathomimetics|mesh-ancestor
65058020|NCT01647685|Prednisolone|prednisolone|mesh-list
65058021|NCT01647685|Prednisolone acetate|prednisolone acetate|mesh-list
65058022|NCT01647685|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65058023|NCT01647685|Prednisolone phosphate|prednisolone phosphate|mesh-list
65058024|NCT01647685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65058025|NCT01647685|Antiemetics|antiemetics|mesh-ancestor
65058026|NCT01647685|Autonomic Agents|autonomic agents|mesh-ancestor
65058027|NCT01647685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058028|NCT01647685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058029|NCT01647685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65058030|NCT01647685|Glucocorticoids|glucocorticoids|mesh-ancestor
65058031|NCT01647685|Hormones|hormones|mesh-ancestor
65058032|NCT01647685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65058033|NCT01647685|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65058034|NCT01647685|Protective Agents|protective agents|mesh-ancestor
65058035|NCT01647685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65058036|NCT01647685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058037|NCT00240266|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65058038|NCT00240266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65058039|NCT00240266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65058040|NCT00240266|Antimetabolites|antimetabolites|mesh-ancestor
65058041|NCT00240266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910073|NCT00000882|Antiviral Agents|antiviral agents|mesh-ancestor
65058071|NCT01648231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65058072|NCT01648231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65058073|NCT01648231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65058074|NCT00264186|Norepinephrine|norepinephrine|mesh-list
65058075|NCT00264186|Nitroglycerin|nitroglycerin|mesh-list
65058076|NCT00264186|Acetylcholine|acetylcholine|mesh-list
65058077|NCT00264186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65058078|NCT00264186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65058079|NCT00264186|Adrenergic Agents|adrenergic agents|mesh-ancestor
65058080|NCT00264186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65058081|NCT00264186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058082|NCT00264186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058083|NCT00264186|Sympathomimetics|sympathomimetics|mesh-ancestor
65058084|NCT00264186|Autonomic Agents|autonomic agents|mesh-ancestor
65058085|NCT00264186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058086|NCT00264186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65058087|NCT00264186|Vasodilator Agents|vasodilator agents|mesh-ancestor
65058088|NCT00264186|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65058089|NCT00264186|Cholinergic Agents|cholinergic agents|mesh-ancestor
65058090|NCT00240422|Telmisartan|telmisartan|mesh-list
65058092|NCT00240422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65058093|NCT00240422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65058094|NCT00240422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65058095|NCT00240422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058096|NCT00240422|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65058097|NCT00240422|Protease Inhibitors|protease inhibitors|mesh-ancestor
65058098|NCT00240422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058099|NCT00264225|Codeine|codeine|mesh-list
65058100|NCT00264225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65058101|NCT00264225|Narcotics|narcotics|mesh-ancestor
65058102|NCT00264225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65058103|NCT00264225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058104|NCT00264225|Analgesics|analgesics|mesh-ancestor
65058105|NCT00264225|Sensory System Agents|sensory system agents|mesh-ancestor
65058106|NCT00264225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058108|NCT00264225|Respiratory System Agents|respiratory system agents|mesh-ancestor
65058109|NCT02279563|Fluticasone|fluticasone|mesh-list
65058110|NCT02279563|Xhance|xhance|mesh-list
65058111|NCT02279563|Azelastine|azelastine|mesh-list
65058112|NCT02279563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65058113|NCT02279563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65058114|NCT02279563|Autonomic Agents|autonomic agents|mesh-ancestor
65058115|NCT02279563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058116|NCT02279563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058117|NCT02279563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65058118|NCT02279563|Respiratory System Agents|respiratory system agents|mesh-ancestor
65058119|NCT02279563|Dermatologic Agents|dermatologic agents|mesh-ancestor
65058120|NCT02279563|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65058121|NCT02279563|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65058122|NCT02279563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058123|NCT02279563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058124|NCT02279563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65058125|NCT02279563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65058126|NCT02279563|Histamine Antagonists|histamine antagonists|mesh-ancestor
65058127|NCT02279563|Histamine Agents|histamine agents|mesh-ancestor
65058128|NCT02279563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65058129|NCT02279758|Metformin|metformin|mesh-list
65058130|NCT02279758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65058131|NCT02279758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058158|NCT01649479|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
65058159|NCT01649479|Immunologic Factors|immunologic factors|mesh-ancestor
65058160|NCT01649479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058161|NCT01649635|Ciprofloxacin|ciprofloxacin|mesh-list
65058162|NCT01649635|Prednisone|prednisone|mesh-list
65058163|NCT01649635|Lenograstim|lenograstim|mesh-list
65058164|NCT01649635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65058165|NCT01649635|Glucocorticoids|glucocorticoids|mesh-ancestor
65058167|NCT01649635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65058168|NCT01649635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058169|NCT01649635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65058170|NCT01649635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058171|NCT01649635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65058172|NCT01649635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65058173|NCT01649635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65058174|NCT01649635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65058175|NCT01649635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058176|NCT01649635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058177|NCT01649635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65058178|NCT01649635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65058179|NCT01649635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65058180|NCT01649635|Immunologic Factors|immunologic factors|mesh-ancestor
65058181|NCT00250536|Nandrolone Decanoate|nandrolone decanoate|mesh-list
65058182|NCT00250536|Nandrolone|nandrolone|mesh-list
65058208|NCT00240617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65058209|NCT01649830|Temozolomide|temozolomide|mesh-list
65058210|NCT01649830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65058211|NCT01649830|Alkylating Agents|alkylating agents|mesh-ancestor
65058212|NCT01649830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058213|NCT01649830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058214|NCT00240656|Carvedilol|carvedilol|mesh-list
65058215|NCT00240656|Captopril|captopril|mesh-list
65058216|NCT00240656|Spironolactone|spironolactone|mesh-list
65058217|NCT00240656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65058218|NCT00240656|Hormone Antagonists|hormone antagonists|mesh-ancestor
65058219|NCT00240656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65058220|NCT00240656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058221|NCT00240656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65058222|NCT00240656|Diuretics|diuretics|mesh-ancestor
65058223|NCT00240656|Natriuretic Agents|natriuretic agents|mesh-ancestor
65058224|NCT00240656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65058225|NCT00240656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65058226|NCT00240656|Adrenergic Agents|adrenergic agents|mesh-ancestor
65058227|NCT00240656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65058228|NCT00240656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058229|NCT00240656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65058230|NCT00240656|Antioxidants|antioxidants|mesh-ancestor
65058231|NCT00240656|Protective Agents|protective agents|mesh-ancestor
65058235|NCT00240656|Vasodilator Agents|vasodilator agents|mesh-ancestor
64910262|NCT02419495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65058256|NCT00240695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058257|NCT00240695|Cholinergic Agents|cholinergic agents|mesh-ancestor
65058258|NCT00240695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65058259|NCT00240695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058260|NCT00240695|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65058261|NCT00240695|Autonomic Agents|autonomic agents|mesh-ancestor
65058262|NCT00240695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058263|NCT00240695|Nootropic Agents|nootropic agents|mesh-ancestor
65058264|NCT00240734|Epoetin Alfa|epoetin alfa|mesh-list
65058265|NCT00240734|Hematinics|hematinics|mesh-ancestor
65058266|NCT04720248|Dipyrone|dipyrone|mesh-list
65058267|NCT04720248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65058268|NCT04720248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65058269|NCT04720248|Analgesics|analgesics|mesh-ancestor
65058270|NCT04720248|Sensory System Agents|sensory system agents|mesh-ancestor
65058271|NCT04720248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058272|NCT04720248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058273|NCT04720248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65058274|NCT04720248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65058275|NCT04720248|Antipyretics|antipyretics|mesh-ancestor
65058276|NCT01646515|Udenafil|udenafil|mesh-list
65058277|NCT01646515|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65058278|NCT01646515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65058279|NCT01646515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058280|NCT01646515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058281|NCT00240773|Acetaminophen|acetaminophen|mesh-list
65058282|NCT00240773|Naproxen|naproxen|mesh-list
65058283|NCT00240773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65058284|NCT00240773|Analgesics|analgesics|mesh-ancestor
65058285|NCT00240773|Sensory System Agents|sensory system agents|mesh-ancestor
65058286|NCT00240773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058298|NCT01688401|Alkylating Agents|alkylating agents|mesh-ancestor
65058299|NCT01688401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058300|NCT01688401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058301|NCT01688401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65058302|NCT01688401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65058303|NCT01688401|Immunologic Factors|immunologic factors|mesh-ancestor
65058304|NCT01688401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058305|NCT04708821|Loteprednol Etabonate|loteprednol etabonate|mesh-list
65058306|NCT04708821|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
65058307|NCT04708821|Dexamethasone|dexamethasone|mesh-list
65058308|NCT04708821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65058309|NCT04708821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65058310|NCT04708821|Antiemetics|antiemetics|mesh-ancestor
65058311|NCT04708821|Autonomic Agents|autonomic agents|mesh-ancestor
65058312|NCT04708821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058313|NCT04708821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058314|NCT04708821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65058315|NCT04708821|Glucocorticoids|glucocorticoids|mesh-ancestor
65058316|NCT04708821|Hormones|hormones|mesh-ancestor
65058317|NCT04708821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65058318|NCT04708821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65058319|NCT04708821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058320|NCT04708821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65058321|NCT04708821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65058322|NCT04708821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65058323|NCT04708821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65058324|NCT04708821|Analgesics|analgesics|mesh-ancestor
65058330|NCT04708821|Histamine Agents|histamine agents|mesh-ancestor
65058344|NCT00240812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65058345|NCT00240812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058346|NCT00240812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058347|NCT00240812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65058348|NCT00240812|Autonomic Agents|autonomic agents|mesh-ancestor
65058349|NCT00240812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65058350|NCT00240812|Respiratory System Agents|respiratory system agents|mesh-ancestor
65058351|NCT00240812|Nasal Decongestants|nasal decongestants|mesh-ancestor
65058352|NCT00240812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65058353|NCT00240812|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65058354|NCT00240812|Sympathomimetics|sympathomimetics|mesh-ancestor
65058355|NCT00240812|Adrenergic Agents|adrenergic agents|mesh-ancestor
65058356|NCT00240812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65058357|NCT01688518|Lidocaine|lidocaine|mesh-list
65058358|NCT01688518|Tetracaine|tetracaine|mesh-list
65058359|NCT01688518|Anesthetics, Local|anesthetics, local|mesh-ancestor
65058360|NCT01688518|Anesthetics|anesthetics|mesh-ancestor
65058361|NCT01688518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65058362|NCT01688518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058363|NCT01688518|Sensory System Agents|sensory system agents|mesh-ancestor
65058364|NCT01688518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058365|NCT01688518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65058366|NCT01688518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65058367|NCT01688518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65058368|NCT01688518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65058369|NCT01688518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058370|NCT00240851|Acetaminophen|acetaminophen|mesh-list
65058371|NCT00240851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65058372|NCT00240851|Analgesics|analgesics|mesh-ancestor
65058373|NCT00240851|Sensory System Agents|sensory system agents|mesh-ancestor
65058388|NCT00250692|Sensory System Agents|sensory system agents|mesh-ancestor
65058389|NCT00250692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058390|NCT01688791|Paclitaxel|paclitaxel|mesh-list
65058391|NCT01688791|Carboplatin|carboplatin|mesh-list
65058392|NCT01688791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65058393|NCT01688791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058394|NCT01688791|Tubulin Modulators|tubulin modulators|mesh-ancestor
65058395|NCT01688791|Antimitotic Agents|antimitotic agents|mesh-ancestor
65058396|NCT01688791|Mitosis Modulators|mitosis modulators|mesh-ancestor
65058397|NCT01688791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058398|NCT01688947|Pregabalin|pregabalin|mesh-list
65058399|NCT01688947|Analgesics|analgesics|mesh-ancestor
65058400|NCT01688947|Sensory System Agents|sensory system agents|mesh-ancestor
65058401|NCT01688947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058402|NCT01688947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058403|NCT01688947|Anticonvulsants|anticonvulsants|mesh-ancestor
65058404|NCT01688947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65058405|NCT01688947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65058406|NCT01688947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058407|NCT01688947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65058408|NCT01688947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65058409|NCT01688947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65058410|NCT01688947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65058411|NCT01688947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65058412|NCT00241007|Valsartan|valsartan|mesh-list
65058413|NCT00241007|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65058414|NCT00241007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65058415|NCT00241007|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65058416|NCT00241007|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65058417|NCT00241007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058418|NCT00241007|Diuretics|diuretics|mesh-ancestor
65058419|NCT00241007|Natriuretic Agents|natriuretic agents|mesh-ancestor
65058423|NCT01689142|Insulin|insulin|mesh-list
65058428|NCT00241046|Letrozole|letrozole|mesh-list
65058429|NCT00241046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058430|NCT00241046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65058431|NCT00241046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65058432|NCT00241046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058433|NCT00241046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058434|NCT00241046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65058435|NCT00241046|Hormone Antagonists|hormone antagonists|mesh-ancestor
65058436|NCT00241046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65058437|NCT00241046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058438|NCT01689259|Cyclobenzaprine|cyclobenzaprine|mesh-list
65058439|NCT01689259|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65058440|NCT01689259|Antidepressive Agents|antidepressive agents|mesh-ancestor
65058441|NCT01689259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65058442|NCT01689259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65058443|NCT01689259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058444|NCT01689259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65058445|NCT01689259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058446|NCT01689259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65058447|NCT01689259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65058448|NCT01689298|Oxytocin|oxytocin|mesh-list
65058449|NCT01689298|Carbetocin|carbetocin|mesh-list
65058450|NCT01689298|Oxytocics|oxytocics|mesh-ancestor
65058451|NCT01689298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65058452|NCT01689298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058453|NCT00241085|Valsartan|valsartan|mesh-list
65058454|NCT00241085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65058455|NCT00241085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65058472|NCT00241124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65058473|NCT00241124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65058474|NCT00241124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058475|NCT00241124|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65058476|NCT00241124|Protease Inhibitors|protease inhibitors|mesh-ancestor
65058477|NCT00241124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058478|NCT00241124|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65058479|NCT00241124|Protective Agents|protective agents|mesh-ancestor
65058480|NCT00241124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058481|NCT00241163|Thrombin|thrombin|mesh-list
65058482|NCT00241163|Hemostatics|hemostatics|mesh-ancestor
65058483|NCT00241163|Coagulants|coagulants|mesh-ancestor
65058484|NCT02277106|Brexanolone|brexanolone|mesh-list
65058485|NCT02277106|Neurosteroids|neurosteroids|mesh-ancestor
65058486|NCT02277106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65058487|NCT02277106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058488|NCT02277106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058489|NCT02277106|GABA Modulators|gaba modulators|mesh-ancestor
65058490|NCT02277106|GABA Agents|gaba agents|mesh-ancestor
65058491|NCT00241241|Interferons|interferons|mesh-list
65058492|NCT00241241|Interferon-alpha|interferon-alpha|mesh-list
65058493|NCT00241241|Interferon alpha-2|interferon alpha-2|mesh-list
65058494|NCT00241241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65058495|NCT00241241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058496|NCT00241241|Antiviral Agents|antiviral agents|mesh-ancestor
65058497|NCT00241241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65058498|NCT00241241|Immunologic Factors|immunologic factors|mesh-ancestor
65058499|NCT00241241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058500|NCT02279602|Fosbretabulin|fosbretabulin|mesh-list
65058501|NCT02279602|Combretastatin|combretastatin|mesh-list
65058502|NCT02279602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65058515|NCT00241436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65058516|NCT00241436|Hormone Antagonists|hormone antagonists|mesh-ancestor
65058517|NCT00241436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65058518|NCT00241436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058519|NCT00264420|Zoledronic Acid|zoledronic acid|mesh-list
64499894|NCT01476202|Nicotine|nicotine|mesh-list
65058520|NCT00264420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65058521|NCT00264420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058522|NCT01689727|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
65058524|NCT01689727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058525|NCT01689766|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
65058526|NCT01689766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65058527|NCT01689766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058528|NCT00241475|Gefitinib|gefitinib|mesh-list
65058529|NCT00241475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058530|NCT00241475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65058531|NCT00241475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058532|NCT00241475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058533|NCT01685359|Epoetin Alfa|epoetin alfa|mesh-list
65058534|NCT01685359|Hematinics|hematinics|mesh-ancestor
65058535|NCT02278978|Nintedanib|nintedanib|mesh-list
65058536|NCT02278978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058537|NCT02278978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65058538|NCT02278978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058539|NCT02278978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058540|NCT02218762|Fluticasone|fluticasone|mesh-list
65058541|NCT02218762|Xhance|xhance|mesh-list
65058542|NCT02218762|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65058543|NCT02218762|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65058544|NCT02218762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64951547|NCT00026351|Pentostatin|pentostatin|mesh-list
65058556|NCT02218762|Adrenergic Agents|adrenergic agents|mesh-ancestor
65058557|NCT02218762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65058558|NCT02218762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058559|NCT02218762|Glucocorticoids|glucocorticoids|mesh-ancestor
65058560|NCT02218762|Hormones|hormones|mesh-ancestor
65058561|NCT02218762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65058562|NCT02218762|Sympathomimetics|sympathomimetics|mesh-ancestor
65058563|NCT00264459|Immunologic Factors|immunologic factors|mesh-list
65058564|NCT00264459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058565|NCT00241514|Esomeprazole|esomeprazole|mesh-list
65058566|NCT00241514|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65058567|NCT00241514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65058568|NCT00241514|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65058569|NCT00241514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058570|NCT00241514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058571|NCT02218879|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65058572|NCT02218879|Dermatologic Agents|dermatologic agents|mesh-ancestor
65058573|NCT02218879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65058574|NCT02218879|Immunologic Factors|immunologic factors|mesh-ancestor
65058575|NCT02218879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058576|NCT00241553|Esomeprazole|esomeprazole|mesh-list
65058577|NCT00241553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65058578|NCT00241553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65058579|NCT00241553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65058580|NCT00241553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058581|NCT00241553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058582|NCT02219152|Tranexamic Acid|tranexamic acid|mesh-list
65058583|NCT02219152|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65058584|NCT02219152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65058585|NCT02219152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058586|NCT02219152|Hemostatics|hemostatics|mesh-ancestor
65058598|NCT00264615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65058599|NCT00264615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65058600|NCT02219191|Puerarin|puerarin|mesh-list
65058601|NCT02219191|Atorvastatin|atorvastatin|mesh-list
65058602|NCT02219191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65058603|NCT02219191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65058604|NCT02219191|Antimetabolites|antimetabolites|mesh-ancestor
65058605|NCT02219191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058606|NCT02219191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65058607|NCT02219191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65058608|NCT02219191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058609|NCT02219191|Vasodilator Agents|vasodilator agents|mesh-ancestor
65494070|NCT03743636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058611|NCT04529512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65058612|NCT04529512|Antiemetics|antiemetics|mesh-ancestor
65058613|NCT04529512|Autonomic Agents|autonomic agents|mesh-ancestor
65058614|NCT04529512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058615|NCT04529512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058616|NCT04529512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65058617|NCT04529512|Glucocorticoids|glucocorticoids|mesh-ancestor
65058618|NCT04529512|Hormones|hormones|mesh-ancestor
65058619|NCT04529512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65058620|NCT04529512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65058621|NCT04529512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058622|NCT04720131|Capecitabine|capecitabine|mesh-list
65058623|NCT04720131|Apatinib|apatinib|mesh-list
65058624|NCT04720131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65058625|NCT04720131|Antimetabolites|antimetabolites|mesh-ancestor
65058633|NCT02219737|Rituximab|rituximab|mesh-list
65058646|NCT02219737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058647|NCT02219737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65058648|NCT02219737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65058649|NCT02219737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65058650|NCT02219737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65058651|NCT02219737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058652|NCT02219737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058653|NCT02219737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65058654|NCT02219737|Alkylating Agents|alkylating agents|mesh-ancestor
65058655|NCT02219737|Keratolytic Agents|keratolytic agents|mesh-ancestor
65058656|NCT02219737|Dermatologic Agents|dermatologic agents|mesh-ancestor
65058657|NCT02219737|Tubulin Modulators|tubulin modulators|mesh-ancestor
65058658|NCT02219737|Antimitotic Agents|antimitotic agents|mesh-ancestor
65058659|NCT02219737|Mitosis Modulators|mitosis modulators|mesh-ancestor
65058660|NCT02219893|Immunotoxins|immunotoxins|mesh-list
65058661|NCT02219893|Immunologic Factors|immunologic factors|mesh-ancestor
65058662|NCT02219893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058663|NCT02218606|Prednisone|prednisone|mesh-list
65058664|NCT02218606|Abiraterone Acetate|abiraterone acetate|mesh-list
65058665|NCT02218606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65058666|NCT02218606|Glucocorticoids|glucocorticoids|mesh-ancestor
65058667|NCT02218606|Hormones|hormones|mesh-ancestor
65058668|NCT02218606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65058669|NCT02218606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058670|NCT02218606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65058671|NCT02218606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058672|NCT02218606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65058674|NCT02218606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058675|NCT02218606|Hormone Antagonists|hormone antagonists|mesh-ancestor
65058676|NCT02218606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65058677|NCT02212951|Insulin Lispro|insulin lispro|mesh-list
65058678|NCT02212951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65058679|NCT02212951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058686|NCT02210806|Respiratory System Agents|respiratory system agents|mesh-ancestor
65058687|NCT02210806|Tocolytic Agents|tocolytic agents|mesh-ancestor
65058688|NCT02210806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65058689|NCT02210806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65058690|NCT02210806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65058691|NCT02210806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65058692|NCT02210806|Adrenergic Agents|adrenergic agents|mesh-ancestor
65058693|NCT02210806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65058694|NCT02210806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058695|NCT00264654|Paroxetine|paroxetine|mesh-list
65058696|NCT00264654|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65058697|NCT00264654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65058698|NCT00264654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65058699|NCT00264654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058700|NCT00264654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65058701|NCT00264654|Serotonin Agents|serotonin agents|mesh-ancestor
65058702|NCT00264654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058703|NCT00264654|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65058704|NCT00264654|Antidepressive Agents|antidepressive agents|mesh-ancestor
65058705|NCT00264654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65058706|NCT00264654|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65058707|NCT00264654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65058708|NCT00264654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058709|NCT02219659|Fentanyl|fentanyl|mesh-list
65058710|NCT02219659|Midazolam|midazolam|mesh-list
65058711|NCT02219659|Propofol|propofol|mesh-list
65058712|NCT02219659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65058713|NCT02219659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65058714|NCT02219659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058715|NCT02219659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65058716|NCT02219659|Anesthetics, General|anesthetics, general|mesh-ancestor
65058728|NCT02219659|GABA Agents|gaba agents|mesh-ancestor
65058729|NCT02219659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65058730|NCT02219659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058731|NCT02214550|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
65058732|NCT02214550|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65058733|NCT02214550|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65058734|NCT02214550|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65058735|NCT02214550|Contraceptive Agents|contraceptive agents|mesh-ancestor
65058736|NCT02214550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65058737|NCT02214550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058738|NCT02214550|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65058739|NCT02214550|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65058740|NCT02214550|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
65058741|NCT02214550|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65058742|NCT00241982|Prednisolone|prednisolone|mesh-list
65058743|NCT00241982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65058744|NCT00241982|Glucocorticoids|glucocorticoids|mesh-ancestor
65058745|NCT00241982|Hormones|hormones|mesh-ancestor
65058746|NCT00241982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65058747|NCT00241982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058748|NCT00241982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65058776|NCT02961842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058777|NCT02961842|Sensory System Agents|sensory system agents|mesh-ancestor
65058778|NCT02961842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058779|NCT02961842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65058780|NCT02961842|Narcotics|narcotics|mesh-ancestor
65058781|NCT02961842|Analgesics|analgesics|mesh-ancestor
65058782|NCT02961842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65058783|NCT02961842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65058784|NCT02961842|Anesthetics, General|anesthetics, general|mesh-ancestor
65058785|NCT02961842|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65058786|NCT02961842|Sympathomimetics|sympathomimetics|mesh-ancestor
65058787|NCT02961842|Autonomic Agents|autonomic agents|mesh-ancestor
65058788|NCT02961842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65058789|NCT02961842|Adrenergic Agents|adrenergic agents|mesh-ancestor
65058790|NCT02961842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65058791|NCT02961842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058792|NCT00272805|Carvedilol|carvedilol|mesh-list
65058793|NCT00272805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65058794|NCT00272805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65058795|NCT00272805|Adrenergic Agents|adrenergic agents|mesh-ancestor
65058796|NCT00272805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65058797|NCT00272805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058798|NCT00272805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058799|NCT00272805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65058825|NCT00242411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65058826|NCT00242411|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65058827|NCT00242411|Autonomic Agents|autonomic agents|mesh-ancestor
65058828|NCT00242411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058829|NCT00242411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058830|NCT00242411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65058831|NCT00242411|Respiratory System Agents|respiratory system agents|mesh-ancestor
65058832|NCT00242411|Glucocorticoids|glucocorticoids|mesh-ancestor
65058833|NCT00242411|Hormones|hormones|mesh-ancestor
65058834|NCT00242411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65058835|NCT00242411|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65058836|NCT00242411|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65058837|NCT00242411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65058838|NCT00242411|Adrenergic Agents|adrenergic agents|mesh-ancestor
65058839|NCT00242411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65058840|NCT00242411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058841|NCT02962037|Melatonin|melatonin|mesh-list
65058842|NCT02962037|Antioxidants|antioxidants|mesh-ancestor
65058843|NCT02962037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058844|NCT02962037|Protective Agents|protective agents|mesh-ancestor
65058845|NCT02962037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058846|NCT02962037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65058847|NCT00282399|Decitabine|decitabine|mesh-list
65058848|NCT00282399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65058849|NCT00282399|Antimetabolites|antimetabolites|mesh-ancestor
65058872|NCT00273039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65058873|NCT00273039|Antidepressive Agents|antidepressive agents|mesh-ancestor
65058874|NCT00273039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65058875|NCT00273039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65058876|NCT00273039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65058877|NCT00273039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058878|NCT00242528|Zoledronic Acid|zoledronic acid|mesh-list
65058879|NCT00242528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65058880|NCT00242528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058881|NCT00242606|Lamotrigine|lamotrigine|mesh-list
65058882|NCT00242606|Levetiracetam|levetiracetam|mesh-list
65058883|NCT00242606|Anticonvulsants|anticonvulsants|mesh-ancestor
65058884|NCT00242606|Nootropic Agents|nootropic agents|mesh-ancestor
65058885|NCT00242606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65058886|NCT00242606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65058887|NCT00242606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058888|NCT00242606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65058889|NCT00242606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058890|NCT00242606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65058891|NCT00242606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65058892|NCT00242606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65058893|NCT00242606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65058922|NCT00282594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65058923|NCT00282594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058924|NCT00242918|Docetaxel|docetaxel|mesh-list
65058925|NCT00242918|Gefitinib|gefitinib|mesh-list
65058926|NCT00242918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058927|NCT00242918|Tubulin Modulators|tubulin modulators|mesh-ancestor
65058928|NCT00242918|Antimitotic Agents|antimitotic agents|mesh-ancestor
65058929|NCT00242918|Mitosis Modulators|mitosis modulators|mesh-ancestor
65058930|NCT00242918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058931|NCT00242918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65058932|NCT00242918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65058933|NCT00273312|Epothilone B|epothilone b|mesh-list
65058934|NCT00273312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65058935|NCT00273312|Tubulin Modulators|tubulin modulators|mesh-ancestor
65058936|NCT00273312|Antimitotic Agents|antimitotic agents|mesh-ancestor
65058937|NCT00273312|Mitosis Modulators|mitosis modulators|mesh-ancestor
65058938|NCT00273312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058940|NCT00242996|Carmustine|carmustine|mesh-list
65058981|NCT00273429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058982|NCT00273429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65058983|NCT00273429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65058984|NCT00273429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65058985|NCT00273429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65058986|NCT00273429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65058987|NCT00273468|Granisetron|granisetron|mesh-list
65058988|NCT00273468|Antiemetics|antiemetics|mesh-ancestor
65058989|NCT00273468|Autonomic Agents|autonomic agents|mesh-ancestor
65058990|NCT00273468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65058991|NCT00273468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65058992|NCT00273468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65058993|NCT00273468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65058994|NCT00273468|Serotonin Agents|serotonin agents|mesh-ancestor
65058995|NCT00273468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65058996|NCT00273468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65058997|NCT00243464|Betamethasone|betamethasone|mesh-list
65058998|NCT00243464|Betamethasone Valerate|betamethasone valerate|mesh-list
65058999|NCT00243464|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65059000|NCT00243464|Betamethasone benzoate|betamethasone benzoate|mesh-list
65059001|NCT00243464|Calcipotriene|calcipotriene|mesh-list
65059002|NCT00243464|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65059003|NCT00243464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65059004|NCT00243464|Glucocorticoids|glucocorticoids|mesh-ancestor
65059005|NCT00243464|Hormones|hormones|mesh-ancestor
65059006|NCT00243464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65059007|NCT00243464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059008|NCT00243464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65059009|NCT00243464|Respiratory System Agents|respiratory system agents|mesh-ancestor
65059010|NCT00243464|Dermatologic Agents|dermatologic agents|mesh-ancestor
65059011|NCT00273507|Paclitaxel|paclitaxel|mesh-list
65059012|NCT00273507|Carboplatin|carboplatin|mesh-list
64911041|NCT00009997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65059024|NCT00273546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059025|NCT00273546|Tubulin Modulators|tubulin modulators|mesh-ancestor
65059026|NCT00273546|Antimitotic Agents|antimitotic agents|mesh-ancestor
65059027|NCT00273546|Mitosis Modulators|mitosis modulators|mesh-ancestor
65059028|NCT00273546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059029|NCT00283101|Dacetuzumab|dacetuzumab|mesh-list
65059030|NCT00283101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65059031|NCT00283101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059032|NCT00243737|Artesunate|artesunate|mesh-list
65059033|NCT00243737|Mefloquine|mefloquine|mesh-list
65059034|NCT00243737|Antimalarials|antimalarials|mesh-ancestor
65059035|NCT00243737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65059036|NCT00243737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65059037|NCT00243737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65059038|NCT00243737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500428|NCT01497496|Ofatumumab|ofatumumab|mesh-list
65059039|NCT00243737|Antiviral Agents|antiviral agents|mesh-ancestor
65059040|NCT00243737|Schistosomicides|schistosomicides|mesh-ancestor
65059041|NCT00243737|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65059042|NCT00243737|Anthelmintics|anthelmintics|mesh-ancestor
65059043|NCT00273702|Acetylcysteine|acetylcysteine|mesh-list
65059044|NCT00273702|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65059045|NCT00273702|Antiviral Agents|antiviral agents|mesh-ancestor
65059046|NCT00273702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65059047|NCT00273702|Expectorants|expectorants|mesh-ancestor
65059048|NCT00273702|Respiratory System Agents|respiratory system agents|mesh-ancestor
65059049|NCT00273702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65059050|NCT00273702|Antioxidants|antioxidants|mesh-ancestor
65059051|NCT00273702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059052|NCT00273702|Protective Agents|protective agents|mesh-ancestor
65059053|NCT00273702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059054|NCT00273702|Antidotes|antidotes|mesh-ancestor
65059055|NCT00243815|Ibuprofen|ibuprofen|mesh-list
65059056|NCT00243815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65059057|NCT00243815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65059058|NCT00243815|Analgesics|analgesics|mesh-ancestor
65059059|NCT00243815|Sensory System Agents|sensory system agents|mesh-ancestor
65059062|NCT00243815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65059063|NCT00243815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65059064|NCT00243815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65059065|NCT00243815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059066|NCT00243815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059067|NCT00283179|Risperidone|risperidone|mesh-list
65059068|NCT00283179|Aripiprazole|aripiprazole|mesh-list
65059069|NCT00283179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65059070|NCT00283179|Serotonin Agents|serotonin agents|mesh-ancestor
65059071|NCT00283179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65059072|NCT00283179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059073|NCT00283179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059074|NCT00283179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65059075|NCT00283179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65059076|NCT00283179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65059077|NCT00283179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65059078|NCT00283179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65059079|NCT00283179|Dopamine Agents|dopamine agents|mesh-ancestor
65059080|NCT00283179|Antidepressive Agents|antidepressive agents|mesh-ancestor
65059081|NCT00283179|Dopamine Agonists|dopamine agonists|mesh-ancestor
65059082|NCT00283179|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65059083|NCT00283179|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65059084|NCT00283179|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65059085|NCT00283179|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65059086|NCT00243854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65059087|NCT00243854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059108|NCT00283218|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65059109|NCT00283218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65059110|NCT00283218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059111|NCT00244127|Prednisone|prednisone|mesh-list
65059112|NCT00244127|Cyclophosphamide|cyclophosphamide|mesh-list
65059113|NCT00244127|Rituximab|rituximab|mesh-list
65059114|NCT00244127|Vincristine|vincristine|mesh-list
65059116|NCT00244127|Immunologic Factors|immunologic factors|mesh-ancestor
65059117|NCT00244127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059118|NCT00244127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65059119|NCT00244127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65059120|NCT00244127|Alkylating Agents|alkylating agents|mesh-ancestor
65059121|NCT00244127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059122|NCT00244127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059123|NCT00244127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65059124|NCT00244127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65059125|NCT00244127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65059126|NCT00244127|Glucocorticoids|glucocorticoids|mesh-ancestor
65059127|NCT00244127|Hormones|hormones|mesh-ancestor
65059128|NCT00244127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65059129|NCT00244127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65059130|NCT00244127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65059131|NCT00244127|Tubulin Modulators|tubulin modulators|mesh-ancestor
65494072|NCT03743636|Vitamin B Complex|vitamin b complex|mesh-ancestor
65059132|NCT00244127|Antimitotic Agents|antimitotic agents|mesh-ancestor
65059133|NCT00244127|Mitosis Modulators|mitosis modulators|mesh-ancestor
65059134|NCT00244166|Prednisolone|prednisolone|mesh-list
65059135|NCT00244166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65059136|NCT00244166|Glucocorticoids|glucocorticoids|mesh-ancestor
65059137|NCT00244166|Hormones|hormones|mesh-ancestor
65059139|NCT00244166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059150|NCT00273975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65059151|NCT00273975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65059152|NCT00273975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65059153|NCT00273975|Antimetabolites|antimetabolites|mesh-ancestor
65059154|NCT00273975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65059155|NCT00273975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65059156|NCT00244283|Sevoflurane|sevoflurane|mesh-list
65059157|NCT00244283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65059158|NCT00244283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65059159|NCT00244283|Anesthetics, General|anesthetics, general|mesh-ancestor
65059160|NCT00244283|Anesthetics|anesthetics|mesh-ancestor
65059161|NCT00244283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65059162|NCT00244283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059163|NCT00283335|Gemfibrozil|gemfibrozil|mesh-list
65059164|NCT00283335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65059165|NCT00283335|Antimetabolites|antimetabolites|mesh-ancestor
65059166|NCT00283335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059167|NCT00283335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65059168|NCT00283335|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65059169|NCT00283335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65059170|NCT00283335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059171|NCT00244361|Rituximab|rituximab|mesh-list
65059172|NCT00244361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65059173|NCT00244361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059174|NCT00244361|Immunologic Factors|immunologic factors|mesh-ancestor
65059175|NCT00244361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059176|NCT00244361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65059177|NCT00274014|Tiotropium Bromide|tiotropium bromide|mesh-list
65059178|NCT00274014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65059179|NCT00274014|Autonomic Agents|autonomic agents|mesh-ancestor
65059180|NCT00274014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65059181|NCT00274014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059182|NCT00274014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65059183|NCT00274014|Respiratory System Agents|respiratory system agents|mesh-ancestor
65059184|NCT00274014|Parasympatholytics|parasympatholytics|mesh-ancestor
65059188|NCT00274014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059189|NCT00244439|Permethrin|permethrin|mesh-list
65059190|NCT00244439|Malathion|malathion|mesh-list
65059191|NCT00244439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059192|NCT00244439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059193|NCT00244439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65059194|NCT00244439|Cholinergic Agents|cholinergic agents|mesh-ancestor
65059195|NCT00244439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65059196|NCT00244439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059197|NCT00417144|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65059198|NCT00417144|Ganirelix|ganirelix|mesh-list
65059199|NCT00417144|Luteolytic Agents|luteolytic agents|mesh-ancestor
65059200|NCT00417144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65059201|NCT00417144|Contraceptive Agents|contraceptive agents|mesh-ancestor
65059202|NCT00417144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65059203|NCT00417144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059204|NCT00417144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65059205|NCT00417144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65059206|NCT00417144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059207|NCT00417144|Hormone Antagonists|hormone antagonists|mesh-ancestor
65059208|NCT00417144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65059209|NCT00274053|Tiotropium Bromide|tiotropium bromide|mesh-list
65059210|NCT00274053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65059211|NCT00274053|Autonomic Agents|autonomic agents|mesh-ancestor
65059212|NCT00274053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65059213|NCT00274053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059214|NCT00274053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65059215|NCT00274053|Respiratory System Agents|respiratory system agents|mesh-ancestor
65059216|NCT00274053|Parasympatholytics|parasympatholytics|mesh-ancestor
65059217|NCT00274053|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65059218|NCT00274053|Cholinergic Agents|cholinergic agents|mesh-ancestor
65059229|NCT00417183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65059230|NCT00417183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059231|NCT00417183|Hormone Antagonists|hormone antagonists|mesh-ancestor
65059232|NCT00417183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65059233|NCT00244517|Remifentanil|remifentanil|mesh-list
65059234|NCT00244517|Sevoflurane|sevoflurane|mesh-list
65059235|NCT00244517|Desflurane|desflurane|mesh-list
65059236|NCT00244517|Isoflurane|isoflurane|mesh-list
65059237|NCT00244517|Anesthetics|anesthetics|mesh-ancestor
65059238|NCT00244517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65059239|NCT00244517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059240|NCT00244517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65059241|NCT00244517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65059242|NCT00244517|Anesthetics, General|anesthetics, general|mesh-ancestor
65059243|NCT00244517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65059244|NCT00244517|Narcotics|narcotics|mesh-ancestor
65059245|NCT00244517|Analgesics|analgesics|mesh-ancestor
65059246|NCT00244517|Sensory System Agents|sensory system agents|mesh-ancestor
65059247|NCT00244517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65059248|NCT00274092|Tiotropium Bromide|tiotropium bromide|mesh-list
65059249|NCT00274092|Ipratropium|ipratropium|mesh-list
65059250|NCT00274092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65059251|NCT00274092|Autonomic Agents|autonomic agents|mesh-ancestor
65059252|NCT00274092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65059253|NCT00274092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059254|NCT00274092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65059255|NCT00274092|Respiratory System Agents|respiratory system agents|mesh-ancestor
65059256|NCT00274092|Parasympatholytics|parasympatholytics|mesh-ancestor
65059257|NCT00274092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65059258|NCT00274092|Cholinergic Agents|cholinergic agents|mesh-ancestor
65059259|NCT00274092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65059260|NCT00274092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059261|NCT00244556|Etanercept|etanercept|mesh-list
65059271|NCT00244556|Dermatologic Agents|dermatologic agents|mesh-ancestor
65059272|NCT00244556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059273|NCT00244556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65059274|NCT00244556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65059275|NCT00244556|Immunologic Factors|immunologic factors|mesh-ancestor
65059276|NCT00244556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65059277|NCT00244556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65059278|NCT00244556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65059279|NCT00244556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65059281|NCT00244556|Sensory System Agents|sensory system agents|mesh-ancestor
65059282|NCT00244556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65059283|NCT00244556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65059284|NCT00244556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65059285|NCT00274131|Pramipexole|pramipexole|mesh-list
65059286|NCT00274131|Antioxidants|antioxidants|mesh-ancestor
65059287|NCT00274131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059288|NCT00274131|Protective Agents|protective agents|mesh-ancestor
65059289|NCT00274131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059290|NCT00274131|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65059291|NCT00274131|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65059292|NCT00274131|Dopamine Agonists|dopamine agonists|mesh-ancestor
65059293|NCT00274131|Dopamine Agents|dopamine agents|mesh-ancestor
65059294|NCT00274131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65059295|NCT00274170|Octreotide|octreotide|mesh-list
65059296|NCT00274170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65059297|NCT00274170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65059298|NCT00274170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059299|NCT00244829|Imatinib Mesylate|imatinib mesylate|mesh-list
65059300|NCT00244829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059301|NCT00244829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65059302|NCT00244829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059303|NCT00244829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059304|NCT00244907|Risedronic Acid|risedronic acid|mesh-list
65059305|NCT00244907|Genistein|genistein|mesh-list
65059311|NCT00244907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65059312|NCT00244907|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65059313|NCT00244907|Protective Agents|protective agents|mesh-ancestor
65059314|NCT00244907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059315|NCT00244907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65059316|NCT00244907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059317|NCT00244907|Phytoestrogens|phytoestrogens|mesh-ancestor
65059318|NCT00244907|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65059319|NCT00244907|Estrogens|estrogens|mesh-ancestor
65059320|NCT00244907|Hormones|hormones|mesh-ancestor
65059321|NCT00244907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65059322|NCT00244946|Cytarabine|cytarabine|mesh-list
65059323|NCT00244946|Etoposide|etoposide|mesh-list
65059324|NCT00244946|Melphalan|melphalan|mesh-list
65059325|NCT00244946|Carmustine|carmustine|mesh-list
65059326|NCT00244946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65059327|NCT00244946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059328|NCT00244946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65059329|NCT00244946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65059330|NCT00244946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059331|NCT00244946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059332|NCT00244946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65059333|NCT00244946|Antimetabolites|antimetabolites|mesh-ancestor
65059334|NCT00244946|Antiviral Agents|antiviral agents|mesh-ancestor
65059335|NCT00244946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65059336|NCT00244946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65059337|NCT00244946|Immunologic Factors|immunologic factors|mesh-ancestor
65059338|NCT00244946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059339|NCT00244946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65059340|NCT00244946|Alkylating Agents|alkylating agents|mesh-ancestor
65059341|NCT00244946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65059342|NCT00245024|Sulindac|sulindac|mesh-list
65059354|NCT00245024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059355|NCT00274326|Satavaptan|satavaptan|mesh-list
65494073|NCT03743636|Vitamins|vitamins|mesh-ancestor
65059356|NCT00274326|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65059357|NCT00274326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059358|NCT00274326|Natriuretic Agents|natriuretic agents|mesh-ancestor
65059359|NCT00274326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059360|NCT00245141|Dactinomycin|dactinomycin|mesh-list
65059361|NCT00245141|Cyclophosphamide|cyclophosphamide|mesh-list
65059362|NCT00245141|Vincristine|vincristine|mesh-list
65059363|NCT00245141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65059364|NCT00245141|Immunologic Factors|immunologic factors|mesh-ancestor
65059365|NCT00245141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059366|NCT00245141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65059367|NCT00245141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65059368|NCT00245141|Alkylating Agents|alkylating agents|mesh-ancestor
65059369|NCT00245141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059370|NCT00245141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059371|NCT00245141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65059372|NCT00245141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65059373|NCT00245141|Tubulin Modulators|tubulin modulators|mesh-ancestor
65059374|NCT00245141|Antimitotic Agents|antimitotic agents|mesh-ancestor
65059375|NCT00245141|Mitosis Modulators|mitosis modulators|mesh-ancestor
65059376|NCT00245141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65059377|NCT00245141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65059378|NCT00245141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65059379|NCT00245141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65059380|NCT00245141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059381|NCT00245141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65059382|NCT00416637|Bevacizumab|bevacizumab|mesh-list
65059383|NCT00416637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65059384|NCT00416637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059385|NCT00416637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65059386|NCT00416637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64911413|NCT00001266|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65059390|NCT00245258|Sildenafil Citrate|sildenafil citrate|mesh-list
64911418|NCT00005948|Interferons|interferons|mesh-list
65059391|NCT00245258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059392|NCT00245258|Vasodilator Agents|vasodilator agents|mesh-ancestor
65059393|NCT00245258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65059394|NCT00245258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65059395|NCT00245258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059396|NCT00245258|Urological Agents|urological agents|mesh-ancestor
65059397|NCT02961803|Biotin|biotin|mesh-list
65059398|NCT02961803|Vitamin B Complex|vitamin b complex|mesh-ancestor
65059399|NCT02961803|Vitamins|vitamins|mesh-ancestor
65059400|NCT02961803|Micronutrients|micronutrients|mesh-ancestor
65059401|NCT02961803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059402|NCT00245297|Factor VIII|factor viii|mesh-list
65059403|NCT00245297|Coagulants|coagulants|mesh-ancestor
65059404|NCT00274404|Valacyclovir|valacyclovir|mesh-list
65059405|NCT00274404|Antiviral Agents|antiviral agents|mesh-ancestor
65059406|NCT00274404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65059407|NCT00283764|Latanoprost|latanoprost|mesh-list
65059408|NCT00283764|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65059409|NCT00283764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65059410|NCT00245336|Thrombin|thrombin|mesh-list
65059411|NCT00245336|Hemostatics|hemostatics|mesh-ancestor
65059412|NCT00245336|Coagulants|coagulants|mesh-ancestor
65059413|NCT00274443|Carboplatin|carboplatin|mesh-list
65059414|NCT00274443|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65059415|NCT00274443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059416|NCT00245375|Acetaminophen|acetaminophen|mesh-list
65059417|NCT00245375|Ibuprofen|ibuprofen|mesh-list
65059418|NCT00245375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65059419|NCT00245375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65059420|NCT00245375|Analgesics|analgesics|mesh-ancestor
65059421|NCT00245375|Sensory System Agents|sensory system agents|mesh-ancestor
65059422|NCT00245375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65059423|NCT00245375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059424|NCT00245375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65059425|NCT00245375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64911451|NCT00005951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059429|NCT00245375|Antipyretics|antipyretics|mesh-ancestor
65059430|NCT00245414|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65059431|NCT00245414|Interferon-alpha|interferon-alpha|mesh-list
65059432|NCT00245414|Antiviral Agents|antiviral agents|mesh-ancestor
65059433|NCT00245414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65059434|NCT00245414|Immunologic Factors|immunologic factors|mesh-ancestor
65059435|NCT00245414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059436|NCT00274521|Tiotropium Bromide|tiotropium bromide|mesh-list
65059437|NCT00274521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65059438|NCT00274521|Autonomic Agents|autonomic agents|mesh-ancestor
65059439|NCT00274521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65059440|NCT00274521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059441|NCT00274521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65059442|NCT00274521|Respiratory System Agents|respiratory system agents|mesh-ancestor
65059443|NCT00274521|Parasympatholytics|parasympatholytics|mesh-ancestor
65059444|NCT00274521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65059445|NCT00274521|Cholinergic Agents|cholinergic agents|mesh-ancestor
65059446|NCT00274521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65059447|NCT00274521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059449|NCT00245453|Clarithromycin|clarithromycin|mesh-list
65059450|NCT00245453|Telithromycin|telithromycin|mesh-list
65059451|NCT00245453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65059480|NCT00245609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059481|NCT00245609|Anticonvulsants|anticonvulsants|mesh-ancestor
65059482|NCT00245609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65059483|NCT00245609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65059484|NCT00245609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059485|NCT00245609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65059486|NCT00245609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65059487|NCT00245609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65059488|NCT00245609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65059489|NCT00245609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65059490|NCT00245609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65059491|NCT00245609|GABA Modulators|gaba modulators|mesh-ancestor
65059492|NCT00245609|GABA Agents|gaba agents|mesh-ancestor
65059493|NCT00245609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65059494|NCT00274599|Telmisartan|telmisartan|mesh-list
65059495|NCT00274599|Ramipril|ramipril|mesh-list
65059496|NCT00274599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65059497|NCT00274599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65059498|NCT00274599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65059499|NCT00274599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059500|NCT00274599|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65059501|NCT00274599|Protease Inhibitors|protease inhibitors|mesh-ancestor
65059502|NCT00274599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059503|NCT00274638|Losartan|losartan|mesh-list
65059504|NCT00274638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65059505|NCT00274638|Telmisartan|telmisartan|mesh-list
65059506|NCT00274638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65059525|NCT00274677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65059526|NCT00274677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65059527|NCT00274677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65059528|NCT00245921|Levonorgestrel|levonorgestrel|mesh-list
65059529|NCT00245921|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65059530|NCT00245921|Estradiol|estradiol|mesh-list
65059531|NCT00245921|Estrogens|estrogens|mesh-ancestor
65059532|NCT00245921|Hormones|hormones|mesh-ancestor
65059533|NCT00245921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65059534|NCT00245921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059535|NCT00245921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65059536|NCT00245921|Contraceptive Agents|contraceptive agents|mesh-ancestor
65059537|NCT00245921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65059538|NCT00245921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65059539|NCT00245921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65059540|NCT00245921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65059541|NCT00245921|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65059542|NCT00274794|Rituximab|rituximab|mesh-list
65059543|NCT00274794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65059544|NCT00274794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059545|NCT00274794|Immunologic Factors|immunologic factors|mesh-ancestor
65059546|NCT00274794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059547|NCT00274794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65059548|NCT00246155|Botulinum Toxins|botulinum toxins|mesh-list
65059549|NCT00246155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65059550|NCT00246155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65059551|NCT00246155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65059552|NCT00246155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65059572|NCT00246194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65059573|NCT00246194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65059574|NCT00246194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65059575|NCT00246194|Dopamine Agents|dopamine agents|mesh-ancestor
65059576|NCT00284232|Insulin|insulin|mesh-list
65059577|NCT00284232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65059578|NCT00284232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059579|NCT00246233|Methylphenidate|methylphenidate|mesh-list
65059580|NCT00246233|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65494074|NCT03743636|Micronutrients|micronutrients|mesh-ancestor
65059581|NCT00246233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059582|NCT00246233|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65059583|NCT00246233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65059584|NCT00246233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65059585|NCT00246233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059586|NCT00246233|Dopamine Agents|dopamine agents|mesh-ancestor
65059587|NCT00246233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65059588|NCT00274833|Temozolomide|temozolomide|mesh-list
65059589|NCT00274833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65059590|NCT00274833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65059591|NCT00274833|Alkylating Agents|alkylating agents|mesh-ancestor
65059592|NCT00274833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059593|NCT00274833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059594|NCT00274833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65059595|NCT00274833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059619|NCT00246272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059620|NCT00246272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65059621|NCT00246272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65059622|NCT00246272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65059623|NCT00246272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65059624|NCT00246272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65059625|NCT00246272|Dopamine Agents|dopamine agents|mesh-ancestor
65059626|NCT00284271|Prednisone|prednisone|mesh-list
65059627|NCT00284271|Cyclophosphamide|cyclophosphamide|mesh-list
65059628|NCT00284271|Vincristine|vincristine|mesh-list
65059629|NCT00284271|Bleomycin|bleomycin|mesh-list
65059630|NCT00284271|Epoetin Alfa|epoetin alfa|mesh-list
65059631|NCT00284271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65059632|NCT00284271|Immunologic Factors|immunologic factors|mesh-ancestor
65059633|NCT00284271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059634|NCT00284271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65059635|NCT00284271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65059636|NCT00284271|Alkylating Agents|alkylating agents|mesh-ancestor
65059637|NCT00284271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059638|NCT00284271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059639|NCT00284271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65059640|NCT00284271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65059641|NCT00284271|Glucocorticoids|glucocorticoids|mesh-ancestor
65059643|NCT00284271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65059644|NCT00284271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65059645|NCT00284271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65059646|NCT00284271|Tubulin Modulators|tubulin modulators|mesh-ancestor
65059649|NCT00284271|Hematinics|hematinics|mesh-ancestor
65059667|NCT00274911|Mitosis Modulators|mitosis modulators|mesh-ancestor
65059668|NCT00274911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059669|NCT00274911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65059670|NCT00274911|Alkylating Agents|alkylating agents|mesh-ancestor
65059671|NCT00246467|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65059672|NCT00246467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65059673|NCT00246467|Immunologic Factors|immunologic factors|mesh-ancestor
65059674|NCT00246467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059675|NCT00246467|Antacids|antacids|mesh-ancestor
65059676|NCT00246467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059677|NCT00246467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65059678|NCT00277251|Alendronate|alendronate|mesh-list
65059679|NCT00277251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65059680|NCT00277251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059681|NCT00416676|Cyclophosphamide|cyclophosphamide|mesh-list
65059682|NCT00416676|Carboplatin|carboplatin|mesh-list
65059683|NCT00416676|Etoposide|etoposide|mesh-list
65059684|NCT00416676|Vincristine|vincristine|mesh-list
65059685|NCT00416676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65059686|NCT00416676|Immunologic Factors|immunologic factors|mesh-ancestor
65059687|NCT00416676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059688|NCT00416676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65059689|NCT00416676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65059690|NCT00416676|Alkylating Agents|alkylating agents|mesh-ancestor
65059691|NCT00416676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059692|NCT00416676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059693|NCT00416676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65059694|NCT00416676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65059695|NCT00416676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65059696|NCT00416676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65059697|NCT00416676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059698|NCT00416676|Tubulin Modulators|tubulin modulators|mesh-ancestor
65059708|NCT00284427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059709|NCT00284427|Protective Agents|protective agents|mesh-ancestor
65059710|NCT00246701|Simvastatin|simvastatin|mesh-list
65059711|NCT00246701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65059712|NCT00246701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65059714|NCT00246701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059715|NCT00246701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65059716|NCT00246701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65059717|NCT00246701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059718|NCT00284505|Thalidomide|thalidomide|mesh-list
65059719|NCT00284505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65059720|NCT00284505|Immunologic Factors|immunologic factors|mesh-ancestor
65059721|NCT00284505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059722|NCT00284505|Leprostatic Agents|leprostatic agents|mesh-ancestor
65059723|NCT00284505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65059724|NCT00284505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65059725|NCT00284505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65059726|NCT00284505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65059727|NCT00284505|Growth Substances|growth substances|mesh-ancestor
65059728|NCT00284505|Growth Inhibitors|growth inhibitors|mesh-ancestor
65059729|NCT00284505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059730|NCT00246974|Gemcitabine|gemcitabine|mesh-list
65059731|NCT00246974|Gefitinib|gefitinib|mesh-list
65494075|NCT03743636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65059732|NCT00246974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059733|NCT00246974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65059734|NCT00246974|Antimetabolites|antimetabolites|mesh-ancestor
65059735|NCT00246974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059736|NCT00246974|Antiviral Agents|antiviral agents|mesh-ancestor
65059737|NCT00246974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65059738|NCT00246974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059739|NCT00246974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65059740|NCT00246974|Immunologic Factors|immunologic factors|mesh-ancestor
65059741|NCT00246974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059742|NCT00246974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65059746|NCT00284583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65059747|NCT00284583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059748|NCT00284583|Sensory System Agents|sensory system agents|mesh-ancestor
65059749|NCT00284583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65059750|NCT00284583|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65059751|NCT00284583|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65059752|NCT00284583|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65059753|NCT00284583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65059754|NCT00284583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059755|NCT00247052|Diclofenac|diclofenac|mesh-list
65059756|NCT00247052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65059757|NCT00247052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65059758|NCT00247052|Analgesics|analgesics|mesh-ancestor
65059759|NCT00247052|Sensory System Agents|sensory system agents|mesh-ancestor
65059760|NCT00247052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65059761|NCT00247052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059762|NCT00247052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65059763|NCT00247052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65059764|NCT00247052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65059765|NCT00247052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059766|NCT00247052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059767|NCT00277602|Riluzole|riluzole|mesh-list
65059768|NCT00277602|Anticonvulsants|anticonvulsants|mesh-ancestor
65059769|NCT00277602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65059770|NCT00277602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65059771|NCT00277602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65059772|NCT00277602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059773|NCT00277602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059774|NCT00277602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65059775|NCT00277602|Protective Agents|protective agents|mesh-ancestor
65059776|NCT00277641|Lamotrigine|lamotrigine|mesh-list
65059784|NCT00277641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65059785|NCT00277641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65059786|NCT00277641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65059787|NCT00277641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65059788|NCT00247130|Omeprazole|omeprazole|mesh-list
65059789|NCT00247130|Ranitidine|ranitidine|mesh-list
65059790|NCT00247130|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65059791|NCT00247130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65059792|NCT00247130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65059793|NCT00247130|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65059794|NCT00247130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059795|NCT00247130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059796|NCT00247130|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65059797|NCT00247130|Histamine Antagonists|histamine antagonists|mesh-ancestor
65059798|NCT00247130|Histamine Agents|histamine agents|mesh-ancestor
65059799|NCT00247130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65059800|NCT00247130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059801|NCT00247169|Progesterone|progesterone|mesh-list
65059802|NCT00247169|Progestins|progestins|mesh-ancestor
65059803|NCT00247169|Hormones|hormones|mesh-ancestor
65059804|NCT00247169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65494076|NCT03743636|Antimetabolites|antimetabolites|mesh-ancestor
65059805|NCT00247169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059807|NCT00247208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65059808|NCT00247208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059809|NCT00247208|Tubulin Modulators|tubulin modulators|mesh-ancestor
65059813|NCT00284778|Docetaxel|docetaxel|mesh-list
65059833|NCT00277758|Antimetabolites|antimetabolites|mesh-ancestor
65059834|NCT00277758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059835|NCT00277758|Immunologic Factors|immunologic factors|mesh-ancestor
65059836|NCT00277758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059837|NCT00277758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65059838|NCT00277758|Analgesics|analgesics|mesh-ancestor
65059839|NCT00277758|Sensory System Agents|sensory system agents|mesh-ancestor
65059840|NCT00277758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65059841|NCT00247364|Levetiracetam|levetiracetam|mesh-list
65059842|NCT00247364|Anticonvulsants|anticonvulsants|mesh-ancestor
65059843|NCT00247364|Nootropic Agents|nootropic agents|mesh-ancestor
65059844|NCT00247403|Deoxyglucose|deoxyglucose|mesh-list
65059845|NCT00247403|Antimetabolites|antimetabolites|mesh-ancestor
65059846|NCT00247403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059847|NCT00247403|Antiviral Agents|antiviral agents|mesh-ancestor
65059848|NCT00247403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65059849|NCT00424814|Ritonavir|ritonavir|mesh-list
65059850|NCT00424814|Lopinavir|lopinavir|mesh-list
65059851|NCT00424814|Lamivudine|lamivudine|mesh-list
65059852|NCT00424814|Zidovudine|zidovudine|mesh-list
65059853|NCT00424814|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
65059854|NCT00424814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65059855|NCT00424814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65059856|NCT00424814|Protease Inhibitors|protease inhibitors|mesh-ancestor
65059857|NCT00424814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545169|NCT03059173|Hormone Antagonists|hormone antagonists|mesh-ancestor
65059858|NCT00424814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059859|NCT00424814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65059860|NCT00424814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65059861|NCT00424814|Antiviral Agents|antiviral agents|mesh-ancestor
65059862|NCT00424814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65059863|NCT00424814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65059864|NCT00424814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65059865|NCT00424814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65059867|NCT00424814|Antimetabolites|antimetabolites|mesh-ancestor
65059873|NCT00247481|Gefitinib|gefitinib|mesh-list
65059874|NCT00247481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059875|NCT00247481|Tubulin Modulators|tubulin modulators|mesh-ancestor
65059876|NCT00247481|Antimitotic Agents|antimitotic agents|mesh-ancestor
65059877|NCT00247481|Mitosis Modulators|mitosis modulators|mesh-ancestor
65059878|NCT00247481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059879|NCT00247481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65059880|NCT00247481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059881|NCT00247559|Botulinum Toxins|botulinum toxins|mesh-list
65059882|NCT00247559|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65059883|NCT00247559|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65059884|NCT00247559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65059885|NCT00247559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65059886|NCT00247559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059887|NCT00247559|Cholinergic Agents|cholinergic agents|mesh-ancestor
65059888|NCT00247559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65059889|NCT00247559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059890|NCT00247559|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65059891|NCT00247559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65059892|NCT00285051|Ondansetron|ondansetron|mesh-list
65059893|NCT00285051|Antiemetics|antiemetics|mesh-ancestor
65059894|NCT00285051|Autonomic Agents|autonomic agents|mesh-ancestor
65059895|NCT00285051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65059896|NCT00285051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059897|NCT00285051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65059898|NCT00285051|Antipruritics|antipruritics|mesh-ancestor
65059899|NCT00285051|Dermatologic Agents|dermatologic agents|mesh-ancestor
65059920|NCT00247715|Histamine Antagonists|histamine antagonists|mesh-ancestor
65059921|NCT00247715|Histamine Agents|histamine agents|mesh-ancestor
65059922|NCT00247715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65059923|NCT00247715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059924|NCT00247715|Antacids|antacids|mesh-ancestor
65059925|NCT00247715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65059926|NCT00247715|Immunologic Factors|immunologic factors|mesh-ancestor
65059927|NCT00285090|Calcium, Dietary|calcium, dietary|mesh-list
65059928|NCT00285090|Vitamin D|vitamin d|mesh-list
65059929|NCT00285090|Ergocalciferols|ergocalciferols|mesh-list
65059930|NCT00285090|Cholecalciferol|cholecalciferol|mesh-list
65059931|NCT00285090|Vitamins|vitamins|mesh-list
65059932|NCT00285090|Calcium|calcium|mesh-list
65059933|NCT00285090|Micronutrients|micronutrients|mesh-ancestor
65059934|NCT00285090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059935|NCT00285090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64501313|NCT04942158|Eugenol|eugenol|mesh-list
65059936|NCT00285090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65059937|NCT00417222|Olmesartan|olmesartan|mesh-list
65059938|NCT00417222|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65059939|NCT00417222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65059940|NCT00417222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65059941|NCT00417222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65059942|NCT00417222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059943|NCT00278070|Vinorelbine|vinorelbine|mesh-list
65059944|NCT00278070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65059945|NCT00278070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059946|NCT00278070|Tubulin Modulators|tubulin modulators|mesh-ancestor
65059947|NCT00278070|Antimitotic Agents|antimitotic agents|mesh-ancestor
65059948|NCT00278070|Mitosis Modulators|mitosis modulators|mesh-ancestor
65059949|NCT00278070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059950|NCT00424983|Zoledronic Acid|zoledronic acid|mesh-list
65059951|NCT00424983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65059961|NCT00278187|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65059962|NCT00278187|Volociximab|volociximab|mesh-list
65059963|NCT00278187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059964|NCT00278187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65059965|NCT00278187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059966|NCT00278187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059967|NCT00278187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65059968|NCT00278187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65059969|NCT00278187|Growth Substances|growth substances|mesh-ancestor
65059970|NCT00278187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65059971|NCT00278187|Growth Inhibitors|growth inhibitors|mesh-ancestor
65059972|NCT00247988|Carboplatin|carboplatin|mesh-list
65059973|NCT00247988|Docetaxel|docetaxel|mesh-list
65059974|NCT00247988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65059975|NCT00247988|Tubulin Modulators|tubulin modulators|mesh-ancestor
65059976|NCT00247988|Antimitotic Agents|antimitotic agents|mesh-ancestor
65059977|NCT00247988|Mitosis Modulators|mitosis modulators|mesh-ancestor
65059978|NCT00247988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059979|NCT00248144|Famciclovir|famciclovir|mesh-list
65059980|NCT00248144|Antiviral Agents|antiviral agents|mesh-ancestor
65059981|NCT00248144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65059982|NCT00248144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65059983|NCT00248144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65059984|NCT00248144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65059985|NCT00278265|Methotrexate|methotrexate|mesh-list
65059986|NCT00278265|Fludarabine phosphate|fludarabine phosphate|mesh-list
65059987|NCT00278265|Fludarabine|fludarabine|mesh-list
65059988|NCT00278265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65059989|NCT00278265|Abortifacient Agents|abortifacient agents|mesh-ancestor
65059990|NCT00278265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65060004|NCT00248183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65060005|NCT00248183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65060006|NCT00248183|Serotonin Agents|serotonin agents|mesh-ancestor
65060007|NCT00248183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65060008|NCT00248183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060009|NCT00248183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060010|NCT00278343|Cediranib|cediranib|mesh-list
65060011|NCT00278343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060012|NCT00278343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060013|NCT00278343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060014|NCT00278343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65060015|NCT00248261|Ziprasidone|ziprasidone|mesh-list
65060016|NCT00248261|Sertraline|sertraline|mesh-list
65060017|NCT00248261|Antidepressive Agents|antidepressive agents|mesh-ancestor
65060018|NCT00248261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65060023|NCT00248261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65060064|NCT00278421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65060065|NCT00278421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65060066|NCT00278421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65060067|NCT00278421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65060068|NCT00278421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060069|NCT00278421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65060070|NCT00278421|Glucocorticoids|glucocorticoids|mesh-ancestor
65060071|NCT00278421|Hormones|hormones|mesh-ancestor
65060072|NCT00278421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65060073|NCT00278421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65060074|NCT00278421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65060075|NCT00278421|Tubulin Modulators|tubulin modulators|mesh-ancestor
65060076|NCT00278421|Antimitotic Agents|antimitotic agents|mesh-ancestor
65060077|NCT00278421|Mitosis Modulators|mitosis modulators|mesh-ancestor
65060078|NCT00248456|Betamethasone|betamethasone|mesh-list
65060079|NCT00248456|Betamethasone Valerate|betamethasone valerate|mesh-list
65060080|NCT00248456|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65060081|NCT00248456|Betamethasone benzoate|betamethasone benzoate|mesh-list
65060082|NCT00248456|Calcipotriene|calcipotriene|mesh-list
65060083|NCT00248456|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
65060084|NCT00248456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65060085|NCT00248456|Glucocorticoids|glucocorticoids|mesh-ancestor
65060086|NCT00248456|Hormones|hormones|mesh-ancestor
65060087|NCT00248456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65060088|NCT00248456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060089|NCT00248456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65060090|NCT00248456|Respiratory System Agents|respiratory system agents|mesh-ancestor
65060091|NCT00248456|Dermatologic Agents|dermatologic agents|mesh-ancestor
65060092|NCT00278460|Gemcitabine|gemcitabine|mesh-list
65060093|NCT00278460|Docetaxel|docetaxel|mesh-list
65060107|NCT00248729|Midazolam|midazolam|mesh-list
65060108|NCT00248729|Etomidate|etomidate|mesh-list
65060109|NCT00248729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65060110|NCT00248729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65060111|NCT00248729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65060112|NCT00248729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060113|NCT00248729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65060114|NCT00248729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65060115|NCT00248729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65060116|NCT00248729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65060117|NCT00248729|Anesthetics, General|anesthetics, general|mesh-ancestor
65060118|NCT00248729|Anesthetics|anesthetics|mesh-ancestor
65060119|NCT00248729|GABA Modulators|gaba modulators|mesh-ancestor
65060120|NCT00248729|GABA Agents|gaba agents|mesh-ancestor
65060121|NCT00248729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65060122|NCT00248729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060123|NCT00278694|Oxaliplatin|oxaliplatin|mesh-list
65060124|NCT00278694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060125|NCT00248963|Levonorgestrel|levonorgestrel|mesh-list
65060126|NCT00248963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65060127|NCT00248963|Estradiol|estradiol|mesh-list
65060128|NCT00248963|Estrogens|estrogens|mesh-ancestor
65060129|NCT00248963|Hormones|hormones|mesh-ancestor
65060130|NCT00248963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65060131|NCT00248963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060132|NCT00248963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65060133|NCT00248963|Contraceptive Agents|contraceptive agents|mesh-ancestor
65060134|NCT00248963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65060135|NCT00248963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65060136|NCT00248963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65060137|NCT00248963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65060138|NCT00248963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65060139|NCT00249041|Etanercept|etanercept|mesh-list
65060140|NCT00249041|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65060141|NCT00249041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65060142|NCT00249041|Analgesics|analgesics|mesh-ancestor
65060143|NCT00249041|Sensory System Agents|sensory system agents|mesh-ancestor
65060147|NCT00249041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65060148|NCT00249041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65060149|NCT00249041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65060150|NCT00249041|Immunologic Factors|immunologic factors|mesh-ancestor
65060151|NCT00285519|Doxazosin|doxazosin|mesh-list
65060152|NCT00285519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65060153|NCT00285519|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65060154|NCT00285519|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65060155|NCT00285519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65060156|NCT00285519|Adrenergic Agents|adrenergic agents|mesh-ancestor
65060157|NCT00285519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65060158|NCT00285519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060159|NCT00285519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060160|NCT00278772|Valproic Acid|valproic acid|mesh-list
65060161|NCT00278772|Anticonvulsants|anticonvulsants|mesh-ancestor
65060162|NCT00278772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060163|NCT00278772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060164|NCT00278772|GABA Agents|gaba agents|mesh-ancestor
65060165|NCT00278772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65060166|NCT00278772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060167|NCT00278772|Antimanic Agents|antimanic agents|mesh-ancestor
65060168|NCT00278772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65060169|NCT00278772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65060170|NCT00278772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65060171|NCT00249119|Risperidone|risperidone|mesh-list
65060172|NCT00249119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65060173|NCT00249119|Serotonin Agents|serotonin agents|mesh-ancestor
65060174|NCT00249119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65060175|NCT00249119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060176|NCT00249119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060190|NCT00249158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060191|NCT00249158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060192|NCT00249158|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65060193|NCT00249158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65060194|NCT00249158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65060195|NCT00249158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65060196|NCT00249158|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65060197|NCT00249158|Dopamine Agents|dopamine agents|mesh-ancestor
65060198|NCT00278928|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65060199|NCT00278928|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65060200|NCT00278928|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65060201|NCT00278928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65060202|NCT00249197|Levofloxacin|levofloxacin|mesh-list
65060204|NCT00249197|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65060205|NCT00249197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65060206|NCT00249197|Renal Agents|renal agents|mesh-ancestor
65060207|NCT00249197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65060208|NCT00249197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65060209|NCT00249197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65060210|NCT00249197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060211|NCT00249197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060212|NCT00249197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060213|NCT00249197|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65060214|NCT00249197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65060215|NCT00278967|Bisacodyl|bisacodyl|mesh-list
65060216|NCT00278967|Cathartics|cathartics|mesh-ancestor
65060217|NCT00278967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65060218|NCT00278967|Laxatives|laxatives|mesh-ancestor
65060235|NCT00285675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65060236|NCT00285675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060237|NCT00285675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65060238|NCT00285675|Vitamins|vitamins|mesh-ancestor
65060239|NCT00285675|Micronutrients|micronutrients|mesh-ancestor
65060240|NCT00285675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65060241|NCT02215096|GSK2636771|gsk2636771|mesh-list
65060242|NCT02215096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060243|NCT02215096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65060244|NCT02215096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060245|NCT02215096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060246|NCT00279045|Metformin|metformin|mesh-list
65060247|NCT00279045|Rosiglitazone|rosiglitazone|mesh-list
65060248|NCT00279045|Glyburide|glyburide|mesh-list
65060249|NCT00279045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65060250|NCT00279045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060251|NCT00249353|Methylphenidate|methylphenidate|mesh-list
65060252|NCT00249353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65060253|NCT00249353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060254|NCT00249353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65060255|NCT00249353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65060256|NCT00249353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65060257|NCT00249353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060258|NCT00249353|Dopamine Agents|dopamine agents|mesh-ancestor
65060259|NCT00249353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65060260|NCT00249431|Sertraline|sertraline|mesh-list
65060261|NCT00249431|Antidepressive Agents|antidepressive agents|mesh-ancestor
65060262|NCT00249431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65060263|NCT00249431|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65060264|NCT00249431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65060265|NCT00249431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65060266|NCT00249431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060275|NCT00249509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65060276|NCT00249509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65060277|NCT00249509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65060278|NCT00249509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060279|NCT00249509|Dopamine Agents|dopamine agents|mesh-ancestor
65060280|NCT00249509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64912366|NCT00006038|Leucovorin|leucovorin|mesh-list
65060343|NCT00249782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060344|NCT00249782|Leprostatic Agents|leprostatic agents|mesh-ancestor
65060345|NCT00279240|Metformin|metformin|mesh-list
65060346|NCT00279240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65060347|NCT00279240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060348|NCT00249860|Interferons|interferons|mesh-list
65060349|NCT00249860|Ribavirin|ribavirin|mesh-list
65060350|NCT00249860|Interferon-beta|interferon-beta|mesh-list
65060351|NCT00249860|Interferon beta-1a|interferon beta-1a|mesh-list
65060352|NCT00249860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060353|NCT00249860|Antiviral Agents|antiviral agents|mesh-ancestor
65060354|NCT00249860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65060355|NCT00249860|Antimetabolites|antimetabolites|mesh-ancestor
65060356|NCT00249860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060357|NCT00249860|Immunologic Factors|immunologic factors|mesh-ancestor
65060358|NCT00249860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060359|NCT00249860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65060360|NCT00249899|Atorvastatin|atorvastatin|mesh-list
65060361|NCT00249899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65060362|NCT00249899|Simvastatin|simvastatin|mesh-list
65060363|NCT00249899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65060364|NCT00249899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65060365|NCT00249899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65060366|NCT00249899|Antimetabolites|antimetabolites|mesh-ancestor
65060367|NCT00249899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060368|NCT00249899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65060369|NCT00249899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060370|NCT00249938|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65060371|NCT00249938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65060372|NCT00249938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65060373|NCT00249938|Antimetabolites|antimetabolites|mesh-ancestor
65060374|NCT00249938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060375|NCT00249938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65060376|NCT00249977|Capecitabine|capecitabine|mesh-list
65060377|NCT00249977|Irinotecan|irinotecan|mesh-list
65060378|NCT00249977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060381|NCT00249977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060382|NCT00249977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65060383|NCT00249977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65060384|NCT00249977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060385|NCT00250094|Topotecan|topotecan|mesh-list
65060386|NCT00250094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65060387|NCT00250094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65060388|NCT00250094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060389|NCT00250094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060390|NCT00250094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060391|NCT00279435|Visilizumab|visilizumab|mesh-list
65060392|NCT00279435|Immunologic Factors|immunologic factors|mesh-ancestor
65060393|NCT00279435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060394|NCT00286026|Azithromycin|azithromycin|mesh-list
65060395|NCT00286026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65060396|NCT00286026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65060397|NCT00250172|Rolipram|rolipram|mesh-list
65060398|NCT00250172|Antidepressive Agents|antidepressive agents|mesh-ancestor
65060399|NCT00250172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65060400|NCT00250172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65060401|NCT00250172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65060402|NCT00250172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060403|NCT00250172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060404|NCT02961608|Tacrolimus|tacrolimus|mesh-list
65060405|NCT02961608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65060406|NCT02961608|Immunologic Factors|immunologic factors|mesh-ancestor
65060407|NCT02961608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060408|NCT02961608|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65060409|NCT02961608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060411|NCT00286104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65060424|NCT00286143|Anesthetics|anesthetics|mesh-ancestor
65060425|NCT00286260|Levetiracetam|levetiracetam|mesh-list
65060426|NCT00286260|Anticonvulsants|anticonvulsants|mesh-ancestor
65060427|NCT00286260|Nootropic Agents|nootropic agents|mesh-ancestor
65060428|NCT00250367|Risperidone|risperidone|mesh-list
65060429|NCT00250367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65060430|NCT00250367|Serotonin Agents|serotonin agents|mesh-ancestor
65060431|NCT00250367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65060432|NCT00250367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060433|NCT00250367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060434|NCT00250367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65060435|NCT00250367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65060436|NCT00250367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65060437|NCT00250367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65060438|NCT00250367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65060439|NCT00250367|Dopamine Agents|dopamine agents|mesh-ancestor
65060440|NCT00250562|Valsartan|valsartan|mesh-list
65060441|NCT00250562|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65060442|NCT00250562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65060443|NCT00250562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65060444|NCT00250562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65060445|NCT00250562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060446|NCT00250562|Diuretics|diuretics|mesh-ancestor
65060447|NCT00250562|Natriuretic Agents|natriuretic agents|mesh-ancestor
65060448|NCT00250562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060449|NCT00250562|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65060450|NCT00250562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65060472|NCT00279747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060473|NCT00279747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060474|NCT00279747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65060475|NCT00250640|Iloprost|iloprost|mesh-list
65060476|NCT00250640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65060477|NCT00250640|Vasodilator Agents|vasodilator agents|mesh-ancestor
65060478|NCT00250796|Interferons|interferons|mesh-list
65060479|NCT00250796|Interferon-alpha|interferon-alpha|mesh-list
65060480|NCT00250796|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65060481|NCT00250796|Thalidomide|thalidomide|mesh-list
65060482|NCT00250796|Octreotide|octreotide|mesh-list
65060483|NCT00250796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060484|NCT00250796|Antiviral Agents|antiviral agents|mesh-ancestor
65060485|NCT00250796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65060486|NCT00250796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65060487|NCT00250796|Immunologic Factors|immunologic factors|mesh-ancestor
65060488|NCT00250796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060489|NCT00250796|Leprostatic Agents|leprostatic agents|mesh-ancestor
65060490|NCT00250796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65060491|NCT00250796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65060492|NCT00250796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65060493|NCT00250796|Growth Substances|growth substances|mesh-ancestor
65060494|NCT00250796|Growth Inhibitors|growth inhibitors|mesh-ancestor
65060495|NCT00250796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65060496|NCT00250796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65060497|NCT00286416|Omalizumab|omalizumab|mesh-list
65060498|NCT00286416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65060499|NCT00286416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65060501|NCT00250874|Docetaxel|docetaxel|mesh-list
65060521|NCT00279825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65060522|NCT00279825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060523|NCT00279825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060524|NCT00279825|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65060525|NCT00279825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060526|NCT00279825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65060527|NCT00279825|Immunologic Factors|immunologic factors|mesh-ancestor
65060528|NCT00279825|Dopamine Agonists|dopamine agonists|mesh-ancestor
65060529|NCT00250952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65060530|NCT00250952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65060531|NCT00250952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65060532|NCT00250952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65060533|NCT00250952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060534|NCT00250952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65060535|NCT00250952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65060536|NCT00250952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060537|NCT00250952|Cholinergic Agents|cholinergic agents|mesh-ancestor
65060538|NCT00250952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65060539|NCT00250991|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65060540|NCT00250991|Eptifibatide|eptifibatide|mesh-list
65060541|NCT00250991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65060542|NCT00250991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65060543|NCT00250991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060544|NCT00250991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65060545|NCT00286611|Amifostine|amifostine|mesh-list
65060546|NCT00286611|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65060547|NCT00286611|Protective Agents|protective agents|mesh-ancestor
65060548|NCT00286611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060549|NCT00416832|Prednisone|prednisone|mesh-list
65060550|NCT00416832|Cyclophosphamide|cyclophosphamide|mesh-list
65060551|NCT00416832|Dacarbazine|dacarbazine|mesh-list
65060552|NCT00416832|Doxorubicin|doxorubicin|mesh-list
65060553|NCT00416832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65060554|NCT00416832|Etoposide|etoposide|mesh-list
65060555|NCT00416832|Vincristine|vincristine|mesh-list
65060560|NCT00416832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65060561|NCT00416832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64912582|NCT00017992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64912583|NCT00017992|Antiviral Agents|antiviral agents|mesh-ancestor
65060562|NCT00416832|Alkylating Agents|alkylating agents|mesh-ancestor
65060563|NCT00416832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060564|NCT00416832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060565|NCT00416832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65060566|NCT00416832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65060567|NCT00416832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65060568|NCT00416832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65060569|NCT00416832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060570|NCT00416832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65060571|NCT00416832|Glucocorticoids|glucocorticoids|mesh-ancestor
65060572|NCT00416832|Hormones|hormones|mesh-ancestor
65060573|NCT00416832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65060574|NCT00416832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65060575|NCT00416832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65060576|NCT00416832|Tubulin Modulators|tubulin modulators|mesh-ancestor
65060577|NCT00416832|Antimitotic Agents|antimitotic agents|mesh-ancestor
65060578|NCT00416832|Mitosis Modulators|mitosis modulators|mesh-ancestor
65060579|NCT00251030|Nelfinavir|nelfinavir|mesh-list
65060580|NCT00251030|Omeprazole|omeprazole|mesh-list
65060581|NCT00251030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65060582|NCT00251030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64545908|NCT02646475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545909|NCT03151057|Idelalisib|idelalisib|mesh-list
64545910|NCT03151057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545911|NCT03151057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545912|NCT03151057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545913|NCT01674283|Glucagon|glucagon|mesh-list
64545914|NCT01674283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65060606|NCT01640002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65060607|NCT01640002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65060608|NCT01640002|Cholinergic Agents|cholinergic agents|mesh-ancestor
65060609|NCT01640002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65060610|NCT01640002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060611|NCT01640002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060612|NCT00279903|Cortisone|cortisone|mesh-list
65060613|NCT00279903|Botulinum Toxins|botulinum toxins|mesh-list
65060614|NCT00279903|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65060615|NCT00279903|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65060616|NCT00279903|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65060617|NCT00279903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65060618|NCT00279903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060619|NCT00279903|Cholinergic Agents|cholinergic agents|mesh-ancestor
65060620|NCT00279903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65060621|NCT00279903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060622|NCT00279903|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65060623|NCT00279903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65060624|NCT00279903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65060625|NCT01640275|Propofol|propofol|mesh-list
65060626|NCT01640275|Isoflurane|isoflurane|mesh-list
65060627|NCT01640275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65060628|NCT01640275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65060643|NCT01640665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65060644|NCT01640665|Antimetabolites|antimetabolites|mesh-ancestor
65060645|NCT01640665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060646|NCT01640665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060647|NCT01640665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65060648|NCT01640665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060649|NCT01640782|Leucovorin|leucovorin|mesh-list
65060650|NCT01640782|Docetaxel|docetaxel|mesh-list
65060651|NCT01640782|Fluorouracil|fluorouracil|mesh-list
65060652|NCT01640782|Irinotecan|irinotecan|mesh-list
65060653|NCT01640782|Levoleucovorin|levoleucovorin|mesh-list
65060654|NCT01640782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060655|NCT01640782|Tubulin Modulators|tubulin modulators|mesh-ancestor
65060656|NCT01640782|Antimitotic Agents|antimitotic agents|mesh-ancestor
65060657|NCT01640782|Mitosis Modulators|mitosis modulators|mesh-ancestor
65060658|NCT01640782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060659|NCT01640782|Antimetabolites|antimetabolites|mesh-ancestor
65060660|NCT01640782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65060661|NCT01640782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65060662|NCT01640782|Immunologic Factors|immunologic factors|mesh-ancestor
65060663|NCT01640782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060664|NCT01640782|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65060665|NCT01640782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65060666|NCT01640782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060667|NCT01640782|Antidotes|antidotes|mesh-ancestor
65060668|NCT01640782|Protective Agents|protective agents|mesh-ancestor
65060669|NCT01640782|Vitamin B Complex|vitamin b complex|mesh-ancestor
65060670|NCT01640782|Vitamins|vitamins|mesh-ancestor
65060671|NCT01640782|Micronutrients|micronutrients|mesh-ancestor
65060672|NCT00251186|Capecitabine|capecitabine|mesh-list
65060673|NCT00251186|Cetuximab|cetuximab|mesh-list
65060674|NCT00251186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65060675|NCT00251186|Antimetabolites|antimetabolites|mesh-ancestor
65060676|NCT00251186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060677|NCT00251186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060678|NCT00251186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65060683|NCT01641250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060684|NCT01641250|Antiviral Agents|antiviral agents|mesh-ancestor
65060685|NCT01641250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65060686|NCT01641250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65060687|NCT01641250|Immunologic Factors|immunologic factors|mesh-ancestor
65060688|NCT01641250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060690|NCT01641289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65060691|NCT01641289|Analgesics|analgesics|mesh-ancestor
65060692|NCT01641289|Sensory System Agents|sensory system agents|mesh-ancestor
65060693|NCT01641289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65060694|NCT01641289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060695|NCT01641289|Antipyretics|antipyretics|mesh-ancestor
65060696|NCT01641406|Cyclophosphamide|cyclophosphamide|mesh-list
65060697|NCT01641406|Bevacizumab|bevacizumab|mesh-list
65060698|NCT01641406|Docetaxel|docetaxel|mesh-list
65060699|NCT01641406|Capecitabine|capecitabine|mesh-list
65060700|NCT01641406|Trastuzumab|trastuzumab|mesh-list
65060701|NCT01641406|Epirubicin|epirubicin|mesh-list
65060702|NCT01641406|Vinorelbine|vinorelbine|mesh-list
65060703|NCT01641406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65060704|NCT01641406|Immunologic Factors|immunologic factors|mesh-ancestor
65494078|NCT03743636|Vasodilator Agents|vasodilator agents|mesh-ancestor
65060705|NCT01641406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060706|NCT01641406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65060707|NCT01641406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65060732|NCT01641796|Paromomycin|paromomycin|mesh-list
65060735|NCT01641796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65060736|NCT01641796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65060737|NCT00280098|Docetaxel|docetaxel|mesh-list
65060738|NCT00280098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060739|NCT00280098|Tubulin Modulators|tubulin modulators|mesh-ancestor
65060740|NCT00280098|Antimitotic Agents|antimitotic agents|mesh-ancestor
65060741|NCT00280098|Mitosis Modulators|mitosis modulators|mesh-ancestor
65060742|NCT00280098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060743|NCT00251381|Cetuximab|cetuximab|mesh-list
65060744|NCT00251381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65060745|NCT00251381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060746|NCT01685827|Eflornithine|eflornithine|mesh-list
65060747|NCT01685827|Nifurtimox|nifurtimox|mesh-list
65060748|NCT01685827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060749|NCT01685827|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65060750|NCT01685827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65060751|NCT01685827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65060752|NCT01685827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65060753|NCT01685827|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
65060754|NCT01685827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060755|NCT01685827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060756|NCT05140096|Fluconazole|fluconazole|mesh-list
65060757|NCT05140096|Isavuconazole|isavuconazole|mesh-list
65060758|NCT05140096|Acalabrutinib|acalabrutinib|mesh-list
65060759|NCT05140096|Antifungal Agents|antifungal agents|mesh-ancestor
65060760|NCT05140096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65060761|NCT05140096|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65060763|NCT05140096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060784|NCT04823065|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65060785|NCT04823065|Antiemetics|antiemetics|mesh-ancestor
65060786|NCT04823065|Autonomic Agents|autonomic agents|mesh-ancestor
65060787|NCT04823065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65060788|NCT04823065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060789|NCT04823065|Mydriatics|mydriatics|mesh-ancestor
65060790|NCT04823065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65060791|NCT04823065|Cholinergic Agents|cholinergic agents|mesh-ancestor
65060792|NCT04823065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65060793|NCT04823065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060794|NCT04823065|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65060795|NCT04823065|Parasympatholytics|parasympatholytics|mesh-ancestor
65060796|NCT00280176|Fluorouracil|fluorouracil|mesh-list
65060797|NCT00280176|Bortezomib|bortezomib|mesh-list
65060798|NCT00280176|Antimetabolites|antimetabolites|mesh-ancestor
65060799|NCT00280176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060800|NCT00280176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65060801|NCT00280176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060802|NCT00280176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65060803|NCT00280176|Immunologic Factors|immunologic factors|mesh-ancestor
65060804|NCT00280176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060805|NCT00280215|Losartan|losartan|mesh-list
65060806|NCT00280215|Lisinopril|lisinopril|mesh-list
65060807|NCT00280215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65060808|NCT00280215|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65060809|NCT00280215|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65060810|NCT00280215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65060811|NCT00280215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65060812|NCT00280215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65060813|NCT00280215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060814|NCT00280215|Protease Inhibitors|protease inhibitors|mesh-ancestor
65060827|NCT02271334|Albuterol|albuterol|mesh-list
65060828|NCT02271334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65060829|NCT02271334|Autonomic Agents|autonomic agents|mesh-ancestor
65060830|NCT02271334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65060831|NCT02271334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060832|NCT02271334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65060833|NCT02271334|Respiratory System Agents|respiratory system agents|mesh-ancestor
65060834|NCT02271334|Tocolytic Agents|tocolytic agents|mesh-ancestor
65060835|NCT02271334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65060836|NCT02271334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65060837|NCT02271334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65060838|NCT02271334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65060839|NCT02271334|Adrenergic Agents|adrenergic agents|mesh-ancestor
65060840|NCT02271334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65060841|NCT02271334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060842|NCT02276755|Vitamin D|vitamin d|mesh-list
65060843|NCT02276755|Cholecalciferol|cholecalciferol|mesh-list
65060844|NCT02276755|Vitamins|vitamins|mesh-ancestor
65060845|NCT02276755|Micronutrients|micronutrients|mesh-ancestor
65060846|NCT02276755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060847|NCT02276755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65060848|NCT02276755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65060879|NCT00286923|Anticonvulsants|anticonvulsants|mesh-ancestor
65060880|NCT00286923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65060881|NCT00286923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060882|NCT00251732|Antidepressive Agents|antidepressive agents|mesh-list
65060883|NCT00251732|Nortriptyline|nortriptyline|mesh-list
65060884|NCT00251732|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
65060885|NCT00251732|Rabeprazole|rabeprazole|mesh-list
65060886|NCT00251732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65060887|NCT00251732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65060888|NCT00251732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65060889|NCT00251732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060890|NCT00251732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060891|NCT00251732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65060892|NCT00251732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65060893|NCT00251732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65060894|NCT00251732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65060895|NCT00251732|Adrenergic Agents|adrenergic agents|mesh-ancestor
65060896|NCT00251732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65060897|NCT00251732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060898|NCT00286962|Insulin|insulin|mesh-list
65060899|NCT00286962|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65060900|NCT00286962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65060901|NCT00286962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060902|NCT03486301|Pembrolizumab|pembrolizumab|mesh-list
65060903|NCT03486301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65060904|NCT03486301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060905|NCT04719650|Zoledronic Acid|zoledronic acid|mesh-list
65060906|NCT04719650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65060907|NCT04719650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060908|NCT00251849|KRM 1648|krm 1648|mesh-list
65060909|NCT00251849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65060914|NCT04822597|Lidocaine|lidocaine|mesh-list
65060922|NCT04822597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65060923|NCT04822597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65060924|NCT04822597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65060925|NCT04822597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060926|NCT00251888|Irinotecan|irinotecan|mesh-list
65060927|NCT00251888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060928|NCT00251888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65060929|NCT00251888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65060930|NCT00251888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060931|NCT00251888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060932|NCT00251966|Esomeprazole|esomeprazole|mesh-list
65060933|NCT00251966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65060934|NCT00251966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65060935|NCT00251966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65060936|NCT00251966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060937|NCT00251966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060938|NCT00252044|Pergolide|pergolide|mesh-list
65060939|NCT00252044|Dopamine Agonists|dopamine agonists|mesh-ancestor
65060940|NCT00252044|Dopamine Agents|dopamine agents|mesh-ancestor
65060941|NCT00252044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65060942|NCT00252044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060943|NCT00252044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060944|NCT01805284|Linezolid|linezolid|mesh-list
65060945|NCT01805284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65060946|NCT01805284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65060947|NCT01805284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65060948|NCT01805284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65060949|NCT01805284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060950|NCT00280605|Alfuzosin|alfuzosin|mesh-list
65060951|NCT00280605|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65060952|NCT00280605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65060953|NCT00280605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65060954|NCT00280605|Adrenergic Agents|adrenergic agents|mesh-ancestor
65060955|NCT00280605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65060958|NCT00280605|Urological Agents|urological agents|mesh-ancestor
65060959|NCT01134601|Capecitabine|capecitabine|mesh-list
65060960|NCT01134601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65060961|NCT01134601|Antimetabolites|antimetabolites|mesh-ancestor
65060962|NCT01134601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060963|NCT01134601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65060964|NCT00252122|Ketamine|ketamine|mesh-list
65060965|NCT00252122|Analgesics|analgesics|mesh-ancestor
65060966|NCT00252122|Sensory System Agents|sensory system agents|mesh-ancestor
65060967|NCT00252122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65060968|NCT00252122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060969|NCT00252122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65060970|NCT00252122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65060971|NCT00252122|Anesthetics, General|anesthetics, general|mesh-ancestor
65060972|NCT00252122|Anesthetics|anesthetics|mesh-ancestor
65060973|NCT00252122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65060974|NCT00252122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65060975|NCT00252122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65060976|NCT00252122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65060977|NCT00252122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65060978|NCT00287157|Tizanidine|tizanidine|mesh-list
65060979|NCT00287157|Analgesics|analgesics|mesh-ancestor
65060980|NCT00287157|Sensory System Agents|sensory system agents|mesh-ancestor
65060981|NCT00287157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65060982|NCT00287157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65060983|NCT00287157|Anticonvulsants|anticonvulsants|mesh-ancestor
65060984|NCT00287157|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65060985|NCT00287157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65060986|NCT00287157|Parasympatholytics|parasympatholytics|mesh-ancestor
65060987|NCT00287157|Autonomic Agents|autonomic agents|mesh-ancestor
65060988|NCT00287157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65060999|NCT00280644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061000|NCT00252200|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65061001|NCT00252200|Natriuretic Agents|natriuretic agents|mesh-ancestor
65061002|NCT00252200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061003|NCT00252278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65061004|NCT00252278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65061005|NCT00252278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65061006|NCT00252278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65061007|NCT00252278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061008|NCT00252278|Adrenergic Agents|adrenergic agents|mesh-ancestor
65061009|NCT00252278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65061010|NCT00252278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061011|NCT00252317|Captopril|captopril|mesh-list
65061012|NCT00252317|Trandolapril|trandolapril|mesh-list
65061013|NCT00252317|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65061014|NCT00252317|Protease Inhibitors|protease inhibitors|mesh-ancestor
65061015|NCT00252317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061016|NCT00252317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061017|NCT00252317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65061018|NCT00252356|Amibegron|amibegron|mesh-list
65061019|NCT00252356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65061020|NCT00252356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65061021|NCT00252356|Adrenergic Agents|adrenergic agents|mesh-ancestor
65061022|NCT00252356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65061023|NCT00252356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061024|NCT00252356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061025|NCT02753998|Paclitaxel|paclitaxel|mesh-list
65061026|NCT02753998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65061027|NCT02753998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061028|NCT02753998|Tubulin Modulators|tubulin modulators|mesh-ancestor
65061032|NCT02754154|Warfarin|warfarin|mesh-list
65061041|NCT02754154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061042|NCT02754154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061043|NCT00252434|Methamphetamine|methamphetamine|mesh-list
65061044|NCT00252434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65061045|NCT00252434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061046|NCT00252434|Sympathomimetics|sympathomimetics|mesh-ancestor
65061047|NCT00252434|Autonomic Agents|autonomic agents|mesh-ancestor
65061048|NCT00252434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65061049|NCT00252434|Dopamine Agents|dopamine agents|mesh-ancestor
65061050|NCT00252434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65061051|NCT00252434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061052|NCT00252434|Adrenergic Agents|adrenergic agents|mesh-ancestor
65061053|NCT00252434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65061054|NCT00252434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65061055|NCT00252434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65061056|NCT00252434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65061057|NCT00280839|Topiramate|topiramate|mesh-list
65061058|NCT00280839|Anticonvulsants|anticonvulsants|mesh-ancestor
65061059|NCT00280839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65061060|NCT00280839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061062|NCT02757898|Vitamin B Complex|vitamin b complex|mesh-ancestor
65061063|NCT02757898|Vitamins|vitamins|mesh-ancestor
65061064|NCT02757898|Micronutrients|micronutrients|mesh-ancestor
65061065|NCT02757898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061066|NCT00280878|Gemcitabine|gemcitabine|mesh-list
65061067|NCT00280878|Rituximab|rituximab|mesh-list
65061068|NCT00280878|Vinorelbine|vinorelbine|mesh-list
65061069|NCT00280878|Ifosfamide|ifosfamide|mesh-list
65061070|NCT00280878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65061071|NCT00280878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061072|NCT00280878|Immunologic Factors|immunologic factors|mesh-ancestor
65061073|NCT00280878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061084|NCT00280878|Antimitotic Agents|antimitotic agents|mesh-ancestor
65061085|NCT00280878|Mitosis Modulators|mitosis modulators|mesh-ancestor
65061086|NCT00280878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65061087|NCT00280878|Alkylating Agents|alkylating agents|mesh-ancestor
65061088|NCT02758717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65061090|NCT02758717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65061091|NCT02758717|Antibodies|antibodies|mesh-list
65061092|NCT02758717|Immunoglobulins|immunoglobulins|mesh-list
65061093|NCT02758717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65061094|NCT02758717|Immunoconjugates|immunoconjugates|mesh-list
65061095|NCT02758717|Immunologic Factors|immunologic factors|mesh-ancestor
65061096|NCT02758717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061097|NCT02758717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061098|NCT02758717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65061099|NCT02758717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061100|NCT00287313|Vitamin K|vitamin k|mesh-list
65061101|NCT00287313|Vitamins|vitamins|mesh-ancestor
65061102|NCT00287313|Micronutrients|micronutrients|mesh-ancestor
65061103|NCT00287313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061104|NCT00287313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65061105|NCT00287313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65061106|NCT00287313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061107|NCT00287313|Hemostatics|hemostatics|mesh-ancestor
65061108|NCT00287313|Coagulants|coagulants|mesh-ancestor
65061109|NCT01680250|Sirolimus|sirolimus|mesh-list
65061110|NCT01680250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65061111|NCT01680250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65061112|NCT01680250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64502500|NCT03889912|Cemiplimab|cemiplimab|mesh-list
65061134|NCT02279875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65061135|NCT02279875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65061136|NCT02279875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65061137|NCT02279875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65061138|NCT02279875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65061139|NCT02279875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65061140|NCT02279875|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65061141|NCT02279875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65061142|NCT02279875|Antimetabolites|antimetabolites|mesh-ancestor
65061143|NCT02279875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65061144|NCT02279875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65061145|NCT00280995|Mipomersen|mipomersen|mesh-list
65061146|NCT00280995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65061147|NCT00280995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65061148|NCT00280995|Antimetabolites|antimetabolites|mesh-ancestor
65061149|NCT00280995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061150|NCT00280995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65061151|NCT05139667|Tacrolimus|tacrolimus|mesh-list
65494079|NCT03701763|Apremilast|apremilast|mesh-list
65061152|NCT05139667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65061154|NCT05139667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061155|NCT05139667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65061156|NCT05139667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061157|NCT05139667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061158|NCT00287352|Amantadine|amantadine|mesh-list
65061159|NCT00287352|Olanzapine|olanzapine|mesh-list
65061160|NCT00287352|Antiemetics|antiemetics|mesh-ancestor
65061161|NCT00287352|Autonomic Agents|autonomic agents|mesh-ancestor
65061162|NCT00287352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65061163|NCT00287352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061164|NCT00287352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65061174|NCT00287352|Serotonin Agents|serotonin agents|mesh-ancestor
65061175|NCT00287352|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65061176|NCT00287352|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65061177|NCT00287352|Antiviral Agents|antiviral agents|mesh-ancestor
65061178|NCT00287352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65061179|NCT00287352|Dopamine Agents|dopamine agents|mesh-ancestor
65061180|NCT00287352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65061181|NCT00287352|Analgesics|analgesics|mesh-ancestor
65061182|NCT00287352|Sensory System Agents|sensory system agents|mesh-ancestor
65061183|NCT04823962|Molgramostim|molgramostim|mesh-list
65061184|NCT04823962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061185|NCT00252668|Etanercept|etanercept|mesh-list
65061186|NCT00252668|Methotrexate|methotrexate|mesh-list
65061187|NCT00252668|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65061188|NCT00252668|Abortifacient Agents|abortifacient agents|mesh-ancestor
65061189|NCT00252668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65061190|NCT00252668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061191|NCT00252668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65061192|NCT00252668|Antimetabolites|antimetabolites|mesh-ancestor
65061193|NCT00252668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061194|NCT00252668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061195|NCT00252668|Dermatologic Agents|dermatologic agents|mesh-ancestor
65061196|NCT00252668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061197|NCT00252668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65061198|NCT00252668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65061199|NCT00252668|Immunologic Factors|immunologic factors|mesh-ancestor
65061200|NCT00252668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65061201|NCT00252668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65061202|NCT00252668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65061203|NCT00252668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65061204|NCT00252668|Analgesics|analgesics|mesh-ancestor
65061205|NCT00252668|Sensory System Agents|sensory system agents|mesh-ancestor
65061206|NCT00252668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65061207|NCT00252668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65061208|NCT00252668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64913194|NCT04619680|Nintedanib|nintedanib|mesh-list
64951548|NCT00026351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64951549|NCT00026351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951550|NCT00026351|Immunologic Factors|immunologic factors|mesh-ancestor
64951551|NCT00026351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951552|NCT00026351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65061209|NCT02271997|Ferrous fumarate|ferrous fumarate|mesh-list
65061210|NCT02271997|Ferrous gluconate|ferrous gluconate|mesh-list
65061212|NCT02271997|Micronutrients|micronutrients|mesh-ancestor
65061213|NCT02271997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061214|NCT02271997|Hematinics|hematinics|mesh-ancestor
65061215|NCT00287391|Rabeprazole|rabeprazole|mesh-list
65061216|NCT00287391|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65061217|NCT00287391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65061218|NCT00287391|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65061219|NCT00287391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061220|NCT00287391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061221|NCT00252707|Docetaxel|docetaxel|mesh-list
65061222|NCT00252707|Gefitinib|gefitinib|mesh-list
65061223|NCT00252707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061224|NCT00252707|Tubulin Modulators|tubulin modulators|mesh-ancestor
65061225|NCT00252707|Antimitotic Agents|antimitotic agents|mesh-ancestor
65061226|NCT00252707|Mitosis Modulators|mitosis modulators|mesh-ancestor
65061227|NCT00252707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061228|NCT00252707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65061229|NCT00252707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061268|NCT01680796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65061269|NCT01680796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65061270|NCT01680796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061271|NCT00252785|Budesonide|budesonide|mesh-list
65061272|NCT00252785|Theophylline|theophylline|mesh-list
65061273|NCT00252785|Formoterol Fumarate|formoterol fumarate|mesh-list
65061274|NCT00252785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65061275|NCT00252785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65061276|NCT00252785|Autonomic Agents|autonomic agents|mesh-ancestor
65061277|NCT00252785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65061278|NCT00252785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061279|NCT00252785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65061280|NCT00252785|Respiratory System Agents|respiratory system agents|mesh-ancestor
65061281|NCT00252785|Glucocorticoids|glucocorticoids|mesh-ancestor
65061282|NCT00252785|Hormones|hormones|mesh-ancestor
65061283|NCT00252785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65061284|NCT00252785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65061285|NCT00252785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65061286|NCT00252785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65061287|NCT00252785|Adrenergic Agents|adrenergic agents|mesh-ancestor
65061288|NCT00252785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65061289|NCT00252785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061290|NCT00252785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65061291|NCT00252785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061292|NCT00252785|Vasodilator Agents|vasodilator agents|mesh-ancestor
65061300|NCT01680952|Sirolimus|sirolimus|mesh-list
65061316|NCT00252824|Formoterol Fumarate|formoterol fumarate|mesh-list
65061317|NCT00252824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65061318|NCT00252824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65061319|NCT00252824|Autonomic Agents|autonomic agents|mesh-ancestor
65061320|NCT00252824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65061321|NCT00252824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061322|NCT00252824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65061323|NCT00252824|Respiratory System Agents|respiratory system agents|mesh-ancestor
65061324|NCT00252824|Glucocorticoids|glucocorticoids|mesh-ancestor
65061325|NCT00252824|Hormones|hormones|mesh-ancestor
65061326|NCT00252824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65061327|NCT00252824|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65061328|NCT00252824|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65061329|NCT00252824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65061330|NCT00252824|Adrenergic Agents|adrenergic agents|mesh-ancestor
65061331|NCT00252824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65061332|NCT00252824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061333|NCT00281190|Dimercaprol|dimercaprol|mesh-list
65061334|NCT00281190|Chelating Agents|chelating agents|mesh-ancestor
65061335|NCT00281190|Sequestering Agents|sequestering agents|mesh-ancestor
65061336|NCT00281190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061337|NCT00252863|Fluticasone|fluticasone|mesh-list
65061339|NCT00252863|Budesonide|budesonide|mesh-list
65061340|NCT00252863|Theophylline|theophylline|mesh-list
65061341|NCT00252863|Albuterol|albuterol|mesh-list
65061342|NCT00252863|Terbutaline|terbutaline|mesh-list
65061343|NCT00252863|Formoterol Fumarate|formoterol fumarate|mesh-list
65061344|NCT00252863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65061345|NCT00252863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65061362|NCT00252863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65061363|NCT00252863|Adrenergic Agents|adrenergic agents|mesh-ancestor
65061364|NCT00252863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65061365|NCT00252863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061366|NCT00252863|Tocolytic Agents|tocolytic agents|mesh-ancestor
65061367|NCT00252863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65061368|NCT00252863|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65061369|NCT00252863|Hormone Antagonists|hormone antagonists|mesh-ancestor
65061370|NCT00252863|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65061371|NCT00252863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65061372|NCT00252863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65061373|NCT00252863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061374|NCT00252863|Vasodilator Agents|vasodilator agents|mesh-ancestor
65061375|NCT00252863|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65061376|NCT00252863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65061377|NCT00252863|Purinergic Agents|purinergic agents|mesh-ancestor
65061378|NCT00252863|Sympathomimetics|sympathomimetics|mesh-ancestor
65061379|NCT01681537|Cytarabine|cytarabine|mesh-list
65061380|NCT01681537|Etoposide|etoposide|mesh-list
65061381|NCT01681537|Mitoxantrone|mitoxantrone|mesh-list
65061382|NCT01681537|Lenalidomide|lenalidomide|mesh-list
65061383|NCT01681537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65061384|NCT01681537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061385|NCT01681537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65061386|NCT01681537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65061387|NCT01681537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061388|NCT01681537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061389|NCT01681537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65061410|NCT01681966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65061411|NCT01681966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061412|NCT01681966|Sensory System Agents|sensory system agents|mesh-ancestor
65061413|NCT01681966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65061414|NCT01682161|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65061415|NCT01682161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65061416|NCT01682161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65061417|NCT01682161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65061418|NCT01682161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061419|NCT01682161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65061420|NCT01682161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65061421|NCT01682161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65061422|NCT01682161|Serotonin Agents|serotonin agents|mesh-ancestor
65061423|NCT01682161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65061424|NCT01682161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061425|NCT01682161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65061426|NCT01682161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65061427|NCT01682161|Dopamine Agents|dopamine agents|mesh-ancestor
65061428|NCT02279914|Misoprostol|misoprostol|mesh-list
65061429|NCT02279914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65061430|NCT02279914|Abortifacient Agents|abortifacient agents|mesh-ancestor
65061464|NCT01683175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061465|NCT01683175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65061466|NCT01683175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061467|NCT01683175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061468|NCT01683175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65061469|NCT01683175|Tubulin Modulators|tubulin modulators|mesh-ancestor
65061470|NCT01683175|Antimitotic Agents|antimitotic agents|mesh-ancestor
65061471|NCT01683175|Mitosis Modulators|mitosis modulators|mesh-ancestor
65061472|NCT01683253|Dopamine|dopamine|mesh-list
65061473|NCT01683253|Levodopa|levodopa|mesh-list
65061474|NCT01683253|Carbidopa|carbidopa|mesh-list
65061475|NCT01683253|Dopamine Agonists|dopamine agonists|mesh-list
65061476|NCT01683253|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65061477|NCT01683253|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65061478|NCT01683253|Dopamine Agents|dopamine agents|mesh-ancestor
65061479|NCT01683253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65061480|NCT01683253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061481|NCT01683253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061482|NCT01683253|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65061483|NCT01683253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061484|NCT01683253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65061485|NCT01683253|Sympathomimetics|sympathomimetics|mesh-ancestor
65061486|NCT01683253|Autonomic Agents|autonomic agents|mesh-ancestor
65061487|NCT01683253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65061488|NCT01683253|Protective Agents|protective agents|mesh-ancestor
65061489|NCT01683292|Apomorphine|apomorphine|mesh-list
65061490|NCT01683292|Emetics|emetics|mesh-ancestor
65061491|NCT01683292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061492|NCT01683292|Autonomic Agents|autonomic agents|mesh-ancestor
65061493|NCT01683292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65061494|NCT01683292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65061495|NCT01683292|Dopamine Agonists|dopamine agonists|mesh-ancestor
65061496|NCT01683292|Dopamine Agents|dopamine agents|mesh-ancestor
65061497|NCT01683292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65061498|NCT01683292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061504|NCT00253058|Histamine Agents|histamine agents|mesh-ancestor
65061505|NCT00253058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65061506|NCT00253058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061507|NCT00253058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061508|NCT01683682|Carboplatin|carboplatin|mesh-list
65061509|NCT01683682|Vinorelbine|vinorelbine|mesh-list
65061510|NCT01683682|Nintedanib|nintedanib|mesh-list
65061511|NCT01683682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061512|NCT01683682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65061513|NCT01683682|Tubulin Modulators|tubulin modulators|mesh-ancestor
65061514|NCT01683682|Antimitotic Agents|antimitotic agents|mesh-ancestor
65061515|NCT01683682|Mitosis Modulators|mitosis modulators|mesh-ancestor
64502878|NCT04509258|Expectorants|expectorants|mesh-ancestor
65061516|NCT01683682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061517|NCT01683682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65061518|NCT01683682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061519|NCT00287742|Risperidone|risperidone|mesh-list
65061520|NCT00287742|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65061521|NCT00287742|Serotonin Agents|serotonin agents|mesh-ancestor
65061522|NCT00287742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65061523|NCT00287742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061524|NCT00287742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061525|NCT00287742|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65061526|NCT00287742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65061527|NCT00287742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65061528|NCT00287742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65061529|NCT00287742|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65061530|NCT00287742|Dopamine Agents|dopamine agents|mesh-ancestor
65061531|NCT04527562|Colchicine|colchicine|mesh-list
65061532|NCT04527562|Gout Suppressants|gout suppressants|mesh-ancestor
65061533|NCT04527562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65061534|NCT04527562|Tubulin Modulators|tubulin modulators|mesh-ancestor
65061536|NCT04527562|Mitosis Modulators|mitosis modulators|mesh-ancestor
65061537|NCT04527562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061545|NCT01684111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061546|NCT01684111|Tubulin Modulators|tubulin modulators|mesh-ancestor
65061547|NCT01684111|Antimitotic Agents|antimitotic agents|mesh-ancestor
65061548|NCT01684111|Mitosis Modulators|mitosis modulators|mesh-ancestor
65061549|NCT01684111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061550|NCT01684111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65061551|NCT01684111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061552|NCT00253136|Risperidone|risperidone|mesh-list
65061553|NCT00253136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65061554|NCT00253136|Serotonin Agents|serotonin agents|mesh-ancestor
65061555|NCT00253136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65061556|NCT00253136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061557|NCT00253136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061558|NCT00253136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65061559|NCT00253136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65061560|NCT00253136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65061561|NCT00253136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65061562|NCT00253136|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65061563|NCT00253136|Dopamine Agents|dopamine agents|mesh-ancestor
65061564|NCT01684306|Modafinil|modafinil|mesh-list
65061565|NCT01684306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65061566|NCT01684306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061567|NCT01684306|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65061568|NCT01684306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65061571|NCT00287781|Lidocaine|lidocaine|mesh-list
64913605|NCT05634564|Mitosis Modulators|mitosis modulators|mesh-ancestor
65061592|NCT00416871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65061593|NCT01684657|Asenapine|asenapine|mesh-list
65061594|NCT01684657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65061595|NCT01684657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65061596|NCT01684657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65061597|NCT01684657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061598|NCT01684657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65061599|NCT00416910|Cyclophosphamide|cyclophosphamide|mesh-list
65061600|NCT00416910|Fludarabine|fludarabine|mesh-list
65061601|NCT00416910|Mitoxantrone|mitoxantrone|mesh-list
65061602|NCT00416910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65061603|NCT00416910|Immunologic Factors|immunologic factors|mesh-ancestor
65061604|NCT00416910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061605|NCT00416910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65061606|NCT00416910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65061607|NCT00416910|Alkylating Agents|alkylating agents|mesh-ancestor
65061608|NCT00416910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061609|NCT00416910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061610|NCT00416910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65061612|NCT00416910|Sensory System Agents|sensory system agents|mesh-ancestor
65061613|NCT00416910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65061614|NCT00416910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65061615|NCT00416910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65061616|NCT00416910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061617|NCT01684774|Bupivacaine|bupivacaine|mesh-list
65061618|NCT01684774|Anesthetics, Local|anesthetics, local|mesh-ancestor
65061619|NCT01684774|Anesthetics|anesthetics|mesh-ancestor
65061620|NCT01684774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65061621|NCT01684774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061622|NCT01684774|Sensory System Agents|sensory system agents|mesh-ancestor
65061636|NCT00253175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061637|NCT00287820|Olanzapine|olanzapine|mesh-list
65061638|NCT00287820|Risperidone|risperidone|mesh-list
65061639|NCT00287820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65061640|NCT00287820|Serotonin Agents|serotonin agents|mesh-ancestor
65061641|NCT00287820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65061642|NCT00287820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061643|NCT00287820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061644|NCT00287820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65061645|NCT00287820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65061646|NCT00287820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65061647|NCT00287820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65061648|NCT00287820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65061649|NCT00287820|Dopamine Agents|dopamine agents|mesh-ancestor
65061650|NCT00287820|Antiemetics|antiemetics|mesh-ancestor
65061651|NCT00287820|Autonomic Agents|autonomic agents|mesh-ancestor
65061652|NCT00287820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65061653|NCT00287820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65061654|NCT00287820|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65061655|NCT00287820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65061656|NCT00287820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65061657|NCT02272348|Insulin|insulin|mesh-list
65061658|NCT02272348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65061659|NCT02272348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061660|NCT00253214|Galantamine|galantamine|mesh-list
65061661|NCT00253214|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65061662|NCT00253214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546993|NCT03666559|Azacitidine|azacitidine|mesh-list
65061663|NCT00253214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061664|NCT00253214|Cholinergic Agents|cholinergic agents|mesh-ancestor
65061665|NCT00253214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65061666|NCT00253214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061667|NCT00253214|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65061676|NCT00287859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061677|NCT01684969|Haloperidol|haloperidol|mesh-list
65061678|NCT01684969|Haloperidol decanoate|haloperidol decanoate|mesh-list
65061679|NCT01684969|Antiemetics|antiemetics|mesh-ancestor
65061680|NCT01684969|Autonomic Agents|autonomic agents|mesh-ancestor
65061681|NCT01684969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65061682|NCT01684969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061683|NCT01684969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65061684|NCT01684969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65061685|NCT01684969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65061686|NCT01684969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65061687|NCT01684969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65061688|NCT01684969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65061689|NCT01684969|Dopamine Agents|dopamine agents|mesh-ancestor
65061690|NCT01684969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65061691|NCT01684969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061692|NCT01684969|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65061693|NCT01685125|Prednisone|prednisone|mesh-list
65061694|NCT01685125|Dasatinib|dasatinib|mesh-list
65061695|NCT01685125|Abiraterone Acetate|abiraterone acetate|mesh-list
65061696|NCT01685125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65061697|NCT01685125|Glucocorticoids|glucocorticoids|mesh-ancestor
65061698|NCT01685125|Hormones|hormones|mesh-ancestor
65061699|NCT01685125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65061700|NCT01685125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061702|NCT01685125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061725|NCT00417066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061726|NCT00417066|Hormone Antagonists|hormone antagonists|mesh-ancestor
65061727|NCT00417066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65061728|NCT01685398|Timolol|timolol|mesh-list
65061729|NCT01685398|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65061730|NCT01685398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65061731|NCT01685398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061732|NCT01685398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65061733|NCT01685398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65061734|NCT01685398|Adrenergic Agents|adrenergic agents|mesh-ancestor
65061735|NCT01685398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65061736|NCT01685398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061737|NCT01685398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65061738|NCT01685398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65061739|NCT01685515|Decitabine|decitabine|mesh-list
65061740|NCT01685515|Tetrahydrouridine|tetrahydrouridine|mesh-list
65061741|NCT01685515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65061742|NCT01685515|Antimetabolites|antimetabolites|mesh-ancestor
65061743|NCT01685515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061781|NCT00253526|Mitogens|mitogens|mesh-list
65061782|NCT00253526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65061783|NCT00253526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061784|NCT00253526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65061785|NCT00253526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65061786|NCT00253526|Growth Substances|growth substances|mesh-ancestor
65061787|NCT00253526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061788|NCT00253526|Growth Inhibitors|growth inhibitors|mesh-ancestor
65061789|NCT00253526|Immunologic Factors|immunologic factors|mesh-ancestor
65061790|NCT00253526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65061791|NCT00253526|Antimetabolites|antimetabolites|mesh-ancestor
65061792|NCT00253526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061793|NCT00253526|Antiviral Agents|antiviral agents|mesh-ancestor
65061794|NCT00253526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65061795|NCT00253526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061796|NCT00253526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65061797|NCT00253526|Mitosis Modulators|mitosis modulators|mesh-ancestor
65061798|NCT01686217|Niacinamide|niacinamide|mesh-list
65061799|NCT01686217|Peficitinib|peficitinib|mesh-list
65061800|NCT01686217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061838|NCT01686607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65061839|NCT01686607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65061840|NCT01686607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061841|NCT01686607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061842|NCT01686607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65061843|NCT01686607|Hormone Antagonists|hormone antagonists|mesh-ancestor
65061844|NCT01686607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65061845|NCT01686607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061846|NCT01686607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65061847|NCT01686607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65061848|NCT01686607|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65061849|NCT01686607|Amebicides|amebicides|mesh-ancestor
65061850|NCT01686607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65061851|NCT01686607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65061852|NCT01686607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65061853|NCT01686607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65061854|NCT01686802|Ibuprofen|ibuprofen|mesh-list
65061855|NCT01686802|Morphine|morphine|mesh-list
65061856|NCT01686802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65061857|NCT01686802|Narcotics|narcotics|mesh-ancestor
65061858|NCT01686802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65061859|NCT01686802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061860|NCT01686802|Analgesics|analgesics|mesh-ancestor
65061861|NCT01686802|Sensory System Agents|sensory system agents|mesh-ancestor
65061862|NCT01686802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65061863|NCT01686802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65061882|NCT00281892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061883|NCT00281892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65061884|NCT00281892|Antimetabolites|antimetabolites|mesh-ancestor
65061885|NCT00281892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061886|NCT00281892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65061887|NCT00281892|Immunologic Factors|immunologic factors|mesh-ancestor
65061888|NCT00281892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061889|NCT00281892|Antiviral Agents|antiviral agents|mesh-ancestor
65061890|NCT00281892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65061892|NCT02274571|Hormones|hormones|mesh-ancestor
65061893|NCT02274571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65061894|NCT02274571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061895|NCT00253799|Hylan|hylan|mesh-list
65061896|NCT00253799|Viscosupplements|viscosupplements|mesh-ancestor
65061897|NCT00253799|Protective Agents|protective agents|mesh-ancestor
65061898|NCT00253799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061899|NCT00281931|Cyclophosphamide|cyclophosphamide|mesh-list
65061900|NCT00281931|Rituximab|rituximab|mesh-list
65061901|NCT00281931|Fludarabine|fludarabine|mesh-list
65061902|NCT00281931|Fludarabine phosphate|fludarabine phosphate|mesh-list
65061903|NCT00281931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65061904|NCT00281931|Immunologic Factors|immunologic factors|mesh-ancestor
65061905|NCT00281931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061906|NCT00281931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65061907|NCT00281931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65061932|NCT01687426|Adrenergic Agents|adrenergic agents|mesh-ancestor
65061933|NCT01687426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65061934|NCT01687426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061935|NCT01687426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061936|NCT01687582|Liraglutide|liraglutide|mesh-list
65061937|NCT01687582|Exenatide|exenatide|mesh-list
65061938|NCT01687582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65061939|NCT01687582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061940|NCT01687582|Incretins|incretins|mesh-ancestor
65061941|NCT01687582|Hormones|hormones|mesh-ancestor
65061942|NCT01687582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65061943|NCT01687582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65061944|NCT01687699|Spironolactone|spironolactone|mesh-list
65061945|NCT01687699|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65061946|NCT01687699|Hormone Antagonists|hormone antagonists|mesh-ancestor
65061947|NCT01687699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65061948|NCT01687699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061949|NCT01687699|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65061950|NCT01687699|Diuretics|diuretics|mesh-ancestor
65061951|NCT01687699|Natriuretic Agents|natriuretic agents|mesh-ancestor
65061952|NCT00287937|Paclitaxel|paclitaxel|mesh-list
65061953|NCT00287937|Carboplatin|carboplatin|mesh-list
65061954|NCT00287937|Vorinostat|vorinostat|mesh-list
65061955|NCT00287937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65061956|NCT00287937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061957|NCT00287937|Tubulin Modulators|tubulin modulators|mesh-ancestor
65061958|NCT00287937|Antimitotic Agents|antimitotic agents|mesh-ancestor
65061959|NCT00287937|Mitosis Modulators|mitosis modulators|mesh-ancestor
65061960|NCT00287937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061961|NCT00287937|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65061976|NCT01687894|Coagulants|coagulants|mesh-ancestor
65061977|NCT01687894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65061978|NCT01687894|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65061979|NCT01687894|Natriuretic Agents|natriuretic agents|mesh-ancestor
65061980|NCT00287976|Irinotecan|irinotecan|mesh-list
65061981|NCT00287976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65061982|NCT00287976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65061983|NCT00287976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935979|NCT00141154|Celecoxib|celecoxib|mesh-list
65061984|NCT00287976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061985|NCT00287976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65061986|NCT01688089|Levodopa|levodopa|mesh-list
65061987|NCT01688089|Carbidopa|carbidopa|mesh-list
65061988|NCT01688089|Entacapone|entacapone|mesh-list
65061989|NCT01688089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65061990|NCT01688089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65061991|NCT01688089|Dopamine Agents|dopamine agents|mesh-ancestor
65061992|NCT01688089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65061993|NCT01688089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65061994|NCT01688089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65061995|NCT01688089|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65061996|NCT01688089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65061997|NCT01688089|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65061998|NCT01688206|Atezolizumab|atezolizumab|mesh-list
65061999|NCT01688206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062000|NCT00288171|Allopurinol|allopurinol|mesh-list
65062001|NCT00288171|Antimetabolites|antimetabolites|mesh-ancestor
65062002|NCT00288171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062003|NCT00288171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062004|NCT00288171|Gout Suppressants|gout suppressants|mesh-ancestor
65062005|NCT00288171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65062006|NCT00288171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65062007|NCT00288171|Antioxidants|antioxidants|mesh-ancestor
65062008|NCT00288171|Protective Agents|protective agents|mesh-ancestor
65062018|NCT00253955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65062019|NCT00253955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65062020|NCT00253955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65062021|NCT00253955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062022|NCT00253955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062023|NCT00253955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062024|NCT00253955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65062025|NCT00253955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65062026|NCT00253955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65062027|NCT00288249|Sagopilone|sagopilone|mesh-list
65062028|NCT00288249|Epothilones|epothilones|mesh-list
65062029|NCT00288249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062030|NCT00288249|Tubulin Modulators|tubulin modulators|mesh-ancestor
65062031|NCT00288249|Antimitotic Agents|antimitotic agents|mesh-ancestor
65062032|NCT00288249|Mitosis Modulators|mitosis modulators|mesh-ancestor
65062033|NCT00288249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062034|NCT00254033|Methylphenidate|methylphenidate|mesh-list
65062035|NCT00254033|Dextroamphetamine|dextroamphetamine|mesh-list
65062036|NCT00254033|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65062037|NCT00254033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062038|NCT00254033|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65062039|NCT00254033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65062040|NCT00254033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65062041|NCT00254033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062042|NCT00254033|Dopamine Agents|dopamine agents|mesh-ancestor
65062043|NCT00254033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65062044|NCT01600573|Topotecan|topotecan|mesh-list
65062045|NCT01600573|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65062046|NCT01600573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65062047|NCT01600573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062048|NCT01600573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062049|NCT01600573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062058|NCT01600768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65062059|NCT00414947|Vildagliptin|vildagliptin|mesh-list
65062060|NCT00414947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65062061|NCT00414947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062062|NCT00414947|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65062063|NCT00414947|Protease Inhibitors|protease inhibitors|mesh-ancestor
65062064|NCT00414947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062065|NCT00414947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062066|NCT00288444|Docetaxel|docetaxel|mesh-list
65062067|NCT00288444|Lonafarnib|lonafarnib|mesh-list
65062068|NCT00288444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062069|NCT00288444|Tubulin Modulators|tubulin modulators|mesh-ancestor
65062070|NCT00288444|Antimitotic Agents|antimitotic agents|mesh-ancestor
65062071|NCT00288444|Mitosis Modulators|mitosis modulators|mesh-ancestor
65062072|NCT00288444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062073|NCT00288444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062074|NCT00417573|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65062075|NCT00417573|Immunologic Factors|immunologic factors|mesh-ancestor
65062076|NCT00417573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062077|NCT00415064|Dexamethasone|dexamethasone|mesh-list
65062078|NCT00415064|Lenalidomide|lenalidomide|mesh-list
65062079|NCT00415064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65062080|NCT00415064|Antiemetics|antiemetics|mesh-ancestor
65062081|NCT00415064|Autonomic Agents|autonomic agents|mesh-ancestor
65062082|NCT00415064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65062083|NCT00415064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062084|NCT00415064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65062085|NCT00415064|Glucocorticoids|glucocorticoids|mesh-ancestor
65062086|NCT00415064|Hormones|hormones|mesh-ancestor
65062087|NCT00415064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65062088|NCT00415064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65062095|NCT00415103|Aprepitant|aprepitant|mesh-list
65062101|NCT00415103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062102|NCT00415103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65062103|NCT00415103|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65062104|NCT00415103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65062105|NCT00415103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062106|NCT00415103|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65062107|NCT00415103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65062108|NCT00415103|Serotonin Agents|serotonin agents|mesh-ancestor
65062109|NCT00417690|Aminosalicylic Acid|aminosalicylic acid|mesh-list
65062110|NCT00417690|Antitubercular Agents|antitubercular agents|mesh-ancestor
65062111|NCT00417690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65062112|NCT00417690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65062113|NCT00417729|Acarbose|acarbose|mesh-list
65062114|NCT00417729|Glyburide|glyburide|mesh-list
65062115|NCT00417729|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65062116|NCT00417729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062117|NCT00417729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062118|NCT00417729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65062119|NCT00417729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062120|NCT00254189|Levonorgestrel|levonorgestrel|mesh-list
65062121|NCT00254189|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65062122|NCT00254189|Estradiol|estradiol|mesh-list
65062123|NCT00254189|Estrogens|estrogens|mesh-ancestor
65062124|NCT00254189|Hormones|hormones|mesh-ancestor
65062125|NCT00254189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65062126|NCT00254189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062127|NCT00254189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65062128|NCT00254189|Contraceptive Agents|contraceptive agents|mesh-ancestor
65062129|NCT00254189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65062145|NCT01600807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062146|NCT01600807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65062147|NCT00288483|Policosanol|policosanol|mesh-list
65062148|NCT00288483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65062149|NCT00288483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65062150|NCT00288483|Antimetabolites|antimetabolites|mesh-ancestor
65062151|NCT00288483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062152|NCT00288483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65062153|NCT00288483|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65062154|NCT01600963|Bedaquiline|bedaquiline|mesh-list
65062155|NCT01600963|Diarylquinolines|diarylquinolines|mesh-list
65062156|NCT01600963|Antitubercular Agents|antitubercular agents|mesh-ancestor
65062157|NCT01600963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65062158|NCT01600963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65062159|NCT01606969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65062160|NCT00288522|Lanreotide|lanreotide|mesh-list
65062161|NCT00288522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062162|NCT00254267|Motesanib diphosphate|motesanib diphosphate|mesh-list
65062163|NCT00254267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65062164|NCT00254267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062165|NCT00254267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062166|NCT01601002|Mirtazapine|mirtazapine|mesh-list
65062167|NCT01601002|Antidepressive Agents|antidepressive agents|mesh-ancestor
65062168|NCT01601002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65062169|NCT01601002|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65062194|NCT01607086|Anticonvulsants|anticonvulsants|mesh-ancestor
65062195|NCT01607086|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65062196|NCT01607086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65062197|NCT01607086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062198|NCT01607086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65062199|NCT01607086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062200|NCT01607086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65062201|NCT01607086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65062202|NCT01607086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65062203|NCT01607086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65062204|NCT01607086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65062205|NCT01607125|Vortioxetine|vortioxetine|mesh-list
65062206|NCT01607125|Antidepressive Agents|antidepressive agents|mesh-ancestor
65062207|NCT01607125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65062208|NCT01607125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65062209|NCT01607125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65062210|NCT01607125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65062211|NCT01607125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062212|NCT01607125|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65062213|NCT01607125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65062214|NCT01607125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65062215|NCT01607125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062216|NCT01607125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65062217|NCT01607125|Serotonin Agents|serotonin agents|mesh-ancestor
65062230|NCT00254618|Analgesics|analgesics|mesh-ancestor
65062241|NCT00288717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062242|NCT01601314|Magnesium Sulfate|magnesium sulfate|mesh-list
65062243|NCT01601314|Analgesics|analgesics|mesh-ancestor
65062244|NCT01601314|Sensory System Agents|sensory system agents|mesh-ancestor
65062245|NCT01601314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65062246|NCT01601314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062247|NCT01601314|Anesthetics|anesthetics|mesh-ancestor
65062248|NCT01601314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65062249|NCT01601314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65062250|NCT01601314|Anticonvulsants|anticonvulsants|mesh-ancestor
65062251|NCT01601314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65062252|NCT01601314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65062253|NCT01601314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062254|NCT01601314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65062255|NCT01601314|Tocolytic Agents|tocolytic agents|mesh-ancestor
65062256|NCT01601314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65062257|NCT00254657|Levetiracetam|levetiracetam|mesh-list
65062258|NCT00254657|Anticonvulsants|anticonvulsants|mesh-ancestor
65062259|NCT00254657|Nootropic Agents|nootropic agents|mesh-ancestor
65062260|NCT02482753|Exemestane|exemestane|mesh-list
65062261|NCT02482753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062262|NCT02482753|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65062263|NCT02482753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65062264|NCT02482753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062265|NCT02482753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062266|NCT02482753|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65062267|NCT02482753|Hormone Antagonists|hormone antagonists|mesh-ancestor
65062268|NCT02482753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65062269|NCT02482753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062271|NCT01607671|Maleic acid|maleic acid|mesh-list
65062272|NCT01607671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062273|NCT01607671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062281|NCT00254735|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65062282|NCT00254735|Clomipramine|clomipramine|mesh-list
65062283|NCT00254735|Antidepressive Agents|antidepressive agents|mesh-ancestor
65062284|NCT00254735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65062285|NCT00254735|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65062286|NCT00254735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65062287|NCT00254735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65062288|NCT00254735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062289|NCT00254735|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65062290|NCT00254735|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65062291|NCT00254735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65062292|NCT00254735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65062293|NCT00254735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062294|NCT00254735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65062295|NCT00254735|Serotonin Agents|serotonin agents|mesh-ancestor
65062296|NCT00288873|Cholecalciferol|cholecalciferol|mesh-list
65062298|NCT00288873|Ergocalciferols|ergocalciferols|mesh-list
65062299|NCT00288873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65062300|NCT00288873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062301|NCT00288873|Vitamins|vitamins|mesh-ancestor
65062302|NCT00288873|Micronutrients|micronutrients|mesh-ancestor
65062303|NCT00288873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65062304|NCT01608139|Curcumin|curcumin|mesh-list
65062305|NCT01608139|Sorafenib|sorafenib|mesh-list
65062306|NCT01608139|Vorinostat|vorinostat|mesh-list
65062307|NCT01608139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062308|NCT01608139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65062309|NCT01608139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062310|NCT01608139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062311|NCT01608139|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65062313|NCT01608139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65062325|NCT00254774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65062326|NCT00254774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65062327|NCT00254774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65062328|NCT00254774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65062329|NCT00254774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062330|NCT00254774|Anticonvulsants|anticonvulsants|mesh-ancestor
65062331|NCT00254774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062332|NCT00254774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062333|NCT00254774|GABA Agents|gaba agents|mesh-ancestor
65062334|NCT00254774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65062335|NCT00254774|Antimanic Agents|antimanic agents|mesh-ancestor
65062336|NCT01608334|Fentanyl|fentanyl|mesh-list
65062337|NCT01608334|Sufentanil|sufentanil|mesh-list
64547674|NCT04435704|Oxytocin|oxytocin|mesh-list
65062338|NCT01608334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65062339|NCT01608334|Narcotics|narcotics|mesh-ancestor
65062340|NCT01608334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65062341|NCT01608334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062342|NCT01608334|Analgesics|analgesics|mesh-ancestor
65062343|NCT01608334|Sensory System Agents|sensory system agents|mesh-ancestor
65062344|NCT01608334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65062345|NCT01608334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65062346|NCT01608334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65062347|NCT01608334|Anesthetics, General|anesthetics, general|mesh-ancestor
65062348|NCT01608334|Anesthetics|anesthetics|mesh-ancestor
65062349|NCT01608373|Lidocaine|lidocaine|mesh-list
65062350|NCT01608373|Anesthetics, Local|anesthetics, local|mesh-ancestor
65062351|NCT01608373|Anesthetics|anesthetics|mesh-ancestor
65062352|NCT01608373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65062353|NCT01608373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062361|NCT01608412|Everolimus|everolimus|mesh-list
65062369|NCT01608412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062370|NCT00254813|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65062371|NCT00254813|Antidepressive Agents|antidepressive agents|mesh-ancestor
65062372|NCT00254813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65062373|NCT00254813|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65062374|NCT00254813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65062375|NCT00254813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65062376|NCT00254813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062377|NCT01608646|Oxaliplatin|oxaliplatin|mesh-list
65062378|NCT01608646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062379|NCT01608841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65062380|NCT01608841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062381|NCT01608841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65062382|NCT01608841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062383|NCT01608841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062384|NCT00254930|Risperidone|risperidone|mesh-list
65062385|NCT00254930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65062386|NCT00254930|Serotonin Agents|serotonin agents|mesh-ancestor
65062387|NCT00254930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65062388|NCT00254930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062389|NCT00254930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062390|NCT00254930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65062391|NCT00254930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65062392|NCT00254930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65062393|NCT00254930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65062394|NCT00254930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65062395|NCT00254930|Dopamine Agents|dopamine agents|mesh-ancestor
65062396|NCT02273440|Theophylline|theophylline|mesh-list
65062397|NCT02273440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65062398|NCT02273440|Autonomic Agents|autonomic agents|mesh-ancestor
65062412|NCT01588717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65062413|NCT01588717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65062414|NCT01588717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65062415|NCT01588717|Cholinergic Agents|cholinergic agents|mesh-ancestor
65062416|NCT01588717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65062417|NCT01588717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062418|NCT01588717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062419|NCT00270075|Epoetin Alfa|epoetin alfa|mesh-list
65062420|NCT00270075|Hematinics|hematinics|mesh-ancestor
65062421|NCT01588756|Mechlorethamine|mechlorethamine|mesh-list
65062422|NCT01588756|Goralatide|goralatide|mesh-list
65062423|NCT01588756|Alkylating Agents|alkylating agents|mesh-ancestor
65062424|NCT01588756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062425|NCT01588756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65062426|NCT01588756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062427|NCT01588756|Growth Inhibitors|growth inhibitors|mesh-ancestor
65062428|NCT01588756|Growth Substances|growth substances|mesh-ancestor
65062429|NCT01588756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062430|NCT01588756|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65062431|NCT01588756|Protective Agents|protective agents|mesh-ancestor
65062468|NCT00107380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65062469|NCT00107380|Vincristine|vincristine|mesh-list
65062470|NCT00107380|Tositumomab I-131|tositumomab i-131|mesh-list
65062471|NCT00107380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65062472|NCT00107380|Immunologic Factors|immunologic factors|mesh-ancestor
65062473|NCT00107380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062474|NCT00107380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65062475|NCT00107380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65062476|NCT00107380|Alkylating Agents|alkylating agents|mesh-ancestor
65062477|NCT00107380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062478|NCT00107380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062479|NCT00107380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65062530|NCT00255476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65062531|NCT00255476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062532|NCT00255476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062533|NCT00270270|Epoetin Alfa|epoetin alfa|mesh-list
65062534|NCT00270270|Hematinics|hematinics|mesh-ancestor
65062535|NCT04512118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65062536|NCT04512118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65062537|NCT04512118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062538|NCT00255515|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65062539|NCT00255515|Antidepressive Agents|antidepressive agents|mesh-ancestor
65062540|NCT00255515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65062541|NCT00255515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65062542|NCT00255515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65062543|NCT00255515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65062544|NCT00255515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062545|NCT00289419|Ketorolac|ketorolac|mesh-list
65062546|NCT00289419|Epinephrine|epinephrine|mesh-list
65062547|NCT00289419|Racepinephrine|racepinephrine|mesh-list
65062548|NCT00289419|Morphine|morphine|mesh-list
65062549|NCT00289419|Ropivacaine|ropivacaine|mesh-list
65062550|NCT00289419|Epinephryl borate|epinephryl borate|mesh-list
65062551|NCT00289419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65062552|NCT00289419|Narcotics|narcotics|mesh-ancestor
65062553|NCT00289419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65062555|NCT00289419|Analgesics|analgesics|mesh-ancestor
65062582|NCT00255554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65062583|NCT00255554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062584|NCT00255554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65062585|NCT00255554|Serotonin Agents|serotonin agents|mesh-ancestor
65062586|NCT00255554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062587|NCT00255554|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65062588|NCT00255554|Antidepressive Agents|antidepressive agents|mesh-ancestor
65062589|NCT00255554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65062590|NCT00270348|Ciclesonide|ciclesonide|mesh-list
65062591|NCT00270348|Glucocorticoids|glucocorticoids|mesh-ancestor
65062592|NCT00270348|Hormones|hormones|mesh-ancestor
65062593|NCT00270348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65062594|NCT00270348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062595|NCT00270348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65062596|NCT00255593|Rituximab|rituximab|mesh-list
65062597|NCT00255593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65062598|NCT00255593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062599|NCT00255593|Immunologic Factors|immunologic factors|mesh-ancestor
65062600|NCT00255593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062601|NCT00255593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65062602|NCT00270387|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65062634|NCT00255749|Epoetin Alfa|epoetin alfa|mesh-list
65062635|NCT00255749|Hematinics|hematinics|mesh-ancestor
65062636|NCT00255788|Everolimus|everolimus|mesh-list
65062637|NCT00255788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062638|NCT00255788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65062639|NCT00255788|Immunologic Factors|immunologic factors|mesh-ancestor
65062640|NCT00255788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062641|NCT04482361|Antibodies|antibodies|mesh-list
65062642|NCT04482361|Immunologic Factors|immunologic factors|mesh-ancestor
65062643|NCT04482361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062644|NCT00270543|Leucovorin|leucovorin|mesh-list
65062645|NCT00270543|Fluorouracil|fluorouracil|mesh-list
65062646|NCT00270543|Docetaxel|docetaxel|mesh-list
65062647|NCT00270543|Antimetabolites|antimetabolites|mesh-ancestor
65062648|NCT00270543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062649|NCT00270543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65062650|NCT00270543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062651|NCT00270543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65062652|NCT00270543|Immunologic Factors|immunologic factors|mesh-ancestor
65062653|NCT00270543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062654|NCT00270543|Antidotes|antidotes|mesh-ancestor
65062655|NCT00270543|Protective Agents|protective agents|mesh-ancestor
65062656|NCT00270543|Vitamin B Complex|vitamin b complex|mesh-ancestor
65062657|NCT00270543|Vitamins|vitamins|mesh-ancestor
65062658|NCT00270543|Micronutrients|micronutrients|mesh-ancestor
65062659|NCT00270543|Tubulin Modulators|tubulin modulators|mesh-ancestor
65062660|NCT00270543|Antimitotic Agents|antimitotic agents|mesh-ancestor
65062661|NCT00270543|Mitosis Modulators|mitosis modulators|mesh-ancestor
65062686|NCT01600456|Sertraline|sertraline|mesh-list
65062687|NCT01600456|Antidepressive Agents|antidepressive agents|mesh-ancestor
65062688|NCT01600456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65062689|NCT01600456|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65062690|NCT01600456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65062691|NCT01600456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65062692|NCT01600456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062693|NCT01600456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65062694|NCT01600456|Serotonin Agents|serotonin agents|mesh-ancestor
65062695|NCT01600456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062696|NCT00289809|Ifosfamide|ifosfamide|mesh-list
65062697|NCT00289809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65062698|NCT00289809|Alkylating Agents|alkylating agents|mesh-ancestor
65062699|NCT00289809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062700|NCT00289809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062701|NCT00256100|PENTA|penta|mesh-list
65062702|NCT00256100|Fondaparinux|fondaparinux|mesh-list
65062703|NCT00256100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65062704|NCT00256100|Antithrombins|antithrombins|mesh-ancestor
65062705|NCT00256100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65062706|NCT00256100|Protease Inhibitors|protease inhibitors|mesh-ancestor
65062707|NCT00256100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062708|NCT00256100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062709|NCT00256100|Anticoagulants|anticoagulants|mesh-ancestor
65062710|NCT00256100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64504083|NCT01653418|Melphalan|melphalan|mesh-list
65062711|NCT00256100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65062712|NCT00289926|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65062713|NCT00289926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65062714|NCT00289926|Immunologic Factors|immunologic factors|mesh-ancestor
65062715|NCT00289926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062716|NCT01609192|Hydroxyurea|hydroxyurea|mesh-list
65062717|NCT01609192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062718|NCT01609192|Antisickling Agents|antisickling agents|mesh-ancestor
65062719|NCT01609192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062720|NCT01609192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062721|NCT01609192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64951553|NCT00026351|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65062722|NCT01609387|Tocopherols|tocopherols|mesh-list
65062723|NCT01609387|Antioxidants|antioxidants|mesh-ancestor
65062724|NCT01609387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062725|NCT01609387|Protective Agents|protective agents|mesh-ancestor
65062726|NCT01609387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062727|NCT01609387|Vitamins|vitamins|mesh-ancestor
65062728|NCT01609387|Micronutrients|micronutrients|mesh-ancestor
65062729|NCT00256178|Simvastatin|simvastatin|mesh-list
65062730|NCT00256178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65062731|NCT00256178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65062732|NCT00256178|Antimetabolites|antimetabolites|mesh-ancestor
65062733|NCT00256178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062735|NCT00256178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65062736|NCT00256178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062737|NCT02488408|Cytarabine|cytarabine|mesh-list
65062738|NCT02488408|Decitabine|decitabine|mesh-list
65062739|NCT02488408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65062740|NCT02488408|Antimetabolites|antimetabolites|mesh-ancestor
65062741|NCT02488408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062742|NCT02488408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062743|NCT02488408|Antiviral Agents|antiviral agents|mesh-ancestor
65062744|NCT02488408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65062745|NCT02488408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65062746|NCT02488408|Immunologic Factors|immunologic factors|mesh-ancestor
65062747|NCT02488408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062748|NCT02488408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062749|NCT00270777|Promethazine|promethazine|mesh-list
65062750|NCT00270777|Diphenhydramine|diphenhydramine|mesh-list
65062751|NCT00270777|Hydrocortisone|hydrocortisone|mesh-list
65062752|NCT00270777|Epinephrine|epinephrine|mesh-list
65062753|NCT00270777|Racepinephrine|racepinephrine|mesh-list
65062754|NCT00270777|Epinephryl borate|epinephryl borate|mesh-list
65062755|NCT00270777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65062757|NCT00270777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65062766|NCT00270777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65062767|NCT00270777|Respiratory System Agents|respiratory system agents|mesh-ancestor
65062768|NCT00270777|Mydriatics|mydriatics|mesh-ancestor
65062769|NCT00270777|Sympathomimetics|sympathomimetics|mesh-ancestor
65062770|NCT00270777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65062771|NCT00270777|Antipruritics|antipruritics|mesh-ancestor
65062772|NCT00270777|Dermatologic Agents|dermatologic agents|mesh-ancestor
65062773|NCT00270777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65062774|NCT00270777|Histamine Antagonists|histamine antagonists|mesh-ancestor
65062775|NCT00270777|Histamine Agents|histamine agents|mesh-ancestor
65062776|NCT00270777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65062777|NCT00270777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65062778|NCT00270777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65062779|NCT00270777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65062780|NCT00270777|Anesthetics, Local|anesthetics, local|mesh-ancestor
65062781|NCT00270777|Anesthetics|anesthetics|mesh-ancestor
65062782|NCT00270777|Sensory System Agents|sensory system agents|mesh-ancestor
65062783|NCT00270777|Antiemetics|antiemetics|mesh-ancestor
65062784|NCT00270777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65062785|NCT00256256|Glucagon|glucagon|mesh-list
65062786|NCT00256256|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64548127|NCT00794547|Calcitriol|calcitriol|mesh-list
65062787|NCT00256256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65062788|NCT00256256|Hormones|hormones|mesh-ancestor
65062789|NCT00256256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65062790|NCT00256256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062791|NCT00256256|Incretins|incretins|mesh-ancestor
65062792|NCT00256334|Resveratrol|resveratrol|mesh-list
65062815|NCT01609855|Parasympatholytics|parasympatholytics|mesh-ancestor
65062816|NCT00270816|Interferons|interferons|mesh-list
65062817|NCT00270816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062818|NCT00270816|Antiviral Agents|antiviral agents|mesh-ancestor
65062819|NCT00270816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65062820|NCT00290004|Motexafin gadolinium|motexafin gadolinium|mesh-list
65062821|NCT00290004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062822|NCT00290004|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65062823|NCT00290004|Dermatologic Agents|dermatologic agents|mesh-ancestor
65062824|NCT01609816|Dasatinib|dasatinib|mesh-list
65062825|NCT01609816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65062826|NCT01609816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65062827|NCT01609816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062828|NCT01609816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062829|NCT00290043|Insulin glulisine|insulin glulisine|mesh-list
65062830|NCT00290043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65062831|NCT00290043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062832|NCT00290082|Midazolam|midazolam|mesh-list
65062833|NCT00290082|Loxapine|loxapine|mesh-list
65062834|NCT00290082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65062835|NCT00290082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65062836|NCT00290082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65062837|NCT00290082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062838|NCT00290082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65062839|NCT00290082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65062843|NCT00290082|Anesthetics|anesthetics|mesh-ancestor
65062867|NCT02270437|Analgesics|analgesics|mesh-ancestor
65062868|NCT02270437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65062869|NCT02270437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65062870|NCT02270437|Anesthetics, General|anesthetics, general|mesh-ancestor
65062871|NCT02270437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65062872|NCT02270437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65062873|NCT02270437|Adrenergic Agents|adrenergic agents|mesh-ancestor
65062874|NCT02270437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65062875|NCT02270437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062876|NCT02270437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65062877|NCT02270437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65062878|NCT02270437|Autonomic Agents|autonomic agents|mesh-ancestor
65062879|NCT02270437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65062880|NCT02270437|Respiratory System Agents|respiratory system agents|mesh-ancestor
65062881|NCT02270437|Mydriatics|mydriatics|mesh-ancestor
65062882|NCT02270437|Sympathomimetics|sympathomimetics|mesh-ancestor
65062883|NCT02270437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65062884|NCT02270749|Vitamin B 12|vitamin b 12|mesh-list
65062885|NCT02270749|Hydroxocobalamin|hydroxocobalamin|mesh-list
65062886|NCT02270749|Vitamins|vitamins|mesh-ancestor
65062887|NCT02270749|Micronutrients|micronutrients|mesh-ancestor
65062888|NCT02270749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062890|NCT02270749|Hematinics|hematinics|mesh-ancestor
65062891|NCT02270788|Leucovorin|leucovorin|mesh-list
65062892|NCT02270788|Cytarabine|cytarabine|mesh-list
65062893|NCT02270788|Hydrocortisone|hydrocortisone|mesh-list
65062894|NCT02270788|Methotrexate|methotrexate|mesh-list
65062895|NCT02270788|Sorafenib|sorafenib|mesh-list
65062896|NCT02270788|Crenolanib|crenolanib|mesh-list
65062897|NCT02270788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65062898|NCT02270788|Abortifacient Agents|abortifacient agents|mesh-ancestor
65062899|NCT02270788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65062914|NCT02270788|Antidotes|antidotes|mesh-ancestor
65062915|NCT02270788|Protective Agents|protective agents|mesh-ancestor
65062916|NCT02270788|Vitamin B Complex|vitamin b complex|mesh-ancestor
65062917|NCT02270788|Vitamins|vitamins|mesh-ancestor
65062918|NCT02270788|Micronutrients|micronutrients|mesh-ancestor
65062919|NCT02270788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65062920|NCT02270788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65062921|NCT02270827|Hydrocortisone|hydrocortisone|mesh-list
65062922|NCT02270827|Aminophylline|aminophylline|mesh-list
65062923|NCT02270827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65062924|NCT02270827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65062925|NCT02270827|Autonomic Agents|autonomic agents|mesh-ancestor
65062926|NCT02270827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65062927|NCT02270827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062928|NCT02270827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65062929|NCT02270827|Respiratory System Agents|respiratory system agents|mesh-ancestor
65062930|NCT02270827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65062931|NCT02270827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65062932|NCT02270827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65062933|NCT02270827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062934|NCT02270827|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65062935|NCT02270827|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65062936|NCT02270827|Purinergic Agents|purinergic agents|mesh-ancestor
65062937|NCT02270827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65062938|NCT02270827|Protective Agents|protective agents|mesh-ancestor
65062939|NCT00290121|Olanzapine|olanzapine|mesh-list
65062940|NCT00290121|Antiemetics|antiemetics|mesh-ancestor
65062941|NCT00290121|Autonomic Agents|autonomic agents|mesh-ancestor
65062942|NCT00290121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65062943|NCT00290121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062955|NCT04709744|Vitamin D|vitamin d|mesh-list
65062961|NCT04709744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65062962|NCT04709744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65062963|NCT02271295|Enoxaparin|enoxaparin|mesh-list
65062964|NCT02271295|Anticoagulants|anticoagulants|mesh-ancestor
65062965|NCT02271295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65062966|NCT02271295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65062967|NCT02271295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062968|NCT02271412|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65062969|NCT02271412|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65062970|NCT02271412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65062971|NCT02271412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65062972|NCT02271412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65062973|NCT02271412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65062974|NCT02271412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062975|NCT02271412|Antidepressive Agents|antidepressive agents|mesh-ancestor
65062976|NCT02271412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65062977|NCT00271050|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65062978|NCT00271050|Immunologic Factors|immunologic factors|mesh-ancestor
65062979|NCT00271050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65062980|NCT02271646|Bupivacaine|bupivacaine|mesh-list
65062981|NCT02271646|Anesthetics, Local|anesthetics, local|mesh-ancestor
65062982|NCT02271646|Anesthetics|anesthetics|mesh-ancestor
65062983|NCT02271646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65063007|NCT02271958|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65063008|NCT02271958|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65063009|NCT00257036|Levofloxacin|levofloxacin|mesh-list
65063010|NCT00257036|Ofloxacin|ofloxacin|mesh-list
65063011|NCT00257036|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65063012|NCT00257036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65063013|NCT00257036|Renal Agents|renal agents|mesh-ancestor
65063014|NCT00257036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65063015|NCT00257036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65063016|NCT00257036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65063017|NCT00257036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063018|NCT00257036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063019|NCT00257036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063020|NCT00257036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65063021|NCT00257036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65063022|NCT00257075|Risperidone|risperidone|mesh-list
65063023|NCT00257075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65063024|NCT00257075|Serotonin Agents|serotonin agents|mesh-ancestor
65063025|NCT00257075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65063026|NCT00257075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063027|NCT00257075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063028|NCT00257075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65063029|NCT00257075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65063030|NCT00257075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65063031|NCT00257075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65063032|NCT00257075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65063033|NCT00257075|Dopamine Agents|dopamine agents|mesh-ancestor
65063034|NCT02272270|Minocycline|minocycline|mesh-list
65063035|NCT02272270|Temozolomide|temozolomide|mesh-list
65063042|NCT02272387|Vitamin D|vitamin d|mesh-list
65063052|NCT00271206|Progestins|progestins|mesh-ancestor
65063053|NCT00271206|Hormones|hormones|mesh-ancestor
65063054|NCT00271206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65063055|NCT00271206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063056|NCT02272582|Heparin|heparin|mesh-list
65063057|NCT02272582|Anticoagulants|anticoagulants|mesh-ancestor
65063058|NCT02272582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65063059|NCT02272582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65063060|NCT02272582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063061|NCT02272660|Parecoxib|parecoxib|mesh-list
65063062|NCT02272660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65063063|NCT02272660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65063064|NCT02272660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063065|NCT02272660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063066|NCT02272660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65063067|NCT02272660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65063068|NCT02272660|Analgesics|analgesics|mesh-ancestor
65063069|NCT02272660|Sensory System Agents|sensory system agents|mesh-ancestor
65063070|NCT02272660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65063071|NCT02272660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063072|NCT02272660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65063073|NCT02272660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65063074|NCT02272699|Paclitaxel|paclitaxel|mesh-list
65063075|NCT02272699|Nimotuzumab|nimotuzumab|mesh-list
65063076|NCT02272699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65063077|NCT02272699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063078|NCT02272699|Tubulin Modulators|tubulin modulators|mesh-ancestor
65063079|NCT02272699|Antimitotic Agents|antimitotic agents|mesh-ancestor
65063080|NCT02272699|Mitosis Modulators|mitosis modulators|mesh-ancestor
65063081|NCT02272699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548360|NCT03803553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64548371|NCT03485677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063083|NCT02272738|Gemcitabine|gemcitabine|mesh-list
65063084|NCT02272738|Paclitaxel|paclitaxel|mesh-list
65063085|NCT02272738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65063086|NCT02272738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65063087|NCT02272738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063088|NCT02272738|Tubulin Modulators|tubulin modulators|mesh-ancestor
65063089|NCT02272738|Antimitotic Agents|antimitotic agents|mesh-ancestor
65063090|NCT02272738|Mitosis Modulators|mitosis modulators|mesh-ancestor
65063091|NCT02272738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063092|NCT02272738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65063093|NCT02272738|Antimetabolites|antimetabolites|mesh-ancestor
65063094|NCT02272738|Antiviral Agents|antiviral agents|mesh-ancestor
65063095|NCT02272738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65063096|NCT02272738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063097|NCT02272738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65063098|NCT02272738|Immunologic Factors|immunologic factors|mesh-ancestor
65063099|NCT02272738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063100|NCT00271245|Selenium|selenium|mesh-list
65063101|NCT00271245|Selenic Acid|selenic acid|mesh-list
65063102|NCT00271245|Antioxidants|antioxidants|mesh-ancestor
65063103|NCT00271245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063104|NCT00271245|Protective Agents|protective agents|mesh-ancestor
65063105|NCT00271245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063106|NCT00271245|Trace Elements|trace elements|mesh-ancestor
65063107|NCT00271245|Micronutrients|micronutrients|mesh-ancestor
65063108|NCT02272855|Ipilimumab|ipilimumab|mesh-list
65063109|NCT02272855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65063110|NCT02272855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063111|NCT02272855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65063112|NCT02272855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063125|NCT00257270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65063126|NCT00257270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063127|NCT00257270|Antimanic Agents|antimanic agents|mesh-ancestor
65063128|NCT00290394|Rosiglitazone|rosiglitazone|mesh-list
65063129|NCT00290394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65063130|NCT00290394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063131|NCT00257348|Docetaxel|docetaxel|mesh-list
65063132|NCT00257348|Capecitabine|capecitabine|mesh-list
65063133|NCT00257348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063134|NCT00257348|Tubulin Modulators|tubulin modulators|mesh-ancestor
65063135|NCT00257348|Antimitotic Agents|antimitotic agents|mesh-ancestor
65063136|NCT00257348|Mitosis Modulators|mitosis modulators|mesh-ancestor
65063137|NCT00257348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063138|NCT00257348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65063139|NCT00257348|Antimetabolites|antimetabolites|mesh-ancestor
65063140|NCT02273128|Calcitonin|calcitonin|mesh-list
65063141|NCT02273128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65063142|NCT02273128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063143|NCT02273128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65063144|NCT00257387|Cyclosporine|cyclosporine|mesh-list
65063145|NCT00257387|Cyclosporins|cyclosporins|mesh-list
65063146|NCT00257387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063147|NCT00257387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063148|NCT00257387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65063149|NCT00257387|Immunologic Factors|immunologic factors|mesh-ancestor
65063150|NCT00257387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063151|NCT00257387|Antifungal Agents|antifungal agents|mesh-ancestor
65063152|NCT00257387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65063153|NCT00257387|Dermatologic Agents|dermatologic agents|mesh-ancestor
65063154|NCT00257387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65063155|NCT00257387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65063156|NCT00257426|Octreotide|octreotide|mesh-list
65063161|NCT01601509|Sympathomimetics|sympathomimetics|mesh-ancestor
65063168|NCT00416325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063169|NCT00416325|Protective Agents|protective agents|mesh-ancestor
65063170|NCT00416325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063171|NCT00416325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65063172|NCT00416325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65063173|NCT00416325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063174|NCT00257465|Vaccines|vaccines|mesh-list
65063175|NCT00257465|Immunologic Factors|immunologic factors|mesh-ancestor
65063176|NCT00257465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063177|NCT01601899|Tenofovir|tenofovir|mesh-list
65063178|NCT01601899|Lamivudine|lamivudine|mesh-list
65063179|NCT01601899|Efavirenz|efavirenz|mesh-list
65063180|NCT01601899|Stavudine|stavudine|mesh-list
65063181|NCT01601899|Antiviral Agents|antiviral agents|mesh-ancestor
65063182|NCT01601899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65063183|NCT01601899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65063184|NCT01601899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65063185|NCT01601899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063186|NCT01601899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063187|NCT01601899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65063188|NCT01601899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65063189|NCT01601899|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65063190|NCT01601899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65063191|NCT01601899|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65063192|NCT01601899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65063193|NCT01601899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65063194|NCT01601899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65063196|NCT01601938|Selenium|selenium|mesh-list
65063214|NCT01602250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65063215|NCT01602250|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65063216|NCT01602250|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65063217|NCT01602250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65063218|NCT00257582|Cetirizine|cetirizine|mesh-list
65063219|NCT00257582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65063220|NCT00257582|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65063221|NCT00257582|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65063222|NCT00257582|Histamine Antagonists|histamine antagonists|mesh-ancestor
65063223|NCT00257582|Histamine Agents|histamine agents|mesh-ancestor
65063224|NCT00257582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65063225|NCT00257582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063226|NCT00257582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063227|NCT01602289|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65063228|NCT01602289|Gefitinib|gefitinib|mesh-list
65063229|NCT01602289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063230|NCT01602289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65063231|NCT01602289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063232|NCT01602289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063233|NCT00257621|Ritonavir|ritonavir|mesh-list
65063234|NCT00257621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65063235|NCT00257621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65063237|NCT00257621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063238|NCT00257621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063239|NCT00257621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65063240|NCT00257621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65063262|NCT00290628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063263|NCT00290628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063264|NCT00290628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65063265|NCT00290628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063266|NCT00290628|Antifungal Agents|antifungal agents|mesh-ancestor
65063267|NCT00290628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65063268|NCT00290628|Dermatologic Agents|dermatologic agents|mesh-ancestor
65063269|NCT00290628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65063270|NCT00290628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65063271|NCT00290628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65063272|NCT00290628|Antitubercular Agents|antitubercular agents|mesh-ancestor
65063273|NCT00290628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65063274|NCT00290628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65063275|NCT00290628|Antiemetics|antiemetics|mesh-ancestor
65063276|NCT00290628|Autonomic Agents|autonomic agents|mesh-ancestor
65063277|NCT00290628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65063278|NCT00290628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65063320|NCT01602640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65063321|NCT01602640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65063322|NCT01602640|GABA Modulators|gaba modulators|mesh-ancestor
65063323|NCT01602640|GABA Agents|gaba agents|mesh-ancestor
65063324|NCT01602640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65063325|NCT01602640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063326|NCT00290667|Prednisone|prednisone|mesh-list
65063327|NCT00290667|Cyclophosphamide|cyclophosphamide|mesh-list
65063328|NCT00290667|Rituximab|rituximab|mesh-list
65063329|NCT00290667|Doxorubicin|doxorubicin|mesh-list
65063330|NCT00290667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65063331|NCT00290667|Vincristine|vincristine|mesh-list
65063332|NCT00290667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65063333|NCT00290667|Immunologic Factors|immunologic factors|mesh-ancestor
65063334|NCT00290667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063335|NCT00290667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65063336|NCT00290667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65063337|NCT00290667|Alkylating Agents|alkylating agents|mesh-ancestor
65063338|NCT00290667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063339|NCT00290667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063340|NCT00290667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65063341|NCT00290667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65063342|NCT00290667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65063343|NCT00290667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65063344|NCT00290667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65063345|NCT00290667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063346|NCT00290667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65063347|NCT00290667|Glucocorticoids|glucocorticoids|mesh-ancestor
65063348|NCT00290667|Hormones|hormones|mesh-ancestor
65063349|NCT00290667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65063350|NCT00290667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65063351|NCT00290667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65063355|NCT01602757|Lidocaine|lidocaine|mesh-list
65063362|NCT01602757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65063363|NCT01602757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65063364|NCT01602757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65063365|NCT01602757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65063366|NCT01602757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65063367|NCT01602757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063368|NCT02961101|Decitabine|decitabine|mesh-list
65063369|NCT02961101|Antibodies|antibodies|mesh-list
65063370|NCT02961101|Immunologic Factors|immunologic factors|mesh-ancestor
65063371|NCT02961101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063372|NCT02961101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65063373|NCT02961101|Antimetabolites|antimetabolites|mesh-ancestor
65063374|NCT02961101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063375|NCT02961101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063376|NCT02961101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063377|NCT01602913|Paroxetine|paroxetine|mesh-list
65063378|NCT01602913|Pravastatin|pravastatin|mesh-list
65063379|NCT01602913|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65063380|NCT01602913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65063381|NCT01602913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65063382|NCT01602913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063383|NCT01602913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65063384|NCT01602913|Serotonin Agents|serotonin agents|mesh-ancestor
65063385|NCT01602913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063386|NCT01602913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65063387|NCT01602913|Antidepressive Agents|antidepressive agents|mesh-ancestor
65063388|NCT01602913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64915418|NCT02490241|Antimanic Agents|antimanic agents|mesh-ancestor
65063406|NCT00257699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063407|NCT00257699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063408|NCT00257699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65063409|NCT00257699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65063410|NCT01603030|Moxifloxacin|moxifloxacin|mesh-list
65063411|NCT01603030|Prednisolone|prednisolone|mesh-list
65063412|NCT01603030|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65063413|NCT01603030|Methylprednisolone|methylprednisolone|mesh-list
65063414|NCT01603030|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65063415|NCT01603030|Prednisolone acetate|prednisolone acetate|mesh-list
65063416|NCT01603030|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65063417|NCT01603030|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65063418|NCT01603030|Prednisolone phosphate|prednisolone phosphate|mesh-list
65063419|NCT01603030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65063420|NCT01603030|Glucocorticoids|glucocorticoids|mesh-ancestor
65063421|NCT01603030|Hormones|hormones|mesh-ancestor
65063422|NCT01603030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65063423|NCT01603030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063424|NCT01603030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65063425|NCT01603030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063426|NCT01603030|Antiemetics|antiemetics|mesh-ancestor
65063427|NCT01603030|Autonomic Agents|autonomic agents|mesh-ancestor
65063428|NCT01603030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65063429|NCT01603030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65063430|NCT01603030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65063431|NCT01603030|Protective Agents|protective agents|mesh-ancestor
65063432|NCT01603030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65063433|NCT01603030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65063434|NCT01603030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65063447|NCT01603108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65063448|NCT00290823|Albendazole|albendazole|mesh-list
65063449|NCT00290823|Dexamethasone|dexamethasone|mesh-list
65063450|NCT00290823|Omeprazole|omeprazole|mesh-list
65063451|NCT00290823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65063452|NCT00290823|Antiemetics|antiemetics|mesh-ancestor
65063453|NCT00290823|Autonomic Agents|autonomic agents|mesh-ancestor
65063454|NCT00290823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65063455|NCT00290823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063456|NCT00290823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65063457|NCT00290823|Glucocorticoids|glucocorticoids|mesh-ancestor
64504843|NCT01681030|Hemostatics|hemostatics|mesh-ancestor
65063458|NCT00290823|Hormones|hormones|mesh-ancestor
65063459|NCT00290823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65063460|NCT00290823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65063461|NCT00290823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063462|NCT00290823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65063463|NCT00290823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65063464|NCT00290823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063465|NCT00290823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063466|NCT00290823|Anthelmintics|anthelmintics|mesh-ancestor
65063467|NCT00290823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65063468|NCT00290823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65063469|NCT00290823|Anticestodal Agents|anticestodal agents|mesh-ancestor
65063470|NCT00290823|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65063471|NCT00290823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65063472|NCT00290823|Tubulin Modulators|tubulin modulators|mesh-ancestor
65063473|NCT00290823|Antimitotic Agents|antimitotic agents|mesh-ancestor
65063474|NCT00290823|Mitosis Modulators|mitosis modulators|mesh-ancestor
65063475|NCT01603186|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65063476|NCT01603186|Antidepressive Agents|antidepressive agents|mesh-ancestor
65063477|NCT01603186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65063491|NCT00257816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65063492|NCT00257816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65063493|NCT00257816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063494|NCT00257816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063495|NCT00271323|Docetaxel|docetaxel|mesh-list
65063496|NCT00271323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063497|NCT00271323|Tubulin Modulators|tubulin modulators|mesh-ancestor
65063498|NCT00271323|Antimitotic Agents|antimitotic agents|mesh-ancestor
65063499|NCT00271323|Mitosis Modulators|mitosis modulators|mesh-ancestor
65063500|NCT00271323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063501|NCT01603342|Clopidogrel|clopidogrel|mesh-list
65063502|NCT01603342|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65063503|NCT01603342|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65063504|NCT01603342|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65063505|NCT01603342|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65063506|NCT01603342|Purinergic Agents|purinergic agents|mesh-ancestor
65063507|NCT01603342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65063508|NCT01603342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063509|NCT01603342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063510|NCT00257855|Lamotrigine|lamotrigine|mesh-list
65063511|NCT00257855|Anticonvulsants|anticonvulsants|mesh-ancestor
65063512|NCT00257855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65063513|NCT00257855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65063514|NCT00257855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063515|NCT00257855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65063516|NCT00257855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063517|NCT00257855|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65063518|NCT00257855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65063519|NCT00257855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65063520|NCT00257855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65063521|NCT00257855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65063531|NCT01603498|Antiemetics|antiemetics|mesh-ancestor
65063532|NCT01603498|Autonomic Agents|autonomic agents|mesh-ancestor
64504921|NCT02495688|Anesthetics|anesthetics|mesh-list
65063533|NCT01603498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65063534|NCT01603498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063535|NCT01603498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65063536|NCT01603498|Glucocorticoids|glucocorticoids|mesh-ancestor
65063537|NCT01603498|Hormones|hormones|mesh-ancestor
65063538|NCT01603498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65063539|NCT01603498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65063540|NCT01603498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063541|NCT01603498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65063542|NCT01603498|Protective Agents|protective agents|mesh-ancestor
65063543|NCT01603654|Ascorbic Acid|ascorbic acid|mesh-list
65063544|NCT01603654|Picosulfate sodium|picosulfate sodium|mesh-list
65063545|NCT01603654|Magnesium citrate|magnesium citrate|mesh-list
65063546|NCT01603654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063547|NCT01603654|Antioxidants|antioxidants|mesh-ancestor
65063548|NCT01603654|Protective Agents|protective agents|mesh-ancestor
65063549|NCT01603654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063550|NCT01603654|Vitamins|vitamins|mesh-ancestor
65063551|NCT01603654|Micronutrients|micronutrients|mesh-ancestor
65063552|NCT01603654|Cathartics|cathartics|mesh-ancestor
65063553|NCT01603654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65063554|NCT00257972|Aripiprazole|aripiprazole|mesh-list
65063555|NCT00257972|Antidepressive Agents|antidepressive agents|mesh-ancestor
65063556|NCT00257972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65063572|NCT01603693|Calcium|calcium|mesh-list
65063579|NCT00258050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65063580|NCT00258050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063581|NCT00258050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65063582|NCT00258050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65063583|NCT00258050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65063584|NCT00258050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65063585|NCT00258050|Anesthetics, General|anesthetics, general|mesh-ancestor
65063586|NCT00258050|Anesthetics|anesthetics|mesh-ancestor
65063587|NCT00258050|GABA Modulators|gaba modulators|mesh-ancestor
65063588|NCT00258050|GABA Agents|gaba agents|mesh-ancestor
65063589|NCT00258050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65063590|NCT00258050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063591|NCT00258050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063592|NCT00258050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65063593|NCT00258050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063594|NCT00271401|Heparin|heparin|mesh-list
65063595|NCT00271401|Anticoagulants|anticoagulants|mesh-ancestor
65063596|NCT00271401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65063597|NCT00271401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65063598|NCT00271401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063599|NCT00258089|Levofloxacin|levofloxacin|mesh-list
65063600|NCT00258089|Ofloxacin|ofloxacin|mesh-list
65063601|NCT00258089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65063602|NCT00258089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65063603|NCT00258089|Renal Agents|renal agents|mesh-ancestor
65063604|NCT00258089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65063605|NCT00258089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65063606|NCT00258089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65063607|NCT00258089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063608|NCT00258089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063609|NCT00258089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063612|NCT00290901|Celecoxib|celecoxib|mesh-list
65063622|NCT00290901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65063623|NCT00290901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65063624|NCT00290901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65063625|NCT00290901|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65063626|NCT00290901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65063627|NCT00290901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063628|NCT00290901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063629|NCT00258245|Aspirin|aspirin|mesh-list
65063630|NCT00258245|Vitamins|vitamins|mesh-list
65063631|NCT00258245|Ascorbic Acid|ascorbic acid|mesh-list
65063632|NCT00258245|Thalidomide|thalidomide|mesh-list
65063633|NCT00258245|Dexamethasone|dexamethasone|mesh-list
65063634|NCT00258245|Dexamethasone acetate|dexamethasone acetate|mesh-list
65063635|NCT00258245|Aspirin, aluminum hydroxide, magnesium hydroxide drug combination|aspirin, aluminum hydroxide, magnesium hydroxide drug combination|mesh-list
65063636|NCT00258245|Bortezomib|bortezomib|mesh-list
65063637|NCT00258245|Arsenic Trioxide|arsenic trioxide|mesh-list
65063638|NCT00258245|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65063639|NCT00258245|BB 1101|bb 1101|mesh-list
65063640|NCT00258245|Micronutrients|micronutrients|mesh-ancestor
65063641|NCT00258245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063642|NCT00258245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65063643|NCT00258245|Antiemetics|antiemetics|mesh-ancestor
65063644|NCT00258245|Autonomic Agents|autonomic agents|mesh-ancestor
65063645|NCT00258245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65063646|NCT00258245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65063647|NCT00258245|Glucocorticoids|glucocorticoids|mesh-ancestor
65063648|NCT00258245|Hormones|hormones|mesh-ancestor
65063649|NCT00258245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65063650|NCT00258245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65063669|NCT00258245|Leprostatic Agents|leprostatic agents|mesh-ancestor
65063670|NCT00258245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65063671|NCT00258245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65063672|NCT00258245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65063673|NCT00258245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65063674|NCT00258245|Growth Substances|growth substances|mesh-ancestor
65063675|NCT00258245|Growth Inhibitors|growth inhibitors|mesh-ancestor
65063676|NCT00271440|Chlorhexidine|chlorhexidine|mesh-list
65063677|NCT00271440|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65063678|NCT00271440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65063679|NCT00271440|Disinfectants|disinfectants|mesh-ancestor
65063680|NCT01604629|Adalimumab|adalimumab|mesh-list
65063681|NCT01604629|Etanercept|etanercept|mesh-list
65063682|NCT01604629|Golimumab|golimumab|mesh-list
65063683|NCT01604629|Infliximab|infliximab|mesh-list
65063684|NCT01604629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65063685|NCT01604629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65063686|NCT01604629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65063687|NCT01604629|Dermatologic Agents|dermatologic agents|mesh-ancestor
65063688|NCT01604629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65063689|NCT01604629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65063690|NCT01604629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65063691|NCT01604629|Analgesics|analgesics|mesh-ancestor
65063692|NCT01604629|Sensory System Agents|sensory system agents|mesh-ancestor
65063693|NCT01604629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65063694|NCT01604629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063695|NCT01604629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65063696|NCT01604629|Immunologic Factors|immunologic factors|mesh-ancestor
65063698|NCT00258284|Docetaxel|docetaxel|mesh-list
65063718|NCT00258323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063719|NCT01604863|Paclitaxel|paclitaxel|mesh-list
65063720|NCT01604863|Etoposide|etoposide|mesh-list
65063721|NCT01604863|Docetaxel|docetaxel|mesh-list
65063722|NCT01604863|Carboplatin|carboplatin|mesh-list
65063723|NCT01604863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65063724|NCT01604863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063725|NCT01604863|Tubulin Modulators|tubulin modulators|mesh-ancestor
65063726|NCT01604863|Antimitotic Agents|antimitotic agents|mesh-ancestor
65063727|NCT01604863|Mitosis Modulators|mitosis modulators|mesh-ancestor
65063728|NCT01604863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063729|NCT01604863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65063730|NCT01604863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65063731|NCT01604863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063732|NCT00290979|Insulin glulisine|insulin glulisine|mesh-list
65063733|NCT00290979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65063734|NCT00290979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063735|NCT00258479|Modafinil|modafinil|mesh-list
65063736|NCT00258479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65063737|NCT00258479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063738|NCT00258479|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65063739|NCT00258479|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65063740|NCT00258479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65063741|NCT00258479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063742|NCT00271518|Hormones|hormones|mesh-list
65063743|NCT00271518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65063744|NCT00271518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063745|NCT01340014|Timolol|timolol|mesh-list
65063746|NCT01340014|Dorzolamide|dorzolamide|mesh-list
65063747|NCT01340014|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65063748|NCT01340014|Brinzolamide|brinzolamide|mesh-list
65063760|NCT00258557|Darunavir|darunavir|mesh-list
65063761|NCT00258557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65063762|NCT00258557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65063763|NCT00258557|Protease Inhibitors|protease inhibitors|mesh-ancestor
65063764|NCT00258557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063765|NCT00258557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063766|NCT00258557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65063767|NCT00258557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65063768|NCT00258557|Antiviral Agents|antiviral agents|mesh-ancestor
65063769|NCT00258557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65063770|NCT00271557|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65063771|NCT00271557|Natriuretic Agents|natriuretic agents|mesh-ancestor
65063772|NCT00271557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063773|NCT00271635|Ascorbic Acid|ascorbic acid|mesh-list
65063774|NCT00271635|Vitamins|vitamins|mesh-ancestor
65063775|NCT00271635|Micronutrients|micronutrients|mesh-ancestor
65063776|NCT00271635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063777|NCT00271635|Antioxidants|antioxidants|mesh-ancestor
65063778|NCT00271635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063779|NCT00271635|Protective Agents|protective agents|mesh-ancestor
65063780|NCT00258596|Sirolimus|sirolimus|mesh-list
65063781|NCT00258596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64937775|NCT00009776|Immunoglobulins|immunoglobulins|mesh-list
65063782|NCT00258596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65063783|NCT00258596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65063784|NCT00258596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063785|NCT00258596|Antifungal Agents|antifungal agents|mesh-ancestor
65063786|NCT00258596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65063807|NCT04709315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65063808|NCT04709315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65063809|NCT04709315|Nootropic Agents|nootropic agents|mesh-ancestor
65063810|NCT04709315|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
65063811|NCT01334710|Sorafenib|sorafenib|mesh-list
65063812|NCT01334710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063813|NCT01334710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65063814|NCT01334710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063815|NCT01334710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063816|NCT00271713|Calcium, Dietary|calcium, dietary|mesh-list
65063817|NCT00271713|Vitamin D|vitamin d|mesh-list
65063818|NCT00271713|Ergocalciferols|ergocalciferols|mesh-list
65063819|NCT00271713|Cholecalciferol|cholecalciferol|mesh-list
65063820|NCT00271713|Ibandronic Acid|ibandronic acid|mesh-list
65063821|NCT00271713|Vitamins|vitamins|mesh-list
65063822|NCT00271713|Calcium|calcium|mesh-list
65063823|NCT00271713|Micronutrients|micronutrients|mesh-ancestor
65063824|NCT00271713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063825|NCT00271713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65063826|NCT00271713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65063827|NCT01334554|Sildenafil Citrate|sildenafil citrate|mesh-list
65063828|NCT01334554|Vasodilator Agents|vasodilator agents|mesh-ancestor
65063829|NCT01334554|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65063830|NCT01334554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65063831|NCT01334554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063832|NCT01334554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063833|NCT01334554|Urological Agents|urological agents|mesh-ancestor
65063834|NCT00291213|Levetiracetam|levetiracetam|mesh-list
65063835|NCT00291213|Anticonvulsants|anticonvulsants|mesh-ancestor
65063836|NCT00291213|Nootropic Agents|nootropic agents|mesh-ancestor
65063837|NCT01332799|Allopurinol|allopurinol|mesh-list
65063838|NCT01332799|Antimetabolites|antimetabolites|mesh-ancestor
65063839|NCT01332799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063840|NCT01332799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063841|NCT01332799|Gout Suppressants|gout suppressants|mesh-ancestor
65063842|NCT01332799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65063847|NCT00258791|Ibuprofen|ibuprofen|mesh-list
65063848|NCT00258791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65063849|NCT00258791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65063850|NCT00258791|Analgesics|analgesics|mesh-ancestor
65063851|NCT00258791|Sensory System Agents|sensory system agents|mesh-ancestor
65063852|NCT00258791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65063853|NCT00258791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063854|NCT00258791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65063855|NCT00258791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65063856|NCT00258791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65063857|NCT00258791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063858|NCT00258791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063859|NCT00291369|Interferons|interferons|mesh-list
65063860|NCT00291369|Interferon-alpha|interferon-alpha|mesh-list
65063861|NCT00291369|Interleukin-2|interleukin-2|mesh-list
65063862|NCT00291369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65063863|NCT00291369|Medroxyprogesterone|medroxyprogesterone|mesh-list
65063864|NCT00291369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063865|NCT00291369|Antiviral Agents|antiviral agents|mesh-ancestor
65063866|NCT00291369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65063867|NCT00291369|Immunologic Factors|immunologic factors|mesh-ancestor
65063868|NCT00291369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063869|NCT00291369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65063870|NCT00291369|Analgesics|analgesics|mesh-ancestor
65063871|NCT00291369|Sensory System Agents|sensory system agents|mesh-ancestor
65063872|NCT00291369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65063874|NCT00291369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65063894|NCT00291408|Vasodilator Agents|vasodilator agents|mesh-ancestor
65063895|NCT00291408|Gasotransmitters|gasotransmitters|mesh-ancestor
65063896|NCT00291408|Protective Agents|protective agents|mesh-ancestor
65063897|NCT00271791|Prednisone|prednisone|mesh-list
65063898|NCT00271791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65063899|NCT00271791|Glucocorticoids|glucocorticoids|mesh-ancestor
65063900|NCT00271791|Hormones|hormones|mesh-ancestor
65063901|NCT00271791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65063902|NCT00271791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063903|NCT00271791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65063904|NCT00271791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063905|NCT01332331|Ambrisentan|ambrisentan|mesh-list
65063906|NCT01332331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65063907|NCT00259064|Gefitinib|gefitinib|mesh-list
65063908|NCT00259064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063909|NCT00259064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65063910|NCT00259064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063911|NCT00259064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063912|NCT01332292|Fluticasone|fluticasone|mesh-list
65063914|NCT01332292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65063915|NCT01332292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65063916|NCT01332292|Autonomic Agents|autonomic agents|mesh-ancestor
65063917|NCT01332292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65063918|NCT01332292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063919|NCT01332292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65063920|NCT01332292|Respiratory System Agents|respiratory system agents|mesh-ancestor
65063921|NCT01332292|Dermatologic Agents|dermatologic agents|mesh-ancestor
65063922|NCT01332292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65063923|NCT00259142|Chloroquine|chloroquine|mesh-list
65063924|NCT00259142|Pyrimethamine|pyrimethamine|mesh-list
65063925|NCT00259142|Sulfadoxine|sulfadoxine|mesh-list
65063926|NCT00259142|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65063927|NCT00259142|Amebicides|amebicides|mesh-ancestor
65063928|NCT00259142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65063937|NCT00259142|Renal Agents|renal agents|mesh-ancestor
65063938|NCT00259181|Chlorhexidine|chlorhexidine|mesh-list
65063939|NCT00259181|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65063940|NCT00259181|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
65063941|NCT00259181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65063942|NCT00259181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65063943|NCT00259181|Disinfectants|disinfectants|mesh-ancestor
65063944|NCT00259181|Dermatologic Agents|dermatologic agents|mesh-ancestor
65063945|NCT00259181|Vasodilator Agents|vasodilator agents|mesh-ancestor
65063946|NCT00259181|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65063947|NCT00259181|Protective Agents|protective agents|mesh-ancestor
65063948|NCT00259181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063949|NCT00291720|Spironolactone|spironolactone|mesh-list
65063950|NCT00291720|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65063951|NCT00291720|Hormone Antagonists|hormone antagonists|mesh-ancestor
65063952|NCT00291720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65063953|NCT00291720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063954|NCT00291720|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65063955|NCT00291720|Diuretics|diuretics|mesh-ancestor
65063956|NCT00291720|Natriuretic Agents|natriuretic agents|mesh-ancestor
65063957|NCT00259220|Erythromycin|erythromycin|mesh-list
65063958|NCT00259220|Erythromycin Estolate|erythromycin estolate|mesh-list
65063959|NCT00259220|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65063960|NCT00259220|Erythromycin stearate|erythromycin stearate|mesh-list
65063961|NCT00259220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65063962|NCT00259220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65063963|NCT00259220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65063964|NCT00259220|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65063965|NCT00259220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063966|NCT00259220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063968|NCT00291759|Anastrozole|anastrozole|mesh-list
65063969|NCT00291759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65063970|NCT00291759|Hormone Antagonists|hormone antagonists|mesh-ancestor
65063974|NCT00291759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65063977|NCT00291759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65063978|NCT00291759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65063979|NCT00291759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65063980|NCT00291759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65063981|NCT00291759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063982|NCT00272025|Citalopram|citalopram|mesh-list
65063983|NCT00272025|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65063984|NCT00272025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65063985|NCT00272025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64549259|NCT03083353|Isradipine|isradipine|mesh-list
65063986|NCT00272025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65063988|NCT00272025|Serotonin Agents|serotonin agents|mesh-ancestor
65063989|NCT00272025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65063990|NCT00272025|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65063991|NCT00272025|Antidepressive Agents|antidepressive agents|mesh-ancestor
65063992|NCT00272025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65063993|NCT04709081|Itraconazole|itraconazole|mesh-list
65063994|NCT04709081|Digoxin|digoxin|mesh-list
65063995|NCT04709081|Midazolam|midazolam|mesh-list
65063996|NCT04709081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65063997|NCT04709081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65063998|NCT04709081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65063999|NCT04709081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064000|NCT04709081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65064001|NCT04709081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65064024|NCT00272064|Metformin|metformin|mesh-list
65064025|NCT00272064|Insulin Glargine|insulin glargine|mesh-list
65064026|NCT00272064|Insulin glulisine|insulin glulisine|mesh-list
65064027|NCT00272064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65064028|NCT00272064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064029|NCT00259376|Dronedarone|dronedarone|mesh-list
65064030|NCT00259376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65064031|NCT01332019|Interferons|interferons|mesh-list
65064032|NCT01332019|Interferon-beta|interferon-beta|mesh-list
65064033|NCT01332019|Interferon beta-1a|interferon beta-1a|mesh-list
65064034|NCT01332019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064035|NCT01332019|Antiviral Agents|antiviral agents|mesh-ancestor
65064036|NCT01332019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65064037|NCT01332019|Immunologic Factors|immunologic factors|mesh-ancestor
65064038|NCT01332019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064039|NCT01332019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65064040|NCT00415376|Levetiracetam|levetiracetam|mesh-list
65064041|NCT00415376|Anticonvulsants|anticonvulsants|mesh-ancestor
65064042|NCT00415376|Nootropic Agents|nootropic agents|mesh-ancestor
65064043|NCT00291915|Adalimumab|adalimumab|mesh-list
65064044|NCT00291915|Methotrexate|methotrexate|mesh-list
65064045|NCT00291915|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65064046|NCT00291915|Abortifacient Agents|abortifacient agents|mesh-ancestor
65064047|NCT00291915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65064048|NCT00291915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064049|NCT00291915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65064050|NCT00291915|Antimetabolites|antimetabolites|mesh-ancestor
65064051|NCT00291915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064053|NCT00291915|Dermatologic Agents|dermatologic agents|mesh-ancestor
65064072|NCT00259766|Hormones|hormones|mesh-ancestor
65064073|NCT00259766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65064074|NCT00259766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65064075|NCT00259766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65064076|NCT00259766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65064077|NCT00259766|Adrenergic Agents|adrenergic agents|mesh-ancestor
65064078|NCT00259766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65064079|NCT00259766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064080|NCT00259766|Sympathomimetics|sympathomimetics|mesh-ancestor
65064081|NCT00259766|Tocolytic Agents|tocolytic agents|mesh-ancestor
65064082|NCT00259766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65064084|NCT00292071|Antifungal Agents|antifungal agents|mesh-ancestor
65064085|NCT00292071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65064086|NCT00292071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064087|NCT00292071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064088|NCT00292110|Methadone|methadone|mesh-list
65064089|NCT00292110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65064090|NCT00292110|Narcotics|narcotics|mesh-ancestor
65064091|NCT00292110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65064092|NCT00292110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064093|NCT00292110|Analgesics|analgesics|mesh-ancestor
65064094|NCT00292110|Sensory System Agents|sensory system agents|mesh-ancestor
65064095|NCT00292110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65064096|NCT00292110|Antitussive Agents|antitussive agents|mesh-ancestor
65064097|NCT00292110|Respiratory System Agents|respiratory system agents|mesh-ancestor
65064098|NCT00259805|Rituximab|rituximab|mesh-list
65064099|NCT00259805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65064100|NCT00259805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064101|NCT00259805|Immunologic Factors|immunologic factors|mesh-ancestor
65064102|NCT00259805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064103|NCT00259805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65064104|NCT00259883|Paroxetine|paroxetine|mesh-list
65064112|NCT00259883|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65064113|NCT00259883|Antidepressive Agents|antidepressive agents|mesh-ancestor
65064114|NCT00259883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65064115|NCT00259883|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65064116|NCT00259883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64549456|NCT01497938|Insulin|insulin|mesh-list
64549457|NCT01497938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64549458|NCT01497938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549459|NCT03092154|Hypolipidemic Agents|hypolipidemic agents|mesh-list
64549460|NCT03092154|Antimetabolites|antimetabolites|mesh-ancestor
64549461|NCT03092154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549462|NCT03092154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64549463|NCT04301310|Rifampin|rifampin|mesh-list
64549464|NCT04301310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64549465|NCT04301310|Antitubercular Agents|antitubercular agents|mesh-ancestor
64549466|NCT04301310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64549467|NCT04301310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64549468|NCT04301310|Leprostatic Agents|leprostatic agents|mesh-ancestor
64549469|NCT04301310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64549470|NCT04301310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064117|NCT00259883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064118|NCT04718376|Mitoxantrone|mitoxantrone|mesh-list
65064119|NCT04718376|Analgesics|analgesics|mesh-ancestor
65064120|NCT04718376|Sensory System Agents|sensory system agents|mesh-ancestor
65064121|NCT04718376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65064122|NCT04718376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064123|NCT04718376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064124|NCT04718376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65064142|NCT00272454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064143|NCT00272454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65064144|NCT00272454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65064145|NCT00272454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65064146|NCT00272454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65064147|NCT00272454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064148|NCT00272454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65064149|NCT00272454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65064150|NCT00272454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064151|NCT00272454|Antipyretics|antipyretics|mesh-ancestor
65064152|NCT00272454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65064153|NCT00272454|Autonomic Agents|autonomic agents|mesh-ancestor
65064154|NCT00272454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65064155|NCT00272454|Respiratory System Agents|respiratory system agents|mesh-ancestor
65064156|NCT00272454|Vasodilator Agents|vasodilator agents|mesh-ancestor
65064157|NCT00272454|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65064158|NCT00272454|Protective Agents|protective agents|mesh-ancestor
65064159|NCT00272454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65064160|NCT00272454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65064161|NCT00272493|Vaccines|vaccines|mesh-list
65064162|NCT00272493|Immunologic Factors|immunologic factors|mesh-ancestor
65064163|NCT00272493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064164|NCT00292266|Interferon beta-1a|interferon beta-1a|mesh-list
65064165|NCT00292266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65064169|NCT00292266|Antiviral Agents|antiviral agents|mesh-ancestor
65064194|NCT00272688|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65064195|NCT00272688|Dopamine Agents|dopamine agents|mesh-ancestor
65064196|NCT00272688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65064197|NCT00272688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064198|NCT00272688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064199|NCT00260390|Methyltestosterone|methyltestosterone|mesh-list
65064200|NCT00260390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65064201|NCT00260390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064202|NCT00260390|Anabolic Agents|anabolic agents|mesh-ancestor
65064203|NCT00260390|Hormones|hormones|mesh-ancestor
65064204|NCT00260390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65064205|NCT00260390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064206|NCT00260624|Citalopram|citalopram|mesh-list
65064207|NCT00260624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65064208|NCT00260624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65064209|NCT00260624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65064210|NCT00260624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064211|NCT00260624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65064212|NCT00260624|Serotonin Agents|serotonin agents|mesh-ancestor
65064213|NCT00260624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064214|NCT00260624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65064215|NCT00260624|Antidepressive Agents|antidepressive agents|mesh-ancestor
65064216|NCT00260624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65064217|NCT00292695|Ifosfamide|ifosfamide|mesh-list
65064218|NCT00292695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064219|NCT00292695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65064220|NCT00292695|Alkylating Agents|alkylating agents|mesh-ancestor
65064221|NCT00292695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064222|NCT00292734|Zolpidem|zolpidem|mesh-list
65064223|NCT00292734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65064235|NCT00260702|Respiratory System Agents|respiratory system agents|mesh-ancestor
65064236|NCT00260819|Bosentan|bosentan|mesh-list
65064237|NCT00260819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65064238|NCT00260819|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65064239|NCT00260819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064240|NCT00298350|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
65064241|NCT00298350|Integrase Inhibitors|integrase inhibitors|mesh-list
65064242|NCT00298350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064243|NCT00298350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064244|NCT00298350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65064245|NCT00298350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65064246|NCT00298350|Antiviral Agents|antiviral agents|mesh-ancestor
65064247|NCT00298350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65064248|NCT00292890|Insulin|insulin|mesh-list
65064249|NCT00292890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65064250|NCT00292890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064251|NCT00292929|Artesunate|artesunate|mesh-list
65064252|NCT00292929|Antimalarials|antimalarials|mesh-ancestor
65064253|NCT00292929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65064254|NCT00292929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65064255|NCT00292929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65064256|NCT00292929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064257|NCT00292929|Antiviral Agents|antiviral agents|mesh-ancestor
65064258|NCT00292929|Schistosomicides|schistosomicides|mesh-ancestor
65064259|NCT00292929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65064260|NCT00292929|Anthelmintics|anthelmintics|mesh-ancestor
65064261|NCT00424853|Gemcitabine|gemcitabine|mesh-list
65064262|NCT00424853|Cisplatin|cisplatin|mesh-list
65064263|NCT00424853|Docetaxel|docetaxel|mesh-list
65064264|NCT00424853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064265|NCT00424853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65064281|NCT00298506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064282|NCT00298506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65064283|NCT00298506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064284|NCT00298506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064285|NCT00298506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65064286|NCT00298506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064287|NCT00298506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65064288|NCT00298506|Antitubercular Agents|antitubercular agents|mesh-ancestor
65064289|NCT00298506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65064290|NCT00298506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65064291|NCT00424892|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65064292|NCT00424892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65064293|NCT00424892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65064294|NCT00424892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65064295|NCT00424892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064296|NCT00424892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65064297|NCT00424892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064298|NCT00424892|Antidepressive Agents|antidepressive agents|mesh-ancestor
65064299|NCT00424892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65064300|NCT00424931|Modafinil|modafinil|mesh-list
65064301|NCT00424931|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65064302|NCT00424931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064303|NCT00424931|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65064304|NCT00424931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65064305|NCT00424931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65064306|NCT00424931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064307|NCT00298545|Calcitriol|calcitriol|mesh-list
65064308|NCT00298545|Calcium|calcium|mesh-list
65064309|NCT00298545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65064310|NCT00298545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064311|NCT00298545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65064312|NCT00298545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65064317|NCT00298545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65064318|NCT01331161|Vaccines|vaccines|mesh-list
65064319|NCT01331161|Immunologic Factors|immunologic factors|mesh-ancestor
65064320|NCT01331161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064321|NCT00424970|Acetazolamide|acetazolamide|mesh-list
65064322|NCT00424970|Anticonvulsants|anticonvulsants|mesh-ancestor
65064323|NCT00424970|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65064324|NCT00424970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064325|NCT00424970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064326|NCT00424970|Diuretics|diuretics|mesh-ancestor
65064327|NCT00424970|Natriuretic Agents|natriuretic agents|mesh-ancestor
65064328|NCT00424970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064329|NCT01331005|Nepafenac|nepafenac|mesh-list
65064330|NCT01331005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65064331|NCT01331005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65064332|NCT01331005|Analgesics|analgesics|mesh-ancestor
65064333|NCT01331005|Sensory System Agents|sensory system agents|mesh-ancestor
65064334|NCT01331005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65064335|NCT01331005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064336|NCT01331005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65064337|NCT01331005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65064338|NCT01330459|Acetaminophen|acetaminophen|mesh-list
65064339|NCT01330459|Ibuprofen|ibuprofen|mesh-list
65064370|NCT01330459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65064371|NCT01330459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65064372|NCT01330459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65064373|NCT01330459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65064374|NCT01330459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65064375|NCT01330459|GABA Modulators|gaba modulators|mesh-ancestor
65064376|NCT01330459|GABA Agents|gaba agents|mesh-ancestor
65064377|NCT01330459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65064378|NCT00293085|Docetaxel|docetaxel|mesh-list
65064379|NCT00293085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064380|NCT00293085|Tubulin Modulators|tubulin modulators|mesh-ancestor
65064381|NCT00293085|Antimitotic Agents|antimitotic agents|mesh-ancestor
65064382|NCT00293085|Mitosis Modulators|mitosis modulators|mesh-ancestor
65064383|NCT00293085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064384|NCT00261053|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
65064385|NCT00261053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65064386|NCT00261053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65064387|NCT00261053|Immunologic Factors|immunologic factors|mesh-ancestor
65064388|NCT00261053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064389|NCT00298662|Interferons|interferons|mesh-list
65064390|NCT00298662|Interferon-beta|interferon-beta|mesh-list
65064391|NCT00298662|Tacrolimus|tacrolimus|mesh-list
65064392|NCT00298662|Interferon beta-1b|interferon beta-1b|mesh-list
65064393|NCT00298662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064394|NCT00298662|Antiviral Agents|antiviral agents|mesh-ancestor
65064395|NCT00298662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65064396|NCT00298662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65064397|NCT00298662|Immunologic Factors|immunologic factors|mesh-ancestor
65064398|NCT00298662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064399|NCT00298662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65064400|NCT00298662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064401|NCT00298662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064402|NCT00298662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65064403|NCT01330381|Prucalopride|prucalopride|mesh-list
65064411|NCT01330381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064412|NCT00261092|Oxaliplatin|oxaliplatin|mesh-list
65064413|NCT00261092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064414|NCT00293124|Imatinib Mesylate|imatinib mesylate|mesh-list
65064415|NCT00293124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064416|NCT00293124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65064417|NCT00293124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549755|NCT04384731|Poractant alfa|poractant alfa|mesh-list
65064418|NCT00293124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064419|NCT01330108|Ambrisentan|ambrisentan|mesh-list
65064420|NCT01330108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65064421|NCT00261131|Botulinum Toxins|botulinum toxins|mesh-list
65064422|NCT00261131|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65064423|NCT00261131|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65064424|NCT00261131|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65064425|NCT00261131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65064426|NCT00261131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064427|NCT00261131|Cholinergic Agents|cholinergic agents|mesh-ancestor
65064428|NCT00261131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65064429|NCT00261131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064430|NCT00261131|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65064431|NCT00261131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65064432|NCT00261170|Bupropion|bupropion|mesh-list
65064433|NCT00261170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65064434|NCT00261170|Antidepressive Agents|antidepressive agents|mesh-ancestor
65064435|NCT00261170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65064457|NCT00261326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65064458|NCT00261326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65064459|NCT00261326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064461|NCT00293163|Viscosupplements|viscosupplements|mesh-ancestor
65064462|NCT00293163|Protective Agents|protective agents|mesh-ancestor
65064463|NCT00293163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064464|NCT00261365|Ipilimumab|ipilimumab|mesh-list
65064465|NCT00261365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65064466|NCT00261365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064467|NCT00261365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65064468|NCT00261365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064469|NCT00293280|Lomustine|lomustine|mesh-list
65064470|NCT00293280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65064471|NCT00293280|Alkylating Agents|alkylating agents|mesh-ancestor
65064472|NCT00293280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064473|NCT00293280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064474|NCT00298779|Bortezomib|bortezomib|mesh-list
65064475|NCT00298779|Omeprazole|omeprazole|mesh-list
65064476|NCT00298779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064477|NCT00298779|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65064478|NCT00298779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65064479|NCT00298779|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65064480|NCT00298779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064481|NCT00298779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064482|NCT00261482|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65064483|NCT00261482|Norelgestromin|norelgestromin|mesh-list
65064484|NCT00261482|Estradiol|estradiol|mesh-list
65064485|NCT00261482|Estrogens|estrogens|mesh-ancestor
65064486|NCT00261482|Hormones|hormones|mesh-ancestor
65064496|NCT00261521|Hematinics|hematinics|mesh-ancestor
65064504|NCT00298857|Antimanic Agents|antimanic agents|mesh-ancestor
65064505|NCT00298857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65064506|NCT00298857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65064507|NCT00298857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65064508|NCT00261560|Acetaminophen|acetaminophen|mesh-list
65064509|NCT00261560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65064510|NCT00261560|Analgesics|analgesics|mesh-ancestor
65064511|NCT00261560|Sensory System Agents|sensory system agents|mesh-ancestor
65064512|NCT00261560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65064513|NCT00261560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064514|NCT00261560|Antipyretics|antipyretics|mesh-ancestor
65064515|NCT00261599|Midazolam|midazolam|mesh-list
65064516|NCT00261599|Fospropofol|fospropofol|mesh-list
65064517|NCT00261599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64938523|NCT00680628|Enoxaparin sodium|enoxaparin sodium|mesh-list
65064518|NCT00261599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65064519|NCT00261599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65064520|NCT00261599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064521|NCT00261599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65064522|NCT00261599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65064523|NCT00261599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65064524|NCT00261599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65064525|NCT00261599|Anesthetics, General|anesthetics, general|mesh-ancestor
65064526|NCT00261599|Anesthetics|anesthetics|mesh-ancestor
65064527|NCT00261599|GABA Modulators|gaba modulators|mesh-ancestor
65064528|NCT00261599|GABA Agents|gaba agents|mesh-ancestor
65064529|NCT00261599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65064530|NCT00261599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064531|NCT00293319|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65064537|NCT00293358|Etoposide|etoposide|mesh-list
65064551|NCT00261755|Sensory System Agents|sensory system agents|mesh-ancestor
65064552|NCT00261755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65064553|NCT00261755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064554|NCT00298974|Acetaminophen|acetaminophen|mesh-list
65064555|NCT00298974|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65064556|NCT00298974|Hydrocodone|hydrocodone|mesh-list
65064557|NCT00298974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65064558|NCT00298974|Analgesics|analgesics|mesh-ancestor
65064559|NCT00298974|Sensory System Agents|sensory system agents|mesh-ancestor
65064560|NCT00298974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65064561|NCT00298974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064562|NCT00298974|Antipyretics|antipyretics|mesh-ancestor
65064563|NCT00298974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65064564|NCT00298974|Narcotics|narcotics|mesh-ancestor
65064565|NCT00298974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64505958|NCT01747330|Pancreatin|pancreatin|mesh-list
65064566|NCT00298974|Antitussive Agents|antitussive agents|mesh-ancestor
65064567|NCT00298974|Respiratory System Agents|respiratory system agents|mesh-ancestor
65064568|NCT00298974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65064569|NCT00298974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65064570|NCT00298974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65064571|NCT00293436|Celecoxib|celecoxib|mesh-list
65064572|NCT00293436|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65064573|NCT00293436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064574|NCT00293436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65064575|NCT00293436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064576|NCT00293436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064579|NCT00293436|Analgesics|analgesics|mesh-ancestor
65064596|NCT00293475|Sodium thiosulfate|sodium thiosulfate|mesh-list
65064597|NCT00293475|Rituximab|rituximab|mesh-list
65064598|NCT00293475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65064599|NCT00293475|Carboplatin|carboplatin|mesh-list
65064600|NCT00293475|Methotrexate|methotrexate|mesh-list
65064601|NCT00293475|Mannitol|mannitol|mesh-list
65064602|NCT00293475|Antibodies|antibodies|mesh-list
65064603|NCT00293475|Immunoglobulins|immunoglobulins|mesh-list
65064604|NCT00293475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65064605|NCT00293475|Antidotes|antidotes|mesh-list
65064606|NCT00293475|Immunologic Factors|immunologic factors|mesh-ancestor
65064607|NCT00293475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064608|NCT00293475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064609|NCT00293475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65064610|NCT00293475|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65064611|NCT00293475|Abortifacient Agents|abortifacient agents|mesh-ancestor
65064612|NCT00293475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65064613|NCT00293475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65064614|NCT00293475|Antimetabolites|antimetabolites|mesh-ancestor
65064615|NCT00293475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064616|NCT00293475|Dermatologic Agents|dermatologic agents|mesh-ancestor
65064617|NCT00293475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064618|NCT00293475|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65064619|NCT00293475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65064620|NCT00293475|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65064621|NCT00293475|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65064622|NCT00293475|Diuretics|diuretics|mesh-ancestor
65064623|NCT00293475|Natriuretic Agents|natriuretic agents|mesh-ancestor
65064624|NCT00293475|Protective Agents|protective agents|mesh-ancestor
65064625|NCT00293475|Antioxidants|antioxidants|mesh-ancestor
65064626|NCT00293475|Antitubercular Agents|antitubercular agents|mesh-ancestor
65064642|NCT00299013|Prednisolone phosphate|prednisolone phosphate|mesh-list
65064643|NCT00299013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65064644|NCT00299013|Glucocorticoids|glucocorticoids|mesh-ancestor
65064645|NCT00299013|Hormones|hormones|mesh-ancestor
65064646|NCT00299013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65064647|NCT00299013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064648|NCT00299013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65064649|NCT00299013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064650|NCT00299013|Antiemetics|antiemetics|mesh-ancestor
65064651|NCT00299013|Autonomic Agents|autonomic agents|mesh-ancestor
65064652|NCT00299013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65064653|NCT00299013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65064654|NCT00299013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65064655|NCT00299013|Protective Agents|protective agents|mesh-ancestor
65064656|NCT00293514|Thrombin|thrombin|mesh-list
65064703|NCT00293592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65064704|NCT00293592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65064705|NCT00293592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064706|NCT00293631|Ketorolac|ketorolac|mesh-list
65064707|NCT00293631|Lornoxicam|lornoxicam|mesh-list
65064708|NCT00293631|Piroxicam|piroxicam|mesh-list
65064709|NCT00293631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65064710|NCT00293631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65064711|NCT00293631|Analgesics|analgesics|mesh-ancestor
65064712|NCT00293631|Sensory System Agents|sensory system agents|mesh-ancestor
65064713|NCT00293631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65064714|NCT00293631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064715|NCT00293631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65064716|NCT00293631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65064717|NCT00293631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65064718|NCT00293631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064719|NCT00293631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064720|NCT00262262|Levetiracetam|levetiracetam|mesh-list
65064721|NCT00262262|Anticonvulsants|anticonvulsants|mesh-ancestor
65064722|NCT00262262|Nootropic Agents|nootropic agents|mesh-ancestor
65064723|NCT00293670|Goserelin|goserelin|mesh-list
65064724|NCT00293670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65064725|NCT00293670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064726|NCT00262379|Epoetin Alfa|epoetin alfa|mesh-list
65064727|NCT00262379|Hematinics|hematinics|mesh-ancestor
65064728|NCT00299247|Pyrimethamine|pyrimethamine|mesh-list
65064729|NCT00299247|Sulfadoxine|sulfadoxine|mesh-list
65064730|NCT00299247|Antimalarials|antimalarials|mesh-ancestor
65064731|NCT00299247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65064752|NCT00293787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65064753|NCT00293787|Latanoprost|latanoprost|mesh-list
65064754|NCT00293787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65064755|NCT00293787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064756|NCT00293787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65064757|NCT00293787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65064758|NCT00293787|Adrenergic Agents|adrenergic agents|mesh-ancestor
65064759|NCT00293787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65064760|NCT00293787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064761|NCT00293787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65064762|NCT00293787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65064763|NCT00299364|Tibolone|tibolone|mesh-list
65064764|NCT00299364|Androgen Antagonists|androgen antagonists|mesh-ancestor
65064765|NCT00299364|Hormone Antagonists|hormone antagonists|mesh-ancestor
65064766|NCT00299364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65064767|NCT00299364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064768|NCT00299364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65064769|NCT00299364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65064770|NCT00299364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064771|NCT00299364|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65064772|NCT00299364|Anabolic Agents|anabolic agents|mesh-ancestor
65064773|NCT00299364|Hormones|hormones|mesh-ancestor
65064774|NCT00293826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65064775|NCT00293826|Immunologic Factors|immunologic factors|mesh-ancestor
65064776|NCT00293826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064777|NCT00262574|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65064778|NCT00262574|Natriuretic Agents|natriuretic agents|mesh-ancestor
65064779|NCT00262574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064780|NCT00262769|Gemcitabine|gemcitabine|mesh-list
65064781|NCT00262769|Cisplatin|cisplatin|mesh-list
65064782|NCT00262769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064783|NCT00262769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65064784|NCT00262769|Antimetabolites|antimetabolites|mesh-ancestor
65064793|NCT00299520|Iclaprim|iclaprim|mesh-list
65064794|NCT00299520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64550123|NCT05686993|Nifedipine|nifedipine|mesh-list
65064795|NCT00299520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65064796|NCT00299520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65064797|NCT00299520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064798|NCT00299520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064799|NCT00299520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65064801|NCT00262808|Fluorouracil|fluorouracil|mesh-list
65064802|NCT00262808|Oxaliplatin|oxaliplatin|mesh-list
65064803|NCT00262808|Calcium|calcium|mesh-list
65064804|NCT00262808|Sargramostim|sargramostim|mesh-list
65064805|NCT00262808|Levoleucovorin|levoleucovorin|mesh-list
65064806|NCT00262808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65064807|NCT00262808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064808|NCT00262808|Antimetabolites|antimetabolites|mesh-ancestor
65064809|NCT00262808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064810|NCT00262808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65064811|NCT00262808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064812|NCT00262808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65064813|NCT00262808|Immunologic Factors|immunologic factors|mesh-ancestor
65064814|NCT00262808|Antidotes|antidotes|mesh-ancestor
65064815|NCT00262808|Protective Agents|protective agents|mesh-ancestor
65064816|NCT00262808|Vitamin B Complex|vitamin b complex|mesh-ancestor
65064817|NCT00262808|Vitamins|vitamins|mesh-ancestor
65064818|NCT00262808|Micronutrients|micronutrients|mesh-ancestor
65064819|NCT00262886|Mycophenolic Acid|mycophenolic acid|mesh-list
65064820|NCT00262886|Cyclophosphamide|cyclophosphamide|mesh-list
65064821|NCT00262886|Fludarabine|fludarabine|mesh-list
65064822|NCT00262886|Fludarabine phosphate|fludarabine phosphate|mesh-list
65064823|NCT00262886|Tacrolimus|tacrolimus|mesh-list
65064824|NCT00262886|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65064825|NCT00262886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65064826|NCT00262886|Immunologic Factors|immunologic factors|mesh-ancestor
65064827|NCT00262886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064828|NCT00262886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65064835|NCT00262886|Antimetabolites|antimetabolites|mesh-ancestor
65064836|NCT00262886|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65064837|NCT00262886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064838|NCT00262886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65064839|NCT00262886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65064840|NCT00262886|Antitubercular Agents|antitubercular agents|mesh-ancestor
65064841|NCT00262886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65064842|NCT00262886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65064843|NCT00263003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65064844|NCT00263003|Irbesartan|irbesartan|mesh-list
65064845|NCT00263003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65064846|NCT00263003|Diuretics|diuretics|mesh-ancestor
65064847|NCT00263003|Natriuretic Agents|natriuretic agents|mesh-ancestor
65064848|NCT00263003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064849|NCT00263003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65064850|NCT00263003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65064851|NCT00263003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064852|NCT00263003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65064853|NCT00263003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65064854|NCT00299559|Camphor|camphor|mesh-list
65064855|NCT00299559|Menthol|menthol|mesh-list
65064856|NCT00299559|Antipruritics|antipruritics|mesh-ancestor
65064857|NCT00299559|Dermatologic Agents|dermatologic agents|mesh-ancestor
65064858|NCT00299559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65064859|NCT00299559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65064860|NCT00299598|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65064861|NCT00299598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65064862|NCT00263198|Letrozole|letrozole|mesh-list
65064863|NCT00263198|Vatalanib|vatalanib|mesh-list
65064864|NCT00263198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064865|NCT00263198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65064879|NCT00294099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064880|NCT00294099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65064881|NCT00299676|Galantamine|galantamine|mesh-list
65064882|NCT00299676|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65064883|NCT00299676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064884|NCT00299676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064885|NCT00299676|Cholinergic Agents|cholinergic agents|mesh-ancestor
65064886|NCT00299676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65064887|NCT00299676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064888|NCT00299676|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65064889|NCT00299676|Autonomic Agents|autonomic agents|mesh-ancestor
65064890|NCT00299676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65064891|NCT00299676|Nootropic Agents|nootropic agents|mesh-ancestor
65064892|NCT00263276|Metformin|metformin|mesh-list
65064893|NCT00263276|Dapagliflozin|dapagliflozin|mesh-list
65064894|NCT00263276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65064895|NCT00263276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064896|NCT00263276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65064897|NCT00263276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064899|NCT00299754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65064900|NCT00299754|Abortifacient Agents|abortifacient agents|mesh-ancestor
65064901|NCT00299754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65064902|NCT00299754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064903|NCT00299754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65064904|NCT00299754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65064905|NCT00299754|Oxytocics|oxytocics|mesh-ancestor
65064906|NCT00263315|Amphotericin B|amphotericin b|mesh-list
65064907|NCT00263315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65064908|NCT00263315|Amebicides|amebicides|mesh-ancestor
65064909|NCT00263315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65064910|NCT00263315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65064923|NCT00263393|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65064924|NCT00263393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65064925|NCT00263393|Diuretics|diuretics|mesh-ancestor
65064926|NCT00263393|Natriuretic Agents|natriuretic agents|mesh-ancestor
65064927|NCT00263393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064928|NCT00263393|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65064929|NCT00263393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65064930|NCT00263393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064931|NCT00263393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65064932|NCT00263393|Sympatholytics|sympatholytics|mesh-ancestor
65064933|NCT00263393|Autonomic Agents|autonomic agents|mesh-ancestor
65064934|NCT00263393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65064935|NCT00263393|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65064936|NCT00263393|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65064937|NCT00263393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65064938|NCT00263393|Adrenergic Agents|adrenergic agents|mesh-ancestor
65064939|NCT00263393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65064940|NCT00263393|Protease Inhibitors|protease inhibitors|mesh-ancestor
65064941|NCT00263393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064942|NCT00299871|Lixisenatide|lixisenatide|mesh-list
65064943|NCT00299871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65064944|NCT00299871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064945|NCT00299910|Montelukast|montelukast|mesh-list
65064946|NCT00299910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65064947|NCT00299910|Respiratory System Agents|respiratory system agents|mesh-ancestor
65064948|NCT00299910|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65064949|NCT00299910|Hormone Antagonists|hormone antagonists|mesh-ancestor
65064951|NCT00299910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064966|NCT00294255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65064967|NCT00294255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65064968|NCT00294255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65064969|NCT00294255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65064970|NCT00294255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65064971|NCT00294255|Dopamine Agents|dopamine agents|mesh-ancestor
65064972|NCT00263705|Capecitabine|capecitabine|mesh-list
65064973|NCT00263705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65064974|NCT00263705|Antimetabolites|antimetabolites|mesh-ancestor
65064975|NCT00263705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064976|NCT00263705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064977|NCT00263744|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65064978|NCT00263744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65064979|NCT00263744|Immunologic Factors|immunologic factors|mesh-ancestor
65064980|NCT00263744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064981|NCT00263744|Antacids|antacids|mesh-ancestor
65064982|NCT00263744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064983|NCT00263744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65064984|NCT00294294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65064985|NCT00294294|Immunologic Factors|immunologic factors|mesh-ancestor
65064986|NCT00294294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65064987|NCT00263822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65064988|NCT00263822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65064989|NCT00263822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65064990|NCT00263822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65064991|NCT00263822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65064992|NCT00300222|Capsaicin|capsaicin|mesh-list
65064998|NCT00263978|Defibrotide|defibrotide|mesh-list
65065011|NCT00264134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65065012|NCT00264134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65065013|NCT00264134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065014|NCT00300339|Clopidogrel|clopidogrel|mesh-list
65065015|NCT00300339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65065016|NCT00300339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65065017|NCT00300339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65065018|NCT00300339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65065019|NCT00300339|Purinergic Agents|purinergic agents|mesh-ancestor
65065020|NCT00300339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65065021|NCT00300339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065022|NCT00300339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065023|NCT00264173|Valproic Acid|valproic acid|mesh-list
65065024|NCT00264173|Anticonvulsants|anticonvulsants|mesh-ancestor
65065025|NCT00264173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065026|NCT00264173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065027|NCT00264173|GABA Agents|gaba agents|mesh-ancestor
65065028|NCT00264173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65065029|NCT00264173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065030|NCT00264173|Antimanic Agents|antimanic agents|mesh-ancestor
65065031|NCT00264173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65065032|NCT00264173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65065033|NCT00264173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65065034|NCT00264212|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65065035|NCT00264212|Irbesartan|irbesartan|mesh-list
65065036|NCT00264212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65065037|NCT00264212|Diuretics|diuretics|mesh-ancestor
65065038|NCT00264212|Natriuretic Agents|natriuretic agents|mesh-ancestor
65065039|NCT00264212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065040|NCT00264212|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65065041|NCT00264212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65065042|NCT00264212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065045|NCT00300378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65065047|NCT00300378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65065048|NCT00300378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65065049|NCT00300378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065050|NCT00300378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65065051|NCT00300378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065052|NCT00300378|Antidepressive Agents|antidepressive agents|mesh-ancestor
65065053|NCT00300378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65065054|NCT00264251|Rosiglitazone|rosiglitazone|mesh-list
65065055|NCT00264251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65065056|NCT00264251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065057|NCT00294567|Amlodipine|amlodipine|mesh-list
65065058|NCT00294567|Calcium Channel Blockers|calcium channel blockers|mesh-list
65065059|NCT00294567|Calcium|calcium|mesh-list
65065060|NCT00294567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65065061|NCT00294567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065062|NCT00294567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65065063|NCT00294567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65065064|NCT00294567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065065|NCT00294567|Vasodilator Agents|vasodilator agents|mesh-ancestor
65065066|NCT00294606|Phenylephrine|phenylephrine|mesh-list
65065067|NCT00294606|Oxymetazoline|oxymetazoline|mesh-list
65065068|NCT00294606|Norepinephrine|norepinephrine|mesh-list
65065069|NCT00294606|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65065070|NCT00294606|Mydriatics|mydriatics|mesh-ancestor
65065071|NCT00294606|Autonomic Agents|autonomic agents|mesh-ancestor
65065096|NCT04708964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065097|NCT00264368|Ganciclovir|ganciclovir|mesh-list
65065098|NCT00264368|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
65065099|NCT00264368|Antiviral Agents|antiviral agents|mesh-ancestor
65065100|NCT00264368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65065101|NCT00264368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65065102|NCT00264368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065103|NCT00264368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065104|NCT00264407|Hormones|hormones|mesh-list
65065105|NCT00264407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65065106|NCT00264407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065107|NCT00300573|Dexelvucitabine|dexelvucitabine|mesh-list
65065108|NCT00300573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65065109|NCT00300573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65065110|NCT00300573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065111|NCT00300573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065112|NCT00300573|Antiviral Agents|antiviral agents|mesh-ancestor
65065113|NCT00300573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65065114|NCT00300573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65065115|NCT00300573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65065116|NCT00264446|Eniluracil|eniluracil|mesh-list
65065117|NCT00264446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065118|NCT00264446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065119|NCT00264485|Fentanyl|fentanyl|mesh-list
65065120|NCT00264485|Morphine|morphine|mesh-list
65065121|NCT00264485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65065122|NCT00264485|Narcotics|narcotics|mesh-ancestor
65065123|NCT00264485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65065124|NCT00264485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065125|NCT00264485|Analgesics|analgesics|mesh-ancestor
65065126|NCT00264485|Sensory System Agents|sensory system agents|mesh-ancestor
65065127|NCT00264485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65065128|NCT00264485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65065129|NCT00264485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65065130|NCT00264485|Anesthetics, General|anesthetics, general|mesh-ancestor
65065131|NCT00264485|Anesthetics|anesthetics|mesh-ancestor
64951554|NCT00026351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065132|NCT00294918|Hormones|hormones|mesh-list
65065133|NCT00294918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65065134|NCT00294918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065135|NCT00264680|Lamotrigine|lamotrigine|mesh-list
65065136|NCT00264680|Anticonvulsants|anticonvulsants|mesh-list
65065137|NCT00264680|Valproic Acid|valproic acid|mesh-list
65065138|NCT00264680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65065139|NCT00264680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65065140|NCT00264680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065141|NCT00264680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65065142|NCT00264680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065143|NCT00264680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65065144|NCT00264680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65065145|NCT00264680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65065146|NCT00264680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65065147|NCT00264680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65065148|NCT00264680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065149|NCT00264680|GABA Agents|gaba agents|mesh-ancestor
65065150|NCT00264680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65065151|NCT00264680|Antimanic Agents|antimanic agents|mesh-ancestor
65065152|NCT00300729|Celecoxib|celecoxib|mesh-list
65065153|NCT00300729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65065154|NCT00300729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65065155|NCT00300729|Analgesics|analgesics|mesh-ancestor
65065156|NCT00300729|Sensory System Agents|sensory system agents|mesh-ancestor
65065157|NCT00300729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65065158|NCT00300729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065159|NCT00300729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65065160|NCT00300729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65065161|NCT00300729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65065162|NCT00300729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65065163|NCT00300729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065165|NCT00264719|Metoclopramide|metoclopramide|mesh-list
65065171|NCT00264719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65065172|NCT00264719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65065173|NCT00264719|Dopamine Agents|dopamine agents|mesh-ancestor
65065174|NCT00264719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65065175|NCT00264719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065176|NCT00264914|Satavaptan|satavaptan|mesh-list
65065177|NCT00264914|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65065178|NCT00264914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065179|NCT00264914|Natriuretic Agents|natriuretic agents|mesh-ancestor
65065180|NCT00264914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065181|NCT00264953|Prednisone|prednisone|mesh-list
65065182|NCT00264953|Etoposide|etoposide|mesh-list
65065183|NCT00264953|Vincristine|vincristine|mesh-list
65065184|NCT00264953|Doxorubicin|doxorubicin|mesh-list
65065185|NCT00264953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65065186|NCT00264953|Bleomycin|bleomycin|mesh-list
65065187|NCT00264953|Vinblastine|vinblastine|mesh-list
65065188|NCT00264953|Procarbazine|procarbazine|mesh-list
65065189|NCT00264953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65065190|NCT00264953|Glucocorticoids|glucocorticoids|mesh-ancestor
65065191|NCT00264953|Hormones|hormones|mesh-ancestor
65065192|NCT00264953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65065193|NCT00264953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065194|NCT00264953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65065195|NCT00264953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065196|NCT00264953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65065197|NCT00264953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65065198|NCT00264953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65065199|NCT00264953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065200|NCT00264953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065201|NCT00264953|Tubulin Modulators|tubulin modulators|mesh-ancestor
65065202|NCT00264953|Antimitotic Agents|antimitotic agents|mesh-ancestor
65065203|NCT00264953|Mitosis Modulators|mitosis modulators|mesh-ancestor
65065204|NCT00264953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65065205|NCT00300846|Aripiprazole|aripiprazole|mesh-list
65065206|NCT00300846|Antidepressive Agents|antidepressive agents|mesh-ancestor
65065209|NCT00300846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65065210|NCT00300846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65065211|NCT00300846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065212|NCT00300846|Dopamine Agonists|dopamine agonists|mesh-ancestor
65065213|NCT00300846|Dopamine Agents|dopamine agents|mesh-ancestor
65065214|NCT00300846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65065215|NCT00300846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065216|NCT00300846|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65065217|NCT00300846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65065218|NCT00300846|Serotonin Agents|serotonin agents|mesh-ancestor
65065219|NCT00300846|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65065220|NCT00300846|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65065221|NCT00300846|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65065222|NCT00300846|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65065223|NCT00294996|Doxorubicin|doxorubicin|mesh-list
65065224|NCT00294996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65065225|NCT00294996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065226|NCT00294996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65065227|NCT00294996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65065228|NCT00294996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065229|NCT00294996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065230|NCT00265031|Prednisone|prednisone|mesh-list
65065231|NCT00265031|Cyclophosphamide|cyclophosphamide|mesh-list
65065232|NCT00265031|Etoposide|etoposide|mesh-list
65065233|NCT00265031|Vincristine|vincristine|mesh-list
65065234|NCT00265031|Doxorubicin|doxorubicin|mesh-list
65065235|NCT00265031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65065236|NCT00265031|Bleomycin|bleomycin|mesh-list
65065237|NCT00265031|Procarbazine|procarbazine|mesh-list
65065238|NCT00265031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64550544|NCT05029063|Rivaroxaban|rivaroxaban|mesh-list
65065252|NCT00265031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65065253|NCT00265031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65065254|NCT00265031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65065255|NCT00265031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065256|NCT00265031|Tubulin Modulators|tubulin modulators|mesh-ancestor
65065257|NCT00265031|Antimitotic Agents|antimitotic agents|mesh-ancestor
65065258|NCT00265031|Mitosis Modulators|mitosis modulators|mesh-ancestor
65065259|NCT00265031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65065260|NCT00300924|Acetaminophen|acetaminophen|mesh-list
65065261|NCT00300924|Rizatriptan|rizatriptan|mesh-list
65065262|NCT00300924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65065263|NCT00300924|Analgesics|analgesics|mesh-ancestor
65065264|NCT00300924|Sensory System Agents|sensory system agents|mesh-ancestor
65065265|NCT00300924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65065266|NCT00300924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065267|NCT00300924|Antipyretics|antipyretics|mesh-ancestor
65065268|NCT00300924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65065269|NCT00300924|Serotonin Agents|serotonin agents|mesh-ancestor
65065270|NCT00300924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65065271|NCT00300924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065272|NCT00265070|Gefitinib|gefitinib|mesh-list
65065273|NCT00265070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065274|NCT00265070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65065275|NCT00265070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065276|NCT00265070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065277|NCT00295035|Celecoxib|celecoxib|mesh-list
65065299|NCT00265265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065300|NCT00418275|Plasminogen|plasminogen|mesh-list
65065301|NCT00418275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65065302|NCT00418275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65065303|NCT00418275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065304|NCT00265304|Ketoprofen|ketoprofen|mesh-list
65065305|NCT00265304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65065306|NCT00265304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65065307|NCT00265304|Analgesics|analgesics|mesh-ancestor
65065308|NCT00265304|Sensory System Agents|sensory system agents|mesh-ancestor
65065309|NCT00265304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65065310|NCT00265304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065311|NCT00265304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65065312|NCT00265304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65065313|NCT00265304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65065314|NCT00265304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065315|NCT00265304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065316|NCT00295191|Dialysis Solutions|dialysis solutions|mesh-list
65065317|NCT00295191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65065318|NCT00265460|Lobeline|lobeline|mesh-list
65065319|NCT00265460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65065320|NCT00265460|Autonomic Agents|autonomic agents|mesh-ancestor
65065321|NCT00265460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65065322|NCT00265460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065323|NCT00265460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65065324|NCT00265460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65065346|NCT00265694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65065347|NCT00265694|Tubulin Modulators|tubulin modulators|mesh-ancestor
65065348|NCT00265694|Antimitotic Agents|antimitotic agents|mesh-ancestor
65065349|NCT00265694|Mitosis Modulators|mitosis modulators|mesh-ancestor
65065351|NCT00265733|Capecitabine|capecitabine|mesh-list
65065352|NCT00265733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
65065353|NCT00265733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65065354|NCT00265733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065355|NCT00265733|Tubulin Modulators|tubulin modulators|mesh-ancestor
65065356|NCT00265733|Antimitotic Agents|antimitotic agents|mesh-ancestor
65065357|NCT00265733|Mitosis Modulators|mitosis modulators|mesh-ancestor
65065358|NCT00265733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065359|NCT00265733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65065360|NCT00265733|Antimetabolites|antimetabolites|mesh-ancestor
65065361|NCT00265772|Prednisolone|prednisolone|mesh-list
65065362|NCT00265772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65065363|NCT00265772|Glucocorticoids|glucocorticoids|mesh-ancestor
65065364|NCT00265772|Hormones|hormones|mesh-ancestor
65065365|NCT00265772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65065366|NCT00265772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065367|NCT00265772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65065368|NCT00265772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065369|NCT00265811|Cetuximab|cetuximab|mesh-list
65065370|NCT00265811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65065371|NCT00265811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065372|NCT00295308|Clonidine|clonidine|mesh-list
65065373|NCT00295308|Analgesics|analgesics|mesh-ancestor
65065374|NCT00295308|Sensory System Agents|sensory system agents|mesh-ancestor
65065375|NCT00295308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65065376|NCT00295308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065377|NCT00295308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65065378|NCT00295308|Sympatholytics|sympatholytics|mesh-ancestor
65065379|NCT00295308|Autonomic Agents|autonomic agents|mesh-ancestor
65065386|NCT00265928|Rituximab|rituximab|mesh-list
65065388|NCT00265928|Antibodies|antibodies|mesh-list
65065389|NCT00265928|Immunoglobulins|immunoglobulins|mesh-list
65065390|NCT00265928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65065391|NCT00265928|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65065392|NCT00265928|Immunologic Factors|immunologic factors|mesh-ancestor
65065393|NCT00265928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065394|NCT00265928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65065395|NCT00265928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065396|NCT00265928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65065397|NCT00265928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065398|NCT00295347|Fludrocortisone|fludrocortisone|mesh-list
65065399|NCT00295347|Spironolactone|spironolactone|mesh-list
65065401|NCT00295347|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65065402|NCT00295347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65065403|NCT00295347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65065404|NCT00295347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065405|NCT00295347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65065406|NCT00295347|Serotonin Agents|serotonin agents|mesh-ancestor
65065407|NCT00295347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065408|NCT00295347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65065409|NCT00295347|Antidepressive Agents|antidepressive agents|mesh-ancestor
65065410|NCT00295347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65065411|NCT00295347|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65065412|NCT00295347|Hormone Antagonists|hormone antagonists|mesh-ancestor
65065413|NCT00295347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65065414|NCT00295347|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65065415|NCT00295347|Diuretics|diuretics|mesh-ancestor
65243446|NCT00629213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65065430|NCT00301236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65065431|NCT00301236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65065432|NCT00301236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65065433|NCT00301236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065434|NCT00301236|Dopamine Agents|dopamine agents|mesh-ancestor
65065435|NCT00301236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65065436|NCT00295425|Cyclosporine|cyclosporine|mesh-list
65065437|NCT00295425|Mycophenolic Acid|mycophenolic acid|mesh-list
65065438|NCT00295425|Cyclosporins|cyclosporins|mesh-list
65065439|NCT00295425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065440|NCT00295425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065441|NCT00295425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65065442|NCT00295425|Immunologic Factors|immunologic factors|mesh-ancestor
65065443|NCT00295425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065444|NCT00295425|Antifungal Agents|antifungal agents|mesh-ancestor
65065445|NCT00295425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65065446|NCT00295425|Dermatologic Agents|dermatologic agents|mesh-ancestor
65065447|NCT00295425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65065448|NCT00295425|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65065449|NCT00295425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65065450|NCT00295425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065451|NCT00295425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65065452|NCT00295425|Antitubercular Agents|antitubercular agents|mesh-ancestor
65065453|NCT00295425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65065454|NCT00266123|Sirolimus|sirolimus|mesh-list
65065455|NCT00266123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65065456|NCT00266123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65065475|NCT00415766|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65065476|NCT00415766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65065477|NCT00415766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065478|NCT00301392|Pitavastatin|pitavastatin|mesh-list
65065479|NCT00301392|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65065480|NCT00301392|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65065481|NCT00301392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65065482|NCT00301392|Antimetabolites|antimetabolites|mesh-ancestor
65065483|NCT00301392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065484|NCT00301392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065485|NCT00301392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65065486|NCT00415844|Levodopa|levodopa|mesh-list
65065487|NCT00415844|Carbidopa|carbidopa|mesh-list
65065489|NCT00415844|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65065490|NCT00415844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65065491|NCT00415844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65065492|NCT00415844|Dopamine Agents|dopamine agents|mesh-ancestor
65065493|NCT00415844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65065494|NCT00415844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065495|NCT00415844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065496|NCT00415844|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65065497|NCT00415844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065498|NCT00415844|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65065499|NCT00415844|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65065500|NCT00415844|Immunologic Factors|immunologic factors|mesh-ancestor
65065501|NCT00415844|Dopamine Agonists|dopamine agonists|mesh-ancestor
65065502|NCT00415883|Valsartan|valsartan|mesh-list
65065503|NCT00415883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65065504|NCT00415883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65065522|NCT00295542|Diuretics|diuretics|mesh-list
65065523|NCT00295542|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65065524|NCT00295542|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65065525|NCT00295542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065526|NCT00295542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65065527|NCT00295542|Adrenergic Agents|adrenergic agents|mesh-ancestor
65065528|NCT00295542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65065529|NCT00295542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065530|NCT00295542|Antioxidants|antioxidants|mesh-ancestor
65065531|NCT00295542|Protective Agents|protective agents|mesh-ancestor
65065532|NCT00295542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65065533|NCT00295542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65065534|NCT00295542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65065535|NCT00295542|Vasodilator Agents|vasodilator agents|mesh-ancestor
65065536|NCT00295542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65065537|NCT00295542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65065538|NCT00295542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65065539|NCT00295542|Protease Inhibitors|protease inhibitors|mesh-ancestor
65065576|NCT00295698|Diethylcarbamazine|diethylcarbamazine|mesh-list
65065577|NCT00295698|Filaricides|filaricides|mesh-ancestor
65065578|NCT00295698|Antinematodal Agents|antinematodal agents|mesh-ancestor
65065579|NCT00295698|Anthelmintics|anthelmintics|mesh-ancestor
65065580|NCT00295698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65065581|NCT00295698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65065582|NCT00295698|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65065583|NCT00295698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065585|NCT00266552|Risperidone|risperidone|mesh-list
65065605|NCT00301587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65065606|NCT00301587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065607|NCT00301587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65065608|NCT00301587|Contraceptive Agents|contraceptive agents|mesh-ancestor
65065609|NCT00301587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65065610|NCT00301587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65065611|NCT00301587|Hematinics|hematinics|mesh-ancestor
65065612|NCT00301587|Vitamin B Complex|vitamin b complex|mesh-ancestor
65065613|NCT00301587|Vitamins|vitamins|mesh-ancestor
65065614|NCT00301587|Micronutrients|micronutrients|mesh-ancestor
65065615|NCT00301587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65065616|NCT00301587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65065617|NCT00301587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65065618|NCT00301587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65065619|NCT00301587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65065620|NCT00301587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65065621|NCT00301587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65065622|NCT00301587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065623|NCT00301587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065624|NCT00301587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065625|NCT00301587|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65065626|NCT00266591|Topiramate|topiramate|mesh-list
65065627|NCT00266591|Anticonvulsants|anticonvulsants|mesh-ancestor
65065628|NCT00266591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65065629|NCT00266591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065630|NCT00301665|Botulinum Toxins|botulinum toxins|mesh-list
65065631|NCT00301665|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65065632|NCT00301665|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65065633|NCT00301665|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65065634|NCT00301665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65065646|NCT00295776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65065647|NCT00295776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065648|NCT00295776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65065649|NCT00295776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65065650|NCT00295776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65065651|NCT00295776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65065652|NCT00295776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65065653|NCT00266669|Nitroglycerin|nitroglycerin|mesh-list
65065654|NCT00266669|Vasodilator Agents|vasodilator agents|mesh-ancestor
65065655|NCT00266747|Amibegron|amibegron|mesh-list
65065656|NCT00266747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65065657|NCT00266747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65065658|NCT00266747|Adrenergic Agents|adrenergic agents|mesh-ancestor
65065659|NCT00266747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65065660|NCT00266747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065661|NCT00266747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065662|NCT00266786|Ketorolac|ketorolac|mesh-list
65065663|NCT00266786|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65065664|NCT00266786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65065665|NCT00266786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65065666|NCT00266786|Analgesics|analgesics|mesh-ancestor
65065667|NCT00266786|Sensory System Agents|sensory system agents|mesh-ancestor
65065668|NCT00266786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65065669|NCT00266786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065670|NCT00266786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65065671|NCT00266786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65065672|NCT00266786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65065673|NCT00266786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243447|NCT00629213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065674|NCT00266786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065675|NCT00295815|Lomustine|lomustine|mesh-list
65065687|NCT00295971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065688|NCT00295971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65065689|NCT00295971|Immunologic Factors|immunologic factors|mesh-ancestor
65065690|NCT00295971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065691|NCT00295971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65065692|NCT00295971|Alkylating Agents|alkylating agents|mesh-ancestor
65065693|NCT00295971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65065694|NCT00267176|Lumiracoxib|lumiracoxib|mesh-list
65065695|NCT00267176|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65065696|NCT00267176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65065697|NCT00267176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065698|NCT00267176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065699|NCT00267176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65065700|NCT00267176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65065701|NCT00267176|Analgesics|analgesics|mesh-ancestor
65065702|NCT00267176|Sensory System Agents|sensory system agents|mesh-ancestor
65065703|NCT00267176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65065704|NCT00267176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065705|NCT00267176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65065706|NCT00267176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65065707|NCT00296010|Cyclophosphamide|cyclophosphamide|mesh-list
65065708|NCT00296010|Doxorubicin|doxorubicin|mesh-list
65065709|NCT00296010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65065710|NCT00296010|Methotrexate|methotrexate|mesh-list
65065711|NCT00296010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65065712|NCT00296010|Immunologic Factors|immunologic factors|mesh-ancestor
65065733|NCT00267215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65065734|NCT00267215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65065735|NCT00267215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065736|NCT00267215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065737|NCT00267215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65065738|NCT00267215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65065739|NCT00267215|Analgesics|analgesics|mesh-ancestor
65065740|NCT00267215|Sensory System Agents|sensory system agents|mesh-ancestor
65065741|NCT00267215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65065742|NCT00267215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065743|NCT00267215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65065744|NCT00267215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65065745|NCT00296049|Vancomycin|vancomycin|mesh-list
65065746|NCT00296049|Daptomycin|daptomycin|mesh-list
65243448|NCT00978341|Pregabalin|pregabalin|mesh-list
65065747|NCT00296049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65065748|NCT00296049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65065749|NCT00267254|Atorvastatin|atorvastatin|mesh-list
65065750|NCT00267254|Simvastatin|simvastatin|mesh-list
65065751|NCT00267254|Torcetrapib|torcetrapib|mesh-list
65065752|NCT00267254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65065753|NCT00267254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65065754|NCT00267254|Antimetabolites|antimetabolites|mesh-ancestor
65065755|NCT00267254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065756|NCT00267254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65065757|NCT00267254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65065758|NCT00267254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065759|NCT00301782|Carboplatin|carboplatin|mesh-list
65065760|NCT00301782|Etoposide|etoposide|mesh-list
65065761|NCT00301782|Vincristine|vincristine|mesh-list
65065762|NCT00301782|Bleomycin|bleomycin|mesh-list
65065777|NCT00267332|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65065778|NCT00267332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65065779|NCT00267332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65065780|NCT00267332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065781|NCT04718649|Celecoxib|celecoxib|mesh-list
65065782|NCT04718649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65065783|NCT04718649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65065784|NCT04718649|Analgesics|analgesics|mesh-ancestor
65065785|NCT04718649|Sensory System Agents|sensory system agents|mesh-ancestor
65065786|NCT04718649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65065787|NCT04718649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065788|NCT04718649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65065789|NCT04718649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65065790|NCT04718649|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65065791|NCT04718649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65065792|NCT04718649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065793|NCT04718649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065794|NCT00301860|Cyclosporine|cyclosporine|mesh-list
65065795|NCT00301860|Methotrexate|methotrexate|mesh-list
65065796|NCT00301860|Fludarabine phosphate|fludarabine phosphate|mesh-list
65065797|NCT00301860|Fludarabine|fludarabine|mesh-list
65065798|NCT00301860|Melphalan|melphalan|mesh-list
65065799|NCT00301860|Cyclosporins|cyclosporins|mesh-list
65065800|NCT00301860|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65065801|NCT00301860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65065802|NCT00301860|Abortifacient Agents|abortifacient agents|mesh-ancestor
65065803|NCT00301860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65065804|NCT00301860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065822|NCT00301899|Trastuzumab|trastuzumab|mesh-list
65065823|NCT00301899|Pertuzumab|pertuzumab|mesh-list
65065824|NCT00301899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65065825|NCT00301899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065826|NCT00296127|Celecoxib|celecoxib|mesh-list
65065827|NCT00296127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65065828|NCT00296127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65065829|NCT00296127|Analgesics|analgesics|mesh-ancestor
65065830|NCT00296127|Sensory System Agents|sensory system agents|mesh-ancestor
65065831|NCT00296127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65065832|NCT00296127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065833|NCT00296127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65065834|NCT00296127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65065835|NCT00296127|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65065836|NCT00296127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65065837|NCT00296127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065838|NCT00296127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065839|NCT00296205|Cyclophosphamide|cyclophosphamide|mesh-list
65065840|NCT00296205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65065841|NCT00296205|Immunologic Factors|immunologic factors|mesh-ancestor
65065842|NCT00296205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065843|NCT00296205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65065844|NCT00296205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65065845|NCT00296205|Alkylating Agents|alkylating agents|mesh-ancestor
65065872|NCT00267917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65065873|NCT00267917|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65065874|NCT00267917|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65065875|NCT00267917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65065876|NCT00267917|Adrenergic Agents|adrenergic agents|mesh-ancestor
65065877|NCT00267917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65065878|NCT00267917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065879|NCT00267917|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65065880|NCT00267917|Cholinergic Agents|cholinergic agents|mesh-ancestor
65065881|NCT00296361|Tacrolimus|tacrolimus|mesh-list
65065882|NCT00296361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65065883|NCT00296361|Immunologic Factors|immunologic factors|mesh-ancestor
65065885|NCT00296361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65065933|NCT00268151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65065934|NCT00268151|Antimetabolites|antimetabolites|mesh-ancestor
65065935|NCT00268151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065936|NCT00268151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065937|NCT00418080|Bicalutamide|bicalutamide|mesh-list
65065938|NCT00418080|Androgen Antagonists|androgen antagonists|mesh-ancestor
65065939|NCT00418080|Hormone Antagonists|hormone antagonists|mesh-ancestor
65065940|NCT00418080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65065941|NCT00418080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065942|NCT00418080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065943|NCT00268229|Cytarabine|cytarabine|mesh-list
65065944|NCT00268229|Imatinib Mesylate|imatinib mesylate|mesh-list
65065945|NCT00268229|Daunorubicin|daunorubicin|mesh-list
65065946|NCT00268229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65065947|NCT00268229|Antimetabolites|antimetabolites|mesh-ancestor
65065948|NCT00268229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551268|NCT03957876|Antiviral Agents|antiviral agents|mesh-ancestor
65065949|NCT00268229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65065950|NCT00268229|Antiviral Agents|antiviral agents|mesh-ancestor
65065951|NCT00268229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65065952|NCT00268229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65065953|NCT00268229|Immunologic Factors|immunologic factors|mesh-ancestor
65065954|NCT00268229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065955|NCT00268229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65065956|NCT00268229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065957|NCT00268229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65065958|NCT00268229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65065959|NCT00268229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65065960|NCT00302289|Caffeine|caffeine|mesh-list
65065961|NCT00302289|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65065970|NCT00296634|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65065974|NCT00296634|Antacids|antacids|mesh-ancestor
65065975|NCT00296634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065976|NCT00296634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65065977|NCT00268619|Ramipril|ramipril|mesh-list
65065978|NCT00268619|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65065979|NCT00268619|Protease Inhibitors|protease inhibitors|mesh-ancestor
65065980|NCT00268619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65065981|NCT00268619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065982|NCT00268619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65065983|NCT00296712|Dexetimide|dexetimide|mesh-list
65065984|NCT00296712|Citalopram|citalopram|mesh-list
65065985|NCT00296712|Bupropion|bupropion|mesh-list
65065986|NCT00296712|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65065987|NCT00296712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65065988|NCT00296712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65065989|NCT00296712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65065990|NCT00296712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65065991|NCT00296712|Serotonin Agents|serotonin agents|mesh-ancestor
65065992|NCT00296712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65065993|NCT00296712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65065994|NCT00296712|Antidepressive Agents|antidepressive agents|mesh-ancestor
65065995|NCT00296712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65065996|NCT00296712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65065997|NCT00296712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65065998|NCT00296712|Parasympatholytics|parasympatholytics|mesh-ancestor
65065999|NCT00296712|Autonomic Agents|autonomic agents|mesh-ancestor
65066000|NCT00296712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066001|NCT00296712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65066020|NCT00296751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65066021|NCT00296751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066022|NCT00296751|Sensory System Agents|sensory system agents|mesh-ancestor
64551330|NCT00875277|Glucocorticoids|glucocorticoids|mesh-ancestor
65066023|NCT00296751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066024|NCT00296751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65066025|NCT00296751|Narcotics|narcotics|mesh-ancestor
65066026|NCT00296751|Analgesics|analgesics|mesh-ancestor
65066027|NCT00296751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65066028|NCT00296751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65066029|NCT00296751|Anesthetics, General|anesthetics, general|mesh-ancestor
65066030|NCT00302367|Methylphenidate|methylphenidate|mesh-list
65066031|NCT00302367|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65066032|NCT00302367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066033|NCT00302367|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65066034|NCT00302367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65066035|NCT00302367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65066036|NCT00302367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066037|NCT00302367|Dopamine Agents|dopamine agents|mesh-ancestor
65066038|NCT00302367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65066039|NCT00296790|Zolpidem|zolpidem|mesh-list
65066040|NCT00296790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65066041|NCT00296790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65066042|NCT00296790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65066043|NCT00296790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066044|NCT00296790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65066045|NCT00296790|GABA Agonists|gaba agonists|mesh-ancestor
65066046|NCT00296790|GABA Agents|gaba agents|mesh-ancestor
65066047|NCT00296790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65066048|NCT00296790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066049|NCT00302406|Methylphenidate|methylphenidate|mesh-list
65066050|NCT00302406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65066051|NCT00302406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066056|NCT00302406|Dopamine Agents|dopamine agents|mesh-ancestor
65066057|NCT00302406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65066058|NCT00268814|Methadone|methadone|mesh-list
65066060|NCT00268814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65066061|NCT00268814|Narcotics|narcotics|mesh-ancestor
65066062|NCT00268814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65066063|NCT00268814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918068|NCT00100906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64918069|NCT00100906|Analgesics|analgesics|mesh-ancestor
64918070|NCT00100906|Sensory System Agents|sensory system agents|mesh-ancestor
64918071|NCT00100906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64918072|NCT00100906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918073|NCT00100906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64918074|NCT00100906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65066064|NCT00268814|Analgesics|analgesics|mesh-ancestor
65066065|NCT00268814|Sensory System Agents|sensory system agents|mesh-ancestor
65066066|NCT00268814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066067|NCT00268814|Antitussive Agents|antitussive agents|mesh-ancestor
65066107|NCT02960412|Furosemide|furosemide|mesh-list
64918112|NCT00101062|Analgesics|analgesics|mesh-ancestor
65066108|NCT02960412|Diuretics|diuretics|mesh-ancestor
65066109|NCT02960412|Natriuretic Agents|natriuretic agents|mesh-ancestor
65066110|NCT02960412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066111|NCT02960412|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65066112|NCT02960412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65066113|NCT02960412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066114|NCT00269126|Fluticasone|fluticasone|mesh-list
65066115|NCT00269126|Xhance|xhance|mesh-list
65066116|NCT00269126|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65066117|NCT00269126|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65066118|NCT00269126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65066119|NCT00269126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65066120|NCT00269126|Autonomic Agents|autonomic agents|mesh-ancestor
65066121|NCT00269126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066122|NCT00269126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066123|NCT00269126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65066124|NCT00269126|Respiratory System Agents|respiratory system agents|mesh-ancestor
65066125|NCT00269126|Dermatologic Agents|dermatologic agents|mesh-ancestor
65066126|NCT00269126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65066127|NCT00269126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65066128|NCT00269126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65066129|NCT00269126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65066130|NCT00269126|Adrenergic Agents|adrenergic agents|mesh-ancestor
65066131|NCT00269126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65066132|NCT00269126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066133|NCT00269126|Glucocorticoids|glucocorticoids|mesh-ancestor
65066134|NCT00269126|Hormones|hormones|mesh-ancestor
65066135|NCT00269126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65066136|NCT00269126|Sympathomimetics|sympathomimetics|mesh-ancestor
65066149|NCT00297141|Capecitabine|capecitabine|mesh-list
65066150|NCT00297141|Oxaliplatin|oxaliplatin|mesh-list
65066151|NCT00297141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65066152|NCT00297141|Antimetabolites|antimetabolites|mesh-ancestor
65066153|NCT00297141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066154|NCT00297141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066155|NCT00269243|Quinapril|quinapril|mesh-list
65066156|NCT00269243|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65066157|NCT00269243|Protease Inhibitors|protease inhibitors|mesh-ancestor
65066158|NCT00269243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066159|NCT00269243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066160|NCT00269243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65066161|NCT04718064|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65066162|NCT04718064|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65066163|NCT04718064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066164|NCT04718064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65066165|NCT04718064|Immunologic Factors|immunologic factors|mesh-ancestor
65066166|NCT04718064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066167|NCT00297219|Calcium, Dietary|calcium, dietary|mesh-list
65066168|NCT00297219|Dialysis Solutions|dialysis solutions|mesh-list
65066169|NCT00297219|Calcium|calcium|mesh-list
65066170|NCT00297219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65066171|NCT00297219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066172|NCT00297219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65066173|NCT00297219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65066174|NCT00302640|Nitazoxanide|nitazoxanide|mesh-list
65066194|NCT00418353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066195|NCT00418353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65066196|NCT00418353|Respiratory System Agents|respiratory system agents|mesh-ancestor
65066197|NCT00418353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65066198|NCT00418392|Minocycline|minocycline|mesh-list
65066199|NCT00418392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65066200|NCT00418392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65066201|NCT00269555|Genistein|genistein|mesh-list
65066202|NCT00269555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65066203|NCT00269555|Protective Agents|protective agents|mesh-ancestor
65066204|NCT00269555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066205|NCT00269555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066206|NCT00269555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65066207|NCT00269555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066208|NCT00269555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066209|NCT00269555|Phytoestrogens|phytoestrogens|mesh-ancestor
65066210|NCT00269555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65066211|NCT00269555|Estrogens|estrogens|mesh-ancestor
65066212|NCT00269555|Hormones|hormones|mesh-ancestor
65066213|NCT00269555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65066214|NCT00418431|Bevacizumab|bevacizumab|mesh-list
65066215|NCT00418431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65066216|NCT00418431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066217|NCT00418431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65066218|NCT00418431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65066219|NCT00418431|Growth Substances|growth substances|mesh-ancestor
65066220|NCT00418431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066221|NCT00418431|Growth Inhibitors|growth inhibitors|mesh-ancestor
64918241|NCT03991884|Cortisone|cortisone|mesh-list
64918242|NCT03991884|Cyclophosphamide|cyclophosphamide|mesh-list
64918243|NCT03991884|Doxorubicin|doxorubicin|mesh-list
64918244|NCT03991884|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64918245|NCT03991884|Etoposide|etoposide|mesh-list
64918246|NCT03991884|Vincristine|vincristine|mesh-list
64918247|NCT03991884|Etoposide phosphate|etoposide phosphate|mesh-list
64918248|NCT03991884|Daunorubicin|daunorubicin|mesh-list
64918249|NCT03991884|Podophyllotoxin|podophyllotoxin|mesh-list
64918250|NCT03991884|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65066239|NCT00269672|Immunologic Factors|immunologic factors|mesh-ancestor
65066240|NCT00269672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066293|NCT00269867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65066294|NCT00269906|Abciximab|abciximab|mesh-list
65066295|NCT00269906|Anticoagulants|anticoagulants|mesh-ancestor
65066296|NCT00269906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65066297|NCT00269945|Epoetin Alfa|epoetin alfa|mesh-list
65066298|NCT00269945|Hematinics|hematinics|mesh-ancestor
65066299|NCT00269984|Epoetin Alfa|epoetin alfa|mesh-list
65066300|NCT00269984|Hematinics|hematinics|mesh-ancestor
65066301|NCT00297336|Topiramate|topiramate|mesh-list
65066302|NCT00297336|Anticonvulsants|anticonvulsants|mesh-ancestor
65066303|NCT00297336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65066304|NCT00297336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066305|NCT00270023|Epoetin Alfa|epoetin alfa|mesh-list
65066306|NCT00270023|Hematinics|hematinics|mesh-ancestor
65066307|NCT00297375|Acetaminophen|acetaminophen|mesh-list
65066308|NCT00297375|Tramadol|tramadol|mesh-list
65066309|NCT00297375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65066310|NCT00297375|Analgesics|analgesics|mesh-ancestor
65066311|NCT00297375|Sensory System Agents|sensory system agents|mesh-ancestor
65066312|NCT00297375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066313|NCT00297375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066353|NCT00270491|Antimetabolites|antimetabolites|mesh-ancestor
65066354|NCT00270530|Pyrimethamine|pyrimethamine|mesh-list
65066355|NCT00270530|Sulfadoxine|sulfadoxine|mesh-list
65066356|NCT00270530|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65066357|NCT00270530|Antimalarials|antimalarials|mesh-ancestor
65066358|NCT00270530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65066359|NCT00270530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65066360|NCT00270530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65066361|NCT00270530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65066362|NCT00270530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066363|NCT00270530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066364|NCT00270530|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65066365|NCT00270530|Renal Agents|renal agents|mesh-ancestor
65066366|NCT00297765|Tacrolimus|tacrolimus|mesh-list
65066367|NCT00297765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65066368|NCT00297765|Immunologic Factors|immunologic factors|mesh-ancestor
65066369|NCT00297765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066370|NCT00297765|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65066371|NCT00297765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066372|NCT00297765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066373|NCT00270569|Cisplatin|cisplatin|mesh-list
65066374|NCT00270569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066375|NCT00297804|Paclitaxel|paclitaxel|mesh-list
65066376|NCT00297804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65066377|NCT00297804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066378|NCT00297804|Tubulin Modulators|tubulin modulators|mesh-ancestor
65066379|NCT00297804|Antimitotic Agents|antimitotic agents|mesh-ancestor
65066380|NCT00297804|Mitosis Modulators|mitosis modulators|mesh-ancestor
65066381|NCT00297804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066401|NCT00297960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65066402|NCT00297960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65066403|NCT00297960|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65066404|NCT00297960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65066405|NCT00297960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65066406|NCT00297960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066407|NCT00297960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65066408|NCT00297960|Serotonin Agents|serotonin agents|mesh-ancestor
65066409|NCT00297960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65066410|NCT00297960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65066411|NCT00297960|Dopamine Agents|dopamine agents|mesh-ancestor
65066412|NCT00270881|Cytarabine|cytarabine|mesh-list
65066413|NCT00270881|Cyclophosphamide|cyclophosphamide|mesh-list
65066414|NCT00270881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65066415|NCT00270881|Immunologic Factors|immunologic factors|mesh-ancestor
65066416|NCT00270881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066417|NCT00270881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65066418|NCT00270881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65066419|NCT00270881|Alkylating Agents|alkylating agents|mesh-ancestor
65066420|NCT00270881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243451|NCT00978341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066421|NCT00270881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066422|NCT00270881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65066423|NCT00270881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65066424|NCT00270881|Antimetabolites|antimetabolites|mesh-ancestor
65066425|NCT00270881|Antiviral Agents|antiviral agents|mesh-ancestor
65066426|NCT00270881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65066428|NCT00298194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65066429|NCT00298194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066431|NCT00298194|Cholinergic Agents|cholinergic agents|mesh-ancestor
65066443|NCT00418548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65066444|NCT00418548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65066445|NCT00418548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65066446|NCT00418548|Immunologic Factors|immunologic factors|mesh-ancestor
65066447|NCT00418587|Vitamin D|vitamin d|mesh-list
65066448|NCT00418587|Ergocalciferols|ergocalciferols|mesh-list
65066449|NCT00418587|Cholecalciferol|cholecalciferol|mesh-list
65066450|NCT00418587|Vitamins|vitamins|mesh-list
65066451|NCT00418587|Micronutrients|micronutrients|mesh-ancestor
65066452|NCT00418587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066453|NCT00418587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65066454|NCT00418587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65066455|NCT00416273|Bortezomib|bortezomib|mesh-list
65066456|NCT00416273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066457|NCT00306462|Magnesium Sulfate|magnesium sulfate|mesh-list
65066458|NCT00306462|Nifedipine|nifedipine|mesh-list
65066459|NCT00306462|Analgesics|analgesics|mesh-ancestor
65066460|NCT00306462|Sensory System Agents|sensory system agents|mesh-ancestor
65066461|NCT00306462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066462|NCT00306462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066463|NCT00306462|Anesthetics|anesthetics|mesh-ancestor
65066464|NCT00306462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65066465|NCT00306462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65066466|NCT00306462|Anticonvulsants|anticonvulsants|mesh-ancestor
65066467|NCT00306462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65066468|NCT00306462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65066469|NCT00306462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066493|NCT00416429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066494|NCT00416429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65066495|NCT00416429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65066496|NCT00416429|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65066497|NCT00416429|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65066498|NCT00416429|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65066499|NCT00416429|Contraceptive Agents|contraceptive agents|mesh-ancestor
65066500|NCT00416429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65066501|NCT00416429|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65066502|NCT00416429|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65066503|NCT00416429|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65066504|NCT00416429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65066505|NCT00306540|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65066506|NCT00306540|Antidepressive Agents|antidepressive agents|mesh-ancestor
65066507|NCT00306540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65066508|NCT00306540|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65066509|NCT00306540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65066510|NCT00306540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65066511|NCT00306540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066512|NCT00271271|Gemcitabine|gemcitabine|mesh-list
65066513|NCT00271271|Vinorelbine|vinorelbine|mesh-list
65066514|NCT00271271|Oxaliplatin|oxaliplatin|mesh-list
65066515|NCT00271271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65066516|NCT00271271|Antimetabolites|antimetabolites|mesh-ancestor
65066517|NCT00271271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066518|NCT00271271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066519|NCT00271271|Antiviral Agents|antiviral agents|mesh-ancestor
65066540|NCT00271349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066541|NCT00271349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65066542|NCT00271349|Respiratory System Agents|respiratory system agents|mesh-ancestor
65066543|NCT00271349|Glucocorticoids|glucocorticoids|mesh-ancestor
65066544|NCT00271349|Hormones|hormones|mesh-ancestor
65066545|NCT00271349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65066546|NCT00306696|Rosiglitazone|rosiglitazone|mesh-list
65066547|NCT00306696|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65066548|NCT00306696|Spironolactone|spironolactone|mesh-list
65066549|NCT00306696|Furosemide|furosemide|mesh-list
65066550|NCT00306696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65066551|NCT00306696|Diuretics|diuretics|mesh-ancestor
65066552|NCT00306696|Natriuretic Agents|natriuretic agents|mesh-ancestor
65066553|NCT00306696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066554|NCT00306696|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65066555|NCT00306696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65066556|NCT00306696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066557|NCT00306696|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65066558|NCT00306696|Hormone Antagonists|hormone antagonists|mesh-ancestor
65066559|NCT00306696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65066560|NCT00306696|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65066561|NCT00306696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65066562|NCT00306696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65066563|NCT00271427|Selenium|selenium|mesh-list
65066564|NCT00271427|Antioxidants|antioxidants|mesh-ancestor
65066565|NCT00271427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066566|NCT00271427|Protective Agents|protective agents|mesh-ancestor
65066567|NCT00271427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066570|NCT00271466|Fentanyl|fentanyl|mesh-list
65066584|NCT00306735|Autonomic Agents|autonomic agents|mesh-ancestor
65066585|NCT00306735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066586|NCT00306735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066587|NCT00306735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65066588|NCT00306735|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65066589|NCT00306735|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65066590|NCT00306735|Serotonin Agents|serotonin agents|mesh-ancestor
65066591|NCT00306735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65066592|NCT00306735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066593|NCT00271583|Levonorgestrel|levonorgestrel|mesh-list
65066594|NCT00271583|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65066595|NCT00271583|Contraceptive Agents|contraceptive agents|mesh-ancestor
65066596|NCT00271583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65066597|NCT00271583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066598|NCT00271583|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65066599|NCT00271583|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65066600|NCT00271583|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65066602|NCT00306774|Cholecalciferol|cholecalciferol|mesh-list
65066603|NCT00306774|Vitamins|vitamins|mesh-ancestor
65066604|NCT00306774|Micronutrients|micronutrients|mesh-ancestor
65066605|NCT00306774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066606|NCT00306774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65066607|NCT00306774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65066608|NCT00306813|Lenalidomide|lenalidomide|mesh-list
65066609|NCT00306813|Immunologic Factors|immunologic factors|mesh-ancestor
65066610|NCT00306813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066611|NCT00306813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65066631|NCT00272012|Insulin glulisine|insulin glulisine|mesh-list
65066632|NCT00272012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65066633|NCT00272012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066634|NCT00307008|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65066635|NCT00307008|Immunologic Factors|immunologic factors|mesh-ancestor
65066636|NCT00307008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066637|NCT00272051|Xaliproden|xaliproden|mesh-list
65066638|NCT00272051|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65066639|NCT00272051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65066640|NCT00272051|Serotonin Agents|serotonin agents|mesh-ancestor
65066641|NCT00272051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65066642|NCT00272051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066643|NCT00272051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066644|NCT00307203|Bupropion|bupropion|mesh-list
65066645|NCT00307203|Nicotine|nicotine|mesh-list
65066646|NCT00307203|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65066647|NCT00307203|Autonomic Agents|autonomic agents|mesh-ancestor
65066648|NCT00307203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066649|NCT00307203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066650|NCT00307203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65066651|NCT00307203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65066652|NCT00307203|Cholinergic Agents|cholinergic agents|mesh-ancestor
65066653|NCT00307203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65066654|NCT00307203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066655|NCT00307203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65066656|NCT00307203|Antidepressive Agents|antidepressive agents|mesh-ancestor
65066657|NCT00307203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65066658|NCT00307203|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65066659|NCT00307203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65066660|NCT00307203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65066661|NCT00307203|Dopamine Agents|dopamine agents|mesh-ancestor
65066662|NCT00307203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65066663|NCT00307203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65066664|NCT00307203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066665|NCT00272090|Insulin Glargine|insulin glargine|mesh-list
64951555|NCT00026351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918654|NCT02972268|Tamsulosin|tamsulosin|mesh-list
65066666|NCT00272090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65066667|NCT00272090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066668|NCT00272207|Nabilone|nabilone|mesh-list
65066669|NCT00272207|Antiemetics|antiemetics|mesh-ancestor
65066670|NCT00272207|Autonomic Agents|autonomic agents|mesh-ancestor
65066671|NCT00272207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066672|NCT00272207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066673|NCT00272207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65066674|NCT00272207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65066675|NCT00272207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65066676|NCT00272207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65066677|NCT00272207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65066678|NCT00307515|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65066679|NCT00307515|Hemostatics|hemostatics|mesh-ancestor
65066680|NCT00307515|Coagulants|coagulants|mesh-ancestor
65066681|NCT00272285|Granisetron|granisetron|mesh-list
65066682|NCT00272285|Ramosetron|ramosetron|mesh-list
65066683|NCT00272285|Antiemetics|antiemetics|mesh-ancestor
65066684|NCT00272285|Autonomic Agents|autonomic agents|mesh-ancestor
65066685|NCT00272285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066686|NCT00272285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066687|NCT00272285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65066688|NCT00272285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65066689|NCT00272285|Serotonin Agents|serotonin agents|mesh-ancestor
65066690|NCT00272285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65066691|NCT00272285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066692|NCT00272324|Aspirin|aspirin|mesh-list
65066693|NCT00272324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65066694|NCT00272324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65066695|NCT00272324|Analgesics|analgesics|mesh-ancestor
65066711|NCT00307593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65066712|NCT00307593|Immunologic Factors|immunologic factors|mesh-ancestor
65066713|NCT00307593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066714|NCT00307593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65066715|NCT00307593|Dermatologic Agents|dermatologic agents|mesh-ancestor
65066716|NCT00307593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65066717|NCT00307632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65066718|NCT00307632|Estradiol|estradiol|mesh-list
65066719|NCT00307632|Estrogens|estrogens|mesh-ancestor
65066720|NCT00307632|Hormones|hormones|mesh-ancestor
65066721|NCT00307632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65066722|NCT00307632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066723|NCT00307632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65066724|NCT00307632|Contraceptive Agents|contraceptive agents|mesh-ancestor
65066725|NCT00307632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65066726|NCT00307632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65066727|NCT00307632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65066728|NCT00307632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65066729|NCT00272480|Lamivudine|lamivudine|mesh-list
65066730|NCT00272480|Zidovudine|zidovudine|mesh-list
65066731|NCT00272480|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65066732|NCT00272480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65066733|NCT00272480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066764|NCT00307671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65066765|NCT00307671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65066766|NCT00307671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65066767|NCT00307671|Abortifacient Agents|abortifacient agents|mesh-ancestor
65066768|NCT00307671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65066769|NCT00307671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65066770|NCT00307671|Antimetabolites|antimetabolites|mesh-ancestor
65066771|NCT00307671|Dermatologic Agents|dermatologic agents|mesh-ancestor
65066772|NCT00307671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066773|NCT00307671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65066774|NCT00307671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65066775|NCT00307671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65066776|NCT00307671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65066777|NCT00307671|Antitubercular Agents|antitubercular agents|mesh-ancestor
65066778|NCT00307671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65066779|NCT00307671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65066780|NCT00307671|Antiemetics|antiemetics|mesh-ancestor
65066781|NCT00307671|Autonomic Agents|autonomic agents|mesh-ancestor
65066782|NCT00307671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066783|NCT00307671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65066784|NCT00307671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65066785|NCT00307671|Protective Agents|protective agents|mesh-ancestor
65066786|NCT00272558|Carboplatin|carboplatin|mesh-list
65066787|NCT00272558|Vinorelbine|vinorelbine|mesh-list
65243467|NCT00695331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65243468|NCT00695331|Abortifacient Agents|abortifacient agents|mesh-ancestor
65243469|NCT00695331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65243470|NCT00695331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65243471|NCT00695643|Mesalamine|mesalamine|mesh-list
65243472|NCT00695643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65243473|NCT00695643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65243474|NCT00695643|Analgesics|analgesics|mesh-ancestor
65243475|NCT00695643|Sensory System Agents|sensory system agents|mesh-ancestor
65243476|NCT00695643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65243477|NCT00695643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243478|NCT00695643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65243479|NCT00695643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65243480|NCT02623881|Progesterone|progesterone|mesh-list
65243481|NCT02623881|Progestins|progestins|mesh-ancestor
65243482|NCT02623881|Hormones|hormones|mesh-ancestor
65243483|NCT02623881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65243484|NCT02623881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243485|NCT04135833|Itraconazole|itraconazole|mesh-list
65243486|NCT04135833|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
65243487|NCT04135833|Rifampin|rifampin|mesh-list
65243488|NCT04135833|Antifungal Agents|antifungal agents|mesh-ancestor
65243489|NCT04135833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65243490|NCT04135833|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65243491|NCT04135833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65243492|NCT04135833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243493|NCT04135833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243494|NCT04135833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65243495|NCT04135833|Hormone Antagonists|hormone antagonists|mesh-ancestor
65243496|NCT04135833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65243508|NCT04135833|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65243509|NCT04135833|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65243510|NCT00696033|Diazepam|diazepam|mesh-list
65243511|NCT00696033|Lorazepam|lorazepam|mesh-list
65243512|NCT00696033|Anticonvulsants|anticonvulsants|mesh-ancestor
65243513|NCT00696033|Antiemetics|antiemetics|mesh-ancestor
65243514|NCT00696033|Autonomic Agents|autonomic agents|mesh-ancestor
65243515|NCT00696033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65243516|NCT00696033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243517|NCT00696033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65243518|NCT00696033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65243519|NCT00696033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65243520|NCT00696033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65243521|NCT00696033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65243522|NCT00696033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65243523|NCT00696033|GABA Modulators|gaba modulators|mesh-ancestor
65243524|NCT00696033|GABA Agents|gaba agents|mesh-ancestor
65243525|NCT00696033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64993783|NCT00087815|Dexamethasone|dexamethasone|mesh-list
65243526|NCT00696033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243527|NCT00696033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65243528|NCT00696033|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65243529|NCT00696033|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65243530|NCT00696033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65243531|NCT00696033|Anesthetics, General|anesthetics, general|mesh-ancestor
65243532|NCT00696033|Anesthetics|anesthetics|mesh-ancestor
65243533|NCT00696111|Leuprolide|leuprolide|mesh-list
65243534|NCT00696111|Progesterone|progesterone|mesh-list
65243535|NCT00696111|Estrogens|estrogens|mesh-list
65243536|NCT00696111|Progestins|progestins|mesh-ancestor
65243537|NCT00696111|Hormones|hormones|mesh-ancestor
65243538|NCT00696111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65243539|NCT00696111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243540|NCT00696111|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65243541|NCT00696111|Fertility Agents|fertility agents|mesh-ancestor
65243542|NCT00696111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65243545|NCT02623569|Atenolol|atenolol|mesh-list
65243548|NCT02623569|Sympatholytics|sympatholytics|mesh-ancestor
65243549|NCT02623569|Autonomic Agents|autonomic agents|mesh-ancestor
65243550|NCT02623569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65243551|NCT02623569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243552|NCT02623569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65243553|NCT02623569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65243554|NCT02623569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65243555|NCT02623569|Adrenergic Agents|adrenergic agents|mesh-ancestor
65243556|NCT02623569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65243557|NCT02623569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243558|NCT00977561|Cisplatin|cisplatin|mesh-list
65243559|NCT00977561|Carboplatin|carboplatin|mesh-list
65243560|NCT00977561|Etoposide|etoposide|mesh-list
65243561|NCT00977561|Etoposide phosphate|etoposide phosphate|mesh-list
65243562|NCT00977561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243563|NCT00977561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65243564|NCT00977561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65243565|NCT00977561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65243566|NCT00977561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243567|NCT00977561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243568|NCT04291313|Vitamin D|vitamin d|mesh-list
65243569|NCT04291313|Ergocalciferols|ergocalciferols|mesh-list
65243570|NCT04291313|Cholecalciferol|cholecalciferol|mesh-list
65243571|NCT04291313|Vitamins|vitamins|mesh-list
65243572|NCT04291313|Micronutrients|micronutrients|mesh-ancestor
65243573|NCT04291313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243574|NCT04291313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65243575|NCT04291313|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65243576|NCT02866253|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65243577|NCT02866253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65243578|NCT02866253|Immunologic Factors|immunologic factors|mesh-ancestor
65243583|NCT02865785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65243591|NCT04049669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65243592|NCT04049669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65243593|NCT04049669|Alkylating Agents|alkylating agents|mesh-ancestor
65243594|NCT04049669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243595|NCT04049669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243596|NCT04049669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65243597|NCT04049669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65243598|NCT04049669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65243599|NCT04049669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65243600|NCT04049669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243601|NCT00594165|Rotigotine|rotigotine|mesh-list
65243602|NCT00594165|Dopamine Agonists|dopamine agonists|mesh-ancestor
65243603|NCT00594165|Dopamine Agents|dopamine agents|mesh-ancestor
65243604|NCT00594165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65243605|NCT00594165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243606|NCT00594165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243607|NCT00928070|Fesoterodine|fesoterodine|mesh-list
65243608|NCT00928070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65243609|NCT00928070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65243610|NCT00928070|Cholinergic Agents|cholinergic agents|mesh-ancestor
65243611|NCT00928070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65243612|NCT00928070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243613|NCT00928070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243614|NCT00928070|Urological Agents|urological agents|mesh-ancestor
65243615|NCT04012073|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
65243616|NCT04012073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65243617|NCT04012073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65243618|NCT04012073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243619|NCT04001621|Capecitabine|capecitabine|mesh-list
65243620|NCT04001621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65243621|NCT04001621|Antimetabolites|antimetabolites|mesh-ancestor
65243622|NCT04001621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243623|NCT04001621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243631|NCT00976937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65243632|NCT00976937|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65243633|NCT00976937|Protease Inhibitors|protease inhibitors|mesh-ancestor
65243634|NCT00976937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243635|NCT00976937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243636|NCT02623023|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
65243637|NCT02623023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65243638|NCT02623023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65243639|NCT02623023|Adrenergic Agents|adrenergic agents|mesh-ancestor
65243640|NCT02623023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65243641|NCT02623023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243642|NCT02623023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243643|NCT02623023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65243644|NCT02623023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65243645|NCT02623023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65243646|NCT04256252|Rituximab|rituximab|mesh-list
65243647|NCT04256252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65243648|NCT04256252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243649|NCT04256252|Immunologic Factors|immunologic factors|mesh-ancestor
65243650|NCT04256252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243651|NCT04256252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65243652|NCT02622555|Mirabegron|mirabegron|mesh-list
65243653|NCT02622555|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65243654|NCT02622555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65243655|NCT02622555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65243656|NCT02622555|Adrenergic Agents|adrenergic agents|mesh-ancestor
65243674|NCT00629447|Anticoagulants|anticoagulants|mesh-ancestor
65243675|NCT00629447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65243676|NCT00629447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65243677|NCT00629447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243678|NCT02622477|Pirfenidone|pirfenidone|mesh-list
65243679|NCT02622477|Analgesics|analgesics|mesh-ancestor
65243680|NCT02622477|Sensory System Agents|sensory system agents|mesh-ancestor
65243681|NCT02622477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65243682|NCT02622477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243683|NCT02622477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65243684|NCT02622477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65243685|NCT02622477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65243686|NCT02622477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65243687|NCT02622477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243688|NCT02622243|Glycopyrrolate|glycopyrrolate|mesh-list
65243689|NCT02622243|Tiotropium Bromide|tiotropium bromide|mesh-list
65243690|NCT02622243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65243691|NCT02622243|Autonomic Agents|autonomic agents|mesh-ancestor
65243692|NCT02622243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65243693|NCT02622243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243728|NCT00696579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243729|NCT00696579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65243730|NCT00696579|Immunologic Factors|immunologic factors|mesh-ancestor
65243731|NCT00696579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243732|NCT02865629|Acetylcysteine|acetylcysteine|mesh-list
65243733|NCT02865629|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65243734|NCT02865629|Antiviral Agents|antiviral agents|mesh-ancestor
65243735|NCT02865629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65243736|NCT02865629|Expectorants|expectorants|mesh-ancestor
65243737|NCT02865629|Respiratory System Agents|respiratory system agents|mesh-ancestor
65243738|NCT02865629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65243739|NCT02865629|Antioxidants|antioxidants|mesh-ancestor
65243740|NCT02865629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243741|NCT02865629|Protective Agents|protective agents|mesh-ancestor
65243742|NCT02865629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243743|NCT02865629|Antidotes|antidotes|mesh-ancestor
65243744|NCT02867345|Cyclophosphamide|cyclophosphamide|mesh-list
65243745|NCT02867345|Interleukin-2|interleukin-2|mesh-list
65243746|NCT02867345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65243747|NCT02867345|Immunologic Factors|immunologic factors|mesh-ancestor
65243748|NCT02867345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243749|NCT02867345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65243750|NCT02867345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65243751|NCT02867345|Alkylating Agents|alkylating agents|mesh-ancestor
65243752|NCT02867345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243753|NCT02867345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243756|NCT02867345|Analgesics|analgesics|mesh-ancestor
65243776|NCT02621385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65243777|NCT02621385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65243778|NCT02621385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65243779|NCT02621385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65243780|NCT02621385|Anesthetics, General|anesthetics, general|mesh-ancestor
65243781|NCT02621385|Anesthetics|anesthetics|mesh-ancestor
65243782|NCT02621385|GABA Modulators|gaba modulators|mesh-ancestor
65243783|NCT02621385|GABA Agents|gaba agents|mesh-ancestor
65243784|NCT02621385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65243785|NCT02621385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243786|NCT00922766|Dalteparin|dalteparin|mesh-list
65243787|NCT00922766|Tinzaparin|tinzaparin|mesh-list
65243788|NCT00922766|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65243789|NCT00922766|Anticoagulants|anticoagulants|mesh-ancestor
65243790|NCT00922766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65243791|NCT00922766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65243792|NCT00922766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243793|NCT04134897|Capecitabine|capecitabine|mesh-list
65243794|NCT04134897|Oxaliplatin|oxaliplatin|mesh-list
65243795|NCT04134897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65243796|NCT04134897|Antimetabolites|antimetabolites|mesh-ancestor
65243797|NCT04134897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243798|NCT04134897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243799|NCT02620995|Sildenafil Citrate|sildenafil citrate|mesh-list
65243800|NCT02620995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243801|NCT02620995|Vasodilator Agents|vasodilator agents|mesh-ancestor
65243802|NCT02620995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65243803|NCT02620995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65243804|NCT02620995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243805|NCT02620995|Urological Agents|urological agents|mesh-ancestor
65243806|NCT02620839|Cisplatin|cisplatin|mesh-list
65243807|NCT02620839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243808|NCT02620605|Cabergoline|cabergoline|mesh-list
65243809|NCT02620605|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65243810|NCT02620605|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64919150|NCT00107848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65243817|NCT00976391|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65243818|NCT00976391|Insulin Glargine|insulin glargine|mesh-list
65243819|NCT00976391|Insulin Lispro|insulin lispro|mesh-list
65243820|NCT00976391|rGLP-1 protein|rglp-1 protein|mesh-list
65243821|NCT00976391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65243822|NCT00976391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243823|NCT00976391|Incretins|incretins|mesh-ancestor
65243824|NCT00976391|Hormones|hormones|mesh-ancestor
65243825|NCT00976391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65243826|NCT04252664|Remdesivir|remdesivir|mesh-list
65243827|NCT04252664|Antimetabolites|antimetabolites|mesh-ancestor
65243828|NCT04252664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243829|NCT04252664|Antiviral Agents|antiviral agents|mesh-ancestor
65243830|NCT04252664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65243831|NCT00696969|Amphotericin B|amphotericin b|mesh-list
65243832|NCT00696969|Paromomycin|paromomycin|mesh-list
65243833|NCT00696969|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65243834|NCT00696969|Miltefosine|miltefosine|mesh-list
65243835|NCT00696969|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
65243836|NCT00696969|Deoxycholic Acid|deoxycholic acid|mesh-list
65243837|NCT00696969|Amebicides|amebicides|mesh-ancestor
65243838|NCT00696969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65243839|NCT00696969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65243840|NCT00696969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65243841|NCT00696969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65243847|NCT04203680|Tryptophan|tryptophan|mesh-list
65243867|NCT02619981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65243868|NCT02619981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65243869|NCT02619981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243870|NCT04859660|Tamsulosin|tamsulosin|mesh-list
65243871|NCT04859660|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65243872|NCT04859660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65243873|NCT04859660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65243874|NCT04859660|Adrenergic Agents|adrenergic agents|mesh-ancestor
65243875|NCT04859660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65243876|NCT04859660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243877|NCT04859660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243878|NCT04859660|Urological Agents|urological agents|mesh-ancestor
65243879|NCT02619669|Letrozole|letrozole|mesh-list
65243880|NCT02619669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243881|NCT02619669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65243882|NCT02619669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65243883|NCT02619669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243884|NCT02619669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243885|NCT02619669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65243886|NCT02619669|Hormone Antagonists|hormone antagonists|mesh-ancestor
65243887|NCT02619669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65243888|NCT02619669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243889|NCT03965117|Norepinephrine|norepinephrine|mesh-list
65243890|NCT03965117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65243891|NCT03965117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64919244|NCT00108511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65243913|NCT02619513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65243914|NCT02619513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65243915|NCT02619513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65243916|NCT02619513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65243917|NCT02619513|Adrenergic Agents|adrenergic agents|mesh-ancestor
65243918|NCT02619513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65243919|NCT02619513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243920|NCT02619513|Anesthetics, Local|anesthetics, local|mesh-ancestor
65243921|NCT02619513|Anesthetics|anesthetics|mesh-ancestor
65243922|NCT03947255|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65243923|NCT03947255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65243924|NCT03947255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243925|NCT02619747|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
65243926|NCT02619747|Antacids|antacids|mesh-ancestor
65243927|NCT02619747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243928|NCT02619747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65243929|NCT00697125|Vaccines|vaccines|mesh-list
65243930|NCT00697125|Immunologic Factors|immunologic factors|mesh-ancestor
65243931|NCT00697125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243932|NCT04134273|Clindamycin|clindamycin|mesh-list
65243933|NCT04134273|Clindamycin palmitate|clindamycin palmitate|mesh-list
65243934|NCT04134273|Clindamycin phosphate|clindamycin phosphate|mesh-list
65243935|NCT04134273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65243936|NCT04134273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65243937|NCT04134273|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65243938|NCT04134273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243939|NCT04134273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243940|NCT03853187|Durvalumab|durvalumab|mesh-list
65243941|NCT03853187|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65243942|NCT03853187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65243943|NCT03853187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243944|NCT03853187|Immunologic Factors|immunologic factors|mesh-ancestor
64919280|NCT03619551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65243949|NCT03849443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243950|NCT03849443|Hemostatics|hemostatics|mesh-ancestor
65243951|NCT03849443|Coagulants|coagulants|mesh-ancestor
65243952|NCT00697281|Indoleacetic Acids|indoleacetic acids|mesh-list
65243953|NCT00697281|Plant Growth Regulators|plant growth regulators|mesh-ancestor
65243954|NCT00697281|Growth Substances|growth substances|mesh-ancestor
65243955|NCT00697281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243956|NCT00979901|Loratadine|loratadine|mesh-list
65243957|NCT00979901|Montelukast|montelukast|mesh-list
65243958|NCT00979901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65243959|NCT00979901|Respiratory System Agents|respiratory system agents|mesh-ancestor
65243960|NCT00979901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65243961|NCT00979901|Hormone Antagonists|hormone antagonists|mesh-ancestor
65243962|NCT00979901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65243963|NCT00979901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243964|NCT00979901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65243965|NCT00979901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65243966|NCT00979901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243967|NCT00979901|Antipruritics|antipruritics|mesh-ancestor
65243968|NCT00979901|Dermatologic Agents|dermatologic agents|mesh-ancestor
65243969|NCT00979901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65244000|NCT00975611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65244001|NCT00975611|Dopamine Agents|dopamine agents|mesh-ancestor
65244002|NCT00975611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65244003|NCT00975611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244004|NCT00975611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244005|NCT00975611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65244006|NCT00975611|Analgesics|analgesics|mesh-ancestor
65244007|NCT00975611|Sensory System Agents|sensory system agents|mesh-ancestor
65244008|NCT00975611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65244009|NCT02865005|Dapsone|dapsone|mesh-list
65244010|NCT02865005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65244011|NCT02865005|Antimalarials|antimalarials|mesh-ancestor
65244012|NCT02865005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65244013|NCT02865005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65244014|NCT02865005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65244015|NCT02865005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244016|NCT02865005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244017|NCT02865005|Leprostatic Agents|leprostatic agents|mesh-ancestor
65244018|NCT02865005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65244019|NCT02862977|Ketoprofen|ketoprofen|mesh-list
65244020|NCT02862977|Amitriptyline|amitriptyline|mesh-list
65244021|NCT02862977|Cyclobenzaprine|cyclobenzaprine|mesh-list
65244022|NCT02862977|Caffeine|caffeine|mesh-list
65244023|NCT02862977|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65244024|NCT02862977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244025|NCT02862977|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65244026|NCT02862977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244027|NCT02862977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244028|NCT02862977|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65244029|NCT02862977|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65244030|NCT02862977|Purinergic Agents|purinergic agents|mesh-ancestor
65244031|NCT02862977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65244032|NCT02862977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65244034|NCT02862977|Analgesics|analgesics|mesh-ancestor
65244040|NCT02862977|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65244041|NCT02862977|Antidepressive Agents|antidepressive agents|mesh-ancestor
65244042|NCT02862977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65244043|NCT02862977|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65244044|NCT02862977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65244045|NCT02862977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65244046|NCT02862977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65244047|NCT02862977|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65244048|NCT02862977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65244049|NCT02862977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65244050|NCT02862977|Adrenergic Agents|adrenergic agents|mesh-ancestor
65244052|NCT02864927|Immunologic Factors|immunologic factors|mesh-ancestor
65244053|NCT02864927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244054|NCT02618499|Oxytocin|oxytocin|mesh-list
65244055|NCT02618499|Oxytocics|oxytocics|mesh-ancestor
65244056|NCT02618499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65244057|NCT02618499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244058|NCT04133961|Phenylephrine|phenylephrine|mesh-list
65244059|NCT04133961|Oxymetazoline|oxymetazoline|mesh-list
65244060|NCT04133961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65244061|NCT04133961|Mydriatics|mydriatics|mesh-ancestor
65244062|NCT04133961|Autonomic Agents|autonomic agents|mesh-ancestor
65244063|NCT04133961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65244064|NCT04133961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244065|NCT04133961|Sympathomimetics|sympathomimetics|mesh-ancestor
65244066|NCT04133961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65244067|NCT04133961|Nasal Decongestants|nasal decongestants|mesh-ancestor
65244087|NCT00970307|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65244088|NCT00970307|Immunologic Factors|immunologic factors|mesh-ancestor
65244089|NCT00970307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244090|NCT00917384|Ramucirumab|ramucirumab|mesh-list
65244091|NCT00917384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244092|NCT04133571|Lidocaine|lidocaine|mesh-list
65244093|NCT04133571|Anesthetics, Local|anesthetics, local|mesh-ancestor
65244094|NCT04133571|Anesthetics|anesthetics|mesh-ancestor
65244095|NCT04133571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65244096|NCT04133571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244097|NCT04133571|Sensory System Agents|sensory system agents|mesh-ancestor
65244098|NCT04133571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65244099|NCT04133571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65244100|NCT04133571|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65244101|NCT04133571|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65244102|NCT04133571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65244103|NCT04133571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244104|NCT00629681|Pregabalin|pregabalin|mesh-list
65244105|NCT00629681|Analgesics|analgesics|mesh-ancestor
65244106|NCT00629681|Sensory System Agents|sensory system agents|mesh-ancestor
65244107|NCT00629681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65244108|NCT00629681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244109|NCT00629681|Anticonvulsants|anticonvulsants|mesh-ancestor
65244110|NCT00629681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65244111|NCT00629681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65244112|NCT00629681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244113|NCT00629681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65244114|NCT00629681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65244115|NCT00629681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65244118|NCT02617485|Prednisone|prednisone|mesh-list
65244129|NCT02617485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244130|NCT02617485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244131|NCT02617485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65244132|NCT02617485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65244133|NCT02617485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65244134|NCT02617485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65244135|NCT02617485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65244136|NCT02617485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244137|NCT02617485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65244138|NCT02617485|Glucocorticoids|glucocorticoids|mesh-ancestor
65244139|NCT02617485|Hormones|hormones|mesh-ancestor
65244140|NCT02617485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65244141|NCT02617485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65244142|NCT02617485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65244143|NCT02617485|Tubulin Modulators|tubulin modulators|mesh-ancestor
65244144|NCT02617485|Antimitotic Agents|antimitotic agents|mesh-ancestor
65244145|NCT02617485|Mitosis Modulators|mitosis modulators|mesh-ancestor
65244146|NCT04289207|Danazol|danazol|mesh-list
65244147|NCT04289207|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65244148|NCT04289207|Hormone Antagonists|hormone antagonists|mesh-ancestor
65244149|NCT04289207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65244150|NCT04289207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244151|NCT02863835|Albuterol|albuterol|mesh-list
65244152|NCT02863835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65244153|NCT02863835|Autonomic Agents|autonomic agents|mesh-ancestor
65244154|NCT02863835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65244155|NCT02863835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244156|NCT02863835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65244157|NCT02863835|Respiratory System Agents|respiratory system agents|mesh-ancestor
65244158|NCT02863835|Tocolytic Agents|tocolytic agents|mesh-ancestor
65244159|NCT02863835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65244160|NCT02863835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65244168|NCT00697437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244169|NCT00697437|Tubulin Modulators|tubulin modulators|mesh-ancestor
65244170|NCT00697437|Antimitotic Agents|antimitotic agents|mesh-ancestor
65244171|NCT00697437|Mitosis Modulators|mitosis modulators|mesh-ancestor
65244172|NCT00697437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244173|NCT00697437|Antifungal Agents|antifungal agents|mesh-ancestor
65244174|NCT00697437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65244175|NCT00697437|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65244176|NCT00697437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65244177|NCT00697437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244178|NCT00697437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65244179|NCT00697437|Hormone Antagonists|hormone antagonists|mesh-ancestor
65244180|NCT00697437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65244181|NCT00697437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244182|NCT00697437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65244183|NCT04252274|Darunavir|darunavir|mesh-list
65244184|NCT04252274|Cobicistat|cobicistat|mesh-list
65244185|NCT04252274|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
65244186|NCT04252274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65244187|NCT04252274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65244188|NCT04252274|Protease Inhibitors|protease inhibitors|mesh-ancestor
65244189|NCT04252274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244190|NCT04252274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244216|NCT04251962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65244217|NCT04251962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65244218|NCT04251962|Narcotics|narcotics|mesh-ancestor
65244219|NCT04251962|Analgesics|analgesics|mesh-ancestor
65244220|NCT04251962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65244221|NCT04251962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65244222|NCT04251962|Anesthetics, General|anesthetics, general|mesh-ancestor
65244223|NCT04255238|Dapagliflozin|dapagliflozin|mesh-list
65244224|NCT04255238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65244225|NCT04255238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244226|NCT04255238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65244227|NCT04255238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244228|NCT04250948|Capecitabine|capecitabine|mesh-list
65244229|NCT04250948|Oxaliplatin|oxaliplatin|mesh-list
65244230|NCT04250948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65244231|NCT04250948|Antimetabolites|antimetabolites|mesh-ancestor
65244232|NCT04250948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244233|NCT04250948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244234|NCT05251766|Paclitaxel|paclitaxel|mesh-list
65244235|NCT05251766|Docetaxel|docetaxel|mesh-list
65244236|NCT05251766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65244237|NCT05251766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244238|NCT05251766|Tubulin Modulators|tubulin modulators|mesh-ancestor
65244239|NCT05251766|Antimitotic Agents|antimitotic agents|mesh-ancestor
65244240|NCT05251766|Mitosis Modulators|mitosis modulators|mesh-ancestor
65244241|NCT05251766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244242|NCT04254380|Insulin Lispro|insulin lispro|mesh-list
65244243|NCT04254380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65244244|NCT04254380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244245|NCT00631514|Acetaminophen|acetaminophen|mesh-list
65244261|NCT04623944|Cyclophosphamide|cyclophosphamide|mesh-list
65244262|NCT04623944|Fludarabine|fludarabine|mesh-list
65244263|NCT04623944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65244264|NCT04623944|Immunologic Factors|immunologic factors|mesh-ancestor
65244265|NCT04623944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244266|NCT04623944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65244267|NCT04623944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65244268|NCT04623944|Alkylating Agents|alkylating agents|mesh-ancestor
65244269|NCT04623944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244270|NCT04623944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244271|NCT04623944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65244272|NCT04623944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65244273|NCT04623944|Antimetabolites|antimetabolites|mesh-ancestor
65244274|NCT04623944|Antiviral Agents|antiviral agents|mesh-ancestor
65244275|NCT04623944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65244276|NCT05253014|Acetaminophen|acetaminophen|mesh-list
65244321|NCT00803725|Sensory System Agents|sensory system agents|mesh-ancestor
65244322|NCT00803725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65244323|NCT00803725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65244324|NCT00803725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65244325|NCT00803725|Anesthetics, General|anesthetics, general|mesh-ancestor
65244326|NCT00803725|Anesthetics|anesthetics|mesh-ancestor
65244327|NCT00803725|Anesthetics, Local|anesthetics, local|mesh-ancestor
65244328|NCT00803803|Pilocarpine|pilocarpine|mesh-list
65244329|NCT00803803|Miotics|miotics|mesh-ancestor
65244330|NCT00803803|Autonomic Agents|autonomic agents|mesh-ancestor
65244331|NCT00803803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65244332|NCT00803803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244333|NCT00803803|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65244334|NCT00803803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65244335|NCT00803803|Cholinergic Agents|cholinergic agents|mesh-ancestor
65244336|NCT00803803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65244337|NCT00803803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244338|NCT04775329|Rifaximin|rifaximin|mesh-list
65244339|NCT04775329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65244340|NCT04775329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65244341|NCT04775329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65244342|NCT00659269|Vitamins|vitamins|mesh-list
65244343|NCT00659269|Vitamin B 12|vitamin b 12|mesh-list
65244344|NCT00659269|Vitamin B 6|vitamin b 6|mesh-list
65244345|NCT00659269|Pyridoxal|pyridoxal|mesh-list
65244346|NCT00659269|Pyridoxine|pyridoxine|mesh-list
65244347|NCT00659269|Vitamin B Complex|vitamin b complex|mesh-list
65244348|NCT00659269|Vincristine|vincristine|mesh-list
65244349|NCT00659269|Vinorelbine|vinorelbine|mesh-list
65244351|NCT00659269|Cisplatin|cisplatin|mesh-list
65244352|NCT00659269|Oxaliplatin|oxaliplatin|mesh-list
65244372|NCT00922129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65244373|NCT00922129|Dermatologic Agents|dermatologic agents|mesh-ancestor
65244374|NCT00922129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65244375|NCT00922129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65244376|NCT00922129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65244377|NCT00922129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244378|NCT00806299|Loperamide|loperamide|mesh-list
65244379|NCT00806299|Antidiarrheals|antidiarrheals|mesh-list
65244380|NCT00806299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65244381|NCT00804115|Timolol|timolol|mesh-list
65244382|NCT00804115|Latanoprost|latanoprost|mesh-list
65244383|NCT00804115|Pilocarpine|pilocarpine|mesh-list
65244384|NCT00804115|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65244385|NCT00804115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65244386|NCT00804115|Adrenergic Agents|adrenergic agents|mesh-ancestor
65244387|NCT00804115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65244388|NCT00804115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244389|NCT00804115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244392|NCT00804115|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65244431|NCT00804271|Dopamine Agents|dopamine agents|mesh-ancestor
65244432|NCT00804271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65244433|NCT00804271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244434|NCT00804271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244435|NCT00804271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65244436|NCT00804271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65244437|NCT00799201|Naloxone|naloxone|mesh-list
65244438|NCT00799201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65244439|NCT00799201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244440|NCT00799201|Sensory System Agents|sensory system agents|mesh-ancestor
65244441|NCT00799201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65244442|NCT00806611|Ethanol|ethanol|mesh-list
65244443|NCT00806611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65244444|NCT00806611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65244445|NCT00806611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65244446|NCT00806611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244447|NCT00799513|Lenalidomide|lenalidomide|mesh-list
65244448|NCT00799513|Immunologic Factors|immunologic factors|mesh-ancestor
65244449|NCT00799513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244450|NCT00799513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65244451|NCT00799513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65244483|NCT00863655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65244484|NCT00863655|Hormone Antagonists|hormone antagonists|mesh-ancestor
65244485|NCT00863655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65244486|NCT00806923|Gemcitabine|gemcitabine|mesh-list
65244487|NCT00806923|Bevacizumab|bevacizumab|mesh-list
65244488|NCT00806923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65244489|NCT00806923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244490|NCT00806923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65244491|NCT00806923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65244492|NCT00806923|Growth Substances|growth substances|mesh-ancestor
65244493|NCT00806923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244494|NCT00806923|Growth Inhibitors|growth inhibitors|mesh-ancestor
65244495|NCT00806923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65244496|NCT00806923|Antimetabolites|antimetabolites|mesh-ancestor
65244497|NCT00806923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244498|NCT00806923|Antiviral Agents|antiviral agents|mesh-ancestor
65244499|NCT00806923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65244500|NCT00806923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244505|NCT00698607|Clopidogrel|clopidogrel|mesh-list
65244506|NCT00698607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244507|NCT00698607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65244539|NCT00698763|Vasodilator Agents|vasodilator agents|mesh-ancestor
65244540|NCT00698763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65244541|NCT00698763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65244542|NCT00698763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244543|NCT00698763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244544|NCT00698763|Protective Agents|protective agents|mesh-ancestor
65244545|NCT00698763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244546|NCT00804895|Cortivazol|cortivazol|mesh-list
65244547|NCT00804895|Verapamil|verapamil|mesh-list
65244548|NCT00804895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65244549|NCT00804895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65244550|NCT00804895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65244551|NCT00804895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244552|NCT00804895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65244553|NCT00804895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244554|NCT00804895|Vasodilator Agents|vasodilator agents|mesh-ancestor
65244555|NCT00804895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65244556|NCT00800137|Heparin|heparin|mesh-list
65244557|NCT00800137|Calcium heparin|calcium heparin|mesh-list
65244558|NCT00800137|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65244559|NCT00800137|Tinzaparin|tinzaparin|mesh-list
65244560|NCT00800137|Dalteparin|dalteparin|mesh-list
65244561|NCT00800137|Warfarin|warfarin|mesh-list
65244562|NCT00800137|Anticoagulants|anticoagulants|mesh-ancestor
65244563|NCT00800137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65244564|NCT00800137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65244566|NCT00807079|Carboplatin|carboplatin|mesh-list
65244597|NCT00658021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65244598|NCT00920816|Sorafenib|sorafenib|mesh-list
65244599|NCT00920816|Axitinib|axitinib|mesh-list
65244600|NCT00920816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244601|NCT00920816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65244602|NCT00920816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244603|NCT00920816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244604|NCT00631592|Dolutegravir|dolutegravir|mesh-list
65244605|NCT00631592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65244606|NCT00631592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65244607|NCT00631592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244608|NCT00631592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244609|NCT00631592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65244610|NCT00631592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65244611|NCT00631592|Antiviral Agents|antiviral agents|mesh-ancestor
65244612|NCT00631592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65244613|NCT05251610|Propranolol|propranolol|mesh-list
65244614|NCT05251610|Oxytocin|oxytocin|mesh-list
65244615|NCT05251610|Oxytocics|oxytocics|mesh-ancestor
65244616|NCT05251610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65244617|NCT05251610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244618|NCT05251610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65244619|NCT05251610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65244620|NCT05251610|Adrenergic Agents|adrenergic agents|mesh-ancestor
65244621|NCT05251610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65244648|NCT00800527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65244649|NCT00800527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65244650|NCT00800527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64994918|NCT02959762|Vitamins|vitamins|mesh-list
65244651|NCT00800527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65244652|NCT00800527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244653|NCT00800527|Antimanic Agents|antimanic agents|mesh-ancestor
65244654|NCT00800527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65244655|NCT00800527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65244656|NCT00800527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65244657|NCT00800527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65244658|NCT00800527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65244659|NCT00800527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244660|NCT00862719|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65244661|NCT00862719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65244662|NCT00862719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244663|NCT00862719|Incretins|incretins|mesh-ancestor
65244664|NCT00862719|Hormones|hormones|mesh-ancestor
65244665|NCT00862719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65244666|NCT00862719|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65244667|NCT00862719|Protease Inhibitors|protease inhibitors|mesh-ancestor
65244668|NCT00862719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244669|NCT00862719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244670|NCT04120779|Sulfamethazine|sulfamethazine|mesh-list
65244671|NCT04120779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65244672|NCT00862641|Regadenoson|regadenoson|mesh-list
65244673|NCT00862641|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65244692|NCT04119921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244693|NCT04119921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244694|NCT04119921|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65244695|NCT04119921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65244696|NCT00861471|Docetaxel|docetaxel|mesh-list
65244697|NCT00861471|Imatinib Mesylate|imatinib mesylate|mesh-list
65244698|NCT00861471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244699|NCT00861471|Tubulin Modulators|tubulin modulators|mesh-ancestor
65244700|NCT00861471|Antimitotic Agents|antimitotic agents|mesh-ancestor
65244701|NCT00861471|Mitosis Modulators|mitosis modulators|mesh-ancestor
65244702|NCT00861471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244703|NCT00861471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65244704|NCT00861471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244705|NCT02613585|Permethrin|permethrin|mesh-list
65244706|NCT02613585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244707|NCT02613585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244708|NCT04119297|Heparinoids|heparinoids|mesh-list
65244709|NCT04119297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65244710|NCT04119297|Anticoagulants|anticoagulants|mesh-ancestor
65244711|NCT00699387|Benzonidazole|benzonidazole|mesh-list
65244712|NCT00699387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65244713|NCT00699387|Immunologic Factors|immunologic factors|mesh-ancestor
65244714|NCT00699387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244715|NCT00699387|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65244716|NCT00699387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65244717|NCT00699387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65244718|NCT00699387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65244719|NCT00699465|Enoxaparin|enoxaparin|mesh-list
65244720|NCT00699465|Enoxaparin sodium|enoxaparin sodium|mesh-list
65244721|NCT00699465|Anticoagulants|anticoagulants|mesh-ancestor
65244725|NCT00858117|Rituximab|rituximab|mesh-list
65244738|NCT00700947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244739|NCT00700947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65244740|NCT00700947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65244741|NCT00700947|Sympatholytics|sympatholytics|mesh-ancestor
65244742|NCT00700947|Autonomic Agents|autonomic agents|mesh-ancestor
65244743|NCT00700947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65244744|NCT00700947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65244745|NCT00652951|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65244746|NCT00652951|Immunologic Factors|immunologic factors|mesh-ancestor
65244747|NCT00652951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244748|NCT04116255|Salicylic Acid|salicylic acid|mesh-list
65244749|NCT04116255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65244750|NCT04116255|Antifungal Agents|antifungal agents|mesh-ancestor
65244751|NCT04116255|Keratolytic Agents|keratolytic agents|mesh-ancestor
65244752|NCT04116255|Dermatologic Agents|dermatologic agents|mesh-ancestor
65244753|NCT00805519|Chloroquine|chloroquine|mesh-list
65244754|NCT00805519|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65244755|NCT00805519|Prednisolone|prednisolone|mesh-list
65244756|NCT00805519|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65244757|NCT00805519|Methylprednisolone|methylprednisolone|mesh-list
65244758|NCT00805519|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65244759|NCT00805519|Prednisolone acetate|prednisolone acetate|mesh-list
65244760|NCT00805519|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65244761|NCT00805519|Prednisolone phosphate|prednisolone phosphate|mesh-list
65244790|NCT00592683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65244791|NCT00592683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65244792|NCT00592683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65244793|NCT00592683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65244794|NCT00592683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244795|NCT00592683|Dopamine Agonists|dopamine agonists|mesh-ancestor
65244796|NCT00592683|Dopamine Agents|dopamine agents|mesh-ancestor
65244797|NCT00592683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65244798|NCT00592683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244799|NCT00592683|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65244800|NCT00592683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65244801|NCT00592683|Serotonin Agents|serotonin agents|mesh-ancestor
65244802|NCT00592683|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65244803|NCT00592683|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65244804|NCT00592683|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65244805|NCT00592683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65244806|NCT02613039|Contraceptive Agents|contraceptive agents|mesh-list
65244807|NCT02613039|Contraceptives, Oral|contraceptives, oral|mesh-list
65244808|NCT02613039|Estrogens|estrogens|mesh-list
65244809|NCT02613039|Progestins|progestins|mesh-list
65244810|NCT02613039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65244811|NCT02613039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244812|NCT02613039|Hormones|hormones|mesh-ancestor
65244813|NCT02613039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65244814|NCT02613039|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65244815|NCT00813475|Insulin|insulin|mesh-list
65244816|NCT00813475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65244817|NCT00813475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65244818|NCT00813475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244819|NCT00701259|Lansoprazole|lansoprazole|mesh-list
65244834|NCT00701337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65244835|NCT00701337|Contraceptive Agents|contraceptive agents|mesh-ancestor
65244836|NCT00701337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65244837|NCT00701337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65244838|NCT00654901|Vaccines|vaccines|mesh-list
65244839|NCT00654901|Immunologic Factors|immunologic factors|mesh-ancestor
65244840|NCT00654901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244841|NCT00701493|Topiramate|topiramate|mesh-list
65244842|NCT00701493|Anticonvulsants|anticonvulsants|mesh-ancestor
65244843|NCT00701493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65244844|NCT00701493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244845|NCT04253678|Vortioxetine|vortioxetine|mesh-list
65244846|NCT04253678|Antidepressive Agents|antidepressive agents|mesh-ancestor
65244847|NCT04253678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65244848|NCT04253678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65244849|NCT04253678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65244850|NCT04253678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65244851|NCT04253678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244852|NCT04253678|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65244853|NCT04253678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65244854|NCT04253678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65244855|NCT04253678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244856|NCT04253678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65244857|NCT04253678|Serotonin Agents|serotonin agents|mesh-ancestor
65244858|NCT04253678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65244859|NCT04253678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65244860|NCT04253678|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65244861|NCT04253678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65244862|NCT00813631|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65244863|NCT00813631|Laxatives|laxatives|mesh-ancestor
65244864|NCT00813631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65244865|NCT02551861|Ribavirin|ribavirin|mesh-list
65244876|NCT00846495|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65244877|NCT00846495|Serotonin Agents|serotonin agents|mesh-ancestor
65244878|NCT00846495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65244879|NCT00846495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244880|NCT00654745|Amlodipine|amlodipine|mesh-list
65244881|NCT00654745|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65244882|NCT00654745|Olmesartan|olmesartan|mesh-list
65244883|NCT00654745|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65244884|NCT00654745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65244885|NCT00654745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65244886|NCT00654745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65244887|NCT00654745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244888|NCT00654745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65244889|NCT00654745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244890|NCT00654745|Vasodilator Agents|vasodilator agents|mesh-ancestor
65244891|NCT00654745|Diuretics|diuretics|mesh-ancestor
65244892|NCT00654745|Natriuretic Agents|natriuretic agents|mesh-ancestor
65244893|NCT00654745|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65244894|NCT00654745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65244895|NCT00654745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65244896|NCT00809887|Micafungin|micafungin|mesh-list
65244897|NCT00809887|Antifungal Agents|antifungal agents|mesh-ancestor
65244928|NCT00807625|Contraceptive Agents|contraceptive agents|mesh-ancestor
65244929|NCT00807625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65244930|NCT00807625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65244931|NCT00807625|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65244932|NCT00807625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65244933|NCT00807625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65244934|NCT00807625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65244935|NCT00807625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65244936|NCT00807625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65244937|NCT02551549|Rezafungin|rezafungin|mesh-list
65244938|NCT02551549|Antifungal Agents|antifungal agents|mesh-ancestor
65244939|NCT02551549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65244940|NCT00810121|Ketoprofen|ketoprofen|mesh-list
65244941|NCT00810121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65244942|NCT00810121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65244943|NCT00810121|Analgesics|analgesics|mesh-ancestor
65244944|NCT00810121|Sensory System Agents|sensory system agents|mesh-ancestor
65244945|NCT00810121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65244946|NCT00810121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244947|NCT00810121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65244948|NCT00810121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65244949|NCT00810121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65244950|NCT00810121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244951|NCT00810121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244952|NCT00652327|Atorvastatin|atorvastatin|mesh-list
65244953|NCT00652327|Simvastatin|simvastatin|mesh-list
65244954|NCT00652327|Ezetimibe|ezetimibe|mesh-list
65244955|NCT00652327|Pravastatin|pravastatin|mesh-list
65244956|NCT00652327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65244957|NCT00652327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65244958|NCT00652327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65244971|NCT00814021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65244972|NCT00814021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65244973|NCT00645853|Warfarin|warfarin|mesh-list
65244974|NCT00645853|Anticoagulants|anticoagulants|mesh-ancestor
65244975|NCT00652093|Acetaminophen|acetaminophen|mesh-list
65244976|NCT00652093|Oxymorphone|oxymorphone|mesh-list
65244977|NCT00652093|Acetaminophen, dextropropoxyphene, drug combination|acetaminophen, dextropropoxyphene, drug combination|mesh-list
65244978|NCT00652093|Dextropropoxyphene|dextropropoxyphene|mesh-list
65244979|NCT00652093|Levopropoxyphene|levopropoxyphene|mesh-list
65244980|NCT00652093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65244981|NCT00652093|Analgesics|analgesics|mesh-ancestor
65244982|NCT00652093|Sensory System Agents|sensory system agents|mesh-ancestor
65244983|NCT00652093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65244984|NCT00652093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65244985|NCT00652093|Antipyretics|antipyretics|mesh-ancestor
65244986|NCT00652093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65244987|NCT00652093|Narcotics|narcotics|mesh-ancestor
65244988|NCT00652093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65244989|NCT00652093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65244990|NCT00652093|Antitussive Agents|antitussive agents|mesh-ancestor
65244991|NCT00652093|Respiratory System Agents|respiratory system agents|mesh-ancestor
65244992|NCT00651937|Melphalan|melphalan|mesh-list
65244993|NCT00651937|Lenograstim|lenograstim|mesh-list
65244995|NCT00651937|Alkylating Agents|alkylating agents|mesh-ancestor
65245022|NCT00808171|Lidocaine|lidocaine|mesh-list
65245023|NCT00808171|Nitrous Oxide|nitrous oxide|mesh-list
65245024|NCT00808171|Anesthetics, Local|anesthetics, local|mesh-list
65245025|NCT00808171|Prilocaine|prilocaine|mesh-list
65245026|NCT00808171|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65245027|NCT00808171|Anesthetics|anesthetics|mesh-list
65245028|NCT00808171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65245029|NCT00808171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245030|NCT00808171|Sensory System Agents|sensory system agents|mesh-ancestor
65245031|NCT00808171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65245032|NCT00808171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65245033|NCT00808171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65245034|NCT00808171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65245035|NCT00808171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65245036|NCT00808171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245037|NCT00808171|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65245038|NCT00808171|Anesthetics, General|anesthetics, general|mesh-ancestor
65245039|NCT00808171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65245040|NCT00808171|Analgesics|analgesics|mesh-ancestor
65245042|NCT04703257|Dipyrone|dipyrone|mesh-list
65245078|NCT02864849|Capecitabine|capecitabine|mesh-list
65245079|NCT02864849|Oxaliplatin|oxaliplatin|mesh-list
65245080|NCT02864849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65245081|NCT02864849|Antimetabolites|antimetabolites|mesh-ancestor
65245082|NCT02864849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245083|NCT02864849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245084|NCT00701961|Artesunate|artesunate|mesh-list
65245085|NCT00701961|Mefloquine|mefloquine|mesh-list
65245086|NCT00701961|Antimalarials|antimalarials|mesh-ancestor
65245087|NCT00701961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65245088|NCT00701961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65245089|NCT00701961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65245090|NCT00701961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245091|NCT00701961|Antiviral Agents|antiviral agents|mesh-ancestor
65245092|NCT00701961|Schistosomicides|schistosomicides|mesh-ancestor
65245093|NCT00701961|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65245094|NCT00701961|Anthelmintics|anthelmintics|mesh-ancestor
65245095|NCT04286711|Paclitaxel|paclitaxel|mesh-list
65245096|NCT04286711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65245097|NCT04286711|Apatinib|apatinib|mesh-list
65245098|NCT04286711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65245099|NCT04286711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245100|NCT04286711|Tubulin Modulators|tubulin modulators|mesh-ancestor
65245101|NCT04286711|Antimitotic Agents|antimitotic agents|mesh-ancestor
65245102|NCT04286711|Mitosis Modulators|mitosis modulators|mesh-ancestor
65245103|NCT04286711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245104|NCT04286711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65245105|NCT04286711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65245106|NCT02863913|Cyclophosphamide|cyclophosphamide|mesh-list
65245107|NCT02863913|Interleukin-2|interleukin-2|mesh-list
65245108|NCT02863913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65245109|NCT02863913|Immunologic Factors|immunologic factors|mesh-ancestor
65245110|NCT02863913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245111|NCT02863913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65245112|NCT02863913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65245113|NCT02863913|Alkylating Agents|alkylating agents|mesh-ancestor
65245119|NCT02863913|Sensory System Agents|sensory system agents|mesh-ancestor
65245120|NCT02863913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65245122|NCT02612649|Antiemetics|antiemetics|mesh-ancestor
65245123|NCT02612649|Autonomic Agents|autonomic agents|mesh-ancestor
65245124|NCT02612649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65245125|NCT02612649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245126|NCT02612649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65245127|NCT02612649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65245128|NCT02612649|Serotonin Agents|serotonin agents|mesh-ancestor
65245129|NCT02612649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65245130|NCT02612649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245131|NCT04908800|Itraconazole|itraconazole|mesh-list
65245132|NCT04908800|Antifungal Agents|antifungal agents|mesh-ancestor
65245133|NCT04908800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65245134|NCT04908800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65245135|NCT04908800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65245136|NCT04908800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65245137|NCT04908800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245138|NCT04908800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65245139|NCT04908800|Hormone Antagonists|hormone antagonists|mesh-ancestor
65245140|NCT04908800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65245141|NCT04908800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245142|NCT04908800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65245143|NCT00844857|Olanzapine|olanzapine|mesh-list
65245144|NCT00844857|Fluoxetine|fluoxetine|mesh-list
65245166|NCT00702117|Procainamide|procainamide|mesh-list
65245167|NCT00702117|Ajmaline|ajmaline|mesh-list
65245168|NCT00702117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65245169|NCT00702117|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65245170|NCT00702117|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65245171|NCT00702117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65245172|NCT00702117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245173|NCT00913107|Lamotrigine|lamotrigine|mesh-list
65245174|NCT00913107|Carbamazepine|carbamazepine|mesh-list
65245175|NCT00913107|Anticonvulsants|anticonvulsants|mesh-list
65245176|NCT00913107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65245177|NCT00913107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64995437|NCT00091286|Immunologic Factors|immunologic factors|mesh-ancestor
65245178|NCT00913107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245179|NCT00913107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65245180|NCT00913107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245181|NCT00913107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65245182|NCT00913107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65245183|NCT00913107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65245184|NCT00913107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65245185|NCT00913107|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65245186|NCT00913107|Antimanic Agents|antimanic agents|mesh-ancestor
65245187|NCT00913107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65245188|NCT00913107|Analgesics|analgesics|mesh-ancestor
65245189|NCT00913107|Sensory System Agents|sensory system agents|mesh-ancestor
65245190|NCT00913107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65245191|NCT00913107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65245192|NCT00913107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65245193|NCT00569803|Abatacept|abatacept|mesh-list
65245194|NCT00569803|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65245195|NCT00569803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245205|NCT00920426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245206|NCT00920426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65245207|NCT00920426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65245208|NCT00920426|Antiviral Agents|antiviral agents|mesh-ancestor
65245209|NCT00920426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65245210|NCT04046185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65245211|NCT04046185|Progesterone|progesterone|mesh-list
65245212|NCT04046185|Progestins|progestins|mesh-ancestor
65245213|NCT04046185|Hormones|hormones|mesh-ancestor
65245214|NCT04046185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65245215|NCT04046185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245216|NCT04046185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245217|NCT04046185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245218|NCT00810589|Insulin|insulin|mesh-list
65245219|NCT00810589|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65245220|NCT00810589|Insulin Lispro|insulin lispro|mesh-list
65245221|NCT00810589|Insulin Detemir|insulin detemir|mesh-list
65245222|NCT00810589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65245223|NCT00810589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245224|NCT04253132|Tolfenamic acid|tolfenamic acid|mesh-list
65245225|NCT04253132|Analgesics|analgesics|mesh-ancestor
65245226|NCT04253132|Sensory System Agents|sensory system agents|mesh-ancestor
65245227|NCT04253132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65245228|NCT04253132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245254|NCT00815269|Enflurane|enflurane|mesh-list
65245255|NCT00815269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65245256|NCT00815269|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65245257|NCT00815269|Anesthetics, General|anesthetics, general|mesh-ancestor
65245258|NCT00815269|Anesthetics|anesthetics|mesh-ancestor
65245259|NCT00815269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65245260|NCT00815269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245261|NCT00914810|Vitamin D|vitamin d|mesh-list
65245262|NCT00914810|Cholecalciferol|cholecalciferol|mesh-list
65245263|NCT00914810|Vitamins|vitamins|mesh-ancestor
65245264|NCT00914810|Micronutrients|micronutrients|mesh-ancestor
65245265|NCT00914810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245266|NCT00914810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65245267|NCT00914810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65245268|NCT00808717|Atorvastatin|atorvastatin|mesh-list
65245269|NCT00808717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65245270|NCT00808717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65245271|NCT00808717|Antimetabolites|antimetabolites|mesh-ancestor
65245272|NCT00808717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245273|NCT00808717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65245274|NCT00808717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65245275|NCT00808717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65245276|NCT00914732|Vaccines|vaccines|mesh-list
65245277|NCT00914732|Immunologic Factors|immunologic factors|mesh-ancestor
65245278|NCT00914732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245279|NCT00844545|Eculizumab|eculizumab|mesh-list
65245280|NCT00844545|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65245302|NCT00702819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65245303|NCT00702819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245304|NCT00702819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65245305|NCT00702819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65245306|NCT00702819|Growth Substances|growth substances|mesh-ancestor
65245307|NCT00702819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245308|NCT00702819|Growth Inhibitors|growth inhibitors|mesh-ancestor
65245309|NCT00650845|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
65245310|NCT00650845|Chelating Agents|chelating agents|mesh-ancestor
65245311|NCT00650845|Sequestering Agents|sequestering agents|mesh-ancestor
65245312|NCT00650845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245313|NCT00842985|Dronabinol|dronabinol|mesh-list
65245314|NCT00842985|Modafinil|modafinil|mesh-list
65245315|NCT00842985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65245316|NCT00842985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245317|NCT00842985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65245318|NCT00842985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65245319|NCT00842985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65245320|NCT00842985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245321|NCT00842985|Hallucinogens|hallucinogens|mesh-ancestor
65245322|NCT00842985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65245323|NCT00842985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65245324|NCT00842985|Analgesics|analgesics|mesh-ancestor
65245325|NCT00842985|Sensory System Agents|sensory system agents|mesh-ancestor
65245326|NCT00842985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65245327|NCT00842985|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65245330|NCT00842985|Hormones|hormones|mesh-ancestor
65245347|NCT00808951|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65245348|NCT00808951|Amodiaquine|amodiaquine|mesh-list
65245349|NCT00808951|Antimalarials|antimalarials|mesh-ancestor
65245350|NCT00808951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65245351|NCT00808951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65245352|NCT00808951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65245353|NCT00808951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245354|NCT00808951|Antiviral Agents|antiviral agents|mesh-ancestor
65245355|NCT00808951|Schistosomicides|schistosomicides|mesh-ancestor
65245356|NCT00808951|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65245357|NCT00808951|Anthelmintics|anthelmintics|mesh-ancestor
65245358|NCT00809029|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
65245359|NCT00809029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65245360|NCT00809029|Incretins|incretins|mesh-ancestor
65245361|NCT00809029|Hormones|hormones|mesh-ancestor
65245362|NCT00809029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65245363|NCT00809029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245364|NCT00842829|Fentanyl|fentanyl|mesh-list
65245365|NCT00842829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65245366|NCT00842829|Narcotics|narcotics|mesh-ancestor
65245367|NCT00842829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65245368|NCT00842829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245401|NCT00811369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245402|NCT00842361|Insulin|insulin|mesh-list
65245403|NCT00842361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65245404|NCT00842361|Insulin Aspart|insulin aspart|mesh-list
65245405|NCT00842361|Insulin, Long-Acting|insulin, long-acting|mesh-list
65245406|NCT00842361|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65245407|NCT00842361|Biphasic Insulins|biphasic insulins|mesh-list
65245408|NCT00842361|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65245409|NCT00842361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65245410|NCT00842361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245411|NCT00811447|Docetaxel|docetaxel|mesh-list
65245412|NCT00811447|Fluorouracil|fluorouracil|mesh-list
65245413|NCT00811447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245414|NCT00811447|Tubulin Modulators|tubulin modulators|mesh-ancestor
65245415|NCT00811447|Antimitotic Agents|antimitotic agents|mesh-ancestor
65245416|NCT00811447|Mitosis Modulators|mitosis modulators|mesh-ancestor
65245417|NCT00811447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245418|NCT00811447|Antimetabolites|antimetabolites|mesh-ancestor
65245419|NCT00811447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65245420|NCT00811447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65245421|NCT00811447|Immunologic Factors|immunologic factors|mesh-ancestor
65245422|NCT00811447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245423|NCT00702975|Paclitaxel|paclitaxel|mesh-list
65245424|NCT00702975|Bevacizumab|bevacizumab|mesh-list
65245425|NCT00702975|Carboplatin|carboplatin|mesh-list
65245426|NCT00702975|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65245427|NCT00702975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65245428|NCT00702975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245429|NCT00702975|Tubulin Modulators|tubulin modulators|mesh-ancestor
65245430|NCT00702975|Antimitotic Agents|antimitotic agents|mesh-ancestor
65245431|NCT00702975|Mitosis Modulators|mitosis modulators|mesh-ancestor
65245432|NCT00702975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245434|NCT00702975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65245442|NCT00809107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65245443|NCT00809107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245444|NCT02612181|Dexmedetomidine|dexmedetomidine|mesh-list
65245445|NCT02612181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65245446|NCT02612181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65245447|NCT02612181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245448|NCT02612181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65245449|NCT02612181|Analgesics|analgesics|mesh-ancestor
65245450|NCT02612181|Sensory System Agents|sensory system agents|mesh-ancestor
65245451|NCT02612181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65245452|NCT02612181|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65245453|NCT02612181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65245454|NCT02612181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65245455|NCT02612181|Adrenergic Agents|adrenergic agents|mesh-ancestor
65245456|NCT02612181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65245457|NCT02612181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245458|NCT02612259|Tryptophan|tryptophan|mesh-list
65245459|NCT02612259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65245460|NCT02612259|Antidepressive Agents|antidepressive agents|mesh-ancestor
65245461|NCT02612259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65245462|NCT00841035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65245463|NCT00841035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245464|NCT00841035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65245465|NCT00841035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65245466|NCT00841035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245488|NCT00642811|Purinergic Agents|purinergic agents|mesh-ancestor
65245489|NCT00642811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65245490|NCT00838929|Vorinostat|vorinostat|mesh-list
65245491|NCT00838929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245492|NCT00838929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65245493|NCT00838929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65245494|NCT00838929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245495|NCT00811603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65245496|NCT00811603|Cefazolin|cefazolin|mesh-list
65245497|NCT00811603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65245498|NCT00811681|Pioglitazone|pioglitazone|mesh-list
65245499|NCT00811681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65245500|NCT00811681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245501|NCT00811759|Temozolomide|temozolomide|mesh-list
65245502|NCT00811759|Sorafenib|sorafenib|mesh-list
65245503|NCT00811759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65245504|NCT00811759|Alkylating Agents|alkylating agents|mesh-ancestor
65245505|NCT00811759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245506|NCT00811759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245507|NCT00811759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65245508|NCT00811759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65245509|NCT00815893|Dexmedetomidine|dexmedetomidine|mesh-list
65245510|NCT00815893|Propofol|propofol|mesh-list
65245511|NCT00815893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65245512|NCT00815893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65245513|NCT00815893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245514|NCT00815893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65245515|NCT00815893|Anesthetics, General|anesthetics, general|mesh-ancestor
65245516|NCT00815893|Anesthetics|anesthetics|mesh-ancestor
65245517|NCT00815893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65245518|NCT00815893|Analgesics|analgesics|mesh-ancestor
65245519|NCT00815893|Sensory System Agents|sensory system agents|mesh-ancestor
65245520|NCT00815893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65245521|NCT00815893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65245522|NCT00815893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65245526|NCT00815893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245527|NCT00816049|Mercaptopurine|mercaptopurine|mesh-list
65245528|NCT00816049|Antimetabolites|antimetabolites|mesh-ancestor
65245529|NCT00816049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245530|NCT00816049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65245531|NCT00816049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245532|NCT00816049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65245533|NCT00816049|Immunologic Factors|immunologic factors|mesh-ancestor
65245534|NCT00816049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245535|NCT00816049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65245536|NCT00816049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65245537|NCT04648891|Lidocaine|lidocaine|mesh-list
65245538|NCT04648891|Anesthetics, Local|anesthetics, local|mesh-ancestor
65245539|NCT04648891|Anesthetics|anesthetics|mesh-ancestor
65245540|NCT04648891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65245541|NCT04648891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245542|NCT04648891|Sensory System Agents|sensory system agents|mesh-ancestor
65245543|NCT04648891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65245544|NCT04648891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65245545|NCT04648891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65245546|NCT04648891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65245547|NCT04648891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65245548|NCT04648891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245549|NCT04045015|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
65245550|NCT04045015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65245551|NCT04648033|Atovaquone|atovaquone|mesh-list
65245552|NCT04648033|Cisplatin|cisplatin|mesh-list
65245571|NCT00811837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65245572|NCT00811837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65245573|NCT00811837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65245574|NCT00811837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65245575|NCT00811837|Anesthetics, General|anesthetics, general|mesh-ancestor
65245576|NCT00811837|Anesthetics|anesthetics|mesh-ancestor
65245577|NCT00811837|GABA Modulators|gaba modulators|mesh-ancestor
65245578|NCT00811837|GABA Agents|gaba agents|mesh-ancestor
65245579|NCT00811837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65245580|NCT00811837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245581|NCT00811837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65245582|NCT00811837|Narcotics|narcotics|mesh-ancestor
65245583|NCT00811837|Analgesics|analgesics|mesh-ancestor
65245584|NCT00811837|Sensory System Agents|sensory system agents|mesh-ancestor
65245585|NCT00811837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65245586|NCT00811915|Sirolimus|sirolimus|mesh-list
65245587|NCT00811915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65245588|NCT00811915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65245589|NCT00811915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65245590|NCT00811915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245591|NCT00811915|Antifungal Agents|antifungal agents|mesh-ancestor
65245592|NCT00811915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65245593|NCT00811915|Immunologic Factors|immunologic factors|mesh-ancestor
65245594|NCT00811915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245595|NCT00816127|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65245596|NCT00816127|Hemostatics|hemostatics|mesh-ancestor
65245597|NCT00816127|Coagulants|coagulants|mesh-ancestor
65245598|NCT00816127|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65245599|NCT00816127|Natriuretic Agents|natriuretic agents|mesh-ancestor
65245600|NCT00816127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245601|NCT00916058|Melphalan|melphalan|mesh-list
65245602|NCT00916058|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65245603|NCT00916058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65245615|NCT04559906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245616|NCT04559906|Sensory System Agents|sensory system agents|mesh-ancestor
65245617|NCT04559906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65245618|NCT00912782|Vitamin D|vitamin d|mesh-list
65245619|NCT00912782|Cholecalciferol|cholecalciferol|mesh-list
65245620|NCT00912782|Vitamins|vitamins|mesh-ancestor
65245621|NCT00912782|Micronutrients|micronutrients|mesh-ancestor
65245622|NCT00912782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245623|NCT00912782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65245624|NCT00912782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65245625|NCT04202978|Capecitabine|capecitabine|mesh-list
65245626|NCT04202978|Oxaliplatin|oxaliplatin|mesh-list
65245627|NCT04202978|Apatinib|apatinib|mesh-list
64995891|NCT00093587|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65245628|NCT04202978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65245629|NCT04202978|Antimetabolites|antimetabolites|mesh-ancestor
65245630|NCT04202978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245631|NCT04202978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245632|NCT04202978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65245633|NCT04202978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65245634|NCT04186442|Botulinum Toxins|botulinum toxins|mesh-list
65245635|NCT04186442|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65245636|NCT04186442|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65245665|NCT04133948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65245666|NCT04133948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245667|NCT00911534|Rabeprazole|rabeprazole|mesh-list
65245668|NCT00911534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65245669|NCT00911534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65245670|NCT00911534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65245671|NCT00911534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65245672|NCT00911534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245673|NCT00911300|Vitamin K|vitamin k|mesh-list
65245674|NCT00911300|Heparin|heparin|mesh-list
65245675|NCT00911300|Calcium heparin|calcium heparin|mesh-list
65245676|NCT00911300|PENTA|penta|mesh-list
65245677|NCT00911300|Fondaparinux|fondaparinux|mesh-list
65245678|NCT00911300|Vitamins|vitamins|mesh-ancestor
65245679|NCT00911300|Micronutrients|micronutrients|mesh-ancestor
65245680|NCT00911300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245681|NCT00911300|Anticoagulants|anticoagulants|mesh-ancestor
65245682|NCT00911300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65245683|NCT00911300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65245684|NCT00911300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245685|NCT00911300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65245686|NCT00911300|Hemostatics|hemostatics|mesh-ancestor
65245687|NCT00911300|Coagulants|coagulants|mesh-ancestor
65245688|NCT00911300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65245689|NCT00911300|Antithrombins|antithrombins|mesh-ancestor
65245690|NCT00911300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65245691|NCT00911300|Protease Inhibitors|protease inhibitors|mesh-ancestor
65245692|NCT00911300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65245693|NCT00911144|Vaccines|vaccines|mesh-list
65245713|NCT04276298|Anesthetics|anesthetics|mesh-ancestor
65245714|NCT04276298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65245715|NCT04276298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245716|NCT04276298|Sensory System Agents|sensory system agents|mesh-ancestor
65245717|NCT04276298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65245718|NCT04276298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65245719|NCT04276298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65245720|NCT04276298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65245721|NCT04276298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65245722|NCT04276298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245723|NCT04276298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65245724|NCT04276298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65245725|NCT04276298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65245726|NCT04276298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65245727|NCT04276298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65245728|NCT04276298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65245729|NCT04276298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65245730|NCT04276298|Vasodilator Agents|vasodilator agents|mesh-ancestor
65245731|NCT04273880|Ascorbic Acid|ascorbic acid|mesh-list
65245732|NCT04273880|Methylphenidate|methylphenidate|mesh-list
65245733|NCT04273880|Vitamins|vitamins|mesh-ancestor
65245734|NCT04273880|Micronutrients|micronutrients|mesh-ancestor
65245735|NCT04273880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245736|NCT04273880|Antioxidants|antioxidants|mesh-ancestor
65245737|NCT04273880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245738|NCT04273880|Protective Agents|protective agents|mesh-ancestor
65245739|NCT04273880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65245740|NCT04273880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65245757|NCT00910988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65245758|NCT00910988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65245759|NCT00910988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245760|NCT00910988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65245761|NCT00910988|Serotonin Agents|serotonin agents|mesh-ancestor
65245762|NCT00910988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65245763|NCT00910988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65245764|NCT00910988|Dopamine Agents|dopamine agents|mesh-ancestor
65245765|NCT00644059|Vaccines|vaccines|mesh-list
65245766|NCT00644059|Immunologic Factors|immunologic factors|mesh-ancestor
65245767|NCT00644059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245768|NCT00817687|Mycophenolic Acid|mycophenolic acid|mesh-list
65245769|NCT00817687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65245770|NCT00817687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245771|NCT00817687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65245772|NCT00817687|Antitubercular Agents|antitubercular agents|mesh-ancestor
65245773|NCT00817687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65245774|NCT00817687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65245775|NCT00817687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65245776|NCT00817687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245778|NCT00811993|Etoposide|etoposide|mesh-list
65245779|NCT00811993|Docetaxel|docetaxel|mesh-list
65245780|NCT00811993|Bevacizumab|bevacizumab|mesh-list
65245781|NCT00811993|Carboplatin|carboplatin|mesh-list
65245782|NCT00811993|Capecitabine|capecitabine|mesh-list
65245783|NCT00811993|Trastuzumab|trastuzumab|mesh-list
65245784|NCT00811993|Irinotecan|irinotecan|mesh-list
65245785|NCT00811993|Cetuximab|cetuximab|mesh-list
65245786|NCT00811993|Temozolomide|temozolomide|mesh-list
65245787|NCT00811993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65245788|NCT00811993|Sorafenib|sorafenib|mesh-list
65245789|NCT00811993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65245790|NCT00811993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245791|NCT00811993|Tubulin Modulators|tubulin modulators|mesh-ancestor
65245792|NCT00811993|Antimitotic Agents|antimitotic agents|mesh-ancestor
65245793|NCT00811993|Mitosis Modulators|mitosis modulators|mesh-ancestor
65245799|NCT00811993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245800|NCT00811993|Growth Inhibitors|growth inhibitors|mesh-ancestor
65245801|NCT00811993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65245802|NCT00811993|Antimetabolites|antimetabolites|mesh-ancestor
65245803|NCT00811993|Antiviral Agents|antiviral agents|mesh-ancestor
65245804|NCT00811993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65245805|NCT00811993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65245806|NCT00811993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65245807|NCT00811993|Immunologic Factors|immunologic factors|mesh-ancestor
65245808|NCT00811993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65245809|NCT00811993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65245810|NCT00811993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65245811|NCT00811993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65245812|NCT00811993|Alkylating Agents|alkylating agents|mesh-ancestor
65245813|NCT00811993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65245814|NCT00817765|Ritonavir|ritonavir|mesh-list
65245815|NCT00817765|Fosamprenavir|fosamprenavir|mesh-list
65245816|NCT00817765|Posaconazole|posaconazole|mesh-list
65245817|NCT00817765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65245818|NCT00817765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65245837|NCT00816205|Nifedipine|nifedipine|mesh-list
65245852|NCT00816283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65245853|NCT00910910|Lenalidomide|lenalidomide|mesh-list
65245854|NCT00910910|Chlorambucil|chlorambucil|mesh-list
65245855|NCT00910910|Immunologic Factors|immunologic factors|mesh-ancestor
65245856|NCT00910910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245857|NCT00910910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65245858|NCT00910910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65245859|NCT00910910|Growth Substances|growth substances|mesh-ancestor
65245860|NCT00910910|Growth Inhibitors|growth inhibitors|mesh-ancestor
65245861|NCT00910910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245862|NCT00910910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65245863|NCT00910910|Alkylating Agents|alkylating agents|mesh-ancestor
65245864|NCT00910910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245865|NCT04522544|Durvalumab|durvalumab|mesh-list
65245866|NCT04522544|Tremelimumab|tremelimumab|mesh-list
65245867|NCT04522544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65245868|NCT04522544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245869|NCT04384562|Methylphenidate|methylphenidate|mesh-list
65245870|NCT04384562|Reboxetine|reboxetine|mesh-list
65245871|NCT04384562|Nicotine|nicotine|mesh-list
65245872|NCT04384562|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65245873|NCT04384562|Autonomic Agents|autonomic agents|mesh-ancestor
65245874|NCT04384562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65245875|NCT04384562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245876|NCT04384562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65245877|NCT04384562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65245878|NCT04384562|Cholinergic Agents|cholinergic agents|mesh-ancestor
65245879|NCT04384562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65245880|NCT04384562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245881|NCT04384562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65245882|NCT04384562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65245883|NCT04384562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65245884|NCT04384562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65245885|NCT04384562|Dopamine Agents|dopamine agents|mesh-ancestor
65245891|NCT04515134|Coenzyme Q10|coenzyme q10|mesh-list
65245892|NCT04515134|Micronutrients|micronutrients|mesh-ancestor
65245893|NCT04515134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245894|NCT04515134|Vitamins|vitamins|mesh-ancestor
65245895|NCT04238390|Meropenem|meropenem|mesh-list
65245896|NCT04238390|Tazobactam|tazobactam|mesh-list
65245897|NCT04238390|Ceftolozane|ceftolozane|mesh-list
65245898|NCT04238390|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
65245899|NCT04238390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65245900|NCT04238390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65245901|NCT04238390|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65245902|NCT04238390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65245903|NCT04238390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245904|NCT04238390|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65245905|NCT04238390|Renal Agents|renal agents|mesh-ancestor
65245906|NCT04236830|Fluorides|fluorides|mesh-list
65245907|NCT04236830|Cariostatic Agents|cariostatic agents|mesh-ancestor
65245908|NCT04236830|Protective Agents|protective agents|mesh-ancestor
65245909|NCT04236830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245910|NCT04203212|Goserelin|goserelin|mesh-list
65245911|NCT04203212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65245912|NCT04203212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245913|NCT00637910|Docetaxel|docetaxel|mesh-list
65245914|NCT00637910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65245915|NCT00637910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245916|NCT00637910|Tubulin Modulators|tubulin modulators|mesh-ancestor
65245917|NCT00637910|Antimitotic Agents|antimitotic agents|mesh-ancestor
65245918|NCT00637910|Mitosis Modulators|mitosis modulators|mesh-ancestor
65245919|NCT00637910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245920|NCT00637910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65245921|NCT00637910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65245922|NCT03408236|Botulinum Toxins|botulinum toxins|mesh-list
65245923|NCT03408236|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65245924|NCT03408236|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65245925|NCT03408236|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65245931|NCT03408236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65245932|NCT03408236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65245933|NCT04449536|Mesna|mesna|mesh-list
65245934|NCT04449536|Protective Agents|protective agents|mesh-ancestor
65245935|NCT04449536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245936|NCT03960554|Denosumab|denosumab|mesh-list
65245937|NCT03960554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65245938|NCT03960554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245939|NCT04084106|Amoxicillin|amoxicillin|mesh-list
65245940|NCT04084106|Clavulanic Acids|clavulanic acids|mesh-list
65245941|NCT04084106|Clavulanic Acid|clavulanic acid|mesh-list
65245942|NCT04084106|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65245943|NCT04084106|Penicillin V|penicillin v|mesh-list
65245944|NCT04084106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65245945|NCT04084106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65245946|NCT04084106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65245947|NCT04084106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245948|NCT04084106|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65245949|NCT02977052|Nivolumab|nivolumab|mesh-list
65245950|NCT02977052|Ipilimumab|ipilimumab|mesh-list
65245951|NCT02977052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65245952|NCT02977052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245953|NCT02977052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65245954|NCT02977052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245955|NCT02973542|Ethosuximide|ethosuximide|mesh-list
65245956|NCT02973542|Anticonvulsants|anticonvulsants|mesh-ancestor
65245957|NCT02973386|Cisplatin|cisplatin|mesh-list
65245958|NCT02973386|Capecitabine|capecitabine|mesh-list
65245959|NCT02973386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245960|NCT02973386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65245961|NCT02973386|Antimetabolites|antimetabolites|mesh-ancestor
65245963|NCT00909428|Solifenacin Succinate|solifenacin succinate|mesh-list
65245975|NCT00908960|Anticoagulants|anticoagulants|mesh-ancestor
65245976|NCT00908960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65245977|NCT00908960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65245978|NCT00908960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65245979|NCT05332106|Dienogest|dienogest|mesh-list
65245980|NCT05332106|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65245981|NCT05332106|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65245982|NCT05332106|Estradiol|estradiol|mesh-list
65245983|NCT05332106|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65245984|NCT05332106|Nandrolone|nandrolone|mesh-list
65245985|NCT05332106|Estrogens|estrogens|mesh-ancestor
65245986|NCT05332106|Hormones|hormones|mesh-ancestor
65245987|NCT05332106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65245988|NCT05332106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65245989|NCT05332106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65245990|NCT05332106|Contraceptive Agents|contraceptive agents|mesh-ancestor
65245991|NCT05332106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65245992|NCT05332106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65245993|NCT05332106|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65245994|NCT05332106|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65245995|NCT05332106|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65245996|NCT05332106|Hormone Antagonists|hormone antagonists|mesh-ancestor
65245997|NCT05332106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65245998|NCT05332106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65245999|NCT05332106|Androgens|androgens|mesh-ancestor
65246000|NCT05332106|Anabolic Agents|anabolic agents|mesh-ancestor
65246001|NCT05332028|Fentanyl|fentanyl|mesh-list
65246002|NCT05332028|Bupivacaine|bupivacaine|mesh-list
65246003|NCT05332028|Propofol|propofol|mesh-list
65246004|NCT05332028|Anesthetics, Local|anesthetics, local|mesh-ancestor
65246005|NCT05332028|Anesthetics|anesthetics|mesh-ancestor
65246006|NCT05332028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65246020|NCT00816517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65246021|NCT00816517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65246022|NCT00816517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246023|NCT00816517|Cholinergic Agents|cholinergic agents|mesh-ancestor
65246024|NCT00816517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65246025|NCT00816517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246026|NCT00816517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65246027|NCT00816517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246028|NCT00643201|Enoxaparin|enoxaparin|mesh-list
65246029|NCT00643201|Warfarin|warfarin|mesh-list
65246030|NCT00643201|Enoxaparin sodium|enoxaparin sodium|mesh-list
65246031|NCT00643201|Apixaban|apixaban|mesh-list
65246032|NCT00643201|Anticoagulants|anticoagulants|mesh-ancestor
65246033|NCT00643201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65246034|NCT00643201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65246035|NCT00643201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246036|NCT00643201|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65246037|NCT00643201|Antithrombins|antithrombins|mesh-ancestor
65246038|NCT00643201|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65246039|NCT00643201|Protease Inhibitors|protease inhibitors|mesh-ancestor
65246040|NCT00643201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65246041|NCT00643123|Allopurinol|allopurinol|mesh-list
65246042|NCT00643123|Antimetabolites|antimetabolites|mesh-ancestor
65246043|NCT00643123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246044|NCT00643123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65246045|NCT00643123|Gout Suppressants|gout suppressants|mesh-ancestor
65246046|NCT00643123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65246048|NCT00643123|Antioxidants|antioxidants|mesh-ancestor
65246066|NCT00641719|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65246067|NCT00641719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65246068|NCT00641719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65246069|NCT00641719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65246070|NCT00641719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246071|NCT00641719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65246072|NCT00641719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246073|NCT00641719|Analgesics|analgesics|mesh-ancestor
65246074|NCT00641719|Sensory System Agents|sensory system agents|mesh-ancestor
65246075|NCT00641719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246076|NCT00641719|Antidepressive Agents|antidepressive agents|mesh-ancestor
65246077|NCT00641719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64996343|NCT00429754|Aprepitant|aprepitant|mesh-list
65246078|NCT00641719|Dopamine Agents|dopamine agents|mesh-ancestor
65246079|NCT02863367|Gemcitabine|gemcitabine|mesh-list
65246080|NCT02863367|Apatinib|apatinib|mesh-list
65246081|NCT02863367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65246082|NCT02863367|Antimetabolites|antimetabolites|mesh-ancestor
65246083|NCT02863367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246084|NCT02863367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65246085|NCT02863367|Antiviral Agents|antiviral agents|mesh-ancestor
65246086|NCT02863367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65246087|NCT02863367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65246088|NCT02863367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65246089|NCT02863367|Immunologic Factors|immunologic factors|mesh-ancestor
65246090|NCT02863367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246112|NCT00975221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246113|NCT00975221|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65246114|NCT00975221|Hormone Antagonists|hormone antagonists|mesh-ancestor
65246115|NCT00975221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65246116|NCT02863679|Tetracaine|tetracaine|mesh-list
65246117|NCT02863679|Anesthetics, Local|anesthetics, local|mesh-ancestor
65246118|NCT02863679|Anesthetics|anesthetics|mesh-ancestor
65246119|NCT02863679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65246120|NCT02863679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246121|NCT02863679|Sensory System Agents|sensory system agents|mesh-ancestor
65246122|NCT02863679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246123|NCT00906698|Vinorelbine|vinorelbine|mesh-list
65246124|NCT00906698|Afatinib|afatinib|mesh-list
65246125|NCT00906698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65246126|NCT00906698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65246127|NCT00906698|Tubulin Modulators|tubulin modulators|mesh-ancestor
65246128|NCT00906698|Antimitotic Agents|antimitotic agents|mesh-ancestor
65246129|NCT00906698|Mitosis Modulators|mitosis modulators|mesh-ancestor
65246130|NCT00906698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246131|NCT00906698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65246132|NCT00906698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65246133|NCT00972023|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65246134|NCT00972023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65246135|NCT00972023|Immunologic Factors|immunologic factors|mesh-ancestor
65246136|NCT00972023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246137|NCT03396926|Bevacizumab|bevacizumab|mesh-list
65246138|NCT03396926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65246139|NCT03396926|Pembrolizumab|pembrolizumab|mesh-list
65246140|NCT03396926|Capecitabine|capecitabine|mesh-list
65246141|NCT03396926|Endothelial Growth Factors|endothelial growth factors|mesh-list
65246142|NCT03396926|Antibodies|antibodies|mesh-list
65246143|NCT03396926|Immunoglobulins|immunoglobulins|mesh-list
65246144|NCT03396926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65246153|NCT03396926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65246154|NCT03396926|Antimetabolites|antimetabolites|mesh-ancestor
65246155|NCT03396926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246156|NCT00971945|Paclitaxel|paclitaxel|mesh-list
65246157|NCT00971945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65246158|NCT00971945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65246159|NCT00971945|Tubulin Modulators|tubulin modulators|mesh-ancestor
65246160|NCT00971945|Antimitotic Agents|antimitotic agents|mesh-ancestor
65246161|NCT00971945|Mitosis Modulators|mitosis modulators|mesh-ancestor
65246162|NCT00971945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246163|NCT03672500|Epinephrine|epinephrine|mesh-list
65246164|NCT03672500|Bupivacaine|bupivacaine|mesh-list
65246165|NCT03672500|Anesthetics, Local|anesthetics, local|mesh-ancestor
65246166|NCT03672500|Anesthetics|anesthetics|mesh-ancestor
65246167|NCT03672500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65246168|NCT03672500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246169|NCT03672500|Sensory System Agents|sensory system agents|mesh-ancestor
65246170|NCT03672500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246171|NCT03672500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65246172|NCT03672500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65246173|NCT03672500|Adrenergic Agents|adrenergic agents|mesh-ancestor
65246174|NCT03672500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65246175|NCT03672500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246176|NCT03672500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65246177|NCT03672500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65246178|NCT03672500|Autonomic Agents|autonomic agents|mesh-ancestor
65246179|NCT03672500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65246180|NCT03672500|Respiratory System Agents|respiratory system agents|mesh-ancestor
65246181|NCT03672500|Mydriatics|mydriatics|mesh-ancestor
65246182|NCT03672500|Sympathomimetics|sympathomimetics|mesh-ancestor
65246183|NCT03672500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65246184|NCT00971867|Paclitaxel|paclitaxel|mesh-list
65246185|NCT00971867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65246193|NCT03667820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65246194|NCT03667820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65246195|NCT03667820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246196|NCT03248570|Pembrolizumab|pembrolizumab|mesh-list
65246197|NCT03248570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65246198|NCT03248570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65246199|NCT03221036|Vedolizumab|vedolizumab|mesh-list
65246200|NCT03221036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65246201|NCT00812851|Dronabinol|dronabinol|mesh-list
65246202|NCT00812851|Hallucinogens|hallucinogens|mesh-ancestor
65246203|NCT00812851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246204|NCT00812851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65246205|NCT00812851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65246206|NCT00812851|Analgesics|analgesics|mesh-ancestor
65246207|NCT00812851|Sensory System Agents|sensory system agents|mesh-ancestor
65246208|NCT00812851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246209|NCT00812851|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65246210|NCT00812851|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65246211|NCT00812851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65246212|NCT00812851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246213|NCT00812851|Hormones|hormones|mesh-ancestor
65246214|NCT00812851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65246215|NCT00648037|Rituximab|rituximab|mesh-list
65246216|NCT00648037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65246217|NCT00648037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65246218|NCT00648037|Immunologic Factors|immunologic factors|mesh-ancestor
65246219|NCT00648037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246220|NCT00648037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65246221|NCT00817375|Milnacipran|milnacipran|mesh-list
65246222|NCT00817375|Mirtazapine|mirtazapine|mesh-list
65246236|NCT00817375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246237|NCT00817375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65246238|NCT00817375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65246239|NCT00817375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65246240|NCT00817375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65246241|NCT00817375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65246242|NCT00817375|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65246243|NCT00817375|Histamine Antagonists|histamine antagonists|mesh-ancestor
65246244|NCT00817375|Histamine Agents|histamine agents|mesh-ancestor
65246245|NCT00817375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65246246|NCT00817375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65246247|NCT00817375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65246248|NCT00817375|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65246249|NCT00817375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65246250|NCT00817375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65246251|NCT00817375|Adrenergic Agents|adrenergic agents|mesh-ancestor
65246252|NCT00817375|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65246253|NCT00817375|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65246254|NCT00817375|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65246255|NCT00817375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65246256|NCT00817375|Analgesics|analgesics|mesh-ancestor
65246257|NCT00817375|Sensory System Agents|sensory system agents|mesh-ancestor
65246258|NCT00817375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246259|NCT00817375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65246260|NCT00817375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65246261|NCT00818701|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65246262|NCT00818701|Sildenafil Citrate|sildenafil citrate|mesh-list
65246263|NCT00818701|Vasodilator Agents|vasodilator agents|mesh-ancestor
65246264|NCT00818701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65246276|NCT00813241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246277|NCT00813241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246278|NCT00813241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65246279|NCT00813241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65246280|NCT00813241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65246281|NCT00813241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65246282|NCT00813241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65246283|NCT00813241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246284|NCT00640393|Etanercept|etanercept|mesh-list
65246285|NCT00640393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65246286|NCT00640393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65246287|NCT00640393|Analgesics|analgesics|mesh-ancestor
65246288|NCT00640393|Sensory System Agents|sensory system agents|mesh-ancestor
65246289|NCT00640393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246290|NCT00640393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246291|NCT00640393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65246292|NCT00640393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65246293|NCT00640393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65246294|NCT00640393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65246295|NCT00640393|Immunologic Factors|immunologic factors|mesh-ancestor
65246296|NCT00821353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
65246297|NCT05315024|Imiquimod|imiquimod|mesh-list
65246298|NCT05315024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65246299|NCT05315024|Immunologic Factors|immunologic factors|mesh-ancestor
65246300|NCT05315024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246301|NCT05315024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65246302|NCT05315024|Interferon Inducers|interferon inducers|mesh-ancestor
65246303|NCT00627445|Insulin|insulin|mesh-list
65246304|NCT00627445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65246305|NCT00627445|Metformin|metformin|mesh-list
65246306|NCT00627445|Insulin Aspart|insulin aspart|mesh-list
65246307|NCT00627445|Insulin, Long-Acting|insulin, long-acting|mesh-list
65246308|NCT00627445|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65246314|NCT02030990|Mitomycins|mitomycins|mesh-list
65246317|NCT02030990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65246318|NCT02030990|Alkylating Agents|alkylating agents|mesh-ancestor
65246319|NCT02030990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246320|NCT02030990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65246321|NCT02030990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65246322|NCT02030990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65246323|NCT02030990|Glucocorticoids|glucocorticoids|mesh-ancestor
65246324|NCT02030990|Hormones|hormones|mesh-ancestor
65246325|NCT02030990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65246326|NCT02030990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246327|NCT02030990|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65246328|NCT00822055|Timolol|timolol|mesh-list
65246329|NCT00822055|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65246330|NCT00822055|Dorzolamide|dorzolamide|mesh-list
65246331|NCT00822055|Maleic acid|maleic acid|mesh-list
65246332|NCT00822055|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
65246333|NCT00822055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65246334|NCT00822055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246335|NCT00822055|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65246336|NCT00822055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65246337|NCT00822055|Adrenergic Agents|adrenergic agents|mesh-ancestor
65246338|NCT00822055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65246339|NCT00822055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246340|NCT00822055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65246341|NCT00822055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65246342|NCT00822055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65246343|NCT00822055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65246344|NCT00822055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65246346|NCT00822133|Lidocaine|lidocaine|mesh-list
65246360|NCT00822133|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65246361|NCT00822133|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65246362|NCT00822133|Anesthetics, General|anesthetics, general|mesh-ancestor
65246363|NCT00822133|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65246364|NCT00822133|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65246365|NCT00822133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65246366|NCT00822211|Vildagliptin|vildagliptin|mesh-list
65246367|NCT00822211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65246368|NCT00822211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246369|NCT00822211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65246370|NCT00822211|Protease Inhibitors|protease inhibitors|mesh-ancestor
65246371|NCT00822211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65246372|NCT00822211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246373|NCT04018417|Amphotericin B|amphotericin b|mesh-list
65246374|NCT04018417|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65246375|NCT04018417|Amebicides|amebicides|mesh-ancestor
65246376|NCT04018417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65246377|NCT04018417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65246378|NCT04018417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65246379|NCT04018417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65246414|NCT03597776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65246415|NCT03597776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246416|NCT00625183|Selenium|selenium|mesh-list
65246417|NCT00625183|Capecitabine|capecitabine|mesh-list
65246418|NCT00625183|Oxaliplatin|oxaliplatin|mesh-list
65246419|NCT00625183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65246420|NCT00625183|Antimetabolites|antimetabolites|mesh-ancestor
65246421|NCT00625183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246422|NCT00625183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65246423|NCT00625183|Antioxidants|antioxidants|mesh-ancestor
65246424|NCT00625183|Protective Agents|protective agents|mesh-ancestor
65246425|NCT00625183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246426|NCT00625183|Trace Elements|trace elements|mesh-ancestor
65246427|NCT00625183|Micronutrients|micronutrients|mesh-ancestor
65246428|NCT00826891|Topotecan|topotecan|mesh-list
65246429|NCT00826891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65246430|NCT00826891|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65246431|NCT00826891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65246432|NCT00826891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65246433|NCT00826891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246434|NCT00826969|Ciclesonide|ciclesonide|mesh-list
65246435|NCT00826969|Glucocorticoids|glucocorticoids|mesh-ancestor
65246436|NCT00826969|Hormones|hormones|mesh-ancestor
65246437|NCT00826969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65246438|NCT00826969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246439|NCT00826969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65246440|NCT03560882|Atorvastatin|atorvastatin|mesh-list
65246441|NCT03560882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65246442|NCT03560882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65246443|NCT03560882|Antimetabolites|antimetabolites|mesh-ancestor
65246457|NCT03553004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246458|NCT03553004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65246459|NCT05242874|Dexamethasone|dexamethasone|mesh-list
65246460|NCT05242874|Olanzapine|olanzapine|mesh-list
65246461|NCT05242874|Fosaprepitant|fosaprepitant|mesh-list
65246462|NCT05242874|Aprepitant|aprepitant|mesh-list
65246463|NCT05242874|Antiemetics|antiemetics|mesh-list
65246464|NCT05242874|Tropisetron|tropisetron|mesh-list
65246465|NCT05242874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65246466|NCT05242874|Autonomic Agents|autonomic agents|mesh-ancestor
65246467|NCT05242874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246468|NCT05242874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246469|NCT05242874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65246470|NCT05242874|Glucocorticoids|glucocorticoids|mesh-ancestor
65246471|NCT05242874|Hormones|hormones|mesh-ancestor
65246472|NCT05242874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65246473|NCT05242874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65246474|NCT05242874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65246475|NCT05242874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246476|NCT05242874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65246477|NCT05242874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65246478|NCT05242874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65246479|NCT05242874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65246480|NCT05242874|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65246481|NCT05242874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65246482|NCT05242874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65246483|NCT05242874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65246484|NCT05242874|Serotonin Agents|serotonin agents|mesh-ancestor
65246485|NCT05242874|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65246486|NCT05242874|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65246487|NCT05242874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65246488|NCT02768948|Losartan|losartan|mesh-list
65246489|NCT02768948|Telmisartan|telmisartan|mesh-list
65246490|NCT02768948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65246491|NCT02768948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64951556|NCT00054444|Topotecan|topotecan|mesh-list
65246494|NCT02768948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246495|NCT00640315|Riociguat|riociguat|mesh-list
65246496|NCT00640315|Enzyme Activators|enzyme activators|mesh-ancestor
65246497|NCT00640315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246498|NCT00904748|Sildenafil Citrate|sildenafil citrate|mesh-list
65246499|NCT00904748|Citric Acid|citric acid|mesh-list
65246500|NCT00904748|Sodium Citrate|sodium citrate|mesh-list
65246501|NCT00904748|Anticoagulants|anticoagulants|mesh-ancestor
65246502|NCT00904748|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65246503|NCT00904748|Chelating Agents|chelating agents|mesh-ancestor
65246504|NCT00904748|Sequestering Agents|sequestering agents|mesh-ancestor
65246505|NCT00904748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246506|NCT00904748|Vasodilator Agents|vasodilator agents|mesh-ancestor
65246507|NCT00904748|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65246508|NCT00904748|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65246509|NCT00904748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65246510|NCT00904748|Urological Agents|urological agents|mesh-ancestor
65246511|NCT00574405|Insulin|insulin|mesh-list
65246512|NCT00574405|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65246513|NCT00574405|Insulin Lispro|insulin lispro|mesh-list
65246514|NCT00574405|Insulin Aspart|insulin aspart|mesh-list
65246515|NCT00574405|Insulin, Isophane|insulin, isophane|mesh-list
65246516|NCT00574405|Isophane Insulin, Human|isophane insulin, human|mesh-list
65246517|NCT00574405|Isophane insulin, beef|isophane insulin, beef|mesh-list
65246518|NCT00574405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65246519|NCT00574405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246520|NCT00971243|Metformin|metformin|mesh-list
65246521|NCT00971243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65246522|NCT00971243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246523|NCT00822913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65246524|NCT00822913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65246525|NCT00822913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65246539|NCT04400383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65246540|NCT04381429|Insulin Aspart|insulin aspart|mesh-list
65246541|NCT04381429|Insulin, Long-Acting|insulin, long-acting|mesh-list
65246542|NCT04381429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65246543|NCT04381429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65246544|NCT04381429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246545|NCT00568555|Naltrexone|naltrexone|mesh-list
65246546|NCT00568555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65246547|NCT00568555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65246548|NCT00568555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246549|NCT00568555|Sensory System Agents|sensory system agents|mesh-ancestor
65246550|NCT00568555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246551|NCT00819325|Pioglitazone|pioglitazone|mesh-list
65246552|NCT00819325|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65246553|NCT00819325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246554|NCT00904670|Methylphenidate|methylphenidate|mesh-list
65246555|NCT00904670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65246556|NCT00904670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246557|NCT00904670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65246558|NCT00904670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65246559|NCT00904670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65246560|NCT00904670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246561|NCT00904670|Dopamine Agents|dopamine agents|mesh-ancestor
65246562|NCT00904670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65246563|NCT00827281|Cycloserine|cycloserine|mesh-list
65246564|NCT00827281|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65246565|NCT00827281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65246566|NCT00827281|Renal Agents|renal agents|mesh-ancestor
65246567|NCT00827281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65246568|NCT00827281|Antitubercular Agents|antitubercular agents|mesh-ancestor
65246569|NCT00827281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65246570|NCT00827281|Antimetabolites|antimetabolites|mesh-ancestor
65246579|NCT00638443|Diphenhydramine|diphenhydramine|mesh-list
65246580|NCT00638443|Promethazine|promethazine|mesh-list
65246581|NCT00638443|Pregabalin|pregabalin|mesh-list
65246582|NCT00638443|Analgesics|analgesics|mesh-ancestor
65246583|NCT00638443|Sensory System Agents|sensory system agents|mesh-ancestor
65246584|NCT00638443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246585|NCT00638443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246586|NCT00638443|Anticonvulsants|anticonvulsants|mesh-ancestor
65246587|NCT00638443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65246588|NCT00638443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65246589|NCT00638443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246590|NCT00638443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65246591|NCT00638443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65246592|NCT00638443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65246593|NCT00638443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65246594|NCT00638443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65246595|NCT00638443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65246596|NCT00638443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65246598|NCT00638443|Anesthetics|anesthetics|mesh-ancestor
65246599|NCT00638443|Antiemetics|antiemetics|mesh-ancestor
65246600|NCT00638443|Autonomic Agents|autonomic agents|mesh-ancestor
65246601|NCT00638443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65246602|NCT00638443|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65246603|NCT00638443|Histamine Antagonists|histamine antagonists|mesh-ancestor
65246604|NCT00638443|Histamine Agents|histamine agents|mesh-ancestor
65246605|NCT00638443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65246606|NCT00638443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65246607|NCT00638443|Antipruritics|antipruritics|mesh-ancestor
65246608|NCT00638443|Dermatologic Agents|dermatologic agents|mesh-ancestor
65246628|NCT04288349|Epinephryl borate|epinephryl borate|mesh-list
65246629|NCT04288349|Anesthetics, Local|anesthetics, local|mesh-ancestor
65246630|NCT04288349|Anesthetics|anesthetics|mesh-ancestor
65246631|NCT04288349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65246632|NCT04288349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246633|NCT04288349|Sensory System Agents|sensory system agents|mesh-ancestor
65246634|NCT04288349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246635|NCT04288349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65246636|NCT04288349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65246637|NCT04288349|Adrenergic Agents|adrenergic agents|mesh-ancestor
65246638|NCT04288349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65246639|NCT04288349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246640|NCT04288349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65246641|NCT04288349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65246642|NCT04288349|Autonomic Agents|autonomic agents|mesh-ancestor
65246643|NCT04288349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65246644|NCT04288349|Respiratory System Agents|respiratory system agents|mesh-ancestor
65246645|NCT04288349|Mydriatics|mydriatics|mesh-ancestor
65246646|NCT04288349|Sympathomimetics|sympathomimetics|mesh-ancestor
65246647|NCT04288349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65246648|NCT03667313|Sirolimus|sirolimus|mesh-list
65246649|NCT03667313|Paclitaxel|paclitaxel|mesh-list
65246650|NCT03667313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65246651|NCT03667313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65246652|NCT03667313|Tubulin Modulators|tubulin modulators|mesh-ancestor
65246653|NCT03667313|Antimitotic Agents|antimitotic agents|mesh-ancestor
65246654|NCT03667313|Mitosis Modulators|mitosis modulators|mesh-ancestor
64922013|NCT00019630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65246678|NCT00634933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65246679|NCT00634933|Prednisolone phosphate|prednisolone phosphate|mesh-list
65246680|NCT00634933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65246681|NCT00634933|Glucocorticoids|glucocorticoids|mesh-ancestor
65246682|NCT00634933|Hormones|hormones|mesh-ancestor
65246683|NCT00634933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65246684|NCT00634933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246685|NCT00634933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65246686|NCT00634933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65246687|NCT00634933|Antiemetics|antiemetics|mesh-ancestor
65246688|NCT00634933|Autonomic Agents|autonomic agents|mesh-ancestor
65246689|NCT00634933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246690|NCT00634933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65246691|NCT00634933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65246692|NCT00634933|Protective Agents|protective agents|mesh-ancestor
65246693|NCT00967499|Ondansetron|ondansetron|mesh-list
65246694|NCT00967499|Palonosetron|palonosetron|mesh-list
65246695|NCT00967499|Antiemetics|antiemetics|mesh-ancestor
65246696|NCT00967499|Autonomic Agents|autonomic agents|mesh-ancestor
65246697|NCT00967499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246698|NCT00967499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246699|NCT00967499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65246700|NCT00967499|Antipruritics|antipruritics|mesh-ancestor
65246701|NCT00967499|Dermatologic Agents|dermatologic agents|mesh-ancestor
65246702|NCT00967499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65246725|NCT04286399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65246726|NCT00629837|Factor VIII|factor viii|mesh-list
65246727|NCT00629837|Coagulants|coagulants|mesh-ancestor
65246728|NCT00827671|Cetuximab|cetuximab|mesh-list
65246729|NCT00827671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65246730|NCT00827671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65246731|NCT00626275|Naproxen|naproxen|mesh-list
65246732|NCT00626275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65246733|NCT00626275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65246734|NCT00626275|Analgesics|analgesics|mesh-ancestor
65246735|NCT00626275|Sensory System Agents|sensory system agents|mesh-ancestor
65246736|NCT00626275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246737|NCT00626275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246738|NCT00626275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65246739|NCT00626275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65246740|NCT00626275|Gout Suppressants|gout suppressants|mesh-ancestor
65246741|NCT00626275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65246742|NCT00626275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65246743|NCT00626275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246744|NCT03643133|Mifamurtide|mifamurtide|mesh-list
65246745|NCT03643133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65246746|NCT03643133|Immunologic Factors|immunologic factors|mesh-ancestor
65246747|NCT03643133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246748|NCT04044313|Lenvatinib|lenvatinib|mesh-list
64997023|NCT00097877|Insulin|insulin|mesh-list
65246749|NCT04044313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65246750|NCT04044313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65246751|NCT04044313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65246752|NCT04044313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246753|NCT00823849|Cilostazol|cilostazol|mesh-list
65246769|NCT00823849|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65246770|NCT00823849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65246771|NCT00823849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65246772|NCT00823849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65246773|NCT00823849|Antimetabolites|antimetabolites|mesh-ancestor
65246774|NCT00823849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65246775|NCT00823849|Antioxidants|antioxidants|mesh-ancestor
65246776|NCT02550067|Copper|copper|mesh-list
65246777|NCT02550067|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65246778|NCT02550067|Levonorgestrel|levonorgestrel|mesh-list
65246779|NCT02550067|Medroxyprogesterone|medroxyprogesterone|mesh-list
65246780|NCT02550067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65246781|NCT02550067|Contraceptive Agents|contraceptive agents|mesh-ancestor
65246782|NCT02550067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65246783|NCT02550067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246784|NCT02550067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65246785|NCT02550067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65246786|NCT02550067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65246787|NCT02550067|Trace Elements|trace elements|mesh-ancestor
65246788|NCT02550067|Micronutrients|micronutrients|mesh-ancestor
65246789|NCT02550067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65246790|NCT02550067|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65246791|NCT02550067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65246792|NCT02550067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65246793|NCT02862509|Budesonide|budesonide|mesh-list
65246794|NCT02862509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65246795|NCT02862509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65246796|NCT02862509|Autonomic Agents|autonomic agents|mesh-ancestor
65246815|NCT00965081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65246816|NCT00965081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65246817|NCT00965081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246818|NCT00965081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65246819|NCT00965081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246820|NCT00965081|Analgesics|analgesics|mesh-ancestor
65246821|NCT00965081|Sensory System Agents|sensory system agents|mesh-ancestor
65246822|NCT00965081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246823|NCT00965081|Antidepressive Agents|antidepressive agents|mesh-ancestor
65246824|NCT00965081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65246825|NCT00965081|Dopamine Agents|dopamine agents|mesh-ancestor
65246826|NCT00961649|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65246827|NCT00961649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65246828|NCT00961649|Brinzolamide|brinzolamide|mesh-list
65246829|NCT00961649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65246830|NCT00961649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65246831|NCT00961649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65246832|NCT00961649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65246833|NCT00961649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65246834|NCT00961649|Adrenergic Agents|adrenergic agents|mesh-ancestor
65246835|NCT00961649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65246836|NCT00961649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246837|NCT00961649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246838|NCT00961649|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65246839|NCT00961649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65246840|NCT04267601|Anagliptin|anagliptin|mesh-list
65246841|NCT04267601|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65246860|NCT02861261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65246861|NCT02861261|Anesthetics, Local|anesthetics, local|mesh-ancestor
65246862|NCT02861261|Anesthetics|anesthetics|mesh-ancestor
65246863|NCT02861261|Sensory System Agents|sensory system agents|mesh-ancestor
65246864|NCT02861261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246865|NCT02861261|Antiemetics|antiemetics|mesh-ancestor
65246866|NCT02861261|Autonomic Agents|autonomic agents|mesh-ancestor
65246867|NCT02861261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65246868|NCT04283435|Sildenafil Citrate|sildenafil citrate|mesh-list
65246869|NCT04283435|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65246870|NCT04283435|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65246871|NCT04283435|Estradiol|estradiol|mesh-list
65246872|NCT04283435|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65246873|NCT04283435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246874|NCT04283435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246875|NCT04283435|Estrogens|estrogens|mesh-ancestor
65246876|NCT04283435|Hormones|hormones|mesh-ancestor
65246877|NCT04283435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65246878|NCT04283435|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65246879|NCT04283435|Contraceptive Agents|contraceptive agents|mesh-ancestor
65246880|NCT04283435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65246881|NCT04283435|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65246882|NCT04283435|Vasodilator Agents|vasodilator agents|mesh-ancestor
65246883|NCT04283435|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65246884|NCT04283435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65246885|NCT04283435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65246886|NCT04283435|Urological Agents|urological agents|mesh-ancestor
65246887|NCT04284761|Bicalutamide|bicalutamide|mesh-list
65246888|NCT04284761|Androgen Antagonists|androgen antagonists|mesh-ancestor
65246889|NCT04284761|Hormone Antagonists|hormone antagonists|mesh-ancestor
65246892|NCT04284761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65246903|NCT00903968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65246904|NCT00903968|Glucocorticoids|glucocorticoids|mesh-ancestor
65246905|NCT00903968|Hormones|hormones|mesh-ancestor
65246906|NCT00903968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65246907|NCT00903968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65246908|NCT00903968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65246909|NCT00903968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65246910|NCT00903968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65246911|NCT00903968|Antiviral Agents|antiviral agents|mesh-ancestor
65246912|NCT00903968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65246913|NCT00632606|Magnesium Sulfate|magnesium sulfate|mesh-list
65246914|NCT00632606|Metoclopramide|metoclopramide|mesh-list
65246915|NCT00632606|Analgesics|analgesics|mesh-ancestor
65246916|NCT00632606|Sensory System Agents|sensory system agents|mesh-ancestor
65246917|NCT00632606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246918|NCT00632606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246919|NCT00632606|Anesthetics|anesthetics|mesh-ancestor
65246920|NCT00632606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65246921|NCT00632606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65246922|NCT00632606|Anticonvulsants|anticonvulsants|mesh-ancestor
65246923|NCT00632606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65246924|NCT00632606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65246925|NCT00632606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246926|NCT00632606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65246927|NCT00632606|Tocolytic Agents|tocolytic agents|mesh-ancestor
65246928|NCT00632606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65246929|NCT00632606|Antiemetics|antiemetics|mesh-ancestor
65246930|NCT00632606|Autonomic Agents|autonomic agents|mesh-ancestor
65246931|NCT00632606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65246932|NCT00632606|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65246933|NCT00632606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65246946|NCT02586038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65246947|NCT02586038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65246948|NCT02586038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65246949|NCT02586038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65246950|NCT02586038|Antiemetics|antiemetics|mesh-ancestor
65246951|NCT02586038|Autonomic Agents|autonomic agents|mesh-ancestor
65246952|NCT02586038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65246953|NCT02586038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65246954|NCT02586038|Glucocorticoids|glucocorticoids|mesh-ancestor
65246955|NCT02586038|Hormones|hormones|mesh-ancestor
65246956|NCT02586038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65246957|NCT02586038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65246958|NCT02586038|Leprostatic Agents|leprostatic agents|mesh-ancestor
65246959|NCT02586038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65246960|NCT02586038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65246961|NCT02586038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65246962|NCT02586038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65246963|NCT02586038|Growth Substances|growth substances|mesh-ancestor
65246964|NCT02586038|Growth Inhibitors|growth inhibitors|mesh-ancestor
65246965|NCT02586038|Protease Inhibitors|protease inhibitors|mesh-ancestor
65246966|NCT02586038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65246967|NCT00903344|Vitamin D|vitamin d|mesh-list
65246968|NCT00903344|Cholecalciferol|cholecalciferol|mesh-list
65246969|NCT00903344|Vitamins|vitamins|mesh-ancestor
65246970|NCT00903344|Micronutrients|micronutrients|mesh-ancestor
65246971|NCT00903344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65246975|NCT02847338|Lisinopril|lisinopril|mesh-list
65246994|NCT02847338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65246995|NCT02847338|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65246996|NCT02847338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65246997|NCT02847104|Insulin|insulin|mesh-list
65246998|NCT02847104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65246999|NCT02847104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65247000|NCT02847104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247001|NCT02849132|Entecavir|entecavir|mesh-list
65247002|NCT02849132|Antiviral Agents|antiviral agents|mesh-ancestor
65247003|NCT02849132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65247004|NCT05116826|Nitazoxanide|nitazoxanide|mesh-list
65247005|NCT05116826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65247006|NCT05116826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65247007|NCT02848508|Metformin|metformin|mesh-list
65247008|NCT02848508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65247009|NCT02848508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247010|NCT00902564|Citalopram|citalopram|mesh-list
65247011|NCT00902564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65247012|NCT00902564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65247013|NCT00902564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65247014|NCT00902564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247015|NCT00902564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65247016|NCT00902564|Serotonin Agents|serotonin agents|mesh-ancestor
65247017|NCT00902564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247018|NCT00902564|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65247019|NCT00902564|Antidepressive Agents|antidepressive agents|mesh-ancestor
65247020|NCT00902564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65247021|NCT00626197|Mycophenolic Acid|mycophenolic acid|mesh-list
65247022|NCT00626197|Cyclophosphamide|cyclophosphamide|mesh-list
65247023|NCT00626197|Azathioprine|azathioprine|mesh-list
65247024|NCT00626197|Ocrelizumab|ocrelizumab|mesh-list
65247025|NCT00626197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65247026|NCT00626197|Immunologic Factors|immunologic factors|mesh-ancestor
65247035|NCT00626197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65247036|NCT00626197|Antitubercular Agents|antitubercular agents|mesh-ancestor
65247037|NCT00626197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65247038|NCT00626197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65247039|NCT00626197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247040|NCT00626197|Antimetabolites|antimetabolites|mesh-ancestor
65247041|NCT00626197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65247042|NCT02847884|Infliximab|infliximab|mesh-list
65247043|NCT02847884|Dermatologic Agents|dermatologic agents|mesh-ancestor
65247044|NCT02847884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65247045|NCT02847884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65247046|NCT00623935|Fludarabine|fludarabine|mesh-list
65247047|NCT00623935|Busulfan|busulfan|mesh-list
65247048|NCT00623935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997316|NCT00098501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247049|NCT00623935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247050|NCT00623935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65247051|NCT00623935|Immunologic Factors|immunologic factors|mesh-ancestor
65247052|NCT00623935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247053|NCT00623935|Alkylating Agents|alkylating agents|mesh-ancestor
65247054|NCT00623935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65247055|NCT00623935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65247057|NCT04029116|Ibrexafungerp|ibrexafungerp|mesh-list
65247058|NCT04029116|Antifungal Agents|antifungal agents|mesh-ancestor
65247059|NCT04029116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65247060|NCT04029116|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65247061|NCT04029116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65247062|NCT04029116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247063|NCT04029116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247078|NCT00623779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65247079|NCT00623779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65247080|NCT00623779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65247081|NCT00623779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247082|NCT00623779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65247083|NCT00623779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65247084|NCT00623779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247085|NCT00623779|Antipyretics|antipyretics|mesh-ancestor
65247086|NCT00828373|Lidocaine|lidocaine|mesh-list
65247087|NCT00828373|Anesthetics, Local|anesthetics, local|mesh-ancestor
65247088|NCT00828373|Anesthetics|anesthetics|mesh-ancestor
65247089|NCT00828373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65247090|NCT00828373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247091|NCT00828373|Sensory System Agents|sensory system agents|mesh-ancestor
65247092|NCT00828373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65247093|NCT00828373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65247094|NCT00828373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65247095|NCT00828373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65247096|NCT00828373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65247097|NCT00828373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247098|NCT00824239|Fentanyl|fentanyl|mesh-list
65247099|NCT00824239|Midazolam|midazolam|mesh-list
65247100|NCT00824239|Propofol|propofol|mesh-list
65247101|NCT00824239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65247102|NCT00824239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65247103|NCT00824239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247104|NCT00824239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65247105|NCT00824239|Anesthetics, General|anesthetics, general|mesh-ancestor
65247106|NCT00824239|Anesthetics|anesthetics|mesh-ancestor
65247107|NCT00824239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65247108|NCT00824239|Narcotics|narcotics|mesh-ancestor
65247109|NCT00824239|Analgesics|analgesics|mesh-ancestor
65247120|NCT04777760|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65247121|NCT04777760|Respiratory System Agents|respiratory system agents|mesh-ancestor
65247122|NCT02548975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65247123|NCT02548975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65247124|NCT02548975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65247125|NCT02548975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65247126|NCT02548975|Antimetabolites|antimetabolites|mesh-ancestor
65247127|NCT02548975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247128|NCT02548975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247129|NCT02548975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65247130|NCT02548975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65247131|NCT02548975|Adrenergic Agents|adrenergic agents|mesh-ancestor
65247132|NCT02548975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65247133|NCT02548975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247134|NCT04044703|Vancomycin|vancomycin|mesh-list
65247135|NCT04044703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65247136|NCT04044703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65247137|NCT02848040|Bile Acids and Salts|bile acids and salts|mesh-list
65247138|NCT02848040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65247139|NCT00824317|Methylphenidate|methylphenidate|mesh-list
65247140|NCT00824317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65247141|NCT00824317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247142|NCT00824317|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65247143|NCT00824317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65247144|NCT00824317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65247145|NCT00824317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247146|NCT00824317|Dopamine Agents|dopamine agents|mesh-ancestor
65247147|NCT00824317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65247148|NCT02847806|Insulin|insulin|mesh-list
65247149|NCT02847806|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65247150|NCT02847806|Estradiol|estradiol|mesh-list
65247151|NCT02847806|Testosterone|testosterone|mesh-list
64922506|NCT00022009|Immunologic Factors|immunologic factors|mesh-ancestor
65247161|NCT00828529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65247162|NCT00632762|Amantadine|amantadine|mesh-list
65247163|NCT00632762|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65247164|NCT00632762|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65247165|NCT00632762|Antiviral Agents|antiviral agents|mesh-ancestor
65247166|NCT00632762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65247167|NCT00632762|Dopamine Agents|dopamine agents|mesh-ancestor
65247168|NCT00632762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65247169|NCT00632762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247170|NCT00632762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247171|NCT00632762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65247172|NCT00632762|Analgesics|analgesics|mesh-ancestor
65247173|NCT00632762|Sensory System Agents|sensory system agents|mesh-ancestor
65247174|NCT00632762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65247175|NCT01351766|Nicotine|nicotine|mesh-list
65247176|NCT01351766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65247177|NCT01351766|Autonomic Agents|autonomic agents|mesh-ancestor
65247178|NCT01351766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65247179|NCT01351766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247180|NCT01351766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65247181|NCT01351766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65247182|NCT01351766|Cholinergic Agents|cholinergic agents|mesh-ancestor
65247183|NCT01351766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65247184|NCT01351766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247185|NCT02846090|Dexmedetomidine|dexmedetomidine|mesh-list
65247186|NCT02846090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65247187|NCT02846090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65247188|NCT02846090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247189|NCT02846090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65247190|NCT02846090|Analgesics|analgesics|mesh-ancestor
65247191|NCT02846090|Sensory System Agents|sensory system agents|mesh-ancestor
65247192|NCT02846090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65247193|NCT02846090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65247194|NCT02846090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65247195|NCT02846090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65247196|NCT02846090|Adrenergic Agents|adrenergic agents|mesh-ancestor
64951557|NCT00054444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247197|NCT02846090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65247198|NCT02846090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247200|NCT00828763|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65247201|NCT00828763|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65247202|NCT00828763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247203|NCT00828763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247204|NCT00828763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65247205|NCT00828763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65247206|NCT00828763|Antiviral Agents|antiviral agents|mesh-ancestor
65247207|NCT00828763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65247208|NCT00824707|Entecavir|entecavir|mesh-list
65247209|NCT00824707|Antiviral Agents|antiviral agents|mesh-ancestor
65247210|NCT00824707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65247211|NCT00824785|Capecitabine|capecitabine|mesh-list
65247212|NCT00824785|Oxaliplatin|oxaliplatin|mesh-list
65247213|NCT00824785|Epirubicin|epirubicin|mesh-list
65247214|NCT00824785|Panitumumab|panitumumab|mesh-list
65247215|NCT00824785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65247216|NCT00824785|Antimetabolites|antimetabolites|mesh-ancestor
65247217|NCT00824785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247218|NCT00824785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247219|NCT00824785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65247220|NCT00824785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65247221|NCT00824785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65247222|NCT00824785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247223|NCT00824785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65247224|NCT00824863|Ketoconazole|ketoconazole|mesh-list
65247225|NCT00824863|Antifungal Agents|antifungal agents|mesh-ancestor
65247226|NCT00824863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65247227|NCT00824863|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65247228|NCT00824863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65247229|NCT00824863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247230|NCT00824863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247231|NCT00824863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64922584|NCT00022126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65247236|NCT02844530|Epratuzumab|epratuzumab|mesh-list
65247237|NCT02844530|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
65247238|NCT02844530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65247239|NCT02844530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247240|NCT02844530|Chelating Agents|chelating agents|mesh-ancestor
65247241|NCT02844530|Sequestering Agents|sequestering agents|mesh-ancestor
65247242|NCT02844530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247243|NCT00820417|Cetuximab|cetuximab|mesh-list
65247244|NCT00820417|Gefitinib|gefitinib|mesh-list
65247245|NCT00820417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65247246|NCT00820417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247247|NCT00820417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65247248|NCT00820417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247249|NCT00820417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247250|NCT04923620|Cetuximab|cetuximab|mesh-list
65247251|NCT04923620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65247252|NCT04923620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247253|NCT00828919|Axitinib|axitinib|mesh-list
65247254|NCT00828919|Crizotinib|crizotinib|mesh-list
65247255|NCT00828919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247256|NCT00828919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65247257|NCT00828919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247258|NCT00828919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247259|NCT00828997|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65247260|NCT00828997|Immunologic Factors|immunologic factors|mesh-ancestor
65247261|NCT00828997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247262|NCT02548741|Metformin|metformin|mesh-list
65247263|NCT02548741|Calcium Carbonate|calcium carbonate|mesh-list
65247264|NCT02548741|Calcium|calcium|mesh-list
65247265|NCT02548741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65247266|NCT02548741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247267|NCT02548741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65247268|NCT02548741|Antacids|antacids|mesh-ancestor
65247269|NCT02548741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247270|NCT02548741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64951558|NCT00054444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65247271|NCT02845856|Cetuximab|cetuximab|mesh-list
65247272|NCT02845856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65247273|NCT02845856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247274|NCT00825019|Paroxetine|paroxetine|mesh-list
65247275|NCT00825019|Amibegron|amibegron|mesh-list
65247276|NCT00825019|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65247277|NCT00825019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65247278|NCT00825019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65247279|NCT00825019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247280|NCT00825019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65247281|NCT00825019|Serotonin Agents|serotonin agents|mesh-ancestor
65247282|NCT00825019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247283|NCT00825019|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65247284|NCT00825019|Antidepressive Agents|antidepressive agents|mesh-ancestor
65247285|NCT00825019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65247286|NCT00825019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65247287|NCT00825019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65247288|NCT00825019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247289|NCT00825019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65247290|NCT00825019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65247291|NCT00825019|Adrenergic Agents|adrenergic agents|mesh-ancestor
65247292|NCT00929006|Progesterone|progesterone|mesh-list
65247293|NCT00929006|Progestins|progestins|mesh-ancestor
65247294|NCT00929006|Hormones|hormones|mesh-ancestor
65247295|NCT00929006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65247296|NCT00929006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247297|NCT00877214|Rituximab|rituximab|mesh-list
65247298|NCT00877214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65247299|NCT00877214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247300|NCT00877214|Immunologic Factors|immunologic factors|mesh-ancestor
65247301|NCT00877214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247302|NCT00877214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65247303|NCT00474032|Botulinum Toxins|botulinum toxins|mesh-list
65247310|NCT05242718|Palmidrol|palmidrol|mesh-list
65247311|NCT05242718|Acetylcysteine|acetylcysteine|mesh-list
65247312|NCT05242718|Curcumin|curcumin|mesh-list
65247313|NCT05242718|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65247314|NCT05242718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65247315|NCT05242718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65247316|NCT05242718|Analgesics|analgesics|mesh-ancestor
65247317|NCT05242718|Sensory System Agents|sensory system agents|mesh-ancestor
65247318|NCT05242718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65247319|NCT05242718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247320|NCT05242718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65247321|NCT05242718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65247322|NCT05242718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247323|NCT05242718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247324|NCT05242718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247325|NCT05242718|Antiviral Agents|antiviral agents|mesh-ancestor
65247326|NCT05242718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65247327|NCT05242718|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65247328|NCT05242718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65247329|NCT05242718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65247330|NCT05242718|Hormones|hormones|mesh-ancestor
65247331|NCT05242718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65247332|NCT05242718|Expectorants|expectorants|mesh-ancestor
65247333|NCT05242718|Respiratory System Agents|respiratory system agents|mesh-ancestor
65247334|NCT05242718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65247335|NCT05242718|Antioxidants|antioxidants|mesh-ancestor
65247336|NCT05242718|Protective Agents|protective agents|mesh-ancestor
65247337|NCT05242718|Antidotes|antidotes|mesh-ancestor
65247338|NCT02845778|Melatonin|melatonin|mesh-list
65247339|NCT02845778|Antioxidants|antioxidants|mesh-ancestor
65247340|NCT02845778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247341|NCT02845778|Protective Agents|protective agents|mesh-ancestor
65247342|NCT02845778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247343|NCT02845778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65247351|NCT05337332|Glucocorticoids|glucocorticoids|mesh-ancestor
65247352|NCT05337332|Hormones|hormones|mesh-ancestor
65247353|NCT05337332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65247354|NCT05337332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247355|NCT05337332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65247356|NCT05337332|Immunologic Factors|immunologic factors|mesh-ancestor
65247357|NCT05337332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247358|NCT05337332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247359|NCT00901394|Folic Acid|folic acid|mesh-list
65247360|NCT00901394|Nitrous Oxide|nitrous oxide|mesh-list
65247361|NCT00901394|Hematinics|hematinics|mesh-ancestor
65247362|NCT00901394|Vitamin B Complex|vitamin b complex|mesh-ancestor
65247363|NCT00901394|Vitamins|vitamins|mesh-ancestor
65247364|NCT00901394|Micronutrients|micronutrients|mesh-ancestor
65247365|NCT00901394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247366|NCT00901394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65247367|NCT00901394|Anesthetics, General|anesthetics, general|mesh-ancestor
65247368|NCT00901394|Anesthetics|anesthetics|mesh-ancestor
65247369|NCT00901394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65247370|NCT00901394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65247371|NCT00901394|Analgesics|analgesics|mesh-ancestor
65247372|NCT00901394|Sensory System Agents|sensory system agents|mesh-ancestor
65247373|NCT00901394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65247374|NCT05337254|Dihydroergotamine|dihydroergotamine|mesh-list
65247375|NCT05337254|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65247376|NCT05337254|Dopamine Agonists|dopamine agonists|mesh-ancestor
65247377|NCT05337254|Dopamine Agents|dopamine agents|mesh-ancestor
65247378|NCT05337254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65247379|NCT05337254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247380|NCT05337254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247381|NCT05337254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65247382|NCT05337254|Analgesics|analgesics|mesh-ancestor
64922745|NCT00010842|Vitamins|vitamins|mesh-ancestor
65247395|NCT00574873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247396|NCT00574873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65247397|NCT00574873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247398|NCT00574873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247399|NCT02843490|Ranibizumab|ranibizumab|mesh-list
65247400|NCT02843490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65247401|NCT02843490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65247402|NCT02843490|Growth Substances|growth substances|mesh-ancestor
65247403|NCT02843490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247404|NCT02843490|Growth Inhibitors|growth inhibitors|mesh-ancestor
65247405|NCT02843490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247406|NCT00902174|Imatinib Mesylate|imatinib mesylate|mesh-list
65247407|NCT00902174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247408|NCT00902174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65247409|NCT00902174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247410|NCT00902174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247411|NCT04201808|Tenofovir|tenofovir|mesh-list
65247412|NCT04201808|Antiviral Agents|antiviral agents|mesh-ancestor
65247413|NCT04201808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65247414|NCT04201808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65247415|NCT04201808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65247416|NCT04201808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247417|NCT04201808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247418|NCT04201808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65247419|NCT04201808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65247420|NCT01341600|Omeprazole|omeprazole|mesh-list
65247421|NCT01341600|Clopidogrel|clopidogrel|mesh-list
65247422|NCT01341600|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65247423|NCT01341600|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65247424|NCT01341600|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65247426|NCT01341600|Purinergic Agents|purinergic agents|mesh-ancestor
65247434|NCT02845388|Sildenafil Citrate|sildenafil citrate|mesh-list
65247435|NCT02845388|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65247436|NCT02845388|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65247437|NCT02845388|Estradiol|estradiol|mesh-list
65247438|NCT02845388|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65247439|NCT02845388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247440|NCT02845388|Estrogens|estrogens|mesh-ancestor
65247441|NCT02845388|Hormones|hormones|mesh-ancestor
65247442|NCT02845388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65247443|NCT02845388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247444|NCT02845388|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65247445|NCT02845388|Contraceptive Agents|contraceptive agents|mesh-ancestor
65247446|NCT02845388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65247447|NCT02845388|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65247448|NCT02845388|Vasodilator Agents|vasodilator agents|mesh-ancestor
65247449|NCT02845388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65247450|NCT02845388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65247451|NCT02845388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247452|NCT02845388|Urological Agents|urological agents|mesh-ancestor
65247453|NCT02845466|Becaplermin|becaplermin|mesh-list
65247454|NCT02845466|Anticoagulants|anticoagulants|mesh-ancestor
65247455|NCT02845466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
65247456|NCT02845466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65247457|NCT02845466|Growth Substances|growth substances|mesh-ancestor
65247458|NCT02845466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247459|NCT04345796|Empagliflozin|empagliflozin|mesh-list
65247460|NCT04345796|Carvedilol|carvedilol|mesh-list
65247461|NCT04345796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65247462|NCT04345796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247463|NCT04345796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65247464|NCT04345796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247474|NCT04345796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65247475|NCT04345796|Vasodilator Agents|vasodilator agents|mesh-ancestor
65247476|NCT04345796|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65247477|NCT04345796|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65247478|NCT00623623|Enoxaparin|enoxaparin|mesh-list
65247479|NCT00623623|Tenecteplase|tenecteplase|mesh-list
65247480|NCT00623623|Clopidogrel|clopidogrel|mesh-list
65247481|NCT00623623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65247482|NCT00623623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65247483|NCT00623623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65247484|NCT00623623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65247485|NCT00623623|Purinergic Agents|purinergic agents|mesh-ancestor
65247486|NCT00623623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65247487|NCT00623623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247488|NCT00623623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247489|NCT00623623|Anticoagulants|anticoagulants|mesh-ancestor
65247490|NCT00623623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65247491|NCT00623623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65247492|NCT00896454|Denosumab|denosumab|mesh-list
65247493|NCT00896454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65247494|NCT00896454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247495|NCT04224584|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65247496|NCT04224584|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65247497|NCT04224584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65247498|NCT04224584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65247499|NCT04224584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247500|NCT04224584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65247501|NCT04224584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247516|NCT02993198|Antioxidants|antioxidants|mesh-ancestor
65247517|NCT02993198|Protective Agents|protective agents|mesh-ancestor
65247518|NCT02993198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65247519|NCT02993198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65247520|NCT02993198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65247521|NCT02993198|Vasodilator Agents|vasodilator agents|mesh-ancestor
65247522|NCT02993198|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65247523|NCT02993198|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65247524|NCT00829231|Sorafenib|sorafenib|mesh-list
65247525|NCT00829231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247526|NCT00829231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65247527|NCT00829231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247528|NCT00829231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247529|NCT00901628|Cefuroxime|cefuroxime|mesh-list
65247530|NCT00901628|Cefuroxime axetil|cefuroxime axetil|mesh-list
65247531|NCT00901628|Ketorolac|ketorolac|mesh-list
65247532|NCT00901628|Epinephrine|epinephrine|mesh-list
65247533|NCT00901628|Morphine|morphine|mesh-list
65247534|NCT00901628|Ropivacaine|ropivacaine|mesh-list
65247535|NCT00901628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65247536|NCT00901628|Narcotics|narcotics|mesh-ancestor
65247537|NCT00901628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65247538|NCT00901628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247539|NCT00901628|Analgesics|analgesics|mesh-ancestor
65247540|NCT00901628|Sensory System Agents|sensory system agents|mesh-ancestor
65247541|NCT00901628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65247542|NCT00901628|Anesthetics, Local|anesthetics, local|mesh-ancestor
65247543|NCT00901628|Anesthetics|anesthetics|mesh-ancestor
65247544|NCT00901628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65247545|NCT00901628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65247546|NCT00901628|Adrenergic Agents|adrenergic agents|mesh-ancestor
65247547|NCT00901628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65247548|NCT00901628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247559|NCT00901628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65247560|NCT00901628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65247561|NCT00901628|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65247562|NCT00901628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247563|NCT00901628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65247564|NCT00901628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65247565|NCT00623545|Exenatide|exenatide|mesh-list
65247566|NCT00623545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65247567|NCT00623545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247568|NCT00623545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65247569|NCT00623545|Incretins|incretins|mesh-ancestor
65247571|NCT00623545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65247572|NCT00825097|Botulinum Toxins|botulinum toxins|mesh-list
65247573|NCT00825097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65247574|NCT00825097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65247575|NCT00825097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247576|NCT00825097|Cholinergic Agents|cholinergic agents|mesh-ancestor
65247577|NCT00825097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65247578|NCT00825097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247579|NCT02839668|Acetaminophen|acetaminophen|mesh-list
65247580|NCT02839668|Lidocaine|lidocaine|mesh-list
65247581|NCT02839668|Atropine|atropine|mesh-list
65247582|NCT02839668|Tramadol|tramadol|mesh-list
65247583|NCT02839668|Sevoflurane|sevoflurane|mesh-list
65247584|NCT02839668|Neostigmine|neostigmine|mesh-list
65247585|NCT02839668|Anesthetics, Local|anesthetics, local|mesh-ancestor
65247586|NCT02839668|Anesthetics|anesthetics|mesh-ancestor
65247587|NCT02839668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65247588|NCT02839668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247589|NCT02839668|Sensory System Agents|sensory system agents|mesh-ancestor
65247597|NCT02839668|Analgesics|analgesics|mesh-ancestor
65247605|NCT02839668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65247606|NCT02839668|Autonomic Agents|autonomic agents|mesh-ancestor
65247607|NCT02839668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65247608|NCT02839668|Respiratory System Agents|respiratory system agents|mesh-ancestor
65247609|NCT02839668|Mydriatics|mydriatics|mesh-ancestor
65247610|NCT02839668|Parasympatholytics|parasympatholytics|mesh-ancestor
65247611|NCT02839668|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65247612|NCT02839668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65247613|NCT02839668|Cholinergic Agents|cholinergic agents|mesh-ancestor
65247614|NCT02839668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65247615|NCT02839668|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65247616|NCT02839668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247617|NCT02839668|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65247618|NCT04701788|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65247619|NCT04701788|Immunologic Factors|immunologic factors|mesh-ancestor
65247620|NCT04701788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247621|NCT04700618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65247622|NCT04700618|Immunologic Factors|immunologic factors|mesh-ancestor
65247623|NCT04700618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247624|NCT00829465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65247625|NCT00829465|Immunologic Factors|immunologic factors|mesh-ancestor
65247626|NCT00829465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247627|NCT02839356|Epinephrine|epinephrine|mesh-list
65247628|NCT02839356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65247629|NCT02839356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65247630|NCT02839356|Adrenergic Agents|adrenergic agents|mesh-ancestor
65247631|NCT02839356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65247632|NCT02839356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247651|NCT02840526|Anesthetics|anesthetics|mesh-ancestor
65247652|NCT02840526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65247653|NCT02840526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247654|NCT02840526|Sensory System Agents|sensory system agents|mesh-ancestor
65247655|NCT02840526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65247656|NCT02840526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65247657|NCT02840526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65247658|NCT02840526|Anesthetics, General|anesthetics, general|mesh-ancestor
65247659|NCT02840526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65247660|NCT02840526|Narcotics|narcotics|mesh-ancestor
65247661|NCT02840526|Analgesics|analgesics|mesh-ancestor
65247662|NCT02840526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65247663|NCT02840526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65247664|NCT02840526|Antipyretics|antipyretics|mesh-ancestor
65247665|NCT02840526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65247666|NCT02840526|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65247667|NCT02342444|Enoxaparin|enoxaparin|mesh-list
65247710|NCT00632840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247711|NCT00632840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65247712|NCT00632840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65247713|NCT00632840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247714|NCT00829699|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65247715|NCT00829699|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65247716|NCT00829699|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65247717|NCT00829699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65247718|NCT00829777|Naloxone|naloxone|mesh-list
65247719|NCT00829777|Lactulose|lactulose|mesh-list
65247720|NCT00829777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65247721|NCT00829777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247722|NCT00829777|Sensory System Agents|sensory system agents|mesh-ancestor
65247723|NCT00829777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65247724|NCT00829777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65247725|NCT02834754|Vedolizumab|vedolizumab|mesh-list
65247726|NCT02834754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65247728|NCT02839122|Dutasteride|dutasteride|mesh-list
65247729|NCT02839122|Vasodilator Agents|vasodilator agents|mesh-ancestor
65247730|NCT02839122|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65247731|NCT02839122|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65247732|NCT02839122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247733|NCT02839122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247734|NCT02839122|Urological Agents|urological agents|mesh-ancestor
65247735|NCT02839122|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65247736|NCT02839122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65247737|NCT02839122|Hormone Antagonists|hormone antagonists|mesh-ancestor
65247738|NCT02839122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65247739|NCT02839122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247740|NCT00633282|Pioglitazone|pioglitazone|mesh-list
64923116|NCT00023998|Leucovorin|leucovorin|mesh-list
65247752|NCT00830245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247753|NCT00830245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65247754|NCT00830245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247755|NCT00830245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247756|NCT02837874|Antidiarrheals|antidiarrheals|mesh-list
65247757|NCT02837874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65247758|NCT02838030|Aspirin|aspirin|mesh-list
65247759|NCT02838030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65247760|NCT02838030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65247761|NCT02838030|Analgesics|analgesics|mesh-ancestor
65247762|NCT02838030|Sensory System Agents|sensory system agents|mesh-ancestor
65247763|NCT02838030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65247764|NCT02838030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247765|NCT02838030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65247766|NCT02838030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65247767|NCT02838030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65247768|NCT02838030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65247769|NCT02838030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247770|NCT02838030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65247771|NCT02838030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65247772|NCT02838030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247773|NCT02838030|Antipyretics|antipyretics|mesh-ancestor
65247774|NCT00825643|Insulin Detemir|insulin detemir|mesh-list
65247775|NCT00825643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65247776|NCT00825643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247777|NCT04044079|Misoprostol|misoprostol|mesh-list
65247778|NCT04044079|Dinoprostone|dinoprostone|mesh-list
65247779|NCT04044079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65247780|NCT04044079|Abortifacient Agents|abortifacient agents|mesh-ancestor
65247781|NCT04044079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65247782|NCT04044079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247783|NCT04044079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65247784|NCT04044079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65247792|NCT00830323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247793|NCT00830323|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65247794|NCT00830323|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65247795|NCT00830323|Dopamine Agents|dopamine agents|mesh-ancestor
65247796|NCT00830323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65247797|NCT00830323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247798|NCT00830323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65247799|NCT00830323|Analgesics|analgesics|mesh-ancestor
65247800|NCT00830323|Sensory System Agents|sensory system agents|mesh-ancestor
65247801|NCT00830323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65247802|NCT00830401|Doxycycline|doxycycline|mesh-list
65247803|NCT00830401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65247804|NCT00830401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65247805|NCT00830401|Antimalarials|antimalarials|mesh-ancestor
65247806|NCT00830401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65247807|NCT00830401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65247808|NCT04249908|Maleic acid|maleic acid|mesh-list
65247809|NCT04249908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247810|NCT04249908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247811|NCT00825721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65247812|NCT00825721|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65247813|NCT02837640|Levodopa|levodopa|mesh-list
65247814|NCT02837640|Carbidopa|carbidopa|mesh-list
65247815|NCT02837640|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65247816|NCT02837640|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65247842|NCT02834286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65247843|NCT02839044|Vitamin K 2|vitamin k 2|mesh-list
65247844|NCT02839044|Vitamin K|vitamin k|mesh-list
65247845|NCT02839044|Vitamin MK 7|vitamin mk 7|mesh-list
65247846|NCT02839044|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65247847|NCT02839044|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65247848|NCT02839044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247849|NCT02839044|Hemostatics|hemostatics|mesh-ancestor
65247850|NCT02839044|Coagulants|coagulants|mesh-ancestor
65247851|NCT02839044|Vitamins|vitamins|mesh-ancestor
65247852|NCT02839044|Micronutrients|micronutrients|mesh-ancestor
65247853|NCT02839044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247854|NCT02833506|Sirolimus|sirolimus|mesh-list
65247855|NCT02833506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65247856|NCT02833506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65247857|NCT02833506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65247858|NCT02833506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247859|NCT02833506|Antifungal Agents|antifungal agents|mesh-ancestor
65247860|NCT02833506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65247861|NCT02833506|Immunologic Factors|immunologic factors|mesh-ancestor
65247862|NCT02833506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247863|NCT02838576|Estrogens|estrogens|mesh-list
65247864|NCT02838576|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65247865|NCT02838576|Hormones|hormones|mesh-ancestor
65247866|NCT02838576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65247867|NCT02838576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247868|NCT00838539|Sirolimus|sirolimus|mesh-list
65247869|NCT00838539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65247870|NCT00838539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65247871|NCT00838539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65247872|NCT00838539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247887|NCT02836704|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65247888|NCT02836704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247889|NCT02836704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247890|NCT02833584|Acetaminophen|acetaminophen|mesh-list
65247891|NCT02833584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65247892|NCT02833584|Analgesics|analgesics|mesh-ancestor
65247893|NCT02833584|Sensory System Agents|sensory system agents|mesh-ancestor
65247894|NCT02833584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65247895|NCT02833584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247896|NCT02833584|Antipyretics|antipyretics|mesh-ancestor
65247897|NCT00837759|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65247898|NCT00837759|Lansoprazole|lansoprazole|mesh-list
65247899|NCT00837759|Dexlansoprazole|dexlansoprazole|mesh-list
65247900|NCT00837759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65247901|NCT00837759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247902|NCT00837759|Incretins|incretins|mesh-ancestor
65247903|NCT00837759|Hormones|hormones|mesh-ancestor
65247904|NCT00837759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65247905|NCT00837759|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65247906|NCT00837759|Protease Inhibitors|protease inhibitors|mesh-ancestor
65247907|NCT00837759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247908|NCT00837759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247909|NCT00837759|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65247910|NCT00837759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65247911|NCT00837759|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65247912|NCT00703365|Gemcitabine|gemcitabine|mesh-list
65247913|NCT00703365|Sorafenib|sorafenib|mesh-list
65247914|NCT00703365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65247915|NCT00703365|Antimetabolites|antimetabolites|mesh-ancestor
65247932|NCT04474938|Daratumumab|daratumumab|mesh-list
65247933|NCT04474938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65247934|NCT04474938|Antiemetics|antiemetics|mesh-ancestor
65247935|NCT04474938|Autonomic Agents|autonomic agents|mesh-ancestor
65247936|NCT04474938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65247937|NCT04474938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247938|NCT04474938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65247939|NCT04474938|Glucocorticoids|glucocorticoids|mesh-ancestor
65247940|NCT04474938|Hormones|hormones|mesh-ancestor
65247941|NCT04474938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65247942|NCT04474938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65247943|NCT04474938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247944|NCT00837213|Doxycycline|doxycycline|mesh-list
65247945|NCT00837213|Clindamycin|clindamycin|mesh-list
65247946|NCT00837213|Clindamycin palmitate|clindamycin palmitate|mesh-list
65247947|NCT00837213|Clindamycin phosphate|clindamycin phosphate|mesh-list
65247948|NCT00837213|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65247949|NCT00837213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65247951|NCT00837213|Antimalarials|antimalarials|mesh-ancestor
65247952|NCT00837213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65247953|NCT00837213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65247954|NCT00837213|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65247955|NCT00837213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65247956|NCT00837213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247957|NCT00837213|Dermatologic Agents|dermatologic agents|mesh-ancestor
65247958|NCT02833038|Magnesium Sulfate|magnesium sulfate|mesh-list
65247959|NCT02833038|Analgesics|analgesics|mesh-ancestor
65247960|NCT02833038|Sensory System Agents|sensory system agents|mesh-ancestor
65247961|NCT02833038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65247962|NCT02833038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247963|NCT02833038|Anesthetics|anesthetics|mesh-ancestor
65247964|NCT02833038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65247965|NCT02833038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65247973|NCT00703755|Metformin|metformin|mesh-list
65247975|NCT00703755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65247976|NCT00703755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247977|NCT00703755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65247978|NCT00703755|Antimetabolites|antimetabolites|mesh-ancestor
65247979|NCT00703755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247980|NCT00703755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65247981|NCT02838342|Interferons|interferons|mesh-list
65247982|NCT02838342|Interferon-alpha|interferon-alpha|mesh-list
65247983|NCT02838342|Cyclophosphamide|cyclophosphamide|mesh-list
65247984|NCT02838342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65247985|NCT02838342|Immunologic Factors|immunologic factors|mesh-ancestor
65247986|NCT02838342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65247987|NCT02838342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65247988|NCT02838342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65247989|NCT02838342|Alkylating Agents|alkylating agents|mesh-ancestor
65247990|NCT02838342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65247991|NCT02838342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247992|NCT02838342|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65247993|NCT02838342|Antiviral Agents|antiviral agents|mesh-ancestor
65247994|NCT02838342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65247995|NCT05333640|Sirolimus|sirolimus|mesh-list
65247996|NCT05333640|Paclitaxel|paclitaxel|mesh-list
65247997|NCT05333640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65247998|NCT05333640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65247999|NCT05333640|Tubulin Modulators|tubulin modulators|mesh-ancestor
65248000|NCT05333640|Antimitotic Agents|antimitotic agents|mesh-ancestor
65248001|NCT05333640|Mitosis Modulators|mitosis modulators|mesh-ancestor
65248002|NCT05333640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248003|NCT05333640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65248004|NCT05333640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65248010|NCT02838264|Itraconazole|itraconazole|mesh-list
65248018|NCT02838264|Hormone Antagonists|hormone antagonists|mesh-ancestor
65248019|NCT02838264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65248020|NCT02838264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248021|NCT02838264|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65248022|NCT00633438|Celecoxib|celecoxib|mesh-list
65248023|NCT00633438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65248024|NCT00633438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65248025|NCT00633438|Analgesics|analgesics|mesh-ancestor
65248026|NCT00633438|Sensory System Agents|sensory system agents|mesh-ancestor
65248027|NCT00633438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65248028|NCT00633438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248029|NCT00633438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65248030|NCT00633438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65248031|NCT00633438|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65248032|NCT00633438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65248033|NCT00633438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248034|NCT00633438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248035|NCT02833116|Dexamethasone|dexamethasone|mesh-list
65248036|NCT02833116|Betamethasone|betamethasone|mesh-list
65248037|NCT02833116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65248038|NCT02833116|Antiemetics|antiemetics|mesh-ancestor
65248039|NCT02833116|Autonomic Agents|autonomic agents|mesh-ancestor
65248040|NCT02833116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65248041|NCT02833116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248042|NCT02833116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65248043|NCT02833116|Glucocorticoids|glucocorticoids|mesh-ancestor
65248044|NCT02833116|Hormones|hormones|mesh-ancestor
65248045|NCT02833116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65248046|NCT02833116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65248047|NCT02833116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65248060|NCT00703989|Immunologic Factors|immunologic factors|mesh-ancestor
65248061|NCT00703989|Chelating Agents|chelating agents|mesh-ancestor
65248062|NCT00703989|Sequestering Agents|sequestering agents|mesh-ancestor
65248063|NCT05335460|Capecitabine|capecitabine|mesh-list
65248064|NCT05335460|Oxaliplatin|oxaliplatin|mesh-list
65248065|NCT05335460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65248066|NCT05335460|Antimetabolites|antimetabolites|mesh-ancestor
65248067|NCT05335460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248068|NCT05335460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65248069|NCT02836002|Pyrimethamine|pyrimethamine|mesh-list
65248070|NCT02836002|Piperaquine|piperaquine|mesh-list
65248071|NCT02836002|Sulfadoxine|sulfadoxine|mesh-list
65248072|NCT02836002|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65248073|NCT02836002|Atovaquone|atovaquone|mesh-list
65248074|NCT02836002|Proguanil|proguanil|mesh-list
65248075|NCT02836002|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
65248076|NCT02836002|Antimalarials|antimalarials|mesh-ancestor
65248077|NCT02836002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65248078|NCT02836002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65248079|NCT02836002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65248080|NCT02836002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65248081|NCT02836002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248082|NCT02836002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248083|NCT02836002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65248084|NCT02836002|Renal Agents|renal agents|mesh-ancestor
65248085|NCT02836002|Antimetabolites|antimetabolites|mesh-ancestor
65248086|NCT02297516|Botulinum Toxins|botulinum toxins|mesh-list
65248087|NCT02297516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65248088|NCT02297516|Hyaluronic Acid|hyaluronic acid|mesh-list
65248089|NCT02297516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65248090|NCT02297516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65248091|NCT02297516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248092|NCT02297516|Cholinergic Agents|cholinergic agents|mesh-ancestor
65248093|NCT02297516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65248094|NCT02297516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248095|NCT02297516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65248096|NCT02297516|Immunologic Factors|immunologic factors|mesh-ancestor
65248099|NCT02842580|Leucovorin|leucovorin|mesh-list
65248100|NCT02842580|Bevacizumab|bevacizumab|mesh-list
65248101|NCT02842580|Capecitabine|capecitabine|mesh-list
65248102|NCT02842580|Oxaliplatin|oxaliplatin|mesh-list
65248103|NCT02842580|Irinotecan|irinotecan|mesh-list
65248104|NCT02842580|Levoleucovorin|levoleucovorin|mesh-list
65248105|NCT02842580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65248106|NCT02842580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65248107|NCT02842580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65248108|NCT02842580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65248109|NCT02842580|Growth Substances|growth substances|mesh-ancestor
65248110|NCT02842580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248111|NCT02842580|Growth Inhibitors|growth inhibitors|mesh-ancestor
65248112|NCT02842580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65248113|NCT02842580|Antimetabolites|antimetabolites|mesh-ancestor
65248114|NCT02842580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248115|NCT02842580|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65248116|NCT02842580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65248117|NCT02842580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248118|NCT02842580|Antidotes|antidotes|mesh-ancestor
65248119|NCT02842580|Protective Agents|protective agents|mesh-ancestor
65248120|NCT02842580|Vitamin B Complex|vitamin b complex|mesh-ancestor
65248121|NCT02842580|Vitamins|vitamins|mesh-ancestor
65248122|NCT02842580|Micronutrients|micronutrients|mesh-ancestor
65248123|NCT00836277|Irinotecan|irinotecan|mesh-list
65248124|NCT00836277|Panitumumab|panitumumab|mesh-list
65248125|NCT00836277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65248126|NCT00836277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65248127|NCT00836277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248128|NCT00836277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248129|NCT00836277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65248131|NCT00835731|Vitamin B 12|vitamin b 12|mesh-list
65248146|NCT03721406|Anesthetics, Local|anesthetics, local|mesh-ancestor
65248147|NCT03721406|Anesthetics|anesthetics|mesh-ancestor
65248148|NCT03721406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65248149|NCT03721406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248150|NCT03721406|Sensory System Agents|sensory system agents|mesh-ancestor
65248151|NCT03721406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65248152|NCT00751166|Cetirizine|cetirizine|mesh-list
65248153|NCT00751166|Desloratadine|desloratadine|mesh-list
65248154|NCT00751166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65248155|NCT00751166|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65248156|NCT00751166|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65248157|NCT00751166|Histamine Antagonists|histamine antagonists|mesh-ancestor
65248158|NCT00751166|Histamine Agents|histamine agents|mesh-ancestor
65248159|NCT00751166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65248160|NCT00751166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248161|NCT00751166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248162|NCT00751166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65248163|NCT00751166|Cholinergic Agents|cholinergic agents|mesh-ancestor
65248164|NCT00837343|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65248165|NCT00837343|Antidepressive Agents|antidepressive agents|mesh-ancestor
65248166|NCT00837343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65248167|NCT00837343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65248168|NCT00837343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65248169|NCT00837343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65248170|NCT00837343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248171|NCT00732368|Mometasone Furoate|mometasone furoate|mesh-list
65248172|NCT00732368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65248173|NCT00732368|Dermatologic Agents|dermatologic agents|mesh-ancestor
65248174|NCT00732368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65248175|NCT00704145|Paclitaxel|paclitaxel|mesh-list
65248176|NCT00704145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65248177|NCT00704145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65248188|NCT00704223|Insulin Aspart|insulin aspart|mesh-list
65248189|NCT00704223|Biphasic Insulins|biphasic insulins|mesh-list
65248190|NCT00704223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65248191|NCT00704223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248192|NCT00704301|Rivastigmine|rivastigmine|mesh-list
65248193|NCT00704301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65248194|NCT00704301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248195|NCT00704301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248196|NCT00704301|Cholinergic Agents|cholinergic agents|mesh-ancestor
65248197|NCT00704301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65248198|NCT00704301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248199|NCT00704301|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65248200|NCT00704301|Protective Agents|protective agents|mesh-ancestor
65248201|NCT00831103|Valacyclovir|valacyclovir|mesh-list
65248202|NCT00831103|Antiviral Agents|antiviral agents|mesh-ancestor
65248203|NCT00831103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65248204|NCT00704444|Ezetimibe|ezetimibe|mesh-list
65248205|NCT00704444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65248206|NCT00704444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65248207|NCT00704444|Antimetabolites|antimetabolites|mesh-ancestor
65248208|NCT00704444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248209|NCT00704444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65248210|NCT00704691|Lenalidomide|lenalidomide|mesh-list
65248211|NCT00704691|Immunologic Factors|immunologic factors|mesh-ancestor
65248212|NCT00704691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248213|NCT00704691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65248214|NCT00704691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65248215|NCT00704691|Growth Substances|growth substances|mesh-ancestor
65248216|NCT00704691|Growth Inhibitors|growth inhibitors|mesh-ancestor
65248217|NCT00704691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65248218|NCT00704925|Amifampridine|amifampridine|mesh-list
65248219|NCT00704925|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65248220|NCT00704925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65248221|NCT00704925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248222|NCT00704925|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65248223|NCT00704925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65248227|NCT00574249|Calcipotriene|calcipotriene|mesh-list
65248228|NCT00574249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65248229|NCT00574249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65248230|NCT00574249|Glucocorticoids|glucocorticoids|mesh-ancestor
65248231|NCT00574249|Hormones|hormones|mesh-ancestor
65248232|NCT00574249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65248233|NCT00574249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248234|NCT00574249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65248235|NCT00574249|Respiratory System Agents|respiratory system agents|mesh-ancestor
65248236|NCT00574249|Dermatologic Agents|dermatologic agents|mesh-ancestor
65248237|NCT00891228|ST 1435|st 1435|mesh-list
65248238|NCT00891228|Testosterone|testosterone|mesh-list
65248239|NCT00891228|Androgens|androgens|mesh-ancestor
65248240|NCT00891228|Hormones|hormones|mesh-ancestor
65248241|NCT00891228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65248242|NCT00891228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248243|NCT00891228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65248244|NCT00891228|Contraceptive Agents|contraceptive agents|mesh-ancestor
65248245|NCT00891228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65248246|NCT00891228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65248247|NCT00896168|Methotrexate|methotrexate|mesh-list
65248248|NCT00896168|Infliximab|infliximab|mesh-list
65248249|NCT00896168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65248250|NCT00896168|Abortifacient Agents|abortifacient agents|mesh-ancestor
65248251|NCT00896168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65248252|NCT00896168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248253|NCT00896168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65248254|NCT00896168|Antimetabolites|antimetabolites|mesh-ancestor
65248255|NCT00896168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248256|NCT00896168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65248270|NCT00833703|Purinergic Agents|purinergic agents|mesh-ancestor
65248271|NCT00833703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65248272|NCT00833703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248273|NCT00833703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248274|NCT00833547|Eszopiclone|eszopiclone|mesh-list
65248275|NCT00833547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65248276|NCT00833547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65248277|NCT00833547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248278|NCT00833469|Citalopram|citalopram|mesh-list
65248279|NCT00833469|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65248280|NCT00833469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65248281|NCT00833469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65248282|NCT00833469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248283|NCT00833469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65248284|NCT00833469|Serotonin Agents|serotonin agents|mesh-ancestor
65248285|NCT00833469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248286|NCT00833469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65248287|NCT00833469|Antidepressive Agents|antidepressive agents|mesh-ancestor
65248288|NCT00833469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65248289|NCT02831478|Sunscreening Agents|sunscreening agents|mesh-list
65248290|NCT02831478|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65248291|NCT02831478|Protective Agents|protective agents|mesh-ancestor
65248292|NCT02831478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248293|NCT02831478|Dermatologic Agents|dermatologic agents|mesh-ancestor
65248294|NCT00837655|Calcium Carbonate|calcium carbonate|mesh-list
65248295|NCT00837655|Calcium|calcium|mesh-list
65248296|NCT00837655|Sevelamer|sevelamer|mesh-list
65248297|NCT00837655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65248298|NCT00837655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248312|NCT00843661|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65248313|NCT00843661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248314|NCT00832377|Timolol|timolol|mesh-list
65248315|NCT00832377|Dorzolamide|dorzolamide|mesh-list
65248316|NCT00832377|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65248317|NCT00832377|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65248318|NCT00832377|Adrenergic Agents|adrenergic agents|mesh-ancestor
65248319|NCT00832377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65248320|NCT00832377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248321|NCT00832377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248322|NCT00832377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65248323|NCT00832377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65248324|NCT00832377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65248325|NCT00832377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248326|NCT00843895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65248327|NCT00843895|Immunologic Factors|immunologic factors|mesh-ancestor
65248328|NCT00843895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248329|NCT00705315|Bevacizumab|bevacizumab|mesh-list
65248330|NCT00705315|Docetaxel|docetaxel|mesh-list
65248331|NCT00705315|Epirubicin|epirubicin|mesh-list
65248332|NCT00705315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65248333|NCT00705315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65248334|NCT00705315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65248362|NCT00623233|Bevacizumab|bevacizumab|mesh-list
65248363|NCT00623233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65248364|NCT00623233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65248365|NCT00623233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65248366|NCT00623233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65248367|NCT00623233|Growth Substances|growth substances|mesh-ancestor
65248368|NCT00623233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248369|NCT00623233|Growth Inhibitors|growth inhibitors|mesh-ancestor
65248370|NCT00623233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65248371|NCT00623233|Antimetabolites|antimetabolites|mesh-ancestor
65248372|NCT00623233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248373|NCT00623233|Antiviral Agents|antiviral agents|mesh-ancestor
65248374|NCT00623233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65248375|NCT00623233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248376|NCT00623233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65248377|NCT00623233|Immunologic Factors|immunologic factors|mesh-ancestor
65248378|NCT00837889|Diuretics|diuretics|mesh-list
65248379|NCT00837889|Natriuretic Agents|natriuretic agents|mesh-ancestor
65248380|NCT00837889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248381|NCT02841488|Fentanyl|fentanyl|mesh-list
65248382|NCT02841488|Ropivacaine|ropivacaine|mesh-list
65248383|NCT02841488|Anesthetics, Local|anesthetics, local|mesh-ancestor
65248384|NCT02841488|Anesthetics|anesthetics|mesh-ancestor
65248385|NCT02841488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65248386|NCT02841488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248414|NCT02690870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65248415|NCT02690870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248416|NCT02690870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65248417|NCT02690870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65248418|NCT02690870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65248419|NCT02690870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65248420|NCT02690870|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65248421|NCT02690870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65248422|NCT02690870|Fertility Agents|fertility agents|mesh-ancestor
65248423|NCT02690870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65248424|NCT00844207|Azithromycin|azithromycin|mesh-list
65248425|NCT00844207|Chloroquine|chloroquine|mesh-list
65248426|NCT00844207|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65248427|NCT00844207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65248428|NCT00844207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65248429|NCT00844207|Amebicides|amebicides|mesh-ancestor
65248430|NCT00844207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65248431|NCT00844207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65248432|NCT00844207|Antimalarials|antimalarials|mesh-ancestor
65248433|NCT00844207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65248436|NCT00844207|Analgesics|analgesics|mesh-ancestor
65248466|NCT02841800|GABA Modulators|gaba modulators|mesh-ancestor
65248467|NCT02841800|GABA Agents|gaba agents|mesh-ancestor
65248468|NCT02841800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65248469|NCT02841800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65248470|NCT02841800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65248471|NCT02832336|Caffeine|caffeine|mesh-list
65248472|NCT02832336|Caffeine citrate|caffeine citrate|mesh-list
65248473|NCT02832336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248474|NCT02832336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65248475|NCT02832336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248476|NCT02832336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65248477|NCT02832336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248478|NCT02832336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65248479|NCT02832336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65248480|NCT02832336|Purinergic Agents|purinergic agents|mesh-ancestor
65248481|NCT02832336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65248482|NCT00621751|Carbamazepine|carbamazepine|mesh-list
65248483|NCT00621751|Anticonvulsants|anticonvulsants|mesh-ancestor
65248484|NCT00621751|Antimanic Agents|antimanic agents|mesh-ancestor
65248485|NCT00621751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65248486|NCT00621751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65248487|NCT00621751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248488|NCT00621751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65248489|NCT00621751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65248490|NCT00621751|Analgesics|analgesics|mesh-ancestor
65248491|NCT00621751|Sensory System Agents|sensory system agents|mesh-ancestor
65248492|NCT00621751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65248493|NCT00621751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65248494|NCT00621751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65248495|NCT00621751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248509|NCT02841332|Bevacizumab|bevacizumab|mesh-list
65248510|NCT02841332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65248511|NCT02841332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65248512|NCT02841332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65248513|NCT02841332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65248514|NCT02841332|Growth Substances|growth substances|mesh-ancestor
65248515|NCT02841332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248516|NCT02841332|Growth Inhibitors|growth inhibitors|mesh-ancestor
65248517|NCT02841332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65248518|NCT02841332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65248519|NCT02841332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65248520|NCT00838357|Plerixafor|plerixafor|mesh-list
65248521|NCT00838357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65248522|NCT00838357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65248523|NCT00838357|Antiviral Agents|antiviral agents|mesh-ancestor
65248524|NCT00838357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65248525|NCT00844285|Certolizumab Pegol|certolizumab pegol|mesh-list
65248526|NCT00844285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65248527|NCT00844285|Immunologic Factors|immunologic factors|mesh-ancestor
65248528|NCT00844285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248529|NCT00844285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65248530|NCT00156104|Haloperidol|haloperidol|mesh-list
65248531|NCT00156104|Haloperidol decanoate|haloperidol decanoate|mesh-list
65248532|NCT00156104|Asenapine|asenapine|mesh-list
65248533|NCT00156104|Antiemetics|antiemetics|mesh-ancestor
65248560|NCT00891930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248561|NCT00891930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65248562|NCT00891930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65248563|NCT02831088|Salicylates|salicylates|mesh-list
65248564|NCT02831088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65248565|NCT02831088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65248566|NCT02831088|Analgesics|analgesics|mesh-ancestor
65248567|NCT02831088|Sensory System Agents|sensory system agents|mesh-ancestor
65248568|NCT02831088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65248569|NCT02831088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248570|NCT02831088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65248571|NCT02831088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65248572|NCT02831088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65248573|NCT02831088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248574|NCT02831088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248575|NCT02841176|Golimumab|golimumab|mesh-list
65248576|NCT02841176|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65248577|NCT02841176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65248578|NCT02841176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65248579|NCT02841176|Immunologic Factors|immunologic factors|mesh-ancestor
65248580|NCT02841176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248581|NCT01615874|Prednisone|prednisone|mesh-list
65248582|NCT01615874|Prednisolone|prednisolone|mesh-list
65248583|NCT01615874|Montelukast|montelukast|mesh-list
65248584|NCT01615874|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
65248585|NCT01615874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65248606|NCT04248348|Tinzaparin|tinzaparin|mesh-list
65248607|NCT04248348|Dalteparin|dalteparin|mesh-list
65248608|NCT04248348|Anticoagulants|anticoagulants|mesh-ancestor
65248609|NCT04248348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65248610|NCT04248348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65248611|NCT04248348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248612|NCT04245774|Bupivacaine|bupivacaine|mesh-list
65248613|NCT04245774|Levobupivacaine|levobupivacaine|mesh-list
65248614|NCT04245774|Anesthetics, Local|anesthetics, local|mesh-ancestor
65248615|NCT04245774|Anesthetics|anesthetics|mesh-ancestor
65248616|NCT04245774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65248617|NCT04245774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248618|NCT04245774|Sensory System Agents|sensory system agents|mesh-ancestor
65248619|NCT04245774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65248620|NCT04247646|Melatonin|melatonin|mesh-list
65248621|NCT04247646|Antioxidants|antioxidants|mesh-ancestor
65248622|NCT04247646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248623|NCT04247646|Protective Agents|protective agents|mesh-ancestor
65248624|NCT04247646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248625|NCT04247646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65248626|NCT00900146|Metformin|metformin|mesh-list
65248627|NCT00900146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65248628|NCT00900146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248629|NCT00140972|Diclofenac|diclofenac|mesh-list
65248630|NCT00140972|Etoricoxib|etoricoxib|mesh-list
65248631|NCT00140972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65248633|NCT00140972|Analgesics|analgesics|mesh-ancestor
65248655|NCT00895310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65248656|NCT00895310|Hormone Antagonists|hormone antagonists|mesh-ancestor
65248657|NCT00895310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65248658|NCT00895310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248659|NCT00895310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65248660|NCT04245618|Gemcitabine|gemcitabine|mesh-list
65248661|NCT04245618|Cisplatin|cisplatin|mesh-list
65248662|NCT04245618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65248663|NCT04245618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65248664|NCT04245618|Antimetabolites|antimetabolites|mesh-ancestor
65248665|NCT04245618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248666|NCT04245618|Antiviral Agents|antiviral agents|mesh-ancestor
65248667|NCT04245618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65248668|NCT04245618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248669|NCT04245618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65248670|NCT04245618|Immunologic Factors|immunologic factors|mesh-ancestor
65248671|NCT04245618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248672|NCT00092768|Celecoxib|celecoxib|mesh-list
65248673|NCT00092768|Etoricoxib|etoricoxib|mesh-list
65248674|NCT00092768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65248675|NCT00092768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65248676|NCT00092768|Analgesics|analgesics|mesh-ancestor
65248677|NCT00092768|Sensory System Agents|sensory system agents|mesh-ancestor
65248681|NCT00092768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65248706|NCT00817076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248707|NCT00817076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248708|NCT00817076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65248709|NCT00817076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65248710|NCT00817076|Histamine Antagonists|histamine antagonists|mesh-ancestor
65248711|NCT00817076|Histamine Agents|histamine agents|mesh-ancestor
65248712|NCT02844062|Cyclophosphamide|cyclophosphamide|mesh-list
65248713|NCT02844062|Fludarabine|fludarabine|mesh-list
65248714|NCT02844062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65248715|NCT02844062|Immunologic Factors|immunologic factors|mesh-ancestor
65248716|NCT02844062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248717|NCT02844062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65248718|NCT02844062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65248719|NCT02844062|Alkylating Agents|alkylating agents|mesh-ancestor
65248720|NCT02844062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248721|NCT02844062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65248722|NCT02844062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65248723|NCT02830230|Azithromycin|azithromycin|mesh-list
65248724|NCT02830230|Cefixime|cefixime|mesh-list
65248725|NCT02830230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65248726|NCT02830230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65248727|NCT02840240|Gabapentin|gabapentin|mesh-list
65248728|NCT02840240|Analgesics|analgesics|mesh-ancestor
65248729|NCT02840240|Sensory System Agents|sensory system agents|mesh-ancestor
65248730|NCT02840240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65248731|NCT02840240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248732|NCT02840240|Anticonvulsants|anticonvulsants|mesh-ancestor
65248733|NCT02840240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65248734|NCT02840240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65248735|NCT02840240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65248750|NCT03238430|Narcotics|narcotics|mesh-ancestor
65248751|NCT03238430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65248752|NCT03238430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248753|NCT03238430|Analgesics|analgesics|mesh-ancestor
65248754|NCT03238430|Sensory System Agents|sensory system agents|mesh-ancestor
65248755|NCT03238430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65248756|NCT03238430|Anesthetics, Local|anesthetics, local|mesh-ancestor
65248757|NCT03238430|Anesthetics|anesthetics|mesh-ancestor
65248758|NCT02829840|Azacitidine|azacitidine|mesh-list
65248759|NCT02829840|Ponatinib|ponatinib|mesh-list
65248760|NCT02829840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65248761|NCT02829840|Antimetabolites|antimetabolites|mesh-ancestor
65248762|NCT02829840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248763|NCT02829840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65248764|NCT02829840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248765|NCT02829840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65248766|NCT03223220|Midazolam|midazolam|mesh-list
65248767|NCT03223220|Ketamine|ketamine|mesh-list
65248768|NCT03223220|Analgesics|analgesics|mesh-ancestor
65248769|NCT03223220|Sensory System Agents|sensory system agents|mesh-ancestor
65248770|NCT03223220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65248771|NCT03223220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248772|NCT03223220|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65248773|NCT03223220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65248774|NCT03223220|Anesthetics, General|anesthetics, general|mesh-ancestor
65248775|NCT03223220|Anesthetics|anesthetics|mesh-ancestor
65248776|NCT03223220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65248778|NCT03223220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65248797|NCT02827890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248798|NCT04250792|Naltrexone|naltrexone|mesh-list
65248799|NCT04250792|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65248800|NCT04250792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65248801|NCT04250792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248802|NCT04250792|Sensory System Agents|sensory system agents|mesh-ancestor
65248803|NCT04250792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65248804|NCT02840162|Celecoxib|celecoxib|mesh-list
65248805|NCT02840162|Benzenesulfonamide|benzenesulfonamide|mesh-list
65248806|NCT02840162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65248807|NCT02840162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65248808|NCT02840162|Analgesics|analgesics|mesh-ancestor
65248809|NCT02840162|Sensory System Agents|sensory system agents|mesh-ancestor
65248810|NCT02840162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65248811|NCT02840162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248812|NCT02840162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65248813|NCT02840162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65248814|NCT02840162|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65248815|NCT02840162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65248816|NCT02840162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248817|NCT02840162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248818|NCT02840162|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65248819|NCT02827656|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65248820|NCT02827656|Luteolytic Agents|luteolytic agents|mesh-ancestor
65248821|NCT02827656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65248822|NCT02827656|Contraceptive Agents|contraceptive agents|mesh-ancestor
65248823|NCT02827656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65248824|NCT02827656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248825|NCT02827656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65248826|NCT02827656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65248827|NCT02827656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65248828|NCT02827578|Tamsulosin|tamsulosin|mesh-list
65248836|NCT02827578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248837|NCT02827578|Urological Agents|urological agents|mesh-ancestor
65248838|NCT02827578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65248839|NCT02827578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65248840|NCT02827578|Cholinergic Agents|cholinergic agents|mesh-ancestor
65248841|NCT02829372|Antibodies|antibodies|mesh-list
65248842|NCT02829372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65248843|NCT02829372|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65248844|NCT02829372|Immunologic Factors|immunologic factors|mesh-ancestor
65248845|NCT02829372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248846|NCT00899678|Certolizumab Pegol|certolizumab pegol|mesh-list
65248847|NCT00899678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65248848|NCT00899678|Immunologic Factors|immunologic factors|mesh-ancestor
65248849|NCT00899678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248850|NCT00899678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65248851|NCT00887484|Clindamycin|clindamycin|mesh-list
65248852|NCT00887484|Clindamycin palmitate|clindamycin palmitate|mesh-list
65248853|NCT00887484|Clindamycin phosphate|clindamycin phosphate|mesh-list
65248854|NCT00887484|Adapalene|adapalene|mesh-list
65248855|NCT00887484|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65248856|NCT00887484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65248857|NCT00887484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65248858|NCT00887484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65248859|NCT00887484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248860|NCT00887484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248861|NCT00887484|Dermatologic Agents|dermatologic agents|mesh-ancestor
65248862|NCT00887484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65248885|NCT00789152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65248886|NCT00789152|Histamine Antagonists|histamine antagonists|mesh-ancestor
65248887|NCT00789152|Histamine Agents|histamine agents|mesh-ancestor
65248888|NCT00789152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65248889|NCT00789152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248890|NCT00789152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248891|NCT00789152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65248892|NCT00789152|Cholinergic Agents|cholinergic agents|mesh-ancestor
65248893|NCT00783458|Fluticasone|fluticasone|mesh-list
65248894|NCT00783458|Mometasone Furoate|mometasone furoate|mesh-list
65248895|NCT00783458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65248896|NCT00783458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65248897|NCT00783458|Autonomic Agents|autonomic agents|mesh-ancestor
65248898|NCT00783458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65248899|NCT00783458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248900|NCT00783458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65248901|NCT00783458|Respiratory System Agents|respiratory system agents|mesh-ancestor
65248902|NCT00783458|Dermatologic Agents|dermatologic agents|mesh-ancestor
65248903|NCT00783458|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65248904|NCT00620659|Modafinil|modafinil|mesh-list
65248905|NCT00620659|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65248906|NCT00620659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248907|NCT00620659|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65248908|NCT00620659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65248909|NCT00620659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65248910|NCT00620659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248911|NCT02829060|Gentamicins|gentamicins|mesh-list
65248912|NCT02829060|Ampicillin|ampicillin|mesh-list
65248913|NCT02829060|Nitrofurantoin|nitrofurantoin|mesh-list
65248914|NCT02829060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65248915|NCT02829060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65248916|NCT02829060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65248917|NCT02829060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248925|NCT00838669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248926|NCT00838669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65248927|NCT00838669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64999196|NCT00435448|Contraceptive Agents|contraceptive agents|mesh-ancestor
65248928|NCT00838669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65248930|NCT00838669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65248931|NCT00838669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248932|NCT00838669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65248933|NCT00838669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65248934|NCT00838669|Dopamine Agents|dopamine agents|mesh-ancestor
65248935|NCT00783146|Fexofenadine|fexofenadine|mesh-list
65248936|NCT00783146|Desloratadine|desloratadine|mesh-list
65248937|NCT00783146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65248938|NCT00783146|Cholinergic Agents|cholinergic agents|mesh-ancestor
65248939|NCT00783146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65248940|NCT00783146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248941|NCT00783146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248942|NCT00783146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65248943|NCT00783146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65248944|NCT00783146|Histamine Antagonists|histamine antagonists|mesh-ancestor
65248945|NCT00783146|Histamine Agents|histamine agents|mesh-ancestor
65248946|NCT00783146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65248947|NCT00844675|Rabeprazole|rabeprazole|mesh-list
65248948|NCT00844675|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65248949|NCT00844675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65248950|NCT00844675|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65248951|NCT00844675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65248952|NCT00844675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248953|NCT02840006|Anesthetics|anesthetics|mesh-list
65248954|NCT02840006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65248955|NCT02840006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248956|NCT02826252|Iloprost|iloprost|mesh-list
65248957|NCT02826252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65248964|NCT02839928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248965|NCT02839928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65248966|NCT02839928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65248967|NCT02839928|Anesthetics, General|anesthetics, general|mesh-ancestor
65248968|NCT02839928|Anesthetics|anesthetics|mesh-ancestor
65248969|NCT02839928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65248970|NCT02839928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65248971|NCT02839928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65248972|NCT02839928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65248973|NCT02839928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248974|NCT02839928|Anesthetics, Local|anesthetics, local|mesh-ancestor
65248975|NCT02839928|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65248976|NCT05018520|Prednisone|prednisone|mesh-list
65248977|NCT05018520|Rituximab|rituximab|mesh-list
65248978|NCT05018520|Cyclophosphamide|cyclophosphamide|mesh-list
65248979|NCT05018520|Vincristine|vincristine|mesh-list
65248980|NCT05018520|Doxorubicin|doxorubicin|mesh-list
65248981|NCT05018520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65248982|NCT05018520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65248983|NCT05018520|Immunologic Factors|immunologic factors|mesh-ancestor
65248984|NCT05018520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65248985|NCT05018520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65248986|NCT05018520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65248987|NCT05018520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65248988|NCT05018520|Alkylating Agents|alkylating agents|mesh-ancestor
65248989|NCT05018520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65248990|NCT05018520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65248991|NCT05018520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65248992|NCT05018520|Glucocorticoids|glucocorticoids|mesh-ancestor
65248993|NCT05018520|Hormones|hormones|mesh-ancestor
65248994|NCT05018520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65248995|NCT05018520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65249005|NCT04321746|Analgesics|analgesics|mesh-ancestor
65249006|NCT04321746|Sensory System Agents|sensory system agents|mesh-ancestor
65249007|NCT04321746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65249008|NCT04321746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249009|NCT04321746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65249010|NCT04321746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65249011|NCT04321746|Anesthetics, General|anesthetics, general|mesh-ancestor
65249012|NCT04321746|Anesthetics|anesthetics|mesh-ancestor
65249013|NCT04321746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65249014|NCT04321746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65249015|NCT04321746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65249016|NCT04321746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65249017|NCT04321746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249018|NCT02839694|Celecoxib|celecoxib|mesh-list
65249019|NCT02839694|Decitabine|decitabine|mesh-list
65249020|NCT02839694|Tetrahydrouridine|tetrahydrouridine|mesh-list
65249021|NCT02839694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65249022|NCT02839694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65249023|NCT02839694|Analgesics|analgesics|mesh-ancestor
65249024|NCT02839694|Sensory System Agents|sensory system agents|mesh-ancestor
65249025|NCT02839694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65249026|NCT02839694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249027|NCT02839694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65249028|NCT02839694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65249029|NCT02839694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65249030|NCT02839694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65249031|NCT02839694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249032|NCT02839694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249033|NCT02839694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65249034|NCT02839694|Antimetabolites|antimetabolites|mesh-ancestor
65249035|NCT02839694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249036|NCT04243434|Prednisone|prednisone|mesh-list
65249046|NCT04243434|Alkylating Agents|alkylating agents|mesh-ancestor
65249047|NCT04243434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249048|NCT04243434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249049|NCT04243434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65249050|NCT04243434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65249051|NCT04243434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65249052|NCT04243434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65249053|NCT04243434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249054|NCT04243434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65249055|NCT04243434|Glucocorticoids|glucocorticoids|mesh-ancestor
65249056|NCT04243434|Hormones|hormones|mesh-ancestor
65249057|NCT04243434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65249058|NCT04243434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65249059|NCT04243434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65249060|NCT04243434|Tubulin Modulators|tubulin modulators|mesh-ancestor
65249061|NCT04243434|Antimitotic Agents|antimitotic agents|mesh-ancestor
65249062|NCT04243434|Mitosis Modulators|mitosis modulators|mesh-ancestor
65249063|NCT00832039|Selenious Acid|selenious acid|mesh-list
65249064|NCT00832039|Sodium Selenite|sodium selenite|mesh-list
65249065|NCT00832039|Trace Elements|trace elements|mesh-ancestor
65249066|NCT00832039|Micronutrients|micronutrients|mesh-ancestor
65249067|NCT00832039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249068|NCT02826564|Pembrolizumab|pembrolizumab|mesh-list
65249069|NCT02826564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65249070|NCT02826564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249071|NCT02837978|Methotrexate|methotrexate|mesh-list
65249093|NCT00839059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65249094|NCT00839059|Growth Substances|growth substances|mesh-ancestor
65249095|NCT00839059|Growth Inhibitors|growth inhibitors|mesh-ancestor
65249096|NCT00839059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249097|NCT02839538|Anesthetics|anesthetics|mesh-list
65249098|NCT02839538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65249099|NCT02839538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249100|NCT02826174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65249101|NCT02826174|Anesthetics|anesthetics|mesh-list
65249102|NCT02826174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65249103|NCT02826174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249104|NCT00621517|Bupropion|bupropion|mesh-list
65249105|NCT00621517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65249106|NCT00621517|Antidepressive Agents|antidepressive agents|mesh-ancestor
65249107|NCT00621517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65249108|NCT00621517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65249109|NCT00621517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65249110|NCT00621517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65249111|NCT00621517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249112|NCT00621517|Dopamine Agents|dopamine agents|mesh-ancestor
65249113|NCT00621517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65249114|NCT00621517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249115|NCT00621517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65249116|NCT00621517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65249117|NCT00621517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249118|NCT02827266|Epoetin Alfa|epoetin alfa|mesh-list
65249119|NCT02827266|Hematinics|hematinics|mesh-ancestor
65249120|NCT00845221|Imatinib Mesylate|imatinib mesylate|mesh-list
65249137|NCT04244448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65249138|NCT04244448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65249139|NCT04244448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65249140|NCT04244448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249141|NCT04244448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249142|NCT04244448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65249143|NCT04244448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65249144|NCT02547025|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65249145|NCT02547025|Amoxicillin|amoxicillin|mesh-list
65249146|NCT02547025|Clarithromycin|clarithromycin|mesh-list
65249147|NCT02547025|Levofloxacin|levofloxacin|mesh-list
65249148|NCT02547025|Ofloxacin|ofloxacin|mesh-list
65249149|NCT02547025|Tetracycline|tetracycline|mesh-list
65249150|NCT02547025|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65249151|NCT02547025|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
65249152|NCT02547025|Rabeprazole|rabeprazole|mesh-list
65249153|NCT02547025|Bismuth|bismuth|mesh-list
65249154|NCT02547025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65249155|NCT02547025|Antitubercular Agents|antitubercular agents|mesh-ancestor
65249156|NCT02547025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65249157|NCT02547025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249158|NCT02547025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249159|NCT02547025|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65249160|NCT02547025|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65249161|NCT02547025|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65249162|NCT02547025|Renal Agents|renal agents|mesh-ancestor
65249170|NCT02547025|Antacids|antacids|mesh-ancestor
65249185|NCT05660382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249186|NCT05660382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65249187|NCT05660382|Hormone Antagonists|hormone antagonists|mesh-ancestor
65249188|NCT05660382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65249189|NCT05660382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249190|NCT05660382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65249191|NCT05660382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65249192|NCT05660382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65249193|NCT05660382|Emollients|emollients|mesh-ancestor
65249194|NCT05660382|Dermatologic Agents|dermatologic agents|mesh-ancestor
65249195|NCT00839371|Midazolam|midazolam|mesh-list
65249196|NCT00839371|Propofol|propofol|mesh-list
65249197|NCT00839371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65249198|NCT00839371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65249199|NCT00839371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249200|NCT00839371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65249201|NCT00839371|Anesthetics, General|anesthetics, general|mesh-ancestor
65249202|NCT00839371|Anesthetics|anesthetics|mesh-ancestor
65249203|NCT00839371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65249204|NCT00839371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65249205|NCT00839371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65249206|NCT00839371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65249207|NCT00839371|GABA Modulators|gaba modulators|mesh-ancestor
65249208|NCT00839371|GABA Agents|gaba agents|mesh-ancestor
65249211|NCT02826408|Rabeprazole|rabeprazole|mesh-list
65249236|NCT00839449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65249237|NCT04958538|Methotrexate|methotrexate|mesh-list
65249238|NCT04958538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65249239|NCT04958538|Abortifacient Agents|abortifacient agents|mesh-ancestor
65249240|NCT04958538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65249241|NCT04958538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249242|NCT04958538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65249243|NCT04958538|Antimetabolites|antimetabolites|mesh-ancestor
65249244|NCT04958538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249245|NCT04958538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249246|NCT04958538|Dermatologic Agents|dermatologic agents|mesh-ancestor
65249247|NCT04958538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249248|NCT04958538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65249249|NCT04958538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65249250|NCT04958538|Immunologic Factors|immunologic factors|mesh-ancestor
65249251|NCT04958538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65249252|NCT04958538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65249253|NCT02548195|Gemcitabine|gemcitabine|mesh-list
65249254|NCT02548195|Capecitabine|capecitabine|mesh-list
65249255|NCT02548195|Oxaliplatin|oxaliplatin|mesh-list
65249256|NCT02548195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65249257|NCT02548195|Antimetabolites|antimetabolites|mesh-ancestor
65249258|NCT02548195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249259|NCT02548195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249260|NCT02548195|Antiviral Agents|antiviral agents|mesh-ancestor
65249261|NCT02548195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65249262|NCT02548195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249263|NCT02548195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65249264|NCT02548195|Immunologic Factors|immunologic factors|mesh-ancestor
65249280|NCT00573859|Adrenergic Agents|adrenergic agents|mesh-ancestor
65249281|NCT00573859|Sympathomimetics|sympathomimetics|mesh-ancestor
65249282|NCT00573859|Autonomic Agents|autonomic agents|mesh-ancestor
65249283|NCT00573859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65249284|NCT04043065|Anti-Infective Agents|anti-infective agents|mesh-list
65249285|NCT04043065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65249286|NCT00839605|Dexmedetomidine|dexmedetomidine|mesh-list
65249287|NCT00839605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65249288|NCT00839605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65249289|NCT00839605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249290|NCT00839605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65249291|NCT00839605|Analgesics|analgesics|mesh-ancestor
65249292|NCT00839605|Sensory System Agents|sensory system agents|mesh-ancestor
65249293|NCT00839605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65249294|NCT00839605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65249295|NCT00839605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65249296|NCT00839605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65249297|NCT00839605|Adrenergic Agents|adrenergic agents|mesh-ancestor
65249298|NCT00839605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65249299|NCT00839605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249300|NCT00839683|Dapagliflozin|dapagliflozin|mesh-list
65249301|NCT00839683|Valsartan|valsartan|mesh-list
65249302|NCT00839683|Simvastatin|simvastatin|mesh-list
65249303|NCT00839683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65249304|NCT00839683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65249305|NCT00839683|Antimetabolites|antimetabolites|mesh-ancestor
65249306|NCT00839683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249307|NCT00839683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65249308|NCT00839683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65249309|NCT00839683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249310|NCT00839683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65249311|NCT00839683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65249322|NCT02825394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65249323|NCT02825394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249324|NCT00845611|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65249325|NCT00845611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65249326|NCT00845611|Immunologic Factors|immunologic factors|mesh-ancestor
65249327|NCT00845611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249328|NCT00845689|Adenosine|adenosine|mesh-list
65249329|NCT00845689|Analgesics|analgesics|mesh-ancestor
65249330|NCT00845689|Sensory System Agents|sensory system agents|mesh-ancestor
65249331|NCT00845689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65249332|NCT00845689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249333|NCT00845689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65249334|NCT00845689|Vasodilator Agents|vasodilator agents|mesh-ancestor
65249335|NCT00845689|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65249336|NCT00845689|Purinergic Agonists|purinergic agonists|mesh-ancestor
65249337|NCT00845689|Purinergic Agents|purinergic agents|mesh-ancestor
65249338|NCT00845689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65249339|NCT00845689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249340|NCT05660694|Vitamin E|vitamin e|mesh-list
65249341|NCT05660694|Triamcinolone|triamcinolone|mesh-list
65249342|NCT05660694|Pentoxifylline|pentoxifylline|mesh-list
65249343|NCT05660694|Vitamins|vitamins|mesh-ancestor
65249344|NCT05660694|Micronutrients|micronutrients|mesh-ancestor
65249345|NCT05660694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249346|NCT05660694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65249347|NCT05660694|Glucocorticoids|glucocorticoids|mesh-ancestor
65249348|NCT05660694|Hormones|hormones|mesh-ancestor
65249349|NCT05660694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65249350|NCT05660694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249351|NCT05660694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249365|NCT05113368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65249366|NCT05113368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249367|NCT02824614|Erythritol|erythritol|mesh-list
65249368|NCT02824614|Vasodilator Agents|vasodilator agents|mesh-ancestor
65249369|NCT00840229|Triamcinolone|triamcinolone|mesh-list
65249370|NCT00840229|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65249371|NCT00840229|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65249372|NCT00840229|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64999645|NCT00439504|Lobeline|lobeline|mesh-list
65249373|NCT00840229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65249374|NCT00840229|Glucocorticoids|glucocorticoids|mesh-ancestor
65249375|NCT00840229|Hormones|hormones|mesh-ancestor
65249376|NCT00840229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65249377|NCT00840229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249378|NCT00840229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65249379|NCT00840229|Immunologic Factors|immunologic factors|mesh-ancestor
65249380|NCT00840229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249381|NCT00840229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249382|NCT00831441|Apixaban|apixaban|mesh-list
65249383|NCT00831441|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65249384|NCT00831441|Antithrombins|antithrombins|mesh-ancestor
65249385|NCT00831441|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65249386|NCT00831441|Protease Inhibitors|protease inhibitors|mesh-ancestor
65249387|NCT00831441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249388|NCT00831441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249389|NCT00831441|Anticoagulants|anticoagulants|mesh-ancestor
65249390|NCT00840385|Vidarabine|vidarabine|mesh-list
65249391|NCT00840385|Fludarabine|fludarabine|mesh-list
65249411|NCT00840931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65249412|NCT00840931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65249413|NCT00840931|Growth Substances|growth substances|mesh-ancestor
65249414|NCT00840931|Growth Inhibitors|growth inhibitors|mesh-ancestor
65249415|NCT00840931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249416|NCT05659992|Cytarabine|cytarabine|mesh-list
65249417|NCT05659992|Azacitidine|azacitidine|mesh-list
65249418|NCT05659992|Venetoclax|venetoclax|mesh-list
65249419|NCT05659992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65249420|NCT05659992|Antimetabolites|antimetabolites|mesh-ancestor
65249421|NCT05659992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249422|NCT05659992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249423|NCT05659992|Antiviral Agents|antiviral agents|mesh-ancestor
65249424|NCT05659992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65249425|NCT05659992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65249426|NCT05659992|Immunologic Factors|immunologic factors|mesh-ancestor
65249427|NCT05659992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249428|NCT05659992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249429|NCT00834379|Pravastatin|pravastatin|mesh-list
65249430|NCT00834379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65249431|NCT00834379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65249432|NCT00834379|Antimetabolites|antimetabolites|mesh-ancestor
65249433|NCT00834379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249434|NCT00834379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65249435|NCT00834379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65249436|NCT00834379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249437|NCT00834457|Ritonavir|ritonavir|mesh-list
65249438|NCT00834457|Lopinavir|lopinavir|mesh-list
65249439|NCT00834457|Zidovudine|zidovudine|mesh-list
65249440|NCT00834457|Lamivudine|lamivudine|mesh-list
65249441|NCT00834457|Abacavir|abacavir|mesh-list
65249442|NCT00834457|Dideoxynucleosides|dideoxynucleosides|mesh-list
65249443|NCT00834457|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65249444|NCT00834457|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65249445|NCT00834457|Protease Inhibitors|protease inhibitors|mesh-ancestor
64999718|NCT00138177|Vitamin B Complex|vitamin b complex|mesh-ancestor
65249446|NCT00834457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249451|NCT00834457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65249452|NCT00834457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65249453|NCT00834457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65249454|NCT00834457|Antimetabolites|antimetabolites|mesh-ancestor
65249455|NCT00834457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65249456|NCT00834457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65249457|NCT03851965|Plasminogen|plasminogen|mesh-list
65249458|NCT03851965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65249459|NCT03851965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65249460|NCT03851965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249461|NCT02611635|Warfarin|warfarin|mesh-list
65249462|NCT02611635|Rivaroxaban|rivaroxaban|mesh-list
65249463|NCT02611635|Dabigatran|dabigatran|mesh-list
65249464|NCT02611635|Apixaban|apixaban|mesh-list
65249465|NCT02611635|Edoxaban|edoxaban|mesh-list
65249466|NCT02611635|Anticoagulants|anticoagulants|mesh-ancestor
65249467|NCT02611635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65249468|NCT02611635|Antithrombins|antithrombins|mesh-ancestor
65249469|NCT02611635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65249470|NCT02611635|Protease Inhibitors|protease inhibitors|mesh-ancestor
65249471|NCT02611635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249472|NCT02611635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249473|NCT02824926|Ketoconazole|ketoconazole|mesh-list
65249474|NCT02824926|Antifungal Agents|antifungal agents|mesh-ancestor
65249475|NCT02824926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65249502|NCT00705549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249503|NCT00705549|Tubulin Modulators|tubulin modulators|mesh-ancestor
65249504|NCT00705549|Antimitotic Agents|antimitotic agents|mesh-ancestor
65249505|NCT00705549|Mitosis Modulators|mitosis modulators|mesh-ancestor
65249506|NCT00705549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65249507|NCT02824770|Tramadol|tramadol|mesh-list
65249508|NCT02824770|Bupivacaine|bupivacaine|mesh-list
65249509|NCT02824770|Anesthetics, Local|anesthetics, local|mesh-ancestor
65249510|NCT02824770|Anesthetics|anesthetics|mesh-ancestor
65249511|NCT02824770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65249512|NCT02824770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249513|NCT02824770|Sensory System Agents|sensory system agents|mesh-ancestor
65249514|NCT02824770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65249515|NCT02824770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65249516|NCT02824770|Narcotics|narcotics|mesh-ancestor
65249517|NCT02824770|Analgesics|analgesics|mesh-ancestor
65249518|NCT02824536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65249519|NCT02824536|Antibodies|antibodies|mesh-list
65249520|NCT02824536|Immunoglobulins|immunoglobulins|mesh-list
65249521|NCT02824536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65249522|NCT02824536|Immunologic Factors|immunologic factors|mesh-ancestor
65249523|NCT02824536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999793|NCT00440128|Antiemetics|antiemetics|mesh-ancestor
65249524|NCT02824536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249525|NCT00831129|Rosiglitazone|rosiglitazone|mesh-list
65249526|NCT00831129|Simvastatin|simvastatin|mesh-list
65249527|NCT00831129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65249528|NCT00831129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65249529|NCT00831129|Antimetabolites|antimetabolites|mesh-ancestor
65249530|NCT00831129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249531|NCT00831129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65249532|NCT00831129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65249533|NCT00831129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249534|NCT00831129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65249542|NCT00637962|Antiviral Agents|antiviral agents|mesh-ancestor
65249543|NCT00637962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65249544|NCT00637962|Interferon Inducers|interferon inducers|mesh-ancestor
65249545|NCT00637962|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65249546|NCT00637962|Protective Agents|protective agents|mesh-ancestor
65249547|NCT00913341|Alprazolam|alprazolam|mesh-list
65249548|NCT00913341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65249549|NCT00913341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65249550|NCT00913341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249551|NCT00913341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65249552|NCT00913341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65249553|NCT00913341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65249554|NCT00913341|GABA Modulators|gaba modulators|mesh-ancestor
65249555|NCT00913341|GABA Agents|gaba agents|mesh-ancestor
65249556|NCT00913341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65249557|NCT00913341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249558|NCT00620113|Vitamin D|vitamin d|mesh-list
65249559|NCT00620113|Cholecalciferol|cholecalciferol|mesh-list
65249560|NCT00620113|Calcium Carbonate|calcium carbonate|mesh-list
65249561|NCT00620113|Calcium|calcium|mesh-list
65249562|NCT00620113|Vitamins|vitamins|mesh-ancestor
65249563|NCT00620113|Micronutrients|micronutrients|mesh-ancestor
65249564|NCT00620113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249565|NCT00620113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65249566|NCT00620113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65249567|NCT00620113|Antacids|antacids|mesh-ancestor
65249568|NCT00620113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249569|NCT00620113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65249570|NCT00830115|Pantoprazole|pantoprazole|mesh-list
65249571|NCT00830115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65249572|NCT00830115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65249573|NCT00830115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65249574|NCT00830115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249575|NCT00830115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249583|NCT00633672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249584|NCT00633672|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65249585|NCT00633672|Histamine Antagonists|histamine antagonists|mesh-ancestor
65249586|NCT00633672|Histamine Agents|histamine agents|mesh-ancestor
65249587|NCT00633672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65249588|NCT00633672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249589|NCT02547103|Chlorhexidine|chlorhexidine|mesh-list
65249590|NCT02547103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65249591|NCT02547103|Mupirocin|mupirocin|mesh-list
65249592|NCT02547103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65249593|NCT02547103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65249594|NCT02547103|Disinfectants|disinfectants|mesh-ancestor
65249595|NCT02547103|Dermatologic Agents|dermatologic agents|mesh-ancestor
65249596|NCT02547103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65249597|NCT02547103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65249598|NCT02547103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999870|NCT00440284|Insulin|insulin|mesh-list
65249599|NCT02547103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249600|NCT02822586|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65249601|NCT02822586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65249603|NCT00848809|Vancomycin|vancomycin|mesh-list
65249604|NCT00848809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65249605|NCT00848809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65249606|NCT00834847|Pravastatin|pravastatin|mesh-list
65249607|NCT00834847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65249608|NCT00834847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65249609|NCT00834847|Antimetabolites|antimetabolites|mesh-ancestor
65249610|NCT00834847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249611|NCT00834847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65249612|NCT00834847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65249614|NCT00841477|Vaccines|vaccines|mesh-list
65249626|NCT00841633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65249627|NCT00841633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65249628|NCT00841633|Adrenergic Agents|adrenergic agents|mesh-ancestor
65249629|NCT00841633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65249630|NCT00841633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249631|NCT00841633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249632|NCT00841633|Sympathomimetics|sympathomimetics|mesh-ancestor
65249633|NCT00841633|Autonomic Agents|autonomic agents|mesh-ancestor
65249634|NCT00841633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65249635|NCT00841633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65249636|NCT02823912|Capsaicin|capsaicin|mesh-list
65249637|NCT02823912|Magnesium Oxide|magnesium oxide|mesh-list
65249638|NCT02823912|Antipruritics|antipruritics|mesh-ancestor
65249639|NCT02823912|Dermatologic Agents|dermatologic agents|mesh-ancestor
65249640|NCT02823912|Sensory System Agents|sensory system agents|mesh-ancestor
65249641|NCT02823912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65249642|NCT02823912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249643|NCT02823912|Antacids|antacids|mesh-ancestor
65249644|NCT02823912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249645|NCT02823912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65249646|NCT00841789|Etanercept|etanercept|mesh-list
65249647|NCT00841789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65249648|NCT00841789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65249649|NCT00841789|Analgesics|analgesics|mesh-ancestor
65249650|NCT00841789|Sensory System Agents|sensory system agents|mesh-ancestor
65249651|NCT00841789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65249654|NCT00841789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65249673|NCT00841945|Glucocorticoids|glucocorticoids|mesh-ancestor
65249674|NCT00841945|Hormones|hormones|mesh-ancestor
64999957|NCT00441181|Travoprost|travoprost|mesh-list
65249675|NCT00841945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65249676|NCT00841945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65249677|NCT00841945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65249678|NCT00841945|Tubulin Modulators|tubulin modulators|mesh-ancestor
65249679|NCT00841945|Antimitotic Agents|antimitotic agents|mesh-ancestor
65249680|NCT00841945|Mitosis Modulators|mitosis modulators|mesh-ancestor
65249681|NCT02822196|Lidocaine|lidocaine|mesh-list
65249682|NCT02822196|Bupivacaine|bupivacaine|mesh-list
65249683|NCT02822196|Anesthetics, Local|anesthetics, local|mesh-ancestor
65249684|NCT02822196|Anesthetics|anesthetics|mesh-ancestor
65249685|NCT02822196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65249686|NCT02822196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249687|NCT02822196|Sensory System Agents|sensory system agents|mesh-ancestor
65249688|NCT02822196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65249689|NCT02822196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65249690|NCT02822196|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65249691|NCT02822196|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65249692|NCT02822196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65249693|NCT02822196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249694|NCT00706017|Insulin Detemir|insulin detemir|mesh-list
65249695|NCT00706017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65249696|NCT00706017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249697|NCT00829179|Omalizumab|omalizumab|mesh-list
65249698|NCT00829179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65249699|NCT00829179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65249700|NCT00829179|Respiratory System Agents|respiratory system agents|mesh-ancestor
65249701|NCT00849355|Rituximab|rituximab|mesh-list
65249716|NCT02822742|Latanoprost|latanoprost|mesh-list
65249717|NCT02822742|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65249718|NCT00835471|Docetaxel|docetaxel|mesh-list
65249719|NCT00835471|Pemetrexed|pemetrexed|mesh-list
65249720|NCT00835471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65249721|NCT00835471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249722|NCT00835471|Tubulin Modulators|tubulin modulators|mesh-ancestor
65249723|NCT00835471|Antimitotic Agents|antimitotic agents|mesh-ancestor
65249724|NCT00835471|Mitosis Modulators|mitosis modulators|mesh-ancestor
65249725|NCT00835471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249726|NCT00835471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249727|NCT00835471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65249728|NCT00835471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65249729|NCT00835471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65249730|NCT00849511|Melatonin|melatonin|mesh-list
65249731|NCT00849511|Antioxidants|antioxidants|mesh-ancestor
65249732|NCT00849511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249733|NCT00849511|Protective Agents|protective agents|mesh-ancestor
65249734|NCT00849511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249735|NCT00849511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65249736|NCT02546791|Dasatinib|dasatinib|mesh-list
65249737|NCT02546791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249738|NCT02546791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65249739|NCT02546791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249740|NCT02546791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249741|NCT00966875|Ixekizumab|ixekizumab|mesh-list
65249765|NCT00842491|Growth Substances|growth substances|mesh-ancestor
65249766|NCT00842491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249767|NCT00842491|Growth Inhibitors|growth inhibitors|mesh-ancestor
65249768|NCT05659212|Lidocaine|lidocaine|mesh-list
65249769|NCT05659212|Magnesium Sulfate|magnesium sulfate|mesh-list
65249770|NCT05659212|Dexmedetomidine|dexmedetomidine|mesh-list
65249771|NCT05659212|Anesthetics, Local|anesthetics, local|mesh-ancestor
65249772|NCT05659212|Anesthetics|anesthetics|mesh-ancestor
65249773|NCT05659212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65249774|NCT05659212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249775|NCT05659212|Sensory System Agents|sensory system agents|mesh-ancestor
65249776|NCT05659212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65249777|NCT05659212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65249778|NCT05659212|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65249779|NCT05659212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65249780|NCT05659212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65249781|NCT05659212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249782|NCT05659212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65249783|NCT05659212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65249784|NCT05659212|Analgesics|analgesics|mesh-ancestor
65249785|NCT05659212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65249786|NCT05659212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65249787|NCT05659212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65249788|NCT05659212|Adrenergic Agents|adrenergic agents|mesh-ancestor
65249789|NCT05659212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65249790|NCT05659212|Anticonvulsants|anticonvulsants|mesh-ancestor
65249791|NCT05659212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65249792|NCT05659212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65249793|NCT05659212|Tocolytic Agents|tocolytic agents|mesh-ancestor
65249794|NCT05659212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65249807|NCT05659368|Tirzepatide|tirzepatide|mesh-list
65249808|NCT05659368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65249809|NCT05659368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249810|NCT05659368|Incretins|incretins|mesh-ancestor
65249811|NCT05659368|Hormones|hormones|mesh-ancestor
65249812|NCT05659368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65249813|NCT00818649|Bortezomib|bortezomib|mesh-list
65249814|NCT00818649|Vorinostat|vorinostat|mesh-list
65249815|NCT00818649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249816|NCT00818649|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65249817|NCT00818649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65249818|NCT00818649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249819|NCT02861105|Enoxaparin|enoxaparin|mesh-list
65249820|NCT02861105|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65249821|NCT02861105|Anticoagulants|anticoagulants|mesh-ancestor
65249822|NCT02861105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65249823|NCT02861105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65249824|NCT02861105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249826|NCT02820558|Neurokinin A|neurokinin a|mesh-list
65249827|NCT02820558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65249828|NCT02820558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249829|NCT02820558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249830|NCT00961571|Capecitabine|capecitabine|mesh-list
65249831|NCT00961571|Sunitinib|sunitinib|mesh-list
65249832|NCT00961571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65249833|NCT00961571|Antimetabolites|antimetabolites|mesh-ancestor
65249834|NCT00961571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249835|NCT00961571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249836|NCT00961571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65249837|NCT00961571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65249838|NCT00961571|Growth Substances|growth substances|mesh-ancestor
65249839|NCT00961571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249850|NCT02820948|Antioxidants|antioxidants|mesh-ancestor
65249851|NCT02820948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249852|NCT02820948|Protective Agents|protective agents|mesh-ancestor
65249853|NCT02860949|Ketorolac|ketorolac|mesh-list
65249854|NCT02860949|Epinephrine|epinephrine|mesh-list
65249855|NCT02860949|Morphine|morphine|mesh-list
65249856|NCT02860949|Bupivacaine|bupivacaine|mesh-list
65249857|NCT02860949|Anesthetics, Local|anesthetics, local|mesh-ancestor
65249858|NCT02860949|Anesthetics|anesthetics|mesh-ancestor
65249859|NCT02860949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65249860|NCT02860949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249861|NCT02860949|Sensory System Agents|sensory system agents|mesh-ancestor
65249862|NCT02860949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65249863|NCT02860949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65249864|NCT02860949|Narcotics|narcotics|mesh-ancestor
65249865|NCT02860949|Analgesics|analgesics|mesh-ancestor
65249866|NCT02860949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65249867|NCT02860949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65249868|NCT02860949|Adrenergic Agents|adrenergic agents|mesh-ancestor
65249869|NCT02860949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65249870|NCT02860949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249871|NCT02860949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65249872|NCT02860949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65249873|NCT02860949|Autonomic Agents|autonomic agents|mesh-ancestor
65249874|NCT02860949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65249875|NCT02860949|Respiratory System Agents|respiratory system agents|mesh-ancestor
65249876|NCT02860949|Mydriatics|mydriatics|mesh-ancestor
65249877|NCT02860949|Sympathomimetics|sympathomimetics|mesh-ancestor
65249882|NCT02860949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65249899|NCT00964223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249900|NCT00964223|Dermatologic Agents|dermatologic agents|mesh-ancestor
65249901|NCT00964223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65249902|NCT00964223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65249904|NCT00964223|Sensory System Agents|sensory system agents|mesh-ancestor
65249905|NCT00964223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65249906|NCT00964223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249907|NCT00964223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65249908|NCT00964223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65249909|NCT05659056|Trastuzumab|trastuzumab|mesh-list
65249910|NCT05659056|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65249911|NCT05659056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65249912|NCT05659056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249913|NCT00620815|Vaccines|vaccines|mesh-list
65249914|NCT00620815|MF59 oil emulsion|mf59 oil emulsion|mesh-list
65249915|NCT00620815|Immunologic Factors|immunologic factors|mesh-ancestor
65249916|NCT00620815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249917|NCT00620815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65249918|NCT04238988|Paclitaxel|paclitaxel|mesh-list
65249919|NCT04238988|Carboplatin|carboplatin|mesh-list
65249920|NCT04238988|Pembrolizumab|pembrolizumab|mesh-list
65249921|NCT04238988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65249922|NCT04238988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65249923|NCT04238988|Tubulin Modulators|tubulin modulators|mesh-ancestor
65249924|NCT04238988|Antimitotic Agents|antimitotic agents|mesh-ancestor
65249925|NCT04238988|Mitosis Modulators|mitosis modulators|mesh-ancestor
65249926|NCT04238988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249946|NCT04238832|Nicotine|nicotine|mesh-list
65249947|NCT04238832|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65249948|NCT04238832|Autonomic Agents|autonomic agents|mesh-ancestor
65249949|NCT04238832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65249950|NCT04238832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249951|NCT04238832|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65249952|NCT04238832|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65249953|NCT04238832|Cholinergic Agents|cholinergic agents|mesh-ancestor
65249954|NCT04238832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65249955|NCT04238832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249956|NCT04622904|Lidocaine|lidocaine|mesh-list
65249957|NCT04622904|Ketamine|ketamine|mesh-list
65249958|NCT04622904|Anesthetics, Local|anesthetics, local|mesh-ancestor
65249959|NCT04622904|Anesthetics|anesthetics|mesh-ancestor
65249960|NCT04622904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65249961|NCT04622904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249962|NCT04622904|Sensory System Agents|sensory system agents|mesh-ancestor
65249963|NCT04622904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65249964|NCT04622904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65249965|NCT04622904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65249966|NCT04622904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65249967|NCT04622904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65249968|NCT04622904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249969|NCT04622904|Analgesics|analgesics|mesh-ancestor
65249970|NCT04622904|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65249971|NCT04622904|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65249972|NCT04622904|Anesthetics, General|anesthetics, general|mesh-ancestor
65249973|NCT04622904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65249974|NCT04622904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65249975|NCT04622904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65249976|NCT00634062|Lamotrigine|lamotrigine|mesh-list
65249987|NCT00634062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65249988|NCT00634140|Ezetimibe|ezetimibe|mesh-list
65249989|NCT00634140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65249990|NCT00634140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65249991|NCT00634140|Antimetabolites|antimetabolites|mesh-ancestor
65249992|NCT00634140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65249993|NCT00634140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65249994|NCT02819544|Ropivacaine|ropivacaine|mesh-list
65249995|NCT02819544|Anesthetics, Local|anesthetics, local|mesh-ancestor
65249996|NCT02819544|Anesthetics|anesthetics|mesh-ancestor
65249997|NCT02819544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65249998|NCT02819544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65249999|NCT02819544|Sensory System Agents|sensory system agents|mesh-ancestor
65250000|NCT02819544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250001|NCT02819388|Contraceptive Agents|contraceptive agents|mesh-list
65250002|NCT02819388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65250003|NCT02819388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250004|NCT02818140|Ropivacaine|ropivacaine|mesh-list
65250005|NCT02818140|Anesthetics, Local|anesthetics, local|mesh-ancestor
65250006|NCT02818140|Anesthetics|anesthetics|mesh-ancestor
65250007|NCT02818140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65250008|NCT02818140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250039|NCT02815722|Antimetabolites|antimetabolites|mesh-ancestor
65250040|NCT02815722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250041|NCT02815722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65250042|NCT02815722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65250043|NCT02815722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65250044|NCT02817750|Zolpidem|zolpidem|mesh-list
65250045|NCT02817750|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65250106|NCT00961415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65250107|NCT00851227|Conivaptan|conivaptan|mesh-list
65250108|NCT00851227|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65250109|NCT00851227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250110|NCT00851227|Natriuretic Agents|natriuretic agents|mesh-ancestor
65250111|NCT00851227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250112|NCT03365609|Bismuth|bismuth|mesh-list
65250113|NCT03365609|Antacids|antacids|mesh-ancestor
65250114|NCT03365609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250115|NCT03365609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65250116|NCT05636904|Minoxidil|minoxidil|mesh-list
65250117|NCT05636904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65250118|NCT05636904|Dinoprost|dinoprost|mesh-list
65250119|NCT05636904|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
65250120|NCT05636904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65250121|NCT05636904|Vasodilator Agents|vasodilator agents|mesh-ancestor
65250122|NCT05636904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65250124|NCT05636904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65250125|NCT05636904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250126|NCT05636904|Oxytocics|oxytocics|mesh-ancestor
65250127|NCT00836485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
65250128|NCT00836485|Ketotifen|ketotifen|mesh-list
65250129|NCT00836485|Lubricant Eye Drops|lubricant eye drops|mesh-list
65250130|NCT00836485|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65250157|NCT00963599|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65250158|NCT00963599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65250159|NCT00963599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250160|NCT00963599|Antipruritics|antipruritics|mesh-ancestor
65250161|NCT00963599|Dermatologic Agents|dermatologic agents|mesh-ancestor
65250162|NCT00963599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65250163|NCT00963599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65250164|NCT00963599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65250165|NCT00963599|Histamine Antagonists|histamine antagonists|mesh-ancestor
65250166|NCT00963599|Histamine Agents|histamine agents|mesh-ancestor
65250167|NCT00963599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65250168|NCT05636592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65250169|NCT05636592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250170|NCT05636592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250171|NCT00851461|Goserelin|goserelin|mesh-list
65250172|NCT00851461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65250173|NCT00851461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250174|NCT04205136|Spironolactone|spironolactone|mesh-list
65250175|NCT04205136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65250176|NCT04205136|Hormone Antagonists|hormone antagonists|mesh-ancestor
65250177|NCT04205136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65250178|NCT04205136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250179|NCT04205136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65250206|NCT02545777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65250207|NCT02545777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65250208|NCT02545777|Analgesics|analgesics|mesh-ancestor
65250209|NCT02545777|Sensory System Agents|sensory system agents|mesh-ancestor
65250210|NCT02545777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250211|NCT02545777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250212|NCT02545777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65250213|NCT02545777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65250214|NCT02545777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65250215|NCT02545777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65250216|NCT02545777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250217|NCT02810886|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65250218|NCT02810886|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65250219|NCT02810886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250220|NCT00962741|Etanercept|etanercept|mesh-list
65250221|NCT00962741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65250222|NCT00962741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65250223|NCT00962741|Analgesics|analgesics|mesh-ancestor
65250224|NCT00962741|Sensory System Agents|sensory system agents|mesh-ancestor
65250225|NCT00962741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250226|NCT00962741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250227|NCT00962741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65250228|NCT00962741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65250232|NCT00851929|Ambrisentan|ambrisentan|mesh-list
65250256|NCT00619645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250257|NCT00619645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65250258|NCT00619645|Antifungal Agents|antifungal agents|mesh-ancestor
65250259|NCT00619645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65250260|NCT00619645|Dermatologic Agents|dermatologic agents|mesh-ancestor
65250261|NCT00619645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65250262|NCT00619645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65250263|NCT00619645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65250264|NCT00619645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65250265|NCT00619645|Antitubercular Agents|antitubercular agents|mesh-ancestor
65250266|NCT00619645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65250267|NCT00619645|Alkylating Agents|alkylating agents|mesh-ancestor
65250268|NCT00619645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65250269|NCT00619645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65250270|NCT05585112|Lidocaine|lidocaine|mesh-list
65250271|NCT05585112|Carticaine|carticaine|mesh-list
65250272|NCT05585112|Anesthetics, Local|anesthetics, local|mesh-ancestor
65250273|NCT05585112|Anesthetics|anesthetics|mesh-ancestor
65250274|NCT05585112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65250275|NCT05585112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250276|NCT05585112|Sensory System Agents|sensory system agents|mesh-ancestor
65250277|NCT05585112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250278|NCT05585112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65250279|NCT05585112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65250280|NCT05585112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65250281|NCT05585112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65250282|NCT05585112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250301|NCT02544919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65250302|NCT00818259|Dexamethasone|dexamethasone|mesh-list
65250303|NCT00818259|Ondansetron|ondansetron|mesh-list
65250304|NCT00818259|Aprepitant|aprepitant|mesh-list
65250305|NCT00818259|Fosaprepitant|fosaprepitant|mesh-list
65250306|NCT00818259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65250307|NCT00818259|Antiemetics|antiemetics|mesh-ancestor
65250308|NCT00818259|Autonomic Agents|autonomic agents|mesh-ancestor
65250309|NCT00818259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250310|NCT00818259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250311|NCT00818259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65250312|NCT00818259|Glucocorticoids|glucocorticoids|mesh-ancestor
65250313|NCT00818259|Hormones|hormones|mesh-ancestor
65250314|NCT00818259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65250315|NCT00818259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65250316|NCT00818259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250317|NCT00818259|Antipruritics|antipruritics|mesh-ancestor
65250318|NCT00818259|Dermatologic Agents|dermatologic agents|mesh-ancestor
65250319|NCT00818259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65250320|NCT00818259|Serotonin Agents|serotonin agents|mesh-ancestor
65250321|NCT00818259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65250322|NCT00818259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250323|NCT00818259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65250324|NCT00818259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65250325|NCT00818259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65250326|NCT00818259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65250327|NCT00818259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65250328|NCT00818259|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65250329|NCT05578482|Mometasone Furoate|mometasone furoate|mesh-list
65250336|NCT02809404|Everolimus|everolimus|mesh-list
65250347|NCT02812992|Gemcitabine|gemcitabine|mesh-list
65250348|NCT02812992|Paclitaxel|paclitaxel|mesh-list
65250349|NCT02812992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65250350|NCT02812992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250351|NCT02812992|Tubulin Modulators|tubulin modulators|mesh-ancestor
65250352|NCT02812992|Antimitotic Agents|antimitotic agents|mesh-ancestor
65250353|NCT02812992|Mitosis Modulators|mitosis modulators|mesh-ancestor
65250354|NCT02812992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250413|NCT00621985|Hormones|hormones|mesh-ancestor
65250414|NCT00621985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65250415|NCT00621985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65250416|NCT00621985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250417|NCT02812368|Clonidine|clonidine|mesh-list
65250418|NCT02812368|Analgesics|analgesics|mesh-ancestor
65250419|NCT02812368|Sensory System Agents|sensory system agents|mesh-ancestor
65250420|NCT02812368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250421|NCT02812368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250422|NCT02812368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65250423|NCT02812368|Sympatholytics|sympatholytics|mesh-ancestor
65250424|NCT02812368|Autonomic Agents|autonomic agents|mesh-ancestor
65250425|NCT02812368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65250426|NCT02812368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65250427|NCT02812368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65250428|NCT02812368|Adrenergic Agents|adrenergic agents|mesh-ancestor
65250429|NCT02812368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65250430|NCT02812368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250431|NCT03312257|Atropine|atropine|mesh-list
65250432|NCT03312257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65250433|NCT03312257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65250434|NCT03312257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65250435|NCT03312257|Autonomic Agents|autonomic agents|mesh-ancestor
65250436|NCT03312257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250437|NCT03312257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250438|NCT03312257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65250439|NCT03312257|Respiratory System Agents|respiratory system agents|mesh-ancestor
65250440|NCT03312257|Mydriatics|mydriatics|mesh-ancestor
65250441|NCT03312257|Parasympatholytics|parasympatholytics|mesh-ancestor
65250442|NCT03312257|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65250443|NCT03312257|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65250454|NCT00856687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65250455|NCT00856687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65250456|NCT00856687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250457|NCT02862665|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65250458|NCT02862665|Hematinics|hematinics|mesh-ancestor
65250459|NCT02807922|Zopiclone|zopiclone|mesh-list
65250460|NCT02807922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65250461|NCT02807922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65250462|NCT02807922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250463|NCT00861367|Aspirin|aspirin|mesh-list
65250464|NCT00861367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65250465|NCT00861367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65250466|NCT00861367|Analgesics|analgesics|mesh-ancestor
65250467|NCT00861367|Sensory System Agents|sensory system agents|mesh-ancestor
65250468|NCT00861367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250469|NCT00861367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250470|NCT00861367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65250471|NCT00861367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65250472|NCT00861367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65250473|NCT00861367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65250474|NCT00861367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250475|NCT00861367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65250476|NCT00861367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65250477|NCT00861367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65250478|NCT00861367|Antipyretics|antipyretics|mesh-ancestor
65250479|NCT04285073|Paclitaxel|paclitaxel|mesh-list
65250480|NCT04285073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65250500|NCT00852709|Immunologic Factors|immunologic factors|mesh-ancestor
65250501|NCT00852709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250502|NCT00852709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65250503|NCT00852709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65250504|NCT00852709|Alkylating Agents|alkylating agents|mesh-ancestor
65250505|NCT00852709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250506|NCT00852709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250507|NCT00852709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65250508|NCT00852709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65250509|NCT00852709|Antimetabolites|antimetabolites|mesh-ancestor
65250510|NCT00861523|Thiamine|thiamine|mesh-list
65250511|NCT00861523|Promethazine|promethazine|mesh-list
65250512|NCT00861523|Diphenhydramine|diphenhydramine|mesh-list
65250513|NCT00861523|Vitamin B Complex|vitamin b complex|mesh-ancestor
65250514|NCT00861523|Vitamins|vitamins|mesh-ancestor
65250515|NCT00861523|Micronutrients|micronutrients|mesh-ancestor
65250516|NCT00861523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250517|NCT00861523|Antipruritics|antipruritics|mesh-ancestor
65250518|NCT00861523|Dermatologic Agents|dermatologic agents|mesh-ancestor
65250519|NCT00861523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65250520|NCT00861523|Histamine Antagonists|histamine antagonists|mesh-ancestor
65250521|NCT00861523|Histamine Agents|histamine agents|mesh-ancestor
65250522|NCT00861523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65250523|NCT00861523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250524|NCT00861523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65250525|NCT00861523|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65250526|NCT00861523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65250527|NCT00861523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65250528|NCT00861523|Anesthetics, Local|anesthetics, local|mesh-ancestor
65250529|NCT00861523|Anesthetics|anesthetics|mesh-ancestor
65250530|NCT00861523|Sensory System Agents|sensory system agents|mesh-ancestor
65250531|NCT00861523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250532|NCT00861523|Antiemetics|antiemetics|mesh-ancestor
65250533|NCT00861523|Autonomic Agents|autonomic agents|mesh-ancestor
65250542|NCT02811978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65250543|NCT02811978|Glucocorticoids|glucocorticoids|mesh-ancestor
65250544|NCT02811978|Hormones|hormones|mesh-ancestor
65250545|NCT02811978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65250546|NCT02811978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65250547|NCT02811978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250548|NCT00630149|Pemetrexed|pemetrexed|mesh-list
65250549|NCT00630149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250550|NCT00630149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65250551|NCT00630149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250552|NCT00630149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65250553|NCT00630149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65250554|NCT04204577|Apatinib|apatinib|mesh-list
65250555|NCT04204577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250556|NCT04204577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65250557|NCT04204577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65250558|NCT04204577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250559|NCT00852787|Digoxin|digoxin|mesh-list
65250560|NCT00852787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65250561|NCT00852787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65250562|NCT00852787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65250563|NCT00852787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250593|NCT04111926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65250594|NCT04111926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250595|NCT04041349|Mitogens|mitogens|mesh-list
65250596|NCT04041349|Mitosis Modulators|mitosis modulators|mesh-ancestor
65250597|NCT04041349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250598|NCT00961181|Paclitaxel|paclitaxel|mesh-list
65250599|NCT00961181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65250600|NCT00961181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250601|NCT00961181|Tubulin Modulators|tubulin modulators|mesh-ancestor
65250602|NCT00961181|Antimitotic Agents|antimitotic agents|mesh-ancestor
65250603|NCT00961181|Mitosis Modulators|mitosis modulators|mesh-ancestor
65250604|NCT00961181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250605|NCT02807610|Propofol|propofol|mesh-list
65250606|NCT02807610|Etomidate|etomidate|mesh-list
65250607|NCT02807610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65250608|NCT02807610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65250609|NCT02807610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250610|NCT02807610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65250611|NCT02807610|Anesthetics, General|anesthetics, general|mesh-ancestor
65250612|NCT02807610|Anesthetics|anesthetics|mesh-ancestor
65250613|NCT04117074|Bupivacaine|bupivacaine|mesh-list
65250614|NCT04117074|Anesthetics, Local|anesthetics, local|mesh-ancestor
65250615|NCT04117074|Anesthetics|anesthetics|mesh-ancestor
65250616|NCT04117074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65250617|NCT04117074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250618|NCT04117074|Sensory System Agents|sensory system agents|mesh-ancestor
65250619|NCT04117074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250620|NCT00857077|Pyrimethamine|pyrimethamine|mesh-list
65250621|NCT00857077|Sulfadoxine|sulfadoxine|mesh-list
65250622|NCT00857077|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65250637|NCT00857155|Purinergic Agents|purinergic agents|mesh-ancestor
65250638|NCT00857155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65250639|NCT00857155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250640|NCT00857155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250641|NCT00817635|Eplerenone|eplerenone|mesh-list
65250642|NCT00817635|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65250643|NCT00817635|Hormone Antagonists|hormone antagonists|mesh-ancestor
65250644|NCT00817635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65250645|NCT00817635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250646|NCT00817635|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65250647|NCT00817635|Diuretics|diuretics|mesh-ancestor
65250648|NCT00817635|Natriuretic Agents|natriuretic agents|mesh-ancestor
65250649|NCT00817635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65250651|NCT00853177|Anesthetics, Local|anesthetics, local|mesh-ancestor
65250652|NCT00853177|Anesthetics|anesthetics|mesh-ancestor
65250653|NCT00853177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65250654|NCT00853177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250655|NCT00853177|Sensory System Agents|sensory system agents|mesh-ancestor
65250656|NCT00853177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250657|NCT00853177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65250658|NCT00853177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65250688|NCT00853411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65250689|NCT00853411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250690|NCT04030533|Ustekinumab|ustekinumab|mesh-list
65250691|NCT04030533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65250692|NCT04030533|Dermatologic Agents|dermatologic agents|mesh-ancestor
65250693|NCT04030533|Immunologic Factors|immunologic factors|mesh-ancestor
65250694|NCT04030533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250695|NCT02807298|Lidocaine|lidocaine|mesh-list
65250696|NCT02807298|Epinephrine|epinephrine|mesh-list
65250697|NCT02807298|Carticaine|carticaine|mesh-list
65250698|NCT02807298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65250699|NCT02807298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65250700|NCT02807298|Adrenergic Agents|adrenergic agents|mesh-ancestor
65250701|NCT02807298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65250702|NCT02807298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250703|NCT02807298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250704|NCT02807298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65250705|NCT02807298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65250706|NCT02807298|Autonomic Agents|autonomic agents|mesh-ancestor
65250707|NCT02807298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250743|NCT00961961|Antidepressive Agents|antidepressive agents|mesh-ancestor
65250744|NCT00961961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65250745|NCT00961961|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65250746|NCT00961961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65250747|NCT00961961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65250748|NCT00961961|Antimanic Agents|antimanic agents|mesh-ancestor
65250749|NCT00961961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65250750|NCT00961961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65250751|NCT02610933|Vitamin K|vitamin k|mesh-list
65250752|NCT02610933|Vitamin K 2|vitamin k 2|mesh-list
65250753|NCT02610933|Rivaroxaban|rivaroxaban|mesh-list
65250754|NCT02610933|Vitamins|vitamins|mesh-ancestor
65250755|NCT02610933|Micronutrients|micronutrients|mesh-ancestor
65250756|NCT02610933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250757|NCT02610933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65250758|NCT02610933|Antithrombins|antithrombins|mesh-ancestor
65250759|NCT02610933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65250760|NCT02610933|Protease Inhibitors|protease inhibitors|mesh-ancestor
65250761|NCT02610933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65250762|NCT02610933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250763|NCT02610933|Anticoagulants|anticoagulants|mesh-ancestor
65250764|NCT02610933|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65250765|NCT02610933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65250766|NCT02610933|Hemostatics|hemostatics|mesh-ancestor
65250767|NCT02610933|Coagulants|coagulants|mesh-ancestor
65250768|NCT04042441|Insulin|insulin|mesh-list
65250769|NCT04042441|Insulin Aspart|insulin aspart|mesh-list
65250770|NCT04042441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65250771|NCT04042441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250772|NCT00817089|Naltrexone|naltrexone|mesh-list
65250773|NCT00817089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65250774|NCT00817089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65250775|NCT00817089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250776|NCT00817089|Sensory System Agents|sensory system agents|mesh-ancestor
65250777|NCT00817089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250778|NCT03296033|Enoxaparin|enoxaparin|mesh-list
65250786|NCT05758389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65250787|NCT05758389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250788|NCT05758389|Tubulin Modulators|tubulin modulators|mesh-ancestor
65250789|NCT05758389|Antimitotic Agents|antimitotic agents|mesh-ancestor
65250790|NCT05758389|Mitosis Modulators|mitosis modulators|mesh-ancestor
65250791|NCT05758389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250792|NCT00857935|Permethrin|permethrin|mesh-list
65250793|NCT00857935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65250794|NCT00857935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250795|NCT00853879|Vitamins|vitamins|mesh-list
65250796|NCT00853879|Folic Acid|folic acid|mesh-list
65250797|NCT00853879|Hydroxocobalamin|hydroxocobalamin|mesh-list
65250798|NCT00853879|Vitamin B 12|vitamin b 12|mesh-list
65250799|NCT00853879|Vitamin B 6|vitamin b 6|mesh-list
65250800|NCT00853879|Pyridoxal|pyridoxal|mesh-list
65250801|NCT00853879|Pyridoxine|pyridoxine|mesh-list
65250802|NCT00853879|Vitamin B Complex|vitamin b complex|mesh-list
65250803|NCT00853879|Micronutrients|micronutrients|mesh-ancestor
65250804|NCT00853879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250805|NCT00853879|Hematinics|hematinics|mesh-ancestor
65250806|NCT04171843|Cyclophosphamide|cyclophosphamide|mesh-list
65250807|NCT04171843|Fludarabine|fludarabine|mesh-list
65250808|NCT04171843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65250840|NCT00854035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250841|NCT00854035|Incretins|incretins|mesh-ancestor
65250842|NCT00854035|Hormones|hormones|mesh-ancestor
65250843|NCT00854035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65250844|NCT00854035|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65250845|NCT00854035|Protease Inhibitors|protease inhibitors|mesh-ancestor
65250846|NCT00854035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65250847|NCT00854035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250848|NCT00957905|Calcium, Dietary|calcium, dietary|mesh-list
65250849|NCT00957905|Leucovorin|leucovorin|mesh-list
65250850|NCT00957905|Folic Acid|folic acid|mesh-list
65250851|NCT00957905|Fluorouracil|fluorouracil|mesh-list
65250852|NCT00957905|Oxaliplatin|oxaliplatin|mesh-list
65250853|NCT00957905|Alvocidib|alvocidib|mesh-list
65250854|NCT00957905|Calcium|calcium|mesh-list
65250855|NCT00957905|Levoleucovorin|levoleucovorin|mesh-list
65250856|NCT00957905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65250857|NCT00957905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250858|NCT00957905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65250859|NCT00957905|Antimetabolites|antimetabolites|mesh-ancestor
65250860|NCT00957905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250861|NCT00957905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65250895|NCT02858297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65250896|NCT02858297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250897|NCT02858297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65250898|NCT02858297|Immunologic Factors|immunologic factors|mesh-ancestor
65250899|NCT02858297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65250900|NCT02858297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250901|NCT00858325|Daptomycin|daptomycin|mesh-list
65250902|NCT00858325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65250903|NCT00858325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65250904|NCT02804490|Vitamin A|vitamin a|mesh-list
65250905|NCT02804490|Beta Carotene|beta carotene|mesh-list
65250906|NCT02804490|Provitamins|provitamins|mesh-list
65250907|NCT02804490|Carotenoids|carotenoids|mesh-list
65250908|NCT02804490|Vitamins|vitamins|mesh-ancestor
65250909|NCT02804490|Micronutrients|micronutrients|mesh-ancestor
65250910|NCT02804490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250911|NCT02804490|Antioxidants|antioxidants|mesh-ancestor
65250912|NCT02804490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250913|NCT02804490|Protective Agents|protective agents|mesh-ancestor
65250914|NCT00960323|Colchicine|colchicine|mesh-list
65250915|NCT00960323|Atorvastatin|atorvastatin|mesh-list
65250916|NCT00960323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65250917|NCT00960323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65250918|NCT00960323|Antimetabolites|antimetabolites|mesh-ancestor
65250919|NCT00960323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250920|NCT00960323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65250921|NCT00960323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65250922|NCT00960323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65250923|NCT00960323|Gout Suppressants|gout suppressants|mesh-ancestor
65250924|NCT00960323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65250941|NCT00617929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250942|NCT00862381|Hydrocortisone|hydrocortisone|mesh-list
65250943|NCT00862381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65250944|NCT02800590|Abp-700|abp-700|mesh-list
65001214|NCT00456313|Autonomic Agents|autonomic agents|mesh-ancestor
65250945|NCT02800590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65250946|NCT02800590|GABA Agonists|gaba agonists|mesh-ancestor
65250947|NCT02800590|GABA Agents|gaba agents|mesh-ancestor
65250948|NCT02800590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65250949|NCT02800590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250950|NCT02800590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250951|NCT00815295|Cetuximab|cetuximab|mesh-list
65250952|NCT00815295|Sorafenib|sorafenib|mesh-list
65250953|NCT00815295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65250954|NCT00815295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65250955|NCT00815295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65250956|NCT00815295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65250957|NCT00815295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250958|NCT00630383|Histamine|histamine|mesh-list
65250959|NCT00630383|Histamine Agonists|histamine agonists|mesh-ancestor
65250960|NCT00630383|Histamine Agents|histamine agents|mesh-ancestor
65250961|NCT00630383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65250962|NCT00630383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250963|NCT00630383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250964|NCT02806752|Triamcinolone|triamcinolone|mesh-list
65250965|NCT02806752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65250966|NCT02806752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65250967|NCT02806752|Ranibizumab|ranibizumab|mesh-list
65250968|NCT02806752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65250977|NCT02806752|Hormones|hormones|mesh-ancestor
65250985|NCT05757999|Magnesium Sulfate|magnesium sulfate|mesh-list
65250986|NCT05757999|Analgesics|analgesics|mesh-ancestor
65250987|NCT05757999|Sensory System Agents|sensory system agents|mesh-ancestor
65250988|NCT05757999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65250989|NCT05757999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65250990|NCT05757999|Anesthetics|anesthetics|mesh-ancestor
65250991|NCT05757999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65250992|NCT05757999|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65250993|NCT05757999|Anticonvulsants|anticonvulsants|mesh-ancestor
65250994|NCT05757999|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65250995|NCT05757999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65250996|NCT05757999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65250997|NCT05757999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65250998|NCT05757999|Tocolytic Agents|tocolytic agents|mesh-ancestor
65250999|NCT05757999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65251000|NCT02544529|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65251001|NCT02544529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65251002|NCT02544529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65251003|NCT02544529|Echothiophate Iodide|echothiophate iodide|mesh-list
65251004|NCT02544529|Laxatives|laxatives|mesh-ancestor
65251005|NCT02544529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65251006|NCT02544529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65251007|NCT02544529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251008|NCT02544529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251009|NCT02544529|Cholinergic Agents|cholinergic agents|mesh-ancestor
65251033|NCT04282031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251034|NCT04282031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65251035|NCT04282031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65251036|NCT00854503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65251037|NCT00854503|Simvastatin|simvastatin|mesh-list
65251038|NCT00854503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65251039|NCT00854503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65251040|NCT00854503|Antimetabolites|antimetabolites|mesh-ancestor
65251041|NCT00854503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251042|NCT00854503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65251043|NCT00854503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65251044|NCT00854503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251045|NCT00858715|Aspirin|aspirin|mesh-list
65251046|NCT00858715|Clopidogrel|clopidogrel|mesh-list
65251047|NCT00858715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65251048|NCT00858715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65251049|NCT00858715|Analgesics|analgesics|mesh-ancestor
65251050|NCT00858715|Sensory System Agents|sensory system agents|mesh-ancestor
65251051|NCT00858715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65251052|NCT00858715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251053|NCT00858715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65251054|NCT00858715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65251055|NCT00858715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65251056|NCT00858715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65251057|NCT00858715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251058|NCT00858715|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65251059|NCT00858715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65251060|NCT00858715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251061|NCT00858715|Antipyretics|antipyretics|mesh-ancestor
65251062|NCT00858715|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65251063|NCT00858715|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65251073|NCT00960869|Analgesics|analgesics|mesh-ancestor
65251074|NCT00960869|Sensory System Agents|sensory system agents|mesh-ancestor
65251075|NCT00960869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65251076|NCT00960869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251077|NCT00960869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65251078|NCT00960869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65251079|NCT00960869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65251080|NCT00960869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65251081|NCT00960869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251082|NCT00960869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65251083|NCT00960869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65251084|NCT00960869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251085|NCT00960869|Antipyretics|antipyretics|mesh-ancestor
65251086|NCT02799888|Cyclosporine|cyclosporine|mesh-list
65251134|NCT02545231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65251135|NCT02545231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65251136|NCT02545231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65251137|NCT02545231|Antimetabolites|antimetabolites|mesh-ancestor
65251138|NCT02545231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251139|NCT02545231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251140|NCT02545231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65251141|NCT02803788|Dexamethasone|dexamethasone|mesh-list
65251142|NCT02803788|Ondansetron|ondansetron|mesh-list
65251143|NCT02803788|Ramosetron|ramosetron|mesh-list
65251144|NCT02803788|Antiemetics|antiemetics|mesh-list
65251145|NCT02803788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65251146|NCT02803788|Autonomic Agents|autonomic agents|mesh-ancestor
65251147|NCT02803788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65251148|NCT02803788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251149|NCT02803788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65251150|NCT02803788|Glucocorticoids|glucocorticoids|mesh-ancestor
65251151|NCT02803788|Hormones|hormones|mesh-ancestor
65251152|NCT02803788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65251153|NCT02803788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65251154|NCT02803788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65251155|NCT02803788|Antipruritics|antipruritics|mesh-ancestor
65251156|NCT02803788|Dermatologic Agents|dermatologic agents|mesh-ancestor
65251157|NCT02803788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65251158|NCT02803788|Serotonin Agents|serotonin agents|mesh-ancestor
65251159|NCT02803788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65251160|NCT02803788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251161|NCT02803788|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65251162|NCT02803788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65251166|NCT02610153|Vitamin K|vitamin k|mesh-list
65251179|NCT00862693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65251180|NCT00862693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251181|NCT00862693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65251182|NCT00862693|Vitamins|vitamins|mesh-ancestor
65251183|NCT00862693|Micronutrients|micronutrients|mesh-ancestor
65251184|NCT00862693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65251185|NCT05757063|Dexmedetomidine|dexmedetomidine|mesh-list
65251186|NCT05757063|Propofol|propofol|mesh-list
65251187|NCT05757063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65251188|NCT05757063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65251189|NCT05757063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251190|NCT05757063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65251191|NCT05757063|Anesthetics, General|anesthetics, general|mesh-ancestor
65251192|NCT05757063|Anesthetics|anesthetics|mesh-ancestor
65251193|NCT05757063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65251194|NCT05757063|Analgesics|analgesics|mesh-ancestor
65251195|NCT05757063|Sensory System Agents|sensory system agents|mesh-ancestor
65251196|NCT05757063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65251197|NCT05757063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65251198|NCT05757063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65251199|NCT05757063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65251200|NCT05757063|Adrenergic Agents|adrenergic agents|mesh-ancestor
65251201|NCT05757063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65251202|NCT05757063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251203|NCT02799498|Etanercept|etanercept|mesh-list
65251204|NCT02799498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65251205|NCT02799498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65251206|NCT02799498|Analgesics|analgesics|mesh-ancestor
65251225|NCT00913809|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65251226|NCT00913809|Antidepressive Agents|antidepressive agents|mesh-ancestor
65251227|NCT00913809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65251228|NCT00913809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251229|NCT00913809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251230|NCT00913809|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65251231|NCT00913809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65251232|NCT00913809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65251233|NCT00913809|Adrenergic Agents|adrenergic agents|mesh-ancestor
65251234|NCT00913809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65251235|NCT00913809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251236|NCT02806362|Ritonavir|ritonavir|mesh-list
65251237|NCT02806362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65251238|NCT02806362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65251239|NCT02806362|Protease Inhibitors|protease inhibitors|mesh-ancestor
65251240|NCT02806362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251241|NCT02806362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251242|NCT02806362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65251243|NCT02806362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65251244|NCT02806362|Antiviral Agents|antiviral agents|mesh-ancestor
65251245|NCT02806362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65251246|NCT02806362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65251247|NCT02806362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65251248|NCT00855049|Acetaminophen|acetaminophen|mesh-list
65251249|NCT00855049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65251250|NCT00855049|Analgesics|analgesics|mesh-ancestor
65251251|NCT00855049|Sensory System Agents|sensory system agents|mesh-ancestor
65251252|NCT00855049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65251253|NCT00855049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251268|NCT04235478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65251269|NCT04235478|Glucocorticoids|glucocorticoids|mesh-ancestor
65251271|NCT04235478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65251272|NCT04235478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251273|NCT04235478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65251274|NCT04235478|Immunologic Factors|immunologic factors|mesh-ancestor
65251275|NCT00619489|Vedolizumab|vedolizumab|mesh-list
65251276|NCT00619489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65251277|NCT02806206|Prucalopride|prucalopride|mesh-list
65251278|NCT02806206|Laxatives|laxatives|mesh-ancestor
65251279|NCT02806206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65251280|NCT02806206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65251281|NCT02806206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65251282|NCT02806206|Serotonin Agents|serotonin agents|mesh-ancestor
65251283|NCT02806206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65251284|NCT02806206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251285|NCT02806206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251286|NCT00855205|Rituximab|rituximab|mesh-list
65251287|NCT00855205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65251288|NCT00855205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65251289|NCT00855205|Immunologic Factors|immunologic factors|mesh-ancestor
65251290|NCT00855205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251291|NCT00855205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65251292|NCT00859807|Amodiaquine|amodiaquine|mesh-list
65251293|NCT00859807|Antimalarials|antimalarials|mesh-ancestor
65251294|NCT00859807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65251295|NCT00859807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65251296|NCT00859807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65251297|NCT00859885|Clopidogrel|clopidogrel|mesh-list
65251298|NCT00859885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251299|NCT00859885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251300|NCT00859885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65251301|NCT00859885|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65251302|NCT00859885|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65251308|NCT02798874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65251309|NCT02798874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65251310|NCT02798874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65251311|NCT02798874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65251312|NCT02798874|Purinergic Agents|purinergic agents|mesh-ancestor
65251313|NCT02798874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65251314|NCT02798874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251315|NCT02798874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251316|NCT02799264|Cabotegravir|cabotegravir|mesh-list
65251317|NCT02799264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65251318|NCT02799264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65251319|NCT02799264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251320|NCT02799264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251321|NCT02799264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65251322|NCT02799264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65251323|NCT02799264|Antiviral Agents|antiviral agents|mesh-ancestor
65251324|NCT02799264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65251325|NCT00959699|Interferons|interferons|mesh-list
65251326|NCT00959699|Ribavirin|ribavirin|mesh-list
65251327|NCT00959699|Interferon-alpha|interferon-alpha|mesh-list
65251328|NCT00959699|Interferon alpha-2|interferon alpha-2|mesh-list
65251329|NCT00959699|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65251330|NCT00959699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65251331|NCT00959699|Antiviral Agents|antiviral agents|mesh-ancestor
65251332|NCT00959699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65251333|NCT00959699|Antimetabolites|antimetabolites|mesh-ancestor
65251334|NCT00959699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251335|NCT00959699|Immunologic Factors|immunologic factors|mesh-ancestor
65251336|NCT00959699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251337|NCT02806128|Kallikreins|kallikreins|mesh-list
65251338|NCT02806128|Coagulants|coagulants|mesh-ancestor
65251339|NCT02806128|Fertility Agents, Male|fertility agents, male|mesh-ancestor
65251350|NCT00860119|GABA Modulators|gaba modulators|mesh-ancestor
65251351|NCT00860119|GABA Agents|gaba agents|mesh-ancestor
65251352|NCT00860119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65251353|NCT00860119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251354|NCT00855283|Glycopyrrolate|glycopyrrolate|mesh-list
65251355|NCT00855283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65251356|NCT00855283|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65251357|NCT00855283|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65251358|NCT00855283|Cholinergic Agents|cholinergic agents|mesh-ancestor
65251359|NCT00855283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65251360|NCT00855283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251361|NCT00855283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251362|NCT02805738|Tenofovir|tenofovir|mesh-list
65251363|NCT02805738|Antiviral Agents|antiviral agents|mesh-ancestor
65251364|NCT02805738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65251365|NCT02805738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65251366|NCT02805738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65251367|NCT02805738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251368|NCT02805738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251369|NCT02805738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65251370|NCT02805738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65251371|NCT00855361|Rabeprazole|rabeprazole|mesh-list
65251372|NCT00855361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65251373|NCT00855361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65251374|NCT00855361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65251375|NCT00855361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251376|NCT00855361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251377|NCT02798406|Pembrolizumab|pembrolizumab|mesh-list
65251378|NCT02798406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65251379|NCT02798406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65251380|NCT05550636|Midazolam|midazolam|mesh-list
65251381|NCT05550636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65251392|NCT05550636|GABA Agents|gaba agents|mesh-ancestor
65251393|NCT05550636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65251394|NCT05550636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001659|NCT00348166|Cyclopentolate|cyclopentolate|mesh-list
65251395|NCT02857829|Caffeine|caffeine|mesh-list
65251396|NCT02857829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65251397|NCT02857829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251398|NCT02857829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65251399|NCT02857829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251400|NCT02857829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251401|NCT02857829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65251402|NCT02857829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65251403|NCT02857829|Purinergic Agents|purinergic agents|mesh-ancestor
65251404|NCT02857829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65251405|NCT00860275|Fluconazole|fluconazole|mesh-list
65251406|NCT00860275|Ketoconazole|ketoconazole|mesh-list
65251407|NCT00860275|Antifungal Agents|antifungal agents|mesh-ancestor
65251408|NCT00860275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65251409|NCT00860275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65251410|NCT00860275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65251411|NCT00860275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251412|NCT00860275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251413|NCT00860275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65251414|NCT00860275|Hormone Antagonists|hormone antagonists|mesh-ancestor
65251415|NCT00860275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65251416|NCT00860275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251417|NCT00860275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65251418|NCT00860275|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65251433|NCT00865111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65251434|NCT00865111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65251435|NCT00865111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251436|NCT00865111|Dopamine Agents|dopamine agents|mesh-ancestor
65251437|NCT00865111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65251438|NCT00865111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251439|NCT00865111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65251440|NCT00865111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65251441|NCT00865111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251442|NCT02802696|Furosemide|furosemide|mesh-list
65251443|NCT02802696|Diuretics|diuretics|mesh-ancestor
65251444|NCT02802696|Natriuretic Agents|natriuretic agents|mesh-ancestor
65251445|NCT02802696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251446|NCT02802696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65251447|NCT02802696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65251448|NCT02802696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251449|NCT00865267|Halobetasol|halobetasol|mesh-list
65251450|NCT00865267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65251451|NCT02798172|Metformin|metformin|mesh-list
65251452|NCT02798172|Alogliptin|alogliptin|mesh-list
65251453|NCT02798172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65251454|NCT02798172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251455|NCT02798172|Incretins|incretins|mesh-ancestor
65251456|NCT02798172|Hormones|hormones|mesh-ancestor
65251457|NCT02798172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65251458|NCT02798172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65251459|NCT02798172|Protease Inhibitors|protease inhibitors|mesh-ancestor
65251460|NCT02798172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251461|NCT02798172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251462|NCT00865423|Gabapentin|gabapentin|mesh-list
65251463|NCT00865423|Analgesics|analgesics|mesh-ancestor
65251473|NCT00865423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65251474|NCT00865423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65251475|NCT00865423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251476|NCT00865423|Antimanic Agents|antimanic agents|mesh-ancestor
65251477|NCT00955721|Gemcitabine|gemcitabine|mesh-list
65251478|NCT00955721|Oxaliplatin|oxaliplatin|mesh-list
65251479|NCT00955721|Sorafenib|sorafenib|mesh-list
65251480|NCT00955721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65251481|NCT00955721|Antimetabolites|antimetabolites|mesh-ancestor
65251482|NCT00955721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251483|NCT00955721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65251484|NCT00955721|Antiviral Agents|antiviral agents|mesh-ancestor
65251485|NCT00955721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65251486|NCT00955721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251487|NCT00955721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65251488|NCT00955721|Immunologic Factors|immunologic factors|mesh-ancestor
65251489|NCT00955721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251490|NCT00955721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65251491|NCT02802540|Nabilone|nabilone|mesh-list
65251492|NCT02802540|Antiemetics|antiemetics|mesh-ancestor
65251493|NCT02802540|Autonomic Agents|autonomic agents|mesh-ancestor
65251494|NCT02802540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65251495|NCT02802540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251496|NCT02802540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65251497|NCT02802540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65251498|NCT02802540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65251499|NCT02802540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65251520|NCT04281095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65251521|NCT04281095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251522|NCT04281095|Cholinergic Agents|cholinergic agents|mesh-ancestor
65251523|NCT04281095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65251524|NCT04281095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251525|NCT04281095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65251526|NCT04281095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65251527|NCT00863161|Lesogaberan|lesogaberan|mesh-list
65251528|NCT00863161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65251529|NCT00863161|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65251530|NCT00863161|GABA Agonists|gaba agonists|mesh-ancestor
65251531|NCT00863161|GABA Agents|gaba agents|mesh-ancestor
65251532|NCT00863161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65251533|NCT00863161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251534|NCT00863161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251535|NCT00863239|Interferons|interferons|mesh-list
65251536|NCT00863239|Ribavirin|ribavirin|mesh-list
65251537|NCT00863239|Interferon-alpha|interferon-alpha|mesh-list
65251538|NCT00863239|Interferon alpha-2|interferon alpha-2|mesh-list
65251539|NCT00863239|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65251540|NCT00863239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65251541|NCT00863239|Antiviral Agents|antiviral agents|mesh-ancestor
65001825|NCT04729140|Ivermectin|ivermectin|mesh-list
65251542|NCT00863239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65251543|NCT00863239|Antimetabolites|antimetabolites|mesh-ancestor
65251544|NCT00863239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251545|NCT00863239|Immunologic Factors|immunologic factors|mesh-ancestor
65251546|NCT00863239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251548|NCT02802072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65251549|NCT02802072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65251550|NCT02802072|Analgesics|analgesics|mesh-ancestor
64926947|NCT00000899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65251563|NCT04276883|Dexmedetomidine|dexmedetomidine|mesh-list
65251564|NCT04276883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65251565|NCT04276883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65251566|NCT04276883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251567|NCT04276883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65251568|NCT04276883|Analgesics|analgesics|mesh-ancestor
65251569|NCT04276883|Sensory System Agents|sensory system agents|mesh-ancestor
65251570|NCT04276883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65251571|NCT04276883|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65251572|NCT04276883|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65251573|NCT04276883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65251574|NCT04276883|Adrenergic Agents|adrenergic agents|mesh-ancestor
65251575|NCT04276883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65251576|NCT04276883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251577|NCT00865657|Alprazolam|alprazolam|mesh-list
65251578|NCT00865657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65251579|NCT00865657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65251580|NCT00865657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251581|NCT00865657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65251582|NCT00865657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65251583|NCT00865657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65251584|NCT00865657|GABA Modulators|gaba modulators|mesh-ancestor
65251585|NCT00865657|GABA Agents|gaba agents|mesh-ancestor
65251586|NCT00865657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65251587|NCT00865657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251588|NCT00863395|Lidocaine|lidocaine|mesh-list
65251589|NCT00863395|Anesthetics, Local|anesthetics, local|mesh-ancestor
65251590|NCT00863395|Anesthetics|anesthetics|mesh-ancestor
65251591|NCT00863395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65251592|NCT00863395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251593|NCT00863395|Sensory System Agents|sensory system agents|mesh-ancestor
65251594|NCT00863395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65251595|NCT00863395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65251596|NCT00863395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65251597|NCT00863395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65251598|NCT00863395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65251599|NCT00863395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251600|NCT02939183|Dexamethasone|dexamethasone|mesh-list
65251601|NCT02939183|Pomalidomide|pomalidomide|mesh-list
65251602|NCT02939183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65251603|NCT02939183|Antiemetics|antiemetics|mesh-ancestor
65251604|NCT02939183|Autonomic Agents|autonomic agents|mesh-ancestor
65251605|NCT02939183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65251606|NCT02939183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251607|NCT02939183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65251608|NCT02939183|Glucocorticoids|glucocorticoids|mesh-ancestor
65251609|NCT02939183|Hormones|hormones|mesh-ancestor
65251610|NCT02939183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65251611|NCT02939183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65251612|NCT02939183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65251613|NCT02939183|Immunologic Factors|immunologic factors|mesh-ancestor
65251614|NCT02939183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65251615|NCT02939183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65251616|NCT02939183|Growth Substances|growth substances|mesh-ancestor
65251617|NCT02939183|Growth Inhibitors|growth inhibitors|mesh-ancestor
65251618|NCT03074513|Bevacizumab|bevacizumab|mesh-list
65251619|NCT03074513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65251620|NCT03074513|Atezolizumab|atezolizumab|mesh-list
65251621|NCT03074513|Endothelial Growth Factors|endothelial growth factors|mesh-list
65251622|NCT03074513|Antibodies|antibodies|mesh-list
65251623|NCT03074513|Immunoglobulins|immunoglobulins|mesh-list
65251624|NCT03074513|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65251646|NCT02797860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65251647|NCT02797860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65251648|NCT02797860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65251649|NCT02797860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251650|NCT00860899|Clonidine|clonidine|mesh-list
65251651|NCT00860899|Levobupivacaine|levobupivacaine|mesh-list
65251652|NCT00860899|Analgesics|analgesics|mesh-ancestor
65251653|NCT00860899|Sensory System Agents|sensory system agents|mesh-ancestor
65251654|NCT00860899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65251655|NCT00860899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251656|NCT00860899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65251657|NCT00860899|Sympatholytics|sympatholytics|mesh-ancestor
65251658|NCT00860899|Autonomic Agents|autonomic agents|mesh-ancestor
65251659|NCT00860899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65251660|NCT00860899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65251661|NCT00860899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65251662|NCT00860899|Adrenergic Agents|adrenergic agents|mesh-ancestor
65251663|NCT00860899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65251664|NCT00860899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251665|NCT00860899|Anesthetics, Local|anesthetics, local|mesh-ancestor
65251666|NCT00860899|Anesthetics|anesthetics|mesh-ancestor
65251667|NCT00860899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65251668|NCT02797782|Antibodies|antibodies|mesh-list
65251669|NCT02797782|Immunologic Factors|immunologic factors|mesh-ancestor
65251670|NCT02797782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251671|NCT00863629|Insulin|insulin|mesh-list
65251672|NCT00863629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65251673|NCT00863629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251674|NCT00860977|Valacyclovir|valacyclovir|mesh-list
65251675|NCT00860977|Antiviral Agents|antiviral agents|mesh-ancestor
65251676|NCT00860977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65251677|NCT00865891|Nifedipine|nifedipine|mesh-list
65251683|NCT00865891|Vasodilator Agents|vasodilator agents|mesh-ancestor
65251688|NCT02797236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251689|NCT00863785|Acetylcysteine|acetylcysteine|mesh-list
65251690|NCT00863785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65251691|NCT00863785|Antiviral Agents|antiviral agents|mesh-ancestor
65251692|NCT00863785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65251693|NCT00863785|Expectorants|expectorants|mesh-ancestor
65251694|NCT00863785|Respiratory System Agents|respiratory system agents|mesh-ancestor
65251695|NCT00863785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65251696|NCT00863785|Antioxidants|antioxidants|mesh-ancestor
65251697|NCT00863785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251698|NCT00863785|Protective Agents|protective agents|mesh-ancestor
65251699|NCT00863785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251700|NCT00863785|Antidotes|antidotes|mesh-ancestor
65251701|NCT02801526|Amlodipine|amlodipine|mesh-list
65251702|NCT02801526|Candesartan|candesartan|mesh-list
65251703|NCT02801526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65251704|NCT02801526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65251705|NCT02801526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65251706|NCT02801526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251707|NCT02801526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65251708|NCT02801526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251709|NCT02801526|Vasodilator Agents|vasodilator agents|mesh-ancestor
65251710|NCT02801526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65251711|NCT02801526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65251712|NCT02805426|Misoprostol|misoprostol|mesh-list
65251713|NCT02805426|Tranexamic Acid|tranexamic acid|mesh-list
65251714|NCT02805426|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65251715|NCT02805426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65251734|NCT02801292|Anesthetics|anesthetics|mesh-ancestor
65251735|NCT02801292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65251736|NCT02801292|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65251737|NCT02801292|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65251738|NCT02801292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65251739|NCT02801292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251740|NCT02544061|Interleukin-12|interleukin-12|mesh-list
65251741|NCT02544061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65251742|NCT02544061|Immunologic Factors|immunologic factors|mesh-ancestor
65251743|NCT02544061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251744|NCT02544061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65251745|NCT02544061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65251746|NCT02544061|Growth Substances|growth substances|mesh-ancestor
65251747|NCT02544061|Growth Inhibitors|growth inhibitors|mesh-ancestor
65251748|NCT02544061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65251749|NCT00863863|Griseofulvin|griseofulvin|mesh-list
65251750|NCT00863863|Antifungal Agents|antifungal agents|mesh-ancestor
65251751|NCT00863863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65251752|NCT03853044|Prednisone|prednisone|mesh-list
65251753|NCT03853044|Cyclophosphamide|cyclophosphamide|mesh-list
65251754|NCT03853044|Doxorubicin|doxorubicin|mesh-list
65251755|NCT03853044|Vincristine|vincristine|mesh-list
65251756|NCT03853044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65251757|NCT03853044|Immunologic Factors|immunologic factors|mesh-ancestor
65251758|NCT03853044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251759|NCT03853044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65251760|NCT03853044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65251781|NCT00870337|Immunologic Factors|immunologic factors|mesh-ancestor
65251782|NCT00870337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251783|NCT00866437|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65251784|NCT00866437|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65251785|NCT00866437|Estropipate|estropipate|mesh-list
65251786|NCT00866437|Estradiol|estradiol|mesh-list
65251787|NCT00866437|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65251788|NCT00866437|Estrone|estrone|mesh-list
65251789|NCT00866437|Progesterone|progesterone|mesh-list
65251790|NCT00866437|Estrogens|estrogens|mesh-ancestor
65251791|NCT00866437|Hormones|hormones|mesh-ancestor
65251792|NCT00866437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65251793|NCT00866437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251794|NCT00866437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65251795|NCT00866437|Contraceptive Agents|contraceptive agents|mesh-ancestor
65251796|NCT00866437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65251797|NCT00866437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65251798|NCT00866437|Progestins|progestins|mesh-ancestor
65251799|NCT00863941|Bupropion|bupropion|mesh-list
65251800|NCT00863941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65251801|NCT00863941|Antidepressive Agents|antidepressive agents|mesh-ancestor
65251802|NCT00863941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65251803|NCT00863941|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65251804|NCT00863941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65251805|NCT00863941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65251806|NCT00863941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251807|NCT00863941|Dopamine Agents|dopamine agents|mesh-ancestor
65251808|NCT00863941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65251809|NCT00863941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251810|NCT00863941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65251811|NCT00863941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65251812|NCT00863941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251813|NCT00812565|gamma-Globulins|gamma-globulins|mesh-list
65251821|NCT00866515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65251822|NCT00866515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65251823|NCT00866515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251824|NCT00866515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251825|NCT00866515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65251826|NCT00866515|Hormone Antagonists|hormone antagonists|mesh-ancestor
65251827|NCT00866515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65251828|NCT00866515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251829|NCT00866515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65251830|NCT02795754|Ritonavir|ritonavir|mesh-list
65251831|NCT02795754|GSK-2838232|gsk-2838232|mesh-list
65251832|NCT02795754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65251833|NCT02795754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65251834|NCT02795754|Protease Inhibitors|protease inhibitors|mesh-ancestor
65251835|NCT02795754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251836|NCT02795754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251837|NCT02795754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65251838|NCT02795754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65251839|NCT02795754|Antiviral Agents|antiviral agents|mesh-ancestor
65002112|NCT00401609|Etoposide|etoposide|mesh-list
65251840|NCT02795754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65251841|NCT02795754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65251842|NCT02795754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65251843|NCT00864019|Sertraline|sertraline|mesh-list
65251844|NCT00864019|Antidepressive Agents|antidepressive agents|mesh-ancestor
65251845|NCT00864019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65251846|NCT00864019|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65251847|NCT00864019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65251848|NCT00864019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65251849|NCT00864019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251861|NCT02800902|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65251862|NCT02800902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65251863|NCT02800902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65251864|NCT02800902|Antimetabolites|antimetabolites|mesh-ancestor
65251865|NCT02800902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251866|NCT02800902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65251867|NCT02800902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65251868|NCT02800902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251869|NCT05756595|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65251870|NCT00617461|Gabapentin|gabapentin|mesh-list
65251871|NCT00617461|Analgesics|analgesics|mesh-ancestor
65251872|NCT00617461|Sensory System Agents|sensory system agents|mesh-ancestor
65251873|NCT00617461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65251874|NCT00617461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251875|NCT00617461|Anticonvulsants|anticonvulsants|mesh-ancestor
65251876|NCT00617461|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65251877|NCT00617461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65251878|NCT00617461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65251879|NCT00617461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65251880|NCT00617461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65251881|NCT00617461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65251882|NCT00617461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65251883|NCT00617461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251884|NCT00617461|Antimanic Agents|antimanic agents|mesh-ancestor
65251885|NCT00812331|Simeprevir|simeprevir|mesh-list
65251886|NCT00812331|Antiviral Agents|antiviral agents|mesh-ancestor
65251887|NCT00812331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927292|NCT00015288|Analgesics|analgesics|mesh-ancestor
65251908|NCT00870571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65251909|NCT00870571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251910|NCT00870571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65251911|NCT00870571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251912|NCT00870571|Vasodilator Agents|vasodilator agents|mesh-ancestor
65251913|NCT05756439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65251914|NCT05756439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65251915|NCT05756439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251916|NCT00616759|Propofol|propofol|mesh-list
65251917|NCT00616759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65251918|NCT00616759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65251919|NCT00616759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251920|NCT00616759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65251921|NCT00616759|Anesthetics, General|anesthetics, general|mesh-ancestor
65251922|NCT00616759|Anesthetics|anesthetics|mesh-ancestor
65251923|NCT02610075|Adavosertib|adavosertib|mesh-list
65251924|NCT02610075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251925|NCT02610075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251926|NCT00866593|Dexetimide|dexetimide|mesh-list
65251927|NCT00866593|Citalopram|citalopram|mesh-list
65251928|NCT00866593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65251929|NCT00866593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65251930|NCT00866593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65251955|NCT02796378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251956|NCT02796378|Micronutrients|micronutrients|mesh-ancestor
65251957|NCT02796378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251958|NCT02796378|Vitamins|vitamins|mesh-ancestor
65251959|NCT00864409|Ropivacaine|ropivacaine|mesh-list
65251960|NCT00864409|Anesthetics, Local|anesthetics, local|mesh-ancestor
65251961|NCT00864409|Anesthetics|anesthetics|mesh-ancestor
65251962|NCT00864409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65251963|NCT00864409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65251964|NCT00864409|Sensory System Agents|sensory system agents|mesh-ancestor
65251965|NCT00864409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65251966|NCT00866983|Sildenafil Citrate|sildenafil citrate|mesh-list
65251967|NCT00866983|Vasodilator Agents|vasodilator agents|mesh-ancestor
65251968|NCT00866983|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65251969|NCT00866983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65251970|NCT00866983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65251971|NCT00866983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65251972|NCT00866983|Urological Agents|urological agents|mesh-ancestor
65251973|NCT05226013|Rasburicase|rasburicase|mesh-list
65251974|NCT05226013|Gout Suppressants|gout suppressants|mesh-ancestor
65251975|NCT05226013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65251976|NCT00870883|Acetylcysteine|acetylcysteine|mesh-list
65251977|NCT00870883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65251978|NCT00870883|Deferoxamine|deferoxamine|mesh-list
65251979|NCT00870883|Antiviral Agents|antiviral agents|mesh-ancestor
65251980|NCT00870883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65251981|NCT00870883|Expectorants|expectorants|mesh-ancestor
65252006|NCT00864565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65252007|NCT00864565|Narcotics|narcotics|mesh-ancestor
65252008|NCT00864565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65252009|NCT00864565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252010|NCT00864565|Analgesics|analgesics|mesh-ancestor
65252011|NCT00864565|Sensory System Agents|sensory system agents|mesh-ancestor
65252012|NCT00864565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65252013|NCT00864565|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65252014|NCT00864565|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65252015|NCT00864565|Anesthetics, General|anesthetics, general|mesh-ancestor
65252016|NCT00864565|Anesthetics|anesthetics|mesh-ancestor
65252017|NCT00864643|Atorvastatin|atorvastatin|mesh-list
65252018|NCT00864643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65252019|NCT00864643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65252020|NCT00864643|Antimetabolites|antimetabolites|mesh-ancestor
65252021|NCT00864643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252022|NCT00864643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65252023|NCT00864643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65252024|NCT00864643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65252025|NCT00871039|Midazolam|midazolam|mesh-list
65252026|NCT00871039|Propofol|propofol|mesh-list
65252027|NCT00871039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65252028|NCT00871039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65252029|NCT00871039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252030|NCT00871039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65252031|NCT00871039|Anesthetics, General|anesthetics, general|mesh-ancestor
65252032|NCT00871039|Anesthetics|anesthetics|mesh-ancestor
65252033|NCT00871039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65252034|NCT00871039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65252035|NCT00871039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65252036|NCT00871039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65252037|NCT00871039|GABA Modulators|gaba modulators|mesh-ancestor
65252038|NCT00871039|GABA Agents|gaba agents|mesh-ancestor
65252048|NCT00864799|Abortifacient Agents|abortifacient agents|mesh-ancestor
65252049|NCT00864799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65252050|NCT00864799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252051|NCT00864799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65252052|NCT00864799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65252053|NCT00864799|Oxytocics|oxytocics|mesh-ancestor
65252054|NCT04234776|Ketamine|ketamine|mesh-list
65252055|NCT04234776|Aripiprazole|aripiprazole|mesh-list
65252056|NCT04234776|Citalopram|citalopram|mesh-list
65252057|NCT04234776|Analgesics|analgesics|mesh-ancestor
65252058|NCT04234776|Sensory System Agents|sensory system agents|mesh-ancestor
65252059|NCT04234776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65252060|NCT04234776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252061|NCT04234776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65252062|NCT04234776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65252063|NCT04234776|Anesthetics, General|anesthetics, general|mesh-ancestor
65252064|NCT04234776|Anesthetics|anesthetics|mesh-ancestor
65252065|NCT04234776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65252066|NCT04234776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65252067|NCT04234776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65252068|NCT04234776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65252069|NCT04234776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252102|NCT04040491|Antibodies, Blocking|antibodies, blocking|mesh-list
65252103|NCT04040491|Immunologic Factors|immunologic factors|mesh-ancestor
65252104|NCT04040491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252105|NCT04040491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65252106|NCT04040491|Antimetabolites|antimetabolites|mesh-ancestor
65252107|NCT04040491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252108|NCT04040491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252109|NCT04040491|Antiviral Agents|antiviral agents|mesh-ancestor
65252110|NCT04040491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65252111|NCT04040491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65252112|NCT04040491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65252113|NCT04040491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65252114|NCT04040491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65252115|NCT04040491|Growth Substances|growth substances|mesh-ancestor
65252116|NCT04040491|Growth Inhibitors|growth inhibitors|mesh-ancestor
65252117|NCT02794584|Sufentanil|sufentanil|mesh-list
65252118|NCT02794584|Dsuvia|dsuvia|mesh-list
65252119|NCT02794584|Anesthetics|anesthetics|mesh-ancestor
65252120|NCT02794584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65252121|NCT02794584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252122|NCT02794584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65252123|NCT02794584|Narcotics|narcotics|mesh-ancestor
65252124|NCT02794584|Analgesics|analgesics|mesh-ancestor
65252125|NCT02794584|Sensory System Agents|sensory system agents|mesh-ancestor
65252126|NCT02794584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65252127|NCT02794584|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65252128|NCT02794584|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65252129|NCT02794584|Anesthetics, General|anesthetics, general|mesh-ancestor
65252140|NCT00871507|Incretins|incretins|mesh-ancestor
65252148|NCT00865033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65252149|NCT00865033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252150|NCT05755737|Ondansetron|ondansetron|mesh-list
65252151|NCT05755737|Antiemetics|antiemetics|mesh-ancestor
65252152|NCT05755737|Autonomic Agents|autonomic agents|mesh-ancestor
65252153|NCT05755737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65252154|NCT05755737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252155|NCT05755737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65252156|NCT05755737|Antipruritics|antipruritics|mesh-ancestor
65252157|NCT05755737|Dermatologic Agents|dermatologic agents|mesh-ancestor
65252158|NCT05755737|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65252159|NCT05755737|Serotonin Agents|serotonin agents|mesh-ancestor
65252160|NCT05755737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65252161|NCT05755737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252162|NCT05755737|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65252163|NCT05755737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65252164|NCT05755737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65252165|NCT05755737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65252166|NCT05755737|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65252167|NCT04234932|Latanoprost|latanoprost|mesh-list
65252168|NCT04234932|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65252169|NCT04234932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65252170|NCT02789592|Clonazepam|clonazepam|mesh-list
65252171|NCT02789592|Melatonin|melatonin|mesh-list
65252172|NCT02789592|Antioxidants|antioxidants|mesh-ancestor
65252173|NCT02789592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252174|NCT02789592|Protective Agents|protective agents|mesh-ancestor
65252175|NCT02789592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252176|NCT02789592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65252177|NCT02789592|Anticonvulsants|anticonvulsants|mesh-ancestor
65252178|NCT02789592|GABA Modulators|gaba modulators|mesh-ancestor
65252179|NCT02789592|GABA Agents|gaba agents|mesh-ancestor
65252180|NCT02789592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65252181|NCT00876421|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65252182|NCT00876421|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65252188|NCT00876421|Urological Agents|urological agents|mesh-ancestor
65252189|NCT00872131|Sertraline|sertraline|mesh-list
65252190|NCT00872131|Antidepressive Agents|antidepressive agents|mesh-ancestor
65252191|NCT00872131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65252192|NCT00872131|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65252193|NCT00872131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65252194|NCT00872131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65252195|NCT00872131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252196|NCT00872131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65252197|NCT00872131|Serotonin Agents|serotonin agents|mesh-ancestor
65252198|NCT00872131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252199|NCT04233294|Decitabine|decitabine|mesh-list
65252200|NCT04233294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65252201|NCT04233294|Antimetabolites|antimetabolites|mesh-ancestor
65252202|NCT04233294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252203|NCT04233294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252204|NCT04233294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65252205|NCT00872209|Ciprofloxacin|ciprofloxacin|mesh-list
65252206|NCT00872209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65252207|NCT00872209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65252208|NCT00872209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65252209|NCT00872209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65252210|NCT00872209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65252211|NCT00872209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252212|NCT00872209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252213|NCT00872209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65252214|NCT00872209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65252215|NCT00872365|Micronutrients|micronutrients|mesh-list
65252216|NCT00872365|Trace Elements|trace elements|mesh-list
65252218|NCT03637062|Progesterone|progesterone|mesh-list
65252231|NCT02793648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252232|NCT02793648|Protective Agents|protective agents|mesh-ancestor
65252233|NCT02789358|Adenosine|adenosine|mesh-list
65252234|NCT02789358|Analgesics|analgesics|mesh-ancestor
65252235|NCT02789358|Sensory System Agents|sensory system agents|mesh-ancestor
65252236|NCT02789358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65252237|NCT02789358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252238|NCT02789358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65252239|NCT02789358|Vasodilator Agents|vasodilator agents|mesh-ancestor
65252240|NCT02789358|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65252241|NCT02789358|Purinergic Agonists|purinergic agonists|mesh-ancestor
65252242|NCT02789358|Purinergic Agents|purinergic agents|mesh-ancestor
65252243|NCT02789358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65252244|NCT02789358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252245|NCT03847506|Amlodipine|amlodipine|mesh-list
65252246|NCT03847506|Candesartan|candesartan|mesh-list
65252247|NCT03847506|Candesartan cilexetil|candesartan cilexetil|mesh-list
65252248|NCT03847506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65252249|NCT03847506|Ezetimibe|ezetimibe|mesh-list
65252250|NCT03847506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65252251|NCT03847506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65252252|NCT03847506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65252253|NCT03847506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252254|NCT03847506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65252255|NCT03847506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252256|NCT03847506|Vasodilator Agents|vasodilator agents|mesh-ancestor
65252257|NCT03847506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65252258|NCT03847506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65252259|NCT03847506|Antimetabolites|antimetabolites|mesh-ancestor
65252260|NCT03847506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65252273|NCT00617305|Urological Agents|urological agents|mesh-ancestor
65252274|NCT00617305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65252275|NCT02792712|Clopidogrel|clopidogrel|mesh-list
65252276|NCT02792712|Ticagrelor|ticagrelor|mesh-list
65252277|NCT02792712|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65252278|NCT02792712|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65252279|NCT02792712|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65252280|NCT02792712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65252281|NCT02792712|Purinergic Agents|purinergic agents|mesh-ancestor
65252282|NCT02792712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65252283|NCT02792712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252284|NCT02792712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252285|NCT02789202|Fluorides|fluorides|mesh-list
65252286|NCT02789202|Sodium Fluoride|sodium fluoride|mesh-list
65252287|NCT02789202|Fluorides, Topical|fluorides, topical|mesh-list
65252288|NCT02789202|Cariostatic Agents|cariostatic agents|mesh-ancestor
65252289|NCT02789202|Protective Agents|protective agents|mesh-ancestor
65252290|NCT02789202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252291|NCT00811395|Interferons|interferons|mesh-list
65252292|NCT00811395|Interferon-beta|interferon-beta|mesh-list
65252293|NCT00811395|Teriflunomide|teriflunomide|mesh-list
65252294|NCT00811395|Glatiramer Acetate|glatiramer acetate|mesh-list
65252295|NCT00811395|Interferon beta-1b|interferon beta-1b|mesh-list
65252296|NCT00811395|(T,G)-A-L|(t,g)-a-l|mesh-list
65252297|NCT00811395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252298|NCT00811395|Antiviral Agents|antiviral agents|mesh-ancestor
65252299|NCT00811395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65252300|NCT00811395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65252321|NCT00876577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252322|NCT00876577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252323|NCT00876577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65252324|NCT00876577|Contraceptive Agents|contraceptive agents|mesh-ancestor
65252325|NCT00876577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65252326|NCT00876577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252327|NCT00876577|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65252328|NCT00876577|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65252329|NCT00876577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65252330|NCT05079789|Amiloride|amiloride|mesh-list
65252331|NCT05079789|Furosemide|furosemide|mesh-list
65252332|NCT05079789|Diuretics|diuretics|mesh-ancestor
65252333|NCT05079789|Natriuretic Agents|natriuretic agents|mesh-ancestor
65252334|NCT05079789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252335|NCT05079789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65252336|NCT05079789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65252337|NCT05079789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252338|NCT05079789|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65252339|NCT05079789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65252340|NCT05079789|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65252341|NCT05079789|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65252342|NCT02787798|Valsartan|valsartan|mesh-list
65252343|NCT02787798|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65252344|NCT02787798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65252345|NCT02787798|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65252346|NCT02787798|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65252347|NCT02787798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252363|NCT02609997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65252364|NCT02609997|Sensory System Agents|sensory system agents|mesh-ancestor
65252365|NCT00876655|Tedizolid phosphate|tedizolid phosphate|mesh-list
65252366|NCT00876655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65252367|NCT00876655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65252368|NCT02609919|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
65252369|NCT02609919|Chelating Agents|chelating agents|mesh-ancestor
65252370|NCT02609919|Sequestering Agents|sequestering agents|mesh-ancestor
65252371|NCT02609919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252373|NCT04114500|Progesterone|progesterone|mesh-list
65252374|NCT04114500|Estrogens|estrogens|mesh-ancestor
65252375|NCT04114500|Hormones|hormones|mesh-ancestor
65252376|NCT04114500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65252377|NCT04114500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252378|NCT04114500|Progestins|progestins|mesh-ancestor
65252379|NCT05755659|Fosaprepitant|fosaprepitant|mesh-list
65252380|NCT05755659|Aprepitant|aprepitant|mesh-list
65252381|NCT05755659|Antiemetics|antiemetics|mesh-ancestor
65252382|NCT05755659|Autonomic Agents|autonomic agents|mesh-ancestor
65252383|NCT05755659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65252384|NCT05755659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252385|NCT05755659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65252386|NCT05755659|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65252389|NCT00913887|Diclofenac|diclofenac|mesh-list
65252412|NCT02792400|Incretins|incretins|mesh-ancestor
65252413|NCT02792400|Hormones|hormones|mesh-ancestor
65252414|NCT02792400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65252415|NCT02792400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65252416|NCT02792400|Protease Inhibitors|protease inhibitors|mesh-ancestor
65252417|NCT02792400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65252418|NCT04040023|Vitamins|vitamins|mesh-list
65252419|NCT04040023|Micronutrients|micronutrients|mesh-ancestor
65252420|NCT04040023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252421|NCT03567720|Paclitaxel|paclitaxel|mesh-list
65252422|NCT03567720|Pembrolizumab|pembrolizumab|mesh-list
65252423|NCT03567720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65252424|NCT03567720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252425|NCT03567720|Tubulin Modulators|tubulin modulators|mesh-ancestor
65252426|NCT03567720|Antimitotic Agents|antimitotic agents|mesh-ancestor
65252427|NCT03567720|Mitosis Modulators|mitosis modulators|mesh-ancestor
65252428|NCT03567720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252429|NCT03567720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65252430|NCT05755581|Antineoplastic Agents|antineoplastic agents|mesh-list
65252431|NCT05755581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-list
65252432|NCT05017155|Mexiletine|mexiletine|mesh-list
65252433|NCT05017155|Lamotrigine|lamotrigine|mesh-list
65252434|NCT05017155|Anticonvulsants|anticonvulsants|mesh-ancestor
65252435|NCT05017155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65252447|NCT05162131|Ticagrelor|ticagrelor|mesh-list
65252461|NCT00868153|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65252536|NCT00615901|Alkylating Agents|alkylating agents|mesh-ancestor
65252537|NCT00615901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252538|NCT00615901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252539|NCT00615901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65252540|NCT00615901|Antimetabolites|antimetabolites|mesh-ancestor
65252541|NCT00615901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65252542|NCT00615901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65252543|NCT00615901|Abortifacient Agents|abortifacient agents|mesh-ancestor
65252544|NCT00615901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65252545|NCT00615901|Dermatologic Agents|dermatologic agents|mesh-ancestor
65252546|NCT00615901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65252547|NCT00615901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65252548|NCT00615901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65252549|NCT00616603|Dexamethasone|dexamethasone|mesh-list
65252550|NCT00616603|Dexamethasone acetate|dexamethasone acetate|mesh-list
65252551|NCT00616603|Ropivacaine|ropivacaine|mesh-list
65252552|NCT00616603|BB 1101|bb 1101|mesh-list
65252553|NCT00616603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65252554|NCT00616603|Antiemetics|antiemetics|mesh-ancestor
65252555|NCT00616603|Autonomic Agents|autonomic agents|mesh-ancestor
65252556|NCT00616603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65252557|NCT00616603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252558|NCT00616603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65252559|NCT00616603|Glucocorticoids|glucocorticoids|mesh-ancestor
65252560|NCT00616603|Hormones|hormones|mesh-ancestor
65252561|NCT00616603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65252562|NCT00616603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65252563|NCT00616603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252564|NCT00616603|Protease Inhibitors|protease inhibitors|mesh-ancestor
65252565|NCT00616603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65252566|NCT00616603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252567|NCT00616603|Anesthetics, Local|anesthetics, local|mesh-ancestor
65252568|NCT00616603|Anesthetics|anesthetics|mesh-ancestor
65252576|NCT00873535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252577|NCT00873535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252578|NCT02790996|Vancomycin|vancomycin|mesh-list
65252579|NCT02790996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65252580|NCT02790996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65252581|NCT00810693|Riociguat|riociguat|mesh-list
65252582|NCT00810693|Enzyme Activators|enzyme activators|mesh-ancestor
65252583|NCT00810693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252584|NCT02790840|Omeprazole|omeprazole|mesh-list
65252585|NCT02790840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65252586|NCT02790840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65252587|NCT02790840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65252588|NCT02790840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65252589|NCT02790840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252591|NCT02362997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65252592|NCT02362997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252593|NCT02790684|Firuglipel|firuglipel|mesh-list
65252594|NCT02790684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65252595|NCT02790684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252596|NCT05003349|Salicylic Acid|salicylic acid|mesh-list
65252597|NCT05003349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65252598|NCT05003349|Antifungal Agents|antifungal agents|mesh-ancestor
65252599|NCT05003349|Keratolytic Agents|keratolytic agents|mesh-ancestor
65252600|NCT05003349|Dermatologic Agents|dermatologic agents|mesh-ancestor
65252601|NCT02790450|Benzbromarone|benzbromarone|mesh-list
65252602|NCT02790450|Uricosuric Agents|uricosuric agents|mesh-ancestor
65252603|NCT02790450|Gout Suppressants|gout suppressants|mesh-ancestor
65252625|NCT00953615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252626|NCT00873769|Loxapine|loxapine|mesh-list
65252627|NCT00873769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65252628|NCT00873769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65252629|NCT00873769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65252630|NCT00873769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252631|NCT00873769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65252632|NCT00873769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65252633|NCT00873769|Dopamine Agents|dopamine agents|mesh-ancestor
65252634|NCT00873769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65252635|NCT00873769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252636|NCT02785614|Trazodone|trazodone|mesh-list
65252637|NCT02785614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65252638|NCT02785614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65252639|NCT02785614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65252640|NCT02785614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252641|NCT02785614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65252642|NCT02785614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65252643|NCT02785614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65252644|NCT02785614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65252645|NCT02785614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252646|NCT02785614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65252647|NCT02785614|Serotonin Agents|serotonin agents|mesh-ancestor
65252648|NCT02785614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65252649|NCT02785614|Antidepressive Agents|antidepressive agents|mesh-ancestor
65252650|NCT02787018|Dexamethasone|dexamethasone|mesh-list
65252651|NCT02787018|Dexmedetomidine|dexmedetomidine|mesh-list
65252652|NCT02787018|Ropivacaine|ropivacaine|mesh-list
65252653|NCT02787018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65252654|NCT02787018|Antiemetics|antiemetics|mesh-ancestor
65252655|NCT02787018|Autonomic Agents|autonomic agents|mesh-ancestor
65252656|NCT02787018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65252666|NCT02787018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65252668|NCT02787018|Sensory System Agents|sensory system agents|mesh-ancestor
65252669|NCT02787018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65252670|NCT02787018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65252671|NCT02787018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65252672|NCT02787018|Adrenergic Agents|adrenergic agents|mesh-ancestor
65252673|NCT02787018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65252674|NCT02787018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252675|NCT02787018|Anesthetics, Local|anesthetics, local|mesh-ancestor
65252676|NCT02787018|Anesthetics|anesthetics|mesh-ancestor
65252677|NCT00873925|Vitamin D|vitamin d|mesh-list
65252678|NCT00873925|Vitamins|vitamins|mesh-ancestor
65252679|NCT00873925|Micronutrients|micronutrients|mesh-ancestor
65252680|NCT00873925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252681|NCT00873925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65252682|NCT03870529|Vitamins|vitamins|mesh-list
65252683|NCT03870529|Vitamin A|vitamin a|mesh-list
65252684|NCT03870529|Anti-Infective Agents|anti-infective agents|mesh-list
65252685|NCT03870529|Retinol palmitate|retinol palmitate|mesh-list
65252686|NCT03870529|Micronutrients|micronutrients|mesh-ancestor
65252687|NCT03870529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252688|NCT03870529|Antioxidants|antioxidants|mesh-ancestor
65252689|NCT03870529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252690|NCT03870529|Protective Agents|protective agents|mesh-ancestor
65252691|NCT03870529|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65252692|NCT03870529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252693|NCT03412266|Cytarabine|cytarabine|mesh-list
65252694|NCT03412266|Cyclophosphamide|cyclophosphamide|mesh-list
65252695|NCT03412266|Busulfan|busulfan|mesh-list
65252696|NCT03412266|Semustine|semustine|mesh-list
65252697|NCT03412266|Fludarabine|fludarabine|mesh-list
65252698|NCT03412266|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65252699|NCT03412266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65252700|NCT03412266|Immunologic Factors|immunologic factors|mesh-ancestor
65252701|NCT03412266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252709|NCT03412266|Antimetabolites|antimetabolites|mesh-ancestor
65252710|NCT03412266|Antiviral Agents|antiviral agents|mesh-ancestor
65252711|NCT03412266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65252712|NCT00877591|Ritonavir|ritonavir|mesh-list
65252713|NCT00877591|Darunavir|darunavir|mesh-list
65252714|NCT00877591|Fosamprenavir|fosamprenavir|mesh-list
65252715|NCT00877591|Rifampin|rifampin|mesh-list
65252716|NCT00877591|Rifabutin|rifabutin|mesh-list
65252717|NCT00877591|Buprenorphine|buprenorphine|mesh-list
65252718|NCT00877591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65252719|NCT00877591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65252720|NCT00877591|Protease Inhibitors|protease inhibitors|mesh-ancestor
65252721|NCT00877591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65252722|NCT00877591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252723|NCT00877591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65252724|NCT00877591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65252725|NCT00877591|Antiviral Agents|antiviral agents|mesh-ancestor
65252726|NCT00877591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65252727|NCT00877591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65252728|NCT00877591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65252729|NCT00877591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65252730|NCT00877591|Narcotics|narcotics|mesh-ancestor
65252731|NCT00877591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65252732|NCT00877591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252733|NCT00877591|Analgesics|analgesics|mesh-ancestor
65252734|NCT00877591|Sensory System Agents|sensory system agents|mesh-ancestor
65252735|NCT00877591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65252736|NCT00877591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65252737|NCT00877591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64928147|NCT00039403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252756|NCT00874003|Histamine Antagonists|histamine antagonists|mesh-ancestor
65252757|NCT00874003|Histamine Agents|histamine agents|mesh-ancestor
65252758|NCT00874003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65252759|NCT00874003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252760|NCT00874003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252761|NCT00874003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65252762|NCT00874003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65252763|NCT00874003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65252764|NCT00874003|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65252765|NCT00874003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65252766|NCT00874003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65252767|NCT00874003|Adrenergic Agents|adrenergic agents|mesh-ancestor
65252768|NCT00874003|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65252769|NCT00874003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65252770|NCT00874003|Serotonin Agents|serotonin agents|mesh-ancestor
65252771|NCT00874003|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65252772|NCT04915365|Acetazolamide|acetazolamide|mesh-list
65252773|NCT04915365|Anticonvulsants|anticonvulsants|mesh-ancestor
65252774|NCT04915365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65252775|NCT04915365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65252776|NCT04915365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252777|NCT04915365|Diuretics|diuretics|mesh-ancestor
65252778|NCT04915365|Natriuretic Agents|natriuretic agents|mesh-ancestor
65252779|NCT04915365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252780|NCT02785146|Calcium, Dietary|calcium, dietary|mesh-list
65252781|NCT02785146|Leucovorin|leucovorin|mesh-list
65252782|NCT02785146|Fluorouracil|fluorouracil|mesh-list
65252783|NCT02785146|Oxaliplatin|oxaliplatin|mesh-list
65252784|NCT02785146|Calcium|calcium|mesh-list
65252785|NCT02785146|Levoleucovorin|levoleucovorin|mesh-list
65252786|NCT02785146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65252789|NCT02785146|Antimetabolites|antimetabolites|mesh-ancestor
65252796|NCT02785146|Protective Agents|protective agents|mesh-ancestor
65252797|NCT02785146|Vitamin B Complex|vitamin b complex|mesh-ancestor
65252798|NCT02785146|Vitamins|vitamins|mesh-ancestor
65252799|NCT02785146|Micronutrients|micronutrients|mesh-ancestor
65252800|NCT00913965|Atenolol|atenolol|mesh-list
65252801|NCT00913965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65252802|NCT00913965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65252803|NCT00913965|Sympatholytics|sympatholytics|mesh-ancestor
65252804|NCT00913965|Autonomic Agents|autonomic agents|mesh-ancestor
65252805|NCT00913965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65252806|NCT00913965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252807|NCT00913965|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65252808|NCT00913965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65252809|NCT00913965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65252810|NCT00913965|Adrenergic Agents|adrenergic agents|mesh-ancestor
65252811|NCT00913965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65252812|NCT00913965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252813|NCT05753865|Paclitaxel|paclitaxel|mesh-list
65003072|NCT00114179|Growth Inhibitors|growth inhibitors|mesh-ancestor
65252814|NCT05753865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65252815|NCT05753865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252816|NCT05753865|Tubulin Modulators|tubulin modulators|mesh-ancestor
65252817|NCT05753865|Antimitotic Agents|antimitotic agents|mesh-ancestor
65252818|NCT05753865|Mitosis Modulators|mitosis modulators|mesh-ancestor
65252819|NCT05753865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252820|NCT00869869|Melatonin|melatonin|mesh-list
65252821|NCT00869869|Antioxidants|antioxidants|mesh-ancestor
65252822|NCT00869869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252823|NCT00869869|Protective Agents|protective agents|mesh-ancestor
65252824|NCT00869869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252825|NCT00869869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65252840|NCT00874315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252841|NCT00874315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65252842|NCT00874315|Immunologic Factors|immunologic factors|mesh-ancestor
65252843|NCT00874315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252844|NCT00874315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65252845|NCT00874315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65252846|NCT00874315|Antifungal Agents|antifungal agents|mesh-ancestor
65252847|NCT00874315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65252848|NCT00874315|Dermatologic Agents|dermatologic agents|mesh-ancestor
65252849|NCT00874315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65252850|NCT00874315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65252851|NCT00874315|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65252852|NCT00874315|Antitubercular Agents|antitubercular agents|mesh-ancestor
65252853|NCT00874315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65252854|NCT00874315|Alkylating Agents|alkylating agents|mesh-ancestor
65252855|NCT00874315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65252856|NCT00874315|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65252857|NCT00874393|Hydrocortisone|hydrocortisone|mesh-list
65252858|NCT00874393|Dopamine|dopamine|mesh-list
65252859|NCT00874393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65252860|NCT00874393|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65252861|NCT00874393|Sympathomimetics|sympathomimetics|mesh-ancestor
65252862|NCT00874393|Autonomic Agents|autonomic agents|mesh-ancestor
65252863|NCT00874393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65252864|NCT00874393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252865|NCT00874393|Dopamine Agents|dopamine agents|mesh-ancestor
65252866|NCT00874393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65252867|NCT00874393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252868|NCT00874393|Protective Agents|protective agents|mesh-ancestor
65252869|NCT04199364|Poractant alfa|poractant alfa|mesh-list
65252870|NCT04199364|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
65252882|NCT02786550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65252883|NCT02786550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252884|NCT02786550|Cholinergic Agents|cholinergic agents|mesh-ancestor
65252885|NCT02786550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65252886|NCT02786550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252887|NCT02786550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65252888|NCT02786550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65003147|NCT00447031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65252889|NCT02784054|Cyclophosphamide|cyclophosphamide|mesh-list
65252891|NCT02784054|Thiotepa|thiotepa|mesh-list
65252892|NCT02784054|Carboplatin|carboplatin|mesh-list
65252893|NCT02784054|Etoposide|etoposide|mesh-list
65252894|NCT02784054|Bleomycin|bleomycin|mesh-list
65252895|NCT02784054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65252896|NCT02784054|Immunologic Factors|immunologic factors|mesh-ancestor
65252897|NCT02784054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252898|NCT02784054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65252899|NCT02784054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65252900|NCT02784054|Alkylating Agents|alkylating agents|mesh-ancestor
65252901|NCT02784054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252902|NCT02784054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252903|NCT02784054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65252904|NCT02784054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65252905|NCT02784054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65252906|NCT02784054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65252907|NCT02784054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65252908|NCT02784054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65252909|NCT00874861|Poly ICLC|poly iclc|mesh-list
65252929|NCT02066220|Carboplatin|carboplatin|mesh-list
65252930|NCT02066220|Vincristine|vincristine|mesh-list
65252931|NCT02066220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65252932|NCT02066220|Immunologic Factors|immunologic factors|mesh-ancestor
65252933|NCT02066220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252934|NCT02066220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65252935|NCT02066220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65252936|NCT02066220|Alkylating Agents|alkylating agents|mesh-ancestor
65252937|NCT02066220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252938|NCT02066220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252939|NCT02066220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65252940|NCT02066220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65252941|NCT02066220|Tubulin Modulators|tubulin modulators|mesh-ancestor
65252942|NCT02066220|Antimitotic Agents|antimitotic agents|mesh-ancestor
65252943|NCT02066220|Mitosis Modulators|mitosis modulators|mesh-ancestor
65252944|NCT00573391|Thalidomide|thalidomide|mesh-list
65252945|NCT00573391|Dexamethasone|dexamethasone|mesh-list
65252946|NCT00573391|Dexamethasone acetate|dexamethasone acetate|mesh-list
65252947|NCT00573391|Melphalan|melphalan|mesh-list
65252948|NCT00573391|Bortezomib|bortezomib|mesh-list
65252949|NCT00573391|BB 1101|bb 1101|mesh-list
65252950|NCT00573391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65252951|NCT00573391|Antiemetics|antiemetics|mesh-ancestor
65252952|NCT00573391|Autonomic Agents|autonomic agents|mesh-ancestor
65252953|NCT00573391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65252954|NCT00573391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252980|NCT02783976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65252981|NCT00878371|Morphine|morphine|mesh-list
65252982|NCT00878371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65252983|NCT00878371|Narcotics|narcotics|mesh-ancestor
65252984|NCT00878371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65252985|NCT00878371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65252986|NCT00878371|Analgesics|analgesics|mesh-ancestor
65252987|NCT00878371|Sensory System Agents|sensory system agents|mesh-ancestor
65252988|NCT00878371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65252989|NCT04230564|Azacitidine|azacitidine|mesh-list
65252990|NCT04230564|Venetoclax|venetoclax|mesh-list
65252991|NCT04230564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65252992|NCT04230564|Antimetabolites|antimetabolites|mesh-ancestor
65252993|NCT04230564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65252994|NCT04230564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65252995|NCT04230564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65252996|NCT04054635|Fluorides|fluorides|mesh-list
65252997|NCT04054635|Cariostatic Agents|cariostatic agents|mesh-ancestor
65252998|NCT04054635|Protective Agents|protective agents|mesh-ancestor
65252999|NCT04054635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253000|NCT00923299|Trastuzumab|trastuzumab|mesh-list
65253001|NCT00923299|Cetuximab|cetuximab|mesh-list
65253002|NCT00923299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65253003|NCT00923299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253004|NCT05753397|Ropivacaine|ropivacaine|mesh-list
65253032|NCT04029831|Anesthetics, General|anesthetics, general|mesh-ancestor
65253033|NCT04029831|Anesthetics|anesthetics|mesh-ancestor
65253034|NCT04029831|Analgesics|analgesics|mesh-ancestor
65253035|NCT04029831|Sensory System Agents|sensory system agents|mesh-ancestor
65253036|NCT04029831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65253037|NCT04029831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65253038|NCT04029831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65253039|NCT04029831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65253040|NCT04029831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65253041|NCT04029831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253042|NCT00878449|Etoposide|etoposide|mesh-list
65253043|NCT00878449|Navitoclax|navitoclax|mesh-list
65253044|NCT00878449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253045|NCT00878449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65253047|NCT00878449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65253048|NCT00878449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253049|NCT00878449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253050|NCT00875407|3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|mesh-list
65253051|NCT00875407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65253052|NCT00875407|Dopamine Agents|dopamine agents|mesh-ancestor
65253053|NCT00875407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65253054|NCT00875407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253055|NCT00875407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253056|NCT00875875|Rifaximin|rifaximin|mesh-list
65253057|NCT00875875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65253058|NCT00875875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65253059|NCT00875875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65253077|NCT01716312|Respiratory System Agents|respiratory system agents|mesh-ancestor
65253078|NCT00880243|Cytarabine|cytarabine|mesh-list
65253079|NCT00880243|Etoposide|etoposide|mesh-list
65253080|NCT00880243|Mitoxantrone|mitoxantrone|mesh-list
65253081|NCT00880243|Daunorubicin|daunorubicin|mesh-list
65253082|NCT00880243|Molgramostim|molgramostim|mesh-list
65253083|NCT00880243|Sargramostim|sargramostim|mesh-list
65253084|NCT00880243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65253085|NCT00880243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253086|NCT00880243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65253087|NCT00880243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65253088|NCT00880243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253089|NCT00880243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253090|NCT00880243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65253091|NCT00880243|Antimetabolites|antimetabolites|mesh-ancestor
65253092|NCT00880243|Antiviral Agents|antiviral agents|mesh-ancestor
65253093|NCT00880243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65253094|NCT00880243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65253095|NCT00880243|Immunologic Factors|immunologic factors|mesh-ancestor
65253096|NCT00880243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253097|NCT00880243|Analgesics|analgesics|mesh-ancestor
65253098|NCT00880243|Sensory System Agents|sensory system agents|mesh-ancestor
65253099|NCT00880243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65253100|NCT00880243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65253101|NCT02783586|Bupivacaine|bupivacaine|mesh-list
65253102|NCT02783586|Anesthetics, Local|anesthetics, local|mesh-ancestor
65253103|NCT02783586|Anesthetics|anesthetics|mesh-ancestor
65253104|NCT02783586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65253105|NCT02783586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253106|NCT02783586|Sensory System Agents|sensory system agents|mesh-ancestor
65253108|NCT00590577|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65253121|NCT00590577|Dopamine Agents|dopamine agents|mesh-ancestor
65253122|NCT00880321|Dabrafenib|dabrafenib|mesh-list
65253123|NCT00880321|Midazolam|midazolam|mesh-list
65253124|NCT00880321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65253125|NCT00880321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65253126|NCT00880321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65253127|NCT00880321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253128|NCT00880321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65253129|NCT00880321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65253130|NCT00880321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65253131|NCT00880321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65253132|NCT00880321|Anesthetics, General|anesthetics, general|mesh-ancestor
65253133|NCT00880321|Anesthetics|anesthetics|mesh-ancestor
65253134|NCT00880321|GABA Modulators|gaba modulators|mesh-ancestor
65253135|NCT00880321|GABA Agents|gaba agents|mesh-ancestor
65253136|NCT00880321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65253137|NCT00880321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253138|NCT00880321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253139|NCT00880321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65253140|NCT00880321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253141|NCT02608437|Ipilimumab|ipilimumab|mesh-list
65253142|NCT02608437|Guadecitabine|guadecitabine|mesh-list
65253143|NCT02608437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65253144|NCT02608437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253145|NCT02608437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65253146|NCT02608437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253147|NCT05753007|Cannabidiol|cannabidiol|mesh-list
65253148|NCT05753007|Anticonvulsants|anticonvulsants|mesh-ancestor
65253149|NCT04230330|Gemcitabine|gemcitabine|mesh-list
65253150|NCT04230330|Dexamethasone|dexamethasone|mesh-list
65253151|NCT04230330|Nivolumab|nivolumab|mesh-list
65253152|NCT04230330|Asparaginase|asparaginase|mesh-list
65253166|NCT04230330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253167|NCT04230330|Antiviral Agents|antiviral agents|mesh-ancestor
65253168|NCT04230330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65253169|NCT04230330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253170|NCT04230330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65253171|NCT04230330|Immunologic Factors|immunologic factors|mesh-ancestor
65253172|NCT04230330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65253173|NCT04230330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65253174|NCT02785068|Leucovorin|leucovorin|mesh-list
65253175|NCT02785068|Fluorouracil|fluorouracil|mesh-list
65253176|NCT02785068|Antimetabolites|antimetabolites|mesh-ancestor
65253177|NCT02785068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253178|NCT02785068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65253179|NCT02785068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253180|NCT02785068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65253181|NCT02785068|Immunologic Factors|immunologic factors|mesh-ancestor
65253182|NCT02785068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253183|NCT02785068|Antidotes|antidotes|mesh-ancestor
65253184|NCT02785068|Protective Agents|protective agents|mesh-ancestor
65253185|NCT02785068|Vitamin B Complex|vitamin b complex|mesh-ancestor
65253186|NCT02785068|Vitamins|vitamins|mesh-ancestor
65253187|NCT02785068|Micronutrients|micronutrients|mesh-ancestor
65253188|NCT05752929|Insulin|insulin|mesh-list
65253189|NCT05752929|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65003452|NCT00115115|Dopamine|dopamine|mesh-list
65253217|NCT02783040|Digoxin|digoxin|mesh-list
65253218|NCT02783040|Midazolam|midazolam|mesh-list
65253219|NCT02783040|BI 425809|bi 425809|mesh-list
65253220|NCT02783040|Omeprazole|omeprazole|mesh-list
65253221|NCT02783040|Warfarin|warfarin|mesh-list
65253222|NCT02783040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65253223|NCT02783040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65253224|NCT02783040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65253225|NCT02783040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253226|NCT02783040|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65253227|NCT02783040|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65253228|NCT02783040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65253229|NCT02783040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65253230|NCT02783040|Anesthetics, General|anesthetics, general|mesh-ancestor
65253231|NCT02783040|Anesthetics|anesthetics|mesh-ancestor
65253232|NCT02783040|GABA Modulators|gaba modulators|mesh-ancestor
65253233|NCT02783040|GABA Agents|gaba agents|mesh-ancestor
65253234|NCT02783040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65253235|NCT02783040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253236|NCT02783040|Anticoagulants|anticoagulants|mesh-ancestor
65253237|NCT02783040|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65253238|NCT02783040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65253239|NCT02783040|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65253240|NCT02783040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253241|NCT02783040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65253242|NCT02783040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65253243|NCT02783040|Protective Agents|protective agents|mesh-ancestor
65253244|NCT02783040|Nootropic Agents|nootropic agents|mesh-ancestor
65253245|NCT02512926|Cyclophosphamide|cyclophosphamide|mesh-list
65253246|NCT02512926|Etoposide|etoposide|mesh-list
65253247|NCT02512926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65253263|NCT02786082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253264|NCT05275686|Fluticasone|fluticasone|mesh-list
65253265|NCT05275686|Xhance|xhance|mesh-list
65253266|NCT05275686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65253267|NCT05275686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65253268|NCT05275686|Autonomic Agents|autonomic agents|mesh-ancestor
65253269|NCT05275686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65253270|NCT05275686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253272|NCT05275686|Respiratory System Agents|respiratory system agents|mesh-ancestor
65253273|NCT05275686|Dermatologic Agents|dermatologic agents|mesh-ancestor
65253274|NCT05275686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65253275|NCT01503606|Clarithromycin|clarithromycin|mesh-list
65253276|NCT01503606|Cefazolin|cefazolin|mesh-list
65253277|NCT01503606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65253278|NCT01503606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65253279|NCT01503606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65253280|NCT01503606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253281|NCT01503606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253282|NCT01503606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65253283|NCT01503606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65253284|NCT00805935|Leuprolide|leuprolide|mesh-list
65253285|NCT00805935|Menotropins|menotropins|mesh-list
65253286|NCT00805935|Progesterone|progesterone|mesh-list
65253287|NCT00805935|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65253288|NCT00805935|Progestins|progestins|mesh-ancestor
65253289|NCT00805935|Hormones|hormones|mesh-ancestor
65253290|NCT00805935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65253291|NCT00805935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253292|NCT00805935|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65253293|NCT00805935|Fertility Agents|fertility agents|mesh-ancestor
65253294|NCT00805935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64928701|NCT00017628|Methylprednisolone|methylprednisolone|mesh-list
64928702|NCT00017628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64928704|NCT00017628|Prednisolone|prednisolone|mesh-list
65253307|NCT00638118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65253308|NCT00638118|Histamine Antagonists|histamine antagonists|mesh-ancestor
65253309|NCT00638118|Histamine Agents|histamine agents|mesh-ancestor
65253310|NCT00638118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65253311|NCT00638118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253312|NCT00638118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253313|NCT00805545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65253314|NCT00805545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65253315|NCT00805545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65253316|NCT00805545|Antitubercular Agents|antitubercular agents|mesh-ancestor
65253317|NCT00590031|Irinotecan|irinotecan|mesh-list
65253318|NCT00590031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253319|NCT00590031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65253320|NCT00590031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65253321|NCT00590031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253322|NCT00590031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253323|NCT02783196|Liraglutide|liraglutide|mesh-list
65253324|NCT02783196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65253325|NCT02783196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253326|NCT02783196|Incretins|incretins|mesh-ancestor
65253327|NCT02783196|Hormones|hormones|mesh-ancestor
65253328|NCT02783196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65253329|NCT05188170|Niclosamide|niclosamide|mesh-list
65253330|NCT05188170|Anticestodal Agents|anticestodal agents|mesh-ancestor
65253331|NCT05188170|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65253332|NCT05188170|Anthelmintics|anthelmintics|mesh-ancestor
65253350|NCT02782338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253351|NCT02782338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253352|NCT02782260|Dipyridamole|dipyridamole|mesh-list
65253353|NCT02782260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65253354|NCT02782260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253355|NCT02782260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253356|NCT02782260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65253357|NCT02782260|Vasodilator Agents|vasodilator agents|mesh-ancestor
65253358|NCT05031936|Ropivacaine|ropivacaine|mesh-list
65253359|NCT05031936|Anesthetics, Local|anesthetics, local|mesh-ancestor
65253360|NCT05031936|Anesthetics|anesthetics|mesh-ancestor
65253361|NCT05031936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65253362|NCT05031936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253363|NCT05031936|Sensory System Agents|sensory system agents|mesh-ancestor
65253364|NCT05031936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65253365|NCT03577704|Gemcitabine|gemcitabine|mesh-list
65253366|NCT03577704|Paclitaxel|paclitaxel|mesh-list
65253367|NCT03577704|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65253368|NCT03577704|Cisplatin|cisplatin|mesh-list
65253369|NCT03577704|Carboplatin|carboplatin|mesh-list
65253370|NCT03577704|Oxaliplatin|oxaliplatin|mesh-list
65253371|NCT03577704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65253372|NCT03577704|Antibodies|antibodies|mesh-list
65253403|NCT05030766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65253404|NCT05030766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253405|NCT05030766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65253406|NCT05030766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65253407|NCT05030766|Cholinergic Agents|cholinergic agents|mesh-ancestor
65253408|NCT05030766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65253409|NCT05030766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253410|NCT00615199|Tofacitinib|tofacitinib|mesh-list
65253411|NCT00615199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65253412|NCT00615199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253413|NCT00615199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253414|NCT00879073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65253415|NCT00879073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65253416|NCT00879073|Alkylating Agents|alkylating agents|mesh-ancestor
65253417|NCT00879073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253418|NCT00879073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253419|NCT00880867|Poly ICLC|poly iclc|mesh-list
65253420|NCT00880867|Interferon Inducers|interferon inducers|mesh-ancestor
65253421|NCT00880867|Immunologic Factors|immunologic factors|mesh-ancestor
65253422|NCT00880867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253423|NCT04228926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65253424|NCT04228926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65253425|NCT02782182|Leucovorin|leucovorin|mesh-list
65253426|NCT02782182|Oxaliplatin|oxaliplatin|mesh-list
65253454|NCT00881101|Mitosis Modulators|mitosis modulators|mesh-ancestor
65253455|NCT00881101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253456|NCT00883909|Dutasteride|dutasteride|mesh-list
65253457|NCT00883909|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65253458|NCT00883909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65253459|NCT00883909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253460|NCT00883909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253461|NCT00883909|Hormone Antagonists|hormone antagonists|mesh-ancestor
65253462|NCT00883909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65253463|NCT00883909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253464|NCT00634686|Vitamin D|vitamin d|mesh-list
65253465|NCT00634686|Calcium|calcium|mesh-list
65253466|NCT00634686|Vitamins|vitamins|mesh-ancestor
65253467|NCT00634686|Micronutrients|micronutrients|mesh-ancestor
65253468|NCT00634686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253469|NCT00634686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65253470|NCT00634686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65253471|NCT05340192|Octreotide|octreotide|mesh-list
65253472|NCT05340192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65253473|NCT05340192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65253474|NCT05340192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253475|NCT03955861|Adalimumab|adalimumab|mesh-list
65253476|NCT03955861|Etanercept|etanercept|mesh-list
65253477|NCT03955861|Golimumab|golimumab|mesh-list
65253478|NCT03955861|Certolizumab Pegol|certolizumab pegol|mesh-list
65253503|NCT02781246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65253504|NCT02781246|Analgesics|analgesics|mesh-ancestor
65253505|NCT02781246|Sensory System Agents|sensory system agents|mesh-ancestor
65253506|NCT02781246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65253507|NCT02781246|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65253508|NCT02781246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65253509|NCT02781246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65253510|NCT02781246|Adrenergic Agents|adrenergic agents|mesh-ancestor
65253511|NCT02781246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65253512|NCT02781246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253513|NCT00613951|Insulin|insulin|mesh-list
65253514|NCT00613951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65253515|NCT00613951|Metformin|metformin|mesh-list
65253516|NCT00613951|Insulin Aspart|insulin aspart|mesh-list
65253517|NCT00613951|Insulin, Long-Acting|insulin, long-acting|mesh-list
65253518|NCT00613951|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65253519|NCT00613951|Biphasic Insulins|biphasic insulins|mesh-list
65253520|NCT00613951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65253521|NCT00613951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253522|NCT00881413|Esomeprazole|esomeprazole|mesh-list
65253523|NCT00881413|Pantoprazole|pantoprazole|mesh-list
65253524|NCT00881413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65253525|NCT00881413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65253526|NCT00881413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65253527|NCT00881413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253528|NCT00881413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253529|NCT00881491|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65253530|NCT00881491|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65253531|NCT00881491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65253532|NCT00881491|Antitubercular Agents|antitubercular agents|mesh-ancestor
65253533|NCT00958841|Pasireotide|pasireotide|mesh-list
65253534|NCT00958841|Hormones|hormones|mesh-ancestor
65253537|NCT02937116|Gemcitabine|gemcitabine|mesh-list
65253547|NCT02937116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253548|NCT02937116|Antiviral Agents|antiviral agents|mesh-ancestor
65253549|NCT02937116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65253550|NCT02937116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253551|NCT02937116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65253552|NCT02937116|Immunologic Factors|immunologic factors|mesh-ancestor
65253553|NCT02937116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253554|NCT02937116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65253555|NCT02937116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65253556|NCT02937116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65253557|NCT02937116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65253558|NCT02937116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65253559|NCT02937116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65253560|NCT03927105|Nivolumab|nivolumab|mesh-list
65253561|NCT03927105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65253565|NCT00613327|Oxybutynin|oxybutynin|mesh-list
65253606|NCT05086224|Anesthetics, Local|anesthetics, local|mesh-list
65253607|NCT05086224|Anesthetics|anesthetics|mesh-list
65253608|NCT05086224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65253609|NCT05086224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253610|NCT05086224|Sensory System Agents|sensory system agents|mesh-ancestor
65253611|NCT05086224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65253612|NCT05086224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65253613|NCT05086224|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65253614|NCT05086224|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65253615|NCT05086224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65253616|NCT05086224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253617|NCT00954941|Ondansetron|ondansetron|mesh-list
65253618|NCT00954941|Aprepitant|aprepitant|mesh-list
65253619|NCT00954941|Antiemetics|antiemetics|mesh-ancestor
65253620|NCT00954941|Autonomic Agents|autonomic agents|mesh-ancestor
65253621|NCT00954941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65253622|NCT00954941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253623|NCT00954941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65253624|NCT00954941|Antipruritics|antipruritics|mesh-ancestor
65253625|NCT00954941|Dermatologic Agents|dermatologic agents|mesh-ancestor
65253626|NCT00954941|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65253627|NCT00954941|Serotonin Agents|serotonin agents|mesh-ancestor
65253628|NCT00954941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65253629|NCT00954941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253630|NCT00954941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65253631|NCT00954941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65253632|NCT00954941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65253633|NCT00954941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65253634|NCT00954941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65253635|NCT00954941|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65253636|NCT05339646|Ritonavir|ritonavir|mesh-list
65253637|NCT05339646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65253638|NCT05339646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65253639|NCT05339646|Protease Inhibitors|protease inhibitors|mesh-ancestor
65253645|NCT05339646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65253646|NCT05339646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65253647|NCT05339646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65253648|NCT00630695|Lanreotide|lanreotide|mesh-list
65253649|NCT00630695|Somatostatin|somatostatin|mesh-list
65003908|NCT03273595|Paclitaxel|paclitaxel|mesh-list
65253650|NCT00630695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253651|NCT00630695|Hormones|hormones|mesh-ancestor
65253652|NCT00630695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65253653|NCT00630695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253654|NCT02843438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65253655|NCT05305014|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65253656|NCT05305014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65253657|NCT00954707|Aspirin|aspirin|mesh-list
65253658|NCT00954707|Clopidogrel|clopidogrel|mesh-list
65253659|NCT00954707|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65253660|NCT00954707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65253661|NCT00954707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65253662|NCT00954707|Analgesics|analgesics|mesh-ancestor
65253663|NCT00954707|Sensory System Agents|sensory system agents|mesh-ancestor
65253664|NCT00954707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65253665|NCT00954707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253666|NCT00954707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65253667|NCT00954707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65253668|NCT00954707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65253669|NCT00954707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65253670|NCT00954707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253690|NCT00613171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65253691|NCT00613171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253692|NCT00613171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253693|NCT05156892|Tamoxifen|tamoxifen|mesh-list
65253694|NCT05156892|Itraconazole|itraconazole|mesh-list
65253695|NCT05156892|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65253696|NCT05156892|Hormone Antagonists|hormone antagonists|mesh-ancestor
65253697|NCT05156892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65253698|NCT05156892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253699|NCT05156892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65253700|NCT05156892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253701|NCT05156892|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65253702|NCT05156892|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65253703|NCT05156892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65253704|NCT05156892|Antifungal Agents|antifungal agents|mesh-ancestor
65253705|NCT05156892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65253706|NCT05156892|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65253707|NCT05156892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65253743|NCT00879307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65253744|NCT00879307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253745|NCT03851835|Ondansetron|ondansetron|mesh-list
65253746|NCT03851835|Antiemetics|antiemetics|mesh-ancestor
65253747|NCT03851835|Autonomic Agents|autonomic agents|mesh-ancestor
65253748|NCT03851835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65253749|NCT03851835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253750|NCT03851835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65253751|NCT03851835|Antipruritics|antipruritics|mesh-ancestor
65253752|NCT03851835|Dermatologic Agents|dermatologic agents|mesh-ancestor
65253753|NCT03851835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65253754|NCT03851835|Serotonin Agents|serotonin agents|mesh-ancestor
65253755|NCT03851835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65253756|NCT03851835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253757|NCT03851835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65253758|NCT03851835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65253759|NCT03851835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65253799|NCT00613015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65253800|NCT00613015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65253801|NCT00613015|Adrenergic Agents|adrenergic agents|mesh-ancestor
65253802|NCT00613015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65253804|NCT02779608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253805|NCT02779608|Tubulin Modulators|tubulin modulators|mesh-ancestor
65253806|NCT02779608|Antimitotic Agents|antimitotic agents|mesh-ancestor
65253807|NCT02779608|Mitosis Modulators|mitosis modulators|mesh-ancestor
65253808|NCT02779608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253809|NCT02543671|Vitamin D|vitamin d|mesh-list
65253810|NCT02543671|Cholecalciferol|cholecalciferol|mesh-list
65253811|NCT02543671|Vitamins|vitamins|mesh-ancestor
65253812|NCT02543671|Micronutrients|micronutrients|mesh-ancestor
65253813|NCT02543671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253814|NCT02543671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65253815|NCT02543671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65253816|NCT02838992|Cyclosporine|cyclosporine|mesh-list
65253817|NCT02838992|Cyclophosphamide|cyclophosphamide|mesh-list
65253818|NCT02838992|Cyclosporins|cyclosporins|mesh-list
65253819|NCT02838992|Thymoglobulin|thymoglobulin|mesh-list
65253820|NCT02838992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65253821|NCT02838992|Immunologic Factors|immunologic factors|mesh-ancestor
65253822|NCT02838992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253823|NCT02838992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65253824|NCT02838992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65253825|NCT02838992|Alkylating Agents|alkylating agents|mesh-ancestor
65253827|NCT02838992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253849|NCT05338476|Midazolam|midazolam|mesh-list
65253850|NCT05338476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65253851|NCT05338476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65253852|NCT05338476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65253853|NCT05338476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253854|NCT05338476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65253855|NCT05338476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65253856|NCT05338476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65253857|NCT05338476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65253858|NCT05338476|Anesthetics, General|anesthetics, general|mesh-ancestor
65253859|NCT05338476|Anesthetics|anesthetics|mesh-ancestor
65253860|NCT05338476|GABA Modulators|gaba modulators|mesh-ancestor
65253861|NCT05338476|GABA Agents|gaba agents|mesh-ancestor
65253862|NCT05338476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65253863|NCT05338476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253864|NCT02838758|Lidocaine|lidocaine|mesh-list
65253865|NCT02838758|Anesthetics, Local|anesthetics, local|mesh-ancestor
65253866|NCT02838758|Anesthetics|anesthetics|mesh-ancestor
65253867|NCT02838758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65253868|NCT02838758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004130|NCT00462787|Glucocorticoids|glucocorticoids|mesh-ancestor
65253869|NCT02838758|Sensory System Agents|sensory system agents|mesh-ancestor
65253870|NCT02838758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65253871|NCT02838758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65253872|NCT02838758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65253873|NCT02838758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65253874|NCT02838758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65253875|NCT02838758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253876|NCT00803595|Oseltamivir|oseltamivir|mesh-list
65253877|NCT00803595|Antiviral Agents|antiviral agents|mesh-ancestor
65253893|NCT04227990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253894|NCT04227990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65253895|NCT04227990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65253896|NCT04227990|Alkylating Agents|alkylating agents|mesh-ancestor
65253897|NCT04227990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253898|NCT04227990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253899|NCT04227990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65253900|NCT04227990|Tubulin Modulators|tubulin modulators|mesh-ancestor
65253901|NCT04227990|Antimitotic Agents|antimitotic agents|mesh-ancestor
65253902|NCT04227990|Mitosis Modulators|mitosis modulators|mesh-ancestor
65253903|NCT04227990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65253904|NCT04227990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65253905|NCT04227990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65253906|NCT04227990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253907|NCT02606409|Dexmedetomidine|dexmedetomidine|mesh-list
65253908|NCT02606409|Propofol|propofol|mesh-list
65253909|NCT02606409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65253910|NCT02606409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65253911|NCT02606409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253912|NCT02606409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65253913|NCT02606409|Anesthetics, General|anesthetics, general|mesh-ancestor
65253914|NCT02606409|Anesthetics|anesthetics|mesh-ancestor
65253915|NCT02606409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65253916|NCT02606409|Analgesics|analgesics|mesh-ancestor
65253942|NCT00803361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65253943|NCT00803361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253944|NCT00803361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65004202|NCT00463762|Sulbactam|sulbactam|mesh-list
65253945|NCT00803361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253947|NCT00803361|Sensory System Agents|sensory system agents|mesh-ancestor
65253948|NCT00803361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65253949|NCT00803361|Antidepressive Agents|antidepressive agents|mesh-ancestor
65253950|NCT00803361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65253951|NCT00803361|Dopamine Agents|dopamine agents|mesh-ancestor
65253952|NCT02837198|Dotinurad|dotinurad|mesh-list
65253953|NCT02837198|FYX-051|fyx-051|mesh-list
65253954|NCT02837198|Uricosuric Agents|uricosuric agents|mesh-ancestor
65253955|NCT02837198|Gout Suppressants|gout suppressants|mesh-ancestor
65253956|NCT02837198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65253957|NCT02837198|Renal Agents|renal agents|mesh-ancestor
65253958|NCT02837198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253959|NCT02837198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253960|NCT00611533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65253961|NCT00611533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65253962|NCT00611533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65253963|NCT00611533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65253964|NCT00611533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253965|NCT00611533|Adrenergic Agents|adrenergic agents|mesh-ancestor
65253966|NCT00611533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65253967|NCT00611533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65253968|NCT04038307|Acetaminophen|acetaminophen|mesh-list
65253969|NCT04038307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65253970|NCT04038307|Analgesics|analgesics|mesh-ancestor
65253971|NCT04038307|Sensory System Agents|sensory system agents|mesh-ancestor
65253974|NCT04038307|Antipyretics|antipyretics|mesh-ancestor
64929376|NCT00045604|Irinotecan|irinotecan|mesh-list
65253986|NCT00884533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253987|NCT00884533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65253988|NCT02842814|Hydroxychloroquine|hydroxychloroquine|mesh-list
65253989|NCT02842814|Glucocorticoids|glucocorticoids|mesh-list
65253990|NCT02842814|Antimalarials|antimalarials|mesh-ancestor
65253991|NCT02842814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65253992|NCT02842814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65253993|NCT02842814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65253994|NCT02842814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65253995|NCT02842814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65253996|NCT02842814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65253997|NCT02842814|Hormones|hormones|mesh-ancestor
65253998|NCT02842814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65253999|NCT02842814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254000|NCT00882193|Ribavirin|ribavirin|mesh-list
65254001|NCT00882193|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65254002|NCT00882193|Betaine|betaine|mesh-list
65254003|NCT00882193|Antimetabolites|antimetabolites|mesh-ancestor
65254004|NCT00882193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254005|NCT00882193|Antiviral Agents|antiviral agents|mesh-ancestor
65254006|NCT00882193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65254007|NCT00882193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65254008|NCT00882193|Lipotropic Agents|lipotropic agents|mesh-ancestor
65254009|NCT00882193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65254010|NCT00882193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65254011|NCT02778360|Methylphenidate|methylphenidate|mesh-list
65254012|NCT02778360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65254030|NCT05333744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65254031|NCT05333744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254032|NCT05333744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65254033|NCT05333744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254034|NCT04250246|Nivolumab|nivolumab|mesh-list
65254035|NCT04250246|Ipilimumab|ipilimumab|mesh-list
65254036|NCT04250246|Guadecitabine|guadecitabine|mesh-list
65254037|NCT04250246|Azacitidine|azacitidine|mesh-list
65254038|NCT04250246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65254039|NCT04250246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254040|NCT04250246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65254041|NCT04250246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254042|NCT04250246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65254043|NCT04250246|Antimetabolites|antimetabolites|mesh-ancestor
65254044|NCT04250246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254045|NCT04273529|Thalidomide|thalidomide|mesh-list
65254046|NCT04273529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65254047|NCT04273529|Immunologic Factors|immunologic factors|mesh-ancestor
65254048|NCT04273529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254049|NCT04273529|Leprostatic Agents|leprostatic agents|mesh-ancestor
65254050|NCT04273529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65254051|NCT04273529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65254052|NCT04273529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65254053|NCT04273529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65254054|NCT04273529|Growth Substances|growth substances|mesh-ancestor
65254055|NCT04273529|Growth Inhibitors|growth inhibitors|mesh-ancestor
65254056|NCT04273529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254057|NCT02858843|Ivacaftor|ivacaftor|mesh-list
65254058|NCT02858843|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65254059|NCT02858843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65254073|NCT00952523|Adapalene|adapalene|mesh-list
65254074|NCT00952523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
65254075|NCT00952523|Tretinoin|tretinoin|mesh-list
65254076|NCT00952523|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65254077|NCT00952523|Dermatologic Agents|dermatologic agents|mesh-ancestor
65254078|NCT00952523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65254079|NCT00952523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65254080|NCT00952523|Analgesics|analgesics|mesh-ancestor
65254081|NCT00952523|Sensory System Agents|sensory system agents|mesh-ancestor
65254082|NCT00952523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254083|NCT00952523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254084|NCT00952523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65254085|NCT00952523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65254086|NCT00952523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254087|NCT00952523|Keratolytic Agents|keratolytic agents|mesh-ancestor
65254088|NCT04249154|Leuprolide|leuprolide|mesh-list
65254089|NCT04249154|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65254090|NCT04249154|Fertility Agents|fertility agents|mesh-ancestor
65254091|NCT04249154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65254092|NCT04249154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254093|NCT04249154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65254094|NCT04249154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254095|NCT02857361|Ketamine|ketamine|mesh-list
65254096|NCT02857361|Analgesics|analgesics|mesh-ancestor
65254097|NCT02857361|Sensory System Agents|sensory system agents|mesh-ancestor
65254098|NCT02857361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254099|NCT02857361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254100|NCT02857361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65254101|NCT02857361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65254102|NCT02857361|Anesthetics, General|anesthetics, general|mesh-ancestor
65254117|NCT02232737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254118|NCT02232737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254119|NCT02232737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65254120|NCT02232737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65254121|NCT02232737|Cholinergic Agents|cholinergic agents|mesh-ancestor
65254122|NCT02232737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65254123|NCT02232737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254124|NCT04272359|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65254125|NCT04272359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254126|NCT02777814|Entecavir|entecavir|mesh-list
65254127|NCT02777814|Antiviral Agents|antiviral agents|mesh-ancestor
65254128|NCT02777814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65254129|NCT04430192|177Lu-PSMA-617|177lu-psma-617|mesh-list
65254130|NCT04430192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65254131|NCT04430192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254132|NCT02778906|Abatacept|abatacept|mesh-list
65254133|NCT02778906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65254134|NCT02778906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254135|NCT02778906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254136|NCT02778906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65254137|NCT02778906|Immunologic Factors|immunologic factors|mesh-ancestor
65254138|NCT02778906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254139|NCT02778906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65254140|NCT00630929|Ibuprofen|ibuprofen|mesh-list
65254141|NCT00630929|Celecoxib|celecoxib|mesh-list
65254166|NCT04227912|Anesthetics|anesthetics|mesh-list
65254167|NCT04227912|Anesthetics, Local|anesthetics, local|mesh-list
65254168|NCT04227912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65254169|NCT04227912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254170|NCT04227912|Sensory System Agents|sensory system agents|mesh-ancestor
65254171|NCT04227912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254172|NCT04227912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65254173|NCT04227912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65254174|NCT04227912|Analgesics|analgesics|mesh-ancestor
65254175|NCT04227912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65254176|NCT04227912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65254177|NCT02854787|Phenylephrine|phenylephrine|mesh-list
65254178|NCT02854787|Oxymetazoline|oxymetazoline|mesh-list
65254179|NCT02854787|Norepinephrine|norepinephrine|mesh-list
65254180|NCT02854787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65254181|NCT02854787|Mydriatics|mydriatics|mesh-ancestor
65254182|NCT02854787|Autonomic Agents|autonomic agents|mesh-ancestor
65254183|NCT02854787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254184|NCT02854787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254185|NCT02854787|Sympathomimetics|sympathomimetics|mesh-ancestor
65254186|NCT02854787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65254187|NCT02854787|Nasal Decongestants|nasal decongestants|mesh-ancestor
65254188|NCT02854787|Respiratory System Agents|respiratory system agents|mesh-ancestor
65254189|NCT02854787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65254190|NCT02854787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65254191|NCT02854787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65254215|NCT02777736|Methotrexate|methotrexate|mesh-list
65254216|NCT02777736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65254217|NCT02777736|Abortifacient Agents|abortifacient agents|mesh-ancestor
65254218|NCT02777736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65254219|NCT02777736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254220|NCT02777736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65254221|NCT02777736|Antimetabolites|antimetabolites|mesh-ancestor
65254222|NCT02777736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254223|NCT02777736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254224|NCT02777736|Dermatologic Agents|dermatologic agents|mesh-ancestor
65254225|NCT02777736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254226|NCT02777736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65254227|NCT02777736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65254228|NCT02777736|Immunologic Factors|immunologic factors|mesh-ancestor
65254229|NCT02777736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65254230|NCT02777736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65254231|NCT02836184|Niacin|niacin|mesh-list
65254232|NCT02836184|Nicotinic Acids|nicotinic acids|mesh-list
65254233|NCT02836184|Niacinamide|niacinamide|mesh-list
65254234|NCT02836184|Calcium Carbonate|calcium carbonate|mesh-list
65254235|NCT02836184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254236|NCT02836184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65254237|NCT02836184|Antimetabolites|antimetabolites|mesh-ancestor
65254238|NCT02836184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254240|NCT02836184|Vasodilator Agents|vasodilator agents|mesh-ancestor
65254267|NCT02775474|Sensory System Agents|sensory system agents|mesh-ancestor
65254268|NCT02775474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254269|NCT02775474|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65254270|NCT02775474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65254271|NCT02775474|Anesthetics, General|anesthetics, general|mesh-ancestor
65254272|NCT02775474|Anesthetics|anesthetics|mesh-ancestor
65254273|NCT02775474|Antitussive Agents|antitussive agents|mesh-ancestor
65254274|NCT02775474|Respiratory System Agents|respiratory system agents|mesh-ancestor
65254275|NCT05158686|Paclitaxel|paclitaxel|mesh-list
65254276|NCT05158686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65254277|NCT05158686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254278|NCT05158686|Tubulin Modulators|tubulin modulators|mesh-ancestor
65254279|NCT05158686|Antimitotic Agents|antimitotic agents|mesh-ancestor
65254280|NCT05158686|Mitosis Modulators|mitosis modulators|mesh-ancestor
65254281|NCT05158686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254282|NCT02835794|Azacitidine|azacitidine|mesh-list
65254283|NCT02835794|Homoharringtonine|homoharringtonine|mesh-list
65254284|NCT02835794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65254285|NCT02835794|Antimetabolites|antimetabolites|mesh-ancestor
65254286|NCT02835794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254287|NCT02835794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254288|NCT02835794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254289|NCT02835794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65254290|NCT02835794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65254291|NCT02836028|Temozolomide|temozolomide|mesh-list
65254292|NCT02836028|Talazoparib|talazoparib|mesh-list
65254293|NCT02836028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65254294|NCT02836028|Alkylating Agents|alkylating agents|mesh-ancestor
65254295|NCT02836028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254296|NCT02836028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254313|NCT04227210|Immunologic Factors|immunologic factors|mesh-ancestor
65254314|NCT04227210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254315|NCT02833766|Doxorubicin|doxorubicin|mesh-list
65254316|NCT02833766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65254317|NCT02833766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254318|NCT02833766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65254319|NCT02833766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65254320|NCT02833766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254321|NCT02833766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254322|NCT04951362|Ivermectin|ivermectin|mesh-list
65254323|NCT04951362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65254324|NCT04951362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65254325|NCT02833610|Denosumab|denosumab|mesh-list
65254326|NCT02833610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65254327|NCT02833610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254328|NCT04225728|Iron|iron|mesh-list
65254329|NCT04225728|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65254330|NCT04225728|Teferrol|teferrol|mesh-list
65254331|NCT04225728|Trace Elements|trace elements|mesh-ancestor
65254332|NCT04225728|Micronutrients|micronutrients|mesh-ancestor
65254333|NCT04225728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254334|NCT04225728|Hematinics|hematinics|mesh-ancestor
65254335|NCT02835716|Ustekinumab|ustekinumab|mesh-list
65254336|NCT02835716|Dermatologic Agents|dermatologic agents|mesh-ancestor
65254337|NCT04247984|Bevacizumab|bevacizumab|mesh-list
65254338|NCT04247984|Fluorouracil|fluorouracil|mesh-list
65254339|NCT04247984|Capecitabine|capecitabine|mesh-list
65254340|NCT04247984|Irinotecan|irinotecan|mesh-list
65254341|NCT04247984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65254342|NCT04247984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254361|NCT00948389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254362|NCT00948389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65254363|NCT00948389|Alkylating Agents|alkylating agents|mesh-ancestor
65254364|NCT02775318|Bupivacaine|bupivacaine|mesh-list
65254365|NCT02775318|Anesthetics, Local|anesthetics, local|mesh-ancestor
65254366|NCT02775318|Anesthetics|anesthetics|mesh-ancestor
65254367|NCT02775318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65254368|NCT02775318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254369|NCT02775318|Sensory System Agents|sensory system agents|mesh-ancestor
65254370|NCT02775318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254371|NCT00948155|Varenicline|varenicline|mesh-list
65254372|NCT00948155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65254373|NCT00948155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65254374|NCT00948155|Cholinergic Agents|cholinergic agents|mesh-ancestor
65254375|NCT00948155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65254376|NCT00948155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254377|NCT00948155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254378|NCT02776956|Atorvastatin|atorvastatin|mesh-list
65254379|NCT02776956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65254380|NCT02776956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65254381|NCT02776956|Antimetabolites|antimetabolites|mesh-ancestor
65254382|NCT02776956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254383|NCT02776956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65254384|NCT02776956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65254385|NCT02776956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254386|NCT04910178|Empagliflozin|empagliflozin|mesh-list
65254387|NCT04910178|Pentoxifylline|pentoxifylline|mesh-list
65254388|NCT04910178|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65254389|NCT04910178|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65254390|NCT04910178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254391|NCT04910178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65254392|NCT04910178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254393|NCT04910178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65254394|NCT04910178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254395|NCT04910178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65254397|NCT04910178|Protective Agents|protective agents|mesh-ancestor
65254398|NCT04910178|Vasodilator Agents|vasodilator agents|mesh-ancestor
65254399|NCT04910178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65254400|NCT04910178|Antioxidants|antioxidants|mesh-ancestor
65254401|NCT04910178|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65254402|NCT04910178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65254403|NCT02778594|Levodopa|levodopa|mesh-list
65254404|NCT02778594|Benserazide|benserazide|mesh-list
65254405|NCT02778594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65254406|NCT02778594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65254407|NCT02778594|Dopamine Agents|dopamine agents|mesh-ancestor
65254408|NCT02778594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65254409|NCT02778594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254410|NCT02778594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254411|NCT02778594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254412|NCT02775006|Docetaxel|docetaxel|mesh-list
65254413|NCT02775006|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65254414|NCT02775006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254415|NCT02775006|Tubulin Modulators|tubulin modulators|mesh-ancestor
65254416|NCT02775006|Antimitotic Agents|antimitotic agents|mesh-ancestor
65254417|NCT02775006|Mitosis Modulators|mitosis modulators|mesh-ancestor
65254418|NCT02775006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254419|NCT02775006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65254420|NCT02775006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254421|NCT04851834|Cisplatin|cisplatin|mesh-list
65254422|NCT04851834|Carboplatin|carboplatin|mesh-list
65254423|NCT04851834|Temozolomide|temozolomide|mesh-list
65254424|NCT04851834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254425|NCT04851834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65254426|NCT04851834|Alkylating Agents|alkylating agents|mesh-ancestor
65254427|NCT04851834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254428|NCT01880567|Rituximab|rituximab|mesh-list
65254429|NCT01880567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65254441|NCT02776722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254442|NCT02776878|Dasatinib|dasatinib|mesh-list
65254443|NCT02776878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254444|NCT02776878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65254445|NCT02776878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254446|NCT02776878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254447|NCT02772822|Rituximab|rituximab|mesh-list
65254448|NCT02772822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65254449|NCT02772822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254450|NCT02772822|Immunologic Factors|immunologic factors|mesh-ancestor
65254451|NCT02772822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254452|NCT02772822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65254453|NCT00635076|Alprazolam|alprazolam|mesh-list
65254454|NCT00635076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65254455|NCT00635076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65254456|NCT00635076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254457|NCT00635076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65254458|NCT00635076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65254459|NCT00635076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65254460|NCT00635076|GABA Modulators|gaba modulators|mesh-ancestor
65254461|NCT00635076|GABA Agents|gaba agents|mesh-ancestor
65254462|NCT00635076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65254463|NCT00635076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254464|NCT02772744|Ribavirin|ribavirin|mesh-list
65254465|NCT02772744|Sofosbuvir|sofosbuvir|mesh-list
65254489|NCT02774460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65254490|NCT02774460|Protective Agents|protective agents|mesh-ancestor
65254491|NCT02772354|Metoprolol|metoprolol|mesh-list
65254492|NCT02772354|Verapamil|verapamil|mesh-list
65254493|NCT02772354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65254494|NCT02772354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65254495|NCT02772354|Sympatholytics|sympatholytics|mesh-ancestor
65254496|NCT02772354|Autonomic Agents|autonomic agents|mesh-ancestor
65254497|NCT02772354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254498|NCT02772354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254499|NCT02772354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65254500|NCT02772354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65254501|NCT02772354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65254502|NCT02772354|Adrenergic Agents|adrenergic agents|mesh-ancestor
65254503|NCT02772354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65254504|NCT02772354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254505|NCT02772354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65254506|NCT02772354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65254507|NCT02772354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65254508|NCT02772354|Vasodilator Agents|vasodilator agents|mesh-ancestor
65254509|NCT00611455|Ofatumumab|ofatumumab|mesh-list
65254510|NCT00611455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254543|NCT02767674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65254544|NCT02767674|Alkylating Agents|alkylating agents|mesh-ancestor
65004805|NCT00476359|Lopinavir|lopinavir|mesh-list
65254545|NCT02767674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254546|NCT02767674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254547|NCT02767674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65254548|NCT02767674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65254549|NCT02767674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65254550|NCT02767674|Antimetabolites|antimetabolites|mesh-ancestor
65254551|NCT02767674|Antiviral Agents|antiviral agents|mesh-ancestor
65254552|NCT02767674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65254553|NCT02767674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254554|NCT02767674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65254555|NCT02767674|Glucocorticoids|glucocorticoids|mesh-ancestor
65254557|NCT02767674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65254558|NCT02767674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65254559|NCT02767674|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65254560|NCT02767674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65254561|NCT02767674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65254562|NCT02767674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65254594|NCT00612313|Antidepressive Agents|antidepressive agents|mesh-ancestor
65254595|NCT00612313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65254596|NCT00612313|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65254597|NCT00612313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65254598|NCT00612313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254599|NCT00890552|Dexamethasone|dexamethasone|mesh-list
65254600|NCT00890552|Dexamethasone acetate|dexamethasone acetate|mesh-list
65254601|NCT00890552|Lenalidomide|lenalidomide|mesh-list
65254602|NCT00890552|Melphalan|melphalan|mesh-list
65254603|NCT00890552|BB 1101|bb 1101|mesh-list
65254604|NCT00890552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65254605|NCT00890552|Antiemetics|antiemetics|mesh-ancestor
65254606|NCT00890552|Autonomic Agents|autonomic agents|mesh-ancestor
65254607|NCT00890552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254608|NCT00890552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254609|NCT00890552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65254610|NCT00890552|Glucocorticoids|glucocorticoids|mesh-ancestor
65254611|NCT00890552|Hormones|hormones|mesh-ancestor
65254612|NCT00890552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65254613|NCT00890552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65254614|NCT00890552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254615|NCT00890552|Protease Inhibitors|protease inhibitors|mesh-ancestor
65254616|NCT00890552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254617|NCT00890552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254618|NCT00890552|Immunologic Factors|immunologic factors|mesh-ancestor
65254619|NCT00890552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65254620|NCT00890552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65254621|NCT00890552|Growth Substances|growth substances|mesh-ancestor
65254622|NCT00890552|Growth Inhibitors|growth inhibitors|mesh-ancestor
65254623|NCT00890552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65254624|NCT00890552|Alkylating Agents|alkylating agents|mesh-ancestor
65254625|NCT00890552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65254626|NCT00890552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65254627|NCT02856503|Vitamin D|vitamin d|mesh-list
65254628|NCT02856503|Cholecalciferol|cholecalciferol|mesh-list
65254634|NCT02833376|Chlorhexidine|chlorhexidine|mesh-list
65254635|NCT02833376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65254636|NCT02833376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65254637|NCT02833376|Disinfectants|disinfectants|mesh-ancestor
65254638|NCT02542813|Oxytocin|oxytocin|mesh-list
65254639|NCT02542813|Oxytocics|oxytocics|mesh-ancestor
65254640|NCT02542813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65254641|NCT02542813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254642|NCT02772120|Progesterone|progesterone|mesh-list
65254643|NCT02772120|Progestins|progestins|mesh-ancestor
65254644|NCT02772120|Hormones|hormones|mesh-ancestor
65254645|NCT02772120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65254646|NCT02772120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254647|NCT04248608|Morphine|morphine|mesh-list
65254648|NCT04248608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65254649|NCT04248608|Narcotics|narcotics|mesh-ancestor
65254650|NCT04248608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65254651|NCT04248608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254652|NCT04248608|Analgesics|analgesics|mesh-ancestor
65254653|NCT04248608|Sensory System Agents|sensory system agents|mesh-ancestor
65254654|NCT04248608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254655|NCT04783194|Dexamethasone|dexamethasone|mesh-list
65254656|NCT04783194|Bupivacaine|bupivacaine|mesh-list
65254657|NCT04783194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65254658|NCT04783194|Antiemetics|antiemetics|mesh-ancestor
65254659|NCT04783194|Autonomic Agents|autonomic agents|mesh-ancestor
65254660|NCT04783194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254661|NCT04783194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254662|NCT04783194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65254663|NCT04783194|Glucocorticoids|glucocorticoids|mesh-ancestor
65254664|NCT04783194|Hormones|hormones|mesh-ancestor
65254665|NCT04783194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65254666|NCT04783194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65254676|NCT02835170|Antibodies|antibodies|mesh-list
65254678|NCT02835170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254679|NCT00946985|Risperidone|risperidone|mesh-list
65254680|NCT00946985|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65254681|NCT00946985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65254682|NCT00946985|Serotonin Agents|serotonin agents|mesh-ancestor
65254683|NCT00946985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65254684|NCT00946985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254685|NCT00946985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254686|NCT00946985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65254687|NCT00946985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65254688|NCT00946985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65254689|NCT00946985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65254690|NCT00946985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65254691|NCT00946985|Dopamine Agents|dopamine agents|mesh-ancestor
65254692|NCT00946985|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65254736|NCT04038073|Antistreptolysin|antistreptolysin|mesh-list
65254737|NCT04038073|Immunologic Factors|immunologic factors|mesh-ancestor
65254738|NCT04038073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254739|NCT04739592|Vitamin D|vitamin d|mesh-list
65254740|NCT04739592|Cholecalciferol|cholecalciferol|mesh-list
65254741|NCT04739592|Alendronate|alendronate|mesh-list
65254742|NCT04739592|Vitamins|vitamins|mesh-ancestor
65254743|NCT04739592|Micronutrients|micronutrients|mesh-ancestor
65254744|NCT04739592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254745|NCT04739592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65254746|NCT04739592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65254747|NCT00633386|Celecoxib|celecoxib|mesh-list
65254748|NCT00633386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65254749|NCT00633386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65254750|NCT00633386|Analgesics|analgesics|mesh-ancestor
65254751|NCT00633386|Sensory System Agents|sensory system agents|mesh-ancestor
65254752|NCT00633386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254753|NCT00633386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254754|NCT00633386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65254755|NCT00633386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65254792|NCT00803049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65254793|NCT00803049|Analgesics|analgesics|mesh-ancestor
65254794|NCT00803049|Sensory System Agents|sensory system agents|mesh-ancestor
65254795|NCT00803049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254796|NCT00803049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254797|NCT00803049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65254798|NCT00803049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65254799|NCT00803049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65254800|NCT00803049|Immunologic Factors|immunologic factors|mesh-ancestor
65254801|NCT00884767|Leucovorin|leucovorin|mesh-list
65254802|NCT00884767|Fluorouracil|fluorouracil|mesh-list
65254803|NCT00884767|Oxaliplatin|oxaliplatin|mesh-list
65254804|NCT00884767|Calcium|calcium|mesh-list
65254805|NCT00884767|Levoleucovorin|levoleucovorin|mesh-list
65254806|NCT00884767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65254807|NCT00884767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254808|NCT00884767|Antimetabolites|antimetabolites|mesh-ancestor
65254809|NCT00884767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254810|NCT00884767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65254811|NCT00884767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254812|NCT00884767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65254813|NCT00884767|Immunologic Factors|immunologic factors|mesh-ancestor
65254814|NCT00884767|Antidotes|antidotes|mesh-ancestor
65254815|NCT00884767|Protective Agents|protective agents|mesh-ancestor
65254816|NCT00884767|Vitamin B Complex|vitamin b complex|mesh-ancestor
65254817|NCT00884767|Vitamins|vitamins|mesh-ancestor
65254818|NCT00884767|Micronutrients|micronutrients|mesh-ancestor
65254819|NCT00890084|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65254820|NCT00890084|Telmisartan|telmisartan|mesh-list
65254822|NCT00890084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65254838|NCT02773602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65254839|NCT02773602|Antiemetics|antiemetics|mesh-ancestor
65254840|NCT02773602|Autonomic Agents|autonomic agents|mesh-ancestor
65254841|NCT02773602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254842|NCT02773602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254843|NCT02773602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65254844|NCT02773602|Glucocorticoids|glucocorticoids|mesh-ancestor
65254845|NCT02773602|Hormones|hormones|mesh-ancestor
65254846|NCT02773602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65254847|NCT02773602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65254848|NCT02773602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254849|NCT02773602|Analgesics|analgesics|mesh-ancestor
65254850|NCT02773602|Sensory System Agents|sensory system agents|mesh-ancestor
65254851|NCT02773602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65254852|NCT02773602|Sympatholytics|sympatholytics|mesh-ancestor
65254853|NCT02773602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65254854|NCT02773602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65254855|NCT02773602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65254856|NCT02773602|Adrenergic Agents|adrenergic agents|mesh-ancestor
65254857|NCT02773602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65254858|NCT02773602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254859|NCT02770950|Indomethacin|indomethacin|mesh-list
65254860|NCT02770950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65254861|NCT02770950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65254862|NCT02770950|Analgesics|analgesics|mesh-ancestor
65254863|NCT02770950|Sensory System Agents|sensory system agents|mesh-ancestor
65254864|NCT02770950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254865|NCT02770950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254866|NCT02770950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65254867|NCT02770950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65254868|NCT02770950|Gout Suppressants|gout suppressants|mesh-ancestor
65254880|NCT05684289|Vasodilator Agents|vasodilator agents|mesh-ancestor
65254881|NCT05684289|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65254882|NCT05684289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65254883|NCT05684289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254884|NCT05684289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254885|NCT05684289|Urological Agents|urological agents|mesh-ancestor
65254886|NCT02829008|Bevacizumab|bevacizumab|mesh-list
65254887|NCT02829008|Pemetrexed|pemetrexed|mesh-list
65254888|NCT02829008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65254889|NCT02829008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254890|NCT02829008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65254891|NCT02829008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65254892|NCT02829008|Growth Substances|growth substances|mesh-ancestor
65254893|NCT02829008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254894|NCT02829008|Growth Inhibitors|growth inhibitors|mesh-ancestor
65254895|NCT02829008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65254896|NCT02829008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254897|NCT02829008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65254898|NCT02829008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65254899|NCT05683821|Nicotine|nicotine|mesh-list
65254900|NCT05683821|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65254901|NCT05683821|Autonomic Agents|autonomic agents|mesh-ancestor
65254902|NCT05683821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254903|NCT05683821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254904|NCT05683821|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65254905|NCT05683821|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65254906|NCT05683821|Cholinergic Agents|cholinergic agents|mesh-ancestor
65254907|NCT05683821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65254908|NCT05683821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254926|NCT02696928|Antimalarials|antimalarials|mesh-ancestor
65254927|NCT02696928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65254928|NCT02696928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65254929|NCT02696928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65254930|NCT00886405|Nitroglycerin|nitroglycerin|mesh-list
65254931|NCT00886405|Vasodilator Agents|vasodilator agents|mesh-ancestor
65254932|NCT00889369|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65254933|NCT00889369|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65254934|NCT00889369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65254935|NCT00889369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65254936|NCT00889369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254937|NCT00889369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65254938|NCT00889369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254939|NCT00889369|Analgesics|analgesics|mesh-ancestor
65254940|NCT00889369|Sensory System Agents|sensory system agents|mesh-ancestor
65254941|NCT00889369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254942|NCT00889369|Antidepressive Agents|antidepressive agents|mesh-ancestor
65254943|NCT00889369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65254944|NCT00889369|Dopamine Agents|dopamine agents|mesh-ancestor
65254945|NCT02766192|Ketamine|ketamine|mesh-list
65254946|NCT02766192|Analgesics|analgesics|mesh-ancestor
65254947|NCT02766192|Sensory System Agents|sensory system agents|mesh-ancestor
65254948|NCT02766192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65254949|NCT02766192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254950|NCT02766192|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65254951|NCT02766192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65254952|NCT02766192|Anesthetics, General|anesthetics, general|mesh-ancestor
65254953|NCT02766192|Anesthetics|anesthetics|mesh-ancestor
65254954|NCT02766192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65254959|NCT05278897|Hyaluronic Acid|hyaluronic acid|mesh-list
65254970|NCT00889525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65254971|NCT00889525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254972|NCT00889525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254973|NCT02770794|Infliximab|infliximab|mesh-list
65254974|NCT02770794|Dermatologic Agents|dermatologic agents|mesh-ancestor
65254975|NCT02770794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65254976|NCT02770794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65254977|NCT04224246|Sodium Oxybate|sodium oxybate|mesh-list
65254978|NCT04224246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65254979|NCT04224246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65254980|NCT04224246|Anesthetics, General|anesthetics, general|mesh-ancestor
65254981|NCT04224246|Anesthetics|anesthetics|mesh-ancestor
65254982|NCT04224246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65254983|NCT04224246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65254984|NCT02766270|Temozolomide|temozolomide|mesh-list
65254985|NCT02766270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65254986|NCT02766270|Alkylating Agents|alkylating agents|mesh-ancestor
65254987|NCT02766270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254988|NCT02766270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254989|NCT04300010|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65254990|NCT04300010|Dermatologic Agents|dermatologic agents|mesh-ancestor
65254991|NCT02766348|Gemcitabine|gemcitabine|mesh-list
65254992|NCT02766348|Cisplatin|cisplatin|mesh-list
65254993|NCT02766348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65254994|NCT02766348|Antimetabolites|antimetabolites|mesh-ancestor
65005257|NCT00479362|Antipyretics|antipyretics|mesh-ancestor
65254995|NCT02766348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65254996|NCT02766348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65254997|NCT02766348|Antiviral Agents|antiviral agents|mesh-ancestor
65255015|NCT00608569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65255016|NCT00608569|Antiviral Agents|antiviral agents|mesh-ancestor
65255017|NCT00608569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65255018|NCT00608569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65255019|NCT00608569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65255020|NCT00608569|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65255021|NCT00608569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65255022|NCT00608569|Antimetabolites|antimetabolites|mesh-ancestor
65255023|NCT04699422|Pirinitramide|pirinitramide|mesh-list
65255024|NCT04699422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65255025|NCT04699422|Narcotics|narcotics|mesh-ancestor
65255026|NCT04699422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65255027|NCT04699422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255028|NCT04699422|Analgesics|analgesics|mesh-ancestor
65255029|NCT04699422|Sensory System Agents|sensory system agents|mesh-ancestor
65255030|NCT04699422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65255031|NCT02828384|Psyllium|psyllium|mesh-list
65255032|NCT02828384|Cathartics|cathartics|mesh-ancestor
65255033|NCT02828384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65255034|NCT00886717|Paclitaxel|paclitaxel|mesh-list
65255035|NCT00886717|Carboplatin|carboplatin|mesh-list
65255036|NCT00886717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65255037|NCT00886717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65255038|NCT00886717|Tubulin Modulators|tubulin modulators|mesh-ancestor
65255039|NCT00886717|Antimitotic Agents|antimitotic agents|mesh-ancestor
65255040|NCT00886717|Mitosis Modulators|mitosis modulators|mesh-ancestor
65255041|NCT00886717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255042|NCT00889837|Loxapine|loxapine|mesh-list
65255043|NCT00889837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65255044|NCT00889837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65255045|NCT00889837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65255047|NCT00889837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65255058|NCT00886873|Mifepristone|mifepristone|mesh-list
65255059|NCT00886873|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65255060|NCT00886873|Abortifacient Agents|abortifacient agents|mesh-ancestor
65255061|NCT00886873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65255062|NCT00886873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255063|NCT00886873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65255064|NCT00886873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65255065|NCT00886873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65255066|NCT00886873|Contraceptive Agents|contraceptive agents|mesh-ancestor
65255067|NCT00886873|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65255068|NCT00886873|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65005326|NCT00480142|Oxycodone|oxycodone|mesh-list
65255069|NCT00886873|Hormone Antagonists|hormone antagonists|mesh-ancestor
65255070|NCT00886873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65255071|NCT00886873|Luteolytic Agents|luteolytic agents|mesh-ancestor
65255072|NCT00886873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65255073|NCT00886873|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65255074|NCT04243850|Empagliflozin|empagliflozin|mesh-list
65255075|NCT04243850|Caffeine|caffeine|mesh-list
65255076|NCT04243850|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65255077|NCT04243850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255078|NCT04243850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65255079|NCT04243850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255080|NCT04243850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255081|NCT04243850|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65255082|NCT04243850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65255083|NCT04243850|Purinergic Agents|purinergic agents|mesh-ancestor
65255084|NCT04243850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65255085|NCT04243850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65255086|NCT04243850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65255087|NCT00892801|Everolimus|everolimus|mesh-list
65255092|NCT04222842|Vorolanib|vorolanib|mesh-list
65255097|NCT00633542|Interferon-alpha|interferon-alpha|mesh-list
65255098|NCT00633542|Thalidomide|thalidomide|mesh-list
65255099|NCT00633542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65255100|NCT00633542|Antiviral Agents|antiviral agents|mesh-ancestor
65255101|NCT00633542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65255102|NCT00633542|Immunologic Factors|immunologic factors|mesh-ancestor
65255103|NCT00633542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255104|NCT00633542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65255105|NCT00633542|Leprostatic Agents|leprostatic agents|mesh-ancestor
65255106|NCT00633542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65255107|NCT00633542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65255108|NCT00633542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65255109|NCT00633542|Growth Substances|growth substances|mesh-ancestor
65255110|NCT00633542|Growth Inhibitors|growth inhibitors|mesh-ancestor
65255111|NCT02766036|Propolis|propolis|mesh-list
65255112|NCT02766036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65255113|NCT00610675|Mirtazapine|mirtazapine|mesh-list
65255114|NCT00610675|Antidepressive Agents|antidepressive agents|mesh-ancestor
65255115|NCT00610675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65255116|NCT00610675|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65255117|NCT00610675|Histamine Antagonists|histamine antagonists|mesh-ancestor
65255118|NCT00610675|Histamine Agents|histamine agents|mesh-ancestor
65255119|NCT00610675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65255120|NCT00610675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255121|NCT00610675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255122|NCT00610675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65255123|NCT00610675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65255124|NCT00610675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65255125|NCT00610675|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65255126|NCT00610675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65255127|NCT00610675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65255128|NCT00610675|Adrenergic Agents|adrenergic agents|mesh-ancestor
65255139|NCT02828228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65255140|NCT02769936|Cycloserine|cycloserine|mesh-list
65255141|NCT02769936|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65255142|NCT02769936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65255143|NCT02769936|Renal Agents|renal agents|mesh-ancestor
65255144|NCT02769936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65255145|NCT02769936|Antitubercular Agents|antitubercular agents|mesh-ancestor
65255146|NCT02769936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65255147|NCT02769936|Antimetabolites|antimetabolites|mesh-ancestor
65255148|NCT02769936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255149|NCT00887029|Timolol|timolol|mesh-list
65255150|NCT00887029|Travoprost|travoprost|mesh-list
65255151|NCT00887029|Latanoprost|latanoprost|mesh-list
65255152|NCT00887029|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65255153|NCT00887029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65255154|NCT00887029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65255155|NCT00887029|Adrenergic Agents|adrenergic agents|mesh-ancestor
65255156|NCT00887029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65255158|NCT00887029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255196|NCT02769390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65255197|NCT02769390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65255198|NCT02769390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65255199|NCT02769390|Adrenergic Agents|adrenergic agents|mesh-ancestor
65255200|NCT02769390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65255201|NCT02769390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255202|NCT02769390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65255203|NCT02769390|Anticonvulsants|anticonvulsants|mesh-ancestor
65255204|NCT02769390|Antiemetics|antiemetics|mesh-ancestor
65255205|NCT02769390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65255206|NCT02769390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65255207|NCT02769390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65255208|NCT02769390|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65255209|NCT02769390|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65255210|NCT02769390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65255211|NCT02769390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65255212|NCT02769390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65255213|NCT02769390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65255214|NCT02769390|Anesthetics, General|anesthetics, general|mesh-ancestor
65255215|NCT02769390|Anesthetics|anesthetics|mesh-ancestor
65255216|NCT02769390|GABA Modulators|gaba modulators|mesh-ancestor
65255217|NCT02769390|GABA Agents|gaba agents|mesh-ancestor
65255218|NCT00890539|Methacholine Chloride|methacholine chloride|mesh-list
65255219|NCT00890539|Miotics|miotics|mesh-ancestor
65255220|NCT00890539|Autonomic Agents|autonomic agents|mesh-ancestor
65255221|NCT00890539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65255222|NCT00890539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255244|NCT00415233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255245|NCT00914667|Warfarin|warfarin|mesh-list
65255246|NCT00914667|Fesoterodine|fesoterodine|mesh-list
65255247|NCT00914667|Anticoagulants|anticoagulants|mesh-ancestor
65255248|NCT00914667|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65255249|NCT00914667|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65255250|NCT00914667|Cholinergic Agents|cholinergic agents|mesh-ancestor
65255251|NCT00914667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65255252|NCT00914667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255253|NCT00914667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255254|NCT00914667|Urological Agents|urological agents|mesh-ancestor
65255255|NCT00887978|Treprostinil|treprostinil|mesh-list
65255256|NCT00887978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65255257|NCT00608023|Tesamorelin|tesamorelin|mesh-list
65255258|NCT00608023|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
65255259|NCT00608023|Growth Substances|growth substances|mesh-ancestor
65255260|NCT00608023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255261|NCT00608023|Hormones|hormones|mesh-ancestor
65255262|NCT00608023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65255263|NCT02765022|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65255264|NCT02765022|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
65255295|NCT02761512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65255296|NCT02761512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65255297|NCT02761512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65255298|NCT02761512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255299|NCT02761512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255300|NCT00893269|Zolpidem|zolpidem|mesh-list
65255301|NCT00893269|Eszopiclone|eszopiclone|mesh-list
65255302|NCT00893269|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65255303|NCT00893269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65255304|NCT00893269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65255305|NCT00893269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255306|NCT00893269|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65255307|NCT00893269|GABA Agonists|gaba agonists|mesh-ancestor
65255308|NCT00893269|GABA Agents|gaba agents|mesh-ancestor
65255309|NCT00893269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65255310|NCT00893269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255311|NCT05672667|Oxytocin|oxytocin|mesh-list
65255312|NCT05672667|Oxytocics|oxytocics|mesh-ancestor
65255313|NCT05672667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65255314|NCT05672667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255315|NCT04115397|Zoledronic Acid|zoledronic acid|mesh-list
65255316|NCT04115397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65255317|NCT04115397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255318|NCT00887822|Bevacizumab|bevacizumab|mesh-list
65255319|NCT00887822|Capecitabine|capecitabine|mesh-list
65255320|NCT00887822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65255321|NCT00887822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65255322|NCT00887822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65255323|NCT00887822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65255324|NCT00887822|Growth Substances|growth substances|mesh-ancestor
65255325|NCT00887822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255326|NCT00887822|Growth Inhibitors|growth inhibitors|mesh-ancestor
65255328|NCT00887822|Antimetabolites|antimetabolites|mesh-ancestor
65255336|NCT04115163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65255337|NCT04115163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65255338|NCT04115163|Tubulin Modulators|tubulin modulators|mesh-ancestor
65255339|NCT04115163|Antimitotic Agents|antimitotic agents|mesh-ancestor
65255340|NCT04115163|Mitosis Modulators|mitosis modulators|mesh-ancestor
65255341|NCT04115163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255342|NCT04115163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65255343|NCT04115163|Antimetabolites|antimetabolites|mesh-ancestor
65255344|NCT04115163|Antiviral Agents|antiviral agents|mesh-ancestor
65255345|NCT04115163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65255346|NCT04115163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255347|NCT04115163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65255348|NCT04115163|Immunologic Factors|immunologic factors|mesh-ancestor
65255349|NCT04115163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255350|NCT02542111|Gemcitabine|gemcitabine|mesh-list
65255351|NCT02542111|Dexamethasone|dexamethasone|mesh-list
65255395|NCT00891163|Sensory System Agents|sensory system agents|mesh-ancestor
65255396|NCT00891163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65255397|NCT00891163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65255398|NCT00891163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65255399|NCT00891163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65255400|NCT00891163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65255401|NCT00891163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255402|NCT02541331|Broncho-Vaxom|broncho-vaxom|mesh-list
65255403|NCT02541331|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65255404|NCT02541331|Immunologic Factors|immunologic factors|mesh-ancestor
65255405|NCT02541331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255406|NCT00893425|Ramipril|ramipril|mesh-list
65255407|NCT00893425|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65255408|NCT00893425|Protease Inhibitors|protease inhibitors|mesh-ancestor
65255409|NCT00893425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255410|NCT00893425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255411|NCT00893425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65255412|NCT00951665|Paclitaxel|paclitaxel|mesh-list
65255413|NCT00951665|Maytansine|maytansine|mesh-list
65255414|NCT00951665|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65255415|NCT00951665|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65255416|NCT00951665|Trastuzumab|trastuzumab|mesh-list
65255417|NCT00951665|Pertuzumab|pertuzumab|mesh-list
65255418|NCT00951665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65255445|NCT04036201|Immunologic Factors|immunologic factors|mesh-ancestor
65255446|NCT04036201|Viscosupplements|viscosupplements|mesh-ancestor
65255447|NCT04036201|Protective Agents|protective agents|mesh-ancestor
65255448|NCT00801099|Amoxicillin|amoxicillin|mesh-list
65255449|NCT00801099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65255450|NCT00801099|Clavulanic Acids|clavulanic acids|mesh-list
65255451|NCT00801099|Clavulanic Acid|clavulanic acid|mesh-list
65255452|NCT00801099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65255453|NCT00801099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65255454|NCT00801099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65255455|NCT00801099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255456|NCT00801099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255457|NCT02768610|Dexmedetomidine|dexmedetomidine|mesh-list
65255458|NCT02768610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65255459|NCT02768610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65255460|NCT02768610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255461|NCT02768610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65255462|NCT02768610|Analgesics|analgesics|mesh-ancestor
65255463|NCT02768610|Sensory System Agents|sensory system agents|mesh-ancestor
65255464|NCT02768610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65255465|NCT02768610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65255466|NCT02768610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65255467|NCT02768610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65255468|NCT02768610|Adrenergic Agents|adrenergic agents|mesh-ancestor
65255469|NCT02768610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65255470|NCT02768610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255471|NCT02764710|Amoxicillin|amoxicillin|mesh-list
65255472|NCT02764710|Clavulanic Acid|clavulanic acid|mesh-list
65255473|NCT02764710|Clavulanic Acids|clavulanic acids|mesh-list
65255489|NCT02541019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65255490|NCT02541019|Antipruritics|antipruritics|mesh-ancestor
65255491|NCT02541019|Dermatologic Agents|dermatologic agents|mesh-ancestor
65255492|NCT02541019|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65255493|NCT02541019|Serotonin Agents|serotonin agents|mesh-ancestor
65255494|NCT02541019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65255495|NCT02541019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255496|NCT02541019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65255497|NCT02541019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65255498|NCT02541019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65255499|NCT02541019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65255500|NCT02541019|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65255501|NCT02541019|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65255502|NCT00893581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65255503|NCT00893581|Antidepressive Agents|antidepressive agents|mesh-ancestor
65255504|NCT00893581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65255505|NCT00893581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65255506|NCT00893581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65255507|NCT00893581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65255508|NCT00893581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255509|NCT04114383|Deuterium Oxide|deuterium oxide|mesh-list
65255510|NCT04114383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65255511|NCT04114383|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65255512|NCT04114383|Protective Agents|protective agents|mesh-ancestor
65255513|NCT04114383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255514|NCT05658003|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
65255537|NCT01786265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255538|NCT01786265|Hormone Antagonists|hormone antagonists|mesh-ancestor
65255539|NCT01786265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65255540|NCT01786265|Androgen Antagonists|androgen antagonists|mesh-ancestor
65255541|NCT04114461|Tofacitinib|tofacitinib|mesh-list
65255542|NCT04114461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255543|NCT04114461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65255544|NCT04114461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255545|NCT02768454|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65255546|NCT02768454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65255547|NCT02768376|Fentanyl|fentanyl|mesh-list
65255548|NCT02768376|Bupivacaine|bupivacaine|mesh-list
65255549|NCT02768376|Anesthetics|anesthetics|mesh-list
65255550|NCT02768376|Anesthetics, Local|anesthetics, local|mesh-ancestor
65255551|NCT02768376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65255552|NCT02768376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255553|NCT02768376|Sensory System Agents|sensory system agents|mesh-ancestor
65255554|NCT02768376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65255555|NCT02768376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65255556|NCT02768376|Narcotics|narcotics|mesh-ancestor
65255557|NCT02768376|Analgesics|analgesics|mesh-ancestor
65255558|NCT02768376|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65255559|NCT02768376|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65255560|NCT02768376|Anesthetics, General|anesthetics, general|mesh-ancestor
65255561|NCT02696460|Lidocaine|lidocaine|mesh-list
65255562|NCT02696460|Prilocaine|prilocaine|mesh-list
65255563|NCT02696460|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65255564|NCT02696460|Anesthetics, Local|anesthetics, local|mesh-ancestor
65255565|NCT02696460|Anesthetics|anesthetics|mesh-ancestor
65255576|NCT00888043|Bevacizumab|bevacizumab|mesh-list
65255582|NCT00888043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255583|NCT00888043|Growth Inhibitors|growth inhibitors|mesh-ancestor
65255584|NCT02768220|Empagliflozin|empagliflozin|mesh-list
65255585|NCT02768220|Linagliptin|linagliptin|mesh-list
65255586|NCT02768220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65255587|NCT02768220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255588|NCT02768220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65255589|NCT02768220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255590|NCT02768220|Incretins|incretins|mesh-ancestor
65255591|NCT02768220|Hormones|hormones|mesh-ancestor
65255592|NCT02768220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65005864|NCT00405171|Nevirapine|nevirapine|mesh-list
65255593|NCT02768220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65255594|NCT02768220|Protease Inhibitors|protease inhibitors|mesh-ancestor
65255595|NCT02768220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255596|NCT02760888|Diclofenac|diclofenac|mesh-list
65255597|NCT02760888|Tramadol|tramadol|mesh-list
65255598|NCT02760888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65255599|NCT02760888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65255600|NCT02760888|Analgesics|analgesics|mesh-ancestor
65255601|NCT02760888|Sensory System Agents|sensory system agents|mesh-ancestor
65255602|NCT02760888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65255603|NCT02760888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255604|NCT02760888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65255605|NCT02760888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65255606|NCT02760888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65255607|NCT02760888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255608|NCT02760888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255609|NCT02760888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65255610|NCT02760888|Narcotics|narcotics|mesh-ancestor
65255611|NCT02760888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65255618|NCT00799617|Hormones|hormones|mesh-ancestor
65255623|NCT00799617|Anabolic Agents|anabolic agents|mesh-ancestor
65255624|NCT00607087|Insulin|insulin|mesh-list
65255625|NCT00607087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65255626|NCT00607087|Insulin Aspart|insulin aspart|mesh-list
65255627|NCT00607087|Insulin Lispro|insulin lispro|mesh-list
65255628|NCT00607087|Insulin glulisine|insulin glulisine|mesh-list
65255629|NCT00607087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65255630|NCT00607087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255631|NCT00610363|Rilonacept|rilonacept|mesh-list
65255632|NCT00610363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65255633|NCT00887588|Valsartan|valsartan|mesh-list
65255634|NCT00887588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65255635|NCT00887588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65255636|NCT00887588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65255637|NCT00887588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65255638|NCT00887588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255639|NCT00799383|Vitamin D|vitamin d|mesh-list
65255640|NCT00799383|Calcium|calcium|mesh-list
65255641|NCT00799383|Vitamins|vitamins|mesh-ancestor
65255642|NCT00799383|Micronutrients|micronutrients|mesh-ancestor
65255643|NCT00799383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255644|NCT00799383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65255645|NCT00799383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65255646|NCT02763852|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
65255647|NCT02763852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255648|NCT02763852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255649|NCT02763852|Dopamine Agents|dopamine agents|mesh-ancestor
65255650|NCT02763852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65255651|NCT02763852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255652|NCT04114149|Analgesics, Opioid|analgesics, opioid|mesh-list
65255653|NCT04114149|Narcotics|narcotics|mesh-ancestor
65255654|NCT04114149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65255656|NCT04114149|Analgesics|analgesics|mesh-ancestor
65255665|NCT00891397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65255666|NCT00891397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65255667|NCT00891397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255668|NCT00891397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65255669|NCT00891397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65255670|NCT00891397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65255671|NCT00891397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65255672|NCT00891397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65255673|NCT02767596|Lixisenatide|lixisenatide|mesh-list
65255674|NCT02767596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65255675|NCT02767596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255676|NCT02826902|Remifentanil|remifentanil|mesh-list
65255677|NCT02826902|Propofol|propofol|mesh-list
65255678|NCT02826902|Desflurane|desflurane|mesh-list
65255679|NCT02826902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65255680|NCT02826902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65255681|NCT02826902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255682|NCT02826902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65255683|NCT02826902|Anesthetics, General|anesthetics, general|mesh-ancestor
65255684|NCT02826902|Anesthetics|anesthetics|mesh-ancestor
65255685|NCT02826902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65255686|NCT02826902|Narcotics|narcotics|mesh-ancestor
65255687|NCT02826902|Analgesics|analgesics|mesh-ancestor
65255688|NCT02826902|Sensory System Agents|sensory system agents|mesh-ancestor
65255689|NCT02826902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65255690|NCT02826902|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65255691|NCT04504734|Bucillamine|bucillamine|mesh-list
65255692|NCT04504734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65255693|NCT04504734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65255694|NCT04504734|Analgesics|analgesics|mesh-ancestor
65255695|NCT04504734|Sensory System Agents|sensory system agents|mesh-ancestor
65255710|NCT00891475|Sunitinib|sunitinib|mesh-list
65255711|NCT00891475|Maleic acid|maleic acid|mesh-list
65255712|NCT00891475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65255713|NCT00891475|Antiviral Agents|antiviral agents|mesh-ancestor
65255714|NCT00891475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65255715|NCT00891475|Immunologic Factors|immunologic factors|mesh-ancestor
65255716|NCT00891475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255717|NCT00891475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65255718|NCT00891475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65255719|NCT00891475|Growth Substances|growth substances|mesh-ancestor
65255720|NCT00891475|Growth Inhibitors|growth inhibitors|mesh-ancestor
65255721|NCT00891475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65255722|NCT00891475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255723|NCT00891475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255724|NCT00887432|Vitamin D|vitamin d|mesh-list
65255725|NCT00887432|Cholecalciferol|cholecalciferol|mesh-list
65255726|NCT00887432|Vitamins|vitamins|mesh-ancestor
65255727|NCT00887432|Micronutrients|micronutrients|mesh-ancestor
65255728|NCT00887432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255729|NCT00887432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65255730|NCT00887432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65255731|NCT04222686|Losartan|losartan|mesh-list
65255732|NCT04222686|Perindopril|perindopril|mesh-list
65255733|NCT04222686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65255734|NCT04222686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65255735|NCT04222686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65255736|NCT04222686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65255737|NCT04222686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255738|NCT04222686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65255739|NCT04222686|Protease Inhibitors|protease inhibitors|mesh-ancestor
65255740|NCT04222686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255741|NCT04113915|Cyclosporine|cyclosporine|mesh-list
65255754|NCT04113915|Hormones|hormones|mesh-ancestor
65255755|NCT04113915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65255756|NCT04113915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65255757|NCT04113915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255758|NCT04113915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255759|NCT04113915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65255760|NCT04113915|Antifungal Agents|antifungal agents|mesh-ancestor
65255761|NCT04113915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65255762|NCT04113915|Dermatologic Agents|dermatologic agents|mesh-ancestor
65255763|NCT04113915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65255764|NCT03590821|Aspirin|aspirin|mesh-list
65255765|NCT03590821|Celecoxib|celecoxib|mesh-list
65255766|NCT03590821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65255767|NCT03590821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65255768|NCT03590821|Analgesics|analgesics|mesh-ancestor
65255769|NCT03590821|Sensory System Agents|sensory system agents|mesh-ancestor
65255770|NCT03590821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65255771|NCT03590821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255772|NCT03590821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65255773|NCT03590821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65255774|NCT03590821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65255775|NCT03590821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65255776|NCT03590821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255777|NCT03590821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65255778|NCT03590821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65255779|NCT03590821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255780|NCT03590821|Antipyretics|antipyretics|mesh-ancestor
65255781|NCT03590821|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65255782|NCT04688658|Nivolumab|nivolumab|mesh-list
65255783|NCT04688658|Axitinib|axitinib|mesh-list
65255790|NCT04113993|Bazedoxifene|bazedoxifene|mesh-list
65255795|NCT04113993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255796|NCT04113993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65255797|NCT02758470|Acetazolamide|acetazolamide|mesh-list
65255798|NCT02758470|Methazolamide|methazolamide|mesh-list
65255799|NCT02758470|Anticonvulsants|anticonvulsants|mesh-ancestor
65255800|NCT02758470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65255801|NCT02758470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255802|NCT02758470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255803|NCT02758470|Diuretics|diuretics|mesh-ancestor
65255804|NCT02758470|Natriuretic Agents|natriuretic agents|mesh-ancestor
65255805|NCT02758470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255806|NCT04223076|Chlorhexidine|chlorhexidine|mesh-list
65255807|NCT04223076|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65255808|NCT04223076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65255809|NCT04223076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65255810|NCT04223076|Disinfectants|disinfectants|mesh-ancestor
65255811|NCT04223076|Dermatologic Agents|dermatologic agents|mesh-ancestor
65255812|NCT00951275|Antirheumatic Agents|antirheumatic agents|mesh-list
65255813|NCT02764008|Bupivacaine|bupivacaine|mesh-list
65255814|NCT02764008|Anesthetics, Local|anesthetics, local|mesh-ancestor
65006075|NCT00120887|Atorvastatin|atorvastatin|mesh-list
65255815|NCT02764008|Anesthetics|anesthetics|mesh-ancestor
65255816|NCT02764008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65255817|NCT02764008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255818|NCT02764008|Sensory System Agents|sensory system agents|mesh-ancestor
65255819|NCT02764008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65255821|NCT00798603|Carboplatin|carboplatin|mesh-list
65255822|NCT00798603|Pemetrexed|pemetrexed|mesh-list
65255823|NCT00798603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65255824|NCT00798603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65255825|NCT00798603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65255839|NCT04036981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255840|NCT04036981|Cholinergic Agents|cholinergic agents|mesh-ancestor
65255841|NCT04036981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65255842|NCT04036981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255843|NCT04036981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65255844|NCT04036981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65255845|NCT00887354|Vitamin D|vitamin d|mesh-list
65255846|NCT00887354|Teriparatide|teriparatide|mesh-list
65255847|NCT00887354|Risedronic Acid|risedronic acid|mesh-list
65255848|NCT00887354|Calcium|calcium|mesh-list
65255849|NCT00887354|Vitamins|vitamins|mesh-ancestor
65255850|NCT00887354|Micronutrients|micronutrients|mesh-ancestor
65255851|NCT00887354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255852|NCT00887354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65255853|NCT00887354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65255854|NCT00887354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65255855|NCT00887354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65255856|NCT00887354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255857|NCT00951041|Vaccines|vaccines|mesh-list
65255858|NCT00951041|Immunologic Factors|immunologic factors|mesh-ancestor
65255859|NCT00951041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255860|NCT02832596|Norepinephrine|norepinephrine|mesh-list
65255861|NCT02832596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65255862|NCT02832596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65255863|NCT02832596|Adrenergic Agents|adrenergic agents|mesh-ancestor
65255864|NCT02832596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65255865|NCT02832596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255866|NCT02832596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255867|NCT02832596|Sympathomimetics|sympathomimetics|mesh-ancestor
65255868|NCT02832596|Autonomic Agents|autonomic agents|mesh-ancestor
65255869|NCT02832596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65255870|NCT02832596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65255881|NCT00945815|Epratuzumab|epratuzumab|mesh-list
65255882|NCT00945815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65255883|NCT00945815|Antimetabolites|antimetabolites|mesh-ancestor
65255884|NCT00945815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255885|NCT00945815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65255886|NCT00945815|Antiviral Agents|antiviral agents|mesh-ancestor
65255887|NCT00945815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65255888|NCT00945815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65255889|NCT00945815|Immunologic Factors|immunologic factors|mesh-ancestor
65255890|NCT00945815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255891|NCT00945815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65255892|NCT00606307|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
65255893|NCT00606307|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65255894|NCT00606307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255895|NCT00606307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255896|NCT00798369|Triamcinolone|triamcinolone|mesh-list
65255897|NCT00798369|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65255903|NCT00798369|Hormones|hormones|mesh-ancestor
65255937|NCT00894283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65255938|NCT00894283|Protease Inhibitors|protease inhibitors|mesh-ancestor
65255939|NCT00894283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255940|NCT00895609|Neostigmine|neostigmine|mesh-list
65255941|NCT00895609|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65255942|NCT00895609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255943|NCT00895609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65255944|NCT00895609|Cholinergic Agents|cholinergic agents|mesh-ancestor
65255945|NCT00895609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65255946|NCT00895609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255947|NCT00895609|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65255948|NCT00895609|Autonomic Agents|autonomic agents|mesh-ancestor
65255949|NCT00895609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65255950|NCT00894439|Piperacillin|piperacillin|mesh-list
65255951|NCT00894439|BLI-489|bli-489|mesh-list
65255952|NCT00894439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65255953|NCT00894439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65255954|NCT00894439|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65255955|NCT00894439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255956|NCT00894439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931315|NCT02969980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64931316|NCT02969980|Immunologic Factors|immunologic factors|mesh-ancestor
64931317|NCT02969980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65255990|NCT02762838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931318|NCT02969980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65255991|NCT02762838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65255992|NCT02762838|Dermatologic Agents|dermatologic agents|mesh-ancestor
65255993|NCT02762838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65255994|NCT02762838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65255995|NCT02762838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65255996|NCT02762838|Immunologic Factors|immunologic factors|mesh-ancestor
65255997|NCT02762838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65255998|NCT02762838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65255999|NCT02762838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65256000|NCT02762838|Hematinics|hematinics|mesh-ancestor
65256001|NCT02762838|Vitamin B Complex|vitamin b complex|mesh-ancestor
65256002|NCT02762838|Vitamins|vitamins|mesh-ancestor
65256003|NCT02762838|Micronutrients|micronutrients|mesh-ancestor
65256004|NCT02753166|Dexamethasone|dexamethasone|mesh-list
65256005|NCT02753166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65256006|NCT02753166|Antiemetics|antiemetics|mesh-ancestor
65256007|NCT02753166|Autonomic Agents|autonomic agents|mesh-ancestor
65256008|NCT02753166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65256009|NCT02753166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256010|NCT02753166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65256011|NCT02753166|Glucocorticoids|glucocorticoids|mesh-ancestor
65256012|NCT02753166|Hormones|hormones|mesh-ancestor
65256013|NCT02753166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65256035|NCT02757534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65256036|NCT02757534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256037|NCT00914901|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65256038|NCT00914901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65256039|NCT00914901|Autonomic Agents|autonomic agents|mesh-ancestor
65256040|NCT00914901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65256041|NCT00914901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006310|NCT00486694|Artesunate|artesunate|mesh-list
65256042|NCT00914901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65256043|NCT00914901|Respiratory System Agents|respiratory system agents|mesh-ancestor
65256044|NCT00914901|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65256045|NCT00914901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65256046|NCT00914901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65256047|NCT00914901|Adrenergic Agents|adrenergic agents|mesh-ancestor
65256048|NCT00914901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65256049|NCT00914901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256050|NCT00797823|Insulin|insulin|mesh-list
65256051|NCT00797823|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65256052|NCT00797823|Glucagon|glucagon|mesh-list
65256053|NCT00797823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65256054|NCT00797823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256055|NCT00797823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65256056|NCT00797823|Hormones|hormones|mesh-ancestor
65256057|NCT00797823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65256058|NCT02760030|Fulvestrant|fulvestrant|mesh-list
65256059|NCT02760030|Palbociclib|palbociclib|mesh-list
65256060|NCT02760030|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65256061|NCT02760030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65256079|NCT04568616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256080|NCT04568616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65256081|NCT04568616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65256082|NCT04568616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256083|NCT04568616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256084|NCT04568616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65256085|NCT04568616|Hormone Antagonists|hormone antagonists|mesh-ancestor
65256086|NCT04568616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65256087|NCT04568616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256088|NCT00950807|Tiotropium Bromide|tiotropium bromide|mesh-list
65256089|NCT00950807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65256090|NCT00950807|Autonomic Agents|autonomic agents|mesh-ancestor
65256091|NCT00950807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65256092|NCT00950807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256093|NCT00950807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65256094|NCT00950807|Respiratory System Agents|respiratory system agents|mesh-ancestor
65256095|NCT00950807|Parasympatholytics|parasympatholytics|mesh-ancestor
65256096|NCT00950807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65256097|NCT00950807|Cholinergic Agents|cholinergic agents|mesh-ancestor
65256098|NCT00950807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65256099|NCT00950807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256100|NCT00608881|Ubiquinone|ubiquinone|mesh-list
65256101|NCT00608881|Coenzyme Q10|coenzyme q10|mesh-list
65256102|NCT00608881|Micronutrients|micronutrients|mesh-ancestor
65256103|NCT00608881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256104|NCT00608881|Vitamins|vitamins|mesh-ancestor
65256105|NCT05608395|Carbon-11 methionine|carbon-11 methionine|mesh-list
65256106|NCT05608395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65256123|NCT00945191|Tubulin Modulators|tubulin modulators|mesh-ancestor
65256124|NCT00945191|Antimitotic Agents|antimitotic agents|mesh-ancestor
65256125|NCT00945191|Mitosis Modulators|mitosis modulators|mesh-ancestor
65256126|NCT00945191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256127|NCT01082393|Mometasone Furoate|mometasone furoate|mesh-list
65256128|NCT01082393|Pimecrolimus|pimecrolimus|mesh-list
65256129|NCT01082393|Tacrolimus|tacrolimus|mesh-list
65256130|NCT01082393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65256131|NCT01082393|Immunologic Factors|immunologic factors|mesh-ancestor
65256132|NCT01082393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256133|NCT01082393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65256134|NCT01082393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256135|NCT01082393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256136|NCT01082393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65256137|NCT01082393|Dermatologic Agents|dermatologic agents|mesh-ancestor
65256138|NCT01082393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65256139|NCT01082393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65256140|NCT01082393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65256141|NCT01082393|Analgesics|analgesics|mesh-ancestor
65256142|NCT01082393|Sensory System Agents|sensory system agents|mesh-ancestor
65256143|NCT01082393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65256144|NCT01082393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65256145|NCT02757066|Melatonin|melatonin|mesh-list
65256146|NCT02757066|Antioxidants|antioxidants|mesh-ancestor
65256147|NCT02757066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256148|NCT02757066|Protective Agents|protective agents|mesh-ancestor
65256149|NCT02757066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256150|NCT02757066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65256151|NCT00894673|Heparin|heparin|mesh-list
65256152|NCT00894673|Calcium heparin|calcium heparin|mesh-list
65256153|NCT00894673|Anticoagulants|anticoagulants|mesh-ancestor
65256154|NCT00894673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65256155|NCT00894673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65256156|NCT00894673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256157|NCT00892489|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65256161|NCT00892489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256162|NCT00892489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65256163|NCT00892489|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65256164|NCT00892489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65256165|NCT00892489|Serotonin Agents|serotonin agents|mesh-ancestor
65256166|NCT00892489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65256167|NCT00892489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256168|NCT00892489|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65256169|NCT00892489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65256170|NCT00892489|Dopamine Agents|dopamine agents|mesh-ancestor
65256171|NCT02752308|Atropine|atropine|mesh-list
65256172|NCT02752308|Epinephrine|epinephrine|mesh-list
65256173|NCT02752308|Fentanyl|fentanyl|mesh-list
65256174|NCT02752308|Bupivacaine|bupivacaine|mesh-list
65256175|NCT02752308|Neostigmine|neostigmine|mesh-list
65256176|NCT02752308|Anesthetics, Local|anesthetics, local|mesh-ancestor
65256177|NCT02752308|Anesthetics|anesthetics|mesh-ancestor
65256178|NCT02752308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65256179|NCT02752308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256180|NCT02752308|Sensory System Agents|sensory system agents|mesh-ancestor
65256181|NCT02752308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65256182|NCT02752308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65256183|NCT02752308|Narcotics|narcotics|mesh-ancestor
65256184|NCT02752308|Analgesics|analgesics|mesh-ancestor
65256185|NCT02752308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65256186|NCT02752308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65256187|NCT02752308|Anesthetics, General|anesthetics, general|mesh-ancestor
65006444|NCT00488215|Prucalopride|prucalopride|mesh-list
65256188|NCT02752308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65256189|NCT02752308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65256190|NCT02752308|Adrenergic Agents|adrenergic agents|mesh-ancestor
65256191|NCT02752308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65256192|NCT02752308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256203|NCT02752308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65256204|NCT02752308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65256205|NCT02752308|Cholinergic Agents|cholinergic agents|mesh-ancestor
65256206|NCT02752308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65256207|NCT02752308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256208|NCT02752308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65256209|NCT00894751|Dexmedetomidine|dexmedetomidine|mesh-list
65256210|NCT00894751|Propofol|propofol|mesh-list
65256211|NCT00894751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65256212|NCT00894751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65256213|NCT00894751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256214|NCT00894751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65256215|NCT00894751|Anesthetics, General|anesthetics, general|mesh-ancestor
65256216|NCT00894751|Anesthetics|anesthetics|mesh-ancestor
65256217|NCT00894751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65256218|NCT00894751|Analgesics|analgesics|mesh-ancestor
65256219|NCT00894751|Sensory System Agents|sensory system agents|mesh-ancestor
65256220|NCT00894751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65256221|NCT00894751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65256222|NCT00894751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65256223|NCT00894751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65256224|NCT00894751|Adrenergic Agents|adrenergic agents|mesh-ancestor
65256225|NCT00894751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65256227|NCT00896077|Lisofylline|lisofylline|mesh-list
65256253|NCT00896311|Nitroglycerin|nitroglycerin|mesh-list
65256254|NCT00896311|Vasodilator Agents|vasodilator agents|mesh-ancestor
65256255|NCT02751996|Tenofovir|tenofovir|mesh-list
65256256|NCT02751996|Antiviral Agents|antiviral agents|mesh-ancestor
65256257|NCT02751996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65256258|NCT02751996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65256259|NCT02751996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65256260|NCT02751996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256261|NCT02751996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256262|NCT02751996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65256263|NCT02751996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65256264|NCT00944645|Niacin|niacin|mesh-list
65256265|NCT00944645|Niacinamide|niacinamide|mesh-list
65256266|NCT00944645|Nicotinic Acids|nicotinic acids|mesh-list
65256267|NCT00944645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65256268|NCT00944645|Antimetabolites|antimetabolites|mesh-ancestor
65256269|NCT00944645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256270|NCT00944645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65256271|NCT00944645|Vasodilator Agents|vasodilator agents|mesh-ancestor
65256272|NCT00944645|Vitamin B Complex|vitamin b complex|mesh-ancestor
65256274|NCT00944645|Micronutrients|micronutrients|mesh-ancestor
65256275|NCT00944645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256276|NCT02751918|Doxorubicin|doxorubicin|mesh-list
65256277|NCT02751918|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65256278|NCT02751918|Maytansine|maytansine|mesh-list
65256279|NCT02751918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65256280|NCT02751918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256281|NCT02751918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65256282|NCT02751918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65256283|NCT02751918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256284|NCT02751918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256285|NCT02751918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65256298|NCT00901069|Alkylating Agents|alkylating agents|mesh-ancestor
65256299|NCT00901069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256300|NCT00901069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256301|NCT00901069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65256302|NCT00901069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65256303|NCT00901069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65256304|NCT00901069|Tubulin Modulators|tubulin modulators|mesh-ancestor
65256305|NCT00901069|Antimitotic Agents|antimitotic agents|mesh-ancestor
65256306|NCT00901069|Mitosis Modulators|mitosis modulators|mesh-ancestor
65256307|NCT00901069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65256308|NCT00901069|Antimetabolites|antimetabolites|mesh-ancestor
65256309|NCT00901069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256310|NCT02853539|Denosumab|denosumab|mesh-list
65256311|NCT02853539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65256312|NCT02853539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256313|NCT02751840|Caffeine|caffeine|mesh-list
65256314|NCT02751840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65256315|NCT02751840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256316|NCT02751840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65256317|NCT02751840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256318|NCT02751840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256319|NCT02751840|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65256320|NCT02751840|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65256321|NCT02751840|Purinergic Agents|purinergic agents|mesh-ancestor
65256322|NCT02751840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65256323|NCT00894829|Heparin|heparin|mesh-list
65256324|NCT00894829|Calcium heparin|calcium heparin|mesh-list
65256325|NCT00894829|Anticoagulants|anticoagulants|mesh-ancestor
65256326|NCT00894829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65256342|NCT00606229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256343|NCT00606229|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65256344|NCT00606229|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65256346|NCT00606229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65256347|NCT00606229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65256348|NCT00606229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65256349|NCT00606229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65256350|NCT02756598|Sufentanil|sufentanil|mesh-list
65256351|NCT02756598|Dsuvia|dsuvia|mesh-list
65256352|NCT02756598|Propofol|propofol|mesh-list
65256353|NCT02756598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65256354|NCT02756598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65256355|NCT02756598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256356|NCT02756598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65256357|NCT02756598|Anesthetics, General|anesthetics, general|mesh-ancestor
65256358|NCT02756598|Anesthetics|anesthetics|mesh-ancestor
65256359|NCT02756598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65256360|NCT02756598|Narcotics|narcotics|mesh-ancestor
65256361|NCT02756598|Analgesics|analgesics|mesh-ancestor
65256362|NCT02756598|Sensory System Agents|sensory system agents|mesh-ancestor
65256363|NCT02756598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65256364|NCT02756598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65256365|NCT00950651|Tramadol|tramadol|mesh-list
65256366|NCT00950651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65256367|NCT00950651|Narcotics|narcotics|mesh-ancestor
65256368|NCT00950651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65256369|NCT00950651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256370|NCT00950651|Analgesics|analgesics|mesh-ancestor
65256371|NCT00950651|Sensory System Agents|sensory system agents|mesh-ancestor
65256372|NCT00950651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65256373|NCT00901147|Bortezomib|bortezomib|mesh-list
65256374|NCT00901147|Panobinostat|panobinostat|mesh-list
65256375|NCT00901147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256376|NCT00901147|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65256385|NCT05598723|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65256386|NCT05598723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65256387|NCT05598723|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65256388|NCT05598723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65256389|NCT05598723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65256390|NCT05598723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256391|NCT05598723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65256392|NCT05598723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65256393|NCT05598723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256394|NCT05598723|Cholinergic Agents|cholinergic agents|mesh-ancestor
65256395|NCT05598723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65256396|NCT00605293|Epoetin Alfa|epoetin alfa|mesh-list
65256397|NCT00605293|Hematinics|hematinics|mesh-ancestor
65256398|NCT04221126|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65256399|NCT04221126|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65256400|NCT04221126|Dermatologic Agents|dermatologic agents|mesh-ancestor
65256401|NCT05594589|Lemborexant|lemborexant|mesh-list
65256402|NCT05594589|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65256403|NCT05594589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65256404|NCT05594589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256405|NCT05594589|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65256406|NCT05594589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65256407|NCT05594589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65256408|NCT05594589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256409|NCT00602303|Torsemide|torsemide|mesh-list
65256410|NCT00602303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65256411|NCT00602303|Diuretics|diuretics|mesh-ancestor
65256412|NCT00602303|Natriuretic Agents|natriuretic agents|mesh-ancestor
65256413|NCT00602303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256414|NCT00602303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65256415|NCT00602303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65256416|NCT00602303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256417|NCT00631085|Tocopherols|tocopherols|mesh-list
65256424|NCT00631085|Protective Agents|protective agents|mesh-ancestor
65256425|NCT00631085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256426|NCT00631085|Vitamins|vitamins|mesh-ancestor
65256427|NCT00631085|Micronutrients|micronutrients|mesh-ancestor
65256428|NCT04269863|Aspirin|aspirin|mesh-list
65256429|NCT04269863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65256430|NCT04269863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65256431|NCT04269863|Analgesics|analgesics|mesh-ancestor
65256432|NCT04269863|Sensory System Agents|sensory system agents|mesh-ancestor
65256433|NCT04269863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65256434|NCT04269863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256435|NCT04269863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65256436|NCT04269863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65256437|NCT04269863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65256438|NCT04269863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65256439|NCT04269863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256440|NCT04269863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65256441|NCT04269863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65256442|NCT04269863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256443|NCT04269863|Antipyretics|antipyretics|mesh-ancestor
65256444|NCT00901381|Lenograstim|lenograstim|mesh-list
65256445|NCT00901381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65256446|NCT00901381|Immunologic Factors|immunologic factors|mesh-ancestor
65256447|NCT00901381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256448|NCT00602381|Lithium Carbonate|lithium carbonate|mesh-list
65256449|NCT00602381|Antidepressive Agents|antidepressive agents|mesh-ancestor
65256450|NCT00602381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65256451|NCT00602381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256452|NCT00602381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256453|NCT00602381|Antimanic Agents|antimanic agents|mesh-ancestor
65256454|NCT00602381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65256455|NCT00602381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65256456|NCT00602381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256465|NCT00901537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256466|NCT00894985|Heparin|heparin|mesh-list
65256467|NCT00894985|Calcium heparin|calcium heparin|mesh-list
65256468|NCT00894985|Anticoagulants|anticoagulants|mesh-ancestor
65256469|NCT00894985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65256470|NCT00894985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65256471|NCT00894985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256472|NCT04585152|Rituximab|rituximab|mesh-list
65256473|NCT04585152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65256474|NCT04585152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256475|NCT04585152|Immunologic Factors|immunologic factors|mesh-ancestor
65256476|NCT04585152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256477|NCT04585152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65256478|NCT00943787|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65256479|NCT00943787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256480|NCT00895063|Botulinum Toxins|botulinum toxins|mesh-list
65256481|NCT00895063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65256482|NCT00895063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65256483|NCT00895063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256484|NCT00895063|Cholinergic Agents|cholinergic agents|mesh-ancestor
65256485|NCT00895063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65256486|NCT00895063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256487|NCT02751294|Tafenoquine|tafenoquine|mesh-list
65256488|NCT02751294|Antimalarials|antimalarials|mesh-ancestor
65256489|NCT02751294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65256490|NCT02751294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65256491|NCT02751294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65256492|NCT00901615|Lenalidomide|lenalidomide|mesh-list
65256493|NCT00901615|Immunologic Factors|immunologic factors|mesh-ancestor
65256494|NCT00901615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256495|NCT00901615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65256496|NCT00901615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65256508|NCT00949325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256509|NCT00949325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65256510|NCT00949325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65256511|NCT00949325|Antifungal Agents|antifungal agents|mesh-ancestor
65256512|NCT00949325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65256513|NCT00949325|Immunologic Factors|immunologic factors|mesh-ancestor
65256514|NCT00949325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256515|NCT02853071|Estramustine|estramustine|mesh-list
65256516|NCT02853071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65256517|NCT02853071|Alkylating Agents|alkylating agents|mesh-ancestor
65256518|NCT02853071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256519|NCT02853071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256520|NCT02853071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65256521|NCT02603757|Vitamin D|vitamin d|mesh-list
65256522|NCT02603757|Cholecalciferol|cholecalciferol|mesh-list
65256523|NCT02603757|Vitamins|vitamins|mesh-ancestor
65256524|NCT02603757|Micronutrients|micronutrients|mesh-ancestor
65256525|NCT02603757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256526|NCT02603757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65256527|NCT02603757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65256528|NCT02758782|Celecoxib|celecoxib|mesh-list
65256529|NCT02758782|Golimumab|golimumab|mesh-list
65256530|NCT02758782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65256531|NCT02758782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65256532|NCT02758782|Analgesics|analgesics|mesh-ancestor
65256533|NCT02758782|Sensory System Agents|sensory system agents|mesh-ancestor
65256534|NCT02758782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65256535|NCT02758782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256536|NCT02758782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65256537|NCT02758782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65256551|NCT00895297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256552|NCT00895297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256553|NCT00943319|Fludarabine|fludarabine|mesh-list
65256554|NCT00943319|Busulfan|busulfan|mesh-list
65256555|NCT00943319|Alemtuzumab|alemtuzumab|mesh-list
65256556|NCT00943319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256557|NCT00943319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256558|NCT00943319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65256559|NCT00943319|Immunologic Factors|immunologic factors|mesh-ancestor
65256560|NCT00943319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256561|NCT00943319|Alkylating Agents|alkylating agents|mesh-ancestor
65256562|NCT00943319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65256563|NCT00943319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65256564|NCT00943319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65256565|NCT02603991|Levetiracetam|levetiracetam|mesh-list
65006794|NCT04844385|Antimetabolites|antimetabolites|mesh-ancestor
65256567|NCT02603991|Nootropic Agents|nootropic agents|mesh-ancestor
65256568|NCT02540785|Levofloxacin|levofloxacin|mesh-list
65256569|NCT02540785|Ofloxacin|ofloxacin|mesh-list
65256570|NCT02540785|Tobramycin|tobramycin|mesh-list
65256571|NCT02540785|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
65256572|NCT02540785|Dexamethasone|dexamethasone|mesh-list
65256573|NCT02540785|Dexamethasone acetate|dexamethasone acetate|mesh-list
65256574|NCT02540785|BB 1101|bb 1101|mesh-list
65256575|NCT02540785|Hyaluronic Acid|hyaluronic acid|mesh-list
65256576|NCT02540785|Dipivefrin|dipivefrin|mesh-list
65256577|NCT02540785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65256578|NCT02540785|Antiemetics|antiemetics|mesh-ancestor
65256579|NCT02540785|Autonomic Agents|autonomic agents|mesh-ancestor
65256580|NCT02540785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65256581|NCT02540785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256582|NCT02540785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65256595|NCT02540785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65256596|NCT02540785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65256597|NCT02540785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65256598|NCT02540785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65256599|NCT02540785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65256600|NCT02540785|Immunologic Factors|immunologic factors|mesh-ancestor
65256601|NCT02540785|Viscosupplements|viscosupplements|mesh-ancestor
65256602|NCT02540785|Protective Agents|protective agents|mesh-ancestor
65256603|NCT02540785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65256604|NCT02540785|Adrenergic Agents|adrenergic agents|mesh-ancestor
65256605|NCT02540785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65256606|NCT02540785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65256607|NCT02540785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65256608|NCT04243278|Aspirin|aspirin|mesh-list
65256609|NCT04243278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65256610|NCT04243278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65256611|NCT04243278|Analgesics|analgesics|mesh-ancestor
65256612|NCT04243278|Sensory System Agents|sensory system agents|mesh-ancestor
65256613|NCT04243278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65256614|NCT04243278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256615|NCT04243278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65256647|NCT04243122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65256648|NCT04243122|Analgesics|analgesics|mesh-ancestor
65256649|NCT04243122|Sensory System Agents|sensory system agents|mesh-ancestor
65256650|NCT04243122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65256651|NCT04243122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256652|NCT04243122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65256653|NCT04243122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65256654|NCT04243122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65256655|NCT04243122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65256656|NCT04243122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256657|NCT04243122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65256658|NCT04243122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65256659|NCT04243122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256660|NCT04243122|Antipyretics|antipyretics|mesh-ancestor
65256661|NCT04243122|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65256662|NCT04243122|Antithrombins|antithrombins|mesh-ancestor
65256663|NCT04243122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65256664|NCT04243122|Protease Inhibitors|protease inhibitors|mesh-ancestor
65256665|NCT04243122|Anticoagulants|anticoagulants|mesh-ancestor
65256666|NCT04268927|Letrozole|letrozole|mesh-list
65256667|NCT04268927|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
65256668|NCT04268927|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65256669|NCT04268927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256670|NCT04268927|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65256671|NCT04268927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65256672|NCT04268927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256673|NCT04268927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256674|NCT04268927|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65256690|NCT00790647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65256691|NCT00790647|Alkylating Agents|alkylating agents|mesh-ancestor
65256692|NCT00790647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256693|NCT00790647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65256694|NCT00790647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65256695|NCT00286013|Gemcitabine|gemcitabine|mesh-list
65256696|NCT00286013|Oxaliplatin|oxaliplatin|mesh-list
65256697|NCT00286013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65256698|NCT00286013|Antimetabolites|antimetabolites|mesh-ancestor
65256699|NCT00286013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256700|NCT00286013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256701|NCT00286013|Antiviral Agents|antiviral agents|mesh-ancestor
65256702|NCT00286013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65256703|NCT00286013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256704|NCT00286013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65256705|NCT00286013|Immunologic Factors|immunologic factors|mesh-ancestor
65256706|NCT00286013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256707|NCT02754882|Paclitaxel|paclitaxel|mesh-list
65256708|NCT02754882|Bevacizumab|bevacizumab|mesh-list
65256709|NCT02754882|Carboplatin|carboplatin|mesh-list
65256710|NCT02754882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65256711|NCT02754882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256712|NCT02754882|Tubulin Modulators|tubulin modulators|mesh-ancestor
65256713|NCT02754882|Antimitotic Agents|antimitotic agents|mesh-ancestor
65256714|NCT02754882|Mitosis Modulators|mitosis modulators|mesh-ancestor
65256715|NCT02754882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256738|NCT00939029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65256739|NCT00939029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65256740|NCT00939029|Cholinergic Agents|cholinergic agents|mesh-ancestor
65256741|NCT00939029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65256742|NCT00939029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256743|NCT00602615|Torsemide|torsemide|mesh-list
65256744|NCT00602615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65256745|NCT00602615|Diuretics|diuretics|mesh-ancestor
65256746|NCT00602615|Natriuretic Agents|natriuretic agents|mesh-ancestor
65256747|NCT00602615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256748|NCT00602615|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65256749|NCT00602615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65256750|NCT00602615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256751|NCT00604253|Insulin|insulin|mesh-list
65256752|NCT00604253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65256753|NCT00604253|Insulin Detemir|insulin detemir|mesh-list
65256754|NCT00604253|Isophane Insulin, Human|isophane insulin, human|mesh-list
65256755|NCT00604253|Insulin, Isophane|insulin, isophane|mesh-list
65256756|NCT00604253|Isophane insulin, beef|isophane insulin, beef|mesh-list
65256757|NCT00604253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65256758|NCT00604253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256759|NCT02754960|Thalidomide|thalidomide|mesh-list
65256760|NCT02754960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65256761|NCT02754960|Immunologic Factors|immunologic factors|mesh-ancestor
65256771|NCT00587847|Alemtuzumab|alemtuzumab|mesh-list
65256789|NCT02540395|Immunologic Factors|immunologic factors|mesh-ancestor
65256790|NCT02540395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256791|NCT02540395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65256792|NCT02540395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256793|NCT02540395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256794|NCT02540395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65256795|NCT02540395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256796|NCT02540395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65256797|NCT02540395|Antitubercular Agents|antitubercular agents|mesh-ancestor
65256798|NCT02540395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65256799|NCT02540395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65256800|NCT02540395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65256801|NCT02540395|Glucocorticoids|glucocorticoids|mesh-ancestor
65256803|NCT02540395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65256804|NCT02540395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65256805|NCT02540395|Antiemetics|antiemetics|mesh-ancestor
65256806|NCT02540395|Autonomic Agents|autonomic agents|mesh-ancestor
65256807|NCT02540395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65256808|NCT02540395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65256809|NCT02540395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65256810|NCT02540395|Protective Agents|protective agents|mesh-ancestor
65256811|NCT05565729|Levocetirizine|levocetirizine|mesh-list
65256812|NCT05565729|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65256813|NCT05565729|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65256814|NCT05565729|Histamine Antagonists|histamine antagonists|mesh-ancestor
65256815|NCT05565729|Histamine Agents|histamine agents|mesh-ancestor
65256816|NCT05565729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65256817|NCT05565729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256818|NCT05565729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256819|NCT04547166|Bevacizumab|bevacizumab|mesh-list
65256820|NCT04547166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65256831|NCT00602693|Allopurinol|allopurinol|mesh-list
65256832|NCT00602693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65256833|NCT00602693|Immunologic Factors|immunologic factors|mesh-ancestor
65256834|NCT00602693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256835|NCT00602693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65256836|NCT00602693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65256837|NCT00602693|Alkylating Agents|alkylating agents|mesh-ancestor
65256838|NCT00602693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256839|NCT00602693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256840|NCT00602693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65256841|NCT00602693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65256842|NCT00602693|Antimetabolites|antimetabolites|mesh-ancestor
65256843|NCT00602693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65256844|NCT00602693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65256845|NCT00602693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65256846|NCT00602693|Antifungal Agents|antifungal agents|mesh-ancestor
65256847|NCT00602693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256848|NCT00602693|Gout Suppressants|gout suppressants|mesh-ancestor
65256849|NCT00602693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65256850|NCT00602693|Antioxidants|antioxidants|mesh-ancestor
65256851|NCT00602693|Protective Agents|protective agents|mesh-ancestor
65256852|NCT00902395|Midazolam|midazolam|mesh-list
65256853|NCT00902395|Ketamine|ketamine|mesh-list
65256854|NCT00902395|Analgesics|analgesics|mesh-ancestor
65256855|NCT00902395|Sensory System Agents|sensory system agents|mesh-ancestor
65256856|NCT00902395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65256857|NCT00902395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256858|NCT00902395|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65256859|NCT00902395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65256860|NCT00902395|Anesthetics, General|anesthetics, general|mesh-ancestor
65256861|NCT00902395|Anesthetics|anesthetics|mesh-ancestor
65256862|NCT00902395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65256863|NCT00902395|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65256872|NCT00902395|GABA Modulators|gaba modulators|mesh-ancestor
65256873|NCT00902395|GABA Agents|gaba agents|mesh-ancestor
65256874|NCT04213404|Spartalizumab|spartalizumab|mesh-list
65256875|NCT04213404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65256876|NCT04213404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256877|NCT04213404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256878|NCT00604409|Capecitabine|capecitabine|mesh-list
65256879|NCT00604409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65256880|NCT00604409|Antimetabolites|antimetabolites|mesh-ancestor
65256881|NCT00604409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256882|NCT00604409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256883|NCT00905905|Simvastatin|simvastatin|mesh-list
65256884|NCT00905905|Ezetimibe|ezetimibe|mesh-list
65256885|NCT00905905|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
65256886|NCT00905905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65256887|NCT00905905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65256888|NCT00905905|Antimetabolites|antimetabolites|mesh-ancestor
65256889|NCT00905905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256890|NCT00905905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65256891|NCT00905905|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65256892|NCT00905905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256893|NCT00902473|Topiramate|topiramate|mesh-list
65256894|NCT00902473|Anticonvulsants|anticonvulsants|mesh-ancestor
65256895|NCT00902473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65256896|NCT00902473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256897|NCT05177484|Ferric maltol|ferric maltol|mesh-list
65256898|NCT05177484|Hematinics|hematinics|mesh-ancestor
65256899|NCT04104789|Oxymetazoline|oxymetazoline|mesh-list
65256900|NCT04104789|Tetracaine|tetracaine|mesh-list
65256901|NCT04104789|Carticaine|carticaine|mesh-list
65256918|NCT00938717|Linaclotide|linaclotide|mesh-list
65256919|NCT00938717|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65256920|NCT00938717|Enzyme Activators|enzyme activators|mesh-ancestor
65256921|NCT00938717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256922|NCT00938717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65256923|NCT00905983|Gemcitabine|gemcitabine|mesh-list
65256924|NCT00905983|Docetaxel|docetaxel|mesh-list
65256925|NCT00905983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65256926|NCT00905983|Antimetabolites|antimetabolites|mesh-ancestor
65256927|NCT00905983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256928|NCT00905983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256929|NCT00905983|Antiviral Agents|antiviral agents|mesh-ancestor
65256930|NCT00905983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65256931|NCT00905983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256932|NCT00905983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65256933|NCT00905983|Immunologic Factors|immunologic factors|mesh-ancestor
65256934|NCT00905983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256935|NCT00905983|Tubulin Modulators|tubulin modulators|mesh-ancestor
65256936|NCT00905983|Antimitotic Agents|antimitotic agents|mesh-ancestor
65256937|NCT00905983|Mitosis Modulators|mitosis modulators|mesh-ancestor
65256938|NCT00906061|Gemcitabine|gemcitabine|mesh-list
65256939|NCT00906061|Docetaxel|docetaxel|mesh-list
65256940|NCT00906061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65007188|NCT00493987|Hormones|hormones|mesh-ancestor
65256941|NCT00906061|Antimetabolites|antimetabolites|mesh-ancestor
65256942|NCT00906061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256943|NCT00906061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256953|NCT02602509|Rifampin|rifampin|mesh-list
65256965|NCT02602509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65256966|NCT02602509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65256967|NCT02602509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65256968|NCT02602509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65256969|NCT02602509|Antitubercular Agents|antitubercular agents|mesh-ancestor
65256970|NCT02602509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65256971|NCT02602509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65256972|NCT02602509|Leprostatic Agents|leprostatic agents|mesh-ancestor
65256973|NCT02602509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65256974|NCT02602509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65256975|NCT02602509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65256976|NCT02602509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65256977|NCT02602509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65256978|NCT02602509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65256979|NCT02602509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65256980|NCT02852837|Daratumumab|daratumumab|mesh-list
65256981|NCT02852837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65256982|NCT04342585|Progesterone|progesterone|mesh-list
65256983|NCT04342585|Progestins|progestins|mesh-ancestor
65256984|NCT04342585|Hormones|hormones|mesh-ancestor
65256985|NCT04342585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65256986|NCT04342585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65256987|NCT04495452|Fentanyl|fentanyl|mesh-list
65256988|NCT04495452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65256989|NCT04495452|Narcotics|narcotics|mesh-ancestor
65256990|NCT04495452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65256991|NCT04495452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932334|NCT00064285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257010|NCT00897871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257011|NCT00897871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65257012|NCT00897871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65257013|NCT00897871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65257014|NCT00897871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65257015|NCT00897871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257016|NCT00902707|Phenylpropanolamine|phenylpropanolamine|mesh-list
65257017|NCT00902707|Guaifenesin|guaifenesin|mesh-list
65257018|NCT00902707|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
65257019|NCT00902707|Expectorants|expectorants|mesh-ancestor
65257020|NCT00902707|Respiratory System Agents|respiratory system agents|mesh-ancestor
65257021|NCT00902707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65257022|NCT00902707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65257023|NCT00902707|Adrenergic Agents|adrenergic agents|mesh-ancestor
65257024|NCT00902707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65257025|NCT00902707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257026|NCT00902707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257027|NCT00902707|Appetite Depressants|appetite depressants|mesh-ancestor
65257028|NCT00902707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65257029|NCT00902707|Sympathomimetics|sympathomimetics|mesh-ancestor
65257030|NCT00902707|Autonomic Agents|autonomic agents|mesh-ancestor
65257031|NCT00902707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65257032|NCT00902707|Nasal Decongestants|nasal decongestants|mesh-ancestor
65257033|NCT00902707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65257034|NCT00906139|Fentanyl|fentanyl|mesh-list
65257035|NCT00906139|Midazolam|midazolam|mesh-list
65257036|NCT00906139|Propofol|propofol|mesh-list
65257037|NCT00906139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65257038|NCT00906139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65257039|NCT00906139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257053|NCT00906139|GABA Agents|gaba agents|mesh-ancestor
65257054|NCT00906139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65257055|NCT00906139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257056|NCT00906295|Chrysarobin|chrysarobin|mesh-list
65257057|NCT00906295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65257058|NCT00906295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65257059|NCT00906295|Analgesics|analgesics|mesh-ancestor
65257060|NCT00906295|Sensory System Agents|sensory system agents|mesh-ancestor
65257061|NCT00906295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65257062|NCT00906295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257063|NCT00906295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65257064|NCT00906295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65257065|NCT02754102|Sunscreening Agents|sunscreening agents|mesh-list
65257066|NCT02754102|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65257067|NCT02754102|Protective Agents|protective agents|mesh-ancestor
65257068|NCT02754102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257069|NCT02754102|Dermatologic Agents|dermatologic agents|mesh-ancestor
65257070|NCT00134303|Metformin|metformin|mesh-list
65257071|NCT00134303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65257072|NCT00134303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257073|NCT00902941|Rasagiline|rasagiline|mesh-list
65257074|NCT00902941|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65257075|NCT00902941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257076|NCT00902941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257077|NCT00902941|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65257078|NCT00902941|Protective Agents|protective agents|mesh-ancestor
65257079|NCT00902941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257080|NCT02754258|Methylphenidate|methylphenidate|mesh-list
65257081|NCT02754258|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65257082|NCT02754258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257083|NCT02754258|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65257084|NCT02754258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65257085|NCT02754258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65257091|NCT04267991|Immunologic Factors|immunologic factors|mesh-ancestor
65257092|NCT04267991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257093|NCT04267991|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65257094|NCT04267991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257095|NCT04267991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257096|NCT02852681|Drospirenone|drospirenone|mesh-list
65257097|NCT02852681|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65257098|NCT02852681|Hormone Antagonists|hormone antagonists|mesh-ancestor
65257099|NCT02852681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65257100|NCT02852681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257101|NCT02852681|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65257102|NCT02852681|Diuretics|diuretics|mesh-ancestor
65257103|NCT02852681|Natriuretic Agents|natriuretic agents|mesh-ancestor
65257104|NCT02754180|Gemcitabine|gemcitabine|mesh-list
65257105|NCT02754180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65257106|NCT02754180|Antimetabolites|antimetabolites|mesh-ancestor
65257107|NCT02754180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257108|NCT02754180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257109|NCT02754180|Antiviral Agents|antiviral agents|mesh-ancestor
65257110|NCT02754180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65257111|NCT02754180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257112|NCT02754180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65257113|NCT02754180|Immunologic Factors|immunologic factors|mesh-ancestor
65257114|NCT02754180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257115|NCT00602849|Sertraline|sertraline|mesh-list
65257116|NCT00602849|Antidepressive Agents|antidepressive agents|mesh-ancestor
65257117|NCT00602849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65257136|NCT00898417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65257137|NCT00898417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257138|NCT00898417|Tubulin Modulators|tubulin modulators|mesh-ancestor
65257139|NCT00898417|Antimitotic Agents|antimitotic agents|mesh-ancestor
65257140|NCT00898417|Mitosis Modulators|mitosis modulators|mesh-ancestor
65257141|NCT00898417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257142|NCT00898417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65257143|NCT00898417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65257144|NCT00898417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65257145|NCT00898417|Growth Substances|growth substances|mesh-ancestor
65257146|NCT00898417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257147|NCT00898417|Growth Inhibitors|growth inhibitors|mesh-ancestor
65257148|NCT05381363|Interferons|interferons|mesh-list
65257149|NCT05381363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257150|NCT05381363|Antiviral Agents|antiviral agents|mesh-ancestor
65257151|NCT05381363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65257152|NCT00906529|Insulin Aspart|insulin aspart|mesh-list
65257153|NCT00906529|Insulin Detemir|insulin detemir|mesh-list
65257154|NCT00906529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65257155|NCT00906529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257156|NCT00783705|Inositol|inositol|mesh-list
65257157|NCT00783705|Vitamin B Complex|vitamin b complex|mesh-ancestor
65257158|NCT00783705|Vitamins|vitamins|mesh-ancestor
65257159|NCT00783705|Micronutrients|micronutrients|mesh-ancestor
65257160|NCT00783705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257161|NCT04268303|Dexmedetomidine|dexmedetomidine|mesh-list
65257162|NCT04268303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65257163|NCT04268303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65257164|NCT04268303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257166|NCT04268303|Analgesics|analgesics|mesh-ancestor
64932507|NCT05083754|Temozolomide|temozolomide|mesh-list
65257179|NCT02755350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257180|NCT02755350|Antiviral Agents|antiviral agents|mesh-ancestor
65257181|NCT02755350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65257182|NCT02755350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65257183|NCT02755350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65257184|NCT04103697|Capecitabine|capecitabine|mesh-list
65257185|NCT04103697|Oxaliplatin|oxaliplatin|mesh-list
65257186|NCT04103697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65257187|NCT04103697|Antimetabolites|antimetabolites|mesh-ancestor
65257188|NCT04103697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257189|NCT04103697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257190|NCT00898573|Lapatinib|lapatinib|mesh-list
65257191|NCT00898573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257192|NCT00898573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65257193|NCT00898573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257194|NCT00898573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257195|NCT04321668|Hylan|hylan|mesh-list
65257196|NCT04321668|Viscosupplements|viscosupplements|mesh-ancestor
65257197|NCT04321668|Protective Agents|protective agents|mesh-ancestor
65257198|NCT04321668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257199|NCT02851745|Linagliptin|linagliptin|mesh-list
65257200|NCT02851745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65257201|NCT02851745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257202|NCT02851745|Incretins|incretins|mesh-ancestor
65257203|NCT02851745|Hormones|hormones|mesh-ancestor
65257204|NCT02851745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65257205|NCT02851745|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65257206|NCT02851745|Protease Inhibitors|protease inhibitors|mesh-ancestor
65257207|NCT02851745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257208|NCT02851745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257209|NCT02602197|Acetaminophen|acetaminophen|mesh-list
65257210|NCT02602197|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65257211|NCT02602197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65257212|NCT02602197|Analgesics|analgesics|mesh-ancestor
65257213|NCT02602197|Sensory System Agents|sensory system agents|mesh-ancestor
64932509|NCT05083754|Alkylating Agents|alkylating agents|mesh-ancestor
65257215|NCT02602197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257216|NCT02602197|Antipyretics|antipyretics|mesh-ancestor
65257217|NCT02602197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65257218|NCT02602197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65257219|NCT02602197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65257220|NCT02753712|Fluticasone|fluticasone|mesh-list
65257221|NCT02753712|Xhance|xhance|mesh-list
65257222|NCT02753712|Formoterol Fumarate|formoterol fumarate|mesh-list
65257223|NCT02753712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65257224|NCT02753712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65257225|NCT02753712|Autonomic Agents|autonomic agents|mesh-ancestor
65257226|NCT02753712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65257227|NCT02753712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257228|NCT02753712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65257229|NCT02753712|Respiratory System Agents|respiratory system agents|mesh-ancestor
65257230|NCT02753712|Dermatologic Agents|dermatologic agents|mesh-ancestor
65257231|NCT02753712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65257232|NCT02753712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65257233|NCT02753712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65257234|NCT02753712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65257235|NCT02753712|Adrenergic Agents|adrenergic agents|mesh-ancestor
65257236|NCT02753712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65257237|NCT02753712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257238|NCT04220892|Pembrolizumab|pembrolizumab|mesh-list
65007471|NCT00496600|Tubulin Modulators|tubulin modulators|mesh-ancestor
65257240|NCT04220892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65257241|NCT04220892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257242|NCT04220892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257243|NCT04220892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257244|NCT04220892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65257246|NCT02696148|Liraglutide|liraglutide|mesh-list
65257257|NCT00887198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65257258|NCT00887198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257259|NCT00887198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65257260|NCT00887198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257261|NCT00887198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65257262|NCT00887198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257263|NCT00887198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257264|NCT00887198|Hormone Antagonists|hormone antagonists|mesh-ancestor
65257265|NCT00887198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65257266|NCT02831894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65257267|NCT02831894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65257268|NCT02831894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257269|NCT00782067|Midostaurin|midostaurin|mesh-list
65257270|NCT00782067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257271|NCT00782067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65257272|NCT00782067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257273|NCT00782067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257274|NCT05520723|Loperamide|loperamide|mesh-list
65257275|NCT05520723|Antidiarrheals|antidiarrheals|mesh-list
65257276|NCT05520723|Lenograstim|lenograstim|mesh-list
65257277|NCT05520723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65257278|NCT05520723|Immunologic Factors|immunologic factors|mesh-ancestor
65257279|NCT05520723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257280|NCT05520723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65257281|NCT02826746|Magnesium Sulfate|magnesium sulfate|mesh-list
65257303|NCT02750904|Cholinergic Agents|cholinergic agents|mesh-ancestor
65257304|NCT02750904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65257305|NCT02750904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257306|NCT02831972|Itraconazole|itraconazole|mesh-list
65257307|NCT02831972|Antifungal Agents|antifungal agents|mesh-ancestor
65257308|NCT02831972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65257309|NCT02831972|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65257310|NCT02831972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65257311|NCT02831972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257312|NCT02831972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257313|NCT02831972|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65257315|NCT02831972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65257316|NCT02831972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257317|NCT02831972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65257318|NCT02695758|Bupivacaine|bupivacaine|mesh-list
65257319|NCT02695758|Anesthetics, Local|anesthetics, local|mesh-ancestor
65257320|NCT02695758|Anesthetics|anesthetics|mesh-ancestor
65257321|NCT02695758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65257322|NCT02695758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257323|NCT02695758|Sensory System Agents|sensory system agents|mesh-ancestor
65257324|NCT02695758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65257325|NCT00605215|Interferons|interferons|mesh-list
65257326|NCT00605215|Interferon beta-1a|interferon beta-1a|mesh-list
65257327|NCT00605215|Interferon-beta|interferon-beta|mesh-list
65257328|NCT00605215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257329|NCT00605215|Antiviral Agents|antiviral agents|mesh-ancestor
65257330|NCT00605215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65257331|NCT00605215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65257332|NCT00605215|Immunologic Factors|immunologic factors|mesh-ancestor
65257333|NCT00605215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257334|NCT02827682|Anesthetics|anesthetics|mesh-list
65257335|NCT02827682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65257336|NCT02827682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257337|NCT02826200|Acenocoumarol|acenocoumarol|mesh-list
65257338|NCT02826200|Anticoagulants|anticoagulants|mesh-ancestor
65257341|NCT04244708|Alkylating Agents|alkylating agents|mesh-ancestor
65257342|NCT04244708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257343|NCT04244708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257344|NCT02750748|Naltrexone|naltrexone|mesh-list
65257345|NCT02750748|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65257346|NCT02750748|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65257347|NCT02750748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257348|NCT02750748|Sensory System Agents|sensory system agents|mesh-ancestor
65257349|NCT02750748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65257350|NCT00604279|Risperidone|risperidone|mesh-list
65257351|NCT00604279|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65257352|NCT00604279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65257353|NCT00604279|Serotonin Agents|serotonin agents|mesh-ancestor
65257354|NCT00604279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65257355|NCT00604279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257356|NCT00604279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257357|NCT00604279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65257358|NCT00604279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65257359|NCT00604279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65257360|NCT00604279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65257361|NCT00604279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65257362|NCT00604279|Dopamine Agents|dopamine agents|mesh-ancestor
65257363|NCT00604279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65257364|NCT00604279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65257365|NCT00635856|Gefitinib|gefitinib|mesh-list
65257366|NCT00635856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257367|NCT00635856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65257368|NCT00635856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257369|NCT00635856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257370|NCT00906685|Bevacizumab|bevacizumab|mesh-list
65257371|NCT00906685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65257382|NCT05660720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65257383|NCT05660720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65257384|NCT05660720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257385|NCT05660720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257386|NCT05660720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257387|NCT05660720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65257388|NCT05660720|Contraceptive Agents|contraceptive agents|mesh-ancestor
65257389|NCT05660720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65257390|NCT05660720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257391|NCT05660720|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65257392|NCT05660720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65257393|NCT05660720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65257394|NCT02695212|Apremilast|apremilast|mesh-list
65257395|NCT02695212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65257396|NCT02695212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65257397|NCT02695212|Analgesics|analgesics|mesh-ancestor
65257398|NCT02695212|Sensory System Agents|sensory system agents|mesh-ancestor
65257399|NCT02695212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65257400|NCT02695212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257401|NCT02695212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65257402|NCT02695212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65257403|NCT02695212|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65257432|NCT02750670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257433|NCT02750670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65257434|NCT02750670|Glucocorticoids|glucocorticoids|mesh-ancestor
65257435|NCT02750670|Hormones|hormones|mesh-ancestor
65257436|NCT02750670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65257437|NCT02750670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65257438|NCT02750670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257439|NCT02750670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65257440|NCT02750670|Antimetabolites|antimetabolites|mesh-ancestor
65257441|NCT02750670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257442|NCT02750670|Antiviral Agents|antiviral agents|mesh-ancestor
65257443|NCT02750670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65257444|NCT02750670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257445|NCT02750670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65257446|NCT02750670|Immunologic Factors|immunologic factors|mesh-ancestor
65257447|NCT02750670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65257448|NCT00605891|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65257449|NCT00605891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65257450|NCT00605891|Autonomic Agents|autonomic agents|mesh-ancestor
65257451|NCT00605891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65257452|NCT00605891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257453|NCT00605891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65257454|NCT00605891|Respiratory System Agents|respiratory system agents|mesh-ancestor
65257455|NCT00605891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65257456|NCT00605891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65257479|NCT00605917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65257480|NCT00605917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257481|NCT00605917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65257482|NCT00605917|Serotonin Agents|serotonin agents|mesh-ancestor
65257483|NCT00605917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257484|NCT04919096|Aflibercept|aflibercept|mesh-list
65257485|NCT04919096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65257486|NCT04919096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65257487|NCT04919096|Growth Substances|growth substances|mesh-ancestor
65257488|NCT04919096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257489|NCT04919096|Growth Inhibitors|growth inhibitors|mesh-ancestor
65257490|NCT04919096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257491|NCT02746848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65257492|NCT02746848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65257493|NCT00781599|Varenicline|varenicline|mesh-list
65257494|NCT00781599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65257495|NCT00781599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65257496|NCT00781599|Cholinergic Agents|cholinergic agents|mesh-ancestor
65257532|NCT00899197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65257533|NCT00899197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65257534|NCT00899197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65257535|NCT00603083|Ketorolac|ketorolac|mesh-list
65257536|NCT00603083|Ropivacaine|ropivacaine|mesh-list
65257537|NCT00603083|Anesthetics, Local|anesthetics, local|mesh-ancestor
65257538|NCT00603083|Anesthetics|anesthetics|mesh-ancestor
65257539|NCT00603083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65257540|NCT00603083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257541|NCT00603083|Sensory System Agents|sensory system agents|mesh-ancestor
65257542|NCT00603083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65257543|NCT00603083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65257544|NCT00603083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65257545|NCT00603083|Analgesics|analgesics|mesh-ancestor
65257546|NCT00603083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65257547|NCT00603083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65257548|NCT00603083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65257549|NCT00603083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257550|NCT00603083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257551|NCT05379257|Furosemide|furosemide|mesh-list
65257552|NCT05379257|Diuretics|diuretics|mesh-ancestor
65257553|NCT05379257|Natriuretic Agents|natriuretic agents|mesh-ancestor
65257554|NCT05379257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257555|NCT05379257|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65257556|NCT05379257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65257557|NCT05379257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257558|NCT04241744|Vancomycin|vancomycin|mesh-list
65257561|NCT02824094|Crizotinib|crizotinib|mesh-list
65257576|NCT02824406|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65257577|NCT02824406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257578|NCT02824406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257579|NCT02824406|Diuretics|diuretics|mesh-ancestor
65257580|NCT02824406|Natriuretic Agents|natriuretic agents|mesh-ancestor
65257581|NCT02824406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257582|NCT04267679|Cannabidiol|cannabidiol|mesh-list
65257583|NCT04267679|Anticonvulsants|anticonvulsants|mesh-ancestor
65257584|NCT00915837|Triamcinolone|triamcinolone|mesh-list
65257585|NCT00915837|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65257586|NCT00915837|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65257587|NCT00915837|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65257588|NCT00915837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65257589|NCT00915837|Glucocorticoids|glucocorticoids|mesh-ancestor
65257590|NCT00915837|Hormones|hormones|mesh-ancestor
65257591|NCT00915837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65257592|NCT00915837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257593|NCT00915837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65257594|NCT00915837|Immunologic Factors|immunologic factors|mesh-ancestor
65257595|NCT00915837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257596|NCT00915837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257597|NCT04951388|Somatomedin B|somatomedin b|mesh-list
65257598|NCT04951388|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65257626|NCT00780273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65257627|NCT00780273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65257628|NCT00780273|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65257629|NCT00780273|Histamine Antagonists|histamine antagonists|mesh-ancestor
65257630|NCT00780273|Histamine Agents|histamine agents|mesh-ancestor
65257631|NCT00780273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65257632|NCT00780273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257633|NCT00780273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257634|NCT00780273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65257635|NCT00780273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65257636|NCT00780273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257637|NCT02827136|Lidocaine|lidocaine|mesh-list
65257638|NCT02827136|Anesthetics, Local|anesthetics, local|mesh-ancestor
65257639|NCT02827136|Anesthetics|anesthetics|mesh-ancestor
65257640|NCT02827136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65257641|NCT02827136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257642|NCT02827136|Sensory System Agents|sensory system agents|mesh-ancestor
65257643|NCT02827136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65257644|NCT02827136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65257645|NCT02827136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65257646|NCT02827136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65257647|NCT02827136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65257648|NCT02827136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257649|NCT04102995|Pregnanolone|pregnanolone|mesh-list
65257650|NCT04102995|Anesthetics|anesthetics|mesh-ancestor
65257651|NCT04102995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65257652|NCT04102995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257653|NCT00899821|Aldesleukin|aldesleukin|mesh-list
65257670|NCT00005112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257671|NCT04163406|Ferrous fumarate|ferrous fumarate|mesh-list
65257672|NCT04163406|Trace Elements|trace elements|mesh-ancestor
65257673|NCT04163406|Micronutrients|micronutrients|mesh-ancestor
65257674|NCT04163406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257675|NCT04218552|Amlodipine|amlodipine|mesh-list
65257676|NCT04218552|Telmisartan|telmisartan|mesh-list
65257677|NCT04218552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65257678|NCT04218552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65257679|NCT04218552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65257680|NCT04218552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257681|NCT04218552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65257682|NCT04218552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257683|NCT04218552|Vasodilator Agents|vasodilator agents|mesh-ancestor
65257684|NCT04218552|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65257685|NCT04218552|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65257686|NCT00904657|Sunitinib|sunitinib|mesh-list
65257687|NCT00904657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257688|NCT00904657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65257689|NCT00904657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65257690|NCT00904657|Growth Substances|growth substances|mesh-ancestor
65257691|NCT00904657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257692|NCT00904657|Growth Inhibitors|growth inhibitors|mesh-ancestor
65257693|NCT00904657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65257694|NCT00904657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257717|NCT00779259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257718|NCT00779259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65257719|NCT00779259|Respiratory System Agents|respiratory system agents|mesh-ancestor
65257720|NCT00779259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65257721|NCT00779259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257722|NCT00779259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257723|NCT00779259|Vasodilator Agents|vasodilator agents|mesh-ancestor
65257724|NCT00779259|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65257725|NCT00779259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65257726|NCT00779259|Purinergic Agents|purinergic agents|mesh-ancestor
65257727|NCT00779259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65257728|NCT00779259|Antimalarials|antimalarials|mesh-ancestor
65257729|NCT00779259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65257730|NCT00779259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65257731|NCT00779259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65257732|NCT00779259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65257733|NCT00779259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65257734|NCT00779259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65257735|NCT00779259|Analgesics|analgesics|mesh-ancestor
65257736|NCT00779259|Sensory System Agents|sensory system agents|mesh-ancestor
65257737|NCT03310957|Pembrolizumab|pembrolizumab|mesh-list
65257738|NCT03310957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65257739|NCT03310957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257740|NCT02746380|Adalimumab|adalimumab|mesh-list
65257741|NCT02746380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65257742|NCT02746380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65257743|NCT02745990|Epoetin Alfa|epoetin alfa|mesh-list
65257766|NCT02538367|Prucalopride|prucalopride|mesh-list
65257767|NCT02538367|YH12852|yh12852|mesh-list
65257768|NCT02538367|Laxatives|laxatives|mesh-ancestor
65257769|NCT02538367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65257770|NCT02538367|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65257771|NCT02538367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65257772|NCT02538367|Serotonin Agents|serotonin agents|mesh-ancestor
65257773|NCT02538367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65257774|NCT02538367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257775|NCT02538367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257776|NCT00900445|Prednisone|prednisone|mesh-list
65257777|NCT00900445|Prednisolone|prednisolone|mesh-list
65257778|NCT00900445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65257779|NCT00900445|Methylprednisolone|methylprednisolone|mesh-list
65257780|NCT00900445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65257781|NCT00900445|Prednisolone acetate|prednisolone acetate|mesh-list
65257782|NCT00900445|Hydrocortisone|hydrocortisone|mesh-list
65257783|NCT00900445|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65257784|NCT00900445|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65257785|NCT00900445|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65257786|NCT00900445|Cortisone|cortisone|mesh-list
65257787|NCT00900445|Vincristine|vincristine|mesh-list
65257821|NCT00936065|Sensory System Agents|sensory system agents|mesh-ancestor
65257822|NCT00936065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65257823|NCT00936065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257824|NCT00936065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65257825|NCT00936065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65257826|NCT00936065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65257827|NCT00936065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65257828|NCT00936065|Immunologic Factors|immunologic factors|mesh-ancestor
65257829|NCT00936065|Keratolytic Agents|keratolytic agents|mesh-ancestor
65257830|NCT00936065|Dermatologic Agents|dermatologic agents|mesh-ancestor
65257831|NCT04241276|Gemcitabine|gemcitabine|mesh-list
65257833|NCT04241276|Tretinoin|tretinoin|mesh-list
65257834|NCT04241276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65257835|NCT04241276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257836|NCT04241276|Tubulin Modulators|tubulin modulators|mesh-ancestor
65257837|NCT04241276|Antimitotic Agents|antimitotic agents|mesh-ancestor
65257838|NCT04241276|Mitosis Modulators|mitosis modulators|mesh-ancestor
65257839|NCT04241276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257880|NCT02823236|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65257881|NCT02823236|Pirfenidone|pirfenidone|mesh-list
65257882|NCT02823236|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65257883|NCT02823236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65257884|NCT02823236|Glucocorticoids|glucocorticoids|mesh-ancestor
65257885|NCT02823236|Hormones|hormones|mesh-ancestor
65257886|NCT02823236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65257887|NCT02823236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257888|NCT02823236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65257889|NCT02823236|Immunologic Factors|immunologic factors|mesh-ancestor
65257890|NCT02823236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257891|NCT02823236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257892|NCT02823236|Analgesics|analgesics|mesh-ancestor
65257893|NCT02823236|Sensory System Agents|sensory system agents|mesh-ancestor
65257894|NCT02823236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65257895|NCT02823236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65257896|NCT02823236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65257897|NCT02823236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65257898|NCT02823236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257899|NCT00633698|Niacin|niacin|mesh-list
65257934|NCT04242758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65257935|NCT04242758|Diuretics|diuretics|mesh-ancestor
65257936|NCT04242758|Natriuretic Agents|natriuretic agents|mesh-ancestor
65257937|NCT04242758|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65257938|NCT04242758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65257939|NCT02745912|Metformin|metformin|mesh-list
65257940|NCT02745912|Naltrexone|naltrexone|mesh-list
65257941|NCT02745912|Bupropion|bupropion|mesh-list
65257942|NCT02745912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65257943|NCT02745912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257944|NCT02745912|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65257945|NCT02745912|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65257946|NCT02745912|Sensory System Agents|sensory system agents|mesh-ancestor
65257947|NCT02745912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65257948|NCT02745912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65257949|NCT02745912|Antidepressive Agents|antidepressive agents|mesh-ancestor
65257950|NCT02745912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65257951|NCT02745912|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65257952|NCT02745912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65257953|NCT02745912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65257954|NCT02745912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257955|NCT02745912|Dopamine Agents|dopamine agents|mesh-ancestor
65257956|NCT02745912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65257957|NCT02745912|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65257958|NCT02745912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65257959|NCT02745912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257960|NCT02825186|Dexamethasone|dexamethasone|mesh-list
65257961|NCT02825186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65257962|NCT02825186|Antiemetics|antiemetics|mesh-ancestor
65257963|NCT02825186|Autonomic Agents|autonomic agents|mesh-ancestor
65257964|NCT02825186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65257965|NCT02825186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257966|NCT02825186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65257967|NCT02825186|Glucocorticoids|glucocorticoids|mesh-ancestor
65257968|NCT02825186|Hormones|hormones|mesh-ancestor
65257972|NCT00604825|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64933317|NCT00072163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65257973|NCT00604825|Estrogens|estrogens|mesh-ancestor
65257974|NCT00604825|Hormones|hormones|mesh-ancestor
65257975|NCT00604825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65257976|NCT00604825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257977|NCT04239560|Boron|boron|mesh-list
65257978|NCT04239560|Trace Elements|trace elements|mesh-ancestor
65257979|NCT04239560|Micronutrients|micronutrients|mesh-ancestor
65257980|NCT04239560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257981|NCT04218162|Lasmiditan|lasmiditan|mesh-list
65257982|NCT04218162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65257983|NCT04218162|Serotonin Agents|serotonin agents|mesh-ancestor
65257984|NCT04218162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65257985|NCT04218162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257986|NCT04218162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257987|NCT00606125|Sorafenib|sorafenib|mesh-list
65257988|NCT00606125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65257989|NCT00606125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65257990|NCT00606125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65257991|NCT00606125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65257992|NCT04242212|Misoprostol|misoprostol|mesh-list
65257993|NCT04242212|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65257994|NCT04242212|Abortifacient Agents|abortifacient agents|mesh-ancestor
65257995|NCT04242212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65257996|NCT04242212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65257997|NCT04242212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65257998|NCT04242212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65257999|NCT04242212|Oxytocics|oxytocics|mesh-ancestor
65258000|NCT02851433|Anesthetics|anesthetics|mesh-list
65258001|NCT02851433|Propofol|propofol|mesh-list
65258002|NCT02851433|Sevoflurane|sevoflurane|mesh-list
65258003|NCT02851433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65258004|NCT02851433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258005|NCT02851433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65258006|NCT02851433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65258010|NCT05629806|Metformin|metformin|mesh-list
65258011|NCT05629806|Pioglitazone|pioglitazone|mesh-list
65258012|NCT05629806|Acarbose|acarbose|mesh-list
65258013|NCT05629806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65258014|NCT05629806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258015|NCT05629806|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65258016|NCT05629806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65258017|NCT05629806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258018|NCT02745756|Vaccines|vaccines|mesh-list
65258019|NCT02745756|Immunologic Factors|immunologic factors|mesh-ancestor
65258020|NCT02745756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258021|NCT04242368|Fluticasone|fluticasone|mesh-list
65258022|NCT04242368|Xhance|xhance|mesh-list
65258023|NCT04242368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65258024|NCT04242368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65258025|NCT04242368|Autonomic Agents|autonomic agents|mesh-ancestor
65258026|NCT04242368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65258027|NCT04242368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258028|NCT04242368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65258029|NCT04242368|Respiratory System Agents|respiratory system agents|mesh-ancestor
65258030|NCT04242368|Dermatologic Agents|dermatologic agents|mesh-ancestor
65258031|NCT04242368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65258032|NCT02822144|Lidocaine|lidocaine|mesh-list
65258033|NCT02822144|Remifentanil|remifentanil|mesh-list
65258034|NCT02822144|Propofol|propofol|mesh-list
65258035|NCT02822144|Etomidate|etomidate|mesh-list
65258036|NCT02822144|Succinylcholine|succinylcholine|mesh-list
65258037|NCT02822144|Anesthetics, Local|anesthetics, local|mesh-ancestor
65258038|NCT02822144|Anesthetics|anesthetics|mesh-ancestor
65258039|NCT02822144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65258058|NCT04217148|Dexamethasone acetate|dexamethasone acetate|mesh-list
65258059|NCT04217148|Tretinoin|tretinoin|mesh-list
65258060|NCT04217148|BB 1101|bb 1101|mesh-list
65258061|NCT04217148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65258062|NCT04217148|Antiemetics|antiemetics|mesh-ancestor
65258063|NCT04217148|Autonomic Agents|autonomic agents|mesh-ancestor
65258064|NCT04217148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65258065|NCT04217148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258066|NCT04217148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65258067|NCT04217148|Glucocorticoids|glucocorticoids|mesh-ancestor
65258068|NCT04217148|Hormones|hormones|mesh-ancestor
65258069|NCT04217148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65258070|NCT04217148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65258071|NCT04217148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258072|NCT04217148|Protease Inhibitors|protease inhibitors|mesh-ancestor
65258073|NCT04217148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65258074|NCT04217148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258075|NCT04217148|Keratolytic Agents|keratolytic agents|mesh-ancestor
65258076|NCT04217148|Dermatologic Agents|dermatologic agents|mesh-ancestor
65258077|NCT00900913|Ropivacaine|ropivacaine|mesh-list
65258078|NCT00900913|Anesthetics, Local|anesthetics, local|mesh-ancestor
65258079|NCT00900913|Anesthetics|anesthetics|mesh-ancestor
65258080|NCT00900913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65258081|NCT00900913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258082|NCT00900913|Sensory System Agents|sensory system agents|mesh-ancestor
65258083|NCT00900913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65258084|NCT04216836|Magnesium Oxide|magnesium oxide|mesh-list
65258085|NCT04216836|Antacids|antacids|mesh-ancestor
65258086|NCT04216836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258089|NCT00937157|(T,G)-A-L|(t,g)-a-l|mesh-list
65258104|NCT04034173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258105|NCT04034173|Antidotes|antidotes|mesh-ancestor
65258106|NCT04034173|Protective Agents|protective agents|mesh-ancestor
65258107|NCT04034173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258108|NCT04034173|Vitamin B Complex|vitamin b complex|mesh-ancestor
65258109|NCT04034173|Vitamins|vitamins|mesh-ancestor
65258110|NCT04034173|Micronutrients|micronutrients|mesh-ancestor
65258111|NCT04034173|Hematinics|hematinics|mesh-ancestor
65258112|NCT04034173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65258113|NCT00606203|Milnacipran|milnacipran|mesh-list
65258114|NCT00606203|Levomilnacipran|levomilnacipran|mesh-list
65258115|NCT00606203|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65258116|NCT00606203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65258117|NCT00606203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65258118|NCT00606203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258119|NCT00606203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65258120|NCT00606203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258121|NCT00606203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65258122|NCT00606203|Analgesics|analgesics|mesh-ancestor
65258123|NCT00606203|Sensory System Agents|sensory system agents|mesh-ancestor
65258124|NCT00606203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65258125|NCT00606203|Antidepressive Agents|antidepressive agents|mesh-ancestor
65258126|NCT00606203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65258127|NCT02539849|Adalimumab|adalimumab|mesh-list
65258128|NCT02539849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65258153|NCT00603317|Clavulanic Acids|clavulanic acids|mesh-list
65258154|NCT00603317|Clavulanic Acid|clavulanic acid|mesh-list
65258155|NCT00603317|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65258156|NCT00603317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65258157|NCT00603317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65258158|NCT00603317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65258159|NCT00603317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258160|NCT00603317|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65258161|NCT02745522|Oxytocin|oxytocin|mesh-list
65258162|NCT02745522|Oxytocics|oxytocics|mesh-ancestor
65258163|NCT02745522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65258164|NCT02745522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258165|NCT02824718|Teriparatide|teriparatide|mesh-list
65258166|NCT02824718|Alfacalcidol|alfacalcidol|mesh-list
65258167|NCT02824718|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65258168|NCT02824718|Sodium Channel Blockers|sodium channel blockers|mesh-list
65258169|NCT02824718|Diuretics|diuretics|mesh-list
65258170|NCT02824718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
65258171|NCT02824718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65258172|NCT02824718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258173|NCT02824718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65258174|NCT02824718|Natriuretic Agents|natriuretic agents|mesh-ancestor
65258175|NCT02824718|Vitamins|vitamins|mesh-ancestor
65258176|NCT02824718|Micronutrients|micronutrients|mesh-ancestor
65258177|NCT02824718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65258178|NCT02824718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258179|NCT05378711|Fluoxetine|fluoxetine|mesh-list
65258180|NCT05378711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65258181|NCT05378711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65258182|NCT05378711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65258196|NCT00777153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65258197|NCT00777153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65258198|NCT00777153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258199|NCT00777153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65258200|NCT00777153|Alkylating Agents|alkylating agents|mesh-ancestor
65258201|NCT02821520|Verteporfin|verteporfin|mesh-list
65258202|NCT02821520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65258203|NCT02821520|Dermatologic Agents|dermatologic agents|mesh-ancestor
65258204|NCT00604955|Paromomycin|paromomycin|mesh-list
65258205|NCT00604955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65258206|NCT00604955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65258207|NCT00604955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65258208|NCT00604955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65258209|NCT04266509|Rifampin|rifampin|mesh-list
65258210|NCT04266509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65258211|NCT04266509|Antitubercular Agents|antitubercular agents|mesh-ancestor
65258212|NCT04266509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65258213|NCT04266509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65258214|NCT04266509|Leprostatic Agents|leprostatic agents|mesh-ancestor
65258215|NCT04266509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65258216|NCT04266509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65258217|NCT04266509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258218|NCT04266509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65258219|NCT04266509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65258220|NCT04266509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65258221|NCT04266509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65258222|NCT04266509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65258240|NCT04267913|Dexamethasone|dexamethasone|mesh-list
65258241|NCT04267913|Dexamethasone acetate|dexamethasone acetate|mesh-list
65258242|NCT04267913|Docetaxel|docetaxel|mesh-list
65258243|NCT04267913|Ramucirumab|ramucirumab|mesh-list
65258244|NCT04267913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65258245|NCT04267913|Antibodies|antibodies|mesh-list
65258246|NCT04267913|Immunoglobulins|immunoglobulins|mesh-list
65258247|NCT04267913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65258248|NCT04267913|Lexatumumab|lexatumumab|mesh-list
65258249|NCT04267913|BB 1101|bb 1101|mesh-list
65258250|NCT04267913|Immunologic Factors|immunologic factors|mesh-ancestor
65258251|NCT04267913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258252|NCT04267913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65258253|NCT04267913|Antiemetics|antiemetics|mesh-ancestor
65258254|NCT04267913|Autonomic Agents|autonomic agents|mesh-ancestor
65258255|NCT04267913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65258256|NCT04267913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65258257|NCT04267913|Glucocorticoids|glucocorticoids|mesh-ancestor
65258258|NCT04267913|Hormones|hormones|mesh-ancestor
65258259|NCT04267913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65258260|NCT04267913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65258261|NCT04267913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258262|NCT04267913|Protease Inhibitors|protease inhibitors|mesh-ancestor
65258263|NCT04267913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65258265|NCT04267913|Tubulin Modulators|tubulin modulators|mesh-ancestor
65258294|NCT02745054|Anticoagulants|anticoagulants|mesh-list
65258295|NCT00908089|Sulfasalazine|sulfasalazine|mesh-list
65258296|NCT00908089|Hydroxychloroquine|hydroxychloroquine|mesh-list
65258297|NCT00908089|Prednisolone|prednisolone|mesh-list
65258298|NCT00908089|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65258299|NCT00908089|Methylprednisolone|methylprednisolone|mesh-list
65258300|NCT00908089|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65258301|NCT00908089|Prednisolone acetate|prednisolone acetate|mesh-list
65258302|NCT00908089|Infliximab|infliximab|mesh-list
65258303|NCT00908089|Naltrexone|naltrexone|mesh-list
65258304|NCT00908089|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65258305|NCT00908089|Prednisolone phosphate|prednisolone phosphate|mesh-list
65258306|NCT00908089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65258307|NCT00908089|Glucocorticoids|glucocorticoids|mesh-ancestor
65258308|NCT00908089|Hormones|hormones|mesh-ancestor
65258309|NCT00908089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65258310|NCT00908089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258311|NCT00908089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65258312|NCT00908089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258313|NCT00908089|Antiemetics|antiemetics|mesh-ancestor
65258314|NCT00908089|Autonomic Agents|autonomic agents|mesh-ancestor
65258315|NCT00908089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65258316|NCT00908089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65258317|NCT00908089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65258347|NCT05378555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65258348|NCT05378555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65258349|NCT05378555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258350|NCT03553446|Sevoflurane|sevoflurane|mesh-list
65258351|NCT03553446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65258352|NCT03553446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65258353|NCT03553446|Anesthetics, General|anesthetics, general|mesh-ancestor
65258354|NCT03553446|Anesthetics|anesthetics|mesh-ancestor
65258355|NCT03553446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65258356|NCT03553446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258357|NCT00908167|Cytarabine|cytarabine|mesh-list
65258358|NCT00908167|Clofarabine|clofarabine|mesh-list
65258359|NCT00908167|Sorafenib|sorafenib|mesh-list
65258360|NCT00908167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65258361|NCT00908167|Antimetabolites|antimetabolites|mesh-ancestor
65258362|NCT00908167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258363|NCT00908167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258364|NCT00908167|Antiviral Agents|antiviral agents|mesh-ancestor
65258365|NCT00908167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65258366|NCT00908167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65258367|NCT00908167|Immunologic Factors|immunologic factors|mesh-ancestor
65258368|NCT00908167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258369|NCT00908167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65258370|NCT00908167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65258371|NCT02821052|Insulin|insulin|mesh-list
65258372|NCT02821052|Insulin Aspart|insulin aspart|mesh-list
65258373|NCT02821052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65258374|NCT02821052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258375|NCT00606515|Paclitaxel|paclitaxel|mesh-list
65258376|NCT00606515|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65258377|NCT00606515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65258378|NCT00606515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258379|NCT00606515|Tubulin Modulators|tubulin modulators|mesh-ancestor
65258380|NCT00606515|Antimitotic Agents|antimitotic agents|mesh-ancestor
65258383|NCT00908323|Vaccines|vaccines|mesh-list
65258388|NCT02749032|Vildagliptin|vildagliptin|mesh-list
65258389|NCT02749032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65258390|NCT02749032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258391|NCT02749032|Incretins|incretins|mesh-ancestor
65258392|NCT02749032|Hormones|hormones|mesh-ancestor
65258393|NCT02749032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65258394|NCT02749032|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65258395|NCT02749032|Protease Inhibitors|protease inhibitors|mesh-ancestor
65258396|NCT02749032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65258397|NCT02749032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258398|NCT00908713|Methylprednisolone|methylprednisolone|mesh-list
65258399|NCT00908713|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65258400|NCT00908713|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65258401|NCT00908713|Prednisolone|prednisolone|mesh-list
65258402|NCT00908713|Prednisolone acetate|prednisolone acetate|mesh-list
65258403|NCT00908713|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65258404|NCT00908713|Prednisolone phosphate|prednisolone phosphate|mesh-list
65258405|NCT00908713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65258406|NCT00908713|Antiemetics|antiemetics|mesh-ancestor
65258407|NCT00908713|Autonomic Agents|autonomic agents|mesh-ancestor
65258408|NCT00908713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65258409|NCT00908713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258410|NCT00908713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65258411|NCT00908713|Glucocorticoids|glucocorticoids|mesh-ancestor
65258412|NCT00908713|Hormones|hormones|mesh-ancestor
65258437|NCT00908869|Mitosis Modulators|mitosis modulators|mesh-ancestor
65258438|NCT00605111|Insulin Aspart|insulin aspart|mesh-list
65258439|NCT00605111|Biphasic Insulins|biphasic insulins|mesh-list
65258440|NCT00605111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65258441|NCT00605111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258442|NCT03465774|Doxycycline|doxycycline|mesh-list
65258443|NCT03465774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65258444|NCT03465774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65258445|NCT03465774|Antimalarials|antimalarials|mesh-ancestor
65258446|NCT03465774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65258447|NCT03465774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65258448|NCT04240496|Clozapine|clozapine|mesh-list
65258449|NCT04240496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65258450|NCT04240496|Serotonin Agents|serotonin agents|mesh-ancestor
65258451|NCT04240496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65258452|NCT04240496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258453|NCT04240496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258454|NCT04240496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65258495|NCT04239794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65258496|NCT04239794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258497|NCT04239794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65258498|NCT04239794|Anesthetics, General|anesthetics, general|mesh-ancestor
65258499|NCT04239794|Anesthetics|anesthetics|mesh-ancestor
65258500|NCT04239794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65258501|NCT04239794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65258502|NCT02850887|Anesthetics|anesthetics|mesh-list
65258503|NCT02850887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65258504|NCT02850887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258505|NCT00931645|Cytarabine|cytarabine|mesh-list
65258506|NCT00931645|Dexamethasone|dexamethasone|mesh-list
65258507|NCT00931645|Cyclophosphamide|cyclophosphamide|mesh-list
65258508|NCT00931645|Cisplatin|cisplatin|mesh-list
65008747|NCT00504283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65258509|NCT00931645|Fludarabine|fludarabine|mesh-list
65258510|NCT00931645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65258511|NCT00931645|Immunologic Factors|immunologic factors|mesh-ancestor
65258512|NCT00931645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258555|NCT05658692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65258556|NCT05658692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258557|NCT05658692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65258558|NCT05658692|Hormones|hormones|mesh-ancestor
65258559|NCT05658692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65258560|NCT05658692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65258561|NCT05658692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258562|NCT05658692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65258563|NCT05658692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258564|NCT05658692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65258565|NCT05658692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65258566|NCT05658692|Anesthetics, General|anesthetics, general|mesh-ancestor
65258567|NCT05658692|Anesthetics|anesthetics|mesh-ancestor
65258568|NCT05658692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65258569|NCT05658692|Analgesics|analgesics|mesh-ancestor
65258570|NCT05658692|Sensory System Agents|sensory system agents|mesh-ancestor
65258571|NCT05658692|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65258572|NCT05658692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65258573|NCT05658692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65258574|NCT05658692|Adrenergic Agents|adrenergic agents|mesh-ancestor
65258575|NCT05658692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65258576|NCT05658692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65258577|NCT05658692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65258578|NCT05658692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65258580|NCT05658692|GABA Modulators|gaba modulators|mesh-ancestor
65258603|NCT05658692|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65258604|NCT05658692|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65258605|NCT05658692|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65258606|NCT05658692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65258607|NCT05658692|Cholinergic Agents|cholinergic agents|mesh-ancestor
65258608|NCT05658692|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65258609|NCT02744508|Dexamethasone|dexamethasone|mesh-list
65258610|NCT02744508|Palonosetron|palonosetron|mesh-list
65258611|NCT02744508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65258612|NCT02744508|Antiemetics|antiemetics|mesh-ancestor
65258613|NCT02744508|Autonomic Agents|autonomic agents|mesh-ancestor
65258614|NCT02744508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65258615|NCT02744508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258616|NCT02744508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65258617|NCT02744508|Glucocorticoids|glucocorticoids|mesh-ancestor
65258618|NCT02744508|Hormones|hormones|mesh-ancestor
65258619|NCT02744508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65258620|NCT02744508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65258621|NCT02744508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258622|NCT02744508|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65258623|NCT02744508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65258624|NCT02744508|Serotonin Agents|serotonin agents|mesh-ancestor
65258625|NCT02744508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65258626|NCT02744508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258627|NCT00927511|Fulvestrant|fulvestrant|mesh-list
65258628|NCT00927511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65258629|NCT00927511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258630|NCT00927511|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65258631|NCT00927511|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65258632|NCT00927511|Hormone Antagonists|hormone antagonists|mesh-ancestor
65258636|NCT04637594|Nivolumab|nivolumab|mesh-list
65258646|NCT03211338|Progestins|progestins|mesh-ancestor
65258647|NCT03211338|Hormones|hormones|mesh-ancestor
65258648|NCT03211338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65258649|NCT03211338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258650|NCT03211338|Mitosis Modulators|mitosis modulators|mesh-ancestor
65258651|NCT03211338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258652|NCT00936611|Panobinostat|panobinostat|mesh-list
65258653|NCT00936611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258654|NCT00936611|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65258655|NCT00936611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65258656|NCT00936611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258657|NCT02744196|Methotrexate|methotrexate|mesh-list
65258658|NCT02744196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258659|NCT02744196|Immunologic Factors|immunologic factors|mesh-ancestor
65258660|NCT02744196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258661|NCT02744196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65258662|NCT02744196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65258701|NCT02748330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65258702|NCT02748330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65258703|NCT02748330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65258704|NCT02748330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65258705|NCT02748330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258706|NCT02748330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65258707|NCT02748330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65258708|NCT02748330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65258709|NCT02748330|Antipyretics|antipyretics|mesh-ancestor
65258710|NCT02748330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65258711|NCT02748330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65258712|NCT02748330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65258713|NCT02748330|Purinergic Agents|purinergic agents|mesh-ancestor
65258714|NCT02748330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65258715|NCT05379569|Cyclophosphamide|cyclophosphamide|mesh-list
65258716|NCT05379569|Fludarabine|fludarabine|mesh-list
65258717|NCT05379569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65258718|NCT05379569|Immunologic Factors|immunologic factors|mesh-ancestor
65258719|NCT05379569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258720|NCT05379569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65258721|NCT05379569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65258722|NCT05379569|Alkylating Agents|alkylating agents|mesh-ancestor
65258723|NCT05379569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258724|NCT05379569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258725|NCT05379569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65258726|NCT02818556|Hyaluronic Acid|hyaluronic acid|mesh-list
65258727|NCT02818556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65258736|NCT04627142|Irinotecan|irinotecan|mesh-list
65258746|NCT00936221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258747|NCT00776919|Clindamycin|clindamycin|mesh-list
65258748|NCT00776919|Clindamycin palmitate|clindamycin palmitate|mesh-list
65258749|NCT00776919|Clindamycin phosphate|clindamycin phosphate|mesh-list
65258750|NCT00776919|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65258751|NCT00776919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65258752|NCT00776919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65258753|NCT00776919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65258754|NCT00776919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65258755|NCT00776919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258756|NCT00776919|Dermatologic Agents|dermatologic agents|mesh-ancestor
65258757|NCT05657678|Vitamin D|vitamin d|mesh-list
65258758|NCT05657678|Ergocalciferols|ergocalciferols|mesh-list
65258759|NCT05657678|Cholecalciferol|cholecalciferol|mesh-list
65258760|NCT05657678|Vitamins|vitamins|mesh-list
65258761|NCT05657678|Micronutrients|micronutrients|mesh-ancestor
65258762|NCT05657678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258763|NCT05657678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65258764|NCT05657678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65258765|NCT02747940|Pregabalin|pregabalin|mesh-list
65258766|NCT02747940|Flunarizine|flunarizine|mesh-list
65258767|NCT02747940|Analgesics|analgesics|mesh-ancestor
65258768|NCT02747940|Sensory System Agents|sensory system agents|mesh-ancestor
65258769|NCT02747940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65258770|NCT02747940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258771|NCT02747940|Anticonvulsants|anticonvulsants|mesh-ancestor
65258772|NCT02747940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65258773|NCT02747940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65258774|NCT02747940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258775|NCT02747940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65258776|NCT02747940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65258777|NCT02747940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65258779|NCT02747940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65258788|NCT04238702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65258789|NCT04238702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65258790|NCT04238702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65258791|NCT04238702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258792|NCT04238702|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65258793|NCT04238702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65258794|NCT04238702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258795|NCT00603785|Omalizumab|omalizumab|mesh-list
65258796|NCT00603785|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65258797|NCT00603785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65258798|NCT00603785|Respiratory System Agents|respiratory system agents|mesh-ancestor
65258799|NCT00633776|Formoterol Fumarate|formoterol fumarate|mesh-list
65258800|NCT00633776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65258801|NCT00633776|Autonomic Agents|autonomic agents|mesh-ancestor
65258802|NCT00633776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65258803|NCT00633776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258804|NCT00633776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65258805|NCT00633776|Respiratory System Agents|respiratory system agents|mesh-ancestor
65258806|NCT00633776|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65258807|NCT00633776|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65258808|NCT00633776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65258809|NCT00633776|Adrenergic Agents|adrenergic agents|mesh-ancestor
65258810|NCT00633776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65258811|NCT00633776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258812|NCT05382923|Melatonin|melatonin|mesh-list
65258813|NCT05382923|Antioxidants|antioxidants|mesh-ancestor
65258814|NCT05382923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258815|NCT05382923|Protective Agents|protective agents|mesh-ancestor
65258816|NCT05382923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258817|NCT05382923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65258818|NCT02743572|Iron|iron|mesh-list
65258819|NCT02743572|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65258820|NCT02743572|Trace Elements|trace elements|mesh-ancestor
65258821|NCT02743572|Micronutrients|micronutrients|mesh-ancestor
65258822|NCT02743572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258824|NCT00775593|Sirolimus|sirolimus|mesh-list
65258825|NCT00775593|Clofarabine|clofarabine|mesh-list
65258826|NCT00775593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65258827|NCT00775593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65258828|NCT00775593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65258829|NCT00775593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258830|NCT00775593|Antifungal Agents|antifungal agents|mesh-ancestor
65258831|NCT00775593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65258832|NCT00775593|Immunologic Factors|immunologic factors|mesh-ancestor
65258833|NCT00775593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258834|NCT00775593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65258835|NCT00775593|Antimetabolites|antimetabolites|mesh-ancestor
65258836|NCT00775593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258837|NCT00606983|Tamsulosin|tamsulosin|mesh-list
65258838|NCT00606983|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65258839|NCT00606983|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65258840|NCT00606983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65258841|NCT00606983|Adrenergic Agents|adrenergic agents|mesh-ancestor
65258842|NCT00606983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65258843|NCT00606983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258844|NCT00606983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258845|NCT00606983|Urological Agents|urological agents|mesh-ancestor
65258846|NCT02817932|Ranolazine|ranolazine|mesh-list
65258847|NCT02817932|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65258848|NCT02817932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65258849|NCT02817932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258850|NCT02743260|Metformin|metformin|mesh-list
65258851|NCT02743260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65258852|NCT02743260|Adefovir|adefovir|mesh-list
65258853|NCT02743260|Digoxin|digoxin|mesh-list
65258854|NCT02743260|Pitavastatin|pitavastatin|mesh-list
65258855|NCT02743260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65258856|NCT02743260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258857|NCT02743260|Incretins|incretins|mesh-ancestor
65258858|NCT02743260|Hormones|hormones|mesh-ancestor
65258863|NCT02743260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258864|NCT02743260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65258865|NCT02743260|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65258866|NCT02743260|Protective Agents|protective agents|mesh-ancestor
65258867|NCT02743260|Antiviral Agents|antiviral agents|mesh-ancestor
65258868|NCT02743260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65258869|NCT02743260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65258870|NCT02743260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65258871|NCT02743260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65258872|NCT02743260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65258873|NCT02743260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65258874|NCT02743260|Antimetabolites|antimetabolites|mesh-ancestor
65258875|NCT02743260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65258876|NCT05629260|Cyclophosphamide|cyclophosphamide|mesh-list
65258877|NCT05629260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65258878|NCT05629260|Immunologic Factors|immunologic factors|mesh-ancestor
65258879|NCT05629260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258880|NCT05629260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65258881|NCT05629260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65258882|NCT05629260|Alkylating Agents|alkylating agents|mesh-ancestor
65258883|NCT05629260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258884|NCT05629260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258885|NCT05629260|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65258886|NCT02819648|Prednisolone|prednisolone|mesh-list
65258887|NCT02819648|Glucocorticoids|glucocorticoids|mesh-list
65258888|NCT02819648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65258890|NCT02819648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65258891|NCT02819648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258892|NCT02819648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65258893|NCT02819648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258894|NCT00934661|Morphine|morphine|mesh-list
65258895|NCT00934661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65258896|NCT00934661|Narcotics|narcotics|mesh-ancestor
65258897|NCT00934661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65258901|NCT00934661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65258902|NCT02743182|Interferons|interferons|mesh-list
65258903|NCT02743182|Interferon-alpha|interferon-alpha|mesh-list
65258904|NCT02743182|Interferon alpha-2|interferon alpha-2|mesh-list
65258905|NCT02743182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65258906|NCT02743182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65258907|NCT02743182|Antiviral Agents|antiviral agents|mesh-ancestor
65258908|NCT02743182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65258909|NCT02743182|Immunologic Factors|immunologic factors|mesh-ancestor
65258910|NCT02743182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258911|NCT00775437|Adalimumab|adalimumab|mesh-list
65258912|NCT00775437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65258913|NCT00775437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65258914|NCT04238078|Contraceptive Agents|contraceptive agents|mesh-list
65258915|NCT04238078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65258916|NCT04238078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258917|NCT02742168|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
65258918|NCT02742168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65258919|NCT02742168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258920|NCT02819414|Acetaminophen|acetaminophen|mesh-list
65258921|NCT02819414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65258922|NCT02819414|Analgesics|analgesics|mesh-ancestor
65258923|NCT02819414|Sensory System Agents|sensory system agents|mesh-ancestor
65258924|NCT02819414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65258925|NCT02819414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258926|NCT02819414|Antipyretics|antipyretics|mesh-ancestor
65258927|NCT02743104|Lidocaine|lidocaine|mesh-list
65258928|NCT02743104|Atropine|atropine|mesh-list
65258929|NCT02743104|Midazolam|midazolam|mesh-list
65258930|NCT02743104|Ketamine|ketamine|mesh-list
65258931|NCT02743104|Propofol|propofol|mesh-list
65258932|NCT02743104|Anesthetics, Local|anesthetics, local|mesh-ancestor
65258947|NCT02743104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65258948|NCT02743104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65258949|NCT02743104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65258950|NCT02743104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65258951|NCT02743104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65258952|NCT02743104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65258953|NCT02743104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65258954|NCT02743104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65258955|NCT02743104|GABA Modulators|gaba modulators|mesh-ancestor
65258956|NCT02743104|GABA Agents|gaba agents|mesh-ancestor
65258957|NCT02743104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65258958|NCT02743104|Autonomic Agents|autonomic agents|mesh-ancestor
65258959|NCT02743104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65258960|NCT02743104|Respiratory System Agents|respiratory system agents|mesh-ancestor
65258961|NCT02743104|Mydriatics|mydriatics|mesh-ancestor
65258962|NCT02743104|Parasympatholytics|parasympatholytics|mesh-ancestor
65258963|NCT02743104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65258964|NCT02743104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65258965|NCT02743104|Cholinergic Agents|cholinergic agents|mesh-ancestor
65258966|NCT00775203|Trazodone|trazodone|mesh-list
65258967|NCT00775203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65258968|NCT00775203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65258969|NCT00775203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65258970|NCT00775203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258971|NCT00775203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65258972|NCT00775203|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65258973|NCT00775203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65258974|NCT00775203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65258975|NCT00775203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65258983|NCT00607217|Vaccines|vaccines|mesh-list
65258993|NCT05648708|Anesthetics, Local|anesthetics, local|mesh-ancestor
65258994|NCT05648708|Anesthetics|anesthetics|mesh-ancestor
65258995|NCT05648708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65258996|NCT05648708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65258997|NCT05648708|Sensory System Agents|sensory system agents|mesh-ancestor
65258998|NCT05648708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65258999|NCT02742948|Ceftriaxone|ceftriaxone|mesh-list
65259000|NCT02742948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65259001|NCT02742948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65259002|NCT00636246|Sertraline|sertraline|mesh-list
65259003|NCT00636246|Reboxetine|reboxetine|mesh-list
65259004|NCT00636246|Antidepressive Agents|antidepressive agents|mesh-ancestor
65259057|NCT02741232|Epinephrine|epinephrine|mesh-list
65259058|NCT02741232|Racepinephrine|racepinephrine|mesh-list
65259059|NCT02741232|Epinephryl borate|epinephryl borate|mesh-list
65259060|NCT02741232|Anesthetics, Local|anesthetics, local|mesh-ancestor
65259061|NCT02741232|Anesthetics|anesthetics|mesh-ancestor
65259062|NCT02741232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65259063|NCT02741232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259064|NCT02741232|Sensory System Agents|sensory system agents|mesh-ancestor
65259065|NCT02741232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65259066|NCT02741232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65259067|NCT02741232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65259068|NCT02741232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65259069|NCT02741232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65259070|NCT02741232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259071|NCT02741232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65259072|NCT02741232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65259073|NCT02741232|Adrenergic Agents|adrenergic agents|mesh-ancestor
65259074|NCT02741232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65259075|NCT02741232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65259076|NCT02741232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65259077|NCT02741232|Autonomic Agents|autonomic agents|mesh-ancestor
65259078|NCT02741232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65259079|NCT02741232|Respiratory System Agents|respiratory system agents|mesh-ancestor
65259080|NCT02741232|Mydriatics|mydriatics|mesh-ancestor
65259081|NCT02741232|Sympathomimetics|sympathomimetics|mesh-ancestor
65259082|NCT02741232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65259083|NCT04237922|Clopidogrel|clopidogrel|mesh-list
65259093|NCT04239014|Olaparib|olaparib|mesh-list
65259103|NCT02742480|Dabigatran|dabigatran|mesh-list
65259104|NCT02742480|Acenocoumarol|acenocoumarol|mesh-list
65259105|NCT02742480|Antithrombins|antithrombins|mesh-ancestor
65259106|NCT02742480|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65259107|NCT02742480|Protease Inhibitors|protease inhibitors|mesh-ancestor
65259108|NCT02742480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259109|NCT02742480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259110|NCT02742480|Anticoagulants|anticoagulants|mesh-ancestor
65259111|NCT00774345|Lenalidomide|lenalidomide|mesh-list
65259112|NCT00774345|Immunologic Factors|immunologic factors|mesh-ancestor
65259113|NCT00774345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259114|NCT00774345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65259115|NCT00774345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65259116|NCT00774345|Growth Substances|growth substances|mesh-ancestor
65259117|NCT00774345|Growth Inhibitors|growth inhibitors|mesh-ancestor
65259118|NCT00774345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259119|NCT02819102|Berotralstat|berotralstat|mesh-list
65259120|NCT02819102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259121|NCT02819102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259122|NCT04342026|Endocrine Disruptors|endocrine disruptors|mesh-list
65259123|NCT04342026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259124|NCT02819180|Vaccines|vaccines|mesh-list
65259125|NCT02819180|Immunologic Factors|immunologic factors|mesh-ancestor
65259126|NCT02819180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259127|NCT04661930|Fenofibrate|fenofibrate|mesh-list
65259143|NCT02601963|Minocycline|minocycline|mesh-list
65259153|NCT00931957|Prednisolone|prednisolone|mesh-list
65259154|NCT00931957|Etanercept|etanercept|mesh-list
65259155|NCT00931957|Methotrexate|methotrexate|mesh-list
65259156|NCT00931957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65259157|NCT00931957|Abortifacient Agents|abortifacient agents|mesh-ancestor
65259158|NCT00931957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65259159|NCT00931957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259160|NCT00931957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65259161|NCT00931957|Antimetabolites|antimetabolites|mesh-ancestor
65259162|NCT00931957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259163|NCT00931957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259164|NCT00931957|Dermatologic Agents|dermatologic agents|mesh-ancestor
65259165|NCT00931957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259166|NCT00931957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65259167|NCT00931957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65259168|NCT00931957|Immunologic Factors|immunologic factors|mesh-ancestor
65259169|NCT00931957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65259170|NCT00931957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65259171|NCT00931957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65259172|NCT00931957|Glucocorticoids|glucocorticoids|mesh-ancestor
65259173|NCT00931957|Hormones|hormones|mesh-ancestor
65259174|NCT00931957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65259175|NCT00931957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65259176|NCT00931957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65259177|NCT00931957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65259178|NCT00931957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65259179|NCT00931957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65259180|NCT00931957|Analgesics|analgesics|mesh-ancestor
65259181|NCT00931957|Sensory System Agents|sensory system agents|mesh-ancestor
65259182|NCT02731950|Magnesium Sulfate|magnesium sulfate|mesh-list
65259183|NCT02731950|Bupivacaine|bupivacaine|mesh-list
65259184|NCT02731950|Anesthetics, Local|anesthetics, local|mesh-ancestor
65259195|NCT02731950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259196|NCT02731950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65259197|NCT02731950|Tocolytic Agents|tocolytic agents|mesh-ancestor
65259198|NCT02731950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65259199|NCT00773253|Botulinum Toxins|botulinum toxins|mesh-list
65259200|NCT00773253|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65259201|NCT00773253|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65259202|NCT00773253|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65259203|NCT00773253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65259204|NCT00773253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259205|NCT00773253|Cholinergic Agents|cholinergic agents|mesh-ancestor
65259206|NCT00773253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65259207|NCT00773253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259208|NCT00773253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65259209|NCT00773253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65259210|NCT00928213|Heparin|heparin|mesh-list
65259211|NCT00928213|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65259212|NCT00928213|Tinzaparin|tinzaparin|mesh-list
65259213|NCT00928213|Dalteparin|dalteparin|mesh-list
65259249|NCT04287816|Protease Inhibitors|protease inhibitors|mesh-ancestor
65259250|NCT04287816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259251|NCT04287816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259252|NCT04287816|Anticoagulants|anticoagulants|mesh-ancestor
65259253|NCT04313790|Heparin|heparin|mesh-list
65259254|NCT04313790|Calcium heparin|calcium heparin|mesh-list
65259255|NCT04313790|Anticoagulants|anticoagulants|mesh-ancestor
65259256|NCT04313790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65259257|NCT04313790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65259258|NCT04313790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259259|NCT02735928|Doxorubicin|doxorubicin|mesh-list
65259260|NCT02735928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259261|NCT02735928|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65259262|NCT02735928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65259263|NCT02735928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65009499|NCT00140517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259264|NCT02735928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259265|NCT02735928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259266|NCT02731560|Rituximab|rituximab|mesh-list
65259267|NCT02731560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65259268|NCT02731560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259269|NCT02731560|Immunologic Factors|immunologic factors|mesh-ancestor
65259270|NCT02731560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259271|NCT02731560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65259272|NCT00773097|Poly ICLC|poly iclc|mesh-list
65259273|NCT00773097|Interferon Inducers|interferon inducers|mesh-ancestor
65259274|NCT00773097|Immunologic Factors|immunologic factors|mesh-ancestor
65259275|NCT00773097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259276|NCT00933335|Tositumomab I-131|tositumomab i-131|mesh-list
65259277|NCT00933335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259278|NCT02814110|Lenograstim|lenograstim|mesh-list
65259279|NCT02814110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65259291|NCT04264481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259292|NCT04264481|Sensory System Agents|sensory system agents|mesh-ancestor
65259293|NCT04264481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65259294|NCT04264481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65259295|NCT04264481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65259296|NCT04264481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65259297|NCT04264481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65259298|NCT04264481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259299|NCT05303909|Gentamicins|gentamicins|mesh-list
65259300|NCT05303909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65259301|NCT05303909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65259302|NCT05303909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65259303|NCT05303909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259305|NCT04306692|Inositol|inositol|mesh-list
65259350|NCT04717375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65259351|NCT04717375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259352|NCT04237532|Dexmedetomidine|dexmedetomidine|mesh-list
65259353|NCT04237532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65259354|NCT04237532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65259355|NCT04237532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259356|NCT04237532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65259357|NCT04237532|Analgesics|analgesics|mesh-ancestor
65259358|NCT04237532|Sensory System Agents|sensory system agents|mesh-ancestor
65259359|NCT04237532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65259360|NCT04237532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65259361|NCT04237532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65259362|NCT04237532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65259363|NCT04237532|Adrenergic Agents|adrenergic agents|mesh-ancestor
65259364|NCT04237532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65259365|NCT04237532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259366|NCT02731092|Lactoferrin|lactoferrin|mesh-list
65259367|NCT02731092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65259368|NCT00928837|Naproxen|naproxen|mesh-list
65259369|NCT00928837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65259370|NCT00928837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65259371|NCT00928837|Analgesics|analgesics|mesh-ancestor
65259372|NCT00928837|Sensory System Agents|sensory system agents|mesh-ancestor
65259373|NCT00928837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65259374|NCT00928837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259375|NCT00928837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65259376|NCT00928837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65259377|NCT00928837|Gout Suppressants|gout suppressants|mesh-ancestor
65259378|NCT00928837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65259379|NCT00928837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259380|NCT00928837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259381|NCT02730936|Anti-Infective Agents|anti-infective agents|mesh-list
65259390|NCT00925093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259391|NCT01562977|Gemcitabine|gemcitabine|mesh-list
65259392|NCT01562977|Rituximab|rituximab|mesh-list
65259393|NCT01562977|Oxaliplatin|oxaliplatin|mesh-list
65259394|NCT01562977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65259395|NCT01562977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259396|NCT01562977|Immunologic Factors|immunologic factors|mesh-ancestor
65259397|NCT01562977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259398|NCT01562977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65259399|NCT01562977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65259400|NCT01562977|Antimetabolites|antimetabolites|mesh-ancestor
65259401|NCT01562977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259402|NCT01562977|Antiviral Agents|antiviral agents|mesh-ancestor
65259403|NCT01562977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65259404|NCT01562977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259405|NCT01562977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65259406|NCT00607685|Fluorouracil|fluorouracil|mesh-list
65259407|NCT00607685|Hyaluronic Acid|hyaluronic acid|mesh-list
65259408|NCT00607685|Antimetabolites|antimetabolites|mesh-ancestor
65259409|NCT00607685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259410|NCT00607685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65259445|NCT02814500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65259446|NCT02814500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259447|NCT02814500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65259448|NCT02814500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259449|NCT02814500|Vasodilator Agents|vasodilator agents|mesh-ancestor
65259450|NCT02814500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65259451|NCT02814500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65259452|NCT02814500|Antimetabolites|antimetabolites|mesh-ancestor
65259453|NCT02814500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65259454|NCT02814500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65259455|NCT02814500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259456|NCT00939341|Budesonide|budesonide|mesh-list
65259457|NCT00939341|Formoterol Fumarate|formoterol fumarate|mesh-list
65259458|NCT00939341|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65259459|NCT00939341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65259460|NCT00939341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65259461|NCT00939341|Autonomic Agents|autonomic agents|mesh-ancestor
65259462|NCT00939341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65259463|NCT00939341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259464|NCT00939341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65259465|NCT00939341|Respiratory System Agents|respiratory system agents|mesh-ancestor
65259466|NCT00939341|Glucocorticoids|glucocorticoids|mesh-ancestor
65259467|NCT00939341|Hormones|hormones|mesh-ancestor
65259468|NCT00939341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65259469|NCT00939341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65259470|NCT00939341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65259471|NCT00939341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65259472|NCT00939341|Adrenergic Agents|adrenergic agents|mesh-ancestor
65259473|NCT00939341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65259474|NCT00939341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934832|NCT00399685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65259486|NCT04237376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65259487|NCT04237376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009721|NCT01154439|Idarubicin|idarubicin|mesh-list
65259488|NCT04237376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259489|NCT04237376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65259490|NCT04237376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65259491|NCT04015687|Lamotrigine|lamotrigine|mesh-list
65259492|NCT04015687|Anticonvulsants|anticonvulsants|mesh-ancestor
65259493|NCT04015687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65259494|NCT04015687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65259495|NCT04015687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259496|NCT04015687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65259497|NCT04015687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259498|NCT04015687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65259499|NCT04015687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65259500|NCT04015687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65259501|NCT04015687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65259502|NCT04015687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65259503|NCT02739906|Insulin|insulin|mesh-list
65259504|NCT02739906|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65259505|NCT02739906|Insulin Lispro|insulin lispro|mesh-list
65259506|NCT02739906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65259507|NCT02739906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259508|NCT02739672|Amlodipine|amlodipine|mesh-list
65259532|NCT00932971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65259533|NCT00932971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259534|NCT00932971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259535|NCT00932971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65259536|NCT00932971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65259537|NCT00932971|Immunologic Factors|immunologic factors|mesh-ancestor
65259538|NCT00932971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259539|NCT00932971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259540|NCT05382143|Atosiban|atosiban|mesh-list
65259541|NCT05382143|Hormone Antagonists|hormone antagonists|mesh-ancestor
65259542|NCT05382143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65259543|NCT05382143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259544|NCT05382143|Tocolytic Agents|tocolytic agents|mesh-ancestor
65259545|NCT05382143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65259546|NCT00933049|Amoxicillin|amoxicillin|mesh-list
65259547|NCT00933049|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65259548|NCT00933049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65259549|NCT00933049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65259550|NCT00933049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65259551|NCT00933049|Renal Agents|renal agents|mesh-ancestor
65259552|NCT00933049|Antimalarials|antimalarials|mesh-ancestor
65259553|NCT00933049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65259554|NCT00933049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65259555|NCT05788458|Bupivacaine|bupivacaine|mesh-list
65259556|NCT05788458|Anesthetics, Local|anesthetics, local|mesh-ancestor
65259557|NCT05788458|Anesthetics|anesthetics|mesh-ancestor
65259558|NCT05788458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65259559|NCT05788458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259560|NCT05788458|Sensory System Agents|sensory system agents|mesh-ancestor
65259561|NCT05788458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65259562|NCT05788393|Lidocaine|lidocaine|mesh-list
65259563|NCT05788393|Dexmedetomidine|dexmedetomidine|mesh-list
65259564|NCT05788393|Anesthetics, Local|anesthetics, local|mesh-ancestor
65259571|NCT05788393|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65259572|NCT05788393|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65259573|NCT05788393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65259574|NCT05788393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259575|NCT05788393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65259576|NCT05788393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65259577|NCT05788393|Analgesics|analgesics|mesh-ancestor
65259578|NCT05788393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65259579|NCT05788393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65259580|NCT05788393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65259581|NCT05788393|Adrenergic Agents|adrenergic agents|mesh-ancestor
65259582|NCT05788393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65259583|NCT05788276|Dapagliflozin|dapagliflozin|mesh-list
65259584|NCT05788276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65259585|NCT05788276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259586|NCT05788276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65259587|NCT05788276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259588|NCT05788159|Lacosamide|lacosamide|mesh-list
65259589|NCT05788159|Anticonvulsants|anticonvulsants|mesh-ancestor
65259591|NCT05788159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65259626|NCT05787808|Micronutrients|micronutrients|mesh-ancestor
65259627|NCT05787808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259628|NCT05787808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65259629|NCT05787743|Tocotrienols|tocotrienols|mesh-list
65259630|NCT05787743|Vitamin E|vitamin e|mesh-list
65259631|NCT05787743|Tocopherols|tocopherols|mesh-list
65259632|NCT05787743|Antioxidants|antioxidants|mesh-ancestor
65259633|NCT05787743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259634|NCT05787743|Protective Agents|protective agents|mesh-ancestor
65259635|NCT05787743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009873|NCT00133562|Glycine|glycine|mesh-list
65259636|NCT05787743|Vitamins|vitamins|mesh-ancestor
65259637|NCT05787743|Micronutrients|micronutrients|mesh-ancestor
65259638|NCT05787574|Dexamethasone|dexamethasone|mesh-list
65259640|NCT05787574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65259641|NCT05787574|Antiemetics|antiemetics|mesh-ancestor
65259642|NCT05787574|Autonomic Agents|autonomic agents|mesh-ancestor
65259643|NCT05787574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65259644|NCT05787574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259645|NCT05787574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65259646|NCT05787574|Glucocorticoids|glucocorticoids|mesh-ancestor
65259647|NCT05787574|Hormones|hormones|mesh-ancestor
65259648|NCT05787574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65259649|NCT05787574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65259650|NCT05787574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259651|NCT05787535|Cyclophosphamide|cyclophosphamide|mesh-list
65259652|NCT05787535|Fludarabine|fludarabine|mesh-list
65259653|NCT05787535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65259654|NCT05787535|Immunologic Factors|immunologic factors|mesh-ancestor
65259662|NCT05787509|Progesterone|progesterone|mesh-list
65259673|NCT05787002|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65259674|NCT05787002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259675|NCT05786950|Bromides|bromides|mesh-list
65259676|NCT05786950|Albuterol|albuterol|mesh-list
65259677|NCT05786950|Ipratropium|ipratropium|mesh-list
65259678|NCT05786950|Anticonvulsants|anticonvulsants|mesh-ancestor
65259679|NCT05786950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65259680|NCT05786950|Autonomic Agents|autonomic agents|mesh-ancestor
65259681|NCT05786950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65259682|NCT05786950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259683|NCT05786950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65259684|NCT05786950|Respiratory System Agents|respiratory system agents|mesh-ancestor
65259685|NCT05786950|Tocolytic Agents|tocolytic agents|mesh-ancestor
65259686|NCT05786950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65259687|NCT05786950|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65259688|NCT05786950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65259689|NCT05786950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65259690|NCT05786950|Adrenergic Agents|adrenergic agents|mesh-ancestor
65259691|NCT05786950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65259692|NCT05786950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259693|NCT05786950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65259694|NCT05786950|Cholinergic Agents|cholinergic agents|mesh-ancestor
65259695|NCT05786885|Vitamins|vitamins|mesh-list
65259696|NCT05786885|Ascorbic Acid|ascorbic acid|mesh-list
65259697|NCT05786885|Micronutrients|micronutrients|mesh-ancestor
65259723|NCT05785897|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65259724|NCT05785897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259725|NCT05785897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259726|NCT05785897|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65259727|NCT05785897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65259728|NCT05785897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65259729|NCT05785897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65259730|NCT05785897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259731|NCT05785897|Antifungal Agents|antifungal agents|mesh-ancestor
65259732|NCT05785897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65259733|NCT05785897|Immunologic Factors|immunologic factors|mesh-ancestor
65259734|NCT05785897|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65259735|NCT05785897|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65259736|NCT05785897|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65259737|NCT05785897|Purinergic Agents|purinergic agents|mesh-ancestor
65259738|NCT05785897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65259739|NCT05785819|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65259740|NCT05785819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259741|NCT05784688|Pembrolizumab|pembrolizumab|mesh-list
65259742|NCT05784688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65259743|NCT05784688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259744|NCT05782270|Warfarin|warfarin|mesh-list
65259745|NCT05782270|Anticoagulants|anticoagulants|mesh-ancestor
65259746|NCT05776459|Prednisolone|prednisolone|mesh-list
65259747|NCT05776459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65259748|NCT05776459|Glucocorticoids|glucocorticoids|mesh-ancestor
65259749|NCT05776459|Hormones|hormones|mesh-ancestor
65259750|NCT05776459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65259751|NCT05776459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259752|NCT05776459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65259753|NCT05776459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259754|NCT05770297|Propolis|propolis|mesh-list
65259763|NCT05764044|Gemcitabine|gemcitabine|mesh-list
65259764|NCT05764044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259765|NCT05764044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65259766|NCT05764044|Antimetabolites|antimetabolites|mesh-ancestor
65259767|NCT05764044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259768|NCT05764044|Antiviral Agents|antiviral agents|mesh-ancestor
65259769|NCT05764044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65259770|NCT05764044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259771|NCT05764044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65259772|NCT05764044|Immunologic Factors|immunologic factors|mesh-ancestor
65259773|NCT05764044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259774|NCT05763121|Pramipexole|pramipexole|mesh-list
65259775|NCT05763121|Antioxidants|antioxidants|mesh-ancestor
65259776|NCT05763121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259777|NCT05763121|Protective Agents|protective agents|mesh-ancestor
65259778|NCT05763121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259779|NCT05763121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65259780|NCT05763121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65259781|NCT05763121|Dopamine Agonists|dopamine agonists|mesh-ancestor
65259782|NCT05763121|Dopamine Agents|dopamine agents|mesh-ancestor
65259784|NCT05760378|Carboplatin|carboplatin|mesh-list
65259819|NCT05739123|Hormone Antagonists|hormone antagonists|mesh-ancestor
65259820|NCT05739123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65259821|NCT05739123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259822|NCT05737030|N-Methylaspartate|n-methylaspartate|mesh-list
65259823|NCT05737030|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
65259824|NCT05737030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65259825|NCT05737030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65259826|NCT05737030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259827|NCT05737030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259828|NCT05723601|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65259829|NCT05723601|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65259830|NCT05723601|Estradiol|estradiol|mesh-list
65259831|NCT05723601|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65259832|NCT05723601|Estrogens|estrogens|mesh-ancestor
65259833|NCT05723601|Hormones|hormones|mesh-ancestor
65259834|NCT05723601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65259835|NCT05723601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259836|NCT05723601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65259837|NCT05723601|Contraceptive Agents|contraceptive agents|mesh-ancestor
65259838|NCT05723601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65259839|NCT05723601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65259840|NCT05716295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65259842|NCT05716295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259865|NCT05708625|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65259866|NCT05708625|Schistosomicides|schistosomicides|mesh-ancestor
65259867|NCT05708625|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65259868|NCT05708625|Anthelmintics|anthelmintics|mesh-ancestor
65259869|NCT05706844|Anesthetics|anesthetics|mesh-list
65259870|NCT05706844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65259871|NCT05706844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259872|NCT05702827|Meloxicam|meloxicam|mesh-list
65259873|NCT05702827|Bupivacaine|bupivacaine|mesh-list
65259874|NCT05702827|Anesthetics, Local|anesthetics, local|mesh-ancestor
65259875|NCT05702827|Anesthetics|anesthetics|mesh-ancestor
65259876|NCT05702827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65259877|NCT05702827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259878|NCT05702827|Sensory System Agents|sensory system agents|mesh-ancestor
65259879|NCT05702827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65259880|NCT05702827|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65259881|NCT05702827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65259882|NCT05702827|Analgesics|analgesics|mesh-ancestor
65259883|NCT05702827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65259884|NCT05702827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65259885|NCT05702827|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65259886|NCT05702827|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65259916|NCT05654298|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65259917|NCT05654298|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65259918|NCT05654298|Serotonin Agents|serotonin agents|mesh-ancestor
65259919|NCT05654298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65259920|NCT05654298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259921|NCT05654298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259922|NCT05649293|Vitamin B 6|vitamin b 6|mesh-list
65259923|NCT05649293|Pyridoxal|pyridoxal|mesh-list
65259924|NCT05649293|Pyridoxine|pyridoxine|mesh-list
65259925|NCT05649293|Vitamins|vitamins|mesh-ancestor
65259926|NCT05649293|Micronutrients|micronutrients|mesh-ancestor
65259927|NCT05649293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259928|NCT05649293|Vitamin B Complex|vitamin b complex|mesh-ancestor
65259929|NCT05647564|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65259930|NCT05647564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65259931|NCT05647564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259932|NCT05639972|Aldesleukin|aldesleukin|mesh-list
65259933|NCT05639972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259934|NCT05639972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65010172|NCT00141960|Histamine Antagonists|histamine antagonists|mesh-ancestor
65259935|NCT05639972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65259946|NCT05622318|Alkylating Agents|alkylating agents|mesh-ancestor
65259947|NCT05622318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259948|NCT05622318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259949|NCT05622318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65259950|NCT05622318|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65259951|NCT05622318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65259952|NCT05622318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65259953|NCT05622318|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65259954|NCT05622318|Antitubercular Agents|antitubercular agents|mesh-ancestor
65259955|NCT05622318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65259956|NCT05622318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65259967|NCT05617963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259977|NCT05587036|Rifaximin|rifaximin|mesh-list
65259978|NCT05587036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65259979|NCT05587036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65259980|NCT05587036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65259981|NCT05570305|Dapagliflozin|dapagliflozin|mesh-list
65259982|NCT05570305|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65259983|NCT05570305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65259984|NCT05570305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65259985|NCT05570305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259986|NCT05567731|Hormones|hormones|mesh-list
65259987|NCT05567731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65259988|NCT05567731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259989|NCT05566756|Ofatumumab|ofatumumab|mesh-list
65259990|NCT05566756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65259991|NCT05561543|Peppermint oil|peppermint oil|mesh-list
65259992|NCT05561543|Antiemetics|antiemetics|mesh-ancestor
65259993|NCT05561543|Autonomic Agents|autonomic agents|mesh-ancestor
65259994|NCT05561543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65259995|NCT05561543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65259996|NCT05561543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65259997|NCT05561543|Parasympatholytics|parasympatholytics|mesh-ancestor
65259998|NCT05550532|Aticaprant|aticaprant|mesh-list
65259999|NCT05550532|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65260000|NCT05550532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260001|NCT05550532|Sensory System Agents|sensory system agents|mesh-ancestor
65260002|NCT05550532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65260023|NCT05503875|Adalimumab|adalimumab|mesh-list
65260024|NCT05503875|Methotrexate|methotrexate|mesh-list
65260025|NCT05503875|Ixekizumab|ixekizumab|mesh-list
65260026|NCT05503875|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
65260027|NCT05503875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65260028|NCT05503875|Abortifacient Agents|abortifacient agents|mesh-ancestor
65260029|NCT05503875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65260030|NCT05503875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260031|NCT05503875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65260032|NCT05503875|Antimetabolites|antimetabolites|mesh-ancestor
65260033|NCT05503875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260034|NCT05503875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260035|NCT05503875|Dermatologic Agents|dermatologic agents|mesh-ancestor
65260036|NCT05503875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260037|NCT05503875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65260038|NCT05503875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65260039|NCT05503875|Immunologic Factors|immunologic factors|mesh-ancestor
65260040|NCT05503875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65260041|NCT05503875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65260080|NCT05455320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65260081|NCT05455320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260082|NCT05455320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65260083|NCT05455320|Glucocorticoids|glucocorticoids|mesh-ancestor
65260084|NCT05455320|Hormones|hormones|mesh-ancestor
65066800|NCT00272597|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65260085|NCT05455320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65260086|NCT05455320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65260087|NCT05455320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260088|NCT05455320|Immunologic Factors|immunologic factors|mesh-ancestor
65260089|NCT05455320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65260090|NCT05455320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65260091|NCT05455320|Growth Substances|growth substances|mesh-ancestor
65260092|NCT05455320|Growth Inhibitors|growth inhibitors|mesh-ancestor
65260093|NCT05452512|Vitamin D|vitamin d|mesh-list
65260094|NCT05452512|Vitamins|vitamins|mesh-list
65260095|NCT05452512|Micronutrients|micronutrients|mesh-ancestor
65260096|NCT05452512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260097|NCT05452512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65260098|NCT05432089|Oxytocin|oxytocin|mesh-list
65260099|NCT05432089|Oxytocics|oxytocics|mesh-ancestor
65260100|NCT05432089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65260101|NCT05432089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260102|NCT05430399|Docetaxel|docetaxel|mesh-list
65260103|NCT05430399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260104|NCT05430399|Tubulin Modulators|tubulin modulators|mesh-ancestor
65260105|NCT05430399|Antimitotic Agents|antimitotic agents|mesh-ancestor
65260106|NCT05430399|Mitosis Modulators|mitosis modulators|mesh-ancestor
65260107|NCT05430399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260108|NCT05428826|Prednisone|prednisone|mesh-list
65260109|NCT05428826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65260110|NCT05428826|Glucocorticoids|glucocorticoids|mesh-ancestor
65260111|NCT05428826|Hormones|hormones|mesh-ancestor
65260112|NCT05428826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65260119|NCT05427513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260120|NCT05427513|Hemostatics|hemostatics|mesh-ancestor
65260121|NCT05427513|Coagulants|coagulants|mesh-ancestor
65260122|NCT05411718|Aspirin|aspirin|mesh-list
65260123|NCT05411718|Naproxen|naproxen|mesh-list
65260124|NCT05411718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65260125|NCT05411718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65260126|NCT05411718|Analgesics|analgesics|mesh-ancestor
65260127|NCT05411718|Sensory System Agents|sensory system agents|mesh-ancestor
65260128|NCT05411718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65260129|NCT05411718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260130|NCT05411718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65260131|NCT05411718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65260132|NCT05411718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65260133|NCT05411718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65260134|NCT05411718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260135|NCT05411718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65260136|NCT05411718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65260137|NCT05411718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260138|NCT05411718|Antipyretics|antipyretics|mesh-ancestor
65260139|NCT05411718|Gout Suppressants|gout suppressants|mesh-ancestor
65260140|NCT05408845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65260141|NCT05408845|Trastuzumab|trastuzumab|mesh-list
65260142|NCT05408845|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65260143|NCT05408845|Docetaxel|docetaxel|mesh-list
65260144|NCT05408845|Maytansine|maytansine|mesh-list
65260145|NCT05408845|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
65260146|NCT05408845|Antibodies|antibodies|mesh-list
65260147|NCT05408845|Immunoglobulins|immunoglobulins|mesh-list
65260148|NCT05408845|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65260149|NCT05408845|Immunoconjugates|immunoconjugates|mesh-list
65260150|NCT05408845|Immunologic Factors|immunologic factors|mesh-ancestor
65260151|NCT05408845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260152|NCT05408845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260153|NCT05408845|Tubulin Modulators|tubulin modulators|mesh-ancestor
65260154|NCT05408845|Antimitotic Agents|antimitotic agents|mesh-ancestor
65260155|NCT05408845|Mitosis Modulators|mitosis modulators|mesh-ancestor
65260158|NCT05403723|Carboplatin|carboplatin|mesh-list
65010398|NCT00152724|Antipyretics|antipyretics|mesh-ancestor
65260159|NCT05403723|Etoposide|etoposide|mesh-list
65260160|NCT05403723|Durvalumab|durvalumab|mesh-list
65260161|NCT05403723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260162|NCT05403723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65260163|NCT05403723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65260164|NCT05403723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65260165|NCT05403723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260166|NCT05403723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260167|NCT05403723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65260168|NCT05388474|Ibalizumab|ibalizumab|mesh-list
65260169|NCT05388474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65260170|NCT05388474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65260171|NCT05388474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65260172|NCT05388474|Antiviral Agents|antiviral agents|mesh-ancestor
65260173|NCT05388474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65260174|NCT05388474|Immunologic Factors|immunologic factors|mesh-ancestor
65260175|NCT05388474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260176|NCT05386095|Bupivacaine|bupivacaine|mesh-list
65260177|NCT05386095|Anesthetics, Local|anesthetics, local|mesh-ancestor
65260178|NCT05386095|Anesthetics|anesthetics|mesh-ancestor
65260213|NCT05327686|Lenvatinib|lenvatinib|mesh-list
65260214|NCT05327686|Axitinib|axitinib|mesh-list
65260215|NCT05327686|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65260216|NCT05327686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65260217|NCT05327686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260218|NCT05327686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65260219|NCT05327686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260220|NCT05327686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65260221|NCT05327686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260222|NCT05327686|Immunologic Factors|immunologic factors|mesh-ancestor
65260223|NCT05327686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260224|NCT05323812|Edaravone|edaravone|mesh-list
65260225|NCT05323812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65260226|NCT05323812|Antioxidants|antioxidants|mesh-ancestor
65260227|NCT05323812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260228|NCT05323812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65260232|NCT05321524|Cathartics|cathartics|mesh-ancestor
65260271|NCT05279937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65260272|NCT05279937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65260273|NCT05279937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65260274|NCT05279937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260275|NCT05275010|Trastuzumab|trastuzumab|mesh-list
65260276|NCT05275010|Pertuzumab|pertuzumab|mesh-list
65260277|NCT05275010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65260278|NCT05275010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260279|NCT05267600|Prednisone|prednisone|mesh-list
65260280|NCT05267600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65260281|NCT05267600|Glucocorticoids|glucocorticoids|mesh-ancestor
65260282|NCT05267600|Hormones|hormones|mesh-ancestor
65260283|NCT05267600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65260284|NCT05267600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260285|NCT05267600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65260286|NCT05267600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260287|NCT05247268|Letrozole|letrozole|mesh-list
65260288|NCT05247268|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65260289|NCT05247268|Megestrol|megestrol|mesh-list
65260290|NCT05247268|Megestrol Acetate|megestrol acetate|mesh-list
65260291|NCT05247268|Medroxyprogesterone|medroxyprogesterone|mesh-list
65260292|NCT05247268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260293|NCT05247268|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65260294|NCT05247268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65260295|NCT05247268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260296|NCT05247268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260297|NCT05247268|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65260298|NCT05247268|Hormone Antagonists|hormone antagonists|mesh-ancestor
65260299|NCT05247268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65260300|NCT05247268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260302|NCT05247268|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65260320|NCT05136560|Dexamethasone|dexamethasone|mesh-list
65260321|NCT05136560|Dexamethasone acetate|dexamethasone acetate|mesh-list
65260322|NCT05136560|BB 1101|bb 1101|mesh-list
65260323|NCT05136560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65260324|NCT05136560|Antiemetics|antiemetics|mesh-ancestor
65260325|NCT05136560|Autonomic Agents|autonomic agents|mesh-ancestor
65260326|NCT05136560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65260327|NCT05136560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260328|NCT05136560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65260329|NCT05136560|Glucocorticoids|glucocorticoids|mesh-ancestor
65260330|NCT05136560|Hormones|hormones|mesh-ancestor
65260331|NCT05136560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65260332|NCT05136560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65260333|NCT05136560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260334|NCT05136560|Protease Inhibitors|protease inhibitors|mesh-ancestor
65260335|NCT05136560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260336|NCT05136560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260337|NCT05125016|Cemiplimab|cemiplimab|mesh-list
65260338|NCT05125016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65260339|NCT05125016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260340|NCT05095376|Temozolomide|temozolomide|mesh-list
65260341|NCT05095376|Lomustine|lomustine|mesh-list
65260343|NCT05095376|Alkylating Agents|alkylating agents|mesh-ancestor
65260380|NCT05059626|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65260381|NCT05059626|Hormone Antagonists|hormone antagonists|mesh-ancestor
65260382|NCT05059626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65260383|NCT05053152|Relugolix|relugolix|mesh-list
65260384|NCT05053152|Androgen Antagonists|androgen antagonists|mesh-ancestor
65260385|NCT05053152|Hormone Antagonists|hormone antagonists|mesh-ancestor
65260386|NCT05053152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65260387|NCT05053152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260388|NCT05050162|Cisplatin|cisplatin|mesh-list
65260389|NCT05050162|1,2-diaminocyclohexaneplatinum II citrate|1,2-diaminocyclohexaneplatinum ii citrate|mesh-list
65260390|NCT05050162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260391|NCT05050084|Leuprolide|leuprolide|mesh-list
65260392|NCT05050084|Goserelin|goserelin|mesh-list
65260393|NCT05050084|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65260394|NCT05050084|Flutamide|flutamide|mesh-list
65260395|NCT05050084|Bicalutamide|bicalutamide|mesh-list
65260396|NCT05050084|Tryptophan|tryptophan|mesh-list
65260397|NCT05050084|Buserelin|buserelin|mesh-list
65260398|NCT05050084|Hormones|hormones|mesh-list
65260399|NCT05050084|Relugolix|relugolix|mesh-list
65260400|NCT05050084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65260401|NCT05050084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260436|NCT05009992|Sympathomimetics|sympathomimetics|mesh-ancestor
65260437|NCT05009992|Autonomic Agents|autonomic agents|mesh-ancestor
65260438|NCT05009992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65260439|NCT05009992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260440|NCT05009992|Dopamine Agents|dopamine agents|mesh-ancestor
65260441|NCT05009992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65260442|NCT05009992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260443|NCT05009992|Protective Agents|protective agents|mesh-ancestor
65260444|NCT05009992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260445|NCT05009992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260446|NCT04975958|Atezolizumab|atezolizumab|mesh-list
65260447|NCT04975958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260448|NCT04973930|Citalopram|citalopram|mesh-list
65260449|NCT04973930|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65260450|NCT04973930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65260451|NCT04973930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65260452|NCT04973930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65260453|NCT04973930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260454|NCT04973930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65260455|NCT04973930|Serotonin Agents|serotonin agents|mesh-ancestor
65260456|NCT04973930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260458|NCT04973930|Antidepressive Agents|antidepressive agents|mesh-ancestor
65260486|NCT04930744|Antimetabolites|antimetabolites|mesh-ancestor
65260487|NCT04930744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65260488|NCT04884763|Erenumab|erenumab|mesh-list
65260489|NCT04884763|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65260490|NCT04884763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260491|NCT04884763|Analgesics|analgesics|mesh-ancestor
65260492|NCT04884763|Sensory System Agents|sensory system agents|mesh-ancestor
65260493|NCT04884763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65260494|NCT04884763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260495|NCT04877093|Clonidine|clonidine|mesh-list
65260496|NCT04877093|Analgesics|analgesics|mesh-ancestor
65260497|NCT04877093|Sensory System Agents|sensory system agents|mesh-ancestor
65260498|NCT04877093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65260499|NCT04877093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260500|NCT04877093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65260501|NCT04877093|Sympatholytics|sympatholytics|mesh-ancestor
65260502|NCT04877093|Autonomic Agents|autonomic agents|mesh-ancestor
65260503|NCT04877093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65260504|NCT04877093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65260505|NCT04877093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65260506|NCT04877093|Adrenergic Agents|adrenergic agents|mesh-ancestor
65260507|NCT04877093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65260509|NCT04866017|Durvalumab|durvalumab|mesh-list
65260543|NCT04827056|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65260544|NCT04827056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65260545|NCT04827056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65260546|NCT04827056|Adrenergic Agents|adrenergic agents|mesh-ancestor
65260547|NCT04827056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65260548|NCT04827056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260549|NCT04827056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65260550|NCT04827056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65260551|NCT04807127|Pembrolizumab|pembrolizumab|mesh-list
65260552|NCT04807127|Durvalumab|durvalumab|mesh-list
65260553|NCT04807127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65260554|NCT04807127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65260555|NCT04807127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260556|NCT04807127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260557|NCT04807114|Pembrolizumab|pembrolizumab|mesh-list
65260558|NCT04807114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65260559|NCT04807114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65260560|NCT04807114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260561|NCT04807114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260562|NCT04804644|Memantine|memantine|mesh-list
65260563|NCT04804644|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65260564|NCT04804644|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65260565|NCT04804644|Dopamine Agents|dopamine agents|mesh-ancestor
65260566|NCT04804644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65260567|NCT04804644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260568|NCT04804644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260569|NCT04804644|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65260578|NCT04746924|Pembrolizumab|pembrolizumab|mesh-list
65260593|NCT04642404|Cannabidiol|cannabidiol|mesh-list
65260594|NCT04642404|Anticonvulsants|anticonvulsants|mesh-ancestor
65260595|NCT04642352|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65260596|NCT04642352|Bupivacaine|bupivacaine|mesh-list
65260597|NCT04642352|Anesthetics, Local|anesthetics, local|mesh-ancestor
65260598|NCT04642352|Anesthetics|anesthetics|mesh-ancestor
65260599|NCT04642352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65260600|NCT04642352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260601|NCT04642352|Sensory System Agents|sensory system agents|mesh-ancestor
65260602|NCT04642352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65260603|NCT04642352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65260604|NCT04642352|Glucocorticoids|glucocorticoids|mesh-ancestor
65260605|NCT04642352|Hormones|hormones|mesh-ancestor
65260606|NCT04642352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65260607|NCT04642352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65260608|NCT04642352|Immunologic Factors|immunologic factors|mesh-ancestor
65010848|NCT00137462|Atorvastatin|atorvastatin|mesh-list
65260610|NCT04637282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65260611|NCT04637282|Antimetabolites|antimetabolites|mesh-ancestor
65260612|NCT04637282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260613|NCT04637282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65260614|NCT04637282|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65260615|NCT04637282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65260616|NCT04637282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260617|NCT04598477|Prednisone|prednisone|mesh-list
65260618|NCT04598477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65260619|NCT04598477|Glucocorticoids|glucocorticoids|mesh-ancestor
65260620|NCT04598477|Hormones|hormones|mesh-ancestor
65260640|NCT04594408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65260641|NCT04594408|Autonomic Agents|autonomic agents|mesh-ancestor
65260642|NCT04594408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65260643|NCT04594408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65260644|NCT04594408|Respiratory System Agents|respiratory system agents|mesh-ancestor
65260645|NCT04594408|Mydriatics|mydriatics|mesh-ancestor
65260646|NCT04594408|Sympathomimetics|sympathomimetics|mesh-ancestor
65260647|NCT04594408|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65260648|NCT04588246|Memantine|memantine|mesh-list
65260649|NCT04588246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65260650|NCT04588246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65260651|NCT04588246|Dopamine Agents|dopamine agents|mesh-ancestor
65260652|NCT04588246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65260653|NCT04588246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260654|NCT04588246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260657|NCT04557215|Acetylcysteine|acetylcysteine|mesh-list
65260702|NCT04498117|Antimitotic Agents|antimitotic agents|mesh-ancestor
65260703|NCT04498117|Mitosis Modulators|mitosis modulators|mesh-ancestor
65260704|NCT04498117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260705|NCT04498117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65260706|NCT04468230|Nicotine|nicotine|mesh-list
65260707|NCT04468230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65260708|NCT04468230|Autonomic Agents|autonomic agents|mesh-ancestor
65260709|NCT04468230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65260710|NCT04468230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260711|NCT04468230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65260712|NCT04468230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65260713|NCT04468230|Cholinergic Agents|cholinergic agents|mesh-ancestor
65260714|NCT04468230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65260715|NCT04468230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260716|NCT04432857|Pembrolizumab|pembrolizumab|mesh-list
65260717|NCT04432857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65260718|NCT04432857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260719|NCT04423627|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65260720|NCT04423627|Clonidine|clonidine|mesh-list
65260721|NCT04423627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65260722|NCT04423627|Diuretics|diuretics|mesh-ancestor
65260723|NCT04423627|Natriuretic Agents|natriuretic agents|mesh-ancestor
65260724|NCT04423627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260725|NCT04423627|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65260726|NCT04423627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65260727|NCT04423627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260728|NCT04423627|Analgesics|analgesics|mesh-ancestor
65260729|NCT04423627|Sensory System Agents|sensory system agents|mesh-ancestor
65260730|NCT04423627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65260731|NCT04423627|Sympatholytics|sympatholytics|mesh-ancestor
65260732|NCT04423627|Autonomic Agents|autonomic agents|mesh-ancestor
65260733|NCT04423627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65260734|NCT04423627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65260735|NCT04423627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65260741|NCT04410653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260742|NCT04410653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260743|NCT04395001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65260744|NCT04395001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65260745|NCT04395001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65260746|NCT04395001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65260747|NCT04395001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260748|NCT04395001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65260749|NCT04395001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260750|NCT04395001|Analgesics|analgesics|mesh-ancestor
65260751|NCT04395001|Sensory System Agents|sensory system agents|mesh-ancestor
65260752|NCT04395001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65260753|NCT04395001|Antidepressive Agents|antidepressive agents|mesh-ancestor
65260754|NCT04395001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65260755|NCT04395001|Dopamine Agents|dopamine agents|mesh-ancestor
65260756|NCT04391764|Naltrexone|naltrexone|mesh-list
65260757|NCT04391764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65260758|NCT04391764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65260759|NCT04391764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260778|NCT04339062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65260780|NCT04339062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65260781|NCT04339062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260782|NCT04339062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65260783|NCT04339062|Immunologic Factors|immunologic factors|mesh-ancestor
65260784|NCT04339062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65260785|NCT04339062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65260786|NCT04339062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65260787|NCT04339062|Antifungal Agents|antifungal agents|mesh-ancestor
65260788|NCT04339062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65260789|NCT04305158|Nitrous Oxide|nitrous oxide|mesh-list
65260790|NCT04305158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65260791|NCT04305158|Anesthetics, General|anesthetics, general|mesh-ancestor
65260792|NCT04305158|Anesthetics|anesthetics|mesh-ancestor
65260793|NCT04305158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65260794|NCT04305158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260796|NCT04305158|Analgesics|analgesics|mesh-ancestor
65260797|NCT04305158|Sensory System Agents|sensory system agents|mesh-ancestor
65260798|NCT04305158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65260799|NCT04303195|Metopimazine|metopimazine|mesh-list
65260800|NCT04303195|Antiemetics|antiemetics|mesh-ancestor
65260801|NCT04303195|Autonomic Agents|autonomic agents|mesh-ancestor
65260802|NCT04303195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65260803|NCT04303195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260804|NCT04303195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65260805|NCT04300192|Vaccines|vaccines|mesh-list
65260806|NCT04300192|Immunologic Factors|immunologic factors|mesh-ancestor
65260807|NCT04300192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260808|NCT04292470|Amitriptyline|amitriptyline|mesh-list
65260809|NCT04292470|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65260810|NCT04292470|Antidepressive Agents|antidepressive agents|mesh-ancestor
65260811|NCT04292470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65260812|NCT04292470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65260813|NCT04292470|Analgesics|analgesics|mesh-ancestor
65260814|NCT04292470|Sensory System Agents|sensory system agents|mesh-ancestor
65260815|NCT04292470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65260816|NCT04292470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260817|NCT04292470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65260818|NCT04292470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65260819|NCT04292470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65260847|NCT04080284|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65260848|NCT04080284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260849|NCT04080284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260850|NCT04080284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260851|NCT04074967|Nivolumab|nivolumab|mesh-list
65260852|NCT04074967|Ipilimumab|ipilimumab|mesh-list
65260853|NCT04074967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65260854|NCT04074967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260855|NCT04074967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65260856|NCT04074967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260857|NCT04073797|Colchicine|colchicine|mesh-list
65260858|NCT04073797|Gout Suppressants|gout suppressants|mesh-ancestor
65260859|NCT04073797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65260860|NCT04073797|Tubulin Modulators|tubulin modulators|mesh-ancestor
65260861|NCT04073797|Antimitotic Agents|antimitotic agents|mesh-ancestor
65260862|NCT04073797|Mitosis Modulators|mitosis modulators|mesh-ancestor
65260863|NCT04073797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260864|NCT04073797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260865|NCT04060017|Calcium, Dietary|calcium, dietary|mesh-list
65260866|NCT04060017|Leucovorin|leucovorin|mesh-list
65260902|NCT04042935|Antioxidants|antioxidants|mesh-ancestor
65260903|NCT04042935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260904|NCT04042935|Protective Agents|protective agents|mesh-ancestor
65260905|NCT04042935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011148|NCT00138710|Letrozole|letrozole|mesh-list
65260906|NCT04042935|Vitamin B Complex|vitamin b complex|mesh-ancestor
65260907|NCT04042935|Vitamins|vitamins|mesh-ancestor
65260908|NCT04042935|Micronutrients|micronutrients|mesh-ancestor
65260909|NCT04027309|Midostaurin|midostaurin|mesh-list
65260910|NCT04027309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260911|NCT04027309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65260912|NCT04027309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260913|NCT04027309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260914|NCT04026412|Nivolumab|nivolumab|mesh-list
65260915|NCT04026412|Ipilimumab|ipilimumab|mesh-list
65260916|NCT04026412|Durvalumab|durvalumab|mesh-list
65260917|NCT04026412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65260918|NCT04026412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260919|NCT04026412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65260920|NCT04026412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260921|NCT03988933|Rifampin|rifampin|mesh-list
65260922|NCT03988933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65260923|NCT03988933|Antitubercular Agents|antitubercular agents|mesh-ancestor
65260924|NCT03988933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65260925|NCT03988933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65260926|NCT03988933|Leprostatic Agents|leprostatic agents|mesh-ancestor
65260950|NCT03910452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65260951|NCT03910452|Immunologic Factors|immunologic factors|mesh-ancestor
65260952|NCT03910452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65260953|NCT03910452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65260954|NCT03910452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65260955|NCT03910452|Alkylating Agents|alkylating agents|mesh-ancestor
65260956|NCT03910452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260957|NCT03910452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260958|NCT03910452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65260959|NCT03910452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65260960|NCT03910452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65260961|NCT03910452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65260962|NCT03910452|Antifungal Agents|antifungal agents|mesh-ancestor
65260963|NCT03910452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65260964|NCT03845296|Rucaparib|rucaparib|mesh-list
65260965|NCT03845296|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65260966|NCT03845296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65260967|NCT03845296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65260968|NCT03845296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65260969|NCT03801876|Paclitaxel|paclitaxel|mesh-list
65261016|NCT03700476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65261017|NCT03700476|Immunologic Factors|immunologic factors|mesh-ancestor
65261018|NCT03700476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261019|NCT03678883|Gemcitabine|gemcitabine|mesh-list
65261020|NCT03678883|Paclitaxel|paclitaxel|mesh-list
65261021|NCT03678883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65261022|NCT03678883|Carboplatin|carboplatin|mesh-list
65261023|NCT03678883|Doxorubicin|doxorubicin|mesh-list
65261024|NCT03678883|Irinotecan|irinotecan|mesh-list
65261025|NCT03678883|Lomustine|lomustine|mesh-list
65261026|NCT03678883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65261027|NCT03678883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261028|NCT03678883|Tubulin Modulators|tubulin modulators|mesh-ancestor
65261029|NCT03678883|Antimitotic Agents|antimitotic agents|mesh-ancestor
65261030|NCT03678883|Mitosis Modulators|mitosis modulators|mesh-ancestor
65261047|NCT03644667|Prednisone|prednisone|mesh-list
65261078|NCT03638141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261079|NCT03638141|Immunologic Factors|immunologic factors|mesh-ancestor
65261080|NCT03638141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261081|NCT03638141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65261082|NCT03638141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261083|NCT03586453|Osimertinib|osimertinib|mesh-list
65261084|NCT03586453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261085|NCT03586453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65261086|NCT03586453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261087|NCT03586453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261088|NCT03330106|Paclitaxel|paclitaxel|mesh-list
65261089|NCT03330106|Docetaxel|docetaxel|mesh-list
65261090|NCT03330106|Carboplatin|carboplatin|mesh-list
65261091|NCT03330106|Pevonedistat|pevonedistat|mesh-list
65261092|NCT03330106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65261093|NCT03330106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261099|NCT03239145|Pembrolizumab|pembrolizumab|mesh-list
65261137|NCT03070886|Goserelin|goserelin|mesh-list
65261145|NCT03070886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261147|NCT03070886|Fertility Agents|fertility agents|mesh-ancestor
65261148|NCT03070886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65261149|NCT03070886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261150|NCT03070886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65261151|NCT03070886|Androgen Antagonists|androgen antagonists|mesh-ancestor
65261152|NCT03070886|Hormone Antagonists|hormone antagonists|mesh-ancestor
65261153|NCT03070886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65261154|NCT03066648|Azacitidine|azacitidine|mesh-list
65261155|NCT03066648|Decitabine|decitabine|mesh-list
65261156|NCT03066648|Spartalizumab|spartalizumab|mesh-list
65261157|NCT03066648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65261158|NCT03066648|Antimetabolites|antimetabolites|mesh-ancestor
65261159|NCT03066648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261160|NCT03066648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261161|NCT03066648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261162|NCT03066648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65261163|NCT02987257|Cyclosporine|cyclosporine|mesh-list
65261164|NCT02987257|Etanercept|etanercept|mesh-list
65261165|NCT02987257|Cyclosporins|cyclosporins|mesh-list
65261166|NCT02987257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261167|NCT02987257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261168|NCT02987257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65261169|NCT02987257|Immunologic Factors|immunologic factors|mesh-ancestor
65261170|NCT02987257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261171|NCT02987257|Antifungal Agents|antifungal agents|mesh-ancestor
65261172|NCT02987257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65261173|NCT02987257|Dermatologic Agents|dermatologic agents|mesh-ancestor
65261174|NCT02987257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65261175|NCT02987257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65261177|NCT02987257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64936447|NCT00390728|Insulin Glargine|insulin glargine|mesh-list
65261194|NCT02913274|Antimitotic Agents|antimitotic agents|mesh-ancestor
65261195|NCT02913274|Mitosis Modulators|mitosis modulators|mesh-ancestor
65261196|NCT02913274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261197|NCT02896335|Palbociclib|palbociclib|mesh-list
65261198|NCT02896335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261199|NCT02896335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65261200|NCT02896335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261201|NCT02896335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261202|NCT02821754|Durvalumab|durvalumab|mesh-list
65261203|NCT02821754|Tremelimumab|tremelimumab|mesh-list
65261204|NCT02821754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65261205|NCT02821754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261206|NCT02781883|Decitabine|decitabine|mesh-list
65261207|NCT02781883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65261208|NCT02781883|Antimetabolites|antimetabolites|mesh-ancestor
65261209|NCT02781883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261210|NCT02781883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011449|NCT00404261|Glucocorticoids|glucocorticoids|mesh-ancestor
65261211|NCT02781883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261247|NCT02617589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261248|NCT02617589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65261249|NCT02617589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261250|NCT02617589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65261251|NCT02617589|Alkylating Agents|alkylating agents|mesh-ancestor
65261252|NCT02540707|Solifenacin Succinate|solifenacin succinate|mesh-list
65261253|NCT02540707|Mirabegron|mirabegron|mesh-list
65261254|NCT02540707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65261255|NCT02540707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65261256|NCT02540707|Cholinergic Agents|cholinergic agents|mesh-ancestor
65261257|NCT02540707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65261258|NCT02540707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261259|NCT02540707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261260|NCT02540707|Urological Agents|urological agents|mesh-ancestor
65261261|NCT02540707|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65261262|NCT02540707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65261263|NCT02540707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65261264|NCT02540707|Adrenergic Agents|adrenergic agents|mesh-ancestor
65261265|NCT02531932|Carboplatin|carboplatin|mesh-list
65261266|NCT02531932|Everolimus|everolimus|mesh-list
65261267|NCT02531932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261268|NCT02531932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65261269|NCT02531932|Immunologic Factors|immunologic factors|mesh-ancestor
65261270|NCT02531932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261271|NCT02506959|Gemcitabine|gemcitabine|mesh-list
65261272|NCT02506959|Melphalan|melphalan|mesh-list
65261273|NCT02506959|Busulfan|busulfan|mesh-list
65261274|NCT02506959|Mechlorethamine|mechlorethamine|mesh-list
65261275|NCT02506959|Panobinostat|panobinostat|mesh-list
65261276|NCT02506959|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65261277|NCT02506959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65261278|NCT02506959|Antimetabolites|antimetabolites|mesh-ancestor
65261279|NCT02506959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261289|NCT02506959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65261290|NCT02506959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65261292|NCT02506153|Interferon-alpha|interferon-alpha|mesh-list
65261293|NCT02506153|Interferon alpha-2|interferon alpha-2|mesh-list
65261294|NCT02506153|Pembrolizumab|pembrolizumab|mesh-list
65261295|NCT02506153|Ipilimumab|ipilimumab|mesh-list
65261296|NCT02506153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65261297|NCT02506153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261298|NCT02506153|Antiviral Agents|antiviral agents|mesh-ancestor
65261299|NCT02506153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65261300|NCT02506153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65261301|NCT02506153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261302|NCT02506153|Immunologic Factors|immunologic factors|mesh-ancestor
65261303|NCT02506153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261304|NCT02504346|Osimertinib|osimertinib|mesh-list
65261305|NCT02504346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261306|NCT02504346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65261307|NCT02504346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261308|NCT02504346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261309|NCT02500797|Nivolumab|nivolumab|mesh-list
65261310|NCT02500797|Ipilimumab|ipilimumab|mesh-list
65261311|NCT02500797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65261312|NCT02500797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261313|NCT02500797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65261314|NCT02500797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261315|NCT02345265|Olaparib|olaparib|mesh-list
65261316|NCT02345265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65261317|NCT02345265|Cediranib|cediranib|mesh-list
65261337|NCT02317874|Tubulin Modulators|tubulin modulators|mesh-ancestor
65261338|NCT02317874|Antimitotic Agents|antimitotic agents|mesh-ancestor
65261339|NCT02317874|Mitosis Modulators|mitosis modulators|mesh-ancestor
65261340|NCT02317874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261341|NCT02317874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65261342|NCT02317874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261343|NCT02257528|Nivolumab|nivolumab|mesh-list
65261344|NCT02257528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65261345|NCT02257528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261346|NCT02257528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65261347|NCT02257528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261348|NCT02179086|Temozolomide|temozolomide|mesh-list
65261349|NCT02179086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65261350|NCT02179086|Alkylating Agents|alkylating agents|mesh-ancestor
65261351|NCT02179086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261352|NCT02179086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261353|NCT02160015|Rituximab|rituximab|mesh-list
65261354|NCT02160015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65261355|NCT02160015|Lenalidomide|lenalidomide|mesh-list
65261356|NCT02160015|Antibodies|antibodies|mesh-list
65261391|NCT01899326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261392|NCT01899326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261393|NCT01899326|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65261394|NCT01899326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65261395|NCT01899326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65261396|NCT01899326|Adrenergic Agents|adrenergic agents|mesh-ancestor
65261397|NCT01899326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65261398|NCT01856192|Prednisone|prednisone|mesh-list
65261399|NCT01856192|Cortisone|cortisone|mesh-list
65261400|NCT01856192|Cyclophosphamide|cyclophosphamide|mesh-list
65261401|NCT01856192|Rituximab|rituximab|mesh-list
65261402|NCT01856192|Doxorubicin|doxorubicin|mesh-list
65261403|NCT01856192|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65261404|NCT01856192|Vincristine|vincristine|mesh-list
65261405|NCT01856192|Lenalidomide|lenalidomide|mesh-list
65261406|NCT01856192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65261407|NCT01856192|Antibodies|antibodies|mesh-list
65261408|NCT01856192|Immunoglobulins|immunoglobulins|mesh-list
65261409|NCT01856192|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65261410|NCT01856192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65261411|NCT01856192|Immunologic Factors|immunologic factors|mesh-ancestor
65261412|NCT01856192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261413|NCT01856192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65261414|NCT01856192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65261415|NCT01856192|Alkylating Agents|alkylating agents|mesh-ancestor
65261416|NCT01856192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261417|NCT01856192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261439|NCT01849146|Alkylating Agents|alkylating agents|mesh-ancestor
65261440|NCT01849146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261441|NCT01849146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261442|NCT01849146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261443|NCT01572480|Dexamethasone|dexamethasone|mesh-list
65261444|NCT01572480|Lenalidomide|lenalidomide|mesh-list
65261445|NCT01572480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65261446|NCT01572480|Antiemetics|antiemetics|mesh-ancestor
65261447|NCT01572480|Autonomic Agents|autonomic agents|mesh-ancestor
65261448|NCT01572480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65261449|NCT01572480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261450|NCT01572480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65261451|NCT01572480|Glucocorticoids|glucocorticoids|mesh-ancestor
65261452|NCT01572480|Hormones|hormones|mesh-ancestor
65261453|NCT01572480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65261454|NCT01572480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65261455|NCT01572480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261456|NCT01572480|Immunologic Factors|immunologic factors|mesh-ancestor
65261457|NCT01572480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65261458|NCT01572480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65261459|NCT01572480|Growth Substances|growth substances|mesh-ancestor
65261460|NCT01572480|Growth Inhibitors|growth inhibitors|mesh-ancestor
65261461|NCT01515137|Sulindac|sulindac|mesh-list
65261462|NCT01515137|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65261463|NCT01515137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261464|NCT01515137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65261465|NCT01515137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261466|NCT01515137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261467|NCT01515137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65261468|NCT01515137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65261469|NCT01515137|Analgesics|analgesics|mesh-ancestor
65261470|NCT01515137|Sensory System Agents|sensory system agents|mesh-ancestor
65261471|NCT01515137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65261472|NCT01515137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261477|NCT01393509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261478|NCT01375829|Sirolimus|sirolimus|mesh-list
65261479|NCT01375829|Epothilone B|epothilone b|mesh-list
65261480|NCT01375829|Epothilones|epothilones|mesh-list
65261481|NCT01375829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65261482|NCT01375829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65261483|NCT01375829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65261484|NCT01375829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261485|NCT01375829|Antifungal Agents|antifungal agents|mesh-ancestor
65261486|NCT01375829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65261487|NCT01375829|Immunologic Factors|immunologic factors|mesh-ancestor
65261488|NCT01375829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261489|NCT01375829|Tubulin Modulators|tubulin modulators|mesh-ancestor
65261490|NCT01375829|Antimitotic Agents|antimitotic agents|mesh-ancestor
65261491|NCT01375829|Mitosis Modulators|mitosis modulators|mesh-ancestor
65261492|NCT01375829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261493|NCT01126190|Docetaxel|docetaxel|mesh-list
65261494|NCT01126190|Doxorubicin|doxorubicin|mesh-list
65261495|NCT01126190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261496|NCT01126190|Tubulin Modulators|tubulin modulators|mesh-ancestor
65261497|NCT01126190|Antimitotic Agents|antimitotic agents|mesh-ancestor
65261531|NCT00323037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261532|NCT00323037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261533|NCT00323037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65261534|NCT00323037|Antioxidants|antioxidants|mesh-ancestor
65261535|NCT00323037|Protective Agents|protective agents|mesh-ancestor
65261536|NCT00323037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65261537|NCT00323037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65261538|NCT00323037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65261539|NCT00323037|Vasodilator Agents|vasodilator agents|mesh-ancestor
65261540|NCT00323037|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65261541|NCT00323037|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65261542|NCT00128297|Pamidronate|pamidronate|mesh-list
65261543|NCT00128297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65261544|NCT00128297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261545|NCT00939185|Azithromycin|azithromycin|mesh-list
65261546|NCT00939185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65261547|NCT00939185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65261548|NCT02808104|Mazindol|mazindol|mesh-list
65261549|NCT02808104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65261550|NCT02808104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261551|NCT02808104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65261552|NCT02808104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65261553|NCT02808104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65261554|NCT02808104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261555|NCT02808104|Adrenergic Agents|adrenergic agents|mesh-ancestor
65261576|NCT02807870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65261577|NCT02807870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261578|NCT02807870|Dopamine Agents|dopamine agents|mesh-ancestor
65261579|NCT02807870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65261580|NCT00925873|Vidarabine|vidarabine|mesh-list
65261581|NCT00925873|Fludarabine|fludarabine|mesh-list
65261582|NCT00925873|Fludarabine phosphate|fludarabine phosphate|mesh-list
65261583|NCT00925873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261584|NCT00925873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65261585|NCT00925873|Antimetabolites|antimetabolites|mesh-ancestor
65011813|NCT00504946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65261586|NCT00925873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261587|NCT00925873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65261588|NCT00925873|Immunologic Factors|immunologic factors|mesh-ancestor
65261589|NCT00925873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261590|NCT00925873|Antiviral Agents|antiviral agents|mesh-ancestor
65261591|NCT00925873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65261592|NCT05590598|Azelastine|azelastine|mesh-list
65261593|NCT05590598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65261594|NCT05590598|Autonomic Agents|autonomic agents|mesh-ancestor
65261595|NCT05590598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65261596|NCT05590598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261597|NCT05590598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65261598|NCT05590598|Respiratory System Agents|respiratory system agents|mesh-ancestor
65261599|NCT05590598|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65261600|NCT05590598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261601|NCT05590598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261602|NCT05590598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65261603|NCT05590598|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65261604|NCT05590598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65261605|NCT05590598|Histamine Antagonists|histamine antagonists|mesh-ancestor
65261606|NCT05590598|Histamine Agents|histamine agents|mesh-ancestor
65261607|NCT05590598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65261614|NCT00925951|Antipyretics|antipyretics|mesh-ancestor
65261615|NCT00933205|Tipranavir|tipranavir|mesh-list
65261616|NCT00933205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65261617|NCT00933205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65261618|NCT00933205|Antiviral Agents|antiviral agents|mesh-ancestor
65261619|NCT00933205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65261620|NCT02813486|Vaccines|vaccines|mesh-list
65261621|NCT02813486|Immunologic Factors|immunologic factors|mesh-ancestor
65261622|NCT02813486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261623|NCT02739516|Letrozole|letrozole|mesh-list
65261624|NCT02739516|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65261625|NCT02739516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261626|NCT02739516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65261627|NCT02739516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65261628|NCT02739516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261629|NCT02739516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261630|NCT02739516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65261631|NCT02739516|Hormone Antagonists|hormone antagonists|mesh-ancestor
65261632|NCT02739516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65261633|NCT02739516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261634|NCT02739516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65261635|NCT04260126|Pembrolizumab|pembrolizumab|mesh-list
65261636|NCT04260126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65261637|NCT04260126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261638|NCT00933283|Methadone|methadone|mesh-list
65261639|NCT00933283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65261640|NCT00933283|Narcotics|narcotics|mesh-ancestor
65261641|NCT00933283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65261642|NCT00933283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261643|NCT00933283|Analgesics|analgesics|mesh-ancestor
65261644|NCT00933283|Sensory System Agents|sensory system agents|mesh-ancestor
65261645|NCT00933283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65261646|NCT00933283|Antitussive Agents|antitussive agents|mesh-ancestor
65261647|NCT00933283|Respiratory System Agents|respiratory system agents|mesh-ancestor
65261648|NCT02813018|Ropivacaine|ropivacaine|mesh-list
65261649|NCT02813018|Anesthetics, Local|anesthetics, local|mesh-ancestor
65261654|NCT02813018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65261655|NCT04253964|Paclitaxel|paclitaxel|mesh-list
65261656|NCT04253964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65261657|NCT04253964|Carboplatin|carboplatin|mesh-list
65261658|NCT04253964|Pembrolizumab|pembrolizumab|mesh-list
65261659|NCT04253964|Pemetrexed|pemetrexed|mesh-list
65261660|NCT04253964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65261661|NCT04253964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261662|NCT04253964|Tubulin Modulators|tubulin modulators|mesh-ancestor
65261663|NCT04253964|Antimitotic Agents|antimitotic agents|mesh-ancestor
65261664|NCT04253964|Mitosis Modulators|mitosis modulators|mesh-ancestor
65261665|NCT04253964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261666|NCT04253964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65261667|NCT04253964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261668|NCT04253964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65261669|NCT04253964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65261670|NCT02810132|Metformin|metformin|mesh-list
65261671|NCT02810132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65261672|NCT02810132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261673|NCT02734524|Carboplatin|carboplatin|mesh-list
65261674|NCT02734524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261675|NCT04174196|Lenalidomide|lenalidomide|mesh-list
65261676|NCT04174196|Cc-486|cc-486|mesh-list
65261677|NCT04174196|Immunologic Factors|immunologic factors|mesh-ancestor
65261678|NCT04174196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261681|NCT04174196|Growth Substances|growth substances|mesh-ancestor
65261705|NCT04173962|GABA Agents|gaba agents|mesh-ancestor
65261706|NCT00772005|Modafinil|modafinil|mesh-list
65261707|NCT00772005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65261708|NCT00772005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261709|NCT00772005|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65261710|NCT00772005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65261711|NCT00772005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65261712|NCT00772005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261713|NCT03333408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65261714|NCT03333408|Clindamycin|clindamycin|mesh-list
65261715|NCT03333408|Clindamycin palmitate|clindamycin palmitate|mesh-list
65261716|NCT03333408|Clindamycin phosphate|clindamycin phosphate|mesh-list
65261717|NCT03333408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65261718|NCT03333408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65261719|NCT03333408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65261720|NCT03333408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261721|NCT03333408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261722|NCT03333408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65261723|NCT04262999|Levetiracetam|levetiracetam|mesh-list
65261724|NCT04262999|Valproic Acid|valproic acid|mesh-list
65261725|NCT04262999|Anticonvulsants|anticonvulsants|mesh-ancestor
65261726|NCT04262999|Nootropic Agents|nootropic agents|mesh-ancestor
65261727|NCT04262999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261728|NCT04262999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261729|NCT04262999|GABA Agents|gaba agents|mesh-ancestor
65261730|NCT04262999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65261731|NCT04262999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261750|NCT00926107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261751|NCT02729766|Empagliflozin|empagliflozin|mesh-list
65261752|NCT02729766|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65261753|NCT02729766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261754|NCT02729766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65261755|NCT02729766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261756|NCT02812940|Everolimus|everolimus|mesh-list
65261757|NCT02812940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261758|NCT02812940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65261759|NCT02812940|Immunologic Factors|immunologic factors|mesh-ancestor
65261760|NCT02812940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261761|NCT00933439|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65261762|NCT00933439|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65261763|NCT00933439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65261764|NCT00933439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65261765|NCT00933439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261766|NCT00933439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65261768|NCT00933439|Analgesics|analgesics|mesh-ancestor
65261802|NCT00929851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261803|NCT02729376|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
65261804|NCT02729376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261805|NCT02729376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261806|NCT00933517|Cyclophosphamide|cyclophosphamide|mesh-list
65261807|NCT00933517|Docetaxel|docetaxel|mesh-list
65261808|NCT00933517|Panitumumab|panitumumab|mesh-list
65261809|NCT00933517|Epirubicin|epirubicin|mesh-list
65261810|NCT00933517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65261811|NCT00933517|Immunologic Factors|immunologic factors|mesh-ancestor
65261812|NCT00933517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261813|NCT00933517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65261814|NCT00933517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65261815|NCT00933517|Alkylating Agents|alkylating agents|mesh-ancestor
65261816|NCT00933517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261817|NCT00933517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261818|NCT00933517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65261819|NCT00933517|Tubulin Modulators|tubulin modulators|mesh-ancestor
65261820|NCT00933517|Antimitotic Agents|antimitotic agents|mesh-ancestor
65261821|NCT00933517|Mitosis Modulators|mitosis modulators|mesh-ancestor
65261822|NCT00933517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65261823|NCT00933517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65261824|NCT00933517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65261827|NCT00926341|Pioglitazone|pioglitazone|mesh-list
65261850|NCT00608231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65261851|NCT00608231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261852|NCT05623592|Methotrexate|methotrexate|mesh-list
65261853|NCT05623592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65261854|NCT05623592|Abortifacient Agents|abortifacient agents|mesh-ancestor
65261855|NCT05623592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65261856|NCT05623592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261857|NCT05623592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65261858|NCT05623592|Antimetabolites|antimetabolites|mesh-ancestor
65261859|NCT05623592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261860|NCT05623592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261861|NCT05623592|Dermatologic Agents|dermatologic agents|mesh-ancestor
65261862|NCT05623592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261863|NCT05623592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65261864|NCT05623592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65261865|NCT05623592|Immunologic Factors|immunologic factors|mesh-ancestor
65261866|NCT05623592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65261867|NCT05623592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65261868|NCT02739204|Celecoxib|celecoxib|mesh-list
65261869|NCT02739204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65261870|NCT02739204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65261871|NCT02739204|Analgesics|analgesics|mesh-ancestor
65261872|NCT02739204|Sensory System Agents|sensory system agents|mesh-ancestor
64937156|NCT02964403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65261897|NCT00926653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261898|NCT00926653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65261899|NCT00926653|Serotonin Agents|serotonin agents|mesh-ancestor
65261900|NCT00926653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261901|NCT00926653|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65261902|NCT00926653|Antidepressive Agents|antidepressive agents|mesh-ancestor
65261903|NCT00926653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65261904|NCT02733822|Naloxone|naloxone|mesh-list
65261905|NCT02733822|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65261906|NCT02733822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261907|NCT02733822|Sensory System Agents|sensory system agents|mesh-ancestor
65261908|NCT02733822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65261909|NCT00930241|Tacrolimus|tacrolimus|mesh-list
65261910|NCT00930241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65261911|NCT00930241|Immunologic Factors|immunologic factors|mesh-ancestor
65261912|NCT00930241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261913|NCT00930241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65261914|NCT00930241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261915|NCT00930241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261916|NCT04260269|Trifluridine|trifluridine|mesh-list
65261917|NCT04260269|Fluorouracil|fluorouracil|mesh-list
65261918|NCT04260269|Capecitabine|capecitabine|mesh-list
65261919|NCT04260269|Tegafur|tegafur|mesh-list
65261920|NCT04260269|Antimetabolites|antimetabolites|mesh-ancestor
65261921|NCT04260269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261922|NCT04260269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65261923|NCT04260269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65261924|NCT04260269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65261925|NCT04260269|Immunologic Factors|immunologic factors|mesh-ancestor
65261926|NCT04260269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261927|NCT04260269|Antiviral Agents|antiviral agents|mesh-ancestor
65261938|NCT00926731|Antiviral Agents|antiviral agents|mesh-ancestor
65261939|NCT00926731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65261940|NCT00926731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65261941|NCT00926731|Immunologic Factors|immunologic factors|mesh-ancestor
65261942|NCT00926731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261943|NCT00926809|Amoxicillin|amoxicillin|mesh-list
65261944|NCT00926809|Clarithromycin|clarithromycin|mesh-list
65261945|NCT00926809|Lansoprazole|lansoprazole|mesh-list
65261946|NCT00926809|Dexlansoprazole|dexlansoprazole|mesh-list
65261947|NCT00926809|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65261948|NCT00926809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65261949|NCT00926809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65261950|NCT00926809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65261951|NCT00926809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65261952|NCT00926809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261953|NCT00926809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65261954|NCT00926809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65261955|NCT00926809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65012183|NCT00162552|Protective Agents|protective agents|mesh-ancestor
65261956|NCT00926809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65261957|NCT02805920|Bupivacaine|bupivacaine|mesh-list
65261958|NCT02805920|Anesthetics, Local|anesthetics, local|mesh-ancestor
65261959|NCT02805920|Anesthetics|anesthetics|mesh-ancestor
65261960|NCT02805920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65261961|NCT02805920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261962|NCT02805920|Sensory System Agents|sensory system agents|mesh-ancestor
65261963|NCT02805920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65261964|NCT04262765|Amlodipine|amlodipine|mesh-list
65261965|NCT04262765|Ramipril|ramipril|mesh-list
65261966|NCT04262765|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
65261981|NCT04262765|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65261982|NCT04262765|Protease Inhibitors|protease inhibitors|mesh-ancestor
65261983|NCT03112434|Botulinum Toxins|botulinum toxins|mesh-list
65261984|NCT03112434|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65261985|NCT03112434|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65261986|NCT03112434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65261987|NCT03112434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65261988|NCT03112434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65261989|NCT03112434|Cholinergic Agents|cholinergic agents|mesh-ancestor
65261990|NCT03112434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65261991|NCT03112434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261992|NCT03112434|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65261993|NCT03112434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65261994|NCT02738814|Propofol|propofol|mesh-list
65261995|NCT02738814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65261996|NCT02738814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65261997|NCT02738814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65261998|NCT02738814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65261999|NCT02738814|Anesthetics, General|anesthetics, general|mesh-ancestor
65262000|NCT02738814|Anesthetics|anesthetics|mesh-ancestor
65262001|NCT02805608|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65262002|NCT02805608|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65262032|NCT00926965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65262033|NCT00926965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65262034|NCT00926965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262035|NCT00926965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65262036|NCT00926965|Serotonin Agents|serotonin agents|mesh-ancestor
65262037|NCT00926965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65262038|NCT00926965|Dopamine Agents|dopamine agents|mesh-ancestor
65262039|NCT00926965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65262040|NCT00926965|Antidepressive Agents|antidepressive agents|mesh-ancestor
65262041|NCT04260113|Apatinib|apatinib|mesh-list
65262042|NCT04260113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262043|NCT04260113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65262044|NCT04260113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262045|NCT04260113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262046|NCT02738658|Everolimus|everolimus|mesh-list
65262047|NCT02738658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262048|NCT02738658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65262049|NCT02738658|Immunologic Factors|immunologic factors|mesh-ancestor
65262050|NCT02738658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262051|NCT02733510|Methylprednisolone|methylprednisolone|mesh-list
65262052|NCT02733510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65262053|NCT02733510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65262054|NCT02733510|Prednisolone|prednisolone|mesh-list
65262055|NCT02733510|Prednisolone acetate|prednisolone acetate|mesh-list
65262056|NCT02733510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65262057|NCT02733510|Prednisolone phosphate|prednisolone phosphate|mesh-list
65262058|NCT02733510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65262059|NCT02733510|Antiemetics|antiemetics|mesh-ancestor
65262060|NCT02733510|Autonomic Agents|autonomic agents|mesh-ancestor
65262061|NCT02733510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65262062|NCT02733510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262063|NCT02733510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65262064|NCT02733510|Glucocorticoids|glucocorticoids|mesh-ancestor
65262065|NCT02733510|Hormones|hormones|mesh-ancestor
65262072|NCT03663504|Neomycin|neomycin|mesh-list
65262073|NCT03663504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65262074|NCT03663504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65262075|NCT03663504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65262076|NCT03663504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65262077|NCT03663504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65262078|NCT03663504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262079|NCT03663504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262080|NCT00927095|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65262081|NCT00927095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65262082|NCT00927095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262083|NCT00933985|Doxorubicin|doxorubicin|mesh-list
65262084|NCT00933985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65262085|NCT00933985|Dexrazoxane|dexrazoxane|mesh-list
65262086|NCT00933985|Vincristine|vincristine|mesh-list
65262087|NCT00933985|Razoxane|razoxane|mesh-list
65262088|NCT00933985|Obatoclax|obatoclax|mesh-list
65262089|NCT00933985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65262090|NCT00933985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262091|NCT00933985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65262092|NCT00933985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65262127|NCT00634400|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65262128|NCT00634400|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65262129|NCT00634400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262130|NCT04262375|Durvalumab|durvalumab|mesh-list
65262131|NCT04262375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65262132|NCT04262375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65262133|NCT00936793|Ritonavir|ritonavir|mesh-list
65262134|NCT00936793|Darunavir|darunavir|mesh-list
65262135|NCT00936793|Beclomethasone|beclomethasone|mesh-list
65262136|NCT00936793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65262137|NCT00936793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65262138|NCT00936793|Protease Inhibitors|protease inhibitors|mesh-ancestor
65262139|NCT00936793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262140|NCT00936793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262141|NCT00936793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65262142|NCT00936793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65262143|NCT00936793|Antiviral Agents|antiviral agents|mesh-ancestor
65262144|NCT00936793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65262145|NCT00936793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65262181|NCT04261907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65262182|NCT04261907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65262183|NCT04261907|Protease Inhibitors|protease inhibitors|mesh-ancestor
65262184|NCT04261907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65262185|NCT04261907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262186|NCT04261907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65262187|NCT04261907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65262188|NCT04261907|Antiviral Agents|antiviral agents|mesh-ancestor
65262189|NCT04261907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65262190|NCT04261907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65262191|NCT04261907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65262192|NCT00930709|Botulinum Toxins|botulinum toxins|mesh-list
65262193|NCT00930709|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65262194|NCT00930709|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65262195|NCT00930709|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65262196|NCT00930709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65262197|NCT00930709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262198|NCT00930709|Cholinergic Agents|cholinergic agents|mesh-ancestor
65262199|NCT00930709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65262234|NCT00937261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65262235|NCT00937261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65262236|NCT00937261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65262237|NCT00937261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65262238|NCT00937261|Dopamine Agents|dopamine agents|mesh-ancestor
65262239|NCT00937261|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65262240|NCT00937261|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65262241|NCT00609557|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65262242|NCT00609557|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65262243|NCT00609557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65262244|NCT00609557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65262245|NCT00609557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65262246|NCT00609557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65262247|NCT00609557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65262248|NCT00609557|Analgesics|analgesics|mesh-ancestor
65224054|NCT04214145|Hemostatics|hemostatics|mesh-ancestor
65224092|NCT00618501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224093|NCT00618501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65224094|NCT00618501|Abortifacient Agents|abortifacient agents|mesh-ancestor
65224095|NCT00618501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65224096|NCT00618501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65224097|NCT00618501|Antimetabolites|antimetabolites|mesh-ancestor
65224098|NCT00618501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224099|NCT00618501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224100|NCT00618501|Dermatologic Agents|dermatologic agents|mesh-ancestor
65224101|NCT00618501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224102|NCT00618501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65224103|NCT00618501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65224104|NCT00618501|Immunologic Factors|immunologic factors|mesh-ancestor
65224105|NCT00618501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65224106|NCT00618501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65224107|NCT00618501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65224108|NCT00618501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65224109|NCT00618501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65224110|NCT00618501|Antiviral Agents|antiviral agents|mesh-ancestor
65224112|NCT00618501|Antidotes|antidotes|mesh-ancestor
65224146|NCT05322603|Analgesics|analgesics|mesh-list
65224147|NCT05322603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
65224148|NCT05322603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65224149|NCT05322603|Narcotics|narcotics|mesh-ancestor
65224150|NCT05322603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65224151|NCT05322603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224152|NCT05322603|Sensory System Agents|sensory system agents|mesh-ancestor
65224153|NCT05322603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65224154|NCT05322603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65224155|NCT05322603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65224156|NCT05322603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65224157|NCT05322603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65224158|NCT05322603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224159|NCT05322603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224160|NCT00618579|Warfarin|warfarin|mesh-list
65224161|NCT00618579|Anticoagulants|anticoagulants|mesh-ancestor
65224162|NCT00781768|Ondansetron|ondansetron|mesh-list
65224163|NCT00781768|Aprepitant|aprepitant|mesh-list
65224164|NCT00781768|Antiemetics|antiemetics|mesh-ancestor
65224165|NCT00781768|Autonomic Agents|autonomic agents|mesh-ancestor
65224166|NCT00781768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65224167|NCT00781768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224168|NCT00781768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65224169|NCT00781768|Antipruritics|antipruritics|mesh-ancestor
65224170|NCT00781768|Dermatologic Agents|dermatologic agents|mesh-ancestor
65224171|NCT00781768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65224172|NCT00781768|Serotonin Agents|serotonin agents|mesh-ancestor
65224173|NCT00781768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65224174|NCT00781768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224175|NCT00781768|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65224176|NCT00781768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65224177|NCT00781768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65224189|NCT01005680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224190|NCT01005680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65224191|NCT01005680|Immunologic Factors|immunologic factors|mesh-ancestor
65224192|NCT01005680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224193|NCT01005680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65224194|NCT01005680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65224195|NCT04101370|Bosentan|bosentan|mesh-list
65224196|NCT04101370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65224197|NCT04101370|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65224198|NCT04101370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224199|NCT00618657|Paclitaxel|paclitaxel|mesh-list
65224200|NCT00618657|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65224201|NCT00618657|Bevacizumab|bevacizumab|mesh-list
65224202|NCT00618657|Carboplatin|carboplatin|mesh-list
65224203|NCT00618657|Trastuzumab|trastuzumab|mesh-list
65224204|NCT00618657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65224205|NCT00618657|Antibodies|antibodies|mesh-list
65224206|NCT00618657|Immunoglobulins|immunoglobulins|mesh-list
65224207|NCT00618657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65224208|NCT00618657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65224244|NCT04103398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224245|NCT04103398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65224246|NCT04103398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224247|NCT04103398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224248|NCT04103398|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65224249|NCT04103398|Estrogens|estrogens|mesh-ancestor
65224250|NCT04103398|Hormones|hormones|mesh-ancestor
65224251|NCT04103398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65224252|NCT04103398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224253|NCT04103398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65224254|NCT00768430|Midazolam|midazolam|mesh-list
65224255|NCT00768430|Ketamine|ketamine|mesh-list
65224256|NCT00768430|Analgesics|analgesics|mesh-ancestor
65224257|NCT00768430|Sensory System Agents|sensory system agents|mesh-ancestor
65224258|NCT00768430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65224259|NCT00768430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224260|NCT00768430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65224261|NCT00768430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65224262|NCT00768430|Anesthetics, General|anesthetics, general|mesh-ancestor
65224263|NCT00768430|Anesthetics|anesthetics|mesh-ancestor
65224264|NCT00768430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65224265|NCT00768430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65224266|NCT00768430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65224267|NCT00768430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65224268|NCT00768430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224269|NCT00768430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65224270|NCT00768430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65224271|NCT00768430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65224272|NCT00768430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65224273|NCT00768430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65224274|NCT00768430|GABA Modulators|gaba modulators|mesh-ancestor
65224275|NCT00768430|GABA Agents|gaba agents|mesh-ancestor
65224276|NCT04101136|Atorvastatin|atorvastatin|mesh-list
65224284|NCT00618969|Busulfan|busulfan|mesh-list
65224285|NCT00618969|Melphalan|melphalan|mesh-list
65224286|NCT00618969|Alkylating Agents|alkylating agents|mesh-ancestor
65224287|NCT00618969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224288|NCT00618969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65224289|NCT00618969|Immunologic Factors|immunologic factors|mesh-ancestor
65224290|NCT00618969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224291|NCT00618969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65224292|NCT00618969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224293|NCT00618969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65224294|NCT01064297|Lamotrigine|lamotrigine|mesh-list
65224295|NCT01064297|Anticonvulsants|anticonvulsants|mesh-list
65224296|NCT01064297|Valproic Acid|valproic acid|mesh-list
65224297|NCT01064297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65224298|NCT01064297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65224299|NCT01064297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224300|NCT01064297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65224301|NCT01064297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224302|NCT01064297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65224303|NCT01064297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65224304|NCT01064297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65224308|NCT01064297|GABA Agents|gaba agents|mesh-ancestor
65224337|NCT01062113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65224338|NCT01062113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224339|NCT01062113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224340|NCT00916396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65224341|NCT00916396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65224342|NCT00916396|Immunologic Factors|immunologic factors|mesh-ancestor
65224343|NCT00916396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224344|NCT04075201|Vaccines|vaccines|mesh-list
65224345|NCT04075201|Immunologic Factors|immunologic factors|mesh-ancestor
65224346|NCT04075201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224347|NCT01038869|Azelaic acid|azelaic acid|mesh-list
65224348|NCT01038869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224349|NCT01038869|Dermatologic Agents|dermatologic agents|mesh-ancestor
65224350|NCT02580331|Metformin|metformin|mesh-list
65224351|NCT02580331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65224352|NCT02580331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224353|NCT00767806|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65224354|NCT00767806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65224355|NCT00767806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65224356|NCT00767806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65224357|NCT00767806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224358|NCT00767806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65224359|NCT00767806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224361|NCT00767806|Sensory System Agents|sensory system agents|mesh-ancestor
65224362|NCT00767806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65224363|NCT00767806|Antidepressive Agents|antidepressive agents|mesh-ancestor
65224384|NCT00771472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224385|NCT00771316|Meropenem|meropenem|mesh-list
65224386|NCT00771316|Ertapenem|ertapenem|mesh-list
65224387|NCT00771316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65224388|NCT00771316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65224389|NCT00770770|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
65224390|NCT00770770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65224391|NCT00770770|Glucocorticoids|glucocorticoids|mesh-ancestor
65224392|NCT00770770|Hormones|hormones|mesh-ancestor
65224393|NCT00770770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65224394|NCT00770770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224395|NCT00766636|Gemcitabine|gemcitabine|mesh-list
65224396|NCT00766636|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65224397|NCT00766636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65224398|NCT00766636|Antimetabolites|antimetabolites|mesh-ancestor
65224399|NCT00766636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224400|NCT00766636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224401|NCT00766636|Antiviral Agents|antiviral agents|mesh-ancestor
65224402|NCT00766636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65224403|NCT00766636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224404|NCT00766636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64867126|NCT01808300|Vitamins|vitamins|mesh-ancestor
65224405|NCT00766636|Immunologic Factors|immunologic factors|mesh-ancestor
65224406|NCT00766636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224407|NCT00766636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65224408|NCT04348045|Durvalumab|durvalumab|mesh-list
65224409|NCT04348045|Olaparib|olaparib|mesh-list
65224410|NCT04348045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65224411|NCT04348045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224412|NCT04348045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65224413|NCT04348045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224426|NCT03277729|Fludarabine|fludarabine|mesh-list
65224427|NCT03277729|Fludarabine phosphate|fludarabine phosphate|mesh-list
65224428|NCT03277729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65224429|NCT03277729|Immunologic Factors|immunologic factors|mesh-ancestor
65224430|NCT03277729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224432|NCT03277729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65224433|NCT03277729|Alkylating Agents|alkylating agents|mesh-ancestor
65224434|NCT03277729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224435|NCT03277729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224436|NCT03277729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65224437|NCT03277729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65224438|NCT03277729|Antimetabolites|antimetabolites|mesh-ancestor
65224439|NCT02581969|Factor VIII|factor viii|mesh-list
65224440|NCT02581969|Coagulants|coagulants|mesh-ancestor
65224441|NCT00770692|Eszopiclone|eszopiclone|mesh-list
65224442|NCT00770692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65224443|NCT00770692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65224444|NCT00770692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224445|NCT02816203|Hemostatics|hemostatics|mesh-list
65224446|NCT02816203|Coagulants|coagulants|mesh-ancestor
65224485|NCT02713009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224486|NCT02713009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65224487|NCT02713009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65224488|NCT03085225|Durvalumab|durvalumab|mesh-list
65224489|NCT03085225|Trabectedin|trabectedin|mesh-list
65224490|NCT03085225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65224491|NCT03085225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224492|NCT03085225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65224493|NCT03085225|Alkylating Agents|alkylating agents|mesh-ancestor
65224494|NCT03085225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224495|NCT02705287|Vitamin D|vitamin d|mesh-list
65224496|NCT02705287|Ergocalciferols|ergocalciferols|mesh-list
65224497|NCT02705287|Cholecalciferol|cholecalciferol|mesh-list
65224498|NCT02705287|Vitamins|vitamins|mesh-list
65224499|NCT02705287|Micronutrients|micronutrients|mesh-ancestor
65224500|NCT02705287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224501|NCT02705287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65224502|NCT02705287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65224503|NCT02688985|Ocrelizumab|ocrelizumab|mesh-list
65224504|NCT02688985|Histamine Antagonists|histamine antagonists|mesh-list
65224505|NCT02688985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
65224506|NCT02688985|Immunologic Factors|immunologic factors|mesh-ancestor
65224508|NCT02688985|Histamine Agents|histamine agents|mesh-ancestor
65224509|NCT02688985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65224510|NCT02688985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224511|NCT04295408|Ropivacaine|ropivacaine|mesh-list
65224512|NCT04295408|Anesthetics, Local|anesthetics, local|mesh-ancestor
65224513|NCT04295408|Anesthetics|anesthetics|mesh-ancestor
65224514|NCT04295408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65224515|NCT04295408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224516|NCT04295408|Sensory System Agents|sensory system agents|mesh-ancestor
65224517|NCT04295408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65224518|NCT02578537|Clopidogrel|clopidogrel|mesh-list
65224519|NCT02578537|Ticagrelor|ticagrelor|mesh-list
64937946|NCT01465074|Nicotine|nicotine|mesh-list
64951559|NCT00054444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64951560|NCT00054444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951561|NCT00054444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951562|NCT00026429|Denileukin diftitox|denileukin diftitox|mesh-list
64937980|NCT00010361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224520|NCT02578537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65224521|NCT02578537|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65224522|NCT02578537|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65224523|NCT02578537|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65224524|NCT02578537|Purinergic Agents|purinergic agents|mesh-ancestor
65224525|NCT02578537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65224526|NCT02578537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224527|NCT02578537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224528|NCT03011671|Temozolomide|temozolomide|mesh-list
65224529|NCT03011671|Acetazolamide|acetazolamide|mesh-list
65224530|NCT03011671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65224531|NCT03011671|Alkylating Agents|alkylating agents|mesh-ancestor
65224532|NCT03011671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224533|NCT03011671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224534|NCT03011671|Anticonvulsants|anticonvulsants|mesh-ancestor
65224535|NCT03011671|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65224536|NCT03011671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224537|NCT03011671|Diuretics|diuretics|mesh-ancestor
65224538|NCT03011671|Natriuretic Agents|natriuretic agents|mesh-ancestor
65224539|NCT03011671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224540|NCT00628706|Dronabinol|dronabinol|mesh-list
65224541|NCT00628706|Hallucinogens|hallucinogens|mesh-ancestor
65224542|NCT00628706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224543|NCT00628706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65224544|NCT00628706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65224545|NCT00628706|Analgesics|analgesics|mesh-ancestor
65224552|NCT00628706|Hormones|hormones|mesh-ancestor
65224563|NCT04462328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224564|NCT01004510|Zoledronic Acid|zoledronic acid|mesh-list
65224565|NCT01004510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65224566|NCT01004510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224567|NCT02609503|Pembrolizumab|pembrolizumab|mesh-list
65224568|NCT02609503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65224569|NCT02609503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224570|NCT04073953|Primaquine|primaquine|mesh-list
65224571|NCT04073953|Antimalarials|antimalarials|mesh-ancestor
65224572|NCT04073953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65224573|NCT04073953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65224574|NCT04073953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65224575|NCT04679389|Acetazolamide|acetazolamide|mesh-list
65224576|NCT04679389|Anticonvulsants|anticonvulsants|mesh-ancestor
65224577|NCT04679389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65224578|NCT04679389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956550|NCT00208897|Fluoxetine|fluoxetine|mesh-list
65224579|NCT04679389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224580|NCT04679389|Diuretics|diuretics|mesh-ancestor
65224581|NCT04679389|Natriuretic Agents|natriuretic agents|mesh-ancestor
65224582|NCT04679389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224583|NCT02589691|Rocuronium|rocuronium|mesh-list
65224584|NCT02589691|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65224585|NCT02589691|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65224586|NCT02589691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65224587|NCT02589691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65224588|NCT02589691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224589|NCT01004432|Golimumab|golimumab|mesh-list
65224590|NCT01004432|Methotrexate|methotrexate|mesh-list
65224591|NCT01004432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65224592|NCT01004432|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65224593|NCT01004432|Abortifacient Agents|abortifacient agents|mesh-ancestor
65224605|NCT01004432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65224606|NCT01004432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65224607|NCT01004432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65224608|NCT01004432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65224609|NCT02539537|Leucovorin|leucovorin|mesh-list
65224610|NCT02539537|Folic Acid|folic acid|mesh-list
65224611|NCT02539537|Gemcitabine|gemcitabine|mesh-list
65224612|NCT02539537|Fluorouracil|fluorouracil|mesh-list
65224613|NCT02539537|Oxaliplatin|oxaliplatin|mesh-list
65224614|NCT02539537|Irinotecan|irinotecan|mesh-list
65224615|NCT02539537|Levoleucovorin|levoleucovorin|mesh-list
65224616|NCT02539537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65224617|NCT02539537|Antimetabolites|antimetabolites|mesh-ancestor
65224618|NCT02539537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224619|NCT02539537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224620|NCT02539537|Antiviral Agents|antiviral agents|mesh-ancestor
65224621|NCT02539537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65224622|NCT02539537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224623|NCT02539537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65224624|NCT02539537|Immunologic Factors|immunologic factors|mesh-ancestor
65224625|NCT02539537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224661|NCT01000610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65224662|NCT01000610|Antimetabolites|antimetabolites|mesh-ancestor
65224663|NCT01000610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224664|NCT01000610|Dermatologic Agents|dermatologic agents|mesh-ancestor
65224665|NCT01000610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224666|NCT01000610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65224667|NCT01000610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65224668|NCT01000610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65224669|NCT01000610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65224670|NCT01000610|Antiemetics|antiemetics|mesh-ancestor
65224671|NCT01000610|Autonomic Agents|autonomic agents|mesh-ancestor
65224672|NCT01000610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65224673|NCT01000610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65224674|NCT01000610|Glucocorticoids|glucocorticoids|mesh-ancestor
65224675|NCT01000610|Hormones|hormones|mesh-ancestor
65224676|NCT01000610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65224677|NCT01000610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65224678|NCT01000610|Protective Agents|protective agents|mesh-ancestor
65224679|NCT01000610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65224714|NCT01038635|Lenalidomide|lenalidomide|mesh-list
65224715|NCT01038635|Azacitidine|azacitidine|mesh-list
65224716|NCT01038635|Immunologic Factors|immunologic factors|mesh-ancestor
65224717|NCT01038635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224718|NCT01038635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65224719|NCT01038635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65224720|NCT01038635|Growth Substances|growth substances|mesh-ancestor
65224721|NCT01038635|Growth Inhibitors|growth inhibitors|mesh-ancestor
65224722|NCT01038635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224723|NCT01038635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65224724|NCT01038635|Antimetabolites|antimetabolites|mesh-ancestor
65224725|NCT01038635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224726|NCT01038635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224727|NCT00619203|Acetaminophen|acetaminophen|mesh-list
65224728|NCT00619203|Glycerol|glycerol|mesh-list
65224729|NCT00619203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65224730|NCT00619203|Analgesics|analgesics|mesh-ancestor
65224731|NCT00619203|Sensory System Agents|sensory system agents|mesh-ancestor
65224772|NCT02874287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65224773|NCT02874287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224774|NCT02874287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224775|NCT02874287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65224776|NCT04100824|Nimodipine|nimodipine|mesh-list
65224777|NCT04100824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65224778|NCT04100824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65224779|NCT04100824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65224780|NCT04100824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224781|NCT04100824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65224782|NCT04100824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224783|NCT04100824|Vasodilator Agents|vasodilator agents|mesh-ancestor
65224784|NCT00580801|Interferons|interferons|mesh-list
65224785|NCT00580801|Ribavirin|ribavirin|mesh-list
65224786|NCT00580801|Interferon-alpha|interferon-alpha|mesh-list
65224787|NCT00580801|Interferon alpha-2|interferon alpha-2|mesh-list
65224788|NCT00580801|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65224789|NCT00580801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224790|NCT00580801|Antiviral Agents|antiviral agents|mesh-ancestor
65224791|NCT00580801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65224792|NCT00580801|Antimetabolites|antimetabolites|mesh-ancestor
65224793|NCT00580801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224794|NCT00580801|Immunologic Factors|immunologic factors|mesh-ancestor
65224795|NCT00580801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224796|NCT00619671|Rituximab|rituximab|mesh-list
65224797|NCT00619671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65224798|NCT00619671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224799|NCT00619671|Immunologic Factors|immunologic factors|mesh-ancestor
65224800|NCT00619671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224801|NCT00619671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65224802|NCT00628550|Vasopressins|vasopressins|mesh-list
65224803|NCT00628550|Arginine Vasopressin|arginine vasopressin|mesh-list
65224814|NCT00628550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65224815|NCT00628550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65224816|NCT00628550|Respiratory System Agents|respiratory system agents|mesh-ancestor
65224817|NCT00628550|Mydriatics|mydriatics|mesh-ancestor
65224818|NCT00628550|Sympathomimetics|sympathomimetics|mesh-ancestor
65224819|NCT00628550|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65224820|NCT00628550|Hemostatics|hemostatics|mesh-ancestor
65224821|NCT00628550|Coagulants|coagulants|mesh-ancestor
65224822|NCT00628550|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65224823|NCT00628550|Natriuretic Agents|natriuretic agents|mesh-ancestor
65224824|NCT01059539|Cariprazine|cariprazine|mesh-list
65224825|NCT01059539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65224826|NCT01059539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65224827|NCT01059539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65224828|NCT01059539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224829|NCT01059539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65224830|NCT00999908|Tiotropium Bromide|tiotropium bromide|mesh-list
65224831|NCT00999908|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65224832|NCT00999908|Autonomic Agents|autonomic agents|mesh-ancestor
65224833|NCT00999908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65224834|NCT00999908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224835|NCT00999908|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65224836|NCT00999908|Respiratory System Agents|respiratory system agents|mesh-ancestor
65224837|NCT00999908|Parasympatholytics|parasympatholytics|mesh-ancestor
65224838|NCT00999908|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65224839|NCT00999908|Cholinergic Agents|cholinergic agents|mesh-ancestor
65224840|NCT00999908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65224841|NCT00999908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224842|NCT02576119|Moxifloxacin|moxifloxacin|mesh-list
65224843|NCT02576119|BMS-955176|bms-955176|mesh-list
65224861|NCT04304144|Immunologic Factors|immunologic factors|mesh-ancestor
65224862|NCT04304144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224863|NCT04304144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65224864|NCT04304144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65224865|NCT04304144|Alkylating Agents|alkylating agents|mesh-ancestor
65224866|NCT04304144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224867|NCT04304144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224868|NCT04304144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65224869|NCT04304144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65224870|NCT04304144|Antiemetics|antiemetics|mesh-ancestor
65224871|NCT04304144|Autonomic Agents|autonomic agents|mesh-ancestor
65224872|NCT04304144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65224873|NCT04304144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65224874|NCT04304144|Glucocorticoids|glucocorticoids|mesh-ancestor
65224875|NCT04304144|Hormones|hormones|mesh-ancestor
65224876|NCT04304144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65224877|NCT04304144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65224878|NCT04676867|Dalcetrapib|dalcetrapib|mesh-list
65224879|NCT04676867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65224880|NCT04676867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65224881|NCT04676867|Antimetabolites|antimetabolites|mesh-ancestor
65224883|NCT04676867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64938365|NCT00012584|Dopamine Agents|dopamine agents|mesh-ancestor
65224913|NCT04594811|Nivolumab|nivolumab|mesh-list
65224914|NCT04594811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65224915|NCT04594811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224916|NCT04594811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65224917|NCT04594811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224918|NCT02399215|Nintedanib|nintedanib|mesh-list
65224919|NCT02399215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224920|NCT02399215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65224921|NCT02399215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224922|NCT02399215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224923|NCT02389465|Celecoxib|celecoxib|mesh-list
65224924|NCT02389465|Dexetimide|dexetimide|mesh-list
65224925|NCT02389465|Citalopram|citalopram|mesh-list
65224926|NCT02389465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65224927|NCT02389465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65224928|NCT02389465|Analgesics|analgesics|mesh-ancestor
65224929|NCT02389465|Sensory System Agents|sensory system agents|mesh-ancestor
65224930|NCT02389465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65224931|NCT02389465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224932|NCT02389465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65224933|NCT02389465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65224934|NCT02389465|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65224935|NCT02389465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65224936|NCT02389465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224937|NCT02389465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224938|NCT02389465|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65224939|NCT02389465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65224940|NCT02389465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65224941|NCT02389465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65224942|NCT02389465|Serotonin Agents|serotonin agents|mesh-ancestor
65224943|NCT02389465|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65224944|NCT02389465|Antidepressive Agents|antidepressive agents|mesh-ancestor
65224945|NCT02389465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65224946|NCT02389465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65224947|NCT02389465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65224948|NCT02389465|Parasympatholytics|parasympatholytics|mesh-ancestor
65224949|NCT02389465|Autonomic Agents|autonomic agents|mesh-ancestor
65224950|NCT02389465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65224951|NCT02389465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65224952|NCT02389465|Cholinergic Agents|cholinergic agents|mesh-ancestor
65224953|NCT01057589|Folic Acid|folic acid|mesh-list
65224954|NCT01057589|Vitamin B 12|vitamin b 12|mesh-list
65224955|NCT01057589|Pemetrexed|pemetrexed|mesh-list
65224956|NCT01057589|Cetuximab|cetuximab|mesh-list
65224957|NCT01057589|Vitamins|vitamins|mesh-ancestor
65224958|NCT01057589|Micronutrients|micronutrients|mesh-ancestor
65224959|NCT01057589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224960|NCT01057589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65224961|NCT01057589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224962|NCT01057589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65224963|NCT01057589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65224964|NCT01057589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65224965|NCT01057589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65224966|NCT01057589|Hematinics|hematinics|mesh-ancestor
65224967|NCT01057589|Vitamin B Complex|vitamin b complex|mesh-ancestor
65224968|NCT02575885|Nicotine|nicotine|mesh-list
65224969|NCT02575885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65224970|NCT02575885|Autonomic Agents|autonomic agents|mesh-ancestor
65225003|NCT01835041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225004|NCT01835041|Antidotes|antidotes|mesh-ancestor
65225005|NCT01835041|Protective Agents|protective agents|mesh-ancestor
65225006|NCT01835041|Vitamin B Complex|vitamin b complex|mesh-ancestor
65225007|NCT01835041|Vitamins|vitamins|mesh-ancestor
65225008|NCT01835041|Micronutrients|micronutrients|mesh-ancestor
65225009|NCT01835041|Antioxidants|antioxidants|mesh-ancestor
65225010|NCT01716117|Calcium Carbonate|calcium carbonate|mesh-list
65225011|NCT01716117|Antacids|antacids|mesh-ancestor
65225012|NCT01716117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225013|NCT01716117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65225014|NCT00579553|Progesterone|progesterone|mesh-list
65225015|NCT00579553|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
65225016|NCT00579553|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
65225017|NCT00579553|Progestins|progestins|mesh-ancestor
65225018|NCT00579553|Hormones|hormones|mesh-ancestor
65225019|NCT00579553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65225020|NCT00579553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225021|NCT00579553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65225022|NCT00579553|Hormone Antagonists|hormone antagonists|mesh-ancestor
65225062|NCT00581893|Anticonvulsants|anticonvulsants|mesh-ancestor
65225063|NCT00581893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65225064|NCT00581893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65225065|NCT00581893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65225066|NCT00581893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225067|NCT00581893|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65225068|NCT00581893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65225069|NCT04211103|Pembrolizumab|pembrolizumab|mesh-list
65225070|NCT04211103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65225071|NCT04211103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225072|NCT04209777|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65225073|NCT04209777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65225125|NCT03890289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225126|NCT03890289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225127|NCT00621699|Ezetimibe|ezetimibe|mesh-list
65225128|NCT00621699|Tacrolimus|tacrolimus|mesh-list
65225129|NCT00621699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65225130|NCT00621699|Immunologic Factors|immunologic factors|mesh-ancestor
65225131|NCT00621699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225132|NCT00621699|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65225133|NCT00621699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225134|NCT00621699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225135|NCT00621699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65225136|NCT00621699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65225137|NCT00621699|Antimetabolites|antimetabolites|mesh-ancestor
65225138|NCT00621699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65225139|NCT00612183|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65225140|NCT00612183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65225141|NCT00612183|Alkylating Agents|alkylating agents|mesh-ancestor
65225142|NCT00612183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225143|NCT00612183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225144|NCT00770146|Mipomersen|mipomersen|mesh-list
65225145|NCT00770146|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65225146|NCT00770146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65225147|NCT00770146|Antimetabolites|antimetabolites|mesh-ancestor
65225148|NCT00770146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225149|NCT00770146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65225150|NCT00915850|Cisplatin|cisplatin|mesh-list
65225151|NCT00915850|Docetaxel|docetaxel|mesh-list
65225152|NCT00915850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225153|NCT00915850|Tubulin Modulators|tubulin modulators|mesh-ancestor
65225157|NCT04208763|Imipenem|imipenem|mesh-list
65225170|NCT00916552|Epoetin Alfa|epoetin alfa|mesh-list
65225171|NCT00916552|Hematinics|hematinics|mesh-ancestor
65225172|NCT03950037|Albendazole|albendazole|mesh-list
65225173|NCT03950037|Anthelmintics|anthelmintics|mesh-ancestor
65225174|NCT03950037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65225175|NCT03950037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65225176|NCT03950037|Anticestodal Agents|anticestodal agents|mesh-ancestor
65225177|NCT03950037|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65225178|NCT03950037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65225179|NCT03950037|Tubulin Modulators|tubulin modulators|mesh-ancestor
65225180|NCT03950037|Antimitotic Agents|antimitotic agents|mesh-ancestor
65225181|NCT03950037|Mitosis Modulators|mitosis modulators|mesh-ancestor
65225182|NCT03950037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225183|NCT03950037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225184|NCT04188171|Polidocanol|polidocanol|mesh-list
65225185|NCT04188171|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65225186|NCT04188171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65225187|NCT00620997|Proxymetacaine|proxymetacaine|mesh-list
65225188|NCT00620997|Anesthetics, Local|anesthetics, local|mesh-ancestor
65225189|NCT00620997|Anesthetics|anesthetics|mesh-ancestor
65225190|NCT00620997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65225191|NCT00620997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225224|NCT03838263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225225|NCT04208373|Itraconazole|itraconazole|mesh-list
65225226|NCT04208373|Etravirine|etravirine|mesh-list
65225227|NCT04208373|Antifungal Agents|antifungal agents|mesh-ancestor
65225228|NCT04208373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65225229|NCT04208373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65225230|NCT04208373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65225231|NCT04208373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867962|NCT01813812|Antioxidants|antioxidants|mesh-ancestor
65225232|NCT04208373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225233|NCT04208373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65225234|NCT04208373|Hormone Antagonists|hormone antagonists|mesh-ancestor
65225235|NCT04208373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65225236|NCT04208373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225237|NCT04208373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65225238|NCT04208373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65225239|NCT04208373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65225240|NCT04208373|Antiviral Agents|antiviral agents|mesh-ancestor
65225275|NCT00999518|Analgesics|analgesics|mesh-ancestor
65225276|NCT00999518|Sensory System Agents|sensory system agents|mesh-ancestor
65225277|NCT00999518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65225278|NCT00999518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225279|NCT00621387|Ofloxacin|ofloxacin|mesh-list
65225280|NCT00621387|Roxithromycin|roxithromycin|mesh-list
65225281|NCT00621387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65225282|NCT00621387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65225283|NCT00621387|Renal Agents|renal agents|mesh-ancestor
65225284|NCT00621387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65225285|NCT00621387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65225286|NCT00621387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65225287|NCT00621387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225288|NCT00621387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225289|NCT00621387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225290|NCT00621387|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65225291|NCT00621387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65225292|NCT02873273|Dexamethasone|dexamethasone|mesh-list
65225332|NCT03548805|Mitomycin|mitomycin|mesh-list
65225333|NCT03548805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65225334|NCT03548805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225335|NCT03548805|Alkylating Agents|alkylating agents|mesh-ancestor
65225336|NCT03548805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225337|NCT03548805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65225338|NCT03548805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225339|NCT01003886|Doxazosin|doxazosin|mesh-list
65225340|NCT01003886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65225341|NCT01003886|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65225342|NCT01003886|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65225343|NCT01003886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65225344|NCT01003886|Adrenergic Agents|adrenergic agents|mesh-ancestor
65225345|NCT01003886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65225346|NCT01003886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225347|NCT01003886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225348|NCT04138641|Cangrelor|cangrelor|mesh-list
65225349|NCT04138641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65225350|NCT04138641|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65225351|NCT04138641|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65225352|NCT04138641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65225353|NCT04138641|Purinergic Agents|purinergic agents|mesh-ancestor
65225357|NCT01003184|Exenatide|exenatide|mesh-list
65225381|NCT04314219|Dermatologic Agents|dermatologic agents|mesh-ancestor
65225382|NCT04314219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225384|NCT04314219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65225385|NCT02407119|Amoxicillin|amoxicillin|mesh-list
65225386|NCT02407119|Clarithromycin|clarithromycin|mesh-list
65225387|NCT02407119|Omeprazole|omeprazole|mesh-list
65225388|NCT02407119|Rabeprazole|rabeprazole|mesh-list
65225389|NCT02407119|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65225390|NCT02407119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65225391|NCT02407119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65225392|NCT02407119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65225393|NCT02407119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65225394|NCT02407119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225395|NCT02407119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225396|NCT02407119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65225397|NCT02407119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65225398|NCT02407119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65225399|NCT01008410|Budesonide|budesonide|mesh-list
65225452|NCT05264883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65225453|NCT05264883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65225454|NCT05264883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65225455|NCT05264805|Bupivacaine|bupivacaine|mesh-list
65225456|NCT05264805|Anesthetics, Local|anesthetics, local|mesh-ancestor
65225457|NCT05264805|Anesthetics|anesthetics|mesh-ancestor
65225458|NCT05264805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65225459|NCT05264805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225460|NCT05264805|Sensory System Agents|sensory system agents|mesh-ancestor
65225461|NCT05264805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65225462|NCT05264493|Naloxone|naloxone|mesh-list
65225463|NCT05264493|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65225464|NCT05264493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225465|NCT05264493|Sensory System Agents|sensory system agents|mesh-ancestor
65225466|NCT05264493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65225467|NCT00612261|Triamcinolone|triamcinolone|mesh-list
65225510|NCT02697201|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65225511|NCT02697201|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65225512|NCT02697201|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65225513|NCT02697045|Aripiprazole|aripiprazole|mesh-list
65225514|NCT02697045|Antidepressive Agents|antidepressive agents|mesh-ancestor
65225515|NCT02697045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65225516|NCT02697045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65225517|NCT02697045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65225518|NCT02697045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65225519|NCT02697045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225520|NCT02697045|Dopamine Agonists|dopamine agonists|mesh-ancestor
65225521|NCT02697045|Dopamine Agents|dopamine agents|mesh-ancestor
65225522|NCT02697045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65225523|NCT02697045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225524|NCT02697045|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65225525|NCT02697045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65225526|NCT02697045|Serotonin Agents|serotonin agents|mesh-ancestor
65225566|NCT01028651|Treprostinil|treprostinil|mesh-list
65225567|NCT01028651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65225568|NCT00627731|Methylprednisolone|methylprednisolone|mesh-list
65225569|NCT00627731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65225570|NCT00627731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65225571|NCT00627731|Prednisolone|prednisolone|mesh-list
65225572|NCT00627731|Prednisolone acetate|prednisolone acetate|mesh-list
65225573|NCT00627731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65225574|NCT00627731|Prednisolone phosphate|prednisolone phosphate|mesh-list
65225575|NCT00627731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65225576|NCT00627731|Antiemetics|antiemetics|mesh-ancestor
65225577|NCT00627731|Autonomic Agents|autonomic agents|mesh-ancestor
65225578|NCT00627731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65225579|NCT00627731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225580|NCT00627731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65225581|NCT00627731|Glucocorticoids|glucocorticoids|mesh-ancestor
65225582|NCT00627731|Hormones|hormones|mesh-ancestor
65225583|NCT00627731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65225584|NCT00627731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65225589|NCT01028027|Tobramycin|tobramycin|mesh-list
65225624|NCT02870036|Thalidomide|thalidomide|mesh-list
65225625|NCT02870036|Fluorouracil|fluorouracil|mesh-list
65225626|NCT02870036|Calcium|calcium|mesh-list
65225627|NCT02870036|Levoleucovorin|levoleucovorin|mesh-list
65225628|NCT02870036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65225629|NCT02870036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225630|NCT02870036|Antimetabolites|antimetabolites|mesh-ancestor
65225631|NCT02870036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225632|NCT02870036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65225633|NCT02870036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225634|NCT02870036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65225635|NCT02870036|Immunologic Factors|immunologic factors|mesh-ancestor
65225636|NCT02870036|Antidotes|antidotes|mesh-ancestor
65225637|NCT02870036|Protective Agents|protective agents|mesh-ancestor
65225638|NCT02870036|Vitamin B Complex|vitamin b complex|mesh-ancestor
65225639|NCT02870036|Vitamins|vitamins|mesh-ancestor
65225640|NCT02870036|Micronutrients|micronutrients|mesh-ancestor
65225641|NCT02870036|Leprostatic Agents|leprostatic agents|mesh-ancestor
65225642|NCT02870036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65225643|NCT02870036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65225644|NCT02870036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65225645|NCT02870036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65225646|NCT02870036|Growth Substances|growth substances|mesh-ancestor
65225647|NCT02870036|Growth Inhibitors|growth inhibitors|mesh-ancestor
65225648|NCT04296422|Ibuprofen|ibuprofen|mesh-list
65225649|NCT04296422|Diclofenac|diclofenac|mesh-list
65225650|NCT04296422|Naproxen|naproxen|mesh-list
65225651|NCT04296422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65225652|NCT04296422|Piroxicam|piroxicam|mesh-list
65225672|NCT00998738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225673|NCT00998738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65225674|NCT00998738|Analgesics|analgesics|mesh-ancestor
65225675|NCT00998738|Sensory System Agents|sensory system agents|mesh-ancestor
65225676|NCT00998738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65225677|NCT00998738|Anesthetics|anesthetics|mesh-ancestor
65225678|NCT00998738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65225679|NCT00998738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65225680|NCT00998738|Anticonvulsants|anticonvulsants|mesh-ancestor
65225681|NCT00998738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65225682|NCT00998738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65225683|NCT00998738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225684|NCT00998738|Tocolytic Agents|tocolytic agents|mesh-ancestor
65225685|NCT00998738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65225686|NCT00997334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65225687|NCT00997334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225688|NCT00997334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65225689|NCT00997334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225690|NCT00997334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225691|NCT04369664|Atorvastatin|atorvastatin|mesh-list
65225692|NCT04369664|Ezetimibe|ezetimibe|mesh-list
65225693|NCT04369664|Evolocumab|evolocumab|mesh-list
65225694|NCT04369664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65225695|NCT04369664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65225696|NCT04369664|Antimetabolites|antimetabolites|mesh-ancestor
65225697|NCT04369664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225698|NCT04369664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65225699|NCT04369664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65225700|NCT04369664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225701|NCT04296578|Selenious Acid|selenious acid|mesh-list
65225714|NCT04296578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225715|NCT04296578|Hormone Antagonists|hormone antagonists|mesh-ancestor
65225716|NCT04296578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65225717|NCT04296578|Trace Elements|trace elements|mesh-ancestor
65225718|NCT04296578|Micronutrients|micronutrients|mesh-ancestor
65225719|NCT00996944|Ropinirole|ropinirole|mesh-list
65225720|NCT00996944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65225721|NCT00996944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65225722|NCT00996944|Dopamine Agonists|dopamine agonists|mesh-ancestor
65225723|NCT00996944|Dopamine Agents|dopamine agents|mesh-ancestor
65225724|NCT00996944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65225725|NCT00996944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225726|NCT00996944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225727|NCT01027949|Treprostinil|treprostinil|mesh-list
65225728|NCT01027949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65225729|NCT01038323|Milnacipran|milnacipran|mesh-list
65225730|NCT01038323|Levomilnacipran|levomilnacipran|mesh-list
65225731|NCT01038323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65225732|NCT01038323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65225766|NCT01025843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65225767|NCT01025843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65225768|NCT01025843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225769|NCT02873351|Levodopa|levodopa|mesh-list
65225770|NCT02873351|Carbidopa|carbidopa|mesh-list
65225771|NCT02873351|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65225772|NCT02873351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65225773|NCT02873351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65225774|NCT02873351|Dopamine Agents|dopamine agents|mesh-ancestor
65225775|NCT02873351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65225776|NCT02873351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225777|NCT02873351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225778|NCT02873351|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65225779|NCT02873351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225780|NCT02873351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65225781|NCT02873351|Immunologic Factors|immunologic factors|mesh-ancestor
65225782|NCT02873351|Dopamine Agonists|dopamine agonists|mesh-ancestor
65225783|NCT04299971|Methotrexate|methotrexate|mesh-list
65225784|NCT04299971|Tofacitinib|tofacitinib|mesh-list
65225785|NCT04299971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65225786|NCT04299971|Abortifacient Agents|abortifacient agents|mesh-ancestor
65225787|NCT04299971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65225788|NCT04299971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225789|NCT04299971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65225790|NCT04299971|Antimetabolites|antimetabolites|mesh-ancestor
65225791|NCT04299971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225792|NCT04299971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225793|NCT04299971|Dermatologic Agents|dermatologic agents|mesh-ancestor
65225794|NCT04299971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225808|NCT01020305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65225809|NCT01020305|Immunologic Factors|immunologic factors|mesh-ancestor
65225810|NCT01020305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225811|NCT01020305|Androgen Antagonists|androgen antagonists|mesh-ancestor
65225812|NCT01020305|Hormone Antagonists|hormone antagonists|mesh-ancestor
65225813|NCT01020305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65225814|NCT00627575|Lamotrigine|lamotrigine|mesh-list
65225815|NCT00627575|Phenytoin|phenytoin|mesh-list
65225816|NCT00627575|Atorvastatin|atorvastatin|mesh-list
65225817|NCT00627575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65225818|NCT00627575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65225819|NCT00627575|Antimetabolites|antimetabolites|mesh-ancestor
65225820|NCT00627575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225821|NCT00627575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65225822|NCT00627575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65225823|NCT00627575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65225824|NCT00627575|Anticonvulsants|anticonvulsants|mesh-ancestor
65225825|NCT00627575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65225826|NCT00627575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65225827|NCT00627575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65225828|NCT00627575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225829|NCT00627575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65225830|NCT00627575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65225831|NCT00627575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65225832|NCT00627575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65225833|NCT00627575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65225854|NCT01019369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65225855|NCT01019369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65225856|NCT01019369|Contraceptive Agents|contraceptive agents|mesh-ancestor
65225857|NCT01019369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65225858|NCT01019369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225859|NCT01019369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65225860|NCT01019369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65225861|NCT01019369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65225862|NCT01019369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65225863|NCT01019369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65225864|NCT01018511|Tamsulosin|tamsulosin|mesh-list
65225865|NCT01018511|Solifenacin Succinate|solifenacin succinate|mesh-list
65225866|NCT01018511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65225867|NCT01018511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65225868|NCT01018511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65225869|NCT01018511|Adrenergic Agents|adrenergic agents|mesh-ancestor
65225870|NCT01018511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65225877|NCT00996476|Simeprevir|simeprevir|mesh-list
65225910|NCT01017731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65225911|NCT01017731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65225912|NCT01017731|Anesthetics, Local|anesthetics, local|mesh-ancestor
65225913|NCT01017731|Anesthetics|anesthetics|mesh-ancestor
65225914|NCT01017731|Sensory System Agents|sensory system agents|mesh-ancestor
65225915|NCT01017731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65225916|NCT01017731|Antiemetics|antiemetics|mesh-ancestor
65225917|NCT01017731|Autonomic Agents|autonomic agents|mesh-ancestor
65225918|NCT01017731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65225919|NCT01017731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65225920|NCT01017731|Histamine Antagonists|histamine antagonists|mesh-ancestor
65225921|NCT01017731|Histamine Agents|histamine agents|mesh-ancestor
65225922|NCT01017731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65225923|NCT01017731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65225924|NCT01017731|Antipruritics|antipruritics|mesh-ancestor
65225925|NCT01017731|Dermatologic Agents|dermatologic agents|mesh-ancestor
65225926|NCT02575183|Varenicline|varenicline|mesh-list
65225927|NCT02575183|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65225928|NCT02575183|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65225929|NCT02575183|Cholinergic Agents|cholinergic agents|mesh-ancestor
65225930|NCT02575183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65225931|NCT02575183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225932|NCT02575183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225933|NCT02255305|Anti-Infective Agents|anti-infective agents|mesh-list
65225934|NCT02255305|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65225935|NCT00779584|Gemcitabine|gemcitabine|mesh-list
65225936|NCT00779584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65225960|NCT00769132|Nicotinic Acids|nicotinic acids|mesh-list
65225961|NCT00769132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65225962|NCT00769132|Antimetabolites|antimetabolites|mesh-ancestor
65225963|NCT00769132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225964|NCT00769132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65225965|NCT00769132|Vasodilator Agents|vasodilator agents|mesh-ancestor
65225966|NCT00769132|Vitamin B Complex|vitamin b complex|mesh-ancestor
65225967|NCT00769132|Vitamins|vitamins|mesh-ancestor
65225968|NCT00769132|Micronutrients|micronutrients|mesh-ancestor
65225969|NCT00769132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65225970|NCT04070755|Minocycline|minocycline|mesh-list
65225971|NCT04070755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65225972|NCT04070755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65225973|NCT04100434|Evolocumab|evolocumab|mesh-list
65225974|NCT04100434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65225975|NCT04100434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65225976|NCT04100434|Antimetabolites|antimetabolites|mesh-ancestor
65225977|NCT04100434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65225978|NCT04100434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65225979|NCT00991952|Irinotecan|irinotecan|mesh-list
65226018|NCT02868632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226019|NCT04021498|Simvastatin|simvastatin|mesh-list
65226020|NCT04021498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65226021|NCT04021498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65226022|NCT04021498|Antimetabolites|antimetabolites|mesh-ancestor
65226023|NCT04021498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226024|NCT04021498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65226025|NCT04021498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65226026|NCT04021498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226027|NCT00994682|Pioglitazone|pioglitazone|mesh-list
65226028|NCT00994682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65226029|NCT00994682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226030|NCT00994448|Bupropion|bupropion|mesh-list
65226031|NCT00994448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65226032|NCT00994448|Antidepressive Agents|antidepressive agents|mesh-ancestor
65226033|NCT00994448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65226034|NCT00994448|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65226036|NCT00994448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65226072|NCT00709423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226073|NCT01017029|Mycophenolic Acid|mycophenolic acid|mesh-list
65226074|NCT01017029|Everolimus|everolimus|mesh-list
65226075|NCT01017029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226076|NCT01017029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65226077|NCT01017029|Immunologic Factors|immunologic factors|mesh-ancestor
65226078|NCT01017029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226079|NCT01017029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65226080|NCT01017029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65226081|NCT01017029|Antitubercular Agents|antitubercular agents|mesh-ancestor
65226082|NCT01017029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65226083|NCT01017029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65226084|NCT01017029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226085|NCT01017029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226086|NCT00627887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65226087|NCT00627887|Antidepressive Agents|antidepressive agents|mesh-ancestor
65226088|NCT00627887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65226089|NCT00627887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226090|NCT00627887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226094|NCT00627887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65226124|NCT01016015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65226125|NCT01016015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226126|NCT01016015|Antifungal Agents|antifungal agents|mesh-ancestor
65226127|NCT01016015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65226128|NCT01016015|Immunologic Factors|immunologic factors|mesh-ancestor
65226129|NCT01016015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226130|NCT00628043|Epoetin Alfa|epoetin alfa|mesh-list
65226131|NCT00628043|Hematinics|hematinics|mesh-ancestor
65226132|NCT00709657|Bevacizumab|bevacizumab|mesh-list
65226133|NCT00709657|Ranibizumab|ranibizumab|mesh-list
65226134|NCT00709657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65226135|NCT00709657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226136|NCT00709657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65226137|NCT00709657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65226138|NCT00709657|Growth Substances|growth substances|mesh-ancestor
65226139|NCT00709657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226140|NCT00709657|Growth Inhibitors|growth inhibitors|mesh-ancestor
65226141|NCT04073173|Analgesics, Opioid|analgesics, opioid|mesh-list
65226142|NCT04073173|Analgesics|analgesics|mesh-list
65226143|NCT04073173|Narcotics|narcotics|mesh-ancestor
65226144|NCT04073173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65226145|NCT04073173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226146|NCT04073173|Sensory System Agents|sensory system agents|mesh-ancestor
65226147|NCT04073173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65226148|NCT00628121|Cetrorelix|cetrorelix|mesh-list
65226149|NCT00628121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65226150|NCT00628121|Fertility Agents|fertility agents|mesh-ancestor
65226151|NCT00628121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65226152|NCT00628121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226153|NCT00628121|Hormone Antagonists|hormone antagonists|mesh-ancestor
65226154|NCT00628121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65226155|NCT00709969|Lumefantrine|lumefantrine|mesh-list
65226156|NCT00709969|Artemether|artemether|mesh-list
65226167|NCT00710125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226168|NCT00710125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226169|NCT02573701|Risperidone|risperidone|mesh-list
65226170|NCT02573701|Antipsychotic Agents|antipsychotic agents|mesh-list
65226171|NCT02573701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65226172|NCT02573701|Serotonin Agents|serotonin agents|mesh-ancestor
65226173|NCT02573701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65226174|NCT02573701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226175|NCT02573701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226176|NCT02573701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65226177|NCT02573701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65226178|NCT02573701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65226179|NCT02573701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65226180|NCT02573701|Dopamine Agents|dopamine agents|mesh-ancestor
65226181|NCT00714649|Cetuximab|cetuximab|mesh-list
65226182|NCT00714649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65226183|NCT00714649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226184|NCT00710359|Vitamins|vitamins|mesh-list
65226185|NCT00710359|Vitamin B 12|vitamin b 12|mesh-list
65226186|NCT00710359|Hydroxocobalamin|hydroxocobalamin|mesh-list
65226221|NCT02574715|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65226222|NCT02574715|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65226223|NCT00714883|Sirolimus|sirolimus|mesh-list
65226224|NCT00714883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65226225|NCT00714883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65226226|NCT00714883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65226227|NCT00714883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226228|NCT00714883|Antifungal Agents|antifungal agents|mesh-ancestor
65226229|NCT00714883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65226230|NCT00714883|Immunologic Factors|immunologic factors|mesh-ancestor
65226231|NCT00714883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226232|NCT00710827|Testosterone undecanoate|testosterone undecanoate|mesh-list
65226233|NCT00710827|Androgens|androgens|mesh-ancestor
65226286|NCT01014767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65226287|NCT01014767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65226288|NCT01014767|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65226289|NCT01014689|Lymecycline|lymecycline|mesh-list
65226291|NCT01014689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65226292|NCT01014689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65226293|NCT01014689|Analgesics|analgesics|mesh-ancestor
65226294|NCT01014689|Sensory System Agents|sensory system agents|mesh-ancestor
65226295|NCT01014689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65226296|NCT01014689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226297|NCT01014689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65226298|NCT01014689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65226299|NCT01014689|Dermatologic Agents|dermatologic agents|mesh-ancestor
65226300|NCT01014689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65226301|NCT01014689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65226302|NCT01014533|Gabapentin|gabapentin|mesh-list
65226303|NCT01014533|Analgesics|analgesics|mesh-ancestor
65226304|NCT01014533|Sensory System Agents|sensory system agents|mesh-ancestor
65226305|NCT01014533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65226306|NCT01014533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226307|NCT01014533|Anticonvulsants|anticonvulsants|mesh-ancestor
65226308|NCT01014533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65226309|NCT01014533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65226310|NCT01014533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65226311|NCT01014533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65226312|NCT01014533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65226313|NCT01014533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65226314|NCT01014533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65226315|NCT01014533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226316|NCT01014533|Antimanic Agents|antimanic agents|mesh-ancestor
65226317|NCT02013427|Naproxen|naproxen|mesh-list
65226318|NCT02013427|Omeprazole|omeprazole|mesh-list
65226319|NCT02013427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65226328|NCT02013427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65226329|NCT02013427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226330|NCT02013427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65226331|NCT02013427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65226332|NCT02013427|Gout Suppressants|gout suppressants|mesh-ancestor
65226333|NCT02013427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65226334|NCT01014143|Chlorhexidine|chlorhexidine|mesh-list
65226335|NCT01014143|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65226336|NCT01014143|Triclosan|triclosan|mesh-list
65226337|NCT01014143|Fluorides|fluorides|mesh-list
65226338|NCT01014143|Cariostatic Agents|cariostatic agents|mesh-ancestor
65226339|NCT01014143|Protective Agents|protective agents|mesh-ancestor
65226340|NCT01014143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226341|NCT01014143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65226342|NCT01014143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65226343|NCT01014143|Disinfectants|disinfectants|mesh-ancestor
65226344|NCT01014143|Dermatologic Agents|dermatologic agents|mesh-ancestor
65226345|NCT01014143|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65226346|NCT01014143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65226347|NCT01014143|Antimetabolites|antimetabolites|mesh-ancestor
65226348|NCT01014143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226349|NCT01014143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65226350|NCT00714961|Clopidogrel|clopidogrel|mesh-list
65226351|NCT00714961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65226352|NCT00714961|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65226353|NCT00714961|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65226354|NCT00714961|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65226374|NCT01013753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65226375|NCT01013753|Adrenergic Agents|adrenergic agents|mesh-ancestor
65226376|NCT01013753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65226377|NCT01013753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226378|NCT00715039|Lorazepam|lorazepam|mesh-list
65226379|NCT00715039|Paroxetine|paroxetine|mesh-list
65226380|NCT00715039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65226381|NCT00715039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65226382|NCT00715039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65226383|NCT00715039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226384|NCT00715039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65226385|NCT00715039|Serotonin Agents|serotonin agents|mesh-ancestor
65226386|NCT00715039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226387|NCT00715039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65226389|NCT00715039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65226390|NCT00715039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65226391|NCT00715039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65226392|NCT00715039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226393|NCT00715039|Anticonvulsants|anticonvulsants|mesh-ancestor
65226394|NCT00715039|Antiemetics|antiemetics|mesh-ancestor
65226395|NCT00715039|Autonomic Agents|autonomic agents|mesh-ancestor
65226396|NCT00715039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65226397|NCT00715039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65226398|NCT00715039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65226399|NCT00715039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65226400|NCT00715039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65226401|NCT00715039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65226402|NCT00715039|GABA Modulators|gaba modulators|mesh-ancestor
65226403|NCT00715039|GABA Agents|gaba agents|mesh-ancestor
65226404|NCT00711295|Vaccines|vaccines|mesh-list
65226405|NCT00711295|Immunologic Factors|immunologic factors|mesh-ancestor
65226406|NCT00711295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226407|NCT02871869|Buformin|buformin|mesh-list
65226408|NCT02871869|Prednisone|prednisone|mesh-list
65226409|NCT02871869|Cyclophosphamide|cyclophosphamide|mesh-list
64939862|NCT00017576|Vitamins|vitamins|mesh-ancestor
65226416|NCT02871869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65226417|NCT02871869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65226418|NCT02871869|Alkylating Agents|alkylating agents|mesh-ancestor
65226419|NCT02871869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226420|NCT02871869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226421|NCT02871869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65226422|NCT02871869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65226423|NCT02871869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65226424|NCT02871869|Glucocorticoids|glucocorticoids|mesh-ancestor
65226425|NCT02871869|Hormones|hormones|mesh-ancestor
65226426|NCT02871869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65226427|NCT02871869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65226428|NCT02871869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65226429|NCT02871869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65226430|NCT02871869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65226431|NCT02871869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226432|NCT02871869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65226470|NCT01013285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226471|NCT00715351|Insulin|insulin|mesh-list
65226472|NCT00715351|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65226473|NCT00715351|Insulin Detemir|insulin detemir|mesh-list
65226474|NCT00715351|Isophane Insulin, Human|isophane insulin, human|mesh-list
65226475|NCT00715351|Insulin, Isophane|insulin, isophane|mesh-list
65226476|NCT00715351|Isophane insulin, beef|isophane insulin, beef|mesh-list
65226477|NCT00715351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65226478|NCT00715351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226479|NCT04245085|Paclitaxel|paclitaxel|mesh-list
65226480|NCT04245085|Bevacizumab|bevacizumab|mesh-list
65226481|NCT04245085|Carboplatin|carboplatin|mesh-list
65226482|NCT04245085|Pemetrexed|pemetrexed|mesh-list
65226534|NCT00712465|Protective Agents|protective agents|mesh-ancestor
65226535|NCT00712465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226536|NCT00715975|Clobetasol|clobetasol|mesh-list
65226537|NCT00715975|Halobetasol|halobetasol|mesh-list
65226538|NCT00715975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65226539|NCT00715975|Glucocorticoids|glucocorticoids|mesh-ancestor
65226540|NCT00715975|Hormones|hormones|mesh-ancestor
65226541|NCT00715975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65226542|NCT00715975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226543|NCT00715975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65226544|NCT02572687|Durvalumab|durvalumab|mesh-list
65226545|NCT02572687|Ramucirumab|ramucirumab|mesh-list
65226546|NCT02572687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65226547|NCT02572687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226548|NCT00712777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65226549|NCT00712777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65226550|NCT00712777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65226551|NCT00712777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65226552|NCT00712777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65226553|NCT00712777|Adrenergic Agents|adrenergic agents|mesh-ancestor
65226554|NCT00712777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65226555|NCT00712777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226556|NCT00712777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226557|NCT00603447|Dexamethasone|dexamethasone|mesh-list
65226558|NCT00603447|Lenalidomide|lenalidomide|mesh-list
65226559|NCT00603447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65226560|NCT00603447|Antiemetics|antiemetics|mesh-ancestor
65226561|NCT00603447|Autonomic Agents|autonomic agents|mesh-ancestor
65226562|NCT00603447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65226563|NCT00603447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226564|NCT00603447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65226565|NCT00603447|Glucocorticoids|glucocorticoids|mesh-ancestor
65226566|NCT00603447|Hormones|hormones|mesh-ancestor
65226576|NCT00718705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65226577|NCT00718705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65226578|NCT00639015|Phenylephrine|phenylephrine|mesh-list
65226579|NCT00639015|Oxymetazoline|oxymetazoline|mesh-list
65226580|NCT00639015|Norepinephrine|norepinephrine|mesh-list
65226581|NCT00639015|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65226582|NCT00639015|Mydriatics|mydriatics|mesh-ancestor
65226583|NCT00639015|Autonomic Agents|autonomic agents|mesh-ancestor
65226584|NCT00639015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65226585|NCT00639015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226586|NCT00639015|Sympathomimetics|sympathomimetics|mesh-ancestor
65226587|NCT00639015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65226588|NCT00639015|Nasal Decongestants|nasal decongestants|mesh-ancestor
65226589|NCT00639015|Respiratory System Agents|respiratory system agents|mesh-ancestor
65226590|NCT00639015|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65226591|NCT00639015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65226592|NCT00639015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65226593|NCT00639015|Adrenergic Agents|adrenergic agents|mesh-ancestor
65226594|NCT00639015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65226595|NCT00639015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226597|NCT00712855|Sorafenib|sorafenib|mesh-list
65226630|NCT04208061|Ritonavir|ritonavir|mesh-list
65226631|NCT04208061|Darunavir|darunavir|mesh-list
65226632|NCT04208061|Dabigatran|dabigatran|mesh-list
65226633|NCT04208061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65226634|NCT04208061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65226635|NCT04208061|Protease Inhibitors|protease inhibitors|mesh-ancestor
65226636|NCT04208061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226637|NCT04208061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226638|NCT04208061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65226639|NCT04208061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65226640|NCT04208061|Antiviral Agents|antiviral agents|mesh-ancestor
65226641|NCT04208061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65226642|NCT04208061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65226643|NCT04208061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65226644|NCT04208061|Antithrombins|antithrombins|mesh-ancestor
65226645|NCT04208061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65226646|NCT04208061|Anticoagulants|anticoagulants|mesh-ancestor
65226647|NCT00988208|Prednisone|prednisone|mesh-list
65226648|NCT00988208|Docetaxel|docetaxel|mesh-list
65226649|NCT00988208|Lenalidomide|lenalidomide|mesh-list
65226650|NCT00988208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226651|NCT00988208|Tubulin Modulators|tubulin modulators|mesh-ancestor
65226652|NCT00988208|Antimitotic Agents|antimitotic agents|mesh-ancestor
65226653|NCT00988208|Mitosis Modulators|mitosis modulators|mesh-ancestor
65226684|NCT02686983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65226685|NCT02686983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65226686|NCT02686983|Respiratory System Agents|respiratory system agents|mesh-ancestor
65226687|NCT02686905|Calcium, Dietary|calcium, dietary|mesh-list
65226688|NCT02686905|Vitamin D|vitamin d|mesh-list
65226689|NCT02686905|Vitamins|vitamins|mesh-list
65226690|NCT02686905|Hydroxocobalamin|hydroxocobalamin|mesh-list
65226691|NCT02686905|Vitamin B 12|vitamin b 12|mesh-list
65226692|NCT02686905|Calcium|calcium|mesh-list
65226750|NCT00993668|Immunologic Factors|immunologic factors|mesh-ancestor
65226751|NCT00993668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226752|NCT00993668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65226753|NCT00778102|Leucovorin|leucovorin|mesh-list
65226754|NCT00778102|Bevacizumab|bevacizumab|mesh-list
65226755|NCT00778102|Oxaliplatin|oxaliplatin|mesh-list
65226756|NCT00778102|Irinotecan|irinotecan|mesh-list
65226757|NCT00778102|Fluorouracil|fluorouracil|mesh-list
65226758|NCT00778102|Levoleucovorin|levoleucovorin|mesh-list
65226759|NCT00778102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65226760|NCT00778102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226761|NCT00778102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65226762|NCT00778102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65226763|NCT00778102|Growth Substances|growth substances|mesh-ancestor
65226764|NCT00778102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226765|NCT00778102|Growth Inhibitors|growth inhibitors|mesh-ancestor
65226766|NCT00778102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65226767|NCT00778102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65226768|NCT00778102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226769|NCT00778102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226770|NCT00778102|Antidotes|antidotes|mesh-ancestor
65226773|NCT00778102|Vitamins|vitamins|mesh-ancestor
65226806|NCT02572375|Narcotics|narcotics|mesh-ancestor
65226807|NCT02572375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65226808|NCT02572375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226809|NCT02572375|Analgesics|analgesics|mesh-ancestor
65226810|NCT02572375|Sensory System Agents|sensory system agents|mesh-ancestor
65226811|NCT02572375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65226812|NCT02572375|Antitussive Agents|antitussive agents|mesh-ancestor
65226813|NCT02572375|Respiratory System Agents|respiratory system agents|mesh-ancestor
65226814|NCT02572375|Expectorants|expectorants|mesh-ancestor
65226815|NCT02572375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65226816|NCT02572375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65226817|NCT02572375|Adrenergic Agents|adrenergic agents|mesh-ancestor
65226818|NCT02572375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65226826|NCT00716911|Ganciclovir|ganciclovir|mesh-list
64940327|NCT05576675|Dsuvia|dsuvia|mesh-list
65226867|NCT00756730|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65226868|NCT00756730|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65226869|NCT00756730|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65226870|NCT00756730|Protease Inhibitors|protease inhibitors|mesh-ancestor
65226871|NCT00756730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226872|NCT00756730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226873|NCT00756730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65226874|NCT00756730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65226875|NCT00756730|Antiviral Agents|antiviral agents|mesh-ancestor
65226876|NCT00756730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65226877|NCT02573935|Clarithromycin|clarithromycin|mesh-list
65226878|NCT02573935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65226879|NCT02573935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65226880|NCT02573935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65226881|NCT02573935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226882|NCT02573935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226883|NCT02573935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65226884|NCT02573935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65226885|NCT00984620|Interferons|interferons|mesh-list
65226886|NCT00984620|Ribavirin|ribavirin|mesh-list
65226887|NCT00984620|Interferon-alpha|interferon-alpha|mesh-list
65226888|NCT00984620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869622|NCT01825031|Isoniazid|isoniazid|mesh-list
65226889|NCT00984620|Antiviral Agents|antiviral agents|mesh-ancestor
65226890|NCT00984620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65226891|NCT00984620|Antimetabolites|antimetabolites|mesh-ancestor
65226892|NCT00984620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226893|NCT00984620|Immunologic Factors|immunologic factors|mesh-ancestor
65226903|NCT00639483|Celecoxib|celecoxib|mesh-list
65226910|NCT00639483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65226911|NCT00639483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65226912|NCT00639483|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65226913|NCT00639483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65226914|NCT00639483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226915|NCT00639483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226916|NCT00777946|Amlodipine|amlodipine|mesh-list
65226917|NCT00777946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65226918|NCT00777946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65226919|NCT00777946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65226920|NCT00777946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226921|NCT00777946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65226922|NCT00777946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226923|NCT00777946|Vasodilator Agents|vasodilator agents|mesh-ancestor
65226924|NCT02686047|Hyaluronic Acid|hyaluronic acid|mesh-list
65226925|NCT02686047|Hylan|hylan|mesh-list
65226926|NCT02686047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65226927|NCT02686047|Immunologic Factors|immunologic factors|mesh-ancestor
65226928|NCT02686047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226929|NCT02686047|Viscosupplements|viscosupplements|mesh-ancestor
65226930|NCT02686047|Protective Agents|protective agents|mesh-ancestor
65226931|NCT00713947|Amoxicillin|amoxicillin|mesh-list
65226932|NCT00713947|Metronidazole|metronidazole|mesh-list
65226933|NCT00713947|Clarithromycin|clarithromycin|mesh-list
65226934|NCT00713947|Pantoprazole|pantoprazole|mesh-list
65226935|NCT00713947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65226936|NCT00713947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65226937|NCT00713947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65226938|NCT00713947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65226939|NCT00713947|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65226940|NCT00713947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226941|NCT00713947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226942|NCT00713947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65226943|NCT00713947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65226950|NCT00990314|Vasodilator Agents|vasodilator agents|mesh-ancestor
65226951|NCT00990314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65226952|NCT00909831|Hydroxychloroquine|hydroxychloroquine|mesh-list
65226953|NCT00909831|Sirolimus|sirolimus|mesh-list
65226954|NCT00909831|Antimalarials|antimalarials|mesh-ancestor
65226955|NCT00909831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65226956|NCT00909831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65226957|NCT00909831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65226958|NCT00909831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65226959|NCT00909831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65226960|NCT00909831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65226961|NCT00909831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65226962|NCT00909831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65226963|NCT00909831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65226964|NCT00909831|Antifungal Agents|antifungal agents|mesh-ancestor
65226965|NCT00909831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65226966|NCT00909831|Immunologic Factors|immunologic factors|mesh-ancestor
65226967|NCT00909831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65226968|NCT00717379|Mycophenolic Acid|mycophenolic acid|mesh-list
65226969|NCT00717379|Prednisone|prednisone|mesh-list
65226970|NCT00717379|Methylprednisolone|methylprednisolone|mesh-list
65226971|NCT00717379|Tacrolimus|tacrolimus|mesh-list
65226972|NCT00717379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65226973|NCT00717379|Glucocorticoids|glucocorticoids|mesh-ancestor
65226974|NCT00717379|Hormones|hormones|mesh-ancestor
65226975|NCT00717379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65226980|NCT00717379|Immunologic Factors|immunologic factors|mesh-ancestor
65226999|NCT02867306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940438|NCT00020943|Cytarabine|cytarabine|mesh-list
65227000|NCT02867306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65227001|NCT02867306|Antimetabolites|antimetabolites|mesh-ancestor
65227002|NCT02867306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227003|NCT02867306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227004|NCT02867306|Dermatologic Agents|dermatologic agents|mesh-ancestor
65227011|NCT00777556|Levonorgestrel|levonorgestrel|mesh-list
65227066|NCT04096768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227068|NCT04096768|Analgesics|analgesics|mesh-ancestor
65227069|NCT04096768|Sensory System Agents|sensory system agents|mesh-ancestor
65227070|NCT04096768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65227071|NCT04096768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65227072|NCT04096768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65227073|NCT04096768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65227074|NCT04096768|Adrenergic Agents|adrenergic agents|mesh-ancestor
65227075|NCT04096768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65227076|NCT04096768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227077|NCT04096768|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65227078|NCT04096768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65227079|NCT04096768|Anesthetics, General|anesthetics, general|mesh-ancestor
65227080|NCT04096768|Anesthetics|anesthetics|mesh-ancestor
65227081|NCT04096768|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65227082|NCT04096768|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65227083|NCT00714103|Adenosine|adenosine|mesh-list
65227084|NCT00714103|Analgesics|analgesics|mesh-ancestor
65227085|NCT00714103|Sensory System Agents|sensory system agents|mesh-ancestor
65227086|NCT00714103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65227087|NCT00714103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227088|NCT00714103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65227118|NCT00714181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65227119|NCT00714181|Alkylating Agents|alkylating agents|mesh-ancestor
65227120|NCT00714181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227121|NCT00714181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227122|NCT00714181|Antimalarials|antimalarials|mesh-ancestor
65227123|NCT00714181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65227124|NCT00714181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65227125|NCT00714181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65227126|NCT00714181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227127|NCT00714181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65227128|NCT02600806|Azithromycin|azithromycin|mesh-list
65227129|NCT02600806|Levofloxacin|levofloxacin|mesh-list
65227130|NCT02600806|Ofloxacin|ofloxacin|mesh-list
65227131|NCT02600806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65227132|NCT02600806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65227133|NCT02600806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65227134|NCT02600806|Renal Agents|renal agents|mesh-ancestor
65227135|NCT02600806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65227136|NCT02600806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65227137|NCT02600806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227138|NCT02600806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227139|NCT02600806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227140|NCT02600806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65227171|NCT04291118|Hormones|hormones|mesh-ancestor
65227172|NCT04291118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65227173|NCT02868944|Sufentanil|sufentanil|mesh-list
65227174|NCT02868944|Morphine|morphine|mesh-list
65227175|NCT02868944|Levobupivacaine|levobupivacaine|mesh-list
65227176|NCT02868944|Anesthetics|anesthetics|mesh-list
65227177|NCT02868944|Anesthetics, Local|anesthetics, local|mesh-list
65227178|NCT02868944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65227179|NCT02868944|Narcotics|narcotics|mesh-ancestor
65227180|NCT02868944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65227181|NCT02868944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227182|NCT02868944|Analgesics|analgesics|mesh-ancestor
65227183|NCT02868944|Sensory System Agents|sensory system agents|mesh-ancestor
65227184|NCT02868944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65227185|NCT02868944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65227186|NCT02868944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65227187|NCT02868944|Anesthetics, General|anesthetics, general|mesh-ancestor
65227188|NCT03292809|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65227189|NCT03292809|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65227190|NCT00722839|Vaccines|vaccines|mesh-list
65227191|NCT00722839|Immunologic Factors|immunologic factors|mesh-ancestor
65227192|NCT00722839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227193|NCT04096690|Pegaspargase|pegaspargase|mesh-list
65227195|NCT04096690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65227196|NCT04096690|Immunologic Factors|immunologic factors|mesh-ancestor
65227197|NCT04096690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227198|NCT04096690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227199|NCT03565783|Cemiplimab|cemiplimab|mesh-list
65227221|NCT00719797|Immunologic Factors|immunologic factors|mesh-ancestor
65227222|NCT00719797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65227223|NCT00719797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65227224|NCT00719797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227225|NCT00719797|Antidotes|antidotes|mesh-ancestor
65227226|NCT00719797|Protective Agents|protective agents|mesh-ancestor
65227227|NCT00719797|Vitamin B Complex|vitamin b complex|mesh-ancestor
65227229|NCT00719797|Micronutrients|micronutrients|mesh-ancestor
65227230|NCT00979628|Insulin|insulin|mesh-list
65227231|NCT00979628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65227232|NCT00979628|Insulin Glargine|insulin glargine|mesh-list
65227233|NCT00979628|Insulin glulisine|insulin glulisine|mesh-list
65227234|NCT00979628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65227235|NCT00979628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227236|NCT00719875|Vorinostat|vorinostat|mesh-list
65227237|NCT00719875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65227238|NCT00719875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227239|NCT00719875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227240|NCT00719875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227241|NCT02685111|Lenograstim|lenograstim|mesh-list
65227242|NCT02685111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65227243|NCT02685111|Immunologic Factors|immunologic factors|mesh-ancestor
65227244|NCT02685111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227245|NCT00717925|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
65227246|NCT00717925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65227247|NCT00717925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227248|NCT00717925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65227249|NCT03258723|Metformin|metformin|mesh-list
65227250|NCT03258723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65227251|NCT03258723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227252|NCT00640029|Meloxicam|meloxicam|mesh-list
65227254|NCT00640029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65227267|NCT02684799|Famotidine|famotidine|mesh-list
65227268|NCT02684799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65227269|NCT02684799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65227270|NCT02684799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65227271|NCT02684799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227272|NCT02684799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227273|NCT02684799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65227274|NCT02684799|Histamine Antagonists|histamine antagonists|mesh-ancestor
65227275|NCT02684799|Histamine Agents|histamine agents|mesh-ancestor
65227276|NCT02684799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65227277|NCT02684799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227278|NCT02684799|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65227279|NCT02684799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65227280|NCT02684799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65227281|NCT02684799|Antiviral Agents|antiviral agents|mesh-ancestor
65227282|NCT02684799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65227283|NCT02685189|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
65227284|NCT02685189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227285|NCT02685189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227286|NCT00992108|Lidocaine|lidocaine|mesh-list
65227287|NCT00992108|Anesthetics, Local|anesthetics, local|mesh-ancestor
65227288|NCT00992108|Anesthetics|anesthetics|mesh-ancestor
65227289|NCT00992108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65227290|NCT00992108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227291|NCT00992108|Sensory System Agents|sensory system agents|mesh-ancestor
65227292|NCT00992108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65227293|NCT00992108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65227294|NCT00992108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65227295|NCT00992108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65227296|NCT00992108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65227297|NCT00992108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227299|NCT00752986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64940738|NCT00022230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227308|NCT02684487|Vitamins|vitamins|mesh-ancestor
65227309|NCT02684487|Micronutrients|micronutrients|mesh-ancestor
65227310|NCT02684487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227311|NCT02684487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65227312|NCT02684487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65227313|NCT02684409|Sumatriptan|sumatriptan|mesh-list
65227314|NCT02684409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65227315|NCT02684409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65227316|NCT02684409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65227317|NCT02684409|Serotonin Agents|serotonin agents|mesh-ancestor
65227318|NCT02684409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65227319|NCT02684409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227320|NCT02684409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227321|NCT00762892|Tenofovir|tenofovir|mesh-list
65227322|NCT00762892|Emtricitabine|emtricitabine|mesh-list
65227323|NCT00762892|Raltegravir Potassium|raltegravir potassium|mesh-list
65227324|NCT00762892|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65227325|NCT00762892|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65227326|NCT00762892|Antiviral Agents|antiviral agents|mesh-ancestor
65227327|NCT00762892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65227328|NCT00762892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65227329|NCT00762892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65227330|NCT00762892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227331|NCT00762892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227332|NCT00762892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65227333|NCT00762892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65227334|NCT00762892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65227335|NCT00762892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65227336|NCT00762892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65227337|NCT00762892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65227338|NCT00762892|Protease Inhibitors|protease inhibitors|mesh-ancestor
65227339|NCT04290572|Isotretinoin|isotretinoin|mesh-list
64940776|NCT00022542|Epothilone B|epothilone b|mesh-list
64940777|NCT00022542|Tubulin Modulators|tubulin modulators|mesh-ancestor
64940778|NCT00022542|Antimitotic Agents|antimitotic agents|mesh-ancestor
64940779|NCT00022542|Mitosis Modulators|mitosis modulators|mesh-ancestor
65227345|NCT04069429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227346|NCT00755716|Topiramate|topiramate|mesh-list
65227347|NCT00755716|Nicotine|nicotine|mesh-list
65227348|NCT00755716|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65227349|NCT00755716|Autonomic Agents|autonomic agents|mesh-ancestor
65227350|NCT00755716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65227351|NCT00755716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227352|NCT00755716|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65227353|NCT00755716|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65227354|NCT00755716|Cholinergic Agents|cholinergic agents|mesh-ancestor
65227355|NCT00755716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65227356|NCT00755716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227357|NCT00755716|Anticonvulsants|anticonvulsants|mesh-ancestor
65227358|NCT00755716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65227359|NCT00629252|Risperidone|risperidone|mesh-list
65227360|NCT00629252|Sertindole|sertindole|mesh-list
65227361|NCT00629252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65227362|NCT00629252|Serotonin Agents|serotonin agents|mesh-ancestor
65227363|NCT00629252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65227364|NCT00629252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227365|NCT00629252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227366|NCT00629252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65227367|NCT00629252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65227388|NCT04095754|Adrenergic Agents|adrenergic agents|mesh-ancestor
65227389|NCT04095754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65227390|NCT04095754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227391|NCT00720265|Tacrolimus|tacrolimus|mesh-list
65227392|NCT00720265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65227393|NCT00720265|Immunologic Factors|immunologic factors|mesh-ancestor
65227394|NCT00720265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227395|NCT00720265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65227396|NCT00720265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227397|NCT00720265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227398|NCT02600650|Testosterone|testosterone|mesh-list
65227399|NCT02600650|Androgens|androgens|mesh-ancestor
65227400|NCT02600650|Hormones|hormones|mesh-ancestor
65227401|NCT02600650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65227402|NCT02600650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227403|NCT03084471|Durvalumab|durvalumab|mesh-list
65227404|NCT03084471|Tremelimumab|tremelimumab|mesh-list
65227405|NCT03084471|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65227406|NCT03084471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65227407|NCT03084471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227408|NCT03084471|Immunologic Factors|immunologic factors|mesh-ancestor
65227409|NCT03084471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227410|NCT00718471|Heparin|heparin|mesh-list
65227440|NCT02684019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65227441|NCT02684019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65227442|NCT02684019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227444|NCT02684019|Analgesics|analgesics|mesh-ancestor
65227445|NCT02684019|Sensory System Agents|sensory system agents|mesh-ancestor
65227446|NCT02684019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65227447|NCT02684019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65227448|NCT02684019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65227449|NCT02684019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65227450|NCT02684019|Adrenergic Agents|adrenergic agents|mesh-ancestor
65227451|NCT02684019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65227452|NCT02684019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227453|NCT02684019|Anesthetics|anesthetics|mesh-ancestor
65227454|NCT02684019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65227455|NCT02684019|Anticonvulsants|anticonvulsants|mesh-ancestor
65227456|NCT02684019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65227457|NCT02684019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65227458|NCT02684019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65227459|NCT02684019|Tocolytic Agents|tocolytic agents|mesh-ancestor
65227460|NCT02684019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65227461|NCT00720421|Lorazepam|lorazepam|mesh-list
65227492|NCT02601508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65227493|NCT02601508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65227494|NCT02601508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65227495|NCT02601508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65227496|NCT02601508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227497|NCT02601508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65227498|NCT02601508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65227499|NCT02601508|Cholinergic Agents|cholinergic agents|mesh-ancestor
65227500|NCT02601508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65227501|NCT02601508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227502|NCT02570581|Acetaminophen|acetaminophen|mesh-list
65227503|NCT02570581|Ramipril|ramipril|mesh-list
65227504|NCT02570581|Furosemide|furosemide|mesh-list
65227505|NCT02570581|Memantine|memantine|mesh-list
65227506|NCT02570581|Alprazolam|alprazolam|mesh-list
65227507|NCT02570581|Zopiclone|zopiclone|mesh-list
65227508|NCT02570581|Oxazepam|oxazepam|mesh-list
65227509|NCT02570581|Donepezil|donepezil|mesh-list
65227510|NCT02570581|Clopidogrel|clopidogrel|mesh-list
65227511|NCT02570581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65227512|NCT02570581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65227513|NCT02570581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65227514|NCT02570581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65227515|NCT02570581|Purinergic Agents|purinergic agents|mesh-ancestor
65227516|NCT02570581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64959424|NCT00128245|Immunologic Factors|immunologic factors|mesh-ancestor
65227517|NCT02570581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227519|NCT02570581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65227520|NCT02570581|Analgesics|analgesics|mesh-ancestor
65227521|NCT02570581|Sensory System Agents|sensory system agents|mesh-ancestor
65227522|NCT02570581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65227523|NCT02570581|Antipyretics|antipyretics|mesh-ancestor
65227524|NCT02570581|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65227525|NCT02570581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227533|NCT02570581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65227534|NCT02570581|Dopamine Agents|dopamine agents|mesh-ancestor
65227535|NCT02570581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65227536|NCT02570581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65227537|NCT02570581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65227538|NCT02570581|Protease Inhibitors|protease inhibitors|mesh-ancestor
65227539|NCT02570581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65227540|NCT02570581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65227541|NCT02570581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65227542|NCT02570581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65227543|NCT02570581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65227544|NCT02570581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65227545|NCT02570581|GABA Modulators|gaba modulators|mesh-ancestor
65227546|NCT02570581|GABA Agents|gaba agents|mesh-ancestor
65227547|NCT00640263|Ritonavir|ritonavir|mesh-list
65227548|NCT00640263|Lopinavir|lopinavir|mesh-list
65227549|NCT00640263|Lamivudine|lamivudine|mesh-list
65227550|NCT00640263|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65227551|NCT00640263|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65227552|NCT00640263|Protease Inhibitors|protease inhibitors|mesh-ancestor
65227553|NCT00640263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227554|NCT00640263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227555|NCT00640263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65227556|NCT00640263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65227557|NCT00640263|Antiviral Agents|antiviral agents|mesh-ancestor
65227558|NCT00640263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65227559|NCT00640263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65227563|NCT02683863|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65227581|NCT02865668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227582|NCT02867930|Dexmedetomidine|dexmedetomidine|mesh-list
65227583|NCT02867930|Ketamine|ketamine|mesh-list
65227584|NCT02867930|Propofol|propofol|mesh-list
65227585|NCT02867930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65227586|NCT02867930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65227587|NCT02867930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227588|NCT02867930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65227589|NCT02867930|Anesthetics, General|anesthetics, general|mesh-ancestor
65227590|NCT02867930|Anesthetics|anesthetics|mesh-ancestor
65227591|NCT02867930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65227592|NCT02867930|Analgesics|analgesics|mesh-ancestor
65227593|NCT02867930|Sensory System Agents|sensory system agents|mesh-ancestor
65227594|NCT02867930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65227595|NCT02867930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65227596|NCT02867930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65227597|NCT02867930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65227598|NCT02867930|Adrenergic Agents|adrenergic agents|mesh-ancestor
65227599|NCT02867930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65227600|NCT02867930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227601|NCT02867930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65227604|NCT02570893|Paclitaxel|paclitaxel|mesh-list
65227633|NCT02866448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65227634|NCT02866448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65227635|NCT02866448|Analgesics|analgesics|mesh-ancestor
65227636|NCT02866448|Sensory System Agents|sensory system agents|mesh-ancestor
65227637|NCT02866448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65227638|NCT02866448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227639|NCT02866448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65227640|NCT02866448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65227641|NCT02866448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65227642|NCT02866448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64870358|NCT01832350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65227643|NCT02866448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227644|NCT02866448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65227645|NCT02866448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65227646|NCT02866448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227647|NCT02866448|Antipyretics|antipyretics|mesh-ancestor
65227648|NCT00578227|Vaccines|vaccines|mesh-list
65227649|NCT00578227|Immunologic Factors|immunologic factors|mesh-ancestor
65227650|NCT00578227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227651|NCT00720577|Pioglitazone|pioglitazone|mesh-list
65227652|NCT00720577|Losartan|losartan|mesh-list
65227653|NCT00720577|Simvastatin|simvastatin|mesh-list
65227654|NCT00720577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65227655|NCT00720577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65227682|NCT05373277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227683|NCT00724321|Iloprost|iloprost|mesh-list
65227684|NCT00724321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65227685|NCT00724321|Vasodilator Agents|vasodilator agents|mesh-ancestor
65227686|NCT00720811|Acetaminophen|acetaminophen|mesh-list
65227687|NCT00720811|Amoxicillin|amoxicillin|mesh-list
65227688|NCT00720811|Lumefantrine|lumefantrine|mesh-list
65227689|NCT00720811|Artemether|artemether|mesh-list
65227690|NCT00720811|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65227691|NCT00720811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65227692|NCT00720811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65227693|NCT00720811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65227694|NCT00720811|Analgesics|analgesics|mesh-ancestor
65227695|NCT00720811|Sensory System Agents|sensory system agents|mesh-ancestor
65227696|NCT00720811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65227697|NCT00720811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227698|NCT00720811|Antipyretics|antipyretics|mesh-ancestor
65227699|NCT00720811|Antimalarials|antimalarials|mesh-ancestor
65227700|NCT00720811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65227701|NCT00720811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65227702|NCT00724633|Dialysis Solutions|dialysis solutions|mesh-list
65227703|NCT00724633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65227704|NCT00577993|Interferons|interferons|mesh-list
65227705|NCT00577993|Interferon-alpha|interferon-alpha|mesh-list
65227706|NCT00577993|Interferon alpha-2|interferon alpha-2|mesh-list
65227707|NCT00577993|Dexamethasone|dexamethasone|mesh-list
65227708|NCT00577993|Prednisone|prednisone|mesh-list
65227709|NCT00577993|Prednisolone|prednisolone|mesh-list
65227710|NCT00577993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65227711|NCT00577993|Methylprednisolone|methylprednisolone|mesh-list
65227712|NCT00577993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65227733|NCT00577993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65227734|NCT00577993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65227735|NCT00577993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65227736|NCT00577993|Antiemetics|antiemetics|mesh-ancestor
65227737|NCT00577993|Autonomic Agents|autonomic agents|mesh-ancestor
65227738|NCT00577993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65227739|NCT00577993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65227740|NCT00577993|Glucocorticoids|glucocorticoids|mesh-ancestor
65227741|NCT00577993|Hormones|hormones|mesh-ancestor
65227742|NCT00577993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65227743|NCT00577993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65227744|NCT00577993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227745|NCT00577993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65227746|NCT00577993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65227747|NCT00577993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65227748|NCT00577993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65227750|NCT00577993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65227751|NCT00577993|Tubulin Modulators|tubulin modulators|mesh-ancestor
65227752|NCT00577993|Antimitotic Agents|antimitotic agents|mesh-ancestor
65227753|NCT00577993|Mitosis Modulators|mitosis modulators|mesh-ancestor
65227754|NCT00577993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65227755|NCT00577993|Protective Agents|protective agents|mesh-ancestor
65227756|NCT00577993|Analgesics|analgesics|mesh-ancestor
65227757|NCT00577993|Sensory System Agents|sensory system agents|mesh-ancestor
65227758|NCT00975806|Lenalidomide|lenalidomide|mesh-list
65227759|NCT00975806|Sunitinib|sunitinib|mesh-list
65227760|NCT00975806|Immunologic Factors|immunologic factors|mesh-ancestor
65227761|NCT00975806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227780|NCT00721201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65227781|NCT00721201|Hormone Antagonists|hormone antagonists|mesh-ancestor
65227782|NCT00721201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65227783|NCT00721201|Luteolytic Agents|luteolytic agents|mesh-ancestor
65227784|NCT00721201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65227785|NCT00721201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65227786|NCT02866370|Paclitaxel|paclitaxel|mesh-list
65227787|NCT02866370|Carboplatin|carboplatin|mesh-list
65227788|NCT02866370|Doxorubicin|doxorubicin|mesh-list
65227789|NCT02866370|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65227790|NCT02866370|Topotecan|topotecan|mesh-list
65227791|NCT02866370|Nintedanib|nintedanib|mesh-list
65227792|NCT02866370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65227793|NCT02866370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227794|NCT02866370|Tubulin Modulators|tubulin modulators|mesh-ancestor
65227795|NCT02866370|Antimitotic Agents|antimitotic agents|mesh-ancestor
65227796|NCT02866370|Mitosis Modulators|mitosis modulators|mesh-ancestor
65227797|NCT02866370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227798|NCT02866370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65227799|NCT02866370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65227800|NCT02866370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65227801|NCT02866370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227832|NCT00629642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227833|NCT00629642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227834|NCT00629642|Urological Agents|urological agents|mesh-ancestor
65227835|NCT00629642|Parasympatholytics|parasympatholytics|mesh-ancestor
65227836|NCT00629642|Autonomic Agents|autonomic agents|mesh-ancestor
65227837|NCT00629642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65227838|NCT02865356|Cyclosporine|cyclosporine|mesh-list
65227839|NCT02865356|Cyclosporins|cyclosporins|mesh-list
65227840|NCT02865356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227841|NCT02865356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227842|NCT02865356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65227843|NCT02865356|Immunologic Factors|immunologic factors|mesh-ancestor
65227844|NCT02865356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227845|NCT02865356|Antifungal Agents|antifungal agents|mesh-ancestor
65227846|NCT02865356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65227847|NCT02865356|Dermatologic Agents|dermatologic agents|mesh-ancestor
65227891|NCT03715933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65227892|NCT03715933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65227893|NCT03715933|Immunologic Factors|immunologic factors|mesh-ancestor
65227894|NCT03715933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227895|NCT03715933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65227896|NCT03715933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65227897|NCT03715933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227898|NCT03715933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65227899|NCT03715933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65227900|NCT03715933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65227901|NCT03715933|Alkylating Agents|alkylating agents|mesh-ancestor
65227902|NCT02689401|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65227903|NCT02689401|Hematinics|hematinics|mesh-ancestor
65227904|NCT02689401|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65227905|NCT02689401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65227906|NCT04541407|Temozolomide|temozolomide|mesh-list
65227907|NCT04541407|Osimertinib|osimertinib|mesh-list
65227908|NCT04541407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65227909|NCT04541407|Alkylating Agents|alkylating agents|mesh-ancestor
65227910|NCT04541407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227914|NCT00640575|Triamcinolone|triamcinolone|mesh-list
65227943|NCT00762034|Paclitaxel|paclitaxel|mesh-list
65227944|NCT00762034|Bevacizumab|bevacizumab|mesh-list
65227945|NCT00762034|Carboplatin|carboplatin|mesh-list
65227946|NCT00762034|Pemetrexed|pemetrexed|mesh-list
65227947|NCT00762034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65227948|NCT00762034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65227949|NCT00762034|Tubulin Modulators|tubulin modulators|mesh-ancestor
65227950|NCT00762034|Antimitotic Agents|antimitotic agents|mesh-ancestor
65227951|NCT00762034|Mitosis Modulators|mitosis modulators|mesh-ancestor
65227952|NCT00762034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227953|NCT00762034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65227954|NCT00762034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65227955|NCT00762034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65227956|NCT00762034|Growth Substances|growth substances|mesh-ancestor
65227957|NCT00762034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65227958|NCT00762034|Growth Inhibitors|growth inhibitors|mesh-ancestor
65227959|NCT00762034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227960|NCT00762034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65227961|NCT00762034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65227962|NCT02387229|Rivaroxaban|rivaroxaban|mesh-list
65227963|NCT02387229|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65227964|NCT02387229|Antithrombins|antithrombins|mesh-ancestor
65227965|NCT02387229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65227966|NCT02387229|Protease Inhibitors|protease inhibitors|mesh-ancestor
65227967|NCT02387229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65227968|NCT02387229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227970|NCT04183881|Brodalumab|brodalumab|mesh-list
65227992|NCT04184115|Cholinergic Agents|cholinergic agents|mesh-ancestor
65227993|NCT04184115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65227994|NCT04184115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65227995|NCT04184115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65227996|NCT00722215|Nifedipine|nifedipine|mesh-list
65227997|NCT00722215|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-list
65227998|NCT00722215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65227999|NCT00722215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65228000|NCT00722215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228001|NCT00722215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65228002|NCT00722215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228003|NCT00722215|Vasodilator Agents|vasodilator agents|mesh-ancestor
65228004|NCT00722215|Tocolytic Agents|tocolytic agents|mesh-ancestor
65228005|NCT00722215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65228006|NCT00722215|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65228007|NCT00640809|Ibuprofen|ibuprofen|mesh-list
65228008|NCT00640809|Celecoxib|celecoxib|mesh-list
65228009|NCT00640809|Omeprazole|omeprazole|mesh-list
65228010|NCT00640809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65228011|NCT00640809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65228012|NCT00640809|Analgesics|analgesics|mesh-ancestor
65228013|NCT00640809|Sensory System Agents|sensory system agents|mesh-ancestor
65228014|NCT00640809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65228015|NCT00640809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228016|NCT00640809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65228017|NCT00640809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65228028|NCT05630209|Doxorubicin|doxorubicin|mesh-list
65228039|NCT00722293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228040|NCT00722293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65228041|NCT00722293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65228042|NCT00722293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228043|NCT00722293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228044|NCT04095832|Anesthetics|anesthetics|mesh-list
65228045|NCT04095832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65228046|NCT04095832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228047|NCT00726505|Dapagliflozin|dapagliflozin|mesh-list
65228048|NCT00726505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65228049|NCT00726505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228050|NCT00726505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65228051|NCT00726505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228053|NCT02683005|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
65228054|NCT02683005|Ledipasvir|ledipasvir|mesh-list
65228055|NCT02683005|Antiviral Agents|antiviral agents|mesh-ancestor
65228056|NCT02683005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65228057|NCT03583957|Caffeine|caffeine|mesh-list
65228095|NCT02682693|Paclitaxel|paclitaxel|mesh-list
65228097|NCT02682693|Carboplatin|carboplatin|mesh-list
65228098|NCT02682693|Trastuzumab|trastuzumab|mesh-list
65228099|NCT02682693|Epirubicin|epirubicin|mesh-list
65228100|NCT02682693|Pertuzumab|pertuzumab|mesh-list
65228101|NCT02682693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65228102|NCT02682693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228103|NCT02682693|Tubulin Modulators|tubulin modulators|mesh-ancestor
65228104|NCT02682693|Antimitotic Agents|antimitotic agents|mesh-ancestor
65228105|NCT02682693|Mitosis Modulators|mitosis modulators|mesh-ancestor
65228106|NCT02682693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228107|NCT02682693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65228108|NCT02682693|Immunologic Factors|immunologic factors|mesh-ancestor
65228109|NCT02682693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228110|NCT02682693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65228111|NCT02682693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65228112|NCT02682693|Alkylating Agents|alkylating agents|mesh-ancestor
65228113|NCT02682693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65228114|NCT02682693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65228115|NCT02682693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65228116|NCT02682693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65228117|NCT02682693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65228118|NCT02682693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228119|NCT02682693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65228120|NCT02571517|Methylprednisolone|methylprednisolone|mesh-list
65228121|NCT02571517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65228122|NCT02571517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65228123|NCT02571517|Prednisolone|prednisolone|mesh-list
65228124|NCT02571517|Prednisolone acetate|prednisolone acetate|mesh-list
65228125|NCT02571517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65228126|NCT02571517|Prednisolone phosphate|prednisolone phosphate|mesh-list
65228127|NCT02571517|Glucocorticoids|glucocorticoids|mesh-list
65228128|NCT02571517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65228129|NCT02571517|Antiemetics|antiemetics|mesh-ancestor
65228130|NCT02571517|Autonomic Agents|autonomic agents|mesh-ancestor
65228131|NCT02571517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65228136|NCT02571517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65228137|NCT02571517|Protective Agents|protective agents|mesh-ancestor
65228138|NCT02571517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65228139|NCT02571517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228140|NCT00586846|Doxorubicin|doxorubicin|mesh-list
65228141|NCT00586846|Methotrexate|methotrexate|mesh-list
65228142|NCT00586846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228143|NCT00586846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65228144|NCT00586846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65228145|NCT00586846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65228146|NCT00586846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228147|NCT00586846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228148|NCT00586846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65228149|NCT00586846|Abortifacient Agents|abortifacient agents|mesh-ancestor
65228150|NCT00586846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65228151|NCT00586846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228152|NCT00586846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65228153|NCT00586846|Antimetabolites|antimetabolites|mesh-ancestor
65228154|NCT00586846|Dermatologic Agents|dermatologic agents|mesh-ancestor
65228155|NCT00586846|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65228156|NCT00586846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65228157|NCT00586846|Immunologic Factors|immunologic factors|mesh-ancestor
65228158|NCT00586846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65228159|NCT00586846|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65228160|NCT04144465|Phenylephrine|phenylephrine|mesh-list
65228161|NCT04144465|Oxymetazoline|oxymetazoline|mesh-list
65228184|NCT04066621|Ceftriaxone|ceftriaxone|mesh-list
65228185|NCT04066621|Sulbactam|sulbactam|mesh-list
65228186|NCT04066621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65228187|NCT04066621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65228188|NCT04066621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65228189|NCT04066621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228190|NCT04066621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228191|NCT00629564|Esomeprazole|esomeprazole|mesh-list
65228192|NCT00629564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65228193|NCT00629564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65228194|NCT00629564|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65228195|NCT00629564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228196|NCT00629564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228197|NCT02227927|Domperidone|domperidone|mesh-list
65228198|NCT02227927|Antiemetics|antiemetics|mesh-ancestor
65228199|NCT02227927|Autonomic Agents|autonomic agents|mesh-ancestor
65228200|NCT02227927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65228201|NCT02227927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228202|NCT02227927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65228203|NCT02227927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65228204|NCT02227927|Dopamine Agents|dopamine agents|mesh-ancestor
65228205|NCT02227927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65228206|NCT02227927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228207|NCT02865824|Aspirin|aspirin|mesh-list
65228208|NCT02865824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65228209|NCT02865824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65228210|NCT02865824|Analgesics|analgesics|mesh-ancestor
65228211|NCT02865824|Sensory System Agents|sensory system agents|mesh-ancestor
65228212|NCT02865824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65228213|NCT02865824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228214|NCT02865824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65228227|NCT02570035|Adrenergic Agents|adrenergic agents|mesh-ancestor
65228228|NCT02570035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65228229|NCT02570035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228230|NCT02570035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228231|NCT02570035|Urological Agents|urological agents|mesh-ancestor
65228232|NCT02865980|Povidone-Iodine|povidone-iodine|mesh-list
65228233|NCT02865980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65228234|NCT02865980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65228235|NCT04098796|Antibodies|antibodies|mesh-list
65228236|NCT04098796|Immunologic Factors|immunologic factors|mesh-ancestor
65228237|NCT04098796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228238|NCT00522145|XL647|xl647|mesh-list
65228239|NCT00522145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228240|NCT00522145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65228241|NCT00522145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228242|NCT00522145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228243|NCT00726973|Ranibizumab|ranibizumab|mesh-list
65228244|NCT00726973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65228245|NCT00726973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65228247|NCT00726973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228283|NCT04290026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65228284|NCT04290026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65228285|NCT04290026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65228286|NCT04290026|Dopamine Agents|dopamine agents|mesh-ancestor
65228287|NCT04290026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65228288|NCT04290026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228289|NCT04290026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65228290|NCT04290026|Serotonin Agents|serotonin agents|mesh-ancestor
65228291|NCT00640887|Ritonavir|ritonavir|mesh-list
65228292|NCT00640887|Lopinavir|lopinavir|mesh-list
65228293|NCT00640887|Nevirapine|nevirapine|mesh-list
65228294|NCT00640887|Efavirenz|efavirenz|mesh-list
65228295|NCT00640887|Rifabutin|rifabutin|mesh-list
65228296|NCT00640887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65228326|NCT00730093|Vitamins|vitamins|mesh-ancestor
65228345|NCT04183725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65228346|NCT04183725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228347|NCT04183725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228349|NCT00730249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65228350|NCT00730249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228351|NCT00730249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65228352|NCT00730249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65228353|NCT00730249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65228354|NCT00730249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228355|NCT00730249|Dopamine Agents|dopamine agents|mesh-ancestor
65228356|NCT00730249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65228357|NCT02570347|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65228358|NCT02570347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65228359|NCT02570347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65228360|NCT02570347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65228361|NCT02570347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228362|NCT02570347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228363|NCT01632657|Sumatriptan|sumatriptan|mesh-list
65228364|NCT01632657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65228365|NCT01632657|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65228366|NCT01632657|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65228367|NCT01632657|Serotonin Agents|serotonin agents|mesh-ancestor
65228368|NCT01632657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65228369|NCT01632657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228390|NCT02620579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228391|NCT02620579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228392|NCT02620579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65228393|NCT02620579|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65228394|NCT02620579|Vasodilator Agents|vasodilator agents|mesh-ancestor
65228396|NCT02682225|Esketamine|esketamine|mesh-list
65228397|NCT02682225|Analgesics|analgesics|mesh-ancestor
65228398|NCT02682225|Sensory System Agents|sensory system agents|mesh-ancestor
65228399|NCT02682225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65228400|NCT02682225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228401|NCT02682225|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65228402|NCT02682225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65228403|NCT02682225|Anesthetics, General|anesthetics, general|mesh-ancestor
65228404|NCT02682225|Anesthetics|anesthetics|mesh-ancestor
65228405|NCT02682225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65228406|NCT02682225|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65228407|NCT02682225|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65228408|NCT02682225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65228409|NCT02682225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228410|NCT02682225|Antidepressive Agents|antidepressive agents|mesh-ancestor
65228411|NCT02682225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65228412|NCT03900793|Sunitinib|sunitinib|mesh-list
65228413|NCT03900793|Losartan|losartan|mesh-list
65228414|NCT03900793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228415|NCT03900793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65228439|NCT04066231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65228440|NCT04066231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65228441|NCT04066231|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65228442|NCT04066231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228443|NCT04066231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228444|NCT04183491|Interferons|interferons|mesh-list
65228445|NCT04183491|Interferon-beta|interferon-beta|mesh-list
65228446|NCT04183491|Interferon beta-1a|interferon beta-1a|mesh-list
65228447|NCT04183491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228448|NCT04183491|Antiviral Agents|antiviral agents|mesh-ancestor
65228449|NCT04183491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65228450|NCT04183491|Immunologic Factors|immunologic factors|mesh-ancestor
65228451|NCT04183491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228452|NCT04183491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65228453|NCT03702283|Penicillins|penicillins|mesh-list
65228454|NCT03702283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65228455|NCT03702283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65228456|NCT00727753|Bevacizumab|bevacizumab|mesh-list
65228457|NCT00727753|Ranibizumab|ranibizumab|mesh-list
65228458|NCT00727753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65228459|NCT00727753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228460|NCT00727753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65228461|NCT00727753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65228462|NCT00727753|Growth Substances|growth substances|mesh-ancestor
65228463|NCT00727753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228464|NCT00727753|Growth Inhibitors|growth inhibitors|mesh-ancestor
65228465|NCT00727831|Leucovorin|leucovorin|mesh-list
65228466|NCT00727831|Methotrexate|methotrexate|mesh-list
65228467|NCT00727831|Calcium|calcium|mesh-list
65228468|NCT00727831|Levoleucovorin|levoleucovorin|mesh-list
65228469|NCT00727831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65228470|NCT00727831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228483|NCT00727831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65228484|NCT00727831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65228485|NCT00727831|Antidotes|antidotes|mesh-ancestor
65228486|NCT00727831|Protective Agents|protective agents|mesh-ancestor
65228487|NCT00727831|Vitamin B Complex|vitamin b complex|mesh-ancestor
65228489|NCT00727831|Micronutrients|micronutrients|mesh-ancestor
65228490|NCT00727987|Golimumab|golimumab|mesh-list
65228491|NCT00727987|Methotrexate|methotrexate|mesh-list
65228492|NCT00727987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65228493|NCT00727987|Abortifacient Agents|abortifacient agents|mesh-ancestor
65228494|NCT00727987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65228495|NCT00727987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228496|NCT00727987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65228497|NCT00727987|Antimetabolites|antimetabolites|mesh-ancestor
65228498|NCT00727987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228499|NCT00727987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228500|NCT00727987|Dermatologic Agents|dermatologic agents|mesh-ancestor
65228501|NCT00727987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228502|NCT00727987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65228503|NCT00727987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65228504|NCT00727987|Immunologic Factors|immunologic factors|mesh-ancestor
65228505|NCT00727987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65228506|NCT00727987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65228507|NCT00727987|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65228508|NCT00727987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65228509|NCT02681913|Adenosine|adenosine|mesh-list
65228510|NCT02681913|Analgesics|analgesics|mesh-ancestor
65228511|NCT02681913|Sensory System Agents|sensory system agents|mesh-ancestor
65228512|NCT02681913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65228513|NCT02681913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228514|NCT02681913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65228515|NCT02681913|Vasodilator Agents|vasodilator agents|mesh-ancestor
65228527|NCT02681679|Sensory System Agents|sensory system agents|mesh-ancestor
65228528|NCT02681679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65228529|NCT02681679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228530|NCT02681679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65228531|NCT02681679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65228532|NCT04183257|Vitamin D|vitamin d|mesh-list
65228533|NCT04183257|Ergocalciferols|ergocalciferols|mesh-list
65228534|NCT04183257|Cholecalciferol|cholecalciferol|mesh-list
65228535|NCT04183257|Vitamins|vitamins|mesh-list
65228536|NCT04183257|Micronutrients|micronutrients|mesh-ancestor
65228537|NCT04183257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228538|NCT04183257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65228539|NCT04183257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65228540|NCT00641433|Sulfadiazine|sulfadiazine|mesh-list
65228541|NCT00641433|Silver Sulfadiazine|silver sulfadiazine|mesh-list
65228542|NCT00641433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65228543|NCT00641433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65228544|NCT00641433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65228545|NCT00641433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65228546|NCT00641433|Coccidiostats|coccidiostats|mesh-ancestor
65228547|NCT00641433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65228548|NCT00641589|Epoetin Alfa|epoetin alfa|mesh-list
65228549|NCT00641589|Hematinics|hematinics|mesh-ancestor
65228550|NCT00734383|Propofol|propofol|mesh-list
65228551|NCT00734383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65228552|NCT00734383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65228578|NCT00586690|Immunoglobulins|immunoglobulins|mesh-list
65228579|NCT00586690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65228580|NCT00586690|Immunologic Factors|immunologic factors|mesh-ancestor
65228581|NCT00586690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228582|NCT00586690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228583|NCT00728611|Hyaluronic Acid|hyaluronic acid|mesh-list
65228584|NCT00728611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65228585|NCT00728611|Immunologic Factors|immunologic factors|mesh-ancestor
65228586|NCT00728611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228587|NCT00728611|Viscosupplements|viscosupplements|mesh-ancestor
65228588|NCT00728611|Protective Agents|protective agents|mesh-ancestor
65228589|NCT05663775|Mesalamine|mesalamine|mesh-list
65228590|NCT05663775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65228591|NCT05663775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65228592|NCT05663775|Analgesics|analgesics|mesh-ancestor
65228593|NCT05663775|Sensory System Agents|sensory system agents|mesh-ancestor
65228594|NCT05663775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65228595|NCT05663775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228596|NCT05663775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65228597|NCT05663775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65228598|NCT00909987|Bevacizumab|bevacizumab|mesh-list
65228599|NCT00909987|Capecitabine|capecitabine|mesh-list
65228630|NCT02680119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65228631|NCT02680119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65228632|NCT02680119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228633|NCT02680119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228634|NCT00734773|Cytarabine|cytarabine|mesh-list
65228635|NCT00734773|Rituximab|rituximab|mesh-list
65228636|NCT00734773|Methotrexate|methotrexate|mesh-list
65228637|NCT00734773|Vincristine|vincristine|mesh-list
65228638|NCT00734773|Procarbazine|procarbazine|mesh-list
65228639|NCT00734773|Motexafin gadolinium|motexafin gadolinium|mesh-list
65228640|NCT00734773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65228641|NCT00734773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228642|NCT00734773|Immunologic Factors|immunologic factors|mesh-ancestor
65228643|NCT00734773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228644|NCT00734773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65228645|NCT00734773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65228646|NCT00734773|Abortifacient Agents|abortifacient agents|mesh-ancestor
65228647|NCT00734773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65228688|NCT00735241|Leucovorin|leucovorin|mesh-list
65228689|NCT00735241|Folic Acid|folic acid|mesh-list
65228690|NCT00735241|Bevacizumab|bevacizumab|mesh-list
65228691|NCT00735241|Fluorouracil|fluorouracil|mesh-list
65228692|NCT00735241|Oxaliplatin|oxaliplatin|mesh-list
65228693|NCT00735241|Levoleucovorin|levoleucovorin|mesh-list
65228694|NCT00735241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65228695|NCT00735241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228696|NCT00735241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65228697|NCT00735241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65228698|NCT00735241|Growth Substances|growth substances|mesh-ancestor
65228699|NCT00735241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228700|NCT00735241|Growth Inhibitors|growth inhibitors|mesh-ancestor
65228701|NCT00735241|Antimetabolites|antimetabolites|mesh-ancestor
65228702|NCT00735241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228703|NCT00735241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65228704|NCT00735241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65228705|NCT00735241|Immunologic Factors|immunologic factors|mesh-ancestor
65228706|NCT00735241|Antidotes|antidotes|mesh-ancestor
65228707|NCT00735241|Protective Agents|protective agents|mesh-ancestor
65228708|NCT00735241|Vitamin B Complex|vitamin b complex|mesh-ancestor
65228709|NCT00735241|Vitamins|vitamins|mesh-ancestor
65228710|NCT00735241|Micronutrients|micronutrients|mesh-ancestor
65228711|NCT00735241|Hematinics|hematinics|mesh-ancestor
65228712|NCT00729313|Lanreotide|lanreotide|mesh-list
65228713|NCT00729313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228714|NCT00641979|Budesonide|budesonide|mesh-list
65228715|NCT00641979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65228716|NCT00641979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65228717|NCT00641979|Autonomic Agents|autonomic agents|mesh-ancestor
65228718|NCT00641979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65228723|NCT00641979|Hormones|hormones|mesh-ancestor
65228735|NCT02679339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65228736|NCT02679339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228737|NCT02679261|Atorvastatin|atorvastatin|mesh-list
65228738|NCT02679261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65228739|NCT02679261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65228740|NCT02679261|Antimetabolites|antimetabolites|mesh-ancestor
65228741|NCT02679261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228742|NCT02679261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65228743|NCT02679261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65228744|NCT02679261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228745|NCT00752206|Saracatinib|saracatinib|mesh-list
65228746|NCT00752206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228747|NCT00752206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228748|NCT00752206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228749|NCT02678949|Fluticasone|fluticasone|mesh-list
65228750|NCT02678949|Xhance|xhance|mesh-list
65228751|NCT02678949|Albuterol|albuterol|mesh-list
65228752|NCT02678949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65228753|NCT02678949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65228754|NCT02678949|Autonomic Agents|autonomic agents|mesh-ancestor
65228755|NCT02678949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65228756|NCT02678949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228757|NCT02678949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65228758|NCT02678949|Respiratory System Agents|respiratory system agents|mesh-ancestor
65228759|NCT02678949|Dermatologic Agents|dermatologic agents|mesh-ancestor
65228760|NCT02678949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65228761|NCT02678949|Tocolytic Agents|tocolytic agents|mesh-ancestor
65228762|NCT02678949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65228763|NCT02678949|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65228764|NCT02678949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65228765|NCT02678949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65228778|NCT00642135|Sympathomimetics|sympathomimetics|mesh-ancestor
65228779|NCT00642135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65228780|NCT00642135|Nasal Decongestants|nasal decongestants|mesh-ancestor
65228781|NCT00642135|Respiratory System Agents|respiratory system agents|mesh-ancestor
65228782|NCT00642135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65228783|NCT00642135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65228784|NCT00642135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65228785|NCT00642135|Adrenergic Agents|adrenergic agents|mesh-ancestor
65228786|NCT00642135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65228787|NCT00642135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228788|NCT00642135|Protective Agents|protective agents|mesh-ancestor
65228789|NCT00642135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65228790|NCT00642135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65228791|NCT00642135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65228792|NCT00642135|Cholinergic Agents|cholinergic agents|mesh-ancestor
65228793|NCT00642291|Emtricitabine|emtricitabine|mesh-list
65228794|NCT00642291|Antiviral Agents|antiviral agents|mesh-ancestor
65228836|NCT02675205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65228837|NCT02675205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65228838|NCT02675205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65228839|NCT02675205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65228840|NCT02675205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228841|NCT02675205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65228842|NCT02675205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65228843|NCT02675205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228844|NCT02675205|Antipyretics|antipyretics|mesh-ancestor
65228845|NCT02675205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65228846|NCT02675205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65228847|NCT02675205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65228848|NCT02675205|Purinergic Agents|purinergic agents|mesh-ancestor
65228849|NCT02675205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65228850|NCT00753454|Certolizumab Pegol|certolizumab pegol|mesh-list
65228851|NCT00753454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65228852|NCT00753454|Immunologic Factors|immunologic factors|mesh-ancestor
65228891|NCT00910065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65228892|NCT00910065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228893|NCT00910065|Antipyretics|antipyretics|mesh-ancestor
65228894|NCT02601040|Vaccines|vaccines|mesh-list
65228895|NCT02601040|Immunologic Factors|immunologic factors|mesh-ancestor
65228896|NCT02601040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228897|NCT04179513|Methotrexate|methotrexate|mesh-list
65228898|NCT04179513|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65228899|NCT04179513|Abortifacient Agents|abortifacient agents|mesh-ancestor
65228900|NCT04179513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65228901|NCT04179513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228902|NCT04179513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65228903|NCT04179513|Antimetabolites|antimetabolites|mesh-ancestor
65228904|NCT04179513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228905|NCT04179513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228906|NCT04179513|Dermatologic Agents|dermatologic agents|mesh-ancestor
65228907|NCT04179513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228908|NCT04179513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65228909|NCT04179513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65228910|NCT04179513|Immunologic Factors|immunologic factors|mesh-ancestor
65228911|NCT04179513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65228912|NCT04179513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65228913|NCT02675049|Dexmedetomidine|dexmedetomidine|mesh-list
65228914|NCT02675049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65228915|NCT02675049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65228916|NCT02675049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228917|NCT02675049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65228918|NCT02675049|Analgesics|analgesics|mesh-ancestor
65228919|NCT02675049|Sensory System Agents|sensory system agents|mesh-ancestor
65228920|NCT02675049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65228927|NCT02674737|Flurbiprofen|flurbiprofen|mesh-list
65228934|NCT02674737|Analgesics|analgesics|mesh-ancestor
65228935|NCT02674737|Sensory System Agents|sensory system agents|mesh-ancestor
65228936|NCT02674737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65228937|NCT02674737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65228938|NCT02674737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65228939|NCT02674737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65228940|NCT02674737|Adrenergic Agents|adrenergic agents|mesh-ancestor
65228941|NCT02674737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65228942|NCT02674737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228943|NCT02674737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65228944|NCT02674737|Narcotics|narcotics|mesh-ancestor
65228945|NCT02674737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65228946|NCT02674737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65228947|NCT02674737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65228948|NCT02674737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65228949|NCT02674737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228950|NCT02674893|Liraglutide|liraglutide|mesh-list
65228951|NCT02674893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65228952|NCT02674893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228953|NCT02674893|Incretins|incretins|mesh-ancestor
65228954|NCT02674893|Hormones|hormones|mesh-ancestor
65228955|NCT02674893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65228956|NCT02717455|Panobinostat|panobinostat|mesh-list
65228957|NCT02717455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65228958|NCT02717455|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65228959|NCT02717455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65228960|NCT02717455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228961|NCT02674581|Fostemsavir|fostemsavir|mesh-list
65228962|NCT02674581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65228963|NCT02674581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65228964|NCT02674581|Antiviral Agents|antiviral agents|mesh-ancestor
65228965|NCT02674581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65228966|NCT02674581|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65228967|NCT02674581|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65228969|NCT04065919|Epinephrine|epinephrine|mesh-list
65228973|NCT04065919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65228974|NCT04065919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65228975|NCT04065919|Sensory System Agents|sensory system agents|mesh-ancestor
65228976|NCT04065919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65228977|NCT04065919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65228978|NCT04065919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65228979|NCT04065919|Adrenergic Agents|adrenergic agents|mesh-ancestor
65228980|NCT04065919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65228981|NCT04065919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65228982|NCT04065919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65228983|NCT04065919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65228984|NCT04065919|Autonomic Agents|autonomic agents|mesh-ancestor
65228985|NCT04065919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65228986|NCT04065919|Respiratory System Agents|respiratory system agents|mesh-ancestor
65228987|NCT04065919|Mydriatics|mydriatics|mesh-ancestor
65228988|NCT04065919|Sympathomimetics|sympathomimetics|mesh-ancestor
65228989|NCT04065919|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65228990|NCT04065529|Zinc|zinc|mesh-list
65228991|NCT04065529|Trace Elements|trace elements|mesh-ancestor
65228992|NCT04065529|Micronutrients|micronutrients|mesh-ancestor
65228993|NCT04065529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229027|NCT00644085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65229028|NCT00644085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65229029|NCT00644085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229031|NCT00731575|Prednisolone|prednisolone|mesh-list
65229032|NCT00731575|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65229033|NCT00731575|Methylprednisolone|methylprednisolone|mesh-list
65229034|NCT00731575|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65229035|NCT00731575|Prednisolone acetate|prednisolone acetate|mesh-list
65229036|NCT00731575|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65229037|NCT00731575|Prednisolone phosphate|prednisolone phosphate|mesh-list
65229038|NCT00731575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65229039|NCT00731575|Glucocorticoids|glucocorticoids|mesh-ancestor
65229040|NCT00731575|Hormones|hormones|mesh-ancestor
65229041|NCT00731575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65229042|NCT00731575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229043|NCT00731575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65229044|NCT00731575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229045|NCT00731575|Antiemetics|antiemetics|mesh-ancestor
65229046|NCT00731575|Autonomic Agents|autonomic agents|mesh-ancestor
65229047|NCT00731575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229048|NCT00731575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65229049|NCT00731575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65229050|NCT00731575|Protective Agents|protective agents|mesh-ancestor
65229051|NCT02674191|Clindamycin|clindamycin|mesh-list
65229052|NCT02674191|Clindamycin palmitate|clindamycin palmitate|mesh-list
65229053|NCT02674191|Clindamycin phosphate|clindamycin phosphate|mesh-list
65229054|NCT02674191|Povidone-Iodine|povidone-iodine|mesh-list
65229055|NCT02674191|Mepivacaine|mepivacaine|mesh-list
65229076|NCT00736021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229077|NCT00736021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65229078|NCT00736021|Serotonin Agents|serotonin agents|mesh-ancestor
65229079|NCT00736021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229080|NCT00736021|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65229081|NCT00736021|Antidepressive Agents|antidepressive agents|mesh-ancestor
65229082|NCT00736021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65229083|NCT04178655|Tranexamic Acid|tranexamic acid|mesh-list
65229084|NCT04178655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65229085|NCT04178655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65229086|NCT04178655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229087|NCT04178655|Hemostatics|hemostatics|mesh-ancestor
65229088|NCT04178655|Coagulants|coagulants|mesh-ancestor
65229089|NCT00738517|Immunoglobulins|immunoglobulins|mesh-list
65229090|NCT00738517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65229091|NCT00738517|Antibodies|antibodies|mesh-list
65229092|NCT00738517|Immunologic Factors|immunologic factors|mesh-ancestor
65229093|NCT00738517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229094|NCT02673879|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65229095|NCT02673879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65229133|NCT05273775|Antimetabolites|antimetabolites|mesh-ancestor
65229134|NCT05273775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65229135|NCT05273775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65229136|NCT05273775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229137|NCT05273775|Anticoagulants|anticoagulants|mesh-ancestor
65229138|NCT05273775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65229139|NCT05273775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65229140|NCT05273775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65229141|NCT05273775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65229142|NCT05273775|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65229143|NCT05273775|Protective Agents|protective agents|mesh-ancestor
65229144|NCT05273775|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65229145|NCT05273775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65229146|NCT05273775|Hemostatics|hemostatics|mesh-ancestor
64871878|NCT01848743|Tenofovir|tenofovir|mesh-list
65229147|NCT05273775|Coagulants|coagulants|mesh-ancestor
65229148|NCT02671851|Acetaminophen|acetaminophen|mesh-list
65229149|NCT02671851|Dipyrone|dipyrone|mesh-list
65229151|NCT02671851|Tramadol|tramadol|mesh-list
65229152|NCT02671851|Bupivacaine|bupivacaine|mesh-list
65229153|NCT02671851|Anesthetics, Local|anesthetics, local|mesh-ancestor
65229191|NCT04177095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65229192|NCT04177095|Immunologic Factors|immunologic factors|mesh-ancestor
65229193|NCT04177095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65229194|NCT04177095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65229195|NCT04177095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65229196|NCT04177095|Antifungal Agents|antifungal agents|mesh-ancestor
65229197|NCT02671695|Amlodipine|amlodipine|mesh-list
65229198|NCT02671695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65229199|NCT02671695|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65229258|NCT00738829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65229259|NCT00738829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229260|NCT00738829|Immunologic Factors|immunologic factors|mesh-ancestor
65229261|NCT00738829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229262|NCT00738829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65229263|NCT00738829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65229264|NCT00738829|Antimetabolites|antimetabolites|mesh-ancestor
65229265|NCT00738829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229266|NCT00738829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65229267|NCT00738829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65229268|NCT00738829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65229269|NCT00738829|Growth Substances|growth substances|mesh-ancestor
65229270|NCT00738829|Growth Inhibitors|growth inhibitors|mesh-ancestor
65229271|NCT02671227|Bupivacaine|bupivacaine|mesh-list
65229272|NCT02671227|Anesthetics, Local|anesthetics, local|mesh-ancestor
65229273|NCT02671227|Anesthetics|anesthetics|mesh-ancestor
65229274|NCT02671227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65229314|NCT02537223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229315|NCT02568943|Panobinostat|panobinostat|mesh-list
65229316|NCT02568943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229317|NCT02568943|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65229318|NCT02568943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229319|NCT02568943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229320|NCT00732277|Hydrocortisone|hydrocortisone|mesh-list
65229321|NCT00732277|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65229322|NCT00732277|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65229323|NCT00732277|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65229324|NCT00732277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65229325|NCT00739453|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65229326|NCT00739453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229327|NCT00739453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65229328|NCT00739453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229329|NCT00739453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229330|NCT02668497|Botulinum Toxins|botulinum toxins|mesh-list
65229369|NCT00758602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229370|NCT00758602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65229371|NCT00758602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229372|NCT00758602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229373|NCT00758602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65229374|NCT00758602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229375|NCT00758602|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65229376|NCT00758602|Antitubercular Agents|antitubercular agents|mesh-ancestor
65229379|NCT00713323|Nabiximols|nabiximols|mesh-list
65229434|NCT00739609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65229435|NCT00739609|Antidepressive Agents|antidepressive agents|mesh-ancestor
65229436|NCT00739609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65229437|NCT00645723|Colistin|colistin|mesh-list
65229438|NCT00645723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65229439|NCT00645723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65229440|NCT00645801|Lubiprostone|lubiprostone|mesh-list
65229441|NCT00645801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65229442|NCT00645801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65229443|NCT00645801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229444|NCT00711529|Gabapentin|gabapentin|mesh-list
65229445|NCT00711529|Analgesics|analgesics|mesh-ancestor
65229446|NCT00711529|Sensory System Agents|sensory system agents|mesh-ancestor
65229447|NCT00711529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229448|NCT00711529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229449|NCT00711529|Anticonvulsants|anticonvulsants|mesh-ancestor
65229450|NCT00711529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65229451|NCT00711529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65229452|NCT00711529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65229453|NCT00711529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65229454|NCT00711529|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65229486|NCT00737659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229487|NCT02666703|Methylprednisolone|methylprednisolone|mesh-list
65229488|NCT02666703|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65229489|NCT02666703|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65229490|NCT02666703|Prednisolone|prednisolone|mesh-list
65229491|NCT02666703|Prednisolone acetate|prednisolone acetate|mesh-list
65229492|NCT02666703|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65229493|NCT02666703|Prednisolone phosphate|prednisolone phosphate|mesh-list
65229494|NCT02666703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65229495|NCT02666703|Antiemetics|antiemetics|mesh-ancestor
65229501|NCT02666703|Hormones|hormones|mesh-ancestor
65229551|NCT02666157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229552|NCT02666157|Anticoagulants|anticoagulants|mesh-ancestor
65229554|NCT02666001|Buprenorphine|buprenorphine|mesh-list
65229555|NCT02666001|Methadone|methadone|mesh-list
65229556|NCT02666001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65229557|NCT02666001|Narcotics|narcotics|mesh-ancestor
65229558|NCT02666001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65229559|NCT02666001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229560|NCT02666001|Analgesics|analgesics|mesh-ancestor
65229561|NCT02666001|Sensory System Agents|sensory system agents|mesh-ancestor
65229562|NCT02666001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229616|NCT02665533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65229617|NCT02665533|Narcotics|narcotics|mesh-ancestor
65229618|NCT02665533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65229619|NCT02665533|Antitussive Agents|antitussive agents|mesh-ancestor
65229620|NCT02665533|Respiratory System Agents|respiratory system agents|mesh-ancestor
65229621|NCT00646503|Telbivudine|telbivudine|mesh-list
65229622|NCT00646503|Antiviral Agents|antiviral agents|mesh-ancestor
65229623|NCT00646503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65229624|NCT00646503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65229625|NCT00646503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229628|NCT04173039|Immunologic Factors|immunologic factors|mesh-ancestor
65229682|NCT02662647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229683|NCT02662647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229684|NCT02662647|Antiviral Agents|antiviral agents|mesh-ancestor
65229685|NCT02662647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65229686|NCT02662647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65229687|NCT02662647|Immunologic Factors|immunologic factors|mesh-ancestor
65229688|NCT02662647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229689|NCT02662647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229690|NCT02662647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65229691|NCT02662647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65229692|NCT02662725|Ipilimumab|ipilimumab|mesh-list
65229693|NCT02662725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65229694|NCT02662725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229695|NCT02662725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65229696|NCT02662725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229697|NCT00648921|Olanzapine|olanzapine|mesh-list
65229698|NCT00648921|Antiemetics|antiemetics|mesh-ancestor
65229699|NCT00648921|Autonomic Agents|autonomic agents|mesh-ancestor
65229700|NCT00648921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65229701|NCT00648921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229702|NCT00648921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65229703|NCT00648921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65229704|NCT00648921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65229705|NCT00648921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65229706|NCT00648921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65229707|NCT00648921|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65229708|NCT00648921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65229709|NCT00648921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65229714|NCT02662491|Vitamin D|vitamin d|mesh-list
65229727|NCT00648999|Protease Inhibitors|protease inhibitors|mesh-ancestor
65229728|NCT00648999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229729|NCT00648999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229730|NCT00648999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65229731|NCT00648999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65229732|NCT00648999|Antiviral Agents|antiviral agents|mesh-ancestor
65229733|NCT00648999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65229734|NCT00648999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65229735|NCT00648999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65229793|NCT02655705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229794|NCT02655705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229795|NCT02655705|Dermatologic Agents|dermatologic agents|mesh-ancestor
65229796|NCT02655705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65229797|NCT02655705|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65229798|NCT02655705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65229799|NCT02655705|Immunologic Factors|immunologic factors|mesh-ancestor
65229800|NCT02655705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65229801|NCT02655705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65229802|NCT02655705|Antifungal Agents|antifungal agents|mesh-ancestor
65229803|NCT02655705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65229804|NCT02655705|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65229856|NCT00732745|Tubulin Modulators|tubulin modulators|mesh-ancestor
65229857|NCT00732745|Antimitotic Agents|antimitotic agents|mesh-ancestor
65229858|NCT00732745|Mitosis Modulators|mitosis modulators|mesh-ancestor
65229859|NCT00732745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229860|NCT00737815|Magnesium citrate|magnesium citrate|mesh-list
65229861|NCT00737815|Cathartics|cathartics|mesh-ancestor
65229862|NCT00737815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65229863|NCT02654379|Rituximab|rituximab|mesh-list
65229864|NCT02654379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65229865|NCT02654379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65229866|NCT02654379|Immunologic Factors|immunologic factors|mesh-ancestor
65229867|NCT02654379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229868|NCT02654379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65229870|NCT04341129|Chelating Agents|chelating agents|mesh-ancestor
65229871|NCT04341129|Sequestering Agents|sequestering agents|mesh-ancestor
65229916|NCT00740467|Dermatologic Agents|dermatologic agents|mesh-ancestor
65229917|NCT00740467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65229918|NCT00740467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65229919|NCT00740467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65229920|NCT00740467|Antitubercular Agents|antitubercular agents|mesh-ancestor
65229921|NCT00740467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65229922|NCT00740545|Enoxaparin|enoxaparin|mesh-list
65229923|NCT00740545|Anticoagulants|anticoagulants|mesh-ancestor
65229924|NCT00740545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65229925|NCT00740545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64961827|NCT00043095|Gemcitabine|gemcitabine|mesh-list
65229926|NCT00740545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65229979|NCT04316169|Hormone Antagonists|hormone antagonists|mesh-ancestor
65229980|NCT04316169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65229981|NCT04316169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65229982|NCT04316169|Antimalarials|antimalarials|mesh-ancestor
65229983|NCT04316169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65229984|NCT04316169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65229985|NCT04316169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65229989|NCT02653209|Pioglitazone|pioglitazone|mesh-list
65230044|NCT00741169|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65230045|NCT00741169|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64872776|NCT01855321|Vitamin D|vitamin d|mesh-list
65230046|NCT00741169|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65230047|NCT00741169|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65230049|NCT00741169|Protease Inhibitors|protease inhibitors|mesh-ancestor
65230050|NCT00741325|Plerixafor|plerixafor|mesh-list
65230051|NCT00741325|Lenograstim|lenograstim|mesh-list
65230052|NCT00741325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65230053|NCT00741325|Immunologic Factors|immunologic factors|mesh-ancestor
65230054|NCT00741325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230109|NCT00650325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65230110|NCT00650325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230111|NCT00650325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65230112|NCT00650325|Serotonin Agents|serotonin agents|mesh-ancestor
65230113|NCT00650325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230114|NCT00650403|Paroxetine|paroxetine|mesh-list
65230115|NCT00650403|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65230116|NCT00650403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65230117|NCT00650403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65230118|NCT00650403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872843|NCT01855581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65230119|NCT00650403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65230121|NCT00650403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230168|NCT02568241|Interferon alpha-2|interferon alpha-2|mesh-list
65230169|NCT02568241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230170|NCT02568241|Antiviral Agents|antiviral agents|mesh-ancestor
65230171|NCT02568241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65230172|NCT02568241|Immunologic Factors|immunologic factors|mesh-ancestor
65230173|NCT02568241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230174|NCT05551897|Itraconazole|itraconazole|mesh-list
65230175|NCT05551897|Antifungal Agents|antifungal agents|mesh-ancestor
65230176|NCT05551897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65230177|NCT05551897|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65230178|NCT05551897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65230179|NCT05551897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230230|NCT02647047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230231|NCT02647047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65230232|NCT02647047|Narcotics|narcotics|mesh-ancestor
65230233|NCT02647047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65230234|NCT02647047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65230235|NCT02647047|Anesthetics, General|anesthetics, general|mesh-ancestor
65230236|NCT00651651|Budesonide|budesonide|mesh-list
65230237|NCT00651651|Formoterol Fumarate|formoterol fumarate|mesh-list
65230238|NCT00651651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65230239|NCT00651651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65230240|NCT00651651|Autonomic Agents|autonomic agents|mesh-ancestor
65230241|NCT00651651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65230242|NCT00651651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230243|NCT00651651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65230244|NCT00651651|Respiratory System Agents|respiratory system agents|mesh-ancestor
65230245|NCT00651651|Glucocorticoids|glucocorticoids|mesh-ancestor
65230246|NCT00651651|Hormones|hormones|mesh-ancestor
65230247|NCT00651651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65230248|NCT00651651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65230249|NCT00651651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64943702|NCT00036153|Dermatologic Agents|dermatologic agents|mesh-ancestor
64943703|NCT00036153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943710|NCT00036231|Secretin|secretin|mesh-list
65230282|NCT02646735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230283|NCT02646735|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65230284|NCT02646735|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65230285|NCT02646735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230286|NCT02646735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230287|NCT05741905|Levofloxacin|levofloxacin|mesh-list
65230288|NCT05741905|Ofloxacin|ofloxacin|mesh-list
65230289|NCT05741905|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65230290|NCT05741905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65230291|NCT05741905|Renal Agents|renal agents|mesh-ancestor
65230292|NCT05741905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65230343|NCT05740657|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65230345|NCT05740657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65230346|NCT05740657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230347|NCT05740657|Analgesics|analgesics|mesh-ancestor
65230348|NCT05740657|Sensory System Agents|sensory system agents|mesh-ancestor
65230349|NCT05740657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65230350|NCT05740657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65230351|NCT05740657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65230352|NCT05740657|Anesthetics, General|anesthetics, general|mesh-ancestor
65230353|NCT05740657|Anesthetics|anesthetics|mesh-ancestor
65230354|NCT02646267|Warfarin|warfarin|mesh-list
65230355|NCT02646267|Dabigatran|dabigatran|mesh-list
65230356|NCT02646267|Anticoagulants|anticoagulants|mesh-ancestor
65230357|NCT02646267|Antithrombins|antithrombins|mesh-ancestor
65230358|NCT02646267|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65230419|NCT05460871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65230420|NCT05460871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230421|NCT05460871|Anticonvulsants|anticonvulsants|mesh-ancestor
65230422|NCT05460871|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65230423|NCT05460871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65230424|NCT05460871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230425|NCT05460871|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65230426|NCT05460871|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65230427|NCT05460871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65230428|NCT05460871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65230483|NCT00707239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65230484|NCT00707239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65230485|NCT00707239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64943869|NCT00037011|Immunologic Factors|immunologic factors|mesh-ancestor
64943870|NCT00037011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230486|NCT00707239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230487|NCT00707239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230489|NCT00968708|Alogliptin|alogliptin|mesh-list
65230548|NCT00629720|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65230549|NCT00629720|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65230550|NCT00629720|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65230551|NCT00629720|Adrenergic Agents|adrenergic agents|mesh-ancestor
65230552|NCT00629720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65230553|NCT00629720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230554|NCT00629720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230555|NCT00629720|Urological Agents|urological agents|mesh-ancestor
65230556|NCT00967616|Leucovorin|leucovorin|mesh-list
65230557|NCT00967616|Fluorouracil|fluorouracil|mesh-list
65230558|NCT00967616|Irinotecan|irinotecan|mesh-list
65230559|NCT00967616|Efatutazone|efatutazone|mesh-list
65230560|NCT00967616|Levoleucovorin|levoleucovorin|mesh-list
65230614|NCT00654225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65230615|NCT00654225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65230616|NCT00654225|Antimetabolites|antimetabolites|mesh-ancestor
65230617|NCT00654225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943994|NCT00037752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64943995|NCT01464671|Heparin|heparin|mesh-list
65230677|NCT03887702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65230678|NCT03887702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65230679|NCT03887702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65230680|NCT03887702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230681|NCT03887702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230682|NCT03887702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65230683|NCT03887702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65230684|NCT02638857|Epirubicin|epirubicin|mesh-list
65230685|NCT02638857|Mitomycins|mitomycins|mesh-list
65230686|NCT02638857|Mitomycin|mitomycin|mesh-list
65230687|NCT02638857|Ethiodized Oil|ethiodized oil|mesh-list
65230688|NCT02638857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65230689|NCT02638857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230690|NCT02638857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65230691|NCT02638857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65230692|NCT02638857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230693|NCT02638857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230694|NCT02638857|Alkylating Agents|alkylating agents|mesh-ancestor
65230695|NCT02638857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65230696|NCT02638545|Dexmedetomidine|dexmedetomidine|mesh-list
65230732|NCT01842399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230733|NCT01842399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65230734|NCT00970502|Celecoxib|celecoxib|mesh-list
65230735|NCT00970502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65230736|NCT00970502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230737|NCT00970502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65230738|NCT00970502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230739|NCT00970502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230740|NCT00970502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65230741|NCT00970502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65230742|NCT00970502|Analgesics|analgesics|mesh-ancestor
65230743|NCT00970502|Sensory System Agents|sensory system agents|mesh-ancestor
65230744|NCT00970502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65230745|NCT00970502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230746|NCT00970502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65230747|NCT00970502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65230748|NCT00970502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65230749|NCT00970502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65230750|NCT02635893|Cycloserine|cycloserine|mesh-list
65230751|NCT02635893|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65230759|NCT05729503|Lidocaine|lidocaine|mesh-list
65230783|NCT02567773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64944165|NCT00846950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65230784|NCT02567773|Anabolic Agents|anabolic agents|mesh-ancestor
65230785|NCT02567773|Hormones|hormones|mesh-ancestor
65230786|NCT00967226|Prednisolone|prednisolone|mesh-list
65230787|NCT00967226|Propranolol|propranolol|mesh-list
65230788|NCT00967226|Prednisolone phosphate|prednisolone phosphate|mesh-list
65230789|NCT00967226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65230790|NCT00967226|Glucocorticoids|glucocorticoids|mesh-ancestor
65230791|NCT00967226|Hormones|hormones|mesh-ancestor
65230795|NCT00967226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230847|NCT04062019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230848|NCT04062019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65230849|NCT04062019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65230850|NCT04062019|Antiviral Agents|antiviral agents|mesh-ancestor
65230851|NCT04062019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65230853|NCT04061863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65230854|NCT04061863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65230855|NCT04061863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65230856|NCT04061863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230857|NCT02861378|Phentolamine|phentolamine|mesh-list
65230858|NCT02861378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65230859|NCT02861378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65230860|NCT02861378|Adrenergic Agents|adrenergic agents|mesh-ancestor
65230861|NCT02861378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65230862|NCT02861378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230863|NCT02861378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230864|NCT02861378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65230905|NCT04283240|Urological Agents|urological agents|mesh-ancestor
65230906|NCT03588884|Cholecalciferol|cholecalciferol|mesh-list
65230908|NCT03588884|Calcifediol|calcifediol|mesh-list
65230909|NCT03588884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65230910|NCT03588884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65230911|NCT03588884|Vitamins|vitamins|mesh-ancestor
65230912|NCT03588884|Micronutrients|micronutrients|mesh-ancestor
65230913|NCT03588884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65230914|NCT02862782|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65230915|NCT02862782|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65230916|NCT02862782|Luteolytic Agents|luteolytic agents|mesh-ancestor
65230926|NCT04283162|Calcium|calcium|mesh-list
65230970|NCT00705679|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65230971|NCT00705679|Antiviral Agents|antiviral agents|mesh-ancestor
65230972|NCT00705679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65230973|NCT00705679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65230974|NCT00705679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65230975|NCT00705679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65230976|NCT00705679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230977|NCT00705679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65230978|NCT00705679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65230979|NCT04092868|Protamines|protamines|mesh-list
65230980|NCT04092868|Heparin Antagonists|heparin antagonists|mesh-ancestor
65230981|NCT04092868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65230982|NCT04092868|Coagulants|coagulants|mesh-ancestor
65231030|NCT02598466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65231031|NCT04089592|Fentanyl|fentanyl|mesh-list
65231032|NCT04089592|Dexmedetomidine|dexmedetomidine|mesh-list
65231033|NCT04089592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65231034|NCT04089592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65231035|NCT04089592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231036|NCT04089592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65231037|NCT04089592|Analgesics|analgesics|mesh-ancestor
65231038|NCT04089592|Sensory System Agents|sensory system agents|mesh-ancestor
65231039|NCT04089592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65231040|NCT04089592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65231041|NCT04089592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65231042|NCT04089592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65231043|NCT04089592|Adrenergic Agents|adrenergic agents|mesh-ancestor
65231044|NCT04089592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65231045|NCT04089592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231046|NCT04089592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65231047|NCT04089592|Narcotics|narcotics|mesh-ancestor
65231048|NCT04089592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65231049|NCT04089592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65231050|NCT04089592|Anesthetics, General|anesthetics, general|mesh-ancestor
65231051|NCT04089592|Anesthetics|anesthetics|mesh-ancestor
65231052|NCT00751036|Imatinib Mesylate|imatinib mesylate|mesh-list
65231053|NCT00751036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231054|NCT00751036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65231055|NCT00751036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231056|NCT00751036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231057|NCT00961298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65231058|NCT00961298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65231059|NCT00961298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65231060|NCT00961298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65231062|NCT00961298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65231069|NCT00961298|Dopamine Agents|dopamine agents|mesh-ancestor
65231070|NCT00744328|Sertraline|sertraline|mesh-list
65231071|NCT00744328|Estradiol|estradiol|mesh-list
65231072|NCT00744328|Estrogens|estrogens|mesh-ancestor
65231073|NCT00744328|Hormones|hormones|mesh-ancestor
65231074|NCT00744328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65231075|NCT00744328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231076|NCT00744328|Antidepressive Agents|antidepressive agents|mesh-ancestor
65231077|NCT00744328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65231078|NCT00744328|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65231079|NCT00744328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65231080|NCT00744328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65231132|NCT00959894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65231133|NCT02599168|Dexmedetomidine|dexmedetomidine|mesh-list
65231134|NCT02599168|Propofol|propofol|mesh-list
65231135|NCT02599168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65231136|NCT02599168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65231137|NCT02599168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231138|NCT02599168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65231139|NCT02599168|Anesthetics, General|anesthetics, general|mesh-ancestor
65231140|NCT02599168|Anesthetics|anesthetics|mesh-ancestor
65231141|NCT02599168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65231142|NCT02599168|Analgesics|analgesics|mesh-ancestor
65231143|NCT02599168|Sensory System Agents|sensory system agents|mesh-ancestor
65231144|NCT02599168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65231145|NCT02599168|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65231192|NCT02598310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65231193|NCT02598310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231194|NCT02598310|Tubulin Modulators|tubulin modulators|mesh-ancestor
65231195|NCT02598310|Antimitotic Agents|antimitotic agents|mesh-ancestor
65231196|NCT02598310|Mitosis Modulators|mitosis modulators|mesh-ancestor
65231197|NCT02598310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231198|NCT02598310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65231199|NCT04091074|Clopidogrel|clopidogrel|mesh-list
65231201|NCT04091074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65231202|NCT04091074|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65231203|NCT04091074|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65231204|NCT04091074|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65231205|NCT04091074|Purinergic Agents|purinergic agents|mesh-ancestor
65231256|NCT00742924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65231257|NCT00742924|Immunologic Factors|immunologic factors|mesh-ancestor
65231258|NCT00742924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65231259|NCT00742924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65231260|NCT00742924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65231261|NCT00742924|Antidotes|antidotes|mesh-ancestor
65231262|NCT00742924|Protective Agents|protective agents|mesh-ancestor
65231263|NCT00742924|Vitamin B Complex|vitamin b complex|mesh-ancestor
65231330|NCT03896815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231331|NCT02598856|Naloxone|naloxone|mesh-list
65231332|NCT02598856|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65231333|NCT02598856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231334|NCT02598856|Sensory System Agents|sensory system agents|mesh-ancestor
65231335|NCT02598856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65231336|NCT05256901|Glycopyrrolate|glycopyrrolate|mesh-list
65231337|NCT05256901|Neostigmine|neostigmine|mesh-list
65231338|NCT05256901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65231339|NCT05256901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231340|NCT05256901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231395|NCT01023815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65231396|NCT01023815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231397|NCT02567383|Docetaxel|docetaxel|mesh-list
65231398|NCT02567383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231399|NCT02567383|Tubulin Modulators|tubulin modulators|mesh-ancestor
65231400|NCT02567383|Antimitotic Agents|antimitotic agents|mesh-ancestor
65231401|NCT02567383|Mitosis Modulators|mitosis modulators|mesh-ancestor
65231402|NCT02567383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231403|NCT01023659|Bupropion|bupropion|mesh-list
65231404|NCT01023659|Varenicline|varenicline|mesh-list
65231406|NCT01023659|Antidepressive Agents|antidepressive agents|mesh-ancestor
65231461|NCT02595346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65231462|NCT02595346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231463|NCT02595346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231464|NCT02595346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65231465|NCT01023581|Metformin|metformin|mesh-list
65231466|NCT01023581|Alogliptin|alogliptin|mesh-list
65231467|NCT01023581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65231468|NCT01023581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874197|NCT01863407|Allantoin|allantoin|mesh-list
65231469|NCT01023581|Incretins|incretins|mesh-ancestor
65231527|NCT00962780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231528|NCT02567851|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65231529|NCT02567851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65231530|NCT02567851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231531|NCT00739882|Antibodies|antibodies|mesh-list
65231532|NCT00739882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65231533|NCT00739882|Immunologic Factors|immunologic factors|mesh-ancestor
65231534|NCT00739882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231535|NCT00961220|Carmustine|carmustine|mesh-list
65231536|NCT00961220|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
65231537|NCT00961220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65231538|NCT00961220|Alkylating Agents|alkylating agents|mesh-ancestor
65231539|NCT00961220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231540|NCT00961220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231588|NCT05324917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231589|NCT05324917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65231590|NCT00739648|Levofloxacin|levofloxacin|mesh-list
65231591|NCT00739648|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65231592|NCT00739648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65231593|NCT00739648|Renal Agents|renal agents|mesh-ancestor
65231594|NCT00739648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65231595|NCT00739648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65231596|NCT00739648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65231597|NCT00739648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231598|NCT00739648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231599|NCT00739648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231600|NCT00739648|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65231601|NCT00739648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65231602|NCT01032239|Baclofen|baclofen|mesh-list
65231603|NCT01032239|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65231604|NCT01032239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231605|NCT01032239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65231606|NCT01032239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65231607|NCT01032239|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65231608|NCT01032239|GABA Agonists|gaba agonists|mesh-ancestor
65231609|NCT01032239|GABA Agents|gaba agents|mesh-ancestor
65231610|NCT01032239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65231611|NCT01032239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231612|NCT04354129|Immunoglobulins|immunoglobulins|mesh-list
65231639|NCT00734578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65231640|NCT00734578|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65231641|NCT00734578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65231642|NCT00734578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65231643|NCT00734578|Adrenergic Agents|adrenergic agents|mesh-ancestor
65231644|NCT00734578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65231645|NCT00734578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231646|NCT00734578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231647|NCT00637715|Alfuzosin|alfuzosin|mesh-list
65231648|NCT00637715|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65231649|NCT00637715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65231650|NCT00637715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65231651|NCT00637715|Adrenergic Agents|adrenergic agents|mesh-ancestor
65231652|NCT00637715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65231653|NCT00637715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231654|NCT00637715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231655|NCT00637715|Urological Agents|urological agents|mesh-ancestor
65231656|NCT02596282|Anesthetics|anesthetics|mesh-list
65231657|NCT02596282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65231658|NCT02596282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231659|NCT04557085|Cenobamate|cenobamate|mesh-list
65231689|NCT00696787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65231690|NCT00696787|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65231691|NCT00696787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65231692|NCT00696787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65231693|NCT00696787|Antidepressive Agents|antidepressive agents|mesh-ancestor
65231694|NCT01012037|Linagliptin|linagliptin|mesh-list
64874450|NCT01865175|Iron|iron|mesh-list
65231697|NCT01012037|Incretins|incretins|mesh-ancestor
65231755|NCT00921505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65231756|NCT00921505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65231757|NCT00921505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65231758|NCT00921505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65231759|NCT00921505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231760|NCT00921505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231761|NCT04280588|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65231762|NCT04280588|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65231763|NCT04280588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231764|NCT04280588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65231765|NCT04280588|Immunologic Factors|immunologic factors|mesh-ancestor
65231766|NCT04280588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231767|NCT04298021|Durvalumab|durvalumab|mesh-list
65231768|NCT04298021|Olaparib|olaparib|mesh-list
65231769|NCT04298021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65231770|NCT04298021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231771|NCT04298021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65231772|NCT04298021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65231773|NCT04298021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231774|NCT02595190|Gabapentin|gabapentin|mesh-list
65231775|NCT02595190|Tramadol|tramadol|mesh-list
65231776|NCT02595190|Analgesics|analgesics|mesh-ancestor
65231777|NCT02595190|Sensory System Agents|sensory system agents|mesh-ancestor
65231780|NCT02595190|Anticonvulsants|anticonvulsants|mesh-ancestor
65231803|NCT04061473|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65231804|NCT04502693|Vaccines|vaccines|mesh-list
65231805|NCT04502693|Immunologic Factors|immunologic factors|mesh-ancestor
65231806|NCT04502693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231807|NCT00733408|Paclitaxel|paclitaxel|mesh-list
65231808|NCT00733408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65231809|NCT00733408|Bevacizumab|bevacizumab|mesh-list
65231810|NCT00733408|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65231811|NCT00733408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65231812|NCT00733408|Antibodies|antibodies|mesh-list
65231813|NCT00733408|Immunoglobulins|immunoglobulins|mesh-list
65231814|NCT00733408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65231815|NCT00733408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65231816|NCT00733408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231817|NCT00733408|Tubulin Modulators|tubulin modulators|mesh-ancestor
65231818|NCT00733408|Antimitotic Agents|antimitotic agents|mesh-ancestor
65231819|NCT00733408|Mitosis Modulators|mitosis modulators|mesh-ancestor
65231820|NCT00733408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231821|NCT00733408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65231822|NCT00733408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65231823|NCT00733408|Growth Substances|growth substances|mesh-ancestor
65231824|NCT00733408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231825|NCT00733408|Growth Inhibitors|growth inhibitors|mesh-ancestor
65231826|NCT00733408|Immunologic Factors|immunologic factors|mesh-ancestor
65231855|NCT00742807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65231856|NCT00742807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65231857|NCT00742807|Analgesics|analgesics|mesh-ancestor
65231858|NCT00742807|Sensory System Agents|sensory system agents|mesh-ancestor
65231859|NCT00742807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65231860|NCT00742807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65231861|NCT00742807|Anesthetics, General|anesthetics, general|mesh-ancestor
65231862|NCT00742807|Anesthetics|anesthetics|mesh-ancestor
65231863|NCT03221257|Mycophenolic Acid|mycophenolic acid|mesh-list
65231864|NCT03221257|Pirfenidone|pirfenidone|mesh-list
65231865|NCT03221257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65231866|NCT03221257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231917|NCT02595034|Dermatologic Agents|dermatologic agents|mesh-ancestor
65231918|NCT00958724|Vinorelbine|vinorelbine|mesh-list
65231919|NCT00958724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65231920|NCT00958724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65231921|NCT00958724|Tubulin Modulators|tubulin modulators|mesh-ancestor
65231922|NCT00958724|Antimitotic Agents|antimitotic agents|mesh-ancestor
65231923|NCT00958724|Mitosis Modulators|mitosis modulators|mesh-ancestor
65231924|NCT00958724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65231983|NCT02858804|Antiemetics|antiemetics|mesh-ancestor
65231984|NCT02858804|Autonomic Agents|autonomic agents|mesh-ancestor
65231985|NCT02858804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65231986|NCT02858804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65231987|NCT02858804|Glucocorticoids|glucocorticoids|mesh-ancestor
65231988|NCT02858804|Hormones|hormones|mesh-ancestor
65231989|NCT02858804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65231990|NCT02858804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65232050|NCT00628667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232051|NCT00628667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232052|NCT02858258|Rituximab|rituximab|mesh-list
65232053|NCT02858258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65232054|NCT02858258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232055|NCT02858258|Immunologic Factors|immunologic factors|mesh-ancestor
65232056|NCT02858258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232057|NCT02858258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65232058|NCT01008995|Ustekinumab|ustekinumab|mesh-list
65232059|NCT01008995|Dermatologic Agents|dermatologic agents|mesh-ancestor
65232060|NCT04295993|Norepinephrine|norepinephrine|mesh-list
65232061|NCT04295993|Methylene Blue|methylene blue|mesh-list
65232062|NCT04295993|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65232063|NCT04295993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65232064|NCT04295993|Adrenergic Agents|adrenergic agents|mesh-ancestor
65232074|NCT00743587|Oxycodone|oxycodone|mesh-list
65232112|NCT01005875|Sorafenib|sorafenib|mesh-list
65232113|NCT01005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232114|NCT01005875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65232115|NCT01005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232116|NCT01005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232117|NCT03064490|Pembrolizumab|pembrolizumab|mesh-list
65232118|NCT03064490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65232119|NCT03064490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232120|NCT02701088|Mitomycins|mitomycins|mesh-list
65232121|NCT02701088|Mitomycin|mitomycin|mesh-list
65232122|NCT02701088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65232123|NCT02701088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232130|NCT04279106|Listerine|listerine|mesh-list
65232174|NCT02856854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65232175|NCT02856854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65232176|NCT02856854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232177|NCT02856854|Dopamine Agents|dopamine agents|mesh-ancestor
65232178|NCT02856854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65232179|NCT02856854|Antimetabolites|antimetabolites|mesh-ancestor
65232180|NCT02856854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232181|NCT02856854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65232182|NCT02856854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65232183|NCT02856854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65232184|NCT02856854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65232236|NCT02100956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65232237|NCT02100956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232238|NCT02073968|Paclitaxel|paclitaxel|mesh-list
65232239|NCT02073968|Carboplatin|carboplatin|mesh-list
65232240|NCT02073968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65232241|NCT02073968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65232242|NCT02073968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232243|NCT02073968|Tubulin Modulators|tubulin modulators|mesh-ancestor
65232244|NCT02073968|Antimitotic Agents|antimitotic agents|mesh-ancestor
65232245|NCT02073968|Mitosis Modulators|mitosis modulators|mesh-ancestor
65232246|NCT02073968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232247|NCT01005329|Paclitaxel|paclitaxel|mesh-list
65232248|NCT01005329|Bevacizumab|bevacizumab|mesh-list
65232249|NCT01005329|Cisplatin|cisplatin|mesh-list
65232250|NCT01005329|Carboplatin|carboplatin|mesh-list
65232297|NCT02856776|Cholecalciferol|cholecalciferol|mesh-list
65232298|NCT02856776|Vitamins|vitamins|mesh-ancestor
65232299|NCT02856776|Micronutrients|micronutrients|mesh-ancestor
65232300|NCT02856776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232301|NCT02856776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65232302|NCT02856776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65232303|NCT04296851|Niclosamide|niclosamide|mesh-list
65232304|NCT04296851|Anticestodal Agents|anticestodal agents|mesh-ancestor
65232305|NCT04296851|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65232306|NCT04296851|Anthelmintics|anthelmintics|mesh-ancestor
65232307|NCT04296851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65232308|NCT04296851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65232309|NCT04296851|Antinematodal Agents|antinematodal agents|mesh-ancestor
65232310|NCT02858024|Dapivirine|dapivirine|mesh-list
65232311|NCT02858024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65232312|NCT02858024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65232313|NCT02858024|Antiviral Agents|antiviral agents|mesh-ancestor
65232314|NCT02858024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65232315|NCT02857946|Linagliptin|linagliptin|mesh-list
65232316|NCT02857946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65232317|NCT02857946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232318|NCT02857946|Incretins|incretins|mesh-ancestor
65232319|NCT02857946|Hormones|hormones|mesh-ancestor
65232320|NCT02857946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65232321|NCT02857946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65232322|NCT02857946|Protease Inhibitors|protease inhibitors|mesh-ancestor
65232323|NCT02857946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232324|NCT02857946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232326|NCT02857712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232344|NCT02007044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232345|NCT02007044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65232346|NCT00630968|Levetiracetam|levetiracetam|mesh-list
65232347|NCT00630968|Anticonvulsants|anticonvulsants|mesh-ancestor
65232418|NCT01007435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65232419|NCT01007435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232420|NCT01007435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65232421|NCT01007435|Antimetabolites|antimetabolites|mesh-ancestor
65232422|NCT01007435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232423|NCT01007435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232424|NCT01007435|Dermatologic Agents|dermatologic agents|mesh-ancestor
65232425|NCT01007435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232426|NCT01007435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65232427|NCT01007435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65232428|NCT01007435|Immunologic Factors|immunologic factors|mesh-ancestor
65232429|NCT01007435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65232479|NCT04060771|Dexamethasone|dexamethasone|mesh-list
65232480|NCT04060771|Palonosetron|palonosetron|mesh-list
65232481|NCT04060771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65232482|NCT04060771|Antiemetics|antiemetics|mesh-ancestor
65232483|NCT04060771|Autonomic Agents|autonomic agents|mesh-ancestor
65232484|NCT04060771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65232485|NCT04060771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232486|NCT04060771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65232487|NCT04060771|Glucocorticoids|glucocorticoids|mesh-ancestor
65232488|NCT04060771|Hormones|hormones|mesh-ancestor
65232489|NCT04060771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65232497|NCT00744913|Nicotine|nicotine|mesh-list
65232542|NCT00948428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232543|NCT00948428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232544|NCT00948428|Interferon Inducers|interferon inducers|mesh-ancestor
65232546|NCT00948194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65232547|NCT00948194|Autonomic Agents|autonomic agents|mesh-ancestor
65232548|NCT00948194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65232549|NCT00948194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232550|NCT00948194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65232551|NCT00948194|Respiratory System Agents|respiratory system agents|mesh-ancestor
65232552|NCT00948194|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65232607|NCT04204382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65232608|NCT04204382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65232609|NCT04204382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232610|NCT04204382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232611|NCT04204382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232612|NCT04204382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65232613|NCT04204382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65232674|NCT02855138|Dermatologic Agents|dermatologic agents|mesh-ancestor
65232675|NCT01471106|Dasatinib|dasatinib|mesh-list
65232676|NCT01471106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232677|NCT01471106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65232678|NCT01471106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232679|NCT01471106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232680|NCT00694369|Acetaminophen|acetaminophen|mesh-list
65232681|NCT00694369|Ibuprofen|ibuprofen|mesh-list
65232682|NCT00694369|Etoricoxib|etoricoxib|mesh-list
65232683|NCT00694369|Codeine|codeine|mesh-list
65232684|NCT00694369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65232685|NCT00694369|Analgesics|analgesics|mesh-ancestor
65232686|NCT00694369|Sensory System Agents|sensory system agents|mesh-ancestor
65232687|NCT00694369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65232688|NCT00694369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232689|NCT00694369|Antipyretics|antipyretics|mesh-ancestor
65232690|NCT00694369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65232691|NCT00694369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65232692|NCT00694369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65232693|NCT00694369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65232694|NCT00694369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232695|NCT00694369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232696|NCT00694369|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65232697|NCT00694369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65232699|NCT00694369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65232700|NCT00694369|Antitussive Agents|antitussive agents|mesh-ancestor
65232701|NCT00694369|Respiratory System Agents|respiratory system agents|mesh-ancestor
65232702|NCT00745693|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
65232703|NCT00745693|BQ 788|bq 788|mesh-list
65232704|NCT00745693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65232705|NCT00745693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65232706|NCT00745693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232707|NCT00745693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65232708|NCT02563405|Doxazosin|doxazosin|mesh-list
64454187|NCT01914926|Adrenergic Agents|adrenergic agents|mesh-ancestor
65232714|NCT02563405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232715|NCT02563405|Vasodilator Agents|vasodilator agents|mesh-ancestor
65232716|NCT02563405|Tocolytic Agents|tocolytic agents|mesh-ancestor
65232717|NCT02563405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65232718|NCT02563405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65232719|NCT02563405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65232720|NCT02563405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65232721|NCT02563405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65232722|NCT02563405|Adrenergic Agents|adrenergic agents|mesh-ancestor
65232723|NCT02563405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65232724|NCT03412747|Adalimumab|adalimumab|mesh-list
65232725|NCT03412747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65232726|NCT03412747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65232778|NCT00691015|Melphalan|melphalan|mesh-list
64454246|NCT02029235|Antipyretics|antipyretics|mesh-ancestor
65232779|NCT00691015|Busulfan|busulfan|mesh-list
65232780|NCT00691015|Carmustine|carmustine|mesh-list
65232781|NCT00691015|Rituximab|rituximab|mesh-list
65232782|NCT00691015|Fludarabine|fludarabine|mesh-list
65232783|NCT00691015|Fludarabine phosphate|fludarabine phosphate|mesh-list
65232784|NCT00691015|Etoposide|etoposide|mesh-list
65232785|NCT00691015|Thymoglobulin|thymoglobulin|mesh-list
65232786|NCT00691015|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65232787|NCT00691015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65232788|NCT00691015|Immunologic Factors|immunologic factors|mesh-ancestor
65232789|NCT00691015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232790|NCT00691015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65232792|NCT00691015|Alkylating Agents|alkylating agents|mesh-ancestor
65232841|NCT00731692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232842|NCT00731692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65232843|NCT00731692|Immunologic Factors|immunologic factors|mesh-ancestor
65232844|NCT00731692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232845|NCT02593474|Naltrexone|naltrexone|mesh-list
65232846|NCT02593474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65232847|NCT02593474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65232848|NCT02593474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232849|NCT02593474|Sensory System Agents|sensory system agents|mesh-ancestor
65232850|NCT02593474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65232851|NCT00687193|Tofacitinib|tofacitinib|mesh-list
65232852|NCT00687193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65232853|NCT00687193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232854|NCT00687193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232855|NCT00917878|Calcium|calcium|mesh-list
65232856|NCT00917878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65232857|NCT00917878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232858|NCT00730912|Loratadine|loratadine|mesh-list
65232859|NCT00730912|Antipruritics|antipruritics|mesh-ancestor
65232860|NCT00730912|Dermatologic Agents|dermatologic agents|mesh-ancestor
65232861|NCT00730912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65232862|NCT00730912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65232863|NCT00730912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65232864|NCT00730912|Histamine Antagonists|histamine antagonists|mesh-ancestor
65232865|NCT00730912|Histamine Agents|histamine agents|mesh-ancestor
65232891|NCT00729586|Megestrol Acetate|megestrol acetate|mesh-list
65232892|NCT00729586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65232893|NCT00729586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65232894|NCT00729586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65232895|NCT00729586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232896|NCT00729586|Antifungal Agents|antifungal agents|mesh-ancestor
65232897|NCT00729586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65232898|NCT00729586|Immunologic Factors|immunologic factors|mesh-ancestor
65232958|NCT04088110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232959|NCT04088110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232960|NCT04088110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65232961|NCT04088110|Hormone Antagonists|hormone antagonists|mesh-ancestor
65232962|NCT04088110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65232963|NCT04088110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232964|NCT04088110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65232965|NCT04088266|Buprenorphine|buprenorphine|mesh-list
65232966|NCT04088266|Naloxone|naloxone|mesh-list
65232967|NCT04088266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65232968|NCT04088266|Narcotics|narcotics|mesh-ancestor
65232969|NCT04088266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65232970|NCT04088266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65232971|NCT04088266|Analgesics|analgesics|mesh-ancestor
65232972|NCT04088266|Sensory System Agents|sensory system agents|mesh-ancestor
65232973|NCT04088266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65232974|NCT04088266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65232975|NCT05311579|Niraparib|niraparib|mesh-list
65232976|NCT05311579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65232977|NCT05311579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65232978|NCT05311579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65232979|NCT05311579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65232980|NCT00602342|Terbinafine|terbinafine|mesh-list
65232981|NCT00602342|Antifungal Agents|antifungal agents|mesh-ancestor
65232982|NCT00602342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65233003|NCT00749359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65233004|NCT00749359|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65233005|NCT00749359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65233006|NCT00749359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233007|NCT00946088|Progesterone|progesterone|mesh-list
65233008|NCT00946088|Progestins|progestins|mesh-ancestor
65233009|NCT00946088|Hormones|hormones|mesh-ancestor
65233010|NCT00946088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65233011|NCT00946088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233012|NCT02562313|Insulin Lispro|insulin lispro|mesh-list
65233013|NCT02562313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65233018|NCT00741949|Propofol|propofol|mesh-list
64454537|NCT01934972|Renal Agents|renal agents|mesh-ancestor
64454538|NCT01934972|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64454539|NCT01934972|Antitubercular Agents|antitubercular agents|mesh-ancestor
64454540|NCT01934972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64454541|NCT01934972|Antimetabolites|antimetabolites|mesh-ancestor
64454542|NCT01934972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233066|NCT00586066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65233067|NCT00586066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65233068|NCT00586066|Dopamine Agents|dopamine agents|mesh-ancestor
65233069|NCT00586066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65233070|NCT00586066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233071|NCT00586066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233072|NCT00586066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65233073|NCT00586066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65233074|NCT00630890|Capecitabine|capecitabine|mesh-list
65233075|NCT00630890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65233076|NCT00630890|Antimetabolites|antimetabolites|mesh-ancestor
65233077|NCT00630890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233079|NCT00728494|Ribavirin|ribavirin|mesh-list
65233114|NCT00941330|Alkylating Agents|alkylating agents|mesh-ancestor
65233115|NCT00941330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233116|NCT00941330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233117|NCT00941330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65233118|NCT00941330|Tubulin Modulators|tubulin modulators|mesh-ancestor
65233119|NCT00941330|Antimitotic Agents|antimitotic agents|mesh-ancestor
65233120|NCT00941330|Mitosis Modulators|mitosis modulators|mesh-ancestor
65233121|NCT00941330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65233122|NCT00941330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65233123|NCT00941330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233124|NCT00941330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65233125|NCT00941330|Hormone Antagonists|hormone antagonists|mesh-ancestor
65233126|NCT00941330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65233127|NCT00736450|Prednisone|prednisone|mesh-list
65233128|NCT00736450|Cyclophosphamide|cyclophosphamide|mesh-list
65233129|NCT00736450|Rituximab|rituximab|mesh-list
65233130|NCT00736450|Doxorubicin|doxorubicin|mesh-list
65233131|NCT00736450|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65233132|NCT00736450|Vincristine|vincristine|mesh-list
65233133|NCT00736450|Oblimersen|oblimersen|mesh-list
65233134|NCT00736450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65233135|NCT00736450|Immunologic Factors|immunologic factors|mesh-ancestor
65233169|NCT02857244|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65233170|NCT02857244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65233171|NCT02857244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65233172|NCT02857244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233173|NCT02857244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65233174|NCT02857244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233175|NCT02857244|Analgesics|analgesics|mesh-ancestor
65233176|NCT02857244|Sensory System Agents|sensory system agents|mesh-ancestor
65233177|NCT02857244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65233178|NCT02857244|Antidepressive Agents|antidepressive agents|mesh-ancestor
65233179|NCT02857244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65233180|NCT02857244|Dopamine Agents|dopamine agents|mesh-ancestor
65233181|NCT02857244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65233182|NCT02857244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233183|NCT02857244|Cholinergic Agents|cholinergic agents|mesh-ancestor
65233184|NCT02857244|Nootropic Agents|nootropic agents|mesh-ancestor
65233185|NCT02857244|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65233186|NCT02857244|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65233187|NCT02857244|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65233188|NCT02857244|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65233189|NCT04273256|Inositol|inositol|mesh-list
65233190|NCT04273256|Vitamin B Complex|vitamin b complex|mesh-ancestor
65233191|NCT04273256|Vitamins|vitamins|mesh-ancestor
65233219|NCT05096468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65233220|NCT05096468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65233221|NCT05096468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65233222|NCT05096468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65233223|NCT05096468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65233224|NCT05096468|Antidepressive Agents|antidepressive agents|mesh-ancestor
65233225|NCT04088032|Durvalumab|durvalumab|mesh-list
65233226|NCT04088032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65233227|NCT04088032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65233228|NCT04088032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233229|NCT04088032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65233230|NCT04088032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233231|NCT04088032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233232|NCT04088032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65233233|NCT04088032|Hormone Antagonists|hormone antagonists|mesh-ancestor
65233234|NCT04088032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65233235|NCT04088032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233236|NCT00688597|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
65233237|NCT00688597|Antiviral Agents|antiviral agents|mesh-ancestor
65233238|NCT00688597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65233239|NCT00688597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233240|NCT00688597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233241|NCT00735904|Gemcitabine|gemcitabine|mesh-list
65233242|NCT00735904|Axitinib|axitinib|mesh-list
65233243|NCT00735904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233244|NCT00735904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65233245|NCT00735904|Antimetabolites|antimetabolites|mesh-ancestor
65233246|NCT00735904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233263|NCT02561923|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65233264|NCT02561923|Protease Inhibitors|protease inhibitors|mesh-ancestor
65233265|NCT02561923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233266|NCT02561923|Anticoagulants|anticoagulants|mesh-ancestor
65233267|NCT00918190|Dexamethasone|dexamethasone|mesh-list
65233268|NCT00918190|Dexamethasone acetate|dexamethasone acetate|mesh-list
65233269|NCT00918190|Midazolam|midazolam|mesh-list
65233270|NCT00918190|Ondansetron|ondansetron|mesh-list
65233271|NCT00918190|BB 1101|bb 1101|mesh-list
65233272|NCT00918190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65233273|NCT00918190|Antiemetics|antiemetics|mesh-ancestor
65233274|NCT00918190|Autonomic Agents|autonomic agents|mesh-ancestor
65233275|NCT00918190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65233276|NCT00918190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233277|NCT00918190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65233278|NCT00918190|Glucocorticoids|glucocorticoids|mesh-ancestor
65233279|NCT00918190|Hormones|hormones|mesh-ancestor
65233280|NCT00918190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65233281|NCT00918190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65233282|NCT00918190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233323|NCT02563327|Antitubercular Agents|antitubercular agents|mesh-ancestor
65233324|NCT02563327|Leprostatic Agents|leprostatic agents|mesh-ancestor
65233325|NCT02563327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65233326|NCT02563327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65233327|NCT02563327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65233328|NCT02563327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65233329|NCT02563327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65233330|NCT02563327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65233331|NCT02563327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65233332|NCT02563327|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65233333|NCT02563327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65233334|NCT02563327|Antimetabolites|antimetabolites|mesh-ancestor
65233388|NCT00721630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65233389|NCT00721630|Antimetabolites|antimetabolites|mesh-ancestor
65233390|NCT00721630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233391|NCT00721630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233392|NCT00721630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65233393|NCT00721630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233394|NCT00686725|Temozolomide|temozolomide|mesh-list
65233395|NCT00686725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65233396|NCT00686725|Alkylating Agents|alkylating agents|mesh-ancestor
65233397|NCT00686725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233398|NCT00686725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233399|NCT04055623|Aldesleukin|aldesleukin|mesh-list
65233400|NCT04055623|Interleukin-2|interleukin-2|mesh-list
65233450|NCT04268966|Brincidofovir|brincidofovir|mesh-list
65233451|NCT04268966|Antiviral Agents|antiviral agents|mesh-ancestor
65233452|NCT04268966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65233453|NCT04269278|Dexmedetomidine|dexmedetomidine|mesh-list
65233454|NCT04269278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65233455|NCT04269278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65233456|NCT04269278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233457|NCT04269278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65233458|NCT04269278|Analgesics|analgesics|mesh-ancestor
65233459|NCT04269278|Sensory System Agents|sensory system agents|mesh-ancestor
65233460|NCT04269278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65233461|NCT04269278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65233512|NCT02851472|Protective Agents|protective agents|mesh-ancestor
65233513|NCT00687973|Atenolol|atenolol|mesh-list
65233514|NCT00687973|Amlodipine|amlodipine|mesh-list
65233515|NCT00687973|Valsartan|valsartan|mesh-list
65233516|NCT00687973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65233517|NCT00687973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65233518|NCT00687973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65233519|NCT00687973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233520|NCT00687973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65233521|NCT00687973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233523|NCT00687973|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65233524|NCT00687973|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65233525|NCT00687973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65233526|NCT00687973|Sympatholytics|sympatholytics|mesh-ancestor
65233573|NCT00943826|Temozolomide|temozolomide|mesh-list
65233574|NCT00943826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65233575|NCT00943826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233576|NCT00943826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65233577|NCT00943826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65233578|NCT00943826|Growth Substances|growth substances|mesh-ancestor
65233579|NCT00943826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233580|NCT00943826|Growth Inhibitors|growth inhibitors|mesh-ancestor
65233581|NCT00943826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65233582|NCT00943826|Alkylating Agents|alkylating agents|mesh-ancestor
65233583|NCT00943826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233584|NCT04268888|Nivolumab|nivolumab|mesh-list
65233585|NCT04268888|Chlorotrianisene|chlorotrianisene|mesh-list
65233586|NCT04268888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65233587|NCT04268888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233588|NCT04268888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65233589|NCT04268888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233590|NCT04268888|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65233591|NCT04268888|Estrogens|estrogens|mesh-ancestor
65233592|NCT04268888|Hormones|hormones|mesh-ancestor
64965478|NCT00054431|Antimetabolites|antimetabolites|mesh-ancestor
65233624|NCT01004003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65233625|NCT01004003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233626|NCT01004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233627|NCT00943670|Trastuzumab|trastuzumab|mesh-list
65233628|NCT00943670|Pertuzumab|pertuzumab|mesh-list
65233629|NCT00943670|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65233630|NCT00943670|Maytansine|maytansine|mesh-list
65233631|NCT00943670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65233632|NCT00943670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233633|NCT00943670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65233634|NCT00943670|Tubulin Modulators|tubulin modulators|mesh-ancestor
65233638|NCT02851004|Pembrolizumab|pembrolizumab|mesh-list
65233689|NCT00492050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65233690|NCT00492050|Antiviral Agents|antiviral agents|mesh-ancestor
65233691|NCT00492050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65233692|NCT04019548|Cisplatin|cisplatin|mesh-list
65233693|NCT04019548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233694|NCT00940316|Irinotecan|irinotecan|mesh-list
65233695|NCT00940316|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65233696|NCT00940316|Panitumumab|panitumumab|mesh-list
65233697|NCT00940316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65233698|NCT00940316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65233699|NCT00940316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233701|NCT00940316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233755|NCT00685945|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65233756|NCT00685945|Diuretics|diuretics|mesh-ancestor
65233757|NCT00685945|Natriuretic Agents|natriuretic agents|mesh-ancestor
65233758|NCT00685945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233759|NCT00685945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65233760|NCT00685945|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65233761|NCT00685945|Protease Inhibitors|protease inhibitors|mesh-ancestor
65233762|NCT00747487|Idebenone|idebenone|mesh-list
65233763|NCT00747487|Antioxidants|antioxidants|mesh-ancestor
65233764|NCT00747487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233765|NCT00747487|Protective Agents|protective agents|mesh-ancestor
65233766|NCT00747487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233767|NCT00750217|Buprenorphine|buprenorphine|mesh-list
65233819|NCT01006889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65233821|NCT01006889|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65233822|NCT01006889|Incretins|incretins|mesh-ancestor
65233823|NCT01006889|Hormones|hormones|mesh-ancestor
65233824|NCT01006889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65233825|NCT02561767|Mycophenolic Acid|mycophenolic acid|mesh-list
65233826|NCT02561767|Tacrolimus|tacrolimus|mesh-list
65233827|NCT02561767|Basiliximab|basiliximab|mesh-list
65233828|NCT02561767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65233829|NCT02561767|Immunologic Factors|immunologic factors|mesh-ancestor
65233830|NCT02561767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233840|NCT00747799|Fluorouracil|fluorouracil|mesh-list
65233883|NCT01000805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65233884|NCT01000805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65233885|NCT01000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233886|NCT01000805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65233887|NCT01000805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233889|NCT01000805|Sensory System Agents|sensory system agents|mesh-ancestor
65233890|NCT01000805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65233891|NCT01000805|Antidepressive Agents|antidepressive agents|mesh-ancestor
65233892|NCT01000805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65233893|NCT01000805|Dopamine Agents|dopamine agents|mesh-ancestor
65233895|NCT00684307|Warfarin|warfarin|mesh-list
65233950|NCT00752479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65233951|NCT00752479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65233952|NCT00752479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65233953|NCT00752479|Immunologic Factors|immunologic factors|mesh-ancestor
64876682|NCT01879930|Antimalarials|antimalarials|mesh-ancestor
65233954|NCT00752479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65233955|NCT00752479|Antifungal Agents|antifungal agents|mesh-ancestor
65233956|NCT00752479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65233957|NCT00752479|Dermatologic Agents|dermatologic agents|mesh-ancestor
65233958|NCT00752479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65233959|NCT00752479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65233960|NCT00752479|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65233961|NCT00752479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233962|NCT00752479|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65233963|NCT00752479|Antitubercular Agents|antitubercular agents|mesh-ancestor
65233964|NCT00752479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65233965|NCT00752479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65233966|NCT00752479|Antiemetics|antiemetics|mesh-ancestor
65233967|NCT00752479|Autonomic Agents|autonomic agents|mesh-ancestor
65233968|NCT00752479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65233969|NCT00752479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65233970|NCT00752479|Glucocorticoids|glucocorticoids|mesh-ancestor
65233971|NCT00752479|Hormones|hormones|mesh-ancestor
65233972|NCT00752479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65233983|NCT00752635|Estradiol|estradiol|mesh-list
65233998|NCT00752635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65233999|NCT00752635|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65234000|NCT00752635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65234001|NCT00752635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65234002|NCT00752635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65234003|NCT00752635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65234004|NCT00752635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65234005|NCT00752635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234006|NCT00752635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234007|NCT00752635|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65234008|NCT00750997|Dextrans|dextrans|mesh-list
65234009|NCT00750997|Anticoagulants|anticoagulants|mesh-ancestor
65234010|NCT00750997|Plasma Substitutes|plasma substitutes|mesh-ancestor
65234011|NCT00750997|Blood Substitutes|blood substitutes|mesh-ancestor
65234012|NCT00748345|Caspofungin|caspofungin|mesh-list
65234013|NCT00748345|Antifungal Agents|antifungal agents|mesh-ancestor
65234014|NCT00748345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65234015|NCT00748345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234016|NCT00748345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234017|NCT00752869|Dutasteride|dutasteride|mesh-list
65234018|NCT00752869|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65234019|NCT00752869|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65234020|NCT00752869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234021|NCT00752869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876772|NCT01880463|Vitamin D|vitamin d|mesh-list
65234047|NCT00748423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234048|NCT00748423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65234049|NCT00748423|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65234050|NCT00748423|Vasodilator Agents|vasodilator agents|mesh-ancestor
65234051|NCT00748423|Gasotransmitters|gasotransmitters|mesh-ancestor
65234052|NCT00748423|Protective Agents|protective agents|mesh-ancestor
65234053|NCT00687271|Atorvastatin|atorvastatin|mesh-list
65234054|NCT00687271|Calcium|calcium|mesh-list
65234055|NCT00687271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65234056|NCT00687271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234057|NCT00687271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65234058|NCT00687271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65234108|NCT00685399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234109|NCT00751699|Mesalamine|mesalamine|mesh-list
65234110|NCT00751699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65234111|NCT00751699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65234112|NCT00751699|Analgesics|analgesics|mesh-ancestor
65234113|NCT00751699|Sensory System Agents|sensory system agents|mesh-ancestor
65234114|NCT00751699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65234115|NCT00751699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234116|NCT00751699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65234117|NCT00751699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65234118|NCT00753103|Mycophenolic Acid|mycophenolic acid|mesh-list
65234119|NCT00753103|Methylprednisolone|methylprednisolone|mesh-list
65234171|NCT05393713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234172|NCT00751855|Hydrocortisone|hydrocortisone|mesh-list
65234173|NCT00751855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65234174|NCT00755833|Insulin Aspart|insulin aspart|mesh-list
65234175|NCT00755833|Biphasic Insulins|biphasic insulins|mesh-list
65234176|NCT00755833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65234177|NCT00755833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234178|NCT00753493|Topiramate|topiramate|mesh-list
65234179|NCT00753493|Anticonvulsants|anticonvulsants|mesh-ancestor
65234180|NCT00753493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65234181|NCT00753493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234182|NCT00753571|Cardiac Glycosides|cardiac glycosides|mesh-list
65234183|NCT00753571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65234184|NCT00753571|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65234185|NCT00753571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234186|NCT00753571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234187|NCT00753571|Protective Agents|protective agents|mesh-ancestor
65234188|NCT00753571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234189|NCT00753727|Sunitinib|sunitinib|mesh-list
65234190|NCT00753727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234191|NCT00753727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65234192|NCT00753727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65234193|NCT00753727|Growth Substances|growth substances|mesh-ancestor
65234194|NCT00753727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234195|NCT00753727|Growth Inhibitors|growth inhibitors|mesh-ancestor
65234196|NCT00753727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65234197|NCT00753727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234198|NCT00753727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234199|NCT00755989|Morphine|morphine|mesh-list
65234200|NCT00755989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65234201|NCT00755989|Narcotics|narcotics|mesh-ancestor
65234202|NCT00755989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65234203|NCT00755989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234212|NCT05388877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65234213|NCT05388877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234214|NCT05388877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234215|NCT04053205|Paclitaxel|paclitaxel|mesh-list
65234216|NCT04053205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65234217|NCT04053205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234218|NCT04053205|Tubulin Modulators|tubulin modulators|mesh-ancestor
65234219|NCT04053205|Antimitotic Agents|antimitotic agents|mesh-ancestor
65234220|NCT04053205|Mitosis Modulators|mitosis modulators|mesh-ancestor
65234221|NCT04053205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234222|NCT02559973|Buprenorphine|buprenorphine|mesh-list
65234223|NCT02559973|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65234224|NCT02559973|Naloxone|naloxone|mesh-list
65234225|NCT02559973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65234226|NCT02559973|Narcotics|narcotics|mesh-ancestor
65234227|NCT02559973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65234228|NCT02559973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234229|NCT02559973|Analgesics|analgesics|mesh-ancestor
65234230|NCT02559973|Sensory System Agents|sensory system agents|mesh-ancestor
65234231|NCT02559973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65234232|NCT02559973|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65234233|NCT00753883|Simvastatin|simvastatin|mesh-list
65234234|NCT00753883|Ezetimibe|ezetimibe|mesh-list
65234235|NCT00753883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65234236|NCT00753883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65234237|NCT00753883|Antimetabolites|antimetabolites|mesh-ancestor
65234238|NCT00753883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234239|NCT00753883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65234240|NCT00753883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65234241|NCT00753883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234242|NCT00720382|Mometasone Furoate|mometasone furoate|mesh-list
65234243|NCT00720382|Azelastine|azelastine|mesh-list
65234254|NCT00720382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234255|NCT00720382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234256|NCT00720382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65234257|NCT00720382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65234258|NCT00720382|Histamine Antagonists|histamine antagonists|mesh-ancestor
65234259|NCT00720382|Histamine Agents|histamine agents|mesh-ancestor
65234260|NCT00720382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65234261|NCT00754039|Fenofibrate|fenofibrate|mesh-list
65234262|NCT00754039|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65234319|NCT04051723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65234320|NCT04051723|Glucocorticoids|glucocorticoids|mesh-ancestor
65234321|NCT04051723|Hormones|hormones|mesh-ancestor
65234322|NCT04051723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65234323|NCT04051723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65234324|NCT04051723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234325|NCT04051723|Anesthetics, Local|anesthetics, local|mesh-ancestor
65234326|NCT04051723|Anesthetics|anesthetics|mesh-ancestor
65234327|NCT04051723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65234328|NCT04051723|Sensory System Agents|sensory system agents|mesh-ancestor
65234329|NCT00918424|Oxcarbazepine|oxcarbazepine|mesh-list
65234330|NCT00918424|Anticonvulsants|anticonvulsants|mesh-ancestor
65234331|NCT00918424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65234337|NCT00756847|Paclitaxel|paclitaxel|mesh-list
65234380|NCT00757393|Cholecalciferol|cholecalciferol|mesh-list
65234381|NCT00757393|Vitamins|vitamins|mesh-list
65234382|NCT00757393|Calcium|calcium|mesh-list
65234383|NCT00757393|Micronutrients|micronutrients|mesh-ancestor
65234384|NCT00757393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234385|NCT00757393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65234386|NCT00757393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65234387|NCT00754351|Gemcitabine|gemcitabine|mesh-list
65234388|NCT00754351|Bevacizumab|bevacizumab|mesh-list
65234389|NCT00754351|Docetaxel|docetaxel|mesh-list
65234390|NCT00754351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65234391|NCT00754351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234392|NCT00754351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65234393|NCT00754351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65234394|NCT00754351|Growth Substances|growth substances|mesh-ancestor
65234395|NCT00754351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234396|NCT00754351|Growth Inhibitors|growth inhibitors|mesh-ancestor
65234397|NCT00754351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65234398|NCT00754351|Antimetabolites|antimetabolites|mesh-ancestor
65234399|NCT00754351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234400|NCT00754351|Antiviral Agents|antiviral agents|mesh-ancestor
65234401|NCT00754351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65234402|NCT00754351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234403|NCT00754351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65234409|NCT00754429|Amlodipine|amlodipine|mesh-list
65234430|NCT00725608|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65234432|NCT00725608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65234433|NCT00725608|Narcotics|narcotics|mesh-ancestor
65234434|NCT00725608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65234435|NCT00725608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234436|NCT00725608|Analgesics|analgesics|mesh-ancestor
65234437|NCT00725608|Sensory System Agents|sensory system agents|mesh-ancestor
65234438|NCT00725608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65234439|NCT00725608|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65234440|NCT00725452|Infliximab|infliximab|mesh-list
65234441|NCT00725452|Dermatologic Agents|dermatologic agents|mesh-ancestor
65234442|NCT00725452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65234443|NCT00725452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65234444|NCT00725296|Infliximab|infliximab|mesh-list
65234445|NCT00725296|Dermatologic Agents|dermatologic agents|mesh-ancestor
65234446|NCT00725296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65234447|NCT00725296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65234448|NCT00585052|Paclitaxel|paclitaxel|mesh-list
65234449|NCT00585052|Lovastatin|lovastatin|mesh-list
65234450|NCT00585052|L 647318|l 647318|mesh-list
65234451|NCT00585052|Dihydromevinolin|dihydromevinolin|mesh-list
65234452|NCT00585052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65234453|NCT00585052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234454|NCT00585052|Tubulin Modulators|tubulin modulators|mesh-ancestor
65234484|NCT00723892|Antiviral Agents|antiviral agents|mesh-ancestor
65234485|NCT00723892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65234486|NCT00723892|Immunologic Factors|immunologic factors|mesh-ancestor
65234487|NCT00723892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234488|NCT04086940|Esmolol|esmolol|mesh-list
65234489|NCT04086940|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65234490|NCT04086940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65234491|NCT04086940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65234492|NCT04086940|Adrenergic Agents|adrenergic agents|mesh-ancestor
65234493|NCT04086940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64966436|NCT04631484|Niacin|niacin|mesh-list
65234494|NCT04086940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234495|NCT04086940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234497|NCT02590900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65234498|NCT02590900|Analgesics|analgesics|mesh-ancestor
65234499|NCT02590900|Sensory System Agents|sensory system agents|mesh-ancestor
65234500|NCT02590900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65234501|NCT02590900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234502|NCT02590900|Antipyretics|antipyretics|mesh-ancestor
65234503|NCT02591914|Bevacizumab|bevacizumab|mesh-list
65234504|NCT02591914|Ranibizumab|ranibizumab|mesh-list
65234505|NCT02591914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65234506|NCT02591914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234507|NCT02591914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65234508|NCT02591914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65234509|NCT02591914|Growth Substances|growth substances|mesh-ancestor
65234510|NCT02591914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234532|NCT00722800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65234533|NCT00722800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234534|NCT00722800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65234535|NCT00722800|Contraceptive Agents|contraceptive agents|mesh-ancestor
65234536|NCT00722800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65234537|NCT00722800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65234538|NCT00722800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65234539|NCT00722800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65234540|NCT00722800|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65234541|NCT00722800|Hormone Antagonists|hormone antagonists|mesh-ancestor
65234542|NCT00722800|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65234543|NCT00722800|Diuretics|diuretics|mesh-ancestor
65234544|NCT00722800|Natriuretic Agents|natriuretic agents|mesh-ancestor
65234545|NCT00741598|Galantamine|galantamine|mesh-list
65234546|NCT00741598|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65234547|NCT00741598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234548|NCT00741598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234549|NCT00741598|Cholinergic Agents|cholinergic agents|mesh-ancestor
65234586|NCT00741286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234587|NCT00741286|Antipyretics|antipyretics|mesh-ancestor
65234588|NCT00741286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65234589|NCT00741286|Autonomic Agents|autonomic agents|mesh-ancestor
65234600|NCT00716092|Linagliptin|linagliptin|mesh-list
65234658|NCT00679783|Olaparib|olaparib|mesh-list
65234659|NCT00679783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65234660|NCT00679783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234661|NCT00679783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234662|NCT00679783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234663|NCT05414305|Lidocaine|lidocaine|mesh-list
65234664|NCT05414305|Heparin|heparin|mesh-list
65234665|NCT05414305|Anesthetics, Local|anesthetics, local|mesh-ancestor
65234666|NCT05414305|Anesthetics|anesthetics|mesh-ancestor
65234667|NCT05414305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65234668|NCT05414305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234669|NCT05414305|Sensory System Agents|sensory system agents|mesh-ancestor
65234670|NCT05414305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65234671|NCT05414305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65234672|NCT05414305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65234679|NCT00757549|Cetuximab|cetuximab|mesh-list
65234716|NCT02589652|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65234717|NCT02589652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234718|NCT02589652|Antiviral Agents|antiviral agents|mesh-ancestor
65234719|NCT02589652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65234720|NCT02589652|Immunologic Factors|immunologic factors|mesh-ancestor
65234721|NCT02589652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234722|NCT00679627|Galantamine|galantamine|mesh-list
65234723|NCT00679627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65234724|NCT00679627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234725|NCT00679627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234726|NCT00679627|Cholinergic Agents|cholinergic agents|mesh-ancestor
65234727|NCT00679627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65234728|NCT00679627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234729|NCT00679627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65234730|NCT00679627|Autonomic Agents|autonomic agents|mesh-ancestor
65234731|NCT00679627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65234732|NCT00679627|Nootropic Agents|nootropic agents|mesh-ancestor
65234733|NCT00714688|Methylphenidate|methylphenidate|mesh-list
65234734|NCT00714688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65234735|NCT00714688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234736|NCT00714688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65234737|NCT00714688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65234738|NCT00714688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65234739|NCT00714688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234740|NCT00714688|Dopamine Agents|dopamine agents|mesh-ancestor
65234741|NCT00714688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65234742|NCT05165212|Amoxicillin|amoxicillin|mesh-list
65234743|NCT05165212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65234744|NCT05165212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65234745|NCT04051099|Dexmedetomidine|dexmedetomidine|mesh-list
65234746|NCT04051099|Bupivacaine|bupivacaine|mesh-list
65234747|NCT04051099|Propofol|propofol|mesh-list
65234748|NCT04051099|Anesthetics, Local|anesthetics, local|mesh-ancestor
65234749|NCT04051099|Anesthetics|anesthetics|mesh-ancestor
65234756|NCT04051099|Anesthetics, General|anesthetics, general|mesh-ancestor
65234757|NCT04051099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65234758|NCT04051099|Analgesics|analgesics|mesh-ancestor
65234759|NCT04051099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65234760|NCT04051099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65234761|NCT04051099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65234762|NCT04051099|Adrenergic Agents|adrenergic agents|mesh-ancestor
65234763|NCT04051099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65234764|NCT04051099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234765|NCT01031069|Vaccines|vaccines|mesh-list
65234766|NCT01031069|Immunologic Factors|immunologic factors|mesh-ancestor
65234767|NCT01031069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234768|NCT04084912|Dexamethasone|dexamethasone|mesh-list
65234769|NCT04084912|Dexamethasone acetate|dexamethasone acetate|mesh-list
65234770|NCT04084912|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65234771|NCT04084912|BB 1101|bb 1101|mesh-list
65234772|NCT04084912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65234773|NCT04084912|Antiemetics|antiemetics|mesh-ancestor
65234774|NCT04084912|Autonomic Agents|autonomic agents|mesh-ancestor
65234775|NCT04084912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65234776|NCT04084912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234777|NCT04084912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65234778|NCT04084912|Glucocorticoids|glucocorticoids|mesh-ancestor
65234779|NCT04084912|Hormones|hormones|mesh-ancestor
65234805|NCT00755209|Hemostatics|hemostatics|mesh-ancestor
65234806|NCT00755209|Coagulants|coagulants|mesh-ancestor
65234807|NCT02589340|Buspirone|buspirone|mesh-list
65234808|NCT02589340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65234809|NCT02589340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65234810|NCT02589340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65234811|NCT02589340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234812|NCT02589340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65234813|NCT02589340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65234814|NCT02589340|Serotonin Agents|serotonin agents|mesh-ancestor
65234815|NCT02589340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65234816|NCT02589340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234817|NCT00682435|Hydromorphone|hydromorphone|mesh-list
65234818|NCT00682435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65234819|NCT00682435|Narcotics|narcotics|mesh-ancestor
65234820|NCT00682435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65234821|NCT00682435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234822|NCT00682435|Analgesics|analgesics|mesh-ancestor
65234823|NCT00682435|Sensory System Agents|sensory system agents|mesh-ancestor
65234824|NCT00682435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65234825|NCT05340205|Misoprostol|misoprostol|mesh-list
65234826|NCT05340205|Tranexamic Acid|tranexamic acid|mesh-list
65234827|NCT05340205|Oxytocin|oxytocin|mesh-list
65234828|NCT05340205|Oxytocics|oxytocics|mesh-ancestor
65234829|NCT05340205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65234830|NCT05340205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234831|NCT05340205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65234832|NCT05340205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65234833|NCT05340205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234834|NCT05340205|Hemostatics|hemostatics|mesh-ancestor
65234835|NCT05340205|Coagulants|coagulants|mesh-ancestor
65234851|NCT05291221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65234852|NCT05291221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65234853|NCT05291221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65234854|NCT05291221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65234855|NCT05291221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65234856|NCT05291221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234857|NCT05291221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65234858|NCT05291221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65234860|NCT05291221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65234861|NCT05291221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65234862|NCT05291221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65234863|NCT05291221|Adrenergic Agents|adrenergic agents|mesh-ancestor
65234864|NCT05291221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65234865|NCT00755521|Etoricoxib|etoricoxib|mesh-list
65234866|NCT00755521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65234867|NCT00755521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65234868|NCT00755521|Analgesics|analgesics|mesh-ancestor
65234871|NCT00755521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234873|NCT00755521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65234874|NCT00755521|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65234875|NCT00755521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65234876|NCT00755521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234877|NCT00755521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234878|NCT00681187|Lanreotide|lanreotide|mesh-list
65234879|NCT00681187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65234880|NCT00681109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65234881|NCT00681109|Lubricant Eye Drops|lubricant eye drops|mesh-list
65234882|NCT00681109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65234883|NCT00681109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65234884|NCT00681109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65234885|NCT00680407|Silymarin|silymarin|mesh-list
65234886|NCT00680407|Antioxidants|antioxidants|mesh-ancestor
65234887|NCT00680407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234894|NCT04007809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65234895|NCT04007809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234899|NCT05170009|Oseltamivir|oseltamivir|mesh-list
65234900|NCT05170009|Baloxavir|baloxavir|mesh-list
65234901|NCT05170009|Antiviral Agents|antiviral agents|mesh-ancestor
65234902|NCT05170009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65234903|NCT05170009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234904|NCT05170009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234905|NCT04083664|Hepcidins|hepcidins|mesh-list
65234906|NCT04083664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65234907|NCT05202730|Anesthetics|anesthetics|mesh-list
65234908|NCT05202730|Anesthetics, Local|anesthetics, local|mesh-list
65234909|NCT05202730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65234910|NCT05202730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65234911|NCT05202730|Sensory System Agents|sensory system agents|mesh-ancestor
65234913|NCT00677365|Levofloxacin|levofloxacin|mesh-list
65234955|NCT05190094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65234956|NCT05190094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65234957|NCT00680017|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65234958|NCT00680017|Fenofibric acid|fenofibric acid|mesh-list
65234959|NCT00680017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65234960|NCT00680017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65234961|NCT00680017|Antimetabolites|antimetabolites|mesh-ancestor
65234962|NCT00680017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65234963|NCT00680017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65234964|NCT00680017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65234965|NCT00680017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65234969|NCT00676663|Exemestane|exemestane|mesh-list
65235016|NCT04989946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65235017|NCT04989946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235018|NCT04989946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65235019|NCT04989946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235020|NCT05101798|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65235021|NCT05101798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65235022|NCT05101798|Dermatologic Agents|dermatologic agents|mesh-ancestor
65235023|NCT05683912|Aflibercept|aflibercept|mesh-list
65235024|NCT05683912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65235025|NCT05683912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65235026|NCT05683912|Growth Substances|growth substances|mesh-ancestor
65235027|NCT05683912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235028|NCT05683912|Growth Inhibitors|growth inhibitors|mesh-ancestor
65235029|NCT05683912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235030|NCT00679939|Metformin|metformin|mesh-list
65235031|NCT00679939|Rosiglitazone|rosiglitazone|mesh-list
65235032|NCT00679939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65235034|NCT04082260|Alemtuzumab|alemtuzumab|mesh-list
65235073|NCT04968106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65235074|NCT04968106|Alkylating Agents|alkylating agents|mesh-ancestor
65235075|NCT00919438|Diuretics|diuretics|mesh-list
65235076|NCT00919438|Natriuretic Agents|natriuretic agents|mesh-ancestor
65235077|NCT00919438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235078|NCT00571519|Metformin|metformin|mesh-list
65235079|NCT00571519|Pioglitazone|pioglitazone|mesh-list
65235080|NCT00571519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65235081|NCT00571519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235082|NCT02588404|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65235083|NCT02588404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65235084|NCT02588404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235085|NCT02588404|Luteolytic Agents|luteolytic agents|mesh-ancestor
65235086|NCT02588404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65235087|NCT02588404|Contraceptive Agents|contraceptive agents|mesh-ancestor
65235088|NCT02588404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65235089|NCT02588404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235091|NCT04935034|Vitamin D|vitamin d|mesh-list
65235092|NCT04935034|Vitamins|vitamins|mesh-ancestor
65235093|NCT04935034|Micronutrients|micronutrients|mesh-ancestor
65235094|NCT04935034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235095|NCT04935034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65235096|NCT04809766|Cyclophosphamide|cyclophosphamide|mesh-list
65235097|NCT04809766|Fludarabine|fludarabine|mesh-list
65235098|NCT04809766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65235099|NCT04809766|Immunologic Factors|immunologic factors|mesh-ancestor
65235100|NCT04809766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235101|NCT04809766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65235102|NCT04809766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65235103|NCT04809766|Alkylating Agents|alkylating agents|mesh-ancestor
65235104|NCT04809766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235105|NCT04809766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235106|NCT04809766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65235107|NCT05068726|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
65235109|NCT04807816|Gemcitabine|gemcitabine|mesh-list
65235113|NCT04807816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235114|NCT04807816|Antiviral Agents|antiviral agents|mesh-ancestor
65235115|NCT04807816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65235116|NCT04807816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235117|NCT04807816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65235118|NCT04807816|Immunologic Factors|immunologic factors|mesh-ancestor
65235119|NCT04807816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235120|NCT00762151|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65235121|NCT00762151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65235122|NCT00921973|Vaccines|vaccines|mesh-list
65235123|NCT00921973|Immunologic Factors|immunologic factors|mesh-ancestor
65235124|NCT00921973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235125|NCT00676195|Acetylcysteine|acetylcysteine|mesh-list
65235126|NCT00676195|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65235127|NCT00676195|Antiviral Agents|antiviral agents|mesh-ancestor
65235128|NCT00676195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65235129|NCT00676195|Expectorants|expectorants|mesh-ancestor
65235130|NCT00676195|Respiratory System Agents|respiratory system agents|mesh-ancestor
65235131|NCT00676195|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65235132|NCT00676195|Antioxidants|antioxidants|mesh-ancestor
65235133|NCT00676195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235134|NCT00676195|Protective Agents|protective agents|mesh-ancestor
65235135|NCT00676195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235136|NCT00676195|Antidotes|antidotes|mesh-ancestor
65235166|NCT05681650|Tubulin Modulators|tubulin modulators|mesh-ancestor
65235167|NCT05681650|Antimitotic Agents|antimitotic agents|mesh-ancestor
65235168|NCT05681650|Mitosis Modulators|mitosis modulators|mesh-ancestor
65235169|NCT05681650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235170|NCT05681650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65235171|NCT05681650|Immunologic Factors|immunologic factors|mesh-ancestor
65235172|NCT05681650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235173|NCT05681650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65235174|NCT05681650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65235175|NCT05681650|Alkylating Agents|alkylating agents|mesh-ancestor
65235176|NCT05681650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65235177|NCT02476279|Indomethacin|indomethacin|mesh-list
65235178|NCT02476279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65235179|NCT02476279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65235180|NCT02476279|Analgesics|analgesics|mesh-ancestor
65235181|NCT02476279|Sensory System Agents|sensory system agents|mesh-ancestor
65235182|NCT02476279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65235183|NCT02476279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235184|NCT02476279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65235185|NCT02476279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65235186|NCT02476279|Gout Suppressants|gout suppressants|mesh-ancestor
65235187|NCT02476279|Tocolytic Agents|tocolytic agents|mesh-ancestor
65235188|NCT02476279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65235217|NCT04895410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65235218|NCT04895410|Glucocorticoids|glucocorticoids|mesh-ancestor
65235219|NCT04895410|Hormones|hormones|mesh-ancestor
65235220|NCT04895410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65235221|NCT04895410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65235222|NCT04895410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235223|NCT04895410|Immunologic Factors|immunologic factors|mesh-ancestor
65235224|NCT04895410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65235225|NCT04895410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65235226|NCT04895410|Growth Substances|growth substances|mesh-ancestor
65235227|NCT04895410|Growth Inhibitors|growth inhibitors|mesh-ancestor
65235228|NCT00675025|Donepezil|donepezil|mesh-list
65235229|NCT00675025|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65235230|NCT00675025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235231|NCT00675025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235232|NCT00675025|Cholinergic Agents|cholinergic agents|mesh-ancestor
65235233|NCT00675025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65235234|NCT00675025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235235|NCT00675025|Nootropic Agents|nootropic agents|mesh-ancestor
65235236|NCT02312245|Gemcitabine|gemcitabine|mesh-list
65235237|NCT02312245|Paclitaxel|paclitaxel|mesh-list
65235238|NCT02312245|Bevacizumab|bevacizumab|mesh-list
65235239|NCT02312245|Doxorubicin|doxorubicin|mesh-list
65235240|NCT02312245|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65235242|NCT02312245|Topotecan|topotecan|mesh-list
65235243|NCT02312245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65235244|NCT02312245|Endothelial Growth Factors|endothelial growth factors|mesh-list
65235245|NCT02312245|Antibodies|antibodies|mesh-list
65235246|NCT02312245|Immunoglobulins|immunoglobulins|mesh-list
65235247|NCT02312245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65235248|NCT02312245|Immunoglobulin G|immunoglobulin g|mesh-list
65235249|NCT02312245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65235250|NCT02312245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235251|NCT02312245|Tubulin Modulators|tubulin modulators|mesh-ancestor
65235260|NCT02312245|Immunologic Factors|immunologic factors|mesh-ancestor
65235261|NCT02312245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65235262|NCT02312245|Antimetabolites|antimetabolites|mesh-ancestor
65235263|NCT02312245|Antiviral Agents|antiviral agents|mesh-ancestor
65235264|NCT02312245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65235265|NCT02312245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235266|NCT02312245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65235267|NCT02312245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65235268|NCT02312245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65235269|NCT02312245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65235270|NCT02312245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65235271|NCT00758407|Methylphenidate|methylphenidate|mesh-list
65235272|NCT00758407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65235273|NCT00758407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235274|NCT00758407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65235275|NCT00758407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65235276|NCT00758407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65235277|NCT00758407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235278|NCT00758407|Dopamine Agents|dopamine agents|mesh-ancestor
65235279|NCT00758407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65235280|NCT04767061|Propranolol|propranolol|mesh-list
65235281|NCT04767061|Metoprolol|metoprolol|mesh-list
65235282|NCT04767061|Atenolol|atenolol|mesh-list
65235283|NCT04767061|Sotalol|sotalol|mesh-list
65235284|NCT04767061|Nadolol|nadolol|mesh-list
65235285|NCT04767061|Acebutolol|acebutolol|mesh-list
65235286|NCT04767061|Carvedilol|carvedilol|mesh-list
65235287|NCT04767061|Nebivolol|nebivolol|mesh-list
65235288|NCT04767061|Bisoprolol|bisoprolol|mesh-list
65235309|NCT04767061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65235310|NCT04767061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65235311|NCT04767061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65235312|NCT04767061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65235313|NCT04767061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65235314|NCT04767061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65235315|NCT04767061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65235316|NCT04767061|Sympathomimetics|sympathomimetics|mesh-ancestor
65235318|NCT04767061|Serotonin Agents|serotonin agents|mesh-ancestor
65235319|NCT05322577|Nivolumab|nivolumab|mesh-list
65235320|NCT05322577|Bemarituzumab|bemarituzumab|mesh-list
65235321|NCT05322577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65235322|NCT05322577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235323|NCT05322577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65235324|NCT05322577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235325|NCT00759421|Olanzapine|olanzapine|mesh-list
65235326|NCT00759421|Sertindole|sertindole|mesh-list
65235327|NCT00759421|Antiemetics|antiemetics|mesh-ancestor
65235328|NCT00759421|Autonomic Agents|autonomic agents|mesh-ancestor
65235329|NCT00759421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65235330|NCT00759421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235331|NCT00759421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65235332|NCT00759421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65235333|NCT00759421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65235334|NCT00759421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65235335|NCT00759421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65235336|NCT00759421|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65235357|NCT00763165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65235358|NCT00763165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65235359|NCT00763165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65235360|NCT00763165|Antimetabolites|antimetabolites|mesh-ancestor
65235361|NCT00763165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235362|NCT00763165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65235363|NCT04049227|Letrozole|letrozole|mesh-list
65235364|NCT04049227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235365|NCT04049227|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65235366|NCT04049227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65235367|NCT04049227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235368|NCT04049227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235369|NCT04049227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65235370|NCT04049227|Hormone Antagonists|hormone antagonists|mesh-ancestor
65235371|NCT04049227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65235372|NCT04049227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235373|NCT00759733|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65235374|NCT00759733|Natriuretic Agents|natriuretic agents|mesh-ancestor
65235375|NCT00759733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235376|NCT00760045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65235377|NCT00760045|Hyaluronic Acid|hyaluronic acid|mesh-list
64878118|NCT01889407|Idarubicin|idarubicin|mesh-list
65235378|NCT00760045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65235379|NCT00760045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65235380|NCT00760045|Immunologic Factors|immunologic factors|mesh-ancestor
65235381|NCT00760045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235382|NCT00760045|Viscosupplements|viscosupplements|mesh-ancestor
65235383|NCT00760045|Protective Agents|protective agents|mesh-ancestor
65235384|NCT00678379|Lidocaine|lidocaine|mesh-list
65235385|NCT00678379|Clonidine|clonidine|mesh-list
65235386|NCT00678379|Bupivacaine|bupivacaine|mesh-list
65235387|NCT00678379|Anesthetics, Local|anesthetics, local|mesh-ancestor
65235398|NCT00678379|Analgesics|analgesics|mesh-ancestor
65235399|NCT00678379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65235400|NCT00678379|Sympatholytics|sympatholytics|mesh-ancestor
65235401|NCT00678379|Autonomic Agents|autonomic agents|mesh-ancestor
65235402|NCT00678379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65235403|NCT00678379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65235404|NCT00678379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65235405|NCT00678379|Adrenergic Agents|adrenergic agents|mesh-ancestor
65235406|NCT00678379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65235407|NCT00760279|Azithromycin|azithromycin|mesh-list
65235408|NCT00760279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65235409|NCT00760279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65235410|NCT00674323|Ranibizumab|ranibizumab|mesh-list
65235411|NCT00674323|Verteporfin|verteporfin|mesh-list
65235412|NCT00674323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65235413|NCT00674323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65235414|NCT00674323|Growth Substances|growth substances|mesh-ancestor
65235415|NCT00674323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235416|NCT00674323|Growth Inhibitors|growth inhibitors|mesh-ancestor
65235417|NCT00674323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235418|NCT00674323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65235419|NCT00674323|Dermatologic Agents|dermatologic agents|mesh-ancestor
65235420|NCT00763633|Vitamins|vitamins|mesh-list
65235421|NCT00763633|Vitamin B 6|vitamin b 6|mesh-list
65235422|NCT00763633|Pyridoxal|pyridoxal|mesh-list
65235423|NCT00763633|Pyridoxine|pyridoxine|mesh-list
65235424|NCT00763633|Vitamin B Complex|vitamin b complex|mesh-list
65235427|NCT00763789|Remifentanil|remifentanil|mesh-list
65235450|NCT04115956|Alkylating Agents|alkylating agents|mesh-ancestor
65235451|NCT04115956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235452|NCT04115956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65235453|NCT04115956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65235454|NCT04115956|Immunologic Factors|immunologic factors|mesh-ancestor
65235455|NCT04081480|Valacyclovir|valacyclovir|mesh-list
65235456|NCT04081480|Antiviral Agents|antiviral agents|mesh-ancestor
65235457|NCT04081480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65235458|NCT00678301|Vaccines|vaccines|mesh-list
65235459|NCT00678301|Immunologic Factors|immunologic factors|mesh-ancestor
65235460|NCT00678301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235461|NCT02586454|Morphine|morphine|mesh-list
65235462|NCT02586454|Ropivacaine|ropivacaine|mesh-list
65235463|NCT02586454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65235464|NCT02586454|Narcotics|narcotics|mesh-ancestor
65235465|NCT02586454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65235466|NCT02586454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235467|NCT02586454|Analgesics|analgesics|mesh-ancestor
65235468|NCT02586454|Sensory System Agents|sensory system agents|mesh-ancestor
65235469|NCT02586454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65235470|NCT02586454|Anesthetics, Local|anesthetics, local|mesh-ancestor
65235471|NCT02586454|Anesthetics|anesthetics|mesh-ancestor
65235472|NCT00939770|Crizotinib|crizotinib|mesh-list
65235473|NCT00939770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235474|NCT00939770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65235475|NCT00939770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235476|NCT00939770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235477|NCT02558569|Levobupivacaine|levobupivacaine|mesh-list
65235478|NCT02558569|Anesthetics, Local|anesthetics, local|mesh-ancestor
65235479|NCT02558569|Anesthetics|anesthetics|mesh-ancestor
65235480|NCT02558569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65235484|NCT00939692|Topiramate|topiramate|mesh-list
65235495|NCT00920608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235496|NCT00920608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235497|NCT00920608|Dermatologic Agents|dermatologic agents|mesh-ancestor
65235498|NCT00920608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235499|NCT00920608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65235500|NCT00920608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65235501|NCT00920608|Immunologic Factors|immunologic factors|mesh-ancestor
65235502|NCT00920608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65235503|NCT00920608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65235504|NCT04674514|Dexamethasone|dexamethasone|mesh-list
65235505|NCT04674514|Lenalidomide|lenalidomide|mesh-list
65235506|NCT04674514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65235507|NCT04674514|Antiemetics|antiemetics|mesh-ancestor
65235508|NCT04674514|Autonomic Agents|autonomic agents|mesh-ancestor
65235509|NCT04674514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65235513|NCT04674514|Hormones|hormones|mesh-ancestor
65235556|NCT00942734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65235557|NCT00942734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235558|NCT00942734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235559|NCT02586142|Botulinum Toxins|botulinum toxins|mesh-list
65235560|NCT02586142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65235561|NCT02586142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65235562|NCT02586142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65235563|NCT02586142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65235564|NCT02586142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235565|NCT02586142|Cholinergic Agents|cholinergic agents|mesh-ancestor
65235566|NCT02586142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65235567|NCT02586142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235568|NCT02586142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65235569|NCT02586142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65235570|NCT00919984|Paclitaxel|paclitaxel|mesh-list
65235571|NCT00919984|Carboplatin|carboplatin|mesh-list
65235572|NCT00919984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65235573|NCT00919984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235574|NCT00919984|Tubulin Modulators|tubulin modulators|mesh-ancestor
65235575|NCT00919984|Antimitotic Agents|antimitotic agents|mesh-ancestor
65235576|NCT00919984|Mitosis Modulators|mitosis modulators|mesh-ancestor
65235577|NCT00919984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235578|NCT00942422|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65235579|NCT00942422|Antioxidants|antioxidants|mesh-ancestor
65235580|NCT00942422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235581|NCT00942422|Protective Agents|protective agents|mesh-ancestor
65235601|NCT05380934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65235602|NCT05380934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65235603|NCT00603824|PENTA|penta|mesh-list
65235604|NCT00603824|Lepirudin|lepirudin|mesh-list
65235605|NCT00603824|Fondaparinux|fondaparinux|mesh-list
65235606|NCT00603824|Argatroban|argatroban|mesh-list
65235607|NCT00603824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65235608|NCT00603824|Antithrombins|antithrombins|mesh-ancestor
65235609|NCT00603824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65235610|NCT00603824|Protease Inhibitors|protease inhibitors|mesh-ancestor
65235611|NCT00603824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235612|NCT00603824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235613|NCT00603824|Anticoagulants|anticoagulants|mesh-ancestor
65235614|NCT00603824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65235615|NCT00603824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65235616|NCT00603824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65235617|NCT00677833|Azithromycin|azithromycin|mesh-list
65235618|NCT00677833|Chloroquine|chloroquine|mesh-list
65235619|NCT00677833|Lumefantrine|lumefantrine|mesh-list
65235620|NCT00677833|Artemether|artemether|mesh-list
65235621|NCT00677833|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65235660|NCT05382182|Hormones|hormones|mesh-ancestor
65235661|NCT05382182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65235662|NCT05382182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235663|NCT04727242|Gemcitabine|gemcitabine|mesh-list
65235664|NCT04727242|Dacarbazine|dacarbazine|mesh-list
65235665|NCT04727242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65235666|NCT04727242|Antimetabolites|antimetabolites|mesh-ancestor
65235667|NCT04727242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235668|NCT04727242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235669|NCT04727242|Antiviral Agents|antiviral agents|mesh-ancestor
65235670|NCT04727242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65235671|NCT04727242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235672|NCT04727242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65235673|NCT04727242|Immunologic Factors|immunologic factors|mesh-ancestor
65235674|NCT04727242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235675|NCT04727242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65235676|NCT04727242|Alkylating Agents|alkylating agents|mesh-ancestor
65235677|NCT04505878|Ascorbic Acid|ascorbic acid|mesh-list
65235678|NCT04505878|Vitamins|vitamins|mesh-ancestor
65235679|NCT04505878|Micronutrients|micronutrients|mesh-ancestor
65235680|NCT04505878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235681|NCT04505878|Antioxidants|antioxidants|mesh-ancestor
65235682|NCT04505878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235683|NCT04505878|Protective Agents|protective agents|mesh-ancestor
65235684|NCT04079374|Etanercept|etanercept|mesh-list
65235685|NCT04079374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65235686|NCT04079374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65235687|NCT04079374|Analgesics|analgesics|mesh-ancestor
65235704|NCT00604058|Vaccines|vaccines|mesh-list
65235706|NCT00604058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235707|NCT02852798|Docetaxel|docetaxel|mesh-list
65235708|NCT02852798|Apatinib|apatinib|mesh-list
65235709|NCT02852798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235710|NCT02852798|Tubulin Modulators|tubulin modulators|mesh-ancestor
65235711|NCT02852798|Antimitotic Agents|antimitotic agents|mesh-ancestor
65235712|NCT02852798|Mitosis Modulators|mitosis modulators|mesh-ancestor
65235713|NCT02852798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235714|NCT02852798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65235715|NCT02852798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235716|NCT02586610|Pembrolizumab|pembrolizumab|mesh-list
65235717|NCT02586610|Capecitabine|capecitabine|mesh-list
65235718|NCT02586610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65235719|NCT02586610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235720|NCT02586610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65235721|NCT02586610|Antimetabolites|antimetabolites|mesh-ancestor
65235722|NCT02586610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235723|NCT00604682|Apremilast|apremilast|mesh-list
65235724|NCT00604682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65235725|NCT00604682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65235726|NCT00604682|Analgesics|analgesics|mesh-ancestor
65235727|NCT00604682|Sensory System Agents|sensory system agents|mesh-ancestor
65235728|NCT00604682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65235729|NCT00604682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235730|NCT00604682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65235731|NCT00604682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65235732|NCT00604682|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65235733|NCT00604682|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65235734|NCT00604682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235735|NCT00604682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235748|NCT00672841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65235749|NCT00672841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235750|NCT00672841|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65235751|NCT00672841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65235752|NCT00920296|Cabotegravir|cabotegravir|mesh-list
65235753|NCT00920296|Etravirine|etravirine|mesh-list
65235754|NCT00920296|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65235755|NCT00920296|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65235756|NCT00920296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235757|NCT00920296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235758|NCT00920296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65235759|NCT00920296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65235761|NCT00920296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65235762|NCT00920296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65235763|NCT00920296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65235764|NCT04080388|Diuretics|diuretics|mesh-list
65235765|NCT04080388|Natriuretic Agents|natriuretic agents|mesh-ancestor
65235766|NCT04080388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235767|NCT04080622|Selenium|selenium|mesh-list
65235768|NCT04080622|Antioxidants|antioxidants|mesh-ancestor
65235769|NCT04080622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235770|NCT04080622|Protective Agents|protective agents|mesh-ancestor
65235773|NCT04080622|Micronutrients|micronutrients|mesh-ancestor
65235800|NCT00764413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65235801|NCT00764413|Antiemetics|antiemetics|mesh-ancestor
65235802|NCT00764413|Autonomic Agents|autonomic agents|mesh-ancestor
65235803|NCT00764413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65235804|NCT00764413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235805|NCT00764413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65235806|NCT00764413|Glucocorticoids|glucocorticoids|mesh-ancestor
65235807|NCT00764413|Hormones|hormones|mesh-ancestor
65235808|NCT00764413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65235809|NCT00764413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65235810|NCT00764413|Protective Agents|protective agents|mesh-ancestor
65235811|NCT00764413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65235812|NCT00764413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235813|NCT00941798|Mometasone Furoate|mometasone furoate|mesh-list
65235814|NCT00941798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65235815|NCT00941798|Dermatologic Agents|dermatologic agents|mesh-ancestor
65235816|NCT00941798|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65235817|NCT00583102|Cytarabine|cytarabine|mesh-list
65235818|NCT00583102|Lovastatin|lovastatin|mesh-list
65235819|NCT00583102|L 647318|l 647318|mesh-list
65235820|NCT00583102|Dihydromevinolin|dihydromevinolin|mesh-list
65235821|NCT00583102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65235822|NCT00583102|Antimetabolites|antimetabolites|mesh-ancestor
65235823|NCT00583102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235824|NCT00583102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235825|NCT00583102|Antiviral Agents|antiviral agents|mesh-ancestor
65235826|NCT00583102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65235827|NCT00583102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65235828|NCT00583102|Immunologic Factors|immunologic factors|mesh-ancestor
65235829|NCT00583102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235830|NCT00583102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65235831|NCT00583102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65235832|NCT00583102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65235843|NCT00605930|Vitamin B Complex|vitamin b complex|mesh-ancestor
65235844|NCT00605930|Vitamins|vitamins|mesh-ancestor
65235845|NCT00605930|Micronutrients|micronutrients|mesh-ancestor
65235846|NCT00605930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235847|NCT00605930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65235848|NCT00605930|Antimetabolites|antimetabolites|mesh-ancestor
65235849|NCT00605930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235850|NCT00605930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65235851|NCT00605930|Vasodilator Agents|vasodilator agents|mesh-ancestor
65235852|NCT04699630|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
65235853|NCT04699630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65235854|NCT04699630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235855|NCT00602186|Prazosin|prazosin|mesh-list
65235856|NCT00602186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65235857|NCT00602186|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65235858|NCT00602186|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65235859|NCT00602186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65235860|NCT00602186|Adrenergic Agents|adrenergic agents|mesh-ancestor
65235861|NCT00602186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65235862|NCT00602186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235864|NCT04204304|Isotretinoin|isotretinoin|mesh-list
65235895|NCT02852564|Ethacrynic Acid|ethacrynic acid|mesh-list
65235896|NCT02852564|Diuretics|diuretics|mesh-ancestor
65235897|NCT02852564|Natriuretic Agents|natriuretic agents|mesh-ancestor
65235898|NCT02852564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235899|NCT02852564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235900|NCT02852564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235901|NCT05593042|Vaccines|vaccines|mesh-list
65235902|NCT05593042|Immunologic Factors|immunologic factors|mesh-ancestor
65235903|NCT05593042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235904|NCT05514106|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65235905|NCT05514106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65235906|NCT05514106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235907|NCT05514106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235908|NCT05514106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65235909|NCT05509816|Midazolam|midazolam|mesh-list
65235910|NCT05509816|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65235911|NCT05509816|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65235912|NCT05509816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65235913|NCT05509816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235914|NCT05509816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65235915|NCT05509816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65235916|NCT05509816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65235917|NCT05509816|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65235918|NCT05509816|Anesthetics, General|anesthetics, general|mesh-ancestor
65235919|NCT05509816|Anesthetics|anesthetics|mesh-ancestor
65235920|NCT05509816|GABA Modulators|gaba modulators|mesh-ancestor
65235921|NCT05509816|GABA Agents|gaba agents|mesh-ancestor
65235922|NCT05509816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65235923|NCT05509816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235924|NCT04080310|Ezetimibe|ezetimibe|mesh-list
65235925|NCT04080310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65235926|NCT04080310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65235927|NCT04080310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65235928|NCT04080310|Antimetabolites|antimetabolites|mesh-ancestor
65235929|NCT04080310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235931|NCT04080310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235934|NCT04078048|Antioxidants|antioxidants|mesh-list
65235935|NCT04078048|Micronutrients|micronutrients|mesh-ancestor
65235936|NCT04078048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235937|NCT04078048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235938|NCT04078048|Protective Agents|protective agents|mesh-ancestor
65235939|NCT00673387|Pramlintide|pramlintide|mesh-list
65235940|NCT00673387|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
65235941|NCT00673387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65235942|NCT00673387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235943|NCT00673387|Appetite Depressants|appetite depressants|mesh-ancestor
65235944|NCT00673387|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65235945|NCT00673387|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
65235946|NCT00673387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235947|NCT00933608|Memantine|memantine|mesh-list
65235948|NCT00933608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65235949|NCT00933608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65235950|NCT00933608|Dopamine Agents|dopamine agents|mesh-ancestor
65235951|NCT00933608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65235952|NCT00933608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235953|NCT00933608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235954|NCT00933608|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65235955|NCT00933608|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65235956|NCT05380310|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65235957|NCT02558023|Nicardipine|nicardipine|mesh-list
65235958|NCT02558023|Urapidil|urapidil|mesh-list
65235959|NCT02558023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65235960|NCT02558023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65235961|NCT02558023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65235978|NCT00607568|Adrenergic Agents|adrenergic agents|mesh-ancestor
65235979|NCT00607568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65235980|NCT00607568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235981|NCT00606164|Bryostatin 1|bryostatin 1|mesh-list
65235982|NCT00606164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65235983|NCT00606164|Immunologic Factors|immunologic factors|mesh-ancestor
65235984|NCT00606164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235986|NCT00574951|Motesanib diphosphate|motesanib diphosphate|mesh-list
65235987|NCT00574951|Imetelstat|imetelstat|mesh-list
65235988|NCT00574951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65235989|NCT00574951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65235990|NCT00574951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65235991|NCT02584816|Vaccines|vaccines|mesh-list
65235992|NCT02584816|Immunologic Factors|immunologic factors|mesh-ancestor
65235993|NCT02584816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65235994|NCT02584738|Methylprednisolone|methylprednisolone|mesh-list
65235995|NCT02584738|Prednisolone|prednisolone|mesh-list
65235996|NCT02584738|Magnesium Sulfate|magnesium sulfate|mesh-list
65235997|NCT02584738|Bromides|bromides|mesh-list
65235998|NCT02584738|Albuterol|albuterol|mesh-list
65235999|NCT02584738|Ipratropium|ipratropium|mesh-list
65236035|NCT00765271|Ritonavir|ritonavir|mesh-list
65236036|NCT00765271|Darunavir|darunavir|mesh-list
65236037|NCT00765271|Raltegravir Potassium|raltegravir potassium|mesh-list
65236038|NCT00765271|Abacavir|abacavir|mesh-list
65236039|NCT00765271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65236040|NCT00765271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65236041|NCT00765271|Protease Inhibitors|protease inhibitors|mesh-ancestor
65236042|NCT00765271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236043|NCT00765271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236044|NCT00765271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65236045|NCT00765271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65236046|NCT00765271|Antiviral Agents|antiviral agents|mesh-ancestor
65236047|NCT00765271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65236048|NCT00765271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65236049|NCT00765271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65236050|NCT00765271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65236051|NCT00765271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65236052|NCT00765271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65236053|NCT00765271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65236054|NCT04416568|Nivolumab|nivolumab|mesh-list
65236055|NCT04416568|Ipilimumab|ipilimumab|mesh-list
65236057|NCT04416568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236087|NCT02583022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236088|NCT00764725|Sulfasalazine|sulfasalazine|mesh-list
65236089|NCT00764725|Methotrexate|methotrexate|mesh-list
65236090|NCT00764725|Infliximab|infliximab|mesh-list
65236091|NCT00764725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65236092|NCT00764725|Abortifacient Agents|abortifacient agents|mesh-ancestor
65236093|NCT00764725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65236094|NCT00764725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236095|NCT00764725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65236096|NCT00764725|Antimetabolites|antimetabolites|mesh-ancestor
65236097|NCT00764725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236098|NCT00764725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236099|NCT00764725|Dermatologic Agents|dermatologic agents|mesh-ancestor
65236100|NCT00764725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236101|NCT00764725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65236102|NCT00764725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65236103|NCT00764725|Immunologic Factors|immunologic factors|mesh-ancestor
65236104|NCT00764725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65236105|NCT00764725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65236106|NCT00764725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65236107|NCT00764725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65236108|NCT00764725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65236109|NCT00764725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65236110|NCT00764725|Analgesics|analgesics|mesh-ancestor
65236111|NCT00764725|Sensory System Agents|sensory system agents|mesh-ancestor
65236112|NCT00764725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236113|NCT00764725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65236114|NCT00936884|Methylnaltrexone|methylnaltrexone|mesh-list
65236115|NCT00936884|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65236131|NCT04077892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65236132|NCT04077892|Hormone Antagonists|hormone antagonists|mesh-ancestor
65236133|NCT04077892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65236134|NCT04077892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65236135|NCT04077892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236136|NCT00606242|Fluticasone|fluticasone|mesh-list
65236137|NCT00606242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65236138|NCT00606242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65236139|NCT00606242|Autonomic Agents|autonomic agents|mesh-ancestor
65236140|NCT00606242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236141|NCT00606242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236142|NCT00606242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65236143|NCT00606242|Respiratory System Agents|respiratory system agents|mesh-ancestor
65236144|NCT00606242|Dermatologic Agents|dermatologic agents|mesh-ancestor
65236145|NCT00606242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65236146|NCT00607646|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65236147|NCT00607646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65236148|NCT00607646|Immunologic Factors|immunologic factors|mesh-ancestor
65236149|NCT00607646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236150|NCT00770263|Sirolimus|sirolimus|mesh-list
65236163|NCT02691026|Pembrolizumab|pembrolizumab|mesh-list
65236185|NCT02584582|Hormones|hormones|mesh-ancestor
65236186|NCT02584582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65236187|NCT02584582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65236188|NCT04266002|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65236189|NCT04266002|Antiviral Agents|antiviral agents|mesh-ancestor
65236190|NCT04266002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65236191|NCT00765973|Topotecan|topotecan|mesh-list
65236192|NCT00765973|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65236193|NCT00765973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65236194|NCT00765973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236195|NCT00765973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236196|NCT00765973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236197|NCT00775177|Doxycycline|doxycycline|mesh-list
65236198|NCT00775177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65236199|NCT00775177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65236200|NCT00775177|Antimalarials|antimalarials|mesh-ancestor
65236201|NCT00775177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65236202|NCT00775177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65236203|NCT05293964|Palbociclib|palbociclib|mesh-list
65236204|NCT05293964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236205|NCT05293964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65236206|NCT05293964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236207|NCT05293964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236208|NCT00770497|Pioglitazone|pioglitazone|mesh-list
65236209|NCT00770497|Ramipril|ramipril|mesh-list
65236210|NCT00770497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65236211|NCT00770497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236212|NCT00770497|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65236213|NCT00770497|Protease Inhibitors|protease inhibitors|mesh-ancestor
65236214|NCT00770497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236215|NCT00770497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236228|NCT02581696|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65236229|NCT02581696|Protective Agents|protective agents|mesh-ancestor
65236230|NCT02581696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65236231|NCT00607958|Ritonavir|ritonavir|mesh-list
65236232|NCT00607958|Tipranavir|tipranavir|mesh-list
65236233|NCT00607958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65236234|NCT00607958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65236235|NCT00607958|Protease Inhibitors|protease inhibitors|mesh-ancestor
65236236|NCT00607958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236237|NCT00607958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236238|NCT00607958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65236239|NCT00607958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65236240|NCT00607958|Antiviral Agents|antiviral agents|mesh-ancestor
65236241|NCT00607958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65236242|NCT00607958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65236243|NCT00607958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65236244|NCT00770575|Pioglitazone|pioglitazone|mesh-list
65236245|NCT00770575|Atorvastatin|atorvastatin|mesh-list
65236246|NCT00770575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65236255|NCT00770731|Sirolimus|sirolimus|mesh-list
64879029|NCT01903109|Cevimeline|cevimeline|mesh-list
65236283|NCT00766285|Vaccines|vaccines|mesh-list
65236284|NCT00766285|Immunologic Factors|immunologic factors|mesh-ancestor
65236285|NCT00766285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236286|NCT04265456|Acetaminophen|acetaminophen|mesh-list
65236287|NCT04265456|Pregabalin|pregabalin|mesh-list
65236288|NCT04265456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65236289|NCT04265456|Analgesics|analgesics|mesh-ancestor
65236290|NCT04265456|Sensory System Agents|sensory system agents|mesh-ancestor
65236291|NCT04265456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236292|NCT04265456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236293|NCT04265456|Antipyretics|antipyretics|mesh-ancestor
65236294|NCT04265456|Anticonvulsants|anticonvulsants|mesh-ancestor
65236295|NCT04265456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65236296|NCT04265456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65236297|NCT04265456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236298|NCT04265456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65236299|NCT04265456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65236303|NCT04379518|Interferons|interferons|mesh-list
65236343|NCT00668863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236344|NCT00668863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65236345|NCT00668863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236346|NCT00668863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65236347|NCT00668863|Immunologic Factors|immunologic factors|mesh-ancestor
65236348|NCT00668863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236349|NCT00668863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65236350|NCT00668863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65236351|NCT00668863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236352|NCT00668863|Antidotes|antidotes|mesh-ancestor
65236353|NCT00668863|Protective Agents|protective agents|mesh-ancestor
65236354|NCT00668863|Vitamin B Complex|vitamin b complex|mesh-ancestor
65236355|NCT00668863|Vitamins|vitamins|mesh-ancestor
64879096|NCT01903824|Modafinil|modafinil|mesh-list
65236356|NCT00668863|Micronutrients|micronutrients|mesh-ancestor
65236357|NCT00668863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65236358|NCT00668863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65236359|NCT00668863|Growth Substances|growth substances|mesh-ancestor
65236360|NCT00668863|Growth Inhibitors|growth inhibitors|mesh-ancestor
65236361|NCT00668863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65236362|NCT04077736|Aldesleukin|aldesleukin|mesh-list
65236363|NCT04077736|Interleukin-2|interleukin-2|mesh-list
65236364|NCT04077736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236365|NCT04077736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65236393|NCT00771043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236394|NCT04267250|Levonorgestrel|levonorgestrel|mesh-list
65236395|NCT04267250|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65236396|NCT04267250|Estradiol|estradiol|mesh-list
65236397|NCT04267250|PF-06700841|pf-06700841|mesh-list
65236398|NCT04267250|Estrogens|estrogens|mesh-ancestor
65236399|NCT04267250|Hormones|hormones|mesh-ancestor
65236400|NCT04267250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65236401|NCT04267250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236402|NCT04267250|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65236403|NCT04267250|Contraceptive Agents|contraceptive agents|mesh-ancestor
65236404|NCT04267250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65236405|NCT04267250|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65236406|NCT04267250|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65236407|NCT04267250|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65236408|NCT04267250|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65236409|NCT04267250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65236410|NCT04267250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236411|NCT04267250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236412|NCT00775489|Beclomethasone|beclomethasone|mesh-list
65236413|NCT00775489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65236414|NCT00775489|Glucocorticoids|glucocorticoids|mesh-ancestor
65236415|NCT00775489|Hormones|hormones|mesh-ancestor
65236416|NCT00775489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65236417|NCT00775489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236418|NCT00775489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65236419|NCT00775489|Respiratory System Agents|respiratory system agents|mesh-ancestor
65236420|NCT00771199|Fentanyl|fentanyl|mesh-list
65236421|NCT00771199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65236422|NCT00771199|Narcotics|narcotics|mesh-ancestor
65236423|NCT00771199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65236424|NCT00771199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236425|NCT00771199|Analgesics|analgesics|mesh-ancestor
65236435|NCT04264130|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65236436|NCT04264130|Pyronaridine|pyronaridine|mesh-list
64879168|NCT01904487|Tiagabine|tiagabine|mesh-list
65236437|NCT04264130|Artefenomel|artefenomel|mesh-list
65236438|NCT04264130|Ferroquine|ferroquine|mesh-list
65236439|NCT04264130|Antimalarials|antimalarials|mesh-ancestor
65236440|NCT04264130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65236441|NCT04264130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65236442|NCT04264130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65236443|NCT04264130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236444|NCT04264130|Antiviral Agents|antiviral agents|mesh-ancestor
65236445|NCT04264130|Schistosomicides|schistosomicides|mesh-ancestor
65236446|NCT04264130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65236447|NCT04264130|Anthelmintics|anthelmintics|mesh-ancestor
65236448|NCT02557867|Dexmedetomidine|dexmedetomidine|mesh-list
65236449|NCT02557867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65236450|NCT02557867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65236451|NCT02557867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236452|NCT02557867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65236454|NCT02557867|Sensory System Agents|sensory system agents|mesh-ancestor
65236455|NCT02557867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236456|NCT02557867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65236457|NCT02557867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65236458|NCT02557867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65236486|NCT04264286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236487|NCT04264286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236488|NCT02582476|Bumetanide|bumetanide|mesh-list
65236489|NCT02582476|Diuretics|diuretics|mesh-ancestor
65236490|NCT02582476|Natriuretic Agents|natriuretic agents|mesh-ancestor
65236491|NCT02582476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236492|NCT02582476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65236493|NCT02582476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65236494|NCT02582476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236495|NCT04078204|3-n-butylphthalide|3-n-butylphthalide|mesh-list
65236496|NCT04078204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65236497|NCT04078204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65236498|NCT04078204|Protective Agents|protective agents|mesh-ancestor
65236499|NCT04078204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236500|NCT04077346|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
65236501|NCT04077346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65236502|NCT04077346|Immunologic Factors|immunologic factors|mesh-ancestor
65236503|NCT04077346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236504|NCT04077580|Methenamine|methenamine|mesh-list
65236505|NCT04077580|Methenamine hippurate|methenamine hippurate|mesh-list
65236538|NCT00766909|Cyclosporine|cyclosporine|mesh-list
65236539|NCT00766909|Tacrolimus|tacrolimus|mesh-list
65236540|NCT00766909|Cyclosporins|cyclosporins|mesh-list
65236541|NCT00766909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65236542|NCT00766909|Immunologic Factors|immunologic factors|mesh-ancestor
65236543|NCT00766909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236544|NCT00766909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65236545|NCT00766909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236546|NCT00766909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236547|NCT00766909|Antifungal Agents|antifungal agents|mesh-ancestor
65236548|NCT00766909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65236549|NCT00766909|Dermatologic Agents|dermatologic agents|mesh-ancestor
65236550|NCT00766909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65236551|NCT00771433|Lenograstim|lenograstim|mesh-list
65236552|NCT00771433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65236553|NCT00771433|Immunologic Factors|immunologic factors|mesh-ancestor
65236554|NCT00771433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236555|NCT00668395|Efavirenz|efavirenz|mesh-list
65236556|NCT00668395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65236557|NCT00668395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65236558|NCT00668395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236559|NCT00668395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236560|NCT00668395|Antiviral Agents|antiviral agents|mesh-ancestor
65236590|NCT00668317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236591|NCT00775879|Sevoflurane|sevoflurane|mesh-list
65236592|NCT00775879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65236593|NCT00775879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65236594|NCT00775879|Anesthetics, General|anesthetics, general|mesh-ancestor
65236595|NCT00775879|Anesthetics|anesthetics|mesh-ancestor
65236596|NCT00775879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65236597|NCT00775879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236599|NCT00767221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65236600|NCT00767221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65236601|NCT00767221|Autonomic Agents|autonomic agents|mesh-ancestor
65236602|NCT00767221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236603|NCT00767221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236604|NCT00767221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65236605|NCT00767221|Respiratory System Agents|respiratory system agents|mesh-ancestor
65236606|NCT00767221|Glucocorticoids|glucocorticoids|mesh-ancestor
65236607|NCT00767221|Hormones|hormones|mesh-ancestor
65236608|NCT00767221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65236609|NCT04024072|Brinzolamide|brinzolamide|mesh-list
65236610|NCT04024072|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65236611|NCT04024072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236612|NCT04024072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236613|NCT00771511|Capsaicin|capsaicin|mesh-list
65236614|NCT00771511|Antipruritics|antipruritics|mesh-ancestor
65236615|NCT00771511|Dermatologic Agents|dermatologic agents|mesh-ancestor
65236616|NCT00771511|Sensory System Agents|sensory system agents|mesh-ancestor
65236617|NCT00771511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236618|NCT00771511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236619|NCT00776113|Carvedilol|carvedilol|mesh-list
65236634|NCT00776113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65236635|NCT02580448|Seviteronel|seviteronel|mesh-list
65236636|NCT02580448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236637|NCT02580448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65236638|NCT02580448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236639|NCT02580448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236640|NCT04008238|Trabectedin|trabectedin|mesh-list
65236641|NCT04008238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65236642|NCT04008238|Alkylating Agents|alkylating agents|mesh-ancestor
65236643|NCT04008238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236644|NCT04008238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236645|NCT00672139|Bromides|bromides|mesh-list
65236646|NCT00672139|Methylnaltrexone|methylnaltrexone|mesh-list
65236647|NCT00672139|Anticonvulsants|anticonvulsants|mesh-ancestor
65236648|NCT00672139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65236649|NCT00672139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236650|NCT00672139|Sensory System Agents|sensory system agents|mesh-ancestor
65236691|NCT03742102|Trastuzumab|trastuzumab|mesh-list
65236692|NCT03742102|Durvalumab|durvalumab|mesh-list
65236693|NCT03742102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65236694|NCT03742102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236695|NCT03742102|Tubulin Modulators|tubulin modulators|mesh-ancestor
65236696|NCT03742102|Antimitotic Agents|antimitotic agents|mesh-ancestor
65236697|NCT03742102|Mitosis Modulators|mitosis modulators|mesh-ancestor
65236698|NCT03742102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236699|NCT03742102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65236700|NCT03711058|Nivolumab|nivolumab|mesh-list
65236701|NCT03711058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65236702|NCT03711058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236703|NCT03711058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65236704|NCT03711058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236705|NCT03710824|Nintedanib|nintedanib|mesh-list
65236706|NCT03710824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236707|NCT03710824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65236708|NCT03710824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236709|NCT03710824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236710|NCT00570739|Metformin|metformin|mesh-list
65236711|NCT00570739|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65236712|NCT00570739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65236713|NCT00570739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236714|NCT00570739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65236715|NCT00570739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65236716|NCT00570739|Antimetabolites|antimetabolites|mesh-ancestor
65236717|NCT00570739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236718|NCT00570739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65236719|NCT04076098|Minocycline|minocycline|mesh-list
65236720|NCT04076098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65236721|NCT04076098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65236722|NCT00771979|Saracatinib|saracatinib|mesh-list
65236723|NCT00771979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236724|NCT00771979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236727|NCT00767689|Pyridoxal|pyridoxal|mesh-list
65236731|NCT00767689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236732|NCT00767689|Vitamin B Complex|vitamin b complex|mesh-ancestor
65236733|NCT00772057|Propranolol|propranolol|mesh-list
65236734|NCT00772057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64879471|NCT01906749|Colchicine|colchicine|mesh-list
65236735|NCT00772057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65236736|NCT00772057|Adrenergic Agents|adrenergic agents|mesh-ancestor
65236737|NCT00772057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65236738|NCT00772057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236739|NCT00772057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236740|NCT00772057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65236741|NCT00772057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65236742|NCT00772057|Vasodilator Agents|vasodilator agents|mesh-ancestor
65236743|NCT00776347|Donepezil|donepezil|mesh-list
65236744|NCT00776347|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65236745|NCT00776347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236747|NCT00776347|Cholinergic Agents|cholinergic agents|mesh-ancestor
65236790|NCT03909412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65236791|NCT03909412|Alkylating Agents|alkylating agents|mesh-ancestor
65236792|NCT03909412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236793|NCT03909412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236794|NCT03909412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65236795|NCT03909412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65236796|NCT03909412|Antiemetics|antiemetics|mesh-ancestor
65236797|NCT03909412|Autonomic Agents|autonomic agents|mesh-ancestor
65236798|NCT03909412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236799|NCT03909412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65236800|NCT03909412|Glucocorticoids|glucocorticoids|mesh-ancestor
65236801|NCT03909412|Hormones|hormones|mesh-ancestor
65236802|NCT03909412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65236803|NCT03909412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65236804|NCT03909412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65236805|NCT00772135|Sildenafil Citrate|sildenafil citrate|mesh-list
65236806|NCT00772135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236807|NCT00772135|Vasodilator Agents|vasodilator agents|mesh-ancestor
65236808|NCT00772135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64879549|NCT01907061|Protective Agents|protective agents|mesh-ancestor
65236809|NCT00772135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65236810|NCT00772135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236811|NCT00772135|Urological Agents|urological agents|mesh-ancestor
65236812|NCT00776503|Vorinostat|vorinostat|mesh-list
65236813|NCT00776503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236814|NCT00776503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65236815|NCT00776503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236816|NCT00776503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236833|NCT04188106|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65236834|NCT04188106|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65236835|NCT04188106|Cholinergic Agents|cholinergic agents|mesh-ancestor
65236836|NCT04188106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65236837|NCT04188106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236838|NCT04188106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236839|NCT04188106|Antipruritics|antipruritics|mesh-ancestor
65236840|NCT04188106|Dermatologic Agents|dermatologic agents|mesh-ancestor
65236841|NCT04188106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65236842|NCT04188106|Histamine Antagonists|histamine antagonists|mesh-ancestor
65236843|NCT04188106|Histamine Agents|histamine agents|mesh-ancestor
65236844|NCT00669955|Amoxicillin|amoxicillin|mesh-list
65236845|NCT00669955|Metronidazole|metronidazole|mesh-list
65236846|NCT00669955|Clarithromycin|clarithromycin|mesh-list
65236847|NCT00669955|Tetracycline|tetracycline|mesh-list
65236848|NCT00669955|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
65236849|NCT00669955|Omeprazole|omeprazole|mesh-list
65236850|NCT00669955|Bismuth|bismuth|mesh-list
65236851|NCT00669955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65236852|NCT00669955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65236853|NCT00669955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65236854|NCT00669955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65236855|NCT00669955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65236856|NCT00669955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65236857|NCT00669955|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65236863|NCT00669955|Antacids|antacids|mesh-ancestor
65236884|NCT05673928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65236885|NCT05673928|Tubulin Modulators|tubulin modulators|mesh-ancestor
65236886|NCT05673928|Antimitotic Agents|antimitotic agents|mesh-ancestor
65236887|NCT05673928|Mitosis Modulators|mitosis modulators|mesh-ancestor
65236888|NCT05673928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236889|NCT05673928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65236890|NCT05673928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236892|NCT03595150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65236893|NCT03595150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65236894|NCT03595150|Analgesics|analgesics|mesh-ancestor
65236895|NCT03595150|Sensory System Agents|sensory system agents|mesh-ancestor
65236896|NCT03595150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65236897|NCT03595150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236898|NCT03595150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65236899|NCT03595150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65236900|NCT03595150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65236901|NCT03595150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236902|NCT03595150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236903|NCT00768157|Lamivudine|lamivudine|mesh-list
65236904|NCT00768157|Entecavir|entecavir|mesh-list
65236938|NCT04149106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65236939|NCT04149106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65236940|NCT04149106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65236941|NCT04149106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65236942|NCT04149106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65236943|NCT04149106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65236944|NCT04149106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65236945|NCT04149106|Renal Agents|renal agents|mesh-ancestor
65236946|NCT02580604|Calcium|calcium|mesh-list
65236947|NCT02580604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65236948|NCT02580604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236949|NCT03523858|Ocrelizumab|ocrelizumab|mesh-list
65236950|NCT03523858|Immunologic Factors|immunologic factors|mesh-ancestor
65236951|NCT03523858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236952|NCT00768391|Olaratumab|olaratumab|mesh-list
65236953|NCT00768391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236954|NCT00669877|Cytarabine|cytarabine|mesh-list
65236955|NCT00669877|Dexamethasone|dexamethasone|mesh-list
65236956|NCT00669877|Cyclophosphamide|cyclophosphamide|mesh-list
65236957|NCT00669877|Rituximab|rituximab|mesh-list
65236958|NCT00669877|Doxorubicin|doxorubicin|mesh-list
65236959|NCT00669877|Methotrexate|methotrexate|mesh-list
65236960|NCT00669877|Vincristine|vincristine|mesh-list
65236961|NCT00669877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65236962|NCT00669877|Immunologic Factors|immunologic factors|mesh-ancestor
65236963|NCT00669877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65236964|NCT00669877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65236965|NCT00669877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65236966|NCT00669877|Alkylating Agents|alkylating agents|mesh-ancestor
65236968|NCT00669877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65236984|NCT00669877|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65236985|NCT00669877|Abortifacient Agents|abortifacient agents|mesh-ancestor
65236986|NCT00669877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65236987|NCT00669877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65236988|NCT00669877|Antimetabolites|antimetabolites|mesh-ancestor
65236989|NCT00669877|Dermatologic Agents|dermatologic agents|mesh-ancestor
65236990|NCT00669877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65236991|NCT00669877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65236992|NCT00669877|Antiviral Agents|antiviral agents|mesh-ancestor
65236993|NCT00669877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65236994|NCT00669877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65236995|NCT00669877|Tubulin Modulators|tubulin modulators|mesh-ancestor
65236996|NCT00669877|Antimitotic Agents|antimitotic agents|mesh-ancestor
65236997|NCT00669877|Mitosis Modulators|mitosis modulators|mesh-ancestor
65236998|NCT00772681|Docetaxel|docetaxel|mesh-list
65236999|NCT00772681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237000|NCT00772681|Tubulin Modulators|tubulin modulators|mesh-ancestor
65237001|NCT00772681|Antimitotic Agents|antimitotic agents|mesh-ancestor
65237002|NCT00772681|Mitosis Modulators|mitosis modulators|mesh-ancestor
65237040|NCT00768859|Antimitotic Agents|antimitotic agents|mesh-ancestor
65237041|NCT00768859|Mitosis Modulators|mitosis modulators|mesh-ancestor
65237042|NCT00768859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237043|NCT00768859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65237044|NCT00768937|Sorafenib|sorafenib|mesh-list
65237045|NCT00768937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237046|NCT00768937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65237047|NCT00768937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237048|NCT00768937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237049|NCT04047745|Bupivacaine|bupivacaine|mesh-list
65237050|NCT04047745|Ropivacaine|ropivacaine|mesh-list
65237051|NCT04047745|Anesthetics, Local|anesthetics, local|mesh-ancestor
65237052|NCT04047745|Anesthetics|anesthetics|mesh-ancestor
65237053|NCT04047745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65237054|NCT04047745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237055|NCT04047745|Sensory System Agents|sensory system agents|mesh-ancestor
65237056|NCT04047745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65237057|NCT00777439|Domperidone|domperidone|mesh-list
65237058|NCT00777439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237059|NCT00777439|Antiemetics|antiemetics|mesh-ancestor
65237060|NCT00777439|Autonomic Agents|autonomic agents|mesh-ancestor
65237061|NCT00777439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65237062|NCT00777439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237063|NCT00777439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65237064|NCT00777439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65237065|NCT00777439|Dopamine Agents|dopamine agents|mesh-ancestor
65237066|NCT00777439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65237067|NCT00769093|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
65237068|NCT00769093|Hematinics|hematinics|mesh-ancestor
65237069|NCT00769093|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65237070|NCT00769093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65237071|NCT00671437|Cetuximab|cetuximab|mesh-list
65237082|NCT00769171|Moxifloxacin|moxifloxacin|mesh-list
65237083|NCT00769171|Metronidazole|metronidazole|mesh-list
65237084|NCT00769171|Ceftriaxone|ceftriaxone|mesh-list
65237085|NCT00769171|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65237086|NCT00769171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65237087|NCT00769171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65237088|NCT00769171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65237089|NCT00769171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65237090|NCT00769171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237091|NCT00769171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237092|NCT00769171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237093|NCT00769171|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65237094|NCT00769171|Contraceptive Agents|contraceptive agents|mesh-ancestor
65237095|NCT00769171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65237096|NCT00769171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237144|NCT02635191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65237145|NCT02635191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65237146|NCT02635191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65237147|NCT02635191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65237148|NCT02635191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65237149|NCT02635191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65237150|NCT02635191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65237151|NCT02635191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237152|NCT02635191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237153|NCT02635191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65237154|NCT02635191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65237155|NCT02635191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65237156|NCT00777673|Paclitaxel|paclitaxel|mesh-list
65237157|NCT00777673|Cyclophosphamide|cyclophosphamide|mesh-list
65237158|NCT00777673|Bevacizumab|bevacizumab|mesh-list
65237159|NCT00777673|Carboplatin|carboplatin|mesh-list
65237160|NCT00777673|Doxorubicin|doxorubicin|mesh-list
65237161|NCT00777673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65237162|NCT00777673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65237163|NCT00777673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237164|NCT00777673|Tubulin Modulators|tubulin modulators|mesh-ancestor
65237165|NCT00777673|Antimitotic Agents|antimitotic agents|mesh-ancestor
65237166|NCT00777673|Mitosis Modulators|mitosis modulators|mesh-ancestor
65237167|NCT00777673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237168|NCT00777673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65237169|NCT00777673|Immunologic Factors|immunologic factors|mesh-ancestor
65237171|NCT00777673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65237193|NCT02557087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65237194|NCT02557087|Narcotics|narcotics|mesh-ancestor
65237195|NCT02557087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65237196|NCT02557087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237197|NCT02557087|Analgesics|analgesics|mesh-ancestor
65237198|NCT02557087|Sensory System Agents|sensory system agents|mesh-ancestor
65237199|NCT02557087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65237200|NCT02557087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65237201|NCT02557087|Antiemetics|antiemetics|mesh-ancestor
65237202|NCT02557087|Autonomic Agents|autonomic agents|mesh-ancestor
65237203|NCT02557087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65237204|NCT02557087|Mydriatics|mydriatics|mesh-ancestor
65237205|NCT02557087|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65237206|NCT02557087|Cholinergic Agents|cholinergic agents|mesh-ancestor
65237207|NCT02557087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65237208|NCT02557087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237209|NCT02557087|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65237210|NCT02579590|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65237211|NCT02579590|Medroxyprogesterone|medroxyprogesterone|mesh-list
65237212|NCT02579590|Desogestrel|desogestrel|mesh-list
65237213|NCT02579590|Etonogestrel|etonogestrel|mesh-list
65237215|NCT02579590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65237246|NCT00582712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237247|NCT00582712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237248|NCT00582712|Antimanic Agents|antimanic agents|mesh-ancestor
65237249|NCT00582712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65237250|NCT00582712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65237251|NCT00582712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237252|NCT03920566|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65237253|NCT03920566|Dalteparin|dalteparin|mesh-list
65237254|NCT03920566|Anticoagulants|anticoagulants|mesh-ancestor
65237255|NCT03920566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65237256|NCT03920566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65237257|NCT03920566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237258|NCT00582790|Zoledronic Acid|zoledronic acid|mesh-list
65237259|NCT00582790|Interleukin-2|interleukin-2|mesh-list
65237260|NCT00582790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237261|NCT00582790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65237262|NCT00582790|Analgesics|analgesics|mesh-ancestor
65237263|NCT00582790|Sensory System Agents|sensory system agents|mesh-ancestor
65237304|NCT00774241|Antimitotic Agents|antimitotic agents|mesh-ancestor
65237305|NCT00774241|Mitosis Modulators|mitosis modulators|mesh-ancestor
65237306|NCT00774241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237307|NCT00774319|Cisplatin|cisplatin|mesh-list
65237308|NCT00774319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237309|NCT00881751|Bevacizumab|bevacizumab|mesh-list
65237310|NCT00881751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65237311|NCT00881751|Sorafenib|sorafenib|mesh-list
65237312|NCT00881751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65237313|NCT00881751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237314|NCT00881751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65237315|NCT00881751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65237316|NCT00881751|Growth Substances|growth substances|mesh-ancestor
65237317|NCT00881751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237318|NCT00881751|Growth Inhibitors|growth inhibitors|mesh-ancestor
65237319|NCT00881751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65237320|NCT00881751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237321|NCT00881751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237322|NCT02634255|Fentanyl|fentanyl|mesh-list
65237323|NCT02634255|Propofol|propofol|mesh-list
65237324|NCT02634255|Rocuronium|rocuronium|mesh-list
65237325|NCT02634255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65237326|NCT02634255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65237327|NCT02634255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237328|NCT02634255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65237329|NCT02634255|Anesthetics, General|anesthetics, general|mesh-ancestor
65237330|NCT02634255|Anesthetics|anesthetics|mesh-ancestor
65237331|NCT02634255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65237332|NCT02634255|Narcotics|narcotics|mesh-ancestor
65237333|NCT02634255|Analgesics|analgesics|mesh-ancestor
65237334|NCT02634255|Sensory System Agents|sensory system agents|mesh-ancestor
65237335|NCT02634255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64880080|NCT01910415|Ivacaftor|ivacaftor|mesh-list
65237336|NCT02634255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65237337|NCT02634255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65237338|NCT02634255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65237339|NCT02634255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65237342|NCT02634021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65237343|NCT02634021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65237344|NCT02634021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237345|NCT02634021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65237346|NCT02634021|Analgesics|analgesics|mesh-ancestor
65237347|NCT02634021|Sensory System Agents|sensory system agents|mesh-ancestor
65237348|NCT02634021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65237349|NCT02634021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65237350|NCT02634021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65237351|NCT02634021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65237352|NCT02634021|Adrenergic Agents|adrenergic agents|mesh-ancestor
65237353|NCT02634021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65237354|NCT02634021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237355|NCT02634021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65237356|NCT02634021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65237357|NCT02634021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65237358|NCT02634021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65237387|NCT00934856|Docetaxel|docetaxel|mesh-list
65237398|NCT00934856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65237399|NCT04265612|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65237400|NCT04265612|Laxatives|laxatives|mesh-ancestor
65237401|NCT04265612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65237402|NCT00934700|Xenon|xenon|mesh-list
65237403|NCT00934700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65237404|NCT00934700|Anesthetics, General|anesthetics, general|mesh-ancestor
65237405|NCT00934700|Anesthetics|anesthetics|mesh-ancestor
65237406|NCT00934700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65237407|NCT00934700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237408|NCT00669409|Tanezumab|tanezumab|mesh-list
65237409|NCT00669409|Analgesics|analgesics|mesh-ancestor
65237410|NCT00669409|Sensory System Agents|sensory system agents|mesh-ancestor
65237411|NCT00669409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65237412|NCT00669409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237413|NCT00778141|Metformin|metformin|mesh-list
65237414|NCT00778141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65237415|NCT00778141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237416|NCT00774475|Clopidogrel|clopidogrel|mesh-list
65237417|NCT00774475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65237418|NCT00774475|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65237419|NCT00774475|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65237427|NCT00669331|Diuretics|diuretics|mesh-ancestor
65237452|NCT02556463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237453|NCT00779389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65237454|NCT00779389|Dasatinib|dasatinib|mesh-list
65237455|NCT00779389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237456|NCT00779389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65237457|NCT00779389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237458|NCT00779389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237459|NCT00778609|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65237460|NCT00778609|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
65237461|NCT00778609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65237462|NCT00778609|Contraceptive Agents|contraceptive agents|mesh-ancestor
65237463|NCT00778609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65237464|NCT00778609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237465|NCT00778609|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65237466|NCT00778609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65237467|NCT00778609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65237507|NCT00780169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237508|NCT00780325|Celecoxib|celecoxib|mesh-list
65237509|NCT00780325|Naproxen|naproxen|mesh-list
65237510|NCT00780325|Acetazolamide|acetazolamide|mesh-list
65237511|NCT00780325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65237512|NCT00780325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65237513|NCT00780325|Analgesics|analgesics|mesh-ancestor
65237514|NCT00780325|Sensory System Agents|sensory system agents|mesh-ancestor
65237515|NCT00780325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65237516|NCT00780325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237517|NCT00780325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65237518|NCT00780325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65237519|NCT00780325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65237520|NCT00780325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65237521|NCT00780325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237522|NCT00780325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237523|NCT00780325|Gout Suppressants|gout suppressants|mesh-ancestor
65237524|NCT00780325|Anticonvulsants|anticonvulsants|mesh-ancestor
65237525|NCT00780325|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65237526|NCT00780325|Diuretics|diuretics|mesh-ancestor
65237527|NCT00780325|Natriuretic Agents|natriuretic agents|mesh-ancestor
65237561|NCT04262804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237562|NCT04262804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65237563|NCT04262804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65237564|NCT04262804|Tubulin Modulators|tubulin modulators|mesh-ancestor
65237565|NCT04262804|Antimitotic Agents|antimitotic agents|mesh-ancestor
65237566|NCT04262804|Mitosis Modulators|mitosis modulators|mesh-ancestor
65237567|NCT00665431|Celecoxib|celecoxib|mesh-list
65237568|NCT00665431|Antacids|antacids|mesh-list
65237569|NCT00665431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65237570|NCT00665431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65237571|NCT00665431|Analgesics|analgesics|mesh-ancestor
65237572|NCT00665431|Sensory System Agents|sensory system agents|mesh-ancestor
65237573|NCT00665431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65237574|NCT00665431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237575|NCT00665431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65237576|NCT00665431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65237577|NCT00665431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65237578|NCT00665431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65237579|NCT00665431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237580|NCT00665431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237581|NCT00665431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65237582|NCT02633709|Itraconazole|itraconazole|mesh-list
65237583|NCT02633709|Risdiplam|risdiplam|mesh-list
65237584|NCT02633709|Antifungal Agents|antifungal agents|mesh-ancestor
65237585|NCT02633709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65237586|NCT02633709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65237587|NCT02633709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65237606|NCT00657033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237607|NCT00657033|Urological Agents|urological agents|mesh-ancestor
65237608|NCT02633007|Levodopa|levodopa|mesh-list
65237609|NCT02633007|Carbidopa|carbidopa|mesh-list
65237610|NCT02633007|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65237611|NCT02633007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65237612|NCT02633007|Dopamine Agents|dopamine agents|mesh-ancestor
65237613|NCT02633007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65237614|NCT02633007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237615|NCT02633007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237616|NCT02633007|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65237617|NCT02633007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237618|NCT01000727|Darapladib|darapladib|mesh-list
65237619|NCT01000727|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
65237620|NCT01000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237621|NCT01000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237622|NCT00881205|Rivastigmine|rivastigmine|mesh-list
65237623|NCT00881205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65237624|NCT00881205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237625|NCT00881205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237626|NCT00881205|Cholinergic Agents|cholinergic agents|mesh-ancestor
65237627|NCT00881205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65237628|NCT00881205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237629|NCT00881205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65237630|NCT00881205|Protective Agents|protective agents|mesh-ancestor
65237631|NCT00879879|Losartan|losartan|mesh-list
65237632|NCT00879879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65237633|NCT00879879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65237634|NCT00879879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65237635|NCT00879879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65237637|NCT00661999|Darbepoetin alfa|darbepoetin alfa|mesh-list
65237648|NCT04156425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65237649|NCT04156425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237650|NCT04156425|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65237651|NCT04156425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65237652|NCT04156425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65237653|NCT04156425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237654|NCT04156425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65237655|NCT04156425|Serotonin Agents|serotonin agents|mesh-ancestor
65237656|NCT04156425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65237657|NCT04156425|Antidepressive Agents|antidepressive agents|mesh-ancestor
65237658|NCT04156425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65237659|NCT04156425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65237660|NCT04156425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65237661|NCT04156425|Parasympatholytics|parasympatholytics|mesh-ancestor
65237662|NCT04156425|Autonomic Agents|autonomic agents|mesh-ancestor
65237663|NCT04156425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65237664|NCT04156425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65237665|NCT04156425|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65237666|NCT04156425|Cholinergic Agents|cholinergic agents|mesh-ancestor
65237668|NCT04156425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65237698|NCT00785083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237699|NCT00780637|Bradykinin|bradykinin|mesh-list
65237700|NCT00780637|Kininogens|kininogens|mesh-list
65237701|NCT00780637|Vasodilator Agents|vasodilator agents|mesh-ancestor
65237702|NCT00780637|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65237703|NCT00780637|Protease Inhibitors|protease inhibitors|mesh-ancestor
65237704|NCT00780637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237705|NCT00780637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237706|NCT00661401|gamma-Globulins|gamma-globulins|mesh-list
65237707|NCT00661401|Immunologic Factors|immunologic factors|mesh-ancestor
65237708|NCT00661401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237709|NCT00790153|Insulin|insulin|mesh-list
65237710|NCT00790153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65237711|NCT00790153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237712|NCT00661635|Valdecoxib|valdecoxib|mesh-list
65237713|NCT00661635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65237715|NCT00661635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237716|NCT00661635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237717|NCT00661635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65237718|NCT00661635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65237719|NCT00661635|Analgesics|analgesics|mesh-ancestor
65237720|NCT00661635|Sensory System Agents|sensory system agents|mesh-ancestor
65237721|NCT00661635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65237722|NCT00661635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237723|NCT00661635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65237724|NCT00661635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65237726|NCT02631603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65237727|NCT02631603|Glucocorticoids|glucocorticoids|mesh-ancestor
65237728|NCT02631603|Hormones|hormones|mesh-ancestor
65237729|NCT02631603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65237730|NCT02631603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237731|NCT02631603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65237732|NCT02631603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237733|NCT00790387|Heparin|heparin|mesh-list
65237734|NCT00790387|Enoxaparin|enoxaparin|mesh-list
65237740|NCT00790387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237741|NCT00790387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65237742|NCT04156035|Lamotrigine|lamotrigine|mesh-list
65237743|NCT04156035|Ketamine|ketamine|mesh-list
65237744|NCT04156035|Analgesics|analgesics|mesh-ancestor
65237745|NCT04156035|Sensory System Agents|sensory system agents|mesh-ancestor
65237746|NCT04156035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65237749|NCT04156035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65237808|NCT02555761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65237809|NCT02555761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237810|NCT02555761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237811|NCT04155879|Colchicine|colchicine|mesh-list
65237812|NCT04155879|Gout Suppressants|gout suppressants|mesh-ancestor
65237813|NCT04155879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65237814|NCT04155879|Tubulin Modulators|tubulin modulators|mesh-ancestor
65237815|NCT04155879|Antimitotic Agents|antimitotic agents|mesh-ancestor
65237816|NCT04155879|Mitosis Modulators|mitosis modulators|mesh-ancestor
65237817|NCT04155879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237818|NCT04155879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237819|NCT00662805|Fluticasone|fluticasone|mesh-list
65237821|NCT00662805|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65237822|NCT00662805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65237823|NCT00662805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65237824|NCT00662805|Autonomic Agents|autonomic agents|mesh-ancestor
65237825|NCT00662805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65237866|NCT00785473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65237867|NCT00785551|Quinine|quinine|mesh-list
65237868|NCT00785551|Antimalarials|antimalarials|mesh-ancestor
65237869|NCT00785551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65237870|NCT00785551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65237871|NCT00785551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65237872|NCT00785551|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65237873|NCT00785551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237874|NCT00785551|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65237875|NCT00785551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65237876|NCT00785551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65237877|NCT00785551|Analgesics|analgesics|mesh-ancestor
65237878|NCT00785551|Sensory System Agents|sensory system agents|mesh-ancestor
65237879|NCT00790777|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65237880|NCT00790777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65237881|NCT00790777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65237882|NCT00790777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65237883|NCT00790777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237884|NCT00790777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65237885|NCT00790777|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65237886|NCT00790777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65237888|NCT00790777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65237889|NCT00790777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237890|NCT00790777|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65237891|NCT00790777|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65237892|NCT00790777|Dopamine Agents|dopamine agents|mesh-ancestor
65237893|NCT00663195|Furosemide|furosemide|mesh-list
65237894|NCT00663195|Spironolactone|spironolactone|mesh-list
65237895|NCT00663195|Diuretics|diuretics|mesh-ancestor
65237896|NCT00663195|Natriuretic Agents|natriuretic agents|mesh-ancestor
65237897|NCT00663195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237898|NCT00663195|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65237899|NCT00663195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65237900|NCT00663195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459292|NCT03026062|Durvalumab|durvalumab|mesh-list
65237904|NCT00663195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65237905|NCT00791011|Bortezomib|bortezomib|mesh-list
65237906|NCT00791011|Vorinostat|vorinostat|mesh-list
65237907|NCT00791011|Conatumumab|conatumumab|mesh-list
65237908|NCT00791011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65237909|NCT00791011|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65237910|NCT00791011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237911|NCT00791011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237912|NCT00791011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65237913|NCT00781105|Telbivudine|telbivudine|mesh-list
65237914|NCT00781105|Antiviral Agents|antiviral agents|mesh-ancestor
65237915|NCT00781105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65237916|NCT00781105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65237917|NCT00781105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237918|NCT00781105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237919|NCT00785863|Ketorolac|ketorolac|mesh-list
65237920|NCT00785863|Parecoxib|parecoxib|mesh-list
65237921|NCT00785863|Remifentanil|remifentanil|mesh-list
65237922|NCT00785863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65237923|NCT00785863|Narcotics|narcotics|mesh-ancestor
65237924|NCT00785863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65237925|NCT00785863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237926|NCT00785863|Analgesics|analgesics|mesh-ancestor
65237927|NCT00785863|Sensory System Agents|sensory system agents|mesh-ancestor
65237928|NCT00785863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65237929|NCT00785863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65237930|NCT00785863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65237931|NCT00785863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65237932|NCT00785863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65237933|NCT00785863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65237934|NCT00785863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65237948|NCT02555605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65237949|NCT02555605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65237950|NCT02555605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237951|NCT02555605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65237952|NCT02555605|Analgesics|analgesics|mesh-ancestor
65237953|NCT02555605|Sensory System Agents|sensory system agents|mesh-ancestor
65237954|NCT02555605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65237955|NCT02555605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65237956|NCT02555605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65237957|NCT02555605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65237958|NCT02555605|Adrenergic Agents|adrenergic agents|mesh-ancestor
65237959|NCT02555605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65237960|NCT02555605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65237961|NCT00791167|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65237962|NCT00791167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65237963|NCT00791167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65237964|NCT00791167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65237965|NCT00791167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65237966|NCT00791167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65237967|NCT00791167|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65237968|NCT00791167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65237969|NCT00791167|Serotonin Agents|serotonin agents|mesh-ancestor
65237970|NCT00791167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65237975|NCT00663741|Sorafenib|sorafenib|mesh-list
65237997|NCT04031859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65237998|NCT04031859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65237999|NCT04031859|Analgesics|analgesics|mesh-ancestor
65238000|NCT04031859|Sensory System Agents|sensory system agents|mesh-ancestor
65238001|NCT04031859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65238002|NCT04031859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238003|NCT04031859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65238004|NCT04031859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65238005|NCT04031859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65238006|NCT04031859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65238007|NCT04031859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238008|NCT04031859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65238009|NCT04031859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65238010|NCT04031859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238011|NCT04031859|Antipyretics|antipyretics|mesh-ancestor
64880761|NCT01914744|Lamivudine|lamivudine|mesh-list
65238012|NCT00664287|Niacin|niacin|mesh-list
65238013|NCT00664287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65238014|NCT00664287|Antimetabolites|antimetabolites|mesh-ancestor
65238015|NCT00664287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238016|NCT00664287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65238019|NCT00664287|Vitamins|vitamins|mesh-ancestor
65238050|NCT02631135|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65238051|NCT02631135|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65238052|NCT02631135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65238053|NCT00664677|Masoprocol|masoprocol|mesh-list
65238054|NCT00664677|Antioxidants|antioxidants|mesh-ancestor
65238055|NCT00664677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238056|NCT00664677|Protective Agents|protective agents|mesh-ancestor
65238057|NCT00664677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238058|NCT00664677|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65238059|NCT00664677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238060|NCT00664677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65238061|NCT00664677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65238062|NCT00664677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65238063|NCT00664677|Analgesics|analgesics|mesh-ancestor
65238064|NCT00664677|Sensory System Agents|sensory system agents|mesh-ancestor
65238065|NCT00664677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65238066|NCT00664677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65238067|NCT00664677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65238068|NCT00596817|Vortioxetine|vortioxetine|mesh-list
65238069|NCT00596817|Antidepressive Agents|antidepressive agents|mesh-ancestor
65238070|NCT00596817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65238071|NCT00596817|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65238072|NCT00596817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65238073|NCT00596817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65238074|NCT00596817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238075|NCT00596817|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65238076|NCT00596817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65238077|NCT00596817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65238078|NCT00596817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238079|NCT00596817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65238080|NCT00596817|Serotonin Agents|serotonin agents|mesh-ancestor
65238091|NCT01000649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238092|NCT00664833|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65238093|NCT00664833|Vasodilator Agents|vasodilator agents|mesh-ancestor
65238094|NCT00664833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65238095|NCT00664833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65238096|NCT00664833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238097|NCT00664833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238098|NCT00664833|Urological Agents|urological agents|mesh-ancestor
65238099|NCT00666835|Epoetin Alfa|epoetin alfa|mesh-list
65238100|NCT00666835|Hematinics|hematinics|mesh-ancestor
65238101|NCT00879411|Telmisartan|telmisartan|mesh-list
65238102|NCT00879411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65238103|NCT00879411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65238104|NCT00879411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65238105|NCT00879411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238106|NCT00671151|Theophylline|theophylline|mesh-list
65238107|NCT00671151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65238108|NCT00671151|Autonomic Agents|autonomic agents|mesh-ancestor
65238109|NCT00671151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65238110|NCT00671151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238111|NCT00671151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65238112|NCT00671151|Respiratory System Agents|respiratory system agents|mesh-ancestor
65238141|NCT00666757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65238142|NCT00666757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65238143|NCT00666757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238144|NCT01000337|Propofol|propofol|mesh-list
65238145|NCT01000337|Sevoflurane|sevoflurane|mesh-list
65238146|NCT01000337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65238147|NCT01000337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65238148|NCT01000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238149|NCT01000337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65238150|NCT01000337|Anesthetics, General|anesthetics, general|mesh-ancestor
65238151|NCT01000337|Anesthetics|anesthetics|mesh-ancestor
65238152|NCT01000337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65238153|NCT01000337|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65238154|NCT02869763|Ethanol|ethanol|mesh-list
65238155|NCT02869763|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65238156|NCT02869763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65238157|NCT02869763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65238158|NCT02869763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238159|NCT04153383|Milrinone|milrinone|mesh-list
65238160|NCT04153383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65238161|NCT04153383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65238162|NCT04153383|Vasodilator Agents|vasodilator agents|mesh-ancestor
65238163|NCT04153383|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65238164|NCT04153383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65238165|NCT04153383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238166|NCT04153383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238167|NCT04153383|Protective Agents|protective agents|mesh-ancestor
65238168|NCT04153383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238169|NCT00671541|Gentamicins|gentamicins|mesh-list
65238170|NCT00671541|Bacitracin|bacitracin|mesh-list
65238185|NCT00666679|Montelukast|montelukast|mesh-list
65238186|NCT00666679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65238187|NCT00666679|Respiratory System Agents|respiratory system agents|mesh-ancestor
65238188|NCT00666679|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65238189|NCT00666679|Hormone Antagonists|hormone antagonists|mesh-ancestor
65238190|NCT00666679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65238191|NCT00666679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238192|NCT00666679|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65238193|NCT00666679|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65238194|NCT00666679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238195|NCT00666679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65238196|NCT00666679|Dermatologic Agents|dermatologic agents|mesh-ancestor
65238197|NCT00666679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65238198|NCT00791401|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65238199|NCT00791401|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65238200|NCT00791401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65238201|NCT00791401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65238202|NCT00791401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238203|NCT00791401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65238204|NCT00791401|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65238205|NCT00791401|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65238235|NCT00791713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65238236|NCT00791713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238237|NCT00791713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65238238|NCT00791713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65238239|NCT00791713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65238240|NCT00791713|Serotonin Agents|serotonin agents|mesh-ancestor
65238241|NCT00791713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65238242|NCT00791713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238243|NCT00791713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65238244|NCT00791713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65238246|NCT00595335|Methylprednisolone|methylprednisolone|mesh-list
65238247|NCT00595335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65238248|NCT00595335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65238249|NCT00595335|Prednisolone|prednisolone|mesh-list
65238250|NCT00595335|Prednisolone acetate|prednisolone acetate|mesh-list
65238251|NCT00595335|Rituximab|rituximab|mesh-list
65238252|NCT00595335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65238253|NCT00595335|Prednisolone phosphate|prednisolone phosphate|mesh-list
65238254|NCT00595335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65238255|NCT00595335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238256|NCT00595335|Immunologic Factors|immunologic factors|mesh-ancestor
65238257|NCT00595335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238258|NCT00595335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65238260|NCT00595335|Antiemetics|antiemetics|mesh-ancestor
65238287|NCT04293809|Sensory System Agents|sensory system agents|mesh-ancestor
65238288|NCT04293809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65238289|NCT00672399|Exenatide|exenatide|mesh-list
65238290|NCT00672399|Moxifloxacin|moxifloxacin|mesh-list
65238291|NCT00672399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65238292|NCT00672399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65238293|NCT00672399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65238294|NCT00672399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65238295|NCT00672399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238296|NCT00672399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238297|NCT00672399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238351|NCT00672867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65238352|NCT00672867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65238353|NCT00672867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65238354|NCT00672867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238355|NCT00672867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238356|NCT00997373|Letrozole|letrozole|mesh-list
65238357|NCT00997373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238358|NCT00997373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65238359|NCT00997373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65238360|NCT00997373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238361|NCT00997373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238362|NCT00997373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65238363|NCT00997373|Hormone Antagonists|hormone antagonists|mesh-ancestor
65238364|NCT00997373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65238365|NCT00997373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238366|NCT04152759|Golimumab|golimumab|mesh-list
65238367|NCT04152759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65238368|NCT04152759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65238369|NCT04152759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65238370|NCT04152759|Immunologic Factors|immunologic factors|mesh-ancestor
65238405|NCT00782041|Hematinics|hematinics|mesh-ancestor
65238406|NCT00673569|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65238407|NCT00673569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238408|NCT00673569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65238409|NCT00673569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238410|NCT00673569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238411|NCT00792181|Midazolam|midazolam|mesh-list
65238412|NCT00792181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65238413|NCT00792181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65238421|NCT00792181|Anesthetics|anesthetics|mesh-ancestor
65238470|NCT00570661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238471|NCT00570661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238472|NCT02870153|Oxaliplatin|oxaliplatin|mesh-list
65238473|NCT02870153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238474|NCT00787501|Citalopram|citalopram|mesh-list
65238475|NCT00787501|Fluoxetine|fluoxetine|mesh-list
65238476|NCT00787501|Sertraline|sertraline|mesh-list
65238477|NCT00787501|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65238478|NCT00787501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65238479|NCT00787501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65238480|NCT00787501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238481|NCT00787501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65238482|NCT00787501|Serotonin Agents|serotonin agents|mesh-ancestor
65238483|NCT00787501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238484|NCT00787501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65238485|NCT00787501|Antidepressive Agents|antidepressive agents|mesh-ancestor
65238486|NCT00787501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65238487|NCT00787501|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65238488|NCT00787501|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65238489|NCT00787501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238490|NCT00787657|Interferons|interferons|mesh-list
65238491|NCT00787657|Interferon-beta|interferon-beta|mesh-list
65238492|NCT00787657|Interferon beta-1b|interferon beta-1b|mesh-list
65238493|NCT00787657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238494|NCT00787657|Antiviral Agents|antiviral agents|mesh-ancestor
65238495|NCT00787657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65238496|NCT00787657|Immunologic Factors|immunologic factors|mesh-ancestor
65238497|NCT00787657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238498|NCT00787657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65238499|NCT04264676|Metronidazole|metronidazole|mesh-list
65238500|NCT04264676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65238501|NCT04264676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65238512|NCT04047355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65238513|NCT04047355|Vasodilator Agents|vasodilator agents|mesh-ancestor
65238514|NCT02869841|Levobupivacaine|levobupivacaine|mesh-list
65238515|NCT02869841|Anesthetics, Local|anesthetics, local|mesh-ancestor
65238516|NCT02869841|Anesthetics|anesthetics|mesh-ancestor
65238517|NCT02869841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65238518|NCT02869841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238519|NCT02869841|Sensory System Agents|sensory system agents|mesh-ancestor
65238520|NCT02869841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65238521|NCT00637637|Ritonavir|ritonavir|mesh-list
65238522|NCT00637637|Indinavir|indinavir|mesh-list
65238523|NCT00637637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65238524|NCT00637637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65238525|NCT00637637|Protease Inhibitors|protease inhibitors|mesh-ancestor
65238526|NCT00637637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238527|NCT00637637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238528|NCT00637637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65238529|NCT00637637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65238530|NCT00637637|Antiviral Agents|antiviral agents|mesh-ancestor
65238531|NCT00637637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65238532|NCT00637637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65238533|NCT00637637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65238534|NCT00927758|Fluticasone|fluticasone|mesh-list
64881287|NCT01917708|Abatacept|abatacept|mesh-list
65238535|NCT00927758|Xhance|xhance|mesh-list
65238536|NCT00927758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65238537|NCT00927758|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65238538|NCT00927758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65238539|NCT00927758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65238540|NCT00927758|Autonomic Agents|autonomic agents|mesh-ancestor
65238541|NCT00927758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65238542|NCT00927758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238543|NCT00927758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65238544|NCT00927758|Respiratory System Agents|respiratory system agents|mesh-ancestor
65238545|NCT00927758|Dermatologic Agents|dermatologic agents|mesh-ancestor
65238551|NCT00927758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65238552|NCT00927758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238553|NCT00927758|Glucocorticoids|glucocorticoids|mesh-ancestor
65238555|NCT00927758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65238556|NCT00927758|Sympathomimetics|sympathomimetics|mesh-ancestor
65238557|NCT00783523|Doxycycline|doxycycline|mesh-list
65238558|NCT00783523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65238559|NCT00783523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65238560|NCT00783523|Antimalarials|antimalarials|mesh-ancestor
65238561|NCT00783523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65238562|NCT00783523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65238563|NCT00783601|Montelukast|montelukast|mesh-list
65238564|NCT00783601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65238565|NCT00783601|Respiratory System Agents|respiratory system agents|mesh-ancestor
65238566|NCT00783601|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65238567|NCT00783601|Hormone Antagonists|hormone antagonists|mesh-ancestor
65238568|NCT00783601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65238573|NCT00787813|Acetylcysteine|acetylcysteine|mesh-list
65238607|NCT00609596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65238608|NCT00609596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238609|NCT00608816|Epinephrine|epinephrine|mesh-list
65238610|NCT00608816|Racepinephrine|racepinephrine|mesh-list
65238611|NCT00608816|Epinephryl borate|epinephryl borate|mesh-list
65238612|NCT00608816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65238613|NCT00608816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65238614|NCT00608816|Adrenergic Agents|adrenergic agents|mesh-ancestor
65238615|NCT00608816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65238616|NCT00608816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238617|NCT00608816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238618|NCT00608816|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64970442|NCT00410254|Anesthetics|anesthetics|mesh-ancestor
65238619|NCT00608816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65238620|NCT00608816|Autonomic Agents|autonomic agents|mesh-ancestor
65238621|NCT00608816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65238622|NCT00608816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65238623|NCT00608816|Respiratory System Agents|respiratory system agents|mesh-ancestor
65238625|NCT00608816|Sympathomimetics|sympathomimetics|mesh-ancestor
65238626|NCT00608816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65238627|NCT02535273|Lidocaine|lidocaine|mesh-list
65238628|NCT02535273|Dexmedetomidine|dexmedetomidine|mesh-list
65238629|NCT02535273|Anesthetics, Local|anesthetics, local|mesh-ancestor
65238630|NCT02535273|Anesthetics|anesthetics|mesh-ancestor
65238631|NCT02535273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65238632|NCT02535273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238633|NCT02535273|Sensory System Agents|sensory system agents|mesh-ancestor
65238653|NCT00788047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65238654|NCT00788047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238655|NCT00788047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238656|NCT04152369|Anti-Infective Agents|anti-infective agents|mesh-list
65238657|NCT04152369|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65238658|NCT05001152|Ozanimod|ozanimod|mesh-list
65238659|NCT05001152|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65238660|NCT05001152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238661|NCT05001152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65238662|NCT05001152|Immunologic Factors|immunologic factors|mesh-ancestor
65238663|NCT05001152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238664|NCT04259684|Nitric Oxide|nitric oxide|mesh-list
65238665|NCT04259684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65238666|NCT04259684|Autonomic Agents|autonomic agents|mesh-ancestor
65238667|NCT04259684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65238668|NCT04259684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238669|NCT04259684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65238670|NCT04259684|Respiratory System Agents|respiratory system agents|mesh-ancestor
65238671|NCT04259684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65238706|NCT00788749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65238707|NCT00788749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65238708|NCT00788749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238709|NCT00609752|Prednisolone|prednisolone|mesh-list
65238710|NCT00609752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65238711|NCT00609752|Glucocorticoids|glucocorticoids|mesh-ancestor
65238712|NCT00609752|Hormones|hormones|mesh-ancestor
65238713|NCT00609752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65238714|NCT00609752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238715|NCT00609752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65238716|NCT00609752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238717|NCT00662857|Insulin|insulin|mesh-list
65238718|NCT00662857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65238719|NCT00662857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65238720|NCT00662857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238721|NCT00878553|Zaleplon|zaleplon|mesh-list
65238722|NCT00878553|Anticonvulsants|anticonvulsants|mesh-ancestor
65238723|NCT00878553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65238724|NCT00878553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65238725|NCT00878553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238726|NCT00878553|GABA Modulators|gaba modulators|mesh-ancestor
65238727|NCT00878553|GABA Agents|gaba agents|mesh-ancestor
65238728|NCT00878553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65238730|NCT05220020|Lenvatinib|lenvatinib|mesh-list
65238756|NCT00662311|Paclitaxel|paclitaxel|mesh-list
65238757|NCT00662311|Vorinostat|vorinostat|mesh-list
64881510|NCT01918917|Morphine|morphine|mesh-list
65238758|NCT00662311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65238759|NCT00662311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238760|NCT00662311|Tubulin Modulators|tubulin modulators|mesh-ancestor
65238761|NCT00662311|Antimitotic Agents|antimitotic agents|mesh-ancestor
65238762|NCT00662311|Mitosis Modulators|mitosis modulators|mesh-ancestor
65238763|NCT00662311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238764|NCT00662311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64970585|NCT00201682|Etanercept|etanercept|mesh-list
65238765|NCT00662311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238766|NCT00929708|Formoterol Fumarate|formoterol fumarate|mesh-list
65238768|NCT00929708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65238769|NCT00929708|Autonomic Agents|autonomic agents|mesh-ancestor
65238770|NCT00929708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65238771|NCT00929708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238772|NCT00929708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65238773|NCT00929708|Respiratory System Agents|respiratory system agents|mesh-ancestor
65238774|NCT00929708|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65238775|NCT00929708|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65238809|NCT00675207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65238810|NCT00675207|Adrenergic Agents|adrenergic agents|mesh-ancestor
65238811|NCT00675207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65238812|NCT00675207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238813|NCT00675207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238814|NCT00675207|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65238815|NCT00675207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238816|NCT00795223|Morphine|morphine|mesh-list
65238817|NCT00795223|Bupivacaine|bupivacaine|mesh-list
65238818|NCT00795223|Anesthetics, Local|anesthetics, local|mesh-ancestor
65238819|NCT00795223|Anesthetics|anesthetics|mesh-ancestor
65238820|NCT00795223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65238821|NCT00795223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238822|NCT00795223|Sensory System Agents|sensory system agents|mesh-ancestor
65238823|NCT00795223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65238824|NCT00795223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65238825|NCT00795223|Narcotics|narcotics|mesh-ancestor
65238826|NCT00795223|Analgesics|analgesics|mesh-ancestor
65238827|NCT00795301|Capecitabine|capecitabine|mesh-list
65238828|NCT00795301|Oxaliplatin|oxaliplatin|mesh-list
65238829|NCT00795301|Cetuximab|cetuximab|mesh-list
65238830|NCT00795301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65238831|NCT00795301|Antimetabolites|antimetabolites|mesh-ancestor
65238832|NCT00795301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238833|NCT00795301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238834|NCT00795301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65238835|NCT00675285|Montelukast|montelukast|mesh-list
65238836|NCT00675285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65238837|NCT00675285|Respiratory System Agents|respiratory system agents|mesh-ancestor
65238838|NCT00675285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65238854|NCT00789763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238855|NCT00789763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65238856|NCT00789763|Immunologic Factors|immunologic factors|mesh-ancestor
65238857|NCT00789763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238858|NCT00789763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65238859|NCT02554357|Bupivacaine|bupivacaine|mesh-list
65238860|NCT02554357|Anesthetics, Local|anesthetics, local|mesh-ancestor
65238861|NCT02554357|Anesthetics|anesthetics|mesh-ancestor
65238862|NCT02554357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65238863|NCT02554357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238864|NCT02554357|Sensory System Agents|sensory system agents|mesh-ancestor
65238865|NCT02554357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65238866|NCT00877929|Amlodipine|amlodipine|mesh-list
65238867|NCT00877929|Telmisartan|telmisartan|mesh-list
65238868|NCT00877929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65238869|NCT00877929|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65238870|NCT00877929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65238871|NCT00877929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238872|NCT00877929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65238873|NCT00877929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238874|NCT00877929|Vasodilator Agents|vasodilator agents|mesh-ancestor
65238875|NCT00877929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65238876|NCT00877929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65238877|NCT00795457|Poly I-C|poly i-c|mesh-list
65238878|NCT00795457|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65238879|NCT00795457|Vaccines|vaccines|mesh-list
65238880|NCT00795457|Poly ICLC|poly iclc|mesh-list
65238902|NCT04979780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65238903|NCT04979780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65238904|NCT04979780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238905|NCT04979780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65238906|NCT04979780|Antithrombins|antithrombins|mesh-ancestor
65238907|NCT04979780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65238908|NCT04979780|Protease Inhibitors|protease inhibitors|mesh-ancestor
65238909|NCT04979780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238910|NCT04598009|Imatinib Mesylate|imatinib mesylate|mesh-list
65238911|NCT04598009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238912|NCT04598009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65238913|NCT04598009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238914|NCT04598009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238915|NCT00795613|Doxorubicin|doxorubicin|mesh-list
65238917|NCT00795613|Vincristine|vincristine|mesh-list
65238918|NCT00795613|Procarbazine|procarbazine|mesh-list
65238919|NCT00795613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65238920|NCT00795613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65238921|NCT00795613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65238922|NCT00795613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65238923|NCT00795613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65238924|NCT00795613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65238925|NCT00795613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65238926|NCT00795613|Tubulin Modulators|tubulin modulators|mesh-ancestor
65238927|NCT00795613|Antimitotic Agents|antimitotic agents|mesh-ancestor
65238952|NCT00800917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238953|NCT00800917|Growth Inhibitors|growth inhibitors|mesh-ancestor
65238954|NCT00800917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65238955|NCT00800917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65238956|NCT00800917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65238957|NCT00800917|Antifungal Agents|antifungal agents|mesh-ancestor
65238958|NCT00800917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65238959|NCT00800917|Immunologic Factors|immunologic factors|mesh-ancestor
65238960|NCT05003102|Fentanyl|fentanyl|mesh-list
65238961|NCT05003102|Dexmedetomidine|dexmedetomidine|mesh-list
65238962|NCT05003102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65238963|NCT05003102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65238964|NCT05003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65238965|NCT05003102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65238966|NCT05003102|Analgesics|analgesics|mesh-ancestor
65238967|NCT05003102|Sensory System Agents|sensory system agents|mesh-ancestor
65238968|NCT05003102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65238969|NCT05003102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65238971|NCT05003102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65239006|NCT00676845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239007|NCT04152057|Paclitaxel|paclitaxel|mesh-list
65239008|NCT04152057|Trastuzumab|trastuzumab|mesh-list
65239009|NCT04152057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65239010|NCT04152057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239011|NCT04152057|Tubulin Modulators|tubulin modulators|mesh-ancestor
65239012|NCT04152057|Antimitotic Agents|antimitotic agents|mesh-ancestor
65239013|NCT04152057|Mitosis Modulators|mitosis modulators|mesh-ancestor
65239014|NCT04152057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239015|NCT04152057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65239016|NCT00610142|Hydrocortisone|hydrocortisone|mesh-list
65239017|NCT00610142|Pimecrolimus|pimecrolimus|mesh-list
65239018|NCT00610142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65239019|NCT00610142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65239020|NCT00610142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65239021|NCT00610142|Analgesics|analgesics|mesh-ancestor
65239022|NCT00610142|Sensory System Agents|sensory system agents|mesh-ancestor
65239023|NCT00610142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65239024|NCT00610142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239025|NCT00610142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65239026|NCT00610142|Dermatologic Agents|dermatologic agents|mesh-ancestor
65239027|NCT00610142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65239028|NCT00610142|Immunologic Factors|immunologic factors|mesh-ancestor
65239029|NCT00610142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65239030|NCT00610142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239031|NCT00610142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239032|NCT04151823|Vitamin D|vitamin d|mesh-list
65239033|NCT04151823|Cholecalciferol|cholecalciferol|mesh-list
65239034|NCT04151823|Vitamins|vitamins|mesh-ancestor
65239035|NCT04151823|Micronutrients|micronutrients|mesh-ancestor
65239036|NCT04151823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239037|NCT04151823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65239039|NCT05199038|Octreotide|octreotide|mesh-list
65239048|NCT00660907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65239049|NCT00660907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239050|NCT00677001|R 306465|r 306465|mesh-list
65239051|NCT00677001|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65239052|NCT00677001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239053|NCT00677001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239054|NCT04992572|Lidocaine|lidocaine|mesh-list
65239055|NCT04992572|Propofol|propofol|mesh-list
65239056|NCT04992572|Anesthetics, Local|anesthetics, local|mesh-ancestor
65239057|NCT04992572|Anesthetics|anesthetics|mesh-ancestor
65239058|NCT04992572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65239059|NCT04992572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239060|NCT04992572|Sensory System Agents|sensory system agents|mesh-ancestor
65239061|NCT04992572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65239062|NCT04992572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65239063|NCT04992572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65239064|NCT04992572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65239065|NCT04992572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65239066|NCT04992572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239067|NCT04992572|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65239068|NCT04992572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65239069|NCT04992572|Anesthetics, General|anesthetics, general|mesh-ancestor
65239070|NCT05083052|Propolis|propolis|mesh-list
65239071|NCT05083052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65239072|NCT04031703|Paclitaxel|paclitaxel|mesh-list
65239073|NCT04031703|Docetaxel|docetaxel|mesh-list
65239074|NCT04031703|Cyclophosphamide|cyclophosphamide|mesh-list
65239075|NCT04031703|Carboplatin|carboplatin|mesh-list
65239076|NCT04031703|Fluorouracil|fluorouracil|mesh-list
65239077|NCT04031703|Epirubicin|epirubicin|mesh-list
65239078|NCT04031703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65239079|NCT04031703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239080|NCT04031703|Tubulin Modulators|tubulin modulators|mesh-ancestor
65239081|NCT04031703|Antimitotic Agents|antimitotic agents|mesh-ancestor
65239082|NCT04031703|Mitosis Modulators|mitosis modulators|mesh-ancestor
65239087|NCT04031703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65239088|NCT04031703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65239089|NCT04031703|Alkylating Agents|alkylating agents|mesh-ancestor
65239090|NCT04031703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65239091|NCT04031703|Antimetabolites|antimetabolites|mesh-ancestor
65239092|NCT04031703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65239093|NCT04031703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65239094|NCT04031703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65239095|NCT04031703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65239096|NCT04031703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239097|NCT00795847|Losartan|losartan|mesh-list
65239098|NCT00795847|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65239099|NCT00795847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65239100|NCT00795847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65239101|NCT00795847|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65239102|NCT00795847|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65239103|NCT00795847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239104|NCT00795847|Diuretics|diuretics|mesh-ancestor
65239105|NCT00795847|Natriuretic Agents|natriuretic agents|mesh-ancestor
65239109|NCT00877773|Sirolimus|sirolimus|mesh-list
65239143|NCT00912171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65239144|NCT00912171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239145|NCT00912171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65239146|NCT00912171|Respiratory System Agents|respiratory system agents|mesh-ancestor
65239147|NCT00912171|Glucocorticoids|glucocorticoids|mesh-ancestor
65239148|NCT00912171|Hormones|hormones|mesh-ancestor
65239149|NCT00912171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65239150|NCT00912171|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65239151|NCT00912171|Hormone Antagonists|hormone antagonists|mesh-ancestor
65239152|NCT00912171|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65239153|NCT00912171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65239154|NCT00912171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239155|NCT00677391|Sibutramine|sibutramine|mesh-list
65239156|NCT00677391|Antidepressive Agents|antidepressive agents|mesh-ancestor
65239157|NCT00677391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65239158|NCT00677391|Appetite Depressants|appetite depressants|mesh-ancestor
65239159|NCT00677391|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65239160|NCT00660829|Azelastine|azelastine|mesh-list
65239161|NCT00660829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65239162|NCT00660829|Autonomic Agents|autonomic agents|mesh-ancestor
65239163|NCT00660829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65239164|NCT00660829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239165|NCT00660829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65239166|NCT00660829|Respiratory System Agents|respiratory system agents|mesh-ancestor
65239167|NCT00660829|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65239168|NCT00660829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239190|NCT00629135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65239191|NCT00629135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239192|NCT00629135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239193|NCT00629135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239194|NCT00629135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65239195|NCT00629135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65239196|NCT00629135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65239197|NCT00795925|Propiverine|propiverine|mesh-list
65239198|NCT00795925|Parasympatholytics|parasympatholytics|mesh-ancestor
65239199|NCT00795925|Autonomic Agents|autonomic agents|mesh-ancestor
65239200|NCT00795925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65239201|NCT00795925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239202|NCT00795925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65239203|NCT00795925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65239204|NCT00795925|Cholinergic Agents|cholinergic agents|mesh-ancestor
65239205|NCT00795925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64881990|NCT01930812|Listerine|listerine|mesh-list
65239206|NCT00795925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239207|NCT00795925|Urological Agents|urological agents|mesh-ancestor
65239208|NCT04293419|Durvalumab|durvalumab|mesh-list
65239209|NCT04293419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65239210|NCT04293419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239211|NCT00793429|Prucalopride|prucalopride|mesh-list
65239212|NCT00793429|Laxatives|laxatives|mesh-ancestor
65239213|NCT00793429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65239214|NCT00793429|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65239215|NCT00793429|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65239236|NCT00796081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65239237|NCT00796081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65239238|NCT00796081|Serotonin Agents|serotonin agents|mesh-ancestor
65239239|NCT00796081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65239240|NCT00796081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239241|NCT00796081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65239242|NCT00796081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65239243|NCT00796081|Dopamine Agents|dopamine agents|mesh-ancestor
65239244|NCT00877383|Tiotropium Bromide|tiotropium bromide|mesh-list
65239245|NCT00877383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65239246|NCT00877383|Autonomic Agents|autonomic agents|mesh-ancestor
65239247|NCT00877383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65239248|NCT00877383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239249|NCT00877383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65239250|NCT00877383|Respiratory System Agents|respiratory system agents|mesh-ancestor
65239251|NCT00877383|Parasympatholytics|parasympatholytics|mesh-ancestor
65239252|NCT00877383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65239253|NCT00877383|Cholinergic Agents|cholinergic agents|mesh-ancestor
65239254|NCT00877383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65239256|NCT00796159|Olmesartan|olmesartan|mesh-list
65239290|NCT00929240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65239291|NCT00929240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65239292|NCT00929240|Growth Substances|growth substances|mesh-ancestor
65239293|NCT00929240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239294|NCT00929240|Growth Inhibitors|growth inhibitors|mesh-ancestor
65239295|NCT00929240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65239296|NCT00929240|Antimetabolites|antimetabolites|mesh-ancestor
65239297|NCT00929240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239298|NCT00793663|Dexamethasone|dexamethasone|mesh-list
65239299|NCT00793663|Dexamethasone acetate|dexamethasone acetate|mesh-list
65239300|NCT00793663|Ondansetron|ondansetron|mesh-list
65239301|NCT00793663|Sevoflurane|sevoflurane|mesh-list
65239302|NCT00793663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65239303|NCT00793663|Antiemetics|antiemetics|mesh-ancestor
65239304|NCT00793663|Autonomic Agents|autonomic agents|mesh-ancestor
65239305|NCT00793663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65239306|NCT00793663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239307|NCT00793663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65239308|NCT00793663|Glucocorticoids|glucocorticoids|mesh-ancestor
65239309|NCT00793663|Hormones|hormones|mesh-ancestor
65239310|NCT00793663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65239311|NCT00793663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65239312|NCT00793663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239313|NCT00793663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65239314|NCT00793663|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65239315|NCT00793663|Anesthetics, General|anesthetics, general|mesh-ancestor
65239316|NCT00793663|Anesthetics|anesthetics|mesh-ancestor
65239318|NCT00793663|Antipruritics|antipruritics|mesh-ancestor
65239337|NCT02554045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65239338|NCT02554045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65239339|NCT02554045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239340|NCT02554045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239341|NCT02554045|Urological Agents|urological agents|mesh-ancestor
65239342|NCT05330390|Levetiracetam|levetiracetam|mesh-list
65239343|NCT05330390|Anticonvulsants|anticonvulsants|mesh-ancestor
65239344|NCT05330390|Nootropic Agents|nootropic agents|mesh-ancestor
65239345|NCT00993317|Methotrexate|methotrexate|mesh-list
65239346|NCT00993317|Certolizumab Pegol|certolizumab pegol|mesh-list
65239347|NCT00993317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65239348|NCT00993317|Abortifacient Agents|abortifacient agents|mesh-ancestor
65239349|NCT00993317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65239350|NCT00993317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239351|NCT00993317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65239352|NCT00993317|Antimetabolites|antimetabolites|mesh-ancestor
65239353|NCT00993317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882120|NCT01931514|Montelukast|montelukast|mesh-list
65239354|NCT00993317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239355|NCT00993317|Dermatologic Agents|dermatologic agents|mesh-ancestor
65239356|NCT00993317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239357|NCT00993317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65239358|NCT00993317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65239359|NCT00993317|Immunologic Factors|immunologic factors|mesh-ancestor
65239360|NCT00993317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65239361|NCT00993317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65239362|NCT00801385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65239363|NCT00801385|Sorafenib|sorafenib|mesh-list
65239364|NCT00801385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239365|NCT00801385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65239366|NCT00801385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239367|NCT00801385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239368|NCT05330078|Botulinum Toxins|botulinum toxins|mesh-list
65239369|NCT05330078|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65239370|NCT05330078|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64460756|NCT03557008|Metronidazole|metronidazole|mesh-list
65239373|NCT05330078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239374|NCT05330078|Cholinergic Agents|cholinergic agents|mesh-ancestor
65239375|NCT05330078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65239376|NCT05330078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239377|NCT05330078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65239378|NCT05330078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65239379|NCT00877071|Doxorubicin|doxorubicin|mesh-list
65239380|NCT00877071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65239381|NCT00877071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239382|NCT00877071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65239383|NCT00877071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65239384|NCT00877071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239385|NCT00877071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239387|NCT02868827|Cholecalciferol|cholecalciferol|mesh-list
65239388|NCT02868827|Vitamins|vitamins|mesh-ancestor
65239389|NCT02868827|Micronutrients|micronutrients|mesh-ancestor
65239390|NCT02868827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239391|NCT02868827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65239392|NCT02868827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65239393|NCT00678327|Prednisolone|prednisolone|mesh-list
65239394|NCT00678327|Cyclophosphamide|cyclophosphamide|mesh-list
65239427|NCT00987389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65239428|NCT00987389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239429|NCT00929162|Paclitaxel|paclitaxel|mesh-list
65239430|NCT00929162|Carboplatin|carboplatin|mesh-list
65239431|NCT00929162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65239432|NCT00929162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239433|NCT00929162|Tubulin Modulators|tubulin modulators|mesh-ancestor
65239434|NCT00929162|Antimitotic Agents|antimitotic agents|mesh-ancestor
65239435|NCT00929162|Mitosis Modulators|mitosis modulators|mesh-ancestor
65239436|NCT00929162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239437|NCT02627625|Tiotropium Bromide|tiotropium bromide|mesh-list
65239438|NCT02627625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65239439|NCT02627625|Autonomic Agents|autonomic agents|mesh-ancestor
65239440|NCT02627625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65239441|NCT02627625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239442|NCT02627625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65239443|NCT02627625|Respiratory System Agents|respiratory system agents|mesh-ancestor
65239444|NCT02627625|Parasympatholytics|parasympatholytics|mesh-ancestor
65239445|NCT02627625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65239446|NCT02627625|Cholinergic Agents|cholinergic agents|mesh-ancestor
65239447|NCT02627625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65239448|NCT02627625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239449|NCT00678483|Rimonabant|rimonabant|mesh-list
65239450|NCT00678483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65239451|NCT00678483|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65239452|NCT00678483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65239453|NCT00678483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65239455|NCT00678483|Hormones|hormones|mesh-ancestor
65239470|NCT00609284|Cetuximab|cetuximab|mesh-list
65239471|NCT00609284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239472|NCT00609284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65239473|NCT00992459|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
65239474|NCT00992459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239475|NCT00930722|Quinapril|quinapril|mesh-list
65239476|NCT00930722|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65239477|NCT00930722|Protease Inhibitors|protease inhibitors|mesh-ancestor
65239478|NCT00930722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239479|NCT00930722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239480|NCT00930722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65239481|NCT00610610|Paroxetine|paroxetine|mesh-list
65239482|NCT00610610|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65239483|NCT00610610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65239484|NCT00610610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65239485|NCT00610610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239486|NCT00610610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65239487|NCT00610610|Serotonin Agents|serotonin agents|mesh-ancestor
65239488|NCT00610610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239489|NCT00610610|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65239490|NCT00610610|Antidepressive Agents|antidepressive agents|mesh-ancestor
65239491|NCT00610610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65239492|NCT00610610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65239493|NCT00610610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65239494|NCT00610610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239495|NCT00912327|Cetuximab|cetuximab|mesh-list
65239496|NCT00912327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65239497|NCT00912327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239498|NCT04257812|Tazobactam|tazobactam|mesh-list
65239499|NCT04257812|Ceftolozane|ceftolozane|mesh-list
65239507|NCT04257812|Renal Agents|renal agents|mesh-ancestor
65239514|NCT00659581|Telmisartan|telmisartan|mesh-list
65239515|NCT00659581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65239516|NCT00659581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65239517|NCT00659581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65239518|NCT00659581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239519|NCT00793741|Somatostatin|somatostatin|mesh-list
65239520|NCT00793741|Hormones|hormones|mesh-ancestor
65239521|NCT00793741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65239522|NCT00793741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239523|NCT00796471|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65239524|NCT00796471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65239525|NCT00796471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65239526|NCT00796471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65239527|NCT00796471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239528|NCT00796471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65239529|NCT00796471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65239530|NCT00796471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65239531|NCT00796471|Serotonin Agents|serotonin agents|mesh-ancestor
65239532|NCT00796471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65239533|NCT00796471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239535|NCT00796471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65239568|NCT00679653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65239569|NCT00679653|Sympatholytics|sympatholytics|mesh-ancestor
65239570|NCT00679653|Autonomic Agents|autonomic agents|mesh-ancestor
65239571|NCT00679653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65239572|NCT00679653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239573|NCT00679653|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65239574|NCT00679653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65239575|NCT00679653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65239576|NCT00679653|Adrenergic Agents|adrenergic agents|mesh-ancestor
65239577|NCT00679653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65239578|NCT00679653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239579|NCT00679653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64882331|NCT01932580|Docetaxel|docetaxel|mesh-list
64971414|NCT00062426|Vitamins|vitamins|mesh-ancestor
65239628|NCT00801697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239629|NCT00684489|Antihypertensive Agents|antihypertensive agents|mesh-list
65239630|NCT00684489|Coal Tar|coal tar|mesh-list
65239631|NCT00684489|Keratolytic Agents|keratolytic agents|mesh-ancestor
65239632|NCT00684489|Dermatologic Agents|dermatologic agents|mesh-ancestor
65239633|NCT00990821|Midazolam|midazolam|mesh-list
65239634|NCT00990821|Aprepitant|aprepitant|mesh-list
65239635|NCT00990821|Fosaprepitant|fosaprepitant|mesh-list
65239636|NCT00990821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65239637|NCT00990821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65239638|NCT00990821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65239639|NCT00990821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239640|NCT00990821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65239641|NCT00990821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65239642|NCT00990821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65239643|NCT00990821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65239644|NCT00990821|Anesthetics, General|anesthetics, general|mesh-ancestor
65239645|NCT00990821|Anesthetics|anesthetics|mesh-ancestor
65239646|NCT00990821|GABA Modulators|gaba modulators|mesh-ancestor
65239647|NCT00990821|GABA Agents|gaba agents|mesh-ancestor
65239648|NCT00990821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65239649|NCT00990821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239650|NCT00990821|Antiemetics|antiemetics|mesh-ancestor
65239651|NCT00990821|Autonomic Agents|autonomic agents|mesh-ancestor
65239652|NCT00990821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65239653|NCT00990821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65239677|NCT00658567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65239678|NCT00658567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65239679|NCT00658567|Serotonin Agents|serotonin agents|mesh-ancestor
65239680|NCT00658567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65239681|NCT00658567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239683|NCT00875433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239684|NCT00875433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65239685|NCT00875433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239686|NCT00875433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239687|NCT00684957|Hormones|hormones|mesh-list
65239688|NCT00684957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65239689|NCT00684957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239690|NCT00685191|Raltegravir Potassium|raltegravir potassium|mesh-list
65239691|NCT00685191|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65239692|NCT00685191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65239693|NCT00685191|Antiviral Agents|antiviral agents|mesh-ancestor
65239694|NCT00685191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65239695|NCT00685191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65239696|NCT00685191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65239697|NCT00685191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239698|NCT00685191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239699|NCT00685269|Eszopiclone|eszopiclone|mesh-list
65239700|NCT00685269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65239701|NCT00685269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65239702|NCT00685269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239703|NCT00794209|Fentanyl|fentanyl|mesh-list
65239704|NCT00794209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65239705|NCT00794209|Narcotics|narcotics|mesh-ancestor
65239708|NCT00794209|Analgesics|analgesics|mesh-ancestor
65239722|NCT00985985|Cholinergic Agents|cholinergic agents|mesh-ancestor
65239723|NCT00985985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65239724|NCT00985985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239725|NCT00685347|Albuterol|albuterol|mesh-list
65239726|NCT00685347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65239727|NCT00685347|Autonomic Agents|autonomic agents|mesh-ancestor
65239728|NCT00685347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65239729|NCT00685347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239730|NCT00685347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64882485|NCT01934088|Analgesics|analgesics|mesh-ancestor
65239731|NCT00685347|Respiratory System Agents|respiratory system agents|mesh-ancestor
65239733|NCT00685347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65239734|NCT00685347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65239735|NCT00685347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65239736|NCT00685347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65239737|NCT00685347|Adrenergic Agents|adrenergic agents|mesh-ancestor
65239738|NCT00685347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65239739|NCT00685347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239741|NCT00685425|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65239742|NCT00685425|Autonomic Agents|autonomic agents|mesh-ancestor
65239743|NCT00685425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65239744|NCT00685425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239745|NCT00685425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65239746|NCT00685425|Respiratory System Agents|respiratory system agents|mesh-ancestor
65239747|NCT00685425|Tocolytic Agents|tocolytic agents|mesh-ancestor
65239748|NCT00685425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65239749|NCT00685425|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65239750|NCT00685425|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65239751|NCT00685425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65239752|NCT00685425|Adrenergic Agents|adrenergic agents|mesh-ancestor
65239753|NCT00685425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65239764|NCT00685503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239765|NCT00802009|Dexamethasone|dexamethasone|mesh-list
65239766|NCT00802009|Mepivacaine|mepivacaine|mesh-list
65239767|NCT00802009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65239768|NCT00802009|Antiemetics|antiemetics|mesh-ancestor
65239769|NCT00802009|Autonomic Agents|autonomic agents|mesh-ancestor
65239770|NCT00802009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65239771|NCT00802009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239772|NCT00802009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65239773|NCT00802009|Glucocorticoids|glucocorticoids|mesh-ancestor
65239774|NCT00802009|Hormones|hormones|mesh-ancestor
65239775|NCT00802009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65239776|NCT00802009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65239777|NCT00802009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239778|NCT00802009|Anesthetics, Local|anesthetics, local|mesh-ancestor
65239779|NCT00802009|Anesthetics|anesthetics|mesh-ancestor
65239780|NCT00802009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65239781|NCT00802009|Sensory System Agents|sensory system agents|mesh-ancestor
65239782|NCT02868437|Hyaluronic Acid|hyaluronic acid|mesh-list
65239783|NCT02868437|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65239820|NCT00797017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239821|NCT00797017|Analgesics|analgesics|mesh-ancestor
65239822|NCT00797017|Sensory System Agents|sensory system agents|mesh-ancestor
65239823|NCT00797017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65239824|NCT00797017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65239825|NCT00797017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65239826|NCT00797017|Anesthetics, General|anesthetics, general|mesh-ancestor
65239827|NCT00797017|Anesthetics|anesthetics|mesh-ancestor
65239828|NCT05330000|Voriconazole|voriconazole|mesh-list
65239829|NCT05330000|Antifungal Agents|antifungal agents|mesh-ancestor
65239830|NCT05330000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65239831|NCT05330000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65239832|NCT05330000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65239833|NCT05330000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239834|NCT05330000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239835|NCT05330000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65239836|NCT05330000|Hormone Antagonists|hormone antagonists|mesh-ancestor
65239837|NCT05330000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65239838|NCT05330000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239839|NCT05330000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65239840|NCT00794443|Diphosphonates|diphosphonates|mesh-list
65239841|NCT00794443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65239842|NCT00794443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239843|NCT00924950|Calcitriol|calcitriol|mesh-list
65239844|NCT00924950|Betamethasone|betamethasone|mesh-list
65239866|NCT02866955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65239867|NCT02866955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239868|NCT02866955|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65239869|NCT02866955|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65239870|NCT02866955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65239871|NCT02866955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65239872|NCT02866955|Alkylating Agents|alkylating agents|mesh-ancestor
65239874|NCT04842643|Immunoglobulins|immunoglobulins|mesh-list
65239931|NCT00686361|Antimetabolites|antimetabolites|mesh-ancestor
65239932|NCT00686361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239933|NCT00686361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65239934|NCT00686361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65239935|NCT00686361|Nootropic Agents|nootropic agents|mesh-ancestor
65239936|NCT00686439|Adalimumab|adalimumab|mesh-list
65239937|NCT00686439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65239938|NCT00686439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65239939|NCT04161755|Atezolizumab|atezolizumab|mesh-list
65239940|NCT04161755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239941|NCT00797485|Leucovorin|leucovorin|mesh-list
65239942|NCT00797485|Bevacizumab|bevacizumab|mesh-list
65239943|NCT00797485|Fluorouracil|fluorouracil|mesh-list
65239944|NCT00797485|Capecitabine|capecitabine|mesh-list
65239945|NCT00797485|Irinotecan|irinotecan|mesh-list
65239946|NCT00797485|Calcium|calcium|mesh-list
65239947|NCT00797485|Levoleucovorin|levoleucovorin|mesh-list
65239948|NCT00797485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65239949|NCT00797485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239950|NCT00797485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65239951|NCT00797485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64882724|NCT01935505|Dopamine Agents|dopamine agents|mesh-ancestor
65239952|NCT00797485|Growth Substances|growth substances|mesh-ancestor
65239953|NCT00797485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239954|NCT00797485|Growth Inhibitors|growth inhibitors|mesh-ancestor
65239955|NCT00797485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65239956|NCT00797485|Antimetabolites|antimetabolites|mesh-ancestor
65239957|NCT00797485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239958|NCT00797485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65239959|NCT00797485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65239960|NCT00797485|Immunologic Factors|immunologic factors|mesh-ancestor
65239961|NCT00797485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65239962|NCT00797485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65239963|NCT00797485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65239965|NCT00797485|Protective Agents|protective agents|mesh-ancestor
65239966|NCT00797485|Vitamin B Complex|vitamin b complex|mesh-ancestor
65239967|NCT00797485|Vitamins|vitamins|mesh-ancestor
64461358|NCT03435718|Tubulin Modulators|tubulin modulators|mesh-ancestor
64951563|NCT00026429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951568|NCT00026468|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65239968|NCT00797485|Micronutrients|micronutrients|mesh-ancestor
65239969|NCT00686985|Carboplatin|carboplatin|mesh-list
65239970|NCT00686985|Docetaxel|docetaxel|mesh-list
65239971|NCT00686985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65239972|NCT00686985|Tubulin Modulators|tubulin modulators|mesh-ancestor
65239973|NCT00686985|Antimitotic Agents|antimitotic agents|mesh-ancestor
65239974|NCT00686985|Mitosis Modulators|mitosis modulators|mesh-ancestor
65239975|NCT00686985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65239976|NCT00687063|Insulin Detemir|insulin detemir|mesh-list
65239977|NCT00687063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65239978|NCT00687063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239979|NCT02625753|Acetaminophen|acetaminophen|mesh-list
65239980|NCT02625753|Codeine|codeine|mesh-list
65239981|NCT02625753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65239982|NCT02625753|Analgesics|analgesics|mesh-ancestor
65239983|NCT02625753|Sensory System Agents|sensory system agents|mesh-ancestor
65239984|NCT02625753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65239985|NCT02625753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65239986|NCT02625753|Antipyretics|antipyretics|mesh-ancestor
65239987|NCT02625753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65239988|NCT02625753|Narcotics|narcotics|mesh-ancestor
65239989|NCT02625753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65239990|NCT02625753|Antitussive Agents|antitussive agents|mesh-ancestor
65239991|NCT02625753|Respiratory System Agents|respiratory system agents|mesh-ancestor
65239992|NCT00687843|polysaccharide-K|polysaccharide-k|mesh-list
65240020|NCT00687999|Ribavirin|ribavirin|mesh-list
65240021|NCT00687999|Interferon-alpha|interferon-alpha|mesh-list
65240022|NCT00687999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240023|NCT00687999|Antiviral Agents|antiviral agents|mesh-ancestor
65240024|NCT00687999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65240025|NCT00687999|Antimetabolites|antimetabolites|mesh-ancestor
65240026|NCT00687999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240027|NCT00687999|Immunologic Factors|immunologic factors|mesh-ancestor
65240028|NCT00687999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240029|NCT00688077|Calcitonin|calcitonin|mesh-list
65240030|NCT00688077|Salmon calcitonin|salmon calcitonin|mesh-list
64882789|NCT01935674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65240031|NCT00688077|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
65240033|NCT00688077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65240034|NCT00688077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240035|NCT00688077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65240036|NCT00688077|Vasodilator Agents|vasodilator agents|mesh-ancestor
65240037|NCT00923156|Ramipril|ramipril|mesh-list
65240038|NCT00923156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65240076|NCT00689169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65240077|NCT00689169|Antimetabolites|antimetabolites|mesh-ancestor
65240078|NCT00689169|Antiviral Agents|antiviral agents|mesh-ancestor
65240079|NCT00689169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65240080|NCT04203914|Empagliflozin|empagliflozin|mesh-list
65240081|NCT04203914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65240082|NCT04203914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240083|NCT04203914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65240084|NCT04203914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240085|NCT00874731|Sirolimus|sirolimus|mesh-list
65240086|NCT00874731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65240087|NCT00874731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65240088|NCT00874731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65240089|NCT00874731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240090|NCT00874731|Antifungal Agents|antifungal agents|mesh-ancestor
65240091|NCT00874731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65240092|NCT00874731|Immunologic Factors|immunologic factors|mesh-ancestor
65240093|NCT00874731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240094|NCT02625519|Hormones|hormones|mesh-list
65240131|NCT00924560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65240132|NCT00924560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65240133|NCT00924560|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65240134|NCT00689559|Aripiprazole|aripiprazole|mesh-list
65240135|NCT00689559|Antidepressive Agents|antidepressive agents|mesh-ancestor
65240136|NCT00689559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65240137|NCT00689559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65240138|NCT00689559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65240139|NCT00689559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65240140|NCT00689559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240141|NCT00689559|Dopamine Agonists|dopamine agonists|mesh-ancestor
65240142|NCT00689559|Dopamine Agents|dopamine agents|mesh-ancestor
65240143|NCT00689559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65240144|NCT00689559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240145|NCT00689559|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65240146|NCT00689559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65240147|NCT00689559|Serotonin Agents|serotonin agents|mesh-ancestor
65240148|NCT00689559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65240149|NCT00689559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65240150|NCT00689559|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65240152|NCT00689637|Warfarin|warfarin|mesh-list
65240184|NCT00611000|Vitamins|vitamins|mesh-ancestor
65240185|NCT00611000|Micronutrients|micronutrients|mesh-ancestor
65240186|NCT00611000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240187|NCT04031157|Antidepressive Agents|antidepressive agents|mesh-list
65240188|NCT04031157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65240189|NCT00690105|Fluticasone|fluticasone|mesh-list
65240190|NCT00690105|Tacrolimus|tacrolimus|mesh-list
65240191|NCT00690105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65240192|NCT00690105|Immunologic Factors|immunologic factors|mesh-ancestor
65240193|NCT00690105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240194|NCT00690105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65240195|NCT00690105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240196|NCT00690105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240197|NCT00690105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65240198|NCT00690105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65240199|NCT00690105|Autonomic Agents|autonomic agents|mesh-ancestor
65240200|NCT00690105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65240201|NCT00690105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65240202|NCT00690105|Respiratory System Agents|respiratory system agents|mesh-ancestor
65240203|NCT00690105|Dermatologic Agents|dermatologic agents|mesh-ancestor
65240204|NCT00690105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65240205|NCT00694317|Zaleplon|zaleplon|mesh-list
65240206|NCT00694317|Anticonvulsants|anticonvulsants|mesh-ancestor
65240207|NCT00694317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65240208|NCT00694317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65240209|NCT00694317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240210|NCT00694317|GABA Modulators|gaba modulators|mesh-ancestor
65240211|NCT00694317|GABA Agents|gaba agents|mesh-ancestor
65240214|NCT04136613|Copper|copper|mesh-list
65240232|NCT00694629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65240233|NCT00694629|Antitubercular Agents|antitubercular agents|mesh-ancestor
65240234|NCT00694629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65240235|NCT00694629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65240236|NCT00694629|Leprostatic Agents|leprostatic agents|mesh-ancestor
65240237|NCT00694629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65240238|NCT00694629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240239|NCT00694629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240240|NCT00694629|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65240241|NCT00694629|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65240242|NCT00694629|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65240243|NCT00694629|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65240244|NCT00694629|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65240245|NCT00694629|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65240246|NCT00912639|Paclitaxel|paclitaxel|mesh-list
65240247|NCT00912639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65240248|NCT00912639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240249|NCT00912639|Tubulin Modulators|tubulin modulators|mesh-ancestor
65240250|NCT00912639|Antimitotic Agents|antimitotic agents|mesh-ancestor
65240251|NCT00912639|Mitosis Modulators|mitosis modulators|mesh-ancestor
65240252|NCT00912639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240253|NCT02866409|Dexmedetomidine|dexmedetomidine|mesh-list
65240254|NCT02866409|Bupivacaine|bupivacaine|mesh-list
64883010|NCT01936636|Sensory System Agents|sensory system agents|mesh-ancestor
65240255|NCT02866409|Anesthetics, Local|anesthetics, local|mesh-ancestor
65240256|NCT02866409|Anesthetics|anesthetics|mesh-ancestor
65240257|NCT02866409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65240258|NCT02866409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240259|NCT02866409|Sensory System Agents|sensory system agents|mesh-ancestor
65240321|NCT05833763|Obinutuzumab|obinutuzumab|mesh-list
65240326|NCT05833529|Anesthetics|anesthetics|mesh-ancestor
64510936|NCT05776108|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65240327|NCT05833529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65240328|NCT05833529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883087|NCT01937338|AZD7624|azd7624|mesh-list
65240330|NCT05833529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65240331|NCT05833529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65240332|NCT05833529|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65240333|NCT05833529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65240334|NCT05833529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65240335|NCT05833529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240336|NCT05833529|Dopamine Agents|dopamine agents|mesh-ancestor
65240337|NCT05833529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65240338|NCT05833477|Epoetin Alfa|epoetin alfa|mesh-list
65240339|NCT05833477|Hematinics|hematinics|mesh-ancestor
65240340|NCT05833399|Carbamazepine|carbamazepine|mesh-list
65240341|NCT05833399|Amitriptyline|amitriptyline|mesh-list
65240342|NCT05833399|Olanzapine|olanzapine|mesh-list
65240343|NCT05833399|Chlorpromazine|chlorpromazine|mesh-list
65240344|NCT05833399|Risperidone|risperidone|mesh-list
65240345|NCT05833399|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65240346|NCT05833399|Mirtazapine|mirtazapine|mesh-list
65240347|NCT05833399|Sertraline|sertraline|mesh-list
65240348|NCT05833399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65240349|NCT05833399|Serotonin Agents|serotonin agents|mesh-ancestor
64461790|NCT05640232|Parasympatholytics|parasympatholytics|mesh-ancestor
64461791|NCT05640232|Autonomic Agents|autonomic agents|mesh-ancestor
64461792|NCT05640232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64461793|NCT05640232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461794|NCT05640232|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64461795|NCT05640232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64461796|NCT05640232|Cholinergic Agents|cholinergic agents|mesh-ancestor
64461797|NCT05640232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64461798|NCT05640232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461799|NCT01970371|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64461801|NCT01970371|Colistin|colistin|mesh-list
64461802|NCT01970371|Tigecycline|tigecycline|mesh-list
64461803|NCT01970371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64461804|NCT01970371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64461805|NCT01970371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240376|NCT05833399|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65240418|NCT05832892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240419|NCT05832892|Tubulin Modulators|tubulin modulators|mesh-ancestor
65240420|NCT05832892|Antimitotic Agents|antimitotic agents|mesh-ancestor
65240421|NCT05832892|Mitosis Modulators|mitosis modulators|mesh-ancestor
65240422|NCT05832892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240423|NCT05832892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65240424|NCT05832892|Antimetabolites|antimetabolites|mesh-ancestor
65240425|NCT05832892|Antiviral Agents|antiviral agents|mesh-ancestor
65240426|NCT05832892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65240427|NCT05832892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240428|NCT05832892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65240429|NCT05832892|Immunologic Factors|immunologic factors|mesh-ancestor
65240430|NCT05832892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240431|NCT05832827|Paclitaxel|paclitaxel|mesh-list
65240432|NCT05832827|Carboplatin|carboplatin|mesh-list
65240433|NCT05832827|Pembrolizumab|pembrolizumab|mesh-list
65240434|NCT05832827|Lenvatinib|lenvatinib|mesh-list
65240435|NCT05832827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65240436|NCT05832827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240437|NCT05832827|Tubulin Modulators|tubulin modulators|mesh-ancestor
65240438|NCT05832827|Antimitotic Agents|antimitotic agents|mesh-ancestor
65240439|NCT05832827|Mitosis Modulators|mitosis modulators|mesh-ancestor
65240440|NCT05832827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240441|NCT05832827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65240442|NCT05832827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65240443|NCT05832827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240444|NCT05832749|Hyaluronic Acid|hyaluronic acid|mesh-list
65240445|NCT05832749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65240446|NCT05832749|Immunologic Factors|immunologic factors|mesh-ancestor
65240447|NCT05832749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240448|NCT05832749|Viscosupplements|viscosupplements|mesh-ancestor
65240449|NCT05832749|Protective Agents|protective agents|mesh-ancestor
65240461|NCT05832580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240462|NCT05832515|Fludarabine|fludarabine|mesh-list
65240463|NCT05832515|Fludarabine phosphate|fludarabine phosphate|mesh-list
65240464|NCT05832515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240465|NCT05832515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65240466|NCT05832515|Antimetabolites|antimetabolites|mesh-ancestor
65240467|NCT05832515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240468|NCT05832515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65240469|NCT05832515|Immunologic Factors|immunologic factors|mesh-ancestor
65240470|NCT05832515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240471|NCT05832489|Methylphenidate|methylphenidate|mesh-list
65240472|NCT05832489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65240473|NCT05832489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240474|NCT05832489|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65240475|NCT05832489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65240476|NCT05832489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65240477|NCT05832489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240478|NCT05832489|Dopamine Agents|dopamine agents|mesh-ancestor
65240479|NCT05832489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65240480|NCT05832398|Leucovorin|leucovorin|mesh-list
65240481|NCT05832398|Fluorouracil|fluorouracil|mesh-list
65240482|NCT05832398|Oxaliplatin|oxaliplatin|mesh-list
65240483|NCT05832398|Irinotecan|irinotecan|mesh-list
65240484|NCT05832398|Antimetabolites|antimetabolites|mesh-ancestor
65240489|NCT05832398|Immunologic Factors|immunologic factors|mesh-ancestor
65240511|NCT05832320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65240512|NCT05832320|Keratolytic Agents|keratolytic agents|mesh-ancestor
65240513|NCT05832320|Dermatologic Agents|dermatologic agents|mesh-ancestor
65240514|NCT05832255|Psilocybin|psilocybin|mesh-list
65240515|NCT05832255|Hallucinogens|hallucinogens|mesh-ancestor
65240516|NCT05832255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240517|NCT05832255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65240518|NCT05832229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65240519|NCT05832229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65240520|NCT05832229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65240521|NCT05832229|Antimetabolites|antimetabolites|mesh-ancestor
65240522|NCT05832229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240523|NCT05832229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65240524|NCT05832229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65240525|NCT05832229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240526|NCT05832216|Daratumumab|daratumumab|mesh-list
65240527|NCT05832216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240528|NCT05832190|Biotin|biotin|mesh-list
65240529|NCT05832190|Vitamin B Complex|vitamin b complex|mesh-ancestor
65240530|NCT05832190|Vitamins|vitamins|mesh-ancestor
65240531|NCT05832190|Micronutrients|micronutrients|mesh-ancestor
65240532|NCT05832190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240533|NCT05832073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65240534|NCT05832073|Antibodies|antibodies|mesh-list
65240535|NCT05832073|Immunoglobulins|immunoglobulins|mesh-list
65240536|NCT05832073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65240537|NCT05832073|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65240538|NCT05832073|Immunologic Factors|immunologic factors|mesh-ancestor
65240539|NCT05832073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240540|NCT05832073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240542|NCT05832034|Immunoglobulins|immunoglobulins|mesh-list
65240543|NCT05832034|Antibodies|antibodies|mesh-list
65240544|NCT05832034|gamma-Globulins|gamma-globulins|mesh-list
65240545|NCT05832034|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65240546|NCT05832034|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65240547|NCT05832034|Immunologic Factors|immunologic factors|mesh-ancestor
65240548|NCT05832034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240549|NCT05831358|Myeloma Proteins|myeloma proteins|mesh-list
64951569|NCT00026468|Protective Agents|protective agents|mesh-ancestor
64725686|NCT00003032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64725687|NCT00003032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65240550|NCT05831358|Paraproteins|paraproteins|mesh-list
65240551|NCT05831358|Immunologic Factors|immunologic factors|mesh-ancestor
65240552|NCT05831358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240553|NCT05830539|Doxorubicin|doxorubicin|mesh-list
65240554|NCT05830539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65240555|NCT05830539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65240556|NCT05830539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240557|NCT05830539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65240558|NCT05830539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65240559|NCT05830539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240560|NCT05830539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240561|NCT05828940|Losartan|losartan|mesh-list
65240562|NCT05828940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65240563|NCT05828940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65240564|NCT05828940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65240565|NCT05828940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65240566|NCT05828940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240567|NCT05827055|Gemcitabine|gemcitabine|mesh-list
65240568|NCT05827055|Paclitaxel|paclitaxel|mesh-list
65240569|NCT05827055|Proglumide|proglumide|mesh-list
65240570|NCT05827055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65240571|NCT05827055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240572|NCT05827055|Tubulin Modulators|tubulin modulators|mesh-ancestor
65240573|NCT05827055|Antimitotic Agents|antimitotic agents|mesh-ancestor
65240601|NCT05818423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65240602|NCT05816785|Cetuximab|cetuximab|mesh-list
65240603|NCT05816785|Imatinib Mesylate|imatinib mesylate|mesh-list
65240604|NCT05816785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65240605|NCT05816785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240606|NCT05816785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65240607|NCT05816785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240608|NCT05816785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240609|NCT05813912|Insulin|insulin|mesh-list
65240610|NCT05813912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65240611|NCT05813912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972346|NCT00230503|Adefovir|adefovir|mesh-list
65240622|NCT05807399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240623|NCT05807399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240624|NCT05807399|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65240625|NCT05807399|Antitubercular Agents|antitubercular agents|mesh-ancestor
65240626|NCT05807399|Leprostatic Agents|leprostatic agents|mesh-ancestor
65240627|NCT05807399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65240628|NCT05807399|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65240662|NCT05798390|Ezetimibe|ezetimibe|mesh-list
65240663|NCT05798390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65240664|NCT05798390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65240665|NCT05798390|Antimetabolites|antimetabolites|mesh-ancestor
65240666|NCT05798390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240667|NCT05798390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65240668|NCT05798390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240669|NCT05798390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65240670|NCT05798390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240709|NCT05771402|Immunologic Factors|immunologic factors|mesh-ancestor
65240710|NCT05771402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240712|NCT05769816|Immunologic Factors|immunologic factors|mesh-ancestor
65240713|NCT05769816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240714|NCT05745142|Sunitinib|sunitinib|mesh-list
65240715|NCT05745142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240716|NCT05745142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65240717|NCT05745142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65240718|NCT05745142|Growth Substances|growth substances|mesh-ancestor
65240719|NCT05745142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240720|NCT05745142|Growth Inhibitors|growth inhibitors|mesh-ancestor
65240721|NCT05745142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65240722|NCT05745142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240723|NCT05745142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240724|NCT05737069|Ibuprofen|ibuprofen|mesh-list
65240725|NCT05737069|Ibuprofen arginine|ibuprofen arginine|mesh-list
65240726|NCT05737069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65240727|NCT05737069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65240728|NCT05737069|Analgesics|analgesics|mesh-ancestor
65240729|NCT05737069|Sensory System Agents|sensory system agents|mesh-ancestor
65240746|NCT05722015|Mitosis Modulators|mitosis modulators|mesh-ancestor
65240747|NCT05722015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240748|NCT05722015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65240749|NCT05722015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240750|NCT05722015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65240751|NCT05722015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65240752|NCT05721937|Abrocitinib|abrocitinib|mesh-list
65240753|NCT05721937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65240754|NCT05721937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240755|NCT05721937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240778|NCT05709483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65240779|NCT05709483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65240780|NCT05709483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65240781|NCT05709483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65240782|NCT05709483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240783|NCT05709483|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65240784|NCT05709483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65240785|NCT05709483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240786|NCT05709483|Antipyretics|antipyretics|mesh-ancestor
65240787|NCT05704049|Dexamethasone|dexamethasone|mesh-list
65240788|NCT05704049|Dexamethasone acetate|dexamethasone acetate|mesh-list
65240789|NCT05704049|BB 1101|bb 1101|mesh-list
65240790|NCT05704049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65240791|NCT05704049|Antiemetics|antiemetics|mesh-ancestor
65240792|NCT05704049|Autonomic Agents|autonomic agents|mesh-ancestor
65240793|NCT05704049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65240794|NCT05704049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240795|NCT05704049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65240796|NCT05704049|Glucocorticoids|glucocorticoids|mesh-ancestor
65240797|NCT05704049|Hormones|hormones|mesh-ancestor
65240798|NCT05704049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65240799|NCT05704049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65240800|NCT05704049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240801|NCT05704049|Protease Inhibitors|protease inhibitors|mesh-ancestor
65240804|NCT05673187|Adagrasib|adagrasib|mesh-list
65240806|NCT05672134|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
65240807|NCT05672134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65240808|NCT05672134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65240809|NCT05672134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240810|NCT05668091|Ritonavir|ritonavir|mesh-list
65240811|NCT05668091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65240812|NCT05668091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65240813|NCT05668091|Protease Inhibitors|protease inhibitors|mesh-ancestor
65240814|NCT05668091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240815|NCT05668091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240816|NCT05668091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65240817|NCT05668091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65240818|NCT05668091|Antiviral Agents|antiviral agents|mesh-ancestor
65240819|NCT05668091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65240820|NCT05668091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65240821|NCT05668091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65240834|NCT05647889|Lidocaine|lidocaine|mesh-list
65240835|NCT05647889|Anesthetics, Local|anesthetics, local|mesh-ancestor
65240836|NCT05647889|Anesthetics|anesthetics|mesh-ancestor
65240837|NCT05647889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65240838|NCT05647889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240842|NCT05647889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65240843|NCT05647889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65240844|NCT05647889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65240845|NCT05647889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240847|NCT05647057|Plasma Substitutes|plasma substitutes|mesh-ancestor
65240848|NCT05647057|Blood Substitutes|blood substitutes|mesh-ancestor
65240849|NCT05646303|Psilocybin|psilocybin|mesh-list
65240873|NCT05641363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65240874|NCT05641363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65240875|NCT05641363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240876|NCT05641363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240877|NCT05639322|Ketamine|ketamine|mesh-list
65240878|NCT05639322|Analgesics|analgesics|mesh-ancestor
65240879|NCT05639322|Sensory System Agents|sensory system agents|mesh-ancestor
65240880|NCT05639322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65240881|NCT05639322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240882|NCT05639322|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65240883|NCT05639322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65240884|NCT05639322|Anesthetics, General|anesthetics, general|mesh-ancestor
65240885|NCT05639322|Anesthetics|anesthetics|mesh-ancestor
65240886|NCT05639322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65240887|NCT05639322|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65240888|NCT05639322|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65240889|NCT05639322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65240890|NCT05639322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240891|NCT05629702|Temozolomide|temozolomide|mesh-list
65240892|NCT05629702|Nabiximols|nabiximols|mesh-list
65240893|NCT05629702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65240894|NCT05629702|Alkylating Agents|alkylating agents|mesh-ancestor
65240895|NCT05629702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240896|NCT05629702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240897|NCT05629702|Analgesics|analgesics|mesh-ancestor
65240898|NCT05629702|Sensory System Agents|sensory system agents|mesh-ancestor
65240899|NCT05629702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65240925|NCT05605964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65240926|NCT05605964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65240927|NCT05605964|Androgen Antagonists|androgen antagonists|mesh-ancestor
65240928|NCT05605964|Hormone Antagonists|hormone antagonists|mesh-ancestor
65240929|NCT05605964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65240936|NCT05594615|Midazolam|midazolam|mesh-list
65240937|NCT05594615|Caffeine|caffeine|mesh-list
65240938|NCT05594615|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65240939|NCT05594615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65240940|NCT05594615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65240941|NCT05594615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65240942|NCT05594615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240943|NCT05594615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65240944|NCT05594615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65240945|NCT05594615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65240946|NCT05594615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65240947|NCT05594615|Anesthetics, General|anesthetics, general|mesh-ancestor
65240948|NCT05594615|Anesthetics|anesthetics|mesh-ancestor
65240949|NCT05594615|GABA Modulators|gaba modulators|mesh-ancestor
65240950|NCT05594615|GABA Agents|gaba agents|mesh-ancestor
65240951|NCT05594615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65240952|NCT05594615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240953|NCT05594615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65240954|NCT05594615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65240955|NCT05594615|Antimetabolites|antimetabolites|mesh-ancestor
65240956|NCT05594615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65240957|NCT05594615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65240958|NCT05594615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240959|NCT05594615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65240960|NCT05594615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65240961|NCT05594615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65240962|NCT05594615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65240963|NCT05594615|Purinergic Agents|purinergic agents|mesh-ancestor
65240964|NCT05594602|Itraconazole|itraconazole|mesh-list
65240971|NCT05594602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65240972|NCT05594602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65240973|NCT05594602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65240974|NCT05594602|Hormone Antagonists|hormone antagonists|mesh-ancestor
65240975|NCT05594602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65240976|NCT05594602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65240977|NCT05594602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65240978|NCT05594602|Anticonvulsants|anticonvulsants|mesh-ancestor
65240979|NCT05594602|Antimanic Agents|antimanic agents|mesh-ancestor
65240980|NCT05594602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65240981|NCT05594602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65240982|NCT05594602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65240983|NCT05594602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65240984|NCT05594602|Analgesics|analgesics|mesh-ancestor
65240985|NCT05594602|Sensory System Agents|sensory system agents|mesh-ancestor
65240986|NCT05594602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65240987|NCT05594602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65240988|NCT05594602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65240989|NCT05594602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65240990|NCT05594602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65240991|NCT05594602|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65240992|NCT05594602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65240993|NCT05594602|Adrenergic Agents|adrenergic agents|mesh-ancestor
65240994|NCT05594602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65240995|NCT05594602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65240996|NCT05594602|Antimalarials|antimalarials|mesh-ancestor
65241004|NCT05590260|Iron|iron|mesh-list
65241048|NCT05503797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65241049|NCT05503797|Antiviral Agents|antiviral agents|mesh-ancestor
65241050|NCT05503797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65241051|NCT05503797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65241052|NCT05503797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65241053|NCT05503797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241054|NCT05503797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241055|NCT05502237|Paclitaxel|paclitaxel|mesh-list
65241056|NCT05502237|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65241057|NCT05502237|Carboplatin|carboplatin|mesh-list
65241058|NCT05502237|Pembrolizumab|pembrolizumab|mesh-list
65241059|NCT05502237|Pemetrexed|pemetrexed|mesh-list
65241060|NCT05502237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65241061|NCT05502237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241062|NCT05502237|Tubulin Modulators|tubulin modulators|mesh-ancestor
65241063|NCT05502237|Antimitotic Agents|antimitotic agents|mesh-ancestor
65241084|NCT05485519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241085|NCT05485519|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65241086|NCT05485519|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65241087|NCT05485519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65241088|NCT05485519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65241089|NCT05485519|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65241090|NCT05485519|Anesthetics, General|anesthetics, general|mesh-ancestor
65241092|NCT05485519|GABA Modulators|gaba modulators|mesh-ancestor
65241093|NCT05485519|GABA Agents|gaba agents|mesh-ancestor
65241117|NCT05467176|Relugolix|relugolix|mesh-list
65241118|NCT05467176|Androgen Antagonists|androgen antagonists|mesh-ancestor
65241122|NCT05439616|Cariprazine|cariprazine|mesh-list
65241181|NCT05400603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241217|NCT05378113|Ondansetron|ondansetron|mesh-list
65241218|NCT05378113|Anesthetics, Local|anesthetics, local|mesh-ancestor
65241219|NCT05378113|Anesthetics|anesthetics|mesh-ancestor
65241220|NCT05378113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65241221|NCT05378113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241222|NCT05378113|Sensory System Agents|sensory system agents|mesh-ancestor
65241223|NCT05378113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65241224|NCT05378113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65241225|NCT05378113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65241226|NCT05378113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65241227|NCT05378113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65241228|NCT05378113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241229|NCT05378113|Antiemetics|antiemetics|mesh-ancestor
65241230|NCT05378113|Autonomic Agents|autonomic agents|mesh-ancestor
65241231|NCT05378113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65241232|NCT05378113|Antipruritics|antipruritics|mesh-ancestor
65241233|NCT05378113|Dermatologic Agents|dermatologic agents|mesh-ancestor
65241234|NCT05378113|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65241235|NCT05378113|Serotonin Agents|serotonin agents|mesh-ancestor
65241236|NCT05378113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65241237|NCT05378113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65241238|NCT05378113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65241239|NCT05378113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65241240|NCT05378113|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65241241|NCT05374603|Durvalumab|durvalumab|mesh-list
65241242|NCT05374603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65241243|NCT05374603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241244|NCT05371093|Prednisone|prednisone|mesh-list
65241245|NCT05371093|Cyclophosphamide|cyclophosphamide|mesh-list
65241246|NCT05371093|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65241247|NCT05371093|Rituximab|rituximab|mesh-list
65241248|NCT05371093|Doxorubicin|doxorubicin|mesh-list
65241249|NCT05371093|Fludarabine|fludarabine|mesh-list
65241258|NCT05371093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241259|NCT05371093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241260|NCT05371093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65241261|NCT05371093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65241262|NCT05371093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65241263|NCT05371093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65241264|NCT05371093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65241265|NCT05371093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241266|NCT05371093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65241267|NCT05371093|Glucocorticoids|glucocorticoids|mesh-ancestor
65241268|NCT05371093|Hormones|hormones|mesh-ancestor
65241269|NCT05371093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65241270|NCT05371093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65241271|NCT05371093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65241272|NCT05371093|Tubulin Modulators|tubulin modulators|mesh-ancestor
65241273|NCT05371093|Antimitotic Agents|antimitotic agents|mesh-ancestor
65241274|NCT05371093|Mitosis Modulators|mitosis modulators|mesh-ancestor
65241275|NCT05371093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65241276|NCT05371093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65241279|NCT05371054|Prednisone|prednisone|mesh-list
65241326|NCT05318105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65241327|NCT05318105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241328|NCT05295784|Caffeine|caffeine|mesh-list
65241329|NCT05295784|Caffeine citrate|caffeine citrate|mesh-list
65241330|NCT05295784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241331|NCT05295784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65241333|NCT05295784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65241397|NCT05171647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241398|NCT05171647|Immunologic Factors|immunologic factors|mesh-ancestor
65241399|NCT05171647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241400|NCT05171647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65241401|NCT05171647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65241402|NCT05171647|Antimetabolites|antimetabolites|mesh-ancestor
65241403|NCT05171647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241404|NCT05171647|Antiviral Agents|antiviral agents|mesh-ancestor
65241405|NCT05171647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65241406|NCT05171647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241407|NCT05171647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65241408|NCT05160922|Crizotinib|crizotinib|mesh-list
65241409|NCT05160922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241410|NCT05160922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65241411|NCT05160922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241412|NCT05160922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241413|NCT05157672|Letrozole|letrozole|mesh-list
65241414|NCT05157672|Nicotine|nicotine|mesh-list
65241415|NCT05157672|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65241416|NCT05157672|Autonomic Agents|autonomic agents|mesh-ancestor
65241417|NCT05157672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65241418|NCT05157672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241419|NCT05157672|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65241420|NCT05157672|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65241421|NCT05157672|Cholinergic Agents|cholinergic agents|mesh-ancestor
65241422|NCT05157672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65241423|NCT05157672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241424|NCT05157672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241443|NCT05149378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241444|NCT05149378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241445|NCT05134857|Zonisamide|zonisamide|mesh-list
65241446|NCT05134857|Anticonvulsants|anticonvulsants|mesh-ancestor
65241447|NCT05134857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65241448|NCT05134857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65241449|NCT05134857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241450|NCT05134857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65241451|NCT05134857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241452|NCT05114590|Insulin Glargine|insulin glargine|mesh-list
65241453|NCT05114590|Lixisenatide|lixisenatide|mesh-list
65241454|NCT05114590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65241455|NCT05114590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241456|NCT05108935|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65241457|NCT05108935|Buprenorphine|buprenorphine|mesh-list
65241458|NCT05108935|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64884217|NCT01944033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65241459|NCT05108935|Naloxone|naloxone|mesh-list
65241460|NCT05108935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65241461|NCT05108935|Narcotics|narcotics|mesh-ancestor
65241462|NCT05108935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65241463|NCT05108935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241464|NCT05108935|Analgesics|analgesics|mesh-ancestor
65241465|NCT05108935|Sensory System Agents|sensory system agents|mesh-ancestor
65241466|NCT05108935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65241467|NCT05108935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65241490|NCT05067283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65241491|NCT05067283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65241492|NCT05067283|Immunologic Factors|immunologic factors|mesh-ancestor
65241493|NCT05067283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241494|NCT05067283|Antidotes|antidotes|mesh-ancestor
65241495|NCT05067283|Protective Agents|protective agents|mesh-ancestor
65241496|NCT05067283|Vitamin B Complex|vitamin b complex|mesh-ancestor
65241497|NCT05067283|Vitamins|vitamins|mesh-ancestor
65241498|NCT05067283|Micronutrients|micronutrients|mesh-ancestor
65241499|NCT05067283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241500|NCT05067283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65241501|NCT05067283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65241502|NCT05059522|Pemetrexed|pemetrexed|mesh-list
65241503|NCT05059522|Avelumab|avelumab|mesh-list
65241504|NCT05059522|Axitinib|axitinib|mesh-list
65241505|NCT05059522|Talazoparib|talazoparib|mesh-list
65241506|NCT05059522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241507|NCT05059522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241508|NCT05059522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241509|NCT05059522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65241510|NCT05059522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65241511|NCT05059522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65241512|NCT05059522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65241513|NCT05059522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65241514|NCT05051527|Silymarin|silymarin|mesh-list
65241515|NCT05051527|Antioxidants|antioxidants|mesh-ancestor
65241530|NCT05013229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241531|NCT04980222|Prednisone|prednisone|mesh-list
65241532|NCT04980222|Cyclophosphamide|cyclophosphamide|mesh-list
65241533|NCT04980222|Rituximab|rituximab|mesh-list
65241550|NCT04980222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65241552|NCT04980222|Hormones|hormones|mesh-ancestor
65241553|NCT04980222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65241554|NCT04980222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65241555|NCT04980222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65241556|NCT04980222|Tubulin Modulators|tubulin modulators|mesh-ancestor
65241557|NCT04980222|Antimitotic Agents|antimitotic agents|mesh-ancestor
65241558|NCT04980222|Mitosis Modulators|mitosis modulators|mesh-ancestor
65241559|NCT04939753|Sevoflurane|sevoflurane|mesh-list
65241560|NCT04939753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65241561|NCT04939753|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65241562|NCT04939753|Anesthetics, General|anesthetics, general|mesh-ancestor
65241563|NCT04939753|Anesthetics|anesthetics|mesh-ancestor
65241564|NCT04939753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65241565|NCT04939753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241572|NCT04924036|Glycopyrrolate|glycopyrrolate|mesh-list
65241573|NCT04924036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65241574|NCT04924036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65241575|NCT04924036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65241576|NCT04924036|Cholinergic Agents|cholinergic agents|mesh-ancestor
65241577|NCT04924036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65241578|NCT04924036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241626|NCT04900220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65241627|NCT04900220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65241628|NCT04900220|Protective Agents|protective agents|mesh-ancestor
65241629|NCT04900220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65241630|NCT04900220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241631|NCT04900220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65241632|NCT04900220|Respiratory System Agents|respiratory system agents|mesh-ancestor
65241633|NCT04895709|Docetaxel|docetaxel|mesh-list
65241634|NCT04895709|Nivolumab|nivolumab|mesh-list
65241635|NCT04895709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241636|NCT04895709|Tubulin Modulators|tubulin modulators|mesh-ancestor
65241637|NCT04895709|Antimitotic Agents|antimitotic agents|mesh-ancestor
65241638|NCT04895709|Mitosis Modulators|mitosis modulators|mesh-ancestor
65241639|NCT04895709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241640|NCT04895709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65241641|NCT04895709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65241652|NCT04868058|Ropivacaine|ropivacaine|mesh-list
65241653|NCT04868058|Anesthetics, Local|anesthetics, local|mesh-ancestor
65241654|NCT04868058|Anesthetics|anesthetics|mesh-ancestor
65241692|NCT04837196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65241693|NCT04837196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241694|NCT04802759|Trastuzumab|trastuzumab|mesh-list
65241695|NCT04802759|Pertuzumab|pertuzumab|mesh-list
65241696|NCT04802759|Everolimus|everolimus|mesh-list
65241697|NCT04802759|Atezolizumab|atezolizumab|mesh-list
65241698|NCT04802759|Palbociclib|palbociclib|mesh-list
65241699|NCT04802759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65241700|NCT04802759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241701|NCT04802759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65241702|NCT04802759|Immunologic Factors|immunologic factors|mesh-ancestor
65241703|NCT04802759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241704|NCT04802759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65241705|NCT04802759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241706|NCT04802759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241707|NCT04799275|Prednisone|prednisone|mesh-list
65241708|NCT04799275|Cortisone|cortisone|mesh-list
65241709|NCT04799275|Cyclophosphamide|cyclophosphamide|mesh-list
65241710|NCT04799275|Rituximab|rituximab|mesh-list
65241711|NCT04799275|Doxorubicin|doxorubicin|mesh-list
65241712|NCT04799275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65241713|NCT04799275|Vincristine|vincristine|mesh-list
65241714|NCT04799275|Azacitidine|azacitidine|mesh-list
65241715|NCT04799275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65241716|NCT04799275|Antibodies|antibodies|mesh-list
65241717|NCT04799275|Immunoglobulins|immunoglobulins|mesh-list
65241718|NCT04799275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65241719|NCT04799275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65241720|NCT04799275|Immunologic Factors|immunologic factors|mesh-ancestor
65241721|NCT04799275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241740|NCT04799275|Mitosis Modulators|mitosis modulators|mesh-ancestor
65241741|NCT04799275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65241742|NCT04799275|Antimetabolites|antimetabolites|mesh-ancestor
65241743|NCT04796194|Pembrolizumab|pembrolizumab|mesh-list
65241751|NCT04777357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65241753|NCT04763759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65241754|NCT04763759|Immunologic Factors|immunologic factors|mesh-ancestor
65241755|NCT04763759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241756|NCT04708418|Pembrolizumab|pembrolizumab|mesh-list
65241757|NCT04708418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64884519|NCT05165082|Timolol|timolol|mesh-list
65241758|NCT04708418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241759|NCT04628988|Prednisone|prednisone|mesh-list
65241760|NCT04628988|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
65241761|NCT04628988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65241762|NCT04628988|Glucocorticoids|glucocorticoids|mesh-ancestor
65241763|NCT04628988|Hormones|hormones|mesh-ancestor
65241764|NCT04628988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65241765|NCT04628988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241766|NCT04628988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65241767|NCT04628988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241809|NCT04530565|Methotrexate|methotrexate|mesh-list
65241810|NCT04530565|Vincristine|vincristine|mesh-list
65241811|NCT04530565|Dasatinib|dasatinib|mesh-list
65241812|NCT04530565|Blinatumomab|blinatumomab|mesh-list
65241813|NCT04530565|Ponatinib|ponatinib|mesh-list
65241814|NCT04530565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65241815|NCT04530565|Muromonab-CD3|muromonab-cd3|mesh-list
65241816|NCT04530565|Antibodies|antibodies|mesh-list
65241817|NCT04530565|Immunoglobulins|immunoglobulins|mesh-list
65241818|NCT04530565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65241819|NCT04530565|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65241820|NCT04530565|BB 1101|bb 1101|mesh-list
65241822|NCT04530565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65241823|NCT04530565|Immunologic Factors|immunologic factors|mesh-ancestor
65241824|NCT04530565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241825|NCT04530565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65241826|NCT04530565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65241827|NCT04530565|Alkylating Agents|alkylating agents|mesh-ancestor
65241828|NCT04530565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241829|NCT04530565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241830|NCT04530565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65241831|NCT04530565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65241832|NCT04530565|Antiemetics|antiemetics|mesh-ancestor
65241833|NCT04530565|Autonomic Agents|autonomic agents|mesh-ancestor
65241834|NCT04530565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65241836|NCT04530565|Glucocorticoids|glucocorticoids|mesh-ancestor
65241861|NCT04526899|Cemiplimab|cemiplimab|mesh-list
65241862|NCT04526899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65241863|NCT04526899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241864|NCT04525274|Dexmedetomidine|dexmedetomidine|mesh-list
65241865|NCT04525274|Ketamine|ketamine|mesh-list
65241866|NCT04525274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65241867|NCT04525274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65241868|NCT04525274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65241869|NCT04525274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65241870|NCT04525274|Analgesics|analgesics|mesh-ancestor
65241871|NCT04525274|Sensory System Agents|sensory system agents|mesh-ancestor
65241872|NCT04525274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65241873|NCT04525274|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65241874|NCT04525274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65241875|NCT04525274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65241876|NCT04525274|Adrenergic Agents|adrenergic agents|mesh-ancestor
65241877|NCT04525274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65241878|NCT04525274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241879|NCT04525274|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65241880|NCT04525274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65241881|NCT04525274|Anesthetics, General|anesthetics, general|mesh-ancestor
65241882|NCT04525274|Anesthetics|anesthetics|mesh-ancestor
65241883|NCT04525274|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65241884|NCT04525274|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65241885|NCT04507503|Futibatinib|futibatinib|mesh-list
65241886|NCT04507503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241887|NCT04503668|Dexamethasone|dexamethasone|mesh-list
65241888|NCT04503668|Ondansetron|ondansetron|mesh-list
65241889|NCT04503668|Olanzapine|olanzapine|mesh-list
65241890|NCT04503668|Fosaprepitant|fosaprepitant|mesh-list
65241891|NCT04503668|Prochlorperazine|prochlorperazine|mesh-list
65241892|NCT04503668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-list
65241893|NCT04503668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65241900|NCT04503668|Hormones|hormones|mesh-ancestor
65241903|NCT04503668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65241904|NCT04503668|Antipruritics|antipruritics|mesh-ancestor
65241905|NCT04503668|Dermatologic Agents|dermatologic agents|mesh-ancestor
65241906|NCT04503668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65241907|NCT04503668|Serotonin Agents|serotonin agents|mesh-ancestor
65241908|NCT04503668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65241909|NCT04503668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241910|NCT04503668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65241911|NCT04503668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65241912|NCT04503668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65241913|NCT04503668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65241914|NCT04503668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65241915|NCT04503668|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65241916|NCT04503668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65241917|NCT04503668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65241918|NCT04503668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65241961|NCT04444921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241962|NCT04444921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65241963|NCT04444921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65241964|NCT04423718|Aflibercept|aflibercept|mesh-list
64973592|NCT00237523|Iodine|iodine|mesh-list
65241993|NCT04368559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65241994|NCT04368559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65241995|NCT04368559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65241996|NCT04368559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65241997|NCT04368559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65241998|NCT04368559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65241999|NCT04368559|Hormone Antagonists|hormone antagonists|mesh-ancestor
65242000|NCT04368559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65242001|NCT04368559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242002|NCT04368559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65242003|NCT04368559|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65242004|NCT04368559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65242005|NCT04368559|Renal Agents|renal agents|mesh-ancestor
65242006|NCT04368559|Antimalarials|antimalarials|mesh-ancestor
65242007|NCT04368559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65242008|NCT04368559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65242009|NCT04368559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65242010|NCT04368559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65242011|NCT04368559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65242065|NCT04270409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65242066|NCT04270409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242067|NCT04270409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65242068|NCT04270409|Glucocorticoids|glucocorticoids|mesh-ancestor
65242069|NCT04270409|Hormones|hormones|mesh-ancestor
65242070|NCT04270409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65242071|NCT04270409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65242072|NCT04270409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242073|NCT04270409|Immunologic Factors|immunologic factors|mesh-ancestor
65242074|NCT04270409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65242075|NCT04270409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65242076|NCT04270409|Growth Substances|growth substances|mesh-ancestor
65242077|NCT04270409|Growth Inhibitors|growth inhibitors|mesh-ancestor
65242102|NCT04233164|Methylprednisolone|methylprednisolone|mesh-list
65242103|NCT04233164|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65242104|NCT04233164|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65242105|NCT04233164|Prednisolone|prednisolone|mesh-list
65242106|NCT04233164|Prednisolone acetate|prednisolone acetate|mesh-list
65242107|NCT04233164|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65242108|NCT04233164|Prednisolone phosphate|prednisolone phosphate|mesh-list
65242109|NCT04233164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65242110|NCT04233164|Antiemetics|antiemetics|mesh-ancestor
65242111|NCT04233164|Autonomic Agents|autonomic agents|mesh-ancestor
65242112|NCT04233164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65242113|NCT04233164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242114|NCT04233164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65242115|NCT04233164|Glucocorticoids|glucocorticoids|mesh-ancestor
65242116|NCT04233164|Hormones|hormones|mesh-ancestor
65242122|NCT04210115|Calcium, Dietary|calcium, dietary|mesh-list
65242142|NCT04182204|Rituximab|rituximab|mesh-list
65242143|NCT04182204|Oxaliplatin|oxaliplatin|mesh-list
65242144|NCT04182204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65242145|NCT04182204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242146|NCT04182204|Immunologic Factors|immunologic factors|mesh-ancestor
65242147|NCT04182204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242148|NCT04182204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65242149|NCT04182204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65242150|NCT04182204|Antimetabolites|antimetabolites|mesh-ancestor
65242151|NCT04182204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242152|NCT04182204|Antiviral Agents|antiviral agents|mesh-ancestor
65242153|NCT04182204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65242154|NCT04182204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65242155|NCT04182204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65242174|NCT04145115|Nivolumab|nivolumab|mesh-list
65242175|NCT04145115|Ipilimumab|ipilimumab|mesh-list
65242176|NCT04145115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65242177|NCT04145115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242178|NCT04145115|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65242179|NCT04145115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242180|NCT04125563|Capsaicin|capsaicin|mesh-list
65242181|NCT04125563|Antipruritics|antipruritics|mesh-ancestor
65242182|NCT04125563|Dermatologic Agents|dermatologic agents|mesh-ancestor
65242183|NCT04125563|Sensory System Agents|sensory system agents|mesh-ancestor
65242184|NCT04125563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65242185|NCT04125563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973793|NCT00238537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65242211|NCT04078295|Nivolumab|nivolumab|mesh-list
64884967|NCT05413096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65242212|NCT04078295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65242228|NCT04068597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65242229|NCT04068597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65242230|NCT04068597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242231|NCT04068597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65242232|NCT04068597|Antimetabolites|antimetabolites|mesh-ancestor
65242233|NCT04068597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242234|NCT04068597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65242235|NCT04068597|Immunologic Factors|immunologic factors|mesh-ancestor
65242236|NCT04068597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65242237|NCT04068597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65242238|NCT04068597|Growth Substances|growth substances|mesh-ancestor
65242239|NCT04068597|Growth Inhibitors|growth inhibitors|mesh-ancestor
65242243|NCT04004611|Mirikizumab|mirikizumab|mesh-list
65242244|NCT04004611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65242245|NCT04004611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65242246|NCT04004611|Analgesics|analgesics|mesh-ancestor
65242247|NCT04004611|Sensory System Agents|sensory system agents|mesh-ancestor
65242248|NCT04004611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65242249|NCT04004611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242250|NCT04004611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65242251|NCT04004611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65242252|NCT04004611|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65242280|NCT03953677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65242281|NCT03953677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65242282|NCT03953677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65242283|NCT03953677|Adrenergic Agents|adrenergic agents|mesh-ancestor
65242284|NCT03953677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65242285|NCT03953677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242286|NCT03948035|Dexamethasone|dexamethasone|mesh-list
65242287|NCT03948035|Dexamethasone acetate|dexamethasone acetate|mesh-list
65242288|NCT03948035|Lenalidomide|lenalidomide|mesh-list
65242289|NCT03948035|Elotuzumab|elotuzumab|mesh-list
65242290|NCT03948035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65242291|NCT03948035|Antiemetics|antiemetics|mesh-ancestor
65242292|NCT03948035|Autonomic Agents|autonomic agents|mesh-ancestor
65242293|NCT03948035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65242294|NCT03948035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242295|NCT03948035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65242296|NCT03948035|Glucocorticoids|glucocorticoids|mesh-ancestor
65242298|NCT03948035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65242299|NCT03948035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65242300|NCT03948035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242301|NCT03948035|Immunologic Factors|immunologic factors|mesh-ancestor
65242306|NCT03937713|Eszopiclone|eszopiclone|mesh-list
65242332|NCT03876873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65242333|NCT03876873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242334|NCT03860844|Cytarabine|cytarabine|mesh-list
65242335|NCT03860844|Dexamethasone|dexamethasone|mesh-list
65242336|NCT03860844|Cyclophosphamide|cyclophosphamide|mesh-list
65242337|NCT03860844|Doxorubicin|doxorubicin|mesh-list
65242338|NCT03860844|Methotrexate|methotrexate|mesh-list
65242339|NCT03860844|Fludarabine|fludarabine|mesh-list
65242340|NCT03860844|Etoposide|etoposide|mesh-list
65242341|NCT03860844|Vincristine|vincristine|mesh-list
65242342|NCT03860844|Daunorubicin|daunorubicin|mesh-list
65242343|NCT03860844|Asparaginase|asparaginase|mesh-list
65242344|NCT03860844|Mitoxantrone|mitoxantrone|mesh-list
65242345|NCT03860844|Idarubicin|idarubicin|mesh-list
65242346|NCT03860844|Hydroxyurea|hydroxyurea|mesh-list
65242347|NCT03860844|Pegaspargase|pegaspargase|mesh-list
65242348|NCT03860844|Montelukast|montelukast|mesh-list
65242349|NCT03860844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65242350|NCT03860844|Immunologic Factors|immunologic factors|mesh-ancestor
65242351|NCT03860844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242352|NCT03860844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65242353|NCT03860844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65242354|NCT03860844|Alkylating Agents|alkylating agents|mesh-ancestor
65242355|NCT03860844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242356|NCT03860844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242357|NCT03860844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65242358|NCT03860844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65242359|NCT03860844|Antiemetics|antiemetics|mesh-ancestor
65242364|NCT03860844|Hormones|hormones|mesh-ancestor
65242382|NCT03860844|Tubulin Modulators|tubulin modulators|mesh-ancestor
65242383|NCT03860844|Antimitotic Agents|antimitotic agents|mesh-ancestor
65242384|NCT03860844|Mitosis Modulators|mitosis modulators|mesh-ancestor
65242385|NCT03860844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65242386|NCT03860844|Respiratory System Agents|respiratory system agents|mesh-ancestor
65242387|NCT03860844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65242388|NCT03860844|Hormone Antagonists|hormone antagonists|mesh-ancestor
65242389|NCT03860844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65242390|NCT03860844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65242391|NCT03860844|Analgesics|analgesics|mesh-ancestor
65242392|NCT03860844|Sensory System Agents|sensory system agents|mesh-ancestor
65242393|NCT03860844|Antisickling Agents|antisickling agents|mesh-ancestor
65242394|NCT03845517|PF-06700841|pf-06700841|mesh-list
65242395|NCT03845517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65242396|NCT03845517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65242397|NCT03845517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242398|NCT03842696|Cyclosporine|cyclosporine|mesh-list
65242399|NCT03842696|Mycophenolic Acid|mycophenolic acid|mesh-list
65242400|NCT03842696|Cyclophosphamide|cyclophosphamide|mesh-list
65242401|NCT03842696|Methotrexate|methotrexate|mesh-list
65242402|NCT03842696|Vorinostat|vorinostat|mesh-list
65242403|NCT03842696|Tacrolimus|tacrolimus|mesh-list
65242404|NCT03842696|Cyclosporins|cyclosporins|mesh-list
65242405|NCT03842696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65242406|NCT03842696|Immunologic Factors|immunologic factors|mesh-ancestor
65242407|NCT03842696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242408|NCT03842696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65242432|NCT03834493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65242433|NCT03834493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242434|NCT03833167|Pembrolizumab|pembrolizumab|mesh-list
65242435|NCT03833167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65242436|NCT03833167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242437|NCT03832361|Maytansine|maytansine|mesh-list
65242438|NCT03832361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65242439|NCT03832361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242440|NCT03832361|Tubulin Modulators|tubulin modulators|mesh-ancestor
65242441|NCT03832361|Antimitotic Agents|antimitotic agents|mesh-ancestor
65242442|NCT03832361|Mitosis Modulators|mitosis modulators|mesh-ancestor
65242443|NCT03832361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242445|NCT03816163|Paclitaxel|paclitaxel|mesh-list
65242446|NCT03816163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65242447|NCT03816163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242448|NCT03816163|Tubulin Modulators|tubulin modulators|mesh-ancestor
65242449|NCT03816163|Antimitotic Agents|antimitotic agents|mesh-ancestor
65242450|NCT03816163|Mitosis Modulators|mitosis modulators|mesh-ancestor
65242451|NCT03816163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242452|NCT03816163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65242453|NCT03816163|Antimetabolites|antimetabolites|mesh-ancestor
65242454|NCT03816163|Antiviral Agents|antiviral agents|mesh-ancestor
65242455|NCT03816163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65242456|NCT03816163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65242457|NCT03816163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65242458|NCT03816163|Immunologic Factors|immunologic factors|mesh-ancestor
65242459|NCT03816163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242460|NCT03811002|Cisplatin|cisplatin|mesh-list
65242461|NCT03811002|Carboplatin|carboplatin|mesh-list
65242479|NCT03811002|Mitosis Modulators|mitosis modulators|mesh-ancestor
65242480|NCT03793179|Carboplatin|carboplatin|mesh-list
65242481|NCT03793179|Pembrolizumab|pembrolizumab|mesh-list
65242482|NCT03793179|Pemetrexed|pemetrexed|mesh-list
65242483|NCT03793179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242484|NCT03793179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65242485|NCT03793179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65242486|NCT03793179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242487|NCT03793179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65242488|NCT03793179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65242489|NCT03793166|Nivolumab|nivolumab|mesh-list
65242490|NCT03793166|Ipilimumab|ipilimumab|mesh-list
65242491|NCT03793166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65242492|NCT03793166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242493|NCT03793166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65242494|NCT03793166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242495|NCT03789240|Rituximab|rituximab|mesh-list
65242496|NCT03789240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65242505|NCT03779191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65242506|NCT03779191|Growth Substances|growth substances|mesh-ancestor
65242507|NCT03779191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242508|NCT03779191|Growth Inhibitors|growth inhibitors|mesh-ancestor
65242509|NCT03765918|Cisplatin|cisplatin|mesh-list
65242510|NCT03765918|Pembrolizumab|pembrolizumab|mesh-list
65242511|NCT03765918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242512|NCT03765918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65242543|NCT03601078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242544|NCT03591510|Cytarabine|cytarabine|mesh-list
65242545|NCT03591510|Fludarabine|fludarabine|mesh-list
65242546|NCT03591510|Etoposide|etoposide|mesh-list
65242547|NCT03591510|Daunorubicin|daunorubicin|mesh-list
65242548|NCT03591510|Mitoxantrone|mitoxantrone|mesh-list
65242549|NCT03591510|Idarubicin|idarubicin|mesh-list
65242550|NCT03591510|Midostaurin|midostaurin|mesh-list
65242551|NCT03591510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242552|NCT03591510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65242553|NCT03591510|Antimetabolites|antimetabolites|mesh-ancestor
65242554|NCT03591510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242555|NCT03591510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65242556|NCT03591510|Immunologic Factors|immunologic factors|mesh-ancestor
65242557|NCT03591510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242558|NCT03591510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65242559|NCT03591510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65242560|NCT03591510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65242561|NCT03591510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65242562|NCT03591510|Antiviral Agents|antiviral agents|mesh-ancestor
65242563|NCT03591510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65242564|NCT03591510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65242565|NCT03591510|Analgesics|analgesics|mesh-ancestor
65242566|NCT03591510|Sensory System Agents|sensory system agents|mesh-ancestor
65242567|NCT03591510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65242568|NCT03591510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65242569|NCT03520660|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
65242570|NCT03520660|Antiviral Agents|antiviral agents|mesh-ancestor
65242571|NCT03520660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65242572|NCT03486873|Pembrolizumab|pembrolizumab|mesh-list
65242573|NCT03486873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65242574|NCT03486873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242575|NCT03479502|Doxycycline|doxycycline|mesh-list
65242576|NCT03479502|Prednisone|prednisone|mesh-list
65242587|NCT03479502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65242588|NCT03479502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242589|NCT03479502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65242590|NCT03479502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242591|NCT03479502|Antiemetics|antiemetics|mesh-ancestor
65242592|NCT03479502|Autonomic Agents|autonomic agents|mesh-ancestor
65242593|NCT03479502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64885341|NCT03993327|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65242594|NCT03479502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65242595|NCT03479502|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65242596|NCT03479502|Protective Agents|protective agents|mesh-ancestor
65242597|NCT03479502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65242598|NCT03479502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65242599|NCT03479502|Antimalarials|antimalarials|mesh-ancestor
65242600|NCT03479502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65242601|NCT03479502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65242602|NCT03478865|Vitamin A|vitamin a|mesh-list
65242603|NCT03478865|Retinol palmitate|retinol palmitate|mesh-list
65242604|NCT03478865|Vitamins|vitamins|mesh-ancestor
65242605|NCT03478865|Micronutrients|micronutrients|mesh-ancestor
65242606|NCT03478865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242607|NCT03478865|Antioxidants|antioxidants|mesh-ancestor
65242640|NCT03407144|Vincristine|vincristine|mesh-list
65242641|NCT03407144|Bleomycin|bleomycin|mesh-list
65242642|NCT03407144|Vinblastine|vinblastine|mesh-list
65242643|NCT03407144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65242644|NCT03407144|Immunologic Factors|immunologic factors|mesh-ancestor
65242645|NCT03407144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242646|NCT03407144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65242647|NCT03407144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65242648|NCT03407144|Alkylating Agents|alkylating agents|mesh-ancestor
65242649|NCT03407144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242650|NCT03407144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242651|NCT03407144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65242652|NCT03407144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65242653|NCT03407144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65242654|NCT03407144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65242655|NCT03407144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65242656|NCT03407144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65242657|NCT03407144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65242658|NCT03407144|Glucocorticoids|glucocorticoids|mesh-ancestor
65242659|NCT03407144|Hormones|hormones|mesh-ancestor
65242660|NCT03407144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65242661|NCT03407144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65242692|NCT03181867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65242693|NCT03181867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65242694|NCT03181867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242695|NCT03126916|Vitamin A|vitamin a|mesh-list
65242696|NCT03126916|Cyclophosphamide|cyclophosphamide|mesh-list
65242697|NCT03126916|Melphalan|melphalan|mesh-list
65242698|NCT03126916|Busulfan|busulfan|mesh-list
65242699|NCT03126916|Thiotepa|thiotepa|mesh-list
65242700|NCT03126916|Cisplatin|cisplatin|mesh-list
65242701|NCT03126916|Carboplatin|carboplatin|mesh-list
65242702|NCT03126916|Doxorubicin|doxorubicin|mesh-list
65242703|NCT03126916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65242704|NCT03126916|Etoposide|etoposide|mesh-list
65242705|NCT03126916|Vincristine|vincristine|mesh-list
65242706|NCT03126916|Topotecan|topotecan|mesh-list
65242707|NCT03126916|Tretinoin|tretinoin|mesh-list
65242708|NCT03126916|Etoposide phosphate|etoposide phosphate|mesh-list
65242709|NCT03126916|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65242710|NCT03126916|Dinutuximab|dinutuximab|mesh-list
65242711|NCT03126916|Dexrazoxane|dexrazoxane|mesh-list
65242712|NCT03126916|Razoxane|razoxane|mesh-list
65242713|NCT03126916|Isotretinoin|isotretinoin|mesh-list
65242714|NCT03126916|Sargramostim|sargramostim|mesh-list
65242715|NCT03126916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65242716|NCT03126916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65242717|NCT03126916|Immunologic Factors|immunologic factors|mesh-ancestor
65242718|NCT03126916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242719|NCT03126916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65242720|NCT03126916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65242721|NCT03126916|Alkylating Agents|alkylating agents|mesh-ancestor
65242722|NCT03126916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242723|NCT03126916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242724|NCT03126916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65242725|NCT03126916|Vitamins|vitamins|mesh-ancestor
65242742|NCT03110107|Ipilimumab|ipilimumab|mesh-list
65242743|NCT03110107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65242744|NCT03110107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242745|NCT03110107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65242746|NCT03110107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242747|NCT03097796|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
65242748|NCT03097796|Respiratory System Agents|respiratory system agents|mesh-ancestor
65242749|NCT03092518|Sodium thiosulfate|sodium thiosulfate|mesh-list
65242750|NCT03092518|Mitomycins|mitomycins|mesh-list
65242751|NCT03092518|Mitomycin|mitomycin|mesh-list
65242752|NCT03092518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242753|NCT03092518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65242754|NCT03092518|Alkylating Agents|alkylating agents|mesh-ancestor
65242755|NCT03092518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242756|NCT03092518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65242757|NCT03092518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65242758|NCT03092518|Antidotes|antidotes|mesh-ancestor
65242759|NCT03092518|Protective Agents|protective agents|mesh-ancestor
65242760|NCT03092518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242761|NCT03092518|Antioxidants|antioxidants|mesh-ancestor
65242762|NCT03092518|Antitubercular Agents|antitubercular agents|mesh-ancestor
65242763|NCT03092518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65242764|NCT03092518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65242765|NCT03092518|Chelating Agents|chelating agents|mesh-ancestor
65242794|NCT03006068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242795|NCT03006068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65242823|NCT02996487|Vancomycin|vancomycin|mesh-list
65242824|NCT02996487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65242825|NCT02996487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65242826|NCT02911142|Prednisone|prednisone|mesh-list
65242827|NCT02911142|Cyclophosphamide|cyclophosphamide|mesh-list
65242828|NCT02911142|Rituximab|rituximab|mesh-list
65242829|NCT02911142|Doxorubicin|doxorubicin|mesh-list
65242830|NCT02911142|Vincristine|vincristine|mesh-list
65242831|NCT02911142|Lenalidomide|lenalidomide|mesh-list
65242832|NCT02911142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65242833|NCT02911142|Immunologic Factors|immunologic factors|mesh-ancestor
65242834|NCT02911142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242835|NCT02911142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65242836|NCT02911142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65242837|NCT02911142|Alkylating Agents|alkylating agents|mesh-ancestor
65242838|NCT02911142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242839|NCT02911142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242840|NCT02911142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65242841|NCT02911142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65242842|NCT02911142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65242843|NCT02911142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65242844|NCT02911142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65242845|NCT02911142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65242846|NCT02911142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65242847|NCT02911142|Glucocorticoids|glucocorticoids|mesh-ancestor
65242848|NCT02911142|Hormones|hormones|mesh-ancestor
65242868|NCT02901067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65242869|NCT02901067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65242870|NCT02901067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65242871|NCT02901067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242872|NCT02901067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65242873|NCT02901067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65242874|NCT02901067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65242875|NCT02901067|Antipyretics|antipyretics|mesh-ancestor
65242876|NCT02901067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65242877|NCT02901067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65242878|NCT02901067|Antimetabolites|antimetabolites|mesh-ancestor
65242879|NCT02901067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65242880|NCT02901067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65242881|NCT02859896|Calcitriol|calcitriol|mesh-list
65242882|NCT02859896|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
65242883|NCT02859896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65242884|NCT02859896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242885|NCT02859896|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65242886|NCT02859896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65242887|NCT02859896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242888|NCT02859896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65242889|NCT02859896|Vitamins|vitamins|mesh-ancestor
65242890|NCT02859896|Micronutrients|micronutrients|mesh-ancestor
65242891|NCT02859896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65242908|NCT02784210|Prednisone|prednisone|mesh-list
65242917|NCT02784210|Glucocorticoids|glucocorticoids|mesh-ancestor
65242918|NCT02784210|Hormones|hormones|mesh-ancestor
65242919|NCT02784210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65242920|NCT02784210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242921|NCT02784210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65242922|NCT02784210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242923|NCT02784210|Antiemetics|antiemetics|mesh-ancestor
65242924|NCT02784210|Autonomic Agents|autonomic agents|mesh-ancestor
65242925|NCT02784210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65242926|NCT02784210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65242927|NCT02784210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65242928|NCT02784210|Protective Agents|protective agents|mesh-ancestor
65242929|NCT02769962|Olaparib|olaparib|mesh-list
65242930|NCT02769962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65242931|NCT02769962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65242932|NCT02769962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242933|NCT02769962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242934|NCT02711670|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65242935|NCT02711670|Chlorthalidone|chlorthalidone|mesh-list
65242936|NCT02711670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65242937|NCT02711670|Diuretics|diuretics|mesh-ancestor
65242938|NCT02711670|Natriuretic Agents|natriuretic agents|mesh-ancestor
65242939|NCT02711670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65242940|NCT02711670|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65242941|NCT02711670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65242942|NCT02711670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242943|NCT02658097|Pembrolizumab|pembrolizumab|mesh-list
65242944|NCT02658097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65242945|NCT02658097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242946|NCT02616640|Dexamethasone|dexamethasone|mesh-list
65242947|NCT02616640|Durvalumab|durvalumab|mesh-list
65242948|NCT02616640|Pomalidomide|pomalidomide|mesh-list
65242949|NCT02616640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65242950|NCT02616640|Antiemetics|antiemetics|mesh-ancestor
65242957|NCT02616640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65242958|NCT02616640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65242959|NCT02616640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65242960|NCT02616640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65242961|NCT02616640|Immunologic Factors|immunologic factors|mesh-ancestor
65242962|NCT02616640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65242963|NCT02616640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65242964|NCT02616640|Growth Substances|growth substances|mesh-ancestor
65242965|NCT02616640|Growth Inhibitors|growth inhibitors|mesh-ancestor
65242966|NCT02581527|Rifampin|rifampin|mesh-list
65242967|NCT02581527|Isoniazid|isoniazid|mesh-list
65242968|NCT02581527|Pyrazinamide|pyrazinamide|mesh-list
65242969|NCT02581527|Ethambutol|ethambutol|mesh-list
65242970|NCT02581527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65242971|NCT02581527|Antitubercular Agents|antitubercular agents|mesh-ancestor
65242972|NCT02581527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65242973|NCT02581527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65242974|NCT02581527|Leprostatic Agents|leprostatic agents|mesh-ancestor
65242975|NCT02581527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65242976|NCT02581527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65242977|NCT02581527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65242978|NCT02581527|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65242979|NCT02581527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65243007|NCT02496663|Immunologic Factors|immunologic factors|mesh-ancestor
65243008|NCT02496663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243009|NCT02473497|Crizotinib|crizotinib|mesh-list
65243010|NCT02473497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243011|NCT02473497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65243012|NCT02473497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243013|NCT02473497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243014|NCT02466074|Acetazolamide|acetazolamide|mesh-list
65243015|NCT02466074|Anticonvulsants|anticonvulsants|mesh-ancestor
65243016|NCT02466074|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65243017|NCT02466074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243018|NCT02466074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243019|NCT02466074|Diuretics|diuretics|mesh-ancestor
65243020|NCT02466074|Natriuretic Agents|natriuretic agents|mesh-ancestor
65243021|NCT02466074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243022|NCT02393794|Nivolumab|nivolumab|mesh-list
65243023|NCT02393794|Romidepsin|romidepsin|mesh-list
65243024|NCT02393794|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65243118|NCT01971489|Antimetabolites|antimetabolites|mesh-ancestor
65243119|NCT01971489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243120|NCT01971489|Antiviral Agents|antiviral agents|mesh-ancestor
65243121|NCT01971489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65243122|NCT01971489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243123|NCT01971489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65243124|NCT01971489|Immunologic Factors|immunologic factors|mesh-ancestor
65243125|NCT01971489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243126|NCT01942135|Fulvestrant|fulvestrant|mesh-list
65243127|NCT01942135|Palbociclib|palbociclib|mesh-list
65243128|NCT01942135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65243129|NCT01942135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243130|NCT01942135|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65243131|NCT01942135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65243132|NCT01942135|Hormone Antagonists|hormone antagonists|mesh-ancestor
65243133|NCT01942135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65243134|NCT01942135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243135|NCT01942135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65243136|NCT01942135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243137|NCT01942135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243138|NCT01838174|Methylprednisolone|methylprednisolone|mesh-list
65243139|NCT01838174|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65243140|NCT01838174|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65243141|NCT01838174|Prednisolone|prednisolone|mesh-list
65243142|NCT01838174|Prednisolone acetate|prednisolone acetate|mesh-list
65243143|NCT01838174|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65243144|NCT01838174|Prednisolone phosphate|prednisolone phosphate|mesh-list
65243145|NCT01838174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65243146|NCT01838174|Antiemetics|antiemetics|mesh-ancestor
65243147|NCT01838174|Autonomic Agents|autonomic agents|mesh-ancestor
65243148|NCT01838174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65243160|NCT01743131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243161|NCT01743131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243162|NCT01743131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65243163|NCT01743131|Immunologic Factors|immunologic factors|mesh-ancestor
65243164|NCT01743131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243165|NCT01743131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65243166|NCT01685814|Lenalidomide|lenalidomide|mesh-list
65243167|NCT01685814|Bortezomib|bortezomib|mesh-list
65243168|NCT01685814|Immunologic Factors|immunologic factors|mesh-ancestor
65243169|NCT01685814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243170|NCT01685814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65243171|NCT01685814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65243172|NCT01685814|Growth Substances|growth substances|mesh-ancestor
65243173|NCT01685814|Growth Inhibitors|growth inhibitors|mesh-ancestor
65243174|NCT01685814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243175|NCT01391962|Sunitinib|sunitinib|mesh-list
65243176|NCT01391962|Cediranib|cediranib|mesh-list
65243177|NCT01391962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243178|NCT01391962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65243179|NCT01391962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65243215|NCT01147016|Tubulin Modulators|tubulin modulators|mesh-ancestor
65243216|NCT01147016|Antimitotic Agents|antimitotic agents|mesh-ancestor
65243217|NCT01147016|Mitosis Modulators|mitosis modulators|mesh-ancestor
65243218|NCT01147016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243219|NCT01147016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65243220|NCT01147016|Immunologic Factors|immunologic factors|mesh-ancestor
65243221|NCT01147016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243222|NCT01147016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65243223|NCT01147016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65243224|NCT01147016|Alkylating Agents|alkylating agents|mesh-ancestor
65243225|NCT01147016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65243226|NCT01147016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65243227|NCT01147016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65243228|NCT01147016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65243229|NCT01147016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243230|NCT00967785|Plerixafor|plerixafor|mesh-list
65243231|NCT00967785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65243232|NCT00967785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65243233|NCT00967785|Antiviral Agents|antiviral agents|mesh-ancestor
65243234|NCT00967785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65243235|NCT00923013|Rituximab|rituximab|mesh-list
65243271|NCT00217737|Calcium, Dietary|calcium, dietary|mesh-list
65243272|NCT00217737|Leucovorin|leucovorin|mesh-list
65243273|NCT00217737|Folic Acid|folic acid|mesh-list
65243274|NCT00217737|Bevacizumab|bevacizumab|mesh-list
65243275|NCT00217737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65243276|NCT00217737|Fluorouracil|fluorouracil|mesh-list
65243277|NCT00217737|Oxaliplatin|oxaliplatin|mesh-list
65243278|NCT00217737|Endothelial Growth Factors|endothelial growth factors|mesh-list
64886024|NCT03626922|Micronutrients|micronutrients|mesh-ancestor
65243279|NCT00217737|Antibodies|antibodies|mesh-list
65243280|NCT00217737|Immunoglobulins|immunoglobulins|mesh-list
65243281|NCT00217737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65243282|NCT00217737|Immunoglobulin G|immunoglobulin g|mesh-list
65243283|NCT00217737|Calcium|calcium|mesh-list
65243284|NCT00217737|Levoleucovorin|levoleucovorin|mesh-list
65243285|NCT00217737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243286|NCT00217737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65243287|NCT00217737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65243288|NCT00217737|Growth Substances|growth substances|mesh-ancestor
65243289|NCT00217737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243290|NCT00217737|Growth Inhibitors|growth inhibitors|mesh-ancestor
65243291|NCT00217737|Immunologic Factors|immunologic factors|mesh-ancestor
65243292|NCT00217737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65243293|NCT00217737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65243294|NCT00217737|Antimetabolites|antimetabolites|mesh-ancestor
65243295|NCT00217737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243296|NCT00217737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65243297|NCT00217737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65243298|NCT00217737|Antidotes|antidotes|mesh-ancestor
65243299|NCT00217737|Protective Agents|protective agents|mesh-ancestor
65243300|NCT00217737|Vitamin B Complex|vitamin b complex|mesh-ancestor
65243301|NCT00217737|Vitamins|vitamins|mesh-ancestor
65243302|NCT00217737|Micronutrients|micronutrients|mesh-ancestor
65243303|NCT00217737|Hematinics|hematinics|mesh-ancestor
65243312|NCT00106587|Paclitaxel|paclitaxel|mesh-list
65243315|NCT00106587|Tubulin Modulators|tubulin modulators|mesh-ancestor
65243316|NCT00106587|Antimitotic Agents|antimitotic agents|mesh-ancestor
65243317|NCT00106587|Mitosis Modulators|mitosis modulators|mesh-ancestor
65243318|NCT00106587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243319|NCT00097474|Hydrocortisone|hydrocortisone|mesh-list
65243320|NCT00097474|Melatonin|melatonin|mesh-list
65243321|NCT00097474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65243322|NCT00097474|Antioxidants|antioxidants|mesh-ancestor
65243323|NCT00097474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243324|NCT00097474|Protective Agents|protective agents|mesh-ancestor
65243325|NCT00097474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243326|NCT00097474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65243327|NCT00092222|Interferons|interferons|mesh-list
65243328|NCT00092222|Interferon-alpha|interferon-alpha|mesh-list
65243329|NCT00092222|Zidovudine|zidovudine|mesh-list
65243330|NCT00092222|Valganciclovir|valganciclovir|mesh-list
65243331|NCT00092222|Sirolimus|sirolimus|mesh-list
65243332|NCT00092222|Prednisone|prednisone|mesh-list
65243333|NCT00092222|Cyclophosphamide|cyclophosphamide|mesh-list
65243334|NCT00092222|Rituximab|rituximab|mesh-list
65243335|NCT00092222|Doxorubicin|doxorubicin|mesh-list
65243336|NCT00092222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65243337|NCT00092222|Etoposide|etoposide|mesh-list
65243338|NCT00092222|Vincristine|vincristine|mesh-list
65243339|NCT00092222|Bortezomib|bortezomib|mesh-list
65243340|NCT00092222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65243341|NCT00092222|Immunologic Factors|immunologic factors|mesh-ancestor
65243342|NCT00092222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243343|NCT00092222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65243344|NCT00092222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65243345|NCT00092222|Alkylating Agents|alkylating agents|mesh-ancestor
65243346|NCT00092222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243347|NCT00092222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243348|NCT00092222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65243349|NCT00092222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65243358|NCT00092222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65243359|NCT00092222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65243360|NCT00092222|Antiviral Agents|antiviral agents|mesh-ancestor
65243361|NCT00092222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65243362|NCT00092222|Tubulin Modulators|tubulin modulators|mesh-ancestor
65243363|NCT00092222|Antimitotic Agents|antimitotic agents|mesh-ancestor
65243364|NCT00092222|Mitosis Modulators|mitosis modulators|mesh-ancestor
65243365|NCT00092222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65243366|NCT00092222|Antifungal Agents|antifungal agents|mesh-ancestor
65243367|NCT00092222|Antimetabolites|antimetabolites|mesh-ancestor
65243368|NCT00092222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65243369|NCT00092222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65243370|NCT00092222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65243371|NCT00092222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65243372|NCT00065676|Quercetin|quercetin|mesh-list
65243373|NCT00065676|Antioxidants|antioxidants|mesh-ancestor
65243374|NCT00065676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243375|NCT00065676|Protective Agents|protective agents|mesh-ancestor
65243376|NCT00065676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243377|NCT00061568|Sirolimus|sirolimus|mesh-list
65243378|NCT00061568|Alemtuzumab|alemtuzumab|mesh-list
65243379|NCT00061568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65243380|NCT00061568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65243381|NCT00061568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65243382|NCT00061568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243383|NCT00061568|Antifungal Agents|antifungal agents|mesh-ancestor
65243384|NCT00061568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65243385|NCT00061568|Immunologic Factors|immunologic factors|mesh-ancestor
65243386|NCT00061568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243402|NCT00018057|Antidepressive Agents|antidepressive agents|mesh-ancestor
65243403|NCT00018057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65243404|NCT00018057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65243405|NCT00018057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65243406|NCT00018057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243407|NCT00018044|Clofazimine|clofazimine|mesh-list
65243408|NCT00018044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65243409|NCT00018044|Leprostatic Agents|leprostatic agents|mesh-ancestor
65243410|NCT00018044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65243411|NCT00018044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65243412|NCT00001521|Hydrocortisone|hydrocortisone|mesh-list
65243413|NCT00001521|Fludrocortisone|fludrocortisone|mesh-list
65243415|NCT00001521|Flutamide|flutamide|mesh-list
65243416|NCT00001521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65243417|NCT00001521|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65243418|NCT00001521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65243419|NCT00001521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65243420|NCT00001521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65243421|NCT00001521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65243422|NCT00001521|Hormone Antagonists|hormone antagonists|mesh-ancestor
65243423|NCT00001521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65243424|NCT00001521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65243425|NCT00001521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65243426|NCT00001521|Androgen Antagonists|androgen antagonists|mesh-ancestor
65243427|NCT00001521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65243428|NCT00001379|Interferons|interferons|mesh-list
65243429|NCT00001379|Rituximab|rituximab|mesh-list
64895048|NCT02006589|Candesartan|candesartan|mesh-list
64895424|NCT02009098|Cefuroxime|cefuroxime|mesh-list
64895496|NCT05778227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64895797|NCT05410158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64896033|NCT04495855|Dienogest|dienogest|mesh-list
64896092|NCT04226690|Hormones|hormones|mesh-ancestor
64896243|NCT03984357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64896408|NCT03325972|Analgesics|analgesics|mesh-ancestor
64896543|NCT02358538|Ganaxolone|ganaxolone|mesh-list
64896698|NCT01163357|Sirolimus|sirolimus|mesh-list
64896848|NCT02009410|Pancreatin|pancreatin|mesh-list
64896933|NCT02010762|Vitamin D|vitamin d|mesh-list
64897149|NCT02012049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64897452|NCT02013570|Analgesics|analgesics|mesh-ancestor
64897535|NCT02014454|Propranolol|propranolol|mesh-list
64897753|NCT02015650|Alkylating Agents|alkylating agents|mesh-ancestor
64897839|NCT02016274|Paclitaxel|paclitaxel|mesh-list
64898513|NCT02020603|Epinephrine|epinephrine|mesh-list
64898810|NCT02022540|Ranibizumab|ranibizumab|mesh-list
64899135|NCT02024555|Ofloxacin|ofloxacin|mesh-list
64899407|NCT02025881|Immunologic Factors|immunologic factors|mesh-ancestor
64899781|NCT02028312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64899963|NCT02029378|Eculizumab|eculizumab|mesh-list
64900535|NCT02041481|Calcium|calcium|mesh-list
64900981|NCT02045368|Dermatologic Agents|dermatologic agents|mesh-ancestor
64901511|NCT00005850|Serotonin Agents|serotonin agents|mesh-ancestor
64902032|NCT00006003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902564|NCT03741933|Apremilast|apremilast|mesh-list
64902707|NCT01959204|Analgesics|analgesics|mesh-ancestor
64903169|NCT00006249|Interferons|interferons|mesh-list
64903395|NCT00005842|Tipifarnib|tipifarnib|mesh-list
64903784|NCT00005959|Hormones|hormones|mesh-ancestor
64904297|NCT00386815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904752|NCT04164199|Antimetabolites|antimetabolites|mesh-ancestor
64904829|NCT03265405|Antiemetics|antiemetics|mesh-ancestor
64904980|NCT00006708|Rituximab|rituximab|mesh-list
64905359|NCT00006133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905593|NCT00006250|Hormones|hormones|mesh-ancestor
64905664|NCT00007605|Adrenergic Agents|adrenergic agents|mesh-ancestor
64905896|NCT00006376|Tipifarnib|tipifarnib|mesh-list
64906491|NCT00008047|Paclitaxel|paclitaxel|mesh-list
64906813|NCT00000145|Zinc|zinc|mesh-list
64907021|NCT00388882|Bromides|bromides|mesh-list
64909204|NCT04713514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909735|NCT04004416|GABA Modulators|gaba modulators|mesh-ancestor
64910571|NCT00001038|Antiviral Agents|antiviral agents|mesh-ancestor
64910805|NCT00017407|Paclitaxel|paclitaxel|mesh-list
64911183|NCT00001191|Omeprazole|omeprazole|mesh-list
64911410|NCT00001266|Suramin|suramin|mesh-list
64911488|NCT00005963|Docetaxel|docetaxel|mesh-list
64911637|NCT00014287|Gemcitabine|gemcitabine|mesh-list
64912838|NCT05485558|Antidotes|antidotes|mesh-ancestor
64913207|NCT00386867|Misoprostol|misoprostol|mesh-list
64913582|NCT05636787|Melphalan|melphalan|mesh-list
64913808|NCT05605665|Interleukin-2|interleukin-2|mesh-list
64914106|NCT01806454|Calcium|calcium|mesh-list
64914406|NCT05361720|Ipilimumab|ipilimumab|mesh-list
64914484|NCT01057069|Cyclophosphamide|cyclophosphamide|mesh-list
64914631|NCT00847093|Anesthetics, Local|anesthetics, local|mesh-ancestor
64914929|NCT00276640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916296|NCT00088816|Tegafur|tegafur|mesh-list
64916372|NCT00088933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64916520|NCT00390156|Alkylating Agents|alkylating agents|mesh-ancestor
64916631|NCT00090727|AQ4N|aq4n|mesh-list
64916758|NCT00006206|Naltrexone|naltrexone|mesh-list
64916820|NCT02972346|beta-Endorphin|beta-endorphin|mesh-list
64916973|NCT00093652|Gefitinib|gefitinib|mesh-list
64917571|NCT00097123|Oxytocics|oxytocics|mesh-ancestor
64917876|NCT04143711|Paclitaxel|paclitaxel|mesh-list
64918119|NCT00006386|Carmustine|carmustine|mesh-list
64918475|NCT00103051|Immunologic Factors|immunologic factors|mesh-ancestor
64918550|NCT00103792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918854|NCT00106288|Micafungin|micafungin|mesh-list
64919080|NCT00006617|Abacavir|abacavir|mesh-list
64919978|NCT00112996|Vitamin B Complex|vitamin b complex|mesh-ancestor
64920380|NCT00115219|Etanercept|etanercept|mesh-list
64920814|NCT00117520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64921043|NCT00118807|Amodiaquine|amodiaquine|mesh-list
64921196|NCT02454933|Durvalumab|durvalumab|mesh-list
64921644|NCT00063414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64922253|NCT00020761|Irinotecan|irinotecan|mesh-list
64922407|NCT00021385|Squalamine|squalamine|mesh-list
64922637|NCT00388739|Autonomic Agents|autonomic agents|mesh-ancestor
64922715|NCT00000146|Hormones|hormones|mesh-ancestor
64922859|NCT02024607|Oxaliplatin|oxaliplatin|mesh-list
64923391|NCT00025285|Thalidomide|thalidomide|mesh-list
64926340|NCT00035347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927095|NCT00014937|Ritonavir|ritonavir|mesh-list
64927179|NCT00000965|Zidovudine|zidovudine|mesh-list
64927248|NCT00000986|Zidovudine|zidovudine|mesh-list
64927316|NCT00000998|Antimetabolites|antimetabolites|mesh-ancestor
64927850|NCT00016419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64928456|NCT00017277|Epoetin Alfa|epoetin alfa|mesh-list
64928904|NCT00043303|Antiviral Agents|antiviral agents|mesh-ancestor
64928988|NCT00043771|Tolvaptan|tolvaptan|mesh-list
64929055|NCT00043927|Cisplatin|cisplatin|mesh-list
64929209|NCT00044629|Zolpidem|zolpidem|mesh-list
64929275|NCT00018213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64929883|NCT00047749|Protective Agents|protective agents|mesh-ancestor
64930714|NCT00053599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930940|NCT00054574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931016|NCT05527704|Albuterol|albuterol|mesh-list
64931465|NCT00058201|Antidotes|antidotes|mesh-ancestor
64931617|NCT00059761|Irinotecan|irinotecan|mesh-list
64932141|NCT00062296|Rituximab|rituximab|mesh-list
64932212|NCT04736823|Paclitaxel|paclitaxel|mesh-list
64932454|NCT04488081|Analgesics|analgesics|mesh-ancestor
64932593|NCT00066508|Bortezomib|bortezomib|mesh-list
64933128|NCT00071266|Niacin|niacin|mesh-list
64933345|NCT00072319|Alkylating Agents|alkylating agents|mesh-ancestor
64933508|NCT04827953|Paclitaxel|paclitaxel|mesh-list
64933573|NCT02966041|Serotonin Agents|serotonin agents|mesh-ancestor
64933725|NCT00074737|Immunologic Factors|immunologic factors|mesh-ancestor
64933798|NCT00075556|Antimetabolites|antimetabolites|mesh-ancestor
64933874|NCT00075751|Gemcitabine|gemcitabine|mesh-list
64934179|NCT00078442|Interferons|interferons|mesh-list
64935153|NCT00135811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64993794|NCT00087815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993795|NCT00087854|Amonafide|amonafide|mesh-list
64993796|NCT00087854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993797|NCT00087854|Antiviral Agents|antiviral agents|mesh-ancestor
64993798|NCT00087854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64993799|NCT00087854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993800|NCT00087854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993801|NCT04715620|Niraparib|niraparib|mesh-list
64993802|NCT04715620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64993803|NCT04715620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993804|NCT04715620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993805|NCT04715620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993806|NCT00125229|Mannitol|mannitol|mesh-list
64993807|NCT00125229|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64993808|NCT00125229|Diuretics|diuretics|mesh-ancestor
64993809|NCT00125229|Natriuretic Agents|natriuretic agents|mesh-ancestor
64993810|NCT00125229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993811|NCT00126906|Pyrimethamine|pyrimethamine|mesh-list
64993812|NCT00126906|Sulfadoxine|sulfadoxine|mesh-list
64993813|NCT00126906|Antimalarials|antimalarials|mesh-ancestor
64993814|NCT00126906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64993815|NCT00126906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64993816|NCT00126906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64993817|NCT00126906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64993818|NCT00126906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993819|NCT00126906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993821|NCT00126906|Renal Agents|renal agents|mesh-ancestor
64993843|NCT00088049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64993844|NCT00088049|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64993845|NCT00088049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64993846|NCT00088049|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64993847|NCT00088049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64993848|NCT00088088|Paclitaxel|paclitaxel|mesh-list
64993849|NCT00088088|Carboplatin|carboplatin|mesh-list
64993850|NCT00088088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64993851|NCT00088088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993852|NCT00088088|Tubulin Modulators|tubulin modulators|mesh-ancestor
64993853|NCT00088088|Antimitotic Agents|antimitotic agents|mesh-ancestor
64993854|NCT00088088|Mitosis Modulators|mitosis modulators|mesh-ancestor
64993855|NCT00088088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993856|NCT00125307|Tacrolimus|tacrolimus|mesh-list
64993857|NCT00125307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64993858|NCT00125307|Immunologic Factors|immunologic factors|mesh-ancestor
64993859|NCT00125307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993860|NCT00125307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64993861|NCT00125307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993863|NCT00127023|Vaccines|vaccines|mesh-list
64993897|NCT00088478|Antiemetics|antiemetics|mesh-ancestor
64993898|NCT00088478|Autonomic Agents|autonomic agents|mesh-ancestor
64993899|NCT00088478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64993900|NCT00088478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993901|NCT00088478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64993902|NCT00088478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64993903|NCT00088478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64993904|NCT00088478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64993905|NCT00088478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64993906|NCT00088478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64993907|NCT00088478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64993908|NCT00088478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64993909|NCT00088478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993910|NCT00088478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64993911|NCT00088478|Serotonin Agents|serotonin agents|mesh-ancestor
64993912|NCT00125346|Tobramycin|tobramycin|mesh-list
64993913|NCT00125346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64993914|NCT00125346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64993915|NCT00333112|Tamsulosin|tamsulosin|mesh-list
64993916|NCT00333112|Solifenacin Succinate|solifenacin succinate|mesh-list
64993917|NCT00333112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64993918|NCT00333112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64993919|NCT00333112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64993920|NCT00333112|Adrenergic Agents|adrenergic agents|mesh-ancestor
64993921|NCT00333112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64401045|NCT03067883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993922|NCT00333112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993944|NCT00088556|Antimitotic Agents|antimitotic agents|mesh-ancestor
64993945|NCT00088556|Mitosis Modulators|mitosis modulators|mesh-ancestor
64993946|NCT00088556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993947|NCT00127140|Vorinostat|vorinostat|mesh-list
64993948|NCT00127140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993949|NCT00127140|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64993950|NCT00127140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993951|NCT00127140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993952|NCT00333307|Methocarbamol|methocarbamol|mesh-list
64993953|NCT00333307|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64993954|NCT00333307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993955|NCT00333307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64993956|NCT00333307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64993957|NCT00125424|Midazolam|midazolam|mesh-list
64993958|NCT00125424|Fospropofol|fospropofol|mesh-list
64993959|NCT00125424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64993960|NCT00125424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64993961|NCT00125424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64993962|NCT00125424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993963|NCT00125424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64993964|NCT00125424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64993965|NCT00125424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64993966|NCT00125424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64993967|NCT00125424|Anesthetics, General|anesthetics, general|mesh-ancestor
64993968|NCT00125424|Anesthetics|anesthetics|mesh-ancestor
64993969|NCT00125424|GABA Modulators|gaba modulators|mesh-ancestor
64993993|NCT00127257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64993994|NCT00127257|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64993995|NCT00127257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64993996|NCT00127257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64993997|NCT00127257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64993998|NCT00127257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64993999|NCT00127257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64994000|NCT00127257|Anesthetics, General|anesthetics, general|mesh-ancestor
64994001|NCT00127257|Anesthetics|anesthetics|mesh-ancestor
64994002|NCT00127257|GABA Modulators|gaba modulators|mesh-ancestor
64994003|NCT00127257|GABA Agents|gaba agents|mesh-ancestor
64994004|NCT00127257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64994005|NCT00127257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994006|NCT00333424|Vaccines|vaccines|mesh-list
64994007|NCT00333424|Immunologic Factors|immunologic factors|mesh-ancestor
64994008|NCT00333424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994009|NCT00125463|Candesartan|candesartan|mesh-list
64994010|NCT00125463|Candesartan cilexetil|candesartan cilexetil|mesh-list
64994011|NCT00125463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64994012|NCT00125463|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64994013|NCT00125463|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64994014|NCT00125463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994015|NCT00088946|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64994016|NCT00088946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994017|NCT00088946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64994018|NCT00088946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994039|NCT00421096|Immunologic Factors|immunologic factors|mesh-ancestor
64994040|NCT00421096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994041|NCT00089063|Sargramostim|sargramostim|mesh-list
64994042|NCT00089063|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64994043|NCT00089063|Freund's Adjuvant|freund's adjuvant|mesh-list
64994044|NCT00089063|Immunologic Factors|immunologic factors|mesh-ancestor
64994045|NCT00089063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994046|NCT00089063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64994047|NCT00333931|Phenytoin|phenytoin|mesh-list
64994048|NCT00333931|Anticonvulsants|anticonvulsants|mesh-ancestor
64994049|NCT00333931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64994050|NCT00333931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64994051|NCT00333931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64994052|NCT00333931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994053|NCT00333931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64994054|NCT00333931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64994055|NCT00334048|Ropinirole|ropinirole|mesh-list
64994056|NCT00334048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64994057|NCT00334048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64994058|NCT00334048|Dopamine Agonists|dopamine agonists|mesh-ancestor
64994059|NCT00334048|Dopamine Agents|dopamine agents|mesh-ancestor
64994060|NCT00334048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64994061|NCT00334048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994062|NCT00334048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994063|NCT00334126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64994064|NCT00334126|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64994065|NCT00334126|Antidepressive Agents|antidepressive agents|mesh-ancestor
64994066|NCT00334126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64994073|NCT00334126|Serotonin Agents|serotonin agents|mesh-ancestor
64994083|NCT00089219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64994084|NCT00334321|Paclitaxel|paclitaxel|mesh-list
64994085|NCT00334321|Carboplatin|carboplatin|mesh-list
64994086|NCT00334321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64994087|NCT00334321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994088|NCT00334321|Tubulin Modulators|tubulin modulators|mesh-ancestor
64994089|NCT00334321|Antimitotic Agents|antimitotic agents|mesh-ancestor
64994090|NCT00334321|Mitosis Modulators|mitosis modulators|mesh-ancestor
64994091|NCT00334321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994092|NCT00334360|Dexmedetomidine|dexmedetomidine|mesh-list
64994093|NCT00334360|Buspirone|buspirone|mesh-list
64994094|NCT00334360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64994095|NCT00334360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64994096|NCT00334360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994097|NCT00334360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64994098|NCT00334360|Analgesics|analgesics|mesh-ancestor
64994099|NCT00334360|Sensory System Agents|sensory system agents|mesh-ancestor
64994100|NCT00334360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64994101|NCT00334360|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64994102|NCT00334360|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64994103|NCT00334360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64994104|NCT00334360|Adrenergic Agents|adrenergic agents|mesh-ancestor
64994105|NCT00334360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64994106|NCT00334360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994107|NCT00334360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64994132|NCT00334477|Urological Agents|urological agents|mesh-ancestor
64994133|NCT04715269|Alprazolam|alprazolam|mesh-list
64994134|NCT04715269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64994135|NCT04715269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64994136|NCT04715269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994137|NCT04715269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64994138|NCT04715269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64994139|NCT04715269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64994140|NCT04715269|GABA Modulators|gaba modulators|mesh-ancestor
64994141|NCT04715269|GABA Agents|gaba agents|mesh-ancestor
64994142|NCT04715269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64994143|NCT04715269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994144|NCT00125541|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64994145|NCT00125541|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64994146|NCT00125541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64994147|NCT00125541|Immunologic Factors|immunologic factors|mesh-ancestor
64994148|NCT00125541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994149|NCT00089258|Isotretinoin|isotretinoin|mesh-list
64994150|NCT00089258|Antibodies|antibodies|mesh-list
64994151|NCT00089258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64994152|NCT00089258|Sargramostim|sargramostim|mesh-list
64994153|NCT00089258|Immunologic Factors|immunologic factors|mesh-ancestor
64994154|NCT00089258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994155|NCT00089258|Dermatologic Agents|dermatologic agents|mesh-ancestor
64994156|NCT00127569|Rituximab|rituximab|mesh-list
64994157|NCT00127569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64994158|NCT00127569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994159|NCT00127569|Immunologic Factors|immunologic factors|mesh-ancestor
64994181|NCT00334672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64994182|NCT00334672|Immunologic Factors|immunologic factors|mesh-ancestor
64994183|NCT00334672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994184|NCT00334672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64994185|NCT00334672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64994186|NCT00334672|Alkylating Agents|alkylating agents|mesh-ancestor
64994187|NCT00334672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994188|NCT00334672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994189|NCT00334672|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64994190|NCT00334672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64994191|NCT00334672|Antiemetics|antiemetics|mesh-ancestor
64994192|NCT00334672|Autonomic Agents|autonomic agents|mesh-ancestor
64994193|NCT00334672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64994194|NCT00334672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64994195|NCT00334672|Glucocorticoids|glucocorticoids|mesh-ancestor
64994196|NCT00334672|Hormones|hormones|mesh-ancestor
64994197|NCT00334672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64994198|NCT00334672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64994199|NCT00334672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64994200|NCT00334672|Abortifacient Agents|abortifacient agents|mesh-ancestor
64994201|NCT00334672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64994202|NCT00334672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64994203|NCT00334672|Antimetabolites|antimetabolites|mesh-ancestor
64994204|NCT00334672|Dermatologic Agents|dermatologic agents|mesh-ancestor
64994205|NCT00334672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994206|NCT00334672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64994207|NCT00334672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64994208|NCT00334672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64994209|NCT00334672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64994210|NCT00334672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64994211|NCT00334672|Antifungal Agents|antifungal agents|mesh-ancestor
64994212|NCT00334672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64994213|NCT00334672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64994219|NCT00089453|Cyclophosphamide|cyclophosphamide|mesh-list
64994220|NCT00089453|Melphalan|melphalan|mesh-list
64994221|NCT00089453|Fludarabine|fludarabine|mesh-list
64994222|NCT00089453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64994223|NCT00089453|Immunologic Factors|immunologic factors|mesh-ancestor
64994224|NCT00089453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994225|NCT00089453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64994226|NCT00089453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64941243|NCT00025038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64994227|NCT00089453|Alkylating Agents|alkylating agents|mesh-ancestor
64994228|NCT00089453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994229|NCT00089453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994230|NCT00089453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64994231|NCT00089453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64994233|NCT00089453|Autonomic Agents|autonomic agents|mesh-ancestor
64994234|NCT00089453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64994235|NCT00089453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64994236|NCT00089453|Glucocorticoids|glucocorticoids|mesh-ancestor
64994238|NCT00089453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64994239|NCT00089453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64994240|NCT00089492|Enfuvirtide|enfuvirtide|mesh-list
64994241|NCT00089492|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64994242|NCT00089492|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64994243|NCT00089492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994244|NCT00089492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64994245|NCT00089492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64994246|NCT00089492|Antiviral Agents|antiviral agents|mesh-ancestor
64994247|NCT00089492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64994248|NCT00127686|Dextromethorphan|dextromethorphan|mesh-list
64994249|NCT00127686|Antitussive Agents|antitussive agents|mesh-ancestor
64994250|NCT00127686|Respiratory System Agents|respiratory system agents|mesh-ancestor
64994263|NCT00334789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994264|NCT00334789|Keratolytic Agents|keratolytic agents|mesh-ancestor
64994265|NCT00334789|Dermatologic Agents|dermatologic agents|mesh-ancestor
64994266|NCT00334789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994267|NCT00334789|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64994268|NCT00334789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994269|NCT00334867|Cyclophosphamide|cyclophosphamide|mesh-list
64994270|NCT00334867|Ifosfamide|ifosfamide|mesh-list
64994271|NCT00334867|Doxorubicin|doxorubicin|mesh-list
64994272|NCT00334867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64994273|NCT00334867|Etoposide|etoposide|mesh-list
64994274|NCT00334867|Vincristine|vincristine|mesh-list
64994275|NCT00334867|Topotecan|topotecan|mesh-list
64994276|NCT00334867|Dexrazoxane|dexrazoxane|mesh-list
64994277|NCT00334867|Razoxane|razoxane|mesh-list
64994278|NCT00334867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64994279|NCT00334867|Immunologic Factors|immunologic factors|mesh-ancestor
64994280|NCT00334867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994281|NCT00334867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64994282|NCT00334867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64994283|NCT00334867|Alkylating Agents|alkylating agents|mesh-ancestor
64994284|NCT00334867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994285|NCT00334867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994286|NCT00334867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64994287|NCT00334867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64994288|NCT00334867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64994289|NCT00334867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64994290|NCT00334867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994291|NCT00334867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64994292|NCT00334867|Tubulin Modulators|tubulin modulators|mesh-ancestor
64994293|NCT00334867|Antimitotic Agents|antimitotic agents|mesh-ancestor
64994294|NCT00334867|Mitosis Modulators|mitosis modulators|mesh-ancestor
64994295|NCT00334867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64994296|NCT00334867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64994297|NCT00334867|Protective Agents|protective agents|mesh-ancestor
64994298|NCT04715152|Dexamethasone|dexamethasone|mesh-list
64994305|NCT04715152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64994306|NCT04715152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994307|NCT04715152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64994308|NCT04715152|Glucocorticoids|glucocorticoids|mesh-ancestor
64994309|NCT04715152|Hormones|hormones|mesh-ancestor
64994310|NCT04715152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64994311|NCT04715152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64994312|NCT04715152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994313|NCT04715152|Protease Inhibitors|protease inhibitors|mesh-ancestor
64994314|NCT04715152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994315|NCT04715152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994316|NCT04715152|Anesthetics, Local|anesthetics, local|mesh-ancestor
64994317|NCT04715152|Anesthetics|anesthetics|mesh-ancestor
64994318|NCT04715152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64994319|NCT04715152|Sensory System Agents|sensory system agents|mesh-ancestor
64994320|NCT00334906|Memantine|memantine|mesh-list
64994321|NCT00334906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64994322|NCT00334906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64994323|NCT00334906|Dopamine Agents|dopamine agents|mesh-ancestor
64994324|NCT00334906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64994325|NCT00334906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994326|NCT00334906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994327|NCT00334906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64994328|NCT00334906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64994329|NCT00089570|Terlipressin|terlipressin|mesh-list
64994353|NCT00127764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64994354|NCT00127764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64994355|NCT00127764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994356|NCT00089726|Cyclophosphamide|cyclophosphamide|mesh-list
64994357|NCT00089726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64994358|NCT00089726|Immunologic Factors|immunologic factors|mesh-ancestor
64994359|NCT00089726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994360|NCT00089726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64994361|NCT00089726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64994362|NCT00089726|Alkylating Agents|alkylating agents|mesh-ancestor
64994363|NCT00089726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994364|NCT00089726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994365|NCT00089726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64994366|NCT00343096|Lorazepam|lorazepam|mesh-list
64994367|NCT00343096|Anticonvulsants|anticonvulsants|mesh-ancestor
64994368|NCT00343096|Antiemetics|antiemetics|mesh-ancestor
64994369|NCT00343096|Autonomic Agents|autonomic agents|mesh-ancestor
64994370|NCT00343096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64994371|NCT00343096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994372|NCT00343096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64994404|NCT00343174|Ancrod|ancrod|mesh-list
64994407|NCT00343174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64994408|NCT00343174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994409|NCT00343369|Cytarabine|cytarabine|mesh-list
64994410|NCT00343369|Dexamethasone|dexamethasone|mesh-list
64994411|NCT00343369|Prednisolone|prednisolone|mesh-list
64994412|NCT00343369|Cyclophosphamide|cyclophosphamide|mesh-list
64994413|NCT00343369|Doxorubicin|doxorubicin|mesh-list
64994414|NCT00343369|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64994415|NCT00343369|Methotrexate|methotrexate|mesh-list
64994416|NCT00343369|Vincristine|vincristine|mesh-list
64994417|NCT00343369|Daunorubicin|daunorubicin|mesh-list
64994418|NCT00343369|Asparaginase|asparaginase|mesh-list
64994419|NCT00343369|Mercaptopurine|mercaptopurine|mesh-list
64994420|NCT00343369|Pegaspargase|pegaspargase|mesh-list
64994421|NCT00343369|Thioguanine|thioguanine|mesh-list
64994422|NCT00343369|Teniposide|teniposide|mesh-list
64994423|NCT00343369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64994424|NCT00343369|Immunologic Factors|immunologic factors|mesh-ancestor
64994425|NCT00343369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994426|NCT00343369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64994427|NCT00343369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64994428|NCT00343369|Alkylating Agents|alkylating agents|mesh-ancestor
64994429|NCT00343369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994430|NCT00343369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994431|NCT00343369|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64994432|NCT00343369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64994433|NCT00343369|Antiemetics|antiemetics|mesh-ancestor
64994434|NCT00343369|Autonomic Agents|autonomic agents|mesh-ancestor
64994435|NCT00343369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64994436|NCT00343369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64994437|NCT00343369|Glucocorticoids|glucocorticoids|mesh-ancestor
64994438|NCT00343369|Hormones|hormones|mesh-ancestor
64994439|NCT00343369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64994451|NCT00343369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64941477|NCT00025779|Guanfacine|guanfacine|mesh-list
64994452|NCT00343369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64994453|NCT00343369|Antiviral Agents|antiviral agents|mesh-ancestor
64994454|NCT00343369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64994455|NCT00343369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64994456|NCT00343369|Tubulin Modulators|tubulin modulators|mesh-ancestor
64994457|NCT00343369|Antimitotic Agents|antimitotic agents|mesh-ancestor
64994458|NCT00343369|Mitosis Modulators|mitosis modulators|mesh-ancestor
64994459|NCT00343408|Leucovorin|leucovorin|mesh-list
64994460|NCT00343408|Gemcitabine|gemcitabine|mesh-list
64994461|NCT00343408|Fluorouracil|fluorouracil|mesh-list
64994462|NCT00343408|Oxaliplatin|oxaliplatin|mesh-list
64994463|NCT00343408|Cediranib|cediranib|mesh-list
64994464|NCT00343408|Calcium|calcium|mesh-list
64994465|NCT00343408|Levoleucovorin|levoleucovorin|mesh-list
64994466|NCT00343408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994467|NCT00343408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64994468|NCT00343408|Antimetabolites|antimetabolites|mesh-ancestor
64994470|NCT00343408|Antiviral Agents|antiviral agents|mesh-ancestor
64994508|NCT00089804|Abetimus|abetimus|mesh-list
64994509|NCT00089804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64994510|NCT00089804|Immunologic Factors|immunologic factors|mesh-ancestor
64994511|NCT00089804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994512|NCT00343525|Bavituximab|bavituximab|mesh-list
64994513|NCT00343525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64994514|NCT00343525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994515|NCT00127881|Zanolimumab|zanolimumab|mesh-list
64994516|NCT00127881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64994517|NCT00127881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994518|NCT00343720|Bortezomib|bortezomib|mesh-list
64994519|NCT00343720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994520|NCT00343759|Lapatinib|lapatinib|mesh-list
64994521|NCT00343759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994522|NCT00343759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64994523|NCT00343759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994524|NCT00343759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994525|NCT00127920|Bevacizumab|bevacizumab|mesh-list
64994526|NCT00127920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64994527|NCT00127920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994528|NCT00127920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64994529|NCT00127920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64994530|NCT00127920|Growth Substances|growth substances|mesh-ancestor
64941546|NCT00026364|Leucovorin|leucovorin|mesh-list
64994531|NCT00127920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994532|NCT00127920|Growth Inhibitors|growth inhibitors|mesh-ancestor
64994533|NCT00343798|Cyclosporine|cyclosporine|mesh-list
64994534|NCT00343798|Mycophenolic Acid|mycophenolic acid|mesh-list
64994535|NCT00343798|Cyclophosphamide|cyclophosphamide|mesh-list
64994536|NCT00343798|Fludarabine|fludarabine|mesh-list
64994537|NCT00343798|Fludarabine phosphate|fludarabine phosphate|mesh-list
64994552|NCT00343798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64994553|NCT00343798|Dermatologic Agents|dermatologic agents|mesh-ancestor
64994554|NCT00343798|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64994555|NCT00343798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64994556|NCT00343798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64994557|NCT00343798|Antitubercular Agents|antitubercular agents|mesh-ancestor
64994558|NCT00343798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64994559|NCT00343876|Aspirin|aspirin|mesh-list
64994560|NCT00343876|Clopidogrel|clopidogrel|mesh-list
64994561|NCT00343876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64994562|NCT00343876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64994563|NCT00343876|Analgesics|analgesics|mesh-ancestor
64994564|NCT00343876|Sensory System Agents|sensory system agents|mesh-ancestor
64994565|NCT00343876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64994566|NCT00343876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994567|NCT00343876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64994568|NCT00343876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64994569|NCT00343876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64994570|NCT00343876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64994571|NCT00343876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994572|NCT00343876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64994573|NCT00343876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64994574|NCT00343876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994575|NCT00343876|Antipyretics|antipyretics|mesh-ancestor
64994576|NCT00343876|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64994577|NCT00343876|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64994578|NCT00343876|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64994579|NCT00343876|Purinergic Agents|purinergic agents|mesh-ancestor
64994580|NCT00343876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64994581|NCT00402636|Sirolimus|sirolimus|mesh-list
64994582|NCT00402636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64994583|NCT00402636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64994584|NCT00402636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64994592|NCT00344149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994593|NCT00344149|Immunologic Factors|immunologic factors|mesh-ancestor
64994594|NCT00344149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994595|NCT00344149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64994596|NCT00089960|Motesanib diphosphate|motesanib diphosphate|mesh-list
64994597|NCT00089960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64994598|NCT00089960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994599|NCT00089960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994600|NCT00344227|Ranibizumab|ranibizumab|mesh-list
64994601|NCT00344227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64994602|NCT00344227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64994603|NCT00344227|Growth Substances|growth substances|mesh-ancestor
64994604|NCT00344227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994605|NCT00344227|Growth Inhibitors|growth inhibitors|mesh-ancestor
64994606|NCT00344227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994607|NCT00344383|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64994608|NCT00344383|Norgestimate|norgestimate|mesh-list
64994609|NCT00344383|Estradiol|estradiol|mesh-list
64994610|NCT00344383|Estrogens|estrogens|mesh-ancestor
64994611|NCT00344383|Hormones|hormones|mesh-ancestor
64994612|NCT00344383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64994613|NCT00344383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994614|NCT00344383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64994615|NCT00344383|Contraceptive Agents|contraceptive agents|mesh-ancestor
64994616|NCT00344383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64994617|NCT00344383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64994618|NCT00344383|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64994640|NCT00344422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994641|NCT00344422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64994642|NCT00344422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64994643|NCT00344422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64994644|NCT00344422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64994645|NCT00344422|Tubulin Modulators|tubulin modulators|mesh-ancestor
64994646|NCT00344422|Antimitotic Agents|antimitotic agents|mesh-ancestor
64994647|NCT00344422|Mitosis Modulators|mitosis modulators|mesh-ancestor
64994648|NCT00090038|Rituximab|rituximab|mesh-list
64994649|NCT00090038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64994650|NCT00090038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994651|NCT00090038|Immunologic Factors|immunologic factors|mesh-ancestor
64994652|NCT00090038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994653|NCT00090038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64994654|NCT00402792|Acetaminophen|acetaminophen|mesh-list
64994655|NCT00402792|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64994656|NCT00402792|Hydrocodone|hydrocodone|mesh-list
64994657|NCT00402792|Oxycodone|oxycodone|mesh-list
64994658|NCT00402792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64994659|NCT00402792|Analgesics|analgesics|mesh-ancestor
64994660|NCT00402792|Sensory System Agents|sensory system agents|mesh-ancestor
64994661|NCT00402792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64994692|NCT00344539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64994693|NCT00344539|Immunologic Factors|immunologic factors|mesh-ancestor
64994694|NCT00344539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994695|NCT00344539|Antacids|antacids|mesh-ancestor
64994696|NCT00344539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994697|NCT00344539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64994698|NCT04715503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64994699|NCT04715503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64994700|NCT04715503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994701|NCT00344617|Bevacizumab|bevacizumab|mesh-list
64994702|NCT00344617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64994703|NCT00344617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994704|NCT00344617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64994705|NCT00344617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64994706|NCT00344617|Growth Substances|growth substances|mesh-ancestor
64994707|NCT00344617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994708|NCT00344617|Growth Inhibitors|growth inhibitors|mesh-ancestor
64994709|NCT00127998|Artesunate|artesunate|mesh-list
64994710|NCT00127998|Chloroquine|chloroquine|mesh-list
64994711|NCT00127998|Lumefantrine|lumefantrine|mesh-list
64994712|NCT00127998|Artemether|artemether|mesh-list
64994713|NCT00127998|Pyrimethamine|pyrimethamine|mesh-list
64994714|NCT00127998|Sulfadoxine|sulfadoxine|mesh-list
64994715|NCT00127998|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64994716|NCT00127998|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64994717|NCT00127998|Amodiaquine|amodiaquine|mesh-list
64994718|NCT00127998|Mefloquine|mefloquine|mesh-list
64994719|NCT00127998|Antimalarials|antimalarials|mesh-ancestor
64994720|NCT00127998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64994721|NCT00127998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64994722|NCT00127998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64994723|NCT00127998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994724|NCT00127998|Antiviral Agents|antiviral agents|mesh-ancestor
64994725|NCT00127998|Schistosomicides|schistosomicides|mesh-ancestor
64994726|NCT00127998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64994727|NCT00127998|Anthelmintics|anthelmintics|mesh-ancestor
64994733|NCT00127998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64994734|NCT00127998|Renal Agents|renal agents|mesh-ancestor
64994735|NCT00420589|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
64994736|NCT00420589|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64994737|NCT00420589|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64994738|NCT00420589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64994739|NCT00420589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994740|NCT00420589|Hormones|hormones|mesh-ancestor
64994741|NCT00420589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64994742|NCT00420589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994743|NCT00344695|Bupropion|bupropion|mesh-list
64994744|NCT00344695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64994745|NCT00344695|Antidepressive Agents|antidepressive agents|mesh-ancestor
64994746|NCT00344695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64994747|NCT00344695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64994748|NCT00344695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64994749|NCT00344695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64994750|NCT00344695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994751|NCT00344695|Dopamine Agents|dopamine agents|mesh-ancestor
64994781|NCT00344812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64994782|NCT00344812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64994783|NCT00344812|Antitussive Agents|antitussive agents|mesh-ancestor
64994784|NCT00344812|Respiratory System Agents|respiratory system agents|mesh-ancestor
64994785|NCT00344851|Metformin|metformin|mesh-list
64994786|NCT00344851|Exenatide|exenatide|mesh-list
64994787|NCT00344851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64994788|NCT00344851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994789|NCT00344851|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64994790|NCT00344851|Incretins|incretins|mesh-ancestor
64994791|NCT00344851|Hormones|hormones|mesh-ancestor
64994792|NCT00344851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64994793|NCT00090155|Ondansetron|ondansetron|mesh-list
64994794|NCT00090155|Aprepitant|aprepitant|mesh-list
64994795|NCT00090155|Antiemetics|antiemetics|mesh-ancestor
64994796|NCT00090155|Autonomic Agents|autonomic agents|mesh-ancestor
64994797|NCT00090155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64994798|NCT00090155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994799|NCT00090155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64994800|NCT00090155|Antipruritics|antipruritics|mesh-ancestor
64994801|NCT00090155|Dermatologic Agents|dermatologic agents|mesh-ancestor
64994802|NCT00090155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64994803|NCT00090155|Serotonin Agents|serotonin agents|mesh-ancestor
64994804|NCT00090155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64994806|NCT00090155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64994834|NCT00345163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994835|NCT00345163|Growth Inhibitors|growth inhibitors|mesh-ancestor
64994836|NCT00345163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64994837|NCT00345163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64994838|NCT00345163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994839|NCT00345163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994840|NCT00345202|Atorvastatin|atorvastatin|mesh-list
64994841|NCT00345202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64994842|NCT00345202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64994843|NCT00345202|Antimetabolites|antimetabolites|mesh-ancestor
64994844|NCT00345202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994845|NCT00345202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64994846|NCT00345202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64994847|NCT00345202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994848|NCT00335647|Fluphenazine|fluphenazine|mesh-list
64994849|NCT00335647|Fluphenazine depot|fluphenazine depot|mesh-list
64994850|NCT00335647|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
64994851|NCT00335647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64994852|NCT00335647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64994853|NCT00335647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64994854|NCT00335647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994855|NCT00335647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64994885|NCT00335686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64994886|NCT00128232|Octreotide|octreotide|mesh-list
64994887|NCT00128232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64994888|NCT00128232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64994889|NCT00128232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994890|NCT04708249|Inositol|inositol|mesh-list
64994891|NCT04708249|Vitamin B Complex|vitamin b complex|mesh-ancestor
64994892|NCT04708249|Vitamins|vitamins|mesh-ancestor
64994893|NCT04708249|Micronutrients|micronutrients|mesh-ancestor
64994894|NCT04708249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994895|NCT00090272|Ertapenem|ertapenem|mesh-list
64994896|NCT00090272|Cefotetan|cefotetan|mesh-list
64994897|NCT00090272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64994898|NCT00090272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64994899|NCT00345787|Buprenorphine|buprenorphine|mesh-list
64994900|NCT00345787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64976148|NCT00254020|Citalopram|citalopram|mesh-list
64994901|NCT00345787|Narcotics|narcotics|mesh-ancestor
64994902|NCT00345787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64994903|NCT00345787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994904|NCT00345787|Analgesics|analgesics|mesh-ancestor
64994905|NCT00345787|Sensory System Agents|sensory system agents|mesh-ancestor
64941923|NCT00028314|Nevirapine|nevirapine|mesh-list
64994906|NCT00345787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64994907|NCT00345787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64994908|NCT00128271|Bavituximab|bavituximab|mesh-list
64994909|NCT00128271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64994910|NCT00128271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994911|NCT00090311|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64994912|NCT00090311|Antidepressive Agents|antidepressive agents|mesh-ancestor
64994913|NCT00090311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64994914|NCT00090311|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64994915|NCT00090311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64994916|NCT00090311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64994917|NCT00090311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994919|NCT02959762|Vitamin K|vitamin k|mesh-list
64994926|NCT02959762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994927|NCT02959762|Hemostatics|hemostatics|mesh-ancestor
64994928|NCT02959762|Coagulants|coagulants|mesh-ancestor
64994929|NCT00345826|Dasatinib|dasatinib|mesh-list
64994930|NCT00345826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994931|NCT00345826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64994932|NCT00345826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994933|NCT00345826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994934|NCT00345982|Sertindole|sertindole|mesh-list
64994935|NCT00345982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64994936|NCT00345982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64994937|NCT00345982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64994938|NCT00345982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994939|NCT00345982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64994940|NCT00346099|Capecitabine|capecitabine|mesh-list
64994941|NCT00346099|Oxaliplatin|oxaliplatin|mesh-list
64994942|NCT00346099|Panitumumab|panitumumab|mesh-list
64994943|NCT00346099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64994944|NCT00346099|Antimetabolites|antimetabolites|mesh-ancestor
64994945|NCT00346099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64994946|NCT00346099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994948|NCT00125736|Rabeprazole|rabeprazole|mesh-list
64994979|NCT00346489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64994980|NCT00346489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994981|NCT00346489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64994982|NCT00346489|Immunologic Factors|immunologic factors|mesh-ancestor
64994983|NCT00346489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64994984|NCT00346489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64994985|NCT00346489|Alkylating Agents|alkylating agents|mesh-ancestor
64994986|NCT00346489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64994987|NCT00346489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64994988|NCT00125814|Interferons|interferons|mesh-list
64994989|NCT00125814|Interferon-alpha|interferon-alpha|mesh-list
64994990|NCT00125814|Interferon alpha-2|interferon alpha-2|mesh-list
64994991|NCT00125814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64994992|NCT00125814|Antiviral Agents|antiviral agents|mesh-ancestor
64994993|NCT00125814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64994994|NCT00125814|Immunologic Factors|immunologic factors|mesh-ancestor
64995038|NCT04728932|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64995039|NCT04728932|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64995040|NCT04728932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995041|NCT04728932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995042|NCT04728932|Protective Agents|protective agents|mesh-ancestor
64995043|NCT04728932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995044|NCT00125892|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64995045|NCT00125892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64995046|NCT00125892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64995047|NCT00125892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64995048|NCT00125892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995049|NCT00125892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64995050|NCT00125892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995051|NCT00125892|Analgesics|analgesics|mesh-ancestor
64995052|NCT00125892|Sensory System Agents|sensory system agents|mesh-ancestor
64995053|NCT00125892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64995054|NCT00125892|Antidepressive Agents|antidepressive agents|mesh-ancestor
64995055|NCT00125892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64995056|NCT00125892|Dopamine Agents|dopamine agents|mesh-ancestor
64995057|NCT00346801|Celecoxib|celecoxib|mesh-list
64995058|NCT00346801|Cisplatin|cisplatin|mesh-list
64995059|NCT00346801|Irinotecan|irinotecan|mesh-list
64995060|NCT00346801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995061|NCT00346801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64995062|NCT00346801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64995083|NCT00346879|PENTA|penta|mesh-list
64995085|NCT00346879|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64995086|NCT00346879|Antithrombins|antithrombins|mesh-ancestor
64995087|NCT00346879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64995088|NCT00346879|Protease Inhibitors|protease inhibitors|mesh-ancestor
64995089|NCT00346879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995090|NCT00346879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995091|NCT00346879|Anticoagulants|anticoagulants|mesh-ancestor
64995092|NCT00346879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64995093|NCT00346879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64995094|NCT00126009|Amisulpride|amisulpride|mesh-list
64995095|NCT00126009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64995096|NCT00126009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64995097|NCT00126009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64995098|NCT00126009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995099|NCT00126009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64995100|NCT00126009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64995101|NCT00126009|Dopamine Agents|dopamine agents|mesh-ancestor
64995102|NCT00126009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64995103|NCT00126009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995104|NCT00126009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64995105|NCT00126009|Antidepressive Agents|antidepressive agents|mesh-ancestor
64995106|NCT00346918|Sirolimus|sirolimus|mesh-list
64995107|NCT00346918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64995137|NCT00402480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64995138|NCT00347035|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64995139|NCT00347035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64995140|NCT00347035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64995141|NCT00347035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64995142|NCT00347035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64995143|NCT00347035|Adrenergic Agents|adrenergic agents|mesh-ancestor
64995144|NCT00347035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64995145|NCT00347035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995146|NCT00347035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995147|NCT00347113|Albendazole|albendazole|mesh-list
64995148|NCT00347113|Praziquantel|praziquantel|mesh-list
64995149|NCT00347113|Anthelmintics|anthelmintics|mesh-ancestor
64995150|NCT00347113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64995151|NCT00347113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64995152|NCT00347113|Anticestodal Agents|anticestodal agents|mesh-ancestor
64995153|NCT00347113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64995154|NCT00347113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64995155|NCT00347113|Tubulin Modulators|tubulin modulators|mesh-ancestor
64995156|NCT00347113|Antimitotic Agents|antimitotic agents|mesh-ancestor
64995157|NCT00347113|Mitosis Modulators|mitosis modulators|mesh-ancestor
64995191|NCT00402558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64995192|NCT00402558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995193|NCT00402558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64995194|NCT00402558|Antimetabolites|antimetabolites|mesh-ancestor
64995195|NCT00402558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995196|NCT00402558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995197|NCT00402558|Dermatologic Agents|dermatologic agents|mesh-ancestor
64995198|NCT00402558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995199|NCT00402558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64995200|NCT00402558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64995201|NCT00402558|Immunologic Factors|immunologic factors|mesh-ancestor
64995202|NCT00402558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64995203|NCT00402558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64995204|NCT00402558|Antiviral Agents|antiviral agents|mesh-ancestor
64995205|NCT00402558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64995206|NCT00402558|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64995207|NCT00402558|Alkylating Agents|alkylating agents|mesh-ancestor
64995208|NCT00402558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64995209|NCT00402558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64995210|NCT00402558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64995211|NCT00402558|Analgesics|analgesics|mesh-ancestor
64995212|NCT00402558|Sensory System Agents|sensory system agents|mesh-ancestor
64995213|NCT00402558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64995214|NCT00402558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64995242|NCT00347425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64995243|NCT00347425|Antidepressive Agents|antidepressive agents|mesh-ancestor
64995244|NCT00347425|Dopamine Agonists|dopamine agonists|mesh-ancestor
64995245|NCT00347425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64995246|NCT00347425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64995247|NCT00347425|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64995248|NCT00347425|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64995249|NCT00126048|Atorvastatin|atorvastatin|mesh-list
64995250|NCT00126048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64995251|NCT00126048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64995252|NCT00126048|Antimetabolites|antimetabolites|mesh-ancestor
64995253|NCT00126048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995254|NCT00126048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64995255|NCT00126048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64995256|NCT00126048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995257|NCT00126087|Dopamine|dopamine|mesh-list
64995258|NCT00126087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64995259|NCT00126087|Sympathomimetics|sympathomimetics|mesh-ancestor
64995260|NCT00126087|Autonomic Agents|autonomic agents|mesh-ancestor
64995261|NCT00126087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64995262|NCT00126087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995263|NCT00126087|Dopamine Agents|dopamine agents|mesh-ancestor
64995264|NCT00126087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64995265|NCT00126087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995266|NCT00126087|Protective Agents|protective agents|mesh-ancestor
64995267|NCT00347503|Ketorolac|ketorolac|mesh-list
64995289|NCT00347581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64995290|NCT00347581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995291|NCT00347581|Sympathomimetics|sympathomimetics|mesh-ancestor
64995292|NCT00347581|Autonomic Agents|autonomic agents|mesh-ancestor
64995293|NCT00347581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64995294|NCT00347581|Dopamine Agents|dopamine agents|mesh-ancestor
64995295|NCT00347581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64995296|NCT00347581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995297|NCT00347581|Adrenergic Agents|adrenergic agents|mesh-ancestor
64995298|NCT00347581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64995299|NCT00347581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64995300|NCT00347581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64995301|NCT00347581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64995350|NCT00426478|Vasodilator Agents|vasodilator agents|mesh-ancestor
64995351|NCT00426478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64995352|NCT00426478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64995353|NCT00426478|Diuretics|diuretics|mesh-ancestor
64995354|NCT00426478|Natriuretic Agents|natriuretic agents|mesh-ancestor
64995355|NCT00426478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64995356|NCT04705519|Paclitaxel|paclitaxel|mesh-list
64995357|NCT04705519|Bevacizumab|bevacizumab|mesh-list
64995358|NCT04705519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64995359|NCT04705519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995360|NCT04705519|Tubulin Modulators|tubulin modulators|mesh-ancestor
64995361|NCT04705519|Antimitotic Agents|antimitotic agents|mesh-ancestor
64995362|NCT04705519|Mitosis Modulators|mitosis modulators|mesh-ancestor
64995363|NCT04705519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995364|NCT04705519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64995365|NCT04705519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64995366|NCT04705519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64995367|NCT04705519|Growth Substances|growth substances|mesh-ancestor
64995368|NCT04705519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995369|NCT04705519|Growth Inhibitors|growth inhibitors|mesh-ancestor
64995370|NCT00126282|Cycloserine|cycloserine|mesh-list
64995371|NCT00126282|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64995372|NCT00126282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64995373|NCT00126282|Renal Agents|renal agents|mesh-ancestor
64995374|NCT00126282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64995375|NCT00126282|Antitubercular Agents|antitubercular agents|mesh-ancestor
64995376|NCT00126282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64995396|NCT00426673|Anticonvulsants|anticonvulsants|mesh-ancestor
64995397|NCT00426712|1018 oligonucleotide|1018 oligonucleotide|mesh-list
64995398|NCT00426712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64995399|NCT00426712|Immunologic Factors|immunologic factors|mesh-ancestor
64995400|NCT00426712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995401|NCT00091247|Tetracycline|tetracycline|mesh-list
64995402|NCT00091247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64995403|NCT00091247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64995404|NCT00091247|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64995405|NCT00091247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995406|NCT00091247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995407|NCT00126360|Anastrozole|anastrozole|mesh-list
64995408|NCT00126360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64995409|NCT00126360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995410|NCT00126360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64995411|NCT00126360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64995412|NCT00126360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995413|NCT00126360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995452|NCT00091325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995453|NCT00091325|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64995454|NCT00091325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64995455|NCT00091325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995456|NCT00091325|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64995457|NCT00126516|Angiotensin II|angiotensin ii|mesh-list
64995458|NCT00126516|Giapreza|giapreza|mesh-list
64995459|NCT00126516|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64995460|NCT00126516|Angiotensinogen|angiotensinogen|mesh-list
64995461|NCT00126516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64995462|NCT00126516|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64995463|NCT00126516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995464|NCT00126516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64995465|NCT00126516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64995466|NCT00126516|Protease Inhibitors|protease inhibitors|mesh-ancestor
64995467|NCT00091520|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64995468|NCT00091520|Natriuretic Agents|natriuretic agents|mesh-ancestor
64995469|NCT00091520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995470|NCT04050462|Nivolumab|nivolumab|mesh-list
64995471|NCT04050462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64995472|NCT04050462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995473|NCT04050462|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64995474|NCT04050462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995475|NCT04710888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64995476|NCT01058005|Interferons|interferons|mesh-list
64995477|NCT01058005|Interferon-beta|interferon-beta|mesh-list
64995478|NCT01058005|Interferon beta-1a|interferon beta-1a|mesh-list
64995480|NCT01058005|Natalizumab|natalizumab|mesh-list
64995499|NCT00426829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64995500|NCT00426829|Growth Substances|growth substances|mesh-ancestor
64995501|NCT00426829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995502|NCT00426829|Growth Inhibitors|growth inhibitors|mesh-ancestor
64995503|NCT00426946|Reboxetine|reboxetine|mesh-list
64995569|NCT00427570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64995570|NCT00427570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995571|NCT00427570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64995572|NCT00427570|Immunologic Factors|immunologic factors|mesh-ancestor
64995573|NCT00427570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995574|NCT00427570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64995575|NCT00427570|Tubulin Modulators|tubulin modulators|mesh-ancestor
64995576|NCT00427570|Antimitotic Agents|antimitotic agents|mesh-ancestor
64995577|NCT00427570|Mitosis Modulators|mitosis modulators|mesh-ancestor
64995578|NCT00427570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64995579|NCT00427570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64995580|NCT00427570|Alkylating Agents|alkylating agents|mesh-ancestor
64995581|NCT00427609|Penicillin G Benzathine|penicillin g benzathine|mesh-list
64995582|NCT00427609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64995583|NCT00427609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64995584|NCT00091910|Epoetin Alfa|epoetin alfa|mesh-list
64995585|NCT00091910|Hematinics|hematinics|mesh-ancestor
64995586|NCT00427882|Alfuzosin|alfuzosin|mesh-list
64995587|NCT00427882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64995588|NCT00427882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64995589|NCT00427882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64995590|NCT00427882|Adrenergic Agents|adrenergic agents|mesh-ancestor
64995591|NCT00427882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64995592|NCT00427882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995593|NCT00427882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995594|NCT00427882|Urological Agents|urological agents|mesh-ancestor
64995595|NCT04704622|Midazolam|midazolam|mesh-list
64995596|NCT04704622|Dexmedetomidine|dexmedetomidine|mesh-list
64995597|NCT04704622|Ketamine|ketamine|mesh-list
64995598|NCT04704622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64995599|NCT04704622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64995600|NCT04704622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995601|NCT04704622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64995610|NCT04704622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995611|NCT04704622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64995612|NCT04704622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64995613|NCT04704622|Anesthetics, General|anesthetics, general|mesh-ancestor
64995614|NCT04704622|Anesthetics|anesthetics|mesh-ancestor
64995615|NCT04704622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64995616|NCT04704622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64995617|NCT04704622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64995618|NCT04704622|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64995619|NCT04704622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64995620|NCT04704622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64995621|NCT04704622|GABA Modulators|gaba modulators|mesh-ancestor
64995622|NCT04704622|GABA Agents|gaba agents|mesh-ancestor
64995623|NCT00428194|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64995624|NCT00428194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995625|NCT00428194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64995626|NCT00428194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995627|NCT00428194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995628|NCT03769467|Pembrolizumab|pembrolizumab|mesh-list
64995629|NCT03769467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64995630|NCT03769467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995631|NCT00092183|Ondansetron|ondansetron|mesh-list
64995632|NCT00092183|Aprepitant|aprepitant|mesh-list
64995633|NCT00092183|Antiemetics|antiemetics|mesh-ancestor
64995661|NCT01580254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64995662|NCT00428311|Metformin|metformin|mesh-list
64995663|NCT00428311|Cyproterone Acetate|cyproterone acetate|mesh-list
64995664|NCT00428311|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64995665|NCT00428311|Estradiol|estradiol|mesh-list
64995666|NCT00428311|Cyproterone|cyproterone|mesh-list
64995667|NCT00428311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64995668|NCT00428311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995669|NCT00428311|Estrogens|estrogens|mesh-ancestor
64995670|NCT00428311|Hormones|hormones|mesh-ancestor
64995671|NCT00428311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64995725|NCT00092339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64995726|NCT00092339|Analgesics|analgesics|mesh-ancestor
64995727|NCT00092339|Sensory System Agents|sensory system agents|mesh-ancestor
64995728|NCT00092339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64995729|NCT00092339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995730|NCT00092339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64995731|NCT00092339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64995732|NCT00428545|Bevacizumab|bevacizumab|mesh-list
64995733|NCT00428545|Bortezomib|bortezomib|mesh-list
64995791|NCT00093158|Antithrombins|antithrombins|mesh-ancestor
64995792|NCT00093158|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64995793|NCT00093158|Protease Inhibitors|protease inhibitors|mesh-ancestor
64995794|NCT00093158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64995795|NCT00093158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995796|NCT03501498|Loperamide|loperamide|mesh-list
64995864|NCT00093509|Protective Agents|protective agents|mesh-ancestor
64995865|NCT00093509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995866|NCT00093548|Vaccines|vaccines|mesh-list
64995867|NCT00093548|Sargramostim|sargramostim|mesh-list
64995868|NCT00093548|Immunologic Factors|immunologic factors|mesh-ancestor
64995869|NCT00093548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995870|NCT05549895|Dexamethasone|dexamethasone|mesh-list
64995871|NCT05549895|Bupivacaine|bupivacaine|mesh-list
64995872|NCT05549895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64995873|NCT05549895|Antiemetics|antiemetics|mesh-ancestor
64995874|NCT05549895|Autonomic Agents|autonomic agents|mesh-ancestor
64995932|NCT05543109|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64995933|NCT05543109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64995934|NCT00093665|Fluorouracil|fluorouracil|mesh-list
64995935|NCT00093665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64995936|NCT00093665|Antimetabolites|antimetabolites|mesh-ancestor
64995937|NCT00093665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64995938|NCT00093665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64995939|NCT00093665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64995940|NCT00093665|Immunologic Factors|immunologic factors|mesh-ancestor
64995941|NCT00093665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64995998|NCT00093743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64995999|NCT00093743|Immunologic Factors|immunologic factors|mesh-ancestor
64996000|NCT00093743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996001|NCT00093743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996002|NCT00093743|Antifungal Agents|antifungal agents|mesh-ancestor
64996003|NCT00093743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996004|NCT00093743|Dermatologic Agents|dermatologic agents|mesh-ancestor
64996005|NCT00093743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64996006|NCT00093743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64996007|NCT00093743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64996008|NCT00093743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64996009|NCT00093743|Antitubercular Agents|antitubercular agents|mesh-ancestor
64996010|NCT00093743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64996011|NCT00400322|Valganciclovir|valganciclovir|mesh-list
64996012|NCT00400322|Antiviral Agents|antiviral agents|mesh-ancestor
64996013|NCT00400322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996014|NCT00093860|Propranolol|propranolol|mesh-list
64996015|NCT00093860|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64996016|NCT00093860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64996017|NCT00093860|Adrenergic Agents|adrenergic agents|mesh-ancestor
64996018|NCT00093860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64996019|NCT00093860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996020|NCT00093860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996021|NCT00093860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64996048|NCT00094367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64996049|NCT00094406|Dimercaprol|dimercaprol|mesh-list
64996050|NCT00094406|Carbon Monoxide|carbon monoxide|mesh-list
64996051|NCT00094406|Chelating Agents|chelating agents|mesh-ancestor
64996052|NCT00094406|Sequestering Agents|sequestering agents|mesh-ancestor
64996053|NCT00094406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996054|NCT00094406|Antimetabolites|antimetabolites|mesh-ancestor
64996055|NCT00094406|Gasotransmitters|gasotransmitters|mesh-ancestor
64996056|NCT00094406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64996057|NCT00094406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996058|NCT00094484|Cinacalcet|cinacalcet|mesh-list
64996059|NCT00094484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64996060|NCT00094484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996061|NCT00094484|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64996062|NCT00094484|Hormone Antagonists|hormone antagonists|mesh-ancestor
64996063|NCT00094484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64996106|NCT00094640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64996107|NCT00094640|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64996108|NCT00094640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64996109|NCT00094640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64996110|NCT00094640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996111|NCT00094640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64996112|NCT00094640|Serotonin Agents|serotonin agents|mesh-ancestor
64996113|NCT02415309|Melatonin|melatonin|mesh-list
64996114|NCT02415309|Antioxidants|antioxidants|mesh-ancestor
64996115|NCT02415309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996169|NCT00095225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996170|NCT00095225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996171|NCT00095264|Darbepoetin alfa|darbepoetin alfa|mesh-list
64996172|NCT00095264|Hematinics|hematinics|mesh-ancestor
64996173|NCT01054729|Sofosbuvir|sofosbuvir|mesh-list
64996174|NCT01054729|Antiviral Agents|antiviral agents|mesh-ancestor
64996175|NCT01054729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996176|NCT00403611|Praziquantel|praziquantel|mesh-list
64996177|NCT00403611|Anthelmintics|anthelmintics|mesh-ancestor
64996178|NCT00403611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64996179|NCT00403611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996180|NCT00428896|Gefitinib|gefitinib|mesh-list
64996181|NCT00428896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996182|NCT00428896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64996183|NCT00428896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996184|NCT00428896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996185|NCT01990911|Diuretics|diuretics|mesh-list
64996186|NCT01990911|Natriuretic Agents|natriuretic agents|mesh-ancestor
64996187|NCT01990911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996188|NCT00429091|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64996189|NCT00429091|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64996190|NCT00429091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64996191|NCT00429091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64943204|NCT00034047|Nafarelin|nafarelin|mesh-list
64996192|NCT00429091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996193|NCT00429091|Adrenergic Agents|adrenergic agents|mesh-ancestor
64996194|NCT00429091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64996195|NCT00429091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996196|NCT00095459|Bevacizumab|bevacizumab|mesh-list
64996197|NCT00095459|Sorafenib|sorafenib|mesh-list
64996198|NCT00095459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64996208|NCT00429208|Nicotine|nicotine|mesh-list
64996211|NCT00429208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64996212|NCT00429208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996213|NCT00429208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64996214|NCT00429208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64996215|NCT00429208|Cholinergic Agents|cholinergic agents|mesh-ancestor
64996216|NCT00429208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64996217|NCT00429208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996218|NCT00429247|Trastuzumab|trastuzumab|mesh-list
64996278|NCT00095810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64996279|NCT00095810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64996280|NCT00095810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996281|NCT00095810|Dopamine Agonists|dopamine agonists|mesh-ancestor
64996282|NCT00095810|Dopamine Agents|dopamine agents|mesh-ancestor
64996283|NCT00095810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64996284|NCT00095810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996285|NCT00095810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64996286|NCT00095810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64996287|NCT00095810|Serotonin Agents|serotonin agents|mesh-ancestor
64996288|NCT00095810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64996289|NCT00095810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64996290|NCT00095810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64996291|NCT00095810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64996292|NCT05234112|Acetic Acid|acetic acid|mesh-list
64996293|NCT05234112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64996294|NCT05234112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996295|NCT01054300|Ertugliflozin|ertugliflozin|mesh-list
64996296|NCT01054300|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64996297|NCT01054300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996298|NCT01054300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64996299|NCT01054300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996300|NCT00095888|Gemcitabine|gemcitabine|mesh-list
64996301|NCT00095888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64996302|NCT00095888|Antimetabolites|antimetabolites|mesh-ancestor
64996303|NCT00095888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996304|NCT00095888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996305|NCT00095888|Antiviral Agents|antiviral agents|mesh-ancestor
64996311|NCT00429676|Haloperidol|haloperidol|mesh-list
64996321|NCT00429676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64996322|NCT00429676|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64996323|NCT00429676|Dopamine Agents|dopamine agents|mesh-ancestor
64996324|NCT00429676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64996325|NCT00429676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996326|NCT00429676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64996327|NCT00429715|Aluminum sulfate|aluminum sulfate|mesh-list
64996328|NCT00429715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64996329|NCT00429715|Immunologic Factors|immunologic factors|mesh-ancestor
64996330|NCT00429715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996331|NCT00095927|Paclitaxel|paclitaxel|mesh-list
64996332|NCT00095927|Carboplatin|carboplatin|mesh-list
64996333|NCT00095927|Amifostine|amifostine|mesh-list
64996334|NCT00095927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64996384|NCT00429832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64996385|NCT00429832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64996386|NCT00429832|Histamine Antagonists|histamine antagonists|mesh-ancestor
64996387|NCT00429832|Histamine Agents|histamine agents|mesh-ancestor
64996388|NCT00429832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64996389|NCT00429832|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64996390|NCT00429832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64996391|NCT00429832|Anesthetics, Local|anesthetics, local|mesh-ancestor
64996392|NCT00429832|Anesthetics|anesthetics|mesh-ancestor
64996393|NCT00429832|Sensory System Agents|sensory system agents|mesh-ancestor
64996394|NCT00429871|Docetaxel|docetaxel|mesh-list
64996395|NCT00429871|Capecitabine|capecitabine|mesh-list
64996396|NCT00429871|Epirubicin|epirubicin|mesh-list
64996397|NCT00429871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996398|NCT00429871|Tubulin Modulators|tubulin modulators|mesh-ancestor
64996399|NCT00429871|Antimitotic Agents|antimitotic agents|mesh-ancestor
64996400|NCT00429871|Mitosis Modulators|mitosis modulators|mesh-ancestor
64996401|NCT00429871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996402|NCT00429871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64996403|NCT00429871|Antimetabolites|antimetabolites|mesh-ancestor
64996404|NCT00429871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64996405|NCT00429871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64996406|NCT00429871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64996408|NCT00095966|Gemcitabine|gemcitabine|mesh-list
64996439|NCT00096005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996440|NCT00430105|Cyclophosphamide|cyclophosphamide|mesh-list
64996441|NCT00430105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64996442|NCT00430105|Immunologic Factors|immunologic factors|mesh-ancestor
64996443|NCT00430105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996444|NCT00430105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64996445|NCT00430105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64996446|NCT00430105|Alkylating Agents|alkylating agents|mesh-ancestor
64996447|NCT00430105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996448|NCT00430105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996449|NCT00430105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64996450|NCT00430144|Belotecan|belotecan|mesh-list
64996451|NCT00430144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64996452|NCT00430144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64996453|NCT00430144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996454|NCT00430144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996455|NCT00430144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996456|NCT00430261|Sunitinib|sunitinib|mesh-list
64996457|NCT00430261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996458|NCT00430261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64996459|NCT00430261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64996460|NCT00430261|Growth Substances|growth substances|mesh-ancestor
64996461|NCT00430261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996462|NCT00430261|Growth Inhibitors|growth inhibitors|mesh-ancestor
64996463|NCT00430261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64996464|NCT00430261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996465|NCT00430261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996466|NCT00096083|Melphalan|melphalan|mesh-list
64996485|NCT01726452|Tubulin Modulators|tubulin modulators|mesh-ancestor
64996486|NCT01726452|Antimitotic Agents|antimitotic agents|mesh-ancestor
64996487|NCT01726452|Mitosis Modulators|mitosis modulators|mesh-ancestor
64996488|NCT01726452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996489|NCT01726452|Antimetabolites|antimetabolites|mesh-ancestor
64996490|NCT01726452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64996491|NCT01726452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64996492|NCT01726452|Immunologic Factors|immunologic factors|mesh-ancestor
64996493|NCT01726452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996494|NCT01726452|Antidotes|antidotes|mesh-ancestor
64996496|NCT01726452|Vitamin B Complex|vitamin b complex|mesh-ancestor
64996497|NCT01726452|Vitamins|vitamins|mesh-ancestor
64996498|NCT01726452|Micronutrients|micronutrients|mesh-ancestor
64996499|NCT01726452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64996500|NCT01726452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64996501|NCT01726452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64996502|NCT01726452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996503|NCT00096317|Ketoconazole|ketoconazole|mesh-list
64996504|NCT00096317|Antifungal Agents|antifungal agents|mesh-ancestor
64996505|NCT00096317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996506|NCT00096317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64996507|NCT00096317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64996508|NCT00096317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996509|NCT00096317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996510|NCT00096317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64996511|NCT00096317|Hormone Antagonists|hormone antagonists|mesh-ancestor
64996512|NCT00096317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64996513|NCT00096317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996515|NCT00096395|Gemcitabine|gemcitabine|mesh-list
64996530|NCT00096434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64996531|NCT00096434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996532|NCT00096434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996533|NCT00096473|Donepezil|donepezil|mesh-list
64996534|NCT00096473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64996535|NCT00096473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996536|NCT00096473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996537|NCT00096473|Cholinergic Agents|cholinergic agents|mesh-ancestor
64996538|NCT00096473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64996539|NCT00096473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996540|NCT00096473|Nootropic Agents|nootropic agents|mesh-ancestor
64996541|NCT00130494|Zoledronic Acid|zoledronic acid|mesh-list
64996542|NCT00130494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64996543|NCT00130494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996544|NCT00096512|Sorafenib|sorafenib|mesh-list
64996545|NCT00096512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996546|NCT00096512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64996547|NCT00096512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996548|NCT00096512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996549|NCT00096551|Metronidazole|metronidazole|mesh-list
64996550|NCT00096551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996551|NCT00096551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64996581|NCT00430807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64996582|NCT00430807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64996583|NCT00430807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996584|NCT00430807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996585|NCT00430807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996586|NCT00430807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64996587|NCT00096668|Paclitaxel|paclitaxel|mesh-list
64467198|NCT00410956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467200|NCT03800524|Antiviral Agents|antiviral agents|mesh-ancestor
64996603|NCT00430924|Eplerenone|eplerenone|mesh-list
64996638|NCT00096863|Ziprasidone|ziprasidone|mesh-list
64943641|NCT01805687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64996639|NCT00096863|Antiemetics|antiemetics|mesh-ancestor
64996640|NCT00096863|Autonomic Agents|autonomic agents|mesh-ancestor
64996641|NCT00096863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64996707|NCT00431119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64996708|NCT00431119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64996709|NCT00431119|Immunologic Factors|immunologic factors|mesh-ancestor
64996710|NCT00431119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996711|NCT00431119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64996712|NCT00097019|Bevacizumab|bevacizumab|mesh-list
64996713|NCT00097019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64996714|NCT00097019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996715|NCT00097019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64996716|NCT00097019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64996717|NCT00097019|Growth Substances|growth substances|mesh-ancestor
64996718|NCT00097019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996719|NCT00097019|Growth Inhibitors|growth inhibitors|mesh-ancestor
64996721|NCT00431197|Testosterone|testosterone|mesh-list
64996722|NCT00431197|Antifungal Agents|antifungal agents|mesh-ancestor
64996723|NCT00431197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996724|NCT00431197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64996725|NCT00431197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64996726|NCT00431197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996727|NCT00431197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996728|NCT00431197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64996729|NCT00431197|Hormone Antagonists|hormone antagonists|mesh-ancestor
64996730|NCT00431197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64996731|NCT00431197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996732|NCT00431197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64996755|NCT00431236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64996756|NCT00431236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64996757|NCT00431236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64996758|NCT00431236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64996759|NCT00431236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64996760|NCT00431236|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64996761|NCT00431275|Tremelimumab|tremelimumab|mesh-list
64996762|NCT00431275|Ipilimumab|ipilimumab|mesh-list
64996763|NCT00431275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996764|NCT00431275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64996765|NCT00431275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64996766|NCT00431275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996767|NCT00431353|Valganciclovir|valganciclovir|mesh-list
64996768|NCT00431353|Ganciclovir|ganciclovir|mesh-list
64996769|NCT00431353|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64996770|NCT00431353|Antiviral Agents|antiviral agents|mesh-ancestor
64996771|NCT00431353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996772|NCT00431353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64996773|NCT00431353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996774|NCT00431353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996775|NCT00130845|Octreotide|octreotide|mesh-list
64996776|NCT00130845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64996777|NCT00130845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64996806|NCT00431392|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64996807|NCT00431392|Cholinergic Agents|cholinergic agents|mesh-ancestor
64996808|NCT00431392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64996809|NCT00431392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64996810|NCT00431392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64996811|NCT00431392|Vasodilator Agents|vasodilator agents|mesh-ancestor
64996812|NCT00431392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996813|NCT00130884|Simendan|simendan|mesh-list
64996814|NCT00130884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64996815|NCT00130884|Vasodilator Agents|vasodilator agents|mesh-ancestor
64996816|NCT00130884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64996817|NCT00130884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64996818|NCT00130884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996819|NCT00130884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996820|NCT00130884|Protective Agents|protective agents|mesh-ancestor
64996821|NCT00130884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996822|NCT01052662|Memantine|memantine|mesh-list
64996823|NCT01052662|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64996824|NCT01052662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64996825|NCT01052662|Dopamine Agents|dopamine agents|mesh-ancestor
64996860|NCT05001828|Antimetabolites|antimetabolites|mesh-ancestor
64996861|NCT05001828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996862|NCT05001828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996863|NCT05001828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996864|NCT04703608|Ivermectin|ivermectin|mesh-list
64996865|NCT04703608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64996866|NCT04703608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996867|NCT04727073|Spironolactone|spironolactone|mesh-list
64996868|NCT04727073|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64996869|NCT04727073|Hormone Antagonists|hormone antagonists|mesh-ancestor
64996870|NCT04727073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64996871|NCT04727073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996872|NCT04727073|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64996873|NCT04727073|Diuretics|diuretics|mesh-ancestor
64996874|NCT04727073|Natriuretic Agents|natriuretic agents|mesh-ancestor
64996875|NCT00432016|Zidovudine|zidovudine|mesh-list
64996876|NCT00432016|Antimetabolites|antimetabolites|mesh-ancestor
64996877|NCT00432016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996878|NCT00432016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64996879|NCT00432016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64996880|NCT00432016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996881|NCT00432016|Antiviral Agents|antiviral agents|mesh-ancestor
64996882|NCT00432016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64996912|NCT01052038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64996913|NCT01052038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64996914|NCT01052038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64996915|NCT01052038|Protease Inhibitors|protease inhibitors|mesh-ancestor
64996916|NCT01052038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996917|NCT01052038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996918|NCT00432055|Botulinum Toxins|botulinum toxins|mesh-list
64996919|NCT00432055|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64996920|NCT00432055|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64996921|NCT00432055|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64996922|NCT00432055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64996923|NCT00432055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64996924|NCT00432055|Cholinergic Agents|cholinergic agents|mesh-ancestor
64996925|NCT00432055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64996926|NCT00432055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996927|NCT00432055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64996928|NCT00432055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64996929|NCT04711044|Menthol|menthol|mesh-list
64996930|NCT04711044|Histamine|histamine|mesh-list
64996931|NCT04711044|Antipruritics|antipruritics|mesh-ancestor
64996932|NCT04711044|Dermatologic Agents|dermatologic agents|mesh-ancestor
64996933|NCT04711044|Histamine Agonists|histamine agonists|mesh-ancestor
64996934|NCT04711044|Histamine Agents|histamine agents|mesh-ancestor
64996935|NCT04711044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64996961|NCT00097760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996962|NCT00432406|Etanercept|etanercept|mesh-list
64996963|NCT00432406|Infliximab|infliximab|mesh-list
64996964|NCT00432406|Dermatologic Agents|dermatologic agents|mesh-ancestor
64996965|NCT00432406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64996966|NCT00432406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64996967|NCT00432406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64996968|NCT00432406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64996969|NCT00432406|Analgesics|analgesics|mesh-ancestor
64996970|NCT00432406|Sensory System Agents|sensory system agents|mesh-ancestor
64996971|NCT00432406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64996972|NCT00432406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996973|NCT00432406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64996974|NCT00432406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64996975|NCT00432406|Immunologic Factors|immunologic factors|mesh-ancestor
64996976|NCT00131118|Zoledronic Acid|zoledronic acid|mesh-list
64996977|NCT00131118|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64996978|NCT00131118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996979|NCT02957656|Vaccines|vaccines|mesh-list
64996980|NCT02957656|Immunologic Factors|immunologic factors|mesh-ancestor
64996981|NCT02957656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64996982|NCT00097799|Ritonavir|ritonavir|mesh-list
64996983|NCT00097799|Tipranavir|tipranavir|mesh-list
64996984|NCT00097799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64996985|NCT00097799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64996986|NCT00097799|Protease Inhibitors|protease inhibitors|mesh-ancestor
64996987|NCT00097799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64996989|NCT00097799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64997009|NCT00432757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64997010|NCT00432757|Histamine Antagonists|histamine antagonists|mesh-ancestor
64997011|NCT00432757|Histamine Agents|histamine agents|mesh-ancestor
64997012|NCT00432757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64997013|NCT00432757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997014|NCT00432757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997015|NCT00432757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64997016|NCT00432796|Dalteparin|dalteparin|mesh-list
64997017|NCT00432796|Tinzaparin|tinzaparin|mesh-list
64997018|NCT00432796|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64997019|NCT00432796|Anticoagulants|anticoagulants|mesh-ancestor
64997020|NCT00432796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64997030|NCT00097916|Memantine|memantine|mesh-list
64997073|NCT00098033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997074|NCT00403065|Dexamethasone|dexamethasone|mesh-list
64997075|NCT00403065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64997076|NCT00403065|Antiemetics|antiemetics|mesh-ancestor
64997077|NCT00403065|Autonomic Agents|autonomic agents|mesh-ancestor
64997078|NCT00403065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64997079|NCT00403065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997080|NCT00403065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64997081|NCT00403065|Glucocorticoids|glucocorticoids|mesh-ancestor
64997082|NCT00403065|Hormones|hormones|mesh-ancestor
64997083|NCT00403065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64997138|NCT00433225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64997139|NCT00433225|Protective Agents|protective agents|mesh-ancestor
64997140|NCT00433225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64997141|NCT00433225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64997142|NCT00433225|Analgesics|analgesics|mesh-ancestor
64997143|NCT00433225|Sensory System Agents|sensory system agents|mesh-ancestor
64997144|NCT00433225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64997145|NCT00433225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64997146|NCT00433225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997147|NCT00433225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997148|NCT00433225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64997149|NCT00433225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997150|NCT00433225|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64997151|NCT00433225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64997152|NCT00433225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64997153|NCT00433225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64997195|NCT00433498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997196|NCT00433498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64997197|NCT00433498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64997198|NCT00433498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64997199|NCT00433498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997200|NCT00433498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997201|NCT00433498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64997202|NCT00433498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64997203|NCT00433498|Antimetabolites|antimetabolites|mesh-ancestor
64997204|NCT00433498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64997205|NCT00433498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64997206|NCT00433576|Resveratrol|resveratrol|mesh-list
64997207|NCT00433576|Antioxidants|antioxidants|mesh-ancestor
64997208|NCT00433576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997209|NCT00433576|Protective Agents|protective agents|mesh-ancestor
64997210|NCT00433576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997211|NCT00433576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997212|NCT00433576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64997213|NCT00433615|Epoetin Alfa|epoetin alfa|mesh-list
64997214|NCT00433615|Hematinics|hematinics|mesh-ancestor
64997215|NCT00098384|Rifaximin|rifaximin|mesh-list
64997247|NCT00098423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997248|NCT01050790|Lenalidomide|lenalidomide|mesh-list
64997249|NCT01050790|Azacitidine|azacitidine|mesh-list
64997250|NCT01050790|Immunologic Factors|immunologic factors|mesh-ancestor
64997251|NCT01050790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997252|NCT01050790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64997253|NCT01050790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64997254|NCT01050790|Growth Substances|growth substances|mesh-ancestor
64997255|NCT01050790|Growth Inhibitors|growth inhibitors|mesh-ancestor
64997256|NCT01050790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997257|NCT01050790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64997258|NCT01050790|Antimetabolites|antimetabolites|mesh-ancestor
64997259|NCT01050790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997260|NCT01050790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997261|NCT00433927|Leucovorin|leucovorin|mesh-list
64997262|NCT00433927|Folic Acid|folic acid|mesh-list
64997263|NCT00433927|Bevacizumab|bevacizumab|mesh-list
64997264|NCT00433927|Cetuximab|cetuximab|mesh-list
64997265|NCT00433927|Irinotecan|irinotecan|mesh-list
64997303|NCT00098462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997304|NCT00098462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997305|NCT00098501|Sirolimus|sirolimus|mesh-list
64997306|NCT00098501|EKB 569|ekb 569|mesh-list
64997307|NCT00098501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64997308|NCT00098501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997309|NCT00098501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64997310|NCT00098501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997311|NCT00098501|Antifungal Agents|antifungal agents|mesh-ancestor
64997312|NCT00098501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64997313|NCT00098501|Immunologic Factors|immunologic factors|mesh-ancestor
64997314|NCT00098501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997315|NCT00098501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64997317|NCT00098501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997318|NCT00434005|Acetylcysteine|acetylcysteine|mesh-list
64997319|NCT00434005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64997320|NCT00434005|Antiviral Agents|antiviral agents|mesh-ancestor
64997321|NCT00434005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997322|NCT00434005|Expectorants|expectorants|mesh-ancestor
64997323|NCT00434005|Respiratory System Agents|respiratory system agents|mesh-ancestor
64997324|NCT00434005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64997325|NCT00434005|Antioxidants|antioxidants|mesh-ancestor
64997326|NCT00434005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997327|NCT00434005|Protective Agents|protective agents|mesh-ancestor
64997328|NCT00434005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997329|NCT00434005|Antidotes|antidotes|mesh-ancestor
64997330|NCT00434044|Etanercept|etanercept|mesh-list
64997331|NCT00434044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64997332|NCT00434044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64997333|NCT00434044|Analgesics|analgesics|mesh-ancestor
64997334|NCT00434044|Sensory System Agents|sensory system agents|mesh-ancestor
64997348|NCT00434083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64997349|NCT00434083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997350|NCT00434083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64997351|NCT00434083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64997352|NCT00434083|Gout Suppressants|gout suppressants|mesh-ancestor
64997353|NCT00434083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64997354|NCT00434083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997355|NCT00434083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997356|NCT00434083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64997357|NCT00434083|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64997358|NCT00434083|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64997359|NCT00434083|Serotonin Agents|serotonin agents|mesh-ancestor
64997360|NCT00434083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64997361|NCT00098540|Sorafenib|sorafenib|mesh-list
64997362|NCT00098540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997363|NCT00098540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64997364|NCT00098540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997365|NCT00098540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997366|NCT00098579|Doxorubicin|doxorubicin|mesh-list
64997367|NCT00098579|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64997368|NCT00098579|Alvocidib|alvocidib|mesh-list
64997369|NCT00098579|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64997370|NCT00098579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997371|NCT00098579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64997372|NCT00098579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64997373|NCT00098579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997374|NCT00098579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997375|NCT00098579|Growth Inhibitors|growth inhibitors|mesh-ancestor
64997376|NCT00098579|Growth Substances|growth substances|mesh-ancestor
64997377|NCT00098579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997378|NCT00098579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64997379|NCT00098618|Interferons|interferons|mesh-list
64997380|NCT00098618|Interferon-alpha|interferon-alpha|mesh-list
64997381|NCT00098618|Interferon alpha-2|interferon alpha-2|mesh-list
64997382|NCT00098618|Sorafenib|sorafenib|mesh-list
64997386|NCT00098618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64997387|NCT00098618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997388|NCT00098618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997389|NCT00098618|Immunologic Factors|immunologic factors|mesh-ancestor
64997390|NCT00098618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997391|NCT00098735|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64997392|NCT00098735|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64997393|NCT00098735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997394|NCT00098735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64997395|NCT00098735|Immunologic Factors|immunologic factors|mesh-ancestor
64997396|NCT00098735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997397|NCT00098852|Rosiglitazone|rosiglitazone|mesh-list
64997398|NCT00098852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64997399|NCT00098852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997400|NCT01059448|Brodalumab|brodalumab|mesh-list
64997401|NCT01059448|Dermatologic Agents|dermatologic agents|mesh-ancestor
64997402|NCT00098891|Entinostat|entinostat|mesh-list
64997403|NCT00098891|Isotretinoin|isotretinoin|mesh-list
64997404|NCT00098891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
64997405|NCT00098891|Dermatologic Agents|dermatologic agents|mesh-ancestor
64997406|NCT00098891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997407|NCT00098891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997437|NCT01057147|Rebamipide|rebamipide|mesh-list
64997438|NCT01057147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64997439|NCT01057147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64997440|NCT01057147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64997441|NCT01057147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64997442|NCT01057147|Antioxidants|antioxidants|mesh-ancestor
64997443|NCT01057147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997447|NCT00099125|Irinotecan|irinotecan|mesh-list
64997506|NCT04621149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997507|NCT04621149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997508|NCT04621149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997509|NCT04621149|Dental Disinfectants|dental disinfectants|mesh-ancestor
64997510|NCT04621149|Disinfectants|disinfectants|mesh-ancestor
64997511|NCT00099203|Zoledronic Acid|zoledronic acid|mesh-list
64997512|NCT00099203|Ibandronic Acid|ibandronic acid|mesh-list
64997513|NCT00099203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64997514|NCT00099203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997515|NCT00099242|Rivastigmine|rivastigmine|mesh-list
64997516|NCT00099242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64997517|NCT00099242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997518|NCT00099242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997519|NCT00099242|Cholinergic Agents|cholinergic agents|mesh-ancestor
64997520|NCT00099242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64997521|NCT00099242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997522|NCT00099242|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64997523|NCT00099242|Protective Agents|protective agents|mesh-ancestor
64997524|NCT00099320|Exenatide|exenatide|mesh-list
64997525|NCT00099320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64997526|NCT00099320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997527|NCT00099320|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64997557|NCT00403806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64997558|NCT00403806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64997559|NCT00403806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997560|NCT00403806|Protease Inhibitors|protease inhibitors|mesh-ancestor
64997561|NCT00403806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997562|NCT00403806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997563|NCT00400556|Lenograstim|lenograstim|mesh-list
64997564|NCT00400556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64997565|NCT00400556|Immunologic Factors|immunologic factors|mesh-ancestor
64997566|NCT00400556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997567|NCT00400595|Mupirocin|mupirocin|mesh-list
64997568|NCT00400595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64997569|NCT00400595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997570|NCT00400595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64997571|NCT00400595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997572|NCT00400595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997573|NCT00099554|Etanercept|etanercept|mesh-list
64997574|NCT00099554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64997575|NCT00099554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64997576|NCT00099554|Analgesics|analgesics|mesh-ancestor
64997577|NCT00099554|Sensory System Agents|sensory system agents|mesh-ancestor
64997578|NCT00099554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64997579|NCT00099554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997580|NCT00099554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64997581|NCT00099554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64997604|NCT00099749|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64997605|NCT00099749|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64997606|NCT00099749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997607|NCT00099749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64997608|NCT00099749|Immunologic Factors|immunologic factors|mesh-ancestor
64997609|NCT00099749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997610|NCT00132093|Eplerenone|eplerenone|mesh-list
64997611|NCT00132093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64997612|NCT00132093|Hormone Antagonists|hormone antagonists|mesh-ancestor
64997613|NCT00132093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64997614|NCT00132093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997615|NCT00132093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64997616|NCT00132093|Diuretics|diuretics|mesh-ancestor
64997617|NCT00132093|Natriuretic Agents|natriuretic agents|mesh-ancestor
64997618|NCT00132093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64997619|NCT00099788|Ranolazine|ranolazine|mesh-list
64997620|NCT00099788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64997621|NCT00099788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64997622|NCT00099788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997623|NCT00099866|Metformin|metformin|mesh-list
64997624|NCT00099866|Vildagliptin|vildagliptin|mesh-list
64997625|NCT00099866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64997653|NCT04352166|Buprenorphine|buprenorphine|mesh-list
64997654|NCT04352166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64997655|NCT04352166|Narcotics|narcotics|mesh-ancestor
64997657|NCT04352166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997725|NCT00100568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997726|NCT00100568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997727|NCT00100568|Antiviral Agents|antiviral agents|mesh-ancestor
64997728|NCT00100568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997729|NCT00100568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64997730|NCT00100568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64997731|NCT00100568|Antimetabolites|antimetabolites|mesh-ancestor
64997732|NCT00100568|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64997733|NCT00100568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64997734|NCT00100568|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64997735|NCT00100568|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64997736|NCT00100568|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64997737|NCT00100568|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64997738|NCT00132561|Artesunate|artesunate|mesh-list
64997739|NCT00132561|Pyrimethamine|pyrimethamine|mesh-list
64997740|NCT00132561|Sulfadoxine|sulfadoxine|mesh-list
64997741|NCT00132561|Antimalarials|antimalarials|mesh-ancestor
64997742|NCT00132561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64997743|NCT00132561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64997744|NCT00132561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997745|NCT00132561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997746|NCT00132561|Antiviral Agents|antiviral agents|mesh-ancestor
64997747|NCT00132561|Schistosomicides|schistosomicides|mesh-ancestor
64997748|NCT00132561|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64997749|NCT00132561|Anthelmintics|anthelmintics|mesh-ancestor
64997750|NCT00132561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64997751|NCT00132561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997752|NCT00132561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997753|NCT00132561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64997754|NCT00132561|Renal Agents|renal agents|mesh-ancestor
64997755|NCT04728581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64956586|NCT00041054|Etoposide|etoposide|mesh-list
64997768|NCT04728581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64997769|NCT04728581|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64997770|NCT04728581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64997771|NCT04728581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64997772|NCT04728581|Adrenergic Agents|adrenergic agents|mesh-ancestor
64997773|NCT04728581|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64997774|NCT04728581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64997775|NCT04728581|Serotonin Agents|serotonin agents|mesh-ancestor
64997776|NCT04728581|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64997777|NCT04728659|Desogestrel|desogestrel|mesh-list
64997778|NCT04728659|Ganirelix|ganirelix|mesh-list
64997779|NCT04728659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64997780|NCT04728659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64997781|NCT04728659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64997782|NCT04728659|Contraceptive Agents|contraceptive agents|mesh-ancestor
64997783|NCT04728659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64997784|NCT04728659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997785|NCT04728659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64997786|NCT04728659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64997787|NCT04728659|Progestins|progestins|mesh-ancestor
64997788|NCT04728659|Hormones|hormones|mesh-ancestor
64997791|NCT00132600|Bacitracin|bacitracin|mesh-list
64997822|NCT00100646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64997823|NCT00100646|Protease Inhibitors|protease inhibitors|mesh-ancestor
64997824|NCT00100646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997892|NCT00101114|Immunologic Factors|immunologic factors|mesh-ancestor
64997893|NCT00101114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997894|NCT00101153|Cytarabine|cytarabine|mesh-list
64997895|NCT00101153|Daunorubicin|daunorubicin|mesh-list
64997896|NCT00101153|Tipifarnib|tipifarnib|mesh-list
64997897|NCT00101153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64997898|NCT00101153|Antimetabolites|antimetabolites|mesh-ancestor
64997899|NCT00101153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997900|NCT00101153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997901|NCT00101153|Antiviral Agents|antiviral agents|mesh-ancestor
64997902|NCT00101153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997903|NCT00101153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64997904|NCT00101153|Immunologic Factors|immunologic factors|mesh-ancestor
64997905|NCT00101153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997906|NCT00101153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64997907|NCT00101153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64997909|NCT00101153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997952|NCT00101270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64997953|NCT00101270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64997954|NCT00101270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997955|NCT00101270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997956|NCT00101309|Aldesleukin|aldesleukin|mesh-list
64997957|NCT00101309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997958|NCT00101309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64997959|NCT00101309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64997960|NCT00101309|Antiviral Agents|antiviral agents|mesh-ancestor
64997961|NCT00101309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64997962|NCT00101348|Bevacizumab|bevacizumab|mesh-list
64997963|NCT00101348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64997964|NCT00101348|Cetuximab|cetuximab|mesh-list
64997965|NCT00101348|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64997966|NCT00101348|Antibodies|antibodies|mesh-list
64997967|NCT00101348|Immunoglobulins|immunoglobulins|mesh-list
64997968|NCT00101348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64997969|NCT00101348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64997970|NCT00101348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64997971|NCT00101348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64997972|NCT00101348|Growth Substances|growth substances|mesh-ancestor
64997973|NCT00101348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997974|NCT00101348|Growth Inhibitors|growth inhibitors|mesh-ancestor
64997975|NCT00101348|Immunologic Factors|immunologic factors|mesh-ancestor
64997976|NCT00101348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64997977|NCT00101348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997978|NCT00101348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997979|NCT00101426|Ranirestat|ranirestat|mesh-list
64997980|NCT00101426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997981|NCT00101426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64997982|NCT00135525|Paroxetine|paroxetine|mesh-list
64997983|NCT00135525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64997984|NCT00135525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64997985|NCT00135525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64997986|NCT00135525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951572|NCT00026468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951573|NCT00026468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951574|NCT00026468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64951575|NCT00026468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64997987|NCT00135525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64997988|NCT00135525|Serotonin Agents|serotonin agents|mesh-ancestor
64997989|NCT00135525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64997990|NCT00135525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64997991|NCT00135525|Antidepressive Agents|antidepressive agents|mesh-ancestor
64997992|NCT00135525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64997993|NCT00135525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64997994|NCT00135525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64997995|NCT00135525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64997996|NCT00133185|Losartan|losartan|mesh-list
64997997|NCT00133185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64997998|NCT00133185|Telmisartan|telmisartan|mesh-list
64997999|NCT00133185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64998000|NCT00133185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64998001|NCT00133185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64998002|NCT00133185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64998003|NCT00133185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998004|NCT00133185|Diuretics|diuretics|mesh-ancestor
64998005|NCT00133185|Natriuretic Agents|natriuretic agents|mesh-ancestor
64998006|NCT00133185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998007|NCT00133185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64998008|NCT00133185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64998009|NCT00135603|Amoxicillin|amoxicillin|mesh-list
64998010|NCT00135603|Clavulanic Acid|clavulanic acid|mesh-list
64998011|NCT00135603|Clavulanic Acids|clavulanic acids|mesh-list
64998012|NCT00135603|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64998013|NCT00135603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64998014|NCT00135603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64998015|NCT00135603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64998016|NCT00135603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998017|NCT00135603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998018|NCT00133224|Prednisone|prednisone|mesh-list
64998019|NCT00133224|Docetaxel|docetaxel|mesh-list
64998020|NCT00133224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64998021|NCT00133224|Tubulin Modulators|tubulin modulators|mesh-ancestor
64998022|NCT00133224|Antimitotic Agents|antimitotic agents|mesh-ancestor
64951576|NCT00026468|Analgesics|analgesics|mesh-ancestor
64951577|NCT00026468|Sensory System Agents|sensory system agents|mesh-ancestor
64998023|NCT00133224|Mitosis Modulators|mitosis modulators|mesh-ancestor
64998024|NCT00133224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998025|NCT00133224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64998026|NCT00133224|Glucocorticoids|glucocorticoids|mesh-ancestor
64998027|NCT00133224|Hormones|hormones|mesh-ancestor
64998028|NCT00133224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64998029|NCT00133224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998030|NCT00133224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64998031|NCT00101738|Mycophenolic Acid|mycophenolic acid|mesh-list
64998032|NCT00101738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64998033|NCT00101738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64998034|NCT00101738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64998035|NCT00101738|Antitubercular Agents|antitubercular agents|mesh-ancestor
64998036|NCT00101738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64998037|NCT00101738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64998038|NCT00101738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998039|NCT00101738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998040|NCT00135681|Nedocromil|nedocromil|mesh-list
64998041|NCT00135681|Budesonide|budesonide|mesh-list
64998042|NCT00135681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64998043|NCT00135681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64998044|NCT00135681|Autonomic Agents|autonomic agents|mesh-ancestor
64998045|NCT00135681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64998046|NCT00135681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998047|NCT00135681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64998048|NCT00135681|Respiratory System Agents|respiratory system agents|mesh-ancestor
64998049|NCT00135681|Glucocorticoids|glucocorticoids|mesh-ancestor
64998069|NCT00101894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64998070|NCT00101894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64998071|NCT00101894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64998072|NCT00101894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998073|NCT00101894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998074|NCT00102050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
64998075|NCT00102050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998076|NCT00102050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998077|NCT00135759|Naltrexone|naltrexone|mesh-list
64998078|NCT00135759|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64998079|NCT00135759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64998080|NCT00135759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998081|NCT00135759|Sensory System Agents|sensory system agents|mesh-ancestor
64998082|NCT00135759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64998083|NCT00133341|Parthenolide|parthenolide|mesh-list
64998084|NCT00133341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64998085|NCT00133341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64998086|NCT00133341|Analgesics|analgesics|mesh-ancestor
64998087|NCT00133341|Sensory System Agents|sensory system agents|mesh-ancestor
64998088|NCT00133341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64998089|NCT00133341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998090|NCT00133341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64998091|NCT00133341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64998092|NCT00135837|Verteporfin|verteporfin|mesh-list
64998093|NCT00135837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64998094|NCT00135837|Dermatologic Agents|dermatologic agents|mesh-ancestor
64998095|NCT00133380|Atorvastatin|atorvastatin|mesh-list
64998096|NCT00133380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64998097|NCT00133380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64998098|NCT00133380|Antimetabolites|antimetabolites|mesh-ancestor
64998099|NCT00133380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998100|NCT00133380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64304115|NCT03067688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64503370|NCT05585346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64490369|NCT04360876|Dexamethasone|dexamethasone|mesh-list
64951578|NCT00026468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64951579|NCT00026468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64951580|NCT00026468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64951581|NCT00054522|Calcitriol|calcitriol|mesh-list
64951582|NCT00054522|Dexamethasone|dexamethasone|mesh-list
64951583|NCT00054522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64951584|NCT00054522|Antiemetics|antiemetics|mesh-ancestor
64998101|NCT00133380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64998102|NCT00133380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998103|NCT00102167|Gaboxadol|gaboxadol|mesh-list
64998104|NCT00102167|Analgesics|analgesics|mesh-ancestor
64998105|NCT00102167|Sensory System Agents|sensory system agents|mesh-ancestor
64998106|NCT00102167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64998107|NCT00102167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998108|NCT00102167|Anticonvulsants|anticonvulsants|mesh-ancestor
64998109|NCT00102167|GABA Agonists|gaba agonists|mesh-ancestor
64998110|NCT00102167|GABA Agents|gaba agents|mesh-ancestor
64998111|NCT00102167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64998112|NCT00102167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998113|NCT00135876|Dalteparin|dalteparin|mesh-list
64998114|NCT00135876|Tinzaparin|tinzaparin|mesh-list
64998115|NCT00135876|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64998116|NCT00135876|Anticoagulants|anticoagulants|mesh-ancestor
64998117|NCT00135876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64998118|NCT00135876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64998119|NCT00135876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998120|NCT00102206|Ritonavir|ritonavir|mesh-list
64998121|NCT00102206|Lopinavir|lopinavir|mesh-list
64998122|NCT00102206|Saquinavir|saquinavir|mesh-list
64998123|NCT00102206|Tenofovir|tenofovir|mesh-list
64998154|NCT00102284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64998155|NCT00102284|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64998156|NCT00102284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998157|NCT00102284|Cholinergic Agents|cholinergic agents|mesh-ancestor
64998158|NCT00102284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64998159|NCT00102284|Protective Agents|protective agents|mesh-ancestor
64998160|NCT00403962|Paroxetine|paroxetine|mesh-list
64998161|NCT00403962|Vestipitant|vestipitant|mesh-list
64998162|NCT00403962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64998163|NCT00403962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64998164|NCT00403962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64998165|NCT00403962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998166|NCT00403962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64998167|NCT00403962|Serotonin Agents|serotonin agents|mesh-ancestor
64998168|NCT00403962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998169|NCT00403962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64998170|NCT00403962|Antidepressive Agents|antidepressive agents|mesh-ancestor
64998171|NCT00403962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64998172|NCT00403962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64998173|NCT00403962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64998174|NCT00403962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998175|NCT00403962|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64998176|NCT00102479|Aripiprazole|aripiprazole|mesh-list
64998177|NCT00102479|Antidepressive Agents|antidepressive agents|mesh-ancestor
64998178|NCT00102479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64998179|NCT00102479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64998199|NCT00135954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64998200|NCT00135954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64998201|NCT00135954|Alkylating Agents|alkylating agents|mesh-ancestor
64998202|NCT00135954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998203|NCT00135954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64998204|NCT00135954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64998206|NCT00135954|Glucocorticoids|glucocorticoids|mesh-ancestor
64998207|NCT00135954|Hormones|hormones|mesh-ancestor
64998208|NCT00135954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64998209|NCT00135954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64998210|NCT00102557|Hydroxychloroquine|hydroxychloroquine|mesh-list
64998211|NCT00102557|Antimalarials|antimalarials|mesh-ancestor
64998212|NCT00102557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64998213|NCT00102557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64998214|NCT00102557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64998215|NCT00102557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998216|NCT00102557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998217|NCT00102557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64998218|NCT00102635|Fenretinide|fenretinide|mesh-list
64998219|NCT00102635|Lonafarnib|lonafarnib|mesh-list
64998228|NCT00133419|Zinc|zinc|mesh-list
64998254|NCT00102713|Anticonvulsants|anticonvulsants|mesh-ancestor
64998255|NCT00102713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998256|NCT00102713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998257|NCT00102713|GABA Agents|gaba agents|mesh-ancestor
64998258|NCT00102713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64998259|NCT00102713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998260|NCT00102713|Antimanic Agents|antimanic agents|mesh-ancestor
64998261|NCT00102713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64998262|NCT00102713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64998263|NCT00102713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64998264|NCT00133458|Albendazole|albendazole|mesh-list
64998265|NCT00133458|Anthelmintics|anthelmintics|mesh-ancestor
64998266|NCT00133458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64998267|NCT00133458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64998268|NCT00133458|Anticestodal Agents|anticestodal agents|mesh-ancestor
64998269|NCT00133458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64998270|NCT00133458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64998271|NCT00133458|Tubulin Modulators|tubulin modulators|mesh-ancestor
64998272|NCT00133458|Antimitotic Agents|antimitotic agents|mesh-ancestor
64998273|NCT00133458|Mitosis Modulators|mitosis modulators|mesh-ancestor
64998274|NCT00133458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998275|NCT00133458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64998276|NCT00102752|Gemcitabine|gemcitabine|mesh-list
64998277|NCT00102752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64998278|NCT00102752|Antimetabolites|antimetabolites|mesh-ancestor
64998279|NCT00102752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998280|NCT00102752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64998281|NCT00102752|Antiviral Agents|antiviral agents|mesh-ancestor
64998282|NCT00102752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64998283|NCT00102752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998298|NCT00136110|GABA Agents|gaba agents|mesh-ancestor
64998299|NCT00136110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64998300|NCT00136110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998301|NCT00136110|Antimanic Agents|antimanic agents|mesh-ancestor
64998302|NCT00136110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64998303|NCT00136110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64998304|NCT00136110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64998305|NCT00136188|Folic Acid|folic acid|mesh-list
64998306|NCT00136188|Hematinics|hematinics|mesh-ancestor
64998307|NCT00136188|Vitamin B Complex|vitamin b complex|mesh-ancestor
64998308|NCT00136188|Vitamins|vitamins|mesh-ancestor
64998309|NCT00136188|Micronutrients|micronutrients|mesh-ancestor
64998310|NCT00136188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998311|NCT00102869|Levodopa|levodopa|mesh-list
64998312|NCT00102869|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64998313|NCT00102869|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64998314|NCT00102869|Dopamine Agents|dopamine agents|mesh-ancestor
64998315|NCT00102869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64998316|NCT00102869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998326|NCT00136266|Vitamin D|vitamin d|mesh-list
64998357|NCT00102986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998358|NCT00102986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998359|NCT00102986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64998360|NCT00102986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64998361|NCT00102986|Antiviral Agents|antiviral agents|mesh-ancestor
64998426|NCT00133692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64998427|NCT00133692|Protease Inhibitors|protease inhibitors|mesh-ancestor
64998428|NCT00133692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998429|NCT00133731|Heparin|heparin|mesh-list
64998430|NCT00133731|Calcium heparin|calcium heparin|mesh-list
64998431|NCT00133731|Otamixaban|otamixaban|mesh-list
64998432|NCT00133731|Anticoagulants|anticoagulants|mesh-ancestor
64998433|NCT00133731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64998434|NCT00133731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64998435|NCT00133731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998436|NCT00133731|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64998437|NCT00133731|Antithrombins|antithrombins|mesh-ancestor
64998438|NCT00133731|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64998439|NCT00133731|Protease Inhibitors|protease inhibitors|mesh-ancestor
64998490|NCT00133887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64998491|NCT00133887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64998492|NCT00133887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64998493|NCT00133887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64998494|NCT00133887|Antifungal Agents|antifungal agents|mesh-ancestor
64998495|NCT00133887|Dermatologic Agents|dermatologic agents|mesh-ancestor
64998496|NCT00133887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64998497|NCT00136539|Cyclophosphamide|cyclophosphamide|mesh-list
64998498|NCT00136539|Doxorubicin|doxorubicin|mesh-list
64998499|NCT00136539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64998500|NCT00136539|Trastuzumab|trastuzumab|mesh-list
64998501|NCT00136539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64998502|NCT00136539|Immunologic Factors|immunologic factors|mesh-ancestor
64998503|NCT00136539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998504|NCT00136539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64998505|NCT00136539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64998506|NCT00136539|Alkylating Agents|alkylating agents|mesh-ancestor
64998507|NCT00136539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998508|NCT00136539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64998509|NCT00136539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64998510|NCT00136539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64998515|NCT00103571|Olanzapine|olanzapine|mesh-list
64998543|NCT00103649|Xaliproden|xaliproden|mesh-list
64998544|NCT00103649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64998545|NCT00103649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64998546|NCT00103649|Serotonin Agents|serotonin agents|mesh-ancestor
64998547|NCT00103649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64998548|NCT00103649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998549|NCT00103649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998550|NCT00136617|Chlordiazepoxide|chlordiazepoxide|mesh-list
64998551|NCT00136617|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64998552|NCT00136617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64998553|NCT00136617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64998554|NCT00136617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998555|NCT00136617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64998556|NCT00136617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64998557|NCT00136617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64998558|NCT00136617|GABA Modulators|gaba modulators|mesh-ancestor
64998559|NCT00136617|GABA Agents|gaba agents|mesh-ancestor
64998560|NCT00136617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64998561|NCT00136617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998562|NCT00103727|Risperidone|risperidone|mesh-list
64998563|NCT00103727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64998564|NCT00103727|Serotonin Agents|serotonin agents|mesh-ancestor
64998565|NCT00103727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64998566|NCT00103727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998567|NCT00103727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998568|NCT00103727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64998590|NCT00103922|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64998591|NCT00103922|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64998592|NCT00103922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453680|NCT01975376|Bococizumab|bococizumab|mesh-list
64998593|NCT00103922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998594|NCT00134160|Amlodipine|amlodipine|mesh-list
64998595|NCT00134160|Olmesartan|olmesartan|mesh-list
64998596|NCT00134160|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64998597|NCT00134160|Calcium Channel Blockers|calcium channel blockers|mesh-list
64998598|NCT00134160|Calcium|calcium|mesh-list
64998599|NCT00134160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64998600|NCT00134160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998601|NCT00134160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64998602|NCT00134160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64998603|NCT00134160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998604|NCT00134160|Vasodilator Agents|vasodilator agents|mesh-ancestor
64998605|NCT00134160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64998606|NCT00134160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64998643|NCT00136773|Vasodilator Agents|vasodilator agents|mesh-ancestor
64998644|NCT00136773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64998645|NCT00136773|Protease Inhibitors|protease inhibitors|mesh-ancestor
64998646|NCT00136773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998647|NCT00136851|Amlodipine|amlodipine|mesh-list
64998648|NCT00136851|Benazepril|benazepril|mesh-list
64998649|NCT00136851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64998650|NCT00136851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64998651|NCT00136851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64998652|NCT00136851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998653|NCT00136851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64998654|NCT00136851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998655|NCT00136851|Vasodilator Agents|vasodilator agents|mesh-ancestor
64998656|NCT00136851|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64998657|NCT00136851|Protease Inhibitors|protease inhibitors|mesh-ancestor
64998658|NCT00136851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998659|NCT00104273|Rasagiline|rasagiline|mesh-list
64998660|NCT00104273|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64998661|NCT00104273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998662|NCT00104273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998663|NCT00104273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64998664|NCT00104273|Protective Agents|protective agents|mesh-ancestor
64998666|NCT00136929|Fibrinolytic Agents|fibrinolytic agents|mesh-list
64998691|NCT00136968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998692|NCT00136968|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64998693|NCT00136968|Hormone Antagonists|hormone antagonists|mesh-ancestor
64998694|NCT00136968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64998695|NCT00136968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998696|NCT00136968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64998697|NCT00104468|Troxacitabine|troxacitabine|mesh-list
64998698|NCT00104468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64998699|NCT00104468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64998700|NCT00104468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64998701|NCT00104468|Antiviral Agents|antiviral agents|mesh-ancestor
64998702|NCT00104468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64998703|NCT00137007|Azithromycin|azithromycin|mesh-list
64998704|NCT00137007|Ampicillin|ampicillin|mesh-list
64998705|NCT00137007|Sulbactam|sulbactam|mesh-list
64998706|NCT00137007|Sultamicillin|sultamicillin|mesh-list
64998707|NCT00137007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64998708|NCT00137007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64998709|NCT00137007|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64998710|NCT00137007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998711|NCT00137007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998712|NCT00137085|Ketamine|ketamine|mesh-list
64998713|NCT00137085|Analgesics|analgesics|mesh-ancestor
64998714|NCT00137085|Sensory System Agents|sensory system agents|mesh-ancestor
64998715|NCT00137085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64998716|NCT00137085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998717|NCT00137085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64998718|NCT00137085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64998719|NCT00137085|Anesthetics, General|anesthetics, general|mesh-ancestor
64998720|NCT00137085|Anesthetics|anesthetics|mesh-ancestor
64998721|NCT00137085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64998722|NCT00137085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64998726|NCT00104546|Vitamin K|vitamin k|mesh-list
64998732|NCT00104546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998733|NCT00104546|Hemostatics|hemostatics|mesh-ancestor
64998734|NCT00104546|Coagulants|coagulants|mesh-ancestor
64998735|NCT00134394|Etanercept|etanercept|mesh-list
64998736|NCT00134394|Tacrolimus|tacrolimus|mesh-list
64998737|NCT00134394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64998738|NCT00134394|Immunologic Factors|immunologic factors|mesh-ancestor
64998739|NCT00134394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453838|NCT02003365|Hormones|hormones|mesh-ancestor
64998740|NCT00134394|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64998741|NCT00134394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998742|NCT00134394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998743|NCT00134394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64998744|NCT00134394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64998745|NCT00134394|Analgesics|analgesics|mesh-ancestor
64998746|NCT00134394|Sensory System Agents|sensory system agents|mesh-ancestor
64998747|NCT00134394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64998751|NCT00104624|Docetaxel|docetaxel|mesh-list
64998788|NCT00134511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64998789|NCT00134511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64998790|NCT00134511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998791|NCT00104780|Freund's Adjuvant|freund's adjuvant|mesh-list
64998792|NCT00104780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64998793|NCT00104780|Immunologic Factors|immunologic factors|mesh-ancestor
64998794|NCT00104780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998795|NCT00134550|Atorvastatin|atorvastatin|mesh-list
64998796|NCT00134550|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64998797|NCT00134550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64998798|NCT00134550|Antimetabolites|antimetabolites|mesh-ancestor
64998799|NCT00134550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998800|NCT00134550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64998801|NCT00134550|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64998802|NCT00134550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998803|NCT00104819|Immunoglobulins|immunoglobulins|mesh-list
64998804|NCT00104819|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64998805|NCT00104819|Antibodies|antibodies|mesh-list
64998806|NCT00104819|Sargramostim|sargramostim|mesh-list
64998807|NCT00104819|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
64998808|NCT00104819|Immunologic Factors|immunologic factors|mesh-ancestor
64998809|NCT00104819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998810|NCT00137202|Diphenhydramine|diphenhydramine|mesh-list
64998811|NCT00137202|Promethazine|promethazine|mesh-list
64998812|NCT00137202|Ondansetron|ondansetron|mesh-list
64998813|NCT00137202|Antiemetics|antiemetics|mesh-ancestor
64998814|NCT00137202|Autonomic Agents|autonomic agents|mesh-ancestor
64998815|NCT00137202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64998816|NCT00137202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998817|NCT00137202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64998818|NCT00137202|Antipruritics|antipruritics|mesh-ancestor
64998819|NCT00137202|Dermatologic Agents|dermatologic agents|mesh-ancestor
64998820|NCT00137202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64998830|NCT00137202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64998831|NCT00137202|Anesthetics, Local|anesthetics, local|mesh-ancestor
64998832|NCT00137202|Anesthetics|anesthetics|mesh-ancestor
64998833|NCT00137202|Sensory System Agents|sensory system agents|mesh-ancestor
64998834|NCT00137202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64998835|NCT00137202|Histamine Antagonists|histamine antagonists|mesh-ancestor
64998836|NCT00137202|Histamine Agents|histamine agents|mesh-ancestor
64998837|NCT00137202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64998838|NCT00104975|Fludarabine|fludarabine|mesh-list
64998839|NCT00104975|Fludarabine phosphate|fludarabine phosphate|mesh-list
64998840|NCT00104975|Melphalan|melphalan|mesh-list
64998841|NCT00104975|Alemtuzumab|alemtuzumab|mesh-list
64998842|NCT00104975|Thiotepa|thiotepa|mesh-list
64998843|NCT00104975|Tacrolimus|tacrolimus|mesh-list
64998844|NCT00104975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64998845|NCT00104975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64998846|NCT00104975|Antimetabolites|antimetabolites|mesh-ancestor
64998847|NCT00104975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998848|NCT00104975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64998849|NCT00104975|Immunologic Factors|immunologic factors|mesh-ancestor
64998850|NCT00104975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998851|NCT00104975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64998852|NCT00104975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998853|NCT00104975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64998854|NCT00104975|Alkylating Agents|alkylating agents|mesh-ancestor
64998855|NCT00104975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64998856|NCT00104975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64998857|NCT00137358|Amifostine|amifostine|mesh-list
64998858|NCT00137358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64998878|NCT00137397|Urological Agents|urological agents|mesh-ancestor
64998879|NCT00134745|Estradiol|estradiol|mesh-list
64998880|NCT00134745|Estrogens|estrogens|mesh-ancestor
64998881|NCT00134745|Hormones|hormones|mesh-ancestor
64998882|NCT00134745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64998883|NCT00134745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998885|NCT00105209|Clopidogrel|clopidogrel|mesh-list
64998886|NCT00105209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64998887|NCT00105209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64998888|NCT00105209|Analgesics|analgesics|mesh-ancestor
64998889|NCT00105209|Sensory System Agents|sensory system agents|mesh-ancestor
64998890|NCT00105209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64998891|NCT00105209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998892|NCT00105209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64998893|NCT00105209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64998894|NCT00105209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64998895|NCT00105209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64998896|NCT00105209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998897|NCT00105209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64998898|NCT00105209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64998899|NCT00105209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998900|NCT00105209|Antipyretics|antipyretics|mesh-ancestor
64998931|NCT00105326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64998932|NCT00105326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64998933|NCT00105326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64998934|NCT00105326|Serotonin Agents|serotonin agents|mesh-ancestor
64998935|NCT00105326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64998936|NCT00105326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998937|NCT00105326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64998938|NCT00105326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64998939|NCT00105326|Dopamine Agents|dopamine agents|mesh-ancestor
64998940|NCT00137553|Pyrimethamine|pyrimethamine|mesh-list
64998941|NCT00137553|Sulfadoxine|sulfadoxine|mesh-list
64998942|NCT00137553|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64998943|NCT00137553|Antimalarials|antimalarials|mesh-ancestor
64998944|NCT00137553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64998945|NCT00137553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64998946|NCT00137553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64998947|NCT00137553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64998948|NCT00137553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64998949|NCT00137553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998950|NCT00137553|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64998951|NCT00137553|Renal Agents|renal agents|mesh-ancestor
64998952|NCT00105404|Triamcinolone|triamcinolone|mesh-list
64998953|NCT00105404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64998954|NCT00105404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64998955|NCT00105404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64998956|NCT00105404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64998957|NCT00105404|Glucocorticoids|glucocorticoids|mesh-ancestor
64998958|NCT00105404|Hormones|hormones|mesh-ancestor
64998959|NCT00105404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64998960|NCT00105404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998961|NCT00105404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64998972|NCT00134979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64998973|NCT00134979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64998974|NCT00134979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64998975|NCT00134979|Adrenergic Agents|adrenergic agents|mesh-ancestor
64998976|NCT00134979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64998977|NCT00134979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64998978|NCT00135018|Celecoxib|celecoxib|mesh-list
64998979|NCT00135018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64998980|NCT00135018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64998981|NCT00135018|Analgesics|analgesics|mesh-ancestor
64998982|NCT00135018|Sensory System Agents|sensory system agents|mesh-ancestor
64998983|NCT00135018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64998984|NCT00135018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64998985|NCT00135018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64998986|NCT00135018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64998987|NCT00135018|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64998988|NCT00135018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64998989|NCT00135018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999028|NCT03277495|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64999029|NCT03277495|Autonomic Agents|autonomic agents|mesh-ancestor
64999030|NCT03277495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64999031|NCT03277495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999032|NCT03277495|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64999033|NCT03277495|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64999034|NCT03277495|Cholinergic Agents|cholinergic agents|mesh-ancestor
64999035|NCT03277495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64999036|NCT03277495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999037|NCT00137787|Ciprofloxacin|ciprofloxacin|mesh-list
64999038|NCT00137787|Cefepime|cefepime|mesh-list
64999039|NCT00137787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64999040|NCT00137787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64999041|NCT00137787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64999042|NCT00137787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64999043|NCT00137787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999044|NCT00137787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999045|NCT00137787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999046|NCT00137787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64999047|NCT00137787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64999049|NCT04702048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64999050|NCT04702048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64999051|NCT04702048|Growth Substances|growth substances|mesh-ancestor
64999052|NCT04702048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999078|NCT00137826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64999079|NCT00137826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64999080|NCT00137826|Growth Substances|growth substances|mesh-ancestor
64999081|NCT00137826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999082|NCT00137826|Growth Inhibitors|growth inhibitors|mesh-ancestor
64999083|NCT00137826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64999084|NCT00137826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999085|NCT00137826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999086|NCT00434824|Methyltestosterone|methyltestosterone|mesh-list
64999087|NCT00434824|Testosterone|testosterone|mesh-list
64999088|NCT00434824|Testosterone undecanoate|testosterone undecanoate|mesh-list
64999089|NCT00434824|Testosterone enanthate|testosterone enanthate|mesh-list
64999090|NCT00434824|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64999091|NCT00434824|Androgens|androgens|mesh-ancestor
64999092|NCT00434824|Hormones|hormones|mesh-ancestor
64999093|NCT00434824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64999094|NCT00434824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999095|NCT00434824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64999096|NCT00434824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999097|NCT00434824|Anabolic Agents|anabolic agents|mesh-ancestor
64999098|NCT00105950|Lapatinib|lapatinib|mesh-list
64999099|NCT00105950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999100|NCT00105950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64999101|NCT00105950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999102|NCT00105950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999126|NCT00435058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64999127|NCT00435058|Travoprost|travoprost|mesh-list
64999128|NCT00435058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999129|NCT00435058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64999130|NCT00435058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64999131|NCT00435058|Adrenergic Agents|adrenergic agents|mesh-ancestor
64999132|NCT00435058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64999133|NCT00435058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999134|NCT00435058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64999135|NCT00435058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64999136|NCT00435058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64999137|NCT00435058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64999138|NCT00435058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64999139|NCT00435175|Estradiol|estradiol|mesh-list
64999140|NCT00435175|Estrogens|estrogens|mesh-ancestor
64999141|NCT00435175|Hormones|hormones|mesh-ancestor
64999142|NCT00435175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64999143|NCT00435175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999144|NCT00135135|Carboplatin|carboplatin|mesh-list
64999145|NCT00135135|Doxorubicin|doxorubicin|mesh-list
64999146|NCT00135135|Irinotecan|irinotecan|mesh-list
64999147|NCT00135135|Etoposide|etoposide|mesh-list
64999148|NCT00135135|Melphalan|melphalan|mesh-list
64999149|NCT00135135|Topotecan|topotecan|mesh-list
64999150|NCT00135135|Gefitinib|gefitinib|mesh-list
64999151|NCT00135135|Tretinoin|tretinoin|mesh-list
64999152|NCT00135135|Isotretinoin|isotretinoin|mesh-list
64999153|NCT00135135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999154|NCT00135135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64999155|NCT00135135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64999156|NCT00135135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64999157|NCT00135135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999158|NCT00135135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999170|NCT00435292|Naproxen|naproxen|mesh-list
64999171|NCT00435292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64999172|NCT00435292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64999173|NCT00435292|Analgesics|analgesics|mesh-ancestor
64999174|NCT00435292|Sensory System Agents|sensory system agents|mesh-ancestor
64999175|NCT00435292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64999176|NCT00435292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999177|NCT00435292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64999178|NCT00435292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64999179|NCT00435292|Gout Suppressants|gout suppressants|mesh-ancestor
64999180|NCT00435292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64999181|NCT00435292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999182|NCT00435292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999183|NCT00435331|Verapamil|verapamil|mesh-list
64999184|NCT00435331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64999185|NCT00435331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64999186|NCT00435331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64999187|NCT00435331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999188|NCT00435331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64999189|NCT00435331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999191|NCT00435448|Lonidamine|lonidamine|mesh-list
64999192|NCT00435448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64454289|NCT02015819|Antidotes|antidotes|mesh-ancestor
64999193|NCT00435448|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
64999194|NCT00435448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999195|NCT00435448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64999197|NCT00435448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64999198|NCT00435448|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64999216|NCT00435799|Riboflavin|riboflavin|mesh-list
64999217|NCT00435799|Dextrans|dextrans|mesh-list
64999218|NCT00435799|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64999219|NCT00435799|Vitamin B Complex|vitamin b complex|mesh-ancestor
64999220|NCT00435799|Vitamins|vitamins|mesh-ancestor
64999221|NCT00435799|Micronutrients|micronutrients|mesh-ancestor
64999222|NCT00435799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999223|NCT00435799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64999224|NCT00435799|Dermatologic Agents|dermatologic agents|mesh-ancestor
64999225|NCT00435799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64999226|NCT00435799|Anticoagulants|anticoagulants|mesh-ancestor
64999227|NCT00435799|Plasma Substitutes|plasma substitutes|mesh-ancestor
64999228|NCT00435799|Blood Substitutes|blood substitutes|mesh-ancestor
64999229|NCT00142467|Gemcitabine|gemcitabine|mesh-list
64999230|NCT00142467|Bevacizumab|bevacizumab|mesh-list
64999231|NCT00142467|Oxaliplatin|oxaliplatin|mesh-list
64999232|NCT00142467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64999233|NCT00142467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999234|NCT00142467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64999235|NCT00142467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64999236|NCT00142467|Growth Substances|growth substances|mesh-ancestor
64999237|NCT00142467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999238|NCT00142467|Growth Inhibitors|growth inhibitors|mesh-ancestor
64999239|NCT00142467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64999240|NCT00142467|Antimetabolites|antimetabolites|mesh-ancestor
64999241|NCT00142467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999247|NCT00435955|Rituximab|rituximab|mesh-list
64999265|NCT00436033|Antidepressive Agents|antidepressive agents|mesh-ancestor
64999266|NCT00436033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64999267|NCT00436072|Irinotecan|irinotecan|mesh-list
64999268|NCT00436072|Cetuximab|cetuximab|mesh-list
64999269|NCT00436072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64999270|NCT00436072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64999271|NCT00436072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999272|NCT00436072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999273|NCT00436072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999274|NCT00436072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64999276|NCT03275857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999277|NCT03276052|Bromides|bromides|mesh-list
64999278|NCT03276052|Anticonvulsants|anticonvulsants|mesh-ancestor
64999279|NCT03273322|Rivaroxaban|rivaroxaban|mesh-list
64999280|NCT03273322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64999281|NCT03273322|Antithrombins|antithrombins|mesh-ancestor
64999282|NCT03273322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64999283|NCT03273322|Protease Inhibitors|protease inhibitors|mesh-ancestor
64999284|NCT03273322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999285|NCT03273322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999286|NCT03273322|Anticoagulants|anticoagulants|mesh-ancestor
64999287|NCT04702360|Ivacaftor|ivacaftor|mesh-list
64999288|NCT04702360|Elexacaftor|elexacaftor|mesh-list
64999320|NCT00142545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999321|NCT00106262|Irinotecan|irinotecan|mesh-list
64999322|NCT00106262|Bortezomib|bortezomib|mesh-list
64999323|NCT00106262|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64999324|NCT00106262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64999325|NCT00106262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999326|NCT00106262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999327|NCT00106262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999328|NCT00106301|Romidepsin|romidepsin|mesh-list
64999329|NCT00106301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64999330|NCT00106301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999331|NCT00436267|Fluorouracil|fluorouracil|mesh-list
64999332|NCT00436267|Antimetabolites|antimetabolites|mesh-ancestor
64999333|NCT00436267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999334|NCT00436267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64999335|NCT00436267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999336|NCT00436267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64999337|NCT00436267|Immunologic Factors|immunologic factors|mesh-ancestor
64999338|NCT00436267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999339|NCT00436306|Contraceptive Agents|contraceptive agents|mesh-list
64999340|NCT00436306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64999341|NCT00436306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999343|NCT00138099|Tinzaparin|tinzaparin|mesh-list
64999344|NCT00138099|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64999345|NCT00138099|Anticoagulants|anticoagulants|mesh-ancestor
64999370|NCT00436423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999371|NCT00436579|Sorafenib|sorafenib|mesh-list
64999372|NCT00436579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999373|NCT00436579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64999374|NCT00436579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999375|NCT00436579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999376|NCT00436657|Cisplatin|cisplatin|mesh-list
64999377|NCT00436657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999378|NCT00106418|Romidepsin|romidepsin|mesh-list
64999379|NCT00106418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64999380|NCT00106418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999381|NCT00436930|Sargramostim|sargramostim|mesh-list
64999382|NCT00436930|Immunologic Factors|immunologic factors|mesh-ancestor
64999383|NCT00436930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999384|NCT00437008|Benphothiamine|benphothiamine|mesh-list
64999385|NCT00437008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64999386|NCT00437008|Immunologic Factors|immunologic factors|mesh-ancestor
64999387|NCT00437008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999388|NCT00437008|Chelating Agents|chelating agents|mesh-ancestor
64999389|NCT00437008|Sequestering Agents|sequestering agents|mesh-ancestor
64999390|NCT00437008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999423|NCT00437476|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64999424|NCT00437476|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
64999425|NCT00437476|Antimetabolites|antimetabolites|mesh-ancestor
64999426|NCT00437476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999427|NCT00437476|Antiviral Agents|antiviral agents|mesh-ancestor
64999428|NCT00437476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64999429|NCT00437476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64999430|NCT00437476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999431|NCT00437554|Glimepiride|glimepiride|mesh-list
64999432|NCT00437554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64999433|NCT00437554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64999434|NCT00437554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999435|NCT00437554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64999436|NCT00437554|Immunologic Factors|immunologic factors|mesh-ancestor
64999437|NCT00437632|Caffeine|caffeine|mesh-list
64999438|NCT00437632|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64999439|NCT00437632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999440|NCT00437632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64999441|NCT00437632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999442|NCT00437632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999443|NCT00437632|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64999444|NCT00437632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64999445|NCT00437632|Purinergic Agents|purinergic agents|mesh-ancestor
64999446|NCT00437632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64999447|NCT00437671|Immunoglobulins|immunoglobulins|mesh-list
64999448|NCT00437671|Antibodies|antibodies|mesh-list
64999471|NCT00401219|Progestins|progestins|mesh-list
64999472|NCT00401219|Hormones|hormones|mesh-ancestor
64999473|NCT00401219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64999474|NCT00401219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999475|NCT04701463|Calcium|calcium|mesh-list
64999476|NCT04701463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64999477|NCT04701463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999478|NCT00438139|Dronabinol|dronabinol|mesh-list
64999479|NCT00438139|Hallucinogens|hallucinogens|mesh-ancestor
64999480|NCT00438139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999481|NCT00438139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64999482|NCT00438139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64999483|NCT00438139|Analgesics|analgesics|mesh-ancestor
64999484|NCT00438139|Sensory System Agents|sensory system agents|mesh-ancestor
64999485|NCT00438139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64999486|NCT00438139|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64999487|NCT00438139|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64999488|NCT00438139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64999489|NCT00438139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999490|NCT00438139|Hormones|hormones|mesh-ancestor
64999491|NCT00438139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64999492|NCT00438178|Obatoclax|obatoclax|mesh-list
64999493|NCT00438178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999495|NCT00438217|Leuprolide|leuprolide|mesh-list
64999519|NCT03279757|Lidocaine|lidocaine|mesh-list
64999520|NCT03279757|Epinephrine|epinephrine|mesh-list
64999521|NCT03279757|Racepinephrine|racepinephrine|mesh-list
64999522|NCT03279757|Tetracaine|tetracaine|mesh-list
64999523|NCT03279757|Carticaine|carticaine|mesh-list
64999524|NCT03279757|Epinephryl borate|epinephryl borate|mesh-list
64999525|NCT03279757|Anesthetics, Local|anesthetics, local|mesh-ancestor
64999526|NCT03279757|Anesthetics|anesthetics|mesh-ancestor
64999527|NCT03279757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64999528|NCT03279757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999529|NCT03279757|Sensory System Agents|sensory system agents|mesh-ancestor
64999530|NCT03279757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64999531|NCT03279757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64999532|NCT03279757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64999533|NCT03279757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64999534|NCT03279757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64999535|NCT03279757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999536|NCT03279757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64999537|NCT03279757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64999538|NCT03279757|Adrenergic Agents|adrenergic agents|mesh-ancestor
64999539|NCT03279757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64999540|NCT03279757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64999541|NCT03279757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64999542|NCT03279757|Autonomic Agents|autonomic agents|mesh-ancestor
64999543|NCT03279757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64999544|NCT03279757|Respiratory System Agents|respiratory system agents|mesh-ancestor
64999545|NCT03279757|Mydriatics|mydriatics|mesh-ancestor
64999546|NCT03279757|Sympathomimetics|sympathomimetics|mesh-ancestor
64999547|NCT03279757|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64999548|NCT00438568|Insulin|insulin|mesh-list
64999549|NCT00438568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64999563|NCT00106847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64999564|NCT00106886|Folic Acid|folic acid|mesh-list
64999565|NCT00106886|Vitamin B 6|vitamin b 6|mesh-list
64999566|NCT00106886|Pyridoxal|pyridoxal|mesh-list
64999567|NCT00106886|Pyridoxine|pyridoxine|mesh-list
64999568|NCT00106886|Vitamins|vitamins|mesh-ancestor
64999569|NCT00106886|Micronutrients|micronutrients|mesh-ancestor
64999570|NCT00106886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999571|NCT00106886|Hematinics|hematinics|mesh-ancestor
64999572|NCT00106886|Vitamin B Complex|vitamin b complex|mesh-ancestor
64999576|NCT00438841|Bortezomib|bortezomib|mesh-list
64999631|NCT00439426|Oxaliplatin|oxaliplatin|mesh-list
64999632|NCT00439426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64999633|NCT00439426|Antimetabolites|antimetabolites|mesh-ancestor
64999634|NCT00439426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999635|NCT00439426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999636|NCT00138138|Methylphenidate|methylphenidate|mesh-list
64999637|NCT00138138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64999638|NCT00138138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999639|NCT00138138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64999640|NCT00138138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64999641|NCT00138138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64454733|NCT02008877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999642|NCT00138138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999643|NCT00138138|Dopamine Agents|dopamine agents|mesh-ancestor
64999644|NCT00138138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64999646|NCT00439504|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64999647|NCT00439504|Autonomic Agents|autonomic agents|mesh-ancestor
64999648|NCT00439504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64999649|NCT00439504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999650|NCT00439504|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64999651|NCT00439504|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64999652|NCT00439504|Cholinergic Agents|cholinergic agents|mesh-ancestor
64999653|NCT00439504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64999655|NCT00439504|Respiratory System Agents|respiratory system agents|mesh-ancestor
64999679|NCT00439855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999680|NCT00107354|Cytarabine|cytarabine|mesh-list
64999681|NCT00107354|Aldesleukin|aldesleukin|mesh-list
64999682|NCT00107354|Etoposide|etoposide|mesh-list
64999683|NCT00107354|Mitoxantrone|mitoxantrone|mesh-list
64999684|NCT00107354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64999685|NCT00107354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999686|NCT00107354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64999687|NCT00107354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64999688|NCT00107354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999689|NCT00107354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999690|NCT00107354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64999691|NCT00107354|Antimetabolites|antimetabolites|mesh-ancestor
64999692|NCT00107354|Antiviral Agents|antiviral agents|mesh-ancestor
64999693|NCT00107354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64999694|NCT00107354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64999695|NCT00107354|Immunologic Factors|immunologic factors|mesh-ancestor
64999696|NCT00107354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999697|NCT00107354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64999698|NCT00107354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64999736|NCT00107393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999737|NCT00107393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999738|NCT00107393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64999739|NCT00138216|Irinotecan|irinotecan|mesh-list
64999740|NCT00138216|Vincristine|vincristine|mesh-list
64999741|NCT00138216|Temozolomide|temozolomide|mesh-list
64999742|NCT00138216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64999743|NCT00138216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64999744|NCT00138216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999745|NCT00138216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999746|NCT00138216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999747|NCT00138216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64999748|NCT00138216|Tubulin Modulators|tubulin modulators|mesh-ancestor
64999749|NCT00138216|Antimitotic Agents|antimitotic agents|mesh-ancestor
64999750|NCT00138216|Mitosis Modulators|mitosis modulators|mesh-ancestor
64999751|NCT00138216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64999752|NCT00138216|Alkylating Agents|alkylating agents|mesh-ancestor
64999753|NCT00105586|Citalopram|citalopram|mesh-list
64999754|NCT00105586|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64999755|NCT00105586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64999756|NCT00105586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64999757|NCT00105586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999758|NCT00105586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64999759|NCT00105586|Serotonin Agents|serotonin agents|mesh-ancestor
64999760|NCT00105586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999761|NCT00105586|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64999781|NCT00439972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999782|NCT00439972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999783|NCT00439972|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64999784|NCT00439972|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64999785|NCT00439972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64999786|NCT00440128|Docetaxel|docetaxel|mesh-list
64999787|NCT00440128|Casopitant|casopitant|mesh-list
64999788|NCT00440128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999789|NCT00440128|Tubulin Modulators|tubulin modulators|mesh-ancestor
64999790|NCT00440128|Antimitotic Agents|antimitotic agents|mesh-ancestor
64999791|NCT00440128|Mitosis Modulators|mitosis modulators|mesh-ancestor
64999792|NCT00440128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999794|NCT00440128|Autonomic Agents|autonomic agents|mesh-ancestor
64999795|NCT00440128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64999796|NCT00440128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999797|NCT00440128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64999798|NCT00440128|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64999799|NCT00440128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64999800|NCT00440167|Gemcitabine|gemcitabine|mesh-list
64999837|NCT02957266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999838|NCT02957266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64999839|NCT02957266|Immunologic Factors|immunologic factors|mesh-ancestor
64999840|NCT02957266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999841|NCT03279562|Nalmefene|nalmefene|mesh-list
64999842|NCT03279562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64999843|NCT03279562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999844|NCT03279562|Sensory System Agents|sensory system agents|mesh-ancestor
64999845|NCT03279562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64999846|NCT00404196|Calcipotriene|calcipotriene|mesh-list
64999847|NCT00404196|Dermatologic Agents|dermatologic agents|mesh-ancestor
64999848|NCT00107510|Carboplatin|carboplatin|mesh-list
64999849|NCT00107510|Docetaxel|docetaxel|mesh-list
64999850|NCT00107510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999851|NCT00107510|Tubulin Modulators|tubulin modulators|mesh-ancestor
64999852|NCT00107510|Antimitotic Agents|antimitotic agents|mesh-ancestor
64999853|NCT00107510|Mitosis Modulators|mitosis modulators|mesh-ancestor
64999854|NCT00107510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999855|NCT00440245|Albuterol|albuterol|mesh-list
64999856|NCT00440245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64999857|NCT00440245|Autonomic Agents|autonomic agents|mesh-ancestor
64999858|NCT00440245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64999859|NCT00440245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999860|NCT00440245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64999861|NCT00440245|Respiratory System Agents|respiratory system agents|mesh-ancestor
64999862|NCT00440245|Tocolytic Agents|tocolytic agents|mesh-ancestor
64999863|NCT00440245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64999886|NCT00142779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64999887|NCT00440323|Zolpidem|zolpidem|mesh-list
64999888|NCT00440323|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64999889|NCT00440323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64999890|NCT00440323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64999891|NCT00440323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999892|NCT00440323|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64999893|NCT00440323|GABA Agonists|gaba agonists|mesh-ancestor
64999894|NCT00440323|GABA Agents|gaba agents|mesh-ancestor
64999895|NCT00440323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64999896|NCT00440323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999897|NCT00440440|Testosterone|testosterone|mesh-list
64999898|NCT00440440|Androgens|androgens|mesh-ancestor
64999899|NCT00440440|Hormones|hormones|mesh-ancestor
64999900|NCT00440440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64999901|NCT00440440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999902|NCT00142896|Morphine|morphine|mesh-list
64999903|NCT00142896|Tramadol|tramadol|mesh-list
64999904|NCT00142896|Naloxone|naloxone|mesh-list
64999905|NCT00142896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64999906|NCT00142896|Narcotics|narcotics|mesh-ancestor
64999907|NCT00142896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64999908|NCT00142896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999909|NCT00142896|Analgesics|analgesics|mesh-ancestor
64999910|NCT00142896|Sensory System Agents|sensory system agents|mesh-ancestor
64999937|NCT00440713|Serotonin Agents|serotonin agents|mesh-ancestor
64999938|NCT00440713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64999939|NCT00440713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64999940|NCT00440713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64999941|NCT00440713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64999942|NCT00440869|Acetylcysteine|acetylcysteine|mesh-list
64999943|NCT00440869|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64999944|NCT00440869|Antiviral Agents|antiviral agents|mesh-ancestor
64999945|NCT00440869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64999946|NCT00440869|Expectorants|expectorants|mesh-ancestor
64999947|NCT00440869|Respiratory System Agents|respiratory system agents|mesh-ancestor
64999948|NCT00440869|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64999949|NCT00440869|Antioxidants|antioxidants|mesh-ancestor
64999950|NCT00440869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64999951|NCT00440869|Protective Agents|protective agents|mesh-ancestor
64999952|NCT00440869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999953|NCT00440869|Antidotes|antidotes|mesh-ancestor
64999954|NCT00441025|Alemtuzumab|alemtuzumab|mesh-list
64999955|NCT00441025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64999956|NCT00441025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64999958|NCT00441181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64999959|NCT00441298|Tenofovir|tenofovir|mesh-list
64999960|NCT00441298|Antiviral Agents|antiviral agents|mesh-ancestor
64999961|NCT00441298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64999962|NCT00441298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64999988|NCT02964728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64999989|NCT00441532|Lidocaine|lidocaine|mesh-list
64999990|NCT00441532|Anesthetics, Local|anesthetics, local|mesh-ancestor
64999991|NCT00441532|Anesthetics|anesthetics|mesh-ancestor
64999992|NCT00441532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64999993|NCT00441532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64999994|NCT00441532|Sensory System Agents|sensory system agents|mesh-ancestor
64999995|NCT00441532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64999996|NCT00441532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64999997|NCT00441532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64999998|NCT00441532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64999999|NCT00441532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65000000|NCT00441532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000001|NCT00441649|Methylphenidate|methylphenidate|mesh-list
65000002|NCT00441649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65000003|NCT00441649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000004|NCT00441649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65000005|NCT00441649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65000006|NCT00441649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65000007|NCT00441649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000008|NCT00441649|Dopamine Agents|dopamine agents|mesh-ancestor
65000009|NCT00441649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000010|NCT00107822|Lidocaine|lidocaine|mesh-list
65000011|NCT00107822|Tetracaine|tetracaine|mesh-list
65000012|NCT00107822|Anesthetics, Local|anesthetics, local|mesh-ancestor
65000013|NCT00107822|Anesthetics|anesthetics|mesh-ancestor
65000023|NCT03279328|Petrolatum|petrolatum|mesh-list
65000033|NCT00441844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65000034|NCT00441844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65000035|NCT00441844|Antimetabolites|antimetabolites|mesh-ancestor
65000036|NCT00441844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000037|NCT00441844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65000038|NCT00441844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65000039|NCT00441844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000040|NCT03279133|Ledipasvir|ledipasvir|mesh-list
65000041|NCT03279133|Antiviral Agents|antiviral agents|mesh-ancestor
65000042|NCT03279133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65000043|NCT00108017|Timolol|timolol|mesh-list
65000044|NCT00108017|Dorzolamide|dorzolamide|mesh-list
65000045|NCT00108017|Maleic acid|maleic acid|mesh-list
65000046|NCT00108017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000047|NCT00108017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000048|NCT00108017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65000049|NCT00108017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65000050|NCT00108017|Adrenergic Agents|adrenergic agents|mesh-ancestor
65000051|NCT00108017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000052|NCT00108017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000053|NCT00108017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65000056|NCT00441922|Docetaxel|docetaxel|mesh-list
65000086|NCT00138411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000087|NCT00138411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65000088|NCT00138411|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65000089|NCT00138411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65000090|NCT00442234|Monteplase|monteplase|mesh-list
65000091|NCT00442234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65000092|NCT00442234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65000093|NCT00442234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000094|NCT00108095|Ondansetron|ondansetron|mesh-list
65000095|NCT00108095|Antiemetics|antiemetics|mesh-ancestor
65000096|NCT00108095|Autonomic Agents|autonomic agents|mesh-ancestor
65000097|NCT00108095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65000098|NCT00108095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000099|NCT00108095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65000100|NCT00108095|Antipruritics|antipruritics|mesh-ancestor
65000101|NCT00108095|Dermatologic Agents|dermatologic agents|mesh-ancestor
65000102|NCT00108095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65000103|NCT00108095|Serotonin Agents|serotonin agents|mesh-ancestor
65000104|NCT00108095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000105|NCT00108095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000106|NCT00108095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65000107|NCT00108095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65000108|NCT00108095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65000109|NCT00108095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65000110|NCT00108095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65000111|NCT03278938|Bupropion|bupropion|mesh-list
65000112|NCT03278938|Citalopram|citalopram|mesh-list
65000131|NCT03278860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000132|NCT00442273|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65000133|NCT00442273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65000134|NCT00442312|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
65000135|NCT00442312|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65000136|NCT00442312|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65000137|NCT00442312|Adrenergic Agents|adrenergic agents|mesh-ancestor
65000138|NCT00442312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000139|NCT00442312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000140|NCT00442312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000141|NCT00442312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65000142|NCT00442312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65000143|NCT00442312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65000144|NCT00442390|Hydrocortisone|hydrocortisone|mesh-list
65000145|NCT00442390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65000146|NCT00442585|Ibuprofen|ibuprofen|mesh-list
65000147|NCT00442585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65000148|NCT00442585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65000149|NCT00442585|Analgesics|analgesics|mesh-ancestor
65000150|NCT00442585|Sensory System Agents|sensory system agents|mesh-ancestor
65000151|NCT00442585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65000152|NCT00442585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000179|NCT00404586|Xhance|xhance|mesh-list
65000180|NCT00404586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65000181|NCT00404586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65000182|NCT00404586|Autonomic Agents|autonomic agents|mesh-ancestor
65000183|NCT00404586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65000184|NCT00404586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000185|NCT00404586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65000186|NCT00404586|Respiratory System Agents|respiratory system agents|mesh-ancestor
65000187|NCT00404586|Dermatologic Agents|dermatologic agents|mesh-ancestor
65000188|NCT00404586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65000189|NCT00442819|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
65000190|NCT00442819|Vasodilator Agents|vasodilator agents|mesh-ancestor
65000191|NCT00442819|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65000192|NCT00442819|Protective Agents|protective agents|mesh-ancestor
65000193|NCT00442819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000194|NCT00108251|Eplerenone|eplerenone|mesh-list
65000195|NCT00108251|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65000196|NCT00108251|Hormone Antagonists|hormone antagonists|mesh-ancestor
65000197|NCT00108251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65000198|NCT00108251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000199|NCT00108251|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65000200|NCT00108251|Diuretics|diuretics|mesh-ancestor
65000201|NCT00108251|Natriuretic Agents|natriuretic agents|mesh-ancestor
65000202|NCT00108251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65000203|NCT00443170|Rosiglitazone|rosiglitazone|mesh-list
65000204|NCT00443170|Flurbiprofen|flurbiprofen|mesh-list
65000205|NCT00443170|Midazolam|midazolam|mesh-list
65000206|NCT00443170|Caffeine|caffeine|mesh-list
65000207|NCT00443170|Omeprazole|omeprazole|mesh-list
65000208|NCT00443170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65000209|NCT00443170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65000210|NCT00443170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65000211|NCT00443170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000212|NCT00443170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65000213|NCT00443170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65000214|NCT00443170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65000215|NCT00443170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65000216|NCT00443170|Anesthetics, General|anesthetics, general|mesh-ancestor
65000218|NCT00443170|GABA Modulators|gaba modulators|mesh-ancestor
65000219|NCT00443170|GABA Agents|gaba agents|mesh-ancestor
65000220|NCT00443170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000221|NCT00443170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000222|NCT00443170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65000223|NCT00443170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65000224|NCT00443170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000225|NCT00443170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65000226|NCT00443170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65000227|NCT00443170|Purinergic Agents|purinergic agents|mesh-ancestor
65000228|NCT00443170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65000229|NCT00443170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65000230|NCT00443170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65000231|NCT00443170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65000232|NCT00443170|Analgesics|analgesics|mesh-ancestor
65000233|NCT00443170|Sensory System Agents|sensory system agents|mesh-ancestor
65000234|NCT00443170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65000235|NCT00443170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65000242|NCT00138567|Vildagliptin|vildagliptin|mesh-list
65000274|NCT00108446|Anesthetics|anesthetics|mesh-ancestor
65000275|NCT00108446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65000276|NCT00108446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000277|NCT00108446|Sensory System Agents|sensory system agents|mesh-ancestor
65000278|NCT00108446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65000279|NCT00108446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65000280|NCT00108446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65000281|NCT00108446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65000282|NCT00108446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65000283|NCT00108446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000284|NCT00108446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65000285|NCT00108446|Narcotics|narcotics|mesh-ancestor
65000286|NCT00108446|Analgesics|analgesics|mesh-ancestor
65000287|NCT00108446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65000288|NCT00108446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65000289|NCT00108446|Anesthetics, General|anesthetics, general|mesh-ancestor
65000290|NCT00108446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65000291|NCT00108446|Antitussive Agents|antitussive agents|mesh-ancestor
65000292|NCT00108446|Respiratory System Agents|respiratory system agents|mesh-ancestor
65000293|NCT00108446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65000294|NCT00108446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65000295|NCT00108446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000296|NCT00138606|Vildagliptin|vildagliptin|mesh-list
65000297|NCT00138606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65000298|NCT00138606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000299|NCT00138606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65000300|NCT00138606|Protease Inhibitors|protease inhibitors|mesh-ancestor
65000301|NCT00138606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000302|NCT00138606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000303|NCT00443482|Formoterol Fumarate|formoterol fumarate|mesh-list
65000304|NCT00443482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65000305|NCT00443482|Autonomic Agents|autonomic agents|mesh-ancestor
65000306|NCT00443482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65000312|NCT00443482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65000313|NCT00443482|Adrenergic Agents|adrenergic agents|mesh-ancestor
65000314|NCT00443482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000315|NCT00443482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000316|NCT00443521|Triamcinolone|triamcinolone|mesh-list
65000317|NCT00443521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65000318|NCT00443521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65000319|NCT00443521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65000320|NCT00443521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65000321|NCT00443521|Glucocorticoids|glucocorticoids|mesh-ancestor
65000322|NCT00443521|Hormones|hormones|mesh-ancestor
65000323|NCT00443521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65000324|NCT00443521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000325|NCT00443521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65000326|NCT00443521|Immunologic Factors|immunologic factors|mesh-ancestor
65000327|NCT00443521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000328|NCT00443521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000329|NCT03278431|Albendazole|albendazole|mesh-list
65000330|NCT03278431|Mebendazole|mebendazole|mesh-list
65000331|NCT03278431|Piperazine|piperazine|mesh-list
65000332|NCT03278431|Piperazine citrate|piperazine citrate|mesh-list
65000333|NCT03278431|Pyrantel|pyrantel|mesh-list
65000334|NCT03278431|Pyrantel Pamoate|pyrantel pamoate|mesh-list
65000335|NCT03278431|Oxantel|oxantel|mesh-list
65000336|NCT03278431|Oxantel pamoate|oxantel pamoate|mesh-list
65000337|NCT03278431|DMP 777|dmp 777|mesh-list
65000338|NCT03278431|Anthelmintics|anthelmintics|mesh-ancestor
65000339|NCT03278431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65000340|NCT03278431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65000341|NCT03278431|Anticestodal Agents|anticestodal agents|mesh-ancestor
65000342|NCT03278431|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65000343|NCT03278431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65000344|NCT03278431|Tubulin Modulators|tubulin modulators|mesh-ancestor
65000345|NCT03278431|Antimitotic Agents|antimitotic agents|mesh-ancestor
65000346|NCT03278431|Mitosis Modulators|mitosis modulators|mesh-ancestor
65000347|NCT03278431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000348|NCT03278431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959116|NCT00043706|Mitogens|mitogens|mesh-list
65000351|NCT03278431|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
65000352|NCT03278431|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65000353|NCT03278431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65000354|NCT03278431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65000355|NCT03278431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000356|NCT04726332|Prednisone|prednisone|mesh-list
65000357|NCT04726332|Fulvestrant|fulvestrant|mesh-list
65000358|NCT04726332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65000359|NCT04726332|Glucocorticoids|glucocorticoids|mesh-ancestor
65000360|NCT04726332|Hormones|hormones|mesh-ancestor
65000361|NCT04726332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65000362|NCT04726332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000363|NCT04726332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65000366|NCT04726332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65000410|NCT00443794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65000411|NCT00443794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65000412|NCT00443794|Sympatholytics|sympatholytics|mesh-ancestor
65000413|NCT00443794|Autonomic Agents|autonomic agents|mesh-ancestor
65000414|NCT00443794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65000415|NCT00443794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65000416|NCT00443794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65000417|NCT00443794|Adrenergic Agents|adrenergic agents|mesh-ancestor
65000418|NCT00443794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000419|NCT00443794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65000420|NCT00443794|Diuretics|diuretics|mesh-ancestor
65000421|NCT00443794|Natriuretic Agents|natriuretic agents|mesh-ancestor
65000422|NCT00108602|Acetazolamide|acetazolamide|mesh-list
65000423|NCT00108602|Anticonvulsants|anticonvulsants|mesh-ancestor
65000424|NCT00108602|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65000425|NCT00108602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000426|NCT00108602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000427|NCT00108602|Diuretics|diuretics|mesh-ancestor
65000428|NCT00108602|Natriuretic Agents|natriuretic agents|mesh-ancestor
65000430|NCT03278314|Ivacaftor|ivacaftor|mesh-list
65000466|NCT00138801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65000467|NCT03275701|Triumeq|triumeq|mesh-list
65000468|NCT03275701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65000469|NCT03275701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65000470|NCT03275701|Antiviral Agents|antiviral agents|mesh-ancestor
65000471|NCT03275701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65000472|NCT00451360|Diacetylrhein|diacetylrhein|mesh-list
65000473|NCT00451360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65000474|NCT00451399|Metformin|metformin|mesh-list
65000475|NCT00451399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65000476|NCT00451399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000477|NCT00108797|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
65000478|NCT00108797|Coagulants|coagulants|mesh-ancestor
65000479|NCT04698772|Ketamine|ketamine|mesh-list
65000480|NCT04698772|Morphine|morphine|mesh-list
65000481|NCT04698772|Analgesics|analgesics|mesh-ancestor
65000482|NCT04698772|Sensory System Agents|sensory system agents|mesh-ancestor
65000483|NCT04698772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65000484|NCT04698772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000485|NCT04698772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65000486|NCT04698772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65000487|NCT04698772|Anesthetics, General|anesthetics, general|mesh-ancestor
65000488|NCT04698772|Anesthetics|anesthetics|mesh-ancestor
65000489|NCT04698772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65000490|NCT04698772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65000491|NCT04698772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65000492|NCT04698772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000493|NCT04698772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000514|NCT00139035|Immunologic Factors|immunologic factors|mesh-ancestor
65000515|NCT00139035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000516|NCT00139035|Antifungal Agents|antifungal agents|mesh-ancestor
65000517|NCT00139035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65000518|NCT00139035|Dermatologic Agents|dermatologic agents|mesh-ancestor
65000519|NCT00139035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65000520|NCT00139035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65000521|NCT00451672|Bromocriptine|bromocriptine|mesh-list
65000522|NCT00451672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65000523|NCT00451672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65000524|NCT00451672|Hormone Antagonists|hormone antagonists|mesh-ancestor
65000578|NCT00143091|Antidepressive Agents|antidepressive agents|mesh-ancestor
65000579|NCT00143091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65000580|NCT00143091|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65000581|NCT00143091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65000582|NCT00143091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65000583|NCT00143091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000584|NCT00143091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000585|NCT00143091|Serotonin Agents|serotonin agents|mesh-ancestor
65000586|NCT00143091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000587|NCT00451984|Interleukin-2|interleukin-2|mesh-list
65000588|NCT00451984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65000589|NCT00451984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65000590|NCT00451984|Analgesics|analgesics|mesh-ancestor
65000591|NCT00451984|Sensory System Agents|sensory system agents|mesh-ancestor
65000592|NCT00451984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65000593|NCT00451984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000594|NCT00452062|Dexamethasone|dexamethasone|mesh-list
65000595|NCT00452062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65000596|NCT00452062|Antiemetics|antiemetics|mesh-ancestor
65000597|NCT00452062|Autonomic Agents|autonomic agents|mesh-ancestor
65000598|NCT00452062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65000599|NCT00452062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000600|NCT00452062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65000601|NCT00452062|Glucocorticoids|glucocorticoids|mesh-ancestor
65000627|NCT00143130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65000628|NCT00143130|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65000629|NCT00143130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65000630|NCT00143130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65000631|NCT00143130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65000632|NCT00109070|Bevacizumab|bevacizumab|mesh-list
65000633|NCT00109070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65000634|NCT00109070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65000635|NCT00109070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65000636|NCT00109070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65000637|NCT00109070|Growth Substances|growth substances|mesh-ancestor
65000638|NCT00109070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000639|NCT00109070|Growth Inhibitors|growth inhibitors|mesh-ancestor
65000640|NCT00452218|Sorafenib|sorafenib|mesh-list
65000641|NCT00452218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65000642|NCT00452218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65000643|NCT00452218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000644|NCT00452218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000645|NCT00143169|Parecoxib|parecoxib|mesh-list
65000646|NCT00143169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65000647|NCT00143169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65000648|NCT00143169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000649|NCT00143169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000650|NCT00143169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65000651|NCT00143169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65000652|NCT00143169|Analgesics|analgesics|mesh-ancestor
65000653|NCT00143169|Sensory System Agents|sensory system agents|mesh-ancestor
65000654|NCT00143169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65000655|NCT00143169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000669|NCT03275116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000670|NCT03275116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65000671|NCT03275116|Respiratory System Agents|respiratory system agents|mesh-ancestor
65000672|NCT03275116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65000673|NCT03275116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65000674|NCT03275116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65000675|NCT03275116|Adrenergic Agents|adrenergic agents|mesh-ancestor
65000676|NCT03275116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000677|NCT03275116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000678|NCT03275116|Parasympatholytics|parasympatholytics|mesh-ancestor
65000679|NCT03275116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65000680|NCT03275116|Cholinergic Agents|cholinergic agents|mesh-ancestor
65000681|NCT03275116|Anticonvulsants|anticonvulsants|mesh-ancestor
65000682|NCT00109148|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
65000683|NCT00109148|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65000684|NCT00109148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65000685|NCT00109148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000686|NCT00109148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000687|NCT00109148|Hormones|hormones|mesh-ancestor
65000688|NCT00109148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65000689|NCT00109148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000690|NCT00452296|Insulin|insulin|mesh-list
65000691|NCT00452296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65000692|NCT00452296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000693|NCT00452569|Thalidomide|thalidomide|mesh-list
65000712|NCT00452569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65000713|NCT00452569|Growth Substances|growth substances|mesh-ancestor
65000714|NCT00452569|Growth Inhibitors|growth inhibitors|mesh-ancestor
65000715|NCT00143286|Varenicline|varenicline|mesh-list
65000716|NCT00143286|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65000717|NCT00143286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65000718|NCT00143286|Cholinergic Agents|cholinergic agents|mesh-ancestor
65000719|NCT00143286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000720|NCT00143286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000721|NCT00143286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000722|NCT00109187|Omalizumab|omalizumab|mesh-list
65000723|NCT00109187|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65000724|NCT00109187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65000725|NCT00109187|Respiratory System Agents|respiratory system agents|mesh-ancestor
65000726|NCT00452608|Atorvastatin|atorvastatin|mesh-list
65000727|NCT00452608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65000728|NCT00452608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65000729|NCT00452608|Antimetabolites|antimetabolites|mesh-ancestor
65000730|NCT00452608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000731|NCT00452608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65000732|NCT00452608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64959573|NCT00078546|Antibodies|antibodies|mesh-list
64959574|NCT00078546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65000764|NCT00452881|Gemcitabine|gemcitabine|mesh-list
65000765|NCT00452881|Oxaliplatin|oxaliplatin|mesh-list
65000766|NCT00452881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65000767|NCT00452881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65000768|NCT00452881|Antimetabolites|antimetabolites|mesh-ancestor
65000769|NCT00452881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000770|NCT00452881|Antiviral Agents|antiviral agents|mesh-ancestor
65000771|NCT00452881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65000772|NCT00452881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000773|NCT00452881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65000774|NCT00452881|Immunologic Factors|immunologic factors|mesh-ancestor
65000775|NCT00452881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000776|NCT00452920|Docetaxel|docetaxel|mesh-list
65000777|NCT00452920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65000778|NCT00452920|Tubulin Modulators|tubulin modulators|mesh-ancestor
65000779|NCT00452920|Antimitotic Agents|antimitotic agents|mesh-ancestor
65000780|NCT00452920|Mitosis Modulators|mitosis modulators|mesh-ancestor
65000781|NCT00452920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000782|NCT00143442|Reboxetine|reboxetine|mesh-list
65000783|NCT00143442|Antidepressive Agents|antidepressive agents|mesh-ancestor
65000784|NCT00143442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65000785|NCT00143442|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65000786|NCT00143442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65000787|NCT00143442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65000788|NCT00143442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000789|NCT00143442|Adrenergic Agents|adrenergic agents|mesh-ancestor
65000790|NCT00143442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000791|NCT00143442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000805|NCT00109382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000806|NCT00109382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65000807|NCT00109382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65000808|NCT00109382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000809|NCT00109382|Antipyretics|antipyretics|mesh-ancestor
65000810|NCT00109382|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65000811|NCT00109382|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65000812|NCT00109382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65000813|NCT00109382|Purinergic Agents|purinergic agents|mesh-ancestor
65000814|NCT00109382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000815|NCT00109382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65000816|NCT00109382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65000817|NCT00109382|Antimetabolites|antimetabolites|mesh-ancestor
65000818|NCT00109382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65000819|NCT00109382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65000820|NCT00453076|Paclitaxel|paclitaxel|mesh-list
65000821|NCT00453076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65000822|NCT00453076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65000823|NCT00453076|Tubulin Modulators|tubulin modulators|mesh-ancestor
65000824|NCT00453076|Antimitotic Agents|antimitotic agents|mesh-ancestor
65000825|NCT00453076|Mitosis Modulators|mitosis modulators|mesh-ancestor
65000826|NCT00453076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000827|NCT00453115|Gemcitabine|gemcitabine|mesh-list
65000828|NCT00453115|Oxaliplatin|oxaliplatin|mesh-list
65000829|NCT00453115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65000830|NCT00453115|Antimetabolites|antimetabolites|mesh-ancestor
65000831|NCT00453115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000832|NCT00453115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65000833|NCT00453115|Antiviral Agents|antiviral agents|mesh-ancestor
65000847|NCT02273557|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
65000848|NCT02273557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65000849|NCT00453232|Etoposide|etoposide|mesh-list
65000850|NCT00453232|Bleomycin|bleomycin|mesh-list
65000851|NCT00453232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65000852|NCT00453232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65000853|NCT00453232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65000854|NCT00453232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65000855|NCT00453232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000856|NCT00453232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000857|NCT00453232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65000858|NCT00453427|Alemtuzumab|alemtuzumab|mesh-list
65000859|NCT00453427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65000860|NCT00453427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65000861|NCT00143520|Pioglitazone|pioglitazone|mesh-list
65000862|NCT00143520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65000863|NCT00143520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000864|NCT00143559|Antibodies|antibodies|mesh-list
65000865|NCT00143559|Immunologic Factors|immunologic factors|mesh-ancestor
65000866|NCT00143559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000867|NCT00453778|Fluticasone|fluticasone|mesh-list
65000868|NCT00453778|Xhance|xhance|mesh-list
65000869|NCT00453778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65000870|NCT00453778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65000898|NCT00454168|Immunologic Factors|immunologic factors|mesh-ancestor
65000899|NCT00454168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000900|NCT00109811|Freund's Adjuvant|freund's adjuvant|mesh-list
65000901|NCT00109811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65000902|NCT00109811|Immunologic Factors|immunologic factors|mesh-ancestor
65000903|NCT00109811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000904|NCT03274765|Estradiol|estradiol|mesh-list
65000905|NCT03274765|Estrogens|estrogens|mesh-ancestor
65000906|NCT03274765|Hormones|hormones|mesh-ancestor
65000907|NCT03274765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65000908|NCT03274765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000909|NCT00454402|Alfuzosin|alfuzosin|mesh-list
65000910|NCT00454402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65000911|NCT00454402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65000912|NCT00454402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65000913|NCT00454402|Adrenergic Agents|adrenergic agents|mesh-ancestor
65000914|NCT00454402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65000915|NCT00454402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000916|NCT00454402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000917|NCT00454402|Urological Agents|urological agents|mesh-ancestor
65000918|NCT00143676|Atorvastatin|atorvastatin|mesh-list
65000919|NCT00143676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65000920|NCT00143676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65000921|NCT00143676|Antimetabolites|antimetabolites|mesh-ancestor
65000922|NCT00143676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000923|NCT00143676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65000924|NCT00143676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65000925|NCT00143676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000926|NCT00454480|Cytarabine|cytarabine|mesh-list
65000927|NCT00454480|Fludarabine|fludarabine|mesh-list
65000928|NCT00454480|Fludarabine phosphate|fludarabine phosphate|mesh-list
65000929|NCT00454480|Azacitidine|azacitidine|mesh-list
65000942|NCT00454480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65000943|NCT00454480|Immunologic Factors|immunologic factors|mesh-ancestor
65000944|NCT00454480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000945|NCT00454480|Antiviral Agents|antiviral agents|mesh-ancestor
65000946|NCT00454480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65000947|NCT00454480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000948|NCT00454480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65000949|NCT00454480|Alkylating Agents|alkylating agents|mesh-ancestor
65000950|NCT00454480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65000951|NCT00454480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65000952|NCT00454480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65000953|NCT00454480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65000954|NCT00454480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65000955|NCT00110006|Prednisone|prednisone|mesh-list
65000956|NCT00110006|Cyclophosphamide|cyclophosphamide|mesh-list
65000957|NCT00110006|Rituximab|rituximab|mesh-list
65000958|NCT00110006|Doxorubicin|doxorubicin|mesh-list
65000959|NCT00110006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65000960|NCT00110006|Vincristine|vincristine|mesh-list
65000961|NCT00110006|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65000962|NCT00110006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65000963|NCT00110006|Immunologic Factors|immunologic factors|mesh-ancestor
65000964|NCT00110006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65000965|NCT00110006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65000966|NCT00110006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65000967|NCT00110006|Alkylating Agents|alkylating agents|mesh-ancestor
65000968|NCT00110006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000969|NCT00110006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65000970|NCT00110006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65000971|NCT00110006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65000972|NCT00110006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65000978|NCT00110006|Hormones|hormones|mesh-ancestor
65000983|NCT00110006|Antimitotic Agents|antimitotic agents|mesh-ancestor
65000984|NCT00110006|Mitosis Modulators|mitosis modulators|mesh-ancestor
65000985|NCT00110006|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65000986|NCT00454519|Mitomycins|mitomycins|mesh-list
65000987|NCT00454519|Mitomycin|mitomycin|mesh-list
65000988|NCT00454519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65000989|NCT00454519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65000990|NCT00454519|Alkylating Agents|alkylating agents|mesh-ancestor
65000991|NCT00454519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000992|NCT00454519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65000993|NCT00454519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65000994|NCT00454558|Riociguat|riociguat|mesh-list
65000995|NCT00454558|Enzyme Activators|enzyme activators|mesh-ancestor
65000996|NCT00454558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65000997|NCT00112749|Infliximab|infliximab|mesh-list
65000998|NCT00112749|Dermatologic Agents|dermatologic agents|mesh-ancestor
65000999|NCT00112749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65001000|NCT00112749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65001001|NCT00110045|Caspofungin|caspofungin|mesh-list
65001002|NCT00110045|Antifungal Agents|antifungal agents|mesh-ancestor
65001003|NCT00110045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65001004|NCT00110045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001005|NCT00110045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001006|NCT00454714|Sildenafil Citrate|sildenafil citrate|mesh-list
65001007|NCT00454714|Vasodilator Agents|vasodilator agents|mesh-ancestor
65001008|NCT00454714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65001009|NCT00454714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65001010|NCT00454714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001011|NCT00454714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001012|NCT00454714|Urological Agents|urological agents|mesh-ancestor
65001028|NCT00454831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65001029|NCT00454831|Chelating Agents|chelating agents|mesh-ancestor
65001030|NCT00454831|Sequestering Agents|sequestering agents|mesh-ancestor
65001031|NCT00454831|Hemostatics|hemostatics|mesh-ancestor
65001032|NCT00454831|Coagulants|coagulants|mesh-ancestor
65001033|NCT00110123|Fotemustine|fotemustine|mesh-list
65001034|NCT00110123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001035|NCT00455026|Remifentanil|remifentanil|mesh-list
65001036|NCT00455026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65001037|NCT00455026|Narcotics|narcotics|mesh-ancestor
65001038|NCT00455026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65001039|NCT00455026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001040|NCT00455026|Analgesics|analgesics|mesh-ancestor
65001041|NCT00455026|Sensory System Agents|sensory system agents|mesh-ancestor
65001042|NCT00455026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65001043|NCT00112983|Eculizumab|eculizumab|mesh-list
65001044|NCT00112983|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65001048|NCT00110162|Hormones|hormones|mesh-list
65001087|NCT00110240|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65001088|NCT00110240|Protease Inhibitors|protease inhibitors|mesh-ancestor
65001089|NCT00110240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001090|NCT00110240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001091|NCT00455416|Selenium|selenium|mesh-list
65001092|NCT00455416|Allicin|allicin|mesh-list
65001093|NCT00455416|Resveratrol|resveratrol|mesh-list
65001094|NCT00455416|Quercetin|quercetin|mesh-list
65001095|NCT00455416|Antioxidants|antioxidants|mesh-ancestor
65001096|NCT00455416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001097|NCT00455416|Protective Agents|protective agents|mesh-ancestor
65001098|NCT00455416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001099|NCT00455416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001100|NCT00455416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65001101|NCT00455416|Trace Elements|trace elements|mesh-ancestor
65001102|NCT00455416|Micronutrients|micronutrients|mesh-ancestor
65001103|NCT00455416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65001104|NCT00455416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65001146|NCT00455806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001147|NCT00455806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001148|NCT00455806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65001149|NCT00455806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65001150|NCT00455806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65001151|NCT00455845|Levonorgestrel|levonorgestrel|mesh-list
65001152|NCT00455845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65001153|NCT00455845|Contraceptive Agents|contraceptive agents|mesh-ancestor
65001154|NCT00455845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65001155|NCT00455845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001156|NCT00455845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65001157|NCT00455845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65001158|NCT00455845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65001159|NCT00110474|Acetaminophen|acetaminophen|mesh-list
65001160|NCT00110474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65001161|NCT00110474|Analgesics|analgesics|mesh-ancestor
65001162|NCT00110474|Sensory System Agents|sensory system agents|mesh-ancestor
65001163|NCT00110474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65001164|NCT00110474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001165|NCT00110474|Antipyretics|antipyretics|mesh-ancestor
65001167|NCT00113100|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65001168|NCT00113100|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65001169|NCT00113100|Estradiol|estradiol|mesh-list
65001170|NCT00113100|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65001171|NCT00113100|Estrogens|estrogens|mesh-ancestor
65001172|NCT00113100|Hormones|hormones|mesh-ancestor
65001173|NCT00113100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65001174|NCT00113100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001175|NCT00113100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65001176|NCT00113100|Contraceptive Agents|contraceptive agents|mesh-ancestor
65001177|NCT00113100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65001188|NCT00143949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001189|NCT00143949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65001190|NCT00143949|Protease Inhibitors|protease inhibitors|mesh-ancestor
65001191|NCT00143949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001192|NCT00456235|Mycophenolic Acid|mycophenolic acid|mesh-list
65001193|NCT00456235|Cyclosporine|cyclosporine|mesh-list
65001194|NCT00456235|Tacrolimus|tacrolimus|mesh-list
65001195|NCT00456235|Cyclosporins|cyclosporins|mesh-list
65001196|NCT00456235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65001197|NCT00456235|Immunologic Factors|immunologic factors|mesh-ancestor
65001198|NCT00456235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001199|NCT00456235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65001200|NCT00456235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001201|NCT00456235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001249|NCT00456586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65001250|NCT00456586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65001251|NCT00456586|Purinergic Agents|purinergic agents|mesh-ancestor
65001252|NCT00456586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65001253|NCT00456586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001254|NCT00456586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001255|NCT00110669|Prednisone|prednisone|mesh-list
65001256|NCT00110669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65001257|NCT00110669|Glucocorticoids|glucocorticoids|mesh-ancestor
65001258|NCT00110669|Hormones|hormones|mesh-ancestor
65001259|NCT00110669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65001260|NCT00110669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001261|NCT00110669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65001262|NCT00110669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001263|NCT00113256|Rubitecan|rubitecan|mesh-list
65001264|NCT00113256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001265|NCT00113256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65001266|NCT00113256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65001267|NCT00113256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001268|NCT00113256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001269|NCT00110708|Immunoglobulins|immunoglobulins|mesh-list
65001271|NCT00110708|Antibodies|antibodies|mesh-list
65001298|NCT00456898|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65001299|NCT00456898|Antidepressive Agents|antidepressive agents|mesh-ancestor
65001300|NCT00456898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65001301|NCT00456898|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65001302|NCT00456898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65001303|NCT00456898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001304|NCT00456898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65001305|NCT00456898|Narcotics|narcotics|mesh-ancestor
65001306|NCT00456898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65001307|NCT00456898|Analgesics|analgesics|mesh-ancestor
65001308|NCT00456898|Sensory System Agents|sensory system agents|mesh-ancestor
65001309|NCT00456898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65001310|NCT00456898|Antitussive Agents|antitussive agents|mesh-ancestor
65001311|NCT00456898|Respiratory System Agents|respiratory system agents|mesh-ancestor
65001312|NCT00456898|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65001313|NCT03274102|Vaccines|vaccines|mesh-list
65001314|NCT03274102|Immunologic Factors|immunologic factors|mesh-ancestor
65001315|NCT03274102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001316|NCT00110747|Lidocaine|lidocaine|mesh-list
65001317|NCT00110747|Tetracaine|tetracaine|mesh-list
65001318|NCT00110747|Anesthetics, Local|anesthetics, local|mesh-ancestor
65001319|NCT00110747|Anesthetics|anesthetics|mesh-ancestor
65001320|NCT00110747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65001321|NCT00110747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001322|NCT00110747|Sensory System Agents|sensory system agents|mesh-ancestor
65001323|NCT00110747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65001324|NCT00110747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65001325|NCT00110747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65001326|NCT00110747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65001327|NCT00110747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65001328|NCT00110747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001329|NCT00456937|Citalopram|citalopram|mesh-list
65001337|NCT00456937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65001338|NCT00456937|Antidepressive Agents|antidepressive agents|mesh-ancestor
65001339|NCT00456937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65001340|NCT00456976|Selegiline|selegiline|mesh-list
65001341|NCT00456976|Antidepressive Agents|antidepressive agents|mesh-ancestor
65001342|NCT00456976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65001343|NCT00456976|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65001344|NCT00456976|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65001345|NCT00456976|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65001346|NCT00456976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001347|NCT00456976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001348|NCT00456976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65001349|NCT00456976|Protective Agents|protective agents|mesh-ancestor
65001350|NCT00456976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001351|NCT00144066|Gefitinib|gefitinib|mesh-list
65001352|NCT00144066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001353|NCT00144066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65001354|NCT00144066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001355|NCT00144066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001356|NCT00457054|Lithium Carbonate|lithium carbonate|mesh-list
65001357|NCT00457054|Antidepressive Agents|antidepressive agents|mesh-ancestor
64456468|NCT01387516|Nicotine|nicotine|mesh-list
65001358|NCT00457054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65001359|NCT00457054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001360|NCT00457054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001362|NCT00457054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65001363|NCT00457054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65001364|NCT00457054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001365|NCT00457093|Insulin Glargine|insulin glargine|mesh-list
65001374|NCT00457483|Valsartan|valsartan|mesh-list
65001380|NCT00457483|Diuretics|diuretics|mesh-ancestor
65001381|NCT00457483|Natriuretic Agents|natriuretic agents|mesh-ancestor
65001382|NCT00457483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001383|NCT00457483|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65001384|NCT00457483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65001385|NCT00110864|Insulin|insulin|mesh-list
65001386|NCT00110864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65001387|NCT00110864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001388|NCT00457678|Dexamethasone|dexamethasone|mesh-list
65001389|NCT00457678|Ranibizumab|ranibizumab|mesh-list
65001390|NCT00457678|Verteporfin|verteporfin|mesh-list
65001391|NCT00457678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65001392|NCT00457678|Antiemetics|antiemetics|mesh-ancestor
65001393|NCT00457678|Autonomic Agents|autonomic agents|mesh-ancestor
65001394|NCT00457678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65001395|NCT00457678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001396|NCT00457678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65001397|NCT00457678|Glucocorticoids|glucocorticoids|mesh-ancestor
65001398|NCT00457678|Hormones|hormones|mesh-ancestor
65001399|NCT00457678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65001400|NCT00457678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65001401|NCT00457678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001402|NCT00457678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65001403|NCT00457678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65001404|NCT00457678|Growth Substances|growth substances|mesh-ancestor
65001405|NCT00457678|Growth Inhibitors|growth inhibitors|mesh-ancestor
65001406|NCT00457678|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65001408|NCT00457717|Atropine|atropine|mesh-list
65001428|NCT00110903|Sensory System Agents|sensory system agents|mesh-ancestor
65001429|NCT00110903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65001430|NCT00110903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001431|NCT00110903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65001433|NCT00110903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65001434|NCT00110903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65001435|NCT00110903|Immunologic Factors|immunologic factors|mesh-ancestor
65001436|NCT00144144|Calcium Channel Blockers|calcium channel blockers|mesh-list
65001437|NCT00144144|Angiotensin II|angiotensin ii|mesh-list
65001438|NCT00144144|Giapreza|giapreza|mesh-list
65001439|NCT00144144|Calcium|calcium|mesh-list
65001440|NCT00144144|Angiotensinogen|angiotensinogen|mesh-list
65001441|NCT00144144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65001442|NCT00144144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65001443|NCT00144144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001444|NCT00144144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65001445|NCT00144144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65001446|NCT00144144|Protease Inhibitors|protease inhibitors|mesh-ancestor
65001447|NCT00144144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001448|NCT00144144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001449|NCT00144144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65001450|NCT00465673|Doxorubicin|doxorubicin|mesh-list
65001451|NCT00465673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65001452|NCT00465673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65001453|NCT00465673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001454|NCT00465673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65001455|NCT00465673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65001456|NCT00465673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001457|NCT00465673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001458|NCT00144183|Zidovudine|zidovudine|mesh-list
65001472|NCT00465751|Cathartics|cathartics|mesh-ancestor
65001473|NCT00465751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65001474|NCT00110981|Etanercept|etanercept|mesh-list
65001475|NCT00110981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65001476|NCT00110981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65001477|NCT00110981|Analgesics|analgesics|mesh-ancestor
65001478|NCT00110981|Sensory System Agents|sensory system agents|mesh-ancestor
65001479|NCT00110981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65001480|NCT00110981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001481|NCT00110981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65001482|NCT00110981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65001483|NCT00110981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65001484|NCT00110981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65001485|NCT00110981|Immunologic Factors|immunologic factors|mesh-ancestor
65001486|NCT00465907|Paclitaxel|paclitaxel|mesh-list
65001487|NCT00465907|Carboplatin|carboplatin|mesh-list
65001488|NCT00465907|Irinotecan|irinotecan|mesh-list
65001489|NCT00465907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65001490|NCT00465907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001491|NCT00465907|Tubulin Modulators|tubulin modulators|mesh-ancestor
65001492|NCT00465907|Antimitotic Agents|antimitotic agents|mesh-ancestor
65001493|NCT00465907|Mitosis Modulators|mitosis modulators|mesh-ancestor
65001494|NCT00465907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001495|NCT00465907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65001496|NCT00465907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65001497|NCT00465907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001498|NCT00113685|Dextrans|dextrans|mesh-list
65001499|NCT00113685|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65001500|NCT00113685|Anticoagulants|anticoagulants|mesh-ancestor
65001501|NCT00113685|Plasma Substitutes|plasma substitutes|mesh-ancestor
65001502|NCT00113685|Blood Substitutes|blood substitutes|mesh-ancestor
65001503|NCT00111020|Sorafenib|sorafenib|mesh-list
65001504|NCT00111020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001513|NCT00466102|Everolimus|everolimus|mesh-list
65001514|NCT00466102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001515|NCT00466102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65001516|NCT00466102|Immunologic Factors|immunologic factors|mesh-ancestor
65001517|NCT00466102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001518|NCT00144222|Telmisartan|telmisartan|mesh-list
65001519|NCT00144222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65001520|NCT00144222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65001521|NCT00144222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65001522|NCT00144222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001523|NCT00466180|Nevirapine|nevirapine|mesh-list
65001524|NCT00466180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65001525|NCT00466180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65001526|NCT00466180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001527|NCT00466180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001528|NCT00466180|Antiviral Agents|antiviral agents|mesh-ancestor
65001529|NCT00466180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65001530|NCT00466180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65001531|NCT00466180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65001532|NCT00466180|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65001568|NCT00347698|Bevacizumab|bevacizumab|mesh-list
65001569|NCT00347698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65001570|NCT00347698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001571|NCT00347698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65001572|NCT00347698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65001573|NCT00347698|Growth Substances|growth substances|mesh-ancestor
65001574|NCT00347698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001575|NCT00347698|Growth Inhibitors|growth inhibitors|mesh-ancestor
65001576|NCT00347737|Teriparatide|teriparatide|mesh-list
65001577|NCT00347737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65001578|NCT00347737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001579|NCT00347737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65001580|NCT00347815|Buprenorphine|buprenorphine|mesh-list
65001581|NCT00347815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65001582|NCT00347815|Narcotics|narcotics|mesh-ancestor
65001583|NCT00347815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65001584|NCT00347815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001585|NCT00347815|Analgesics|analgesics|mesh-ancestor
65001586|NCT00347815|Sensory System Agents|sensory system agents|mesh-ancestor
65001587|NCT00347815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65001623|NCT00144417|Moxifloxacin|moxifloxacin|mesh-list
65001624|NCT00144417|Rifampin|rifampin|mesh-list
65001625|NCT00144417|Isoniazid|isoniazid|mesh-list
65001626|NCT00144417|Pyrazinamide|pyrazinamide|mesh-list
65001627|NCT00144417|Ethambutol|ethambutol|mesh-list
65001628|NCT00144417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65001629|NCT00144417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65001630|NCT00144417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65001631|NCT00144417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65001632|NCT00144417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001633|NCT00144417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001634|NCT00144417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001635|NCT00144417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65001636|NCT00144417|Antitubercular Agents|antitubercular agents|mesh-ancestor
65001637|NCT00144417|Leprostatic Agents|leprostatic agents|mesh-ancestor
65001638|NCT00144417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65001639|NCT00144417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65001640|NCT00144417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65001641|NCT00144417|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65001642|NCT00144417|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65001643|NCT00144417|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65001644|NCT00144417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65001645|NCT00144417|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65001646|NCT00144417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65001647|NCT00144417|Antimetabolites|antimetabolites|mesh-ancestor
65001648|NCT00144417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65001649|NCT00111215|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65001650|NCT00111215|Tranexamic Acid|tranexamic acid|mesh-list
65001651|NCT00111215|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65001652|NCT00111215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65001653|NCT00111215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001667|NCT00348166|Cholinergic Agents|cholinergic agents|mesh-ancestor
65001668|NCT00348166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65001669|NCT00348166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001670|NCT00348244|Prednisolone|prednisolone|mesh-list
65001671|NCT00348244|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65001672|NCT00348244|Methylprednisolone|methylprednisolone|mesh-list
65001673|NCT00348244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65001674|NCT00348244|Prednisolone acetate|prednisolone acetate|mesh-list
65001675|NCT00348244|Ketorolac|ketorolac|mesh-list
65001676|NCT00348244|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65001677|NCT00348244|Prednisolone phosphate|prednisolone phosphate|mesh-list
65001678|NCT00348244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65001679|NCT00348244|Glucocorticoids|glucocorticoids|mesh-ancestor
65001680|NCT00348244|Hormones|hormones|mesh-ancestor
65001681|NCT00348244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65001682|NCT00348244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001683|NCT00348244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65001684|NCT00348244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001685|NCT00348244|Antiemetics|antiemetics|mesh-ancestor
65001686|NCT00348244|Autonomic Agents|autonomic agents|mesh-ancestor
65001687|NCT00348244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65001721|NCT00348400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65001722|NCT00348400|Adrenergic Agents|adrenergic agents|mesh-ancestor
65001723|NCT00348400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65001724|NCT00348400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001725|NCT00348400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001726|NCT00348400|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65001728|NCT00144456|Alfacalcidol|alfacalcidol|mesh-list
65001729|NCT00144456|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
64456836|NCT01859702|Antiemetics|antiemetics|mesh-ancestor
65001730|NCT00144456|Eldecalcitol|eldecalcitol|mesh-list
65001731|NCT00144456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65001732|NCT00144456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001733|NCT00144456|Vitamins|vitamins|mesh-ancestor
65001734|NCT00144456|Micronutrients|micronutrients|mesh-ancestor
65001735|NCT00348439|Fibrinolysin|fibrinolysin|mesh-list
65001782|NCT00349024|Protective Agents|protective agents|mesh-ancestor
65001783|NCT00349024|Plasma Substitutes|plasma substitutes|mesh-ancestor
65001784|NCT00349024|Blood Substitutes|blood substitutes|mesh-ancestor
65001785|NCT00111371|Levodopa|levodopa|mesh-list
65001786|NCT00111371|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65001787|NCT00111371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65001788|NCT00111371|Dopamine Agents|dopamine agents|mesh-ancestor
65001789|NCT00111371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65001790|NCT00111371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001791|NCT00111371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001792|NCT00349180|Enoxaparin|enoxaparin|mesh-list
65001793|NCT00349180|Enoxaparin sodium|enoxaparin sodium|mesh-list
65001794|NCT00349180|Anticoagulants|anticoagulants|mesh-ancestor
65001795|NCT00349180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65001796|NCT00349180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65001797|NCT00349180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001798|NCT00421369|Sertraline|sertraline|mesh-list
65001799|NCT00421369|Reboxetine|reboxetine|mesh-list
65001800|NCT00421369|Antidepressive Agents|antidepressive agents|mesh-ancestor
65001801|NCT00421369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65001802|NCT00421369|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65001803|NCT00421369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65001804|NCT00421369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65001805|NCT00421369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001807|NCT00421369|Serotonin Agents|serotonin agents|mesh-ancestor
65001808|NCT00421369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001809|NCT00421369|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65001810|NCT00421369|Adrenergic Agents|adrenergic agents|mesh-ancestor
65001811|NCT00111410|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65001812|NCT00111410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65001827|NCT04729140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65001828|NCT04729140|Antimalarials|antimalarials|mesh-ancestor
65001829|NCT04729140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65001830|NCT04729140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65001831|NCT00349219|Gemcitabine|gemcitabine|mesh-list
65001832|NCT00349219|Cisplatin|cisplatin|mesh-list
65001833|NCT00349219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65001834|NCT00349219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001835|NCT00349219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65001836|NCT00349219|Antimetabolites|antimetabolites|mesh-ancestor
65001837|NCT00349219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001838|NCT00349219|Antiviral Agents|antiviral agents|mesh-ancestor
65001839|NCT00349219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65001840|NCT00349219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001841|NCT00349219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65001842|NCT00349219|Immunologic Factors|immunologic factors|mesh-ancestor
65001843|NCT00349219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001885|NCT00349492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001886|NCT00349492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001887|NCT00349531|Pramipexole|pramipexole|mesh-list
65001888|NCT00349531|Antioxidants|antioxidants|mesh-ancestor
65001889|NCT00349531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001890|NCT00349531|Protective Agents|protective agents|mesh-ancestor
65001891|NCT00349531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001892|NCT00349531|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65001893|NCT00349531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65001894|NCT00349531|Dopamine Agonists|dopamine agonists|mesh-ancestor
65001895|NCT00349531|Dopamine Agents|dopamine agents|mesh-ancestor
65001896|NCT00349531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65001897|NCT00111566|Eptifibatide|eptifibatide|mesh-list
65001898|NCT00111566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65001899|NCT00404703|Bevacizumab|bevacizumab|mesh-list
65001900|NCT00404703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65001901|NCT00404703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65001944|NCT00350116|Vitamin B Complex|vitamin b complex|mesh-ancestor
65001945|NCT00350116|Hematinics|hematinics|mesh-ancestor
65001946|NCT00350155|Lumiracoxib|lumiracoxib|mesh-list
65001947|NCT00350155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65001948|NCT00350155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65001949|NCT00350155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65001950|NCT00350155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65001951|NCT00350155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65001952|NCT00350155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65001953|NCT00350155|Analgesics|analgesics|mesh-ancestor
65001954|NCT00350155|Sensory System Agents|sensory system agents|mesh-ancestor
65001955|NCT00350155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65001956|NCT00350155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65001957|NCT00350155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65001958|NCT00350155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65001960|NCT00404781|Cilostazol|cilostazol|mesh-list
65001961|NCT00404781|Clopidogrel|clopidogrel|mesh-list
65001962|NCT00404781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65001963|NCT00404781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65001964|NCT00404781|Analgesics|analgesics|mesh-ancestor
65001976|NCT00404781|Antipyretics|antipyretics|mesh-ancestor
65001998|NCT00350311|Cholinergic Agents|cholinergic agents|mesh-ancestor
65001999|NCT00350311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65002000|NCT00350311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002001|NCT00114192|Thalidomide|thalidomide|mesh-list
65002002|NCT00114192|Docetaxel|docetaxel|mesh-list
65002003|NCT00114192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002004|NCT00114192|Tubulin Modulators|tubulin modulators|mesh-ancestor
65002005|NCT00114192|Antimitotic Agents|antimitotic agents|mesh-ancestor
65002006|NCT00114192|Mitosis Modulators|mitosis modulators|mesh-ancestor
65002007|NCT00114192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002008|NCT00114192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65002009|NCT00114192|Immunologic Factors|immunologic factors|mesh-ancestor
65002010|NCT00114192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002011|NCT00114192|Leprostatic Agents|leprostatic agents|mesh-ancestor
65002012|NCT00114192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65002013|NCT00114192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65002014|NCT00114192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65002015|NCT00114192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65002016|NCT00114192|Growth Substances|growth substances|mesh-ancestor
65002054|NCT00350857|Anticonvulsants|anticonvulsants|mesh-ancestor
65002055|NCT00350857|Antimanic Agents|antimanic agents|mesh-ancestor
65002056|NCT00350857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65002057|NCT00350857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65002058|NCT00350857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002059|NCT00350857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65002060|NCT00350857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65002061|NCT00350857|Analgesics|analgesics|mesh-ancestor
65002062|NCT00350857|Sensory System Agents|sensory system agents|mesh-ancestor
65002063|NCT00350857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65002064|NCT00350857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65002065|NCT00350857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65002066|NCT00350857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002067|NCT00350857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65002069|NCT00111956|Etanercept|etanercept|mesh-list
65002114|NCT00401609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002115|NCT00401609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65002116|NCT00401609|Antimetabolites|antimetabolites|mesh-ancestor
65002117|NCT00401609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002118|NCT00401609|Antiviral Agents|antiviral agents|mesh-ancestor
65002119|NCT00401609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65002120|NCT00401609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002121|NCT00401609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65002122|NCT00401609|Immunologic Factors|immunologic factors|mesh-ancestor
65002123|NCT00401609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002124|NCT00401609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65002125|NCT00401609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65002126|NCT00401609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65002127|NCT00401609|Tubulin Modulators|tubulin modulators|mesh-ancestor
65002128|NCT00401609|Antimitotic Agents|antimitotic agents|mesh-ancestor
65002129|NCT00401609|Mitosis Modulators|mitosis modulators|mesh-ancestor
65002130|NCT00351091|Risedronic Acid|risedronic acid|mesh-list
65002131|NCT00351091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65002132|NCT00351091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65002133|NCT00351091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002134|NCT00351091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65002135|NCT00351091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002162|NCT00351169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65002163|NCT00401648|Brivaracetam|brivaracetam|mesh-list
65002164|NCT00401648|Anticonvulsants|anticonvulsants|mesh-ancestor
65002165|NCT00351286|Simvastatin|simvastatin|mesh-list
65002166|NCT00351286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65002167|NCT00351286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65002168|NCT00351286|Antimetabolites|antimetabolites|mesh-ancestor
65002169|NCT00351286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002170|NCT00351286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65002171|NCT00351286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65002172|NCT00351286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002173|NCT00112034|Methylprednisolone|methylprednisolone|mesh-list
65002175|NCT00112034|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65002176|NCT00112034|Prednisolone|prednisolone|mesh-list
65002177|NCT00112034|Prednisolone acetate|prednisolone acetate|mesh-list
65002223|NCT00351364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002224|NCT00351364|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65002225|NCT00351364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65002226|NCT00351364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002227|NCT00351403|Ribavirin|ribavirin|mesh-list
65002228|NCT00351403|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65002229|NCT00351403|Antimetabolites|antimetabolites|mesh-ancestor
65002230|NCT00351403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002231|NCT00351403|Antiviral Agents|antiviral agents|mesh-ancestor
65002232|NCT00351403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65002233|NCT05595096|Anesthetics|anesthetics|mesh-list
65002234|NCT05595096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65002235|NCT05595096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002236|NCT00351637|Methadone|methadone|mesh-list
65002237|NCT00351637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65002238|NCT00351637|Narcotics|narcotics|mesh-ancestor
65002239|NCT00351637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65002240|NCT00351637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002241|NCT00351637|Analgesics|analgesics|mesh-ancestor
65002242|NCT00351637|Sensory System Agents|sensory system agents|mesh-ancestor
65002243|NCT00351637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65002244|NCT00351637|Antitussive Agents|antitussive agents|mesh-ancestor
65002245|NCT00351637|Respiratory System Agents|respiratory system agents|mesh-ancestor
65002246|NCT00351715|Methadone|methadone|mesh-list
65002247|NCT00351715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65002248|NCT00351715|Narcotics|narcotics|mesh-ancestor
65002250|NCT00351715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002251|NCT00351715|Analgesics|analgesics|mesh-ancestor
65002270|NCT00351910|Amitriptyline|amitriptyline|mesh-list
65002271|NCT00351910|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65002272|NCT00351910|Citalopram|citalopram|mesh-list
65002273|NCT00351910|Bupropion|bupropion|mesh-list
65002274|NCT00351910|Fluoxetine|fluoxetine|mesh-list
65002275|NCT00351910|Paroxetine|paroxetine|mesh-list
65002276|NCT00351910|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65002277|NCT00351910|Sertraline|sertraline|mesh-list
65002278|NCT00351910|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65002279|NCT00351910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65002280|NCT00351910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65002281|NCT00351910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002282|NCT00351910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65002283|NCT00351910|Serotonin Agents|serotonin agents|mesh-ancestor
65002284|NCT00351910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002285|NCT00351910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65002286|NCT00351910|Antidepressive Agents|antidepressive agents|mesh-ancestor
65002287|NCT00351910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65002288|NCT00351910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65002289|NCT00351910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65002290|NCT00351910|Dopamine Agents|dopamine agents|mesh-ancestor
65002291|NCT00351910|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65002292|NCT00351910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65002293|NCT00351910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002294|NCT00351910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65002295|NCT00351910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65002296|NCT00351910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65002297|NCT00351910|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65002298|NCT00351910|Analgesics|analgesics|mesh-ancestor
65002299|NCT00351910|Sensory System Agents|sensory system agents|mesh-ancestor
65002314|NCT00112346|Immunologic Factors|immunologic factors|mesh-ancestor
65002315|NCT00112346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002316|NCT00112346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65002317|NCT00352144|Eszopiclone|eszopiclone|mesh-list
65002318|NCT00352144|Zopiclone|zopiclone|mesh-list
65002319|NCT00352144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65002320|NCT00352144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65002321|NCT00352144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002322|NCT00352183|Simvastatin|simvastatin|mesh-list
65002324|NCT00352183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65002325|NCT00352183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65002326|NCT00352183|Antimetabolites|antimetabolites|mesh-ancestor
65002327|NCT00352183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002328|NCT00352183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65002329|NCT00352183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65002330|NCT00352183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002332|NCT00112619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65002333|NCT00112619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65002345|NCT00352300|Paclitaxel|paclitaxel|mesh-list
65002372|NCT00112658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65002373|NCT00112658|Antidotes|antidotes|mesh-ancestor
65002374|NCT00112658|Protective Agents|protective agents|mesh-ancestor
65002375|NCT00112658|Vitamin B Complex|vitamin b complex|mesh-ancestor
65002376|NCT00112658|Vitamins|vitamins|mesh-ancestor
65002377|NCT00112658|Micronutrients|micronutrients|mesh-ancestor
65002378|NCT00352339|Aripiprazole|aripiprazole|mesh-list
65002379|NCT00352339|Antidepressive Agents|antidepressive agents|mesh-ancestor
65002380|NCT00352339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65002381|NCT00352339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65002382|NCT00352339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65002383|NCT00352339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65002384|NCT00352339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002385|NCT00352339|Dopamine Agonists|dopamine agonists|mesh-ancestor
65002386|NCT00352339|Dopamine Agents|dopamine agents|mesh-ancestor
65002391|NCT00352339|Serotonin Agents|serotonin agents|mesh-ancestor
65002435|NCT00112697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65002436|NCT00112697|Immunologic Factors|immunologic factors|mesh-ancestor
65002437|NCT00112697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002438|NCT02959606|Sarpogrelate|sarpogrelate|mesh-list
65002439|NCT02959606|Clopidogrel|clopidogrel|mesh-list
65002440|NCT02959606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65002441|NCT02959606|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65002442|NCT02959606|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65002443|NCT02959606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65002444|NCT02959606|Purinergic Agents|purinergic agents|mesh-ancestor
65002445|NCT02959606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65002446|NCT02959606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002447|NCT02959606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002448|NCT02959606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65002449|NCT02959606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65002450|NCT02959606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65002451|NCT02959606|Serotonin Agents|serotonin agents|mesh-ancestor
65002452|NCT00352651|Pregabalin|pregabalin|mesh-list
65002453|NCT00352651|Analgesics|analgesics|mesh-ancestor
65002454|NCT00352651|Sensory System Agents|sensory system agents|mesh-ancestor
65002455|NCT00352651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65002456|NCT00352651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002457|NCT00352651|Anticonvulsants|anticonvulsants|mesh-ancestor
65002458|NCT00352651|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65002459|NCT00352651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65002460|NCT00352651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002467|NCT00112775|Dasatinib|dasatinib|mesh-list
64457582|NCT01852292|Paclitaxel|paclitaxel|mesh-list
65002480|NCT00352768|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65002481|NCT00352768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65002482|NCT00352768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65002483|NCT00352768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65002484|NCT00352768|Serotonin Agents|serotonin agents|mesh-ancestor
65002485|NCT00352768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65002486|NCT00352768|Antidepressive Agents|antidepressive agents|mesh-ancestor
65002487|NCT00352768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65002488|NCT00352768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65002489|NCT00352768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65002490|NCT00352807|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65002491|NCT00352807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65002492|NCT00352807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65002493|NCT00352807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65002494|NCT00352807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65002495|NCT00352807|Adrenergic Agents|adrenergic agents|mesh-ancestor
65002496|NCT00352807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65002497|NCT00352807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002498|NCT00352807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002499|NCT00112853|Etoposide|etoposide|mesh-list
65002500|NCT00112853|Etoposide phosphate|etoposide phosphate|mesh-list
65002528|NCT00353041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65002529|NCT00353041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65002530|NCT00353041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65002531|NCT00353041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65002532|NCT00353041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002533|NCT00353080|Risedronic Acid|risedronic acid|mesh-list
65002534|NCT00353080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65002535|NCT00353080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65002536|NCT00353080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002537|NCT00353080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65002538|NCT00353080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002539|NCT00353080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65002540|NCT00112892|Selenium|selenium|mesh-list
65002541|NCT00112892|Irinotecan|irinotecan|mesh-list
65002542|NCT00112892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65002543|NCT00112892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65002544|NCT00112892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002545|NCT00112892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002546|NCT00112892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002547|NCT00112892|Antioxidants|antioxidants|mesh-ancestor
65002548|NCT00112892|Protective Agents|protective agents|mesh-ancestor
65002549|NCT00112892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457653|NCT00210184|Fluorouracil|fluorouracil|mesh-list
65002550|NCT00112892|Trace Elements|trace elements|mesh-ancestor
65002551|NCT00112892|Micronutrients|micronutrients|mesh-ancestor
65002552|NCT00112931|Rituximab|rituximab|mesh-list
65002574|NCT05594784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65002575|NCT05594784|Glucocorticoids|glucocorticoids|mesh-ancestor
65002576|NCT05594784|Hormones|hormones|mesh-ancestor
65002577|NCT05594784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65002578|NCT05594784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002579|NCT05594784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65002580|NCT05594784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002581|NCT05594784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65002582|NCT05594784|Tubulin Modulators|tubulin modulators|mesh-ancestor
65002583|NCT05594784|Antimitotic Agents|antimitotic agents|mesh-ancestor
65002584|NCT05594784|Mitosis Modulators|mitosis modulators|mesh-ancestor
65002585|NCT05594784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002586|NCT00113048|Alemtuzumab|alemtuzumab|mesh-list
65002588|NCT00113048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002633|NCT00354406|Anticoagulants|anticoagulants|mesh-ancestor
65002634|NCT00354406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65002635|NCT00354523|Capecitabine|capecitabine|mesh-list
65002636|NCT00354523|Imatinib Mesylate|imatinib mesylate|mesh-list
65002637|NCT00354523|Dacarbazine|dacarbazine|mesh-list
65002638|NCT00354523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65002639|NCT00354523|Antimetabolites|antimetabolites|mesh-ancestor
65002640|NCT00354523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002641|NCT00354523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002642|NCT00354523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65002643|NCT00354523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002644|NCT00354523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65002645|NCT00354523|Alkylating Agents|alkylating agents|mesh-ancestor
65002646|NCT00114933|Ritonavir|ritonavir|mesh-list
65002647|NCT00114933|Lopinavir|lopinavir|mesh-list
65002648|NCT00114933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65002649|NCT00114933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65002650|NCT00114933|Protease Inhibitors|protease inhibitors|mesh-ancestor
65002651|NCT00114933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002652|NCT00114933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002653|NCT00114933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65002654|NCT00114933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65002655|NCT00114933|Antiviral Agents|antiviral agents|mesh-ancestor
65002656|NCT00114933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65002657|NCT00114933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65002658|NCT00114933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65002659|NCT00113282|Interleukin-2|interleukin-2|mesh-list
65002660|NCT00113282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002661|NCT00113282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65002662|NCT00113282|Analgesics|analgesics|mesh-ancestor
65002663|NCT00113282|Sensory System Agents|sensory system agents|mesh-ancestor
65002666|NCT00425932|Rituximab|rituximab|mesh-list
65002676|NCT00426010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002677|NCT00426010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002678|NCT00426010|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65002679|NCT00426010|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65002680|NCT00426010|Purinergic Agents|purinergic agents|mesh-ancestor
65002681|NCT00426010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65002682|NCT00115011|Citalopram|citalopram|mesh-list
65002683|NCT00115011|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65002684|NCT00115011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65002685|NCT00115011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65002686|NCT00115011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002687|NCT00115011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65002688|NCT00115011|Serotonin Agents|serotonin agents|mesh-ancestor
65002689|NCT00115011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002690|NCT00115011|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65002691|NCT00115011|Antidepressive Agents|antidepressive agents|mesh-ancestor
65002692|NCT00115011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65002693|NCT00113594|Olanzapine|olanzapine|mesh-list
65002694|NCT00113594|Antiemetics|antiemetics|mesh-ancestor
65002695|NCT00113594|Autonomic Agents|autonomic agents|mesh-ancestor
65002727|NCT00115128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65002728|NCT00115128|Immunologic Factors|immunologic factors|mesh-ancestor
65002729|NCT00115128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002730|NCT00115167|Darbepoetin alfa|darbepoetin alfa|mesh-list
65002731|NCT00115167|Hematinics|hematinics|mesh-ancestor
65002732|NCT00115245|Adefovir|adefovir|mesh-list
65002733|NCT00115245|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65002734|NCT00115245|Telbivudine|telbivudine|mesh-list
65002735|NCT00115245|Antiviral Agents|antiviral agents|mesh-ancestor
65002736|NCT00115245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65002737|NCT00115245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65002738|NCT00115245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65002739|NCT00115245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002740|NCT00115245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002741|NCT01059526|Ecallantide|ecallantide|mesh-list
65002742|NCT01059526|Analgesics|analgesics|mesh-ancestor
65002743|NCT01059526|Sensory System Agents|sensory system agents|mesh-ancestor
65002744|NCT01059526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65002745|NCT01059526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002746|NCT01059526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65002747|NCT01059526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65002748|NCT01059526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65002749|NCT01059526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65002750|NCT00444340|Etanercept|etanercept|mesh-list
65002751|NCT00444340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65002777|NCT00444379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65002778|NCT00444379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65002779|NCT00444379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65002780|NCT00444379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65002781|NCT00444379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65002782|NCT00444379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65002783|NCT00444379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65002784|NCT00444379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65002785|NCT00444379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65002786|NCT00444418|Naltrexone|naltrexone|mesh-list
65002787|NCT00444418|Naloxone|naloxone|mesh-list
65002788|NCT00444418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65002789|NCT00444418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65002790|NCT00444418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002791|NCT00444418|Sensory System Agents|sensory system agents|mesh-ancestor
65002792|NCT00444418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65002833|NCT00113828|Dermatologic Agents|dermatologic agents|mesh-ancestor
65002834|NCT00113828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65002835|NCT00113828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65002836|NCT00444886|Botulinum Toxins|botulinum toxins|mesh-list
65002837|NCT00444886|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65002839|NCT00444886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65002840|NCT00444886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65002841|NCT00444886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002842|NCT00444886|Cholinergic Agents|cholinergic agents|mesh-ancestor
65002843|NCT00444886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65002844|NCT00444886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002845|NCT00444886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65002846|NCT00444886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65002847|NCT05594121|Buprenorphine|buprenorphine|mesh-list
65002848|NCT05594121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65002849|NCT05594121|Narcotics|narcotics|mesh-ancestor
65002850|NCT05594121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65002851|NCT05594121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002852|NCT05594121|Analgesics|analgesics|mesh-ancestor
65002853|NCT05594121|Sensory System Agents|sensory system agents|mesh-ancestor
65002854|NCT05594121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65002855|NCT05594121|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65002856|NCT00115362|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65002857|NCT00115362|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65002881|NCT00445081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002882|NCT00445081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002883|NCT00445081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65002884|NCT00445081|Immunologic Factors|immunologic factors|mesh-ancestor
65002885|NCT00445081|Antifungal Agents|antifungal agents|mesh-ancestor
65002886|NCT00445081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65002887|NCT00445081|Dermatologic Agents|dermatologic agents|mesh-ancestor
65002888|NCT00445081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65002889|NCT00445081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65002890|NCT00113906|Melatonin|melatonin|mesh-list
65002891|NCT00113906|Antioxidants|antioxidants|mesh-ancestor
65002892|NCT00113906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002893|NCT00113906|Protective Agents|protective agents|mesh-ancestor
65002894|NCT00113906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002895|NCT00113906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65002896|NCT00113945|Cinacalcet|cinacalcet|mesh-list
65002897|NCT00113945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65002898|NCT00113945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002899|NCT00113945|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65002900|NCT00113945|Hormone Antagonists|hormone antagonists|mesh-ancestor
65002901|NCT00113945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65002902|NCT00445159|Treprostinil|treprostinil|mesh-list
65002903|NCT00445159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65002904|NCT00445276|Diacetylrhein|diacetylrhein|mesh-list
65002905|NCT00445276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65002906|NCT00113984|Metronidazole|metronidazole|mesh-list
65002907|NCT00113984|Ipilimumab|ipilimumab|mesh-list
65002908|NCT00113984|Sargramostim|sargramostim|mesh-list
65002909|NCT00113984|Immunologic Factors|immunologic factors|mesh-ancestor
64984117|NCT00310336|Interferons|interferons|mesh-list
65002910|NCT00113984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002911|NCT00113984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002913|NCT00113984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65002920|NCT00445510|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65002921|NCT00445510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65002922|NCT00445510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002923|NCT00445510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002924|NCT00114023|Imiquimod|imiquimod|mesh-list
65002925|NCT00114023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65002926|NCT00114023|Immunologic Factors|immunologic factors|mesh-ancestor
65002927|NCT00114023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002928|NCT00114023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002929|NCT00114023|Interferon Inducers|interferon inducers|mesh-ancestor
65002930|NCT00445861|Docetaxel|docetaxel|mesh-list
65002931|NCT00445861|Cetuximab|cetuximab|mesh-list
65002932|NCT00445861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65002933|NCT00445861|Tubulin Modulators|tubulin modulators|mesh-ancestor
65002934|NCT00445861|Antimitotic Agents|antimitotic agents|mesh-ancestor
65002935|NCT00445861|Mitosis Modulators|mitosis modulators|mesh-ancestor
65002936|NCT00445861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002937|NCT00445861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65002938|NCT00445900|Thalidomide|thalidomide|mesh-list
65002939|NCT00445900|Prednisone|prednisone|mesh-list
65002940|NCT00445900|Cyclophosphamide|cyclophosphamide|mesh-list
65002975|NCT00446017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65002976|NCT00446017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65002977|NCT00446017|Adrenergic Agents|adrenergic agents|mesh-ancestor
65002978|NCT00446017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65002979|NCT00446017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65002980|NCT00446017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65002981|NCT00446017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65002982|NCT00446017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65002983|NCT00446017|Autonomic Agents|autonomic agents|mesh-ancestor
65002984|NCT00446017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65002986|NCT00446017|Respiratory System Agents|respiratory system agents|mesh-ancestor
65002987|NCT00446017|Mydriatics|mydriatics|mesh-ancestor
65002988|NCT00446017|Sympathomimetics|sympathomimetics|mesh-ancestor
65002989|NCT00446017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65002990|NCT00446017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65002991|NCT00446017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65002992|NCT00446017|Vasodilator Agents|vasodilator agents|mesh-ancestor
65002993|NCT00446017|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65002994|NCT00446017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65002995|NCT00446017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65002996|NCT00446017|Protective Agents|protective agents|mesh-ancestor
65002997|NCT00446173|Cyclophosphamide|cyclophosphamide|mesh-list
65002999|NCT00446173|Sargramostim|sargramostim|mesh-list
65003000|NCT00446173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65003001|NCT00446173|Immunologic Factors|immunologic factors|mesh-ancestor
65003002|NCT00446173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003025|NCT00446368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003026|NCT00446368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65003027|NCT00446368|Immunologic Factors|immunologic factors|mesh-ancestor
65003028|NCT00446368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003029|NCT00401765|Docetaxel|docetaxel|mesh-list
65003030|NCT00401765|Siltuximab|siltuximab|mesh-list
65003031|NCT00401765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003032|NCT00401765|Tubulin Modulators|tubulin modulators|mesh-ancestor
65003033|NCT00401765|Antimitotic Agents|antimitotic agents|mesh-ancestor
65003034|NCT00401765|Mitosis Modulators|mitosis modulators|mesh-ancestor
65003035|NCT00401765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003036|NCT00115518|Cetuximab|cetuximab|mesh-list
65003037|NCT00115518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65003038|NCT00115518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003039|NCT00446524|Amlodipine|amlodipine|mesh-list
65003040|NCT00446524|Valsartan|valsartan|mesh-list
65003041|NCT00446524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65003042|NCT00446524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65003043|NCT00446524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65003081|NCT00446680|Mannitol|mannitol|mesh-list
65003083|NCT00446680|Diuretics|diuretics|mesh-ancestor
65003084|NCT00446680|Natriuretic Agents|natriuretic agents|mesh-ancestor
65003085|NCT00446680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003086|NCT00114257|Decitabine|decitabine|mesh-list
65003087|NCT00114257|Romidepsin|romidepsin|mesh-list
65003088|NCT00114257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65003089|NCT00114257|Antimetabolites|antimetabolites|mesh-ancestor
65003090|NCT00114257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003091|NCT00114257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003092|NCT00114257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003093|NCT00114257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65003094|NCT00404937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65003095|NCT00404937|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
65003096|NCT00404937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65003097|NCT00404937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65003098|NCT00404937|Glucocorticoids|glucocorticoids|mesh-ancestor
65003099|NCT00404937|Hormones|hormones|mesh-ancestor
65003100|NCT00404937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65003101|NCT00404937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003102|NCT00404937|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65003103|NCT00404937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65003104|NCT00446836|Paclitaxel|paclitaxel|mesh-list
65003105|NCT00446836|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
65003106|NCT00446836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65003107|NCT00446836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003108|NCT00446836|Tubulin Modulators|tubulin modulators|mesh-ancestor
65003130|NCT00446953|Respiratory System Agents|respiratory system agents|mesh-ancestor
65003131|NCT00447031|Triamcinolone|triamcinolone|mesh-list
65003132|NCT00447031|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65003133|NCT00447031|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65003134|NCT00447031|Bevacizumab|bevacizumab|mesh-list
65003135|NCT00447031|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65003136|NCT00447031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65003137|NCT00447031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003138|NCT00447031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65003139|NCT00447031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65003140|NCT00447031|Growth Substances|growth substances|mesh-ancestor
65003141|NCT00447031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003142|NCT00447031|Growth Inhibitors|growth inhibitors|mesh-ancestor
65003143|NCT00447031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65003144|NCT00447031|Glucocorticoids|glucocorticoids|mesh-ancestor
65003146|NCT00447031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65003148|NCT00447031|Immunologic Factors|immunologic factors|mesh-ancestor
65003149|NCT00447031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003150|NCT00447031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003151|NCT00447070|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65003157|NCT00447070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65003185|NCT00447577|Tobramycin|tobramycin|mesh-list
65003186|NCT00447577|Dexamethasone|dexamethasone|mesh-list
65003187|NCT00447577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65003188|NCT00447577|Antiemetics|antiemetics|mesh-ancestor
65003189|NCT00447577|Autonomic Agents|autonomic agents|mesh-ancestor
65003190|NCT00447577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65003191|NCT00447577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003192|NCT00447577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65003193|NCT00447577|Glucocorticoids|glucocorticoids|mesh-ancestor
65003194|NCT00447577|Hormones|hormones|mesh-ancestor
65003195|NCT00447577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65003196|NCT00447577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65003197|NCT00447577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003198|NCT00447577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65003199|NCT00447577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65003200|NCT00447577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65003201|NCT05569512|Fludarabine|fludarabine|mesh-list
65003202|NCT05569512|Busulfan|busulfan|mesh-list
65003203|NCT05569512|Clofarabine|clofarabine|mesh-list
65003204|NCT05569512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003205|NCT05569512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65003206|NCT05569512|Antimetabolites|antimetabolites|mesh-ancestor
65003207|NCT05569512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003208|NCT05569512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65003209|NCT05569512|Immunologic Factors|immunologic factors|mesh-ancestor
65003210|NCT05569512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003211|NCT05569512|Alkylating Agents|alkylating agents|mesh-ancestor
65003212|NCT05569512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65003213|NCT05569512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65003231|NCT00114569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65003232|NCT00114569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65003233|NCT00114569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65003234|NCT00114569|GABA Modulators|gaba modulators|mesh-ancestor
65003235|NCT00114569|GABA Agents|gaba agents|mesh-ancestor
65003236|NCT00114569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65003237|NCT00114569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003238|NCT05564598|Valganciclovir|valganciclovir|mesh-list
65003239|NCT05564598|Ganciclovir|ganciclovir|mesh-list
65003240|NCT05564598|Antiviral Agents|antiviral agents|mesh-list
65003241|NCT05564598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65003242|NCT00447928|Nitroglycerin|nitroglycerin|mesh-list
65003243|NCT00447928|Vasodilator Agents|vasodilator agents|mesh-ancestor
65003244|NCT00447967|Leucovorin|leucovorin|mesh-list
65003245|NCT00447967|Fluorouracil|fluorouracil|mesh-list
65003246|NCT00447967|Oxaliplatin|oxaliplatin|mesh-list
65003247|NCT00447967|Irinotecan|irinotecan|mesh-list
65003248|NCT00447967|Antimetabolites|antimetabolites|mesh-ancestor
65003249|NCT00447967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003250|NCT00447967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65003251|NCT00447967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003252|NCT00447967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65003253|NCT00447967|Immunologic Factors|immunologic factors|mesh-ancestor
65003254|NCT00447967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003255|NCT00447967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65003256|NCT00447967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65003257|NCT00447967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003258|NCT00447967|Antidotes|antidotes|mesh-ancestor
65003259|NCT00447967|Protective Agents|protective agents|mesh-ancestor
65003260|NCT00447967|Vitamin B Complex|vitamin b complex|mesh-ancestor
65003261|NCT00447967|Vitamins|vitamins|mesh-ancestor
65003262|NCT00447967|Micronutrients|micronutrients|mesh-ancestor
65003263|NCT00401856|Eplerenone|eplerenone|mesh-list
65003264|NCT00401856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65003265|NCT00401856|Hormone Antagonists|hormone antagonists|mesh-ancestor
65003266|NCT00401856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65003273|NCT00448240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003274|NCT00448240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65003275|NCT00448240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003276|NCT00448240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003277|NCT00448396|Epothilone B|epothilone b|mesh-list
65003278|NCT00448396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003279|NCT00448396|Tubulin Modulators|tubulin modulators|mesh-ancestor
65003280|NCT00448396|Antimitotic Agents|antimitotic agents|mesh-ancestor
65003281|NCT00448396|Mitosis Modulators|mitosis modulators|mesh-ancestor
65003282|NCT00448396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003283|NCT00114686|Valproic Acid|valproic acid|mesh-list
65003284|NCT00114686|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65003285|NCT00114686|Antidepressive Agents|antidepressive agents|mesh-ancestor
65003286|NCT00114686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65003287|NCT00114686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65003333|NCT00448786|Vitamin B Complex|vitamin b complex|mesh-ancestor
65003334|NCT00448786|Vitamins|vitamins|mesh-ancestor
65003335|NCT00448786|Micronutrients|micronutrients|mesh-ancestor
65003336|NCT00448786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003337|NCT00114803|Calcitonin|calcitonin|mesh-list
65003338|NCT00114803|Salmon calcitonin|salmon calcitonin|mesh-list
65003339|NCT00114803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
65003340|NCT00114803|Katacalcin|katacalcin|mesh-list
65003341|NCT00114803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65003342|NCT00114803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003343|NCT00114803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65003344|NCT00114803|Vasodilator Agents|vasodilator agents|mesh-ancestor
65003345|NCT00448825|Topiramate|topiramate|mesh-list
65003346|NCT00448825|Anticonvulsants|anticonvulsants|mesh-ancestor
65003347|NCT00448825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65003348|NCT00448825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003349|NCT00448903|Bemiparin|bemiparin|mesh-list
65003350|NCT00448903|Anticoagulants|anticoagulants|mesh-ancestor
65003351|NCT00448942|Chlorhexidine|chlorhexidine|mesh-list
65003352|NCT00448942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65003353|NCT00448942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65003354|NCT00448942|Disinfectants|disinfectants|mesh-ancestor
65003391|NCT00115752|Valdecoxib|valdecoxib|mesh-list
65003392|NCT00115752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
65003393|NCT00115752|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65003394|NCT00115752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003395|NCT00115752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003396|NCT00115752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65003397|NCT00115752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65003398|NCT00115752|Analgesics|analgesics|mesh-ancestor
65003399|NCT00115752|Sensory System Agents|sensory system agents|mesh-ancestor
65003400|NCT00115752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65003401|NCT00115752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003402|NCT00115752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65003403|NCT00115752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65003404|NCT00449059|Nitroglycerin|nitroglycerin|mesh-list
65003405|NCT00449059|Vasodilator Agents|vasodilator agents|mesh-ancestor
65003406|NCT00449137|Leucovorin|leucovorin|mesh-list
65003407|NCT00449137|Fluorouracil|fluorouracil|mesh-list
65003408|NCT00449137|Arsenic Trioxide|arsenic trioxide|mesh-list
65003409|NCT00449137|Calcium|calcium|mesh-list
65003410|NCT00449137|Levoleucovorin|levoleucovorin|mesh-list
65003411|NCT00449137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65003412|NCT00449137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003445|NCT00449449|Sensory System Agents|sensory system agents|mesh-ancestor
65003446|NCT00449449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65003447|NCT00449449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65003448|NCT00449449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64458566|NCT04147390|Immunologic Factors|immunologic factors|mesh-ancestor
65003449|NCT00449449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65003450|NCT00449449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65003451|NCT00449449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003453|NCT00115115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65003454|NCT00115115|Sympathomimetics|sympathomimetics|mesh-ancestor
65003455|NCT00115115|Autonomic Agents|autonomic agents|mesh-ancestor
65003456|NCT00115115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65003457|NCT00115115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003458|NCT00115115|Dopamine Agents|dopamine agents|mesh-ancestor
65003459|NCT00115115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65003460|NCT00115115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003461|NCT00115115|Protective Agents|protective agents|mesh-ancestor
65003462|NCT00449488|Epoetin Alfa|epoetin alfa|mesh-list
65003463|NCT00449488|Hematinics|hematinics|mesh-ancestor
65003464|NCT00115830|Atorvastatin|atorvastatin|mesh-list
65003465|NCT00115830|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65003466|NCT00115830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65003467|NCT00115830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65003468|NCT00115830|Antimetabolites|antimetabolites|mesh-ancestor
65003469|NCT00115830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003470|NCT00115830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65003471|NCT00115830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65003472|NCT00115830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003474|NCT00115154|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65003475|NCT00115154|Immunologic Factors|immunologic factors|mesh-ancestor
65003476|NCT00115154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003477|NCT00115154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003479|NCT00449527|Budesonide|budesonide|mesh-list
65003485|NCT00449527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003486|NCT00449527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65003487|NCT00449527|Respiratory System Agents|respiratory system agents|mesh-ancestor
65003488|NCT00449527|Glucocorticoids|glucocorticoids|mesh-ancestor
65003489|NCT00449527|Hormones|hormones|mesh-ancestor
65003490|NCT00449527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65003491|NCT00449527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65003492|NCT00449527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65003493|NCT00449527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65003494|NCT00449527|Adrenergic Agents|adrenergic agents|mesh-ancestor
65003495|NCT00449527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65003496|NCT00449527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003497|NCT00449683|Terazosin|terazosin|mesh-list
65003498|NCT00449683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65003499|NCT00449683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65003500|NCT00449683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65003501|NCT00449683|Adrenergic Agents|adrenergic agents|mesh-ancestor
65003502|NCT00449683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65003503|NCT00449683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003504|NCT00449683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003505|NCT00449683|Urological Agents|urological agents|mesh-ancestor
65003506|NCT00449722|Mesalamine|mesalamine|mesh-list
65003507|NCT00449722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65003534|NCT04699279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003535|NCT04699279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65003536|NCT04699279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65003537|NCT04699279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003538|NCT00450307|Antibodies|antibodies|mesh-list
65003539|NCT00450307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65003540|NCT00450307|Sargramostim|sargramostim|mesh-list
65003541|NCT00450307|Immunologic Factors|immunologic factors|mesh-ancestor
65003542|NCT00450307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003543|NCT03276013|Pembrolizumab|pembrolizumab|mesh-list
65003544|NCT03276013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65003545|NCT03276013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003546|NCT00450736|Celecoxib|celecoxib|mesh-list
65003547|NCT00450736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65003548|NCT00450736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65003549|NCT00450736|Analgesics|analgesics|mesh-ancestor
65003550|NCT00450736|Sensory System Agents|sensory system agents|mesh-ancestor
65003551|NCT00450736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65003552|NCT00450736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003553|NCT00450736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65003554|NCT00450736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65003555|NCT00450736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65003556|NCT00450736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65003557|NCT00450736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003558|NCT00450736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003559|NCT05536362|Clonidine|clonidine|mesh-list
65003560|NCT05536362|Ketamine|ketamine|mesh-list
65003561|NCT05536362|Propofol|propofol|mesh-list
65003562|NCT05536362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65003563|NCT05536362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65003564|NCT05536362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003576|NCT05536362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65003577|NCT05536362|Sympatholytics|sympatholytics|mesh-ancestor
65003578|NCT05536362|Autonomic Agents|autonomic agents|mesh-ancestor
65003579|NCT05536362|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65003580|NCT05536362|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65003581|NCT05536362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65003582|NCT05536362|Adrenergic Agents|adrenergic agents|mesh-ancestor
65003583|NCT00450853|Granisetron|granisetron|mesh-list
65003584|NCT00450853|Antiemetics|antiemetics|mesh-ancestor
65003585|NCT00450853|Autonomic Agents|autonomic agents|mesh-ancestor
65003586|NCT00450853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65003587|NCT00450853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003588|NCT00450853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65003589|NCT00450853|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65003590|NCT00450853|Serotonin Agents|serotonin agents|mesh-ancestor
65003591|NCT00450853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65003635|NCT00458419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65003636|NCT00458458|Leuprolide|leuprolide|mesh-list
65003637|NCT00458458|Norethindrone|norethindrone|mesh-list
65003638|NCT00458458|Norethindrone Acetate|norethindrone acetate|mesh-list
65003639|NCT00458458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65003640|NCT00458458|Fertility Agents|fertility agents|mesh-ancestor
65003641|NCT00458458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65003642|NCT00458458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003643|NCT00458458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65003644|NCT00458458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003645|NCT00458458|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65003646|NCT00458458|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65003647|NCT00458458|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65003648|NCT00458458|Contraceptive Agents|contraceptive agents|mesh-ancestor
65003649|NCT00458458|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65003650|NCT00458458|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65003651|NCT00458614|Lansoprazole|lansoprazole|mesh-list
65003652|NCT00458614|Dexlansoprazole|dexlansoprazole|mesh-list
65003653|NCT00458614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65003654|NCT00458614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65003660|NCT00458731|Cediranib|cediranib|mesh-list
65003690|NCT00459004|Rimonabant|rimonabant|mesh-list
65003691|NCT00459004|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65003692|NCT00459004|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65003693|NCT00459004|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65003694|NCT00459004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65003695|NCT00459004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003696|NCT00459004|Hormones|hormones|mesh-ancestor
65003697|NCT00459004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65003698|NCT00459004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003699|NCT00459160|Antihypertensive Agents|antihypertensive agents|mesh-list
65003700|NCT00115583|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
65003701|NCT00115583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65003702|NCT00115583|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65003703|NCT00115583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003704|NCT00115622|Fluticasone|fluticasone|mesh-list
65003705|NCT00115622|Xhance|xhance|mesh-list
65003706|NCT00115622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65003707|NCT00115622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65003708|NCT00115622|Autonomic Agents|autonomic agents|mesh-ancestor
65003709|NCT00115622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65003710|NCT00115622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003711|NCT00115622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65003712|NCT00115622|Respiratory System Agents|respiratory system agents|mesh-ancestor
65003713|NCT00115622|Dermatologic Agents|dermatologic agents|mesh-ancestor
65003714|NCT00115622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65003715|NCT00459511|Hydrocortisone|hydrocortisone|mesh-list
65003716|NCT00459511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65003717|NCT00115661|Rosiglitazone|rosiglitazone|mesh-list
65003718|NCT00115661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65003719|NCT00115661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003720|NCT04728321|Lenvatinib|lenvatinib|mesh-list
65003731|NCT00459901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65003732|NCT00459901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003733|NCT00401804|Dexamethasone|dexamethasone|mesh-list
65003734|NCT00401804|Doxorubicin|doxorubicin|mesh-list
65003735|NCT00401804|Bortezomib|bortezomib|mesh-list
65003736|NCT00401804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65003737|NCT00401804|Antiemetics|antiemetics|mesh-ancestor
65003738|NCT00401804|Autonomic Agents|autonomic agents|mesh-ancestor
65003739|NCT00401804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65003740|NCT00401804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003741|NCT00401804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65003742|NCT00401804|Glucocorticoids|glucocorticoids|mesh-ancestor
65003743|NCT00401804|Hormones|hormones|mesh-ancestor
65003744|NCT00401804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65003745|NCT00401804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65003746|NCT00401804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003747|NCT00401804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65003748|NCT00401804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65003749|NCT00401804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65003750|NCT00401804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003751|NCT00401804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003752|NCT00459940|Pioglitazone|pioglitazone|mesh-list
65003753|NCT00459940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65003754|NCT00459940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003755|NCT00460057|Alendronate|alendronate|mesh-list
65003756|NCT00460057|Diphosphonates|diphosphonates|mesh-list
65003757|NCT00460057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65003758|NCT00460057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003759|NCT00401921|Minocycline|minocycline|mesh-list
65003776|NCT00460174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003777|NCT00460174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65003778|NCT00460174|Immunologic Factors|immunologic factors|mesh-ancestor
65003779|NCT00460213|Valsartan|valsartan|mesh-list
65003780|NCT00460213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65003781|NCT00460213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65003782|NCT00460213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65003783|NCT00460213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003784|NCT00460252|Insulin|insulin|mesh-list
65003785|NCT00460252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65003786|NCT00460252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003787|NCT00115817|Atorvastatin|atorvastatin|mesh-list
65003788|NCT00115817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65003789|NCT00115817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65003790|NCT00115817|Antimetabolites|antimetabolites|mesh-ancestor
65003791|NCT00115817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003792|NCT00115817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65003793|NCT00115817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65003794|NCT00115817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003795|NCT00460369|Artesunate|artesunate|mesh-list
65003796|NCT00460369|Lumefantrine|lumefantrine|mesh-list
65003797|NCT00460369|Artemether|artemether|mesh-list
65003798|NCT00460369|Pyrimethamine|pyrimethamine|mesh-list
65003799|NCT00460369|Sulfadoxine|sulfadoxine|mesh-list
65003800|NCT00460369|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65003801|NCT00460369|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65003802|NCT00460369|Amodiaquine|amodiaquine|mesh-list
65003803|NCT00460369|Antimalarials|antimalarials|mesh-ancestor
65003804|NCT00460369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65003823|NCT00460642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65003824|NCT00460642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003825|NCT00460642|Hormone Antagonists|hormone antagonists|mesh-ancestor
65003826|NCT00460642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65003827|NCT00460681|Thymopentin|thymopentin|mesh-list
65003828|NCT00460681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65003829|NCT00460681|Immunologic Factors|immunologic factors|mesh-ancestor
65003830|NCT00460681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003831|NCT00460759|Moxifloxacin|moxifloxacin|mesh-list
65003832|NCT00460759|Rifapentine|rifapentine|mesh-list
65003833|NCT00460759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65003834|NCT00460759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65003835|NCT00460759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65003836|NCT00460759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65003837|NCT00460759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65003838|NCT00460759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003839|NCT00460759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003840|NCT00460759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65003841|NCT00460759|Antitubercular Agents|antitubercular agents|mesh-ancestor
65003842|NCT00460759|Leprostatic Agents|leprostatic agents|mesh-ancestor
65003843|NCT00460837|Picosulfate sodium|picosulfate sodium|mesh-list
65003844|NCT00460837|Cathartics|cathartics|mesh-ancestor
65003845|NCT00460837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65003873|NCT00460954|Immunologic Factors|immunologic factors|mesh-ancestor
65003874|NCT00460954|Dopamine Agonists|dopamine agonists|mesh-ancestor
65003875|NCT00461149|Octreotide|octreotide|mesh-list
65003876|NCT00461149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65003877|NCT00461149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65003878|NCT00461149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65003879|NCT00115973|Insulin Aspart|insulin aspart|mesh-list
65003880|NCT00115973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65003881|NCT00115973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003882|NCT00461266|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65003883|NCT00461266|Enfuvirtide|enfuvirtide|mesh-list
65003939|NCT03273556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65003940|NCT03273556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65003941|NCT03273556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65003942|NCT03273556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65003943|NCT03273556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65003944|NCT04728308|Bupivacaine|bupivacaine|mesh-list
65003945|NCT04728308|Anesthetics, Local|anesthetics, local|mesh-ancestor
65003946|NCT04728308|Anesthetics|anesthetics|mesh-ancestor
65003947|NCT04728308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65003948|NCT04728308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003949|NCT04728308|Sensory System Agents|sensory system agents|mesh-ancestor
65003950|NCT04728308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65003951|NCT00461422|Ganirelix|ganirelix|mesh-list
65003952|NCT00461422|Hormone Antagonists|hormone antagonists|mesh-ancestor
65003953|NCT00461422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65003954|NCT00461422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003955|NCT04697992|Vitamins|vitamins|mesh-list
65003956|NCT04697992|Ascorbic Acid|ascorbic acid|mesh-list
65003957|NCT04697992|Tranexamic Acid|tranexamic acid|mesh-list
65003958|NCT04697992|Micronutrients|micronutrients|mesh-ancestor
65003959|NCT04697992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003960|NCT04697992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65003961|NCT04697992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65003992|NCT00116064|Paraldehyde|paraldehyde|mesh-list
65003993|NCT00116064|Anticonvulsants|anticonvulsants|mesh-ancestor
65003994|NCT00116064|Antiemetics|antiemetics|mesh-ancestor
65003995|NCT00116064|Autonomic Agents|autonomic agents|mesh-ancestor
65003996|NCT00116064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65003997|NCT00116064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65003998|NCT00116064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65003999|NCT00116064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65004000|NCT00116064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65004001|NCT00116064|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65004002|NCT00116064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65004003|NCT00116064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65004004|NCT00116064|GABA Modulators|gaba modulators|mesh-ancestor
65004005|NCT00116064|GABA Agents|gaba agents|mesh-ancestor
65004006|NCT00116064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65004007|NCT00116064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004008|NCT04728035|Irinotecan|irinotecan|mesh-list
65004011|NCT04728035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004049|NCT00462358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004050|NCT00462358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459167|NCT03585556|Hormones|hormones|mesh-ancestor
65004051|NCT00116181|Etanercept|etanercept|mesh-list
65004052|NCT00116181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65004053|NCT00116181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65004054|NCT00116181|Analgesics|analgesics|mesh-ancestor
65004055|NCT00116181|Sensory System Agents|sensory system agents|mesh-ancestor
65004056|NCT00116181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65004057|NCT00116181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004058|NCT00116181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65004059|NCT00116181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65004060|NCT00116181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65004061|NCT00116181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65004062|NCT00116181|Immunologic Factors|immunologic factors|mesh-ancestor
65004063|NCT00462397|Paclitaxel|paclitaxel|mesh-list
65004064|NCT00462397|Carboplatin|carboplatin|mesh-list
65004065|NCT00462397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65004066|NCT00462397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65004067|NCT00462397|Tubulin Modulators|tubulin modulators|mesh-ancestor
65004068|NCT00462397|Antimitotic Agents|antimitotic agents|mesh-ancestor
65004069|NCT00462397|Mitosis Modulators|mitosis modulators|mesh-ancestor
65004070|NCT00462397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004071|NCT00462475|Hormones|hormones|mesh-list
65004073|NCT00462475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004097|NCT00462592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004098|NCT00462592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65004099|NCT00462592|Respiratory System Agents|respiratory system agents|mesh-ancestor
65004100|NCT00462592|Glucocorticoids|glucocorticoids|mesh-ancestor
65004101|NCT00462592|Hormones|hormones|mesh-ancestor
65004102|NCT00462592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65004103|NCT00462592|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65004104|NCT00462592|Hormone Antagonists|hormone antagonists|mesh-ancestor
65004105|NCT00462592|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65004106|NCT00462592|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65004107|NCT00462592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004108|NCT00405015|Rosiglitazone|rosiglitazone|mesh-list
65004109|NCT00405015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65004110|NCT00405015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004111|NCT00462631|Paclitaxel|paclitaxel|mesh-list
65004112|NCT00462631|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64985328|NCT00122304|Eculizumab|eculizumab|mesh-list
65004113|NCT00462631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65004153|NCT00463021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004154|NCT00463021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65004155|NCT00116259|Aripiprazole|aripiprazole|mesh-list
65004156|NCT00116259|Antidepressive Agents|antidepressive agents|mesh-ancestor
65004157|NCT00116259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65004158|NCT00116259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65004159|NCT00116259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65004160|NCT00116259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65004161|NCT00116259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004162|NCT00116259|Dopamine Agonists|dopamine agonists|mesh-ancestor
65004163|NCT00116259|Dopamine Agents|dopamine agents|mesh-ancestor
65004164|NCT00116259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65004165|NCT00116259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004166|NCT00116259|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65004167|NCT00116259|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65004168|NCT00116259|Serotonin Agents|serotonin agents|mesh-ancestor
65004169|NCT00116259|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65004170|NCT00116259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65004171|NCT00116259|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65004172|NCT00116259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65004173|NCT00116324|Montelukast|montelukast|mesh-list
65004177|NCT00116324|Hormone Antagonists|hormone antagonists|mesh-ancestor
65004204|NCT00463762|Sulperazone|sulperazone|mesh-list
65004205|NCT00463762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65004206|NCT00463762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65004207|NCT00463762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65004208|NCT00463762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004209|NCT00463762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004210|NCT00463762|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65004211|NCT00463762|Renal Agents|renal agents|mesh-ancestor
65004212|NCT00116480|Misoprostol|misoprostol|mesh-list
65004213|NCT00116480|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65004214|NCT00116480|Abortifacient Agents|abortifacient agents|mesh-ancestor
65004215|NCT00116480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65004216|NCT00116480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004217|NCT00116480|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65004218|NCT00116480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65004219|NCT00116480|Oxytocics|oxytocics|mesh-ancestor
65004220|NCT00463879|Galantamine|galantamine|mesh-list
65004221|NCT00463879|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65004222|NCT00463879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004223|NCT00463879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004224|NCT00463879|Cholinergic Agents|cholinergic agents|mesh-ancestor
65004225|NCT00463879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65004226|NCT00463879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004227|NCT00463879|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65004254|NCT00464191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65004255|NCT00464191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004256|NCT00464191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65004257|NCT00464191|Serotonin Agents|serotonin agents|mesh-ancestor
65004258|NCT00464191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004259|NCT00464191|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65004260|NCT00464191|Antidepressive Agents|antidepressive agents|mesh-ancestor
65004261|NCT00464191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65004262|NCT00464347|Triamcinolone|triamcinolone|mesh-list
65004263|NCT00464347|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65004264|NCT00464347|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65004265|NCT00464347|Bevacizumab|bevacizumab|mesh-list
65004266|NCT00464347|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65004267|NCT00464347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65004268|NCT00464347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65004269|NCT00464347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65004270|NCT00464347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65004271|NCT00464347|Growth Substances|growth substances|mesh-ancestor
65004272|NCT00464347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004274|NCT00464347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65004276|NCT00464347|Hormones|hormones|mesh-ancestor
65004309|NCT00464503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65004310|NCT00464503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004311|NCT00116532|Citalopram|citalopram|mesh-list
65004312|NCT00116532|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65004313|NCT00116532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65004314|NCT00116532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65004315|NCT00116532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004316|NCT00116532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65004317|NCT00116532|Serotonin Agents|serotonin agents|mesh-ancestor
65004318|NCT00116532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004319|NCT00116532|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65004320|NCT00116532|Antidepressive Agents|antidepressive agents|mesh-ancestor
65004322|NCT00464854|Insulin Aspart|insulin aspart|mesh-list
65004371|NCT00465244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004372|NCT00465283|Donepezil|donepezil|mesh-list
65004373|NCT00465283|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65004374|NCT00465283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004375|NCT00465283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004376|NCT00465283|Cholinergic Agents|cholinergic agents|mesh-ancestor
65004377|NCT00465283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65004378|NCT00465283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004379|NCT00465283|Nootropic Agents|nootropic agents|mesh-ancestor
65004380|NCT03272425|Allopurinol|allopurinol|mesh-list
65004381|NCT03272425|Lesinurad|lesinurad|mesh-list
65004382|NCT03272425|Antimetabolites|antimetabolites|mesh-ancestor
65004383|NCT03272425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004384|NCT03272425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004430|NCT00465439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004431|NCT00465439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65004432|NCT00465439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65004433|NCT00465439|Adrenergic Agents|adrenergic agents|mesh-ancestor
65004434|NCT00465439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65004435|NCT00465439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65004436|NCT00465439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65004437|NCT00465439|Autonomic Agents|autonomic agents|mesh-ancestor
65004438|NCT00465439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65004439|NCT00465439|Respiratory System Agents|respiratory system agents|mesh-ancestor
65004440|NCT00465439|Mydriatics|mydriatics|mesh-ancestor
65004441|NCT00465439|Sympathomimetics|sympathomimetics|mesh-ancestor
65004442|NCT00465439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65004443|NCT00116727|Etanercept|etanercept|mesh-list
65004444|NCT00116727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65004445|NCT00116727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65004446|NCT00116727|Analgesics|analgesics|mesh-ancestor
65004489|NCT00473980|Sensory System Agents|sensory system agents|mesh-ancestor
65004490|NCT00473980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65004491|NCT00473980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004492|NCT00473980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65004493|NCT00473980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65004494|NCT00473980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65004495|NCT00473980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65004496|NCT00473980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004497|NCT00473980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004498|NCT00473980|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65004499|NCT00473980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65004500|NCT00473980|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65004502|NCT00473980|Tocolytic Agents|tocolytic agents|mesh-ancestor
65004503|NCT00473980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65004504|NCT00474019|Esomeprazole|esomeprazole|mesh-list
65004505|NCT00474019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65004506|NCT00474019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65004507|NCT00474019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65004508|NCT00474019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004509|NCT00474019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004510|NCT00117065|Darbepoetin alfa|darbepoetin alfa|mesh-list
65004511|NCT00117065|Hematinics|hematinics|mesh-ancestor
65004512|NCT00474136|Diclofenac|diclofenac|mesh-list
65004513|NCT00474136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65004514|NCT00474136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65004515|NCT00474136|Analgesics|analgesics|mesh-ancestor
65004539|NCT00117182|Albuterol|albuterol|mesh-list
65004540|NCT00117182|Ipratropium|ipratropium|mesh-list
65004541|NCT00117182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65004542|NCT00117182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65004543|NCT00117182|Autonomic Agents|autonomic agents|mesh-ancestor
65004544|NCT00117182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65004545|NCT00117182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004546|NCT00117182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65004547|NCT00117182|Respiratory System Agents|respiratory system agents|mesh-ancestor
65004548|NCT00117182|Glucocorticoids|glucocorticoids|mesh-ancestor
65004549|NCT00117182|Hormones|hormones|mesh-ancestor
65004550|NCT00117182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65004551|NCT00117182|Anticonvulsants|anticonvulsants|mesh-ancestor
65004552|NCT00117182|Tocolytic Agents|tocolytic agents|mesh-ancestor
65004553|NCT00117182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65004554|NCT00117182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65004555|NCT00117182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65004556|NCT00117182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65004557|NCT00117182|Adrenergic Agents|adrenergic agents|mesh-ancestor
65004558|NCT00117182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65004559|NCT00117182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004560|NCT00117182|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65004561|NCT00117182|Diuretics|diuretics|mesh-ancestor
65004562|NCT00117182|Natriuretic Agents|natriuretic agents|mesh-ancestor
65004563|NCT00117182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65004564|NCT00117182|Cholinergic Agents|cholinergic agents|mesh-ancestor
65004565|NCT00116922|Metformin|metformin|mesh-list
65004566|NCT00116922|Rosiglitazone|rosiglitazone|mesh-list
65004567|NCT00116922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65004568|NCT00116922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004570|NCT00116961|Bortezomib|bortezomib|mesh-list
65004586|NCT00474721|Analgesics|analgesics|mesh-ancestor
65004587|NCT00474721|Sensory System Agents|sensory system agents|mesh-ancestor
65004588|NCT00474721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65004589|NCT00474721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004590|NCT00474721|Antipyretics|antipyretics|mesh-ancestor
65004591|NCT00474721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65004592|NCT00474721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65004593|NCT00474721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65004594|NCT00474721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65004595|NCT00474721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004596|NCT00474721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004597|NCT00474721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65004598|NCT00474721|Narcotics|narcotics|mesh-ancestor
65004599|NCT00474721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65004600|NCT00474721|Antitussive Agents|antitussive agents|mesh-ancestor
65004601|NCT00474721|Respiratory System Agents|respiratory system agents|mesh-ancestor
65004602|NCT00117260|Levonorgestrel|levonorgestrel|mesh-list
65004603|NCT00117260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65004604|NCT00117260|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65004605|NCT00117260|Estradiol|estradiol|mesh-list
65004606|NCT00117260|Estrogens|estrogens|mesh-ancestor
65004607|NCT00117260|Hormones|hormones|mesh-ancestor
65004608|NCT00117260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65004609|NCT00117260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004610|NCT00117260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65004611|NCT00117260|Contraceptive Agents|contraceptive agents|mesh-ancestor
65004633|NCT00475072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004634|NCT00475072|Antiviral Agents|antiviral agents|mesh-ancestor
65004635|NCT00475072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65004636|NCT00117299|Vatalanib|vatalanib|mesh-list
65004637|NCT00117299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65004638|NCT00117299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004639|NCT00117299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004640|NCT00117000|Methyltestosterone|methyltestosterone|mesh-list
65004641|NCT00117000|Testosterone|testosterone|mesh-list
65004642|NCT00117000|Testosterone undecanoate|testosterone undecanoate|mesh-list
65004643|NCT00117000|Testosterone enanthate|testosterone enanthate|mesh-list
64985835|NCT00314782|Docetaxel|docetaxel|mesh-list
65004644|NCT00117000|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65004645|NCT00117000|Androgens|androgens|mesh-ancestor
65004646|NCT00117000|Hormones|hormones|mesh-ancestor
65004647|NCT00117000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65004648|NCT00117000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004649|NCT00117000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65004650|NCT00117000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65004651|NCT00117000|Anabolic Agents|anabolic agents|mesh-ancestor
65004652|NCT02956408|Vitamin D|vitamin d|mesh-list
65004653|NCT02956408|Cholecalciferol|cholecalciferol|mesh-list
65004654|NCT02956408|Vitamins|vitamins|mesh-ancestor
65004655|NCT02956408|Micronutrients|micronutrients|mesh-ancestor
65004656|NCT02956408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004657|NCT02956408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65004658|NCT02956408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65004678|NCT00117377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65004679|NCT00117377|Analgesics|analgesics|mesh-ancestor
65004680|NCT00117377|Sensory System Agents|sensory system agents|mesh-ancestor
65004681|NCT00117377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65004682|NCT00117377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004683|NCT00117377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65004684|NCT00117377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65004685|NCT00117377|Dermatologic Agents|dermatologic agents|mesh-ancestor
65004686|NCT00117377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65004687|NCT00117377|Immunologic Factors|immunologic factors|mesh-ancestor
65004688|NCT00117377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65004689|NCT00117377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004690|NCT00117377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004691|NCT02964195|Rifaximin|rifaximin|mesh-list
65004692|NCT02964195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65004693|NCT02964195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65004694|NCT02964195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65004695|NCT00475462|Metoprolol|metoprolol|mesh-list
65004696|NCT00475462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65004697|NCT00475462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65004733|NCT03270007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65004734|NCT03270007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65004735|NCT03270007|Tubulin Modulators|tubulin modulators|mesh-ancestor
65004736|NCT03270007|Antimitotic Agents|antimitotic agents|mesh-ancestor
65004737|NCT03270007|Mitosis Modulators|mitosis modulators|mesh-ancestor
65004738|NCT03270007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004739|NCT00475813|Fluticasone|fluticasone|mesh-list
65004740|NCT00475813|Xhance|xhance|mesh-list
65004741|NCT00475813|Formoterol Fumarate|formoterol fumarate|mesh-list
65004742|NCT00475813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65004743|NCT00475813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65004744|NCT00475813|Autonomic Agents|autonomic agents|mesh-ancestor
65004745|NCT00475813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65004746|NCT00475813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004747|NCT00475813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65004748|NCT00475813|Respiratory System Agents|respiratory system agents|mesh-ancestor
65004749|NCT00475813|Dermatologic Agents|dermatologic agents|mesh-ancestor
65004750|NCT00475813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65004751|NCT00475813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65004752|NCT00475813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65004753|NCT00475813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65004754|NCT00475813|Adrenergic Agents|adrenergic agents|mesh-ancestor
65004755|NCT00475813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65004757|NCT00117078|Darbepoetin alfa|darbepoetin alfa|mesh-list
65004782|NCT00475969|Dopamine Agents|dopamine agents|mesh-ancestor
65004783|NCT00476164|Rituximab|rituximab|mesh-list
65004784|NCT00476164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65004785|NCT00476164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65004786|NCT00476164|Immunologic Factors|immunologic factors|mesh-ancestor
65004787|NCT00476164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004788|NCT00476164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65004789|NCT00402077|Pramlintide|pramlintide|mesh-list
65004852|NCT00117611|Respiratory System Agents|respiratory system agents|mesh-ancestor
65004853|NCT04727684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65004854|NCT04727684|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65004855|NCT04727684|Cetrorelix|cetrorelix|mesh-list
65004856|NCT04727684|Menotropins|menotropins|mesh-list
65004857|NCT04727684|Luteolytic Agents|luteolytic agents|mesh-ancestor
65004858|NCT04727684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65004859|NCT04727684|Contraceptive Agents|contraceptive agents|mesh-ancestor
65004860|NCT04727684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65004861|NCT04727684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004862|NCT04727684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65004863|NCT04727684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65004864|NCT04727684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65004865|NCT04727684|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65004866|NCT04727684|Fertility Agents|fertility agents|mesh-ancestor
65004867|NCT04727684|Hormone Antagonists|hormone antagonists|mesh-ancestor
65004868|NCT04727684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65004869|NCT03277261|Teriflunomide|teriflunomide|mesh-list
65004870|NCT03277261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65004871|NCT03277261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65004872|NCT03277261|Analgesics|analgesics|mesh-ancestor
65004873|NCT03277261|Sensory System Agents|sensory system agents|mesh-ancestor
65004874|NCT03277261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65004875|NCT03277261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004876|NCT03277261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65004880|NCT02273947|BMS-955176|bms-955176|mesh-list
65004901|NCT00476515|Immunologic Factors|immunologic factors|mesh-ancestor
65004902|NCT00476515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004903|NCT00476515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65004904|NCT00117689|Mycophenolic Acid|mycophenolic acid|mesh-list
65004905|NCT00117689|Tacrolimus|tacrolimus|mesh-list
65004906|NCT00117689|Thymoglobulin|thymoglobulin|mesh-list
65004907|NCT00117689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65004908|NCT00117689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65004909|NCT00117689|Immunologic Factors|immunologic factors|mesh-ancestor
65004910|NCT00117689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004911|NCT00117689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65004912|NCT00117689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004913|NCT00117689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004914|NCT00117689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65004915|NCT00117689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65004916|NCT00117689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65004917|NCT00117689|Antitubercular Agents|antitubercular agents|mesh-ancestor
65004918|NCT00117689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65004919|NCT00117689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65004920|NCT00117273|Levonorgestrel|levonorgestrel|mesh-list
65004921|NCT00117273|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65004922|NCT00117273|Estradiol|estradiol|mesh-list
65004923|NCT00117273|Estrogens|estrogens|mesh-ancestor
65004924|NCT00117273|Hormones|hormones|mesh-ancestor
65004928|NCT00117273|Contraceptive Agents|contraceptive agents|mesh-ancestor
65004950|NCT00117728|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65004951|NCT00117767|Terbinafine|terbinafine|mesh-list
65004952|NCT00117767|Griseofulvin|griseofulvin|mesh-list
65004953|NCT00117767|Antifungal Agents|antifungal agents|mesh-ancestor
65004954|NCT00117767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65004955|NCT00117767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004956|NCT00117767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004958|NCT03277066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65004959|NCT03277066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65004960|NCT03277066|Analgesics|analgesics|mesh-ancestor
65004961|NCT03277066|Sensory System Agents|sensory system agents|mesh-ancestor
65004962|NCT03277066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65004963|NCT03277066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65004964|NCT03277066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65004965|NCT03277066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65004966|NCT03277066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65004967|NCT03277066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65004968|NCT03277066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004969|NCT00117351|Bortezomib|bortezomib|mesh-list
65004970|NCT00117351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65004971|NCT00118196|Azacitidine|azacitidine|mesh-list
65004972|NCT00118196|Arsenic Trioxide|arsenic trioxide|mesh-list
65004973|NCT00118196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65004974|NCT00118196|Antimetabolites|antimetabolites|mesh-ancestor
65004975|NCT00118196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65004976|NCT00118196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65004980|NCT00118235|Irinotecan|irinotecan|mesh-list
65004999|NCT00118313|Immunologic Factors|immunologic factors|mesh-ancestor
65005000|NCT00118313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005001|NCT00118313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005002|NCT00118313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65005003|NCT00118313|Interferon Inducers|interferon inducers|mesh-ancestor
65005004|NCT00118313|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65005005|NCT00118313|Protective Agents|protective agents|mesh-ancestor
65005006|NCT00118313|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65005007|NCT00118313|Antioxidants|antioxidants|mesh-ancestor
65005008|NCT00118313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005009|NCT03271021|Minocycline|minocycline|mesh-list
65005010|NCT03271021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65005011|NCT03271021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65005012|NCT02273986|Digoxin|digoxin|mesh-list
65005013|NCT02273986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65005014|NCT02273986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65005015|NCT02273986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005016|NCT02273986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005017|NCT02273986|Protective Agents|protective agents|mesh-ancestor
65005018|NCT02273986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005019|NCT00118508|Risedronic Acid|risedronic acid|mesh-list
65005020|NCT00118508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65005021|NCT00118508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65005022|NCT00118508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005024|NCT00118508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005047|NCT00477061|Analgesics|analgesics|mesh-ancestor
65005048|NCT00477061|Sensory System Agents|sensory system agents|mesh-ancestor
65005049|NCT00477061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65005050|NCT00477217|Zoledronic Acid|zoledronic acid|mesh-list
65005051|NCT00477217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65005052|NCT00477217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005053|NCT00477373|Valproic Acid|valproic acid|mesh-list
65005054|NCT00477373|Anticonvulsants|anticonvulsants|mesh-ancestor
65005055|NCT00477373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005056|NCT00477373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005057|NCT00477373|GABA Agents|gaba agents|mesh-ancestor
65005058|NCT00477373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65005059|NCT00477373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005060|NCT00477373|Antimanic Agents|antimanic agents|mesh-ancestor
65005061|NCT00477373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65005062|NCT00477373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65005063|NCT00477373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65005064|NCT00477763|Cyclosporine|cyclosporine|mesh-list
65005065|NCT00477763|Cyclosporins|cyclosporins|mesh-list
65005066|NCT00477763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005067|NCT00477763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460216|NCT01590771|Protease Inhibitors|protease inhibitors|mesh-ancestor
65005101|NCT00478075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65005102|NCT00478075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005103|NCT00478114|Sorafenib|sorafenib|mesh-list
65005104|NCT00478114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005105|NCT00478114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65005106|NCT00478114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005107|NCT00478114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005108|NCT00478270|Ibandronic Acid|ibandronic acid|mesh-list
65005109|NCT00478270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65005110|NCT00478270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005111|NCT00478504|Letrozole|letrozole|mesh-list
65005112|NCT00478504|Clomiphene|clomiphene|mesh-list
65005113|NCT00478504|Enclomiphene|enclomiphene|mesh-list
65005114|NCT00478504|Zuclomiphene|zuclomiphene|mesh-list
65005115|NCT00478504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005116|NCT00478504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005117|NCT00478504|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65005118|NCT00478504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65005119|NCT00478504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005120|NCT00478504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65005121|NCT00478504|Hormone Antagonists|hormone antagonists|mesh-ancestor
65005122|NCT00478504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65005123|NCT00478504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005124|NCT00478504|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65005125|NCT00478504|Fertility Agents|fertility agents|mesh-ancestor
65005126|NCT00478504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65005127|NCT00478504|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65005128|NCT00478504|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65005129|NCT00117468|Progesterone|progesterone|mesh-list
65005130|NCT00117468|Progestins|progestins|mesh-ancestor
65005131|NCT00117468|Hormones|hormones|mesh-ancestor
65005140|NCT00478543|Diuretics|diuretics|mesh-ancestor
65005141|NCT00478543|Natriuretic Agents|natriuretic agents|mesh-ancestor
65005142|NCT00478543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005143|NCT00478543|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65005144|NCT00478543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65005145|NCT00478543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005146|NCT00118937|Metformin|metformin|mesh-list
65005147|NCT00118937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65005148|NCT00118937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005149|NCT00478621|Vaccines|vaccines|mesh-list
65005150|NCT00478621|Immunologic Factors|immunologic factors|mesh-ancestor
65005151|NCT00478621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005152|NCT00478660|Adalimumab|adalimumab|mesh-list
65005153|NCT00478660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65005154|NCT00478660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65005155|NCT00478699|Gemcitabine|gemcitabine|mesh-list
65005156|NCT00478699|Cisplatin|cisplatin|mesh-list
65005157|NCT00478699|Docetaxel|docetaxel|mesh-list
65005158|NCT00478699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005160|NCT00478699|Antimetabolites|antimetabolites|mesh-ancestor
65005195|NCT00478855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005196|NCT00478855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005197|NCT00117546|Methyldopa|methyldopa|mesh-list
65005198|NCT00117546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65005199|NCT00117546|Sympatholytics|sympatholytics|mesh-ancestor
65005200|NCT00117546|Autonomic Agents|autonomic agents|mesh-ancestor
65005201|NCT00117546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65005202|NCT00117546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005203|NCT00117546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65005204|NCT00117546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65005205|NCT00117546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65005206|NCT00117546|Adrenergic Agents|adrenergic agents|mesh-ancestor
65005207|NCT00117546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65005208|NCT00117546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005209|NCT00479206|Artesunate|artesunate|mesh-list
65005210|NCT00479206|Antimalarials|antimalarials|mesh-ancestor
65005211|NCT00479206|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65005212|NCT00479206|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65005213|NCT00479206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65005214|NCT00479206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005215|NCT00479206|Antiviral Agents|antiviral agents|mesh-ancestor
65005216|NCT00479206|Schistosomicides|schistosomicides|mesh-ancestor
65005217|NCT00479206|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65005218|NCT00479206|Anthelmintics|anthelmintics|mesh-ancestor
65005219|NCT00119132|Artesunate|artesunate|mesh-list
65005220|NCT00119132|Pyrimethamine|pyrimethamine|mesh-list
65005246|NCT00479362|Sensory System Agents|sensory system agents|mesh-ancestor
65005247|NCT00479362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65005248|NCT00479362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005249|NCT00479362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64460368|NCT03806530|Anticonvulsants|anticonvulsants|mesh-ancestor
65005250|NCT00479362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65005251|NCT00479362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65005252|NCT00479362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65005253|NCT00479362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005254|NCT00479362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65005255|NCT00479362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65005256|NCT00479362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005258|NCT00479362|Anticoagulants|anticoagulants|mesh-ancestor
65005259|NCT00119171|Capecitabine|capecitabine|mesh-list
65005260|NCT00119171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65005261|NCT00119171|Antimetabolites|antimetabolites|mesh-ancestor
65005262|NCT00119171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005263|NCT00119171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005264|NCT00117624|Darbepoetin alfa|darbepoetin alfa|mesh-list
65005265|NCT00117624|Hematinics|hematinics|mesh-ancestor
65005266|NCT00479479|Vitamin B 12|vitamin b 12|mesh-list
65005268|NCT00479479|Vitamins|vitamins|mesh-ancestor
65005298|NCT00119249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005299|NCT00479908|Sildenafil Citrate|sildenafil citrate|mesh-list
65005300|NCT00479908|Nitroglycerin|nitroglycerin|mesh-list
65005301|NCT00479908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005302|NCT00479908|Vasodilator Agents|vasodilator agents|mesh-ancestor
65005303|NCT00479908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65005304|NCT00479908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65005305|NCT00479908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005306|NCT00479908|Urological Agents|urological agents|mesh-ancestor
65005307|NCT00479986|Pioglitazone|pioglitazone|mesh-list
65005308|NCT00479986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65005309|NCT00479986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005310|NCT00480064|Cytarabine|cytarabine|mesh-list
65005311|NCT00480064|Lomustine|lomustine|mesh-list
65005312|NCT00480064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65005313|NCT00480064|Antimetabolites|antimetabolites|mesh-ancestor
65005314|NCT00480064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005315|NCT00480064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005316|NCT00480064|Antiviral Agents|antiviral agents|mesh-ancestor
65005317|NCT00480064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65005318|NCT00480064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65005319|NCT00480064|Immunologic Factors|immunologic factors|mesh-ancestor
65005320|NCT00480064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005321|NCT00480064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65005322|NCT00480064|Alkylating Agents|alkylating agents|mesh-ancestor
65005323|NCT00480103|Mineral Oil|mineral oil|mesh-list
65005324|NCT00480103|Emollients|emollients|mesh-ancestor
65005325|NCT00480103|Dermatologic Agents|dermatologic agents|mesh-ancestor
65005345|NCT00119483|Anabolic Agents|anabolic agents|mesh-ancestor
65005346|NCT00480181|Nabilone|nabilone|mesh-list
65005347|NCT00480181|Antiemetics|antiemetics|mesh-ancestor
65005348|NCT00480181|Autonomic Agents|autonomic agents|mesh-ancestor
65005349|NCT00480181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65005350|NCT00480181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005351|NCT00480181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65005352|NCT00480181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65005353|NCT00480181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65005354|NCT00480181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65005355|NCT00480181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65005356|NCT00480298|Methylprednisolone|methylprednisolone|mesh-list
65005357|NCT00480298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65005358|NCT00480298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65005359|NCT00480298|Prednisolone|prednisolone|mesh-list
65005360|NCT00480298|Prednisolone acetate|prednisolone acetate|mesh-list
65005361|NCT00480298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65005362|NCT00480298|Prednisolone phosphate|prednisolone phosphate|mesh-list
65005363|NCT00480298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65005364|NCT00480298|Antiemetics|antiemetics|mesh-ancestor
65005365|NCT00480298|Autonomic Agents|autonomic agents|mesh-ancestor
65005366|NCT00480298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65005367|NCT00480298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005368|NCT00480298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65005369|NCT00480298|Glucocorticoids|glucocorticoids|mesh-ancestor
65005370|NCT00480298|Hormones|hormones|mesh-ancestor
65005371|NCT00480298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65005372|NCT00480298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65005373|NCT00480298|Protective Agents|protective agents|mesh-ancestor
65005374|NCT00480298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65005390|NCT00117702|Everolimus|everolimus|mesh-list
65005391|NCT00117702|Tacrolimus|tacrolimus|mesh-list
65005392|NCT00117702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65005393|NCT00117702|Immunologic Factors|immunologic factors|mesh-ancestor
65005394|NCT00117702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005395|NCT00117702|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65005396|NCT00117702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005397|NCT00117702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005398|NCT00117702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005399|NCT00480454|Vaccines|vaccines|mesh-list
65005400|NCT00480454|Immunologic Factors|immunologic factors|mesh-ancestor
65005401|NCT00480454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005402|NCT00480571|Perphenazine|perphenazine|mesh-list
65005403|NCT00480571|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
65005404|NCT00480571|GABA Agents|gaba agents|mesh-ancestor
65005405|NCT00480571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65005406|NCT00480571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005407|NCT00480571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005408|NCT00480571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65005409|NCT00480571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65005410|NCT00480571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65005411|NCT00480571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65005412|NCT00480571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65005413|NCT00480571|Dopamine Agents|dopamine agents|mesh-ancestor
65005414|NCT00480610|Tacrolimus|tacrolimus|mesh-list
65005415|NCT00480610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65005416|NCT00480610|Immunologic Factors|immunologic factors|mesh-ancestor
65005417|NCT00480610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005418|NCT00480610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65005419|NCT00480610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005421|NCT00480649|Fluticasone|fluticasone|mesh-list
65005435|NCT00480649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65005436|NCT00480649|Adrenergic Agents|adrenergic agents|mesh-ancestor
65005437|NCT00480649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65005438|NCT00480649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005439|NCT00119639|Sorafenib|sorafenib|mesh-list
65005440|NCT00119639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005441|NCT00119639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65005442|NCT00119639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005443|NCT00119639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005444|NCT00480844|Risperidone|risperidone|mesh-list
65005445|NCT00480844|Sertindole|sertindole|mesh-list
65005446|NCT00480844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65005447|NCT00480844|Serotonin Agents|serotonin agents|mesh-ancestor
65005448|NCT00480844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65005449|NCT00480844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005450|NCT00480844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005451|NCT00480844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65005452|NCT00480844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65005453|NCT00480844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65005454|NCT00480844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65005455|NCT00480844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65005456|NCT00480844|Dopamine Agents|dopamine agents|mesh-ancestor
65005457|NCT00480883|Meglumine Antimoniate|meglumine antimoniate|mesh-list
65005458|NCT00480883|Allopurinol|allopurinol|mesh-list
65005459|NCT00480883|Antimetabolites|antimetabolites|mesh-ancestor
65005484|NCT01240096|Antidepressive Agents|antidepressive agents|mesh-ancestor
65005485|NCT01240096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65005486|NCT01240096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65005487|NCT01240096|Histamine Antagonists|histamine antagonists|mesh-ancestor
65005488|NCT01240096|Histamine Agents|histamine agents|mesh-ancestor
65005489|NCT01240096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65005490|NCT01240096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005491|NCT01240096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005492|NCT01240096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65005493|NCT01240096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65005494|NCT01240096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65005495|NCT01240096|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65005496|NCT01240096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65005497|NCT01240096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65005498|NCT01240096|Adrenergic Agents|adrenergic agents|mesh-ancestor
65005499|NCT01240096|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65005500|NCT01240096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65005501|NCT01240096|Serotonin Agents|serotonin agents|mesh-ancestor
65005502|NCT01240096|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65005503|NCT00119756|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65005504|NCT00119756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65005505|NCT00119756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65005534|NCT05233605|Adrenergic Agents|adrenergic agents|mesh-ancestor
65005535|NCT05233605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65005536|NCT05233605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005537|NCT00117780|Insulin|insulin|mesh-list
65005538|NCT00117780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65005539|NCT00117780|Insulin Aspart|insulin aspart|mesh-list
65005540|NCT00117780|Insulin Detemir|insulin detemir|mesh-list
65005541|NCT00117780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65005542|NCT00117780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005544|NCT01240408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005545|NCT01240408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65005546|NCT01240408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005547|NCT01240408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005548|NCT00481273|Azacitidine|azacitidine|mesh-list
65005549|NCT00481273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64460733|NCT04761952|Azathioprine|azathioprine|mesh-list
65005550|NCT00481273|Antimetabolites|antimetabolites|mesh-ancestor
65005551|NCT00481273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005552|NCT00481273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005553|NCT00481273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005554|NCT00481312|Midazolam|midazolam|mesh-list
65005555|NCT00481312|Dexmedetomidine|dexmedetomidine|mesh-list
65005556|NCT00481312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65005582|NCT00119990|Icodextrin|icodextrin|mesh-list
65005587|NCT00117897|Lenograstim|lenograstim|mesh-list
65005588|NCT00117897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65005589|NCT00117897|Immunologic Factors|immunologic factors|mesh-ancestor
65005590|NCT00117897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005591|NCT00481663|Metformin|metformin|mesh-list
65005592|NCT00481663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65005593|NCT00481663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65005594|NCT00481663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005595|NCT00481663|Incretins|incretins|mesh-ancestor
65005596|NCT00481663|Hormones|hormones|mesh-ancestor
65005597|NCT00481663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65005598|NCT00481663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65005599|NCT00481663|Protease Inhibitors|protease inhibitors|mesh-ancestor
65005600|NCT00481663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005601|NCT00481663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005602|NCT00481702|Metronidazole|metronidazole|mesh-list
65005603|NCT00481702|Ceftriaxone|ceftriaxone|mesh-list
65005604|NCT00481702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65005605|NCT00481702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65005606|NCT00481702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65005607|NCT00481702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65005608|NCT00481741|Hemostatics|hemostatics|mesh-list
65005609|NCT00481741|Coagulants|coagulants|mesh-ancestor
65005610|NCT00481819|Mycophenolic Acid|mycophenolic acid|mesh-list
65005640|NCT00481819|Protective Agents|protective agents|mesh-ancestor
65005641|NCT00481819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65005642|NCT02958059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65005643|NCT02958059|Cefoxitin|cefoxitin|mesh-list
65005644|NCT02958059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65005645|NCT00481975|Rimonabant|rimonabant|mesh-list
65005646|NCT00481975|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65005647|NCT00481975|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65005648|NCT00481975|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65005649|NCT00481975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65005650|NCT00481975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005651|NCT00481975|Hormones|hormones|mesh-ancestor
65005652|NCT00481975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65005653|NCT00481975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005654|NCT00482209|Misoprostol|misoprostol|mesh-list
65005655|NCT00482209|Mifepristone|mifepristone|mesh-list
65005656|NCT00482209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65005657|NCT00482209|Abortifacient Agents|abortifacient agents|mesh-ancestor
65005658|NCT00482209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65005659|NCT00482209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005660|NCT00482209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65005661|NCT00482209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65005691|NCT00117975|Galiximab|galiximab|mesh-list
65005692|NCT00117975|Rituximab|rituximab|mesh-list
64986891|NCT00328432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005693|NCT00117975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65005694|NCT00117975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005695|NCT00117975|Immunologic Factors|immunologic factors|mesh-ancestor
65005696|NCT00117975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005697|NCT00117975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65005698|NCT00117975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65005699|NCT00482521|Pomalidomide|pomalidomide|mesh-list
65005700|NCT00482521|Immunologic Factors|immunologic factors|mesh-ancestor
65005701|NCT00482521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005702|NCT00482521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65005703|NCT00482521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65005704|NCT00482521|Growth Substances|growth substances|mesh-ancestor
65005705|NCT00482521|Growth Inhibitors|growth inhibitors|mesh-ancestor
65005706|NCT00482521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005707|NCT00120302|Pimecrolimus|pimecrolimus|mesh-list
65005708|NCT00120302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65005709|NCT00120302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65005710|NCT00120302|Analgesics|analgesics|mesh-ancestor
65005711|NCT00120302|Sensory System Agents|sensory system agents|mesh-ancestor
65005712|NCT00120302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65005713|NCT00120302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005714|NCT00120302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65005715|NCT00120302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65005716|NCT00120302|Dermatologic Agents|dermatologic agents|mesh-ancestor
65005717|NCT00120302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65005718|NCT00120302|Immunologic Factors|immunologic factors|mesh-ancestor
65005738|NCT00482755|Growth Substances|growth substances|mesh-ancestor
65005739|NCT00482755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005740|NCT00482755|Growth Inhibitors|growth inhibitors|mesh-ancestor
65005741|NCT00482755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65005742|NCT00482755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005743|NCT00482755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005744|NCT00120341|Analgesics|analgesics|mesh-list
65005745|NCT00120341|Sensory System Agents|sensory system agents|mesh-ancestor
65005746|NCT00120341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65005747|NCT00120341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005748|NCT00482989|Sifalimumab|sifalimumab|mesh-list
65005749|NCT00482989|Immunologic Factors|immunologic factors|mesh-ancestor
65005750|NCT00482989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005751|NCT00120380|Iloprost|iloprost|mesh-list
65005752|NCT00120380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65005753|NCT00120380|Vasodilator Agents|vasodilator agents|mesh-ancestor
65005754|NCT00483028|Donepezil|donepezil|mesh-list
65005756|NCT00483028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005796|NCT01241032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65005797|NCT01241032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005798|NCT01241032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005799|NCT00483067|Cytarabine|cytarabine|mesh-list
65005800|NCT00483067|Cladribine|cladribine|mesh-list
65005801|NCT00483067|Lenograstim|lenograstim|mesh-list
65005802|NCT00483067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65005803|NCT00483067|Antimetabolites|antimetabolites|mesh-ancestor
65005804|NCT00483067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005805|NCT00483067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005806|NCT00483067|Antiviral Agents|antiviral agents|mesh-ancestor
65005807|NCT00483067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65005808|NCT00483067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65005809|NCT00483067|Immunologic Factors|immunologic factors|mesh-ancestor
65005810|NCT00483067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005811|NCT00483067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65005812|NCT00483106|Methylphenidate|methylphenidate|mesh-list
65005813|NCT00483106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65005814|NCT00483106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005815|NCT00483106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65005816|NCT00483106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65005817|NCT00483106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65005818|NCT00483106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005819|NCT00483106|Dopamine Agents|dopamine agents|mesh-ancestor
65005820|NCT00483106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65005821|NCT00118170|Sorafenib|sorafenib|mesh-list
65005822|NCT00118170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005823|NCT00118170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65005824|NCT00118170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005825|NCT00118170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005826|NCT00120497|Hormones|hormones|mesh-list
65005827|NCT00120497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65005833|NCT00483301|Sorafenib|sorafenib|mesh-list
65005835|NCT00483301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005836|NCT00483301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65005837|NCT00483301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005838|NCT00483301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005839|NCT00483457|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65005840|NCT00483457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005841|NCT00120536|Vildagliptin|vildagliptin|mesh-list
64987043|NCT00329446|Citalopram|citalopram|mesh-list
65005843|NCT00120536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005844|NCT00120536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65005845|NCT00120536|Protease Inhibitors|protease inhibitors|mesh-ancestor
65005846|NCT00120536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65005847|NCT00120536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005894|NCT00483964|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65005895|NCT00483964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65005896|NCT00483964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65005897|NCT00483964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65005898|NCT00483964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65005899|NCT00483964|Serotonin Agents|serotonin agents|mesh-ancestor
65005900|NCT00484003|Pimecrolimus|pimecrolimus|mesh-list
65005901|NCT00484003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65005902|NCT00484003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65005903|NCT00484003|Analgesics|analgesics|mesh-ancestor
65005904|NCT00484003|Sensory System Agents|sensory system agents|mesh-ancestor
65005905|NCT00484003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65005906|NCT00484003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005907|NCT00484003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65005908|NCT00484003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65005950|NCT00484237|Etanercept|etanercept|mesh-list
65005951|NCT00484237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65005952|NCT00484237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65005953|NCT00484237|Analgesics|analgesics|mesh-ancestor
65005954|NCT00484237|Sensory System Agents|sensory system agents|mesh-ancestor
65005955|NCT00484237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65005956|NCT00484237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65005957|NCT00484237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65005958|NCT00484237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65005959|NCT00484237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65005960|NCT00484237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65005961|NCT00484237|Immunologic Factors|immunologic factors|mesh-ancestor
65005962|NCT00120692|Epoetin Alfa|epoetin alfa|mesh-list
65005963|NCT00120692|Darbepoetin alfa|darbepoetin alfa|mesh-list
65005964|NCT00120692|Hematinics|hematinics|mesh-ancestor
65005965|NCT00484432|Doxorubicin|doxorubicin|mesh-list
65005966|NCT00484432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65005967|NCT00484432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65005973|NCT00484510|Vitamins|vitamins|mesh-ancestor
65006009|NCT00484822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65006010|NCT00484822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006011|NCT00405210|Docetaxel|docetaxel|mesh-list
65006012|NCT00405210|Sorafenib|sorafenib|mesh-list
65006013|NCT00405210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65006014|NCT00405210|Tubulin Modulators|tubulin modulators|mesh-ancestor
65006015|NCT00405210|Antimitotic Agents|antimitotic agents|mesh-ancestor
65006016|NCT00405210|Mitosis Modulators|mitosis modulators|mesh-ancestor
65006017|NCT00405210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006018|NCT00405210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65006019|NCT00405210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006020|NCT00120809|Pyrimethamine|pyrimethamine|mesh-list
65006021|NCT00120809|Sulfadoxine|sulfadoxine|mesh-list
65006022|NCT00120809|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65006023|NCT00120809|Antimalarials|antimalarials|mesh-ancestor
65006024|NCT00120809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65006025|NCT00120809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65006026|NCT00120809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006027|NCT00120809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65006028|NCT00120809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006029|NCT00120809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006030|NCT00120809|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65006031|NCT00120809|Renal Agents|renal agents|mesh-ancestor
65006032|NCT00484900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65006060|NCT05062356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65006061|NCT05062356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65006062|NCT05062356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65006063|NCT05062356|Analgesics|analgesics|mesh-ancestor
65006064|NCT05062356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65006065|NCT05062356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65006066|NCT05062356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65006067|NCT05062356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006069|NCT01241383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65006070|NCT01241383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65006071|NCT01241383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006072|NCT00485056|Pioglitazone|pioglitazone|mesh-list
65006073|NCT00485056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65006074|NCT00485056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006076|NCT00120887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65006077|NCT00120887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65006078|NCT00120887|Antimetabolites|antimetabolites|mesh-ancestor
65006079|NCT00120887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006080|NCT00120887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65006081|NCT00120887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65006082|NCT00120887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006083|NCT01241422|Montelukast|montelukast|mesh-list
65006084|NCT01241422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65006085|NCT01241422|Respiratory System Agents|respiratory system agents|mesh-ancestor
65006086|NCT01241422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65006087|NCT01241422|Hormone Antagonists|hormone antagonists|mesh-ancestor
65006088|NCT01241422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65006089|NCT01241422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006090|NCT01241422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65006091|NCT01241422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65006092|NCT01241422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006093|NCT00118638|Darbepoetin alfa|darbepoetin alfa|mesh-list
65006099|NCT00485368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006100|NCT00485368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65006101|NCT00485407|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65006102|NCT00485407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65006103|NCT00485407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65006104|NCT00485407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65006105|NCT00485407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006106|NCT00485407|Adrenergic Agents|adrenergic agents|mesh-ancestor
65006107|NCT00485407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65006108|NCT00485407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006109|NCT01241500|ON 01910|on 01910|mesh-list
65006158|NCT00485680|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65006159|NCT00485680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65006160|NCT00485680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65006161|NCT00485680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006162|NCT00485680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65006163|NCT00485680|Serotonin Agents|serotonin agents|mesh-ancestor
65006164|NCT00485680|Antidepressive Agents|antidepressive agents|mesh-ancestor
65006165|NCT00485680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006166|NCT00485680|Antimanic Agents|antimanic agents|mesh-ancestor
65006167|NCT00118794|Lumefantrine|lumefantrine|mesh-list
65006168|NCT00118794|Artemether|artemether|mesh-list
65006169|NCT00118794|Dapsone|dapsone|mesh-list
65006170|NCT00118794|Chlorproguanil|chlorproguanil|mesh-list
65006171|NCT00118794|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65006172|NCT00118794|Antimalarials|antimalarials|mesh-ancestor
65006173|NCT00118794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65006174|NCT00118794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65006175|NCT00118794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006176|NCT00118794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65006213|NCT00485797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65006214|NCT00485797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65006215|NCT00485797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006216|NCT00485797|Dopamine Agents|dopamine agents|mesh-ancestor
64461342|NCT01688037|Adrenergic Agents|adrenergic agents|mesh-ancestor
65006217|NCT00485797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65006218|NCT00485875|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65006219|NCT00485875|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65006220|NCT00485875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65006221|NCT00485875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65006222|NCT00485875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006223|NCT00485875|Adrenergic Agents|adrenergic agents|mesh-ancestor
65006224|NCT00485875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65006225|NCT00485875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006226|NCT00121316|Pimecrolimus|pimecrolimus|mesh-list
65006227|NCT00121316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65006228|NCT00121316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65006229|NCT00121316|Analgesics|analgesics|mesh-ancestor
65006230|NCT00121316|Sensory System Agents|sensory system agents|mesh-ancestor
65006231|NCT00121316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65006232|NCT00121316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006233|NCT00121316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65006234|NCT00121316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65006235|NCT00121316|Dermatologic Agents|dermatologic agents|mesh-ancestor
65006260|NCT00486343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65006261|NCT00486343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65006262|NCT00486343|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65006263|NCT00486343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006264|NCT00486343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006265|NCT00486343|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65006266|NCT00486343|Hormone Antagonists|hormone antagonists|mesh-ancestor
65006267|NCT00486343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65006268|NCT00486421|Prednisone|prednisone|mesh-list
65006269|NCT00486421|Rituximab|rituximab|mesh-list
65006270|NCT00486421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65006271|NCT00486421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65006272|NCT00486421|Immunologic Factors|immunologic factors|mesh-ancestor
65006273|NCT00486421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006274|NCT00486421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65006275|NCT00486421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65006276|NCT00486421|Glucocorticoids|glucocorticoids|mesh-ancestor
65006277|NCT00486421|Hormones|hormones|mesh-ancestor
65006278|NCT00486421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65006315|NCT00486694|Antimalarials|antimalarials|mesh-ancestor
65006316|NCT00486694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65006317|NCT00486694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65006318|NCT00486694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006319|NCT00486694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65006320|NCT00486694|Antiviral Agents|antiviral agents|mesh-ancestor
65006321|NCT00486694|Schistosomicides|schistosomicides|mesh-ancestor
65006322|NCT00486694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65006323|NCT00486694|Anthelmintics|anthelmintics|mesh-ancestor
65006324|NCT00486694|Amebicides|amebicides|mesh-ancestor
65006325|NCT00486694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65006326|NCT00486694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65006327|NCT00486694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006328|NCT00486694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006329|NCT00486694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65006330|NCT00486694|Renal Agents|renal agents|mesh-ancestor
65006331|NCT00486772|Calcium|calcium|mesh-list
65006332|NCT00486772|Sevelamer|sevelamer|mesh-list
65006333|NCT00486772|Calcium acetate|calcium acetate|mesh-list
65006334|NCT00486772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65006335|NCT00486772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006336|NCT00486772|Chelating Agents|chelating agents|mesh-ancestor
65006337|NCT00486772|Sequestering Agents|sequestering agents|mesh-ancestor
65006338|NCT00486772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006339|NCT00121550|Clarithromycin|clarithromycin|mesh-list
65006340|NCT00121550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65006341|NCT00121550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006342|NCT00121550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65006343|NCT00121550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006344|NCT00121550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006345|NCT00121550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65006346|NCT00121550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65006347|NCT01242046|Caffeine|caffeine|mesh-list
65006348|NCT01242046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65006354|NCT01242046|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65006355|NCT01242046|Purinergic Agents|purinergic agents|mesh-ancestor
65006356|NCT01242046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65006357|NCT01242202|Acarbose|acarbose|mesh-list
65006358|NCT01242202|Voglibose|voglibose|mesh-list
65006359|NCT01242202|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
65006361|NCT01242202|Ipragliflozin|ipragliflozin|mesh-list
65006362|NCT01242202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006363|NCT01242202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006364|NCT01242202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65006365|NCT01242202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006366|NCT01242202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65006367|NCT00119145|Artesunate|artesunate|mesh-list
65006369|NCT00119145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65006370|NCT00119145|Antimalarials|antimalarials|mesh-ancestor
65006371|NCT00119145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65006372|NCT00119145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65006373|NCT00119145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006374|NCT00119145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65006375|NCT00119145|Antiviral Agents|antiviral agents|mesh-ancestor
65006376|NCT00119145|Schistosomicides|schistosomicides|mesh-ancestor
65006377|NCT00119145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65006378|NCT00119145|Anthelmintics|anthelmintics|mesh-ancestor
65006379|NCT00119184|Anesthetics|anesthetics|mesh-list
65006382|NCT00487123|Valsartan|valsartan|mesh-list
65006406|NCT00487591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65006407|NCT00487591|Antimetabolites|antimetabolites|mesh-ancestor
65006408|NCT00487591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006409|NCT00487591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65006410|NCT00487591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65006411|NCT00487591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006412|NCT00487786|Docetaxel|docetaxel|mesh-list
65006413|NCT00487786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65006414|NCT00487786|Tubulin Modulators|tubulin modulators|mesh-ancestor
65006415|NCT00487786|Antimitotic Agents|antimitotic agents|mesh-ancestor
65006416|NCT00487786|Mitosis Modulators|mitosis modulators|mesh-ancestor
65006417|NCT00487786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006418|NCT00488137|Prucalopride|prucalopride|mesh-list
65006419|NCT00488137|Laxatives|laxatives|mesh-ancestor
65006420|NCT00488137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65006421|NCT00488137|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65006422|NCT00488137|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65006423|NCT00488137|Serotonin Agents|serotonin agents|mesh-ancestor
65006424|NCT00488137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65006425|NCT00488137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006426|NCT00488137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006427|NCT00488176|Cetirizine|cetirizine|mesh-list
65006428|NCT00488176|Montelukast|montelukast|mesh-list
65006429|NCT00488176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65006430|NCT00488176|Respiratory System Agents|respiratory system agents|mesh-ancestor
65006431|NCT00488176|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65006432|NCT00488176|Hormone Antagonists|hormone antagonists|mesh-ancestor
65006433|NCT00488176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65006434|NCT00488176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006435|NCT00488176|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65006436|NCT00488176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65006448|NCT00488215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65006449|NCT00488215|Serotonin Agents|serotonin agents|mesh-ancestor
65006450|NCT00488215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65006451|NCT00488215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006452|NCT00488215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006453|NCT00121628|Motesanib diphosphate|motesanib diphosphate|mesh-list
65006454|NCT00121628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65006455|NCT00121628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006456|NCT00121628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006457|NCT04957329|Latanoprost|latanoprost|mesh-list
65006458|NCT04957329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65006459|NCT04957329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65006460|NCT00488371|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65006461|NCT00488371|Immunologic Factors|immunologic factors|mesh-ancestor
65006462|NCT00488371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006463|NCT00488527|Insulin Glargine|insulin glargine|mesh-list
65006464|NCT00488527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65006465|NCT00488527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006466|NCT00488566|Lamotrigine|lamotrigine|mesh-list
65006467|NCT00488566|Anticonvulsants|anticonvulsants|mesh-ancestor
65006468|NCT00488566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65006469|NCT00488566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65006470|NCT00488566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006471|NCT00488566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65006472|NCT00488566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006473|NCT00488566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65006474|NCT00488566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65006475|NCT00488566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65006476|NCT00488566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65006477|NCT00488566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65006478|NCT00488605|Leucovorin|leucovorin|mesh-list
65006489|NCT00488605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65006490|NCT00488605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65006491|NCT00488605|Abortifacient Agents|abortifacient agents|mesh-ancestor
65006492|NCT00488605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65006493|NCT00488605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64461650|NCT05688202|Prilocaine|prilocaine|mesh-list
64461651|NCT05688202|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64461652|NCT05688202|Anesthetics, Local|anesthetics, local|mesh-ancestor
64461653|NCT05688202|Anesthetics|anesthetics|mesh-ancestor
64461654|NCT05688202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64461655|NCT05688202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461656|NCT05688202|Sensory System Agents|sensory system agents|mesh-ancestor
64461657|NCT05688202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64461658|NCT05688202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64461659|NCT05688202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64461660|NCT05688202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64461661|NCT05688202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64987709|NCT00325858|Analgesics|analgesics|mesh-ancestor
64461663|NCT05688202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65006524|NCT00121784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65006525|NCT00121784|Antitubercular Agents|antitubercular agents|mesh-ancestor
65006526|NCT00121784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65006527|NCT00121784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006528|NCT00121784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006529|NCT00121784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006530|NCT00145236|Nebivolol|nebivolol|mesh-list
65006531|NCT00145236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65006532|NCT00145236|Vasodilator Agents|vasodilator agents|mesh-ancestor
65006533|NCT00145236|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65006534|NCT00145236|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65006535|NCT00145236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65006536|NCT00145236|Adrenergic Agents|adrenergic agents|mesh-ancestor
65006537|NCT00145236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65006538|NCT00145236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006539|NCT00145236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006540|NCT01242592|Antitubercular Agents|antitubercular agents|mesh-list
65006541|NCT01242592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65006542|NCT01242592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006577|NCT00489151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006578|NCT00489151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006579|NCT00489151|Antiviral Agents|antiviral agents|mesh-ancestor
65006580|NCT00489151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006581|NCT00489151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65006582|NCT00489151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65006583|NCT00145314|Leucovorin|leucovorin|mesh-list
65006584|NCT00145314|Folic Acid|folic acid|mesh-list
65006585|NCT00145314|Fluorouracil|fluorouracil|mesh-list
65006586|NCT00145314|Oxaliplatin|oxaliplatin|mesh-list
65006587|NCT00145314|Cetuximab|cetuximab|mesh-list
65006588|NCT00145314|Levoleucovorin|levoleucovorin|mesh-list
65006589|NCT00145314|Antimetabolites|antimetabolites|mesh-ancestor
65006590|NCT00145314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006591|NCT00145314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65006592|NCT00145314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65006593|NCT00145314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65006594|NCT00145314|Immunologic Factors|immunologic factors|mesh-ancestor
65006595|NCT00145314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006596|NCT00145314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65006597|NCT00145314|Antidotes|antidotes|mesh-ancestor
65006598|NCT00145314|Protective Agents|protective agents|mesh-ancestor
65006599|NCT00145314|Vitamin B Complex|vitamin b complex|mesh-ancestor
65006600|NCT00145314|Vitamins|vitamins|mesh-ancestor
65006601|NCT00145314|Micronutrients|micronutrients|mesh-ancestor
65006602|NCT00145314|Hematinics|hematinics|mesh-ancestor
65006603|NCT00489190|Insulin glulisine|insulin glulisine|mesh-list
65006604|NCT00489190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65006605|NCT00489190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006606|NCT00489229|Rosiglitazone|rosiglitazone|mesh-list
65006607|NCT00489229|Ramipril|ramipril|mesh-list
65006608|NCT00489229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65006623|NCT01242631|Immunologic Factors|immunologic factors|mesh-ancestor
65006624|NCT01242631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006625|NCT01242826|Insulin Aspart|insulin aspart|mesh-list
65006626|NCT01242826|Biphasic Insulins|biphasic insulins|mesh-list
65006627|NCT01242826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65006628|NCT01242826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006629|NCT01242904|Icodextrin|icodextrin|mesh-list
65006630|NCT01242904|Dialysis Solutions|dialysis solutions|mesh-ancestor
65006631|NCT01242904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65006632|NCT00145353|Insulin Aspart|insulin aspart|mesh-list
65006633|NCT00145353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65006634|NCT00145353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006635|NCT00121979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
65006636|NCT00121979|Racivir|racivir|mesh-list
65006637|NCT00121979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65006638|NCT00121979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006639|NCT00121979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006640|NCT00121979|Antiviral Agents|antiviral agents|mesh-ancestor
65006641|NCT00121979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006642|NCT00489658|Eflornithine|eflornithine|mesh-list
65006643|NCT00489658|Nifurtimox|nifurtimox|mesh-list
65006644|NCT00489658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65006645|NCT00489658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65006646|NCT00489658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65006647|NCT00489658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65006648|NCT00489658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006649|NCT00489658|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
65006650|NCT00489658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006652|NCT00122018|Acetylcysteine|acetylcysteine|mesh-list
65006671|NCT00489775|Paroxetine|paroxetine|mesh-list
65006672|NCT00489775|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65006673|NCT00489775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65006674|NCT00489775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65006675|NCT00489775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006676|NCT00489775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65006677|NCT00489775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006678|NCT00489775|Analgesics|analgesics|mesh-ancestor
65006679|NCT00489775|Sensory System Agents|sensory system agents|mesh-ancestor
65006680|NCT00489775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65006681|NCT00489775|Antidepressive Agents|antidepressive agents|mesh-ancestor
65006682|NCT00489775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65006683|NCT00489775|Dopamine Agents|dopamine agents|mesh-ancestor
65006684|NCT00489775|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65006685|NCT00489775|Serotonin Agents|serotonin agents|mesh-ancestor
65006686|NCT00489775|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65006687|NCT00489775|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65006688|NCT00489775|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65006689|NCT00489775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006690|NCT00122057|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65006691|NCT00122057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006692|NCT00489892|Modafinil|modafinil|mesh-list
65006693|NCT00489892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65006719|NCT00490204|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65006720|NCT00490204|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65006721|NCT00490204|Histamine Antagonists|histamine antagonists|mesh-ancestor
65006722|NCT00490204|Histamine Agents|histamine agents|mesh-ancestor
65006723|NCT00490204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65006724|NCT00490204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006725|NCT00490204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006726|NCT00122096|Valdecoxib|valdecoxib|mesh-list
65006727|NCT00122096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65006728|NCT00122096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65006729|NCT00122096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006730|NCT00122096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006731|NCT00122096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65006732|NCT00122096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65006733|NCT00122096|Analgesics|analgesics|mesh-ancestor
65006734|NCT00122096|Sensory System Agents|sensory system agents|mesh-ancestor
65006735|NCT00122096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65006736|NCT00122096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006737|NCT00122096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65006738|NCT00122096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65006739|NCT00490243|Budesonide|budesonide|mesh-list
65006740|NCT00490243|Formoterol Fumarate|formoterol fumarate|mesh-list
65006741|NCT00490243|Montelukast|montelukast|mesh-list
65006742|NCT00490243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65006743|NCT00490243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65006744|NCT00490243|Autonomic Agents|autonomic agents|mesh-ancestor
65006745|NCT00490243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65006764|NCT00490360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65006765|NCT00490360|Antimetabolites|antimetabolites|mesh-ancestor
65006766|NCT00490360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006767|NCT00490360|Antiviral Agents|antiviral agents|mesh-ancestor
65006768|NCT00490360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006769|NCT00490360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006770|NCT00490360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65006771|NCT00490360|Immunologic Factors|immunologic factors|mesh-ancestor
65006772|NCT00490360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006773|NCT00490399|Gemcitabine|gemcitabine|mesh-list
65006774|NCT00490399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65006775|NCT00490399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65006776|NCT00490399|Antimetabolites|antimetabolites|mesh-ancestor
65006777|NCT00490399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006778|NCT00490399|Antiviral Agents|antiviral agents|mesh-ancestor
65006779|NCT00490399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006780|NCT00490399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006781|NCT00490399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65006782|NCT00490399|Immunologic Factors|immunologic factors|mesh-ancestor
65006783|NCT00490399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006784|NCT04844385|Paclitaxel|paclitaxel|mesh-list
65006785|NCT04844385|Capecitabine|capecitabine|mesh-list
65006786|NCT04844385|Nedaplatin|nedaplatin|mesh-list
65006787|NCT04844385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65006788|NCT04844385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65006789|NCT04844385|Tubulin Modulators|tubulin modulators|mesh-ancestor
65006790|NCT04844385|Antimitotic Agents|antimitotic agents|mesh-ancestor
65006791|NCT04844385|Mitosis Modulators|mitosis modulators|mesh-ancestor
65006811|NCT00490711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65006812|NCT00490711|Antimetabolites|antimetabolites|mesh-ancestor
65006813|NCT00490711|Antiviral Agents|antiviral agents|mesh-ancestor
65006814|NCT00490711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006815|NCT00490711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006816|NCT00490711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65006817|NCT00490711|Immunologic Factors|immunologic factors|mesh-ancestor
65006818|NCT00490711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006819|NCT00122291|Capecitabine|capecitabine|mesh-list
65006820|NCT00122291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65006821|NCT00122291|Antimetabolites|antimetabolites|mesh-ancestor
65006822|NCT00122291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006823|NCT00122291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65006824|NCT00490789|Sirolimus|sirolimus|mesh-list
65006825|NCT00490789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65006826|NCT00490789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006827|NCT00490789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65006828|NCT00490789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65006829|NCT00490789|Antifungal Agents|antifungal agents|mesh-ancestor
65006830|NCT00490789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65006831|NCT00490789|Immunologic Factors|immunologic factors|mesh-ancestor
65006832|NCT00490789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006833|NCT00490828|Hydrocortisone|hydrocortisone|mesh-list
65006834|NCT00490828|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65006835|NCT00490828|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65006836|NCT00490828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65006837|NCT00490828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65006838|NCT04829604|Immunoconjugates|immunoconjugates|mesh-list
65006859|NCT00490906|Interferon beta-1b|interferon beta-1b|mesh-list
65006860|NCT00490906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65006861|NCT00490906|Antiviral Agents|antiviral agents|mesh-ancestor
65006862|NCT00490906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006863|NCT00490906|Immunologic Factors|immunologic factors|mesh-ancestor
65006864|NCT00490906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006865|NCT00490906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65006866|NCT00490906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65006867|NCT00490906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64462071|NCT05185024|Iron|iron|mesh-list
65006868|NCT00122486|Tenofovir|tenofovir|mesh-list
65006869|NCT00122486|Antiviral Agents|antiviral agents|mesh-ancestor
65006870|NCT00122486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65006871|NCT00122486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65006872|NCT00122486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65006874|NCT00122486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006875|NCT00122486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65006876|NCT00122486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65006885|NCT00491725|Metformin|metformin|mesh-list
65006917|NCT00491998|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65006918|NCT00491998|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65006919|NCT00491998|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65006920|NCT00491998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006921|NCT00491998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006922|NCT00492037|Conivaptan|conivaptan|mesh-list
65006923|NCT00492037|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65006924|NCT00492037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006925|NCT00492037|Natriuretic Agents|natriuretic agents|mesh-ancestor
65006926|NCT00492037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006927|NCT00402272|Everolimus|everolimus|mesh-list
65006928|NCT00402272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65006929|NCT00402272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65006930|NCT00402272|Immunologic Factors|immunologic factors|mesh-ancestor
65006931|NCT00402272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006932|NCT00492388|Ketamine|ketamine|mesh-list
65006933|NCT00492388|Analgesics|analgesics|mesh-ancestor
65006934|NCT00492388|Sensory System Agents|sensory system agents|mesh-ancestor
65006935|NCT00492388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65006936|NCT00492388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006937|NCT00492388|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65006938|NCT00492388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65006940|NCT00492388|Anesthetics|anesthetics|mesh-ancestor
65006941|NCT00492388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65006942|NCT00492388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65006943|NCT00492388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65006944|NCT00492388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65006946|NCT01243528|Vitamin D|vitamin d|mesh-list
65006963|NCT00492466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65006964|NCT00492466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006965|NCT00492466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65006966|NCT00492466|Glucocorticoids|glucocorticoids|mesh-ancestor
65006967|NCT00492466|Hormones|hormones|mesh-ancestor
65006968|NCT00492466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65006969|NCT00492466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65006970|NCT00492466|Protective Agents|protective agents|mesh-ancestor
65006971|NCT00492466|Immunologic Factors|immunologic factors|mesh-ancestor
65006972|NCT00492466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65006973|NCT00492505|Tamoxifen|tamoxifen|mesh-list
65006974|NCT00492505|Sorafenib|sorafenib|mesh-list
65006975|NCT00492505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65006976|NCT00492505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65006977|NCT00492505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65006978|NCT00492505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65006979|NCT00492505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65006980|NCT00492505|Hormone Antagonists|hormone antagonists|mesh-ancestor
65006981|NCT00492505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65006982|NCT00492505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65006983|NCT00492505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65006984|NCT00492505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65006985|NCT00492505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65007012|NCT00492934|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65007013|NCT00492934|Fertility Agents|fertility agents|mesh-ancestor
65007014|NCT00492934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65007015|NCT00492934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007017|NCT02274454|Calcium|calcium|mesh-list
65007018|NCT02274454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65007019|NCT02274454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007020|NCT02274454|Oxytocics|oxytocics|mesh-ancestor
65007021|NCT02274454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65007022|NCT04760730|Vaccines|vaccines|mesh-list
65007023|NCT04760730|Immunologic Factors|immunologic factors|mesh-ancestor
65007024|NCT04760730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007025|NCT00122759|Ketamine|ketamine|mesh-list
65007026|NCT00122759|Analgesics|analgesics|mesh-ancestor
65007027|NCT00122759|Sensory System Agents|sensory system agents|mesh-ancestor
65007028|NCT00122759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65007029|NCT00122759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007030|NCT00122759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65007031|NCT00122759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65007032|NCT00122759|Anesthetics, General|anesthetics, general|mesh-ancestor
65007033|NCT00122759|Anesthetics|anesthetics|mesh-ancestor
65007034|NCT00122759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65007035|NCT00122759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65007036|NCT00122759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65007037|NCT00122759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65007038|NCT00122759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007039|NCT00493129|Denileukin diftitox|denileukin diftitox|mesh-list
65007060|NCT00126542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65007061|NCT00126542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007062|NCT00126542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007063|NCT00493324|Alefacept|alefacept|mesh-list
65007064|NCT00493324|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65007065|NCT00493324|Immunologic Factors|immunologic factors|mesh-ancestor
65007066|NCT00493324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007067|NCT00493324|Dermatologic Agents|dermatologic agents|mesh-ancestor
65007068|NCT01243801|Ketamine|ketamine|mesh-list
65007069|NCT01243801|Analgesics|analgesics|mesh-ancestor
65007070|NCT01243801|Sensory System Agents|sensory system agents|mesh-ancestor
65007071|NCT01243801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65007072|NCT01243801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007073|NCT01243801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65007074|NCT01243801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65007075|NCT01243801|Anesthetics, General|anesthetics, general|mesh-ancestor
65007076|NCT01243801|Anesthetics|anesthetics|mesh-ancestor
65007077|NCT01243801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65007078|NCT01243801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65007079|NCT01243801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65007080|NCT01243801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65007081|NCT01243801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007083|NCT00126620|Sorafenib|sorafenib|mesh-list
65007111|NCT00126698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65007112|NCT00126698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65007113|NCT00126698|Renal Agents|renal agents|mesh-ancestor
65007114|NCT00126698|Antimalarials|antimalarials|mesh-ancestor
65007115|NCT00126698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65007116|NCT00126698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65007117|NCT00126698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65007118|NCT00126698|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65007119|NCT00126698|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65007120|NCT00493402|Chlorotrianisene|chlorotrianisene|mesh-list
65007121|NCT00493402|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65007122|NCT00493402|Estrogens|estrogens|mesh-ancestor
65007124|NCT00493402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65007125|NCT00493402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007126|NCT00493402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65007127|NCT00493402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007128|NCT00145938|Sildenafil Citrate|sildenafil citrate|mesh-list
65007129|NCT00145938|Vasodilator Agents|vasodilator agents|mesh-ancestor
65007130|NCT00145938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65007131|NCT00145938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65007135|NCT00493480|Propranolol|propranolol|mesh-list
65007164|NCT01243996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007165|NCT01244113|Propofol|propofol|mesh-list
65007166|NCT01244113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65007167|NCT01244113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65007168|NCT01244113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007169|NCT01244113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65007170|NCT01244113|Anesthetics, General|anesthetics, general|mesh-ancestor
65007171|NCT01244113|Anesthetics|anesthetics|mesh-ancestor
65007172|NCT00405249|Dexelvucitabine|dexelvucitabine|mesh-list
65007173|NCT00405249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65007174|NCT00405249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65007175|NCT00405249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007176|NCT00405249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007177|NCT00405249|Antiviral Agents|antiviral agents|mesh-ancestor
65007178|NCT00405249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65007179|NCT00405249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65007180|NCT00405249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65007181|NCT00493987|Methyltestosterone|methyltestosterone|mesh-list
65007182|NCT00493987|Testosterone|testosterone|mesh-list
65007183|NCT00493987|Testosterone undecanoate|testosterone undecanoate|mesh-list
65007184|NCT00493987|Testosterone enanthate|testosterone enanthate|mesh-list
65007185|NCT00493987|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65007186|NCT00493987|Dutasteride|dutasteride|mesh-list
65007187|NCT00493987|Androgens|androgens|mesh-ancestor
65007189|NCT00493987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65007190|NCT00493987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007193|NCT00493987|Anabolic Agents|anabolic agents|mesh-ancestor
65007212|NCT00494338|Antimitotic Agents|antimitotic agents|mesh-ancestor
65007213|NCT00494338|Mitosis Modulators|mitosis modulators|mesh-ancestor
65007214|NCT00494338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007215|NCT00494377|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65007216|NCT00494377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65007217|NCT00494377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65007218|NCT00494377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65007219|NCT00494377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007220|NCT00494377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65007221|NCT00494377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007222|NCT00494377|Analgesics|analgesics|mesh-ancestor
65007223|NCT00494377|Sensory System Agents|sensory system agents|mesh-ancestor
65007224|NCT00494377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65007225|NCT00494377|Antidepressive Agents|antidepressive agents|mesh-ancestor
65007226|NCT00494377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65007227|NCT00494377|Dopamine Agents|dopamine agents|mesh-ancestor
65007228|NCT00146016|Amantadine|amantadine|mesh-list
65007229|NCT00146016|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65007230|NCT00146016|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65007231|NCT00146016|Antiviral Agents|antiviral agents|mesh-ancestor
65007232|NCT00146016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65007233|NCT00146016|Dopamine Agents|dopamine agents|mesh-ancestor
65007234|NCT00146016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65007237|NCT00146016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65007260|NCT01244230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007261|NCT01244269|Methylphenidate|methylphenidate|mesh-list
65007262|NCT01244269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65007263|NCT01244269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007264|NCT01244269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65007265|NCT01244269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65007266|NCT01244269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65007267|NCT01244269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007268|NCT01244269|Dopamine Agents|dopamine agents|mesh-ancestor
65007269|NCT01244269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65007270|NCT00127010|Vaccines|vaccines|mesh-list
65007271|NCT00127010|Immunologic Factors|immunologic factors|mesh-ancestor
65007272|NCT00127010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007273|NCT00494533|Treprostinil|treprostinil|mesh-list
65007274|NCT00494533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65007275|NCT00494572|Montelukast|montelukast|mesh-list
65007276|NCT00494572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65007277|NCT00494572|Respiratory System Agents|respiratory system agents|mesh-ancestor
65007278|NCT00494572|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65007279|NCT00494572|Hormone Antagonists|hormone antagonists|mesh-ancestor
65007280|NCT00494572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65007281|NCT00494572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007282|NCT00494572|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65007283|NCT00494572|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65007284|NCT00494572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007285|NCT00494611|Cetuximab|cetuximab|mesh-list
65007286|NCT00494611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65007287|NCT00494611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007288|NCT00127049|Gemcitabine|gemcitabine|mesh-list
65007289|NCT00127049|Ifosfamide|ifosfamide|mesh-list
65007301|NCT00127049|Alkylating Agents|alkylating agents|mesh-ancestor
65007302|NCT00494884|Vildagliptin|vildagliptin|mesh-list
65007303|NCT00494884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65007304|NCT00494884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007305|NCT00494884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65007306|NCT00494884|Protease Inhibitors|protease inhibitors|mesh-ancestor
65007307|NCT00494884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007308|NCT00494884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007309|NCT00127088|Docetaxel|docetaxel|mesh-list
65007310|NCT00127088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007311|NCT00127088|Tubulin Modulators|tubulin modulators|mesh-ancestor
65007312|NCT00127088|Antimitotic Agents|antimitotic agents|mesh-ancestor
65007313|NCT00127088|Mitosis Modulators|mitosis modulators|mesh-ancestor
65007314|NCT00127088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007315|NCT02957877|Heparin|heparin|mesh-list
65007316|NCT02957877|Calcium heparin|calcium heparin|mesh-list
65007317|NCT02957877|Nadroparin|nadroparin|mesh-list
65007360|NCT00495313|Metronidazole|metronidazole|mesh-list
65007361|NCT00495313|Doxycycline|doxycycline|mesh-list
65007362|NCT00495313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65007363|NCT00495313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65007364|NCT00495313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65007365|NCT00495313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65007366|NCT00495313|Antimalarials|antimalarials|mesh-ancestor
65007367|NCT00495352|Bupropion|bupropion|mesh-list
65007368|NCT00495352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65007369|NCT00495352|Antidepressive Agents|antidepressive agents|mesh-ancestor
65007370|NCT00495352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65007371|NCT00495352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65007372|NCT00495352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65007373|NCT00495352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65007374|NCT00495352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007375|NCT00495352|Dopamine Agents|dopamine agents|mesh-ancestor
65007376|NCT00495352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65007377|NCT00495352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007378|NCT00495352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65007379|NCT00495352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65007380|NCT00495352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007381|NCT00495547|Azacitidine|azacitidine|mesh-list
65007382|NCT00495547|Epoetin Alfa|epoetin alfa|mesh-list
65007413|NCT00495898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65007414|NCT00495898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007415|NCT00495898|Antifungal Agents|antifungal agents|mesh-ancestor
65007416|NCT00495898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65007417|NCT00495898|Immunologic Factors|immunologic factors|mesh-ancestor
65007418|NCT00495898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007419|NCT00496093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65007420|NCT00496093|Immunologic Factors|immunologic factors|mesh-ancestor
65007421|NCT00496093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007422|NCT00127478|Atrasentan|atrasentan|mesh-list
65007423|NCT00127478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007424|NCT00127478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65007425|NCT00127478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65007426|NCT00127478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007427|NCT00146211|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
65007428|NCT00146211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65007429|NCT00146211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65007430|NCT00496405|Bevacizumab|bevacizumab|mesh-list
65007431|NCT00496405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65007432|NCT00496405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007433|NCT00496405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65007434|NCT00496405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65007435|NCT00496405|Growth Substances|growth substances|mesh-ancestor
65007436|NCT00496405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007437|NCT00496405|Growth Inhibitors|growth inhibitors|mesh-ancestor
65007459|NCT00146250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65007460|NCT00146250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007461|NCT00146250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65007462|NCT00146250|Analgesics|analgesics|mesh-ancestor
65007463|NCT00146250|Sensory System Agents|sensory system agents|mesh-ancestor
65007464|NCT00146250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65007465|NCT00496600|Everolimus|everolimus|mesh-list
65007466|NCT00496600|Epothilone B|epothilone b|mesh-list
65007467|NCT00496600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007468|NCT00496600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65007469|NCT00496600|Immunologic Factors|immunologic factors|mesh-ancestor
65007470|NCT00496600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007472|NCT00496600|Antimitotic Agents|antimitotic agents|mesh-ancestor
65007473|NCT00496600|Mitosis Modulators|mitosis modulators|mesh-ancestor
65007474|NCT00496600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007475|NCT00127595|Gemcitabine|gemcitabine|mesh-list
65007476|NCT00127595|Oxaliplatin|oxaliplatin|mesh-list
65007477|NCT00127595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65007478|NCT00127595|Antimetabolites|antimetabolites|mesh-ancestor
65007479|NCT00127595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007480|NCT00127595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007481|NCT00127595|Antiviral Agents|antiviral agents|mesh-ancestor
65007482|NCT00127595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65007483|NCT00127595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007484|NCT00127595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65007485|NCT00127595|Immunologic Factors|immunologic factors|mesh-ancestor
65007486|NCT00127595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007487|NCT04665765|Rituximab|rituximab|mesh-list
65007488|NCT04665765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65007489|NCT04665765|Carboplatin|carboplatin|mesh-list
65007490|NCT04665765|Etoposide|etoposide|mesh-list
65007492|NCT04665765|Ifosfamide|ifosfamide|mesh-list
65007505|NCT04665765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65007506|NCT04665765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007507|NCT04665765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007508|NCT04665765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65007509|NCT04665765|Alkylating Agents|alkylating agents|mesh-ancestor
65007510|NCT04665765|Keratolytic Agents|keratolytic agents|mesh-ancestor
65007511|NCT04665765|Dermatologic Agents|dermatologic agents|mesh-ancestor
65007512|NCT04665765|Tubulin Modulators|tubulin modulators|mesh-ancestor
65007513|NCT04665765|Antimitotic Agents|antimitotic agents|mesh-ancestor
65007514|NCT04665765|Mitosis Modulators|mitosis modulators|mesh-ancestor
65007515|NCT00497029|Fluorides|fluorides|mesh-list
65007516|NCT00497029|Fluorides, Topical|fluorides, topical|mesh-list
65007517|NCT00497029|Cariostatic Agents|cariostatic agents|mesh-ancestor
65007518|NCT00497029|Protective Agents|protective agents|mesh-ancestor
65007519|NCT00497029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007520|NCT00497107|Calcium, Dietary|calcium, dietary|mesh-list
65007521|NCT00497107|Leucovorin|leucovorin|mesh-list
65007522|NCT00497107|Calcium|calcium|mesh-list
65007523|NCT00497107|Levoleucovorin|levoleucovorin|mesh-list
65007524|NCT00497107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65007527|NCT00497107|Antidotes|antidotes|mesh-ancestor
65007560|NCT04599894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65007561|NCT04599894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65007562|NCT04599894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65007563|NCT04599894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65007564|NCT00497224|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65007565|NCT00497224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007566|NCT00497224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65007567|NCT00497224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007568|NCT00497224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007569|NCT04726982|Acetazolamide|acetazolamide|mesh-list
65007570|NCT04726982|Anticonvulsants|anticonvulsants|mesh-ancestor
65007571|NCT04726982|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65007572|NCT04726982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007573|NCT04726982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007574|NCT04726982|Diuretics|diuretics|mesh-ancestor
65007575|NCT04726982|Natriuretic Agents|natriuretic agents|mesh-ancestor
65007576|NCT04726982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007617|NCT00127868|Hormone Antagonists|hormone antagonists|mesh-ancestor
65007618|NCT00127868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65007619|NCT00127868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007620|NCT00127868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65007621|NCT00127868|Antioxidants|antioxidants|mesh-ancestor
65007622|NCT00127868|Protective Agents|protective agents|mesh-ancestor
65007623|NCT00127868|Trace Elements|trace elements|mesh-ancestor
65007624|NCT00127868|Micronutrients|micronutrients|mesh-ancestor
65007625|NCT00127868|Dermatologic Agents|dermatologic agents|mesh-ancestor
65007626|NCT00497536|Insulin|insulin|mesh-list
65007627|NCT00497536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65007628|NCT00497536|Insulin Aspart|insulin aspart|mesh-list
65007629|NCT00497536|Insulin, Long-Acting|insulin, long-acting|mesh-list
65007630|NCT00497536|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65007631|NCT00497536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65007632|NCT00497536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007633|NCT00497614|Adalimumab|adalimumab|mesh-list
65007677|NCT00498004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65007678|NCT00498004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65007679|NCT00498004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65007680|NCT00498004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65007681|NCT00498004|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65007682|NCT00498004|Dopamine Agents|dopamine agents|mesh-ancestor
65007683|NCT00498004|Antidepressive Agents|antidepressive agents|mesh-ancestor
65007684|NCT00146523|Mifepristone|mifepristone|mesh-list
65007685|NCT00146523|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65007686|NCT00146523|Abortifacient Agents|abortifacient agents|mesh-ancestor
65007687|NCT00146523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65007688|NCT00146523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007689|NCT00146523|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65007690|NCT00146523|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65007691|NCT00146523|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65007692|NCT00146523|Contraceptive Agents|contraceptive agents|mesh-ancestor
65007693|NCT00146523|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65007694|NCT00146523|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65007695|NCT00146523|Hormone Antagonists|hormone antagonists|mesh-ancestor
65007696|NCT00146523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65007731|NCT00498316|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65007732|NCT00498316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65007733|NCT00498316|Immunologic Factors|immunologic factors|mesh-ancestor
65007734|NCT00498316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007735|NCT00498316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65007736|NCT00498316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65007737|NCT00498316|Alkylating Agents|alkylating agents|mesh-ancestor
65007738|NCT00498316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007739|NCT00498316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007740|NCT00498316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65007741|NCT00498316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65007742|NCT00498316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65007743|NCT00498316|Antimetabolites|antimetabolites|mesh-ancestor
65007744|NCT00498316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65007745|NCT00498316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65007746|NCT00498316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007747|NCT00498316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65007748|NCT00498316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65007749|NCT00498316|Antitubercular Agents|antitubercular agents|mesh-ancestor
65007750|NCT00498316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65007751|NCT00146562|Paclitaxel|paclitaxel|mesh-list
65007752|NCT00146562|Cyclophosphamide|cyclophosphamide|mesh-list
65007753|NCT00146562|Doxorubicin|doxorubicin|mesh-list
65007754|NCT00146562|Darbepoetin alfa|darbepoetin alfa|mesh-list
65007755|NCT00146562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65007756|NCT00146562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007757|NCT00146562|Tubulin Modulators|tubulin modulators|mesh-ancestor
65007778|NCT01245166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007779|NCT01245166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007780|NCT00146601|Fulvestrant|fulvestrant|mesh-list
65007781|NCT00146601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65007782|NCT00146601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007783|NCT00146601|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65007784|NCT00146601|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65007785|NCT00146601|Hormone Antagonists|hormone antagonists|mesh-ancestor
65007786|NCT00146601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65007787|NCT00146601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007788|NCT00498589|Methotrexate|methotrexate|mesh-list
65007789|NCT00498589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65007790|NCT00498589|Abortifacient Agents|abortifacient agents|mesh-ancestor
65007791|NCT00498589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65007837|NCT00498979|Immunologic Factors|immunologic factors|mesh-ancestor
65007838|NCT00498979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007839|NCT00498979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65007840|NCT00498979|Alkylating Agents|alkylating agents|mesh-ancestor
65007841|NCT00498979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007842|NCT00498979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65007843|NCT00498979|Tubulin Modulators|tubulin modulators|mesh-ancestor
65007844|NCT00498979|Antimitotic Agents|antimitotic agents|mesh-ancestor
65007845|NCT00498979|Mitosis Modulators|mitosis modulators|mesh-ancestor
65007846|NCT00498979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65007847|NCT00498979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64462999|NCT01549041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65007848|NCT00498979|Schistosomicides|schistosomicides|mesh-ancestor
65007849|NCT00498979|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65007850|NCT00498979|Anthelmintics|anthelmintics|mesh-ancestor
65007851|NCT01245205|Lapatinib|lapatinib|mesh-list
65007852|NCT01245205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007853|NCT01245205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65007854|NCT01245205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007855|NCT01245205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007856|NCT01245244|Morphine|morphine|mesh-list
65007857|NCT01245244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65007858|NCT01245244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65007859|NCT01245244|Narcotics|narcotics|mesh-ancestor
65007860|NCT01245244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65007861|NCT01245244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007886|NCT00499018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007887|NCT00499018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65007888|NCT00499018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65007889|NCT00499018|Glucocorticoids|glucocorticoids|mesh-ancestor
65007890|NCT00499018|Hormones|hormones|mesh-ancestor
65007891|NCT00499018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65007892|NCT00499018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65007893|NCT00499018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65007894|NCT00499018|Antimetabolites|antimetabolites|mesh-ancestor
65007895|NCT00499018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007896|NCT00499018|Antiviral Agents|antiviral agents|mesh-ancestor
65007897|NCT00499018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65007898|NCT00499018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65007899|NCT00499018|Analgesics|analgesics|mesh-ancestor
65007900|NCT00499018|Sensory System Agents|sensory system agents|mesh-ancestor
65007901|NCT00499018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65007902|NCT00499018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65007903|NCT00499018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65007904|NCT00499018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007914|NCT00127985|Prednisolone|prednisolone|mesh-list
65007939|NCT00424164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65007940|NCT00424164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007941|NCT00424164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65007942|NCT00424164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007943|NCT00424164|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65007944|NCT00424164|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65007945|NCT00424164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65007946|NCT00424164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65007947|NCT00424164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007948|NCT00499135|Alovudine|alovudine|mesh-list
65007949|NCT00499135|Sunitinib|sunitinib|mesh-list
65007950|NCT00499135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007951|NCT00499135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65007952|NCT00499135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65007953|NCT00499135|Growth Substances|growth substances|mesh-ancestor
65007954|NCT00499135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65007955|NCT00499135|Growth Inhibitors|growth inhibitors|mesh-ancestor
65007956|NCT00499135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65007957|NCT00499135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007958|NCT00499135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007959|NCT00499135|Antiviral Agents|antiviral agents|mesh-ancestor
65007960|NCT00499135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65007961|NCT01245361|Infliximab|infliximab|mesh-list
65007962|NCT01245361|Dermatologic Agents|dermatologic agents|mesh-ancestor
65007963|NCT01245361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65007964|NCT01245361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65007965|NCT00424203|Cyclophosphamide|cyclophosphamide|mesh-list
65007966|NCT00424203|Doxorubicin|doxorubicin|mesh-list
65007967|NCT00424203|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65007968|NCT00424203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65007969|NCT00424203|Immunologic Factors|immunologic factors|mesh-ancestor
64951585|NCT00054522|Autonomic Agents|autonomic agents|mesh-ancestor
65007980|NCT00424203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65007981|NCT00499291|Paclitaxel|paclitaxel|mesh-list
65007982|NCT00499291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65007983|NCT00499291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65007984|NCT00499291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007985|NCT00499291|Tubulin Modulators|tubulin modulators|mesh-ancestor
65007986|NCT00499291|Antimitotic Agents|antimitotic agents|mesh-ancestor
65007987|NCT00499291|Mitosis Modulators|mitosis modulators|mesh-ancestor
65007988|NCT00499291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007990|NCT01245556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65007991|NCT01245556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007992|NCT01245556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65007993|NCT01245556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65007994|NCT00499525|Paclitaxel|paclitaxel|mesh-list
65007995|NCT00499525|Sorafenib|sorafenib|mesh-list
65007996|NCT00499525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64463147|NCT01515189|Ipilimumab|ipilimumab|mesh-list
65007997|NCT00499525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65007998|NCT00499525|Tubulin Modulators|tubulin modulators|mesh-ancestor
65007999|NCT00499525|Antimitotic Agents|antimitotic agents|mesh-ancestor
65008000|NCT00499525|Mitosis Modulators|mitosis modulators|mesh-ancestor
65008001|NCT00499525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008002|NCT00499525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65008003|NCT00499525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008004|NCT00499642|Moxifloxacin|moxifloxacin|mesh-list
65008005|NCT00499642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65008006|NCT00499642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65008007|NCT00499642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65008008|NCT00499642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65008009|NCT00499642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008010|NCT00499642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008011|NCT00499642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008012|NCT00499720|Aztreonam|aztreonam|mesh-list
65008020|NCT05562518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65008021|NCT05562518|Immunologic Factors|immunologic factors|mesh-ancestor
65008022|NCT00499837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65008023|NCT00499837|Protein C Inhibitor|protein c inhibitor|mesh-list
65008024|NCT00499837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65008025|NCT00499837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65008026|NCT00499837|Protease Inhibitors|protease inhibitors|mesh-ancestor
65008027|NCT00499837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008028|NCT00499837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008029|NCT00499876|Mefloquine|mefloquine|mesh-list
65008030|NCT00499876|Antimalarials|antimalarials|mesh-ancestor
65008031|NCT00499876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65008032|NCT00499876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65008033|NCT00499876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65008034|NCT00146718|Pyrimethamine|pyrimethamine|mesh-list
65008035|NCT00146718|Sulfadoxine|sulfadoxine|mesh-list
65008036|NCT00146718|Amodiaquine|amodiaquine|mesh-list
65008045|NCT00146718|Renal Agents|renal agents|mesh-ancestor
65008081|NCT01245868|Bupivacaine|bupivacaine|mesh-list
65008082|NCT01245868|Anesthetics, Local|anesthetics, local|mesh-ancestor
65008083|NCT01245868|Anesthetics|anesthetics|mesh-ancestor
65008084|NCT01245868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65008085|NCT01245868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008086|NCT01245868|Sensory System Agents|sensory system agents|mesh-ancestor
65008087|NCT01245868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65008088|NCT01245868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65008089|NCT01245868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65008090|NCT01245868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65008091|NCT01245868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65008092|NCT01245868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008093|NCT00500422|Gemcitabine|gemcitabine|mesh-list
65008094|NCT00500422|Doxorubicin|doxorubicin|mesh-list
65008095|NCT00500422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65008096|NCT00500422|Bortezomib|bortezomib|mesh-list
65008097|NCT00500422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65008098|NCT00500422|Antimetabolites|antimetabolites|mesh-ancestor
65008099|NCT00500422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008100|NCT00500422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008101|NCT00500422|Antiviral Agents|antiviral agents|mesh-ancestor
65008102|NCT00500422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65008103|NCT00500422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008104|NCT00500422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65008105|NCT00500422|Immunologic Factors|immunologic factors|mesh-ancestor
65008106|NCT00500422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008107|NCT00500422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65008108|NCT00500422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65008109|NCT00500422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65008126|NCT00146913|Interferons|interferons|mesh-list
65008127|NCT00146913|Imatinib Mesylate|imatinib mesylate|mesh-list
65008128|NCT00146913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008129|NCT00146913|Antiviral Agents|antiviral agents|mesh-ancestor
65008130|NCT00146913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65008131|NCT00146913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65008132|NCT00146913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008133|NCT00146913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008134|NCT00501124|Clevudine|clevudine|mesh-list
65008135|NCT00501124|Antiviral Agents|antiviral agents|mesh-ancestor
65008136|NCT00501124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65008137|NCT00501241|ATI 7505|ati 7505|mesh-list
65008138|NCT00501241|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65008139|NCT00501241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65008140|NCT00501241|Serotonin Agents|serotonin agents|mesh-ancestor
65008141|NCT00501241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65008142|NCT00501241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008143|NCT00501241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008144|NCT01246180|Diclofenac|diclofenac|mesh-list
65008145|NCT01246180|Amiloride|amiloride|mesh-list
65008146|NCT01246180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65008147|NCT01246180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65008148|NCT01246180|Analgesics|analgesics|mesh-ancestor
64463298|NCT01924234|Analgesics|analgesics|mesh-ancestor
65008149|NCT01246180|Sensory System Agents|sensory system agents|mesh-ancestor
65008150|NCT01246180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65008152|NCT01246180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65008173|NCT02274610|Antimitotic Agents|antimitotic agents|mesh-ancestor
65008174|NCT02274610|Mitosis Modulators|mitosis modulators|mesh-ancestor
65008175|NCT02274610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008176|NCT00501397|Ketoconazole|ketoconazole|mesh-list
65008177|NCT00501397|Antifungal Agents|antifungal agents|mesh-ancestor
65008178|NCT00501397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65008179|NCT00501397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65008180|NCT00501397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65008181|NCT00501397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008182|NCT00501397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008183|NCT00501397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65008184|NCT00501397|Hormone Antagonists|hormone antagonists|mesh-ancestor
65008234|NCT00502099|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65008235|NCT00502099|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65008236|NCT00502099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008237|NCT00502099|Antiviral Agents|antiviral agents|mesh-ancestor
65008238|NCT00502099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65008239|NCT00502099|Antimetabolites|antimetabolites|mesh-ancestor
65008240|NCT00502099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008241|NCT00502099|Immunologic Factors|immunologic factors|mesh-ancestor
65008242|NCT00502099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008243|NCT00502138|Pramlintide|pramlintide|mesh-list
65008244|NCT00502138|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
65008245|NCT00502138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65008246|NCT00502138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008247|NCT00502138|Appetite Depressants|appetite depressants|mesh-ancestor
65008248|NCT00502138|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65008249|NCT00502138|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
65008250|NCT00502138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008251|NCT00502294|Visilizumab|visilizumab|mesh-list
65008252|NCT00502294|Immunologic Factors|immunologic factors|mesh-ancestor
65008253|NCT00502294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008254|NCT00502411|Doxorubicin|doxorubicin|mesh-list
65008288|NCT00502567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008289|NCT00502567|Antimetabolites|antimetabolites|mesh-ancestor
65008290|NCT00502567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65008291|NCT00502567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65008292|NCT00502567|Immunologic Factors|immunologic factors|mesh-ancestor
65008293|NCT00502567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008294|NCT00502567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65008295|NCT00502567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65008296|NCT00502567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008297|NCT00502567|Antidotes|antidotes|mesh-ancestor
65008298|NCT00502567|Protective Agents|protective agents|mesh-ancestor
65008299|NCT00502567|Vitamin B Complex|vitamin b complex|mesh-ancestor
65008300|NCT00502567|Vitamins|vitamins|mesh-ancestor
65008301|NCT00502567|Micronutrients|micronutrients|mesh-ancestor
65008302|NCT00502567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65008303|NCT00502567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65008304|NCT00502567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65008305|NCT00502567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65008306|NCT05561231|Pyrithione zinc|pyrithione zinc|mesh-list
65008307|NCT05561231|Keratolytic Agents|keratolytic agents|mesh-ancestor
65008308|NCT05561231|Dermatologic Agents|dermatologic agents|mesh-ancestor
65008309|NCT00502684|Etodolac|etodolac|mesh-list
65008310|NCT00502684|Propranolol|propranolol|mesh-list
65008311|NCT00502684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65008312|NCT00502684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65008313|NCT00502684|Adrenergic Agents|adrenergic agents|mesh-ancestor
65008314|NCT00502684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65008315|NCT00502684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008316|NCT00502684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008317|NCT00502684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65008318|NCT00502684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65008330|NCT00502762|Topotecan|topotecan|mesh-list
65008331|NCT00502762|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65008332|NCT00502762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65008333|NCT00502762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008334|NCT00502762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008335|NCT00502762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008336|NCT00502879|Etanercept|etanercept|mesh-list
65008337|NCT00502879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65008338|NCT00502879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65008339|NCT00502879|Analgesics|analgesics|mesh-ancestor
65008340|NCT00502879|Sensory System Agents|sensory system agents|mesh-ancestor
65008341|NCT00502879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65008342|NCT00502879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008343|NCT00502879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65008344|NCT00502879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65008345|NCT00502879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65008346|NCT00502879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65008347|NCT00502879|Immunologic Factors|immunologic factors|mesh-ancestor
65008348|NCT00503152|Valsartan|valsartan|mesh-list
65008349|NCT00503152|Benazepril|benazepril|mesh-list
65008350|NCT00503152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65008351|NCT00503152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65008352|NCT00503152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65008353|NCT00503152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008354|NCT00503152|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65008355|NCT00503152|Protease Inhibitors|protease inhibitors|mesh-ancestor
65008356|NCT00503152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008357|NCT00503347|Bavituximab|bavituximab|mesh-list
65008358|NCT00503347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65008359|NCT00503347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008360|NCT00503386|Palonosetron|palonosetron|mesh-list
65008362|NCT00503386|Antiemetics|antiemetics|mesh-ancestor
65008363|NCT00503386|Autonomic Agents|autonomic agents|mesh-ancestor
65008372|NCT00503503|Etanercept|etanercept|mesh-list
65008373|NCT00503503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65008374|NCT00503503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65008375|NCT00503503|Analgesics|analgesics|mesh-ancestor
65008376|NCT00503503|Sensory System Agents|sensory system agents|mesh-ancestor
65008377|NCT00503503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65008378|NCT00503503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008379|NCT00503503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65008380|NCT00503503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65008381|NCT00503503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65008382|NCT00503503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65008383|NCT00503503|Immunologic Factors|immunologic factors|mesh-ancestor
65008384|NCT00503542|Metronidazole|metronidazole|mesh-list
65008385|NCT00503542|Clindamycin|clindamycin|mesh-list
65008386|NCT00503542|Clindamycin palmitate|clindamycin palmitate|mesh-list
65008387|NCT00503542|Clindamycin phosphate|clindamycin phosphate|mesh-list
65008388|NCT00503542|Fluconazole|fluconazole|mesh-list
65008389|NCT00503542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65008390|NCT00503542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65008391|NCT00503542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65008392|NCT00503542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65008393|NCT00503542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65008394|NCT00503542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008396|NCT00503542|Antifungal Agents|antifungal agents|mesh-ancestor
65008422|NCT01246804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65008423|NCT01246804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65008424|NCT01246804|Antiviral Agents|antiviral agents|mesh-ancestor
65008425|NCT01246804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65008426|NCT01246804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65008427|NCT01246804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65008428|NCT01246804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008429|NCT01246804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008430|NCT00147654|Tamsulosin|tamsulosin|mesh-list
65008431|NCT00147654|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65008432|NCT00147654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65008434|NCT00147654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65008486|NCT00503659|Autonomic Agents|autonomic agents|mesh-ancestor
65008487|NCT00503659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65008488|NCT00503659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008489|NCT00503659|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65008490|NCT00503659|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
65008491|NCT00503659|Respiratory System Agents|respiratory system agents|mesh-ancestor
65008492|NCT00503659|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65008493|NCT00503659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65008494|NCT00503659|Cholinergic Agents|cholinergic agents|mesh-ancestor
65008495|NCT00503659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65008496|NCT00503659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008497|NCT04063163|Carboplatin|carboplatin|mesh-list
65008498|NCT04063163|Etoposide|etoposide|mesh-list
65008499|NCT04063163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008500|NCT04063163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65008501|NCT04063163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65008502|NCT04063163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65008506|NCT00503815|Laxatives|laxatives|mesh-ancestor
65008543|NCT03981146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65008544|NCT03981146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008545|NCT03981146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65008546|NCT03981146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008547|NCT01247857|Ropivacaine|ropivacaine|mesh-list
65008548|NCT01247857|Anesthetics, Local|anesthetics, local|mesh-ancestor
65008549|NCT01247857|Anesthetics|anesthetics|mesh-ancestor
65008550|NCT01247857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65008551|NCT01247857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008552|NCT01247857|Sensory System Agents|sensory system agents|mesh-ancestor
65008553|NCT01247857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65008554|NCT04331730|Aflibercept|aflibercept|mesh-list
65008555|NCT04331730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65008556|NCT04331730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65008557|NCT04331730|Growth Substances|growth substances|mesh-ancestor
65008558|NCT04331730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008559|NCT04331730|Growth Inhibitors|growth inhibitors|mesh-ancestor
65008599|NCT01248403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65008600|NCT01248403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008601|NCT01248403|Tubulin Modulators|tubulin modulators|mesh-ancestor
65008602|NCT01248403|Antimitotic Agents|antimitotic agents|mesh-ancestor
65008603|NCT01248403|Mitosis Modulators|mitosis modulators|mesh-ancestor
65008604|NCT01248403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008605|NCT01248403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65008606|NCT01248403|Immunologic Factors|immunologic factors|mesh-ancestor
65008607|NCT01248403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008608|NCT01248442|Cholecalciferol|cholecalciferol|mesh-list
65008609|NCT01248442|Vitamin D|vitamin d|mesh-list
65008610|NCT01248442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65008611|NCT01248442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008659|NCT04088292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65008660|NCT04088292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008661|NCT04085250|Nivolumab|nivolumab|mesh-list
65008662|NCT04085250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65008663|NCT04085250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008664|NCT04085250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65008665|NCT04085250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008666|NCT01249690|Thalidomide|thalidomide|mesh-list
65008667|NCT01249690|Dexamethasone|dexamethasone|mesh-list
64463834|NCT01903837|Naltrexone|naltrexone|mesh-list
65008668|NCT01249690|Dexamethasone acetate|dexamethasone acetate|mesh-list
65008670|NCT01249690|Pirarubicin|pirarubicin|mesh-list
65008671|NCT01249690|Doxorubicin|doxorubicin|mesh-list
65008722|NCT00504244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008723|NCT00405444|Fentanyl|fentanyl|mesh-list
65008724|NCT00405444|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65008725|NCT00405444|Narcotics|narcotics|mesh-ancestor
65008726|NCT00405444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65008727|NCT00405444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008728|NCT00405444|Analgesics|analgesics|mesh-ancestor
65008729|NCT00405444|Sensory System Agents|sensory system agents|mesh-ancestor
65008730|NCT00405444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65008731|NCT00405444|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65008732|NCT00405444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65008733|NCT00405444|Anesthetics, General|anesthetics, general|mesh-ancestor
65008734|NCT00405444|Anesthetics|anesthetics|mesh-ancestor
65008735|NCT00504283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65008737|NCT00504283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65008738|NCT00504283|Narcotics|narcotics|mesh-ancestor
65008739|NCT00504283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64463897|NCT04274608|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65008740|NCT00504283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008779|NCT03622775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008780|NCT01249651|Esomeprazole|esomeprazole|mesh-list
65008781|NCT01249651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65008782|NCT01249651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65008783|NCT01249651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65008784|NCT01249651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008785|NCT01249651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008786|NCT03999723|Ascorbic Acid|ascorbic acid|mesh-list
65008787|NCT03999723|Vitamins|vitamins|mesh-ancestor
65008788|NCT03999723|Micronutrients|micronutrients|mesh-ancestor
65008789|NCT03999723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008790|NCT03999723|Antioxidants|antioxidants|mesh-ancestor
65008791|NCT03999723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008792|NCT03999723|Protective Agents|protective agents|mesh-ancestor
65008793|NCT01249417|Botulinum Toxins|botulinum toxins|mesh-list
65008794|NCT01249417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65008795|NCT01249417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65008838|NCT03546686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008839|NCT04725942|Posaconazole|posaconazole|mesh-list
65008840|NCT04725942|Antifungal Agents|antifungal agents|mesh-ancestor
65008841|NCT04725942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65008842|NCT04725942|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65008843|NCT04725942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65008844|NCT04725942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65008845|NCT04725942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65008846|NCT04725942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65008876|NCT03761511|Niacin|niacin|mesh-list
65008903|NCT02824523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65008904|NCT02824523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008905|NCT02824523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65008906|NCT02824523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65008907|NCT02824523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65008908|NCT02824523|Antipyretics|antipyretics|mesh-ancestor
65008910|NCT02736422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65008911|NCT02736422|Anesthetics, General|anesthetics, general|mesh-ancestor
65008912|NCT02736422|Anesthetics|anesthetics|mesh-ancestor
65008913|NCT02736422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65008914|NCT02736422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008915|NCT03721497|Methyltestosterone|methyltestosterone|mesh-list
65008916|NCT03721497|Testosterone|testosterone|mesh-list
65008917|NCT03721497|Testosterone undecanoate|testosterone undecanoate|mesh-list
65008918|NCT03721497|Testosterone enanthate|testosterone enanthate|mesh-list
65008919|NCT03721497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65008964|NCT03648996|Gout Suppressants|gout suppressants|mesh-ancestor
65008965|NCT03648996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65008966|NCT03648996|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65008967|NCT03648996|Antioxidants|antioxidants|mesh-ancestor
65008968|NCT03648996|Protective Agents|protective agents|mesh-ancestor
65008969|NCT03648996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008971|NCT02086175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65008972|NCT02086175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008973|NCT02086175|Immunologic Factors|immunologic factors|mesh-ancestor
65008974|NCT02086175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008975|NCT02086175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65008976|NCT00139269|Docetaxel|docetaxel|mesh-list
65008977|NCT00139269|Fluorouracil|fluorouracil|mesh-list
65008978|NCT00139269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008979|NCT00139269|Tubulin Modulators|tubulin modulators|mesh-ancestor
65008980|NCT00139269|Antimitotic Agents|antimitotic agents|mesh-ancestor
65008981|NCT00139269|Mitosis Modulators|mitosis modulators|mesh-ancestor
65008982|NCT00139269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008983|NCT00139269|Antimetabolites|antimetabolites|mesh-ancestor
65008984|NCT00139269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65008985|NCT00139269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65008986|NCT00139269|Immunologic Factors|immunologic factors|mesh-ancestor
65008987|NCT00139269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008988|NCT02065154|Cyclophosphamide|cyclophosphamide|mesh-list
65008989|NCT02065154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65008990|NCT02065154|Immunologic Factors|immunologic factors|mesh-ancestor
65008991|NCT02065154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65008992|NCT02065154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65008993|NCT02065154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65008994|NCT02065154|Alkylating Agents|alkylating agents|mesh-ancestor
65008995|NCT02065154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65008996|NCT02065154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65008997|NCT02065154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65009006|NCT00403364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009007|NCT00403364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65009008|NCT00403364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65009009|NCT00403364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65009010|NCT00403364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65009011|NCT00403364|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65009012|NCT00403364|Alkylating Agents|alkylating agents|mesh-ancestor
65009013|NCT00403364|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65009014|NCT00403364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65009015|NCT00403364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65009016|NCT00403442|Bevacizumab|bevacizumab|mesh-list
65009017|NCT00403442|Verteporfin|verteporfin|mesh-list
65009018|NCT00403442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65009068|NCT01731236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65009069|NCT01731236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65009070|NCT01731236|Lipotropic Agents|lipotropic agents|mesh-ancestor
65009071|NCT01731236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65009072|NCT01731236|Antimetabolites|antimetabolites|mesh-ancestor
65009073|NCT01731236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65009074|NCT01731236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65009075|NCT01731236|Nootropic Agents|nootropic agents|mesh-ancestor
65009076|NCT01731236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65009077|NCT03510078|Insulin|insulin|mesh-list
65009131|NCT00130676|Contraceptive Agents|contraceptive agents|mesh-ancestor
65009132|NCT00130676|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65009133|NCT00130676|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65009134|NCT00130676|Hormone Antagonists|hormone antagonists|mesh-ancestor
65009135|NCT00130676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65009136|NCT00130676|Luteolytic Agents|luteolytic agents|mesh-ancestor
65009137|NCT00130676|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65009138|NCT00130676|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65009139|NCT00404274|Casopitant|casopitant|mesh-list
65009140|NCT00404274|Warfarin|warfarin|mesh-list
65009141|NCT00404274|Anticoagulants|anticoagulants|mesh-ancestor
65009142|NCT00404274|Antiemetics|antiemetics|mesh-ancestor
65009143|NCT00404274|Autonomic Agents|autonomic agents|mesh-ancestor
65009144|NCT00404274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65009145|NCT00404274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009146|NCT00404274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65009147|NCT00404274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65009148|NCT00404274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65009150|NCT00130754|Thymoglobulin|thymoglobulin|mesh-list
65009187|NCT00139815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65009188|NCT00139815|Protease Inhibitors|protease inhibitors|mesh-ancestor
65009189|NCT00139815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009190|NCT00131027|Cytarabine|cytarabine|mesh-list
65009191|NCT00131027|Dexamethasone|dexamethasone|mesh-list
65009192|NCT00131027|Prednisolone|prednisolone|mesh-list
65009193|NCT00131027|Cyclophosphamide|cyclophosphamide|mesh-list
65009194|NCT00131027|Doxorubicin|doxorubicin|mesh-list
64464356|NCT01455532|Antiviral Agents|antiviral agents|mesh-ancestor
65009195|NCT00131027|Methotrexate|methotrexate|mesh-list
65009196|NCT00131027|Etoposide|etoposide|mesh-list
65009197|NCT00131027|Vincristine|vincristine|mesh-list
65009198|NCT00131027|Daunorubicin|daunorubicin|mesh-list
65009199|NCT00131027|Asparaginase|asparaginase|mesh-list
65009200|NCT00131027|Mercaptopurine|mercaptopurine|mesh-list
65009201|NCT00131027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65009202|NCT00131027|Immunologic Factors|immunologic factors|mesh-ancestor
65009203|NCT00131027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009204|NCT00131027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65009205|NCT00131027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65009206|NCT00131027|Alkylating Agents|alkylating agents|mesh-ancestor
65009207|NCT00131027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009208|NCT00131027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009209|NCT00131027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65009210|NCT00131027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65009211|NCT00131027|Antiemetics|antiemetics|mesh-ancestor
65009212|NCT00131027|Autonomic Agents|autonomic agents|mesh-ancestor
65009213|NCT00131027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65009216|NCT00131027|Hormones|hormones|mesh-ancestor
65009236|NCT00131027|Mitosis Modulators|mitosis modulators|mesh-ancestor
65009237|NCT00139854|Alprazolam|alprazolam|mesh-list
65009238|NCT00139854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65009239|NCT00139854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65009240|NCT00139854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009241|NCT00139854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65009242|NCT00139854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65009243|NCT00139854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65009244|NCT00139854|GABA Modulators|gaba modulators|mesh-ancestor
65009245|NCT00139854|GABA Agents|gaba agents|mesh-ancestor
65009246|NCT00139854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65009247|NCT00139854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009248|NCT00131144|Octreotide|octreotide|mesh-list
65009249|NCT00131144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65009250|NCT00131144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65009251|NCT00131144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009252|NCT00139893|Metoclopramide|metoclopramide|mesh-list
65009253|NCT00139893|Antiemetics|antiemetics|mesh-ancestor
65009294|NCT00131261|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65009295|NCT00131261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009296|NCT00131261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009297|NCT00131300|Hylan|hylan|mesh-list
65009298|NCT00131300|Viscosupplements|viscosupplements|mesh-ancestor
65009299|NCT00131300|Protective Agents|protective agents|mesh-ancestor
65009300|NCT00131300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009301|NCT00131339|Cycloserine|cycloserine|mesh-list
65009302|NCT00131339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65009303|NCT00131339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65009304|NCT00131339|Renal Agents|renal agents|mesh-ancestor
65009305|NCT00131339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65009306|NCT00131339|Antitubercular Agents|antitubercular agents|mesh-ancestor
65009307|NCT00131339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65009308|NCT00131339|Antimetabolites|antimetabolites|mesh-ancestor
65009309|NCT00131339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009310|NCT00139971|Gemcitabine|gemcitabine|mesh-list
65009311|NCT00139971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65009312|NCT00139971|Antimetabolites|antimetabolites|mesh-ancestor
65009313|NCT00139971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009314|NCT00139971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009315|NCT00139971|Antiviral Agents|antiviral agents|mesh-ancestor
65009316|NCT00139971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65009346|NCT03117309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009347|NCT03117309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65009348|NCT03117309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009349|NCT00140166|Pyridoxine|pyridoxine|mesh-list
65009350|NCT00140166|Niacinamide|niacinamide|mesh-list
65009351|NCT00140166|Niacin|niacin|mesh-list
65009352|NCT00140166|Nicotinic Acids|nicotinic acids|mesh-list
65009353|NCT00140166|Vitamin B Complex|vitamin b complex|mesh-ancestor
65009354|NCT00140166|Vitamins|vitamins|mesh-ancestor
65009355|NCT00140166|Micronutrients|micronutrients|mesh-ancestor
65009356|NCT00140166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009357|NCT00140166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65009358|NCT00140166|Antimetabolites|antimetabolites|mesh-ancestor
65009359|NCT00140166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009360|NCT00140166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65009361|NCT00140166|Vasodilator Agents|vasodilator agents|mesh-ancestor
65009362|NCT03095274|Durvalumab|durvalumab|mesh-list
65009363|NCT03095274|Tremelimumab|tremelimumab|mesh-list
65009364|NCT03095274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65009365|NCT03095274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009366|NCT00131768|Hylan|hylan|mesh-list
65009367|NCT00131768|Viscosupplements|viscosupplements|mesh-ancestor
65009368|NCT00131768|Protective Agents|protective agents|mesh-ancestor
65009369|NCT00131768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009370|NCT01248949|Paclitaxel|paclitaxel|mesh-list
65009371|NCT01248949|Bevacizumab|bevacizumab|mesh-list
65009398|NCT01248793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65009399|NCT01248793|Immunologic Factors|immunologic factors|mesh-ancestor
65009400|NCT01248793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009401|NCT01248715|Oseltamivir|oseltamivir|mesh-list
65009402|NCT01248715|Antiviral Agents|antiviral agents|mesh-ancestor
65009403|NCT01248715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65009404|NCT01248715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009405|NCT01248715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009406|NCT00403715|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65009407|NCT00403715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65009408|NCT01248364|Empagliflozin|empagliflozin|mesh-list
65009409|NCT01248364|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65009410|NCT01248364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009411|NCT01248364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65009412|NCT01248364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009413|NCT00140361|Artesunate|artesunate|mesh-list
65009414|NCT00140361|Lumefantrine|lumefantrine|mesh-list
65009415|NCT00140361|Artemether|artemether|mesh-list
65009416|NCT00140361|Pyrimethamine|pyrimethamine|mesh-list
65009417|NCT00140361|Sulfadoxine|sulfadoxine|mesh-list
65009418|NCT00140361|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65009419|NCT00140361|Antimalarials|antimalarials|mesh-ancestor
65009451|NCT00131963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65009452|NCT00131963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65009453|NCT00131963|Alkylating Agents|alkylating agents|mesh-ancestor
65009454|NCT00131963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65009455|NCT00131963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65009456|NCT00131963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65009457|NCT00131963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65009458|NCT00131963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009517|NCT00132275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65009518|NCT00132275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65009519|NCT00132275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009520|NCT00132275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009521|NCT01246999|Vaccines|vaccines|mesh-list
65009522|NCT01246999|Immunologic Factors|immunologic factors|mesh-ancestor
65009523|NCT01246999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009524|NCT00140595|Cyclophosphamide|cyclophosphamide|mesh-list
65009525|NCT00140595|Rituximab|rituximab|mesh-list
65009526|NCT00140595|Doxorubicin|doxorubicin|mesh-list
65009527|NCT00140595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65009528|NCT00140595|Immunologic Factors|immunologic factors|mesh-ancestor
65009529|NCT00140595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009530|NCT00140595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65009531|NCT00140595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65009532|NCT00140595|Alkylating Agents|alkylating agents|mesh-ancestor
65009533|NCT00140595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009534|NCT00140595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009535|NCT00140595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65009536|NCT00140595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65009537|NCT00140595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65009538|NCT00140595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65009539|NCT00140595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65009540|NCT00140595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009541|NCT04696783|Esomeprazole|esomeprazole|mesh-list
65009542|NCT04696783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65009543|NCT04696783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65009544|NCT04696783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65009562|NCT00132548|Pyrimethamine|pyrimethamine|mesh-list
65009563|NCT00132548|Sulfadoxine|sulfadoxine|mesh-list
65009564|NCT00132548|Amodiaquine|amodiaquine|mesh-list
65009565|NCT00132548|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65009566|NCT00132548|Antimalarials|antimalarials|mesh-ancestor
65009567|NCT00132548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65009568|NCT00132548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65009569|NCT00132548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65009570|NCT00132548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009571|NCT00132548|Antiviral Agents|antiviral agents|mesh-ancestor
65009572|NCT00132548|Schistosomicides|schistosomicides|mesh-ancestor
65009573|NCT00132548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65009574|NCT00132548|Anthelmintics|anthelmintics|mesh-ancestor
65009575|NCT00132548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65009576|NCT00132548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009577|NCT00132548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009578|NCT00132548|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65009580|NCT00140751|Ritonavir|ritonavir|mesh-list
65009581|NCT00140751|Lopinavir|lopinavir|mesh-list
65009582|NCT00140751|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65009583|NCT00140751|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65009584|NCT00140751|Protease Inhibitors|protease inhibitors|mesh-ancestor
65009617|NCT02261415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009618|NCT02261415|Hemostatics|hemostatics|mesh-ancestor
65009619|NCT02261415|Coagulants|coagulants|mesh-ancestor
65009620|NCT00132743|Cilostazol|cilostazol|mesh-list
65009621|NCT00132743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65009622|NCT00132743|Autonomic Agents|autonomic agents|mesh-ancestor
65009623|NCT00132743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65009624|NCT00132743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009625|NCT00132743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65009681|NCT00132899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65009682|NCT00132899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65009683|NCT00140868|Phenobarbital|phenobarbital|mesh-list
65009684|NCT00140868|Anticonvulsants|anticonvulsants|mesh-ancestor
65009685|NCT00140868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65009686|NCT00140868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65009687|NCT00140868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009688|NCT00140868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65009689|NCT00140868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65009690|NCT00140868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65009691|NCT00140868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009692|NCT00140868|GABA Modulators|gaba modulators|mesh-ancestor
65009693|NCT00140868|GABA Agents|gaba agents|mesh-ancestor
65009694|NCT00140868|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65009702|NCT02955706|Vitamins|vitamins|mesh-ancestor
65009742|NCT01154439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65009743|NCT01154439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65009744|NCT01154439|Alkylating Agents|alkylating agents|mesh-ancestor
65009745|NCT00133172|Mycophenolic Acid|mycophenolic acid|mesh-list
65009746|NCT00133172|Prednisone|prednisone|mesh-list
65009747|NCT00133172|Tacrolimus|tacrolimus|mesh-list
65009748|NCT00133172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65009749|NCT00133172|Glucocorticoids|glucocorticoids|mesh-ancestor
65009750|NCT00133172|Hormones|hormones|mesh-ancestor
65009751|NCT00133172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65009752|NCT00133172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009753|NCT00133172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65009754|NCT00133172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009755|NCT00133172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65009756|NCT00133172|Immunologic Factors|immunologic factors|mesh-ancestor
65009757|NCT00133172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65009758|NCT00133172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009759|NCT00133172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009760|NCT00133172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65009761|NCT00133172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65009762|NCT00133172|Antitubercular Agents|antitubercular agents|mesh-ancestor
65009763|NCT00133172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65009764|NCT00133172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65009765|NCT00141141|Atorvastatin|atorvastatin|mesh-list
65009766|NCT00141141|Simvastatin|simvastatin|mesh-list
65009767|NCT00141141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65009768|NCT00141141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65009769|NCT00141141|Antimetabolites|antimetabolites|mesh-ancestor
65009770|NCT00141141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009771|NCT00141141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65009772|NCT00141141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65009773|NCT00141141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009774|NCT00133250|Heparin|heparin|mesh-list
65009775|NCT00133250|Calcium heparin|calcium heparin|mesh-list
65009781|NCT00133250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65009782|NCT00144495|Epoetin Alfa|epoetin alfa|mesh-list
65009783|NCT00144495|Hematinics|hematinics|mesh-ancestor
65009784|NCT00133328|Valsartan|valsartan|mesh-list
65009785|NCT00133328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65009786|NCT00133328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65009787|NCT00133328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65009788|NCT00133328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009789|NCT00133367|Sirolimus|sirolimus|mesh-list
65009790|NCT00133367|Fludarabine|fludarabine|mesh-list
65009791|NCT00133367|Melphalan|melphalan|mesh-list
65009792|NCT00133367|Tacrolimus|tacrolimus|mesh-list
65009793|NCT00133367|Thymoglobulin|thymoglobulin|mesh-list
65009794|NCT00133367|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65009795|NCT00133367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009796|NCT00133367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009797|NCT00133367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65009798|NCT00133367|Immunologic Factors|immunologic factors|mesh-ancestor
65009799|NCT00133367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009800|NCT00133367|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65009801|NCT00133367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009802|NCT00133367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65009803|NCT00133367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65009804|NCT00133367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65009805|NCT00133367|Antifungal Agents|antifungal agents|mesh-ancestor
65009806|NCT00133367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65009807|NCT00133367|Alkylating Agents|alkylating agents|mesh-ancestor
65009808|NCT00133367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65009809|NCT00141258|Pregabalin|pregabalin|mesh-list
65009810|NCT00141258|Analgesics|analgesics|mesh-ancestor
65009826|NCT00403910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65009827|NCT00403910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009828|NCT00403910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65009829|NCT00403910|Diuretics|diuretics|mesh-ancestor
65009830|NCT00403910|Natriuretic Agents|natriuretic agents|mesh-ancestor
65009831|NCT00141336|Pregabalin|pregabalin|mesh-list
65009832|NCT00141336|Analgesics|analgesics|mesh-ancestor
65009833|NCT00141336|Sensory System Agents|sensory system agents|mesh-ancestor
65009834|NCT00141336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65009835|NCT00141336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009836|NCT00141336|Anticonvulsants|anticonvulsants|mesh-ancestor
65009837|NCT00141336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65009838|NCT00141336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65009839|NCT00141336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009840|NCT00141336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65009841|NCT00141336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65009842|NCT00141336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65009843|NCT00141336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65009844|NCT00141336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65009845|NCT00133406|Vitamin A|vitamin a|mesh-list
65009846|NCT00133406|Glycine|glycine|mesh-list
65009847|NCT00133406|Vitamins|vitamins|mesh-ancestor
65009848|NCT00133406|Micronutrients|micronutrients|mesh-ancestor
65009849|NCT00133406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009850|NCT00133406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009851|NCT00133406|Glycine Agents|glycine agents|mesh-ancestor
65009852|NCT00133406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65009853|NCT00133445|Vaccines|vaccines|mesh-list
65009854|NCT00133445|Immunologic Factors|immunologic factors|mesh-ancestor
65009856|NCT00141375|Pregabalin|pregabalin|mesh-list
65009870|NCT00133523|Vaccines|vaccines|mesh-list
65009871|NCT00133523|Immunologic Factors|immunologic factors|mesh-ancestor
65009872|NCT00133523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009874|NCT00133562|Glycine Agents|glycine agents|mesh-ancestor
65009875|NCT00133562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65009876|NCT00133562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009877|NCT00133562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009878|NCT00404391|Acetaminophen|acetaminophen|mesh-list
65009879|NCT00404391|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65009880|NCT00404391|Hydrocodone|hydrocodone|mesh-list
65009881|NCT00404391|Oxycodone|oxycodone|mesh-list
65009882|NCT00404391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65009883|NCT00404391|Analgesics|analgesics|mesh-ancestor
65009884|NCT00404391|Sensory System Agents|sensory system agents|mesh-ancestor
65009885|NCT00404391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65009886|NCT00404391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009887|NCT00404391|Antipyretics|antipyretics|mesh-ancestor
65009888|NCT00404391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65009889|NCT00404391|Narcotics|narcotics|mesh-ancestor
65009890|NCT00404391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65009891|NCT00404391|Antitussive Agents|antitussive agents|mesh-ancestor
65009892|NCT00404391|Respiratory System Agents|respiratory system agents|mesh-ancestor
65009893|NCT00404391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65009894|NCT00404391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65009895|NCT00404391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65009920|NCT01244191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65009921|NCT01244191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009922|NCT01244191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65009923|NCT01244191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009924|NCT01244191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009925|NCT00404508|Hydralazine|hydralazine|mesh-list
65009926|NCT00404508|Valproic Acid|valproic acid|mesh-list
65009927|NCT00404508|Anticonvulsants|anticonvulsants|mesh-ancestor
65009928|NCT00404508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65009929|NCT00404508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009930|NCT00404508|GABA Agents|gaba agents|mesh-ancestor
65009931|NCT00404508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65009932|NCT00404508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009933|NCT00404508|Antimanic Agents|antimanic agents|mesh-ancestor
65009934|NCT00404508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65009935|NCT00404508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65009936|NCT00404508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65009937|NCT00404508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65009938|NCT00404508|Vasodilator Agents|vasodilator agents|mesh-ancestor
65009939|NCT00133757|Bupropion|bupropion|mesh-list
65009940|NCT00133757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65009941|NCT00133757|Antidepressive Agents|antidepressive agents|mesh-ancestor
65009942|NCT00133757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65009943|NCT00133757|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64465116|NCT04411069|Dopamine Agents|dopamine agents|mesh-ancestor
65009968|NCT00133796|Trastuzumab|trastuzumab|mesh-list
65009969|NCT00133796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65009970|NCT00133796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65009971|NCT00133874|Retapamulin|retapamulin|mesh-list
65009972|NCT00133874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65009973|NCT00133874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65009974|NCT00141414|Pregabalin|pregabalin|mesh-list
65009975|NCT00141414|Analgesics|analgesics|mesh-ancestor
65009976|NCT00141414|Sensory System Agents|sensory system agents|mesh-ancestor
65009977|NCT00141414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65009978|NCT00141414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009979|NCT00141414|Anticonvulsants|anticonvulsants|mesh-ancestor
65009980|NCT00141414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65009981|NCT00141414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65009982|NCT00141414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65009983|NCT00141414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65009984|NCT00141414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65009985|NCT00141414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65009986|NCT00141414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65009987|NCT00141414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65009988|NCT00145002|Lenograstim|lenograstim|mesh-list
65009989|NCT00145002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65009990|NCT00145002|Immunologic Factors|immunologic factors|mesh-ancestor
65009991|NCT00145002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65009992|NCT00134030|Interferons|interferons|mesh-list
65009993|NCT00134030|Interferon-alpha|interferon-alpha|mesh-list
65009994|NCT00134030|Interferon alpha-2|interferon alpha-2|mesh-list
65009995|NCT00134030|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65009996|NCT00134030|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65009997|NCT00134030|Cisplatin|cisplatin|mesh-list
65010015|NCT00134030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010016|NCT00134030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65010017|NCT00134030|Antimetabolites|antimetabolites|mesh-ancestor
65010018|NCT00134030|Dermatologic Agents|dermatologic agents|mesh-ancestor
64465187|NCT04121416|Anesthetics|anesthetics|mesh-ancestor
65010019|NCT00134030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65010020|NCT00134030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65010021|NCT00134030|Immunologic Factors|immunologic factors|mesh-ancestor
65010022|NCT00134030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65010023|NCT00134030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65010024|NCT00134030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65010025|NCT00134030|Antiviral Agents|antiviral agents|mesh-ancestor
65010026|NCT00134030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65010027|NCT00134030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65010028|NCT00134030|Alkylating Agents|alkylating agents|mesh-ancestor
65010029|NCT00134030|Keratolytic Agents|keratolytic agents|mesh-ancestor
65010030|NCT00134030|Tubulin Modulators|tubulin modulators|mesh-ancestor
65010074|NCT00403988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010075|NCT00403988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65010076|NCT00403988|Tubulin Modulators|tubulin modulators|mesh-ancestor
65010077|NCT00403988|Antimitotic Agents|antimitotic agents|mesh-ancestor
65010078|NCT00403988|Mitosis Modulators|mitosis modulators|mesh-ancestor
65010079|NCT00403988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010080|NCT00134186|Motexafin gadolinium|motexafin gadolinium|mesh-list
65010081|NCT00134186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010082|NCT00134186|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65010083|NCT00134186|Dermatologic Agents|dermatologic agents|mesh-ancestor
65010084|NCT00141648|Prednisolone|prednisolone|mesh-list
65010085|NCT00141648|Cyclophosphamide|cyclophosphamide|mesh-list
65010086|NCT00141648|Doxorubicin|doxorubicin|mesh-list
65010087|NCT00141648|Vincristine|vincristine|mesh-list
65010088|NCT00141648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65010089|NCT00141648|Immunologic Factors|immunologic factors|mesh-ancestor
65010090|NCT00141648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010091|NCT00141648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65010092|NCT00141648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65010093|NCT00141648|Alkylating Agents|alkylating agents|mesh-ancestor
65010094|NCT00141648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010095|NCT00141648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010126|NCT00141804|Sirolimus|sirolimus|mesh-list
65010127|NCT00141804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65010128|NCT00141804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65010129|NCT00141804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65010130|NCT00141804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010131|NCT00141804|Antifungal Agents|antifungal agents|mesh-ancestor
65010132|NCT00141804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65010133|NCT00141804|Immunologic Factors|immunologic factors|mesh-ancestor
65010134|NCT00141804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010135|NCT00134498|Atorvastatin|atorvastatin|mesh-list
65010136|NCT00134498|Torcetrapib|torcetrapib|mesh-list
65010137|NCT00134498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65010138|NCT00134498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65010139|NCT00134498|Antimetabolites|antimetabolites|mesh-ancestor
65010140|NCT00134498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010141|NCT00134498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65010142|NCT00134498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65010143|NCT00134498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010184|NCT00134693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65010185|NCT00134693|Glucocorticoids|glucocorticoids|mesh-ancestor
65010186|NCT00134693|Hormones|hormones|mesh-ancestor
65010187|NCT00134693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65010188|NCT00134693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010189|NCT00134693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65010190|NCT00134693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010191|NCT00134693|Antiemetics|antiemetics|mesh-ancestor
65010192|NCT00134693|Autonomic Agents|autonomic agents|mesh-ancestor
65010193|NCT00134693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65010194|NCT00134693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65010195|NCT00134693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65010196|NCT00134693|Protective Agents|protective agents|mesh-ancestor
65010197|NCT00152412|Levocetirizine|levocetirizine|mesh-list
64465428|NCT01894477|Treosulfan|treosulfan|mesh-list
65010246|NCT00134888|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65010247|NCT00134888|Naloxone|naloxone|mesh-list
65010248|NCT00134888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65010249|NCT00134888|Narcotics|narcotics|mesh-ancestor
65010250|NCT00134888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65010251|NCT00134888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010252|NCT00134888|Analgesics|analgesics|mesh-ancestor
65010253|NCT00134888|Sensory System Agents|sensory system agents|mesh-ancestor
65010254|NCT00134888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65010255|NCT00134888|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65010256|NCT00134966|Levodopa|levodopa|mesh-list
65010257|NCT00134966|Carbidopa|carbidopa|mesh-list
65010258|NCT00134966|Entacapone|entacapone|mesh-list
65010259|NCT00134966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65010260|NCT00134966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65010261|NCT00134966|Dopamine Agents|dopamine agents|mesh-ancestor
65010262|NCT00134966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65010263|NCT00134966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010301|NCT00135122|Prednisolone phosphate|prednisolone phosphate|mesh-list
65010302|NCT00135122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65010303|NCT00135122|Glucocorticoids|glucocorticoids|mesh-ancestor
65010304|NCT00135122|Hormones|hormones|mesh-ancestor
65010305|NCT00135122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65010306|NCT00135122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010307|NCT00135122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65010308|NCT00135122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010309|NCT00135122|Antiemetics|antiemetics|mesh-ancestor
65010311|NCT00135122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65010312|NCT00135122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65010313|NCT00135122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65010314|NCT00135122|Protective Agents|protective agents|mesh-ancestor
65010315|NCT00142350|Fluorouracil|fluorouracil|mesh-list
65010316|NCT00142350|Irinotecan|irinotecan|mesh-list
65010318|NCT00142350|Antimetabolites|antimetabolites|mesh-ancestor
65010360|NCT00142428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65010361|NCT00142428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010362|NCT00135551|Benidipine|benidipine|mesh-list
65010363|NCT00135551|Diuretics|diuretics|mesh-list
65010364|NCT00135551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65010365|NCT00135551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
65010366|NCT00135551|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65010367|NCT00135551|Natriuretic Agents|natriuretic agents|mesh-ancestor
65010368|NCT00135551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010369|NCT00135551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010370|NCT00135551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65010371|NCT00135551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65010372|NCT00135551|Adrenergic Agents|adrenergic agents|mesh-ancestor
65010373|NCT00135551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65010374|NCT00135551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65010375|NCT00135551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65010376|NCT00135551|Vasodilator Agents|vasodilator agents|mesh-ancestor
65010377|NCT00152724|Aspirin|aspirin|mesh-list
65010378|NCT00152724|Celecoxib|celecoxib|mesh-list
65010379|NCT00152724|Indomethacin|indomethacin|mesh-list
65010380|NCT00152724|Nitroprusside|nitroprusside|mesh-list
65010381|NCT00152724|Acetylcholine|acetylcholine|mesh-list
65010382|NCT00152724|Capsaicin|capsaicin|mesh-list
65010383|NCT00152724|Clopidogrel|clopidogrel|mesh-list
65010386|NCT00152724|Analgesics|analgesics|mesh-ancestor
65010412|NCT00152724|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65010413|NCT00152724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65010414|NCT00152724|Cholinergic Agents|cholinergic agents|mesh-ancestor
65010415|NCT00135668|Nitroprusside|nitroprusside|mesh-list
65010416|NCT00135668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65010417|NCT00135668|Vasodilator Agents|vasodilator agents|mesh-ancestor
65010418|NCT00135668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65010419|NCT00135668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010420|NCT00152802|Vaccines|vaccines|mesh-list
65010421|NCT00152802|Immunologic Factors|immunologic factors|mesh-ancestor
65010422|NCT00152802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010423|NCT00135746|Nicotine|nicotine|mesh-list
65010424|NCT00135746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65010425|NCT00135746|Autonomic Agents|autonomic agents|mesh-ancestor
65010426|NCT00135746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65010427|NCT00135746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010428|NCT00135746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65010429|NCT00135746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65010430|NCT00135746|Cholinergic Agents|cholinergic agents|mesh-ancestor
65010468|NCT00152841|Micronutrients|micronutrients|mesh-ancestor
65010469|NCT00152841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010470|NCT00152841|Antioxidants|antioxidants|mesh-ancestor
65010471|NCT00152841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010472|NCT00152841|Protective Agents|protective agents|mesh-ancestor
65010473|NCT00159120|Antipsychotic Agents|antipsychotic agents|mesh-list
65010474|NCT00159120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65010475|NCT00159120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65010476|NCT00159120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010477|NCT00159120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65010478|NCT00159159|Cyclosporine|cyclosporine|mesh-list
65010479|NCT00159159|Cyclosporins|cyclosporins|mesh-list
65010480|NCT00159159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010481|NCT00159159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010482|NCT00159159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65010483|NCT00159159|Immunologic Factors|immunologic factors|mesh-ancestor
65010484|NCT00159159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010485|NCT00159159|Antifungal Agents|antifungal agents|mesh-ancestor
65010486|NCT00159159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65010487|NCT00159159|Dermatologic Agents|dermatologic agents|mesh-ancestor
65010488|NCT00159159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65010522|NCT00152919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65010523|NCT00152919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010524|NCT00152919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65010525|NCT00152919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65010526|NCT00152919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65010527|NCT00152919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65010528|NCT00152919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010529|NCT00152919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010530|NCT00406146|Artesunate|artesunate|mesh-list
65010531|NCT00406146|Lumefantrine|lumefantrine|mesh-list
65010532|NCT00406146|Artemether|artemether|mesh-list
65010533|NCT00406146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65010534|NCT00406146|Amodiaquine|amodiaquine|mesh-list
65010535|NCT00406146|Antimalarials|antimalarials|mesh-ancestor
65010536|NCT00406146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65010537|NCT00406146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65010538|NCT00406146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65010539|NCT00406146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010540|NCT00406146|Antiviral Agents|antiviral agents|mesh-ancestor
65010541|NCT00406146|Schistosomicides|schistosomicides|mesh-ancestor
65010542|NCT00406146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65010543|NCT00406146|Anthelmintics|anthelmintics|mesh-ancestor
65010544|NCT00136058|Alendronate|alendronate|mesh-list
65010545|NCT00136058|Risedronic Acid|risedronic acid|mesh-list
65010546|NCT00136058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65010553|NCT00152958|Antioxidants|antioxidants|mesh-ancestor
65010573|NCT00136175|Antiviral Agents|antiviral agents|mesh-ancestor
65010574|NCT00136175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65010575|NCT00136175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010576|NCT00136175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65010577|NCT00136175|Immunologic Factors|immunologic factors|mesh-ancestor
65010578|NCT00136175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010579|NCT00152997|Pramipexole|pramipexole|mesh-list
65010580|NCT00152997|Antioxidants|antioxidants|mesh-ancestor
65010581|NCT00152997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010582|NCT00152997|Protective Agents|protective agents|mesh-ancestor
65010583|NCT00152997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010584|NCT00152997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65010585|NCT00152997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65010586|NCT00152997|Dopamine Agonists|dopamine agonists|mesh-ancestor
65010587|NCT00152997|Dopamine Agents|dopamine agents|mesh-ancestor
65010588|NCT00152997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65010589|NCT00136292|Daptomycin|daptomycin|mesh-list
65010590|NCT00136292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65010591|NCT00136292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65010592|NCT00153075|Fenoterol|fenoterol|mesh-list
65010593|NCT00153075|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
65010594|NCT00153075|Ipratropium|ipratropium|mesh-list
65010595|NCT00153075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65010596|NCT00153075|Autonomic Agents|autonomic agents|mesh-ancestor
65010597|NCT00153075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65010598|NCT00153075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010599|NCT00153075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65010600|NCT00153075|Respiratory System Agents|respiratory system agents|mesh-ancestor
65010601|NCT00153075|Sympathomimetics|sympathomimetics|mesh-ancestor
65010602|NCT00153075|Tocolytic Agents|tocolytic agents|mesh-ancestor
65010603|NCT00153075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65010604|NCT00153075|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65010617|NCT00159471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010618|NCT00159471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010619|NCT00159471|Antiviral Agents|antiviral agents|mesh-ancestor
65010620|NCT00159471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65010621|NCT00159471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010622|NCT00159471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65010623|NCT00159471|Immunologic Factors|immunologic factors|mesh-ancestor
65010624|NCT00159471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010625|NCT00159471|Tubulin Modulators|tubulin modulators|mesh-ancestor
65010626|NCT00159471|Antimitotic Agents|antimitotic agents|mesh-ancestor
65010627|NCT00159471|Mitosis Modulators|mitosis modulators|mesh-ancestor
65010628|NCT00136370|Chlorhexidine|chlorhexidine|mesh-list
65010629|NCT00136370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65010630|NCT00136370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65010631|NCT00136370|Disinfectants|disinfectants|mesh-ancestor
65010632|NCT00159510|Nitric Oxide|nitric oxide|mesh-list
65010633|NCT00159510|Methylene Blue|methylene blue|mesh-list
65010634|NCT00159510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65010635|NCT00159510|Autonomic Agents|autonomic agents|mesh-ancestor
65010636|NCT00159510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65010637|NCT00159510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010638|NCT00159510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65010639|NCT00159510|Respiratory System Agents|respiratory system agents|mesh-ancestor
65010640|NCT00159510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65010641|NCT00159510|Antioxidants|antioxidants|mesh-ancestor
65010642|NCT00159510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010643|NCT00159510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65010644|NCT00159510|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65010645|NCT00159510|Vasodilator Agents|vasodilator agents|mesh-ancestor
65010663|NCT00136448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010664|NCT00136448|Antiviral Agents|antiviral agents|mesh-ancestor
65010665|NCT00136448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65010666|NCT00136448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65010667|NCT00136448|Immunologic Factors|immunologic factors|mesh-ancestor
65010668|NCT00136448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010669|NCT00136448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65010670|NCT00136448|Analgesics|analgesics|mesh-ancestor
65010671|NCT00136448|Sensory System Agents|sensory system agents|mesh-ancestor
65010672|NCT00136448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65010673|NCT00136448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65010674|NCT00136448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65010675|NCT00136448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65010676|NCT00136448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010677|NCT00153153|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65010678|NCT00153153|Laxatives|laxatives|mesh-ancestor
65010679|NCT00153153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65010680|NCT00136487|Celecoxib|celecoxib|mesh-list
65010719|NCT00136526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010720|NCT00136526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65010721|NCT00136565|Prednisone|prednisone|mesh-list
65010722|NCT00136565|Cyclophosphamide|cyclophosphamide|mesh-list
65010723|NCT00136565|Doxorubicin|doxorubicin|mesh-list
65010724|NCT00136565|Bortezomib|bortezomib|mesh-list
65010725|NCT00136565|Bleomycin|bleomycin|mesh-list
65010726|NCT00136565|Vindesine|vindesine|mesh-list
65010727|NCT00136565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65010728|NCT00136565|Immunologic Factors|immunologic factors|mesh-ancestor
65010729|NCT00136565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010730|NCT00136565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65010731|NCT00136565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65010732|NCT00136565|Alkylating Agents|alkylating agents|mesh-ancestor
65010733|NCT00136565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010734|NCT00136565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010735|NCT00136565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65010736|NCT00136565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65010737|NCT00136565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65010738|NCT00136565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65010739|NCT00136565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010740|NCT00136565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65010742|NCT00136565|Hormones|hormones|mesh-ancestor
65010772|NCT00153270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65010773|NCT00153270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010774|NCT00153270|Antimanic Agents|antimanic agents|mesh-ancestor
65010775|NCT00153270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65010776|NCT00153270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65010777|NCT00153270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65010778|NCT00159705|Pregabalin|pregabalin|mesh-list
65010779|NCT00159705|Analgesics|analgesics|mesh-ancestor
65010780|NCT00159705|Sensory System Agents|sensory system agents|mesh-ancestor
65010781|NCT00159705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65010782|NCT00159705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010783|NCT00159705|Anticonvulsants|anticonvulsants|mesh-ancestor
65010784|NCT00159705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65010785|NCT00159705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65010786|NCT00159705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010787|NCT00159705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65010788|NCT00159705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65010789|NCT00159705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65010790|NCT00159705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65010791|NCT00159705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65010792|NCT00136994|Ziprasidone|ziprasidone|mesh-list
65010793|NCT00136994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65010794|NCT00136994|Serotonin Agents|serotonin agents|mesh-ancestor
65010795|NCT00136994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65010796|NCT00136994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010797|NCT00136994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010798|NCT00136994|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65010817|NCT00137033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010818|NCT00137033|Gout Suppressants|gout suppressants|mesh-ancestor
65010819|NCT00137072|Sildenafil Citrate|sildenafil citrate|mesh-list
65010820|NCT00137072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010821|NCT00137072|Vasodilator Agents|vasodilator agents|mesh-ancestor
65010822|NCT00137072|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65010823|NCT00137072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65010824|NCT00137072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010825|NCT00137072|Urological Agents|urological agents|mesh-ancestor
65010826|NCT04724538|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
65010827|NCT04724538|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65010828|NCT04724538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010829|NCT00159900|Sildenafil Citrate|sildenafil citrate|mesh-list
65010830|NCT00159900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010831|NCT00159900|Vasodilator Agents|vasodilator agents|mesh-ancestor
65010832|NCT00159900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65010833|NCT00159900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65010834|NCT00159900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010835|NCT00159900|Urological Agents|urological agents|mesh-ancestor
65010836|NCT00159978|Alovudine|alovudine|mesh-list
65010837|NCT00159978|Antiviral Agents|antiviral agents|mesh-ancestor
65010838|NCT00159978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65010839|NCT00137345|Sirolimus|sirolimus|mesh-list
65010840|NCT00137345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65010841|NCT00137345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65010842|NCT00137345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65010843|NCT00137345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010863|NCT00137501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65010864|NCT00137501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010865|NCT00137501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65010866|NCT00137501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010867|NCT00137501|Vasodilator Agents|vasodilator agents|mesh-ancestor
65010868|NCT00137501|Tocolytic Agents|tocolytic agents|mesh-ancestor
65010869|NCT00137501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65010870|NCT00137540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
65010871|NCT00153660|Celecoxib|celecoxib|mesh-list
65010872|NCT00153660|Naproxen|naproxen|mesh-list
65010873|NCT00153660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65010874|NCT00153660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65010875|NCT00153660|Analgesics|analgesics|mesh-ancestor
65010876|NCT00153660|Sensory System Agents|sensory system agents|mesh-ancestor
65010877|NCT00153660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65010878|NCT00153660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010879|NCT00153660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65010880|NCT00153660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65010881|NCT00153660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65010882|NCT00153660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65010883|NCT00153660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010916|NCT00137735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65010917|NCT00137735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65010918|NCT00137735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65010919|NCT00137735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65010920|NCT00137735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65010921|NCT00137735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010922|NCT00137735|Antimanic Agents|antimanic agents|mesh-ancestor
65010923|NCT00137774|Bevacizumab|bevacizumab|mesh-list
65010924|NCT00137774|Temozolomide|temozolomide|mesh-list
65010925|NCT00137774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65010926|NCT00137774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010927|NCT00137774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65010928|NCT00137774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65010929|NCT00137774|Growth Substances|growth substances|mesh-ancestor
65010930|NCT00137774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010931|NCT00137774|Growth Inhibitors|growth inhibitors|mesh-ancestor
65010932|NCT00137774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65010933|NCT00137774|Alkylating Agents|alkylating agents|mesh-ancestor
65010934|NCT00137774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010935|NCT00160329|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65010968|NCT00137852|Sensory System Agents|sensory system agents|mesh-ancestor
65010969|NCT00137852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65010970|NCT00137852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010971|NCT00137852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65010972|NCT00137852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65010973|NCT00137852|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65010974|NCT00137852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65010975|NCT00160407|Orlistat|orlistat|mesh-list
65010976|NCT00160407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65010977|NCT00160407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65010978|NCT00160407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65010979|NCT00160407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65010980|NCT00153933|Lenalidomide|lenalidomide|mesh-list
65010981|NCT00153933|Bortezomib|bortezomib|mesh-list
65010982|NCT00153933|Immunologic Factors|immunologic factors|mesh-ancestor
65010983|NCT00153933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65010984|NCT00153933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65010985|NCT00153933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65010986|NCT00153933|Growth Substances|growth substances|mesh-ancestor
65010987|NCT00153933|Growth Inhibitors|growth inhibitors|mesh-ancestor
65010988|NCT00153933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65010989|NCT00138164|Denileukin diftitox|denileukin diftitox|mesh-list
65010991|NCT00153972|Levodopa|levodopa|mesh-list
65011021|NCT00154011|Rosiglitazone|rosiglitazone|mesh-list
65011022|NCT00154011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65011023|NCT00154011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011024|NCT00404222|Acetaminophen|acetaminophen|mesh-list
65011025|NCT00404222|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65011026|NCT00404222|Hydrocodone|hydrocodone|mesh-list
65011027|NCT00404222|Oxycodone|oxycodone|mesh-list
65011028|NCT00404222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65011029|NCT00404222|Analgesics|analgesics|mesh-ancestor
65011030|NCT00404222|Sensory System Agents|sensory system agents|mesh-ancestor
65011031|NCT00404222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65011032|NCT00404222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011033|NCT00404222|Antipyretics|antipyretics|mesh-ancestor
65011034|NCT00404222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65011035|NCT00404222|Narcotics|narcotics|mesh-ancestor
65011036|NCT00404222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65011037|NCT00404222|Antitussive Agents|antitussive agents|mesh-ancestor
65011038|NCT00404222|Respiratory System Agents|respiratory system agents|mesh-ancestor
65011039|NCT00404222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65011040|NCT00404222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65011041|NCT00404222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65011047|NCT00138242|Carboplatin|carboplatin|mesh-list
65011075|NCT00154089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65011076|NCT00154089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65011077|NCT00154089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65011078|NCT00138359|Niclosamide|niclosamide|mesh-list
65011079|NCT00138359|Anticestodal Agents|anticestodal agents|mesh-ancestor
65011080|NCT00138359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65011081|NCT00138359|Anthelmintics|anthelmintics|mesh-ancestor
65011082|NCT00138359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65011083|NCT00138359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65011084|NCT00138359|Antinematodal Agents|antinematodal agents|mesh-ancestor
65011085|NCT00154128|Salicylic Acid|salicylic acid|mesh-list
65011086|NCT00154128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65011087|NCT00154128|Antifungal Agents|antifungal agents|mesh-ancestor
65011088|NCT00154128|Keratolytic Agents|keratolytic agents|mesh-ancestor
65011089|NCT00154128|Dermatologic Agents|dermatologic agents|mesh-ancestor
65011090|NCT00154167|Phentolamine|phentolamine|mesh-list
65011091|NCT00154167|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65011092|NCT00154167|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65011093|NCT00154167|Adrenergic Agents|adrenergic agents|mesh-ancestor
65011094|NCT00154167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65011095|NCT00154167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011096|NCT00154167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011097|NCT00154167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65011098|NCT00138515|Vildagliptin|vildagliptin|mesh-list
65011099|NCT00138515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65011100|NCT00138515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011101|NCT00138515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65011102|NCT00138515|Protease Inhibitors|protease inhibitors|mesh-ancestor
65011103|NCT00138515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011104|NCT00138515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011119|NCT00138554|Protease Inhibitors|protease inhibitors|mesh-ancestor
65011120|NCT00138554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011121|NCT00138554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011122|NCT00138593|Vildagliptin|vildagliptin|mesh-list
65011123|NCT00138593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65011124|NCT00138593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011125|NCT00138593|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65011126|NCT00138593|Protease Inhibitors|protease inhibitors|mesh-ancestor
65011127|NCT00138593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011128|NCT00138593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011129|NCT00154245|Mycophenolic Acid|mycophenolic acid|mesh-list
65011130|NCT00154245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65011131|NCT00154245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011132|NCT00154245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65011133|NCT00154245|Antitubercular Agents|antitubercular agents|mesh-ancestor
65011134|NCT00154245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65011135|NCT00154245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65011136|NCT00154245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011138|NCT00138632|Vatalanib|vatalanib|mesh-list
65011171|NCT00138866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011172|NCT00138866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65011173|NCT00154362|Oxcarbazepine|oxcarbazepine|mesh-list
65011174|NCT00154362|Anticonvulsants|anticonvulsants|mesh-ancestor
65011175|NCT00154362|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65011176|NCT00154362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65011177|NCT00154362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65011178|NCT00154362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011179|NCT00154362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65011180|NCT00154362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65011181|NCT00161031|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65011182|NCT00161031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65011183|NCT00161031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65011184|NCT00161031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65011185|NCT00161031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011186|NCT00161031|Adrenergic Agents|adrenergic agents|mesh-ancestor
65011187|NCT00161031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65011188|NCT00161031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011189|NCT00154401|Liraglutide|liraglutide|mesh-list
65011190|NCT00154401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65011191|NCT00154401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011192|NCT00154401|Incretins|incretins|mesh-ancestor
65011193|NCT00154401|Hormones|hormones|mesh-ancestor
65011194|NCT00154401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65011195|NCT00138944|Eplerenone|eplerenone|mesh-list
65011196|NCT00138944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65011197|NCT00138944|Hormone Antagonists|hormone antagonists|mesh-ancestor
65011198|NCT00138944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65011199|NCT00138944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011200|NCT00138944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65011201|NCT00138944|Diuretics|diuretics|mesh-ancestor
65011202|NCT00138944|Natriuretic Agents|natriuretic agents|mesh-ancestor
64969882|NCT00196846|Goserelin|goserelin|mesh-list
64951586|NCT00054522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64951587|NCT00054522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951588|NCT00054522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65011203|NCT00138944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65011204|NCT00161070|Aspirin|aspirin|mesh-list
65011205|NCT00161070|Dipyridamole|dipyridamole|mesh-list
65011206|NCT00161070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65011276|NCT04705584|Cyclosporins|cyclosporins|mesh-list
65011288|NCT04705584|Glucocorticoids|glucocorticoids|mesh-ancestor
65011350|NCT00161421|Androgens|androgens|mesh-ancestor
65011351|NCT00161421|Hormones|hormones|mesh-ancestor
65011352|NCT00161421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65011353|NCT00161421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011354|NCT00161421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65011355|NCT00161421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011356|NCT00161421|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65011357|NCT00161421|Fertility Agents|fertility agents|mesh-ancestor
65011358|NCT00161421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65011359|NCT00161421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65011360|NCT00161421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65011361|NCT00161421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011362|NCT00161421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011363|NCT00161421|Hormone Antagonists|hormone antagonists|mesh-ancestor
65011365|NCT00139568|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65011366|NCT00139568|Serotonin Agents|serotonin agents|mesh-ancestor
65011367|NCT00139568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65011368|NCT00139568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011369|NCT00139568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011370|NCT00139646|Diclofenac|diclofenac|mesh-list
65011371|NCT00139646|Parecoxib|parecoxib|mesh-list
65011372|NCT00139646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65011373|NCT00139646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65011374|NCT00139646|Analgesics|analgesics|mesh-ancestor
65011375|NCT00139646|Sensory System Agents|sensory system agents|mesh-ancestor
65011376|NCT00139646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65011377|NCT00139646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011378|NCT00139646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65011379|NCT00139646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65011380|NCT00139646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65011381|NCT00139646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011382|NCT00139646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011383|NCT00139646|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65011384|NCT00406302|Docetaxel|docetaxel|mesh-list
65011385|NCT00406302|Oxaliplatin|oxaliplatin|mesh-list
65011388|NCT00406302|Tubulin Modulators|tubulin modulators|mesh-ancestor
65011389|NCT00406302|Antimitotic Agents|antimitotic agents|mesh-ancestor
65011390|NCT00406302|Mitosis Modulators|mitosis modulators|mesh-ancestor
65011391|NCT00406302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011392|NCT00406302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65011393|NCT00139685|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65011394|NCT00139685|Contraceptive Agents|contraceptive agents|mesh-list
65011395|NCT00139685|Medroxyprogesterone|medroxyprogesterone|mesh-list
65011396|NCT00139685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65011397|NCT00139685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011398|NCT00139685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65011399|NCT00139685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65011400|NCT00139685|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65011401|NCT00139685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65011402|NCT00139685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011403|NCT00139685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65011404|NCT00139685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65011405|NCT00139685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65011406|NCT00406341|Difluprednate|difluprednate|mesh-list
65011407|NCT00406341|Glucocorticoids|glucocorticoids|mesh-ancestor
65011408|NCT00406341|Hormones|hormones|mesh-ancestor
65011409|NCT00406341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65011410|NCT00406341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011411|NCT00139724|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65011412|NCT00139724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65011413|NCT00139724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65011414|NCT00139724|Cholinergic Agents|cholinergic agents|mesh-ancestor
65011432|NCT00404261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65011433|NCT00404261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65011434|NCT00404261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65011435|NCT00404261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65011436|NCT00404261|Autonomic Agents|autonomic agents|mesh-ancestor
65011437|NCT00404261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65011438|NCT00404261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011439|NCT00404261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65011440|NCT00404261|Respiratory System Agents|respiratory system agents|mesh-ancestor
65011441|NCT00404261|Dermatologic Agents|dermatologic agents|mesh-ancestor
65011442|NCT00404261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65011443|NCT00404261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65011444|NCT00404261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65011445|NCT00404261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65011446|NCT00404261|Adrenergic Agents|adrenergic agents|mesh-ancestor
65011447|NCT00404261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65011448|NCT00404261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011450|NCT00404261|Hormones|hormones|mesh-ancestor
65011451|NCT00404261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65011452|NCT00404261|Sympathomimetics|sympathomimetics|mesh-ancestor
65011453|NCT00406380|Bevacizumab|bevacizumab|mesh-list
65011454|NCT00406380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65011455|NCT00406380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011456|NCT00406380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65011457|NCT00406380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65011480|NCT00161655|Immunologic Factors|immunologic factors|mesh-ancestor
65011481|NCT00161655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65011482|NCT00161655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65011483|NCT00161655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65011484|NCT00161655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65011485|NCT00161655|Analgesics|analgesics|mesh-ancestor
65011486|NCT00161655|Sensory System Agents|sensory system agents|mesh-ancestor
65011487|NCT00161655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65011488|NCT00161655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65011489|NCT00161655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65011490|NCT00161733|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65011491|NCT00161733|Hemostatics|hemostatics|mesh-ancestor
65011492|NCT00161733|Coagulants|coagulants|mesh-ancestor
65011493|NCT00139841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65011494|NCT00139841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65011495|NCT00139841|Alkylating Agents|alkylating agents|mesh-ancestor
65011496|NCT00139841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011497|NCT00139841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011536|NCT04724343|Contraceptive Agents|contraceptive agents|mesh-ancestor
65011537|NCT04724343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65011538|NCT04724343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011539|NCT04724343|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65011540|NCT04724343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65011541|NCT04724343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011542|NCT04724343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65011543|NCT04724343|Fertility Agents|fertility agents|mesh-ancestor
65011544|NCT04724343|Hormone Antagonists|hormone antagonists|mesh-ancestor
65011545|NCT04724343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65011546|NCT00140075|Cyclophosphamide|cyclophosphamide|mesh-list
65011547|NCT00140075|Epirubicin|epirubicin|mesh-list
65011548|NCT00140075|Taxane|taxane|mesh-list
65011549|NCT00140075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65011550|NCT00140075|Immunologic Factors|immunologic factors|mesh-ancestor
65011551|NCT00140075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011552|NCT00140075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65011553|NCT00140075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65011554|NCT00140075|Alkylating Agents|alkylating agents|mesh-ancestor
65011555|NCT00140075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011556|NCT00140075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011557|NCT00140075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65011558|NCT00140075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65011559|NCT00140075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65011560|NCT00140075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65011561|NCT00140075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011562|NCT00140114|Misoprostol|misoprostol|mesh-list
65011563|NCT00140114|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65011564|NCT00140114|Abortifacient Agents|abortifacient agents|mesh-ancestor
65011565|NCT00140114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65011566|NCT00140114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011567|NCT00140114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65011577|NCT00140309|Isoniazid|isoniazid|mesh-list
65011578|NCT00140309|Pyrazinamide|pyrazinamide|mesh-list
65011579|NCT00140309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65011580|NCT00140309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65011581|NCT00140309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65011582|NCT00140309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65011583|NCT00140309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011584|NCT00140309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011585|NCT00140309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011586|NCT00140309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65011587|NCT00140309|Antitubercular Agents|antitubercular agents|mesh-ancestor
65011588|NCT00140309|Leprostatic Agents|leprostatic agents|mesh-ancestor
65011589|NCT00140309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65011590|NCT00140309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65011591|NCT00140309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65011592|NCT00140309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65011593|NCT00140309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65011594|NCT00140309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65011595|NCT00140309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65011596|NCT00140309|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65011597|NCT00140309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65011600|NCT00161811|Vaccines|vaccines|mesh-list
65011628|NCT00504673|Insulin Aspart|insulin aspart|mesh-list
65011629|NCT00504673|Insulin Detemir|insulin detemir|mesh-list
65011630|NCT00504673|Isophane Insulin, Human|isophane insulin, human|mesh-list
65011631|NCT00504673|Insulin, Isophane|insulin, isophane|mesh-list
65011632|NCT00504673|Isophane insulin, beef|isophane insulin, beef|mesh-list
65011633|NCT00504673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65011634|NCT00504673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011635|NCT01247701|Cyclophosphamide|cyclophosphamide|mesh-list
65011636|NCT01247701|Busulfan|busulfan|mesh-list
65011637|NCT01247701|Fludarabine|fludarabine|mesh-list
65011638|NCT01247701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65011639|NCT01247701|Immunologic Factors|immunologic factors|mesh-ancestor
65011640|NCT01247701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011641|NCT01247701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65011642|NCT01247701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65011643|NCT01247701|Alkylating Agents|alkylating agents|mesh-ancestor
65011644|NCT01247701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011645|NCT01247701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011646|NCT01247701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65011647|NCT00140543|Mycophenolic Acid|mycophenolic acid|mesh-list
65011648|NCT00140543|Sirolimus|sirolimus|mesh-list
65011649|NCT00140543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65011650|NCT00140543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011682|NCT00154869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011683|NCT00154869|Antiviral Agents|antiviral agents|mesh-ancestor
65011684|NCT00154869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65011685|NCT00140660|Rituximab|rituximab|mesh-list
65011686|NCT00140660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65011687|NCT00140660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011688|NCT00140660|Immunologic Factors|immunologic factors|mesh-ancestor
65011689|NCT00140660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011690|NCT00140660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65011691|NCT00162006|Immunoglobulins|immunoglobulins|mesh-list
65011692|NCT00162006|Antibodies|antibodies|mesh-list
65011693|NCT00162006|gamma-Globulins|gamma-globulins|mesh-list
65011694|NCT00162006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65011695|NCT00162006|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65011696|NCT00162006|Immunologic Factors|immunologic factors|mesh-ancestor
65011697|NCT00162006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011698|NCT00162045|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
65011699|NCT00162045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65011700|NCT00162045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011701|NCT02964572|Empagliflozin|empagliflozin|mesh-list
65011702|NCT02964572|Glimepiride|glimepiride|mesh-list
65011703|NCT02964572|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65011704|NCT02964572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011705|NCT02964572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65011706|NCT02964572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011707|NCT02964572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65011708|NCT02964572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65011709|NCT02964572|Immunologic Factors|immunologic factors|mesh-ancestor
65011710|NCT00162201|Abatacept|abatacept|mesh-list
65011711|NCT00162201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65011712|NCT00162201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011713|NCT00162201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011714|NCT00162201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65011722|NCT01248247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011723|NCT01248247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011724|NCT00140894|Rofecoxib|rofecoxib|mesh-list
65011725|NCT00140894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011726|NCT00140894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011727|NCT00140894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65011728|NCT00140894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65011729|NCT00140894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65011730|NCT00140894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011731|NCT00140894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65011732|NCT00140894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65011734|NCT00140894|Sensory System Agents|sensory system agents|mesh-ancestor
65011735|NCT00140894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65011736|NCT00140894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65011737|NCT00155064|Losartan|losartan|mesh-list
65011738|NCT00155064|Captopril|captopril|mesh-list
65011739|NCT00155064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65011740|NCT00155064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65011741|NCT00155064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65011742|NCT00155064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65011743|NCT00155064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011744|NCT00155064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65011771|NCT04515628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011772|NCT04515628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65011773|NCT04515628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65011774|NCT04515628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011775|NCT04515628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65011776|NCT00407043|Loteprednol Etabonate|loteprednol etabonate|mesh-list
65011777|NCT00407043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65011778|NCT04510051|Cyclophosphamide|cyclophosphamide|mesh-list
65011779|NCT04510051|Fludarabine|fludarabine|mesh-list
65011780|NCT04510051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65011781|NCT04510051|Immunologic Factors|immunologic factors|mesh-ancestor
65011782|NCT04510051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011783|NCT04510051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65011785|NCT04510051|Alkylating Agents|alkylating agents|mesh-ancestor
65011831|NCT04511416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011832|NCT00407082|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
65011833|NCT00407082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65011834|NCT00407082|Glucocorticoids|glucocorticoids|mesh-ancestor
65011835|NCT00407082|Hormones|hormones|mesh-ancestor
65011836|NCT00407082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65011837|NCT00407082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011838|NCT00141089|Tegaserod|tegaserod|mesh-list
65011839|NCT00141089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65011840|NCT00141089|Serotonin Agents|serotonin agents|mesh-ancestor
65011841|NCT00141089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65011842|NCT00141089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011843|NCT00141089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011844|NCT00407121|Bevacizumab|bevacizumab|mesh-list
65011845|NCT00407121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65011846|NCT00407121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011847|NCT00407121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65011848|NCT00407121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65011849|NCT00407121|Growth Substances|growth substances|mesh-ancestor
65011850|NCT00407121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011851|NCT00407121|Growth Inhibitors|growth inhibitors|mesh-ancestor
65011852|NCT00141167|Varenicline|varenicline|mesh-list
65011853|NCT00141167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65011854|NCT00141167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65011855|NCT00141167|Cholinergic Agents|cholinergic agents|mesh-ancestor
65011856|NCT00141167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65011857|NCT00141167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011858|NCT00141167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011859|NCT00141206|Varenicline|varenicline|mesh-list
65011860|NCT00141206|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65011861|NCT00141206|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65011862|NCT00141206|Cholinergic Agents|cholinergic agents|mesh-ancestor
65011863|NCT00141206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970518|NCT00061256|Alendronate|alendronate|mesh-list
64951589|NCT00054522|Glucocorticoids|glucocorticoids|mesh-ancestor
64951590|NCT00054522|Hormones|hormones|mesh-ancestor
64951591|NCT00054522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64951592|NCT00054522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64951593|NCT00054522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011864|NCT00141206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011865|NCT00141206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011866|NCT00141245|Pregabalin|pregabalin|mesh-list
65011867|NCT00141245|Analgesics|analgesics|mesh-ancestor
65011868|NCT00141245|Sensory System Agents|sensory system agents|mesh-ancestor
65011869|NCT00141245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65011870|NCT00141245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011871|NCT00141245|Anticonvulsants|anticonvulsants|mesh-ancestor
65011872|NCT00141245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65011873|NCT00141245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65011874|NCT00141245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011875|NCT00141245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65011876|NCT00141245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65011877|NCT00141245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65011878|NCT00141245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65011879|NCT00141245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65011881|NCT00141362|Analgesics|analgesics|mesh-ancestor
65011882|NCT00141362|Sensory System Agents|sensory system agents|mesh-ancestor
65011918|NCT00141401|Anticonvulsants|anticonvulsants|mesh-ancestor
65011919|NCT00141401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65011920|NCT00141401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65011921|NCT00141401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011922|NCT00141401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65011923|NCT00141401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65011924|NCT00141401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65011925|NCT00141401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65011926|NCT00141401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65011927|NCT00505102|Everolimus|everolimus|mesh-list
65011928|NCT00505102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65011929|NCT00505102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65011930|NCT00505102|Immunologic Factors|immunologic factors|mesh-ancestor
65011931|NCT00505102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011932|NCT00404378|Ketoconazole|ketoconazole|mesh-list
65011933|NCT00404378|Casopitant|casopitant|mesh-list
65011934|NCT00404378|Antifungal Agents|antifungal agents|mesh-ancestor
65011935|NCT00404378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65011936|NCT00404378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65011937|NCT00404378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65011938|NCT00404378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65011939|NCT00404378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011969|NCT00404417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65011970|NCT00404417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011971|NCT00404417|Cholinergic Agents|cholinergic agents|mesh-ancestor
65011972|NCT00404417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65011973|NCT00404417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011974|NCT00404417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65011975|NCT00404417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65011976|NCT04519762|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65011977|NCT04519762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65011978|NCT00162357|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
65011979|NCT00162357|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65011980|NCT00162357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011981|NCT00404456|Melatonin|melatonin|mesh-list
65011982|NCT00404456|Antioxidants|antioxidants|mesh-ancestor
65011983|NCT00404456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65011984|NCT00404456|Protective Agents|protective agents|mesh-ancestor
65011985|NCT00404456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65011986|NCT00404456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65011987|NCT00404534|Amoxicillin|amoxicillin|mesh-list
65011988|NCT00404534|Clarithromycin|clarithromycin|mesh-list
65011989|NCT00404534|Omeprazole|omeprazole|mesh-list
65011990|NCT00404534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65011991|NCT00404534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65011992|NCT00404534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65012017|NCT00162396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65012018|NCT00162396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012019|NCT00162435|Warfarin|warfarin|mesh-list
65012020|NCT00162435|Anticoagulants|anticoagulants|mesh-ancestor
65012021|NCT04518982|Lenalidomide|lenalidomide|mesh-list
65012022|NCT04518982|Immunologic Factors|immunologic factors|mesh-ancestor
65012023|NCT04518982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012025|NCT04518982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65012026|NCT04518982|Growth Substances|growth substances|mesh-ancestor
65012027|NCT04518982|Growth Inhibitors|growth inhibitors|mesh-ancestor
65012028|NCT04518982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65012029|NCT00155376|Morphine|morphine|mesh-list
65012030|NCT00155376|Glucagon|glucagon|mesh-list
65012031|NCT00155376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65012032|NCT00155376|Narcotics|narcotics|mesh-ancestor
65012033|NCT00155376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65012034|NCT00155376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012035|NCT00155376|Analgesics|analgesics|mesh-ancestor
65012036|NCT00155376|Sensory System Agents|sensory system agents|mesh-ancestor
65012038|NCT00155376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65012075|NCT00505336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65012076|NCT00505336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012077|NCT00505336|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65012078|NCT00505336|Hormone Antagonists|hormone antagonists|mesh-ancestor
65012079|NCT00505336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65012080|NCT00505336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012081|NCT00505336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65012082|NCT00505336|Diuretics|diuretics|mesh-ancestor
65012083|NCT00505336|Natriuretic Agents|natriuretic agents|mesh-ancestor
65012084|NCT00505336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65012085|NCT04518202|Lidocaine|lidocaine|mesh-list
65012086|NCT04518202|Anesthetics, Local|anesthetics, local|mesh-ancestor
65012087|NCT04518202|Anesthetics|anesthetics|mesh-ancestor
65012088|NCT04518202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65012089|NCT04518202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012090|NCT04518202|Sensory System Agents|sensory system agents|mesh-ancestor
65012091|NCT04518202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65012092|NCT04518202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65012093|NCT04518202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65012094|NCT04518202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65012095|NCT04518202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65012096|NCT04518202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012097|NCT04517890|Lidocaine|lidocaine|mesh-list
65012098|NCT04517890|Anesthetics, Local|anesthetics, local|mesh-ancestor
65012099|NCT04517890|Anesthetics|anesthetics|mesh-ancestor
65012100|NCT04517890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65012101|NCT04517890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012102|NCT04517890|Sensory System Agents|sensory system agents|mesh-ancestor
65012103|NCT04517890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64951594|NCT00054522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64951595|NCT00054522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64951596|NCT00054522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64951597|NCT00054522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951598|NCT00054522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64951599|NCT00054522|Vitamins|vitamins|mesh-ancestor
64951600|NCT00054522|Micronutrients|micronutrients|mesh-ancestor
64951601|NCT00054522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64951602|NCT00054561|Vitamin E|vitamin e|mesh-list
64951603|NCT00054561|Interferons|interferons|mesh-list
64951604|NCT00054561|Interferon-alpha|interferon-alpha|mesh-list
64951605|NCT00054561|Isotretinoin|isotretinoin|mesh-list
64951606|NCT00054561|Vitamins|vitamins|mesh-ancestor
64951607|NCT00054561|Micronutrients|micronutrients|mesh-ancestor
65012104|NCT04517890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65012105|NCT04517890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65012106|NCT04517890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65012107|NCT04517890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65012108|NCT04517890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012110|NCT00141596|Furosemide|furosemide|mesh-list
65012111|NCT00141596|Diuretics|diuretics|mesh-ancestor
65012112|NCT00141596|Natriuretic Agents|natriuretic agents|mesh-ancestor
65012113|NCT00141596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012114|NCT00141596|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65012115|NCT00141596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65012116|NCT00141596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012117|NCT00141596|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65012118|NCT00141596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65012119|NCT00141596|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65012120|NCT00141596|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65012121|NCT02275663|Cytarabine|cytarabine|mesh-list
65012122|NCT02275663|Fludarabine|fludarabine|mesh-list
65012123|NCT02275663|Azacitidine|azacitidine|mesh-list
65012124|NCT02275663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65012125|NCT02275663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65012126|NCT02275663|Antimetabolites|antimetabolites|mesh-ancestor
65012127|NCT02275663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012128|NCT02275663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65012129|NCT02275663|Immunologic Factors|immunologic factors|mesh-ancestor
65012131|NCT02275663|Antiviral Agents|antiviral agents|mesh-ancestor
65012150|NCT04518163|Hemostatics|hemostatics|mesh-ancestor
65012151|NCT04518163|Coagulants|coagulants|mesh-ancestor
65012152|NCT04517227|Durvalumab|durvalumab|mesh-list
65012153|NCT04517227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65012154|NCT04517227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65012155|NCT00141713|Etanercept|etanercept|mesh-list
65012156|NCT00141713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65012157|NCT00141713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65012158|NCT00141713|Analgesics|analgesics|mesh-ancestor
65012159|NCT00141713|Sensory System Agents|sensory system agents|mesh-ancestor
65012160|NCT00141713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65012161|NCT00141713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012162|NCT00141713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65012163|NCT00141713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65012164|NCT00141713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65012165|NCT00141713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65012166|NCT00141713|Immunologic Factors|immunologic factors|mesh-ancestor
65012167|NCT04517188|Iodine|iodine|mesh-list
65012168|NCT04517188|Povidone-Iodine|povidone-iodine|mesh-list
65012169|NCT04517188|Povidone|povidone|mesh-list
65012170|NCT04517188|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65012171|NCT04517188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65012206|NCT00141791|Immunologic Factors|immunologic factors|mesh-ancestor
65012207|NCT04516603|4-Aminopyridine|4-aminopyridine|mesh-list
65012208|NCT04516603|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65012209|NCT04516603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65012210|NCT04516603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012211|NCT00162591|Remifentanil|remifentanil|mesh-list
65012212|NCT00162591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65012213|NCT00162591|Narcotics|narcotics|mesh-ancestor
65012214|NCT00162591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65012215|NCT00162591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012216|NCT00162591|Analgesics|analgesics|mesh-ancestor
65012217|NCT00162591|Sensory System Agents|sensory system agents|mesh-ancestor
65012218|NCT00162591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65012219|NCT00505492|Paclitaxel|paclitaxel|mesh-list
65012220|NCT00505492|Cisplatin|cisplatin|mesh-list
65012221|NCT00505492|Carboplatin|carboplatin|mesh-list
65012222|NCT00505492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65012223|NCT00505492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65012224|NCT00505492|Tubulin Modulators|tubulin modulators|mesh-ancestor
65012225|NCT00505492|Antimitotic Agents|antimitotic agents|mesh-ancestor
65012226|NCT00505492|Mitosis Modulators|mitosis modulators|mesh-ancestor
65012227|NCT00505492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012228|NCT00141830|Methotrexate|methotrexate|mesh-list
65012229|NCT00141830|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65012255|NCT04516174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65012256|NCT04516174|Adrenergic Agents|adrenergic agents|mesh-ancestor
65012257|NCT04516174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65012258|NCT04516174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012259|NCT04516174|Anesthetics, Local|anesthetics, local|mesh-ancestor
65012260|NCT04516174|Anesthetics|anesthetics|mesh-ancestor
65012261|NCT04515979|Pembrolizumab|pembrolizumab|mesh-list
65012262|NCT04515979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65012263|NCT04515979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65012264|NCT00505531|Diphenhydramine|diphenhydramine|mesh-list
65012265|NCT00505531|Tramadol|tramadol|mesh-list
65012266|NCT00505531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65012267|NCT00505531|Narcotics|narcotics|mesh-ancestor
65012268|NCT00505531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65012269|NCT00505531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012270|NCT00505531|Analgesics|analgesics|mesh-ancestor
65012271|NCT00505531|Sensory System Agents|sensory system agents|mesh-ancestor
65012276|NCT00505531|Anesthetics|anesthetics|mesh-ancestor
65012314|NCT04514770|Oxytocics|oxytocics|mesh-ancestor
65012315|NCT00141986|Vitamin D|vitamin d|mesh-list
65012316|NCT00141986|Ergocalciferols|ergocalciferols|mesh-list
65012317|NCT00141986|Cholecalciferol|cholecalciferol|mesh-list
65012318|NCT00141986|Vitamins|vitamins|mesh-list
65012319|NCT00141986|Micronutrients|micronutrients|mesh-ancestor
65012320|NCT00141986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012321|NCT00141986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65012322|NCT00141986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65012323|NCT04514731|Magnesium Sulfate|magnesium sulfate|mesh-list
65012324|NCT04514731|Analgesics|analgesics|mesh-ancestor
65012325|NCT04514731|Sensory System Agents|sensory system agents|mesh-ancestor
65012326|NCT04514731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65012327|NCT04514731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012328|NCT04514731|Anesthetics|anesthetics|mesh-ancestor
65012329|NCT04514731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65012330|NCT04514731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65012331|NCT04514731|Anticonvulsants|anticonvulsants|mesh-ancestor
65012332|NCT04514731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65012333|NCT04514731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65012334|NCT04514731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012335|NCT04514731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65012336|NCT04514731|Tocolytic Agents|tocolytic agents|mesh-ancestor
65012337|NCT04514731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65012338|NCT04514419|Docetaxel|docetaxel|mesh-list
65012339|NCT04514419|Trastuzumab|trastuzumab|mesh-list
65012340|NCT04514419|Pertuzumab|pertuzumab|mesh-list
65012347|NCT00142025|Oxcarbazepine|oxcarbazepine|mesh-list
65012361|NCT02275897|Dopamine Agents|dopamine agents|mesh-ancestor
65012362|NCT02275897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65012363|NCT02275897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012364|NCT02275897|Adrenergic Agents|adrenergic agents|mesh-ancestor
65012365|NCT02275897|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65012366|NCT02275897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65012367|NCT02275897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65012368|NCT02275897|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65012369|NCT00162786|Hydroxyzine|hydroxyzine|mesh-list
65012370|NCT00162786|Antipruritics|antipruritics|mesh-ancestor
65012371|NCT00162786|Dermatologic Agents|dermatologic agents|mesh-ancestor
65012372|NCT00162786|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65012373|NCT00162786|Histamine Antagonists|histamine antagonists|mesh-ancestor
65012374|NCT00162786|Histamine Agents|histamine agents|mesh-ancestor
65012375|NCT00162786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65012376|NCT00162786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012377|NCT00162786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012378|NCT00142181|Alemtuzumab|alemtuzumab|mesh-list
65012379|NCT00142181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65012380|NCT00142181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65012381|NCT00505804|Dexmedetomidine|dexmedetomidine|mesh-list
65012382|NCT00505804|Haloperidol|haloperidol|mesh-list
65012383|NCT00505804|Haloperidol decanoate|haloperidol decanoate|mesh-list
65012384|NCT00505804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65012385|NCT00505804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65012386|NCT00505804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012410|NCT00505843|Dopamine Agents|dopamine agents|mesh-ancestor
65012411|NCT00505843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65012412|NCT00505843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012413|NCT00505843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012414|NCT00505843|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65012415|NCT00505843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012416|NCT00505882|Pramlintide|pramlintide|mesh-list
65012417|NCT00505882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65012418|NCT00505882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012419|NCT00142337|Zidovudine|zidovudine|mesh-list
65012420|NCT00142337|Didanosine|didanosine|mesh-list
65012421|NCT00142337|Antimetabolites|antimetabolites|mesh-ancestor
65012422|NCT00142337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012423|NCT00142337|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65012440|NCT04512313|Rocuronium|rocuronium|mesh-list
64469122|NCT05819632|Analgesics|analgesics|mesh-ancestor
64469338|NCT05815784|Autonomic Agents|autonomic agents|mesh-ancestor
64469489|NCT05814731|Antimetabolites|antimetabolites|mesh-ancestor
64469653|NCT05797662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64469874|NCT05664386|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64469951|NCT05608005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470174|NCT05497778|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65012466|NCT00142493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64470345|NCT05389722|Antimetabolites|antimetabolites|mesh-ancestor
65012467|NCT00142493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65012468|NCT00142493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65012469|NCT00142493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65012470|NCT00142493|GABA Modulators|gaba modulators|mesh-ancestor
65012471|NCT00142493|GABA Agents|gaba agents|mesh-ancestor
65012472|NCT00142493|Anticonvulsants|anticonvulsants|mesh-ancestor
65012473|NCT04511923|Heparin|heparin|mesh-list
65012474|NCT04511923|Anticoagulants|anticoagulants|mesh-ancestor
65012475|NCT04511923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65012476|NCT04511923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65012477|NCT04511923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012478|NCT04511611|Rivaroxaban|rivaroxaban|mesh-list
65012479|NCT04511611|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65012480|NCT04511611|Antithrombins|antithrombins|mesh-ancestor
65012481|NCT04511611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65012482|NCT04511611|Protease Inhibitors|protease inhibitors|mesh-ancestor
65012483|NCT04511611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470851|NCT04960618|Gemcitabine|gemcitabine|mesh-list
65012510|NCT00142610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012511|NCT00142610|Protective Agents|protective agents|mesh-ancestor
65012512|NCT04510870|Ferric Compounds|ferric compounds|mesh-list
65012513|NCT04510870|Hematinics|hematinics|mesh-ancestor
65012514|NCT00406575|Methocarbamol|methocarbamol|mesh-list
64471063|NCT04798339|Darbepoetin alfa|darbepoetin alfa|mesh-list
65012515|NCT00406575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65012516|NCT00406575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65012517|NCT00406575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65012518|NCT00406575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65012519|NCT02275975|Fluconazole|fluconazole|mesh-list
65012520|NCT02275975|Antifungal Agents|antifungal agents|mesh-ancestor
65012521|NCT02275975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65012522|NCT02275975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65012523|NCT02275975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65012524|NCT02275975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65012525|NCT02275975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65012526|NCT02275975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65012527|NCT02275975|Hormone Antagonists|hormone antagonists|mesh-ancestor
64958831|NCT00078000|Sunitinib|sunitinib|mesh-list
64958983|NCT00402454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64959052|NCT00126256|Leucovorin|leucovorin|mesh-list
64959502|NCT00078390|S 3304|s 3304|mesh-list
64498445|NCT01307956|Antidotes|antidotes|mesh-ancestor
64959795|NCT04263298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64960479|NCT00131404|Hormones|hormones|mesh-ancestor
64961299|NCT00134992|Prednisolone|prednisolone|mesh-list
64961448|NCT00145639|Ifosfamide|ifosfamide|mesh-list
64961748|NCT00147355|Codeine|codeine|mesh-list
64961918|NCT00147979|Heparin|heparin|mesh-list
64962047|NCT00043134|Decitabine|decitabine|mesh-list
64962339|NCT00150007|Antitubercular Agents|antitubercular agents|mesh-ancestor
64962415|NCT00150358|Sildenafil Citrate|sildenafil citrate|mesh-list
64962641|NCT00151450|Pregabalin|pregabalin|mesh-list
64962708|NCT00049829|Zoledronic Acid|zoledronic acid|mesh-list
64963382|NCT00154219|Analgesics|analgesics|mesh-ancestor
64963455|NCT00154414|Incretins|incretins|mesh-ancestor
64963532|NCT00154687|Antimetabolites|antimetabolites|mesh-ancestor
64963603|NCT00154882|Paclitaxel|paclitaxel|mesh-list
64964580|NCT00162214|Antifungal Agents|antifungal agents|mesh-ancestor
64965275|NCT00165490|Irinotecan|irinotecan|mesh-list
64965328|NCT00054002|Trioxsalen|trioxsalen|mesh-list
64965551|NCT00167557|Interferons|interferons|mesh-list
64972345|NCT00096915|Hematinics|hematinics|mesh-ancestor
64972539|NCT00097188|Rituximab|rituximab|mesh-list
64511689|NCT05161637|Bupivacaine|bupivacaine|mesh-list
64973021|NCT00233935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973160|NCT00234910|Ritonavir|ritonavir|mesh-list
64973452|NCT00236821|Levofloxacin|levofloxacin|mesh-list
64973514|NCT00237211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973589|NCT00237484|Dermatologic Agents|dermatologic agents|mesh-ancestor
64973590|NCT00237484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64973591|NCT00237484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64973593|NCT00237523|Cadexomer iodine|cadexomer iodine|mesh-list
64973727|NCT00238225|Calcitriol|calcitriol|mesh-list
64974071|NCT00239980|Dalteparin|dalteparin|mesh-list
64513436|NCT01948505|Acetaminophen|acetaminophen|mesh-list
64974730|NCT00077220|Paclitaxel|paclitaxel|mesh-list
64974952|NCT00102843|Vitamins|vitamins|mesh-ancestor
64975025|NCT00246103|Antimanic Agents|antimanic agents|mesh-ancestor
64975115|NCT00424801|Vitamins|vitamins|mesh-ancestor
64975250|NCT00099684|Ezetimibe|ezetimibe|mesh-list
64975612|NCT00099996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64991593|NCT04302870|Analgesics|analgesics|mesh-ancestor
64991749|NCT04190433|Carvedilol|carvedilol|mesh-list
64992503|NCT03654716|Cytarabine|cytarabine|mesh-list
64992734|NCT03440372|Immunologic Factors|immunologic factors|mesh-ancestor
64992810|NCT03258554|Cetuximab|cetuximab|mesh-list
64992880|NCT03178149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64993333|NCT02496208|Nivolumab|nivolumab|mesh-list
64514698|NCT01751087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64514699|NCT01751087|Luteolytic Agents|luteolytic agents|mesh-ancestor
64514700|NCT01751087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64514701|NCT01751087|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64514702|NCT02143401|Sorafenib|sorafenib|mesh-list
64514703|NCT02143401|Navitoclax|navitoclax|mesh-list
64514704|NCT02143401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514705|NCT02143401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64514706|NCT02143401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514707|NCT02143401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514708|NCT02401503|Venetoclax|venetoclax|mesh-list
64514709|NCT02401503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64514710|NCT02401503|Obinutuzumab|obinutuzumab|mesh-list
64514711|NCT02401503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514712|NCT02401503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64514714|NCT02401503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467847|NCT00060346|Alkylating Agents|alkylating agents|mesh-ancestor
64467875|NCT03026907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64467876|NCT00060424|Cyclosporine|cyclosporine|mesh-list
64467877|NCT00060424|Mycophenolic Acid|mycophenolic acid|mesh-list
64467878|NCT00060424|Fludarabine|fludarabine|mesh-list
64467879|NCT00060424|Fludarabine phosphate|fludarabine phosphate|mesh-list
64467880|NCT00060424|Cyclosporins|cyclosporins|mesh-list
64467881|NCT00060424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467882|NCT00060424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64467883|NCT00060424|Antimetabolites|antimetabolites|mesh-ancestor
64467884|NCT00060424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467885|NCT00060424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64467886|NCT00060424|Immunologic Factors|immunologic factors|mesh-ancestor
64467887|NCT00060424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467888|NCT00060424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467889|NCT00060424|Antifungal Agents|antifungal agents|mesh-ancestor
64467890|NCT00060424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64467891|NCT00060424|Dermatologic Agents|dermatologic agents|mesh-ancestor
64467892|NCT00060424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64467893|NCT00060424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64467894|NCT00060424|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64467895|NCT00060424|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64467896|NCT00060424|Antitubercular Agents|antitubercular agents|mesh-ancestor
64467897|NCT00060424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64467899|NCT00062764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64467900|NCT00062764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467927|NCT00153166|Antimetabolites|antimetabolites|mesh-ancestor
64467928|NCT00153166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467929|NCT00153166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64467930|NCT00153166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64467931|NCT00153166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467932|NCT00153166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64467933|NCT00153166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467934|NCT00156910|Botulinum Toxins|botulinum toxins|mesh-list
64467935|NCT00156910|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64467936|NCT00156910|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64467937|NCT00156910|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64467938|NCT00156910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64467939|NCT00156910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467940|NCT00156910|Cholinergic Agents|cholinergic agents|mesh-ancestor
64467941|NCT00156910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64467986|NCT00068770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467987|NCT00068770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467988|NCT01475331|Ethanol|ethanol|mesh-list
64467989|NCT01475331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64467990|NCT01475331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64467991|NCT01475331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64467992|NCT01475331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467993|NCT01500213|Dexamethasone|dexamethasone|mesh-list
64467994|NCT01500213|Granisetron|granisetron|mesh-list
64467995|NCT01500213|Rolapitant|rolapitant|mesh-list
64467996|NCT01500213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64467997|NCT01500213|Antiemetics|antiemetics|mesh-ancestor
64453760|NCT04069936|Nivolumab|nivolumab|mesh-list
64467998|NCT01500213|Autonomic Agents|autonomic agents|mesh-ancestor
64467999|NCT01500213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64468000|NCT01500213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468001|NCT01500213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64468002|NCT01500213|Glucocorticoids|glucocorticoids|mesh-ancestor
64468003|NCT01500213|Hormones|hormones|mesh-ancestor
64468004|NCT01500213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64468005|NCT01500213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64468006|NCT01500213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468007|NCT01500213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64468008|NCT01500213|Serotonin Agents|serotonin agents|mesh-ancestor
64468009|NCT01500213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64468036|NCT01475253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468037|NCT01475253|Sensory System Agents|sensory system agents|mesh-ancestor
64468038|NCT01475253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64468039|NCT01475253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64468040|NCT01475253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64468041|NCT01475253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64468042|NCT01475253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64468043|NCT01475253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468044|NCT00072514|Gemcitabine|gemcitabine|mesh-list
64468045|NCT00072514|Dexamethasone|dexamethasone|mesh-list
64468046|NCT00072514|Rituximab|rituximab|mesh-list
64468047|NCT00072514|Carboplatin|carboplatin|mesh-list
64468048|NCT00072514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64468049|NCT00072514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468050|NCT00072514|Immunologic Factors|immunologic factors|mesh-ancestor
64468051|NCT00072514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468052|NCT00072514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64468053|NCT00072514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64468054|NCT00072514|Antiemetics|antiemetics|mesh-ancestor
64468055|NCT00072514|Autonomic Agents|autonomic agents|mesh-ancestor
64468056|NCT00072514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64468057|NCT00072514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64468087|NCT00166036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64468088|NCT00166036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64468089|NCT00166036|Antimetabolites|antimetabolites|mesh-ancestor
64468090|NCT00166036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468091|NCT00166036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64468092|NCT00166036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64468093|NCT00166036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468094|NCT00167206|Cyclophosphamide|cyclophosphamide|mesh-list
64468095|NCT00167206|Fludarabine|fludarabine|mesh-list
64468096|NCT00167206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64468097|NCT00167206|Immunologic Factors|immunologic factors|mesh-ancestor
64468098|NCT00167206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468099|NCT00167206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64468100|NCT00167206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64468101|NCT00167206|Alkylating Agents|alkylating agents|mesh-ancestor
64468102|NCT00167206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468103|NCT00167206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468104|NCT00167206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64468105|NCT01474551|Vemurafenib|vemurafenib|mesh-list
64468140|NCT00078286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64468141|NCT00078286|Serotonin Agents|serotonin agents|mesh-ancestor
64468142|NCT00078286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468143|NCT00078754|Valproic Acid|valproic acid|mesh-list
64468144|NCT00078754|Fluoxetine|fluoxetine|mesh-list
64468145|NCT00078754|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64468146|NCT00078754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64468147|NCT00078754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64468148|NCT00078754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468149|NCT00078754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64468150|NCT00078754|Serotonin Agents|serotonin agents|mesh-ancestor
64468151|NCT00078754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468152|NCT00078754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64468153|NCT00078754|Antidepressive Agents|antidepressive agents|mesh-ancestor
64468154|NCT00078754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64468155|NCT00078754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64468156|NCT00078754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64468157|NCT00078754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468158|NCT00078754|Anticonvulsants|anticonvulsants|mesh-ancestor
64468159|NCT00078754|GABA Agents|gaba agents|mesh-ancestor
64468160|NCT00078754|Antimanic Agents|antimanic agents|mesh-ancestor
64468161|NCT00078754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64468191|NCT01474239|Growth Substances|growth substances|mesh-ancestor
64468192|NCT01474239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468193|NCT01474239|Growth Inhibitors|growth inhibitors|mesh-ancestor
64468194|NCT01473381|Dexetimide|dexetimide|mesh-list
64468195|NCT01473381|Citalopram|citalopram|mesh-list
64468196|NCT01473381|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
64468197|NCT01473381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64468198|NCT01473381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64468199|NCT01473381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64468200|NCT01473381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468201|NCT01473381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64468202|NCT01473381|Serotonin Agents|serotonin agents|mesh-ancestor
64468203|NCT01473381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468204|NCT01473381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64468205|NCT01473381|Antidepressive Agents|antidepressive agents|mesh-ancestor
64468206|NCT01473381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64468207|NCT01473381|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64468208|NCT01473381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64468209|NCT01473381|Parasympatholytics|parasympatholytics|mesh-ancestor
64468247|NCT00176878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64468248|NCT00176878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468249|NCT00176878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64468250|NCT00176878|Antimetabolites|antimetabolites|mesh-ancestor
64468251|NCT00176878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468252|NCT00176878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64468253|NCT00176878|Immunologic Factors|immunologic factors|mesh-ancestor
64468254|NCT00176878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468255|NCT00176878|Alkylating Agents|alkylating agents|mesh-ancestor
64468256|NCT00176878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64468257|NCT00176878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64468258|NCT01898182|Kinetin|kinetin|mesh-list
64468259|NCT01898182|Plant Growth Regulators|plant growth regulators|mesh-ancestor
64468260|NCT01898182|Growth Substances|growth substances|mesh-ancestor
64468261|NCT01898182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468262|NCT01499199|Dolutegravir|dolutegravir|mesh-list
64468263|NCT01499199|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64468264|NCT01499199|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64468265|NCT01499199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468266|NCT01499199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468267|NCT01499199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64468268|NCT01499199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64468269|NCT01499199|Antiviral Agents|antiviral agents|mesh-ancestor
64468270|NCT01499199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64468271|NCT02119468|Dexamethasone|dexamethasone|mesh-list
64468272|NCT02119468|Pomalidomide|pomalidomide|mesh-list
64468296|NCT02119468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64468297|NCT00090844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64468298|NCT00090844|Luteolytic Agents|luteolytic agents|mesh-ancestor
64468299|NCT00090844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64468300|NCT00090844|Contraceptive Agents|contraceptive agents|mesh-ancestor
64468301|NCT00090844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64468302|NCT00090844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468303|NCT00090844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64468304|NCT00090844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64468305|NCT00090844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468306|NCT01897012|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64468308|NCT01897012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64468309|NCT01897012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64468310|NCT01897012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468311|NCT01498887|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64468312|NCT01498887|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64468313|NCT01498887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468314|NCT01498887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64468315|NCT01498887|Immunologic Factors|immunologic factors|mesh-ancestor
64468316|NCT01498887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468317|NCT01498185|Dapagliflozin|dapagliflozin|mesh-list
64468318|NCT01498185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64468347|NCT01472835|Anesthetics|anesthetics|mesh-ancestor
64468348|NCT01472835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64468349|NCT01472835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64468350|NCT01472835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64468351|NCT01472835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64468352|NCT01472835|GABA Modulators|gaba modulators|mesh-ancestor
64468353|NCT01472835|GABA Agents|gaba agents|mesh-ancestor
64468354|NCT01472835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64468355|NCT01472835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468356|NCT00185692|Acetaminophen|acetaminophen|mesh-list
64468357|NCT00185692|Cyclosporine|cyclosporine|mesh-list
64468358|NCT00185692|Mycophenolic Acid|mycophenolic acid|mesh-list
64468359|NCT00185692|Methylprednisolone|methylprednisolone|mesh-list
64468360|NCT00185692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64468361|NCT00185692|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64468362|NCT00185692|Prednisolone|prednisolone|mesh-list
64468409|NCT01526733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468410|NCT00094900|Rilonacept|rilonacept|mesh-list
64468411|NCT00094900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64468412|NCT00096460|Cyclophosphamide|cyclophosphamide|mesh-list
64468413|NCT00096460|Carmustine|carmustine|mesh-list
64468414|NCT00096460|Rituximab|rituximab|mesh-list
64468415|NCT00096460|Methotrexate|methotrexate|mesh-list
64468416|NCT00096460|Fludarabine|fludarabine|mesh-list
64468417|NCT00096460|Etoposide|etoposide|mesh-list
64468418|NCT00096460|Tacrolimus|tacrolimus|mesh-list
64468419|NCT00096460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64468420|NCT00096460|Immunologic Factors|immunologic factors|mesh-ancestor
64468421|NCT00096460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468422|NCT00096460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64468423|NCT00096460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64468424|NCT00096460|Alkylating Agents|alkylating agents|mesh-ancestor
64468425|NCT00096460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468426|NCT00096460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468427|NCT00096460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64468428|NCT00096460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64468429|NCT00096460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64468430|NCT00096460|Abortifacient Agents|abortifacient agents|mesh-ancestor
64468431|NCT00096460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64468460|NCT00098956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64468461|NCT00098956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468462|NCT00098956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468463|NCT00098956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468464|NCT00098956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64468465|NCT02197156|Acetaminophen|acetaminophen|mesh-list
64468466|NCT02197156|Hydrocodone|hydrocodone|mesh-list
64468467|NCT02197156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64468468|NCT02197156|Analgesics|analgesics|mesh-ancestor
64468469|NCT02197156|Sensory System Agents|sensory system agents|mesh-ancestor
64468470|NCT02197156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64468471|NCT02197156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468472|NCT02197156|Antipyretics|antipyretics|mesh-ancestor
64468473|NCT02197156|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64468478|NCT00187720|Metformin|metformin|mesh-list
64468521|NCT00006400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468522|NCT00006400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64468523|NCT01496469|Febuxostat|febuxostat|mesh-list
64468524|NCT01496469|Gout Suppressants|gout suppressants|mesh-ancestor
64468525|NCT01496469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64468526|NCT00189436|Budesonide|budesonide|mesh-list
64468527|NCT00189436|Albuterol|albuterol|mesh-list
64468528|NCT00189436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64468529|NCT00189436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64468530|NCT00189436|Autonomic Agents|autonomic agents|mesh-ancestor
64468531|NCT00189436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64468532|NCT00189436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468533|NCT00189436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64468534|NCT00189436|Respiratory System Agents|respiratory system agents|mesh-ancestor
64468535|NCT00189436|Glucocorticoids|glucocorticoids|mesh-ancestor
64468536|NCT00189436|Hormones|hormones|mesh-ancestor
64468537|NCT00189436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64468538|NCT00189436|Tocolytic Agents|tocolytic agents|mesh-ancestor
64468539|NCT00189436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64468540|NCT00189436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64468541|NCT00189436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64468542|NCT00189436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64468543|NCT00189436|Adrenergic Agents|adrenergic agents|mesh-ancestor
64468544|NCT00189436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64468546|NCT01471353|Capecitabine|capecitabine|mesh-list
64468570|NCT01471197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64468571|NCT01471197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64468572|NCT01471197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64468573|NCT01471197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64468574|NCT04408989|Bevacizumab|bevacizumab|mesh-list
64468575|NCT04408989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64468576|NCT04408989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468577|NCT04408989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64468578|NCT04408989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64468579|NCT04408989|Growth Substances|growth substances|mesh-ancestor
64468580|NCT04408989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468581|NCT04408989|Growth Inhibitors|growth inhibitors|mesh-ancestor
64468582|NCT00011986|Gemcitabine|gemcitabine|mesh-list
64468583|NCT00011986|Paclitaxel|paclitaxel|mesh-list
64468584|NCT00011986|Carboplatin|carboplatin|mesh-list
64468585|NCT00011986|Doxorubicin|doxorubicin|mesh-list
64468586|NCT00011986|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64468587|NCT00011986|Topotecan|topotecan|mesh-list
64468588|NCT00011986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64468589|NCT00011986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468590|NCT00011986|Tubulin Modulators|tubulin modulators|mesh-ancestor
64468591|NCT00011986|Antimitotic Agents|antimitotic agents|mesh-ancestor
64468592|NCT00011986|Mitosis Modulators|mitosis modulators|mesh-ancestor
64468593|NCT00011986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468594|NCT00011986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64468595|NCT00011986|Antimetabolites|antimetabolites|mesh-ancestor
64468596|NCT00011986|Antiviral Agents|antiviral agents|mesh-ancestor
64468597|NCT00011986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64468618|NCT01494987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468619|NCT01494987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64468620|NCT01494987|Immunologic Factors|immunologic factors|mesh-ancestor
64468621|NCT01494987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64468622|NCT01494987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64468623|NCT01494987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468624|NCT04409769|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64468625|NCT04409769|Ceftobiprole|ceftobiprole|mesh-list
64468626|NCT04409769|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
64468627|NCT04409769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64468628|NCT04409769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64468629|NCT01470417|Gemcitabine|gemcitabine|mesh-list
64468630|NCT01470417|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64468631|NCT01470417|Paclitaxel|paclitaxel|mesh-list
64468632|NCT01470417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64468633|NCT01470417|Antimetabolites|antimetabolites|mesh-ancestor
64468634|NCT01470417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468635|NCT01470417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468636|NCT01470417|Antiviral Agents|antiviral agents|mesh-ancestor
64468637|NCT01470417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64468638|NCT01470417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468639|NCT01470417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64468640|NCT01470417|Immunologic Factors|immunologic factors|mesh-ancestor
64468641|NCT01470417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468642|NCT01470417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64468643|NCT01470417|Tubulin Modulators|tubulin modulators|mesh-ancestor
64468644|NCT01470417|Antimitotic Agents|antimitotic agents|mesh-ancestor
64468645|NCT01470417|Mitosis Modulators|mitosis modulators|mesh-ancestor
64468664|NCT04409223|Sunitinib|sunitinib|mesh-list
64468665|NCT04409223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468666|NCT04409223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64468667|NCT04409223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64468668|NCT04409223|Growth Substances|growth substances|mesh-ancestor
64468669|NCT04409223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468670|NCT04409223|Growth Inhibitors|growth inhibitors|mesh-ancestor
64468671|NCT04409223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64468672|NCT04409223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468673|NCT04409223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468674|NCT00012298|Rituximab|rituximab|mesh-list
64468675|NCT00012298|Oprelvekin|oprelvekin|mesh-list
64468676|NCT00012298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64468677|NCT00012298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64468678|NCT00012298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468679|NCT00012298|Immunologic Factors|immunologic factors|mesh-ancestor
64468680|NCT00012298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468681|NCT00012298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64468682|NCT00193258|Bevacizumab|bevacizumab|mesh-list
64468683|NCT00193258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64468684|NCT00193258|Imatinib Mesylate|imatinib mesylate|mesh-list
64468718|NCT00194116|Antimanic Agents|antimanic agents|mesh-ancestor
64468719|NCT00194116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64468720|NCT00194116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64468721|NCT00194116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64468722|NCT02096458|Dexlansoprazole|dexlansoprazole|mesh-list
64468723|NCT02096458|Lansoprazole|lansoprazole|mesh-list
64468724|NCT02096458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64468725|NCT02096458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64468726|NCT02096458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64468727|NCT02096458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468728|NCT02096458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468729|NCT00194896|Rosiglitazone|rosiglitazone|mesh-list
64468731|NCT00194896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64468732|NCT00194896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468733|NCT04348474|Azithromycin|azithromycin|mesh-list
64468734|NCT04348474|Hydroxychloroquine|hydroxychloroquine|mesh-list
64468735|NCT04348474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64468736|NCT04348474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64468737|NCT04348474|Antimalarials|antimalarials|mesh-ancestor
64468738|NCT04348474|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64468739|NCT04348474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64468740|NCT04348474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468741|NCT04348474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468742|NCT04348474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64468743|NCT00107536|Lapatinib|lapatinib|mesh-list
64468744|NCT00107536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468745|NCT00107536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64468747|NCT00107536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468748|NCT00108550|Gabapentin|gabapentin|mesh-list
64468766|NCT02093962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468767|NCT02093962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64468768|NCT02093962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64468769|NCT00200902|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64468770|NCT00200902|Citalopram|citalopram|mesh-list
64468771|NCT00200902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64468772|NCT00200902|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64468773|NCT00200902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64468774|NCT00200902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64468775|NCT00200902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468776|NCT00200902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64468777|NCT00200902|Serotonin Agents|serotonin agents|mesh-ancestor
64468778|NCT00200902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468779|NCT00200902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64468780|NCT00200902|Antidepressive Agents|antidepressive agents|mesh-ancestor
64468781|NCT00200902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64468782|NCT00200902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64468783|NCT00200902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64468784|NCT00200902|Analgesics|analgesics|mesh-ancestor
64468785|NCT00200902|Sensory System Agents|sensory system agents|mesh-ancestor
64468786|NCT00200902|Dopamine Agents|dopamine agents|mesh-ancestor
64468787|NCT00201448|Vaccines|vaccines|mesh-list
64468788|NCT00201448|Immunologic Factors|immunologic factors|mesh-ancestor
64468789|NCT00201448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468790|NCT00201760|Gemcitabine|gemcitabine|mesh-list
64468791|NCT00201760|Trastuzumab|trastuzumab|mesh-list
64468792|NCT00201760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468793|NCT00201760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64468794|NCT00201760|Antimetabolites|antimetabolites|mesh-ancestor
64468795|NCT00201760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468796|NCT00201760|Antiviral Agents|antiviral agents|mesh-ancestor
64468797|NCT00201760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64468798|NCT00201760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468799|NCT00201760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64468800|NCT00201760|Immunologic Factors|immunologic factors|mesh-ancestor
64972301|NCT00230035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64511098|NCT05659329|Gentamicins|gentamicins|mesh-list
64972314|NCT00230035|Antiemetics|antiemetics|mesh-ancestor
64972315|NCT00230035|Autonomic Agents|autonomic agents|mesh-ancestor
64972316|NCT00230035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64972317|NCT00230035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64972318|NCT00230035|Glucocorticoids|glucocorticoids|mesh-ancestor
64972319|NCT00230035|Hormones|hormones|mesh-ancestor
64972320|NCT00230035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64972321|NCT00230035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64972322|NCT00230035|Protective Agents|protective agents|mesh-ancestor
64468801|NCT00201760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468802|NCT00201760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64468803|NCT00201838|Gemcitabine|gemcitabine|mesh-list
64468851|NCT00041938|Warfarin|warfarin|mesh-list
64468852|NCT00041938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64468853|NCT00041938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64468854|NCT00041938|Analgesics|analgesics|mesh-ancestor
64468855|NCT00041938|Sensory System Agents|sensory system agents|mesh-ancestor
64468856|NCT00041938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64468857|NCT00041938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468858|NCT00041938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64468859|NCT00041938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64468860|NCT00041938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64468861|NCT00041938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64468862|NCT00041938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468863|NCT00041938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64468864|NCT00041938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64468865|NCT00041938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64468866|NCT00041938|Antipyretics|antipyretics|mesh-ancestor
64468867|NCT00041938|Anticoagulants|anticoagulants|mesh-ancestor
64468868|NCT00202930|Rituximab|rituximab|mesh-list
64468869|NCT00202930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64468870|NCT00202930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468871|NCT00202930|Immunologic Factors|immunologic factors|mesh-ancestor
64468872|NCT00202930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468873|NCT00202930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64468903|NCT00112918|Oxaliplatin|oxaliplatin|mesh-list
64468904|NCT00112918|Calcium|calcium|mesh-list
64468905|NCT00112918|Levoleucovorin|levoleucovorin|mesh-list
64468906|NCT00112918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64468907|NCT00112918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468908|NCT00112918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64468909|NCT00112918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64468910|NCT00112918|Growth Substances|growth substances|mesh-ancestor
64468911|NCT00112918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468912|NCT00112918|Growth Inhibitors|growth inhibitors|mesh-ancestor
64468913|NCT00112918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64468914|NCT00112918|Antimetabolites|antimetabolites|mesh-ancestor
64468915|NCT00112918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468916|NCT00112918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64468917|NCT00112918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64468918|NCT00112918|Immunologic Factors|immunologic factors|mesh-ancestor
64468919|NCT00112918|Antidotes|antidotes|mesh-ancestor
64468920|NCT00112918|Protective Agents|protective agents|mesh-ancestor
64468921|NCT00112918|Vitamin B Complex|vitamin b complex|mesh-ancestor
64468922|NCT00112918|Vitamins|vitamins|mesh-ancestor
64468923|NCT00112918|Micronutrients|micronutrients|mesh-ancestor
64468924|NCT00046228|Reteplase|reteplase|mesh-list
64468925|NCT00046228|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64468926|NCT00046228|Abciximab|abciximab|mesh-list
64468927|NCT00046228|Anticoagulants|anticoagulants|mesh-ancestor
64468928|NCT00046228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64468929|NCT00046228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64468951|NCT00113230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468952|NCT00113230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64468953|NCT00113230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64468954|NCT00113230|Growth Substances|growth substances|mesh-ancestor
64468955|NCT00113230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468956|NCT00113230|Growth Inhibitors|growth inhibitors|mesh-ancestor
64468957|NCT00113230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64468958|NCT00113230|Antimetabolites|antimetabolites|mesh-ancestor
64468959|NCT00113230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468960|NCT00049036|Prednisone|prednisone|mesh-list
64468961|NCT00049036|Cyclophosphamide|cyclophosphamide|mesh-list
64468962|NCT00049036|Rituximab|rituximab|mesh-list
64468963|NCT00049036|Doxorubicin|doxorubicin|mesh-list
64468964|NCT00049036|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64468965|NCT00049036|Etoposide|etoposide|mesh-list
64468966|NCT00049036|Vincristine|vincristine|mesh-list
64468967|NCT00049036|Etoposide phosphate|etoposide phosphate|mesh-list
64468968|NCT00049036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64468969|NCT00049036|Immunologic Factors|immunologic factors|mesh-ancestor
64468970|NCT00049036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64468971|NCT00049036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64468972|NCT00049036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64468973|NCT00049036|Alkylating Agents|alkylating agents|mesh-ancestor
64468974|NCT00049036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469003|NCT00049504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469004|NCT00049504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64469005|NCT00049504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64469006|NCT00049504|Antimetabolites|antimetabolites|mesh-ancestor
64469007|NCT00049504|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64469008|NCT00049504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469009|NCT00049504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64469010|NCT00049504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64513653|NCT01457859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64469011|NCT00049504|Antitubercular Agents|antitubercular agents|mesh-ancestor
64469012|NCT00049504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64469013|NCT00049504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64469014|NCT00050986|Temozolomide|temozolomide|mesh-list
64469015|NCT00050986|Tipifarnib|tipifarnib|mesh-list
64469016|NCT00050986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64469017|NCT00050986|Alkylating Agents|alkylating agents|mesh-ancestor
64469018|NCT00050986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469019|NCT00050986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469020|NCT00118144|Bortezomib|bortezomib|mesh-list
64469021|NCT00118144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469022|NCT00118378|Modafinil|modafinil|mesh-list
64469023|NCT00118378|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64469024|NCT00118378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469025|NCT00118378|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64469026|NCT00118378|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64469027|NCT00118378|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64469028|NCT00118378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469029|NCT00217438|Melphalan|melphalan|mesh-list
64469031|NCT00217438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64469032|NCT00217438|Alkylating Agents|alkylating agents|mesh-ancestor
64469034|NCT00217438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469043|NCT04480450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469044|NCT04480450|Immunologic Factors|immunologic factors|mesh-ancestor
64469045|NCT04480450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469046|NCT04480450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64469047|NCT00217594|Alemtuzumab|alemtuzumab|mesh-list
64469048|NCT00217594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64469049|NCT00217594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469050|NCT00052078|Sertraline|sertraline|mesh-list
64469051|NCT00052078|Antidepressive Agents|antidepressive agents|mesh-ancestor
64469052|NCT00052078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64469053|NCT00052078|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64469054|NCT00052078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64469055|NCT00052078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64469056|NCT00052078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469057|NCT00052078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64469058|NCT00052078|Serotonin Agents|serotonin agents|mesh-ancestor
64469059|NCT00052078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469060|NCT05820594|BCG Vaccine|bcg vaccine|mesh-list
64469061|NCT05820594|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64469097|NCT05819970|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64469098|NCT05819970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469099|NCT05819970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64469100|NCT05819970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469107|NCT05819892|Cisplatin|cisplatin|mesh-list
64469108|NCT05819892|Carboplatin|carboplatin|mesh-list
64469109|NCT05819892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64469110|NCT05819892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469111|NCT05819892|Tubulin Modulators|tubulin modulators|mesh-ancestor
64469112|NCT05819892|Antimitotic Agents|antimitotic agents|mesh-ancestor
64469113|NCT05819892|Mitosis Modulators|mitosis modulators|mesh-ancestor
64469115|NCT05819710|Zopiclone|zopiclone|mesh-list
64469169|NCT05819541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64469170|NCT05819541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469171|NCT05819541|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64469172|NCT05819541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64469173|NCT05819541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469174|NCT05819541|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64469175|NCT05819541|Autonomic Agents|autonomic agents|mesh-ancestor
64469176|NCT05819541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64469177|NCT05819541|Tocolytic Agents|tocolytic agents|mesh-ancestor
64469178|NCT05819541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64469179|NCT05819541|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64469180|NCT05819541|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64469181|NCT05819541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64469182|NCT05819541|Adrenergic Agents|adrenergic agents|mesh-ancestor
64469183|NCT05819541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64469184|NCT05819229|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64469185|NCT05819229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64469186|NCT05819060|Bevacizumab|bevacizumab|mesh-list
64469187|NCT05819060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64469188|NCT05819060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469189|NCT05819060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64469190|NCT05819060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64469191|NCT05819060|Growth Substances|growth substances|mesh-ancestor
64469192|NCT05819060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469193|NCT05819060|Growth Inhibitors|growth inhibitors|mesh-ancestor
64469194|NCT05818995|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64469195|NCT05818995|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64469211|NCT05818982|Irinotecan|irinotecan|mesh-list
64469212|NCT05818982|Afatinib|afatinib|mesh-list
64469213|NCT05818982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64469214|NCT05818982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64469215|NCT05818982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469216|NCT05818982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469217|NCT05818982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469218|NCT05818982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64469219|NCT05818852|Moxifloxacin|moxifloxacin|mesh-list
64469220|NCT05818852|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64469221|NCT05818852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64469222|NCT05818852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64469223|NCT05818852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64469235|NCT05818826|Hydrocortisone|hydrocortisone|mesh-list
64469270|NCT05816512|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64469271|NCT05816512|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64469272|NCT05816512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64469273|NCT05816512|Disinfectants|disinfectants|mesh-ancestor
64469274|NCT05816512|Dermatologic Agents|dermatologic agents|mesh-ancestor
64469275|NCT05816499|Docetaxel|docetaxel|mesh-list
64469276|NCT05816499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469277|NCT05816499|Tubulin Modulators|tubulin modulators|mesh-ancestor
64469278|NCT05816499|Antimitotic Agents|antimitotic agents|mesh-ancestor
64469279|NCT05816499|Mitosis Modulators|mitosis modulators|mesh-ancestor
64469280|NCT05816499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469281|NCT05816356|Decitabine|decitabine|mesh-list
64469282|NCT05816356|Tetrahydrouridine|tetrahydrouridine|mesh-list
64469283|NCT05816356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64469284|NCT05816356|Antimetabolites|antimetabolites|mesh-ancestor
64469285|NCT05816356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469286|NCT05816356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469287|NCT05816356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469288|NCT05816343|Orlistat|orlistat|mesh-list
64469289|NCT05816343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469290|NCT05816343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469323|NCT05816070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469324|NCT05816070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469325|NCT05816070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469326|NCT05816070|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64469327|NCT05816070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64469328|NCT05815927|Pembrolizumab|pembrolizumab|mesh-list
64469329|NCT05815927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64469330|NCT05815927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469331|NCT05815901|Febuxostat|febuxostat|mesh-list
64469332|NCT05815901|Gout Suppressants|gout suppressants|mesh-ancestor
64469333|NCT05815901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64469334|NCT05815784|Atropine|atropine|mesh-list
64469335|NCT05815784|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64469336|NCT05815784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64469337|NCT05815784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64469339|NCT05815784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64469340|NCT05815784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469341|NCT05815784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64469342|NCT05815784|Respiratory System Agents|respiratory system agents|mesh-ancestor
64469343|NCT05815784|Mydriatics|mydriatics|mesh-ancestor
64469344|NCT05815784|Parasympatholytics|parasympatholytics|mesh-ancestor
64469345|NCT05815784|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64469346|NCT05815784|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64469347|NCT05815784|Cholinergic Agents|cholinergic agents|mesh-ancestor
64469348|NCT05815784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64469349|NCT05815784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469350|NCT05815758|Ketotifen|ketotifen|mesh-list
64469370|NCT05815719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64469371|NCT05815719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469372|NCT05815680|Metformin|metformin|mesh-list
64469373|NCT05815680|Digoxin|digoxin|mesh-list
64469374|NCT05815680|Warfarin|warfarin|mesh-list
64469375|NCT05815680|Atorvastatin|atorvastatin|mesh-list
64469376|NCT05815680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64469377|NCT05815680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469378|NCT05815680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64469379|NCT05815680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64469380|NCT05815680|Antimetabolites|antimetabolites|mesh-ancestor
64469381|NCT05815680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469382|NCT05815680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64469383|NCT05815680|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64469384|NCT05815680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469389|NCT05815654|Analgesics|analgesics|mesh-list
64469431|NCT05815160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469432|NCT05815160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469433|NCT05814939|Tofacitinib|tofacitinib|mesh-list
64469434|NCT05814939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469435|NCT05814939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64469436|NCT05814939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469437|NCT05814874|Selenium|selenium|mesh-list
64469438|NCT05814874|Antioxidants|antioxidants|mesh-ancestor
64469439|NCT05814874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469440|NCT05814874|Protective Agents|protective agents|mesh-ancestor
64469441|NCT05814874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469442|NCT05814874|Trace Elements|trace elements|mesh-ancestor
64469443|NCT05814874|Micronutrients|micronutrients|mesh-ancestor
64469444|NCT05814770|Spironolactone|spironolactone|mesh-list
64469445|NCT05814770|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64469446|NCT05814770|Hormone Antagonists|hormone antagonists|mesh-ancestor
64469447|NCT05814770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64469448|NCT05814770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469449|NCT05814770|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64469450|NCT05814770|Diuretics|diuretics|mesh-ancestor
64469451|NCT05814770|Natriuretic Agents|natriuretic agents|mesh-ancestor
64469452|NCT05814744|Dexmedetomidine|dexmedetomidine|mesh-list
64469453|NCT05814744|Bupivacaine|bupivacaine|mesh-list
64469454|NCT05814744|Anesthetics, Local|anesthetics, local|mesh-ancestor
64469455|NCT05814744|Anesthetics|anesthetics|mesh-ancestor
64469456|NCT05814744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64469480|NCT05814731|Immunologic Factors|immunologic factors|mesh-ancestor
64469481|NCT05814731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469482|NCT05814731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64469483|NCT05814731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64469484|NCT05814731|Alkylating Agents|alkylating agents|mesh-ancestor
64469485|NCT05814731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469486|NCT05814731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469487|NCT05814731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64469488|NCT05814731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64469490|NCT05814731|Antiviral Agents|antiviral agents|mesh-ancestor
64469491|NCT05814731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64469492|NCT05814731|Analgesics|analgesics|mesh-ancestor
64469493|NCT05814731|Sensory System Agents|sensory system agents|mesh-ancestor
64469494|NCT05814731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64469495|NCT05814731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64469496|NCT05814731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64469497|NCT05814731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469498|NCT05814718|Cytarabine|cytarabine|mesh-list
64469499|NCT05814718|Etoposide|etoposide|mesh-list
64469500|NCT05814718|Mitoxantrone|mitoxantrone|mesh-list
64469501|NCT05814718|Etoposide phosphate|etoposide phosphate|mesh-list
64469502|NCT05814718|Melphalan|melphalan|mesh-list
64469503|NCT05814718|Carmustine|carmustine|mesh-list
64469504|NCT05814718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64469505|NCT05814718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469506|NCT05814718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64469507|NCT05814718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64469508|NCT05814718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469528|NCT05814640|Aripiprazole|aripiprazole|mesh-list
64469529|NCT05814640|Lithium Carbonate|lithium carbonate|mesh-list
64469530|NCT05814640|Vortioxetine|vortioxetine|mesh-list
64469531|NCT05814640|Sertraline|sertraline|mesh-list
64469532|NCT05814640|Fluoxetine|fluoxetine|mesh-list
64469533|NCT05814640|Antiemetics|antiemetics|mesh-ancestor
64469534|NCT05814640|Autonomic Agents|autonomic agents|mesh-ancestor
64469535|NCT05814640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64469536|NCT05814640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469537|NCT05814640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64469538|NCT05814640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64469539|NCT05814640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64469540|NCT05814640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64469541|NCT05814640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64469542|NCT05814640|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64469543|NCT05814640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64469544|NCT05814640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64469545|NCT05814640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469546|NCT05814640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64469547|NCT05814640|Serotonin Agents|serotonin agents|mesh-ancestor
64469548|NCT05814640|Antidepressive Agents|antidepressive agents|mesh-ancestor
64469549|NCT05814640|Dopamine Agonists|dopamine agonists|mesh-ancestor
64469550|NCT05814640|Dopamine Agents|dopamine agents|mesh-ancestor
64469551|NCT05814640|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64469552|NCT05814640|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64469583|NCT05814601|Autonomic Agents|autonomic agents|mesh-ancestor
64469584|NCT05814601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64469585|NCT05814601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64469593|NCT05810597|Tirzepatide|tirzepatide|mesh-list
64469594|NCT05810597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64469595|NCT05810597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469596|NCT05810597|Incretins|incretins|mesh-ancestor
64469597|NCT05810597|Hormones|hormones|mesh-ancestor
64469598|NCT05810597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64469599|NCT05810363|Propofol|propofol|mesh-list
64469600|NCT05810363|Etomidate|etomidate|mesh-list
64469601|NCT05810363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64469602|NCT05810363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64469603|NCT05810363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469604|NCT05810363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64469605|NCT05810363|Anesthetics, General|anesthetics, general|mesh-ancestor
64469606|NCT05810363|Anesthetics|anesthetics|mesh-ancestor
64469607|NCT05809921|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64469608|NCT05809921|Tenecteplase|tenecteplase|mesh-list
64469609|NCT05809921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64513655|NCT01457859|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64469611|NCT05809921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469612|NCT05807139|Spironolactone|spironolactone|mesh-list
64469613|NCT05807139|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64469614|NCT05807139|Hormone Antagonists|hormone antagonists|mesh-ancestor
64469637|NCT05805605|Antitubercular Agents|antitubercular agents|mesh-ancestor
64469638|NCT05805605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64469639|NCT05805605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64469640|NCT05805605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469641|NCT05805605|Antifungal Agents|antifungal agents|mesh-ancestor
64469642|NCT05805605|Gout Suppressants|gout suppressants|mesh-ancestor
64469643|NCT05805605|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64469644|NCT05805605|Antioxidants|antioxidants|mesh-ancestor
64469645|NCT05805605|Protective Agents|protective agents|mesh-ancestor
64469646|NCT05797662|Propranolol|propranolol|mesh-list
64469647|NCT05797662|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64469648|NCT05797662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64469649|NCT05797662|Adrenergic Agents|adrenergic agents|mesh-ancestor
64469650|NCT05797662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64469651|NCT05797662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469652|NCT05797662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469654|NCT05797662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64469655|NCT05797662|Vasodilator Agents|vasodilator agents|mesh-ancestor
64469696|NCT05768360|Antimetabolites|antimetabolites|mesh-ancestor
64469697|NCT05768360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469698|NCT05768360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64469699|NCT05768360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64469700|NCT05768360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64469701|NCT05768360|Diuretics|diuretics|mesh-ancestor
64469702|NCT05768360|Natriuretic Agents|natriuretic agents|mesh-ancestor
64469703|NCT05768360|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64469704|NCT05768360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64469705|NCT05768360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64469706|NCT05768360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64469707|NCT05768360|Protective Agents|protective agents|mesh-ancestor
64469708|NCT05766358|Tirzepatide|tirzepatide|mesh-list
64469709|NCT05766358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64469710|NCT05766358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469711|NCT05766358|Incretins|incretins|mesh-ancestor
64469712|NCT05766358|Hormones|hormones|mesh-ancestor
64469713|NCT05766358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64469714|NCT05757557|Nitric Oxide|nitric oxide|mesh-list
64469715|NCT05757557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64469716|NCT05757557|Autonomic Agents|autonomic agents|mesh-ancestor
64469717|NCT05757557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64469718|NCT05757557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469719|NCT05757557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64469720|NCT05757557|Respiratory System Agents|respiratory system agents|mesh-ancestor
64469721|NCT05757557|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64469722|NCT05757557|Antioxidants|antioxidants|mesh-ancestor
64469723|NCT05757557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469741|NCT05735431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469742|NCT05735431|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64469743|NCT05735431|Respiratory System Agents|respiratory system agents|mesh-ancestor
64469744|NCT05735431|Dermatologic Agents|dermatologic agents|mesh-ancestor
64469745|NCT05735431|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64469746|NCT05735431|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64469747|NCT05735431|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64469748|NCT05735431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64469749|NCT05735431|Adrenergic Agents|adrenergic agents|mesh-ancestor
64469750|NCT05735431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64469751|NCT05735431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469752|NCT05730036|Dexamethasone|dexamethasone|mesh-list
64469753|NCT05730036|Pomalidomide|pomalidomide|mesh-list
64469754|NCT05730036|Elotuzumab|elotuzumab|mesh-list
64469755|NCT05730036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64469756|NCT05730036|Antiemetics|antiemetics|mesh-ancestor
64469757|NCT05730036|Autonomic Agents|autonomic agents|mesh-ancestor
64469758|NCT05730036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64469759|NCT05730036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469760|NCT05730036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64469761|NCT05730036|Glucocorticoids|glucocorticoids|mesh-ancestor
64469762|NCT05730036|Hormones|hormones|mesh-ancestor
64469763|NCT05730036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64469764|NCT05730036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64469765|NCT05730036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469766|NCT05730036|Immunologic Factors|immunologic factors|mesh-ancestor
64469767|NCT05730036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64469768|NCT05730036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64469769|NCT05730036|Growth Substances|growth substances|mesh-ancestor
64469770|NCT05730036|Growth Inhibitors|growth inhibitors|mesh-ancestor
64469785|NCT05690984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64469786|NCT05690984|Antiemetics|antiemetics|mesh-ancestor
64469787|NCT05690984|Autonomic Agents|autonomic agents|mesh-ancestor
64469788|NCT05690984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64469789|NCT05690984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455554|NCT01429792|Ribavirin|ribavirin|mesh-list
64469790|NCT05690984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64469791|NCT05690984|Glucocorticoids|glucocorticoids|mesh-ancestor
64469792|NCT05690984|Hormones|hormones|mesh-ancestor
64469793|NCT05690984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64469794|NCT05690984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64469795|NCT05690984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469796|NCT05690984|Immunologic Factors|immunologic factors|mesh-ancestor
64469797|NCT05690984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64469812|NCT05687357|Paclitaxel|paclitaxel|mesh-list
64469846|NCT05683574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64469847|NCT05679492|Meplazumab|meplazumab|mesh-list
64469848|NCT05679492|Antiviral Agents|antiviral agents|mesh-ancestor
64469849|NCT05679492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64469850|NCT05677295|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64469851|NCT05677295|Imipramine|imipramine|mesh-list
64469852|NCT05677295|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64469853|NCT05677295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64469854|NCT05677295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64469855|NCT05677295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469856|NCT05677295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64469857|NCT05677295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469858|NCT05677295|Analgesics|analgesics|mesh-ancestor
64469859|NCT05677295|Sensory System Agents|sensory system agents|mesh-ancestor
64469860|NCT05677295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64469861|NCT05677295|Antidepressive Agents|antidepressive agents|mesh-ancestor
64469906|NCT05632133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64469907|NCT05632133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469910|NCT05629585|Capecitabine|capecitabine|mesh-list
64469911|NCT05629585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64469912|NCT05629585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469913|NCT05629585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64469914|NCT05629585|Antimetabolites|antimetabolites|mesh-ancestor
64469915|NCT05629585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469916|NCT05626803|Vaccines|vaccines|mesh-list
64469917|NCT05626803|Immunologic Factors|immunologic factors|mesh-ancestor
64469918|NCT05626803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469919|NCT05619289|Vitamin D|vitamin d|mesh-list
64469920|NCT05619289|Ergocalciferols|ergocalciferols|mesh-list
64469921|NCT05619289|Vitamins|vitamins|mesh-ancestor
64469922|NCT05619289|Micronutrients|micronutrients|mesh-ancestor
64469923|NCT05619289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469924|NCT05619289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64469925|NCT05619289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64469926|NCT05618002|Clonidine|clonidine|mesh-list
64469927|NCT05618002|Lemborexant|lemborexant|mesh-list
64469928|NCT05618002|Zopiclone|zopiclone|mesh-list
64469929|NCT05618002|Analgesics|analgesics|mesh-ancestor
64469930|NCT05618002|Sensory System Agents|sensory system agents|mesh-ancestor
64469931|NCT05618002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64469932|NCT05618002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469933|NCT05618002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64469934|NCT05618002|Sympatholytics|sympatholytics|mesh-ancestor
64469935|NCT05618002|Autonomic Agents|autonomic agents|mesh-ancestor
64469936|NCT05618002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64469937|NCT05618002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64469938|NCT05618002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64469939|NCT05618002|Adrenergic Agents|adrenergic agents|mesh-ancestor
64469940|NCT05618002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64469941|NCT05618002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469946|NCT05615844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64469947|NCT05615844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64469948|NCT05608005|MF59 oil emulsion|mf59 oil emulsion|mesh-list
64469949|NCT05608005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64469950|NCT05608005|Immunologic Factors|immunologic factors|mesh-ancestor
64469952|NCT05605899|Prednisone|prednisone|mesh-list
64469953|NCT05605899|Cyclophosphamide|cyclophosphamide|mesh-list
64469954|NCT05605899|Rituximab|rituximab|mesh-list
64469955|NCT05605899|Doxorubicin|doxorubicin|mesh-list
64469956|NCT05605899|Fludarabine|fludarabine|mesh-list
64469957|NCT05605899|Etoposide|etoposide|mesh-list
64469958|NCT05605899|Vincristine|vincristine|mesh-list
64469959|NCT05605899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64469960|NCT05605899|Immunologic Factors|immunologic factors|mesh-ancestor
64469961|NCT05605899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469962|NCT05605899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64469963|NCT05605899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64469964|NCT05605899|Alkylating Agents|alkylating agents|mesh-ancestor
64469965|NCT05605899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64469966|NCT05605899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64469967|NCT05605899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64469968|NCT05605899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64469969|NCT05605899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64469970|NCT05605899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64470008|NCT05592223|Antimetabolites|antimetabolites|mesh-ancestor
64470009|NCT05592223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470010|NCT05592223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64470011|NCT05592223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64470012|NCT05592223|Immunologic Factors|immunologic factors|mesh-ancestor
64470013|NCT05592223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470014|NCT05586776|Chlorhexidine|chlorhexidine|mesh-list
64470015|NCT05586776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64470016|NCT05586776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
64470017|NCT05586776|Mupirocin|mupirocin|mesh-list
64470018|NCT05586776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64470019|NCT05586776|Disinfectants|disinfectants|mesh-ancestor
64470020|NCT05586776|Dermatologic Agents|dermatologic agents|mesh-ancestor
64470021|NCT05586776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64470031|NCT05586360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64470049|NCT05567094|Dexamethasone|dexamethasone|mesh-list
64470050|NCT05567094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64470051|NCT05567094|Antiemetics|antiemetics|mesh-ancestor
64470052|NCT05567094|Autonomic Agents|autonomic agents|mesh-ancestor
64470053|NCT05567094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64470054|NCT05567094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470055|NCT05567094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64470056|NCT05567094|Glucocorticoids|glucocorticoids|mesh-ancestor
64470058|NCT05567094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64470059|NCT05567094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64470060|NCT05567094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470061|NCT05565222|Meropenem|meropenem|mesh-list
64470062|NCT05565222|Tazobactam|tazobactam|mesh-list
64470063|NCT05565222|Piperacillin|piperacillin|mesh-list
64470064|NCT05565222|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64470065|NCT05565222|Temocillin|temocillin|mesh-list
64470066|NCT05565222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64470067|NCT05565222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64470068|NCT05565222|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64470069|NCT05565222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470071|NCT05563766|Itraconazole|itraconazole|mesh-list
64470073|NCT05563766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64470074|NCT05563766|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64470075|NCT05563766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64470076|NCT05563766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470077|NCT05563766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470078|NCT05563766|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64470079|NCT05563766|Hormone Antagonists|hormone antagonists|mesh-ancestor
64470080|NCT05563766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64470081|NCT05563766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470082|NCT05563766|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64470083|NCT05562492|Insulin|insulin|mesh-list
64470084|NCT05562492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64470085|NCT05562492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470086|NCT05549661|Onvansertib|onvansertib|mesh-list
64470087|NCT05549661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64470088|NCT05549661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470089|NCT05549661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470144|NCT05536349|Venetoclax|venetoclax|mesh-list
64470145|NCT05536349|Obinutuzumab|obinutuzumab|mesh-list
64470146|NCT05536349|Allopurinol|allopurinol|mesh-list
64470147|NCT05536349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470148|NCT05536349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64470149|NCT05536349|Antimetabolites|antimetabolites|mesh-ancestor
64470178|NCT05497778|Antimitotic Agents|antimitotic agents|mesh-ancestor
64470179|NCT05497778|Mitosis Modulators|mitosis modulators|mesh-ancestor
64470180|NCT05497778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470181|NCT05497778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64470182|NCT05497778|Antimetabolites|antimetabolites|mesh-ancestor
64470183|NCT05497778|Antiviral Agents|antiviral agents|mesh-ancestor
64470184|NCT05497778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64470185|NCT05497778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470186|NCT05497778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64470245|NCT05453903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470246|NCT05453903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470247|NCT05453903|Antiviral Agents|antiviral agents|mesh-ancestor
64470248|NCT05453903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64470257|NCT05450562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64470259|NCT05449392|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
64470260|NCT05449392|Petrolatum|petrolatum|mesh-list
64470261|NCT05449392|Emollients|emollients|mesh-ancestor
64470262|NCT05449392|Dermatologic Agents|dermatologic agents|mesh-ancestor
64470263|NCT05449392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64470264|NCT05449392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64470265|NCT05449392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64470266|NCT05445076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64470267|NCT05445076|Antibodies|antibodies|mesh-list
64470268|NCT05445076|Immunoglobulins|immunoglobulins|mesh-list
64470269|NCT05445076|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64470270|NCT05445076|Immunologic Factors|immunologic factors|mesh-ancestor
64470271|NCT05445076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470272|NCT05445076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470273|NCT05428488|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
64470274|NCT05428488|Abatacept|abatacept|mesh-list
64470275|NCT05428488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64470276|NCT05428488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470277|NCT05428488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470278|NCT05428488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64470279|NCT05428488|Immunologic Factors|immunologic factors|mesh-ancestor
64470311|NCT05405439|Prednisone|prednisone|mesh-list
64470312|NCT05405439|Abiraterone Acetate|abiraterone acetate|mesh-list
64470313|NCT05405439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64470314|NCT05405439|Glucocorticoids|glucocorticoids|mesh-ancestor
64470315|NCT05405439|Hormones|hormones|mesh-ancestor
64470316|NCT05405439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64470317|NCT05405439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470318|NCT05405439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64470319|NCT05405439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470320|NCT05405439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64470321|NCT05405439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470322|NCT05405439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470323|NCT05405439|Hormone Antagonists|hormone antagonists|mesh-ancestor
64470324|NCT05405439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64470325|NCT05405114|Decitabine|decitabine|mesh-list
64470326|NCT05405114|Hydroxyurea|hydroxyurea|mesh-list
64470327|NCT05405114|Tetrahydrouridine|tetrahydrouridine|mesh-list
64470328|NCT05405114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64470329|NCT05405114|Antimetabolites|antimetabolites|mesh-ancestor
64470330|NCT05405114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470331|NCT05405114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470332|NCT05405114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470333|NCT05405114|Antisickling Agents|antisickling agents|mesh-ancestor
64470334|NCT05405114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64470335|NCT05403476|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64470336|NCT05403476|Hormones|hormones|mesh-ancestor
64470337|NCT05403476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64470338|NCT05403476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470339|NCT05389722|Itraconazole|itraconazole|mesh-list
64470354|NCT05389722|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64470355|NCT05389722|Hormone Antagonists|hormone antagonists|mesh-ancestor
64470356|NCT05389722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64470357|NCT05389722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470358|NCT05389722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64470359|NCT05389722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64470360|NCT05389722|Antitubercular Agents|antitubercular agents|mesh-ancestor
64470361|NCT05389722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64470362|NCT05389722|Leprostatic Agents|leprostatic agents|mesh-ancestor
64470363|NCT05389722|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64470364|NCT05389722|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64470365|NCT05389722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64470366|NCT05389722|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64470367|NCT05389722|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64470368|NCT05389722|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64470369|NCT05389722|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64470370|NCT05389722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64470371|NCT05389722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64470372|NCT05389722|Protective Agents|protective agents|mesh-ancestor
64470374|NCT05383170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64470375|NCT05383170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470376|NCT05382286|Gemcitabine|gemcitabine|mesh-list
64470377|NCT05382286|Paclitaxel|paclitaxel|mesh-list
64470378|NCT05382286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64470379|NCT05382286|Carboplatin|carboplatin|mesh-list
64470380|NCT05382286|Pembrolizumab|pembrolizumab|mesh-list
64470381|NCT05382286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64470383|NCT05382286|Tubulin Modulators|tubulin modulators|mesh-ancestor
64470398|NCT05378464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470399|NCT05373680|Metformin|metformin|mesh-list
64470400|NCT05373680|Empagliflozin|empagliflozin|mesh-list
64470401|NCT05373680|Biguanides|biguanides|mesh-list
64470402|NCT05373680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64470403|NCT05373680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470404|NCT05373680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64470405|NCT05373680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470406|NCT05353348|Iron|iron|mesh-list
64470407|NCT05353348|Ascorbic Acid|ascorbic acid|mesh-list
64470408|NCT05353348|Epoetin Alfa|epoetin alfa|mesh-list
64470409|NCT05353348|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64470410|NCT05353348|Trace Elements|trace elements|mesh-ancestor
64470411|NCT05353348|Micronutrients|micronutrients|mesh-ancestor
64470412|NCT05353348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470413|NCT05353348|Antioxidants|antioxidants|mesh-ancestor
64470414|NCT05353348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470415|NCT05353348|Protective Agents|protective agents|mesh-ancestor
64470416|NCT05353348|Vitamins|vitamins|mesh-ancestor
64470417|NCT05353348|Hematinics|hematinics|mesh-ancestor
64470418|NCT05344469|Interferons|interferons|mesh-list
64470419|NCT05344469|Interferon-beta|interferon-beta|mesh-list
64470420|NCT05344469|Ofatumumab|ofatumumab|mesh-list
64470421|NCT05344469|Glatiramer Acetate|glatiramer acetate|mesh-list
64470422|NCT05344469|(T,G)-A-L|(t,g)-a-l|mesh-list
64470431|NCT05304520|Natalizumab|natalizumab|mesh-list
64470463|NCT05265728|Immunologic Factors|immunologic factors|mesh-ancestor
64470464|NCT05265728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470465|NCT05261594|Caffeine|caffeine|mesh-list
64470466|NCT05261594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64470467|NCT05261594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470468|NCT05261594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64470469|NCT05261594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470470|NCT05261594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470471|NCT05261594|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64470472|NCT05261594|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64470473|NCT05261594|Purinergic Agents|purinergic agents|mesh-ancestor
64470474|NCT05261594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64470475|NCT05256290|Temozolomide|temozolomide|mesh-list
64470476|NCT05256290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64470480|NCT05253651|Leucovorin|leucovorin|mesh-list
64470523|NCT05246111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470524|NCT05246111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470525|NCT05245071|Maytansine|maytansine|mesh-list
64470526|NCT05245071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64470527|NCT05245071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470528|NCT05245071|Tubulin Modulators|tubulin modulators|mesh-ancestor
64470529|NCT05245071|Antimitotic Agents|antimitotic agents|mesh-ancestor
64470530|NCT05245071|Mitosis Modulators|mitosis modulators|mesh-ancestor
64470531|NCT05245071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470532|NCT05242965|Vaccines|vaccines|mesh-list
64470533|NCT05242965|Sargramostim|sargramostim|mesh-list
64470534|NCT05242965|Immunologic Factors|immunologic factors|mesh-ancestor
64470535|NCT05242965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470536|NCT05241288|Albuterol|albuterol|mesh-list
64470537|NCT05241288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64470538|NCT05241288|Autonomic Agents|autonomic agents|mesh-ancestor
64470539|NCT05241288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64470540|NCT05241288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470541|NCT05241288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64470542|NCT05241288|Respiratory System Agents|respiratory system agents|mesh-ancestor
64470543|NCT05241288|Tocolytic Agents|tocolytic agents|mesh-ancestor
64470610|NCT05137119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64470611|NCT05137119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470612|NCT05137119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470613|NCT05132829|Azithromycin|azithromycin|mesh-list
64470614|NCT05132829|Cefazolin|cefazolin|mesh-list
64470615|NCT05132829|Indomethacin|indomethacin|mesh-list
64470616|NCT05132829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64470617|NCT05132829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64470618|NCT05132829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64470619|NCT05132829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64470620|NCT05132829|Analgesics|analgesics|mesh-ancestor
64470621|NCT05132829|Sensory System Agents|sensory system agents|mesh-ancestor
64470622|NCT05132829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64470623|NCT05132829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470624|NCT05132829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64470625|NCT05132829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64470626|NCT05132829|Gout Suppressants|gout suppressants|mesh-ancestor
64470627|NCT05132829|Tocolytic Agents|tocolytic agents|mesh-ancestor
64470628|NCT05132829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64470629|NCT05132829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64470630|NCT05132829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470631|NCT05132829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470632|NCT05132582|Trastuzumab|trastuzumab|mesh-list
64470670|NCT05086250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64470671|NCT05086250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470672|NCT05085808|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64470674|NCT05085808|Antidepressive Agents|antidepressive agents|mesh-ancestor
64470675|NCT05085808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64470676|NCT05085808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64470677|NCT05085808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64470678|NCT05085808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64470679|NCT05085808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470680|NCT05085808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64470681|NCT05085808|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64470682|NCT05085808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64470683|NCT05085808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64470684|NCT05085808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470685|NCT05085808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64470686|NCT05085808|Serotonin Agents|serotonin agents|mesh-ancestor
64470687|NCT05085808|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64470688|NCT05081609|Pembrolizumab|pembrolizumab|mesh-list
64470689|NCT05081609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64470690|NCT05081609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470691|NCT05081102|Ibuprofen|ibuprofen|mesh-list
64470692|NCT05081102|Oxycodone|oxycodone|mesh-list
64470693|NCT05081102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64470694|NCT05081102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64470695|NCT05081102|Analgesics|analgesics|mesh-ancestor
64470696|NCT05081102|Sensory System Agents|sensory system agents|mesh-ancestor
64470697|NCT05081102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64470698|NCT05081102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470699|NCT05081102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64470713|NCT05078944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470714|NCT05078944|Nootropic Agents|nootropic agents|mesh-ancestor
64470715|NCT05076019|Atorvastatin|atorvastatin|mesh-list
64470716|NCT05076019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64470717|NCT05076019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64470718|NCT05076019|Antimetabolites|antimetabolites|mesh-ancestor
64470719|NCT05076019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470720|NCT05076019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64470721|NCT05076019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64470722|NCT05076019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470723|NCT05071937|Talazoparib|talazoparib|mesh-list
64470724|NCT05071937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64470725|NCT05071937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470726|NCT05071937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470727|NCT05071937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470728|NCT05067634|Cenobamate|cenobamate|mesh-list
64470729|NCT05067634|Anticonvulsants|anticonvulsants|mesh-ancestor
64470730|NCT05063162|Rozanolixizumab|rozanolixizumab|mesh-list
64470731|NCT05063162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64470732|NCT05063162|Immunologic Factors|immunologic factors|mesh-ancestor
64470733|NCT05063162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470734|NCT05063097|Carbon Monoxide|carbon monoxide|mesh-list
64470735|NCT05063097|Antimetabolites|antimetabolites|mesh-ancestor
64470736|NCT05063097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470785|NCT05019846|Luteolytic Agents|luteolytic agents|mesh-ancestor
64470786|NCT05019846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64470787|NCT05019846|Contraceptive Agents|contraceptive agents|mesh-ancestor
64470788|NCT05019846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64470789|NCT05019846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64470790|NCT05019846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64470791|NCT05004025|Nivolumab|nivolumab|mesh-list
64470792|NCT05004025|Ipilimumab|ipilimumab|mesh-list
64470793|NCT05004025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64470794|NCT05004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470795|NCT05004025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64470796|NCT05004025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470797|NCT04998240|Myeloma Proteins|myeloma proteins|mesh-list
64470798|NCT04998240|Paraproteins|paraproteins|mesh-list
64470799|NCT04998240|Immunologic Factors|immunologic factors|mesh-ancestor
64470800|NCT04998240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470801|NCT04996823|Ipilimumab|ipilimumab|mesh-list
64470802|NCT04996823|Axitinib|axitinib|mesh-list
64470803|NCT04996823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64470804|NCT04996823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470805|NCT04996823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64470806|NCT04996823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470807|NCT04996823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64470808|NCT04996823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470809|NCT04996004|Doxorubicin|doxorubicin|mesh-list
64470810|NCT04996004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64470811|NCT04996004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470812|NCT04996004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64470813|NCT04996004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64470814|NCT04996004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470815|NCT04996004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470824|NCT04994509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64470825|NCT04994509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64470826|NCT04984759|Primaquine|primaquine|mesh-list
64470827|NCT04984759|Tafenoquine|tafenoquine|mesh-list
64470828|NCT04984759|Antimalarials|antimalarials|mesh-ancestor
64470829|NCT04984759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64470830|NCT04984759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64470831|NCT04984759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64470832|NCT04975152|Cemiplimab|cemiplimab|mesh-list
64470833|NCT04975152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64470834|NCT04975152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470897|NCT04943341|Triamcinolone|triamcinolone|mesh-list
64470898|NCT04943341|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64470899|NCT04943341|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64470900|NCT04943341|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64470901|NCT04943341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64470902|NCT04943341|Glucocorticoids|glucocorticoids|mesh-ancestor
64470904|NCT04943341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64470905|NCT04943341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470906|NCT04943341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64470907|NCT04943341|Immunologic Factors|immunologic factors|mesh-ancestor
64470908|NCT04943341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470909|NCT04943341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470910|NCT04941664|Levobupivacaine|levobupivacaine|mesh-list
64470911|NCT04941664|Anesthetics, Local|anesthetics, local|mesh-ancestor
64470912|NCT04941664|Anesthetics|anesthetics|mesh-ancestor
64470913|NCT04941664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64470914|NCT04941664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470915|NCT04941664|Sensory System Agents|sensory system agents|mesh-ancestor
64470916|NCT04941664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64470924|NCT04933266|Levobupivacaine|levobupivacaine|mesh-list
64470925|NCT04933266|Anesthetics, Local|anesthetics, local|mesh-ancestor
64470957|NCT04919382|Immunologic Factors|immunologic factors|mesh-ancestor
64470958|NCT04919382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470959|NCT04918823|Cyclosporine|cyclosporine|mesh-list
64470960|NCT04918823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64470961|NCT04918823|Cyclosporins|cyclosporins|mesh-list
64470962|NCT04918823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470963|NCT04918823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470988|NCT04887259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456667|NCT01397890|Hormones|hormones|mesh-ancestor
64470989|NCT04887259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470990|NCT04873362|Trastuzumab|trastuzumab|mesh-list
64470991|NCT04873362|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64470992|NCT04873362|Atezolizumab|atezolizumab|mesh-list
64470993|NCT04873362|Maytansine|maytansine|mesh-list
64470994|NCT04873362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64470995|NCT04873362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470996|NCT04873362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64470997|NCT04873362|Tubulin Modulators|tubulin modulators|mesh-ancestor
64470998|NCT04873362|Antimitotic Agents|antimitotic agents|mesh-ancestor
64471069|NCT04792385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64471070|NCT04792385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471071|NCT04792385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64471072|NCT04792385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64471073|NCT04792385|Hormone Antagonists|hormone antagonists|mesh-ancestor
64471074|NCT04792385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64471075|NCT04792385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64471076|NCT04792385|Diuretics|diuretics|mesh-ancestor
64471077|NCT04792385|Natriuretic Agents|natriuretic agents|mesh-ancestor
64471078|NCT04785651|Tranexamic Acid|tranexamic acid|mesh-list
64471079|NCT04785651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64471080|NCT04785651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64471081|NCT04785651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471082|NCT04785651|Hemostatics|hemostatics|mesh-ancestor
64471083|NCT04785651|Coagulants|coagulants|mesh-ancestor
64471084|NCT04780204|Tenofovir|tenofovir|mesh-list
64471085|NCT04780204|Antiviral Agents|antiviral agents|mesh-ancestor
64471086|NCT04780204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64471087|NCT04780204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64471088|NCT04780204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64945388|NCT05672225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64471168|NCT04735510|Immunologic Factors|immunologic factors|mesh-ancestor
64471169|NCT04735510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471170|NCT04735510|Antifungal Agents|antifungal agents|mesh-ancestor
64471171|NCT04735510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64471172|NCT04735510|Dermatologic Agents|dermatologic agents|mesh-ancestor
64471173|NCT04735510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64471174|NCT04735510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64471346|NCT04592744|Protease Inhibitors|protease inhibitors|mesh-ancestor
64471230|NCT04669197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471231|NCT04669197|Antimalarials|antimalarials|mesh-ancestor
64471232|NCT04669197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64471233|NCT04669197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64471234|NCT04669197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64471235|NCT04662944|Ranibizumab|ranibizumab|mesh-list
64471237|NCT04662944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64471238|NCT04662944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64471239|NCT04662944|Growth Substances|growth substances|mesh-ancestor
64471240|NCT04662944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471241|NCT04662944|Growth Inhibitors|growth inhibitors|mesh-ancestor
64471242|NCT04662944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471244|NCT04655222|Interferon-beta|interferon-beta|mesh-list
64471245|NCT04655222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471246|NCT04655222|Antiviral Agents|antiviral agents|mesh-ancestor
64471247|NCT04655222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64471248|NCT04655222|Immunologic Factors|immunologic factors|mesh-ancestor
64471249|NCT04655222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471250|NCT04652440|Antibodies|antibodies|mesh-list
64471251|NCT04652440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64471252|NCT04652440|Immunologic Factors|immunologic factors|mesh-ancestor
64471253|NCT04652440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471310|NCT04615013|Antidotes|antidotes|mesh-ancestor
64471311|NCT04615013|Protective Agents|protective agents|mesh-ancestor
64471328|NCT04592744|Adrenergic Agents|adrenergic agents|mesh-ancestor
64471329|NCT04592744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64514715|NCT02401503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64471330|NCT04592744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514716|NCT02395497|Antibodies|antibodies|mesh-list
64471331|NCT04592744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514717|NCT02395497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64471332|NCT04592744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64471333|NCT04592744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64471334|NCT04592744|Autonomic Agents|autonomic agents|mesh-ancestor
64471335|NCT04592744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64471336|NCT04592744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64471337|NCT04592744|Respiratory System Agents|respiratory system agents|mesh-ancestor
64471338|NCT04592744|Mydriatics|mydriatics|mesh-ancestor
64471339|NCT04592744|Sympathomimetics|sympathomimetics|mesh-ancestor
64514718|NCT02395497|Tacrolimus|tacrolimus|mesh-list
64471340|NCT04592744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64471342|NCT04592744|Coagulants|coagulants|mesh-ancestor
64471343|NCT04592744|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64471344|NCT04592744|Natriuretic Agents|natriuretic agents|mesh-ancestor
64471345|NCT04592744|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64471347|NCT04592744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473306|NCT00053014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64473307|NCT00053014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64473308|NCT00053014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64473309|NCT00053014|Antitubercular Agents|antitubercular agents|mesh-ancestor
64473310|NCT00053014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64473311|NCT00123604|Metoprolol|metoprolol|mesh-list
64473312|NCT00123604|Carvedilol|carvedilol|mesh-list
64473313|NCT00123604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64473314|NCT00123604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64473316|NCT00123604|Autonomic Agents|autonomic agents|mesh-ancestor
64473317|NCT00123604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64473318|NCT00123604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600054|NCT00728507|Antimetabolites|antimetabolites|mesh-ancestor
64600120|NCT02999633|Histamine Antagonists|histamine antagonists|mesh-ancestor
64600201|NCT01270451|Insulin|insulin|mesh-list
64600348|NCT02890784|Dasatinib|dasatinib|mesh-list
64600495|NCT00749125|Citalopram|citalopram|mesh-list
64600718|NCT00707759|Glucocorticoids|glucocorticoids|mesh-ancestor
64473319|NCT00123604|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64473320|NCT00123604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64473321|NCT00123604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64473323|NCT00123604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64473324|NCT00123604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473325|NCT00123604|Antioxidants|antioxidants|mesh-ancestor
64473326|NCT00123604|Protective Agents|protective agents|mesh-ancestor
64473327|NCT00123604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64473328|NCT00123604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64473367|NCT00130780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473368|NCT00130780|Growth Inhibitors|growth inhibitors|mesh-ancestor
64473369|NCT00130780|Tubulin Modulators|tubulin modulators|mesh-ancestor
64473370|NCT00130780|Antimitotic Agents|antimitotic agents|mesh-ancestor
64473371|NCT00130780|Mitosis Modulators|mitosis modulators|mesh-ancestor
64473372|NCT00130780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473373|NCT00225784|Gemcitabine|gemcitabine|mesh-list
64473374|NCT00225784|Cetuximab|cetuximab|mesh-list
64473375|NCT00225784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64473376|NCT00225784|Antimetabolites|antimetabolites|mesh-ancestor
64473377|NCT00225784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473378|NCT00225784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473379|NCT00225784|Antiviral Agents|antiviral agents|mesh-ancestor
64473380|NCT00225784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64473381|NCT00225784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473382|NCT00225784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64473383|NCT00225784|Immunologic Factors|immunologic factors|mesh-ancestor
64473384|NCT00225784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473386|NCT02092168|Opicapone|opicapone|mesh-list
64473422|NCT00254488|Valproic Acid|valproic acid|mesh-list
64473423|NCT00254488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64473424|NCT00254488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473425|NCT00254488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473426|NCT00254488|Antimanic Agents|antimanic agents|mesh-ancestor
64473427|NCT00254488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64473428|NCT00254488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64473429|NCT00254488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473430|NCT00254488|Anticonvulsants|anticonvulsants|mesh-ancestor
64473431|NCT00254488|GABA Agents|gaba agents|mesh-ancestor
64473432|NCT00254488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64473433|NCT01899118|Capecitabine|capecitabine|mesh-list
64473434|NCT01899118|Oxaliplatin|oxaliplatin|mesh-list
64473435|NCT01899118|Nimotuzumab|nimotuzumab|mesh-list
64473436|NCT01899118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64473437|NCT01899118|Antimetabolites|antimetabolites|mesh-ancestor
64473438|NCT01899118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473439|NCT01899118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473441|NCT00231868|Paclitaxel|paclitaxel|mesh-list
64473478|NCT01523457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473479|NCT01523301|Rotigotine|rotigotine|mesh-list
64473480|NCT01523301|Dopamine Agonists|dopamine agonists|mesh-ancestor
64473481|NCT01523301|Dopamine Agents|dopamine agents|mesh-ancestor
64473482|NCT01523301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64473483|NCT01523301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473484|NCT01523301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473485|NCT01609556|Maytansine|maytansine|mesh-list
64473486|NCT01609556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64473487|NCT01609556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473488|NCT01609556|Tubulin Modulators|tubulin modulators|mesh-ancestor
64473489|NCT01609556|Antimitotic Agents|antimitotic agents|mesh-ancestor
64473490|NCT01609556|Mitosis Modulators|mitosis modulators|mesh-ancestor
64473492|NCT01766336|Inositol|inositol|mesh-list
64473540|NCT01764464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64473541|NCT01764464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64473542|NCT01764464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473543|NCT01764464|Antimanic Agents|antimanic agents|mesh-ancestor
64473544|NCT01763996|Febuxostat|febuxostat|mesh-list
64473545|NCT01763996|Gout Suppressants|gout suppressants|mesh-ancestor
64473546|NCT01763996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64473547|NCT01763918|Evolocumab|evolocumab|mesh-list
64473548|NCT01763918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64473549|NCT01763918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64473551|NCT01763918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473552|NCT01763918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64473553|NCT01606748|Gemcitabine|gemcitabine|mesh-list
64473554|NCT01606748|Necitumumab|necitumumab|mesh-list
64473555|NCT01606748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473556|NCT01606748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64473557|NCT01606748|Antimetabolites|antimetabolites|mesh-ancestor
64473558|NCT01606748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473559|NCT01606748|Antiviral Agents|antiviral agents|mesh-ancestor
64473560|NCT01606748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64473561|NCT01606748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974484|NCT00077025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473595|NCT01790828|Coagulants|coagulants|mesh-ancestor
64473596|NCT01790594|Mycophenolic Acid|mycophenolic acid|mesh-list
64473597|NCT01790594|Methylprednisolone|methylprednisolone|mesh-list
64473598|NCT01790594|Abatacept|abatacept|mesh-list
64473599|NCT01790594|Tacrolimus|tacrolimus|mesh-list
64473600|NCT01790594|Thymoglobulin|thymoglobulin|mesh-list
64473601|NCT01790594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64473602|NCT01790594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64473603|NCT01790594|Immunologic Factors|immunologic factors|mesh-ancestor
64473604|NCT01790594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473605|NCT01790594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64473606|NCT01790594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473607|NCT01790594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473608|NCT01790594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64473609|NCT01790594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473610|NCT01790594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64473611|NCT01790594|Antitubercular Agents|antitubercular agents|mesh-ancestor
64473612|NCT01790594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64473613|NCT01790594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64473614|NCT01790594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64473616|NCT01790594|Autonomic Agents|autonomic agents|mesh-ancestor
64473617|NCT01790594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64473618|NCT01790594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64473645|NCT01734902|Scopolamine|scopolamine|mesh-list
64473646|NCT01734902|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64473647|NCT01734902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64473648|NCT01734902|Antiemetics|antiemetics|mesh-ancestor
64473649|NCT01734902|Autonomic Agents|autonomic agents|mesh-ancestor
64473650|NCT01734902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64473651|NCT01734902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473652|NCT01734902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64473653|NCT01734902|Mydriatics|mydriatics|mesh-ancestor
64473654|NCT01734902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64473655|NCT01734902|Cholinergic Agents|cholinergic agents|mesh-ancestor
64473656|NCT01734902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64473657|NCT01734902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473658|NCT01734902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64473659|NCT01734902|Parasympatholytics|parasympatholytics|mesh-ancestor
64473660|NCT01789970|Hydrocodone|hydrocodone|mesh-list
64473661|NCT01789970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64473662|NCT01789970|Narcotics|narcotics|mesh-ancestor
64473663|NCT01789970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64473664|NCT01789970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473665|NCT01789970|Analgesics|analgesics|mesh-ancestor
64473700|NCT01732640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473701|NCT01732640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64473702|NCT01732640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473703|NCT04560686|Atezolizumab|atezolizumab|mesh-list
64473704|NCT04560686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473705|NCT01757288|Paclitaxel|paclitaxel|mesh-list
64473706|NCT01757288|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64473707|NCT01757288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64473708|NCT01757288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473709|NCT01757288|Tubulin Modulators|tubulin modulators|mesh-ancestor
64473710|NCT01757288|Antimitotic Agents|antimitotic agents|mesh-ancestor
64473711|NCT01757288|Mitosis Modulators|mitosis modulators|mesh-ancestor
64473712|NCT01757288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473713|NCT01731938|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64473714|NCT01731938|Hemostatics|hemostatics|mesh-ancestor
64473715|NCT01731938|Coagulants|coagulants|mesh-ancestor
64473716|NCT01731002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64473717|NCT01731002|Latanoprost|latanoprost|mesh-list
64473718|NCT01731002|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64473719|NCT01783886|Aflibercept|aflibercept|mesh-list
64473720|NCT01783886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64473721|NCT01783886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64473722|NCT01783886|Growth Substances|growth substances|mesh-ancestor
64473723|NCT01783886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473724|NCT01783886|Growth Inhibitors|growth inhibitors|mesh-ancestor
64473725|NCT01783886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473726|NCT00234832|Sibutramine|sibutramine|mesh-list
64473727|NCT00234832|Antidepressive Agents|antidepressive agents|mesh-ancestor
64473728|NCT00234832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64473729|NCT00234832|Appetite Depressants|appetite depressants|mesh-ancestor
64473731|NCT00259090|Fulvestrant|fulvestrant|mesh-list
64473745|NCT00236938|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64473746|NCT00236938|Hematinics|hematinics|mesh-ancestor
64473747|NCT01898728|Iodine|iodine|mesh-list
64473748|NCT01898728|Cadexomer iodine|cadexomer iodine|mesh-list
64473749|NCT01898728|Povidone-Iodine|povidone-iodine|mesh-list
64473750|NCT01898728|Povidone|povidone|mesh-list
64473751|NCT01898728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64473752|NCT01898728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64473753|NCT01898728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64473754|NCT01898728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64473756|NCT01898728|Micronutrients|micronutrients|mesh-ancestor
64473757|NCT01898728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473758|NCT01898728|Plasma Substitutes|plasma substitutes|mesh-ancestor
64473759|NCT01898728|Blood Substitutes|blood substitutes|mesh-ancestor
64473760|NCT00260962|Olanzapine|olanzapine|mesh-list
64473761|NCT00260962|Antiemetics|antiemetics|mesh-ancestor
64473762|NCT00260962|Autonomic Agents|autonomic agents|mesh-ancestor
64473763|NCT00260962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64473764|NCT00260962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473765|NCT00260962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64473766|NCT00260962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64473767|NCT00260962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64473768|NCT00260962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64473769|NCT00260962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64473770|NCT00260962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64473799|NCT00266110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64473800|NCT00266110|Tubulin Modulators|tubulin modulators|mesh-ancestor
64473801|NCT00266110|Antimitotic Agents|antimitotic agents|mesh-ancestor
64473802|NCT00266110|Mitosis Modulators|mitosis modulators|mesh-ancestor
64473803|NCT00266110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473804|NCT00266110|Immunologic Factors|immunologic factors|mesh-ancestor
64473805|NCT00266110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473806|NCT00240526|Immunoglobulins|immunoglobulins|mesh-list
64473807|NCT00240526|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64473808|NCT00240526|Antibodies|antibodies|mesh-list
64473809|NCT00240526|Immunologic Factors|immunologic factors|mesh-ancestor
64473810|NCT00240526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473811|NCT00242632|Memantine|memantine|mesh-list
64473812|NCT00242632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64473820|NCT01899430|Metformin|metformin|mesh-list
64473854|NCT00247624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64473855|NCT00248560|Gemcitabine|gemcitabine|mesh-list
64473856|NCT00248560|Docetaxel|docetaxel|mesh-list
64473857|NCT00248560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64473858|NCT00248560|Antimetabolites|antimetabolites|mesh-ancestor
64473859|NCT00248560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473860|NCT00248560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473861|NCT00248560|Antiviral Agents|antiviral agents|mesh-ancestor
64473862|NCT00248560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64473863|NCT00248560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473864|NCT00248560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64473865|NCT00248560|Immunologic Factors|immunologic factors|mesh-ancestor
64473866|NCT00248560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473867|NCT00248560|Tubulin Modulators|tubulin modulators|mesh-ancestor
64473868|NCT00248560|Antimitotic Agents|antimitotic agents|mesh-ancestor
64473869|NCT00248560|Mitosis Modulators|mitosis modulators|mesh-ancestor
64473870|NCT00268762|Argatroban|argatroban|mesh-list
64473871|NCT00268762|Antithrombins|antithrombins|mesh-ancestor
64473872|NCT00268762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64473873|NCT00268762|Protease Inhibitors|protease inhibitors|mesh-ancestor
64473910|NCT00271570|Immunologic Factors|immunologic factors|mesh-ancestor
64473911|NCT00271570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473912|NCT00271570|Dermatologic Agents|dermatologic agents|mesh-ancestor
64473913|NCT00271570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64473914|NCT00271570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64473915|NCT05237596|Acetaminophen|acetaminophen|mesh-list
64473916|NCT05237596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64473917|NCT05237596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64473918|NCT05237596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64473919|NCT05237596|Analgesics|analgesics|mesh-ancestor
64473920|NCT05237596|Sensory System Agents|sensory system agents|mesh-ancestor
64473921|NCT05237596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64473922|NCT05237596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473923|NCT05237596|Antipyretics|antipyretics|mesh-ancestor
64473924|NCT05237596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64473925|NCT02102932|Metformin|metformin|mesh-list
64473926|NCT02102932|Empagliflozin|empagliflozin|mesh-list
64473927|NCT02102932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64473928|NCT02102932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473929|NCT02102932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64473930|NCT02102932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473932|NCT00273754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64473933|NCT00273754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473934|NCT00273754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64473935|NCT00273754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473936|NCT00273754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473937|NCT00273754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64473938|NCT00273754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64473939|NCT00273754|Purinergic Agents|purinergic agents|mesh-ancestor
64473940|NCT00273754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64473952|NCT00273910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473953|NCT00273910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473954|NCT00273910|Interferon Inducers|interferon inducers|mesh-ancestor
64473955|NCT00274768|Capecitabine|capecitabine|mesh-list
64473956|NCT00274768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64473957|NCT00274768|Antimetabolites|antimetabolites|mesh-ancestor
64473958|NCT00274768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473959|NCT00274768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473960|NCT00280384|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
64473961|NCT00280384|Botulinum Toxins|botulinum toxins|mesh-list
64473962|NCT00280384|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64473963|NCT00280384|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64473964|NCT00280384|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64473965|NCT00280384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64473966|NCT00280384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473967|NCT00280384|Cholinergic Agents|cholinergic agents|mesh-ancestor
64473968|NCT00280384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64473969|NCT00280384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473970|NCT00280384|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64473971|NCT00280384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64473972|NCT00280384|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64473973|NCT01790464|Lidocaine|lidocaine|mesh-list
64474004|NCT02100748|Sensory System Agents|sensory system agents|mesh-ancestor
64474005|NCT02100748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64474006|NCT00283504|Omalizumab|omalizumab|mesh-list
64474007|NCT00283504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64474008|NCT00283504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64474009|NCT00283504|Respiratory System Agents|respiratory system agents|mesh-ancestor
64474010|NCT00283816|Metformin|metformin|mesh-list
64474011|NCT00283816|Contraceptive Agents|contraceptive agents|mesh-list
64474012|NCT00283816|Contraceptives, Oral|contraceptives, oral|mesh-list
64474013|NCT00283816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64474014|NCT00283816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64474015|NCT00283816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474016|NCT00283816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64474017|NCT00283816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64474018|NCT00284518|Botulinum Toxins|botulinum toxins|mesh-list
64474019|NCT00284518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64474020|NCT00284518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64474021|NCT00284518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64474022|NCT00284518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64474023|NCT00284518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474024|NCT00284518|Cholinergic Agents|cholinergic agents|mesh-ancestor
64474025|NCT00284518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64474026|NCT00284518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474027|NCT00284518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64474029|NCT04339426|Azithromycin|azithromycin|mesh-list
64474055|NCT00287872|Leprostatic Agents|leprostatic agents|mesh-ancestor
64474056|NCT00287872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64474057|NCT00287872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64474058|NCT00287872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64474059|NCT00287872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64474060|NCT00287872|Growth Substances|growth substances|mesh-ancestor
64474061|NCT00287872|Growth Inhibitors|growth inhibitors|mesh-ancestor
64474062|NCT00288574|Fluoxetine|fluoxetine|mesh-list
64474063|NCT00288574|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64474064|NCT00288574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64474065|NCT00288574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64474066|NCT00288574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474067|NCT00288574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64474068|NCT00288574|Serotonin Agents|serotonin agents|mesh-ancestor
64474069|NCT00288574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474070|NCT00288574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64474112|NCT01791166|Immunologic Factors|immunologic factors|mesh-ancestor
64474113|NCT01791166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474114|NCT00291694|Celecoxib|celecoxib|mesh-list
64474115|NCT00291694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64474116|NCT00291694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64474117|NCT00291694|Analgesics|analgesics|mesh-ancestor
64474118|NCT00291694|Sensory System Agents|sensory system agents|mesh-ancestor
64474120|NCT00291694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474121|NCT00291694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64474122|NCT00291694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64474123|NCT00291694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64474176|NCT00296296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64474177|NCT00296296|Dermatologic Agents|dermatologic agents|mesh-ancestor
64474178|NCT00296296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64474179|NCT01791400|Sumatriptan|sumatriptan|mesh-list
64474180|NCT01791400|Metoclopramide|metoclopramide|mesh-list
64474181|NCT01791400|Antiemetics|antiemetics|mesh-ancestor
64474182|NCT01791400|Autonomic Agents|autonomic agents|mesh-ancestor
64474183|NCT01791400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64474184|NCT01791400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474185|NCT01791400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64474186|NCT01791400|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64474187|NCT01791400|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64474188|NCT01791400|Dopamine Agents|dopamine agents|mesh-ancestor
64474189|NCT01791400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64474190|NCT01791400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474191|NCT01791400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64474192|NCT01791400|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64474193|NCT01791400|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64474195|NCT00300430|Calcium, Dietary|calcium, dietary|mesh-list
64474196|NCT00300430|Atorvastatin|atorvastatin|mesh-list
64474197|NCT00300430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64474198|NCT00300430|Simvastatin|simvastatin|mesh-list
64474199|NCT00300430|Fenofibrate|fenofibrate|mesh-list
64474200|NCT00300430|Calcium|calcium|mesh-list
64474201|NCT00300430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64474202|NCT00300430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474227|NCT02104414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64474228|NCT02104414|Respiratory System Agents|respiratory system agents|mesh-ancestor
64474229|NCT02104414|Mydriatics|mydriatics|mesh-ancestor
64474230|NCT02104414|Sympathomimetics|sympathomimetics|mesh-ancestor
64474231|NCT02104414|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64474232|NCT02100826|Cephalexin|cephalexin|mesh-list
64474233|NCT02100826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64474234|NCT02100826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64474235|NCT03587272|Sirolimus|sirolimus|mesh-list
64474236|NCT03587272|Alemtuzumab|alemtuzumab|mesh-list
64474237|NCT03587272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64474238|NCT03587272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64474239|NCT03587272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64474240|NCT03587272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474241|NCT03587272|Antifungal Agents|antifungal agents|mesh-ancestor
64474242|NCT03587272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64474243|NCT03587272|Immunologic Factors|immunologic factors|mesh-ancestor
64474244|NCT03587272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474245|NCT03587272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64474246|NCT02101918|Aflibercept|aflibercept|mesh-list
64474247|NCT02101918|Endothelial Growth Factors|endothelial growth factors|mesh-list
64474283|NCT00302848|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64474284|NCT00302848|Hormone Antagonists|hormone antagonists|mesh-ancestor
64474285|NCT00302848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64474286|NCT00302848|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64474287|NCT00302848|Diuretics|diuretics|mesh-ancestor
64474288|NCT00302848|Natriuretic Agents|natriuretic agents|mesh-ancestor
64474289|NCT00302848|Hormones|hormones|mesh-ancestor
64474290|NCT00303862|Cediranib|cediranib|mesh-list
64474291|NCT00303862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64474292|NCT00303862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474293|NCT00303862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474294|NCT00303862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64474295|NCT00304096|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64474296|NCT00304096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64474297|NCT00304096|Immunologic Factors|immunologic factors|mesh-ancestor
64474298|NCT00304096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474299|NCT05267392|Durvalumab|durvalumab|mesh-list
64471355|NCT04585711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64474300|NCT05267392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64474301|NCT05267392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474302|NCT00142168|Rituximab|rituximab|mesh-list
64474303|NCT00142168|Lenalidomide|lenalidomide|mesh-list
64474304|NCT00142168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64474305|NCT00142168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474306|NCT00142168|Immunologic Factors|immunologic factors|mesh-ancestor
64474307|NCT00142168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474308|NCT00142168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64474323|NCT00148798|Cisplatin|cisplatin|mesh-list
64474329|NCT00148798|Tubulin Modulators|tubulin modulators|mesh-ancestor
64474330|NCT00148798|Antimitotic Agents|antimitotic agents|mesh-ancestor
64474331|NCT00148798|Mitosis Modulators|mitosis modulators|mesh-ancestor
64474332|NCT00148798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474333|NCT00149734|Ondansetron|ondansetron|mesh-list
64474334|NCT00149734|Antiemetics|antiemetics|mesh-ancestor
64474335|NCT00149734|Autonomic Agents|autonomic agents|mesh-ancestor
64474336|NCT00149734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64474337|NCT00149734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474338|NCT00149734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64474339|NCT00149734|Antipruritics|antipruritics|mesh-ancestor
64474340|NCT00149734|Dermatologic Agents|dermatologic agents|mesh-ancestor
64474341|NCT00149734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64474342|NCT00149734|Serotonin Agents|serotonin agents|mesh-ancestor
64474343|NCT00149734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64474344|NCT00149734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474345|NCT00149734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64474346|NCT00149734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64474350|NCT00198328|Bleomycin|bleomycin|mesh-list
64474384|NCT00325780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64474385|NCT00325780|Antimetabolites|antimetabolites|mesh-ancestor
64474386|NCT00325780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474387|NCT00325780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64474388|NCT00325780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64474389|NCT00326170|Azacitidine|azacitidine|mesh-list
64474390|NCT00326170|Tretinoin|tretinoin|mesh-list
64474391|NCT00326170|Valproic Acid|valproic acid|mesh-list
64474392|NCT00326170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64474393|NCT00326170|Antimetabolites|antimetabolites|mesh-ancestor
64474394|NCT00326170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474395|NCT00326170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474396|NCT00326170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64474397|NCT00326170|Keratolytic Agents|keratolytic agents|mesh-ancestor
64474398|NCT00326170|Dermatologic Agents|dermatologic agents|mesh-ancestor
64474399|NCT00326170|Anticonvulsants|anticonvulsants|mesh-ancestor
64474400|NCT00326170|GABA Agents|gaba agents|mesh-ancestor
64474401|NCT00326170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64474402|NCT00326170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474403|NCT00326170|Antimanic Agents|antimanic agents|mesh-ancestor
64474404|NCT00326170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64474405|NCT00326170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64474406|NCT00326170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64474407|NCT00326872|Cediranib|cediranib|mesh-list
64474437|NCT00331162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64474438|NCT00331162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474439|NCT01790308|Liraglutide|liraglutide|mesh-list
64474440|NCT01790308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64474441|NCT01790308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474442|NCT01790308|Incretins|incretins|mesh-ancestor
64474443|NCT01790308|Hormones|hormones|mesh-ancestor
64474444|NCT01790308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64474445|NCT01609010|Interferons|interferons|mesh-list
64474446|NCT01609010|Interferon alpha-2|interferon alpha-2|mesh-list
64474447|NCT01609010|Rituximab|rituximab|mesh-list
64474448|NCT01609010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64471357|NCT04585711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64474449|NCT01609010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474450|NCT01609010|Immunologic Factors|immunologic factors|mesh-ancestor
64474451|NCT01609010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474452|NCT01609010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64474453|NCT01609010|Antiviral Agents|antiviral agents|mesh-ancestor
64474454|NCT01609010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64474455|NCT01608308|Acetaminophen|acetaminophen|mesh-list
64474456|NCT01608308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64474457|NCT01608308|Analgesics|analgesics|mesh-ancestor
64474458|NCT01608308|Sensory System Agents|sensory system agents|mesh-ancestor
64474459|NCT01608308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64474460|NCT01608308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474461|NCT01608308|Antipyretics|antipyretics|mesh-ancestor
64474463|NCT00332644|Nicotine|nicotine|mesh-list
64474464|NCT00332644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64474465|NCT00332644|Autonomic Agents|autonomic agents|mesh-ancestor
64474468|NCT00332644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64474482|NCT00332644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64474483|NCT01755416|Insulin|insulin|mesh-list
64474484|NCT01755416|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64474485|NCT01755416|Liraglutide|liraglutide|mesh-list
64474486|NCT01755416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64474487|NCT01755416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474488|NCT01755416|Incretins|incretins|mesh-ancestor
64474490|NCT01755416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64474491|NCT01755026|Cefazolin|cefazolin|mesh-list
64474492|NCT01755026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64474493|NCT01755026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64474494|NCT00333814|Dexamethasone|dexamethasone|mesh-list
64474495|NCT00333814|Dexamethasone acetate|dexamethasone acetate|mesh-list
64474496|NCT00333814|BB 1101|bb 1101|mesh-list
64474497|NCT00333814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64474498|NCT00333814|Antiemetics|antiemetics|mesh-ancestor
64474499|NCT00333814|Autonomic Agents|autonomic agents|mesh-ancestor
64474500|NCT00333814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64474501|NCT00333814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474502|NCT00333814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64474540|NCT01522443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64474541|NCT01522443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474542|NCT01522443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64474543|NCT01522443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474544|NCT01522443|Analgesics|analgesics|mesh-ancestor
64474545|NCT01522443|Sensory System Agents|sensory system agents|mesh-ancestor
64474546|NCT01522443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64474547|NCT01522443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64474548|NCT01522443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64474549|NCT01522443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64474550|NCT01522443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474551|NCT00336232|Vitamin K|vitamin k|mesh-list
64474552|NCT00336232|Vitamin K 1|vitamin k 1|mesh-list
64474553|NCT00336232|Vitamins|vitamins|mesh-ancestor
64474554|NCT00336232|Micronutrients|micronutrients|mesh-ancestor
64474555|NCT00336232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474559|NCT00336232|Hemostatics|hemostatics|mesh-ancestor
64474597|NCT01754402|Growth Substances|growth substances|mesh-ancestor
64474598|NCT01754402|Growth Inhibitors|growth inhibitors|mesh-ancestor
64474599|NCT01521897|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64474600|NCT01521897|Immunologic Factors|immunologic factors|mesh-ancestor
64474601|NCT01521897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474602|NCT01782872|Ropivacaine|ropivacaine|mesh-list
64474603|NCT01782872|Anesthetics, Local|anesthetics, local|mesh-ancestor
64474604|NCT01782872|Anesthetics|anesthetics|mesh-ancestor
64474605|NCT01782872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64713987|NCT03043105|Prednisone|prednisone|mesh-list
64460144|NCT01591863|Fidaxomicin|fidaxomicin|mesh-list
64474606|NCT01782872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474607|NCT01782872|Sensory System Agents|sensory system agents|mesh-ancestor
64474608|NCT01782872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64474609|NCT01490697|Cycloserine|cycloserine|mesh-list
64474610|NCT01490697|Mifepristone|mifepristone|mesh-list
64474611|NCT01490697|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64474612|NCT01490697|Abortifacient Agents|abortifacient agents|mesh-ancestor
64474613|NCT01490697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64474614|NCT01490697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474615|NCT01490697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64474616|NCT01490697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64474617|NCT01490697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64474618|NCT01490697|Contraceptive Agents|contraceptive agents|mesh-ancestor
64474619|NCT01490697|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64474620|NCT01490697|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64474641|NCT01728194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474642|NCT01728194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64474643|NCT01728194|Antidepressive Agents|antidepressive agents|mesh-ancestor
64474644|NCT01728194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64474645|NCT04408911|Midazolam|midazolam|mesh-list
64474646|NCT04408911|Lormetazepam|lormetazepam|mesh-list
64474647|NCT04408911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64474648|NCT04408911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64474649|NCT04408911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64474650|NCT04408911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474651|NCT04408911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64474652|NCT04408911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64474653|NCT04408911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64474654|NCT04408911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64474655|NCT04408911|Anesthetics, General|anesthetics, general|mesh-ancestor
64474656|NCT04408911|Anesthetics|anesthetics|mesh-ancestor
64474657|NCT04408911|GABA Modulators|gaba modulators|mesh-ancestor
64474658|NCT04408911|GABA Agents|gaba agents|mesh-ancestor
64474659|NCT04408911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64474660|NCT04408911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474661|NCT01466673|Moxifloxacin|moxifloxacin|mesh-list
64474662|NCT01466673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64474663|NCT01466673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64474664|NCT01466673|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64474665|NCT01466673|Desogestrel|desogestrel|mesh-list
64474666|NCT01466673|Norgestimate|norgestimate|mesh-list
64474667|NCT01466673|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64474668|NCT01466673|Estradiol|estradiol|mesh-list
64514719|NCT02395497|Immunologic Factors|immunologic factors|mesh-ancestor
64474685|NCT01466673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64474686|NCT01466673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64474687|NCT01466673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474688|NCT01466673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474689|NCT01466673|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64474690|NCT01753856|Vitamin D|vitamin d|mesh-list
64474691|NCT01753856|Denosumab|denosumab|mesh-list
64474692|NCT01753856|Teriparatide|teriparatide|mesh-list
64474693|NCT01753856|Tetracycline|tetracycline|mesh-list
64474694|NCT01753856|Demeclocycline|demeclocycline|mesh-list
64474695|NCT01753856|Calcium|calcium|mesh-list
64474696|NCT01753856|Vitamins|vitamins|mesh-ancestor
64474697|NCT01753856|Micronutrients|micronutrients|mesh-ancestor
64474698|NCT01753856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474699|NCT01753856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64474700|NCT01753856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64474701|NCT01753856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64474702|NCT01753856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64474703|NCT01753856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64474704|NCT01753856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64474705|NCT01753856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474706|NCT01753310|Botulinum Toxins|botulinum toxins|mesh-list
64474707|NCT01753310|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64474708|NCT01753310|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64474709|NCT01753310|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64474710|NCT01753310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64474717|NCT01521117|Donepezil|donepezil|mesh-list
64474733|NCT02073747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474734|NCT02073747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64474735|NCT02073747|Respiratory System Agents|respiratory system agents|mesh-ancestor
64474736|NCT02073747|Tocolytic Agents|tocolytic agents|mesh-ancestor
64474737|NCT02073747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64474738|NCT02073747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64474739|NCT02073747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64474740|NCT02073747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64474741|NCT02073747|Adrenergic Agents|adrenergic agents|mesh-ancestor
64474742|NCT02073747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64474743|NCT02073747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474744|NCT01465659|Temozolomide|temozolomide|mesh-list
64474745|NCT01465659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64474746|NCT01465659|Alkylating Agents|alkylating agents|mesh-ancestor
64474791|NCT01462227|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64474792|NCT01462227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64474793|NCT01462227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474794|NCT01462227|Sensory System Agents|sensory system agents|mesh-ancestor
64474795|NCT01462227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64474796|NCT01464879|Testosterone|testosterone|mesh-list
64474797|NCT01464879|Androgens|androgens|mesh-ancestor
64474798|NCT01464879|Hormones|hormones|mesh-ancestor
64474799|NCT01464879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64474800|NCT01464879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474856|NCT01752842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64474857|NCT01461057|Capecitabine|capecitabine|mesh-list
64474858|NCT01461057|Trastuzumab|trastuzumab|mesh-list
64474860|NCT01461057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474861|NCT01461057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64474862|NCT01461057|Antimetabolites|antimetabolites|mesh-ancestor
64474863|NCT01461057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474864|NCT01461057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64474865|NCT04567407|Ropivacaine|ropivacaine|mesh-list
64474866|NCT04567407|Anesthetics, Local|anesthetics, local|mesh-ancestor
64474867|NCT04567407|Anesthetics|anesthetics|mesh-ancestor
64474868|NCT04567407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64474869|NCT04567407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474874|NCT01519635|Diuretics|diuretics|mesh-ancestor
64474914|NCT01519167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64474915|NCT01519167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64474916|NCT01519167|GABA Modulators|gaba modulators|mesh-ancestor
64474917|NCT01519167|GABA Agents|gaba agents|mesh-ancestor
64474918|NCT00318136|Paclitaxel|paclitaxel|mesh-list
64474920|NCT00318136|Carboplatin|carboplatin|mesh-list
64474921|NCT00318136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64474922|NCT00318136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474923|NCT00318136|Tubulin Modulators|tubulin modulators|mesh-ancestor
64474924|NCT00318136|Antimitotic Agents|antimitotic agents|mesh-ancestor
64474925|NCT00318136|Mitosis Modulators|mitosis modulators|mesh-ancestor
64474926|NCT00318136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474927|NCT00318136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64474928|NCT00318136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64474929|NCT00318136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64474930|NCT00318136|Growth Substances|growth substances|mesh-ancestor
64474931|NCT00318136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474932|NCT00318136|Growth Inhibitors|growth inhibitors|mesh-ancestor
64474933|NCT00318292|Epinephrine|epinephrine|mesh-list
64474934|NCT00318292|Bupivacaine|bupivacaine|mesh-list
64474935|NCT00318292|Anesthetics, Local|anesthetics, local|mesh-ancestor
64474969|NCT00348946|Androgens|androgens|mesh-list
64474970|NCT00348946|Oxandrolone|oxandrolone|mesh-list
64474971|NCT00348946|Hormones|hormones|mesh-ancestor
64474972|NCT00348946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64474973|NCT00348946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474974|NCT00348946|Anabolic Agents|anabolic agents|mesh-ancestor
64474975|NCT00349336|Bevacizumab|bevacizumab|mesh-list
64474976|NCT00349336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64474977|NCT00349336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64474978|NCT00349336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64474979|NCT00349336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64474980|NCT00349336|Growth Substances|growth substances|mesh-ancestor
64474981|NCT00349336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64474982|NCT00349336|Growth Inhibitors|growth inhibitors|mesh-ancestor
64474983|NCT04751188|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64474984|NCT04751188|Bezafibrate|bezafibrate|mesh-list
64474985|NCT04751188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64474986|NCT04751188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64474987|NCT04751188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64474988|NCT04751188|Antimetabolites|antimetabolites|mesh-ancestor
64474989|NCT04751188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474990|NCT04751188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64474991|NCT00352612|Clindamycin|clindamycin|mesh-list
64600838|NCT00738023|Rosiglitazone|rosiglitazone|mesh-list
64474992|NCT00352612|Clindamycin palmitate|clindamycin palmitate|mesh-list
64474993|NCT00352612|Clindamycin phosphate|clindamycin phosphate|mesh-list
64474994|NCT00352612|Cephalexin|cephalexin|mesh-list
64475017|NCT00390364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475018|NCT00354640|Anastrozole|anastrozole|mesh-list
64475019|NCT00354640|Simvastatin|simvastatin|mesh-list
64475020|NCT00354640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64475021|NCT00354640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64475022|NCT00354640|Antimetabolites|antimetabolites|mesh-ancestor
64475023|NCT00354640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475024|NCT00354640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64475025|NCT00354640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64475026|NCT00354640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475027|NCT00354640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64475028|NCT00354640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475029|NCT00354640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64475030|NCT00354640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64475031|NCT00354640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64475032|NCT00354640|Hormone Antagonists|hormone antagonists|mesh-ancestor
64475033|NCT00354640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64475034|NCT00354640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475035|NCT00392392|Paclitaxel|paclitaxel|mesh-list
64475036|NCT00392392|Bevacizumab|bevacizumab|mesh-list
64475037|NCT00392392|Trastuzumab|trastuzumab|mesh-list
64475038|NCT00392392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64475039|NCT00392392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475040|NCT00392392|Tubulin Modulators|tubulin modulators|mesh-ancestor
64475041|NCT00392392|Antimitotic Agents|antimitotic agents|mesh-ancestor
64475063|NCT00392704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475064|NCT00392704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64475065|NCT00392704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64475066|NCT00392704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64475067|NCT00392704|Growth Substances|growth substances|mesh-ancestor
64475068|NCT00392704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475069|NCT00392704|Growth Inhibitors|growth inhibitors|mesh-ancestor
64475070|NCT00392704|Antimetabolites|antimetabolites|mesh-ancestor
64475071|NCT00392704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64475072|NCT00392704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64475073|NCT00392704|Immunologic Factors|immunologic factors|mesh-ancestor
64475074|NCT00392704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64475075|NCT00392704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475076|NCT00392782|Fludarabine|fludarabine|mesh-list
64475077|NCT00392782|Fludarabine phosphate|fludarabine phosphate|mesh-list
64475078|NCT00392782|Thiotepa|thiotepa|mesh-list
64475079|NCT00392782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64475080|NCT00392782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475081|NCT00392782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64475082|NCT00392782|Antimetabolites|antimetabolites|mesh-ancestor
64475083|NCT00392782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475112|NCT01518309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475113|NCT01518309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64475114|NCT01518309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64475115|NCT01518309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64475116|NCT01518309|Serotonin Agents|serotonin agents|mesh-ancestor
64475117|NCT01518309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64475118|NCT01518309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475119|NCT01419717|Denosumab|denosumab|mesh-list
64475120|NCT01419717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64475121|NCT01419717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513664|NCT01890993|Hormones|hormones|mesh-ancestor
64475123|NCT01458951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64475124|NCT01458951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475125|NCT01458951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475126|NCT01458639|Xenon|xenon|mesh-list
64475127|NCT01458639|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64475128|NCT01458639|Anesthetics, General|anesthetics, general|mesh-ancestor
64475129|NCT01458639|Anesthetics|anesthetics|mesh-ancestor
64475130|NCT01458639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64475131|NCT01458639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475132|NCT00393796|Sunitinib|sunitinib|mesh-list
64475133|NCT00393796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475134|NCT00393796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64475135|NCT00393796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64475136|NCT00393796|Growth Substances|growth substances|mesh-ancestor
64475138|NCT00393796|Growth Inhibitors|growth inhibitors|mesh-ancestor
64475160|NCT00395044|Analgesics|analgesics|mesh-ancestor
64475161|NCT00395044|Sensory System Agents|sensory system agents|mesh-ancestor
64475162|NCT00395044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64475163|NCT00395044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475164|NCT00395044|Anticonvulsants|anticonvulsants|mesh-ancestor
64475165|NCT00395044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64475166|NCT00395044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64475167|NCT00395044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64475168|NCT00395044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64475169|NCT00395044|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64475170|NCT00395044|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64475171|NCT00395044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64475172|NCT00395044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475173|NCT00395044|Antimanic Agents|antimanic agents|mesh-ancestor
64475174|NCT01457703|Letrozole|letrozole|mesh-list
64475175|NCT01457703|Cetrorelix|cetrorelix|mesh-list
64475176|NCT01457703|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64475177|NCT01457703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475178|NCT01457703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64475216|NCT03652870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64475217|NCT03652870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475218|NCT03652870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64475219|NCT03652870|Serotonin Agents|serotonin agents|mesh-ancestor
64475220|NCT03652870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475221|NCT03652870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64475222|NCT03652870|Antidepressive Agents|antidepressive agents|mesh-ancestor
64475223|NCT03652870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64475224|NCT03652870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64475225|NCT03652870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64475235|NCT01437267|Vaccines|vaccines|mesh-list
64475278|NCT00398476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64475279|NCT00398476|Autonomic Agents|autonomic agents|mesh-ancestor
64475280|NCT00398476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64475281|NCT00398476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475282|NCT00398476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64475283|NCT00398476|Respiratory System Agents|respiratory system agents|mesh-ancestor
64475284|NCT00398476|Dermatologic Agents|dermatologic agents|mesh-ancestor
64475285|NCT00398476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64475286|NCT01436643|Fluoxetine|fluoxetine|mesh-list
64475287|NCT01436643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64475288|NCT01436643|Citalopram|citalopram|mesh-list
64475289|NCT01436643|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64475290|NCT01436643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64475291|NCT01436643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64475292|NCT01436643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64475293|NCT01436643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475294|NCT01436643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64475295|NCT01436643|Serotonin Agents|serotonin agents|mesh-ancestor
64475296|NCT01436643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475297|NCT01436643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64475298|NCT01436643|Antidepressive Agents|antidepressive agents|mesh-ancestor
64475299|NCT01436643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64475300|NCT01436643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64475301|NCT01436643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64475326|NCT02109640|Oxycodone|oxycodone|mesh-list
64475327|NCT02109640|Naloxone|naloxone|mesh-list
64475328|NCT02109640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64475329|NCT02109640|Narcotics|narcotics|mesh-ancestor
64475330|NCT02109640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64475331|NCT02109640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475332|NCT02109640|Analgesics|analgesics|mesh-ancestor
64475333|NCT02109640|Sensory System Agents|sensory system agents|mesh-ancestor
64475334|NCT02109640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64475335|NCT02109640|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64475336|NCT01454739|Factor VIII|factor viii|mesh-list
64475337|NCT01454739|Coagulants|coagulants|mesh-ancestor
64475338|NCT00366106|Dexamethasone|dexamethasone|mesh-list
64475339|NCT00366106|Doxorubicin|doxorubicin|mesh-list
64475340|NCT00366106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64475341|NCT00366106|Bortezomib|bortezomib|mesh-list
64475342|NCT00366106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64475343|NCT00366106|Antiemetics|antiemetics|mesh-ancestor
64475344|NCT00366106|Autonomic Agents|autonomic agents|mesh-ancestor
64475387|NCT01416441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64475388|NCT01416441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64475389|NCT01416441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64475390|NCT01416441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475391|NCT01416441|Dopamine Agonists|dopamine agonists|mesh-ancestor
64475392|NCT01416441|Dopamine Agents|dopamine agents|mesh-ancestor
64475393|NCT01416441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64475394|NCT01416441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475395|NCT01416441|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64475396|NCT01416441|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64475397|NCT01416441|Serotonin Agents|serotonin agents|mesh-ancestor
64471361|NCT04585711|Immunologic Factors|immunologic factors|mesh-ancestor
64471362|NCT04581824|Pembrolizumab|pembrolizumab|mesh-list
64475398|NCT01416441|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64475399|NCT01416441|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64475400|NCT01416441|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64475401|NCT01416441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64475402|NCT00406276|Docetaxel|docetaxel|mesh-list
64475403|NCT00406276|Everolimus|everolimus|mesh-list
64475404|NCT00406276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475440|NCT03675412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64475441|NCT03675412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475442|NCT03675412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475443|NCT03675412|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64475444|NCT03675412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64475445|NCT03675412|Purinergic Agents|purinergic agents|mesh-ancestor
64475446|NCT03675412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64475447|NCT02111200|Sodium Benzoate|sodium benzoate|mesh-list
64475448|NCT02111200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64475449|NCT02111200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475450|NCT02111200|Antifungal Agents|antifungal agents|mesh-ancestor
64475451|NCT02111200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64475452|NCT02111746|Bupivacaine|bupivacaine|mesh-list
64475453|NCT02111746|Anesthetics, Local|anesthetics, local|mesh-ancestor
64475454|NCT02111746|Anesthetics|anesthetics|mesh-ancestor
64475455|NCT02111746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64475456|NCT02111746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475457|NCT02111746|Sensory System Agents|sensory system agents|mesh-ancestor
64475458|NCT02111746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64475459|NCT01793272|Pentoxifylline|pentoxifylline|mesh-list
64475460|NCT01793272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64475461|NCT01793272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475462|NCT01793272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475463|NCT01793272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64475464|NCT01793272|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64475465|NCT01793272|Protective Agents|protective agents|mesh-ancestor
64475466|NCT01793272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475467|NCT01793272|Vasodilator Agents|vasodilator agents|mesh-ancestor
64475468|NCT01793272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64475469|NCT01793272|Antioxidants|antioxidants|mesh-ancestor
64475470|NCT00410488|Dexamethasone|dexamethasone|mesh-list
64475471|NCT00410488|Dexamethasone acetate|dexamethasone acetate|mesh-list
64475472|NCT00410488|Doxorubicin|doxorubicin|mesh-list
64475482|NCT00410488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64475483|NCT00410488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475484|NCT00410488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64475485|NCT00410488|Glucocorticoids|glucocorticoids|mesh-ancestor
64475486|NCT00410488|Hormones|hormones|mesh-ancestor
64475487|NCT00410488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64475488|NCT00410488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64475489|NCT00410488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475490|NCT00410488|Protease Inhibitors|protease inhibitors|mesh-ancestor
64475491|NCT00410488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475492|NCT00410488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475493|NCT00410488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64475494|NCT00410488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64475495|NCT00410488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64475496|NCT00410488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64475497|NCT00410488|Tubulin Modulators|tubulin modulators|mesh-ancestor
64475498|NCT00410488|Antimitotic Agents|antimitotic agents|mesh-ancestor
64475499|NCT00410488|Mitosis Modulators|mitosis modulators|mesh-ancestor
64475500|NCT00410488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64475501|NCT00410488|Alkylating Agents|alkylating agents|mesh-ancestor
64475502|NCT00410488|Protective Agents|protective agents|mesh-ancestor
64475503|NCT00410488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64475504|NCT00410488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64475505|NCT00410488|Serotonin Agents|serotonin agents|mesh-ancestor
64475506|NCT00410488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64475507|NCT00410488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64475509|NCT01793350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64475510|NCT01793350|Immunologic Factors|immunologic factors|mesh-ancestor
64475528|NCT00416494|Oxaliplatin|oxaliplatin|mesh-list
64475529|NCT00416494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64475530|NCT00416494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475531|NCT00416494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64475532|NCT00416494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64475533|NCT00416494|Growth Substances|growth substances|mesh-ancestor
64475534|NCT00416494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475535|NCT00416494|Growth Inhibitors|growth inhibitors|mesh-ancestor
64475536|NCT00416494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64475537|NCT00416494|Antimetabolites|antimetabolites|mesh-ancestor
64475538|NCT00416494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475539|NCT02845882|Cytarabine|cytarabine|mesh-list
64475540|NCT02845882|Dexamethasone|dexamethasone|mesh-list
64475541|NCT02845882|Dexamethasone acetate|dexamethasone acetate|mesh-list
64475542|NCT02845882|Prednisone|prednisone|mesh-list
64475543|NCT02845882|Cyclophosphamide|cyclophosphamide|mesh-list
64475544|NCT02845882|Ifosfamide|ifosfamide|mesh-list
64475588|NCT02845882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64475589|NCT02845882|Tubulin Modulators|tubulin modulators|mesh-ancestor
64475590|NCT02845882|Antimitotic Agents|antimitotic agents|mesh-ancestor
64475591|NCT02845882|Mitosis Modulators|mitosis modulators|mesh-ancestor
64475592|NCT03509584|Nivolumab|nivolumab|mesh-list
64475593|NCT03509584|Ipilimumab|ipilimumab|mesh-list
64475594|NCT03509584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64475595|NCT03509584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475596|NCT03509584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64475597|NCT03509584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475598|NCT00417274|Quinacrine|quinacrine|mesh-list
64475599|NCT00417274|Anticestodal Agents|anticestodal agents|mesh-ancestor
64475600|NCT00417274|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64475601|NCT00417274|Anthelmintics|anthelmintics|mesh-ancestor
64475602|NCT00417274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64475603|NCT00417274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64475604|NCT00417274|Antimalarials|antimalarials|mesh-ancestor
64475605|NCT00417274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64475606|NCT00417274|Antinematodal Agents|antinematodal agents|mesh-ancestor
64475607|NCT00417274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475608|NCT00417274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475609|NCT00417274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475610|NCT04749940|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64475640|NCT00423358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64475641|NCT00424840|Bevacizumab|bevacizumab|mesh-list
64475642|NCT00424840|Carboplatin|carboplatin|mesh-list
64475643|NCT00424840|Bortezomib|bortezomib|mesh-list
64475644|NCT00424840|Docetaxel|docetaxel|mesh-list
64475645|NCT00424840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64475646|NCT00424840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475647|NCT00424840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64475648|NCT00424840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64475649|NCT00424840|Growth Substances|growth substances|mesh-ancestor
64475650|NCT00424840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475652|NCT00424840|Tubulin Modulators|tubulin modulators|mesh-ancestor
64475653|NCT00424840|Antimitotic Agents|antimitotic agents|mesh-ancestor
64475654|NCT00424840|Mitosis Modulators|mitosis modulators|mesh-ancestor
64475655|NCT00424840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475656|NCT00425386|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64475657|NCT00425386|Sunitinib|sunitinib|mesh-list
64475658|NCT00425386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475659|NCT00425386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64475660|NCT00425386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475661|NCT00425386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475662|NCT00425386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64475663|NCT00425386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64475664|NCT00425386|Growth Substances|growth substances|mesh-ancestor
64475667|NCT01164202|Sunitinib|sunitinib|mesh-list
64475690|NCT02112370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64475691|NCT02112370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475692|NCT02112370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64475693|NCT02112370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64475694|NCT02112370|Autonomic Agents|autonomic agents|mesh-ancestor
64475695|NCT02112370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64475696|NCT02112370|Respiratory System Agents|respiratory system agents|mesh-ancestor
64475697|NCT02112370|Mydriatics|mydriatics|mesh-ancestor
64475698|NCT02112370|Sympathomimetics|sympathomimetics|mesh-ancestor
64475699|NCT02112370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64475700|NCT00427336|Cyclophosphamide|cyclophosphamide|mesh-list
64475701|NCT00427336|Fludarabine|fludarabine|mesh-list
64471363|NCT04581824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64475702|NCT00427336|Fludarabine phosphate|fludarabine phosphate|mesh-list
64475703|NCT00427336|Thymoglobulin|thymoglobulin|mesh-list
64475704|NCT00427336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64475705|NCT00427336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64475706|NCT00427336|Immunologic Factors|immunologic factors|mesh-ancestor
64475707|NCT00427336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475708|NCT00427336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64475743|NCT00428584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64475744|NCT05187286|Apixaban|apixaban|mesh-list
64475745|NCT05187286|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64475746|NCT05187286|Antithrombins|antithrombins|mesh-ancestor
64475747|NCT05187286|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64475748|NCT05187286|Protease Inhibitors|protease inhibitors|mesh-ancestor
64475749|NCT05187286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475750|NCT05187286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475751|NCT05187286|Anticoagulants|anticoagulants|mesh-ancestor
64475752|NCT00372970|Botulinum Toxins|botulinum toxins|mesh-list
64475753|NCT00372970|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64475754|NCT00372970|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64475755|NCT00372970|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64475756|NCT00372970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64475757|NCT00372970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475758|NCT00372970|Cholinergic Agents|cholinergic agents|mesh-ancestor
64475759|NCT00372970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64475760|NCT00372970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475761|NCT00372970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64475762|NCT00372970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64475763|NCT00373360|Treprostinil|treprostinil|mesh-list
64475764|NCT00373360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64475796|NCT00434356|Paclitaxel|paclitaxel|mesh-list
64475797|NCT00434356|Bevacizumab|bevacizumab|mesh-list
64475798|NCT00434356|Sunitinib|sunitinib|mesh-list
64713991|NCT03043105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475799|NCT00434356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64461345|NCT03084328|Vitamin D|vitamin d|mesh-list
64475800|NCT00434356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475801|NCT00434356|Tubulin Modulators|tubulin modulators|mesh-ancestor
64475802|NCT00434356|Antimitotic Agents|antimitotic agents|mesh-ancestor
64475803|NCT00434356|Mitosis Modulators|mitosis modulators|mesh-ancestor
64475804|NCT00434356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475805|NCT00434356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64475806|NCT00434356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64475807|NCT00434356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64475808|NCT00434356|Growth Substances|growth substances|mesh-ancestor
64475809|NCT00434356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475810|NCT00434356|Growth Inhibitors|growth inhibitors|mesh-ancestor
64475811|NCT00434356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64475812|NCT00434356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475848|NCT00456508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64475849|NCT00456508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64475850|NCT00456508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64475851|NCT00457366|Lorazepam|lorazepam|mesh-list
64475852|NCT00457366|Haloperidol|haloperidol|mesh-list
64475853|NCT00457366|Benztropine|benztropine|mesh-list
64475854|NCT00457366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64475855|NCT00457366|Haloperidol decanoate|haloperidol decanoate|mesh-list
64475856|NCT00457366|Antidepressive Agents|antidepressive agents|mesh-ancestor
64475857|NCT00457366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64475858|NCT00457366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64475859|NCT00457366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64475860|NCT00457366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64475861|NCT00457366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475862|NCT00457366|Antiemetics|antiemetics|mesh-ancestor
64475863|NCT00457366|Autonomic Agents|autonomic agents|mesh-ancestor
64475864|NCT00457366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64475865|NCT00457366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64475866|NCT00457366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64475867|NCT00457366|Dopamine Agents|dopamine agents|mesh-ancestor
64475868|NCT00457366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64475869|NCT00457366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475870|NCT00457366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64475871|NCT00457366|Anticonvulsants|anticonvulsants|mesh-ancestor
64475872|NCT00457366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64713992|NCT03043105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64475900|NCT00458848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64475901|NCT00458848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64475902|NCT00458848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64475903|NCT00458848|Abortifacient Agents|abortifacient agents|mesh-ancestor
64475904|NCT00458848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64475905|NCT00458848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64475906|NCT00458848|Antimetabolites|antimetabolites|mesh-ancestor
64475907|NCT00458848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475908|NCT00458848|Dermatologic Agents|dermatologic agents|mesh-ancestor
64475909|NCT00458848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475910|NCT00458848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64475911|NCT00458848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64475912|NCT00458848|Immunologic Factors|immunologic factors|mesh-ancestor
64475913|NCT00458848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64475914|NCT00458848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64475915|NCT00458848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64475916|NCT00458848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64475917|NCT00458848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64475918|NCT00458848|Tubulin Modulators|tubulin modulators|mesh-ancestor
64475919|NCT00458848|Antimitotic Agents|antimitotic agents|mesh-ancestor
64475920|NCT00458848|Mitosis Modulators|mitosis modulators|mesh-ancestor
64475921|NCT00458848|Antiemetics|antiemetics|mesh-ancestor
64475922|NCT00458848|Autonomic Agents|autonomic agents|mesh-ancestor
64475923|NCT00458848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64475924|NCT00458848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64475925|NCT00458848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64475926|NCT00458848|Protective Agents|protective agents|mesh-ancestor
64475927|NCT00458848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64475928|NCT00458848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64475929|NCT00458848|Analgesics|analgesics|mesh-ancestor
64475930|NCT00458848|Sensory System Agents|sensory system agents|mesh-ancestor
64475943|NCT00438880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64475944|NCT00438880|Antibodies|antibodies|mesh-list
64475945|NCT00438880|Immunoglobulins|immunoglobulins|mesh-list
64475946|NCT00438880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64475947|NCT00438880|Immunologic Factors|immunologic factors|mesh-ancestor
64713993|NCT03043105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64475948|NCT00438880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475949|NCT00438880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461488|NCT05346952|Pemetrexed|pemetrexed|mesh-list
64475950|NCT00438880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64475951|NCT00378352|Epoetin Alfa|epoetin alfa|mesh-list
64475952|NCT00378352|Hematinics|hematinics|mesh-ancestor
64475954|NCT00462280|L 647318|l 647318|mesh-list
64475955|NCT00462280|Dihydromevinolin|dihydromevinolin|mesh-list
64475956|NCT00462280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64475957|NCT00462280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64475958|NCT00462280|Antimetabolites|antimetabolites|mesh-ancestor
64475959|NCT00462280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475960|NCT00462280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64475961|NCT00462280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64475962|NCT00462280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64475963|NCT00381004|Cyclophosphamide|cyclophosphamide|mesh-list
64475964|NCT00381004|Rituximab|rituximab|mesh-list
64475965|NCT00381004|Fludarabine|fludarabine|mesh-list
64475966|NCT00381004|Fludarabine phosphate|fludarabine phosphate|mesh-list
64475967|NCT00381004|Sargramostim|sargramostim|mesh-list
64475968|NCT00381004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64475969|NCT00381004|Immunologic Factors|immunologic factors|mesh-ancestor
64475970|NCT00381004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475979|NCT00381004|Antimetabolites|antimetabolites|mesh-ancestor
64475989|NCT00440830|Nicotine|nicotine|mesh-list
64475990|NCT00440830|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64475991|NCT00440830|Autonomic Agents|autonomic agents|mesh-ancestor
64475992|NCT00440830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64475993|NCT00440830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64475994|NCT00440830|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64475995|NCT00440830|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64475996|NCT00440830|Cholinergic Agents|cholinergic agents|mesh-ancestor
64475997|NCT00440830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64475998|NCT00440830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64475999|NCT00381862|Leucovorin|leucovorin|mesh-list
64476000|NCT00381862|Dexamethasone|dexamethasone|mesh-list
64476001|NCT00381862|Fluorouracil|fluorouracil|mesh-list
64476002|NCT00381862|Oxaliplatin|oxaliplatin|mesh-list
64476003|NCT00381862|Irinotecan|irinotecan|mesh-list
64476004|NCT00381862|Camptothecin|camptothecin|mesh-list
64476005|NCT00381862|Aprepitant|aprepitant|mesh-list
64476006|NCT00381862|Palonosetron|palonosetron|mesh-list
64476007|NCT00381862|Levoleucovorin|levoleucovorin|mesh-list
64476008|NCT00381862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64476009|NCT00381862|Antiemetics|antiemetics|mesh-ancestor
64476010|NCT00381862|Autonomic Agents|autonomic agents|mesh-ancestor
64476011|NCT00381862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64476012|NCT00381862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476041|NCT00464698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64476042|NCT00464698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476043|NCT00464698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64476044|NCT00464698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476045|NCT00464698|Analgesics|analgesics|mesh-ancestor
64476046|NCT00464698|Sensory System Agents|sensory system agents|mesh-ancestor
64476047|NCT00464698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64476048|NCT00464698|Antidepressive Agents|antidepressive agents|mesh-ancestor
64476049|NCT00464698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64476050|NCT00464698|Dopamine Agents|dopamine agents|mesh-ancestor
64476052|NCT00465088|Niacinamide|niacinamide|mesh-list
64476053|NCT00465088|Nicotinic Acids|nicotinic acids|mesh-list
64476054|NCT00465088|Atorvastatin|atorvastatin|mesh-list
64476055|NCT00465088|Simvastatin|simvastatin|mesh-list
64476056|NCT00465088|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64476057|NCT00465088|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64476058|NCT00465088|Antimetabolites|antimetabolites|mesh-ancestor
64476060|NCT00465088|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64476100|NCT00444028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64476101|NCT00444028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476103|NCT00444028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64476105|NCT00444028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64476106|NCT00444028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476107|NCT00444964|Hormones|hormones|mesh-list
64476108|NCT00444964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64476109|NCT00444964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476110|NCT00445588|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64476111|NCT00445588|Sorafenib|sorafenib|mesh-list
64476112|NCT00445588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476113|NCT00445588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64476114|NCT00445588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476115|NCT00445588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476116|NCT00445744|Cyclophosphamide|cyclophosphamide|mesh-list
64476117|NCT00445744|Busulfan|busulfan|mesh-list
64476118|NCT00445744|Methotrexate|methotrexate|mesh-list
64476119|NCT00445744|Tacrolimus|tacrolimus|mesh-list
64476156|NCT00385138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476157|NCT00446290|Docetaxel|docetaxel|mesh-list
64476158|NCT00446290|Capecitabine|capecitabine|mesh-list
64476159|NCT00446290|Oxaliplatin|oxaliplatin|mesh-list
64476160|NCT00446290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476161|NCT00446290|Tubulin Modulators|tubulin modulators|mesh-ancestor
64476162|NCT00446290|Antimitotic Agents|antimitotic agents|mesh-ancestor
64476163|NCT00446290|Mitosis Modulators|mitosis modulators|mesh-ancestor
64476164|NCT00446290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476165|NCT00446290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64476166|NCT00446290|Antimetabolites|antimetabolites|mesh-ancestor
64476167|NCT00385216|Nicotine|nicotine|mesh-list
64476168|NCT00385216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64476169|NCT00385216|Autonomic Agents|autonomic agents|mesh-ancestor
64476170|NCT00385216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64476171|NCT00385216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476172|NCT00385216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64476173|NCT00385216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64476174|NCT00385216|Cholinergic Agents|cholinergic agents|mesh-ancestor
64476175|NCT00385216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64476176|NCT00385216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476177|NCT00385996|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64476178|NCT00385996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476179|NCT00385996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64476180|NCT00385996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476181|NCT00385996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476184|NCT00470392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64476185|NCT00470392|Immunologic Factors|immunologic factors|mesh-ancestor
64476187|NCT00470392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476204|NCT00470548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64476205|NCT00388414|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64476206|NCT00388414|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64476207|NCT00388414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64476208|NCT00388414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64476209|NCT00388414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476210|NCT00388414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64476211|NCT00388414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476212|NCT00388414|Analgesics|analgesics|mesh-ancestor
64476213|NCT00388414|Sensory System Agents|sensory system agents|mesh-ancestor
64476214|NCT00388414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64476215|NCT00388414|Antidepressive Agents|antidepressive agents|mesh-ancestor
64476216|NCT00388414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64476217|NCT00388414|Dopamine Agents|dopamine agents|mesh-ancestor
64476218|NCT00475150|Cediranib|cediranib|mesh-list
64476219|NCT00475150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476220|NCT00475150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476221|NCT00475150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476222|NCT00475150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64476223|NCT00451048|Sunitinib|sunitinib|mesh-list
64476224|NCT00451048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476225|NCT00451048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64476226|NCT00451048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64476227|NCT00451048|Growth Substances|growth substances|mesh-ancestor
64476253|NCT00389818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64476254|NCT00389818|Immunologic Factors|immunologic factors|mesh-ancestor
64476255|NCT00389818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476256|NCT00389818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64476257|NCT00389818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64476258|NCT00389818|Alkylating Agents|alkylating agents|mesh-ancestor
64476259|NCT00389818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476260|NCT00389818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476261|NCT00389818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64476262|NCT00389818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64476263|NCT00389818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64476264|NCT00389818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64476265|NCT00389818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64476266|NCT00389818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476267|NCT00389818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64476268|NCT00389818|Glucocorticoids|glucocorticoids|mesh-ancestor
64476270|NCT00389818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64476271|NCT00389818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64476272|NCT00389818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64476273|NCT00389818|Tubulin Modulators|tubulin modulators|mesh-ancestor
64476274|NCT00389818|Antimitotic Agents|antimitotic agents|mesh-ancestor
64476275|NCT00389818|Mitosis Modulators|mitosis modulators|mesh-ancestor
64476276|NCT00452374|Cytarabine|cytarabine|mesh-list
64476277|NCT00452374|Rituximab|rituximab|mesh-list
64476278|NCT00452374|Oxaliplatin|oxaliplatin|mesh-list
64476279|NCT00452374|Fludarabine|fludarabine|mesh-list
64476280|NCT00452374|Fludarabine phosphate|fludarabine phosphate|mesh-list
64476281|NCT00452374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64476282|NCT00452374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476283|NCT00452374|Immunologic Factors|immunologic factors|mesh-ancestor
64476284|NCT00452374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476294|NCT03286114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476295|NCT00476242|Naltrexone|naltrexone|mesh-list
64476296|NCT00476242|Memantine|memantine|mesh-list
64476297|NCT00476242|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64476298|NCT00476242|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64471365|NCT04559334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64471366|NCT04551495|Letrozole|letrozole|mesh-list
64476299|NCT00476242|Dopamine Agents|dopamine agents|mesh-ancestor
64476300|NCT00476242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64476301|NCT00476242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476360|NCT04062123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64476361|NCT04062123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64476362|NCT04062123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476363|NCT04062123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64476364|NCT04062123|Anesthetics, General|anesthetics, general|mesh-ancestor
64476365|NCT04062123|Anesthetics|anesthetics|mesh-ancestor
64476366|NCT04062123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64476367|NCT04062123|Analgesics|analgesics|mesh-ancestor
64476368|NCT04062123|Sensory System Agents|sensory system agents|mesh-ancestor
64476369|NCT04062123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64476370|NCT04062123|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64476371|NCT04062123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64471367|NCT04551495|Goserelin|goserelin|mesh-list
64476372|NCT04062123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64476373|NCT04062123|Adrenergic Agents|adrenergic agents|mesh-ancestor
64476374|NCT04062123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64476375|NCT04062123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476376|NCT04062123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64476377|NCT04062123|Narcotics|narcotics|mesh-ancestor
64476378|NCT04062123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64476379|NCT00389974|Sunitinib|sunitinib|mesh-list
64476380|NCT00389974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476381|NCT00389974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64476382|NCT00389974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64476389|NCT01453725|Golimumab|golimumab|mesh-list
64476409|NCT02110264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64476410|NCT01795222|Midazolam|midazolam|mesh-list
64476411|NCT01795222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64476412|NCT01795222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64476413|NCT01795222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64476414|NCT01795222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476415|NCT01795222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64476416|NCT01795222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64476417|NCT01795222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64476418|NCT01795222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64476419|NCT01795222|Anesthetics, General|anesthetics, general|mesh-ancestor
64476420|NCT01795222|Anesthetics|anesthetics|mesh-ancestor
64476421|NCT01795222|GABA Modulators|gaba modulators|mesh-ancestor
64476422|NCT01795222|GABA Agents|gaba agents|mesh-ancestor
64476423|NCT01795222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64476424|NCT01795222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476425|NCT01415349|Omeprazole|omeprazole|mesh-list
64476426|NCT01415349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64476427|NCT01415349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64476428|NCT01415349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64476429|NCT01415349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476430|NCT01415349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476431|NCT00528190|Itraconazole|itraconazole|mesh-list
64476432|NCT00528190|Antifungal Agents|antifungal agents|mesh-ancestor
64476433|NCT00528190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64476434|NCT00528190|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64476435|NCT00528190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64476455|NCT02334813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476456|NCT00478036|Prednisolone|prednisolone|mesh-list
64476457|NCT00478036|Prednisolone acetate|prednisolone acetate|mesh-list
64476458|NCT00478036|Ketorolac|ketorolac|mesh-list
64476459|NCT00478036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64476460|NCT00478036|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64476461|NCT00478036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64476462|NCT00478036|Glucocorticoids|glucocorticoids|mesh-ancestor
64476463|NCT00478036|Hormones|hormones|mesh-ancestor
64476464|NCT00478036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64476465|NCT00478036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476466|NCT00478036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64476467|NCT00478036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476468|NCT00478036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64476469|NCT00478036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64600861|NCT02993159|Afimoxifene|afimoxifene|mesh-list
64476470|NCT00478036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64476471|NCT00478036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64476472|NCT00478036|Analgesics|analgesics|mesh-ancestor
64476473|NCT00478036|Sensory System Agents|sensory system agents|mesh-ancestor
64476474|NCT00478036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64476510|NCT00478192|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64476511|NCT00478192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476512|NCT00478192|Natriuretic Agents|natriuretic agents|mesh-ancestor
64476513|NCT00478192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476514|NCT01414257|Methotrexate|methotrexate|mesh-list
64476515|NCT01414257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64476516|NCT01414257|Abortifacient Agents|abortifacient agents|mesh-ancestor
64476517|NCT01414257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64471369|NCT04551495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471370|NCT04551495|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64476518|NCT01414257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476519|NCT01414257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64476521|NCT01414257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476522|NCT01414257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476523|NCT01414257|Dermatologic Agents|dermatologic agents|mesh-ancestor
64476524|NCT01414257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476525|NCT01414257|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64476526|NCT01414257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64476527|NCT01414257|Immunologic Factors|immunologic factors|mesh-ancestor
64476528|NCT01414257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64476532|NCT00528580|Simvastatin|simvastatin|mesh-list
64476560|NCT00529126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64476561|NCT00529204|Exenatide|exenatide|mesh-list
64476562|NCT00529204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64476563|NCT00529204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476564|NCT00529204|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64476565|NCT00529204|Incretins|incretins|mesh-ancestor
64476566|NCT00529204|Hormones|hormones|mesh-ancestor
64476567|NCT00529204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64476568|NCT01451541|Ciclesonide|ciclesonide|mesh-list
64476569|NCT01451541|Glucocorticoids|glucocorticoids|mesh-ancestor
64476570|NCT01451541|Hormones|hormones|mesh-ancestor
64476571|NCT01451541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64476572|NCT01451541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476573|NCT01451541|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64476574|NCT00530764|Nabiximols|nabiximols|mesh-list
64476575|NCT00530764|Dronabinol|dronabinol|mesh-list
64476576|NCT00530764|Cannabidiol|cannabidiol|mesh-list
64476577|NCT00530764|Analgesics|analgesics|mesh-ancestor
64476578|NCT00530764|Sensory System Agents|sensory system agents|mesh-ancestor
64476579|NCT00530764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64476580|NCT00530764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476581|NCT00530764|Anticonvulsants|anticonvulsants|mesh-ancestor
64476582|NCT00530764|Hallucinogens|hallucinogens|mesh-ancestor
64476583|NCT00530764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64476610|NCT00483496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476611|NCT00483496|Dermatologic Agents|dermatologic agents|mesh-ancestor
64476612|NCT00483496|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64476613|NCT00485836|Ranibizumab|ranibizumab|mesh-list
64476614|NCT00485836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64476615|NCT00485836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64476616|NCT00485836|Growth Substances|growth substances|mesh-ancestor
64476617|NCT00485836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476618|NCT00485836|Growth Inhibitors|growth inhibitors|mesh-ancestor
64476619|NCT00485836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476620|NCT00488488|Tigecycline|tigecycline|mesh-list
64476621|NCT00488488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64713995|NCT03043105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476622|NCT00488488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64476623|NCT00488488|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64476624|NCT00488488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476625|NCT00488488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476626|NCT04149574|Nivolumab|nivolumab|mesh-list
64476627|NCT04149574|BCG Vaccine|bcg vaccine|mesh-list
64476628|NCT04149574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64476629|NCT04149574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476630|NCT04149574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64476631|NCT04149574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476632|NCT04149574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64476633|NCT04149574|Immunologic Factors|immunologic factors|mesh-ancestor
64476657|NCT00538642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64476658|NCT00538642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64476659|NCT00538642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64476660|NCT00538642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64476661|NCT00538642|Dopamine Agents|dopamine agents|mesh-ancestor
64476662|NCT01433991|Lenvatinib|lenvatinib|mesh-list
64476663|NCT01433991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476664|NCT01433991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64476665|NCT01433991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476666|NCT01433991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476667|NCT01450683|Itraconazole|itraconazole|mesh-list
64476668|NCT01450683|Antifungal Agents|antifungal agents|mesh-ancestor
64476669|NCT01450683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64476670|NCT01450683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64476671|NCT01450683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64476672|NCT01450683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476673|NCT01450683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476713|NCT01411995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64476714|NCT01411995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64476715|NCT01411995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64476716|NCT01411995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64476717|NCT01411995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64476718|NCT01411995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476719|NCT01411215|Etanercept|etanercept|mesh-list
64476720|NCT01411215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64476721|NCT01411215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64476722|NCT01411215|Analgesics|analgesics|mesh-ancestor
64476723|NCT01411215|Sensory System Agents|sensory system agents|mesh-ancestor
64476724|NCT01411215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64476725|NCT01411215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476726|NCT01411215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64476771|NCT00540982|Antimitotic Agents|antimitotic agents|mesh-ancestor
64476772|NCT00540982|Mitosis Modulators|mitosis modulators|mesh-ancestor
64476773|NCT00542308|Zalutumumab|zalutumumab|mesh-list
64476774|NCT00542308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64476775|NCT00542308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476777|NCT00542620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64476778|NCT00542620|Insulin Aspart|insulin aspart|mesh-list
64476779|NCT00542620|Insulin, Long-Acting|insulin, long-acting|mesh-list
64476780|NCT00542620|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64476781|NCT00542620|Insulin Detemir|insulin detemir|mesh-list
64476782|NCT00542620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64476783|NCT00542620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476784|NCT00543400|Heparin|heparin|mesh-list
64476785|NCT00543400|Calcium heparin|calcium heparin|mesh-list
64476786|NCT00543400|Anticoagulants|anticoagulants|mesh-ancestor
64476787|NCT00543400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64476788|NCT00543400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64476789|NCT00543400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476790|NCT01796938|Lacosamide|lacosamide|mesh-list
64476791|NCT01796938|Anticonvulsants|anticonvulsants|mesh-ancestor
64476792|NCT01796938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64476793|NCT01796938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64476794|NCT01796938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64476795|NCT01796938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476796|NCT00492544|Vaccines|vaccines|mesh-list
64476797|NCT00492544|Immunologic Factors|immunologic factors|mesh-ancestor
64476799|NCT00492622|Omeprazole|omeprazole|mesh-list
64476819|NCT03145558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64476820|NCT03145558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476821|NCT03145558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476822|NCT00497770|Pemetrexed|pemetrexed|mesh-list
64476823|NCT00497770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476824|NCT00497770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476825|NCT00497770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476826|NCT00497770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64476827|NCT00497770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64476828|NCT00498550|Clozapine|clozapine|mesh-list
64476829|NCT00498550|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64476830|NCT00498550|Serotonin Agents|serotonin agents|mesh-ancestor
64476881|NCT03495388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64476882|NCT00500578|Ribavirin|ribavirin|mesh-list
64476883|NCT00500578|Antimetabolites|antimetabolites|mesh-ancestor
64476884|NCT00500578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476885|NCT00500578|Antiviral Agents|antiviral agents|mesh-ancestor
64476886|NCT00500578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64476887|NCT01430559|Meloxicam|meloxicam|mesh-list
64476888|NCT01430559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64476889|NCT01430559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64476890|NCT01430559|Analgesics|analgesics|mesh-ancestor
64476891|NCT01430559|Sensory System Agents|sensory system agents|mesh-ancestor
64476892|NCT01430559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64476893|NCT01430559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476894|NCT01430559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64476895|NCT01430559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64476896|NCT01430559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64476897|NCT01430559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64476898|NCT01430559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476899|NCT01430559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476900|NCT00500656|Icatibant|icatibant|mesh-list
64476901|NCT00500656|Tranexamic Acid|tranexamic acid|mesh-list
64476902|NCT00500656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64476903|NCT00500656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64476904|NCT00500656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476905|NCT00500656|Hemostatics|hemostatics|mesh-ancestor
64476906|NCT00500656|Coagulants|coagulants|mesh-ancestor
64476907|NCT00500656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64476908|NCT00500656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64476910|NCT00500656|Sensory System Agents|sensory system agents|mesh-ancestor
64476911|NCT00500656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64476912|NCT00500656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476913|NCT00500656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64476914|NCT00500656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64476915|NCT00500656|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
64476916|NCT00500656|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
64977747|NCT00265408|Aspirin|aspirin|mesh-list
64951608|NCT00054561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951609|NCT00054561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476917|NCT00500656|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64476918|NCT00500656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64476919|NCT00500656|Immunologic Factors|immunologic factors|mesh-ancestor
64476920|NCT01409811|Zoledronic Acid|zoledronic acid|mesh-list
64476921|NCT01409811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64476922|NCT01409811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476923|NCT01445847|Lidocaine|lidocaine|mesh-list
64476924|NCT01445847|Anesthetics, Local|anesthetics, local|mesh-ancestor
64476925|NCT01445847|Anesthetics|anesthetics|mesh-ancestor
64476926|NCT01445847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64476927|NCT01445847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64476928|NCT01445847|Sensory System Agents|sensory system agents|mesh-ancestor
64476929|NCT01445847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64476930|NCT01445847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64476935|NCT00502216|Naltrexone|naltrexone|mesh-list
64476976|NCT02675452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476977|NCT02675452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64476978|NCT02675452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476979|NCT02675452|Antifungal Agents|antifungal agents|mesh-ancestor
64476980|NCT02675452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64476981|NCT02675452|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64476982|NCT02675452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64476983|NCT02675452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64476984|NCT02675452|Hormone Antagonists|hormone antagonists|mesh-ancestor
64476985|NCT02675452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64476986|NCT02675452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477037|NCT01445535|Rituximab|rituximab|mesh-list
64477038|NCT01445535|Doxorubicin|doxorubicin|mesh-list
64477039|NCT01445535|Etoposide|etoposide|mesh-list
64477040|NCT01445535|Vincristine|vincristine|mesh-list
64477041|NCT01445535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64477042|NCT01445535|Immunologic Factors|immunologic factors|mesh-ancestor
64477043|NCT01445535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477044|NCT01445535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64477045|NCT01445535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64477046|NCT01445535|Alkylating Agents|alkylating agents|mesh-ancestor
64477047|NCT01445535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477048|NCT01445535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477049|NCT01445535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64477050|NCT01445535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64477051|NCT01445535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64471375|NCT04551495|Hormone Antagonists|hormone antagonists|mesh-ancestor
64477098|NCT01429077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477099|NCT01408563|Fludarabine|fludarabine|mesh-list
64477100|NCT01408563|Melphalan|melphalan|mesh-list
64477101|NCT01408563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477102|NCT01408563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477103|NCT01408563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64477104|NCT01408563|Immunologic Factors|immunologic factors|mesh-ancestor
64477105|NCT01408563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477106|NCT01408563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64477107|NCT01408563|Alkylating Agents|alkylating agents|mesh-ancestor
64477108|NCT01408563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64477109|NCT01442493|Methadone|methadone|mesh-list
64477110|NCT01442493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64477111|NCT01442493|Narcotics|narcotics|mesh-ancestor
64477112|NCT01442493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64477113|NCT01442493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477114|NCT01442493|Analgesics|analgesics|mesh-ancestor
64477115|NCT01442493|Sensory System Agents|sensory system agents|mesh-ancestor
64477116|NCT01442493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64477117|NCT01442493|Antitussive Agents|antitussive agents|mesh-ancestor
64477118|NCT01442493|Respiratory System Agents|respiratory system agents|mesh-ancestor
64477119|NCT04407975|Betamethasone|betamethasone|mesh-list
64477120|NCT04407975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64477121|NCT04407975|Glucocorticoids|glucocorticoids|mesh-ancestor
64477122|NCT04407975|Hormones|hormones|mesh-ancestor
64477123|NCT04407975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64477124|NCT04407975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477145|NCT00513292|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64477147|NCT00513292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64477148|NCT00513292|Antibodies|antibodies|mesh-list
64477149|NCT00513292|Immunoglobulins|immunoglobulins|mesh-list
64477150|NCT00513292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64477151|NCT00513292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64477152|NCT00513292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477153|NCT00513292|Tubulin Modulators|tubulin modulators|mesh-ancestor
64477154|NCT00513292|Antimitotic Agents|antimitotic agents|mesh-ancestor
64477155|NCT00513292|Mitosis Modulators|mitosis modulators|mesh-ancestor
64477156|NCT00513292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477157|NCT00513292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64477158|NCT00513292|Immunologic Factors|immunologic factors|mesh-ancestor
64477159|NCT00513292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477160|NCT00513292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64477161|NCT00513292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64477162|NCT00513292|Alkylating Agents|alkylating agents|mesh-ancestor
64477163|NCT00513292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64477164|NCT00513292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64477165|NCT00513292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64477166|NCT00513292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64477167|NCT00513292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477168|NCT00513370|Adalimumab|adalimumab|mesh-list
64477169|NCT00513370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64477170|NCT00513370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64477171|NCT00559468|Bromides|bromides|mesh-list
64477172|NCT00559468|Propofol|propofol|mesh-list
64477173|NCT00559468|Sevoflurane|sevoflurane|mesh-list
64477174|NCT00559468|Rocuronium|rocuronium|mesh-list
64477175|NCT00559468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64514720|NCT02395497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477176|NCT00559468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64477177|NCT00559468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477178|NCT00559468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64477180|NCT00559468|Anesthetics|anesthetics|mesh-ancestor
64477181|NCT00559468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64477182|NCT00559468|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64477183|NCT00559468|Anticonvulsants|anticonvulsants|mesh-ancestor
64951610|NCT00054561|Antiviral Agents|antiviral agents|mesh-ancestor
64477184|NCT00559468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64477185|NCT00559468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64477186|NCT00559468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64477187|NCT00559468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64477188|NCT00513526|Vaccines|vaccines|mesh-list
64477189|NCT00513526|Immunologic Factors|immunologic factors|mesh-ancestor
64477190|NCT00513526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477191|NCT00561418|Vorinostat|vorinostat|mesh-list
64477192|NCT00561418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477193|NCT00561418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64477194|NCT00561418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477195|NCT00561418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477196|NCT00514852|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64477197|NCT00514852|Lubricant Eye Drops|lubricant eye drops|mesh-list
64477198|NCT00514852|Glycerol|glycerol|mesh-list
64477199|NCT00514852|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64477200|NCT00514852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64477201|NCT00514852|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64477202|NCT00514852|Protective Agents|protective agents|mesh-ancestor
64477203|NCT00514852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477204|NCT00514852|Laxatives|laxatives|mesh-ancestor
64477205|NCT00514852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64477206|NCT00555880|Midodrine|midodrine|mesh-list
64477207|NCT00555880|Sympathomimetics|sympathomimetics|mesh-ancestor
64477208|NCT00555880|Autonomic Agents|autonomic agents|mesh-ancestor
64477209|NCT00555880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64477210|NCT00555880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477211|NCT00555880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64477212|NCT00555880|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64477213|NCT00555880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64477214|NCT00555880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64477215|NCT00555880|Adrenergic Agents|adrenergic agents|mesh-ancestor
64477216|NCT00555880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64477217|NCT00555880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477218|NCT00563290|Dasatinib|dasatinib|mesh-list
64477222|NCT00563290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477223|NCT00556504|Ribavirin|ribavirin|mesh-list
64477224|NCT00556504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64477225|NCT00556504|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64477226|NCT00556504|Antimetabolites|antimetabolites|mesh-ancestor
64477227|NCT00556504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477228|NCT00556504|Antiviral Agents|antiviral agents|mesh-ancestor
64477229|NCT00556504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64477230|NCT02128828|Cenicriviroc|cenicriviroc|mesh-list
64477231|NCT02128828|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64477232|NCT02128828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477233|NCT02128828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64477234|NCT02128828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64477235|NCT02128828|Antiviral Agents|antiviral agents|mesh-ancestor
64477236|NCT02128828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64477237|NCT00520234|Caspofungin|caspofungin|mesh-list
64477238|NCT00520234|Antifungal Agents|antifungal agents|mesh-ancestor
64477239|NCT00520234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64477240|NCT00520234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477241|NCT00520234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477243|NCT00520468|Prednisone|prednisone|mesh-list
64477275|NCT05560516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64477276|NCT05560516|Dopamine Agents|dopamine agents|mesh-ancestor
64477277|NCT05559268|Denosumab|denosumab|mesh-list
64477278|NCT05559268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64477279|NCT05559268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477280|NCT02121418|Cytarabine|cytarabine|mesh-list
64477281|NCT02121418|Decitabine|decitabine|mesh-list
64477282|NCT02121418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64477283|NCT02121418|Antimetabolites|antimetabolites|mesh-ancestor
64477284|NCT02121418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477285|NCT02121418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477286|NCT02121418|Antiviral Agents|antiviral agents|mesh-ancestor
64477287|NCT02121418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64477288|NCT02121418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64477289|NCT02121418|Immunologic Factors|immunologic factors|mesh-ancestor
64477290|NCT02121418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477291|NCT02121418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477292|NCT01441635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64477293|NCT01441635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64477294|NCT01441635|Norethindrone|norethindrone|mesh-list
64477295|NCT01441635|Norethindrone Acetate|norethindrone acetate|mesh-list
64477296|NCT01441635|Estradiol|estradiol|mesh-list
64477329|NCT02985333|Immunologic Factors|immunologic factors|mesh-ancestor
64477330|NCT02985333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477331|NCT02985333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64477332|NCT02985333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64477333|NCT02985333|Alkylating Agents|alkylating agents|mesh-ancestor
64477334|NCT02985333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64477335|NCT02985333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64477336|NCT02985333|Antiemetics|antiemetics|mesh-ancestor
64477337|NCT02985333|Autonomic Agents|autonomic agents|mesh-ancestor
64477338|NCT02985333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64477339|NCT02985333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64477340|NCT02985333|Glucocorticoids|glucocorticoids|mesh-ancestor
64477341|NCT02985333|Hormones|hormones|mesh-ancestor
64477342|NCT02985333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64477343|NCT02985333|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64477344|NCT01427751|Dexamethasone|dexamethasone|mesh-list
64477345|NCT01427751|Ranibizumab|ranibizumab|mesh-list
64477346|NCT01427751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64477347|NCT01427751|Antiemetics|antiemetics|mesh-ancestor
64477348|NCT01427751|Autonomic Agents|autonomic agents|mesh-ancestor
64477388|NCT04415983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64477389|NCT04415983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64477390|NCT01426269|Metronidazole|metronidazole|mesh-list
64477391|NCT01426269|Doxycycline|doxycycline|mesh-list
64477392|NCT01426269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64477393|NCT01426269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64477394|NCT01426269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64477395|NCT01426269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64477396|NCT01426269|Antimalarials|antimalarials|mesh-ancestor
64477397|NCT01426113|Timolol|timolol|mesh-list
64477398|NCT01426113|Bimatoprost|bimatoprost|mesh-list
64477399|NCT01426113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64477400|NCT01426113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64477401|NCT01426113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64477402|NCT01426113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64477403|NCT01426113|Adrenergic Agents|adrenergic agents|mesh-ancestor
64477404|NCT01426113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64477405|NCT01426113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477407|NCT01426113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64477443|NCT01425801|Adrenergic Agents|adrenergic agents|mesh-ancestor
64477444|NCT01425801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64477445|NCT01425801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477446|NCT02335125|Psychotropic Drugs|psychotropic drugs|mesh-list
64477447|NCT02076243|Paclitaxel|paclitaxel|mesh-list
64477448|NCT02076243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64477449|NCT02076243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477451|NCT02076243|Antimitotic Agents|antimitotic agents|mesh-ancestor
64477452|NCT02076243|Mitosis Modulators|mitosis modulators|mesh-ancestor
64477453|NCT02076243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477454|NCT01392963|Botulinum Toxins|botulinum toxins|mesh-list
64477456|NCT01392963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64477505|NCT01392183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64477506|NCT01392183|Antiemetics|antiemetics|mesh-ancestor
64477507|NCT01392183|Autonomic Agents|autonomic agents|mesh-ancestor
64477508|NCT01392183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64477509|NCT01392183|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64477510|NCT01392183|Histamine Antagonists|histamine antagonists|mesh-ancestor
64477511|NCT01392183|Histamine Agents|histamine agents|mesh-ancestor
64477512|NCT01392183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64477513|NCT01392183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477514|NCT01392183|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64477515|NCT01402947|Ciprofloxacin|ciprofloxacin|mesh-list
64477516|NCT01402947|Mesalamine|mesalamine|mesh-list
64477521|NCT01402947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477566|NCT01402869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64477567|NCT01402869|Autonomic Agents|autonomic agents|mesh-ancestor
64477568|NCT01402869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64477569|NCT01402869|Respiratory System Agents|respiratory system agents|mesh-ancestor
64477570|NCT01402869|Mydriatics|mydriatics|mesh-ancestor
64477571|NCT01402869|Sympathomimetics|sympathomimetics|mesh-ancestor
64477572|NCT01402869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64477573|NCT01391793|Dexamethasone|dexamethasone|mesh-list
64477574|NCT01391793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64477575|NCT01391793|Antiemetics|antiemetics|mesh-ancestor
64477576|NCT01391793|Autonomic Agents|autonomic agents|mesh-ancestor
64477577|NCT01391793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64477578|NCT01391793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477579|NCT01391793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64477580|NCT01391793|Glucocorticoids|glucocorticoids|mesh-ancestor
64477581|NCT01391793|Hormones|hormones|mesh-ancestor
64477582|NCT01391793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64477583|NCT01391793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64477584|NCT01391793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477585|NCT01422915|Colestipol|colestipol|mesh-list
64477586|NCT01422915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64477587|NCT01422915|Antimetabolites|antimetabolites|mesh-ancestor
64477588|NCT01422915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477589|NCT01422915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64477590|NCT01422915|Sequestering Agents|sequestering agents|mesh-ancestor
64477591|NCT01727024|Tiotropium Bromide|tiotropium bromide|mesh-list
64477592|NCT01727024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64477604|NCT04558736|Fludarabine|fludarabine|mesh-list
64477615|NCT04558736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64477616|NCT01422213|Vortioxetine|vortioxetine|mesh-list
64477617|NCT01422213|Antidepressive Agents|antidepressive agents|mesh-ancestor
64471376|NCT04551495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64477618|NCT01422213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64477619|NCT01422213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64477620|NCT01422213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64477621|NCT01422213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64477622|NCT01422213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477623|NCT01422213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64477624|NCT01422213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64477625|NCT01422213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64477674|NCT01891669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64477675|NCT01891669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477676|NCT01891669|Antimitotic Agents|antimitotic agents|mesh-ancestor
64513665|NCT01890993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64477677|NCT01891669|Mitosis Modulators|mitosis modulators|mesh-ancestor
64477678|NCT01891669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477679|NCT01421511|Linezolid|linezolid|mesh-list
64477680|NCT01421511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64477681|NCT01421511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64477682|NCT01421511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64477683|NCT01421511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477735|NCT03835533|Immunologic Factors|immunologic factors|mesh-ancestor
64477736|NCT03835533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477737|NCT01401465|Mometasone Furoate|mometasone furoate|mesh-list
64477738|NCT01401465|Ciclesonide|ciclesonide|mesh-list
64477739|NCT01401465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64477740|NCT01401465|Dermatologic Agents|dermatologic agents|mesh-ancestor
64477741|NCT01401465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64477742|NCT01401465|Glucocorticoids|glucocorticoids|mesh-ancestor
64477743|NCT01401465|Hormones|hormones|mesh-ancestor
64477744|NCT01401465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64477745|NCT01401465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477746|NCT01890967|Atorvastatin|atorvastatin|mesh-list
64477747|NCT01890967|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64477748|NCT01890967|Simvastatin|simvastatin|mesh-list
64477749|NCT01890967|Ezetimibe|ezetimibe|mesh-list
64477750|NCT01890967|Pravastatin|pravastatin|mesh-list
64477751|NCT01890967|Pitavastatin|pitavastatin|mesh-list
64477752|NCT01890967|Lovastatin|lovastatin|mesh-list
64477753|NCT01890967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64477754|NCT01890967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64477755|NCT01890967|Antimetabolites|antimetabolites|mesh-ancestor
64477772|NCT01614457|Ivacaftor|ivacaftor|mesh-list
64477791|NCT01880593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64477792|NCT01880593|Anesthetics, General|anesthetics, general|mesh-ancestor
64477793|NCT01880593|Anesthetics|anesthetics|mesh-ancestor
64477794|NCT01880593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64477795|NCT01880593|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64477796|NCT01880593|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64477797|NCT01880593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64477798|NCT01880593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477799|NCT01880593|Antidepressive Agents|antidepressive agents|mesh-ancestor
64477800|NCT01880593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64477801|NCT01880593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477802|NCT01880593|Antimanic Agents|antimanic agents|mesh-ancestor
64477803|NCT01880593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64477804|NCT01880515|Tetracycline|tetracycline|mesh-list
64477805|NCT01880515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64477806|NCT01880515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64477807|NCT01880515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64477845|NCT01724528|Febuxostat|febuxostat|mesh-list
64477846|NCT01724528|Antimetabolites|antimetabolites|mesh-ancestor
64477847|NCT01724528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477848|NCT01724528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477849|NCT01724528|Gout Suppressants|gout suppressants|mesh-ancestor
64477850|NCT01724528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64477851|NCT01724528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64477852|NCT01724528|Antioxidants|antioxidants|mesh-ancestor
64477853|NCT01724528|Protective Agents|protective agents|mesh-ancestor
64477854|NCT01724528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477855|NCT01750268|Topiramate|topiramate|mesh-list
64477856|NCT01750268|Anticonvulsants|anticonvulsants|mesh-ancestor
64477857|NCT01750268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64477858|NCT01750268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477859|NCT01880437|Cytarabine|cytarabine|mesh-list
64477860|NCT01880437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64477861|NCT01880437|Antimetabolites|antimetabolites|mesh-ancestor
64477862|NCT01880437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477863|NCT01880437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477864|NCT01880437|Antiviral Agents|antiviral agents|mesh-ancestor
64477865|NCT01880437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64477866|NCT01880437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64477867|NCT01880437|Immunologic Factors|immunologic factors|mesh-ancestor
64477868|NCT01880437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477869|NCT01861717|Lanreotide|lanreotide|mesh-list
64477870|NCT01861717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477871|NCT01834729|Alfuzosin|alfuzosin|mesh-list
64477872|NCT01834729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64477873|NCT01834729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64477874|NCT01834729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64477875|NCT01834729|Adrenergic Agents|adrenergic agents|mesh-ancestor
64477876|NCT01834729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64477877|NCT01834729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477878|NCT01834729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477879|NCT01834729|Urological Agents|urological agents|mesh-ancestor
64477880|NCT01860703|Moxifloxacin|moxifloxacin|mesh-list
64477881|NCT01860703|Deferiprone|deferiprone|mesh-list
64477884|NCT01860703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64477885|NCT01860703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64477886|NCT01860703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477887|NCT01860703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477888|NCT01860703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477889|NCT01860703|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64477890|NCT01860703|Chelating Agents|chelating agents|mesh-ancestor
64477891|NCT01860703|Sequestering Agents|sequestering agents|mesh-ancestor
64477892|NCT01399593|Eculizumab|eculizumab|mesh-list
64477893|NCT01399593|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64477894|NCT01399593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64477895|NCT01399593|Immunologic Factors|immunologic factors|mesh-ancestor
64477896|NCT01399593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477897|NCT01388985|Vaccines|vaccines|mesh-list
64477900|NCT01388361|Insulin|insulin|mesh-list
64477940|NCT04040439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64477941|NCT04040439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64477942|NCT04040439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64477943|NCT04040439|Adrenergic Agents|adrenergic agents|mesh-ancestor
64477944|NCT04040439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64477945|NCT04040439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477946|NCT04012827|Doxorubicin|doxorubicin|mesh-list
64477947|NCT04012827|Apatinib|apatinib|mesh-list
64477948|NCT04012827|Ifosfamide|ifosfamide|mesh-list
64477949|NCT04012827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64477950|NCT04012827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477951|NCT04012827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64477952|NCT04012827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64477953|NCT04012827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64477954|NCT04012827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64477955|NCT04012827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64477956|NCT04012827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64477957|NCT04012827|Alkylating Agents|alkylating agents|mesh-ancestor
64477996|NCT01748162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64477997|NCT01748162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64477998|NCT01748162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64477999|NCT01723904|Rotigotine|rotigotine|mesh-list
64478000|NCT01723904|Dopamine Agonists|dopamine agonists|mesh-ancestor
64478001|NCT01723904|Dopamine Agents|dopamine agents|mesh-ancestor
64478002|NCT01723904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64478003|NCT01723904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478004|NCT01723904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478005|NCT01830127|Ribavirin|ribavirin|mesh-list
64478006|NCT01830127|Antimetabolites|antimetabolites|mesh-ancestor
64478007|NCT01830127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478008|NCT01830127|Antiviral Agents|antiviral agents|mesh-ancestor
64478009|NCT01830127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64478010|NCT01614067|Ganirelix|ganirelix|mesh-list
64478011|NCT01614067|Hormone Antagonists|hormone antagonists|mesh-ancestor
64478012|NCT01614067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64478013|NCT01614067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478014|NCT01397409|Ranibizumab|ranibizumab|mesh-list
64478015|NCT01397409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64478016|NCT01397409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64478017|NCT01397409|Growth Substances|growth substances|mesh-ancestor
64478018|NCT01397409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478019|NCT01397409|Growth Inhibitors|growth inhibitors|mesh-ancestor
64478020|NCT01397409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478021|NCT04766775|Fluorides|fluorides|mesh-list
64478022|NCT04766775|Cariostatic Agents|cariostatic agents|mesh-ancestor
64478023|NCT04766775|Protective Agents|protective agents|mesh-ancestor
64478024|NCT04766775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478025|NCT01777334|Tiotropium Bromide|tiotropium bromide|mesh-list
64478039|NCT03024879|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64478040|NCT03024879|Erythromycin stearate|erythromycin stearate|mesh-list
64478041|NCT03024879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64713996|NCT03043105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478042|NCT03024879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64478043|NCT03024879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64471384|NCT04546009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64478044|NCT03024879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64478045|NCT03024879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478046|NCT03024879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478047|NCT01383993|Voriconazole|voriconazole|mesh-list
64478048|NCT01383993|Antifungal Agents|antifungal agents|mesh-ancestor
64478049|NCT01383993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64478050|NCT01383993|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64478051|NCT01383993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64478052|NCT01383993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478053|NCT01383993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478054|NCT01383993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64478055|NCT01383993|Hormone Antagonists|hormone antagonists|mesh-ancestor
64478056|NCT01383993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64478057|NCT01383993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478058|NCT01383993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64478059|NCT01396395|Nicorandil|nicorandil|mesh-list
64478060|NCT01396395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64478061|NCT01396395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64478062|NCT01396395|Vasodilator Agents|vasodilator agents|mesh-ancestor
64478063|NCT01396395|Vitamin B Complex|vitamin b complex|mesh-ancestor
64478064|NCT01396395|Vitamins|vitamins|mesh-ancestor
64478065|NCT01396395|Micronutrients|micronutrients|mesh-ancestor
64478066|NCT01396395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478067|NCT01396083|Dexamethasone|dexamethasone|mesh-list
64978909|NCT00273442|Timolol|timolol|mesh-list
64951611|NCT00054561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951612|NCT00054561|Immunologic Factors|immunologic factors|mesh-ancestor
64951613|NCT00054561|Antioxidants|antioxidants|mesh-ancestor
64951614|NCT00054561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951615|NCT00054561|Protective Agents|protective agents|mesh-ancestor
64951616|NCT00054561|Dermatologic Agents|dermatologic agents|mesh-ancestor
64951617|NCT00026585|Tamoxifen|tamoxifen|mesh-list
64951618|NCT00026585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64951619|NCT00026585|Hormone Antagonists|hormone antagonists|mesh-ancestor
64478068|NCT01396083|Ranibizumab|ranibizumab|mesh-list
64478069|NCT01396083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64478070|NCT01396083|Antiemetics|antiemetics|mesh-ancestor
64478071|NCT01396083|Autonomic Agents|autonomic agents|mesh-ancestor
64478072|NCT01396083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478073|NCT01396083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478074|NCT01396083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64478075|NCT01396083|Glucocorticoids|glucocorticoids|mesh-ancestor
64478076|NCT01396083|Hormones|hormones|mesh-ancestor
64478077|NCT01396083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64478078|NCT01396083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64478079|NCT01396083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478080|NCT01396083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64478081|NCT01396083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64478082|NCT01396083|Growth Substances|growth substances|mesh-ancestor
64478083|NCT01396083|Growth Inhibitors|growth inhibitors|mesh-ancestor
64478084|NCT01776008|Anastrozole|anastrozole|mesh-list
64513668|NCT01457937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64478126|NCT03024957|Anesthetics|anesthetics|mesh-ancestor
64478127|NCT03024957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64478128|NCT03024957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478129|NCT03024957|Sensory System Agents|sensory system agents|mesh-ancestor
64478130|NCT03024957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478131|NCT03024957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64478132|NCT03024957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64478133|NCT03024957|Analgesics|analgesics|mesh-ancestor
64478134|NCT03024957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64478135|NCT03024957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64478136|NCT03024957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64478137|NCT03024957|Adrenergic Agents|adrenergic agents|mesh-ancestor
64478138|NCT03024957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64478139|NCT03024957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478140|NCT03024957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64478141|NCT03024957|Narcotics|narcotics|mesh-ancestor
64478142|NCT03025113|Ketoprofen|ketoprofen|mesh-list
64478143|NCT03025113|Amitriptyline|amitriptyline|mesh-list
64478144|NCT03025113|Cyclobenzaprine|cyclobenzaprine|mesh-list
64478145|NCT03025113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64478146|NCT03025113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64478147|NCT03025113|Analgesics|analgesics|mesh-ancestor
64478148|NCT03025113|Sensory System Agents|sensory system agents|mesh-ancestor
64478149|NCT03025113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478150|NCT03025113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478151|NCT03025113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64478152|NCT03025113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64478153|NCT03025113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64478154|NCT03025113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478169|NCT01877083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478170|NCT01877083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64478171|NCT01877083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478172|NCT01877083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478173|NCT01380327|Immunologic Factors|immunologic factors|mesh-list
64478174|NCT01380327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478175|NCT01829425|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64478176|NCT01829425|Oxybutynin|oxybutynin|mesh-list
64478177|NCT01829425|Cholinergic Antagonists|cholinergic antagonists|mesh-list
64478178|NCT01829425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64478179|NCT01829425|Cholinergic Agents|cholinergic agents|mesh-ancestor
64478180|NCT01829425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64478181|NCT01829425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478182|NCT01829425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478183|NCT01829425|Urological Agents|urological agents|mesh-ancestor
64478184|NCT01829425|Parasympatholytics|parasympatholytics|mesh-ancestor
64478185|NCT01829425|Autonomic Agents|autonomic agents|mesh-ancestor
64478186|NCT01829425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478187|NCT01394991|Epoetin Alfa|epoetin alfa|mesh-list
64478189|NCT05368623|Mydriatics|mydriatics|mesh-list
64478227|NCT00211185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64478228|NCT00211185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64478229|NCT00211185|Alkylating Agents|alkylating agents|mesh-ancestor
64478230|NCT00211185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478231|NCT00211185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478232|NCT00211185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64478233|NCT00211185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64478234|NCT00211185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64478235|NCT00211185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64478236|NCT00211185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478237|NCT00211185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64478238|NCT00211185|Glucocorticoids|glucocorticoids|mesh-ancestor
64478239|NCT00211185|Hormones|hormones|mesh-ancestor
64478240|NCT00211185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64478241|NCT00211185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64478242|NCT00211185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64478243|NCT00211185|Tubulin Modulators|tubulin modulators|mesh-ancestor
64478244|NCT00211185|Antimitotic Agents|antimitotic agents|mesh-ancestor
64478245|NCT00211185|Mitosis Modulators|mitosis modulators|mesh-ancestor
64478279|NCT01721408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478280|NCT01721408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478281|NCT01721408|Protease Inhibitors|protease inhibitors|mesh-ancestor
64478282|NCT03998709|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64478283|NCT03998709|Somatostatin|somatostatin|mesh-list
64478284|NCT03998709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478285|NCT03998709|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64478286|NCT03998709|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64478287|NCT03998709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64478288|NCT03998709|Hormones|hormones|mesh-ancestor
64478289|NCT03998709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64478290|NCT01744496|Rotigotine|rotigotine|mesh-list
64478291|NCT01744496|Dopamine Agonists|dopamine agonists|mesh-ancestor
64478292|NCT01744496|Dopamine Agents|dopamine agents|mesh-ancestor
64478293|NCT01744496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64478294|NCT01744496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478295|NCT01744496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478296|NCT05631405|Dexamethasone|dexamethasone|mesh-list
64478297|NCT05631405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64478298|NCT05631405|Antiemetics|antiemetics|mesh-ancestor
64478299|NCT05631405|Autonomic Agents|autonomic agents|mesh-ancestor
64478300|NCT05631405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478301|NCT05631405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478302|NCT05631405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64478303|NCT05631405|Glucocorticoids|glucocorticoids|mesh-ancestor
64478304|NCT05631405|Hormones|hormones|mesh-ancestor
64478305|NCT05631405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64478306|NCT05631405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64478307|NCT05631405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478308|NCT04007055|Ticagrelor|ticagrelor|mesh-list
64478309|NCT04007055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64478310|NCT04007055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64478317|NCT01721330|Naltrexone|naltrexone|mesh-list
64478318|NCT01721330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64478319|NCT01721330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64478320|NCT01721330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478321|NCT01721330|Sensory System Agents|sensory system agents|mesh-ancestor
64478322|NCT01721330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478326|NCT03592407|Pembrolizumab|pembrolizumab|mesh-list
64478327|NCT03592407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64478328|NCT03592407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478329|NCT03595371|Dapansutrile|dapansutrile|mesh-list
64478330|NCT03595371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64478331|NCT05634057|Anisodamine|anisodamine|mesh-list
64478332|NCT05634057|Heparin|heparin|mesh-list
64478333|NCT05634057|Calcium heparin|calcium heparin|mesh-list
64478334|NCT05634057|Anticoagulants|anticoagulants|mesh-ancestor
64478335|NCT05634057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64478336|NCT05634057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64478346|NCT05634057|Analgesics|analgesics|mesh-ancestor
64478382|NCT03596385|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64478383|NCT01828099|Carboplatin|carboplatin|mesh-list
64478384|NCT01828099|Pemetrexed|pemetrexed|mesh-list
64478385|NCT01828099|Ceritinib|ceritinib|mesh-list
64478386|NCT01828099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478387|NCT01828099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478388|NCT01828099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478389|NCT01828099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64478390|NCT01828099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64478391|NCT01828099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64478392|NCT01828021|Margetuximab|margetuximab|mesh-list
64478393|NCT01828021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478394|NCT03784599|Trastuzumab|trastuzumab|mesh-list
64478395|NCT03784599|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64478396|NCT03784599|Osimertinib|osimertinib|mesh-list
64478397|NCT03784599|Maytansine|maytansine|mesh-list
64478398|NCT03784599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64478399|NCT03784599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478400|NCT03784599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64478437|NCT00217971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64478438|NCT03976323|Cisplatin|cisplatin|mesh-list
64478439|NCT03976323|Carboplatin|carboplatin|mesh-list
64478440|NCT03976323|Pembrolizumab|pembrolizumab|mesh-list
64478441|NCT03976323|Pemetrexed|pemetrexed|mesh-list
64478442|NCT03976323|Olaparib|olaparib|mesh-list
64478443|NCT03976323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478444|NCT03976323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64478445|NCT03976323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478446|NCT03976323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478447|NCT03976323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64478448|NCT03976323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64478449|NCT03976323|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64478450|NCT00217581|Bevacizumab|bevacizumab|mesh-list
64478451|NCT00217581|Docetaxel|docetaxel|mesh-list
64478452|NCT00217581|Oxaliplatin|oxaliplatin|mesh-list
64478453|NCT00217581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64478454|NCT00217581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478455|NCT00217581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64478456|NCT00217581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64478457|NCT00217581|Growth Substances|growth substances|mesh-ancestor
64478458|NCT00217581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478459|NCT00217581|Growth Inhibitors|growth inhibitors|mesh-ancestor
64478460|NCT00217581|Tubulin Modulators|tubulin modulators|mesh-ancestor
64478461|NCT00217581|Antimitotic Agents|antimitotic agents|mesh-ancestor
64478462|NCT00217581|Mitosis Modulators|mitosis modulators|mesh-ancestor
64478463|NCT00217581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478464|NCT01856257|Mycophenolic Acid|mycophenolic acid|mesh-list
64478465|NCT01856257|Methylprednisolone|methylprednisolone|mesh-list
64478467|NCT01856257|Tacrolimus|tacrolimus|mesh-list
64478468|NCT01856257|Thymoglobulin|thymoglobulin|mesh-list
64478469|NCT01856257|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64478470|NCT01856257|Basiliximab|basiliximab|mesh-list
64478471|NCT01856257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64478479|NCT01856257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64478480|NCT01856257|Antitubercular Agents|antitubercular agents|mesh-ancestor
64478481|NCT01856257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64478482|NCT01856257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64478483|NCT01856257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64478484|NCT01856257|Antiemetics|antiemetics|mesh-ancestor
64478485|NCT01856257|Autonomic Agents|autonomic agents|mesh-ancestor
64478486|NCT01856257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478487|NCT01856257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64478488|NCT01856257|Glucocorticoids|glucocorticoids|mesh-ancestor
64478489|NCT01856257|Hormones|hormones|mesh-ancestor
64478490|NCT01856257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64478491|NCT01856257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64464031|NCT05606692|Anesthetics|anesthetics|mesh-ancestor
64478492|NCT01856257|Protective Agents|protective agents|mesh-ancestor
64478493|NCT01856257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64478494|NCT01856257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64478495|NCT00215943|Zoledronic Acid|zoledronic acid|mesh-list
64478496|NCT00215943|Thalidomide|thalidomide|mesh-list
64478497|NCT00215943|Dexamethasone|dexamethasone|mesh-list
64478498|NCT00215943|Doxorubicin|doxorubicin|mesh-list
64478499|NCT00215943|Vincristine|vincristine|mesh-list
64478500|NCT00215943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64478501|NCT00215943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64478502|NCT00215943|Antiemetics|antiemetics|mesh-ancestor
64478503|NCT00215943|Autonomic Agents|autonomic agents|mesh-ancestor
64478504|NCT00215943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478505|NCT00215943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478506|NCT00215943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64478507|NCT00215943|Glucocorticoids|glucocorticoids|mesh-ancestor
64478508|NCT00215943|Hormones|hormones|mesh-ancestor
64478524|NCT00215943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64478525|NCT00215943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64478526|NCT00215943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64478527|NCT00215943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64478528|NCT00215943|Growth Substances|growth substances|mesh-ancestor
64478529|NCT00215943|Growth Inhibitors|growth inhibitors|mesh-ancestor
64478530|NCT00215943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64478531|NCT03593811|Cyproheptadine|cyproheptadine|mesh-list
64478532|NCT03593811|Ondansetron|ondansetron|mesh-list
64478533|NCT03593811|Antiemetics|antiemetics|mesh-ancestor
64478534|NCT03593811|Autonomic Agents|autonomic agents|mesh-ancestor
64478535|NCT03593811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600891|NCT00724009|Antimetabolites|antimetabolites|mesh-ancestor
64478536|NCT03593811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478537|NCT03593811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64478539|NCT03593811|Dermatologic Agents|dermatologic agents|mesh-ancestor
64478540|NCT03593811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64478541|NCT03593811|Serotonin Agents|serotonin agents|mesh-ancestor
64478544|NCT03593811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64478579|NCT00211887|Antiviral Agents|antiviral agents|mesh-ancestor
64478580|NCT00211887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64478581|NCT00211887|Immunologic Factors|immunologic factors|mesh-ancestor
64478582|NCT00211887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478583|NCT00211887|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64478584|NCT00211887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64478585|NCT00211887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64478586|NCT04002453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64478587|NCT04002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64478589|NCT04002297|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64478590|NCT04002297|Zanubrutinib|zanubrutinib|mesh-list
64478644|NCT03599427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64478645|NCT03599427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64478646|NCT03599427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64478647|NCT03599427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64478648|NCT03599427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478649|NCT01855789|Methotrexate|methotrexate|mesh-list
64478650|NCT01855789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64478651|NCT01855789|Abortifacient Agents|abortifacient agents|mesh-ancestor
64478652|NCT01855789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64478653|NCT01855789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478654|NCT01855789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64478655|NCT01855789|Antimetabolites|antimetabolites|mesh-ancestor
64478656|NCT01855789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478708|NCT03591471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64478709|NCT03591471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64478710|NCT03591471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478711|NCT03591471|Anticoagulants|anticoagulants|mesh-ancestor
64471388|NCT04546009|Hormone Antagonists|hormone antagonists|mesh-ancestor
64478712|NCT03591471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64478713|NCT03591471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64478714|NCT03591471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478715|NCT03591471|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64478716|NCT03591471|Protease Inhibitors|protease inhibitors|mesh-ancestor
64478717|NCT03591471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478767|NCT01854697|Interferon-alpha|interferon-alpha|mesh-list
64478768|NCT01854697|Interferon alpha-2|interferon alpha-2|mesh-list
64478769|NCT01854697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64478770|NCT01854697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478771|NCT01854697|Antiviral Agents|antiviral agents|mesh-ancestor
64478772|NCT01854697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64478773|NCT01854697|Antimetabolites|antimetabolites|mesh-ancestor
64478774|NCT01854697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478775|NCT01854697|Immunologic Factors|immunologic factors|mesh-ancestor
64478776|NCT01854697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478777|NCT03594123|Brexpiprazole|brexpiprazole|mesh-list
64478778|NCT03594123|Serotonin Agents|serotonin agents|mesh-ancestor
64478779|NCT03594123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64478780|NCT03594123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478781|NCT03594123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478782|NCT03594123|Dopamine Agonists|dopamine agonists|mesh-ancestor
64478783|NCT03594123|Dopamine Agents|dopamine agents|mesh-ancestor
64478784|NCT01824823|Afatinib|afatinib|mesh-list
64478785|NCT01824823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478786|NCT01824823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64478822|NCT04191135|Gemcitabine|gemcitabine|mesh-list
64478823|NCT04191135|Carboplatin|carboplatin|mesh-list
64478824|NCT04191135|Pembrolizumab|pembrolizumab|mesh-list
64478825|NCT04191135|Olaparib|olaparib|mesh-list
64478826|NCT04191135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478827|NCT04191135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64478828|NCT04191135|Antimetabolites|antimetabolites|mesh-ancestor
64478829|NCT04191135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478830|NCT04191135|Antiviral Agents|antiviral agents|mesh-ancestor
64478831|NCT04191135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64478832|NCT04191135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478834|NCT04191135|Immunologic Factors|immunologic factors|mesh-ancestor
64478835|NCT04191135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478836|NCT04191135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64478837|NCT04191135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64478838|NCT04194255|Ferrous fumarate|ferrous fumarate|mesh-list
64478839|NCT04194255|Trace Elements|trace elements|mesh-ancestor
64478840|NCT04194255|Micronutrients|micronutrients|mesh-ancestor
64478841|NCT04194255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478879|NCT03952299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64478880|NCT03952299|Renal Agents|renal agents|mesh-ancestor
64478881|NCT03597867|Diclofenac|diclofenac|mesh-list
64478882|NCT03597867|Indomethacin|indomethacin|mesh-list
64478884|NCT03597867|Bromfenac|bromfenac|mesh-list
64478885|NCT03597867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64478886|NCT03597867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64478887|NCT03597867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64478888|NCT03597867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64478889|NCT03597867|Analgesics|analgesics|mesh-ancestor
64478890|NCT03597867|Sensory System Agents|sensory system agents|mesh-ancestor
64478891|NCT03597867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478892|NCT03597867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478893|NCT03597867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64478894|NCT03597867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64478895|NCT03597867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64478899|NCT03597867|Tocolytic Agents|tocolytic agents|mesh-ancestor
64471392|NCT04545424|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
64471393|NCT04545424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64471394|NCT04545424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64471395|NCT04545424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471396|NCT04544449|Ocrelizumab|ocrelizumab|mesh-list
64471397|NCT04544449|Immunologic Factors|immunologic factors|mesh-ancestor
64478933|NCT04193319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64478934|NCT04193319|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64478935|NCT04192617|Methotrexate|methotrexate|mesh-list
64478936|NCT04192617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64478937|NCT04192617|Abortifacient Agents|abortifacient agents|mesh-ancestor
64478938|NCT04192617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64478939|NCT04192617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478940|NCT04192617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64478941|NCT04192617|Antimetabolites|antimetabolites|mesh-ancestor
64478942|NCT04192617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478943|NCT04192617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478944|NCT04192617|Dermatologic Agents|dermatologic agents|mesh-ancestor
64478945|NCT04192617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478946|NCT04192617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64478947|NCT04192617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64478948|NCT04192617|Immunologic Factors|immunologic factors|mesh-ancestor
64478949|NCT04192617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64478976|NCT04190745|Paclitaxel|paclitaxel|mesh-list
64478977|NCT04190745|Apatinib|apatinib|mesh-list
64478978|NCT04190745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64478979|NCT04190745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64478981|NCT04190745|Antimitotic Agents|antimitotic agents|mesh-ancestor
64478982|NCT04190745|Mitosis Modulators|mitosis modulators|mesh-ancestor
64478983|NCT04190745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478984|NCT04190745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64478985|NCT04190745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64478986|NCT04198623|Montelukast|montelukast|mesh-list
64478987|NCT04198623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64478988|NCT04198623|Respiratory System Agents|respiratory system agents|mesh-ancestor
64478989|NCT04198623|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64478990|NCT04198623|Hormone Antagonists|hormone antagonists|mesh-ancestor
64478991|NCT04198623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64478992|NCT04198623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64478993|NCT04198623|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64478994|NCT04198623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64478995|NCT04198623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478996|NCT01873729|Naltrexone|naltrexone|mesh-list
64478997|NCT01873729|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64478998|NCT01873729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64478999|NCT01873729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479000|NCT01873729|Sensory System Agents|sensory system agents|mesh-ancestor
64479001|NCT01873729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64479002|NCT01873495|Homoharringtonine|homoharringtonine|mesh-list
64479004|NCT01873495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479023|NCT04344951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64479024|NCT04344951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64479025|NCT04344951|Analgesics|analgesics|mesh-ancestor
64479026|NCT04344951|Sensory System Agents|sensory system agents|mesh-ancestor
64479027|NCT04344951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64479028|NCT04344951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479029|NCT04344951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64479030|NCT04344951|Filaricides|filaricides|mesh-ancestor
64479031|NCT04344951|Antinematodal Agents|antinematodal agents|mesh-ancestor
64479032|NCT04344951|Anthelmintics|anthelmintics|mesh-ancestor
64479033|NCT01822561|Eplerenone|eplerenone|mesh-list
64479034|NCT01822561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64479035|NCT01822561|Hormone Antagonists|hormone antagonists|mesh-ancestor
64479036|NCT01822561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64479037|NCT01822561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479038|NCT01822561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64479039|NCT01822561|Diuretics|diuretics|mesh-ancestor
64479040|NCT01822561|Natriuretic Agents|natriuretic agents|mesh-ancestor
64479041|NCT01822561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64479075|NCT03960957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479076|NCT03960957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64479077|NCT03960957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64479078|NCT04027179|Chlorhexidine|chlorhexidine|mesh-list
64479079|NCT04027179|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64479080|NCT04027179|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64479081|NCT04027179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479082|NCT04027179|Disinfectants|disinfectants|mesh-ancestor
64479083|NCT04027179|Dermatologic Agents|dermatologic agents|mesh-ancestor
64479084|NCT04199169|Vaccines|vaccines|mesh-list
64479085|NCT04199169|Immunologic Factors|immunologic factors|mesh-ancestor
64479086|NCT04199169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479087|NCT03022929|Anti-Infective Agents|anti-infective agents|mesh-list
64479088|NCT03022929|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64479089|NCT01821391|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
64479090|NCT01821391|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64479091|NCT01821391|Dermatologic Agents|dermatologic agents|mesh-ancestor
64479092|NCT04020705|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64479093|NCT04020705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64479094|NCT04020705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64479095|NCT04020705|Nootropic Agents|nootropic agents|mesh-ancestor
64479096|NCT01873417|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64479097|NCT01873417|Dermatologic Agents|dermatologic agents|mesh-ancestor
64479098|NCT01873417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64479099|NCT01873417|Immunologic Factors|immunologic factors|mesh-ancestor
64479100|NCT01873417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479121|NCT03932643|TIC10 compound|tic10 compound|mesh-list
64479127|NCT01613599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479128|NCT01613599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64479129|NCT03930771|Capecitabine|capecitabine|mesh-list
64479130|NCT03930771|Temozolomide|temozolomide|mesh-list
64479131|NCT03930771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64479132|NCT03930771|Antimetabolites|antimetabolites|mesh-ancestor
64479133|NCT03930771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479134|NCT03930771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479135|NCT03930771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64479136|NCT03930771|Alkylating Agents|alkylating agents|mesh-ancestor
64471398|NCT04544449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471399|NCT04539938|Trastuzumab|trastuzumab|mesh-list
64479137|NCT04024683|Ropivacaine|ropivacaine|mesh-list
64479138|NCT04024683|Anesthetics, Local|anesthetics, local|mesh-ancestor
64479139|NCT04024683|Anesthetics|anesthetics|mesh-ancestor
64479140|NCT04024683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64479144|NCT04024527|Amoxicillin|amoxicillin|mesh-list
64479184|NCT04022811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64479185|NCT04022811|Immunologic Factors|immunologic factors|mesh-ancestor
64479186|NCT04022811|Viscosupplements|viscosupplements|mesh-ancestor
64479187|NCT04022811|Protective Agents|protective agents|mesh-ancestor
64479188|NCT04022811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64479189|NCT04022811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64479190|NCT04022811|Analgesics|analgesics|mesh-ancestor
64479191|NCT04022811|Sensory System Agents|sensory system agents|mesh-ancestor
64479192|NCT04022811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64479193|NCT04145583|Voriconazole|voriconazole|mesh-list
64479194|NCT04145583|Antifungal Agents|antifungal agents|mesh-ancestor
64479195|NCT04145583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479196|NCT04145583|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64479197|NCT04145583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64479198|NCT04145583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479199|NCT04145583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479201|NCT04145583|Hormone Antagonists|hormone antagonists|mesh-ancestor
64479202|NCT04145583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64479203|NCT04145583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479204|NCT04145583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64479205|NCT04022421|Hydroxychloroquine|hydroxychloroquine|mesh-list
64479206|NCT04022421|Antimalarials|antimalarials|mesh-ancestor
64479207|NCT04022421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64479208|NCT04022421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64471400|NCT04539938|Tucatinib|tucatinib|mesh-list
64479209|NCT04022421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479210|NCT04022421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479211|NCT04022421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479212|NCT04022421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64479213|NCT04145193|Leucovorin|leucovorin|mesh-list
64479214|NCT04145193|Fluorouracil|fluorouracil|mesh-list
64479215|NCT04145193|Oxaliplatin|oxaliplatin|mesh-list
64479216|NCT04145193|Durvalumab|durvalumab|mesh-list
64479217|NCT04145193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64479218|NCT04145193|Antimetabolites|antimetabolites|mesh-ancestor
64479221|NCT04145193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479223|NCT04145193|Immunologic Factors|immunologic factors|mesh-ancestor
64479224|NCT04145193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479225|NCT04145193|Antidotes|antidotes|mesh-ancestor
64479226|NCT04145193|Protective Agents|protective agents|mesh-ancestor
64479227|NCT04145193|Vitamin B Complex|vitamin b complex|mesh-ancestor
64479228|NCT04145193|Vitamins|vitamins|mesh-ancestor
64479229|NCT04145193|Micronutrients|micronutrients|mesh-ancestor
64479230|NCT04145193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64479231|NCT04147845|Triamcinolone|triamcinolone|mesh-list
64479232|NCT04147845|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64479233|NCT04147845|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64479234|NCT04147845|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64479235|NCT04147845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64479236|NCT04147845|Glucocorticoids|glucocorticoids|mesh-ancestor
64945389|NCT05672225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479237|NCT04147845|Hormones|hormones|mesh-ancestor
64479238|NCT04147845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64479239|NCT04147845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479240|NCT04147845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64479241|NCT04147845|Immunologic Factors|immunologic factors|mesh-ancestor
64479242|NCT04147845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479243|NCT04147845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479244|NCT01849783|Thalidomide|thalidomide|mesh-list
64479245|NCT01849783|Dexamethasone|dexamethasone|mesh-list
64479246|NCT01849783|Cyclophosphamide|cyclophosphamide|mesh-list
64479247|NCT01849783|Melphalan|melphalan|mesh-list
64479248|NCT01849783|Doxorubicin|doxorubicin|mesh-list
64479249|NCT01849783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64479250|NCT01849783|Etoposide|etoposide|mesh-list
64479251|NCT01849783|Etoposide phosphate|etoposide phosphate|mesh-list
64479252|NCT01849783|Bortezomib|bortezomib|mesh-list
64479253|NCT01849783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64479254|NCT01849783|Immunologic Factors|immunologic factors|mesh-ancestor
64479255|NCT01849783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479256|NCT01849783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64479265|NCT01849783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64479266|NCT01849783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64479267|NCT01849783|Glucocorticoids|glucocorticoids|mesh-ancestor
64479268|NCT01849783|Hormones|hormones|mesh-ancestor
64479269|NCT01849783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64479270|NCT01849783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64479271|NCT01849783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64479272|NCT01849783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64479273|NCT01849783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64479274|NCT01849783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479275|NCT01849783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64479276|NCT01849783|Leprostatic Agents|leprostatic agents|mesh-ancestor
64479277|NCT01849783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64479278|NCT01849783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479279|NCT01849783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64479280|NCT01849783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64479281|NCT01849783|Growth Substances|growth substances|mesh-ancestor
64479282|NCT01849783|Growth Inhibitors|growth inhibitors|mesh-ancestor
64479283|NCT01611883|Ezetimibe|ezetimibe|mesh-list
64479284|NCT01611883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64479285|NCT01611883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64479286|NCT01611883|Antimetabolites|antimetabolites|mesh-ancestor
64479287|NCT01611883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479288|NCT01611883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64479289|NCT04170517|Progesterone|progesterone|mesh-list
64479291|NCT04170517|Hormones|hormones|mesh-ancestor
64479312|NCT01848457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64479313|NCT01848457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64479314|NCT01870999|Aripiprazole|aripiprazole|mesh-list
64479315|NCT01870999|Antidepressive Agents|antidepressive agents|mesh-ancestor
64479316|NCT01870999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64479317|NCT01870999|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64479318|NCT01870999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64479319|NCT01870999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64479320|NCT01870999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479321|NCT01870999|Dopamine Agonists|dopamine agonists|mesh-ancestor
64479322|NCT01870999|Dopamine Agents|dopamine agents|mesh-ancestor
64479323|NCT01870999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64479324|NCT01870999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479325|NCT01870999|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64479326|NCT01870999|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64479327|NCT01870999|Serotonin Agents|serotonin agents|mesh-ancestor
64479328|NCT01870999|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64479329|NCT01870999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64479330|NCT01870999|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64479331|NCT01870999|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64479333|NCT01870921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64479334|NCT01870921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64479335|NCT01870921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64513669|NCT01457937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479336|NCT01870921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64479337|NCT01870921|Purinergic Agents|purinergic agents|mesh-ancestor
64479338|NCT01870921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64471401|NCT04539938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64471402|NCT04539938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479356|NCT01847443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64479357|NCT01847443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479358|NCT01847443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64479359|NCT01847443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64479360|NCT01847443|Cholinergic Agents|cholinergic agents|mesh-ancestor
64479361|NCT01847443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64479362|NCT01847443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479363|NCT00527878|Ranitidine|ranitidine|mesh-list
64479364|NCT00527878|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
64479365|NCT00527878|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64479366|NCT00527878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64479367|NCT00527878|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64479368|NCT00527878|Histamine Antagonists|histamine antagonists|mesh-ancestor
64479369|NCT00527878|Histamine Agents|histamine agents|mesh-ancestor
64479370|NCT00527878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64479371|NCT00527878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479372|NCT00527878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479373|NCT05558878|Ambroxol|ambroxol|mesh-list
64479374|NCT05558878|Expectorants|expectorants|mesh-ancestor
64479375|NCT05558878|Respiratory System Agents|respiratory system agents|mesh-ancestor
64479376|NCT05621668|Cyclophosphamide|cyclophosphamide|mesh-list
64479377|NCT05621668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64479378|NCT05621668|Immunologic Factors|immunologic factors|mesh-ancestor
64479379|NCT05621668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479380|NCT05621668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64479381|NCT05621668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64479382|NCT05621668|Alkylating Agents|alkylating agents|mesh-ancestor
64479383|NCT05621668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479389|NCT04741204|Metformin|metformin|mesh-list
64479396|NCT01870843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479397|NCT01870843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64479398|NCT01870843|Serotonin Agents|serotonin agents|mesh-ancestor
64479399|NCT01870843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479400|NCT01870843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64479401|NCT01870843|Antidepressive Agents|antidepressive agents|mesh-ancestor
64479402|NCT01870843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64479403|NCT01816477|Ropivacaine|ropivacaine|mesh-list
64479404|NCT01816477|Anesthetics, Local|anesthetics, local|mesh-ancestor
64479405|NCT01816477|Anesthetics|anesthetics|mesh-ancestor
64479406|NCT01816477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64479407|NCT01816477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479453|NCT01816243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479454|NCT01816243|Analgesics|analgesics|mesh-ancestor
64479455|NCT01816243|Sensory System Agents|sensory system agents|mesh-ancestor
64479456|NCT01816243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64479457|NCT01816243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64479458|NCT01816243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64479459|NCT01816243|Anesthetics, General|anesthetics, general|mesh-ancestor
64479460|NCT01816243|Anesthetics|anesthetics|mesh-ancestor
64479461|NCT05576896|Hydroxychloroquine|hydroxychloroquine|mesh-list
64479462|NCT05576896|Cetuximab|cetuximab|mesh-list
64479463|NCT05576896|Panitumumab|panitumumab|mesh-list
64479517|NCT05072236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64479518|NCT05072236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64479519|NCT05072236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64479520|NCT05072236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64479521|NCT05072236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64479522|NCT05072236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479523|NCT05193994|Lamivudine|lamivudine|mesh-list
64479524|NCT05193994|Abacavir|abacavir|mesh-list
64479525|NCT05193994|Dolutegravir|dolutegravir|mesh-list
64479526|NCT05193994|Triumeq|triumeq|mesh-list
64479527|NCT05193994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64479528|NCT05193994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64479529|NCT05193994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479530|NCT05193994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479531|NCT05193994|Antiviral Agents|antiviral agents|mesh-ancestor
64479532|NCT05193994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479533|NCT05193994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64479534|NCT05193994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64479535|NCT05193994|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64479536|NCT05193994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64479537|NCT04847440|Tenofovir|tenofovir|mesh-list
64479538|NCT04847440|Antiviral Agents|antiviral agents|mesh-ancestor
64479539|NCT04847440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479540|NCT04847440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64479541|NCT04847440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64479542|NCT04847440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479543|NCT04847440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479544|NCT04847440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64479545|NCT04847440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64479546|NCT03667846|Topiramate|topiramate|mesh-list
64479547|NCT03667846|Anticonvulsants|anticonvulsants|mesh-ancestor
64479550|NCT03519412|Pembrolizumab|pembrolizumab|mesh-list
64479558|NCT05174650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479559|NCT01870297|Liraglutide|liraglutide|mesh-list
64479560|NCT01870297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64600908|NCT01279499|Sensory System Agents|sensory system agents|mesh-ancestor
64479561|NCT01870297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479562|NCT01870297|Incretins|incretins|mesh-ancestor
64479564|NCT01870297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64479565|NCT01814761|Bimatoprost|bimatoprost|mesh-list
64479566|NCT01814761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64479567|NCT04616248|Poly I-C|poly i-c|mesh-list
64479568|NCT04616248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64479624|NCT01813435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64479625|NCT01813435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479626|NCT01813435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64479627|NCT01813435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64479628|NCT01813435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479629|NCT01813435|Antipyretics|antipyretics|mesh-ancestor
64479630|NCT01813435|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64479631|NCT01813435|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64479632|NCT01813435|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64479633|NCT01813435|Purinergic Agents|purinergic agents|mesh-ancestor
64479634|NCT01813435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64479635|NCT01798498|Hyaluronic Acid|hyaluronic acid|mesh-list
64479636|NCT01798498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64479637|NCT01798498|Immunologic Factors|immunologic factors|mesh-ancestor
64479638|NCT01798498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479639|NCT01798498|Viscosupplements|viscosupplements|mesh-ancestor
64471405|NCT04539938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479640|NCT01798498|Protective Agents|protective agents|mesh-ancestor
64479641|NCT04934800|Cladribine|cladribine|mesh-list
64479642|NCT04934800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479643|NCT04934800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64479644|NCT04934800|Immunologic Factors|immunologic factors|mesh-ancestor
64479645|NCT04934800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479671|NCT03895762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479672|NCT03895762|Analgesics|analgesics|mesh-ancestor
64479673|NCT03895762|Sensory System Agents|sensory system agents|mesh-ancestor
64479674|NCT03895762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64479675|NCT03895762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64479676|NCT03895762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64479677|NCT03895762|Anesthetics, General|anesthetics, general|mesh-ancestor
64479678|NCT03895762|Anesthetics|anesthetics|mesh-ancestor
64479679|NCT01033552|Cyclosporine|cyclosporine|mesh-list
64479680|NCT01033552|Mycophenolic Acid|mycophenolic acid|mesh-list
64479681|NCT01033552|Cyclophosphamide|cyclophosphamide|mesh-list
64479682|NCT01033552|Fludarabine|fludarabine|mesh-list
64479683|NCT01033552|Cyclosporins|cyclosporins|mesh-list
64479684|NCT01033552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64479685|NCT01033552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64945390|NCT05664789|Acetylcysteine|acetylcysteine|mesh-list
64479686|NCT01033552|Immunologic Factors|immunologic factors|mesh-ancestor
64479687|NCT01033552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479688|NCT01033552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64479689|NCT01033552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64479690|NCT01033552|Alkylating Agents|alkylating agents|mesh-ancestor
64479691|NCT01033552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479692|NCT01033552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479693|NCT01033552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64479694|NCT01033552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479695|NCT01033552|Antifungal Agents|antifungal agents|mesh-ancestor
64479696|NCT01033552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479697|NCT01033552|Dermatologic Agents|dermatologic agents|mesh-ancestor
64479698|NCT01033552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64479699|NCT01033552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64479700|NCT01033552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64479701|NCT01033552|Antitubercular Agents|antitubercular agents|mesh-ancestor
64479702|NCT01033552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64479703|NCT00997906|Gemcitabine|gemcitabine|mesh-list
64471406|NCT04531982|Pimavanserin|pimavanserin|mesh-list
64479712|NCT00997906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64479713|NCT00997906|Antimetabolites|antimetabolites|mesh-ancestor
64479714|NCT00997906|Antiviral Agents|antiviral agents|mesh-ancestor
64479715|NCT00997906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479716|NCT00997906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479717|NCT00997906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64479718|NCT00997906|Immunologic Factors|immunologic factors|mesh-ancestor
64479719|NCT00997906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479720|NCT05246644|Acetaminophen|acetaminophen|mesh-list
64479721|NCT05246644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64479722|NCT05246644|Analgesics|analgesics|mesh-ancestor
64479723|NCT05246644|Sensory System Agents|sensory system agents|mesh-ancestor
64479724|NCT05246644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64479725|NCT05246644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479726|NCT05246644|Antipyretics|antipyretics|mesh-ancestor
64479727|NCT01798576|Interferons|interferons|mesh-list
64479728|NCT01798576|Ribavirin|ribavirin|mesh-list
64479729|NCT01798576|Interferon-alpha|interferon-alpha|mesh-list
64479730|NCT01798576|Interferon alpha-2|interferon alpha-2|mesh-list
64479731|NCT01798576|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64479732|NCT01798576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479733|NCT01798576|Antiviral Agents|antiviral agents|mesh-ancestor
64479734|NCT01798576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479735|NCT01798576|Antimetabolites|antimetabolites|mesh-ancestor
64479737|NCT01798576|Immunologic Factors|immunologic factors|mesh-ancestor
64479762|NCT04170283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479763|NCT01807117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64479764|NCT01807117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64479765|NCT01807117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479766|NCT01613131|Estradiol|estradiol|mesh-list
64479767|NCT01613131|Estrogens|estrogens|mesh-ancestor
64479768|NCT01613131|Hormones|hormones|mesh-ancestor
64479769|NCT01613131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64479770|NCT01613131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479771|NCT05362942|Cytarabine|cytarabine|mesh-list
64479772|NCT05362942|Azacitidine|azacitidine|mesh-list
64479773|NCT05362942|Decitabine|decitabine|mesh-list
64479774|NCT05362942|Venetoclax|venetoclax|mesh-list
64479775|NCT05362942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64479776|NCT05362942|Antimetabolites|antimetabolites|mesh-ancestor
64479777|NCT05362942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479778|NCT05362942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479779|NCT05362942|Antiviral Agents|antiviral agents|mesh-ancestor
64479780|NCT05362942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479781|NCT05362942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64479782|NCT05362942|Immunologic Factors|immunologic factors|mesh-ancestor
64479783|NCT05362942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479784|NCT05362942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479787|NCT01868893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64471407|NCT04531982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64479788|NCT01868893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479789|NCT01868893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64479791|NCT01868893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479792|NCT03481972|Doxycycline|doxycycline|mesh-list
64479793|NCT03481972|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
64479794|NCT03481972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64479795|NCT03481972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479806|NCT01868503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479807|NCT05204368|Meropenem|meropenem|mesh-list
64479808|NCT05204368|Imipenem|imipenem|mesh-list
64479809|NCT05204368|Cilastatin|cilastatin|mesh-list
64479810|NCT05204368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64479811|NCT05204368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479812|NCT05204368|Protease Inhibitors|protease inhibitors|mesh-ancestor
64479813|NCT05204368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64479814|NCT05204368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479815|NCT01868035|Tositumomab I-131|tositumomab i-131|mesh-list
64479816|NCT01868035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479817|NCT04414969|Asparaginase|asparaginase|mesh-list
64479818|NCT04414969|Pegaspargase|pegaspargase|mesh-list
64479819|NCT04414969|Antibodies|antibodies|mesh-list
64479820|NCT04414969|Immunoglobulins|immunoglobulins|mesh-list
64479821|NCT04414969|Immunologic Factors|immunologic factors|mesh-ancestor
64479822|NCT04414969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479867|NCT02958514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64479868|NCT02958514|Antiemetics|antiemetics|mesh-ancestor
64479869|NCT02958514|Autonomic Agents|autonomic agents|mesh-ancestor
64479870|NCT02958514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64479871|NCT02958514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479872|NCT02958514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64479873|NCT02958514|Glucocorticoids|glucocorticoids|mesh-ancestor
64479874|NCT02958514|Hormones|hormones|mesh-ancestor
64479875|NCT02958514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64479876|NCT02958514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64479877|NCT02958514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479878|NCT02958514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64479879|NCT02958514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64479880|NCT01867021|Vaccines|vaccines|mesh-list
64479881|NCT01867021|Immunologic Factors|immunologic factors|mesh-ancestor
64479882|NCT01867021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479883|NCT01866709|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
64479884|NCT01866709|Chelating Agents|chelating agents|mesh-ancestor
64479885|NCT01866709|Sequestering Agents|sequestering agents|mesh-ancestor
64479886|NCT01866709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479887|NCT01841593|Raltegravir Potassium|raltegravir potassium|mesh-list
64479888|NCT01841593|Amlodipine|amlodipine|mesh-list
64479889|NCT01841593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64479890|NCT01841593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64479916|NCT04507204|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64479917|NCT04507204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64479922|NCT05183854|Vaccines|vaccines|mesh-list
64479989|NCT04387786|Autonomic Agents|autonomic agents|mesh-ancestor
64479990|NCT04387786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64479991|NCT04387786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64479992|NCT04387786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64479993|NCT04387786|Respiratory System Agents|respiratory system agents|mesh-ancestor
64479994|NCT04387786|Tocolytic Agents|tocolytic agents|mesh-ancestor
64479995|NCT04387786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64479996|NCT04387786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64479997|NCT04387786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64479998|NCT04387786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64479999|NCT04387786|Adrenergic Agents|adrenergic agents|mesh-ancestor
64480000|NCT04387786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64480001|NCT04387786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480002|NCT00569530|Calfactant|calfactant|mesh-list
64480049|NCT04259398|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64480050|NCT04259398|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64480051|NCT01592110|Risperidone|risperidone|mesh-list
64480052|NCT01592110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64480053|NCT01592110|Serotonin Agents|serotonin agents|mesh-ancestor
64480054|NCT01592110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64480055|NCT01592110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480056|NCT01592110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480057|NCT01592110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64480058|NCT01592110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64480060|NCT01592110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64480114|NCT02134210|Sensory System Agents|sensory system agents|mesh-ancestor
64480115|NCT02134210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64480116|NCT02134210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480117|NCT02134210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64480118|NCT02134210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64480119|NCT02134210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64480120|NCT02134210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64480121|NCT02134210|Immunologic Factors|immunologic factors|mesh-ancestor
64480122|NCT00607594|Saracatinib|saracatinib|mesh-list
64480123|NCT00607594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480124|NCT00607594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480125|NCT00607594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480126|NCT01866319|Pembrolizumab|pembrolizumab|mesh-list
64480127|NCT01866319|Ipilimumab|ipilimumab|mesh-list
64480133|NCT00607672|Ramipril|ramipril|mesh-list
64480169|NCT00608062|Hormone Antagonists|hormone antagonists|mesh-ancestor
64480170|NCT02135146|Plasma-lyte 148|plasma-lyte 148|mesh-list
64480171|NCT02135146|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64480172|NCT02135146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64480173|NCT02829268|Dantrolene|dantrolene|mesh-list
64480174|NCT02829268|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64480175|NCT02829268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480176|NCT02829268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64480177|NCT02829268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64480178|NCT02202772|Gemcitabine|gemcitabine|mesh-list
64480179|NCT02202772|Cisplatin|cisplatin|mesh-list
64480180|NCT02202772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480181|NCT02202772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64480182|NCT02202772|Antimetabolites|antimetabolites|mesh-ancestor
64480184|NCT02202772|Antiviral Agents|antiviral agents|mesh-ancestor
64480231|NCT01571128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64480232|NCT01571128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64480233|NCT00614458|Raltegravir Potassium|raltegravir potassium|mesh-list
64480234|NCT00614458|Valproic Acid|valproic acid|mesh-list
64480235|NCT00614458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64480236|NCT00614458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64480237|NCT00614458|Antiviral Agents|antiviral agents|mesh-ancestor
64480238|NCT00614458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64480239|NCT00614458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64480240|NCT00614458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64480241|NCT00614458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480242|NCT00614458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480243|NCT00614458|Anticonvulsants|anticonvulsants|mesh-ancestor
64480244|NCT00614458|GABA Agents|gaba agents|mesh-ancestor
64480245|NCT00614458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64480246|NCT00614458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480247|NCT00614458|Antimanic Agents|antimanic agents|mesh-ancestor
64480248|NCT00614458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64480249|NCT00614458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64480250|NCT00614458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64480251|NCT01429168|Etoricoxib|etoricoxib|mesh-list
64480252|NCT01429168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64480253|NCT01429168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64480254|NCT01429168|Analgesics|analgesics|mesh-ancestor
64480255|NCT01429168|Sensory System Agents|sensory system agents|mesh-ancestor
64480258|NCT01429168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64480280|NCT00756418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64480281|NCT00756418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480282|NCT00756418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64480283|NCT00756418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64480284|NCT00756418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480285|NCT00756418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64480286|NCT00756418|Autonomic Agents|autonomic agents|mesh-ancestor
64480287|NCT00756418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64465858|NCT05586568|Itraconazole|itraconazole|mesh-list
64480289|NCT00756418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480290|NCT00756418|Vasodilator Agents|vasodilator agents|mesh-ancestor
64480291|NCT00756418|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64480292|NCT00756418|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64480293|NCT00756418|Purinergic Agents|purinergic agents|mesh-ancestor
64480294|NCT00756418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64480295|NCT00615472|Remifentanil|remifentanil|mesh-list
64480296|NCT00615472|Propofol|propofol|mesh-list
64480297|NCT00615472|Isoflurane|isoflurane|mesh-list
64480298|NCT00615472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64480299|NCT00615472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64480300|NCT00615472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480301|NCT00615472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64480302|NCT00615472|Anesthetics, General|anesthetics, general|mesh-ancestor
64480329|NCT00652444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64480330|NCT00652444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480331|NCT00585910|Methylphenidate|methylphenidate|mesh-list
64480332|NCT00585910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64480333|NCT00585910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64480334|NCT00585910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480335|NCT00585910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64480336|NCT00585910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64480337|NCT00585910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64480338|NCT00585910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480339|NCT00585910|Dopamine Agents|dopamine agents|mesh-ancestor
64480340|NCT00585910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64480341|NCT00585910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64480342|NCT00585910|Adrenergic Agents|adrenergic agents|mesh-ancestor
64480343|NCT00489346|Fluticasone|fluticasone|mesh-list
64480344|NCT00489346|Xhance|xhance|mesh-list
64480345|NCT00489346|Montelukast|montelukast|mesh-list
64480346|NCT00489346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64480347|NCT00489346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64480348|NCT00489346|Autonomic Agents|autonomic agents|mesh-ancestor
64480349|NCT00489346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64480350|NCT00489346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480351|NCT00489346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64480352|NCT00489346|Respiratory System Agents|respiratory system agents|mesh-ancestor
64480353|NCT00489346|Dermatologic Agents|dermatologic agents|mesh-ancestor
64480354|NCT00489346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64480373|NCT00618436|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64480374|NCT00618436|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64471410|NCT04531982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64480375|NCT00618436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64480376|NCT00618436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480377|NCT00618436|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64480379|NCT00619060|Niacin|niacin|mesh-list
64480380|NCT00619060|Nicotinic Acids|nicotinic acids|mesh-list
64480381|NCT00619060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64480382|NCT00619060|Antimetabolites|antimetabolites|mesh-ancestor
64480383|NCT00619060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480384|NCT00619060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64480385|NCT00619060|Vasodilator Agents|vasodilator agents|mesh-ancestor
64480386|NCT00619060|Vitamin B Complex|vitamin b complex|mesh-ancestor
64480387|NCT00619060|Vitamins|vitamins|mesh-ancestor
64480388|NCT00619060|Micronutrients|micronutrients|mesh-ancestor
64480389|NCT00619060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480390|NCT05247424|Heparin|heparin|mesh-list
64480391|NCT05247424|Calcium heparin|calcium heparin|mesh-list
64480392|NCT05247424|Anticoagulants|anticoagulants|mesh-ancestor
64480393|NCT05247424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64480394|NCT05247424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64480395|NCT05247424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480396|NCT00092716|Atorvastatin|atorvastatin|mesh-list
64480397|NCT00092716|Ezetimibe|ezetimibe|mesh-list
64480398|NCT00092716|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64480399|NCT00092716|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64480400|NCT00092716|Antimetabolites|antimetabolites|mesh-ancestor
64480401|NCT00092716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480402|NCT00092716|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64480403|NCT00092716|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64480404|NCT00092716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480405|NCT00619684|Lenalidomide|lenalidomide|mesh-list
64480406|NCT00619684|Immunologic Factors|immunologic factors|mesh-ancestor
64480407|NCT00619684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480408|NCT00619684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64480410|NCT00619684|Growth Substances|growth substances|mesh-ancestor
64480411|NCT00619684|Growth Inhibitors|growth inhibitors|mesh-ancestor
64480412|NCT00619684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480413|NCT00588406|Prednisone|prednisone|mesh-list
64480414|NCT00588406|Budesonide|budesonide|mesh-list
64480415|NCT00588406|Bromides|bromides|mesh-list
64480416|NCT00588406|Albuterol|albuterol|mesh-list
64480417|NCT00588406|Ipratropium|ipratropium|mesh-list
64480418|NCT00588406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64480419|NCT00588406|Glucocorticoids|glucocorticoids|mesh-ancestor
64480420|NCT00588406|Hormones|hormones|mesh-ancestor
64480421|NCT00588406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64480422|NCT00588406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480423|NCT00588406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64480424|NCT00588406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480425|NCT00588406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64480426|NCT00588406|Autonomic Agents|autonomic agents|mesh-ancestor
64480427|NCT00588406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64480428|NCT00588406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64480429|NCT00588406|Respiratory System Agents|respiratory system agents|mesh-ancestor
64480430|NCT00588406|Anticonvulsants|anticonvulsants|mesh-ancestor
64480431|NCT00588406|Tocolytic Agents|tocolytic agents|mesh-ancestor
64480432|NCT00588406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64480433|NCT00588406|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64480434|NCT00588406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64480435|NCT00588406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64480436|NCT00588406|Adrenergic Agents|adrenergic agents|mesh-ancestor
64480437|NCT00588406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64480438|NCT00588406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480441|NCT00668434|Prednisone|prednisone|mesh-list
64480456|NCT00589888|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64480457|NCT00589888|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64480458|NCT00589888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64480459|NCT00621946|Dexetimide|dexetimide|mesh-list
64480460|NCT00621946|Citalopram|citalopram|mesh-list
64480461|NCT00621946|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64480462|NCT00621946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64480463|NCT00621946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64480464|NCT00621946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480465|NCT00621946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64480466|NCT00621946|Serotonin Agents|serotonin agents|mesh-ancestor
64480467|NCT00621946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480468|NCT00621946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64480469|NCT00621946|Antidepressive Agents|antidepressive agents|mesh-ancestor
64480515|NCT00593866|Antimetabolites|antimetabolites|mesh-ancestor
64480516|NCT00593866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480517|NCT00593866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480518|NCT00593866|Antiviral Agents|antiviral agents|mesh-ancestor
64480519|NCT00593866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64480520|NCT00593866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480521|NCT00593866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64480522|NCT00593866|Immunologic Factors|immunologic factors|mesh-ancestor
64480523|NCT00593866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471411|NCT04531982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64480524|NCT00624910|Bupivacaine|bupivacaine|mesh-list
64480525|NCT00624910|Anesthetics, Local|anesthetics, local|mesh-ancestor
64480526|NCT00624910|Anesthetics|anesthetics|mesh-ancestor
64480527|NCT00624910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64480528|NCT00624910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480529|NCT00624910|Sensory System Agents|sensory system agents|mesh-ancestor
64480530|NCT00624910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64480531|NCT00626626|Alemtuzumab|alemtuzumab|mesh-list
64480569|NCT00627406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64480570|NCT00627406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480571|NCT00627406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64480573|NCT00673738|Docetaxel|docetaxel|mesh-list
64480574|NCT00673738|Cetuximab|cetuximab|mesh-list
64480575|NCT00673738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480576|NCT00673738|Tubulin Modulators|tubulin modulators|mesh-ancestor
64480577|NCT00673738|Antimitotic Agents|antimitotic agents|mesh-ancestor
64480578|NCT00673738|Mitosis Modulators|mitosis modulators|mesh-ancestor
64480579|NCT00673738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480580|NCT00673738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64480581|NCT00674206|Gemcitabine|gemcitabine|mesh-list
64480582|NCT00674206|Oxaliplatin|oxaliplatin|mesh-list
64480583|NCT00674206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64480584|NCT00674206|Antimetabolites|antimetabolites|mesh-ancestor
64480585|NCT00674206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480586|NCT00674206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480587|NCT00674206|Antiviral Agents|antiviral agents|mesh-ancestor
64480588|NCT00674206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64480589|NCT00674206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480590|NCT00674206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64480591|NCT00674206|Immunologic Factors|immunologic factors|mesh-ancestor
64480620|NCT00629122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64480621|NCT00629122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64480622|NCT00629122|Ionophores|ionophores|mesh-ancestor
64480623|NCT00629122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64480624|NCT00596440|Nicotine|nicotine|mesh-list
64480625|NCT00596440|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64480626|NCT00596440|Autonomic Agents|autonomic agents|mesh-ancestor
64480627|NCT00596440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64480628|NCT00596440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480629|NCT00596440|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64480630|NCT00596440|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64480631|NCT00596440|Cholinergic Agents|cholinergic agents|mesh-ancestor
64480632|NCT00596440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64480633|NCT00596440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480634|NCT00632632|Cycloserine|cycloserine|mesh-list
64480635|NCT00632632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64480636|NCT00632632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64480637|NCT00632632|Renal Agents|renal agents|mesh-ancestor
64480638|NCT00632632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64480639|NCT00632632|Antitubercular Agents|antitubercular agents|mesh-ancestor
64480640|NCT00632632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64480641|NCT00632632|Antimetabolites|antimetabolites|mesh-ancestor
64480642|NCT00632632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480669|NCT00675922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64480670|NCT00675922|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64480671|NCT00675922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480672|NCT00675922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480673|NCT00678418|Naltrexone|naltrexone|mesh-list
64480674|NCT00678418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64480675|NCT00678418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64480676|NCT00678418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480677|NCT00678418|Sensory System Agents|sensory system agents|mesh-ancestor
64480678|NCT00678418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64480679|NCT00600340|Paclitaxel|paclitaxel|mesh-list
64480680|NCT00600340|Bevacizumab|bevacizumab|mesh-list
64480681|NCT00600340|Capecitabine|capecitabine|mesh-list
64480682|NCT00600340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64480683|NCT00600340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480684|NCT00600340|Tubulin Modulators|tubulin modulators|mesh-ancestor
64480685|NCT00600340|Antimitotic Agents|antimitotic agents|mesh-ancestor
64480726|NCT00602290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64480727|NCT00602290|Antidepressive Agents|antidepressive agents|mesh-ancestor
64480728|NCT00602290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64480729|NCT00637780|Sulfasalazine|sulfasalazine|mesh-list
64480730|NCT00637780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64714001|NCT03043105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64480731|NCT00637780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64480732|NCT00637780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64480733|NCT00637780|Analgesics|analgesics|mesh-ancestor
64480759|NCT00602836|Rituximab|rituximab|mesh-list
64480787|NCT00640822|Calcitriol|calcitriol|mesh-list
64480788|NCT00640822|Hydrocortisone|hydrocortisone|mesh-list
64480789|NCT00640822|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64480790|NCT00640822|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64480791|NCT00640822|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64480792|NCT00640822|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
64480793|NCT00640822|Calcipotriene|calcipotriene|mesh-list
64480794|NCT00640822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64480795|NCT00640822|Dermatologic Agents|dermatologic agents|mesh-ancestor
64480796|NCT00640822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64480797|NCT00640822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480798|NCT00640822|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64480799|NCT00640822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64480800|NCT00640822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480801|NCT00640822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64480802|NCT00640822|Vitamins|vitamins|mesh-ancestor
64480803|NCT00640822|Micronutrients|micronutrients|mesh-ancestor
64480805|NCT00640978|Everolimus|everolimus|mesh-list
64480841|NCT00705874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480842|NCT00705874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64480843|NCT00705874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64480844|NCT00705874|Growth Substances|growth substances|mesh-ancestor
64480845|NCT00705874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480846|NCT00705874|Growth Inhibitors|growth inhibitors|mesh-ancestor
64480847|NCT00705874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64480848|NCT00705874|Antimetabolites|antimetabolites|mesh-ancestor
64480849|NCT00705874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480850|NCT00705874|Antiviral Agents|antiviral agents|mesh-ancestor
64480851|NCT00705874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64480852|NCT00705874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480853|NCT00705874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64480854|NCT00705874|Immunologic Factors|immunologic factors|mesh-ancestor
64480855|NCT00705874|Tubulin Modulators|tubulin modulators|mesh-ancestor
64480904|NCT00687544|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64480906|NCT00687544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480907|NCT00687544|Antiviral Agents|antiviral agents|mesh-ancestor
64480908|NCT00687544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64480909|NCT02143648|Nalbuphine|nalbuphine|mesh-list
64480910|NCT02143648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64480911|NCT02143648|Narcotics|narcotics|mesh-ancestor
64480912|NCT02143648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64480913|NCT02143648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480914|NCT02143648|Analgesics|analgesics|mesh-ancestor
64480915|NCT02143648|Sensory System Agents|sensory system agents|mesh-ancestor
64480916|NCT02143648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64480917|NCT02997982|Valacyclovir|valacyclovir|mesh-list
64480918|NCT02997982|Antiviral Agents|antiviral agents|mesh-ancestor
64480919|NCT02997982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64480920|NCT00689572|Ondansetron|ondansetron|mesh-list
64480921|NCT00689572|Antiemetics|antiemetics|mesh-ancestor
64480922|NCT00689572|Autonomic Agents|autonomic agents|mesh-ancestor
64480923|NCT00689572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64480924|NCT00689572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480925|NCT00689572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64480937|NCT01840579|Paclitaxel|paclitaxel|mesh-list
64480962|NCT00651040|Hormones|hormones|mesh-ancestor
64714002|NCT03043105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64480963|NCT00651040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64480964|NCT00651040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480965|NCT00651040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64480966|NCT00651040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480967|NCT00651040|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64480968|NCT00651040|Abortifacient Agents|abortifacient agents|mesh-ancestor
64480969|NCT00651040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64480970|NCT00651040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64480971|NCT00651040|Antimetabolites|antimetabolites|mesh-ancestor
64480972|NCT00651040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480973|NCT00651040|Dermatologic Agents|dermatologic agents|mesh-ancestor
64480974|NCT00651040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480975|NCT00651040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64480976|NCT00651040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64480977|NCT00651040|Immunologic Factors|immunologic factors|mesh-ancestor
64480978|NCT00651040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64480979|NCT00651040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64480981|NCT00654784|Antioxidants|antioxidants|mesh-ancestor
64480982|NCT00654784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64480983|NCT00654784|Protective Agents|protective agents|mesh-ancestor
64480984|NCT00654784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64480985|NCT02997514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64480986|NCT01801111|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64480987|NCT01801111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64480988|NCT01801111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64480989|NCT01801111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64480991|NCT00691600|Trimethoprim|trimethoprim|mesh-list
64481004|NCT00691600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64481005|NCT00655642|Promethazine|promethazine|mesh-list
64481006|NCT00655642|Diphenhydramine|diphenhydramine|mesh-list
64481007|NCT00655642|Ondansetron|ondansetron|mesh-list
64481008|NCT00655642|Metoclopramide|metoclopramide|mesh-list
64481009|NCT00655642|Antiemetics|antiemetics|mesh-ancestor
64481010|NCT00655642|Autonomic Agents|autonomic agents|mesh-ancestor
64481011|NCT00655642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64481012|NCT00655642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481013|NCT00655642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64481015|NCT00655642|Dermatologic Agents|dermatologic agents|mesh-ancestor
64481016|NCT00655642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64481017|NCT00655642|Serotonin Agents|serotonin agents|mesh-ancestor
64481018|NCT00655642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64481019|NCT00655642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481020|NCT00655642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64481021|NCT00655642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64481022|NCT00655642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64481023|NCT00655642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64481024|NCT00655642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64481025|NCT00655642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64481026|NCT00655642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64481027|NCT00655642|Dopamine Agents|dopamine agents|mesh-ancestor
64481028|NCT00655642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64481054|NCT00656656|Antimetabolites|antimetabolites|mesh-ancestor
64481055|NCT00656656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481056|NCT00656656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64481057|NCT00656656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64481058|NCT01773889|Interferon alpha-2|interferon alpha-2|mesh-list
64481059|NCT01773889|Denileukin diftitox|denileukin diftitox|mesh-list
64481060|NCT01773889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481061|NCT01773889|Antiviral Agents|antiviral agents|mesh-ancestor
64481062|NCT01773889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64481063|NCT00656968|Esomeprazole|esomeprazole|mesh-list
64481064|NCT00656968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64481065|NCT00656968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64481066|NCT00656968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64481067|NCT00656968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481068|NCT00656968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481069|NCT00657280|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64481070|NCT00657280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64481110|NCT00695188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64481111|NCT00695188|Immunologic Factors|immunologic factors|mesh-ancestor
64481112|NCT00695188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64481113|NCT00695188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64481114|NCT00706264|Silicon|silicon|mesh-list
64481115|NCT00706264|Trace Elements|trace elements|mesh-ancestor
64481116|NCT00706264|Micronutrients|micronutrients|mesh-ancestor
64481117|NCT00706264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481118|NCT00695500|Varenicline|varenicline|mesh-list
64481119|NCT00695500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64481120|NCT00695500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64481121|NCT00695500|Cholinergic Agents|cholinergic agents|mesh-ancestor
64481125|NCT00695578|Bacitracin|bacitracin|mesh-list
64481173|NCT00661960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64481174|NCT00661960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64481175|NCT00661960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64481176|NCT00661960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64481177|NCT00661960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64481178|NCT00661960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64481179|NCT00661960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64481180|NCT00661960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64481181|NCT00661960|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64481182|NCT00661960|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64481183|NCT00662818|Acetaminophen|acetaminophen|mesh-list
64481236|NCT01839487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64481237|NCT01839487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64481238|NCT01839487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64481239|NCT01839487|Antimetabolites|antimetabolites|mesh-ancestor
64481240|NCT01839487|Antiviral Agents|antiviral agents|mesh-ancestor
64481241|NCT01839487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64481242|NCT01839487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481243|NCT01839487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64481244|NCT01839487|Immunologic Factors|immunologic factors|mesh-ancestor
64481245|NCT01839487|Anticoagulants|anticoagulants|mesh-ancestor
64481246|NCT01839487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64481298|NCT00702364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481299|NCT00702364|Adrenergic Agents|adrenergic agents|mesh-ancestor
64481300|NCT00702364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64481301|NCT00702364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481302|NCT00713284|Sirolimus|sirolimus|mesh-list
64481303|NCT00713284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64481304|NCT00713284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64481305|NCT00713284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64481306|NCT00713284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481307|NCT00713284|Antifungal Agents|antifungal agents|mesh-ancestor
64481308|NCT00713284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64481309|NCT00713284|Immunologic Factors|immunologic factors|mesh-ancestor
64481310|NCT00713284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481311|NCT00702754|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
64481312|NCT00702754|Botulinum Toxins|botulinum toxins|mesh-list
64481313|NCT00702754|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64481314|NCT00702754|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64481315|NCT00702754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64481316|NCT00702754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64481317|NCT00702754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481318|NCT00702754|Cholinergic Agents|cholinergic agents|mesh-ancestor
64481319|NCT00702754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64481320|NCT00702754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481321|NCT00702754|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64481322|NCT00702754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64481323|NCT00702754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64481324|NCT02995720|Amlodipine|amlodipine|mesh-list
64481325|NCT02995720|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64481326|NCT02995720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64481327|NCT02995720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64481328|NCT02995720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64481329|NCT02995720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481330|NCT02995720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64481331|NCT02995720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481332|NCT02995720|Vasodilator Agents|vasodilator agents|mesh-ancestor
64982173|NCT04718233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481333|NCT02995720|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64481334|NCT02995720|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64481336|NCT02995720|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64481337|NCT02995720|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64481338|NCT02995720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481339|NCT02999230|Listerine|listerine|mesh-list
64481340|NCT02999230|Fluorides|fluorides|mesh-list
64481341|NCT02999230|Sodium Fluoride|sodium fluoride|mesh-list
64481342|NCT02999230|Cariostatic Agents|cariostatic agents|mesh-ancestor
64481343|NCT02999230|Protective Agents|protective agents|mesh-ancestor
64481344|NCT02999230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481345|NCT02999230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64481346|NCT02999230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64481347|NCT02990728|Metformin|metformin|mesh-list
64481348|NCT02990728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64481349|NCT02990728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481350|NCT02995330|Cyclophosphamide|cyclophosphamide|mesh-list
64481351|NCT02995330|Methyltestosterone|methyltestosterone|mesh-list
64481352|NCT02995330|Testosterone|testosterone|mesh-list
64481353|NCT02995330|Testosterone undecanoate|testosterone undecanoate|mesh-list
64481354|NCT02995330|Testosterone enanthate|testosterone enanthate|mesh-list
64481355|NCT02995330|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64481356|NCT02995330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64481387|NCT02999776|Etanercept|etanercept|mesh-list
64481388|NCT02999776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64481389|NCT02999776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64481390|NCT02999776|Analgesics|analgesics|mesh-ancestor
64481391|NCT02999776|Sensory System Agents|sensory system agents|mesh-ancestor
64481392|NCT02999776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64481393|NCT02999776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481394|NCT02999776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64481395|NCT02999776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64481399|NCT02996656|Ceftriaxone|ceftriaxone|mesh-list
64481451|NCT00704938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64481452|NCT00704938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64481453|NCT00704938|Antiviral Agents|antiviral agents|mesh-ancestor
64481454|NCT00704938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64481455|NCT02994082|Bupropion|bupropion|mesh-list
64481456|NCT02994082|Nicotine|nicotine|mesh-list
64481457|NCT02994082|Varenicline|varenicline|mesh-list
64481458|NCT02994082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64481459|NCT02994082|Autonomic Agents|autonomic agents|mesh-ancestor
64481460|NCT02994082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64481461|NCT02994082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481462|NCT02994082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64481463|NCT02994082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64481464|NCT02994082|Cholinergic Agents|cholinergic agents|mesh-ancestor
64481465|NCT02994082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64481466|NCT02994082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481467|NCT02994082|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64481468|NCT02994082|Antidepressive Agents|antidepressive agents|mesh-ancestor
64481469|NCT02994082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64481470|NCT02994082|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64481471|NCT02994082|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64481472|NCT02994082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64481473|NCT02994082|Dopamine Agents|dopamine agents|mesh-ancestor
64481474|NCT02994082|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64481501|NCT01270438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481502|NCT01270438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64481503|NCT01270438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64481504|NCT01270438|Growth Substances|growth substances|mesh-ancestor
64481505|NCT01270438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481506|NCT01270438|Growth Inhibitors|growth inhibitors|mesh-ancestor
64481507|NCT01270438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64481508|NCT01270438|Antimetabolites|antimetabolites|mesh-ancestor
64481509|NCT01270438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481519|NCT01270672|Carvedilol|carvedilol|mesh-list
64481565|NCT02992678|Pentoxifylline|pentoxifylline|mesh-list
64481566|NCT02992678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64481567|NCT02992678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481568|NCT02992678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481569|NCT02992678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64481570|NCT02992678|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64481571|NCT02992678|Protective Agents|protective agents|mesh-ancestor
64481572|NCT02992678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481573|NCT02992678|Vasodilator Agents|vasodilator agents|mesh-ancestor
64481574|NCT02992678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64481575|NCT02992678|Antioxidants|antioxidants|mesh-ancestor
64481576|NCT02992912|Atezolizumab|atezolizumab|mesh-list
64481577|NCT02992912|Antibodies|antibodies|mesh-list
64481578|NCT02992912|Immunologic Factors|immunologic factors|mesh-ancestor
64481579|NCT02992912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481580|NCT02992912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481581|NCT01271140|Insulin|insulin|mesh-list
64481582|NCT01271140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64481583|NCT01271140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481584|NCT01271374|Losartan|losartan|mesh-list
64481585|NCT01271374|Amlodipine|amlodipine|mesh-list
64481586|NCT01271374|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64481618|NCT00711490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64481619|NCT00711490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481620|NCT00711490|Antifungal Agents|antifungal agents|mesh-ancestor
64481621|NCT00711490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64481622|NCT00711490|Immunologic Factors|immunologic factors|mesh-ancestor
64481623|NCT00711490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481624|NCT01271998|Tedizolid phosphate|tedizolid phosphate|mesh-list
64481625|NCT01271998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64481626|NCT01271998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64481627|NCT00717418|Cyclosporine|cyclosporine|mesh-list
64481628|NCT00717418|Lubricant Eye Drops|lubricant eye drops|mesh-list
64481629|NCT00717418|Cyclosporins|cyclosporins|mesh-list
64481630|NCT00717418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481631|NCT00717418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481632|NCT00717418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64481633|NCT00717418|Immunologic Factors|immunologic factors|mesh-ancestor
64481642|NCT00717574|Nitrous Oxide|nitrous oxide|mesh-list
64481678|NCT01277770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64481679|NCT01277770|Immunologic Factors|immunologic factors|mesh-ancestor
64481680|NCT01277770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481681|NCT01277770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64481682|NCT00721162|Ramucirumab|ramucirumab|mesh-list
64481683|NCT00721162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481684|NCT01838941|Betaine|betaine|mesh-list
64481685|NCT01838941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64481686|NCT01838941|Lipotropic Agents|lipotropic agents|mesh-ancestor
64481687|NCT01838941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64481688|NCT01838941|Antimetabolites|antimetabolites|mesh-ancestor
64481689|NCT01838941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481690|NCT01838941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64481691|NCT01773109|Irinotecan|irinotecan|mesh-list
64481692|NCT01773109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
64481693|NCT01773109|Etirinotecan pegol|etirinotecan pegol|mesh-list
64481738|NCT01278238|Autonomic Agents|autonomic agents|mesh-ancestor
64481739|NCT01278238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64481740|NCT01278238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481741|NCT01278238|Sympathomimetics|sympathomimetics|mesh-ancestor
64481742|NCT01278238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64481743|NCT01278238|Nasal Decongestants|nasal decongestants|mesh-ancestor
64481744|NCT01278238|Respiratory System Agents|respiratory system agents|mesh-ancestor
64481745|NCT01278238|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64481746|NCT01278238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64481747|NCT01278238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64481748|NCT01278238|Adrenergic Agents|adrenergic agents|mesh-ancestor
64481749|NCT01278238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64481750|NCT01278238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481751|NCT01278238|Protective Agents|protective agents|mesh-ancestor
64481752|NCT02706795|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64481753|NCT02706795|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64481754|NCT02706795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64481755|NCT02706795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64481756|NCT02706795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481757|NCT02706795|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64481758|NCT02706795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64481759|NCT02706795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481760|NCT02706795|Cholinergic Agents|cholinergic agents|mesh-ancestor
64481761|NCT02706795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64481762|NCT01272310|Interferons|interferons|mesh-list
64481763|NCT01272310|Ribavirin|ribavirin|mesh-list
64481764|NCT01272310|Interferon-alpha|interferon-alpha|mesh-list
64481765|NCT01272310|Interferon alpha-2|interferon alpha-2|mesh-list
64481783|NCT05586477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64481784|NCT05586477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64481785|NCT05586477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481786|NCT05586477|Anesthetics, Local|anesthetics, local|mesh-ancestor
64481787|NCT05586477|Anesthetics|anesthetics|mesh-ancestor
64481788|NCT05586477|Sensory System Agents|sensory system agents|mesh-ancestor
64481789|NCT05586477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64481790|NCT05586477|Antiemetics|antiemetics|mesh-ancestor
64481791|NCT05586477|Autonomic Agents|autonomic agents|mesh-ancestor
64481792|NCT05586477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64481793|NCT05586477|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64481794|NCT05586477|Histamine Antagonists|histamine antagonists|mesh-ancestor
64481795|NCT05586477|Histamine Agents|histamine agents|mesh-ancestor
64481796|NCT05586477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64481797|NCT05586477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481798|NCT05586477|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64481799|NCT05586477|Antipruritics|antipruritics|mesh-ancestor
64481800|NCT05586477|Dermatologic Agents|dermatologic agents|mesh-ancestor
64481801|NCT04386850|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
64481802|NCT04386850|Calcifediol|calcifediol|mesh-list
64481804|NCT04386850|Micronutrients|micronutrients|mesh-ancestor
64481805|NCT04386850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481806|NCT04386850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64481807|NCT01272778|Lorazepam|lorazepam|mesh-list
64481808|NCT01272778|Anticonvulsants|anticonvulsants|mesh-ancestor
64481809|NCT01272778|Antiemetics|antiemetics|mesh-ancestor
64481810|NCT01272778|Autonomic Agents|autonomic agents|mesh-ancestor
64481811|NCT01272778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64481812|NCT01272778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481813|NCT01272778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64481814|NCT01272778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64481815|NCT01272778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64481826|NCT01272856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481827|NCT01272856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64481828|NCT01272856|Immunologic Factors|immunologic factors|mesh-ancestor
64481829|NCT01272856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481830|NCT01272856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64481831|NCT01273090|Imetelstat|imetelstat|mesh-list
64481832|NCT01273090|Motesanib diphosphate|motesanib diphosphate|mesh-list
64481833|NCT01273090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481834|NCT01273090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481835|NCT01273090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64481836|NCT01273246|Vaccines|vaccines|mesh-list
64481837|NCT01273246|Immunologic Factors|immunologic factors|mesh-ancestor
64481838|NCT01273246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481839|NCT00730522|Vigabatrin|vigabatrin|mesh-list
64481840|NCT00730522|Anticonvulsants|anticonvulsants|mesh-ancestor
64481841|NCT00730522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481842|NCT00730522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481843|NCT00730522|GABA Agents|gaba agents|mesh-ancestor
64481844|NCT00730522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64481845|NCT00730522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481846|NCT04345276|Ritonavir|ritonavir|mesh-list
64481847|NCT04345276|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64481848|NCT04345276|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64481849|NCT04345276|Protease Inhibitors|protease inhibitors|mesh-ancestor
64481850|NCT04345276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481851|NCT04345276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481852|NCT04345276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64481853|NCT04345276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64481854|NCT04345276|Antiviral Agents|antiviral agents|mesh-ancestor
64481855|NCT04345276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64481856|NCT04345276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64481857|NCT04345276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64714005|NCT03043105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64481858|NCT01273558|Canagliflozin|canagliflozin|mesh-list
64982698|NCT00301990|Aldesleukin|aldesleukin|mesh-list
64481859|NCT01273558|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64481860|NCT01273558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481861|NCT01273558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64481862|NCT01273558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481863|NCT00733096|Methylprednisolone|methylprednisolone|mesh-list
64481864|NCT00733096|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64481865|NCT00733096|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64481866|NCT00733096|Prednisolone|prednisolone|mesh-list
64481867|NCT00733096|Prednisolone acetate|prednisolone acetate|mesh-list
64481868|NCT00733096|Etanercept|etanercept|mesh-list
64481869|NCT00733096|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64481870|NCT00733096|Prednisolone phosphate|prednisolone phosphate|mesh-list
64481871|NCT00733096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64481872|NCT00733096|Antiemetics|antiemetics|mesh-ancestor
64481873|NCT00733096|Autonomic Agents|autonomic agents|mesh-ancestor
64481874|NCT00733096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64481875|NCT00733096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481877|NCT00733096|Glucocorticoids|glucocorticoids|mesh-ancestor
64481878|NCT00733096|Hormones|hormones|mesh-ancestor
64481879|NCT00733096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64481880|NCT00733096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64481881|NCT00733096|Protective Agents|protective agents|mesh-ancestor
64481882|NCT00733096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64481883|NCT00733096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481884|NCT00733096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64481885|NCT00733096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64481886|NCT00733096|Analgesics|analgesics|mesh-ancestor
64481887|NCT00733096|Sensory System Agents|sensory system agents|mesh-ancestor
64481891|NCT02991196|Nivolumab|nivolumab|mesh-list
64481901|NCT01278784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64481902|NCT01278784|Antiviral Agents|antiviral agents|mesh-ancestor
64481903|NCT01278784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64481904|NCT01278784|Expectorants|expectorants|mesh-ancestor
64481905|NCT01278784|Respiratory System Agents|respiratory system agents|mesh-ancestor
64481906|NCT01278784|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64481907|NCT01278784|Antioxidants|antioxidants|mesh-ancestor
64481908|NCT01278784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481909|NCT01278784|Protective Agents|protective agents|mesh-ancestor
64481910|NCT01278784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481911|NCT01278784|Antidotes|antidotes|mesh-ancestor
64481912|NCT01278784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64481913|NCT01278784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64481914|NCT01278784|Antimetabolites|antimetabolites|mesh-ancestor
64481915|NCT01278784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64481916|NCT01278784|Chelating Agents|chelating agents|mesh-ancestor
64481917|NCT01278784|Sequestering Agents|sequestering agents|mesh-ancestor
64481918|NCT01278784|Hemostatics|hemostatics|mesh-ancestor
64481919|NCT01278784|Coagulants|coagulants|mesh-ancestor
64481920|NCT01276288|Empagliflozin|empagliflozin|mesh-list
64481921|NCT01276288|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64481922|NCT01276288|Torsemide|torsemide|mesh-list
64481923|NCT01276288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64481924|NCT01276288|Diuretics|diuretics|mesh-ancestor
64481925|NCT01276288|Natriuretic Agents|natriuretic agents|mesh-ancestor
64481926|NCT01276288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481927|NCT01276288|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64481928|NCT01276288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64481929|NCT01276288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64481930|NCT01276288|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64481931|NCT01276288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64481932|NCT01276288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64481933|NCT00722566|Bortezomib|bortezomib|mesh-list
64481934|NCT00722566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481935|NCT00722722|Bortezomib|bortezomib|mesh-list
64481942|NCT00723580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481943|NCT00723580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64481944|NCT00723580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64481945|NCT00723580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64481946|NCT00723580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64481947|NCT00723580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64481948|NCT00723580|Dopamine Agents|dopamine agents|mesh-ancestor
64481949|NCT01273948|Interferons|interferons|mesh-list
64481950|NCT01273948|Bavituximab|bavituximab|mesh-list
64481951|NCT01273948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64481952|NCT01273948|Antiviral Agents|antiviral agents|mesh-ancestor
64481953|NCT01273948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64481954|NCT01273948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64481955|NCT00734344|Tenofovir|tenofovir|mesh-list
64481956|NCT00734344|Efavirenz|efavirenz|mesh-list
64481957|NCT00734344|Raltegravir Potassium|raltegravir potassium|mesh-list
64481958|NCT00734344|Antiviral Agents|antiviral agents|mesh-ancestor
64481959|NCT00734344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64481960|NCT00734344|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64481962|NCT00734344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64481998|NCT00735436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64481999|NCT00735436|Growth Substances|growth substances|mesh-ancestor
64482000|NCT00735436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482001|NCT00735436|Growth Inhibitors|growth inhibitors|mesh-ancestor
64482002|NCT00735436|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64482003|NCT00735436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64482004|NCT00735436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482005|NCT00735436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482006|NCT04143165|Lidocaine|lidocaine|mesh-list
64482007|NCT04143165|Anesthetics, Local|anesthetics, local|mesh-ancestor
64482008|NCT04143165|Anesthetics|anesthetics|mesh-ancestor
64482058|NCT00724594|Protective Agents|protective agents|mesh-ancestor
64482059|NCT00724594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482060|NCT00724594|Antidotes|antidotes|mesh-ancestor
64482061|NCT04142931|Nivolumab|nivolumab|mesh-list
64482062|NCT04142931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64482063|NCT04142931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482064|NCT04142931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64482065|NCT04142931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482066|NCT04143477|Peficitinib|peficitinib|mesh-list
64482067|NCT04143477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482068|NCT04143477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482069|NCT04143477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64482070|NCT04143477|Immunologic Factors|immunologic factors|mesh-ancestor
64482071|NCT04143477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482072|NCT05586009|Cisplatin|cisplatin|mesh-list
64482073|NCT05586009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482074|NCT03020979|Apatinib|apatinib|mesh-list
64482075|NCT03020979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482076|NCT03020979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64482077|NCT03020979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482078|NCT03020979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482079|NCT04142151|Aspirin|aspirin|mesh-list
64482080|NCT04142151|Clopidogrel|clopidogrel|mesh-list
64482083|NCT04142151|Analgesics|analgesics|mesh-ancestor
64482107|NCT02985099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64482108|NCT02985099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482110|NCT04141995|Leucovorin|leucovorin|mesh-list
64482111|NCT04141995|Fluorouracil|fluorouracil|mesh-list
64482112|NCT04141995|Oxaliplatin|oxaliplatin|mesh-list
64482113|NCT04141995|Irinotecan|irinotecan|mesh-list
64482114|NCT04141995|Camptothecin|camptothecin|mesh-list
64482115|NCT04141995|Digoxin|digoxin|mesh-list
64482116|NCT04141995|Calcium|calcium|mesh-list
64482117|NCT04141995|Levoleucovorin|levoleucovorin|mesh-list
64482118|NCT04141995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64482119|NCT04141995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482120|NCT04141995|Antimetabolites|antimetabolites|mesh-ancestor
64482121|NCT04141995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482122|NCT04141995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64482123|NCT04141995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482124|NCT04141995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64482125|NCT04141995|Immunologic Factors|immunologic factors|mesh-ancestor
64482126|NCT04141995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64482127|NCT04141995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64482128|NCT04141995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482129|NCT04141995|Antidotes|antidotes|mesh-ancestor
64482130|NCT04141995|Protective Agents|protective agents|mesh-ancestor
64482131|NCT04141995|Vitamin B Complex|vitamin b complex|mesh-ancestor
64482132|NCT04141995|Vitamins|vitamins|mesh-ancestor
64482133|NCT04141995|Micronutrients|micronutrients|mesh-ancestor
64482134|NCT04141995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64482135|NCT04141995|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64482157|NCT05582577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482158|NCT05582577|Growth Inhibitors|growth inhibitors|mesh-ancestor
64482159|NCT04149015|Paclitaxel|paclitaxel|mesh-list
64482160|NCT04149015|Fluorouracil|fluorouracil|mesh-list
64482161|NCT04149015|Oxaliplatin|oxaliplatin|mesh-list
64482162|NCT04149015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64482163|NCT04149015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482164|NCT04149015|Tubulin Modulators|tubulin modulators|mesh-ancestor
64482165|NCT04149015|Antimitotic Agents|antimitotic agents|mesh-ancestor
64482166|NCT04149015|Mitosis Modulators|mitosis modulators|mesh-ancestor
64482167|NCT04149015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482168|NCT04149015|Antimetabolites|antimetabolites|mesh-ancestor
64482169|NCT04149015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64482170|NCT04149015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64482171|NCT04149015|Immunologic Factors|immunologic factors|mesh-ancestor
64482172|NCT04149015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482177|NCT04149171|Hemostatics|hemostatics|mesh-ancestor
64482215|NCT05581875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482216|NCT05581875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64482217|NCT05581875|Glucocorticoids|glucocorticoids|mesh-ancestor
64482218|NCT05581875|Hormones|hormones|mesh-ancestor
64482219|NCT05581875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64482220|NCT05581875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64482221|NCT05581875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482222|NCT05581875|Immunologic Factors|immunologic factors|mesh-ancestor
64482223|NCT05581875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64482224|NCT05581875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64482225|NCT05581875|Growth Substances|growth substances|mesh-ancestor
64482226|NCT05581875|Growth Inhibitors|growth inhibitors|mesh-ancestor
64482227|NCT03945513|Dienogest|dienogest|mesh-list
64482228|NCT03945513|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64482229|NCT03945513|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64482230|NCT03945513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64482273|NCT03580473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64482274|NCT03580473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482275|NCT03580473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482276|NCT03580473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482277|NCT03580473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64482278|NCT03580473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64482279|NCT03580473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64482280|NCT03580473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64482281|NCT03580473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64482282|NCT03580473|Contraceptive Agents|contraceptive agents|mesh-ancestor
64482283|NCT03580473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64482284|NCT03580473|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64482285|NCT03580473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64482286|NCT03580473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64482287|NCT03581487|Durvalumab|durvalumab|mesh-list
64482288|NCT03581487|Ipilimumab|ipilimumab|mesh-list
64482289|NCT03581487|Tremelimumab|tremelimumab|mesh-list
64482290|NCT03581487|Immunoglobulins|immunoglobulins|mesh-list
64482291|NCT03581487|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64482292|NCT03581487|Immunoglobulin G|immunoglobulin g|mesh-list
64482293|NCT03581487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64482294|NCT03581487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482318|NCT03588351|Chitosan|chitosan|mesh-list
64482319|NCT03588351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64482320|NCT03588351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64482321|NCT03588351|Disinfectants|disinfectants|mesh-ancestor
64482322|NCT03588351|Dermatologic Agents|dermatologic agents|mesh-ancestor
64482323|NCT03588351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64482324|NCT03588351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64482325|NCT03588351|Antimetabolites|antimetabolites|mesh-ancestor
64482326|NCT03588351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482327|NCT03588351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64482328|NCT03588351|Chelating Agents|chelating agents|mesh-ancestor
64482329|NCT03588351|Sequestering Agents|sequestering agents|mesh-ancestor
64482330|NCT03588351|Hemostatics|hemostatics|mesh-ancestor
64482331|NCT03588351|Coagulants|coagulants|mesh-ancestor
64482377|NCT02984865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64482378|NCT02984865|Anesthetics, General|anesthetics, general|mesh-ancestor
64482379|NCT02984865|Anesthetics|anesthetics|mesh-ancestor
64482380|NCT02984865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64467961|NCT00065806|Atorvastatin|atorvastatin|mesh-list
64482381|NCT02984865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64482382|NCT02984865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64482383|NCT02984865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64482384|NCT02984865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64482385|NCT02984865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482386|NCT02984865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482387|NCT01797445|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64482388|NCT01797445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64482389|NCT01797445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64482391|NCT01797445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64482392|NCT03935451|Apixaban|apixaban|mesh-list
64482393|NCT03935451|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64482394|NCT03935451|Antithrombins|antithrombins|mesh-ancestor
64482395|NCT03935451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64482396|NCT03935451|Protease Inhibitors|protease inhibitors|mesh-ancestor
64482397|NCT03935451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482398|NCT03935451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482399|NCT03935451|Anticoagulants|anticoagulants|mesh-ancestor
64482401|NCT01611259|Lenalidomide|lenalidomide|mesh-list
64482402|NCT01611259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64482403|NCT01611259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482404|NCT01611259|Immunologic Factors|immunologic factors|mesh-ancestor
64482405|NCT01611259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482406|NCT01611259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64482407|NCT01611259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64482420|NCT03586869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482421|NCT03586869|Tubulin Modulators|tubulin modulators|mesh-ancestor
64482422|NCT03586869|Antimitotic Agents|antimitotic agents|mesh-ancestor
64482423|NCT03586869|Mitosis Modulators|mitosis modulators|mesh-ancestor
64482424|NCT03586869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482425|NCT03586869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64482426|NCT03586869|Immunologic Factors|immunologic factors|mesh-ancestor
64482427|NCT03586869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482428|NCT03586869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64482429|NCT03586869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64482430|NCT03586869|Alkylating Agents|alkylating agents|mesh-ancestor
64482431|NCT03586869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64482432|NCT03586869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64482433|NCT03586869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64482434|NCT03586869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64482477|NCT01795495|Analgesics|analgesics|mesh-ancestor
64482478|NCT01795495|Sensory System Agents|sensory system agents|mesh-ancestor
64482479|NCT01795495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64482480|NCT01795495|Anesthetics|anesthetics|mesh-ancestor
64482481|NCT01795495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64482482|NCT01795495|Anticonvulsants|anticonvulsants|mesh-ancestor
64482483|NCT01795495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64482484|NCT01795495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64482485|NCT01795495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482486|NCT01795495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64482487|NCT01795495|Tocolytic Agents|tocolytic agents|mesh-ancestor
64482488|NCT01795495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64482489|NCT01795495|Antitussive Agents|antitussive agents|mesh-ancestor
64482490|NCT01795495|Respiratory System Agents|respiratory system agents|mesh-ancestor
64482491|NCT04765527|Turmeric extract|turmeric extract|mesh-list
64482492|NCT04765527|Antioxidants|antioxidants|mesh-ancestor
64601001|NCT00741455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482521|NCT03586089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64482522|NCT03586089|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64482523|NCT03586089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64482524|NCT03586089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64482525|NCT03586089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64482526|NCT03586089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64482527|NCT03586089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64714007|NCT03043105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64482528|NCT03586089|Anesthetics, General|anesthetics, general|mesh-ancestor
64482529|NCT03586089|Anesthetics|anesthetics|mesh-ancestor
64482530|NCT03586089|GABA Modulators|gaba modulators|mesh-ancestor
64482531|NCT03586089|GABA Agents|gaba agents|mesh-ancestor
64482532|NCT03586089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64482533|NCT03586089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482534|NCT03586089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64482561|NCT01770145|Apomorphine|apomorphine|mesh-list
64482562|NCT01770145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64482563|NCT01770145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64482564|NCT01770145|Dopamine Agents|dopamine agents|mesh-ancestor
64482565|NCT01770145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64601684|NCT03802747|Durvalumab|durvalumab|mesh-list
64482566|NCT01770145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482567|NCT01770145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482574|NCT01770145|Autonomic Agents|autonomic agents|mesh-ancestor
64482613|NCT05702073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482615|NCT05701995|Dermatologic Agents|dermatologic agents|mesh-ancestor
64482616|NCT05701995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64482617|NCT05701995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482618|NCT05701995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482619|NCT01985321|Ethanol|ethanol|mesh-list
64482620|NCT01985321|Glycolic acid|glycolic acid|mesh-list
64482621|NCT01985321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64482622|NCT01985321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64602469|NCT02000973|Lidocaine|lidocaine|mesh-list
64482623|NCT01985321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64482624|NCT01985321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482625|NCT01985321|Keratolytic Agents|keratolytic agents|mesh-ancestor
64482626|NCT01985321|Dermatologic Agents|dermatologic agents|mesh-ancestor
64482627|NCT03584919|Doxycycline|doxycycline|mesh-list
64482630|NCT03584919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64482631|NCT03584919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64482632|NCT03584919|Antimalarials|antimalarials|mesh-ancestor
64482633|NCT03584919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64482634|NCT03584919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64482635|NCT03584841|Pilocarpine|pilocarpine|mesh-list
64602818|NCT02069847|Hormones|hormones|mesh-ancestor
64482636|NCT03584841|Miotics|miotics|mesh-ancestor
64482637|NCT03584841|Autonomic Agents|autonomic agents|mesh-ancestor
64482638|NCT03584841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64482666|NCT03584529|Vitamin D|vitamin d|mesh-list
64482667|NCT03584529|Cholecalciferol|cholecalciferol|mesh-list
64482669|NCT03584529|Micronutrients|micronutrients|mesh-ancestor
64482670|NCT03584529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482671|NCT03584529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64482672|NCT03584529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64482673|NCT00724984|Abexinostat|abexinostat|mesh-list
64482674|NCT00724984|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64482675|NCT00724984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482676|NCT00724984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482677|NCT03113253|Tranexamic Acid|tranexamic acid|mesh-list
64482678|NCT03113253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64482679|NCT03113253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64714008|NCT03043105|Growth Substances|growth substances|mesh-ancestor
64482680|NCT03113253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482681|NCT03113253|Hemostatics|hemostatics|mesh-ancestor
64482682|NCT03113253|Coagulants|coagulants|mesh-ancestor
64482683|NCT01836523|Liraglutide|liraglutide|mesh-list
64482684|NCT01836523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64482685|NCT01836523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482686|NCT01836523|Incretins|incretins|mesh-ancestor
64482687|NCT01836523|Hormones|hormones|mesh-ancestor
64482688|NCT01836523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64482689|NCT01275196|Imatinib Mesylate|imatinib mesylate|mesh-list
64482690|NCT01275196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482691|NCT01275196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64482692|NCT01275196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482693|NCT01275196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482706|NCT02000531|Cisplatin|cisplatin|mesh-list
64482707|NCT02000531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64482708|NCT02000531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482709|NCT02000531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64482710|NCT02000531|Antimetabolites|antimetabolites|mesh-ancestor
64603271|NCT03804749|Suramin|suramin|mesh-list
64482711|NCT02000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482712|NCT02000531|Antiviral Agents|antiviral agents|mesh-ancestor
64482713|NCT02000531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64482714|NCT02000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482715|NCT02000531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64482716|NCT02000531|Immunologic Factors|immunologic factors|mesh-ancestor
64482717|NCT02000531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482718|NCT02000531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64482720|NCT01609231|Cetuximab|cetuximab|mesh-list
64603405|NCT02368431|Zonisamide|zonisamide|mesh-list
64482721|NCT01609231|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64482722|NCT01609231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64482723|NCT01609231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482724|NCT01609231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482725|NCT01609231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482726|NCT01609231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64482727|NCT04664933|Neuroprotective Agents|neuroprotective agents|mesh-list
64482728|NCT04664933|Protective Agents|protective agents|mesh-ancestor
64482729|NCT04664933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482730|NCT04438187|Anti-Infective Agents|anti-infective agents|mesh-list
64482731|NCT04438187|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64482732|NCT02092025|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
64482733|NCT02092025|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64482736|NCT04405011|Entecavir|entecavir|mesh-list
64482749|NCT01984229|Posaconazole|posaconazole|mesh-list
64482750|NCT01984229|Antifungal Agents|antifungal agents|mesh-ancestor
64482751|NCT01984229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64482752|NCT01984229|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64482753|NCT01984229|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64482754|NCT01984229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64482755|NCT01984229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64603825|NCT02394951|Pregabalin|pregabalin|mesh-list
64482756|NCT01984229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64482758|NCT01984229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482759|NCT01984229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64482760|NCT01984229|Hormone Antagonists|hormone antagonists|mesh-ancestor
64603960|NCT04825275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64482761|NCT01984229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64482762|NCT01984229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482763|NCT01274026|Verapamil|verapamil|mesh-list
64604034|NCT05416073|Sufentanil|sufentanil|mesh-list
64482764|NCT01274026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64604179|NCT04383275|Capecitabine|capecitabine|mesh-list
64482765|NCT01274026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64482766|NCT01274026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64482767|NCT01274026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482768|NCT01274026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64482769|NCT01274026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482770|NCT01274026|Vasodilator Agents|vasodilator agents|mesh-ancestor
64482771|NCT01274104|Vitamin D|vitamin d|mesh-list
64482772|NCT01274104|Cholecalciferol|cholecalciferol|mesh-list
64482773|NCT01274104|Vitamins|vitamins|mesh-ancestor
64482791|NCT01279096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64482792|NCT01279096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64482793|NCT01279096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604908|NCT00858689|Minocycline|minocycline|mesh-list
64482794|NCT01279096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482795|NCT01279096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482796|NCT01279096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64482797|NCT01279096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64482798|NCT01279096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64482799|NCT01279096|Analgesics|analgesics|mesh-ancestor
64482800|NCT01279096|Sensory System Agents|sensory system agents|mesh-ancestor
64482801|NCT01279096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64482802|NCT01279096|Antimetabolites|antimetabolites|mesh-ancestor
64482803|NCT01272934|Diclofenac|diclofenac|mesh-list
64482846|NCT01274260|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64482847|NCT01274260|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64482848|NCT01274260|Prednisolone|prednisolone|mesh-list
64482849|NCT01274260|Prednisolone acetate|prednisolone acetate|mesh-list
64482850|NCT01274260|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64606202|NCT00888979|Nicotine|nicotine|mesh-list
64482851|NCT01274260|Prednisolone phosphate|prednisolone phosphate|mesh-list
64482852|NCT01274260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64606355|NCT01830517|Losartan|losartan|mesh-list
64482854|NCT01274260|Autonomic Agents|autonomic agents|mesh-ancestor
64606407|NCT01830829|Urological Agents|urological agents|mesh-ancestor
64482855|NCT01274260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64482856|NCT01274260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606554|NCT00363610|Pegaspargase|pegaspargase|mesh-list
64482857|NCT01274260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64482858|NCT01274260|Glucocorticoids|glucocorticoids|mesh-ancestor
64482859|NCT01274260|Hormones|hormones|mesh-ancestor
64606703|NCT00902161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64606780|NCT03215797|Phenylephrine|phenylephrine|mesh-list
64482860|NCT01274260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64482900|NCT01998893|Rituximab|rituximab|mesh-list
64482901|NCT01998893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64471540|NCT04397484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64471541|NCT04397484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64471542|NCT04397484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471543|NCT04397484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64471544|NCT04397484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64482948|NCT05701059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482949|NCT05701059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64482950|NCT05701059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64482951|NCT05701059|Analgesics|analgesics|mesh-ancestor
64482952|NCT05701059|Sensory System Agents|sensory system agents|mesh-ancestor
64482953|NCT05701059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64482955|NCT05701059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64482956|NCT05701059|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64482957|NCT05701059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64482958|NCT03157479|Anesthetics|anesthetics|mesh-list
64482959|NCT03157479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
64482960|NCT03157479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64482961|NCT03157479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482962|NCT03157479|Anesthetics, General|anesthetics, general|mesh-ancestor
64482964|NCT03013491|Vemurafenib|vemurafenib|mesh-list
64482965|NCT03013491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64482966|NCT03013491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482967|NCT03013491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64482968|NCT03013491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610375|NCT01839851|Hormones|hormones|mesh-ancestor
64482969|NCT03013491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64482970|NCT03013491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482971|NCT01272232|Liraglutide|liraglutide|mesh-list
64482997|NCT00739960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64482998|NCT00739960|Immunologic Factors|immunologic factors|mesh-ancestor
64611674|NCT00944671|Histamine Agents|histamine agents|mesh-ancestor
64482999|NCT00739960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483000|NCT00739960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64483002|NCT03153657|Piroxicam-beta-cyclodextrin|piroxicam-beta-cyclodextrin|mesh-list
64483003|NCT03153657|Betadex|betadex|mesh-list
64483004|NCT03153657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64483005|NCT03153657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64483006|NCT03153657|Analgesics|analgesics|mesh-ancestor
64611977|NCT04361305|Tadalafil|tadalafil|mesh-list
64483007|NCT03153657|Sensory System Agents|sensory system agents|mesh-ancestor
64483008|NCT03153657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612114|NCT02825212|Ledipasvir|ledipasvir|mesh-list
64483009|NCT03153657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483010|NCT03153657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64483011|NCT03153657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64483012|NCT03153657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64483016|NCT01670955|Folic Acid|folic acid|mesh-list
64483049|NCT01676259|Antimitotic Agents|antimitotic agents|mesh-ancestor
64483050|NCT01676259|Mitosis Modulators|mitosis modulators|mesh-ancestor
64483051|NCT01676259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613727|NCT02244515|Analgesics|analgesics|mesh-ancestor
64483052|NCT01676259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64483053|NCT01676259|Antimetabolites|antimetabolites|mesh-ancestor
64483054|NCT01676259|Antiviral Agents|antiviral agents|mesh-ancestor
64483055|NCT01676259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64483056|NCT01676259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64483057|NCT01676259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64483058|NCT01676259|Immunologic Factors|immunologic factors|mesh-ancestor
64483059|NCT01676259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483060|NCT02662257|Propofol|propofol|mesh-list
64483061|NCT02662257|Sevoflurane|sevoflurane|mesh-list
64483062|NCT02662257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64483063|NCT02662257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64483064|NCT02662257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483065|NCT02662257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64483066|NCT02662257|Anesthetics, General|anesthetics, general|mesh-ancestor
64483067|NCT02662257|Anesthetics|anesthetics|mesh-ancestor
64483068|NCT02662257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64483069|NCT02662257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64483070|NCT03153267|Doxycycline|doxycycline|mesh-list
64483071|NCT03153267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64483072|NCT03153267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64483073|NCT03153267|Antimalarials|antimalarials|mesh-ancestor
64483074|NCT03153267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64614008|NCT02163421|Vedolizumab|vedolizumab|mesh-list
64483075|NCT03153267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64614150|NCT00980785|Ramipril|ramipril|mesh-list
64483077|NCT00746512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64483078|NCT00746512|Glucocorticoids|glucocorticoids|mesh-ancestor
64483079|NCT00746512|Hormones|hormones|mesh-ancestor
64614230|NCT05017545|Abatacept|abatacept|mesh-list
64483080|NCT00746512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64483087|NCT05409027|Hormones|hormones|mesh-ancestor
64483088|NCT05409027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64483089|NCT05409027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483090|NCT01982435|Ranibizumab|ranibizumab|mesh-list
64483091|NCT01982435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64483092|NCT01982435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64483093|NCT01982435|Growth Substances|growth substances|mesh-ancestor
64483094|NCT01982435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483095|NCT01982435|Growth Inhibitors|growth inhibitors|mesh-ancestor
64483096|NCT01982435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483097|NCT00747214|Prednisolone|prednisolone|mesh-list
64483098|NCT00747214|Antirheumatic Agents|antirheumatic agents|mesh-list
64483099|NCT00747214|Dipyridamole|dipyridamole|mesh-list
64483100|NCT00747214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64483101|NCT00747214|Glucocorticoids|glucocorticoids|mesh-ancestor
64483102|NCT00747214|Hormones|hormones|mesh-ancestor
64483103|NCT00747214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64483104|NCT00747214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483105|NCT00747214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64483106|NCT00747214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483107|NCT00747214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64483108|NCT00747214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64483109|NCT00747214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483110|NCT00747214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64483111|NCT00747214|Vasodilator Agents|vasodilator agents|mesh-ancestor
64483115|NCT00753142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64483133|NCT00753220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64483134|NCT00753220|Alkylating Agents|alkylating agents|mesh-ancestor
64483135|NCT00753220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483136|NCT00753220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483137|NCT00753220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64483138|NCT01279954|Abatacept|abatacept|mesh-list
64483139|NCT01279954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64483140|NCT01279954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483141|NCT01279954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483142|NCT01279954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64483143|NCT01279954|Immunologic Factors|immunologic factors|mesh-ancestor
64483144|NCT01279954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614987|NCT00993655|Paclitaxel|paclitaxel|mesh-list
64483145|NCT01279954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64483196|NCT01736917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64483197|NCT01736917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615765|NCT01000285|Bortezomib|bortezomib|mesh-list
64483198|NCT01736917|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64483199|NCT01736917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64615912|NCT01929668|Micronutrients|micronutrients|mesh-ancestor
64615988|NCT01923818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64616063|NCT02150785|Streptokinase|streptokinase|mesh-list
64483200|NCT01736917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483201|NCT01277302|Ranibizumab|ranibizumab|mesh-list
64483202|NCT01277302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64616138|NCT03122444|Antidepressive Agents|antidepressive agents|mesh-ancestor
64483203|NCT01277302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64616285|NCT01052701|Ribavirin|ribavirin|mesh-list
64483204|NCT01277302|Growth Substances|growth substances|mesh-ancestor
64483205|NCT01277302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483206|NCT01277302|Growth Inhibitors|growth inhibitors|mesh-ancestor
64483207|NCT01277302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483208|NCT04414579|Insulin|insulin|mesh-list
64483209|NCT04414579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64483210|NCT04414579|Insulin Aspart|insulin aspart|mesh-list
64483211|NCT04414579|Insulin, Long-Acting|insulin, long-acting|mesh-list
64483212|NCT04414579|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64483213|NCT04414579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64616730|NCT05136157|Insulin|insulin|mesh-list
64483214|NCT04414579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483216|NCT01980875|Idelalisib|idelalisib|mesh-list
64483234|NCT01790503|Temozolomide|temozolomide|mesh-list
64483235|NCT01790503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64483236|NCT01790503|Alkylating Agents|alkylating agents|mesh-ancestor
64617905|NCT03030911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64483237|NCT01790503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483238|NCT01790503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483239|NCT01765543|Rifampin|rifampin|mesh-list
64483240|NCT01765543|Vemurafenib|vemurafenib|mesh-list
64483241|NCT01765543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64619128|NCT01167829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483286|NCT01764997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64483287|NCT01764997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64483288|NCT01764997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64483289|NCT01764997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64483290|NCT01764997|Analgesics|analgesics|mesh-ancestor
64483291|NCT01764997|Sensory System Agents|sensory system agents|mesh-ancestor
64483292|NCT01764997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64483293|NCT01764997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64483294|NCT01276756|Interferons|interferons|mesh-list
64483296|NCT01276756|Interferon-alpha|interferon-alpha|mesh-list
64483297|NCT01276756|Interferon alpha-2|interferon alpha-2|mesh-list
64483298|NCT01276756|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64483299|NCT01276756|Nitazoxanide|nitazoxanide|mesh-list
64483301|NCT01276756|Antiviral Agents|antiviral agents|mesh-ancestor
64483302|NCT01276756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64483303|NCT01276756|Antimetabolites|antimetabolites|mesh-ancestor
64483304|NCT01276756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483342|NCT01764841|Ciprofloxacin|ciprofloxacin|mesh-list
64483343|NCT01764841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64483345|NCT01764841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64483346|NCT01764841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64483347|NCT01764841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620961|NCT04392128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64621118|NCT03821714|Hormones|hormones|mesh-ancestor
64483348|NCT01764841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483350|NCT01764841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64483352|NCT00245050|Pyridoxine|pyridoxine|mesh-list
64483353|NCT00245050|Vitamin B 6|vitamin b 6|mesh-list
64483355|NCT00245050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64483356|NCT00245050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64483357|NCT00245050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483358|NCT00245050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64483359|NCT00245050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64483360|NCT00245050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64483361|NCT00245050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622726|NCT02556918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64483400|NCT03806374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64622805|NCT01194856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64483402|NCT03806374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64622878|NCT01108666|Nelfinavir|nelfinavir|mesh-list
64483403|NCT03806374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64483404|NCT03806374|Narcotics|narcotics|mesh-ancestor
64483405|NCT03806374|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64483407|NCT03806374|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64483408|NCT00763360|Hyaluronic Acid|hyaluronic acid|mesh-list
64483409|NCT00763360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64623104|NCT03780894|Hemostatics|hemostatics|mesh-ancestor
64483410|NCT00763360|Immunologic Factors|immunologic factors|mesh-ancestor
64483411|NCT00763360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483412|NCT00763360|Viscosupplements|viscosupplements|mesh-ancestor
64483413|NCT00763360|Protective Agents|protective agents|mesh-ancestor
64483414|NCT00756106|Temozolomide|temozolomide|mesh-list
64483415|NCT00756106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64483416|NCT00756106|Alkylating Agents|alkylating agents|mesh-ancestor
64483417|NCT00756106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483419|NCT00243412|Methylprednisolone|methylprednisolone|mesh-list
64513675|NCT05021913|Hyaluronic Acid|hyaluronic acid|mesh-list
64483452|NCT00765232|Sensory System Agents|sensory system agents|mesh-ancestor
64483453|NCT00765232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64624870|NCT02891538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483454|NCT00765232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625170|NCT00000310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64625245|NCT02725424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483455|NCT00765232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64483456|NCT00765232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64483457|NCT00765232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64625396|NCT02498912|Cyclophosphamide|cyclophosphamide|mesh-list
64483459|NCT00765232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483460|NCT03805282|Lidocaine|lidocaine|mesh-list
64483461|NCT03805282|Anesthetics, Local|anesthetics, local|mesh-ancestor
64483462|NCT03805282|Anesthetics|anesthetics|mesh-ancestor
64483463|NCT03805282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64483464|NCT03805282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483465|NCT03805282|Sensory System Agents|sensory system agents|mesh-ancestor
64483466|NCT03805282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64483467|NCT03805282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64625832|NCT00000484|Diuretics|diuretics|mesh-ancestor
64483468|NCT03805282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64483469|NCT03805282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64483470|NCT03805282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64483471|NCT03805282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483472|NCT03805750|Dronabinol|dronabinol|mesh-list
64483473|NCT03805750|Cannabidiol|cannabidiol|mesh-list
64483474|NCT03805750|Anticonvulsants|anticonvulsants|mesh-ancestor
64483475|NCT03805750|Hallucinogens|hallucinogens|mesh-ancestor
64483476|NCT03805750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483477|NCT03805750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64483478|NCT03805750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64483479|NCT03805750|Analgesics|analgesics|mesh-ancestor
64626436|NCT00000700|Zidovudine|zidovudine|mesh-list
64483484|NCT03805750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64626654|NCT00002326|Antiviral Agents|antiviral agents|mesh-ancestor
64483485|NCT03805750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483486|NCT03805750|Hormones|hormones|mesh-ancestor
64483487|NCT03805750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64483488|NCT03804268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64483489|NCT03804268|Pilocarpine|pilocarpine|mesh-list
64483490|NCT03804268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64483492|NCT03804268|Autonomic Agents|autonomic agents|mesh-ancestor
64483493|NCT03804268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64483494|NCT03804268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483495|NCT03804268|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64483496|NCT03804268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64483497|NCT03804268|Cholinergic Agents|cholinergic agents|mesh-ancestor
64483498|NCT03804268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64483499|NCT03804268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483500|NCT00765856|Oxymorphone|oxymorphone|mesh-list
64483501|NCT00765856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64483502|NCT00765856|Narcotics|narcotics|mesh-ancestor
64483503|NCT00765856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64483504|NCT00765856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483505|NCT00765856|Analgesics|analgesics|mesh-ancestor
64483506|NCT00765856|Sensory System Agents|sensory system agents|mesh-ancestor
64483507|NCT00765856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64483508|NCT00765856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64483509|NCT00780208|Methylphenidate|methylphenidate|mesh-list
64626935|NCT01153711|Ketoconazole|ketoconazole|mesh-list
64627084|NCT00002236|Zidovudine|zidovudine|mesh-list
64483527|NCT03805360|Anesthetics|anesthetics|mesh-list
64627525|NCT00002446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64483528|NCT03805360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64483529|NCT03805360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627597|NCT00002458|Antibodies|antibodies|mesh-list
64483530|NCT03805360|Sensory System Agents|sensory system agents|mesh-ancestor
64483531|NCT03805360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64483532|NCT00756964|Rasburicase|rasburicase|mesh-list
64483533|NCT00756964|Gout Suppressants|gout suppressants|mesh-ancestor
64483534|NCT00756964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64483535|NCT00780442|Cycloserine|cycloserine|mesh-list
64483536|NCT00780442|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64627748|NCT00002494|Leucovorin|leucovorin|mesh-list
64483537|NCT00780442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64483539|NCT00780442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64483540|NCT00780442|Antitubercular Agents|antitubercular agents|mesh-ancestor
64483541|NCT00780442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64483542|NCT00780442|Antimetabolites|antimetabolites|mesh-ancestor
64627889|NCT00002524|Leucovorin|leucovorin|mesh-list
64483543|NCT00780442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483544|NCT04384666|Rotigotine|rotigotine|mesh-list
64483545|NCT04384666|Dopamine Agonists|dopamine agonists|mesh-ancestor
64483546|NCT04384666|Dopamine Agents|dopamine agents|mesh-ancestor
64483547|NCT04384666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64483548|NCT04384666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483549|NCT04384666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483550|NCT00767572|Atorvastatin|atorvastatin|mesh-list
64483551|NCT00767572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64483552|NCT00767572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64483553|NCT00767572|Antimetabolites|antimetabolites|mesh-ancestor
64483554|NCT00767572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483555|NCT00767572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64951620|NCT00026585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64951621|NCT00026585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951622|NCT00026585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64951623|NCT00026585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951624|NCT00026585|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64951625|NCT00026585|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64951626|NCT00026585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64951627|NCT00026624|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
64951628|NCT00026624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64951629|NCT00026624|Immunologic Factors|immunologic factors|mesh-ancestor
64483556|NCT00767572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64483557|NCT00767572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64483559|NCT00780676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483560|NCT00780676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64483561|NCT00780676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64483562|NCT00780676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483564|NCT00768118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64483565|NCT00768118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64483566|NCT00768118|Analgesics|analgesics|mesh-ancestor
64483567|NCT00768118|Sensory System Agents|sensory system agents|mesh-ancestor
64628856|NCT05073718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64483568|NCT00768118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64483569|NCT00768118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629007|NCT05271292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64483570|NCT00768118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64483571|NCT00768118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64483572|NCT00768118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483573|NCT00768118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64483574|NCT00768118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483575|NCT04345432|Gabapentin|gabapentin|mesh-list
64483577|NCT04345432|Sensory System Agents|sensory system agents|mesh-ancestor
64483578|NCT04345432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64483579|NCT04345432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483580|NCT04345432|Anticonvulsants|anticonvulsants|mesh-ancestor
64483581|NCT04345432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64483582|NCT04345432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64483583|NCT04345432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64483584|NCT04345432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64483585|NCT04345432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64483586|NCT04345432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64483587|NCT04345432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64629748|NCT02169479|Immunologic Factors|immunologic factors|mesh-ancestor
64951630|NCT00026624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951631|NCT00054600|Methoxsalen|methoxsalen|mesh-list
64951632|NCT00054600|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64951633|NCT00054600|Dermatologic Agents|dermatologic agents|mesh-ancestor
64725691|NCT00002155|Indinavir|indinavir|mesh-list
64725692|NCT00002155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64483588|NCT04345432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483589|NCT04345432|Antimanic Agents|antimanic agents|mesh-ancestor
64483590|NCT00757822|Dronabinol|dronabinol|mesh-list
64483591|NCT00757822|Ondansetron|ondansetron|mesh-list
64483592|NCT00757822|Antiemetics|antiemetics|mesh-ancestor
64483593|NCT00757822|Autonomic Agents|autonomic agents|mesh-ancestor
64629824|NCT04162522|Antidepressive Agents|antidepressive agents|mesh-ancestor
64483594|NCT00757822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64483595|NCT00757822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483596|NCT00757822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64483598|NCT00757822|Dermatologic Agents|dermatologic agents|mesh-ancestor
64483599|NCT00757822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64483600|NCT00757822|Serotonin Agents|serotonin agents|mesh-ancestor
64483601|NCT00757822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64483602|NCT00757822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483603|NCT00757822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64483604|NCT00757822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64483605|NCT00757822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64483606|NCT00757822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64483607|NCT00757822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64483608|NCT00757822|Hallucinogens|hallucinogens|mesh-ancestor
64483609|NCT00757822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64483610|NCT00757822|Analgesics|analgesics|mesh-ancestor
64483611|NCT00757822|Sensory System Agents|sensory system agents|mesh-ancestor
64483612|NCT00757822|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64483613|NCT00757822|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64483614|NCT00757822|Hormones|hormones|mesh-ancestor
64483616|NCT00758836|Acetaminophen|acetaminophen|mesh-list
64483635|NCT00769600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64483636|NCT00769600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64630158|NCT03009643|Antioxidants|antioxidants|mesh-ancestor
64483637|NCT00769600|Antifungal Agents|antifungal agents|mesh-ancestor
64483638|NCT00769600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64483639|NCT00769600|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64483640|NCT00769600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64483641|NCT00769600|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64483642|NCT00769600|Hormone Antagonists|hormone antagonists|mesh-ancestor
64483643|NCT00769600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64483644|NCT00769600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630537|NCT02822092|Risperidone|risperidone|mesh-list
64483645|NCT00769600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64483646|NCT03809650|Macitentan|macitentan|mesh-list
64630743|NCT04780958|Vitamin A|vitamin a|mesh-list
64483692|NCT04730999|Growth Substances|growth substances|mesh-ancestor
64483693|NCT04730999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483694|NCT04730999|Growth Inhibitors|growth inhibitors|mesh-ancestor
64483695|NCT04730999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64483696|NCT04730999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64483697|NCT04730999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64483698|NCT04730999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631849|NCT04773236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64483699|NCT04730999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483700|NCT00759772|Teriparatide|teriparatide|mesh-list
64483701|NCT00759772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64483702|NCT00759772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483703|NCT00759772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64483704|NCT01977677|Plerixafor|plerixafor|mesh-list
64483705|NCT01977677|Temozolomide|temozolomide|mesh-list
64483706|NCT01977677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64483742|NCT04414267|Immunologic Factors|immunologic factors|mesh-ancestor
64483743|NCT04414267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483744|NCT04414267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64483745|NCT01619423|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
64483746|NCT01619423|Edetic Acid|edetic acid|mesh-list
64483747|NCT01619423|Anticoagulants|anticoagulants|mesh-ancestor
64633131|NCT00003862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64483748|NCT01619423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64483749|NCT01619423|Chelating Agents|chelating agents|mesh-ancestor
64483750|NCT01619423|Sequestering Agents|sequestering agents|mesh-ancestor
64483751|NCT01619423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483752|NCT01619423|Vitamin B Complex|vitamin b complex|mesh-ancestor
64483753|NCT01619423|Vitamins|vitamins|mesh-ancestor
64483754|NCT01619423|Micronutrients|micronutrients|mesh-ancestor
64483755|NCT01619423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483756|NCT03802552|Cephalexin|cephalexin|mesh-list
64483757|NCT03802552|Cefadroxil|cefadroxil|mesh-list
64483758|NCT03802552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64483759|NCT03802552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64483760|NCT01735279|Mineral Oil|mineral oil|mesh-list
64483761|NCT01735279|Emollients|emollients|mesh-ancestor
64483763|NCT03802318|Amoxicillin|amoxicillin|mesh-list
64483764|NCT03802318|Rabeprazole|rabeprazole|mesh-list
64483765|NCT03802318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64483766|NCT03802318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64483767|NCT03802318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64483768|NCT03802318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64483769|NCT03802318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64483770|NCT03802318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64483784|NCT00773422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483785|NCT00773422|Sensory System Agents|sensory system agents|mesh-ancestor
64483786|NCT00773422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64483787|NCT00773422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64483788|NCT00773422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64483789|NCT00773422|Cholinergic Agents|cholinergic agents|mesh-ancestor
64483790|NCT00773422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64483791|NCT00773422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483792|NCT00786994|Petrolatum|petrolatum|mesh-list
64483793|NCT00786994|Emollients|emollients|mesh-ancestor
64483794|NCT00786994|Dermatologic Agents|dermatologic agents|mesh-ancestor
64483795|NCT00774202|Prednisone|prednisone|mesh-list
64483796|NCT00774202|Cyclophosphamide|cyclophosphamide|mesh-list
64483797|NCT00774202|Rituximab|rituximab|mesh-list
64483798|NCT00774202|Vincristine|vincristine|mesh-list
64483799|NCT00774202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64633558|NCT05775289|Paclitaxel|paclitaxel|mesh-list
64633705|NCT05635227|Glucocorticoids|glucocorticoids|mesh-ancestor
64483801|NCT00774202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483802|NCT00774202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64483804|NCT00774202|Alkylating Agents|alkylating agents|mesh-ancestor
64483805|NCT00774202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634229|NCT04500158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64634230|NCT04500158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634231|NCT04439318|Trametinib|trametinib|mesh-list
64634232|NCT04439318|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
64634233|NCT04439318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634234|NCT04439318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64634235|NCT04439318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634236|NCT04439318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634237|NCT04439318|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64483806|NCT00774202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634378|NCT03837509|Daratumumab|daratumumab|mesh-list
64483807|NCT00774202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64483808|NCT00774202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64483809|NCT00774202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64483810|NCT00774202|Glucocorticoids|glucocorticoids|mesh-ancestor
64483811|NCT00774202|Hormones|hormones|mesh-ancestor
64483812|NCT00774202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64483813|NCT00774202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64483814|NCT00774202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64483815|NCT00774202|Tubulin Modulators|tubulin modulators|mesh-ancestor
64483816|NCT00774202|Antimitotic Agents|antimitotic agents|mesh-ancestor
64483817|NCT00774202|Mitosis Modulators|mitosis modulators|mesh-ancestor
64634684|NCT00199056|Cytarabine|cytarabine|mesh-list
64483818|NCT03808168|Nivolumab|nivolumab|mesh-list
64483819|NCT03808168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64634831|NCT00004144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64483820|NCT03808168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483821|NCT03808168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64635059|NCT00005014|Risperidone|risperidone|mesh-list
64483822|NCT03808168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483823|NCT03802162|Memantine|memantine|mesh-list
64483824|NCT03802162|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64483825|NCT03802162|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64483826|NCT03802162|Dopamine Agents|dopamine agents|mesh-ancestor
64483827|NCT03802162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64483828|NCT03802162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483829|NCT03802162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483830|NCT03802162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64483831|NCT03802162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64483832|NCT01757275|Esomeprazole|esomeprazole|mesh-list
64483833|NCT01757275|Cimetidine|cimetidine|mesh-list
64483834|NCT01757275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64635576|NCT00030992|Antipruritics|antipruritics|mesh-ancestor
64483835|NCT01757275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64483836|NCT01757275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64483837|NCT01757275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635653|NCT00004426|Leuprolide|leuprolide|mesh-list
64635719|NCT00004450|Interferons|interferons|mesh-list
64483845|NCT01757275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64483847|NCT00787852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64483849|NCT00787852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64483850|NCT00787852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483851|NCT00787852|Tubulin Modulators|tubulin modulators|mesh-ancestor
64483852|NCT00787852|Antimitotic Agents|antimitotic agents|mesh-ancestor
64483853|NCT00787852|Mitosis Modulators|mitosis modulators|mesh-ancestor
64636003|NCT00004804|Interferon-alpha|interferon-alpha|mesh-list
64483854|NCT00787852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483855|NCT00787852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64483856|NCT00787852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64483857|NCT00788008|Propofol|propofol|mesh-list
64483858|NCT00788008|Isoflurane|isoflurane|mesh-list
64637307|NCT02941926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64483905|NCT01784029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637391|NCT02397720|Ipilimumab|ipilimumab|mesh-list
64483906|NCT01784029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64483907|NCT01784029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64483908|NCT00789256|Bortezomib|bortezomib|mesh-list
64483909|NCT00789256|Melphalan|melphalan|mesh-list
64483910|NCT00789256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637605|NCT00178178|Anesthetics|anesthetics|mesh-ancestor
64483911|NCT00789256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64483912|NCT00789256|Alkylating Agents|alkylating agents|mesh-ancestor
64483913|NCT00789256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637825|NCT01048697|Ethambutol|ethambutol|mesh-list
64483964|NCT01607593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64483965|NCT01607593|Serotonin Agents|serotonin agents|mesh-ancestor
64483966|NCT01607593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483967|NCT00789724|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64483968|NCT00789724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64483969|NCT01755637|Albendazole|albendazole|mesh-list
64483970|NCT01755637|Anthelmintics|anthelmintics|mesh-ancestor
64483971|NCT01755637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64483972|NCT01755637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64483973|NCT01755637|Anticestodal Agents|anticestodal agents|mesh-ancestor
64483974|NCT01755637|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64483975|NCT01755637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64483976|NCT01755637|Tubulin Modulators|tubulin modulators|mesh-ancestor
64483977|NCT01755637|Antimitotic Agents|antimitotic agents|mesh-ancestor
64483978|NCT01755637|Mitosis Modulators|mitosis modulators|mesh-ancestor
64483979|NCT01755637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483980|NCT01755637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483982|NCT03801226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64483983|NCT03801226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484017|NCT00789802|Gout Suppressants|gout suppressants|mesh-ancestor
64484018|NCT00789802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64484019|NCT00789802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484020|NCT00789802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484021|NCT04567225|Insulin Glargine|insulin glargine|mesh-list
64484022|NCT04567225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64484023|NCT04567225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484024|NCT02149342|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
64484025|NCT02149342|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64484026|NCT02149342|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64469610|NCT05809921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64484027|NCT02149342|Dermatologic Agents|dermatologic agents|mesh-ancestor
64484029|NCT05574712|Abiraterone Acetate|abiraterone acetate|mesh-list
64484030|NCT05574712|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64484031|NCT05574712|Fertility Agents|fertility agents|mesh-ancestor
64484032|NCT05574712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64471588|NCT04310995|Vitamins|vitamins|mesh-ancestor
64640325|NCT00392834|Ifosfamide|ifosfamide|mesh-list
64484033|NCT05574712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484034|NCT05574712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64484035|NCT05574712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64484036|NCT05574712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64484037|NCT05574712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484038|NCT05574712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484039|NCT05574712|Hormone Antagonists|hormone antagonists|mesh-ancestor
64640697|NCT00402896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484040|NCT05574712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64484041|NCT05574712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64484042|NCT01783015|Etanercept|etanercept|mesh-list
64484043|NCT01783015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64484044|NCT01783015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64484045|NCT01783015|Analgesics|analgesics|mesh-ancestor
64484046|NCT01783015|Sensory System Agents|sensory system agents|mesh-ancestor
64484052|NCT01783015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64484053|NCT01783015|Immunologic Factors|immunologic factors|mesh-ancestor
64484054|NCT05567770|Androgens|androgens|mesh-list
64484055|NCT05567770|Hormones|hormones|mesh-ancestor
64484056|NCT05567770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64484057|NCT05567770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484058|NCT01782859|Prednisone|prednisone|mesh-list
64484059|NCT01782859|Hydrocortisone|hydrocortisone|mesh-list
64484060|NCT01782859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64484061|NCT01782859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64484062|NCT01782859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64484063|NCT01782859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64484064|NCT01782859|Glucocorticoids|glucocorticoids|mesh-ancestor
64484065|NCT01782859|Hormones|hormones|mesh-ancestor
64484066|NCT01782859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64484067|NCT01782859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484068|NCT01782859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64484069|NCT01782859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64484070|NCT04574947|Lidocaine|lidocaine|mesh-list
64484071|NCT04574947|Anesthetics, Local|anesthetics, local|mesh-ancestor
64484072|NCT04574947|Anesthetics|anesthetics|mesh-ancestor
64484073|NCT04574947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64484074|NCT04574947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484075|NCT04574947|Sensory System Agents|sensory system agents|mesh-ancestor
64484076|NCT04574947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484077|NCT04574947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64484078|NCT04574947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64484079|NCT04574947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64484080|NCT04574947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64484081|NCT04574947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484082|NCT00790192|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64484083|NCT00790192|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64484091|NCT00790192|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64484092|NCT00790192|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64484093|NCT00790192|Adrenergic Agents|adrenergic agents|mesh-ancestor
64484094|NCT00790192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64484095|NCT00790192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484096|NCT00790192|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64714010|NCT00374647|Mycophenolic Acid|mycophenolic acid|mesh-list
64484097|NCT00790192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64471589|NCT04310995|Micronutrients|micronutrients|mesh-ancestor
64484098|NCT00790192|Serotonin Agents|serotonin agents|mesh-ancestor
64484099|NCT00790192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64484100|NCT00790192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64484101|NCT00790192|Dopamine Agents|dopamine agents|mesh-ancestor
64484102|NCT01781611|Aspirin|aspirin|mesh-list
64484103|NCT01781611|Dipyridamole|dipyridamole|mesh-list
64484104|NCT01781611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64484105|NCT01781611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64484145|NCT00790270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64484146|NCT00790270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64484147|NCT00790270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64484148|NCT00790270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64484149|NCT00790270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64484150|NCT00790270|Adrenergic Agents|adrenergic agents|mesh-ancestor
64484151|NCT00790270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64484152|NCT01780987|Heparin|heparin|mesh-list
64484153|NCT01780987|Calcium heparin|calcium heparin|mesh-list
64484154|NCT01780987|Warfarin|warfarin|mesh-list
64484155|NCT01780987|Apixaban|apixaban|mesh-list
64484157|NCT01780987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64642902|NCT01489969|Melatonin|melatonin|mesh-list
64484158|NCT01780987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64484159|NCT01780987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484160|NCT01780987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64484162|NCT01780987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64484163|NCT01780987|Protease Inhibitors|protease inhibitors|mesh-ancestor
64484164|NCT01780987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484165|NCT03800290|Clenbuterol|clenbuterol|mesh-list
64484166|NCT03800290|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64484167|NCT03800290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64484168|NCT03800290|Adrenergic Agents|adrenergic agents|mesh-ancestor
64484169|NCT03800290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64484170|NCT03800290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643270|NCT00524342|Oprelvekin|oprelvekin|mesh-list
64643488|NCT01508455|Analgesics|analgesics|mesh-ancestor
64643561|NCT01401595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64484171|NCT03800290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484172|NCT03800290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64484173|NCT03800290|Autonomic Agents|autonomic agents|mesh-ancestor
64484175|NCT03800290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64484186|NCT01753297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484187|NCT01753297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64484188|NCT01753297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64484189|NCT01753297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64484190|NCT03831334|Minoxidil|minoxidil|mesh-list
64484191|NCT03831334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64484192|NCT03831334|Vasodilator Agents|vasodilator agents|mesh-ancestor
64484193|NCT04795336|Melatonin|melatonin|mesh-list
64484194|NCT04795336|Antioxidants|antioxidants|mesh-ancestor
64513678|NCT05021913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64513679|NCT05021913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513680|NCT05021913|Sensory System Agents|sensory system agents|mesh-ancestor
64513681|NCT05021913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64513682|NCT05021913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64513683|NCT05021913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64644375|NCT02135432|Ivacaftor|ivacaftor|mesh-list
64513684|NCT05021913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64644513|NCT05540743|Adalimumab|adalimumab|mesh-list
64513685|NCT05021913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64513686|NCT05021913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513687|NCT05021913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64513688|NCT05021913|Immunologic Factors|immunologic factors|mesh-ancestor
64513689|NCT05021913|Viscosupplements|viscosupplements|mesh-ancestor
64513714|NCT01458015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64513715|NCT01458015|Narcotics|narcotics|mesh-ancestor
64513716|NCT01458015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64513717|NCT01458015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513718|NCT01458015|Analgesics|analgesics|mesh-ancestor
64513719|NCT01458015|Sensory System Agents|sensory system agents|mesh-ancestor
64513720|NCT01458015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64513721|NCT01458015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64645822|NCT02221219|Tocolytic Agents|tocolytic agents|mesh-ancestor
64513722|NCT01458015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64645885|NCT02137538|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64645957|NCT00639158|Fenofibric acid|fenofibric acid|mesh-list
64513723|NCT01458015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64646035|NCT00645710|Antimetabolites|antimetabolites|mesh-ancestor
64513724|NCT01458015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513725|NCT01458015|Adrenergic Agents|adrenergic agents|mesh-ancestor
64513726|NCT01458015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64513727|NCT02893293|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64513728|NCT02893293|Hematinics|hematinics|mesh-ancestor
64513729|NCT02893293|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64513731|NCT05022927|Bevacizumab|bevacizumab|mesh-list
64513732|NCT05022927|Atezolizumab|atezolizumab|mesh-list
64513733|NCT05022927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64513734|NCT05022927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513735|NCT05022927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64646400|NCT01288859|Curcumin|curcumin|mesh-list
64513757|NCT04391439|Methylprednisolone|methylprednisolone|mesh-list
64513758|NCT04391439|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64513759|NCT04391439|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64513760|NCT04391439|Prednisolone|prednisolone|mesh-list
64513761|NCT04391439|Prednisolone acetate|prednisolone acetate|mesh-list
64513762|NCT04391439|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64513763|NCT04391439|Prednisolone phosphate|prednisolone phosphate|mesh-list
64513764|NCT04391439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64513765|NCT04391439|Antiemetics|antiemetics|mesh-ancestor
64513766|NCT04391439|Autonomic Agents|autonomic agents|mesh-ancestor
64513767|NCT04391439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64513768|NCT04391439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513769|NCT04391439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64513770|NCT04391439|Glucocorticoids|glucocorticoids|mesh-ancestor
64648341|NCT03807596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648417|NCT01337687|Oxytocin|oxytocin|mesh-list
64513839|NCT04391127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513840|NCT04391127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64513841|NCT05024253|Tranexamic Acid|tranexamic acid|mesh-list
64513842|NCT05024253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64513843|NCT05024253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64513844|NCT05024253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513846|NCT05024253|Coagulants|coagulants|mesh-ancestor
64513847|NCT05026593|Carboplatin|carboplatin|mesh-list
64513848|NCT05026593|Etoposide|etoposide|mesh-list
64513849|NCT05026593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513850|NCT05026593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64513851|NCT05026593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64649003|NCT01349231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64513852|NCT05026593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64513854|NCT05026593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513856|NCT01459809|Glimepiride|glimepiride|mesh-list
64513857|NCT01459809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64513858|NCT01459809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649222|NCT00802412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64649294|NCT05116202|Ipilimumab|ipilimumab|mesh-list
64513885|NCT01459887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64513886|NCT01459887|Tubulin Modulators|tubulin modulators|mesh-ancestor
64513887|NCT01459887|Antimitotic Agents|antimitotic agents|mesh-ancestor
64513888|NCT01459887|Mitosis Modulators|mitosis modulators|mesh-ancestor
64513889|NCT02876211|Vitamin D|vitamin d|mesh-list
64513890|NCT02876211|Vitamins|vitamins|mesh-ancestor
64513891|NCT02876211|Micronutrients|micronutrients|mesh-ancestor
64513892|NCT02876211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513893|NCT02876211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64513894|NCT02682147|Sildenafil Citrate|sildenafil citrate|mesh-list
64513895|NCT02682147|Vasodilator Agents|vasodilator agents|mesh-ancestor
64513896|NCT02682147|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64513897|NCT02682147|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64513898|NCT02682147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64513899|NCT02682147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513900|NCT02682147|Urological Agents|urological agents|mesh-ancestor
64513901|NCT01892787|Formoterol Fumarate|formoterol fumarate|mesh-list
64513937|NCT02669901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651557|NCT00895934|Vorinostat|vorinostat|mesh-list
64513938|NCT02669901|Sensory System Agents|sensory system agents|mesh-ancestor
64651629|NCT01831622|Methylphenidate|methylphenidate|mesh-list
64513939|NCT02669901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64513941|NCT01893099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513942|NCT01893099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64513943|NCT01893099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651780|NCT01450319|Cetuximab|cetuximab|mesh-list
64513944|NCT01893099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513945|NCT02327403|Abatacept|abatacept|mesh-list
64513946|NCT02327403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64471622|NCT04309552|Antiviral Agents|antiviral agents|mesh-ancestor
64471623|NCT04309552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64471624|NCT04275180|Argatroban|argatroban|mesh-list
64471625|NCT04275180|Antithrombins|antithrombins|mesh-ancestor
64471626|NCT04275180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64471627|NCT04275180|Protease Inhibitors|protease inhibitors|mesh-ancestor
64471629|NCT04275180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513977|NCT02349867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64513978|NCT02349867|Antimetabolites|antimetabolites|mesh-ancestor
64513979|NCT02349867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513981|NCT02349867|Antiviral Agents|antiviral agents|mesh-ancestor
64513982|NCT02349867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64513983|NCT02349867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652865|NCT03001661|Dinoprostone|dinoprostone|mesh-list
64513984|NCT02349867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64513985|NCT02349867|Immunologic Factors|immunologic factors|mesh-ancestor
64513986|NCT02349867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513987|NCT02349867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64513988|NCT02349867|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64513989|NCT02630043|Oxaliplatin|oxaliplatin|mesh-list
64513990|NCT02630043|Tolcapone|tolcapone|mesh-list
64471638|NCT04271332|GABA Agonists|gaba agonists|mesh-ancestor
64471639|NCT04271332|GABA Agents|gaba agents|mesh-ancestor
64513991|NCT02630043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513992|NCT02630043|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64513993|NCT02630043|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64513994|NCT02630043|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64513995|NCT02630043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64513996|NCT02630043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513997|NCT02629419|Amphotericin B|amphotericin b|mesh-list
64513998|NCT02629419|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64513999|NCT02629419|Amebicides|amebicides|mesh-ancestor
64514000|NCT02629419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64514001|NCT02629419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64514002|NCT02629419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64514003|NCT02629419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64514004|NCT02629419|Antifungal Agents|antifungal agents|mesh-ancestor
64514005|NCT02334735|Vaccines|vaccines|mesh-list
64514006|NCT02334735|Poly ICLC|poly iclc|mesh-list
64514007|NCT02334735|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64514019|NCT02329600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64514020|NCT02329600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514021|NCT02329600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64514022|NCT02329600|Immunologic Factors|immunologic factors|mesh-ancestor
64514023|NCT02329600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514024|NCT02329600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514026|NCT02620761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64514027|NCT02620761|Vasodilator Agents|vasodilator agents|mesh-ancestor
64514028|NCT02620761|Dopamine Agonists|dopamine agonists|mesh-ancestor
64653425|NCT01041638|Vitamin A|vitamin a|mesh-list
64514029|NCT02620761|Dopamine Agents|dopamine agents|mesh-ancestor
64514030|NCT02620761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653492|NCT01725620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64653563|NCT03400592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653565|NCT03400592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64378866|NCT03195023|Amlodipine|amlodipine|mesh-list
64653566|NCT02218463|Estradiol|estradiol|mesh-list
64653567|NCT02218463|Estrogens|estrogens|mesh-ancestor
64653568|NCT02218463|Hormones|hormones|mesh-ancestor
64653570|NCT02218463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514031|NCT02620761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514033|NCT02615691|Factor VIII|factor viii|mesh-list
64514062|NCT02611323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64514063|NCT02608359|Abiraterone Acetate|abiraterone acetate|mesh-list
64654138|NCT02245256|Analgesics|analgesics|mesh-ancestor
64514064|NCT02608359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514065|NCT02608359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64514067|NCT02608359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514068|NCT02608359|Hormone Antagonists|hormone antagonists|mesh-ancestor
64654507|NCT01632995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64514069|NCT02608359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64514070|NCT02608359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514071|NCT02608359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64514074|NCT01729559|Calcium heparin|calcium heparin|mesh-list
64514075|NCT01729559|Enoxaparin sodium|enoxaparin sodium|mesh-list
64514076|NCT01729559|Anticoagulants|anticoagulants|mesh-ancestor
64654806|NCT04366622|Riociguat|riociguat|mesh-list
64514077|NCT01729559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64514078|NCT01729559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64654878|NCT02486952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64514079|NCT01729559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514080|NCT01926496|Imiquimod|imiquimod|mesh-list
64514081|NCT01926496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64514082|NCT01926496|Immunologic Factors|immunologic factors|mesh-ancestor
64514083|NCT01926496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514084|NCT01926496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514085|NCT01926496|Interferon Inducers|interferon inducers|mesh-ancestor
64514086|NCT01728779|Nelfinavir|nelfinavir|mesh-list
64514087|NCT01728779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64514107|NCT01927120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64514108|NCT01927120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514109|NCT01927120|Antifungal Agents|antifungal agents|mesh-ancestor
64514110|NCT01927120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64655376|NCT01658657|Lisinopril|lisinopril|mesh-list
64514111|NCT01927120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64514112|NCT01927120|Antiviral Agents|antiviral agents|mesh-ancestor
64514114|NCT02600949|Imiquimod|imiquimod|mesh-list
64514115|NCT02600949|Vaccines|vaccines|mesh-list
64514116|NCT02600949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64514117|NCT02600949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514118|NCT02600949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64514119|NCT02600949|Immunologic Factors|immunologic factors|mesh-ancestor
64514120|NCT02600949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514121|NCT02600949|Interferon Inducers|interferon inducers|mesh-ancestor
64514123|NCT01728623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514124|NCT01728623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64514125|NCT01728623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514126|NCT01728623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514127|NCT02573337|Lidocaine|lidocaine|mesh-list
64514128|NCT02573337|Anesthetics, Local|anesthetics, local|mesh-ancestor
64514129|NCT02573337|Anesthetics|anesthetics|mesh-ancestor
64655805|NCT00946478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64514130|NCT02573337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64514154|NCT02304783|Acetaminophen|acetaminophen|mesh-list
64514156|NCT02304783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64657209|NCT01076504|Amrubicin|amrubicin|mesh-list
64514157|NCT02304783|Analgesics|analgesics|mesh-ancestor
64514158|NCT02304783|Sensory System Agents|sensory system agents|mesh-ancestor
64514159|NCT02304783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64657286|NCT02485184|Propranolol|propranolol|mesh-list
64514160|NCT02304783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514161|NCT02304783|Antipyretics|antipyretics|mesh-ancestor
64514162|NCT02304783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64514163|NCT02304783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64514164|NCT02304783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64514165|NCT02304783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64514166|NCT02304783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657645|NCT03013400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64514167|NCT02304783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514168|NCT02553447|Vitamin D|vitamin d|mesh-list
64514169|NCT02553447|Cholecalciferol|cholecalciferol|mesh-list
64514170|NCT02553447|Vitamins|vitamins|mesh-ancestor
64514171|NCT02553447|Micronutrients|micronutrients|mesh-ancestor
64514172|NCT02553447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514173|NCT02553447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64514174|NCT02553447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64514175|NCT01928290|Leucovorin|leucovorin|mesh-list
64514176|NCT01928290|Tetrahydrofolates|tetrahydrofolates|mesh-list
64514177|NCT01928290|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
64514178|NCT01928290|Fluorouracil|fluorouracil|mesh-list
64514201|NCT02282319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64514202|NCT02282319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64514203|NCT02282319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514204|NCT02282319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64514205|NCT02282319|Analgesics|analgesics|mesh-ancestor
64514206|NCT02282319|Sensory System Agents|sensory system agents|mesh-ancestor
64514207|NCT02282319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64514208|NCT02282319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64514209|NCT02282319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64658450|NCT03011996|Amoxicillin|amoxicillin|mesh-list
64514210|NCT02282319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64514211|NCT02282319|Adrenergic Agents|adrenergic agents|mesh-ancestor
64514212|NCT02282319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64514213|NCT02282319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658657|NCT02579343|Dexetimide|dexetimide|mesh-list
64658728|NCT00422175|Siponimod|siponimod|mesh-list
64514215|NCT02282319|Anesthetics|anesthetics|mesh-ancestor
64514216|NCT02772081|Poractant alfa|poractant alfa|mesh-list
64514217|NCT02772081|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
64514218|NCT02772081|Respiratory System Agents|respiratory system agents|mesh-ancestor
64514219|NCT02278965|Metformin|metformin|mesh-list
64514220|NCT02278965|Biguanides|biguanides|mesh-list
64659094|NCT01159262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64514222|NCT02278965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514223|NCT02766465|Sirolimus|sirolimus|mesh-list
64514224|NCT02766465|Methotrexate|methotrexate|mesh-list
64514225|NCT02766465|Fludarabine|fludarabine|mesh-list
64514226|NCT02766465|Melphalan|melphalan|mesh-list
64514251|NCT02766465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64514252|NCT02766465|Antifungal Agents|antifungal agents|mesh-ancestor
64514253|NCT02766465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64514255|NCT02766465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64514256|NCT02766465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64514257|NCT02766465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64514258|NCT02757885|Cyclophosphamide|cyclophosphamide|mesh-list
64514259|NCT02757885|Thiotepa|thiotepa|mesh-list
64514260|NCT02757885|Fludarabine|fludarabine|mesh-list
64514261|NCT02757885|Fludarabine phosphate|fludarabine phosphate|mesh-list
64514262|NCT02757885|Hydroxyurea|hydroxyurea|mesh-list
64514263|NCT02757885|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64514264|NCT02757885|Thymoglobulin|thymoglobulin|mesh-list
64514265|NCT02757885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64714012|NCT00374647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64660789|NCT01248416|Letrozole|letrozole|mesh-list
64514266|NCT02757885|Immunologic Factors|immunologic factors|mesh-ancestor
64664500|NCT05448183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514295|NCT05733286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514296|NCT05733286|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64664722|NCT00371007|Incretins|incretins|mesh-ancestor
64514297|NCT05733286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64514298|NCT05733286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514300|NCT02753283|Zoledronic Acid|zoledronic acid|mesh-list
64514302|NCT02753283|Calcium|calcium|mesh-list
64514303|NCT02753283|Vitamins|vitamins|mesh-ancestor
64665024|NCT04849377|Cisplatin|cisplatin|mesh-list
64514304|NCT02753283|Micronutrients|micronutrients|mesh-ancestor
64514305|NCT02753283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514306|NCT02753283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64514307|NCT02753283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64514308|NCT02748369|Glucagon|glucagon|mesh-list
64514309|NCT02748369|Hormones|hormones|mesh-list
64514310|NCT02748369|Somatostatin|somatostatin|mesh-list
64514311|NCT02748369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64514312|NCT02748369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514313|NCT02748369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64514314|NCT01928680|Capecitabine|capecitabine|mesh-list
64665310|NCT04895592|Dexamethasone|dexamethasone|mesh-list
64665376|NCT02209610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64514315|NCT01928680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665822|NCT00372645|Vitamins|vitamins|mesh-ancestor
64514316|NCT01928680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64514317|NCT01928680|Antimetabolites|antimetabolites|mesh-ancestor
64514318|NCT01928680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514320|NCT01929460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64514321|NCT01929460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64514322|NCT01929460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64514323|NCT01929460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64514324|NCT01929460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666274|NCT02802111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64666275|NCT02802111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64666276|NCT02802111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64666277|NCT02802111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64666278|NCT02802111|Adrenergic Agents|adrenergic agents|mesh-ancestor
64666279|NCT02802111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64666280|NCT02802111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666317|NCT01576874|Oxytocin|oxytocin|mesh-list
64666318|NCT01576874|Oxytocics|oxytocics|mesh-ancestor
64666319|NCT01576874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64666320|NCT01576874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666321|NCT01576952|Bromfenac|bromfenac|mesh-list
64666322|NCT01576952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64666323|NCT01576952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64666324|NCT01576952|Analgesics|analgesics|mesh-ancestor
64666325|NCT01576952|Sensory System Agents|sensory system agents|mesh-ancestor
64666326|NCT01576952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64666327|NCT01576952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666328|NCT01576952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64666329|NCT01576952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64666330|NCT01577966|Sulfasalazine|sulfasalazine|mesh-list
64666331|NCT01577966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64666332|NCT01577966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64666333|NCT01577966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64514326|NCT01929460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514329|NCT02248701|Methyltestosterone|methyltestosterone|mesh-list
64514369|NCT05739682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514370|NCT05739682|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64514371|NCT05739682|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64514372|NCT05739682|Autonomic Agents|autonomic agents|mesh-ancestor
64667928|NCT04850846|Metformin|metformin|mesh-list
64514373|NCT05739682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668055|NCT03686657|Valsartan|valsartan|mesh-list
64668213|NCT01822652|Pembrolizumab|pembrolizumab|mesh-list
64514374|NCT05739682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64514375|NCT05739682|Respiratory System Agents|respiratory system agents|mesh-ancestor
64514376|NCT05739682|Mydriatics|mydriatics|mesh-ancestor
64514377|NCT05739682|Sympathomimetics|sympathomimetics|mesh-ancestor
64514378|NCT05739682|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64668902|NCT03093207|Aspirin|aspirin|mesh-list
64514379|NCT05739682|Sensory System Agents|sensory system agents|mesh-ancestor
64514381|NCT02462421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64669109|NCT01602068|Citric Acid|citric acid|mesh-list
64514382|NCT02462421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514383|NCT02462421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64669268|NCT01706666|Antiemetics|antiemetics|mesh-ancestor
64471645|NCT04267978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64471646|NCT04267978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64471647|NCT04267978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64471648|NCT04267978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514384|NCT02462421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514406|NCT02727387|Cyclophosphamide|cyclophosphamide|mesh-list
64514407|NCT02727387|Temozolomide|temozolomide|mesh-list
64514408|NCT02727387|Melphalan|melphalan|mesh-list
64514409|NCT02727387|Busulfan|busulfan|mesh-list
64514410|NCT02727387|Ifosfamide|ifosfamide|mesh-list
64514428|NCT02727387|Tubulin Modulators|tubulin modulators|mesh-ancestor
64514429|NCT02727387|Antimitotic Agents|antimitotic agents|mesh-ancestor
64514432|NCT01753115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64514433|NCT01753115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64514434|NCT01753115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64514435|NCT01753115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64514436|NCT01753115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514437|NCT01753115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670523|NCT02196155|Cortisone|cortisone|mesh-list
64670596|NCT04501523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670747|NCT03226899|Antimetabolites|antimetabolites|mesh-ancestor
64670826|NCT01687400|Decitabine|decitabine|mesh-list
64514438|NCT01753115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670983|NCT04153760|Antipyretics|antipyretics|mesh-ancestor
64514439|NCT01753115|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64514440|NCT01753115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64514441|NCT02445651|Acetylcysteine|acetylcysteine|mesh-list
64514442|NCT02445651|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64514443|NCT02445651|Antiviral Agents|antiviral agents|mesh-ancestor
64514444|NCT02445651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64671205|NCT03261999|Leuprolide|leuprolide|mesh-list
64514445|NCT02445651|Expectorants|expectorants|mesh-ancestor
64514446|NCT02445651|Respiratory System Agents|respiratory system agents|mesh-ancestor
64514447|NCT02445651|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64514448|NCT02445651|Antioxidants|antioxidants|mesh-ancestor
64514449|NCT02445651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514450|NCT02445651|Protective Agents|protective agents|mesh-ancestor
64514451|NCT02445651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514452|NCT02445651|Antidotes|antidotes|mesh-ancestor
64514453|NCT05719714|Dapagliflozin|dapagliflozin|mesh-list
64672161|NCT03211286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64672235|NCT02383043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64514454|NCT05719714|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64514456|NCT05719714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64514464|NCT02284516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64514465|NCT02721537|Niacinamide|niacinamide|mesh-list
64514467|NCT02721537|Nicotinic Acids|nicotinic acids|mesh-list
64672688|NCT00356447|Estradiol|estradiol|mesh-list
64514470|NCT02721537|Micronutrients|micronutrients|mesh-ancestor
64672984|NCT03511521|Insulin|insulin|mesh-list
64514471|NCT02721537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673060|NCT03594045|Apixaban|apixaban|mesh-list
64514472|NCT02721537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64673234|NCT02363478|Buspirone|buspirone|mesh-list
64673287|NCT01803074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64673358|NCT02271698|Antiemetics|antiemetics|mesh-ancestor
64514473|NCT02721537|Antimetabolites|antimetabolites|mesh-ancestor
64673432|NCT01831232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64673509|NCT04923776|Atezolizumab|atezolizumab|mesh-list
64673517|NCT04410159|Listerine|listerine|mesh-list
64484330|NCT01743560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673679|NCT03654417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514474|NCT02721537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514475|NCT02721537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64673930|NCT02354586|Niraparib|niraparib|mesh-list
64514476|NCT02721537|Vasodilator Agents|vasodilator agents|mesh-ancestor
64514478|NCT02185209|Metronidazole|metronidazole|mesh-list
64514479|NCT02185209|Penicillin V|penicillin v|mesh-list
64514480|NCT02185209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64514481|NCT02185209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64514482|NCT02185209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64514483|NCT02185209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64514484|NCT01894035|Iloprost|iloprost|mesh-list
64514485|NCT01894035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64514486|NCT01894035|Vasodilator Agents|vasodilator agents|mesh-ancestor
64514487|NCT01727141|Glycopyrrolate|glycopyrrolate|mesh-list
64675387|NCT03756818|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64675460|NCT01902758|Purinergic Agents|purinergic agents|mesh-ancestor
64714021|NCT00374647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64714022|NCT00374647|Immunologic Factors|immunologic factors|mesh-ancestor
64714023|NCT00374647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714024|NCT02964416|Tramadol|tramadol|mesh-list
64714025|NCT02964416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64714026|NCT02964416|Narcotics|narcotics|mesh-ancestor
64675754|NCT01941615|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64714027|NCT02964416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64675979|NCT01587963|Vitamins|vitamins|mesh-ancestor
64714028|NCT02964416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714029|NCT02964416|Analgesics|analgesics|mesh-ancestor
64676132|NCT05721755|Antimetabolites|antimetabolites|mesh-ancestor
64676201|NCT00501345|Aspirin|aspirin|mesh-list
64714030|NCT02964416|Sensory System Agents|sensory system agents|mesh-ancestor
64676349|NCT00118053|Trastuzumab|trastuzumab|mesh-list
64676425|NCT05663801|Analgesics|analgesics|mesh-ancestor
64676498|NCT02681211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64676597|NCT01692717|Losartan|losartan|mesh-list
64714031|NCT02964416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64677036|NCT00000861|Indinavir|indinavir|mesh-list
64714060|NCT02813551|Diuretics|diuretics|mesh-ancestor
64714061|NCT02813551|Natriuretic Agents|natriuretic agents|mesh-ancestor
64679802|NCT05751044|Dasatinib|dasatinib|mesh-list
64679876|NCT05648201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679952|NCT05597722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64679953|NCT05597722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679954|NCT05597722|Adrenergic Agents|adrenergic agents|mesh-ancestor
64679955|NCT05597722|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64679956|NCT05597722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64679979|NCT05492851|Hylan|hylan|mesh-list
64680027|NCT05423535|Fibrin Foam|fibrin foam|mesh-list
64680106|NCT05283720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64714063|NCT02813551|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64714064|NCT02813551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64714065|NCT02813551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714066|NCT02817763|Dipyrone|dipyrone|mesh-list
64714067|NCT02817763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64714068|NCT02817763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64714069|NCT02817763|Analgesics|analgesics|mesh-ancestor
64714070|NCT02817763|Sensory System Agents|sensory system agents|mesh-ancestor
64714071|NCT02817763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714072|NCT02817763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680193|NCT05045950|Memantine|memantine|mesh-list
64680245|NCT04837014|Sensory System Agents|sensory system agents|mesh-ancestor
64680246|NCT04837014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64680247|NCT04837014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680248|NCT04837014|Antipyretics|antipyretics|mesh-ancestor
64680257|NCT04837014|Narcotics|narcotics|mesh-ancestor
64680304|NCT04735978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471651|NCT04267978|Alkylating Agents|alkylating agents|mesh-ancestor
64680305|NCT04704050|Dronedarone|dronedarone|mesh-list
64680306|NCT04704050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64680307|NCT04696146|Complement C1s|complement c1s|mesh-list
64680308|NCT04696146|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64680309|NCT04696146|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
64680310|NCT04696146|Immunologic Factors|immunologic factors|mesh-ancestor
64680322|NCT04691986|Antimetabolites|antimetabolites|mesh-ancestor
64680550|NCT04177355|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64714073|NCT02817763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64714074|NCT02817763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64714076|NCT02846792|Nivolumab|nivolumab|mesh-list
64714077|NCT02846792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64714078|NCT02846792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64714079|NCT02846792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64714080|NCT02846792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680626|NCT04145349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680627|NCT04145349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680628|NCT04145349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64680629|NCT04145349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64680630|NCT04145349|Tubulin Modulators|tubulin modulators|mesh-ancestor
64680631|NCT04145349|Antimitotic Agents|antimitotic agents|mesh-ancestor
64680632|NCT04145349|Mitosis Modulators|mitosis modulators|mesh-ancestor
64680633|NCT04095442|Benzocaine|benzocaine|mesh-list
64680634|NCT04095442|Anesthetics, Local|anesthetics, local|mesh-ancestor
64680635|NCT04095442|Anesthetics|anesthetics|mesh-ancestor
64680636|NCT04095442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64680637|NCT04095442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680638|NCT04095442|Sensory System Agents|sensory system agents|mesh-ancestor
64680639|NCT04095442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64680751|NCT03869892|Trifluridine|trifluridine|mesh-list
64680752|NCT03869892|Bevacizumab|bevacizumab|mesh-list
64406086|NCT01594931|Antimalarials|antimalarials|mesh-ancestor
64680753|NCT03869892|Capecitabine|capecitabine|mesh-list
64680754|NCT03869892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64680755|NCT03869892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680756|NCT03869892|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64680757|NCT03869892|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64680758|NCT03869892|Growth Substances|growth substances|mesh-ancestor
64680759|NCT03869892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680760|NCT03869892|Growth Inhibitors|growth inhibitors|mesh-ancestor
64680761|NCT03869892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64680762|NCT03869892|Antimetabolites|antimetabolites|mesh-ancestor
64680763|NCT03869892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680764|NCT03869892|Antiviral Agents|antiviral agents|mesh-ancestor
64680765|NCT03869892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64680766|NCT03822663|Caffeine|caffeine|mesh-list
64680767|NCT03822663|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64680768|NCT03822663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680769|NCT03822663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64514520|NCT02290444|Hormones|hormones|mesh-list
64514521|NCT02290444|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64514522|NCT02290444|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64514523|NCT02290444|beta-Endorphin|beta-endorphin|mesh-list
64514524|NCT02290444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64680919|NCT03072238|Prednisone|prednisone|mesh-list
64514525|NCT02290444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681037|NCT02542657|Glucocorticoids|glucocorticoids|mesh-ancestor
64681109|NCT01794520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681193|NCT01323465|Analgesics|analgesics|mesh-ancestor
64514526|NCT02290444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64681257|NCT00885326|Bevacizumab|bevacizumab|mesh-list
64514527|NCT02290444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681406|NCT00002649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64514528|NCT01726517|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64514529|NCT01726517|Antiviral Agents|antiviral agents|mesh-ancestor
64681632|NCT04739345|Pentoxifylline|pentoxifylline|mesh-list
64514530|NCT01726517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64682049|NCT05749575|Paclitaxel|paclitaxel|mesh-list
64682170|NCT01641445|Topiramate|topiramate|mesh-list
64682234|NCT03561259|Vorinostat|vorinostat|mesh-list
64514531|NCT01752023|Gemcitabine|gemcitabine|mesh-list
64514532|NCT01752023|Itraconazole|itraconazole|mesh-list
64514533|NCT01752023|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
64514535|NCT01752023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514536|NCT01752023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64682752|NCT00000339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64514538|NCT01752023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514539|NCT01752023|Antiviral Agents|antiviral agents|mesh-ancestor
64514540|NCT01752023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64514541|NCT01752023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514542|NCT01752023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64514543|NCT01752023|Immunologic Factors|immunologic factors|mesh-ancestor
64514545|NCT01752023|Antifungal Agents|antifungal agents|mesh-ancestor
64514548|NCT01752023|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64514549|NCT01752023|Hormone Antagonists|hormone antagonists|mesh-ancestor
64684026|NCT03467373|Hormones|hormones|mesh-ancestor
64514550|NCT01752023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64684234|NCT03200847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684309|NCT04195256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64514551|NCT01752023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64514553|NCT02986906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64684685|NCT02975141|Gemcitabine|gemcitabine|mesh-list
64514555|NCT02986906|Hormones|hormones|mesh-ancestor
64514556|NCT02986906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64514557|NCT02986906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685290|NCT00003111|Paclitaxel|paclitaxel|mesh-list
64514558|NCT05658562|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
64685513|NCT04581343|Gemcitabine|gemcitabine|mesh-list
64514559|NCT05658562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64514561|NCT01726049|Sildenafil Citrate|sildenafil citrate|mesh-list
64685894|NCT05473273|Estradiol|estradiol|mesh-list
64685963|NCT04744727|Meperidine|meperidine|mesh-list
64514563|NCT01726049|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64686286|NCT02471651|Hormones|hormones|mesh-ancestor
64686346|NCT02519387|Buprenorphine|buprenorphine|mesh-list
64514564|NCT01726049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64514565|NCT01726049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686640|NCT02267083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64686788|NCT02431637|Piperaquine|piperaquine|mesh-list
64686864|NCT00559507|Saracatinib|saracatinib|mesh-list
64687012|NCT02505269|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64688807|NCT02659787|Buprenorphine|buprenorphine|mesh-list
64514576|NCT01605617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514577|NCT01605617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688944|NCT00586391|Ipilimumab|ipilimumab|mesh-list
64689019|NCT02697071|Ketamine|ketamine|mesh-list
64514578|NCT01605617|Urological Agents|urological agents|mesh-ancestor
64514579|NCT05402020|Tiotropium Bromide|tiotropium bromide|mesh-list
64514581|NCT05402020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64514582|NCT05402020|Autonomic Agents|autonomic agents|mesh-ancestor
64689389|NCT01948141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64689692|NCT00369863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514583|NCT05402020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689838|NCT01951963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64689839|NCT01951963|Narcotics|narcotics|mesh-ancestor
64689840|NCT02377271|Bosentan|bosentan|mesh-list
64689841|NCT02377271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64689842|NCT02377271|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64689843|NCT02377271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689844|NCT01894555|Aspirin|aspirin|mesh-list
64689845|NCT01894555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64689846|NCT01894555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64689847|NCT01894555|Analgesics|analgesics|mesh-ancestor
64689848|NCT01894555|Sensory System Agents|sensory system agents|mesh-ancestor
64689849|NCT01894555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689850|NCT01894555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689851|NCT01894555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64689862|NCT02344355|Vitamins|vitamins|mesh-ancestor
64514584|NCT05402020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690212|NCT04969211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64690286|NCT01904071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690294|NCT04903223|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64690295|NCT04903223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64690296|NCT04903223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64690297|NCT04903223|Antimetabolites|antimetabolites|mesh-ancestor
64690298|NCT04903223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471652|NCT04267978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64514585|NCT05402020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64514587|NCT05402020|Parasympatholytics|parasympatholytics|mesh-ancestor
64514589|NCT05402020|Cholinergic Agents|cholinergic agents|mesh-ancestor
64514590|NCT05402020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64690733|NCT00371735|Artesunate|artesunate|mesh-list
64690812|NCT02741687|Insulin Aspart|insulin aspart|mesh-list
64690961|NCT02296099|Anesthetics|anesthetics|mesh-ancestor
64691112|NCT04535401|Fluorouracil|fluorouracil|mesh-list
64691189|NCT04365049|Gemcitabine|gemcitabine|mesh-list
64691263|NCT03339635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514591|NCT05402020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691416|NCT04188665|Lectins|lectins|mesh-list
64691491|NCT04982237|Paclitaxel|paclitaxel|mesh-list
64691565|NCT02789033|Isosorbide|isosorbide|mesh-list
64691641|NCT02882711|Anesthetics|anesthetics|mesh-ancestor
64691716|NCT02803229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64691717|NCT01938001|Rituximab|rituximab|mesh-list
64691718|NCT01938001|Lenalidomide|lenalidomide|mesh-list
64691719|NCT01938001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64691720|NCT01938001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691721|NCT01938001|Immunologic Factors|immunologic factors|mesh-ancestor
64514592|NCT02284828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64514593|NCT02284828|Anticonvulsants|anticonvulsants|mesh-ancestor
64514594|NCT02284828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64514595|NCT02284828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64514598|NCT01751867|Decitabine|decitabine|mesh-list
64514618|NCT05633914|Paclitaxel|paclitaxel|mesh-list
64693119|NCT02036840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64693268|NCT02360774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64693417|NCT03048383|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64693644|NCT02996591|Analgesics|analgesics|mesh-ancestor
64514619|NCT05633914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64514620|NCT05633914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694014|NCT02068027|Clonidine|clonidine|mesh-list
64514621|NCT05633914|Tubulin Modulators|tubulin modulators|mesh-ancestor
64514622|NCT05633914|Antimitotic Agents|antimitotic agents|mesh-ancestor
64514623|NCT05633914|Mitosis Modulators|mitosis modulators|mesh-ancestor
64514624|NCT05633914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514625|NCT05383612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64514626|NCT05383612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64514627|NCT05382364|Tucatinib|tucatinib|mesh-list
64514628|NCT05382364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514629|NCT05382364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64514630|NCT05382364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64471654|NCT04267978|Growth Substances|growth substances|mesh-ancestor
64514631|NCT05382364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514632|NCT02712801|Ritonavir|ritonavir|mesh-list
64514633|NCT02712801|Lopinavir|lopinavir|mesh-list
64514634|NCT02712801|Lamivudine|lamivudine|mesh-list
64694395|NCT05637086|Phenytoin|phenytoin|mesh-list
64714083|NCT03053401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64694520|NCT03302741|Cholinergic Agents|cholinergic agents|mesh-ancestor
64694828|NCT03994874|Natriuretic Agents|natriuretic agents|mesh-ancestor
64514638|NCT02712801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64695054|NCT01349192|Chlorhexidine|chlorhexidine|mesh-list
64514639|NCT02712801|Protease Inhibitors|protease inhibitors|mesh-ancestor
64695445|NCT00355927|Propofol|propofol|mesh-list
64695581|NCT01768767|Ketamine|ketamine|mesh-list
64695730|NCT00003213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64421167|NCT02489903|Taxane|taxane|mesh-list
64695879|NCT00358358|Hormones|hormones|mesh-ancestor
64695960|NCT03256253|Pregabalin|pregabalin|mesh-list
64696105|NCT03269435|Anesthetics|anesthetics|mesh-ancestor
64514641|NCT02712801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514642|NCT02712801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64514644|NCT02712801|Antiviral Agents|antiviral agents|mesh-ancestor
64696552|NCT04343768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64696553|NCT04343768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64696554|NCT04343768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64696555|NCT04343768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64696556|NCT04343768|Antimalarials|antimalarials|mesh-ancestor
64696566|NCT02259348|Aldesleukin|aldesleukin|mesh-list
64514646|NCT02712801|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64696661|NCT03596723|Hormones|hormones|mesh-ancestor
64696706|NCT03472469|Antimanic Agents|antimanic agents|mesh-ancestor
64514647|NCT02712801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64696929|NCT04486352|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64696930|NCT01642602|Dexlansoprazole|dexlansoprazole|mesh-list
64696931|NCT01642602|Lansoprazole|lansoprazole|mesh-list
64696932|NCT01642602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64696933|NCT01642602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64696934|NCT01642602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64514648|NCT02712801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64697312|NCT03925532|Denosumab|denosumab|mesh-list
64514649|NCT02712801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64514650|NCT02712801|Antimetabolites|antimetabolites|mesh-ancestor
64514651|NCT02712801|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64514652|NCT02712801|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64514653|NCT02712723|Letrozole|letrozole|mesh-list
64697898|NCT00361322|Clindamycin phosphate|clindamycin phosphate|mesh-list
64514654|NCT02712723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514655|NCT02712723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64514656|NCT02712723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64698051|NCT05448872|Valsartan|valsartan|mesh-list
64698420|NCT02460133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64514667|NCT02156739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514668|NCT02156739|Chelating Agents|chelating agents|mesh-ancestor
64698724|NCT04341818|Vitamin D|vitamin d|mesh-list
64514669|NCT02156739|Sequestering Agents|sequestering agents|mesh-ancestor
64514670|NCT02156739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471655|NCT04267978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471656|NCT04267978|Growth Inhibitors|growth inhibitors|mesh-ancestor
64514671|NCT02156739|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64514672|NCT02156739|Anticoagulants|anticoagulants|mesh-ancestor
64514673|NCT02156739|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64514675|NCT02402439|Pancreatin|pancreatin|mesh-list
64699468|NCT04676035|Warfarin|warfarin|mesh-list
64699767|NCT01634100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64514676|NCT02402439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64514677|NCT01751087|Vitamins|vitamins|mesh-list
64514678|NCT01751087|Vitamin B 12|vitamin b 12|mesh-list
64514679|NCT01751087|Misoprostol|misoprostol|mesh-list
64700230|NCT03614221|Tacrolimus|tacrolimus|mesh-list
64700303|NCT00002835|Antiemetics|antiemetics|mesh-ancestor
64514680|NCT01751087|Mifepristone|mifepristone|mesh-list
64514681|NCT01751087|Micronutrients|micronutrients|mesh-ancestor
64514682|NCT01751087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700601|NCT03498391|Anesthetics|anesthetics|mesh-ancestor
64514684|NCT01751087|Abortifacient Agents|abortifacient agents|mesh-ancestor
64514692|NCT01751087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64514693|NCT01751087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64707649|NCT05061901|Lisinopril|lisinopril|mesh-list
64514694|NCT01751087|Contraceptive Agents|contraceptive agents|mesh-ancestor
64708013|NCT03233347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64708164|NCT04093531|Ustekinumab|ustekinumab|mesh-list
64708236|NCT02197416|Dabigatran|dabigatran|mesh-list
64708385|NCT05453552|Antimetabolites|antimetabolites|mesh-ancestor
64708530|NCT02737891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64708607|NCT00370669|Growth Substances|growth substances|mesh-ancestor
64708830|NCT05032183|Antidotes|antidotes|mesh-ancestor
64708980|NCT01190306|Riboflavin|riboflavin|mesh-list
64709054|NCT02192970|Growth Substances|growth substances|mesh-ancestor
64709573|NCT05055752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64709574|NCT05055752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64709575|NCT05055752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64709576|NCT05055752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64709577|NCT05055752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711151|NCT05676034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436386|NCT04428385|Artemisinin|artemisinin|mesh-list
64711152|NCT05675800|Psilocybin|psilocybin|mesh-list
64711153|NCT05675800|Hallucinogens|hallucinogens|mesh-ancestor
64711154|NCT05675800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711224|NCT05641376|Dexmedetomidine|dexmedetomidine|mesh-list
64711225|NCT05641376|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64711226|NCT05641376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64711227|NCT05641376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711228|NCT05641376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64711229|NCT05641376|Analgesics|analgesics|mesh-ancestor
64711230|NCT05641376|Sensory System Agents|sensory system agents|mesh-ancestor
64711231|NCT05641376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64711232|NCT05641376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64711233|NCT05641376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64711234|NCT05641376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64711500|NCT05376319|Immunologic Factors|immunologic factors|mesh-ancestor
64711501|NCT05376319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711502|NCT05376319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64711503|NCT05374512|Paclitaxel|paclitaxel|mesh-list
64711504|NCT05374512|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64711505|NCT05374512|Carboplatin|carboplatin|mesh-list
64711506|NCT05374512|Capecitabine|capecitabine|mesh-list
64711507|NCT05374512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64711508|NCT05374512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711509|NCT05374512|Tubulin Modulators|tubulin modulators|mesh-ancestor
64711510|NCT05374512|Antimitotic Agents|antimitotic agents|mesh-ancestor
64711511|NCT05374512|Mitosis Modulators|mitosis modulators|mesh-ancestor
64711513|NCT05374512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64711523|NCT05362058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711524|NCT05358587|Anesthetics|anesthetics|mesh-list
64711525|NCT05358587|Anesthetics, Local|anesthetics, local|mesh-list
64711526|NCT05358587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64711527|NCT05358587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64711528|NCT05358587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711529|NCT05358587|Sensory System Agents|sensory system agents|mesh-ancestor
64711601|NCT05322252|Abortifacient Agents|abortifacient agents|mesh-ancestor
64711769|NCT05096663|Hormones|hormones|mesh-ancestor
64711770|NCT05096663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64711771|NCT05096663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64711772|NCT05096663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711773|NCT05096663|Protease Inhibitors|protease inhibitors|mesh-ancestor
64711774|NCT05096663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64711777|NCT05096663|Antimetabolites|antimetabolites|mesh-ancestor
64945628|NCT05402553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64711980|NCT04902950|Tranexamic Acid|tranexamic acid|mesh-list
64711981|NCT04902950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64711982|NCT04902950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64437214|NCT05582798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64711984|NCT04902950|Hemostatics|hemostatics|mesh-ancestor
64712268|NCT04579224|Antimetabolites|antimetabolites|mesh-ancestor
64712269|NCT04579224|Antiviral Agents|antiviral agents|mesh-ancestor
64945629|NCT05402553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64712282|NCT04538378|Durvalumab|durvalumab|mesh-list
64712283|NCT04538378|Olaparib|olaparib|mesh-list
64712284|NCT04538378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64712285|NCT04538378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712286|NCT04538378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64712287|NCT04538378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712289|NCT04531943|Progesterone|progesterone|mesh-list
64712349|NCT04503460|Fluticasone|fluticasone|mesh-list
64712350|NCT04503460|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64712351|NCT04503460|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64712352|NCT04503460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64712426|NCT04395196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64712427|NCT04395196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64712428|NCT04395196|Nootropic Agents|nootropic agents|mesh-ancestor
64712525|NCT04195633|Treosulfan|treosulfan|mesh-list
64712526|NCT04195633|Busulfan|busulfan|mesh-list
64712527|NCT04195633|Fludarabine|fludarabine|mesh-list
64712528|NCT04195633|Cyclosporins|cyclosporins|mesh-list
64712529|NCT04195633|Lenograstim|lenograstim|mesh-list
64712530|NCT04195633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64712531|NCT04195633|Immunologic Factors|immunologic factors|mesh-ancestor
64712532|NCT04195633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712533|NCT04195633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64712534|NCT04195633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64712535|NCT04195633|Alkylating Agents|alkylating agents|mesh-ancestor
64712536|NCT04195633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712537|NCT04195633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712656|NCT04093323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64712730|NCT03971474|Immunoglobulins|immunoglobulins|mesh-list
64712731|NCT03971474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64712732|NCT03971474|Lexatumumab|lexatumumab|mesh-list
64712733|NCT03971474|Immunologic Factors|immunologic factors|mesh-ancestor
64712734|NCT03971474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712735|NCT03971474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64712736|NCT03971474|Antimetabolites|antimetabolites|mesh-ancestor
64712738|NCT03971474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712807|NCT03869190|Gemcitabine|gemcitabine|mesh-list
64712808|NCT03869190|Atezolizumab|atezolizumab|mesh-list
64712809|NCT03869190|Niraparib|niraparib|mesh-list
64712810|NCT03869190|Magrolimab|magrolimab|mesh-list
64712811|NCT03869190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712812|NCT03869190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64712813|NCT03869190|Antimetabolites|antimetabolites|mesh-ancestor
64712814|NCT03869190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712815|NCT03869190|Antiviral Agents|antiviral agents|mesh-ancestor
64713036|NCT03456076|Pemetrexed|pemetrexed|mesh-list
64713125|NCT03149211|UB-421|ub-421|mesh-list
64713183|NCT03043430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64713263|NCT03007147|Antidotes|antidotes|mesh-ancestor
64713341|NCT02989597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64713342|NCT02989597|Antitussive Agents|antitussive agents|mesh-ancestor
64713343|NCT02989597|Respiratory System Agents|respiratory system agents|mesh-ancestor
64713344|NCT02933255|Nivolumab|nivolumab|mesh-list
64713345|NCT02933255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64713346|NCT02933255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713347|NCT02933255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64713348|NCT02933255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713349|NCT02913482|Risdiplam|risdiplam|mesh-list
64713350|NCT02913482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64713351|NCT02913482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64713603|NCT02185560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713604|NCT02185560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64713605|NCT02185560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64713606|NCT02185560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713607|NCT02169310|Raclopride|raclopride|mesh-list
64713608|NCT02169310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64713609|NCT02169310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64713610|NCT02169310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64713611|NCT02169310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713612|NCT02169310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64713613|NCT02169310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64713614|NCT02169310|Dopamine Agents|dopamine agents|mesh-ancestor
64713615|NCT02169310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64713616|NCT02169310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713617|NCT02107963|Cyclophosphamide|cyclophosphamide|mesh-list
64713618|NCT02107963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64713619|NCT02107963|Immunologic Factors|immunologic factors|mesh-ancestor
64713620|NCT02107963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713722|NCT01517100|Dronabinol|dronabinol|mesh-list
64495033|NCT03466632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64495186|NCT01099618|Protease Inhibitors|protease inhibitors|mesh-ancestor
64945711|NCT05287425|Gentamicins|gentamicins|mesh-list
64502793|NCT03358524|Protective Agents|protective agents|mesh-ancestor
64502876|NCT04509258|Antiviral Agents|antiviral agents|mesh-ancestor
64502947|NCT03363984|Midazolam|midazolam|mesh-list
64485196|NCT01943435|Misoprostol|misoprostol|mesh-list
64503295|NCT03349008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64946432|NCT04134936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64946506|NCT03941262|Avelumab|avelumab|mesh-list
64947260|NCT05772871|Prednisone|prednisone|mesh-list
64486521|NCT01923467|Nicotine|nicotine|mesh-list
64947780|NCT05406401|Glucocorticoids|glucocorticoids|mesh-ancestor
64947854|NCT05007041|Vaccines|vaccines|mesh-list
64948156|NCT04580134|Clozapine|clozapine|mesh-list
64948525|NCT03865940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64948970|NCT01526603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64503325|NCT03348696|BB 1101|bb 1101|mesh-list
64488458|NCT01592708|Mydriatics|mydriatics|mesh-ancestor
64949723|NCT00020774|Gemcitabine|gemcitabine|mesh-list
64950090|NCT00049413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950317|NCT00050154|Tipifarnib|tipifarnib|mesh-list
64951288|NCT00025610|Cyclophosphamide|cyclophosphamide|mesh-list
64510921|NCT05781217|Fertility Agents|fertility agents|mesh-ancestor
64510922|NCT05781152|Adalimumab|adalimumab|mesh-list
64510923|NCT05781152|Infliximab|infliximab|mesh-list
64510924|NCT05781152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64510925|NCT05781152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64510926|NCT05781152|Dermatologic Agents|dermatologic agents|mesh-ancestor
64510927|NCT05781152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64510935|NCT05776108|Cabotegravir|cabotegravir|mesh-list
64510954|NCT05753618|Lenograstim|lenograstim|mesh-list
64510955|NCT05753618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64510956|NCT05753618|Immunologic Factors|immunologic factors|mesh-ancestor
64510957|NCT05753618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510958|NCT05752461|Enoxaparin|enoxaparin|mesh-list
64510959|NCT05752461|Enoxaparin sodium|enoxaparin sodium|mesh-list
64510960|NCT05752461|Anticoagulants|anticoagulants|mesh-ancestor
64510961|NCT05752461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64510962|NCT05752461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64511141|NCT05647551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64511153|NCT05633654|Pembrolizumab|pembrolizumab|mesh-list
64511154|NCT05633654|Capecitabine|capecitabine|mesh-list
64512505|NCT04322318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64512506|NCT04322318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64512507|NCT04322318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64512508|NCT04322318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64512509|NCT04322318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64512510|NCT04322318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64512511|NCT04322318|Tubulin Modulators|tubulin modulators|mesh-ancestor
64512512|NCT04322318|Antimitotic Agents|antimitotic agents|mesh-ancestor
64512513|NCT04322318|Mitosis Modulators|mitosis modulators|mesh-ancestor
64512514|NCT04322318|Keratolytic Agents|keratolytic agents|mesh-ancestor
64512515|NCT04322318|Dermatologic Agents|dermatologic agents|mesh-ancestor
64512544|NCT04256941|Letrozole|letrozole|mesh-list
64512545|NCT04256941|Fulvestrant|fulvestrant|mesh-list
64512546|NCT04256941|Palbociclib|palbociclib|mesh-list
64512568|NCT04235608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64512569|NCT04235608|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64512571|NCT04232306|Anesthetics, Local|anesthetics, local|mesh-ancestor
64512572|NCT04232306|Anesthetics|anesthetics|mesh-ancestor
64512573|NCT04232306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64512574|NCT04232306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512575|NCT04232306|Sensory System Agents|sensory system agents|mesh-ancestor
64512576|NCT04232306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64512925|NCT03887780|Antithrombins|antithrombins|mesh-ancestor
64512926|NCT03887780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64512927|NCT03887780|Protease Inhibitors|protease inhibitors|mesh-ancestor
64512928|NCT03887780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64512930|NCT03887780|Anticoagulants|anticoagulants|mesh-ancestor
64513013|NCT03778502|Apixaban|apixaban|mesh-list
64513014|NCT03778502|Edoxaban|edoxaban|mesh-list
64513015|NCT03778502|Dabigatran|dabigatran|mesh-list
64513016|NCT03778502|Anticoagulants|anticoagulants|mesh-list
64513017|NCT03778502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64513018|NCT03778502|Antithrombins|antithrombins|mesh-ancestor
64513023|NCT03775200|Psilocybin|psilocybin|mesh-list
64513228|NCT02985957|Prednisone|prednisone|mesh-list
64955612|NCT00203905|Growth Inhibitors|growth inhibitors|mesh-ancestor
64955678|NCT00039026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64955735|NCT00204646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955812|NCT00072345|Immunologic Factors|immunologic factors|mesh-ancestor
64955813|NCT00072345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955814|NCT00072345|Leprostatic Agents|leprostatic agents|mesh-ancestor
64955815|NCT00072345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64955816|NCT00072345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64955973|NCT00039611|Vitamins|vitamins|mesh-ancestor
64955998|NCT00072618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64956019|NCT00411073|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
64956034|NCT00411190|Sensory System Agents|sensory system agents|mesh-ancestor
64514695|NCT01751087|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64956073|NCT00206557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64956074|NCT00206557|Hormone Antagonists|hormone antagonists|mesh-ancestor
64956075|NCT00206557|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64514696|NCT01751087|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64557293|NCT03891173|Tubulin Modulators|tubulin modulators|mesh-ancestor
64714414|NCT02876900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64714415|NCT02876900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714416|NCT02876900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64951639|NCT00026819|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64951640|NCT00026819|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64951641|NCT00026819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951642|NCT00026819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951643|NCT00026819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64951644|NCT00026819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64951646|NCT00026819|Sensory System Agents|sensory system agents|mesh-ancestor
64951647|NCT00026819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64951648|NCT00026819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951649|NCT00026819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64951650|NCT00026819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64951651|NCT00054834|Epratuzumab|epratuzumab|mesh-list
64951652|NCT00054834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64714417|NCT02876900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64322691|NCT02782169|Pregabalin|pregabalin|mesh-list
64714658|NCT02860507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64714660|NCT03082196|Sodium Fluoride|sodium fluoride|mesh-list
64714662|NCT03082196|Cariostatic Agents|cariostatic agents|mesh-ancestor
64714663|NCT03082196|Protective Agents|protective agents|mesh-ancestor
64714815|NCT04611152|Aflibercept|aflibercept|mesh-list
64714816|NCT04611152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64714817|NCT04611152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64714818|NCT04611152|Growth Substances|growth substances|mesh-ancestor
64714819|NCT04611152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714820|NCT04611152|Growth Inhibitors|growth inhibitors|mesh-ancestor
64714821|NCT04611152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64714822|NCT03104725|Acetylcysteine|acetylcysteine|mesh-list
64714823|NCT03104725|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64714824|NCT03104725|Antiviral Agents|antiviral agents|mesh-ancestor
64714825|NCT03104725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64714960|NCT03115801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323216|NCT03114813|Adrenergic Agents|adrenergic agents|mesh-ancestor
64328338|NCT02403687|Baclofen|baclofen|mesh-list
64328339|NCT02403687|Capsaicin|capsaicin|mesh-list
64328340|NCT02403687|Menthol|menthol|mesh-list
64328341|NCT02403687|Anesthetics, Local|anesthetics, local|mesh-ancestor
64328342|NCT02403687|Anesthetics|anesthetics|mesh-ancestor
64328343|NCT02403687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64328344|NCT02403687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328345|NCT02403687|Sensory System Agents|sensory system agents|mesh-ancestor
64328346|NCT02403687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64328347|NCT02403687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64328364|NCT02403687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64328365|NCT02403687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64328366|NCT02403687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64328367|NCT02403687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64328368|NCT02403687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64328369|NCT02403687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328370|NCT02403687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64328371|NCT02403687|Antipruritics|antipruritics|mesh-ancestor
64328372|NCT02403687|Dermatologic Agents|dermatologic agents|mesh-ancestor
64328411|NCT02183051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64328412|NCT02183051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328413|NCT02183051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64720601|NCT00002144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720602|NCT00002144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720603|NCT00002144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720605|NCT00000578|Theophylline|theophylline|mesh-list
64720606|NCT00000578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64459902|NCT02081638|Antipyretics|antipyretics|mesh-ancestor
64720607|NCT00000578|Glucocorticoids|glucocorticoids|mesh-ancestor
64720608|NCT00000578|Hormones|hormones|mesh-ancestor
64720623|NCT00000578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64720624|NCT03774745|Mifepristone|mifepristone|mesh-list
64720625|NCT03774745|Progesterone|progesterone|mesh-list
64720626|NCT03774745|Progestins|progestins|mesh-ancestor
64720627|NCT03774745|Hormones|hormones|mesh-ancestor
64720628|NCT03774745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64720629|NCT03774745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720630|NCT03774745|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64720631|NCT03774745|Abortifacient Agents|abortifacient agents|mesh-ancestor
64720632|NCT03774745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64720633|NCT03774745|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64720634|NCT03774745|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64720635|NCT03774745|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64720636|NCT03774745|Contraceptive Agents|contraceptive agents|mesh-ancestor
64720637|NCT03774745|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64720638|NCT03774745|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64720639|NCT03774745|Hormone Antagonists|hormone antagonists|mesh-ancestor
64720783|NCT00000650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720784|NCT00000656|Zidovudine|zidovudine|mesh-list
64720785|NCT00000656|Didanosine|didanosine|mesh-list
64720786|NCT00000656|Antimetabolites|antimetabolites|mesh-ancestor
64720787|NCT00000656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720788|NCT00000656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64720789|NCT00000656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720790|NCT00000656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720791|NCT00000656|Antiviral Agents|antiviral agents|mesh-ancestor
64720792|NCT00000656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720793|NCT00000656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64328656|NCT02184065|Meloxicam|meloxicam|mesh-list
64720798|NCT00000662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64720799|NCT00000662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720800|NCT00000662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720801|NCT00000662|Antiviral Agents|antiviral agents|mesh-ancestor
64720802|NCT00000662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720803|NCT00000662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64720804|NCT00000662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64720805|NCT00002168|Lamivudine|lamivudine|mesh-list
64720843|NCT00000668|Antiviral Agents|antiviral agents|mesh-ancestor
64720844|NCT00000668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720845|NCT00000668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720846|NCT00000668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720847|NCT00000668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720849|NCT00000680|Aldesleukin|aldesleukin|mesh-list
64720850|NCT00000680|Antimetabolites|antimetabolites|mesh-ancestor
64720851|NCT00000680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720852|NCT00000680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64720853|NCT00000680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720854|NCT00000680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720855|NCT00000680|Antiviral Agents|antiviral agents|mesh-ancestor
64720856|NCT00000680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720857|NCT00000680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64720858|NCT00000680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64720859|NCT00000680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64720860|NCT00000692|Miglustat|miglustat|mesh-list
64720861|NCT00000692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720862|NCT00000692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720863|NCT00000692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64720864|NCT00000692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64720865|NCT00000692|Antiviral Agents|antiviral agents|mesh-ancestor
64721026|NCT00002216|Abacavir|abacavir|mesh-list
64721027|NCT00002216|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64721028|NCT00002216|Nelfinavir|nelfinavir|mesh-list
64721029|NCT00002216|Amprenavir|amprenavir|mesh-list
64721030|NCT00002216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64721031|NCT00002216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64721032|NCT00002216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721033|NCT00002216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471663|NCT04267887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64721034|NCT00002216|Antiviral Agents|antiviral agents|mesh-ancestor
64721035|NCT00002216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721036|NCT00002216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64721037|NCT00002216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64721038|NCT00002216|Antimetabolites|antimetabolites|mesh-ancestor
64721039|NCT00002216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64721040|NCT00002216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64721041|NCT00002216|Protease Inhibitors|protease inhibitors|mesh-ancestor
64721042|NCT00002216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64328991|NCT02181023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328992|NCT02286973|Tranexamic Acid|tranexamic acid|mesh-list
64328993|NCT02286973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64328994|NCT02286973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64328995|NCT02286973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328996|NCT02286973|Hemostatics|hemostatics|mesh-ancestor
64328997|NCT02286973|Coagulants|coagulants|mesh-ancestor
64329003|NCT02287129|Paclitaxel|paclitaxel|mesh-list
64329065|NCT02030483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64329066|NCT02030483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329067|NCT02030483|Immunologic Factors|immunologic factors|mesh-ancestor
64329068|NCT02030483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64329069|NCT02030483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64329070|NCT02030483|Growth Substances|growth substances|mesh-ancestor
64329071|NCT02030483|Growth Inhibitors|growth inhibitors|mesh-ancestor
64329072|NCT02030483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64329073|NCT02030483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329074|NCT02030483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329075|NCT00528697|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64329079|NCT00528697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329081|NCT00528697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64329082|NCT00528697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329083|NCT02385435|Dexmedetomidine|dexmedetomidine|mesh-list
64329084|NCT02385435|Bupivacaine|bupivacaine|mesh-list
64329092|NCT02385435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64329094|NCT02385435|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64329095|NCT02385435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64329096|NCT02385435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64329097|NCT02385435|Adrenergic Agents|adrenergic agents|mesh-ancestor
64329100|NCT02753075|Fluorides|fluorides|mesh-list
64329167|NCT05089175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329281|NCT00514267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64329282|NCT04199104|Pembrolizumab|pembrolizumab|mesh-list
64329283|NCT04199104|Lenvatinib|lenvatinib|mesh-list
64329284|NCT04199104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64329285|NCT04199104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329286|NCT04199104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64329287|NCT04199104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329288|NCT04199104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329289|NCT02384967|Darunavir|darunavir|mesh-list
64329290|NCT02384967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64721543|NCT05709626|Analgesics|analgesics|mesh-ancestor
64721544|NCT05709626|Sensory System Agents|sensory system agents|mesh-ancestor
64721545|NCT05709626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64721546|NCT05709626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721547|NCT05709626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64721548|NCT05709626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64721549|NCT05709626|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64721550|NCT05709626|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64721551|NCT05709626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721552|NCT05709626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64721553|NCT05709626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64721554|NCT05709626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721555|NCT05709626|Antipyretics|antipyretics|mesh-ancestor
64721592|NCT00002426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721593|NCT00002426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64721594|NCT00002426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64329418|NCT02384343|Dexmedetomidine|dexmedetomidine|mesh-list
64329419|NCT02384343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64329420|NCT02384343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64329442|NCT02328040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64329443|NCT02328040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329444|NCT02328040|Incretins|incretins|mesh-ancestor
64329445|NCT02328040|Hormones|hormones|mesh-ancestor
64329446|NCT02328040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64329447|NCT02328040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64329448|NCT02328040|Protease Inhibitors|protease inhibitors|mesh-ancestor
64329449|NCT02328040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329450|NCT02328040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329590|NCT02191475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64329591|NCT02191475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64329592|NCT02191475|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64329593|NCT02191475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329594|NCT02191475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329604|NCT00326287|Linezolid|linezolid|mesh-list
64329627|NCT00320203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329628|NCT00320203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64329629|NCT00071461|Bosentan|bosentan|mesh-list
64329643|NCT02192411|Anesthetics, Local|anesthetics, local|mesh-ancestor
64329644|NCT02192411|Anesthetics|anesthetics|mesh-ancestor
64329671|NCT02384187|Antimanic Agents|antimanic agents|mesh-ancestor
64722148|NCT00002588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329885|NCT00004915|Hormone Antagonists|hormone antagonists|mesh-ancestor
64329886|NCT00004915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64329887|NCT00004915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329888|NCT00004915|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64329889|NCT00004915|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64329890|NCT00004915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64329892|NCT03535415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64329899|NCT02030717|Sensory System Agents|sensory system agents|mesh-ancestor
64329900|NCT02030717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64329901|NCT02030717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64329902|NCT02030717|Sympatholytics|sympatholytics|mesh-ancestor
64329903|NCT02030717|Autonomic Agents|autonomic agents|mesh-ancestor
64329905|NCT02030717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64722531|NCT00002720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64722533|NCT00002720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64722534|NCT00002720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64722535|NCT00002720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64722536|NCT01821859|Bevacizumab|bevacizumab|mesh-list
64722537|NCT01821859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64722538|NCT01821859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64722539|NCT01821859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722540|NCT01821859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64722541|NCT01821859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64722604|NCT00002744|Vincristine|vincristine|mesh-list
64722605|NCT00002744|Daunorubicin|daunorubicin|mesh-list
64722606|NCT00002744|Asparaginase|asparaginase|mesh-list
64722607|NCT00002744|Mercaptopurine|mercaptopurine|mesh-list
64722608|NCT00002744|Pegaspargase|pegaspargase|mesh-list
64722609|NCT00002744|Thioguanine|thioguanine|mesh-list
64722610|NCT00002744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64722611|NCT00002744|Immunologic Factors|immunologic factors|mesh-ancestor
64722612|NCT00002744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722613|NCT00002744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64722614|NCT00002744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64722615|NCT00002744|Alkylating Agents|alkylating agents|mesh-ancestor
64722616|NCT00002744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722617|NCT00002744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722618|NCT00002744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64722619|NCT00002744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64722620|NCT00002744|Antiemetics|antiemetics|mesh-ancestor
64722621|NCT00002744|Autonomic Agents|autonomic agents|mesh-ancestor
64722622|NCT00002744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64722623|NCT00002744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64722624|NCT00002744|Glucocorticoids|glucocorticoids|mesh-ancestor
64722625|NCT00002744|Hormones|hormones|mesh-ancestor
64330240|NCT05708521|Hydromorphone|hydromorphone|mesh-list
64330398|NCT04109885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64330399|NCT04109885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330400|NCT04109885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64330401|NCT04109885|Antipruritics|antipruritics|mesh-ancestor
64330402|NCT04109885|Dermatologic Agents|dermatologic agents|mesh-ancestor
64330633|NCT03529201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64330634|NCT03529201|Narcotics|narcotics|mesh-ancestor
64723385|NCT00476827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64723386|NCT00476827|Immunologic Factors|immunologic factors|mesh-ancestor
64723387|NCT00476827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64723388|NCT00476827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64723400|NCT00904423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723401|NCT00904423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64723402|NCT05328895|Betahistine|betahistine|mesh-list
64723403|NCT05328895|Vasodilator Agents|vasodilator agents|mesh-ancestor
64723404|NCT05328895|Histamine Agonists|histamine agonists|mesh-ancestor
64723409|NCT00879619|Prednisone|prednisone|mesh-list
64724500|NCT00000547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64724501|NCT00002930|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64724502|NCT00002930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64724503|NCT00002930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724504|NCT00000577|Colchicine|colchicine|mesh-list
64724505|NCT00000577|Albuterol|albuterol|mesh-list
64724506|NCT00000577|Hormones|hormones|mesh-list
64724507|NCT00000577|Adrenergic Agents|adrenergic agents|mesh-list
64724508|NCT00000577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-list
64724509|NCT00000577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64724510|NCT00000577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64724511|NCT00000577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64724512|NCT00000577|Autonomic Agents|autonomic agents|mesh-ancestor
64724513|NCT00000577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64724514|NCT00000577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64724515|NCT00000577|Respiratory System Agents|respiratory system agents|mesh-ancestor
64724516|NCT00000577|Tocolytic Agents|tocolytic agents|mesh-ancestor
64724517|NCT00000577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64724518|NCT00000577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64724519|NCT00000577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64724520|NCT00000577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64724521|NCT00000577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724522|NCT00000577|Gout Suppressants|gout suppressants|mesh-ancestor
64724523|NCT00000577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64724524|NCT00000577|Tubulin Modulators|tubulin modulators|mesh-ancestor
64724525|NCT00000577|Antimitotic Agents|antimitotic agents|mesh-ancestor
64724526|NCT00000577|Mitosis Modulators|mitosis modulators|mesh-ancestor
64724527|NCT00000577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64724528|NCT03321799|Anti-Infective Agents|anti-infective agents|mesh-list
64724529|NCT03321799|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64724530|NCT03015896|Nivolumab|nivolumab|mesh-list
64724531|NCT03015896|Lenalidomide|lenalidomide|mesh-list
64724532|NCT03015896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64724533|NCT03015896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64724538|NCT03015896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64724539|NCT03015896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64724540|NCT03015896|Growth Substances|growth substances|mesh-ancestor
64724541|NCT03015896|Growth Inhibitors|growth inhibitors|mesh-ancestor
64724542|NCT02994836|Adalimumab|adalimumab|mesh-list
64724543|NCT02994836|Infliximab|infliximab|mesh-list
64724544|NCT02994836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64724545|NCT02994836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64724546|NCT02994836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64724547|NCT02994836|Dermatologic Agents|dermatologic agents|mesh-ancestor
64724964|NCT00002305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64724965|NCT00002305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724966|NCT00002305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727809|NCT00002701|Mercaptopurine|mercaptopurine|mesh-list
64727810|NCT00002701|Idarubicin|idarubicin|mesh-list
64727811|NCT00002701|Tretinoin|tretinoin|mesh-list
64727812|NCT00002701|Thioguanine|thioguanine|mesh-list
64727813|NCT00002701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727814|NCT00002701|Immunologic Factors|immunologic factors|mesh-ancestor
64727815|NCT00002701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727816|NCT00002701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64727817|NCT00002701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64727818|NCT00002701|Alkylating Agents|alkylating agents|mesh-ancestor
64335210|NCT03949673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64727986|NCT00003614|Tubulin Modulators|tubulin modulators|mesh-ancestor
64727987|NCT00003614|Antimitotic Agents|antimitotic agents|mesh-ancestor
64727988|NCT00003614|Mitosis Modulators|mitosis modulators|mesh-ancestor
64728023|NCT00004100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64728024|NCT00004100|Tubulin Modulators|tubulin modulators|mesh-ancestor
64728025|NCT00004100|Antimitotic Agents|antimitotic agents|mesh-ancestor
64728026|NCT00004100|Mitosis Modulators|mitosis modulators|mesh-ancestor
64728028|NCT00002737|Interferon-alpha|interferon-alpha|mesh-list
64728029|NCT00002737|Isotretinoin|isotretinoin|mesh-list
64728372|NCT00004160|Paclitaxel|paclitaxel|mesh-list
64728373|NCT00004160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64728374|NCT00004160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728375|NCT00004160|Tubulin Modulators|tubulin modulators|mesh-ancestor
64728551|NCT00384566|Metoprolol|metoprolol|mesh-list
64728552|NCT00384566|Carvedilol|carvedilol|mesh-list
64728553|NCT00384566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64728554|NCT00384566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64728555|NCT00384566|Sympatholytics|sympatholytics|mesh-ancestor
64728556|NCT00384566|Autonomic Agents|autonomic agents|mesh-ancestor
64728557|NCT00384566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64728558|NCT00384566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335919|NCT02307721|Narcotics|narcotics|mesh-ancestor
64728603|NCT00002791|Ifosfamide|ifosfamide|mesh-list
64728604|NCT00002791|Dacarbazine|dacarbazine|mesh-list
64728605|NCT00002791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64728606|NCT00002791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728607|NCT00002791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64728608|NCT00002791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64728609|NCT00002791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728610|NCT00002791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728611|NCT00002791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64728612|NCT00002791|Alkylating Agents|alkylating agents|mesh-ancestor
64728613|NCT00004190|Gemcitabine|gemcitabine|mesh-list
64728614|NCT00004190|Oxaliplatin|oxaliplatin|mesh-list
64728615|NCT00004190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64728616|NCT00004190|Antimetabolites|antimetabolites|mesh-ancestor
64728617|NCT00004190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728873|NCT00003728|Antimetabolites|antimetabolites|mesh-ancestor
64728874|NCT00003728|Dermatologic Agents|dermatologic agents|mesh-ancestor
64728875|NCT00003728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64728876|NCT00003728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64728877|NCT00003728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64728898|NCT00003734|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64728899|NCT00003734|Flutamide|flutamide|mesh-list
64728900|NCT00003734|Luteolytic Agents|luteolytic agents|mesh-ancestor
64728901|NCT00003734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64728902|NCT00003734|Contraceptive Agents|contraceptive agents|mesh-ancestor
64728903|NCT00003734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64728904|NCT00003734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728905|NCT00003734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64728906|NCT00003734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64728907|NCT00003734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728908|NCT00003734|Androgen Antagonists|androgen antagonists|mesh-ancestor
64728909|NCT00003734|Hormone Antagonists|hormone antagonists|mesh-ancestor
64728910|NCT00003734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64728911|NCT00003740|Trastuzumab|trastuzumab|mesh-list
64728912|NCT00003740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64728913|NCT00003740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728914|NCT05477875|Acetaminophen|acetaminophen|mesh-list
64728915|NCT05477875|Dronabinol|dronabinol|mesh-list
64728916|NCT05477875|Codeine|codeine|mesh-list
64728917|NCT05477875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64728918|NCT05477875|Analgesics|analgesics|mesh-ancestor
64729326|NCT00004406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64729328|NCT00005024|Carboplatin|carboplatin|mesh-list
64729329|NCT00005024|Doxorubicin|doxorubicin|mesh-list
64729330|NCT00005024|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64729331|NCT00005024|Granisetron|granisetron|mesh-list
64729332|NCT00005024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64729333|NCT00005024|Immunologic Factors|immunologic factors|mesh-ancestor
64729334|NCT00005024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729335|NCT00005024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64729336|NCT00005024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64729337|NCT00005024|Alkylating Agents|alkylating agents|mesh-ancestor
64729338|NCT00005024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729339|NCT00005024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729340|NCT00005024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64729341|NCT00005024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64729342|NCT00005024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64729343|NCT00005024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64729473|NCT00005048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729475|NCT00005048|Alkylating Agents|alkylating agents|mesh-ancestor
64729476|NCT00005048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64729477|NCT04756765|Talazoparib|talazoparib|mesh-list
64736771|NCT05599919|Vasodilator Agents|vasodilator agents|mesh-ancestor
64729516|NCT00003884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64729517|NCT00003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729518|NCT00005066|Carmustine|carmustine|mesh-list
64729519|NCT00005066|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64729520|NCT00005066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64729521|NCT00005066|Alkylating Agents|alkylating agents|mesh-ancestor
64729522|NCT00005066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729523|NCT00005066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729524|NCT00005066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729525|NCT04711915|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
64729526|NCT04711915|Hallucinogens|hallucinogens|mesh-ancestor
64729527|NCT04711915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729528|NCT04711915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64729529|NCT04711915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64729530|NCT04711915|Serotonin Agents|serotonin agents|mesh-ancestor
64729531|NCT04711915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64729532|NCT04711915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729542|NCT00004496|alpha-MSH|alpha-msh|mesh-list
64730109|NCT00005654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64730110|NCT00005654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64730111|NCT00005654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64730112|NCT00005684|Heparin|heparin|mesh-list
64730113|NCT00005684|Warfarin|warfarin|mesh-list
64730114|NCT00005684|Anticoagulants|anticoagulants|mesh-ancestor
64730115|NCT00005684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64730116|NCT00005684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64730117|NCT00005684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730118|NCT00386282|Misoprostol|misoprostol|mesh-list
64730119|NCT00386282|Mifepristone|mifepristone|mesh-list
64730120|NCT00386282|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64730121|NCT00386282|Abortifacient Agents|abortifacient agents|mesh-ancestor
64730122|NCT00386282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64730123|NCT00386282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730124|NCT00386282|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64730125|NCT00386282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64730126|NCT00386282|Oxytocics|oxytocics|mesh-ancestor
64730127|NCT00386282|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64730128|NCT00386282|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64730130|NCT00386282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64730131|NCT00386282|Contraceptive Agents|contraceptive agents|mesh-ancestor
64730132|NCT00386282|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64730133|NCT00386282|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64730134|NCT00386282|Hormone Antagonists|hormone antagonists|mesh-ancestor
64730135|NCT00386282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64730136|NCT00386282|Luteolytic Agents|luteolytic agents|mesh-ancestor
64730137|NCT00386282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64730138|NCT00386282|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64730139|NCT04456699|Leucovorin|leucovorin|mesh-list
64730140|NCT04456699|Bevacizumab|bevacizumab|mesh-list
64730141|NCT04456699|Fluorouracil|fluorouracil|mesh-list
64730151|NCT04456699|Growth Inhibitors|growth inhibitors|mesh-ancestor
64730152|NCT04456699|Antimetabolites|antimetabolites|mesh-ancestor
64730578|NCT03472495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730579|NCT03472495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64730580|NCT03472495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730581|NCT03472495|Vasodilator Agents|vasodilator agents|mesh-ancestor
64730582|NCT04094701|Analgesics, Opioid|analgesics, opioid|mesh-list
64730584|NCT04094701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64730585|NCT04094701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730586|NCT04094701|Analgesics|analgesics|mesh-ancestor
64730587|NCT04094701|Sensory System Agents|sensory system agents|mesh-ancestor
64730588|NCT04094701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64730752|NCT02461927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64730753|NCT02461927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64730754|NCT02461927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64730755|NCT02461927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64730818|NCT02283853|Immunologic Factors|immunologic factors|mesh-ancestor
64730819|NCT02283853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730820|NCT02283853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64730821|NCT03668041|Gabapentin|gabapentin|mesh-list
64730822|NCT03668041|Trazodone|trazodone|mesh-list
64730823|NCT03668041|Eszopiclone|eszopiclone|mesh-list
64730824|NCT03668041|Analgesics|analgesics|mesh-ancestor
64730825|NCT03668041|Sensory System Agents|sensory system agents|mesh-ancestor
64730826|NCT03668041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64730827|NCT03668041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731085|NCT01478035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731087|NCT01478035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64731088|NCT00003013|Tamoxifen|tamoxifen|mesh-list
64731089|NCT00003013|Paclitaxel|paclitaxel|mesh-list
64731090|NCT00003013|Cyclophosphamide|cyclophosphamide|mesh-list
64731091|NCT00003013|Doxorubicin|doxorubicin|mesh-list
64731092|NCT00003013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64731093|NCT00003013|Fluorouracil|fluorouracil|mesh-list
64731094|NCT00003013|Methotrexate|methotrexate|mesh-list
64731095|NCT00003013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64731096|NCT00003013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731097|NCT00003013|Tubulin Modulators|tubulin modulators|mesh-ancestor
64731098|NCT00003013|Antimitotic Agents|antimitotic agents|mesh-ancestor
64731099|NCT00003013|Mitosis Modulators|mitosis modulators|mesh-ancestor
64731100|NCT00003013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731594|NCT00003073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64731595|NCT00003073|Immunologic Factors|immunologic factors|mesh-ancestor
64731596|NCT00003073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731597|NCT00003079|Cytarabine|cytarabine|mesh-list
64731598|NCT00003079|Bryostatin 1|bryostatin 1|mesh-list
64731599|NCT00003079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64731600|NCT00003079|Antimetabolites|antimetabolites|mesh-ancestor
64731601|NCT00003079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731602|NCT00003079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731603|NCT00003079|Antiviral Agents|antiviral agents|mesh-ancestor
64731604|NCT00003079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64731605|NCT00003079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64731606|NCT00003079|Immunologic Factors|immunologic factors|mesh-ancestor
64731607|NCT00003079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731608|NCT00003079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64731609|NCT00003601|Tretinoin|tretinoin|mesh-list
64731933|NCT00003667|Immunologic Factors|immunologic factors|mesh-ancestor
64731934|NCT00003667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731935|NCT00003667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64731936|NCT00003667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64731937|NCT00003667|Alkylating Agents|alkylating agents|mesh-ancestor
64731938|NCT00003667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731939|NCT00003667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731940|NCT00003667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64731941|NCT00003667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64731942|NCT00003667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64731943|NCT00003667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731944|NCT00003667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731945|NCT00003667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64731946|NCT00003667|Tubulin Modulators|tubulin modulators|mesh-ancestor
64731947|NCT00003667|Antimitotic Agents|antimitotic agents|mesh-ancestor
64731948|NCT00003667|Mitosis Modulators|mitosis modulators|mesh-ancestor
64731949|NCT00003667|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64731950|NCT00003667|Protective Agents|protective agents|mesh-ancestor
64733132|NCT00003331|Protective Agents|protective agents|mesh-ancestor
64733133|NCT00003331|Vitamin B Complex|vitamin b complex|mesh-ancestor
64733134|NCT00003331|Vitamins|vitamins|mesh-ancestor
64733135|NCT00003331|Micronutrients|micronutrients|mesh-ancestor
64733136|NCT00003331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64733137|NCT00003331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64733138|NCT00003331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733139|NCT00004885|Leucovorin|leucovorin|mesh-list
64733140|NCT00004885|Fluorouracil|fluorouracil|mesh-list
64733141|NCT00004885|Irinotecan|irinotecan|mesh-list
64733142|NCT00004885|Calcium|calcium|mesh-list
64733143|NCT00004885|Levoleucovorin|levoleucovorin|mesh-list
64733144|NCT00004885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64733145|NCT00004885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733146|NCT00004885|Antimetabolites|antimetabolites|mesh-ancestor
64733147|NCT00004885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733148|NCT00004885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64733149|NCT00004885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733150|NCT00004885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64733151|NCT00004885|Immunologic Factors|immunologic factors|mesh-ancestor
64733152|NCT00004885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64733153|NCT00004885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64733264|NCT00004933|Homoharringtonine|homoharringtonine|mesh-list
64733265|NCT00004933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733266|NCT00004933|Antisickling Agents|antisickling agents|mesh-ancestor
64733267|NCT00004933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733268|NCT00004933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733269|NCT00004933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64733270|NCT00004933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64733271|NCT00004933|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64733272|NCT00004981|Lamivudine|lamivudine|mesh-list
64733273|NCT00004981|Zidovudine|zidovudine|mesh-list
64733274|NCT00004981|Abacavir|abacavir|mesh-list
64733275|NCT00004981|Dideoxynucleosides|dideoxynucleosides|mesh-list
64733276|NCT00004981|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64733277|NCT00004981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64733278|NCT00004981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64733279|NCT00004981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733280|NCT00004981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733281|NCT00004981|Antiviral Agents|antiviral agents|mesh-ancestor
64733282|NCT00004981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64733283|NCT00004981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64733284|NCT00004981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64733285|NCT00004981|Antimetabolites|antimetabolites|mesh-ancestor
64733286|NCT00004993|Hormones|hormones|mesh-list
64733287|NCT00004993|Parathyroid Hormone|parathyroid hormone|mesh-list
64733288|NCT00004993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64733289|NCT00004993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733311|NCT00003361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733312|NCT00003361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733313|NCT00003361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733770|NCT00004747|Antibodies|antibodies|mesh-list
64733771|NCT00004747|gamma-Globulins|gamma-globulins|mesh-list
64733772|NCT00004747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64733773|NCT00004747|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64733774|NCT00004747|Immunologic Factors|immunologic factors|mesh-ancestor
64733775|NCT00004747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733776|NCT00004759|Methylprednisolone|methylprednisolone|mesh-list
64733777|NCT00004759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64733787|NCT00004759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64733788|NCT00004759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733789|NCT00004759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64733790|NCT00004759|Glucocorticoids|glucocorticoids|mesh-ancestor
64733791|NCT00004759|Hormones|hormones|mesh-ancestor
64733792|NCT00004759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64733793|NCT00004759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64733794|NCT00004759|Protective Agents|protective agents|mesh-ancestor
64733795|NCT00004759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64733830|NCT00004807|Respiratory System Agents|respiratory system agents|mesh-ancestor
64733831|NCT00004807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64733832|NCT00004807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64733833|NCT00004825|Insulin|insulin|mesh-list
64733834|NCT00004825|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64733835|NCT00004825|Mitogens|mitogens|mesh-list
64733836|NCT00004825|Mecasermin|mecasermin|mesh-list
64733837|NCT00004825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64733838|NCT00004825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733839|NCT00004825|Mitosis Modulators|mitosis modulators|mesh-ancestor
64733840|NCT00004825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733841|NCT00004825|Growth Substances|growth substances|mesh-ancestor
64733973|NCT02130024|Aflibercept|aflibercept|mesh-list
64733974|NCT02130024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64733975|NCT02130024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64733976|NCT02130024|Growth Substances|growth substances|mesh-ancestor
64733977|NCT02130024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733978|NCT02130024|Growth Inhibitors|growth inhibitors|mesh-ancestor
64733979|NCT02130024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733980|NCT02105688|Grazoprevir|grazoprevir|mesh-list
64734017|NCT02125734|Bromides|bromides|mesh-list
64734018|NCT02125734|Tiotropium Bromide|tiotropium bromide|mesh-list
64734019|NCT02125734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64734020|NCT02125734|Autonomic Agents|autonomic agents|mesh-ancestor
64734021|NCT02125734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64734022|NCT02125734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734023|NCT02125734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64734024|NCT02125734|Respiratory System Agents|respiratory system agents|mesh-ancestor
64734025|NCT02125734|Parasympatholytics|parasympatholytics|mesh-ancestor
64734026|NCT02125734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64734027|NCT02125734|Cholinergic Agents|cholinergic agents|mesh-ancestor
64734028|NCT02125734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64734029|NCT02125734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734030|NCT02125734|Anticonvulsants|anticonvulsants|mesh-ancestor
64734031|NCT02124798|Belimumab|belimumab|mesh-list
64734032|NCT02124798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64734033|NCT02124798|Immunologic Factors|immunologic factors|mesh-ancestor
64734034|NCT02124798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734035|NCT04735770|Levobupivacaine|levobupivacaine|mesh-list
64734036|NCT04735770|Anesthetics|anesthetics|mesh-ancestor
64734037|NCT04735770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64734175|NCT02097108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734267|NCT02095158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64734268|NCT02095158|Protective Agents|protective agents|mesh-ancestor
64734269|NCT02118714|Atrasentan|atrasentan|mesh-list
64734270|NCT02118714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734271|NCT02118714|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64734272|NCT02118714|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64734273|NCT02118714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734274|NCT02138916|Benralizumab|benralizumab|mesh-list
64734333|NCT02116530|Cyclophosphamide|cyclophosphamide|mesh-list
64734334|NCT02116530|Doxorubicin|doxorubicin|mesh-list
64734346|NCT02116530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64734347|NCT02116530|Alkylating Agents|alkylating agents|mesh-ancestor
64734348|NCT02116530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734349|NCT02116530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734350|NCT02116530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64734351|NCT02116530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64734352|NCT02116530|Autonomic Agents|autonomic agents|mesh-ancestor
64734353|NCT02116530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64734354|NCT02116530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64734355|NCT02116530|Glucocorticoids|glucocorticoids|mesh-ancestor
64734356|NCT02116530|Hormones|hormones|mesh-ancestor
64734357|NCT02116530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64734358|NCT02116530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64734359|NCT02116530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64734360|NCT02116530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64734361|NCT02116530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64734362|NCT02116530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734561|NCT01624974|Hormone Antagonists|hormone antagonists|mesh-ancestor
64734562|NCT01624974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64734563|NCT01624974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734564|NCT01624974|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64734565|NCT01624974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64734566|NCT01624974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734567|NCT01624662|Fluticasone|fluticasone|mesh-list
64734568|NCT01624662|Xhance|xhance|mesh-list
64734569|NCT01624662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64734570|NCT01624662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64734571|NCT01624662|Autonomic Agents|autonomic agents|mesh-ancestor
64734572|NCT01624662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64734573|NCT01624662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734574|NCT01624662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64735047|NCT02052960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64735049|NCT02008890|Immunologic Factors|immunologic factors|mesh-ancestor
64735050|NCT02008890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735051|NCT02052414|Gabapentin|gabapentin|mesh-list
64735052|NCT02052414|Analgesics|analgesics|mesh-ancestor
64735053|NCT02052414|Sensory System Agents|sensory system agents|mesh-ancestor
64735054|NCT02052414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64735055|NCT02052414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735056|NCT02052414|Anticonvulsants|anticonvulsants|mesh-ancestor
64735057|NCT02052414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64735058|NCT02052414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64735081|NCT02007096|Sensory System Agents|sensory system agents|mesh-ancestor
64735082|NCT02007096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64735083|NCT02006706|Methylprednisolone|methylprednisolone|mesh-list
64735084|NCT02006706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64735085|NCT02006706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64735086|NCT02006706|Prednisolone|prednisolone|mesh-list
64735087|NCT02006706|Prednisolone acetate|prednisolone acetate|mesh-list
64735088|NCT02006706|Rituximab|rituximab|mesh-list
64735089|NCT02006706|Methotrexate|methotrexate|mesh-list
64735090|NCT02006706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64735091|NCT02006706|Prednisolone phosphate|prednisolone phosphate|mesh-list
64735092|NCT02006706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64735093|NCT02006706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735094|NCT02006706|Immunologic Factors|immunologic factors|mesh-ancestor
64735095|NCT02006706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735096|NCT02006706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64735344|NCT01996332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64735345|NCT01996332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735346|NCT01996332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735347|NCT01987596|Lenograstim|lenograstim|mesh-list
64735348|NCT01987596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64735349|NCT01987596|Immunologic Factors|immunologic factors|mesh-ancestor
64471675|NCT04267887|Hormone Antagonists|hormone antagonists|mesh-ancestor
64735350|NCT01987596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735352|NCT01964898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64735353|NCT01964898|Autonomic Agents|autonomic agents|mesh-ancestor
64735387|NCT01945866|Hormones|hormones|mesh-ancestor
64735388|NCT01945866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64735389|NCT01945866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64735390|NCT01945866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735391|NCT01945866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64735392|NCT01945866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64735761|NCT01935336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64735762|NCT01935336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735763|NCT01935336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735764|NCT01978236|Trametinib|trametinib|mesh-list
64735765|NCT01978236|Dabrafenib|dabrafenib|mesh-list
64735766|NCT01978236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735767|NCT01978236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64735768|NCT01978236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735769|NCT01978236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735770|NCT01934790|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64735771|NCT01934790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735772|NCT01934556|Ranibizumab|ranibizumab|mesh-list
64735773|NCT01934556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64735774|NCT01934556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64735775|NCT01934556|Growth Substances|growth substances|mesh-ancestor
64735776|NCT01934556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735777|NCT01934556|Growth Inhibitors|growth inhibitors|mesh-ancestor
64735778|NCT01934556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735779|NCT04411212|Lenograstim|lenograstim|mesh-list
64735780|NCT04411212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64515185|NCT03583528|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64515187|NCT03583528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64515188|NCT03583528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515189|NCT02180724|Acalabrutinib|acalabrutinib|mesh-list
64515190|NCT02180724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515191|NCT01949337|Prednisone|prednisone|mesh-list
64516175|NCT02069704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516720|NCT03269916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64516722|NCT02346916|Capsaicin|capsaicin|mesh-list
64516723|NCT02346916|Antipruritics|antipruritics|mesh-ancestor
64516724|NCT02346916|Dermatologic Agents|dermatologic agents|mesh-ancestor
64516725|NCT02346916|Sensory System Agents|sensory system agents|mesh-ancestor
64516776|NCT05075460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516777|NCT05075460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516778|NCT05075460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64516779|NCT01966978|Insulin|insulin|mesh-list
64516780|NCT01966978|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64516781|NCT01966978|Metformin|metformin|mesh-list
64516783|NCT01966978|Insulin, Long-Acting|insulin, long-acting|mesh-list
64518902|NCT01747499|Antimetabolites|antimetabolites|mesh-ancestor
64518903|NCT01747499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518904|NCT01747499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518905|NCT01747499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518907|NCT00071721|Anticonvulsants|anticonvulsants|mesh-ancestor
64518908|NCT00071721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518909|NCT00071721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518910|NCT00071721|GABA Agents|gaba agents|mesh-ancestor
64518911|NCT00071721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64519390|NCT00082017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519391|NCT00082329|Plerixafor|plerixafor|mesh-list
64519392|NCT00082329|Lenograstim|lenograstim|mesh-list
64519393|NCT00082329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64519394|NCT00082329|Immunologic Factors|immunologic factors|mesh-ancestor
64519395|NCT00082329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519396|NCT00082329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64519397|NCT00082329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64519398|NCT00082329|Antiviral Agents|antiviral agents|mesh-ancestor
64519399|NCT00082329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64519400|NCT02451462|Zoledronic Acid|zoledronic acid|mesh-list
64519401|NCT02451462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64519402|NCT02451462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519403|NCT03207204|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64519404|NCT03207204|Carbamide Peroxide|carbamide peroxide|mesh-list
64519405|NCT03207204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64519406|NCT03207204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64519407|NCT02451306|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64519408|NCT02451306|Antidepressive Agents|antidepressive agents|mesh-ancestor
64519435|NCT03220152|Tenofovir|tenofovir|mesh-list
64989312|NCT05830630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989313|NCT05830630|Sensory System Agents|sensory system agents|mesh-ancestor
64989314|NCT05830630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64989315|NCT05830630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64989316|NCT05830630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989317|NCT05830604|Salicylic Acid|salicylic acid|mesh-list
64989318|NCT05830604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64519765|NCT02404168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64519766|NCT02404168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64519767|NCT02404168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64519768|NCT02404168|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64519769|NCT04733937|Caseins|caseins|mesh-list
64519770|NCT04733937|Chelating Agents|chelating agents|mesh-ancestor
64519771|NCT04733937|Sequestering Agents|sequestering agents|mesh-ancestor
64989364|NCT05830071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520469|NCT03208764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64520470|NCT03208764|Antioxidants|antioxidants|mesh-ancestor
64520471|NCT03208764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521212|NCT02445066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521213|NCT02445066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64521214|NCT02445066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64521215|NCT03197298|Clopidogrel|clopidogrel|mesh-list
64521216|NCT03197298|Ticagrelor|ticagrelor|mesh-list
64521217|NCT03197298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64521218|NCT03197298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64521219|NCT03197298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64521220|NCT03197298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64521221|NCT03197298|Purinergic Agents|purinergic agents|mesh-ancestor
64521222|NCT03197298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64521224|NCT03197298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521637|NCT00030147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64521638|NCT00030147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64521661|NCT03833596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64521662|NCT03833596|Glucocorticoids|glucocorticoids|mesh-ancestor
64521663|NCT03833596|Hormones|hormones|mesh-ancestor
64521664|NCT03833596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64521665|NCT03833596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521666|NCT03833596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64521667|NCT03833596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521668|NCT02831998|Ethanol|ethanol|mesh-list
64521669|NCT02831998|Chlorhexidine|chlorhexidine|mesh-list
64521670|NCT02831998|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64521671|NCT02831998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64521672|NCT02831998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64521673|NCT02831998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64521674|NCT02831998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521675|NCT02831998|Disinfectants|disinfectants|mesh-ancestor
64521676|NCT02831998|Dermatologic Agents|dermatologic agents|mesh-ancestor
64521677|NCT02434614|Cisplatin|cisplatin|mesh-list
64521678|NCT02434614|Docetaxel|docetaxel|mesh-list
64521679|NCT02434614|Fluorouracil|fluorouracil|mesh-list
64521680|NCT02434614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521690|NCT05720260|Durvalumab|durvalumab|mesh-list
64521711|NCT04483674|Emtricitabine|emtricitabine|mesh-list
64521712|NCT04483674|Antiviral Agents|antiviral agents|mesh-ancestor
64521713|NCT04483674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64471678|NCT04267887|Protective Agents|protective agents|mesh-ancestor
64471679|NCT04267887|Vitamins|vitamins|mesh-ancestor
64521714|NCT04483674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64521715|NCT04483674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64521716|NCT04483674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521717|NCT04483674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521718|NCT04483674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64521719|NCT04483674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64521720|NCT02438982|Rituximab|rituximab|mesh-list
64521721|NCT02438982|Tacrolimus|tacrolimus|mesh-list
64521722|NCT02438982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
64521723|NCT02438982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64521724|NCT02438982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521725|NCT02438982|Immunologic Factors|immunologic factors|mesh-ancestor
64521726|NCT02438982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521727|NCT02438982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64521728|NCT02438982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64521852|NCT05718544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521853|NCT05718544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64521854|NCT05718544|Narcotics|narcotics|mesh-ancestor
64521855|NCT05718544|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64521856|NCT05718544|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64521857|NCT05718544|Anesthetics, General|anesthetics, general|mesh-ancestor
64521858|NCT05718544|Anesthetics|anesthetics|mesh-ancestor
64521859|NCT05718544|Antidepressive Agents|antidepressive agents|mesh-ancestor
64521860|NCT05718544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64521861|NCT05616598|Ribavirin|ribavirin|mesh-list
64521862|NCT05616598|Sofosbuvir|sofosbuvir|mesh-list
64521863|NCT05616598|Simeprevir|simeprevir|mesh-list
64521864|NCT05616598|Antimetabolites|antimetabolites|mesh-ancestor
64521865|NCT05616598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521866|NCT05616598|Antiviral Agents|antiviral agents|mesh-ancestor
64521867|NCT05616598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64521868|NCT05616598|Protease Inhibitors|protease inhibitors|mesh-ancestor
64521869|NCT05616598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521870|NCT03187392|Lidocaine|lidocaine|mesh-list
64521871|NCT03187392|Anesthetics, Local|anesthetics, local|mesh-ancestor
64521872|NCT03187392|Anesthetics|anesthetics|mesh-ancestor
64521873|NCT03187392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64521874|NCT03187392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471680|NCT04267887|Micronutrients|micronutrients|mesh-ancestor
64471681|NCT04267887|Estrogens|estrogens|mesh-ancestor
64521875|NCT03187392|Sensory System Agents|sensory system agents|mesh-ancestor
64521876|NCT03187392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64523190|NCT01704287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64523481|NCT02061514|Anesthetics|anesthetics|mesh-ancestor
64523500|NCT01681433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523825|NCT02414568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523826|NCT02414568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64523827|NCT02414568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64523828|NCT02414568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523829|NCT02414568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523830|NCT02414568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64523832|NCT02414568|Hormones|hormones|mesh-ancestor
64523833|NCT02414568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64523834|NCT02414568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523835|NCT02414568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64523836|NCT02414568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64523837|NCT02414568|Alkylating Agents|alkylating agents|mesh-ancestor
64523838|NCT02414568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64523839|NCT02414568|Tubulin Modulators|tubulin modulators|mesh-ancestor
64523840|NCT02414568|Antimitotic Agents|antimitotic agents|mesh-ancestor
64523841|NCT02414568|Mitosis Modulators|mitosis modulators|mesh-ancestor
64523842|NCT04348877|Antibodies|antibodies|mesh-list
64523843|NCT04348877|Immunologic Factors|immunologic factors|mesh-ancestor
64523844|NCT04348877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523845|NCT03176628|Niacinamide|niacinamide|mesh-list
64523846|NCT03176628|Vitamin B Complex|vitamin b complex|mesh-ancestor
64523847|NCT03176628|Vitamins|vitamins|mesh-ancestor
64523848|NCT03176628|Micronutrients|micronutrients|mesh-ancestor
64523849|NCT03176628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523850|NCT02414490|Immunoglobulins|immunoglobulins|mesh-list
64523851|NCT02414490|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64523852|NCT02414490|Antibodies|antibodies|mesh-list
64523853|NCT02414490|gamma-Globulins|gamma-globulins|mesh-list
64523854|NCT02414490|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64523870|NCT03178500|Fertility Agents|fertility agents|mesh-ancestor
64523871|NCT03178500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64523872|NCT03178500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64523873|NCT03178500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64523874|NCT01700387|Topiramate|topiramate|mesh-list
64523875|NCT01700387|Botulinum Toxins|botulinum toxins|mesh-list
64523876|NCT01700387|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64523877|NCT01700387|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64523878|NCT01700387|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64523879|NCT01700387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64523880|NCT01700387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523881|NCT01700387|Cholinergic Agents|cholinergic agents|mesh-ancestor
64523882|NCT01700387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64523883|NCT01700387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523884|NCT01700387|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64523885|NCT01700387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64523886|NCT01700387|Anticonvulsants|anticonvulsants|mesh-ancestor
64523887|NCT01700387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64526749|NCT04103476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64526750|NCT04103476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526751|NCT04103476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64526752|NCT04103476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64526753|NCT04103476|Hormone Antagonists|hormone antagonists|mesh-ancestor
64526754|NCT04103476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64526755|NCT01566149|Mometasone Furoate|mometasone furoate|mesh-list
64526756|NCT01566149|Formoterol Fumarate|formoterol fumarate|mesh-list
64526757|NCT01566149|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
64526758|NCT01566149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64526759|NCT01566149|Autonomic Agents|autonomic agents|mesh-ancestor
64526760|NCT01566149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526761|NCT01566149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526762|NCT01566149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64526763|NCT01566149|Respiratory System Agents|respiratory system agents|mesh-ancestor
64526764|NCT01566149|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64526765|NCT01566149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64528306|NCT00130923|Dopamine Agents|dopamine agents|mesh-ancestor
64528307|NCT04117581|Vitamin D|vitamin d|mesh-list
64528308|NCT04117581|Cholecalciferol|cholecalciferol|mesh-list
64528309|NCT04117581|Vitamins|vitamins|mesh-ancestor
64528310|NCT04117581|Micronutrients|micronutrients|mesh-ancestor
64528311|NCT04117581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528312|NCT04117581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64528313|NCT04117581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64528314|NCT00272337|Aspirin|aspirin|mesh-list
64484422|NCT01709084|Emtricitabine|emtricitabine|mesh-list
64528315|NCT00272337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64528316|NCT00272337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64528317|NCT00272337|Analgesics|analgesics|mesh-ancestor
64528329|NCT00272337|Antipyretics|antipyretics|mesh-ancestor
64528395|NCT01578499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64528396|NCT01578499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64528397|NCT01578499|Immunologic Factors|immunologic factors|mesh-ancestor
64528398|NCT01578499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64528525|NCT02387892|Micronutrients|micronutrients|mesh-ancestor
64528526|NCT02387892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528527|NCT02387892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64528528|NCT02387892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64528529|NCT01664910|Rituximab|rituximab|mesh-list
64528530|NCT01664910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64528531|NCT01664910|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
64528532|NCT01664910|Methotrexate|methotrexate|mesh-list
64528533|NCT01664910|Fludarabine|fludarabine|mesh-list
64528534|NCT01664910|Fludarabine phosphate|fludarabine phosphate|mesh-list
64528535|NCT01664910|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64528536|NCT01664910|Antibodies|antibodies|mesh-list
64528537|NCT01664910|Immunoglobulins|immunoglobulins|mesh-list
64528538|NCT01664910|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64528540|NCT01664910|Thymoglobulin|thymoglobulin|mesh-list
64528541|NCT01664910|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64528542|NCT01664910|Immunologic Factors|immunologic factors|mesh-ancestor
64528543|NCT01664910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528544|NCT01664910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528545|NCT01664910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64528546|NCT01664910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64528547|NCT01664910|Abortifacient Agents|abortifacient agents|mesh-ancestor
64528548|NCT01664910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64528561|NCT00133575|Vaccines|vaccines|mesh-list
64528568|NCT00134043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528569|NCT03715998|Ramipril|ramipril|mesh-list
64528570|NCT03715998|Firibastat|firibastat|mesh-list
64528571|NCT03715998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64528572|NCT03715998|Protease Inhibitors|protease inhibitors|mesh-ancestor
64528573|NCT03715998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528574|NCT03715998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528575|NCT03715998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64528576|NCT01790529|Metronidazole|metronidazole|mesh-list
64528577|NCT01790529|Cefuroxime|cefuroxime|mesh-list
64528578|NCT01790529|Cefuroxime axetil|cefuroxime axetil|mesh-list
64528579|NCT01790529|Anesthetics|anesthetics|mesh-list
64528580|NCT01790529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64528581|NCT01790529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528582|NCT01790529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64528583|NCT01790529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64528584|NCT01790529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64529185|NCT02381184|Clomiphene|clomiphene|mesh-list
64529186|NCT02381184|Enclomiphene|enclomiphene|mesh-list
64529187|NCT02381184|Zuclomiphene|zuclomiphene|mesh-list
64529188|NCT02381184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64529189|NCT02381184|Hormone Antagonists|hormone antagonists|mesh-ancestor
64529190|NCT02381184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64530126|NCT05799924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64530241|NCT05798819|Tubulin Modulators|tubulin modulators|mesh-ancestor
64530242|NCT05798819|Antimitotic Agents|antimitotic agents|mesh-ancestor
64530243|NCT05798819|Mitosis Modulators|mitosis modulators|mesh-ancestor
64530244|NCT05798819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530701|NCT05327023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64530702|NCT05327023|Immunologic Factors|immunologic factors|mesh-ancestor
64530703|NCT05327023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530704|NCT05327023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64530705|NCT05327023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64530706|NCT05327023|Alkylating Agents|alkylating agents|mesh-ancestor
64530707|NCT05327023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530708|NCT05327023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530709|NCT05327023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64530710|NCT05327023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64530711|NCT05327023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64530712|NCT05327023|Antitubercular Agents|antitubercular agents|mesh-ancestor
64530713|NCT05327023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64530714|NCT05327023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64530764|NCT05252416|Hormone Antagonists|hormone antagonists|mesh-ancestor
64530765|NCT05252416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64530766|NCT05252416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530768|NCT05233228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64530769|NCT05233228|Autonomic Agents|autonomic agents|mesh-ancestor
64530770|NCT05233228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64530771|NCT05233228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530772|NCT05233228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64530773|NCT05233228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64530774|NCT05233228|Cholinergic Agents|cholinergic agents|mesh-ancestor
64530775|NCT05233228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64530776|NCT05233228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530778|NCT05221554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64530779|NCT05221554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530780|NCT05221554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530781|NCT05221554|Cholinergic Agents|cholinergic agents|mesh-ancestor
64530782|NCT05221554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64530783|NCT05221554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530784|NCT05221554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64530785|NCT05221554|Autonomic Agents|autonomic agents|mesh-ancestor
64530786|NCT05221554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64530787|NCT05221554|Nootropic Agents|nootropic agents|mesh-ancestor
64530788|NCT05218733|Fentanyl|fentanyl|mesh-list
64530789|NCT05218733|Morphine|morphine|mesh-list
64530790|NCT05218733|Anesthetics|anesthetics|mesh-ancestor
64530791|NCT05218733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64530792|NCT05218733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530793|NCT05218733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64530794|NCT05218733|Narcotics|narcotics|mesh-ancestor
64530795|NCT05218733|Analgesics|analgesics|mesh-ancestor
64530796|NCT05218733|Sensory System Agents|sensory system agents|mesh-ancestor
64530797|NCT05218733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64530798|NCT05218733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64989947|NCT05581589|Irinotecan|irinotecan|mesh-list
64532460|NCT02372292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532461|NCT01554241|Vitamin D|vitamin d|mesh-list
64532462|NCT01554241|Cholecalciferol|cholecalciferol|mesh-list
64532464|NCT01554241|Micronutrients|micronutrients|mesh-ancestor
64532465|NCT01554241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532466|NCT01554241|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64532467|NCT01554241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64532468|NCT02353026|Artesunate|artesunate|mesh-list
64532469|NCT02353026|Antimalarials|antimalarials|mesh-ancestor
64532470|NCT02353026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64471685|NCT04266730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471686|NCT04251533|Paclitaxel|paclitaxel|mesh-list
64532471|NCT02353026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64532472|NCT02353026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64532473|NCT02353026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532474|NCT02353026|Antiviral Agents|antiviral agents|mesh-ancestor
64532475|NCT02353026|Schistosomicides|schistosomicides|mesh-ancestor
64532476|NCT02353026|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64532477|NCT02353026|Anthelmintics|anthelmintics|mesh-ancestor
64532478|NCT01521559|Aflibercept|aflibercept|mesh-list
64532479|NCT01521559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64532480|NCT01521559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64532481|NCT01521559|Growth Substances|growth substances|mesh-ancestor
64532482|NCT01521559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532483|NCT01521559|Growth Inhibitors|growth inhibitors|mesh-ancestor
64532484|NCT01521559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532485|NCT04438980|Methylprednisolone|methylprednisolone|mesh-list
64532508|NCT03824847|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64532509|NCT03824847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532510|NCT03824847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532511|NCT03824847|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64532512|NCT03824847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64532513|NCT01554163|Celecoxib|celecoxib|mesh-list
64532514|NCT01554163|Etoricoxib|etoricoxib|mesh-list
64532515|NCT01554163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64532516|NCT01554163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64532517|NCT01554163|Analgesics|analgesics|mesh-ancestor
64532518|NCT01554163|Sensory System Agents|sensory system agents|mesh-ancestor
64532519|NCT01554163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64532520|NCT01554163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532521|NCT01554163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64532522|NCT01554163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64532523|NCT01554163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64532524|NCT01554163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64532525|NCT01554163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297025|NCT03103568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64533101|NCT02353182|Analgesics|analgesics|mesh-ancestor
64533102|NCT02353182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64533103|NCT02353182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64533104|NCT02353182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64533105|NCT02353182|Adrenergic Agents|adrenergic agents|mesh-ancestor
64533106|NCT02353182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64533107|NCT02353182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533108|NCT02353182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64533317|NCT01489891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533318|NCT01489891|Sensory System Agents|sensory system agents|mesh-ancestor
64533662|NCT02338674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64533663|NCT02338674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64533664|NCT02338674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64533665|NCT02338674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533666|NCT02338674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533667|NCT02338674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64533668|NCT02338674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64533669|NCT02338518|Oxaliplatin|oxaliplatin|mesh-list
64533670|NCT02338518|Etoposide|etoposide|mesh-list
64533671|NCT02338518|Epirubicin|epirubicin|mesh-list
64533672|NCT02338518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533673|NCT02338518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64533674|NCT02338518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64533723|NCT00401817|Growth Substances|growth substances|mesh-ancestor
64533724|NCT00401817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533725|NCT00401817|Growth Inhibitors|growth inhibitors|mesh-ancestor
64533726|NCT00401817|Immunologic Factors|immunologic factors|mesh-ancestor
64533727|NCT00401817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64533728|NCT04417179|Bupivacaine|bupivacaine|mesh-list
64534471|NCT01491737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64534472|NCT01491737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534473|NCT01491737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64534474|NCT01491737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534475|NCT01491737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299031|NCT04434482|Temozolomide|temozolomide|mesh-list
64534572|NCT01491035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64534573|NCT01491035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64534574|NCT01491035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64534575|NCT01491035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535322|NCT00461331|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64535324|NCT00461331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64535325|NCT00461331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535326|NCT00531453|Thalidomide|thalidomide|mesh-list
64535327|NCT00531453|Dexamethasone|dexamethasone|mesh-list
64535328|NCT00531453|Dexamethasone acetate|dexamethasone acetate|mesh-list
64535682|NCT00538863|Fentanyl|fentanyl|mesh-list
64535683|NCT00538863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64535684|NCT00538863|Narcotics|narcotics|mesh-ancestor
64535685|NCT00538863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64535686|NCT00538863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535687|NCT00538863|Analgesics|analgesics|mesh-ancestor
64535688|NCT00538863|Sensory System Agents|sensory system agents|mesh-ancestor
64535689|NCT00538863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64535690|NCT00538863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64535691|NCT00538863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64535767|NCT01563536|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64535815|NCT03022773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535816|NCT03022773|Protective Agents|protective agents|mesh-ancestor
64535817|NCT03022773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535819|NCT02954991|Mocetinostat|mocetinostat|mesh-list
64535820|NCT02954991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64535821|NCT02954991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535822|NCT02954991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64535823|NCT02954991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535824|NCT02954991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64535827|NCT02892591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64535828|NCT02892591|Narcotics|narcotics|mesh-ancestor
64535881|NCT00471705|Meglumine Antimoniate|meglumine antimoniate|mesh-list
64535882|NCT00471705|Antifungal Agents|antifungal agents|mesh-ancestor
64535883|NCT00471705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64535884|NCT00471705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535885|NCT00471705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64535886|NCT00471705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64535887|NCT00472797|Interferon beta-1a|interferon beta-1a|mesh-list
64535888|NCT00472797|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64535889|NCT00472797|Immunologic Factors|immunologic factors|mesh-ancestor
64535890|NCT00472797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535892|NCT00472797|Antiviral Agents|antiviral agents|mesh-ancestor
64536175|NCT04082767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64536176|NCT04082767|Analgesics|analgesics|mesh-ancestor
64536177|NCT04082767|Sensory System Agents|sensory system agents|mesh-ancestor
64536178|NCT04082767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64536179|NCT04082767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64536180|NCT04082767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64536181|NCT04082767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64536182|NCT04082767|Adrenergic Agents|adrenergic agents|mesh-ancestor
64536183|NCT04082767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64536184|NCT04082767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536185|NCT04082767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64536218|NCT00553839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536219|NCT00553839|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64536220|NCT00553839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64536221|NCT00553839|Anesthetics, General|anesthetics, general|mesh-ancestor
64536223|NCT00553839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64536224|NCT00553839|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64536225|NCT00553839|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64536226|NCT00553839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64536551|NCT01584440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536552|NCT01584440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536553|NCT01584440|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64536554|NCT01584440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64536555|NCT01584440|Adrenergic Agents|adrenergic agents|mesh-ancestor
64536556|NCT01584440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64536557|NCT01584440|Antimalarials|antimalarials|mesh-ancestor
64536558|NCT01584440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64537385|NCT01798017|Misoprostol|misoprostol|mesh-list
64537386|NCT01798017|Mifepristone|mifepristone|mesh-list
64537387|NCT01798017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64537388|NCT01798017|Abortifacient Agents|abortifacient agents|mesh-ancestor
64537389|NCT01798017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64537390|NCT01798017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537391|NCT01798017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64537392|NCT01798017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64537393|NCT01798017|Oxytocics|oxytocics|mesh-ancestor
64537394|NCT01798017|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64537395|NCT01798017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64537396|NCT01798017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64537406|NCT00502905|Fludarabine|fludarabine|mesh-list
64538745|NCT00627861|Sympatholytics|sympatholytics|mesh-ancestor
64538746|NCT00627861|Autonomic Agents|autonomic agents|mesh-ancestor
64538838|NCT04105946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64538839|NCT04105946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64538840|NCT04105946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64538842|NCT04105946|Adrenergic Agents|adrenergic agents|mesh-ancestor
64538843|NCT04105946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64538844|NCT04105946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538845|NCT04105946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64538847|NCT01440569|Darunavir|darunavir|mesh-list
64538848|NCT01440569|Cobicistat|cobicistat|mesh-list
64303526|NCT02253199|Analgesics|analgesics|mesh-ancestor
64538876|NCT00629499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64538877|NCT00631449|Raltegravir Potassium|raltegravir potassium|mesh-list
64539177|NCT01437995|Xhance|xhance|mesh-list
64990470|NCT05216250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64990471|NCT05216250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64539249|NCT00588159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539250|NCT00588159|Anticonvulsants|anticonvulsants|mesh-ancestor
64539251|NCT00588159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64539252|NCT00588159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64539253|NCT00588159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64539254|NCT00588159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64539256|NCT00588159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64539327|NCT00589563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64539328|NCT00589563|Alkylating Agents|alkylating agents|mesh-ancestor
64539329|NCT00589563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539330|NCT00589563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64539331|NCT00589563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64539332|NCT00589563|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64539347|NCT00589563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64539348|NCT00589563|Antifungal Agents|antifungal agents|mesh-ancestor
64539349|NCT00645333|Docetaxel|docetaxel|mesh-list
64539350|NCT00645333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64539351|NCT00645333|Tubulin Modulators|tubulin modulators|mesh-ancestor
64539352|NCT00645333|Antimitotic Agents|antimitotic agents|mesh-ancestor
64539353|NCT00645333|Mitosis Modulators|mitosis modulators|mesh-ancestor
64539354|NCT00645333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539355|NCT00646581|Insulin|insulin|mesh-list
64539356|NCT00646581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64539357|NCT00646581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64539358|NCT00646581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539359|NCT00648375|Propranolol|propranolol|mesh-list
64539360|NCT00648375|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64539361|NCT00648375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64539362|NCT00648375|Adrenergic Agents|adrenergic agents|mesh-ancestor
64539363|NCT00648375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64539364|NCT00648375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539365|NCT00648375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539366|NCT00648375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64539367|NCT00648375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64539368|NCT00648375|Vasodilator Agents|vasodilator agents|mesh-ancestor
64539370|NCT00654069|Niacinamide|niacinamide|mesh-list
64539371|NCT00654069|Nicotinic Acids|nicotinic acids|mesh-list
64539372|NCT00654069|Oxycodone|oxycodone|mesh-list
64539373|NCT00654069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64539374|NCT00654069|Narcotics|narcotics|mesh-ancestor
64539375|NCT00654069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64951653|NCT00054834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951654|NCT00054873|Fluorouracil|fluorouracil|mesh-list
64490443|NCT03557385|Adenosine|adenosine|mesh-list
64503371|NCT05585346|Glucocorticoids|glucocorticoids|mesh-ancestor
64503372|NCT05585346|Hormones|hormones|mesh-ancestor
64951655|NCT00054873|Tezacitabine|tezacitabine|mesh-list
64951656|NCT00054873|Antimetabolites|antimetabolites|mesh-ancestor
64951657|NCT00054873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990572|NCT05141474|Sensory System Agents|sensory system agents|mesh-ancestor
64990573|NCT05141474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64990574|NCT05141474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64990575|NCT05141474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64990576|NCT05141474|Antiviral Agents|antiviral agents|mesh-ancestor
64539376|NCT00654069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539377|NCT00654069|Analgesics|analgesics|mesh-ancestor
64539378|NCT00654069|Sensory System Agents|sensory system agents|mesh-ancestor
64539379|NCT00654069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64539380|NCT00654069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64539381|NCT00654069|Antimetabolites|antimetabolites|mesh-ancestor
64539382|NCT00654069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539383|NCT00654069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64539384|NCT00654069|Vasodilator Agents|vasodilator agents|mesh-ancestor
64539385|NCT00654069|Vitamin B Complex|vitamin b complex|mesh-ancestor
64539386|NCT00654069|Vitamins|vitamins|mesh-ancestor
64539387|NCT00654069|Micronutrients|micronutrients|mesh-ancestor
64539388|NCT00654147|Ritonavir|ritonavir|mesh-list
64539389|NCT00654147|Lopinavir|lopinavir|mesh-list
64539390|NCT00654147|Tenofovir|tenofovir|mesh-list
64539435|NCT01418209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64539436|NCT01418209|Progestins|progestins|mesh-ancestor
64539437|NCT01418209|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64539438|NCT01418209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64539439|NCT01418209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64539440|NCT01418209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539441|NCT01418209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64539442|NCT01418209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64539443|NCT01418209|Antidepressive Agents|antidepressive agents|mesh-ancestor
64539444|NCT01418209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64539445|NCT00655473|Dalcetrapib|dalcetrapib|mesh-list
64539446|NCT00655473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64539447|NCT00655473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64539448|NCT00655473|Antimetabolites|antimetabolites|mesh-ancestor
64539449|NCT00655473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539450|NCT00655473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64990682|NCT05037032|Naltrexone|naltrexone|mesh-list
64990683|NCT05037032|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64990684|NCT05037032|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64539499|NCT01436201|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64539500|NCT01436201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539501|NCT01436201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539502|NCT01436201|Protective Agents|protective agents|mesh-ancestor
64539503|NCT01436201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539576|NCT01436305|Hormones|hormones|mesh-ancestor
64539577|NCT01436305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64484454|NCT01727713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64539578|NCT01436305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64539579|NCT01436305|Protective Agents|protective agents|mesh-ancestor
64539580|NCT01436305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64539581|NCT01436305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64539582|NCT01436305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64539584|NCT04069273|Pembrolizumab|pembrolizumab|mesh-list
64539585|NCT04069273|Ramucirumab|ramucirumab|mesh-list
64539586|NCT04069273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64539587|NCT04069273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64539588|NCT04069273|Tubulin Modulators|tubulin modulators|mesh-ancestor
64539589|NCT04069273|Antimitotic Agents|antimitotic agents|mesh-ancestor
64539590|NCT04069273|Mitosis Modulators|mitosis modulators|mesh-ancestor
64539591|NCT04069273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304282|NCT05357612|Pimavanserin|pimavanserin|mesh-list
64539626|NCT04049851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64539627|NCT04049851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64539628|NCT04049851|Anthelmintics|anthelmintics|mesh-ancestor
64539629|NCT04049851|Antinematodal Agents|antinematodal agents|mesh-ancestor
64539630|NCT01414855|Prednisone|prednisone|mesh-list
64540192|NCT01430455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540193|NCT01430455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64540194|NCT01430455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64540195|NCT01430455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64540196|NCT01430455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540197|NCT04051957|Isosorbide|isosorbide|mesh-list
64540198|NCT04051957|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64540199|NCT04051957|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64540200|NCT04051957|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64540201|NCT04051957|Diuretics|diuretics|mesh-ancestor
64540202|NCT04051957|Natriuretic Agents|natriuretic agents|mesh-ancestor
64540203|NCT04051957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540210|NCT05084196|Protective Agents|protective agents|mesh-ancestor
64540211|NCT05084196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540212|NCT05084196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64540213|NCT00591123|Leucovorin|leucovorin|mesh-list
64540214|NCT00591123|Fluorouracil|fluorouracil|mesh-list
64540215|NCT00591123|Oxaliplatin|oxaliplatin|mesh-list
64540216|NCT00591123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64540217|NCT00591123|Levoleucovorin|levoleucovorin|mesh-list
64540218|NCT00591123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540219|NCT00591123|Antimetabolites|antimetabolites|mesh-ancestor
64540220|NCT00591123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540221|NCT00591123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64540222|NCT00591123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540223|NCT00591123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64540224|NCT00591123|Immunologic Factors|immunologic factors|mesh-ancestor
64540225|NCT00591123|Antidotes|antidotes|mesh-ancestor
64540226|NCT00591123|Protective Agents|protective agents|mesh-ancestor
64540227|NCT00591123|Vitamin B Complex|vitamin b complex|mesh-ancestor
64540228|NCT00591123|Vitamins|vitamins|mesh-ancestor
64540229|NCT00591123|Micronutrients|micronutrients|mesh-ancestor
64540633|NCT01411085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64540634|NCT01411085|Serotonin Agents|serotonin agents|mesh-ancestor
64540635|NCT01411085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64540636|NCT01411085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540637|NCT01411085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540705|NCT02998437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64540706|NCT02998437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64540707|NCT02618148|Estrogens|estrogens|mesh-list
64540708|NCT02618148|Hormones|hormones|mesh-ancestor
64540709|NCT02618148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64540710|NCT02618148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540711|NCT04680936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64540712|NCT01404325|Everolimus|everolimus|mesh-list
64540747|NCT04655586|Protein C|protein c|mesh-list
64540748|NCT04655586|Anticoagulants|anticoagulants|mesh-list
64540749|NCT04655586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64540750|NCT04655586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64305499|NCT03063866|GABA Agents|gaba agents|mesh-ancestor
64540783|NCT03110640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64540784|NCT03110640|Immunologic Factors|immunologic factors|mesh-ancestor
64540785|NCT03110640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540786|NCT03110640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64540787|NCT03110640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64540788|NCT03110640|Alkylating Agents|alkylating agents|mesh-ancestor
64540789|NCT03110640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540823|NCT04351230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540876|NCT00691665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64540877|NCT00691665|Autonomic Agents|autonomic agents|mesh-ancestor
64540914|NCT03025477|Cisplatin|cisplatin|mesh-list
64540915|NCT03025477|Carboplatin|carboplatin|mesh-list
64540916|NCT03025477|Epirubicin|epirubicin|mesh-list
64540961|NCT04041973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64540962|NCT04041973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64540963|NCT04041973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64540964|NCT00713817|Nabiximols|nabiximols|mesh-list
64540965|NCT00713817|Analgesics|analgesics|mesh-ancestor
64540966|NCT00713817|Sensory System Agents|sensory system agents|mesh-ancestor
64540967|NCT00713817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64540968|NCT00713817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540969|NCT02914470|Atezolizumab|atezolizumab|mesh-list
64540970|NCT02914470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540971|NCT05088330|Daratumumab|daratumumab|mesh-list
64540972|NCT05088330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540973|NCT00695097|Rituximab|rituximab|mesh-list
64540974|NCT00695097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64305701|NCT03561935|Propafenone|propafenone|mesh-list
64541045|NCT00695409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64541046|NCT00695409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541047|NCT00695409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541141|NCT05086614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64541142|NCT05086614|Immunologic Factors|immunologic factors|mesh-ancestor
64541143|NCT05086614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541144|NCT01795131|Vitamin B 12|vitamin b 12|mesh-list
64541145|NCT01795131|Hydroxocobalamin|hydroxocobalamin|mesh-list
64541146|NCT01795131|Vitamins|vitamins|mesh-ancestor
64541169|NCT03113994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64541170|NCT03113994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64541201|NCT02339415|Protease Inhibitors|protease inhibitors|mesh-ancestor
64541202|NCT02339415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541203|NCT02339415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541205|NCT02998047|Lintuzumab|lintuzumab|mesh-list
64541206|NCT02998047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64541207|NCT02998047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541208|NCT03110172|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64305953|NCT02055131|Antipyretics|antipyretics|mesh-ancestor
64541487|NCT04335084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541488|NCT04335084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64541489|NCT04335084|Antimalarials|antimalarials|mesh-ancestor
64541490|NCT04335084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64541491|NCT04335084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64541492|NCT04335084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541493|NCT04335084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541494|NCT04335084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541495|NCT04335084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64541496|NCT02996019|Etrolizumab|etrolizumab|mesh-list
64541497|NCT02996019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64541498|NCT02996019|Immunologic Factors|immunologic factors|mesh-ancestor
64541521|NCT02998827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541522|NCT02998827|Antimetabolites|antimetabolites|mesh-ancestor
64541523|NCT02998827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541524|NCT02998827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64541525|NCT02995707|Thalidomide|thalidomide|mesh-list
64541841|NCT01395901|Palonosetron|palonosetron|mesh-list
64541842|NCT01395901|Antiemetics|antiemetics|mesh-ancestor
64541843|NCT01395901|Autonomic Agents|autonomic agents|mesh-ancestor
64541844|NCT01395901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64541845|NCT01395901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541846|NCT01395901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64541847|NCT01395901|Antipruritics|antipruritics|mesh-ancestor
64541848|NCT01395901|Dermatologic Agents|dermatologic agents|mesh-ancestor
64541849|NCT01395901|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64541850|NCT01395901|Serotonin Agents|serotonin agents|mesh-ancestor
64541851|NCT01395901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64541853|NCT01395901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64542210|NCT05366101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64306948|NCT02071355|Protease Inhibitors|protease inhibitors|mesh-ancestor
64542335|NCT04088864|Cyclophosphamide|cyclophosphamide|mesh-list
64542336|NCT04088864|Fludarabine|fludarabine|mesh-list
64542337|NCT04088864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64542338|NCT04088864|Immunologic Factors|immunologic factors|mesh-ancestor
64542339|NCT04088864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542340|NCT04088864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64542341|NCT04088864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64542342|NCT04088864|Alkylating Agents|alkylating agents|mesh-ancestor
64542343|NCT04088864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542344|NCT04088864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542376|NCT03597997|Propofol|propofol|mesh-list
64542377|NCT03597997|Sevoflurane|sevoflurane|mesh-list
64542378|NCT03597997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64542379|NCT03597997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64542380|NCT03597997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542381|NCT03597997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64542382|NCT03597997|Anesthetics, General|anesthetics, general|mesh-ancestor
64542383|NCT03597997|Anesthetics|anesthetics|mesh-ancestor
64542384|NCT03597997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64542385|NCT03597997|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64542386|NCT01277835|Lidocaine|lidocaine|mesh-list
64542387|NCT01277835|Anesthetics, Local|anesthetics, local|mesh-ancestor
64542417|NCT04017013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64542418|NCT04017013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542420|NCT04017013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498532|NCT01275664|Serotonin Agents|serotonin agents|mesh-ancestor
64991166|NCT04685135|Adagrasib|adagrasib|mesh-list
64991167|NCT04685135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542561|NCT01278459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64542562|NCT01278459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542563|NCT00731055|Varenicline|varenicline|mesh-list
64542564|NCT00731055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64542565|NCT00731055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64542566|NCT00731055|Cholinergic Agents|cholinergic agents|mesh-ancestor
64542567|NCT00731055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64498688|NCT01376362|Interferons|interferons|mesh-list
64542568|NCT00731055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542569|NCT00731055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542570|NCT03594565|Fluticasone|fluticasone|mesh-list
64542572|NCT03594565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64542573|NCT03594565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64542574|NCT03594565|Autonomic Agents|autonomic agents|mesh-ancestor
64471699|NCT04233190|Autonomic Agents|autonomic agents|mesh-ancestor
64486687|NCT00879190|Gentamicins|gentamicins|mesh-list
64542575|NCT03594565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64542576|NCT03594565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542577|NCT03594565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64542578|NCT03594565|Respiratory System Agents|respiratory system agents|mesh-ancestor
64542580|NCT03594565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64542643|NCT01428713|Coagulants|coagulants|mesh-ancestor
64542648|NCT03976375|Pembrolizumab|pembrolizumab|mesh-list
64991228|NCT04616560|Trastuzumab|trastuzumab|mesh-list
64991229|NCT04616560|Camptothecin|camptothecin|mesh-list
64991230|NCT04616560|Immunoconjugates|immunoconjugates|mesh-list
64991231|NCT04616560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64991232|NCT04616560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991233|NCT04616560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64991234|NCT04616560|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64991235|NCT04616560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64991236|NCT04616560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991240|NCT04609046|Rituximab|rituximab|mesh-list
64542772|NCT03984097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543363|NCT04565574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543364|NCT04565574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64543365|NCT04565574|Antitubercular Agents|antitubercular agents|mesh-ancestor
64543366|NCT04565574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64543367|NCT04565574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64543368|NCT04565574|Leprostatic Agents|leprostatic agents|mesh-ancestor
64543369|NCT04565574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64543370|NCT04565574|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64543533|NCT01275105|Sympathomimetics|sympathomimetics|mesh-ancestor
64543740|NCT01279707|Veltuzumab|veltuzumab|mesh-list
64543741|NCT01279707|Antibodies|antibodies|mesh-list
64543742|NCT01279707|Immunoglobulins|immunoglobulins|mesh-list
64543743|NCT01279707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64543744|NCT01279707|Immunologic Factors|immunologic factors|mesh-ancestor
64543745|NCT01279707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543746|NCT01279707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543747|NCT02957292|Levonorgestrel|levonorgestrel|mesh-list
64543748|NCT02957292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64543749|NCT02957292|Contraceptive Agents|contraceptive agents|mesh-ancestor
64543750|NCT02957292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64543751|NCT02957292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543794|NCT03022123|Hormones|hormones|mesh-ancestor
64543885|NCT05100186|Antiemetics|antiemetics|mesh-ancestor
64543886|NCT05100186|Autonomic Agents|autonomic agents|mesh-ancestor
64499966|NCT01439854|Dapagliflozin|dapagliflozin|mesh-list
64486914|NCT03837886|Calcium|calcium|mesh-list
64543887|NCT05100186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64543888|NCT05100186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543889|NCT05100186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64543890|NCT05100186|Glucocorticoids|glucocorticoids|mesh-ancestor
64543891|NCT05100186|Hormones|hormones|mesh-ancestor
64543892|NCT05100186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64543893|NCT05100186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64543895|NCT04323462|Insulin|insulin|mesh-list
64544087|NCT04144933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64544088|NCT04144933|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64544122|NCT05087862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64544123|NCT05087862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544124|NCT05087862|Sensory System Agents|sensory system agents|mesh-ancestor
64544125|NCT05087862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64544126|NCT01519700|Lenograstim|lenograstim|mesh-list
64544127|NCT01519700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64544128|NCT01519700|Immunologic Factors|immunologic factors|mesh-ancestor
64544129|NCT01519700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486984|NCT03215056|Methoxyflurane|methoxyflurane|mesh-list
64544133|NCT04143685|Misoprostol|misoprostol|mesh-list
64544165|NCT05110482|Oxytocics|oxytocics|mesh-ancestor
64544166|NCT05110482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64991526|NCT04340843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991527|NCT04340843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991528|NCT04340843|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64991534|NCT04334941|Atezolizumab|atezolizumab|mesh-list
64991535|NCT04334941|Talazoparib|talazoparib|mesh-list
64544362|NCT03896737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64544363|NCT03896737|Protease Inhibitors|protease inhibitors|mesh-ancestor
64544364|NCT03896737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544365|NCT03896737|Leprostatic Agents|leprostatic agents|mesh-ancestor
64544366|NCT03896737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64544367|NCT03896737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544368|NCT03896737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64544369|NCT03896737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64544370|NCT03896737|Growth Substances|growth substances|mesh-ancestor
64544371|NCT03896737|Growth Inhibitors|growth inhibitors|mesh-ancestor
64544372|NCT04685772|Methylprednisolone|methylprednisolone|mesh-list
64544373|NCT04685772|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64544374|NCT04685772|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64544375|NCT04685772|Prednisolone|prednisolone|mesh-list
64544376|NCT04685772|Prednisolone acetate|prednisolone acetate|mesh-list
64544377|NCT04685772|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64544378|NCT04685772|Prednisolone phosphate|prednisolone phosphate|mesh-list
64544379|NCT04685772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64544381|NCT04685772|Autonomic Agents|autonomic agents|mesh-ancestor
64544463|NCT03912805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544464|NCT03912805|Cholinergic Agents|cholinergic agents|mesh-ancestor
64544465|NCT03912805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64544466|NCT03912805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544467|NCT03912805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64544468|NCT03912805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64544469|NCT03630055|Rivaroxaban|rivaroxaban|mesh-list
64544470|NCT03630055|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64544471|NCT03630055|Antithrombins|antithrombins|mesh-ancestor
64544472|NCT03630055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64544473|NCT03630055|Protease Inhibitors|protease inhibitors|mesh-ancestor
64544474|NCT03630055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544509|NCT04030182|Vitamin D|vitamin d|mesh-list
64544510|NCT04030182|Vitamins|vitamins|mesh-ancestor
64544632|NCT03588091|Mitosis Modulators|mitosis modulators|mesh-ancestor
64544633|NCT03588091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544634|NCT03588091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64544635|NCT05065554|Rituximab|rituximab|mesh-list
64544636|NCT05065554|Acalabrutinib|acalabrutinib|mesh-list
64544637|NCT05065554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64544638|NCT05065554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544639|NCT05065554|Immunologic Factors|immunologic factors|mesh-ancestor
64544640|NCT05065554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544641|NCT05065554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64544642|NCT04436172|Anesthetics|anesthetics|mesh-list
64484457|NCT01727713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64544847|NCT03020563|Anesthetics|anesthetics|mesh-ancestor
64544848|NCT03020563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64991698|NCT04216316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991699|NCT04216316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64991700|NCT04216290|Gemcitabine|gemcitabine|mesh-list
64544849|NCT03020563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544850|NCT03020563|Sensory System Agents|sensory system agents|mesh-ancestor
64544851|NCT03020563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64544852|NCT04591626|Insulin Glargine|insulin glargine|mesh-list
64544853|NCT04591626|Dulaglutide|dulaglutide|mesh-list
64544854|NCT04591626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64544855|NCT04591626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544856|NCT04518306|Amlodipine|amlodipine|mesh-list
64309630|NCT03194061|Cisplatin|cisplatin|mesh-list
64544889|NCT05701969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544890|NCT05701969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64544892|NCT03583255|Dexamethasone acetate|dexamethasone acetate|mesh-list
64544893|NCT03583255|Ichthammol|ichthammol|mesh-list
64544894|NCT03583255|BB 1101|bb 1101|mesh-list
64544895|NCT03583255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64544896|NCT03583255|Antiemetics|antiemetics|mesh-ancestor
64544897|NCT03583255|Autonomic Agents|autonomic agents|mesh-ancestor
64544898|NCT03583255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64544950|NCT03899467|Androgen Antagonists|androgen antagonists|mesh-ancestor
64544951|NCT03899467|Hormone Antagonists|hormone antagonists|mesh-ancestor
64544952|NCT05701813|Inositol|inositol|mesh-list
64544953|NCT05701813|Vitamin B Complex|vitamin b complex|mesh-ancestor
64544976|NCT03158389|Palbociclib|palbociclib|mesh-list
64544977|NCT03158389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544978|NCT03158389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64309751|NCT02439411|Trametinib|trametinib|mesh-list
64545013|NCT04405375|Autonomic Agents|autonomic agents|mesh-ancestor
64545014|NCT04405375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64545015|NCT04405375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545016|NCT04405375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64545017|NCT04405375|Glucocorticoids|glucocorticoids|mesh-ancestor
64501087|NCT01570348|Antimetabolites|antimetabolites|mesh-ancestor
64545018|NCT04405375|Hormones|hormones|mesh-ancestor
64545019|NCT04405375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64545047|NCT05701501|Micronutrients|micronutrients|mesh-ancestor
64545048|NCT05701501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545049|NCT05701501|Vitamin B Complex|vitamin b complex|mesh-ancestor
64545050|NCT03589495|Acetylcysteine|acetylcysteine|mesh-list
64545051|NCT03589495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64545052|NCT03589495|Antiviral Agents|antiviral agents|mesh-ancestor
64545053|NCT03589495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64545054|NCT03589495|Expectorants|expectorants|mesh-ancestor
64545055|NCT03589495|Respiratory System Agents|respiratory system agents|mesh-ancestor
64545056|NCT03589495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64545057|NCT03589495|Antioxidants|antioxidants|mesh-ancestor
64545058|NCT03589495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545059|NCT03589495|Protective Agents|protective agents|mesh-ancestor
64545061|NCT03589495|Antidotes|antidotes|mesh-ancestor
64545186|NCT05122338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545187|NCT05122338|Sensory System Agents|sensory system agents|mesh-ancestor
64545188|NCT05122338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64545189|NCT05122338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64545190|NCT05122338|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64545191|NCT05122338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64545215|NCT03589027|Antiviral Agents|antiviral agents|mesh-ancestor
64545216|NCT03589027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64545217|NCT03589027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64545218|NCT03589027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64545219|NCT03589027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64545220|NCT03589027|Contraceptive Agents|contraceptive agents|mesh-ancestor
64545221|NCT03589027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64545222|NCT03589027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545223|NCT03589027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64545349|NCT05120622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545350|NCT02895373|Alprostadil|alprostadil|mesh-list
64545351|NCT02895373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64545352|NCT02895373|Vasodilator Agents|vasodilator agents|mesh-ancestor
64545353|NCT02895373|Urological Agents|urological agents|mesh-ancestor
64545354|NCT05698771|Niacinamide|niacinamide|mesh-list
64545355|NCT05698771|Niacin|niacin|mesh-list
64545356|NCT05698771|Nicotinic Acids|nicotinic acids|mesh-list
64545357|NCT05698771|Vitamin B Complex|vitamin b complex|mesh-ancestor
64545358|NCT05698771|Vitamins|vitamins|mesh-ancestor
64545359|NCT05698771|Micronutrients|micronutrients|mesh-ancestor
64545444|NCT05119452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64545445|NCT05119452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545446|NCT05119452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64545447|NCT05119452|Immunologic Factors|immunologic factors|mesh-ancestor
64545448|NCT05119452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64545449|NCT05119452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545450|NCT05119452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545451|NCT05119452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64545453|NCT02788591|Omeprazole|omeprazole|mesh-list
64545454|NCT02788591|Pantoprazole|pantoprazole|mesh-list
64545455|NCT02788591|Lansoprazole|lansoprazole|mesh-list
64991905|NCT04092283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991906|NCT04092283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64991907|NCT04092283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64991908|NCT04092283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991909|NCT04092283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64991910|NCT04092283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64991911|NCT04092283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64991912|NCT04092283|Immunologic Factors|immunologic factors|mesh-ancestor
64991913|NCT04092283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545508|NCT02673996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64545509|NCT02673996|Mydriatics|mydriatics|mesh-ancestor
64545510|NCT02673996|Autonomic Agents|autonomic agents|mesh-ancestor
64545511|NCT02673996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64545512|NCT02673996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545711|NCT00698022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64545712|NCT00698022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64545713|NCT00698022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64545742|NCT02570503|Respiratory System Agents|respiratory system agents|mesh-ancestor
64545743|NCT02570503|Mydriatics|mydriatics|mesh-ancestor
64545744|NCT02570503|Sympathomimetics|sympathomimetics|mesh-ancestor
64545745|NCT02570503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64545746|NCT02570503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64545747|NCT02570503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64545748|NCT02570503|Analgesics|analgesics|mesh-ancestor
64545749|NCT02570503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64545750|NCT02570503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64545751|NCT02570503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64545752|NCT02570503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545753|NCT02570503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64545754|NCT02570503|Sympatholytics|sympatholytics|mesh-ancestor
64545755|NCT02570503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64545756|NCT02492269|Dexmedetomidine|dexmedetomidine|mesh-list
64545757|NCT02492269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64545758|NCT02492269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64310558|NCT02145559|Metformin|metformin|mesh-list
64545812|NCT05391061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545813|NCT05391061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545814|NCT03463525|Osimertinib|osimertinib|mesh-list
64545815|NCT03463525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545816|NCT03463525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64545817|NCT03463525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545859|NCT03243175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545860|NCT03243175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545861|NCT03243175|Anticoagulants|anticoagulants|mesh-ancestor
64545862|NCT04764955|Vitamin D|vitamin d|mesh-list
64545863|NCT04764955|Cholecalciferol|cholecalciferol|mesh-list
64545864|NCT04764955|Vitamins|vitamins|mesh-ancestor
64545865|NCT04764955|Micronutrients|micronutrients|mesh-ancestor
64545866|NCT04764955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545867|NCT04764955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64545868|NCT04764955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64545869|NCT03126331|Nivolumab|nivolumab|mesh-list
64545870|NCT03126331|Ipilimumab|ipilimumab|mesh-list
64545871|NCT03126331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64545872|NCT03126331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545905|NCT02646475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64545907|NCT02646475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545915|NCT01674283|Hormones|hormones|mesh-ancestor
64545916|NCT01674283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64545917|NCT01674283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545918|NCT04404517|Adalimumab|adalimumab|mesh-list
64545919|NCT04404517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64546045|NCT01403051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546046|NCT01403051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64546047|NCT03873337|Nicotine|nicotine|mesh-list
64546048|NCT03873337|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64546049|NCT03873337|Autonomic Agents|autonomic agents|mesh-ancestor
64546050|NCT03873337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64546051|NCT03873337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546052|NCT03873337|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64546053|NCT03873337|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64546054|NCT03873337|Cholinergic Agents|cholinergic agents|mesh-ancestor
64546055|NCT03873337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64546056|NCT03873337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546057|NCT03841357|Abatacept|abatacept|mesh-list
64546092|NCT03870919|Palbociclib|palbociclib|mesh-list
64546227|NCT03826693|Nitrous Oxide|nitrous oxide|mesh-list
64546228|NCT03826693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64546229|NCT03826693|Anesthetics, General|anesthetics, general|mesh-ancestor
64546230|NCT03826693|Anesthetics|anesthetics|mesh-ancestor
64546231|NCT03826693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64546232|NCT03826693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546233|NCT03826693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64546234|NCT03826693|Analgesics|analgesics|mesh-ancestor
64546299|NCT04827030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546301|NCT04827030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64546302|NCT03820141|Trastuzumab|trastuzumab|mesh-list
64546303|NCT03820141|Durvalumab|durvalumab|mesh-list
64546304|NCT03820141|Pertuzumab|pertuzumab|mesh-list
64546306|NCT03820141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546574|NCT02083861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546575|NCT02083861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546576|NCT02083861|Sympathomimetics|sympathomimetics|mesh-ancestor
64546577|NCT02083861|Autonomic Agents|autonomic agents|mesh-ancestor
64311374|NCT02089529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64546602|NCT03783715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546603|NCT03783715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64546604|NCT03783715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64546605|NCT03783715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64546606|NCT03783715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546607|NCT03783715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546609|NCT01279629|Calcipotriene|calcipotriene|mesh-list
64546610|NCT01279629|Dermatologic Agents|dermatologic agents|mesh-ancestor
64546611|NCT01279629|Keratolytic Agents|keratolytic agents|mesh-ancestor
64546612|NCT01274325|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64546613|NCT01274325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64546614|NCT01274325|Autonomic Agents|autonomic agents|mesh-ancestor
64546615|NCT01274325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64546616|NCT01274325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546617|NCT01274325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64546618|NCT01274325|Respiratory System Agents|respiratory system agents|mesh-ancestor
64546619|NCT01274325|Glucocorticoids|glucocorticoids|mesh-ancestor
64546620|NCT01274325|Hormones|hormones|mesh-ancestor
64546621|NCT01274325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64546622|NCT01274325|Sympathomimetics|sympathomimetics|mesh-ancestor
64546623|NCT04502394|Acalabrutinib|acalabrutinib|mesh-list
64546624|NCT04502394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546625|NCT01274403|Thalidomide|thalidomide|mesh-list
64546626|NCT01274403|Prednisone|prednisone|mesh-list
64546627|NCT01274403|Melphalan|melphalan|mesh-list
64546628|NCT01274403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64546721|NCT00754923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546722|NCT03696199|Anesthetics|anesthetics|mesh-list
64546723|NCT03696199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64546724|NCT03696199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546725|NCT00746421|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64546726|NCT00746421|Antidepressive Agents|antidepressive agents|mesh-ancestor
64546727|NCT00746421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64546728|NCT00746421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64546729|NCT00746421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64546730|NCT00746421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64546731|NCT00746421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546732|NCT02117076|Gabapentin|gabapentin|mesh-list
64546733|NCT02117076|Analgesics|analgesics|mesh-ancestor
64546734|NCT02117076|Sensory System Agents|sensory system agents|mesh-ancestor
64546735|NCT02117076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64311531|NCT00358163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64311585|NCT02093195|Bosentan|bosentan|mesh-list
64546799|NCT03600649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546800|NCT03600649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64546801|NCT03600649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64546802|NCT03600649|Alkylating Agents|alkylating agents|mesh-ancestor
64546803|NCT03600649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546804|NCT03600649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546903|NCT00005803|Antitubercular Agents|antitubercular agents|mesh-ancestor
64546904|NCT00005803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64546906|NCT00005803|Tubulin Modulators|tubulin modulators|mesh-ancestor
64546907|NCT00005803|Antimitotic Agents|antimitotic agents|mesh-ancestor
64546908|NCT00005803|Mitosis Modulators|mitosis modulators|mesh-ancestor
64546909|NCT00244725|Warfarin|warfarin|mesh-list
64546910|NCT00244725|Anticoagulants|anticoagulants|mesh-ancestor
64546911|NCT02649894|Silver Nitrate|silver nitrate|mesh-list
64546912|NCT02649894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64546913|NCT02649894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64546914|NCT04185012|Benralizumab|benralizumab|mesh-list
64546915|NCT04185012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64546916|NCT04185012|Respiratory System Agents|respiratory system agents|mesh-ancestor
64546917|NCT01275183|Raltegravir Potassium|raltegravir potassium|mesh-list
64546918|NCT01275183|Cisplatin|cisplatin|mesh-list
64546919|NCT01275183|Docetaxel|docetaxel|mesh-list
64546920|NCT01275183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546921|NCT01275183|Tubulin Modulators|tubulin modulators|mesh-ancestor
64546922|NCT01275183|Antimitotic Agents|antimitotic agents|mesh-ancestor
64546923|NCT01275183|Mitosis Modulators|mitosis modulators|mesh-ancestor
64546924|NCT01275183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546925|NCT01275183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64546926|NCT01275183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64546927|NCT01275183|Antiviral Agents|antiviral agents|mesh-ancestor
64546928|NCT01275183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64546929|NCT01275183|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64546930|NCT01275183|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64546931|NCT01275183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546932|NCT05126004|Acetylcysteine|acetylcysteine|mesh-list
64546933|NCT05126004|Azacitidine|azacitidine|mesh-list
64546934|NCT05126004|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64547024|NCT01275729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547028|NCT00243867|Paclitaxel|paclitaxel|mesh-list
64992325|NCT03866382|Nivolumab|nivolumab|mesh-list
64992326|NCT03866382|Ipilimumab|ipilimumab|mesh-list
64547038|NCT01679899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547039|NCT01679899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64547040|NCT01679899|Protease Inhibitors|protease inhibitors|mesh-ancestor
64547067|NCT00245037|Phenytoin|phenytoin|mesh-list
64547068|NCT00245037|Cyclosporins|cyclosporins|mesh-list
64547069|NCT00245037|Lenograstim|lenograstim|mesh-list
64547070|NCT00245037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64547071|NCT00245037|Abortifacient Agents|abortifacient agents|mesh-ancestor
64547072|NCT00245037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64547073|NCT00245037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547074|NCT00245037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64547075|NCT00245037|Antimetabolites|antimetabolites|mesh-ancestor
64547076|NCT00245037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547077|NCT00245037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547078|NCT00245037|Dermatologic Agents|dermatologic agents|mesh-ancestor
64547079|NCT00245037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547080|NCT00245037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64547081|NCT00245037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64547082|NCT00245037|Immunologic Factors|immunologic factors|mesh-ancestor
64547083|NCT00245037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64547084|NCT00245037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64547086|NCT00245037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64547087|NCT00245037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64547088|NCT00245037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64547089|NCT00245037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64547090|NCT00245037|Antitubercular Agents|antitubercular agents|mesh-ancestor
64547091|NCT00245037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64311909|NCT02101151|Vitamin D|vitamin d|mesh-list
64547144|NCT02651688|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64547146|NCT02651688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64547147|NCT02651688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64547148|NCT02651688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64992361|NCT03816345|Nivolumab|nivolumab|mesh-list
64992362|NCT03816345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64992363|NCT03816345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992364|NCT03816345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64992365|NCT03816345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547181|NCT01675609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64547182|NCT01675609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64547183|NCT01675609|Adrenergic Agents|adrenergic agents|mesh-ancestor
64547321|NCT03513445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547322|NCT03513445|Analgesics|analgesics|mesh-ancestor
64547323|NCT03513445|Sensory System Agents|sensory system agents|mesh-ancestor
64547324|NCT03513445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547325|NCT03513445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64547326|NCT03513445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64547327|NCT03513445|Adrenergic Agents|adrenergic agents|mesh-ancestor
64547328|NCT03513445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64547329|NCT03513445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547330|NCT03513445|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64547331|NCT03513445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64547332|NCT03513445|Autonomic Agents|autonomic agents|mesh-ancestor
64547333|NCT03513445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64547334|NCT03513445|Respiratory System Agents|respiratory system agents|mesh-ancestor
64547335|NCT03513445|Mydriatics|mydriatics|mesh-ancestor
64547336|NCT03513445|Sympathomimetics|sympathomimetics|mesh-ancestor
64547337|NCT03513445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64547338|NCT03513445|Anesthetics, Local|anesthetics, local|mesh-ancestor
64547339|NCT03513445|Anesthetics|anesthetics|mesh-ancestor
64547340|NCT03802071|Doxorubicin|doxorubicin|mesh-list
64547341|NCT03802071|Durvalumab|durvalumab|mesh-list
64547342|NCT03802071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64471736|NCT04217317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64471737|NCT04217317|Alkylating Agents|alkylating agents|mesh-ancestor
64547343|NCT03802071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547344|NCT03802071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64547345|NCT03802071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64547409|NCT00778167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64547411|NCT00778167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547412|NCT00778167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64547413|NCT00778167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547414|NCT00778167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547415|NCT00778167|Immunologic Factors|immunologic factors|mesh-ancestor
64547416|NCT00778167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547417|NCT00778869|Infliximab|infliximab|mesh-list
64547422|NCT05008536|Cyclophosphamide|cyclophosphamide|mesh-list
64547477|NCT03806673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547478|NCT03291990|Temozolomide|temozolomide|mesh-list
64547479|NCT03291990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64547480|NCT03291990|Alkylating Agents|alkylating agents|mesh-ancestor
64547481|NCT03291990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547482|NCT03291990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547483|NCT03806595|Lidocaine|lidocaine|mesh-list
64547484|NCT03806595|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64547485|NCT03806595|Anesthetics, Local|anesthetics, local|mesh-ancestor
64547486|NCT03806595|Anesthetics|anesthetics|mesh-ancestor
64547487|NCT03806595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64312309|NCT03041948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64547515|NCT04762147|Narcotics|narcotics|mesh-ancestor
64547516|NCT04762147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64547517|NCT04762147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547518|NCT04762147|Analgesics|analgesics|mesh-ancestor
64547519|NCT04762147|Sensory System Agents|sensory system agents|mesh-ancestor
64547520|NCT04762147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547521|NCT04762147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64312749|NCT04851392|Analgesics|analgesics|mesh-ancestor
64471738|NCT04217317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488028|NCT01729468|Aspirin|aspirin|mesh-list
64547926|NCT04912518|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64547928|NCT04912518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64547929|NCT04912518|Adrenergic Agents|adrenergic agents|mesh-ancestor
64547930|NCT04912518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64547931|NCT04912518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547933|NCT00087685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547934|NCT00087685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64547935|NCT00087685|Immunologic Factors|immunologic factors|mesh-ancestor
64547936|NCT00087685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547937|NCT04094558|Lactulose|lactulose|mesh-list
64547938|NCT04094558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64547939|NCT01502228|Sunitinib|sunitinib|mesh-list
64547940|NCT01502228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548041|NCT01479530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548042|NCT01479374|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64548043|NCT01479374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64548078|NCT00794313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64548079|NCT00794313|Analgesics|analgesics|mesh-ancestor
64548080|NCT00794313|Sensory System Agents|sensory system agents|mesh-ancestor
64548081|NCT00794313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64548082|NCT05743101|Levofloxacin|levofloxacin|mesh-list
64548083|NCT05743101|Ofloxacin|ofloxacin|mesh-list
64548084|NCT05743101|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64548114|NCT01500434|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64548209|NCT05742789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64548210|NCT05742789|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64548211|NCT01500278|Adalimumab|adalimumab|mesh-list
64548212|NCT01500278|Methotrexate|methotrexate|mesh-list
64548214|NCT01500278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64548215|NCT01500278|Abortifacient Agents|abortifacient agents|mesh-ancestor
64548216|NCT01500278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64548310|NCT04079192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64548312|NCT04079192|Tubulin Modulators|tubulin modulators|mesh-ancestor
64548313|NCT04079192|Antimitotic Agents|antimitotic agents|mesh-ancestor
64548314|NCT04079192|Mitosis Modulators|mitosis modulators|mesh-ancestor
64548315|NCT04079192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548316|NCT04079192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64548317|NCT04079192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64548318|NCT04079192|Immunologic Factors|immunologic factors|mesh-ancestor
64548412|NCT00799227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64548413|NCT00799227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548414|NCT00799227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64548415|NCT00799227|Glucocorticoids|glucocorticoids|mesh-ancestor
64548416|NCT00799227|Hormones|hormones|mesh-ancestor
64548417|NCT00799227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64548418|NCT00799227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64548419|NCT00799227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548431|NCT03439267|Calcium|calcium|mesh-list
64548432|NCT03439267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64548434|NCT00770133|Ketotifen|ketotifen|mesh-list
64548740|NCT02856438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64548741|NCT02856438|Growth Substances|growth substances|mesh-ancestor
64548742|NCT02856438|Growth Inhibitors|growth inhibitors|mesh-ancestor
64548743|NCT01678495|Plasminogen|plasminogen|mesh-list
64548744|NCT01678495|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64548745|NCT01678495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64548921|NCT04403191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64548923|NCT04403191|Dermatologic Agents|dermatologic agents|mesh-ancestor
64548924|NCT04403191|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64548925|NCT04403191|Serotonin Agents|serotonin agents|mesh-ancestor
64548926|NCT04403191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64548927|NCT04403191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548928|NCT04403191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64548929|NCT04403191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64548930|NCT04403191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64548931|NCT04403191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64548932|NCT04403191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64548933|NCT04383093|Tadalafil|tadalafil|mesh-list
64548934|NCT04383093|Tamsulosin|tamsulosin|mesh-list
64548935|NCT04383093|Vasodilator Agents|vasodilator agents|mesh-ancestor
64548936|NCT04383093|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64548937|NCT04383093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64548947|NCT05301660|Nicotine|nicotine|mesh-list
64549035|NCT00801723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64549036|NCT05346211|Curcumin|curcumin|mesh-list
64945402|NCT05663580|Rilpivirine|rilpivirine|mesh-list
64471739|NCT04217317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549037|NCT05346211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64549038|NCT05346211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64549039|NCT05346211|Analgesics|analgesics|mesh-ancestor
64549040|NCT05346211|Sensory System Agents|sensory system agents|mesh-ancestor
64549043|NCT05346211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64549598|NCT05044962|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64549599|NCT05044962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64549600|NCT05044962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549601|NCT05044962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64549602|NCT05044962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64549603|NCT05044962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549604|NCT05044962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549605|NCT05044962|Antiviral Agents|antiviral agents|mesh-ancestor
64549606|NCT05044962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64549607|NCT05044962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64549608|NCT05044962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64549609|NCT05044962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64549610|NCT05044962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64549611|NCT04198506|Tacrolimus|tacrolimus|mesh-list
64549612|NCT04198506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64549613|NCT04198506|Immunologic Factors|immunologic factors|mesh-ancestor
64551177|NCT00841971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64551178|NCT00841971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64551179|NCT00841971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64551180|NCT00841971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551181|NCT00841971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551182|NCT00841971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64551183|NCT00841971|Hormone Antagonists|hormone antagonists|mesh-ancestor
64551184|NCT00841971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64551185|NCT00841971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551186|NCT00841971|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64551187|NCT00841971|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64992849|NCT03199885|Immunologic Factors|immunologic factors|mesh-ancestor
64992850|NCT03199885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992851|NCT03198650|Obinutuzumab|obinutuzumab|mesh-list
64992852|NCT03198650|Acalabrutinib|acalabrutinib|mesh-list
64992853|NCT03198650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64551234|NCT03995004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64551832|NCT05070468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64551833|NCT05070468|Glucocorticoids|glucocorticoids|mesh-ancestor
64551834|NCT05070468|Hormones|hormones|mesh-ancestor
64551835|NCT05070468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64551836|NCT05070468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64551837|NCT05070468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551838|NCT01390181|Losartan|losartan|mesh-list
64551839|NCT01390181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64551840|NCT01390181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64551841|NCT01390181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64507968|NCT03308604|Cisplatin|cisplatin|mesh-list
64551842|NCT01390181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64551843|NCT01390181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553784|NCT05045274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64553785|NCT05045274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64553786|NCT05045274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64554086|NCT00983905|Tubulin Modulators|tubulin modulators|mesh-ancestor
64554087|NCT00983905|Antimitotic Agents|antimitotic agents|mesh-ancestor
64554088|NCT00983905|Mitosis Modulators|mitosis modulators|mesh-ancestor
64554089|NCT00983905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554090|NCT00983905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554091|NCT00983905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64554092|NCT00983905|Autonomic Agents|autonomic agents|mesh-ancestor
64554093|NCT00983905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64554094|NCT00983905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554095|NCT00983905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64554096|NCT00983905|Respiratory System Agents|respiratory system agents|mesh-ancestor
64554097|NCT00983905|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64554098|NCT00983905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554099|NCT00983905|Vasodilator Agents|vasodilator agents|mesh-ancestor
64554100|NCT00983905|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64554101|NCT00983905|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64554102|NCT00983905|Purinergic Agents|purinergic agents|mesh-ancestor
64774823|NCT05316168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774824|NCT05316168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64774825|NCT05316168|Glucocorticoids|glucocorticoids|mesh-ancestor
64774826|NCT05316168|Hormones|hormones|mesh-ancestor
64774828|NCT05316168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64775218|NCT01785810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775219|NCT01785810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64775220|NCT01785810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64775221|NCT01785810|Antiviral Agents|antiviral agents|mesh-ancestor
64775222|NCT01785810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64775277|NCT01794702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64775279|NCT01794702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775280|NCT01794702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775281|NCT01794702|Antiviral Agents|antiviral agents|mesh-ancestor
64775282|NCT01794702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64775283|NCT01794702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64775284|NCT01794702|Immunologic Factors|immunologic factors|mesh-ancestor
64775285|NCT01794702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775286|NCT01794702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64471745|NCT04189263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64775341|NCT01810692|Cholinergic Agents|cholinergic agents|mesh-ancestor
64775342|NCT01810692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64775343|NCT01810692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775344|NCT01811940|Topiramate|topiramate|mesh-list
64775345|NCT01811940|Adderall|adderall|mesh-list
64775346|NCT01811940|Anticonvulsants|anticonvulsants|mesh-ancestor
64775347|NCT01811940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64775348|NCT01811940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775503|NCT01842594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775505|NCT01842594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64775506|NCT01842594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64775507|NCT01842594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64775508|NCT01842594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775509|NCT01842594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64775510|NCT01843920|Trimethoprim|trimethoprim|mesh-list
64775511|NCT01843920|Polymyxins|polymyxins|mesh-list
64775512|NCT01843920|Polymyxin B|polymyxin b|mesh-list
64775513|NCT01843920|Prednisolone|prednisolone|mesh-list
64775514|NCT01843920|Timolol|timolol|mesh-list
64775692|NCT01877538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775693|NCT01877538|Cholinergic Agents|cholinergic agents|mesh-ancestor
64775694|NCT01877538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64775695|NCT01877538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775696|NCT01877538|Nootropic Agents|nootropic agents|mesh-ancestor
64775697|NCT01878006|Morphine|morphine|mesh-list
64775698|NCT01878006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64775699|NCT01878006|Narcotics|narcotics|mesh-ancestor
64775700|NCT01878006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64775701|NCT01878006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544380|NCT04685772|Antiemetics|antiemetics|mesh-ancestor
64775703|NCT01878006|Sensory System Agents|sensory system agents|mesh-ancestor
64776126|NCT01890642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776127|NCT01890642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64776128|NCT01890642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64776129|NCT01890642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64776130|NCT01890642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64776131|NCT01890642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776132|NCT01891968|Bortezomib|bortezomib|mesh-list
64776133|NCT01891968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776134|NCT01901250|Fluorides|fluorides|mesh-list
64776135|NCT01901250|Fluorides, Topical|fluorides, topical|mesh-list
64776136|NCT01901250|Cariostatic Agents|cariostatic agents|mesh-ancestor
64776137|NCT01901250|Protective Agents|protective agents|mesh-ancestor
64776138|NCT01901250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776139|NCT01904526|Guanfacine|guanfacine|mesh-list
64776140|NCT01904526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64776141|NCT01904526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64776142|NCT01904526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64776143|NCT01904526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64776144|NCT01904526|Adrenergic Agents|adrenergic agents|mesh-ancestor
64776145|NCT01904526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64776238|NCT01920282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64776348|NCT01953432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64776349|NCT01953432|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64776350|NCT01953432|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64776351|NCT01953432|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64776352|NCT01953432|Adrenergic Agents|adrenergic agents|mesh-ancestor
64776353|NCT01953432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64776354|NCT01953432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471746|NCT04189263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776355|NCT01953432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776356|NCT01955382|Artesunate|artesunate|mesh-list
64776357|NCT01955382|Amodiaquine|amodiaquine|mesh-list
64776358|NCT01955382|Charcoal|charcoal|mesh-list
64776395|NCT05740098|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64776396|NCT05740098|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64776397|NCT05740098|Cholinergic Agents|cholinergic agents|mesh-ancestor
64776425|NCT05739630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64776426|NCT05739630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64776427|NCT05739630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776428|NCT05739630|Analgesics|analgesics|mesh-ancestor
64776429|NCT05739630|Sensory System Agents|sensory system agents|mesh-ancestor
64776433|NCT05739474|Vaccines|vaccines|mesh-list
64776528|NCT05725200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64776529|NCT05725200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64776530|NCT05725200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64776531|NCT05725200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64776532|NCT05725200|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64776533|NCT05725200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64776534|NCT05721144|Nitric Oxide|nitric oxide|mesh-list
64776568|NCT05574894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776570|NCT05567952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64388034|NCT02357303|Protective Agents|protective agents|mesh-ancestor
64776637|NCT05242692|Anesthetics, General|anesthetics, general|mesh-ancestor
64776638|NCT05242692|Anesthetics|anesthetics|mesh-ancestor
64776639|NCT05242692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64776640|NCT05242692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64776641|NCT05242692|Antidepressive Agents|antidepressive agents|mesh-ancestor
64776642|NCT05242692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64776643|NCT05193552|gamma-Globulins|gamma-globulins|mesh-list
64776644|NCT05193552|Immunologic Factors|immunologic factors|mesh-ancestor
64776645|NCT05193552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776646|NCT05087940|Diuretics|diuretics|mesh-list
64776647|NCT05087940|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
64776648|NCT05087940|Natriuretic Agents|natriuretic agents|mesh-ancestor
64776738|NCT04538742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776739|NCT04438902|Osimertinib|osimertinib|mesh-list
64776740|NCT04438902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776741|NCT04438902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64388933|NCT02442817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388934|NCT02437591|Fidaxomicin|fidaxomicin|mesh-list
64388935|NCT02437591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64388936|NCT02437591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64388938|NCT02442739|Analgesics|analgesics|mesh-ancestor
64389018|NCT02441803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389066|NCT03117595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64389217|NCT04031729|Antipyretics|antipyretics|mesh-ancestor
64389218|NCT02433847|Mosapride|mosapride|mesh-list
64389219|NCT02433847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64389220|NCT02433847|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64389221|NCT02433847|Serotonin Agents|serotonin agents|mesh-ancestor
64389222|NCT02433847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64389223|NCT02433847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389224|NCT02433847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389225|NCT02435095|Antipsychotic Agents|antipsychotic agents|mesh-list
64389226|NCT02435095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64389267|NCT02039999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389269|NCT02434861|Digoxin|digoxin|mesh-list
64389290|NCT03187015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64389291|NCT03187015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64389292|NCT03187015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64389293|NCT03187015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389294|NCT03187015|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64389418|NCT03191539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389419|NCT02433925|Resveratrol|resveratrol|mesh-list
64389420|NCT02433925|Antioxidants|antioxidants|mesh-ancestor
64389421|NCT02433925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389422|NCT02433925|Protective Agents|protective agents|mesh-ancestor
64389423|NCT02433925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389424|NCT02433925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389425|NCT02433925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64389426|NCT02332967|Palmitic Acid|palmitic acid|mesh-list
64389427|NCT02332967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389428|NCT02332967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389429|NCT02327663|Emtricitabine|emtricitabine|mesh-list
64389430|NCT02327663|Antiviral Agents|antiviral agents|mesh-ancestor
64389471|NCT03145025|Glucocorticoids|glucocorticoids|mesh-ancestor
64389619|NCT03588767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64389620|NCT02440399|Acetaminophen|acetaminophen|mesh-list
64389621|NCT02440399|Diclofenac|diclofenac|mesh-list
64389622|NCT02440399|Morphine|morphine|mesh-list
64389623|NCT02440399|Oxycodone|oxycodone|mesh-list
64389624|NCT02440399|Tramadol|tramadol|mesh-list
64389625|NCT02440399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64389626|NCT02440399|Narcotics|narcotics|mesh-ancestor
64389627|NCT02440399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64389628|NCT02440399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389629|NCT02440399|Analgesics|analgesics|mesh-ancestor
64389630|NCT02440399|Sensory System Agents|sensory system agents|mesh-ancestor
64389657|NCT02429713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389658|NCT02429713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389659|NCT02429713|Sympathomimetics|sympathomimetics|mesh-ancestor
64389670|NCT03144401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64389671|NCT03144401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389673|NCT03144401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64389674|NCT03144401|Oxytocics|oxytocics|mesh-ancestor
64389675|NCT04483765|Anesthetics|anesthetics|mesh-list
64389676|NCT04483765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64389677|NCT04483765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389678|NCT03186313|Ribavirin|ribavirin|mesh-list
64389679|NCT03186313|Sofosbuvir|sofosbuvir|mesh-list
64389680|NCT03186313|Antimetabolites|antimetabolites|mesh-ancestor
64389681|NCT03186313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389682|NCT03186313|Antiviral Agents|antiviral agents|mesh-ancestor
64389683|NCT03186313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64389684|NCT03144245|Pembrolizumab|pembrolizumab|mesh-list
64389685|NCT03144245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64389686|NCT03144245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64389734|NCT02326103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389735|NCT02326103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64389736|NCT02326103|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64389737|NCT02326103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64389738|NCT04984733|Nivolumab|nivolumab|mesh-list
64389739|NCT04984733|Temozolomide|temozolomide|mesh-list
64389752|NCT02432599|Lipotropic Agents|lipotropic agents|mesh-ancestor
64389753|NCT02432599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64389754|NCT02432599|Antimetabolites|antimetabolites|mesh-ancestor
64389755|NCT02432599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389756|NCT02432599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64471753|NCT04165317|Immunologic Factors|immunologic factors|mesh-ancestor
64778339|NCT02369172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64389757|NCT02432599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64389758|NCT02432599|Nootropic Agents|nootropic agents|mesh-ancestor
64389760|NCT03185143|Sumatriptan|sumatriptan|mesh-list
64389761|NCT03185143|Naltrexone|naltrexone|mesh-list
64389762|NCT03185143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64389763|NCT03185143|Analgesics|analgesics|mesh-ancestor
64389764|NCT03185143|Sensory System Agents|sensory system agents|mesh-ancestor
64389765|NCT03185143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64389851|NCT05076461|Autonomic Agents|autonomic agents|mesh-ancestor
64389852|NCT05076461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64389853|NCT05076461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389854|NCT05076461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64389855|NCT05076461|Antipruritics|antipruritics|mesh-ancestor
64389856|NCT05076461|Dermatologic Agents|dermatologic agents|mesh-ancestor
64389857|NCT05076461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64389858|NCT05076461|Serotonin Agents|serotonin agents|mesh-ancestor
64389859|NCT05076461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64389860|NCT05076461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389861|NCT05076461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64389862|NCT05076461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64778475|NCT05718492|Fluorouracil|fluorouracil|mesh-list
64778476|NCT05718492|Oxaliplatin|oxaliplatin|mesh-list
64778477|NCT05718492|Antimetabolites|antimetabolites|mesh-ancestor
64778478|NCT05718492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778479|NCT05718492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64778480|NCT05718492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778548|NCT05543694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64471754|NCT04165317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778550|NCT05495568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64778551|NCT05495568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64778552|NCT05359068|Valsartan|valsartan|mesh-list
64778553|NCT05359068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64389948|NCT02431975|Antimetabolites|antimetabolites|mesh-ancestor
64778589|NCT04967196|Ipilimumab|ipilimumab|mesh-list
64390000|NCT03185845|Warfarin|warfarin|mesh-list
64390036|NCT02431429|Miltefosine|miltefosine|mesh-list
64390037|NCT02431429|Antifungal Agents|antifungal agents|mesh-ancestor
64390038|NCT02431429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64390039|NCT02431429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390040|NCT02431429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64390041|NCT02431429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64390043|NCT02027428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64390044|NCT02027428|Carboplatin|carboplatin|mesh-list
64390045|NCT02027428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64390046|NCT02027428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390047|NCT02027428|Tubulin Modulators|tubulin modulators|mesh-ancestor
64390048|NCT02027428|Antimitotic Agents|antimitotic agents|mesh-ancestor
64390049|NCT02027428|Mitosis Modulators|mitosis modulators|mesh-ancestor
64390050|NCT02027428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390051|NCT03184363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64390052|NCT03184363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64390053|NCT03184363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64390061|NCT02431039|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64390062|NCT02431039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64390063|NCT01995136|Travoprost|travoprost|mesh-list
64390064|NCT01995136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64390065|NCT01995136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64390066|NCT01995136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64390067|NCT03141593|Vitamin D|vitamin d|mesh-list
64390068|NCT03141593|Ergocalciferols|ergocalciferols|mesh-list
64390112|NCT02427295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390113|NCT01994590|Prednisone|prednisone|mesh-list
64390114|NCT01994590|Abiraterone Acetate|abiraterone acetate|mesh-list
64390115|NCT01994590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64390116|NCT01994590|Glucocorticoids|glucocorticoids|mesh-ancestor
64390117|NCT01994590|Hormones|hormones|mesh-ancestor
64390118|NCT01994590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64390119|NCT01994590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390120|NCT01994590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64390121|NCT01994590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390122|NCT01994590|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64778790|NCT02828358|Abortifacient Agents|abortifacient agents|mesh-ancestor
64778791|NCT02828358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64778792|NCT02828358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64778793|NCT02828358|Antimetabolites|antimetabolites|mesh-ancestor
64778794|NCT02828358|Dermatologic Agents|dermatologic agents|mesh-ancestor
64778795|NCT02828358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64778796|NCT02828358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64778797|NCT02828358|Antiviral Agents|antiviral agents|mesh-ancestor
64778798|NCT02828358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64778799|NCT02828358|Antidotes|antidotes|mesh-ancestor
64778800|NCT02828358|Protective Agents|protective agents|mesh-ancestor
64778801|NCT02828358|Vitamin B Complex|vitamin b complex|mesh-ancestor
64778802|NCT02828358|Vitamins|vitamins|mesh-ancestor
64778803|NCT02828358|Micronutrients|micronutrients|mesh-ancestor
64778804|NCT02828358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64778805|NCT02828358|Tubulin Modulators|tubulin modulators|mesh-ancestor
64390313|NCT03139253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64390314|NCT03139253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64390315|NCT03139253|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64390316|NCT03139253|Renal Agents|renal agents|mesh-ancestor
64390317|NCT03139253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64390318|NCT03139253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64390319|NCT03139253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390320|NCT03139253|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64390321|NCT03139253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64390322|NCT03139253|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64390323|NCT03139253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64390324|NCT03139253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64390325|NCT03139253|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64390326|NCT03139253|Alkylating Agents|alkylating agents|mesh-ancestor
64390327|NCT03139409|Chlorhexidine|chlorhexidine|mesh-list
64390328|NCT03139409|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64390344|NCT00157937|Respiratory System Agents|respiratory system agents|mesh-ancestor
64390345|NCT00157937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64390346|NCT00157937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64390347|NCT00157937|Hormone Antagonists|hormone antagonists|mesh-ancestor
64390348|NCT00157937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64390349|NCT00157937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64390350|NCT00157937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64390351|NCT00157937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64390352|NCT00157937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64390399|NCT02936687|Ambrisentan|ambrisentan|mesh-list
64390400|NCT02936687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64390401|NCT04722809|Botulinum Toxins|botulinum toxins|mesh-list
64390402|NCT04722809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64390403|NCT04722809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64390404|NCT04722809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390405|NCT04722809|Cholinergic Agents|cholinergic agents|mesh-ancestor
64390406|NCT04722809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64390407|NCT04722809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390408|NCT05083793|Pregabalin|pregabalin|mesh-list
64390409|NCT05083793|Analgesics|analgesics|mesh-ancestor
64390410|NCT05083793|Sensory System Agents|sensory system agents|mesh-ancestor
64390411|NCT05083793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64390419|NCT05083793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64390420|NCT05083793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64390421|NCT05083793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64390422|NCT05083013|Chrysarobin|chrysarobin|mesh-list
64390423|NCT05083013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64390425|NCT05083013|Analgesics|analgesics|mesh-ancestor
64390445|NCT03223883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390446|NCT02420899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64390447|NCT02420899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64390448|NCT02420899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64390449|NCT02420899|Antimetabolites|antimetabolites|mesh-ancestor
64390527|NCT02425813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64390529|NCT02425813|Hormones|hormones|mesh-ancestor
64390530|NCT02425813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64390531|NCT02425813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64390532|NCT02425813|Protective Agents|protective agents|mesh-ancestor
64390533|NCT02425813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64390534|NCT02425813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390535|NCT02425813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64390536|NCT02425813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64779168|NCT05436678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64779169|NCT05436678|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64779170|NCT05436678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64779171|NCT05436678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779172|NCT05436678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779173|NCT05436678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64779174|NCT05436678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64779175|NCT05436678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64779176|NCT05436678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64779177|NCT05436678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779178|NCT05436678|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64779189|NCT05413122|Nicotine|nicotine|mesh-list
64390630|NCT03519893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64390631|NCT03519893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64390632|NCT03519893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64390645|NCT02425579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390647|NCT03178591|Vildagliptin|vildagliptin|mesh-list
64390648|NCT03178591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64390649|NCT03178591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390650|NCT03178591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64390653|NCT03178591|Protease Inhibitors|protease inhibitors|mesh-ancestor
64390708|NCT02416531|Clobetasol|clobetasol|mesh-list
64390709|NCT02416531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64390710|NCT02416531|Glucocorticoids|glucocorticoids|mesh-ancestor
64390711|NCT02416531|Hormones|hormones|mesh-ancestor
64390712|NCT02416531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64390713|NCT02416531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390714|NCT04483063|Chlorhexidine|chlorhexidine|mesh-list
64390715|NCT04483063|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64390716|NCT04483063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64390717|NCT04483063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64390718|NCT04483063|Disinfectants|disinfectants|mesh-ancestor
64390719|NCT04483063|Dermatologic Agents|dermatologic agents|mesh-ancestor
64390720|NCT02416141|Tramadol|tramadol|mesh-list
64390721|NCT02416141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64390722|NCT02416141|Narcotics|narcotics|mesh-ancestor
64390725|NCT02416141|Analgesics|analgesics|mesh-ancestor
64779414|NCT04599816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779415|NCT04546230|Anesthetics|anesthetics|mesh-list
64779416|NCT04546230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64779417|NCT04546230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779418|NCT04534218|Aspirin|aspirin|mesh-list
64779419|NCT04534218|Cyclophosphamide|cyclophosphamide|mesh-list
64779420|NCT04534218|Capecitabine|capecitabine|mesh-list
64779421|NCT04534218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64779422|NCT04534218|Immunologic Factors|immunologic factors|mesh-ancestor
64779423|NCT04534218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779424|NCT04534218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64390845|NCT03140033|Ranitidine|ranitidine|mesh-list
64390846|NCT03140033|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
64779521|NCT04320342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390964|NCT02624765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390965|NCT02624765|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64390966|NCT02624765|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64390967|NCT02624765|Adrenergic Agents|adrenergic agents|mesh-ancestor
64390968|NCT02624765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64390969|NCT02624765|Sympatholytics|sympatholytics|mesh-ancestor
64390970|NCT02624765|Autonomic Agents|autonomic agents|mesh-ancestor
64390971|NCT02624765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64390972|NCT02624765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64390973|NCT02624765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64390974|NCT02624765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64390975|NCT05085587|Fluticasone|fluticasone|mesh-list
64391002|NCT05084573|Anesthetics, Local|anesthetics, local|mesh-ancestor
64391003|NCT05084573|Anesthetics|anesthetics|mesh-ancestor
64391004|NCT05084573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64391005|NCT05084573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391006|NCT05084573|Sensory System Agents|sensory system agents|mesh-ancestor
64391007|NCT05084573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64391017|NCT05028257|Immunologic Factors|immunologic factors|mesh-ancestor
64391018|NCT05028257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391019|NCT01990300|Pioglitazone|pioglitazone|mesh-list
64391020|NCT01990300|Alogliptin|alogliptin|mesh-list
64391021|NCT01990300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64391022|NCT01990300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391023|NCT01990300|Incretins|incretins|mesh-ancestor
64391024|NCT01990300|Hormones|hormones|mesh-ancestor
64391025|NCT01990300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64391026|NCT01990300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64391027|NCT01990300|Protease Inhibitors|protease inhibitors|mesh-ancestor
64391030|NCT03135977|Etoposide|etoposide|mesh-list
64391045|NCT04850651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64391046|NCT04850651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64391047|NCT04850651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391055|NCT04837235|Hemay005|hemay005|mesh-list
64391067|NCT03116971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64391068|NCT03116971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64391069|NCT03116971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64391070|NCT03116971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391071|NCT03116971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391072|NCT03116971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64391073|NCT02414581|Ethanol|ethanol|mesh-list
64391074|NCT02414581|Chlorhexidine|chlorhexidine|mesh-list
64391082|NCT02419105|Vitamin D|vitamin d|mesh-list
64391097|NCT04643249|Caffeine|caffeine|mesh-list
64391098|NCT04643249|Bupropion|bupropion|mesh-list
64391099|NCT04643249|Omeprazole|omeprazole|mesh-list
64391100|NCT04643249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64391101|NCT04643249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64391102|NCT04643249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64391103|NCT04643249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391109|NCT04643249|Anesthetics|anesthetics|mesh-ancestor
64391176|NCT03116893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64391177|NCT03116893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64391207|NCT05737511|Sensory System Agents|sensory system agents|mesh-ancestor
64391208|NCT05737511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64391209|NCT05737511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391211|NCT05737511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64391212|NCT05737511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64391213|NCT05737511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64391214|NCT05737511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64391215|NCT05737511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64391226|NCT05737511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64391228|NCT05737511|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64391229|NCT05737511|Antidepressive Agents|antidepressive agents|mesh-ancestor
64391230|NCT05737511|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64391231|NCT05737511|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64391232|NCT05737511|Parasympatholytics|parasympatholytics|mesh-ancestor
64391233|NCT05737511|Autonomic Agents|autonomic agents|mesh-ancestor
64391236|NCT05737511|Cholinergic Agents|cholinergic agents|mesh-ancestor
64779880|NCT02037048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64779881|NCT02037048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779882|NCT02037048|Tubulin Modulators|tubulin modulators|mesh-ancestor
64779883|NCT02037048|Antimitotic Agents|antimitotic agents|mesh-ancestor
64779884|NCT02037048|Mitosis Modulators|mitosis modulators|mesh-ancestor
64779885|NCT02037048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779886|NCT02037048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64779887|NCT02037048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779888|NCT02037048|Antimetabolites|antimetabolites|mesh-ancestor
64779922|NCT01659606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64779923|NCT01659606|Immunologic Factors|immunologic factors|mesh-ancestor
64779924|NCT01659606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779925|NCT01659606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64779926|NCT01659606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779927|NCT01659606|Antifungal Agents|antifungal agents|mesh-ancestor
64779928|NCT01659606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64779929|NCT01659606|Dermatologic Agents|dermatologic agents|mesh-ancestor
64779930|NCT01659606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64780079|NCT02452866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64780080|NCT02452866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64780081|NCT02462148|Dexamethasone|dexamethasone|mesh-list
64780082|NCT02462148|Dexamethasone acetate|dexamethasone acetate|mesh-list
64780083|NCT02462148|Epinephrine|epinephrine|mesh-list
64780084|NCT02462148|Bupivacaine|bupivacaine|mesh-list
64780085|NCT02462148|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64780086|NCT02462148|BB 1101|bb 1101|mesh-list
64780087|NCT02462148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64780088|NCT02462148|Antiemetics|antiemetics|mesh-ancestor
64780089|NCT02462148|Autonomic Agents|autonomic agents|mesh-ancestor
64780090|NCT02462148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64391471|NCT02412475|Cytarabine|cytarabine|mesh-list
64391528|NCT03199157|Anesthetics, General|anesthetics, general|mesh-ancestor
64391529|NCT03199157|Anesthetics|anesthetics|mesh-ancestor
64391530|NCT00641381|Cyclophosphamide|cyclophosphamide|mesh-list
64391531|NCT00641381|Carmustine|carmustine|mesh-list
64391532|NCT00641381|Etoposide|etoposide|mesh-list
64391533|NCT00641381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64391534|NCT00641381|Immunologic Factors|immunologic factors|mesh-ancestor
64391535|NCT00641381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391536|NCT00641381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64391537|NCT00641381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64391539|NCT00641381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391540|NCT00641381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64391541|NCT00641381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64391542|NCT00641381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64391543|NCT00641381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64391557|NCT02416999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780215|NCT02486016|Anesthetics, General|anesthetics, general|mesh-ancestor
64780217|NCT02486328|Midazolam|midazolam|mesh-list
64780218|NCT02486328|Meperidine|meperidine|mesh-list
64780219|NCT02486328|Remifentanil|remifentanil|mesh-list
64780220|NCT02486328|Propofol|propofol|mesh-list
64780221|NCT02486328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64780222|NCT02486328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64780223|NCT02486328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780224|NCT02486328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64780225|NCT02486328|Anesthetics, General|anesthetics, general|mesh-ancestor
64780226|NCT02486328|Anesthetics|anesthetics|mesh-ancestor
64780227|NCT02486328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64780228|NCT02486328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64780229|NCT02486328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64780230|NCT02486328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64780231|NCT02486328|GABA Modulators|gaba modulators|mesh-ancestor
64780232|NCT02486328|GABA Agents|gaba agents|mesh-ancestor
64780233|NCT02486328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64391599|NCT00301457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391656|NCT02703259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64391657|NCT02703259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64391658|NCT02703259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64391659|NCT02703259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64391660|NCT02703259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64391661|NCT02703259|Antimanic Agents|antimanic agents|mesh-ancestor
64391662|NCT02416687|Etonogestrel|etonogestrel|mesh-list
64391663|NCT02416687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64391664|NCT02416687|Contraceptive Agents|contraceptive agents|mesh-ancestor
64391665|NCT02416687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64391669|NCT02411695|Serotonin Agents|serotonin agents|mesh-ancestor
64391722|NCT02410135|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64391723|NCT02410135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64391724|NCT02410135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64391725|NCT02410135|Adrenergic Agents|adrenergic agents|mesh-ancestor
64391746|NCT02409823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64391747|NCT02401477|Amoxicillin|amoxicillin|mesh-list
64391748|NCT02401477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64391749|NCT02401477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64391750|NCT03174457|Micafungin|micafungin|mesh-list
64391751|NCT03174457|Antifungal Agents|antifungal agents|mesh-ancestor
64391752|NCT03174457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64391753|NCT02401243|Insulin Glargine|insulin glargine|mesh-list
64391754|NCT02401243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64391755|NCT02401243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391756|NCT02409433|Lacosamide|lacosamide|mesh-list
64391757|NCT02409433|Phenytoin|phenytoin|mesh-list
64391758|NCT02409433|Anticonvulsants|anticonvulsants|mesh-ancestor
64391759|NCT02409433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64391760|NCT02409433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64391761|NCT02409433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64391762|NCT02409433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391763|NCT02409433|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64391764|NCT02409433|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64391853|NCT02449655|Mitosis Modulators|mitosis modulators|mesh-ancestor
64391892|NCT03197207|Menthol|menthol|mesh-list
64391893|NCT03197207|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64391894|NCT03197207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64391895|NCT03197207|Antipruritics|antipruritics|mesh-ancestor
64391896|NCT03197207|Dermatologic Agents|dermatologic agents|mesh-ancestor
64391897|NCT03197207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64471764|NCT04140396|Anesthetics|anesthetics|mesh-ancestor
64471765|NCT04140396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64391902|NCT03197207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391903|NCT03197207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64391904|NCT03197207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64391905|NCT03197207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64391906|NCT03197207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391907|NCT03197207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391908|NCT01603121|Lisofylline|lisofylline|mesh-list
64391909|NCT01603121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64391910|NCT01603121|Immunologic Factors|immunologic factors|mesh-ancestor
64391911|NCT01603121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391932|NCT02449265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64391933|NCT02449265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64391975|NCT03593759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64391976|NCT03593759|Glucocorticoids|glucocorticoids|mesh-ancestor
64391977|NCT03593759|Hormones|hormones|mesh-ancestor
64391978|NCT03593759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64391979|NCT03593759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391980|NCT03593759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64391981|NCT03593759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64391982|NCT03593759|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64391983|NCT03593759|Abortifacient Agents|abortifacient agents|mesh-ancestor
64391984|NCT03593759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64391985|NCT03593759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64391986|NCT03593759|Antimetabolites|antimetabolites|mesh-ancestor
64391987|NCT03593759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391988|NCT03593759|Dermatologic Agents|dermatologic agents|mesh-ancestor
64391989|NCT03593759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780618|NCT02584608|Antiviral Agents|antiviral agents|mesh-ancestor
64780619|NCT02584608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64392040|NCT05095571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392041|NCT05095571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64392043|NCT05095571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392044|NCT05095571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64471766|NCT04140396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392091|NCT05084027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64392092|NCT05084027|Immunologic Factors|immunologic factors|mesh-ancestor
64392093|NCT05084027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392094|NCT05084027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64392095|NCT05084027|Alkylating Agents|alkylating agents|mesh-ancestor
64392105|NCT02448797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64392106|NCT02448797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64392108|NCT02448797|Antimitotic Agents|antimitotic agents|mesh-ancestor
64392109|NCT02448797|Mitosis Modulators|mitosis modulators|mesh-ancestor
64392110|NCT02448797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392111|NCT04438421|Chlorhexidine|chlorhexidine|mesh-list
64392112|NCT04438421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64780749|NCT02056236|Autonomic Agents|autonomic agents|mesh-ancestor
64780750|NCT02056236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780751|NCT02056236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64780752|NCT01962246|Capecitabine|capecitabine|mesh-list
64780753|NCT01962246|Oxaliplatin|oxaliplatin|mesh-list
64780754|NCT01962246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64392252|NCT05099471|Antiemetics|antiemetics|mesh-ancestor
64392253|NCT05099471|Autonomic Agents|autonomic agents|mesh-ancestor
64392254|NCT05099471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392255|NCT05099471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64392256|NCT05099471|Glucocorticoids|glucocorticoids|mesh-ancestor
64392257|NCT05099471|Hormones|hormones|mesh-ancestor
64392258|NCT05099471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64392266|NCT04517357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64392267|NCT04517357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64392311|NCT04658836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64392312|NCT04658836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392313|NCT01677377|Risperidone|risperidone|mesh-list
64392314|NCT01677377|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64392315|NCT01677377|Serotonin Agents|serotonin agents|mesh-ancestor
64392316|NCT01677377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64392317|NCT01677377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392318|NCT01677377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392319|NCT01677377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64392335|NCT05097365|Vitamin B 12|vitamin b 12|mesh-list
64392337|NCT05097365|Vitamins|vitamins|mesh-ancestor
64392414|NCT01964326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64392416|NCT01964326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781011|NCT03958344|Protective Agents|protective agents|mesh-ancestor
64781013|NCT02960646|Melphalan|melphalan|mesh-list
64781014|NCT02960646|Mechlorethamine|mechlorethamine|mesh-list
64781015|NCT02960646|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64781016|NCT02960646|Rituximab|rituximab|mesh-list
64781017|NCT02960646|Fludarabine|fludarabine|mesh-list
64781018|NCT02960646|Fludarabine phosphate|fludarabine phosphate|mesh-list
64781019|NCT02960646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64781020|NCT02960646|Tacrolimus|tacrolimus|mesh-list
64781021|NCT02960646|Antibodies|antibodies|mesh-list
64781022|NCT02960646|Immunoglobulins|immunoglobulins|mesh-list
64781023|NCT02960646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64781024|NCT02960646|Lenograstim|lenograstim|mesh-list
64781025|NCT02960646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64781026|NCT02960646|Immunologic Factors|immunologic factors|mesh-ancestor
64781027|NCT02960646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781028|NCT02960646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64781029|NCT02960646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64781030|NCT02960646|Alkylating Agents|alkylating agents|mesh-ancestor
64781031|NCT02960646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781032|NCT02960646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781033|NCT02960646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64781034|NCT02960646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64781035|NCT02960646|Antimetabolites|antimetabolites|mesh-ancestor
64781036|NCT02960646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64781037|NCT02960646|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64781038|NCT02960646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781039|NCT02517684|Prednisolone|prednisolone|mesh-list
64781040|NCT02517684|Azathioprine|azathioprine|mesh-list
64781041|NCT02517684|Infliximab|infliximab|mesh-list
64781056|NCT02517684|Immunologic Factors|immunologic factors|mesh-ancestor
64392482|NCT03847181|Vitamins|vitamins|mesh-ancestor
64392483|NCT03847181|Micronutrients|micronutrients|mesh-ancestor
64392484|NCT03847181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392485|NCT03847181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64392486|NCT03847181|Antithrombins|antithrombins|mesh-ancestor
64392487|NCT03847181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64392488|NCT03847181|Protease Inhibitors|protease inhibitors|mesh-ancestor
64392500|NCT03477851|Analgesics|analgesics|mesh-ancestor
64392501|NCT03477851|Sensory System Agents|sensory system agents|mesh-ancestor
64392509|NCT02409199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392510|NCT02409199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64781149|NCT02635542|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64781150|NCT02635542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64781151|NCT02635542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64781152|NCT02635542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781153|NCT02635542|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
64781177|NCT05510856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64781178|NCT05510856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64781179|NCT05510856|Antidepressive Agents|antidepressive agents|mesh-ancestor
64781180|NCT05510856|Dopamine Agents|dopamine agents|mesh-ancestor
64781181|NCT05510856|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64781182|NCT05510856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64781183|NCT05403138|Daratumumab|daratumumab|mesh-list
64781184|NCT05403138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781185|NCT05281770|Erenumab|erenumab|mesh-list
64781186|NCT05281770|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64781187|NCT05281770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781188|NCT05281770|Analgesics|analgesics|mesh-ancestor
64781189|NCT05281770|Sensory System Agents|sensory system agents|mesh-ancestor
64781190|NCT05281770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64781191|NCT05281770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781192|NCT05225610|Dexmedetomidine|dexmedetomidine|mesh-list
64781193|NCT05225610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64781194|NCT05225610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64781196|NCT05225610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64781197|NCT05225610|Analgesics|analgesics|mesh-ancestor
64781198|NCT05225610|Sensory System Agents|sensory system agents|mesh-ancestor
64781199|NCT05225610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64781200|NCT05225610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64781201|NCT05225610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64781202|NCT05225610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64781203|NCT05225610|Adrenergic Agents|adrenergic agents|mesh-ancestor
64392644|NCT02400619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392645|NCT02400619|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64392646|NCT02400619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392647|NCT05083949|Metformin|metformin|mesh-list
64392648|NCT05083949|Empagliflozin|empagliflozin|mesh-list
64392649|NCT05083949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64392670|NCT04279535|Protective Agents|protective agents|mesh-ancestor
64392671|NCT04279535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392712|NCT05100719|Emollients|emollients|mesh-ancestor
64392714|NCT05100719|Parasympatholytics|parasympatholytics|mesh-ancestor
64392715|NCT05100719|Autonomic Agents|autonomic agents|mesh-ancestor
64392716|NCT05100719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64471769|NCT04140396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64490304|NCT04355026|Bromhexine|bromhexine|mesh-list
64781350|NCT02653872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781351|NCT02653872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64781352|NCT02653872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64781353|NCT02653872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64781354|NCT02653872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64781355|NCT02653872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64781356|NCT02653872|Vasodilator Agents|vasodilator agents|mesh-ancestor
64781357|NCT02653872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64781358|NCT02655354|Diphenhydramine|diphenhydramine|mesh-list
64781359|NCT02655354|Promethazine|promethazine|mesh-list
64781360|NCT02655354|Prazosin|prazosin|mesh-list
64781361|NCT02655354|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64781363|NCT02655354|Fluvoxamine|fluvoxamine|mesh-list
64781364|NCT02655354|Trazodone|trazodone|mesh-list
64781365|NCT02655354|Sertraline|sertraline|mesh-list
64781366|NCT02655354|Fluoxetine|fluoxetine|mesh-list
64781367|NCT02655354|Paroxetine|paroxetine|mesh-list
64781368|NCT02655354|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64781369|NCT02655354|Citalopram|citalopram|mesh-list
64781370|NCT02655354|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64392744|NCT02698891|Paclitaxel|paclitaxel|mesh-list
64781391|NCT02655354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64781392|NCT02655354|Anesthetics, Local|anesthetics, local|mesh-ancestor
64781415|NCT02657928|Letrozole|letrozole|mesh-list
64392861|NCT05106803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64392863|NCT05106803|Antimalarials|antimalarials|mesh-ancestor
64392864|NCT05106803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64392865|NCT05106803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64392889|NCT05106179|Adrenergic Agents|adrenergic agents|mesh-ancestor
64392890|NCT05106179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64392891|NCT05106179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392892|NCT05106179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392893|NCT05106179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64392894|NCT05106179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64392895|NCT05106179|Vasodilator Agents|vasodilator agents|mesh-ancestor
64392896|NCT05106179|Sympatholytics|sympatholytics|mesh-ancestor
64392918|NCT02406781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392919|NCT02406781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64392920|NCT05106023|Temozolomide|temozolomide|mesh-list
64392921|NCT05106023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64392922|NCT05106023|Alkylating Agents|alkylating agents|mesh-ancestor
64392923|NCT05106023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392924|NCT05106023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64392925|NCT02398123|Bupivacaine|bupivacaine|mesh-list
64781522|NCT02701062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781524|NCT02704104|Coagulants|coagulants|mesh-ancestor
64781525|NCT02705352|Fluorouracil|fluorouracil|mesh-list
64781526|NCT02705352|Antimetabolites|antimetabolites|mesh-ancestor
64781527|NCT02705352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781528|NCT02705352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64781529|NCT02705352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781530|NCT02705352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64781531|NCT02705352|Immunologic Factors|immunologic factors|mesh-ancestor
64781532|NCT02705352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781533|NCT02708238|Simethicone|simethicone|mesh-list
64781534|NCT02708238|Antifoaming Agents|antifoaming agents|mesh-ancestor
64781535|NCT02708238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781536|NCT02708238|Emollients|emollients|mesh-ancestor
64781537|NCT02708238|Dermatologic Agents|dermatologic agents|mesh-ancestor
64781540|NCT02709018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64392926|NCT02398123|Anesthetics, Local|anesthetics, local|mesh-ancestor
64392983|NCT02658149|Anesthetics, Local|anesthetics, local|mesh-ancestor
64392984|NCT02658149|Anesthetics|anesthetics|mesh-ancestor
64392985|NCT02658149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64392986|NCT02658149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64392987|NCT02658149|Adrenergic Agents|adrenergic agents|mesh-ancestor
64392988|NCT02658149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64392989|NCT02658149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392990|NCT02658149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64392991|NCT02658149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64392992|NCT02658149|Autonomic Agents|autonomic agents|mesh-ancestor
64392993|NCT02658149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64781584|NCT02716818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64392994|NCT02658149|Respiratory System Agents|respiratory system agents|mesh-ancestor
64392995|NCT02658149|Mydriatics|mydriatics|mesh-ancestor
64392996|NCT02658149|Sympathomimetics|sympathomimetics|mesh-ancestor
64392997|NCT02658149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64392998|NCT02658149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64393189|NCT03170323|Mycophenolic Acid|mycophenolic acid|mesh-list
64393207|NCT02396563|Anesthetics, Local|anesthetics, local|mesh-ancestor
64393208|NCT02396563|Anesthetics|anesthetics|mesh-ancestor
64393209|NCT02396563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64393210|NCT02396563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393211|NCT02396563|Sensory System Agents|sensory system agents|mesh-ancestor
64393212|NCT02396563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393213|NCT05109377|Tadalafil|tadalafil|mesh-list
64393214|NCT05109377|Vasodilator Agents|vasodilator agents|mesh-ancestor
64393215|NCT05109377|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64393216|NCT05109377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64393217|NCT05109377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393218|NCT05109377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393219|NCT05109377|Urological Agents|urological agents|mesh-ancestor
64393220|NCT05109299|Fluorides|fluorides|mesh-list
64393222|NCT05109299|Protective Agents|protective agents|mesh-ancestor
64393284|NCT04309877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393285|NCT04309877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393286|NCT04309877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64393287|NCT04309877|Respiratory System Agents|respiratory system agents|mesh-ancestor
64393288|NCT04309877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64393289|NCT04309877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393290|NCT04309877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393291|NCT04309877|Vasodilator Agents|vasodilator agents|mesh-ancestor
64393292|NCT04309877|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64393293|NCT04309877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64393294|NCT04309877|Purinergic Agents|purinergic agents|mesh-ancestor
64393376|NCT03540875|Sensory System Agents|sensory system agents|mesh-ancestor
64393377|NCT03540875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393378|NCT03536507|Acetazolamide|acetazolamide|mesh-list
64393379|NCT03536507|Anticonvulsants|anticonvulsants|mesh-ancestor
64393380|NCT03536507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64393381|NCT03536507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393382|NCT03536507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393383|NCT03536507|Diuretics|diuretics|mesh-ancestor
64393384|NCT03536507|Natriuretic Agents|natriuretic agents|mesh-ancestor
64393393|NCT04765787|Antipyretics|antipyretics|mesh-ancestor
64393394|NCT04765787|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64393395|NCT04765787|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64393397|NCT04765787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64393414|NCT02944799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64393415|NCT02944799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64393416|NCT05115149|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
64782176|NCT02905578|Immunologic Factors|immunologic factors|mesh-ancestor
64782177|NCT02905578|Antioxidants|antioxidants|mesh-ancestor
64550858|NCT01397201|Xhance|xhance|mesh-list
64782179|NCT00783510|Adalimumab|adalimumab|mesh-list
64782180|NCT00783510|Methotrexate|methotrexate|mesh-list
64471770|NCT04140396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64782181|NCT00783510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64782183|NCT00783510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64782184|NCT00783510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782185|NCT00783510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64782186|NCT00783510|Antimetabolites|antimetabolites|mesh-ancestor
64782187|NCT00783510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782188|NCT00783510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782189|NCT00783510|Dermatologic Agents|dermatologic agents|mesh-ancestor
64782190|NCT00783510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782191|NCT00783510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64782192|NCT00783510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64782193|NCT00783510|Immunologic Factors|immunologic factors|mesh-ancestor
64782194|NCT00783510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64782195|NCT00783510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64393757|NCT05120687|Adalimumab|adalimumab|mesh-list
64393758|NCT05120687|Cyclophosphamide|cyclophosphamide|mesh-list
64393759|NCT05120687|Methotrexate|methotrexate|mesh-list
64393760|NCT05120687|Cyclosporins|cyclosporins|mesh-list
64393761|NCT05120687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64393762|NCT05120687|Immunologic Factors|immunologic factors|mesh-ancestor
64393763|NCT05120687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393764|NCT05120687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64393774|NCT05120687|Antimetabolites|antimetabolites|mesh-ancestor
64393786|NCT05120687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64393787|NCT03416855|Insulin|insulin|mesh-list
64393788|NCT03416855|Insulin Aspart|insulin aspart|mesh-list
64393789|NCT03416855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64393790|NCT03416855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393791|NCT05121779|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64393792|NCT05121779|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64393793|NCT05121779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393819|NCT05121233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393820|NCT05745259|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64393822|NCT05745259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64393823|NCT05745259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64393824|NCT05745259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393825|NCT02893241|Cafedrine|cafedrine|mesh-list
64393986|NCT03169777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64393987|NCT03169777|Hormone Antagonists|hormone antagonists|mesh-ancestor
64393989|NCT01980706|Baclofen|baclofen|mesh-list
64782621|NCT03568890|Antipyretics|antipyretics|mesh-ancestor
64782622|NCT03568890|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64782623|NCT03568890|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64782624|NCT03568890|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64782625|NCT03568890|Purinergic Agents|purinergic agents|mesh-ancestor
64782626|NCT03568890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64782627|NCT03568890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64782628|NCT03568890|Antithrombins|antithrombins|mesh-ancestor
64394058|NCT04255277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64394059|NCT04255277|Antidotes|antidotes|mesh-ancestor
64394060|NCT04255277|Protective Agents|protective agents|mesh-ancestor
64394061|NCT04255277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64394062|NCT04255277|Estrogens|estrogens|mesh-ancestor
64394063|NCT04255277|Hormones|hormones|mesh-ancestor
64394096|NCT05117957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394156|NCT02393599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64394157|NCT02393599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782853|NCT02821338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782854|NCT02821338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64782855|NCT02821338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64782856|NCT02821338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64782857|NCT02821338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64471771|NCT04140396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64394302|NCT03106363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394303|NCT03106363|Hormones|hormones|mesh-ancestor
64394304|NCT03106363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64394305|NCT03106519|Bupivacaine|bupivacaine|mesh-list
64394306|NCT03106519|Anesthetics, Local|anesthetics, local|mesh-ancestor
64394375|NCT01057121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64394376|NCT01057121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64394377|NCT01057121|Growth Substances|growth substances|mesh-ancestor
64394378|NCT01057121|Growth Inhibitors|growth inhibitors|mesh-ancestor
64394379|NCT01057121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394381|NCT02695537|Anticonvulsants|anticonvulsants|mesh-ancestor
64394382|NCT04620941|Chrysarobin|chrysarobin|mesh-list
64394383|NCT04620941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64394384|NCT04620941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64394385|NCT04620941|Analgesics|analgesics|mesh-ancestor
64394386|NCT04620941|Sensory System Agents|sensory system agents|mesh-ancestor
64394387|NCT04620941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64394388|NCT04620941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394389|NCT04620941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64394390|NCT04620941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64394406|NCT04746989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394467|NCT03874091|Epinephryl borate|epinephryl borate|mesh-list
64394468|NCT03874091|Anesthetics, Local|anesthetics, local|mesh-ancestor
64394582|NCT03165097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64394583|NCT03165097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394584|NCT03165097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64394585|NCT03165097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64394586|NCT03165097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64394588|NCT03165097|Anesthetics, General|anesthetics, general|mesh-ancestor
64394596|NCT03165097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64394597|NCT03165409|Nivolumab|nivolumab|mesh-list
64394598|NCT03165409|Ipilimumab|ipilimumab|mesh-list
64394599|NCT03165409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64394631|NCT04563845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64394632|NCT04563845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64394670|NCT05697055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64394671|NCT05697055|Protease Inhibitors|protease inhibitors|mesh-ancestor
64394672|NCT05697055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394673|NCT05697055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394732|NCT03165253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64394733|NCT05543317|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64394734|NCT05543317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64394735|NCT05543317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394736|NCT04718389|Benralizumab|benralizumab|mesh-list
64394737|NCT04718389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64394738|NCT04718389|Respiratory System Agents|respiratory system agents|mesh-ancestor
64394791|NCT01999114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64394792|NCT01999114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394793|NCT01999114|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64394794|NCT01999114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64394795|NCT01999114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64394796|NCT01999114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64394797|NCT01999114|Narcotics|narcotics|mesh-ancestor
64394798|NCT01999114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64394799|NCT01999114|Analgesics|analgesics|mesh-ancestor
64394826|NCT02214407|Antisickling Agents|antisickling agents|mesh-ancestor
64394827|NCT02214407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64394828|NCT01899989|Carboplatin|carboplatin|mesh-list
64394829|NCT01899989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394830|NCT02261285|Nivolumab|nivolumab|mesh-list
64394837|NCT01288625|Protective Agents|protective agents|mesh-ancestor
64394838|NCT01288625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394839|NCT01374451|Everolimus|everolimus|mesh-list
64394840|NCT01374451|Pasireotide|pasireotide|mesh-list
64394841|NCT01374451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394842|NCT01374451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64394843|NCT01374451|Immunologic Factors|immunologic factors|mesh-ancestor
64394847|NCT02674399|Hylan|hylan|mesh-list
64394873|NCT03161509|GABA Agents|gaba agents|mesh-ancestor
64395147|NCT05030545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64395148|NCT05030545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395149|NCT05030545|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64395150|NCT05030545|Diuretics|diuretics|mesh-ancestor
64395162|NCT00754949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64395164|NCT00754949|Autonomic Agents|autonomic agents|mesh-ancestor
64395165|NCT00754949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395166|NCT00754949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395167|NCT00754949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64395168|NCT00754949|Glucocorticoids|glucocorticoids|mesh-ancestor
64395169|NCT00754949|Hormones|hormones|mesh-ancestor
64783827|NCT03287310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64783828|NCT03287310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64396231|NCT03412591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396232|NCT03377023|Nivolumab|nivolumab|mesh-list
64396233|NCT03377023|Ipilimumab|ipilimumab|mesh-list
64396257|NCT00916747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64396258|NCT00916747|Antimetabolites|antimetabolites|mesh-ancestor
64396259|NCT00916747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396260|NCT00916747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64396261|NCT00916747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64396262|NCT00916747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396263|NCT02391883|Clopidogrel|clopidogrel|mesh-list
64396264|NCT02391883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64396265|NCT02391883|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64396283|NCT02391805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396285|NCT02391805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64396286|NCT02391181|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64396287|NCT02391181|Hematinics|hematinics|mesh-ancestor
64396288|NCT02381899|Rituximab|rituximab|mesh-list
64396289|NCT02381899|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64396290|NCT02381899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64951658|NCT00054873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64951659|NCT00054873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951660|NCT00054873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951661|NCT00054873|Immunologic Factors|immunologic factors|mesh-ancestor
64951662|NCT00054873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951663|NCT00054873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785117|NCT05524584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64785119|NCT05524584|Hormone Antagonists|hormone antagonists|mesh-ancestor
64785120|NCT05524584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64396318|NCT02386033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396354|NCT03105661|Sympatholytics|sympatholytics|mesh-ancestor
64396355|NCT03105661|Autonomic Agents|autonomic agents|mesh-ancestor
64396356|NCT03105661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64396357|NCT03105661|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64471774|NCT04119284|Terephthalic acid|terephthalic acid|mesh-list
64786364|NCT00002010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786365|NCT00002010|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64951664|NCT00398385|Gemcitabine|gemcitabine|mesh-list
64951665|NCT00398385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951666|NCT00398385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64951667|NCT00398385|Antimetabolites|antimetabolites|mesh-ancestor
64951668|NCT00398385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951669|NCT00398385|Antiviral Agents|antiviral agents|mesh-ancestor
64951670|NCT00398385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951671|NCT00398385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951672|NCT00398385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951673|NCT00398385|Immunologic Factors|immunologic factors|mesh-ancestor
64951674|NCT00398385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951675|NCT00027014|Fentanyl|fentanyl|mesh-list
64951676|NCT00027014|Oxycodone|oxycodone|mesh-list
64951677|NCT00027014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64951678|NCT00027014|Narcotics|narcotics|mesh-ancestor
64951679|NCT00027014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64951680|NCT00027014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951681|NCT00027014|Analgesics|analgesics|mesh-ancestor
64951682|NCT00027014|Sensory System Agents|sensory system agents|mesh-ancestor
64951683|NCT00027014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64951684|NCT00027014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64951685|NCT00027014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64951686|NCT00027014|Anesthetics, General|anesthetics, general|mesh-ancestor
64951687|NCT00027014|Anesthetics|anesthetics|mesh-ancestor
64951688|NCT00398424|Cisplatin|cisplatin|mesh-list
64951689|NCT00398424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951690|NCT00027053|Trazodone|trazodone|mesh-list
64951691|NCT00027053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64951692|NCT00027053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64951693|NCT00027053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64951694|NCT00027053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951695|NCT00027053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64951696|NCT00027053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64591789|NCT02121041|Amlodipine|amlodipine|mesh-list
64951697|NCT00027053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64951698|NCT00027053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64951699|NCT00027053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951700|NCT00027053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64951702|NCT00027053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64951703|NCT00027053|Antidepressive Agents|antidepressive agents|mesh-ancestor
64951704|NCT00055107|Nitazoxanide|nitazoxanide|mesh-list
64786366|NCT00002010|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64786367|NCT00002022|Epoetin Alfa|epoetin alfa|mesh-list
64786368|NCT00002022|Hematinics|hematinics|mesh-ancestor
64786369|NCT00002028|Didanosine|didanosine|mesh-list
64786370|NCT00002028|Antimetabolites|antimetabolites|mesh-ancestor
64786371|NCT00002028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786372|NCT00002028|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786373|NCT00002028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786374|NCT00002028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786375|NCT00002028|Antiviral Agents|antiviral agents|mesh-ancestor
64786376|NCT00002028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786377|NCT00002028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786378|NCT00002028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786379|NCT00002034|Zidovudine|zidovudine|mesh-list
64786380|NCT00002034|Ganciclovir|ganciclovir|mesh-list
64786381|NCT00002034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64786382|NCT00002034|Antimetabolites|antimetabolites|mesh-ancestor
64786383|NCT00002034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786384|NCT00002034|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786385|NCT00002034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786406|NCT00002046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786407|NCT00002046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786408|NCT00002046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786409|NCT00002046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786410|NCT00002046|Antiviral Agents|antiviral agents|mesh-ancestor
64786411|NCT00002046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786412|NCT00002046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786413|NCT00002046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786414|NCT00002052|Amoxicillin|amoxicillin|mesh-list
64786415|NCT00002052|Ceftriaxone|ceftriaxone|mesh-list
64786416|NCT00002052|Ampicillin|ampicillin|mesh-list
64786430|NCT00002064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64786431|NCT00002064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786432|NCT00002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786434|NCT00002064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64786435|NCT00002064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64786436|NCT00002064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64786437|NCT00002070|Ganciclovir|ganciclovir|mesh-list
64786438|NCT00002070|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64786439|NCT00002070|Sargramostim|sargramostim|mesh-list
64786440|NCT00002070|Immunologic Factors|immunologic factors|mesh-ancestor
64786459|NCT00002076|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64786460|NCT00002082|Azithromycin|azithromycin|mesh-list
64786461|NCT00002082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64786462|NCT00002082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786463|NCT00002094|Atevirdine|atevirdine|mesh-list
64786464|NCT00002094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786465|NCT00002094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786466|NCT00002094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786467|NCT00002094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786519|NCT00002124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786520|NCT00002124|Antiviral Agents|antiviral agents|mesh-ancestor
64786521|NCT00002124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786522|NCT00002124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786523|NCT00002124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786524|NCT00002124|Antimetabolites|antimetabolites|mesh-ancestor
64786525|NCT00002130|Vesnarinone|vesnarinone|mesh-list
64786526|NCT00002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64786527|NCT00002130|Immunologic Factors|immunologic factors|mesh-ancestor
64786528|NCT00002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786529|NCT00002130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64786530|NCT00002130|Antiviral Agents|antiviral agents|mesh-ancestor
64786531|NCT00002130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786532|NCT00002130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64786533|NCT00002130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64786534|NCT00002130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786535|NCT00002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786536|NCT00002130|Protective Agents|protective agents|mesh-ancestor
64786537|NCT00002142|Cidofovir|cidofovir|mesh-list
64786538|NCT00002142|Probenecid|probenecid|mesh-list
64786539|NCT00002142|Uricosuric Agents|uricosuric agents|mesh-ancestor
64786540|NCT00002142|Gout Suppressants|gout suppressants|mesh-ancestor
64786541|NCT00002142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64786542|NCT00002142|Renal Agents|renal agents|mesh-ancestor
64786543|NCT00002142|Antiviral Agents|antiviral agents|mesh-ancestor
64786544|NCT00002142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786545|NCT00002142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786546|NCT00002142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786547|NCT00002148|OPC 14117|opc 14117|mesh-list
64786549|NCT00002148|Antioxidants|antioxidants|mesh-ancestor
64786573|NCT00002160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64786574|NCT00002160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786575|NCT00002160|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64786576|NCT00002160|Protective Agents|protective agents|mesh-ancestor
64786577|NCT00002160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64786578|NCT00002160|Analgesics|analgesics|mesh-ancestor
64786579|NCT00002160|Sensory System Agents|sensory system agents|mesh-ancestor
64786580|NCT00002160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64786581|NCT00002166|Nevirapine|nevirapine|mesh-list
64786582|NCT00002166|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786583|NCT00002166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786584|NCT00002166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786585|NCT00002166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786586|NCT00002166|Antiviral Agents|antiviral agents|mesh-ancestor
64786587|NCT00002166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786588|NCT00002166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786589|NCT00002166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786590|NCT00002166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64786591|NCT00002166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64786592|NCT00002178|Ritonavir|ritonavir|mesh-list
64786593|NCT00002178|Nelfinavir|nelfinavir|mesh-list
64786594|NCT00002178|Saquinavir|saquinavir|mesh-list
64786595|NCT00002178|Delavirdine|delavirdine|mesh-list
64786596|NCT00002178|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64786597|NCT00002178|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64786598|NCT00002178|Protease Inhibitors|protease inhibitors|mesh-ancestor
64786599|NCT00002178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786601|NCT00002178|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786636|NCT00002190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786637|NCT00002190|Antiviral Agents|antiviral agents|mesh-ancestor
64786638|NCT00002190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786639|NCT00002190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786640|NCT00002190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786641|NCT00002190|Antimetabolites|antimetabolites|mesh-ancestor
64786642|NCT00002190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64786643|NCT00002190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64786644|NCT00002190|Protease Inhibitors|protease inhibitors|mesh-ancestor
64786645|NCT00002190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64786646|NCT00002190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64786647|NCT00002202|Indinavir|indinavir|mesh-list
64786648|NCT00002202|Amprenavir|amprenavir|mesh-list
64786649|NCT00002202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64786650|NCT00002202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64786651|NCT00002202|Protease Inhibitors|protease inhibitors|mesh-ancestor
64786652|NCT00002202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555267|NCT03023501|Anticonvulsants|anticonvulsants|mesh-ancestor
64786653|NCT00002202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786654|NCT00002202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786655|NCT00002202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786656|NCT00002202|Antiviral Agents|antiviral agents|mesh-ancestor
64786657|NCT00002202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786658|NCT00002202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64786659|NCT00002202|Antitubercular Agents|antitubercular agents|mesh-ancestor
64786660|NCT00002202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64786696|NCT00002220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64786697|NCT00002220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64786698|NCT00002220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64786699|NCT00002220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64786700|NCT00002220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64786701|NCT00002220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64786702|NCT00002220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64786703|NCT00002220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64786704|NCT00002220|Protease Inhibitors|protease inhibitors|mesh-ancestor
64786705|NCT00002220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786706|NCT00002220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786707|NCT00002226|Semaxinib|semaxinib|mesh-list
64786708|NCT00002226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64786709|NCT00002226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64786710|NCT00002226|Growth Substances|growth substances|mesh-ancestor
64786711|NCT00002226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786712|NCT00002226|Growth Inhibitors|growth inhibitors|mesh-ancestor
64786713|NCT00002226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64786714|NCT00002226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64786715|NCT00002226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786716|NCT00002226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786749|NCT00002274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786750|NCT00002274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786751|NCT00002274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786752|NCT00002274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786753|NCT00002274|Antiviral Agents|antiviral agents|mesh-ancestor
64786754|NCT00002274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786755|NCT00002274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786756|NCT00002274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786757|NCT00002280|Didanosine|didanosine|mesh-list
64786758|NCT00002280|Antimetabolites|antimetabolites|mesh-ancestor
64786759|NCT00002280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786760|NCT00002280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786761|NCT00002280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786762|NCT00002280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786763|NCT00002280|Antiviral Agents|antiviral agents|mesh-ancestor
64786764|NCT00002280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786765|NCT00002280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786766|NCT00002280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786767|NCT00002286|Zidovudine|zidovudine|mesh-list
64786777|NCT00002292|Pentamidine|pentamidine|mesh-list
64786801|NCT00002304|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64786802|NCT00002304|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64786803|NCT00002316|Amphotericin B|amphotericin b|mesh-list
64786804|NCT00002316|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64786805|NCT00002316|Amebicides|amebicides|mesh-ancestor
64786806|NCT00002316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64786807|NCT00002316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64786828|NCT00002334|Antimetabolites|antimetabolites|mesh-ancestor
64786829|NCT00002334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786830|NCT00002334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786831|NCT00002334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786832|NCT00002334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786833|NCT00002334|Antiviral Agents|antiviral agents|mesh-ancestor
64786834|NCT00002334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786835|NCT00002334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786836|NCT00002334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786837|NCT00002334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64786838|NCT00002334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64786839|NCT00002334|Protease Inhibitors|protease inhibitors|mesh-ancestor
64786840|NCT00002334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64786841|NCT00002334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64786843|NCT00002340|Pentamidine|pentamidine|mesh-list
64786844|NCT00002340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786880|NCT00002364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786881|NCT00002364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786883|NCT00002370|Antifungal Agents|antifungal agents|mesh-ancestor
64786884|NCT00002370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786885|NCT00002370|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64786886|NCT00002370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64786887|NCT00002370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786888|NCT00002370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786889|NCT00002370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64786890|NCT00002370|Hormone Antagonists|hormone antagonists|mesh-ancestor
64786891|NCT00002370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64786892|NCT00002370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786893|NCT00002370|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64786894|NCT00002376|Lamivudine|lamivudine|mesh-list
64786895|NCT00002376|Zidovudine|zidovudine|mesh-list
64786896|NCT00002376|Didanosine|didanosine|mesh-list
64786897|NCT00002376|Stavudine|stavudine|mesh-list
64786898|NCT00002376|Indinavir|indinavir|mesh-list
64786899|NCT00002376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786900|NCT00002376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786901|NCT00002376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786943|NCT00002400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786944|NCT00002400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786945|NCT00002400|Antiviral Agents|antiviral agents|mesh-ancestor
64786946|NCT00002400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786947|NCT00002400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786948|NCT00002400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786949|NCT00002400|Antimetabolites|antimetabolites|mesh-ancestor
64786950|NCT00002400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64555584|NCT05018988|Vitamin D|vitamin d|mesh-list
64786951|NCT00002400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64786952|NCT00002400|Protease Inhibitors|protease inhibitors|mesh-ancestor
64786953|NCT00002406|Indinavir|indinavir|mesh-list
64786954|NCT00002406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64786955|NCT00002406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64786956|NCT00002406|Protease Inhibitors|protease inhibitors|mesh-ancestor
64786957|NCT00002406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786958|NCT00002406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786959|NCT00002406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786960|NCT00002406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786961|NCT00002406|Antiviral Agents|antiviral agents|mesh-ancestor
64786962|NCT00002406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786963|NCT00002412|Didanosine|didanosine|mesh-list
64786964|NCT00002412|Stavudine|stavudine|mesh-list
64786965|NCT00002412|Emivirine|emivirine|mesh-list
64786966|NCT00002412|Hydroxyurea|hydroxyurea|mesh-list
64786967|NCT00002412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64786968|NCT00002412|Antisickling Agents|antisickling agents|mesh-ancestor
64786969|NCT00002412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786970|NCT00002412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786971|NCT00002412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786972|NCT00002412|Antimetabolites|antimetabolites|mesh-ancestor
64786973|NCT00002412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786974|NCT00002412|Antiviral Agents|antiviral agents|mesh-ancestor
64786975|NCT00002412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786976|NCT00002412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786985|NCT00002418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786986|NCT00002418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786987|NCT00002418|Antiviral Agents|antiviral agents|mesh-ancestor
64786988|NCT00002418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786989|NCT00002418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786990|NCT00002418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786991|NCT00002418|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64786992|NCT00002418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64786993|NCT00002418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64786994|NCT00002418|Antisickling Agents|antisickling agents|mesh-ancestor
64786995|NCT00002418|Antimetabolites|antimetabolites|mesh-ancestor
64786996|NCT00002424|Lamivudine|lamivudine|mesh-list
64786997|NCT00002424|Stavudine|stavudine|mesh-list
64786998|NCT00002424|Indinavir|indinavir|mesh-list
64787007|NCT00002424|Antimetabolites|antimetabolites|mesh-ancestor
64787008|NCT00002424|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64787009|NCT00002424|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64787010|NCT00002424|Protease Inhibitors|protease inhibitors|mesh-ancestor
64787012|NCT00002430|Stavudine|stavudine|mesh-list
64787051|NCT00002442|Antimetabolites|antimetabolites|mesh-ancestor
64787052|NCT00002442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64787053|NCT00002442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64787054|NCT00002442|Protease Inhibitors|protease inhibitors|mesh-ancestor
64787055|NCT00002448|Ritonavir|ritonavir|mesh-list
64787056|NCT00002448|Saquinavir|saquinavir|mesh-list
64787057|NCT00002448|Efavirenz|efavirenz|mesh-list
64787058|NCT00002448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64787059|NCT00002448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64787060|NCT00002448|Protease Inhibitors|protease inhibitors|mesh-ancestor
64787061|NCT00002448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787062|NCT00002448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787063|NCT00002448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64787064|NCT00002448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64787065|NCT00002448|Antiviral Agents|antiviral agents|mesh-ancestor
64787066|NCT00002448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64787081|NCT00002460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787082|NCT00002460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64787083|NCT00002460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787084|NCT00002460|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64787085|NCT00002460|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64787086|NCT00002460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64787087|NCT00002466|Cyclophosphamide|cyclophosphamide|mesh-list
64787088|NCT00002466|Ifosfamide|ifosfamide|mesh-list
64787089|NCT00002466|Doxorubicin|doxorubicin|mesh-list
64787090|NCT00002466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64787091|NCT00002466|Etoposide|etoposide|mesh-list
64787092|NCT00002466|Vincristine|vincristine|mesh-list
64787093|NCT00002466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64787094|NCT00002466|Immunologic Factors|immunologic factors|mesh-ancestor
64787095|NCT00002466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787096|NCT00002466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64787098|NCT00002466|Alkylating Agents|alkylating agents|mesh-ancestor
64787107|NCT00002466|Tubulin Modulators|tubulin modulators|mesh-ancestor
64787108|NCT00002466|Antimitotic Agents|antimitotic agents|mesh-ancestor
64787109|NCT00002466|Mitosis Modulators|mitosis modulators|mesh-ancestor
64787110|NCT00002472|Etoposide|etoposide|mesh-list
64787111|NCT00002472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787112|NCT00002472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64787113|NCT00002472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64787114|NCT00002472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64787115|NCT00002472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787116|NCT00002472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787117|NCT00002478|Etoposide|etoposide|mesh-list
64787118|NCT00002478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64787119|NCT00002478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787120|NCT00002478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64787121|NCT00002478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64787122|NCT00002478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787131|NCT00002490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64787132|NCT00002490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787133|NCT00002490|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64787134|NCT00002490|Immunologic Factors|immunologic factors|mesh-ancestor
64787135|NCT00002490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787137|NCT00002496|Fluorouracil|fluorouracil|mesh-list
64787138|NCT00002496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787139|NCT00002496|Antimetabolites|antimetabolites|mesh-ancestor
64787167|NCT00002508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64787168|NCT00002508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64787169|NCT00002508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787170|NCT00002508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787171|NCT00002514|Leucovorin|leucovorin|mesh-list
64787172|NCT00002514|Cytarabine|cytarabine|mesh-list
64787173|NCT00002514|Dexamethasone|dexamethasone|mesh-list
64787174|NCT00002514|Prednisone|prednisone|mesh-list
64787175|NCT00002514|Cyclophosphamide|cyclophosphamide|mesh-list
64787176|NCT00002514|Methotrexate|methotrexate|mesh-list
64787177|NCT00002514|Etoposide|etoposide|mesh-list
64787178|NCT00002514|Vincristine|vincristine|mesh-list
64787179|NCT00002514|Imatinib Mesylate|imatinib mesylate|mesh-list
64787180|NCT00002514|Daunorubicin|daunorubicin|mesh-list
64787181|NCT00002514|Asparaginase|asparaginase|mesh-list
64787182|NCT00002514|Mercaptopurine|mercaptopurine|mesh-list
64787183|NCT00002514|Thioguanine|thioguanine|mesh-list
64787184|NCT00002514|Sargramostim|sargramostim|mesh-list
64787185|NCT00002514|Levoleucovorin|levoleucovorin|mesh-list
64787186|NCT00002514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64787187|NCT00002514|Immunologic Factors|immunologic factors|mesh-ancestor
64787188|NCT00002514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787189|NCT00002514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64787190|NCT00002514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64787191|NCT00002514|Alkylating Agents|alkylating agents|mesh-ancestor
64787239|NCT00002526|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64787240|NCT00002526|Ifosfamide|ifosfamide|mesh-list
64787241|NCT00002526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64787242|NCT00002526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787243|NCT00002526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64787244|NCT00002526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64787245|NCT00002526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787246|NCT00002526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787247|NCT00002526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64787248|NCT00002526|Alkylating Agents|alkylating agents|mesh-ancestor
64787258|NCT00002532|Idarubicin|idarubicin|mesh-list
64787259|NCT00002532|Vindesine|vindesine|mesh-list
64787260|NCT00002532|Levoleucovorin|levoleucovorin|mesh-list
64787261|NCT00002532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64787262|NCT00002532|Antiemetics|antiemetics|mesh-ancestor
64787263|NCT00002532|Autonomic Agents|autonomic agents|mesh-ancestor
64787264|NCT00002532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64787265|NCT00002532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787266|NCT00002532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64787267|NCT00002532|Glucocorticoids|glucocorticoids|mesh-ancestor
64787268|NCT00002532|Hormones|hormones|mesh-ancestor
64787269|NCT00002532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64787270|NCT00002532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64787271|NCT00002532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787272|NCT00002532|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64787273|NCT00002532|Abortifacient Agents|abortifacient agents|mesh-ancestor
64787274|NCT00002532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64787275|NCT00002532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64787292|NCT00002532|Vitamin B Complex|vitamin b complex|mesh-ancestor
64787294|NCT00002532|Micronutrients|micronutrients|mesh-ancestor
64787295|NCT00002532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64787296|NCT00002532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64787297|NCT00002532|Alkylating Agents|alkylating agents|mesh-ancestor
64787298|NCT00002532|Tubulin Modulators|tubulin modulators|mesh-ancestor
64787299|NCT00002532|Antimitotic Agents|antimitotic agents|mesh-ancestor
64787300|NCT00002532|Mitosis Modulators|mitosis modulators|mesh-ancestor
64787301|NCT00002544|Docetaxel|docetaxel|mesh-list
64787302|NCT00002544|Mitoxantrone|mitoxantrone|mesh-list
64787303|NCT00002544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787304|NCT00002544|Tubulin Modulators|tubulin modulators|mesh-ancestor
64787305|NCT00002544|Antimitotic Agents|antimitotic agents|mesh-ancestor
64787306|NCT00002544|Mitosis Modulators|mitosis modulators|mesh-ancestor
64787307|NCT00002544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787308|NCT00002544|Analgesics|analgesics|mesh-ancestor
64787309|NCT00002544|Sensory System Agents|sensory system agents|mesh-ancestor
64787310|NCT00002544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64787311|NCT00002544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787312|NCT00002544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64787313|NCT00002544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64787314|NCT00002544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787315|NCT00002550|Etoposide|etoposide|mesh-list
64787316|NCT00002550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787317|NCT00002550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64787318|NCT00002550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64787319|NCT00002550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64787320|NCT00002550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787333|NCT00002556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64787335|NCT00002556|Alkylating Agents|alkylating agents|mesh-ancestor
64787350|NCT00002562|Paclitaxel|paclitaxel|mesh-list
64787351|NCT00002562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64787352|NCT00002562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787353|NCT00002562|Tubulin Modulators|tubulin modulators|mesh-ancestor
64787354|NCT00002562|Antimitotic Agents|antimitotic agents|mesh-ancestor
64787355|NCT00002562|Mitosis Modulators|mitosis modulators|mesh-ancestor
64787356|NCT00002562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787357|NCT00002568|Paclitaxel|paclitaxel|mesh-list
64787358|NCT00002568|Cisplatin|cisplatin|mesh-list
64787359|NCT00002568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64787360|NCT00002568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787361|NCT00002568|Tubulin Modulators|tubulin modulators|mesh-ancestor
64787362|NCT00002568|Antimitotic Agents|antimitotic agents|mesh-ancestor
64787363|NCT00002568|Mitosis Modulators|mitosis modulators|mesh-ancestor
64787364|NCT00002568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787365|NCT00002574|Interferons|interferons|mesh-list
64787366|NCT00002574|Interferon-alpha|interferon-alpha|mesh-list
64787367|NCT00002574|Homoharringtonine|homoharringtonine|mesh-list
64787368|NCT00002574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787369|NCT00002574|Antiviral Agents|antiviral agents|mesh-ancestor
64787370|NCT00002574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64471809|NCT04094961|Antiemetics|antiemetics|mesh-ancestor
64471810|NCT04094961|Autonomic Agents|autonomic agents|mesh-ancestor
64787371|NCT00002574|Immunologic Factors|immunologic factors|mesh-ancestor
64787372|NCT00002574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787373|NCT00002574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64787374|NCT00002574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64787375|NCT00002574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787376|NCT00002574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787377|NCT00002580|Tamoxifen|tamoxifen|mesh-list
64787396|NCT00002580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64787397|NCT00002580|Dermatologic Agents|dermatologic agents|mesh-ancestor
64787398|NCT00002580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787399|NCT00002580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64787400|NCT00002580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64787401|NCT00002580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64787402|NCT00002580|Hormone Antagonists|hormone antagonists|mesh-ancestor
64787403|NCT00002580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64787404|NCT00002580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64787405|NCT00002580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64787406|NCT00002580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64787407|NCT00002580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64787408|NCT00002580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64787409|NCT00002580|Fertility Agents|fertility agents|mesh-ancestor
64556031|NCT05006664|Glucocorticoids|glucocorticoids|mesh-ancestor
64787410|NCT00002586|Vitamin E|vitamin e|mesh-list
64787411|NCT00002586|Tocopherols|tocopherols|mesh-list
64787412|NCT00002586|Tocotrienols|tocotrienols|mesh-list
64787413|NCT00002586|alpha-Tocopherol|alpha-tocopherol|mesh-list
64787414|NCT00002586|Tretinoin|tretinoin|mesh-list
64787415|NCT00002586|Isotretinoin|isotretinoin|mesh-list
64787416|NCT00002586|Vitamins|vitamins|mesh-ancestor
64787417|NCT00002586|Micronutrients|micronutrients|mesh-ancestor
64787418|NCT00002586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787419|NCT00002586|Antioxidants|antioxidants|mesh-ancestor
64787420|NCT00002586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787421|NCT00002586|Protective Agents|protective agents|mesh-ancestor
64787425|NCT00002592|Cyclophosphamide|cyclophosphamide|mesh-list
64787444|NCT00002598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64787445|NCT00002598|Immunologic Factors|immunologic factors|mesh-ancestor
64787446|NCT00002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471811|NCT04094961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64787447|NCT00002598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64787448|NCT00002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64787449|NCT00002598|Alkylating Agents|alkylating agents|mesh-ancestor
64787450|NCT00002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787451|NCT00002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787452|NCT00002598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64787453|NCT00002598|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64787454|NCT00002598|Abortifacient Agents|abortifacient agents|mesh-ancestor
64787455|NCT00002598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64787456|NCT00002598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64398534|NCT01918306|Cisplatin|cisplatin|mesh-list
64787463|NCT00002598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64787464|NCT00002598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64787465|NCT00002598|Antiviral Agents|antiviral agents|mesh-ancestor
64787466|NCT00002598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64787467|NCT00002598|Analgesics|analgesics|mesh-ancestor
64787502|NCT00002610|Mitosis Modulators|mitosis modulators|mesh-ancestor
64787503|NCT00002610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64787504|NCT00002610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64787505|NCT00002610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64787506|NCT00002610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64787507|NCT00002616|Aldesleukin|aldesleukin|mesh-list
64787508|NCT00002616|Cyclophosphamide|cyclophosphamide|mesh-list
64787510|NCT00002616|Carboplatin|carboplatin|mesh-list
64787511|NCT00002616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64787512|NCT00002616|Immunologic Factors|immunologic factors|mesh-ancestor
64787513|NCT00002616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787514|NCT00002616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64787515|NCT00002616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64787516|NCT00002616|Alkylating Agents|alkylating agents|mesh-ancestor
64787517|NCT00002616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787518|NCT00002616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787519|NCT00002616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64787520|NCT00002616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64787521|NCT00002616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64787522|NCT00002616|Antiviral Agents|antiviral agents|mesh-ancestor
64787523|NCT00002616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64787524|NCT00002628|Paclitaxel|paclitaxel|mesh-list
64787525|NCT00002628|Cyclophosphamide|cyclophosphamide|mesh-list
64787526|NCT00002628|Carboplatin|carboplatin|mesh-list
64787527|NCT00002628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64787559|NCT00002634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64787560|NCT00002634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787561|NCT00002634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64787562|NCT00002634|Tubulin Modulators|tubulin modulators|mesh-ancestor
64787563|NCT00002634|Antimitotic Agents|antimitotic agents|mesh-ancestor
64787564|NCT00002634|Mitosis Modulators|mitosis modulators|mesh-ancestor
64556165|NCT04363203|Antimalarials|antimalarials|mesh-ancestor
64787565|NCT00002634|Trace Elements|trace elements|mesh-ancestor
64787566|NCT00002634|Micronutrients|micronutrients|mesh-ancestor
64787567|NCT00002646|Tamoxifen|tamoxifen|mesh-list
64787568|NCT00002646|Fenretinide|fenretinide|mesh-list
64787569|NCT00002646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64787570|NCT00002646|Hormone Antagonists|hormone antagonists|mesh-ancestor
64787571|NCT00002646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64787572|NCT00002646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787573|NCT00002646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64787574|NCT00002646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787575|NCT00002646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64787576|NCT00002646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64787577|NCT00002646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64787578|NCT00002646|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64787579|NCT00002646|Protective Agents|protective agents|mesh-ancestor
64787580|NCT00002652|Suramin|suramin|mesh-list
64787581|NCT00002652|Antinematodal Agents|antinematodal agents|mesh-ancestor
64787582|NCT00002652|Anthelmintics|anthelmintics|mesh-ancestor
64787583|NCT00002652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64787584|NCT00002652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64787585|NCT00002652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787586|NCT00002652|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64787587|NCT00002652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64787588|NCT00002658|Cytarabine|cytarabine|mesh-list
64787589|NCT00002658|Cyclophosphamide|cyclophosphamide|mesh-list
64787590|NCT00002658|Etoposide|etoposide|mesh-list
64787591|NCT00002658|Daunorubicin|daunorubicin|mesh-list
64787607|NCT00002658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64787608|NCT00002658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64787609|NCT00002658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787610|NCT00002658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64787611|NCT00002658|Antimetabolites|antimetabolites|mesh-ancestor
64787612|NCT00002658|Antiviral Agents|antiviral agents|mesh-ancestor
64787613|NCT00002658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64787614|NCT00002658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64787615|NCT00002658|Analgesics|analgesics|mesh-ancestor
64787616|NCT00002658|Sensory System Agents|sensory system agents|mesh-ancestor
64787617|NCT00002658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64787618|NCT00002658|Keratolytic Agents|keratolytic agents|mesh-ancestor
64787619|NCT00002658|Dermatologic Agents|dermatologic agents|mesh-ancestor
64787620|NCT00002664|Sargramostim|sargramostim|mesh-list
64787621|NCT00002664|Edrecolomab|edrecolomab|mesh-list
64787622|NCT00002664|Immunologic Factors|immunologic factors|mesh-ancestor
64787623|NCT00002664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787624|NCT00002664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64787625|NCT00002670|Cobalt|cobalt|mesh-list
64787626|NCT00002670|Trace Elements|trace elements|mesh-ancestor
64787627|NCT00002670|Micronutrients|micronutrients|mesh-ancestor
64787628|NCT00002670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787629|NCT00002676|Cobalt|cobalt|mesh-list
64787630|NCT00002676|Cytarabine|cytarabine|mesh-list
64787631|NCT00002676|Dexamethasone|dexamethasone|mesh-list
64787632|NCT00002676|Cyclophosphamide|cyclophosphamide|mesh-list
64787661|NCT00002676|Abortifacient Agents|abortifacient agents|mesh-ancestor
64787662|NCT00002676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64787663|NCT00002676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64787664|NCT00002676|Antimetabolites|antimetabolites|mesh-ancestor
64787665|NCT00002676|Dermatologic Agents|dermatologic agents|mesh-ancestor
64787666|NCT00002676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64787667|NCT00002676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64787668|NCT00002676|Antiviral Agents|antiviral agents|mesh-ancestor
64787669|NCT00002676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64787670|NCT00002676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64787671|NCT00002676|Tubulin Modulators|tubulin modulators|mesh-ancestor
64787679|NCT00002682|Tetracycline|tetracycline|mesh-list
64787680|NCT00002682|Omeprazole|omeprazole|mesh-list
64787681|NCT00002682|Bismuth|bismuth|mesh-list
64787682|NCT00002682|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
64787683|NCT00002682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64787684|NCT00002682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64787685|NCT00002682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64787686|NCT00002682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64787687|NCT00002682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64787688|NCT00002682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64787689|NCT00002682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64787690|NCT00002682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787691|NCT00002682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787692|NCT00002682|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64787693|NCT00002682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64787694|NCT00002682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64787695|NCT00002682|Antacids|antacids|mesh-ancestor
64787696|NCT00002682|Antidiarrheals|antidiarrheals|mesh-ancestor
64787697|NCT00002688|Cyclosporine|cyclosporine|mesh-list
64787698|NCT00002688|Etoposide|etoposide|mesh-list
64787710|NCT00002688|Antifungal Agents|antifungal agents|mesh-ancestor
64787711|NCT00002688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64787712|NCT00002688|Dermatologic Agents|dermatologic agents|mesh-ancestor
64787713|NCT00002688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64787714|NCT00002688|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64787715|NCT00002688|Analgesics|analgesics|mesh-ancestor
64787716|NCT00002688|Sensory System Agents|sensory system agents|mesh-ancestor
64787717|NCT00002688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64787718|NCT00002700|Leucovorin|leucovorin|mesh-list
64787719|NCT00002700|Cytarabine|cytarabine|mesh-list
64787720|NCT00002700|Dexamethasone|dexamethasone|mesh-list
64787721|NCT00002700|Prednisone|prednisone|mesh-list
64787722|NCT00002700|Prednisolone|prednisolone|mesh-list
64787723|NCT00002700|Hydrocortisone|hydrocortisone|mesh-list
64787724|NCT00002700|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64787725|NCT00002700|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64787726|NCT00002700|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64787727|NCT00002700|Cyclophosphamide|cyclophosphamide|mesh-list
64787728|NCT00002700|Doxorubicin|doxorubicin|mesh-list
64787729|NCT00002700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64787730|NCT00002700|Methotrexate|methotrexate|mesh-list
64787731|NCT00002700|Vincristine|vincristine|mesh-list
64787732|NCT00002700|Daunorubicin|daunorubicin|mesh-list
64787733|NCT00002700|Asparaginase|asparaginase|mesh-list
64787734|NCT00002700|Mitoxantrone|mitoxantrone|mesh-list
64787735|NCT00002700|Mercaptopurine|mercaptopurine|mesh-list
64787736|NCT00002700|Levoleucovorin|levoleucovorin|mesh-list
64787737|NCT00002700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64787738|NCT00002700|Immunologic Factors|immunologic factors|mesh-ancestor
64787739|NCT00002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787740|NCT00002700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64787741|NCT00002700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64787742|NCT00002700|Alkylating Agents|alkylating agents|mesh-ancestor
64787743|NCT00002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787767|NCT00002700|Antiviral Agents|antiviral agents|mesh-ancestor
64787768|NCT00002700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64787769|NCT00002700|Antidotes|antidotes|mesh-ancestor
64787770|NCT00002700|Protective Agents|protective agents|mesh-ancestor
64787771|NCT00002700|Vitamin B Complex|vitamin b complex|mesh-ancestor
64787772|NCT00002700|Vitamins|vitamins|mesh-ancestor
64787773|NCT00002700|Micronutrients|micronutrients|mesh-ancestor
64787774|NCT00002700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64787775|NCT00002700|Tubulin Modulators|tubulin modulators|mesh-ancestor
64787776|NCT00002700|Antimitotic Agents|antimitotic agents|mesh-ancestor
64787777|NCT00002700|Mitosis Modulators|mitosis modulators|mesh-ancestor
64787778|NCT00002700|Analgesics|analgesics|mesh-ancestor
64787779|NCT00002700|Sensory System Agents|sensory system agents|mesh-ancestor
64787780|NCT00002718|Cytarabine|cytarabine|mesh-list
64787781|NCT00002718|Methylprednisolone|methylprednisolone|mesh-list
64787782|NCT00002718|Cyclophosphamide|cyclophosphamide|mesh-list
64787783|NCT00002718|Thiotepa|thiotepa|mesh-list
64471814|NCT04094961|Glucocorticoids|glucocorticoids|mesh-ancestor
64471815|NCT04094961|Hormones|hormones|mesh-ancestor
64787784|NCT00002718|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64787785|NCT00002718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64787786|NCT00002718|Immunologic Factors|immunologic factors|mesh-ancestor
64787787|NCT00002718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787788|NCT00002718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64787789|NCT00002718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64787790|NCT00002718|Alkylating Agents|alkylating agents|mesh-ancestor
64787791|NCT00002718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787792|NCT00002718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787793|NCT00002718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64787794|NCT00002718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64787795|NCT00002718|Antimetabolites|antimetabolites|mesh-ancestor
64787796|NCT00002718|Antiviral Agents|antiviral agents|mesh-ancestor
64787797|NCT00002718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64787798|NCT00002718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64398879|NCT05026229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64787816|NCT00002730|Immunologic Factors|immunologic factors|mesh-ancestor
64787817|NCT00002730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787818|NCT00002730|Antimetabolites|antimetabolites|mesh-ancestor
64787819|NCT00002730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64787820|NCT00002730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787821|NCT00002730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64787822|NCT00002730|Protective Agents|protective agents|mesh-ancestor
64787823|NCT00002742|Amphotericin B|amphotericin b|mesh-list
64787824|NCT00002742|Nystatin|nystatin|mesh-list
64787825|NCT00002742|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64787826|NCT00002742|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
64787827|NCT00002742|Deoxycholic Acid|deoxycholic acid|mesh-list
64787828|NCT00002742|Amebicides|amebicides|mesh-ancestor
64787829|NCT00002742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64787830|NCT00002742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64787831|NCT00002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64787832|NCT00002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64787833|NCT00002742|Antifungal Agents|antifungal agents|mesh-ancestor
64787834|NCT00002742|Ionophores|ionophores|mesh-ancestor
64787835|NCT00002742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64787836|NCT00002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787837|NCT00002742|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64787838|NCT00002742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64787839|NCT00002748|Interleukin-2|interleukin-2|mesh-list
64787840|NCT00002748|Vaccines|vaccines|mesh-list
64787841|NCT00002748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787842|NCT00002748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64787843|NCT00002748|Analgesics|analgesics|mesh-ancestor
64471816|NCT04094961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64787862|NCT00002760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64787863|NCT00002760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787864|NCT00002760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787865|NCT00002760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64787866|NCT00002760|Hormone Antagonists|hormone antagonists|mesh-ancestor
64787867|NCT00002760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64787868|NCT00002760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787869|NCT00002760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64787870|NCT00002772|Tamoxifen|tamoxifen|mesh-list
64787871|NCT00002772|Paclitaxel|paclitaxel|mesh-list
64787872|NCT00002772|Cyclophosphamide|cyclophosphamide|mesh-list
64787873|NCT00002772|Carboplatin|carboplatin|mesh-list
64787874|NCT00002772|Doxorubicin|doxorubicin|mesh-list
64787875|NCT00002772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64787876|NCT00002772|Thiotepa|thiotepa|mesh-list
64787877|NCT00002772|Carmustine|carmustine|mesh-list
64787878|NCT00002772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64787922|NCT00002784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64787923|NCT00002784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64787924|NCT00002784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787925|NCT00002784|Antimetabolites|antimetabolites|mesh-ancestor
64787926|NCT00002784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64787927|NCT00002784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64787928|NCT00002784|Abortifacient Agents|abortifacient agents|mesh-ancestor
64787929|NCT00002784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64787930|NCT00002784|Dermatologic Agents|dermatologic agents|mesh-ancestor
64787931|NCT00002784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64787932|NCT00002784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64787933|NCT00002784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64787934|NCT00002784|Hormone Antagonists|hormone antagonists|mesh-ancestor
64787935|NCT00002784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64787936|NCT00002784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64787937|NCT00002784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64787938|NCT00002784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64787939|NCT00002784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64787941|NCT00002790|Sirolimus|sirolimus|mesh-list
64787942|NCT00002790|Methotrexate|methotrexate|mesh-list
64787943|NCT00002790|Cyclosporins|cyclosporins|mesh-list
64787944|NCT00002790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64787945|NCT00002790|Abortifacient Agents|abortifacient agents|mesh-ancestor
64399006|NCT05008367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787953|NCT00002790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787954|NCT00002790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64787955|NCT00002790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64787956|NCT00002790|Immunologic Factors|immunologic factors|mesh-ancestor
64787957|NCT00002790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64787958|NCT00002790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64787959|NCT00002790|Antifungal Agents|antifungal agents|mesh-ancestor
64787960|NCT00002790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64787970|NCT05752110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64787971|NCT05752110|Anesthetics, General|anesthetics, general|mesh-ancestor
64787972|NCT05752110|Anesthetics|anesthetics|mesh-ancestor
64787973|NCT05752110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64787974|NCT05752110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64787975|NCT05752110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64787976|NCT05752110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64787977|NCT05752110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787978|NCT05751876|Dienogest|dienogest|mesh-list
64787979|NCT05751876|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64787980|NCT05751876|Contraceptive Agents|contraceptive agents|mesh-ancestor
64787981|NCT05751876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64787982|NCT05751876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787983|NCT05751876|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64787984|NCT05751876|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64787985|NCT05751876|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64787986|NCT05751876|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64787987|NCT05751876|Hormone Antagonists|hormone antagonists|mesh-ancestor
64787988|NCT05751876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64787989|NCT05751876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64787990|NCT05751876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787991|NCT05751252|Ganirelix|ganirelix|mesh-list
64787992|NCT05751252|Hormone Antagonists|hormone antagonists|mesh-ancestor
64787993|NCT05751252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64787994|NCT05751252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787995|NCT05750628|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64787996|NCT05750628|Antimalarials|antimalarials|mesh-ancestor
64787997|NCT05750628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64787998|NCT05750628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64787999|NCT05750628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64788000|NCT05749926|Vaccines|vaccines|mesh-list
64788009|NCT05749614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64788023|NCT05748990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788024|NCT05748834|Doxorubicin|doxorubicin|mesh-list
64788025|NCT05748834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64788026|NCT05748834|Tucatinib|tucatinib|mesh-list
64788027|NCT05748834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64788028|NCT05748834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788029|NCT05748834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64788030|NCT05748834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64788031|NCT05748834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64471817|NCT04094961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64788032|NCT05748834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788033|NCT05748834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64788035|NCT05746806|Hormones|hormones|mesh-ancestor
64788036|NCT05746806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64788037|NCT05746806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788038|NCT05677698|Peppermint oil|peppermint oil|mesh-list
64788039|NCT05677698|Antiemetics|antiemetics|mesh-ancestor
64788040|NCT05677698|Autonomic Agents|autonomic agents|mesh-ancestor
64788041|NCT05677698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64788042|NCT05677698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788043|NCT05677698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64788044|NCT05677698|Parasympatholytics|parasympatholytics|mesh-ancestor
64788045|NCT05588388|Bevacizumab|bevacizumab|mesh-list
64788046|NCT05588388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64788047|NCT05588388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788048|NCT05588388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64788049|NCT05588388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64788050|NCT05588388|Growth Substances|growth substances|mesh-ancestor
64788051|NCT05588388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788052|NCT05588388|Growth Inhibitors|growth inhibitors|mesh-ancestor
64788053|NCT05543850|Pancrelipase|pancrelipase|mesh-list
64788063|NCT05516628|Growth Inhibitors|growth inhibitors|mesh-ancestor
64788064|NCT05497674|Rifampin|rifampin|mesh-list
64788065|NCT05497674|Probenecid|probenecid|mesh-list
64788066|NCT05497674|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64788067|NCT05497674|Antitubercular Agents|antitubercular agents|mesh-ancestor
64788068|NCT05497674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64788069|NCT05497674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64788070|NCT05497674|Leprostatic Agents|leprostatic agents|mesh-ancestor
64788071|NCT05497674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64788072|NCT05497674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788077|NCT05497674|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64788078|NCT05497674|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64788079|NCT05497674|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64788080|NCT05497674|Uricosuric Agents|uricosuric agents|mesh-ancestor
64788081|NCT05497674|Gout Suppressants|gout suppressants|mesh-ancestor
64788082|NCT05497674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64788084|NCT05458674|Trastuzumab|trastuzumab|mesh-list
64788085|NCT05458674|Tucatinib|tucatinib|mesh-list
64788086|NCT05458674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64788087|NCT05458674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788088|NCT05458674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64788089|NCT05458674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788090|NCT05458674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788091|NCT05408910|Rifaximin|rifaximin|mesh-list
64788092|NCT05408910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64788093|NCT05408910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64788094|NCT05408910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64788095|NCT05391828|Cimetidine|cimetidine|mesh-list
64788096|NCT05391828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64788097|NCT05391828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64788098|NCT05391828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64788100|NCT05391828|Histamine Agents|histamine agents|mesh-ancestor
64788110|NCT05360628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788111|NCT05360628|Gout Suppressants|gout suppressants|mesh-ancestor
64788112|NCT05360628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64788113|NCT05360628|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64788114|NCT05360628|Antioxidants|antioxidants|mesh-ancestor
64788115|NCT05360628|Protective Agents|protective agents|mesh-ancestor
64788116|NCT05360628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788117|NCT05326308|Zanubrutinib|zanubrutinib|mesh-list
64788118|NCT05326308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788119|NCT05326308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64788120|NCT05326308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788121|NCT05326308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788122|NCT05321940|Interferons|interferons|mesh-list
64788123|NCT05321940|Vaccines|vaccines|mesh-list
64788124|NCT05321940|Immunologic Factors|immunologic factors|mesh-ancestor
64788125|NCT05321940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788126|NCT05321940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788127|NCT05321940|Antiviral Agents|antiviral agents|mesh-ancestor
64788128|NCT05321940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64788129|NCT05312112|Venetoclax|venetoclax|mesh-list
64788130|NCT05312112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788131|NCT05311176|Paclitaxel|paclitaxel|mesh-list
64788132|NCT05311176|Pembrolizumab|pembrolizumab|mesh-list
64788133|NCT05311176|Ramucirumab|ramucirumab|mesh-list
64788134|NCT05311176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64788135|NCT05311176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788136|NCT05311176|Tubulin Modulators|tubulin modulators|mesh-ancestor
64788137|NCT05311176|Antimitotic Agents|antimitotic agents|mesh-ancestor
64788167|NCT05271552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788168|NCT05218668|Fasudil|fasudil|mesh-list
64788169|NCT05218668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64788170|NCT05218668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64788171|NCT05218668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788172|NCT05218668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64788173|NCT05218668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788174|NCT05218668|Vasodilator Agents|vasodilator agents|mesh-ancestor
64788175|NCT05218668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64788176|NCT05218668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788177|NCT05182164|Pembrolizumab|pembrolizumab|mesh-list
64788178|NCT05182164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64788179|NCT05182164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788180|NCT05162976|Nivolumab|nivolumab|mesh-list
64788181|NCT05162976|Azacitidine|azacitidine|mesh-list
64788182|NCT05162976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64788183|NCT05162976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788184|NCT05162976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64788185|NCT05162976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788186|NCT05162976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64788187|NCT05162976|Antimetabolites|antimetabolites|mesh-ancestor
64788188|NCT05162976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951711|NCT00055302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64951712|NCT00055302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951713|NCT00055302|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64951714|NCT00055302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64951715|NCT00055302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951716|NCT00055302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951717|NCT00055302|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64951718|NCT00055302|Hormone Antagonists|hormone antagonists|mesh-ancestor
64951719|NCT00055302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64951720|NCT00055302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951721|NCT00027248|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
64951722|NCT00027248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951724|NCT00055341|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64490527|NCT05620498|Lenvatinib|lenvatinib|mesh-list
64951725|NCT00055341|Antimetabolites|antimetabolites|mesh-ancestor
64951726|NCT00055341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951727|NCT00055341|Antiviral Agents|antiviral agents|mesh-ancestor
64951728|NCT00055341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951729|NCT00027287|Vitamin E|vitamin e|mesh-list
64951730|NCT00027287|Vitamins|vitamins|mesh-ancestor
64951731|NCT00027287|Micronutrients|micronutrients|mesh-ancestor
64951732|NCT00027287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951733|NCT00027287|Antioxidants|antioxidants|mesh-ancestor
64951734|NCT00027287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951735|NCT00027287|Protective Agents|protective agents|mesh-ancestor
64951736|NCT00055419|Cetuximab|cetuximab|mesh-list
64788189|NCT05161338|Estradiol|estradiol|mesh-list
64788190|NCT05161338|Progesterone|progesterone|mesh-list
64788191|NCT05161338|Estrogens|estrogens|mesh-ancestor
64471818|NCT04094961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471819|NCT04094961|Protease Inhibitors|protease inhibitors|mesh-ancestor
64788192|NCT05161338|Hormones|hormones|mesh-ancestor
64788193|NCT05161338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64788194|NCT05161338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788195|NCT05161338|Progestins|progestins|mesh-ancestor
64788196|NCT05083182|Ustekinumab|ustekinumab|mesh-list
64788197|NCT05083182|Dermatologic Agents|dermatologic agents|mesh-ancestor
64788198|NCT05048940|Vaccines|vaccines|mesh-list
64788199|NCT05048940|Immunologic Factors|immunologic factors|mesh-ancestor
64788200|NCT05048940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788201|NCT04836780|Dexamethasone|dexamethasone|mesh-list
64788202|NCT04836780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64788203|NCT04836780|Antiemetics|antiemetics|mesh-ancestor
64788204|NCT04836780|Autonomic Agents|autonomic agents|mesh-ancestor
64788205|NCT04836780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64788206|NCT04836780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788207|NCT04836780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64788208|NCT04836780|Glucocorticoids|glucocorticoids|mesh-ancestor
64788209|NCT04836780|Hormones|hormones|mesh-ancestor
64788222|NCT04740294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64788224|NCT04740294|Anticonvulsants|anticonvulsants|mesh-ancestor
64788250|NCT04609020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788251|NCT04605978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64788252|NCT04529538|Vaccines|vaccines|mesh-list
64788253|NCT04529538|Immunologic Factors|immunologic factors|mesh-ancestor
64788254|NCT04529538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788255|NCT04521114|Leronlimab|leronlimab|mesh-list
64788256|NCT04521114|HIV Antibodies|hiv antibodies|mesh-list
64788257|NCT04521114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64788258|NCT04521114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64788259|NCT04521114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788260|NCT04521114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64788261|NCT04521114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64788262|NCT04521114|Antiviral Agents|antiviral agents|mesh-ancestor
64788263|NCT04521114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64788264|NCT04521114|Immunologic Factors|immunologic factors|mesh-ancestor
64788265|NCT04521114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788266|NCT04519164|Eplerenone|eplerenone|mesh-list
64788267|NCT04519164|Chlorthalidone|chlorthalidone|mesh-list
64788268|NCT04519164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64788269|NCT04519164|Hormone Antagonists|hormone antagonists|mesh-ancestor
64399337|NCT02336347|Quinidine|quinidine|mesh-list
64788281|NCT04471974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788282|NCT04416750|Imatinib Mesylate|imatinib mesylate|mesh-list
64788283|NCT04416750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788284|NCT04416750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64788285|NCT04416750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788286|NCT04416750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788287|NCT04360824|Enoxaparin|enoxaparin|mesh-list
64788288|NCT04360824|Anticoagulants|anticoagulants|mesh-ancestor
64788289|NCT04360824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64788290|NCT04360824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64788291|NCT04360824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788292|NCT04331652|Anesthetics|anesthetics|mesh-list
64788293|NCT04331652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64788294|NCT04331652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788299|NCT04168710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788300|NCT04168710|Sensory System Agents|sensory system agents|mesh-ancestor
64788301|NCT04168710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64788302|NCT04016142|Paclitaxel|paclitaxel|mesh-list
64788303|NCT04016142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64788304|NCT04016142|Carboplatin|carboplatin|mesh-list
64788305|NCT04016142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64788306|NCT04016142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788307|NCT04016142|Tubulin Modulators|tubulin modulators|mesh-ancestor
64788308|NCT04016142|Antimitotic Agents|antimitotic agents|mesh-ancestor
64788309|NCT04016142|Mitosis Modulators|mitosis modulators|mesh-ancestor
64788310|NCT04016142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788311|NCT03978624|Pembrolizumab|pembrolizumab|mesh-list
64788312|NCT03978624|Entinostat|entinostat|mesh-list
64788313|NCT03978624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64788314|NCT03978624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788315|NCT03978624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64788316|NCT03978624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788317|NCT03978624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788318|NCT03946800|Durvalumab|durvalumab|mesh-list
64788319|NCT03946800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64788320|NCT03946800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788321|NCT03915678|Atezolizumab|atezolizumab|mesh-list
64788322|NCT03915678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64788323|NCT03915678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788324|NCT03915678|Immunologic Factors|immunologic factors|mesh-ancestor
64788325|NCT03915678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788326|NCT03915366|Valganciclovir|valganciclovir|mesh-list
64788327|NCT03915366|Antitubercular Agents|antitubercular agents|mesh-list
64788328|NCT03915366|Antiviral Agents|antiviral agents|mesh-ancestor
64951737|NCT00055419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64951738|NCT00055419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951739|NCT00027404|Fluoxetine|fluoxetine|mesh-list
64951740|NCT00027404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64951741|NCT00027404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64951742|NCT00027404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64951743|NCT00027404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951744|NCT00027404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64951745|NCT00027404|Serotonin Agents|serotonin agents|mesh-ancestor
64951746|NCT00027404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951747|NCT00027404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64951748|NCT00027404|Antidepressive Agents|antidepressive agents|mesh-ancestor
64951749|NCT00027404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64788329|NCT03915366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64788330|NCT03915366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64788331|NCT03874338|Colchicine|colchicine|mesh-list
64788338|NCT03874338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788339|NCT03846570|Beclomethasone|beclomethasone|mesh-list
64788340|NCT03846570|Formoterol Fumarate|formoterol fumarate|mesh-list
64788341|NCT03846570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64788342|NCT03846570|Autonomic Agents|autonomic agents|mesh-ancestor
64788343|NCT03846570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64788344|NCT03846570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788345|NCT03846570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64788346|NCT03846570|Respiratory System Agents|respiratory system agents|mesh-ancestor
64788347|NCT03846570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64788348|NCT03846570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64788349|NCT03846570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64788350|NCT03846570|Adrenergic Agents|adrenergic agents|mesh-ancestor
64788351|NCT03846570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64788352|NCT03846570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788353|NCT03846570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64788354|NCT03846570|Glucocorticoids|glucocorticoids|mesh-ancestor
64788355|NCT03846570|Hormones|hormones|mesh-ancestor
64788356|NCT03846570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64788357|NCT03838848|Carboplatin|carboplatin|mesh-list
64788358|NCT03838848|Pemetrexed|pemetrexed|mesh-list
64788359|NCT03838848|Antibodies|antibodies|mesh-list
64788360|NCT03838848|Immunoglobulins|immunoglobulins|mesh-list
64788361|NCT03838848|Immunologic Factors|immunologic factors|mesh-ancestor
64788362|NCT03838848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788363|NCT03838848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788364|NCT03838848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64401047|NCT03067883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64788365|NCT03838848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788366|NCT03838848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64951750|NCT00027404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64951751|NCT00027404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64951752|NCT00027404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951753|NCT00055536|Natalizumab|natalizumab|mesh-list
64951754|NCT00055536|Immunologic Factors|immunologic factors|mesh-ancestor
64951755|NCT00055536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951756|NCT00027443|Cyclosporine|cyclosporine|mesh-list
64951757|NCT00027443|Cyclosporins|cyclosporins|mesh-list
64951758|NCT00027443|Muromonab-CD3|muromonab-cd3|mesh-list
64788367|NCT03838848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64788368|NCT03787602|Avelumab|avelumab|mesh-list
64788369|NCT03787602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64788370|NCT03787602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788371|NCT03782376|Ustekinumab|ustekinumab|mesh-list
64788372|NCT03782376|Dermatologic Agents|dermatologic agents|mesh-ancestor
64788373|NCT03745170|Capecitabine|capecitabine|mesh-list
64788374|NCT03745170|Oxaliplatin|oxaliplatin|mesh-list
64788375|NCT03745170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64788376|NCT03745170|Antimetabolites|antimetabolites|mesh-ancestor
64788377|NCT03745170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788378|NCT03745170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788379|NCT03737370|Docetaxel|docetaxel|mesh-list
64788380|NCT03737370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788381|NCT03737370|Tubulin Modulators|tubulin modulators|mesh-ancestor
64788382|NCT03737370|Antimitotic Agents|antimitotic agents|mesh-ancestor
64788383|NCT03737370|Mitosis Modulators|mitosis modulators|mesh-ancestor
64788384|NCT03737370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788385|NCT03701490|Progesterone|progesterone|mesh-list
64788386|NCT03701490|Progestins|progestins|mesh-ancestor
64788387|NCT03701490|Hormones|hormones|mesh-ancestor
64788388|NCT03701490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64788389|NCT03701490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788390|NCT03691974|Fasinumab|fasinumab|mesh-list
64788391|NCT03691974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64788392|NCT03691974|Analgesics|analgesics|mesh-ancestor
64788393|NCT03691974|Sensory System Agents|sensory system agents|mesh-ancestor
64556997|NCT04366869|Salicylic Acid|salicylic acid|mesh-list
64788394|NCT03691974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64788395|NCT03691974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788396|NCT03662022|Rifampin|rifampin|mesh-list
64788415|NCT03652428|Tubulin Modulators|tubulin modulators|mesh-ancestor
64788416|NCT03652428|Antimitotic Agents|antimitotic agents|mesh-ancestor
64788417|NCT03652428|Mitosis Modulators|mitosis modulators|mesh-ancestor
64788418|NCT03652428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788419|NCT03652428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64788420|NCT03652428|Antimetabolites|antimetabolites|mesh-ancestor
64788421|NCT03652428|Antiviral Agents|antiviral agents|mesh-ancestor
64788422|NCT03652428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64788423|NCT03652428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788424|NCT03652428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64788425|NCT03652428|Immunologic Factors|immunologic factors|mesh-ancestor
64788426|NCT03652428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788427|NCT03580044|Aztreonam|aztreonam|mesh-list
64788428|NCT03580044|Avibactam|avibactam|mesh-list
64788429|NCT03580044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64788430|NCT03580044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64788431|NCT03580044|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64788432|NCT03580044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788433|NCT03580044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788434|NCT03459222|Nivolumab|nivolumab|mesh-list
64788435|NCT03459222|Ipilimumab|ipilimumab|mesh-list
64788436|NCT03459222|Linrodostat|linrodostat|mesh-list
64788437|NCT03459222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64788438|NCT03459222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788439|NCT03459222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64788440|NCT03459222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788441|NCT03459222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788442|NCT03351348|Bupivacaine|bupivacaine|mesh-list
64788443|NCT03351348|Anesthetics, Local|anesthetics, local|mesh-ancestor
64788444|NCT03351348|Anesthetics|anesthetics|mesh-ancestor
64471820|NCT04094961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64471821|NCT04094961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493058|NCT05263947|Bevacizumab|bevacizumab|mesh-list
64788445|NCT03351348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64788452|NCT02881554|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
64788453|NCT02881554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64788454|NCT02881554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788455|NCT02829918|Nivolumab|nivolumab|mesh-list
64788456|NCT02829918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64788457|NCT02829918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788458|NCT02829918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64788459|NCT02829918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788460|NCT02795988|Fluorouracil|fluorouracil|mesh-list
64788461|NCT02795988|Capecitabine|capecitabine|mesh-list
64788462|NCT02795988|Oxaliplatin|oxaliplatin|mesh-list
64788463|NCT02795988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788464|NCT02795988|Antimetabolites|antimetabolites|mesh-ancestor
64788465|NCT02795988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788466|NCT02795988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64788467|NCT02795988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64788468|NCT02795988|Immunologic Factors|immunologic factors|mesh-ancestor
64788479|NCT01821690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64788480|NCT01821690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64788481|NCT01821690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64788482|NCT01821690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788483|NCT01821690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64788484|NCT01821690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64788486|NCT01821690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64788487|NCT01821690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788511|NCT01096368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788512|NCT01096368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788513|NCT01096368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64788514|NCT01096368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64788515|NCT01096368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64788516|NCT01096368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64788517|NCT01096368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788518|NCT01096368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64788519|NCT01096368|Tubulin Modulators|tubulin modulators|mesh-ancestor
64788520|NCT01096368|Antimitotic Agents|antimitotic agents|mesh-ancestor
64788521|NCT01096368|Mitosis Modulators|mitosis modulators|mesh-ancestor
64788522|NCT01096368|Protective Agents|protective agents|mesh-ancestor
64788523|NCT01096368|Keratolytic Agents|keratolytic agents|mesh-ancestor
64493128|NCT04392375|Tocolytic Agents|tocolytic agents|mesh-ancestor
64788524|NCT01096368|Dermatologic Agents|dermatologic agents|mesh-ancestor
64788525|NCT00978822|Clevidipine|clevidipine|mesh-list
64788526|NCT00978822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64788527|NCT00978822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64788528|NCT00978822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788529|NCT00978822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64788530|NCT00978822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788531|NCT00577200|Midazolam|midazolam|mesh-list
64788575|NCT00002796|Tocolytic Agents|tocolytic agents|mesh-ancestor
64788576|NCT00002796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64788577|NCT00002796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64788578|NCT00002796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788580|NCT00002802|Cyclophosphamide|cyclophosphamide|mesh-list
64788582|NCT00002802|Ifosfamide|ifosfamide|mesh-list
64788583|NCT00002802|Dacarbazine|dacarbazine|mesh-list
64788584|NCT00002802|Carboplatin|carboplatin|mesh-list
64788585|NCT00002802|Doxorubicin|doxorubicin|mesh-list
64788586|NCT00002802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64788587|NCT00002802|Etoposide|etoposide|mesh-list
64788588|NCT00002802|Vincristine|vincristine|mesh-list
64788589|NCT00002802|Vindesine|vindesine|mesh-list
64788590|NCT00002802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64788591|NCT00002802|Immunologic Factors|immunologic factors|mesh-ancestor
64788592|NCT00002802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788593|NCT00002802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64788594|NCT00002802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64788595|NCT00002802|Alkylating Agents|alkylating agents|mesh-ancestor
64788596|NCT00002802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788597|NCT00002802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788603|NCT00002802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64788604|NCT00002802|Tubulin Modulators|tubulin modulators|mesh-ancestor
64788605|NCT00002802|Antimitotic Agents|antimitotic agents|mesh-ancestor
64788606|NCT00002802|Mitosis Modulators|mitosis modulators|mesh-ancestor
64788607|NCT00002802|Trace Elements|trace elements|mesh-ancestor
64788608|NCT00002802|Micronutrients|micronutrients|mesh-ancestor
64788609|NCT00002814|Paclitaxel|paclitaxel|mesh-list
64788610|NCT00002814|Topotecan|topotecan|mesh-list
64788611|NCT00002814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64788612|NCT00002814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788613|NCT00002814|Tubulin Modulators|tubulin modulators|mesh-ancestor
64788614|NCT00002814|Antimitotic Agents|antimitotic agents|mesh-ancestor
64788615|NCT00002814|Mitosis Modulators|mitosis modulators|mesh-ancestor
64788626|NCT00002826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788627|NCT00002832|Cyclosporine|cyclosporine|mesh-list
64788628|NCT00002832|Decitabine|decitabine|mesh-list
64788629|NCT00002832|Cyclosporins|cyclosporins|mesh-list
64788630|NCT00002832|Immunologic Factors|immunologic factors|mesh-ancestor
64788631|NCT00002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788632|NCT00002832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788633|NCT00002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788634|NCT00002832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64788635|NCT00002832|Antifungal Agents|antifungal agents|mesh-ancestor
64788636|NCT00002832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64788637|NCT00002832|Dermatologic Agents|dermatologic agents|mesh-ancestor
64788638|NCT00002832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64788639|NCT00002832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64788640|NCT00002832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64788641|NCT00002832|Antimetabolites|antimetabolites|mesh-ancestor
64788642|NCT00002832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788643|NCT00002838|Cyclophosphamide|cyclophosphamide|mesh-list
64788644|NCT00002838|Fludarabine|fludarabine|mesh-list
64788645|NCT00002838|Fludarabine phosphate|fludarabine phosphate|mesh-list
64788646|NCT00002838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64788647|NCT00002838|Immunologic Factors|immunologic factors|mesh-ancestor
64788648|NCT00002838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788649|NCT00002838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64788650|NCT00002838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64788651|NCT00002838|Alkylating Agents|alkylating agents|mesh-ancestor
64788652|NCT00002838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788653|NCT00002838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788654|NCT00002838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64788655|NCT00002838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64788688|NCT00002868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64788689|NCT00002868|Immunologic Factors|immunologic factors|mesh-ancestor
64788690|NCT00002868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788691|NCT00002868|Alkylating Agents|alkylating agents|mesh-ancestor
64788692|NCT00002868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64788693|NCT00002868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64788694|NCT00002868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64788695|NCT00002868|Antisickling Agents|antisickling agents|mesh-ancestor
64788696|NCT00002868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64788697|NCT00002880|Etoposide|etoposide|mesh-list
64788698|NCT00002880|Etoposide phosphate|etoposide phosphate|mesh-list
64788699|NCT00002880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64788700|NCT00002880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788701|NCT00002880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64788702|NCT00002880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64788703|NCT00002880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788704|NCT00002880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788706|NCT00002892|Interferon-alpha|interferon-alpha|mesh-list
64788707|NCT00002892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788708|NCT00002892|Antiviral Agents|antiviral agents|mesh-ancestor
64788709|NCT00002892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64788710|NCT00002892|Immunologic Factors|immunologic factors|mesh-ancestor
64471823|NCT04094961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64788711|NCT00002892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788712|NCT00002898|Dactinomycin|dactinomycin|mesh-list
64788746|NCT00002922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64788747|NCT00002922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788748|NCT00002922|Tubulin Modulators|tubulin modulators|mesh-ancestor
64788749|NCT00002922|Antimitotic Agents|antimitotic agents|mesh-ancestor
64788750|NCT00002922|Mitosis Modulators|mitosis modulators|mesh-ancestor
64788751|NCT00002922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788752|NCT00002928|Paclitaxel|paclitaxel|mesh-list
64788753|NCT00002928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64788754|NCT00002928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788755|NCT00002928|Tubulin Modulators|tubulin modulators|mesh-ancestor
64788756|NCT00002928|Antimitotic Agents|antimitotic agents|mesh-ancestor
64788757|NCT00002928|Mitosis Modulators|mitosis modulators|mesh-ancestor
64788758|NCT00002928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788759|NCT00002940|Hydroxyurea|hydroxyurea|mesh-list
64788760|NCT00002940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788761|NCT00002940|Antisickling Agents|antisickling agents|mesh-ancestor
64788762|NCT00002940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788763|NCT00002940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788764|NCT00002940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64788765|NCT00002946|Penclomedine|penclomedine|mesh-list
64788766|NCT00002946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788767|NCT00002952|Interleukin-12|interleukin-12|mesh-list
64788768|NCT00002952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64788769|NCT00002952|Immunologic Factors|immunologic factors|mesh-ancestor
64788770|NCT00002952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788771|NCT00002952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64788772|NCT00002952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64788773|NCT00002952|Growth Substances|growth substances|mesh-ancestor
64788774|NCT00002952|Growth Inhibitors|growth inhibitors|mesh-ancestor
64788775|NCT00002952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788776|NCT00002964|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
64788777|NCT00002964|Trioxsalen|trioxsalen|mesh-list
64788778|NCT00002964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788779|NCT00002964|Dermatologic Agents|dermatologic agents|mesh-ancestor
64788780|NCT00002964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64788785|NCT00002970|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64788786|NCT00002970|Methotrexate|methotrexate|mesh-list
64788787|NCT00002970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64788788|NCT00002970|Abortifacient Agents|abortifacient agents|mesh-ancestor
64788789|NCT00002970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64788790|NCT00002970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788791|NCT00002970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64493342|NCT01062568|Cosyntropin|cosyntropin|mesh-list
64493343|NCT01062568|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64493345|NCT01062568|beta-Endorphin|beta-endorphin|mesh-list
64399855|NCT02332447|Naloxone|naloxone|mesh-list
64788793|NCT00002970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788794|NCT00002970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788795|NCT00002970|Dermatologic Agents|dermatologic agents|mesh-ancestor
64788796|NCT00002970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788797|NCT00002970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64788798|NCT00002970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64788799|NCT00002970|Immunologic Factors|immunologic factors|mesh-ancestor
64788800|NCT00002970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64788801|NCT00002970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64788802|NCT00002970|Antiviral Agents|antiviral agents|mesh-ancestor
64788803|NCT00002970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64788804|NCT00002970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64788805|NCT00002976|Estrogens|estrogens|mesh-list
64788806|NCT00002976|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64788807|NCT00002976|Hormones|hormones|mesh-ancestor
64788808|NCT00002976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64788809|NCT00002976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788829|NCT00002982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64788830|NCT00002982|Alkylating Agents|alkylating agents|mesh-ancestor
64788831|NCT00002982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64788832|NCT00002988|Irinotecan|irinotecan|mesh-list
64788833|NCT00002988|Carmustine|carmustine|mesh-list
64788834|NCT00002988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64788835|NCT00002988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64788836|NCT00002988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788837|NCT00002988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788838|NCT00002988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788839|NCT00002988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64788840|NCT00002988|Alkylating Agents|alkylating agents|mesh-ancestor
64788841|NCT00002994|Interleukin-2|interleukin-2|mesh-list
64788842|NCT00002994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788843|NCT00002994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64788844|NCT00002994|Analgesics|analgesics|mesh-ancestor
64788845|NCT00002994|Sensory System Agents|sensory system agents|mesh-ancestor
64788846|NCT00002994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64788847|NCT00002994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788848|NCT00003000|Fentanyl|fentanyl|mesh-list
64788849|NCT00003000|Morphine|morphine|mesh-list
64788850|NCT00003000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64788851|NCT00003000|Narcotics|narcotics|mesh-ancestor
64788852|NCT00003000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64788853|NCT00003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471938|NCT03979599|Analgesics|analgesics|mesh-ancestor
64471939|NCT03979599|Sensory System Agents|sensory system agents|mesh-ancestor
64471940|NCT03979599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64471941|NCT03979599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64471942|NCT03979599|Anesthetics|anesthetics|mesh-ancestor
64471943|NCT03979599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64471944|NCT03979599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64471945|NCT03979599|Anticonvulsants|anticonvulsants|mesh-ancestor
64471946|NCT03979599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64471947|NCT03979599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64471948|NCT03979599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493423|NCT01064830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64788865|NCT00003012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64788866|NCT00003012|Immunologic Factors|immunologic factors|mesh-ancestor
64788867|NCT00003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788868|NCT00003012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64788872|NCT00003012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788873|NCT00003012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64788874|NCT00003012|Antimetabolites|antimetabolites|mesh-ancestor
64788875|NCT00003012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64788876|NCT00003012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64788877|NCT00003012|Abortifacient Agents|abortifacient agents|mesh-ancestor
64788878|NCT00003012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64788879|NCT00003012|Dermatologic Agents|dermatologic agents|mesh-ancestor
64788880|NCT00003012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64471953|NCT03975647|Tucatinib|tucatinib|mesh-list
64788889|NCT00003018|Mitomycin|mitomycin|mesh-list
64788890|NCT00003018|Dipyridamole|dipyridamole|mesh-list
64788891|NCT00003018|Calcium|calcium|mesh-list
64788892|NCT00003018|Levoleucovorin|levoleucovorin|mesh-list
64788893|NCT00003018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64788894|NCT00003018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788895|NCT00003018|Antimetabolites|antimetabolites|mesh-ancestor
64788896|NCT00003018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788897|NCT00003018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64788898|NCT00003018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788899|NCT00003018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64788900|NCT00003018|Immunologic Factors|immunologic factors|mesh-ancestor
64788901|NCT00003018|Antidotes|antidotes|mesh-ancestor
64788902|NCT00003018|Protective Agents|protective agents|mesh-ancestor
64788903|NCT00003018|Vitamin B Complex|vitamin b complex|mesh-ancestor
64788904|NCT00003018|Vitamins|vitamins|mesh-ancestor
64788905|NCT00003018|Micronutrients|micronutrients|mesh-ancestor
64788906|NCT00003018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64788907|NCT00003018|Alkylating Agents|alkylating agents|mesh-ancestor
64788908|NCT00003018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64788909|NCT00003018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788910|NCT00003018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64788911|NCT00003018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64788912|NCT00003018|Vasodilator Agents|vasodilator agents|mesh-ancestor
64788913|NCT00003048|Amifostine|amifostine|mesh-list
64788914|NCT00003048|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64788915|NCT00003048|Protective Agents|protective agents|mesh-ancestor
64788916|NCT00003048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788917|NCT00003054|Paclitaxel|paclitaxel|mesh-list
64788918|NCT00003054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64788919|NCT00003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788933|NCT00003060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64788934|NCT00003060|Alkylating Agents|alkylating agents|mesh-ancestor
64788935|NCT00003060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788936|NCT00003060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788937|NCT00003060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64788938|NCT00003060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64788939|NCT00003060|Abortifacient Agents|abortifacient agents|mesh-ancestor
64788940|NCT00003060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64788946|NCT00003060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64788948|NCT00003060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64788949|NCT00003060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64788950|NCT00003066|Docetaxel|docetaxel|mesh-list
64788951|NCT00003066|Estramustine|estramustine|mesh-list
64788952|NCT00003066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788953|NCT00003066|Tubulin Modulators|tubulin modulators|mesh-ancestor
64788954|NCT00003066|Antimitotic Agents|antimitotic agents|mesh-ancestor
64788955|NCT00003066|Mitosis Modulators|mitosis modulators|mesh-ancestor
64788956|NCT00003066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788957|NCT00003066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64788958|NCT00003066|Alkylating Agents|alkylating agents|mesh-ancestor
64788959|NCT00003066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64788960|NCT00003072|Paclitaxel|paclitaxel|mesh-list
64788961|NCT00003072|Carboplatin|carboplatin|mesh-list
64788962|NCT00003072|Amifostine|amifostine|mesh-list
64788963|NCT00003072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64788964|NCT00003072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788965|NCT00003072|Tubulin Modulators|tubulin modulators|mesh-ancestor
64788966|NCT00003072|Antimitotic Agents|antimitotic agents|mesh-ancestor
64788967|NCT00003072|Mitosis Modulators|mitosis modulators|mesh-ancestor
64788968|NCT00003072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788969|NCT00003072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64788979|NCT00003078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788980|NCT00003084|Ketoconazole|ketoconazole|mesh-list
64788981|NCT00003084|Paclitaxel|paclitaxel|mesh-list
64788982|NCT00003084|Etoposide|etoposide|mesh-list
64788983|NCT00003084|Vinblastine|vinblastine|mesh-list
64788984|NCT00003084|Doxorubicin|doxorubicin|mesh-list
64788985|NCT00003084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64788986|NCT00003084|Estramustine|estramustine|mesh-list
64788987|NCT00003084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64788988|NCT00003084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788989|NCT00003084|Tubulin Modulators|tubulin modulators|mesh-ancestor
64788990|NCT00003084|Antimitotic Agents|antimitotic agents|mesh-ancestor
64788991|NCT00003084|Mitosis Modulators|mitosis modulators|mesh-ancestor
64788992|NCT00003084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788993|NCT00003084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64788994|NCT00003084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64788995|NCT00003084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64788996|NCT00003084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788997|NCT00003084|Antifungal Agents|antifungal agents|mesh-ancestor
64788998|NCT00003084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64788999|NCT00003084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64789000|NCT00003084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64789001|NCT00003084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64789002|NCT00003084|Hormone Antagonists|hormone antagonists|mesh-ancestor
64945438|NCT05633615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64557412|NCT05581979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64789003|NCT00003084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64789004|NCT00003084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493602|NCT04352686|Buspirone|buspirone|mesh-list
64789005|NCT00003084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64789006|NCT00003084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64789007|NCT00003084|Alkylating Agents|alkylating agents|mesh-ancestor
64789028|NCT00003114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64789029|NCT00003114|Alkylating Agents|alkylating agents|mesh-ancestor
64789030|NCT00003114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789031|NCT00003114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789032|NCT00003114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64789033|NCT00003114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64789034|NCT00003114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64789035|NCT00003114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64789036|NCT00003114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789037|NCT00003120|Paclitaxel|paclitaxel|mesh-list
64789038|NCT00003120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64789039|NCT00003120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789040|NCT00003120|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789041|NCT00003120|Antimitotic Agents|antimitotic agents|mesh-ancestor
64789042|NCT00003120|Mitosis Modulators|mitosis modulators|mesh-ancestor
64789043|NCT00003120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789044|NCT00003126|Aldesleukin|aldesleukin|mesh-list
64789045|NCT00003126|Interleukin-2|interleukin-2|mesh-list
64789046|NCT00003126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789047|NCT00003126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64789048|NCT00003126|Analgesics|analgesics|mesh-ancestor
64789049|NCT00003126|Sensory System Agents|sensory system agents|mesh-ancestor
64789050|NCT00003126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64789051|NCT00003126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789052|NCT00003126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64789053|NCT00003126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64789054|NCT00003126|Antiviral Agents|antiviral agents|mesh-ancestor
64789055|NCT00003126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64789056|NCT00003132|Bryostatin 1|bryostatin 1|mesh-list
64789057|NCT00003132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789058|NCT00003132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64789059|NCT00003132|Immunologic Factors|immunologic factors|mesh-ancestor
64789060|NCT00003132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789061|NCT00003144|Gemcitabine|gemcitabine|mesh-list
64789062|NCT00003144|Amifostine|amifostine|mesh-list
64789063|NCT00003144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951759|NCT00027443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789064|NCT00003144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64789065|NCT00003144|Antimetabolites|antimetabolites|mesh-ancestor
64789066|NCT00003144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789067|NCT00003144|Antiviral Agents|antiviral agents|mesh-ancestor
64789068|NCT00003144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64789069|NCT00003144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789070|NCT00003144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789071|NCT00003144|Immunologic Factors|immunologic factors|mesh-ancestor
64789072|NCT00003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789073|NCT00003144|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64789074|NCT00003144|Protective Agents|protective agents|mesh-ancestor
64789086|NCT00003150|Alkylating Agents|alkylating agents|mesh-ancestor
64789087|NCT00003150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789088|NCT00003150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789089|NCT00003150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64789090|NCT00003150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64789091|NCT00003150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64789092|NCT00003150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64789093|NCT00003150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64789094|NCT00003150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789095|NCT00003150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64789096|NCT00003150|Glucocorticoids|glucocorticoids|mesh-ancestor
64789097|NCT00003150|Hormones|hormones|mesh-ancestor
64789098|NCT00003150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64789099|NCT00003150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64789100|NCT00003150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64789101|NCT00003150|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789102|NCT00003150|Antimitotic Agents|antimitotic agents|mesh-ancestor
64789103|NCT00003150|Mitosis Modulators|mitosis modulators|mesh-ancestor
64789104|NCT00003156|Topotecan|topotecan|mesh-list
64789117|NCT00003198|Topotecan|topotecan|mesh-list
64789118|NCT00003198|Ifosfamide|ifosfamide|mesh-list
64789119|NCT00003198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64789120|NCT00003198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64789121|NCT00003198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789122|NCT00003198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789123|NCT00003198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789124|NCT00003198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64789125|NCT00003198|Alkylating Agents|alkylating agents|mesh-ancestor
64789126|NCT00003204|Prednisone|prednisone|mesh-list
64789127|NCT00003204|Cyclophosphamide|cyclophosphamide|mesh-list
64789128|NCT00003204|Rituximab|rituximab|mesh-list
64789129|NCT00003204|Fludarabine|fludarabine|mesh-list
64789130|NCT00003204|Fludarabine phosphate|fludarabine phosphate|mesh-list
64789131|NCT00003204|Vincristine|vincristine|mesh-list
64789132|NCT00003204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789133|NCT00003204|Immunologic Factors|immunologic factors|mesh-ancestor
64789134|NCT00003204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789135|NCT00003204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64789136|NCT00003204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64789137|NCT00003204|Alkylating Agents|alkylating agents|mesh-ancestor
64789138|NCT00003204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400205|NCT02328079|Hormones|hormones|mesh-ancestor
64789153|NCT00003210|Interleukin-12|interleukin-12|mesh-list
64789154|NCT00003210|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64789155|NCT00003210|Immunologic Factors|immunologic factors|mesh-ancestor
64789180|NCT00003234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789181|NCT00003240|Vinorelbine|vinorelbine|mesh-list
64789182|NCT00003240|Ifosfamide|ifosfamide|mesh-list
64789183|NCT00003240|Mitomycins|mitomycins|mesh-list
64789184|NCT00003240|Mitomycin|mitomycin|mesh-list
64789185|NCT00003240|Vinblastine|vinblastine|mesh-list
64789186|NCT00003240|Vindesine|vindesine|mesh-list
64789187|NCT00003240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789188|NCT00003240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64789189|NCT00003240|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789190|NCT00003240|Antimitotic Agents|antimitotic agents|mesh-ancestor
64789191|NCT00003240|Mitosis Modulators|mitosis modulators|mesh-ancestor
64789192|NCT00003240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789193|NCT00003240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64789194|NCT00003240|Alkylating Agents|alkylating agents|mesh-ancestor
64789195|NCT00003240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64789196|NCT00003240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64789197|NCT00003240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789198|NCT00003252|Amifostine|amifostine|mesh-list
64789199|NCT00003252|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64789215|NCT00003276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64789216|NCT00003276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789217|NCT00003276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789218|NCT00003276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789219|NCT00003288|Cyclophosphamide|cyclophosphamide|mesh-list
64789220|NCT00003288|Tirapazamine|tirapazamine|mesh-list
64789221|NCT00003288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789222|NCT00003288|Immunologic Factors|immunologic factors|mesh-ancestor
64789223|NCT00003288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789224|NCT00003288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64789225|NCT00003288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64789226|NCT00003288|Alkylating Agents|alkylating agents|mesh-ancestor
64789227|NCT00003288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789228|NCT00003288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789229|NCT00003288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64789233|NCT00003294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64789234|NCT00003294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789235|NCT00003294|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789236|NCT00003294|Antimitotic Agents|antimitotic agents|mesh-ancestor
64789237|NCT00003294|Mitosis Modulators|mitosis modulators|mesh-ancestor
64789238|NCT00003294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789239|NCT00003294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789240|NCT00003294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64789241|NCT00003294|Protective Agents|protective agents|mesh-ancestor
64789242|NCT00003330|Interleukin-12|interleukin-12|mesh-list
64789243|NCT00003330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64789244|NCT00003330|Immunologic Factors|immunologic factors|mesh-ancestor
64789245|NCT00003330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789246|NCT00003330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64789247|NCT00003330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64789248|NCT00003330|Growth Substances|growth substances|mesh-ancestor
64789249|NCT00003330|Growth Inhibitors|growth inhibitors|mesh-ancestor
64789250|NCT00003330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789251|NCT00003336|Methylprednisolone|methylprednisolone|mesh-list
64789252|NCT00003336|Cyclophosphamide|cyclophosphamide|mesh-list
64789253|NCT00003336|Melphalan|melphalan|mesh-list
64789254|NCT00003336|Busulfan|busulfan|mesh-list
64789276|NCT00003342|Paclitaxel|paclitaxel|mesh-list
64789301|NCT00003348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789302|NCT00003348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789303|NCT00003348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789304|NCT00003360|Antibodies|antibodies|mesh-list
64557894|NCT04404881|Bevacizumab|bevacizumab|mesh-list
64789305|NCT00003360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64789306|NCT00003360|Immunologic Factors|immunologic factors|mesh-ancestor
64789307|NCT00003360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789308|NCT00003372|Topotecan|topotecan|mesh-list
64789309|NCT00003372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64789310|NCT00003372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64789311|NCT00003372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789312|NCT00003372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789313|NCT00003372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789314|NCT00003378|Gemcitabine|gemcitabine|mesh-list
64789315|NCT00003378|Paclitaxel|paclitaxel|mesh-list
64789316|NCT00003378|Carboplatin|carboplatin|mesh-list
64789317|NCT00003378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64789318|NCT00003378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400401|NCT03074123|Hormones|hormones|mesh-ancestor
64789337|NCT00003396|Melphalan|melphalan|mesh-list
64789338|NCT00003396|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64789339|NCT00003396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789340|NCT00003396|Immunologic Factors|immunologic factors|mesh-ancestor
64789341|NCT00003396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789342|NCT00003396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64789343|NCT00003396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64789344|NCT00003396|Alkylating Agents|alkylating agents|mesh-ancestor
64789345|NCT00003396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789346|NCT00003396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789347|NCT00003396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64789348|NCT00003402|Dexamethasone|dexamethasone|mesh-list
64789349|NCT00003402|Paclitaxel|paclitaxel|mesh-list
64789350|NCT00003402|Etoposide|etoposide|mesh-list
64789351|NCT00003402|Cyclophosphamide|cyclophosphamide|mesh-list
64789352|NCT00003402|Melphalan|melphalan|mesh-list
64789359|NCT00003402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789360|NCT00003402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789361|NCT00003402|Immunologic Factors|immunologic factors|mesh-ancestor
64789362|NCT00003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789363|NCT00003402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64789364|NCT00003402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64789365|NCT00003402|Alkylating Agents|alkylating agents|mesh-ancestor
64789366|NCT00003402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64789367|NCT00003402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64789368|NCT00003402|Antiemetics|antiemetics|mesh-ancestor
64789369|NCT00003402|Autonomic Agents|autonomic agents|mesh-ancestor
64789370|NCT00003402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64789371|NCT00003402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64789372|NCT00003402|Glucocorticoids|glucocorticoids|mesh-ancestor
64789373|NCT00003402|Hormones|hormones|mesh-ancestor
64789374|NCT00003402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64789375|NCT00003402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64789396|NCT00003414|Cyclosporins|cyclosporins|mesh-list
64789397|NCT00003414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789398|NCT00003414|Immunologic Factors|immunologic factors|mesh-ancestor
64789432|NCT00003462|Busulfan|busulfan|mesh-list
64789433|NCT00003462|Alkylating Agents|alkylating agents|mesh-ancestor
64789434|NCT00003462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789435|NCT00003462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789446|NCT00003528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64789447|NCT00003528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789448|NCT00003540|Gemcitabine|gemcitabine|mesh-list
64789449|NCT00003540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64789450|NCT00003540|Antimetabolites|antimetabolites|mesh-ancestor
64789451|NCT00003540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789452|NCT00003540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789453|NCT00003540|Antiviral Agents|antiviral agents|mesh-ancestor
64789454|NCT00003540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64789455|NCT00003540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789456|NCT00003540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789457|NCT00003540|Immunologic Factors|immunologic factors|mesh-ancestor
64789458|NCT00003540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789459|NCT00003546|Gemcitabine|gemcitabine|mesh-list
64789460|NCT00003546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64789461|NCT00003546|Antimetabolites|antimetabolites|mesh-ancestor
64789462|NCT00003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789463|NCT00003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789464|NCT00003546|Antiviral Agents|antiviral agents|mesh-ancestor
64789465|NCT00003546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64789466|NCT00003546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789467|NCT00003546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789468|NCT00003546|Immunologic Factors|immunologic factors|mesh-ancestor
64789469|NCT00003546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789470|NCT00003552|Cyclophosphamide|cyclophosphamide|mesh-list
64789471|NCT00003552|Fludarabine|fludarabine|mesh-list
64789472|NCT00003552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64789473|NCT00003552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789482|NCT00003558|Leucovorin|leucovorin|mesh-list
64789484|NCT00003558|Etoposide|etoposide|mesh-list
64789485|NCT00003558|Carboplatin|carboplatin|mesh-list
64789486|NCT00003558|Fluorouracil|fluorouracil|mesh-list
64789487|NCT00003558|Calcium|calcium|mesh-list
64789488|NCT00003558|Levoleucovorin|levoleucovorin|mesh-list
64789489|NCT00003558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64789490|NCT00003558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789491|NCT00003558|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789492|NCT00003558|Antimitotic Agents|antimitotic agents|mesh-ancestor
64789493|NCT00003558|Mitosis Modulators|mitosis modulators|mesh-ancestor
64789494|NCT00003558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789495|NCT00003558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64789496|NCT00003558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789497|NCT00003558|Antimetabolites|antimetabolites|mesh-ancestor
64789498|NCT00003558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64789499|NCT00003558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789500|NCT00003558|Immunologic Factors|immunologic factors|mesh-ancestor
64789520|NCT00003576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789521|NCT00003582|Paclitaxel|paclitaxel|mesh-list
64789522|NCT00003582|Fluorouracil|fluorouracil|mesh-list
64789523|NCT00003582|Amifostine|amifostine|mesh-list
64789524|NCT00003582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64789525|NCT00003582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789526|NCT00003582|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789527|NCT00003582|Antimitotic Agents|antimitotic agents|mesh-ancestor
64789528|NCT00003582|Mitosis Modulators|mitosis modulators|mesh-ancestor
64789529|NCT00003582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789530|NCT00003582|Antimetabolites|antimetabolites|mesh-ancestor
64789531|NCT00003582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64789532|NCT00003582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789533|NCT00003582|Immunologic Factors|immunologic factors|mesh-ancestor
64789534|NCT00003582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789535|NCT00003582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64789537|NCT00003594|Leucovorin|leucovorin|mesh-list
64789545|NCT00003594|Antimetabolites|antimetabolites|mesh-ancestor
64789546|NCT00003594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789547|NCT00003594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64789548|NCT00003594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789549|NCT00003594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789550|NCT00003594|Immunologic Factors|immunologic factors|mesh-ancestor
64789551|NCT00003594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64789552|NCT00003594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64789553|NCT00003594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789554|NCT00003594|Antidotes|antidotes|mesh-ancestor
64789555|NCT00003594|Protective Agents|protective agents|mesh-ancestor
64789556|NCT00003594|Vitamin B Complex|vitamin b complex|mesh-ancestor
64789557|NCT00003594|Vitamins|vitamins|mesh-ancestor
64789558|NCT00003594|Micronutrients|micronutrients|mesh-ancestor
64789559|NCT00003600|Epoetin Alfa|epoetin alfa|mesh-list
64789560|NCT00003600|Hematinics|hematinics|mesh-ancestor
64789581|NCT00003612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64789582|NCT00003612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789583|NCT00003612|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789584|NCT00003612|Antimitotic Agents|antimitotic agents|mesh-ancestor
64789585|NCT00003612|Mitosis Modulators|mitosis modulators|mesh-ancestor
64789586|NCT00003612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789587|NCT00003612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64789588|NCT00003624|Paclitaxel|paclitaxel|mesh-list
64789589|NCT00003624|Amifostine|amifostine|mesh-list
64789590|NCT00003624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64789591|NCT00003624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789592|NCT00003624|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789593|NCT00003624|Antimitotic Agents|antimitotic agents|mesh-ancestor
64789611|NCT00003654|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
64789612|NCT00003654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64789613|NCT00003654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789614|NCT00003666|Irofulven|irofulven|mesh-list
64400684|NCT03070379|Sensory System Agents|sensory system agents|mesh-ancestor
64789620|NCT00003678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64789621|NCT00003678|Hormone Antagonists|hormone antagonists|mesh-ancestor
64789622|NCT00003678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64789623|NCT00003678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789624|NCT00003678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64789625|NCT00003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789626|NCT00003678|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64789627|NCT00003678|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64789628|NCT00003678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64789629|NCT00003684|Theophylline|theophylline|mesh-list
64789630|NCT00003684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64789631|NCT00003684|Autonomic Agents|autonomic agents|mesh-ancestor
64789632|NCT00003684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64789669|NCT00003696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64789670|NCT00003696|Alkylating Agents|alkylating agents|mesh-ancestor
64789671|NCT00003696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64789672|NCT00003696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64789673|NCT00003696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64789674|NCT00003696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64789675|NCT00003696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789676|NCT00003708|Temozolomide|temozolomide|mesh-list
64789677|NCT00003708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64789678|NCT00003708|Alkylating Agents|alkylating agents|mesh-ancestor
64789679|NCT00003708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789680|NCT00003708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789681|NCT00003714|NSC 366140|nsc 366140|mesh-list
64789682|NCT00003714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789688|NCT00003720|Growth Inhibitors|growth inhibitors|mesh-ancestor
64789689|NCT00003720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789690|NCT00003720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64789691|NCT00003720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789692|NCT00003720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789693|NCT00003732|Paclitaxel|paclitaxel|mesh-list
64789694|NCT00003732|Carboplatin|carboplatin|mesh-list
64789695|NCT00003732|Topotecan|topotecan|mesh-list
64789696|NCT00003732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64789697|NCT00003732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789698|NCT00003732|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789699|NCT00003732|Antimitotic Agents|antimitotic agents|mesh-ancestor
64789700|NCT00003732|Mitosis Modulators|mitosis modulators|mesh-ancestor
64789701|NCT00003732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789702|NCT00003732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64789703|NCT00003732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64789704|NCT00003732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789705|NCT00003744|Gemcitabine|gemcitabine|mesh-list
64789715|NCT00003744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789716|NCT00003762|Gemcitabine|gemcitabine|mesh-list
64789717|NCT00003762|Docetaxel|docetaxel|mesh-list
64789718|NCT00003762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64789719|NCT00003762|Antimetabolites|antimetabolites|mesh-ancestor
64789720|NCT00003762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789721|NCT00003762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789722|NCT00003762|Antiviral Agents|antiviral agents|mesh-ancestor
64789723|NCT00003762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64789724|NCT00003762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789725|NCT00003762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789726|NCT00003762|Immunologic Factors|immunologic factors|mesh-ancestor
64789727|NCT00003762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789728|NCT00003762|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789729|NCT00003762|Antimitotic Agents|antimitotic agents|mesh-ancestor
64789730|NCT00003762|Mitosis Modulators|mitosis modulators|mesh-ancestor
64789731|NCT00003768|Fosbretabulin|fosbretabulin|mesh-list
64789732|NCT00003768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64789733|NCT00003768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789734|NCT00003780|Gemcitabine|gemcitabine|mesh-list
64789735|NCT00003780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64789736|NCT00003780|Antimetabolites|antimetabolites|mesh-ancestor
64789737|NCT00003780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789738|NCT00003780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789739|NCT00003780|Antiviral Agents|antiviral agents|mesh-ancestor
64789740|NCT00003780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64789741|NCT00003780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789742|NCT00003780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789743|NCT00003780|Immunologic Factors|immunologic factors|mesh-ancestor
64789745|NCT00003786|Irofulven|irofulven|mesh-list
64789762|NCT00003804|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789763|NCT00003804|Antimitotic Agents|antimitotic agents|mesh-ancestor
64789764|NCT00003804|Mitosis Modulators|mitosis modulators|mesh-ancestor
64789765|NCT00003804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789766|NCT00003804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64789767|NCT00003804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64789768|NCT00003804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64789769|NCT00003804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64789770|NCT00003804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789771|NCT00003804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64789772|NCT00003810|Gemcitabine|gemcitabine|mesh-list
64789773|NCT00003810|Docetaxel|docetaxel|mesh-list
64789774|NCT00003810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64789775|NCT00003810|Antimetabolites|antimetabolites|mesh-ancestor
64789776|NCT00003810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789777|NCT00003810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789778|NCT00003810|Antiviral Agents|antiviral agents|mesh-ancestor
64789779|NCT00003810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64789780|NCT00003810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789781|NCT00003810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789782|NCT00003810|Immunologic Factors|immunologic factors|mesh-ancestor
64789783|NCT00003810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789784|NCT00003810|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789785|NCT00003810|Antimitotic Agents|antimitotic agents|mesh-ancestor
64789786|NCT00003810|Mitosis Modulators|mitosis modulators|mesh-ancestor
64789787|NCT00003828|Vinorelbine|vinorelbine|mesh-list
64789788|NCT00003828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64789789|NCT00003828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789790|NCT00003828|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789791|NCT00003828|Antimitotic Agents|antimitotic agents|mesh-ancestor
64789792|NCT00003828|Mitosis Modulators|mitosis modulators|mesh-ancestor
64789793|NCT00003828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789794|NCT00003834|Leucovorin|leucovorin|mesh-list
64789795|NCT00003834|Fluorouracil|fluorouracil|mesh-list
64789802|NCT00003834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789803|NCT00003834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64789804|NCT00003834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789805|NCT00003834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789806|NCT00003834|Immunologic Factors|immunologic factors|mesh-ancestor
64789807|NCT00003834|Antidotes|antidotes|mesh-ancestor
64789808|NCT00003834|Protective Agents|protective agents|mesh-ancestor
64789809|NCT00003834|Vitamin B Complex|vitamin b complex|mesh-ancestor
64789810|NCT00003834|Vitamins|vitamins|mesh-ancestor
64789811|NCT00003834|Micronutrients|micronutrients|mesh-ancestor
64789812|NCT00003846|Cyclophosphamide|cyclophosphamide|mesh-list
64789813|NCT00003846|Thiotepa|thiotepa|mesh-list
64789814|NCT00003846|Carboplatin|carboplatin|mesh-list
64789815|NCT00003846|Vincristine|vincristine|mesh-list
64789816|NCT00003846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789817|NCT00003846|Immunologic Factors|immunologic factors|mesh-ancestor
64789818|NCT00003846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789819|NCT00003846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64789820|NCT00003846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64789821|NCT00003846|Alkylating Agents|alkylating agents|mesh-ancestor
64789822|NCT00003846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789823|NCT00003846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789824|NCT00003846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64789837|NCT00003852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789838|NCT00003852|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789839|NCT00003852|Antimitotic Agents|antimitotic agents|mesh-ancestor
64789840|NCT00003852|Mitosis Modulators|mitosis modulators|mesh-ancestor
64789841|NCT00003852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789842|NCT00003852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789843|NCT00003852|Immunologic Factors|immunologic factors|mesh-ancestor
64789844|NCT00003852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789845|NCT00003852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64789846|NCT00003852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64789847|NCT00003852|Alkylating Agents|alkylating agents|mesh-ancestor
64789853|NCT00003858|Mitoxantrone|mitoxantrone|mesh-list
64789854|NCT00003858|Analgesics|analgesics|mesh-ancestor
64789855|NCT00003858|Sensory System Agents|sensory system agents|mesh-ancestor
64789856|NCT00003858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64789857|NCT00003858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789858|NCT00003858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789859|NCT00003858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64789860|NCT00003858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64789861|NCT00003858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789862|NCT00003858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789863|NCT00003864|Carboplatin|carboplatin|mesh-list
64789864|NCT00003864|Docetaxel|docetaxel|mesh-list
64789865|NCT00003864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789866|NCT00003864|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789867|NCT00003864|Antimitotic Agents|antimitotic agents|mesh-ancestor
64789868|NCT00003864|Mitosis Modulators|mitosis modulators|mesh-ancestor
64789869|NCT00003864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789870|NCT00003870|Cyclophosphamide|cyclophosphamide|mesh-list
64789871|NCT00003870|Methotrexate|methotrexate|mesh-list
64789872|NCT00003870|Antibodies|antibodies|mesh-list
64789873|NCT00003870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64789874|NCT00003870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789875|NCT00003870|Immunologic Factors|immunologic factors|mesh-ancestor
64789876|NCT00003870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789877|NCT00003870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64789878|NCT00003870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64789879|NCT00003870|Alkylating Agents|alkylating agents|mesh-ancestor
64789880|NCT00003870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789881|NCT00003870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789882|NCT00003870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64789883|NCT00003870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64789884|NCT00003870|Abortifacient Agents|abortifacient agents|mesh-ancestor
64789908|NCT00003888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789909|NCT00003894|Thalidomide|thalidomide|mesh-list
64789910|NCT00003894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789911|NCT00003894|Immunologic Factors|immunologic factors|mesh-ancestor
64789912|NCT00003894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789913|NCT00003894|Leprostatic Agents|leprostatic agents|mesh-ancestor
64789914|NCT00003894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64789915|NCT00003894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64789916|NCT00003894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64789917|NCT00003894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64789918|NCT00003894|Growth Substances|growth substances|mesh-ancestor
64789919|NCT00003894|Growth Inhibitors|growth inhibitors|mesh-ancestor
64789920|NCT00003894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789921|NCT00003900|Docetaxel|docetaxel|mesh-list
64789922|NCT00003900|Irinotecan|irinotecan|mesh-list
64789923|NCT00003900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789924|NCT00003900|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789925|NCT00003900|Antimitotic Agents|antimitotic agents|mesh-ancestor
64789926|NCT00003900|Mitosis Modulators|mitosis modulators|mesh-ancestor
64789927|NCT00003900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789928|NCT00003900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64789929|NCT00003900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64789930|NCT00003900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789931|NCT00003906|Tamoxifen|tamoxifen|mesh-list
64471969|NCT03946514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789963|NCT00003930|Antimitotic Agents|antimitotic agents|mesh-ancestor
64789964|NCT00003930|Mitosis Modulators|mitosis modulators|mesh-ancestor
64789965|NCT00003930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789966|NCT00003930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64789967|NCT00003930|Antimetabolites|antimetabolites|mesh-ancestor
64789968|NCT00003930|Antiviral Agents|antiviral agents|mesh-ancestor
64789969|NCT00003930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64789970|NCT00003930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789971|NCT00003930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789972|NCT00003930|Immunologic Factors|immunologic factors|mesh-ancestor
64789973|NCT00003930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789974|NCT00003936|Bryostatin 1|bryostatin 1|mesh-list
64789975|NCT00003936|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64789976|NCT00003936|Immunologic Factors|immunologic factors|mesh-ancestor
64789977|NCT00003936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789978|NCT00003936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789979|NCT00003954|Cyclosporine|cyclosporine|mesh-list
64789980|NCT00003954|Mycophenolic Acid|mycophenolic acid|mesh-list
64789981|NCT00003954|Melphalan|melphalan|mesh-list
64789982|NCT00003954|Cyclosporins|cyclosporins|mesh-list
64789983|NCT00003954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789984|NCT00003954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789985|NCT00003954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789986|NCT00003954|Immunologic Factors|immunologic factors|mesh-ancestor
64789987|NCT00003954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789988|NCT00003954|Antifungal Agents|antifungal agents|mesh-ancestor
64789989|NCT00003954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64789990|NCT00003954|Dermatologic Agents|dermatologic agents|mesh-ancestor
64789991|NCT00003954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64789992|NCT00003954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64789993|NCT00003954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64789994|NCT00003954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790001|NCT00003960|Methylprednisolone|methylprednisolone|mesh-list
64790006|NCT00003960|Cyclophosphamide|cyclophosphamide|mesh-list
64790007|NCT00003960|Busulfan|busulfan|mesh-list
64790008|NCT00003960|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64790009|NCT00003960|Prednisolone phosphate|prednisolone phosphate|mesh-list
64790010|NCT00003960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64790011|NCT00003960|Immunologic Factors|immunologic factors|mesh-ancestor
64790012|NCT00003960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790014|NCT00003960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64790015|NCT00003960|Alkylating Agents|alkylating agents|mesh-ancestor
64790016|NCT00003960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790017|NCT00003960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790018|NCT00003960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64790019|NCT00003960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64790020|NCT00003960|Antiemetics|antiemetics|mesh-ancestor
64790021|NCT00003960|Autonomic Agents|autonomic agents|mesh-ancestor
64790022|NCT00003960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64790026|NCT00003960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64790028|NCT00003960|Protective Agents|protective agents|mesh-ancestor
64790029|NCT00003960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64790030|NCT00003966|Defibrotide|defibrotide|mesh-list
64790031|NCT00003966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64790032|NCT00003966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64790033|NCT00003966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790034|NCT00003966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64790035|NCT00003972|Tamoxifen|tamoxifen|mesh-list
64790036|NCT00003972|Paclitaxel|paclitaxel|mesh-list
64790059|NCT00003972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64790060|NCT00003972|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64790061|NCT00003972|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64790062|NCT00003972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64790063|NCT00003984|Lintuzumab|lintuzumab|mesh-list
64790064|NCT00003984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64790065|NCT00003984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790066|NCT00003996|Etoposide|etoposide|mesh-list
64790067|NCT00003996|Carmustine|carmustine|mesh-list
64790068|NCT00003996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790069|NCT00003996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64790070|NCT00003996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64790071|NCT00003996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64790072|NCT00003996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790073|NCT00003996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790074|NCT00003996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64790075|NCT00003996|Alkylating Agents|alkylating agents|mesh-ancestor
64790076|NCT00004002|Bortezomib|bortezomib|mesh-list
64790077|NCT00004002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790078|NCT00004008|Bryostatin 1|bryostatin 1|mesh-list
64790079|NCT00004008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64790080|NCT00004008|Immunologic Factors|immunologic factors|mesh-ancestor
64790081|NCT00004008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790082|NCT00004008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790083|NCT00004014|Doxorubicin|doxorubicin|mesh-list
64790084|NCT00004014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64790085|NCT00004014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64790086|NCT00004014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790110|NCT00004056|Antimetabolites|antimetabolites|mesh-ancestor
64790111|NCT00004056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790112|NCT00004056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790113|NCT00004056|Antiviral Agents|antiviral agents|mesh-ancestor
64790114|NCT00004056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64790115|NCT00004056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64790116|NCT00004056|Immunologic Factors|immunologic factors|mesh-ancestor
64790117|NCT00004056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790118|NCT00004056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64790119|NCT00004056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64790120|NCT00004056|Alkylating Agents|alkylating agents|mesh-ancestor
64790121|NCT00004056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64790122|NCT00004056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64790123|NCT00004056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64790124|NCT00004056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64790125|NCT00004056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790126|NCT00004062|Azacitidine|azacitidine|mesh-list
64790127|NCT00004062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64790128|NCT00004062|Antimetabolites|antimetabolites|mesh-ancestor
64790129|NCT00004062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790130|NCT00004062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790131|NCT00004062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790132|NCT00004068|Irinotecan|irinotecan|mesh-list
64790133|NCT00004068|Temozolomide|temozolomide|mesh-list
64790134|NCT00004068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64790135|NCT00004068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64790136|NCT00004068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790137|NCT00004068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790138|NCT00004068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790139|NCT00004068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64790140|NCT00004068|Alkylating Agents|alkylating agents|mesh-ancestor
64790141|NCT00004074|Carboplatin|carboplatin|mesh-list
64790151|NCT00004074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64790152|NCT00004074|Growth Substances|growth substances|mesh-ancestor
64790153|NCT00004074|Growth Inhibitors|growth inhibitors|mesh-ancestor
64790154|NCT00004086|Cytarabine|cytarabine|mesh-list
64790155|NCT00004086|Etoposide|etoposide|mesh-list
64790156|NCT00004086|Ifosfamide|ifosfamide|mesh-list
64790157|NCT00004086|Epratuzumab|epratuzumab|mesh-list
64790158|NCT00004086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790159|NCT00004086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64790160|NCT00004086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64790161|NCT00004086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64790162|NCT00004086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790163|NCT00004086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790164|NCT00004086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64790165|NCT00004086|Antimetabolites|antimetabolites|mesh-ancestor
64790175|NCT00004104|Interferon-alpha|interferon-alpha|mesh-list
64790176|NCT00004104|Interleukin-2|interleukin-2|mesh-list
64790177|NCT00004104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64471971|NCT03946514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64471972|NCT03946514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64471973|NCT03946514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64471974|NCT03946514|Diuretics|diuretics|mesh-ancestor
64471975|NCT03946514|Natriuretic Agents|natriuretic agents|mesh-ancestor
64790192|NCT00004110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64790193|NCT00004110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790194|NCT00004110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64790195|NCT00004110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64790196|NCT00004110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790197|NCT00004110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790198|NCT00004110|Dermatologic Agents|dermatologic agents|mesh-ancestor
64790199|NCT00004122|Interferons|interferons|mesh-list
64790200|NCT00004122|Interferon-alpha|interferon-alpha|mesh-list
64790201|NCT00004122|BCG Vaccine|bcg vaccine|mesh-list
64790202|NCT00004122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790203|NCT00004122|Antiviral Agents|antiviral agents|mesh-ancestor
64790204|NCT00004122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64790205|NCT00004122|Immunologic Factors|immunologic factors|mesh-ancestor
64790206|NCT00004122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790207|NCT00004122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64790208|NCT00004128|Cytarabine|cytarabine|mesh-list
64790209|NCT00004128|Aldesleukin|aldesleukin|mesh-list
64790210|NCT00004128|Cyclophosphamide|cyclophosphamide|mesh-list
64790211|NCT00004128|Busulfan|busulfan|mesh-list
64790212|NCT00004128|Etoposide|etoposide|mesh-list
64790213|NCT00004128|Daunorubicin|daunorubicin|mesh-list
64790214|NCT00004128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64790215|NCT00004128|Immunologic Factors|immunologic factors|mesh-ancestor
64790216|NCT00004128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790217|NCT00004128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64790257|NCT00004164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790258|NCT00004164|Antimetabolites|antimetabolites|mesh-ancestor
64790259|NCT00004164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64790260|NCT00004164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64790261|NCT00004164|Immunologic Factors|immunologic factors|mesh-ancestor
64790262|NCT00004164|Antidotes|antidotes|mesh-ancestor
64790263|NCT00004164|Protective Agents|protective agents|mesh-ancestor
64790264|NCT00004164|Vitamin B Complex|vitamin b complex|mesh-ancestor
64790265|NCT00004164|Vitamins|vitamins|mesh-ancestor
64790266|NCT00004164|Micronutrients|micronutrients|mesh-ancestor
64790267|NCT00004176|Etoposide|etoposide|mesh-list
64790268|NCT00004176|Amifostine|amifostine|mesh-list
64790269|NCT00004176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790270|NCT00004176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64790271|NCT00004176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64790272|NCT00004176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64790273|NCT00004176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790274|NCT00004176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790275|NCT00004176|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64790276|NCT00004176|Protective Agents|protective agents|mesh-ancestor
64790277|NCT00004176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790278|NCT00004188|Cyclophosphamide|cyclophosphamide|mesh-list
64790279|NCT00004188|Melphalan|melphalan|mesh-list
64790280|NCT00004188|Mechlorethamine|mechlorethamine|mesh-list
64790281|NCT00004188|Cisplatin|cisplatin|mesh-list
64790282|NCT00004188|Carboplatin|carboplatin|mesh-list
64790283|NCT00004188|Doxorubicin|doxorubicin|mesh-list
64790284|NCT00004188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64790285|NCT00004188|Etoposide|etoposide|mesh-list
64790312|NCT00004194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790313|NCT00004194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64790314|NCT00004194|Antimetabolites|antimetabolites|mesh-ancestor
64790315|NCT00004194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790316|NCT00004194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64790317|NCT00004194|Immunologic Factors|immunologic factors|mesh-ancestor
64790318|NCT00004194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790319|NCT00004200|Temozolomide|temozolomide|mesh-list
64790320|NCT00004200|Prinomastat|prinomastat|mesh-list
64790321|NCT00004200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64790322|NCT00004200|Alkylating Agents|alkylating agents|mesh-ancestor
64790323|NCT00004200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790324|NCT00004200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790325|NCT00004200|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
64790326|NCT00004200|Protease Inhibitors|protease inhibitors|mesh-ancestor
64790327|NCT00004200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790328|NCT00004206|Leucovorin|leucovorin|mesh-list
64790329|NCT00004206|Fluorouracil|fluorouracil|mesh-list
64790330|NCT00004206|Oxaliplatin|oxaliplatin|mesh-list
64790331|NCT00004206|Calcium|calcium|mesh-list
64790332|NCT00004206|Levoleucovorin|levoleucovorin|mesh-list
64790333|NCT00004206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64790334|NCT00004206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790335|NCT00004206|Antimetabolites|antimetabolites|mesh-ancestor
64790336|NCT00004206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790337|NCT00004206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64790338|NCT00004206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790339|NCT00004206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64790340|NCT00004206|Immunologic Factors|immunologic factors|mesh-ancestor
64790358|NCT00004218|Fludarabine phosphate|fludarabine phosphate|mesh-list
64790359|NCT00004218|Vincristine|vincristine|mesh-list
64790360|NCT00004218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64790361|NCT00004218|Immunologic Factors|immunologic factors|mesh-ancestor
64790362|NCT00004218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790363|NCT00004218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64790364|NCT00004218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64790365|NCT00004218|Alkylating Agents|alkylating agents|mesh-ancestor
64790366|NCT00004218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790369|NCT00004218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64790370|NCT00004218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64790372|NCT00004218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790373|NCT00004218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64790374|NCT00004218|Antimetabolites|antimetabolites|mesh-ancestor
64790375|NCT00004218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64790376|NCT00004218|Tubulin Modulators|tubulin modulators|mesh-ancestor
64790377|NCT00004218|Antimitotic Agents|antimitotic agents|mesh-ancestor
64790379|NCT00004218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64790380|NCT00004218|Glucocorticoids|glucocorticoids|mesh-ancestor
64790381|NCT00004218|Hormones|hormones|mesh-ancestor
64790382|NCT00004218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64790383|NCT00004218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64790384|NCT00004224|Cyclophosphamide|cyclophosphamide|mesh-list
64790385|NCT00004224|Etoposide|etoposide|mesh-list
64790386|NCT00004224|Vincristine|vincristine|mesh-list
64471993|NCT03935958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790387|NCT00004224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64790388|NCT00004224|Immunologic Factors|immunologic factors|mesh-ancestor
64790389|NCT00004224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790390|NCT00004224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64790391|NCT00004224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64790392|NCT00004224|Alkylating Agents|alkylating agents|mesh-ancestor
64790393|NCT00004224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790394|NCT00004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790395|NCT00004224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64790398|NCT00004224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64790399|NCT00004224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790400|NCT00004224|Tubulin Modulators|tubulin modulators|mesh-ancestor
64790401|NCT00004224|Antimitotic Agents|antimitotic agents|mesh-ancestor
64790402|NCT00004224|Mitosis Modulators|mitosis modulators|mesh-ancestor
64790403|NCT00004236|Doxorubicin|doxorubicin|mesh-list
64790404|NCT00004236|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64790405|NCT00004236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64790406|NCT00004236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790407|NCT00004236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64790408|NCT00004236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64790409|NCT00004236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790410|NCT00004236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790411|NCT00004242|Gemcitabine|gemcitabine|mesh-list
64790412|NCT00004242|Fluorouracil|fluorouracil|mesh-list
64790413|NCT00004242|Oxaliplatin|oxaliplatin|mesh-list
64790414|NCT00004242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64790415|NCT00004242|Antimetabolites|antimetabolites|mesh-ancestor
64790416|NCT00004242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790417|NCT00004242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790418|NCT00004242|Antiviral Agents|antiviral agents|mesh-ancestor
64790419|NCT00004242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64790420|NCT00004242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790421|NCT00004242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64790422|NCT00004242|Immunologic Factors|immunologic factors|mesh-ancestor
64790423|NCT00004242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790424|NCT00004248|Aldesleukin|aldesleukin|mesh-list
64790444|NCT00004260|Rituximab|rituximab|mesh-list
64790450|NCT00004260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64790451|NCT00004260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64790452|NCT00004260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64790453|NCT00004260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64790454|NCT00004260|Growth Substances|growth substances|mesh-ancestor
64790455|NCT00004260|Growth Inhibitors|growth inhibitors|mesh-ancestor
64790456|NCT00004266|Lisinopril|lisinopril|mesh-list
64790457|NCT00004266|Nifedipine|nifedipine|mesh-list
64790458|NCT00004266|Simvastatin|simvastatin|mesh-list
64790459|NCT00004266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64790460|NCT00004266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64790461|NCT00004266|Antimetabolites|antimetabolites|mesh-ancestor
64790462|NCT00004266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790463|NCT00004266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64471994|NCT03935958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790464|NCT00004266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64790465|NCT00004266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790466|NCT00004266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64790467|NCT00004266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64790468|NCT00004266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64790469|NCT00004266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790470|NCT00004266|Vasodilator Agents|vasodilator agents|mesh-ancestor
64790471|NCT00004266|Tocolytic Agents|tocolytic agents|mesh-ancestor
64790472|NCT00004266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64790473|NCT00004266|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64790474|NCT00004266|Protease Inhibitors|protease inhibitors|mesh-ancestor
64790475|NCT00004266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64790476|NCT00004266|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64790477|NCT00004266|Protective Agents|protective agents|mesh-ancestor
64790478|NCT00004278|Ganciclovir|ganciclovir|mesh-list
64790479|NCT00004278|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64790480|NCT00004278|Antiviral Agents|antiviral agents|mesh-ancestor
64790485|NCT00004284|Potassium Citrate|potassium citrate|mesh-list
64790491|NCT00004284|Respiratory System Agents|respiratory system agents|mesh-ancestor
64790492|NCT00004284|Cariostatic Agents|cariostatic agents|mesh-ancestor
64790493|NCT00004284|Protective Agents|protective agents|mesh-ancestor
64790494|NCT00004344|Leuprolide|leuprolide|mesh-list
64790495|NCT00004344|Testosterone|testosterone|mesh-list
64790496|NCT00004344|Androgens|androgens|mesh-ancestor
64790497|NCT00004344|Hormones|hormones|mesh-ancestor
64790498|NCT00004344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64790499|NCT00004344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790500|NCT00004344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64790501|NCT00004344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790502|NCT00004344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64790503|NCT00004344|Fertility Agents|fertility agents|mesh-ancestor
64790504|NCT00004344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64790505|NCT00004368|Colchicine|colchicine|mesh-list
64790506|NCT00004368|Gout Suppressants|gout suppressants|mesh-ancestor
64790507|NCT00004368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64790508|NCT00004368|Tubulin Modulators|tubulin modulators|mesh-ancestor
64790509|NCT00004368|Antimitotic Agents|antimitotic agents|mesh-ancestor
64790510|NCT00004368|Mitosis Modulators|mitosis modulators|mesh-ancestor
64401551|NCT01603459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64790528|NCT00004404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64790529|NCT00004404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64790531|NCT00004404|Antifungal Agents|antifungal agents|mesh-ancestor
64790532|NCT00004404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64790533|NCT00004404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64790534|NCT00004404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64790535|NCT00004404|Hormone Antagonists|hormone antagonists|mesh-ancestor
64790536|NCT00004404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64790537|NCT00004404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790551|NCT00004416|Cholinergic Agents|cholinergic agents|mesh-ancestor
64790552|NCT00004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64471995|NCT03935958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471996|NCT03935295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64790553|NCT00004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790554|NCT00004416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64790555|NCT00004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64790556|NCT00004422|Immunoglobulins|immunoglobulins|mesh-list
64790557|NCT00004422|Antibodies|antibodies|mesh-list
64790558|NCT00004422|gamma-Globulins|gamma-globulins|mesh-list
64790559|NCT00004422|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64790560|NCT00004422|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64790561|NCT00004422|Immunologic Factors|immunologic factors|mesh-ancestor
64790562|NCT00004422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790563|NCT00004440|Ibuprofen|ibuprofen|mesh-list
64790564|NCT00004440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64401628|NCT03066557|Hormones|hormones|mesh-ancestor
64790582|NCT00004446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790583|NCT00004446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64790584|NCT00004446|Antidepressive Agents|antidepressive agents|mesh-ancestor
64790585|NCT00004446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64790586|NCT00004446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64790587|NCT00004446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64790588|NCT00004446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790589|NCT00004464|Cyclophosphamide|cyclophosphamide|mesh-list
64790590|NCT00004464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64790591|NCT00004464|Immunologic Factors|immunologic factors|mesh-ancestor
64790612|NCT00004482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790613|NCT00004482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64790614|NCT00004482|Immunologic Factors|immunologic factors|mesh-ancestor
64790615|NCT00004482|Antifungal Agents|antifungal agents|mesh-ancestor
64790616|NCT00004482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64790617|NCT00004482|Dermatologic Agents|dermatologic agents|mesh-ancestor
64790618|NCT00004482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64790619|NCT00004482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64401682|NCT04710199|Maraviroc|maraviroc|mesh-list
64790638|NCT00004488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64790639|NCT00004554|Naltrexone|naltrexone|mesh-list
64790640|NCT00004554|Sertraline|sertraline|mesh-list
64790641|NCT00004554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64790642|NCT00004554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64790643|NCT00004554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790644|NCT00004554|Sensory System Agents|sensory system agents|mesh-ancestor
64790647|NCT00004554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64790676|NCT00004650|Medroxyprogesterone|medroxyprogesterone|mesh-list
64790677|NCT00004650|Estrogens|estrogens|mesh-list
64790678|NCT00004650|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64790679|NCT00004650|Hormones|hormones|mesh-ancestor
64790685|NCT00004650|Contraceptive Agents|contraceptive agents|mesh-ancestor
64790686|NCT00004650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64790687|NCT00004650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64790688|NCT00004650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64790689|NCT00004650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64790690|NCT00004650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64790691|NCT00004650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790692|NCT00004662|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64790693|NCT00004662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64790694|NCT00004662|Immunologic Factors|immunologic factors|mesh-ancestor
64790695|NCT00004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790696|NCT00004686|Prednisone|prednisone|mesh-list
64790697|NCT00004686|Methotrexate|methotrexate|mesh-list
64790698|NCT00004686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64790699|NCT00004686|Glucocorticoids|glucocorticoids|mesh-ancestor
64790700|NCT00004686|Hormones|hormones|mesh-ancestor
64790701|NCT00004686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64790702|NCT00004686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790703|NCT00004686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64790704|NCT00004686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790705|NCT00004686|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64790706|NCT00004686|Abortifacient Agents|abortifacient agents|mesh-ancestor
64790707|NCT00004686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64790708|NCT00004686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64790709|NCT00004686|Antimetabolites|antimetabolites|mesh-ancestor
64790710|NCT00004686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790711|NCT00004686|Dermatologic Agents|dermatologic agents|mesh-ancestor
64790712|NCT00004686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472009|NCT03915444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790713|NCT00004686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64790714|NCT00004686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951760|NCT00027443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951761|NCT00027443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951762|NCT00027443|Immunologic Factors|immunologic factors|mesh-ancestor
64790715|NCT00004686|Immunologic Factors|immunologic factors|mesh-ancestor
64790716|NCT00004686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64790717|NCT00004686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64790718|NCT00004728|Aspirin|aspirin|mesh-list
64790719|NCT00004728|Warfarin|warfarin|mesh-list
64790720|NCT00004728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64790721|NCT00004728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64790722|NCT00004728|Analgesics|analgesics|mesh-ancestor
64790723|NCT00004728|Sensory System Agents|sensory system agents|mesh-ancestor
64790724|NCT00004728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64790725|NCT00004728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790726|NCT00004728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64790727|NCT00004728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64790728|NCT00004728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64790729|NCT00004728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64790730|NCT00004728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790731|NCT00004728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64790732|NCT00004728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64790733|NCT00004728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790734|NCT00004728|Antipyretics|antipyretics|mesh-ancestor
64790735|NCT00004728|Anticoagulants|anticoagulants|mesh-ancestor
64790736|NCT00004734|Folic Acid|folic acid|mesh-list
64790737|NCT00004734|Pyridoxine|pyridoxine|mesh-list
64790738|NCT00004734|Vitamin B 12|vitamin b 12|mesh-list
64790739|NCT00004734|Hydroxocobalamin|hydroxocobalamin|mesh-list
64790740|NCT00004734|Hematinics|hematinics|mesh-ancestor
64790741|NCT00004734|Vitamin B Complex|vitamin b complex|mesh-ancestor
64790742|NCT00004734|Vitamins|vitamins|mesh-ancestor
64790743|NCT00004734|Micronutrients|micronutrients|mesh-ancestor
64790744|NCT00004734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790745|NCT00004740|Isoniazid|isoniazid|mesh-list
64790746|NCT00004740|Antitubercular Agents|antitubercular agents|mesh-ancestor
64790747|NCT00004740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64790748|NCT00004740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64790760|NCT00004758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790761|NCT00004758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790762|NCT00004758|GABA Agents|gaba agents|mesh-ancestor
64790763|NCT00004758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64790765|NCT00004758|Antimanic Agents|antimanic agents|mesh-ancestor
64790766|NCT00004758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64790767|NCT00004758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64790768|NCT00004758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64790769|NCT00004758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64790770|NCT00004758|Analgesics|analgesics|mesh-ancestor
64790771|NCT00004758|Sensory System Agents|sensory system agents|mesh-ancestor
64790772|NCT00004758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64790773|NCT00004758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64790774|NCT00004758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64790775|NCT00004758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64790776|NCT00004758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64790777|NCT00004758|Vitamin B Complex|vitamin b complex|mesh-ancestor
64790778|NCT00004758|Vitamins|vitamins|mesh-ancestor
64790779|NCT00004758|Micronutrients|micronutrients|mesh-ancestor
64790780|NCT00004758|Hormones|hormones|mesh-ancestor
64790781|NCT00004758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64790782|NCT00004758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64790783|NCT00004758|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64790784|NCT00004758|GABA Modulators|gaba modulators|mesh-ancestor
64790785|NCT00004770|Thioctic Acid|thioctic acid|mesh-list
64790786|NCT00004770|Antioxidants|antioxidants|mesh-ancestor
64790787|NCT00004770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790788|NCT00004770|Protective Agents|protective agents|mesh-ancestor
64790789|NCT00004770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790790|NCT00004770|Vitamin B Complex|vitamin b complex|mesh-ancestor
64790791|NCT00004770|Vitamins|vitamins|mesh-ancestor
64790792|NCT00004770|Micronutrients|micronutrients|mesh-ancestor
64951763|NCT00027443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951764|NCT00027443|Antifungal Agents|antifungal agents|mesh-ancestor
64951765|NCT00027443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951766|NCT00027443|Dermatologic Agents|dermatologic agents|mesh-ancestor
64951767|NCT00027443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64951768|NCT00027443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64951769|NCT00055614|Topotecan|topotecan|mesh-list
64951770|NCT00055614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64951771|NCT00055614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64951772|NCT00055614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951778|NCT00027599|Bevacizumab|bevacizumab|mesh-list
64951779|NCT00027599|Sargramostim|sargramostim|mesh-list
64951780|NCT00027599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64951781|NCT00027599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951782|NCT00027599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64951783|NCT00027599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64951784|NCT00027599|Growth Substances|growth substances|mesh-ancestor
64951785|NCT00027599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951786|NCT00027599|Growth Inhibitors|growth inhibitors|mesh-ancestor
64951787|NCT00027599|Immunologic Factors|immunologic factors|mesh-ancestor
64790793|NCT00004776|Topiramate|topiramate|mesh-list
64790794|NCT00004776|Anticonvulsants|anticonvulsants|mesh-ancestor
64790795|NCT00004776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64790796|NCT00004776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790797|NCT00004794|Cidofovir|cidofovir|mesh-list
64790798|NCT00004794|Antiviral Agents|antiviral agents|mesh-ancestor
64790799|NCT00004794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64790800|NCT00004794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790801|NCT00004794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790802|NCT00004800|Vaccines|vaccines|mesh-list
64790803|NCT00004800|Immunologic Factors|immunologic factors|mesh-ancestor
64790804|NCT00004800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790805|NCT00004842|Budesonide|budesonide|mesh-list
64790806|NCT00004842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64790807|NCT00004842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64790808|NCT00004842|Autonomic Agents|autonomic agents|mesh-ancestor
64790809|NCT00004842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64790810|NCT00004842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790811|NCT00004842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64790812|NCT00004842|Respiratory System Agents|respiratory system agents|mesh-ancestor
64790813|NCT00004842|Glucocorticoids|glucocorticoids|mesh-ancestor
64790814|NCT00004842|Hormones|hormones|mesh-ancestor
64401865|NCT04447469|Mavrilimumab|mavrilimumab|mesh-list
64790819|NCT00004854|Adrenergic Agents|adrenergic agents|mesh-ancestor
64790820|NCT00004854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64790821|NCT00004854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790822|NCT00004854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790823|NCT00004854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64790824|NCT00004854|Antioxidants|antioxidants|mesh-ancestor
64790825|NCT00004854|Protective Agents|protective agents|mesh-ancestor
64790826|NCT00004854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64790827|NCT00004854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64559406|NCT00988143|Vaccines|vaccines|mesh-list
64790840|NCT00004860|Vitamin B Complex|vitamin b complex|mesh-ancestor
64790841|NCT00004860|Vitamins|vitamins|mesh-ancestor
64790842|NCT00004860|Micronutrients|micronutrients|mesh-ancestor
64790843|NCT00004860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64790844|NCT00004860|Antimetabolites|antimetabolites|mesh-ancestor
64790845|NCT00004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790846|NCT00004860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790847|NCT00004866|Exatecan|exatecan|mesh-list
64790848|NCT00004866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64790849|NCT00004866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64790850|NCT00004866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790851|NCT00004866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790852|NCT00004866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790853|NCT00004872|Endostatins|endostatins|mesh-list
64790854|NCT00004872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790855|NCT00004872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64790856|NCT00004872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64790857|NCT00004872|Growth Substances|growth substances|mesh-ancestor
64790858|NCT00004872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790859|NCT00004872|Growth Inhibitors|growth inhibitors|mesh-ancestor
64790860|NCT00004878|Cytarabine|cytarabine|mesh-list
64790861|NCT00004878|Methotrexate|methotrexate|mesh-list
64790862|NCT00004878|Fludarabine phosphate|fludarabine phosphate|mesh-list
64790863|NCT00004878|Fludarabine|fludarabine|mesh-list
64790864|NCT00004878|Idarubicin|idarubicin|mesh-list
64790865|NCT00004878|Tacrolimus|tacrolimus|mesh-list
64790866|NCT00004878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64790867|NCT00004878|Abortifacient Agents|abortifacient agents|mesh-ancestor
64790868|NCT00004878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64790869|NCT00004878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790870|NCT00004878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64790871|NCT00004878|Antimetabolites|antimetabolites|mesh-ancestor
64790872|NCT00004878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790873|NCT00004878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790874|NCT00004878|Dermatologic Agents|dermatologic agents|mesh-ancestor
64790875|NCT00004878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790876|NCT00004878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64951788|NCT00055653|Cyclosporine|cyclosporine|mesh-list
64951789|NCT00055653|Methylprednisolone|methylprednisolone|mesh-list
64790877|NCT00004878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64790878|NCT00004878|Immunologic Factors|immunologic factors|mesh-ancestor
64790879|NCT00004878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64472010|NCT03915444|Tubulin Modulators|tubulin modulators|mesh-ancestor
64790880|NCT00004878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64790881|NCT00004878|Antiviral Agents|antiviral agents|mesh-ancestor
64790882|NCT00004878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64790883|NCT00004878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64790884|NCT00004878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64790885|NCT00004878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64790894|NCT00004884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64790895|NCT00004884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790896|NCT00004884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64790897|NCT00004884|Immunologic Factors|immunologic factors|mesh-ancestor
64790898|NCT00004884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790899|NCT00004884|Tubulin Modulators|tubulin modulators|mesh-ancestor
64790900|NCT00004884|Antimitotic Agents|antimitotic agents|mesh-ancestor
64790901|NCT00004884|Mitosis Modulators|mitosis modulators|mesh-ancestor
64790902|NCT00004890|Aldesleukin|aldesleukin|mesh-list
64790903|NCT00004890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790904|NCT00004890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64790905|NCT00004890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64790906|NCT00004890|Antiviral Agents|antiviral agents|mesh-ancestor
64790907|NCT00004890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64790908|NCT00004920|Raltitrexed|raltitrexed|mesh-list
64790909|NCT00004920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790910|NCT00004920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64790911|NCT00004920|Antimetabolites|antimetabolites|mesh-ancestor
64790912|NCT00004920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790913|NCT00004920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64790914|NCT00004920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790915|NCT00004926|Vitamin D|vitamin d|mesh-list
64790916|NCT00004926|Cholecalciferol|cholecalciferol|mesh-list
64790917|NCT00004926|Ro 23-7553|ro 23-7553|mesh-list
64790918|NCT00004926|Vitamins|vitamins|mesh-ancestor
64790926|NCT00004932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64790927|NCT00004932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790928|NCT00004932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790929|NCT00004938|Fluconazole|fluconazole|mesh-list
64790930|NCT00004938|Antifungal Agents|antifungal agents|mesh-ancestor
64790931|NCT00004938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64790932|NCT00004938|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64790933|NCT00004938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64790934|NCT00004938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790935|NCT00004938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790936|NCT00004938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64790937|NCT00004938|Hormone Antagonists|hormone antagonists|mesh-ancestor
64790938|NCT00004938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64790939|NCT00004938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790940|NCT00004938|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64790941|NCT00004938|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64790942|NCT00004986|Nitazoxanide|nitazoxanide|mesh-list
64790945|NCT00004992|Metformin|metformin|mesh-list
64790983|NCT00005022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790984|NCT00005028|Paclitaxel|paclitaxel|mesh-list
64790985|NCT00005028|Bryostatin 1|bryostatin 1|mesh-list
64790986|NCT00005028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64790987|NCT00005028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790988|NCT00005028|Tubulin Modulators|tubulin modulators|mesh-ancestor
64790989|NCT00005028|Antimitotic Agents|antimitotic agents|mesh-ancestor
64790990|NCT00005028|Mitosis Modulators|mitosis modulators|mesh-ancestor
64790991|NCT00005028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790992|NCT00005028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64790993|NCT00005028|Immunologic Factors|immunologic factors|mesh-ancestor
64790994|NCT00005028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790995|NCT00005040|Arsenic Trioxide|arsenic trioxide|mesh-list
64790996|NCT00005040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790997|NCT00005046|Paclitaxel|paclitaxel|mesh-list
64790998|NCT00005046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64790999|NCT00005046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791000|NCT00005046|Tubulin Modulators|tubulin modulators|mesh-ancestor
64791001|NCT00005046|Antimitotic Agents|antimitotic agents|mesh-ancestor
64791002|NCT00005046|Mitosis Modulators|mitosis modulators|mesh-ancestor
64791003|NCT00005046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791004|NCT00005064|Bortezomib|bortezomib|mesh-list
64791005|NCT00005064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791006|NCT00005070|Irofulven|irofulven|mesh-list
64791007|NCT00005070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64791008|NCT00005070|Alkylating Agents|alkylating agents|mesh-ancestor
64791010|NCT00005070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791038|NCT00005106|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64791039|NCT00005106|Nelfinavir|nelfinavir|mesh-list
64791040|NCT00005106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64791041|NCT00005106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64791042|NCT00005106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791043|NCT00005106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791044|NCT00005106|Antiviral Agents|antiviral agents|mesh-ancestor
64791045|NCT00005106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64472011|NCT03915444|Antimitotic Agents|antimitotic agents|mesh-ancestor
64472012|NCT03915444|Mitosis Modulators|mitosis modulators|mesh-ancestor
64472013|NCT03915444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472014|NCT03915444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64791046|NCT00005106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64791047|NCT00005106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64791048|NCT00005106|Antimetabolites|antimetabolites|mesh-ancestor
64791049|NCT00005106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64791050|NCT00005106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64791051|NCT00005106|Protease Inhibitors|protease inhibitors|mesh-ancestor
64791052|NCT00005118|Ritonavir|ritonavir|mesh-list
64791053|NCT00005118|Indinavir|indinavir|mesh-list
64791054|NCT00005118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64791055|NCT00005118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64791056|NCT00005118|Protease Inhibitors|protease inhibitors|mesh-ancestor
64791057|NCT00005118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791058|NCT00005118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791059|NCT00005118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64791061|NCT00005118|Antiviral Agents|antiviral agents|mesh-ancestor
64791080|NCT00005574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791081|NCT00005574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791082|NCT00005580|Fludarabine|fludarabine|mesh-list
64791083|NCT00005580|Fludarabine phosphate|fludarabine phosphate|mesh-list
64791084|NCT00005580|Bryostatin 1|bryostatin 1|mesh-list
64791085|NCT00005580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791086|NCT00005580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64791087|NCT00005580|Antimetabolites|antimetabolites|mesh-ancestor
64791092|NCT00005580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64791094|NCT00005586|Fluorouracil|fluorouracil|mesh-list
64791095|NCT00005586|Levoleucovorin|levoleucovorin|mesh-list
64791096|NCT00005586|Antimetabolites|antimetabolites|mesh-ancestor
64791097|NCT00005586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791098|NCT00005586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64791099|NCT00005586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791100|NCT00005586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64791101|NCT00005586|Immunologic Factors|immunologic factors|mesh-ancestor
64791102|NCT00005586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791103|NCT00005586|Antidotes|antidotes|mesh-ancestor
64791135|NCT00005604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64791136|NCT00005604|Antiviral Agents|antiviral agents|mesh-ancestor
64791137|NCT00005604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64791138|NCT00005604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64791139|NCT00005604|Immunologic Factors|immunologic factors|mesh-ancestor
64791140|NCT00005604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64791141|NCT00005604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64791142|NCT00005604|Growth Substances|growth substances|mesh-ancestor
64791143|NCT00005604|Growth Inhibitors|growth inhibitors|mesh-ancestor
64791144|NCT00005610|Sargramostim|sargramostim|mesh-list
64791145|NCT00005610|Immunologic Factors|immunologic factors|mesh-ancestor
64791146|NCT00005610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791147|NCT00005616|Antibodies|antibodies|mesh-list
64791148|NCT00005616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64791149|NCT00005616|Immunologic Factors|immunologic factors|mesh-ancestor
64791150|NCT00005616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791151|NCT00005622|Cyclophosphamide|cyclophosphamide|mesh-list
64791152|NCT00005622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64791153|NCT00005622|Immunologic Factors|immunologic factors|mesh-ancestor
64791154|NCT00005622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791155|NCT00005622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64791156|NCT00005622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64791157|NCT00005622|Alkylating Agents|alkylating agents|mesh-ancestor
64791201|NCT00005802|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64791202|NCT00005802|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64791203|NCT00005802|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64791204|NCT00005802|Methotrexate|methotrexate|mesh-list
64791205|NCT00005802|Fludarabine phosphate|fludarabine phosphate|mesh-list
64791206|NCT00005802|Fludarabine|fludarabine|mesh-list
64791207|NCT00005802|Etoposide|etoposide|mesh-list
64791208|NCT00005802|Mitoxantrone|mitoxantrone|mesh-list
64791209|NCT00005802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64791210|NCT00005802|Abortifacient Agents|abortifacient agents|mesh-ancestor
64791211|NCT00005802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64791212|NCT00005802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791213|NCT00005802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64791214|NCT00005802|Antimetabolites|antimetabolites|mesh-ancestor
64791215|NCT00005802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791216|NCT00005802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791217|NCT00005802|Dermatologic Agents|dermatologic agents|mesh-ancestor
64791218|NCT00005802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791227|NCT00005802|Antiviral Agents|antiviral agents|mesh-ancestor
64791228|NCT00005802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64791229|NCT00005802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64791230|NCT00005802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64791231|NCT00005802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64791232|NCT00005802|Analgesics|analgesics|mesh-ancestor
64791233|NCT00005802|Sensory System Agents|sensory system agents|mesh-ancestor
64791234|NCT00005802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64791235|NCT00005808|Motexafin lutetium|motexafin lutetium|mesh-list
64791236|NCT00005808|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64791237|NCT00005808|Dermatologic Agents|dermatologic agents|mesh-ancestor
64791238|NCT00005814|Cetuximab|cetuximab|mesh-list
64791239|NCT00005814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791240|NCT00005814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64791241|NCT00354900|Aprotinin|aprotinin|mesh-list
64791242|NCT00354900|Hemostatics|hemostatics|mesh-ancestor
64791252|NCT00355290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791253|NCT00355290|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64791254|NCT00355290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64791255|NCT00355290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791256|NCT00355290|Hemostatics|hemostatics|mesh-ancestor
64791257|NCT00355290|Coagulants|coagulants|mesh-ancestor
64791258|NCT00355446|Bimatoprost|bimatoprost|mesh-list
64791259|NCT00355446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64791260|NCT00355524|Ritonavir|ritonavir|mesh-list
64791261|NCT00355524|Darunavir|darunavir|mesh-list
64791262|NCT00355524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64791263|NCT00355524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64791264|NCT00355524|Protease Inhibitors|protease inhibitors|mesh-ancestor
64791265|NCT00355524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791266|NCT00355524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791267|NCT00355524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64791268|NCT00355524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64791269|NCT00355524|Antiviral Agents|antiviral agents|mesh-ancestor
64791270|NCT00355524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64791271|NCT00355524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64791272|NCT00355524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64791273|NCT00355602|Metronidazole|metronidazole|mesh-list
64791274|NCT00355602|Vancomycin|vancomycin|mesh-list
64791275|NCT00355602|Clarithromycin|clarithromycin|mesh-list
64791276|NCT00355602|Doxycycline|doxycycline|mesh-list
64791277|NCT00355602|Ciprofloxacin|ciprofloxacin|mesh-list
64791278|NCT00355602|Rifaximin|rifaximin|mesh-list
64791279|NCT00355602|Cefuroxime|cefuroxime|mesh-list
64791280|NCT00355602|Neomycin|neomycin|mesh-list
64559900|NCT01023711|Vaccines|vaccines|mesh-list
64791281|NCT00355602|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64945440|NCT05633615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791282|NCT00355602|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64791283|NCT00355602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64791284|NCT00355602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64791295|NCT00355602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791296|NCT00355602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64791297|NCT00355602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64791298|NCT00355602|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64791299|NCT00355602|Renal Agents|renal agents|mesh-ancestor
64791300|NCT00355602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64791301|NCT00356070|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64791302|NCT00356070|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64791303|NCT00356070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64791304|NCT00356070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64791305|NCT00356070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791306|NCT00356070|Adrenergic Agents|adrenergic agents|mesh-ancestor
64791307|NCT00356070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64791308|NCT00356070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791310|NCT00356226|Analgesics|analgesics|mesh-ancestor
64791311|NCT00356226|Sensory System Agents|sensory system agents|mesh-ancestor
64791312|NCT00356226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64791313|NCT00356226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791315|NCT00356226|Sympatholytics|sympatholytics|mesh-ancestor
64791350|NCT00356928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64791351|NCT00356928|Immunologic Factors|immunologic factors|mesh-ancestor
64791352|NCT00356928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791353|NCT00356928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64791354|NCT00356928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64791368|NCT00357084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64791369|NCT00357084|Glucocorticoids|glucocorticoids|mesh-ancestor
64791370|NCT00357084|Hormones|hormones|mesh-ancestor
64791371|NCT00357084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64791372|NCT00357084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791373|NCT00357084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64791374|NCT00357084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791375|NCT00357084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64791376|NCT00357084|Abortifacient Agents|abortifacient agents|mesh-ancestor
64791377|NCT00357084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64791378|NCT00357084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64791379|NCT00357084|Antimetabolites|antimetabolites|mesh-ancestor
64791380|NCT00357084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791381|NCT00357084|Dermatologic Agents|dermatologic agents|mesh-ancestor
64791382|NCT00357084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791383|NCT00357084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64791384|NCT00357084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64791385|NCT00357084|Immunologic Factors|immunologic factors|mesh-ancestor
64791386|NCT00357084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64791387|NCT00357084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64791388|NCT00357084|Antiemetics|antiemetics|mesh-ancestor
64791389|NCT00357084|Autonomic Agents|autonomic agents|mesh-ancestor
64791394|NCT00357240|Ritonavir|ritonavir|mesh-list
64791408|NCT00357240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64791409|NCT00357240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64791410|NCT00357240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64791411|NCT00357318|Bevacizumab|bevacizumab|mesh-list
64791412|NCT00357318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64791413|NCT00357318|Sunitinib|sunitinib|mesh-list
64791414|NCT00357318|Antibodies|antibodies|mesh-list
64791415|NCT00357318|Immunoglobulins|immunoglobulins|mesh-list
64791416|NCT00357318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64791417|NCT00357318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791426|NCT00357318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791427|NCT00357474|Ethanol|ethanol|mesh-list
64791428|NCT00357474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64791429|NCT00357474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64791430|NCT00357474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64945441|NCT05633615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64791431|NCT00357474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791432|NCT00357630|Gemcitabine|gemcitabine|mesh-list
64791434|NCT00357630|Antimetabolites|antimetabolites|mesh-ancestor
64791473|NCT00357942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64791474|NCT00358020|Thalidomide|thalidomide|mesh-list
64791475|NCT00358020|Bortezomib|bortezomib|mesh-list
64791476|NCT00358020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791477|NCT00358020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64791478|NCT00358020|Immunologic Factors|immunologic factors|mesh-ancestor
64791479|NCT00358020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791480|NCT00358020|Leprostatic Agents|leprostatic agents|mesh-ancestor
64791481|NCT00358020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64791482|NCT00358020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64791483|NCT00358020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64791484|NCT00358020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64791494|NCT00358410|Casopitant|casopitant|mesh-list
64791495|NCT00358410|Antiemetics|antiemetics|mesh-ancestor
64791496|NCT00358410|Autonomic Agents|autonomic agents|mesh-ancestor
64791497|NCT00358410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64791498|NCT00358410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791499|NCT00358410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64791500|NCT00358410|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64791501|NCT00358410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64791502|NCT00358410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791503|NCT00358488|Albuterol|albuterol|mesh-list
64791504|NCT00358488|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64791505|NCT00358488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64791506|NCT00358488|Autonomic Agents|autonomic agents|mesh-ancestor
64791507|NCT00358488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64791508|NCT00358488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791509|NCT00358488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64791510|NCT00358488|Respiratory System Agents|respiratory system agents|mesh-ancestor
64791511|NCT00358488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64791512|NCT00358488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64791513|NCT00358488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64791514|NCT00358488|Adrenergic Agents|adrenergic agents|mesh-ancestor
64791515|NCT00358488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64791516|NCT00358488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791517|NCT00358488|Tocolytic Agents|tocolytic agents|mesh-ancestor
64791519|NCT00358566|Gemcitabine|gemcitabine|mesh-list
64791520|NCT00358566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64791521|NCT00358566|Antimetabolites|antimetabolites|mesh-ancestor
64791522|NCT00358566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791523|NCT00358566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791524|NCT00358566|Antiviral Agents|antiviral agents|mesh-ancestor
64791525|NCT00358566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64791526|NCT00358566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791527|NCT00358566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64791528|NCT00358566|Immunologic Factors|immunologic factors|mesh-ancestor
64791529|NCT00358566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791530|NCT00359112|Metformin|metformin|mesh-list
64791531|NCT00359112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64791532|NCT00359112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791533|NCT00359190|Lapatinib|lapatinib|mesh-list
64472024|NCT03892785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64337481|NCT02236169|Bromides|bromides|mesh-list
64791534|NCT00359190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791535|NCT00359190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64791536|NCT00359190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791537|NCT00359190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791629|NCT00361452|Tocolytic Agents|tocolytic agents|mesh-ancestor
64791630|NCT00361452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64791631|NCT00361452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64791632|NCT00361686|Tramadol|tramadol|mesh-list
64791633|NCT00361686|Remifentanil|remifentanil|mesh-list
64791634|NCT00361686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64791635|NCT00361686|Narcotics|narcotics|mesh-ancestor
64791636|NCT00361686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64791637|NCT00361686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791638|NCT00361686|Analgesics|analgesics|mesh-ancestor
64791639|NCT00361686|Sensory System Agents|sensory system agents|mesh-ancestor
64791640|NCT00361686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64791641|NCT00361920|Prednisone|prednisone|mesh-list
64791642|NCT00361920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64791643|NCT00361920|Glucocorticoids|glucocorticoids|mesh-ancestor
64791644|NCT00361920|Hormones|hormones|mesh-ancestor
64791645|NCT00361920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64791658|NCT00362310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791659|NCT00362310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791660|NCT00362310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64791661|NCT00362310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64791662|NCT00362310|Antiviral Agents|antiviral agents|mesh-ancestor
64791663|NCT00362310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64791664|NCT00362544|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64791665|NCT00362544|Antifungal Agents|antifungal agents|mesh-ancestor
64791666|NCT00362544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64791692|NCT00363090|Immunologic Factors|immunologic factors|mesh-ancestor
64791693|NCT00363090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791694|NCT00363090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64791695|NCT00363090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64791696|NCT00363090|Alkylating Agents|alkylating agents|mesh-ancestor
64791697|NCT00363090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791698|NCT00363090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791699|NCT00363090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64791700|NCT00363090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64791701|NCT00363090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64791702|NCT00363090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64791703|NCT00363090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791704|NCT00363090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64791705|NCT00363090|Glucocorticoids|glucocorticoids|mesh-ancestor
64791706|NCT00363090|Hormones|hormones|mesh-ancestor
64791707|NCT00363090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64791708|NCT00363090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64791709|NCT00363090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64791719|NCT00363948|Incretins|incretins|mesh-ancestor
64791720|NCT00363948|Hormones|hormones|mesh-ancestor
64791721|NCT00363948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64791722|NCT00363948|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64791723|NCT00363948|Protease Inhibitors|protease inhibitors|mesh-ancestor
64791724|NCT00363948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791725|NCT00363948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791726|NCT00364026|Darusentan|darusentan|mesh-list
64791727|NCT00364026|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64791728|NCT00364026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791729|NCT00364260|Epoetin Alfa|epoetin alfa|mesh-list
64791730|NCT00364260|Hematinics|hematinics|mesh-ancestor
64791731|NCT00364572|Etanercept|etanercept|mesh-list
64791740|NCT00364572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64791741|NCT00364572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64791742|NCT00364572|Immunologic Factors|immunologic factors|mesh-ancestor
64791743|NCT00364806|Metoclopramide|metoclopramide|mesh-list
64791744|NCT00364806|Prochlorperazine|prochlorperazine|mesh-list
64791745|NCT00364806|Antiemetics|antiemetics|mesh-ancestor
64791746|NCT00364806|Autonomic Agents|autonomic agents|mesh-ancestor
64791747|NCT00364806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64791748|NCT00364806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791749|NCT00364806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64791750|NCT00364806|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64791751|NCT00364806|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64791752|NCT00364806|Dopamine Agents|dopamine agents|mesh-ancestor
64791753|NCT00364806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64791754|NCT00364806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791755|NCT00364806|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64791756|NCT00364806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64791757|NCT00364806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64791758|NCT00364806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64791759|NCT00365040|Mitomycins|mitomycins|mesh-list
64791760|NCT00365040|Mitomycin|mitomycin|mesh-list
64791761|NCT00365040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64791762|NCT00365040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791763|NCT00365040|Alkylating Agents|alkylating agents|mesh-ancestor
64791764|NCT00365040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791765|NCT00365040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64791766|NCT00365040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791767|NCT00365586|Ketoprofen|ketoprofen|mesh-list
64951790|NCT00055653|Cyclophosphamide|cyclophosphamide|mesh-list
64951791|NCT00055653|Melphalan|melphalan|mesh-list
64951792|NCT00055653|Busulfan|busulfan|mesh-list
64951793|NCT00055653|Fludarabine|fludarabine|mesh-list
64951794|NCT00055653|Fludarabine phosphate|fludarabine phosphate|mesh-list
64951795|NCT00055653|Cyclosporins|cyclosporins|mesh-list
64951796|NCT00055653|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64951797|NCT00055653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951798|NCT00055653|Immunologic Factors|immunologic factors|mesh-ancestor
64951799|NCT00055653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951800|NCT00055653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64951801|NCT00055653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64951802|NCT00055653|Alkylating Agents|alkylating agents|mesh-ancestor
64951803|NCT00055653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951804|NCT00055653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951805|NCT00055653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64951806|NCT00055653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64951807|NCT00055653|Antimetabolites|antimetabolites|mesh-ancestor
64791768|NCT00365586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64791769|NCT00365586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64791770|NCT00365586|Analgesics|analgesics|mesh-ancestor
64791771|NCT00365586|Sensory System Agents|sensory system agents|mesh-ancestor
64791772|NCT00365586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64791773|NCT00365586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791774|NCT00365586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64791775|NCT00365586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64791795|NCT00365898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64791796|NCT00365898|Narcotics|narcotics|mesh-ancestor
64791797|NCT00365898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64791798|NCT00365898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791799|NCT00365898|Analgesics|analgesics|mesh-ancestor
64791800|NCT00365898|Sensory System Agents|sensory system agents|mesh-ancestor
64791801|NCT00365898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64791802|NCT00366834|Dexamethasone|dexamethasone|mesh-list
64791803|NCT00366834|Dexamethasone acetate|dexamethasone acetate|mesh-list
64791804|NCT00366834|Ondansetron|ondansetron|mesh-list
64791806|NCT00366834|BB 1101|bb 1101|mesh-list
64791807|NCT00366834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64791808|NCT00366834|Antiemetics|antiemetics|mesh-ancestor
64791809|NCT00366834|Autonomic Agents|autonomic agents|mesh-ancestor
64791810|NCT00366834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64791811|NCT00366834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791812|NCT00366834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64791814|NCT00366834|Hormones|hormones|mesh-ancestor
64791815|NCT00366834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64791816|NCT00366834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64791817|NCT00366834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791818|NCT00366834|Protease Inhibitors|protease inhibitors|mesh-ancestor
64791819|NCT00366834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791820|NCT00366834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791821|NCT00366834|Antipruritics|antipruritics|mesh-ancestor
64951808|NCT00055653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951809|NCT00055653|Antifungal Agents|antifungal agents|mesh-ancestor
64951810|NCT00055653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951811|NCT00055653|Dermatologic Agents|dermatologic agents|mesh-ancestor
64951812|NCT00055653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64951813|NCT00055653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64951814|NCT00055653|Antiemetics|antiemetics|mesh-ancestor
64951815|NCT00055653|Autonomic Agents|autonomic agents|mesh-ancestor
64791822|NCT00366834|Dermatologic Agents|dermatologic agents|mesh-ancestor
64791823|NCT00366834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64791824|NCT00366834|Serotonin Agents|serotonin agents|mesh-ancestor
64791825|NCT00366834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64791826|NCT00366834|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64791827|NCT00366834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64791828|NCT00366834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64791829|NCT00366834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64791830|NCT00366834|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64402897|NCT04979273|Mydriatics|mydriatics|mesh-ancestor
64791841|NCT00367068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791843|NCT00367302|Methadone|methadone|mesh-list
64791844|NCT00367302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64791845|NCT00367302|Narcotics|narcotics|mesh-ancestor
64791846|NCT00367302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64791847|NCT00367302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791848|NCT00367302|Analgesics|analgesics|mesh-ancestor
64791849|NCT00367302|Sensory System Agents|sensory system agents|mesh-ancestor
64791850|NCT00367302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64791851|NCT00367302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64791852|NCT00367302|Antitussive Agents|antitussive agents|mesh-ancestor
64791853|NCT00367302|Respiratory System Agents|respiratory system agents|mesh-ancestor
64791854|NCT00367536|Bazedoxifene|bazedoxifene|mesh-list
64791855|NCT00367536|Estrogens|estrogens|mesh-list
64791857|NCT00367536|Hormones|hormones|mesh-ancestor
64791882|NCT00368238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64791883|NCT00368238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791884|NCT00368238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64791885|NCT00368238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64791886|NCT00368238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64791887|NCT00368238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64791888|NCT00368238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791889|NCT00368238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64791890|NCT00368238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64791891|NCT00368238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791892|NCT00368238|Antipyretics|antipyretics|mesh-ancestor
64791893|NCT00368238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64402953|NCT04834063|Trace Elements|trace elements|mesh-ancestor
64791909|NCT00368706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791910|NCT00368706|Urological Agents|urological agents|mesh-ancestor
64791911|NCT00368862|Memantine|memantine|mesh-list
64791912|NCT00368862|Citalopram|citalopram|mesh-list
64791913|NCT00368862|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64791914|NCT00368862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64791915|NCT00368862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64791948|NCT00369798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64791949|NCT00369798|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64791950|NCT00369798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64791951|NCT00369798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791952|NCT00369798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791953|NCT00369954|Gemcitabine|gemcitabine|mesh-list
64791963|NCT00369954|Immunologic Factors|immunologic factors|mesh-ancestor
64791964|NCT00369954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791967|NCT00370188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64791968|NCT00370188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791969|NCT00370266|Triamcinolone|triamcinolone|mesh-list
64791970|NCT00370266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64791971|NCT00370266|Glucocorticoids|glucocorticoids|mesh-ancestor
64791972|NCT00370266|Hormones|hormones|mesh-ancestor
64791973|NCT00370266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64791974|NCT00370266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791975|NCT00370422|Triamcinolone|triamcinolone|mesh-list
64791976|NCT00370422|Bevacizumab|bevacizumab|mesh-list
64791977|NCT00370422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64791978|NCT00370422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791979|NCT00370422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64791980|NCT00370422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64791981|NCT00370422|Growth Substances|growth substances|mesh-ancestor
64791982|NCT00370422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791983|NCT00370422|Growth Inhibitors|growth inhibitors|mesh-ancestor
64792007|NCT00370656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64792008|NCT00370656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64792009|NCT00370656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64792010|NCT00370656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64792011|NCT00370656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64792012|NCT00370656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64792013|NCT00370656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64792014|NCT00370656|Antidepressive Agents|antidepressive agents|mesh-ancestor
64792015|NCT00370656|Dopamine Agents|dopamine agents|mesh-ancestor
64792016|NCT00370656|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64792017|NCT00370656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64792018|NCT00370656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64792030|NCT00370734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64792031|NCT00370968|Zinc Sulfate|zinc sulfate|mesh-list
64792032|NCT00370968|Astringents|astringents|mesh-ancestor
64792033|NCT00370968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792076|NCT00372294|Clindamycin phosphate|clindamycin phosphate|mesh-list
64792077|NCT00372294|Sulfadiazine|sulfadiazine|mesh-list
64792078|NCT00372294|Pyrimethamine|pyrimethamine|mesh-list
64792079|NCT00372294|Dexamethasone|dexamethasone|mesh-list
64792080|NCT00372294|Prednisolone|prednisolone|mesh-list
64792081|NCT00372294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64792082|NCT00372294|Antiemetics|antiemetics|mesh-ancestor
64792083|NCT00372294|Autonomic Agents|autonomic agents|mesh-ancestor
64792097|NCT00372294|Antimalarials|antimalarials|mesh-ancestor
64792098|NCT00372294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64792099|NCT00372294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64792100|NCT00372294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64792101|NCT00372294|Coccidiostats|coccidiostats|mesh-ancestor
64792102|NCT00372372|Risedronic Acid|risedronic acid|mesh-list
64792103|NCT00372372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64792104|NCT00372372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64792105|NCT00372372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792106|NCT00372372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64792107|NCT00372372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792108|NCT00372372|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64792150|NCT00373776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64792152|NCT00374478|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64792153|NCT00374478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64792154|NCT00374478|Antiemetics|antiemetics|mesh-ancestor
64792155|NCT00374478|Autonomic Agents|autonomic agents|mesh-ancestor
64792156|NCT00374478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64792157|NCT00374478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792158|NCT00374478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64792159|NCT00374478|Mydriatics|mydriatics|mesh-ancestor
64792160|NCT00374478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64792161|NCT00374478|Cholinergic Agents|cholinergic agents|mesh-ancestor
64792162|NCT00374478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64792163|NCT00374478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792164|NCT00374478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64792165|NCT00374478|Parasympatholytics|parasympatholytics|mesh-ancestor
64792166|NCT00375258|Tranexamic Acid|tranexamic acid|mesh-list
64792167|NCT00375258|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64792168|NCT00375258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64792169|NCT00375258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792170|NCT00375258|Hemostatics|hemostatics|mesh-ancestor
64792171|NCT00375258|Coagulants|coagulants|mesh-ancestor
64792172|NCT00375648|Zoledronic Acid|zoledronic acid|mesh-list
64792173|NCT00375648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64792202|NCT00376662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792203|NCT00376662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64792204|NCT00376740|Zoledronic Acid|zoledronic acid|mesh-list
64792205|NCT00376740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64792206|NCT00376740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792207|NCT00376818|Hormones|hormones|mesh-list
64792212|NCT00377052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64792213|NCT00377052|Antimetabolites|antimetabolites|mesh-ancestor
64792214|NCT00377052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792215|NCT00377052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792216|NCT00377052|Antiviral Agents|antiviral agents|mesh-ancestor
64472027|NCT03892785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64792217|NCT00377052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64792218|NCT00377052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792219|NCT00377052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64792220|NCT00377052|Immunologic Factors|immunologic factors|mesh-ancestor
64792221|NCT00377052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792223|NCT00377442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64792224|NCT00377442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64792225|NCT00377442|Antimetabolites|antimetabolites|mesh-ancestor
64792226|NCT00377442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792227|NCT00377442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64792229|NCT00377442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792254|NCT00378066|Capecitabine|capecitabine|mesh-list
64792255|NCT00378066|Oxaliplatin|oxaliplatin|mesh-list
64792256|NCT00378066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64792257|NCT00378066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560829|NCT01110135|Etoposide|etoposide|mesh-list
64792258|NCT00378066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64792259|NCT00378066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64792260|NCT00378066|Growth Substances|growth substances|mesh-ancestor
64792261|NCT00378066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792262|NCT00378066|Growth Inhibitors|growth inhibitors|mesh-ancestor
64792263|NCT00378066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64792265|NCT00378066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792266|NCT00378144|Acetaminophen|acetaminophen|mesh-list
64792267|NCT00378144|Pseudoephedrine|pseudoephedrine|mesh-list
64792268|NCT00378144|Ephedrine|ephedrine|mesh-list
64792269|NCT00378144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64792270|NCT00378144|Analgesics|analgesics|mesh-ancestor
64792271|NCT00378144|Sensory System Agents|sensory system agents|mesh-ancestor
64792272|NCT00378144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64792273|NCT00378144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792274|NCT00378144|Antipyretics|antipyretics|mesh-ancestor
64792275|NCT00378144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64792276|NCT00378144|Autonomic Agents|autonomic agents|mesh-ancestor
64403338|NCT05110339|Anesthetics|anesthetics|mesh-ancestor
64792312|NCT00378612|Immunologic Factors|immunologic factors|mesh-ancestor
64792313|NCT00378612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792314|NCT00378690|Leuprolide|leuprolide|mesh-list
64792315|NCT00378690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64792316|NCT00378690|Fertility Agents|fertility agents|mesh-ancestor
64792317|NCT00378690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64792318|NCT00378690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792319|NCT00378690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64792320|NCT00378690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792342|NCT00380484|Autonomic Agents|autonomic agents|mesh-ancestor
64792344|NCT00380484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792345|NCT00380484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64792346|NCT00380484|Respiratory System Agents|respiratory system agents|mesh-ancestor
64792347|NCT00380484|Glucocorticoids|glucocorticoids|mesh-ancestor
64792348|NCT00380484|Hormones|hormones|mesh-ancestor
64792349|NCT00380484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64792350|NCT00380484|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64792351|NCT00380484|Hormone Antagonists|hormone antagonists|mesh-ancestor
64792352|NCT00380484|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64792353|NCT00380484|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64792354|NCT00380484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792355|NCT00380640|Trimethoprim|trimethoprim|mesh-list
64792356|NCT00380640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64792357|NCT00380640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64792358|NCT00380640|Renal Agents|renal agents|mesh-ancestor
64792359|NCT00380640|Antimalarials|antimalarials|mesh-ancestor
64792360|NCT00380640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64792361|NCT00380640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64792362|NCT00380640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64792363|NCT00380640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792364|NCT00380640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792404|NCT00381654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792405|NCT00381654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792406|NCT00381732|Tadalafil|tadalafil|mesh-list
64792407|NCT00381732|Vasodilator Agents|vasodilator agents|mesh-ancestor
64792408|NCT00381732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64792409|NCT00381732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64792410|NCT00381732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792412|NCT00381732|Urological Agents|urological agents|mesh-ancestor
64792480|NCT00383994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792481|NCT00383994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64561050|NCT01118091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64792482|NCT00384072|Bazedoxifene|bazedoxifene|mesh-list
64792483|NCT00384072|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64792484|NCT00384072|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64792485|NCT00384072|Hormone Antagonists|hormone antagonists|mesh-ancestor
64792486|NCT00384072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64792487|NCT00384072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792488|NCT00384072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64792489|NCT00384306|Prednisolone|prednisolone|mesh-list
64792490|NCT00384306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64792491|NCT00384306|Glucocorticoids|glucocorticoids|mesh-ancestor
64792492|NCT00384306|Hormones|hormones|mesh-ancestor
64792493|NCT00384306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64792494|NCT00384306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792495|NCT00384306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64792496|NCT00384306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792497|NCT00384384|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
64792498|NCT00384384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64792499|NCT00384540|Dobutamine|dobutamine|mesh-list
64792500|NCT00384540|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64792501|NCT00384540|Sympathomimetics|sympathomimetics|mesh-ancestor
64792502|NCT00384540|Autonomic Agents|autonomic agents|mesh-ancestor
64792534|NCT00384696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64792535|NCT00384696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792536|NCT00385086|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
64792537|NCT00385086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64792538|NCT00385398|Temozolomide|temozolomide|mesh-list
64792539|NCT00385398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64792540|NCT00385398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64792541|NCT00385398|Alkylating Agents|alkylating agents|mesh-ancestor
64792542|NCT00385398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792543|NCT00385398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792544|NCT00385398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64792545|NCT00385398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792546|NCT00385554|UC-781|uc-781|mesh-list
64792547|NCT00385554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64792548|NCT00385554|Antiviral Agents|antiviral agents|mesh-ancestor
64792549|NCT00385554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64792550|NCT00385632|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64792551|NCT00385632|Antiviral Agents|antiviral agents|mesh-ancestor
64792552|NCT00385632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64792553|NCT00385710|Valproic Acid|valproic acid|mesh-list
64792554|NCT00385710|Anticonvulsants|anticonvulsants|mesh-ancestor
64792555|NCT00385710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792557|NCT00385710|GABA Agents|gaba agents|mesh-ancestor
64792587|NCT00421980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792588|NCT00421980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64792589|NCT00421980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64472029|NCT03892785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64472030|NCT03892785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792590|NCT00421980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64792591|NCT00421980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64792592|NCT00421980|Immunologic Factors|immunologic factors|mesh-ancestor
64792593|NCT00422214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64792594|NCT00422214|Antidepressive Agents|antidepressive agents|mesh-ancestor
64792595|NCT00422214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64792596|NCT00422214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64792597|NCT00422214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64792598|NCT00422214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64792599|NCT00422214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792600|NCT00422526|Progesterone|progesterone|mesh-list
64792601|NCT00422526|Progestins|progestins|mesh-ancestor
64792632|NCT00422682|Mitosis Modulators|mitosis modulators|mesh-ancestor
64792633|NCT00422682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792634|NCT00422682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64792635|NCT00422682|Antimetabolites|antimetabolites|mesh-ancestor
64792636|NCT00422682|Antiviral Agents|antiviral agents|mesh-ancestor
64792637|NCT00422682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64792638|NCT00422682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792639|NCT00422682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64792640|NCT00422682|Immunologic Factors|immunologic factors|mesh-ancestor
64792652|NCT00422994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64792653|NCT00422994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792654|NCT00422994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792655|NCT00423228|Donepezil|donepezil|mesh-list
64792656|NCT00423228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64792657|NCT00423228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792658|NCT00423228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792659|NCT00423228|Cholinergic Agents|cholinergic agents|mesh-ancestor
64792660|NCT00423228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64792661|NCT00423228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792662|NCT00423228|Nootropic Agents|nootropic agents|mesh-ancestor
64792663|NCT01799616|Pamidronate|pamidronate|mesh-list
64792666|NCT01799850|Pioglitazone|pioglitazone|mesh-list
64792694|NCT01799460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64792695|NCT01799460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64792696|NCT01799460|Alkylating Agents|alkylating agents|mesh-ancestor
64792697|NCT01799460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792698|NCT01799460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792699|NCT01799460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64792700|NCT01799460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64792701|NCT01799460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792702|NCT01799460|Antifungal Agents|antifungal agents|mesh-ancestor
64792703|NCT01799460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64792704|NCT01799460|Dermatologic Agents|dermatologic agents|mesh-ancestor
64792705|NCT01799460|Hormones|hormones|mesh-ancestor
64403776|NCT02623829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64792713|NCT02999724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64792714|NCT02999724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64792715|NCT02999724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64792716|NCT02999724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64792717|NCT02999724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64792718|NCT02999724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64792719|NCT02999724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64792720|NCT02999724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792721|NCT02999724|Antimanic Agents|antimanic agents|mesh-ancestor
64792722|NCT02999490|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64792723|NCT02999490|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64792724|NCT02999490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792725|NCT02998242|Apatinib|apatinib|mesh-list
64792726|NCT02998242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792727|NCT02998242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64792728|NCT02998242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792729|NCT02998242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792730|NCT02998398|Infliximab|infliximab|mesh-list
64792731|NCT02998398|Dermatologic Agents|dermatologic agents|mesh-ancestor
64792732|NCT02998398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64792739|NCT02996916|Amlodipine|amlodipine|mesh-list
64792740|NCT02996916|Olmesartan|olmesartan|mesh-list
64792741|NCT02996916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64792742|NCT02996916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64792743|NCT02996916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64792744|NCT02996916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792745|NCT02996916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64792746|NCT02996916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792747|NCT02996916|Vasodilator Agents|vasodilator agents|mesh-ancestor
64401048|NCT03067883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64792748|NCT02996916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64792749|NCT02996916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64792750|NCT02996214|Gemcitabine|gemcitabine|mesh-list
64792803|NCT02993718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64792804|NCT02993718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64792805|NCT02993718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64792806|NCT02993718|Adrenergic Agents|adrenergic agents|mesh-ancestor
64792807|NCT02993718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64792808|NCT02993718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792809|NCT02993640|Vasopressins|vasopressins|mesh-list
64792810|NCT02993640|Arginine Vasopressin|arginine vasopressin|mesh-list
64792811|NCT02993640|Hemostatics|hemostatics|mesh-ancestor
64792812|NCT02993640|Coagulants|coagulants|mesh-ancestor
64792813|NCT02993640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64792814|NCT02993640|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64792815|NCT02993640|Natriuretic Agents|natriuretic agents|mesh-ancestor
64792816|NCT02993640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792817|NCT02993094|Carboplatin|carboplatin|mesh-list
64792818|NCT02993094|Ixazomib|ixazomib|mesh-list
64792819|NCT02993094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792820|NCT02993094|Protease Inhibitors|protease inhibitors|mesh-ancestor
64792821|NCT02993094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792822|NCT02993094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792823|NCT02992938|Acetazolamide|acetazolamide|mesh-list
64792824|NCT02992938|Anticonvulsants|anticonvulsants|mesh-ancestor
64792825|NCT02992938|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64792826|NCT02992938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792827|NCT02992938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792828|NCT02992938|Diuretics|diuretics|mesh-ancestor
64792829|NCT02992938|Natriuretic Agents|natriuretic agents|mesh-ancestor
64792830|NCT02992938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792831|NCT02992704|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64792832|NCT02992704|Antiviral Agents|antiviral agents|mesh-ancestor
64792833|NCT02992704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64792834|NCT02992548|Pravastatin|pravastatin|mesh-list
64792856|NCT02991768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64792857|NCT02991612|Rifaximin|rifaximin|mesh-list
64792858|NCT02991612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64792859|NCT02991612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64792860|NCT02991612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64792861|NCT02990286|Mycophenolic Acid|mycophenolic acid|mesh-list
64792862|NCT02990286|Rituximab|rituximab|mesh-list
64792863|NCT02990286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64792864|NCT02990286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792865|NCT02990286|Immunologic Factors|immunologic factors|mesh-ancestor
64792866|NCT02990286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792867|NCT02990286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64792868|NCT02990286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64792869|NCT02990286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64792870|NCT02990286|Antitubercular Agents|antitubercular agents|mesh-ancestor
64792871|NCT02990286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64792872|NCT02990286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64792873|NCT02990286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792874|NCT02990286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792875|NCT02999958|Thioctic Acid|thioctic acid|mesh-list
64792876|NCT02999958|Acetylcarnitine|acetylcarnitine|mesh-list
64792877|NCT02999958|Acetylcysteine|acetylcysteine|mesh-list
64792878|NCT02999958|Antioxidants|antioxidants|mesh-list
64792879|NCT02999958|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64792881|NCT02999958|Protective Agents|protective agents|mesh-ancestor
64403979|NCT04574479|Analgesics|analgesics|mesh-ancestor
64792918|NCT02990364|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64792919|NCT01270074|Azithromycin|azithromycin|mesh-list
64792920|NCT01270074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64792921|NCT01270074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64792922|NCT01270308|Lansoprazole|lansoprazole|mesh-list
64792923|NCT01270308|Dexlansoprazole|dexlansoprazole|mesh-list
64792924|NCT01270308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64401049|NCT03067883|Antiviral Agents|antiviral agents|mesh-ancestor
64472034|NCT03892785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64792925|NCT01270308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64792926|NCT01270308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64792927|NCT01270308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792928|NCT01270308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792929|NCT01270386|Apatinib|apatinib|mesh-list
64792930|NCT01270386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792931|NCT01270386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64792932|NCT01270386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561498|NCT03527147|Immunologic Factors|immunologic factors|mesh-ancestor
64792933|NCT01270386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792934|NCT01270854|Plasma-lyte 148|plasma-lyte 148|mesh-list
64792935|NCT01270854|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64792936|NCT01270854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64792937|NCT01270932|Dexamethasone|dexamethasone|mesh-list
64792938|NCT01270932|Dexamethasone acetate|dexamethasone acetate|mesh-list
64792939|NCT01270932|Lenalidomide|lenalidomide|mesh-list
64792940|NCT01270932|BB 1101|bb 1101|mesh-list
64792941|NCT01270932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64792942|NCT01270932|Antiemetics|antiemetics|mesh-ancestor
64792943|NCT01270932|Autonomic Agents|autonomic agents|mesh-ancestor
64792944|NCT01270932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64792945|NCT01270932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792959|NCT01270932|Growth Inhibitors|growth inhibitors|mesh-ancestor
64792960|NCT01271088|Acetylcysteine|acetylcysteine|mesh-list
64792961|NCT01271088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64792962|NCT01271088|Antiviral Agents|antiviral agents|mesh-ancestor
64792963|NCT01271088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64792964|NCT01271088|Expectorants|expectorants|mesh-ancestor
64792965|NCT01271088|Respiratory System Agents|respiratory system agents|mesh-ancestor
64792966|NCT01271088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64792967|NCT01271088|Antioxidants|antioxidants|mesh-ancestor
64404044|NCT04400201|Propofol|propofol|mesh-list
64792976|NCT01271166|Imatinib Mesylate|imatinib mesylate|mesh-list
64792977|NCT01271166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64792978|NCT01271166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792979|NCT01271166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64792980|NCT01271166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64792981|NCT01271166|Growth Substances|growth substances|mesh-ancestor
64792982|NCT01271166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792983|NCT01271166|Growth Inhibitors|growth inhibitors|mesh-ancestor
64792984|NCT01271166|Antimetabolites|antimetabolites|mesh-ancestor
64792985|NCT01271166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792986|NCT01271166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64792987|NCT01271166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64792988|NCT01271166|Immunologic Factors|immunologic factors|mesh-ancestor
64792989|NCT01271166|Antidotes|antidotes|mesh-ancestor
64792990|NCT01271166|Protective Agents|protective agents|mesh-ancestor
64792991|NCT01271166|Vitamin B Complex|vitamin b complex|mesh-ancestor
64792992|NCT01271166|Vitamins|vitamins|mesh-ancestor
64792993|NCT01271166|Micronutrients|micronutrients|mesh-ancestor
64792994|NCT01271166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64792995|NCT01271166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792996|NCT01271556|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64792997|NCT01271556|Bronchodilator Agents|bronchodilator agents|mesh-list
64792998|NCT01271556|Autonomic Agents|autonomic agents|mesh-ancestor
64792999|NCT01271556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793000|NCT01271556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793008|NCT01271556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793009|NCT01272258|Leronlimab|leronlimab|mesh-list
64793010|NCT01272258|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64793011|NCT01272258|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64793012|NCT01272258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793013|NCT01272258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64793014|NCT01272258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64793015|NCT01272258|Antiviral Agents|antiviral agents|mesh-ancestor
64793016|NCT01272258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64793017|NCT01272414|Botulinum Toxins|botulinum toxins|mesh-list
64793018|NCT01272414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64793019|NCT01272414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64793020|NCT01272414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64793021|NCT01272414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64793022|NCT01272414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793023|NCT01272414|Cholinergic Agents|cholinergic agents|mesh-ancestor
64793024|NCT01272414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64793025|NCT01272414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793026|NCT01272414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64793027|NCT01272414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793028|NCT01273506|Tapentadol|tapentadol|mesh-list
64793029|NCT01273506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64793030|NCT01273506|Narcotics|narcotics|mesh-ancestor
64793031|NCT01273506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64793032|NCT01273506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793033|NCT01273506|Analgesics|analgesics|mesh-ancestor
64793034|NCT01273506|Sensory System Agents|sensory system agents|mesh-ancestor
64793064|NCT01276704|Phytoestrogens|phytoestrogens|mesh-ancestor
64793065|NCT01276704|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64793066|NCT01276704|Estrogens|estrogens|mesh-ancestor
64793067|NCT01276704|Hormones|hormones|mesh-ancestor
64793068|NCT01276704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64793069|NCT01276704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793070|NCT01277172|Rituximab|rituximab|mesh-list
64793071|NCT01277172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64793072|NCT01277172|Antibodies|antibodies|mesh-list
64793073|NCT01277172|Immunoglobulins|immunoglobulins|mesh-list
64793074|NCT01277172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64793075|NCT01277172|Immunologic Factors|immunologic factors|mesh-ancestor
64793076|NCT01277172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793077|NCT01277172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793078|NCT01277172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64793079|NCT01277640|Dapivirine|dapivirine|mesh-list
64793080|NCT01277640|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64793081|NCT01277640|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64793082|NCT01277640|Antiviral Agents|antiviral agents|mesh-ancestor
64793083|NCT01277640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64561653|NCT03454451|Pembrolizumab|pembrolizumab|mesh-list
64793084|NCT01278576|Botulinum Toxins|botulinum toxins|mesh-list
64793085|NCT01278576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64793086|NCT01278576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64793087|NCT01278576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64793088|NCT01278576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64793089|NCT01278576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793090|NCT01278576|Cholinergic Agents|cholinergic agents|mesh-ancestor
64793091|NCT01278576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64793092|NCT01278576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793120|NCT01279668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64793121|NCT01279668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793122|NCT01279902|Rituximab|rituximab|mesh-list
64793123|NCT01279902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64793124|NCT01279902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793125|NCT01279902|Immunologic Factors|immunologic factors|mesh-ancestor
64793126|NCT01279902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793127|NCT01279902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64793128|NCT01278342|Octreotide|octreotide|mesh-list
64793129|NCT01278342|Cabergoline|cabergoline|mesh-list
64793130|NCT01278342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64793131|NCT01278342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64793132|NCT01278342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793133|NCT01278342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64793134|NCT01278342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64793135|NCT01278342|Dopamine Agonists|dopamine agonists|mesh-ancestor
64793136|NCT01278342|Dopamine Agents|dopamine agents|mesh-ancestor
64793137|NCT01278342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64793138|NCT01278342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793139|NCT01278342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793140|NCT01277718|Rabeprazole|rabeprazole|mesh-list
64793141|NCT01277718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64793142|NCT01277718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64793143|NCT01277718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64793144|NCT01277718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64793145|NCT01277718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793146|NCT01276236|Maraviroc|maraviroc|mesh-list
64793147|NCT01276236|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64793171|NCT01275144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64793172|NCT01275144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64793173|NCT01275144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64793174|NCT01275144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64793175|NCT01275144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64793176|NCT01275144|GABA Modulators|gaba modulators|mesh-ancestor
64793177|NCT01275144|GABA Agents|gaba agents|mesh-ancestor
64793178|NCT01275144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64793179|NCT01275144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793180|NCT01272180|Vaccines|vaccines|mesh-list
64793181|NCT01272180|Immunologic Factors|immunologic factors|mesh-ancestor
64793182|NCT01272180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793183|NCT01271010|Cyclophosphamide|cyclophosphamide|mesh-list
64793185|NCT01271010|Fludarabine|fludarabine|mesh-list
64793186|NCT01271010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64793187|NCT01271010|Immunologic Factors|immunologic factors|mesh-ancestor
64793188|NCT01271010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793189|NCT01271010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64793190|NCT01271010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64793228|NCT01270152|Protective Agents|protective agents|mesh-ancestor
64793229|NCT01270152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793230|NCT01270152|Vitamins|vitamins|mesh-ancestor
64793237|NCT01274988|Analgesics|analgesics|mesh-ancestor
64793238|NCT01274988|Sensory System Agents|sensory system agents|mesh-ancestor
64793239|NCT01274988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793240|NCT01274988|Antitussive Agents|antitussive agents|mesh-ancestor
64793241|NCT01274988|Respiratory System Agents|respiratory system agents|mesh-ancestor
64793242|NCT01278498|Citalopram|citalopram|mesh-list
64793243|NCT01278498|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64793244|NCT01278498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64793245|NCT01278498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64793246|NCT01278498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793247|NCT01278498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64793248|NCT01278498|Serotonin Agents|serotonin agents|mesh-ancestor
64793249|NCT01278498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793250|NCT01278498|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64793251|NCT01278498|Antidepressive Agents|antidepressive agents|mesh-ancestor
64793252|NCT01278498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64793253|NCT01279980|Anesthetics|anesthetics|mesh-list
64793254|NCT01279980|Anesthetics, Local|anesthetics, local|mesh-list
64793255|NCT01279980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64793256|NCT01279980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793257|NCT01279980|Sensory System Agents|sensory system agents|mesh-ancestor
64793258|NCT01279980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793259|NCT00249834|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64793260|NCT00249834|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64793261|NCT00249834|Hormones|hormones|mesh-ancestor
64472035|NCT03892785|Antimetabolites|antimetabolites|mesh-ancestor
64793262|NCT00249834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64793263|NCT00249834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793264|NCT00249834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64793265|NCT00249444|Mirtazapine|mirtazapine|mesh-list
64793266|NCT00249444|Antidepressive Agents|antidepressive agents|mesh-ancestor
64793272|NCT00249444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793273|NCT00249444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793274|NCT00249444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64793275|NCT00249444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64793276|NCT00249444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64793277|NCT00249444|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64793278|NCT00249444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64793279|NCT00249444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64793280|NCT00249444|Adrenergic Agents|adrenergic agents|mesh-ancestor
64793281|NCT00249444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64793282|NCT00249444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64793283|NCT00249444|Serotonin Agents|serotonin agents|mesh-ancestor
64793284|NCT00249444|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64793285|NCT00249288|Folic Acid|folic acid|mesh-list
64793286|NCT00249288|Vitamin B Complex|vitamin b complex|mesh-list
64793287|NCT00249288|Hematinics|hematinics|mesh-ancestor
64793288|NCT00249288|Vitamins|vitamins|mesh-ancestor
64793289|NCT00249288|Micronutrients|micronutrients|mesh-ancestor
64793290|NCT00249288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793291|NCT00247962|Sulfasalazine|sulfasalazine|mesh-list
64793292|NCT00247962|Etanercept|etanercept|mesh-list
64793293|NCT00247962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64793295|NCT00247962|Analgesics|analgesics|mesh-ancestor
64793330|NCT00246012|Alkylating Agents|alkylating agents|mesh-ancestor
64793331|NCT00246012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793332|NCT00246012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793333|NCT00246012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64793334|NCT00245856|Dalteparin|dalteparin|mesh-list
64793335|NCT00245856|Tinzaparin|tinzaparin|mesh-list
64793336|NCT00245856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64793337|NCT00245856|Warfarin|warfarin|mesh-list
64793338|NCT00245856|Anticoagulants|anticoagulants|mesh-ancestor
64793339|NCT00245856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64793340|NCT00245856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64472036|NCT03892785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295445|NCT02995005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64793341|NCT00245856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793342|NCT00242580|Triamcinolone|triamcinolone|mesh-list
64793343|NCT00242580|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64793344|NCT00242580|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64793345|NCT00242580|Verteporfin|verteporfin|mesh-list
64793346|NCT00242580|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64793347|NCT00242580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64793348|NCT00242580|Glucocorticoids|glucocorticoids|mesh-ancestor
64793350|NCT00242580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64793351|NCT00242580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793352|NCT00242580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64793353|NCT00242580|Immunologic Factors|immunologic factors|mesh-ancestor
64793354|NCT00242580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64793355|NCT00242580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793356|NCT00242580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64793357|NCT00242580|Dermatologic Agents|dermatologic agents|mesh-ancestor
64793358|NCT00241644|Vaccines|vaccines|mesh-list
64793359|NCT00241644|Immunologic Factors|immunologic factors|mesh-ancestor
64793360|NCT00241644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793361|NCT03805152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64793362|NCT03805152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64793368|NCT03805152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793369|NCT03805152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64793370|NCT03805152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793384|NCT03804840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64793386|NCT03804372|Rituximab|rituximab|mesh-list
64793387|NCT03804372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64793388|NCT03804372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793389|NCT03804372|Immunologic Factors|immunologic factors|mesh-ancestor
64793390|NCT03804372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793391|NCT03804372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64793392|NCT03804372|Antiviral Agents|antiviral agents|mesh-ancestor
64793393|NCT03804372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64793394|NCT03804372|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64793395|NCT03804372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64793396|NCT03804372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64793445|NCT05742750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793446|NCT05742750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64793447|NCT05742750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64793448|NCT05742750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793449|NCT05740332|Hand Sanitizers|hand sanitizers|mesh-list
64793450|NCT05740332|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64793451|NCT05740332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64793452|NCT05740332|Disinfectants|disinfectants|mesh-ancestor
64793453|NCT05481684|Progesterone|progesterone|mesh-list
64793454|NCT05481684|Progestins|progestins|mesh-ancestor
64793455|NCT05481684|Hormones|hormones|mesh-ancestor
64793456|NCT05481684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64793457|NCT05481684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793458|NCT05338398|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64793459|NCT05338398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64793460|NCT05338398|Benzydamine|benzydamine|mesh-list
64793461|NCT05338398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64793462|NCT05119296|Pembrolizumab|pembrolizumab|mesh-list
64793463|NCT05119296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64793464|NCT05119296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793465|NCT04741074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64793466|NCT04581408|Ivacaftor|ivacaftor|mesh-list
64793467|NCT04581408|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64793468|NCT04581408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64793469|NCT04581408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793470|NCT04295772|Islatravir|islatravir|mesh-list
64793494|NCT03467256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64793495|NCT03467256|Immunologic Factors|immunologic factors|mesh-ancestor
64793496|NCT03467256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793510|NCT03467256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64793512|NCT03467256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64793513|NCT03467256|Antimetabolites|antimetabolites|mesh-ancestor
64793514|NCT03467256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64472039|NCT03892785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64793515|NCT03467256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64793516|NCT03467256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64793518|NCT03467256|Antiviral Agents|antiviral agents|mesh-ancestor
64793519|NCT03467256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64793520|NCT03265080|Pembrolizumab|pembrolizumab|mesh-list
64793521|NCT03265080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64793522|NCT03265080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793523|NCT03017820|Iodine|iodine|mesh-list
64793524|NCT03017820|Interferons|interferons|mesh-list
64793525|NCT03017820|Interferon-beta|interferon-beta|mesh-list
64793526|NCT03017820|Cyclophosphamide|cyclophosphamide|mesh-list
64793527|NCT03017820|Nivolumab|nivolumab|mesh-list
64793528|NCT03017820|Ipilimumab|ipilimumab|mesh-list
64793529|NCT03017820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64793530|NCT03017820|Immunologic Factors|immunologic factors|mesh-ancestor
64793531|NCT03017820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793532|NCT03017820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64793534|NCT03017820|Alkylating Agents|alkylating agents|mesh-ancestor
64793559|NCT02017704|Oxaliplatin|oxaliplatin|mesh-list
64793565|NCT02017704|Immunologic Factors|immunologic factors|mesh-ancestor
64793566|NCT02017704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793567|NCT02017704|Antidotes|antidotes|mesh-ancestor
64793568|NCT02017704|Protective Agents|protective agents|mesh-ancestor
64793569|NCT02017704|Vitamin B Complex|vitamin b complex|mesh-ancestor
64793570|NCT02017704|Vitamins|vitamins|mesh-ancestor
64793571|NCT02017704|Micronutrients|micronutrients|mesh-ancestor
64793572|NCT01622322|Nitrous Oxide|nitrous oxide|mesh-list
64793573|NCT01622322|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64793574|NCT01622322|Anesthetics, General|anesthetics, general|mesh-ancestor
64793575|NCT01622322|Anesthetics|anesthetics|mesh-ancestor
64793576|NCT01622322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64793582|NCT05313282|Apatinib|apatinib|mesh-list
64793629|NCT03215940|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64404700|NCT04910477|Analgesics|analgesics|mesh-ancestor
64793651|NCT03218124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64793652|NCT03218124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793653|NCT03218124|Analgesics|analgesics|mesh-ancestor
64793654|NCT03218124|Sensory System Agents|sensory system agents|mesh-ancestor
64793655|NCT03218124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793656|NCT03217734|Adalimumab|adalimumab|mesh-list
64793657|NCT03217734|Methotrexate|methotrexate|mesh-list
64793658|NCT03217734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64793659|NCT03217734|Abortifacient Agents|abortifacient agents|mesh-ancestor
64793660|NCT03217734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64793661|NCT03217734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793662|NCT03217734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64793663|NCT03217734|Antimetabolites|antimetabolites|mesh-ancestor
64793664|NCT03217734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793665|NCT03217734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793666|NCT03217734|Dermatologic Agents|dermatologic agents|mesh-ancestor
64793667|NCT03217734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64793668|NCT03217734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64793669|NCT03217734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64793670|NCT03217734|Immunologic Factors|immunologic factors|mesh-ancestor
64793671|NCT03217734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64793672|NCT03217734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64793673|NCT03217734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64793674|NCT03216876|Ursolic acid|ursolic acid|mesh-list
64951816|NCT00055653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64951817|NCT00055653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64951818|NCT00055653|Glucocorticoids|glucocorticoids|mesh-ancestor
64951819|NCT00055653|Hormones|hormones|mesh-ancestor
64951820|NCT00055653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64951821|NCT00055653|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64951822|NCT00055653|Protective Agents|protective agents|mesh-ancestor
64951823|NCT00055770|Docetaxel|docetaxel|mesh-list
64951824|NCT00055770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64951825|NCT00055770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951826|NCT00055770|Tubulin Modulators|tubulin modulators|mesh-ancestor
64951827|NCT00055770|Antimitotic Agents|antimitotic agents|mesh-ancestor
64951828|NCT00055770|Mitosis Modulators|mitosis modulators|mesh-ancestor
64951829|NCT00055770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951830|NCT00055770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64951831|NCT00055770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951832|NCT00027638|Thalidomide|thalidomide|mesh-list
64951833|NCT00027638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951835|NCT00027638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951837|NCT00027638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64951838|NCT00027638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951839|NCT00027638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64793675|NCT03216876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64793676|NCT03216876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64793677|NCT03216876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793678|NCT03216876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64793679|NCT03216876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64793680|NCT03216876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793681|NCT03216876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64793682|NCT03216876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64793694|NCT03216408|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64793695|NCT03216408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64793696|NCT03216408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793698|NCT03216408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64793699|NCT03216408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793700|NCT03216408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64793701|NCT03216408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793702|NCT03216564|Vitamin D|vitamin d|mesh-list
64793703|NCT03216564|Calcitriol|calcitriol|mesh-list
64793704|NCT03216564|Vitamins|vitamins|mesh-ancestor
64793705|NCT03216564|Micronutrients|micronutrients|mesh-ancestor
64793706|NCT03216564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793707|NCT03216564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64793708|NCT03216564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64793709|NCT03216564|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64793710|NCT03216564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64793711|NCT03216564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793712|NCT03216564|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64793731|NCT03213834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64793732|NCT03213834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64793733|NCT03213834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793734|NCT03213444|Oxaliplatin|oxaliplatin|mesh-list
64793735|NCT03213444|Fluorouracil|fluorouracil|mesh-list
64793736|NCT03213444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793737|NCT03213444|Antimetabolites|antimetabolites|mesh-ancestor
64793738|NCT03213444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793739|NCT03213444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64793740|NCT03213444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64793741|NCT03213444|Immunologic Factors|immunologic factors|mesh-ancestor
64793742|NCT03213444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793743|NCT03212820|Methamphetamine|methamphetamine|mesh-list
64404819|NCT04918589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64793751|NCT03212820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793753|NCT03212820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64793754|NCT03212820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64793755|NCT03212820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64793756|NCT03212820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64793757|NCT03211728|Pregabalin|pregabalin|mesh-list
64793758|NCT03211728|Analgesics|analgesics|mesh-ancestor
64793759|NCT03211728|Sensory System Agents|sensory system agents|mesh-ancestor
64793762|NCT03211728|Anticonvulsants|anticonvulsants|mesh-ancestor
64793786|NCT03211650|Hyaluronic Acid|hyaluronic acid|mesh-list
64793787|NCT03211650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64793788|NCT03211650|Immunologic Factors|immunologic factors|mesh-ancestor
64793789|NCT03211650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793790|NCT03211650|Viscosupplements|viscosupplements|mesh-ancestor
64793791|NCT03211650|Protective Agents|protective agents|mesh-ancestor
64793792|NCT03211104|Curcumin|curcumin|mesh-list
64793793|NCT03211104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64793794|NCT03211104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64793795|NCT03211104|Analgesics|analgesics|mesh-ancestor
64793796|NCT03211104|Sensory System Agents|sensory system agents|mesh-ancestor
64793797|NCT03211104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793798|NCT03211104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793799|NCT03211104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64793800|NCT03211104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64793801|NCT03211104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793802|NCT03211104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64793803|NCT03211104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793804|NCT03210246|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64793805|NCT03210246|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
64793806|NCT03210246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64404888|NCT03056495|Vorinostat|vorinostat|mesh-list
64793811|NCT03210246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64793812|NCT03210246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64793813|NCT03210246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64793814|NCT03210246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64793815|NCT03210246|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
64793816|NCT03210246|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64793817|NCT03210246|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64793818|NCT03210324|Mifepristone|mifepristone|mesh-list
64793819|NCT03210324|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64793820|NCT03210324|Abortifacient Agents|abortifacient agents|mesh-ancestor
64793821|NCT03210324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64793827|NCT03210324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64793828|NCT03210324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64793829|NCT03210324|Hormone Antagonists|hormone antagonists|mesh-ancestor
64793830|NCT03210324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64793831|NCT03210324|Luteolytic Agents|luteolytic agents|mesh-ancestor
64793832|NCT03210324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64793833|NCT03210324|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64793834|NCT03210480|Lithium Carbonate|lithium carbonate|mesh-list
64793835|NCT03210480|Antidepressive Agents|antidepressive agents|mesh-ancestor
64793836|NCT03210480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64793837|NCT03210480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64793838|NCT03210480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793839|NCT03210480|Antimanic Agents|antimanic agents|mesh-ancestor
64793840|NCT03210480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64793841|NCT03210480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64793842|NCT03210480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793843|NCT01831674|Metformin|metformin|mesh-list
64793844|NCT01831674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64793845|NCT01831674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793846|NCT01832922|Rituximab|rituximab|mesh-list
64793847|NCT01832922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64793856|NCT01833312|Meperidine|meperidine|mesh-list
64793886|NCT01834014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64793887|NCT01834014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64793888|NCT01834014|Immunologic Factors|immunologic factors|mesh-ancestor
64793889|NCT01834170|Gemcitabine|gemcitabine|mesh-list
64793890|NCT01834170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64793891|NCT01834170|Antimetabolites|antimetabolites|mesh-ancestor
64793892|NCT01834170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793893|NCT01834170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793894|NCT01834170|Antiviral Agents|antiviral agents|mesh-ancestor
64793895|NCT01834170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64793896|NCT01834170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64793897|NCT01834170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64793898|NCT01834170|Immunologic Factors|immunologic factors|mesh-ancestor
64793899|NCT01834170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793900|NCT01835184|Vemurafenib|vemurafenib|mesh-list
64793901|NCT01835184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793902|NCT01835184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64793903|NCT01835184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562470|NCT01218399|Hormones|hormones|mesh-ancestor
64793904|NCT01835184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793905|NCT01835340|Anesthetics|anesthetics|mesh-list
64793906|NCT01835340|Propofol|propofol|mesh-list
64793907|NCT01835340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64793908|NCT01835340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793909|NCT01835340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64793910|NCT01835340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64793935|NCT01838460|Nicotine|nicotine|mesh-list
64793936|NCT01838460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64793937|NCT01838460|Autonomic Agents|autonomic agents|mesh-ancestor
64793938|NCT01838460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793939|NCT01838460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793940|NCT01838460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64793941|NCT01838460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64793942|NCT01838460|Cholinergic Agents|cholinergic agents|mesh-ancestor
64793948|NCT01838538|Carboplatin|carboplatin|mesh-list
64793949|NCT01838538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64793950|NCT01838538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793951|NCT01838538|Tubulin Modulators|tubulin modulators|mesh-ancestor
64793952|NCT01838538|Antimitotic Agents|antimitotic agents|mesh-ancestor
64793953|NCT01838538|Mitosis Modulators|mitosis modulators|mesh-ancestor
64793954|NCT01838538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793955|NCT01838538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64793956|NCT01838538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64793957|NCT01838538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64793958|NCT01838538|Growth Substances|growth substances|mesh-ancestor
64793959|NCT01838538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793960|NCT01838538|Growth Inhibitors|growth inhibitors|mesh-ancestor
64793961|NCT01838772|Interferons|interferons|mesh-list
64793962|NCT01838772|Ribavirin|ribavirin|mesh-list
64793963|NCT01838772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793964|NCT01838772|Antiviral Agents|antiviral agents|mesh-ancestor
64793965|NCT01838772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64793966|NCT01838772|Antimetabolites|antimetabolites|mesh-ancestor
64793967|NCT01838772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793968|NCT01838928|Bupivacaine|bupivacaine|mesh-list
64793969|NCT01838928|Anesthetics, Local|anesthetics, local|mesh-ancestor
64793970|NCT01838928|Anesthetics|anesthetics|mesh-ancestor
64793971|NCT01838928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64793972|NCT01838928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793973|NCT01838928|Sensory System Agents|sensory system agents|mesh-ancestor
64793980|NCT01839084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793981|NCT01839240|Cytarabine|cytarabine|mesh-list
64793982|NCT01839240|Azacitidine|azacitidine|mesh-list
64793983|NCT01839240|Mitoxantrone|mitoxantrone|mesh-list
64793984|NCT01839240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64793985|NCT01839240|Antimetabolites|antimetabolites|mesh-ancestor
64793986|NCT01839240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793987|NCT01839240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793988|NCT01839240|Antiviral Agents|antiviral agents|mesh-ancestor
64793989|NCT01839240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64793990|NCT01839240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64793991|NCT01839240|Immunologic Factors|immunologic factors|mesh-ancestor
64793992|NCT01839240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793993|NCT01839240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64793994|NCT01839240|Analgesics|analgesics|mesh-ancestor
64793995|NCT01839240|Sensory System Agents|sensory system agents|mesh-ancestor
64793996|NCT01839240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793997|NCT01839240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64793998|NCT01839240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64793999|NCT01839552|Fentanyl|fentanyl|mesh-list
64794000|NCT01839552|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64794001|NCT01839552|Narcotics|narcotics|mesh-ancestor
64794002|NCT01839552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64794003|NCT01839552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794004|NCT01839552|Analgesics|analgesics|mesh-ancestor
64794005|NCT01839552|Sensory System Agents|sensory system agents|mesh-ancestor
64794006|NCT01839552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794007|NCT01839552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64794008|NCT01839552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64794009|NCT01839552|Anesthetics, General|anesthetics, general|mesh-ancestor
64794010|NCT01839552|Anesthetics|anesthetics|mesh-ancestor
64794011|NCT01839630|Sorafenib|sorafenib|mesh-list
64794032|NCT01834248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794033|NCT01834248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794034|NCT01834248|Interferon Inducers|interferon inducers|mesh-ancestor
64794035|NCT01834248|Immunologic Factors|immunologic factors|mesh-ancestor
64794036|NCT01834248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794037|NCT01834248|Laxatives|laxatives|mesh-ancestor
64794038|NCT01834248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64794039|NCT01834248|Antiviral Agents|antiviral agents|mesh-ancestor
64794040|NCT01834248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64794041|NCT01833858|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64794042|NCT01833858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64794043|NCT01833858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794044|NCT01836432|Leucovorin|leucovorin|mesh-list
64794045|NCT01836432|Gemcitabine|gemcitabine|mesh-list
64794046|NCT01836432|Paclitaxel|paclitaxel|mesh-list
64794047|NCT01836432|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64794048|NCT01836432|Fluorouracil|fluorouracil|mesh-list
64794049|NCT01836432|Capecitabine|capecitabine|mesh-list
64794050|NCT01836432|Oxaliplatin|oxaliplatin|mesh-list
64794051|NCT01836432|Irinotecan|irinotecan|mesh-list
64794052|NCT01836432|Folfirinox|folfirinox|mesh-list
64794053|NCT01836432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64794054|NCT01836432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794055|NCT01836432|Tubulin Modulators|tubulin modulators|mesh-ancestor
64794056|NCT01836432|Antimitotic Agents|antimitotic agents|mesh-ancestor
64794057|NCT01836432|Mitosis Modulators|mitosis modulators|mesh-ancestor
64794058|NCT01836432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794059|NCT01836432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64794060|NCT01836432|Antimetabolites|antimetabolites|mesh-ancestor
64794061|NCT01836432|Antiviral Agents|antiviral agents|mesh-ancestor
64794069|NCT01836432|Antidotes|antidotes|mesh-ancestor
64794080|NCT01720056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794081|NCT01720056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64794082|NCT01720056|Immunologic Factors|immunologic factors|mesh-ancestor
64794083|NCT01720056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794093|NCT01720212|Adrenergic Agents|adrenergic agents|mesh-ancestor
64794094|NCT01720212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64794095|NCT01720212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794096|NCT01720212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794097|NCT01720212|Urological Agents|urological agents|mesh-ancestor
64794098|NCT01720290|Metformin|metformin|mesh-list
64794099|NCT01720290|Repaglinide|repaglinide|mesh-list
64794100|NCT01720290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64794101|NCT01720290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794102|NCT01721382|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64794103|NCT01721382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64794104|NCT01721382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794105|NCT01721382|Incretins|incretins|mesh-ancestor
64794106|NCT01721382|Hormones|hormones|mesh-ancestor
64794107|NCT01721382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64794108|NCT01721382|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64794109|NCT01721382|Protease Inhibitors|protease inhibitors|mesh-ancestor
64794110|NCT01721382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794111|NCT01721382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794140|NCT01722942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64794141|NCT01722942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794142|NCT01722942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64794143|NCT01722942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64794144|NCT01722942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64794145|NCT01722942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794146|NCT01722942|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64794147|NCT01722942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64794148|NCT01722942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64794158|NCT01724190|Vitamins|vitamins|mesh-ancestor
64794159|NCT01724190|Micronutrients|micronutrients|mesh-ancestor
64794160|NCT01724190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794161|NCT01724190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64794162|NCT01724190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64794163|NCT01724268|Prednisolone|prednisolone|mesh-list
64794164|NCT01724268|Methotrexate|methotrexate|mesh-list
64794165|NCT01724268|Methamphetamine|methamphetamine|mesh-list
64794166|NCT01724268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64794167|NCT01724268|Abortifacient Agents|abortifacient agents|mesh-ancestor
64794168|NCT01724268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64794169|NCT01724268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794170|NCT01724268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64794171|NCT01724268|Antimetabolites|antimetabolites|mesh-ancestor
64794172|NCT01724268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794173|NCT01724268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794174|NCT01724268|Dermatologic Agents|dermatologic agents|mesh-ancestor
64794175|NCT01724268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794176|NCT01724268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64794177|NCT01724268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64794178|NCT01724268|Immunologic Factors|immunologic factors|mesh-ancestor
64794179|NCT01724268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64794180|NCT01724268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64794187|NCT01724268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794188|NCT01724268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64794189|NCT01724268|Sympathomimetics|sympathomimetics|mesh-ancestor
64794190|NCT01724268|Dopamine Agents|dopamine agents|mesh-ancestor
64794191|NCT01724268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64794192|NCT01724268|Adrenergic Agents|adrenergic agents|mesh-ancestor
64794193|NCT01724268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64794194|NCT01724268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64794195|NCT01724268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64794196|NCT01724268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64472042|NCT03892785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64794197|NCT01724424|Melatonin|melatonin|mesh-list
64794198|NCT01724424|Antioxidants|antioxidants|mesh-ancestor
64794199|NCT01724424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794203|NCT01724814|Insulin|insulin|mesh-list
64794249|NCT01725672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794250|NCT01725672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64794251|NCT01725672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64794252|NCT01725672|Immunologic Factors|immunologic factors|mesh-ancestor
64794253|NCT01725906|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64794254|NCT01725906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64794255|NCT01725906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64794256|NCT01725906|Antitubercular Agents|antitubercular agents|mesh-ancestor
64794257|NCT01726530|Fentanyl|fentanyl|mesh-list
64794258|NCT01726530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64794259|NCT01726530|Narcotics|narcotics|mesh-ancestor
64794260|NCT01726530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64794261|NCT01726530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794262|NCT01726530|Analgesics|analgesics|mesh-ancestor
64794263|NCT01726530|Sensory System Agents|sensory system agents|mesh-ancestor
64794264|NCT01726530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794265|NCT01726530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64794266|NCT01726530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64794267|NCT01726530|Anesthetics, General|anesthetics, general|mesh-ancestor
64794268|NCT01726530|Anesthetics|anesthetics|mesh-ancestor
64794269|NCT01726686|Ropivacaine|ropivacaine|mesh-list
64794271|NCT01726686|Anesthetics|anesthetics|mesh-ancestor
64794311|NCT01728948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794312|NCT01729104|Rituximab|rituximab|mesh-list
64794313|NCT01729104|Lenalidomide|lenalidomide|mesh-list
64794314|NCT01729104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64794315|NCT01729104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794316|NCT01729104|Immunologic Factors|immunologic factors|mesh-ancestor
64794317|NCT01729104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794318|NCT01729104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64794319|NCT01729104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64794320|NCT01729104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64794321|NCT01729104|Growth Substances|growth substances|mesh-ancestor
64794322|NCT01729104|Growth Inhibitors|growth inhibitors|mesh-ancestor
64794323|NCT01729260|Mebendazole|mebendazole|mesh-list
64794324|NCT01729260|Piperazine|piperazine|mesh-list
64794325|NCT01729260|Piperazine citrate|piperazine citrate|mesh-list
64794326|NCT01729260|DMP 777|dmp 777|mesh-list
64794327|NCT01729260|Antinematodal Agents|antinematodal agents|mesh-ancestor
64794328|NCT01729260|Anthelmintics|anthelmintics|mesh-ancestor
64794329|NCT01729260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64794330|NCT01729260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64794331|NCT01729260|Tubulin Modulators|tubulin modulators|mesh-ancestor
64794332|NCT01729260|Antimitotic Agents|antimitotic agents|mesh-ancestor
64794333|NCT01729260|Mitosis Modulators|mitosis modulators|mesh-ancestor
64794334|NCT01729260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951840|NCT00027638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64951841|NCT00027638|Growth Substances|growth substances|mesh-ancestor
64951842|NCT00027638|Growth Inhibitors|growth inhibitors|mesh-ancestor
64951843|NCT00027638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951844|NCT00055809|Interferons|interferons|mesh-list
64951853|NCT00055809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951854|NCT00055809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64951855|NCT00055809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64951856|NCT00055809|Growth Substances|growth substances|mesh-ancestor
64951857|NCT00055809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951858|NCT00055809|Growth Inhibitors|growth inhibitors|mesh-ancestor
64951859|NCT00055809|Immunologic Factors|immunologic factors|mesh-ancestor
64951860|NCT00055809|Antiviral Agents|antiviral agents|mesh-ancestor
64951861|NCT00055809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951862|NCT00027677|Halofuginone|halofuginone|mesh-list
64951863|NCT00027677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951864|NCT00027677|Coccidiostats|coccidiostats|mesh-ancestor
64951865|NCT00027677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64951866|NCT00027677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64951867|NCT00027677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951868|NCT00027677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64951869|NCT00027677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951870|NCT00027677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951871|NCT00027677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64951872|NCT00027677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64951873|NCT00027677|Growth Substances|growth substances|mesh-ancestor
64951874|NCT00027677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794335|NCT01729260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794336|NCT01729260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794337|NCT01729806|Rituximab|rituximab|mesh-list
64794338|NCT01729806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64794339|NCT01729806|Ipilimumab|ipilimumab|mesh-list
64794340|NCT01729806|Antibodies|antibodies|mesh-list
64794341|NCT01729806|Immunoglobulins|immunoglobulins|mesh-list
64794342|NCT01729806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64794343|NCT01729806|Immunologic Factors|immunologic factors|mesh-ancestor
64794344|NCT01729806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794345|NCT01729806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794346|NCT01729806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64794347|NCT01729806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64794348|NCT01729806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794349|NCT01720836|Poly ICLC|poly iclc|mesh-list
64794350|NCT01720836|Interferon Inducers|interferon inducers|mesh-ancestor
64794360|NCT01724658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64794362|NCT01724658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64794363|NCT01724658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794364|NCT01724658|Anabolic Agents|anabolic agents|mesh-ancestor
64794365|NCT01049334|Flurbiprofen|flurbiprofen|mesh-list
64794366|NCT01049334|Analgesics|analgesics|mesh-ancestor
64794367|NCT01049334|Sensory System Agents|sensory system agents|mesh-ancestor
64794368|NCT01049334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64305400|NCT03545347|Androgens|androgens|mesh-ancestor
64794369|NCT01049334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794370|NCT01049334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64794371|NCT01049334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64794372|NCT01049334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64794373|NCT01049334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64794374|NCT01049334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64794375|NCT01049334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794377|NCT01048944|Bupropion|bupropion|mesh-list
64794378|NCT01048944|Nicotine|nicotine|mesh-list
64794386|NCT01048944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64794387|NCT01048944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794388|NCT01048944|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64794389|NCT01048944|Antidepressive Agents|antidepressive agents|mesh-ancestor
64794390|NCT01048944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64794391|NCT01048944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64794392|NCT01048944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64794393|NCT01048944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64794394|NCT01048944|Dopamine Agents|dopamine agents|mesh-ancestor
64794395|NCT01048944|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64794396|NCT01048944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64794397|NCT01048944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794398|NCT01048866|Acetaminophen|acetaminophen|mesh-list
64794399|NCT01048866|Flurbiprofen|flurbiprofen|mesh-list
64794400|NCT01048866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64794401|NCT01048866|Analgesics|analgesics|mesh-ancestor
64794402|NCT01048866|Sensory System Agents|sensory system agents|mesh-ancestor
64794403|NCT01048866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794404|NCT01048866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794405|NCT01048866|Antipyretics|antipyretics|mesh-ancestor
64794406|NCT01048866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64794407|NCT01048866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64794408|NCT01048866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64794409|NCT01048866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64794410|NCT01048866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794411|NCT01048866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794412|NCT01048788|Tolvaptan|tolvaptan|mesh-list
64794413|NCT01048788|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64794414|NCT01048788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794424|NCT01046682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64794425|NCT01046682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64794427|NCT01044498|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64794428|NCT01044498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64794429|NCT01044498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64794430|NCT01044498|Contraceptive Agents|contraceptive agents|mesh-ancestor
64794431|NCT01044498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64794432|NCT01044498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794433|NCT01044498|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64794434|NCT01044498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64794435|NCT01042938|Curcumin|curcumin|mesh-list
64794436|NCT01042938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64794437|NCT01042938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64794438|NCT01042938|Analgesics|analgesics|mesh-ancestor
64794439|NCT01042938|Sensory System Agents|sensory system agents|mesh-ancestor
64794440|NCT01042938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794441|NCT01042938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794442|NCT01042938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64794443|NCT01042938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64794444|NCT01042938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794445|NCT01042938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794446|NCT01042938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794447|NCT01042158|Ambrisentan|ambrisentan|mesh-list
64794448|NCT01042158|Tadalafil|tadalafil|mesh-list
64794449|NCT01042158|Vasodilator Agents|vasodilator agents|mesh-ancestor
64472043|NCT03892785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64794478|NCT03407976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405566|NCT04898387|Timolol|timolol|mesh-list
64794484|NCT03405948|Botulinum Toxins|botulinum toxins|mesh-list
64794485|NCT03405948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64794486|NCT03405948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64794487|NCT03405948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794488|NCT03405948|Cholinergic Agents|cholinergic agents|mesh-ancestor
64794489|NCT03405948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64794490|NCT03405948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794491|NCT03405168|Moxifloxacin|moxifloxacin|mesh-list
64794492|NCT03405168|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64794493|NCT03405168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64794494|NCT03405168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64794495|NCT03405168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64794496|NCT03405168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64794497|NCT03405168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794498|NCT03405168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794499|NCT03405168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794500|NCT03405168|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64794501|NCT03405168|Contraceptive Agents|contraceptive agents|mesh-ancestor
64794502|NCT03405168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64794503|NCT03405168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794504|NCT03405168|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64794505|NCT03405168|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64794506|NCT03405168|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64794507|NCT03403452|Apatinib|apatinib|mesh-list
64794508|NCT03403452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794509|NCT03403452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64794510|NCT03403452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794523|NCT03403140|Immunologic Factors|immunologic factors|mesh-ancestor
64794524|NCT03402984|Z 338|z 338|mesh-list
64794525|NCT03402984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64794526|NCT03402984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794527|NCT03402984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794528|NCT03402984|Cholinergic Agents|cholinergic agents|mesh-ancestor
64794529|NCT03402984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64794530|NCT03402984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794531|NCT03402984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64794532|NCT03402438|Fulacimstat|fulacimstat|mesh-list
64794533|NCT03402438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794534|NCT03402438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794535|NCT03402204|Ubenimex|ubenimex|mesh-list
64794536|NCT03402204|Simvastatin|simvastatin|mesh-list
64794537|NCT03402204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64794538|NCT03402204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64794539|NCT03402204|Antimetabolites|antimetabolites|mesh-ancestor
64794540|NCT03402204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794541|NCT03402204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64794542|NCT03402204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64794543|NCT03402204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794544|NCT03402204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64405627|NCT04895657|Tazobactam|tazobactam|mesh-list
64794550|NCT03402204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794551|NCT03402204|Protease Inhibitors|protease inhibitors|mesh-ancestor
64794552|NCT03402204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64794553|NCT03402204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64794554|NCT03402204|Antiviral Agents|antiviral agents|mesh-ancestor
64794555|NCT03402048|Gemcitabine|gemcitabine|mesh-list
64794556|NCT03402048|Carboplatin|carboplatin|mesh-list
64794557|NCT03402048|Docetaxel|docetaxel|mesh-list
64794558|NCT03402048|Pemetrexed|pemetrexed|mesh-list
64794559|NCT03402048|Vinorelbine|vinorelbine|mesh-list
64794560|NCT03402048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794561|NCT03402048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64794562|NCT03402048|Antimetabolites|antimetabolites|mesh-ancestor
64794563|NCT03402048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794564|NCT03402048|Antiviral Agents|antiviral agents|mesh-ancestor
64794566|NCT03402048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794567|NCT03402048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64794568|NCT03402048|Immunologic Factors|immunologic factors|mesh-ancestor
64794569|NCT03402048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794570|NCT03402048|Tubulin Modulators|tubulin modulators|mesh-ancestor
64794571|NCT03402048|Antimitotic Agents|antimitotic agents|mesh-ancestor
64794572|NCT03402048|Mitosis Modulators|mitosis modulators|mesh-ancestor
64794573|NCT03402048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64794574|NCT03402048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64794575|NCT03402048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64794576|NCT03401502|Ranolazine|ranolazine|mesh-list
64794577|NCT03401502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64794578|NCT03401502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64794579|NCT03401502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794580|NCT03401346|Dihydroergotamine|dihydroergotamine|mesh-list
64794581|NCT03401346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64794582|NCT03401346|Dopamine Agonists|dopamine agonists|mesh-ancestor
64794630|NCT02240160|Sensory System Agents|sensory system agents|mesh-ancestor
64794631|NCT02240160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794632|NCT02240160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794633|NCT02240238|Gemcitabine|gemcitabine|mesh-list
64794634|NCT02240238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64794635|NCT02240238|Antimetabolites|antimetabolites|mesh-ancestor
64794636|NCT02240238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794637|NCT02240238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794638|NCT02240238|Antiviral Agents|antiviral agents|mesh-ancestor
64794639|NCT02240238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64794640|NCT02240238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794641|NCT02240238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64794642|NCT02240238|Immunologic Factors|immunologic factors|mesh-ancestor
64794643|NCT02240238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794644|NCT02241096|Lidocaine|lidocaine|mesh-list
64794645|NCT02241096|Anesthetics, Local|anesthetics, local|mesh-ancestor
64794646|NCT02241096|Anesthetics|anesthetics|mesh-ancestor
64794647|NCT02241096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64794648|NCT02241096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794649|NCT02241096|Sensory System Agents|sensory system agents|mesh-ancestor
64794650|NCT02241096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794651|NCT02241096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64794652|NCT02241096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64794653|NCT02241096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64794679|NCT02241876|Antioxidants|antioxidants|mesh-ancestor
64794680|NCT02241876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794681|NCT02241876|Protective Agents|protective agents|mesh-ancestor
64794682|NCT02241876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794683|NCT02241876|Antidotes|antidotes|mesh-ancestor
64794684|NCT02242032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64794691|NCT02242266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64794692|NCT02242266|Respiratory System Agents|respiratory system agents|mesh-ancestor
64794693|NCT02242266|Parasympatholytics|parasympatholytics|mesh-ancestor
64794694|NCT02242266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64794695|NCT02242266|Cholinergic Agents|cholinergic agents|mesh-ancestor
64794696|NCT02242266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64794697|NCT02242266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794698|NCT02242344|Telmisartan|telmisartan|mesh-list
64794699|NCT02242344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64794700|NCT02242344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64794701|NCT02242344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64794702|NCT02242344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794704|NCT02242656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64794705|NCT02242656|Narcotics|narcotics|mesh-ancestor
64794706|NCT02242656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64794707|NCT02242656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794708|NCT02242656|Analgesics|analgesics|mesh-ancestor
64794709|NCT02242656|Sensory System Agents|sensory system agents|mesh-ancestor
64794710|NCT02242656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794711|NCT02242656|Antidiarrheals|antidiarrheals|mesh-ancestor
64794712|NCT02242656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64794713|NCT02242656|Antitussive Agents|antitussive agents|mesh-ancestor
64794714|NCT02242656|Respiratory System Agents|respiratory system agents|mesh-ancestor
64794715|NCT02242812|Metoprolol|metoprolol|mesh-list
64794716|NCT02242812|Telmisartan|telmisartan|mesh-list
64794717|NCT02242812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64794718|NCT02242812|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64794725|NCT02242812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794726|NCT02242812|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64794727|NCT02242812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64794728|NCT02242812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64794729|NCT02242812|Adrenergic Agents|adrenergic agents|mesh-ancestor
64794730|NCT02242812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64794731|NCT02243124|Dexamethasone|dexamethasone|mesh-list
64794732|NCT02243124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64794734|NCT02243124|Autonomic Agents|autonomic agents|mesh-ancestor
64794735|NCT02243124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794736|NCT02243124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794737|NCT02243124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64794738|NCT02243124|Glucocorticoids|glucocorticoids|mesh-ancestor
64794739|NCT02243124|Hormones|hormones|mesh-ancestor
64794740|NCT02243124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64794794|NCT02244216|Adrenergic Agents|adrenergic agents|mesh-ancestor
64794795|NCT02244216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64794796|NCT02244216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794797|NCT02244294|Tamsulosin|tamsulosin|mesh-list
64794798|NCT02244294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64794799|NCT02244294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64794800|NCT02244294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64794801|NCT02244294|Adrenergic Agents|adrenergic agents|mesh-ancestor
64794802|NCT02244294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64794803|NCT02244294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794804|NCT02244294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563376|NCT01255449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64794806|NCT02244528|Sildenafil Citrate|sildenafil citrate|mesh-list
64794807|NCT02244528|Vasodilator Agents|vasodilator agents|mesh-ancestor
64794808|NCT02244528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64794809|NCT02244528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64794810|NCT02244528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794811|NCT02244528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794812|NCT02244528|Urological Agents|urological agents|mesh-ancestor
64794813|NCT02245464|Telmisartan|telmisartan|mesh-list
64794814|NCT02245464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64794815|NCT02245464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64794822|NCT02246244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794823|NCT02246244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64794847|NCT02247258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64794848|NCT02247414|Aspirin|aspirin|mesh-list
64794849|NCT02247414|Heparin|heparin|mesh-list
64794850|NCT02247414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64794851|NCT02247414|Tinzaparin|tinzaparin|mesh-list
64794852|NCT02247414|Dalteparin|dalteparin|mesh-list
64794853|NCT02247414|Dipyridamole|dipyridamole|mesh-list
64794854|NCT02247414|Warfarin|warfarin|mesh-list
64794855|NCT02247414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64794856|NCT02247414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64794857|NCT02247414|Analgesics|analgesics|mesh-ancestor
64794858|NCT02247414|Sensory System Agents|sensory system agents|mesh-ancestor
64794859|NCT02247414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794860|NCT02247414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794861|NCT02247414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64794862|NCT02247414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64794863|NCT02247414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64794864|NCT02247414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64794865|NCT02247414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794866|NCT02247414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64794867|NCT02247414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64794868|NCT02247414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794869|NCT02247414|Antipyretics|antipyretics|mesh-ancestor
64794870|NCT02247414|Anticoagulants|anticoagulants|mesh-ancestor
64794871|NCT02247414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64794872|NCT02247414|Vasodilator Agents|vasodilator agents|mesh-ancestor
64794873|NCT02247648|Tramadol|tramadol|mesh-list
64794874|NCT02247648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64794875|NCT02247648|Narcotics|narcotics|mesh-ancestor
64794876|NCT02247648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64794877|NCT02247648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794902|NCT02248428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64794903|NCT02248428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64794904|NCT02248428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64794905|NCT02248428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64794906|NCT02248428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794907|NCT02248428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64794908|NCT02248428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64794909|NCT02248428|Leprostatic Agents|leprostatic agents|mesh-ancestor
64794910|NCT02248428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64794911|NCT02248428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64794912|NCT02248428|Growth Substances|growth substances|mesh-ancestor
64794913|NCT02248428|Growth Inhibitors|growth inhibitors|mesh-ancestor
64794914|NCT02248506|Clotrimazole|clotrimazole|mesh-list
64794915|NCT02248506|Miconazole|miconazole|mesh-list
64794916|NCT02248506|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64794917|NCT02248506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64794918|NCT02248506|Antifungal Agents|antifungal agents|mesh-ancestor
64794919|NCT02248506|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64794920|NCT02248506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64794921|NCT02248506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794922|NCT02248506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794923|NCT02248506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64794924|NCT02248506|Hormone Antagonists|hormone antagonists|mesh-ancestor
64794925|NCT02248506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64794926|NCT02248506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472050|NCT03870763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64794947|NCT02249130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794948|NCT02249130|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64794949|NCT02249130|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64794950|NCT02249130|Antiviral Agents|antiviral agents|mesh-ancestor
64406037|NCT04383743|Vinblastine|vinblastine|mesh-list
64794956|NCT02249130|Antimetabolites|antimetabolites|mesh-ancestor
64794957|NCT02249364|Propofol|propofol|mesh-list
64794958|NCT02249364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64794959|NCT02249364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64794960|NCT02249364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794961|NCT02249364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64794962|NCT02249364|Anesthetics, General|anesthetics, general|mesh-ancestor
64794963|NCT02249364|Anesthetics|anesthetics|mesh-ancestor
64794964|NCT02249442|Ritonavir|ritonavir|mesh-list
64794965|NCT02249442|Tipranavir|tipranavir|mesh-list
64794966|NCT02249442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64794967|NCT02249442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64794968|NCT02249442|Protease Inhibitors|protease inhibitors|mesh-ancestor
64794969|NCT02249442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794970|NCT02249442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794971|NCT02249442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64794972|NCT02249442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64794973|NCT02249442|Antiviral Agents|antiviral agents|mesh-ancestor
64794974|NCT02249442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64794975|NCT02249442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64794976|NCT02249442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64794977|NCT02244762|Hydrocodone|hydrocodone|mesh-list
64794978|NCT02244762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64794979|NCT02244762|Narcotics|narcotics|mesh-ancestor
64794980|NCT02244762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64794981|NCT02244762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794982|NCT02244762|Analgesics|analgesics|mesh-ancestor
64794983|NCT02244762|Sensory System Agents|sensory system agents|mesh-ancestor
64794984|NCT02244762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794985|NCT02244762|Antitussive Agents|antitussive agents|mesh-ancestor
64794986|NCT02244762|Respiratory System Agents|respiratory system agents|mesh-ancestor
64794991|NCT02242734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794992|NCT02242734|Analgesics|analgesics|mesh-ancestor
64794993|NCT02242734|Sensory System Agents|sensory system agents|mesh-ancestor
64794994|NCT02242734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794995|NCT02242734|Antitussive Agents|antitussive agents|mesh-ancestor
64794996|NCT02242734|Respiratory System Agents|respiratory system agents|mesh-ancestor
64794997|NCT02244606|Fluconazole|fluconazole|mesh-list
64794998|NCT02244606|Micafungin|micafungin|mesh-list
64794999|NCT02244606|Ibrexafungerp|ibrexafungerp|mesh-list
64795000|NCT02244606|Antifungal Agents|antifungal agents|mesh-ancestor
64795001|NCT02244606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64795002|NCT02244606|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64795003|NCT02244606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64795004|NCT02244606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795005|NCT02244606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472051|NCT03870763|Immunologic Factors|immunologic factors|mesh-ancestor
64795006|NCT02244606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64795007|NCT02244606|Hormone Antagonists|hormone antagonists|mesh-ancestor
64795008|NCT02244606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64795009|NCT02244606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795010|NCT02244606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64795011|NCT02244606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64795012|NCT02245308|Bupropion|bupropion|mesh-list
64795013|NCT02245308|Nicotine|nicotine|mesh-list
64795014|NCT02245308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64795015|NCT02245308|Autonomic Agents|autonomic agents|mesh-ancestor
64795016|NCT02245308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64795017|NCT02245308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795026|NCT02245308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64795041|NCT02243358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64795042|NCT02243358|Immunologic Factors|immunologic factors|mesh-ancestor
64795043|NCT02243358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795044|NCT00559962|Atorvastatin|atorvastatin|mesh-list
64795045|NCT00559962|Ezetimibe|ezetimibe|mesh-list
64795046|NCT00559962|Fenofibrate|fenofibrate|mesh-list
64795047|NCT00559962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64795048|NCT00559962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64795049|NCT00559962|Antimetabolites|antimetabolites|mesh-ancestor
64795050|NCT00559962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795051|NCT00559962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64795052|NCT00559962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64795053|NCT00559962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795054|NCT00559104|Cyclophosphamide|cyclophosphamide|mesh-list
64795055|NCT00559104|Carmustine|carmustine|mesh-list
64795056|NCT00559104|Etoposide|etoposide|mesh-list
64795057|NCT00559104|Lenograstim|lenograstim|mesh-list
64795058|NCT00559104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64795059|NCT00559104|Immunologic Factors|immunologic factors|mesh-ancestor
64795060|NCT00559104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795061|NCT00559104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64795101|NCT00557622|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64795102|NCT00557622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64795103|NCT00557622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795104|NCT00557466|Formoterol Fumarate|formoterol fumarate|mesh-list
64795105|NCT00557466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64795106|NCT00557466|Autonomic Agents|autonomic agents|mesh-ancestor
64795107|NCT00557466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64795108|NCT00557466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795109|NCT00557466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64795110|NCT00557466|Respiratory System Agents|respiratory system agents|mesh-ancestor
64795111|NCT00557466|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64795112|NCT00557466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64795113|NCT00557466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64795114|NCT00557466|Adrenergic Agents|adrenergic agents|mesh-ancestor
64795115|NCT00557466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64795116|NCT00557466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795117|NCT00557310|Teriparatide|teriparatide|mesh-list
64795118|NCT00557310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64795119|NCT00557310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795120|NCT00557310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64795121|NCT00555438|PENTA|penta|mesh-list
64795122|NCT00555438|Fondaparinux|fondaparinux|mesh-list
64795123|NCT00555438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64795124|NCT00555438|Antithrombins|antithrombins|mesh-ancestor
64795125|NCT00555438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64795126|NCT00555438|Protease Inhibitors|protease inhibitors|mesh-ancestor
64795127|NCT00555438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795128|NCT00555438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795129|NCT00555438|Anticoagulants|anticoagulants|mesh-ancestor
64795130|NCT00555438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64795131|NCT00555438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64795132|NCT00553644|Lenalidomide|lenalidomide|mesh-list
64795133|NCT00553644|Bortezomib|bortezomib|mesh-list
64795134|NCT00553644|Immunologic Factors|immunologic factors|mesh-ancestor
64951875|NCT00027677|Growth Inhibitors|growth inhibitors|mesh-ancestor
64951876|NCT00027716|Bortezomib|bortezomib|mesh-list
64951877|NCT00027716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951878|NCT00055887|Gemcitabine|gemcitabine|mesh-list
64951879|NCT00055887|Paclitaxel|paclitaxel|mesh-list
64951880|NCT00055887|Vinorelbine|vinorelbine|mesh-list
64951881|NCT00055887|Carboplatin|carboplatin|mesh-list
64795135|NCT00553644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795136|NCT00553644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64795137|NCT00553644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64795138|NCT00553644|Growth Substances|growth substances|mesh-ancestor
64795139|NCT00553644|Growth Inhibitors|growth inhibitors|mesh-ancestor
64795140|NCT00553644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64795141|NCT00552240|Ritonavir|ritonavir|mesh-list
64795142|NCT00552240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64795143|NCT00552240|Tenofovir|tenofovir|mesh-list
64795144|NCT00552240|Emtricitabine|emtricitabine|mesh-list
64795145|NCT00552240|Nevirapine|nevirapine|mesh-list
64795146|NCT00552240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64795147|NCT00552240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64795148|NCT00552240|Protease Inhibitors|protease inhibitors|mesh-ancestor
64795155|NCT00552240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64795156|NCT00552240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64795157|NCT00552240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64795158|NCT00552240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64795161|NCT00550836|Gemcitabine|gemcitabine|mesh-list
64795197|NCT00552708|Protease Inhibitors|protease inhibitors|mesh-ancestor
64795198|NCT00552708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795199|NCT00552708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795200|NCT00552708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64795201|NCT00552708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64795202|NCT00552708|Protective Agents|protective agents|mesh-ancestor
64795203|NCT00552708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795204|NCT00552708|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64795205|NCT00552708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64795206|NCT00552708|Adrenergic Agents|adrenergic agents|mesh-ancestor
64795207|NCT00552708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64795208|NCT00552708|Antioxidants|antioxidants|mesh-ancestor
64795209|NCT00552708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64795210|NCT00552708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64795211|NCT00552708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64795212|NCT00552708|Vasodilator Agents|vasodilator agents|mesh-ancestor
64795213|NCT00552708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64795214|NCT00552708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64795215|NCT00556374|Zoledronic Acid|zoledronic acid|mesh-list
64795216|NCT00556374|Denosumab|denosumab|mesh-list
64795222|NCT00556374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795223|NCT00556374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64795226|NCT03028350|Ifetroban|ifetroban|mesh-list
64795252|NCT04270344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64795253|NCT04270344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64795254|NCT04270344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795255|NCT04270344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64795256|NCT04270344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64795257|NCT04270344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64795258|NCT04270344|Antimetabolites|antimetabolites|mesh-ancestor
64795259|NCT04270344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795260|NCT04270344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64795261|NCT04271202|Erenumab|erenumab|mesh-list
64795262|NCT04271202|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64795263|NCT04271202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795264|NCT04271202|Analgesics|analgesics|mesh-ancestor
64795265|NCT04271202|Sensory System Agents|sensory system agents|mesh-ancestor
64795325|NCT03838068|Sensory System Agents|sensory system agents|mesh-ancestor
64795326|NCT03838068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64795328|NCT05440734|Antioxidants|antioxidants|mesh-ancestor
64795329|NCT05440734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795330|NCT05440734|Protective Agents|protective agents|mesh-ancestor
64795331|NCT05440734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795332|NCT05440734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64795333|NCT05447208|Hormones|hormones|mesh-list
64795334|NCT05447208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64795335|NCT05447208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795336|NCT05444556|Repaglinide|repaglinide|mesh-list
64795337|NCT05444556|Quinidine|quinidine|mesh-list
64795338|NCT05444556|Digoxin|digoxin|mesh-list
64795339|NCT05444556|Dextromethorphan|dextromethorphan|mesh-list
64795340|NCT05444556|Omeprazole|omeprazole|mesh-list
64795341|NCT05444556|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64795342|NCT05444556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64795343|NCT05444556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64795344|NCT05444556|Antimetabolites|antimetabolites|mesh-ancestor
64795345|NCT05444556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795346|NCT05444556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64795356|NCT05444556|Antitussive Agents|antitussive agents|mesh-ancestor
64795357|NCT05444556|Respiratory System Agents|respiratory system agents|mesh-ancestor
64795358|NCT05444556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64795359|NCT05444556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64795360|NCT05444556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64795383|NCT05440578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64795384|NCT05440578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64795385|NCT05440578|Growth Substances|growth substances|mesh-ancestor
64795386|NCT05440578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795387|NCT05440578|Growth Inhibitors|growth inhibitors|mesh-ancestor
64795388|NCT05440578|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64795389|NCT05440578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795390|NCT05440578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795391|NCT01689558|Endostatins|endostatins|mesh-list
64795392|NCT01689558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64795393|NCT01689558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64795394|NCT01689558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64795395|NCT01689558|Growth Substances|growth substances|mesh-ancestor
64795396|NCT01689558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795397|NCT01689558|Growth Inhibitors|growth inhibitors|mesh-ancestor
64563974|NCT00636155|Fludarabine|fludarabine|mesh-list
64795398|NCT01689636|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
64795399|NCT01689636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64795400|NCT01689636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795401|NCT01689714|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
64795402|NCT01689714|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64795403|NCT01689714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795404|NCT01689870|Ipilimumab|ipilimumab|mesh-list
64795405|NCT01689870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64795406|NCT01689870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64795407|NCT01689870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64795408|NCT01689870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795415|NCT05768542|Sympatholytics|sympatholytics|mesh-ancestor
64795425|NCT05768464|Axitinib|axitinib|mesh-list
64795428|NCT05768464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795429|NCT05768464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795430|NCT05768373|Fluorides|fluorides|mesh-list
64795431|NCT05768373|Cariostatic Agents|cariostatic agents|mesh-ancestor
64795432|NCT05768373|Protective Agents|protective agents|mesh-ancestor
64795433|NCT05768373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795434|NCT05768334|Lubiprostone|lubiprostone|mesh-list
64795435|NCT05768334|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64795436|NCT05768334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64795437|NCT05768334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795438|NCT05768243|Hyaluronic Acid|hyaluronic acid|mesh-list
64795439|NCT05768243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64795440|NCT05768243|Immunologic Factors|immunologic factors|mesh-ancestor
64795441|NCT05768243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795442|NCT05768243|Viscosupplements|viscosupplements|mesh-ancestor
64795443|NCT05768243|Protective Agents|protective agents|mesh-ancestor
64795444|NCT05768230|Simendan|simendan|mesh-list
64795445|NCT05768230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64795446|NCT05768230|Vasodilator Agents|vasodilator agents|mesh-ancestor
64795447|NCT05768230|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64795448|NCT05768230|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64795449|NCT05768230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795450|NCT05768230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795451|NCT05768230|Protective Agents|protective agents|mesh-ancestor
64795452|NCT05768230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795453|NCT05768204|Prednisolone|prednisolone|mesh-list
64795454|NCT05768204|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64795455|NCT05768204|Methylprednisolone|methylprednisolone|mesh-list
64795456|NCT05768204|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64795457|NCT05768204|Prednisolone acetate|prednisolone acetate|mesh-list
64795458|NCT05768204|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64795461|NCT05768204|Glucocorticoids|glucocorticoids|mesh-ancestor
64564049|NCT05602129|Calcium heparin|calcium heparin|mesh-list
64795470|NCT05768204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64795471|NCT05768204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64795472|NCT05768204|Protective Agents|protective agents|mesh-ancestor
64795474|NCT05768191|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64795475|NCT05768191|Isophane Insulin, Human|isophane insulin, human|mesh-list
64795476|NCT05768191|Insulin, Isophane|insulin, isophane|mesh-list
64795477|NCT05768191|Isophane insulin, beef|isophane insulin, beef|mesh-list
64795483|NCT05768126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795484|NCT05768126|Cholinergic Agents|cholinergic agents|mesh-ancestor
64795485|NCT05768126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64795486|NCT05768126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795487|NCT05768126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64795488|NCT05768126|Protective Agents|protective agents|mesh-ancestor
64795489|NCT05767944|Anesthetics|anesthetics|mesh-list
64795490|NCT05767944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64795492|NCT05767827|Lidocaine|lidocaine|mesh-list
64795534|NCT05767749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64795535|NCT05767749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795536|NCT05767749|Sensory System Agents|sensory system agents|mesh-ancestor
64795537|NCT05767749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64795538|NCT05767749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64795539|NCT05767749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64795540|NCT05767749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64795541|NCT05767749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64795542|NCT05767749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795543|NCT05767749|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64795544|NCT05767749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64795545|NCT05767749|Adrenergic Agents|adrenergic agents|mesh-ancestor
64795546|NCT05767749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64795547|NCT05767749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64795548|NCT05767749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64795555|NCT05767736|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64795556|NCT05767736|Dermatologic Agents|dermatologic agents|mesh-ancestor
64795557|NCT05767736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64795558|NCT05767736|Immunologic Factors|immunologic factors|mesh-ancestor
64795559|NCT05767736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795561|NCT05767723|Ticagrelor|ticagrelor|mesh-list
64795562|NCT05767723|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64795563|NCT05767723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64795564|NCT05767723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64795565|NCT05767723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64795566|NCT05767723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64795567|NCT05767723|Purinergic Agents|purinergic agents|mesh-ancestor
64795568|NCT05767723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64795569|NCT05767723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795570|NCT05767723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795571|NCT05767723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64795572|NCT05767723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64795573|NCT05767723|Analgesics|analgesics|mesh-ancestor
64795574|NCT05767723|Sensory System Agents|sensory system agents|mesh-ancestor
64795575|NCT05767723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64795576|NCT05767723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64795577|NCT05767723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64795578|NCT05767723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64310296|NCT04906772|Ketamine|ketamine|mesh-list
64795579|NCT05767723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64795580|NCT05767723|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64795581|NCT05767723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795582|NCT05767723|Antipyretics|antipyretics|mesh-ancestor
64795583|NCT05767684|Nivolumab|nivolumab|mesh-list
64795584|NCT05767684|Lenvatinib|lenvatinib|mesh-list
64795585|NCT05767684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64795586|NCT05767684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64795587|NCT05767684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64795588|NCT05767684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795589|NCT05767684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64795590|NCT05767684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795591|NCT05767671|Dimercaprol|dimercaprol|mesh-list
64795592|NCT05767671|Chelating Agents|chelating agents|mesh-ancestor
64795593|NCT05767671|Sequestering Agents|sequestering agents|mesh-ancestor
64795594|NCT05767671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795595|NCT05767632|Solifenacin Succinate|solifenacin succinate|mesh-list
64795596|NCT05767632|Mirabegron|mirabegron|mesh-list
64795597|NCT05767632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64795598|NCT05767632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64795599|NCT05767632|Cholinergic Agents|cholinergic agents|mesh-ancestor
64795600|NCT05767632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64795601|NCT05767632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795602|NCT05767632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795603|NCT05767632|Urological Agents|urological agents|mesh-ancestor
64795604|NCT05767632|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64795605|NCT05767632|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64795606|NCT05767632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64795617|NCT05767346|Metoprolol|metoprolol|mesh-list
64795618|NCT05767346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64795619|NCT05767346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64795620|NCT05767346|Sympatholytics|sympatholytics|mesh-ancestor
64795625|NCT05767346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64795626|NCT05767346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64795627|NCT05767346|Adrenergic Agents|adrenergic agents|mesh-ancestor
64795628|NCT05767346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64795629|NCT05767346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795630|NCT05767255|Insulin|insulin|mesh-list
64795631|NCT05767255|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64795632|NCT05767255|Insulin Glargine|insulin glargine|mesh-list
64795633|NCT05767255|Insulin Aspart|insulin aspart|mesh-list
64795634|NCT05767255|Liraglutide|liraglutide|mesh-list
64795635|NCT05767255|Xultophy|xultophy|mesh-list
64795636|NCT05767255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64795637|NCT05767255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795638|NCT05767255|Incretins|incretins|mesh-ancestor
64795639|NCT05767255|Hormones|hormones|mesh-ancestor
64795640|NCT05767255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64795641|NCT05767229|Carvedilol|carvedilol|mesh-list
64795642|NCT05767229|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64795643|NCT05767229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64795644|NCT05767229|Adrenergic Agents|adrenergic agents|mesh-ancestor
64795645|NCT05767229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64795646|NCT05767229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795647|NCT05767229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795648|NCT05767229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64795649|NCT05767229|Antioxidants|antioxidants|mesh-ancestor
64795650|NCT05767229|Protective Agents|protective agents|mesh-ancestor
64795651|NCT05767229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64795652|NCT05767229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64795653|NCT05767229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64795654|NCT05767229|Vasodilator Agents|vasodilator agents|mesh-ancestor
64795655|NCT05767229|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64795656|NCT05767229|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64514730|NCT02393157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64795658|NCT05767060|Immunologic Factors|immunologic factors|mesh-ancestor
64795659|NCT05767060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795660|NCT05765513|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64795662|NCT05761431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64795663|NCT05761431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64795664|NCT05761431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64795665|NCT05755789|Cefoxitin|cefoxitin|mesh-list
64795666|NCT05755789|Cefotaxime|cefotaxime|mesh-list
64795667|NCT05755789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64795668|NCT05755789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64795669|NCT05754073|Oxytocin|oxytocin|mesh-list
64795670|NCT05754073|Oxytocics|oxytocics|mesh-ancestor
64795671|NCT05754073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64795672|NCT05754073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795673|NCT05753267|Mesalamine|mesalamine|mesh-list
64795674|NCT05753267|Fenofibrate|fenofibrate|mesh-list
64795675|NCT05753267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64795676|NCT05753267|Antimetabolites|antimetabolites|mesh-ancestor
64795677|NCT05753267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795678|NCT05753267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64795679|NCT05753267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64795680|NCT05753267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64795681|NCT05753267|Analgesics|analgesics|mesh-ancestor
64795682|NCT05753267|Sensory System Agents|sensory system agents|mesh-ancestor
64795683|NCT05753267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64795684|NCT05753267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795685|NCT05753267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64795686|NCT05753267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64795687|NCT05751343|Bevacizumab|bevacizumab|mesh-list
64795688|NCT05751343|Atezolizumab|atezolizumab|mesh-list
64795723|NCT05647681|Acetaminophen|acetaminophen|mesh-list
64795724|NCT05647681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64795725|NCT05647681|Analgesics|analgesics|mesh-ancestor
64795726|NCT05647681|Sensory System Agents|sensory system agents|mesh-ancestor
64795727|NCT05647681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64795728|NCT05647681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795729|NCT05647681|Antipyretics|antipyretics|mesh-ancestor
64795730|NCT05644145|Vaccines|vaccines|mesh-list
64795731|NCT05644145|Immunologic Factors|immunologic factors|mesh-ancestor
64795732|NCT05644145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795733|NCT05642416|Ropivacaine|ropivacaine|mesh-list
64795734|NCT05642416|Anesthetics, Local|anesthetics, local|mesh-ancestor
64795735|NCT05642416|Anesthetics|anesthetics|mesh-ancestor
64795736|NCT05642416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64795737|NCT05642416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795738|NCT05642416|Sensory System Agents|sensory system agents|mesh-ancestor
64795739|NCT05642416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64795740|NCT05631028|Dexmedetomidine|dexmedetomidine|mesh-list
64795741|NCT05631028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64795742|NCT05631028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64795743|NCT05631028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795744|NCT05631028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64795745|NCT05631028|Analgesics|analgesics|mesh-ancestor
64795746|NCT05631028|Sensory System Agents|sensory system agents|mesh-ancestor
64795747|NCT05631028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64795756|NCT05630976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64795758|NCT05621616|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64795759|NCT05621616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64795760|NCT05621616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64472057|NCT03869034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795774|NCT05612074|Antioxidants|antioxidants|mesh-ancestor
64795775|NCT05612074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795776|NCT05612074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64795777|NCT05612074|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64795778|NCT05612074|Vasodilator Agents|vasodilator agents|mesh-ancestor
64795779|NCT05612074|Gasotransmitters|gasotransmitters|mesh-ancestor
64795780|NCT05612074|Protective Agents|protective agents|mesh-ancestor
64795781|NCT05604599|Fentanyl|fentanyl|mesh-list
64795782|NCT05604599|Dexmedetomidine|dexmedetomidine|mesh-list
64795783|NCT05604599|Propofol|propofol|mesh-list
64795784|NCT05604599|Isoflurane|isoflurane|mesh-list
64795785|NCT05604599|Atracurium|atracurium|mesh-list
64795786|NCT05604599|Cisatracurium|cisatracurium|mesh-list
64795787|NCT05604599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64795788|NCT05604599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64795789|NCT05604599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795790|NCT05604599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64795791|NCT05604599|Anesthetics, General|anesthetics, general|mesh-ancestor
64795792|NCT05604599|Anesthetics|anesthetics|mesh-ancestor
64795793|NCT05604599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64795794|NCT05604599|Analgesics|analgesics|mesh-ancestor
64795799|NCT05604599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64795843|NCT05602519|Analgesics|analgesics|mesh-ancestor
64795844|NCT05602519|Sensory System Agents|sensory system agents|mesh-ancestor
64795845|NCT05602519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64795846|NCT05602519|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64795847|NCT05602519|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64795848|NCT05602519|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64795849|NCT05602519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64795850|NCT05583110|Trastuzumab|trastuzumab|mesh-list
64795851|NCT05583110|Vinorelbine|vinorelbine|mesh-list
64795852|NCT05583110|Tucatinib|tucatinib|mesh-list
64795853|NCT05583110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64795854|NCT05583110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64795855|NCT05583110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64795856|NCT05583110|Tubulin Modulators|tubulin modulators|mesh-ancestor
64795857|NCT05583110|Antimitotic Agents|antimitotic agents|mesh-ancestor
64795858|NCT05583110|Mitosis Modulators|mitosis modulators|mesh-ancestor
64795859|NCT05583110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795860|NCT05583110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64795861|NCT05583110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795862|NCT05574504|Avelumab|avelumab|mesh-list
64795863|NCT05574504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64795864|NCT05574504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64795865|NCT05574504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64795866|NCT05574504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795867|NCT05543837|Capsaicin|capsaicin|mesh-list
64795868|NCT05543837|Antipruritics|antipruritics|mesh-ancestor
64795869|NCT05543837|Dermatologic Agents|dermatologic agents|mesh-ancestor
64795870|NCT05543837|Sensory System Agents|sensory system agents|mesh-ancestor
64795896|NCT05483465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795897|NCT05483465|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64795898|NCT05483465|Antimetabolites|antimetabolites|mesh-ancestor
64795899|NCT05483465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795900|NCT05483465|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64795901|NCT05483465|Vasodilator Agents|vasodilator agents|mesh-ancestor
64795902|NCT05468099|Chlorhexidine|chlorhexidine|mesh-list
64795903|NCT05468099|Povidone-Iodine|povidone-iodine|mesh-list
64795904|NCT05468099|Povidone|povidone|mesh-list
64795905|NCT05468099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64795907|NCT05468099|Disinfectants|disinfectants|mesh-ancestor
64795974|NCT05284019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795975|NCT05284019|Analgesics|analgesics|mesh-ancestor
64795976|NCT05284019|Sensory System Agents|sensory system agents|mesh-ancestor
64795977|NCT05284019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64795978|NCT05284019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795979|NCT05284019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64795980|NCT05284019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64795981|NCT05284019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64795982|NCT05284019|Cholinergic Agents|cholinergic agents|mesh-ancestor
64795983|NCT05284019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64795984|NCT05275439|Azacitidine|azacitidine|mesh-list
64795985|NCT05275439|Venetoclax|venetoclax|mesh-list
64795986|NCT05275439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64795987|NCT05275439|Antimetabolites|antimetabolites|mesh-ancestor
64795988|NCT05275439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795989|NCT05275439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64795990|NCT05275439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795991|NCT05271162|Empagliflozin|empagliflozin|mesh-list
64795992|NCT05271162|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64795993|NCT05271162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795994|NCT05271162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64795995|NCT05271162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795996|NCT05257083|Dexamethasone|dexamethasone|mesh-list
64796027|NCT05249634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64796028|NCT05249634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796029|NCT05217342|Diuretics|diuretics|mesh-list
64796030|NCT05217342|Natriuretic Agents|natriuretic agents|mesh-ancestor
64796031|NCT05217342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796032|NCT05199714|Pramlintide|pramlintide|mesh-list
64796033|NCT05199714|Pancrelipase|pancrelipase|mesh-list
64796034|NCT05199714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64796035|NCT05199714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64796036|NCT05199714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796037|NCT05193370|Vasopressins|vasopressins|mesh-list
64796038|NCT05193370|Arginine Vasopressin|arginine vasopressin|mesh-list
64796039|NCT05193370|Angiotensin II|angiotensin ii|mesh-list
64796040|NCT05193370|Giapreza|giapreza|mesh-list
64796102|NCT05081180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796103|NCT05081180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796104|NCT05081180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64796105|NCT05078827|Fluorouracil|fluorouracil|mesh-list
64796106|NCT05078827|Antimetabolites|antimetabolites|mesh-ancestor
64796107|NCT05078827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796108|NCT05078827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64796109|NCT05078827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796110|NCT05078827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64796111|NCT05078827|Immunologic Factors|immunologic factors|mesh-ancestor
64796112|NCT05078827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796113|NCT05076981|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64796114|NCT05076981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64796115|NCT05076981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796116|NCT05065164|Denosumab|denosumab|mesh-list
64796117|NCT05065164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64796118|NCT05065164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796119|NCT05057819|Empagliflozin|empagliflozin|mesh-list
64796120|NCT05057819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64796121|NCT05057819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796122|NCT05057819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64796123|NCT05057819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796124|NCT05044819|Cannabidiol|cannabidiol|mesh-list
64796125|NCT05044819|Anticonvulsants|anticonvulsants|mesh-ancestor
64796126|NCT05037812|Ketorolac|ketorolac|mesh-list
64796127|NCT05037812|Clonidine|clonidine|mesh-list
64796128|NCT05037812|Epinephrine|epinephrine|mesh-list
64796129|NCT05037812|Morphine|morphine|mesh-list
64796130|NCT05037812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64796131|NCT05037812|Narcotics|narcotics|mesh-ancestor
64796132|NCT05037812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64796134|NCT05037812|Analgesics|analgesics|mesh-ancestor
64796158|NCT05037812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64796159|NCT05019638|Ketorolac|ketorolac|mesh-list
64796160|NCT05019638|Epinephrine|epinephrine|mesh-list
64796161|NCT05019638|Racepinephrine|racepinephrine|mesh-list
64796162|NCT05019638|Morphine|morphine|mesh-list
64796163|NCT05019638|Bupivacaine|bupivacaine|mesh-list
64796164|NCT05019638|Epinephryl borate|epinephryl borate|mesh-list
64796165|NCT05019638|Anesthetics, Local|anesthetics, local|mesh-ancestor
64796166|NCT05019638|Anesthetics|anesthetics|mesh-ancestor
64796167|NCT05019638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64796168|NCT05019638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796169|NCT05019638|Sensory System Agents|sensory system agents|mesh-ancestor
64796170|NCT05019638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64796171|NCT05019638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64796172|NCT05019638|Narcotics|narcotics|mesh-ancestor
64796173|NCT05019638|Analgesics|analgesics|mesh-ancestor
64796174|NCT05019638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64796175|NCT05019638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64796176|NCT05019638|Adrenergic Agents|adrenergic agents|mesh-ancestor
64796177|NCT05019638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64796178|NCT05019638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796179|NCT05019638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64796180|NCT05019638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64796181|NCT05019638|Autonomic Agents|autonomic agents|mesh-ancestor
64796182|NCT05019638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64796183|NCT05019638|Respiratory System Agents|respiratory system agents|mesh-ancestor
64796184|NCT05019638|Mydriatics|mydriatics|mesh-ancestor
64796185|NCT05019638|Sympathomimetics|sympathomimetics|mesh-ancestor
64796186|NCT05019638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64796187|NCT05019638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64796188|NCT05019638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64796189|NCT05019638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64796190|NCT05019638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64796191|NCT05019638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64796192|NCT05019638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796193|NCT04997993|Leflunomide|leflunomide|mesh-list
64796198|NCT04997993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796199|NCT04907253|Quercetin|quercetin|mesh-list
64796207|NCT04905979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64796208|NCT04905979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796209|NCT04905979|Adrenergic Agents|adrenergic agents|mesh-ancestor
64796210|NCT04905979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64796211|NCT04905979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796213|NCT04854512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64796214|NCT04854512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796218|NCT04806386|Psyllium|psyllium|mesh-list
64796219|NCT04806386|Cathartics|cathartics|mesh-ancestor
64796220|NCT04806386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64796221|NCT04804072|Analgesics, Opioid|analgesics, opioid|mesh-list
64796222|NCT04804072|Narcotics|narcotics|mesh-ancestor
64796223|NCT04804072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64796224|NCT04804072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796225|NCT04804072|Analgesics|analgesics|mesh-ancestor
64796226|NCT04804072|Sensory System Agents|sensory system agents|mesh-ancestor
64796227|NCT04804072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64796228|NCT04797156|Tranexamic Acid|tranexamic acid|mesh-list
64796229|NCT04797156|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64796230|NCT04797156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64796231|NCT04797156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796232|NCT04797156|Hemostatics|hemostatics|mesh-ancestor
64796233|NCT04797156|Coagulants|coagulants|mesh-ancestor
64796234|NCT04772300|Sirolimus|sirolimus|mesh-list
64796235|NCT04772300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64796236|NCT04772300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64796237|NCT04772300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64796238|NCT04772300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796239|NCT04772300|Antifungal Agents|antifungal agents|mesh-ancestor
64796240|NCT04772300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64796241|NCT04772300|Immunologic Factors|immunologic factors|mesh-ancestor
64796242|NCT04772300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796250|NCT04724031|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64796251|NCT04724031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796252|NCT04724031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796253|NCT04724031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796254|NCT04679376|Atorvastatin|atorvastatin|mesh-list
64796255|NCT04679376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64796256|NCT04679376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64796257|NCT04679376|Antimetabolites|antimetabolites|mesh-ancestor
64796258|NCT04679376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796259|NCT04679376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64796260|NCT04679376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64796261|NCT04679376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796262|NCT04677959|Fluticasone|fluticasone|mesh-list
64796263|NCT04677959|Xhance|xhance|mesh-list
64796264|NCT04677959|Albuterol|albuterol|mesh-list
64796265|NCT04677959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64796266|NCT04677959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64796270|NCT04677959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796271|NCT04677959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64796272|NCT04677959|Respiratory System Agents|respiratory system agents|mesh-ancestor
64796273|NCT04677959|Dermatologic Agents|dermatologic agents|mesh-ancestor
64796274|NCT04677959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64796276|NCT04677959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64796305|NCT04643002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796306|NCT04643002|Immunologic Factors|immunologic factors|mesh-ancestor
64796307|NCT04643002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64796308|NCT04643002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64796309|NCT04643002|Growth Substances|growth substances|mesh-ancestor
64796310|NCT04643002|Growth Inhibitors|growth inhibitors|mesh-ancestor
64796312|NCT04641975|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64796313|NCT04641975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64796314|NCT04641975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64796315|NCT04641975|Adrenergic Agents|adrenergic agents|mesh-ancestor
64796316|NCT04641975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64796317|NCT04641975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796318|NCT04641975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796319|NCT04641975|Urological Agents|urological agents|mesh-ancestor
64796320|NCT04612920|Acetaminophen|acetaminophen|mesh-list
64796321|NCT04612920|Ibuprofen|ibuprofen|mesh-list
64796322|NCT04612920|Oxycodone|oxycodone|mesh-list
64796323|NCT04612920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64796324|NCT04612920|Analgesics|analgesics|mesh-ancestor
64796325|NCT04612920|Sensory System Agents|sensory system agents|mesh-ancestor
64796326|NCT04612920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64796327|NCT04612920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796328|NCT04612920|Antipyretics|antipyretics|mesh-ancestor
64796329|NCT04612920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64796330|NCT04612920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64796331|NCT04612920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64796332|NCT04612920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64796333|NCT04612920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796334|NCT04612920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796336|NCT04612920|Narcotics|narcotics|mesh-ancestor
64796358|NCT04560595|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64796359|NCT04560595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796360|NCT04560595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64796361|NCT04560595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796364|NCT04560595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64796365|NCT04560595|Purinergic Agents|purinergic agents|mesh-ancestor
64796366|NCT04560595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64796367|NCT04551222|Probenecid|probenecid|mesh-list
64796368|NCT04551222|Uricosuric Agents|uricosuric agents|mesh-ancestor
64796369|NCT04551222|Gout Suppressants|gout suppressants|mesh-ancestor
64796370|NCT04551222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64796371|NCT04551222|Renal Agents|renal agents|mesh-ancestor
64796372|NCT04540705|Nivolumab|nivolumab|mesh-list
64796373|NCT04540705|Axitinib|axitinib|mesh-list
64796374|NCT04540705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64796375|NCT04540705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796376|NCT04540705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64796377|NCT04540705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796378|NCT04540705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64796379|NCT04540705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796380|NCT04531462|Empagliflozin|empagliflozin|mesh-list
64796381|NCT04531462|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64796382|NCT04531462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796383|NCT04531462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64796384|NCT04531462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796385|NCT04520139|Acetylcysteine|acetylcysteine|mesh-list
64796386|NCT04520139|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64796387|NCT04520139|Antiviral Agents|antiviral agents|mesh-ancestor
64796388|NCT04520139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64796389|NCT04520139|Expectorants|expectorants|mesh-ancestor
64796390|NCT04520139|Respiratory System Agents|respiratory system agents|mesh-ancestor
64796391|NCT04520139|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64796403|NCT04512105|Antimetabolites|antimetabolites|mesh-ancestor
64407509|NCT05069779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64796429|NCT04497142|Anticonvulsants|anticonvulsants|mesh-ancestor
64796430|NCT04497142|Nootropic Agents|nootropic agents|mesh-ancestor
64796431|NCT04477317|Epinephrine|epinephrine|mesh-list
64796432|NCT04477317|Racepinephrine|racepinephrine|mesh-list
64796433|NCT04477317|Nordefrin|nordefrin|mesh-list
64796434|NCT04477317|Mepivacaine|mepivacaine|mesh-list
64796435|NCT04477317|Carticaine|carticaine|mesh-list
64796436|NCT04477317|Epinephryl borate|epinephryl borate|mesh-list
64796437|NCT04477317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64796438|NCT04477317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64796439|NCT04477317|Adrenergic Agents|adrenergic agents|mesh-ancestor
64796440|NCT04477317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64796441|NCT04477317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796442|NCT04477317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796443|NCT04477317|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64796444|NCT04477317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64796445|NCT04477317|Autonomic Agents|autonomic agents|mesh-ancestor
64796446|NCT04477317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64796447|NCT04477317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64796448|NCT04477317|Respiratory System Agents|respiratory system agents|mesh-ancestor
64796449|NCT04477317|Mydriatics|mydriatics|mesh-ancestor
64796450|NCT04477317|Sympathomimetics|sympathomimetics|mesh-ancestor
64796451|NCT04477317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64796452|NCT04477317|Anesthetics, Local|anesthetics, local|mesh-ancestor
64796453|NCT04477317|Anesthetics|anesthetics|mesh-ancestor
64565034|NCT01922843|Vitamins|vitamins|mesh-ancestor
64796454|NCT04477317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64796486|NCT04381897|Expectorants|expectorants|mesh-ancestor
64796487|NCT04381897|Respiratory System Agents|respiratory system agents|mesh-ancestor
64796488|NCT04381897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64796489|NCT04381897|Antioxidants|antioxidants|mesh-ancestor
64796490|NCT04381897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796491|NCT04381897|Protective Agents|protective agents|mesh-ancestor
64796492|NCT04381897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796493|NCT04381897|Antidotes|antidotes|mesh-ancestor
64796494|NCT04344262|Atracurium|atracurium|mesh-list
64796495|NCT04344262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64796496|NCT04344262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64796497|NCT04344262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64796498|NCT04344262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64796499|NCT04344262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796500|NCT04344262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64796501|NCT04344262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64796502|NCT04344262|Cholinergic Agents|cholinergic agents|mesh-ancestor
64796503|NCT04344262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64796504|NCT04344262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796505|NCT04330638|Siltuximab|siltuximab|mesh-list
64796551|NCT04263064|Adrenergic Agents|adrenergic agents|mesh-ancestor
64796552|NCT04263064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64796553|NCT04263064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796554|NCT04189783|Bupivacaine|bupivacaine|mesh-list
64796555|NCT04189783|Anesthetics, Local|anesthetics, local|mesh-ancestor
64796556|NCT04189783|Anesthetics|anesthetics|mesh-ancestor
64796557|NCT04189783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64796558|NCT04189783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796559|NCT04189783|Sensory System Agents|sensory system agents|mesh-ancestor
64796560|NCT04189783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64796561|NCT04189744|Metronidazole|metronidazole|mesh-list
64796562|NCT04189744|Pyrimethamine|pyrimethamine|mesh-list
64796563|NCT04189744|Piperaquine|piperaquine|mesh-list
64796564|NCT04189744|Sulfadoxine|sulfadoxine|mesh-list
64796565|NCT04189744|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64796566|NCT04189744|Artenimol|artenimol|mesh-list
64796567|NCT04189744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64796568|NCT04189744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64796569|NCT04189744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64796570|NCT04189744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64796571|NCT04189744|Antimalarials|antimalarials|mesh-ancestor
64796572|NCT04189744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64796573|NCT04189744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796574|NCT04189744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796575|NCT04189744|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64796576|NCT04189744|Renal Agents|renal agents|mesh-ancestor
64796577|NCT04157348|Benralizumab|benralizumab|mesh-list
64796578|NCT04157348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64796579|NCT04157348|Respiratory System Agents|respiratory system agents|mesh-ancestor
64796580|NCT04131309|Dexamethasone|dexamethasone|mesh-list
64796581|NCT04131309|Bortezomib|bortezomib|mesh-list
64796582|NCT04131309|Daratumumab|daratumumab|mesh-list
64796583|NCT04131309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64796584|NCT04131309|Antiemetics|antiemetics|mesh-ancestor
64407695|NCT05067517|Nintedanib|nintedanib|mesh-list
64796588|NCT04131309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64796589|NCT04131309|Glucocorticoids|glucocorticoids|mesh-ancestor
64796593|NCT04131309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796594|NCT04125134|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64796595|NCT04125134|Lubricant Eye Drops|lubricant eye drops|mesh-list
64796596|NCT04125134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64796597|NCT04117945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64796598|NCT04117945|Cetuximab|cetuximab|mesh-list
64796599|NCT04117945|Panitumumab|panitumumab|mesh-list
64796600|NCT04117945|Irinotecan|irinotecan|mesh-list
64796601|NCT04117945|Antibodies|antibodies|mesh-list
64796602|NCT04117945|Immunoglobulins|immunoglobulins|mesh-list
64796603|NCT04117945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64796604|NCT04117945|Immunologic Factors|immunologic factors|mesh-ancestor
64796605|NCT04117945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796606|NCT04117945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796607|NCT04117945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64796608|NCT04117945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64796609|NCT04117945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796610|NCT04117945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796611|NCT04091217|Bevacizumab|bevacizumab|mesh-list
64796612|NCT04091217|Atezolizumab|atezolizumab|mesh-list
64796613|NCT04091217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64796614|NCT04091217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796615|NCT04091217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64314357|NCT02122055|Analgesics|analgesics|mesh-ancestor
64796616|NCT04091217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64796617|NCT04091217|Growth Substances|growth substances|mesh-ancestor
64796618|NCT04091217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796643|NCT04040959|Vitamin B Complex|vitamin b complex|mesh-ancestor
64796644|NCT04040959|Vitamins|vitamins|mesh-ancestor
64796645|NCT04040959|Micronutrients|micronutrients|mesh-ancestor
64796646|NCT04040959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796647|NCT04040959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64796648|NCT04040959|Antimetabolites|antimetabolites|mesh-ancestor
64796649|NCT04040959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796650|NCT04040959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64796651|NCT04040959|Vasodilator Agents|vasodilator agents|mesh-ancestor
64796652|NCT04039464|Bosentan|bosentan|mesh-list
64796653|NCT04039464|Sildenafil Citrate|sildenafil citrate|mesh-list
64796654|NCT04039464|Vasodilator Agents|vasodilator agents|mesh-ancestor
64796655|NCT04039464|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64796656|NCT04039464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64796657|NCT04039464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407754|NCT01659567|Interferons|interferons|mesh-list
64796663|NCT04035031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64796664|NCT04035031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796665|NCT04035031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64796666|NCT04035031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796667|NCT03980561|Varenicline|varenicline|mesh-list
64796668|NCT03980561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64796674|NCT03965689|Paclitaxel|paclitaxel|mesh-list
64796698|NCT03936998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64796699|NCT03911505|Miglustat|miglustat|mesh-list
64796700|NCT03911505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796701|NCT03911505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796702|NCT03911505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64796703|NCT03911505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64796704|NCT03911505|Antiviral Agents|antiviral agents|mesh-ancestor
64796705|NCT03911505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64796706|NCT03911505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64796707|NCT03911505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64796708|NCT03911505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796709|NCT03910660|Pembrolizumab|pembrolizumab|mesh-list
64796710|NCT03910660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64796711|NCT03910660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796712|NCT03835065|Calpastatin|calpastatin|mesh-list
64796713|NCT03835065|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64796714|NCT03835065|Protease Inhibitors|protease inhibitors|mesh-ancestor
64796715|NCT03835065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796716|NCT03835065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796717|NCT03786783|Vitamin A|vitamin a|mesh-list
64796718|NCT03786783|Cyclophosphamide|cyclophosphamide|mesh-list
64796719|NCT03786783|Melphalan|melphalan|mesh-list
64796720|NCT03786783|Mechlorethamine|mechlorethamine|mesh-list
64796721|NCT03786783|Thiotepa|thiotepa|mesh-list
64796722|NCT03786783|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64796723|NCT03786783|Cisplatin|cisplatin|mesh-list
64796724|NCT03786783|Carboplatin|carboplatin|mesh-list
64796725|NCT03786783|Doxorubicin|doxorubicin|mesh-list
64796726|NCT03786783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64796727|NCT03786783|Etoposide|etoposide|mesh-list
64796728|NCT03786783|Vincristine|vincristine|mesh-list
64796752|NCT03786783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64796753|NCT03786783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64796754|NCT03786783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796755|NCT03786783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64796756|NCT03786783|Tubulin Modulators|tubulin modulators|mesh-ancestor
64796757|NCT03786783|Antimitotic Agents|antimitotic agents|mesh-ancestor
64796758|NCT03786783|Mitosis Modulators|mitosis modulators|mesh-ancestor
64796759|NCT03786783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64796760|NCT03786783|Keratolytic Agents|keratolytic agents|mesh-ancestor
64796761|NCT03786783|Dermatologic Agents|dermatologic agents|mesh-ancestor
64796762|NCT03786783|Protective Agents|protective agents|mesh-ancestor
64796763|NCT03786783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64796764|NCT03785587|Bromides|bromides|mesh-list
64796765|NCT03785587|Anticonvulsants|anticonvulsants|mesh-ancestor
64796766|NCT03769181|Cemiplimab|cemiplimab|mesh-list
64796767|NCT03769181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64796768|NCT03769181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796769|NCT03768349|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64796770|NCT03768349|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64796771|NCT03768349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796772|NCT03735875|Venetoclax|venetoclax|mesh-list
64796773|NCT03735875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796774|NCT03670056|Nivolumab|nivolumab|mesh-list
64796775|NCT03670056|Ipilimumab|ipilimumab|mesh-list
64796776|NCT03670056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64796777|NCT03670056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796812|NCT03635333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796813|NCT03634839|Nicotine|nicotine|mesh-list
64796814|NCT03634839|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64796815|NCT03634839|Autonomic Agents|autonomic agents|mesh-ancestor
64796816|NCT03634839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64796817|NCT03634839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796818|NCT03634839|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64796819|NCT03634839|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64796820|NCT03634839|Cholinergic Agents|cholinergic agents|mesh-ancestor
64796821|NCT03634839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64796822|NCT03634839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796823|NCT03441061|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
64796824|NCT03441061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64796825|NCT03441061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796826|NCT03441061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64796827|NCT03426904|Leucovorin|leucovorin|mesh-list
64796828|NCT03426904|Fluorouracil|fluorouracil|mesh-list
64796829|NCT03426904|Oxaliplatin|oxaliplatin|mesh-list
64796830|NCT03426904|Antimetabolites|antimetabolites|mesh-ancestor
64796831|NCT03426904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796832|NCT03426904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64796833|NCT03426904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796834|NCT03426904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64796835|NCT03426904|Immunologic Factors|immunologic factors|mesh-ancestor
64796836|NCT03426904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796837|NCT03426904|Antidotes|antidotes|mesh-ancestor
64796838|NCT03426904|Protective Agents|protective agents|mesh-ancestor
64796839|NCT03426904|Vitamin B Complex|vitamin b complex|mesh-ancestor
64796840|NCT03426904|Vitamins|vitamins|mesh-ancestor
64796858|NCT03332667|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64796859|NCT03287778|Pyridoxine|pyridoxine|mesh-list
64796860|NCT03287778|Vitamin B 6|vitamin b 6|mesh-list
64472074|NCT03841097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796861|NCT03287778|Vitamins|vitamins|mesh-ancestor
64796862|NCT03287778|Micronutrients|micronutrients|mesh-ancestor
64796863|NCT03287778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796864|NCT03287778|Vitamin B Complex|vitamin b complex|mesh-ancestor
64796865|NCT03273413|Pravastatin|pravastatin|mesh-list
64407966|NCT04834427|Ketamine|ketamine|mesh-list
64796873|NCT03227458|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64796874|NCT03227458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64796875|NCT03227458|Immunologic Factors|immunologic factors|mesh-ancestor
64796876|NCT03227458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796877|NCT03182244|Cytarabine|cytarabine|mesh-list
64796878|NCT03182244|Fludarabine|fludarabine|mesh-list
64796879|NCT03182244|Etoposide|etoposide|mesh-list
64796880|NCT03182244|Mitoxantrone|mitoxantrone|mesh-list
64796881|NCT03182244|Lenograstim|lenograstim|mesh-list
64796882|NCT03182244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796883|NCT03182244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64796884|NCT03182244|Antimetabolites|antimetabolites|mesh-ancestor
64796885|NCT03182244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796886|NCT03182244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64796887|NCT03182244|Immunologic Factors|immunologic factors|mesh-ancestor
64796888|NCT03182244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796889|NCT03182244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64796890|NCT03182244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64796891|NCT03182244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64796892|NCT03182244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796893|NCT03182244|Antiviral Agents|antiviral agents|mesh-ancestor
64796894|NCT03182244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64796895|NCT03182244|Analgesics|analgesics|mesh-ancestor
64796896|NCT03182244|Sensory System Agents|sensory system agents|mesh-ancestor
64796897|NCT03182244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64796898|NCT03182244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64796900|NCT03141983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64796904|NCT03075527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796905|NCT03074539|Riociguat|riociguat|mesh-list
64796906|NCT03074539|Enzyme Activators|enzyme activators|mesh-ancestor
64796907|NCT03074539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796908|NCT03030131|Durvalumab|durvalumab|mesh-list
64796909|NCT03030131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64796910|NCT03030131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796911|NCT03011021|Liraglutide|liraglutide|mesh-list
64796912|NCT03011021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64796913|NCT03011021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796914|NCT03011021|Incretins|incretins|mesh-ancestor
64796915|NCT03011021|Hormones|hormones|mesh-ancestor
64796916|NCT03011021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64796918|NCT02995252|Liver Extracts|liver extracts|mesh-list
64796919|NCT02995252|Antiviral Agents|antiviral agents|mesh-ancestor
64796920|NCT02995252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64796921|NCT02995252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64796986|NCT02817360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796987|NCT02817360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64796988|NCT02817360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64796989|NCT02817360|Adrenergic Agents|adrenergic agents|mesh-ancestor
64796990|NCT02817360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64796991|NCT02817360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796992|NCT02817360|Antioxidants|antioxidants|mesh-ancestor
64796993|NCT02817360|Protective Agents|protective agents|mesh-ancestor
64796994|NCT02817360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64797025|NCT02689778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797026|NCT02689778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64797027|NCT02689778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64797028|NCT02689778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64797029|NCT02689778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64797030|NCT02689778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797031|NCT02678377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64797032|NCT02678377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64797033|NCT02678377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64797034|NCT02678377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64797106|NCT02537613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797107|NCT02419040|Lidocaine|lidocaine|mesh-list
64797108|NCT02419040|Anesthetics, Local|anesthetics, local|mesh-ancestor
64797109|NCT02419040|Anesthetics|anesthetics|mesh-ancestor
64797110|NCT02419040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64797111|NCT02419040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797112|NCT02419040|Sensory System Agents|sensory system agents|mesh-ancestor
64797113|NCT02419040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64797114|NCT02419040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64797115|NCT02419040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64797116|NCT02419040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64797117|NCT02419040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64797118|NCT02419040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797119|NCT02387203|Amoxicillin|amoxicillin|mesh-list
64797120|NCT02387203|Clarithromycin|clarithromycin|mesh-list
64797121|NCT02387203|Lansoprazole|lansoprazole|mesh-list
64797122|NCT02387203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64797170|NCT01992653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64797171|NCT01992653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64797172|NCT01992653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64797173|NCT01992653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797174|NCT01992653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64797175|NCT01992653|Glucocorticoids|glucocorticoids|mesh-ancestor
64797176|NCT01992653|Hormones|hormones|mesh-ancestor
64797177|NCT01992653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64797178|NCT01992653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64797179|NCT01972217|Prednisone|prednisone|mesh-list
64797180|NCT01972217|Prednisolone|prednisolone|mesh-list
64797181|NCT01972217|Olaparib|olaparib|mesh-list
64797183|NCT01972217|Glucocorticoids|glucocorticoids|mesh-ancestor
64797248|NCT01750567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797249|NCT01696435|Vitamin D|vitamin d|mesh-list
64797250|NCT01696435|Ergocalciferols|ergocalciferols|mesh-list
64797251|NCT01696435|Cholecalciferol|cholecalciferol|mesh-list
64797252|NCT01696435|Vitamins|vitamins|mesh-list
64797253|NCT01696435|Micronutrients|micronutrients|mesh-ancestor
64797254|NCT01696435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797255|NCT01696435|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64797256|NCT01696435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64797257|NCT01682083|Trametinib|trametinib|mesh-list
64797258|NCT01682083|Dabrafenib|dabrafenib|mesh-list
64797259|NCT01682083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797260|NCT01682083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64797261|NCT01682083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797262|NCT01682083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797263|NCT01681264|Guanfacine|guanfacine|mesh-list
64797264|NCT01681264|Morphine|morphine|mesh-list
64797265|NCT01681264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64797266|NCT01681264|Narcotics|narcotics|mesh-ancestor
64797267|NCT01681264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64797268|NCT01681264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797269|NCT01681264|Analgesics|analgesics|mesh-ancestor
64797281|NCT01654276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64797282|NCT01527591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64797283|NCT01527591|Immunologic Factors|immunologic factors|mesh-ancestor
64797284|NCT01527591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797286|NCT00590122|Carbidopa|carbidopa|mesh-list
64797287|NCT00590122|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64797288|NCT00590122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64797289|NCT00590122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64797290|NCT00590122|Dopamine Agents|dopamine agents|mesh-ancestor
64797291|NCT00590122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64472076|NCT03831425|Coenzyme Q10|coenzyme q10|mesh-list
64797299|NCT00309192|Triamcinolone|triamcinolone|mesh-list
64797302|NCT00309192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64797303|NCT00309192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64797304|NCT00309192|Glucocorticoids|glucocorticoids|mesh-ancestor
64797305|NCT00309192|Hormones|hormones|mesh-ancestor
64797306|NCT00309192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64797307|NCT00309192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797308|NCT00309192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64797309|NCT00309192|Immunologic Factors|immunologic factors|mesh-ancestor
64797310|NCT00309192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797311|NCT00309192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797312|NCT00295893|Paclitaxel|paclitaxel|mesh-list
64797313|NCT00295893|Docetaxel|docetaxel|mesh-list
64797314|NCT00295893|Cyclophosphamide|cyclophosphamide|mesh-list
64797315|NCT00295893|Carboplatin|carboplatin|mesh-list
64797316|NCT00295893|Doxorubicin|doxorubicin|mesh-list
64797317|NCT00295893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64797318|NCT00295893|Trastuzumab|trastuzumab|mesh-list
64797319|NCT00295893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64797320|NCT00295893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797321|NCT00295893|Tubulin Modulators|tubulin modulators|mesh-ancestor
64797322|NCT00295893|Antimitotic Agents|antimitotic agents|mesh-ancestor
64797323|NCT00295893|Mitosis Modulators|mitosis modulators|mesh-ancestor
64797324|NCT00295893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797325|NCT00295893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64797326|NCT00295893|Immunologic Factors|immunologic factors|mesh-ancestor
64797328|NCT00295893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64797363|NCT01683786|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64797364|NCT01683786|Antiviral Agents|antiviral agents|mesh-ancestor
64797365|NCT01683786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64797366|NCT01683084|Telmisartan|telmisartan|mesh-list
64797367|NCT01683084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64797368|NCT01683084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64797369|NCT01683084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64797370|NCT01683084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797371|NCT04823442|Bisoprolol|bisoprolol|mesh-list
64797372|NCT04823442|Mirabegron|mirabegron|mesh-list
64797373|NCT04823442|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64797374|NCT04823442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64472077|NCT03831425|Micronutrients|micronutrients|mesh-ancestor
64472078|NCT03831425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797375|NCT04823442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64797376|NCT04823442|Adrenergic Agents|adrenergic agents|mesh-ancestor
64797377|NCT04823442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64797378|NCT04823442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797379|NCT04823442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797380|NCT04823442|Urological Agents|urological agents|mesh-ancestor
64797381|NCT04823442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64797382|NCT04823442|Sympatholytics|sympatholytics|mesh-ancestor
64797383|NCT04823442|Autonomic Agents|autonomic agents|mesh-ancestor
64797384|NCT04823442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64797385|NCT04823442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64797386|NCT04823442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64797387|NCT04823442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64797410|NCT01384578|Tocopherols|tocopherols|mesh-list
64797411|NCT01384578|Tocotrienols|tocotrienols|mesh-list
64797412|NCT01384578|alpha-Tocopherol|alpha-tocopherol|mesh-list
64797413|NCT01384578|Pentoxifylline|pentoxifylline|mesh-list
64797425|NCT01384643|Propofol|propofol|mesh-list
64797426|NCT01384643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64797427|NCT01384643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64797428|NCT01384643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797429|NCT01384643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64797430|NCT01384643|Anesthetics, General|anesthetics, general|mesh-ancestor
64797431|NCT01384643|Anesthetics|anesthetics|mesh-ancestor
64797432|NCT01384656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64797433|NCT01384682|Maraviroc|maraviroc|mesh-list
64797434|NCT01384682|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64797435|NCT01384682|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64797436|NCT01384682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797437|NCT01384682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64797438|NCT01384682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64797439|NCT01384682|Antiviral Agents|antiviral agents|mesh-ancestor
64797440|NCT01384682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64797441|NCT01384682|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64797442|NCT01384695|Proflavine|proflavine|mesh-list
64797443|NCT01384695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64797444|NCT01384695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64797445|NCT01384708|Proflavine|proflavine|mesh-list
64797446|NCT01384708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64797447|NCT01384708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64797448|NCT01384799|Cisplatin|cisplatin|mesh-list
64797450|NCT01384812|Dinoprostone|dinoprostone|mesh-list
64797530|NCT01385683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797531|NCT01385683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797532|NCT01385683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64797533|NCT01385683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64797534|NCT01385683|Antithrombins|antithrombins|mesh-ancestor
64797535|NCT01385683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64797536|NCT01385683|Protease Inhibitors|protease inhibitors|mesh-ancestor
64797537|NCT01385683|Anticoagulants|anticoagulants|mesh-ancestor
64797538|NCT01385735|Rasagiline|rasagiline|mesh-list
64797539|NCT01385735|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64797540|NCT01385735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797541|NCT01385735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797542|NCT01385735|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64797543|NCT01385735|Protective Agents|protective agents|mesh-ancestor
64797598|NCT01386177|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
64797599|NCT01386177|Hallucinogens|hallucinogens|mesh-ancestor
64797600|NCT01386177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797601|NCT01386177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64797602|NCT01386177|Serotonin Agents|serotonin agents|mesh-ancestor
64797603|NCT01386177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64797604|NCT01386177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797613|NCT01386229|Ketamine|ketamine|mesh-list
64797672|NCT01386372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797673|NCT01386372|Natriuretic Agents|natriuretic agents|mesh-ancestor
64797674|NCT01386372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797676|NCT01386398|Vorinostat|vorinostat|mesh-list
64797677|NCT01386398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797678|NCT01386398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64797679|NCT01386398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797680|NCT01386398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797681|NCT01386502|Pidilizumab|pidilizumab|mesh-list
64797682|NCT01386502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64797701|NCT01386567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64797702|NCT01386567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797713|NCT01386580|Doxorubicin|doxorubicin|mesh-list
64797757|NCT01386593|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64797758|NCT01386593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64797759|NCT01386593|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64797760|NCT01386593|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64797761|NCT01386593|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64797762|NCT01386593|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64797764|NCT01386658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64797765|NCT01386658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64797766|NCT01386658|Analgesics|analgesics|mesh-ancestor
64797767|NCT01386658|Sensory System Agents|sensory system agents|mesh-ancestor
64797768|NCT01386658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64797769|NCT01386658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797770|NCT01386658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64797771|NCT01386658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64797772|NCT01386658|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
64472116|NCT03780543|Antiviral Agents|antiviral agents|mesh-ancestor
64472117|NCT03780543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64797773|NCT01386658|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
64797828|NCT01387048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797829|NCT01387048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64797830|NCT01387048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64797831|NCT01387048|Dermatologic Agents|dermatologic agents|mesh-ancestor
64797832|NCT01387048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797833|NCT01387087|Peficitinib|peficitinib|mesh-list
64797834|NCT01387087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797835|NCT01387087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797836|NCT01387087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64797837|NCT01387087|Immunologic Factors|immunologic factors|mesh-ancestor
64797838|NCT01387087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797839|NCT01387191|Epoprostenol|epoprostenol|mesh-list
64797841|NCT01387191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64797904|NCT01387997|Antibodies|antibodies|mesh-list
64797905|NCT01387997|Immunologic Factors|immunologic factors|mesh-ancestor
64797906|NCT01387997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797907|NCT01388023|Chlorhexidine|chlorhexidine|mesh-list
64797908|NCT01388023|Listerine|listerine|mesh-list
64797909|NCT01388023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64797910|NCT01388023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64797911|NCT01388023|Disinfectants|disinfectants|mesh-ancestor
64797912|NCT01388036|Esmolol|esmolol|mesh-list
64797913|NCT01388036|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64797914|NCT01388036|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64797915|NCT01388036|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64797916|NCT01388036|Adrenergic Agents|adrenergic agents|mesh-ancestor
64797917|NCT01388036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64797929|NCT01388075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64797930|NCT01388075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64797931|NCT01388075|Leprostatic Agents|leprostatic agents|mesh-ancestor
64797932|NCT01388075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64797933|NCT01388075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797934|NCT01388075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797935|NCT01388075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64797936|NCT01388075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64797937|NCT01388075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64797938|NCT01388075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64797939|NCT01388075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64472118|NCT03780543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64566549|NCT04265105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64566550|NCT04246229|Bilirubin|bilirubin|mesh-list
64566551|NCT04246229|Antioxidants|antioxidants|mesh-ancestor
64566552|NCT04246229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566553|NCT04246229|Protective Agents|protective agents|mesh-ancestor
64797958|NCT01388114|Antibodies|antibodies|mesh-list
64797959|NCT01388114|Immunologic Factors|immunologic factors|mesh-ancestor
64797960|NCT01388114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797961|NCT01388153|Acarbose|acarbose|mesh-list
64797962|NCT01388153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64797963|NCT01388153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797964|NCT01388153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798024|NCT01388582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64798025|NCT01388582|Progestins|progestins|mesh-ancestor
64798026|NCT01388582|Hormones|hormones|mesh-ancestor
64798027|NCT01388582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64798028|NCT01388595|Fluticasone|fluticasone|mesh-list
64798029|NCT01388595|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64798030|NCT01388595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64798031|NCT01388595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64798032|NCT01388595|Autonomic Agents|autonomic agents|mesh-ancestor
64798033|NCT01388595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64798034|NCT01388595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798035|NCT01388595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64472119|NCT03780543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798036|NCT01388595|Respiratory System Agents|respiratory system agents|mesh-ancestor
64798037|NCT01388595|Dermatologic Agents|dermatologic agents|mesh-ancestor
64798038|NCT01388595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64798039|NCT01388595|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64798054|NCT01388621|Antiviral Agents|antiviral agents|mesh-ancestor
64798055|NCT01388621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64798056|NCT01388621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798057|NCT01388621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64798058|NCT01388621|Immunologic Factors|immunologic factors|mesh-ancestor
64798059|NCT01388621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798060|NCT01388621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64798061|NCT01388621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64798062|NCT01388621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64798063|NCT01388621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64798064|NCT01388660|Clopidogrel|clopidogrel|mesh-list
64798065|NCT01388660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64798081|NCT01388842|Autonomic Agents|autonomic agents|mesh-ancestor
64798082|NCT01388842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64798083|NCT01388842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798084|NCT01388842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64798085|NCT01388842|Respiratory System Agents|respiratory system agents|mesh-ancestor
64798086|NCT01388842|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64798087|NCT01388842|Antioxidants|antioxidants|mesh-ancestor
64798088|NCT01388842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798089|NCT01388842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64798090|NCT01388842|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64798091|NCT01388842|Vasodilator Agents|vasodilator agents|mesh-ancestor
64798092|NCT01388842|Gasotransmitters|gasotransmitters|mesh-ancestor
64798093|NCT01388842|Protective Agents|protective agents|mesh-ancestor
64798094|NCT01388855|Vitamin D|vitamin d|mesh-list
64798095|NCT01388855|Cholecalciferol|cholecalciferol|mesh-list
64798096|NCT01388855|Vitamins|vitamins|mesh-ancestor
64798146|NCT01389271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64798147|NCT01389271|Vasodilator Agents|vasodilator agents|mesh-ancestor
64798148|NCT01389388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64798149|NCT01389388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64798150|NCT01389388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64798151|NCT01389388|Antimetabolites|antimetabolites|mesh-ancestor
64798152|NCT01389388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798153|NCT01389388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64798154|NCT01389388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64798222|NCT01389505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64798223|NCT01389505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798224|NCT01389505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64798225|NCT01389505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64798226|NCT01389505|Growth Substances|growth substances|mesh-ancestor
64798227|NCT01389505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798228|NCT01389505|Growth Inhibitors|growth inhibitors|mesh-ancestor
64798232|NCT01389544|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64798234|NCT01389544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798235|NCT01389544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798236|NCT01389544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64798237|NCT01389544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64798238|NCT01389544|Antiviral Agents|antiviral agents|mesh-ancestor
64798239|NCT01389544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64798240|NCT01389544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64798242|NCT01389544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64798283|NCT01389713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64798284|NCT01389713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64798285|NCT01389713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798286|NCT01389778|Metformin|metformin|mesh-list
64798287|NCT01389778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64798288|NCT01389778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798289|NCT01389791|Magnesium Sulfate|magnesium sulfate|mesh-list
64798290|NCT01389791|Rocuronium|rocuronium|mesh-list
64798291|NCT01389791|Analgesics|analgesics|mesh-ancestor
64798292|NCT01389791|Sensory System Agents|sensory system agents|mesh-ancestor
64398035|NCT02640053|Paclitaxel|paclitaxel|mesh-list
64798326|NCT01390012|BB 1101|bb 1101|mesh-list
64798359|NCT01390324|Sensory System Agents|sensory system agents|mesh-ancestor
64798360|NCT01390324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409492|NCT04992481|Fluorides|fluorides|mesh-list
64798369|NCT01390324|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64798370|NCT01390324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64798371|NCT01390324|Serotonin Agents|serotonin agents|mesh-ancestor
64798372|NCT01390324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64798373|NCT01390337|Cytarabine|cytarabine|mesh-list
64798374|NCT01390337|Daunorubicin|daunorubicin|mesh-list
64798375|NCT01390337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64798376|NCT01390337|Antimetabolites|antimetabolites|mesh-ancestor
64798377|NCT01390337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798378|NCT01390337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798379|NCT01390337|Antiviral Agents|antiviral agents|mesh-ancestor
64798380|NCT01390337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64798381|NCT01390337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64798426|NCT01390766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64798427|NCT01390766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798444|NCT01390883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64798445|NCT01390883|Protease Inhibitors|protease inhibitors|mesh-ancestor
64798446|NCT01390883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798447|NCT01390883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798449|NCT01390883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64798450|NCT01390883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64798451|NCT01390896|PENTA|penta|mesh-list
64798452|NCT01390896|Fondaparinux|fondaparinux|mesh-list
64798453|NCT01390896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64798454|NCT01390896|Antithrombins|antithrombins|mesh-ancestor
64798455|NCT01390896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64798456|NCT01390896|Protease Inhibitors|protease inhibitors|mesh-ancestor
64798457|NCT01390896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798515|NCT01391156|Finasteride|finasteride|mesh-list
64798516|NCT01391156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64798517|NCT01391156|Vasodilator Agents|vasodilator agents|mesh-ancestor
64798518|NCT01391156|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64798519|NCT01391156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64798520|NCT01391156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798521|NCT01391156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798522|NCT01391156|Hormone Antagonists|hormone antagonists|mesh-ancestor
64798523|NCT01391156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64798524|NCT01391156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798525|NCT01391156|Urological Agents|urological agents|mesh-ancestor
64798526|NCT01391221|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64798527|NCT01391221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64798528|NCT01391221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64798529|NCT01391221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64798530|NCT01391221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798531|NCT01391221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64798532|NCT01391221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798533|NCT01391221|Analgesics|analgesics|mesh-ancestor
64798534|NCT01391221|Sensory System Agents|sensory system agents|mesh-ancestor
64798536|NCT01391221|Antidepressive Agents|antidepressive agents|mesh-ancestor
64798575|NCT01391572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64798576|NCT01391572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64798577|NCT01391572|Immunologic Factors|immunologic factors|mesh-ancestor
64798578|NCT01391572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798579|NCT01391598|Lidocaine|lidocaine|mesh-list
64798580|NCT01391598|Anesthetics, Local|anesthetics, local|mesh-ancestor
64798581|NCT01391598|Anesthetics|anesthetics|mesh-ancestor
64798582|NCT01391598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64798583|NCT01391598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798584|NCT01391598|Sensory System Agents|sensory system agents|mesh-ancestor
64798585|NCT01391598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64798586|NCT01391598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64798587|NCT01391598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64798588|NCT01391598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64798589|NCT01391598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64798590|NCT01391598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798591|NCT01391624|Mineral Oil|mineral oil|mesh-list
64798592|NCT01391624|Emollients|emollients|mesh-ancestor
64798593|NCT01391624|Dermatologic Agents|dermatologic agents|mesh-ancestor
64798638|NCT01392157|Levonorgestrel|levonorgestrel|mesh-list
64798639|NCT01392157|Trace Elements|trace elements|mesh-ancestor
64798640|NCT01392157|Micronutrients|micronutrients|mesh-ancestor
64798641|NCT01392157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798642|NCT01392157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64798643|NCT01392157|Contraceptive Agents|contraceptive agents|mesh-ancestor
64798644|NCT01392157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64798645|NCT01392157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64798646|NCT01392157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64798647|NCT01392157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64798648|NCT01392209|Bevacizumab|bevacizumab|mesh-list
64798649|NCT01392209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64798650|NCT01392209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798651|NCT01392209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64798652|NCT01392209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64798653|NCT01392209|Growth Substances|growth substances|mesh-ancestor
64798654|NCT01392209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798706|NCT01392638|Vasodilator Agents|vasodilator agents|mesh-ancestor
64798707|NCT01392638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64798708|NCT01392638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64798709|NCT01392638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798710|NCT01392638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798711|NCT01392638|Urological Agents|urological agents|mesh-ancestor
64798712|NCT01392716|Rituximab|rituximab|mesh-list
64798713|NCT01392716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64798714|NCT01392716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798715|NCT01392716|Immunologic Factors|immunologic factors|mesh-ancestor
64798716|NCT01392716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798717|NCT01392716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64798718|NCT01392755|Ritonavir|ritonavir|mesh-list
64798719|NCT01392755|Omeprazole|omeprazole|mesh-list
64798720|NCT01392755|Ranitidine|ranitidine|mesh-list
64798721|NCT01392755|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
64798754|NCT01392807|Naloxegol|naloxegol|mesh-list
64798782|NCT01392833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798783|NCT01392833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64798784|NCT01392833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64798785|NCT01392833|Immunologic Factors|immunologic factors|mesh-ancestor
64798786|NCT01392833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64798787|NCT01392898|Liraglutide|liraglutide|mesh-list
64798788|NCT01392898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64409930|NCT04240821|Purinergic Agents|purinergic agents|mesh-ancestor
64798798|NCT01392911|Leprostatic Agents|leprostatic agents|mesh-ancestor
64798799|NCT01392911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64798800|NCT01392911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798801|NCT01392911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798851|NCT01393288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798852|NCT01393288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64798853|NCT01393288|Antipruritics|antipruritics|mesh-ancestor
64567458|NCT04954014|Bevacizumab|bevacizumab|mesh-list
64798864|NCT01393288|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64798866|NCT01393288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64798867|NCT01393288|GABA Modulators|gaba modulators|mesh-ancestor
64798868|NCT01393288|GABA Agents|gaba agents|mesh-ancestor
64798869|NCT01393340|Omalizumab|omalizumab|mesh-list
64798870|NCT01393340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64798871|NCT01393340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64798872|NCT01393340|Respiratory System Agents|respiratory system agents|mesh-ancestor
64798873|NCT01393548|Brompheniramine|brompheniramine|mesh-list
64798943|NCT01393795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64798944|NCT01393795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798945|NCT01393912|Crenolanib|crenolanib|mesh-list
64798946|NCT01393912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798947|NCT01393925|Parecoxib|parecoxib|mesh-list
64798948|NCT01393925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64798949|NCT01393925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64798950|NCT01393925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798951|NCT01393925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798952|NCT01393925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64798953|NCT01393925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64798954|NCT01393925|Analgesics|analgesics|mesh-ancestor
64798955|NCT01393925|Sensory System Agents|sensory system agents|mesh-ancestor
64798956|NCT01393925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64798957|NCT01393925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798958|NCT01393925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64798959|NCT01393925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64798960|NCT01394029|Deferasirox|deferasirox|mesh-list
64798961|NCT01394029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64798962|NCT01394029|Chelating Agents|chelating agents|mesh-ancestor
64798963|NCT01394029|Sequestering Agents|sequestering agents|mesh-ancestor
64798964|NCT01394029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798965|NCT01394094|Calcium|calcium|mesh-list
64798966|NCT01394094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64798967|NCT01394094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798968|NCT01394133|Ritonavir|ritonavir|mesh-list
64798969|NCT01394133|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64798970|NCT01394133|Tenofovir|tenofovir|mesh-list
64798971|NCT01394133|Emtricitabine|emtricitabine|mesh-list
64798972|NCT01394133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64798973|NCT01394133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64798999|NCT01394354|Doxorubicin|doxorubicin|mesh-list
64799000|NCT01394354|Bortezomib|bortezomib|mesh-list
64799001|NCT01394354|Vorinostat|vorinostat|mesh-list
64799002|NCT01394354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64799003|NCT01394354|Antiemetics|antiemetics|mesh-ancestor
64799004|NCT01394354|Autonomic Agents|autonomic agents|mesh-ancestor
64567610|NCT01457131|Fludarabine|fludarabine|mesh-list
64799005|NCT01394354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64945443|NCT05633615|Alkylating Agents|alkylating agents|mesh-ancestor
64799007|NCT01394354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64799071|NCT01394471|Oxytocics|oxytocics|mesh-ancestor
64799072|NCT01394471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64799073|NCT01394471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799074|NCT01394497|Acetylcysteine|acetylcysteine|mesh-list
64799075|NCT01394497|Antiviral Agents|antiviral agents|mesh-ancestor
64799076|NCT01394497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64799077|NCT01394497|Expectorants|expectorants|mesh-ancestor
64799078|NCT01394497|Respiratory System Agents|respiratory system agents|mesh-ancestor
64799079|NCT01394497|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64799080|NCT01394497|Antioxidants|antioxidants|mesh-ancestor
64567692|NCT03058536|Hormones|hormones|mesh-ancestor
64799081|NCT01394497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799082|NCT01394497|Protective Agents|protective agents|mesh-ancestor
64799083|NCT01394497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799084|NCT01394640|Vaccines|vaccines|mesh-list
64799085|NCT01394640|Immunologic Factors|immunologic factors|mesh-ancestor
64799086|NCT01394640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799087|NCT01394653|Ramosetron|ramosetron|mesh-list
64799088|NCT01394653|Antiemetics|antiemetics|mesh-ancestor
64799089|NCT01394653|Autonomic Agents|autonomic agents|mesh-ancestor
64799090|NCT01394653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64799091|NCT01394653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799092|NCT01394653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64799093|NCT01394653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64799094|NCT01394653|Serotonin Agents|serotonin agents|mesh-ancestor
64799095|NCT01394653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64799096|NCT01394653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799097|NCT01394679|Deoxyglucose|deoxyglucose|mesh-list
64799098|NCT01394679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799099|NCT01394679|Antimetabolites|antimetabolites|mesh-ancestor
64799100|NCT01394679|Antiviral Agents|antiviral agents|mesh-ancestor
64799101|NCT01394679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64799102|NCT01394731|Acetaminophen|acetaminophen|mesh-list
64799121|NCT01394757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64799123|NCT01394757|Anesthetics|anesthetics|mesh-ancestor
64799124|NCT01394757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64799125|NCT01394757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64799126|NCT01394757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64799127|NCT01394757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64799128|NCT01394757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799129|NCT01394757|Antidepressive Agents|antidepressive agents|mesh-ancestor
64799130|NCT01394757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64799131|NCT01394770|Amlodipine|amlodipine|mesh-list
64799140|NCT01394796|Antioxidants|antioxidants|mesh-ancestor
64799205|NCT01395147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64799206|NCT01395147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64799207|NCT01395147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64799208|NCT01395147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64799209|NCT01395147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799210|NCT01395147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64799211|NCT01395147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64799212|NCT01395147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64799213|NCT01395147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799214|NCT01395147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64799215|NCT01395147|Serotonin Agents|serotonin agents|mesh-ancestor
64799216|NCT01395147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64799217|NCT01395147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64410379|NCT05189535|Paclitaxel|paclitaxel|mesh-list
64799227|NCT01395199|Vasodilator Agents|vasodilator agents|mesh-ancestor
64799228|NCT01395251|Prednisolone|prednisolone|mesh-list
64799229|NCT01395251|Glucocorticoids|glucocorticoids|mesh-list
64799230|NCT01395251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64799231|NCT01395251|Hormones|hormones|mesh-ancestor
64799232|NCT01395251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64799266|NCT01395433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64799267|NCT01395433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799268|NCT01395433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64799269|NCT01395433|Serotonin Agents|serotonin agents|mesh-ancestor
64799270|NCT01395433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799271|NCT01395433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64799272|NCT01395433|Antidepressive Agents|antidepressive agents|mesh-ancestor
64799273|NCT01395433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64799274|NCT01395433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64799275|NCT01395433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64799276|NCT01395433|Parasympatholytics|parasympatholytics|mesh-ancestor
64799277|NCT01395433|Autonomic Agents|autonomic agents|mesh-ancestor
64799278|NCT01395433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64799279|NCT01395433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64799280|NCT01395433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64799281|NCT01395433|Cholinergic Agents|cholinergic agents|mesh-ancestor
64799293|NCT01395602|Dopamine Agents|dopamine agents|mesh-ancestor
64799294|NCT01395602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64799295|NCT01395602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799296|NCT01395602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799328|NCT01395667|Antidotes|antidotes|mesh-ancestor
64799329|NCT01395667|Protective Agents|protective agents|mesh-ancestor
64799330|NCT01395667|Vitamin B Complex|vitamin b complex|mesh-ancestor
64799331|NCT01395667|Vitamins|vitamins|mesh-ancestor
64799332|NCT01395667|Micronutrients|micronutrients|mesh-ancestor
64799333|NCT01395732|Bosentan|bosentan|mesh-list
64799334|NCT01395732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64799335|NCT01395732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64799336|NCT01395732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799337|NCT01395849|Fluticasone|fluticasone|mesh-list
64799338|NCT01395849|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64799339|NCT01395849|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64799340|NCT01395849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64799341|NCT01395849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64799342|NCT01395849|Autonomic Agents|autonomic agents|mesh-ancestor
64799343|NCT01395849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64799344|NCT01395849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799345|NCT01395849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64799346|NCT01395849|Respiratory System Agents|respiratory system agents|mesh-ancestor
64799347|NCT01395849|Dermatologic Agents|dermatologic agents|mesh-ancestor
64799358|NCT01395849|Sympathomimetics|sympathomimetics|mesh-ancestor
64799391|NCT01395875|Respiratory System Agents|respiratory system agents|mesh-ancestor
64799392|NCT01395875|Dermatologic Agents|dermatologic agents|mesh-ancestor
64799393|NCT01395875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64799394|NCT01395875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64799395|NCT01395875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64799396|NCT01395875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64799397|NCT01395875|Adrenergic Agents|adrenergic agents|mesh-ancestor
64799398|NCT01395875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64799399|NCT01395875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799400|NCT01395875|Cholinergic Agents|cholinergic agents|mesh-ancestor
64799401|NCT01395927|Canagliflozin|canagliflozin|mesh-list
64799402|NCT01395927|Rifampin|rifampin|mesh-list
64799403|NCT01395927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64799404|NCT01395927|Antitubercular Agents|antitubercular agents|mesh-ancestor
64799405|NCT01395927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64799406|NCT01395927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64799407|NCT01395927|Leprostatic Agents|leprostatic agents|mesh-ancestor
64799408|NCT01395927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64799409|NCT01395927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799410|NCT01395927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799411|NCT01395927|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64799412|NCT01395927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64799419|NCT01395927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799420|NCT01395953|Buspirone|buspirone|mesh-list
64799421|NCT01395953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64799422|NCT01395953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64799423|NCT01395953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64799424|NCT01395953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799425|NCT01395953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64799426|NCT01395953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64799427|NCT01395953|Serotonin Agents|serotonin agents|mesh-ancestor
64799428|NCT01395953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64799429|NCT01395953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799430|NCT01395992|Asenapine|asenapine|mesh-list
64799431|NCT01395992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64799433|NCT01395992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64799434|NCT01395992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799435|NCT01395992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64799436|NCT01396200|Hydroxychloroquine|hydroxychloroquine|mesh-list
64799437|NCT01396200|Sirolimus|sirolimus|mesh-list
64799438|NCT01396200|Antimalarials|antimalarials|mesh-ancestor
64799439|NCT01396200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64799440|NCT01396200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64799441|NCT01396200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64799442|NCT01396200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799443|NCT01396200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799444|NCT01396200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64799445|NCT01396200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64799446|NCT01396200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64799447|NCT01396200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799448|NCT01396200|Antifungal Agents|antifungal agents|mesh-ancestor
64799449|NCT01396200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64799450|NCT01396200|Immunologic Factors|immunologic factors|mesh-ancestor
64799451|NCT01396200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799452|NCT01396291|Asenapine|asenapine|mesh-list
64799453|NCT01396291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64799454|NCT01396291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64799455|NCT01396291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64799456|NCT01396291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799494|NCT01396681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799495|NCT01396681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64799496|NCT01396681|Antimetabolites|antimetabolites|mesh-ancestor
64799497|NCT01396681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799498|NCT01396681|Antiviral Agents|antiviral agents|mesh-ancestor
64799499|NCT01396681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64799500|NCT01396681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799501|NCT01396681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64799502|NCT01396681|Immunologic Factors|immunologic factors|mesh-ancestor
64799503|NCT01396681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799504|NCT01396707|Capecitabine|capecitabine|mesh-list
64799505|NCT01396707|Oxaliplatin|oxaliplatin|mesh-list
64799506|NCT01396707|Trastuzumab|trastuzumab|mesh-list
64799507|NCT01396707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64799508|NCT01396707|Antimetabolites|antimetabolites|mesh-ancestor
64799509|NCT01396707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799510|NCT01396707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799511|NCT01396707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64799512|NCT01396720|Fluvoxamine|fluvoxamine|mesh-list
64799513|NCT01396720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64799514|NCT01396720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64799536|NCT01396733|Vitamins|vitamins|mesh-ancestor
64799558|NCT01397019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472147|NCT03772314|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64799559|NCT01397019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799560|NCT01397019|Antidotes|antidotes|mesh-ancestor
64799561|NCT01397019|Protective Agents|protective agents|mesh-ancestor
64799562|NCT01397019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799563|NCT01397019|Vitamin B Complex|vitamin b complex|mesh-ancestor
64799564|NCT01397019|Vitamins|vitamins|mesh-ancestor
64799565|NCT01397019|Micronutrients|micronutrients|mesh-ancestor
64799566|NCT01397097|Etonogestrel|etonogestrel|mesh-list
64799567|NCT01397097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64799568|NCT01397097|Contraceptive Agents|contraceptive agents|mesh-ancestor
64799569|NCT01397097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64799570|NCT01397097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799571|NCT01397097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64799572|NCT01397175|Everolimus|everolimus|mesh-list
64799573|NCT01397175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799574|NCT01397175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64799575|NCT01397175|Immunologic Factors|immunologic factors|mesh-ancestor
64799576|NCT01397175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799577|NCT01397214|Megestrol Acetate|megestrol acetate|mesh-list
64799578|NCT01397214|Megestrol|megestrol|mesh-list
64799579|NCT01397214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64799580|NCT01397214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799581|NCT01397214|Appetite Stimulants|appetite stimulants|mesh-ancestor
64799582|NCT01397214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64799583|NCT01397214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799584|NCT01397214|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64799585|NCT01397214|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64799586|NCT01397214|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64799587|NCT01397214|Contraceptive Agents|contraceptive agents|mesh-ancestor
64799588|NCT01397214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64799599|NCT01397331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64799600|NCT01397331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64799601|NCT01397331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799602|NCT01397331|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64799609|NCT05268835|Clindamycin|clindamycin|mesh-list
64799697|NCT04604353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799698|NCT04500756|Metformin|metformin|mesh-list
64799699|NCT04500756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64799700|NCT04500756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799701|NCT04472416|Analgesics|analgesics|mesh-list
64799702|NCT04472416|Sensory System Agents|sensory system agents|mesh-ancestor
64799703|NCT04472416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64799704|NCT04472416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799705|NCT04466540|Hydroxychloroquine|hydroxychloroquine|mesh-list
64799706|NCT04466540|Antimalarials|antimalarials|mesh-ancestor
64799707|NCT04466540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64799708|NCT04466540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64799709|NCT04466540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64799768|NCT03245827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64799769|NCT03245827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799770|NCT03245827|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64799771|NCT03245827|Fertility Agents|fertility agents|mesh-ancestor
64799772|NCT03245827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64799773|NCT03245827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64799774|NCT03245827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64799775|NCT03129321|Econazole|econazole|mesh-list
64799776|NCT03129321|Antifungal Agents|antifungal agents|mesh-ancestor
64799777|NCT03129321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64799840|NCT02094716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799841|NCT02094716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799842|NCT01460810|Silicon|silicon|mesh-list
64799843|NCT01460810|Trace Elements|trace elements|mesh-ancestor
64799844|NCT01460810|Micronutrients|micronutrients|mesh-ancestor
64799845|NCT01460810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799936|NCT05273398|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64799937|NCT05273398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64799938|NCT05273398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64799939|NCT05273398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64799940|NCT05273398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64799941|NCT05273398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64799942|NCT05273398|Anesthetics, General|anesthetics, general|mesh-ancestor
64799943|NCT05273398|Anesthetics|anesthetics|mesh-ancestor
64799944|NCT05273398|GABA Modulators|gaba modulators|mesh-ancestor
64799945|NCT05273398|GABA Agents|gaba agents|mesh-ancestor
64799946|NCT05273398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64799947|NCT05273398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799948|NCT05272839|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64799949|NCT05272839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799950|NCT05272462|Minoxidil|minoxidil|mesh-list
64799951|NCT05272462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64799952|NCT05272462|Vasodilator Agents|vasodilator agents|mesh-ancestor
64799953|NCT05272371|Dinutuximab|dinutuximab|mesh-list
64799954|NCT05272371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799955|NCT05271539|Dexamethasone|dexamethasone|mesh-list
64799956|NCT05271539|Ranibizumab|ranibizumab|mesh-list
64799957|NCT05271539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64799958|NCT05271539|Antiemetics|antiemetics|mesh-ancestor
64799959|NCT05271539|Autonomic Agents|autonomic agents|mesh-ancestor
64799960|NCT05271539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64799961|NCT05271539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799962|NCT05271539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64799963|NCT05271539|Glucocorticoids|glucocorticoids|mesh-ancestor
64799964|NCT05271539|Hormones|hormones|mesh-ancestor
64799965|NCT05271539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64799966|NCT05271539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64799967|NCT05271539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799994|NCT05271370|Immunologic Factors|immunologic factors|mesh-ancestor
64799995|NCT05271370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799996|NCT05271253|Dexmedetomidine|dexmedetomidine|mesh-list
64799997|NCT05271253|Bupivacaine|bupivacaine|mesh-list
64799998|NCT05271253|Anesthetics, Local|anesthetics, local|mesh-ancestor
64799999|NCT05271253|Anesthetics|anesthetics|mesh-ancestor
64800000|NCT05271253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64800001|NCT05271253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800002|NCT05271253|Sensory System Agents|sensory system agents|mesh-ancestor
64800003|NCT05271253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800004|NCT05271253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64800005|NCT05271253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64800006|NCT05271253|Analgesics|analgesics|mesh-ancestor
64800007|NCT05271253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64800008|NCT05271253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64800009|NCT05271253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64800010|NCT05271253|Adrenergic Agents|adrenergic agents|mesh-ancestor
64472150|NCT03772314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64800012|NCT05271253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800013|NCT05271188|Anesthetics|anesthetics|mesh-list
64800014|NCT05271188|Anesthetics, Local|anesthetics, local|mesh-list
64800015|NCT05271188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64800016|NCT05271188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800062|NCT05270434|Narcotics|narcotics|mesh-ancestor
64800063|NCT05270434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64800064|NCT05270434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800065|NCT05270434|Sensory System Agents|sensory system agents|mesh-ancestor
64800066|NCT05270434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800067|NCT05270434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64800068|NCT05270434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64800069|NCT05270434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64800070|NCT05270434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64800071|NCT05270434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64800072|NCT05270434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64800073|NCT05270434|Antipyretics|antipyretics|mesh-ancestor
64800074|NCT05270421|Furosemide|furosemide|mesh-list
64800075|NCT05270421|Diuretics|diuretics|mesh-ancestor
64800076|NCT05270421|Natriuretic Agents|natriuretic agents|mesh-ancestor
64800077|NCT05270421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800078|NCT05270421|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64800079|NCT05270421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64800080|NCT05270421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800081|NCT05270382|Cetylpyridinium|cetylpyridinium|mesh-list
64800082|NCT05270382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64800083|NCT05270382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64800084|NCT05270343|Cholecalciferol|cholecalciferol|mesh-list
64800085|NCT05270343|Vitamin D|vitamin d|mesh-list
64800119|NCT05250141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800120|NCT05250141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800121|NCT05250141|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64800122|NCT05250141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800123|NCT05248724|Ketorolac|ketorolac|mesh-list
64800124|NCT05248724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64800125|NCT05248724|Epinephrine|epinephrine|mesh-list
64800126|NCT05248724|Racepinephrine|racepinephrine|mesh-list
64800127|NCT05248724|Morphine|morphine|mesh-list
64800128|NCT05248724|Ropivacaine|ropivacaine|mesh-list
64800129|NCT05248724|Epinephryl borate|epinephryl borate|mesh-list
64800130|NCT05248724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64800131|NCT05248724|Narcotics|narcotics|mesh-ancestor
64800132|NCT05248724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64800133|NCT05248724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800134|NCT05248724|Analgesics|analgesics|mesh-ancestor
64800135|NCT05248724|Sensory System Agents|sensory system agents|mesh-ancestor
64800136|NCT05248724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800137|NCT05248724|Anesthetics, Local|anesthetics, local|mesh-ancestor
64800138|NCT05248724|Anesthetics|anesthetics|mesh-ancestor
64800139|NCT05248724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64800140|NCT05248724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64800141|NCT05248724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64800142|NCT05248724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64800143|NCT05248724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64800144|NCT05248724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800169|NCT05209841|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64411312|NCT04426409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64800193|NCT05173142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64800194|NCT05173142|Immunologic Factors|immunologic factors|mesh-ancestor
64800195|NCT05173142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800196|NCT05173142|Tubulin Modulators|tubulin modulators|mesh-ancestor
64800197|NCT05173142|Antimitotic Agents|antimitotic agents|mesh-ancestor
64800198|NCT05173142|Mitosis Modulators|mitosis modulators|mesh-ancestor
64800200|NCT05166746|Clindamycin palmitate|clindamycin palmitate|mesh-list
64800201|NCT05166746|Clindamycin phosphate|clindamycin phosphate|mesh-list
64800202|NCT05166746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64800203|NCT05166746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64800204|NCT05166746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64800205|NCT05166746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800206|NCT05166746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800207|NCT05165875|Hydrocortisone|hydrocortisone|mesh-list
64800208|NCT05165875|Lidocaine|lidocaine|mesh-list
64800209|NCT05165875|Anesthetics, Local|anesthetics, local|mesh-ancestor
64800210|NCT05165875|Anesthetics|anesthetics|mesh-ancestor
64800211|NCT05165875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64800212|NCT05165875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800255|NCT05138029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800256|NCT05138029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800257|NCT05138029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64800258|NCT05138029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64800259|NCT05138029|Growth Substances|growth substances|mesh-ancestor
64800260|NCT05138029|Growth Inhibitors|growth inhibitors|mesh-ancestor
64800261|NCT05135039|Canagliflozin|canagliflozin|mesh-list
64800262|NCT05135039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64800263|NCT05135039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800264|NCT05135039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64800265|NCT05135039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800266|NCT05128591|Rivaroxaban|rivaroxaban|mesh-list
64800267|NCT05128591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64800268|NCT05128591|Antithrombins|antithrombins|mesh-ancestor
64800269|NCT05128591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64800270|NCT05128591|Protease Inhibitors|protease inhibitors|mesh-ancestor
64800271|NCT05128591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800272|NCT05128591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800273|NCT05128591|Anticoagulants|anticoagulants|mesh-ancestor
64800274|NCT05088928|Rivaroxaban|rivaroxaban|mesh-list
64800275|NCT05088928|Apixaban|apixaban|mesh-list
64800276|NCT05088928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64800277|NCT05088928|Antithrombins|antithrombins|mesh-ancestor
64800278|NCT05088928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64800279|NCT05088928|Protease Inhibitors|protease inhibitors|mesh-ancestor
64800280|NCT05088928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800281|NCT05088928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800282|NCT05088928|Anticoagulants|anticoagulants|mesh-ancestor
64800283|NCT05075122|Pembrolizumab|pembrolizumab|mesh-list
64800284|NCT05075122|Sargramostim|sargramostim|mesh-list
64800299|NCT05067439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64800300|NCT05067439|Purinergic Agents|purinergic agents|mesh-ancestor
64800314|NCT05067439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64800315|NCT05067439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64800317|NCT05064137|Fluorides|fluorides|mesh-list
64800318|NCT05064137|Sodium Fluoride|sodium fluoride|mesh-list
64800319|NCT05064137|Fluorides, Topical|fluorides, topical|mesh-list
64800320|NCT05064137|Cariostatic Agents|cariostatic agents|mesh-ancestor
64800321|NCT05064137|Protective Agents|protective agents|mesh-ancestor
64800322|NCT05064137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800323|NCT05064137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64800324|NCT05064137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64800325|NCT05052528|Cyclophosphamide|cyclophosphamide|mesh-list
64800326|NCT05052528|Rituximab|rituximab|mesh-list
64800327|NCT05052528|Fludarabine|fludarabine|mesh-list
64800328|NCT05052528|Fludarabine phosphate|fludarabine phosphate|mesh-list
64800329|NCT05052528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64800330|NCT05052528|Antibodies|antibodies|mesh-list
64800331|NCT05052528|Immunoglobulins|immunoglobulins|mesh-list
64800332|NCT05052528|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64800333|NCT05052528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64800334|NCT05052528|Immunologic Factors|immunologic factors|mesh-ancestor
64800335|NCT05052528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800336|NCT05052528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64800377|NCT05007561|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64800378|NCT05007561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64800379|NCT05007561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800380|NCT05007561|Sensory System Agents|sensory system agents|mesh-ancestor
64800381|NCT05007561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800382|NCT04961801|Methotrexate|methotrexate|mesh-list
64800383|NCT04961801|Acalabrutinib|acalabrutinib|mesh-list
64800384|NCT04961801|Tacrolimus|tacrolimus|mesh-list
64800385|NCT04961801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64800386|NCT04961801|Abortifacient Agents|abortifacient agents|mesh-ancestor
64800387|NCT04961801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64800388|NCT04961801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472153|NCT03772314|Sympathomimetics|sympathomimetics|mesh-ancestor
64472154|NCT03772314|Autonomic Agents|autonomic agents|mesh-ancestor
64800443|NCT04768829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64800444|NCT04760912|Bromides|bromides|mesh-list
64800445|NCT04760912|Anesthetics|anesthetics|mesh-list
64800446|NCT04760912|Rocuronium|rocuronium|mesh-list
64800447|NCT04760912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64800448|NCT04760912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800449|NCT04760912|Anticonvulsants|anticonvulsants|mesh-ancestor
64800450|NCT04760912|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64800454|NCT04710641|Sorafenib|sorafenib|mesh-list
64800526|NCT04433390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800527|NCT04433390|Sensory System Agents|sensory system agents|mesh-ancestor
64800528|NCT04433390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800529|NCT04399746|Cholecalciferol|cholecalciferol|mesh-list
64800530|NCT04399746|Vitamin D|vitamin d|mesh-list
64800531|NCT04399746|Azithromycin|azithromycin|mesh-list
64800532|NCT04399746|Ivermectin|ivermectin|mesh-list
64800533|NCT04399746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64800534|NCT04399746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800535|NCT04399746|Vitamins|vitamins|mesh-ancestor
64800536|NCT04399746|Micronutrients|micronutrients|mesh-ancestor
64800537|NCT04399746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64800538|NCT04399746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64800539|NCT04399746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64800540|NCT04399746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64800541|NCT04391608|Tenofovir|tenofovir|mesh-list
64800542|NCT04391608|Antiviral Agents|antiviral agents|mesh-ancestor
64800543|NCT04391608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64800602|NCT04238845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800603|NCT04223037|Vaccines|vaccines|mesh-list
64800604|NCT04223037|Immunologic Factors|immunologic factors|mesh-ancestor
64800605|NCT04223037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800606|NCT04186663|Fluorides|fluorides|mesh-list
64800607|NCT04186663|Cariostatic Agents|cariostatic agents|mesh-ancestor
64800608|NCT04186663|Protective Agents|protective agents|mesh-ancestor
64800609|NCT04186663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800610|NCT04108026|Durvalumab|durvalumab|mesh-list
64800613|NCT04095104|Topiramate|topiramate|mesh-list
64800677|NCT03883412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800678|NCT03883412|Incretins|incretins|mesh-ancestor
64800679|NCT03883412|Hormones|hormones|mesh-ancestor
64800680|NCT03883412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64800681|NCT03867682|Venetoclax|venetoclax|mesh-list
64800682|NCT03867682|Lintuzumab|lintuzumab|mesh-list
64800683|NCT03867682|Spironolactone|spironolactone|mesh-list
64800684|NCT03867682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800685|NCT03867682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64800686|NCT03867682|Hormone Antagonists|hormone antagonists|mesh-ancestor
64411821|NCT05546879|Growth Substances|growth substances|mesh-ancestor
64800710|NCT03845270|Antimitotic Agents|antimitotic agents|mesh-ancestor
64800711|NCT03845270|Mitosis Modulators|mitosis modulators|mesh-ancestor
64800712|NCT03845270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800713|NCT03845270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64800715|NCT03777462|Paclitaxel|paclitaxel|mesh-list
64800716|NCT03777462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64800717|NCT03777462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64800718|NCT03777462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800719|NCT03777462|Tubulin Modulators|tubulin modulators|mesh-ancestor
64800720|NCT03777462|Antimitotic Agents|antimitotic agents|mesh-ancestor
64800739|NCT03758170|Hormones|hormones|mesh-ancestor
64800771|NCT03661996|Lidocaine|lidocaine|mesh-list
64800772|NCT03661996|Epinephrine|epinephrine|mesh-list
64800773|NCT03661996|Capsaicin|capsaicin|mesh-list
64800774|NCT03661996|Anesthetics, Local|anesthetics, local|mesh-ancestor
64800775|NCT03661996|Anesthetics|anesthetics|mesh-ancestor
64800776|NCT03661996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64800777|NCT03661996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800778|NCT03661996|Sensory System Agents|sensory system agents|mesh-ancestor
64800779|NCT03661996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800780|NCT03661996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64800781|NCT03661996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64800782|NCT03661996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64800783|NCT03661996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64800784|NCT03661996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800785|NCT03661996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64800786|NCT03661996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64800787|NCT03661996|Adrenergic Agents|adrenergic agents|mesh-ancestor
64800788|NCT03661996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64800789|NCT03661996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64800790|NCT03661996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64800791|NCT03661996|Autonomic Agents|autonomic agents|mesh-ancestor
64800792|NCT03661996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64800793|NCT03661996|Respiratory System Agents|respiratory system agents|mesh-ancestor
64800794|NCT03661996|Mydriatics|mydriatics|mesh-ancestor
64800795|NCT03661996|Sympathomimetics|sympathomimetics|mesh-ancestor
64800796|NCT03661996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64800797|NCT03661996|Antipruritics|antipruritics|mesh-ancestor
64800798|NCT03661996|Dermatologic Agents|dermatologic agents|mesh-ancestor
64800799|NCT03659799|Insulin|insulin|mesh-list
64800806|NCT03620903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64800808|NCT03620903|Immunologic Factors|immunologic factors|mesh-ancestor
64800822|NCT03563690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800823|NCT03563690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800824|NCT03555877|Letrozole|letrozole|mesh-list
64800825|NCT03555877|Fulvestrant|fulvestrant|mesh-list
64800826|NCT03555877|Anastrozole|anastrozole|mesh-list
64800827|NCT03555877|Exemestane|exemestane|mesh-list
64800828|NCT03555877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800829|NCT03555877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64800830|NCT03555877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64800831|NCT03555877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800832|NCT03555877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800833|NCT03555877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64800834|NCT03555877|Hormone Antagonists|hormone antagonists|mesh-ancestor
64800835|NCT03555877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64800836|NCT03555877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800837|NCT03555877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64800838|NCT03555877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64800839|NCT03522584|Durvalumab|durvalumab|mesh-list
64800840|NCT03522584|Ipilimumab|ipilimumab|mesh-list
64800841|NCT03522584|Tremelimumab|tremelimumab|mesh-list
64800842|NCT03522584|Immunoglobulins|immunoglobulins|mesh-list
64800843|NCT03522584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64800881|NCT03359239|Immunologic Factors|immunologic factors|mesh-ancestor
64800882|NCT03359239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800883|NCT03332173|Zanubrutinib|zanubrutinib|mesh-list
64800884|NCT03332173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800885|NCT03332173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64800886|NCT03332173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800887|NCT03332173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800888|NCT03328676|Chlorophyllin|chlorophyllin|mesh-list
64800889|NCT03328676|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64800890|NCT03328676|Protective Agents|protective agents|mesh-ancestor
64800891|NCT03328676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800892|NCT03322293|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64800893|NCT03322293|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64800894|NCT03322293|Dermatologic Agents|dermatologic agents|mesh-ancestor
64800895|NCT03317405|Tamoxifen|tamoxifen|mesh-list
64800896|NCT03317405|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64800897|NCT03317405|Hormone Antagonists|hormone antagonists|mesh-ancestor
64800898|NCT03317405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64800899|NCT03317405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800900|NCT03317405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64800901|NCT03317405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800903|NCT03317405|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64800931|NCT03276533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64800932|NCT03276533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64800933|NCT03276533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64800934|NCT03276533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800935|NCT03276533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64800936|NCT03276533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64800937|NCT03276533|Analgesics|analgesics|mesh-ancestor
64800947|NCT03254394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800948|NCT03254394|Sensory System Agents|sensory system agents|mesh-ancestor
64800949|NCT03254394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800950|NCT03254394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64800951|NCT03254394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64800952|NCT03254394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64800953|NCT03254394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64800954|NCT03254394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800956|NCT03203876|Ipilimumab|ipilimumab|mesh-list
64800958|NCT03203876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800997|NCT03071601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800998|NCT03071601|Sensory System Agents|sensory system agents|mesh-ancestor
64800999|NCT03071601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64801000|NCT03071601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64801001|NCT03071601|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64801002|NCT03071601|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64801003|NCT03071601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64801007|NCT03071601|Adrenergic Agents|adrenergic agents|mesh-ancestor
64801008|NCT03071601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64801009|NCT03071601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64801010|NCT03071601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64801012|NCT03071601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64801013|NCT03071601|Respiratory System Agents|respiratory system agents|mesh-ancestor
64801014|NCT03071601|Mydriatics|mydriatics|mesh-ancestor
64801015|NCT03071601|Sympathomimetics|sympathomimetics|mesh-ancestor
64801016|NCT03071601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64801017|NCT03071601|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64801018|NCT03061903|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64801019|NCT03061903|Laxatives|laxatives|mesh-ancestor
64801020|NCT03061903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64801021|NCT03061643|Docetaxel|docetaxel|mesh-list
64801022|NCT03061643|Androgens|androgens|mesh-list
64801023|NCT03061643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801024|NCT03061643|Tubulin Modulators|tubulin modulators|mesh-ancestor
64801025|NCT03061643|Antimitotic Agents|antimitotic agents|mesh-ancestor
64801026|NCT03061643|Mitosis Modulators|mitosis modulators|mesh-ancestor
64801027|NCT03061643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801028|NCT03061643|Hormones|hormones|mesh-ancestor
64801029|NCT03061643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64801030|NCT03061643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801031|NCT03061630|Gemcitabine|gemcitabine|mesh-list
64801032|NCT03061630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801033|NCT03061630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64801034|NCT03061630|Antimetabolites|antimetabolites|mesh-ancestor
64801035|NCT03061630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503373|NCT05585346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64801036|NCT03061630|Antiviral Agents|antiviral agents|mesh-ancestor
64801037|NCT03061630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64801038|NCT03061630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801039|NCT03061630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64801040|NCT03061630|Immunologic Factors|immunologic factors|mesh-ancestor
64801041|NCT03061630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801042|NCT03055390|Scopolamine|scopolamine|mesh-list
64801118|NCT03011775|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64801119|NCT03011775|Diuretics|diuretics|mesh-ancestor
64801120|NCT03011775|Natriuretic Agents|natriuretic agents|mesh-ancestor
64801121|NCT03011775|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64801122|NCT02960997|Sirolimus|sirolimus|mesh-list
64801123|NCT02960997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64801124|NCT02960997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64801125|NCT02960997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64801126|NCT02960997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801127|NCT02960997|Antifungal Agents|antifungal agents|mesh-ancestor
64801128|NCT02960997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64801129|NCT02960997|Immunologic Factors|immunologic factors|mesh-ancestor
64801130|NCT02960997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801188|NCT02810457|Mitosis Modulators|mitosis modulators|mesh-ancestor
64801189|NCT02810457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801190|NCT02810457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64801191|NCT02810457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64801192|NCT02810457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64801193|NCT02810457|Growth Substances|growth substances|mesh-ancestor
64801194|NCT02810457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801195|NCT02810457|Growth Inhibitors|growth inhibitors|mesh-ancestor
64801197|NCT02745535|Velpatasvir|velpatasvir|mesh-list
64801198|NCT02745535|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64801199|NCT02745535|Antiviral Agents|antiviral agents|mesh-ancestor
64801200|NCT02745535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64801201|NCT02729701|Bazedoxifene|bazedoxifene|mesh-list
64801202|NCT02729701|Estrogens|estrogens|mesh-list
64801203|NCT02729701|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64801204|NCT02729701|Hormones|hormones|mesh-ancestor
64801277|NCT02666794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64801278|NCT02666794|Narcotics|narcotics|mesh-ancestor
64801279|NCT02666794|Analgesics|analgesics|mesh-ancestor
64801280|NCT02666794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64801281|NCT02666794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64801282|NCT02666794|Anesthetics, General|anesthetics, general|mesh-ancestor
64801283|NCT02656550|Thymoglobulin|thymoglobulin|mesh-list
64801284|NCT02656550|Immunologic Factors|immunologic factors|mesh-ancestor
64801285|NCT02656550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801286|NCT02656550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64801287|NCT02642094|Sirolimus|sirolimus|mesh-list
64801288|NCT02642094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64400878|NCT05214911|Loratadine|loratadine|mesh-list
64801289|NCT02642094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64801290|NCT02642094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64801291|NCT02642094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801292|NCT02642094|Antifungal Agents|antifungal agents|mesh-ancestor
64801293|NCT02642094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64801294|NCT02642094|Immunologic Factors|immunologic factors|mesh-ancestor
64801295|NCT02642094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801346|NCT02619552|Hormones|hormones|mesh-ancestor
64801347|NCT02619552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64801348|NCT02619552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801349|NCT02619552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64801350|NCT02619552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801351|NCT02619552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64801352|NCT02619552|Autonomic Agents|autonomic agents|mesh-ancestor
64801353|NCT02619552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64801354|NCT02619552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64801355|NCT02619552|Respiratory System Agents|respiratory system agents|mesh-ancestor
64801356|NCT02619552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64801357|NCT02619552|Dermatologic Agents|dermatologic agents|mesh-ancestor
64801358|NCT02619552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64801359|NCT02619552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64801360|NCT02619552|Immunologic Factors|immunologic factors|mesh-ancestor
64801361|NCT02578368|Leucovorin|leucovorin|mesh-list
64801362|NCT02578368|Docetaxel|docetaxel|mesh-list
64801363|NCT02578368|Fluorouracil|fluorouracil|mesh-list
64801364|NCT02578368|Oxaliplatin|oxaliplatin|mesh-list
64801365|NCT02578368|Trastuzumab|trastuzumab|mesh-list
64801404|NCT02575963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64801406|NCT02539225|Oxaliplatin|oxaliplatin|mesh-list
64801407|NCT02539225|Ramucirumab|ramucirumab|mesh-list
64801408|NCT02539225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64801409|NCT02539225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801484|NCT02293109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64801485|NCT02293109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64801486|NCT02293109|Antiemetics|antiemetics|mesh-ancestor
64801487|NCT02293109|Autonomic Agents|autonomic agents|mesh-ancestor
64801488|NCT02293109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64801489|NCT02293109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64801490|NCT02293109|Glucocorticoids|glucocorticoids|mesh-ancestor
64801491|NCT02293109|Hormones|hormones|mesh-ancestor
64801492|NCT02293109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64801493|NCT02293109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64801494|NCT02293109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64801495|NCT02293109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64801496|NCT02293109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64570094|NCT01897441|Antibodies|antibodies|mesh-list
64801497|NCT02293109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801511|NCT02293109|Vitamins|vitamins|mesh-ancestor
64801548|NCT01951469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64801549|NCT01951469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64801550|NCT01940809|Nivolumab|nivolumab|mesh-list
64801551|NCT01940809|Ipilimumab|ipilimumab|mesh-list
64801552|NCT01940809|Trametinib|trametinib|mesh-list
64801553|NCT01940809|Dabrafenib|dabrafenib|mesh-list
64801554|NCT01940809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64801555|NCT01940809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801556|NCT01940809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64801557|NCT01940809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801558|NCT01940809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64801559|NCT01940809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801560|NCT01879228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64801561|NCT01879228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64801562|NCT01879228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801563|NCT01879228|Incretins|incretins|mesh-ancestor
64801564|NCT01879228|Hormones|hormones|mesh-ancestor
64801566|NCT01879228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64801622|NCT01591629|Sensory System Agents|sensory system agents|mesh-ancestor
64801623|NCT01591629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64801624|NCT01591629|Hallucinogens|hallucinogens|mesh-ancestor
64801625|NCT01591629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64801626|NCT01591629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64801627|NCT01591629|Analgesics|analgesics|mesh-ancestor
64801628|NCT01591629|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64801629|NCT01591629|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64801630|NCT01591629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64801631|NCT01591629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801632|NCT01591629|Hormones|hormones|mesh-ancestor
64801697|NCT00962988|Antidepressive Agents|antidepressive agents|mesh-ancestor
64801698|NCT00962988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64801699|NCT00962988|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64801700|NCT00962988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64801701|NCT00962988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64801702|NCT00962988|Dopamine Agents|dopamine agents|mesh-ancestor
64801703|NCT00962988|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64801704|NCT00962988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64801705|NCT00962988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801706|NCT00785525|Lenograstim|lenograstim|mesh-list
64801707|NCT00785525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64801708|NCT00785525|Immunologic Factors|immunologic factors|mesh-ancestor
64801709|NCT00785525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801710|NCT00768820|Risperidone|risperidone|mesh-list
64801711|NCT00768820|Methylphenidate|methylphenidate|mesh-list
64801712|NCT00768820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64801713|NCT00768820|Serotonin Agents|serotonin agents|mesh-ancestor
64801714|NCT00768820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64801715|NCT00768820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801716|NCT00768820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801717|NCT00768820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64801718|NCT00768820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64801719|NCT00768820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64801720|NCT00768820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64801721|NCT00768820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64801722|NCT00768820|Dopamine Agents|dopamine agents|mesh-ancestor
64801724|NCT00768820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64801747|NCT00500071|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64801748|NCT00500071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64801749|NCT00500071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801750|NCT00500071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64801751|NCT00500071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64801752|NCT00500071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64801753|NCT00500071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801754|NCT00500071|Dopamine Agents|dopamine agents|mesh-ancestor
64801755|NCT00500071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64801756|NCT00447122|Gemcitabine|gemcitabine|mesh-list
64801757|NCT00447122|Oxaliplatin|oxaliplatin|mesh-list
64801758|NCT00447122|Lapatinib|lapatinib|mesh-list
64801759|NCT00447122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64801760|NCT00447122|Antimetabolites|antimetabolites|mesh-ancestor
64801761|NCT00447122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801762|NCT00447122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801770|NCT00430040|Carvedilol|carvedilol|mesh-list
64801810|NCT01397513|Analgesics|analgesics|mesh-ancestor
64801811|NCT01397513|Sensory System Agents|sensory system agents|mesh-ancestor
64801812|NCT01397513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64801813|NCT01397513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801814|NCT01397513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64801815|NCT01397513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64801816|NCT01397513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64801817|NCT01397513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64801818|NCT01397513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801819|NCT01397513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64801820|NCT01397513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64801821|NCT01397513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801822|NCT01397513|Antipyretics|antipyretics|mesh-ancestor
64801823|NCT01397630|Oxytocin|oxytocin|mesh-list
64801824|NCT01397630|Oxytocics|oxytocics|mesh-ancestor
64801825|NCT01397630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64801826|NCT01397630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801827|NCT01397734|Arsenic Trioxide|arsenic trioxide|mesh-list
64801828|NCT01397734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801829|NCT01397799|Tirbanibulin|tirbanibulin|mesh-list
64801830|NCT01397799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801832|NCT01397994|Nicorandil|nicorandil|mesh-list
64801875|NCT01398072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64801876|NCT01398072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64801877|NCT01398072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64801878|NCT01398072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801879|NCT01398072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801880|NCT01398072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801881|NCT01398072|Antimalarials|antimalarials|mesh-ancestor
64801882|NCT01398072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64801883|NCT01398072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64801884|NCT01398111|Glycopyrrolate|glycopyrrolate|mesh-list
64801885|NCT01398111|Formoterol Fumarate|formoterol fumarate|mesh-list
64801886|NCT01398111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64801887|NCT01398111|Autonomic Agents|autonomic agents|mesh-ancestor
64801888|NCT01398111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64801889|NCT01398111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801890|NCT01398111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64801891|NCT01398111|Respiratory System Agents|respiratory system agents|mesh-ancestor
64801893|NCT01398111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64801940|NCT01398293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801941|NCT01398293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64801942|NCT01398293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64801943|NCT01398293|Antiviral Agents|antiviral agents|mesh-ancestor
64801944|NCT01398293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64801945|NCT01398293|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64801946|NCT01398293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64801947|NCT01398293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64801948|NCT01398293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64801949|NCT01398293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64801950|NCT01398293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801951|NCT01398293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64801952|NCT01398293|Contraceptive Agents|contraceptive agents|mesh-ancestor
64801953|NCT01398293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64801954|NCT01398293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801955|NCT01398293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64801956|NCT01398293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64801957|NCT01398293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64801958|NCT01398371|Digoxin|digoxin|mesh-list
64801959|NCT01398371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64801960|NCT01398371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64801961|NCT01398371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801962|NCT01398371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801963|NCT01398371|Protective Agents|protective agents|mesh-ancestor
64801964|NCT01398371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801965|NCT01398384|Nitric Oxide|nitric oxide|mesh-list
64801966|NCT01398384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64801967|NCT01398384|Autonomic Agents|autonomic agents|mesh-ancestor
64801984|NCT01398501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801985|NCT01398592|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64801986|NCT01398592|Vildagliptin|vildagliptin|mesh-list
64801987|NCT01398592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64801988|NCT01398592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801989|NCT01398592|Incretins|incretins|mesh-ancestor
64801990|NCT01398592|Hormones|hormones|mesh-ancestor
64801991|NCT01398592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64801992|NCT01398592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64801993|NCT01398592|Protease Inhibitors|protease inhibitors|mesh-ancestor
64801994|NCT01398592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801995|NCT01398592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802003|NCT01398618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64802004|NCT01398618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802005|NCT01398618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802006|NCT01398618|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64802007|NCT01398618|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64802008|NCT01398618|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64802009|NCT01398618|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64802010|NCT01398618|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64802041|NCT01399151|Ergocalciferols|ergocalciferols|mesh-list
64802042|NCT01399151|Cholecalciferol|cholecalciferol|mesh-list
64802043|NCT01399151|Vitamins|vitamins|mesh-list
64802044|NCT01399151|Micronutrients|micronutrients|mesh-ancestor
64802045|NCT01399151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802046|NCT01399151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64802047|NCT01399151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64802048|NCT01399216|Fucoidan|fucoidan|mesh-list
64802049|NCT01399216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64802050|NCT01399216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64802051|NCT01399216|Anticoagulants|anticoagulants|mesh-ancestor
64472166|NCT03760575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64802052|NCT01399216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802053|NCT01399242|Everolimus|everolimus|mesh-list
64802054|NCT01399242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64802055|NCT01399242|Immunologic Factors|immunologic factors|mesh-ancestor
64802056|NCT01399242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802057|NCT01399242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802058|NCT01399255|Insulin Lispro|insulin lispro|mesh-list
64802059|NCT01399255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64802061|NCT01399346|Insulin|insulin|mesh-list
64802101|NCT01399645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64802102|NCT01399645|Metformin|metformin|mesh-list
64802103|NCT01399645|Insulin Glargine|insulin glargine|mesh-list
64802104|NCT01399645|Liraglutide|liraglutide|mesh-list
64802105|NCT01399645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64802106|NCT01399645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802107|NCT01399645|Incretins|incretins|mesh-ancestor
64802108|NCT01399645|Hormones|hormones|mesh-ancestor
64802109|NCT01399645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64802110|NCT01399840|Talazoparib|talazoparib|mesh-list
64802165|NCT01400217|Glucocorticoids|glucocorticoids|mesh-ancestor
64802166|NCT01400217|Hormones|hormones|mesh-ancestor
64802167|NCT01400217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64802168|NCT01400217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802169|NCT01400217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64802170|NCT01400217|Respiratory System Agents|respiratory system agents|mesh-ancestor
64802171|NCT01400256|Valsartan|valsartan|mesh-list
64802172|NCT01400256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64802173|NCT01400256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64802174|NCT01400256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64802175|NCT01400256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802176|NCT01400308|Mupirocin|mupirocin|mesh-list
64802177|NCT01400308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64802178|NCT01400308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64802179|NCT01400308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64802180|NCT01400308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802181|NCT01400308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802182|NCT01400360|Vasodilator Agents|vasodilator agents|mesh-list
64802183|NCT01400464|Prednisone|prednisone|mesh-list
64802184|NCT01400464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64802185|NCT01400464|Glucocorticoids|glucocorticoids|mesh-ancestor
64802186|NCT01400464|Hormones|hormones|mesh-ancestor
64802188|NCT01400464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802229|NCT01400672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802230|NCT01400672|Interferon Inducers|interferon inducers|mesh-ancestor
64802231|NCT01400685|Rituximab|rituximab|mesh-list
64802232|NCT01400685|Lenalidomide|lenalidomide|mesh-list
64802233|NCT01400685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64802234|NCT01400685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64802235|NCT01400685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802236|NCT01400685|Immunologic Factors|immunologic factors|mesh-ancestor
64802237|NCT01400685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802238|NCT01400685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64802239|NCT01400685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64802240|NCT01400685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64802241|NCT01400685|Growth Substances|growth substances|mesh-ancestor
64802242|NCT01400685|Growth Inhibitors|growth inhibitors|mesh-ancestor
64802243|NCT01400685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64802244|NCT01400685|Alkylating Agents|alkylating agents|mesh-ancestor
64802245|NCT01400685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802246|NCT01400737|Ibuprofen|ibuprofen|mesh-list
64802247|NCT01400737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64802248|NCT01400737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64802249|NCT01400737|Analgesics|analgesics|mesh-ancestor
64802250|NCT01400737|Sensory System Agents|sensory system agents|mesh-ancestor
64802251|NCT01400737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64802252|NCT01400737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802253|NCT01400737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64802254|NCT01400737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64802255|NCT01400737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64802256|NCT01400737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802257|NCT01400737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802258|NCT01400750|Ciprofloxacin|ciprofloxacin|mesh-list
64802288|NCT01400867|Clindamycin|clindamycin|mesh-list
64802289|NCT01400867|Clindamycin palmitate|clindamycin palmitate|mesh-list
64802290|NCT01400867|Clindamycin phosphate|clindamycin phosphate|mesh-list
64802291|NCT01400867|Cefazolin|cefazolin|mesh-list
64802292|NCT01400867|Linezolid|linezolid|mesh-list
64802293|NCT01400867|Cephalexin|cephalexin|mesh-list
64802294|NCT01400867|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64802295|NCT01400867|Aztreonam|aztreonam|mesh-list
64802296|NCT01400867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64802299|NCT01400867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802370|NCT01401491|GABA Antagonists|gaba antagonists|mesh-ancestor
64802371|NCT01401491|GABA Agents|gaba agents|mesh-ancestor
64802372|NCT01401491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64802373|NCT01401491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64802374|NCT01401491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64802375|NCT01401491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64802376|NCT01401491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64802377|NCT01401491|Antidepressive Agents|antidepressive agents|mesh-ancestor
64802378|NCT01401491|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64802379|NCT01401491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64802380|NCT01401491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802381|NCT01401491|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64802382|NCT01401803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64802383|NCT01401803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64802384|NCT01401803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64802414|NCT01402076|Midazolam|midazolam|mesh-list
64802461|NCT01402180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64802462|NCT01402180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802463|NCT01402193|Anastrozole|anastrozole|mesh-list
64802464|NCT01402193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64802465|NCT01402193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802466|NCT01402193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64802467|NCT01402193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64802468|NCT01402193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802469|NCT01402193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802470|NCT01402193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64802471|NCT01402193|Hormone Antagonists|hormone antagonists|mesh-ancestor
64802472|NCT01402193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64802473|NCT01402193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802476|NCT01402245|Immunologic Factors|immunologic factors|mesh-ancestor
64802543|NCT01402674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802544|NCT01402674|Appetite Depressants|appetite depressants|mesh-ancestor
64802545|NCT01402674|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64802546|NCT01402674|Sympathomimetics|sympathomimetics|mesh-ancestor
64802547|NCT01402674|Autonomic Agents|autonomic agents|mesh-ancestor
64413625|NCT03057769|Mydriatics|mydriatics|mesh-ancestor
64802554|NCT01402843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64802555|NCT01402843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64802615|NCT01403363|Analgesics|analgesics|mesh-ancestor
64802616|NCT01403363|Sensory System Agents|sensory system agents|mesh-ancestor
64802617|NCT01403363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64802624|NCT01403389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64802625|NCT01403389|Immunologic Factors|immunologic factors|mesh-ancestor
64802626|NCT01403389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802627|NCT01403415|Sirolimus|sirolimus|mesh-list
64802628|NCT01403415|Dexamethasone|dexamethasone|mesh-list
64802629|NCT01403415|Dexamethasone acetate|dexamethasone acetate|mesh-list
64802700|NCT01403740|Cyclosporine|cyclosporine|mesh-list
64802701|NCT01403740|Rituximab|rituximab|mesh-list
64802702|NCT01403740|Azathioprine|azathioprine|mesh-list
64802703|NCT01403740|Cyclosporins|cyclosporins|mesh-list
64802704|NCT01403740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64472171|NCT03738579|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64802705|NCT01403740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802706|NCT01403740|Immunologic Factors|immunologic factors|mesh-ancestor
64802707|NCT01403740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802708|NCT01403740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64802709|NCT01403740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802710|NCT01403740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802711|NCT01403740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64802712|NCT01403740|Antifungal Agents|antifungal agents|mesh-ancestor
64802713|NCT01403740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64802714|NCT01403740|Dermatologic Agents|dermatologic agents|mesh-ancestor
64802715|NCT01403740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64802716|NCT01403740|Antimetabolites|antimetabolites|mesh-ancestor
64802717|NCT01403740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64802718|NCT01403818|Ipragliflozin|ipragliflozin|mesh-list
64802719|NCT01403818|Mitiglinide|mitiglinide|mesh-list
64802720|NCT01403818|Calcium|calcium|mesh-list
64802721|NCT01403818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64802722|NCT01403818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802723|NCT01403818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64802724|NCT01403818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802725|NCT01403818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64802726|NCT01403844|Carotenoids|carotenoids|mesh-list
64802727|NCT01403844|Antioxidants|antioxidants|mesh-ancestor
64802728|NCT01403844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802729|NCT01403844|Protective Agents|protective agents|mesh-ancestor
64802731|NCT01403896|Plerixafor|plerixafor|mesh-list
64802743|NCT01404013|Montelukast|montelukast|mesh-list
64802744|NCT01404013|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64802745|NCT01404013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64802746|NCT01404013|Respiratory System Agents|respiratory system agents|mesh-ancestor
64802747|NCT01404013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64802748|NCT01404013|Hormone Antagonists|hormone antagonists|mesh-ancestor
64802749|NCT01404013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64802750|NCT01404013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802751|NCT01404013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64413814|NCT04938583|Carboplatin|carboplatin|mesh-list
64802757|NCT01404104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64802758|NCT01404104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802759|NCT01404104|Antifungal Agents|antifungal agents|mesh-ancestor
64802760|NCT01404104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64802761|NCT01404104|Immunologic Factors|immunologic factors|mesh-ancestor
64802762|NCT01404104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802763|NCT01404117|Interferons|interferons|mesh-list
64802764|NCT01404117|Interferon-beta|interferon-beta|mesh-list
64802765|NCT01404117|Glatiramer Acetate|glatiramer acetate|mesh-list
64802766|NCT01404117|(T,G)-A-L|(t,g)-a-l|mesh-list
64802767|NCT01404117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802768|NCT01404117|Antiviral Agents|antiviral agents|mesh-ancestor
64802769|NCT01404117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64802770|NCT01404117|Immunologic Factors|immunologic factors|mesh-ancestor
64802771|NCT01404117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802772|NCT01404117|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64802773|NCT01404117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64802774|NCT01404117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64802775|NCT01404130|Isotretinoin|isotretinoin|mesh-list
64802793|NCT01404156|Immunologic Factors|immunologic factors|mesh-ancestor
64802794|NCT01404156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802795|NCT01404156|Antidotes|antidotes|mesh-ancestor
64802796|NCT01404156|Protective Agents|protective agents|mesh-ancestor
64802797|NCT01404156|Vitamin B Complex|vitamin b complex|mesh-ancestor
64802798|NCT01404156|Vitamins|vitamins|mesh-ancestor
64802799|NCT01404156|Micronutrients|micronutrients|mesh-ancestor
64802800|NCT01404156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64802801|NCT01404156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64802802|NCT01404156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64802803|NCT01404156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802804|NCT01404169|Donepezil|donepezil|mesh-list
64802805|NCT01404169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64802867|NCT01404442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802868|NCT01404442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64802869|NCT01404442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64802870|NCT01404442|Anesthetics, General|anesthetics, general|mesh-ancestor
64802871|NCT01404442|Anesthetics|anesthetics|mesh-ancestor
64802872|NCT01404442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64802873|NCT01404442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64802942|NCT01404689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64802943|NCT01404689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64802944|NCT01404689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64802945|NCT01404689|Adrenergic Agents|adrenergic agents|mesh-ancestor
64802946|NCT01404689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64802947|NCT01404689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802948|NCT01404702|Zoledronic Acid|zoledronic acid|mesh-list
64802949|NCT01404702|Aldesleukin|aldesleukin|mesh-list
64802950|NCT01404702|Interleukin-2|interleukin-2|mesh-list
64802951|NCT01404702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802952|NCT01404702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64802953|NCT01404702|Analgesics|analgesics|mesh-ancestor
64802954|NCT01404702|Sensory System Agents|sensory system agents|mesh-ancestor
64802955|NCT01404702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64802969|NCT01404715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802970|NCT01404741|Azacitidine|azacitidine|mesh-list
64802971|NCT01404741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64802972|NCT01404741|Antimetabolites|antimetabolites|mesh-ancestor
64802973|NCT01404741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802974|NCT01404741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802975|NCT01404741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802976|NCT01404767|Metoprolol|metoprolol|mesh-list
64802977|NCT01404767|Esmolol|esmolol|mesh-list
64802978|NCT01404767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64802979|NCT01404767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64803003|NCT01404806|Antiviral Agents|antiviral agents|mesh-ancestor
64803004|NCT01404806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64803006|NCT01404819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64803007|NCT01404819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803008|NCT01404871|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64803009|NCT01404871|Citalopram|citalopram|mesh-list
64803010|NCT01404871|Clomipramine|clomipramine|mesh-list
64803011|NCT01404871|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64803012|NCT01404871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64803013|NCT01404871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64803071|NCT01405144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803072|NCT01405157|Methylprednisolone|methylprednisolone|mesh-list
64803073|NCT01405157|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64803074|NCT01405157|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64803075|NCT01405157|Prednisolone|prednisolone|mesh-list
64803076|NCT01405157|Prednisolone acetate|prednisolone acetate|mesh-list
64571670|NCT02635841|Deferiprone|deferiprone|mesh-list
64803077|NCT01405157|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64803078|NCT01405157|Prednisolone phosphate|prednisolone phosphate|mesh-list
64803079|NCT01405157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64803080|NCT01405157|Antiemetics|antiemetics|mesh-ancestor
64803081|NCT01405157|Autonomic Agents|autonomic agents|mesh-ancestor
64803082|NCT01405157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64803083|NCT01405157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803084|NCT01405157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64803085|NCT01405157|Glucocorticoids|glucocorticoids|mesh-ancestor
64803086|NCT01405157|Hormones|hormones|mesh-ancestor
64803087|NCT01405157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64803088|NCT01405157|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64803136|NCT01405339|Glucocorticoids|glucocorticoids|mesh-ancestor
64803137|NCT01405339|Hormones|hormones|mesh-ancestor
64803138|NCT01405339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64803139|NCT01405352|Vitamin A|vitamin a|mesh-list
64803140|NCT01405352|Vitamins|vitamins|mesh-ancestor
64803141|NCT01405352|Micronutrients|micronutrients|mesh-ancestor
64803142|NCT01405352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803143|NCT01405365|Metronidazole|metronidazole|mesh-list
64803144|NCT01405365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64803145|NCT01405365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64803146|NCT01405365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64803147|NCT01405365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64803148|NCT01405430|Bevacizumab|bevacizumab|mesh-list
64803214|NCT01405989|Hormone Antagonists|hormone antagonists|mesh-ancestor
64803215|NCT01405989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64803222|NCT01405989|Anticoagulants|anticoagulants|mesh-ancestor
64803224|NCT01406002|Darexaban|darexaban|mesh-list
64803225|NCT01406002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64803226|NCT01406002|Antitubercular Agents|antitubercular agents|mesh-ancestor
64571819|NCT01454609|Clonidine|clonidine|mesh-list
64803227|NCT01406002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64803228|NCT01406002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64803296|NCT01406262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803297|NCT01406262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803298|NCT01406262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803299|NCT01406262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803301|NCT01406262|Hormones|hormones|mesh-ancestor
64803302|NCT01406262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64803303|NCT01406275|Amoxicillin|amoxicillin|mesh-list
64803304|NCT01406275|Clavulanic Acid|clavulanic acid|mesh-list
64803305|NCT01406275|Clavulanic Acids|clavulanic acids|mesh-list
64803368|NCT01406535|Vasodilator Agents|vasodilator agents|mesh-ancestor
64803369|NCT01406535|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64803370|NCT01406535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64803371|NCT01406535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803372|NCT01406535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803373|NCT01406535|Urological Agents|urological agents|mesh-ancestor
64803374|NCT01406600|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64803375|NCT01406600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64571967|NCT00394147|Antiviral Agents|antiviral agents|mesh-ancestor
64803376|NCT01406600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803377|NCT01406639|Ranibizumab|ranibizumab|mesh-list
64472174|NCT03720522|Analgesics|analgesics|mesh-ancestor
64472175|NCT03720522|Sensory System Agents|sensory system agents|mesh-ancestor
64803378|NCT01406639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64803379|NCT01406639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64803380|NCT01406639|Growth Substances|growth substances|mesh-ancestor
64803381|NCT01406639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803382|NCT01406639|Growth Inhibitors|growth inhibitors|mesh-ancestor
64803383|NCT01406639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803385|NCT01406678|Dsuvia|dsuvia|mesh-list
64803386|NCT01406678|Isoflurane|isoflurane|mesh-list
64803387|NCT01406678|Anesthetics|anesthetics|mesh-ancestor
64803388|NCT01406678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64803430|NCT01407237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803431|NCT01407237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803433|NCT01407289|Insulin Glargine|insulin glargine|mesh-list
64803434|NCT01407289|Insulin Aspart|insulin aspart|mesh-list
64803435|NCT01407289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64803436|NCT01407289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803437|NCT01407432|Folic Acid|folic acid|mesh-list
64803438|NCT01407432|Vitamin B Complex|vitamin b complex|mesh-list
64803439|NCT01407432|Hematinics|hematinics|mesh-ancestor
64803440|NCT01407432|Vitamins|vitamins|mesh-ancestor
64803441|NCT01407432|Micronutrients|micronutrients|mesh-ancestor
64803442|NCT01407432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803443|NCT01407471|Clobetasol|clobetasol|mesh-list
64803444|NCT01407471|Spironolactone|spironolactone|mesh-list
64803445|NCT01407471|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64803446|NCT01407471|Hormone Antagonists|hormone antagonists|mesh-ancestor
64803503|NCT01408004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803504|NCT01408004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64803505|NCT01408004|Immunologic Factors|immunologic factors|mesh-ancestor
64803506|NCT01408004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803507|NCT01408056|Mupirocin|mupirocin|mesh-list
64803508|NCT01408056|Timolol|timolol|mesh-list
64803509|NCT01408056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64803510|NCT01408056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64803511|NCT01408056|Adrenergic Agents|adrenergic agents|mesh-ancestor
64803512|NCT01408056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64803513|NCT01408056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803514|NCT01408056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803515|NCT01408056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64803516|NCT01408056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64803517|NCT01408056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64803518|NCT01408056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64803519|NCT01408056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64803520|NCT01408056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803562|NCT01408186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64803563|NCT01408186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803565|NCT01408199|Immunologic Factors|immunologic factors|mesh-ancestor
64803566|NCT01408199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803567|NCT01408199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64803568|NCT01408199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64803569|NCT01408199|Growth Substances|growth substances|mesh-ancestor
64803570|NCT01408199|Growth Inhibitors|growth inhibitors|mesh-ancestor
64803571|NCT01408199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803635|NCT01408836|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64803636|NCT01408836|Methylprednisolone|methylprednisolone|mesh-list
64803637|NCT01408836|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64803638|NCT01408836|Prednisolone acetate|prednisolone acetate|mesh-list
64803639|NCT01408836|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64803640|NCT01408836|Prednisolone phosphate|prednisolone phosphate|mesh-list
64803641|NCT01408836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64803642|NCT01408836|Glucocorticoids|glucocorticoids|mesh-ancestor
64803643|NCT01408836|Hormones|hormones|mesh-ancestor
64803644|NCT01408836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64803645|NCT01408836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803646|NCT01408836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64803647|NCT01408836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803648|NCT01408836|Antiemetics|antiemetics|mesh-ancestor
64803649|NCT01408836|Autonomic Agents|autonomic agents|mesh-ancestor
64803650|NCT01408836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64803705|NCT01409005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64803706|NCT01409005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803707|NCT01409005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64803708|NCT01409005|Immunologic Factors|immunologic factors|mesh-ancestor
64803709|NCT01409005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803710|NCT01409018|Itraconazole|itraconazole|mesh-list
64803711|NCT01409018|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
64803712|NCT01409018|Antifungal Agents|antifungal agents|mesh-ancestor
64803713|NCT01409018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64803778|NCT01409278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64803779|NCT01409369|Charcoal|charcoal|mesh-list
64803780|NCT01409369|Antidotes|antidotes|mesh-ancestor
64803781|NCT01409369|Protective Agents|protective agents|mesh-ancestor
64803782|NCT01409369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803783|NCT01409395|Metformin|metformin|mesh-list
64803784|NCT01409395|Nizatidine|nizatidine|mesh-list
64803785|NCT01409395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64803786|NCT01409395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803787|NCT01409395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64803788|NCT01409395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64803789|NCT01409395|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64803790|NCT01409395|Histamine Antagonists|histamine antagonists|mesh-ancestor
64803791|NCT01409395|Histamine Agents|histamine agents|mesh-ancestor
64803792|NCT01409395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64803793|NCT01409395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803794|NCT01409408|Amlodipine|amlodipine|mesh-list
64803795|NCT01409408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64472179|NCT03720522|Vasodilator Agents|vasodilator agents|mesh-ancestor
64803839|NCT01409616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64803840|NCT01409616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64803841|NCT01409616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64803842|NCT01409616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64803843|NCT01409616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803844|NCT01409616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64803845|NCT01409616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64803847|NCT01409616|Antipyretics|antipyretics|mesh-ancestor
64803916|NCT01410214|Vinorelbine|vinorelbine|mesh-list
64803917|NCT01410214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803918|NCT01410214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64803919|NCT01410214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803920|NCT01410214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803921|NCT01410214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64803922|NCT01410214|Tubulin Modulators|tubulin modulators|mesh-ancestor
64803923|NCT01410214|Antimitotic Agents|antimitotic agents|mesh-ancestor
64803924|NCT01410214|Mitosis Modulators|mitosis modulators|mesh-ancestor
64803925|NCT01410370|Endostar protein|endostar protein|mesh-list
64803926|NCT01410370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64803927|NCT01410370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64803928|NCT01410370|Growth Substances|growth substances|mesh-ancestor
64803929|NCT01410370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803930|NCT01410370|Growth Inhibitors|growth inhibitors|mesh-ancestor
64803931|NCT01410370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803932|NCT01410630|Telbivudine|telbivudine|mesh-list
64803933|NCT01410630|Antiviral Agents|antiviral agents|mesh-ancestor
64803990|NCT01411111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803991|NCT01411124|Diphenhydramine|diphenhydramine|mesh-list
64803992|NCT01411124|Promethazine|promethazine|mesh-list
64803993|NCT01411124|Gabapentin|gabapentin|mesh-list
64803994|NCT01411124|Analgesics|analgesics|mesh-ancestor
64803995|NCT01411124|Sensory System Agents|sensory system agents|mesh-ancestor
64803996|NCT01411124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64803997|NCT01411124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803998|NCT01411124|Anticonvulsants|anticonvulsants|mesh-ancestor
64803999|NCT01411124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64804000|NCT01411124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64804001|NCT01411124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64804002|NCT01411124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64804003|NCT01411124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64804004|NCT01411124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64804029|NCT01411202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64804030|NCT01411202|Antimalarials|antimalarials|mesh-ancestor
64804031|NCT01411202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64804032|NCT01411202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64804033|NCT01411254|Betamethasone|betamethasone|mesh-list
64804034|NCT01411254|Betamethasone Valerate|betamethasone valerate|mesh-list
64804035|NCT01411254|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64804036|NCT01411254|Betamethasone benzoate|betamethasone benzoate|mesh-list
64804037|NCT01411254|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64804066|NCT01411436|Sorafenib|sorafenib|mesh-list
64804067|NCT01411436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804068|NCT01411436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64804069|NCT01411436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804070|NCT01411436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804071|NCT01411514|Prednisone|prednisone|mesh-list
64804072|NCT01411514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64804073|NCT01411514|Glucocorticoids|glucocorticoids|mesh-ancestor
64804074|NCT01411514|Hormones|hormones|mesh-ancestor
64804075|NCT01411514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64804076|NCT01411514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804077|NCT01411514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64804078|NCT01411514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804079|NCT01411670|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
64804080|NCT01411670|Protein C|protein c|mesh-list
64804081|NCT01411670|Anticoagulants|anticoagulants|mesh-ancestor
64804082|NCT01411670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64804083|NCT01411670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64401052|NCT03067883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64804084|NCT01411670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804085|NCT01411670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64804086|NCT01411735|Enalapril|enalapril|mesh-list
64804087|NCT01411735|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64804088|NCT01411735|Protease Inhibitors|protease inhibitors|mesh-ancestor
64804089|NCT01411735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804091|NCT01411735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64804104|NCT01411930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64804105|NCT01411930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64804106|NCT01411930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804107|NCT01411930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64804108|NCT01411930|Serotonin Agents|serotonin agents|mesh-ancestor
64804109|NCT01411930|Antidepressive Agents|antidepressive agents|mesh-ancestor
64804110|NCT01411930|Dopamine Agonists|dopamine agonists|mesh-ancestor
64804111|NCT01411930|Dopamine Agents|dopamine agents|mesh-ancestor
64804112|NCT01411930|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64804113|NCT01411930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64804114|NCT01411930|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64804115|NCT01411930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64804116|NCT01411930|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64804117|NCT01411930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64804118|NCT01411969|Phenylephrine|phenylephrine|mesh-list
64804119|NCT01411969|Oxymetazoline|oxymetazoline|mesh-list
64804120|NCT01411969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64804121|NCT01411969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64804122|NCT01411969|Adrenergic Agents|adrenergic agents|mesh-ancestor
64804123|NCT01411969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64804124|NCT01411969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804125|NCT01411969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804126|NCT01411969|Sympathomimetics|sympathomimetics|mesh-ancestor
64804146|NCT01412073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64804147|NCT01412073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804148|NCT01412073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64804149|NCT01412073|Abortifacient Agents|abortifacient agents|mesh-ancestor
64804150|NCT01412073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64804151|NCT01412073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64804152|NCT01412294|Capecitabine|capecitabine|mesh-list
64951882|NCT00055887|Efaproxiral|efaproxiral|mesh-list
64951883|NCT00055887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64951884|NCT00055887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951885|NCT00055887|Tubulin Modulators|tubulin modulators|mesh-ancestor
64951886|NCT00055887|Antimitotic Agents|antimitotic agents|mesh-ancestor
64951887|NCT00055887|Mitosis Modulators|mitosis modulators|mesh-ancestor
64951888|NCT00055887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951889|NCT00055887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64951890|NCT00055887|Antimetabolites|antimetabolites|mesh-ancestor
64951891|NCT00055887|Antiviral Agents|antiviral agents|mesh-ancestor
64951892|NCT00055887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64804153|NCT01412294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804154|NCT01412294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64804155|NCT01412294|Antimetabolites|antimetabolites|mesh-ancestor
64804156|NCT01412294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804157|NCT01412307|Lenalidomide|lenalidomide|mesh-list
64804158|NCT01412307|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64804159|NCT01412307|Immunologic Factors|immunologic factors|mesh-ancestor
64804160|NCT01412307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804161|NCT01412307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64804162|NCT01412307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64804163|NCT01412307|Growth Substances|growth substances|mesh-ancestor
64804164|NCT01412307|Growth Inhibitors|growth inhibitors|mesh-ancestor
64804171|NCT01412385|Antibodies|antibodies|mesh-list
64804221|NCT01412658|Sequestering Agents|sequestering agents|mesh-ancestor
64804222|NCT01412658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804223|NCT01412658|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64804224|NCT01412658|Protective Agents|protective agents|mesh-ancestor
64804225|NCT01412658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804226|NCT01412671|Sorafenib|sorafenib|mesh-list
64804227|NCT01412671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804228|NCT01412671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64804229|NCT01412671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804230|NCT01412671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804231|NCT01412840|Diclofenac|diclofenac|mesh-list
64804232|NCT01412840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64804233|NCT01412840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64804234|NCT01412840|Analgesics|analgesics|mesh-ancestor
64804235|NCT01412840|Sensory System Agents|sensory system agents|mesh-ancestor
64804236|NCT01412840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64804237|NCT01412840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804238|NCT01412840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64804239|NCT01412840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64804240|NCT01412840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64804241|NCT01412840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804242|NCT01412840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804243|NCT01412892|Everolimus|everolimus|mesh-list
64804244|NCT01412892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804245|NCT01412892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64804246|NCT01412892|Immunologic Factors|immunologic factors|mesh-ancestor
64804247|NCT01412892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804248|NCT01413022|Leucovorin|leucovorin|mesh-list
64804249|NCT01413022|Fluorouracil|fluorouracil|mesh-list
64804250|NCT01413022|Oxaliplatin|oxaliplatin|mesh-list
64804251|NCT01413022|Irinotecan|irinotecan|mesh-list
64951893|NCT00055887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951894|NCT00055887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951895|NCT00055887|Immunologic Factors|immunologic factors|mesh-ancestor
64951896|NCT00055887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951897|NCT00055887|Antisickling Agents|antisickling agents|mesh-ancestor
64951898|NCT00055965|Gemcitabine|gemcitabine|mesh-list
64951899|NCT00055965|Carboplatin|carboplatin|mesh-list
64951900|NCT00055965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951901|NCT00055965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64951902|NCT00055965|Antimetabolites|antimetabolites|mesh-ancestor
64804261|NCT01413022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804262|NCT01413022|Antidotes|antidotes|mesh-ancestor
64804263|NCT01413022|Protective Agents|protective agents|mesh-ancestor
64804264|NCT01413022|Vitamin B Complex|vitamin b complex|mesh-ancestor
64804265|NCT01413022|Vitamins|vitamins|mesh-ancestor
64804266|NCT01413022|Micronutrients|micronutrients|mesh-ancestor
64804267|NCT01413048|Carvedilol|carvedilol|mesh-list
64804268|NCT01413048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64804269|NCT01413048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64804270|NCT01413048|Adrenergic Agents|adrenergic agents|mesh-ancestor
64804271|NCT01413048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64804272|NCT01413048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804273|NCT01413048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804274|NCT01413048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64804275|NCT01413048|Antioxidants|antioxidants|mesh-ancestor
64804276|NCT01413048|Protective Agents|protective agents|mesh-ancestor
64804277|NCT01413048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64804278|NCT01413048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64804279|NCT01413048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64804280|NCT01413048|Vasodilator Agents|vasodilator agents|mesh-ancestor
64804281|NCT01413048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64804282|NCT01413048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64804283|NCT01413230|Cholecalciferol|cholecalciferol|mesh-list
64804285|NCT01413230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64804286|NCT01413230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804287|NCT01413230|Vitamins|vitamins|mesh-ancestor
64804290|NCT01413477|Calcitriol|calcitriol|mesh-list
64804309|NCT01413477|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64804310|NCT01413477|Vitamins|vitamins|mesh-ancestor
64804311|NCT01413477|Micronutrients|micronutrients|mesh-ancestor
64804312|NCT01413477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64804313|NCT01413490|Rimantadine|rimantadine|mesh-list
64804314|NCT01413490|Antiviral Agents|antiviral agents|mesh-ancestor
64804315|NCT01413490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64804316|NCT01413490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64415380|NCT04870489|Isotretinoin|isotretinoin|mesh-list
64804350|NCT01413854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804351|NCT01413854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64804352|NCT01413854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64804353|NCT01413854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64804354|NCT01413854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804355|NCT01413854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804411|NCT01414608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804412|NCT01414608|Tubulin Modulators|tubulin modulators|mesh-ancestor
64804413|NCT01414608|Antimitotic Agents|antimitotic agents|mesh-ancestor
64804414|NCT01414608|Mitosis Modulators|mitosis modulators|mesh-ancestor
64804415|NCT01414608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804416|NCT01414816|Interferons|interferons|mesh-list
64415500|NCT03044587|Vitamins|vitamins|mesh-ancestor
64804434|NCT01414868|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64804435|NCT01414868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64804436|NCT01414868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804437|NCT01414881|Mipomersen|mipomersen|mesh-list
64804438|NCT01414881|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64804439|NCT01414881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64804440|NCT01414881|Antimetabolites|antimetabolites|mesh-ancestor
64804441|NCT01414881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804442|NCT01414881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64804443|NCT01414972|Vitamin A|vitamin a|mesh-list
64804444|NCT01414972|Vitamins|vitamins|mesh-ancestor
64804445|NCT01414972|Micronutrients|micronutrients|mesh-ancestor
64804446|NCT01414972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804447|NCT01414998|Nicotine|nicotine|mesh-list
64804448|NCT01414998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64804449|NCT01414998|Autonomic Agents|autonomic agents|mesh-ancestor
64804450|NCT01414998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64804451|NCT01414998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804452|NCT01414998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64804453|NCT01414998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64804457|NCT01415011|Afatinib|afatinib|mesh-list
64804489|NCT01415336|Cyclophosphamide|cyclophosphamide|mesh-list
64804490|NCT01415336|Doxorubicin|doxorubicin|mesh-list
64804491|NCT01415336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64804492|NCT01415336|Capecitabine|capecitabine|mesh-list
64804493|NCT01415336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64804494|NCT01415336|Immunologic Factors|immunologic factors|mesh-ancestor
64804495|NCT01415336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804496|NCT01415336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64804513|NCT01415505|Valsartan|valsartan|mesh-list
64804564|NCT01415713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64804565|NCT01415713|Antimetabolites|antimetabolites|mesh-ancestor
64804566|NCT01415713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804567|NCT01415713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804568|NCT01415713|Antiviral Agents|antiviral agents|mesh-ancestor
64804569|NCT01415713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64804570|NCT01415713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804571|NCT01415713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64804572|NCT01415713|Immunologic Factors|immunologic factors|mesh-ancestor
64804573|NCT01415713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804574|NCT01415713|Antidotes|antidotes|mesh-ancestor
64804575|NCT01415713|Protective Agents|protective agents|mesh-ancestor
64804576|NCT01415713|Vitamin B Complex|vitamin b complex|mesh-ancestor
64804577|NCT01415713|Vitamins|vitamins|mesh-ancestor
64804578|NCT01415713|Micronutrients|micronutrients|mesh-ancestor
64804579|NCT01415765|Prednisone|prednisone|mesh-list
64804624|NCT01415895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64804625|NCT01415895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804626|NCT01415895|Sensory System Agents|sensory system agents|mesh-ancestor
64804627|NCT01415895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64804628|NCT01415895|Analgesics|analgesics|mesh-ancestor
64804629|NCT01415895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64804630|NCT01415895|Sympatholytics|sympatholytics|mesh-ancestor
64804631|NCT01415895|Autonomic Agents|autonomic agents|mesh-ancestor
64804632|NCT01415895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64804633|NCT01415895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64804634|NCT01415895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64804635|NCT01415895|Adrenergic Agents|adrenergic agents|mesh-ancestor
64804636|NCT01415895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64804637|NCT01415895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804638|NCT01416038|Cyclophosphamide|cyclophosphamide|mesh-list
64804639|NCT01416038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64804640|NCT01416038|Immunologic Factors|immunologic factors|mesh-ancestor
64804641|NCT01416038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804642|NCT01416038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64804643|NCT01416038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64804644|NCT01416038|Alkylating Agents|alkylating agents|mesh-ancestor
64804645|NCT01416038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804646|NCT01416038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804647|NCT01416038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64804648|NCT01416116|Lidocaine|lidocaine|mesh-list
64804649|NCT01416116|Tramadol|tramadol|mesh-list
64804650|NCT01416116|Capsaicin|capsaicin|mesh-list
64804651|NCT01416116|Anesthetics, Local|anesthetics, local|mesh-ancestor
64804652|NCT01416116|Anesthetics|anesthetics|mesh-ancestor
64804653|NCT01416116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64804654|NCT01416116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804661|NCT01416116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804662|NCT01416116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64804663|NCT01416116|Narcotics|narcotics|mesh-ancestor
64804664|NCT01416116|Analgesics|analgesics|mesh-ancestor
64804665|NCT01416116|Antipruritics|antipruritics|mesh-ancestor
64804666|NCT01416116|Dermatologic Agents|dermatologic agents|mesh-ancestor
64804667|NCT01416207|Interferons|interferons|mesh-list
64804668|NCT01416207|Interferon beta-1a|interferon beta-1a|mesh-list
64804669|NCT01416207|Interferon-beta|interferon-beta|mesh-list
64804670|NCT01416207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804671|NCT01416207|Antiviral Agents|antiviral agents|mesh-ancestor
64804672|NCT01416207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64804673|NCT01416207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64804674|NCT01416207|Immunologic Factors|immunologic factors|mesh-ancestor
64415735|NCT05519111|Dronabinol|dronabinol|mesh-list
64804682|NCT01416220|Antimanic Agents|antimanic agents|mesh-ancestor
64804683|NCT01416220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64804684|NCT01416220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64804685|NCT01416220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804686|NCT01416220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64804687|NCT01416220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64804688|NCT01416220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64804689|NCT01416220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64804690|NCT01416220|Serotonin Agents|serotonin agents|mesh-ancestor
64804691|NCT01416220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64804692|NCT01416220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64804693|NCT01416220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64804694|NCT01416246|Anti-Infective Agents|anti-infective agents|mesh-list
64804695|NCT01416246|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64804696|NCT01416337|Trametinib|trametinib|mesh-list
64804697|NCT01416337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804698|NCT01416337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64804699|NCT01416337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951903|NCT00055965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951904|NCT00055965|Antiviral Agents|antiviral agents|mesh-ancestor
64951905|NCT00055965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951906|NCT00055965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951907|NCT00055965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951908|NCT00055965|Immunologic Factors|immunologic factors|mesh-ancestor
64725720|NCT00003044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725722|NCT00002161|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64804700|NCT01416337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804701|NCT01416350|Azithromycin|azithromycin|mesh-list
64804702|NCT01416350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64804703|NCT01416350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64804704|NCT01416415|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64804705|NCT01416415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64804706|NCT01416480|Theobromine|theobromine|mesh-list
64804707|NCT01416480|Dipropizine|dipropizine|mesh-list
64804708|NCT01416480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64804709|NCT01416480|Autonomic Agents|autonomic agents|mesh-ancestor
64804710|NCT01416480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64804711|NCT01416480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804712|NCT01416480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64804713|NCT01416480|Respiratory System Agents|respiratory system agents|mesh-ancestor
64804714|NCT01416480|Vasodilator Agents|vasodilator agents|mesh-ancestor
64804715|NCT01416480|Antitussive Agents|antitussive agents|mesh-ancestor
64804716|NCT01416558|Paclitaxel|paclitaxel|mesh-list
64804717|NCT01416558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64804718|NCT01416558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804719|NCT01416558|Tubulin Modulators|tubulin modulators|mesh-ancestor
64804720|NCT01416558|Antimitotic Agents|antimitotic agents|mesh-ancestor
64804723|NCT01416649|Exenatide|exenatide|mesh-list
64804757|NCT01416883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64804758|NCT01416883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804759|NCT01416883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804760|NCT01416909|Laxatives|laxatives|mesh-list
64804761|NCT01416909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64804762|NCT01416948|Methylphenidate|methylphenidate|mesh-list
64804763|NCT01416948|Galantamine|galantamine|mesh-list
64804770|NCT01416948|Dopamine Agents|dopamine agents|mesh-ancestor
64804833|NCT01417364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804834|NCT01417364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64804835|NCT01417364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804836|NCT01417364|Anabolic Agents|anabolic agents|mesh-ancestor
64804837|NCT01417390|Gemcitabine|gemcitabine|mesh-list
64804838|NCT01417390|Cisplatin|cisplatin|mesh-list
64804839|NCT01417390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804840|NCT01417390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64804841|NCT01417390|Antimetabolites|antimetabolites|mesh-ancestor
64804842|NCT01417390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804843|NCT01417390|Antiviral Agents|antiviral agents|mesh-ancestor
64804844|NCT01417390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64804845|NCT01417390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804846|NCT01417390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64804847|NCT01417390|Immunologic Factors|immunologic factors|mesh-ancestor
64804848|NCT01417390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804849|NCT01417403|Hydroxychloroquine|hydroxychloroquine|mesh-list
64804850|NCT01417403|Antimalarials|antimalarials|mesh-ancestor
64804851|NCT01417403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64804852|NCT01417403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64804933|NCT01417858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64804934|NCT01417858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64804935|NCT01417858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64804936|NCT01417858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64804937|NCT01417858|Adrenergic Agents|adrenergic agents|mesh-ancestor
64804938|NCT01417858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64804939|NCT01417858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804940|NCT01417858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804941|NCT01417897|Insulin|insulin|mesh-list
64804942|NCT01417897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64804943|NCT01417897|Insulin Aspart|insulin aspart|mesh-list
64804944|NCT01417897|Insulin glulisine|insulin glulisine|mesh-list
64804945|NCT01417897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64804946|NCT01417897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804947|NCT01417923|Vitamin D|vitamin d|mesh-list
64804948|NCT01417923|Vitamins|vitamins|mesh-ancestor
64804949|NCT01417923|Micronutrients|micronutrients|mesh-ancestor
64804950|NCT01417923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804951|NCT01417923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64804952|NCT01417949|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64805000|NCT01418157|Natriuretic Agents|natriuretic agents|mesh-ancestor
64805001|NCT01418157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805002|NCT01418183|Levobupivacaine|levobupivacaine|mesh-list
64805003|NCT01418183|Anesthetics, Local|anesthetics, local|mesh-ancestor
64805004|NCT01418183|Anesthetics|anesthetics|mesh-ancestor
64805005|NCT01418183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64805006|NCT01418183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805007|NCT01418183|Sensory System Agents|sensory system agents|mesh-ancestor
64805008|NCT01418183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64805009|NCT01418235|MF59 oil emulsion|mf59 oil emulsion|mesh-list
64805010|NCT01418235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64805011|NCT01418235|Immunologic Factors|immunologic factors|mesh-ancestor
64805012|NCT01418235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805013|NCT01418274|Ritonavir|ritonavir|mesh-list
64805014|NCT01418274|Citalopram|citalopram|mesh-list
64805015|NCT01418274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64805016|NCT01418274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64805017|NCT01418274|Protease Inhibitors|protease inhibitors|mesh-ancestor
64805018|NCT01418274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805019|NCT01418274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805020|NCT01418274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64805021|NCT01418274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64805022|NCT01418274|Antiviral Agents|antiviral agents|mesh-ancestor
64805023|NCT01418274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64805024|NCT01418274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64805025|NCT01418274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64805026|NCT01418274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64805051|NCT01418456|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64805052|NCT01418456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64805053|NCT01418521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64805054|NCT01418534|Isosorbide|isosorbide|mesh-list
64805055|NCT01418534|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64805056|NCT01418534|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64805057|NCT01418534|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64805058|NCT01418534|Diuretics|diuretics|mesh-ancestor
64805059|NCT01418534|Natriuretic Agents|natriuretic agents|mesh-ancestor
64805060|NCT01418534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805061|NCT01418534|Vasodilator Agents|vasodilator agents|mesh-ancestor
64805062|NCT01418534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64805063|NCT01418534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805064|NCT01418547|Isosorbide|isosorbide|mesh-list
64805065|NCT01418547|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64805066|NCT01418547|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64805067|NCT01418547|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64805068|NCT01418547|Diuretics|diuretics|mesh-ancestor
64805069|NCT01418547|Natriuretic Agents|natriuretic agents|mesh-ancestor
64805070|NCT01418547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805071|NCT01418547|Vasodilator Agents|vasodilator agents|mesh-ancestor
64805072|NCT01418547|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64805073|NCT01418547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805074|NCT01418586|Alfuzosin|alfuzosin|mesh-list
64805075|NCT01418586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64805076|NCT01418586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64805077|NCT01418586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64805092|NCT01418612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64805093|NCT01418612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64805094|NCT01418612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64805095|NCT01418612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64805096|NCT01418612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805097|NCT01418612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64805098|NCT01418612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805099|NCT01418612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64805100|NCT01418612|Antidepressive Agents|antidepressive agents|mesh-ancestor
64805101|NCT01418612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64805102|NCT01418625|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64805103|NCT01418625|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64805104|NCT01418625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64805175|NCT01419262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64805176|NCT01419262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64805177|NCT01419340|Donepezil|donepezil|mesh-list
64805178|NCT01419340|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64805179|NCT01419340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805180|NCT01419340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805181|NCT01419340|Cholinergic Agents|cholinergic agents|mesh-ancestor
64805251|NCT01419730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805252|NCT01419730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64805253|NCT01419730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64805254|NCT01419821|Vitamin D|vitamin d|mesh-list
64805255|NCT01419821|Ergocalciferols|ergocalciferols|mesh-list
64805256|NCT01419821|Cholecalciferol|cholecalciferol|mesh-list
64805257|NCT01419821|Vitamins|vitamins|mesh-list
64805258|NCT01419821|Micronutrients|micronutrients|mesh-ancestor
64805259|NCT01419821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805260|NCT01419821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64805261|NCT01419821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64805262|NCT01419847|Ciclopirox|ciclopirox|mesh-list
64805263|NCT01419847|Antifungal Agents|antifungal agents|mesh-ancestor
64805264|NCT01419847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64805265|NCT01419873|Insulin|insulin|mesh-list
64805266|NCT01419873|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64805267|NCT01419873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64805268|NCT01419873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805269|NCT01420055|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64805270|NCT01420055|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64805271|NCT01420055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805272|NCT01420055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64805273|NCT01420055|Immunologic Factors|immunologic factors|mesh-ancestor
64805274|NCT01420055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805275|NCT01420094|Aspirin|aspirin|mesh-list
64805276|NCT01420094|Acetaminophen|acetaminophen|mesh-list
64805279|NCT01420094|Analgesics|analgesics|mesh-ancestor
64805302|NCT01420328|Simvastatin|simvastatin|mesh-list
64805303|NCT01420328|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
64805304|NCT01420328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64805305|NCT01420328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64805306|NCT01420328|Antimetabolites|antimetabolites|mesh-ancestor
64805307|NCT01420328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805308|NCT01420328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64805309|NCT01420328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64805310|NCT01420328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805311|NCT01420341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64805312|NCT01420341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64805313|NCT01420341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64805314|NCT01420341|Renal Agents|renal agents|mesh-ancestor
64805315|NCT01420341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64805316|NCT01420341|Antimalarials|antimalarials|mesh-ancestor
64805317|NCT01420341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64805318|NCT01420341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64805319|NCT01420367|Metronidazole|metronidazole|mesh-list
64805320|NCT01420367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64805321|NCT01420367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64805322|NCT01420367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64805323|NCT01420367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64805325|NCT01420406|Vitamins|vitamins|mesh-ancestor
64805326|NCT01420406|Micronutrients|micronutrients|mesh-ancestor
64805327|NCT01420406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805328|NCT01420471|Triamcinolone|triamcinolone|mesh-list
64805329|NCT01420471|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64805330|NCT01420471|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64805331|NCT01420471|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64805332|NCT01420471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64805333|NCT01420471|Glucocorticoids|glucocorticoids|mesh-ancestor
64805334|NCT01420471|Hormones|hormones|mesh-ancestor
64573937|NCT02205515|Everolimus|everolimus|mesh-list
64805340|NCT01420471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805341|NCT01420523|Raltegravir Potassium|raltegravir potassium|mesh-list
64805342|NCT01420523|Maraviroc|maraviroc|mesh-list
64805343|NCT01420523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64805344|NCT01420523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64805345|NCT01420523|Antiviral Agents|antiviral agents|mesh-ancestor
64805346|NCT01420523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64805347|NCT01420523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64805348|NCT01420523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64805349|NCT01420523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805350|NCT01420523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805351|NCT01420523|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64805352|NCT01420523|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64805353|NCT01420523|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64805354|NCT01420575|Olanzapine|olanzapine|mesh-list
64805355|NCT01420575|Antiemetics|antiemetics|mesh-ancestor
64805356|NCT01420575|Autonomic Agents|autonomic agents|mesh-ancestor
64805357|NCT01420575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64805358|NCT01420575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805359|NCT01420575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64805360|NCT01420575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64805361|NCT01420575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64416429|NCT02612779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64805380|NCT01420666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64805381|NCT01420666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64805382|NCT01420666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805383|NCT01420666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805384|NCT01420692|Insulin Detemir|insulin detemir|mesh-list
64805385|NCT01420692|Gliclazide|gliclazide|mesh-list
64805401|NCT01420900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805402|NCT01420900|Cholinergic Agents|cholinergic agents|mesh-ancestor
64805403|NCT01420900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64805404|NCT01420900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805405|NCT01420900|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64805406|NCT01420900|Autonomic Agents|autonomic agents|mesh-ancestor
64805408|NCT01420900|Nootropic Agents|nootropic agents|mesh-ancestor
64401053|NCT02936843|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
64472185|NCT03712943|Nivolumab|nivolumab|mesh-list
64472186|NCT03712943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64805505|NCT01421368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64805506|NCT01421368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64805507|NCT01421368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64805508|NCT01421693|Ceftriaxone|ceftriaxone|mesh-list
64805509|NCT01421693|Gatifloxacin|gatifloxacin|mesh-list
64805510|NCT01421693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64805511|NCT01421693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64805512|NCT01421693|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64805513|NCT01421693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64805514|NCT01421693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64805515|NCT01421693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64805516|NCT01421693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805517|NCT01421693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805518|NCT01421693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64805519|NCT01421706|Clarithromycin|clarithromycin|mesh-list
64805520|NCT01421706|Sibutramine|sibutramine|mesh-list
64805521|NCT01421706|Clopidogrel|clopidogrel|mesh-list
64805522|NCT01421706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64805523|NCT01421706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64805524|NCT01421706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64805525|NCT01421706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64805526|NCT01421706|Purinergic Agents|purinergic agents|mesh-ancestor
64805527|NCT01421706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64805528|NCT01421706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805569|NCT01421979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805570|NCT01421979|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64805571|NCT01421979|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64805572|NCT01421979|Purinergic Agents|purinergic agents|mesh-ancestor
64805573|NCT01421979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64805574|NCT01421992|Methylphenidate|methylphenidate|mesh-list
64805575|NCT01421992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64805576|NCT01421992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805577|NCT01421992|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64805578|NCT01421992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64805586|NCT01422018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64805587|NCT01422018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64805588|NCT01422018|Growth Substances|growth substances|mesh-ancestor
64805589|NCT01422018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805590|NCT01422018|Growth Inhibitors|growth inhibitors|mesh-ancestor
64805630|NCT01422291|Morphine|morphine|mesh-list
64805631|NCT01422291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64805632|NCT01422291|Narcotics|narcotics|mesh-ancestor
64574235|NCT04836078|Chitosan|chitosan|mesh-list
64805633|NCT01422291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64805634|NCT01422291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805635|NCT01422291|Analgesics|analgesics|mesh-ancestor
64805636|NCT01422291|Sensory System Agents|sensory system agents|mesh-ancestor
64805637|NCT01422291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64805638|NCT01422291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64805639|NCT01422291|Antipyretics|antipyretics|mesh-ancestor
64805640|NCT01422291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64805641|NCT01422291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64805642|NCT01422291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64805643|NCT01422317|Tocopherols|tocopherols|mesh-list
64805644|NCT01422317|Vitamin E|vitamin e|mesh-list
64805645|NCT01422317|Tocotrienols|tocotrienols|mesh-list
64805656|NCT01422330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805657|NCT01422330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805658|NCT01422330|Antiviral Agents|antiviral agents|mesh-ancestor
64805659|NCT01422330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64805660|NCT01422460|Mitogens|mitogens|mesh-list
64805661|NCT01422460|Mitosis Modulators|mitosis modulators|mesh-ancestor
64805662|NCT01422460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805663|NCT01422499|Vorinostat|vorinostat|mesh-list
64805664|NCT01422499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64805665|NCT01422499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64805666|NCT01422499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805667|NCT01422499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805668|NCT01422590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64805669|NCT01422590|Mitiglinide|mitiglinide|mesh-list
64805670|NCT01422590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64805671|NCT01422590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805672|NCT01422590|Incretins|incretins|mesh-ancestor
64805673|NCT01422590|Hormones|hormones|mesh-ancestor
64805675|NCT01422590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64805676|NCT01422590|Protease Inhibitors|protease inhibitors|mesh-ancestor
64805677|NCT01422590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805678|NCT01422590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805679|NCT01422603|Clofarabine|clofarabine|mesh-list
64805680|NCT01422603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64805681|NCT01422603|Antimetabolites|antimetabolites|mesh-ancestor
64805682|NCT01422603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805683|NCT01422603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64805684|NCT01422616|Metoprolol|metoprolol|mesh-list
64805685|NCT01422616|Clonidine|clonidine|mesh-list
64805686|NCT01422616|Labetalol|labetalol|mesh-list
64805687|NCT01422616|Hydralazine|hydralazine|mesh-list
64805688|NCT01422616|Nicardipine|nicardipine|mesh-list
64805689|NCT01422616|Phentolamine|phentolamine|mesh-list
64805795|NCT01423123|Antimitotic Agents|antimitotic agents|mesh-ancestor
64805796|NCT01423123|Mitosis Modulators|mitosis modulators|mesh-ancestor
64805797|NCT01423123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805798|NCT01423123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64805799|NCT01423175|Clofarabine|clofarabine|mesh-list
64805800|NCT01423175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64805801|NCT01423175|Antimetabolites|antimetabolites|mesh-ancestor
64805802|NCT01423175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805830|NCT01423305|Formoterol Fumarate|formoterol fumarate|mesh-list
64805831|NCT01423305|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64805832|NCT01423305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64805833|NCT01423305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64805834|NCT01423305|Autonomic Agents|autonomic agents|mesh-ancestor
64805835|NCT01423305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64805836|NCT01423305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805975|NCT01424124|Respiratory System Agents|respiratory system agents|mesh-ancestor
64805976|NCT01424124|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64805977|NCT01424124|Hormone Antagonists|hormone antagonists|mesh-ancestor
64805978|NCT01424124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64805979|NCT01424124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805980|NCT01424124|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64805981|NCT01424124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64805982|NCT01424124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805983|NCT01424137|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64805984|NCT01424137|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64805985|NCT01424137|Autonomic Agents|autonomic agents|mesh-ancestor
64805986|NCT01424137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64805987|NCT01424137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805988|NCT01424137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64805989|NCT01424137|Respiratory System Agents|respiratory system agents|mesh-ancestor
64805990|NCT01424137|Glucocorticoids|glucocorticoids|mesh-ancestor
64805991|NCT01424137|Hormones|hormones|mesh-ancestor
64805992|NCT01424137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64805993|NCT01424137|Sympathomimetics|sympathomimetics|mesh-ancestor
64805994|NCT01424176|Pramipexole|pramipexole|mesh-list
64805995|NCT01424176|Antioxidants|antioxidants|mesh-ancestor
64805996|NCT01424176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805997|NCT01424176|Protective Agents|protective agents|mesh-ancestor
64805998|NCT01424176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806004|NCT01424241|Octreotide|octreotide|mesh-list
64806043|NCT01424345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806045|NCT01424384|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64806046|NCT01424384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64806047|NCT01424384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64806048|NCT01424384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806049|NCT01424384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64806050|NCT01424384|Serotonin Agents|serotonin agents|mesh-ancestor
64806051|NCT01424384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806052|NCT01424384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64806053|NCT01424384|Antidepressive Agents|antidepressive agents|mesh-ancestor
64806054|NCT01424384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64806055|NCT01424449|Aripiprazole|aripiprazole|mesh-list
64806056|NCT01424449|Antidepressive Agents|antidepressive agents|mesh-ancestor
64806057|NCT01424449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64806058|NCT01424449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64806059|NCT01424449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64806069|NCT01424449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64806070|NCT01424449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64806071|NCT01424449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64806072|NCT01424449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64806074|NCT01424618|Ganirelix|ganirelix|mesh-list
64806075|NCT01424618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64806076|NCT01424618|Fertility Agents|fertility agents|mesh-ancestor
64806077|NCT01424618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64806078|NCT01424618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806079|NCT01424618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64806080|NCT01424618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806081|NCT01424618|Hormone Antagonists|hormone antagonists|mesh-ancestor
64806082|NCT01424618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64806083|NCT01424709|Gemcitabine|gemcitabine|mesh-list
64725723|NCT00002161|Antiviral Agents|antiviral agents|mesh-ancestor
64725724|NCT00002161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725725|NCT00002161|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64725726|NCT00002161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64725727|NCT00002161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725728|NCT00002161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951911|NCT00027833|Fluorouracil|fluorouracil|mesh-list
64951912|NCT00027833|Irinotecan|irinotecan|mesh-list
64951913|NCT00027833|Calcium|calcium|mesh-list
64951914|NCT00027833|Levoleucovorin|levoleucovorin|mesh-list
64806084|NCT01424709|Cisplatin|cisplatin|mesh-list
64806085|NCT01424709|Docetaxel|docetaxel|mesh-list
64806086|NCT01424709|Irinotecan|irinotecan|mesh-list
64806087|NCT01424709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806088|NCT01424709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64806089|NCT01424709|Antimetabolites|antimetabolites|mesh-ancestor
64806090|NCT01424709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806091|NCT01424709|Antiviral Agents|antiviral agents|mesh-ancestor
64806092|NCT01424709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64806093|NCT01424709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806094|NCT01424709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64806095|NCT01424709|Immunologic Factors|immunologic factors|mesh-ancestor
64806096|NCT01424709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806097|NCT01424709|Tubulin Modulators|tubulin modulators|mesh-ancestor
64806098|NCT01424709|Antimitotic Agents|antimitotic agents|mesh-ancestor
64806099|NCT01424709|Mitosis Modulators|mitosis modulators|mesh-ancestor
64806100|NCT01424709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64806101|NCT01424709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64806102|NCT01424761|Ubiquinone|ubiquinone|mesh-list
64806103|NCT01424761|Coenzyme Q10|coenzyme q10|mesh-list
64806104|NCT01424761|Micronutrients|micronutrients|mesh-ancestor
64806105|NCT01424761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806106|NCT01424761|Vitamins|vitamins|mesh-ancestor
64806107|NCT01424826|Raltegravir Potassium|raltegravir potassium|mesh-list
64806108|NCT01424826|Rifampin|rifampin|mesh-list
64806109|NCT01424826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64806110|NCT01424826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64806152|NCT01425060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494094|NCT03673462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472188|NCT03712943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64806153|NCT01425073|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64806154|NCT01425073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64806155|NCT01425073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64806156|NCT01425073|Renal Agents|renal agents|mesh-ancestor
64806158|NCT01425073|Antimalarials|antimalarials|mesh-ancestor
64806159|NCT01425073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64806160|NCT01425073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64806161|NCT01425099|Dolutegravir|dolutegravir|mesh-list
64806163|NCT01425099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64806164|NCT01425099|Glucocorticoids|glucocorticoids|mesh-ancestor
64806165|NCT01425099|Hormones|hormones|mesh-ancestor
64806166|NCT01425099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64806167|NCT01425099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806168|NCT01425099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64806169|NCT01425099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806170|NCT01425099|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64806171|NCT01425099|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64806172|NCT01425099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806250|NCT01425424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806251|NCT01425424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64806252|NCT01425424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64806253|NCT01425476|Vitamin D|vitamin d|mesh-list
64806254|NCT01425476|Cholecalciferol|cholecalciferol|mesh-list
64806255|NCT01425476|Celecoxib|celecoxib|mesh-list
64806256|NCT01425476|Vitamins|vitamins|mesh-ancestor
64806257|NCT01425476|Micronutrients|micronutrients|mesh-ancestor
64806258|NCT01425476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806259|NCT01425476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64806260|NCT01425476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64806261|NCT01425476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64806262|NCT01425476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64806263|NCT01425476|Analgesics|analgesics|mesh-ancestor
64806264|NCT01425476|Sensory System Agents|sensory system agents|mesh-ancestor
64806265|NCT01425476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806297|NCT01425619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64806298|NCT01425619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806299|NCT01425658|Clonidine|clonidine|mesh-list
64806300|NCT01425658|Fentanyl|fentanyl|mesh-list
64806301|NCT01425658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64806302|NCT01425658|Narcotics|narcotics|mesh-ancestor
64806303|NCT01425658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64806338|NCT01425736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64806339|NCT01425736|Immunologic Factors|immunologic factors|mesh-ancestor
64806340|NCT01425736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806341|NCT01425736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64806342|NCT01425775|Vitamin D|vitamin d|mesh-list
64806343|NCT01425775|Vitamins|vitamins|mesh-ancestor
64806344|NCT01425775|Micronutrients|micronutrients|mesh-ancestor
64806345|NCT01425775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806346|NCT01425775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64806347|NCT05386446|Interferons|interferons|mesh-list
64806348|NCT05386446|Interferon-gamma|interferon-gamma|mesh-list
64806349|NCT05386446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806350|NCT05386446|Antiviral Agents|antiviral agents|mesh-ancestor
64806351|NCT05386446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64806352|NCT05386290|Mesalamine|mesalamine|mesh-list
64806353|NCT05386290|Infliximab|infliximab|mesh-list
64806354|NCT05386290|Ustekinumab|ustekinumab|mesh-list
64806355|NCT05386290|Vedolizumab|vedolizumab|mesh-list
64806356|NCT05386290|Dermatologic Agents|dermatologic agents|mesh-ancestor
64806357|NCT05386290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64806358|NCT05386290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64806359|NCT05386290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64806360|NCT05386290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64806361|NCT05386290|Analgesics|analgesics|mesh-ancestor
64806367|NCT05386186|Glimepiride|glimepiride|mesh-list
64806411|NCT05385887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64806412|NCT05385887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64806413|NCT05385887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806414|NCT05385887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494096|NCT03649880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806415|NCT05385887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806416|NCT05385887|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64806417|NCT05385887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64806418|NCT05385861|Carboplatin|carboplatin|mesh-list
64806419|NCT05385861|Irinotecan|irinotecan|mesh-list
64806420|NCT05385861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806421|NCT05385861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64806422|NCT05385861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64806423|NCT05385861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806424|NCT05385861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806425|NCT05385744|Teriflunomide|teriflunomide|mesh-list
64806426|NCT05385744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64806427|NCT05385744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64806428|NCT05385744|Analgesics|analgesics|mesh-ancestor
64806429|NCT05385744|Sensory System Agents|sensory system agents|mesh-ancestor
64806447|NCT05385094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806448|NCT05385068|Niraparib|niraparib|mesh-list
64806449|NCT05385068|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64806450|NCT05385068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806451|NCT05385068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806452|NCT05385068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806453|NCT05385029|Carbimazole|carbimazole|mesh-list
64806454|NCT05385029|Antithyroid Agents|antithyroid agents|mesh-ancestor
64575070|NCT00070135|Antimetabolites|antimetabolites|mesh-ancestor
64806455|NCT05385029|Hormone Antagonists|hormone antagonists|mesh-ancestor
64806456|NCT05385029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64806457|NCT05385029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806458|NCT05379413|Botulinum Toxins|botulinum toxins|mesh-list
64951918|NCT00027833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806459|NCT05379413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64806460|NCT05379413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64806461|NCT05379413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64806462|NCT05379413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64806463|NCT05379413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806464|NCT05379413|Cholinergic Agents|cholinergic agents|mesh-ancestor
64806465|NCT05379413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64806466|NCT05379413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806467|NCT05379413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64806468|NCT05379413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806469|NCT05379374|Morphine|morphine|mesh-list
64806470|NCT05379374|Bupivacaine|bupivacaine|mesh-list
64806471|NCT05379374|Anesthetics, Local|anesthetics, local|mesh-ancestor
64806472|NCT05379374|Anesthetics|anesthetics|mesh-ancestor
64806473|NCT05379374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64806474|NCT05379374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806475|NCT05379374|Sensory System Agents|sensory system agents|mesh-ancestor
64806476|NCT05379374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806477|NCT05379374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64806478|NCT05379374|Narcotics|narcotics|mesh-ancestor
64806479|NCT05379374|Analgesics|analgesics|mesh-ancestor
64806480|NCT05375708|Bevacizumab|bevacizumab|mesh-list
64806481|NCT05375708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64806482|NCT05375708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806483|NCT05375708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64806484|NCT05375708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64806485|NCT05375708|Growth Substances|growth substances|mesh-ancestor
64806509|NCT05176379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64806510|NCT05176379|Hormone Antagonists|hormone antagonists|mesh-ancestor
64806511|NCT05176379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64951919|NCT00027833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64951921|NCT00027833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951922|NCT00027833|Immunologic Factors|immunologic factors|mesh-ancestor
64951923|NCT00027833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64951924|NCT00027833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64951925|NCT00027833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951926|NCT00027833|Antidotes|antidotes|mesh-ancestor
64951927|NCT00027833|Protective Agents|protective agents|mesh-ancestor
64951928|NCT00027833|Vitamin B Complex|vitamin b complex|mesh-ancestor
64951929|NCT00027833|Vitamins|vitamins|mesh-ancestor
64951930|NCT00027833|Micronutrients|micronutrients|mesh-ancestor
64806512|NCT05176379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806513|NCT05176379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64806514|NCT05176379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64806515|NCT05113615|Bromides|bromides|mesh-list
64806516|NCT05113615|Tiotropium Bromide|tiotropium bromide|mesh-list
64806517|NCT05113615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64806518|NCT05113615|Autonomic Agents|autonomic agents|mesh-ancestor
64806519|NCT05113615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806520|NCT05113615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806521|NCT05113615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64806522|NCT05113615|Respiratory System Agents|respiratory system agents|mesh-ancestor
64806523|NCT05113615|Parasympatholytics|parasympatholytics|mesh-ancestor
64806524|NCT05113615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64806525|NCT05113615|Cholinergic Agents|cholinergic agents|mesh-ancestor
64472189|NCT03712943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806526|NCT05113615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64806527|NCT05113615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806528|NCT05113615|Anticonvulsants|anticonvulsants|mesh-ancestor
64806529|NCT04850378|Dalteparin|dalteparin|mesh-list
64806530|NCT04850378|Tinzaparin|tinzaparin|mesh-list
64806531|NCT04850378|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64806532|NCT04850378|Apixaban|apixaban|mesh-list
64806533|NCT04850378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64806534|NCT04850378|Antithrombins|antithrombins|mesh-ancestor
64806582|NCT04729517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64806583|NCT04729517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806584|NCT04729517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806585|NCT04729517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64806606|NCT04698525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64806607|NCT04698525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64806608|NCT04673162|Methylprednisolone|methylprednisolone|mesh-list
64806609|NCT04673162|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64806610|NCT04673162|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64806611|NCT04673162|Prednisolone|prednisolone|mesh-list
64806612|NCT04673162|Prednisolone acetate|prednisolone acetate|mesh-list
64806613|NCT04673162|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64806614|NCT04673162|Prednisolone phosphate|prednisolone phosphate|mesh-list
64806615|NCT04673162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64806616|NCT04673162|Antiemetics|antiemetics|mesh-ancestor
64806617|NCT04673162|Autonomic Agents|autonomic agents|mesh-ancestor
64806618|NCT04673162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806619|NCT04673162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806620|NCT04673162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64806621|NCT04673162|Glucocorticoids|glucocorticoids|mesh-ancestor
64806623|NCT04673162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64806624|NCT04673162|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64806625|NCT04673162|Protective Agents|protective agents|mesh-ancestor
64806626|NCT04673162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64806627|NCT04673162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806628|NCT04638660|Phentolamine|phentolamine|mesh-list
64806629|NCT04638660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64806630|NCT04638660|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64806631|NCT04638660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64806632|NCT04638660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64806633|NCT04638660|Adrenergic Agents|adrenergic agents|mesh-ancestor
64806634|NCT04638660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64806635|NCT04638660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951931|NCT00027872|Tipifarnib|tipifarnib|mesh-list
64806636|NCT04638660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806637|NCT04638660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64806638|NCT04622020|Anesthetics|anesthetics|mesh-list
64806639|NCT04622020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64806640|NCT04622020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806641|NCT04560556|Antibodies|antibodies|mesh-list
64806666|NCT04425902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64806667|NCT04425902|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65494097|NCT03649880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64806670|NCT04425902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64806671|NCT04425902|Purinergic Agents|purinergic agents|mesh-ancestor
64806672|NCT04425902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64806673|NCT04425902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64806674|NCT04425902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64806797|NCT03759028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64806798|NCT03759028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64806799|NCT03759028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64806800|NCT03759028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64806801|NCT03759028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806802|NCT03759028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806803|NCT03759028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64806804|NCT03759028|Narcotics|narcotics|mesh-ancestor
64806805|NCT03759028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64806809|NCT03737292|Bupivacaine|bupivacaine|mesh-list
64806811|NCT03737292|Anesthetics|anesthetics|mesh-ancestor
64806878|NCT03142035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64806879|NCT03142035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64806880|NCT03142035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806881|NCT02786875|Vitamin D|vitamin d|mesh-list
64806882|NCT02786875|Ergocalciferols|ergocalciferols|mesh-list
64806883|NCT02786875|Cholecalciferol|cholecalciferol|mesh-list
64806899|NCT02767882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64806900|NCT02767882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806901|NCT02547662|Dexamethasone|dexamethasone|mesh-list
64806902|NCT02547662|Dexamethasone acetate|dexamethasone acetate|mesh-list
64806903|NCT02547662|Pomalidomide|pomalidomide|mesh-list
64806904|NCT02547662|Ixazomib|ixazomib|mesh-list
64334642|NCT03152877|Sensory System Agents|sensory system agents|mesh-ancestor
64334643|NCT03152877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334645|NCT02295709|Dexamethasone acetate|dexamethasone acetate|mesh-list
64806963|NCT02094794|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64806964|NCT02094794|Alkylating Agents|alkylating agents|mesh-ancestor
64806965|NCT02094794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806966|NCT02094794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806967|NCT02094794|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64806968|NCT02094794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64806969|NCT02094794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64806970|NCT02094794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64806971|NCT02094794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806972|NCT02010385|Octreotide|octreotide|mesh-list
64806973|NCT02010385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64806974|NCT02010385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64806975|NCT02010385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806976|NCT01949714|Epinephrine|epinephrine|mesh-list
64806977|NCT01949714|Racepinephrine|racepinephrine|mesh-list
64806978|NCT01949714|Epinephryl borate|epinephryl borate|mesh-list
64806979|NCT01949714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64806991|NCT01949714|Mydriatics|mydriatics|mesh-ancestor
64806995|NCT01596621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64806996|NCT01596621|Alkylating Agents|alkylating agents|mesh-ancestor
64806997|NCT01596621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806998|NCT01596621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806999|NCT01231906|Cyclophosphamide|cyclophosphamide|mesh-list
64807000|NCT01231906|Ifosfamide|ifosfamide|mesh-list
64807001|NCT01231906|Isophosphamide mustard|isophosphamide mustard|mesh-list
64807002|NCT01231906|Doxorubicin|doxorubicin|mesh-list
64807003|NCT01231906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64807004|NCT01231906|Etoposide|etoposide|mesh-list
64807005|NCT01231906|Vincristine|vincristine|mesh-list
64807006|NCT01231906|Etoposide phosphate|etoposide phosphate|mesh-list
64807007|NCT01231906|Topotecan|topotecan|mesh-list
64807008|NCT01231906|Podophyllotoxin|podophyllotoxin|mesh-list
64807031|NCT01231906|Dermatologic Agents|dermatologic agents|mesh-ancestor
64807032|NCT01231906|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64807033|NCT01231906|Protective Agents|protective agents|mesh-ancestor
64807034|NCT00223145|Goserelin|goserelin|mesh-list
64807035|NCT00223145|Bicalutamide|bicalutamide|mesh-list
64807036|NCT00223145|Androgens|androgens|mesh-list
64807037|NCT00223145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64472190|NCT03699631|Methotrexate|methotrexate|mesh-list
64807038|NCT00223145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807055|NCT01425827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64807056|NCT01425827|Dopamine Agents|dopamine agents|mesh-ancestor
64807057|NCT01425840|Lidocaine|lidocaine|mesh-list
64807058|NCT01425840|Anesthetics, Local|anesthetics, local|mesh-ancestor
64807059|NCT01425840|Anesthetics|anesthetics|mesh-ancestor
64807079|NCT01426022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64807080|NCT01426022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807081|NCT01426074|Bevacizumab|bevacizumab|mesh-list
64807082|NCT01426074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64807083|NCT01426074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807084|NCT01426074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64807085|NCT01426074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64807086|NCT01426074|Growth Substances|growth substances|mesh-ancestor
64807087|NCT01426074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807088|NCT01426074|Growth Inhibitors|growth inhibitors|mesh-ancestor
64807089|NCT01426087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64807158|NCT01426542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64807159|NCT01426542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807178|NCT01426737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807179|NCT01426737|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64807180|NCT01426737|Protease Inhibitors|protease inhibitors|mesh-ancestor
64807181|NCT01426737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807182|NCT01426737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807183|NCT01426802|Vildagliptin|vildagliptin|mesh-list
64807184|NCT01426802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64807185|NCT01426802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807186|NCT01426802|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64807187|NCT01426802|Protease Inhibitors|protease inhibitors|mesh-ancestor
64807188|NCT01426802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807189|NCT01426802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807190|NCT01426815|Golimumab|golimumab|mesh-list
64807191|NCT01426815|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64807192|NCT01426815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64807193|NCT01426815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64807194|NCT01426815|Immunologic Factors|immunologic factors|mesh-ancestor
64807195|NCT01426815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807196|NCT01426880|Paclitaxel|paclitaxel|mesh-list
64807197|NCT01426880|Carboplatin|carboplatin|mesh-list
64807198|NCT01426880|Lapatinib|lapatinib|mesh-list
64807199|NCT01426880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64807200|NCT01426880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807201|NCT01426880|Tubulin Modulators|tubulin modulators|mesh-ancestor
64807202|NCT01426880|Antimitotic Agents|antimitotic agents|mesh-ancestor
64807203|NCT01426880|Mitosis Modulators|mitosis modulators|mesh-ancestor
64807204|NCT01426880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807239|NCT01426971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64807240|NCT01426971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64807241|NCT01426971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64807242|NCT01426971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807243|NCT01426971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807244|NCT01426971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64807245|NCT01426971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64807246|NCT01426971|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64807247|NCT01426971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64807248|NCT01426971|Purinergic Agents|purinergic agents|mesh-ancestor
64807249|NCT01426971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64807303|NCT01427244|Trastuzumab|trastuzumab|mesh-list
64807304|NCT01427244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64807305|NCT01427244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807306|NCT01427270|Oxycodone|oxycodone|mesh-list
64807307|NCT01427270|Naloxone|naloxone|mesh-list
64807308|NCT01427270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64807309|NCT01427270|Narcotics|narcotics|mesh-ancestor
64807310|NCT01427270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64807311|NCT01427270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807312|NCT01427270|Analgesics|analgesics|mesh-ancestor
64807313|NCT01427270|Sensory System Agents|sensory system agents|mesh-ancestor
64807314|NCT01427270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807315|NCT01427270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64807316|NCT01427283|Oxycodone|oxycodone|mesh-list
64807317|NCT01427283|Naloxone|naloxone|mesh-list
64807318|NCT01427283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64807319|NCT01427283|Narcotics|narcotics|mesh-ancestor
64807320|NCT01427283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64807321|NCT01427283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807322|NCT01427283|Analgesics|analgesics|mesh-ancestor
64807323|NCT01427283|Sensory System Agents|sensory system agents|mesh-ancestor
64807324|NCT01427283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807325|NCT01427283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64807326|NCT01427322|Lapatinib|lapatinib|mesh-list
64807327|NCT01427322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807328|NCT01427322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64807329|NCT01427322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807330|NCT01427322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418417|NCT05550415|Simvastatin|simvastatin|mesh-list
64807359|NCT01427491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64807360|NCT01427582|Trabectedin|trabectedin|mesh-list
64807361|NCT01427582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64807362|NCT01427582|Alkylating Agents|alkylating agents|mesh-ancestor
64807363|NCT01427582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807364|NCT01427582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807365|NCT01427686|Dobutamine|dobutamine|mesh-list
64807366|NCT01427686|Dopamine|dopamine|mesh-list
64807367|NCT01427686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64807368|NCT01427686|Sympathomimetics|sympathomimetics|mesh-ancestor
64807369|NCT01427686|Autonomic Agents|autonomic agents|mesh-ancestor
64807370|NCT01427686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807371|NCT01427686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807372|NCT01427686|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65494102|NCT03592992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64472193|NCT03699631|Abortifacient Agents|abortifacient agents|mesh-ancestor
64807373|NCT01427686|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64807374|NCT01427686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64807375|NCT01427686|Adrenergic Agents|adrenergic agents|mesh-ancestor
64418475|NCT01905631|Promethazine|promethazine|mesh-list
64807401|NCT01427985|Analgesics|analgesics|mesh-ancestor
64807402|NCT01427985|Sensory System Agents|sensory system agents|mesh-ancestor
64807403|NCT01427985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807404|NCT01427985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64807405|NCT01427985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64807406|NCT01427985|Anesthetics, General|anesthetics, general|mesh-ancestor
64807407|NCT01427985|Anesthetics|anesthetics|mesh-ancestor
64807408|NCT01427985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64807409|NCT01427985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64807486|NCT01428414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64807487|NCT01428414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64807488|NCT01428414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64807489|NCT01428414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64807490|NCT01428414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807492|NCT01428427|Trametinib|trametinib|mesh-list
64807493|NCT01428427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64807494|NCT01428427|Antimetabolites|antimetabolites|mesh-ancestor
64807495|NCT01428427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807496|NCT01428427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807497|NCT01428427|Antiviral Agents|antiviral agents|mesh-ancestor
64807498|NCT01428427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64807499|NCT01428427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807500|NCT01428427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64807501|NCT01428427|Immunologic Factors|immunologic factors|mesh-ancestor
64807502|NCT01428427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807503|NCT01428427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64807504|NCT01428466|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64807505|NCT01428466|Dermatologic Agents|dermatologic agents|mesh-ancestor
64807506|NCT01428492|Dexamethasone|dexamethasone|mesh-list
64807507|NCT01428492|Bortezomib|bortezomib|mesh-list
64807508|NCT01428492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64807509|NCT01428492|Antiemetics|antiemetics|mesh-ancestor
64807510|NCT01428492|Autonomic Agents|autonomic agents|mesh-ancestor
64807511|NCT01428492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807512|NCT01428492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807513|NCT01428492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65494103|NCT03592992|Narcotics|narcotics|mesh-ancestor
64807532|NCT01428531|Fondaparinux|fondaparinux|mesh-list
64807533|NCT01428531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64807534|NCT01428531|Antithrombins|antithrombins|mesh-ancestor
64807535|NCT01428531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64807573|NCT01428986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64807574|NCT01428986|Antiviral Agents|antiviral agents|mesh-ancestor
64418690|NCT05678257|Vitamins|vitamins|mesh-ancestor
64807598|NCT01429090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807600|NCT01429129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64807601|NCT01429129|Autonomic Agents|autonomic agents|mesh-ancestor
64807602|NCT01429129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807603|NCT01429129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807604|NCT01429129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64807605|NCT01429129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64807606|NCT01429129|Cholinergic Agents|cholinergic agents|mesh-ancestor
64807607|NCT01429129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64807608|NCT01429129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807609|NCT01429181|Methadone|methadone|mesh-list
64807610|NCT01429181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64807611|NCT01429181|Narcotics|narcotics|mesh-ancestor
64807612|NCT01429181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64807613|NCT01429181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807614|NCT01429181|Analgesics|analgesics|mesh-ancestor
64807615|NCT01429181|Sensory System Agents|sensory system agents|mesh-ancestor
64807616|NCT01429181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807617|NCT01429181|Antitussive Agents|antitussive agents|mesh-ancestor
64807618|NCT01429181|Respiratory System Agents|respiratory system agents|mesh-ancestor
64807736|NCT01429831|Dopamine Agonists|dopamine agonists|mesh-ancestor
64807737|NCT01429831|Dopamine Agents|dopamine agents|mesh-ancestor
64807738|NCT01429831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64807739|NCT01429831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807740|NCT01429831|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64807741|NCT01429831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64807742|NCT01429831|Serotonin Agents|serotonin agents|mesh-ancestor
65494104|NCT03592992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64807760|NCT01429870|Triamcinolone|triamcinolone|mesh-list
64807761|NCT01429870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64807762|NCT01429870|Glucocorticoids|glucocorticoids|mesh-ancestor
64807763|NCT01429870|Hormones|hormones|mesh-ancestor
64807764|NCT01429870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64807765|NCT01429870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807766|NCT01429935|Ibuprofen|ibuprofen|mesh-list
64807767|NCT01429935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64807768|NCT01429935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64807769|NCT01429935|Analgesics|analgesics|mesh-ancestor
64807770|NCT01429935|Sensory System Agents|sensory system agents|mesh-ancestor
64807771|NCT01429935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807772|NCT01429935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807773|NCT01429935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64807774|NCT01429935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64807775|NCT01429935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64807776|NCT01429935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807799|NCT01430065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64807800|NCT01430065|Immunologic Factors|immunologic factors|mesh-ancestor
64807806|NCT01430078|Peficitinib|peficitinib|mesh-list
64807807|NCT01430078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807808|NCT01430078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807809|NCT01430078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64807810|NCT01430078|Immunologic Factors|immunologic factors|mesh-ancestor
64807811|NCT01430078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807812|NCT01430078|Vitamin B Complex|vitamin b complex|mesh-ancestor
64807813|NCT01430078|Vitamins|vitamins|mesh-ancestor
64807814|NCT01430078|Micronutrients|micronutrients|mesh-ancestor
64807815|NCT01430195|Afamelanotide|afamelanotide|mesh-list
64807817|NCT01430234|Pancreatin|pancreatin|mesh-list
64807869|NCT01430910|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64807870|NCT01430910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807883|NCT01431053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64807884|NCT01431053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64807885|NCT01431053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64807886|NCT01431053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64807887|NCT01431053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807888|NCT01431053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64807889|NCT01431053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64807890|NCT01431053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807892|NCT01431053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807893|NCT01431053|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64807894|NCT01431053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64807895|NCT01431053|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64807896|NCT01431053|Hormone Antagonists|hormone antagonists|mesh-ancestor
64807897|NCT01431053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64807898|NCT01431092|Melatonin|melatonin|mesh-list
64807899|NCT01431092|Antioxidants|antioxidants|mesh-ancestor
64807900|NCT01431092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807901|NCT01431092|Protective Agents|protective agents|mesh-ancestor
64807902|NCT01431092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807903|NCT01431092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64807904|NCT01431118|Camphor|camphor|mesh-list
64807905|NCT01431118|Salicylates|salicylates|mesh-list
64807906|NCT01431118|Methyl salicylate|methyl salicylate|mesh-list
64807907|NCT01431118|Menthol|menthol|mesh-list
64807908|NCT01431118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64807909|NCT01431118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64807910|NCT01431118|Antipruritics|antipruritics|mesh-ancestor
64807911|NCT01431118|Dermatologic Agents|dermatologic agents|mesh-ancestor
64807912|NCT01431118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64807913|NCT01431118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64807914|NCT01431118|Analgesics|analgesics|mesh-ancestor
64807915|NCT01431118|Sensory System Agents|sensory system agents|mesh-ancestor
64807916|NCT01431118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807917|NCT01431118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951932|NCT00027872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807918|NCT01431118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64807919|NCT01431118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64807920|NCT01431118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64807921|NCT01431118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807922|NCT01431118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807923|NCT01431326|Vancomycin|vancomycin|mesh-list
64807924|NCT01431326|Ciprofloxacin|ciprofloxacin|mesh-list
64807925|NCT01431326|Tazobactam|tazobactam|mesh-list
64807926|NCT01431326|Piperacillin|piperacillin|mesh-list
64807927|NCT01431326|Tobramycin|tobramycin|mesh-list
64807928|NCT01431326|Amikacin|amikacin|mesh-list
64807929|NCT01431326|Fosfomycin|fosfomycin|mesh-list
64807930|NCT01431326|Cefepime|cefepime|mesh-list
64807931|NCT01431326|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64807932|NCT01431326|Nafcillin|nafcillin|mesh-list
64807933|NCT01431326|Cidofovir|cidofovir|mesh-list
64807934|NCT01431326|Methylprednisolone|methylprednisolone|mesh-list
64807935|NCT01431326|Bosentan|bosentan|mesh-list
64807960|NCT01431326|Glucocorticoids|glucocorticoids|mesh-ancestor
64807961|NCT01431326|Hormones|hormones|mesh-ancestor
64807962|NCT01431326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64807963|NCT01431326|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64807964|NCT01431326|Protective Agents|protective agents|mesh-ancestor
64807965|NCT01431326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807966|NCT01431326|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64807967|NCT01431326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64807968|NCT01431326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807969|NCT01431326|Hemostatics|hemostatics|mesh-ancestor
64807992|NCT01431326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64807993|NCT01431326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64419084|NCT04425187|Growth Substances|growth substances|mesh-ancestor
64808024|NCT01431326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64808026|NCT01431326|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64808027|NCT01431326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64808028|NCT01431326|Anesthetics, General|anesthetics, general|mesh-ancestor
64808029|NCT01431326|Anesthetics|anesthetics|mesh-ancestor
64808030|NCT01431326|Antiviral Agents|antiviral agents|mesh-ancestor
64808031|NCT01431326|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64808032|NCT01431326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64808033|NCT01431326|Cholinergic Agents|cholinergic agents|mesh-ancestor
64808034|NCT01431326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64808035|NCT01431326|GABA Modulators|gaba modulators|mesh-ancestor
64808036|NCT01431352|Letrozole|letrozole|mesh-list
64808037|NCT01431352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64808038|NCT01431352|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64808048|NCT01431404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64808050|NCT01431404|Sensory System Agents|sensory system agents|mesh-ancestor
64808051|NCT01431404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64808052|NCT01431404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808053|NCT01431404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64808054|NCT01431404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64808055|NCT01431404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64808056|NCT01431404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64808057|NCT01431404|Immunologic Factors|immunologic factors|mesh-ancestor
64808058|NCT01431430|Cholecalciferol|cholecalciferol|mesh-list
64808059|NCT01431430|Vitamin D|vitamin d|mesh-list
64808060|NCT01431430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64808061|NCT01431430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808062|NCT01431430|Vitamins|vitamins|mesh-ancestor
64808063|NCT01431430|Micronutrients|micronutrients|mesh-ancestor
64808064|NCT01431430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64808065|NCT01431443|Theobromine|theobromine|mesh-list
64808066|NCT01431443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64808067|NCT01431443|Autonomic Agents|autonomic agents|mesh-ancestor
64808072|NCT01431443|Vasodilator Agents|vasodilator agents|mesh-ancestor
64406742|NCT00484471|Serotonin Agents|serotonin agents|mesh-ancestor
64808073|NCT01431456|Nadroparin|nadroparin|mesh-list
64808074|NCT01431456|Rivaroxaban|rivaroxaban|mesh-list
64808075|NCT01431456|Dabigatran|dabigatran|mesh-list
64808076|NCT01431456|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64808077|NCT01431456|Antithrombins|antithrombins|mesh-ancestor
64808078|NCT01431456|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64808079|NCT01431456|Protease Inhibitors|protease inhibitors|mesh-ancestor
64808080|NCT01431456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64808081|NCT01431456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808082|NCT01431456|Anticoagulants|anticoagulants|mesh-ancestor
64808083|NCT01431456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64808084|NCT01431456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64808085|NCT01431495|Clopidogrel|clopidogrel|mesh-list
64808086|NCT01431495|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64808087|NCT01431495|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64808088|NCT01431495|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64808089|NCT01431495|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64808090|NCT01431495|Purinergic Agents|purinergic agents|mesh-ancestor
64808091|NCT01431495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808092|NCT01431495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808093|NCT01431495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808094|NCT01431547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64808149|NCT01431924|Respiratory System Agents|respiratory system agents|mesh-ancestor
64808150|NCT01431924|Dermatologic Agents|dermatologic agents|mesh-ancestor
64808183|NCT01432080|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64808185|NCT01432080|Glucocorticoids|glucocorticoids|mesh-ancestor
64808186|NCT01432080|Hormones|hormones|mesh-ancestor
64808187|NCT01432080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64808188|NCT01432080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808189|NCT01432080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64808190|NCT01432080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64808191|NCT01432080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64808192|NCT01432080|Autonomic Agents|autonomic agents|mesh-ancestor
64419297|NCT02342223|Hyaluronic Acid|hyaluronic acid|mesh-list
64808215|NCT01432106|Protease Inhibitors|protease inhibitors|mesh-ancestor
64808216|NCT01432106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64808218|NCT01432119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64808219|NCT01432119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64808220|NCT01432119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64808221|NCT01432119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64808222|NCT01432119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64808223|NCT01432119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808224|NCT01432158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64808225|NCT01432158|Immunologic Factors|immunologic factors|mesh-ancestor
64808226|NCT01432158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808227|NCT01432223|Paclitaxel|paclitaxel|mesh-list
65494105|NCT03592992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472194|NCT03699631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64808228|NCT01432223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64808229|NCT01432223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64808230|NCT01432223|Tubulin Modulators|tubulin modulators|mesh-ancestor
64808231|NCT01432223|Antimitotic Agents|antimitotic agents|mesh-ancestor
64808261|NCT01432522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64808262|NCT01432522|Adrenergic Agents|adrenergic agents|mesh-ancestor
64808263|NCT01432522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808264|NCT01432522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808265|NCT01432522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808266|NCT01432522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64808267|NCT01432522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64808268|NCT01432522|Autonomic Agents|autonomic agents|mesh-ancestor
64808269|NCT01432522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64808270|NCT01432522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64808271|NCT01432522|Respiratory System Agents|respiratory system agents|mesh-ancestor
64808273|NCT01432522|Sympathomimetics|sympathomimetics|mesh-ancestor
64808274|NCT01432522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64808276|NCT01432587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64808277|NCT01432587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64808278|NCT01432587|Analgesics|analgesics|mesh-ancestor
64808279|NCT01432587|Sensory System Agents|sensory system agents|mesh-ancestor
64808280|NCT01432587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64808281|NCT01432587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808282|NCT01432587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64808283|NCT01432587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64808284|NCT01432587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64808285|NCT01432587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64808286|NCT01432587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808287|NCT01432665|Sildenafil Citrate|sildenafil citrate|mesh-list
64808288|NCT01432665|Testosterone|testosterone|mesh-list
64808289|NCT01432665|Androgens|androgens|mesh-ancestor
64808290|NCT01432665|Hormones|hormones|mesh-ancestor
64808291|NCT01432665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64808292|NCT01432665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808293|NCT01432665|Vasodilator Agents|vasodilator agents|mesh-ancestor
64808294|NCT01432665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64808295|NCT01432665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64808296|NCT01432665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951933|NCT00027911|Sargramostim|sargramostim|mesh-list
64951934|NCT00027911|Immunologic Factors|immunologic factors|mesh-ancestor
64951935|NCT00027911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951936|NCT00027989|Gemcitabine|gemcitabine|mesh-list
64419388|NCT05122741|Antipyretics|antipyretics|mesh-ancestor
64808344|NCT01432977|Antipyretics|antipyretics|mesh-ancestor
64808345|NCT01432977|Antiemetics|antiemetics|mesh-ancestor
64808346|NCT01432977|Autonomic Agents|autonomic agents|mesh-ancestor
64808347|NCT01432977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64808348|NCT01432977|Antipruritics|antipruritics|mesh-ancestor
64808349|NCT01432977|Dermatologic Agents|dermatologic agents|mesh-ancestor
64808350|NCT01432977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64808351|NCT01432977|Serotonin Agents|serotonin agents|mesh-ancestor
64808352|NCT01432977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808353|NCT01432977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808354|NCT01432977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64808355|NCT01432977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64808356|NCT01432977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64808357|NCT01432977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64808358|NCT01432977|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64808359|NCT01432977|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64808360|NCT01432977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64808361|NCT01432977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64808362|NCT01432977|Dopamine Agents|dopamine agents|mesh-ancestor
64808363|NCT01433289|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
64808364|NCT01433289|Antioxidants|antioxidants|mesh-ancestor
64808365|NCT01433289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808366|NCT01433289|Protective Agents|protective agents|mesh-ancestor
65494106|NCT03592992|Analgesics|analgesics|mesh-ancestor
64472195|NCT03699631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472196|NCT03699631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64808367|NCT01433289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808368|NCT01433289|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64808369|NCT01433289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64808370|NCT01433289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64808371|NCT01433289|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64808372|NCT01433445|Panobinostat|panobinostat|mesh-list
64808375|NCT01433445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64808382|NCT01433614|Tubulin Modulators|tubulin modulators|mesh-ancestor
64808383|NCT01433614|Antimitotic Agents|antimitotic agents|mesh-ancestor
64808384|NCT01433614|Mitosis Modulators|mitosis modulators|mesh-ancestor
64808385|NCT01433614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808386|NCT01433614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64808387|NCT01433614|Antimetabolites|antimetabolites|mesh-ancestor
64808388|NCT01433614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64808389|NCT01433614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64808390|NCT01433614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64808391|NCT01433614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64808392|NCT01433627|Hirudins|hirudins|mesh-list
64808393|NCT01433627|Bivalirudin|bivalirudin|mesh-list
64808394|NCT01433627|Antithrombins|antithrombins|mesh-ancestor
64808395|NCT01433627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64808396|NCT01433627|Protease Inhibitors|protease inhibitors|mesh-ancestor
64808397|NCT01433627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64808424|NCT01433887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808425|NCT01433887|Antiviral Agents|antiviral agents|mesh-ancestor
64808426|NCT01433887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64808427|NCT01433900|Latanoprost|latanoprost|mesh-list
64808428|NCT01433900|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64808429|NCT01433900|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64808430|NCT01433952|Thiamine|thiamine|mesh-list
64808431|NCT01433952|Vitamin B Complex|vitamin b complex|mesh-ancestor
64808432|NCT01433952|Vitamins|vitamins|mesh-ancestor
64808433|NCT01433952|Micronutrients|micronutrients|mesh-ancestor
64808434|NCT01433952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808435|NCT01434017|Dexamethasone|dexamethasone|mesh-list
64808436|NCT01434017|Dexamethasone acetate|dexamethasone acetate|mesh-list
64808473|NCT01434069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64808474|NCT01434069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64808475|NCT01434069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64808476|NCT01434069|Immunologic Factors|immunologic factors|mesh-ancestor
64808477|NCT01434069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808478|NCT01434069|Antidotes|antidotes|mesh-ancestor
64808479|NCT01434069|Protective Agents|protective agents|mesh-ancestor
64808480|NCT01434069|Vitamin B Complex|vitamin b complex|mesh-ancestor
64808481|NCT01434069|Vitamins|vitamins|mesh-ancestor
65494107|NCT03592992|Sensory System Agents|sensory system agents|mesh-ancestor
65494108|NCT03592992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65494109|NCT03447808|Daratumumab|daratumumab|mesh-list
64808482|NCT01434069|Micronutrients|micronutrients|mesh-ancestor
64808483|NCT01434069|Hormones|hormones|mesh-ancestor
64808484|NCT01434069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64808485|NCT01434108|Phenylacetic acid|phenylacetic acid|mesh-list
64808486|NCT01434108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64808487|NCT01434108|Antimetabolites|antimetabolites|mesh-ancestor
64808488|NCT01434108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808489|NCT01434108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64808490|NCT01434134|Metoprolol|metoprolol|mesh-list
64808491|NCT01434134|Candesartan|candesartan|mesh-list
64808492|NCT01434134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64808493|NCT01434134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64808494|NCT01434134|Sympatholytics|sympatholytics|mesh-ancestor
64808495|NCT01434134|Autonomic Agents|autonomic agents|mesh-ancestor
64808496|NCT01434134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64808497|NCT01434134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808528|NCT01434173|Moxifloxacin|moxifloxacin|mesh-list
64808529|NCT01434173|Clarithromycin|clarithromycin|mesh-list
64808530|NCT01434173|Doxycycline|doxycycline|mesh-list
64808531|NCT01434173|Levofloxacin|levofloxacin|mesh-list
64808532|NCT01434173|Clavulanic Acids|clavulanic acids|mesh-list
64808533|NCT01434173|Clavulanic Acid|clavulanic acid|mesh-list
64808534|NCT01434173|Cefuroxime|cefuroxime|mesh-list
64808535|NCT01434173|Telithromycin|telithromycin|mesh-list
64808537|NCT01434173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64808652|NCT01434901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64808653|NCT01434901|Cholinergic Agents|cholinergic agents|mesh-ancestor
64808654|NCT01434901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808655|NCT01434901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808656|NCT01434914|Octenidine|octenidine|mesh-list
64808657|NCT01434914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64808658|NCT01434914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64808659|NCT01435083|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64808686|NCT01435213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808688|NCT01435213|Sensory System Agents|sensory system agents|mesh-ancestor
64808689|NCT01435213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64808690|NCT01435213|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64808691|NCT01435213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64808692|NCT01435213|Anesthetics, General|anesthetics, general|mesh-ancestor
64808693|NCT01435213|Anesthetics|anesthetics|mesh-ancestor
64808694|NCT01435213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64808695|NCT01435213|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64808696|NCT01435213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64808697|NCT01435213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808698|NCT01435213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808699|NCT01435213|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64808706|NCT01435252|Cetuximab|cetuximab|mesh-list
64808751|NCT01435486|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64808752|NCT01435486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808753|NCT01435486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64808754|NCT01435486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64808755|NCT01435486|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64808756|NCT01435486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64808757|NCT01435486|Purinergic Agents|purinergic agents|mesh-ancestor
64808775|NCT01435707|Hormones|hormones|mesh-ancestor
64808776|NCT01435707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64808777|NCT01435707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808778|NCT01435707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64808779|NCT01435707|Immunologic Factors|immunologic factors|mesh-ancestor
64808780|NCT01435707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64808781|NCT01435707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808782|NCT01435837|Caffeine|caffeine|mesh-list
64808783|NCT01435837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64808784|NCT01435837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808785|NCT01435837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64808792|NCT01435902|Fluticasone|fluticasone|mesh-list
64808836|NCT01435954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64808837|NCT01435954|Hormone Antagonists|hormone antagonists|mesh-ancestor
64808838|NCT01435954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64808839|NCT01435954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64808840|NCT01435980|Exenatide|exenatide|mesh-list
64808841|NCT01435980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64808842|NCT01435980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808843|NCT01435980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64808844|NCT01435980|Incretins|incretins|mesh-ancestor
64808845|NCT01435980|Hormones|hormones|mesh-ancestor
64808846|NCT01435980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64808847|NCT01436123|Everolimus|everolimus|mesh-list
64808848|NCT01436123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64808849|NCT01436123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64808850|NCT01436123|Immunologic Factors|immunologic factors|mesh-ancestor
64808851|NCT01436123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808853|NCT01436188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64808854|NCT01436188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64808855|NCT01436188|Analgesics|analgesics|mesh-ancestor
64808856|NCT01436188|Sensory System Agents|sensory system agents|mesh-ancestor
64808857|NCT01436188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64808858|NCT01436188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808859|NCT01436188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64808860|NCT01436188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64808862|NCT01436188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64808915|NCT01436838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64808916|NCT01436916|Cholecalciferol|cholecalciferol|mesh-list
64808917|NCT01436916|Vitamin D|vitamin d|mesh-list
64808932|NCT01436994|Antithyroid Agents|antithyroid agents|mesh-ancestor
64808933|NCT01436994|Hormone Antagonists|hormone antagonists|mesh-ancestor
64808934|NCT01436994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64808935|NCT01436994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808936|NCT01437020|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64808937|NCT01437020|Antifungal Agents|antifungal agents|mesh-ancestor
64808938|NCT01437020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64808939|NCT01437020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64808940|NCT01437020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64808941|NCT01437046|Doxazosin|doxazosin|mesh-list
64808942|NCT01437046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64808943|NCT01437046|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64808944|NCT01437046|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64808945|NCT01437046|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64808946|NCT01437046|Adrenergic Agents|adrenergic agents|mesh-ancestor
64808947|NCT01437046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808948|NCT01437046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808949|NCT01437046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808950|NCT01437189|Sertraline|sertraline|mesh-list
64808951|NCT01437189|Antidepressive Agents|antidepressive agents|mesh-ancestor
64808952|NCT01437189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64808953|NCT01437189|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64951937|NCT00027989|Doxorubicin|doxorubicin|mesh-list
64951938|NCT00027989|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64951939|NCT00027989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64951940|NCT00027989|Antimetabolites|antimetabolites|mesh-ancestor
64951941|NCT00027989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951942|NCT00027989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951943|NCT00027989|Antiviral Agents|antiviral agents|mesh-ancestor
64951944|NCT00027989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951945|NCT00027989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951946|NCT00027989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951947|NCT00027989|Immunologic Factors|immunologic factors|mesh-ancestor
64951948|NCT00027989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951949|NCT00027989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64951950|NCT00027989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64951951|NCT00027989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64951952|NCT00056004|Zileuton|zileuton|mesh-list
64951953|NCT00056004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64951954|NCT00056004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64951955|NCT00056004|Analgesics|analgesics|mesh-ancestor
64951956|NCT00056004|Sensory System Agents|sensory system agents|mesh-ancestor
64951957|NCT00056004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64951958|NCT00056004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951959|NCT00056004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64951960|NCT00056004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64808954|NCT01437189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64808955|NCT01437189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64808956|NCT01437189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808957|NCT01437189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808958|NCT01437189|Serotonin Agents|serotonin agents|mesh-ancestor
64808959|NCT01437189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808960|NCT01437228|Povidone-Iodine|povidone-iodine|mesh-list
64808961|NCT01437228|Povidone|povidone|mesh-list
64808962|NCT01437228|Plasma Substitutes|plasma substitutes|mesh-ancestor
64808963|NCT01437228|Blood Substitutes|blood substitutes|mesh-ancestor
64808964|NCT01437228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64808965|NCT01437228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64808966|NCT01437293|Carbidopa|carbidopa|mesh-list
64808967|NCT01437293|Entacapone|entacapone|mesh-list
64808968|NCT01437293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64808969|NCT01437293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64808970|NCT01437293|Dopamine Agents|dopamine agents|mesh-ancestor
64808971|NCT01437293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808972|NCT01437293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808973|NCT01437293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808974|NCT01437293|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64808975|NCT01437293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64808976|NCT01437293|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64809013|NCT01437566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64809014|NCT01437566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809015|NCT01437566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64809046|NCT01437670|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64809047|NCT01437670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64809048|NCT01437670|Cholinergic Agents|cholinergic agents|mesh-ancestor
64809049|NCT01437670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64809050|NCT01437670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809051|NCT01437670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809095|NCT01437826|Micronutrients|micronutrients|mesh-ancestor
64809143|NCT01438086|Growth Substances|growth substances|mesh-ancestor
64809144|NCT01438086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809145|NCT01438112|Gemcitabine|gemcitabine|mesh-list
64809146|NCT01438112|Interferons|interferons|mesh-list
64809147|NCT01438112|Mitomycins|mitomycins|mesh-list
64809148|NCT01438112|Mitomycin|mitomycin|mesh-list
64809149|NCT01438112|Valrubicin|valrubicin|mesh-list
64809150|NCT01438112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64809151|NCT01438112|Antimetabolites|antimetabolites|mesh-ancestor
64809152|NCT01438112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809153|NCT01438112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809154|NCT01438112|Antiviral Agents|antiviral agents|mesh-ancestor
64809218|NCT05418088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64809219|NCT05418088|Antimetabolites|antimetabolites|mesh-ancestor
64809220|NCT05387525|Diclofenac|diclofenac|mesh-list
64809221|NCT05387525|Tirbanibulin|tirbanibulin|mesh-list
64809222|NCT05387525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64809223|NCT05387525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64809224|NCT05387525|Analgesics|analgesics|mesh-ancestor
64809225|NCT05387525|Sensory System Agents|sensory system agents|mesh-ancestor
64809226|NCT05387525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64809227|NCT05387525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809228|NCT05387525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64809229|NCT05387525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64809230|NCT05387525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64809231|NCT05387525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809232|NCT05387525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809233|NCT05382312|Bedaquiline|bedaquiline|mesh-list
64809234|NCT05382312|GSK656|gsk656|mesh-list
64809235|NCT05382312|Antitubercular Agents|antitubercular agents|mesh-ancestor
64809236|NCT05382312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64809237|NCT05382312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64809238|NCT05371275|Palbociclib|palbociclib|mesh-list
64809239|NCT05371275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809240|NCT05371275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64809241|NCT05371275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809242|NCT05371275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809243|NCT05370794|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64809244|NCT05370794|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64809246|NCT05343507|Ketamine|ketamine|mesh-list
64809285|NCT05197439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64809286|NCT05197439|Analgesics|analgesics|mesh-ancestor
64809287|NCT05197439|Sensory System Agents|sensory system agents|mesh-ancestor
64809288|NCT05197439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64809289|NCT05197439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64809290|NCT05197439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64809291|NCT05197439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64809292|NCT05197439|Adrenergic Agents|adrenergic agents|mesh-ancestor
64809293|NCT05197439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64809294|NCT05197439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809295|NCT05164159|Propofol|propofol|mesh-list
64809296|NCT05164159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64809297|NCT05164159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64809298|NCT05164159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472198|NCT03699631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472199|NCT03699631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472200|NCT03699631|Dermatologic Agents|dermatologic agents|mesh-ancestor
64472201|NCT03699631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472202|NCT03699631|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64472203|NCT03699631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64472204|NCT03699631|Immunologic Factors|immunologic factors|mesh-ancestor
64809299|NCT05164159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64809370|NCT04955470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64809371|NCT04955470|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64809372|NCT04955470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64809373|NCT04955470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64809374|NCT04955470|GABA Modulators|gaba modulators|mesh-ancestor
64809375|NCT04955470|GABA Agents|gaba agents|mesh-ancestor
64809376|NCT04938557|Insulin|insulin|mesh-list
64809377|NCT04938557|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64809378|NCT04938557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64809379|NCT04938557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809380|NCT04927390|Mycophenolic Acid|mycophenolic acid|mesh-list
64809381|NCT04927390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64809382|NCT04927390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809383|NCT04927390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64809384|NCT04927390|Antitubercular Agents|antitubercular agents|mesh-ancestor
64809385|NCT04927390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64809386|NCT04927390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64809387|NCT04927390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809388|NCT04927390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809389|NCT04922567|Prednisone|prednisone|mesh-list
64809390|NCT04922567|Cyclophosphamide|cyclophosphamide|mesh-list
64809391|NCT04922567|Doxorubicin|doxorubicin|mesh-list
64809392|NCT04922567|Vincristine|vincristine|mesh-list
64809393|NCT04922567|Lenalidomide|lenalidomide|mesh-list
64809394|NCT04922567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64809395|NCT04922567|Immunologic Factors|immunologic factors|mesh-ancestor
64809396|NCT04922567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809397|NCT04922567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64809398|NCT04922567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64809399|NCT04922567|Alkylating Agents|alkylating agents|mesh-ancestor
64809400|NCT04922567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809401|NCT04922567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494113|NCT03386240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494114|NCT03386240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65494115|NCT03386240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64809404|NCT04922567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64809405|NCT04922567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64809406|NCT04922567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809407|NCT04922567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64809408|NCT04922567|Glucocorticoids|glucocorticoids|mesh-ancestor
64809410|NCT04922567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64809411|NCT04922567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64420498|NCT03879109|Folfirinox|folfirinox|mesh-list
64809439|NCT04850222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809440|NCT04801966|Pembrolizumab|pembrolizumab|mesh-list
64809441|NCT04801966|Nivolumab|nivolumab|mesh-list
64809442|NCT04801966|Atezolizumab|atezolizumab|mesh-list
64809443|NCT04801966|Olaparib|olaparib|mesh-list
64809444|NCT04801966|Palbociclib|palbociclib|mesh-list
64809445|NCT04801966|Trametinib|trametinib|mesh-list
64809446|NCT04801966|Vemurafenib|vemurafenib|mesh-list
64809447|NCT04801966|Dabrafenib|dabrafenib|mesh-list
64809448|NCT04801966|Talazoparib|talazoparib|mesh-list
64809449|NCT04801966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64809450|NCT04801966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809451|NCT04801966|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64809452|NCT04801966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809453|NCT04801966|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64809454|NCT04801966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809455|NCT04801966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64809456|NCT04800692|Verapamil|verapamil|mesh-list
64809457|NCT04800692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64809458|NCT04800692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64809468|NCT04787848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809470|NCT04787848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64809471|NCT04660799|Diphenhydramine|diphenhydramine|mesh-list
64809472|NCT04660799|Promethazine|promethazine|mesh-list
64809473|NCT04660799|Prednisone|prednisone|mesh-list
64809475|NCT04660799|Rituximab|rituximab|mesh-list
64809486|NCT04660799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809487|NCT04660799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809488|NCT04660799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64809489|NCT04660799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64809490|NCT04660799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64809491|NCT04660799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64809492|NCT04660799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64809493|NCT04660799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809494|NCT04660799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64809495|NCT04660799|Glucocorticoids|glucocorticoids|mesh-ancestor
64809496|NCT04660799|Hormones|hormones|mesh-ancestor
64809497|NCT04660799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64809498|NCT04660799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64809499|NCT04660799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64809500|NCT04660799|Tubulin Modulators|tubulin modulators|mesh-ancestor
64809501|NCT04660799|Antimitotic Agents|antimitotic agents|mesh-ancestor
64809567|NCT04375202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64809568|NCT04375202|Tubulin Modulators|tubulin modulators|mesh-ancestor
64809569|NCT04375202|Antimitotic Agents|antimitotic agents|mesh-ancestor
64809570|NCT04375202|Mitosis Modulators|mitosis modulators|mesh-ancestor
64809578|NCT04345744|Dermatologic Agents|dermatologic agents|mesh-ancestor
64809579|NCT04343885|Docetaxel|docetaxel|mesh-list
64809580|NCT04343885|177Lu-PSMA-617|177lu-psma-617|mesh-list
64809581|NCT04343885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809582|NCT04343885|Tubulin Modulators|tubulin modulators|mesh-ancestor
64809583|NCT04343885|Antimitotic Agents|antimitotic agents|mesh-ancestor
64809584|NCT04343885|Mitosis Modulators|mitosis modulators|mesh-ancestor
64809585|NCT04343885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809586|NCT04343885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64809587|NCT04332393|Metformin|metformin|mesh-list
64809588|NCT04332393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64809589|NCT04332393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809590|NCT04329572|Azithromycin|azithromycin|mesh-list
64809591|NCT04329572|Hydroxychloroquine|hydroxychloroquine|mesh-list
64809592|NCT04329572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64809593|NCT04329572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64809594|NCT04329572|Antimalarials|antimalarials|mesh-ancestor
64809595|NCT04329572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64809596|NCT04329572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64809597|NCT04329572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809598|NCT04329572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809599|NCT04329572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64809600|NCT04322552|Apatinib|apatinib|mesh-list
64809601|NCT04322552|Digoxin|digoxin|mesh-list
64809602|NCT04322552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809603|NCT04322552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64809604|NCT04322552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809605|NCT04322552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809619|NCT04322305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64809620|NCT04322305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64809621|NCT04322305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64809622|NCT04322305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64472205|NCT03699631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64472206|NCT03699631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64407808|NCT04822649|Adenosine|adenosine|mesh-list
64809623|NCT04322305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64809624|NCT04189848|Dulaglutide|dulaglutide|mesh-list
64809625|NCT04189848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64809626|NCT04189848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809627|NCT04156334|Anesthetics|anesthetics|mesh-list
64809628|NCT04156334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64809629|NCT04156334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809630|NCT04078906|SMOFlipid|smoflipid|mesh-list
64809631|NCT04078906|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
64809632|NCT04078906|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64809633|NCT04078906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64809634|NCT03980171|Lenalidomide|lenalidomide|mesh-list
64809635|NCT03980171|Venetoclax|venetoclax|mesh-list
64809636|NCT03980171|Obinutuzumab|obinutuzumab|mesh-list
64809637|NCT03980171|Immunologic Factors|immunologic factors|mesh-ancestor
64809638|NCT03980171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809639|NCT03980171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64809688|NCT03671746|Analgesics|analgesics|mesh-ancestor
64809689|NCT03671746|Sensory System Agents|sensory system agents|mesh-ancestor
64809690|NCT03671746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64809691|NCT03671746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809692|NCT03671746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64809693|NCT03671746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64809694|NCT03671746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64809695|NCT03671746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809696|NCT03671746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809705|NCT03512496|Caffeine|caffeine|mesh-list
64809706|NCT03512496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64809707|NCT03512496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809708|NCT03512496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64809709|NCT03512496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809710|NCT03512496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809711|NCT03512496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64809712|NCT03512496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64809713|NCT03512496|Purinergic Agents|purinergic agents|mesh-ancestor
64809714|NCT03512496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64809715|NCT03495960|Rituximab|rituximab|mesh-list
64809716|NCT03495960|Methotrexate|methotrexate|mesh-list
64809717|NCT03495960|Lenalidomide|lenalidomide|mesh-list
64809718|NCT03495960|Temozolomide|temozolomide|mesh-list
64809719|NCT03495960|Procarbazine|procarbazine|mesh-list
64809720|NCT03495960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64809721|NCT03495960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809722|NCT03495960|Immunologic Factors|immunologic factors|mesh-ancestor
64809723|NCT03495960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809724|NCT03495960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64809725|NCT03495960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64809768|NCT03250975|Hormones|hormones|mesh-ancestor
64809769|NCT03250975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64809770|NCT03250975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64809771|NCT03250975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64809772|NCT03232346|Buprenorphine|buprenorphine|mesh-list
64809773|NCT03232346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64809774|NCT03232346|Narcotics|narcotics|mesh-ancestor
64809775|NCT03232346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64809776|NCT03232346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809777|NCT03232346|Analgesics|analgesics|mesh-ancestor
64809778|NCT03232346|Sensory System Agents|sensory system agents|mesh-ancestor
64809779|NCT03232346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64809780|NCT03232346|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64809781|NCT03227731|Tenofovir|tenofovir|mesh-list
64809862|NCT02426502|Antifungal Agents|antifungal agents|mesh-ancestor
64809863|NCT02426502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64809864|NCT02426502|Dermatologic Agents|dermatologic agents|mesh-ancestor
64809865|NCT02426502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64809866|NCT02426502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64809867|NCT02426502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64809868|NCT02426502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64809869|NCT02426502|Antitubercular Agents|antitubercular agents|mesh-ancestor
64809870|NCT02426502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64809871|NCT02426502|Antimetabolites|antimetabolites|mesh-ancestor
64809872|NCT02426502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64809873|NCT02275156|Evolocumab|evolocumab|mesh-list
64809874|NCT02275156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64809875|NCT02275156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64809876|NCT02275156|Antimetabolites|antimetabolites|mesh-ancestor
64809877|NCT02275156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809878|NCT02275156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64809879|NCT02124902|Carboplatin|carboplatin|mesh-list
64809880|NCT02124902|Docetaxel|docetaxel|mesh-list
64809881|NCT02124902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809882|NCT02124902|Tubulin Modulators|tubulin modulators|mesh-ancestor
64809883|NCT02124902|Antimitotic Agents|antimitotic agents|mesh-ancestor
64809884|NCT02124902|Mitosis Modulators|mitosis modulators|mesh-ancestor
64809885|NCT02124902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809886|NCT02067182|Dabigatran|dabigatran|mesh-list
64809887|NCT02067182|Antithrombins|antithrombins|mesh-ancestor
64809888|NCT02067182|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64809936|NCT00364013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809937|NCT00345839|Cinacalcet|cinacalcet|mesh-list
64809938|NCT00345839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64809939|NCT00345839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809940|NCT00345839|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64809941|NCT00345839|Hormone Antagonists|hormone antagonists|mesh-ancestor
64809942|NCT00345839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64809943|NCT00330759|Zoledronic Acid|zoledronic acid|mesh-list
64809944|NCT00330759|Denosumab|denosumab|mesh-list
64421047|NCT05508815|Antimetabolites|antimetabolites|mesh-ancestor
64809949|NCT00113763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809950|NCT01438359|Furosemide|furosemide|mesh-list
64809951|NCT01438359|Diuretics|diuretics|mesh-ancestor
64809952|NCT01438359|Natriuretic Agents|natriuretic agents|mesh-ancestor
64809953|NCT01438359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809954|NCT01438359|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64809955|NCT01438359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64809956|NCT01438359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809957|NCT01438372|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64809958|NCT01438372|Hematinics|hematinics|mesh-ancestor
64809959|NCT01438515|Chlorhexidine|chlorhexidine|mesh-list
64809960|NCT01438515|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64809961|NCT01438515|Doxycycline|doxycycline|mesh-list
64809962|NCT01438515|Rifampin|rifampin|mesh-list
64809963|NCT01438515|Mupirocin|mupirocin|mesh-list
64809964|NCT01438515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65494124|NCT03366766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64472208|NCT03686488|Ramucirumab|ramucirumab|mesh-list
64472209|NCT03686488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472210|NCT03686150|Vitamin D|vitamin d|mesh-list
64472211|NCT03686150|Cholecalciferol|cholecalciferol|mesh-list
64472212|NCT03686150|Vitamins|vitamins|mesh-ancestor
64472213|NCT03686150|Micronutrients|micronutrients|mesh-ancestor
64472217|NCT03678233|Testosterone|testosterone|mesh-list
64809971|NCT01438515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64809972|NCT01438515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64809973|NCT01438515|Antitubercular Agents|antitubercular agents|mesh-ancestor
64809974|NCT01438515|Leprostatic Agents|leprostatic agents|mesh-ancestor
64809975|NCT01438515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64809976|NCT01438515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809977|NCT01438515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809978|NCT01438515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64809979|NCT01438515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64809980|NCT01438515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64809981|NCT01438515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64809982|NCT01438515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64809983|NCT01438515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64809984|NCT01438515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64809985|NCT01438554|Trametinib|trametinib|mesh-list
64809986|NCT01438554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809987|NCT01438554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64809988|NCT01438554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809989|NCT01438554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809990|NCT01438567|Oxycodone|oxycodone|mesh-list
64809991|NCT01438567|Naloxone|naloxone|mesh-list
64809992|NCT01438567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64809993|NCT01438567|Narcotics|narcotics|mesh-ancestor
64809994|NCT01438567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64809995|NCT01438567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809996|NCT01438567|Analgesics|analgesics|mesh-ancestor
64809997|NCT01438567|Sensory System Agents|sensory system agents|mesh-ancestor
64809998|NCT01438567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64809999|NCT01438567|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64810014|NCT01438580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64810037|NCT01438749|Diazepam|diazepam|mesh-list
64810038|NCT01438749|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64810039|NCT01438749|Anticonvulsants|anticonvulsants|mesh-ancestor
64810040|NCT01438749|Antiemetics|antiemetics|mesh-ancestor
64810041|NCT01438749|Autonomic Agents|autonomic agents|mesh-ancestor
65494125|NCT03366766|Antimetabolites|antimetabolites|mesh-ancestor
65494126|NCT03366766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494127|NCT03366766|Antiviral Agents|antiviral agents|mesh-ancestor
65494128|NCT03366766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494129|NCT03366766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494130|NCT03366766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65494131|NCT03366766|Immunologic Factors|immunologic factors|mesh-ancestor
65494132|NCT03366766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494133|NCT03366766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64472219|NCT03678233|Hormones|hormones|mesh-ancestor
64408129|NCT04816097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810042|NCT01438749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64810043|NCT01438749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810044|NCT01438749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64810045|NCT01438749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64810047|NCT01438749|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64810096|NCT01439178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64810097|NCT01439178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810098|NCT01439178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64810099|NCT01439178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64810100|NCT01439178|Growth Substances|growth substances|mesh-ancestor
64810101|NCT01439178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810102|NCT01439178|Growth Inhibitors|growth inhibitors|mesh-ancestor
64810103|NCT01439191|Vinorelbine|vinorelbine|mesh-list
64810104|NCT01439191|Antibodies|antibodies|mesh-list
64810155|NCT01439542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64810156|NCT01439542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810157|NCT01439750|Rituximab|rituximab|mesh-list
64810158|NCT01439750|Bortezomib|bortezomib|mesh-list
64810159|NCT01439750|Cladribine|cladribine|mesh-list
64810160|NCT01439750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64810161|NCT01439750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810162|NCT01439750|Immunologic Factors|immunologic factors|mesh-ancestor
64810163|NCT01439750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810164|NCT01439750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64810165|NCT01439750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64810166|NCT01439984|Clomipramine|clomipramine|mesh-list
64810167|NCT01439984|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64472311|NCT03564691|Pembrolizumab|pembrolizumab|mesh-list
64472312|NCT03564691|Pemetrexed|pemetrexed|mesh-list
64472313|NCT03564691|Lenvatinib|lenvatinib|mesh-list
64472314|NCT03564691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64472315|NCT03564691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472316|NCT03564691|Tubulin Modulators|tubulin modulators|mesh-ancestor
64810185|NCT01440088|Doxorubicin|doxorubicin|mesh-list
64810186|NCT01440088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64810187|NCT01440088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64810188|NCT01440088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810189|NCT01440088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64810190|NCT01440088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64810191|NCT01440088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810205|NCT01440127|Metformin|metformin|mesh-list
64810206|NCT01440127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64810207|NCT01440127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810208|NCT01440140|Insulin|insulin|mesh-list
64810209|NCT01440140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64810210|NCT01440140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810211|NCT01440270|Cetuximab|cetuximab|mesh-list
64810212|NCT01440270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64810213|NCT01440270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494170|NCT03121586|Pimavanserin|pimavanserin|mesh-list
65494171|NCT03121586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65494172|NCT03121586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65494173|NCT03121586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65494174|NCT03121586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64472317|NCT03564691|Antimitotic Agents|antimitotic agents|mesh-ancestor
64472318|NCT03564691|Mitosis Modulators|mitosis modulators|mesh-ancestor
64472319|NCT03564691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472320|NCT03564691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64472321|NCT03564691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472322|NCT03564691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64810286|NCT01440621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64810287|NCT01440621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64810288|NCT01440621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810289|NCT01440621|Vitamin B Complex|vitamin b complex|mesh-ancestor
65494175|NCT03121586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65494176|NCT03121586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494177|NCT03121586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65494178|NCT03121586|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65494179|NCT03121586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65494180|NCT03121586|Serotonin Agents|serotonin agents|mesh-ancestor
65494181|NCT03121586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65494182|NCT03121586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494183|NCT03039036|Misoprostol|misoprostol|mesh-list
65494184|NCT03039036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64810356|NCT01440998|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64810357|NCT01440998|Dasatinib|dasatinib|mesh-list
64810358|NCT01440998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64810359|NCT01440998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810360|NCT01440998|Tubulin Modulators|tubulin modulators|mesh-ancestor
64810361|NCT01440998|Antimitotic Agents|antimitotic agents|mesh-ancestor
64810362|NCT01440998|Mitosis Modulators|mitosis modulators|mesh-ancestor
64810363|NCT01440998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810364|NCT01440998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64810508|NCT01441908|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64810509|NCT01441908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810510|NCT01441934|Sildenafil Citrate|sildenafil citrate|mesh-list
64579146|NCT05554848|Magnesium Sulfate|magnesium sulfate|mesh-list
64810511|NCT01441934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810512|NCT01441934|Vasodilator Agents|vasodilator agents|mesh-ancestor
64810513|NCT01441934|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64810514|NCT01441934|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64810515|NCT01441934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810516|NCT01441934|Urological Agents|urological agents|mesh-ancestor
64810518|NCT01441986|Dextromethorphan|dextromethorphan|mesh-list
64810519|NCT01441986|Antitussive Agents|antitussive agents|mesh-ancestor
64810520|NCT01441986|Respiratory System Agents|respiratory system agents|mesh-ancestor
64810521|NCT01441986|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64810523|NCT01441986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64810545|NCT01442168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810546|NCT01442272|Calcifediol|calcifediol|mesh-list
64810547|NCT01442272|Vitamins|vitamins|mesh-ancestor
64810548|NCT01442272|Micronutrients|micronutrients|mesh-ancestor
64810549|NCT01442272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810550|NCT01442272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64810551|NCT01442311|Interferons|interferons|mesh-list
64810552|NCT01442311|Ribavirin|ribavirin|mesh-list
64810553|NCT01442311|Interferon-alpha|interferon-alpha|mesh-list
64810554|NCT01442311|Interferon alpha-2|interferon alpha-2|mesh-list
64810555|NCT01442311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64810556|NCT01442311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810557|NCT01442311|Antiviral Agents|antiviral agents|mesh-ancestor
64810558|NCT01442311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64810559|NCT01442311|Antimetabolites|antimetabolites|mesh-ancestor
64810560|NCT01442311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810561|NCT01442311|Immunologic Factors|immunologic factors|mesh-ancestor
64810562|NCT01442311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810606|NCT01442532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64810607|NCT01442532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810608|NCT01442532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64810609|NCT01442532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64810610|NCT01442532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64810611|NCT01442532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64810612|NCT01442532|Anesthetics, General|anesthetics, general|mesh-ancestor
64810613|NCT01442532|Anesthetics|anesthetics|mesh-ancestor
64810614|NCT01442532|GABA Modulators|gaba modulators|mesh-ancestor
64810615|NCT01442532|GABA Agents|gaba agents|mesh-ancestor
64810616|NCT01442532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64810617|NCT01442532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810618|NCT01442558|Bupivacaine|bupivacaine|mesh-list
64810619|NCT01442558|Anesthetics, Local|anesthetics, local|mesh-ancestor
64810620|NCT01442558|Anesthetics|anesthetics|mesh-ancestor
64810621|NCT01442558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64810622|NCT01442558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810647|NCT01442662|Immunologic Factors|immunologic factors|mesh-ancestor
64810648|NCT01442662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810650|NCT01442701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64810651|NCT01442701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64810652|NCT01442701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64810653|NCT01442701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64810698|NCT01442935|Cetuximab|cetuximab|mesh-list
64810699|NCT01442935|Oxaliplatin|oxaliplatin|mesh-list
64810700|NCT01442935|Irinotecan|irinotecan|mesh-list
64810701|NCT01442935|Fluorouracil|fluorouracil|mesh-list
64810702|NCT01442935|Levoleucovorin|levoleucovorin|mesh-list
64810703|NCT01442935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64810704|NCT01442935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810705|NCT01442935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64810706|NCT01442935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64810707|NCT01442935|Growth Substances|growth substances|mesh-ancestor
64810708|NCT01442935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810709|NCT01442935|Growth Inhibitors|growth inhibitors|mesh-ancestor
64810710|NCT01442935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64810711|NCT01442935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64810712|NCT01442935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810713|NCT01442935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810714|NCT01442935|Antidotes|antidotes|mesh-ancestor
64810715|NCT01442935|Protective Agents|protective agents|mesh-ancestor
64810716|NCT01442935|Vitamin B Complex|vitamin b complex|mesh-ancestor
64810717|NCT01442935|Vitamins|vitamins|mesh-ancestor
64810718|NCT01442935|Micronutrients|micronutrients|mesh-ancestor
64810795|NCT01443169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64810797|NCT01443169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64810798|NCT01443169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64810799|NCT01443169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64810801|NCT01443195|Trace Elements|trace elements|mesh-ancestor
64810802|NCT01443195|Micronutrients|micronutrients|mesh-ancestor
64810803|NCT01443195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810804|NCT01443208|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64810805|NCT01443208|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64810879|NCT01443676|Growth Inhibitors|growth inhibitors|mesh-ancestor
64810880|NCT01443741|Insulin|insulin|mesh-list
64810881|NCT01443741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64810882|NCT01443741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64810883|NCT01443741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810884|NCT01443780|Selenium|selenium|mesh-list
64810885|NCT01443780|Antioxidants|antioxidants|mesh-ancestor
64810886|NCT01443780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810887|NCT01443780|Protective Agents|protective agents|mesh-ancestor
64810888|NCT01443780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810889|NCT01443780|Trace Elements|trace elements|mesh-ancestor
64810890|NCT01443780|Micronutrients|micronutrients|mesh-ancestor
64810891|NCT01443806|Oseltamivir|oseltamivir|mesh-list
64810892|NCT01443806|Antiviral Agents|antiviral agents|mesh-ancestor
64810893|NCT01443806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64810894|NCT01443806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810895|NCT01443806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810896|NCT01443897|Vitamin D|vitamin d|mesh-list
64810897|NCT01443897|Ergocalciferols|ergocalciferols|mesh-list
64810898|NCT01443897|Cholecalciferol|cholecalciferol|mesh-list
64810925|NCT01444131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64810927|NCT01444131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64810928|NCT01444131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810929|NCT01444131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64810930|NCT01444131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64810931|NCT01444131|Cholinergic Agents|cholinergic agents|mesh-ancestor
64810932|NCT01444131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64810933|NCT01444131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810934|NCT01444196|Desloratadine|desloratadine|mesh-list
65494212|NCT02939742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65494213|NCT02939742|Glucocorticoids|glucocorticoids|mesh-ancestor
65494214|NCT02939742|Hormones|hormones|mesh-ancestor
65494215|NCT02939742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65494216|NCT02939742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472358|NCT03485209|Carboplatin|carboplatin|mesh-list
64472359|NCT03485209|Pembrolizumab|pembrolizumab|mesh-list
64472360|NCT03485209|Tisotumab vedotin|tisotumab vedotin|mesh-list
64472363|NCT03458221|Itraconazole|itraconazole|mesh-list
64811032|NCT01444846|Protective Agents|protective agents|mesh-ancestor
64811033|NCT01444846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65494217|NCT02939742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65494218|NCT02939742|Respiratory System Agents|respiratory system agents|mesh-ancestor
65494219|NCT02759419|Riociguat|riociguat|mesh-list
65494220|NCT02759419|Enzyme Activators|enzyme activators|mesh-ancestor
65494221|NCT02759419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494222|NCT02693535|Pembrolizumab|pembrolizumab|mesh-list
65494223|NCT02693535|Nivolumab|nivolumab|mesh-list
65494224|NCT02693535|Trastuzumab|trastuzumab|mesh-list
65494225|NCT02693535|Ipilimumab|ipilimumab|mesh-list
65494226|NCT02693535|Pertuzumab|pertuzumab|mesh-list
65494227|NCT02693535|Atezolizumab|atezolizumab|mesh-list
65494228|NCT02693535|Sunitinib|sunitinib|mesh-list
65494229|NCT02693535|Olaparib|olaparib|mesh-list
64472370|NCT03458221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472371|NCT03458221|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64472372|NCT03458221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64472373|NCT03458221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472374|NCT03458221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472375|NCT03458221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64472376|NCT03458221|Hormone Antagonists|hormone antagonists|mesh-ancestor
64472393|NCT03410030|Paclitaxel|paclitaxel|mesh-list
64811053|NCT01444976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64811054|NCT01444976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64811055|NCT01444976|Anesthetics, General|anesthetics, general|mesh-ancestor
64811056|NCT01444976|GABA Modulators|gaba modulators|mesh-ancestor
64811057|NCT01444976|GABA Agents|gaba agents|mesh-ancestor
64811058|NCT01444976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64811059|NCT01444976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811060|NCT01445106|Nelfinavir|nelfinavir|mesh-list
64811061|NCT01445106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64811062|NCT01445106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64811063|NCT01445106|Protease Inhibitors|protease inhibitors|mesh-ancestor
64811068|NCT01445106|Antiviral Agents|antiviral agents|mesh-ancestor
65494230|NCT02693535|Palbociclib|palbociclib|mesh-list
64811089|NCT01445223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64811090|NCT01445223|Antiviral Agents|antiviral agents|mesh-ancestor
64811091|NCT01445223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64811092|NCT01445223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64811093|NCT01445223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64422209|NCT05476991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64811153|NCT01445522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64811154|NCT01445522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64811155|NCT01445522|Alkylating Agents|alkylating agents|mesh-ancestor
64811156|NCT01445522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811157|NCT01445522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811158|NCT01445522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64811159|NCT01445522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64811160|NCT01445522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811162|NCT01445561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811163|NCT01445561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64811164|NCT01445561|Analgesics|analgesics|mesh-ancestor
64811165|NCT01445561|Sensory System Agents|sensory system agents|mesh-ancestor
64811166|NCT01445561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64811167|NCT01445561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811168|NCT01445587|Bortezomib|bortezomib|mesh-list
64811169|NCT01445587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811170|NCT01445600|Retapamulin|retapamulin|mesh-list
64811171|NCT01445600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64811173|NCT01445639|Dexmedetomidine|dexmedetomidine|mesh-list
64811211|NCT01445860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64811212|NCT01445860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811213|NCT01445938|Lumefantrine|lumefantrine|mesh-list
64811214|NCT01445938|Antimalarials|antimalarials|mesh-ancestor
64811215|NCT01445938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64811216|NCT01445938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64811217|NCT01445938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64811218|NCT01445964|Atenolol|atenolol|mesh-list
64811221|NCT01445964|Sympatholytics|sympatholytics|mesh-ancestor
64811289|NCT01446328|Amisulpride|amisulpride|mesh-list
64811290|NCT01446328|Antiemetics|antiemetics|mesh-ancestor
64811291|NCT01446328|Autonomic Agents|autonomic agents|mesh-ancestor
64811292|NCT01446328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65494275|NCT02581787|Immunoglobulins|immunoglobulins|mesh-list
64472423|NCT03382301|Dermatologic Agents|dermatologic agents|mesh-ancestor
64811293|NCT01446328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811294|NCT01446328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64811295|NCT01446328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64811296|NCT01446328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64811297|NCT01446328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64811298|NCT01446328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64811361|NCT01446523|Lactulose|lactulose|mesh-list
64811362|NCT01446523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64811363|NCT01446562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64811364|NCT01446562|Immunologic Factors|immunologic factors|mesh-ancestor
64811365|NCT01446562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811366|NCT01446679|Atorvastatin|atorvastatin|mesh-list
64811367|NCT01446679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64811368|NCT01446679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64811369|NCT01446679|Antimetabolites|antimetabolites|mesh-ancestor
64811370|NCT01446679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811371|NCT01446679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64811372|NCT01446679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64811373|NCT01446679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811397|NCT01446952|Tocotrienols|tocotrienols|mesh-list
64811398|NCT01446952|Vitamins|vitamins|mesh-ancestor
64811399|NCT01446952|Micronutrients|micronutrients|mesh-ancestor
65494276|NCT02581787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64472424|NCT03382301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64811400|NCT01446952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811401|NCT01446952|Antioxidants|antioxidants|mesh-ancestor
64811402|NCT01446952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811403|NCT01446952|Protective Agents|protective agents|mesh-ancestor
64811404|NCT01446978|Vaccines|vaccines|mesh-list
64811405|NCT01446978|Immunologic Factors|immunologic factors|mesh-ancestor
64811406|NCT01446978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811407|NCT01447043|Ranibizumab|ranibizumab|mesh-list
64811408|NCT01447043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64811439|NCT01447173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811440|NCT01447173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64811441|NCT01447212|Hydromorphone|hydromorphone|mesh-list
64811442|NCT01447212|Heroin|heroin|mesh-list
64811443|NCT01447212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64811444|NCT01447212|Narcotics|narcotics|mesh-ancestor
64811445|NCT01447212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64811446|NCT01447212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811447|NCT01447212|Analgesics|analgesics|mesh-ancestor
64811448|NCT01447212|Sensory System Agents|sensory system agents|mesh-ancestor
64811449|NCT01447212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64811450|NCT01447355|Vitamin D|vitamin d|mesh-list
64811451|NCT01447355|Cholecalciferol|cholecalciferol|mesh-list
64811452|NCT01447355|Vitamins|vitamins|mesh-ancestor
64811453|NCT01447355|Micronutrients|micronutrients|mesh-ancestor
64811454|NCT01447355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811455|NCT01447355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64811456|NCT01447355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64811457|NCT01447368|Cinacalcet|cinacalcet|mesh-list
64811458|NCT01447368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64811459|NCT01447368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811460|NCT01447368|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64811461|NCT01447368|Hormone Antagonists|hormone antagonists|mesh-ancestor
64811462|NCT01447368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64811463|NCT01447394|Interferons|interferons|mesh-list
64811464|NCT01447394|Ribavirin|ribavirin|mesh-list
64811465|NCT01447394|Interferon-alpha|interferon-alpha|mesh-list
64811466|NCT01447394|Interferon alpha-2|interferon alpha-2|mesh-list
64811467|NCT01447394|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64811468|NCT01447394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811469|NCT01447394|Antiviral Agents|antiviral agents|mesh-ancestor
64811470|NCT01447394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64811471|NCT01447394|Antimetabolites|antimetabolites|mesh-ancestor
64811472|NCT01447394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811473|NCT01447394|Immunologic Factors|immunologic factors|mesh-ancestor
64811479|NCT01447485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811480|NCT01447550|Bosentan|bosentan|mesh-list
64811481|NCT01447550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65494277|NCT02581787|Immunoglobulin G|immunoglobulin g|mesh-list
64472425|NCT03382301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64811482|NCT01447550|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64811483|NCT01447550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811484|NCT01447563|Clopidogrel|clopidogrel|mesh-list
64811485|NCT01447563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64811488|NCT01447563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64811566|NCT01448174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64811568|NCT01448239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64811569|NCT01448239|Immunologic Factors|immunologic factors|mesh-ancestor
64811570|NCT01448239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811571|NCT01448291|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64811572|NCT01448291|Etonogestrel|etonogestrel|mesh-list
64811573|NCT01448291|NuvaRing|nuvaring|mesh-list
64811574|NCT01448291|Contraceptive Agents|contraceptive agents|mesh-list
64811575|NCT01448291|Estradiol|estradiol|mesh-list
64811576|NCT01448291|Estrogens|estrogens|mesh-ancestor
64811577|NCT01448291|Hormones|hormones|mesh-ancestor
64811578|NCT01448291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64811579|NCT01448291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811580|NCT01448291|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64811581|NCT01448291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65494278|NCT02581787|Immunologic Factors|immunologic factors|mesh-ancestor
64472426|NCT03371017|Gemcitabine|gemcitabine|mesh-list
64472427|NCT03371017|Carboplatin|carboplatin|mesh-list
64811582|NCT01448291|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64811583|NCT01448291|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64811589|NCT01448330|Aspirin|aspirin|mesh-list
64811629|NCT01448499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64811630|NCT01448499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64811631|NCT01448499|GABA Antagonists|gaba antagonists|mesh-ancestor
64811633|NCT01448499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64811634|NCT01448499|Dopamine Agents|dopamine agents|mesh-ancestor
64811635|NCT01448499|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64811636|NCT01448499|Antidepressive Agents|antidepressive agents|mesh-ancestor
64811637|NCT01448642|Atorvastatin|atorvastatin|mesh-list
64811638|NCT01448642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64811639|NCT01448642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64811640|NCT01448642|Antimetabolites|antimetabolites|mesh-ancestor
64811641|NCT01448642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811642|NCT01448642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64811643|NCT01448642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64811662|NCT01448733|Tretinoin|tretinoin|mesh-list
64811749|NCT01449188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811750|NCT01449188|Antiemetics|antiemetics|mesh-ancestor
64811751|NCT01449188|Autonomic Agents|autonomic agents|mesh-ancestor
64811752|NCT01449188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64811753|NCT01449188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64811754|NCT01449188|Antipruritics|antipruritics|mesh-ancestor
64811755|NCT01449188|Dermatologic Agents|dermatologic agents|mesh-ancestor
64811756|NCT01449188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64811757|NCT01449188|Serotonin Agents|serotonin agents|mesh-ancestor
64811758|NCT01449188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64811759|NCT01449188|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64811760|NCT01449188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64811761|NCT01449188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64811868|NCT01449617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811869|NCT01449617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64811870|NCT01449617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64811873|NCT01449617|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64811874|NCT01449617|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64811875|NCT01449617|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64811876|NCT01449617|Purinergic Agents|purinergic agents|mesh-ancestor
64811878|NCT01449799|Fluticasone|fluticasone|mesh-list
64472435|NCT03371017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64472436|NCT03371017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472437|NCT03371017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64472438|NCT03371017|Immunologic Factors|immunologic factors|mesh-ancestor
64472439|NCT03371017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494290|NCT02005289|Lenalidomide|lenalidomide|mesh-list
65494291|NCT02005289|Immunologic Factors|immunologic factors|mesh-ancestor
65494292|NCT02005289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494293|NCT02005289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64811966|NCT01451853|Sensory System Agents|sensory system agents|mesh-ancestor
64811967|NCT01451853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64811968|NCT01451853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811969|NCT01451853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64811970|NCT01451853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64811971|NCT01451853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64811979|NCT01452243|Vitamin D|vitamin d|mesh-list
64812044|NCT01455636|Micronutrients|micronutrients|mesh-list
64812045|NCT01455636|Trace Elements|trace elements|mesh-list
64812046|NCT01455636|Hand Sanitizers|hand sanitizers|mesh-list
64423129|NCT05341609|Ritonavir|ritonavir|mesh-list
64812065|NCT01456585|Gemcitabine|gemcitabine|mesh-list
64812066|NCT01456585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64812067|NCT01456585|Antimetabolites|antimetabolites|mesh-ancestor
64812068|NCT01456585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812069|NCT01456585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812070|NCT01456585|Antiviral Agents|antiviral agents|mesh-ancestor
64812071|NCT01456585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812143|NCT01460212|Fluoxetine|fluoxetine|mesh-list
64812144|NCT01460212|Paroxetine|paroxetine|mesh-list
64812145|NCT01460212|Sertraline|sertraline|mesh-list
64812146|NCT01460212|Antidepressive Agents|antidepressive agents|mesh-list
64812147|NCT01460212|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64812148|NCT01460212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64812149|NCT01460212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64812150|NCT01460212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812151|NCT01460212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64812152|NCT01460212|Serotonin Agents|serotonin agents|mesh-ancestor
64812153|NCT01460212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812154|NCT01460212|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64812155|NCT01460212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64812156|NCT01460212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64812157|NCT01460212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64812158|NCT01460212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812159|NCT01460212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64812160|NCT01460212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64812161|NCT01460212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64812162|NCT01460212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64812170|NCT01460355|Cholinergic Agents|cholinergic agents|mesh-ancestor
64812171|NCT01460355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65494294|NCT02005289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64409975|NCT05214573|Glucagon|glucagon|mesh-list
64812172|NCT01460355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812196|NCT01460537|Antiviral Agents|antiviral agents|mesh-ancestor
64812197|NCT01460537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812198|NCT01460537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812199|NCT01460537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64812200|NCT01460537|Immunologic Factors|immunologic factors|mesh-ancestor
64812201|NCT01460537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812202|NCT01460563|Magnesium Sulfate|magnesium sulfate|mesh-list
64812203|NCT01460563|Analgesics|analgesics|mesh-ancestor
64812204|NCT01460563|Sensory System Agents|sensory system agents|mesh-ancestor
64812205|NCT01460563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64812206|NCT01460563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812207|NCT01460563|Anesthetics|anesthetics|mesh-ancestor
64812208|NCT01460563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64812209|NCT01460563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64812210|NCT01460563|Anticonvulsants|anticonvulsants|mesh-ancestor
64812211|NCT01460563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64812212|NCT01460563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64812213|NCT01460563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812217|NCT01460602|Rituximab|rituximab|mesh-list
64812268|NCT01461018|Immunologic Factors|immunologic factors|mesh-ancestor
64812269|NCT01461018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812270|NCT01461031|Nefopam|nefopam|mesh-list
64812271|NCT01461031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64812272|NCT01461031|Analgesics|analgesics|mesh-ancestor
64812273|NCT01461031|Sensory System Agents|sensory system agents|mesh-ancestor
64812274|NCT01461031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64812275|NCT01461031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812276|NCT01461174|Memantine|memantine|mesh-list
65494300|NCT01924533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65494301|NCT01924533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410151|NCT04801511|Micronutrients|micronutrients|mesh-ancestor
64812342|NCT01462058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812343|NCT01462058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64812344|NCT01462058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64812345|NCT01462149|Carboplatin|carboplatin|mesh-list
64812346|NCT01462149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812347|NCT01462214|Everolimus|everolimus|mesh-list
64812348|NCT01462214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812349|NCT01462214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64812350|NCT01462214|Immunologic Factors|immunologic factors|mesh-ancestor
64812351|NCT01462214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812352|NCT01462422|Misoprostol|misoprostol|mesh-list
64812353|NCT01462422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64812354|NCT01462422|Abortifacient Agents|abortifacient agents|mesh-ancestor
64812355|NCT01462422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64812374|NCT01462617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64812375|NCT01462617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812377|NCT01462669|Ezogabine|ezogabine|mesh-list
64812411|NCT01463150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812412|NCT01463150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812413|NCT01463163|Ticagrelor|ticagrelor|mesh-list
64812414|NCT01463163|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64812424|NCT01463215|Expectorants|expectorants|mesh-ancestor
64812425|NCT01463215|Respiratory System Agents|respiratory system agents|mesh-ancestor
64812426|NCT01463228|Metformin|metformin|mesh-list
64812427|NCT01463228|Canagliflozin|canagliflozin|mesh-list
64812428|NCT01463228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64812429|NCT01463228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812430|NCT01463228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64812431|NCT01463228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812470|NCT01463592|Antimetabolites|antimetabolites|mesh-ancestor
64812471|NCT01463592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812472|NCT01463592|Immunologic Factors|immunologic factors|mesh-ancestor
64812473|NCT01463592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812474|NCT01463592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64812475|NCT01463592|Trace Elements|trace elements|mesh-ancestor
64812476|NCT01463592|Micronutrients|micronutrients|mesh-ancestor
64812477|NCT01463605|Nimotuzumab|nimotuzumab|mesh-list
64812478|NCT01463605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64812492|NCT01463774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812494|NCT01463813|Ergocalciferols|ergocalciferols|mesh-list
64812495|NCT01463813|Cholecalciferol|cholecalciferol|mesh-list
64812496|NCT01463813|Vitamins|vitamins|mesh-list
64812497|NCT01463813|Micronutrients|micronutrients|mesh-ancestor
64812530|NCT01464008|Antimetabolites|antimetabolites|mesh-ancestor
64812531|NCT01464008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812532|NCT01464008|Immunologic Factors|immunologic factors|mesh-ancestor
64812533|NCT01464008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812534|NCT01464060|Amoxicillin|amoxicillin|mesh-list
64812535|NCT01464060|Metronidazole|metronidazole|mesh-list
64812536|NCT01464060|Clarithromycin|clarithromycin|mesh-list
64812537|NCT01464060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64812538|NCT01464060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812539|NCT01464060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64812540|NCT01464060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64812541|NCT01464060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64812542|NCT01464060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423612|NCT05248945|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64812553|NCT01464112|Dexamethasone|dexamethasone|mesh-list
64812554|NCT01464112|Bortezomib|bortezomib|mesh-list
64812555|NCT01464112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64812556|NCT01464112|Antiemetics|antiemetics|mesh-ancestor
64812557|NCT01464112|Autonomic Agents|autonomic agents|mesh-ancestor
64812558|NCT01464112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64812559|NCT01464112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812560|NCT01464112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64812561|NCT01464112|Glucocorticoids|glucocorticoids|mesh-ancestor
64812562|NCT01464112|Hormones|hormones|mesh-ancestor
64812563|NCT01464112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64812564|NCT01464112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64812565|NCT01464112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812566|NCT01464125|Azithromycin|azithromycin|mesh-list
64812567|NCT01464125|Fosmidomycin|fosmidomycin|mesh-list
64812568|NCT01464125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64812585|NCT01464242|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65494313|NCT01683955|Coagulants|coagulants|mesh-ancestor
65494314|NCT01674140|Tamoxifen|tamoxifen|mesh-list
65494315|NCT01674140|Everolimus|everolimus|mesh-list
65494316|NCT01674140|Letrozole|letrozole|mesh-list
65494317|NCT01674140|Anastrozole|anastrozole|mesh-list
65494318|NCT01674140|Leuprolide|leuprolide|mesh-list
65494319|NCT01674140|Exemestane|exemestane|mesh-list
64472487|NCT03204188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64472488|NCT03204188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472490|NCT03203850|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64472491|NCT03203850|Chelating Agents|chelating agents|mesh-ancestor
64812586|NCT01464242|Protective Agents|protective agents|mesh-ancestor
64812587|NCT01464242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812588|NCT01464242|Vasodilator Agents|vasodilator agents|mesh-ancestor
64812589|NCT01464242|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64812590|NCT01464242|Antioxidants|antioxidants|mesh-ancestor
64812656|NCT01466712|Hormones|hormones|mesh-ancestor
64812657|NCT01466712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64812658|NCT01466829|Hormones|hormones|mesh-list
64812659|NCT01466829|Parathyroid Hormone|parathyroid hormone|mesh-list
64812674|NCT01466959|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64812675|NCT01466959|Chelating Agents|chelating agents|mesh-ancestor
64812676|NCT01466959|Sequestering Agents|sequestering agents|mesh-ancestor
64812677|NCT01466959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812678|NCT01466959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64812679|NCT01466959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64812680|NCT01466959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812681|NCT01466959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64812682|NCT01466959|Immunologic Factors|immunologic factors|mesh-ancestor
64812683|NCT01466959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812684|NCT01466959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64812685|NCT01466959|Protective Agents|protective agents|mesh-ancestor
64812713|NCT01467115|Protective Agents|protective agents|mesh-ancestor
64812714|NCT01467115|Vitamin B Complex|vitamin b complex|mesh-ancestor
64812716|NCT01467115|Micronutrients|micronutrients|mesh-ancestor
64812717|NCT01467115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64812718|NCT01467115|Hematinics|hematinics|mesh-ancestor
64812719|NCT01467141|Insulin|insulin|mesh-list
64812720|NCT01467141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64812721|NCT01467141|Insulin Aspart|insulin aspart|mesh-list
64812722|NCT01467141|Isophane Insulin, Human|isophane insulin, human|mesh-list
64812733|NCT01467258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64812734|NCT01467258|Antiviral Agents|antiviral agents|mesh-ancestor
64812735|NCT01467258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812736|NCT01467258|Dopamine Agents|dopamine agents|mesh-ancestor
64812737|NCT01467258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64812738|NCT01467258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812739|NCT01467258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812740|NCT01467258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64812741|NCT01467258|Analgesics|analgesics|mesh-ancestor
64812742|NCT01467258|Sensory System Agents|sensory system agents|mesh-ancestor
64812743|NCT01467258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64812744|NCT01467297|Levofloxacin|levofloxacin|mesh-list
64812745|NCT01467297|Ofloxacin|ofloxacin|mesh-list
64812746|NCT01467297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64812747|NCT01467297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812748|NCT01467297|Renal Agents|renal agents|mesh-ancestor
64812754|NCT01467297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812755|NCT01467297|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64812756|NCT01467297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64812757|NCT01467310|Trametinib|trametinib|mesh-list
64812758|NCT01467310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812759|NCT01467310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64812760|NCT01467310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812761|NCT01467310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812762|NCT01467323|Insulin|insulin|mesh-list
64812763|NCT01467323|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64812764|NCT01467323|Insulin Aspart|insulin aspart|mesh-list
64812765|NCT01467323|Biphasic Insulins|biphasic insulins|mesh-list
64812766|NCT01467323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64812767|NCT01467323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812768|NCT01467362|Desonide|desonide|mesh-list
64812769|NCT01467362|V0034CR|v0034cr|mesh-list
64812770|NCT01467362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64812771|NCT01467362|Emollients|emollients|mesh-ancestor
64812772|NCT01467362|Dermatologic Agents|dermatologic agents|mesh-ancestor
64812773|NCT01467375|Insulin Aspart|insulin aspart|mesh-list
64812774|NCT01467375|Biphasic Insulins|biphasic insulins|mesh-list
64812775|NCT01467375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64812776|NCT01467375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812777|NCT01467401|Insulin|insulin|mesh-list
64812778|NCT01467401|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65494336|NCT01674140|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65494337|NCT01674140|Fertility Agents|fertility agents|mesh-ancestor
65494338|NCT01674140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65494339|NCT01606436|Moxifloxacin|moxifloxacin|mesh-list
65494340|NCT01606436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65494341|NCT01606436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494342|NCT01606436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65494343|NCT01606436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65494344|NCT01606436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472515|NCT03184870|Immunologic Factors|immunologic factors|mesh-ancestor
64472516|NCT03184870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472517|NCT03184870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64472518|NCT03184870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64472519|NCT03184870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64472520|NCT03184870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64472521|NCT03184870|Antidotes|antidotes|mesh-ancestor
64472522|NCT03184870|Protective Agents|protective agents|mesh-ancestor
64472523|NCT03184870|Vitamin B Complex|vitamin b complex|mesh-ancestor
64472524|NCT03184870|Vitamins|vitamins|mesh-ancestor
64472525|NCT03184870|Micronutrients|micronutrients|mesh-ancestor
64472541|NCT03138720|Gemcitabine|gemcitabine|mesh-list
64472542|NCT03138720|Paclitaxel|paclitaxel|mesh-list
64472543|NCT03138720|Cisplatin|cisplatin|mesh-list
64472544|NCT03138720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64472545|NCT03138720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64472546|NCT03138720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472547|NCT03138720|Tubulin Modulators|tubulin modulators|mesh-ancestor
64472548|NCT03138720|Antimitotic Agents|antimitotic agents|mesh-ancestor
64472549|NCT03138720|Mitosis Modulators|mitosis modulators|mesh-ancestor
64472550|NCT03138720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812815|NCT01467596|Lidocaine|lidocaine|mesh-list
64812828|NCT01467648|Doripenem|doripenem|mesh-list
64812829|NCT01467648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64812830|NCT01467648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812831|NCT01467687|Verapamil|verapamil|mesh-list
64812832|NCT01467687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64812833|NCT01467687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64812834|NCT01467687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64812835|NCT01467687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812836|NCT01467687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64812837|NCT01467687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812838|NCT01467687|Vasodilator Agents|vasodilator agents|mesh-ancestor
64812839|NCT01467804|Sertraline|sertraline|mesh-list
64812840|NCT01467804|Antidepressive Agents|antidepressive agents|mesh-ancestor
64812841|NCT01467804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64812842|NCT01467804|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64812843|NCT01467804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65494345|NCT01606436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494346|NCT01606436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494347|NCT01453088|Bortezomib|bortezomib|mesh-list
65494348|NCT01453088|Melphalan|melphalan|mesh-list
65494349|NCT01453088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494350|NCT01453088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65494351|NCT01453088|Alkylating Agents|alkylating agents|mesh-ancestor
65494352|NCT01453088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494353|NCT01453088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65494354|NCT01453088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65494355|NCT01453088|Immunologic Factors|immunologic factors|mesh-ancestor
65494356|NCT01453088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472560|NCT03131726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64472561|NCT03131726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64472562|NCT03131726|Antimetabolites|antimetabolites|mesh-ancestor
64472563|NCT03131726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472564|NCT03131726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64472565|NCT03131726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64472566|NCT03131726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472567|NCT03114319|Nazartinib|nazartinib|mesh-list
64472568|NCT03114319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64472569|NCT03113500|Prednisone|prednisone|mesh-list
64472570|NCT03113500|Cortisone|cortisone|mesh-list
64472571|NCT03113500|Cyclophosphamide|cyclophosphamide|mesh-list
64472572|NCT03113500|Doxorubicin|doxorubicin|mesh-list
64472573|NCT03113500|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64472574|NCT03113500|Etoposide|etoposide|mesh-list
64472575|NCT03113500|Etoposide phosphate|etoposide phosphate|mesh-list
64472576|NCT03113500|Daunorubicin|daunorubicin|mesh-list
64812844|NCT01467804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64812845|NCT01467804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812846|NCT01467804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64812847|NCT01467804|Serotonin Agents|serotonin agents|mesh-ancestor
64812848|NCT01467804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812849|NCT01467921|Oxaliplatin|oxaliplatin|mesh-list
64812850|NCT01467921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812851|NCT01467986|Sirolimus|sirolimus|mesh-list
65494372|NCT01257139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494373|NCT01257139|Tubulin Modulators|tubulin modulators|mesh-ancestor
65494374|NCT01257139|Antimitotic Agents|antimitotic agents|mesh-ancestor
65494375|NCT01257139|Mitosis Modulators|mitosis modulators|mesh-ancestor
65494376|NCT01257139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494377|NCT01243190|Ofatumumab|ofatumumab|mesh-list
65494378|NCT01243190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494379|NCT01046825|Leucovorin|leucovorin|mesh-list
65494380|NCT01046825|Folic Acid|folic acid|mesh-list
65494381|NCT01046825|Cytarabine|cytarabine|mesh-list
64812909|NCT01468155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812910|NCT01468155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812911|NCT01468155|Anticoagulants|anticoagulants|mesh-ancestor
64812912|NCT01468259|Droxidopa|droxidopa|mesh-list
64812913|NCT01468259|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64812914|NCT01468259|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64812915|NCT01468272|Beclomethasone|beclomethasone|mesh-list
65494393|NCT01046825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65494394|NCT01046825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494395|NCT01046825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65494396|NCT01046825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494397|NCT01046825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65494398|NCT01046825|Immunologic Factors|immunologic factors|mesh-ancestor
65494399|NCT01046825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65494400|NCT01046825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65494401|NCT01046825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65494402|NCT01046825|Alkylating Agents|alkylating agents|mesh-ancestor
64812937|NCT01468285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64812938|NCT01468285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812939|NCT01468285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812940|NCT01468389|Capecitabine|capecitabine|mesh-list
64812941|NCT01468389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64812942|NCT01468389|Antimetabolites|antimetabolites|mesh-ancestor
64812943|NCT01468389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812944|NCT01468389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812945|NCT01468415|Phenol|phenol|mesh-list
64812946|NCT01468415|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64812947|NCT01468415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812948|NCT01468415|Disinfectants|disinfectants|mesh-ancestor
64812949|NCT01468415|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64812950|NCT01468415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64812951|NCT01468441|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64812952|NCT01468441|Cetrorelix|cetrorelix|mesh-list
64812953|NCT01468441|Luteolytic Agents|luteolytic agents|mesh-ancestor
64812954|NCT01468441|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64812955|NCT01468441|Contraceptive Agents|contraceptive agents|mesh-ancestor
64812956|NCT01468441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64812957|NCT01468441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812958|NCT01468441|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64812959|NCT01468441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64812960|NCT01468441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494410|NCT01046825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65494411|NCT01046825|Antimetabolites|antimetabolites|mesh-ancestor
65494412|NCT01046825|Antiviral Agents|antiviral agents|mesh-ancestor
64812962|NCT01468441|Fertility Agents|fertility agents|mesh-ancestor
64812963|NCT01468441|Hormone Antagonists|hormone antagonists|mesh-ancestor
64812964|NCT01468441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64812965|NCT01468480|Calcium, Dietary|calcium, dietary|mesh-list
64812966|NCT01468480|Calcium|calcium|mesh-list
64812967|NCT01468480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64812968|NCT01468480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812969|NCT01468480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64812970|NCT01468519|Insulin|insulin|mesh-list
64812971|NCT01468519|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64812972|NCT01468519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64812973|NCT01468519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812974|NCT01468545|Iloprost|iloprost|mesh-list
64812975|NCT01468545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64812976|NCT01468545|Vasodilator Agents|vasodilator agents|mesh-ancestor
64812977|NCT01468571|Spironolactone|spironolactone|mesh-list
64812978|NCT01468571|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64812979|NCT01468571|Hormone Antagonists|hormone antagonists|mesh-ancestor
64812980|NCT01468571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64812981|NCT01468571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813025|NCT01468740|Alkylating Agents|alkylating agents|mesh-ancestor
64813026|NCT01468740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813027|NCT01468740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813028|NCT01468740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64813029|NCT01468740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64813030|NCT01468740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64813031|NCT01468740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64813032|NCT01468740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813033|NCT01468740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64813034|NCT01468740|Glucocorticoids|glucocorticoids|mesh-ancestor
64813035|NCT01468740|Hormones|hormones|mesh-ancestor
64813036|NCT01468740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65494430|NCT00936936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494431|NCT00936936|Antiviral Agents|antiviral agents|mesh-ancestor
65494432|NCT00936936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494433|NCT00936936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813037|NCT01468740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64813038|NCT01468740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64813152|NCT01469650|Vitamin D|vitamin d|mesh-list
64813153|NCT01469650|Ergocalciferols|ergocalciferols|mesh-list
64813154|NCT01469650|Cholecalciferol|cholecalciferol|mesh-list
64813155|NCT01469650|Vitamins|vitamins|mesh-list
64813156|NCT01469650|Micronutrients|micronutrients|mesh-ancestor
64813157|NCT01469650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813158|NCT01469650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64813159|NCT01469650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64813160|NCT01469702|Azithromycin|azithromycin|mesh-list
64813161|NCT01469702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64813162|NCT01469702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64813163|NCT01469884|Cyclosporine|cyclosporine|mesh-list
64813164|NCT01469884|Everolimus|everolimus|mesh-list
64813165|NCT01469884|Tacrolimus|tacrolimus|mesh-list
64813166|NCT01469884|Cyclosporins|cyclosporins|mesh-list
64813167|NCT01469884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64813168|NCT01469884|Immunologic Factors|immunologic factors|mesh-ancestor
64813169|NCT01469884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813170|NCT01469884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64813171|NCT01469884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813172|NCT01469884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813173|NCT01469884|Antifungal Agents|antifungal agents|mesh-ancestor
64813174|NCT01469884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64813175|NCT01469884|Dermatologic Agents|dermatologic agents|mesh-ancestor
64813176|NCT01469884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64813177|NCT01469884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813178|NCT01469975|Edetic Acid|edetic acid|mesh-list
64813179|NCT01469975|Pentetic Acid|pentetic acid|mesh-list
64813190|NCT01469988|Androgens|androgens|mesh-ancestor
64813192|NCT01469988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64813204|NCT01470040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64813205|NCT01470040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813206|NCT01470040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64813207|NCT01470040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64813208|NCT01470040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813209|NCT01470040|Antipyretics|antipyretics|mesh-ancestor
64813210|NCT01470053|Mometasone Furoate|mometasone furoate|mesh-list
64813211|NCT01470053|Azelastine|azelastine|mesh-list
64813212|NCT01470053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64813213|NCT01470053|Dermatologic Agents|dermatologic agents|mesh-ancestor
64813214|NCT01470053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64813215|NCT01470053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64813216|NCT01470053|Autonomic Agents|autonomic agents|mesh-ancestor
64813217|NCT01470053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64813218|NCT01470053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813219|NCT01470053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65494435|NCT00936936|Immunologic Factors|immunologic factors|mesh-ancestor
65494436|NCT00936936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494437|NCT00936936|Tubulin Modulators|tubulin modulators|mesh-ancestor
65494438|NCT00936936|Antimitotic Agents|antimitotic agents|mesh-ancestor
65494439|NCT00936936|Mitosis Modulators|mitosis modulators|mesh-ancestor
65494440|NCT00936936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64472623|NCT03085394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64472624|NCT03085394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64472625|NCT03085394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472626|NCT03085394|Hemostatics|hemostatics|mesh-ancestor
64472627|NCT03085394|Coagulants|coagulants|mesh-ancestor
64472628|NCT03065621|Palbociclib|palbociclib|mesh-list
64472629|NCT03065621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813280|NCT01470352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64813281|NCT01470352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64813282|NCT01470352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64813283|NCT01470352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813284|NCT01470352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64813285|NCT01470352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813286|NCT01470352|Analgesics|analgesics|mesh-ancestor
64813287|NCT01470352|Sensory System Agents|sensory system agents|mesh-ancestor
64813288|NCT01470352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64813289|NCT01470352|Antidepressive Agents|antidepressive agents|mesh-ancestor
64813290|NCT01470352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64813324|NCT01470937|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64813325|NCT01470937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813326|NCT01470937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813327|NCT01470937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64813328|NCT01470937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813329|NCT01471067|Mycophenolic Acid|mycophenolic acid|mesh-list
64813330|NCT01471067|Rituximab|rituximab|mesh-list
64813331|NCT01471067|Fludarabine|fludarabine|mesh-list
64813332|NCT01471067|Fludarabine phosphate|fludarabine phosphate|mesh-list
64813333|NCT01471067|Melphalan|melphalan|mesh-list
64813334|NCT01471067|Busulfan|busulfan|mesh-list
64813335|NCT01471067|Clofarabine|clofarabine|mesh-list
64813336|NCT01471067|Tacrolimus|tacrolimus|mesh-list
64813337|NCT01471067|Thymoglobulin|thymoglobulin|mesh-list
64813338|NCT01471067|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64813339|NCT01471067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64813340|NCT01471067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813341|NCT01471067|Immunologic Factors|immunologic factors|mesh-ancestor
64813342|NCT01471067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813343|NCT01471067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64813344|NCT01471067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64813345|NCT01471067|Antimetabolites|antimetabolites|mesh-ancestor
64813346|NCT01471067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813347|NCT01471067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64813348|NCT01471067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64813349|NCT01471067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65494441|NCT00936936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65494442|NCT00936936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65494443|NCT00936936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65494444|NCT00936936|Alkylating Agents|alkylating agents|mesh-ancestor
65494445|NCT00936936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65494446|NCT04478292|Sodium thiosulfate|sodium thiosulfate|mesh-list
65494447|NCT04478292|Cisplatin|cisplatin|mesh-list
64472630|NCT03065621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64472632|NCT03065621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472633|NCT03060434|Acetaminophen|acetaminophen|mesh-list
64725729|NCT00002167|Tin etiopurpurin|tin etiopurpurin|mesh-list
64725730|NCT00002167|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64725731|NCT00002167|Dermatologic Agents|dermatologic agents|mesh-ancestor
64472634|NCT03060434|Ibuprofen|ibuprofen|mesh-list
64472635|NCT03060434|Pregabalin|pregabalin|mesh-list
64472636|NCT03060434|Pentoxifylline|pentoxifylline|mesh-list
64813350|NCT01471067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813351|NCT01471067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64813352|NCT01471067|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64813353|NCT01471067|Antitubercular Agents|antitubercular agents|mesh-ancestor
64813354|NCT01471067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64813355|NCT01471067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64813356|NCT01471067|Alkylating Agents|alkylating agents|mesh-ancestor
64813357|NCT01471067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64813358|NCT01471132|Paclitaxel|paclitaxel|mesh-list
65494450|NCT04478292|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65494451|NCT04478292|Fluorouracil|fluorouracil|mesh-list
65494452|NCT04478292|Irinotecan|irinotecan|mesh-list
65494453|NCT04478292|Vincristine|vincristine|mesh-list
65494454|NCT04478292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494455|NCT04478292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64472637|NCT03060434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64411207|NCT03064633|Dexamethasone|dexamethasone|mesh-list
64813443|NCT01471678|Hormone Antagonists|hormone antagonists|mesh-ancestor
64813444|NCT01471678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64813445|NCT01471704|Verapamil|verapamil|mesh-list
64813446|NCT01471704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64813447|NCT01471704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64813448|NCT01471704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64813449|NCT01471704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813450|NCT01471704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64813506|NCT01471899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64813507|NCT01471899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64813508|NCT01471899|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64813509|NCT01471899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813510|NCT01471899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813511|NCT01471899|Gout Suppressants|gout suppressants|mesh-ancestor
64813512|NCT01471925|Esomeprazole|esomeprazole|mesh-list
64813513|NCT01471925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64813514|NCT01471925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64813515|NCT01471925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64813516|NCT01471925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813517|NCT01471925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813518|NCT01471964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64813519|NCT01471964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813520|NCT01471964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64813521|NCT01471964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813522|NCT01471964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813523|NCT01471990|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
64813571|NCT01472263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813572|NCT01472263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813573|NCT01472263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64813574|NCT01472263|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64813575|NCT01472263|Protective Agents|protective agents|mesh-ancestor
64813576|NCT01472263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813577|NCT01472263|Vasodilator Agents|vasodilator agents|mesh-ancestor
64813578|NCT01472263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64813579|NCT01472263|Antioxidants|antioxidants|mesh-ancestor
64813580|NCT01472315|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64813581|NCT01472315|Medroxyprogesterone|medroxyprogesterone|mesh-list
64813582|NCT01472315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64813583|NCT01472315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64813584|NCT01472315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64813650|NCT01472926|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64813651|NCT01472926|Plasminogen|plasminogen|mesh-list
64813652|NCT01472926|Tenecteplase|tenecteplase|mesh-list
64813653|NCT01472926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64813654|NCT01472926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64813655|NCT01472926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813656|NCT01472978|Metronidazole|metronidazole|mesh-list
64813657|NCT01472978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64813658|NCT01472978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64813659|NCT01472978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64813660|NCT01472978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64813661|NCT01473043|Axitinib|axitinib|mesh-list
64813662|NCT01473043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813663|NCT01473043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64813671|NCT01473069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813673|NCT01473069|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64813715|NCT01473277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64813716|NCT01473277|Cholinergic Agents|cholinergic agents|mesh-ancestor
64813717|NCT01473277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64813718|NCT01473303|Leucovorin|leucovorin|mesh-list
64813719|NCT01473303|Fluorouracil|fluorouracil|mesh-list
64813720|NCT01473303|Oxaliplatin|oxaliplatin|mesh-list
64813721|NCT01473303|Irinotecan|irinotecan|mesh-list
64813722|NCT01473303|Calcium|calcium|mesh-list
64813723|NCT01473303|Levoleucovorin|levoleucovorin|mesh-list
64813726|NCT01473303|Antimetabolites|antimetabolites|mesh-ancestor
64813791|NCT01473914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813803|NCT01474187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64813804|NCT01474187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813805|NCT01474265|Varenicline|varenicline|mesh-list
64813806|NCT01474265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64813807|NCT01474265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64813808|NCT01474265|Cholinergic Agents|cholinergic agents|mesh-ancestor
64813809|NCT01474265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64813810|NCT01474265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813811|NCT01474265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813812|NCT01474304|Acetaminophen|acetaminophen|mesh-list
64813813|NCT01474304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64813814|NCT01474304|Analgesics|analgesics|mesh-ancestor
64813815|NCT01474304|Sensory System Agents|sensory system agents|mesh-ancestor
64813818|NCT01474304|Antipyretics|antipyretics|mesh-ancestor
64813879|NCT01475019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64813880|NCT01475019|Appetite Depressants|appetite depressants|mesh-ancestor
64813881|NCT01475032|Beclomethasone|beclomethasone|mesh-list
64813882|NCT01475032|Formoterol Fumarate|formoterol fumarate|mesh-list
64813883|NCT01475032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64813884|NCT01475032|Autonomic Agents|autonomic agents|mesh-ancestor
64813885|NCT01475032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64813886|NCT01475032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813887|NCT01475032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64813888|NCT01475032|Respiratory System Agents|respiratory system agents|mesh-ancestor
64813889|NCT01475032|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64813890|NCT01475032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64813891|NCT01475032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64813892|NCT01475032|Adrenergic Agents|adrenergic agents|mesh-ancestor
64813896|NCT01475032|Glucocorticoids|glucocorticoids|mesh-ancestor
64813942|NCT01475552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64813943|NCT01475552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64813944|NCT01475552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64813945|NCT01475552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64813946|NCT01475552|Purinergic Agents|purinergic agents|mesh-ancestor
64813947|NCT01475552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64813948|NCT01475552|Anticoagulants|anticoagulants|mesh-ancestor
64813949|NCT01475578|Ergoloid Mesylates|ergoloid mesylates|mesh-list
64813950|NCT01475578|Dihydroergotoxine|dihydroergotoxine|mesh-list
64813951|NCT01475578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64813952|NCT01475578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64813953|NCT01475578|Adrenergic Agents|adrenergic agents|mesh-ancestor
64813954|NCT01475578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64813955|NCT01475578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813956|NCT01475578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813957|NCT01475578|Vasodilator Agents|vasodilator agents|mesh-ancestor
64813958|NCT01475578|Nootropic Agents|nootropic agents|mesh-ancestor
64813959|NCT01475578|Dopamine Agonists|dopamine agonists|mesh-ancestor
64813960|NCT01475578|Dopamine Agents|dopamine agents|mesh-ancestor
64813961|NCT01475617|Calcium, Dietary|calcium, dietary|mesh-list
64813962|NCT01475617|Vitamin B 12|vitamin b 12|mesh-list
64813963|NCT01475617|Hydroxocobalamin|hydroxocobalamin|mesh-list
64813964|NCT01475617|Calcium|calcium|mesh-list
64813965|NCT01475617|Vitamins|vitamins|mesh-ancestor
64813966|NCT01475617|Micronutrients|micronutrients|mesh-ancestor
64813967|NCT01475617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814008|NCT01476007|Hydroxocobalamin|hydroxocobalamin|mesh-list
64814009|NCT01476007|Vitamin B 12|vitamin b 12|mesh-list
64814010|NCT01476007|Vitamin B Complex|vitamin b complex|mesh-list
64814011|NCT01476007|Micronutrients|micronutrients|mesh-ancestor
64814012|NCT01476007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814013|NCT01476007|Hematinics|hematinics|mesh-ancestor
64814014|NCT01476124|Morphine|morphine|mesh-list
64814015|NCT01476124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64814016|NCT01476124|Narcotics|narcotics|mesh-ancestor
64814017|NCT01476124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64814018|NCT01476124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64472645|NCT03060434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64472646|NCT03060434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64472647|NCT03060434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64472649|NCT03060434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64472650|NCT03060434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64472651|NCT03060434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64472652|NCT03060434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64472653|NCT03060434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64472654|NCT03060434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64472655|NCT03060434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64472656|NCT03060434|Antipyretics|antipyretics|mesh-ancestor
64472657|NCT03060434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64472658|NCT03060434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64472659|NCT03060434|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64472660|NCT03060434|Protective Agents|protective agents|mesh-ancestor
65494475|NCT04478292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494476|NCT04478292|Chelating Agents|chelating agents|mesh-ancestor
65494477|NCT04478292|Sequestering Agents|sequestering agents|mesh-ancestor
65494478|NCT01141296|Fenofibrate|fenofibrate|mesh-list
65494479|NCT01141296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65494480|NCT01141296|Antimetabolites|antimetabolites|mesh-ancestor
65494481|NCT01141296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494482|NCT01141296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65494483|NCT01238328|Thymoglobulin|thymoglobulin|mesh-list
65494484|NCT01238328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65494485|NCT01238328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65494486|NCT01238328|Immunologic Factors|immunologic factors|mesh-ancestor
64472666|NCT03036930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814102|NCT01476488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64814103|NCT01476488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814104|NCT01476488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814105|NCT01476592|Resveratrol|resveratrol|mesh-list
64814106|NCT01476592|Antioxidants|antioxidants|mesh-ancestor
64814107|NCT01476592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814108|NCT01476592|Protective Agents|protective agents|mesh-ancestor
64814109|NCT01476592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814110|NCT01476592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814111|NCT01476592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64814112|NCT01476605|Sodium Morrhuate|sodium morrhuate|mesh-list
64814113|NCT01476605|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64814115|NCT01476683|Racecadotril|racecadotril|mesh-list
64814154|NCT01476800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64814155|NCT01476800|Hormone Antagonists|hormone antagonists|mesh-ancestor
64814156|NCT01476800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64814157|NCT01476800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814158|NCT01476800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64814159|NCT01476800|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64814160|NCT01476800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64814161|NCT01476800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64814162|NCT01476800|Adrenergic Agents|adrenergic agents|mesh-ancestor
64814163|NCT01476800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64814164|NCT01476800|Urological Agents|urological agents|mesh-ancestor
64814165|NCT01476813|Glycopyrrolate|glycopyrrolate|mesh-list
64814166|NCT01476813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64814167|NCT01476813|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64814168|NCT01476813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64814169|NCT01476813|Cholinergic Agents|cholinergic agents|mesh-ancestor
64814170|NCT01476813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64814171|NCT01476813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814200|NCT01477073|Hormones|hormones|mesh-ancestor
64814227|NCT01477203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64814228|NCT01477203|Antidepressive Agents|antidepressive agents|mesh-ancestor
64814229|NCT01477203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64814230|NCT01477242|Ondansetron|ondansetron|mesh-list
64814238|NCT01477242|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64814239|NCT01477242|Serotonin Agents|serotonin agents|mesh-ancestor
64814240|NCT01477242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64814241|NCT01477242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814309|NCT01477606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814310|NCT01477606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64814311|NCT01477632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64814312|NCT01477632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64814313|NCT01477632|Norethindrone|norethindrone|mesh-list
64814314|NCT01477632|Norethindrone Acetate|norethindrone acetate|mesh-list
64814315|NCT01477632|Estradiol|estradiol|mesh-list
64814316|NCT01477632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64814317|NCT01477632|Estrogens|estrogens|mesh-ancestor
64814318|NCT01477632|Hormones|hormones|mesh-ancestor
64814319|NCT01477632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64814320|NCT01477632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814321|NCT01477632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64814322|NCT01477632|Contraceptive Agents|contraceptive agents|mesh-ancestor
64814323|NCT01477632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64814324|NCT01477632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64814326|NCT01477632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64814385|NCT01478022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64814386|NCT01478022|Analgesics|analgesics|mesh-ancestor
64814387|NCT01478022|Sensory System Agents|sensory system agents|mesh-ancestor
64814388|NCT01478022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814389|NCT01478022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814390|NCT01478022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64814391|NCT01478022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64814392|NCT01478022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64814465|NCT01478490|Mirabegron|mirabegron|mesh-list
64814466|NCT01478490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64814467|NCT01478490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64814468|NCT01478490|Sympatholytics|sympatholytics|mesh-ancestor
64814469|NCT01478490|Autonomic Agents|autonomic agents|mesh-ancestor
64814470|NCT01478490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814471|NCT01478490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814472|NCT01478490|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64814473|NCT01478490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64814474|NCT01478490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64814475|NCT01478490|Adrenergic Agents|adrenergic agents|mesh-ancestor
64814535|NCT01478685|Carboplatin|carboplatin|mesh-list
64814536|NCT01478685|Azacitidine|azacitidine|mesh-list
64814537|NCT01478685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64814538|NCT01478685|Cc-486|cc-486|mesh-list
64814539|NCT01478685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64814540|NCT01478685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814546|NCT01478685|Antimetabolites|antimetabolites|mesh-ancestor
64814634|NCT01479283|Antitubercular Agents|antitubercular agents|mesh-ancestor
64814635|NCT01479296|Vaccines|vaccines|mesh-list
64814636|NCT01479296|Immunologic Factors|immunologic factors|mesh-ancestor
64814637|NCT01479296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814638|NCT01479361|Atovaquone|atovaquone|mesh-list
64814639|NCT01479361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64814640|NCT01479361|Antimalarials|antimalarials|mesh-ancestor
64814641|NCT01479361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64814642|NCT01479361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64814643|NCT01479361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814644|NCT01479361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814645|NCT01479504|Cisplatin|cisplatin|mesh-list
64814646|NCT01479504|Docetaxel|docetaxel|mesh-list
64814647|NCT01479504|Nedaplatin|nedaplatin|mesh-list
64814648|NCT01479504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814649|NCT01479504|Tubulin Modulators|tubulin modulators|mesh-ancestor
64814650|NCT01479504|Antimitotic Agents|antimitotic agents|mesh-ancestor
64814651|NCT01479504|Mitosis Modulators|mitosis modulators|mesh-ancestor
64814652|NCT01479504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814653|NCT01479556|Pregabalin|pregabalin|mesh-list
64814709|NCT01479881|Cyclosporins|cyclosporins|mesh-list
64814710|NCT01479881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64814711|NCT01479881|Immunologic Factors|immunologic factors|mesh-ancestor
64814712|NCT01479881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814713|NCT01479881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64814714|NCT01479881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814715|NCT01479881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814716|NCT01479881|Antifungal Agents|antifungal agents|mesh-ancestor
64814717|NCT01479881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64814718|NCT01479881|Dermatologic Agents|dermatologic agents|mesh-ancestor
64814719|NCT01479881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64814720|NCT01479881|Antiviral Agents|antiviral agents|mesh-ancestor
64814721|NCT01479881|Protease Inhibitors|protease inhibitors|mesh-ancestor
64814722|NCT01479920|Fluoxetine|fluoxetine|mesh-list
64814736|NCT01479933|Vitamin D|vitamin d|mesh-list
64814737|NCT01479933|Ergocalciferols|ergocalciferols|mesh-list
64814738|NCT01479933|Cholecalciferol|cholecalciferol|mesh-list
64814739|NCT01479933|Vitamins|vitamins|mesh-list
64814740|NCT01479933|Micronutrients|micronutrients|mesh-ancestor
64814741|NCT01479933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814742|NCT01479933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64814743|NCT01479933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64814774|NCT01480323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814775|NCT01480323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64814776|NCT01480323|Analgesics|analgesics|mesh-ancestor
64814777|NCT01480323|Sensory System Agents|sensory system agents|mesh-ancestor
64814778|NCT01480323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814830|NCT01480752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64814831|NCT01480752|Analgesics|analgesics|mesh-ancestor
64814832|NCT01480752|Sensory System Agents|sensory system agents|mesh-ancestor
64814833|NCT01480752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814834|NCT01480752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814835|NCT01480752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64814836|NCT01480752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64814837|NCT01480765|Pregabalin|pregabalin|mesh-list
64814838|NCT01480765|Ketamine|ketamine|mesh-list
64814839|NCT01480765|Analgesics|analgesics|mesh-ancestor
64814840|NCT01480765|Sensory System Agents|sensory system agents|mesh-ancestor
64814841|NCT01480765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814842|NCT01480765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814843|NCT01480765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64814844|NCT01480765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64814845|NCT01480765|Anesthetics, General|anesthetics, general|mesh-ancestor
64814846|NCT01480765|Anesthetics|anesthetics|mesh-ancestor
64814847|NCT01480765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64814848|NCT01480765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64814884|NCT01480817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814885|NCT01480869|Calcium, Dietary|calcium, dietary|mesh-list
64814886|NCT01480869|Cholecalciferol|cholecalciferol|mesh-list
64814887|NCT01480869|Vitamin D|vitamin d|mesh-list
64814888|NCT01480869|Calcium|calcium|mesh-list
64814889|NCT01480869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64814890|NCT01480869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814891|NCT01480869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64814892|NCT01480869|Vitamins|vitamins|mesh-ancestor
64814893|NCT01480869|Micronutrients|micronutrients|mesh-ancestor
64814894|NCT01480986|Irinotecan|irinotecan|mesh-list
64814895|NCT01480986|Octreotide|octreotide|mesh-list
64814955|NCT01481350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814956|NCT01481350|Urological Agents|urological agents|mesh-ancestor
64814957|NCT01481389|Theobromine|theobromine|mesh-list
64814958|NCT01481389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64814959|NCT01481389|Autonomic Agents|autonomic agents|mesh-ancestor
64814960|NCT01481389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814961|NCT01481389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814962|NCT01481389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64814963|NCT01481389|Respiratory System Agents|respiratory system agents|mesh-ancestor
64814964|NCT01481389|Vasodilator Agents|vasodilator agents|mesh-ancestor
64814965|NCT01481454|Vaccines|vaccines|mesh-list
64815025|NCT01481714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64815026|NCT01481714|Antacids|antacids|mesh-ancestor
64815027|NCT01481831|Palonosetron|palonosetron|mesh-list
64583650|NCT00287339|Esomeprazole|esomeprazole|mesh-list
64815028|NCT01481831|Antiemetics|antiemetics|mesh-ancestor
64815029|NCT01481831|Autonomic Agents|autonomic agents|mesh-ancestor
64815030|NCT01481831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64815031|NCT01481831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815032|NCT01481831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64815033|NCT01481831|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64815034|NCT01481831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64815035|NCT01481831|Serotonin Agents|serotonin agents|mesh-ancestor
64815101|NCT01482117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64815102|NCT01482117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64815103|NCT01482117|Respiratory System Agents|respiratory system agents|mesh-ancestor
64815104|NCT01482117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64815105|NCT01482117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64815106|NCT01482117|Vasodilator Agents|vasodilator agents|mesh-ancestor
64815107|NCT01482117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64815108|NCT01482117|Protective Agents|protective agents|mesh-ancestor
64815109|NCT01482117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64815110|NCT01482117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64815111|NCT01482117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815112|NCT01482156|Everolimus|everolimus|mesh-list
64815113|NCT01482156|Dactolisib|dactolisib|mesh-list
64815114|NCT01482156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815115|NCT01482156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64815116|NCT01482156|Immunologic Factors|immunologic factors|mesh-ancestor
64815117|NCT01482156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815118|NCT01482299|Everolimus|everolimus|mesh-list
64815119|NCT01482299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815120|NCT01482299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64815121|NCT01482299|Immunologic Factors|immunologic factors|mesh-ancestor
64426197|NCT02817633|Nivolumab|nivolumab|mesh-list
64815130|NCT01482338|Diuretics|diuretics|mesh-ancestor
64815161|NCT01482468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65494493|NCT03724890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815162|NCT01482468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815163|NCT01482468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64815164|NCT01482468|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64815165|NCT01482468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64815166|NCT01482468|Serotonin Agents|serotonin agents|mesh-ancestor
64815167|NCT01482468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64815168|NCT01482468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815169|NCT01482559|Dopamine|dopamine|mesh-list
64815170|NCT01482559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64815171|NCT01482559|Sympathomimetics|sympathomimetics|mesh-ancestor
64815172|NCT01482559|Autonomic Agents|autonomic agents|mesh-ancestor
64815173|NCT01482559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64815174|NCT01482559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815175|NCT01482559|Dopamine Agents|dopamine agents|mesh-ancestor
64815176|NCT01482559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64815178|NCT01482559|Protective Agents|protective agents|mesh-ancestor
64815228|NCT01483014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815229|NCT01483053|S 20098|s 20098|mesh-list
64815230|NCT01483053|Citalopram|citalopram|mesh-list
64815231|NCT01483053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64815232|NCT01483053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64815233|NCT01483053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64815234|NCT01483053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815235|NCT01483053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64815236|NCT01483053|Serotonin Agents|serotonin agents|mesh-ancestor
64815237|NCT01483053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815238|NCT01483053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64815239|NCT01483053|Antidepressive Agents|antidepressive agents|mesh-ancestor
64815240|NCT01483053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64815241|NCT01483053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64815242|NCT01483053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64815243|NCT01483248|Interferons|interferons|mesh-list
64815244|NCT01483248|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64815245|NCT01483248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815246|NCT01483248|Antiviral Agents|antiviral agents|mesh-ancestor
65494494|NCT03724890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64490419|NCT02982148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815312|NCT01484145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815313|NCT01484145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815314|NCT01484171|Idarubicin|idarubicin|mesh-list
64815315|NCT01484171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64815316|NCT01484171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815317|NCT01484171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64815318|NCT01484171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64815319|NCT01484171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815320|NCT01484171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815321|NCT01484184|Levodopa|levodopa|mesh-list
64815322|NCT01484184|Buspirone|buspirone|mesh-list
64815323|NCT01484184|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64815324|NCT01484184|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64815325|NCT01484184|Dopamine Agents|dopamine agents|mesh-ancestor
64815326|NCT01484184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64815327|NCT01484184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815328|NCT01484184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815329|NCT01484184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64815330|NCT01484184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64815331|NCT01484184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64815332|NCT01484184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64815333|NCT01484184|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64815334|NCT01484184|Serotonin Agents|serotonin agents|mesh-ancestor
64815335|NCT01484262|Liraglutide|liraglutide|mesh-list
64815336|NCT01484262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64815337|NCT01484262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815338|NCT01484262|Incretins|incretins|mesh-ancestor
64815339|NCT01484262|Hormones|hormones|mesh-ancestor
64815355|NCT01484327|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64815356|NCT01484327|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64815357|NCT01484457|Pancrelipase|pancrelipase|mesh-list
64815358|NCT01484457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64815359|NCT01484600|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64815360|NCT01484600|Immunologic Factors|immunologic factors|mesh-ancestor
64815361|NCT01484600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815362|NCT01484613|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64815363|NCT01484613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64815364|NCT01484613|Contraceptive Agents|contraceptive agents|mesh-ancestor
64426440|NCT05031897|Mycophenolic Acid|mycophenolic acid|mesh-list
64815373|NCT01484717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64815374|NCT01484717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815375|NCT01484717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64815381|NCT01484756|Trace Elements|trace elements|mesh-list
64815420|NCT01485146|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
64815421|NCT01485146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64815422|NCT01485146|Antimetabolites|antimetabolites|mesh-ancestor
64815423|NCT01485146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815424|NCT01485146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64815425|NCT01485146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815426|NCT01485146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64815427|NCT01485146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815428|NCT01485185|Gabapentin|gabapentin|mesh-list
64815429|NCT01485185|Donepezil|donepezil|mesh-list
64815430|NCT01485185|Analgesics|analgesics|mesh-ancestor
64815452|NCT01485198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64815453|NCT01485198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815454|NCT01485198|Antipyretics|antipyretics|mesh-ancestor
64815455|NCT01485211|Riboflavin|riboflavin|mesh-list
64815456|NCT01485211|Vitamin B Complex|vitamin b complex|mesh-ancestor
64815458|NCT01485211|Micronutrients|micronutrients|mesh-ancestor
64815459|NCT01485211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815460|NCT01485211|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64815461|NCT01485211|Dermatologic Agents|dermatologic agents|mesh-ancestor
64815462|NCT01485224|Thalidomide|thalidomide|mesh-list
64815463|NCT01485224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64815464|NCT01485224|Immunologic Factors|immunologic factors|mesh-ancestor
64815465|NCT01485224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815466|NCT01485224|Leprostatic Agents|leprostatic agents|mesh-ancestor
64815467|NCT01485224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64815468|NCT01485224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64815469|NCT01485224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64815470|NCT01485224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64815471|NCT01485224|Growth Substances|growth substances|mesh-ancestor
64815472|NCT01485224|Growth Inhibitors|growth inhibitors|mesh-ancestor
64815473|NCT01485224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815474|NCT01485315|Mannitol|mannitol|mesh-list
64815475|NCT01485315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64815483|NCT01485367|Sensory System Agents|sensory system agents|mesh-ancestor
64815484|NCT01485367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64815545|NCT01485692|Autonomic Agents|autonomic agents|mesh-ancestor
64815546|NCT01485692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64815547|NCT01485692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64815548|NCT01485692|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64815549|NCT01485692|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64815550|NCT01485692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64815551|NCT01485692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64815552|NCT01485692|Serotonin Agents|serotonin agents|mesh-ancestor
64815619|NCT01485835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64815620|NCT01485835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815621|NCT01485848|Paclitaxel|paclitaxel|mesh-list
64815622|NCT01485848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64815623|NCT01485848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815624|NCT01485848|Tubulin Modulators|tubulin modulators|mesh-ancestor
64815694|NCT01486433|Simvastatin|simvastatin|mesh-list
64815695|NCT01486433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64815696|NCT01486433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64815697|NCT01486433|Analgesics|analgesics|mesh-ancestor
64815698|NCT01486433|Sensory System Agents|sensory system agents|mesh-ancestor
64815699|NCT01486433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64815700|NCT01486433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815701|NCT01486433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64815702|NCT01486433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64815737|NCT01486485|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64815738|NCT01486485|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64815739|NCT01486485|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64815740|NCT01486485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64815741|NCT01486485|Immunologic Factors|immunologic factors|mesh-ancestor
64815742|NCT01486511|Liver Extracts|liver extracts|mesh-list
64815748|NCT01486563|Plasma Substitutes|plasma substitutes|mesh-ancestor
64815749|NCT01486563|Blood Substitutes|blood substitutes|mesh-ancestor
64815750|NCT01486576|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
64815751|NCT01486576|Plasma Substitutes|plasma substitutes|mesh-ancestor
64815752|NCT01486576|Blood Substitutes|blood substitutes|mesh-ancestor
64815754|NCT01486602|Carboplatin|carboplatin|mesh-list
64815761|NCT01486706|Gabapentin|gabapentin|mesh-list
64815787|NCT01486862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64815788|NCT01486862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815789|NCT01486875|Insulin Aspart|insulin aspart|mesh-list
64815790|NCT01486875|Biphasic Insulins|biphasic insulins|mesh-list
64815791|NCT01486875|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64815792|NCT01486875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64815793|NCT01486875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815794|NCT01486888|Insulin|insulin|mesh-list
64815886|NCT01487317|Protective Agents|protective agents|mesh-ancestor
64815888|NCT01487369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64815889|NCT01487369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815890|NCT01487382|Insulin Aspart|insulin aspart|mesh-list
64815891|NCT01487382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64815892|NCT01487382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815893|NCT01487395|Donepezil|donepezil|mesh-list
64815894|NCT01487395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64815895|NCT01487395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815896|NCT01487395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815897|NCT01487395|Cholinergic Agents|cholinergic agents|mesh-ancestor
64815898|NCT01487395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64815899|NCT01487395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815900|NCT01487395|Nootropic Agents|nootropic agents|mesh-ancestor
64815901|NCT01487408|Insulin Aspart|insulin aspart|mesh-list
64815902|NCT01487408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64472676|NCT03021486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64413363|NCT05587673|Prednisolone|prednisolone|mesh-list
64815903|NCT01487408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815904|NCT01487421|Insulin|insulin|mesh-list
64815905|NCT01487421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64815954|NCT01487811|Biphasic Insulins|biphasic insulins|mesh-list
64815955|NCT01487811|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64815956|NCT01487811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64815957|NCT01487811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815958|NCT01487993|Metformin|metformin|mesh-list
64815959|NCT01487993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64815960|NCT01487993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815961|NCT01488045|Fentanyl|fentanyl|mesh-list
64815962|NCT01488045|Midazolam|midazolam|mesh-list
64815963|NCT01488045|Propofol|propofol|mesh-list
64815964|NCT01488045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64815965|NCT01488045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64815966|NCT01488045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815967|NCT01488045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64815968|NCT01488045|Anesthetics, General|anesthetics, general|mesh-ancestor
64815969|NCT01488045|Anesthetics|anesthetics|mesh-ancestor
64815970|NCT01488045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64815971|NCT01488045|Narcotics|narcotics|mesh-ancestor
64815972|NCT01488045|Analgesics|analgesics|mesh-ancestor
64815973|NCT01488045|Sensory System Agents|sensory system agents|mesh-ancestor
64815974|NCT01488045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64815975|NCT01488045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64816027|NCT01488266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64816028|NCT01488266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64816029|NCT01488266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64816030|NCT01488266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64816031|NCT01488266|Dopamine Agents|dopamine agents|mesh-ancestor
64816032|NCT01488266|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64816033|NCT01488266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64816034|NCT01488266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816035|NCT01488266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64816036|NCT01488266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64816037|NCT01488266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64816038|NCT01488266|Dopamine Agonists|dopamine agonists|mesh-ancestor
64816039|NCT01488266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64816040|NCT01488266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64816041|NCT01488266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64816042|NCT01488266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64816043|NCT01488266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64816044|NCT01488266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64816045|NCT01488266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64816046|NCT01488266|Analgesics|analgesics|mesh-ancestor
64816047|NCT01488266|Sensory System Agents|sensory system agents|mesh-ancestor
64816048|NCT01488266|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64816049|NCT01488266|Histamine Antagonists|histamine antagonists|mesh-ancestor
64816050|NCT01488266|Histamine Agents|histamine agents|mesh-ancestor
64816051|NCT01488266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64816052|NCT01488266|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64816065|NCT01488344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816066|NCT01488396|Cyclosporine|cyclosporine|mesh-list
64816082|NCT01488526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64816083|NCT01488526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64816084|NCT01488526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64816085|NCT01488526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816086|NCT01488526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816087|NCT01488526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64816088|NCT01488526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64816090|NCT01488552|Gemcitabine|gemcitabine|mesh-list
64816091|NCT01488552|Paclitaxel|paclitaxel|mesh-list
64816092|NCT01488552|Folfirinox|folfirinox|mesh-list
64816093|NCT01488552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64816094|NCT01488552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816095|NCT01488552|Tubulin Modulators|tubulin modulators|mesh-ancestor
64816096|NCT01488552|Antimitotic Agents|antimitotic agents|mesh-ancestor
65494497|NCT01141452|Fluticasone|fluticasone|mesh-list
64472677|NCT03021486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64413565|NCT04943029|Paclitaxel|paclitaxel|mesh-list
64816097|NCT01488552|Mitosis Modulators|mitosis modulators|mesh-ancestor
64816098|NCT01488552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816099|NCT01488552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64816100|NCT01488552|Antimetabolites|antimetabolites|mesh-ancestor
64816101|NCT01488552|Antiviral Agents|antiviral agents|mesh-ancestor
64816102|NCT01488552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64816156|NCT01488955|Analgesics|analgesics|mesh-ancestor
64816157|NCT01488955|Sensory System Agents|sensory system agents|mesh-ancestor
64816158|NCT01488955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64816159|NCT01488955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816160|NCT01488955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64816161|NCT01488955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64584785|NCT04129619|Ether|ether|mesh-list
64816162|NCT01488955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64816163|NCT01488955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816164|NCT01488955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816165|NCT01488955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64816166|NCT01488955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64816167|NCT01489059|Ipilimumab|ipilimumab|mesh-list
64816199|NCT01489202|Micronutrients|micronutrients|mesh-ancestor
64816200|NCT01489228|Benzonidazole|benzonidazole|mesh-list
64816201|NCT01489228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64816202|NCT01489228|Immunologic Factors|immunologic factors|mesh-ancestor
64816204|NCT01489228|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64816252|NCT01489488|Enzyme Activators|enzyme activators|mesh-ancestor
64816253|NCT01489488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816254|NCT01489566|Fluorouracil|fluorouracil|mesh-list
64816255|NCT01489566|Mitomycins|mitomycins|mesh-list
64816256|NCT01489566|Mitomycin|mitomycin|mesh-list
64816257|NCT01489566|Antimetabolites|antimetabolites|mesh-ancestor
64816258|NCT01489566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816259|NCT01489566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64816260|NCT01489566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816273|NCT01489631|Sufentanil|sufentanil|mesh-list
64816363|NCT01489904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816364|NCT01489904|Cholinergic Agents|cholinergic agents|mesh-ancestor
64816365|NCT01489904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64816366|NCT01489904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816367|NCT01489904|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64816368|NCT01489904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64816369|NCT01489917|Heparin|heparin|mesh-list
64816370|NCT01489917|Hemostatics|hemostatics|mesh-list
64816395|NCT01489943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64816396|NCT01489943|Antimetabolites|antimetabolites|mesh-ancestor
64816397|NCT01489943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64816398|NCT01489943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64816399|NCT01489943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816455|NCT01490203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816456|NCT01490203|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64816457|NCT01490203|Anticoagulants|anticoagulants|mesh-ancestor
65494502|NCT01141452|Autonomic Agents|autonomic agents|mesh-ancestor
64472680|NCT03021486|Dopamine Agents|dopamine agents|mesh-ancestor
64472681|NCT03021486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64816458|NCT01490203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64816459|NCT01490216|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64816460|NCT01490216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64816461|NCT01490216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816462|NCT01490216|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64816463|NCT01490216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64816464|NCT01490216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64816465|NCT01490216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816466|NCT01490216|Dopamine Agents|dopamine agents|mesh-ancestor
64816485|NCT01490268|Dsuvia|dsuvia|mesh-list
64816536|NCT01490476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816537|NCT01490476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64816538|NCT01490476|Immunologic Factors|immunologic factors|mesh-ancestor
64585156|NCT01390220|Anesthetics|anesthetics|mesh-ancestor
64816549|NCT01490658|Repaglinide|repaglinide|mesh-list
64816550|NCT01490658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64816551|NCT01490658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816552|NCT01490671|Tenofovir|tenofovir|mesh-list
64816553|NCT01490671|Antiviral Agents|antiviral agents|mesh-ancestor
64816554|NCT01490671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64816555|NCT01490671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64816556|NCT01490671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64816557|NCT01490671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816558|NCT01490671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816559|NCT01490671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64816560|NCT01490671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64816561|NCT01490749|Carboplatin|carboplatin|mesh-list
64816562|NCT01490749|Capecitabine|capecitabine|mesh-list
64816602|NCT01490996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816603|NCT01490996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816604|NCT01490996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64816605|NCT01490996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64816626|NCT01491009|GABA Agents|gaba agents|mesh-ancestor
64816710|NCT01491295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816711|NCT01491295|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64816712|NCT01491295|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64816713|NCT01491321|Loxoprofen|loxoprofen|mesh-list
64816714|NCT01491321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64427798|NCT02168439|Anesthetics|anesthetics|mesh-ancestor
64816744|NCT01491711|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64816745|NCT01491711|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
64816746|NCT01491711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64816747|NCT01491711|Dermatologic Agents|dermatologic agents|mesh-ancestor
64816748|NCT01491867|Travoprost|travoprost|mesh-list
64816749|NCT01491867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64816750|NCT01492062|Pancrelipase|pancrelipase|mesh-list
64816751|NCT01492062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64816752|NCT01492114|Resveratrol|resveratrol|mesh-list
64816753|NCT01492114|Antioxidants|antioxidants|mesh-ancestor
64816754|NCT01492114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816755|NCT01492114|Protective Agents|protective agents|mesh-ancestor
64816756|NCT01492114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816757|NCT01492114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816758|NCT01492114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64557415|NCT05331144|Amlodipine|amlodipine|mesh-list
64557447|NCT00951561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557448|NCT00951561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64557449|NCT00951561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64557450|NCT00951561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64557451|NCT00951561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557452|NCT00951561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557453|NCT03031119|Atorvastatin|atorvastatin|mesh-list
64557454|NCT03031119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64557455|NCT03031119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64557456|NCT03031119|Antimetabolites|antimetabolites|mesh-ancestor
64557457|NCT03031119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557458|NCT03031119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64557459|NCT03031119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64557460|NCT03031119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557461|NCT03076203|Niraparib|niraparib|mesh-list
64557462|NCT03076203|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64557464|NCT03076203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816795|NCT01492504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816796|NCT01492543|Tegafur|tegafur|mesh-list
64816797|NCT01492543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64816798|NCT01492543|Antimetabolites|antimetabolites|mesh-ancestor
64816799|NCT01492543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816800|NCT01492543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816801|NCT01492556|Etoposide|etoposide|mesh-list
65494505|NCT01141452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65494506|NCT01141452|Respiratory System Agents|respiratory system agents|mesh-ancestor
64414169|NCT02496039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64816802|NCT01492556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64816803|NCT01492556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816804|NCT01492556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64816805|NCT01492556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64816806|NCT01492556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816807|NCT01492556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816849|NCT01492881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816850|NCT01492881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64816851|NCT01492881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64816852|NCT01492881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816853|NCT01492881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816854|NCT01492881|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64816855|NCT01492894|Cyclosporine|cyclosporine|mesh-list
64816856|NCT01492894|Sirolimus|sirolimus|mesh-list
64816857|NCT01492894|Tacrolimus|tacrolimus|mesh-list
64816858|NCT01492894|Cyclosporins|cyclosporins|mesh-list
64816859|NCT01492894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64816860|NCT01492894|Immunologic Factors|immunologic factors|mesh-ancestor
64816861|NCT01492894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816862|NCT01492894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64816863|NCT01492894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816864|NCT01492894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816865|NCT01492894|Antifungal Agents|antifungal agents|mesh-ancestor
64816866|NCT01492894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64816867|NCT01492894|Dermatologic Agents|dermatologic agents|mesh-ancestor
64816868|NCT01492894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64816869|NCT01492894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64816870|NCT01492894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64816871|NCT01492894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816872|NCT01492920|Acetylcarnitine|acetylcarnitine|mesh-list
64816873|NCT01492920|Vitamin B Complex|vitamin b complex|mesh-ancestor
64816874|NCT01492920|Vitamins|vitamins|mesh-ancestor
65494507|NCT01141452|Dermatologic Agents|dermatologic agents|mesh-ancestor
64816913|NCT01493115|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64816914|NCT01493115|Insulin Glargine|insulin glargine|mesh-list
64816915|NCT01493115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64816916|NCT01493115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816917|NCT01493154|Cyclophosphamide|cyclophosphamide|mesh-list
64816918|NCT01493154|Vaccines|vaccines|mesh-list
64816919|NCT01493154|Immunologic Factors|immunologic factors|mesh-ancestor
64816920|NCT01493154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816921|NCT01493154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64816922|NCT01493154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64816923|NCT01493154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64816924|NCT01493154|Alkylating Agents|alkylating agents|mesh-ancestor
64816925|NCT01493154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816926|NCT01493154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816927|NCT01493154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64816928|NCT01493310|Paclitaxel|paclitaxel|mesh-list
64816929|NCT01493310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64816930|NCT01493310|Mifepristone|mifepristone|mesh-list
64816931|NCT01493310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64816932|NCT01493310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816966|NCT01493479|Rituximab|rituximab|mesh-list
65494510|NCT01141452|Hormones|hormones|mesh-ancestor
64816980|NCT01493635|Sensory System Agents|sensory system agents|mesh-ancestor
64816981|NCT01493635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64816982|NCT01493635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816983|NCT01493648|Vitamin D|vitamin d|mesh-list
64816984|NCT01493648|Cholecalciferol|cholecalciferol|mesh-list
64816985|NCT01493648|Vitamins|vitamins|mesh-ancestor
64816986|NCT01493648|Micronutrients|micronutrients|mesh-ancestor
64816987|NCT01493648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816988|NCT01493648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64816989|NCT01493648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64816990|NCT01493674|Folic Acid|folic acid|mesh-list
64816991|NCT01493674|Vitamin B Complex|vitamin b complex|mesh-list
64816992|NCT01493674|Hematinics|hematinics|mesh-ancestor
64816993|NCT01493674|Vitamins|vitamins|mesh-ancestor
64816994|NCT01493674|Micronutrients|micronutrients|mesh-ancestor
64816995|NCT01493674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816996|NCT01493791|Ulipristal acetate|ulipristal acetate|mesh-list
64816997|NCT01493791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64816998|NCT01493791|Contraceptive Agents|contraceptive agents|mesh-ancestor
64817002|NCT01493843|Paclitaxel|paclitaxel|mesh-list
64817053|NCT01494155|Capecitabine|capecitabine|mesh-list
64817054|NCT01494155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64817055|NCT01494155|Antimetabolites|antimetabolites|mesh-ancestor
64817056|NCT01494155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817057|NCT01494155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817058|NCT01494155|Antimalarials|antimalarials|mesh-ancestor
64817059|NCT01494155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64428227|NCT02531633|Prednisone|prednisone|mesh-list
64817079|NCT01494259|Autonomic Agents|autonomic agents|mesh-ancestor
64817133|NCT01494402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64817134|NCT01494402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64817135|NCT01494402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64817136|NCT01494402|Antipyretics|antipyretics|mesh-ancestor
64817137|NCT01494415|Paclitaxel|paclitaxel|mesh-list
64817138|NCT01494415|Carboplatin|carboplatin|mesh-list
64817139|NCT01494415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64817140|NCT01494415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817141|NCT01494415|Tubulin Modulators|tubulin modulators|mesh-ancestor
64817146|NCT01494441|Calcium|calcium|mesh-list
64817211|NCT01495026|Tamsulosin|tamsulosin|mesh-list
64817212|NCT01495026|Dutasteride|dutasteride|mesh-list
64817213|NCT01495026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64817214|NCT01495026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64817215|NCT01495026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64817216|NCT01495026|Adrenergic Agents|adrenergic agents|mesh-ancestor
64817217|NCT01495026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64817218|NCT01495026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817219|NCT01495026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817220|NCT01495026|Urological Agents|urological agents|mesh-ancestor
64817221|NCT01495026|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64817222|NCT01495026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64817223|NCT01495026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817224|NCT01495026|Hormone Antagonists|hormone antagonists|mesh-ancestor
64817225|NCT01495026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64817226|NCT01495039|Nystatin|nystatin|mesh-list
64817227|NCT01495039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64817228|NCT01495039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64817229|NCT01495039|Antifungal Agents|antifungal agents|mesh-ancestor
64817230|NCT01495039|Ionophores|ionophores|mesh-ancestor
64817231|NCT01495039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64817232|NCT01495039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817233|NCT01495104|Valproic Acid|valproic acid|mesh-list
64817234|NCT01495104|Anticonvulsants|anticonvulsants|mesh-ancestor
64817235|NCT01495104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817236|NCT01495104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817237|NCT01495104|GABA Agents|gaba agents|mesh-ancestor
64817238|NCT01495104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64817239|NCT01495104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817240|NCT01495104|Antimanic Agents|antimanic agents|mesh-ancestor
64817241|NCT01495104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64817242|NCT01495104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64817243|NCT01495104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64817244|NCT01495117|Iodine|iodine|mesh-list
64817246|NCT01495117|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64817251|NCT01495117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64817252|NCT01495117|Disinfectants|disinfectants|mesh-ancestor
64817253|NCT01495117|Dermatologic Agents|dermatologic agents|mesh-ancestor
64817254|NCT01495117|Trace Elements|trace elements|mesh-ancestor
64817255|NCT01495117|Micronutrients|micronutrients|mesh-ancestor
64817256|NCT01495117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817257|NCT01495117|Plasma Substitutes|plasma substitutes|mesh-ancestor
64817258|NCT01495117|Blood Substitutes|blood substitutes|mesh-ancestor
64817259|NCT01495156|Antipsychotic Agents|antipsychotic agents|mesh-list
64428403|NCT05379491|Linaclotide|linaclotide|mesh-list
64817296|NCT01495260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64817297|NCT01495260|Vitamins|vitamins|mesh-ancestor
64817298|NCT01495260|Micronutrients|micronutrients|mesh-ancestor
64817299|NCT01495260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428464|NCT05529173|Povidone|povidone|mesh-list
64817307|NCT01495260|Protective Agents|protective agents|mesh-ancestor
64817308|NCT01495260|Antidotes|antidotes|mesh-ancestor
64817309|NCT01495260|Vitamin B Complex|vitamin b complex|mesh-ancestor
64817352|NCT01495520|Ranolazine|ranolazine|mesh-list
64817353|NCT01495520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64817354|NCT01495520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64817355|NCT01495520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817356|NCT01495624|Dexamethasone|dexamethasone|mesh-list
64817357|NCT01495624|Dexamethasone acetate|dexamethasone acetate|mesh-list
64817358|NCT01495624|Ropivacaine|ropivacaine|mesh-list
64817359|NCT01495624|Anesthetics|anesthetics|mesh-list
64817360|NCT01495624|BB 1101|bb 1101|mesh-list
64817361|NCT01495624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64817362|NCT01495624|Antiemetics|antiemetics|mesh-ancestor
64817363|NCT01495624|Autonomic Agents|autonomic agents|mesh-ancestor
64817364|NCT01495624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64817365|NCT01495624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817366|NCT01495624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64817367|NCT01495624|Glucocorticoids|glucocorticoids|mesh-ancestor
64817368|NCT01495624|Hormones|hormones|mesh-ancestor
64817380|NCT01495715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817381|NCT01495715|Protective Agents|protective agents|mesh-ancestor
64817382|NCT01495715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817383|NCT01495806|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
64817384|NCT01495806|Cathartics|cathartics|mesh-ancestor
64817385|NCT01495806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64817386|NCT01495845|Clopidogrel|clopidogrel|mesh-list
64817387|NCT01495845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64817412|NCT01495949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64817413|NCT01495949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817414|NCT01495949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64817415|NCT01495949|Anesthetics, General|anesthetics, general|mesh-ancestor
64817416|NCT01495949|Anesthetics|anesthetics|mesh-ancestor
64817417|NCT01495949|Anticonvulsants|anticonvulsants|mesh-ancestor
64817418|NCT01495949|GABA Modulators|gaba modulators|mesh-ancestor
64817419|NCT01495949|GABA Agents|gaba agents|mesh-ancestor
64817420|NCT01495949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64817421|NCT01495949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817422|NCT01495962|Botulinum Toxins|botulinum toxins|mesh-list
64817423|NCT01495962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64817424|NCT01495962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64817478|NCT01496326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64817479|NCT01496326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817480|NCT01496326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64817481|NCT01496326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64817482|NCT01496326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64817483|NCT01496326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817484|NCT01496326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817485|NCT01496417|Abatacept|abatacept|mesh-list
64817486|NCT01496417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64817487|NCT01496417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817488|NCT01496417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817489|NCT01496417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64817490|NCT01496417|Immunologic Factors|immunologic factors|mesh-ancestor
64817491|NCT01496417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817492|NCT01496417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64817503|NCT01496521|Sensory System Agents|sensory system agents|mesh-ancestor
64817504|NCT01496521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64817514|NCT01496521|Antipyretics|antipyretics|mesh-ancestor
64817542|NCT01496742|Mitosis Modulators|mitosis modulators|mesh-ancestor
64817543|NCT01496742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817544|NCT01496742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64817545|NCT01496742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64817546|NCT01496742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64817547|NCT01496742|Growth Substances|growth substances|mesh-ancestor
64817548|NCT01496742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817549|NCT01496742|Growth Inhibitors|growth inhibitors|mesh-ancestor
64817550|NCT01496742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817551|NCT01496742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64817552|NCT01496742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64817553|NCT01496911|Hydroxyzine|hydroxyzine|mesh-list
64817554|NCT01496911|Levocetirizine|levocetirizine|mesh-list
64817555|NCT01496911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64817556|NCT01496911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64817577|NCT01497002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817578|NCT01497002|Antiviral Agents|antiviral agents|mesh-ancestor
64817579|NCT01497002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64817580|NCT01497002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64817581|NCT01497002|Immunologic Factors|immunologic factors|mesh-ancestor
64817582|NCT01497002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817583|NCT01497041|Docetaxel|docetaxel|mesh-list
64817584|NCT01497041|Oxaliplatin|oxaliplatin|mesh-list
64817585|NCT01497041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817586|NCT01497041|Tubulin Modulators|tubulin modulators|mesh-ancestor
64817587|NCT01497041|Antimitotic Agents|antimitotic agents|mesh-ancestor
64817588|NCT01497041|Mitosis Modulators|mitosis modulators|mesh-ancestor
64817589|NCT01497041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817590|NCT01497093|Thalidomide|thalidomide|mesh-list
64817591|NCT01497093|Dexamethasone|dexamethasone|mesh-list
64817592|NCT01497093|Bortezomib|bortezomib|mesh-list
64817593|NCT01497093|Pomalidomide|pomalidomide|mesh-list
64817594|NCT01497093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64817595|NCT01497093|Antiemetics|antiemetics|mesh-ancestor
64817596|NCT01497093|Autonomic Agents|autonomic agents|mesh-ancestor
64817597|NCT01497093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64817598|NCT01497093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725732|NCT03805022|Doxorubicin|doxorubicin|mesh-list
64333241|NCT02208791|Sirolimus|sirolimus|mesh-list
64817599|NCT01497093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64817600|NCT01497093|Glucocorticoids|glucocorticoids|mesh-ancestor
64817601|NCT01497093|Hormones|hormones|mesh-ancestor
64817602|NCT01497093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64817603|NCT01497093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64817604|NCT01497093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817605|NCT01497093|Immunologic Factors|immunologic factors|mesh-ancestor
64817606|NCT01497093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64817607|NCT01497093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64817608|NCT01497093|Growth Substances|growth substances|mesh-ancestor
64817609|NCT01497093|Growth Inhibitors|growth inhibitors|mesh-ancestor
64817610|NCT01497093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64817611|NCT01497093|Leprostatic Agents|leprostatic agents|mesh-ancestor
64817637|NCT01497327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64817638|NCT01497431|Selenium|selenium|mesh-list
64817639|NCT01497431|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
64817640|NCT01497431|Antioxidants|antioxidants|mesh-ancestor
64817641|NCT01497431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817642|NCT01497431|Protective Agents|protective agents|mesh-ancestor
64817643|NCT01497431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817644|NCT01497431|Trace Elements|trace elements|mesh-ancestor
64817645|NCT01497431|Micronutrients|micronutrients|mesh-ancestor
64817646|NCT01497431|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64817647|NCT01497431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817648|NCT01497444|Sorafenib|sorafenib|mesh-list
64817649|NCT01497444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817650|NCT01497444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64817651|NCT01497444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817652|NCT01497444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817653|NCT01497470|Paclitaxel|paclitaxel|mesh-list
64817654|NCT01497470|Carboplatin|carboplatin|mesh-list
64817655|NCT01497470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64817656|NCT01497470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817657|NCT01497470|Tubulin Modulators|tubulin modulators|mesh-ancestor
64817658|NCT01497470|Antimitotic Agents|antimitotic agents|mesh-ancestor
64817664|NCT01497483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428812|NCT02187159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64817674|NCT01497483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64817675|NCT01497483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64817676|NCT01497483|Antimetabolites|antimetabolites|mesh-ancestor
64817677|NCT01497483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64817678|NCT01497483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64817679|NCT01497522|Vildagliptin|vildagliptin|mesh-list
64817680|NCT01497522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64817681|NCT01497522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817682|NCT01497522|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64817683|NCT01497522|Protease Inhibitors|protease inhibitors|mesh-ancestor
64817684|NCT01497522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817685|NCT01497522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817687|NCT01497535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64817688|NCT01497535|Insulin Glargine|insulin glargine|mesh-list
64817689|NCT01497535|Insulin Detemir|insulin detemir|mesh-list
64817692|NCT01497548|Methylphenidate|methylphenidate|mesh-list
64817740|NCT01497717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64817741|NCT01497717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64817742|NCT01497873|Topotecan|topotecan|mesh-list
64817743|NCT01497873|Belotecan|belotecan|mesh-list
64817744|NCT01497873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64817745|NCT01497873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64817746|NCT01497873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817747|NCT01497873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65494513|NCT00219557|Axitinib|axitinib|mesh-list
64817748|NCT01497873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817749|NCT01497912|Atorvastatin|atorvastatin|mesh-list
64817750|NCT01497912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64817751|NCT01497912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64817752|NCT01497912|Antimetabolites|antimetabolites|mesh-ancestor
64817753|NCT01497912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817754|NCT01497912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64817755|NCT01497912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64817756|NCT01497912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817757|NCT01497977|Phytoestrogens|phytoestrogens|mesh-list
64817758|NCT01497977|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64817759|NCT01497977|Estrogens|estrogens|mesh-ancestor
64817760|NCT01497977|Hormones|hormones|mesh-ancestor
64817761|NCT01497977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64817791|NCT01498081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817792|NCT01498380|Dexmedetomidine|dexmedetomidine|mesh-list
64817793|NCT01498380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64817794|NCT01498380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64817811|NCT01498406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817812|NCT01498406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64817813|NCT01498406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64817814|NCT01498523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64817815|NCT01498562|Gefitinib|gefitinib|mesh-list
64817816|NCT01498562|Nimotuzumab|nimotuzumab|mesh-list
64817817|NCT01498562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817818|NCT01498562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64817819|NCT01498562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586444|NCT00385801|Risperidone|risperidone|mesh-list
64817820|NCT01498562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817821|NCT01498562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64817822|NCT01498718|Vaccines|vaccines|mesh-list
64817823|NCT01498718|Immunologic Factors|immunologic factors|mesh-ancestor
64817825|NCT01498783|Fluorouracil|fluorouracil|mesh-list
64817864|NCT01498835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64817865|NCT01498835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817866|NCT01498835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817868|NCT01498861|Moxifloxacin|moxifloxacin|mesh-list
64817869|NCT01498861|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64817870|NCT01498861|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64817871|NCT01498861|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64817872|NCT01498861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817873|NCT01498861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817874|NCT01498861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64817875|NCT01498861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64817876|NCT01498861|Antiviral Agents|antiviral agents|mesh-ancestor
64817877|NCT01498861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64817878|NCT01498861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64817879|NCT01498861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64817880|NCT01498861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64817881|NCT01498861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817882|NCT01498861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64817883|NCT01498861|Contraceptive Agents|contraceptive agents|mesh-ancestor
64817884|NCT01498861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64817885|NCT01498861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817886|NCT01498861|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64817887|NCT01498861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64817888|NCT01498861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64817889|NCT01498900|Repaglinide|repaglinide|mesh-list
64817890|NCT01498900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64817891|NCT01498900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586506|NCT00390611|Mitosis Modulators|mitosis modulators|mesh-ancestor
64817892|NCT01498913|Repaglinide|repaglinide|mesh-list
64817893|NCT01498913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64817895|NCT01498926|Insulin|insulin|mesh-list
64817906|NCT01499004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817907|NCT01499069|Solifenacin Succinate|solifenacin succinate|mesh-list
64817908|NCT01499069|Fesoterodine|fesoterodine|mesh-list
64817909|NCT01499069|Propiverine|propiverine|mesh-list
64817910|NCT01499069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64817911|NCT01499069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64817912|NCT01499069|Cholinergic Agents|cholinergic agents|mesh-ancestor
64817913|NCT01499069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64817914|NCT01499069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817915|NCT01499069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558008|NCT01005459|Bupivacaine|bupivacaine|mesh-list
64429055|NCT05346731|Antipruritics|antipruritics|mesh-ancestor
64817925|NCT01499108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64817975|NCT01499485|Diuretics|diuretics|mesh-ancestor
64817976|NCT01499485|Natriuretic Agents|natriuretic agents|mesh-ancestor
64817977|NCT01499485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817978|NCT01499589|Anesthetics|anesthetics|mesh-list
64817979|NCT01499589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64817980|NCT01499589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817981|NCT01499602|Norethindrone|norethindrone|mesh-list
64817982|NCT01499602|Norethindrone Acetate|norethindrone acetate|mesh-list
64429125|NCT01657877|Calcium|calcium|mesh-list
64818013|NCT01499693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64818014|NCT01499693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64818020|NCT01499758|Antimetabolites|antimetabolites|mesh-ancestor
64818078|NCT01500070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818079|NCT01500161|Cytarabine|cytarabine|mesh-list
64818080|NCT01500161|Fludarabine|fludarabine|mesh-list
64818081|NCT01500161|Etoposide|etoposide|mesh-list
64818082|NCT01500161|Melphalan|melphalan|mesh-list
64818083|NCT01500161|Busulfan|busulfan|mesh-list
64818084|NCT01500161|Carmustine|carmustine|mesh-list
64818085|NCT01500161|Clofarabine|clofarabine|mesh-list
64818086|NCT01500161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818087|NCT01500161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64818088|NCT01500161|Antimetabolites|antimetabolites|mesh-ancestor
64818089|NCT01500161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818090|NCT01500161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64818091|NCT01500161|Immunologic Factors|immunologic factors|mesh-ancestor
64818092|NCT01500161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818112|NCT01500473|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64818113|NCT01500473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64818174|NCT01500824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818175|NCT01500837|Levofloxacin|levofloxacin|mesh-list
64818176|NCT01500837|Ofloxacin|ofloxacin|mesh-list
64818177|NCT01500837|Rifampin|rifampin|mesh-list
64818178|NCT01500837|Clindamycin|clindamycin|mesh-list
64818179|NCT01500837|Clindamycin palmitate|clindamycin palmitate|mesh-list
64818180|NCT01500837|Clindamycin phosphate|clindamycin phosphate|mesh-list
64818181|NCT01500837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64818182|NCT01500837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64818183|NCT01500837|Renal Agents|renal agents|mesh-ancestor
64818184|NCT01500837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64818185|NCT01500837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64818186|NCT01500837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64818187|NCT01500837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818188|NCT01500837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818189|NCT01500837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818190|NCT01500837|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64818191|NCT01500837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64818192|NCT01500837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64586810|NCT00400205|Docetaxel|docetaxel|mesh-list
64818193|NCT01500837|Antitubercular Agents|antitubercular agents|mesh-ancestor
64818194|NCT01500837|Leprostatic Agents|leprostatic agents|mesh-ancestor
64818195|NCT01500837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64818196|NCT01500837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64818231|NCT01500915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64818232|NCT01500915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65494518|NCT00219557|Antiviral Agents|antiviral agents|mesh-ancestor
64818233|NCT01500915|Growth Substances|growth substances|mesh-ancestor
64818234|NCT01500915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818235|NCT01500915|Growth Inhibitors|growth inhibitors|mesh-ancestor
64818236|NCT01500915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818317|NCT01501136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64818318|NCT01501136|Antimetabolites|antimetabolites|mesh-ancestor
64818319|NCT01501136|Antiviral Agents|antiviral agents|mesh-ancestor
64818320|NCT01501136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64818321|NCT01501136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64818322|NCT01501136|Immunologic Factors|immunologic factors|mesh-ancestor
64818323|NCT01501136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64818324|NCT01501136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64818325|NCT01501136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64558307|NCT04364802|Povidone|povidone|mesh-list
64818326|NCT01501136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64818327|NCT01501136|Alkylating Agents|alkylating agents|mesh-ancestor
64818328|NCT01501136|Protective Agents|protective agents|mesh-ancestor
64818329|NCT01501149|Gemcitabine|gemcitabine|mesh-list
64818330|NCT01501149|Dexamethasone|dexamethasone|mesh-list
64818331|NCT01501149|Etoposide|etoposide|mesh-list
64818332|NCT01501149|Pegaspargase|pegaspargase|mesh-list
64818333|NCT01501149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64818362|NCT01501253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64818369|NCT01501344|Calcium|calcium|mesh-list
64818415|NCT01501396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64818416|NCT01501396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64818417|NCT01501396|Serotonin Agents|serotonin agents|mesh-ancestor
64818418|NCT01501396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64818419|NCT01501396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64818420|NCT01501396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64818421|NCT01501396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64818422|NCT01501396|Contraceptive Agents|contraceptive agents|mesh-ancestor
64818423|NCT01501396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64818424|NCT01501396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64818425|NCT01501396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64818426|NCT01501396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64818427|NCT01501396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818428|NCT01501396|Appetite Stimulants|appetite stimulants|mesh-ancestor
64818429|NCT01501396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64818430|NCT01501422|Estrogens|estrogens|mesh-list
64818431|NCT01501422|Hormones|hormones|mesh-ancestor
64818432|NCT01501422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64818516|NCT01501708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818517|NCT01501708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64818518|NCT01501708|Hormone Antagonists|hormone antagonists|mesh-ancestor
64818520|NCT01501708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818594|NCT01501890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64818595|NCT01501890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64818596|NCT01501890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64818632|NCT01502046|Hallucinogens|hallucinogens|mesh-ancestor
64818633|NCT01502046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818634|NCT01502046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64818635|NCT01502046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64818636|NCT01502046|Analgesics|analgesics|mesh-ancestor
64818637|NCT01502046|Sensory System Agents|sensory system agents|mesh-ancestor
64429799|NCT05075993|Tubulin Modulators|tubulin modulators|mesh-ancestor
64818655|NCT01502241|Alkylating Agents|alkylating agents|mesh-ancestor
64818656|NCT01502241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818657|NCT01502241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818658|NCT01502267|Rituximab|rituximab|mesh-list
64818659|NCT01502267|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64818660|NCT01502267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64818661|NCT01502267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818662|NCT01502267|Immunologic Factors|immunologic factors|mesh-ancestor
64818663|NCT01502267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818664|NCT01502267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64818665|NCT01502280|Ascorbic Acid|ascorbic acid|mesh-list
64818666|NCT01502280|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64818667|NCT01502280|Antioxidants|antioxidants|mesh-ancestor
64818668|NCT01502280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818671|NCT01502280|Vitamins|vitamins|mesh-ancestor
64818715|NCT01502904|Pravastatin|pravastatin|mesh-list
64818716|NCT01502904|Pitavastatin|pitavastatin|mesh-list
65494521|NCT00219557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64818717|NCT01502904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64818718|NCT01502904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64818719|NCT01502904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64818720|NCT01502904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818721|NCT01502904|Antifungal Agents|antifungal agents|mesh-ancestor
64818722|NCT01502904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64818723|NCT01502904|Immunologic Factors|immunologic factors|mesh-ancestor
64818724|NCT01502904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818725|NCT01502904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64818726|NCT01502904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64818729|NCT01502904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64818786|NCT01503242|Dermatologic Agents|dermatologic agents|mesh-ancestor
64818787|NCT01503242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64818788|NCT01503242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64818789|NCT01503242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64818790|NCT01503242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64818791|NCT01503242|Antitubercular Agents|antitubercular agents|mesh-ancestor
64818864|NCT01503437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64818865|NCT01503437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818866|NCT01503437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64818867|NCT01503437|Serotonin Agents|serotonin agents|mesh-ancestor
64818868|NCT01503450|Olanzapine|olanzapine|mesh-list
64818869|NCT01503450|Antiemetics|antiemetics|mesh-ancestor
64818870|NCT01503450|Autonomic Agents|autonomic agents|mesh-ancestor
64818871|NCT01503450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64818872|NCT01503450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818873|NCT01503450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64818899|NCT01503593|Calcium|calcium|mesh-list
64818958|NCT01503801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64818959|NCT01503801|Autonomic Agents|autonomic agents|mesh-ancestor
64818960|NCT01503801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64818961|NCT01503801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818962|NCT01503801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64818963|NCT01503801|Respiratory System Agents|respiratory system agents|mesh-ancestor
64818964|NCT01503801|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64818965|NCT01503801|Antioxidants|antioxidants|mesh-ancestor
64818966|NCT01503801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818967|NCT01503801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64818968|NCT01503801|Vasodilator Agents|vasodilator agents|mesh-ancestor
64818969|NCT01503801|Gasotransmitters|gasotransmitters|mesh-ancestor
64818970|NCT01503801|Protective Agents|protective agents|mesh-ancestor
64818971|NCT01503905|Tamoxifen|tamoxifen|mesh-list
64818972|NCT01503905|Cyclophosphamide|cyclophosphamide|mesh-list
64818973|NCT01503905|Docetaxel|docetaxel|mesh-list
64818974|NCT01503905|Trastuzumab|trastuzumab|mesh-list
64818975|NCT01503905|Epirubicin|epirubicin|mesh-list
64818976|NCT01503905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64818977|NCT01503905|Immunologic Factors|immunologic factors|mesh-ancestor
64818978|NCT01503905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818979|NCT01503905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64818980|NCT01503905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64818981|NCT01503905|Alkylating Agents|alkylating agents|mesh-ancestor
64818982|NCT01503905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818983|NCT01503905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819011|NCT01503983|Oxaliplatin|oxaliplatin|mesh-list
64819012|NCT01503983|Trastuzumab|trastuzumab|mesh-list
64819013|NCT01503983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64819014|NCT01503983|Antimetabolites|antimetabolites|mesh-ancestor
64819015|NCT01503983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819016|NCT01503983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819017|NCT01503983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64819018|NCT01504074|Triamcinolone|triamcinolone|mesh-list
64587636|NCT01397162|Xhance|xhance|mesh-list
64819019|NCT01504074|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64819020|NCT01504074|Levobunolol|levobunolol|mesh-list
64819021|NCT01504074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64819022|NCT01504074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64819023|NCT01504074|Glucocorticoids|glucocorticoids|mesh-ancestor
64819024|NCT01504074|Hormones|hormones|mesh-ancestor
64819025|NCT01504074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64819026|NCT01504074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819028|NCT01504074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64819085|NCT01504256|Antimitotic Agents|antimitotic agents|mesh-ancestor
64819086|NCT01504256|Mitosis Modulators|mitosis modulators|mesh-ancestor
64819087|NCT01504256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819088|NCT01504256|Antimetabolites|antimetabolites|mesh-ancestor
64472690|NCT02981628|Calcium, Dietary|calcium, dietary|mesh-list
64472691|NCT02981628|Leucovorin|leucovorin|mesh-list
64472692|NCT02981628|Folic Acid|folic acid|mesh-list
64472693|NCT02981628|Cytarabine|cytarabine|mesh-list
64819089|NCT01504256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64819090|NCT01504256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64819091|NCT01504256|Immunologic Factors|immunologic factors|mesh-ancestor
64819092|NCT01504256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819093|NCT01504256|Antidotes|antidotes|mesh-ancestor
64819094|NCT01504256|Protective Agents|protective agents|mesh-ancestor
64819095|NCT01504256|Vitamin B Complex|vitamin b complex|mesh-ancestor
64819097|NCT01504256|Micronutrients|micronutrients|mesh-ancestor
64819098|NCT01504256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64819099|NCT01504282|Mitomycins|mitomycins|mesh-list
64819100|NCT01504282|Mitomycin|mitomycin|mesh-list
64819101|NCT01504282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64819102|NCT01504282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819103|NCT01504282|Alkylating Agents|alkylating agents|mesh-ancestor
64819104|NCT01504282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819105|NCT01504282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64819106|NCT01504282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64819107|NCT01504295|Metadoxine|metadoxine|mesh-list
64819108|NCT01504295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64819109|NCT01504321|Moxonidine|moxonidine|mesh-list
64819154|NCT01504581|Antiviral Agents|antiviral agents|mesh-ancestor
64819155|NCT01504581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64819156|NCT01504620|Insulin|insulin|mesh-list
64819157|NCT01504620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64819158|NCT01504620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819159|NCT01504646|Lyprinol|lyprinol|mesh-list
64819160|NCT01504646|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64819161|NCT01504646|Hormone Antagonists|hormone antagonists|mesh-ancestor
64819162|NCT01504646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64819163|NCT01504646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819164|NCT01504659|Ketamine|ketamine|mesh-list
64819165|NCT01504659|Analgesics|analgesics|mesh-ancestor
64819166|NCT01504659|Sensory System Agents|sensory system agents|mesh-ancestor
64819167|NCT01504659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64819168|NCT01504659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819169|NCT01504659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64819170|NCT01504659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64819171|NCT01504659|Anesthetics, General|anesthetics, general|mesh-ancestor
64819172|NCT01504659|Anesthetics|anesthetics|mesh-ancestor
64819173|NCT01504659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64819174|NCT01504659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64819175|NCT01504659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64819176|NCT01504659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64819177|NCT01504659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819178|NCT01504724|Bevacizumab|bevacizumab|mesh-list
64819204|NCT01504906|Immunologic Factors|immunologic factors|mesh-ancestor
64819205|NCT01504906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819206|NCT01504906|Antifungal Agents|antifungal agents|mesh-ancestor
64819207|NCT01504906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64819208|NCT01504906|Dermatologic Agents|dermatologic agents|mesh-ancestor
64819209|NCT01504906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64819210|NCT01504906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64819211|NCT01504906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64819212|NCT01504906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64819213|NCT01504906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64819279|NCT01505218|Anesthetics|anesthetics|mesh-ancestor
64819280|NCT01505231|Vasopressins|vasopressins|mesh-list
64819281|NCT01505231|Arginine Vasopressin|arginine vasopressin|mesh-list
64819282|NCT01505231|Norepinephrine|norepinephrine|mesh-list
64819283|NCT01505231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64819284|NCT01505231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64819285|NCT01505231|Adrenergic Agents|adrenergic agents|mesh-ancestor
64819286|NCT01505231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64819287|NCT01505231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819288|NCT01505231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819289|NCT01505231|Sympathomimetics|sympathomimetics|mesh-ancestor
64819290|NCT01505231|Autonomic Agents|autonomic agents|mesh-ancestor
64819291|NCT01505231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64819297|NCT01505283|Lidocaine|lidocaine|mesh-list
64819350|NCT01505504|Histamine Agents|histamine agents|mesh-ancestor
64819351|NCT01505504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64819352|NCT01505504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819353|NCT01505504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819354|NCT01505504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64819355|NCT01505504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64819356|NCT01505504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64819357|NCT01505504|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64819358|NCT01505504|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64819359|NCT01505504|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64819360|NCT01505504|Adrenergic Agents|adrenergic agents|mesh-ancestor
64819423|NCT01506011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819424|NCT01506011|Vasodilator Agents|vasodilator agents|mesh-ancestor
64819425|NCT01506011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64819426|NCT01506011|Protease Inhibitors|protease inhibitors|mesh-ancestor
64819427|NCT01506011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64819428|NCT01506024|Tacrine|tacrine|mesh-list
64819429|NCT01506024|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64819430|NCT01506024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64819431|NCT01506024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819432|NCT01506024|Cholinergic Agents|cholinergic agents|mesh-ancestor
64819433|NCT01506024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64819434|NCT01506024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819435|NCT01506024|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64430577|NCT01879618|Dalteparin|dalteparin|mesh-list
64819451|NCT01506050|Cholinergic Agents|cholinergic agents|mesh-ancestor
64819452|NCT01506050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64819453|NCT01506050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819454|NCT01506050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819458|NCT01506050|Histamine Agents|histamine agents|mesh-ancestor
64819492|NCT01506167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64819493|NCT01506167|Growth Substances|growth substances|mesh-ancestor
64819494|NCT01506167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819499|NCT01506167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64819500|NCT01506167|Immunologic Factors|immunologic factors|mesh-ancestor
64819501|NCT01506167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64819502|NCT01506167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64819503|NCT01506167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64819564|NCT01506505|Protease Inhibitors|protease inhibitors|mesh-ancestor
64819565|NCT01506505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64819582|NCT01506570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819583|NCT01506622|Fentanyl|fentanyl|mesh-list
64819584|NCT01506622|Propofol|propofol|mesh-list
64819585|NCT01506622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64819586|NCT01506622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64819587|NCT01506622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819588|NCT01506622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64819589|NCT01506622|Anesthetics, General|anesthetics, general|mesh-ancestor
64819590|NCT01506622|Anesthetics|anesthetics|mesh-ancestor
64819662|NCT01506791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64819663|NCT01506791|Sympathomimetics|sympathomimetics|mesh-ancestor
64819664|NCT01506791|Adrenergic Agents|adrenergic agents|mesh-ancestor
64819665|NCT01506804|Methylprednisolone|methylprednisolone|mesh-list
64819666|NCT01506804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64819667|NCT01506804|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64819668|NCT01506804|Prednisolone|prednisolone|mesh-list
64819669|NCT01506804|Prednisolone acetate|prednisolone acetate|mesh-list
64819670|NCT01506804|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64819671|NCT01506804|Prednisolone phosphate|prednisolone phosphate|mesh-list
64819672|NCT01506804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64819673|NCT01506804|Antiemetics|antiemetics|mesh-ancestor
64819769|NCT01507363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64819770|NCT01507363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64819771|NCT01507363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64819772|NCT01507363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64819773|NCT01507363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64819774|NCT01507363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819775|NCT01507363|Antimanic Agents|antimanic agents|mesh-ancestor
64819776|NCT01507376|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64819777|NCT01507376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64819778|NCT01507376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819779|NCT01507389|Liraglutide|liraglutide|mesh-list
64819780|NCT01507389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64819781|NCT01507389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819782|NCT01507389|Incretins|incretins|mesh-ancestor
64819783|NCT01507389|Hormones|hormones|mesh-ancestor
64819784|NCT01507389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64819785|NCT01507428|Deoxyglucose|deoxyglucose|mesh-list
64819800|NCT01507428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64819801|NCT01507428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64819802|NCT01507428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64819803|NCT01507454|Estradiol|estradiol|mesh-list
64819804|NCT01507454|Estrogens|estrogens|mesh-ancestor
64819805|NCT01507454|Hormones|hormones|mesh-ancestor
64819806|NCT01507454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64819807|NCT01507454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819833|NCT01507558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64819834|NCT01507558|Antiemetics|antiemetics|mesh-ancestor
64819835|NCT01507558|Autonomic Agents|autonomic agents|mesh-ancestor
64819836|NCT01507558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64819837|NCT01507558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819838|NCT01507558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64819839|NCT01507558|Glucocorticoids|glucocorticoids|mesh-ancestor
64819840|NCT01507558|Hormones|hormones|mesh-ancestor
64819841|NCT01507558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64819842|NCT01507558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64819843|NCT01507558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819844|NCT01507558|Protease Inhibitors|protease inhibitors|mesh-ancestor
64819845|NCT01507558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945445|NCT05633615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819846|NCT01507558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819847|NCT01507571|Psychotropic Drugs|psychotropic drugs|mesh-list
64819871|NCT01507727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819873|NCT01507727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819874|NCT01507740|Bevacizumab|bevacizumab|mesh-list
64819875|NCT01507740|Sorafenib|sorafenib|mesh-list
64819876|NCT01507740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64819877|NCT01507740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819878|NCT01507740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64819879|NCT01507740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64819880|NCT01507740|Growth Substances|growth substances|mesh-ancestor
64819881|NCT01507740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819911|NCT01507922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819912|NCT01507974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64819913|NCT01507974|Amoxicillin|amoxicillin|mesh-list
64819914|NCT01507974|Clavulanic Acid|clavulanic acid|mesh-list
64819915|NCT01507974|Cephalexin|cephalexin|mesh-list
64819916|NCT01507974|Cefuroxime|cefuroxime|mesh-list
64819917|NCT01507974|Nitrofurantoin|nitrofurantoin|mesh-list
64819918|NCT01507974|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64819919|NCT01507974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64819920|NCT01507974|Trimethoprim|trimethoprim|mesh-list
64819921|NCT01507974|Sulfamethoxazole|sulfamethoxazole|mesh-list
64819922|NCT01507974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64819923|NCT01507974|Antitubercular Agents|antitubercular agents|mesh-ancestor
64819924|NCT01507974|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64819925|NCT01507974|Renal Agents|renal agents|mesh-ancestor
64472720|NCT02981628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64472721|NCT02981628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64472722|NCT02981628|Antiviral Agents|antiviral agents|mesh-ancestor
64472723|NCT02981628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64472724|NCT02981628|Antidotes|antidotes|mesh-ancestor
64472725|NCT02981628|Protective Agents|protective agents|mesh-ancestor
64472726|NCT02981628|Vitamin B Complex|vitamin b complex|mesh-ancestor
64472727|NCT02981628|Vitamins|vitamins|mesh-ancestor
64819997|NCT01508260|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64819998|NCT01508260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64819999|NCT01508260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820001|NCT01508286|Antimetabolites|antimetabolites|mesh-ancestor
64820002|NCT01508286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820003|NCT01508286|Antiviral Agents|antiviral agents|mesh-ancestor
64820004|NCT01508286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64820005|NCT01508364|Sorafenib|sorafenib|mesh-list
64820006|NCT01508364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820007|NCT01508364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64820008|NCT01508364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64820010|NCT01508429|Misoprostol|misoprostol|mesh-list
64820068|NCT01508637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64820069|NCT01508637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64820070|NCT01508637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64472729|NCT02981628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64820071|NCT01508637|Adrenergic Agents|adrenergic agents|mesh-ancestor
64820072|NCT01508637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64820073|NCT01508637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820074|NCT01508637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820075|NCT01508637|Urological Agents|urological agents|mesh-ancestor
64820077|NCT01508663|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64820078|NCT01508663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820079|NCT01508663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64820080|NCT01508663|Immunologic Factors|immunologic factors|mesh-ancestor
64820165|NCT01509209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820166|NCT01509209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820167|NCT01509209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64820168|NCT01509209|Autonomic Agents|autonomic agents|mesh-ancestor
64820169|NCT01509209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64820170|NCT01509209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64820171|NCT01509209|Respiratory System Agents|respiratory system agents|mesh-ancestor
64820172|NCT01509209|Nasal Decongestants|nasal decongestants|mesh-ancestor
64820173|NCT01509209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64820174|NCT01509209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64820175|NCT01509209|Sympathomimetics|sympathomimetics|mesh-ancestor
64820176|NCT01509209|Adrenergic Agents|adrenergic agents|mesh-ancestor
64820177|NCT01509261|Lansoprazole|lansoprazole|mesh-list
64820178|NCT01509261|Dexlansoprazole|dexlansoprazole|mesh-list
64820179|NCT01509261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64820180|NCT01509261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65494554|NCT01329666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64820181|NCT01509261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64820182|NCT01509261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64820183|NCT01509261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820184|NCT01509300|Mycophenolic Acid|mycophenolic acid|mesh-list
64820185|NCT01509300|Cyclophosphamide|cyclophosphamide|mesh-list
64820186|NCT01509300|Rituximab|rituximab|mesh-list
64820187|NCT01509300|Fludarabine|fludarabine|mesh-list
64820188|NCT01509300|Tacrolimus|tacrolimus|mesh-list
64820189|NCT01509300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64820190|NCT01509300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64820211|NCT01509365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64820212|NCT01509365|Purinergic Agents|purinergic agents|mesh-ancestor
64820213|NCT01509365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64820223|NCT01509469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820225|NCT01509521|Oxymetazoline|oxymetazoline|mesh-list
64820226|NCT01509521|Ephedrine|ephedrine|mesh-list
64820227|NCT01509521|Pseudoephedrine|pseudoephedrine|mesh-list
64820228|NCT01509521|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64820229|NCT01509521|Mydriatics|mydriatics|mesh-ancestor
64820230|NCT01509521|Autonomic Agents|autonomic agents|mesh-ancestor
64820231|NCT01509521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64820232|NCT01509521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820233|NCT01509521|Sympathomimetics|sympathomimetics|mesh-ancestor
64820234|NCT01509521|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64820235|NCT01509521|Nasal Decongestants|nasal decongestants|mesh-ancestor
64820236|NCT01509521|Respiratory System Agents|respiratory system agents|mesh-ancestor
64820237|NCT01509521|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64820238|NCT01509521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64820239|NCT01509521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64820240|NCT01509521|Adrenergic Agents|adrenergic agents|mesh-ancestor
64820241|NCT01509521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64820242|NCT01509521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820243|NCT01509521|Protective Agents|protective agents|mesh-ancestor
64820244|NCT01509521|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64820245|NCT01509521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64820247|NCT01509560|Everolimus|everolimus|mesh-list
64820271|NCT01509911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64820272|NCT01509911|Antimetabolites|antimetabolites|mesh-ancestor
64820273|NCT01509911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820274|NCT01509911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820275|NCT01509911|Antiviral Agents|antiviral agents|mesh-ancestor
64820276|NCT01509911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64820277|NCT01509911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64820278|NCT01509911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64820279|NCT01509911|Immunologic Factors|immunologic factors|mesh-ancestor
64820294|NCT01510015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820355|NCT01510561|Antiviral Agents|antiviral agents|mesh-ancestor
64820356|NCT01510561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64820357|NCT01510561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64820358|NCT01510561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64820359|NCT01510561|Immunologic Factors|immunologic factors|mesh-ancestor
64820360|NCT01510561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820361|NCT01510561|Chelating Agents|chelating agents|mesh-ancestor
64820362|NCT01510561|Sequestering Agents|sequestering agents|mesh-ancestor
64820363|NCT01510574|Misoprostol|misoprostol|mesh-list
64820364|NCT01510574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64820365|NCT01510574|Abortifacient Agents|abortifacient agents|mesh-ancestor
64820366|NCT01510574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64820367|NCT01510574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820368|NCT01510574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64820369|NCT01510574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64820370|NCT01510574|Oxytocics|oxytocics|mesh-ancestor
64820371|NCT01510613|Dexamethasone|dexamethasone|mesh-list
64820372|NCT01510613|Pomalidomide|pomalidomide|mesh-list
64820373|NCT01510613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64820374|NCT01510613|Antiemetics|antiemetics|mesh-ancestor
64820376|NCT01510613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64820377|NCT01510613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820378|NCT01510613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64820379|NCT01510613|Glucocorticoids|glucocorticoids|mesh-ancestor
64820380|NCT01510613|Hormones|hormones|mesh-ancestor
64820381|NCT01510613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64820382|NCT01510613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64820383|NCT01510613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820384|NCT01510613|Immunologic Factors|immunologic factors|mesh-ancestor
64820385|NCT01510613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64820401|NCT01510795|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64820402|NCT01510795|Diuretics|diuretics|mesh-ancestor
64820403|NCT01510795|Natriuretic Agents|natriuretic agents|mesh-ancestor
64820404|NCT01510847|Testosterone undecanoate|testosterone undecanoate|mesh-list
64820405|NCT01510847|Androgens|androgens|mesh-ancestor
64820406|NCT01510847|Hormones|hormones|mesh-ancestor
64820407|NCT01510847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64820408|NCT01510847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820409|NCT01510860|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64820419|NCT01510990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64820421|NCT01511003|Tacrolimus|tacrolimus|mesh-list
64820476|NCT01511172|Hormones|hormones|mesh-ancestor
64820477|NCT01511172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64820478|NCT01511172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64820500|NCT01511211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820501|NCT01511211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64820502|NCT01511211|Glucocorticoids|glucocorticoids|mesh-ancestor
64820503|NCT01511211|Hormones|hormones|mesh-ancestor
64820504|NCT01511211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64820506|NCT01511211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820602|NCT01511562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64820603|NCT01511562|Immunologic Factors|immunologic factors|mesh-ancestor
64820604|NCT01511562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820605|NCT01511562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64820606|NCT01511562|Alkylating Agents|alkylating agents|mesh-ancestor
64820607|NCT01511562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64820608|NCT01511627|Anesthetics|anesthetics|mesh-list
64820609|NCT01511627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64820610|NCT01511627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820611|NCT01511692|Liraglutide|liraglutide|mesh-list
64820682|NCT01511770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64820683|NCT01511770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820684|NCT01511770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64820685|NCT01511770|Hormone Antagonists|hormone antagonists|mesh-ancestor
64820686|NCT01511770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64820687|NCT01511770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820691|NCT01511822|Drospirenone|drospirenone|mesh-list
64820788|NCT01512147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820789|NCT01512147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64820790|NCT01512173|Propranolol|propranolol|mesh-list
64820791|NCT01512173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64820792|NCT01512173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64820793|NCT01512173|Adrenergic Agents|adrenergic agents|mesh-ancestor
64820794|NCT01512173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64820795|NCT01512173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820888|NCT01512901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64820889|NCT01512901|Glucocorticoids|glucocorticoids|mesh-ancestor
64820890|NCT01512901|Hormones|hormones|mesh-ancestor
64820891|NCT01512901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64472733|NCT02981628|Hematinics|hematinics|mesh-ancestor
64560268|NCT05593731|Melatonin|melatonin|mesh-list
64820892|NCT01512901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820893|NCT01512901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64820894|NCT01512901|Respiratory System Agents|respiratory system agents|mesh-ancestor
64820895|NCT01512914|Ropivacaine|ropivacaine|mesh-list
64820896|NCT01512914|Anesthetics, Local|anesthetics, local|mesh-ancestor
64820897|NCT01512914|Anesthetics|anesthetics|mesh-ancestor
64820898|NCT01512914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64820899|NCT01512914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820900|NCT01512914|Sensory System Agents|sensory system agents|mesh-ancestor
64820901|NCT01512914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64820902|NCT01512953|Lansoprazole|lansoprazole|mesh-list
64820903|NCT01512953|Dexlansoprazole|dexlansoprazole|mesh-list
64820909|NCT01512966|Aflibercept|aflibercept|mesh-list
64820965|NCT01513083|Antimitotic Agents|antimitotic agents|mesh-ancestor
64820966|NCT01513083|Mitosis Modulators|mitosis modulators|mesh-ancestor
64820967|NCT01513083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820990|NCT01513525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64820991|NCT01513564|Morphine|morphine|mesh-list
64820992|NCT01513564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64820993|NCT01513564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820994|NCT01513564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64820995|NCT01513564|Narcotics|narcotics|mesh-ancestor
64820996|NCT01513564|Analgesics|analgesics|mesh-ancestor
64820997|NCT01513564|Sensory System Agents|sensory system agents|mesh-ancestor
64820998|NCT01513564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64820999|NCT01513603|Cytarabine|cytarabine|mesh-list
64821000|NCT01513603|Mitoxantrone|mitoxantrone|mesh-list
64821001|NCT01513603|Cladribine|cladribine|mesh-list
64821002|NCT01513603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64821003|NCT01513603|Antimetabolites|antimetabolites|mesh-ancestor
64821004|NCT01513603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821005|NCT01513603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821006|NCT01513603|Antiviral Agents|antiviral agents|mesh-ancestor
64821007|NCT01513603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65494555|NCT01329666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64821056|NCT01513772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64821057|NCT01513772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64821058|NCT01513772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64821059|NCT01513772|Adrenergic Agents|adrenergic agents|mesh-ancestor
64821060|NCT01513772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64821061|NCT01513772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821062|NCT01513785|Amoxicillin|amoxicillin|mesh-list
64821063|NCT01513785|Rabeprazole|rabeprazole|mesh-list
64821064|NCT01513785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64821065|NCT01513785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64821066|NCT01513785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64821067|NCT01513785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64821068|NCT01513785|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64821069|NCT01513785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821070|NCT01513785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821071|NCT01513811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64821103|NCT01514110|Carboplatin|carboplatin|mesh-list
64821105|NCT01514110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64821106|NCT01514110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821107|NCT01514110|Tubulin Modulators|tubulin modulators|mesh-ancestor
64821108|NCT01514110|Antimitotic Agents|antimitotic agents|mesh-ancestor
64821109|NCT01514110|Mitosis Modulators|mitosis modulators|mesh-ancestor
64821110|NCT01514110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821111|NCT01514110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64821112|NCT01514110|Immunologic Factors|immunologic factors|mesh-ancestor
64821114|NCT01514123|Bevacizumab|bevacizumab|mesh-list
64821195|NCT01514695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64821196|NCT01514695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64821197|NCT01514695|GABA Modulators|gaba modulators|mesh-ancestor
64821198|NCT01514695|GABA Agents|gaba agents|mesh-ancestor
64821199|NCT01514695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64821200|NCT01514695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821201|NCT01514721|Timolol|timolol|mesh-list
64821202|NCT01514721|Travoprost|travoprost|mesh-list
64821219|NCT01514812|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64821220|NCT01514812|Antithrombins|antithrombins|mesh-ancestor
64821221|NCT01514812|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64821222|NCT01514812|Protease Inhibitors|protease inhibitors|mesh-ancestor
64821223|NCT01514812|Anticoagulants|anticoagulants|mesh-ancestor
64821224|NCT01514825|Darexaban|darexaban|mesh-list
64821304|NCT01515228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821305|NCT01515228|Tubulin Modulators|tubulin modulators|mesh-ancestor
64821306|NCT01515228|Antimitotic Agents|antimitotic agents|mesh-ancestor
64821307|NCT01515228|Mitosis Modulators|mitosis modulators|mesh-ancestor
64821308|NCT01515228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821309|NCT01515228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64821343|NCT01515553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64821344|NCT01515579|Liraglutide|liraglutide|mesh-list
64821345|NCT01515579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64821346|NCT01515579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821347|NCT01515579|Incretins|incretins|mesh-ancestor
64472734|NCT02981628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64472735|NCT02981628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64821398|NCT01515826|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64821440|NCT01515839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65494558|NCT05255484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494559|NCT01141998|Cholecalciferol|cholecalciferol|mesh-list
65494560|NCT01141998|Vitamin D|vitamin d|mesh-list
65494561|NCT01141998|Calcium, Dietary|calcium, dietary|mesh-list
65494562|NCT01141998|Calcium|calcium|mesh-list
65494563|NCT01141998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65494564|NCT01141998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494565|NCT01141998|Vitamins|vitamins|mesh-ancestor
65494566|NCT01141998|Micronutrients|micronutrients|mesh-ancestor
65494567|NCT01141998|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65494568|NCT01238718|Lidocaine|lidocaine|mesh-list
65494569|NCT01238718|Anesthetics, Local|anesthetics, local|mesh-ancestor
65494570|NCT01238718|Anesthetics|anesthetics|mesh-ancestor
65494571|NCT01238718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65494572|NCT01238718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65494573|NCT01238718|Sensory System Agents|sensory system agents|mesh-ancestor
65494574|NCT01238718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65494575|NCT01238718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65494577|NCT01238718|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64821470|NCT01516060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64821471|NCT01516060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64821472|NCT01516060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64821473|NCT01516060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64821474|NCT01516138|Insulin|insulin|mesh-list
64821475|NCT01516138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64821476|NCT01516138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821477|NCT01516255|Liraglutide|liraglutide|mesh-list
64821478|NCT01516255|Moxifloxacin|moxifloxacin|mesh-list
64821574|NCT01516580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64821575|NCT01516580|Antimetabolites|antimetabolites|mesh-ancestor
64821576|NCT01516580|Dermatologic Agents|dermatologic agents|mesh-ancestor
64821577|NCT01516580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64821578|NCT01516580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64821579|NCT01516580|Antiviral Agents|antiviral agents|mesh-ancestor
64821580|NCT01516580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64821581|NCT01516580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64821582|NCT01516580|Tubulin Modulators|tubulin modulators|mesh-ancestor
64821583|NCT01516580|Antimitotic Agents|antimitotic agents|mesh-ancestor
64821584|NCT01516580|Mitosis Modulators|mitosis modulators|mesh-ancestor
64821585|NCT01516710|Liver Extracts|liver extracts|mesh-list
64821586|NCT01516710|Hematinics|hematinics|mesh-ancestor
64821587|NCT01516723|Sirolimus|sirolimus|mesh-list
64821588|NCT01516723|Everolimus|everolimus|mesh-list
64821589|NCT01516723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821590|NCT01516723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64821591|NCT01516723|Immunologic Factors|immunologic factors|mesh-ancestor
64821592|NCT01516723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821593|NCT01516723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64821606|NCT01516814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821607|NCT01516814|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64821608|NCT01516814|Antithrombins|antithrombins|mesh-ancestor
64821609|NCT01516814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64821610|NCT01516814|Protease Inhibitors|protease inhibitors|mesh-ancestor
64821611|NCT01516814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821612|NCT01516840|Heparin|heparin|mesh-list
64821638|NCT01516944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821639|NCT01516944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821640|NCT01516996|Docetaxel|docetaxel|mesh-list
64821641|NCT01516996|Nimotuzumab|nimotuzumab|mesh-list
64821642|NCT01516996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65494581|NCT01238796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64821643|NCT01516996|Tubulin Modulators|tubulin modulators|mesh-ancestor
64821644|NCT01516996|Antimitotic Agents|antimitotic agents|mesh-ancestor
64821645|NCT01516996|Mitosis Modulators|mitosis modulators|mesh-ancestor
64821646|NCT01516996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821647|NCT01516996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64821648|NCT01517009|Docetaxel|docetaxel|mesh-list
64557486|NCT02555007|Tubulin Modulators|tubulin modulators|mesh-ancestor
64821706|NCT01517399|Vitamin K|vitamin k|mesh-list
64821707|NCT01517399|Digoxin|digoxin|mesh-list
64821708|NCT01517399|Midazolam|midazolam|mesh-list
64821709|NCT01517399|Caffeine|caffeine|mesh-list
64821710|NCT01517399|Omeprazole|omeprazole|mesh-list
64821711|NCT01517399|Warfarin|warfarin|mesh-list
64821712|NCT01517399|Vitamins|vitamins|mesh-ancestor
64821713|NCT01517399|Micronutrients|micronutrients|mesh-ancestor
64821714|NCT01517399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821715|NCT01517399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64821716|NCT01517399|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64821717|NCT01517399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64821718|NCT01517399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64821719|NCT01517399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64821720|NCT01517399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64821721|NCT01517399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64821722|NCT01517399|Anesthetics, General|anesthetics, general|mesh-ancestor
64821723|NCT01517399|Anesthetics|anesthetics|mesh-ancestor
64821724|NCT01517399|GABA Modulators|gaba modulators|mesh-ancestor
64821725|NCT01517399|GABA Agents|gaba agents|mesh-ancestor
64821815|NCT01517854|Urological Agents|urological agents|mesh-ancestor
64821816|NCT01517932|Dexmedetomidine|dexmedetomidine|mesh-list
64821817|NCT01517932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64821818|NCT01517932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64821819|NCT01517932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821820|NCT01517932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64821821|NCT01517932|Analgesics|analgesics|mesh-ancestor
64821822|NCT01517932|Sensory System Agents|sensory system agents|mesh-ancestor
64821823|NCT01517932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64821824|NCT01517932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64821825|NCT01517932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64821826|NCT01517932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64821827|NCT01517932|Adrenergic Agents|adrenergic agents|mesh-ancestor
64821828|NCT01517932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64821829|NCT01517932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821830|NCT01517997|Paclitaxel|paclitaxel|mesh-list
64821848|NCT01518101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64821850|NCT01518101|Protease Inhibitors|protease inhibitors|mesh-ancestor
64821851|NCT01518101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821852|NCT01518101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821853|NCT01518166|Liraglutide|liraglutide|mesh-list
64821854|NCT01518166|Griseofulvin|griseofulvin|mesh-list
64821855|NCT01518166|Digoxin|digoxin|mesh-list
64821856|NCT01518166|Lisinopril|lisinopril|mesh-list
64821857|NCT01518166|Atorvastatin|atorvastatin|mesh-list
64821858|NCT01518166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64821859|NCT01518166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64821879|NCT01518231|Edaravone|edaravone|mesh-list
64821880|NCT01518231|Warfarin|warfarin|mesh-list
64821881|NCT01518231|Atorvastatin|atorvastatin|mesh-list
64821882|NCT01518231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64821883|NCT01518231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64821884|NCT01518231|Analgesics|analgesics|mesh-ancestor
64821885|NCT01518231|Sensory System Agents|sensory system agents|mesh-ancestor
64821886|NCT01518231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64821887|NCT01518231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821888|NCT01518231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64821912|NCT01518413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821914|NCT01518413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64821915|NCT01518465|Dexamethasone|dexamethasone|mesh-list
64821916|NCT01518465|Lenalidomide|lenalidomide|mesh-list
64821917|NCT01518465|Dalteparin|dalteparin|mesh-list
64821918|NCT01518465|Tinzaparin|tinzaparin|mesh-list
64821919|NCT01518465|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64821920|NCT01518465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64821921|NCT01518465|Antiemetics|antiemetics|mesh-ancestor
64821922|NCT01518465|Autonomic Agents|autonomic agents|mesh-ancestor
64821923|NCT01518465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64821926|NCT01518465|Glucocorticoids|glucocorticoids|mesh-ancestor
64821978|NCT01518712|Canagliflozin|canagliflozin|mesh-list
64821979|NCT01518712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64821980|NCT01518712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821981|NCT01518712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64821982|NCT01518712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821983|NCT01518725|Vitamin D|vitamin d|mesh-list
64821984|NCT01518725|Cholecalciferol|cholecalciferol|mesh-list
65494582|NCT01238796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64472769|NCT02790710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64560903|NCT01114503|Antiemetics|antiemetics|mesh-ancestor
64821985|NCT01518725|Vitamins|vitamins|mesh-ancestor
64821986|NCT01518725|Micronutrients|micronutrients|mesh-ancestor
64821987|NCT01518725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821988|NCT01518725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64821989|NCT01518725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64821990|NCT01518790|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64821991|NCT01518790|Laxatives|laxatives|mesh-ancestor
64821992|NCT01518790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64821993|NCT01518855|Amlodipine|amlodipine|mesh-list
64822003|NCT01518855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64822005|NCT01518933|Silymarin|silymarin|mesh-list
64822006|NCT01518933|Antioxidants|antioxidants|mesh-ancestor
64822007|NCT01518933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822008|NCT01518933|Protective Agents|protective agents|mesh-ancestor
64822009|NCT01518933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822010|NCT01518933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64822011|NCT01518933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822012|NCT01518959|Cholecalciferol|cholecalciferol|mesh-list
64822013|NCT01518959|Vitamin D|vitamin d|mesh-list
65095512|NCT00502034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095513|NCT00502034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65095514|NCT00502034|Analgesics|analgesics|mesh-ancestor
65095515|NCT00502034|Sensory System Agents|sensory system agents|mesh-ancestor
65095516|NCT00502034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095517|NCT00510666|Tramadol|tramadol|mesh-list
65095518|NCT00510666|Butorphanol|butorphanol|mesh-list
65095519|NCT00510666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65095520|NCT00510666|Narcotics|narcotics|mesh-ancestor
65095521|NCT00510666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65095522|NCT00510666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095523|NCT00510666|Analgesics|analgesics|mesh-ancestor
65095524|NCT00510666|Sensory System Agents|sensory system agents|mesh-ancestor
65095525|NCT00510666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095526|NCT00510666|Antitussive Agents|antitussive agents|mesh-ancestor
65095527|NCT00510666|Respiratory System Agents|respiratory system agents|mesh-ancestor
65095528|NCT00510666|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65095529|NCT00510705|Metformin|metformin|mesh-list
65095530|NCT00510705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65095531|NCT00510705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095532|NCT00502073|Cyclosporine|cyclosporine|mesh-list
65095533|NCT00502073|Cyclosporins|cyclosporins|mesh-list
65095534|NCT00502073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095535|NCT00502073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095536|NCT00502073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65095537|NCT00502073|Immunologic Factors|immunologic factors|mesh-ancestor
65095538|NCT00502073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095539|NCT00502073|Antifungal Agents|antifungal agents|mesh-ancestor
65095540|NCT00502073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65095541|NCT00502073|Dermatologic Agents|dermatologic agents|mesh-ancestor
64668553|NCT05735717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64668554|NCT05735717|Anticonvulsants|anticonvulsants|mesh-ancestor
64668555|NCT05735717|Nootropic Agents|nootropic agents|mesh-ancestor
64668556|NCT01626092|Cyclosporine|cyclosporine|mesh-list
64668557|NCT01626092|Mycophenolic Acid|mycophenolic acid|mesh-list
65095558|NCT01248923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65095567|NCT01249001|Aprepitant|aprepitant|mesh-list
64668614|NCT03270020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668615|NCT01921751|Gemcitabine|gemcitabine|mesh-list
64668616|NCT01921751|Paclitaxel|paclitaxel|mesh-list
64737817|NCT00001835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095623|NCT00510159|Antimalarials|antimalarials|mesh-ancestor
65095624|NCT00510159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65095625|NCT00510159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65095626|NCT00510159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65095627|NCT00510159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095628|NCT00510159|Antiviral Agents|antiviral agents|mesh-ancestor
65095629|NCT00510159|Schistosomicides|schistosomicides|mesh-ancestor
65095630|NCT00510159|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65095631|NCT00510159|Anthelmintics|anthelmintics|mesh-ancestor
65095632|NCT00510159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65095633|NCT00510159|Renal Agents|renal agents|mesh-ancestor
65095634|NCT02952807|Misoprostol|misoprostol|mesh-list
65095635|NCT02952807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65095636|NCT02952807|Abortifacient Agents|abortifacient agents|mesh-ancestor
65095637|NCT02952807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65095638|NCT02952807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095639|NCT02952807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65095640|NCT02952807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65095641|NCT02952807|Oxytocics|oxytocics|mesh-ancestor
65095642|NCT02275130|Calcium, Dietary|calcium, dietary|mesh-list
65095643|NCT02275130|Calcium|calcium|mesh-list
65095644|NCT02275130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65095645|NCT02275130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095647|NCT03459417|Morphine|morphine|mesh-list
65095669|NCT00502541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65095670|NCT00502541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095671|NCT01249430|Cytarabine|cytarabine|mesh-list
65095672|NCT01249430|Etoposide|etoposide|mesh-list
65095673|NCT01249430|Mitoxantrone|mitoxantrone|mesh-list
64668657|NCT01696760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668658|NCT01696760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668659|NCT01696760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64668660|NCT01696760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64668661|NCT01696760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64668662|NCT01696760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65095674|NCT01249430|Azacitidine|azacitidine|mesh-list
65095675|NCT01249430|Etoposide phosphate|etoposide phosphate|mesh-list
65095676|NCT01249430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65095677|NCT01249430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095678|NCT01249430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65095679|NCT01249430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65095680|NCT01249430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095720|NCT00504101|Arsenic Trioxide|arsenic trioxide|mesh-list
65095721|NCT00504101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095722|NCT00504101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65095723|NCT00504101|Alkylating Agents|alkylating agents|mesh-ancestor
65095724|NCT00504101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095725|NCT00504101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65095726|NCT00504101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65095727|NCT00504101|Immunologic Factors|immunologic factors|mesh-ancestor
65095785|NCT00511719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668756|NCT03078075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64668757|NCT03078075|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64668759|NCT03078075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095786|NCT01246232|Amisulpride|amisulpride|mesh-list
65095787|NCT01246232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65095788|NCT01246232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65095789|NCT01246232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65095790|NCT01246232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095791|NCT01246232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65095792|NCT01246232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65095793|NCT01246232|Dopamine Agents|dopamine agents|mesh-ancestor
65095794|NCT01246232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65095795|NCT01246232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095796|NCT01246232|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65095797|NCT01246232|Antidepressive Agents|antidepressive agents|mesh-ancestor
65095798|NCT01248962|Carboplatin|carboplatin|mesh-list
65095799|NCT01248962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095800|NCT00511446|Docetaxel|docetaxel|mesh-list
65095801|NCT00511446|Capecitabine|capecitabine|mesh-list
65095802|NCT00511446|Oxaliplatin|oxaliplatin|mesh-list
65095803|NCT00511446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095804|NCT00511446|Tubulin Modulators|tubulin modulators|mesh-ancestor
65095805|NCT00511446|Antimitotic Agents|antimitotic agents|mesh-ancestor
65095806|NCT00511446|Mitosis Modulators|mitosis modulators|mesh-ancestor
65095807|NCT00511446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095808|NCT00511446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65095809|NCT00511446|Antimetabolites|antimetabolites|mesh-ancestor
65095810|NCT00511602|Insulin|insulin|mesh-list
65095827|NCT00511953|Antimanic Agents|antimanic agents|mesh-ancestor
65095828|NCT01249820|Anidulafungin|anidulafungin|mesh-list
65095829|NCT01249820|Antifungal Agents|antifungal agents|mesh-ancestor
65095830|NCT01249820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65095831|NCT01247090|Vasopressins|vasopressins|mesh-list
65095832|NCT01247090|Arginine Vasopressin|arginine vasopressin|mesh-list
65095833|NCT01247090|Hemostatics|hemostatics|mesh-ancestor
65095834|NCT01247090|Coagulants|coagulants|mesh-ancestor
65095835|NCT01247090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65095836|NCT01247090|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65095837|NCT01247090|Natriuretic Agents|natriuretic agents|mesh-ancestor
65095838|NCT01247090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095839|NCT00504764|Arsenic Trioxide|arsenic trioxide|mesh-list
65095840|NCT00504764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095841|NCT00504296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
65095842|NCT00504296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095843|NCT00504296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095844|NCT02951754|Methylphenidate|methylphenidate|mesh-list
65095845|NCT02951754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65095846|NCT02951754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095847|NCT02951754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65095848|NCT02951754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65095849|NCT02951754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65095853|NCT00504413|Digoxin|digoxin|mesh-list
65095878|NCT00504413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65095879|NCT00504413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095880|NCT00504413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65095881|NCT00504413|Narcotics|narcotics|mesh-ancestor
65095882|NCT00504413|Analgesics|analgesics|mesh-ancestor
64668847|NCT03837860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64668848|NCT03837860|Serotonin Agents|serotonin agents|mesh-ancestor
64668849|NCT03837860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65095891|NCT01243658|Oxytocin|oxytocin|mesh-list
65095941|NCT00513396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095942|NCT00513396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65095943|NCT01249274|Progesterone|progesterone|mesh-list
65095944|NCT01249274|Progestins|progestins|mesh-ancestor
65095945|NCT01249274|Hormones|hormones|mesh-ancestor
64668901|NCT01950299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64668903|NCT03093207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64668904|NCT03093207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64668905|NCT03093207|Analgesics|analgesics|mesh-ancestor
64668906|NCT03093207|Sensory System Agents|sensory system agents|mesh-ancestor
65095999|NCT02275247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65096000|NCT04515719|Belimumab|belimumab|mesh-list
65096001|NCT04515719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65096002|NCT04515719|Immunologic Factors|immunologic factors|mesh-ancestor
65096003|NCT04515719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096004|NCT00513786|Paclitaxel|paclitaxel|mesh-list
65096005|NCT00513786|Bevacizumab|bevacizumab|mesh-list
65096006|NCT00513786|Carboplatin|carboplatin|mesh-list
65096007|NCT00513786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64738192|NCT00000695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65096008|NCT00513786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096009|NCT00513786|Tubulin Modulators|tubulin modulators|mesh-ancestor
65096010|NCT00513786|Antimitotic Agents|antimitotic agents|mesh-ancestor
65096011|NCT00513786|Mitosis Modulators|mitosis modulators|mesh-ancestor
65096012|NCT00513786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668953|NCT02342886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096056|NCT00512850|Micronutrients|micronutrients|mesh-ancestor
65096057|NCT00512850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096058|NCT00512928|Vitamin K 2|vitamin k 2|mesh-list
65096059|NCT00512928|Vitamin K|vitamin k|mesh-list
64668995|NCT02389998|Mydriatics|mydriatics|mesh-ancestor
64668996|NCT02389998|Parasympatholytics|parasympatholytics|mesh-ancestor
64668997|NCT02389998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64668998|NCT02389998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65096060|NCT00512928|Acenocoumarol|acenocoumarol|mesh-list
65096061|NCT00512928|Vitamin MK 7|vitamin mk 7|mesh-list
65096062|NCT00512928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65096063|NCT00512928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65096064|NCT00512928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096065|NCT00512928|Hemostatics|hemostatics|mesh-ancestor
65096066|NCT00512928|Coagulants|coagulants|mesh-ancestor
65096067|NCT00512928|Vitamins|vitamins|mesh-ancestor
65096068|NCT00512928|Micronutrients|micronutrients|mesh-ancestor
65096069|NCT00512928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096070|NCT00512928|Anticoagulants|anticoagulants|mesh-ancestor
65096071|NCT00505154|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65096072|NCT00505154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65096073|NCT00505154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65096074|NCT00505154|Antimetabolites|antimetabolites|mesh-ancestor
65096106|NCT00513981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096107|NCT00513981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096108|NCT00513981|Dermatologic Agents|dermatologic agents|mesh-ancestor
65096109|NCT00513981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096110|NCT00513981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65096111|NCT00513981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65096112|NCT00513981|Immunologic Factors|immunologic factors|mesh-ancestor
65096113|NCT00513981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65096114|NCT00513981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65096115|NCT00513981|Antidotes|antidotes|mesh-ancestor
65096116|NCT00513981|Protective Agents|protective agents|mesh-ancestor
65096117|NCT00513981|Vitamin B Complex|vitamin b complex|mesh-ancestor
65096118|NCT00513981|Vitamins|vitamins|mesh-ancestor
65096119|NCT00513981|Micronutrients|micronutrients|mesh-ancestor
65096120|NCT00505232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65096167|NCT01244984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65096168|NCT01244984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65096169|NCT01244984|Autonomic Agents|autonomic agents|mesh-ancestor
64483563|NCT00768118|Curcumin|curcumin|mesh-list
65096170|NCT01244984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65096171|NCT01244984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096173|NCT01244984|Respiratory System Agents|respiratory system agents|mesh-ancestor
65096174|NCT01244984|Dermatologic Agents|dermatologic agents|mesh-ancestor
65096175|NCT01244984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65096176|NCT04695483|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65096177|NCT04695483|Hormones|hormones|mesh-ancestor
65096178|NCT04695483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65096179|NCT04695483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096180|NCT01244126|Fentanyl|fentanyl|mesh-list
65096181|NCT01244126|Morphine|morphine|mesh-list
65096182|NCT01244126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65096183|NCT01244126|Narcotics|narcotics|mesh-ancestor
65096184|NCT01244126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65096185|NCT01244126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096186|NCT01244126|Analgesics|analgesics|mesh-ancestor
65096187|NCT01244126|Sensory System Agents|sensory system agents|mesh-ancestor
65096188|NCT01244126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65096189|NCT01244126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65096190|NCT01244126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65096191|NCT01244126|Anesthetics, General|anesthetics, general|mesh-ancestor
65096192|NCT01244126|Anesthetics|anesthetics|mesh-ancestor
65096193|NCT01243775|Docetaxel|docetaxel|mesh-list
65096194|NCT01243775|Oxaliplatin|oxaliplatin|mesh-list
65096195|NCT01243775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096196|NCT01243775|Tubulin Modulators|tubulin modulators|mesh-ancestor
65096197|NCT01243775|Antimitotic Agents|antimitotic agents|mesh-ancestor
65096198|NCT01243775|Mitosis Modulators|mitosis modulators|mesh-ancestor
65096199|NCT01243775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096200|NCT00514293|Carboplatin|carboplatin|mesh-list
65096201|NCT00514293|Docetaxel|docetaxel|mesh-list
65096202|NCT00514293|Capecitabine|capecitabine|mesh-list
65096209|NCT00514293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096210|NCT00514293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64669143|NCT02978157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64669144|NCT02978157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64669145|NCT02978157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669148|NCT02978157|Antacids|antacids|mesh-ancestor
65096211|NCT00514293|Antimetabolites|antimetabolites|mesh-ancestor
65096272|NCT00514410|Vitamin B Complex|vitamin b complex|mesh-ancestor
65096273|NCT00514410|Vitamins|vitamins|mesh-ancestor
65096274|NCT00514410|Micronutrients|micronutrients|mesh-ancestor
65096275|NCT00514410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096276|NCT01241318|Chlorhexidine|chlorhexidine|mesh-list
65096277|NCT01241318|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64669199|NCT01706588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669200|NCT01706588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64394550|NCT05746351|Narcotics|narcotics|mesh-ancestor
64669202|NCT01706588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64669203|NCT01706588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096332|NCT01240811|Copper|copper|mesh-list
65096333|NCT01240811|Levonorgestrel|levonorgestrel|mesh-list
65096334|NCT01240811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65096335|NCT01240811|Contraceptive Agents|contraceptive agents|mesh-ancestor
65096336|NCT01240811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65096337|NCT01240811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096338|NCT01240811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64669249|NCT01605032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669250|NCT01605032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64669251|NCT01605032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65096339|NCT01240811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65096340|NCT01240811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65096341|NCT01240811|Trace Elements|trace elements|mesh-ancestor
65096342|NCT01240811|Micronutrients|micronutrients|mesh-ancestor
65096343|NCT03459144|Ranibizumab|ranibizumab|mesh-list
65096344|NCT03459144|Verteporfin|verteporfin|mesh-list
65096345|NCT03459144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65096347|NCT03459144|Growth Substances|growth substances|mesh-ancestor
65096387|NCT01243346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096388|NCT01249443|Paclitaxel|paclitaxel|mesh-list
65096389|NCT01249443|Carboplatin|carboplatin|mesh-list
65096390|NCT01249443|Vorinostat|vorinostat|mesh-list
64669286|NCT03149991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64669287|NCT03149991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64669288|NCT03149991|Anesthetics, General|anesthetics, general|mesh-ancestor
64669289|NCT03149991|Anesthetics|anesthetics|mesh-ancestor
65096391|NCT01249443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65096392|NCT01249443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096393|NCT01249443|Tubulin Modulators|tubulin modulators|mesh-ancestor
65096394|NCT01249443|Antimitotic Agents|antimitotic agents|mesh-ancestor
65096395|NCT01249443|Mitosis Modulators|mitosis modulators|mesh-ancestor
65096396|NCT01249443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096397|NCT01249443|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65096398|NCT01249443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096399|NCT01243073|Imetelstat|imetelstat|mesh-list
65096400|NCT01243073|Motesanib diphosphate|motesanib diphosphate|mesh-list
65096401|NCT01243073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096402|NCT01243073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096403|NCT01243073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65096404|NCT00516243|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65096405|NCT00516243|Antioxidants|antioxidants|mesh-ancestor
65096434|NCT01249521|Growth Substances|growth substances|mesh-ancestor
65096435|NCT01249521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096436|NCT01249521|Growth Inhibitors|growth inhibitors|mesh-ancestor
65096437|NCT01249677|Insulin Glargine|insulin glargine|mesh-list
65096438|NCT01249677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65096439|NCT01249677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096440|NCT04511975|Azacitidine|azacitidine|mesh-list
65096441|NCT04511975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65096442|NCT04511975|Antimetabolites|antimetabolites|mesh-ancestor
65096443|NCT04511975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096444|NCT04511975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096445|NCT04511975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096446|NCT04511897|Expectorants|expectorants|mesh-list
65096447|NCT04511897|Respiratory System Agents|respiratory system agents|mesh-ancestor
65096448|NCT04519463|Lidocaine|lidocaine|mesh-list
65096449|NCT04519463|Anesthetics, Local|anesthetics, local|mesh-ancestor
65096450|NCT04519463|Anesthetics|anesthetics|mesh-ancestor
65096451|NCT04519463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65096452|NCT04519463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096453|NCT04519463|Sensory System Agents|sensory system agents|mesh-ancestor
64669386|NCT02331095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64669387|NCT02331095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096486|NCT01244256|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65096487|NCT01249833|Oseltamivir|oseltamivir|mesh-list
65096488|NCT01249833|Antiviral Agents|antiviral agents|mesh-ancestor
65096489|NCT01249833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65096490|NCT01249833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096491|NCT01249833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096492|NCT02950233|N-Methylaspartate|n-methylaspartate|mesh-list
65096493|NCT02950233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
65096494|NCT02950233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65096495|NCT02950233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65096496|NCT02950233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096497|NCT02950233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096498|NCT04519151|Pembrolizumab|pembrolizumab|mesh-list
65096499|NCT04519151|Lenvatinib|lenvatinib|mesh-list
65096500|NCT04519151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65096501|NCT04519151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096502|NCT04519151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65096503|NCT04519151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096504|NCT04519151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096505|NCT01249404|Botulinum Toxins|botulinum toxins|mesh-list
65096506|NCT01249404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65096532|NCT04519385|Hormones|hormones|mesh-ancestor
64669429|NCT05316935|Hormones|hormones|mesh-ancestor
65096533|NCT04519385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65096534|NCT04519385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65096535|NCT04519385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096537|NCT00506051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096538|NCT00506051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096539|NCT00506051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096540|NCT00506051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65096541|NCT00506051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65096542|NCT00504465|Dinoprostone|dinoprostone|mesh-list
65096543|NCT00504465|Oxytocics|oxytocics|mesh-ancestor
65096544|NCT00504465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65096545|NCT00504465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096546|NCT00516360|Chlorhexidine|chlorhexidine|mesh-list
65096547|NCT00516360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
65096548|NCT00516360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65096549|NCT00516360|Disinfectants|disinfectants|mesh-ancestor
65096550|NCT04510649|Rifampin|rifampin|mesh-list
65096551|NCT04510649|Rabeprazole|rabeprazole|mesh-list
65096552|NCT04510649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65096553|NCT04510649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65096554|NCT04510649|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65096555|NCT04510649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096556|NCT04510649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096580|NCT02275182|Dexmedetomidine|dexmedetomidine|mesh-list
65096581|NCT02275182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65096582|NCT02275182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65096583|NCT02275182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096584|NCT02275182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65096585|NCT02275182|Analgesics|analgesics|mesh-ancestor
65096586|NCT02275182|Sensory System Agents|sensory system agents|mesh-ancestor
65096587|NCT02275182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65096588|NCT02275182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65096589|NCT02275182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65096590|NCT02275182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65096591|NCT02275182|Adrenergic Agents|adrenergic agents|mesh-ancestor
65096592|NCT02275182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65096640|NCT01248468|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65096641|NCT01248468|Serotonin Agents|serotonin agents|mesh-ancestor
65096642|NCT02275299|Methotrexate|methotrexate|mesh-list
65096643|NCT02275299|Leflunomide|leflunomide|mesh-list
65096644|NCT02275299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65096645|NCT02275299|Abortifacient Agents|abortifacient agents|mesh-ancestor
65096646|NCT02275299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65096647|NCT02275299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096648|NCT02275299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65096649|NCT02275299|Antimetabolites|antimetabolites|mesh-ancestor
65096650|NCT02275299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096651|NCT02275299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096652|NCT02275299|Dermatologic Agents|dermatologic agents|mesh-ancestor
65096653|NCT02275299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096654|NCT02275299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65096655|NCT02275299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65096656|NCT02275299|Immunologic Factors|immunologic factors|mesh-ancestor
65096657|NCT02275299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65096658|NCT02275299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65096659|NCT01247922|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65096660|NCT01247922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096661|NCT01247922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65096662|NCT01247922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096663|NCT01247922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096664|NCT01246206|Tacrolimus|tacrolimus|mesh-list
65096665|NCT01246206|Thymoglobulin|thymoglobulin|mesh-list
65096666|NCT01246206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65096667|NCT01246206|Immunologic Factors|immunologic factors|mesh-ancestor
65096668|NCT01246206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096669|NCT01246206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65096670|NCT01246206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096682|NCT01246011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65096683|NCT01246011|Protease Inhibitors|protease inhibitors|mesh-ancestor
65096684|NCT01246011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096685|NCT01246011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096686|NCT01246011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65096687|NCT01244490|Guanfacine|guanfacine|mesh-list
65096688|NCT01244490|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65096689|NCT01244490|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65096690|NCT01244490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65096691|NCT01244490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65096692|NCT01244490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096693|NCT01244490|Adrenergic Agents|adrenergic agents|mesh-ancestor
65096694|NCT01244490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65096695|NCT01244490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096696|NCT01244490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65096697|NCT01244490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65096698|NCT01244490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65096699|NCT01244490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65096700|NCT01243944|Lenalidomide|lenalidomide|mesh-list
65096701|NCT01243944|Pomalidomide|pomalidomide|mesh-list
65096702|NCT01243944|Hydroxyurea|hydroxyurea|mesh-list
65096703|NCT01243944|Pipobroman|pipobroman|mesh-list
65096704|NCT01243944|Anagrelide|anagrelide|mesh-list
65096705|NCT01243944|Immunologic Factors|immunologic factors|mesh-ancestor
65096706|NCT01243944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096707|NCT01243944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65096708|NCT01243944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65096709|NCT01243944|Growth Substances|growth substances|mesh-ancestor
65096710|NCT01243944|Growth Inhibitors|growth inhibitors|mesh-ancestor
65096711|NCT01243944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096712|NCT01243944|Antisickling Agents|antisickling agents|mesh-ancestor
65096713|NCT01243944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669626|NCT04997525|Progesterone|progesterone|mesh-list
64669627|NCT04997525|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64669628|NCT04997525|Estrogens|estrogens|mesh-ancestor
64669629|NCT04997525|Hormones|hormones|mesh-ancestor
64669630|NCT04997525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65096724|NCT00516399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64669683|NCT05710328|Antimetabolites|antimetabolites|mesh-ancestor
64669684|NCT05710328|Antiviral Agents|antiviral agents|mesh-ancestor
64669685|NCT05710328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64669686|NCT04901975|Spironolactone|spironolactone|mesh-list
65096787|NCT00516750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65096788|NCT00516750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65096789|NCT00516750|Tubulin Modulators|tubulin modulators|mesh-ancestor
65096790|NCT00516750|Antimitotic Agents|antimitotic agents|mesh-ancestor
65096791|NCT00516750|Mitosis Modulators|mitosis modulators|mesh-ancestor
65096792|NCT00505427|Thioctic Acid|thioctic acid|mesh-list
65096793|NCT00505427|Antioxidants|antioxidants|mesh-ancestor
65096848|NCT00516828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096849|NCT00516828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096850|NCT00516828|Antiviral Agents|antiviral agents|mesh-ancestor
65096851|NCT00516828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65096852|NCT00516828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65096853|NCT00516828|Immunologic Factors|immunologic factors|mesh-ancestor
65096854|NCT00516828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096856|NCT02949765|Trace Elements|trace elements|mesh-ancestor
65096857|NCT02949765|Micronutrients|micronutrients|mesh-ancestor
65096858|NCT02949765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096859|NCT04518176|Oxytocin|oxytocin|mesh-list
65096860|NCT04518176|Oxytocics|oxytocics|mesh-ancestor
65096861|NCT04518176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65096862|NCT04518176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096863|NCT00516945|Lamivudine|lamivudine|mesh-list
65096864|NCT00516945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65096865|NCT00516945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65096866|NCT00516945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096867|NCT00516945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096903|NCT00506246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64739096|NCT00002219|Nelfinavir|nelfinavir|mesh-list
65096904|NCT00506246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65096905|NCT00506246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096906|NCT00506246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65096907|NCT00506246|Anesthetics, General|anesthetics, general|mesh-ancestor
65096908|NCT00506246|Anesthetics|anesthetics|mesh-ancestor
65096910|NCT01243242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65096911|NCT00517491|Lanreotide|lanreotide|mesh-list
65096912|NCT00517491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096913|NCT04517201|Insulin|insulin|mesh-list
65096914|NCT04517201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65096915|NCT04517201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65096916|NCT04517201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096917|NCT01241292|Elotuzumab|elotuzumab|mesh-list
65096918|NCT01241292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096919|NCT00517725|Carvedilol|carvedilol|mesh-list
65096920|NCT00517725|Nebivolol|nebivolol|mesh-list
65096921|NCT00517725|Bisoprolol|bisoprolol|mesh-list
65096922|NCT00517725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65096923|NCT00517725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65096924|NCT00517725|Adrenergic Agents|adrenergic agents|mesh-ancestor
65096925|NCT00517725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65096926|NCT00517725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096927|NCT00517725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096928|NCT00517725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65096929|NCT00517725|Antioxidants|antioxidants|mesh-ancestor
65096930|NCT00517725|Protective Agents|protective agents|mesh-ancestor
64669844|NCT01661114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669845|NCT01661114|Antiviral Agents|antiviral agents|mesh-ancestor
64669846|NCT01661114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64669847|NCT01661114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65096952|NCT01240863|Antitussive Agents|antitussive agents|mesh-ancestor
65096953|NCT01240863|Respiratory System Agents|respiratory system agents|mesh-ancestor
65096954|NCT01240746|Vaccines|vaccines|mesh-list
65096955|NCT01240746|Immunologic Factors|immunologic factors|mesh-ancestor
65096956|NCT01240746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096957|NCT01240590|Cisplatin|cisplatin|mesh-list
65096958|NCT01240590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096959|NCT01240200|Insulin Glargine|insulin glargine|mesh-list
65096960|NCT01240200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65096961|NCT01240200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096962|NCT00504543|Everolimus|everolimus|mesh-list
65096963|NCT00504543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65096964|NCT00504543|Immunologic Factors|immunologic factors|mesh-ancestor
65096965|NCT00504543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65096966|NCT00504543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096967|NCT02949843|Pembrolizumab|pembrolizumab|mesh-list
65096968|NCT02949843|Nivolumab|nivolumab|mesh-list
65096969|NCT02949843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65096970|NCT02949843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65096971|NCT02949843|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65096972|NCT02949843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65096973|NCT00517764|Citalopram|citalopram|mesh-list
65096974|NCT00517764|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65096976|NCT00517764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65096996|NCT04517435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65096997|NCT04517435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65096998|NCT04517435|Alkylating Agents|alkylating agents|mesh-ancestor
65096999|NCT04517435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097000|NCT04517435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669881|NCT03000309|Apremilast|apremilast|mesh-list
64669882|NCT03000309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64669883|NCT03000309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64669884|NCT03000309|Analgesics|analgesics|mesh-ancestor
64669885|NCT03000309|Sensory System Agents|sensory system agents|mesh-ancestor
65097001|NCT04517435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65097002|NCT04517435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65097003|NCT04517435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65097004|NCT04517435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65097005|NCT04517435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65097006|NCT04517435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097007|NCT04517435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65097008|NCT04517435|Glucocorticoids|glucocorticoids|mesh-ancestor
65097009|NCT04517435|Hormones|hormones|mesh-ancestor
65097010|NCT04517435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65097044|NCT01241214|Histamine Antagonists|histamine antagonists|mesh-ancestor
65097045|NCT01241214|Histamine Agents|histamine agents|mesh-ancestor
65097046|NCT01241214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65097047|NCT01241214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097048|NCT01241214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097054|NCT01240512|Vitamin D|vitamin d|mesh-list
65097055|NCT01240512|Cholecalciferol|cholecalciferol|mesh-list
65097056|NCT01240512|Vitamins|vitamins|mesh-ancestor
65097057|NCT01240512|Micronutrients|micronutrients|mesh-ancestor
65097058|NCT01240512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097059|NCT01240512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65097060|NCT01240512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65097061|NCT01240629|Doxorubicin|doxorubicin|mesh-list
65097062|NCT01240629|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65097063|NCT01240629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65097064|NCT01240629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097065|NCT01240629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65097066|NCT01240629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65097067|NCT01240629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097068|NCT01240629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097069|NCT04515641|Islatravir|islatravir|mesh-list
65097070|NCT04515641|Antiviral Agents|antiviral agents|mesh-ancestor
65097100|NCT00518271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65097101|NCT00518271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097102|NCT00518271|Antifungal Agents|antifungal agents|mesh-ancestor
65097103|NCT00518193|Cetuximab|cetuximab|mesh-list
65097104|NCT00518193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65097105|NCT00518193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097106|NCT00518427|Insulin Glargine|insulin glargine|mesh-list
65097107|NCT00518427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65097108|NCT00518427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097109|NCT00518466|Topiramate|topiramate|mesh-list
65097110|NCT00518466|Phentermine|phentermine|mesh-list
65097111|NCT00518466|Anticonvulsants|anticonvulsants|mesh-ancestor
65097112|NCT00518466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65097113|NCT00518466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097114|NCT00518466|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65097115|NCT00518466|Appetite Depressants|appetite depressants|mesh-ancestor
65097116|NCT00518466|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65097117|NCT00518466|Sympathomimetics|sympathomimetics|mesh-ancestor
65097118|NCT00518466|Autonomic Agents|autonomic agents|mesh-ancestor
65097119|NCT00518466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65097120|NCT00518466|Adrenergic Agents|adrenergic agents|mesh-ancestor
65097123|NCT00518583|Paclitaxel|paclitaxel|mesh-list
65097155|NCT00519870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64483597|NCT00757822|Antipruritics|antipruritics|mesh-ancestor
65097156|NCT00519870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65097157|NCT00519870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65097158|NCT00519870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097159|NCT00519870|Vasodilator Agents|vasodilator agents|mesh-ancestor
65097160|NCT00519870|Tocolytic Agents|tocolytic agents|mesh-ancestor
65097161|NCT00519870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65097162|NCT00519909|Calcium|calcium|mesh-list
65097163|NCT00519909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65097164|NCT00519909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097165|NCT02949492|Interleukin-2|interleukin-2|mesh-list
65097166|NCT02949492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097167|NCT02949492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65097168|NCT02949492|Analgesics|analgesics|mesh-ancestor
65097169|NCT02949492|Sensory System Agents|sensory system agents|mesh-ancestor
65097170|NCT02949492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65097171|NCT02949492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097172|NCT04511234|Sirolimus|sirolimus|mesh-list
65097173|NCT04511234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65097174|NCT04511234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65097175|NCT04511234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65097176|NCT04511234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097177|NCT04511234|Antifungal Agents|antifungal agents|mesh-ancestor
65097178|NCT04511234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65097179|NCT04511234|Immunologic Factors|immunologic factors|mesh-ancestor
65097180|NCT04511234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097181|NCT04514588|Caffeine|caffeine|mesh-list
65097182|NCT04514588|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65097183|NCT04514588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097184|NCT04514588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65097185|NCT04514588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097186|NCT04514588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097194|NCT00519987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65097195|NCT00519987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097196|NCT00519987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65097197|NCT00519987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64670067|NCT03247569|Edoxaban|edoxaban|mesh-list
64670068|NCT03247569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65097199|NCT00519987|Anesthetics|anesthetics|mesh-ancestor
65097259|NCT00519012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65097260|NCT00519012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097261|NCT00519012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65097262|NCT00519012|Serotonin Agents|serotonin agents|mesh-ancestor
65097263|NCT00519012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670127|NCT05357079|Tranexamic Acid|tranexamic acid|mesh-list
65097324|NCT00505700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65097325|NCT00505700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65097326|NCT00505700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097327|NCT02275832|Minoxidil|minoxidil|mesh-list
65097328|NCT02275832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65097329|NCT02275832|Vasodilator Agents|vasodilator agents|mesh-ancestor
64670190|NCT05293509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64670191|NCT05293509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670192|NCT05293509|Antifungal Agents|antifungal agents|mesh-ancestor
64670193|NCT05293509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65097382|NCT00519246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65097383|NCT00519246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65097384|NCT00519246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65097385|NCT00519246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65097386|NCT00519324|Everolimus|everolimus|mesh-list
64670242|NCT02594111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670243|NCT02594111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670244|NCT03186261|Chlorhexidine|chlorhexidine|mesh-list
64670245|NCT03186261|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64670247|NCT03186261|Fluorides|fluorides|mesh-list
65097387|NCT00519324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097388|NCT00519324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65097389|NCT00519324|Immunologic Factors|immunologic factors|mesh-ancestor
65097391|NCT00520650|Aripiprazole|aripiprazole|mesh-list
65097437|NCT00519519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097439|NCT02598557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097440|NCT02598557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65097441|NCT02598557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65097442|NCT02598557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097443|NCT02598557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097444|NCT02598557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65097445|NCT02598557|Hormone Antagonists|hormone antagonists|mesh-ancestor
65097446|NCT02598557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64670302|NCT03190005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65097448|NCT00520806|Methocarbamol|methocarbamol|mesh-list
65097497|NCT05144945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670350|NCT01683422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65097498|NCT04513379|Efavirenz|efavirenz|mesh-list
65097499|NCT04513379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65097500|NCT04513379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65097501|NCT04513379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097502|NCT04513379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097503|NCT04513379|Antiviral Agents|antiviral agents|mesh-ancestor
65097504|NCT04513379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65097505|NCT04513379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65097560|NCT00521430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65097561|NCT00521430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65097562|NCT00521430|Protective Agents|protective agents|mesh-ancestor
65097563|NCT00521430|Alkylating Agents|alkylating agents|mesh-ancestor
65097564|NCT00521430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65097565|NCT00521430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65097566|NCT00521274|Docetaxel|docetaxel|mesh-list
65097567|NCT00521274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097568|NCT00521274|Tubulin Modulators|tubulin modulators|mesh-ancestor
65097569|NCT00521274|Antimitotic Agents|antimitotic agents|mesh-ancestor
65097570|NCT00521274|Mitosis Modulators|mitosis modulators|mesh-ancestor
65097571|NCT00521274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097572|NCT05146778|Lidocaine|lidocaine|mesh-list
65097573|NCT05146778|Fentanyl|fentanyl|mesh-list
64670481|NCT03978767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65097620|NCT02948283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65097621|NCT02948283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65097622|NCT04512872|Denosumab|denosumab|mesh-list
65097623|NCT04512872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65097624|NCT04512872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097625|NCT04512638|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65097626|NCT04512638|Amoxicillin|amoxicillin|mesh-list
65097627|NCT04512638|Chlorhexidine|chlorhexidine|mesh-list
65097628|NCT04512638|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65097629|NCT04512638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64670482|NCT03978767|Analgesics|analgesics|mesh-ancestor
65097682|NCT00521742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65097683|NCT00521742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097684|NCT00521781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64670530|NCT02196155|Cholinergic Agents|cholinergic agents|mesh-ancestor
64670531|NCT02196155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64670532|NCT02196155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097685|NCT00521781|Leuprolide|leuprolide|mesh-list
65097686|NCT00521781|Bicalutamide|bicalutamide|mesh-list
65097687|NCT00521781|Androgens|androgens|mesh-list
65097688|NCT00521781|Androgen Antagonists|androgen antagonists|mesh-list
65097689|NCT00521781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097690|NCT00521781|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65097691|NCT00521781|Fertility Agents|fertility agents|mesh-ancestor
65097692|NCT00521781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65097693|NCT00521781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097740|NCT00523458|Nevirapine|nevirapine|mesh-list
64670584|NCT02334059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65097741|NCT00523458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65097742|NCT00523458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65097743|NCT00523458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097744|NCT00523458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097745|NCT00523458|Antiviral Agents|antiviral agents|mesh-ancestor
65097746|NCT00523458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65097747|NCT00523458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65097748|NCT00523458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65097749|NCT00523458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65097750|NCT00523458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65097799|NCT00522249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097800|NCT00522249|Growth Inhibitors|growth inhibitors|mesh-ancestor
65097801|NCT00522249|Immunologic Factors|immunologic factors|mesh-ancestor
65097803|NCT05148767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65097804|NCT05148767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65097805|NCT05148767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097806|NCT05148767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097807|NCT05148767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097808|NCT00523692|Etanercept|etanercept|mesh-list
65097809|NCT00523692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65097810|NCT00523692|Methotrexate|methotrexate|mesh-list
65097811|NCT00523692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65097812|NCT00523692|Abortifacient Agents|abortifacient agents|mesh-ancestor
65097813|NCT00523692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65097814|NCT00523692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097815|NCT00523692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65097816|NCT00523692|Antimetabolites|antimetabolites|mesh-ancestor
65097817|NCT00523692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097818|NCT00523692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097819|NCT00523692|Dermatologic Agents|dermatologic agents|mesh-ancestor
65097820|NCT00523692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097821|NCT00523692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65097822|NCT00523692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65097823|NCT00523692|Immunologic Factors|immunologic factors|mesh-ancestor
65097849|NCT05148689|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65097850|NCT05148689|Protective Agents|protective agents|mesh-ancestor
65097851|NCT00522444|Magnesium Sulfate|magnesium sulfate|mesh-list
65097852|NCT00522444|Analgesics|analgesics|mesh-ancestor
65097853|NCT00522444|Sensory System Agents|sensory system agents|mesh-ancestor
65097854|NCT00522444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65097855|NCT00522444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097856|NCT00522444|Anesthetics|anesthetics|mesh-ancestor
65097857|NCT00522444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65097858|NCT00522444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65097859|NCT00522444|Anticonvulsants|anticonvulsants|mesh-ancestor
65097860|NCT00522444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65097861|NCT00522444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65097862|NCT00522444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097863|NCT00522444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65097864|NCT00522444|Tocolytic Agents|tocolytic agents|mesh-ancestor
65097865|NCT00522444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65097866|NCT05148143|Raltitrexed|raltitrexed|mesh-list
65097867|NCT05148143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65097868|NCT05148143|Antimetabolites|antimetabolites|mesh-ancestor
65097869|NCT05148143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097870|NCT05148143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65097871|NCT05148143|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65097872|NCT05148143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65097898|NCT05146271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097899|NCT00522639|Deoxyglucose|deoxyglucose|mesh-list
65097900|NCT00522639|Antimetabolites|antimetabolites|mesh-ancestor
65097901|NCT00522639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65097902|NCT00522639|Antiviral Agents|antiviral agents|mesh-ancestor
64670743|NCT03226899|Antimitotic Agents|antimitotic agents|mesh-ancestor
64670744|NCT03226899|Mitosis Modulators|mitosis modulators|mesh-ancestor
65097904|NCT05142098|Dexamethasone|dexamethasone|mesh-list
65097960|NCT00524160|Fentanyl|fentanyl|mesh-list
65097961|NCT00524160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65097962|NCT00524160|Narcotics|narcotics|mesh-ancestor
65097963|NCT00524160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64670802|NCT03298113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670803|NCT03232749|Methylprednisolone|methylprednisolone|mesh-list
64670804|NCT03232749|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64670806|NCT03232749|Antiemetics|antiemetics|mesh-ancestor
65097964|NCT00524160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65097965|NCT00524160|Analgesics|analgesics|mesh-ancestor
65097966|NCT00524160|Sensory System Agents|sensory system agents|mesh-ancestor
65097967|NCT00524160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65097968|NCT00524160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65097971|NCT00524160|Anesthetics|anesthetics|mesh-ancestor
65098019|NCT05146154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65098020|NCT05146154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65098021|NCT05146154|Protease Inhibitors|protease inhibitors|mesh-ancestor
64670861|NCT01688336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64670862|NCT01688336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64670863|NCT01688336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098022|NCT05146154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098023|NCT05146154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098024|NCT05146154|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65098025|NCT00524667|Fludarabine|fludarabine|mesh-list
65098026|NCT00524667|Valproic Acid|valproic acid|mesh-list
65098027|NCT00524667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098028|NCT00524667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098029|NCT00524667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098030|NCT00524667|Anticonvulsants|anticonvulsants|mesh-ancestor
65098031|NCT00524667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098032|NCT00524667|GABA Agents|gaba agents|mesh-ancestor
65098033|NCT00524667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65098034|NCT00524667|Antimanic Agents|antimanic agents|mesh-ancestor
65098035|NCT00524667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65098038|NCT00524706|Leucovorin|leucovorin|mesh-list
65098071|NCT00525993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65098072|NCT00525993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65098073|NCT00525993|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65098074|NCT00525993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65098075|NCT00525993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098076|NCT00525993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098077|NCT05147753|Moxonidine|moxonidine|mesh-list
65098078|NCT05147753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65098079|NCT02947854|Photosensitizing Agents|photosensitizing agents|mesh-list
65098080|NCT02947854|Poly ICLC|poly iclc|mesh-list
65098081|NCT02947854|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
65098082|NCT02947854|Interferon Inducers|interferon inducers|mesh-ancestor
65098083|NCT02947854|Immunologic Factors|immunologic factors|mesh-ancestor
65098084|NCT02947854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098085|NCT02947854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65098086|NCT02947854|Dermatologic Agents|dermatologic agents|mesh-ancestor
65098087|NCT02947815|Botulinum Toxins|botulinum toxins|mesh-list
65098088|NCT02947815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64670966|NCT01999517|Nitroglycerin|nitroglycerin|mesh-list
64670967|NCT01999517|Vasodilator Agents|vasodilator agents|mesh-ancestor
64670968|NCT04153760|Aspirin|aspirin|mesh-list
64670969|NCT04153760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64670970|NCT04153760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65098128|NCT05144243|Azacitidine|azacitidine|mesh-list
65098129|NCT05144243|Venetoclax|venetoclax|mesh-list
65098130|NCT05144243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65098131|NCT05144243|Antimetabolites|antimetabolites|mesh-ancestor
65098132|NCT05144243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098133|NCT05144243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098134|NCT05144243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098139|NCT02954588|Vitamins|vitamins|mesh-ancestor
65098186|NCT05146232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098187|NCT00525096|Celecoxib|celecoxib|mesh-list
65098188|NCT00525096|Exemestane|exemestane|mesh-list
65098189|NCT00525096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65098190|NCT00525096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65098191|NCT00525096|Analgesics|analgesics|mesh-ancestor
65098192|NCT00525096|Sensory System Agents|sensory system agents|mesh-ancestor
65098193|NCT00525096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65098194|NCT00525096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098195|NCT00525096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65098196|NCT00525096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65098197|NCT00525096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65098198|NCT00525096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65098199|NCT00525096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098200|NCT00525096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098201|NCT00525096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098202|NCT00525096|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65098203|NCT00525096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65098204|NCT00525096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65098205|NCT00525096|Hormone Antagonists|hormone antagonists|mesh-ancestor
65098206|NCT00525096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65098207|NCT04693026|Remdesivir|remdesivir|mesh-list
65098208|NCT04693026|Antimetabolites|antimetabolites|mesh-ancestor
65098209|NCT04693026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098210|NCT04693026|Antiviral Agents|antiviral agents|mesh-ancestor
65098211|NCT04693026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65098212|NCT02276859|Insulin|insulin|mesh-list
65098213|NCT02276859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65098214|NCT02276859|Insulin Aspart|insulin aspart|mesh-list
65098215|NCT02276859|Insulin Lispro|insulin lispro|mesh-list
65098216|NCT02276859|Insulin glulisine|insulin glulisine|mesh-list
65098217|NCT02276859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65098218|NCT02276859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098219|NCT05143970|Trastuzumab|trastuzumab|mesh-list
65098226|NCT05147090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098227|NCT00525252|Baclofen|baclofen|mesh-list
65098228|NCT00525252|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65098229|NCT00525252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098230|NCT00525252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65098231|NCT00525252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65098232|NCT00525252|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65098233|NCT00525252|GABA Agonists|gaba agonists|mesh-ancestor
65098234|NCT00525252|GABA Agents|gaba agents|mesh-ancestor
65098235|NCT00525252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65098236|NCT00525252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098237|NCT02947113|Etoposide|etoposide|mesh-list
65098238|NCT02947113|Pemetrexed|pemetrexed|mesh-list
65098239|NCT02947113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098240|NCT02947113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65098241|NCT02947113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64469238|NCT05818735|Citalopram|citalopram|mesh-list
65098242|NCT02947113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65098243|NCT02947113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098244|NCT02947113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098281|NCT00526305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65098282|NCT00526305|Glucocorticoids|glucocorticoids|mesh-ancestor
65098283|NCT00526305|Hormones|hormones|mesh-ancestor
65098284|NCT00526305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64671105|NCT02005601|Analgesics|analgesics|mesh-ancestor
64671106|NCT02005601|Sensory System Agents|sensory system agents|mesh-ancestor
64671107|NCT02005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64671108|NCT02005601|Antidepressive Agents|antidepressive agents|mesh-ancestor
65098285|NCT00526305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65098286|NCT00526305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65098287|NCT00526305|Tubulin Modulators|tubulin modulators|mesh-ancestor
65098288|NCT00526305|Antimitotic Agents|antimitotic agents|mesh-ancestor
65098289|NCT00526305|Mitosis Modulators|mitosis modulators|mesh-ancestor
65098290|NCT00526305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65098291|NCT00526305|Antimetabolites|antimetabolites|mesh-ancestor
65098292|NCT00526305|Antiviral Agents|antiviral agents|mesh-ancestor
65098293|NCT00526305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65098294|NCT00526305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65098295|NCT00526305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65098332|NCT00525447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65098333|NCT00525447|Growth Substances|growth substances|mesh-ancestor
65098334|NCT00525447|Growth Inhibitors|growth inhibitors|mesh-ancestor
65098335|NCT00525447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65098336|NCT00525486|Nifedipine|nifedipine|mesh-list
65098337|NCT00525486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65098338|NCT00525486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64671153|NCT03468075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671154|NCT03468075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671155|NCT03468075|Antiviral Agents|antiviral agents|mesh-ancestor
64671156|NCT03468075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64671157|NCT03468075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671158|NCT03468075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64671159|NCT03468075|Immunologic Factors|immunologic factors|mesh-ancestor
65098383|NCT00525642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65098384|NCT00525642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65098385|NCT00525642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65098386|NCT00525642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098387|NCT00525681|Cyclosporine|cyclosporine|mesh-list
65098388|NCT00525681|Tacrolimus|tacrolimus|mesh-list
65098389|NCT00525681|Cyclosporins|cyclosporins|mesh-list
65098390|NCT00525681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65098391|NCT00525681|Immunologic Factors|immunologic factors|mesh-ancestor
65098392|NCT00525681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098393|NCT00525681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65098394|NCT00525681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098395|NCT00525681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098396|NCT00525681|Antifungal Agents|antifungal agents|mesh-ancestor
65098397|NCT00525681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65098398|NCT00525681|Dermatologic Agents|dermatologic agents|mesh-ancestor
65098399|NCT00525681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65098400|NCT03456635|Anti-Infective Agents|anti-infective agents|mesh-list
65098401|NCT03456635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65098402|NCT02945982|Entecavir|entecavir|mesh-list
65098403|NCT02945982|Carvedilol|carvedilol|mesh-list
65098404|NCT02945982|Antiviral Agents|antiviral agents|mesh-ancestor
65098405|NCT02945982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65098406|NCT02945982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65098407|NCT02945982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65098408|NCT02945982|Adrenergic Agents|adrenergic agents|mesh-ancestor
65098433|NCT02954276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098434|NCT02954276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098435|NCT00507494|Pioglitazone|pioglitazone|mesh-list
65098436|NCT00507494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65098437|NCT00507494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098438|NCT00526617|Temozolomide|temozolomide|mesh-list
65098439|NCT00526617|Veliparib|veliparib|mesh-list
65098440|NCT00526617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65098441|NCT00526617|Alkylating Agents|alkylating agents|mesh-ancestor
65098442|NCT00526617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098443|NCT00526617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098444|NCT00526617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65098445|NCT00526617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098446|NCT00507845|Felodipine|felodipine|mesh-list
65098447|NCT00507845|Ramipril|ramipril|mesh-list
65098448|NCT00507845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65098449|NCT00507845|Protease Inhibitors|protease inhibitors|mesh-ancestor
65098450|NCT00507845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098451|NCT00507845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098452|NCT00507845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65098453|NCT00507845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65098454|NCT00507845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65098455|NCT00507845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65098456|NCT00507845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65098457|NCT00507845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098458|NCT00507845|Vasodilator Agents|vasodilator agents|mesh-ancestor
64671291|NCT03496545|Sensory System Agents|sensory system agents|mesh-ancestor
64671292|NCT03496545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64671294|NCT03496545|Antipyretics|antipyretics|mesh-ancestor
65098469|NCT00525759|Alkylating Agents|alkylating agents|mesh-ancestor
65098470|NCT00525759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098536|NCT02946801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64740764|NCT00003395|Arsenic Trioxide|arsenic trioxide|mesh-list
65098537|NCT02946801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65098538|NCT02946801|Cariostatic Agents|cariostatic agents|mesh-ancestor
65098539|NCT02946801|Protective Agents|protective agents|mesh-ancestor
65098540|NCT02946801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098541|NCT02953847|Rifampin|rifampin|mesh-list
65098542|NCT02953847|Isoniazid|isoniazid|mesh-list
65098543|NCT02953847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65098544|NCT02953847|Antitubercular Agents|antitubercular agents|mesh-ancestor
65098545|NCT02953847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65098546|NCT02953847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65098547|NCT02953847|Leprostatic Agents|leprostatic agents|mesh-ancestor
65098548|NCT02953847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65098549|NCT02953847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098550|NCT02953847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098551|NCT02953847|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65098552|NCT02953847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65098553|NCT02953847|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65098554|NCT02953847|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65098555|NCT02953847|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65098556|NCT02953847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65098557|NCT02953847|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65098558|NCT02953847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65098559|NCT02953847|Antimetabolites|antimetabolites|mesh-ancestor
65098560|NCT02953847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65098561|NCT00526695|Sevoflurane|sevoflurane|mesh-list
65098562|NCT00526695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65098563|NCT00526695|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65098564|NCT00526695|Anesthetics, General|anesthetics, general|mesh-ancestor
65098565|NCT00526695|Anesthetics|anesthetics|mesh-ancestor
65098566|NCT00526695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65098576|NCT00526734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64671395|NCT01717742|Plasminogen|plasminogen|mesh-list
65098577|NCT00526734|Alkylating Agents|alkylating agents|mesh-ancestor
65098578|NCT00526734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098579|NCT00526734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098580|NCT00526734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65098581|NCT00526734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65098582|NCT00508859|Sertraline|sertraline|mesh-list
65098583|NCT00508859|Antidepressive Agents|antidepressive agents|mesh-ancestor
65098584|NCT00508859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65098585|NCT00508859|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65098586|NCT00508859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65098587|NCT00508859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65098588|NCT00508859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098589|NCT00508859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65098590|NCT00508859|Serotonin Agents|serotonin agents|mesh-ancestor
65098591|NCT00508859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098629|NCT00510536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098630|NCT00510536|Antipyretics|antipyretics|mesh-ancestor
65098631|NCT03458715|Empagliflozin|empagliflozin|mesh-list
65098632|NCT03458715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65098633|NCT03458715|Linagliptin|linagliptin|mesh-list
65098634|NCT03458715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65098635|NCT03458715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098636|NCT03458715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65098637|NCT03458715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098638|NCT03458715|Incretins|incretins|mesh-ancestor
65098639|NCT03458715|Hormones|hormones|mesh-ancestor
65098640|NCT03458715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65098641|NCT03458715|Protease Inhibitors|protease inhibitors|mesh-ancestor
65098642|NCT03458715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098643|NCT00510614|Tinidazole|tinidazole|mesh-list
65098644|NCT00510614|Alkylating Agents|alkylating agents|mesh-ancestor
65098645|NCT00510614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098685|NCT00509015|Schistosomicides|schistosomicides|mesh-ancestor
65098686|NCT00509015|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65098687|NCT00509015|Anthelmintics|anthelmintics|mesh-ancestor
65098688|NCT00509015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65098689|NCT00509015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098690|NCT00509015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098691|NCT00509015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65098692|NCT00509015|Renal Agents|renal agents|mesh-ancestor
65098693|NCT00528060|Ritonavir|ritonavir|mesh-list
65098694|NCT00528060|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65098695|NCT00528060|Tenofovir|tenofovir|mesh-list
65098696|NCT00528060|Emtricitabine|emtricitabine|mesh-list
65098697|NCT00528060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65098698|NCT00528060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65098699|NCT00528060|Protease Inhibitors|protease inhibitors|mesh-ancestor
65098700|NCT00528060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098701|NCT00528060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098702|NCT00528060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65098703|NCT00528060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65098704|NCT00528060|Antiviral Agents|antiviral agents|mesh-ancestor
65098705|NCT00528060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65098706|NCT00528060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65098707|NCT00528060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65098708|NCT00528060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65098709|NCT00528060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65098710|NCT00527085|Cinacalcet|cinacalcet|mesh-list
65098711|NCT00527085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65098712|NCT00527085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671551|NCT02032433|Analgesics|analgesics|mesh-ancestor
64671552|NCT02032433|Sensory System Agents|sensory system agents|mesh-ancestor
64671553|NCT02032433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64671554|NCT02032433|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65098731|NCT00509561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098733|NCT00509639|Metronidazole|metronidazole|mesh-list
64671613|NCT02033993|Mitosis Modulators|mitosis modulators|mesh-ancestor
65098798|NCT03459404|Narcotics|narcotics|mesh-ancestor
65098799|NCT03459404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65098800|NCT03459404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098801|NCT03459404|Analgesics|analgesics|mesh-ancestor
65098802|NCT03459404|Sensory System Agents|sensory system agents|mesh-ancestor
65098803|NCT03459404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65098804|NCT03459404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65098863|NCT00511121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64671669|NCT02044367|Dabigatran|dabigatran|mesh-list
65098864|NCT04692051|Gemcitabine|gemcitabine|mesh-list
65098865|NCT04692051|Paclitaxel|paclitaxel|mesh-list
65098866|NCT04692051|Cisplatin|cisplatin|mesh-list
65098867|NCT04692051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65098868|NCT04692051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65098869|NCT04692051|Tubulin Modulators|tubulin modulators|mesh-ancestor
65098870|NCT04692051|Antimitotic Agents|antimitotic agents|mesh-ancestor
65098871|NCT04692051|Mitosis Modulators|mitosis modulators|mesh-ancestor
65098872|NCT04692051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098873|NCT04692051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65098874|NCT04692051|Antimetabolites|antimetabolites|mesh-ancestor
65098875|NCT04692051|Antiviral Agents|antiviral agents|mesh-ancestor
65098876|NCT04692051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65098877|NCT04692051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098878|NCT04692051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65098879|NCT04692051|Immunologic Factors|immunologic factors|mesh-ancestor
65098881|NCT00528723|Albuterol|albuterol|mesh-list
64671724|NCT01727414|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64671725|NCT01727414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671726|NCT01727414|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64671727|NCT01727414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64671728|NCT01727414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64671729|NCT01727414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098921|NCT02953184|Doxorubicin|doxorubicin|mesh-list
65098978|NCT00529269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098979|NCT00515268|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
65098980|NCT00515268|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65098981|NCT00515268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65098982|NCT00515268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65098983|NCT00515268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65098985|NCT01356966|Hematinics|hematinics|mesh-ancestor
65098986|NCT01356966|Vitamin B Complex|vitamin b complex|mesh-ancestor
65098988|NCT01356966|Micronutrients|micronutrients|mesh-ancestor
65098989|NCT01356966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65098990|NCT02944734|Amlodipine|amlodipine|mesh-list
65098991|NCT02944734|Candesartan|candesartan|mesh-list
65099002|NCT00510263|Valacyclovir|valacyclovir|mesh-list
65099038|NCT00529425|Anesthetics, Local|anesthetics, local|mesh-ancestor
65099039|NCT00529425|Anesthetics|anesthetics|mesh-ancestor
65099040|NCT00529425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65099041|NCT00529425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099042|NCT00529425|Sensory System Agents|sensory system agents|mesh-ancestor
65099043|NCT00529425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65099044|NCT02950935|Progesterone|progesterone|mesh-list
65099045|NCT02950935|Progestins|progestins|mesh-ancestor
65099046|NCT02950935|Hormones|hormones|mesh-ancestor
65099047|NCT02950935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65099048|NCT02950935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099049|NCT00529620|Pyrimethamine|pyrimethamine|mesh-list
65099050|NCT00529620|Piperaquine|piperaquine|mesh-list
65099051|NCT00529620|Sulfadoxine|sulfadoxine|mesh-list
65099052|NCT00529620|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65099053|NCT00529620|Amodiaquine|amodiaquine|mesh-list
65099054|NCT00529620|Artenimol|artenimol|mesh-list
65099055|NCT00529620|Sulfalene|sulfalene|mesh-list
65099056|NCT00529620|Antimalarials|antimalarials|mesh-ancestor
65099057|NCT00529620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65099058|NCT00529620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65099059|NCT00529620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65099060|NCT00529620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65099061|NCT00529620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099062|NCT00529620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099063|NCT00529620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65099064|NCT00529620|Renal Agents|renal agents|mesh-ancestor
65099065|NCT00512993|Zoledronic Acid|zoledronic acid|mesh-list
65099066|NCT00512993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65099067|NCT00512993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099068|NCT00513032|Methylene Blue|methylene blue|mesh-list
65099069|NCT00513032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099070|NCT00513032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099080|NCT00513110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65099081|NCT02951897|Pemetrexed|pemetrexed|mesh-list
65099082|NCT02951897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099084|NCT02951897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099085|NCT02951897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64671874|NCT02052557|Anesthetics|anesthetics|mesh-ancestor
64671875|NCT02052557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64671876|NCT02052557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671877|NCT02052557|Sensory System Agents|sensory system agents|mesh-ancestor
64671878|NCT02052557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65099086|NCT02951897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65099087|NCT00511823|Rosiglitazone|rosiglitazone|mesh-list
65099088|NCT00511823|Granisetron|granisetron|mesh-list
65099089|NCT00511823|Casopitant|casopitant|mesh-list
65099090|NCT00511823|Dolasetron|dolasetron|mesh-list
65099139|NCT00513188|Vincristine|vincristine|mesh-list
64741373|NCT00003587|Gemcitabine|gemcitabine|mesh-list
65099140|NCT00513188|Denileukin diftitox|denileukin diftitox|mesh-list
65099142|NCT00513188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65099143|NCT00513188|Immunologic Factors|immunologic factors|mesh-ancestor
65099144|NCT00513188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099145|NCT00513188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65099146|NCT00513188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65099147|NCT00513188|Alkylating Agents|alkylating agents|mesh-ancestor
65099148|NCT00513188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099205|NCT00513266|Vitamin B Complex|vitamin b complex|mesh-ancestor
65099206|NCT00513266|Vitamins|vitamins|mesh-ancestor
65099207|NCT00513266|Micronutrients|micronutrients|mesh-ancestor
65099208|NCT00513383|Paclitaxel|paclitaxel|mesh-list
65099209|NCT00513383|Docetaxel|docetaxel|mesh-list
64671989|NCT03711188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099276|NCT00513929|Astringents|astringents|mesh-ancestor
65099277|NCT00513929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099278|NCT00513929|Dermatologic Agents|dermatologic agents|mesh-ancestor
65099279|NCT00513968|Adefovir|adefovir|mesh-list
65099280|NCT00513968|Antiviral Agents|antiviral agents|mesh-ancestor
65099281|NCT00513968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65099282|NCT00513968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65099283|NCT00513968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65099284|NCT00513968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099285|NCT00513968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099286|NCT02944500|Liraglutide|liraglutide|mesh-list
65099287|NCT02944500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65099288|NCT02944500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099289|NCT02944500|Incretins|incretins|mesh-ancestor
65099290|NCT02944500|Hormones|hormones|mesh-ancestor
65099291|NCT02944500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65099292|NCT03459248|Anesthetics|anesthetics|mesh-list
65099293|NCT03459248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65099294|NCT03459248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099295|NCT00512291|Olanzapine|olanzapine|mesh-list
65099296|NCT00512291|Fluoxetine|fluoxetine|mesh-list
65099329|NCT00514202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65099330|NCT00514202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099331|NCT00514202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65099332|NCT00514202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65099333|NCT00514202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65099334|NCT00514202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099335|NCT00514202|Dopamine Agents|dopamine agents|mesh-ancestor
65099336|NCT00514202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65099337|NCT00530361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65099338|NCT00530361|Natriuretic Agents|natriuretic agents|mesh-ancestor
65099339|NCT00530361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099340|NCT00512408|Testosterone|testosterone|mesh-list
65099341|NCT00512408|Androgens|androgens|mesh-ancestor
65099390|NCT02943759|Disinfectants|disinfectants|mesh-ancestor
65099391|NCT02943759|Dermatologic Agents|dermatologic agents|mesh-ancestor
65099392|NCT02944110|Glucagon|glucagon|mesh-list
65099393|NCT02944110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65099394|NCT02944110|Hormones|hormones|mesh-ancestor
65099395|NCT02944110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65099396|NCT02944110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099397|NCT02951975|Dexamethasone|dexamethasone|mesh-list
65099398|NCT02951975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65099399|NCT02951975|Antiemetics|antiemetics|mesh-ancestor
65099400|NCT02951975|Autonomic Agents|autonomic agents|mesh-ancestor
65099401|NCT02951975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65099402|NCT02951975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099403|NCT02951975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65099404|NCT02951975|Glucocorticoids|glucocorticoids|mesh-ancestor
65099405|NCT02951975|Hormones|hormones|mesh-ancestor
65099406|NCT02951975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65099407|NCT02951975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65099408|NCT02951975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099409|NCT00514397|Temozolomide|temozolomide|mesh-list
65099410|NCT00514397|Motexafin gadolinium|motexafin gadolinium|mesh-list
65099411|NCT00514397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65099421|NCT00531687|Paclitaxel|paclitaxel|mesh-list
65099442|NCT00512681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65099443|NCT00512681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65099444|NCT00512681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099445|NCT00512681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099447|NCT00530868|Letrozole|letrozole|mesh-list
64672218|NCT02383043|Amphetamine|amphetamine|mesh-list
64672219|NCT02383043|Dextroamphetamine|dextroamphetamine|mesh-list
64672220|NCT02383043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64672221|NCT02383043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672222|NCT02383043|Sympathomimetics|sympathomimetics|mesh-ancestor
65099448|NCT00530868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65099449|NCT00530868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099450|NCT00530868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65099451|NCT00530868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65099498|NCT00531063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099499|NCT02943798|Paclitaxel|paclitaxel|mesh-list
65099500|NCT02943798|Etoposide|etoposide|mesh-list
65099501|NCT02943798|Carboplatin|carboplatin|mesh-list
65099502|NCT02943798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65099503|NCT02943798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099504|NCT02943798|Tubulin Modulators|tubulin modulators|mesh-ancestor
65099505|NCT02943798|Antimitotic Agents|antimitotic agents|mesh-ancestor
65099506|NCT02943798|Mitosis Modulators|mitosis modulators|mesh-ancestor
65099507|NCT02943798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099508|NCT02943798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65099509|NCT02943798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65099510|NCT02943798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64672332|NCT02393339|Analgesics|analgesics|mesh-ancestor
64672333|NCT02393339|Sensory System Agents|sensory system agents|mesh-ancestor
64672337|NCT05235191|Methadone|methadone|mesh-list
65099559|NCT02951234|gamma-Globulins|gamma-globulins|mesh-list
65099560|NCT02951234|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65099628|NCT05319912|Omeprazole|omeprazole|mesh-list
65099629|NCT05319912|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64672405|NCT01420874|Leucovorin|leucovorin|mesh-list
64672406|NCT01420874|Fluorouracil|fluorouracil|mesh-list
64672407|NCT01420874|Oxaliplatin|oxaliplatin|mesh-list
64672408|NCT01420874|Antimetabolites|antimetabolites|mesh-ancestor
64672409|NCT01420874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672410|NCT01420874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64672411|NCT01420874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672412|NCT01420874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64672413|NCT01420874|Immunologic Factors|immunologic factors|mesh-ancestor
65099630|NCT05319912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65099631|NCT05319912|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65099632|NCT05319912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099682|NCT00515255|Minocycline|minocycline|mesh-list
65099683|NCT00515255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65099684|NCT00515255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65099685|NCT00516113|Paroxetine|paroxetine|mesh-list
65099686|NCT00516113|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65099687|NCT00516113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65099688|NCT00516113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65099689|NCT00516113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099690|NCT00516113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65099691|NCT00516113|Serotonin Agents|serotonin agents|mesh-ancestor
65099692|NCT00516113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099693|NCT00516113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65099694|NCT00516113|Antidepressive Agents|antidepressive agents|mesh-ancestor
65099695|NCT00516113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65099696|NCT00516113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65099697|NCT00516113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65099698|NCT00516113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099699|NCT04695197|Artesunate|artesunate|mesh-list
65099700|NCT04695197|Lumefantrine|lumefantrine|mesh-list
65099738|NCT00516191|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65099739|NCT00516191|Bortezomib|bortezomib|mesh-list
65099740|NCT00516191|Melphalan|melphalan|mesh-list
65099741|NCT00516191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65099742|NCT00516191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099743|NCT00516191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64741984|NCT00004223|Gemcitabine|gemcitabine|mesh-list
65099744|NCT00516191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65099745|NCT00516191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099746|NCT00516191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099803|NCT02951117|Autonomic Agents|autonomic agents|mesh-ancestor
65099804|NCT02951117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65099805|NCT02951117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099806|NCT02951117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65099808|NCT02951117|Hormones|hormones|mesh-ancestor
65099809|NCT02951117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65099810|NCT02951117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65099811|NCT02951117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099812|NCT02950220|Pembrolizumab|pembrolizumab|mesh-list
65099813|NCT02950220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65099814|NCT02950220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099815|NCT00515684|Bevacizumab|bevacizumab|mesh-list
65099816|NCT00515684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65099817|NCT00515684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099818|NCT00515684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65099820|NCT00515684|Growth Substances|growth substances|mesh-ancestor
65099864|NCT00516425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099865|NCT00516425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65099866|NCT00516425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65099867|NCT00516425|Alkylating Agents|alkylating agents|mesh-ancestor
65099868|NCT00516425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099869|NCT00516425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099870|NCT00516425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65099871|NCT00516425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65099872|NCT00516425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65099873|NCT00516425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65099874|NCT00516425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65099875|NCT02942706|Cetuximab|cetuximab|mesh-list
65099876|NCT02942706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65099877|NCT02942706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099878|NCT00516464|Ranibizumab|ranibizumab|mesh-list
65099879|NCT00516464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65099880|NCT00516464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65099881|NCT00516464|Growth Substances|growth substances|mesh-ancestor
64632621|NCT00004024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65099882|NCT00516464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099883|NCT00516464|Growth Inhibitors|growth inhibitors|mesh-ancestor
65099884|NCT00516464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099885|NCT00516542|Letrozole|letrozole|mesh-list
65099886|NCT00516542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099913|NCT02949752|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65099914|NCT02949752|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65099915|NCT02949752|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65099916|NCT02949752|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65099917|NCT02942550|Bromides|bromides|mesh-list
65099918|NCT02942550|Methylnaltrexone|methylnaltrexone|mesh-list
65099919|NCT02942550|Anticonvulsants|anticonvulsants|mesh-ancestor
65099920|NCT02942550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65099921|NCT02942550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65099922|NCT02942550|Sensory System Agents|sensory system agents|mesh-ancestor
65099923|NCT02942550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65099924|NCT04694612|Remdesivir|remdesivir|mesh-list
65099925|NCT04694612|Favipiravir|favipiravir|mesh-list
65099926|NCT04694612|Antimetabolites|antimetabolites|mesh-ancestor
65099927|NCT04694612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099928|NCT04694612|Antiviral Agents|antiviral agents|mesh-ancestor
65099929|NCT04694612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65099930|NCT02941224|Sirolimus|sirolimus|mesh-list
65099931|NCT02941224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65099932|NCT02941224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65099933|NCT02941224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65099934|NCT02941224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65099935|NCT02941224|Antifungal Agents|antifungal agents|mesh-ancestor
65099936|NCT02941224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65099937|NCT02941224|Immunologic Factors|immunologic factors|mesh-ancestor
64672728|NCT02819843|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
64672729|NCT02819843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64672730|NCT02819843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672731|NCT01878656|Sevoflurane|sevoflurane|mesh-list
64672732|NCT01878656|Desflurane|desflurane|mesh-list
64672733|NCT01878656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65099966|NCT02940990|Antimitotic Agents|antimitotic agents|mesh-ancestor
65099967|NCT02940990|Mitosis Modulators|mitosis modulators|mesh-ancestor
65099968|NCT02940990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65099969|NCT02940990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65099970|NCT02940990|Antimetabolites|antimetabolites|mesh-ancestor
65099995|NCT00518375|Sirolimus|sirolimus|mesh-list
64672778|NCT01812044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672779|NCT01812044|Sensory System Agents|sensory system agents|mesh-ancestor
64672780|NCT01812044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64672781|NCT01812044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64672782|NCT01812044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64672783|NCT01812044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65100021|NCT00516971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65100022|NCT00516971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100023|NCT00516971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100024|NCT00518570|Levetiracetam|levetiracetam|mesh-list
65100025|NCT00518570|Anticonvulsants|anticonvulsants|mesh-ancestor
65100026|NCT00518570|Nootropic Agents|nootropic agents|mesh-ancestor
65100027|NCT03458208|Metformin|metformin|mesh-list
65100028|NCT03458208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65100029|NCT03458208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100030|NCT00517283|Exenatide|exenatide|mesh-list
65100031|NCT00517283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65100032|NCT00517283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100033|NCT00517283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65100071|NCT02939430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65100072|NCT02939430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100073|NCT02939430|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65100074|NCT02939430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100075|NCT02939430|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65100076|NCT02940717|Lithium Carbonate|lithium carbonate|mesh-list
65100077|NCT02940717|Antidepressive Agents|antidepressive agents|mesh-ancestor
65100078|NCT02940717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65100079|NCT02940717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100081|NCT02940717|Antimanic Agents|antimanic agents|mesh-ancestor
65100136|NCT04694183|Immunologic Factors|immunologic factors|mesh-ancestor
65100137|NCT04694183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100138|NCT00517946|Cetirizine|cetirizine|mesh-list
65100139|NCT00517946|Pseudoephedrine|pseudoephedrine|mesh-list
65100140|NCT00517946|Ephedrine|ephedrine|mesh-list
65100141|NCT00517946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65100142|NCT00517946|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65100143|NCT00517946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65100144|NCT00517946|Histamine Antagonists|histamine antagonists|mesh-ancestor
64672884|NCT01815008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100190|NCT04690920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672930|NCT03279237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100191|NCT04690920|Antimetabolites|antimetabolites|mesh-ancestor
65100192|NCT04690920|Antiviral Agents|antiviral agents|mesh-ancestor
65100193|NCT00518102|Becaplermin|becaplermin|mesh-list
65100194|NCT00518102|Anticoagulants|anticoagulants|mesh-ancestor
65100195|NCT00518102|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
65100196|NCT00518102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65100201|NCT02939235|Ticagrelor|ticagrelor|mesh-list
65100257|NCT00519116|Tacrolimus|tacrolimus|mesh-list
65100258|NCT00519116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65100259|NCT00519116|Immunologic Factors|immunologic factors|mesh-ancestor
65100260|NCT00519116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100261|NCT00519116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65100262|NCT00519116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100263|NCT00519116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100264|NCT00519116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65100325|NCT02940405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65100326|NCT02940405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65100327|NCT02940405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65100328|NCT02940405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100329|NCT02940405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100330|NCT02940444|Heparin|heparin|mesh-list
65100347|NCT04690647|Hormones|hormones|mesh-ancestor
65100394|NCT00520091|Sensory System Agents|sensory system agents|mesh-ancestor
65100395|NCT00520091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100396|NCT00520091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100397|NCT00520091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65100398|NCT00520091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65100399|NCT00520091|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65100400|NCT00520091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65100401|NCT00520169|Ketamine|ketamine|mesh-list
65100402|NCT00520169|Analgesics|analgesics|mesh-ancestor
65100403|NCT00520169|Sensory System Agents|sensory system agents|mesh-ancestor
65100404|NCT00520169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100405|NCT00520169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100406|NCT00520169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65100407|NCT00520169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65100408|NCT00520169|Anesthetics, General|anesthetics, general|mesh-ancestor
65100409|NCT00520169|Anesthetics|anesthetics|mesh-ancestor
65100410|NCT00520169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65100411|NCT00520169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65100412|NCT00520169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65100413|NCT00520169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65100414|NCT00520169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100415|NCT00520247|Folic Acid|folic acid|mesh-list
65100416|NCT00520247|Enalapril|enalapril|mesh-list
65100417|NCT00520247|Hematinics|hematinics|mesh-ancestor
65100418|NCT00520247|Vitamin B Complex|vitamin b complex|mesh-ancestor
65100419|NCT00520247|Vitamins|vitamins|mesh-ancestor
65100420|NCT00520247|Micronutrients|micronutrients|mesh-ancestor
65100421|NCT00520247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100422|NCT00520247|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65100423|NCT00520247|Protease Inhibitors|protease inhibitors|mesh-ancestor
65100424|NCT00520247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100425|NCT00520247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742668|NCT01926444|Trimebutine|trimebutine|mesh-list
65100426|NCT00520247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65100427|NCT00520325|Lectins|lectins|mesh-list
65100428|NCT00520325|Agglutinins|agglutinins|mesh-ancestor
65100429|NCT00520325|Immunologic Factors|immunologic factors|mesh-ancestor
64673172|NCT03366207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673173|NCT03366207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673174|NCT03366207|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64673175|NCT03366207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64673176|NCT03368235|Prednisolone|prednisolone|mesh-list
64673177|NCT03368235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64673178|NCT03368235|Glucocorticoids|glucocorticoids|mesh-ancestor
64673179|NCT03368235|Hormones|hormones|mesh-ancestor
64673180|NCT03368235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64673181|NCT03368235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100430|NCT00520325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100431|NCT00520325|Coagulants|coagulants|mesh-ancestor
65100479|NCT00520949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65100480|NCT00520949|Furazolidone|furazolidone|mesh-list
65100481|NCT00520949|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
65100482|NCT00520949|Esomeprazole|esomeprazole|mesh-list
65100483|NCT00520949|Bismuth|bismuth|mesh-list
65100484|NCT00520949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65100485|NCT00520949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65100486|NCT00520949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65100487|NCT00520949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65100488|NCT00520949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65100489|NCT00520949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100490|NCT00520949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100491|NCT00520949|Antacids|antacids|mesh-ancestor
65100492|NCT00520949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65100493|NCT00520949|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65100494|NCT00520949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65100495|NCT00520949|Renal Agents|renal agents|mesh-ancestor
65100496|NCT00520949|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65100497|NCT00520949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65100534|NCT00521612|Anesthetics, General|anesthetics, general|mesh-ancestor
64673267|NCT02360280|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65100535|NCT00521612|Anesthetics|anesthetics|mesh-ancestor
65100536|NCT00521612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65100537|NCT00521612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100538|NCT00521261|Antibodies|antibodies|mesh-list
65100539|NCT00521261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65100540|NCT00521261|Immunologic Factors|immunologic factors|mesh-ancestor
65100541|NCT00521261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100542|NCT02931591|Metformin|metformin|mesh-list
65100543|NCT02931591|Hormones|hormones|mesh-list
65100544|NCT02931591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65100545|NCT02931591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100546|NCT02931591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65100594|NCT00521963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65100595|NCT00521963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65100596|NCT02937402|Dimercaprol|dimercaprol|mesh-list
64673327|NCT01823510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673328|NCT01823510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65100597|NCT02937402|Chelating Agents|chelating agents|mesh-ancestor
65100598|NCT02937402|Sequestering Agents|sequestering agents|mesh-ancestor
65100661|NCT00522587|Anesthetics, General|anesthetics, general|mesh-ancestor
65100662|NCT00522587|Anesthetics|anesthetics|mesh-ancestor
64673391|NCT05748236|Antimanic Agents|antimanic agents|mesh-ancestor
64673393|NCT05748236|Analgesics|analgesics|mesh-ancestor
65100663|NCT00522665|Irinotecan|irinotecan|mesh-list
65100664|NCT00522665|Cetuximab|cetuximab|mesh-list
65100665|NCT00522665|Everolimus|everolimus|mesh-list
65100730|NCT04694105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65100731|NCT04694105|Antiemetics|antiemetics|mesh-ancestor
65100732|NCT04694105|Autonomic Agents|autonomic agents|mesh-ancestor
65100733|NCT04694105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100734|NCT04694105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100735|NCT04694105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64673456|NCT03383523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64673457|NCT03383523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64673458|NCT03383523|Coccidiostats|coccidiostats|mesh-ancestor
64673459|NCT03383523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64673460|NCT00377091|PENTA|penta|mesh-list
64673461|NCT00377091|Fondaparinux|fondaparinux|mesh-list
65100736|NCT04694105|Glucocorticoids|glucocorticoids|mesh-ancestor
65100737|NCT04694105|Hormones|hormones|mesh-ancestor
64483762|NCT01735279|Dermatologic Agents|dermatologic agents|mesh-ancestor
65100738|NCT04694105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65100739|NCT04694105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65100740|NCT04694105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100741|NCT04694105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65100742|NCT04694105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65100743|NCT04694105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65100744|NCT04694105|Analgesics|analgesics|mesh-ancestor
65100745|NCT04694105|Sensory System Agents|sensory system agents|mesh-ancestor
65100748|NCT04694105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65100773|NCT00523289|Anesthetics, Local|anesthetics, local|mesh-ancestor
65100774|NCT00523289|Anesthetics|anesthetics|mesh-ancestor
65100775|NCT00523289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65100776|NCT00523289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100777|NCT00523289|Sensory System Agents|sensory system agents|mesh-ancestor
65100778|NCT00523289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100779|NCT00524381|Etanercept|etanercept|mesh-list
65100780|NCT00524381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65100781|NCT00524381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65100782|NCT00524381|Analgesics|analgesics|mesh-ancestor
65100783|NCT00524381|Sensory System Agents|sensory system agents|mesh-ancestor
65100784|NCT00524381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100785|NCT00524381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100786|NCT00524381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65100787|NCT00524381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65100788|NCT00524381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65100789|NCT00524381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65100790|NCT00524381|Immunologic Factors|immunologic factors|mesh-ancestor
65100829|NCT02948075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65100830|NCT02948075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65100831|NCT02948075|Tubulin Modulators|tubulin modulators|mesh-ancestor
65100832|NCT02948075|Antimitotic Agents|antimitotic agents|mesh-ancestor
65100833|NCT02948075|Mitosis Modulators|mitosis modulators|mesh-ancestor
65100834|NCT02948075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100835|NCT02930811|Sildenafil Citrate|sildenafil citrate|mesh-list
65100836|NCT02930811|Vasodilator Agents|vasodilator agents|mesh-ancestor
65100837|NCT02930811|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65100838|NCT02930811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65100839|NCT02930811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65100840|NCT02930811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100841|NCT02930811|Urological Agents|urological agents|mesh-ancestor
65100842|NCT02947880|Bumetanide|bumetanide|mesh-list
65100843|NCT02947880|Diuretics|diuretics|mesh-ancestor
65100844|NCT02947880|Natriuretic Agents|natriuretic agents|mesh-ancestor
65100845|NCT02947880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100846|NCT02947880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65100847|NCT02947880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65100848|NCT02947880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65100849|NCT04748172|Antibodies|antibodies|mesh-list
65100879|NCT02936427|Autonomic Agents|autonomic agents|mesh-ancestor
65100880|NCT02936427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65100881|NCT02936427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100882|NCT02936427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65100883|NCT02936427|Glucocorticoids|glucocorticoids|mesh-ancestor
65100884|NCT02936427|Hormones|hormones|mesh-ancestor
65100885|NCT02936427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65100886|NCT02936427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65100945|NCT00524849|Zoledronic Acid|zoledronic acid|mesh-list
65100946|NCT00524849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65100947|NCT00524849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65100948|NCT00524927|Methoxyflurane|methoxyflurane|mesh-list
65100949|NCT00524927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65100950|NCT00524927|Anesthetics, General|anesthetics, general|mesh-ancestor
65100951|NCT00524927|Anesthetics|anesthetics|mesh-ancestor
65100952|NCT00524927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65100953|NCT00524927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101012|NCT02930109|Antiviral Agents|antiviral agents|mesh-ancestor
65101013|NCT02930109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65101014|NCT02930109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65101015|NCT02930109|Immunologic Factors|immunologic factors|mesh-ancestor
65101016|NCT02930109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673689|NCT00376701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101079|NCT02930265|Incretins|incretins|mesh-ancestor
64673747|NCT00558896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65101080|NCT02930265|Hormones|hormones|mesh-ancestor
65101081|NCT02930265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65101082|NCT02947178|Bupivacaine|bupivacaine|mesh-list
65101083|NCT02947178|Anesthetics, Local|anesthetics, local|mesh-ancestor
65101084|NCT02947178|Anesthetics|anesthetics|mesh-ancestor
65101085|NCT02947178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65101086|NCT02947178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101087|NCT02947178|Sensory System Agents|sensory system agents|mesh-ancestor
65101088|NCT02947178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65101089|NCT02929797|Gemcitabine|gemcitabine|mesh-list
65101090|NCT02929797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65101091|NCT02929797|Antimetabolites|antimetabolites|mesh-ancestor
65101092|NCT02929797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101093|NCT02929797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101094|NCT02929797|Antiviral Agents|antiviral agents|mesh-ancestor
65101135|NCT00525278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65101136|NCT00525278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101137|NCT00525278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101138|NCT02929719|Dapsone|dapsone|mesh-list
65101139|NCT02929719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65101140|NCT02929719|Antimalarials|antimalarials|mesh-ancestor
65101141|NCT02929719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65101142|NCT02929719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65101143|NCT02929719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65101144|NCT02929719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101145|NCT02929719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101196|NCT00526175|Abortifacient Agents|abortifacient agents|mesh-ancestor
65101197|NCT00526175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65101198|NCT00526175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65101199|NCT00526175|Antimetabolites|antimetabolites|mesh-ancestor
65101200|NCT00526175|Dermatologic Agents|dermatologic agents|mesh-ancestor
65101201|NCT00526175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101202|NCT00526175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65101203|NCT00526175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65101204|NCT00526175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65101205|NCT00526175|Tubulin Modulators|tubulin modulators|mesh-ancestor
65101206|NCT00526175|Antimitotic Agents|antimitotic agents|mesh-ancestor
65101207|NCT00526175|Mitosis Modulators|mitosis modulators|mesh-ancestor
65101208|NCT00526175|Antiviral Agents|antiviral agents|mesh-ancestor
65101209|NCT00526175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65101210|NCT00526175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65101211|NCT00526175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65101256|NCT02946437|Midazolam|midazolam|mesh-list
65101257|NCT02946437|Propofol|propofol|mesh-list
65101258|NCT02946437|Sevoflurane|sevoflurane|mesh-list
65101259|NCT02946437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65101260|NCT02946437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65101261|NCT02946437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101262|NCT02946437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65101263|NCT02946437|Anesthetics, General|anesthetics, general|mesh-ancestor
65101264|NCT02946437|Anesthetics|anesthetics|mesh-ancestor
65101265|NCT02946437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65101266|NCT02946437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65101267|NCT02946437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65101268|NCT02946437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65101269|NCT02946437|GABA Modulators|gaba modulators|mesh-ancestor
65101270|NCT02946437|GABA Agents|gaba agents|mesh-ancestor
65101275|NCT02946632|Metformin|metformin|mesh-list
65101320|NCT02929095|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65101321|NCT02929095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65101322|NCT02929095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65101323|NCT02929095|Adrenergic Agents|adrenergic agents|mesh-ancestor
65101324|NCT02929095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65101325|NCT02929095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101326|NCT02929095|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65101332|NCT02929095|Anesthetics|anesthetics|mesh-ancestor
65101387|NCT02947061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634161|NCT04643405|Paclitaxel|paclitaxel|mesh-list
65101388|NCT02947061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65101389|NCT02947061|Antimetabolites|antimetabolites|mesh-ancestor
65101390|NCT02928315|Magnesium Sulfate|magnesium sulfate|mesh-list
65101391|NCT02928315|Analgesics|analgesics|mesh-ancestor
65101392|NCT02928315|Sensory System Agents|sensory system agents|mesh-ancestor
65101454|NCT02946671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65101455|NCT02946671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101457|NCT02927886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64674117|NCT04076787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674118|NCT00554840|Varenicline|varenicline|mesh-list
64674119|NCT00554840|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65101515|NCT00526760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65101516|NCT00526760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65101517|NCT00526760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65101518|NCT00526760|Adrenergic Agents|adrenergic agents|mesh-ancestor
65101519|NCT00526760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65101520|NCT00526760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101521|NCT02927379|Dexmedetomidine|dexmedetomidine|mesh-list
64674172|NCT04066647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674173|NCT04041453|Ivermectin|ivermectin|mesh-list
65101575|NCT02945072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65101576|NCT02945072|Anesthetics, General|anesthetics, general|mesh-ancestor
65101577|NCT02945072|Anesthetics|anesthetics|mesh-ancestor
65101578|NCT02945072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65101579|NCT02945072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101580|NCT02924922|Mannitol|mannitol|mesh-list
65101581|NCT02924922|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65101582|NCT02924922|Diuretics|diuretics|mesh-ancestor
65101583|NCT02924922|Natriuretic Agents|natriuretic agents|mesh-ancestor
65101584|NCT02924922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101640|NCT02924766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101641|NCT02924766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101642|NCT02924766|Hormone Antagonists|hormone antagonists|mesh-ancestor
65101643|NCT02924766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65101707|NCT00527150|Cholinergic Agents|cholinergic agents|mesh-ancestor
65101708|NCT00527150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65101709|NCT00527150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101710|NCT00527150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101711|NCT00527228|Deflazacort|deflazacort|mesh-list
65101712|NCT00527228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65101713|NCT00527228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65101714|NCT00527228|Immunologic Factors|immunologic factors|mesh-ancestor
65101715|NCT00527228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101716|NCT00527267|Cinacalcet|cinacalcet|mesh-list
65101717|NCT00527267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65101718|NCT00527267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101719|NCT00527267|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65101767|NCT02926248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101768|NCT02926248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101769|NCT00528593|Epoetin Alfa|epoetin alfa|mesh-list
65101770|NCT00528593|Hematinics|hematinics|mesh-ancestor
65101771|NCT02926326|Azithromycin|azithromycin|mesh-list
65101772|NCT02926326|Acumapimod|acumapimod|mesh-list
65101773|NCT02926326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65101774|NCT02926326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65101775|NCT02926326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65101778|NCT00528671|Phenprocoumon|phenprocoumon|mesh-list
65101834|NCT00527501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101835|NCT00527540|Interferons|interferons|mesh-list
65101836|NCT00527540|Ribavirin|ribavirin|mesh-list
64674495|NCT02351934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64674496|NCT02351934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674498|NCT02351934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65101837|NCT00527540|Interferon-alpha|interferon-alpha|mesh-list
65101900|NCT00529022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65101901|NCT00529022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65101902|NCT00529022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65101903|NCT02923557|Pirarubicin|pirarubicin|mesh-list
64674558|NCT00377559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64674559|NCT00377559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64674560|NCT00377559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674561|NCT02301390|Amiodarone|amiodarone|mesh-list
64674562|NCT02301390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64674563|NCT02301390|Vasodilator Agents|vasodilator agents|mesh-ancestor
64674564|NCT02301390|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65101904|NCT02923557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101905|NCT02925975|Carvedilol|carvedilol|mesh-list
65101906|NCT02925975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65101907|NCT02925975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65101908|NCT02925975|Adrenergic Agents|adrenergic agents|mesh-ancestor
65101909|NCT02925975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65101913|NCT02925975|Antioxidants|antioxidants|mesh-ancestor
65101949|NCT02922933|Omeprazole|omeprazole|mesh-list
65101950|NCT02922933|Famotidine|famotidine|mesh-list
65101951|NCT02922933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64674600|NCT00551642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64674601|NCT00551642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674602|NCT00551642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65101952|NCT02922933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65101953|NCT02922933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65101954|NCT02922933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65101955|NCT02922933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101956|NCT02922933|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65101957|NCT02922933|Histamine Antagonists|histamine antagonists|mesh-ancestor
65101959|NCT02922933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65101960|NCT02922933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65101961|NCT02922933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101962|NCT02922933|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65101963|NCT02945267|Tegafur|tegafur|mesh-list
65101964|NCT02945267|Nimotuzumab|nimotuzumab|mesh-list
65101965|NCT02945267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65101966|NCT02945267|Antimetabolites|antimetabolites|mesh-ancestor
65101967|NCT02945267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65101968|NCT02945267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101969|NCT02945267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65101970|NCT00529646|APD791|apd791|mesh-list
65101971|NCT00529646|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64674643|NCT04004481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64674644|NCT03997851|Acetaminophen|acetaminophen|mesh-list
65101996|NCT00531089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65101997|NCT00531089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65101998|NCT00531089|Immunologic Factors|immunologic factors|mesh-ancestor
65101999|NCT00531089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102000|NCT00531089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65102001|NCT02922699|Omeprazole|omeprazole|mesh-list
65102002|NCT02922699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65102003|NCT02922699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65102004|NCT02922699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65102005|NCT02922699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102006|NCT02922699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102007|NCT02922660|Remifentanil|remifentanil|mesh-list
65102008|NCT02922660|Anesthetics|anesthetics|mesh-list
65102009|NCT02922660|Propofol|propofol|mesh-list
65102010|NCT02922660|Desflurane|desflurane|mesh-list
65102011|NCT02922660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65102012|NCT02922660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102050|NCT02922426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65102051|NCT02922426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102052|NCT02922426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65102053|NCT02922426|Serotonin Agents|serotonin agents|mesh-ancestor
65102054|NCT00531128|Gamma-sitosterol|gamma-sitosterol|mesh-list
65102055|NCT00531128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65102056|NCT00531128|Antimetabolites|antimetabolites|mesh-ancestor
65102057|NCT00531128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102058|NCT00531128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65102059|NCT02925351|Clofarabine|clofarabine|mesh-list
65102064|NCT00531167|Lamivudine|lamivudine|mesh-list
64674762|NCT01483209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64674763|NCT01483209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64674764|NCT01483209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674765|NCT01483209|Cholinergic Agents|cholinergic agents|mesh-ancestor
64674766|NCT01483209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64674767|NCT01483209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674768|NCT01483209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64674769|NCT01483209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65102116|NCT02922387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102117|NCT00531323|Etravirine|etravirine|mesh-list
65102172|NCT00530387|Sensory System Agents|sensory system agents|mesh-ancestor
65102173|NCT00530387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65102174|NCT00530387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102175|NCT00530387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65102176|NCT00530387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65102177|NCT00530387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65102178|NCT00530387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102179|NCT00530387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102180|NCT00530387|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65102181|NCT00530387|Protective Agents|protective agents|mesh-ancestor
65102182|NCT00530387|Dermatologic Agents|dermatologic agents|mesh-ancestor
65102183|NCT00530387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65102184|NCT04689165|Vaccines|vaccines|mesh-list
65102185|NCT04689165|Immunologic Factors|immunologic factors|mesh-ancestor
65102186|NCT04689165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102187|NCT00530582|Progesterone|progesterone|mesh-list
65102188|NCT00530582|Progestins|progestins|mesh-ancestor
65102189|NCT00530582|Hormones|hormones|mesh-ancestor
65102190|NCT00530582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65102191|NCT00530582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102192|NCT02944175|Neostigmine|neostigmine|mesh-list
65102193|NCT02944175|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65102194|NCT02944175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102195|NCT02944175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102196|NCT02944175|Cholinergic Agents|cholinergic agents|mesh-ancestor
65102197|NCT02944175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65102198|NCT02944175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102199|NCT02944175|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65102200|NCT02944175|Autonomic Agents|autonomic agents|mesh-ancestor
65102202|NCT02917746|Imiquimod|imiquimod|mesh-list
64674849|NCT02300610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64674850|NCT02300610|Antimetabolites|antimetabolites|mesh-ancestor
64674851|NCT02300610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674852|NCT02300610|Antiviral Agents|antiviral agents|mesh-ancestor
64674853|NCT02300610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64674854|NCT02300610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674855|NCT02300610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64674858|NCT01880840|Azelastine|azelastine|mesh-list
65102216|NCT00531557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65102217|NCT00531557|Antiviral Agents|antiviral agents|mesh-ancestor
65102274|NCT02917512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102275|NCT02917512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65102276|NCT02917512|Immunologic Factors|immunologic factors|mesh-ancestor
65102277|NCT02917512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102278|NCT02917512|Antifungal Agents|antifungal agents|mesh-ancestor
64674896|NCT01882868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64674897|NCT01882868|Growth Substances|growth substances|mesh-ancestor
64674898|NCT01882868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674899|NCT01882868|Growth Inhibitors|growth inhibitors|mesh-ancestor
64674900|NCT01882868|Antidotes|antidotes|mesh-ancestor
64674901|NCT01882868|Protective Agents|protective agents|mesh-ancestor
64674902|NCT01882868|Vitamin B Complex|vitamin b complex|mesh-ancestor
65102279|NCT02917512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65102280|NCT02917512|Dermatologic Agents|dermatologic agents|mesh-ancestor
65102281|NCT02917512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65102282|NCT02917512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65102283|NCT02943902|Vaccines|vaccines|mesh-list
65102284|NCT02943902|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65102285|NCT02943902|Immunologic Factors|immunologic factors|mesh-ancestor
65102287|NCT00531908|Furosemide|furosemide|mesh-list
65102321|NCT00531986|Protease Inhibitors|protease inhibitors|mesh-ancestor
65102322|NCT00531986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102323|NCT00531986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674938|NCT01379469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64674939|NCT01379469|Analgesics|analgesics|mesh-ancestor
64674940|NCT01379469|Sensory System Agents|sensory system agents|mesh-ancestor
65102324|NCT00531986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65102325|NCT00531986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65102326|NCT00531986|Antiviral Agents|antiviral agents|mesh-ancestor
65102327|NCT00531986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65102328|NCT00531986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65102329|NCT00531986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65102330|NCT05319899|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
65102332|NCT05319899|Omeprazole|omeprazole|mesh-list
65102333|NCT05319899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65102334|NCT05319899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65102335|NCT05319899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65102336|NCT05319899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102337|NCT05319899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102338|NCT05319899|Lipotropic Agents|lipotropic agents|mesh-ancestor
65102339|NCT05319899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65102340|NCT05319899|Antimetabolites|antimetabolites|mesh-ancestor
65102341|NCT05319899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65102342|NCT05319899|Nootropic Agents|nootropic agents|mesh-ancestor
65102343|NCT05319899|Chelating Agents|chelating agents|mesh-ancestor
65102344|NCT05319899|Sequestering Agents|sequestering agents|mesh-ancestor
65102345|NCT05319899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65102369|NCT02920905|Atracurium|atracurium|mesh-list
65102370|NCT02920905|Anesthetics, Local|anesthetics, local|mesh-ancestor
65102371|NCT02920905|Anesthetics|anesthetics|mesh-ancestor
65102372|NCT02920905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65102373|NCT02920905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102374|NCT02920905|Sensory System Agents|sensory system agents|mesh-ancestor
65102375|NCT02920905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65102376|NCT02920905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65102377|NCT02920905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65102378|NCT02920905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65102379|NCT02920905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64744616|NCT01814046|Antiviral Agents|antiviral agents|mesh-ancestor
65102380|NCT02920905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102381|NCT02920905|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65102382|NCT02920905|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65102383|NCT02920905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65102384|NCT02920905|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65102385|NCT02920905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65102386|NCT02920905|Cholinergic Agents|cholinergic agents|mesh-ancestor
65102387|NCT02920905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65102388|NCT02917200|Moxifloxacin|moxifloxacin|mesh-list
65102393|NCT02917200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675030|NCT02349048|Simeprevir|simeprevir|mesh-list
64675031|NCT02349048|Antiviral Agents|antiviral agents|mesh-ancestor
64675032|NCT02349048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64675033|NCT02349048|Protease Inhibitors|protease inhibitors|mesh-ancestor
64675034|NCT02349048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675035|NCT02349048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102419|NCT02942810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65102420|NCT02920710|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65102421|NCT02920710|Hormones|hormones|mesh-ancestor
65102422|NCT02920710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65102423|NCT02920710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102424|NCT02941913|Palonosetron|palonosetron|mesh-list
65102425|NCT02941913|Antiemetics|antiemetics|mesh-ancestor
65102426|NCT02941913|Autonomic Agents|autonomic agents|mesh-ancestor
65102427|NCT02941913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65102428|NCT02941913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102429|NCT02941913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65102435|NCT02942693|Apatinib|apatinib|mesh-list
65102469|NCT02920359|Fertility Agents|fertility agents|mesh-ancestor
65102470|NCT02920359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65102471|NCT02920359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102472|NCT02920359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65102473|NCT02920359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102474|NCT02916654|Iron|iron|mesh-list
64675077|NCT02299206|Sunscreening Agents|sunscreening agents|mesh-ancestor
64675078|NCT02299206|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64675079|NCT02299206|Protective Agents|protective agents|mesh-ancestor
64675080|NCT02299206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675081|NCT02640573|Hydroxyurea|hydroxyurea|mesh-list
64675082|NCT02640573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102475|NCT02916654|Trace Elements|trace elements|mesh-ancestor
65102476|NCT02916654|Micronutrients|micronutrients|mesh-ancestor
65102477|NCT02916654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102479|NCT02941562|Fluorouracil|fluorouracil|mesh-list
65102480|NCT02941562|Oxaliplatin|oxaliplatin|mesh-list
65102523|NCT03458468|Hemostatics|hemostatics|mesh-ancestor
65102524|NCT03458468|Coagulants|coagulants|mesh-ancestor
65102525|NCT02942303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65102526|NCT02942303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65102527|NCT02942303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65102528|NCT02942303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102529|NCT02942303|Cholinergic Agents|cholinergic agents|mesh-ancestor
65102530|NCT02942303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65102531|NCT02942303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102532|NCT02916381|Anesthetics|anesthetics|mesh-list
65102533|NCT02916381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65102534|NCT02916381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102536|NCT02920047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65102537|NCT02920047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65102538|NCT02920047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65102539|NCT02920047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102540|NCT02920047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65102541|NCT02920047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102542|NCT02920047|Vasodilator Agents|vasodilator agents|mesh-ancestor
65102543|NCT02941016|Evolocumab|evolocumab|mesh-list
65102544|NCT02941016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65102545|NCT02941016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65102546|NCT02941016|Antimetabolites|antimetabolites|mesh-ancestor
65102548|NCT02941016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64675171|NCT02515851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675172|NCT02515851|Sensory System Agents|sensory system agents|mesh-ancestor
64675173|NCT02515851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675180|NCT02492295|Anesthetics|anesthetics|mesh-ancestor
65102572|NCT02919501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65102573|NCT02919501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102574|NCT02919501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65102575|NCT02919501|Serotonin Agents|serotonin agents|mesh-ancestor
65102576|NCT02919501|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65102577|NCT02919501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65102578|NCT02919501|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65102579|NCT02919501|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65102580|NCT02919579|Esketamine|esketamine|mesh-list
65102581|NCT02919579|Antidepressive Agents|antidepressive agents|mesh-ancestor
65102582|NCT02919579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65102583|NCT05317676|Palmidrol|palmidrol|mesh-list
65102584|NCT05317676|Analgesics|analgesics|mesh-ancestor
65102585|NCT05317676|Sensory System Agents|sensory system agents|mesh-ancestor
65102624|NCT03160638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65102625|NCT03160638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64675221|NCT01118013|Immunologic Factors|immunologic factors|mesh-ancestor
64675222|NCT01118013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64675223|NCT01118013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64675224|NCT01118013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64675230|NCT01118013|Alkylating Agents|alkylating agents|mesh-ancestor
65102627|NCT02919462|Pemetrexed|pemetrexed|mesh-list
65102628|NCT02919462|Vinorelbine|vinorelbine|mesh-list
65102629|NCT02919462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102630|NCT02919462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102631|NCT02919462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102632|NCT02919462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65102633|NCT02919462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65102638|NCT02941367|Metformin|metformin|mesh-list
65102684|NCT05302388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65102685|NCT05302388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65102686|NCT05302388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102687|NCT05302388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65102688|NCT05302388|Protective Agents|protective agents|mesh-ancestor
65102689|NCT05302388|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65102690|NCT05302388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65102691|NCT05302388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65102692|NCT05302388|Anesthetics, Local|anesthetics, local|mesh-ancestor
65102693|NCT05302388|Anesthetics|anesthetics|mesh-ancestor
64675269|NCT02277548|Pregabalin|pregabalin|mesh-list
65102739|NCT02915289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65102740|NCT02915289|Disinfectants|disinfectants|mesh-ancestor
65102741|NCT02915289|Dermatologic Agents|dermatologic agents|mesh-ancestor
65102742|NCT02915289|Plasma Substitutes|plasma substitutes|mesh-ancestor
65102743|NCT02915289|Blood Substitutes|blood substitutes|mesh-ancestor
65102744|NCT02939417|Grape Seed Extract|grape seed extract|mesh-list
65102745|NCT02939417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65102746|NCT02939417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102747|NCT02939417|Antioxidants|antioxidants|mesh-ancestor
65102751|NCT05034536|Pembrolizumab|pembrolizumab|mesh-list
65102805|NCT02918760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65102806|NCT02918760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65102807|NCT02918760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65102808|NCT02918760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102809|NCT02918760|Antimanic Agents|antimanic agents|mesh-ancestor
65102810|NCT04690751|Cenobamate|cenobamate|mesh-list
65102811|NCT04690751|Anticonvulsants|anticonvulsants|mesh-ancestor
64675377|NCT02379585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64675378|NCT02379585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64675379|NCT02379585|Alkylating Agents|alkylating agents|mesh-ancestor
64675380|NCT02379585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64675381|NCT02379585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64675382|NCT02379585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64675384|NCT02379585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102812|NCT03458078|Magnesium Sulfate|magnesium sulfate|mesh-list
65102813|NCT03458078|Midazolam|midazolam|mesh-list
65102814|NCT03458078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65102815|NCT03458078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65102816|NCT03458078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65102817|NCT03458078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102853|NCT02914626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65102854|NCT02914626|Growth Substances|growth substances|mesh-ancestor
65102855|NCT02914626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102856|NCT02914626|Growth Inhibitors|growth inhibitors|mesh-ancestor
65102857|NCT02914626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102858|NCT02918331|Dexamethasone|dexamethasone|mesh-list
65102859|NCT02918331|Lenalidomide|lenalidomide|mesh-list
65102860|NCT02918331|Daratumumab|daratumumab|mesh-list
65102861|NCT02918331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65102862|NCT02918331|Antiemetics|antiemetics|mesh-ancestor
65102863|NCT02918331|Autonomic Agents|autonomic agents|mesh-ancestor
65102864|NCT02918331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65102865|NCT02918331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675481|NCT02318901|Antimitotic Agents|antimitotic agents|mesh-ancestor
65102916|NCT03077685|Tubulin Modulators|tubulin modulators|mesh-ancestor
64675482|NCT02318901|Mitosis Modulators|mitosis modulators|mesh-ancestor
64675483|NCT02318901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102917|NCT03077685|Antimitotic Agents|antimitotic agents|mesh-ancestor
65102918|NCT03077685|Mitosis Modulators|mitosis modulators|mesh-ancestor
65102919|NCT03077685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102920|NCT02910141|Insulin|insulin|mesh-list
65102921|NCT02910141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65102922|NCT02910141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65102923|NCT02910141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102924|NCT04817033|Midazolam|midazolam|mesh-list
65102925|NCT04817033|Dexmedetomidine|dexmedetomidine|mesh-list
65102977|NCT01292239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65102978|NCT01292239|Antiviral Agents|antiviral agents|mesh-ancestor
65102979|NCT01292239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65102980|NCT01292239|Protease Inhibitors|protease inhibitors|mesh-ancestor
65102981|NCT01292239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65102982|NCT05600179|Dexamethasone|dexamethasone|mesh-list
65102983|NCT05600179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65102984|NCT05600179|Antiemetics|antiemetics|mesh-ancestor
65102985|NCT05600179|Autonomic Agents|autonomic agents|mesh-ancestor
65102986|NCT05600179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65102987|NCT05600179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65102988|NCT05600179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65102989|NCT05600179|Glucocorticoids|glucocorticoids|mesh-ancestor
65102990|NCT05600179|Hormones|hormones|mesh-ancestor
65102991|NCT05600179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65102992|NCT05600179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65102993|NCT05600179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65102995|NCT02937662|Cyclophosphamide|cyclophosphamide|mesh-list
65102996|NCT02937662|Idarubicin|idarubicin|mesh-list
65102997|NCT02937662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65102998|NCT02937662|Immunologic Factors|immunologic factors|mesh-ancestor
65102999|NCT02937662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103000|NCT02937662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65103001|NCT02937662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65103002|NCT02937662|Alkylating Agents|alkylating agents|mesh-ancestor
65103003|NCT02937662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103004|NCT02937662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103005|NCT02937662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65103006|NCT02937662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65103007|NCT02937662|Antimetabolites|antimetabolites|mesh-ancestor
65103008|NCT02937662|Antiviral Agents|antiviral agents|mesh-ancestor
65103009|NCT02937662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65103014|NCT01290757|Dabigatran|dabigatran|mesh-list
65103019|NCT01290757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103020|NCT01290757|Anticoagulants|anticoagulants|mesh-ancestor
65103021|NCT02937857|Antipyretics|antipyretics|mesh-list
64675568|NCT00924807|Androgen Antagonists|androgen antagonists|mesh-ancestor
64675569|NCT00924807|Hormone Antagonists|hormone antagonists|mesh-ancestor
64675571|NCT00896025|Acetylcysteine|acetylcysteine|mesh-list
65103022|NCT02937857|Expectorants|expectorants|mesh-list
65103023|NCT02937857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-list
65103024|NCT02937857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103025|NCT02937857|Respiratory System Agents|respiratory system agents|mesh-ancestor
65103026|NCT04324060|Danazol|danazol|mesh-list
65103027|NCT04324060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65103028|NCT04324060|Hormone Antagonists|hormone antagonists|mesh-ancestor
65103029|NCT04324060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65103030|NCT04324060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103031|NCT01290718|Capecitabine|capecitabine|mesh-list
65103032|NCT01290718|Trastuzumab|trastuzumab|mesh-list
65103033|NCT01290718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65103034|NCT01290718|Antimetabolites|antimetabolites|mesh-ancestor
65103035|NCT01290718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103072|NCT02937779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65103073|NCT02937779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65103074|NCT01290679|Ribavirin|ribavirin|mesh-list
65103075|NCT01290679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65103076|NCT01290679|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65103077|NCT01290679|Simeprevir|simeprevir|mesh-list
65103078|NCT01290679|Antimetabolites|antimetabolites|mesh-ancestor
65103079|NCT01290679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103080|NCT01290679|Antiviral Agents|antiviral agents|mesh-ancestor
65103081|NCT01290679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65103082|NCT01290679|Protease Inhibitors|protease inhibitors|mesh-ancestor
65103083|NCT01290679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103084|NCT03457389|Cabergoline|cabergoline|mesh-list
65103085|NCT03457389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65103086|NCT03457389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65103087|NCT03457389|Dopamine Agonists|dopamine agonists|mesh-ancestor
65103088|NCT03457389|Dopamine Agents|dopamine agents|mesh-ancestor
65103089|NCT03457389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65103090|NCT03457389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103092|NCT02890186|Remifentanil|remifentanil|mesh-list
65103131|NCT02909751|Protective Agents|protective agents|mesh-ancestor
65103132|NCT02909751|Vitamins|vitamins|mesh-ancestor
65103133|NCT02909751|Micronutrients|micronutrients|mesh-ancestor
65103134|NCT02909712|Pyrimethamine|pyrimethamine|mesh-list
65103135|NCT02909712|Piperaquine|piperaquine|mesh-list
65103136|NCT02909712|Sulfadoxine|sulfadoxine|mesh-list
65103137|NCT02909712|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65103138|NCT02909712|Artenimol|artenimol|mesh-list
65103139|NCT02909712|Antimalarials|antimalarials|mesh-ancestor
65103140|NCT02909712|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65103141|NCT02909712|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64483846|NCT00787852|Paclitaxel|paclitaxel|mesh-list
65103142|NCT02909712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65103143|NCT02909712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65103144|NCT02909712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103145|NCT02909712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103146|NCT02909712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65103148|NCT02913885|Fluorides|fluorides|mesh-list
65103149|NCT02913885|Fluorides, Topical|fluorides, topical|mesh-list
65103150|NCT02913885|Cariostatic Agents|cariostatic agents|mesh-ancestor
65103151|NCT02913885|Protective Agents|protective agents|mesh-ancestor
65103152|NCT02913885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103153|NCT01290601|Chloroquine|chloroquine|mesh-list
64675730|NCT00765765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675731|NCT00765765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64675732|NCT00760461|Domperidone|domperidone|mesh-list
64675733|NCT00760461|Antiemetics|antiemetics|mesh-ancestor
64675734|NCT00760461|Autonomic Agents|autonomic agents|mesh-ancestor
64675735|NCT00760461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103187|NCT02978391|Mydriatics|mydriatics|mesh-ancestor
65103252|NCT02913417|Ipilimumab|ipilimumab|mesh-list
65103253|NCT02913417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65103254|NCT02913417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103255|NCT02913417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64675783|NCT00684255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675784|NCT00684255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675799|NCT01856361|Ramipril|ramipril|mesh-list
65103256|NCT02913417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103257|NCT02936492|Clobetasol|clobetasol|mesh-list
65103258|NCT02936492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65103313|NCT01289119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65103314|NCT01289119|Protease Inhibitors|protease inhibitors|mesh-ancestor
65103315|NCT01289119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103316|NCT01289119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103317|NCT01287832|Vancomycin|vancomycin|mesh-list
65103318|NCT01287832|Daptomycin|daptomycin|mesh-list
64675833|NCT00633087|Deoxyglucose|deoxyglucose|mesh-list
64675834|NCT00633087|Antimetabolites|antimetabolites|mesh-ancestor
64675835|NCT00633087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675836|NCT00633087|Antiviral Agents|antiviral agents|mesh-ancestor
64675837|NCT00633087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65103371|NCT02935829|Locust bean gum|locust bean gum|mesh-list
65103372|NCT02935829|Antidiarrheals|antidiarrheals|mesh-ancestor
65103373|NCT02935829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65103374|NCT02912676|Methotrexate|methotrexate|mesh-list
65103375|NCT02912676|Mercaptopurine|mercaptopurine|mesh-list
65103376|NCT02912676|Thioguanine|thioguanine|mesh-list
65103377|NCT02912676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65103378|NCT02912676|Abortifacient Agents|abortifacient agents|mesh-ancestor
65103379|NCT02912676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65103380|NCT02912676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103381|NCT02912676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65103382|NCT02912676|Antimetabolites|antimetabolites|mesh-ancestor
65103383|NCT02912676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103384|NCT02912676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103385|NCT02912676|Dermatologic Agents|dermatologic agents|mesh-ancestor
65103386|NCT02912676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103387|NCT02912676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65103388|NCT02912676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65103389|NCT02912676|Immunologic Factors|immunologic factors|mesh-ancestor
65103390|NCT02912676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65103391|NCT02912676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65103392|NCT02935985|Fibrin fragment D|fibrin fragment d|mesh-list
65103393|NCT02935985|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65103394|NCT02935985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65103395|NCT02935985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103396|NCT02935985|Hemostatics|hemostatics|mesh-ancestor
65103397|NCT02935985|Coagulants|coagulants|mesh-ancestor
65103398|NCT02912169|Anesthetics|anesthetics|mesh-list
65103399|NCT02912169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65103400|NCT02912169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103416|NCT02935959|Adrenergic Agents|adrenergic agents|mesh-ancestor
65103417|NCT02935959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65103418|NCT02935959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103419|NCT02935959|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65103420|NCT02935959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65103421|NCT02935959|Anesthetics, General|anesthetics, general|mesh-ancestor
65103422|NCT02935959|Anesthetics|anesthetics|mesh-ancestor
65103423|NCT02935959|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65103424|NCT02935959|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65103425|NCT02935959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65103426|NCT02935959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65103427|NCT02935959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65103428|NCT02935959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65103429|NCT02935959|GABA Modulators|gaba modulators|mesh-ancestor
65103430|NCT02935959|GABA Agents|gaba agents|mesh-ancestor
65103431|NCT02935322|Chlorhexidine|chlorhexidine|mesh-list
65103432|NCT02935322|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65103433|NCT02935322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65103434|NCT02935322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65103435|NCT02935322|Disinfectants|disinfectants|mesh-ancestor
65103436|NCT02935322|Dermatologic Agents|dermatologic agents|mesh-ancestor
65103437|NCT02935647|Propofol|propofol|mesh-list
65103438|NCT02935647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65103439|NCT02935647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65103440|NCT02935647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103441|NCT02935647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65103442|NCT02935647|Anesthetics, General|anesthetics, general|mesh-ancestor
65103443|NCT02935647|Anesthetics|anesthetics|mesh-ancestor
65103444|NCT02912247|Adalimumab|adalimumab|mesh-list
64675977|NCT01587963|Protective Agents|protective agents|mesh-ancestor
64675978|NCT01587963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675980|NCT01587963|Micronutrients|micronutrients|mesh-ancestor
65103465|NCT02935010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65103466|NCT02935010|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65103467|NCT02935010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103468|NCT02935010|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64676039|NCT01548651|Protease Inhibitors|protease inhibitors|mesh-ancestor
64676040|NCT01548651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676041|NCT01548651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676042|NCT01548651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64676043|NCT01533753|Gabapentin|gabapentin|mesh-list
64676044|NCT01533753|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64676045|NCT01533753|Analgesics|analgesics|mesh-ancestor
64676046|NCT01533753|Sensory System Agents|sensory system agents|mesh-ancestor
64676047|NCT01533753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64676048|NCT01533753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103531|NCT02934035|Sensory System Agents|sensory system agents|mesh-ancestor
65103532|NCT02934035|Dopamine Agents|dopamine agents|mesh-ancestor
65103585|NCT02934945|Formoterol Fumarate|formoterol fumarate|mesh-list
65103586|NCT02934945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65103587|NCT02934945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65103588|NCT02934945|Autonomic Agents|autonomic agents|mesh-ancestor
65103589|NCT02934945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103590|NCT02934945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103591|NCT02934945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65103592|NCT02934945|Respiratory System Agents|respiratory system agents|mesh-ancestor
65103593|NCT02934945|Glucocorticoids|glucocorticoids|mesh-ancestor
65103594|NCT02934945|Hormones|hormones|mesh-ancestor
65103595|NCT02934945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65103596|NCT02934945|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64676082|NCT01534143|Thymoglobulin|thymoglobulin|mesh-list
65103639|NCT02670252|Immunologic Factors|immunologic factors|mesh-ancestor
65103640|NCT02670252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103641|NCT02670252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65103642|NCT02670252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65103643|NCT02670252|Alkylating Agents|alkylating agents|mesh-ancestor
65103644|NCT02670252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103645|NCT02670252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103646|NCT02670252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65103647|NCT02934789|Contraceptive Agents|contraceptive agents|mesh-list
65103648|NCT02934789|Contraceptives, Oral|contraceptives, oral|mesh-list
65103649|NCT02934789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65103650|NCT02934789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65103651|NCT02934789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103652|NCT02934789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65103653|NCT02933099|Dexamethasone|dexamethasone|mesh-list
65103654|NCT02933099|Dexamethasone acetate|dexamethasone acetate|mesh-list
65103655|NCT02933099|Aprepitant|aprepitant|mesh-list
65103656|NCT02933099|Palonosetron|palonosetron|mesh-list
65103657|NCT02933099|BB 1101|bb 1101|mesh-list
65103658|NCT02933099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65103659|NCT02933099|Antiemetics|antiemetics|mesh-ancestor
65103660|NCT02933099|Autonomic Agents|autonomic agents|mesh-ancestor
65103661|NCT02933099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103662|NCT02933099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103663|NCT02933099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65103664|NCT02933099|Glucocorticoids|glucocorticoids|mesh-ancestor
65103665|NCT02933099|Hormones|hormones|mesh-ancestor
65103666|NCT02933099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65103667|NCT02933099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65103668|NCT02933099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103669|NCT02933099|Protease Inhibitors|protease inhibitors|mesh-ancestor
65103670|NCT02933099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676165|NCT05715437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65103681|NCT04630886|Anesthetics|anesthetics|mesh-ancestor
65103682|NCT04630886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65103683|NCT04630886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103684|NCT04630886|Sensory System Agents|sensory system agents|mesh-ancestor
65103685|NCT04630886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103686|NCT04630886|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65103687|NCT04630886|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65103688|NCT04630886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65103689|NCT04630886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65103690|NCT04630886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103691|NCT04630886|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65103692|NCT04630886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65103693|NCT04630886|Hemostatics|hemostatics|mesh-ancestor
65103694|NCT04630886|Coagulants|coagulants|mesh-ancestor
65103695|NCT04630886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65103696|NCT04630886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65103697|NCT04630886|Adrenergic Agents|adrenergic agents|mesh-ancestor
65103698|NCT04630886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65103699|NCT04630886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65103700|NCT04630886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65103701|NCT04630886|Autonomic Agents|autonomic agents|mesh-ancestor
65103702|NCT04630886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65103703|NCT04630886|Respiratory System Agents|respiratory system agents|mesh-ancestor
65103704|NCT04630886|Mydriatics|mydriatics|mesh-ancestor
65103705|NCT04630886|Sympathomimetics|sympathomimetics|mesh-ancestor
65103706|NCT04630886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65103707|NCT02934906|Immunoglobulins|immunoglobulins|mesh-list
65103708|NCT02934906|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65103709|NCT02934906|Antibodies|antibodies|mesh-list
65103710|NCT02934906|gamma-Globulins|gamma-globulins|mesh-list
65103714|NCT02911350|Paclitaxel|paclitaxel|mesh-list
65103722|NCT02911350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65103723|NCT02911350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103724|NCT02932397|Propofol|propofol|mesh-list
65103725|NCT02932397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64676205|NCT00501345|Sensory System Agents|sensory system agents|mesh-ancestor
64676206|NCT00501345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64676207|NCT00501345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676208|NCT00501345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65103726|NCT02932397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65103727|NCT02932397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103728|NCT02932397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65103729|NCT02932397|Anesthetics, General|anesthetics, general|mesh-ancestor
65103730|NCT02932397|Anesthetics|anesthetics|mesh-ancestor
65103731|NCT02911272|Oxytocin|oxytocin|mesh-list
65103732|NCT02911272|Oxytocics|oxytocics|mesh-ancestor
65103733|NCT02911272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65103777|NCT02665143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65103778|NCT02665143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103779|NCT02665143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103780|NCT02924987|Aflibercept|aflibercept|mesh-list
65103781|NCT02924987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65103782|NCT02924987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65103783|NCT02924987|Growth Substances|growth substances|mesh-ancestor
65103784|NCT02924987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103785|NCT02924987|Growth Inhibitors|growth inhibitors|mesh-ancestor
65103786|NCT02924987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103787|NCT02924909|Paclitaxel|paclitaxel|mesh-list
65103788|NCT02924909|Carboplatin|carboplatin|mesh-list
65103789|NCT02924909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65103790|NCT02924909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103791|NCT02924909|Tubulin Modulators|tubulin modulators|mesh-ancestor
65103792|NCT02924909|Antimitotic Agents|antimitotic agents|mesh-ancestor
65103793|NCT02924909|Mitosis Modulators|mitosis modulators|mesh-ancestor
65103794|NCT02924909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103795|NCT02934321|Erythritol|erythritol|mesh-list
65103796|NCT02934321|Vasodilator Agents|vasodilator agents|mesh-ancestor
65103797|NCT02924753|Cyclophosphamide|cyclophosphamide|mesh-list
65103798|NCT02924753|Fludarabine|fludarabine|mesh-list
65103799|NCT02924753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65103800|NCT02924753|Immunologic Factors|immunologic factors|mesh-ancestor
65103801|NCT02924753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103802|NCT02924753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65103803|NCT02924753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65103804|NCT02924753|Alkylating Agents|alkylating agents|mesh-ancestor
65103805|NCT02924753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103806|NCT02924753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103807|NCT02924753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65103808|NCT02924675|Pregabalin|pregabalin|mesh-list
65103809|NCT02924675|Analgesics|analgesics|mesh-ancestor
65103810|NCT02924675|Sensory System Agents|sensory system agents|mesh-ancestor
64676295|NCT00271011|Alkylating Agents|alkylating agents|mesh-ancestor
64676296|NCT00271011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65103817|NCT02924675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65103818|NCT02924675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65103819|NCT02924675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65103820|NCT02924675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65103821|NCT02924675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65103822|NCT03847545|4-Aminopyridine|4-aminopyridine|mesh-list
65103823|NCT03847545|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65103824|NCT03847545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65103825|NCT03847545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103826|NCT02924285|Amiodarone|amiodarone|mesh-list
65103827|NCT02924285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65103828|NCT02924285|Vasodilator Agents|vasodilator agents|mesh-ancestor
65103829|NCT02924285|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65103830|NCT02924285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65103831|NCT02924285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103832|NCT02924285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65103833|NCT02924285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65103834|NCT02924285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65103835|NCT02924285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103836|NCT02924285|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65103837|NCT02924285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65103838|NCT02924285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65103839|NCT01287520|Carboplatin|carboplatin|mesh-list
65103840|NCT01287520|Pemetrexed|pemetrexed|mesh-list
65103841|NCT01287520|Ranitidine|ranitidine|mesh-list
65103842|NCT01287520|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65103855|NCT00623740|Hydrocortisone|hydrocortisone|mesh-list
65103857|NCT00623740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65103858|NCT00623740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65103859|NCT00623740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65103860|NCT02923934|Nivolumab|nivolumab|mesh-list
65103861|NCT02923934|Ipilimumab|ipilimumab|mesh-list
65103862|NCT02923934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65103863|NCT02923934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65103864|NCT02923934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65103865|NCT02923934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103866|NCT01287364|Mometasone Furoate|mometasone furoate|mesh-list
65103867|NCT01287364|Ciclesonide|ciclesonide|mesh-list
65103868|NCT01287364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65103869|NCT01287364|Dermatologic Agents|dermatologic agents|mesh-ancestor
65103870|NCT01287364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65103871|NCT01287364|Glucocorticoids|glucocorticoids|mesh-ancestor
65103872|NCT01287364|Hormones|hormones|mesh-ancestor
65103873|NCT01287364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65103874|NCT01287364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103875|NCT02889835|Chlorhexidine|chlorhexidine|mesh-list
65103876|NCT02889835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65103877|NCT02889835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65103878|NCT02889835|Disinfectants|disinfectants|mesh-ancestor
65103879|NCT02924090|Ketamine|ketamine|mesh-list
65103909|NCT01286740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65103910|NCT01286740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65103911|NCT01286740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65103912|NCT01286740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103913|NCT01286740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103914|NCT01286740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65103915|NCT01286740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65103916|NCT04049084|Adenosine|adenosine|mesh-list
65103917|NCT04049084|Analgesics|analgesics|mesh-ancestor
65103918|NCT04049084|Sensory System Agents|sensory system agents|mesh-ancestor
65103919|NCT04049084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65103920|NCT04049084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65103921|NCT04049084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65103922|NCT04049084|Vasodilator Agents|vasodilator agents|mesh-ancestor
65103923|NCT04049084|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65103924|NCT04049084|Purinergic Agonists|purinergic agonists|mesh-ancestor
65103925|NCT04049084|Purinergic Agents|purinergic agents|mesh-ancestor
65103926|NCT04049084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65103927|NCT04049084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103928|NCT02923856|Clarithromycin|clarithromycin|mesh-list
65103929|NCT02923856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65103930|NCT02923856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65103931|NCT02923856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65103932|NCT02923856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65103933|NCT02923856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65103934|NCT02923856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65103935|NCT02923856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65103936|NCT02934204|Methotrexate|methotrexate|mesh-list
65103937|NCT02934204|Temozolomide|temozolomide|mesh-list
65103938|NCT02934204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65103939|NCT02934204|Abortifacient Agents|abortifacient agents|mesh-ancestor
65103940|NCT02934204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64401791|NCT05727475|Fluorides|fluorides|mesh-list
64676431|NCT05663801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64676432|NCT05663801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676433|NCT05663801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64676434|NCT05663801|Anticonvulsants|anticonvulsants|mesh-ancestor
64676435|NCT05663801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64676436|NCT05663801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64676440|NCT03866499|Gefitinib|gefitinib|mesh-list
65104008|NCT02923388|Vitamin B 12|vitamin b 12|mesh-list
65104009|NCT02923388|Pyridoxine|pyridoxine|mesh-list
65104010|NCT02923388|Vitamin B 6|vitamin b 6|mesh-list
65104011|NCT02923388|Vitamin B Complex|vitamin b complex|mesh-list
65104012|NCT02923388|Micronutrients|micronutrients|mesh-ancestor
65104013|NCT02923388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104014|NCT02933658|Amlodipine|amlodipine|mesh-list
65104015|NCT02933658|Telmisartan|telmisartan|mesh-list
64676481|NCT00000189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64676482|NCT00000189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676483|NCT00000189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64676484|NCT00000189|Serotonin Agents|serotonin agents|mesh-ancestor
64676485|NCT00000189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64676486|NCT00000189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676487|NCT02681211|Diphenhydramine|diphenhydramine|mesh-list
65104016|NCT02933658|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65104059|NCT02922803|Cholecalciferol|cholecalciferol|mesh-list
65104060|NCT02922803|Vitamins|vitamins|mesh-list
65104061|NCT02922803|Calcium|calcium|mesh-list
65104062|NCT02922803|Micronutrients|micronutrients|mesh-ancestor
65104063|NCT02922803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104064|NCT02922803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65104065|NCT02922803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65104066|NCT02834559|Fluorouracil|fluorouracil|mesh-list
65104067|NCT02834559|Heparin|heparin|mesh-list
64676525|NCT00000195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65104123|NCT03981341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65104124|NCT03981341|Hormone Antagonists|hormone antagonists|mesh-ancestor
65104125|NCT03981341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65104126|NCT03924440|Nonoxynol|nonoxynol|mesh-list
65104127|NCT03924440|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
64676579|NCT01807611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676580|NCT01807611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676581|NCT01807611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64676582|NCT01807611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65104128|NCT03924440|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
65104129|NCT03924440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104130|NCT03924440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65104131|NCT03924440|Contraceptive Agents|contraceptive agents|mesh-ancestor
65104132|NCT03924440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65104133|NCT03924440|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65104134|NCT01285492|Tiotropium Bromide|tiotropium bromide|mesh-list
65104135|NCT01285492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65104136|NCT01285492|Autonomic Agents|autonomic agents|mesh-ancestor
65104137|NCT01285492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65104138|NCT01285492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104146|NCT01284634|Cannabidiol|cannabidiol|mesh-list
65104172|NCT01283971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104173|NCT01283971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65104174|NCT01283971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65104175|NCT01283971|Immunologic Factors|immunologic factors|mesh-ancestor
65104176|NCT01283971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65104177|NCT01283971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65104178|NCT01283971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65104179|NCT02921282|Dopamine|dopamine|mesh-list
65104180|NCT02921282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65104181|NCT02921282|Sympathomimetics|sympathomimetics|mesh-ancestor
65104182|NCT02921282|Autonomic Agents|autonomic agents|mesh-ancestor
65104183|NCT02921282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65104184|NCT02921282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104185|NCT02921282|Dopamine Agents|dopamine agents|mesh-ancestor
65104186|NCT02921282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65104187|NCT02921282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104188|NCT02921282|Protective Agents|protective agents|mesh-ancestor
65104189|NCT02921360|Aspirin|aspirin|mesh-list
65104190|NCT02921360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65104191|NCT02921360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65104192|NCT02921360|Analgesics|analgesics|mesh-ancestor
65104193|NCT02921360|Sensory System Agents|sensory system agents|mesh-ancestor
65104194|NCT02921360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65104195|NCT02921360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104196|NCT02921360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65104197|NCT02921360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64746411|NCT01529268|Cysteamine|cysteamine|mesh-list
65104198|NCT02921360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65104199|NCT02921360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64676666|NCT02294604|Chlorhexidine|chlorhexidine|mesh-list
64676667|NCT02294604|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64676668|NCT02294604|Povidone-Iodine|povidone-iodine|mesh-list
64676670|NCT02294604|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64676671|NCT02294604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64676672|NCT02294604|Disinfectants|disinfectants|mesh-ancestor
65104218|NCT01283581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104219|NCT01283542|Pasireotide|pasireotide|mesh-list
65104220|NCT01283542|Hormones|hormones|mesh-ancestor
65104277|NCT02920931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64676722|NCT05637671|Parasympatholytics|parasympatholytics|mesh-ancestor
65104278|NCT01283152|Lactulose|lactulose|mesh-list
65104279|NCT01283152|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65104280|NCT01283152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65104281|NCT01283152|Laxatives|laxatives|mesh-ancestor
65104282|NCT01282801|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65104283|NCT01282801|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65104284|NCT01282801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65104341|NCT05466708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65104342|NCT05466708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104343|NCT05466708|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65104344|NCT05466708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65104345|NCT05466708|Anesthetics, General|anesthetics, general|mesh-ancestor
65104346|NCT05466708|Anesthetics|anesthetics|mesh-ancestor
65104347|NCT05466708|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65104348|NCT05466708|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65104349|NCT05466708|Antidepressive Agents|antidepressive agents|mesh-ancestor
65104408|NCT01280968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65104409|NCT01280968|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65104410|NCT01280968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65104411|NCT01280968|Cholinergic Agents|cholinergic agents|mesh-ancestor
65104412|NCT01280968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65104413|NCT01280968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104414|NCT01280968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65104415|NCT01280968|Antacids|antacids|mesh-ancestor
65104416|NCT01280968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65104417|NCT02932020|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65104418|NCT02932020|Methylprednisolone|methylprednisolone|mesh-list
65104419|NCT02932020|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65104471|NCT03741530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65104472|NCT03741530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104473|NCT01280617|Thymoglobulin|thymoglobulin|mesh-list
65104474|NCT01280617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65104475|NCT01280617|Immunologic Factors|immunologic factors|mesh-ancestor
65104476|NCT01280617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104477|NCT01280617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65104478|NCT02932137|Interleukin-2|interleukin-2|mesh-list
65104479|NCT02932137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104480|NCT02932137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65104481|NCT02932137|Analgesics|analgesics|mesh-ancestor
65104482|NCT02932137|Sensory System Agents|sensory system agents|mesh-ancestor
65104483|NCT02932137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65104484|NCT02932137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104485|NCT01280266|Amlodipine|amlodipine|mesh-list
65104532|NCT02920190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65104533|NCT02920190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104604|NCT05465304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65104605|NCT02919293|Vaccines|vaccines|mesh-list
65104606|NCT02919293|Immunologic Factors|immunologic factors|mesh-ancestor
65104607|NCT02919293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104608|NCT02919371|Bevacizumab|bevacizumab|mesh-list
65104609|NCT02919371|Sunitinib|sunitinib|mesh-list
65104675|NCT02918825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65104676|NCT02918825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65104677|NCT02918825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65104678|NCT02918825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65104679|NCT02918825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104680|NCT02918825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65104681|NCT02918825|Serotonin Agents|serotonin agents|mesh-ancestor
65104682|NCT02918825|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65104683|NCT02918825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65104684|NCT02918825|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65104685|NCT02918825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65104686|NCT02918825|Dopamine Agents|dopamine agents|mesh-ancestor
65104687|NCT02918747|Gemcitabine|gemcitabine|mesh-list
65104688|NCT02918747|Dexamethasone|dexamethasone|mesh-list
65104689|NCT02918747|Prednisone|prednisone|mesh-list
65104690|NCT02918747|Cyclophosphamide|cyclophosphamide|mesh-list
65104691|NCT02918747|Doxorubicin|doxorubicin|mesh-list
65104692|NCT02918747|Oxaliplatin|oxaliplatin|mesh-list
65104693|NCT02918747|Vincristine|vincristine|mesh-list
65104694|NCT02918747|Pegaspargase|pegaspargase|mesh-list
65104695|NCT02918747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65104696|NCT02918747|Immunologic Factors|immunologic factors|mesh-ancestor
65104697|NCT02918747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104698|NCT02918747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65104699|NCT02918747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65104700|NCT02918747|Alkylating Agents|alkylating agents|mesh-ancestor
65104701|NCT02918747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104702|NCT02918747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65104703|NCT02918747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65104721|NCT02918747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65104722|NCT02918747|Tubulin Modulators|tubulin modulators|mesh-ancestor
65104723|NCT02918747|Antimitotic Agents|antimitotic agents|mesh-ancestor
65104724|NCT02918747|Mitosis Modulators|mitosis modulators|mesh-ancestor
65104725|NCT02918708|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65104726|NCT02918708|Immunologic Factors|immunologic factors|mesh-ancestor
65104727|NCT02918708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104729|NCT02918591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65104730|NCT02918591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104731|NCT02918591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65104732|NCT02918591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104733|NCT02918045|Cellulose, Oxidized|cellulose, oxidized|mesh-list
65104734|NCT02918045|Hemostatics|hemostatics|mesh-ancestor
65104735|NCT02918045|Coagulants|coagulants|mesh-ancestor
65104736|NCT00532545|Teriparatide|teriparatide|mesh-list
65104737|NCT00532545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64677219|NCT02321436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64677221|NCT02321436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65104780|NCT00533559|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
65104851|NCT00532662|Anesthetics|anesthetics|mesh-ancestor
65104852|NCT00532662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65104853|NCT00532662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65104854|NCT00532662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65104855|NCT00532662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65104856|NCT00532662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104857|NCT05341167|Phenylephrine|phenylephrine|mesh-list
65104858|NCT05341167|Oxymetazoline|oxymetazoline|mesh-list
65104859|NCT05341167|Norepinephrine|norepinephrine|mesh-list
65104860|NCT05341167|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65104861|NCT05341167|Mydriatics|mydriatics|mesh-ancestor
65104862|NCT05341167|Autonomic Agents|autonomic agents|mesh-ancestor
65104863|NCT05341167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65104864|NCT05341167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104913|NCT05466695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65104914|NCT05466695|Urological Agents|urological agents|mesh-ancestor
65104915|NCT05466578|Abrocitinib|abrocitinib|mesh-list
65104916|NCT05466578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65104917|NCT05466578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65104982|NCT01275625|Antiviral Agents|antiviral agents|mesh-ancestor
65104983|NCT01275625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65104984|NCT01275625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65104985|NCT05459792|Lidocaine|lidocaine|mesh-list
65104986|NCT05459792|Bupivacaine|bupivacaine|mesh-list
65104987|NCT05459792|Anesthetics, Local|anesthetics, local|mesh-ancestor
65104988|NCT05459792|Anesthetics|anesthetics|mesh-ancestor
65104989|NCT05459792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65104990|NCT05459792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65104991|NCT05459792|Sensory System Agents|sensory system agents|mesh-ancestor
65105047|NCT04312503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64677488|NCT00001059|Doxorubicin|doxorubicin|mesh-list
65105048|NCT04312503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65105049|NCT04312503|Antidepressive Agents|antidepressive agents|mesh-ancestor
65105050|NCT04312503|Dopamine Agonists|dopamine agonists|mesh-ancestor
65105051|NCT04312503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65105052|NCT04312503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65105053|NCT04312503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65105054|NCT04312503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65105055|NCT04312503|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65105056|NCT04312503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65105057|NCT04312503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65105058|NCT04312503|Adrenergic Agents|adrenergic agents|mesh-ancestor
65105059|NCT00532688|Acetylcysteine|acetylcysteine|mesh-list
65105105|NCT00532727|Carboplatin|carboplatin|mesh-list
65105106|NCT00532727|Docetaxel|docetaxel|mesh-list
65105107|NCT00532727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105108|NCT00532727|Tubulin Modulators|tubulin modulators|mesh-ancestor
65105109|NCT00532727|Antimitotic Agents|antimitotic agents|mesh-ancestor
65105110|NCT00532727|Mitosis Modulators|mitosis modulators|mesh-ancestor
65105111|NCT00532727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105112|NCT04261218|Paclitaxel|paclitaxel|mesh-list
65105113|NCT04261218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65105114|NCT04261218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105115|NCT04261218|Tubulin Modulators|tubulin modulators|mesh-ancestor
65105122|NCT04687449|Analgesics|analgesics|mesh-ancestor
65105169|NCT05209035|Antidepressive Agents|antidepressive agents|mesh-ancestor
65105170|NCT00534261|Interferons|interferons|mesh-list
65105171|NCT00534261|Interferon-beta|interferon-beta|mesh-list
65105172|NCT00534261|Interferon beta-1a|interferon beta-1a|mesh-list
65105237|NCT00534378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65105238|NCT00534378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65105239|NCT00534378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65105240|NCT00534378|Anesthetics, General|anesthetics, general|mesh-ancestor
65105241|NCT00534378|Anesthetics|anesthetics|mesh-ancestor
65105242|NCT00534378|GABA Modulators|gaba modulators|mesh-ancestor
65105243|NCT00534378|GABA Agents|gaba agents|mesh-ancestor
65105244|NCT00534378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65105245|NCT00534378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105246|NCT05131997|Atorvastatin|atorvastatin|mesh-list
65105247|NCT05131997|Ezetimibe|ezetimibe|mesh-list
65105248|NCT05131997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65105249|NCT05131997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65105250|NCT05131997|Antimetabolites|antimetabolites|mesh-ancestor
65105299|NCT00534573|Moclobemide|moclobemide|mesh-list
65105300|NCT00534573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65105301|NCT00534573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65105302|NCT00534573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65105303|NCT00534573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105304|NCT00534573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65105305|NCT00534573|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65105306|NCT00534573|Dopamine Agents|dopamine agents|mesh-ancestor
65105307|NCT00534573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65105308|NCT00534573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105312|NCT00534573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105362|NCT05080959|Sensory System Agents|sensory system agents|mesh-ancestor
65105363|NCT05080959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65105364|NCT04942730|Mycophenolic Acid|mycophenolic acid|mesh-list
65105365|NCT04942730|Cyclophosphamide|cyclophosphamide|mesh-list
65105366|NCT04942730|Busulfan|busulfan|mesh-list
65105367|NCT04942730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65105368|NCT04942730|Fludarabine|fludarabine|mesh-list
65105369|NCT04942730|Tacrolimus|tacrolimus|mesh-list
65105370|NCT04942730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65105371|NCT04942730|Immunologic Factors|immunologic factors|mesh-ancestor
65105372|NCT04942730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105386|NCT01272193|Insulin|insulin|mesh-list
65105428|NCT01269385|Antibodies|antibodies|mesh-list
65105429|NCT01269385|Immunoglobulins|immunoglobulins|mesh-list
65105430|NCT01269385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65105431|NCT01269385|Immunologic Factors|immunologic factors|mesh-ancestor
65105432|NCT01269385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105433|NCT01269385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65105434|NCT01269385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65105435|NCT04687176|Arsenic Trioxide|arsenic trioxide|mesh-list
65105437|NCT02071862|Paclitaxel|paclitaxel|mesh-list
65105497|NCT05471453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105498|NCT05471453|Antioxidants|antioxidants|mesh-ancestor
65105499|NCT05471453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105500|NCT05471453|Protective Agents|protective agents|mesh-ancestor
65105501|NCT05471453|Vitamins|vitamins|mesh-ancestor
65105502|NCT05471453|Micronutrients|micronutrients|mesh-ancestor
65105503|NCT03457233|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65105504|NCT03457233|Cetrorelix|cetrorelix|mesh-list
65105505|NCT03457233|Menotropins|menotropins|mesh-list
65105506|NCT03457233|Progesterone|progesterone|mesh-list
65105507|NCT03457233|Progestins|progestins|mesh-ancestor
65105508|NCT03457233|Hormones|hormones|mesh-ancestor
65105513|NCT03457233|Fertility Agents|fertility agents|mesh-ancestor
64677996|NCT00001449|Antidotes|antidotes|mesh-ancestor
65105561|NCT04910100|Adrenergic Agents|adrenergic agents|mesh-ancestor
65105562|NCT04910100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65105634|NCT00593710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105635|NCT00593710|Sympatholytics|sympatholytics|mesh-ancestor
65105636|NCT00593710|Autonomic Agents|autonomic agents|mesh-ancestor
65105637|NCT00593710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65105638|NCT00593710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105639|NCT00593710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65105640|NCT00593710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65105641|NCT00593710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65105642|NCT00593710|Adrenergic Agents|adrenergic agents|mesh-ancestor
65105643|NCT00593710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65105644|NCT04885686|Formaldehyde|formaldehyde|mesh-list
65105646|NCT04885686|Dexamethasone|dexamethasone|mesh-list
65105697|NCT01260181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105698|NCT00536276|Vitamin D|vitamin d|mesh-list
65105699|NCT00536276|Ergocalciferols|ergocalciferols|mesh-list
65105700|NCT00536276|Cholecalciferol|cholecalciferol|mesh-list
65105701|NCT00536276|Vitamins|vitamins|mesh-list
65105702|NCT00536276|Micronutrients|micronutrients|mesh-ancestor
65105703|NCT00536276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65105704|NCT00536276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65105705|NCT00536276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65105706|NCT02690064|Vitamins|vitamins|mesh-list
65105707|NCT02690064|Ascorbic Acid|ascorbic acid|mesh-list
65105708|NCT02690064|Vitamin E|vitamin e|mesh-list
65105762|NCT01260142|Anesthetics, General|anesthetics, general|mesh-ancestor
65105763|NCT01260142|Anesthetics|anesthetics|mesh-ancestor
65105764|NCT02116335|Bosentan|bosentan|mesh-list
65105765|NCT02116335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65105766|NCT02116335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65105767|NCT02116335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105830|NCT05469035|Heparin|heparin|mesh-list
65105831|NCT05469035|Calcium heparin|calcium heparin|mesh-list
65105832|NCT05469035|Anticoagulants|anticoagulants|mesh-ancestor
65105833|NCT05469035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65105834|NCT05469035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65105836|NCT05582590|Cyclophosphamide|cyclophosphamide|mesh-list
65105900|NCT00595543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65105901|NCT00595543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65105902|NCT00595543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65105903|NCT04326868|Albendazole|albendazole|mesh-list
65105906|NCT04326868|Pyrantel|pyrantel|mesh-list
65105973|NCT02888899|Calcium polycarbophil|calcium polycarbophil|mesh-list
65105974|NCT02888899|Psyllium|psyllium|mesh-list
65105975|NCT02888899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65106045|NCT00596596|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65106046|NCT00596596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65106047|NCT00596596|Serotonin Agents|serotonin agents|mesh-ancestor
65106048|NCT00596596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65106051|NCT05468294|Nivolumab|nivolumab|mesh-list
65106114|NCT00597064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65106115|NCT00597064|Glucocorticoids|glucocorticoids|mesh-ancestor
65106116|NCT00597064|Hormones|hormones|mesh-ancestor
65106117|NCT00597064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65106118|NCT00597064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106121|NCT00597181|Mitomycins|mitomycins|mesh-list
65106183|NCT05467826|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64678611|NCT00002217|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64678612|NCT00002217|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65106252|NCT00598858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65106253|NCT00598858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106254|NCT00598858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65106256|NCT05466305|Trace Elements|trace elements|mesh-ancestor
65106321|NCT00624208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65106322|NCT00624208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65106323|NCT00624208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65106324|NCT00624208|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65106325|NCT00624208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65106326|NCT00624208|Dopamine Agents|dopamine agents|mesh-ancestor
65106327|NCT00536783|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64678820|NCT00002481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64678821|NCT00002481|Antimetabolites|antimetabolites|mesh-ancestor
65106390|NCT05312190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106391|NCT00537173|Paclitaxel|paclitaxel|mesh-list
65106392|NCT00537173|Bevacizumab|bevacizumab|mesh-list
65106393|NCT00537173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65106394|NCT00537173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106395|NCT00537173|Tubulin Modulators|tubulin modulators|mesh-ancestor
65106456|NCT05469204|Digoxin|digoxin|mesh-list
65106457|NCT05469204|Midazolam|midazolam|mesh-list
65106458|NCT05469204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65106459|NCT05469204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65106530|NCT05226871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65106531|NCT05226871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106532|NCT05226871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106533|NCT05226871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65106534|NCT05226871|Hormone Antagonists|hormone antagonists|mesh-ancestor
65106535|NCT05226871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65106536|NCT05226871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106537|NCT05226871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65106538|NCT05226871|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65106539|NCT05226871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65106540|NCT01366612|Vidarabine|vidarabine|mesh-list
65106541|NCT01366612|Fludarabine|fludarabine|mesh-list
65106542|NCT01366612|Fludarabine phosphate|fludarabine phosphate|mesh-list
65106591|NCT05180773|Antithrombins|antithrombins|mesh-ancestor
65106592|NCT05180773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65106593|NCT05180773|Protease Inhibitors|protease inhibitors|mesh-ancestor
65106594|NCT05180773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106595|NCT05180773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106596|NCT05180773|Anticoagulants|anticoagulants|mesh-ancestor
65106597|NCT05180773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65106598|NCT05180773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65106599|NCT05180773|Hormone Antagonists|hormone antagonists|mesh-ancestor
65106600|NCT05180773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65106602|NCT05180773|Dopamine Agonists|dopamine agonists|mesh-ancestor
65106655|NCT02277171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65106656|NCT02277171|Autonomic Agents|autonomic agents|mesh-ancestor
65106657|NCT02277171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65106658|NCT02277171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106659|NCT02277171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65106660|NCT02277171|Respiratory System Agents|respiratory system agents|mesh-ancestor
65106661|NCT02277171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65106662|NCT02277171|Antioxidants|antioxidants|mesh-ancestor
65106663|NCT02277171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106664|NCT02277171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65106717|NCT00536640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65106718|NCT00536640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106719|NCT00536640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65106720|NCT00536640|Immunologic Factors|immunologic factors|mesh-ancestor
65106721|NCT00536640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65106722|NCT00552227|Ruboxistaurin|ruboxistaurin|mesh-list
65106723|NCT00552227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106724|NCT00552227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106725|NCT01259089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65106726|NCT01259089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106727|NCT01259089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65106728|NCT01259089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106729|NCT01259089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106730|NCT00552266|Methylphenidate|methylphenidate|mesh-list
65106731|NCT00552266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65106732|NCT00552266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106733|NCT00552266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65106734|NCT00552266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65106769|NCT01258738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65106770|NCT01258738|Analgesics|analgesics|mesh-ancestor
65106771|NCT01258738|Sensory System Agents|sensory system agents|mesh-ancestor
65106772|NCT01258738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65106773|NCT01258738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106774|NCT01258738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65106775|NCT01258738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65106776|NCT01258738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65106777|NCT01258738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65106778|NCT01258738|Immunologic Factors|immunologic factors|mesh-ancestor
65106779|NCT00552656|Sirolimus|sirolimus|mesh-list
65106780|NCT00552656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64679274|NCT00002571|Sulfamethoxazole|sulfamethoxazole|mesh-list
64679275|NCT00002571|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64679276|NCT00002571|Prednisone|prednisone|mesh-list
65106835|NCT04362527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106836|NCT04362527|Protective Agents|protective agents|mesh-ancestor
65106837|NCT04362527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106838|NCT04758975|Rituximab|rituximab|mesh-list
65106839|NCT04758975|Venetoclax|venetoclax|mesh-list
65106840|NCT04758975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64679277|NCT00002571|Cyclophosphamide|cyclophosphamide|mesh-list
64679278|NCT00002571|Doxorubicin|doxorubicin|mesh-list
64679279|NCT00002571|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65106841|NCT04758975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106842|NCT04758975|Immunologic Factors|immunologic factors|mesh-ancestor
65106844|NCT04758975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65106889|NCT04158440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65106890|NCT04137107|Oxaliplatin|oxaliplatin|mesh-list
65106891|NCT04137107|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65106892|NCT04137107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106893|NCT04137107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65106894|NCT04137107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65106895|NCT04137107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65106896|NCT04137107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106897|NCT04137107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65106898|NCT04137107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749119|NCT04027530|Ertugliflozin|ertugliflozin|mesh-list
65106899|NCT04137107|Analgesics|analgesics|mesh-ancestor
65106900|NCT04137107|Sensory System Agents|sensory system agents|mesh-ancestor
65106901|NCT04137107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65106902|NCT04137107|Antidepressive Agents|antidepressive agents|mesh-ancestor
65106903|NCT04137107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65106904|NCT04137107|Dopamine Agents|dopamine agents|mesh-ancestor
65106905|NCT05527470|Gemcitabine|gemcitabine|mesh-list
65106906|NCT05527470|Cisplatin|cisplatin|mesh-list
65106907|NCT05527470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106908|NCT05527470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65106909|NCT05527470|Antimetabolites|antimetabolites|mesh-ancestor
65106910|NCT05527470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106911|NCT05527470|Antiviral Agents|antiviral agents|mesh-ancestor
65106912|NCT05527470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65106913|NCT05527470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106914|NCT05527470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65106915|NCT05527470|Immunologic Factors|immunologic factors|mesh-ancestor
65106916|NCT05527470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106917|NCT01258348|Sunitinib|sunitinib|mesh-list
65106918|NCT01258348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106919|NCT01258348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65106920|NCT01258348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65106921|NCT01258348|Growth Substances|growth substances|mesh-ancestor
65106922|NCT01258348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65106923|NCT01258348|Growth Inhibitors|growth inhibitors|mesh-ancestor
65106925|NCT01258348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106926|NCT01258348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106927|NCT05136898|Mitomycins|mitomycins|mesh-list
65106928|NCT05136898|Mitomycin|mitomycin|mesh-list
65106929|NCT05136898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65106930|NCT05136898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65106931|NCT05136898|Alkylating Agents|alkylating agents|mesh-ancestor
64679365|NCT00002589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679366|NCT00002589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64679367|NCT00002589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64679368|NCT00002589|Antiviral Agents|antiviral agents|mesh-ancestor
65106932|NCT05136898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106933|NCT05136898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65106981|NCT01256476|Pravastatin|pravastatin|mesh-list
65106982|NCT01256476|Pitavastatin|pitavastatin|mesh-list
65106983|NCT01256476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65106984|NCT01256476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65106985|NCT01256476|Antimetabolites|antimetabolites|mesh-ancestor
65106986|NCT01256476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679409|NCT00002619|Alkylating Agents|alkylating agents|mesh-ancestor
64679410|NCT00002619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679411|NCT00002619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64679412|NCT00002619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64679413|NCT00002625|Topotecan|topotecan|mesh-list
64679414|NCT00002625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65106987|NCT01256476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65106988|NCT01256476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65106989|NCT01256476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65106990|NCT05507892|Canagliflozin|canagliflozin|mesh-list
65106991|NCT05507892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65106992|NCT05507892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65106993|NCT05507892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65107028|NCT04207021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65107029|NCT04207021|Analgesics|analgesics|mesh-ancestor
65107030|NCT04207021|Sensory System Agents|sensory system agents|mesh-ancestor
65107031|NCT04207021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65107032|NCT04207021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107033|NCT04207021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65107034|NCT04207021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65107035|NCT04207021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107036|NCT04207021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107037|NCT04207021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107038|NCT01255423|Diclofenac|diclofenac|mesh-list
65107039|NCT01255423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65107040|NCT01255423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65107041|NCT01255423|Analgesics|analgesics|mesh-ancestor
65107042|NCT01255423|Sensory System Agents|sensory system agents|mesh-ancestor
65107043|NCT01255423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65107044|NCT01255423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107045|NCT01255423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64749269|NCT04198662|Autonomic Agents|autonomic agents|mesh-ancestor
65107046|NCT01255423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65107047|NCT01255423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65107048|NCT01255423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107049|NCT01255423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107050|NCT01255306|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65107051|NCT01255306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65107052|NCT01255306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65107053|NCT01255306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65107054|NCT01255306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65107055|NCT01255306|Adrenergic Agents|adrenergic agents|mesh-ancestor
65107056|NCT01255306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64679498|NCT05806931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107070|NCT04005053|Expectorants|expectorants|mesh-ancestor
65107071|NCT04005053|Respiratory System Agents|respiratory system agents|mesh-ancestor
65107072|NCT04005053|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65107073|NCT04005053|Antioxidants|antioxidants|mesh-ancestor
65107074|NCT04005053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107075|NCT04005053|Protective Agents|protective agents|mesh-ancestor
65107076|NCT04005053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107077|NCT04005053|Antidotes|antidotes|mesh-ancestor
65107078|NCT04003805|Nicotine|nicotine|mesh-list
65107094|NCT01254604|Timolol|timolol|mesh-list
65107135|NCT04390698|Sensory System Agents|sensory system agents|mesh-ancestor
65107136|NCT04390698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65107137|NCT03795701|Liraglutide|liraglutide|mesh-list
65107138|NCT03795701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64679551|NCT05806385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64679552|NCT05806385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679553|NCT05806385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679554|NCT05806307|Vasopressins|vasopressins|mesh-list
65107139|NCT03795701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107140|NCT03795701|Incretins|incretins|mesh-ancestor
65107141|NCT03795701|Hormones|hormones|mesh-ancestor
65107142|NCT03795701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64749419|NCT04025658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64749420|NCT04025658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107189|NCT03724019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65107190|NCT03724019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65107191|NCT03724019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65107192|NCT03724019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107193|NCT00537420|Sibutramine|sibutramine|mesh-list
65107194|NCT00537420|Antidepressive Agents|antidepressive agents|mesh-ancestor
65107195|NCT00537420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65107196|NCT00537420|Appetite Depressants|appetite depressants|mesh-ancestor
65107197|NCT00537420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65107198|NCT03534284|Trazodone|trazodone|mesh-list
65107199|NCT03534284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65107200|NCT03534284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65107201|NCT03534284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65107245|NCT04319770|Protective Agents|protective agents|mesh-ancestor
65107246|NCT04548349|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65107247|NCT04548349|Dermatologic Agents|dermatologic agents|mesh-ancestor
65107248|NCT02722616|Pancrelipase|pancrelipase|mesh-list
65107249|NCT02722616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64679667|NCT05805800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64679668|NCT05805800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679669|NCT05805800|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64679670|NCT05805800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64679672|NCT05805800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65107250|NCT01253200|Acifluorfen|acifluorfen|mesh-list
65107251|NCT01253200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107252|NCT01253200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107253|NCT04515901|Lidocaine|lidocaine|mesh-list
65107254|NCT04515901|Anesthetics, Local|anesthetics, local|mesh-ancestor
65107255|NCT04515901|Anesthetics|anesthetics|mesh-ancestor
65107256|NCT04515901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65107257|NCT04515901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107258|NCT04515901|Sensory System Agents|sensory system agents|mesh-ancestor
65107260|NCT04515901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65107297|NCT04320589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65107298|NCT04320589|Adrenergic Agents|adrenergic agents|mesh-ancestor
65107299|NCT04320589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65107300|NCT04320589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107301|NCT04397692|Nitric Oxide|nitric oxide|mesh-list
65107302|NCT04397692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65107303|NCT04397692|Autonomic Agents|autonomic agents|mesh-ancestor
65107304|NCT04397692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65107305|NCT04397692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107306|NCT04397692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65107307|NCT04397692|Respiratory System Agents|respiratory system agents|mesh-ancestor
65107308|NCT04397692|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65107309|NCT04397692|Antioxidants|antioxidants|mesh-ancestor
65107310|NCT04397692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107311|NCT04397692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65107312|NCT04397692|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65107313|NCT04397692|Vasodilator Agents|vasodilator agents|mesh-ancestor
65107314|NCT04397692|Gasotransmitters|gasotransmitters|mesh-ancestor
65107315|NCT04397692|Protective Agents|protective agents|mesh-ancestor
65107316|NCT02203643|Dexamethasone|dexamethasone|mesh-list
65107317|NCT02203643|Cyclophosphamide|cyclophosphamide|mesh-list
65107318|NCT02203643|Lenalidomide|lenalidomide|mesh-list
65107319|NCT02203643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65107320|NCT02203643|Immunologic Factors|immunologic factors|mesh-ancestor
65107322|NCT02203643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64679761|NCT05775237|Sensory System Agents|sensory system agents|mesh-ancestor
64679762|NCT05775237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64679764|NCT05775237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64383207|NCT03175679|Interleukin-2|interleukin-2|mesh-list
64679822|NCT05751044|Antimetabolites|antimetabolites|mesh-ancestor
64679823|NCT05751044|Antiviral Agents|antiviral agents|mesh-ancestor
64679827|NCT05741164|Pembrolizumab|pembrolizumab|mesh-list
65107412|NCT01229072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107413|NCT01199978|Losartan|losartan|mesh-list
65107414|NCT01199978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65107415|NCT01199978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65107416|NCT01199978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65107417|NCT01199978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65107418|NCT01199978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107419|NCT00532116|Selegiline|selegiline|mesh-list
65107420|NCT00532116|Antidepressive Agents|antidepressive agents|mesh-ancestor
65107421|NCT00532116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65107422|NCT00532116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65107423|NCT00532116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65107424|NCT00532116|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65107425|NCT00532116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107426|NCT00532116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107427|NCT00532116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65107428|NCT00532116|Protective Agents|protective agents|mesh-ancestor
65107430|NCT04283513|Ribavirin|ribavirin|mesh-list
65107461|NCT02888548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65107462|NCT02888548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107463|NCT02888548|Cholinergic Agents|cholinergic agents|mesh-ancestor
64679870|NCT05648201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64679871|NCT05648201|Antiviral Agents|antiviral agents|mesh-ancestor
64679872|NCT05648201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64679873|NCT05648201|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64679874|NCT05648201|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64679875|NCT05648201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679877|NCT05631236|Methamphetamine|methamphetamine|mesh-list
64679878|NCT05631236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64679879|NCT05631236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107464|NCT02888548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64484028|NCT05574712|Leuprolide|leuprolide|mesh-list
65107512|NCT01250119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107513|NCT04320277|Ritonavir|ritonavir|mesh-list
65107514|NCT04320277|Lopinavir|lopinavir|mesh-list
65107515|NCT04320277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65107516|NCT04320277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65107517|NCT04320277|Protease Inhibitors|protease inhibitors|mesh-ancestor
65107518|NCT04320277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679915|NCT05627635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679916|NCT05627635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64679917|NCT05627635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64679918|NCT05627635|Antidotes|antidotes|mesh-ancestor
65107567|NCT05329116|Antioxidants|antioxidants|mesh-ancestor
65107568|NCT00537888|Fluconazole|fluconazole|mesh-list
64679968|NCT05580562|TIC10 compound|tic10 compound|mesh-list
64679969|NCT05580562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107569|NCT00537888|Antifungal Agents|antifungal agents|mesh-ancestor
65107570|NCT00537888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65107571|NCT00537888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65107572|NCT00537888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65107573|NCT00537888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107574|NCT00537888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107575|NCT00537888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65107576|NCT00537888|Hormone Antagonists|hormone antagonists|mesh-ancestor
65107626|NCT01246960|Micronutrients|micronutrients|mesh-ancestor
65107627|NCT00544986|Anastrozole|anastrozole|mesh-list
64680035|NCT05411575|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64680036|NCT05411575|Antiviral Agents|antiviral agents|mesh-ancestor
64680037|NCT05411575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64680038|NCT05367401|Azacitidine|azacitidine|mesh-list
65107628|NCT00544986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65107629|NCT00544986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107630|NCT00544986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65107631|NCT00544986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65107632|NCT00544986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107633|NCT00544986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107634|NCT00544986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65107635|NCT00544986|Hormone Antagonists|hormone antagonists|mesh-ancestor
65107636|NCT00544986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65107683|NCT00545142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107684|NCT00545142|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65107685|NCT00545142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65107686|NCT00545142|Serotonin Agents|serotonin agents|mesh-ancestor
65107687|NCT00545142|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65107688|NCT00545142|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65107689|NCT00545142|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65107690|NCT00545142|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65107691|NCT00545142|Anticonvulsants|anticonvulsants|mesh-ancestor
65107692|NCT00545142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107693|NCT00545142|GABA Agents|gaba agents|mesh-ancestor
65107694|NCT00545142|Antimanic Agents|antimanic agents|mesh-ancestor
65107695|NCT01267201|Methylprednisolone|methylprednisolone|mesh-list
64680080|NCT05286814|Antiviral Agents|antiviral agents|mesh-ancestor
65107740|NCT03736616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65107741|NCT03736616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65107742|NCT03736616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65107743|NCT03736616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65107744|NCT03736616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107745|NCT03736616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107746|NCT03736616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65107747|NCT03736616|Antimetabolites|antimetabolites|mesh-ancestor
65107748|NCT03736616|Antiviral Agents|antiviral agents|mesh-ancestor
64680123|NCT05262400|Fulvestrant|fulvestrant|mesh-list
64680124|NCT05262400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680125|NCT05262400|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64680126|NCT05262400|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64680127|NCT05262400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680128|NCT05262400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107791|NCT00537966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65107792|NCT00537966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65107793|NCT00537966|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65107794|NCT00537966|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65107795|NCT01266967|Dabrafenib|dabrafenib|mesh-list
65107796|NCT01266967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107797|NCT01266967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65107798|NCT01266967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107799|NCT01266967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107800|NCT03615326|Pembrolizumab|pembrolizumab|mesh-list
65107801|NCT03615326|Capecitabine|capecitabine|mesh-list
65107802|NCT03615326|Oxaliplatin|oxaliplatin|mesh-list
65107803|NCT03615326|Trastuzumab|trastuzumab|mesh-list
65107804|NCT03615326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107805|NCT03615326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65107806|NCT03615326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65107807|NCT03615326|Antimetabolites|antimetabolites|mesh-ancestor
65107808|NCT03615326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107809|NCT00538005|Bevacizumab|bevacizumab|mesh-list
65107810|NCT00538005|Oxaliplatin|oxaliplatin|mesh-list
65107811|NCT00538005|Sorafenib|sorafenib|mesh-list
65107812|NCT00538005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65107813|NCT00538005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107814|NCT00538005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65107815|NCT00538005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65107816|NCT00538005|Growth Substances|growth substances|mesh-ancestor
65107817|NCT00538005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65107818|NCT00538005|Growth Inhibitors|growth inhibitors|mesh-ancestor
65107819|NCT00538005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64680211|NCT04925479|Vitamin B Complex|vitamin b complex|mesh-ancestor
64680212|NCT04925479|Vitamins|vitamins|mesh-ancestor
64680213|NCT04925479|Micronutrients|micronutrients|mesh-ancestor
64680214|NCT04925479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680215|NCT04924101|Cisplatin|cisplatin|mesh-list
64680216|NCT04924101|Carboplatin|carboplatin|mesh-list
64680217|NCT04924101|Pembrolizumab|pembrolizumab|mesh-list
65107836|NCT03504956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65107837|NCT03504956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65107838|NCT03504956|Sympatholytics|sympatholytics|mesh-ancestor
64680331|NCT04669210|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65107897|NCT03268382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107898|NCT03268382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107899|NCT01266148|Cyclosporine|cyclosporine|mesh-list
64680332|NCT04669210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680333|NCT04669210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107900|NCT01266148|Mycophenolic Acid|mycophenolic acid|mesh-list
65107901|NCT01266148|Everolimus|everolimus|mesh-list
65107902|NCT01266148|Cyclosporins|cyclosporins|mesh-list
65107903|NCT01266148|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65107904|NCT01266148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107905|NCT01266148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107906|NCT01266148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65107957|NCT03202628|Hormones|hormones|mesh-ancestor
65107958|NCT03202628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64680386|NCT04617002|TIC10 compound|tic10 compound|mesh-list
64680387|NCT04617002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107959|NCT03202628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65107960|NCT03202628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65107961|NCT03202628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65107962|NCT03202628|Protease Inhibitors|protease inhibitors|mesh-ancestor
65107963|NCT03202628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65107964|NCT03202628|Immunologic Factors|immunologic factors|mesh-ancestor
65107965|NCT03202628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65107966|NCT03202628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65108017|NCT01265056|Antimanic Agents|antimanic agents|mesh-ancestor
65108018|NCT02942498|Vitamins|vitamins|mesh-list
65108019|NCT02942498|Vitamin E|vitamin e|mesh-list
65108020|NCT02942498|Micronutrients|micronutrients|mesh-ancestor
65108021|NCT02942498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108022|NCT02942498|Antioxidants|antioxidants|mesh-ancestor
65108023|NCT02942498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108024|NCT02942498|Protective Agents|protective agents|mesh-ancestor
65108025|NCT00545961|Amoxicillin|amoxicillin|mesh-list
65108026|NCT00545961|Clavulanic Acid|clavulanic acid|mesh-list
65108027|NCT00545961|Clavulanic Acids|clavulanic acids|mesh-list
65108028|NCT00545961|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65108029|NCT00545961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65108030|NCT00545961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65108031|NCT00545961|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65108032|NCT00545961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108033|NCT00545961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108034|NCT01264939|Omalizumab|omalizumab|mesh-list
65108035|NCT01264939|Diphenhydramine|diphenhydramine|mesh-list
65108036|NCT01264939|Promethazine|promethazine|mesh-list
65108037|NCT01264939|Leukotriene Antagonists|leukotriene antagonists|mesh-list
65108038|NCT01264939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
65108039|NCT01264939|Histamine Antagonists|histamine antagonists|mesh-list
65108040|NCT01264939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65108041|NCT01264939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65108042|NCT01264939|Respiratory System Agents|respiratory system agents|mesh-ancestor
65108043|NCT01264939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65108044|NCT01264939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65108045|NCT01264939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65108046|NCT01264939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108047|NCT01264939|Anesthetics, Local|anesthetics, local|mesh-ancestor
65108048|NCT01264939|Anesthetics|anesthetics|mesh-ancestor
65108049|NCT01264939|Sensory System Agents|sensory system agents|mesh-ancestor
65108050|NCT01264939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65108059|NCT01264939|Hormone Antagonists|hormone antagonists|mesh-ancestor
65108060|NCT01264939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65108061|NCT02889367|Odalasvir|odalasvir|mesh-list
65108062|NCT02889367|Antiviral Agents|antiviral agents|mesh-ancestor
65108063|NCT02889367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65108064|NCT00546039|Genistein|genistein|mesh-list
65108065|NCT00546039|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65108066|NCT00546039|Protective Agents|protective agents|mesh-ancestor
65108067|NCT00546039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108068|NCT00546039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108069|NCT00546039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65108070|NCT00546039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108071|NCT00546039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108072|NCT00546039|Phytoestrogens|phytoestrogens|mesh-ancestor
65108073|NCT00546039|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
65108074|NCT00546039|Estrogens|estrogens|mesh-ancestor
65108075|NCT00546039|Hormones|hormones|mesh-ancestor
65108076|NCT00546039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65108077|NCT01264081|Lapatinib|lapatinib|mesh-list
65108078|NCT01264081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108079|NCT01264081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65108080|NCT01264081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108081|NCT01264081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108082|NCT02711969|Apatinib|apatinib|mesh-list
65108083|NCT02711969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108084|NCT02711969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65108085|NCT02711969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108087|NCT01263925|Pentoxifylline|pentoxifylline|mesh-list
65108105|NCT04323631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108106|NCT04323631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108107|NCT04323631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65108108|NCT00546234|Tiotropium Bromide|tiotropium bromide|mesh-list
65108109|NCT00546234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65108110|NCT00546234|Autonomic Agents|autonomic agents|mesh-ancestor
65108111|NCT00546234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65108112|NCT00546234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108174|NCT02178410|Micronutrients|micronutrients|mesh-ancestor
65108175|NCT02178410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108176|NCT02178410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65108177|NCT02178410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65108178|NCT00539448|Insulin|insulin|mesh-list
65108179|NCT00539448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65108180|NCT00539448|Insulin Glargine|insulin glargine|mesh-list
65108181|NCT00539448|Insulin glulisine|insulin glulisine|mesh-list
65108182|NCT00539448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65108183|NCT00539448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108184|NCT05541484|Dapagliflozin|dapagliflozin|mesh-list
65108185|NCT05541484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65108186|NCT05541484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108188|NCT05541484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108189|NCT01808456|Vaccines|vaccines|mesh-list
65108190|NCT01808456|Immunologic Factors|immunologic factors|mesh-ancestor
65108191|NCT01808456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108192|NCT01715714|Atorvastatin|atorvastatin|mesh-list
65108193|NCT01715714|Simvastatin|simvastatin|mesh-list
65108232|NCT00539565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65108233|NCT00539565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108234|NCT00539565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65108235|NCT00539565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108236|NCT00539799|Prednisolone|prednisolone|mesh-list
65108237|NCT00539799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65108238|NCT00539799|Glucocorticoids|glucocorticoids|mesh-ancestor
64750467|NCT03878316|Oxytocics|oxytocics|mesh-ancestor
65108239|NCT00539799|Hormones|hormones|mesh-ancestor
65108240|NCT00539799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65108241|NCT00539799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108242|NCT00539799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65108243|NCT00539799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108244|NCT00945152|Vancomycin|vancomycin|mesh-list
65108245|NCT00945152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65108246|NCT00945152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65108247|NCT00546507|Celecoxib|celecoxib|mesh-list
65108248|NCT00546507|Diclofenac|diclofenac|mesh-list
65108249|NCT00546507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64680844|NCT03474497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680845|NCT03395223|Methylene Blue|methylene blue|mesh-list
64680846|NCT03395223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680847|NCT03395223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680848|NCT03370172|Factor VIII|factor viii|mesh-list
64680849|NCT03370172|Coagulants|coagulants|mesh-ancestor
64680850|NCT03289650|Tacrolimus|tacrolimus|mesh-list
64680851|NCT03289650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64680852|NCT03289650|Immunologic Factors|immunologic factors|mesh-ancestor
64680853|NCT03289650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108285|NCT00659711|Protease Inhibitors|protease inhibitors|mesh-ancestor
65108286|NCT00659711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108288|NCT02581007|Cyclophosphamide|cyclophosphamide|mesh-list
65108338|NCT02231723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65108339|NCT02231723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108340|NCT02231723|Tubulin Modulators|tubulin modulators|mesh-ancestor
65108341|NCT02231723|Antimitotic Agents|antimitotic agents|mesh-ancestor
65108342|NCT02231723|Mitosis Modulators|mitosis modulators|mesh-ancestor
65108343|NCT02231723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108344|NCT02231723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65108345|NCT02231723|Antimetabolites|antimetabolites|mesh-ancestor
65108346|NCT02231723|Antiviral Agents|antiviral agents|mesh-ancestor
65108347|NCT02231723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65108348|NCT02231723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108349|NCT02231723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65108350|NCT02231723|Immunologic Factors|immunologic factors|mesh-ancestor
65108351|NCT02231723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108352|NCT02231723|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65108353|NCT02231723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65108354|NCT02231723|Antidotes|antidotes|mesh-ancestor
65108355|NCT02231723|Protective Agents|protective agents|mesh-ancestor
65108356|NCT02231723|Vitamin B Complex|vitamin b complex|mesh-ancestor
65108357|NCT02231723|Vitamins|vitamins|mesh-ancestor
65108358|NCT02231723|Micronutrients|micronutrients|mesh-ancestor
65108359|NCT01263496|Alogliptin|alogliptin|mesh-list
65108360|NCT01263496|Voglibose|voglibose|mesh-list
65108361|NCT01263496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65108362|NCT01263496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108363|NCT01263496|Incretins|incretins|mesh-ancestor
65108364|NCT01263496|Hormones|hormones|mesh-ancestor
65108365|NCT01263496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65108366|NCT01263496|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65108367|NCT01263496|Protease Inhibitors|protease inhibitors|mesh-ancestor
65108368|NCT01263496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108369|NCT01263496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108370|NCT01263496|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65108380|NCT04681937|Antiemetics|antiemetics|mesh-ancestor
65108381|NCT04681937|Autonomic Agents|autonomic agents|mesh-ancestor
65108382|NCT04681937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65108383|NCT04681937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680929|NCT02975492|Ergocalciferols|ergocalciferols|mesh-list
64680930|NCT02975492|Cholecalciferol|cholecalciferol|mesh-list
64680931|NCT02975492|Vitamins|vitamins|mesh-list
64680932|NCT02975492|Micronutrients|micronutrients|mesh-ancestor
65108384|NCT04681937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65108385|NCT04681937|Glucocorticoids|glucocorticoids|mesh-ancestor
65108386|NCT04681937|Hormones|hormones|mesh-ancestor
65108387|NCT04681937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65108388|NCT04681937|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65108389|NCT04681937|Protective Agents|protective agents|mesh-ancestor
65108390|NCT04681937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65108391|NCT04681937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108392|NCT04681937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65108393|NCT04681937|Immunologic Factors|immunologic factors|mesh-ancestor
65108394|NCT04681937|Viscosupplements|viscosupplements|mesh-ancestor
65108395|NCT00547053|Amiloride|amiloride|mesh-list
65108396|NCT00547053|Diuretics|diuretics|mesh-ancestor
65108397|NCT00547053|Natriuretic Agents|natriuretic agents|mesh-ancestor
65108398|NCT00547053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108399|NCT00547053|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65108400|NCT00547053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65108401|NCT00547053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65108402|NCT00547053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108403|NCT00547053|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65108404|NCT00547053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65108405|NCT00547092|Sildenafil Citrate|sildenafil citrate|mesh-list
65108420|NCT01964495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65108421|NCT01964495|Antitubercular Agents|antitubercular agents|mesh-ancestor
65108422|NCT00547170|Doxycycline|doxycycline|mesh-list
65108423|NCT00547170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65108424|NCT00547170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65108425|NCT00547170|Antimalarials|antimalarials|mesh-ancestor
65108426|NCT00547170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65108427|NCT00547170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65108428|NCT00547209|Nitrous Oxide|nitrous oxide|mesh-list
65108429|NCT00547209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65108430|NCT00547209|Anesthetics, General|anesthetics, general|mesh-ancestor
65108431|NCT00547209|Anesthetics|anesthetics|mesh-ancestor
65108432|NCT00547209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65108433|NCT00547209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108434|NCT00547209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65108435|NCT00547209|Analgesics|analgesics|mesh-ancestor
65108436|NCT00547209|Sensory System Agents|sensory system agents|mesh-ancestor
65108437|NCT00547209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65108478|NCT00547443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108479|NCT00547599|Tadalafil|tadalafil|mesh-list
65108480|NCT00547599|Vasodilator Agents|vasodilator agents|mesh-ancestor
65108481|NCT00547599|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65108482|NCT00547599|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65108483|NCT00547599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108484|NCT00547599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108485|NCT00547599|Urological Agents|urological agents|mesh-ancestor
65108486|NCT02908763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65108487|NCT02908763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65108488|NCT02908763|Antiviral Agents|antiviral agents|mesh-ancestor
65108489|NCT02908763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65108490|NCT02908412|Bupivacaine|bupivacaine|mesh-list
65108491|NCT02908412|Anesthetics, Local|anesthetics, local|mesh-ancestor
65108492|NCT02908412|Anesthetics|anesthetics|mesh-ancestor
65108493|NCT02908412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65108494|NCT02908412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108495|NCT02908412|Sensory System Agents|sensory system agents|mesh-ancestor
65108496|NCT02908412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65108497|NCT02908295|Misoprostol|misoprostol|mesh-list
65108498|NCT02908295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65108499|NCT02908295|Abortifacient Agents|abortifacient agents|mesh-ancestor
65108500|NCT02908295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65108501|NCT02908295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108502|NCT02908295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65108503|NCT02908295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65108504|NCT02908295|Oxytocics|oxytocics|mesh-ancestor
65108505|NCT03809442|Dexamethasone|dexamethasone|mesh-list
65108506|NCT03809442|Midazolam|midazolam|mesh-list
65108507|NCT03809442|Dexmedetomidine|dexmedetomidine|mesh-list
65108508|NCT03809442|Ketamine|ketamine|mesh-list
65108509|NCT03809442|Tramadol|tramadol|mesh-list
65108510|NCT03809442|Ropivacaine|ropivacaine|mesh-list
65108511|NCT03809442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65108512|NCT03809442|Antiemetics|antiemetics|mesh-ancestor
65108513|NCT03809442|Autonomic Agents|autonomic agents|mesh-ancestor
65108520|NCT03809442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65108521|NCT03809442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681066|NCT02287623|Sensory System Agents|sensory system agents|mesh-ancestor
64681067|NCT02287623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64681068|NCT02266329|Prazosin|prazosin|mesh-list
64681069|NCT02266329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64681070|NCT02266329|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64681071|NCT02266329|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65108522|NCT03809442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65108523|NCT03809442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65108524|NCT03809442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65108576|NCT00534846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65108577|NCT00534846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65108578|NCT00534846|Hormone Antagonists|hormone antagonists|mesh-ancestor
65108579|NCT00534846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65108580|NCT00534846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108581|NCT00534846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65108582|NCT00548067|Amlodipine|amlodipine|mesh-list
64681111|NCT01787487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64681112|NCT01787487|Antimetabolites|antimetabolites|mesh-ancestor
64681113|NCT01787487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108631|NCT02907593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65108632|NCT02907593|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
65108633|NCT00548301|Cyclosporine|cyclosporine|mesh-list
65108634|NCT00548301|Cyclosporins|cyclosporins|mesh-list
65108635|NCT00548301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108636|NCT00548301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108637|NCT00548301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65108638|NCT00548301|Immunologic Factors|immunologic factors|mesh-ancestor
65108639|NCT00548301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108640|NCT00548301|Antifungal Agents|antifungal agents|mesh-ancestor
65108641|NCT00548301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65108642|NCT00548301|Dermatologic Agents|dermatologic agents|mesh-ancestor
65108643|NCT00548301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65108644|NCT00548301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65108645|NCT02907710|Endostar protein|endostar protein|mesh-list
65108646|NCT02907710|Endostatins|endostatins|mesh-list
65108647|NCT02907710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65108648|NCT02907710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65108649|NCT02907710|Growth Substances|growth substances|mesh-ancestor
65108650|NCT02907710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108651|NCT02907710|Growth Inhibitors|growth inhibitors|mesh-ancestor
65108652|NCT02907710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108653|NCT03781362|Capecitabine|capecitabine|mesh-list
65108654|NCT03781362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65108681|NCT04682210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108682|NCT04682210|Growth Inhibitors|growth inhibitors|mesh-ancestor
65108683|NCT04682132|Antibodies|antibodies|mesh-list
65108684|NCT04682132|Immunologic Factors|immunologic factors|mesh-ancestor
65108685|NCT04682132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108686|NCT02907554|Cyclosporine|cyclosporine|mesh-list
65108687|NCT02907554|Cyclosporins|cyclosporins|mesh-list
65108688|NCT02907554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750942|NCT03824106|Vitamin D|vitamin d|mesh-list
65108689|NCT02907554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108690|NCT02907554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65108691|NCT02907554|Immunologic Factors|immunologic factors|mesh-ancestor
65108692|NCT02907554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108693|NCT02907554|Antifungal Agents|antifungal agents|mesh-ancestor
65108694|NCT02907554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65108695|NCT02907554|Dermatologic Agents|dermatologic agents|mesh-ancestor
65108696|NCT02907554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65108697|NCT02907554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65108698|NCT02907632|Metoclopramide|metoclopramide|mesh-list
65108699|NCT02907632|Antiemetics|antiemetics|mesh-ancestor
65108700|NCT02907632|Autonomic Agents|autonomic agents|mesh-ancestor
65108701|NCT02907632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65108702|NCT02907632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108703|NCT02907632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65108704|NCT02907632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65108705|NCT02907632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65108706|NCT02907632|Dopamine Agents|dopamine agents|mesh-ancestor
65108712|NCT01262872|Vaccines|vaccines|mesh-list
65108729|NCT00548574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65108730|NCT00548574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65108731|NCT00548574|Analgesics|analgesics|mesh-ancestor
65108732|NCT00548574|Sensory System Agents|sensory system agents|mesh-ancestor
65108733|NCT00548574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65108734|NCT00548574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108735|NCT00548574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65108736|NCT00548574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65108737|NCT01262677|Pregabalin|pregabalin|mesh-list
65108738|NCT01262677|Analgesics|analgesics|mesh-ancestor
65108739|NCT01262677|Sensory System Agents|sensory system agents|mesh-ancestor
65108740|NCT01262677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65108741|NCT01262677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108742|NCT01262677|Anticonvulsants|anticonvulsants|mesh-ancestor
65108743|NCT01262677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65108744|NCT01262677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65108745|NCT01262677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108746|NCT01262677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65108747|NCT01262677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65108748|NCT01262677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65108749|NCT01262677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65108750|NCT01262677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65108751|NCT02899364|Sodium thiosulfate|sodium thiosulfate|mesh-list
65108752|NCT02899364|Antidotes|antidotes|mesh-ancestor
65108753|NCT02899364|Protective Agents|protective agents|mesh-ancestor
65108754|NCT02899364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108755|NCT02899364|Antioxidants|antioxidants|mesh-ancestor
64484087|NCT00790192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65108756|NCT02899364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108757|NCT02899364|Antitubercular Agents|antitubercular agents|mesh-ancestor
64681306|NCT00390793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64681307|NCT00390793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65108770|NCT00535080|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65108771|NCT00535080|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65108772|NCT00535080|Dermatologic Agents|dermatologic agents|mesh-ancestor
65108773|NCT01262638|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
65108774|NCT01262638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65108775|NCT01262638|Antimetabolites|antimetabolites|mesh-ancestor
65108839|NCT04043494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65108840|NCT04043494|Immunologic Factors|immunologic factors|mesh-ancestor
65108841|NCT04043494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65108842|NCT04043494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64681362|NCT00002643|Cyclophosphamide|cyclophosphamide|mesh-list
64681363|NCT00002643|Ifosfamide|ifosfamide|mesh-list
64681364|NCT00002643|Doxorubicin|doxorubicin|mesh-list
64681365|NCT00002643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65108843|NCT04043494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65108844|NCT04043494|Alkylating Agents|alkylating agents|mesh-ancestor
65108845|NCT04043494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108846|NCT04043494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108847|NCT04043494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65108848|NCT04043494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65108849|NCT04043494|Antiemetics|antiemetics|mesh-ancestor
65108850|NCT04043494|Autonomic Agents|autonomic agents|mesh-ancestor
65108851|NCT04043494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65108852|NCT04043494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65108854|NCT04043494|Hormones|hormones|mesh-ancestor
65108890|NCT02899169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65108891|NCT02899169|Keratolytic Agents|keratolytic agents|mesh-ancestor
65108892|NCT02899169|Dermatologic Agents|dermatologic agents|mesh-ancestor
65108893|NCT02899169|Antisickling Agents|antisickling agents|mesh-ancestor
65108894|NCT02899169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65108895|NCT02899169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108896|NCT02899169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65108897|NCT00548964|Ketamine|ketamine|mesh-list
64681411|NCT00002649|Analgesics|analgesics|mesh-ancestor
64681412|NCT00002649|Sensory System Agents|sensory system agents|mesh-ancestor
64681413|NCT00002649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64681414|NCT00002649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64681415|NCT00002649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64681418|NCT01151605|Insulin|insulin|mesh-list
65108898|NCT00548964|Lithium Carbonate|lithium carbonate|mesh-list
65108899|NCT00548964|Analgesics|analgesics|mesh-ancestor
65108944|NCT02898779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65108945|NCT02898779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65108946|NCT02898779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65108947|NCT00549120|Propranolol|propranolol|mesh-list
65108948|NCT00549120|Albuterol|albuterol|mesh-list
65108949|NCT00549120|Ipratropium|ipratropium|mesh-list
65108950|NCT00549120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65108951|NCT00549120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65108952|NCT00549120|Adrenergic Agents|adrenergic agents|mesh-ancestor
65108953|NCT00549120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65108954|NCT00549120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65108955|NCT00549120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109008|NCT00535665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109009|NCT03971110|Goserelin|goserelin|mesh-list
65109010|NCT03971110|Bicalutamide|bicalutamide|mesh-list
65109011|NCT03971110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65109012|NCT03971110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109013|NCT03971110|Androgen Antagonists|androgen antagonists|mesh-ancestor
65109014|NCT03971110|Hormone Antagonists|hormone antagonists|mesh-ancestor
65109015|NCT03971110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65109016|NCT03971110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109017|NCT01262287|Dutasteride|dutasteride|mesh-list
65109018|NCT01262287|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65109019|NCT01262287|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65109020|NCT01262287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109021|NCT01262287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109025|NCT01262092|Buprenorphine|buprenorphine|mesh-list
65109065|NCT03088410|Antiviral Agents|antiviral agents|mesh-ancestor
65109066|NCT03088410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65109067|NCT03088410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65109068|NCT03088410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65109069|NCT03088410|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65109070|NCT03088410|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64681579|NCT00002715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64681580|NCT00002715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64681581|NCT00002715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681582|NCT00002715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681583|NCT00002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64681584|NCT00002715|Glucocorticoids|glucocorticoids|mesh-ancestor
65109121|NCT00549666|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
65109122|NCT00549666|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65109123|NCT00549666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65109124|NCT00549666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65109125|NCT00549666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65109126|NCT00549666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109127|NCT00549666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65109128|NCT00549666|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65109129|NCT00549666|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65109130|NCT00549666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65109131|NCT00549666|Adrenergic Agents|adrenergic agents|mesh-ancestor
65109132|NCT00549666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65109133|NCT00549666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109134|NCT00549666|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65109135|NCT00549666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65109136|NCT00549666|Serotonin Agents|serotonin agents|mesh-ancestor
65109137|NCT00549666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65109138|NCT00549666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65109139|NCT00549666|Dopamine Agents|dopamine agents|mesh-ancestor
65109140|NCT00549666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65109141|NCT00549666|Contraceptive Agents|contraceptive agents|mesh-ancestor
65109142|NCT00549666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65109143|NCT00549666|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65109144|NCT00549666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65109145|NCT00549666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65109146|NCT00549666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65109147|NCT00549666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65109165|NCT04933383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65109166|NCT04933383|Respiratory System Agents|respiratory system agents|mesh-ancestor
65109167|NCT04933383|Glucocorticoids|glucocorticoids|mesh-ancestor
65109168|NCT04933383|Hormones|hormones|mesh-ancestor
65109169|NCT04933383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65109170|NCT00551538|Insulin Glargine|insulin glargine|mesh-list
65109171|NCT00551538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65109172|NCT00551538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109173|NCT03694522|Bemarituzumab|bemarituzumab|mesh-list
65109174|NCT03694522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65109175|NCT03694522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109176|NCT04891419|Lidocaine|lidocaine|mesh-list
65109177|NCT04891419|Anesthetics, Local|anesthetics, local|mesh-ancestor
65109178|NCT04891419|Anesthetics|anesthetics|mesh-ancestor
65109179|NCT04891419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65109180|NCT04891419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109181|NCT04891419|Sensory System Agents|sensory system agents|mesh-ancestor
65109182|NCT04891419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109183|NCT04891419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65109184|NCT04891419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65109185|NCT04891419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65109186|NCT04891419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65109187|NCT04891419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109188|NCT00551577|Carboplatin|carboplatin|mesh-list
64681724|NCT01625923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681725|NCT01625923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65109212|NCT04321096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109213|NCT04321096|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65109214|NCT04321096|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65109215|NCT03556696|Remifentanil|remifentanil|mesh-list
65109216|NCT03556696|Propofol|propofol|mesh-list
65109217|NCT03556696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65109218|NCT03556696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65109219|NCT03556696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109220|NCT03556696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65109221|NCT03556696|Anesthetics, General|anesthetics, general|mesh-ancestor
65109222|NCT03556696|Anesthetics|anesthetics|mesh-ancestor
65109223|NCT03556696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65109224|NCT03556696|Narcotics|narcotics|mesh-ancestor
65109225|NCT03556696|Analgesics|analgesics|mesh-ancestor
65109226|NCT03556696|Sensory System Agents|sensory system agents|mesh-ancestor
65109227|NCT03556696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109228|NCT04320706|Oxytocin|oxytocin|mesh-list
64681775|NCT00002757|Mitosis Modulators|mitosis modulators|mesh-ancestor
65109266|NCT02896205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109267|NCT04922424|Atorvastatin|atorvastatin|mesh-list
65109268|NCT04922424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65109269|NCT04922424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65109270|NCT04922424|Antimetabolites|antimetabolites|mesh-ancestor
65109271|NCT04922424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109272|NCT04922424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65109273|NCT04922424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65109274|NCT04922424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109275|NCT00553748|Alovudine|alovudine|mesh-list
65109276|NCT00553748|Antiviral Agents|antiviral agents|mesh-ancestor
65109277|NCT00553748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65109279|NCT00551850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109280|NCT00551850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65109281|NCT00551850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109282|NCT00551850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109283|NCT00550095|Valsartan|valsartan|mesh-list
65109284|NCT00550095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65109285|NCT00550095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64681829|NCT02975453|Antithrombins|antithrombins|mesh-ancestor
64681830|NCT02975453|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64681831|NCT02975453|Protease Inhibitors|protease inhibitors|mesh-ancestor
64681832|NCT02975453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681833|NCT02975453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109318|NCT04902495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65109320|NCT03433183|Sirolimus|sirolimus|mesh-list
65109381|NCT00550563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65109382|NCT00550563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109383|NCT00550563|Vitamins|vitamins|mesh-ancestor
65109384|NCT00550563|Micronutrients|micronutrients|mesh-ancestor
65109385|NCT00550563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65109386|NCT02895191|Urinastatin|urinastatin|mesh-list
65109387|NCT02895191|Trypsin Inhibitors|trypsin inhibitors|mesh-list
65109388|NCT02895191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65109389|NCT02895191|Protease Inhibitors|protease inhibitors|mesh-ancestor
65109390|NCT02895191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109391|NCT02895191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109392|NCT04680650|Anesthetics|anesthetics|mesh-list
65109393|NCT04680650|Propofol|propofol|mesh-list
65109394|NCT04680650|Sevoflurane|sevoflurane|mesh-list
65109395|NCT04680650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65109396|NCT04680650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109397|NCT04680650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65109398|NCT04680650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65109399|NCT04680650|Anesthetics, General|anesthetics, general|mesh-ancestor
65109400|NCT04680650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65109402|NCT02895113|Aspirin|aspirin|mesh-list
65109436|NCT00550992|Prednisone|prednisone|mesh-list
65109437|NCT00550992|Prednisolone|prednisolone|mesh-list
65109438|NCT00550992|Hydrocortisone|hydrocortisone|mesh-list
65109439|NCT00550992|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65109440|NCT00550992|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65109441|NCT00550992|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65109442|NCT00550992|Cyclophosphamide|cyclophosphamide|mesh-list
65109443|NCT00550992|Melphalan|melphalan|mesh-list
64681941|NCT04266197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681943|NCT04266197|Urological Agents|urological agents|mesh-ancestor
65109498|NCT00550992|Sensory System Agents|sensory system agents|mesh-ancestor
65109499|NCT02895074|Proxymetacaine|proxymetacaine|mesh-list
65109500|NCT02895074|Tropicamide|tropicamide|mesh-list
65109501|NCT02895074|Mydriatics|mydriatics|mesh-ancestor
65109502|NCT02895074|Autonomic Agents|autonomic agents|mesh-ancestor
64681991|NCT04248179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64681992|NCT04248179|Anesthetics, General|anesthetics, general|mesh-ancestor
64681993|NCT00361517|Amphotericin B|amphotericin b|mesh-list
64681994|NCT00361517|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64681996|NCT00361517|Deoxycholic Acid|deoxycholic acid|mesh-list
65109503|NCT02895074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109504|NCT02895074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109505|NCT02895074|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65109506|NCT02895074|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65109507|NCT02895074|Cholinergic Agents|cholinergic agents|mesh-ancestor
65109508|NCT02895074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65109509|NCT02895074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109510|NCT02895074|Anesthetics, Local|anesthetics, local|mesh-ancestor
65109511|NCT02895074|Anesthetics|anesthetics|mesh-ancestor
65109512|NCT02895074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65109513|NCT02895074|Sensory System Agents|sensory system agents|mesh-ancestor
65109514|NCT02894918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65109515|NCT02894918|Antiviral Agents|antiviral agents|mesh-ancestor
65109516|NCT02894918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65109518|NCT00551109|Nootropic Agents|nootropic agents|mesh-ancestor
65109546|NCT00551382|Montelukast|montelukast|mesh-list
65109547|NCT00551382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65109548|NCT00551382|Respiratory System Agents|respiratory system agents|mesh-ancestor
65109549|NCT00551382|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65109550|NCT00551382|Hormone Antagonists|hormone antagonists|mesh-ancestor
65109551|NCT00551382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65109552|NCT00551382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109553|NCT00551382|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65109554|NCT00551382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65109555|NCT00551382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109556|NCT02894684|Aztreonam|aztreonam|mesh-list
65109557|NCT02894684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65109558|NCT02894684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65109559|NCT02894645|Cytarabine|cytarabine|mesh-list
65109560|NCT02894645|Dexamethasone|dexamethasone|mesh-list
65109561|NCT02894645|Prednisolone|prednisolone|mesh-list
65109562|NCT02894645|Cyclophosphamide|cyclophosphamide|mesh-list
65109563|NCT02894645|Doxorubicin|doxorubicin|mesh-list
65109564|NCT02894645|Methotrexate|methotrexate|mesh-list
65109565|NCT02894645|Fludarabine|fludarabine|mesh-list
65109566|NCT02894645|Vincristine|vincristine|mesh-list
65109567|NCT02894645|Daunorubicin|daunorubicin|mesh-list
65109568|NCT02894645|Asparaginase|asparaginase|mesh-list
65109569|NCT02894645|Mercaptopurine|mercaptopurine|mesh-list
65109570|NCT02894645|Thioguanine|thioguanine|mesh-list
65109571|NCT02894645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65109572|NCT02894645|Immunologic Factors|immunologic factors|mesh-ancestor
65109573|NCT02894645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109574|NCT02894645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65109575|NCT02894645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65109576|NCT02894645|Alkylating Agents|alkylating agents|mesh-ancestor
65109578|NCT02894645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109590|NCT02894645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65109591|NCT02894645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65109592|NCT02894645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109593|NCT02894645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65109594|NCT02894645|Abortifacient Agents|abortifacient agents|mesh-ancestor
65109595|NCT02894645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64682077|NCT05614089|Insulin|insulin|mesh-list
64682078|NCT05614089|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64682079|NCT05614089|Insulin Glargine|insulin glargine|mesh-list
65109596|NCT02894645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65109597|NCT02894645|Antimetabolites|antimetabolites|mesh-ancestor
65109651|NCT05427305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109652|NCT05427305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65109653|NCT05427305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65109654|NCT05427305|Growth Substances|growth substances|mesh-ancestor
65109655|NCT05427305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109656|NCT05427305|Growth Inhibitors|growth inhibitors|mesh-ancestor
64682127|NCT04218851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109712|NCT04369794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109713|NCT05409885|Anesthetics|anesthetics|mesh-list
65109714|NCT05409885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65109715|NCT05409885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109716|NCT00552864|Ropivacaine|ropivacaine|mesh-list
65109717|NCT00552864|Levobupivacaine|levobupivacaine|mesh-list
65109718|NCT00552864|Anesthetics, Local|anesthetics, local|mesh-ancestor
64682183|NCT05513937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64682184|NCT05513937|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64682185|NCT05513937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64682186|NCT05513937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682187|NCT05513937|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64682188|NCT05513937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109719|NCT00552864|Anesthetics|anesthetics|mesh-ancestor
65109720|NCT00552864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65109721|NCT00552864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109722|NCT00552864|Sensory System Agents|sensory system agents|mesh-ancestor
65109723|NCT00552864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109760|NCT01232491|Insulin Detemir|insulin detemir|mesh-list
65109761|NCT01232491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65109762|NCT01232491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109763|NCT04335305|Pembrolizumab|pembrolizumab|mesh-list
65109764|NCT04335305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65109765|NCT04335305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109766|NCT04288089|Palbociclib|palbociclib|mesh-list
65109767|NCT04288089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109768|NCT04288089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65109769|NCT04288089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109770|NCT04288089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109771|NCT05371899|Chiauranib|chiauranib|mesh-list
65109772|NCT05371899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109773|NCT05371899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65109774|NCT05371899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109775|NCT05371899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109776|NCT05353140|Aspirin|aspirin|mesh-list
65109777|NCT05353140|Rivaroxaban|rivaroxaban|mesh-list
65109778|NCT05353140|Clopidogrel|clopidogrel|mesh-list
65109779|NCT05353140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65109780|NCT05353140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65109781|NCT05353140|Analgesics|analgesics|mesh-ancestor
65109782|NCT05353140|Sensory System Agents|sensory system agents|mesh-ancestor
65109783|NCT05353140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65109784|NCT05353140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109785|NCT05353140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65109786|NCT05353140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65109787|NCT05353140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65109788|NCT05353140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65109789|NCT05353140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109790|NCT05353140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65109791|NCT05353140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65109792|NCT05353140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109793|NCT05353140|Antipyretics|antipyretics|mesh-ancestor
65109794|NCT05353140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65109795|NCT05353140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64509169|NCT01933984|Fluticasone|fluticasone|mesh-list
64682259|NCT04120883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64682260|NCT04120883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109796|NCT05353140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65109797|NCT05353140|Purinergic Agents|purinergic agents|mesh-ancestor
65109798|NCT05353140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65109799|NCT05353140|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65109800|NCT05353140|Antithrombins|antithrombins|mesh-ancestor
65109801|NCT05353140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65109802|NCT05353140|Protease Inhibitors|protease inhibitors|mesh-ancestor
65109803|NCT05353140|Anticoagulants|anticoagulants|mesh-ancestor
65109804|NCT04152980|Pentoxifylline|pentoxifylline|mesh-list
65109805|NCT04152980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65109806|NCT04152980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109807|NCT04152980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109808|NCT04152980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65109809|NCT04152980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65109810|NCT04152980|Protective Agents|protective agents|mesh-ancestor
65109811|NCT04152980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109812|NCT04152980|Vasodilator Agents|vasodilator agents|mesh-ancestor
65109813|NCT04152980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65109814|NCT04152980|Antioxidants|antioxidants|mesh-ancestor
65109815|NCT01232452|Pemetrexed|pemetrexed|mesh-list
65109816|NCT01232452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109817|NCT01232452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65109818|NCT01232452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65109819|NCT01232452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65109842|NCT01211197|Metformin|metformin|mesh-list
65109843|NCT01211197|Empagliflozin|empagliflozin|mesh-list
65109844|NCT01211197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65109845|NCT01211197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65109846|NCT01211197|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65109848|NCT00553137|Fluconazole|fluconazole|mesh-list
65109907|NCT04116528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65109908|NCT04116528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65109909|NCT04116528|Anesthetics, General|anesthetics, general|mesh-ancestor
65109910|NCT04116528|Anesthetics|anesthetics|mesh-ancestor
65109911|NCT04116528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65109912|NCT04116528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65109913|NCT04116528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65109969|NCT05255367|Disinfectants|disinfectants|mesh-ancestor
65109970|NCT05255367|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65109971|NCT05255367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65109972|NCT04017936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65109973|NCT04017936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65109974|NCT03678350|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
65109975|NCT03678350|Trioxsalen|trioxsalen|mesh-list
65109976|NCT03678350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65109977|NCT03678350|Dermatologic Agents|dermatologic agents|mesh-ancestor
65109978|NCT03678350|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64682506|NCT01658995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65110035|NCT03570983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65110036|NCT03570983|Immunologic Factors|immunologic factors|mesh-ancestor
65110037|NCT03570983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110038|NCT03570983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65110039|NCT03570983|Alkylating Agents|alkylating agents|mesh-ancestor
65110040|NCT03570983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65110041|NCT03570983|Gout Suppressants|gout suppressants|mesh-ancestor
65110046|NCT03540758|Niacin|niacin|mesh-list
64682573|NCT00000315|Anesthetics, Local|anesthetics, local|mesh-ancestor
65110104|NCT05093205|Estradiol|estradiol|mesh-list
64484156|NCT01780987|Anticoagulants|anticoagulants|mesh-ancestor
65110105|NCT05093205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65110106|NCT05093205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65110107|NCT05093205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65110108|NCT05093205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110109|NCT05093205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65110110|NCT05093205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65110111|NCT05093205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65110112|NCT05093205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65110113|NCT05093205|Anesthetics, General|anesthetics, general|mesh-ancestor
65110115|NCT05093205|GABA Modulators|gaba modulators|mesh-ancestor
65110165|NCT02465606|Glucocorticoids|glucocorticoids|mesh-ancestor
65110166|NCT02465606|Hormones|hormones|mesh-ancestor
65110167|NCT02465606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65110168|NCT02465606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110169|NCT02465606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65110173|NCT05080530|Vitamin D|vitamin d|mesh-list
65110235|NCT03230565|Anesthetics|anesthetics|mesh-ancestor
65110236|NCT03230565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65110237|NCT03230565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110240|NCT02389985|Paclitaxel|paclitaxel|mesh-list
64682763|NCT00000345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64682764|NCT00000345|Adrenergic Agents|adrenergic agents|mesh-ancestor
64682765|NCT00000345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64682766|NCT00000345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682767|NCT00000357|Buprenorphine|buprenorphine|mesh-list
65110307|NCT05007132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65110308|NCT05007132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65110309|NCT05007132|Growth Substances|growth substances|mesh-ancestor
65110310|NCT05007132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110311|NCT05007132|Growth Inhibitors|growth inhibitors|mesh-ancestor
65110312|NCT05007132|Antimetabolites|antimetabolites|mesh-ancestor
65110313|NCT05007132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110314|NCT05007132|Antiviral Agents|antiviral agents|mesh-ancestor
65110315|NCT05007132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65110316|NCT04684017|Carboplatin|carboplatin|mesh-list
65110317|NCT04684017|Etoposide|etoposide|mesh-list
65110318|NCT04684017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110349|NCT04683198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65110350|NCT04683198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65110351|NCT04683198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65110352|NCT04683198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110353|NCT04683198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110354|NCT04683198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65110355|NCT03075423|Nivolumab|nivolumab|mesh-list
65110356|NCT03075423|Ipilimumab|ipilimumab|mesh-list
65110357|NCT03075423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65110358|NCT03075423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110359|NCT03075423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65110360|NCT03075423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110361|NCT02342249|Oseltamivir|oseltamivir|mesh-list
65110362|NCT02342249|Antiviral Agents|antiviral agents|mesh-ancestor
65110363|NCT02342249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65110364|NCT02342249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110365|NCT02342249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110366|NCT02339129|Ibuprofen|ibuprofen|mesh-list
65110367|NCT02339129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65110368|NCT02339129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65110369|NCT02339129|Analgesics|analgesics|mesh-ancestor
65110370|NCT02339129|Sensory System Agents|sensory system agents|mesh-ancestor
65110371|NCT02339129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65110372|NCT02339129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110373|NCT02339129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65110374|NCT02339129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65110375|NCT02339129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65110376|NCT02339129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110377|NCT02339129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110378|NCT02884206|Valsartan|valsartan|mesh-list
65110379|NCT02884206|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65110380|NCT02884206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65110381|NCT02884206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65110384|NCT02331134|Lenograstim|lenograstim|mesh-list
65110385|NCT02331134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65110386|NCT02331134|Immunologic Factors|immunologic factors|mesh-ancestor
65110387|NCT02331134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110388|NCT04961541|Vaccines|vaccines|mesh-list
65110389|NCT04961541|Immunologic Factors|immunologic factors|mesh-ancestor
65110390|NCT04961541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110391|NCT02326454|Talaporfin|talaporfin|mesh-list
64682848|NCT01610011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65110449|NCT04678076|Sensory System Agents|sensory system agents|mesh-ancestor
64682902|NCT00000441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65110450|NCT04678076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65110451|NCT04678076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110452|NCT04678076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65110453|NCT04678076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65110462|NCT02257619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110464|NCT04891302|Antiviral Agents|antiviral agents|mesh-ancestor
65110465|NCT04891302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65110466|NCT02224235|Aspirin|aspirin|mesh-list
65110467|NCT02224235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65110468|NCT02224235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65110469|NCT02224235|Analgesics|analgesics|mesh-ancestor
65110470|NCT02224235|Sensory System Agents|sensory system agents|mesh-ancestor
65110526|NCT02221232|Chlorhexidine|chlorhexidine|mesh-list
64682962|NCT01948310|Ranolazine|ranolazine|mesh-list
65110527|NCT02221232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65110528|NCT02221232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65110529|NCT02221232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65110530|NCT02221232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65110531|NCT02221232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110596|NCT01210144|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64683029|NCT00000483|Vasodilator Agents|vasodilator agents|mesh-ancestor
65110597|NCT01210144|Hormones|hormones|mesh-list
65110598|NCT01210144|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65110599|NCT01210144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65110600|NCT01210144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110601|NCT01210144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65110661|NCT01230892|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65110662|NCT01230892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65110663|NCT01230892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65110664|NCT01230892|Adrenergic Agents|adrenergic agents|mesh-ancestor
65110665|NCT01230892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65110666|NCT01230892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65110667|NCT01230892|Vasodilator Agents|vasodilator agents|mesh-ancestor
65110668|NCT01230892|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65110669|NCT01230892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65110722|NCT00556634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65110723|NCT00556634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65110724|NCT00556634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65110725|NCT00556634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65110726|NCT00556634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65110727|NCT00556634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65110728|NCT01209520|Paclitaxel|paclitaxel|mesh-list
65110729|NCT01209520|Vinorelbine|vinorelbine|mesh-list
65110730|NCT01209520|Docetaxel|docetaxel|mesh-list
65110731|NCT01209520|Cisplatin|cisplatin|mesh-list
65110732|NCT01209520|Carboplatin|carboplatin|mesh-list
65110733|NCT01209520|Pemetrexed|pemetrexed|mesh-list
65110734|NCT01209520|Azacitidine|azacitidine|mesh-list
65110735|NCT01209520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65110736|NCT01209520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110737|NCT01209520|Tubulin Modulators|tubulin modulators|mesh-ancestor
65110738|NCT01209520|Antimitotic Agents|antimitotic agents|mesh-ancestor
65110739|NCT01209520|Mitosis Modulators|mitosis modulators|mesh-ancestor
65110778|NCT04666805|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65110779|NCT04666805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65110781|NCT04766853|Hyaluronic Acid|hyaluronic acid|mesh-list
65110782|NCT04766853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65110783|NCT04766853|Antiemetics|antiemetics|mesh-ancestor
65110784|NCT04766853|Autonomic Agents|autonomic agents|mesh-ancestor
65110785|NCT04766853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65110786|NCT04766853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110787|NCT04766853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65110788|NCT04766853|Glucocorticoids|glucocorticoids|mesh-ancestor
65110789|NCT04766853|Hormones|hormones|mesh-ancestor
65110790|NCT04766853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65110791|NCT04766853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65110792|NCT04766853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65110793|NCT04766853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65110794|NCT04766853|Immunologic Factors|immunologic factors|mesh-ancestor
65110795|NCT04766853|Viscosupplements|viscosupplements|mesh-ancestor
65110796|NCT04766853|Protective Agents|protective agents|mesh-ancestor
65110797|NCT04721457|Povidone-Iodine|povidone-iodine|mesh-list
65110798|NCT04721457|Listerine|listerine|mesh-list
65110799|NCT04721457|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65110800|NCT04721457|Cetylpyridinium|cetylpyridinium|mesh-list
65110801|NCT04721457|Sodium Hypochlorite|sodium hypochlorite|mesh-list
65110802|NCT04721457|Eusol|eusol|mesh-list
65110803|NCT04721457|Povidone|povidone|mesh-list
65110804|NCT04721457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65110805|NCT04721457|Sodium Fluoride|sodium fluoride|mesh-list
65110806|NCT04721457|Plasma Substitutes|plasma substitutes|mesh-ancestor
65110807|NCT04721457|Blood Substitutes|blood substitutes|mesh-ancestor
65110808|NCT04721457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64683263|NCT00000633|Vaccines|vaccines|mesh-list
64683264|NCT00000633|Immunologic Factors|immunologic factors|mesh-ancestor
65110828|NCT04632927|Ustekinumab|ustekinumab|mesh-list
65110829|NCT04632927|Dermatologic Agents|dermatologic agents|mesh-ancestor
65110830|NCT04665830|Evolocumab|evolocumab|mesh-list
65110831|NCT04665830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65110832|NCT04665830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65110833|NCT04665830|Antimetabolites|antimetabolites|mesh-ancestor
64683329|NCT04942899|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65110894|NCT00557102|Immunologic Factors|immunologic factors|mesh-ancestor
65110895|NCT00557102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65110896|NCT00557102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65110897|NCT00557102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65110898|NCT00557102|Antidotes|antidotes|mesh-ancestor
65110899|NCT00557102|Protective Agents|protective agents|mesh-ancestor
65110900|NCT00557102|Vitamin B Complex|vitamin b complex|mesh-ancestor
65110901|NCT00557102|Vitamins|vitamins|mesh-ancestor
65110902|NCT00557102|Micronutrients|micronutrients|mesh-ancestor
65110903|NCT00557102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65110904|NCT04682691|Erythromycin|erythromycin|mesh-list
65110960|NCT04185051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65110961|NCT04185051|Sensory System Agents|sensory system agents|mesh-ancestor
65110962|NCT04185051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65110963|NCT04171050|Anesthetics|anesthetics|mesh-list
64683385|NCT00000723|Glucocorticoids|glucocorticoids|mesh-ancestor
64683386|NCT00000723|Hormones|hormones|mesh-ancestor
64683387|NCT00000723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64683388|NCT00000723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65110969|NCT04662788|Antibodies|antibodies|mesh-list
65111023|NCT04662125|Sensory System Agents|sensory system agents|mesh-ancestor
65111024|NCT04662125|Anticonvulsants|anticonvulsants|mesh-ancestor
65111025|NCT04662125|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65111026|NCT04662125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65111027|NCT04662125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111028|NCT04662125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65111029|NCT04662125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65111030|NCT04662125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65111031|NCT04662125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65111032|NCT04662125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65111033|NCT04662125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65111034|NCT04662125|Antipyretics|antipyretics|mesh-ancestor
65111035|NCT04662125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65111036|NCT04662125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65111043|NCT00557180|Bromides|bromides|mesh-list
65111084|NCT03818685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111085|NCT03818685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65111086|NCT03818685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65111087|NCT00539877|Irinotecan|irinotecan|mesh-list
65111088|NCT00539877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65111089|NCT00539877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65111090|NCT00539877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111091|NCT00539877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111092|NCT00539877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111093|NCT03798405|Analgesics|analgesics|mesh-list
65111094|NCT03798405|Narcotics|narcotics|mesh-list
65111095|NCT03798405|Sensory System Agents|sensory system agents|mesh-ancestor
65111096|NCT03798405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65111097|NCT03798405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111145|NCT04660565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65111146|NCT04660565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111147|NCT04660565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65111148|NCT04660565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111149|NCT04660565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65111150|NCT04660565|Immunologic Factors|immunologic factors|mesh-ancestor
65111151|NCT04319341|Autoantibodies|autoantibodies|mesh-list
65111152|NCT04319341|Immunologic Factors|immunologic factors|mesh-ancestor
65111153|NCT04319341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111154|NCT05420935|Immunoglobulin G|immunoglobulin g|mesh-list
65111210|NCT00540345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111211|NCT00540345|Immunologic Factors|immunologic factors|mesh-ancestor
65111212|NCT00540345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111213|NCT01207414|Iloperidone|iloperidone|mesh-list
65111214|NCT01207414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65111215|NCT01207414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65111216|NCT01207414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65111217|NCT01207414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111219|NCT00540384|Darbepoetin alfa|darbepoetin alfa|mesh-list
65111275|NCT01206439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111276|NCT01206439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111277|NCT01206322|Insulin|insulin|mesh-list
65111278|NCT01206322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65111279|NCT01206322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111280|NCT00540501|Oseltamivir|oseltamivir|mesh-list
65111281|NCT00540501|Zanamivir|zanamivir|mesh-list
65111282|NCT00540501|Antiviral Agents|antiviral agents|mesh-ancestor
65111283|NCT00540501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65111341|NCT04658225|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65111342|NCT04658225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65111343|NCT04658225|Disinfectants|disinfectants|mesh-ancestor
65111344|NCT05086692|Interleukin-2|interleukin-2|mesh-list
65111345|NCT05086692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111346|NCT05086692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65111347|NCT05086692|Analgesics|analgesics|mesh-ancestor
65111348|NCT05086692|Sensory System Agents|sensory system agents|mesh-ancestor
65111349|NCT05086692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65111350|NCT05086692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111351|NCT00540930|Ranibizumab|ranibizumab|mesh-list
65111358|NCT00541008|Sunitinib|sunitinib|mesh-list
64683821|NCT02974439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683822|NCT02974439|Vasodilator Agents|vasodilator agents|mesh-ancestor
64683823|NCT03345823|Upadacitinib|upadacitinib|mesh-list
65111405|NCT04657484|Glucocorticoids|glucocorticoids|mesh-ancestor
65111406|NCT04657484|Hormones|hormones|mesh-ancestor
65111407|NCT04657484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65111408|NCT04657484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111409|NCT04657484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65111470|NCT00541320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111471|NCT00541320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111472|NCT00541320|Anticoagulants|anticoagulants|mesh-ancestor
65111473|NCT04657172|Pilocarpine|pilocarpine|mesh-list
65111474|NCT04657172|Miotics|miotics|mesh-ancestor
65111475|NCT04657172|Autonomic Agents|autonomic agents|mesh-ancestor
65111536|NCT03013218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683947|NCT04230681|Fentanyl|fentanyl|mesh-list
65111537|NCT03013218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65111538|NCT04655807|Adalimumab|adalimumab|mesh-list
65111539|NCT04655807|Ustekinumab|ustekinumab|mesh-list
65111540|NCT04655807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65111541|NCT04655807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65111542|NCT04655807|Dermatologic Agents|dermatologic agents|mesh-ancestor
65111543|NCT04655417|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
65111544|NCT04655417|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65111545|NCT04655417|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65111601|NCT00541905|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65111602|NCT00541905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64753857|NCT04129710|Growth Substances|growth substances|mesh-ancestor
65111603|NCT00541905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65111604|NCT00541905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111605|NCT00541905|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65111606|NCT00541905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65111624|NCT02546583|Furosemide|furosemide|mesh-list
65111668|NCT03454841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111669|NCT03454841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111670|NCT02335944|Nazartinib|nazartinib|mesh-list
65111671|NCT02335944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111672|NCT02293980|Nivolumab|nivolumab|mesh-list
64684075|NCT04173507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64684076|NCT04173507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684077|NCT04173507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65111728|NCT00542763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65111729|NCT00542763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111730|NCT00542763|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65111731|NCT00542763|Antitubercular Agents|antitubercular agents|mesh-ancestor
65111732|NCT00542763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65111733|NCT00542763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64684129|NCT00421967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684130|NCT00421967|Sensory System Agents|sensory system agents|mesh-ancestor
64684131|NCT00421967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64684132|NCT00421967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64684134|NCT00421967|Analgesics|analgesics|mesh-ancestor
65111734|NCT00542763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65111735|NCT00542763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65111736|NCT01854684|Temoporfin|temoporfin|mesh-list
65111737|NCT01854684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111740|NCT00542802|Carbamazepine|carbamazepine|mesh-list
65111781|NCT00543075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111782|NCT00543114|Rituximab|rituximab|mesh-list
65111783|NCT00543114|Fludarabine|fludarabine|mesh-list
65111784|NCT00543114|Lenalidomide|lenalidomide|mesh-list
65111785|NCT00543114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65111786|NCT00543114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111787|NCT00543114|Immunologic Factors|immunologic factors|mesh-ancestor
65111788|NCT00543114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111789|NCT00543114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65111790|NCT00543114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65111791|NCT00543114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65111792|NCT00543114|Growth Substances|growth substances|mesh-ancestor
65111793|NCT00543114|Growth Inhibitors|growth inhibitors|mesh-ancestor
65111794|NCT03454724|Sirolimus|sirolimus|mesh-list
65111795|NCT03454724|Everolimus|everolimus|mesh-list
65111796|NCT03454724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65111797|NCT03454724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65111798|NCT03454724|Immunologic Factors|immunologic factors|mesh-ancestor
65111799|NCT03454724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65111800|NCT03454724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65111801|NCT03454724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65111802|NCT03454724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65111803|NCT03454724|Antifungal Agents|antifungal agents|mesh-ancestor
65111804|NCT01014546|Vitamins|vitamins|mesh-list
65111805|NCT01014546|Ascorbic Acid|ascorbic acid|mesh-list
65111806|NCT01014546|Arsenic Trioxide|arsenic trioxide|mesh-list
65111807|NCT01014546|Micronutrients|micronutrients|mesh-ancestor
65111808|NCT01014546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684222|NCT05114486|Miotics|miotics|mesh-ancestor
64684223|NCT05114486|Autonomic Agents|autonomic agents|mesh-ancestor
64684224|NCT05114486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64684225|NCT05114486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684226|NCT05114486|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64684227|NCT05114486|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65111831|NCT04651556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65111832|NCT04651556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65111833|NCT04651556|Analgesics|analgesics|mesh-ancestor
65111834|NCT04651556|Antipyretics|antipyretics|mesh-ancestor
65111835|NCT04651556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65111836|NCT04651556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65111858|NCT04651205|Thiamine|thiamine|mesh-list
64684267|NCT04388163|Gentian Violet|gentian violet|mesh-list
65111888|NCT00557921|Antipyretics|antipyretics|mesh-ancestor
65111889|NCT00557921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65111890|NCT00557921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65111891|NCT00557921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64684268|NCT04388163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64684269|NCT04388163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64684270|NCT03166761|Dexamethasone|dexamethasone|mesh-list
65111892|NCT00557921|Purinergic Agents|purinergic agents|mesh-ancestor
64684327|NCT00002901|Tubulin Modulators|tubulin modulators|mesh-ancestor
64684328|NCT00002901|Antimitotic Agents|antimitotic agents|mesh-ancestor
64684329|NCT00002901|Mitosis Modulators|mitosis modulators|mesh-ancestor
64684330|NCT00002901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684331|NCT00002907|Bryostatin 1|bryostatin 1|mesh-list
64684332|NCT00002907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64684333|NCT00002907|Immunologic Factors|immunologic factors|mesh-ancestor
65111952|NCT00558077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65111953|NCT00558077|Fertility Agents|fertility agents|mesh-ancestor
65111954|NCT00558077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65111955|NCT00558077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65112010|NCT00544011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65112011|NCT00544011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65112012|NCT00544011|Growth Substances|growth substances|mesh-ancestor
65112013|NCT00544011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112014|NCT00544011|Growth Inhibitors|growth inhibitors|mesh-ancestor
65112015|NCT00544011|Antimetabolites|antimetabolites|mesh-ancestor
65112016|NCT00544011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112017|NCT00544011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65112018|NCT00544011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65112019|NCT00544011|Immunologic Factors|immunologic factors|mesh-ancestor
65112073|NCT00544128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65112074|NCT00544128|Antiviral Agents|antiviral agents|mesh-ancestor
65112075|NCT00544128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65112076|NCT00544128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65112077|NCT00544128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65112078|NCT00544128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65112079|NCT00544128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65112080|NCT05476432|Leucovorin|leucovorin|mesh-list
65112081|NCT05476432|Fluorouracil|fluorouracil|mesh-list
65112082|NCT05476432|Oxaliplatin|oxaliplatin|mesh-list
65112083|NCT05476432|Antimetabolites|antimetabolites|mesh-ancestor
65112084|NCT05476432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112085|NCT05476432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65112086|NCT05476432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112133|NCT03456531|Analgesics|analgesics|mesh-list
65112134|NCT03456531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65112135|NCT03456531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65112136|NCT03456531|Sensory System Agents|sensory system agents|mesh-ancestor
65112137|NCT03456531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65112138|NCT03456531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112139|NCT03456531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65112140|NCT03456531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65112141|NCT03456531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65112147|NCT03456531|Antipyretics|antipyretics|mesh-ancestor
65112199|NCT01238575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112200|NCT01238575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112201|NCT01237951|Gemcitabine|gemcitabine|mesh-list
65112202|NCT01237951|Dexamethasone|dexamethasone|mesh-list
65112203|NCT01237951|Melphalan|melphalan|mesh-list
65112204|NCT01237951|Busulfan|busulfan|mesh-list
65112206|NCT01237951|Antiemetics|antiemetics|mesh-ancestor
65112270|NCT00544518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112271|NCT00544518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65112272|NCT00544518|Appetite Depressants|appetite depressants|mesh-ancestor
64684620|NCT01728337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64684621|NCT01728337|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64684622|NCT01728337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65112273|NCT00544518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65112274|NCT02908698|Prednisone|prednisone|mesh-list
65112275|NCT02908698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65112276|NCT02908698|Glucocorticoids|glucocorticoids|mesh-ancestor
65112332|NCT04647773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112333|NCT04647773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64684679|NCT01731691|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64684680|NCT02247739|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
65112334|NCT04647773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65112335|NCT04647773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65112336|NCT04647773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65112337|NCT04647773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65112338|NCT01237678|Carboplatin|carboplatin|mesh-list
65112339|NCT01237678|Etoposide|etoposide|mesh-list
65112340|NCT01237678|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
65112341|NCT01237678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112342|NCT01237678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65112343|NCT01237678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65112344|NCT01237678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65112345|NCT01237678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112346|NCT01237678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112348|NCT04647461|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65112384|NCT01237327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65112385|NCT01237327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112386|NCT01237327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65112387|NCT01237327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65112388|NCT01237327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65112389|NCT01237327|Contraceptive Agents|contraceptive agents|mesh-ancestor
65112390|NCT01237327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65112391|NCT01237327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65112392|NCT01237327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65112447|NCT04646876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65112448|NCT04646876|Tocolytic Agents|tocolytic agents|mesh-ancestor
65112449|NCT04646876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65112450|NCT02908035|Sirolimus|sirolimus|mesh-list
65112451|NCT02908035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65112452|NCT02908035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65112453|NCT02908035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65112454|NCT02908035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112455|NCT02908035|Antifungal Agents|antifungal agents|mesh-ancestor
65112456|NCT02908035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65112457|NCT02908035|Immunologic Factors|immunologic factors|mesh-ancestor
65112458|NCT02908035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112459|NCT04646759|Capecitabine|capecitabine|mesh-list
65112460|NCT04646759|Fulvestrant|fulvestrant|mesh-list
65112461|NCT04646759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65112462|NCT04646759|Antimetabolites|antimetabolites|mesh-ancestor
65112474|NCT04646135|Lorazepam|lorazepam|mesh-list
65112506|NCT04682184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65112507|NCT04682184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65112508|NCT04682184|Respiratory System Agents|respiratory system agents|mesh-ancestor
65112509|NCT04682184|Nasal Decongestants|nasal decongestants|mesh-ancestor
65112510|NCT04682184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65112511|NCT04682184|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65112512|NCT04682184|Sympathomimetics|sympathomimetics|mesh-ancestor
65112513|NCT04645940|Rabeprazole|rabeprazole|mesh-list
65112514|NCT04645940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65112515|NCT04645940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65112516|NCT04645940|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65112517|NCT04645940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112518|NCT04645940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112519|NCT00558506|Abatacept|abatacept|mesh-list
65112520|NCT00558506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65112521|NCT00558506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112522|NCT00558506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112523|NCT00558506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65112524|NCT00558506|Immunologic Factors|immunologic factors|mesh-ancestor
65112525|NCT00558506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112526|NCT00558506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65112527|NCT00558623|Calcium Carbonate|calcium carbonate|mesh-list
65112528|NCT00558623|Calcium|calcium|mesh-list
65112556|NCT02905890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65112557|NCT02905890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65112558|NCT02906163|Gefitinib|gefitinib|mesh-list
65112559|NCT02906163|Afatinib|afatinib|mesh-list
65112560|NCT02906163|Thymalfasin|thymalfasin|mesh-list
65112561|NCT02906163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112562|NCT02906163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65112563|NCT02906163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112564|NCT02906163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112565|NCT02906163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65112566|NCT02906163|Immunologic Factors|immunologic factors|mesh-ancestor
65112567|NCT02906163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112568|NCT04645745|Folic Acid|folic acid|mesh-list
65112569|NCT04645745|Inositol|inositol|mesh-list
65112570|NCT04645745|Hematinics|hematinics|mesh-ancestor
65112571|NCT04645745|Vitamin B Complex|vitamin b complex|mesh-ancestor
65112572|NCT04645745|Vitamins|vitamins|mesh-ancestor
65112573|NCT04645745|Micronutrients|micronutrients|mesh-ancestor
65112574|NCT04645745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112575|NCT02905695|Levobupivacaine|levobupivacaine|mesh-list
65112576|NCT02905695|Anesthetics, Local|anesthetics, local|mesh-ancestor
65112577|NCT02905695|Anesthetics|anesthetics|mesh-ancestor
65112578|NCT02905695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65112579|NCT02905695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112580|NCT02905695|Sensory System Agents|sensory system agents|mesh-ancestor
65112611|NCT02905734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112612|NCT02905734|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65112613|NCT02905734|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65112614|NCT02905734|Cholinergic Agents|cholinergic agents|mesh-ancestor
65112615|NCT02905734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65112616|NCT02905734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112617|NCT04644185|Myeloma Proteins|myeloma proteins|mesh-list
65112618|NCT04644185|Paraproteins|paraproteins|mesh-list
65112619|NCT04644185|Immunologic Factors|immunologic factors|mesh-ancestor
65112620|NCT04644185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112621|NCT02905461|Contraceptive Agents|contraceptive agents|mesh-list
65112676|NCT04643132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65112677|NCT04643132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65112678|NCT04643132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65112679|NCT04643132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112680|NCT04643132|Antidepressive Agents|antidepressive agents|mesh-ancestor
65112681|NCT04643132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65112682|NCT02899143|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65112684|NCT02899026|Prednisone|prednisone|mesh-list
65112743|NCT04642001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112744|NCT04642001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65112745|NCT04642001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65112746|NCT00559286|Telmisartan|telmisartan|mesh-list
65112747|NCT00559286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65112748|NCT00559286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65112749|NCT00559286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65112751|NCT04640870|Afatinib|afatinib|mesh-list
65112811|NCT04640285|Nicotine|nicotine|mesh-list
65112812|NCT04640285|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65112813|NCT04640285|Autonomic Agents|autonomic agents|mesh-ancestor
65112814|NCT04640285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65112815|NCT04640285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112816|NCT04640285|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65112817|NCT04640285|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65112818|NCT04640285|Cholinergic Agents|cholinergic agents|mesh-ancestor
65112819|NCT04640285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65112820|NCT04640285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112821|NCT04640285|Antipruritics|antipruritics|mesh-ancestor
65112822|NCT04640285|Dermatologic Agents|dermatologic agents|mesh-ancestor
65112823|NCT00559481|Ketoconazole|ketoconazole|mesh-list
65112824|NCT00559481|Dexamethasone|dexamethasone|mesh-list
65112825|NCT00559481|Hydrocortisone|hydrocortisone|mesh-list
65112826|NCT00559481|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65112827|NCT00559481|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65112830|NCT00559481|Antiemetics|antiemetics|mesh-ancestor
65112869|NCT04206631|Antimalarials|antimalarials|mesh-ancestor
65112870|NCT04206631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65112871|NCT04206631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65112872|NCT04639817|Levofloxacin|levofloxacin|mesh-list
65112873|NCT04639817|Ofloxacin|ofloxacin|mesh-list
65112874|NCT04639817|Trimethoprim|trimethoprim|mesh-list
65112875|NCT04639817|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65112876|NCT04639817|Sulfamethoxazole|sulfamethoxazole|mesh-list
65112877|NCT04639817|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65112878|NCT04639817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65112879|NCT04639817|Renal Agents|renal agents|mesh-ancestor
65112880|NCT04639817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65112881|NCT04639817|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65112882|NCT04639817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65112883|NCT04639817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112884|NCT04639817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112929|NCT01235728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112930|NCT01235728|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65112931|NCT01235728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65112932|NCT01235728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65112933|NCT01235728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65112934|NCT01235728|Vitamins|vitamins|mesh-ancestor
65112935|NCT01235728|Micronutrients|micronutrients|mesh-ancestor
65112936|NCT01235728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65112937|NCT01235728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65112938|NCT01235728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65112939|NCT01235728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65112940|NCT00559676|Leucovorin|leucovorin|mesh-list
65112993|NCT01235689|Glucocorticoids|glucocorticoids|mesh-ancestor
65112994|NCT01235689|Hormones|hormones|mesh-ancestor
65112995|NCT01235689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65112996|NCT01235689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65112997|NCT01235689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65112998|NCT01235689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65112999|NCT01235689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65113000|NCT01235689|Antimetabolites|antimetabolites|mesh-ancestor
65113060|NCT00553683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113061|NCT00553683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65113062|NCT00553683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65113063|NCT00553683|Interferon Inducers|interferon inducers|mesh-ancestor
65113064|NCT01229176|Vaccines|vaccines|mesh-list
65113065|NCT01229176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65113066|NCT01229176|Immunologic Factors|immunologic factors|mesh-ancestor
65113067|NCT01229176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113123|NCT02896101|Tacrolimus|tacrolimus|mesh-list
65113124|NCT02896101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65113125|NCT02896101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65113126|NCT02896101|Analgesics|analgesics|mesh-ancestor
65113127|NCT02896101|Sensory System Agents|sensory system agents|mesh-ancestor
65113128|NCT02896101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65113129|NCT02896101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113130|NCT02896101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65113191|NCT04637360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65113192|NCT04637360|Vitamins|vitamins|mesh-ancestor
65113193|NCT04637360|Micronutrients|micronutrients|mesh-ancestor
65113194|NCT04637360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65113195|NCT04637360|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65113196|NCT04637360|Hormone Antagonists|hormone antagonists|mesh-ancestor
65113197|NCT04637360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65113198|NCT04317703|Metformin|metformin|mesh-list
65113199|NCT04317703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65113200|NCT04317703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113201|NCT05656534|Suvorexant|suvorexant|mesh-list
65113202|NCT05656534|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65113203|NCT05656534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65113204|NCT05656534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65113205|NCT05656534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113206|NCT05656534|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65113207|NCT05656534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65113208|NCT05656534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113209|NCT00560222|Lactoferrin|lactoferrin|mesh-list
65113210|NCT00560222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65113211|NCT04317508|Benzocaine|benzocaine|mesh-list
65113212|NCT04317508|Anesthetics, Local|anesthetics, local|mesh-ancestor
65113213|NCT04317508|Anesthetics|anesthetics|mesh-ancestor
65113214|NCT04317508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64685594|NCT04514653|Growth Substances|growth substances|mesh-ancestor
64685595|NCT04514653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685596|NCT04514653|Growth Inhibitors|growth inhibitors|mesh-ancestor
65113243|NCT02904369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65113244|NCT02904369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65113249|NCT00560378|Tacrolimus|tacrolimus|mesh-list
65113310|NCT04635293|Vasodilator Agents|vasodilator agents|mesh-ancestor
65113311|NCT04635293|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65113312|NCT04635293|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65113313|NCT04635293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113314|NCT04635293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113315|NCT04635293|Protective Agents|protective agents|mesh-ancestor
65113316|NCT04635293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113317|NCT01227889|Dacarbazine|dacarbazine|mesh-list
65113319|NCT01227889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65113320|NCT01227889|Alkylating Agents|alkylating agents|mesh-ancestor
65113321|NCT01227889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113322|NCT01227889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65113323|NCT01227889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65113324|NCT01227889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113325|NCT02888392|Psyllium|psyllium|mesh-list
65113326|NCT02888392|Cathartics|cathartics|mesh-ancestor
65113327|NCT02888392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65113328|NCT00624676|Salicylic Acid|salicylic acid|mesh-list
65113329|NCT00624676|Benzoic Acid|benzoic acid|mesh-list
65113330|NCT00624676|Salicylates|salicylates|mesh-list
65113331|NCT00624676|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65113332|NCT00624676|Dermatologic Agents|dermatologic agents|mesh-ancestor
65113333|NCT00624676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64755586|NCT01924260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113334|NCT00624676|Antifungal Agents|antifungal agents|mesh-ancestor
65113335|NCT00624676|Keratolytic Agents|keratolytic agents|mesh-ancestor
65113336|NCT00624676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65113337|NCT00624676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65113338|NCT00624676|Analgesics|analgesics|mesh-ancestor
65113339|NCT00624676|Sensory System Agents|sensory system agents|mesh-ancestor
65113340|NCT00624676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65113341|NCT00624676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113347|NCT05655754|Methohexital|methohexital|mesh-list
65113351|NCT05655754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65113352|NCT05655754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113353|NCT05655715|Nivolumab|nivolumab|mesh-list
65113354|NCT05655715|Ipilimumab|ipilimumab|mesh-list
65113355|NCT05655715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65113356|NCT05655715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65113357|NCT05655715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65113358|NCT05655715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113417|NCT05658484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65113418|NCT05658484|Immunologic Factors|immunologic factors|mesh-ancestor
65113419|NCT05658484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113420|NCT04633967|Alemtuzumab|alemtuzumab|mesh-list
65113421|NCT04633967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65113422|NCT04633967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65113423|NCT04633850|Dexamethasone|dexamethasone|mesh-list
65113424|NCT04633850|Bupivacaine|bupivacaine|mesh-list
65113425|NCT04633850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65113426|NCT04633850|Antiemetics|antiemetics|mesh-ancestor
65113427|NCT04633850|Autonomic Agents|autonomic agents|mesh-ancestor
65113428|NCT04633850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65113429|NCT04633850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113430|NCT04633850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65113431|NCT04633850|Glucocorticoids|glucocorticoids|mesh-ancestor
65113432|NCT04633850|Hormones|hormones|mesh-ancestor
65113433|NCT04633850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65113434|NCT04633850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65113435|NCT04633850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65113436|NCT04633850|Anesthetics, Local|anesthetics, local|mesh-ancestor
65113437|NCT04633850|Anesthetics|anesthetics|mesh-ancestor
65113438|NCT04633850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65113439|NCT04633850|Sensory System Agents|sensory system agents|mesh-ancestor
65113440|NCT04633733|Tacrolimus|tacrolimus|mesh-list
65113441|NCT04633733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65113442|NCT04633733|Immunologic Factors|immunologic factors|mesh-ancestor
65113443|NCT04633733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113444|NCT04633733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65113445|NCT04633733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113446|NCT04633733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113447|NCT05427942|Adalimumab|adalimumab|mesh-list
65113448|NCT05427942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65113449|NCT05427942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65113450|NCT05427903|Epinephrine|epinephrine|mesh-list
65113451|NCT05427903|Anesthetics|anesthetics|mesh-list
65113452|NCT05427903|Carticaine|carticaine|mesh-list
65113453|NCT05427903|Anesthetics, Local|anesthetics, local|mesh-list
65113454|NCT05427903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65113455|NCT05427903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113456|NCT05427903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65113457|NCT05427903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65113458|NCT05427903|Adrenergic Agents|adrenergic agents|mesh-ancestor
65113459|NCT05427903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65113460|NCT05427903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113461|NCT05427903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65113462|NCT05427903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65113463|NCT05427903|Autonomic Agents|autonomic agents|mesh-ancestor
65113464|NCT05427903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65113465|NCT05427903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65113466|NCT05427903|Respiratory System Agents|respiratory system agents|mesh-ancestor
65113467|NCT05427903|Mydriatics|mydriatics|mesh-ancestor
65113468|NCT05427903|Sympathomimetics|sympathomimetics|mesh-ancestor
65113469|NCT05427903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65113470|NCT05427903|Sensory System Agents|sensory system agents|mesh-ancestor
65113471|NCT05427747|Meropenem|meropenem|mesh-list
65113514|NCT02903004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65113515|NCT02903004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65113516|NCT02903004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65113517|NCT02903004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65113518|NCT02903004|Alkylating Agents|alkylating agents|mesh-ancestor
65113519|NCT05427084|Canagliflozin|canagliflozin|mesh-list
65113520|NCT05427084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65113521|NCT05427084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113522|NCT05427084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64513730|NCT02893293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65113523|NCT05427084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113524|NCT00445796|Artesunate|artesunate|mesh-list
65113525|NCT00445796|Amodiaquine|amodiaquine|mesh-list
65113526|NCT00445796|Antimalarials|antimalarials|mesh-ancestor
65113527|NCT00445796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65113528|NCT00445796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65113529|NCT00445796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65113530|NCT00445796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65113531|NCT00445796|Antiviral Agents|antiviral agents|mesh-ancestor
65113532|NCT00445796|Schistosomicides|schistosomicides|mesh-ancestor
65113533|NCT00445796|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65113534|NCT00445796|Anthelmintics|anthelmintics|mesh-ancestor
65113535|NCT01225822|Enoxaparin|enoxaparin|mesh-list
65113536|NCT01225822|Dabigatran|dabigatran|mesh-list
65113537|NCT01225822|Anticoagulants|anticoagulants|mesh-ancestor
65113538|NCT01225822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65113539|NCT01225822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65113540|NCT01225822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113541|NCT01225822|Antithrombins|antithrombins|mesh-ancestor
65113542|NCT01225822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65113543|NCT01225822|Protease Inhibitors|protease inhibitors|mesh-ancestor
65113544|NCT01225822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113545|NCT00445874|Ketotifen|ketotifen|mesh-list
65113546|NCT00445874|Antipruritics|antipruritics|mesh-ancestor
65113547|NCT00445874|Dermatologic Agents|dermatologic agents|mesh-ancestor
65113548|NCT00445874|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65113549|NCT00445874|Histamine Antagonists|histamine antagonists|mesh-ancestor
64509170|NCT01933984|Fenoterol|fenoterol|mesh-list
64509171|NCT01933984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64509172|NCT01933984|Bronchodilator Agents|bronchodilator agents|mesh-list
65113550|NCT00445874|Histamine Agents|histamine agents|mesh-ancestor
65113551|NCT00445874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65113552|NCT00445874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113553|NCT00445874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113554|NCT00445874|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65113555|NCT02902731|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65113556|NCT02902731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65113557|NCT01225549|Budesonide|budesonide|mesh-list
65113558|NCT01225549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65113559|NCT01225549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65113560|NCT01225549|Autonomic Agents|autonomic agents|mesh-ancestor
65113561|NCT01225549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65113562|NCT01225549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113563|NCT01225549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65113564|NCT01225549|Respiratory System Agents|respiratory system agents|mesh-ancestor
65113565|NCT01225549|Glucocorticoids|glucocorticoids|mesh-ancestor
65113566|NCT01225549|Hormones|hormones|mesh-ancestor
65113567|NCT01225549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65113568|NCT05469685|Amoxicillin|amoxicillin|mesh-list
65113569|NCT05469685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65113570|NCT05469685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65113571|NCT02956772|Arsenic Trioxide|arsenic trioxide|mesh-list
65113572|NCT02956772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65113574|NCT00446069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65113575|NCT00446069|Narcotics|narcotics|mesh-ancestor
65113600|NCT01223404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65113601|NCT01223404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113602|NCT01223404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65113603|NCT01223404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65113604|NCT01223404|Cholinergic Agents|cholinergic agents|mesh-ancestor
65113605|NCT01223404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65113606|NCT01223404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113607|NCT01223404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65113611|NCT00446420|Fentanyl|fentanyl|mesh-list
65113666|NCT02956811|Dapagliflozin|dapagliflozin|mesh-list
65113667|NCT02956811|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65113668|NCT02956811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113669|NCT02956811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65113670|NCT02956811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113671|NCT04319419|Micronutrients|micronutrients|mesh-list
65113672|NCT04319419|Trace Elements|trace elements|mesh-list
65113673|NCT04319419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113674|NCT05657704|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65113676|NCT05657704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65113677|NCT05657704|Narcotics|narcotics|mesh-ancestor
65113678|NCT05657704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65113679|NCT05657704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113680|NCT05657704|Analgesics|analgesics|mesh-ancestor
65113681|NCT05657704|Sensory System Agents|sensory system agents|mesh-ancestor
65113684|NCT05657704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65113725|NCT02902380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65113726|NCT02902380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65113727|NCT02902380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113728|NCT02902380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65113729|NCT02902380|Analgesics|analgesics|mesh-ancestor
65113730|NCT02902380|Sensory System Agents|sensory system agents|mesh-ancestor
65113731|NCT02902380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65113732|NCT02902380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65113733|NCT02902380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65113734|NCT02902380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65113735|NCT02902380|Adrenergic Agents|adrenergic agents|mesh-ancestor
65113736|NCT02902380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65113737|NCT02902380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113738|NCT01221727|Denosumab|denosumab|mesh-list
65113739|NCT01221727|Midazolam|midazolam|mesh-list
65113740|NCT01221727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65113741|NCT01221727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65113782|NCT05426499|Cefotaxime|cefotaxime|mesh-list
65113783|NCT05426499|Cefoxitin|cefoxitin|mesh-list
65113784|NCT05426499|Antifungal Agents|antifungal agents|mesh-ancestor
65113785|NCT05426499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65113786|NCT05426499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65113787|NCT05426499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65113788|NCT05426499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113789|NCT05426499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113790|NCT05426499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65113791|NCT05426499|Hormone Antagonists|hormone antagonists|mesh-ancestor
65113792|NCT05426499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65113793|NCT05426499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113794|NCT05426499|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65113843|NCT05425875|Chelating Agents|chelating agents|mesh-ancestor
65113844|NCT05425875|Sequestering Agents|sequestering agents|mesh-ancestor
65113845|NCT05425875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113846|NCT00447473|Ketoconazole|ketoconazole|mesh-list
65113847|NCT00447473|Mitoxantrone|mitoxantrone|mesh-list
65113848|NCT00447473|Analgesics|analgesics|mesh-ancestor
65113849|NCT00447473|Sensory System Agents|sensory system agents|mesh-ancestor
65113850|NCT00447473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65113851|NCT00447473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113852|NCT00447473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65113853|NCT00447473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65113854|NCT00447473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65113855|NCT00447473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65113856|NCT00447473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113857|NCT00447473|Antifungal Agents|antifungal agents|mesh-ancestor
65113858|NCT00447473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65113859|NCT00447473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65113860|NCT00447473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65113861|NCT00447473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65113862|NCT00447473|Hormone Antagonists|hormone antagonists|mesh-ancestor
65113863|NCT00447473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65113864|NCT00447473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65113865|NCT00553488|Insulin|insulin|mesh-list
65113866|NCT00553488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65113867|NCT00553488|Insulin Lispro|insulin lispro|mesh-list
65113891|NCT00447863|Levonorgestrel|levonorgestrel|mesh-list
65113892|NCT00447863|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65113893|NCT00447863|Estradiol|estradiol|mesh-list
65113894|NCT00447863|Estrogens|estrogens|mesh-ancestor
65113895|NCT00447863|Hormones|hormones|mesh-ancestor
65113896|NCT00447863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65113897|NCT00447863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65113898|NCT00447863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65113899|NCT00447863|Contraceptive Agents|contraceptive agents|mesh-ancestor
65113900|NCT00447863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65113901|NCT00447863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65113902|NCT00447863|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65113903|NCT00447863|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65113904|NCT00447863|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65113905|NCT00448097|Docetaxel|docetaxel|mesh-list
65113906|NCT00448097|Cetuximab|cetuximab|mesh-list
65113907|NCT00448097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65113908|NCT00448097|Tubulin Modulators|tubulin modulators|mesh-ancestor
65113909|NCT00448097|Antimitotic Agents|antimitotic agents|mesh-ancestor
65113910|NCT00448097|Mitosis Modulators|mitosis modulators|mesh-ancestor
65113913|NCT00448214|Warfarin|warfarin|mesh-list
65113947|NCT03276689|Anticonvulsants|anticonvulsants|mesh-ancestor
65113948|NCT03276689|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65113949|NCT03276689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65113950|NCT03276689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65113951|NCT03276689|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65113952|NCT03276689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65113953|NCT03276689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65113954|NCT03276689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65113955|NCT03276689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65113956|NCT03276689|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65113957|NCT03276689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65113958|NCT03276689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65113959|NCT03276689|Antidepressive Agents|antidepressive agents|mesh-ancestor
65113960|NCT03276689|Dopamine Agents|dopamine agents|mesh-ancestor
65113961|NCT01220128|Paclitaxel|paclitaxel|mesh-list
65113962|NCT01220128|Docetaxel|docetaxel|mesh-list
65113963|NCT01220128|Cyclophosphamide|cyclophosphamide|mesh-list
65113964|NCT01220128|Carboplatin|carboplatin|mesh-list
65113965|NCT01220128|Doxorubicin|doxorubicin|mesh-list
65113966|NCT01220128|Fluorouracil|fluorouracil|mesh-list
65114001|NCT04698941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114002|NCT04698941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65114003|NCT04698941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65114004|NCT04698941|Antimetabolites|antimetabolites|mesh-ancestor
65114005|NCT04698941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65114006|NCT04698941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65114007|NCT04698941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114008|NCT02901288|Levofloxacin|levofloxacin|mesh-list
65114009|NCT02901288|Ofloxacin|ofloxacin|mesh-list
65114010|NCT02901288|Rifampin|rifampin|mesh-list
65114067|NCT01219933|Methylprednisolone|methylprednisolone|mesh-list
65114068|NCT01219933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65114069|NCT01219933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65114070|NCT01219933|Prednisolone|prednisolone|mesh-list
65114071|NCT01219933|Prednisolone acetate|prednisolone acetate|mesh-list
65114072|NCT01219933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65114073|NCT01219933|Prednisolone phosphate|prednisolone phosphate|mesh-list
65114074|NCT01219933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65114075|NCT01219933|Antiemetics|antiemetics|mesh-ancestor
65114076|NCT01219933|Autonomic Agents|autonomic agents|mesh-ancestor
65114077|NCT01219933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65114078|NCT01219933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114079|NCT01219933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65114080|NCT01219933|Glucocorticoids|glucocorticoids|mesh-ancestor
65114081|NCT01219933|Hormones|hormones|mesh-ancestor
65114082|NCT01219933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65114083|NCT01219933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65114084|NCT01219933|Protective Agents|protective agents|mesh-ancestor
65114085|NCT01219933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65114125|NCT05468359|Growth Inhibitors|growth inhibitors|mesh-ancestor
65114126|NCT05468359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65114127|NCT05468359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114128|NCT04316845|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
65114129|NCT04316845|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65114130|NCT04316845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114131|NCT01218802|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65114132|NCT01218802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65114133|NCT01218802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65114134|NCT01218802|Antimetabolites|antimetabolites|mesh-ancestor
65114135|NCT01218802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114187|NCT01188772|Antiviral Agents|antiviral agents|mesh-ancestor
65114188|NCT01188772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65114189|NCT01188655|Etanercept|etanercept|mesh-list
65114190|NCT01188655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65114191|NCT01188655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65114192|NCT01188655|Analgesics|analgesics|mesh-ancestor
65114193|NCT01188655|Sensory System Agents|sensory system agents|mesh-ancestor
65114194|NCT01188655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65114195|NCT01188655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114196|NCT01188655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65114197|NCT01188655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65114198|NCT01188655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65114199|NCT01188655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65114200|NCT01188655|Immunologic Factors|immunologic factors|mesh-ancestor
65114201|NCT00449618|Aspirin|aspirin|mesh-list
65114202|NCT00449618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65114246|NCT04318444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65114247|NCT04318444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65114248|NCT04318444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65114249|NCT04318444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114250|NCT04318444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114251|NCT04318444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65114252|NCT03276143|Enoxaparin|enoxaparin|mesh-list
65114314|NCT01218100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65114315|NCT00450008|Thalidomide|thalidomide|mesh-list
65114316|NCT00450008|Docetaxel|docetaxel|mesh-list
65114317|NCT00450008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114318|NCT00450008|Tubulin Modulators|tubulin modulators|mesh-ancestor
65114319|NCT00450008|Antimitotic Agents|antimitotic agents|mesh-ancestor
65114320|NCT00450008|Mitosis Modulators|mitosis modulators|mesh-ancestor
65114321|NCT00450008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114322|NCT00450008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65114323|NCT00450008|Immunologic Factors|immunologic factors|mesh-ancestor
65114324|NCT00450008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114378|NCT00450164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65114379|NCT00450164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65114380|NCT00450164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65114381|NCT00450164|Sympatholytics|sympatholytics|mesh-ancestor
65114382|NCT00450164|Autonomic Agents|autonomic agents|mesh-ancestor
65114383|NCT00450164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65114384|NCT02900157|Durvalumab|durvalumab|mesh-list
65114385|NCT02900157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65114386|NCT02900157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114443|NCT00450398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65114444|NCT00450398|Immunologic Factors|immunologic factors|mesh-ancestor
65114445|NCT00450398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114446|NCT00450398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65114447|NCT00450398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114448|NCT00450398|Antiviral Agents|antiviral agents|mesh-ancestor
65114449|NCT00450398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65114450|NCT00450398|Interferon Inducers|interferon inducers|mesh-ancestor
65114451|NCT00450398|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65114452|NCT00450398|Protective Agents|protective agents|mesh-ancestor
65114453|NCT00450515|Capecitabine|capecitabine|mesh-list
65114454|NCT00450515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65114455|NCT00450515|Antimetabolites|antimetabolites|mesh-ancestor
65114456|NCT00450515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114457|NCT00450515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114458|NCT04447989|Sildenafil Citrate|sildenafil citrate|mesh-list
65114459|NCT04447989|Vasodilator Agents|vasodilator agents|mesh-ancestor
65114460|NCT04447989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65114461|NCT04447989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65114499|NCT04341441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65114500|NCT04341441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114501|NCT04341441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114570|NCT01186939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114571|NCT04447040|Acetaminophen|acetaminophen|mesh-list
65114572|NCT04447040|Naproxen|naproxen|mesh-list
65114573|NCT04447040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65114574|NCT04447040|Analgesics|analgesics|mesh-ancestor
65114575|NCT04447040|Sensory System Agents|sensory system agents|mesh-ancestor
65114576|NCT04447040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65114577|NCT04447040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114578|NCT04447040|Antipyretics|antipyretics|mesh-ancestor
65114579|NCT04447040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65114580|NCT04447040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65114581|NCT04447040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65114582|NCT04447040|Gout Suppressants|gout suppressants|mesh-ancestor
65114583|NCT04447040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65114584|NCT04447040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65114585|NCT04447040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114586|NCT05321043|Riboflavin|riboflavin|mesh-list
65114587|NCT05321043|Vitamins|vitamins|mesh-ancestor
65114588|NCT05321043|Micronutrients|micronutrients|mesh-ancestor
65114589|NCT05321043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114590|NCT05321043|Vitamin B Complex|vitamin b complex|mesh-ancestor
65114592|NCT05321043|Dermatologic Agents|dermatologic agents|mesh-ancestor
65114625|NCT05289492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114626|NCT05289492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65114627|NCT05289492|Glucocorticoids|glucocorticoids|mesh-ancestor
65114628|NCT05289492|Hormones|hormones|mesh-ancestor
65114629|NCT05289492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65114630|NCT05289492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65114631|NCT05289492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114632|NCT02930057|Betamethasone|betamethasone|mesh-list
65114633|NCT02930057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65114634|NCT02930057|Glucocorticoids|glucocorticoids|mesh-ancestor
65114687|NCT05219409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114688|NCT04689893|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
65114689|NCT04689893|Chelating Agents|chelating agents|mesh-ancestor
65114690|NCT04689893|Sequestering Agents|sequestering agents|mesh-ancestor
65114691|NCT04689893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114692|NCT05184192|Gabapentin|gabapentin|mesh-list
65114693|NCT05184192|Analgesics|analgesics|mesh-ancestor
65114694|NCT05184192|Sensory System Agents|sensory system agents|mesh-ancestor
65114695|NCT05184192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65114696|NCT05184192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114697|NCT05184192|Anticonvulsants|anticonvulsants|mesh-ancestor
65114698|NCT05184192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65114699|NCT05184192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65114700|NCT05184192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65114701|NCT05184192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65114702|NCT05184192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65114703|NCT05184192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65114704|NCT05184192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65114705|NCT05184192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114706|NCT05184192|Antimanic Agents|antimanic agents|mesh-ancestor
65114707|NCT02929121|Doxycycline|doxycycline|mesh-list
65114708|NCT02929121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65114709|NCT02929121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65114710|NCT02929121|Antimalarials|antimalarials|mesh-ancestor
65114711|NCT02929121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65114712|NCT02929121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65114713|NCT02929394|Trabectedin|trabectedin|mesh-list
65114714|NCT02929394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65114715|NCT02929394|Alkylating Agents|alkylating agents|mesh-ancestor
65114716|NCT02929394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114717|NCT02929394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114718|NCT02929316|Vedolizumab|vedolizumab|mesh-list
65114719|NCT02929316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64509174|NCT01933984|Autonomic Agents|autonomic agents|mesh-ancestor
64509175|NCT01933984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509176|NCT01933984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509177|NCT01933984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64509178|NCT01933984|Respiratory System Agents|respiratory system agents|mesh-ancestor
65114720|NCT05134974|Phentolamine|phentolamine|mesh-list
65114721|NCT05134974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65114722|NCT05134974|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65114723|NCT05134974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65114724|NCT05134974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65114725|NCT05134974|Adrenergic Agents|adrenergic agents|mesh-ancestor
65114726|NCT05134974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65114727|NCT05134974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114728|NCT05134974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114729|NCT05134974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65114730|NCT02928965|Minocycline|minocycline|mesh-list
65114731|NCT02928965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65114732|NCT02928965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65114782|NCT03685500|Protease Inhibitors|protease inhibitors|mesh-ancestor
65114783|NCT03685500|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65114784|NCT03685500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65114785|NCT02928575|Temozolomide|temozolomide|mesh-list
65114786|NCT02928575|Sunitinib|sunitinib|mesh-list
65114787|NCT02928575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65114788|NCT02928575|Alkylating Agents|alkylating agents|mesh-ancestor
65114790|NCT02928575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114848|NCT02927522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114849|NCT02927522|Nootropic Agents|nootropic agents|mesh-ancestor
65114850|NCT02926976|Valproic Acid|valproic acid|mesh-list
65114851|NCT02926976|Risperidone|risperidone|mesh-list
65114852|NCT02926976|Aripiprazole|aripiprazole|mesh-list
65114853|NCT02926976|Clozapine|clozapine|mesh-list
65114854|NCT02926976|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65114855|NCT02926976|Serotonin Agents|serotonin agents|mesh-ancestor
65114856|NCT02926976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65114857|NCT02926976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65114915|NCT04680195|Growth Substances|growth substances|mesh-ancestor
65114916|NCT04680195|Growth Inhibitors|growth inhibitors|mesh-ancestor
65114917|NCT04680195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65114918|NCT04864431|Vitamin D|vitamin d|mesh-list
65114919|NCT04864431|Cholecalciferol|cholecalciferol|mesh-list
65114920|NCT04864431|Vitamins|vitamins|mesh-ancestor
65114921|NCT04864431|Micronutrients|micronutrients|mesh-ancestor
65114922|NCT04864431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114923|NCT04864431|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65114924|NCT04864431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65114925|NCT00553995|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
65114926|NCT00553995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65114927|NCT00553995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65114928|NCT00553995|Analgesics|analgesics|mesh-ancestor
65114929|NCT00553995|Sensory System Agents|sensory system agents|mesh-ancestor
65114930|NCT00553995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65114931|NCT00553995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65114974|NCT02917889|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65114975|NCT02917889|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65114976|NCT02917889|Purinergic Agents|purinergic agents|mesh-ancestor
65114977|NCT02917889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65114978|NCT02917967|Botulinum Toxins|botulinum toxins|mesh-list
65114979|NCT02917967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65115044|NCT02153502|Antimalarials|antimalarials|mesh-ancestor
65115045|NCT02153502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65115046|NCT02153502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65115047|NCT02153502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65115048|NCT02153502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115049|NCT02153502|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65115050|NCT02153502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65115051|NCT02153502|Cholinergic Agents|cholinergic agents|mesh-ancestor
65115052|NCT02153502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65115053|NCT02153502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65115054|NCT02153502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65115055|NCT02153502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65115056|NCT02153502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65115057|NCT02130687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65115058|NCT02130687|Aprepitant|aprepitant|mesh-list
65115059|NCT02130687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65115060|NCT02130687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115061|NCT02130687|Incretins|incretins|mesh-ancestor
65115062|NCT02130687|Hormones|hormones|mesh-ancestor
65115063|NCT02130687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65115064|NCT02130687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65115065|NCT02130687|Protease Inhibitors|protease inhibitors|mesh-ancestor
65115066|NCT02130687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115068|NCT02130687|Antiemetics|antiemetics|mesh-ancestor
65115094|NCT02125266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65115095|NCT02125266|Abortifacient Agents|abortifacient agents|mesh-ancestor
65115096|NCT02125266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65115097|NCT02125266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115098|NCT02125266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65115099|NCT02125266|Antimetabolites|antimetabolites|mesh-ancestor
65115100|NCT02125266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115101|NCT02125266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115159|NCT02916602|Natriuretic Agents|natriuretic agents|mesh-ancestor
65115160|NCT02916602|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65115161|NCT02916251|Glucagon|glucagon|mesh-list
65115162|NCT02916251|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65115163|NCT02916251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65115164|NCT02916251|Hormones|hormones|mesh-ancestor
65115165|NCT02916251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65115166|NCT02916251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115225|NCT01699464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65115226|NCT01699464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115227|NCT01699464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65115228|NCT01699464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65115229|NCT04688645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65115230|NCT02104050|Dapansutrile|dapansutrile|mesh-list
65115231|NCT02104050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65115232|NCT02102802|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65115233|NCT02102802|Hallucinogens|hallucinogens|mesh-ancestor
65115234|NCT02102802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115235|NCT02102802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65115288|NCT02915354|Analgesics|analgesics|mesh-ancestor
65115289|NCT02915354|Sensory System Agents|sensory system agents|mesh-ancestor
65115290|NCT02915354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65115291|NCT02915354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115292|NCT02915354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65115293|NCT02915354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65115294|NCT02915354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65115295|NCT02915354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65115356|NCT02914652|Tocolytic Agents|tocolytic agents|mesh-ancestor
65115357|NCT02914652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65115358|NCT02914652|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65115359|NCT02914652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65115360|NCT02914652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65115361|NCT02914652|Adrenergic Agents|adrenergic agents|mesh-ancestor
65115362|NCT02914652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65115363|NCT02914652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115364|NCT02081118|Exenatide|exenatide|mesh-list
65115365|NCT02081118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65115366|NCT02081118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115367|NCT02081118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65115368|NCT02081118|Incretins|incretins|mesh-ancestor
65115369|NCT02081118|Hormones|hormones|mesh-ancestor
65115370|NCT02081118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65115371|NCT02914613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65115372|NCT02914613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65115373|NCT02077881|Gemcitabine|gemcitabine|mesh-list
65115374|NCT02077881|Paclitaxel|paclitaxel|mesh-list
65115413|NCT01628094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65115414|NCT01628094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65115415|NCT01628094|Antimetabolites|antimetabolites|mesh-ancestor
65115416|NCT02073123|Pembrolizumab|pembrolizumab|mesh-list
65115417|NCT02073123|Nivolumab|nivolumab|mesh-list
65115418|NCT02073123|Ipilimumab|ipilimumab|mesh-list
65115419|NCT02073123|Tryptophan|tryptophan|mesh-list
65115420|NCT02073123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65115421|NCT02073123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115422|NCT02073123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65115423|NCT02073123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115424|NCT02073123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65115425|NCT02073123|Antidepressive Agents|antidepressive agents|mesh-ancestor
65115426|NCT02073123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65115427|NCT02914145|Piperaquine|piperaquine|mesh-list
65115428|NCT02914145|Artenimol|artenimol|mesh-list
65115429|NCT02914145|Antimalarials|antimalarials|mesh-ancestor
65115430|NCT02914145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65115433|NCT02914028|Acetaminophen|acetaminophen|mesh-list
65115471|NCT02063997|Tubulin Modulators|tubulin modulators|mesh-ancestor
65115472|NCT02063997|Antimitotic Agents|antimitotic agents|mesh-ancestor
65115473|NCT02063997|Mitosis Modulators|mitosis modulators|mesh-ancestor
65115474|NCT02063997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115475|NCT02063997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115476|NCT02063997|Antimetabolites|antimetabolites|mesh-ancestor
65115477|NCT02063997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115478|NCT02063997|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65115538|NCT02052648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65115539|NCT02052648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65115540|NCT02052648|Growth Substances|growth substances|mesh-ancestor
65115541|NCT02052648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115542|NCT02052648|Growth Inhibitors|growth inhibitors|mesh-ancestor
65115543|NCT02052648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65115544|NCT02052648|Alkylating Agents|alkylating agents|mesh-ancestor
65115545|NCT02052648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115604|NCT02912702|Methylprednisolone|methylprednisolone|mesh-list
65115605|NCT02912702|Doxorubicin|doxorubicin|mesh-list
65115606|NCT02912702|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65115607|NCT02912702|Etoposide|etoposide|mesh-list
65115608|NCT02912702|Etoposide phosphate|etoposide phosphate|mesh-list
65115609|NCT02912702|Pegaspargase|pegaspargase|mesh-list
65115610|NCT02912702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65115611|NCT02912702|Antiemetics|antiemetics|mesh-ancestor
65115612|NCT02912702|Autonomic Agents|autonomic agents|mesh-ancestor
65115613|NCT02912702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65115614|NCT02912702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115615|NCT02912702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65115616|NCT02912702|Glucocorticoids|glucocorticoids|mesh-ancestor
65115617|NCT02912702|Hormones|hormones|mesh-ancestor
65115618|NCT02912702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65115620|NCT02912702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115664|NCT03455049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65115665|NCT02912234|Clarithromycin|clarithromycin|mesh-list
65115666|NCT02912234|Apixaban|apixaban|mesh-list
65115667|NCT02912234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65115668|NCT02912234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64757929|NCT00151320|Rituximab|rituximab|mesh-list
65115669|NCT02912234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65115670|NCT02912234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115671|NCT02912234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115679|NCT04676139|Fluoxetine|fluoxetine|mesh-list
65115727|NCT02911766|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65115728|NCT02911766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65115729|NCT02911766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65115730|NCT02911766|Disinfectants|disinfectants|mesh-ancestor
65115731|NCT02911766|Dermatologic Agents|dermatologic agents|mesh-ancestor
65115732|NCT01993641|Azacitidine|azacitidine|mesh-list
65115733|NCT01993641|Decitabine|decitabine|mesh-list
65115734|NCT01993641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65115735|NCT01993641|Antimetabolites|antimetabolites|mesh-ancestor
65115736|NCT01993641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115737|NCT01993641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65115738|NCT01993641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115792|NCT02550470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65115793|NCT02550470|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65115794|NCT02550470|Anesthetics, General|anesthetics, general|mesh-ancestor
65115795|NCT02550470|Anesthetics|anesthetics|mesh-ancestor
65115796|NCT02550470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65115797|NCT02550470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115798|NCT02910518|Insulin|insulin|mesh-list
65115799|NCT02910518|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65115800|NCT02910518|Insulin Aspart|insulin aspart|mesh-list
65115801|NCT02910518|Insulin glulisine|insulin glulisine|mesh-list
65115802|NCT02910518|Insulin, Isophane|insulin, isophane|mesh-list
65115803|NCT02910518|Isophane Insulin, Human|isophane insulin, human|mesh-list
65115804|NCT02910518|Isophane insulin, beef|isophane insulin, beef|mesh-list
65115805|NCT02910518|Heparin|heparin|mesh-list
65115806|NCT02910518|Calcium heparin|calcium heparin|mesh-list
65115807|NCT02910518|Glucagon|glucagon|mesh-list
65115855|NCT02910596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115856|NCT04316377|Hydroxychloroquine|hydroxychloroquine|mesh-list
65115857|NCT04316377|Antimalarials|antimalarials|mesh-ancestor
65115858|NCT04316377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65115859|NCT04316377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65115860|NCT04316377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65115861|NCT04316377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115862|NCT04316377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115863|NCT04316377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65115864|NCT02886988|Botulinum Toxins|botulinum toxins|mesh-list
65115865|NCT02886988|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65115866|NCT02886988|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65115867|NCT02886988|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65115868|NCT02886988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65115869|NCT02886988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115870|NCT02886988|Cholinergic Agents|cholinergic agents|mesh-ancestor
65115871|NCT02886988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65115872|NCT02886988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115873|NCT02886988|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65115874|NCT02886988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65115875|NCT04676997|Paclitaxel|paclitaxel|mesh-list
65115909|NCT02910206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65115910|NCT02910206|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65115911|NCT02910206|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65115912|NCT02910206|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65115913|NCT04675086|Antiviral Agents|antiviral agents|mesh-list
65115914|NCT04675086|Remdesivir|remdesivir|mesh-list
65115915|NCT04675086|Protease Inhibitors|protease inhibitors|mesh-list
65115916|NCT04675086|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65115917|NCT04675086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65115918|NCT04675086|Antimetabolites|antimetabolites|mesh-ancestor
65115919|NCT04675086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115920|NCT04675086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115923|NCT02909972|Cytarabine|cytarabine|mesh-list
65115972|NCT02910245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65115973|NCT02910245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65115974|NCT02910245|Analgesics|analgesics|mesh-ancestor
65115975|NCT02910245|Sensory System Agents|sensory system agents|mesh-ancestor
65115976|NCT02910245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65115977|NCT02910245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65115978|NCT01185340|Serotonin|serotonin|mesh-list
65115979|NCT01185340|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
65115980|NCT01185340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65115981|NCT01185340|Serotonin Agents|serotonin agents|mesh-ancestor
65115982|NCT01185340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65115983|NCT01185340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65115984|NCT01185340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65115985|NCT01185340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65115986|NCT01185340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65115987|NCT01959282|Niacinamide|niacinamide|mesh-list
65115988|NCT01959282|Peficitinib|peficitinib|mesh-list
65115989|NCT01959282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65115990|NCT01959282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116024|NCT01940991|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65116025|NCT01940991|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65116029|NCT01940991|Cholinergic Agents|cholinergic agents|mesh-ancestor
65116098|NCT00555984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
65116099|NCT00555984|Anesthetics|anesthetics|mesh-list
65116100|NCT00555984|Sevoflurane|sevoflurane|mesh-list
65116101|NCT00555984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65116102|NCT00555984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65116103|NCT00555984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116104|NCT00555984|Anesthetics, General|anesthetics, general|mesh-ancestor
65116106|NCT00555984|Narcotics|narcotics|mesh-ancestor
65116167|NCT01871415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65116168|NCT01871415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116169|NCT05189717|Everolimus|everolimus|mesh-list
65116170|NCT05189717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116171|NCT05189717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65116172|NCT05189717|Immunologic Factors|immunologic factors|mesh-ancestor
65116173|NCT05189717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116174|NCT01866930|Interferons|interferons|mesh-list
65116175|NCT01866930|Ribavirin|ribavirin|mesh-list
65116176|NCT01866930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116177|NCT01866930|Antiviral Agents|antiviral agents|mesh-ancestor
65116178|NCT01866930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65116179|NCT01866930|Antimetabolites|antimetabolites|mesh-ancestor
65116180|NCT01866930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116181|NCT05182463|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65116182|NCT05182463|Antiviral Agents|antiviral agents|mesh-ancestor
65116183|NCT05182463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65116184|NCT02277197|Cetuximab|cetuximab|mesh-list
65116228|NCT05011214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65116229|NCT05011214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116230|NCT05011214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65116231|NCT05011214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65116232|NCT05011214|Anesthetics, General|anesthetics, general|mesh-ancestor
65116233|NCT05011214|Anesthetics|anesthetics|mesh-ancestor
65116234|NCT05011214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65116235|NCT05011214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65116236|NCT05011214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65116293|NCT01825980|Ritonavir|ritonavir|mesh-list
65116294|NCT01825980|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65116295|NCT01825980|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65116296|NCT01825980|Protease Inhibitors|protease inhibitors|mesh-ancestor
65116297|NCT01825980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116298|NCT01825980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116299|NCT01825980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65116300|NCT01825980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65116301|NCT01825980|Antiviral Agents|antiviral agents|mesh-ancestor
65116302|NCT01825980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65116303|NCT01825980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65116304|NCT01825980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65116305|NCT04858490|Diazepam|diazepam|mesh-list
65116306|NCT04858490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65116307|NCT04858490|Anticonvulsants|anticonvulsants|mesh-ancestor
65116308|NCT04858490|Antiemetics|antiemetics|mesh-ancestor
65116309|NCT04858490|Autonomic Agents|autonomic agents|mesh-ancestor
65116327|NCT04790045|Venetoclax|venetoclax|mesh-list
65116352|NCT01655225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65116353|NCT01655225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65116354|NCT01655225|Hormone Antagonists|hormone antagonists|mesh-ancestor
65116355|NCT01655225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65116356|NCT01655225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65116357|NCT01655225|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65116359|NCT01818921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65116360|NCT01818921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65116361|NCT01818921|Growth Substances|growth substances|mesh-ancestor
65116362|NCT01818921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116363|NCT01818921|Growth Inhibitors|growth inhibitors|mesh-ancestor
65116364|NCT01818921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116365|NCT01810575|Alprostadil|alprostadil|mesh-list
65116366|NCT01810575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65116367|NCT01810575|Vasodilator Agents|vasodilator agents|mesh-ancestor
65116368|NCT01810575|Urological Agents|urological agents|mesh-ancestor
65116369|NCT01785771|Exenatide|exenatide|mesh-list
65116411|NCT04607252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65116412|NCT04607252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116413|NCT04607252|Appetite Stimulants|appetite stimulants|mesh-ancestor
65116414|NCT04607252|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65116415|NCT01782729|Tacrolimus|tacrolimus|mesh-list
65116416|NCT01782729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65116417|NCT01782729|Immunologic Factors|immunologic factors|mesh-ancestor
65116418|NCT01782729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116419|NCT01782729|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65116420|NCT01782729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116476|NCT01779453|Antimetabolites|antimetabolites|mesh-ancestor
65116477|NCT01779453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116478|NCT01779453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65116479|NCT01779453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65116480|NCT01779453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116481|NCT01779453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65116482|NCT01779453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116483|NCT01776606|Botulinum Toxins|botulinum toxins|mesh-list
65116484|NCT01776606|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65116485|NCT01776606|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65116486|NCT01776606|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65116489|NCT01776606|Cholinergic Agents|cholinergic agents|mesh-ancestor
65116539|NCT04670601|Flurbiprofen|flurbiprofen|mesh-list
65116540|NCT04670601|Analgesics|analgesics|mesh-ancestor
65116541|NCT04670601|Sensory System Agents|sensory system agents|mesh-ancestor
65116542|NCT04670601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65116543|NCT04670601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116544|NCT04670601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65116545|NCT04670601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65116546|NCT04670601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65116547|NCT04670601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65116548|NCT04670601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65116549|NCT04670601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116550|NCT04670601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116551|NCT04670913|Apatinib|apatinib|mesh-list
65116556|NCT04671069|Clopidogrel|clopidogrel|mesh-list
65116600|NCT01718145|Protease Inhibitors|protease inhibitors|mesh-ancestor
65116601|NCT01718145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116602|NCT00556257|Cyclosporine|cyclosporine|mesh-list
65116603|NCT00556257|Cyclosporins|cyclosporins|mesh-list
65116604|NCT00556257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116605|NCT00556257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116606|NCT00556257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65116607|NCT00556257|Immunologic Factors|immunologic factors|mesh-ancestor
65116608|NCT00556257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116609|NCT00556257|Antifungal Agents|antifungal agents|mesh-ancestor
65116610|NCT00556257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65116611|NCT00556257|Dermatologic Agents|dermatologic agents|mesh-ancestor
65116612|NCT00556257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65116613|NCT00556257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65116614|NCT01712451|Fluticasone|fluticasone|mesh-list
65116615|NCT01712451|Xhance|xhance|mesh-list
65116616|NCT01712451|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65116617|NCT01712451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65116618|NCT01712451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65116619|NCT01712451|Autonomic Agents|autonomic agents|mesh-ancestor
65116620|NCT01712451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65116621|NCT01712451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116622|NCT01712451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65116623|NCT01712451|Respiratory System Agents|respiratory system agents|mesh-ancestor
65116624|NCT01712451|Dermatologic Agents|dermatologic agents|mesh-ancestor
65116625|NCT01712451|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65116626|NCT01712451|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65116627|NCT01712451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65116628|NCT01712451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65116629|NCT01712451|Adrenergic Agents|adrenergic agents|mesh-ancestor
65116630|NCT01712451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65116632|NCT01712217|Crizotinib|crizotinib|mesh-list
65116644|NCT04669821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65116645|NCT04669821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116646|NCT04669821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65116647|NCT04669821|Anesthetics, General|anesthetics, general|mesh-ancestor
65116648|NCT04669821|Anesthetics|anesthetics|mesh-ancestor
65116649|NCT00532025|Sorafenib|sorafenib|mesh-list
65116650|NCT00532025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116654|NCT04669392|Ethanol|ethanol|mesh-list
65116711|NCT04668456|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65116712|NCT04668456|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65116713|NCT04668456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65116714|NCT04668456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116715|NCT04668456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65116716|NCT04668456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65116717|NCT04668456|Analgesics|analgesics|mesh-ancestor
65116718|NCT04668456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65116719|NCT04668456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65116720|NCT04668456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65116721|NCT04668456|Adrenergic Agents|adrenergic agents|mesh-ancestor
65116777|NCT04622813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65116778|NCT04622813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65116779|NCT04622813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65116780|NCT04622813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65116781|NCT04622813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116782|NCT04622813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116783|NCT00533585|Paclitaxel|paclitaxel|mesh-list
65116784|NCT00533585|Bevacizumab|bevacizumab|mesh-list
65116785|NCT00533585|Carboplatin|carboplatin|mesh-list
65116786|NCT00533585|Sorafenib|sorafenib|mesh-list
65116787|NCT00533585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65116788|NCT00533585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116789|NCT00533585|Tubulin Modulators|tubulin modulators|mesh-ancestor
65116790|NCT00533585|Antimitotic Agents|antimitotic agents|mesh-ancestor
65116791|NCT00533585|Mitosis Modulators|mitosis modulators|mesh-ancestor
65116792|NCT00533585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116793|NCT00533585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65116794|NCT00533585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65116795|NCT00533585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65116796|NCT00533585|Growth Substances|growth substances|mesh-ancestor
65116797|NCT00533585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116798|NCT00533585|Growth Inhibitors|growth inhibitors|mesh-ancestor
65116799|NCT00533585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65116800|NCT00533585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116801|NCT00533624|Mycophenolic Acid|mycophenolic acid|mesh-list
65116810|NCT04562441|Avelumab|avelumab|mesh-list
65116825|NCT04659057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65116826|NCT04659057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65116827|NCT04659057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65116828|NCT04659057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65116829|NCT04659057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116830|NCT04659057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65116831|NCT04659057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65116832|NCT04659057|Analgesics|analgesics|mesh-ancestor
65116833|NCT04659057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65116834|NCT04659057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65116835|NCT04659057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65116836|NCT04659057|Adrenergic Agents|adrenergic agents|mesh-ancestor
65116837|NCT04659057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65116838|NCT04547153|Docetaxel|docetaxel|mesh-list
65116839|NCT04547153|Fluorouracil|fluorouracil|mesh-list
65116840|NCT04547153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116841|NCT04547153|Tubulin Modulators|tubulin modulators|mesh-ancestor
65116842|NCT04547153|Antimitotic Agents|antimitotic agents|mesh-ancestor
65116843|NCT04547153|Mitosis Modulators|mitosis modulators|mesh-ancestor
65116844|NCT04547153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116845|NCT04547153|Antimetabolites|antimetabolites|mesh-ancestor
65116846|NCT04547153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65116847|NCT04547153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65116875|NCT04658355|Dermatologic Agents|dermatologic agents|mesh-ancestor
65116876|NCT04658355|Plasma Substitutes|plasma substitutes|mesh-ancestor
65116877|NCT04658355|Blood Substitutes|blood substitutes|mesh-ancestor
65116878|NCT00533936|Paclitaxel|paclitaxel|mesh-list
65116879|NCT00533936|Cyclophosphamide|cyclophosphamide|mesh-list
65116880|NCT00533936|Doxorubicin|doxorubicin|mesh-list
65116881|NCT00533936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65116882|NCT00533936|Fluorouracil|fluorouracil|mesh-list
65116883|NCT00533936|Trastuzumab|trastuzumab|mesh-list
65116884|NCT00533936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65116885|NCT00533936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116886|NCT00533936|Tubulin Modulators|tubulin modulators|mesh-ancestor
65116887|NCT00533936|Antimitotic Agents|antimitotic agents|mesh-ancestor
65116888|NCT00533936|Mitosis Modulators|mitosis modulators|mesh-ancestor
65116889|NCT00533936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116890|NCT00533936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65116891|NCT00533936|Immunologic Factors|immunologic factors|mesh-ancestor
65116892|NCT00533936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116893|NCT00533936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65116894|NCT00533936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65116895|NCT00533936|Alkylating Agents|alkylating agents|mesh-ancestor
65116896|NCT00533936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65116897|NCT00533936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65116898|NCT00533936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65116899|NCT00533936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65116904|NCT00557544|Ketoprofen|ketoprofen|mesh-list
65116925|NCT04667910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65116926|NCT04667910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65116927|NCT04667910|Growth Substances|growth substances|mesh-ancestor
65116928|NCT04667910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116929|NCT04667910|Growth Inhibitors|growth inhibitors|mesh-ancestor
65116930|NCT04667910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116931|NCT00556608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65116932|NCT00556608|Hyaluronic Acid|hyaluronic acid|mesh-list
65116933|NCT00556608|Hylan|hylan|mesh-list
65116934|NCT00556608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65116935|NCT00556608|Immunologic Factors|immunologic factors|mesh-ancestor
65116936|NCT00556608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116937|NCT00556608|Viscosupplements|viscosupplements|mesh-ancestor
65116938|NCT00556608|Protective Agents|protective agents|mesh-ancestor
65116939|NCT00534287|Moxifloxacin|moxifloxacin|mesh-list
65116940|NCT00534287|Meropenem|meropenem|mesh-list
65116941|NCT00534287|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65116942|NCT00534287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65116943|NCT00534287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65116944|NCT00534287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65116945|NCT00534287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65116946|NCT00534287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65116947|NCT00534287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116948|NCT00534287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116949|NCT00534287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65116950|NCT00534287|Contraceptive Agents|contraceptive agents|mesh-ancestor
65116951|NCT00534287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65116954|NCT00534287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65116971|NCT01215916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65116972|NCT01184872|Vancomycin|vancomycin|mesh-list
65116973|NCT01184872|Daptomycin|daptomycin|mesh-list
65116974|NCT01184872|Penicillins|penicillins|mesh-list
65116975|NCT01184872|Floxacillin|floxacillin|mesh-list
65116976|NCT01184872|Cloxacillin|cloxacillin|mesh-list
65116977|NCT01184872|Oxacillin|oxacillin|mesh-list
65116978|NCT01184872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65116979|NCT01184872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65116980|NCT01215721|Solifenacin Succinate|solifenacin succinate|mesh-list
65116981|NCT01215721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65116982|NCT01215721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65116983|NCT01215721|Cholinergic Agents|cholinergic agents|mesh-ancestor
65116984|NCT01215721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65116985|NCT01215721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116986|NCT01215721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65116987|NCT01215721|Urological Agents|urological agents|mesh-ancestor
65116988|NCT04083365|Capecitabine|capecitabine|mesh-list
65116989|NCT04083365|Durvalumab|durvalumab|mesh-list
65116990|NCT04083365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65116991|NCT04083365|Antimetabolites|antimetabolites|mesh-ancestor
65116992|NCT04083365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65116993|NCT04083365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65116995|NCT04666623|Esketamine|esketamine|mesh-list
65117025|NCT01215253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65117026|NCT01215253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64759281|NCT00478218|Hormones|hormones|mesh-ancestor
65117029|NCT01184053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117099|NCT04664595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65117100|NCT04664595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117101|NCT04664595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65117102|NCT04664595|Anesthetics, General|anesthetics, general|mesh-ancestor
65117103|NCT04664595|Anesthetics|anesthetics|mesh-ancestor
65117104|NCT01215175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65117105|NCT01215175|Immunologic Factors|immunologic factors|mesh-ancestor
65117106|NCT01215175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117108|NCT03580148|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65117109|NCT03580148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65117110|NCT04664517|Anesthetics|anesthetics|mesh-list
65117111|NCT04664517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65117112|NCT04664517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117113|NCT05335915|Nicotine|nicotine|mesh-list
65117114|NCT05335915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65117115|NCT05335915|Autonomic Agents|autonomic agents|mesh-ancestor
65117159|NCT04664010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65117160|NCT04664010|Antimetabolites|antimetabolites|mesh-ancestor
65117161|NCT04664010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117162|NCT04664010|Immunologic Factors|immunologic factors|mesh-ancestor
65117163|NCT04664010|Antioxidants|antioxidants|mesh-ancestor
65117226|NCT03312738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65117227|NCT03303339|Cytarabine|cytarabine|mesh-list
65117228|NCT03303339|Decitabine|decitabine|mesh-list
65117229|NCT03303339|Onvansertib|onvansertib|mesh-list
65117230|NCT03303339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65117231|NCT03303339|Antimetabolites|antimetabolites|mesh-ancestor
65117232|NCT03303339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117293|NCT04679064|Bevacizumab|bevacizumab|mesh-list
65117294|NCT04679064|Doxorubicin|doxorubicin|mesh-list
65117295|NCT04679064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65117296|NCT04679064|Topotecan|topotecan|mesh-list
65117297|NCT04679064|Niraparib|niraparib|mesh-list
65117298|NCT04679064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65117299|NCT04679064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117300|NCT04679064|Tubulin Modulators|tubulin modulators|mesh-ancestor
65117301|NCT04679064|Antimitotic Agents|antimitotic agents|mesh-ancestor
65117302|NCT04679064|Mitosis Modulators|mitosis modulators|mesh-ancestor
65117303|NCT04679064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117304|NCT04679064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64689693|NCT00369863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117358|NCT00535574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117359|NCT04678830|Leronlimab|leronlimab|mesh-list
65117360|NCT04678830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65117361|NCT04678830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65117362|NCT04678830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117363|NCT04678830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65117364|NCT04678830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65117423|NCT03098589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117424|NCT04662177|Dexmedetomidine|dexmedetomidine|mesh-list
65117425|NCT04662177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65117426|NCT04662177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65117427|NCT04662177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117428|NCT04662177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65117429|NCT04662177|Analgesics|analgesics|mesh-ancestor
65117430|NCT04662177|Sensory System Agents|sensory system agents|mesh-ancestor
65117431|NCT04662177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65117432|NCT04662177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65117487|NCT02650986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117488|NCT02650986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65117489|NCT02650986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65117490|NCT02650986|Alkylating Agents|alkylating agents|mesh-ancestor
65117491|NCT02650986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117492|NCT02650986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117493|NCT02650986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65117494|NCT02650986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65117495|NCT02650986|Antimetabolites|antimetabolites|mesh-ancestor
65117496|NCT02650986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117497|NCT00538070|Glycine|glycine|mesh-list
65117498|NCT00538070|Glycine Agents|glycine agents|mesh-ancestor
65117550|NCT04661709|Trimetazidine|trimetazidine|mesh-list
65117551|NCT04661709|Clopidogrel|clopidogrel|mesh-list
65117552|NCT04661709|Atorvastatin|atorvastatin|mesh-list
65117553|NCT04661709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117554|NCT04661709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65117555|NCT04661709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65117556|NCT04661709|Analgesics|analgesics|mesh-ancestor
65117557|NCT04661709|Sensory System Agents|sensory system agents|mesh-ancestor
65117558|NCT04661709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64759813|NCT00546156|Growth Substances|growth substances|mesh-ancestor
65117559|NCT04661709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65117560|NCT04661709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65117561|NCT04661709|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65117562|NCT04661709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65117564|NCT04661709|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65117610|NCT02462811|Promethazine|promethazine|mesh-list
65117611|NCT02462811|Diphenhydramine|diphenhydramine|mesh-list
65117612|NCT02462811|Hydrocodone|hydrocodone|mesh-list
65117613|NCT02462811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65117614|NCT02462811|Analgesics|analgesics|mesh-ancestor
65117615|NCT02462811|Sensory System Agents|sensory system agents|mesh-ancestor
65117616|NCT02462811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65117617|NCT02462811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117618|NCT02462811|Antipyretics|antipyretics|mesh-ancestor
65117619|NCT02462811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65117620|NCT02462811|Narcotics|narcotics|mesh-ancestor
65117622|NCT02462811|Antitussive Agents|antitussive agents|mesh-ancestor
65117677|NCT00538499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65117678|NCT00538499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117679|NCT00538499|Sensory System Agents|sensory system agents|mesh-ancestor
65117680|NCT00538499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65117681|NCT00538499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65117682|NCT00538499|Narcotics|narcotics|mesh-ancestor
65117683|NCT00538499|Analgesics|analgesics|mesh-ancestor
65117684|NCT00538499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65117685|NCT00538499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65117686|NCT00538499|Anesthetics, General|anesthetics, general|mesh-ancestor
65117687|NCT00538538|Ranibizumab|ranibizumab|mesh-list
65117688|NCT00538538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65117689|NCT00538538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65117690|NCT00538538|Growth Substances|growth substances|mesh-ancestor
65117691|NCT00538538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117692|NCT00538538|Growth Inhibitors|growth inhibitors|mesh-ancestor
65117693|NCT00538538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117734|NCT00538811|Antiviral Agents|antiviral agents|mesh-ancestor
65117735|NCT00538811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65117736|NCT00538811|Antimetabolites|antimetabolites|mesh-ancestor
65117737|NCT00538811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117738|NCT00538811|Immunologic Factors|immunologic factors|mesh-ancestor
65117739|NCT00538811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117740|NCT00538811|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65117741|NCT00538811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65117742|NCT00538811|Dopamine Agents|dopamine agents|mesh-ancestor
65117743|NCT00538811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65117744|NCT00538811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65117745|NCT00538811|Analgesics|analgesics|mesh-ancestor
65117746|NCT00538811|Sensory System Agents|sensory system agents|mesh-ancestor
65117747|NCT00538811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65117748|NCT04660773|Pregabalin|pregabalin|mesh-list
65117749|NCT04660773|Analgesics|analgesics|mesh-ancestor
65117792|NCT00539123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65117793|NCT00539123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117794|NCT00539123|Analgesics|analgesics|mesh-ancestor
65117795|NCT00539123|Sensory System Agents|sensory system agents|mesh-ancestor
65117796|NCT00539123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65117797|NCT00539123|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65117798|NCT02382510|Tiotropium Bromide|tiotropium bromide|mesh-list
65117799|NCT02382510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65117800|NCT02382510|Autonomic Agents|autonomic agents|mesh-ancestor
65117801|NCT02382510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65117802|NCT02382510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117803|NCT02382510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65117804|NCT02382510|Respiratory System Agents|respiratory system agents|mesh-ancestor
65117805|NCT02382510|Parasympatholytics|parasympatholytics|mesh-ancestor
65117806|NCT02382510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65117807|NCT02382510|Cholinergic Agents|cholinergic agents|mesh-ancestor
65117808|NCT02382510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65117809|NCT02382510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117810|NCT00539396|Insulin|insulin|mesh-list
65117811|NCT00539396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65117812|NCT00539396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117813|NCT00539435|Insulin|insulin|mesh-list
65117814|NCT00539435|Insulin Aspart|insulin aspart|mesh-list
65117815|NCT00539435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65117816|NCT00539435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117817|NCT00539630|Docetaxel|docetaxel|mesh-list
65117823|NCT04660461|Lansoprazole|lansoprazole|mesh-list
65117840|NCT00554424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117841|NCT00554424|Sensory System Agents|sensory system agents|mesh-ancestor
65117842|NCT00554424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65117843|NCT00554424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65117844|NCT00554424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65117845|NCT00554424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65117846|NCT00554424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65117847|NCT00554424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117848|NCT04660305|Insulin Aspart|insulin aspart|mesh-list
65117849|NCT04660305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65117850|NCT04660305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117851|NCT00554502|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65117852|NCT00554502|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65117853|NCT00554502|Immunologic Factors|immunologic factors|mesh-ancestor
65117854|NCT00554502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117855|NCT00554502|Protease Inhibitors|protease inhibitors|mesh-ancestor
65117856|NCT00554502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117857|NCT00554502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117858|NCT00539786|Rabeprazole|rabeprazole|mesh-list
65117859|NCT00539786|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65117860|NCT00539786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65117861|NCT00539786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65117862|NCT00539786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117863|NCT00539786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117864|NCT02341989|Carboplatin|carboplatin|mesh-list
65117865|NCT02341989|Etoposide|etoposide|mesh-list
65117866|NCT02341989|Bleomycin|bleomycin|mesh-list
65117867|NCT02341989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65117868|NCT02341989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65117869|NCT02341989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65117871|NCT02341989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117880|NCT00540098|Serotonin Agents|serotonin agents|mesh-ancestor
65117881|NCT00540098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65117882|NCT00540098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65117883|NCT00540098|Antidepressive Agents|antidepressive agents|mesh-ancestor
65117884|NCT00540098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65117885|NCT00540098|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65117886|NCT00540098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65117887|NCT00540098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117888|NCT00540137|Ritonavir|ritonavir|mesh-list
65117889|NCT00540137|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65117890|NCT00540137|Nevirapine|nevirapine|mesh-list
65117891|NCT00540137|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65117892|NCT00540137|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65117893|NCT00540137|Protease Inhibitors|protease inhibitors|mesh-ancestor
65117894|NCT00540137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65117895|NCT00540137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117896|NCT00540137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65117938|NCT00540527|Plasminogen|plasminogen|mesh-list
65117939|NCT00540527|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65117940|NCT00540527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65117941|NCT00540527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65117942|NCT00540527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65117943|NCT00540605|Tenofovir|tenofovir|mesh-list
65117944|NCT00540605|Antiviral Agents|antiviral agents|mesh-ancestor
65117945|NCT00540605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65117946|NCT00540605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65117948|NCT00540605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118003|NCT00541073|Vitamins|vitamins|mesh-ancestor
65118004|NCT00541073|Micronutrients|micronutrients|mesh-ancestor
65118005|NCT00541073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118006|NCT00541073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118007|NCT00541073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118008|NCT00541073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118009|NCT00541073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65118073|NCT02324985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65118074|NCT02324985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118075|NCT02324985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118076|NCT04659642|Fentanyl|fentanyl|mesh-list
65118077|NCT04659642|Dexmedetomidine|dexmedetomidine|mesh-list
65118078|NCT04659642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65118079|NCT04659642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65118080|NCT04659642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118081|NCT04659642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65118137|NCT02300142|Vaccines|vaccines|mesh-list
65118138|NCT02300142|Immunologic Factors|immunologic factors|mesh-ancestor
65118139|NCT02300142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118140|NCT01214668|Doxorubicin|doxorubicin|mesh-list
65118141|NCT01214668|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65118142|NCT01214668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65118143|NCT01214668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118144|NCT01214668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65118145|NCT01214668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65118146|NCT01214668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118199|NCT00542711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118200|NCT00542711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65118201|NCT00542711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65118202|NCT00542711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118203|NCT00542711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118204|NCT00542711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118205|NCT00542984|Teriparatide|teriparatide|mesh-list
65118206|NCT00542984|Calcitonin|calcitonin|mesh-list
65118207|NCT00542984|Salmon calcitonin|salmon calcitonin|mesh-list
65118208|NCT00542984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
65118209|NCT00542984|Katacalcin|katacalcin|mesh-list
65118210|NCT00542984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65118211|NCT00542984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118212|NCT00542984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65118213|NCT00542984|Vasodilator Agents|vasodilator agents|mesh-ancestor
65118214|NCT02257983|Ubiquinone|ubiquinone|mesh-list
65118215|NCT02257983|Micronutrients|micronutrients|mesh-ancestor
65118216|NCT02257983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118217|NCT00543023|Teriparatide|teriparatide|mesh-list
65118218|NCT00543023|Calcitonin|calcitonin|mesh-list
65118219|NCT00543023|Salmon calcitonin|salmon calcitonin|mesh-list
65118220|NCT00543023|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
65118221|NCT00543023|Katacalcin|katacalcin|mesh-list
65118222|NCT00543023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65118226|NCT04648917|Caffeic acid|caffeic acid|mesh-list
65118251|NCT03456752|Dexamethasone|dexamethasone|mesh-list
65118252|NCT03456752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65118253|NCT03456752|Antiemetics|antiemetics|mesh-ancestor
65118254|NCT03456752|Autonomic Agents|autonomic agents|mesh-ancestor
65118255|NCT03456752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65118256|NCT03456752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118257|NCT03456752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65118258|NCT03456752|Glucocorticoids|glucocorticoids|mesh-ancestor
65118259|NCT03456752|Hormones|hormones|mesh-ancestor
65118260|NCT03456752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65118261|NCT03456752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65118262|NCT03456752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118263|NCT03456713|Mirikizumab|mirikizumab|mesh-list
65118264|NCT03456713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65118265|NCT03456713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65118266|NCT03456713|Analgesics|analgesics|mesh-ancestor
65118267|NCT03456713|Sensory System Agents|sensory system agents|mesh-ancestor
65118268|NCT03456713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65118269|NCT03456713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118270|NCT03456713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65118303|NCT00554658|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65118304|NCT00554658|Antidepressive Agents|antidepressive agents|mesh-ancestor
65118305|NCT00554658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65118306|NCT00554658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65118307|NCT00554658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65118308|NCT00554658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65118309|NCT00554658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118311|NCT00543608|Iclaprim|iclaprim|mesh-list
65118312|NCT00543608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65118313|NCT00543608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65118314|NCT00543608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65118315|NCT00543608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118316|NCT00543608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118317|NCT00554775|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65118318|NCT00554775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118363|NCT00543842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65118364|NCT00543842|Growth Substances|growth substances|mesh-ancestor
65118365|NCT00543842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118366|NCT00543842|Growth Inhibitors|growth inhibitors|mesh-ancestor
65118367|NCT00543842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65118368|NCT00543842|Antimetabolites|antimetabolites|mesh-ancestor
65118369|NCT00543842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118370|NCT00543842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65118371|NCT00543842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118372|NCT04638816|Lidocaine|lidocaine|mesh-list
65118373|NCT04638816|Hyaluronic Acid|hyaluronic acid|mesh-list
65118374|NCT04638816|Anesthetics, Local|anesthetics, local|mesh-ancestor
65118375|NCT04638816|Anesthetics|anesthetics|mesh-ancestor
65118376|NCT04638816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65118377|NCT04638816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118378|NCT04638816|Sensory System Agents|sensory system agents|mesh-ancestor
65118379|NCT04638816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65118387|NCT04638816|Viscosupplements|viscosupplements|mesh-ancestor
65118421|NCT00544193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65118422|NCT00544193|Antimetabolites|antimetabolites|mesh-ancestor
65118423|NCT00544193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118424|NCT00544193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118425|NCT00544193|Antiviral Agents|antiviral agents|mesh-ancestor
65118426|NCT00544193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65118427|NCT00544193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118490|NCT00544349|Micronutrients|micronutrients|mesh-ancestor
65118491|NCT00544349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65118492|NCT01191190|Ofatumumab|ofatumumab|mesh-list
65118493|NCT01191190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118494|NCT00544388|Levocetirizine|levocetirizine|mesh-list
65118495|NCT00544388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65118496|NCT00544388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65118497|NCT00544388|Histamine Antagonists|histamine antagonists|mesh-ancestor
65118498|NCT00544388|Histamine Agents|histamine agents|mesh-ancestor
65118499|NCT00544388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65118503|NCT00544505|Fluorouracil|fluorouracil|mesh-list
65118554|NCT05824455|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65118555|NCT05824455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65118556|NCT05824455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118557|NCT05824455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118627|NCT05823870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65118628|NCT05823870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118629|NCT05823870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65118630|NCT05823870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118631|NCT05823701|Azacitidine|azacitidine|mesh-list
65118632|NCT05823701|Mitoxantrone|mitoxantrone|mesh-list
65118633|NCT05823701|Obinutuzumab|obinutuzumab|mesh-list
65118634|NCT05823701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65118635|NCT05823701|Antimetabolites|antimetabolites|mesh-ancestor
65118691|NCT05823480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65118692|NCT05823467|Trimethoprim|trimethoprim|mesh-list
65118693|NCT05823467|Sulfamethoxazole|sulfamethoxazole|mesh-list
65118694|NCT05823467|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65118695|NCT05823467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65118696|NCT05823467|Renal Agents|renal agents|mesh-ancestor
65118697|NCT05823467|Antimalarials|antimalarials|mesh-ancestor
65118698|NCT05823467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65118699|NCT05823467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65118700|NCT05823467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65118701|NCT05823467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65118702|NCT05823467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118703|NCT05823467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65118704|NCT05823467|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65118705|NCT05823467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65118706|NCT05823441|Oxytocin|oxytocin|mesh-list
65118707|NCT05823441|Oxytocics|oxytocics|mesh-ancestor
65118708|NCT05823441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65118709|NCT05823441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118710|NCT05823337|Selenium|selenium|mesh-list
65118711|NCT05823337|Antioxidants|antioxidants|mesh-ancestor
65118712|NCT05823337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118713|NCT05823337|Protective Agents|protective agents|mesh-ancestor
65118714|NCT05823337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118715|NCT05823337|Trace Elements|trace elements|mesh-ancestor
65118716|NCT05823337|Micronutrients|micronutrients|mesh-ancestor
65118717|NCT05823311|Gemcitabine|gemcitabine|mesh-list
65118718|NCT05823311|Cisplatin|cisplatin|mesh-list
65118719|NCT05823311|Lenvatinib|lenvatinib|mesh-list
65118720|NCT05823311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118738|NCT05822882|Anesthetics|anesthetics|mesh-list
65118739|NCT05822882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65118740|NCT05822882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118741|NCT05822817|Propofol|propofol|mesh-list
65118742|NCT05822817|Sevoflurane|sevoflurane|mesh-list
65118743|NCT05822817|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65118744|NCT05822817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65118745|NCT05822817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118746|NCT05822817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65118747|NCT05822817|Anesthetics, General|anesthetics, general|mesh-ancestor
65118748|NCT05822817|Anesthetics|anesthetics|mesh-ancestor
65118802|NCT05822583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118803|NCT05822583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118804|NCT05822583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65118805|NCT05822583|Immunologic Factors|immunologic factors|mesh-ancestor
65118806|NCT05822583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118807|NCT05822583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65118808|NCT05820451|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65118809|NCT05817474|Lidocaine|lidocaine|mesh-list
65118810|NCT05817474|Tranexamic Acid|tranexamic acid|mesh-list
65118811|NCT05817474|Anesthetics, Local|anesthetics, local|mesh-ancestor
65118812|NCT05817474|Anesthetics|anesthetics|mesh-ancestor
65118813|NCT05817474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65118814|NCT05817474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118815|NCT05817474|Sensory System Agents|sensory system agents|mesh-ancestor
65118816|NCT05817474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65118817|NCT05817474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65118824|NCT05817474|Hemostatics|hemostatics|mesh-ancestor
65118858|NCT05780567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118859|NCT05780567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65118860|NCT05780567|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65118861|NCT05780567|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65118862|NCT05780567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65118863|NCT05774717|Tranexamic Acid|tranexamic acid|mesh-list
65118864|NCT05774717|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65118865|NCT05774717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65118866|NCT05774717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118867|NCT05774717|Hemostatics|hemostatics|mesh-ancestor
65118868|NCT05774717|Coagulants|coagulants|mesh-ancestor
65118869|NCT05767359|Cyclophosphamide|cyclophosphamide|mesh-list
65118870|NCT05767359|Fludarabine|fludarabine|mesh-list
65118871|NCT05767359|Fludarabine phosphate|fludarabine phosphate|mesh-list
65118872|NCT05767359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65118873|NCT05767359|Immunologic Factors|immunologic factors|mesh-ancestor
65118874|NCT05767359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118912|NCT05736640|Denosumab|denosumab|mesh-list
65118913|NCT05736640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65118914|NCT05736640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65118915|NCT05729568|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65118916|NCT05729568|Antiviral Agents|antiviral agents|mesh-ancestor
65118917|NCT05729568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65118918|NCT05728294|Ropivacaine|ropivacaine|mesh-list
65118919|NCT05728294|Anesthetics, Local|anesthetics, local|mesh-ancestor
65118981|NCT05685004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65118982|NCT05685004|Alkylating Agents|alkylating agents|mesh-ancestor
65118983|NCT05685004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65118984|NCT05685004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118985|NCT05684276|Paclitaxel|paclitaxel|mesh-list
65118986|NCT05684276|Carboplatin|carboplatin|mesh-list
65118987|NCT05684276|Nivolumab|nivolumab|mesh-list
65118988|NCT05684276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65118989|NCT05684276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65118990|NCT05684276|Tubulin Modulators|tubulin modulators|mesh-ancestor
65118991|NCT05684276|Antimitotic Agents|antimitotic agents|mesh-ancestor
65118992|NCT05684276|Mitosis Modulators|mitosis modulators|mesh-ancestor
65119054|NCT05630755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65119055|NCT05630755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65119056|NCT05630755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64761319|NCT05765240|Protective Agents|protective agents|mesh-ancestor
65119057|NCT05625932|Tinzaparin|tinzaparin|mesh-list
65119058|NCT05625932|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65119059|NCT05625932|Dalteparin|dalteparin|mesh-list
65119060|NCT05625932|Anticoagulants|anticoagulants|mesh-ancestor
65119061|NCT05625932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65119062|NCT05625932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65119063|NCT05625932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119064|NCT05608252|Fulvestrant|fulvestrant|mesh-list
65119065|NCT05608252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65119112|NCT05557877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65119114|NCT05557877|Antipyretics|antipyretics|mesh-ancestor
65119115|NCT05556265|BMS-986165|bms-986165|mesh-list
65119116|NCT05556265|Dermatologic Agents|dermatologic agents|mesh-ancestor
65119117|NCT05556265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65119118|NCT05556265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119119|NCT05556265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119120|NCT05491200|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65119121|NCT05491200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65119122|NCT05490888|Terlipressin|terlipressin|mesh-list
65119123|NCT05490888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65119124|NCT05490888|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65119125|NCT05477576|Everolimus|everolimus|mesh-list
65119126|NCT05477576|Sunitinib|sunitinib|mesh-list
65119127|NCT05477576|Octreotide|octreotide|mesh-list
65119128|NCT05477576|Lanreotide|lanreotide|mesh-list
65119172|NCT05388487|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65119173|NCT05388487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65119174|NCT05388487|Immunologic Factors|immunologic factors|mesh-ancestor
65119175|NCT05388487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119176|NCT05382806|Flumazenil|flumazenil|mesh-list
65119177|NCT05382806|Antidotes|antidotes|mesh-ancestor
65119178|NCT05382806|Protective Agents|protective agents|mesh-ancestor
65119179|NCT05382806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119180|NCT05382806|GABA Modulators|gaba modulators|mesh-ancestor
65119181|NCT05382806|GABA Agents|gaba agents|mesh-ancestor
65119268|NCT05171816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65119269|NCT05171816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119270|NCT05171816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65119271|NCT05139017|Gemcitabine|gemcitabine|mesh-list
65119272|NCT05139017|Rituximab|rituximab|mesh-list
65119273|NCT05139017|Oxaliplatin|oxaliplatin|mesh-list
65119274|NCT05139017|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65119275|NCT05139017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65119276|NCT05139017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119277|NCT05139017|Immunologic Factors|immunologic factors|mesh-ancestor
65119278|NCT05139017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119279|NCT05139017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65119280|NCT05139017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65119282|NCT05139017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119283|NCT05139017|Antiviral Agents|antiviral agents|mesh-ancestor
65119284|NCT05139017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65119285|NCT05139017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119325|NCT05094336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119326|NCT05065294|Psilocybin|psilocybin|mesh-list
65119327|NCT05065294|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
65119328|NCT05065294|Hallucinogens|hallucinogens|mesh-ancestor
65119329|NCT05065294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119330|NCT05065294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65119331|NCT05065294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65119332|NCT05065294|Serotonin Agents|serotonin agents|mesh-ancestor
65119333|NCT05065294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64513953|NCT01893177|Vaccines|vaccines|mesh-list
65119334|NCT05065294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119335|NCT05065294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65119337|NCT05058287|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65119338|NCT05058287|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65119339|NCT05058287|Prednisolone|prednisolone|mesh-list
65119340|NCT05058287|Prednisolone acetate|prednisolone acetate|mesh-list
65119341|NCT05058287|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65119342|NCT05058287|Prednisolone phosphate|prednisolone phosphate|mesh-list
65119343|NCT05058287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65119344|NCT05058287|Antiemetics|antiemetics|mesh-ancestor
65119345|NCT05058287|Autonomic Agents|autonomic agents|mesh-ancestor
65119349|NCT05058287|Glucocorticoids|glucocorticoids|mesh-ancestor
65119380|NCT04968899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65119381|NCT04968899|Glucocorticoids|glucocorticoids|mesh-ancestor
65119382|NCT04968899|Hormones|hormones|mesh-ancestor
65119383|NCT04968899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65119384|NCT04968899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65119385|NCT04968899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119386|NCT04968899|Immunologic Factors|immunologic factors|mesh-ancestor
65119387|NCT04965818|Futibatinib|futibatinib|mesh-list
65119388|NCT04965818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119389|NCT04963296|Acetaminophen|acetaminophen|mesh-list
65119390|NCT04963296|Diphenhydramine|diphenhydramine|mesh-list
65119391|NCT04963296|Promethazine|promethazine|mesh-list
65119392|NCT04963296|Methylprednisolone|methylprednisolone|mesh-list
65119393|NCT04963296|Obinutuzumab|obinutuzumab|mesh-list
65119394|NCT04963296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65119395|NCT04963296|Analgesics|analgesics|mesh-ancestor
65119396|NCT04963296|Sensory System Agents|sensory system agents|mesh-ancestor
65119397|NCT04963296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65119398|NCT04963296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119399|NCT04963296|Antipyretics|antipyretics|mesh-ancestor
65119400|NCT04963296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65119401|NCT04963296|Antiemetics|antiemetics|mesh-ancestor
65119402|NCT04963296|Autonomic Agents|autonomic agents|mesh-ancestor
65119403|NCT04963296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65119404|NCT04963296|Glucocorticoids|glucocorticoids|mesh-ancestor
65119406|NCT04963296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65119423|NCT04963296|Dermatologic Agents|dermatologic agents|mesh-ancestor
65119424|NCT04949256|Calcium, Dietary|calcium, dietary|mesh-list
65119425|NCT04949256|Leucovorin|leucovorin|mesh-list
65119427|NCT04949256|Pembrolizumab|pembrolizumab|mesh-list
65119428|NCT04949256|Oxaliplatin|oxaliplatin|mesh-list
65119429|NCT04949256|Lenvatinib|lenvatinib|mesh-list
65119430|NCT04949256|Calcium|calcium|mesh-list
65119431|NCT04949256|Levoleucovorin|levoleucovorin|mesh-list
65119432|NCT04949256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65119433|NCT04949256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119434|NCT04949256|Tubulin Modulators|tubulin modulators|mesh-ancestor
65119435|NCT04949256|Antimitotic Agents|antimitotic agents|mesh-ancestor
65119436|NCT04949256|Mitosis Modulators|mitosis modulators|mesh-ancestor
65119437|NCT04949256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119438|NCT04949256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65119439|NCT04949256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65119440|NCT04949256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119441|NCT04949256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65119442|NCT04949256|Antidotes|antidotes|mesh-ancestor
65119443|NCT04949256|Protective Agents|protective agents|mesh-ancestor
65119444|NCT04949256|Vitamin B Complex|vitamin b complex|mesh-ancestor
65119445|NCT04949256|Vitamins|vitamins|mesh-ancestor
65119446|NCT04949256|Micronutrients|micronutrients|mesh-ancestor
65119447|NCT04949256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65119448|NCT04949256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119449|NCT04943224|Trametinib|trametinib|mesh-list
65119450|NCT04943224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119451|NCT04943224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65119452|NCT04943224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119453|NCT04943224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119472|NCT04919226|Oxaliplatin|oxaliplatin|mesh-list
65119473|NCT04919226|Everolimus|everolimus|mesh-list
65119474|NCT04919226|Temozolomide|temozolomide|mesh-list
65119475|NCT04919226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65119476|NCT04919226|Levoleucovorin|levoleucovorin|mesh-list
65119477|NCT04919226|Edotreotide|edotreotide|mesh-list
65119478|NCT04919226|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
65119479|NCT04919226|Antimetabolites|antimetabolites|mesh-ancestor
65119480|NCT04919226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119481|NCT04919226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65119482|NCT04919226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119483|NCT04919226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65119484|NCT04919226|Immunologic Factors|immunologic factors|mesh-ancestor
65119485|NCT04919226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119486|NCT04919226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65119487|NCT04919226|Alkylating Agents|alkylating agents|mesh-ancestor
65119488|NCT04919226|Antidotes|antidotes|mesh-ancestor
65119489|NCT04919226|Protective Agents|protective agents|mesh-ancestor
65119490|NCT04919226|Vitamin B Complex|vitamin b complex|mesh-ancestor
65119491|NCT04919226|Vitamins|vitamins|mesh-ancestor
65119492|NCT04919226|Micronutrients|micronutrients|mesh-ancestor
65119493|NCT04919226|Hematinics|hematinics|mesh-ancestor
65119494|NCT04919226|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65119498|NCT04884815|Prednisolone|prednisolone|mesh-list
65119499|NCT04884815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64761777|NCT05059873|Hormones|hormones|mesh-ancestor
65119500|NCT04884815|Glucocorticoids|glucocorticoids|mesh-ancestor
65119524|NCT04860141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119525|NCT04860141|Antimanic Agents|antimanic agents|mesh-ancestor
65119526|NCT04823156|Calcium|calcium|mesh-list
65119527|NCT04823156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65119528|NCT04823156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119529|NCT04813653|Cyclosporine|cyclosporine|mesh-list
65119530|NCT04813653|Dexamethasone|dexamethasone|mesh-list
65119531|NCT04813653|Cyclosporins|cyclosporins|mesh-list
65119532|NCT04813653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65119533|NCT04813653|Antiemetics|antiemetics|mesh-ancestor
65119534|NCT04813653|Autonomic Agents|autonomic agents|mesh-ancestor
65119535|NCT04813653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65119536|NCT04813653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119537|NCT04813653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65119538|NCT04813653|Glucocorticoids|glucocorticoids|mesh-ancestor
65119539|NCT04813653|Hormones|hormones|mesh-ancestor
65119540|NCT04813653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65119541|NCT04813653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65119543|NCT04813653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119544|NCT04813653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119546|NCT04813653|Immunologic Factors|immunologic factors|mesh-ancestor
65119579|NCT04790474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65119580|NCT04790474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65119581|NCT04790474|Growth Substances|growth substances|mesh-ancestor
65119582|NCT04790474|Growth Inhibitors|growth inhibitors|mesh-ancestor
65119583|NCT04790474|Protease Inhibitors|protease inhibitors|mesh-ancestor
65119584|NCT04790474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119585|NCT04790474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119587|NCT04778410|Etoposide|etoposide|mesh-list
65119588|NCT04778410|Mitoxantrone|mitoxantrone|mesh-list
65119589|NCT04778410|Azacitidine|azacitidine|mesh-list
65119590|NCT04778410|Venetoclax|venetoclax|mesh-list
65119591|NCT04778410|Cc-486|cc-486|mesh-list
65119592|NCT04778410|Magrolimab|magrolimab|mesh-list
65119593|NCT04778410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65119594|NCT04778410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119606|NCT04778410|Analgesics|analgesics|mesh-ancestor
64761927|NCT04859829|gamma-Globulins|gamma-globulins|mesh-list
64761928|NCT04859829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64761929|NCT04859829|Immunologic Factors|immunologic factors|mesh-ancestor
64761930|NCT04859829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761931|NCT04851158|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64761932|NCT04851158|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65119647|NCT04718025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65119648|NCT04718025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65119649|NCT04718025|Analgesics|analgesics|mesh-ancestor
65119650|NCT04718025|Sensory System Agents|sensory system agents|mesh-ancestor
65119651|NCT04718025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65119652|NCT04718025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119653|NCT04718025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65119654|NCT04718025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65119655|NCT04718025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65119656|NCT04718025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65119657|NCT04718025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119658|NCT04718025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65119659|NCT04718025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65119660|NCT04718025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119661|NCT04718025|Antipyretics|antipyretics|mesh-ancestor
65119662|NCT04718025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65119692|NCT04642430|Apixaban|apixaban|mesh-list
65119693|NCT04642430|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65119694|NCT04642430|Antithrombins|antithrombins|mesh-ancestor
65119695|NCT04642430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65119696|NCT04642430|Protease Inhibitors|protease inhibitors|mesh-ancestor
65119697|NCT04642430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119698|NCT04642430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119699|NCT04642430|Anticoagulants|anticoagulants|mesh-ancestor
65119700|NCT04609176|Apatinib|apatinib|mesh-list
65119701|NCT04609176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119702|NCT04609176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65119703|NCT04609176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762008|NCT04735471|Cyclophosphamide|cyclophosphamide|mesh-list
64762009|NCT04735471|Fludarabine|fludarabine|mesh-list
64762010|NCT04735471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64762011|NCT04735471|Immunologic Factors|immunologic factors|mesh-ancestor
64762012|NCT04735471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762013|NCT04735471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64762014|NCT04735471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64762015|NCT04735471|Alkylating Agents|alkylating agents|mesh-ancestor
64762016|NCT04735471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762017|NCT04735471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762018|NCT04735471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64762019|NCT04718181|Omeprazole|omeprazole|mesh-list
65119726|NCT04593940|Antiviral Agents|antiviral agents|mesh-ancestor
65119727|NCT04593940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65119728|NCT04593940|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65119729|NCT04593940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65119730|NCT04593940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65119731|NCT04562090|Mirabegron|mirabegron|mesh-list
65119732|NCT04562090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65119733|NCT04562090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65119734|NCT04562090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65119735|NCT04562090|Adrenergic Agents|adrenergic agents|mesh-ancestor
65119736|NCT04562090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64652579|NCT01568255|Vitamin D|vitamin d|mesh-list
65119788|NCT04442919|Purinergic Agents|purinergic agents|mesh-ancestor
65119789|NCT04442919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65119790|NCT04442919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119791|NCT04442919|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65119792|NCT04442919|Anesthetics, General|anesthetics, general|mesh-ancestor
65119793|NCT04442919|Anesthetics|anesthetics|mesh-ancestor
65119794|NCT04435197|Pembrolizumab|pembrolizumab|mesh-list
65119795|NCT04435197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65119796|NCT04435197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119797|NCT04431453|Remdesivir|remdesivir|mesh-list
65119798|NCT04431453|Antimetabolites|antimetabolites|mesh-ancestor
65119799|NCT04431453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119800|NCT04431453|Antiviral Agents|antiviral agents|mesh-ancestor
65119801|NCT04431453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65119802|NCT04424901|Dipyridamole|dipyridamole|mesh-list
65119851|NCT04293562|Razoxane|razoxane|mesh-list
65119852|NCT04293562|Calicheamicins|calicheamicins|mesh-list
65119853|NCT04293562|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65119854|NCT04293562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65119855|NCT04293562|Abortifacient Agents|abortifacient agents|mesh-ancestor
65119856|NCT04293562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65119857|NCT04293562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119858|NCT04293562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65119859|NCT04293562|Antimetabolites|antimetabolites|mesh-ancestor
65119860|NCT04293562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119861|NCT04293562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119862|NCT04293562|Dermatologic Agents|dermatologic agents|mesh-ancestor
65119863|NCT04293562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119864|NCT04293562|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65119865|NCT04293562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65119866|NCT04293562|Immunologic Factors|immunologic factors|mesh-ancestor
65119913|NCT04129086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119914|NCT04129086|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65119915|NCT04129086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65119916|NCT04129086|Anesthetics, General|anesthetics, general|mesh-ancestor
65119917|NCT04129086|Anesthetics|anesthetics|mesh-ancestor
65119918|NCT04129086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65119919|NCT04129086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65119920|NCT04129086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65119921|NCT04129086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65119922|NCT04129086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119923|NCT04123366|Pembrolizumab|pembrolizumab|mesh-list
65119924|NCT04123366|Olaparib|olaparib|mesh-list
65119972|NCT03992404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65119973|NCT03992404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119974|NCT03992404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65119975|NCT03992404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65119976|NCT03961438|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
65119977|NCT03961438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65119978|NCT03961438|Immunologic Factors|immunologic factors|mesh-ancestor
65119979|NCT03961438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119980|NCT03933163|Resveratrol|resveratrol|mesh-list
65119981|NCT03933163|Antioxidants|antioxidants|mesh-ancestor
65119982|NCT03933163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119983|NCT03933163|Protective Agents|protective agents|mesh-ancestor
65119984|NCT03933163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65119985|NCT03933163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65119986|NCT03933163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65119987|NCT03873818|Pembrolizumab|pembrolizumab|mesh-list
65119988|NCT03873818|Ipilimumab|ipilimumab|mesh-list
65119989|NCT03873818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65119990|NCT03873818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65119991|NCT03873818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65119992|NCT03873818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65119993|NCT03867851|Heparin|heparin|mesh-list
65119994|NCT03867851|Anticoagulants|anticoagulants|mesh-ancestor
65120023|NCT03762018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120024|NCT03762018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65120025|NCT03762018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65120026|NCT03762018|Growth Substances|growth substances|mesh-ancestor
65120027|NCT03762018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120028|NCT03762018|Growth Inhibitors|growth inhibitors|mesh-ancestor
65120029|NCT03762018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120030|NCT03762018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120031|NCT03762018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65120032|NCT03762018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65120033|NCT03737643|Paclitaxel|paclitaxel|mesh-list
65120034|NCT03737643|Bevacizumab|bevacizumab|mesh-list
65120035|NCT03737643|Carboplatin|carboplatin|mesh-list
65120036|NCT03737643|Durvalumab|durvalumab|mesh-list
65120037|NCT03737643|Olaparib|olaparib|mesh-list
65120038|NCT03737643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65120039|NCT03737643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65120040|NCT03737643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120041|NCT03737643|Tubulin Modulators|tubulin modulators|mesh-ancestor
65120042|NCT03737643|Antimitotic Agents|antimitotic agents|mesh-ancestor
65120043|NCT03737643|Mitosis Modulators|mitosis modulators|mesh-ancestor
65120044|NCT03737643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120045|NCT03737643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65120046|NCT03737643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65120047|NCT03737643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65120048|NCT03737643|Growth Substances|growth substances|mesh-ancestor
65120049|NCT03737643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120054|NCT03682068|Gemcitabine|gemcitabine|mesh-list
65120070|NCT03644186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65120071|NCT03644186|Trastuzumab|trastuzumab|mesh-list
65120072|NCT03644186|Letrozole|letrozole|mesh-list
65120073|NCT03644186|Palbociclib|palbociclib|mesh-list
65120074|NCT03644186|Pertuzumab|pertuzumab|mesh-list
65120075|NCT03644186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65120076|NCT03644186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120077|NCT03644186|Tubulin Modulators|tubulin modulators|mesh-ancestor
65120078|NCT03644186|Antimitotic Agents|antimitotic agents|mesh-ancestor
65120079|NCT03644186|Mitosis Modulators|mitosis modulators|mesh-ancestor
65120080|NCT03644186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120081|NCT03644186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65120082|NCT03644186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65120083|NCT03644186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65120084|NCT03644186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120085|NCT03644186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65120086|NCT03644186|Hormone Antagonists|hormone antagonists|mesh-ancestor
65120087|NCT03644186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65120088|NCT03644186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120126|NCT03416179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65120127|NCT03416179|Immunologic Factors|immunologic factors|mesh-ancestor
65120128|NCT03416179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120129|NCT03416179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120130|NCT03416179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65120131|NCT03416179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65120132|NCT03416179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65120133|NCT03338959|Pembrolizumab|pembrolizumab|mesh-list
65120134|NCT03338959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65120135|NCT03338959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120136|NCT03319940|Pembrolizumab|pembrolizumab|mesh-list
65120137|NCT03319940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65120138|NCT03319940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120139|NCT03313544|Nivolumab|nivolumab|mesh-list
65120140|NCT03313544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65120141|NCT03313544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120142|NCT03313544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65120143|NCT03313544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120144|NCT03309150|Paclitaxel|paclitaxel|mesh-list
65120145|NCT03309150|Carboplatin|carboplatin|mesh-list
65120146|NCT03309150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65120180|NCT03186638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65120181|NCT03186638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65120182|NCT03186638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120183|NCT03186638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120184|NCT03176134|Tedizolid|tedizolid|mesh-list
65120185|NCT03176134|Tedizolid phosphate|tedizolid phosphate|mesh-list
65120186|NCT03176134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65120187|NCT03176134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65120188|NCT03064126|Paclitaxel|paclitaxel|mesh-list
65120189|NCT03064126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65120190|NCT03064126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65120191|NCT03064126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120192|NCT03064126|Tubulin Modulators|tubulin modulators|mesh-ancestor
65120193|NCT03064126|Antimitotic Agents|antimitotic agents|mesh-ancestor
65120194|NCT03064126|Mitosis Modulators|mitosis modulators|mesh-ancestor
65120195|NCT03064126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120196|NCT03043872|Carboplatin|carboplatin|mesh-list
65120197|NCT03043872|Etoposide|etoposide|mesh-list
65120198|NCT03043872|Durvalumab|durvalumab|mesh-list
65120236|NCT02923128|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65120237|NCT02923128|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65120238|NCT02923128|Adrenergic Agents|adrenergic agents|mesh-ancestor
65120239|NCT02923128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65120240|NCT02923128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120241|NCT02923128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65120242|NCT02923128|Narcotics|narcotics|mesh-ancestor
65120243|NCT02923128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65120244|NCT02923128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65120245|NCT02923128|Anesthetics, General|anesthetics, general|mesh-ancestor
65120246|NCT02923128|Anesthetics|anesthetics|mesh-ancestor
65120247|NCT02918409|Tobramycin|tobramycin|mesh-list
65120248|NCT02918409|Colistin|colistin|mesh-list
65120249|NCT02918409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65120250|NCT02918409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65120251|NCT02866747|Durvalumab|durvalumab|mesh-list
65120252|NCT02866747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65120253|NCT02866747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120254|NCT02859792|Riluzole|riluzole|mesh-list
65120255|NCT02859792|Anticonvulsants|anticonvulsants|mesh-ancestor
65120256|NCT02859792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65120257|NCT02859792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65120258|NCT02859792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65120259|NCT02859792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120260|NCT02859792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120261|NCT02859792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65120262|NCT02859792|Protective Agents|protective agents|mesh-ancestor
65120263|NCT02852213|Dopa Decarboxylase|dopa decarboxylase|mesh-list
65120285|NCT02695771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120286|NCT02695771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120287|NCT02695771|Antiviral Agents|antiviral agents|mesh-ancestor
65120288|NCT02695771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65120289|NCT02695771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120290|NCT02695771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65120291|NCT02695771|Immunologic Factors|immunologic factors|mesh-ancestor
65120292|NCT02695771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120293|NCT02695771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65120294|NCT02695771|Alkylating Agents|alkylating agents|mesh-ancestor
65120375|NCT01792934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120376|NCT01792934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120377|NCT01749969|Dexamethasone|dexamethasone|mesh-list
65120378|NCT01749969|Lenalidomide|lenalidomide|mesh-list
65120379|NCT01749969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65120380|NCT01749969|Antiemetics|antiemetics|mesh-ancestor
65120381|NCT01749969|Autonomic Agents|autonomic agents|mesh-ancestor
64762653|NCT03188705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65120382|NCT01749969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653273|NCT01588457|Antidepressive Agents|antidepressive agents|mesh-ancestor
65120443|NCT01356290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120444|NCT01356290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65120445|NCT01356290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65120446|NCT01356290|Alkylating Agents|alkylating agents|mesh-ancestor
65120447|NCT01356290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120448|NCT01356290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120501|NCT00521222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120502|NCT00521222|Tocolytic Agents|tocolytic agents|mesh-ancestor
65120503|NCT00521222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65120504|NCT00521222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65120505|NCT00521222|Cholinergic Agents|cholinergic agents|mesh-ancestor
65120506|NCT00521222|Glucocorticoids|glucocorticoids|mesh-ancestor
65120507|NCT00521222|Hormones|hormones|mesh-ancestor
65120569|NCT04646694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65120570|NCT04646694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65120571|NCT04646694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120572|NCT04638036|Cetuximab|cetuximab|mesh-list
65120573|NCT04638036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65120613|NCT00545675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65120614|NCT00545675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120615|NCT00545675|Dopamine Agonists|dopamine agonists|mesh-ancestor
65120616|NCT00545675|Dopamine Agents|dopamine agents|mesh-ancestor
65120617|NCT00545675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65120618|NCT00545675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120619|NCT00545675|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64762971|NCT01946074|Paclitaxel|paclitaxel|mesh-list
65120672|NCT00560079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120673|NCT00560079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120674|NCT00560079|Gout Suppressants|gout suppressants|mesh-ancestor
65120675|NCT00560079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65120676|NCT00560079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65120677|NCT00560079|Antioxidants|antioxidants|mesh-ancestor
65120678|NCT00560079|Protective Agents|protective agents|mesh-ancestor
65120679|NCT00560079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120680|NCT00560079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65120681|NCT00560079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65120682|NCT00560079|Vasodilator Agents|vasodilator agents|mesh-ancestor
65120683|NCT00560118|Fotemustine|fotemustine|mesh-list
65120684|NCT00560118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120685|NCT00546494|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65120695|NCT00546533|Etanercept|etanercept|mesh-list
65120729|NCT00546923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120730|NCT00546923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65120731|NCT00546923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120732|NCT00546923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65120733|NCT00546923|Antidepressive Agents|antidepressive agents|mesh-ancestor
65120734|NCT00546923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65120736|NCT00547001|Estrogens|estrogens|mesh-ancestor
65120737|NCT00547001|Hormones|hormones|mesh-ancestor
65120738|NCT00547001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65120739|NCT00547001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120740|NCT00547352|Sildenafil Citrate|sildenafil citrate|mesh-list
65120741|NCT00547352|Tadalafil|tadalafil|mesh-list
65120742|NCT00547352|Vasodilator Agents|vasodilator agents|mesh-ancestor
65120743|NCT00547352|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65120744|NCT00547352|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65120745|NCT00547352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120746|NCT00547352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120747|NCT00547352|Urological Agents|urological agents|mesh-ancestor
65120748|NCT00547508|Tadalafil|tadalafil|mesh-list
65120749|NCT00547508|Vasodilator Agents|vasodilator agents|mesh-ancestor
65120750|NCT00547508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65120782|NCT00547625|Urological Agents|urological agents|mesh-ancestor
65120783|NCT00547664|Morphine|morphine|mesh-list
65120784|NCT00547664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65120785|NCT00547664|Narcotics|narcotics|mesh-ancestor
65120786|NCT00547664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65120787|NCT00547664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120788|NCT00547664|Analgesics|analgesics|mesh-ancestor
65120789|NCT00547664|Sensory System Agents|sensory system agents|mesh-ancestor
65120790|NCT00547664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65120791|NCT00560430|Telmisartan|telmisartan|mesh-list
65120792|NCT00560430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65120793|NCT00560430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65120794|NCT00560430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65120795|NCT00560430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120796|NCT00560547|Epoetin Alfa|epoetin alfa|mesh-list
65120797|NCT00560547|Hematinics|hematinics|mesh-ancestor
65120798|NCT04636125|Doxycycline|doxycycline|mesh-list
65120813|NCT04644354|Nifedipine|nifedipine|mesh-list
65120840|NCT04635852|Analgesics|analgesics|mesh-ancestor
65120841|NCT04635852|Sensory System Agents|sensory system agents|mesh-ancestor
65120842|NCT04635852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65120843|NCT04635852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65120844|NCT04635852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65120845|NCT04635852|Anesthetics, General|anesthetics, general|mesh-ancestor
65120846|NCT04635852|Anesthetics|anesthetics|mesh-ancestor
65120847|NCT00548561|Dexrazoxane|dexrazoxane|mesh-list
65120848|NCT00548561|Razoxane|razoxane|mesh-list
65120849|NCT00548561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65120850|NCT00548561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65120851|NCT00548561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65120852|NCT00548561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65120853|NCT00548561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65120867|NCT00548678|Diclofenac|diclofenac|mesh-list
65120903|NCT00560586|Glucocorticoids|glucocorticoids|mesh-ancestor
65120904|NCT00560586|Hormones|hormones|mesh-ancestor
65120905|NCT00560586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65120907|NCT00549068|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65120908|NCT00549068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65120910|NCT00549068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65120972|NCT04643691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65120973|NCT04643691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65120974|NCT04643691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65120975|NCT04643691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65120976|NCT04643691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65120977|NCT04643691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65120978|NCT04643691|Hormone Antagonists|hormone antagonists|mesh-ancestor
65120979|NCT04643691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65120980|NCT04643691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120981|NCT04643691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65120983|NCT04643691|Natriuretic Agents|natriuretic agents|mesh-ancestor
65120984|NCT00549536|Calcium, Dietary|calcium, dietary|mesh-list
65120985|NCT00549536|Calcium|calcium|mesh-list
65120986|NCT00549536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65120987|NCT00549536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65120988|NCT00549536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65120989|NCT00549614|Acipimox|acipimox|mesh-list
65121025|NCT00550004|Antimetabolites|antimetabolites|mesh-ancestor
65121026|NCT00550004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121027|NCT00550004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121028|NCT00550004|Antiviral Agents|antiviral agents|mesh-ancestor
65121029|NCT00550004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65121030|NCT00550004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121031|NCT00550004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65121032|NCT00550004|Immunologic Factors|immunologic factors|mesh-ancestor
65121033|NCT00550004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121034|NCT04634721|Bupivacaine|bupivacaine|mesh-list
65121035|NCT04634721|Anesthetics, Local|anesthetics, local|mesh-ancestor
65121090|NCT04898231|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65121091|NCT04898231|Prednisolone phosphate|prednisolone phosphate|mesh-list
65121092|NCT04898231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65121093|NCT04898231|Antiemetics|antiemetics|mesh-ancestor
65121094|NCT04898231|Autonomic Agents|autonomic agents|mesh-ancestor
65121095|NCT04898231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121096|NCT04898231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121097|NCT04898231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65121098|NCT04898231|Glucocorticoids|glucocorticoids|mesh-ancestor
65121099|NCT04898231|Hormones|hormones|mesh-ancestor
65121107|NCT04634058|Antibodies|antibodies|mesh-list
65121156|NCT04633746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121157|NCT04633746|Growth Inhibitors|growth inhibitors|mesh-ancestor
65121158|NCT00551018|Tenofovir|tenofovir|mesh-list
65121159|NCT00551018|Emtricitabine|emtricitabine|mesh-list
65121160|NCT00551018|Antiviral Agents|antiviral agents|mesh-ancestor
65121161|NCT00551018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65121162|NCT00551018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65121163|NCT00551018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65121164|NCT00551018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121165|NCT00551018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121166|NCT00551018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65121168|NCT04643106|Hemostatics|hemostatics|mesh-list
65121220|NCT00871013|Thalidomide|thalidomide|mesh-list
65121221|NCT00871013|Dexamethasone|dexamethasone|mesh-list
65121222|NCT00871013|Cyclophosphamide|cyclophosphamide|mesh-list
65121223|NCT00871013|Melphalan|melphalan|mesh-list
65121224|NCT00871013|Doxorubicin|doxorubicin|mesh-list
65121225|NCT00871013|Etoposide|etoposide|mesh-list
65121226|NCT00871013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65121227|NCT00871013|Bortezomib|bortezomib|mesh-list
65121228|NCT00871013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65121229|NCT00871013|Immunologic Factors|immunologic factors|mesh-ancestor
65121230|NCT00871013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121231|NCT00871013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65121232|NCT00871013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65121233|NCT00871013|Alkylating Agents|alkylating agents|mesh-ancestor
65121234|NCT00871013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121235|NCT00871013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121236|NCT00871013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65121237|NCT00871013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64763560|NCT04357392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65121238|NCT00871013|Antiemetics|antiemetics|mesh-ancestor
65121239|NCT00871013|Autonomic Agents|autonomic agents|mesh-ancestor
65121240|NCT00871013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121241|NCT00871013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65121242|NCT00871013|Glucocorticoids|glucocorticoids|mesh-ancestor
65121243|NCT00871013|Hormones|hormones|mesh-ancestor
65121244|NCT00871013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65121245|NCT00871013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65121269|NCT05431595|Antiemetics|antiemetics|mesh-ancestor
65121270|NCT05431595|Autonomic Agents|autonomic agents|mesh-ancestor
65121271|NCT05431595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121272|NCT05431595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121273|NCT05431595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65121274|NCT05431595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65121275|NCT05431595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65121276|NCT05431595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65121277|NCT05431595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65121278|NCT05431595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65121279|NCT05431595|Dopamine Agents|dopamine agents|mesh-ancestor
65121280|NCT05431595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65121335|NCT00559455|Antidotes|antidotes|mesh-ancestor
65121336|NCT00559455|Protective Agents|protective agents|mesh-ancestor
65121337|NCT00559455|Vitamin B Complex|vitamin b complex|mesh-ancestor
65121338|NCT00559455|Vitamins|vitamins|mesh-ancestor
65121339|NCT00559455|Micronutrients|micronutrients|mesh-ancestor
65121340|NCT00559494|Minocycline|minocycline|mesh-list
65121341|NCT00559494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65121342|NCT00559494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65121343|NCT05209412|Aspirin|aspirin|mesh-list
65121344|NCT05209412|Paclitaxel|paclitaxel|mesh-list
65121345|NCT05209412|Clopidogrel|clopidogrel|mesh-list
65121346|NCT05209412|Ticagrelor|ticagrelor|mesh-list
65121347|NCT05209412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65121348|NCT05209412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121349|NCT05209412|Tubulin Modulators|tubulin modulators|mesh-ancestor
65121350|NCT05209412|Antimitotic Agents|antimitotic agents|mesh-ancestor
65121351|NCT05209412|Mitosis Modulators|mitosis modulators|mesh-ancestor
65121352|NCT05209412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121353|NCT05209412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65121355|NCT05209412|Analgesics|analgesics|mesh-ancestor
65121393|NCT05172791|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64763719|NCT04351308|Apatinib|apatinib|mesh-list
65121395|NCT04639362|Venetoclax|venetoclax|mesh-list
65121396|NCT04639362|Obinutuzumab|obinutuzumab|mesh-list
65121397|NCT04639362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121398|NCT04639362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65121399|NCT05120141|Listerine|listerine|mesh-list
65121400|NCT05120141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65121401|NCT05120141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65121402|NCT04639284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
65121403|NCT04639284|Antibodies|antibodies|mesh-list
65121404|NCT04639284|Immunologic Factors|immunologic factors|mesh-ancestor
65121405|NCT04639284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121410|NCT00559689|Budesonide|budesonide|mesh-list
65121456|NCT04628559|Sensory System Agents|sensory system agents|mesh-ancestor
65121457|NCT04628559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121458|NCT04628559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65121459|NCT04628559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65121460|NCT04628559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65121461|NCT04628559|Adrenergic Agents|adrenergic agents|mesh-ancestor
65121462|NCT04628559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65121463|NCT04628559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121464|NCT04628559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65121465|NCT04628559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65121466|NCT04628559|Anesthetics, General|anesthetics, general|mesh-ancestor
65121467|NCT04628559|Anesthetics|anesthetics|mesh-ancestor
65121469|NCT04628559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65121517|NCT04657497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121518|NCT04657497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121519|NCT04657497|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65121520|NCT04657497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65121521|NCT01214434|Emollients|emollients|mesh-list
65121522|NCT01214434|Dermatologic Agents|dermatologic agents|mesh-ancestor
65121523|NCT04971356|Aspirin|aspirin|mesh-list
65121585|NCT01213264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121586|NCT04657107|Ketamine|ketamine|mesh-list
65121587|NCT04657107|Esketamine|esketamine|mesh-list
65121588|NCT04657107|Analgesics|analgesics|mesh-ancestor
65121589|NCT04657107|Sensory System Agents|sensory system agents|mesh-ancestor
65121590|NCT04657107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121591|NCT04657107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121592|NCT04657107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65121593|NCT04657107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65121594|NCT04657107|Anesthetics, General|anesthetics, general|mesh-ancestor
65121595|NCT04657107|Anesthetics|anesthetics|mesh-ancestor
65121598|NCT04657107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65121648|NCT04824911|Sensory System Agents|sensory system agents|mesh-ancestor
65121649|NCT04824911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121650|NCT04824911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121651|NCT04824911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65121652|NCT04824911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65121653|NCT04824911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65121654|NCT04824911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65121656|NCT04824911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65121714|NCT04710719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65121715|NCT04710719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121716|NCT04710719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65121717|NCT04710719|Immunologic Factors|immunologic factors|mesh-ancestor
65121718|NCT04710719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121719|NCT04710719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65121783|NCT04655508|Respiratory System Agents|respiratory system agents|mesh-ancestor
65121784|NCT04655508|Glucocorticoids|glucocorticoids|mesh-ancestor
65121785|NCT04655508|Hormones|hormones|mesh-ancestor
65121786|NCT04655508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65121787|NCT04655508|Sympathomimetics|sympathomimetics|mesh-ancestor
65121788|NCT04655040|Caffeine|caffeine|mesh-list
65121789|NCT04655040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65121790|NCT04655040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121791|NCT04655040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65121848|NCT00561990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121849|NCT02905994|Cytarabine|cytarabine|mesh-list
65121850|NCT02905994|Idarubicin|idarubicin|mesh-list
65121851|NCT02905994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65121852|NCT02905994|Antimetabolites|antimetabolites|mesh-ancestor
65121853|NCT02905994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121854|NCT02905994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65121855|NCT02905994|Antiviral Agents|antiviral agents|mesh-ancestor
65121856|NCT02905994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65121857|NCT02905994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65121858|NCT02905994|Immunologic Factors|immunologic factors|mesh-ancestor
65121859|NCT02905994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121860|NCT02905994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65121861|NCT02905994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65121862|NCT02905994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65121863|NCT02905994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121864|NCT02905682|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65121865|NCT02905682|Hemostatics|hemostatics|mesh-ancestor
65121866|NCT02905682|Coagulants|coagulants|mesh-ancestor
65121867|NCT02905682|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65121868|NCT02905682|Natriuretic Agents|natriuretic agents|mesh-ancestor
65121869|NCT02905682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121870|NCT04626258|Fluconazole|fluconazole|mesh-list
65121871|NCT04626258|Antifungal Agents|antifungal agents|mesh-ancestor
65121872|NCT04626258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65121873|NCT04626258|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65121874|NCT04626258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65121875|NCT04626258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65121893|NCT04626063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121894|NCT04626063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121895|NCT04626063|Antipyretics|antipyretics|mesh-ancestor
65121896|NCT04626063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65121897|NCT04625985|Metformin|metformin|mesh-list
65121898|NCT04625985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65121899|NCT04625985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121900|NCT02905760|Furosemide|furosemide|mesh-list
65121901|NCT02905760|Diuretics|diuretics|mesh-list
65121902|NCT02905760|Natriuretic Agents|natriuretic agents|mesh-ancestor
65121903|NCT02905760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121904|NCT02905760|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65121905|NCT02905760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65121906|NCT02905760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121907|NCT02905526|Contraceptive Agents|contraceptive agents|mesh-list
65121908|NCT02905526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65121909|NCT02905526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121949|NCT04625595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65121950|NCT04625595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65121951|NCT02905058|Ketoprofen|ketoprofen|mesh-list
65121952|NCT02905058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65121953|NCT02905058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65121954|NCT02905058|Analgesics|analgesics|mesh-ancestor
65121955|NCT02905058|Sensory System Agents|sensory system agents|mesh-ancestor
65121956|NCT02905058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65121957|NCT02905058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65121958|NCT02905058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65122012|NCT02903888|Contraceptive Agents|contraceptive agents|mesh-ancestor
65122013|NCT02903888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65122014|NCT02903888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122015|NCT02903888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65122016|NCT02903888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65122017|NCT02903888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65122018|NCT04624269|Hydroxychloroquine|hydroxychloroquine|mesh-list
65122019|NCT04624269|Antimalarials|antimalarials|mesh-ancestor
65122020|NCT04624269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65122021|NCT04624269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65122027|NCT04652739|Lycopene|lycopene|mesh-list
65122076|NCT00562068|Prednisolone|prednisolone|mesh-list
65122077|NCT00562068|Cyclophosphamide|cyclophosphamide|mesh-list
65122078|NCT00562068|Doxorubicin|doxorubicin|mesh-list
65122079|NCT00562068|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65122080|NCT00562068|Vincristine|vincristine|mesh-list
65122081|NCT00562068|Alemtuzumab|alemtuzumab|mesh-list
65122082|NCT00562068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65122083|NCT00562068|Immunologic Factors|immunologic factors|mesh-ancestor
65122084|NCT00562068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122085|NCT00562068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65122086|NCT00562068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65122087|NCT00562068|Alkylating Agents|alkylating agents|mesh-ancestor
65122088|NCT00562068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122101|NCT00562068|Hormones|hormones|mesh-ancestor
65122137|NCT02902640|Renal Agents|renal agents|mesh-ancestor
65122138|NCT02902640|Antimalarials|antimalarials|mesh-ancestor
65122139|NCT02902640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65122140|NCT02902640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65122141|NCT02902640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65122142|NCT02902640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122143|NCT02902640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122144|NCT02902640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65122145|NCT02902640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
65122146|NCT02902640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65122147|NCT02902640|Expectorants|expectorants|mesh-ancestor
65122148|NCT02902640|Respiratory System Agents|respiratory system agents|mesh-ancestor
65122199|NCT04623021|Anticoagulants|anticoagulants|mesh-ancestor
65122200|NCT04623021|Protease Inhibitors|protease inhibitors|mesh-ancestor
65122201|NCT04623021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122202|NCT04623021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122203|NCT04623021|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65122204|NCT04623021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65122205|NCT04623021|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65122212|NCT02901977|Ramipril|ramipril|mesh-list
65122265|NCT02901587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122267|NCT04622397|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65122268|NCT04622397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65122269|NCT04622397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122270|NCT04622397|Hemostatics|hemostatics|mesh-ancestor
65122271|NCT04622397|Coagulants|coagulants|mesh-ancestor
65122272|NCT04621929|Topiramate|topiramate|mesh-list
65122273|NCT04621929|Phentermine|phentermine|mesh-list
65122274|NCT04621929|Allopurinol|allopurinol|mesh-list
65122275|NCT04621929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122276|NCT04621929|Anticonvulsants|anticonvulsants|mesh-ancestor
65122332|NCT04621617|Adrenergic Agents|adrenergic agents|mesh-ancestor
65122333|NCT04621617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65122334|NCT04621617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122335|NCT01212757|Thalidomide|thalidomide|mesh-list
65122336|NCT01212757|Apremilast|apremilast|mesh-list
65122337|NCT01212757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65122338|NCT01212757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65122339|NCT01212757|Analgesics|analgesics|mesh-ancestor
65122340|NCT01212757|Sensory System Agents|sensory system agents|mesh-ancestor
65122341|NCT01212757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122342|NCT01212757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122343|NCT01212757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65122344|NCT01212757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65122345|NCT01212757|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65122346|NCT01212757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65122347|NCT01212757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122348|NCT01212757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122349|NCT01212757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65122350|NCT01212757|Immunologic Factors|immunologic factors|mesh-ancestor
65122351|NCT01212757|Leprostatic Agents|leprostatic agents|mesh-ancestor
65122352|NCT01212757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65122353|NCT01212757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65122356|NCT01212757|Growth Substances|growth substances|mesh-ancestor
65122382|NCT02900729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122383|NCT02900729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65122384|NCT02900729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122385|NCT02900729|Vasodilator Agents|vasodilator agents|mesh-ancestor
65122386|NCT02900729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65122387|NCT02900729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65122388|NCT02900729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65122389|NCT02900729|Diuretics|diuretics|mesh-ancestor
65122390|NCT02900729|Natriuretic Agents|natriuretic agents|mesh-ancestor
65122391|NCT02900729|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65122392|NCT05440201|Enoxaparin|enoxaparin|mesh-list
65122393|NCT05440201|Anticoagulants|anticoagulants|mesh-list
65122394|NCT05440201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65122395|NCT05440201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65122396|NCT05440201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122397|NCT04621227|Midazolam|midazolam|mesh-list
65122398|NCT04621227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65122403|NCT04621227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65122437|NCT00562692|Natriuretic Agents|natriuretic agents|mesh-ancestor
65122438|NCT00562692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122439|NCT04621110|Fentanyl|fentanyl|mesh-list
65122440|NCT04621110|Midazolam|midazolam|mesh-list
65122441|NCT04621110|Dexmedetomidine|dexmedetomidine|mesh-list
65122442|NCT04621110|Ketamine|ketamine|mesh-list
65122443|NCT04621110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65122444|NCT04621110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65122445|NCT04621110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122446|NCT04621110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65122503|NCT02900105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122504|NCT02900105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65122505|NCT02900105|Hormone Antagonists|hormone antagonists|mesh-ancestor
65122506|NCT02900105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65122507|NCT02900105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122508|NCT04620213|Phentolamine|phentolamine|mesh-list
65122509|NCT04620213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65122510|NCT04620213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65122511|NCT04620213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65122512|NCT04620213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65122513|NCT04620213|Adrenergic Agents|adrenergic agents|mesh-ancestor
65122514|NCT04620213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65122515|NCT04620213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122516|NCT04620213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122517|NCT04620213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65122518|NCT04619862|Gabapentin|gabapentin|mesh-list
65122519|NCT04619862|Analgesics|analgesics|mesh-ancestor
65122520|NCT04619862|Sensory System Agents|sensory system agents|mesh-ancestor
65122521|NCT04619862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122522|NCT04619862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122523|NCT04619862|Anticonvulsants|anticonvulsants|mesh-ancestor
65122524|NCT04619862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65122525|NCT04619862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65122526|NCT04619862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65122533|NCT01190839|Infliximab|infliximab|mesh-list
65122552|NCT05424692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122553|NCT05424692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65122554|NCT05424692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65122555|NCT05424692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65122556|NCT05424692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65122557|NCT05424692|Vitamin B Complex|vitamin b complex|mesh-ancestor
65122558|NCT05424692|Vitamins|vitamins|mesh-ancestor
65122559|NCT05424692|Micronutrients|micronutrients|mesh-ancestor
65122560|NCT04618965|Dexmedetomidine|dexmedetomidine|mesh-list
65122561|NCT04618965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65122562|NCT04618965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65122563|NCT04618965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122564|NCT04618965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65122565|NCT04618965|Analgesics|analgesics|mesh-ancestor
65122566|NCT04618965|Sensory System Agents|sensory system agents|mesh-ancestor
65122567|NCT04618965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122568|NCT04618965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65122569|NCT04618965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65122570|NCT04618965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65122571|NCT04618965|Adrenergic Agents|adrenergic agents|mesh-ancestor
65122605|NCT02885740|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65122606|NCT02885740|Purinergic Agonists|purinergic agonists|mesh-ancestor
65122607|NCT02885740|Purinergic Agents|purinergic agents|mesh-ancestor
65122677|NCT01183234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65122678|NCT01183234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122679|NCT01183234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65122680|NCT01183234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65122681|NCT01183234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65122682|NCT01183234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122683|NCT01183234|Dopamine Agents|dopamine agents|mesh-ancestor
65122745|NCT01165216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65122746|NCT01165216|Tubulin Modulators|tubulin modulators|mesh-ancestor
65122752|NCT04652115|Defibrotide|defibrotide|mesh-list
65122820|NCT05419583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65122821|NCT05419583|Protease Inhibitors|protease inhibitors|mesh-ancestor
65122822|NCT05419583|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65122827|NCT05387408|Narcotics|narcotics|mesh-ancestor
65122893|NCT00557934|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65122894|NCT00557934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65122895|NCT00557934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65122896|NCT00557934|Adrenergic Agents|adrenergic agents|mesh-ancestor
65122897|NCT00557934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65122898|NCT00557934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122899|NCT00557934|Protective Agents|protective agents|mesh-ancestor
65122900|NCT00558051|Vaccines|vaccines|mesh-list
65122901|NCT00558051|Immunologic Factors|immunologic factors|mesh-ancestor
65122902|NCT00558051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122903|NCT00558090|Morphine|morphine|mesh-list
65122904|NCT00558090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65122905|NCT00558090|Narcotics|narcotics|mesh-ancestor
65122906|NCT00558090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65122907|NCT00558090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122908|NCT00558090|Analgesics|analgesics|mesh-ancestor
65122909|NCT00558090|Sensory System Agents|sensory system agents|mesh-ancestor
65122910|NCT00558090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122911|NCT04617015|Bromides|bromides|mesh-list
65122912|NCT04617015|Ipratropium|ipratropium|mesh-list
65122924|NCT04650828|Tenofovir|tenofovir|mesh-list
65122948|NCT04650321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122949|NCT05153525|Cisatracurium|cisatracurium|mesh-list
65122950|NCT05153525|Atracurium|atracurium|mesh-list
65122951|NCT05153525|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65122952|NCT05153525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65122953|NCT05153525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122954|NCT05153525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122955|NCT05153525|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65122956|NCT05153525|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65122957|NCT05153525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65122958|NCT05153525|Cholinergic Agents|cholinergic agents|mesh-ancestor
65122959|NCT05153525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65122960|NCT05153525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122961|NCT04649892|Naltrexone|naltrexone|mesh-list
65122962|NCT04649892|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64765302|NCT00393354|Etoricoxib|etoricoxib|mesh-list
65122963|NCT04649892|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65122964|NCT04649892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122965|NCT04649892|Sensory System Agents|sensory system agents|mesh-ancestor
65122966|NCT04649892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122967|NCT05125796|Acetaminophen|acetaminophen|mesh-list
65122968|NCT05125796|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65122969|NCT05125796|Ketoprofen|ketoprofen|mesh-list
65122970|NCT05125796|Lidocaine|lidocaine|mesh-list
65122971|NCT05125796|Anesthetics, Local|anesthetics, local|mesh-ancestor
65122972|NCT05125796|Anesthetics|anesthetics|mesh-ancestor
65122973|NCT05125796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65122974|NCT05125796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122975|NCT05125796|Sensory System Agents|sensory system agents|mesh-ancestor
65122993|NCT05096117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65122994|NCT05096117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65122995|NCT05096117|GABA Modulators|gaba modulators|mesh-ancestor
65122996|NCT05096117|GABA Agents|gaba agents|mesh-ancestor
65122997|NCT05096117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65122998|NCT05096117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65122999|NCT04616859|Ethanol|ethanol|mesh-list
65123004|NCT04616586|Siltuximab|siltuximab|mesh-list
65123062|NCT04934228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65123063|NCT04934228|Diuretics|diuretics|mesh-ancestor
65123064|NCT04934228|Natriuretic Agents|natriuretic agents|mesh-ancestor
65123065|NCT04934228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123066|NCT04934228|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65123067|NCT04934228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65123068|NCT04934228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123069|NCT04934228|Analgesics|analgesics|mesh-ancestor
65123070|NCT04934228|Sensory System Agents|sensory system agents|mesh-ancestor
65123071|NCT04934228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65123127|NCT04833959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65123128|NCT04833959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123129|NCT04790786|Bamlanivimab|bamlanivimab|mesh-list
65123130|NCT04790786|Antiviral Agents|antiviral agents|mesh-ancestor
65123131|NCT04790786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65123132|NCT04725812|Eculizumab|eculizumab|mesh-list
65123133|NCT04725812|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65123196|NCT00563394|Renal Agents|renal agents|mesh-ancestor
65123197|NCT00563394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65123198|NCT00563394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65123199|NCT00563394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65123200|NCT00563394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123201|NCT00563394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123202|NCT00563394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123203|NCT00563394|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65123204|NCT00563394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65123205|NCT00563433|Ofloxacin|ofloxacin|mesh-list
65123207|NCT00563433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65123257|NCT04612998|Metoclopramide|metoclopramide|mesh-list
65123258|NCT04612998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65123259|NCT04612998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65123260|NCT04612998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65123261|NCT04612998|Autonomic Agents|autonomic agents|mesh-ancestor
65123262|NCT04612998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64765602|NCT00647400|Adalimumab|adalimumab|mesh-list
65123263|NCT04612998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123264|NCT04612998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65123265|NCT04612998|Respiratory System Agents|respiratory system agents|mesh-ancestor
65123266|NCT04612998|Mydriatics|mydriatics|mesh-ancestor
65123267|NCT04612998|Parasympatholytics|parasympatholytics|mesh-ancestor
65123268|NCT04612998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65123269|NCT04612998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65123270|NCT04612998|Cholinergic Agents|cholinergic agents|mesh-ancestor
65123271|NCT04612998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65123316|NCT04465487|Cemiplimab|cemiplimab|mesh-list
65123317|NCT04465487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65123318|NCT04465487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123319|NCT04612803|Histamine Antagonists|histamine antagonists|mesh-list
65123320|NCT04612803|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
65123321|NCT04612803|Histamine Agents|histamine agents|mesh-ancestor
65123322|NCT04612803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65123325|NCT02204345|Paclitaxel|paclitaxel|mesh-list
65123387|NCT04633044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65123388|NCT04633044|Lipotropic Agents|lipotropic agents|mesh-ancestor
65123389|NCT04633044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65123390|NCT04633044|Antimetabolites|antimetabolites|mesh-ancestor
65123391|NCT04633044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123392|NCT04633044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65123455|NCT02074007|Anesthetics|anesthetics|mesh-ancestor
65123456|NCT02074007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65123457|NCT02074007|Sensory System Agents|sensory system agents|mesh-ancestor
65123458|NCT02074007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65123459|NCT02072954|Asenapine|asenapine|mesh-list
65123460|NCT02072954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65123461|NCT02072954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65123462|NCT02072954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65123463|NCT02072954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123464|NCT02072954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65123465|NCT00554918|Zoledronic Acid|zoledronic acid|mesh-list
65123518|NCT02046395|Diuretics|diuretics|mesh-ancestor
65123519|NCT02046395|Natriuretic Agents|natriuretic agents|mesh-ancestor
65123520|NCT02046395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65123521|NCT02046395|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65123522|NCT02046395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65123523|NCT02046395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65123524|NCT02046395|Adrenergic Agents|adrenergic agents|mesh-ancestor
65123525|NCT02046395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65123526|NCT02046395|Urological Agents|urological agents|mesh-ancestor
65123527|NCT02042378|Rucaparib|rucaparib|mesh-list
65123528|NCT02042378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65123529|NCT02042378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123530|NCT02042378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123531|NCT02042378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123532|NCT02032277|Paclitaxel|paclitaxel|mesh-list
65123533|NCT02032277|Cyclophosphamide|cyclophosphamide|mesh-list
65123534|NCT02032277|Carboplatin|carboplatin|mesh-list
65123535|NCT02032277|Doxorubicin|doxorubicin|mesh-list
65123536|NCT02032277|Veliparib|veliparib|mesh-list
65123575|NCT04611126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65123576|NCT04611126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65123577|NCT04611126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65123578|NCT04611126|Antimetabolites|antimetabolites|mesh-ancestor
65123579|NCT02026232|Hydroxychloroquine|hydroxychloroquine|mesh-list
65123580|NCT02026232|Antimalarials|antimalarials|mesh-ancestor
65123581|NCT02026232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65123582|NCT02026232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65123583|NCT02026232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65123584|NCT02026232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123585|NCT02026232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123586|NCT02026232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65123587|NCT04611165|Nivolumab|nivolumab|mesh-list
65123588|NCT04611165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65123589|NCT04611165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123590|NCT04611165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65123592|NCT02014649|Laninamivir|laninamivir|mesh-list
65123633|NCT00564057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123634|NCT00564057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65123635|NCT00564057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65123636|NCT00564057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65123637|NCT00564057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123638|NCT04610541|Remdesivir|remdesivir|mesh-list
65123639|NCT04610541|Antimetabolites|antimetabolites|mesh-ancestor
65123640|NCT04610541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123641|NCT04610541|Antiviral Agents|antiviral agents|mesh-ancestor
65123642|NCT04610541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65123643|NCT04677335|Lovastatin|lovastatin|mesh-list
65123644|NCT04677335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65123645|NCT04677335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65123646|NCT04677335|Antimetabolites|antimetabolites|mesh-ancestor
65123647|NCT04677335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514142|NCT01606007|Dapagliflozin|dapagliflozin|mesh-list
65123648|NCT04677335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65123649|NCT04677335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65123650|NCT04677335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123651|NCT04630548|Copper|copper|mesh-list
65123652|NCT04630548|Trace Elements|trace elements|mesh-ancestor
65123653|NCT04630548|Micronutrients|micronutrients|mesh-ancestor
65123654|NCT04630548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123655|NCT01975610|Spebrutinib|spebrutinib|mesh-list
65123656|NCT01975610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65123657|NCT01975610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123658|NCT01975610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123659|NCT01969838|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
65123675|NCT01165138|Autonomic Agents|autonomic agents|mesh-ancestor
65123676|NCT01165138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65123677|NCT01165138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123678|NCT01165138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65123679|NCT01165138|Respiratory System Agents|respiratory system agents|mesh-ancestor
65123680|NCT01165138|Dermatologic Agents|dermatologic agents|mesh-ancestor
65123681|NCT01165138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65123682|NCT00561054|Cetuximab|cetuximab|mesh-list
65123683|NCT00561054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65123684|NCT00561054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123685|NCT04206358|Molgramostim|molgramostim|mesh-list
65123739|NCT01956812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65123740|NCT01956812|Immunologic Factors|immunologic factors|mesh-ancestor
65123741|NCT01956812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123742|NCT01952990|Phenylephrine|phenylephrine|mesh-list
65123743|NCT01952990|Oxymetazoline|oxymetazoline|mesh-list
65123744|NCT01952990|Tetracaine|tetracaine|mesh-list
65123745|NCT01952990|Anesthetics, Local|anesthetics, local|mesh-ancestor
65123746|NCT01952990|Anesthetics|anesthetics|mesh-ancestor
65123747|NCT01952990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65123748|NCT01952990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123749|NCT01952990|Sensory System Agents|sensory system agents|mesh-ancestor
65123750|NCT01952990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65123751|NCT01952990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65123752|NCT01952990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65123753|NCT01952990|Adrenergic Agents|adrenergic agents|mesh-ancestor
65123754|NCT01952990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65123755|NCT01952990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123756|NCT01952990|Sympathomimetics|sympathomimetics|mesh-ancestor
65123757|NCT01952990|Autonomic Agents|autonomic agents|mesh-ancestor
65123765|NCT04314310|Tenoxicam|tenoxicam|mesh-list
65123794|NCT01164007|Bevacizumab|bevacizumab|mesh-list
65123795|NCT01164007|Dacarbazine|dacarbazine|mesh-list
65123796|NCT01164007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65123797|NCT01164007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123798|NCT01164007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65123799|NCT01164007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65123800|NCT01164007|Growth Substances|growth substances|mesh-ancestor
65123801|NCT01164007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123802|NCT01164007|Growth Inhibitors|growth inhibitors|mesh-ancestor
65123803|NCT01164007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65123804|NCT01164007|Alkylating Agents|alkylating agents|mesh-ancestor
65123805|NCT01164007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123806|NCT01941836|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
65123807|NCT01941836|Ezetimibe|ezetimibe|mesh-list
65123808|NCT01941836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65123809|NCT01941836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65123810|NCT01941836|Antimetabolites|antimetabolites|mesh-ancestor
65123811|NCT01941836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123812|NCT01941836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65123813|NCT01941836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123814|NCT01941836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65123815|NCT01941836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123816|NCT04629885|Oxytocin|oxytocin|mesh-list
65123817|NCT04629885|Oxytocics|oxytocics|mesh-ancestor
65123818|NCT04629885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65123819|NCT04629885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123820|NCT01163851|Bococizumab|bococizumab|mesh-list
65123821|NCT01163851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65123822|NCT01163851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65123823|NCT01163851|Antimetabolites|antimetabolites|mesh-ancestor
65123837|NCT01917383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65123838|NCT01163617|Adalimumab|adalimumab|mesh-list
65123839|NCT01163617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65123840|NCT01163617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65123841|NCT01911767|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65123842|NCT01911767|Dermatologic Agents|dermatologic agents|mesh-ancestor
65123843|NCT01911767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65123844|NCT01911767|Immunologic Factors|immunologic factors|mesh-ancestor
65123845|NCT01911767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123846|NCT04629846|Docetaxel|docetaxel|mesh-list
65123847|NCT04629846|Trastuzumab|trastuzumab|mesh-list
65123903|NCT01163266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65123904|NCT01163266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65123905|NCT01163266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123906|NCT01163266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65123907|NCT01163266|Serotonin Agents|serotonin agents|mesh-ancestor
65123908|NCT01163266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65123909|NCT01163266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65123910|NCT01163266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65123911|NCT01163266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65123912|NCT01873703|Azacitidine|azacitidine|mesh-list
65123913|NCT01873703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65123914|NCT01873703|Antimetabolites|antimetabolites|mesh-ancestor
65123915|NCT01873703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123916|NCT01873703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123917|NCT01873703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123960|NCT01858883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65123961|NCT01858883|Tubulin Modulators|tubulin modulators|mesh-ancestor
65123962|NCT01858883|Antimitotic Agents|antimitotic agents|mesh-ancestor
65123963|NCT01858883|Mitosis Modulators|mitosis modulators|mesh-ancestor
65123964|NCT01858883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65123965|NCT01858883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65123966|NCT01858883|Antimetabolites|antimetabolites|mesh-ancestor
65123967|NCT01858883|Antiviral Agents|antiviral agents|mesh-ancestor
65123968|NCT01858883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65123969|NCT01858883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65123970|NCT01858883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65123971|NCT01858883|Immunologic Factors|immunologic factors|mesh-ancestor
65123972|NCT01858883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65123973|NCT04609488|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65123974|NCT04609488|Respiratory System Agents|respiratory system agents|mesh-ancestor
65123975|NCT01847573|Halofuginone|halofuginone|mesh-list
65124018|NCT04609293|Apatinib|apatinib|mesh-list
65124019|NCT04609293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124020|NCT04609293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65124021|NCT04609293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124022|NCT04609293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124023|NCT04676789|Pegaspargase|pegaspargase|mesh-list
65124024|NCT04676789|Antibodies|antibodies|mesh-list
65124025|NCT04676789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65124026|NCT04676789|Immunologic Factors|immunologic factors|mesh-ancestor
65124027|NCT04676789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124028|NCT04676789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124029|NCT01811576|Hormones|hormones|mesh-list
65124081|NCT00564330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124082|NCT01780844|Mycophenolic Acid|mycophenolic acid|mesh-list
65124084|NCT01780844|Tacrolimus|tacrolimus|mesh-list
65124085|NCT01780844|Basiliximab|basiliximab|mesh-list
65124086|NCT01780844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65124087|NCT01780844|Glucocorticoids|glucocorticoids|mesh-ancestor
65124088|NCT01780844|Hormones|hormones|mesh-ancestor
65124089|NCT01780844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65124090|NCT01780844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124091|NCT01780844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65124092|NCT01780844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124093|NCT01780844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65124094|NCT01780844|Immunologic Factors|immunologic factors|mesh-ancestor
65124095|NCT01780844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65124144|NCT04608981|Diclofenac|diclofenac|mesh-list
65124145|NCT04608981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65124146|NCT04608981|Glucocorticoids|glucocorticoids|mesh-ancestor
65124147|NCT04608981|Hormones|hormones|mesh-ancestor
65124148|NCT04608981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65124149|NCT04608981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124150|NCT04608981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65124151|NCT04608981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124152|NCT04608981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124153|NCT04608981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65124154|NCT04608981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65124155|NCT04608981|Analgesics|analgesics|mesh-ancestor
65124205|NCT04600089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124206|NCT04600089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124207|NCT04600089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65124208|NCT04600089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65124209|NCT04600089|Anesthetics, General|anesthetics, general|mesh-ancestor
65124210|NCT04600089|Anesthetics|anesthetics|mesh-ancestor
65124211|NCT04600089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65124212|NCT04600089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65124213|NCT04600089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65124214|NCT04600089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65124215|NCT04600089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124216|NCT01704365|Vaccines|vaccines|mesh-list
65124217|NCT01704365|Immunologic Factors|immunologic factors|mesh-ancestor
65124218|NCT01704365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124219|NCT01698281|Dexamethasone|dexamethasone|mesh-list
65124220|NCT01698281|Doxorubicin|doxorubicin|mesh-list
65124221|NCT01698281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65124222|NCT01698281|Antiemetics|antiemetics|mesh-ancestor
65124223|NCT01698281|Autonomic Agents|autonomic agents|mesh-ancestor
65124224|NCT01698281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124225|NCT01698281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124226|NCT01698281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65124227|NCT01698281|Glucocorticoids|glucocorticoids|mesh-ancestor
65124228|NCT01698281|Hormones|hormones|mesh-ancestor
65124255|NCT00565500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65124256|NCT00565500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65124257|NCT00565500|Analgesics|analgesics|mesh-ancestor
65124258|NCT00565500|Sensory System Agents|sensory system agents|mesh-ancestor
65124259|NCT00565500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124260|NCT00565500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124261|NCT00565500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65124262|NCT00565500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65124263|NCT00565500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65124264|NCT00565500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124265|NCT00565500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124266|NCT00565500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65124267|NCT04608084|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65124268|NCT04608084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65124269|NCT01691846|Metformin|metformin|mesh-list
65124270|NCT01691846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65124271|NCT01691846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124272|NCT01658501|Metformin|metformin|mesh-list
65124273|NCT01658501|Liraglutide|liraglutide|mesh-list
65124274|NCT01658501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65124275|NCT01658501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124276|NCT01658501|Incretins|incretins|mesh-ancestor
65124277|NCT01658501|Hormones|hormones|mesh-ancestor
65124278|NCT01658501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65124279|NCT01651871|Cetirizine|cetirizine|mesh-list
65124280|NCT01651871|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65124288|NCT04608006|Fentanyl|fentanyl|mesh-list
65124304|NCT04599621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124305|NCT04599621|Protective Agents|protective agents|mesh-ancestor
65124306|NCT04599621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124307|NCT00564525|Amitriptyline|amitriptyline|mesh-list
65124308|NCT00564525|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65124309|NCT00564525|Antidepressive Agents|antidepressive agents|mesh-ancestor
64766660|NCT00793650|Bortezomib|bortezomib|mesh-list
65124333|NCT01632137|Rebamipide|rebamipide|mesh-list
65124369|NCT01563731|Natriuretic Agents|natriuretic agents|mesh-ancestor
65124370|NCT01563731|Protease Inhibitors|protease inhibitors|mesh-ancestor
65124371|NCT01563731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65124372|NCT01563731|Hormone Antagonists|hormone antagonists|mesh-ancestor
65124373|NCT01563731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65124375|NCT01516346|Hydralazine|hydralazine|mesh-list
65124376|NCT01516346|Isosorbide|isosorbide|mesh-list
65124377|NCT01516346|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
65124378|NCT01516346|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65124379|NCT01516346|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65124380|NCT01516346|Diuretics|diuretics|mesh-ancestor
65124381|NCT01516346|Natriuretic Agents|natriuretic agents|mesh-ancestor
65124382|NCT01516346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124383|NCT01516346|Vasodilator Agents|vasodilator agents|mesh-ancestor
64766726|NCT00798720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124384|NCT01516346|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65124386|NCT01516346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65124427|NCT00565656|Growth Inhibitors|growth inhibitors|mesh-ancestor
65124428|NCT00564603|Dexamethasone|dexamethasone|mesh-list
65124429|NCT00564603|Dexamethasone acetate|dexamethasone acetate|mesh-list
65124430|NCT00564603|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
65124431|NCT00564603|BB 1101|bb 1101|mesh-list
65124432|NCT00564603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65124433|NCT00564603|Antiemetics|antiemetics|mesh-ancestor
65124434|NCT00564603|Autonomic Agents|autonomic agents|mesh-ancestor
65124435|NCT00564603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124436|NCT00564603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124437|NCT00564603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65124438|NCT00564603|Glucocorticoids|glucocorticoids|mesh-ancestor
65124439|NCT00564603|Hormones|hormones|mesh-ancestor
65124440|NCT00564603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65124442|NCT00564603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124488|NCT04606836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124489|NCT01163149|Immunoglobulin G|immunoglobulin g|mesh-list
65124490|NCT01163149|Immunologic Factors|immunologic factors|mesh-ancestor
65124491|NCT01163149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124492|NCT04676126|Dorzolamide|dorzolamide|mesh-list
65124493|NCT04676126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65124494|NCT04676126|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65124495|NCT04676126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124496|NCT04676126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124497|NCT04675619|Pirfenidone|pirfenidone|mesh-list
65124498|NCT04675619|Analgesics|analgesics|mesh-ancestor
65124505|NCT04675619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65124551|NCT00565968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124552|NCT01162486|Rifampin|rifampin|mesh-list
65124553|NCT01162486|Rifapentine|rifapentine|mesh-list
65124554|NCT01162486|Midazolam|midazolam|mesh-list
65124555|NCT01162486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65124556|NCT01162486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65124557|NCT01162486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65124558|NCT01162486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124559|NCT01162486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65124560|NCT01162486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65124561|NCT01162486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65124562|NCT01162486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65124563|NCT01162486|Anesthetics, General|anesthetics, general|mesh-ancestor
65124564|NCT01162486|Anesthetics|anesthetics|mesh-ancestor
65124565|NCT01162486|GABA Modulators|gaba modulators|mesh-ancestor
65124566|NCT01162486|GABA Agents|gaba agents|mesh-ancestor
65124567|NCT01162486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65124568|NCT01162486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124569|NCT01162486|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65124570|NCT01162486|Antitubercular Agents|antitubercular agents|mesh-ancestor
65124571|NCT01162486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65124582|NCT01162135|Digoxin|digoxin|mesh-list
65124604|NCT01161628|Rituximab|rituximab|mesh-list
65124605|NCT01161628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65124606|NCT01161628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124607|NCT01161628|Immunologic Factors|immunologic factors|mesh-ancestor
65124608|NCT01161628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124610|NCT04314505|Analgesics, Opioid|analgesics, opioid|mesh-list
65124611|NCT04314505|Narcotics|narcotics|mesh-ancestor
65124612|NCT04314505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65124613|NCT04314505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124614|NCT04314505|Analgesics|analgesics|mesh-ancestor
65124615|NCT04314505|Sensory System Agents|sensory system agents|mesh-ancestor
65124616|NCT04314505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124617|NCT02885545|Anticoagulants|anticoagulants|mesh-list
65124618|NCT01161472|Alprazolam|alprazolam|mesh-list
65124619|NCT01161472|Fesoterodine|fesoterodine|mesh-list
65124620|NCT01161472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65124621|NCT01161472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65124622|NCT01161472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124623|NCT01161472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65124624|NCT01161472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65124625|NCT01161472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65124626|NCT01161472|GABA Modulators|gaba modulators|mesh-ancestor
65124627|NCT01161472|GABA Agents|gaba agents|mesh-ancestor
65124658|NCT04674956|Tubulin Modulators|tubulin modulators|mesh-ancestor
65124659|NCT04674956|Antimitotic Agents|antimitotic agents|mesh-ancestor
65124660|NCT04674956|Mitosis Modulators|mitosis modulators|mesh-ancestor
65124661|NCT04674956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124662|NCT04674956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65124663|NCT04674956|Antimetabolites|antimetabolites|mesh-ancestor
65124664|NCT04674956|Antiviral Agents|antiviral agents|mesh-ancestor
65124665|NCT04674956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65124666|NCT04674956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65124667|NCT04674956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65124668|NCT04674956|Immunologic Factors|immunologic factors|mesh-ancestor
65124669|NCT04674956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124670|NCT00564720|Gemcitabine|gemcitabine|mesh-list
65124671|NCT00564720|Oxaliplatin|oxaliplatin|mesh-list
65124672|NCT00564720|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65124673|NCT00564720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65124717|NCT00566124|Insulin, Isophane|insulin, isophane|mesh-list
65124718|NCT00566124|Isophane insulin, beef|isophane insulin, beef|mesh-list
65124719|NCT00566124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65124720|NCT00566124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124721|NCT01159912|Fluticasone|fluticasone|mesh-list
65124722|NCT01159912|Xhance|xhance|mesh-list
65124723|NCT01159912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65124724|NCT01159912|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65124725|NCT01159912|Autonomic Agents|autonomic agents|mesh-ancestor
65124726|NCT01159912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124727|NCT01159912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124728|NCT01159912|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65124729|NCT01159912|Respiratory System Agents|respiratory system agents|mesh-ancestor
65124730|NCT01159912|Dermatologic Agents|dermatologic agents|mesh-ancestor
65124731|NCT01159912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65124732|NCT04606212|Losartan|losartan|mesh-list
65124733|NCT04606212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65124734|NCT04606212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65124735|NCT04606212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65124736|NCT04606212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65124737|NCT04606212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124738|NCT04606017|Calcium Carbonate|calcium carbonate|mesh-list
65124739|NCT04606017|Antacids|antacids|mesh-ancestor
65124740|NCT04606017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124741|NCT04606017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65124742|NCT04631822|Dexamethasone|dexamethasone|mesh-list
65124743|NCT04631822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65124744|NCT04631822|Antiemetics|antiemetics|mesh-ancestor
65124745|NCT04631822|Autonomic Agents|autonomic agents|mesh-ancestor
65124746|NCT04631822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124747|NCT04631822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124748|NCT04631822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65124749|NCT04631822|Glucocorticoids|glucocorticoids|mesh-ancestor
65124759|NCT04605705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124760|NCT04605705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124761|NCT04605705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65124762|NCT04605705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65124763|NCT00560924|Estradiol|estradiol|mesh-list
65124764|NCT00560924|Estrogens|estrogens|mesh-ancestor
65124765|NCT00560924|Hormones|hormones|mesh-ancestor
65124766|NCT00560924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65124767|NCT00560924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124768|NCT00560963|Everolimus|everolimus|mesh-list
65124769|NCT00560963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65124822|NCT01159171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65124823|NCT01159171|Growth Substances|growth substances|mesh-ancestor
65124824|NCT01159171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124825|NCT01159171|Growth Inhibitors|growth inhibitors|mesh-ancestor
65124826|NCT01159171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65124827|NCT01159171|Antimetabolites|antimetabolites|mesh-ancestor
65124828|NCT01159171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124829|NCT04631315|Prednisolone|prednisolone|mesh-list
65124830|NCT04631315|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65124831|NCT04631315|Methylprednisolone|methylprednisolone|mesh-list
64767178|NCT00835926|Vaccines|vaccines|mesh-list
65124832|NCT04631315|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65124833|NCT04631315|Prednisolone acetate|prednisolone acetate|mesh-list
65124834|NCT04631315|Phenylephrine|phenylephrine|mesh-list
65124835|NCT04631315|Oxymetazoline|oxymetazoline|mesh-list
65124836|NCT04631315|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65124837|NCT04631315|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65124838|NCT04631315|Prednisolone phosphate|prednisolone phosphate|mesh-list
65124839|NCT04631315|Difluprednate|difluprednate|mesh-list
65124840|NCT04631315|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65124841|NCT04631315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65124842|NCT04631315|Glucocorticoids|glucocorticoids|mesh-ancestor
65124843|NCT04631315|Hormones|hormones|mesh-ancestor
65124844|NCT04631315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65124873|NCT01158118|Sargramostim|sargramostim|mesh-list
65124874|NCT01158118|Immunologic Factors|immunologic factors|mesh-ancestor
65124875|NCT01158118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124876|NCT01158118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65124877|NCT01158118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65124878|NCT01158118|Antiviral Agents|antiviral agents|mesh-ancestor
65124879|NCT01158118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65124880|NCT02885311|Naltrexone|naltrexone|mesh-list
65124881|NCT02885311|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65124882|NCT02885311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65124883|NCT02885311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124884|NCT02885311|Sensory System Agents|sensory system agents|mesh-ancestor
65124885|NCT02885311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124886|NCT00566241|Mecasermin|mecasermin|mesh-list
65124887|NCT00566241|Growth Substances|growth substances|mesh-ancestor
65124935|NCT04604886|Dobutamine|dobutamine|mesh-list
65124936|NCT04604886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65124937|NCT04604886|Sympathomimetics|sympathomimetics|mesh-ancestor
65124938|NCT04604886|Autonomic Agents|autonomic agents|mesh-ancestor
65124939|NCT04604886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65124940|NCT04604886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124941|NCT04604886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65124942|NCT04604886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65124943|NCT04604886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65124944|NCT04604886|Adrenergic Agents|adrenergic agents|mesh-ancestor
65124945|NCT04604886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65124946|NCT04604886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65124947|NCT04604886|Protective Agents|protective agents|mesh-ancestor
65124948|NCT04595877|Dipyrone|dipyrone|mesh-list
65124949|NCT04595877|Endorphins|endorphins|mesh-list
65124950|NCT04595877|beta-Endorphin|beta-endorphin|mesh-list
65124995|NCT01157182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65124996|NCT01157182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65124997|NCT01157182|Contraceptive Agents|contraceptive agents|mesh-ancestor
65124998|NCT01157182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65124999|NCT01157182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65125000|NCT01157182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65125001|NCT01157182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65125002|NCT01157182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65125003|NCT01157065|Ranibizumab|ranibizumab|mesh-list
65125004|NCT01157065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65125005|NCT01157065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65125006|NCT01157065|Growth Substances|growth substances|mesh-ancestor
65125007|NCT01157065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125008|NCT01157065|Growth Inhibitors|growth inhibitors|mesh-ancestor
65125054|NCT00561587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65125055|NCT00561587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125056|NCT01156363|Epoetin Alfa|epoetin alfa|mesh-list
65125057|NCT01156363|Hematinics|hematinics|mesh-ancestor
64767404|NCT00886626|Exenatide|exenatide|mesh-list
65125058|NCT02884921|Acetaminophen|acetaminophen|mesh-list
65125059|NCT02884921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65125060|NCT02884921|Analgesics|analgesics|mesh-ancestor
65125061|NCT02884921|Sensory System Agents|sensory system agents|mesh-ancestor
65125062|NCT02884921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125064|NCT02884921|Antipyretics|antipyretics|mesh-ancestor
65125119|NCT04603833|Mitosis Modulators|mitosis modulators|mesh-ancestor
65125120|NCT04603833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125121|NCT04603872|Dasatinib|dasatinib|mesh-list
65125122|NCT04603872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125123|NCT04603872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65125124|NCT04603872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125125|NCT04603872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125126|NCT04603794|Chlorhexidine|chlorhexidine|mesh-list
65125127|NCT04603794|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65125128|NCT04603794|Povidone-Iodine|povidone-iodine|mesh-list
65125129|NCT04603794|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65125130|NCT04603794|Povidone|povidone|mesh-list
65125131|NCT04603794|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65125132|NCT04603794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65125134|NCT04603794|Dermatologic Agents|dermatologic agents|mesh-ancestor
65125135|NCT04603794|Plasma Substitutes|plasma substitutes|mesh-ancestor
65125136|NCT04603794|Blood Substitutes|blood substitutes|mesh-ancestor
65125137|NCT01155583|Dexamethasone|dexamethasone|mesh-list
65125138|NCT01155583|Lenalidomide|lenalidomide|mesh-list
65125139|NCT01155583|Azacitidine|azacitidine|mesh-list
65125140|NCT01155583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65125141|NCT01155583|Antiemetics|antiemetics|mesh-ancestor
65125142|NCT01155583|Autonomic Agents|autonomic agents|mesh-ancestor
65125143|NCT01155583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125144|NCT01155583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125145|NCT01155583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65125146|NCT01155583|Glucocorticoids|glucocorticoids|mesh-ancestor
65125147|NCT01155583|Hormones|hormones|mesh-ancestor
65125148|NCT01155583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65125149|NCT01155583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65125150|NCT01155583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125151|NCT01155583|Immunologic Factors|immunologic factors|mesh-ancestor
65125164|NCT04627181|Vitamin B 12|vitamin b 12|mesh-list
65125165|NCT04627181|Hematinics|hematinics|mesh-ancestor
65125166|NCT04627181|Vitamin B Complex|vitamin b complex|mesh-ancestor
65125167|NCT04627181|Vitamins|vitamins|mesh-ancestor
64514181|NCT01928290|Irinotecan|irinotecan|mesh-list
65125168|NCT04627181|Micronutrients|micronutrients|mesh-ancestor
65125169|NCT04627181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125170|NCT04626752|Cyclophosphamide|cyclophosphamide|mesh-list
65125171|NCT04626752|Fludarabine|fludarabine|mesh-list
65125172|NCT04626752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65125173|NCT04626752|Immunologic Factors|immunologic factors|mesh-ancestor
65125174|NCT04626752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125175|NCT04626752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65125176|NCT04626752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65125177|NCT04626752|Alkylating Agents|alkylating agents|mesh-ancestor
65125178|NCT04626752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125179|NCT04626752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125180|NCT04626752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65125181|NCT01155466|Rasagiline|rasagiline|mesh-list
65125182|NCT01155466|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65125183|NCT01155466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125184|NCT01155466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125185|NCT01155466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65125186|NCT01155466|Protective Agents|protective agents|mesh-ancestor
65125187|NCT01155466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125188|NCT00561899|Piperaquine|piperaquine|mesh-list
65125189|NCT00561899|Amodiaquine|amodiaquine|mesh-list
65125190|NCT00561899|Artenimol|artenimol|mesh-list
65125191|NCT00561899|Antimalarials|antimalarials|mesh-ancestor
65125192|NCT00561899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65125210|NCT00565227|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65125211|NCT00565227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125212|NCT04602273|Azacitidine|azacitidine|mesh-list
65125213|NCT04602273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65125214|NCT04602273|Antimetabolites|antimetabolites|mesh-ancestor
65125215|NCT04602273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125216|NCT04602273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125217|NCT04602273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125218|NCT04313764|Bupivacaine|bupivacaine|mesh-list
65125219|NCT04313764|Anesthetics, Local|anesthetics, local|mesh-ancestor
65125220|NCT04313764|Anesthetics|anesthetics|mesh-ancestor
65125221|NCT04313764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65125222|NCT04313764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125223|NCT04313764|Sensory System Agents|sensory system agents|mesh-ancestor
65125224|NCT04313764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125225|NCT04626089|Metformin|metformin|mesh-list
65125226|NCT04626089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65125227|NCT04626089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125228|NCT04601688|Dexamethasone|dexamethasone|mesh-list
65125229|NCT04601688|Bevacizumab|bevacizumab|mesh-list
65125230|NCT04601688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65125231|NCT04601688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125232|NCT04601688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65125262|NCT04601142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65125263|NCT04601142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65125264|NCT04601142|Prednisolone|prednisolone|mesh-list
65125265|NCT04601142|Prednisolone acetate|prednisolone acetate|mesh-list
65125266|NCT04601142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65125334|NCT00567099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65125335|NCT00567099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125336|NCT00567099|Dopamine Agonists|dopamine agonists|mesh-ancestor
65125337|NCT00567099|Dopamine Agents|dopamine agents|mesh-ancestor
65125338|NCT00567099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65125339|NCT00567099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125340|NCT00567099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65125341|NCT00567099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65125342|NCT00567099|Serotonin Agents|serotonin agents|mesh-ancestor
65125343|NCT00567099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65125344|NCT00567099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65125395|NCT04624217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65125396|NCT04624217|Immunologic Factors|immunologic factors|mesh-ancestor
65125397|NCT04624217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125398|NCT04623866|Valsartan|valsartan|mesh-list
65125399|NCT04623866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65125400|NCT04623866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65125401|NCT04623866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65125402|NCT04623866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125403|NCT00567372|Bevacizumab|bevacizumab|mesh-list
65125404|NCT00567372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65125405|NCT00567372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125406|NCT00567372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65125407|NCT00567372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65125408|NCT00567372|Growth Substances|growth substances|mesh-ancestor
65125409|NCT00567372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125410|NCT00567372|Growth Inhibitors|growth inhibitors|mesh-ancestor
65125411|NCT00562133|Insulin|insulin|mesh-list
65125412|NCT00562133|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65125413|NCT00562133|Insulin glulisine|insulin glulisine|mesh-list
65125417|NCT00567411|Apraclonidine|apraclonidine|mesh-list
65125449|NCT00567528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65125450|NCT00567528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65125451|NCT00567528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65125452|NCT00567528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125453|NCT00567528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125454|NCT00567606|Risedronic Acid|risedronic acid|mesh-list
65125455|NCT00567606|Calcium|calcium|mesh-list
65125456|NCT00567606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65125457|NCT00567606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125458|NCT00567606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65125459|NCT00567606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65125460|NCT00567606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125461|NCT00567606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65125462|NCT04590612|Levodopa|levodopa|mesh-list
65125464|NCT04590612|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65125465|NCT04590612|Citalopram|citalopram|mesh-list
65125507|NCT00562289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64767848|NCT00945282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65125508|NCT00562289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65125509|NCT00562289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65125510|NCT00562289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65125511|NCT00562289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125512|NCT00562289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65125513|NCT00562289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65125514|NCT00562289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125515|NCT00562289|Antipyretics|antipyretics|mesh-ancestor
65125516|NCT00562289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65125517|NCT00562289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65125518|NCT00562289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65125519|NCT00562289|Purinergic Agents|purinergic agents|mesh-ancestor
65125568|NCT04590183|Prednisolone acetate|prednisolone acetate|mesh-list
65125569|NCT04590183|Tacrolimus|tacrolimus|mesh-list
65125570|NCT04590183|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65125571|NCT04590183|Prednisolone phosphate|prednisolone phosphate|mesh-list
65125572|NCT04590183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65125573|NCT04590183|Immunologic Factors|immunologic factors|mesh-ancestor
65125574|NCT04590183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125575|NCT04590183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65125576|NCT04590183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125577|NCT04590183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125578|NCT04590183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65125579|NCT04590183|Glucocorticoids|glucocorticoids|mesh-ancestor
65125580|NCT04590183|Hormones|hormones|mesh-ancestor
65125582|NCT04590183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65125628|NCT01153009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65125629|NCT01153009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65125630|NCT01153009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125631|NCT01153009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65125632|NCT01153009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125633|NCT01153009|Analgesics|analgesics|mesh-ancestor
65125634|NCT01153009|Sensory System Agents|sensory system agents|mesh-ancestor
65125635|NCT01153009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125636|NCT01153009|Antidepressive Agents|antidepressive agents|mesh-ancestor
65125637|NCT01153009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65125638|NCT01153009|Dopamine Agents|dopamine agents|mesh-ancestor
65125639|NCT01153009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65125640|NCT01153009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65125641|NCT01153009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65125642|NCT01153009|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65125643|NCT01153009|Serotonin Agents|serotonin agents|mesh-ancestor
65125644|NCT01153009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65125645|NCT01153009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65125646|NCT01153009|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65125647|NCT01153009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65125679|NCT04589130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65125680|NCT04589130|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65125681|NCT04589130|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65125682|NCT04589130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65125683|NCT04589130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125684|NCT04589130|Dopamine Agents|dopamine agents|mesh-ancestor
65125685|NCT04589130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65125686|NCT04589130|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65125687|NCT04589130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65125688|NCT04589130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125689|NCT04589130|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65125690|NCT04621487|Amoxicillin|amoxicillin|mesh-list
65125691|NCT04621487|Metronidazole|metronidazole|mesh-list
65125692|NCT04621487|Clarithromycin|clarithromycin|mesh-list
65125693|NCT04621487|Pantoprazole|pantoprazole|mesh-list
65125694|NCT04621487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65125695|NCT04621487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65125696|NCT04621487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65125697|NCT04621487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65125698|NCT04621487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65125699|NCT04621487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125700|NCT04621487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125731|NCT04621409|Anti-Infective Agents|anti-infective agents|mesh-list
64768089|NCT00997620|Xhance|xhance|mesh-list
65125732|NCT04621409|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65125733|NCT04588935|Bisoprolol|bisoprolol|mesh-list
65125734|NCT04588935|Perindopril|perindopril|mesh-list
65125735|NCT04588935|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65125736|NCT04588935|Sympatholytics|sympatholytics|mesh-ancestor
65125737|NCT04588935|Autonomic Agents|autonomic agents|mesh-ancestor
65125738|NCT04588935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125739|NCT04588935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125740|NCT04588935|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65125749|NCT00562523|Sorafenib|sorafenib|mesh-list
65125794|NCT00567762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65125795|NCT00567762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125796|NCT00567762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125797|NCT04620785|Methylene Blue|methylene blue|mesh-list
65125798|NCT04620785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65125799|NCT04620785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125800|NCT04620590|Dapagliflozin|dapagliflozin|mesh-list
65125801|NCT04620590|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65125802|NCT04620590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125803|NCT04620590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65125804|NCT04620590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125805|NCT04691063|Carboplatin|carboplatin|mesh-list
65125806|NCT04691063|Etoposide|etoposide|mesh-list
65125807|NCT04691063|Etoposide phosphate|etoposide phosphate|mesh-list
65125808|NCT04691063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125851|NCT00637234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65125852|NCT04588194|Dexamethasone|dexamethasone|mesh-list
65125853|NCT04588194|Rituximab|rituximab|mesh-list
65125854|NCT04588194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65125855|NCT04588194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65125856|NCT04588194|Immunologic Factors|immunologic factors|mesh-ancestor
65125857|NCT04588194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125858|NCT04588194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65125859|NCT04588194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65125860|NCT04588194|Antiemetics|antiemetics|mesh-ancestor
65125861|NCT04588194|Autonomic Agents|autonomic agents|mesh-ancestor
65125862|NCT04588194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125863|NCT04588194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65125864|NCT04588194|Glucocorticoids|glucocorticoids|mesh-ancestor
65125865|NCT04588194|Hormones|hormones|mesh-ancestor
65125866|NCT04588194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65125867|NCT04588194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65125868|NCT02940314|Solifenacin Succinate|solifenacin succinate|mesh-list
65125869|NCT02940314|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65125870|NCT02940314|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65125871|NCT02940314|Cholinergic Agents|cholinergic agents|mesh-ancestor
65125872|NCT02940314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65125873|NCT02940314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125874|NCT02940314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125875|NCT02940314|Urological Agents|urological agents|mesh-ancestor
65125876|NCT04581213|Anesthetics|anesthetics|mesh-list
65125877|NCT04581213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65125878|NCT04581213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125879|NCT01151137|Dronedarone|dronedarone|mesh-list
65125880|NCT01151137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65125882|NCT01151098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65125883|NCT01151098|Narcotics|narcotics|mesh-ancestor
65125884|NCT01151098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65125892|NCT04587843|Bupropion|bupropion|mesh-list
65125893|NCT04587843|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65125894|NCT04587843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65125895|NCT04587843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125896|NCT04587843|Sensory System Agents|sensory system agents|mesh-ancestor
65125897|NCT04587843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125898|NCT04587843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65125899|NCT04587843|Antidepressive Agents|antidepressive agents|mesh-ancestor
65125900|NCT04587843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65125901|NCT04587843|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65125902|NCT04587843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65125903|NCT04587843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65125905|NCT04587843|Dopamine Agents|dopamine agents|mesh-ancestor
65125951|NCT00568503|Respiratory System Agents|respiratory system agents|mesh-ancestor
65125952|NCT00568503|Parasympatholytics|parasympatholytics|mesh-ancestor
65125953|NCT00568503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65125954|NCT00568503|Cholinergic Agents|cholinergic agents|mesh-ancestor
65125955|NCT00568503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65125956|NCT00568503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65125957|NCT00568503|Anticonvulsants|anticonvulsants|mesh-ancestor
65125958|NCT00568542|Epoetin Alfa|epoetin alfa|mesh-list
65125959|NCT00568542|Hematinics|hematinics|mesh-ancestor
65125960|NCT00562835|Thiamine|thiamine|mesh-list
65125961|NCT00562835|Methylprednisolone|methylprednisolone|mesh-list
65125962|NCT00562835|Vitamins|vitamins|mesh-ancestor
65125963|NCT00562835|Micronutrients|micronutrients|mesh-ancestor
65125964|NCT00562835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65125965|NCT00562835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65125966|NCT00562835|Antiemetics|antiemetics|mesh-ancestor
65125967|NCT00562835|Autonomic Agents|autonomic agents|mesh-ancestor
65125968|NCT00562835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125969|NCT00562835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65125970|NCT00562835|Glucocorticoids|glucocorticoids|mesh-ancestor
65125972|NCT00562835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65125973|NCT00562835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65125974|NCT00562835|Protective Agents|protective agents|mesh-ancestor
65125975|NCT00562835|Vitamin B Complex|vitamin b complex|mesh-ancestor
65125976|NCT00568737|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
65125977|NCT00568737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65125978|NCT04587141|Ferric gluconate|ferric gluconate|mesh-list
65125979|NCT04587141|Hematinics|hematinics|mesh-ancestor
65125980|NCT04586790|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65125981|NCT04586790|Epinephrine|epinephrine|mesh-list
65125982|NCT04586790|Racepinephrine|racepinephrine|mesh-list
65125983|NCT04586790|Midodrine|midodrine|mesh-list
65125984|NCT04586790|Norepinephrine|norepinephrine|mesh-list
65125985|NCT04586790|Epinephryl borate|epinephryl borate|mesh-list
65125986|NCT04586790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65125987|NCT04586790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65125994|NCT04586790|Autonomic Agents|autonomic agents|mesh-ancestor
65125995|NCT04586790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65125996|NCT04586790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65125997|NCT04586790|Respiratory System Agents|respiratory system agents|mesh-ancestor
65125998|NCT04586790|Mydriatics|mydriatics|mesh-ancestor
65125999|NCT04586790|Sympathomimetics|sympathomimetics|mesh-ancestor
65126000|NCT04586790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65126001|NCT04586790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65126002|NCT04586790|Hemostatics|hemostatics|mesh-ancestor
65126003|NCT04586790|Coagulants|coagulants|mesh-ancestor
65126062|NCT04618367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126063|NCT04618367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65126064|NCT04618367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126065|NCT04618367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126066|NCT00562952|Telmisartan|telmisartan|mesh-list
65126067|NCT00562952|Bisoprolol|bisoprolol|mesh-list
65126068|NCT00562952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65126069|NCT00562952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65126070|NCT00562952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65126071|NCT00562952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126072|NCT00562952|Sympatholytics|sympatholytics|mesh-ancestor
65126073|NCT00562952|Autonomic Agents|autonomic agents|mesh-ancestor
65126074|NCT00562952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65126075|NCT00562952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126076|NCT00562952|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65126077|NCT00562952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65126117|NCT00569712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65126118|NCT00569712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65126119|NCT00569712|Autonomic Agents|autonomic agents|mesh-ancestor
65126120|NCT00569712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65126121|NCT00569712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126122|NCT00569712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65126123|NCT00569712|Respiratory System Agents|respiratory system agents|mesh-ancestor
65126124|NCT00569712|Glucocorticoids|glucocorticoids|mesh-ancestor
65126125|NCT00569712|Hormones|hormones|mesh-ancestor
65126126|NCT00569712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65126127|NCT00569712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65126128|NCT00569712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65126129|NCT00569712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65126130|NCT00569712|Adrenergic Agents|adrenergic agents|mesh-ancestor
65126131|NCT00569712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65126132|NCT00569712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126133|NCT00569712|Chelating Agents|chelating agents|mesh-ancestor
65126134|NCT00569712|Sequestering Agents|sequestering agents|mesh-ancestor
65126135|NCT00569751|Paclitaxel|paclitaxel|mesh-list
65126136|NCT00569751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65126137|NCT00569751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126138|NCT00569751|Tubulin Modulators|tubulin modulators|mesh-ancestor
65126139|NCT00569751|Antimitotic Agents|antimitotic agents|mesh-ancestor
65126140|NCT00569751|Mitosis Modulators|mitosis modulators|mesh-ancestor
65126141|NCT00569751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126142|NCT00569790|Bevacizumab|bevacizumab|mesh-list
65126143|NCT00569790|Irinotecan|irinotecan|mesh-list
65126144|NCT00569790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65126145|NCT00569790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126146|NCT00569790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65126148|NCT00569790|Growth Substances|growth substances|mesh-ancestor
65126159|NCT00567957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126160|NCT00567957|Analgesics|analgesics|mesh-ancestor
65126161|NCT00567957|Sensory System Agents|sensory system agents|mesh-ancestor
65126162|NCT00567957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65126163|NCT02940002|Betamethasone|betamethasone|mesh-list
65126164|NCT02940002|Clobetasol|clobetasol|mesh-list
65126165|NCT02940002|Calcipotriene|calcipotriene|mesh-list
65126166|NCT02940002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65126167|NCT02940002|Glucocorticoids|glucocorticoids|mesh-ancestor
65126168|NCT02940002|Hormones|hormones|mesh-ancestor
65126169|NCT02940002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65126170|NCT02940002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126171|NCT02940002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65126172|NCT02940002|Respiratory System Agents|respiratory system agents|mesh-ancestor
65126173|NCT02940002|Dermatologic Agents|dermatologic agents|mesh-ancestor
65126174|NCT04618328|Tretinoin|tretinoin|mesh-list
65126175|NCT04618328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126176|NCT04618328|Keratolytic Agents|keratolytic agents|mesh-ancestor
65126177|NCT04618328|Dermatologic Agents|dermatologic agents|mesh-ancestor
64768524|NCT04316910|Anesthetics|anesthetics|mesh-list
65126178|NCT04617782|Donepezil|donepezil|mesh-list
65126179|NCT04617782|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65126180|NCT04617782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514221|NCT02278965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65126181|NCT04617782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126183|NCT04617782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65126184|NCT04617782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126208|NCT04585230|Dermatologic Agents|dermatologic agents|mesh-ancestor
65126209|NCT00570180|Bortezomib|bortezomib|mesh-list
65126210|NCT00570180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126211|NCT02939846|Trametinib|trametinib|mesh-list
65126212|NCT02939846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126213|NCT02939846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65126214|NCT02939846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126215|NCT02939846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126216|NCT02939495|Sildenafil Citrate|sildenafil citrate|mesh-list
65126217|NCT02939495|Vasodilator Agents|vasodilator agents|mesh-ancestor
65126218|NCT02939495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65126219|NCT02939495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65126220|NCT02939495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126221|NCT02939495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126222|NCT02939495|Urological Agents|urological agents|mesh-ancestor
65126223|NCT00570219|Valproic Acid|valproic acid|mesh-list
65126224|NCT00570219|Anticonvulsants|anticonvulsants|mesh-ancestor
65126225|NCT00570219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126226|NCT00570219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126227|NCT00570219|GABA Agents|gaba agents|mesh-ancestor
65126228|NCT00570219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65126229|NCT00570219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126230|NCT00570219|Antimanic Agents|antimanic agents|mesh-ancestor
65126231|NCT00570219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65126232|NCT00570219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65126233|NCT00570219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65126234|NCT00570375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65126235|NCT00570375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126237|NCT00570375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126254|NCT00568113|Antioxidants|antioxidants|mesh-ancestor
65126255|NCT00568113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126256|NCT00568113|Protective Agents|protective agents|mesh-ancestor
65126257|NCT00568113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126258|NCT00568113|Antidotes|antidotes|mesh-ancestor
65126259|NCT00568152|Aspirin|aspirin|mesh-list
65126260|NCT00568152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65126261|NCT00568152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65126262|NCT00568152|Analgesics|analgesics|mesh-ancestor
65126263|NCT00568152|Sensory System Agents|sensory system agents|mesh-ancestor
65126264|NCT00568152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65126265|NCT00568152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126266|NCT00568152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65126267|NCT00568152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65126314|NCT00570726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126315|NCT00570843|Lubricant Eye Drops|lubricant eye drops|mesh-list
65126316|NCT00570843|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65126317|NCT00570843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65126318|NCT00563069|Midazolam|midazolam|mesh-list
65126319|NCT00563069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65126320|NCT00563069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65126321|NCT00563069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65126322|NCT00563069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126323|NCT00563069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64768671|NCT05822453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64768672|NCT05822453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768673|NCT05822453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64768674|NCT05822453|Immunologic Factors|immunologic factors|mesh-ancestor
64768675|NCT05822453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126324|NCT00563069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65126325|NCT00563069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65126370|NCT04616261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65126371|NCT04616261|Respiratory System Agents|respiratory system agents|mesh-ancestor
65126372|NCT04616261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65126373|NCT04616261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65126374|NCT04616261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65126375|NCT04616261|Adrenergic Agents|adrenergic agents|mesh-ancestor
65126376|NCT04616261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65126377|NCT04616261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126378|NCT00563225|Insulin Glargine|insulin glargine|mesh-list
65126379|NCT00563225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65126435|NCT04614194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126436|NCT04614194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65126437|NCT04614194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65126438|NCT04614194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126439|NCT04614194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126440|NCT04614194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65126441|NCT04614194|Hormone Antagonists|hormone antagonists|mesh-ancestor
65126442|NCT04614194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65126443|NCT04614194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126444|NCT04613609|Nicotine|nicotine|mesh-list
65126445|NCT04613609|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65126446|NCT04613609|Autonomic Agents|autonomic agents|mesh-ancestor
65126447|NCT04613609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65126448|NCT04613609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126449|NCT04613609|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65126450|NCT04613609|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65126451|NCT04613609|Cholinergic Agents|cholinergic agents|mesh-ancestor
65126452|NCT04613609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65126453|NCT04613609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126454|NCT00571740|Leucovorin|leucovorin|mesh-list
65126455|NCT00571740|Bevacizumab|bevacizumab|mesh-list
65126456|NCT00571740|Cetuximab|cetuximab|mesh-list
65126457|NCT00571740|Fluorouracil|fluorouracil|mesh-list
65126486|NCT04583046|Vasodilator Agents|vasodilator agents|mesh-ancestor
65126487|NCT04582929|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65126488|NCT04582929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65126489|NCT04582929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65126490|NCT04582929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126491|NCT04582929|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65126492|NCT04582929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65126493|NCT04582929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126494|NCT04582929|Cholinergic Agents|cholinergic agents|mesh-ancestor
65126495|NCT04582929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65126496|NCT04613726|Ondansetron|ondansetron|mesh-list
65126497|NCT04613726|Granisetron|granisetron|mesh-list
65126498|NCT04613726|Antiemetics|antiemetics|mesh-ancestor
64768902|NCT05821062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64768903|NCT05821062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126542|NCT04613180|Hormone Antagonists|hormone antagonists|mesh-ancestor
65126543|NCT04613180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65126544|NCT04613180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126545|NCT04613180|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65126546|NCT04613180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65126547|NCT04613180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126548|NCT00571935|Insulin|insulin|mesh-list
65126549|NCT00571935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65126603|NCT00572208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65126604|NCT00572208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65126605|NCT00572208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65126606|NCT00572208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65126607|NCT00572208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65126608|NCT00572208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65126609|NCT00572208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65126610|NCT00572208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126611|NCT00572208|Antimanic Agents|antimanic agents|mesh-ancestor
65126612|NCT00572364|Olaparib|olaparib|mesh-list
65126613|NCT00572364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65126614|NCT00572364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126665|NCT00572559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126666|NCT04611464|Misoprostol|misoprostol|mesh-list
65126667|NCT04611464|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65126668|NCT04611464|Abortifacient Agents|abortifacient agents|mesh-ancestor
65126669|NCT04611464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65126670|NCT04611464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126671|NCT04611464|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65126672|NCT04611464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65126673|NCT04611464|Oxytocics|oxytocics|mesh-ancestor
65126674|NCT04611776|Gemcitabine|gemcitabine|mesh-list
65126675|NCT04611776|Paclitaxel|paclitaxel|mesh-list
65126676|NCT04611776|Carboplatin|carboplatin|mesh-list
65126677|NCT04611776|Pemetrexed|pemetrexed|mesh-list
65126678|NCT04611776|Atezolizumab|atezolizumab|mesh-list
65126679|NCT04611776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65126680|NCT04611776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126681|NCT04611776|Tubulin Modulators|tubulin modulators|mesh-ancestor
65126682|NCT04611776|Antimitotic Agents|antimitotic agents|mesh-ancestor
65126683|NCT04611776|Mitosis Modulators|mitosis modulators|mesh-ancestor
65126684|NCT04611776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126685|NCT04611776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65126686|NCT04611776|Antimetabolites|antimetabolites|mesh-ancestor
65126687|NCT04611776|Antiviral Agents|antiviral agents|mesh-ancestor
65126688|NCT04611776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65126689|NCT04611776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126690|NCT04611776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65126691|NCT04611776|Immunologic Factors|immunologic factors|mesh-ancestor
65126692|NCT04611776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126712|NCT01149655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65126713|NCT01149655|Serotonin Agents|serotonin agents|mesh-ancestor
65126714|NCT01149655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65126715|NCT01149655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65126716|NCT01149655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65126717|NCT01149655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65126718|NCT00575406|Prednisolone|prednisolone|mesh-list
65126719|NCT00575406|Cyclophosphamide|cyclophosphamide|mesh-list
65126720|NCT00575406|Rituximab|rituximab|mesh-list
65126721|NCT00575406|Doxorubicin|doxorubicin|mesh-list
65126722|NCT00575406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65126723|NCT00575406|Vincristine|vincristine|mesh-list
65126724|NCT00575406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65126725|NCT00575406|Immunologic Factors|immunologic factors|mesh-ancestor
65126726|NCT00575406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126775|NCT01149421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65126776|NCT01149421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126777|NCT00575601|Simvastatin|simvastatin|mesh-list
65126778|NCT00575601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65126779|NCT00575601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65126780|NCT00575601|Antimetabolites|antimetabolites|mesh-ancestor
65126781|NCT00575601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126782|NCT00575601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65126783|NCT00575601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65126784|NCT00575601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126785|NCT04600271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65126787|NCT04600271|Norepinephrine|norepinephrine|mesh-list
65126837|NCT04600037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65126838|NCT04600037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126839|NCT04600037|Anticonvulsants|anticonvulsants|mesh-ancestor
65126840|NCT04600037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64769202|NCT05580003|Moxifloxacin|moxifloxacin|mesh-list
65126841|NCT04600037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65126842|NCT04600037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126843|NCT04600037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65126844|NCT04600037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65126845|NCT04600037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65126846|NCT04600037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65126847|NCT04600037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65126848|NCT00575796|Vinblastine|vinblastine|mesh-list
65126849|NCT00575796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65126850|NCT00575796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126851|NCT00575796|Tubulin Modulators|tubulin modulators|mesh-ancestor
65126852|NCT00575796|Antimitotic Agents|antimitotic agents|mesh-ancestor
65126853|NCT00575796|Mitosis Modulators|mitosis modulators|mesh-ancestor
65126855|NCT00575835|Vitamin D|vitamin d|mesh-list
65126891|NCT04579302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126892|NCT04579302|Sensory System Agents|sensory system agents|mesh-ancestor
65126893|NCT04579302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65126894|NCT00565682|Etoricoxib|etoricoxib|mesh-list
65126895|NCT00565682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65126896|NCT00565682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65126897|NCT00565682|Analgesics|analgesics|mesh-ancestor
65126898|NCT00565682|Sensory System Agents|sensory system agents|mesh-ancestor
65126899|NCT00565682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65126900|NCT00565682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126901|NCT00565682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65126902|NCT00565682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65126903|NCT00565682|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65126904|NCT00565682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65126905|NCT00565682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126907|NCT00575952|Paclitaxel|paclitaxel|mesh-list
65126942|NCT04598594|Nicotine|nicotine|mesh-list
65126943|NCT04598594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65126944|NCT04598594|Autonomic Agents|autonomic agents|mesh-ancestor
65126945|NCT04598594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65126946|NCT04598594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126947|NCT04598594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65126948|NCT04598594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65126949|NCT04598594|Cholinergic Agents|cholinergic agents|mesh-ancestor
65126950|NCT04598594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65126951|NCT04598594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126952|NCT00576069|Fluticasone|fluticasone|mesh-list
65126953|NCT00576069|Mometasone Furoate|mometasone furoate|mesh-list
65126954|NCT00576069|Prednisone|prednisone|mesh-list
65126955|NCT00576069|Budesonide|budesonide|mesh-list
65126956|NCT00576069|Formoterol Fumarate|formoterol fumarate|mesh-list
65126957|NCT00576069|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65126958|NCT00576069|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65126959|NCT00576069|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65126960|NCT00576069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65126961|NCT00576069|Glucocorticoids|glucocorticoids|mesh-ancestor
65126962|NCT00576069|Hormones|hormones|mesh-ancestor
65126963|NCT00576069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65126964|NCT00576069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65126965|NCT00576069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65126966|NCT00576069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126989|NCT00573690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65126990|NCT00573690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65126991|NCT00573690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65126992|NCT00573690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65126993|NCT00573690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65126994|NCT00576225|Paclitaxel|paclitaxel|mesh-list
65126995|NCT00576225|Carboplatin|carboplatin|mesh-list
65126996|NCT00576225|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
65126997|NCT00576225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65126998|NCT00576225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65126999|NCT00576225|Tubulin Modulators|tubulin modulators|mesh-ancestor
65127000|NCT00576225|Antimitotic Agents|antimitotic agents|mesh-ancestor
65127001|NCT00576225|Mitosis Modulators|mitosis modulators|mesh-ancestor
65127002|NCT00576225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127003|NCT04597931|Zoledronic Acid|zoledronic acid|mesh-list
65127004|NCT04597931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65127005|NCT04597931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127006|NCT00576459|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
65127007|NCT00576459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65127008|NCT00576459|Glucocorticoids|glucocorticoids|mesh-ancestor
65127009|NCT00576459|Hormones|hormones|mesh-ancestor
65127010|NCT00576459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65127011|NCT00576459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127012|NCT04597775|Hydroxychloroquine|hydroxychloroquine|mesh-list
65127013|NCT04597775|Antimalarials|antimalarials|mesh-ancestor
65127014|NCT04597775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65127015|NCT04597775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65127016|NCT04597775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65127034|NCT04597424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65127035|NCT00573924|Lansoprazole|lansoprazole|mesh-list
65127036|NCT00573924|Dexlansoprazole|dexlansoprazole|mesh-list
65127037|NCT00573924|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65127038|NCT00573924|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65127039|NCT00573924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65127040|NCT00573924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127041|NCT00573924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127042|NCT00573963|Ropivacaine|ropivacaine|mesh-list
65127043|NCT00573963|Anesthetics, Local|anesthetics, local|mesh-ancestor
65127044|NCT00573963|Anesthetics|anesthetics|mesh-ancestor
65127045|NCT00573963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65127046|NCT00573963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127047|NCT00573963|Sensory System Agents|sensory system agents|mesh-ancestor
65127048|NCT00573963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127049|NCT00576615|Propofol|propofol|mesh-list
65127050|NCT00576615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65127051|NCT00576615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65127052|NCT00576615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127053|NCT00576615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65127054|NCT00576615|Anesthetics, General|anesthetics, general|mesh-ancestor
65127055|NCT00576615|Anesthetics|anesthetics|mesh-ancestor
65127056|NCT00574041|Interferons|interferons|mesh-list
65127057|NCT00574041|Interferon-beta|interferon-beta|mesh-list
65127058|NCT00574041|Interferon beta-1a|interferon beta-1a|mesh-list
65127059|NCT00574041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127060|NCT00574041|Antiviral Agents|antiviral agents|mesh-ancestor
65127061|NCT00574041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65127062|NCT00574041|Immunologic Factors|immunologic factors|mesh-ancestor
65127063|NCT00574041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127081|NCT04596839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127082|NCT04596839|Antiviral Agents|antiviral agents|mesh-ancestor
65127083|NCT04596839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65127084|NCT00574470|Infliximab|infliximab|mesh-list
65127085|NCT00574470|Daclizumab|daclizumab|mesh-list
65127086|NCT00574470|Dermatologic Agents|dermatologic agents|mesh-ancestor
65127087|NCT00574470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65127088|NCT00574470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65127089|NCT00574470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65127090|NCT00574470|Immunologic Factors|immunologic factors|mesh-ancestor
65127091|NCT00574470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127092|NCT00577161|Vidarabine|vidarabine|mesh-list
65127093|NCT00577161|Rituximab|rituximab|mesh-list
65127094|NCT00577161|Fludarabine|fludarabine|mesh-list
65127095|NCT00577161|Fludarabine phosphate|fludarabine phosphate|mesh-list
65127096|NCT00577161|Pixantrone|pixantrone|mesh-list
65127097|NCT00577161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65127098|NCT00577161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127099|NCT00577161|Immunologic Factors|immunologic factors|mesh-ancestor
65127100|NCT00577161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127101|NCT00577161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65127102|NCT00577161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65127103|NCT00577161|Antimetabolites|antimetabolites|mesh-ancestor
65127104|NCT00577161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127105|NCT00577161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65127106|NCT00577161|Antiviral Agents|antiviral agents|mesh-ancestor
65127107|NCT00577161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65127108|NCT00577161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65127109|NCT00577161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65127110|NCT00577161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127111|NCT00574509|Tositumomab I-131|tositumomab i-131|mesh-list
65127112|NCT00574509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127113|NCT04596488|Efavirenz|efavirenz|mesh-list
65127114|NCT04596488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65127115|NCT04596488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65127116|NCT04596488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127120|NCT04596488|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65127121|NCT04596488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65127122|NCT04596488|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65127123|NCT04596488|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65127124|NCT04596488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65127125|NCT04596488|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65127126|NCT04595942|Fludrocortisone|fludrocortisone|mesh-list
65127127|NCT04595942|Midodrine|midodrine|mesh-list
65127128|NCT04595942|Sympathomimetics|sympathomimetics|mesh-ancestor
65127129|NCT04595942|Autonomic Agents|autonomic agents|mesh-ancestor
65127130|NCT04595942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127131|NCT04595942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127132|NCT04595942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65127133|NCT04595942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65127134|NCT04595942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65127179|NCT00577668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65127180|NCT00577668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65127181|NCT00577668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127182|NCT00577668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65127183|NCT00577668|Alkylating Agents|alkylating agents|mesh-ancestor
65127184|NCT00577668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127185|NCT00577668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65127186|NCT00577668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65127187|NCT00577668|Immunologic Factors|immunologic factors|mesh-ancestor
65127188|NCT00577668|Leprostatic Agents|leprostatic agents|mesh-ancestor
65127189|NCT00577668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65127190|NCT00577668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65127191|NCT00577668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65127192|NCT00577668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65127193|NCT00577668|Growth Substances|growth substances|mesh-ancestor
65127194|NCT00577668|Growth Inhibitors|growth inhibitors|mesh-ancestor
65127195|NCT01147744|Fluticasone|fluticasone|mesh-list
65127197|NCT01147744|Montelukast|montelukast|mesh-list
65127198|NCT01147744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65127199|NCT01147744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65127200|NCT01147744|Autonomic Agents|autonomic agents|mesh-ancestor
64769576|NCT05063552|Bevacizumab|bevacizumab|mesh-list
64769577|NCT05063552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64769578|NCT05063552|Cetuximab|cetuximab|mesh-list
65127201|NCT01147744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127202|NCT01147744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127203|NCT01147744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65127204|NCT01147744|Respiratory System Agents|respiratory system agents|mesh-ancestor
65127221|NCT04313374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127222|NCT04313374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65127223|NCT04313374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65127224|NCT04313374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65127225|NCT04313374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65127226|NCT04313335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65127227|NCT04313335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65127228|NCT04313335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65127229|NCT04313335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65127230|NCT04313335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127231|NCT04313335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65127232|NCT04313335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127233|NCT04313335|Analgesics|analgesics|mesh-ancestor
65127234|NCT04313335|Sensory System Agents|sensory system agents|mesh-ancestor
65127235|NCT04313335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127236|NCT04313335|Antidepressive Agents|antidepressive agents|mesh-ancestor
65127237|NCT04313335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65127238|NCT04313335|Dopamine Agents|dopamine agents|mesh-ancestor
65127239|NCT00577980|Testosterone|testosterone|mesh-list
65127240|NCT00577980|Androgens|androgens|mesh-ancestor
65127241|NCT00577980|Hormones|hormones|mesh-ancestor
65127242|NCT00577980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65127243|NCT00577980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127244|NCT04594343|Disulfiram|disulfiram|mesh-list
65127245|NCT04594343|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65127246|NCT04594343|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65127247|NCT04594343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127248|NCT04594343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127250|NCT01147393|Veltuzumab|veltuzumab|mesh-list
65127263|NCT00578097|Cholinergic Agents|cholinergic agents|mesh-ancestor
65127264|NCT00578097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65127265|NCT00578097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127266|NCT00578097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65127267|NCT00578097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127268|NCT00578370|Cyclosporine|cyclosporine|mesh-list
65127269|NCT00578370|Betamethasone|betamethasone|mesh-list
65127270|NCT00578370|Calcipotriene|calcipotriene|mesh-list
65127271|NCT00578370|Cyclosporins|cyclosporins|mesh-list
64769650|NCT04971226|Imatinib Mesylate|imatinib mesylate|mesh-list
65127272|NCT00578370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127273|NCT00578370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127274|NCT00578370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65127275|NCT00578370|Immunologic Factors|immunologic factors|mesh-ancestor
65127276|NCT00578370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127277|NCT00578370|Antifungal Agents|antifungal agents|mesh-ancestor
65127278|NCT00578370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65127279|NCT00578370|Dermatologic Agents|dermatologic agents|mesh-ancestor
65127280|NCT00578370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65127281|NCT00578370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65127282|NCT00578370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65127283|NCT00578370|Glucocorticoids|glucocorticoids|mesh-ancestor
65127284|NCT00578370|Hormones|hormones|mesh-ancestor
65127285|NCT00578370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65127286|NCT00578370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65127287|NCT00578370|Respiratory System Agents|respiratory system agents|mesh-ancestor
65127288|NCT04593836|Peppermint oil|peppermint oil|mesh-list
65127289|NCT04593836|Menthol|menthol|mesh-list
65127290|NCT04593836|Antipruritics|antipruritics|mesh-ancestor
65127298|NCT04593524|Vitamin D|vitamin d|mesh-list
65127310|NCT00578526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65127311|NCT00578526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127312|NCT00578526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127313|NCT04593446|Picosulfate sodium|picosulfate sodium|mesh-list
65127314|NCT04593446|Cathartics|cathartics|mesh-ancestor
65127315|NCT04593446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65127316|NCT00566891|Tirofiban|tirofiban|mesh-list
65127317|NCT00566891|Clopidogrel|clopidogrel|mesh-list
65127318|NCT00566891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65127319|NCT00566891|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65127320|NCT00566891|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65127321|NCT00566891|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65127322|NCT00566891|Purinergic Agents|purinergic agents|mesh-ancestor
65127323|NCT00566891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65127324|NCT00566891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769727|NCT04897217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769728|NCT04897217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64769729|NCT04897217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64769730|NCT04897217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64769731|NCT04897217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64769732|NCT04897217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64769733|NCT04897217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769734|NCT04897217|Appetite Stimulants|appetite stimulants|mesh-ancestor
64769735|NCT04897217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64769736|NCT04870645|Chelating Agents|chelating agents|mesh-list
64769737|NCT04870645|Sequestering Agents|sequestering agents|mesh-ancestor
64769738|NCT04870645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769763|NCT04838379|Dexamethasone|dexamethasone|mesh-list
64769764|NCT04838379|Dexmedetomidine|dexmedetomidine|mesh-list
64769765|NCT04838379|Bupivacaine|bupivacaine|mesh-list
64769766|NCT04838379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65127329|NCT00578721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65127330|NCT00578721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65127331|NCT00578721|Analgesics|analgesics|mesh-ancestor
65127332|NCT00578721|Sensory System Agents|sensory system agents|mesh-ancestor
65127333|NCT00578721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127334|NCT00578721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127335|NCT00578721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65127336|NCT00578721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65127337|NCT00578721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65127338|NCT00578721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65127339|NCT00578721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127340|NCT00578721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65127341|NCT00578721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65127342|NCT00578721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127343|NCT00578721|Antipyretics|antipyretics|mesh-ancestor
65127344|NCT00578760|Aspirin|aspirin|mesh-list
65127345|NCT00578760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65127346|NCT00578760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65127347|NCT00578760|Analgesics|analgesics|mesh-ancestor
65127348|NCT00578760|Sensory System Agents|sensory system agents|mesh-ancestor
65127349|NCT00578760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127350|NCT00578760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514254|NCT02766465|Alkylating Agents|alkylating agents|mesh-ancestor
65127380|NCT04592666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65127381|NCT04593056|Warfarin|warfarin|mesh-list
65127382|NCT04593056|Rivaroxaban|rivaroxaban|mesh-list
65127383|NCT04593056|Anticoagulants|anticoagulants|mesh-ancestor
65127384|NCT04593056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65127385|NCT04593056|Antithrombins|antithrombins|mesh-ancestor
65127386|NCT04593056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65127387|NCT04593056|Protease Inhibitors|protease inhibitors|mesh-ancestor
65127388|NCT04593056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127389|NCT04593056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127390|NCT04592198|Palonosetron|palonosetron|mesh-list
65127391|NCT04592198|Antiemetics|antiemetics|mesh-ancestor
65127392|NCT04592198|Autonomic Agents|autonomic agents|mesh-ancestor
65127393|NCT04592198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127394|NCT04592198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127395|NCT04592198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65127396|NCT04592198|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65127397|NCT04592198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65127398|NCT04592198|Serotonin Agents|serotonin agents|mesh-ancestor
65127399|NCT04592198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65127400|NCT04592198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127401|NCT04592081|Dexamethasone|dexamethasone|mesh-list
65127402|NCT04592081|Dexamethasone acetate|dexamethasone acetate|mesh-list
65127403|NCT04592081|BB 1101|bb 1101|mesh-list
65127404|NCT04592081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65127405|NCT04592081|Antiemetics|antiemetics|mesh-ancestor
65127427|NCT00579969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65127428|NCT00579969|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65127429|NCT00579969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65127430|NCT04591847|Vitamin D|vitamin d|mesh-list
65127431|NCT04591847|Ergocalciferols|ergocalciferols|mesh-list
65127432|NCT04591847|Vitamins|vitamins|mesh-ancestor
65127433|NCT04591847|Micronutrients|micronutrients|mesh-ancestor
65127434|NCT04591847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127435|NCT04591847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65127436|NCT04591847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65127437|NCT04591535|Levodopa|levodopa|mesh-list
65127438|NCT04591535|Carbidopa|carbidopa|mesh-list
65127439|NCT04591535|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65127440|NCT04591535|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65127441|NCT04591535|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65127442|NCT04591535|Dopamine Agents|dopamine agents|mesh-ancestor
65127443|NCT04591535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65127482|NCT00580437|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65127483|NCT00580437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65127484|NCT00580437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65127485|NCT00580437|Adrenergic Agents|adrenergic agents|mesh-ancestor
65127486|NCT00580437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65127487|NCT00580437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127488|NCT00580437|Protective Agents|protective agents|mesh-ancestor
65127489|NCT00580827|Disulfiram|disulfiram|mesh-list
65127490|NCT00580827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65127491|NCT00580827|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65127492|NCT00580827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127493|NCT00580827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127494|NCT00580905|Adenosine|adenosine|mesh-list
65127495|NCT00580905|Nitroprusside|nitroprusside|mesh-list
65127496|NCT00580905|Analgesics|analgesics|mesh-ancestor
65127497|NCT00580905|Sensory System Agents|sensory system agents|mesh-ancestor
65127498|NCT00580905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127499|NCT00580905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127500|NCT00580905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65127501|NCT00580905|Vasodilator Agents|vasodilator agents|mesh-ancestor
65127502|NCT00580905|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65127503|NCT00580905|Purinergic Agonists|purinergic agonists|mesh-ancestor
65127504|NCT00580905|Purinergic Agents|purinergic agents|mesh-ancestor
65127505|NCT00580905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65127506|NCT00580905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127507|NCT00580905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65127508|NCT00580905|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
65127509|NCT04590638|Epinephrine|epinephrine|mesh-list
65127510|NCT04590638|Racepinephrine|racepinephrine|mesh-list
65127511|NCT04590638|Epinephryl borate|epinephryl borate|mesh-list
65127512|NCT04590638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65127513|NCT04590638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65127514|NCT04590638|Adrenergic Agents|adrenergic agents|mesh-ancestor
65127520|NCT04590638|Autonomic Agents|autonomic agents|mesh-ancestor
65127522|NCT04590638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65127523|NCT04590638|Respiratory System Agents|respiratory system agents|mesh-ancestor
65127525|NCT04590638|Sympathomimetics|sympathomimetics|mesh-ancestor
65127526|NCT04590638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65127527|NCT00567554|Paclitaxel|paclitaxel|mesh-list
65127528|NCT00567554|Docetaxel|docetaxel|mesh-list
65127529|NCT00567554|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65127530|NCT00567554|Cyclophosphamide|cyclophosphamide|mesh-list
65127531|NCT00567554|Bevacizumab|bevacizumab|mesh-list
65127532|NCT00567554|Trastuzumab|trastuzumab|mesh-list
65127533|NCT00567554|Everolimus|everolimus|mesh-list
65127534|NCT00567554|Epirubicin|epirubicin|mesh-list
65127535|NCT00567554|Lapatinib|lapatinib|mesh-list
65127536|NCT00567554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65127537|NCT00567554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127538|NCT00567554|Tubulin Modulators|tubulin modulators|mesh-ancestor
65127539|NCT00567554|Antimitotic Agents|antimitotic agents|mesh-ancestor
65127540|NCT00567554|Mitosis Modulators|mitosis modulators|mesh-ancestor
65127541|NCT00567554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127542|NCT00567554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64769963|NCT04660344|Atezolizumab|atezolizumab|mesh-list
65127543|NCT00567554|Immunologic Factors|immunologic factors|mesh-ancestor
65127544|NCT00567554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127545|NCT00567554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65127546|NCT00567554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65127547|NCT00567554|Alkylating Agents|alkylating agents|mesh-ancestor
65127548|NCT00567554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65127549|NCT00567554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65127550|NCT00567554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65127551|NCT00567554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65127552|NCT00567554|Growth Substances|growth substances|mesh-ancestor
65127553|NCT00567554|Growth Inhibitors|growth inhibitors|mesh-ancestor
65127554|NCT00567554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65127555|NCT00567554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65127556|NCT00567554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65127557|NCT00567554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127558|NCT00567554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65127562|NCT00581139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127563|NCT00581139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65127564|NCT00581139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65127565|NCT00581139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65127566|NCT00581139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65127567|NCT00581139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65127568|NCT00581139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65127569|NCT00581139|Anesthetics, General|anesthetics, general|mesh-ancestor
65127570|NCT00581139|GABA Modulators|gaba modulators|mesh-ancestor
65127571|NCT00581139|GABA Agents|gaba agents|mesh-ancestor
65127572|NCT00581139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65127573|NCT00581139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127574|NCT04590482|Letrozole|letrozole|mesh-list
65127575|NCT04590482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127576|NCT04590482|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65127577|NCT04590482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65127578|NCT04590482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127579|NCT04590482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127580|NCT04590482|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65127581|NCT04590482|Hormone Antagonists|hormone antagonists|mesh-ancestor
65127582|NCT04590482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65127583|NCT04590482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127584|NCT00581217|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65127585|NCT00581217|Laxatives|laxatives|mesh-ancestor
65127586|NCT00581217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65127587|NCT00567710|Risperidone|risperidone|mesh-list
65127588|NCT00567710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65127589|NCT00567710|Serotonin Agents|serotonin agents|mesh-ancestor
65127599|NCT04589429|Morphine|morphine|mesh-list
64770036|NCT04521478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64770037|NCT04521478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64770038|NCT04521478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64770039|NCT04521478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770049|NCT04483102|Liver Extracts|liver extracts|mesh-list
64770050|NCT04483102|Hematinics|hematinics|mesh-ancestor
64770051|NCT04474483|Melatonin|melatonin|mesh-list
64770052|NCT04474483|Antioxidants|antioxidants|mesh-ancestor
64770053|NCT04474483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770054|NCT04474483|Protective Agents|protective agents|mesh-ancestor
64770057|NCT04432207|Atezolizumab|atezolizumab|mesh-list
65127604|NCT04589429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127605|NCT04589429|Analgesics|analgesics|mesh-ancestor
65127606|NCT04589429|Sensory System Agents|sensory system agents|mesh-ancestor
65127607|NCT04589429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127608|NCT04589390|Selexipag|selexipag|mesh-list
65127609|NCT04589390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65127610|NCT04577040|Tadalafil|tadalafil|mesh-list
65127611|NCT04577040|Vasodilator Agents|vasodilator agents|mesh-ancestor
65127612|NCT04577040|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65127613|NCT04577040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65127614|NCT04577040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127615|NCT04577040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127616|NCT04577040|Urological Agents|urological agents|mesh-ancestor
65127617|NCT04589234|Gemcitabine|gemcitabine|mesh-list
65127618|NCT04589234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65127619|NCT04589234|Folfirinox|folfirinox|mesh-list
65127620|NCT04589234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65127621|NCT04589234|Antimetabolites|antimetabolites|mesh-ancestor
65127622|NCT04589234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127623|NCT04589234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127624|NCT04589234|Antiviral Agents|antiviral agents|mesh-ancestor
65127638|NCT04588532|Histamine Agents|histamine agents|mesh-ancestor
65127639|NCT04588532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65127640|NCT04588532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127641|NCT04588532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127642|NCT04588532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65127643|NCT04588532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65127644|NCT04588532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65127645|NCT04588532|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65127646|NCT04588532|Antidepressive Agents|antidepressive agents|mesh-ancestor
65127647|NCT04588532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65127648|NCT04588532|Histamine Antagonists|histamine antagonists|mesh-ancestor
65127649|NCT04577430|Dexmedetomidine|dexmedetomidine|mesh-list
65127650|NCT04577430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65127651|NCT04577430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65127652|NCT04577430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127653|NCT04577430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65127654|NCT04577430|Analgesics|analgesics|mesh-ancestor
65127655|NCT04577430|Sensory System Agents|sensory system agents|mesh-ancestor
65127656|NCT04577430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127657|NCT04577430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65127658|NCT04577430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65127659|NCT04577430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65127660|NCT04577430|Adrenergic Agents|adrenergic agents|mesh-ancestor
65127661|NCT04577430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65127662|NCT04577430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127663|NCT00567788|Bimatoprost|bimatoprost|mesh-list
65127664|NCT00567788|Latanoprost|latanoprost|mesh-list
65127665|NCT00567788|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65127670|NCT00581607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65127671|NCT00581607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127672|NCT00581685|Celecoxib|celecoxib|mesh-list
65127673|NCT00581685|Pregabalin|pregabalin|mesh-list
65127674|NCT00581685|Analgesics|analgesics|mesh-ancestor
65127675|NCT00581685|Sensory System Agents|sensory system agents|mesh-ancestor
65127676|NCT00581685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127677|NCT00581685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127678|NCT00581685|Anticonvulsants|anticonvulsants|mesh-ancestor
65127679|NCT00581685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65127680|NCT00581685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65127681|NCT00581685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127682|NCT00581685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65127683|NCT00581685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65127684|NCT00581685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65127685|NCT00581685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65127686|NCT00581685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65127687|NCT00581685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65127688|NCT00581685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65127689|NCT00581685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65127690|NCT00581685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65127691|NCT00581685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65127692|NCT00581685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65127693|NCT00581685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127694|NCT04588220|Plasminogen|plasminogen|mesh-list
65127695|NCT04588220|Melatonin|melatonin|mesh-list
65127696|NCT04588220|Antioxidants|antioxidants|mesh-ancestor
65127697|NCT04588220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127698|NCT04588220|Protective Agents|protective agents|mesh-ancestor
65127699|NCT04588220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127712|NCT04586543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65127713|NCT04586543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65127714|NCT04586543|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65127715|NCT04586543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127716|NCT04586543|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65127717|NCT04586543|Protective Agents|protective agents|mesh-ancestor
65127718|NCT04586543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127719|NCT04593654|Dalteparin|dalteparin|mesh-list
65127721|NCT04593654|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65127722|NCT04593654|Anticoagulants|anticoagulants|mesh-ancestor
65127723|NCT04593654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65127724|NCT04593654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65127725|NCT04593654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127726|NCT04586465|Gemcitabine|gemcitabine|mesh-list
65127727|NCT04586465|Carboplatin|carboplatin|mesh-list
65127728|NCT04586465|Pembrolizumab|pembrolizumab|mesh-list
65127729|NCT04586465|Pemetrexed|pemetrexed|mesh-list
65127730|NCT04586465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127731|NCT04586465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65127732|NCT04586465|Antimetabolites|antimetabolites|mesh-ancestor
65127733|NCT04586465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127734|NCT04586465|Antiviral Agents|antiviral agents|mesh-ancestor
65127735|NCT04586465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65127736|NCT04586465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127737|NCT04586465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65127738|NCT04586465|Immunologic Factors|immunologic factors|mesh-ancestor
64770179|NCT04164082|Gemcitabine|gemcitabine|mesh-list
64770180|NCT04164082|Pembrolizumab|pembrolizumab|mesh-list
64770181|NCT04164082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65127761|NCT04593108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127762|NCT04593108|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65127763|NCT04593108|Hormone Antagonists|hormone antagonists|mesh-ancestor
65127764|NCT04593108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65127765|NCT04593108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127766|NCT04593108|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65127767|NCT04593108|Abortifacient Agents|abortifacient agents|mesh-ancestor
65127768|NCT04593108|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65127769|NCT04593108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65127770|NCT04593108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65127772|NCT04585334|Diclofenac|diclofenac|mesh-list
65127817|NCT00567983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127818|NCT00567983|Antifungal Agents|antifungal agents|mesh-ancestor
65127819|NCT00567983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65127820|NCT00567983|Dermatologic Agents|dermatologic agents|mesh-ancestor
65127821|NCT00567983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65127822|NCT00567983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65127823|NCT00582582|Vitamin D|vitamin d|mesh-list
65127824|NCT00582582|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
65127825|NCT00582582|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65127826|NCT00582582|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
65127827|NCT00582582|Docetaxel|docetaxel|mesh-list
65127828|NCT00582582|Vitamins|vitamins|mesh-ancestor
65127829|NCT00582582|Micronutrients|micronutrients|mesh-ancestor
65127830|NCT00582582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127831|NCT00582582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127832|NCT00582582|Tubulin Modulators|tubulin modulators|mesh-ancestor
65127833|NCT00582582|Antimitotic Agents|antimitotic agents|mesh-ancestor
65127834|NCT00582582|Mitosis Modulators|mitosis modulators|mesh-ancestor
65127835|NCT00582582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127836|NCT00582582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65127837|NCT00566904|Aspirin|aspirin|mesh-list
65127838|NCT00566904|Lidocaine|lidocaine|mesh-list
65127839|NCT00566904|Anesthetics, Local|anesthetics, local|mesh-list
65127840|NCT00566904|Anesthetics|anesthetics|mesh-list
65127841|NCT00566904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65127842|NCT00566904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127843|NCT00566904|Sensory System Agents|sensory system agents|mesh-ancestor
65127844|NCT00566904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65127845|NCT00566904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65127846|NCT00566904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64700400|NCT00002865|Cobalt|cobalt|mesh-list
65127861|NCT04584983|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65127862|NCT04584983|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64770329|NCT03901482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64770330|NCT03901482|Analgesics|analgesics|mesh-ancestor
64770331|NCT03901482|Sensory System Agents|sensory system agents|mesh-ancestor
64770332|NCT03901482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64770339|NCT03834519|Prednisone|prednisone|mesh-list
64770340|NCT03834519|Prednisolone|prednisolone|mesh-list
64770341|NCT03834519|Pembrolizumab|pembrolizumab|mesh-list
64770342|NCT03834519|Olaparib|olaparib|mesh-list
64770343|NCT03834519|Abiraterone Acetate|abiraterone acetate|mesh-list
64770344|NCT03834519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64770345|NCT03834519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770346|NCT03834519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65127863|NCT04584983|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65127864|NCT04584983|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65127865|NCT04584515|Itraconazole|itraconazole|mesh-list
65127866|NCT04584515|Rifampin|rifampin|mesh-list
65127867|NCT04584515|Antifungal Agents|antifungal agents|mesh-ancestor
65127868|NCT04584515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65127869|NCT04584515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65127870|NCT04584515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65127871|NCT04584515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127872|NCT04584515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127873|NCT04584515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65127874|NCT04584515|Hormone Antagonists|hormone antagonists|mesh-ancestor
65127875|NCT04584515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65127876|NCT04584515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127877|NCT04584515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65127892|NCT04584671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65127893|NCT04584671|Anesthetics, General|anesthetics, general|mesh-ancestor
65127894|NCT04584671|Anesthetics|anesthetics|mesh-ancestor
65127895|NCT04584671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65127896|NCT04584671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65127897|NCT04584008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65127898|NCT04584008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127899|NCT04584008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127900|NCT04584008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127901|NCT04592211|Paclitaxel|paclitaxel|mesh-list
65127902|NCT04592211|Pembrolizumab|pembrolizumab|mesh-list
65127903|NCT04592211|Olaparib|olaparib|mesh-list
65127904|NCT04592211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65127905|NCT04592211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65127906|NCT04592211|Tubulin Modulators|tubulin modulators|mesh-ancestor
65127907|NCT04592211|Antimitotic Agents|antimitotic agents|mesh-ancestor
65127908|NCT04592211|Mitosis Modulators|mitosis modulators|mesh-ancestor
65127937|NCT04576143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65127938|NCT04576143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127939|NCT04583267|Tenofovir|tenofovir|mesh-list
65127940|NCT04583267|Emtricitabine|emtricitabine|mesh-list
65127941|NCT04583267|Antiviral Agents|antiviral agents|mesh-ancestor
65127942|NCT04583267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65127943|NCT04583267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65127944|NCT04583267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65127945|NCT04583267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65127946|NCT04583267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127947|NCT04583267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65127948|NCT04583267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65127949|NCT04583111|Domperidone|domperidone|mesh-list
65127950|NCT04583111|Sulpiride|sulpiride|mesh-list
64770484|NCT03454035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770488|NCT03429543|Empagliflozin|empagliflozin|mesh-list
65127993|NCT04591743|Cholinergic Agents|cholinergic agents|mesh-ancestor
65127994|NCT04591743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65127995|NCT04591743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65127996|NCT02884180|Dexamethasone|dexamethasone|mesh-list
65127997|NCT02884180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65127998|NCT02884180|Antiemetics|antiemetics|mesh-ancestor
65127999|NCT02884180|Autonomic Agents|autonomic agents|mesh-ancestor
65128000|NCT02884180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65128001|NCT02884180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128002|NCT02884180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65128003|NCT02884180|Glucocorticoids|glucocorticoids|mesh-ancestor
65128004|NCT02884180|Hormones|hormones|mesh-ancestor
65128005|NCT02884180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65128006|NCT02884180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65128007|NCT02884180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128008|NCT00567060|Piracetam|piracetam|mesh-list
65128009|NCT00567060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65128010|NCT00567060|Protective Agents|protective agents|mesh-ancestor
65128011|NCT00567060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128012|NCT00567060|Nootropic Agents|nootropic agents|mesh-ancestor
65128013|NCT00568217|Acetaminophen|acetaminophen|mesh-list
65128014|NCT00568217|Ibuprofen|ibuprofen|mesh-list
65128015|NCT00568217|Diclofenac|diclofenac|mesh-list
65128016|NCT00568217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65128017|NCT00568217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65128018|NCT00568217|Analgesics|analgesics|mesh-ancestor
65128019|NCT00568217|Sensory System Agents|sensory system agents|mesh-ancestor
65128020|NCT00568217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65128021|NCT00568217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128022|NCT00568217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65128023|NCT00568217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65128024|NCT00568217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65128025|NCT00568217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128027|NCT00568217|Antipyretics|antipyretics|mesh-ancestor
65128029|NCT00583323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65128030|NCT04582604|Decitabine|decitabine|mesh-list
65128031|NCT04582604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65128032|NCT04582604|Antimetabolites|antimetabolites|mesh-ancestor
65128033|NCT04582604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128034|NCT04582604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128035|NCT04582604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128036|NCT00590928|Esomeprazole|esomeprazole|mesh-list
65128037|NCT00590928|Ranitidine|ranitidine|mesh-list
65128038|NCT00590928|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
65128039|NCT00590928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65128040|NCT00590928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65128041|NCT00590928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65128042|NCT00590928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64770553|NCT03093909|Gemcitabine|gemcitabine|mesh-list
64770554|NCT03093909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64770555|NCT03093909|Antimetabolites|antimetabolites|mesh-ancestor
64770556|NCT03093909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770558|NCT03093909|Antiviral Agents|antiviral agents|mesh-ancestor
64770559|NCT03093909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64770560|NCT03093909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64770561|NCT03093909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64770562|NCT03093909|Immunologic Factors|immunologic factors|mesh-ancestor
64770563|NCT03093909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770564|NCT03070223|Pitavastatin|pitavastatin|mesh-list
64770565|NCT03070223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64770566|NCT03070223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64770567|NCT03070223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64770568|NCT03070223|Antimetabolites|antimetabolites|mesh-ancestor
64770569|NCT03070223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770599|NCT02979873|Sirolimus|sirolimus|mesh-list
65128050|NCT01145482|Insulin Aspart|insulin aspart|mesh-list
65128051|NCT01145482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65128052|NCT01145482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128053|NCT00568295|Acetaminophen|acetaminophen|mesh-list
65128054|NCT00568295|Rofecoxib|rofecoxib|mesh-list
65128055|NCT00568295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65128056|NCT00568295|Analgesics|analgesics|mesh-ancestor
65128057|NCT00568295|Sensory System Agents|sensory system agents|mesh-ancestor
65128058|NCT00568295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65128059|NCT00568295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128060|NCT00568295|Antipyretics|antipyretics|mesh-ancestor
65128061|NCT00568295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65128062|NCT00568295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65128063|NCT00568295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128064|NCT00568295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128065|NCT00568295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65128066|NCT00568295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65128067|NCT00568295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65128068|NCT00591162|Tetracycline|tetracycline|mesh-list
65128069|NCT00591162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65128070|NCT00591162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65128071|NCT00591162|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65128072|NCT00591162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128073|NCT00591162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128074|NCT00583518|Hormones|hormones|mesh-list
65128075|NCT00583518|Parathyroid Hormone|parathyroid hormone|mesh-list
65128076|NCT00583518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65128077|NCT00583518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128078|NCT00583518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65128079|NCT04582136|Sirolimus|sirolimus|mesh-list
65128080|NCT04582136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65128081|NCT04582136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65128088|NCT00591201|Infliximab|infliximab|mesh-list
65128090|NCT00591201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65128091|NCT00591201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65128092|NCT04582097|Ramipril|ramipril|mesh-list
65128093|NCT04582097|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65128094|NCT04582097|Protease Inhibitors|protease inhibitors|mesh-ancestor
65128095|NCT04582097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128096|NCT04582097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128097|NCT04582097|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65128098|NCT00591357|Loperamide|loperamide|mesh-list
65128099|NCT00591357|Antidiarrheals|antidiarrheals|mesh-list
65128100|NCT00591357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65128101|NCT04575675|Dapagliflozin|dapagliflozin|mesh-list
65128102|NCT04575675|Valsartan|valsartan|mesh-list
65128103|NCT04575675|Carvedilol|carvedilol|mesh-list
65128104|NCT04575675|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65128105|NCT04575675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65128106|NCT04575675|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
65128107|NCT04575675|Mineralocorticoids|mineralocorticoids|mesh-list
65128108|NCT04575675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65128109|NCT04575675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128110|NCT04575675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65128111|NCT04575675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128112|NCT04575675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65128113|NCT04575675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65128114|NCT04575675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65128115|NCT04575675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64770633|NCT02527434|Durvalumab|durvalumab|mesh-list
65128116|NCT04575675|Adrenergic Agents|adrenergic agents|mesh-ancestor
65128117|NCT04575675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65128118|NCT04575675|Antioxidants|antioxidants|mesh-ancestor
65128132|NCT00568412|Pimecrolimus|pimecrolimus|mesh-list
65128133|NCT00568412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65128134|NCT00568412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65128135|NCT00568412|Analgesics|analgesics|mesh-ancestor
65128136|NCT00568412|Sensory System Agents|sensory system agents|mesh-ancestor
65128137|NCT00568412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65128138|NCT00568412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128139|NCT00568412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65128140|NCT00568412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65128141|NCT00568412|Dermatologic Agents|dermatologic agents|mesh-ancestor
65128142|NCT00568412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65128143|NCT00568412|Immunologic Factors|immunologic factors|mesh-ancestor
65128144|NCT00568412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65128145|NCT00568412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128193|NCT00568880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65128194|NCT00568880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65128195|NCT00568880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128196|NCT00568880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128197|NCT00568880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65128199|NCT03451695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65128200|NCT03451695|Narcotics|narcotics|mesh-ancestor
65128201|NCT03451695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65128202|NCT03451695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128203|NCT03451695|Analgesics|analgesics|mesh-ancestor
65128204|NCT03451695|Sensory System Agents|sensory system agents|mesh-ancestor
65128205|NCT03451695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65128206|NCT00569465|Acetylcysteine|acetylcysteine|mesh-list
65128207|NCT00569465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65128208|NCT00569465|Antiviral Agents|antiviral agents|mesh-ancestor
65128209|NCT00569465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65128210|NCT00569465|Expectorants|expectorants|mesh-ancestor
65128211|NCT00569465|Respiratory System Agents|respiratory system agents|mesh-ancestor
65128212|NCT00569465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65128213|NCT00569465|Antioxidants|antioxidants|mesh-ancestor
65128214|NCT00569465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128215|NCT00569465|Protective Agents|protective agents|mesh-ancestor
65128216|NCT00569465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128217|NCT00569465|Antidotes|antidotes|mesh-ancestor
65128218|NCT00583986|Albuterol|albuterol|mesh-list
65128219|NCT00583986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65128220|NCT00583986|Autonomic Agents|autonomic agents|mesh-ancestor
65128221|NCT00583986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65128222|NCT00583986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128223|NCT00583986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65128224|NCT00583986|Respiratory System Agents|respiratory system agents|mesh-ancestor
65128225|NCT00583986|Tocolytic Agents|tocolytic agents|mesh-ancestor
65128226|NCT00583986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65128236|NCT00569621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65128237|NCT00569621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128238|NCT00569699|Bevacizumab|bevacizumab|mesh-list
65128239|NCT00569699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65128240|NCT00569699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128241|NCT00569699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65128242|NCT00569699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65128304|NCT00570440|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65128305|NCT00570479|Anecortave|anecortave|mesh-list
65128306|NCT00570479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65128307|NCT00570479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65128308|NCT00570479|Growth Substances|growth substances|mesh-ancestor
65128309|NCT00570479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128310|NCT00570479|Growth Inhibitors|growth inhibitors|mesh-ancestor
65128311|NCT00570479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128312|NCT00584298|Octreotide|octreotide|mesh-list
65128313|NCT00584298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65128314|NCT00584298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65128315|NCT00584298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128316|NCT00584376|Pregabalin|pregabalin|mesh-list
65128318|NCT00584376|Sensory System Agents|sensory system agents|mesh-ancestor
65128319|NCT00584376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65128320|NCT00584376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128321|NCT00584376|Anticonvulsants|anticonvulsants|mesh-ancestor
65128322|NCT00584376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65128323|NCT00584376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65128324|NCT00584376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128325|NCT00584376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65128326|NCT00584376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65128327|NCT00584376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65128328|NCT00584376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65128329|NCT00584376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65128330|NCT00570830|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
65128331|NCT00570830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65128332|NCT00570830|Glucocorticoids|glucocorticoids|mesh-ancestor
65128333|NCT00570830|Hormones|hormones|mesh-ancestor
65128334|NCT00570830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65128335|NCT00570830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128336|NCT00584493|Tremelimumab|tremelimumab|mesh-list
65128344|NCT04580342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128345|NCT04580342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65128346|NCT04580342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65128347|NCT04580342|Vasodilator Agents|vasodilator agents|mesh-ancestor
65128348|NCT00571142|Bevacizumab|bevacizumab|mesh-list
65128349|NCT00571142|Temazepam|temazepam|mesh-list
65128350|NCT00571142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65128354|NCT00571142|Growth Substances|growth substances|mesh-ancestor
65128412|NCT00571298|Amifostine|amifostine|mesh-list
65128413|NCT00571298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128414|NCT00571298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65128415|NCT00571298|Antimetabolites|antimetabolites|mesh-ancestor
65128416|NCT00571298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128417|NCT00571298|Antiviral Agents|antiviral agents|mesh-ancestor
65128418|NCT00571298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65128419|NCT00571298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128420|NCT00571298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65128421|NCT00571298|Immunologic Factors|immunologic factors|mesh-ancestor
65128422|NCT00571298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128423|NCT00571298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65128424|NCT00571298|Protective Agents|protective agents|mesh-ancestor
65128425|NCT00571298|Antidotes|antidotes|mesh-ancestor
65128426|NCT00571298|Antioxidants|antioxidants|mesh-ancestor
65128427|NCT00571298|Antitubercular Agents|antitubercular agents|mesh-ancestor
65128428|NCT00571298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65128429|NCT00571298|Chelating Agents|chelating agents|mesh-ancestor
65128430|NCT00571298|Sequestering Agents|sequestering agents|mesh-ancestor
65128431|NCT00571337|Infliximab|infliximab|mesh-list
65128432|NCT00571337|Dermatologic Agents|dermatologic agents|mesh-ancestor
65128433|NCT00571337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65128434|NCT00571337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65128435|NCT04575519|Aspirin|aspirin|mesh-list
65128436|NCT04575519|Ibuprofen|ibuprofen|mesh-list
65128437|NCT04575519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65128438|NCT04575519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65128439|NCT04575519|Analgesics|analgesics|mesh-ancestor
65128440|NCT04575519|Sensory System Agents|sensory system agents|mesh-ancestor
65128441|NCT04575519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65128459|NCT04573803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128460|NCT04573803|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65128461|NCT04573803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65128462|NCT00584688|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65128463|NCT00584688|Antidepressive Agents|antidepressive agents|mesh-ancestor
65128464|NCT00584688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65128465|NCT00584688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65128466|NCT00584688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65128467|NCT00584688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65128468|NCT00584688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128470|NCT00571727|Growth Substances|growth substances|mesh-ancestor
65128471|NCT00571727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128472|NCT04573686|Epoetin Alfa|epoetin alfa|mesh-list
65128473|NCT04573686|Hematinics|hematinics|mesh-ancestor
65128474|NCT01143337|Methotrexate|methotrexate|mesh-list
65128475|NCT01143337|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65128476|NCT01143337|Abortifacient Agents|abortifacient agents|mesh-ancestor
65128477|NCT01143337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65128478|NCT01143337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128479|NCT01143337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65128480|NCT01143337|Antimetabolites|antimetabolites|mesh-ancestor
65128481|NCT01143337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128482|NCT01143337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128483|NCT01143337|Dermatologic Agents|dermatologic agents|mesh-ancestor
65128484|NCT01143337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128507|NCT02883556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128508|NCT00585000|Tremelimumab|tremelimumab|mesh-list
65128509|NCT00585000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128510|NCT00572078|Sorafenib|sorafenib|mesh-list
65128511|NCT00572078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128512|NCT00572078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65128513|NCT00572078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128514|NCT00572078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128515|NCT00572312|Atorvastatin|atorvastatin|mesh-list
65128516|NCT00572312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65128517|NCT00572312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65128518|NCT00572312|Antimetabolites|antimetabolites|mesh-ancestor
65128519|NCT00572312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128520|NCT00572312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65128521|NCT00572312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65128522|NCT00572312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128523|NCT00585156|Celecoxib|celecoxib|mesh-list
65128524|NCT00585156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65128525|NCT00585156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65128526|NCT00585156|Analgesics|analgesics|mesh-ancestor
65128527|NCT00585156|Sensory System Agents|sensory system agents|mesh-ancestor
65128561|NCT01142089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65128562|NCT00572663|Acetylcysteine|acetylcysteine|mesh-list
65128563|NCT00572663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65128564|NCT00572663|Antiviral Agents|antiviral agents|mesh-ancestor
65128565|NCT00572663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65128566|NCT00572663|Expectorants|expectorants|mesh-ancestor
65128567|NCT00572663|Respiratory System Agents|respiratory system agents|mesh-ancestor
65128568|NCT00572663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65128569|NCT00572663|Antioxidants|antioxidants|mesh-ancestor
65128570|NCT00572663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128571|NCT00572663|Protective Agents|protective agents|mesh-ancestor
65128572|NCT00572663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128573|NCT00572663|Antidotes|antidotes|mesh-ancestor
65128574|NCT01140880|Tenofovir|tenofovir|mesh-list
65128575|NCT01140880|Emtricitabine|emtricitabine|mesh-list
65128576|NCT01140880|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65128577|NCT01140880|Antiviral Agents|antiviral agents|mesh-ancestor
65128578|NCT01140880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65128579|NCT01140880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65128580|NCT01140880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65128581|NCT01140880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128582|NCT01140880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128583|NCT01140880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65128584|NCT01140880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65128585|NCT00572741|Cod Liver Oil|cod liver oil|mesh-list
65128586|NCT00572741|Vitamins|vitamins|mesh-ancestor
65128587|NCT00572741|Micronutrients|micronutrients|mesh-ancestor
65128588|NCT00572741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128589|NCT00572819|Misoprostol|misoprostol|mesh-list
65128590|NCT00572819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65128591|NCT00572819|Abortifacient Agents|abortifacient agents|mesh-ancestor
65128606|NCT03451110|Lemborexant|lemborexant|mesh-list
65128607|NCT03451110|Famotidine|famotidine|mesh-list
65128608|NCT03451110|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
65128609|NCT03451110|Antifungal Agents|antifungal agents|mesh-ancestor
65128610|NCT03451110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65128611|NCT03451110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64514275|NCT02757885|Antimetabolites|antimetabolites|mesh-ancestor
65128612|NCT03451110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65128613|NCT03451110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128614|NCT03451110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128615|NCT03451110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65128616|NCT03451110|Hormone Antagonists|hormone antagonists|mesh-ancestor
65128617|NCT03451110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65128618|NCT03451110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128619|NCT03451110|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65128620|NCT03451110|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65128621|NCT03451110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65128622|NCT03451110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65128623|NCT03451110|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65128624|NCT03451110|Histamine Antagonists|histamine antagonists|mesh-ancestor
65128625|NCT03451110|Histamine Agents|histamine agents|mesh-ancestor
65128626|NCT03451110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65128627|NCT03451110|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65128652|NCT01140061|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65128653|NCT01140061|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65128654|NCT01140061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128655|NCT01140061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128656|NCT04312750|Lidocaine|lidocaine|mesh-list
65128657|NCT04312750|Anesthetics, Local|anesthetics, local|mesh-ancestor
65128658|NCT04312750|Anesthetics|anesthetics|mesh-ancestor
65128659|NCT04312750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65128660|NCT04312750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128661|NCT04312750|Sensory System Agents|sensory system agents|mesh-ancestor
65128715|NCT00573599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128716|NCT00573599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65128717|NCT00573599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65128718|NCT00573599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65128719|NCT00573599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65128720|NCT00573599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65128721|NCT00573599|Dopamine Agents|dopamine agents|mesh-ancestor
65128722|NCT04572516|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65128723|NCT04572516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65128724|NCT04572516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65128725|NCT04572516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65128726|NCT04572516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128727|NCT04572516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65128728|NCT04572516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65128729|NCT04572516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128730|NCT04572516|Cholinergic Agents|cholinergic agents|mesh-ancestor
65128731|NCT04572516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65128732|NCT00573638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65128733|NCT00573638|Latanoprost|latanoprost|mesh-list
65128734|NCT00573638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65128736|NCT01138657|Adalimumab|adalimumab|mesh-list
65128737|NCT01138657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65128767|NCT00586092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65128768|NCT00586092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128769|NCT00586092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65128770|NCT00586092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65128771|NCT00586092|Growth Substances|growth substances|mesh-ancestor
65128772|NCT00586092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128773|NCT00586092|Growth Inhibitors|growth inhibitors|mesh-ancestor
65128774|NCT01137955|Rifaximin|rifaximin|mesh-list
65128775|NCT01137955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65128776|NCT01137955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65128777|NCT01137955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65128778|NCT00573950|Cilostazol|cilostazol|mesh-list
65128779|NCT00573950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65128780|NCT00573950|Autonomic Agents|autonomic agents|mesh-ancestor
65128781|NCT00573950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65128782|NCT00573950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128783|NCT00573950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65128784|NCT00573950|Respiratory System Agents|respiratory system agents|mesh-ancestor
65128785|NCT00573950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65128786|NCT00573950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65128787|NCT00573950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128788|NCT00573950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65128790|NCT00573950|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65128791|NCT00573950|Protective Agents|protective agents|mesh-ancestor
65128792|NCT00573950|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65128793|NCT00573950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65128794|NCT00573950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128795|NCT00586131|Citric Acid|citric acid|mesh-list
65128796|NCT00586131|Sodium Citrate|sodium citrate|mesh-list
65128797|NCT00586131|Anticoagulants|anticoagulants|mesh-ancestor
65128798|NCT00586131|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65128811|NCT00586365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65128812|NCT00586365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65128813|NCT00586365|Gout Suppressants|gout suppressants|mesh-ancestor
65128814|NCT00586365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65128815|NCT00586365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128816|NCT00586365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128817|NCT00574652|Aldesleukin|aldesleukin|mesh-list
65128818|NCT00574652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128819|NCT00574652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65128820|NCT00574652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65128821|NCT00574652|Antiviral Agents|antiviral agents|mesh-ancestor
65128822|NCT00574652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65128823|NCT00574730|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65128824|NCT00574730|Rituximab|rituximab|mesh-list
65128825|NCT00574730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65128826|NCT00574730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128827|NCT00574730|Immunologic Factors|immunologic factors|mesh-ancestor
65128828|NCT00574730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128829|NCT00574730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65128830|NCT00574730|Antiviral Agents|antiviral agents|mesh-ancestor
65128831|NCT00574730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65128832|NCT00574769|Bevacizumab|bevacizumab|mesh-list
65128833|NCT00574769|Docetaxel|docetaxel|mesh-list
65128834|NCT00574769|Everolimus|everolimus|mesh-list
65128835|NCT00574769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65128836|NCT00574769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128837|NCT00574769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65128838|NCT00574769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65128839|NCT00574769|Growth Substances|growth substances|mesh-ancestor
65128840|NCT00574769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128841|NCT00574769|Growth Inhibitors|growth inhibitors|mesh-ancestor
65128848|NCT00586443|Bevacizumab|bevacizumab|mesh-list
65128856|NCT00586443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128857|NCT00586443|Growth Inhibitors|growth inhibitors|mesh-ancestor
65128858|NCT00586443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65128859|NCT00586443|Immunologic Factors|immunologic factors|mesh-ancestor
65128860|NCT00574925|Esomeprazole|esomeprazole|mesh-list
64771385|NCT01139190|Naproxen|naproxen|mesh-list
65128861|NCT00574925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65128862|NCT00574925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65128863|NCT00574925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65128864|NCT00574925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65128865|NCT00574925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128866|NCT00586560|Cyclophosphamide|cyclophosphamide|mesh-list
65128867|NCT00586560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65128868|NCT00586560|Immunologic Factors|immunologic factors|mesh-ancestor
65128869|NCT00586560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128870|NCT00586560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65128871|NCT00586560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65128872|NCT00586560|Alkylating Agents|alkylating agents|mesh-ancestor
65128873|NCT00586560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128874|NCT00586560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128875|NCT00586560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65128876|NCT00574964|Temozolomide|temozolomide|mesh-list
65128877|NCT00574964|Carmustine|carmustine|mesh-list
65128878|NCT00574964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65128879|NCT00574964|Alkylating Agents|alkylating agents|mesh-ancestor
65128880|NCT00574964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128881|NCT00574964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128901|NCT00586833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128902|NCT00586833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128903|NCT00575354|Sevoflurane|sevoflurane|mesh-list
65128904|NCT00575354|Isoflurane|isoflurane|mesh-list
65128905|NCT00575354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65128906|NCT00575354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65128907|NCT00575354|Anesthetics, General|anesthetics, general|mesh-ancestor
65128909|NCT00575354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65128910|NCT00575354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65128911|NCT00586911|Betaine|betaine|mesh-list
65128912|NCT00586911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65128913|NCT00586911|Lipotropic Agents|lipotropic agents|mesh-ancestor
65128965|NCT04674176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65128966|NCT04674176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65128967|NCT04674176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65128968|NCT04674527|Temozolomide|temozolomide|mesh-list
65128969|NCT04674527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65128970|NCT04674527|Alkylating Agents|alkylating agents|mesh-ancestor
65128971|NCT04674527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65128972|NCT04674527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65128973|NCT00199836|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65128974|NCT00199836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65128975|NCT00199836|Immunologic Factors|immunologic factors|mesh-ancestor
65128976|NCT00199836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129028|NCT05204134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129029|NCT05181436|Chrysarobin|chrysarobin|mesh-list
65129030|NCT05181436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65129031|NCT05181436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65129032|NCT05181436|Analgesics|analgesics|mesh-ancestor
65129033|NCT05181436|Sensory System Agents|sensory system agents|mesh-ancestor
65129034|NCT05181436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65129035|NCT05181436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129036|NCT05181436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65129037|NCT05181436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65129038|NCT01137292|Voriconazole|voriconazole|mesh-list
65129039|NCT01137292|Antifungal Agents|antifungal agents|mesh-ancestor
65129040|NCT01137292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65129041|NCT01137292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65129042|NCT01137292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65129043|NCT01137292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129044|NCT01137292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129045|NCT01137292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65129046|NCT01137292|Hormone Antagonists|hormone antagonists|mesh-ancestor
65129047|NCT01137292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65129048|NCT01137292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129049|NCT01137292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65129050|NCT02883478|Riboflavin|riboflavin|mesh-list
65129051|NCT02883478|Vitamin B Complex|vitamin b complex|mesh-ancestor
65129052|NCT02883478|Vitamins|vitamins|mesh-ancestor
65129053|NCT02883478|Micronutrients|micronutrients|mesh-ancestor
65129054|NCT02883478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129055|NCT02883478|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65129056|NCT02883478|Dermatologic Agents|dermatologic agents|mesh-ancestor
65129057|NCT00197145|Aplaviroc|aplaviroc|mesh-list
65129058|NCT00197145|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65129059|NCT00197145|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65129069|NCT04674137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65129070|NCT04674137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129071|NCT04674137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129072|NCT04674137|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65129073|NCT04674137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129074|NCT04312438|Caseins|caseins|mesh-list
65129075|NCT04312438|Chelating Agents|chelating agents|mesh-ancestor
65129076|NCT04312438|Sequestering Agents|sequestering agents|mesh-ancestor
65129077|NCT04312438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129078|NCT04312360|Metronidazole|metronidazole|mesh-list
65129079|NCT04312360|Fosfomycin|fosfomycin|mesh-list
65129080|NCT04312360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65129081|NCT04312360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65129082|NCT04312360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65129083|NCT04312360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65129084|NCT00197106|Fluticasone|fluticasone|mesh-list
65129085|NCT00197106|Xhance|xhance|mesh-list
65129086|NCT00197106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65129087|NCT00197106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65129088|NCT00197106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65129089|NCT00197106|Autonomic Agents|autonomic agents|mesh-ancestor
65129090|NCT00197106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65129091|NCT00197106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129092|NCT00197106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65129093|NCT00197106|Respiratory System Agents|respiratory system agents|mesh-ancestor
65129094|NCT00197106|Dermatologic Agents|dermatologic agents|mesh-ancestor
65129095|NCT00197106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65129096|NCT00197106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65129097|NCT00197106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65129098|NCT00197106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65129099|NCT00197106|Adrenergic Agents|adrenergic agents|mesh-ancestor
65129100|NCT00197106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65129113|NCT01136356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129114|NCT01136356|Analgesics|analgesics|mesh-ancestor
65129115|NCT01136356|Sensory System Agents|sensory system agents|mesh-ancestor
65129116|NCT01136356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65129117|NCT01136356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65129118|NCT00587379|Atorvastatin|atorvastatin|mesh-list
65129119|NCT00587379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65129120|NCT00587379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65129121|NCT00587379|Antimetabolites|antimetabolites|mesh-ancestor
65129122|NCT00587379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129123|NCT00587379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65129124|NCT00587379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65129125|NCT00587379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129126|NCT04673396|Norcantharidin|norcantharidin|mesh-list
65129127|NCT04673396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129128|NCT04673396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129129|NCT04673396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129131|NCT00637390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65129132|NCT00637390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129133|NCT00196326|Levonorgestrel|levonorgestrel|mesh-list
65129134|NCT00196326|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65129135|NCT00196326|Estradiol|estradiol|mesh-list
65129165|NCT00587496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65129166|NCT00195663|Adalimumab|adalimumab|mesh-list
64771682|NCT01198158|Everolimus|everolimus|mesh-list
65129168|NCT00195663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65129169|NCT00195663|Abortifacient Agents|abortifacient agents|mesh-ancestor
65129170|NCT00195663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65129171|NCT00195663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129172|NCT00195663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65129173|NCT00195663|Antimetabolites|antimetabolites|mesh-ancestor
65129174|NCT00195663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129175|NCT00195663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129176|NCT00195663|Dermatologic Agents|dermatologic agents|mesh-ancestor
65129177|NCT00195663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129178|NCT00195663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65129179|NCT00195663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65129180|NCT00195663|Immunologic Factors|immunologic factors|mesh-ancestor
65129181|NCT00195663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65129182|NCT00195663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65129183|NCT00195663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65129184|NCT01135498|Bevacizumab|bevacizumab|mesh-list
65129185|NCT01135498|Capecitabine|capecitabine|mesh-list
65129186|NCT01135498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65129187|NCT01135498|Oxaliplatin|oxaliplatin|mesh-list
65129188|NCT01135498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65129189|NCT01135498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129190|NCT01135498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65129191|NCT01135498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65129192|NCT01135498|Growth Substances|growth substances|mesh-ancestor
65129193|NCT01135498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129209|NCT04610567|Dermatologic Agents|dermatologic agents|mesh-ancestor
65129210|NCT04610567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129211|NCT04610567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65129212|NCT04610567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65129213|NCT04610567|Immunologic Factors|immunologic factors|mesh-ancestor
65129214|NCT04610567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65129279|NCT04609748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65129280|NCT04609748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129281|NCT04609748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129282|NCT00195273|Cyclosporine|cyclosporine|mesh-list
65129283|NCT00195273|Sirolimus|sirolimus|mesh-list
65129284|NCT00195273|Mycophenolic Acid|mycophenolic acid|mesh-list
65129285|NCT00195273|Cyclosporins|cyclosporins|mesh-list
65129286|NCT00195273|Daclizumab|daclizumab|mesh-list
65129287|NCT00195273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129288|NCT00195273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129289|NCT00195273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65129290|NCT00195273|Immunologic Factors|immunologic factors|mesh-ancestor
65129291|NCT00195273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129343|NCT00193479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65129344|NCT00193479|Tubulin Modulators|tubulin modulators|mesh-ancestor
65129345|NCT00193479|Antimitotic Agents|antimitotic agents|mesh-ancestor
65129346|NCT00193479|Mitosis Modulators|mitosis modulators|mesh-ancestor
65129347|NCT00193479|Analgesics|analgesics|mesh-ancestor
65129348|NCT00193479|Sensory System Agents|sensory system agents|mesh-ancestor
65129349|NCT00193479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65129350|NCT00193479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65129351|NCT00193479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65129352|NCT00193479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129353|NCT00193206|Gemcitabine|gemcitabine|mesh-list
65129354|NCT00193206|Paclitaxel|paclitaxel|mesh-list
65129355|NCT00193206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65129356|NCT00193206|Epirubicin|epirubicin|mesh-list
65129357|NCT00193206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65129358|NCT00193206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129359|NCT00193206|Tubulin Modulators|tubulin modulators|mesh-ancestor
65129360|NCT00193206|Antimitotic Agents|antimitotic agents|mesh-ancestor
65129402|NCT04608734|Anesthetics, General|anesthetics, general|mesh-ancestor
65129403|NCT04608734|Anesthetics|anesthetics|mesh-ancestor
65129404|NCT04608734|GABA Modulators|gaba modulators|mesh-ancestor
65129405|NCT04608734|GABA Agents|gaba agents|mesh-ancestor
65129406|NCT04608734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65129407|NCT04608734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129408|NCT00192075|Leucovorin|leucovorin|mesh-list
65129409|NCT00192075|Folic Acid|folic acid|mesh-list
65129410|NCT00192075|Gemcitabine|gemcitabine|mesh-list
65129411|NCT00192075|Oxaliplatin|oxaliplatin|mesh-list
65129412|NCT00192075|Levoleucovorin|levoleucovorin|mesh-list
65129413|NCT00192075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65129414|NCT00192075|Antimetabolites|antimetabolites|mesh-ancestor
65129415|NCT00192075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129416|NCT00192075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129417|NCT00192075|Antiviral Agents|antiviral agents|mesh-ancestor
65129418|NCT00192075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65129419|NCT00192075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129420|NCT00192075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65129421|NCT00192075|Immunologic Factors|immunologic factors|mesh-ancestor
65129422|NCT00192075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129423|NCT00192075|Antidotes|antidotes|mesh-ancestor
65129424|NCT00192075|Protective Agents|protective agents|mesh-ancestor
65129425|NCT00192075|Vitamin B Complex|vitamin b complex|mesh-ancestor
65129426|NCT00192075|Vitamins|vitamins|mesh-ancestor
65129427|NCT00192075|Micronutrients|micronutrients|mesh-ancestor
65129428|NCT00192075|Hematinics|hematinics|mesh-ancestor
65129429|NCT00192036|Gemcitabine|gemcitabine|mesh-list
65129430|NCT00192036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129431|NCT00192036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65129432|NCT00192036|Antimetabolites|antimetabolites|mesh-ancestor
65129433|NCT00192036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129434|NCT00192036|Antiviral Agents|antiviral agents|mesh-ancestor
65129435|NCT00192036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65129436|NCT00192036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129441|NCT00191724|Enoxaparin|enoxaparin|mesh-list
65129446|NCT00191724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129447|NCT00191724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65129448|NCT00191646|Gemcitabine|gemcitabine|mesh-list
65129449|NCT00191646|Paclitaxel|paclitaxel|mesh-list
65129450|NCT00191646|Carboplatin|carboplatin|mesh-list
65129451|NCT00191646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65129452|NCT00191646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129453|NCT00191646|Tubulin Modulators|tubulin modulators|mesh-ancestor
65129454|NCT00191646|Antimitotic Agents|antimitotic agents|mesh-ancestor
65129455|NCT00191646|Mitosis Modulators|mitosis modulators|mesh-ancestor
65129456|NCT00191646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129457|NCT00191646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65129458|NCT00191646|Antimetabolites|antimetabolites|mesh-ancestor
65129459|NCT00191646|Antiviral Agents|antiviral agents|mesh-ancestor
65129460|NCT00191646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65129461|NCT00191646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129462|NCT00191646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65129463|NCT00191646|Immunologic Factors|immunologic factors|mesh-ancestor
65129504|NCT00191139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129505|NCT00191139|Tubulin Modulators|tubulin modulators|mesh-ancestor
65129506|NCT00191139|Antimitotic Agents|antimitotic agents|mesh-ancestor
65129507|NCT00191139|Mitosis Modulators|mitosis modulators|mesh-ancestor
65129508|NCT00191139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65129509|NCT00191139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65129510|NCT00191139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65129511|NCT00564512|Cyclophosphamide|cyclophosphamide|mesh-list
65129513|NCT00564512|Fludarabine|fludarabine|mesh-list
65129514|NCT00564512|Alemtuzumab|alemtuzumab|mesh-list
65129515|NCT00564512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65129516|NCT00564512|Immunologic Factors|immunologic factors|mesh-ancestor
65129517|NCT00564512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129518|NCT00564512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65129519|NCT00564512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65129520|NCT00564512|Alkylating Agents|alkylating agents|mesh-ancestor
65129521|NCT00564512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129522|NCT00564512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129523|NCT00564512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65129524|NCT00564512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65129525|NCT00564551|Calcium, Dietary|calcium, dietary|mesh-list
65129557|NCT04607447|Atorvastatin|atorvastatin|mesh-list
65129558|NCT04607447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65129559|NCT04607447|Antiemetics|antiemetics|mesh-ancestor
65129560|NCT04607447|Autonomic Agents|autonomic agents|mesh-ancestor
65129561|NCT04607447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65129562|NCT04607447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129563|NCT04607447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65129564|NCT04607447|Glucocorticoids|glucocorticoids|mesh-ancestor
65129565|NCT04607447|Hormones|hormones|mesh-ancestor
65129566|NCT04607447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65129567|NCT04607447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65129568|NCT04607447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129569|NCT04607447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65129570|NCT04607447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65129571|NCT04607447|Antimetabolites|antimetabolites|mesh-ancestor
65129572|NCT04607447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129573|NCT04607447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65129574|NCT04607447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65129575|NCT04607447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129576|NCT00190671|Cyclophosphamide|cyclophosphamide|mesh-list
65129577|NCT00190671|Pemetrexed|pemetrexed|mesh-list
65129578|NCT00190671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65129604|NCT00198276|Bleomycin|bleomycin|mesh-list
65129606|NCT00198276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129607|NCT04607642|Manganese|manganese|mesh-list
65129608|NCT04607642|Trace Elements|trace elements|mesh-ancestor
65129609|NCT04607642|Micronutrients|micronutrients|mesh-ancestor
65129610|NCT04607642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129611|NCT00588003|Anastrozole|anastrozole|mesh-list
65129612|NCT00588003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65129613|NCT00588003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129614|NCT00588003|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65129615|NCT00588003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65129616|NCT00588003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129617|NCT00588003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129618|NCT00588003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65129619|NCT00588003|Hormone Antagonists|hormone antagonists|mesh-ancestor
65129620|NCT00588003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65129621|NCT00588003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129622|NCT04607057|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
65129623|NCT04607057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65129624|NCT00564590|Melatonin|melatonin|mesh-list
65129625|NCT00564590|Omeprazole|omeprazole|mesh-list
65129626|NCT00564590|Antioxidants|antioxidants|mesh-ancestor
65129627|NCT00564590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129628|NCT00564590|Protective Agents|protective agents|mesh-ancestor
65129629|NCT00564590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129630|NCT00564590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65129631|NCT00564590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65129632|NCT00564590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65129633|NCT00564590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65129634|NCT00564590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129650|NCT04574778|Acetaminophen|acetaminophen|mesh-list
65129651|NCT04574778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65129652|NCT04574778|Analgesics|analgesics|mesh-ancestor
65129653|NCT04574778|Sensory System Agents|sensory system agents|mesh-ancestor
65129654|NCT04574778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65129655|NCT04574778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129657|NCT04606082|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65129658|NCT04606082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65129659|NCT04606082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129660|NCT04605770|Pemetrexed|pemetrexed|mesh-list
65129661|NCT04605770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129662|NCT04605770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129663|NCT04605770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129664|NCT04605770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65129665|NCT04605770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65129666|NCT04605887|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
65129667|NCT04605887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65129668|NCT04605887|Vasodilator Agents|vasodilator agents|mesh-ancestor
65129669|NCT04605419|Calcium|calcium|mesh-list
65129670|NCT04605419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65129671|NCT04605419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129672|NCT04605575|Vinorelbine|vinorelbine|mesh-list
65129673|NCT04605575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65129674|NCT04605575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129675|NCT04605575|Tubulin Modulators|tubulin modulators|mesh-ancestor
65129676|NCT04605575|Antimitotic Agents|antimitotic agents|mesh-ancestor
65129677|NCT04605575|Mitosis Modulators|mitosis modulators|mesh-ancestor
65129678|NCT04605575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129679|NCT00589134|Ganirelix|ganirelix|mesh-list
65129694|NCT00564824|Purinergic Agents|purinergic agents|mesh-ancestor
65129695|NCT00564824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65129696|NCT00589485|Cobalt|cobalt|mesh-list
65129697|NCT00589485|Trace Elements|trace elements|mesh-ancestor
65129698|NCT00589485|Micronutrients|micronutrients|mesh-ancestor
65129699|NCT00589485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129700|NCT00564941|Deferasirox|deferasirox|mesh-list
65129701|NCT00564941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65129702|NCT00564941|Chelating Agents|chelating agents|mesh-ancestor
65129703|NCT00564941|Sequestering Agents|sequestering agents|mesh-ancestor
65129704|NCT00564941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129759|NCT04604678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65129760|NCT04604795|Itraconazole|itraconazole|mesh-list
65129761|NCT04604795|Antifungal Agents|antifungal agents|mesh-ancestor
65129762|NCT04604795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65129763|NCT04604795|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65129764|NCT04604795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65129765|NCT04604795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129766|NCT04604795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129767|NCT04604795|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65129769|NCT04604795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65129770|NCT04604795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129771|NCT04604795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65129772|NCT04604327|Bemiparin|bemiparin|mesh-list
65129773|NCT04604327|Anticoagulants|anticoagulants|mesh-ancestor
65129774|NCT00590694|Ranibizumab|ranibizumab|mesh-list
65129775|NCT00590694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65129776|NCT00590694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65129777|NCT00590694|Growth Substances|growth substances|mesh-ancestor
65129778|NCT00590694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129779|NCT00590694|Growth Inhibitors|growth inhibitors|mesh-ancestor
65129780|NCT00590694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129781|NCT00565175|Famotidine|famotidine|mesh-list
65129782|NCT00565175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65129783|NCT00565175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65129784|NCT00565175|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65129785|NCT00565175|Histamine Antagonists|histamine antagonists|mesh-ancestor
65129786|NCT00565175|Histamine Agents|histamine agents|mesh-ancestor
65129805|NCT00476229|Thymoglobulin|thymoglobulin|mesh-list
65129806|NCT00476229|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65129807|NCT00476229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65129808|NCT00476229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129809|NCT00476229|Immunologic Factors|immunologic factors|mesh-ancestor
65129810|NCT00476229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129811|NCT00476229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65129812|NCT00476229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65129813|NCT04603976|Erenumab|erenumab|mesh-list
65129814|NCT04603976|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
65129815|NCT04603976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129816|NCT04603976|Analgesics|analgesics|mesh-ancestor
65129817|NCT04603976|Sensory System Agents|sensory system agents|mesh-ancestor
65129818|NCT04603976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65129819|NCT04603976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129820|NCT00476151|Ketamine|ketamine|mesh-list
65129821|NCT00476151|Amitriptyline|amitriptyline|mesh-list
65129822|NCT00476151|Analgesics|analgesics|mesh-ancestor
65129823|NCT00476151|Sensory System Agents|sensory system agents|mesh-ancestor
65129824|NCT00476151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65129825|NCT00476151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129826|NCT00476151|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65129827|NCT00476151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65129828|NCT00476151|Anesthetics, General|anesthetics, general|mesh-ancestor
65129829|NCT00476151|Anesthetics|anesthetics|mesh-ancestor
65129830|NCT00476151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65129831|NCT00476151|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65129832|NCT00476151|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65129833|NCT00476151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65129834|NCT00476151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129847|NCT04603664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129848|NCT00474903|Aspirin|aspirin|mesh-list
65129849|NCT00474903|Esomeprazole|esomeprazole|mesh-list
65129850|NCT00474903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65129851|NCT00474903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65129852|NCT00474903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65129853|NCT00474903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129854|NCT00474903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129855|NCT00474903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65129856|NCT00474903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65129857|NCT00474903|Analgesics|analgesics|mesh-ancestor
65129858|NCT00474903|Sensory System Agents|sensory system agents|mesh-ancestor
65129908|NCT04602767|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65129909|NCT04602767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65129910|NCT04602767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65129911|NCT04602767|Adrenergic Agents|adrenergic agents|mesh-ancestor
65129912|NCT04602767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65129913|NCT04602767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129914|NCT04602767|Protective Agents|protective agents|mesh-ancestor
65129915|NCT04602767|Hemostatics|hemostatics|mesh-ancestor
65129916|NCT04602767|Coagulants|coagulants|mesh-ancestor
65129917|NCT04602767|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65129918|NCT04602767|Natriuretic Agents|natriuretic agents|mesh-ancestor
65129919|NCT00473889|Paclitaxel|paclitaxel|mesh-list
65129920|NCT00473889|Carboplatin|carboplatin|mesh-list
65129921|NCT00473889|Vorinostat|vorinostat|mesh-list
65129922|NCT00473889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65129923|NCT00473889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65129924|NCT00473889|Tubulin Modulators|tubulin modulators|mesh-ancestor
65129925|NCT00473889|Antimitotic Agents|antimitotic agents|mesh-ancestor
65129926|NCT00473889|Mitosis Modulators|mitosis modulators|mesh-ancestor
65129927|NCT00473889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65129929|NCT00473889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65129963|NCT02277600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65129964|NCT02277600|Antiviral Agents|antiviral agents|mesh-ancestor
65129965|NCT02277600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65129966|NCT02277600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65129967|NCT02277600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65129968|NCT02277600|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65129969|NCT02277600|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65129970|NCT04602143|Testosterone|testosterone|mesh-list
65129971|NCT04602143|Androgens|androgens|mesh-ancestor
65129972|NCT04602143|Hormones|hormones|mesh-ancestor
65129973|NCT04602143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65129974|NCT04602143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129975|NCT02277678|Morphine|morphine|mesh-list
65129976|NCT02277678|Oxycodone|oxycodone|mesh-list
65129977|NCT02277678|Analgesics, Opioid|analgesics, opioid|mesh-list
65129978|NCT02277678|Narcotics|narcotics|mesh-ancestor
65129979|NCT02277678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65129980|NCT02277678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65129981|NCT02277678|Analgesics|analgesics|mesh-ancestor
65129982|NCT02277678|Sensory System Agents|sensory system agents|mesh-ancestor
65129983|NCT02277678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65129984|NCT02277717|Trastuzumab|trastuzumab|mesh-list
65130017|NCT01580865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130018|NCT01580865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65130019|NCT01580865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130020|NCT01580865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65130021|NCT01580865|Antitubercular Agents|antitubercular agents|mesh-ancestor
65130022|NCT01580865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65130023|NCT01580865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65130024|NCT00473694|Glycopyrrolate|glycopyrrolate|mesh-list
65130025|NCT00473694|Rocuronium|rocuronium|mesh-list
65130026|NCT00473694|Vecuronium Bromide|vecuronium bromide|mesh-list
65130027|NCT00473694|Neostigmine|neostigmine|mesh-list
65130028|NCT00473694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65130079|NCT02215980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65130080|NCT02215980|Growth Substances|growth substances|mesh-ancestor
65130081|NCT02215980|Growth Inhibitors|growth inhibitors|mesh-ancestor
65130082|NCT00565331|Rituximab|rituximab|mesh-list
65130083|NCT00565331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65130084|NCT00565331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130085|NCT00565331|Immunologic Factors|immunologic factors|mesh-ancestor
65130086|NCT00565331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130087|NCT00565331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65130088|NCT00473655|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65130089|NCT00473655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65130090|NCT00473655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65130091|NCT00473655|Antimetabolites|antimetabolites|mesh-ancestor
65130092|NCT00473655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130093|NCT00473655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65130094|NCT00473655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65130095|NCT00473655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130209|NCT00583427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65130210|NCT00583427|Antimetabolites|antimetabolites|mesh-ancestor
65130211|NCT00583427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130212|NCT00583427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65130213|NCT00583427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65130214|NCT00583427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65130215|NCT00583427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65130216|NCT00583427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130217|NCT01133626|Prednisone|prednisone|mesh-list
65130218|NCT01133626|Beclomethasone|beclomethasone|mesh-list
65130219|NCT01133626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65130220|NCT01133626|Glucocorticoids|glucocorticoids|mesh-ancestor
65130221|NCT01133626|Hormones|hormones|mesh-ancestor
65130222|NCT01133626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65130223|NCT01133626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130224|NCT01133626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65130225|NCT01133626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130226|NCT01133626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65130227|NCT01133626|Respiratory System Agents|respiratory system agents|mesh-ancestor
65130228|NCT01133392|Insulin|insulin|mesh-list
65130229|NCT01133392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65130230|NCT01133392|Insulin Lispro|insulin lispro|mesh-list
65130231|NCT01133392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65130232|NCT01133392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130233|NCT00471354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65130234|NCT00471354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65130235|NCT00471354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65130236|NCT00471354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65130237|NCT00471354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130252|NCT01133275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65130253|NCT01133275|Growth Substances|growth substances|mesh-ancestor
65130254|NCT01133275|Growth Inhibitors|growth inhibitors|mesh-ancestor
65130255|NCT02882893|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65130256|NCT02882893|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65130257|NCT02882893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65130258|NCT02882893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65130259|NCT02882893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130260|NCT02882893|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65130261|NCT02882893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65130313|NCT00470847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130314|NCT00584090|Solifenacin Succinate|solifenacin succinate|mesh-list
64663381|NCT02731833|Fluorides|fluorides|mesh-list
65130315|NCT00584090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65130322|NCT00584168|Dexamethasone|dexamethasone|mesh-list
65130383|NCT00584636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65130384|NCT00584636|Respiratory System Agents|respiratory system agents|mesh-ancestor
65130385|NCT00584636|Glucocorticoids|glucocorticoids|mesh-ancestor
65130386|NCT00584636|Hormones|hormones|mesh-ancestor
65130387|NCT00584636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65130388|NCT00479817|Paclitaxel|paclitaxel|mesh-list
65130389|NCT00479817|Trebananib|trebananib|mesh-list
65130452|NCT00475020|Antimetabolites|antimetabolites|mesh-ancestor
65130453|NCT00475020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130454|NCT00475020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65130455|NCT00475020|Immunologic Factors|immunologic factors|mesh-ancestor
65130456|NCT00475020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130457|NCT00475020|Alkylating Agents|alkylating agents|mesh-ancestor
65130459|NCT00475020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65130520|NCT01089543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130521|NCT04569630|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65130522|NCT04569630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130523|NCT01089504|Phenobarbital|phenobarbital|mesh-list
65130524|NCT01089504|Anticonvulsants|anticonvulsants|mesh-ancestor
65130525|NCT01089504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65130526|NCT01089504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65130527|NCT01089504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130528|NCT01089504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65130529|NCT01089504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65130530|NCT01089504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65130582|NCT00586274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65130583|NCT00586430|Lorazepam|lorazepam|mesh-list
65130584|NCT00586430|Anticonvulsants|anticonvulsants|mesh-ancestor
65130585|NCT00586430|Antiemetics|antiemetics|mesh-ancestor
65130586|NCT00586430|Autonomic Agents|autonomic agents|mesh-ancestor
65130587|NCT00586430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65130651|NCT01087905|Cholinergic Agents|cholinergic agents|mesh-ancestor
65130652|NCT01087905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65130653|NCT01087905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130722|NCT02278302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65130723|NCT02278302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130724|NCT02278302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65130725|NCT00587717|Simvastatin|simvastatin|mesh-list
65130726|NCT00587717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65130727|NCT00587717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65130728|NCT00587717|Antimetabolites|antimetabolites|mesh-ancestor
65130729|NCT00587717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130730|NCT00587717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65130731|NCT00587717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65130732|NCT00587717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130733|NCT01085136|Afatinib|afatinib|mesh-list
65130734|NCT01085136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130735|NCT01085136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65130736|NCT01085136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65130737|NCT01085136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130738|NCT00587873|Leucovorin|leucovorin|mesh-list
65130739|NCT00587873|Methotrexate|methotrexate|mesh-list
65130740|NCT00587873|Thioguanine|thioguanine|mesh-list
65130778|NCT04574960|Gemcitabine|gemcitabine|mesh-list
65130779|NCT04574960|Carboplatin|carboplatin|mesh-list
65130780|NCT04574960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130781|NCT04574960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65130782|NCT04574960|Antimetabolites|antimetabolites|mesh-ancestor
65130783|NCT04574960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130784|NCT04574960|Antiviral Agents|antiviral agents|mesh-ancestor
65130846|NCT00588926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65130847|NCT00589082|Daunorubicin|daunorubicin|mesh-list
65130848|NCT00589082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65130849|NCT00589082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130917|NCT00589901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65130918|NCT00589901|Immunologic Factors|immunologic factors|mesh-ancestor
65130919|NCT00589901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65130920|NCT00589901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65130921|NCT00589901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65130922|NCT00589901|Alkylating Agents|alkylating agents|mesh-ancestor
65130923|NCT00589901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65130924|NCT00589901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65130925|NCT00589901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65130926|NCT00589901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65130979|NCT03452345|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65130980|NCT03452345|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65130981|NCT03452345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65130982|NCT03452345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131052|NCT01085097|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65131053|NCT01085097|Protective Agents|protective agents|mesh-ancestor
65131054|NCT00590837|Lomustine|lomustine|mesh-list
65131055|NCT00590837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65131056|NCT00590837|Alkylating Agents|alkylating agents|mesh-ancestor
65131057|NCT00590837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131058|NCT00590837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131059|NCT01086267|Cetuximab|cetuximab|mesh-list
65131060|NCT01086267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65131061|NCT01086267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131062|NCT00590915|Asparaginase|asparaginase|mesh-list
65131063|NCT00590915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131064|NCT04567290|Ticagrelor|ticagrelor|mesh-list
65131065|NCT04567290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65131066|NCT04567290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65131067|NCT04567290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65131109|NCT00591383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131110|NCT01081782|Ceralifimod|ceralifimod|mesh-list
65131111|NCT01081782|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65131112|NCT01081782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131113|NCT01081782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65131114|NCT01081782|Immunologic Factors|immunologic factors|mesh-ancestor
65131116|NCT01080222|Ribavirin|ribavirin|mesh-list
65131177|NCT04572620|Abatacept|abatacept|mesh-list
65131178|NCT04572620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65131179|NCT04572620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131180|NCT04572620|Immunologic Factors|immunologic factors|mesh-ancestor
64773697|NCT01588158|Narcotics|narcotics|mesh-ancestor
65131181|NCT04572620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131182|NCT04572620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65131183|NCT04572620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65131244|NCT03450317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65131245|NCT03450317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65131246|NCT03450317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65131247|NCT03450317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131248|NCT03450317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65131249|NCT03450317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65131250|NCT03450317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131251|NCT03450317|Antipyretics|antipyretics|mesh-ancestor
65131252|NCT04565496|Pembrolizumab|pembrolizumab|mesh-list
65131311|NCT03456947|Sensory System Agents|sensory system agents|mesh-ancestor
65131312|NCT03456947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65131313|NCT03456947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131314|NCT03456947|Anticonvulsants|anticonvulsants|mesh-ancestor
65131315|NCT03456947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65131326|NCT04564638|Cyclosporine|cyclosporine|mesh-list
65131381|NCT00196976|Pentetic Acid|pentetic acid|mesh-list
65131382|NCT00196976|Immunologic Factors|immunologic factors|mesh-ancestor
65131383|NCT00196976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131384|NCT00196976|Antidotes|antidotes|mesh-ancestor
65131386|NCT00196976|Chelating Agents|chelating agents|mesh-ancestor
65131453|NCT00194987|Immunoglobulins|immunoglobulins|mesh-list
65131454|NCT00194987|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65131455|NCT00194987|Antibodies|antibodies|mesh-list
65131524|NCT00194012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65131525|NCT00194012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65131526|NCT00194012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65131527|NCT00194012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65131594|NCT00191984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131595|NCT00191984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65131596|NCT00191984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65131609|NCT00191789|Gemcitabine|gemcitabine|mesh-list
65131664|NCT00198107|Dopamine Agents|dopamine agents|mesh-ancestor
65131665|NCT00198107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65131666|NCT00198107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131667|NCT00198107|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65131668|NCT00198107|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65131733|NCT04559841|Antimetabolites|antimetabolites|mesh-ancestor
65131734|NCT04559841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131735|NCT04559841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65131736|NCT04559841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65131737|NCT04559841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65131738|NCT02489942|Empagliflozin|empagliflozin|mesh-list
65131739|NCT02489942|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65131740|NCT02489942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65131741|NCT02489942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65131799|NCT00176462|Antidotes|antidotes|mesh-ancestor
65131873|NCT00476606|Lamivudine|lamivudine|mesh-list
65131874|NCT00476606|Zidovudine|zidovudine|mesh-list
65131875|NCT00476606|Nevirapine|nevirapine|mesh-list
65131876|NCT00476606|Stavudine|stavudine|mesh-list
65131946|NCT00479336|Natriuretic Agents|natriuretic agents|mesh-ancestor
65131947|NCT00479336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65131948|NCT00478244|Cyclophosphamide|cyclophosphamide|mesh-list
65131949|NCT00478244|Busulfan|busulfan|mesh-list
65131950|NCT00478244|Fludarabine|fludarabine|mesh-list
65132016|NCT00476996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65132017|NCT00476996|Antimetabolites|antimetabolites|mesh-ancestor
65132018|NCT00476996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132019|NCT00476996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132020|NCT00476996|Dermatologic Agents|dermatologic agents|mesh-ancestor
65132021|NCT00476996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132022|NCT00476996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65132023|NCT00476996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65132024|NCT00476996|Immunologic Factors|immunologic factors|mesh-ancestor
65132025|NCT00476996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65132026|NCT00476996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65132027|NCT00476957|Sirolimus|sirolimus|mesh-list
65132028|NCT00476957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65132078|NCT00474929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132079|NCT00474812|Dasatinib|dasatinib|mesh-list
65132080|NCT00474812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132081|NCT00474812|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65132082|NCT00474812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132083|NCT00474812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132084|NCT00474383|Abiraterone Acetate|abiraterone acetate|mesh-list
65132085|NCT00474383|Glucocorticoids|glucocorticoids|mesh-list
65132086|NCT00474383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65132087|NCT00474383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65132088|NCT00474383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132089|NCT00474383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132090|NCT00474383|Hormone Antagonists|hormone antagonists|mesh-ancestor
65132091|NCT00474383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65132092|NCT00474383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132093|NCT00474383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65132094|NCT00474383|Hormones|hormones|mesh-ancestor
65132095|NCT00472199|Pramipexole|pramipexole|mesh-list
65132096|NCT00472199|Antioxidants|antioxidants|mesh-ancestor
65132105|NCT04556136|Vitamin D|vitamin d|mesh-list
65132206|NCT01089647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65132207|NCT01089647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65132208|NCT01089647|Autonomic Agents|autonomic agents|mesh-ancestor
65132211|NCT01089647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65132276|NCT02212821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65132277|NCT02212821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132279|NCT01088243|Mesalamine|mesalamine|mesh-list
65132349|NCT01087502|Immunologic Factors|immunologic factors|mesh-ancestor
65132350|NCT01087502|Incretins|incretins|mesh-ancestor
65132351|NCT01087502|Hormones|hormones|mesh-ancestor
65132352|NCT01087502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65132422|NCT02213718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65132423|NCT02213718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65132424|NCT02213718|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65132425|NCT01085045|Bromides|bromides|mesh-list
65132426|NCT01085045|Formoterol Fumarate|formoterol fumarate|mesh-list
65132427|NCT01085045|Tiotropium Bromide|tiotropium bromide|mesh-list
65132491|NCT01084538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65132492|NCT00179517|Anastrozole|anastrozole|mesh-list
65132493|NCT00179517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65132563|NCT01083485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65132564|NCT01083485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132576|NCT04671836|Lorazepam|lorazepam|mesh-list
65132671|NCT00177216|Serotonin Agents|serotonin agents|mesh-ancestor
65132672|NCT00177216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65132673|NCT00177216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65132675|NCT00177216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65132676|NCT00177216|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65132677|NCT00177216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65132740|NCT00174915|Gout Suppressants|gout suppressants|mesh-ancestor
65132741|NCT00174915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65132743|NCT00174915|Antioxidants|antioxidants|mesh-ancestor
65132815|NCT00171249|Imatinib Mesylate|imatinib mesylate|mesh-list
65132820|NCT04671056|Pioglitazone|pioglitazone|mesh-list
65132889|NCT00479856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65132890|NCT00479856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65132891|NCT00479856|Antimetabolites|antimetabolites|mesh-ancestor
65132892|NCT00479856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65132893|NCT00479856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65132894|NCT04997759|Neostigmine|neostigmine|mesh-list
65132895|NCT04997759|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65132959|NCT00556127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65132960|NCT00556127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65133030|NCT00477750|Lenalidomide|lenalidomide|mesh-list
65133031|NCT00477750|Melphalan|melphalan|mesh-list
65133032|NCT00477750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65133033|NCT00477750|Glucocorticoids|glucocorticoids|mesh-ancestor
65133034|NCT00477750|Hormones|hormones|mesh-ancestor
65133036|NCT00477750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133100|NCT00556361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65133101|NCT00556361|Anesthetics, General|anesthetics, general|mesh-ancestor
65133102|NCT00556361|Anesthetics|anesthetics|mesh-ancestor
65133103|NCT00556361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65133104|NCT00556361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65133105|NCT00556361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65133106|NCT00556361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65133107|NCT00556361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133108|NCT04571606|Bupivacaine|bupivacaine|mesh-list
65133109|NCT04571606|Anesthetics, Local|anesthetics, local|mesh-ancestor
65133166|NCT04540926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65133167|NCT04540965|Famotidine|famotidine|mesh-list
65133168|NCT04540965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65133169|NCT04540965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65133170|NCT04540965|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65133236|NCT04548219|Analgesics|analgesics|mesh-ancestor
65133237|NCT04548219|Sensory System Agents|sensory system agents|mesh-ancestor
65133241|NCT04548219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65133310|NCT01129960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65133311|NCT01129960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65133313|NCT04559165|Chitosan|chitosan|mesh-list
65133382|NCT01129882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65133383|NCT01129882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65133384|NCT02278419|Sofosbuvir|sofosbuvir|mesh-list
65133385|NCT02278419|Simeprevir|simeprevir|mesh-list
65133454|NCT04538820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65133455|NCT04538820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65133456|NCT04538820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133457|NCT04538820|Protease Inhibitors|protease inhibitors|mesh-ancestor
65133458|NCT04538820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133460|NCT00575978|Hydralazine|hydralazine|mesh-list
65133523|NCT01128244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133524|NCT01128244|Vitamin B Complex|vitamin b complex|mesh-ancestor
65133525|NCT01127893|Tanezumab|tanezumab|mesh-list
65133526|NCT01127893|Analgesics|analgesics|mesh-ancestor
65133527|NCT01127893|Sensory System Agents|sensory system agents|mesh-ancestor
65133528|NCT01127893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65133530|NCT00576173|Acetaminophen|acetaminophen|mesh-list
65133593|NCT00625456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133594|NCT00625456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133595|NCT04539444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65133596|NCT04539444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133667|NCT04558268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65133668|NCT04558268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133669|NCT04558268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65133670|NCT04558268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65133671|NCT04558268|Progestins|progestins|mesh-ancestor
65133672|NCT04558268|Hematinics|hematinics|mesh-ancestor
65133673|NCT04558268|Vitamin B Complex|vitamin b complex|mesh-ancestor
65133674|NCT04558268|Vitamins|vitamins|mesh-ancestor
65133733|NCT00576602|Hematinics|hematinics|mesh-ancestor
64776237|NCT01920282|Nebivolol|nebivolol|mesh-list
65133734|NCT02212223|Vitamin D|vitamin d|mesh-list
65133735|NCT02212223|Cholecalciferol|cholecalciferol|mesh-list
65133736|NCT02212223|Vitamins|vitamins|mesh-ancestor
65133737|NCT02212223|Micronutrients|micronutrients|mesh-ancestor
65133738|NCT02212223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133739|NCT02212223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65133740|NCT02212223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65133741|NCT00637585|Fexofenadine|fexofenadine|mesh-list
65133742|NCT00637585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65133743|NCT00637585|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65133744|NCT00637585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65133745|NCT00637585|Histamine Antagonists|histamine antagonists|mesh-ancestor
65133746|NCT00637585|Histamine Agents|histamine agents|mesh-ancestor
65133747|NCT00637585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65133748|NCT00637585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133749|NCT00637585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133750|NCT02214810|Bupivacaine|bupivacaine|mesh-list
65133751|NCT02214810|Anesthetics, Local|anesthetics, local|mesh-ancestor
65133752|NCT02214810|Anesthetics|anesthetics|mesh-ancestor
65133753|NCT02214810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65133754|NCT02214810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65133785|NCT04538976|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65133786|NCT04538976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65133787|NCT04538976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65133857|NCT04205890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65133858|NCT04205890|Anesthetics, General|anesthetics, general|mesh-ancestor
65133859|NCT04205890|Anesthetics|anesthetics|mesh-ancestor
65133865|NCT00577109|Leucovorin|leucovorin|mesh-list
65133931|NCT04545099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65133938|NCT02882269|Capecitabine|capecitabine|mesh-list
65134001|NCT00577850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134002|NCT00577850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65134003|NCT00577850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65134004|NCT00577850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134005|NCT00577850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65134006|NCT00577967|Gabapentin|gabapentin|mesh-list
65134007|NCT00577967|Analgesics|analgesics|mesh-ancestor
65134008|NCT00577967|Sensory System Agents|sensory system agents|mesh-ancestor
65134009|NCT00577967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65134010|NCT00577967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134011|NCT00577967|Anticonvulsants|anticonvulsants|mesh-ancestor
65134012|NCT00577967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65134013|NCT00577967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65134014|NCT00577967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65134061|NCT04544163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65134063|NCT04544163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65134134|NCT04536363|Alprostadil|alprostadil|mesh-list
65134135|NCT04536363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65134136|NCT04536363|Vasodilator Agents|vasodilator agents|mesh-ancestor
65134137|NCT04536363|Urological Agents|urological agents|mesh-ancestor
65134138|NCT00578825|Ritonavir|ritonavir|mesh-list
65134139|NCT00578825|Lopinavir|lopinavir|mesh-list
65134140|NCT00578825|Ribavirin|ribavirin|mesh-list
65134141|NCT00578825|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65134142|NCT00578825|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65134143|NCT00578825|Protease Inhibitors|protease inhibitors|mesh-ancestor
65134144|NCT00578825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134145|NCT00578825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134146|NCT00578825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65134147|NCT00578825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65134148|NCT00578825|Antiviral Agents|antiviral agents|mesh-ancestor
65134149|NCT00578825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134150|NCT00578825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65134151|NCT00578825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65134152|NCT00578825|Antimetabolites|antimetabolites|mesh-ancestor
65134153|NCT04536129|Hydrocortisone|hydrocortisone|mesh-list
65134154|NCT04536129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65134155|NCT04556708|Chlorhexidine|chlorhexidine|mesh-list
65134156|NCT04556708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65134157|NCT04556708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134158|NCT04556708|Disinfectants|disinfectants|mesh-ancestor
65134159|NCT04535973|Hormones|hormones|mesh-list
65134162|NCT04536051|Acetaminophen|acetaminophen|mesh-list
65134183|NCT02215044|Antiviral Agents|antiviral agents|mesh-ancestor
65134184|NCT02215044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134185|NCT02215044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134186|NCT02215044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65134187|NCT02215044|Immunologic Factors|immunologic factors|mesh-ancestor
65134188|NCT02215044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134189|NCT04556279|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
65134190|NCT04556279|Hormone Antagonists|hormone antagonists|mesh-ancestor
65134191|NCT04556279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65134192|NCT04556279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134193|NCT04556279|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65134194|NCT04556279|Diuretics|diuretics|mesh-ancestor
65134195|NCT04556279|Natriuretic Agents|natriuretic agents|mesh-ancestor
65134196|NCT02216331|Rifampin|rifampin|mesh-list
65134197|NCT02216331|Rifapentine|rifapentine|mesh-list
65134198|NCT02216331|Bedaquiline|bedaquiline|mesh-list
65134199|NCT02216331|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65134242|NCT04542213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134243|NCT04542213|Incretins|incretins|mesh-ancestor
65134244|NCT04542213|Hormones|hormones|mesh-ancestor
65134250|NCT04542369|Etoposide|etoposide|mesh-list
65134316|NCT04532775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65134317|NCT04532775|Protective Agents|protective agents|mesh-ancestor
65134318|NCT04532775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65134388|NCT04555733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65134389|NCT04555733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134391|NCT02216994|Lactulose|lactulose|mesh-list
65134461|NCT00580112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65134462|NCT00580112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134463|NCT00580112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65134533|NCT00580424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65134534|NCT00580424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134535|NCT00580424|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65134536|NCT00580424|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65134537|NCT01121575|Crizotinib|crizotinib|mesh-list
65134538|NCT01121575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134539|NCT01121575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65134540|NCT01121575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65134541|NCT01121575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134542|NCT00625573|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65134543|NCT00625573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134544|NCT04205851|Gimsilumab|gimsilumab|mesh-list
65134545|NCT04205851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65134546|NCT04205851|Antiviral Agents|antiviral agents|mesh-ancestor
65134547|NCT04205851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65134548|NCT02882113|Tacrolimus|tacrolimus|mesh-list
65134558|NCT01121536|Modafinil|modafinil|mesh-list
65134591|NCT04554524|Mitosis Modulators|mitosis modulators|mesh-ancestor
65134592|NCT04554524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134593|NCT04554524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65134664|NCT01120600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134665|NCT01120600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65134667|NCT01120600|Antacids|antacids|mesh-ancestor
65134735|NCT02882191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65134736|NCT02882191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134808|NCT01119625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65134809|NCT01119625|Immunologic Factors|immunologic factors|mesh-ancestor
65134810|NCT01119625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65134811|NCT02218827|Loteprednol Etabonate|loteprednol etabonate|mesh-list
65134812|NCT02218827|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65134813|NCT02881762|Maraviroc|maraviroc|mesh-list
65134814|NCT02881762|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65134815|NCT02881762|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65134816|NCT02881762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65134817|NCT02881762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65134818|NCT02881762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65134822|NCT04561947|Mitogens|mitogens|mesh-list
65134869|NCT02219100|Mifepristone|mifepristone|mesh-list
65134870|NCT02219100|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65134871|NCT02219100|Abortifacient Agents|abortifacient agents|mesh-ancestor
65134875|NCT02219100|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65134941|NCT04577378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65134942|NCT04577378|Keratolytic Agents|keratolytic agents|mesh-ancestor
65134943|NCT04577378|Dermatologic Agents|dermatologic agents|mesh-ancestor
65134945|NCT02219412|Ticagrelor|ticagrelor|mesh-list
65134946|NCT02219412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65135010|NCT04553510|Growth Inhibitors|growth inhibitors|mesh-ancestor
65135011|NCT03453281|Aflibercept|aflibercept|mesh-list
65135083|NCT01117987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135084|NCT01117987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135085|NCT02219490|Ritonavir|ritonavir|mesh-list
65135156|NCT04551833|Levobupivacaine|levobupivacaine|mesh-list
65135157|NCT04551833|Anesthetics, Local|anesthetics, local|mesh-ancestor
65135158|NCT04551833|Anesthetics|anesthetics|mesh-ancestor
65135159|NCT04551833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65135160|NCT04551833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135161|NCT04551833|Sensory System Agents|sensory system agents|mesh-ancestor
65135162|NCT04551833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65135163|NCT04551755|Doxycycline|doxycycline|mesh-list
65135164|NCT04551755|Ivermectin|ivermectin|mesh-list
65135224|NCT01640535|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65135225|NCT01640535|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65135226|NCT01640535|Histamine Antagonists|histamine antagonists|mesh-ancestor
65135227|NCT01640535|Histamine Agents|histamine agents|mesh-ancestor
65135228|NCT01640535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64777715|NCT02203578|Romidepsin|romidepsin|mesh-list
65135229|NCT01640535|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65135230|NCT04550936|Isavuconazole|isavuconazole|mesh-list
65135231|NCT04550936|Antifungal Agents|antifungal agents|mesh-ancestor
65135232|NCT04550936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65135233|NCT04550858|Rebamipide|rebamipide|mesh-list
65135234|NCT04550858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65135235|NCT04550858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65135236|NCT04550858|Antioxidants|antioxidants|mesh-ancestor
65135241|NCT01640574|Chloroquine|chloroquine|mesh-list
65135288|NCT04529226|Antiemetics|antiemetics|mesh-ancestor
65135289|NCT04529226|Autonomic Agents|autonomic agents|mesh-ancestor
65135290|NCT04529226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65135291|NCT04529226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65135292|NCT04529226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65135359|NCT01643889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65135433|NCT04529187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65135434|NCT04529187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65135435|NCT04529187|Adrenergic Agents|adrenergic agents|mesh-ancestor
65135436|NCT04529187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65135437|NCT04529187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135438|NCT04529187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65135439|NCT04529187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65135440|NCT04529187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65135441|NCT04529187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65135442|NCT04529187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65135443|NCT04529187|Anesthetics, General|anesthetics, general|mesh-ancestor
65135444|NCT04529187|Anesthetics|anesthetics|mesh-ancestor
65135445|NCT04529187|GABA Modulators|gaba modulators|mesh-ancestor
65135446|NCT04529187|GABA Agents|gaba agents|mesh-ancestor
65135495|NCT04315909|Coagulants|coagulants|mesh-ancestor
65135496|NCT01181167|Enoxaparin|enoxaparin|mesh-list
65135497|NCT01181167|Enoxaparin sodium|enoxaparin sodium|mesh-list
65135498|NCT01181167|Edoxaban|edoxaban|mesh-list
65135499|NCT01181167|Anticoagulants|anticoagulants|mesh-ancestor
65135500|NCT01181167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65135501|NCT01181167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65135502|NCT01181167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135503|NCT01181167|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65135504|NCT01181167|Antithrombins|antithrombins|mesh-ancestor
65135505|NCT01181167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65135506|NCT01181167|Protease Inhibitors|protease inhibitors|mesh-ancestor
65135507|NCT01181167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135508|NCT04548557|Immunoglobulins|immunoglobulins|mesh-list
65135509|NCT04548557|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65135510|NCT04548557|Antibodies|antibodies|mesh-list
65135511|NCT04548557|gamma-Globulins|gamma-globulins|mesh-list
65135512|NCT04548557|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65135513|NCT04548557|Immunologic Factors|immunologic factors|mesh-ancestor
65135514|NCT04548557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135515|NCT01181128|Factor VIII|factor viii|mesh-list
65135516|NCT01181128|Coagulants|coagulants|mesh-ancestor
65135517|NCT04548401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
65135518|NCT04548284|Glucocorticoids|glucocorticoids|mesh-list
65135519|NCT04548284|Hormones|hormones|mesh-ancestor
65135520|NCT04548284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65135522|NCT04547894|TMC-310911|tmc-310911|mesh-list
65135545|NCT04547855|Alkylating Agents|alkylating agents|mesh-ancestor
64708146|NCT02229578|Sensory System Agents|sensory system agents|mesh-ancestor
64708147|NCT02229578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64708148|NCT02229578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64708149|NCT02229578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64708150|NCT02229578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64708151|NCT02229578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64708152|NCT02229578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708165|NCT04093531|Dermatologic Agents|dermatologic agents|mesh-ancestor
65135546|NCT04547855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135548|NCT01641510|Clopidogrel|clopidogrel|mesh-list
65135597|NCT01645254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65135598|NCT01645254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65135599|NCT01645254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65135600|NCT01181011|Amlodipine|amlodipine|mesh-list
65135601|NCT01181011|Telmisartan|telmisartan|mesh-list
65135602|NCT01181011|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
65135604|NCT01181011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65135605|NCT01181011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65135606|NCT01181011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135607|NCT01181011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65135608|NCT01181011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135609|NCT01181011|Vasodilator Agents|vasodilator agents|mesh-ancestor
65135610|NCT01181011|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65135611|NCT01181011|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65135612|NCT01641783|Paclitaxel|paclitaxel|mesh-list
65135613|NCT01641783|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65135614|NCT01641783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65135615|NCT01641783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135652|NCT01645410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65135653|NCT01645410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135654|NCT04546334|Magnesium Sulfate|magnesium sulfate|mesh-list
65135655|NCT04546334|Analgesics|analgesics|mesh-ancestor
65135656|NCT04546334|Sensory System Agents|sensory system agents|mesh-ancestor
65135657|NCT04546334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65135658|NCT04546334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135659|NCT04546334|Anesthetics|anesthetics|mesh-ancestor
65135660|NCT04546334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65135661|NCT04546334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65135662|NCT04546334|Anticonvulsants|anticonvulsants|mesh-ancestor
65135663|NCT04546334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65135664|NCT04546334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65135665|NCT04546334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135666|NCT04546334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65135684|NCT04546256|Xhance|xhance|mesh-list
65135708|NCT01645449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65135709|NCT01645449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135710|NCT01645449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65135711|NCT01645449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65135712|NCT01645449|Antimetabolites|antimetabolites|mesh-ancestor
65135713|NCT01645449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135714|NCT01645449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65135715|NCT01645449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65135716|NCT01645449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135717|NCT04546022|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65135718|NCT01645800|Muramidase|muramidase|mesh-list
65135719|NCT01645800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65135720|NCT02214680|Timolol|timolol|mesh-list
65135721|NCT02214680|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65135722|NCT02214680|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
65135723|NCT02214680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65135724|NCT02214680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65135725|NCT02214680|Adrenergic Agents|adrenergic agents|mesh-ancestor
65135726|NCT02214680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65135727|NCT02214680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135728|NCT02214680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135729|NCT02214680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65135759|NCT01680042|Anticonvulsants|anticonvulsants|mesh-ancestor
65135760|NCT01680042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65135761|NCT01680042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65135762|NCT01680042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65135763|NCT01680042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135764|NCT01680042|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65135765|NCT01680042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65135766|NCT04545710|Osimertinib|osimertinib|mesh-list
65135767|NCT04545710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135768|NCT04545710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65135769|NCT04545710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65135770|NCT04545710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135771|NCT01646229|Polymyxins|polymyxins|mesh-list
65135772|NCT01646229|Polymyxin B|polymyxin b|mesh-list
65135773|NCT01646229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65135774|NCT01646229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65135775|NCT01680081|Adenosine|adenosine|mesh-list
65135776|NCT01680081|Analgesics|analgesics|mesh-ancestor
65135777|NCT01680081|Sensory System Agents|sensory system agents|mesh-ancestor
65135778|NCT01680081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65135813|NCT04544813|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65135814|NCT04544813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65135815|NCT04541732|Anesthetics|anesthetics|mesh-list
65135816|NCT04541732|Propofol|propofol|mesh-list
65135817|NCT04541732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65135818|NCT04541732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65135883|NCT04542005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65135884|NCT04542005|Respiratory System Agents|respiratory system agents|mesh-ancestor
65135885|NCT04542005|Tocolytic Agents|tocolytic agents|mesh-ancestor
65135886|NCT04542005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65135887|NCT04542005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65135888|NCT04542005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65135889|NCT04542005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65135890|NCT04542005|Adrenergic Agents|adrenergic agents|mesh-ancestor
65135891|NCT04542005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65135892|NCT04542005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135893|NCT01646775|Fentanyl|fentanyl|mesh-list
65135894|NCT01646775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65135895|NCT01646775|Narcotics|narcotics|mesh-ancestor
65135944|NCT04543916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65135945|NCT04543916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65135946|NCT04541147|Dexamethasone|dexamethasone|mesh-list
65135947|NCT04541147|Analgesics|analgesics|mesh-list
65135948|NCT04541147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65135949|NCT04541147|Antiemetics|antiemetics|mesh-ancestor
65135950|NCT04541147|Autonomic Agents|autonomic agents|mesh-ancestor
65136013|NCT04543565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65136014|NCT04543565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65136015|NCT01647555|Cetuximab|cetuximab|mesh-list
65136016|NCT01647555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65136017|NCT01647555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136018|NCT04543370|Deflazacort|deflazacort|mesh-list
65136019|NCT04543370|Midazolam|midazolam|mesh-list
65136020|NCT04543370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65136021|NCT04543370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65136022|NCT04543370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65136023|NCT04543370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136024|NCT04543370|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65136078|NCT02215382|Parasympatholytics|parasympatholytics|mesh-ancestor
65136079|NCT02215382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65136080|NCT02215382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65136081|NCT02215382|Cholinergic Agents|cholinergic agents|mesh-ancestor
65136082|NCT02215382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65136083|NCT02215382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136084|NCT02215382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65136085|NCT02215382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136086|NCT02215382|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65136087|NCT01682109|Valacyclovir|valacyclovir|mesh-list
65136142|NCT01682421|Dexamethasone acetate|dexamethasone acetate|mesh-list
65136143|NCT01682421|BB 1101|bb 1101|mesh-list
65136144|NCT01682421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136145|NCT01682421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136146|NCT01682421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65136147|NCT01682421|Antiemetics|antiemetics|mesh-ancestor
65136148|NCT01682421|Autonomic Agents|autonomic agents|mesh-ancestor
65136149|NCT01682421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65136150|NCT01682421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65136151|NCT01682421|Glucocorticoids|glucocorticoids|mesh-ancestor
65136152|NCT01682421|Hormones|hormones|mesh-ancestor
65136206|NCT01202227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65136207|NCT01202227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136209|NCT01202227|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65136210|NCT01202227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65136211|NCT01202227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136212|NCT01202227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65136241|NCT01682772|Olaparib|olaparib|mesh-list
65136273|NCT04539119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136274|NCT04539119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136275|NCT04539119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65136276|NCT04539119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65136277|NCT02279511|Adenosine|adenosine|mesh-list
65136278|NCT02279511|Analgesics|analgesics|mesh-ancestor
65136279|NCT02279511|Sensory System Agents|sensory system agents|mesh-ancestor
65136280|NCT02279511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778765|NCT02828358|2-Aminopurine|2-aminopurine|mesh-list
65136281|NCT02279511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136282|NCT02279511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65136283|NCT02279511|Vasodilator Agents|vasodilator agents|mesh-ancestor
65136284|NCT02279511|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65136285|NCT02279511|Purinergic Agonists|purinergic agonists|mesh-ancestor
65136286|NCT02279511|Purinergic Agents|purinergic agents|mesh-ancestor
65136289|NCT02279628|Morphine|morphine|mesh-list
65136332|NCT01202188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65136333|NCT01202188|Autonomic Agents|autonomic agents|mesh-ancestor
65136334|NCT01202188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64669484|NCT05710874|Fluorides|fluorides|mesh-list
65136335|NCT01202188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136336|NCT01202188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65136337|NCT01202188|Respiratory System Agents|respiratory system agents|mesh-ancestor
65136338|NCT01202188|Parasympatholytics|parasympatholytics|mesh-ancestor
65136339|NCT01202188|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65136340|NCT01202188|Cholinergic Agents|cholinergic agents|mesh-ancestor
65136396|NCT04532684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65136397|NCT04532684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65136398|NCT04532684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65136399|NCT04532684|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65136400|NCT04532684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65136401|NCT04532684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65136402|NCT04532684|Antidepressive Agents|antidepressive agents|mesh-ancestor
65136403|NCT04532684|Dopamine Agents|dopamine agents|mesh-ancestor
65136404|NCT01649466|Insulin|insulin|mesh-list
65136405|NCT01649466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65136406|NCT01649466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64514412|NCT02727387|Etoposide|etoposide|mesh-list
65136407|NCT01649466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136409|NCT01200589|Ofatumumab|ofatumumab|mesh-list
65136410|NCT01200589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65136411|NCT01200589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65136416|NCT01683552|Fexofenadine|fexofenadine|mesh-list
65136454|NCT01649544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136455|NCT01649544|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65136456|NCT01649544|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65136457|NCT01649544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65136458|NCT04528290|Ozanimod|ozanimod|mesh-list
65136459|NCT04528290|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65136460|NCT04528290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136461|NCT04528290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65136462|NCT04528290|Immunologic Factors|immunologic factors|mesh-ancestor
65136463|NCT04528290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136464|NCT01179334|Sildenafil Citrate|sildenafil citrate|mesh-list
65136465|NCT01179334|Riociguat|riociguat|mesh-list
65136466|NCT01179334|Vasodilator Agents|vasodilator agents|mesh-ancestor
65136513|NCT04532060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65136514|NCT04532060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136515|NCT01649739|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65136516|NCT01649739|Vasodilator Agents|vasodilator agents|mesh-ancestor
65136517|NCT01649739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65136518|NCT01649739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65136519|NCT01649739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65136520|NCT01649739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136578|NCT04531748|Protective Agents|protective agents|mesh-ancestor
65136579|NCT04531748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136580|NCT04531748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65136581|NCT04531748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65136582|NCT04531748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136583|NCT04531748|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65136584|NCT04531748|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65136585|NCT04531748|Hormone Antagonists|hormone antagonists|mesh-ancestor
65136586|NCT04531748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65136588|NCT01177813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65136640|NCT01684449|Gemcitabine|gemcitabine|mesh-list
65136641|NCT01684449|Sirolimus|sirolimus|mesh-list
65136642|NCT01684449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65136712|NCT01200355|Posaconazole|posaconazole|mesh-list
65136713|NCT01200355|Micafungin|micafungin|mesh-list
65136714|NCT01200355|Antifungal Agents|antifungal agents|mesh-ancestor
65136715|NCT01200355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65136788|NCT02887534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65136789|NCT02887534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136790|NCT02887534|Anticonvulsants|anticonvulsants|mesh-ancestor
65136791|NCT02887534|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65136792|NCT02887534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65136793|NCT02887534|Parasympatholytics|parasympatholytics|mesh-ancestor
65136794|NCT02887534|Autonomic Agents|autonomic agents|mesh-ancestor
65136795|NCT02887534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65136796|NCT02887534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65136797|NCT02887534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64779290|NCT05251038|Micronutrients|micronutrients|mesh-ancestor
65136798|NCT02887534|Adrenergic Agents|adrenergic agents|mesh-ancestor
65136799|NCT02887534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65136800|NCT02887534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136801|NCT01685931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65136802|NCT01685931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65136803|NCT01685931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65136804|NCT01685931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65136805|NCT01685931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136806|NCT01685931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65136807|NCT01685931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65136839|NCT04536662|Prednisone|prednisone|mesh-list
65136840|NCT04536662|Hydrocortisone|hydrocortisone|mesh-list
65136841|NCT04536662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65136842|NCT04536662|Antiemetics|antiemetics|mesh-ancestor
65136914|NCT01687062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136915|NCT02217956|Bevacizumab|bevacizumab|mesh-list
65136916|NCT02217956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65136917|NCT02217956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65136918|NCT02217956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65136919|NCT02217956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65136920|NCT02217956|Growth Substances|growth substances|mesh-ancestor
65136921|NCT02217956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65136937|NCT04535960|Hormones|hormones|mesh-ancestor
65136979|NCT01199263|Tubulin Modulators|tubulin modulators|mesh-ancestor
65136980|NCT01199263|Antimitotic Agents|antimitotic agents|mesh-ancestor
65136981|NCT01199263|Mitosis Modulators|mitosis modulators|mesh-ancestor
65136982|NCT01199263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65136983|NCT02218034|Nicotinic Acids|nicotinic acids|mesh-list
65136984|NCT02218034|Tazarotene|tazarotene|mesh-list
65136985|NCT02218034|Dermatologic Agents|dermatologic agents|mesh-ancestor
65136986|NCT02218034|Keratolytic Agents|keratolytic agents|mesh-ancestor
65136987|NCT02218034|Vitamin B Complex|vitamin b complex|mesh-ancestor
65136988|NCT02218034|Vitamins|vitamins|mesh-ancestor
65136989|NCT02218034|Micronutrients|micronutrients|mesh-ancestor
65136990|NCT02218034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137045|NCT05126121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137046|NCT05126121|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65137047|NCT05126121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65137048|NCT05126121|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65137049|NCT05126121|Renal Agents|renal agents|mesh-ancestor
65137050|NCT05126121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65137051|NCT05126121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65137052|NCT05126121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137053|NCT05126121|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65137108|NCT02216552|Resveratrol|resveratrol|mesh-list
65137109|NCT02216552|Antioxidants|antioxidants|mesh-ancestor
65137110|NCT02216552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137111|NCT02216552|Protective Agents|protective agents|mesh-ancestor
65137112|NCT02216552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137179|NCT03772158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65137180|NCT03772158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65137181|NCT03772158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65137182|NCT03772158|Histamine Antagonists|histamine antagonists|mesh-ancestor
65137183|NCT03772158|Histamine Agents|histamine agents|mesh-ancestor
65137249|NCT02219672|Contraceptive Agents|contraceptive agents|mesh-ancestor
65137250|NCT02219672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65137251|NCT02219672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65137252|NCT02219672|Immunologic Factors|immunologic factors|mesh-ancestor
65137253|NCT02219672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65137254|NCT02219672|Alkylating Agents|alkylating agents|mesh-ancestor
65137255|NCT02219672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137256|NCT03113955|Epirubicin|epirubicin|mesh-list
65137257|NCT03113955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65137258|NCT03113955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137259|NCT03113955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65137260|NCT03113955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65137261|NCT03113955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137262|NCT03113955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137263|NCT02219750|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65137264|NCT02219750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65137265|NCT02219750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137266|NCT04534452|Phenylephrine|phenylephrine|mesh-list
65137267|NCT04534452|Oxymetazoline|oxymetazoline|mesh-list
65137268|NCT04534452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65137269|NCT04534452|Mydriatics|mydriatics|mesh-ancestor
65137270|NCT04534452|Autonomic Agents|autonomic agents|mesh-ancestor
65137271|NCT04534452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65137272|NCT04534452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137273|NCT04534452|Sympathomimetics|sympathomimetics|mesh-ancestor
65137274|NCT04534452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65137275|NCT04534452|Nasal Decongestants|nasal decongestants|mesh-ancestor
65137295|NCT02219789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65137296|NCT02219789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137297|NCT02219828|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65137298|NCT02219828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65137299|NCT04533867|Ondansetron|ondansetron|mesh-list
65137300|NCT04533867|Palonosetron|palonosetron|mesh-list
65137301|NCT04533867|Antiemetics|antiemetics|mesh-ancestor
65137302|NCT04533867|Autonomic Agents|autonomic agents|mesh-ancestor
65137303|NCT04533867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65137304|NCT04533867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137305|NCT04533867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65137306|NCT04533867|Antipruritics|antipruritics|mesh-ancestor
65137358|NCT04533321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137359|NCT04533321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137360|NCT01195831|Calcipotriene|calcipotriene|mesh-list
65137361|NCT01195831|Dermatologic Agents|dermatologic agents|mesh-ancestor
65137362|NCT01195675|Empagliflozin|empagliflozin|mesh-list
65137363|NCT01195675|Moxifloxacin|moxifloxacin|mesh-list
65137364|NCT01195675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65137365|NCT01195675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65137366|NCT01195675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65137375|NCT04532931|Sofosbuvir|sofosbuvir|mesh-list
65137424|NCT02213627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137425|NCT02216799|Insulin|insulin|mesh-list
65137426|NCT02216799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65137427|NCT02216799|Insulin Glargine|insulin glargine|mesh-list
65137428|NCT02216799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65137494|NCT01177540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137495|NCT01177540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137496|NCT02211131|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
65137497|NCT02211131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65137498|NCT02211131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137563|NCT01640639|Immunologic Factors|immunologic factors|mesh-ancestor
65137564|NCT01640639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780113|NCT02462148|Mydriatics|mydriatics|mesh-ancestor
65137565|NCT01640639|Leprostatic Agents|leprostatic agents|mesh-ancestor
65137566|NCT01640639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65137567|NCT01640639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65137568|NCT01640639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65137569|NCT01640639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65137570|NCT01640639|Growth Substances|growth substances|mesh-ancestor
65137571|NCT01640639|Growth Inhibitors|growth inhibitors|mesh-ancestor
65137572|NCT01640639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137573|NCT01642667|Saruplase|saruplase|mesh-list
65137574|NCT01642667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65137575|NCT01642667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65137576|NCT01642667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137621|NCT04497519|Antimalarials|antimalarials|mesh-ancestor
65137622|NCT04497519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65137623|NCT04497519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65137624|NCT04497519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65137625|NCT04497519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65137626|NCT04497519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137627|NCT04497519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65137628|NCT01641224|Pinaverium|pinaverium|mesh-list
65137629|NCT01641224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65137630|NCT01641224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65137631|NCT01641224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137632|NCT01641224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65137633|NCT01641224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137634|NCT01641224|Parasympatholytics|parasympatholytics|mesh-ancestor
65137635|NCT01641224|Autonomic Agents|autonomic agents|mesh-ancestor
65137637|NCT01643135|Tranylcypromine|tranylcypromine|mesh-list
65137681|NCT01643252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137682|NCT01643252|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65137683|NCT01643252|Dermatologic Agents|dermatologic agents|mesh-ancestor
65137684|NCT01641458|Capecitabine|capecitabine|mesh-list
65137685|NCT01641458|Fluorouracil|fluorouracil|mesh-list
65137687|NCT01641458|Antimetabolites|antimetabolites|mesh-ancestor
65137752|NCT02755844|Alkylating Agents|alkylating agents|mesh-ancestor
65137753|NCT02755844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137754|NCT02755844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65137755|NCT02755844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65137822|NCT01680107|Antimetabolites|antimetabolites|mesh-ancestor
65137823|NCT01680107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137824|NCT01680146|Caseins|caseins|mesh-list
65137825|NCT01680146|Chelating Agents|chelating agents|mesh-ancestor
65137826|NCT01680146|Sequestering Agents|sequestering agents|mesh-ancestor
65137827|NCT01680146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65137828|NCT01680185|Insulin|insulin|mesh-list
65137829|NCT01680185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65137830|NCT01680185|Insulin Lispro|insulin lispro|mesh-list
65137832|NCT01680185|Insulin, Isophane|insulin, isophane|mesh-list
65137888|NCT01644071|Antidepressive Agents|antidepressive agents|mesh-ancestor
65137961|NCT01681667|Analgesics|analgesics|mesh-ancestor
65137962|NCT01681667|Sensory System Agents|sensory system agents|mesh-ancestor
65137963|NCT01681667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65137964|NCT01681667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65137965|NCT01681667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65137966|NCT01681667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65137967|NCT01681667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65138028|NCT01603212|Immunologic Factors|immunologic factors|mesh-ancestor
65138029|NCT01603212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138030|NCT01603212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65138031|NCT01603212|Analgesics|analgesics|mesh-ancestor
65138032|NCT01603212|Sensory System Agents|sensory system agents|mesh-ancestor
65138033|NCT01603212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65138034|NCT01603212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65138035|NCT01603212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65138036|NCT01603212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65138037|NCT01603212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138038|NCT01603212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138039|NCT01645748|Cisplatin|cisplatin|mesh-list
65138040|NCT01645748|Docetaxel|docetaxel|mesh-list
65138041|NCT01645748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138042|NCT01645748|Tubulin Modulators|tubulin modulators|mesh-ancestor
65138043|NCT01645748|Antimitotic Agents|antimitotic agents|mesh-ancestor
65138044|NCT01645748|Mitosis Modulators|mitosis modulators|mesh-ancestor
65138045|NCT01645748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138046|NCT02484924|Clopidogrel|clopidogrel|mesh-list
65138047|NCT02484924|Ticagrelor|ticagrelor|mesh-list
65138048|NCT02484924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65138049|NCT02484924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65138050|NCT02484924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65138051|NCT02484924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65138078|NCT01603251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65138079|NCT01603251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65138080|NCT01603251|Antimalarials|antimalarials|mesh-ancestor
65138081|NCT01603251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65138082|NCT01646294|Mirabegron|mirabegron|mesh-list
65138083|NCT01646294|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65138084|NCT01646294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65138085|NCT01646294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64780637|NCT05249556|GABA Agents|gaba agents|mesh-ancestor
65138086|NCT01646294|Adrenergic Agents|adrenergic agents|mesh-ancestor
65138087|NCT01646294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65138088|NCT01646294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138090|NCT01646294|Urological Agents|urological agents|mesh-ancestor
65138141|NCT01646684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65138142|NCT01646684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138143|NCT01607580|Methylprednisolone|methylprednisolone|mesh-list
65138144|NCT01607580|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65138145|NCT01607580|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65138146|NCT01607580|Prednisolone|prednisolone|mesh-list
65138147|NCT01607580|Prednisolone acetate|prednisolone acetate|mesh-list
65138148|NCT01607580|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65138149|NCT01607580|Prednisolone phosphate|prednisolone phosphate|mesh-list
65138150|NCT01607580|Glucocorticoids|glucocorticoids|mesh-list
65138151|NCT01607580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65138152|NCT01607580|Antiemetics|antiemetics|mesh-ancestor
65138153|NCT01607580|Autonomic Agents|autonomic agents|mesh-ancestor
65138154|NCT01607580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65138155|NCT01607580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138156|NCT01607580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65138157|NCT01607580|Hormones|hormones|mesh-ancestor
65138158|NCT01607580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65138159|NCT01607580|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64780696|NCT03907176|Acetaminophen|acetaminophen|mesh-list
65138195|NCT01604382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65138196|NCT01604382|Anesthetics, General|anesthetics, general|mesh-ancestor
65138197|NCT01604382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65138265|NCT01683032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65138266|NCT01683032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138267|NCT01683032|Dopamine Agents|dopamine agents|mesh-ancestor
65138268|NCT01683032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65138269|NCT01604928|Mirabegron|mirabegron|mesh-list
65138270|NCT01604928|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65138271|NCT01604928|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65138272|NCT01604928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65138273|NCT01604928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65138274|NCT01604928|Adrenergic Agents|adrenergic agents|mesh-ancestor
65138275|NCT01604928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65138276|NCT01604928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138327|NCT01605318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65138328|NCT01605318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65138329|NCT01605318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138403|NCT01608984|Anesthetics, General|anesthetics, general|mesh-ancestor
65138404|NCT01608984|Anesthetics|anesthetics|mesh-ancestor
65138405|NCT01608984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65138406|NCT01648517|Gemcitabine|gemcitabine|mesh-list
65138477|NCT01688544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65138478|NCT01688583|Fentanyl|fentanyl|mesh-list
65138479|NCT01688583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65138480|NCT01688583|Narcotics|narcotics|mesh-ancestor
65138481|NCT01688583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65138482|NCT01688583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138483|NCT01688583|Analgesics|analgesics|mesh-ancestor
65138484|NCT01688583|Sensory System Agents|sensory system agents|mesh-ancestor
65138546|NCT01684319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138547|NCT02279576|Paclitaxel|paclitaxel|mesh-list
65138548|NCT02279576|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65138549|NCT02279576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65138550|NCT02279576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138551|NCT02279576|Tubulin Modulators|tubulin modulators|mesh-ancestor
65138552|NCT02279576|Antimitotic Agents|antimitotic agents|mesh-ancestor
65138553|NCT02279576|Mitosis Modulators|mitosis modulators|mesh-ancestor
65138554|NCT02279576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138555|NCT02279615|Tamsulosin|tamsulosin|mesh-list
65138556|NCT02279615|Mirabegron|mirabegron|mesh-list
65138557|NCT02279615|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65138559|NCT02279615|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65138607|NCT01606527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138608|NCT01606527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65138609|NCT01606527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65138610|NCT01606527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65138611|NCT01606527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138612|NCT01606527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781139|NCT02634684|Dopamine Agents|dopamine agents|mesh-ancestor
65138613|NCT01609335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65138614|NCT01609335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65138615|NCT01609335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138616|NCT01609413|Calcium Carbonate|calcium carbonate|mesh-list
65138668|NCT01649336|Tubulin Modulators|tubulin modulators|mesh-ancestor
65138669|NCT01649336|Mitosis Modulators|mitosis modulators|mesh-ancestor
65138670|NCT01649336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138671|NCT01609491|Phenylephrine|phenylephrine|mesh-list
65138672|NCT01609491|Oxymetazoline|oxymetazoline|mesh-list
65138673|NCT01609491|Norepinephrine|norepinephrine|mesh-list
65138674|NCT01609491|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65138675|NCT01609491|Mydriatics|mydriatics|mesh-ancestor
65138676|NCT01609491|Autonomic Agents|autonomic agents|mesh-ancestor
65138677|NCT01609491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65138678|NCT01609491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138733|NCT01580163|Antitussive Agents|antitussive agents|mesh-ancestor
65138734|NCT01580163|Respiratory System Agents|respiratory system agents|mesh-ancestor
65138735|NCT01609647|Clopidogrel|clopidogrel|mesh-list
65138736|NCT01609647|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65138737|NCT01609647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65138738|NCT01609647|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65138739|NCT01609647|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65138740|NCT01609647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65138741|NCT01609647|Purinergic Agents|purinergic agents|mesh-ancestor
65138742|NCT01609647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65138743|NCT01609647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138745|NCT01580202|Lamivudine|lamivudine|mesh-list
65138795|NCT01605162|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
65138796|NCT01605162|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65138797|NCT01605162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138798|NCT01605162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138799|NCT01605162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138800|NCT01649999|Peficitinib|peficitinib|mesh-list
65138801|NCT01649999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138802|NCT01649999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138803|NCT01649999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65138804|NCT01649999|Immunologic Factors|immunologic factors|mesh-ancestor
65138805|NCT01649999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138806|NCT01604889|Ipilimumab|ipilimumab|mesh-list
65138807|NCT01604889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65138808|NCT01604889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138809|NCT01604889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65138810|NCT01604889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138811|NCT01685762|Metformin|metformin|mesh-list
65138812|NCT01685762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65138813|NCT01685762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138814|NCT01602822|Ritonavir|ritonavir|mesh-list
65138815|NCT01602822|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65138816|NCT01602822|Tenofovir|tenofovir|mesh-list
65138817|NCT01602822|Emtricitabine|emtricitabine|mesh-list
65138819|NCT01602822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65138841|NCT02273154|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65138842|NCT02273154|Antidepressive Agents|antidepressive agents|mesh-ancestor
65138843|NCT02273154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65138844|NCT02273154|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65138845|NCT02273154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65138846|NCT02273154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138847|NCT02273154|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65138848|NCT02273154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65138849|NCT02273154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65138850|NCT02273154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65138851|NCT01602393|Flurbiprofen|flurbiprofen|mesh-list
65138852|NCT01602393|Analgesics|analgesics|mesh-ancestor
65138853|NCT01602393|Sensory System Agents|sensory system agents|mesh-ancestor
65138854|NCT01602393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65138855|NCT01602393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138856|NCT01602393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65138857|NCT01602393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65138858|NCT01602393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65138859|NCT01602393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65138860|NCT01602393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65138861|NCT01602393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138862|NCT01602393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138863|NCT01645787|4-Aminopyridine|4-aminopyridine|mesh-list
65138864|NCT01645787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65138865|NCT01645787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65138866|NCT01645787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138867|NCT02270034|Crizotinib|crizotinib|mesh-list
65138868|NCT02270034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138869|NCT02270034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65138870|NCT02270034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65138871|NCT02270034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138872|NCT02273271|Alovudine|alovudine|mesh-list
65138880|NCT02270307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65138881|NCT02270307|Alkylating Agents|alkylating agents|mesh-ancestor
65138882|NCT02270307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138883|NCT02270307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138884|NCT02270307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65138885|NCT02270424|Fluticasone|fluticasone|mesh-list
65138886|NCT02270424|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65138887|NCT02270424|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65138888|NCT02270424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65138889|NCT02270424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65138890|NCT02270424|Autonomic Agents|autonomic agents|mesh-ancestor
65138942|NCT01688570|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65138943|NCT01688570|Serotonin Agents|serotonin agents|mesh-ancestor
65138944|NCT01688570|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65138945|NCT01686464|Valacyclovir|valacyclovir|mesh-list
65138946|NCT01686464|Prednisone|prednisone|mesh-list
65138947|NCT01686464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65138948|NCT01686464|Glucocorticoids|glucocorticoids|mesh-ancestor
65138949|NCT01686464|Hormones|hormones|mesh-ancestor
65138950|NCT01686464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65138951|NCT01686464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138952|NCT01686464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65138953|NCT01686464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65138954|NCT01686464|Antiviral Agents|antiviral agents|mesh-ancestor
65138955|NCT01686464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65138956|NCT02270970|Belimumab|belimumab|mesh-list
65138957|NCT02270970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65138958|NCT02270970|Immunologic Factors|immunologic factors|mesh-ancestor
65138959|NCT02270970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138960|NCT01688648|Lidocaine|lidocaine|mesh-list
65138961|NCT01688648|Dexmedetomidine|dexmedetomidine|mesh-list
65138962|NCT01688648|Anesthetics, Local|anesthetics, local|mesh-ancestor
65138963|NCT01688648|Anesthetics|anesthetics|mesh-ancestor
65138965|NCT01688648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65138995|NCT02271126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65138996|NCT02271126|Hemostatics|hemostatics|mesh-ancestor
65138997|NCT02271126|Coagulants|coagulants|mesh-ancestor
65138998|NCT02271165|Immunoglobulins|immunoglobulins|mesh-list
65138999|NCT02271165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65139000|NCT02271165|Antibodies|antibodies|mesh-list
65139001|NCT02271165|Immunologic Factors|immunologic factors|mesh-ancestor
65139002|NCT02271165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139003|NCT02271204|Ibandronic Acid|ibandronic acid|mesh-list
65139004|NCT02271204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65139005|NCT02271204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139006|NCT02271282|Toremifene|toremifene|mesh-list
65139057|NCT02271399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65139058|NCT02271399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139059|NCT02271399|Antipyretics|antipyretics|mesh-ancestor
65139060|NCT02271399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65139061|NCT02271399|Antithrombins|antithrombins|mesh-ancestor
65139062|NCT02271399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65139063|NCT02271399|Protease Inhibitors|protease inhibitors|mesh-ancestor
65139064|NCT02271399|Anticoagulants|anticoagulants|mesh-ancestor
65139065|NCT02271438|Moxifloxacin|moxifloxacin|mesh-list
65139124|NCT01689116|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65139125|NCT01689116|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65139126|NCT01689116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65139127|NCT01689194|Cisplatin|cisplatin|mesh-list
65139128|NCT01689194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139129|NCT01687439|Vinorelbine|vinorelbine|mesh-list
65139130|NCT01687439|Endostar protein|endostar protein|mesh-list
64781673|NCT05423340|Nicotine|nicotine|mesh-list
65139131|NCT01687439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139132|NCT01687439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65139134|NCT01687439|Antimitotic Agents|antimitotic agents|mesh-ancestor
65139135|NCT01687439|Mitosis Modulators|mitosis modulators|mesh-ancestor
65139136|NCT01687439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139186|NCT02272101|Vitamin D|vitamin d|mesh-list
65139187|NCT02272101|Vitamins|vitamins|mesh-ancestor
65139188|NCT02272101|Micronutrients|micronutrients|mesh-ancestor
65139189|NCT02272101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139190|NCT02272101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65139191|NCT02278133|Cetuximab|cetuximab|mesh-list
65139192|NCT02278133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65139193|NCT02278133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139195|NCT01687868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65139196|NCT01687868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65139197|NCT01687868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139198|NCT01687868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65139199|NCT01687868|Analgesics|analgesics|mesh-ancestor
65139200|NCT01687868|Sensory System Agents|sensory system agents|mesh-ancestor
65139201|NCT01687868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65139202|NCT01687868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65139246|NCT02272647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65139247|NCT02272647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139248|NCT02272647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65139249|NCT02272647|Contraceptive Agents|contraceptive agents|mesh-ancestor
65139250|NCT02272647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65139251|NCT02272647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65139252|NCT02272647|Progestins|progestins|mesh-ancestor
65139253|NCT02272647|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65139254|NCT02272647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65139308|NCT05654064|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65139309|NCT05654064|Narcotics|narcotics|mesh-ancestor
65139310|NCT05654064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65139311|NCT05654064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65139312|NCT05654064|Anesthetics, General|anesthetics, general|mesh-ancestor
65139313|NCT05654064|Anesthetics|anesthetics|mesh-ancestor
65139314|NCT01687985|Laxatives|laxatives|mesh-list
65139315|NCT01687985|Cathartics|cathartics|mesh-list
65139316|NCT01687985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65139317|NCT01686620|Insulin Lispro|insulin lispro|mesh-list
65139318|NCT01686620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65139319|NCT01686620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139320|NCT05653401|Diclofenac|diclofenac|mesh-list
65139321|NCT05653401|Lidocaine|lidocaine|mesh-list
65139322|NCT05653401|Magnesium Sulfate|magnesium sulfate|mesh-list
65139323|NCT05653401|Anesthetics, Local|anesthetics, local|mesh-ancestor
65139324|NCT05653401|Anesthetics|anesthetics|mesh-ancestor
65139325|NCT05653401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65139326|NCT05653401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139336|NCT05653401|Analgesics|analgesics|mesh-ancestor
65139367|NCT01683188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139368|NCT01339923|Vaccines|vaccines|mesh-list
65139369|NCT01339923|Immunologic Factors|immunologic factors|mesh-ancestor
65139370|NCT01339923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139371|NCT04417088|Carboplatin|carboplatin|mesh-list
65139372|NCT04417088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139373|NCT01380093|Naltrexone|naltrexone|mesh-list
65139374|NCT01380093|Morphine|morphine|mesh-list
65139375|NCT01380093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65139376|NCT01380093|Narcotics|narcotics|mesh-ancestor
65139432|NCT01371747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139433|NCT01371747|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65139434|NCT01371747|Hormone Antagonists|hormone antagonists|mesh-ancestor
65139435|NCT01371747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65139436|NCT01371747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139437|NCT01371747|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65139438|NCT01371747|Diuretics|diuretics|mesh-ancestor
65139439|NCT01371747|Natriuretic Agents|natriuretic agents|mesh-ancestor
65139440|NCT01335399|Dexamethasone|dexamethasone|mesh-list
65139441|NCT01335399|Dexamethasone acetate|dexamethasone acetate|mesh-list
65139442|NCT01335399|Lenalidomide|lenalidomide|mesh-list
65139443|NCT01335399|Elotuzumab|elotuzumab|mesh-list
65139444|NCT01335399|BB 1101|bb 1101|mesh-list
65139445|NCT01335399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65139446|NCT01335399|Antiemetics|antiemetics|mesh-ancestor
65139492|NCT01332630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65139493|NCT01332630|Anesthetics, Local|anesthetics, local|mesh-ancestor
65139494|NCT01332630|Anesthetics|anesthetics|mesh-ancestor
65139495|NCT01332630|Sensory System Agents|sensory system agents|mesh-ancestor
65139496|NCT01332630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65139497|NCT01332630|Histamine Antagonists|histamine antagonists|mesh-ancestor
65139498|NCT01332630|Histamine Agents|histamine agents|mesh-ancestor
65139499|NCT01332630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65139500|NCT01332630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139501|NCT01332630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65139502|NCT01332630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65139503|NCT01332630|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65139504|NCT01366209|Pirfenidone|pirfenidone|mesh-list
64782027|NCT04415892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65139505|NCT01366209|Analgesics|analgesics|mesh-ancestor
65139506|NCT01366209|Sensory System Agents|sensory system agents|mesh-ancestor
65139507|NCT01366209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65139508|NCT01366209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139509|NCT01366209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65139510|NCT01366209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65139511|NCT01366209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65139512|NCT01366209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65139513|NCT01366209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139514|NCT01365507|Insulin|insulin|mesh-list
65139515|NCT01365507|Insulin Aspart|insulin aspart|mesh-list
65139516|NCT01365507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65139541|NCT01357980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139542|NCT01357980|Cholinergic Agents|cholinergic agents|mesh-ancestor
65139543|NCT01357980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65139544|NCT01357980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139612|NCT01357161|Mitosis Modulators|mitosis modulators|mesh-ancestor
65139613|NCT01357161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139614|NCT01357161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139615|NCT01351350|Paclitaxel|paclitaxel|mesh-list
65139616|NCT01351350|Trastuzumab|trastuzumab|mesh-list
65139617|NCT01351350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65139618|NCT01351350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139619|NCT01351350|Tubulin Modulators|tubulin modulators|mesh-ancestor
65139620|NCT01351350|Antimitotic Agents|antimitotic agents|mesh-ancestor
65139621|NCT01351350|Mitosis Modulators|mitosis modulators|mesh-ancestor
65139622|NCT01351350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139623|NCT01351350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65139624|NCT02271503|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65139625|NCT02271503|Carbidopa|carbidopa|mesh-list
65139626|NCT02271503|Levodopa|levodopa|mesh-list
65139627|NCT02271503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65139628|NCT02271503|Immunologic Factors|immunologic factors|mesh-ancestor
65139629|NCT02271503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139630|NCT02271503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65139631|NCT02271503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65139632|NCT02271503|Dopamine Agonists|dopamine agonists|mesh-ancestor
65139633|NCT02271503|Dopamine Agents|dopamine agents|mesh-ancestor
65139634|NCT02271503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65139637|NCT02271503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139661|NCT01348542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65139662|NCT01348542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65139663|NCT01348542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139664|NCT01348542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65139665|NCT01348542|Serotonin Agents|serotonin agents|mesh-ancestor
65139666|NCT01348542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65139667|NCT01348542|Antidepressive Agents|antidepressive agents|mesh-ancestor
65139668|NCT01346592|Vaccines|vaccines|mesh-list
65139669|NCT01346592|Immunologic Factors|immunologic factors|mesh-ancestor
65139670|NCT01346592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139671|NCT01193335|Vaccines|vaccines|mesh-list
65139672|NCT01193335|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65139723|NCT01340625|Norethindrone Acetate|norethindrone acetate|mesh-list
65139724|NCT01340625|Estradiol|estradiol|mesh-list
65139725|NCT01340625|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65139726|NCT01340625|Estrogens|estrogens|mesh-ancestor
65139727|NCT01340625|Hormones|hormones|mesh-ancestor
65139728|NCT01340625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64782265|NCT04674462|Vaccines|vaccines|mesh-list
65139729|NCT01340625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139792|NCT01327599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65139793|NCT01327599|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65139794|NCT01327599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65139795|NCT01327599|Adrenergic Agents|adrenergic agents|mesh-ancestor
65139796|NCT01327599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65139797|NCT01327599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139798|NCT01327599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139799|NCT01327599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65139800|NCT01327599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65139861|NCT02893371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139862|NCT02893371|Dopamine Agonists|dopamine agonists|mesh-ancestor
65139863|NCT02893371|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65139864|NCT02893371|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65139865|NCT02893371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65139866|NCT02893371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65139867|NCT02893371|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65139868|NCT02893371|Analgesics|analgesics|mesh-ancestor
65139869|NCT02893371|Sensory System Agents|sensory system agents|mesh-ancestor
65139870|NCT02893371|Antimanic Agents|antimanic agents|mesh-ancestor
65139875|NCT02893371|GABA Agents|gaba agents|mesh-ancestor
65139922|NCT04328805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65139923|NCT04328805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65139924|NCT04328805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65139925|NCT04328805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65139926|NCT04328805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65139927|NCT04328805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139928|NCT04328805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139929|NCT04329000|Esomeprazole|esomeprazole|mesh-list
65139930|NCT04329000|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65139931|NCT04329000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65139932|NCT04329000|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65139933|NCT04329000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139934|NCT04329000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139935|NCT01192399|Eculizumab|eculizumab|mesh-list
65139936|NCT01192399|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65139937|NCT01192399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65139981|NCT01600625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65139982|NCT01600625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65139983|NCT01600742|Vorinostat|vorinostat|mesh-list
65139984|NCT01600742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65139985|NCT01600742|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65139986|NCT01600742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65139987|NCT01600742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65139988|NCT01327482|Raltegravir Potassium|raltegravir potassium|mesh-list
65139989|NCT01327482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65139990|NCT01327482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65139997|NCT02893488|Lamivudine|lamivudine|mesh-list
65140047|NCT00592137|Calcium|calcium|mesh-list
65140048|NCT00592137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65140049|NCT00592137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140050|NCT00592137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65140051|NCT04455776|Propofol|propofol|mesh-list
65140052|NCT04455776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65140053|NCT04455776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65140054|NCT04455776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140055|NCT04455776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65140056|NCT04455776|Anesthetics, General|anesthetics, general|mesh-ancestor
65140057|NCT04455776|Anesthetics|anesthetics|mesh-ancestor
65140058|NCT04135092|Aldesleukin|aldesleukin|mesh-list
65140059|NCT04135092|Cyclophosphamide|cyclophosphamide|mesh-list
65140060|NCT04135092|Pembrolizumab|pembrolizumab|mesh-list
65140061|NCT04135092|Fludarabine|fludarabine|mesh-list
65140062|NCT04135092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65140106|NCT00592332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65140107|NCT00592332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140108|NCT04477382|Tretinoin|tretinoin|mesh-list
65140109|NCT04477382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65140110|NCT04477382|Keratolytic Agents|keratolytic agents|mesh-ancestor
65140111|NCT04477382|Dermatologic Agents|dermatologic agents|mesh-ancestor
65140112|NCT01600274|Dienogest|dienogest|mesh-list
65140113|NCT01600274|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65140114|NCT01600274|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65140115|NCT01600274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65140116|NCT01600274|Estradiol|estradiol|mesh-list
65140117|NCT01600274|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65140171|NCT00591708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140172|NCT01176058|Fluconazole|fluconazole|mesh-list
65140173|NCT01176058|Anidulafungin|anidulafungin|mesh-list
65140174|NCT01176058|Antifungal Agents|antifungal agents|mesh-ancestor
65140175|NCT01176058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65140176|NCT01176058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65140177|NCT01176058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65140178|NCT01176058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140179|NCT01176058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140180|NCT01176058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65140181|NCT01176058|Hormone Antagonists|hormone antagonists|mesh-ancestor
64782706|NCT04040790|Cholinergic Agents|cholinergic agents|mesh-ancestor
65140182|NCT01176058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65140183|NCT01176058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140186|NCT02273765|Tenofovir|tenofovir|mesh-list
65140226|NCT01601093|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65140227|NCT01601093|Renal Agents|renal agents|mesh-ancestor
65140228|NCT04367688|Tenofovir|tenofovir|mesh-list
65140229|NCT04367688|Emtricitabine|emtricitabine|mesh-list
65140230|NCT04367688|Antiviral Agents|antiviral agents|mesh-ancestor
65140231|NCT04367688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65140232|NCT04367688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65140233|NCT04367688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65140235|NCT04367688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140236|NCT04367688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65140237|NCT04367688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65140238|NCT02485418|Propofol|propofol|mesh-list
65140239|NCT02485418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65140240|NCT02485418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65140241|NCT02485418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140289|NCT01175668|GABA Modulators|gaba modulators|mesh-ancestor
65140290|NCT01175668|GABA Agents|gaba agents|mesh-ancestor
65140291|NCT01175668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65140292|NCT01175668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65140293|NCT01175668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65140294|NCT01601327|Methyltestosterone|methyltestosterone|mesh-list
65140295|NCT01601327|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65140296|NCT01601327|Testosterone|testosterone|mesh-list
65140297|NCT01601327|Testosterone undecanoate|testosterone undecanoate|mesh-list
65140298|NCT01601327|Testosterone enanthate|testosterone enanthate|mesh-list
65140299|NCT01601327|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65140300|NCT01601327|Androgens|androgens|mesh-ancestor
65140301|NCT01601327|Hormones|hormones|mesh-ancestor
65140302|NCT01601327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65140303|NCT01601327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140348|NCT04327947|Protective Agents|protective agents|mesh-ancestor
65140349|NCT01607879|Androgens|androgens|mesh-list
65140350|NCT01607879|Hormones|hormones|mesh-ancestor
65140351|NCT01607879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65140352|NCT01607879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140353|NCT01607918|Amoxicillin|amoxicillin|mesh-list
65140354|NCT01607918|Metronidazole|metronidazole|mesh-list
65140355|NCT01607918|Clarithromycin|clarithromycin|mesh-list
65140356|NCT01607918|Lansoprazole|lansoprazole|mesh-list
65140357|NCT01607918|Dexlansoprazole|dexlansoprazole|mesh-list
65140358|NCT01607918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65140359|NCT01607918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65140360|NCT01607918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65140361|NCT01607918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65140362|NCT01607918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65140363|NCT01607918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140364|NCT01607918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140365|NCT01607918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65140366|NCT01607918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65140367|NCT01607918|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65140368|NCT01607918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65140403|NCT01601912|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65140404|NCT01601912|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65140405|NCT01601912|Cholinergic Agents|cholinergic agents|mesh-ancestor
65140406|NCT01601912|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65140407|NCT01601912|Adrenergic Agents|adrenergic agents|mesh-ancestor
65140408|NCT01111825|Sirolimus|sirolimus|mesh-list
65140409|NCT01111825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65140410|NCT01111825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65140411|NCT01111825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65140412|NCT01111825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65140413|NCT01111825|Antifungal Agents|antifungal agents|mesh-ancestor
65140414|NCT01111825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65140415|NCT01111825|Immunologic Factors|immunologic factors|mesh-ancestor
65140416|NCT01111825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140417|NCT01175590|Besifloxacin|besifloxacin|mesh-list
65140418|NCT01175590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65140419|NCT01175590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65140420|NCT01175590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65140421|NCT01175590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65140422|NCT01175590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140423|NCT01175590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140424|NCT01175590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65140425|NCT01175473|Metformin|metformin|mesh-list
65140426|NCT01175473|Liraglutide|liraglutide|mesh-list
65140427|NCT01175473|Lixisenatide|lixisenatide|mesh-list
65140428|NCT01175473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65140429|NCT01175473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140430|NCT01175473|Incretins|incretins|mesh-ancestor
65140431|NCT01175473|Hormones|hormones|mesh-ancestor
65140450|NCT01111552|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65140451|NCT01111552|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65140452|NCT01111552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65140453|NCT01111552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65140454|NCT01111552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65140455|NCT01111552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65140456|NCT01602185|Memantine|memantine|mesh-list
65140521|NCT01608464|Tubulin Modulators|tubulin modulators|mesh-ancestor
65140522|NCT01608464|Antimitotic Agents|antimitotic agents|mesh-ancestor
65140523|NCT01608464|Mitosis Modulators|mitosis modulators|mesh-ancestor
65140524|NCT01608464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140525|NCT01608464|Antimetabolites|antimetabolites|mesh-ancestor
65140526|NCT01608464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65140527|NCT01608464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65140533|NCT01608698|Drospirenone|drospirenone|mesh-list
65140589|NCT01609166|Antimetabolites|antimetabolites|mesh-ancestor
65140590|NCT01609166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140591|NCT01609166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140592|NCT01609166|Gout Suppressants|gout suppressants|mesh-ancestor
65140593|NCT01609166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65140594|NCT01609166|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65140595|NCT01609166|Antioxidants|antioxidants|mesh-ancestor
65140596|NCT01609166|Protective Agents|protective agents|mesh-ancestor
65140597|NCT01609166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140598|NCT01609205|Adalimumab|adalimumab|mesh-list
65140599|NCT01609205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65140600|NCT01609205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65140601|NCT01604057|Teriparatide|teriparatide|mesh-list
65140602|NCT01604057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65140603|NCT01604057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140604|NCT01604057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65140605|NCT00592566|Dexamethasone|dexamethasone|mesh-list
65140606|NCT00592566|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65140614|NCT00592566|Hormones|hormones|mesh-ancestor
65140646|NCT01173679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140647|NCT01173679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65140648|NCT01173679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140649|NCT02881528|Metformin|metformin|mesh-list
65140650|NCT02881528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65140651|NCT02881528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140652|NCT01609439|Vitamin D|vitamin d|mesh-list
65140653|NCT01609439|Vitamins|vitamins|mesh-ancestor
65140654|NCT01609439|Micronutrients|micronutrients|mesh-ancestor
65140655|NCT01609439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140657|NCT01110382|Amoxicillin|amoxicillin|mesh-list
65140712|NCT01609673|Everolimus|everolimus|mesh-list
65140713|NCT01609673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65140714|NCT01609673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65140715|NCT01609673|Immunologic Factors|immunologic factors|mesh-ancestor
65140716|NCT01609673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140717|NCT01173055|Milnacipran|milnacipran|mesh-list
65140718|NCT01173055|Levomilnacipran|levomilnacipran|mesh-list
65140719|NCT01173055|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65140720|NCT01173055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65140721|NCT01173055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65140722|NCT01173055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140723|NCT01173055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65140724|NCT01173055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140726|NCT01173055|Analgesics|analgesics|mesh-ancestor
65140773|NCT01609907|Valsartan|valsartan|mesh-list
65140774|NCT01609907|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65140775|NCT01609907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65140776|NCT01609907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65140777|NCT01609907|Antimetabolites|antimetabolites|mesh-ancestor
65140778|NCT01609907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140779|NCT01609907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65140780|NCT01609907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65140781|NCT01609907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140782|NCT01609907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65140783|NCT01609907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65140784|NCT01609907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65140785|NCT00593580|Cholecalciferol|cholecalciferol|mesh-list
65140835|NCT01601522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140836|NCT01601522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140837|NCT01601522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65140838|NCT01601522|Histamine Agents|histamine agents|mesh-ancestor
65140839|NCT01601522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65140840|NCT01601522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65140841|NCT01601522|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65140842|NCT00593853|Methylphenidate|methylphenidate|mesh-list
65140843|NCT00593853|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65140844|NCT00593853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140845|NCT00593853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65140846|NCT00593853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65140895|NCT00592410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65140896|NCT00592410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65140897|NCT00592410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140898|NCT04328064|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65140899|NCT04328064|Calcium|calcium|mesh-list
65140900|NCT04328064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65140901|NCT04328064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140902|NCT04328064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65140903|NCT04328064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65140904|NCT04328064|Antimetabolites|antimetabolites|mesh-ancestor
65140906|NCT04328064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65140960|NCT02270606|Antimetabolites|antimetabolites|mesh-ancestor
65140961|NCT02270606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140962|NCT02270606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65140963|NCT02270606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65140964|NCT02270606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65140965|NCT02270606|Immunologic Factors|immunologic factors|mesh-ancestor
65140966|NCT02270606|Antidotes|antidotes|mesh-ancestor
65140967|NCT02270606|Protective Agents|protective agents|mesh-ancestor
65140968|NCT02270606|Vitamin B Complex|vitamin b complex|mesh-ancestor
65140969|NCT02270606|Vitamins|vitamins|mesh-ancestor
65140970|NCT02270606|Micronutrients|micronutrients|mesh-ancestor
65140971|NCT00594633|Donepezil|donepezil|mesh-list
65140972|NCT00594633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64514477|NCT02185209|Amoxicillin|amoxicillin|mesh-list
65140973|NCT00594633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65140974|NCT00594633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65140975|NCT00594633|Cholinergic Agents|cholinergic agents|mesh-ancestor
65140976|NCT00594633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65140977|NCT00594633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65140978|NCT00594633|Nootropic Agents|nootropic agents|mesh-ancestor
65140979|NCT01605968|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65140980|NCT01605968|Laxatives|laxatives|mesh-ancestor
65141012|NCT00594867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65141013|NCT00594867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141014|NCT00594867|Antipyretics|antipyretics|mesh-ancestor
65141015|NCT01606241|Cyclophosphamide|cyclophosphamide|mesh-list
65141016|NCT01606241|Vaccines|vaccines|mesh-list
65141017|NCT01606241|Immunologic Factors|immunologic factors|mesh-ancestor
65141018|NCT01606241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141019|NCT01606241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65141020|NCT01606241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65141021|NCT01606241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65141022|NCT01606241|Alkylating Agents|alkylating agents|mesh-ancestor
65141023|NCT01606241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141024|NCT01606241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141025|NCT01606241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65141026|NCT02270918|Apixaban|apixaban|mesh-list
65141027|NCT02270918|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65141036|NCT00595140|Octreotide|octreotide|mesh-list
65141073|NCT02271191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65141074|NCT02271191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65141075|NCT02271191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141076|NCT02271191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65141077|NCT02271191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141078|NCT02271191|Vasodilator Agents|vasodilator agents|mesh-ancestor
65141079|NCT00595374|Insulin|insulin|mesh-list
65141080|NCT00595374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65141081|NCT00595374|Insulin Aspart|insulin aspart|mesh-list
65141082|NCT00595374|Insulin Detemir|insulin detemir|mesh-list
65141083|NCT00595374|Isophane Insulin, Human|isophane insulin, human|mesh-list
65141084|NCT00595374|Insulin, Isophane|insulin, isophane|mesh-list
65141085|NCT00595374|Isophane insulin, beef|isophane insulin, beef|mesh-list
65141086|NCT00595374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65141087|NCT00595374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141088|NCT00595569|Insulin|insulin|mesh-list
64783653|NCT03883074|Antacids|antacids|mesh-ancestor
65141089|NCT00595569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65141090|NCT00595569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141091|NCT02271347|Brincidofovir|brincidofovir|mesh-list
65141092|NCT02271347|Antiviral Agents|antiviral agents|mesh-ancestor
65141093|NCT02271347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65141094|NCT01172938|Thalidomide|thalidomide|mesh-list
65141095|NCT01172938|Apremilast|apremilast|mesh-list
65141096|NCT01172938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65141097|NCT01172938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65141098|NCT01172938|Analgesics|analgesics|mesh-ancestor
65141099|NCT01172938|Sensory System Agents|sensory system agents|mesh-ancestor
65141100|NCT01172938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65141101|NCT01172938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141102|NCT01172938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65141103|NCT01172938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65141104|NCT01172938|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65141105|NCT01172938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65141106|NCT01172938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141107|NCT01172938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141111|NCT01172938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65141112|NCT01172938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65141113|NCT01172938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65141114|NCT01172938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65141115|NCT01172938|Growth Substances|growth substances|mesh-ancestor
65141116|NCT01172938|Growth Inhibitors|growth inhibitors|mesh-ancestor
65141117|NCT01172938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141118|NCT02271464|Cyclophosphamide|cyclophosphamide|mesh-list
65141119|NCT02271464|Bevacizumab|bevacizumab|mesh-list
65141120|NCT02271464|Capecitabine|capecitabine|mesh-list
65141121|NCT02271464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65141176|NCT01109524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141177|NCT01109524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65141178|NCT01109524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65141179|NCT01109524|Tubulin Modulators|tubulin modulators|mesh-ancestor
65141180|NCT01109524|Antimitotic Agents|antimitotic agents|mesh-ancestor
65141181|NCT01109524|Mitosis Modulators|mitosis modulators|mesh-ancestor
65141182|NCT01109524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141183|NCT01109173|Nepafenac|nepafenac|mesh-list
65141184|NCT01109173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65141185|NCT01109173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65141186|NCT01109173|Analgesics|analgesics|mesh-ancestor
65141187|NCT01109173|Sensory System Agents|sensory system agents|mesh-ancestor
65141188|NCT01109173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65141189|NCT01109173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141190|NCT01109173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65141191|NCT01109173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65141192|NCT02271971|Vitamin D|vitamin d|mesh-list
65141193|NCT02271971|Cholecalciferol|cholecalciferol|mesh-list
65141194|NCT02271971|Vitamins|vitamins|mesh-ancestor
65141232|NCT05034952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65141233|NCT05034952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141234|NCT05034952|Antipyretics|antipyretics|mesh-ancestor
65141235|NCT00596037|Hormones|hormones|mesh-list
65141236|NCT00596037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65141237|NCT00596037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141238|NCT02273102|Tretinoin|tretinoin|mesh-list
65141239|NCT02273102|Tranylcypromine|tranylcypromine|mesh-list
64783765|NCT03223272|Reserpine|reserpine|mesh-list
65141240|NCT02273102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141241|NCT02273102|Keratolytic Agents|keratolytic agents|mesh-ancestor
65141242|NCT02273102|Dermatologic Agents|dermatologic agents|mesh-ancestor
65141243|NCT02273102|Antidepressive Agents|antidepressive agents|mesh-ancestor
65141244|NCT02273102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65141291|NCT00596115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65141292|NCT00596115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65141293|NCT00596115|Dopamine Agonists|dopamine agonists|mesh-ancestor
65141294|NCT00596115|Dopamine Agents|dopamine agents|mesh-ancestor
65141295|NCT00596115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65141296|NCT02272868|Rifaximin|rifaximin|mesh-list
65141297|NCT02272868|Omeprazole|omeprazole|mesh-list
65141298|NCT02272868|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65141299|NCT02272868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65141300|NCT02272868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65141301|NCT02272868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65141302|NCT02272868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141303|NCT02272868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141304|NCT02272868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65141305|NCT02272868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65141306|NCT02272868|Laxatives|laxatives|mesh-ancestor
65141307|NCT02273453|Oxazepam|oxazepam|mesh-list
65141351|NCT04327401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65141352|NCT04327401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141353|NCT04327401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65141354|NCT04327401|Glucocorticoids|glucocorticoids|mesh-ancestor
65141355|NCT04327401|Hormones|hormones|mesh-ancestor
65141356|NCT04327401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65141357|NCT04327401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65141358|NCT04327401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141360|NCT01340027|Mirabegron|mirabegron|mesh-list
65141416|NCT00107900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141417|NCT00107900|Anticoagulants|anticoagulants|mesh-ancestor
65141418|NCT00107315|Bevacizumab|bevacizumab|mesh-list
65141419|NCT00107315|Capecitabine|capecitabine|mesh-list
65141420|NCT00107315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65141421|NCT00107315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141422|NCT00107315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65141423|NCT00107315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65141483|NCT00107198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65141484|NCT00107198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65141485|NCT00107198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65141486|NCT00107198|Tubulin Modulators|tubulin modulators|mesh-ancestor
65141487|NCT00107198|Antimitotic Agents|antimitotic agents|mesh-ancestor
65141488|NCT00107198|Mitosis Modulators|mitosis modulators|mesh-ancestor
65141489|NCT00107120|Citalopram|citalopram|mesh-list
65141490|NCT00107120|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65141491|NCT00107120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65141492|NCT00107120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65141493|NCT00107120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141494|NCT00107120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65141495|NCT00107120|Serotonin Agents|serotonin agents|mesh-ancestor
65141496|NCT00107120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141497|NCT00107120|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65141498|NCT00107120|Antidepressive Agents|antidepressive agents|mesh-ancestor
65141499|NCT00107120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65141500|NCT01335464|Nintedanib|nintedanib|mesh-list
65141501|NCT01335464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141502|NCT01335464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65141503|NCT01335464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141504|NCT01335464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141505|NCT00106184|Rituximab|rituximab|mesh-list
65141506|NCT00106184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65141507|NCT00106184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141508|NCT00106184|Immunologic Factors|immunologic factors|mesh-ancestor
65141509|NCT00106184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141510|NCT00106184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65141526|NCT01334918|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
65141527|NCT01334918|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65141528|NCT01334918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65141597|NCT00599274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141598|NCT00599274|Antiviral Agents|antiviral agents|mesh-ancestor
65141599|NCT00599274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65141600|NCT00599274|Immunologic Factors|immunologic factors|mesh-ancestor
65141601|NCT00599274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141602|NCT00599274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65141603|NCT01332227|Ritonavir|ritonavir|mesh-list
65141604|NCT01332227|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65141605|NCT01332227|Tenofovir|tenofovir|mesh-list
65141606|NCT01332227|Emtricitabine|emtricitabine|mesh-list
65141623|NCT01332149|Pregabalin|pregabalin|mesh-list
65141663|NCT05649878|Methylprednisolone|methylprednisolone|mesh-list
65141664|NCT05649878|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65141665|NCT05649878|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65141666|NCT05649878|Prednisolone|prednisolone|mesh-list
65141667|NCT05649878|Prednisolone acetate|prednisolone acetate|mesh-list
65141668|NCT05649878|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65141669|NCT05649878|Prednisolone phosphate|prednisolone phosphate|mesh-list
65141670|NCT05649878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65141671|NCT05649878|Antiemetics|antiemetics|mesh-ancestor
65141672|NCT05649878|Autonomic Agents|autonomic agents|mesh-ancestor
65141675|NCT05649878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65141726|NCT01371851|Doxazosin|doxazosin|mesh-list
65141727|NCT01371851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65141728|NCT01371851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65141729|NCT01371851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65141730|NCT01371851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65141731|NCT01371851|Adrenergic Agents|adrenergic agents|mesh-ancestor
65141732|NCT01371851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65141733|NCT01371851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141734|NCT01371851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141735|NCT01371734|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65141736|NCT01371734|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65141786|NCT01351025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141787|NCT01351025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65141788|NCT01351025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65141789|NCT01351025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65141790|NCT01348763|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65141791|NCT01348763|Maraviroc|maraviroc|mesh-list
65141792|NCT01348763|Darunavir|darunavir|mesh-list
65141793|NCT01348763|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65141849|NCT01342445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65141850|NCT01342445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65141851|NCT01342445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141852|NCT01342445|Dopamine Agents|dopamine agents|mesh-ancestor
65141853|NCT01342445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65141854|NCT01342367|Bicalutamide|bicalutamide|mesh-list
65141855|NCT01342367|Finasteride|finasteride|mesh-list
65141856|NCT01342367|Dutasteride|dutasteride|mesh-list
65141857|NCT01342367|Androgen Antagonists|androgen antagonists|mesh-ancestor
65141858|NCT01342367|Hormone Antagonists|hormone antagonists|mesh-ancestor
65141859|NCT01342367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65141912|NCT02880943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65141913|NCT04207632|Botulinum Toxins|botulinum toxins|mesh-list
65141914|NCT04207632|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65141915|NCT04207632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65141916|NCT04207632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65141917|NCT04207632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65141918|NCT04207632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65141919|NCT04207632|Cholinergic Agents|cholinergic agents|mesh-ancestor
65141922|NCT04207632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65141977|NCT00600366|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65141978|NCT00600366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65141979|NCT00600366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65141981|NCT01326546|Antiviral Agents|antiviral agents|mesh-ancestor
65141982|NCT01326546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65141983|NCT00600600|Tigecycline|tigecycline|mesh-list
65141984|NCT00600600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65141985|NCT00600600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65141986|NCT00600600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65141987|NCT00600600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142040|NCT00601614|Alkylating Agents|alkylating agents|mesh-ancestor
65142041|NCT00601614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142042|NCT00601614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142043|NCT00601692|Docetaxel|docetaxel|mesh-list
65142044|NCT00601692|Irinotecan|irinotecan|mesh-list
65142045|NCT00601692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142046|NCT00601692|Tubulin Modulators|tubulin modulators|mesh-ancestor
65142047|NCT00601692|Antimitotic Agents|antimitotic agents|mesh-ancestor
65142048|NCT00601692|Mitosis Modulators|mitosis modulators|mesh-ancestor
65142049|NCT00601692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142050|NCT00601692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64784586|NCT02345460|Antidotes|antidotes|mesh-ancestor
65142051|NCT00601692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65142059|NCT00602082|Capecitabine|capecitabine|mesh-list
65142101|NCT01169701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65142102|NCT01169701|Antitubercular Agents|antitubercular agents|mesh-ancestor
65142103|NCT01169701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65142104|NCT01169701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65142105|NCT01167907|Ropivacaine|ropivacaine|mesh-list
65142106|NCT01167907|Anesthetics, Local|anesthetics, local|mesh-ancestor
65142170|NCT04308343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65142171|NCT04308343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142172|NCT04308343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65142173|NCT04308343|Antimetabolites|antimetabolites|mesh-ancestor
65142174|NCT04308343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142175|NCT04308343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142176|NCT04308343|Dermatologic Agents|dermatologic agents|mesh-ancestor
65142177|NCT04308343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142178|NCT04308343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65142234|NCT02878837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65142235|NCT02878837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65142236|NCT02878837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65142237|NCT02878837|Adrenergic Agents|adrenergic agents|mesh-ancestor
65142238|NCT02878837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65142239|NCT02878837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142240|NCT02878837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65142241|NCT02878837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65142300|NCT02893826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142301|NCT02893826|Vasodilator Agents|vasodilator agents|mesh-ancestor
65142302|NCT02893280|Aspirin|aspirin|mesh-list
65142303|NCT02893280|Enoxaparin|enoxaparin|mesh-list
65142304|NCT02893280|Streptokinase|streptokinase|mesh-list
65142305|NCT02893280|Clopidogrel|clopidogrel|mesh-list
65142306|NCT02893280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65142307|NCT02893280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65142308|NCT02893280|Analgesics|analgesics|mesh-ancestor
65142309|NCT02893280|Sensory System Agents|sensory system agents|mesh-ancestor
65142310|NCT02893280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65142311|NCT02893280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142312|NCT02893280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65142313|NCT02893280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65142314|NCT02893280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65142315|NCT02893280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65142316|NCT02893280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142358|NCT00592670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65142359|NCT00592670|Antidepressive Agents|antidepressive agents|mesh-ancestor
65142360|NCT00592670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65142361|NCT00592670|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65142362|NCT00592670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65142363|NCT00592670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142364|NCT04327232|Spironolactone|spironolactone|mesh-list
65142365|NCT04327232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65142366|NCT04327232|Hormone Antagonists|hormone antagonists|mesh-ancestor
65142367|NCT04327232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65142421|NCT00594542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142422|NCT00594542|Sensory System Agents|sensory system agents|mesh-ancestor
65142423|NCT00594542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65142424|NCT00594542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65142425|NCT00594542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65142426|NCT00594542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65142427|NCT00594542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65142428|NCT00594542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142430|NCT00595322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65142431|NCT00595322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142432|NCT00595322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65142433|NCT00595322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65142434|NCT00595322|Growth Substances|growth substances|mesh-ancestor
65142435|NCT00595322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142436|NCT00595322|Growth Inhibitors|growth inhibitors|mesh-ancestor
65142437|NCT00596336|Imiquimod|imiquimod|mesh-list
65142438|NCT00596336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65142478|NCT00598052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65142479|NCT00598052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65142480|NCT00598052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142481|NCT00598052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65142482|NCT00598052|Serotonin Agents|serotonin agents|mesh-ancestor
65142483|NCT00598052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142484|NCT00598052|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65142485|NCT00598052|Antidepressive Agents|antidepressive agents|mesh-ancestor
65142543|NCT04325984|Antiemetics|antiemetics|mesh-ancestor
65142544|NCT04325984|Autonomic Agents|autonomic agents|mesh-ancestor
65142545|NCT04325984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65142546|NCT04325984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142547|NCT04325984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65142548|NCT04325984|Glucocorticoids|glucocorticoids|mesh-ancestor
65142549|NCT04325984|Hormones|hormones|mesh-ancestor
65142550|NCT04325984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65142551|NCT04325984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65142552|NCT04325984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142553|NCT00600548|Miltefosine|miltefosine|mesh-list
65142554|NCT00600548|Meglumine Antimoniate|meglumine antimoniate|mesh-list
65142555|NCT00600548|Antifungal Agents|antifungal agents|mesh-ancestor
65142556|NCT00600548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65142557|NCT00600548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142558|NCT00600548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65142602|NCT00601874|Pilocarpine|pilocarpine|mesh-list
65142603|NCT00601874|Miotics|miotics|mesh-ancestor
65142604|NCT00601874|Autonomic Agents|autonomic agents|mesh-ancestor
65142605|NCT00601874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65142606|NCT00601874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142607|NCT00601874|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65142608|NCT00601874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65142609|NCT00601874|Cholinergic Agents|cholinergic agents|mesh-ancestor
65142610|NCT00601874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65142611|NCT00601874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142612|NCT01326026|Insulin|insulin|mesh-list
65142613|NCT01326026|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65142614|NCT01326026|Insulin, Long-Acting|insulin, long-acting|mesh-list
65142615|NCT01326026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65142616|NCT01326026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142617|NCT01097629|Suvorexant|suvorexant|mesh-list
65142618|NCT01097629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65142619|NCT01097629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65142620|NCT01097629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65142621|NCT01097629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142622|NCT01097629|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65142623|NCT01097629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65142624|NCT01097629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142625|NCT04308031|Digoxin|digoxin|mesh-list
65142626|NCT04308031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65142627|NCT04308031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65142628|NCT04308031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142629|NCT04308031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142630|NCT04308031|Protective Agents|protective agents|mesh-ancestor
65142631|NCT04308031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142632|NCT01096849|Levofloxacin|levofloxacin|mesh-list
65142633|NCT01096849|Ofloxacin|ofloxacin|mesh-list
65142643|NCT01096849|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65142644|NCT01096849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65142645|NCT01324388|Dulaglutide|dulaglutide|mesh-list
65142646|NCT01324388|Metoprolol|metoprolol|mesh-list
64785179|NCT03582930|Calfactant|calfactant|mesh-list
65142647|NCT01324388|Lisinopril|lisinopril|mesh-list
65142712|NCT01324232|Dextromethorphan|dextromethorphan|mesh-list
65142713|NCT01324232|Antitussive Agents|antitussive agents|mesh-ancestor
65142714|NCT01324232|Respiratory System Agents|respiratory system agents|mesh-ancestor
65142715|NCT01324232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65142716|NCT01324232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65142717|NCT01324232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65142718|NCT01324232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142719|NCT01324232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142720|NCT01324232|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65142721|NCT01324232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65142722|NCT01324232|Adrenergic Agents|adrenergic agents|mesh-ancestor
65142774|NCT00598377|Cosyntropin|cosyntropin|mesh-list
65142775|NCT00598377|Hormones|hormones|mesh-ancestor
65142776|NCT00598377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65142777|NCT00598377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142778|NCT00598533|Sirolimus|sirolimus|mesh-list
65142779|NCT00598533|Probucol|probucol|mesh-list
65142780|NCT00598533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65142781|NCT00598533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65142782|NCT00598533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65142783|NCT00598533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65142784|NCT00598533|Antifungal Agents|antifungal agents|mesh-ancestor
65142785|NCT00598533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65142795|NCT00598611|Loratadine|loratadine|mesh-list
65142838|NCT00600405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65142839|NCT00600405|Analgesics|analgesics|mesh-ancestor
65142840|NCT00600405|Sensory System Agents|sensory system agents|mesh-ancestor
65142841|NCT00600405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65142842|NCT00600405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142843|NCT00600405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65142907|NCT00601575|Antidepressive Agents|antidepressive agents|mesh-ancestor
65142908|NCT00601575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65142909|NCT00601575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142910|NCT00601575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142911|NCT00601575|Antimanic Agents|antimanic agents|mesh-ancestor
65142912|NCT00601575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65142913|NCT00601575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65142914|NCT00601575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142915|NCT00601887|Meloxicam|meloxicam|mesh-list
65142916|NCT00601887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65142917|NCT00601887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65142918|NCT00601887|Analgesics|analgesics|mesh-ancestor
65142968|NCT01101841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142969|NCT02877511|Sunscreening Agents|sunscreening agents|mesh-list
65142970|NCT02877511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65142971|NCT02877511|Protective Agents|protective agents|mesh-ancestor
65142972|NCT02877511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65142973|NCT02877511|Dermatologic Agents|dermatologic agents|mesh-ancestor
65142974|NCT01324323|Rifampin|rifampin|mesh-list
65142975|NCT01324323|Romidepsin|romidepsin|mesh-list
65142976|NCT01324323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65142977|NCT01324323|Antitubercular Agents|antitubercular agents|mesh-ancestor
65142978|NCT01324323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65142979|NCT01324323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65142980|NCT01324323|Leprostatic Agents|leprostatic agents|mesh-ancestor
65142981|NCT01324323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65142982|NCT01324323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65142983|NCT01324323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65142984|NCT01324323|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65142985|NCT01324323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65142986|NCT01324323|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65142987|NCT01324323|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65142991|NCT01324323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143021|NCT01323621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65143022|NCT01323621|Autonomic Agents|autonomic agents|mesh-ancestor
65143023|NCT01323621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143024|NCT01323621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143025|NCT01323621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65143091|NCT01100437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65143092|NCT01100437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65143093|NCT01322490|Molgramostim|molgramostim|mesh-list
65143094|NCT01322490|Sargramostim|sargramostim|mesh-list
65143095|NCT01322490|Immunologic Factors|immunologic factors|mesh-ancestor
65143096|NCT01322490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143097|NCT01322490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143098|NCT01314261|Interferons|interferons|mesh-list
65143099|NCT01314261|Ribavirin|ribavirin|mesh-list
65143100|NCT01314261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143101|NCT01314261|Antiviral Agents|antiviral agents|mesh-ancestor
65143102|NCT01314261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65143103|NCT01314261|Antimetabolites|antimetabolites|mesh-ancestor
65143104|NCT01314261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143105|NCT02891616|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65143106|NCT02891616|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65143107|NCT02891616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143108|NCT01321710|Acetaminophen|acetaminophen|mesh-list
65143109|NCT01321710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65143110|NCT01321710|Analgesics|analgesics|mesh-ancestor
65143111|NCT01321710|Sensory System Agents|sensory system agents|mesh-ancestor
65143146|NCT01313637|Bromides|bromides|mesh-list
65143147|NCT01313637|Anticonvulsants|anticonvulsants|mesh-ancestor
65143148|NCT01320722|Vitamin D|vitamin d|mesh-list
65143149|NCT01320722|Ergocalciferols|ergocalciferols|mesh-list
65143150|NCT01320722|Cholecalciferol|cholecalciferol|mesh-list
65143151|NCT01320722|Vitamins|vitamins|mesh-list
65143152|NCT01320722|Allopurinol|allopurinol|mesh-list
65143153|NCT01320722|Probenecid|probenecid|mesh-list
65143154|NCT01320722|Micronutrients|micronutrients|mesh-ancestor
65143155|NCT01320722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143156|NCT01320722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65143157|NCT01320722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65143158|NCT01320722|Antimetabolites|antimetabolites|mesh-ancestor
65143160|NCT01320722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143213|NCT01318902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143214|NCT01318902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143215|NCT01318902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65143216|NCT01318902|Glucocorticoids|glucocorticoids|mesh-ancestor
65143217|NCT01318902|Hormones|hormones|mesh-ancestor
65143218|NCT01318902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65143219|NCT01318902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65143220|NCT01318902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143224|NCT01313858|Golimumab|golimumab|mesh-list
65143280|NCT01169038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65143281|NCT01169038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65143282|NCT01169038|Antitubercular Agents|antitubercular agents|mesh-ancestor
65143283|NCT01169038|Leprostatic Agents|leprostatic agents|mesh-ancestor
65143348|NCT01114516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65143349|NCT01114516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143350|NCT01114516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143351|NCT01114516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65143352|NCT01114516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65143353|NCT01114516|Analgesics|analgesics|mesh-ancestor
65143354|NCT01114516|Sensory System Agents|sensory system agents|mesh-ancestor
65143355|NCT01114516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143357|NCT01114516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65143414|NCT01078441|Antiemetics|antiemetics|mesh-ancestor
65143415|NCT01078441|Autonomic Agents|autonomic agents|mesh-ancestor
65143416|NCT01078441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143417|NCT01078441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65143418|NCT01078441|Glucocorticoids|glucocorticoids|mesh-ancestor
65143419|NCT01078441|Hormones|hormones|mesh-ancestor
65143485|NCT00626509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65143486|NCT00626509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143557|NCT01074307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65143558|NCT01074307|Sympatholytics|sympatholytics|mesh-ancestor
65143559|NCT01074307|Autonomic Agents|autonomic agents|mesh-ancestor
65143560|NCT01074307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143561|NCT01074307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143562|NCT01074307|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65143563|NCT01074307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65143564|NCT01074307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65143565|NCT01074307|Adrenergic Agents|adrenergic agents|mesh-ancestor
65143566|NCT01074307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65143567|NCT01074307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143620|NCT05320705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65143621|NCT05320705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65143622|NCT05320705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143623|NCT05320705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65143624|NCT05320705|Analgesics|analgesics|mesh-ancestor
65143625|NCT05320705|Sensory System Agents|sensory system agents|mesh-ancestor
64786128|NCT00001104|Antiviral Agents|antiviral agents|mesh-ancestor
65143626|NCT05320705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143627|NCT05320705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65143628|NCT05320705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65143629|NCT05320705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65143681|NCT01104376|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65143682|NCT01104376|Antifungal Agents|antifungal agents|mesh-ancestor
65143683|NCT01104376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65143684|NCT01104376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65143685|NCT01104376|Hormone Antagonists|hormone antagonists|mesh-ancestor
65143686|NCT01104376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65143687|NCT01104376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143688|NCT01104376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65143717|NCT01072201|Triclosan|triclosan|mesh-list
65143747|NCT04972396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65143748|NCT04972396|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65143749|NCT04972396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143750|NCT04972396|Anticoagulants|anticoagulants|mesh-ancestor
65143751|NCT04972396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65143752|NCT04972396|Contraceptive Agents|contraceptive agents|mesh-ancestor
65143753|NCT04972396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65143754|NCT04972396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65143755|NCT04972396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65143756|NCT04972396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65143757|NCT04972396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65143809|NCT02893553|Autonomic Agents|autonomic agents|mesh-ancestor
65143810|NCT02893553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65143811|NCT02893553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65143812|NCT02893553|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65143813|NCT02893553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65143814|NCT02893553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65143815|NCT02893553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143816|NCT02893553|Cholinergic Agents|cholinergic agents|mesh-ancestor
65143817|NCT01087489|Lidocaine|lidocaine|mesh-list
65143874|NCT01102426|Hormones|hormones|mesh-ancestor
65143875|NCT01102426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65143876|NCT01102426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65143877|NCT01102426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143878|NCT04308850|Vitamin D|vitamin d|mesh-list
65143879|NCT04308850|Vitamins|vitamins|mesh-ancestor
65143880|NCT04308850|Micronutrients|micronutrients|mesh-ancestor
65143881|NCT04308850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143882|NCT04308850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65143883|NCT01101334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65143884|NCT01101334|Efatutazone|efatutazone|mesh-list
65143885|NCT01101334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65143886|NCT01101334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65143936|NCT04325061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143937|NCT04325061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143938|NCT01307319|Beclomethasone|beclomethasone|mesh-list
65143939|NCT01307319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65143940|NCT01307319|Glucocorticoids|glucocorticoids|mesh-ancestor
65143941|NCT01307319|Hormones|hormones|mesh-ancestor
65143942|NCT01307319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65143943|NCT01307319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65143944|NCT01307319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65143945|NCT01307319|Respiratory System Agents|respiratory system agents|mesh-ancestor
65143946|NCT04365725|Remdesivir|remdesivir|mesh-list
65143947|NCT04365725|Antimetabolites|antimetabolites|mesh-ancestor
65143948|NCT04365725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65143951|NCT01080391|Dexamethasone|dexamethasone|mesh-list
65143995|NCT04327427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65143996|NCT04327427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65143997|NCT04327427|Antipyretics|antipyretics|mesh-ancestor
65143998|NCT02875717|Aspirin|aspirin|mesh-list
65143999|NCT02875717|Heparin|heparin|mesh-list
65144000|NCT02875717|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65144001|NCT02875717|Tinzaparin|tinzaparin|mesh-list
65144002|NCT02875717|Dalteparin|dalteparin|mesh-list
65144003|NCT02875717|Anticoagulants|anticoagulants|mesh-ancestor
65144004|NCT02875717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65144005|NCT02875717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65144006|NCT02875717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144007|NCT02875717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65144008|NCT02875717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65144009|NCT02875717|Analgesics|analgesics|mesh-ancestor
65144010|NCT02875717|Sensory System Agents|sensory system agents|mesh-ancestor
65144011|NCT02875717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65144012|NCT02875717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144013|NCT02875717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65144053|NCT00593879|Autonomic Agents|autonomic agents|mesh-ancestor
65144054|NCT00593879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65144055|NCT00593879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144056|NCT00593879|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65144057|NCT00593879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65144058|NCT00593879|Cholinergic Agents|cholinergic agents|mesh-ancestor
65144059|NCT00593879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65144060|NCT00593879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144061|NCT00594191|Simvastatin|simvastatin|mesh-list
65144062|NCT00594191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65144063|NCT00594191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65144064|NCT00594191|Antimetabolites|antimetabolites|mesh-ancestor
65144065|NCT00594191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144066|NCT00594191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65144067|NCT00594191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65144068|NCT00594191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144069|NCT00594269|Risperidone|risperidone|mesh-list
65144070|NCT00594269|Citalopram|citalopram|mesh-list
65144071|NCT00594269|Sertraline|sertraline|mesh-list
65144072|NCT00594269|Paroxetine|paroxetine|mesh-list
65144073|NCT00594269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65144074|NCT00594269|Serotonin Agents|serotonin agents|mesh-ancestor
65144075|NCT00594269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65144076|NCT00594269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144078|NCT00594269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65144079|NCT00594269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65144080|NCT00594269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65144081|NCT00594269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65144099|NCT04326959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65144100|NCT04326959|Glucocorticoids|glucocorticoids|mesh-ancestor
65144101|NCT04326959|Hormones|hormones|mesh-ancestor
65144102|NCT04326959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65144103|NCT04326959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144104|NCT04326959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65144105|NCT04326959|Immunologic Factors|immunologic factors|mesh-ancestor
65144106|NCT04326959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144107|NCT04326959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144108|NCT00594737|Memantine|memantine|mesh-list
65144109|NCT00594737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65144110|NCT00594737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65144111|NCT00594737|Dopamine Agents|dopamine agents|mesh-ancestor
65144112|NCT00594737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65144117|NCT00595049|Bosentan|bosentan|mesh-list
65144158|NCT00596375|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65144159|NCT00596375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65144160|NCT00596375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65144161|NCT00596375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144162|NCT00596531|Acamprosate|acamprosate|mesh-list
65144163|NCT00596531|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65144164|NCT00596609|Morphine|morphine|mesh-list
65144165|NCT00596609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65144166|NCT00596609|Narcotics|narcotics|mesh-ancestor
65144167|NCT00596609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65144168|NCT00596609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144169|NCT00596609|Analgesics|analgesics|mesh-ancestor
65144170|NCT00596609|Sensory System Agents|sensory system agents|mesh-ancestor
65144171|NCT00596609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65144172|NCT04326803|Vaccines|vaccines|mesh-list
65144175|NCT00597233|Insulin|insulin|mesh-list
65144219|NCT00597623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65144220|NCT00597623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65144221|NCT00597857|Hydrocortisone|hydrocortisone|mesh-list
65144222|NCT00597857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65144223|NCT00627133|Levetiracetam|levetiracetam|mesh-list
65144224|NCT00627133|Anticonvulsants|anticonvulsants|mesh-ancestor
65144225|NCT00627133|Nootropic Agents|nootropic agents|mesh-ancestor
65144226|NCT00598013|Pioglitazone|pioglitazone|mesh-list
65144227|NCT00598013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65144288|NCT00598169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144289|NCT00598169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65144290|NCT00598169|Alkylating Agents|alkylating agents|mesh-ancestor
65144291|NCT00598247|Paclitaxel|paclitaxel|mesh-list
65144292|NCT00598247|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
65144293|NCT00598247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65144294|NCT00598247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144295|NCT00598247|Tubulin Modulators|tubulin modulators|mesh-ancestor
65144296|NCT00598247|Antimitotic Agents|antimitotic agents|mesh-ancestor
65144297|NCT00598247|Mitosis Modulators|mitosis modulators|mesh-ancestor
65144298|NCT00598247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144299|NCT00598403|Ciprofloxacin|ciprofloxacin|mesh-list
65144350|NCT01062763|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65144351|NCT01062763|Diuretics|diuretics|mesh-ancestor
65144352|NCT01062763|Natriuretic Agents|natriuretic agents|mesh-ancestor
65144353|NCT00599417|Broncho-Vaxom|broncho-vaxom|mesh-list
65144354|NCT00599417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65144355|NCT00599417|Immunologic Factors|immunologic factors|mesh-ancestor
65144356|NCT00599417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144357|NCT00599573|Ondansetron|ondansetron|mesh-list
65144358|NCT00599573|Antiemetics|antiemetics|mesh-ancestor
65144359|NCT00599573|Autonomic Agents|autonomic agents|mesh-ancestor
65144360|NCT00599573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65144361|NCT00599573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144362|NCT00599573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65144363|NCT00599573|Antipruritics|antipruritics|mesh-ancestor
65144364|NCT00599573|Dermatologic Agents|dermatologic agents|mesh-ancestor
65144365|NCT00599573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65144366|NCT00599573|Serotonin Agents|serotonin agents|mesh-ancestor
65144367|NCT00599573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65144368|NCT00599573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144369|NCT00599573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65144370|NCT00599573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65144371|NCT00599573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64786882|NCT00002370|Itraconazole|itraconazole|mesh-list
65144372|NCT00599573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65144373|NCT00599573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65144401|NCT01303965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144402|NCT01303965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65144403|NCT01303965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65144404|NCT01303965|Growth Substances|growth substances|mesh-ancestor
65144405|NCT01303965|Growth Inhibitors|growth inhibitors|mesh-ancestor
65144406|NCT01303965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144407|NCT01303965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65144408|NCT01303965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65144411|NCT00600041|Pantoprazole|pantoprazole|mesh-list
65144468|NCT00600977|Doxorubicin|doxorubicin|mesh-list
65144469|NCT00600977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65144470|NCT00600977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65144471|NCT00600977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144472|NCT00600977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65144473|NCT00600977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65144474|NCT00600977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144475|NCT00600977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144476|NCT04695847|Antibodies|antibodies|mesh-list
65144477|NCT04695847|Immunoglobulins|immunoglobulins|mesh-list
65144478|NCT04695847|Immunoconjugates|immunoconjugates|mesh-list
65144479|NCT04695847|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65144480|NCT04695847|Immunologic Factors|immunologic factors|mesh-ancestor
65144481|NCT04695847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144482|NCT00601211|Pilocarpine|pilocarpine|mesh-list
65144483|NCT00601211|Miotics|miotics|mesh-ancestor
65144484|NCT00601211|Autonomic Agents|autonomic agents|mesh-ancestor
65144485|NCT00601211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714036|NCT02969876|Antidepressive Agents|antidepressive agents|mesh-ancestor
65144525|NCT04325633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144527|NCT05643651|Vitamin K|vitamin k|mesh-list
65144528|NCT05643651|Warfarin|warfarin|mesh-list
65144529|NCT05643651|Rivaroxaban|rivaroxaban|mesh-list
65144530|NCT05643651|Clopidogrel|clopidogrel|mesh-list
65144531|NCT05643651|Vitamins|vitamins|mesh-ancestor
65144532|NCT05643651|Micronutrients|micronutrients|mesh-ancestor
65144533|NCT05643651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144534|NCT05643651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65144535|NCT05643651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65144536|NCT05643651|Analgesics|analgesics|mesh-ancestor
65144537|NCT05643651|Sensory System Agents|sensory system agents|mesh-ancestor
65144538|NCT05643651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65144539|NCT05643651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65144540|NCT05643651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65144541|NCT05643651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65144585|NCT00626977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65144586|NCT00626977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144587|NCT00626977|Sensory System Agents|sensory system agents|mesh-ancestor
65144588|NCT00626977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65144589|NCT00626977|Analgesics|analgesics|mesh-ancestor
65144590|NCT00626977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65144591|NCT00626977|Sympatholytics|sympatholytics|mesh-ancestor
65144592|NCT00626977|Autonomic Agents|autonomic agents|mesh-ancestor
65144593|NCT00626977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65144650|NCT01301001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144651|NCT01301001|Antimanic Agents|antimanic agents|mesh-ancestor
65144652|NCT01035463|Cytarabine|cytarabine|mesh-list
65144653|NCT01035463|Rituximab|rituximab|mesh-list
65144654|NCT01035463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65144655|NCT01035463|Etoposide|etoposide|mesh-list
65144656|NCT01035463|Lenalidomide|lenalidomide|mesh-list
65144657|NCT01035463|Etoposide phosphate|etoposide phosphate|mesh-list
65144658|NCT01035463|Melphalan|melphalan|mesh-list
65144659|NCT01035463|Mechlorethamine|mechlorethamine|mesh-list
65144660|NCT01035463|Carmustine|carmustine|mesh-list
65144661|NCT01035463|Podophyllotoxin|podophyllotoxin|mesh-list
65144662|NCT01035463|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65144663|NCT01035463|Antibodies|antibodies|mesh-list
65144664|NCT01035463|Immunoglobulins|immunoglobulins|mesh-list
65144665|NCT01035463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65144666|NCT01035463|Immunologic Factors|immunologic factors|mesh-ancestor
65144667|NCT01035463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144711|NCT01300455|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65144712|NCT01300455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65144713|NCT01300455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144714|NCT01101178|Oxycodone|oxycodone|mesh-list
65144715|NCT01101178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65144716|NCT01101178|Narcotics|narcotics|mesh-ancestor
65144717|NCT01101178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65144718|NCT01101178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144719|NCT01101178|Analgesics|analgesics|mesh-ancestor
65144720|NCT01101178|Sensory System Agents|sensory system agents|mesh-ancestor
65144721|NCT01101178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65144722|NCT05637645|Bupivacaine|bupivacaine|mesh-list
65144723|NCT05637645|Anesthetics, Local|anesthetics, local|mesh-ancestor
65144724|NCT05637645|Anesthetics|anesthetics|mesh-ancestor
65144725|NCT05637645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65144726|NCT05637645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144727|NCT05637645|Sensory System Agents|sensory system agents|mesh-ancestor
65144728|NCT05637645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65144729|NCT01101022|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65144730|NCT01101022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65144748|NCT01100944|Belinostat|belinostat|mesh-list
65144763|NCT01100320|Oxycodone|oxycodone|mesh-list
65144764|NCT01100320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65144765|NCT01100320|Narcotics|narcotics|mesh-ancestor
65144766|NCT01100320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65144767|NCT01100320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144768|NCT01100320|Analgesics|analgesics|mesh-ancestor
65144769|NCT01100320|Sensory System Agents|sensory system agents|mesh-ancestor
65144770|NCT01100320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65144771|NCT04309708|Nimodipine|nimodipine|mesh-list
65144779|NCT01100086|Oxycodone|oxycodone|mesh-list
65144830|NCT04307290|Sensory System Agents|sensory system agents|mesh-ancestor
65144831|NCT04307290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65144832|NCT04307290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65144833|NCT04307290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65144834|NCT04307290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65144835|NCT04307290|Adrenergic Agents|adrenergic agents|mesh-ancestor
65144836|NCT04307290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65144838|NCT01325207|Trastuzumab|trastuzumab|mesh-list
65144900|NCT01320683|Immunoglobulins|immunoglobulins|mesh-list
65144901|NCT01320683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65144902|NCT01320683|Levoleucovorin|levoleucovorin|mesh-list
65144903|NCT01320683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144904|NCT01320683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65144905|NCT01320683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65144906|NCT01320683|Growth Substances|growth substances|mesh-ancestor
65144907|NCT01320683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65144908|NCT01320683|Growth Inhibitors|growth inhibitors|mesh-ancestor
65144909|NCT01320683|Immunologic Factors|immunologic factors|mesh-ancestor
65144910|NCT01320683|Antimetabolites|antimetabolites|mesh-ancestor
65144911|NCT01320683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144912|NCT01320683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65144913|NCT01320683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65144914|NCT01320683|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65144960|NCT01093222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65144961|NCT01093222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65144962|NCT01093222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65144963|NCT01093222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65144964|NCT02878018|Hormones|hormones|mesh-list
65144965|NCT02878018|Adrenergic Agents|adrenergic agents|mesh-list
65144966|NCT02878018|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65144967|NCT02878018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65145025|NCT01091974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65145026|NCT01091974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145027|NCT01313117|Thioctic Acid|thioctic acid|mesh-list
65145028|NCT01313117|Antioxidants|antioxidants|mesh-ancestor
65145029|NCT01313117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145030|NCT01313117|Protective Agents|protective agents|mesh-ancestor
65145031|NCT01313117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145032|NCT01313117|Vitamin B Complex|vitamin b complex|mesh-ancestor
65145091|NCT01310777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145092|NCT01310777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145093|NCT01310777|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65145094|NCT01310777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145095|NCT01309997|Rituximab|rituximab|mesh-list
65145096|NCT01309997|Imatinib Mesylate|imatinib mesylate|mesh-list
65145097|NCT01309997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65145098|NCT01309997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65145099|NCT01309997|Immunologic Factors|immunologic factors|mesh-ancestor
65145100|NCT01309997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145101|NCT01309997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65145102|NCT01309997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65145103|NCT01309997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145105|NCT01309841|Naloxegol|naloxegol|mesh-list
65145150|NCT01307579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145151|NCT01307579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65145152|NCT01307579|Hormone Antagonists|hormone antagonists|mesh-ancestor
65145153|NCT01307579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65145154|NCT01307579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145215|NCT01056289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65145216|NCT02875093|Cytarabine|cytarabine|mesh-list
65145217|NCT02875093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65145218|NCT02875093|Antimetabolites|antimetabolites|mesh-ancestor
65145219|NCT02875093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145220|NCT02875093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65145221|NCT02875093|Antiviral Agents|antiviral agents|mesh-ancestor
65145222|NCT02875093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65145223|NCT02875093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65145224|NCT02875093|Immunologic Factors|immunologic factors|mesh-ancestor
65145225|NCT02875093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145279|NCT01096186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145280|NCT01096186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65145281|NCT01096186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65145282|NCT01096186|Dopamine Agonists|dopamine agonists|mesh-ancestor
65145283|NCT01096186|Dopamine Agents|dopamine agents|mesh-ancestor
65145284|NCT01096186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65145285|NCT01096186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145286|NCT01096186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65145287|NCT01096186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145288|NCT01032889|Deoxycholic Acid|deoxycholic acid|mesh-list
65145289|NCT01032889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65145290|NCT01032889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65145291|NCT01049503|Fluorides|fluorides|mesh-list
65145292|NCT01049503|Cariostatic Agents|cariostatic agents|mesh-ancestor
65145342|NCT01023217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65145343|NCT01023217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65145344|NCT01023217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145345|NCT01023217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145346|NCT01023217|Antiviral Agents|antiviral agents|mesh-ancestor
65145347|NCT01023217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65145348|NCT01023217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65145349|NCT01023217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65145350|NCT01095796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65145351|NCT01095796|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65145360|NCT01023061|Prednisone|prednisone|mesh-list
65145402|NCT01294683|Micronutrients|micronutrients|mesh-ancestor
65145403|NCT01294683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145404|NCT01294449|Cytarabine|cytarabine|mesh-list
65145405|NCT01294449|Dexamethasone|dexamethasone|mesh-list
65145471|NCT01291173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145472|NCT01291173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65145473|NCT01291173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65145474|NCT01291173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65145475|NCT01291173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145476|NCT01291173|Dopamine Agents|dopamine agents|mesh-ancestor
65145477|NCT01291173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65145478|NCT01291017|Palbociclib|palbociclib|mesh-list
65145479|NCT01291017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65145480|NCT01291017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65145481|NCT01291017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145482|NCT01291017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145483|NCT01290315|Dextrans|dextrans|mesh-list
65145484|NCT01290315|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65145485|NCT01290315|Iron-Dextran Complex|iron-dextran complex|mesh-list
65145486|NCT01290315|Hematinics|hematinics|mesh-ancestor
65145528|NCT01020799|Antidepressive Agents|antidepressive agents|mesh-ancestor
65145529|NCT01020799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65145530|NCT02872597|Dexamethasone|dexamethasone|mesh-list
65145531|NCT02872597|Prednisone|prednisone|mesh-list
65145532|NCT02872597|Methylprednisolone|methylprednisolone|mesh-list
65145533|NCT02872597|Prednisolone|prednisolone|mesh-list
65145534|NCT02872597|Albuterol|albuterol|mesh-list
65145535|NCT02872597|Ipratropium|ipratropium|mesh-list
65145536|NCT02872597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65145537|NCT02872597|Antiemetics|antiemetics|mesh-ancestor
65145538|NCT02872597|Autonomic Agents|autonomic agents|mesh-ancestor
65145539|NCT02872597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65145540|NCT02872597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145541|NCT02872597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65145542|NCT02872597|Glucocorticoids|glucocorticoids|mesh-ancestor
65145543|NCT02872597|Hormones|hormones|mesh-ancestor
65145544|NCT02872597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65145590|NCT00628225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145591|NCT00628225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65145592|NCT00628225|Antidepressive Agents|antidepressive agents|mesh-ancestor
65145593|NCT00628225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65145594|NCT00628225|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65145595|NCT00628225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65145596|NCT00628225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65145597|NCT00628225|Dopamine Agents|dopamine agents|mesh-ancestor
65145600|NCT00628225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65145654|NCT01019317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65145655|NCT02877238|Sevoflurane|sevoflurane|mesh-list
65145656|NCT02877238|Anesthetics|anesthetics|mesh-ancestor
65145657|NCT02877238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65145658|NCT02877238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145659|NCT02877238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65145660|NCT02877238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65145661|NCT02877238|Anesthetics, General|anesthetics, general|mesh-ancestor
65145662|NCT01288911|Bicalutamide|bicalutamide|mesh-list
65145663|NCT01288911|Androgen Antagonists|androgen antagonists|mesh-ancestor
65145664|NCT01288911|Hormone Antagonists|hormone antagonists|mesh-ancestor
65145665|NCT01288911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65145666|NCT01288911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145667|NCT01288911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65145716|NCT01285401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145717|NCT01285401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65145718|NCT01285323|Reslizumab|reslizumab|mesh-list
65145719|NCT01285323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65145720|NCT01285323|Respiratory System Agents|respiratory system agents|mesh-ancestor
65145721|NCT01284621|Empagliflozin|empagliflozin|mesh-list
65145722|NCT01284621|Ramipril|ramipril|mesh-list
65145723|NCT01284621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65145724|NCT01284621|Protease Inhibitors|protease inhibitors|mesh-ancestor
65145784|NCT04306666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145785|NCT01280955|Plerixafor|plerixafor|mesh-list
65145786|NCT01280955|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65145787|NCT01280955|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65145788|NCT01280955|Antiviral Agents|antiviral agents|mesh-ancestor
65145789|NCT01280955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65145790|NCT01280721|Tolvaptan|tolvaptan|mesh-list
65145791|NCT01280721|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65145792|NCT01280721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145793|NCT01280721|Natriuretic Agents|natriuretic agents|mesh-ancestor
65145794|NCT01280721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145849|NCT01277523|Autonomic Agents|autonomic agents|mesh-ancestor
65145850|NCT01277523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65145851|NCT01277523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145852|NCT01277523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65145853|NCT01277523|Respiratory System Agents|respiratory system agents|mesh-ancestor
65145854|NCT01277523|Parasympatholytics|parasympatholytics|mesh-ancestor
65145855|NCT01277523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65145856|NCT01277523|Cholinergic Agents|cholinergic agents|mesh-ancestor
65145857|NCT01277523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65145858|NCT01277523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145859|NCT01081834|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65145860|NCT01081834|Canagliflozin|canagliflozin|mesh-list
65145861|NCT01081834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65145910|NCT01313676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65145911|NCT01313676|Respiratory System Agents|respiratory system agents|mesh-ancestor
65145912|NCT01313676|Dermatologic Agents|dermatologic agents|mesh-ancestor
65145913|NCT01313676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65145914|NCT00623376|Dronabinol|dronabinol|mesh-list
65145915|NCT00623376|Nabilone|nabilone|mesh-list
65145916|NCT00623376|Antiemetics|antiemetics|mesh-ancestor
65145917|NCT00623376|Autonomic Agents|autonomic agents|mesh-ancestor
65145918|NCT00623376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65145919|NCT00623376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145975|NCT04527991|Antimitotic Agents|antimitotic agents|mesh-ancestor
65145976|NCT04527991|Mitosis Modulators|mitosis modulators|mesh-ancestor
65145977|NCT04527991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65145978|NCT01012999|Sufentanil|sufentanil|mesh-list
65145979|NCT01012999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65145980|NCT01012999|Narcotics|narcotics|mesh-ancestor
65145981|NCT01012999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65145982|NCT01012999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65145983|NCT01012999|Analgesics|analgesics|mesh-ancestor
64788579|NCT00002802|Cobalt|cobalt|mesh-list
65146041|NCT01012765|Cholinergic Agents|cholinergic agents|mesh-ancestor
65146042|NCT01012765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65146043|NCT01012765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146045|NCT00628459|Trace Elements|trace elements|mesh-list
65146046|NCT00628459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146047|NCT00627913|Anesthetics|anesthetics|mesh-list
65146048|NCT00627913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65146049|NCT00627913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146050|NCT00627991|Valsartan|valsartan|mesh-list
65146051|NCT00627991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65146058|NCT01006291|Insulin|insulin|mesh-list
65146105|NCT04297501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65146106|NCT01012219|Aspirin|aspirin|mesh-list
65146108|NCT01012219|Clopidogrel|clopidogrel|mesh-list
65146109|NCT01012219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65146110|NCT01012219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65146111|NCT01012219|Analgesics|analgesics|mesh-ancestor
65146112|NCT01012219|Sensory System Agents|sensory system agents|mesh-ancestor
65146113|NCT01012219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65146114|NCT01012219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146115|NCT01012219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65146116|NCT01012219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65146117|NCT01012219|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65146118|NCT01012219|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65146119|NCT01012219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146169|NCT04406857|Ropidoxuridine|ropidoxuridine|mesh-list
65146170|NCT04406857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65146171|NCT04406857|Antimetabolites|antimetabolites|mesh-ancestor
65146172|NCT04406857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146173|NCT04406857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146174|NCT01311024|Vaccines|vaccines|mesh-list
65146175|NCT01311024|Immunologic Factors|immunologic factors|mesh-ancestor
65146176|NCT01311024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788705|NCT00002892|Interferons|interferons|mesh-list
65146177|NCT02871193|Dexamethasone|dexamethasone|mesh-list
65146178|NCT02871193|Ropivacaine|ropivacaine|mesh-list
65146179|NCT02871193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65146180|NCT02871193|Antiemetics|antiemetics|mesh-ancestor
65146181|NCT02871193|Autonomic Agents|autonomic agents|mesh-ancestor
65146182|NCT02871193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65146186|NCT02871193|Hormones|hormones|mesh-ancestor
65146228|NCT02889549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65146229|NCT02889549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65146230|NCT02889549|Purinergic Agents|purinergic agents|mesh-ancestor
65146231|NCT02889549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65146232|NCT02889549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146233|NCT02889549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146234|NCT01309386|Morphine|morphine|mesh-list
65146235|NCT01309386|Tapentadol|tapentadol|mesh-list
65146236|NCT01309386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65146237|NCT01309386|Narcotics|narcotics|mesh-ancestor
65146238|NCT01309386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65146239|NCT01309386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146240|NCT01309386|Analgesics|analgesics|mesh-ancestor
65146241|NCT01309386|Sensory System Agents|sensory system agents|mesh-ancestor
65146289|NCT01266291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146290|NCT01004263|Rizatriptan|rizatriptan|mesh-list
65146291|NCT01004263|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65146292|NCT01004263|Serotonin Agents|serotonin agents|mesh-ancestor
65146293|NCT01004263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65146294|NCT01004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146295|NCT01004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146296|NCT01265823|Adalimumab|adalimumab|mesh-list
65146297|NCT01265823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65146298|NCT01265823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65146299|NCT01004185|Aminosalicylic Acid|aminosalicylic acid|mesh-list
65146355|NCT01263483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65146356|NCT01263483|Protease Inhibitors|protease inhibitors|mesh-ancestor
65146357|NCT01263483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146358|NCT01263483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146359|NCT01263483|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65146360|NCT01263483|Vitamin B Complex|vitamin b complex|mesh-ancestor
65146361|NCT01263483|Vitamins|vitamins|mesh-ancestor
65146362|NCT01263483|Micronutrients|micronutrients|mesh-ancestor
65146363|NCT01011049|Vaccines|vaccines|mesh-list
65146364|NCT01011049|Immunologic Factors|immunologic factors|mesh-ancestor
65146365|NCT01011049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146366|NCT01263093|Clopidogrel|clopidogrel|mesh-list
65146367|NCT01263093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64714052|NCT02970032|Heparin|heparin|mesh-list
65146368|NCT01263093|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65146416|NCT01003639|Narcotics|narcotics|mesh-ancestor
65146417|NCT01003639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65146418|NCT01003639|Antitussive Agents|antitussive agents|mesh-ancestor
65146419|NCT01003639|Respiratory System Agents|respiratory system agents|mesh-ancestor
65146420|NCT01003249|Baclofen|baclofen|mesh-list
65146421|NCT01003249|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65146422|NCT01003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146423|NCT01003249|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65146424|NCT01003249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65146425|NCT01003249|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65146426|NCT01003249|GABA Agonists|gaba agonists|mesh-ancestor
65146427|NCT01003249|GABA Agents|gaba agents|mesh-ancestor
65146428|NCT01003249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65146429|NCT01003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146430|NCT04297033|Lovastatin|lovastatin|mesh-list
65146431|NCT04297033|L 647318|l 647318|mesh-list
65146432|NCT04297033|Dihydromevinolin|dihydromevinolin|mesh-list
65146433|NCT04297033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65146434|NCT04297033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65146447|NCT01306032|Veliparib|veliparib|mesh-list
65146471|NCT01263015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65146472|NCT01263015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65146473|NCT01263015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65146474|NCT01263015|Antimetabolites|antimetabolites|mesh-ancestor
65146475|NCT04322955|Nivolumab|nivolumab|mesh-list
65146476|NCT04322955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65146477|NCT04322955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146478|NCT04322955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65146479|NCT04322955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146480|NCT04322175|Meloxicam|meloxicam|mesh-list
65146481|NCT04322175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65146482|NCT04322175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65146483|NCT04322175|Analgesics|analgesics|mesh-ancestor
65146484|NCT04322175|Sensory System Agents|sensory system agents|mesh-ancestor
65146485|NCT04322175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65146486|NCT04322175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146487|NCT04322175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65146488|NCT04322175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65146491|NCT04322175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146523|NCT05576415|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65146524|NCT05576415|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65146525|NCT05576415|Cholinergic Agents|cholinergic agents|mesh-ancestor
65146526|NCT05576415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65146527|NCT05576415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146528|NCT05576415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146529|NCT00624039|Pilocarpine|pilocarpine|mesh-list
65146531|NCT00624039|Autonomic Agents|autonomic agents|mesh-ancestor
65146532|NCT00624039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65146533|NCT00624039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146534|NCT00624039|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65146535|NCT00624039|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65146536|NCT00624039|Cholinergic Agents|cholinergic agents|mesh-ancestor
65146537|NCT00624039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65146538|NCT00624039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146585|NCT05226663|Protective Agents|protective agents|mesh-ancestor
65146586|NCT05226663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146587|NCT05141877|Anesthetics|anesthetics|mesh-list
65146588|NCT05141877|Propofol|propofol|mesh-list
65146589|NCT05141877|Sevoflurane|sevoflurane|mesh-list
65146590|NCT05141877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65146591|NCT05141877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146592|NCT05141877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65146593|NCT05141877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65146594|NCT05141877|Anesthetics, General|anesthetics, general|mesh-ancestor
65146655|NCT04439799|Testosterone enanthate|testosterone enanthate|mesh-list
65146656|NCT04439799|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65146657|NCT04439799|Androgens|androgens|mesh-ancestor
65146658|NCT04439799|Hormones|hormones|mesh-ancestor
65146659|NCT04439799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65146660|NCT04439799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146661|NCT04439799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65146662|NCT04439799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146663|NCT04439799|Anabolic Agents|anabolic agents|mesh-ancestor
65146664|NCT04021017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65146665|NCT04021017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65146666|NCT04021017|Estradiol|estradiol|mesh-list
65146667|NCT04021017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65146668|NCT04021017|Estrogens|estrogens|mesh-ancestor
65146669|NCT04021017|Hormones|hormones|mesh-ancestor
65146670|NCT04021017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65146671|NCT04021017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146672|NCT04021017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65146673|NCT04021017|Contraceptive Agents|contraceptive agents|mesh-ancestor
65146674|NCT04021017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65146675|NCT04021017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65146676|NCT03916185|Vaccines|vaccines|mesh-list
65146677|NCT03916185|Immunologic Factors|immunologic factors|mesh-ancestor
65146678|NCT03916185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146679|NCT03764553|Leucovorin|leucovorin|mesh-list
65146680|NCT03764553|Carboplatin|carboplatin|mesh-list
65146706|NCT04320225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65146707|NCT04320225|Glucocorticoids|glucocorticoids|mesh-ancestor
65146708|NCT04320225|Hormones|hormones|mesh-ancestor
65146709|NCT04320225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65146710|NCT04320225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65146711|NCT04320225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146712|NCT03221751|Prazosin|prazosin|mesh-list
65146713|NCT03221751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65146715|NCT03221751|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65146772|NCT02890602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65146773|NCT02890602|Immunologic Factors|immunologic factors|mesh-ancestor
65146774|NCT02890602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146775|NCT02890602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65146776|NCT02890602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65146777|NCT02890602|Alkylating Agents|alkylating agents|mesh-ancestor
65146778|NCT02890602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146779|NCT02890602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146780|NCT02890602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65146781|NCT02890602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65146835|NCT01300572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146836|NCT01300572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65146837|NCT01300572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146838|NCT01300572|Antifungal Agents|antifungal agents|mesh-ancestor
65146839|NCT01300572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65146840|NCT01300572|Dermatologic Agents|dermatologic agents|mesh-ancestor
65146841|NCT01300572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65146842|NCT01300572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65146843|NCT01300572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65146844|NCT01300572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65146845|NCT01300572|Antitubercular Agents|antitubercular agents|mesh-ancestor
65146846|NCT01300572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65146847|NCT01077154|Denosumab|denosumab|mesh-list
65146848|NCT01077154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65146849|NCT01077154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146850|NCT01258101|Ribavirin|ribavirin|mesh-list
65146851|NCT01258101|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65146852|NCT01258101|Interferon-alpha|interferon-alpha|mesh-list
65146853|NCT01258101|Antimetabolites|antimetabolites|mesh-ancestor
65146854|NCT01258101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146855|NCT01258101|Antiviral Agents|antiviral agents|mesh-ancestor
65146856|NCT01258101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65146888|NCT01256385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65146889|NCT01256385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65146890|NCT01256385|Antifungal Agents|antifungal agents|mesh-ancestor
65146891|NCT01256385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65146892|NCT00637182|Anastrozole|anastrozole|mesh-list
65146893|NCT00637182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65146894|NCT00637182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146895|NCT00637182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65146896|NCT00637182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65146897|NCT00637182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146898|NCT00637182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146899|NCT00637182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65146900|NCT00637182|Hormone Antagonists|hormone antagonists|mesh-ancestor
65146901|NCT00637182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65146902|NCT00637182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146903|NCT01298778|Acetaminophen|acetaminophen|mesh-list
65146904|NCT01298778|Morphine|morphine|mesh-list
65146945|NCT01297062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65146946|NCT01297062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65146947|NCT01297062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65146948|NCT01297062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65146949|NCT01297062|Incretins|incretins|mesh-ancestor
65146950|NCT01297062|Hormones|hormones|mesh-ancestor
65146951|NCT01297062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65146953|NCT01296672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65146954|NCT01296672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65146955|NCT01296672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65146956|NCT01296672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65146957|NCT01296672|Hormone Antagonists|hormone antagonists|mesh-ancestor
65146958|NCT01296672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65146959|NCT01296672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147007|NCT01295034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147008|NCT01295034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65147009|NCT01295034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65147010|NCT01253421|Amisulpride|amisulpride|mesh-list
65147011|NCT01253421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65147012|NCT01253421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65147013|NCT01253421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65147014|NCT01253421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147015|NCT01253421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65147016|NCT01253421|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65147017|NCT01253421|Dopamine Agents|dopamine agents|mesh-ancestor
65147018|NCT01253421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65147019|NCT01253421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147020|NCT01253421|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65147021|NCT01253421|Antidepressive Agents|antidepressive agents|mesh-ancestor
65147022|NCT01077076|Omeprazole|omeprazole|mesh-list
65147023|NCT01077076|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
65147024|NCT01077076|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65147025|NCT01077076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65147026|NCT01077076|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65147058|NCT01253187|Diuretics|diuretics|mesh-ancestor
65147059|NCT01253187|Natriuretic Agents|natriuretic agents|mesh-ancestor
65147060|NCT01253187|Vitamin B Complex|vitamin b complex|mesh-ancestor
65147061|NCT01253187|Vitamins|vitamins|mesh-ancestor
65147062|NCT01253187|Micronutrients|micronutrients|mesh-ancestor
65147063|NCT01252953|Oxazolidinones|oxazolidinones|mesh-list
65147064|NCT01252953|Anacetrapib|anacetrapib|mesh-list
65147065|NCT01252953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65147066|NCT01252953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65147067|NCT01252953|Antimetabolites|antimetabolites|mesh-ancestor
65147125|NCT00624273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147126|NCT00624273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147127|NCT00624273|Urological Agents|urological agents|mesh-ancestor
65147128|NCT04305964|Silicon|silicon|mesh-list
65147129|NCT04305964|Trace Elements|trace elements|mesh-ancestor
65147130|NCT04305964|Micronutrients|micronutrients|mesh-ancestor
65147131|NCT04305964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147132|NCT04306042|Pembrolizumab|pembrolizumab|mesh-list
65147133|NCT04306042|Nivolumab|nivolumab|mesh-list
65147134|NCT04306042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65147135|NCT04306042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147136|NCT04306042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65147137|NCT04306042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147138|NCT01074502|Apremilast|apremilast|mesh-list
65147139|NCT01074502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65147140|NCT01074502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65147184|NCT01074190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65147185|NCT01074190|Narcotics|narcotics|mesh-ancestor
65147186|NCT01074190|Analgesics|analgesics|mesh-ancestor
65147187|NCT01074190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65147188|NCT01074190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65147189|NCT01074190|Anesthetics, General|anesthetics, general|mesh-ancestor
65147190|NCT01073566|Insulin|insulin|mesh-list
65147191|NCT01073566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65147192|NCT01073566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65147193|NCT01073566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147194|NCT01072396|Tiotropium Bromide|tiotropium bromide|mesh-list
65147195|NCT01072396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65147196|NCT01072396|Autonomic Agents|autonomic agents|mesh-ancestor
65147197|NCT01072396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65147198|NCT01072396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147199|NCT01072396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65147244|NCT04305028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65147245|NCT04305028|Analgesics|analgesics|mesh-ancestor
65147246|NCT04305028|Sensory System Agents|sensory system agents|mesh-ancestor
65147247|NCT04305028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65147248|NCT04305028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147249|NCT04305028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65147250|NCT04305028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65147251|NCT04305028|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65147252|NCT04305028|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65147253|NCT04305028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147254|NCT04305028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65147255|NCT04305028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65147256|NCT04305028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147257|NCT04305028|Antipyretics|antipyretics|mesh-ancestor
65147258|NCT04305028|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65147259|NCT04305028|Antithrombins|antithrombins|mesh-ancestor
65147303|NCT01250379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65147304|NCT01250379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147305|NCT01250379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65147306|NCT01250379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65147307|NCT01250379|Growth Substances|growth substances|mesh-ancestor
65147308|NCT01250379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147309|NCT01250379|Growth Inhibitors|growth inhibitors|mesh-ancestor
65147368|NCT04640896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65147369|NCT04640896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65147370|NCT04640896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65147371|NCT04640896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147372|NCT01273818|Gentamicins|gentamicins|mesh-list
65147373|NCT01273818|Cefazolin|cefazolin|mesh-list
65147374|NCT01273818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65147375|NCT01273818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65147376|NCT01273818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65147377|NCT01273818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147378|NCT01273818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147379|NCT01037218|Udenafil|udenafil|mesh-list
65147380|NCT01037218|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65147387|NCT01038856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147428|NCT01036594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65147429|NCT01036594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65147430|NCT01036594|Hormone Antagonists|hormone antagonists|mesh-ancestor
65147431|NCT01036594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65147432|NCT04301908|Interferons|interferons|mesh-list
65147433|NCT04301908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147434|NCT04301908|Antiviral Agents|antiviral agents|mesh-ancestor
65147435|NCT04301908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65147436|NCT04304248|Paclitaxel|paclitaxel|mesh-list
65147437|NCT04304248|Carboplatin|carboplatin|mesh-list
65147438|NCT04304248|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65147440|NCT04304248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147491|NCT02889432|Protective Agents|protective agents|mesh-ancestor
65147492|NCT02889432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147493|NCT02889432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65147494|NCT01033942|Tenofovir|tenofovir|mesh-list
65147495|NCT01033942|Emtricitabine|emtricitabine|mesh-list
65147496|NCT01033942|Antiviral Agents|antiviral agents|mesh-ancestor
65147497|NCT01033942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65147498|NCT01033942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65147499|NCT01033942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65147500|NCT01033942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147501|NCT01033942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147554|NCT01032382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147555|NCT01032382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65147556|NCT01032382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65147557|NCT01029652|Triamcinolone|triamcinolone|mesh-list
65147558|NCT01029652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65147559|NCT01029652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65147560|NCT01029652|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65147561|NCT01029652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65147622|NCT01028014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147623|NCT01028014|Urological Agents|urological agents|mesh-ancestor
65147624|NCT01028014|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65147625|NCT01028014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65147626|NCT01028014|Cholinergic Agents|cholinergic agents|mesh-ancestor
65147627|NCT01028014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65147628|NCT01028014|Autonomic Agents|autonomic agents|mesh-ancestor
65147629|NCT01028014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65147630|NCT01028014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65147631|NCT01028014|Respiratory System Agents|respiratory system agents|mesh-ancestor
65147632|NCT01028014|Nasal Decongestants|nasal decongestants|mesh-ancestor
65147633|NCT01028014|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65147634|NCT01028014|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65147635|NCT01028014|Sympathomimetics|sympathomimetics|mesh-ancestor
65147636|NCT01028014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65147637|NCT01028014|Antidepressive Agents|antidepressive agents|mesh-ancestor
65147638|NCT01028014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65147639|NCT01028014|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65147640|NCT01028014|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65147676|NCT01237899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65147677|NCT01237899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147678|NCT01237899|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65147679|NCT01237899|Diuretics|diuretics|mesh-ancestor
65147680|NCT01237899|Natriuretic Agents|natriuretic agents|mesh-ancestor
65147682|NCT01263444|Timolol|timolol|mesh-list
65147683|NCT01263444|Bimatoprost|bimatoprost|mesh-list
65147684|NCT01263444|Travoprost|travoprost|mesh-list
65147685|NCT01263444|Latanoprost|latanoprost|mesh-list
65147686|NCT01263444|Brinzolamide|brinzolamide|mesh-list
65147687|NCT01263444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65147688|NCT01263444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65147689|NCT01263444|Adrenergic Agents|adrenergic agents|mesh-ancestor
65147690|NCT01263444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65147693|NCT01263444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65147738|NCT01030900|Alemtuzumab|alemtuzumab|mesh-list
65147739|NCT01030900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65147740|NCT01030900|Immunologic Factors|immunologic factors|mesh-ancestor
65147741|NCT01030900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147742|NCT01030900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65147743|NCT01030900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65147744|NCT01030900|Alkylating Agents|alkylating agents|mesh-ancestor
65147745|NCT01030900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147805|NCT01026142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65147806|NCT01026142|Antimetabolites|antimetabolites|mesh-ancestor
65147807|NCT01026142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147808|NCT01026142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65147809|NCT01026142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65147810|NCT01030666|Chlorhexidine|chlorhexidine|mesh-list
65147811|NCT01030666|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65147812|NCT01030666|Doxycycline|doxycycline|mesh-list
65147813|NCT01030666|Ibuprofen|ibuprofen|mesh-list
65147814|NCT01030666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65147815|NCT01030666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65147816|NCT01030666|Analgesics|analgesics|mesh-ancestor
65147817|NCT01030666|Sensory System Agents|sensory system agents|mesh-ancestor
65147818|NCT01030666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65147819|NCT01030666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147820|NCT01030666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65147863|NCT01301066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65147864|NCT01301066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65147865|NCT01301066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147866|NCT01022398|Vitamin D|vitamin d|mesh-list
65147867|NCT01022398|Cholecalciferol|cholecalciferol|mesh-list
65147868|NCT01022398|Vitamins|vitamins|mesh-ancestor
65147869|NCT01022398|Micronutrients|micronutrients|mesh-ancestor
65147870|NCT01022398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147871|NCT01022398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65147872|NCT01022398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65147873|NCT05642624|Amphotericin B|amphotericin b|mesh-list
65147874|NCT05642624|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65147875|NCT05642624|Deoxycholic Acid|deoxycholic acid|mesh-list
65147889|NCT04324346|Paclitaxel|paclitaxel|mesh-list
65147928|NCT01299896|Autonomic Agents|autonomic agents|mesh-ancestor
65147929|NCT01299896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65147930|NCT01299896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65147931|NCT01299896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65147932|NCT01299896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65147933|NCT01299896|Cholinergic Agents|cholinergic agents|mesh-ancestor
65147934|NCT01299896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65147935|NCT01299896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65147994|NCT04322214|Antiviral Agents|antiviral agents|mesh-ancestor
65147995|NCT04322214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65147996|NCT04322214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65147997|NCT04322214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65147998|NCT04322214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65147999|NCT04322214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148000|NCT01057810|Ipilimumab|ipilimumab|mesh-list
65148001|NCT01057810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65148002|NCT01057810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148003|NCT01057810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65148005|NCT01262352|Ivacaftor|ivacaftor|mesh-list
65148009|NCT01299272|Serotonin|serotonin|mesh-list
65148054|NCT01261338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64790602|NCT00004482|Cyclosporins|cyclosporins|mesh-list
65148056|NCT01260948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65148057|NCT01260948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148058|NCT01260948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148059|NCT01260948|Cholinergic Agents|cholinergic agents|mesh-ancestor
65148060|NCT01260948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65148061|NCT01260948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148123|NCT01259856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148124|NCT01259856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65148125|NCT01259856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65148126|NCT01259856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65148127|NCT01259856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65148128|NCT01259856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148129|NCT01259856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65148130|NCT01259856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65148132|NCT01259856|Antipyretics|antipyretics|mesh-ancestor
65148133|NCT01259856|Immunologic Factors|immunologic factors|mesh-ancestor
65148140|NCT01259466|Nicotine|nicotine|mesh-list
65148188|NCT04752696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65148189|NCT04752696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148190|NCT04752696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65148191|NCT04752696|Immunologic Factors|immunologic factors|mesh-ancestor
65148192|NCT04752696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148193|NCT04752696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65148194|NCT04752696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65148258|NCT02583672|Acetylcysteine|acetylcysteine|mesh-list
65148259|NCT02583672|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65148260|NCT02583672|Antiviral Agents|antiviral agents|mesh-ancestor
65148261|NCT02583672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65148262|NCT02583672|Expectorants|expectorants|mesh-ancestor
65148263|NCT02583672|Respiratory System Agents|respiratory system agents|mesh-ancestor
65148264|NCT02583672|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65148265|NCT02583672|Antioxidants|antioxidants|mesh-ancestor
65148266|NCT02583672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148267|NCT02583672|Protective Agents|protective agents|mesh-ancestor
65148268|NCT02583672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148269|NCT02583672|Antidotes|antidotes|mesh-ancestor
65148270|NCT02888730|Tobramycin|tobramycin|mesh-list
65148271|NCT02888730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65148273|NCT01696734|Domperidone|domperidone|mesh-list
65148318|NCT01235949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148319|NCT01235949|Antipyretics|antipyretics|mesh-ancestor
65148320|NCT00691158|Pramlintide|pramlintide|mesh-list
65148321|NCT00691158|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
65148322|NCT00691158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65148323|NCT00691158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148324|NCT00691158|Appetite Depressants|appetite depressants|mesh-ancestor
65148325|NCT00691158|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65148326|NCT00691158|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
65148327|NCT00691158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148328|NCT01235793|Temozolomide|temozolomide|mesh-list
65148329|NCT01235793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65148330|NCT01235793|Alkylating Agents|alkylating agents|mesh-ancestor
65148331|NCT01235793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148333|NCT05601648|Psilocybin|psilocybin|mesh-list
65148376|NCT01233609|Valproic Acid|valproic acid|mesh-list
65148377|NCT01233609|Anticonvulsants|anticonvulsants|mesh-ancestor
65148378|NCT01233609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148379|NCT01233609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148380|NCT01233609|GABA Agents|gaba agents|mesh-ancestor
65148381|NCT01233609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65148382|NCT01233609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148383|NCT01233609|Antimanic Agents|antimanic agents|mesh-ancestor
65148384|NCT01233609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65148442|NCT01231659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65148443|NCT02875288|Bupivacaine|bupivacaine|mesh-list
65148444|NCT02875288|Anesthetics, Local|anesthetics, local|mesh-ancestor
65148445|NCT02875288|Anesthetics|anesthetics|mesh-ancestor
65148446|NCT02875288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65148447|NCT02875288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148448|NCT02875288|Sensory System Agents|sensory system agents|mesh-ancestor
65148449|NCT02875288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65148450|NCT01054222|Fesoterodine|fesoterodine|mesh-list
65148451|NCT01054222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65148452|NCT01054222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65148453|NCT01054222|Cholinergic Agents|cholinergic agents|mesh-ancestor
65148505|NCT01231581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148506|NCT01231581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148508|NCT01231581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65148509|NCT01231581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148510|NCT01231581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65148511|NCT01231581|Immunologic Factors|immunologic factors|mesh-ancestor
65148512|NCT01231581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148513|NCT01231581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65148514|NCT01050634|Exemestane|exemestane|mesh-list
65148515|NCT01050634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148571|NCT01228071|Hormones|hormones|mesh-ancestor
65148572|NCT01228071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65148573|NCT01228071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148574|NCT04319289|Vitamin D|vitamin d|mesh-list
65148575|NCT04319289|Ergocalciferols|ergocalciferols|mesh-list
65148576|NCT04319289|Cholecalciferol|cholecalciferol|mesh-list
65148577|NCT04319289|Vitamins|vitamins|mesh-list
65148578|NCT04319289|Micronutrients|micronutrients|mesh-ancestor
65148579|NCT04319289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791130|NCT00005604|Analgesics|analgesics|mesh-ancestor
65148634|NCT01001221|Gemcitabine|gemcitabine|mesh-list
65148635|NCT01001221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65148636|NCT01001221|Antimetabolites|antimetabolites|mesh-ancestor
65148637|NCT01001221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148638|NCT01001221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148639|NCT01001221|Antiviral Agents|antiviral agents|mesh-ancestor
65148640|NCT01001221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65148641|NCT01001221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148642|NCT01001221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65148643|NCT01001221|Immunologic Factors|immunologic factors|mesh-ancestor
65148644|NCT01001221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148645|NCT01296152|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65148646|NCT01296152|Medroxyprogesterone|medroxyprogesterone|mesh-list
65148695|NCT04325659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65148696|NCT04325659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65148697|NCT04325659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148698|NCT04325659|Sensory System Agents|sensory system agents|mesh-ancestor
65148699|NCT04325659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65148700|NCT04325659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65148701|NCT04325659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65148702|NCT04325659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65148703|NCT04325659|Adrenergic Agents|adrenergic agents|mesh-ancestor
65148704|NCT04325659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65148705|NCT04325659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148758|NCT01006603|Incretins|incretins|mesh-ancestor
65148759|NCT01006603|Hormones|hormones|mesh-ancestor
65148760|NCT01006603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65148761|NCT01006603|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65148762|NCT01006603|Protease Inhibitors|protease inhibitors|mesh-ancestor
65148763|NCT01006603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148764|NCT01006603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148765|NCT00997321|Ketamine|ketamine|mesh-list
65148766|NCT00997321|Propofol|propofol|mesh-list
65148767|NCT00997321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65148770|NCT00997321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65148820|NCT01294436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65148821|NCT01294436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148822|NCT01294358|Gemcitabine|gemcitabine|mesh-list
65148823|NCT01294358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65148824|NCT01294358|Antimetabolites|antimetabolites|mesh-ancestor
65148825|NCT01294358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148826|NCT01294358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148827|NCT01294358|Antiviral Agents|antiviral agents|mesh-ancestor
65148828|NCT01294358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65148886|NCT01223937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148887|NCT01223235|Bevacizumab|bevacizumab|mesh-list
65148888|NCT01223235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65148889|NCT01223235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148890|NCT01223235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65148891|NCT01223235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65148892|NCT01223235|Growth Substances|growth substances|mesh-ancestor
65148893|NCT01223235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148894|NCT01223235|Growth Inhibitors|growth inhibitors|mesh-ancestor
65148895|NCT00993967|Idebenone|idebenone|mesh-list
65148896|NCT00993967|Antioxidants|antioxidants|mesh-ancestor
65148897|NCT00993967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148898|NCT00993967|Protective Agents|protective agents|mesh-ancestor
65148900|NCT01222533|Tiotropium Bromide|tiotropium bromide|mesh-list
65148948|NCT00993499|Sirolimus|sirolimus|mesh-list
65148949|NCT00993499|Afatinib|afatinib|mesh-list
65148950|NCT00993499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65148951|NCT00993499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65148952|NCT00993499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65148953|NCT00993499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65148954|NCT00993499|Antifungal Agents|antifungal agents|mesh-ancestor
65148955|NCT00993499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65148956|NCT00993499|Immunologic Factors|immunologic factors|mesh-ancestor
65148957|NCT00993499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65148958|NCT00993499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65148959|NCT00993499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65148960|NCT00993499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65148961|NCT01014442|Mycophenolic Acid|mycophenolic acid|mesh-list
65148962|NCT01014442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65148963|NCT01014442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149008|NCT04205578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65149009|NCT04205578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65149010|NCT04205578|Protective Agents|protective agents|mesh-ancestor
65149011|NCT04205578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149012|NCT00991939|Dexamethasone|dexamethasone|mesh-list
65149013|NCT00991939|Prednisone|prednisone|mesh-list
65149014|NCT00991939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65149015|NCT00991939|Antiemetics|antiemetics|mesh-ancestor
65149016|NCT00991939|Autonomic Agents|autonomic agents|mesh-ancestor
65149017|NCT00991939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65149018|NCT00991939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149073|NCT01010776|Serotonin Agents|serotonin agents|mesh-ancestor
65149074|NCT01010776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65149075|NCT01010776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149076|NCT01010776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65149077|NCT01010776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65149078|NCT01010776|Dopamine Agents|dopamine agents|mesh-ancestor
65149080|NCT04291729|Ritonavir|ritonavir|mesh-list
65149081|NCT04291729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149082|NCT04291729|Antiviral Agents|antiviral agents|mesh-ancestor
65149083|NCT04291729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65149137|NCT01018186|Xhance|xhance|mesh-list
65149141|NCT01018186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65149142|NCT01018186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149143|NCT01018186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65149144|NCT01018186|Respiratory System Agents|respiratory system agents|mesh-ancestor
65149145|NCT01018186|Dermatologic Agents|dermatologic agents|mesh-ancestor
65149146|NCT01018186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65149147|NCT04566328|Dexamethasone|dexamethasone|mesh-list
65149148|NCT04566328|Dexamethasone acetate|dexamethasone acetate|mesh-list
65149149|NCT04566328|Lenalidomide|lenalidomide|mesh-list
65149150|NCT04566328|Bortezomib|bortezomib|mesh-list
65149151|NCT04566328|Daratumumab|daratumumab|mesh-list
65149152|NCT04566328|Ichthammol|ichthammol|mesh-list
65149153|NCT04566328|BB 1101|bb 1101|mesh-list
65149154|NCT04566328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65149155|NCT04566328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65149156|NCT04566328|Antiemetics|antiemetics|mesh-ancestor
65149203|NCT00989833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65149204|NCT00989833|Respiratory System Agents|respiratory system agents|mesh-ancestor
65149205|NCT00989833|Glucocorticoids|glucocorticoids|mesh-ancestor
65149206|NCT00989833|Hormones|hormones|mesh-ancestor
64401035|NCT02034331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149207|NCT00989833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65149271|NCT01217073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149272|NCT00985621|Oxycodone|oxycodone|mesh-list
65149273|NCT00985621|Tanezumab|tanezumab|mesh-list
65149274|NCT00985621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65149275|NCT00985621|Narcotics|narcotics|mesh-ancestor
65149276|NCT00985621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65149277|NCT00985621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149278|NCT00985621|Analgesics|analgesics|mesh-ancestor
65149279|NCT00985621|Sensory System Agents|sensory system agents|mesh-ancestor
65149280|NCT00985621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65149281|NCT01215981|Vaccines|vaccines|mesh-list
65149282|NCT01215981|Immunologic Factors|immunologic factors|mesh-ancestor
65149284|NCT01215435|Insulin|insulin|mesh-list
65149334|NCT01009840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65149335|NCT04420936|Benzocaine|benzocaine|mesh-list
65149336|NCT04420936|Anesthetics, Local|anesthetics, local|mesh-ancestor
65149337|NCT04420936|Anesthetics|anesthetics|mesh-ancestor
65149338|NCT04420936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65149339|NCT04420936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149340|NCT04420936|Sensory System Agents|sensory system agents|mesh-ancestor
65149341|NCT04420936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65149342|NCT04542148|Insulin|insulin|mesh-list
65149343|NCT04542148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65149344|NCT04542148|Insulin Aspart|insulin aspart|mesh-list
65149400|NCT01005316|Antitubercular Agents|antitubercular agents|mesh-ancestor
65149401|NCT01005316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65149402|NCT01005316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65149403|NCT00988429|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
65149404|NCT00988429|Anticonvulsants|anticonvulsants|mesh-ancestor
65149405|NCT00988429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65149406|NCT00988429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65149407|NCT00988429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64791965|NCT00370188|Topiramate|topiramate|mesh-list
65149410|NCT01008904|Antacids|antacids|mesh-ancestor
65149465|NCT04297072|Rivaroxaban|rivaroxaban|mesh-list
65149466|NCT04297072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65149467|NCT04297072|Antithrombins|antithrombins|mesh-ancestor
65149468|NCT04297072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65149469|NCT04297072|Protease Inhibitors|protease inhibitors|mesh-ancestor
65149470|NCT04297072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149471|NCT04297072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149472|NCT04297072|Anticoagulants|anticoagulants|mesh-ancestor
65149473|NCT01008748|Nicotine|nicotine|mesh-list
65149474|NCT01008748|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65149475|NCT01008748|Autonomic Agents|autonomic agents|mesh-ancestor
65149476|NCT01008748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65149477|NCT01008748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149478|NCT01008748|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65149479|NCT01008748|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65149480|NCT01008748|Cholinergic Agents|cholinergic agents|mesh-ancestor
65149481|NCT01008748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65149522|NCT00978757|Ketamine|ketamine|mesh-list
65149523|NCT00978757|Analgesics|analgesics|mesh-ancestor
65149524|NCT00978757|Sensory System Agents|sensory system agents|mesh-ancestor
65149525|NCT00978757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65149526|NCT00978757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149527|NCT00978757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65149528|NCT00978757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65149529|NCT00978757|Anesthetics, General|anesthetics, general|mesh-ancestor
65149530|NCT00978757|Anesthetics|anesthetics|mesh-ancestor
65149531|NCT00978757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65149532|NCT00978757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65149533|NCT00978757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65149534|NCT00978757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65149583|NCT01002820|GABA Modulators|gaba modulators|mesh-ancestor
65149584|NCT01002820|GABA Agents|gaba agents|mesh-ancestor
65149585|NCT01012258|Cetuximab|cetuximab|mesh-list
65149586|NCT01012258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65149587|NCT01012258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149656|NCT01213173|Autonomic Agents|autonomic agents|mesh-ancestor
65149657|NCT01213173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65149658|NCT01213173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149659|NCT01213173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65149660|NCT01213173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65149661|NCT01213173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65149662|NCT01213173|Adrenergic Agents|adrenergic agents|mesh-ancestor
65149663|NCT01213173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65149664|NCT01213173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149719|NCT02863861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65149720|NCT02863861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65149721|NCT02863861|Adrenergic Agents|adrenergic agents|mesh-ancestor
65149722|NCT02863861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65149723|NCT02863861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149724|NCT02863861|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65149725|NCT02863861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65149726|NCT02863861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65149727|NCT05406765|Bupivacaine|bupivacaine|mesh-list
65149728|NCT05406765|Anesthetics, Local|anesthetics, local|mesh-ancestor
65149729|NCT05406765|Anesthetics|anesthetics|mesh-ancestor
65149730|NCT05406765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65149731|NCT05406765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149732|NCT05406765|Sensory System Agents|sensory system agents|mesh-ancestor
65149733|NCT05406765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65149734|NCT03846505|Oxytocin|oxytocin|mesh-list
65149735|NCT03846505|Oxytocics|oxytocics|mesh-ancestor
65149774|NCT01210443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149775|NCT04287361|Clonazepam|clonazepam|mesh-list
65149776|NCT04287361|Anticonvulsants|anticonvulsants|mesh-ancestor
65149777|NCT04287361|GABA Modulators|gaba modulators|mesh-ancestor
65149778|NCT04287361|GABA Agents|gaba agents|mesh-ancestor
65149779|NCT04287361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65149780|NCT04287361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149781|NCT04287361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149782|NCT00624429|Budesonide|budesonide|mesh-list
65149783|NCT00624429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65149784|NCT00624429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65149785|NCT00624429|Autonomic Agents|autonomic agents|mesh-ancestor
65149786|NCT00624429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65149787|NCT00624429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149788|NCT00624429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65149789|NCT00624429|Respiratory System Agents|respiratory system agents|mesh-ancestor
65149790|NCT00624429|Glucocorticoids|glucocorticoids|mesh-ancestor
65149791|NCT00624429|Hormones|hormones|mesh-ancestor
65149792|NCT00624429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65149794|NCT01001572|Valsartan|valsartan|mesh-list
65149795|NCT01001572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65149796|NCT01001572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65149797|NCT01001572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65149798|NCT01001572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149806|NCT04287205|Hormones|hormones|mesh-ancestor
65149824|NCT04370548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65149825|NCT04370548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65149826|NCT04370548|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65149827|NCT04370548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149828|NCT04370548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149829|NCT01208181|Etoricoxib|etoricoxib|mesh-list
65149830|NCT01208181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65149831|NCT01208181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65149832|NCT01208181|Analgesics|analgesics|mesh-ancestor
65149833|NCT01208181|Sensory System Agents|sensory system agents|mesh-ancestor
65149834|NCT01208181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65149835|NCT01208181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149836|NCT01208181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65149837|NCT01208181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65149838|NCT01208181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65149839|NCT01208181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65149840|NCT01208181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149841|NCT01208181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149842|NCT01208103|Bevacizumab|bevacizumab|mesh-list
65149843|NCT01208103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65149844|NCT01208103|Capecitabine|capecitabine|mesh-list
65149845|NCT01208103|Oxaliplatin|oxaliplatin|mesh-list
65149846|NCT01208103|Endothelial Growth Factors|endothelial growth factors|mesh-list
65149847|NCT01208103|Antibodies|antibodies|mesh-list
65149875|NCT01205685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149876|NCT01205685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65149877|NCT01205685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65149878|NCT01205685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65149879|NCT01205685|Hormone Antagonists|hormone antagonists|mesh-ancestor
65149880|NCT01205685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65149881|NCT01205685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149882|NCT01205685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65149883|NCT01205529|Procainamide|procainamide|mesh-list
65149884|NCT01205529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65149885|NCT01205529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65149886|NCT01205529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65149889|NCT04294966|Dronabinol|dronabinol|mesh-list
65149932|NCT04204954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65149933|NCT04204954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65149934|NCT04204954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65149935|NCT04204954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149936|NCT04204954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149937|NCT04204954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65149938|NCT04204954|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65149939|NCT04204954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65149940|NCT04204954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65149941|NCT01204671|Vaccines|vaccines|mesh-list
65149942|NCT01204671|Immunologic Factors|immunologic factors|mesh-ancestor
65149943|NCT01204671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149944|NCT01202955|Tolcapone|tolcapone|mesh-list
65149945|NCT01202955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65149991|NCT01200069|Sensory System Agents|sensory system agents|mesh-ancestor
65149992|NCT01200069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65149993|NCT01200069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65149994|NCT01200069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65149995|NCT01200069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65149996|NCT01200069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65149997|NCT01200069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65149998|NCT01200069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65149999|NCT01199289|Brodalumab|brodalumab|mesh-list
65150001|NCT01199055|Paclitaxel|paclitaxel|mesh-list
65150056|NCT00977431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150057|NCT04290169|Botulinum Toxins|botulinum toxins|mesh-list
65150058|NCT04290169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65150059|NCT04290169|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65150060|NCT04290169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65150061|NCT04290169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65150062|NCT04290169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150063|NCT04290169|Cholinergic Agents|cholinergic agents|mesh-ancestor
65150064|NCT04290169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64792647|NCT00422994|Ropinirole|ropinirole|mesh-list
65150120|NCT00974233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150121|NCT00974233|Immunologic Factors|immunologic factors|mesh-ancestor
65150122|NCT00974233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150123|NCT00974233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65150124|NCT00974233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65150125|NCT00974233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65150126|NCT00974233|Growth Substances|growth substances|mesh-ancestor
65150127|NCT00974233|Growth Inhibitors|growth inhibitors|mesh-ancestor
65150128|NCT00974233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65150129|NCT00974233|Alkylating Agents|alkylating agents|mesh-ancestor
65150131|NCT00972595|Ondansetron|ondansetron|mesh-list
65150184|NCT05366049|Sensory System Agents|sensory system agents|mesh-ancestor
65150185|NCT05366049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65150186|NCT05366049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150187|NCT05366049|Antipyretics|antipyretics|mesh-ancestor
65150188|NCT00969709|Milnacipran|milnacipran|mesh-list
65150189|NCT00969709|Levomilnacipran|levomilnacipran|mesh-list
65150190|NCT00969709|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65150191|NCT00969709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65150192|NCT00969709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65150193|NCT00969709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150194|NCT00969709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65150195|NCT00969709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150196|NCT00969709|Antidepressive Agents|antidepressive agents|mesh-ancestor
65150197|NCT00969709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65150198|NCT00969709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65150199|NCT00969709|Analgesics|analgesics|mesh-ancestor
65150204|NCT01193517|Decitabine|decitabine|mesh-list
65150241|NCT01193283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65150242|NCT01193283|Dermatologic Agents|dermatologic agents|mesh-ancestor
65150243|NCT01193283|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65150244|NCT02863471|Gemcitabine|gemcitabine|mesh-list
65150245|NCT02863471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65150246|NCT02863471|Antimetabolites|antimetabolites|mesh-ancestor
65150247|NCT02863471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150248|NCT02863471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150249|NCT02863471|Antiviral Agents|antiviral agents|mesh-ancestor
65150250|NCT02863471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65150306|NCT01306643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150307|NCT05656833|Cysteamine|cysteamine|mesh-list
65150308|NCT05656833|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
65150309|NCT05656833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150310|NCT01306331|Nonoxynol|nonoxynol|mesh-list
65150311|NCT01306331|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
65150312|NCT01306331|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
65150313|NCT01306331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150314|NCT01306331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65150315|NCT01306331|Contraceptive Agents|contraceptive agents|mesh-ancestor
65150316|NCT01306331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65150317|NCT01306331|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65150368|NCT01305941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150369|NCT01305941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65150370|NCT01305941|Immunologic Factors|immunologic factors|mesh-ancestor
65150371|NCT01305941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150372|NCT01305941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65150373|NCT01305941|Tubulin Modulators|tubulin modulators|mesh-ancestor
65150374|NCT01305941|Antimitotic Agents|antimitotic agents|mesh-ancestor
65150375|NCT01305941|Mitosis Modulators|mitosis modulators|mesh-ancestor
65150376|NCT01305941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150377|NCT05658549|Acetylcysteine|acetylcysteine|mesh-list
65150378|NCT05658549|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65150379|NCT05658549|Antiviral Agents|antiviral agents|mesh-ancestor
65150429|NCT01304693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150430|NCT01304693|Growth Inhibitors|growth inhibitors|mesh-ancestor
65150431|NCT01304693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150432|NCT01304147|Ketamine|ketamine|mesh-list
65150433|NCT01304147|Analgesics|analgesics|mesh-ancestor
65150434|NCT01304147|Sensory System Agents|sensory system agents|mesh-ancestor
65150435|NCT01304147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65150436|NCT01304147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150437|NCT01304147|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65150438|NCT01304147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65150492|NCT01187901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150493|NCT01187901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150494|NCT01187901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65150495|NCT01187901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65150496|NCT01187901|Analgesics|analgesics|mesh-ancestor
65150497|NCT01187901|Sensory System Agents|sensory system agents|mesh-ancestor
65150498|NCT01187901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65150499|NCT01187901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150500|NCT01187901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64947323|NCT05772429|Anticonvulsants|anticonvulsants|mesh-ancestor
64947324|NCT05772377|Carboplatin|carboplatin|mesh-list
65150557|NCT05641649|GABA Agents|gaba agents|mesh-ancestor
65150558|NCT05641649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65150559|NCT05641649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150560|NCT05641649|Antimanic Agents|antimanic agents|mesh-ancestor
65150561|NCT05641649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65150562|NCT05641649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65150563|NCT05641649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65150564|NCT01184859|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65150619|NCT01300247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150620|NCT01300247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65150621|NCT01300247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65150622|NCT02890277|Anti-Infective Agents|anti-infective agents|mesh-list
65150623|NCT02890277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65150624|NCT02890277|Chitosan|chitosan|mesh-list
65150625|NCT02890277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65150626|NCT02890277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65150627|NCT02890277|Antimetabolites|antimetabolites|mesh-ancestor
65150628|NCT02890277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150629|NCT02890277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65150630|NCT02890277|Chelating Agents|chelating agents|mesh-ancestor
65150631|NCT02890277|Sequestering Agents|sequestering agents|mesh-ancestor
65150632|NCT02890277|Hemostatics|hemostatics|mesh-ancestor
65150684|NCT04315935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65150685|NCT04315935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150686|NCT04315935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65150687|NCT04315935|Anesthetics, General|anesthetics, general|mesh-ancestor
65150688|NCT04315935|Anesthetics|anesthetics|mesh-ancestor
65150689|NCT04315935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65150690|NCT04315935|Narcotics|narcotics|mesh-ancestor
65150691|NCT04315935|Analgesics|analgesics|mesh-ancestor
65150692|NCT04315935|Sensory System Agents|sensory system agents|mesh-ancestor
65150693|NCT04315935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65150694|NCT04315935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65150695|NCT04315935|Antitussive Agents|antitussive agents|mesh-ancestor
65150696|NCT04315935|Respiratory System Agents|respiratory system agents|mesh-ancestor
65150697|NCT04315935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65150698|NCT01182207|Drospirenone|drospirenone|mesh-list
65150699|NCT01182207|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65150744|NCT01181271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65150745|NCT01181271|Alkylating Agents|alkylating agents|mesh-ancestor
65150746|NCT01181271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150747|NCT01181271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150748|NCT01181271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65150749|NCT01181271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65150750|NCT01181271|Abortifacient Agents|abortifacient agents|mesh-ancestor
64793315|NCT00247416|Hormones|hormones|mesh-ancestor
65150751|NCT01181271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65150752|NCT01181271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65150753|NCT01181271|Antimetabolites|antimetabolites|mesh-ancestor
65150754|NCT01181271|Dermatologic Agents|dermatologic agents|mesh-ancestor
65150755|NCT01181271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65150756|NCT01181271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65150757|NCT01181271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65150758|NCT01181271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65150759|NCT01181271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65150799|NCT04286035|Anesthetics|anesthetics|mesh-ancestor
65150800|NCT04286035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65150801|NCT04286035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150802|NCT04286035|Sensory System Agents|sensory system agents|mesh-ancestor
65150803|NCT04286035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65150804|NCT05194111|Valsartan|valsartan|mesh-list
65150805|NCT05194111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65150806|NCT05194111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65150807|NCT05194111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65150808|NCT05194111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65150809|NCT05194111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150810|NCT00629473|Dexamethasone|dexamethasone|mesh-list
65150811|NCT00629473|Proteasome Inhibitors|proteasome inhibitors|mesh-list
65150860|NCT03792841|Pembrolizumab|pembrolizumab|mesh-list
65150861|NCT03792841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65150862|NCT03792841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65150863|NCT03792841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65150864|NCT03792841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65150865|NCT03792841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65150866|NCT03792841|Analgesics|analgesics|mesh-ancestor
65150867|NCT03792841|Sensory System Agents|sensory system agents|mesh-ancestor
65150868|NCT03792841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65150869|NCT03792841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150870|NCT03792841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65150871|NCT03792841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65150872|NCT03792841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65150873|NCT03792841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65150874|NCT03792841|Immunologic Factors|immunologic factors|mesh-ancestor
65150875|NCT03792841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150876|NCT00968617|Darbepoetin alfa|darbepoetin alfa|mesh-list
65150877|NCT00968617|Hematinics|hematinics|mesh-ancestor
65150878|NCT00968539|Vaccines|vaccines|mesh-list
65150879|NCT00968539|Immunologic Factors|immunologic factors|mesh-ancestor
65150880|NCT00968539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150881|NCT00976573|Paclitaxel|paclitaxel|mesh-list
65150882|NCT00976573|Bevacizumab|bevacizumab|mesh-list
65150913|NCT00629863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65150914|NCT00629863|Immunologic Factors|immunologic factors|mesh-ancestor
65150915|NCT00629863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150916|NCT02865733|Treprostinil|treprostinil|mesh-list
65150917|NCT02865733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65150918|NCT00976495|Dapagliflozin|dapagliflozin|mesh-list
65150919|NCT00976495|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65150920|NCT00976495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65150921|NCT00976495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150922|NCT00976495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65150923|NCT00976495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150924|NCT00976495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65150925|NCT00976495|Diuretics|diuretics|mesh-ancestor
65150926|NCT00976495|Natriuretic Agents|natriuretic agents|mesh-ancestor
65150927|NCT00976495|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65150971|NCT00997984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65150972|NCT00997984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65150973|NCT00997984|Adrenergic Agents|adrenergic agents|mesh-ancestor
65150974|NCT00997984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65150975|NCT00997984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65150976|NCT00997984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65150978|NCT01177293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65150979|NCT01177293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65151036|NCT01298765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65151037|NCT01298765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65151038|NCT04296214|Azacitidine|azacitidine|mesh-list
65151039|NCT04296214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65151040|NCT04296214|Antimetabolites|antimetabolites|mesh-ancestor
65151041|NCT04296214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151042|NCT04296214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151044|NCT04296370|Apatinib|apatinib|mesh-list
65151104|NCT02862691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65151105|NCT02862691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65151106|NCT02862691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65151107|NCT00965341|Methyltestosterone|methyltestosterone|mesh-list
65151108|NCT00965341|Testosterone|testosterone|mesh-list
65151109|NCT00965341|Testosterone undecanoate|testosterone undecanoate|mesh-list
65151110|NCT00965341|Testosterone enanthate|testosterone enanthate|mesh-list
65151111|NCT00965341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65151112|NCT00965341|Androgens|androgens|mesh-ancestor
65151113|NCT00965341|Hormones|hormones|mesh-ancestor
65151115|NCT00965341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151166|NCT02862769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151167|NCT00965185|Atorvastatin|atorvastatin|mesh-list
65151168|NCT00965185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65151169|NCT00965185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65151170|NCT00965185|Antimetabolites|antimetabolites|mesh-ancestor
65151171|NCT00965185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151172|NCT00965185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65151173|NCT00965185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65151174|NCT00965185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151175|NCT01174563|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65151176|NCT01174563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151177|NCT01174563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65151178|NCT01174563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151179|NCT01174563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151180|NCT01298531|Etanercept|etanercept|mesh-list
65151181|NCT01298531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65151224|NCT01172847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151225|NCT01172847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151226|NCT01172847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65151227|NCT00966355|Octreotide|octreotide|mesh-list
65151228|NCT00966355|Terlipressin|terlipressin|mesh-list
65151229|NCT00966355|Somatostatin|somatostatin|mesh-list
65151230|NCT00966355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65151231|NCT00966355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65151232|NCT00966355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151233|NCT00966355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65151234|NCT00966355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65151235|NCT00966355|Hormones|hormones|mesh-ancestor
65151238|NCT01172535|Ritonavir|ritonavir|mesh-list
65151287|NCT04324307|Folfirinox|folfirinox|mesh-list
65151288|NCT04324307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65151289|NCT04324307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151290|NCT04324307|Tubulin Modulators|tubulin modulators|mesh-ancestor
65151291|NCT04324307|Antimitotic Agents|antimitotic agents|mesh-ancestor
65151292|NCT04324307|Mitosis Modulators|mitosis modulators|mesh-ancestor
65151294|NCT04324307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65151355|NCT01294553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151356|NCT04326023|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65151357|NCT04326023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151358|NCT04326023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151359|NCT04326023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151360|NCT01294397|Denosumab|denosumab|mesh-list
65151361|NCT01294397|Etanercept|etanercept|mesh-list
65151362|NCT01294397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65151363|NCT01294397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65151364|NCT01294397|Analgesics|analgesics|mesh-ancestor
65151365|NCT01294397|Sensory System Agents|sensory system agents|mesh-ancestor
65151366|NCT01294397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65151367|NCT01294397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151368|NCT01294397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65151369|NCT01294397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65151370|NCT01294397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65151371|NCT01294397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65151372|NCT01294397|Immunologic Factors|immunologic factors|mesh-ancestor
65151373|NCT01294397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65151374|NCT01293695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65151375|NCT01293695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65151406|NCT00630175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65151407|NCT00630175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151408|NCT00630175|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65151409|NCT00630175|GABA Agonists|gaba agonists|mesh-ancestor
65151410|NCT00630175|GABA Agents|gaba agents|mesh-ancestor
65151411|NCT00630175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65151412|NCT00630175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151413|NCT00965575|Melatonin|melatonin|mesh-list
65151414|NCT00965575|Antioxidants|antioxidants|mesh-ancestor
65151415|NCT00965575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151469|NCT01286558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151470|NCT01286558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65151471|NCT01286558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151472|NCT01286558|Vasodilator Agents|vasodilator agents|mesh-ancestor
65151473|NCT01286558|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65151474|NCT01286558|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65151475|NCT01169103|Hormones|hormones|mesh-list
65151476|NCT01169103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65151477|NCT01169103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151478|NCT01286168|Chlorhexidine|chlorhexidine|mesh-list
65151531|NCT01285310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151532|NCT01285310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65151533|NCT01285310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65151534|NCT01285310|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65151535|NCT01285310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65151536|NCT01285310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151537|NCT01285310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151538|NCT01285310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65151596|NCT01292603|Cyclophosphamide|cyclophosphamide|mesh-list
65151597|NCT01292603|Rituximab|rituximab|mesh-list
65151598|NCT01292603|Fludarabine|fludarabine|mesh-list
65151599|NCT01292603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65151600|NCT01292603|Immunologic Factors|immunologic factors|mesh-ancestor
65151601|NCT01292603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151602|NCT01292603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65151603|NCT01292603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65151604|NCT01292603|Alkylating Agents|alkylating agents|mesh-ancestor
65151605|NCT01292603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151606|NCT01292603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151607|NCT01292603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65151608|NCT01292603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65151609|NCT01292057|Aripiprazole|aripiprazole|mesh-list
65151610|NCT01292057|Antidepressive Agents|antidepressive agents|mesh-ancestor
65151611|NCT01292057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65151612|NCT01292057|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65151613|NCT01292057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65151614|NCT01292057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65151615|NCT01292057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151616|NCT01292057|Dopamine Agonists|dopamine agonists|mesh-ancestor
65151617|NCT01292057|Dopamine Agents|dopamine agents|mesh-ancestor
65151649|NCT01290263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65151650|NCT01290263|Growth Substances|growth substances|mesh-ancestor
65151651|NCT01290263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151652|NCT01290263|Growth Inhibitors|growth inhibitors|mesh-ancestor
65151653|NCT01290029|Cinacalcet|cinacalcet|mesh-list
65151654|NCT01290029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65151655|NCT01290029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151656|NCT01290029|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65151657|NCT01290029|Hormone Antagonists|hormone antagonists|mesh-ancestor
65151658|NCT01290029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65151659|NCT02890199|Lidocaine|lidocaine|mesh-list
65151709|NCT01288079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151710|NCT01288079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64401038|NCT02034331|Cholinergic Agents|cholinergic agents|mesh-ancestor
65151711|NCT01288079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151716|NCT01288079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65151779|NCT02885961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151780|NCT02885961|Anticoagulants|anticoagulants|mesh-ancestor
65151781|NCT02885727|Durvalumab|durvalumab|mesh-list
65151782|NCT02885727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65151783|NCT02885727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151784|NCT00963235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64685132|NCT00003027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65151785|NCT00963235|Immunologic Factors|immunologic factors|mesh-ancestor
65151786|NCT00963235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151787|NCT00630097|Modafinil|modafinil|mesh-list
65151788|NCT00630097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65151789|NCT00630097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151790|NCT00630097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65151791|NCT00630097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65151794|NCT01165281|Oxycodone|oxycodone|mesh-list
65151837|NCT04284007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151838|NCT04284007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151839|NCT04284007|Anesthetics, Local|anesthetics, local|mesh-ancestor
65151840|NCT04284007|Anesthetics|anesthetics|mesh-ancestor
65151841|NCT04284007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65151842|NCT04284007|Sensory System Agents|sensory system agents|mesh-ancestor
65151843|NCT02965963|Dopamine|dopamine|mesh-list
65151844|NCT02965963|Metoclopramide|metoclopramide|mesh-list
65151845|NCT02965963|Antiemetics|antiemetics|mesh-ancestor
65151846|NCT02965963|Autonomic Agents|autonomic agents|mesh-ancestor
65151847|NCT02965963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65151848|NCT02965963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151849|NCT02965963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65151850|NCT02965963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65151851|NCT02965963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65151852|NCT02965963|Dopamine Agents|dopamine agents|mesh-ancestor
65151853|NCT02965963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65151854|NCT02965963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151855|NCT02965963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65151856|NCT02965963|Sympathomimetics|sympathomimetics|mesh-ancestor
65151857|NCT02965963|Protective Agents|protective agents|mesh-ancestor
65151858|NCT01165203|Vaccines|vaccines|mesh-list
65151859|NCT01165203|Immunologic Factors|immunologic factors|mesh-ancestor
65151860|NCT01165203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65151890|NCT00959647|Bevacizumab|bevacizumab|mesh-list
65151891|NCT00959647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65151892|NCT00959647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65151898|NCT00957853|Cetuximab|cetuximab|mesh-list
65151962|NCT02869009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65151963|NCT02869009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65151964|NCT02869009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65151965|NCT02869009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65151966|NCT02869009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65151967|NCT02869009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65151968|NCT02869009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65151969|NCT02869009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65151970|NCT02869009|Antipyretics|antipyretics|mesh-ancestor
65152028|NCT03202849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65152029|NCT04277533|Calcium|calcium|mesh-list
65152030|NCT04277533|Bilirubin|bilirubin|mesh-list
65152031|NCT04277533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65152032|NCT04277533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152033|NCT04277533|Antioxidants|antioxidants|mesh-ancestor
65152034|NCT04277533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152035|NCT04277533|Protective Agents|protective agents|mesh-ancestor
65152036|NCT02445391|Cisplatin|cisplatin|mesh-list
65152037|NCT02445391|Carboplatin|carboplatin|mesh-list
65152038|NCT02445391|Capecitabine|capecitabine|mesh-list
65152039|NCT02445391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152040|NCT02445391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65152041|NCT02445391|Antimetabolites|antimetabolites|mesh-ancestor
65152042|NCT02445391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152043|NCT01246986|Sorafenib|sorafenib|mesh-list
65152044|NCT01246986|Ramucirumab|ramucirumab|mesh-list
65152045|NCT01246986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152085|NCT04280263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65152086|NCT02140255|Ritonavir|ritonavir|mesh-list
65152087|NCT02140255|Lopinavir|lopinavir|mesh-list
65152088|NCT02140255|Raltegravir Potassium|raltegravir potassium|mesh-list
65152089|NCT02140255|Nevirapine|nevirapine|mesh-list
65152090|NCT02140255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
65152091|NCT02140255|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65152092|NCT02140255|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65152093|NCT02140255|Protease Inhibitors|protease inhibitors|mesh-ancestor
64794657|NCT02241174|Eusol|eusol|mesh-list
65152094|NCT02140255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152095|NCT02140255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152096|NCT02140255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65152097|NCT02140255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65152098|NCT02140255|Antiviral Agents|antiviral agents|mesh-ancestor
65152146|NCT00955357|Lacosamide|lacosamide|mesh-list
65152147|NCT00955357|Anticonvulsants|anticonvulsants|mesh-ancestor
65152148|NCT00955357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65152149|NCT00955357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65152150|NCT00955357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65152151|NCT00955357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152152|NCT02338609|Everolimus|everolimus|mesh-list
65152153|NCT02338609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152154|NCT02338609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65152155|NCT02338609|Immunologic Factors|immunologic factors|mesh-ancestor
65152156|NCT02338609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152157|NCT00955279|Golimumab|golimumab|mesh-list
65152158|NCT00955279|Ustekinumab|ustekinumab|mesh-list
65152159|NCT00955279|Dermatologic Agents|dermatologic agents|mesh-ancestor
65152160|NCT00955279|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65152161|NCT00955279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65152175|NCT02857309|Hormones|hormones|mesh-ancestor
65152204|NCT02857465|Narcotics|narcotics|mesh-ancestor
65152205|NCT02857465|Analgesics|analgesics|mesh-ancestor
65152206|NCT02857465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65152207|NCT02857465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65152208|NCT02857465|Anesthetics, General|anesthetics, general|mesh-ancestor
65152209|NCT04260139|Metronidazole|metronidazole|mesh-list
65152210|NCT04260139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65152211|NCT04260139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65152212|NCT04260139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65152213|NCT04260139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65152214|NCT04206618|Denosumab|denosumab|mesh-list
65152269|NCT01962415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152270|NCT01962415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65152271|NCT01962415|Immunologic Factors|immunologic factors|mesh-ancestor
65152272|NCT01962415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152273|NCT01962415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65152274|NCT01962415|Alkylating Agents|alkylating agents|mesh-ancestor
65152275|NCT01962415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65152276|NCT01962415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65152277|NCT01962415|Antisickling Agents|antisickling agents|mesh-ancestor
65152278|NCT01962415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152279|NCT01962415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65152280|NCT02860663|Vitamin D|vitamin d|mesh-list
65152281|NCT02860663|Ergocalciferols|ergocalciferols|mesh-list
65152282|NCT02860663|Cholecalciferol|cholecalciferol|mesh-list
65152283|NCT02860663|Vitamins|vitamins|mesh-list
65152284|NCT02860663|Micronutrients|micronutrients|mesh-ancestor
65152285|NCT02860663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152286|NCT02860663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65152287|NCT02860663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65152288|NCT02854345|Parathyroid Hormone|parathyroid hormone|mesh-list
65152289|NCT02854345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65152290|NCT02854345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152291|NCT01239342|Everolimus|everolimus|mesh-list
65152292|NCT01239342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152293|NCT01239342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65152294|NCT01239342|Immunologic Factors|immunologic factors|mesh-ancestor
65152295|NCT01239342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152296|NCT00946309|Sulforaphane|sulforaphane|mesh-list
65152297|NCT00946309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65152298|NCT00946309|Protective Agents|protective agents|mesh-ancestor
65152299|NCT00946309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152300|NCT00946309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152309|NCT01235598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65152310|NCT01235598|Immunologic Factors|immunologic factors|mesh-ancestor
65152311|NCT01235598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152382|NCT01232790|Expectorants|expectorants|mesh-ancestor
65152383|NCT01232790|Respiratory System Agents|respiratory system agents|mesh-ancestor
65152384|NCT01232790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65152456|NCT01809691|Hormone Antagonists|hormone antagonists|mesh-ancestor
64514562|NCT01726049|Vasodilator Agents|vasodilator agents|mesh-ancestor
65152457|NCT01809691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65152458|NCT01809691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152460|NCT01231464|Fluticasone|fluticasone|mesh-list
65152461|NCT01231464|Xhance|xhance|mesh-list
65152462|NCT01231464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65152463|NCT01231464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65152464|NCT01231464|Autonomic Agents|autonomic agents|mesh-ancestor
65152465|NCT01231464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65152466|NCT01231464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152467|NCT01231464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65152468|NCT01231464|Respiratory System Agents|respiratory system agents|mesh-ancestor
65152471|NCT01156311|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65152518|NCT01155063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152519|NCT01155063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65152520|NCT01155063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65152521|NCT01155063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152522|NCT01155063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152523|NCT01155063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65152524|NCT01155063|Hormone Antagonists|hormone antagonists|mesh-ancestor
65152525|NCT01155063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65152526|NCT01155063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152527|NCT03040999|Cisplatin|cisplatin|mesh-list
65152528|NCT03040999|Pembrolizumab|pembrolizumab|mesh-list
65152529|NCT03040999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152530|NCT03040999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65152531|NCT01154673|Ritonavir|ritonavir|mesh-list
65152533|NCT01154673|Tenofovir|tenofovir|mesh-list
65152534|NCT01154673|Emtricitabine|emtricitabine|mesh-list
65152579|NCT01154127|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65152580|NCT01154127|Cholinergic Agents|cholinergic agents|mesh-ancestor
65152581|NCT01154127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65152582|NCT01154127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152583|NCT01154127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152584|NCT01228734|Leucovorin|leucovorin|mesh-list
65152585|NCT01228734|Folic Acid|folic acid|mesh-list
65152586|NCT01228734|Fluorouracil|fluorouracil|mesh-list
65152587|NCT01228734|Oxaliplatin|oxaliplatin|mesh-list
65152588|NCT01228734|Cetuximab|cetuximab|mesh-list
65152589|NCT01228734|Levoleucovorin|levoleucovorin|mesh-list
65152590|NCT01228734|Antimetabolites|antimetabolites|mesh-ancestor
65152591|NCT01228734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152641|NCT01153269|Antiviral Agents|antiviral agents|mesh-ancestor
65152642|NCT01153269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65152643|NCT01153269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65152644|NCT01153269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65152645|NCT02884635|Methotrexate|methotrexate|mesh-list
65152646|NCT02884635|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65152647|NCT02884635|Abortifacient Agents|abortifacient agents|mesh-ancestor
65152648|NCT02884635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65152649|NCT02884635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152650|NCT02884635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65152651|NCT02884635|Antimetabolites|antimetabolites|mesh-ancestor
65152652|NCT02884635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152701|NCT01149369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152702|NCT01149369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65152703|NCT01149369|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65152704|NCT01149369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65152705|NCT01149369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152706|NCT01740427|Letrozole|letrozole|mesh-list
65152707|NCT01740427|Palbociclib|palbociclib|mesh-list
65152708|NCT01740427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152709|NCT01740427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65152710|NCT01740427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65152711|NCT01740427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152712|NCT01740427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152713|NCT01740427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65152714|NCT01740427|Hormone Antagonists|hormone antagonists|mesh-ancestor
65152715|NCT01740427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65152716|NCT01740427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152756|NCT01148979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65152757|NCT01148979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152758|NCT01148979|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65152759|NCT01148979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65152760|NCT01148979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65152761|NCT01148979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152762|NCT01148979|Dopamine Agents|dopamine agents|mesh-ancestor
65152763|NCT01148979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65152819|NCT04269109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152820|NCT04269109|Analgesics|analgesics|mesh-ancestor
65152821|NCT04269109|Sensory System Agents|sensory system agents|mesh-ancestor
65152822|NCT04269109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65152823|NCT01661881|Cytarabine|cytarabine|mesh-list
65152824|NCT01661881|Rituximab|rituximab|mesh-list
65152825|NCT01661881|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65152826|NCT01661881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65152827|NCT01661881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152828|NCT01661881|Immunologic Factors|immunologic factors|mesh-ancestor
65152829|NCT01661881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152830|NCT01661881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65152831|NCT01661881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65152832|NCT01661881|Antimetabolites|antimetabolites|mesh-ancestor
65152833|NCT01661881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152834|NCT01661881|Antiviral Agents|antiviral agents|mesh-ancestor
65152835|NCT01661881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65152836|NCT01661881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65152837|NCT01661881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65152838|NCT01661881|Alkylating Agents|alkylating agents|mesh-ancestor
65152839|NCT01226472|Mogamulizumab|mogamulizumab|mesh-list
65152840|NCT01226472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152841|NCT04268563|Metformin|metformin|mesh-list
65152842|NCT04268563|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65152843|NCT04268563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65152844|NCT04268563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152845|NCT04268563|Incretins|incretins|mesh-ancestor
65152846|NCT04268563|Hormones|hormones|mesh-ancestor
65152847|NCT04268563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65152864|NCT00950911|Denosumab|denosumab|mesh-list
65152865|NCT00950911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65152866|NCT00950911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152867|NCT02855515|Anesthetics|anesthetics|mesh-list
65152868|NCT02855515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65152869|NCT02855515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65152870|NCT04206228|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
65152871|NCT04206228|Hematinics|hematinics|mesh-ancestor
65152872|NCT01218594|Endostatins|endostatins|mesh-list
65152873|NCT01218594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65152874|NCT01218594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65152930|NCT01147107|Raltegravir Potassium|raltegravir potassium|mesh-list
65152931|NCT01147107|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65152932|NCT01147107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65152933|NCT01147107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65152934|NCT01147107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152935|NCT01147107|Antiviral Agents|antiviral agents|mesh-ancestor
65152936|NCT01147107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65152937|NCT01147107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65152938|NCT01147107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65152939|NCT01147107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65152940|NCT01147107|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65152941|NCT01147107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65152942|NCT01147107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65152943|NCT01147107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65152944|NCT01147107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65152945|NCT01147107|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65152946|NCT01147107|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65152947|NCT01146951|Rufinamide|rufinamide|mesh-list
65152948|NCT01146951|Anticonvulsants|anticonvulsants|mesh-ancestor
65152949|NCT01146951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65152950|NCT01146951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65152951|NCT01146951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65152952|NCT01146951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152953|NCT01146873|Ritonavir|ritonavir|mesh-list
65152954|NCT01146873|Lopinavir|lopinavir|mesh-list
65152955|NCT01146873|Abacavir|abacavir|mesh-list
65152956|NCT01146873|Stavudine|stavudine|mesh-list
65152957|NCT01146873|Efavirenz|efavirenz|mesh-list
65152974|NCT01146873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65152976|NCT01146873|Antimetabolites|antimetabolites|mesh-ancestor
65152977|NCT01146795|Paclitaxel|paclitaxel|mesh-list
65152978|NCT01146795|Bevacizumab|bevacizumab|mesh-list
65152979|NCT01146795|Carboplatin|carboplatin|mesh-list
65152980|NCT01146795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65152981|NCT01146795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65152982|NCT01146795|Tubulin Modulators|tubulin modulators|mesh-ancestor
65152983|NCT01146795|Antimitotic Agents|antimitotic agents|mesh-ancestor
65152984|NCT01146795|Mitosis Modulators|mitosis modulators|mesh-ancestor
65152985|NCT01146795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65152986|NCT01146795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64795560|NCT05767723|Aspirin|aspirin|mesh-list
65152987|NCT01146795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65152988|NCT01146795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65152989|NCT01146795|Growth Substances|growth substances|mesh-ancestor
65152990|NCT01146795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153032|NCT01489813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65153033|NCT02852083|Pioglitazone|pioglitazone|mesh-list
65153034|NCT02852083|Clarithromycin|clarithromycin|mesh-list
65153035|NCT02852083|Nivolumab|nivolumab|mesh-list
65153036|NCT02852083|Treosulfan|treosulfan|mesh-list
65153037|NCT02852083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65153038|NCT02852083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153039|NCT02852083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65153040|NCT02852083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153041|NCT02852083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65153042|NCT02852083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153043|NCT02852083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65153044|NCT02852083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65153045|NCT02852083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65153046|NCT02852083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153047|NCT02852083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65153048|NCT02852083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65153087|NCT01143207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65153088|NCT01143207|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65153089|NCT01143207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65153090|NCT01143207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153091|NCT01143051|Epinephrine|epinephrine|mesh-list
65153092|NCT01143051|Racepinephrine|racepinephrine|mesh-list
65153093|NCT01143051|Epinephryl borate|epinephryl borate|mesh-list
65153094|NCT01143051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65153095|NCT01143051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65153096|NCT01143051|Adrenergic Agents|adrenergic agents|mesh-ancestor
65153097|NCT01143051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65153098|NCT01143051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153099|NCT01143051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153100|NCT01143051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65153147|NCT05367063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65153148|NCT05367063|Protease Inhibitors|protease inhibitors|mesh-ancestor
65153149|NCT05367063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153150|NCT05367063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153151|NCT05367063|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65153152|NCT01283282|Clopidogrel|clopidogrel|mesh-list
65153153|NCT01283282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65153154|NCT01283282|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65153155|NCT01283282|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65153156|NCT01283282|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65153157|NCT01283282|Purinergic Agents|purinergic agents|mesh-ancestor
65153158|NCT01283282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65153159|NCT01283282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153160|NCT01283282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153161|NCT01282814|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65153162|NCT01282814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65153163|NCT01282814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65153199|NCT01282424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153200|NCT01282424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153201|NCT01282424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153202|NCT00602251|Terbinafine|terbinafine|mesh-list
65153203|NCT00602251|Antifungal Agents|antifungal agents|mesh-ancestor
65153204|NCT00602251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65153205|NCT00602251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153206|NCT00602251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153207|NCT01281956|Naluzotan|naluzotan|mesh-list
65153208|NCT01281956|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65153209|NCT01281956|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65153210|NCT01281956|Serotonin Agents|serotonin agents|mesh-ancestor
65153211|NCT01281956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65153212|NCT01281956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153257|NCT00604435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65153258|NCT00604435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153259|NCT00604435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65153260|NCT00604435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65153261|NCT00604435|Growth Substances|growth substances|mesh-ancestor
65153262|NCT00604435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153263|NCT00604435|Growth Inhibitors|growth inhibitors|mesh-ancestor
65153264|NCT01136967|Lenvatinib|lenvatinib|mesh-list
65153265|NCT01136967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153266|NCT01136967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65153267|NCT01136967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65153268|NCT01136967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153269|NCT01218516|Paclitaxel|paclitaxel|mesh-list
65153270|NCT01218516|Carboplatin|carboplatin|mesh-list
65153271|NCT01218516|Pemetrexed|pemetrexed|mesh-list
65153272|NCT01218516|Farletuzumab|farletuzumab|mesh-list
65153273|NCT01218516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65153283|NCT00938431|Anticonvulsants|anticonvulsants|mesh-ancestor
65153315|NCT04312347|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65153316|NCT04312347|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65153317|NCT04312347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65153318|NCT00938041|Tositumomab I-131|tositumomab i-131|mesh-list
65153319|NCT00938041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153320|NCT05379283|Lidocaine|lidocaine|mesh-list
65153321|NCT05379283|Anesthetics, Local|anesthetics, local|mesh-ancestor
65153322|NCT05379283|Anesthetics|anesthetics|mesh-ancestor
65153323|NCT05379283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65153324|NCT05379283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153325|NCT05379283|Sensory System Agents|sensory system agents|mesh-ancestor
65153326|NCT05379283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65153327|NCT05379283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65153378|NCT05379049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65153379|NCT05379049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65153380|NCT05379049|Analgesics|analgesics|mesh-ancestor
65153381|NCT05379049|Sensory System Agents|sensory system agents|mesh-ancestor
65153449|NCT05378503|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65153450|NCT05378503|Sympathomimetics|sympathomimetics|mesh-ancestor
65153451|NCT05378503|Autonomic Agents|autonomic agents|mesh-ancestor
65153521|NCT00934843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65153522|NCT00934843|Antiemetics|antiemetics|mesh-ancestor
65153523|NCT00934843|Autonomic Agents|autonomic agents|mesh-ancestor
65153524|NCT00934843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65153526|NCT00934843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65153592|NCT01266590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153593|NCT01266590|Protective Agents|protective agents|mesh-ancestor
65153594|NCT01266590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153595|NCT01265498|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
65153596|NCT01265498|Cathartics|cathartics|mesh-ancestor
65153597|NCT01265498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65153598|NCT00607711|Isophosphamide mustard|isophosphamide mustard|mesh-list
65153599|NCT00607711|Ifosfamide|ifosfamide|mesh-list
65153600|NCT00607711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65153657|NCT01262456|Coagulants|coagulants|mesh-ancestor
65153658|NCT01262456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65153659|NCT01262456|Natriuretic Agents|natriuretic agents|mesh-ancestor
65153660|NCT01262456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153661|NCT04321694|Mogamulizumab|mogamulizumab|mesh-list
65153662|NCT04321694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153663|NCT04321850|Zinc|zinc|mesh-list
65153664|NCT04321850|Zinc Sulfate|zinc sulfate|mesh-list
65153665|NCT04321850|Trace Elements|trace elements|mesh-ancestor
65153666|NCT04321850|Micronutrients|micronutrients|mesh-ancestor
65153667|NCT04321850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153668|NCT04321850|Astringents|astringents|mesh-ancestor
65153669|NCT04321850|Dermatologic Agents|dermatologic agents|mesh-ancestor
65153670|NCT04321616|Hydroxychloroquine|hydroxychloroquine|mesh-list
65153671|NCT04321616|Remdesivir|remdesivir|mesh-list
65153720|NCT01260584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65153721|NCT01260584|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65153722|NCT01260584|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65153723|NCT01260584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65153724|NCT01260584|Purinergic Agents|purinergic agents|mesh-ancestor
64796311|NCT04641975|Mirabegron|mirabegron|mesh-list
65153789|NCT00932113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65153790|NCT00932113|Antimetabolites|antimetabolites|mesh-ancestor
65153792|NCT00932113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65153863|NCT00609193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65153864|NCT00609193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65153865|NCT00609193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65153866|NCT00930553|Alemtuzumab|alemtuzumab|mesh-list
65153867|NCT00930553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65153933|NCT04260607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65153934|NCT00927355|Pioglitazone|pioglitazone|mesh-list
65153935|NCT00927355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65154004|NCT00922987|Pregabalin|pregabalin|mesh-list
65154005|NCT00922987|Analgesics|analgesics|mesh-ancestor
65154006|NCT00922987|Sensory System Agents|sensory system agents|mesh-ancestor
65154007|NCT00922987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65154008|NCT00922987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154009|NCT00922987|Anticonvulsants|anticonvulsants|mesh-ancestor
65154010|NCT00922987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65154011|NCT00922987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65154012|NCT00922987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154013|NCT00922987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65154014|NCT00922987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65154015|NCT00922987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65154016|NCT00922987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65154017|NCT00922987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65154018|NCT00610909|Paroxetine|paroxetine|mesh-list
65154019|NCT00610909|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65154020|NCT00610909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65154021|NCT00610909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65154022|NCT00610909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154023|NCT00610909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65154055|NCT01218204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154056|NCT00926575|Beclomethasone|beclomethasone|mesh-list
65154057|NCT00926575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65154058|NCT00926575|Glucocorticoids|glucocorticoids|mesh-ancestor
65154059|NCT00926575|Hormones|hormones|mesh-ancestor
65154061|NCT00926575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154127|NCT01136733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154128|NCT05178693|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65154129|NCT05178693|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65154130|NCT05178693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154196|NCT00922207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154197|NCT01134315|Calcitriol|calcitriol|mesh-list
65154198|NCT01134315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65154200|NCT01134315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65154265|NCT00637455|Fexofenadine|fexofenadine|mesh-list
65154266|NCT00637455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65154267|NCT00637455|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65154268|NCT00637455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65154270|NCT00637455|Histamine Agents|histamine agents|mesh-ancestor
65154336|NCT01130493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65154337|NCT01130493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154338|NCT01130493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154339|NCT01130493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65154340|NCT01130493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154341|NCT01130493|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65154342|NCT01130493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65154343|NCT01130493|Immunologic Factors|immunologic factors|mesh-ancestor
65154400|NCT00625209|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65154476|NCT04962841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65154477|NCT04962841|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65154478|NCT04962841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65154479|NCT04962841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154480|NCT04962841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65154481|NCT04962841|Vasodilator Agents|vasodilator agents|mesh-ancestor
65154482|NCT04962841|Antidepressive Agents|antidepressive agents|mesh-ancestor
65154483|NCT04962841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65154484|NCT04962841|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65154485|NCT04962841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65154486|NCT04962841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65154487|NCT04962841|Serotonin Agents|serotonin agents|mesh-ancestor
65154488|NCT04962841|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65154535|NCT04251871|Ritonavir|ritonavir|mesh-list
65154536|NCT04251871|Lopinavir|lopinavir|mesh-list
65154537|NCT04251871|Interferon-alpha|interferon-alpha|mesh-list
65154538|NCT04251871|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65154539|NCT04251871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154540|NCT04251871|Antiviral Agents|antiviral agents|mesh-ancestor
65154541|NCT04251871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65154542|NCT04251871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65154544|NCT04251871|Protease Inhibitors|protease inhibitors|mesh-ancestor
65154604|NCT00925015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65154605|NCT00925015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65154614|NCT01127763|Everolimus|everolimus|mesh-list
65154677|NCT00918385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65154678|NCT00918385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65154679|NCT00918385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154680|NCT00918385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154681|NCT00918385|Androgen Antagonists|androgen antagonists|mesh-ancestor
65154682|NCT00918385|Hormone Antagonists|hormone antagonists|mesh-ancestor
65154683|NCT00918385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65154684|NCT00918385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65154685|NCT00637819|Leflunomide|leflunomide|mesh-list
65154686|NCT00637819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154688|NCT00637819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65154740|NCT00916279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154741|NCT01209078|Linezolid|linezolid|mesh-list
65154742|NCT01209078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65154743|NCT01209078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65154744|NCT01209078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65154745|NCT01209078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65154746|NCT01209078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65154806|NCT04404049|UB-421|ub-421|mesh-list
65154807|NCT04404049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65154808|NCT04404049|Antiviral Agents|antiviral agents|mesh-ancestor
65154809|NCT04404049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65154810|NCT04636255|Calcium|calcium|mesh-list
65154880|NCT00910273|Etanercept|etanercept|mesh-list
65154882|NCT00910273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65154954|NCT01284959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65154955|NCT01284959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65154956|NCT01284959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65154957|NCT01284959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65154958|NCT01284959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65154959|NCT01284959|Dopamine Agents|dopamine agents|mesh-ancestor
65155024|NCT01280591|Gout Suppressants|gout suppressants|mesh-ancestor
65155025|NCT01280591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65155026|NCT01280591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155027|NCT01280591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155028|NCT04323761|Remdesivir|remdesivir|mesh-list
65155033|NCT05566223|Aldesleukin|aldesleukin|mesh-list
65155095|NCT04323527|Sensory System Agents|sensory system agents|mesh-ancestor
65155096|NCT04323527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155097|NCT04323527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155098|NCT04323527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65155099|NCT04323527|Filaricides|filaricides|mesh-ancestor
65155100|NCT04323527|Antinematodal Agents|antinematodal agents|mesh-ancestor
65155101|NCT04323527|Anthelmintics|anthelmintics|mesh-ancestor
65155164|NCT05542667|Fluorides|fluorides|mesh-list
65155165|NCT05542667|Fluorides, Topical|fluorides, topical|mesh-list
65155166|NCT05542667|Cariostatic Agents|cariostatic agents|mesh-ancestor
65155167|NCT05542667|Protective Agents|protective agents|mesh-ancestor
65155169|NCT01263509|Inositol|inositol|mesh-list
65155238|NCT04321655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155239|NCT04321655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155240|NCT05529251|Carboplatin|carboplatin|mesh-list
65155241|NCT05529251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155242|NCT01261325|Brivaracetam|brivaracetam|mesh-list
65155308|NCT04650893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65155309|NCT04650893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65155310|NCT04650893|Analgesics|analgesics|mesh-ancestor
65155311|NCT04650893|Sensory System Agents|sensory system agents|mesh-ancestor
65155312|NCT04650893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65155313|NCT04650893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65155314|NCT04650893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155316|NCT04540835|Calcium|calcium|mesh-list
65155328|NCT04320173|Lidocaine|lidocaine|mesh-list
65155376|NCT02029001|Tremelimumab|tremelimumab|mesh-list
65155386|NCT01613495|Octreotide|octreotide|mesh-list
65155451|NCT01126359|Sensory System Agents|sensory system agents|mesh-ancestor
65155452|NCT01126359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155454|NCT01126359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65155455|NCT01126359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65155456|NCT01126359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65155457|NCT01126359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155458|NCT00637533|Botulinum Toxins|botulinum toxins|mesh-list
65155516|NCT01256879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65155517|NCT01256879|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65155518|NCT01256879|Histamine Antagonists|histamine antagonists|mesh-ancestor
65155519|NCT01256879|Histamine Agents|histamine agents|mesh-ancestor
65155520|NCT01256879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65155521|NCT01256879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155522|NCT01256879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155523|NCT01256879|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65155524|NCT01256879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65155525|NCT01256879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155580|NCT01256411|Amlodipine|amlodipine|mesh-list
65155581|NCT01256411|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65155582|NCT01256411|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65155650|NCT02869984|Autonomic Agents|autonomic agents|mesh-ancestor
65155651|NCT02869984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65155652|NCT02869984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155721|NCT01254305|Antidepressive Agents|antidepressive agents|mesh-ancestor
65155722|NCT01254305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65155723|NCT01254305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65155724|NCT01254305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65155791|NCT01121913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65155792|NCT01121913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65155861|NCT01253135|Petrolatum|petrolatum|mesh-list
65155862|NCT01253135|Emollients|emollients|mesh-ancestor
65155863|NCT01253135|Dermatologic Agents|dermatologic agents|mesh-ancestor
65155864|NCT00993616|Carboplatin|carboplatin|mesh-list
65155865|NCT00993616|Belinostat|belinostat|mesh-list
65155866|NCT00993616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65155867|NCT00993616|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65155868|NCT00993616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155869|NCT00993616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155870|NCT01120899|Minocycline|minocycline|mesh-list
65155871|NCT01120899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65155872|NCT01120899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65155873|NCT01120275|R04929097|r04929097|mesh-list
65155874|NCT01120275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155875|NCT01120275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155876|NCT00991510|Mycophenolic Acid|mycophenolic acid|mesh-list
65155923|NCT02868580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65155924|NCT02868580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65155926|NCT02868580|Antiviral Agents|antiviral agents|mesh-ancestor
65155994|NCT00991276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65155995|NCT00991276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65155997|NCT00991276|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65156066|NCT02867800|Fludarabine|fludarabine|mesh-list
65156067|NCT02867800|Melphalan|melphalan|mesh-list
65156068|NCT02867800|Alemtuzumab|alemtuzumab|mesh-list
65156069|NCT02867800|Abatacept|abatacept|mesh-list
65156070|NCT02867800|Thiotepa|thiotepa|mesh-list
65156071|NCT02867800|Meperidine|meperidine|mesh-list
65156072|NCT02867800|Tacrolimus|tacrolimus|mesh-list
65156073|NCT02867800|Cyclosporins|cyclosporins|mesh-list
65156074|NCT02867800|Thymoglobulin|thymoglobulin|mesh-list
65156075|NCT02867800|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65156076|NCT02867800|Abortifacient Agents|abortifacient agents|mesh-ancestor
65156077|NCT02867800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65156078|NCT02867800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156079|NCT02867800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65156080|NCT02867800|Antimetabolites|antimetabolites|mesh-ancestor
65156130|NCT00629200|Interferons|interferons|mesh-list
65156131|NCT00629200|Interferon-alpha|interferon-alpha|mesh-list
65156132|NCT00629200|Interferon alpha-2|interferon alpha-2|mesh-list
65156133|NCT00629200|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
65156134|NCT00629200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65156135|NCT00629200|Antiviral Agents|antiviral agents|mesh-ancestor
65156136|NCT00629200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65156137|NCT00629200|Immunologic Factors|immunologic factors|mesh-ancestor
65156138|NCT00629200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156139|NCT00629200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65156140|NCT00629200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65156141|NCT00629200|Schistosomicides|schistosomicides|mesh-ancestor
65156142|NCT00629200|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65156143|NCT00629200|Anthelmintics|anthelmintics|mesh-ancestor
65156195|NCT01260350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65156196|NCT01260194|Trastuzumab|trastuzumab|mesh-list
65156268|NCT00624026|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65156269|NCT05512910|Minocycline|minocycline|mesh-list
65156270|NCT05512910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65156342|NCT04187469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65156343|NCT04187469|Antitubercular Agents|antitubercular agents|mesh-ancestor
65156344|NCT04187469|Leprostatic Agents|leprostatic agents|mesh-ancestor
65156353|NCT04187469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65156415|NCT01114737|Verapamil|verapamil|mesh-list
65156416|NCT01114737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65156417|NCT01114737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65156418|NCT01114737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65156422|NCT01114737|Vasodilator Agents|vasodilator agents|mesh-ancestor
65156487|NCT04128748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65156488|NCT04128748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65156489|NCT04128748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65156490|NCT04128748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156491|NCT04116502|Interferons|interferons|mesh-list
65156492|NCT04116502|Interferon-alpha|interferon-alpha|mesh-list
65156493|NCT04116502|Interferon alpha-2|interferon alpha-2|mesh-list
65156556|NCT04084210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65156557|NCT04084210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156558|NCT04084210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65156559|NCT04084210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65156560|NCT04084210|Cholinergic Agents|cholinergic agents|mesh-ancestor
65156561|NCT04084210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65156563|NCT02865460|Coenzyme Q10|coenzyme q10|mesh-list
65156626|NCT01257698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65156627|NCT01257698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65156628|NCT01257698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65156629|NCT01257698|Adrenergic Agents|adrenergic agents|mesh-ancestor
65156630|NCT01257698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65156631|NCT01257698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156632|NCT01257698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156633|NCT01257698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65156634|NCT01257698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65156635|NCT01257698|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65156636|NCT01257698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65156637|NCT01257698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65156638|NCT01257542|Dextromethorphan|dextromethorphan|mesh-list
65156639|NCT01257542|Antitussive Agents|antitussive agents|mesh-ancestor
65156640|NCT01257542|Respiratory System Agents|respiratory system agents|mesh-ancestor
65156685|NCT01256450|Sensory System Agents|sensory system agents|mesh-ancestor
65156686|NCT01256450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65156687|NCT01256450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65156688|NCT01204398|Amlodipine|amlodipine|mesh-list
65156689|NCT01204398|Telmisartan|telmisartan|mesh-list
65156690|NCT01204398|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
65156691|NCT01204398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65156692|NCT01204398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65156693|NCT01204398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65156694|NCT01204398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156695|NCT01204398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65156696|NCT01204398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156697|NCT01204398|Vasodilator Agents|vasodilator agents|mesh-ancestor
65156698|NCT01204398|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65156745|NCT01255904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65156746|NCT01255904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65156748|NCT01255904|Analgesics|analgesics|mesh-ancestor
65156817|NCT01105065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65156818|NCT01105065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65156819|NCT01105065|Adrenergic Agents|adrenergic agents|mesh-ancestor
65156820|NCT01105065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65156823|NCT01111539|Aripiprazole|aripiprazole|mesh-list
65156885|NCT01111149|Antidepressive Agents|antidepressive agents|mesh-ancestor
65156886|NCT01111149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65156887|NCT01111149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65156888|NCT01111149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65156889|NCT01111149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65156890|NCT01111149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65156891|NCT01111149|Dopamine Agents|dopamine agents|mesh-ancestor
65156892|NCT01111149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65156949|NCT01109979|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65156950|NCT01109979|Drospirenone|drospirenone|mesh-list
65156951|NCT01109979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65156952|NCT01109979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64799604|NCT01397331|Anesthetics|anesthetics|mesh-ancestor
65157020|NCT02879721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65157088|NCT01101321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157089|NCT01101321|Analgesics|analgesics|mesh-ancestor
65157090|NCT01101321|Sensory System Agents|sensory system agents|mesh-ancestor
65157091|NCT01101321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157093|NCT04309929|Sensory System Agents|sensory system agents|mesh-ancestor
65157160|NCT01097577|Sensory System Agents|sensory system agents|mesh-ancestor
65157161|NCT01097577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64799753|NCT03283813|Micronutrients|micronutrients|mesh-ancestor
65157162|NCT01097577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157163|NCT01097577|Anticonvulsants|anticonvulsants|mesh-ancestor
65157228|NCT01251146|Adrenergic Agents|adrenergic agents|mesh-ancestor
65157229|NCT01251146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65157230|NCT01251146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157245|NCT04999215|Choline|choline|mesh-list
65157301|NCT02878161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65157302|NCT02878161|Abortifacient Agents|abortifacient agents|mesh-ancestor
65157303|NCT02878161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65157304|NCT02878161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65157305|NCT02878161|Antimetabolites|antimetabolites|mesh-ancestor
65157306|NCT02878161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157307|NCT02878161|Dermatologic Agents|dermatologic agents|mesh-ancestor
65157308|NCT02878161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157309|NCT02878161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65157310|NCT02878161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65157365|NCT01078545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65157366|NCT01078545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157367|NCT01078545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65157369|NCT01091259|Bevacizumab|bevacizumab|mesh-list
65157435|NCT01200342|Mitosis Modulators|mitosis modulators|mesh-ancestor
65157436|NCT01200342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157437|NCT05392452|Insulin|insulin|mesh-list
65157438|NCT05392452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65157440|NCT01198548|Vitamin D|vitamin d|mesh-list
65157508|NCT01090011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65157509|NCT01090011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65157510|NCT01090011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65157511|NCT01090011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157512|NCT01090011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157513|NCT02877615|S44819|s44819|mesh-list
65157514|NCT02877615|GABA-A Receptor Antagonists|gaba-a receptor antagonists|mesh-ancestor
65157515|NCT02877615|GABA Antagonists|gaba antagonists|mesh-ancestor
65157516|NCT02877615|GABA Agents|gaba agents|mesh-ancestor
65157574|NCT04306653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157575|NCT04306653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65157576|NCT04306653|Respiratory System Agents|respiratory system agents|mesh-ancestor
65157577|NCT04306731|Trimethoprim|trimethoprim|mesh-list
65157590|NCT02877537|Albuterol|albuterol|mesh-list
65157645|NCT01248065|Cholecalciferol|cholecalciferol|mesh-list
65157646|NCT01248065|Ciclesonide|ciclesonide|mesh-list
65157720|NCT00626613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65157721|NCT00626613|Dopamine Agents|dopamine agents|mesh-ancestor
65157722|NCT00626613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65157723|NCT00626613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157724|NCT00626613|Cholinergic Agents|cholinergic agents|mesh-ancestor
65157725|NCT00626613|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65157726|NCT00626613|Autonomic Agents|autonomic agents|mesh-ancestor
65157727|NCT00626613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157728|NCT00626613|Nootropic Agents|nootropic agents|mesh-ancestor
65157729|NCT01080807|Modafinil|modafinil|mesh-list
65157730|NCT01080807|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65157731|NCT01080807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65157732|NCT01080807|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65157733|NCT01080807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65157734|NCT01080807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65157735|NCT01080807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157736|NCT01079949|Cetrorelix|cetrorelix|mesh-list
65157737|NCT01079949|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65157776|NCT04289194|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65157777|NCT04289194|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65157850|NCT05580523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65157851|NCT05580523|Analgesics|analgesics|mesh-ancestor
65157852|NCT05580523|Sensory System Agents|sensory system agents|mesh-ancestor
65157853|NCT05580523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65157854|NCT05580523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65157855|NCT05580523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65157919|NCT02864602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65157921|NCT02864602|Protease Inhibitors|protease inhibitors|mesh-ancestor
65157922|NCT02864602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65157923|NCT02864602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65157924|NCT03667651|Decanoic acid|decanoic acid|mesh-list
65157925|NCT03667651|Antifungal Agents|antifungal agents|mesh-ancestor
65157989|NCT02555839|Dexamethasone acetate|dexamethasone acetate|mesh-list
65157990|NCT02555839|Bortezomib|bortezomib|mesh-list
65158063|NCT02850445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65158064|NCT02850445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64800662|NCT03932318|Venetoclax|venetoclax|mesh-list
65158065|NCT02850445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65158135|NCT04202887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65158136|NCT04202887|Anesthetics, General|anesthetics, general|mesh-ancestor
65158137|NCT04202887|Anesthetics|anesthetics|mesh-ancestor
65158138|NCT05324215|Fentanyl|fentanyl|mesh-list
65158150|NCT02131753|Cladribine|cladribine|mesh-list
65158208|NCT00903409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65158209|NCT00903409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65158210|NCT00903409|Antimetabolites|antimetabolites|mesh-ancestor
65158211|NCT00903409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158212|NCT00903409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65158213|NCT00903409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65158214|NCT00903409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158215|NCT01237223|Amlodipine|amlodipine|mesh-list
65158216|NCT01237223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65158217|NCT01237223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65158218|NCT01237223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65158269|NCT01868269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65158270|NCT01868269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65158271|NCT01868269|Antiemetics|antiemetics|mesh-ancestor
65158276|NCT01868269|Hormones|hormones|mesh-ancestor
65158341|NCT04413253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65158342|NCT04413253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65158343|NCT04413253|Antiemetics|antiemetics|mesh-ancestor
65158344|NCT04413253|Autonomic Agents|autonomic agents|mesh-ancestor
65158345|NCT04413253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158411|NCT04304157|Sensory System Agents|sensory system agents|mesh-ancestor
65158412|NCT04304157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158483|NCT01074255|Aprepitant|aprepitant|mesh-list
65158484|NCT01074255|Antiemetics|antiemetics|mesh-ancestor
65158485|NCT01074255|Autonomic Agents|autonomic agents|mesh-ancestor
65158486|NCT01074255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158487|NCT01074255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158488|NCT01074255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65158489|NCT01074255|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65158550|NCT04697485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65158551|NCT04697485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158552|NCT01073631|Voriconazole|voriconazole|mesh-list
65158553|NCT01073631|Antifungal Agents|antifungal agents|mesh-ancestor
65158554|NCT01073631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65158555|NCT01073631|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65158556|NCT01073631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65158557|NCT01073631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158558|NCT01073631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158611|NCT04304313|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65158612|NCT04304313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65158613|NCT04304313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158614|NCT04304313|Urological Agents|urological agents|mesh-ancestor
65158681|NCT01230827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65158682|NCT01230827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
65158683|NCT01230827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65158684|NCT01230749|Pioglitazone|pioglitazone|mesh-list
65158753|NCT02848417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158754|NCT02848417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158755|NCT02848417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65158756|NCT02848417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65158757|NCT02848417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158758|NCT02848417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158759|NCT02848417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65158760|NCT02847403|Exenatide|exenatide|mesh-list
65158761|NCT02847403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65158762|NCT02847403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65158763|NCT02847403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65158764|NCT02847403|Incretins|incretins|mesh-ancestor
65158765|NCT02847403|Hormones|hormones|mesh-ancestor
65158813|NCT02846935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158814|NCT02846935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65158815|NCT02844673|Hydroxyurea|hydroxyurea|mesh-list
65158816|NCT02844673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65158817|NCT02844673|Antisickling Agents|antisickling agents|mesh-ancestor
65158883|NCT00992446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65158884|NCT00992446|Etoposide|etoposide|mesh-list
65158885|NCT00992446|Etoposide phosphate|etoposide phosphate|mesh-list
65158886|NCT00992446|Bortezomib|bortezomib|mesh-list
65158887|NCT00992446|Melphalan|melphalan|mesh-list
65158888|NCT00992446|Mechlorethamine|mechlorethamine|mesh-list
65158889|NCT00992446|Vorinostat|vorinostat|mesh-list
65158890|NCT00992446|Carmustine|carmustine|mesh-list
65158891|NCT00992446|Podophyllotoxin|podophyllotoxin|mesh-list
65158892|NCT00992446|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
65158893|NCT00992446|Antibodies|antibodies|mesh-list
65158894|NCT00992446|Immunoglobulins|immunoglobulins|mesh-list
65158895|NCT00992446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65158949|NCT02863120|Sensory System Agents|sensory system agents|mesh-ancestor
65158950|NCT02863120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65158951|NCT03823534|Acetaminophen|acetaminophen|mesh-list
65158952|NCT03823534|Ketorolac|ketorolac|mesh-list
65158953|NCT03823534|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65159017|NCT04191421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65159018|NCT04191421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159091|NCT02845843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65159092|NCT02845999|Cyclophosphamide|cyclophosphamide|mesh-list
65159165|NCT00903721|Dermatologic Agents|dermatologic agents|mesh-ancestor
65159166|NCT00903721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65159167|NCT02845219|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
65159235|NCT03679312|Gasotransmitters|gasotransmitters|mesh-ancestor
65159236|NCT03679312|Protective Agents|protective agents|mesh-ancestor
65159237|NCT02842567|Vitamin E|vitamin e|mesh-list
65159238|NCT02842567|Tocopherols|tocopherols|mesh-list
65159239|NCT02842567|alpha-Tocopherol|alpha-tocopherol|mesh-list
65159240|NCT02842567|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
65159241|NCT02842567|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
65159242|NCT02842567|Vitamins|vitamins|mesh-ancestor
65159243|NCT02842567|Micronutrients|micronutrients|mesh-ancestor
65159244|NCT02842567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159304|NCT02838823|Immunologic Factors|immunologic factors|mesh-ancestor
65159305|NCT02838823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159306|NCT00156091|Olanzapine|olanzapine|mesh-list
65159307|NCT00156091|Asenapine|asenapine|mesh-list
65159308|NCT00156091|Antiemetics|antiemetics|mesh-ancestor
65159309|NCT00156091|Autonomic Agents|autonomic agents|mesh-ancestor
65159310|NCT00156091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65159311|NCT00156091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159312|NCT00156091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65159313|NCT00156091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65159323|NCT00140959|Losartan|losartan|mesh-list
65159368|NCT00092755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159369|NCT00092755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159443|NCT01228175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159444|NCT01228175|Vitamin B Complex|vitamin b complex|mesh-ancestor
65159445|NCT01228175|Vitamins|vitamins|mesh-ancestor
65159520|NCT00895843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65159521|NCT00895843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65159522|NCT00895843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65159534|NCT00895843|Mydriatics|mydriatics|mesh-ancestor
65159592|NCT00893113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65159666|NCT00968812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65159667|NCT00968812|Immunologic Factors|immunologic factors|mesh-ancestor
65159668|NCT00968812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65159669|NCT00968812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159670|NCT02834845|Sevoflurane|sevoflurane|mesh-list
65159671|NCT02834845|Desflurane|desflurane|mesh-list
65159672|NCT02834845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65159673|NCT02834845|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65159674|NCT02834845|Anesthetics, General|anesthetics, general|mesh-ancestor
65159675|NCT02834845|Anesthetics|anesthetics|mesh-ancestor
65159676|NCT02834845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65159677|NCT02834845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65159683|NCT00992056|Metoprolol|metoprolol|mesh-list
65159727|NCT04248205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65159728|NCT04248205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159729|NCT02833831|Moxifloxacin|moxifloxacin|mesh-list
65159730|NCT02833831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65159731|NCT02833831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65159732|NCT02833831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65159733|NCT02833831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65159734|NCT02833831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159736|NCT02833831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159794|NCT02836483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65159795|NCT02836483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159796|NCT02836483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159797|NCT02836171|Itraconazole|itraconazole|mesh-list
65159798|NCT02836171|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
65159799|NCT02836171|Apatinib|apatinib|mesh-list
65159800|NCT02836171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65159801|NCT02836171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65159802|NCT02836171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65159804|NCT02836171|Antifungal Agents|antifungal agents|mesh-ancestor
65159858|NCT00970684|Growth Inhibitors|growth inhibitors|mesh-ancestor
65159859|NCT00970684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65159860|NCT00970684|Antimetabolites|antimetabolites|mesh-ancestor
65159861|NCT00970684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802478|NCT01402297|Acetovanillone|acetovanillone|mesh-list
65159862|NCT00970684|Antiviral Agents|antiviral agents|mesh-ancestor
65159928|NCT04285528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65159929|NCT04285528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65159930|NCT04285528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65159931|NCT04285528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65159932|NCT04285528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65159933|NCT04285528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65159934|NCT04285528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65159935|NCT04285528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65159936|NCT04285528|Anesthetics, General|anesthetics, general|mesh-ancestor
65159937|NCT04285528|Analgesics|analgesics|mesh-ancestor
64802552|NCT01402843|Valsartan|valsartan|mesh-list
65159938|NCT04285528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65159939|NCT04285528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65159990|NCT03263650|Hormones|hormones|mesh-ancestor
65159991|NCT03263650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65160064|NCT00960076|Protease Inhibitors|protease inhibitors|mesh-ancestor
65160065|NCT00960076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160066|NCT00960076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160067|NCT04281082|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
65160068|NCT04281082|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65160069|NCT04281082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65160070|NCT04284202|Dasatinib|dasatinib|mesh-list
65160075|NCT01227629|Warfarin|warfarin|mesh-list
65160131|NCT04283110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65160132|NCT04283110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160133|NCT04283110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65160134|NCT04283110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65160135|NCT04283110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65160136|NCT04283110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65160203|NCT02861716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65160204|NCT02861716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160205|NCT02861716|Sensory System Agents|sensory system agents|mesh-ancestor
65160206|NCT02861716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65160207|NCT02861716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65160208|NCT02861716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65160209|NCT02861716|Analgesics|analgesics|mesh-ancestor
65160210|NCT02861716|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65160211|NCT02861716|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64693709|NCT00375245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65160268|NCT00892099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65160269|NCT00892099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65160270|NCT00960856|Fenofibric acid|fenofibric acid|mesh-list
65160271|NCT00960856|Fenofibrate|fenofibrate|mesh-list
65160272|NCT00960856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65160273|NCT00960856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65160274|NCT00960856|Antimetabolites|antimetabolites|mesh-ancestor
65160276|NCT00960856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65160334|NCT02831491|Tubulin Modulators|tubulin modulators|mesh-ancestor
65160335|NCT02831491|Antimitotic Agents|antimitotic agents|mesh-ancestor
65160336|NCT02831491|Mitosis Modulators|mitosis modulators|mesh-ancestor
65160337|NCT02831491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160338|NCT02860234|Capecitabine|capecitabine|mesh-list
65160339|NCT02860234|Oxaliplatin|oxaliplatin|mesh-list
65160340|NCT02860234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65160341|NCT02860234|Antimetabolites|antimetabolites|mesh-ancestor
65160342|NCT02860234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160343|NCT02860234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65160344|NCT00630370|ATI 7505|ati 7505|mesh-list
65160345|NCT00630370|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65160346|NCT00630370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65160347|NCT00630370|Serotonin Agents|serotonin agents|mesh-ancestor
65160348|NCT00630370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65160349|NCT00630370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160350|NCT00630370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160351|NCT04281706|Propofol|propofol|mesh-list
65160352|NCT04281706|Etomidate|etomidate|mesh-list
65160353|NCT04281706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65160354|NCT04281706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65160355|NCT04281706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160387|NCT02831179|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65160388|NCT02831179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803005|NCT01404819|Anesthetics|anesthetics|mesh-list
65160389|NCT02830789|Calcium, Dietary|calcium, dietary|mesh-list
65160390|NCT02830789|Calcium Carbonate|calcium carbonate|mesh-list
65160391|NCT02830789|Calcium|calcium|mesh-list
65160392|NCT02830789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65160393|NCT02830789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160394|NCT02830789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65160397|NCT02830789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65160451|NCT02831023|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65160452|NCT02831023|Renal Agents|renal agents|mesh-ancestor
65160453|NCT04244695|Dexamethasone|dexamethasone|mesh-list
65160454|NCT04244695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65160525|NCT00953680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65160526|NCT00953680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65160527|NCT00953680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160528|NCT00953680|Diuretics|diuretics|mesh-ancestor
65160529|NCT00953680|Natriuretic Agents|natriuretic agents|mesh-ancestor
65160530|NCT00953680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160531|NCT00953680|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65160532|NCT00953680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65160533|NCT00890929|Lenalidomide|lenalidomide|mesh-list
65160534|NCT00890929|Azacitidine|azacitidine|mesh-list
65160535|NCT00890929|Immunologic Factors|immunologic factors|mesh-ancestor
65160536|NCT00890929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160588|NCT02826343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160589|NCT02826343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65160590|NCT02826343|Autonomic Agents|autonomic agents|mesh-ancestor
65160591|NCT02826343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65160592|NCT02826343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65160593|NCT02826343|Respiratory System Agents|respiratory system agents|mesh-ancestor
65160594|NCT02826343|Glucocorticoids|glucocorticoids|mesh-ancestor
65160595|NCT02826343|Hormones|hormones|mesh-ancestor
65160596|NCT02826343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65160597|NCT02826343|Sympathomimetics|sympathomimetics|mesh-ancestor
65160598|NCT05660785|Cyclosporine|cyclosporine|mesh-list
65160599|NCT05660785|Cyclosporins|cyclosporins|mesh-list
65160600|NCT05660785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160601|NCT05660785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160602|NCT05660785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65160610|NCT04246255|Lidocaine|lidocaine|mesh-list
65160647|NCT02829697|Anesthetics, Local|anesthetics, local|mesh-ancestor
65160653|NCT02829151|Aspirin|aspirin|mesh-list
65160721|NCT02825797|Immunoglobulins|immunoglobulins|mesh-list
65160722|NCT02825797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65160723|NCT02825797|Immunologic Factors|immunologic factors|mesh-ancestor
65160724|NCT02825797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160725|NCT02825797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65160726|NCT02824315|Simeprevir|simeprevir|mesh-list
65160727|NCT02824315|Odalasvir|odalasvir|mesh-list
65160728|NCT02824315|Antiviral Agents|antiviral agents|mesh-ancestor
65160729|NCT02824315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65160730|NCT02824315|Protease Inhibitors|protease inhibitors|mesh-ancestor
65160731|NCT02824315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160733|NCT04242433|Antiviral Agents|antiviral agents|mesh-list
65160785|NCT02825095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65160786|NCT02825095|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65160787|NCT02825095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65160856|NCT04238923|Vancomycin|vancomycin|mesh-list
65160857|NCT04238923|Gentamicins|gentamicins|mesh-list
65160858|NCT04238923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65160859|NCT04238923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65160860|NCT04238923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65160861|NCT04238923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160862|NCT04238923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160863|NCT05659537|Dulaglutide|dulaglutide|mesh-list
65160864|NCT05659537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65160865|NCT05659537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65160866|NCT02815657|Valsartan|valsartan|mesh-list
65160867|NCT02815657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65160918|NCT01061151|Ritonavir|ritonavir|mesh-list
65160919|NCT01061151|Lopinavir|lopinavir|mesh-list
65160920|NCT01061151|Tenofovir|tenofovir|mesh-list
65160921|NCT01061151|Lamivudine|lamivudine|mesh-list
65160922|NCT01061151|Zidovudine|zidovudine|mesh-list
65160923|NCT01061151|Emtricitabine|emtricitabine|mesh-list
65160924|NCT01061151|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65160925|NCT01061151|Nevirapine|nevirapine|mesh-list
65160926|NCT01061151|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
65160927|NCT01061151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65160928|NCT01061151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65160929|NCT01061151|Protease Inhibitors|protease inhibitors|mesh-ancestor
65160930|NCT01061151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65160943|NCT04472143|Granisetron|granisetron|mesh-list
65160979|NCT02817217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65160980|NCT02817217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160981|NCT00948922|Fludarabine|fludarabine|mesh-list
65160982|NCT00948922|Bortezomib|bortezomib|mesh-list
65160983|NCT00948922|Melphalan|melphalan|mesh-list
65160984|NCT00948922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65160985|NCT00948922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65160986|NCT00948922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65160992|NCT00634309|Candesartan|candesartan|mesh-list
65161046|NCT04303767|Caseins|caseins|mesh-list
65161047|NCT04303767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65161049|NCT04303767|Chelating Agents|chelating agents|mesh-ancestor
65161120|NCT05296629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65161121|NCT05296629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65161122|NCT05296629|Antimalarials|antimalarials|mesh-ancestor
65161123|NCT05296629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65161124|NCT05296629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65161125|NCT01238588|Sevelamer|sevelamer|mesh-list
65161126|NCT01238588|Chelating Agents|chelating agents|mesh-ancestor
65161127|NCT01238588|Sequestering Agents|sequestering agents|mesh-ancestor
65161128|NCT01238588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161129|NCT00627003|Cabergoline|cabergoline|mesh-list
65161130|NCT00627003|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65161131|NCT00627003|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65161132|NCT00627003|Dopamine Agonists|dopamine agonists|mesh-ancestor
65161133|NCT00627003|Dopamine Agents|dopamine agents|mesh-ancestor
65161134|NCT00627003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65161135|NCT00627003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161136|NCT00627003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161151|NCT01238120|Ibuprofen|ibuprofen|mesh-list
65161178|NCT04237987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161179|NCT04237987|Antifungal Agents|antifungal agents|mesh-ancestor
65161180|NCT04237987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65161181|NCT04237987|Dermatologic Agents|dermatologic agents|mesh-ancestor
65161182|NCT04237987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65161183|NCT04237987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65161184|NCT04237987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161185|NCT04237987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65161186|NCT04237987|Analgesics|analgesics|mesh-ancestor
65161187|NCT04237987|Sensory System Agents|sensory system agents|mesh-ancestor
65161188|NCT04237987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161189|NCT04237987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65161190|NCT04237987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65161191|NCT04237987|Antiviral Agents|antiviral agents|mesh-ancestor
65161238|NCT04275661|Levobupivacaine|levobupivacaine|mesh-list
65161239|NCT04275661|Analgesics|analgesics|mesh-ancestor
65161309|NCT01053429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161310|NCT01053429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65161311|NCT01053429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65161312|NCT01053429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65161316|NCT01233284|Bromides|bromides|mesh-list
65161379|NCT01232738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161380|NCT01232738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65161381|NCT01232738|Protective Agents|protective agents|mesh-ancestor
65161382|NCT01232738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161383|NCT00957268|Alogliptin|alogliptin|mesh-list
65161384|NCT00957268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65161385|NCT00957268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161386|NCT00957268|Incretins|incretins|mesh-ancestor
65161387|NCT00957268|Hormones|hormones|mesh-ancestor
65161390|NCT00957268|Protease Inhibitors|protease inhibitors|mesh-ancestor
65161444|NCT02811055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65161445|NCT02811055|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65161517|NCT02815189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65161518|NCT02815189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65161519|NCT02815189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65161520|NCT02815189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161588|NCT02809573|Mitosis Modulators|mitosis modulators|mesh-ancestor
65161589|NCT04388683|Nitric Oxide|nitric oxide|mesh-list
65161590|NCT04388683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65161591|NCT04388683|Autonomic Agents|autonomic agents|mesh-ancestor
65161592|NCT04388683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161593|NCT04388683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161594|NCT04388683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65161597|NCT04388683|Antioxidants|antioxidants|mesh-ancestor
65161652|NCT02090998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161653|NCT02090998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65161654|NCT02090998|Antidepressive Agents|antidepressive agents|mesh-ancestor
65161655|NCT02090998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65161657|NCT02090998|Analgesics|analgesics|mesh-ancestor
65161721|NCT04303065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161722|NCT02814877|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65161723|NCT02814877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65161724|NCT00952822|Factor VIII|factor viii|mesh-list
65161725|NCT00952822|Coagulants|coagulants|mesh-ancestor
65161726|NCT02854072|Gemcitabine|gemcitabine|mesh-list
65161793|NCT02811991|Sensory System Agents|sensory system agents|mesh-ancestor
65161794|NCT02811991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161795|NCT02811991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161796|NCT02811991|Antipyretics|antipyretics|mesh-ancestor
65161797|NCT04237675|Anesthetics|anesthetics|mesh-list
65161798|NCT04237675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65161799|NCT04237675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161800|NCT05598853|Nivolumab|nivolumab|mesh-list
65161801|NCT05598853|Ipilimumab|ipilimumab|mesh-list
65161802|NCT05598853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65161803|NCT05598853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161804|NCT05598853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65161805|NCT05598853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161806|NCT01229150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65161807|NCT01229150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161808|NCT01229150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65161809|NCT01229150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65161810|NCT01229150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161811|NCT02804815|Aspirin|aspirin|mesh-list
65161812|NCT02804815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65161813|NCT02804815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65161814|NCT02804815|Analgesics|analgesics|mesh-ancestor
65161815|NCT02804815|Sensory System Agents|sensory system agents|mesh-ancestor
65161816|NCT02804815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161817|NCT02804815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161818|NCT02804815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65161819|NCT02804815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65161820|NCT02804815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64695288|NCT05664139|Paclitaxel|paclitaxel|mesh-list
65161821|NCT02804815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65161822|NCT02804815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161834|NCT02814409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65161835|NCT02814409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65161836|NCT02814409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161837|NCT01227902|Ezogabine|ezogabine|mesh-list
65161838|NCT01227902|Anticonvulsants|anticonvulsants|mesh-ancestor
65161905|NCT01038921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161906|NCT01038921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65161907|NCT02023996|Trastuzumab|trastuzumab|mesh-list
65161908|NCT02023996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65161909|NCT02023996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161910|NCT02856568|Gemcitabine|gemcitabine|mesh-list
65161911|NCT02856568|Cisplatin|cisplatin|mesh-list
65161912|NCT02856568|Ricolinostat|ricolinostat|mesh-list
65161913|NCT02856568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65161914|NCT02856568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65161915|NCT02856568|Antimetabolites|antimetabolites|mesh-ancestor
65161916|NCT02856568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65161917|NCT02856568|Antiviral Agents|antiviral agents|mesh-ancestor
65161918|NCT02856568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65161919|NCT02856568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65161921|NCT02856568|Immunologic Factors|immunologic factors|mesh-ancestor
65161963|NCT01038609|Antitussive Agents|antitussive agents|mesh-ancestor
65161964|NCT01038609|Respiratory System Agents|respiratory system agents|mesh-ancestor
65161965|NCT01038609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65161966|NCT01038609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65161967|NCT01038609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65161968|NCT02857582|Metronidazole|metronidazole|mesh-list
65161969|NCT02857582|Vancomycin|vancomycin|mesh-list
65161970|NCT02857582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65161971|NCT02857582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65161972|NCT02857582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65161973|NCT02857582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65161974|NCT04301895|Remifentanil|remifentanil|mesh-list
65161975|NCT04301895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65161976|NCT04301895|Narcotics|narcotics|mesh-ancestor
65161977|NCT04301895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65161978|NCT04301895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65161979|NCT04301895|Analgesics|analgesics|mesh-ancestor
65161980|NCT04301895|Sensory System Agents|sensory system agents|mesh-ancestor
65161981|NCT04301895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65161982|NCT02853526|Propranolol|propranolol|mesh-list
65162018|NCT04236115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65162019|NCT02853370|Rituximab|rituximab|mesh-list
65162020|NCT02853370|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65162021|NCT02853370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65162022|NCT02853370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162023|NCT02853370|Immunologic Factors|immunologic factors|mesh-ancestor
65162024|NCT02853370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162087|NCT02853136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65162088|NCT02853136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162095|NCT02853136|Serotonin Agents|serotonin agents|mesh-ancestor
65162158|NCT02802163|Glucocorticoids|glucocorticoids|mesh-ancestor
65162159|NCT02802163|Hormones|hormones|mesh-ancestor
65162160|NCT02802163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65162161|NCT02802163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65162162|NCT02802163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162163|NCT02802163|Immunologic Factors|immunologic factors|mesh-ancestor
65162164|NCT02802163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65162165|NCT02802163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65162166|NCT02802163|Growth Substances|growth substances|mesh-ancestor
65162167|NCT02802163|Growth Inhibitors|growth inhibitors|mesh-ancestor
65162168|NCT02802163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65162169|NCT02802163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162170|NCT02802163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162220|NCT02801305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65162221|NCT02801305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162222|NCT02801305|Emollients|emollients|mesh-ancestor
65162223|NCT02801305|Dermatologic Agents|dermatologic agents|mesh-ancestor
65162224|NCT00637975|Pregabalin|pregabalin|mesh-list
65162225|NCT00637975|Oxycodone|oxycodone|mesh-list
65162226|NCT00637975|Analgesics|analgesics|mesh-ancestor
65162227|NCT00637975|Sensory System Agents|sensory system agents|mesh-ancestor
65162228|NCT00637975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65162229|NCT00637975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162230|NCT00637975|Anticonvulsants|anticonvulsants|mesh-ancestor
65162231|NCT00637975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65162232|NCT00637975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65162233|NCT00637975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162234|NCT00637975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65162235|NCT00637975|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65162236|NCT00637975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65162237|NCT00637975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65162238|NCT00637975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65162239|NCT00637975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65162240|NCT00637975|Narcotics|narcotics|mesh-ancestor
65162241|NCT02801227|Oxytocin|oxytocin|mesh-list
65162242|NCT02801227|Dinoprostone|dinoprostone|mesh-list
65162243|NCT02801227|Oxytocics|oxytocics|mesh-ancestor
65162244|NCT02801227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65162245|NCT02801227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162246|NCT02795299|Folic Acid|folic acid|mesh-list
65162247|NCT02795299|Methotrexate|methotrexate|mesh-list
65162248|NCT02795299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65162249|NCT02795299|Abortifacient Agents|abortifacient agents|mesh-ancestor
65162250|NCT02795299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65162264|NCT02795299|Vitamin B Complex|vitamin b complex|mesh-ancestor
65162265|NCT02795299|Vitamins|vitamins|mesh-ancestor
65162266|NCT02795299|Micronutrients|micronutrients|mesh-ancestor
64804888|NCT01417494|Antidotes|antidotes|mesh-ancestor
65162267|NCT02795143|Isotretinoin|isotretinoin|mesh-list
65162268|NCT02795143|Dermatologic Agents|dermatologic agents|mesh-ancestor
65162270|NCT02799277|Androgens|androgens|mesh-ancestor
65162271|NCT02799277|Hormones|hormones|mesh-ancestor
65162272|NCT02799277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65162273|NCT02799277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162274|NCT01198002|Methotrexate|methotrexate|mesh-list
65162275|NCT01198002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65162276|NCT01198002|Abortifacient Agents|abortifacient agents|mesh-ancestor
65162277|NCT01198002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65162278|NCT01198002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162279|NCT01198002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65162280|NCT01198002|Antimetabolites|antimetabolites|mesh-ancestor
65162282|NCT01198002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162323|NCT04233463|Glucocorticoids|glucocorticoids|mesh-ancestor
65162324|NCT04233463|Hormones|hormones|mesh-ancestor
65162325|NCT04233463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65162326|NCT02793739|Hyaluronic Acid|hyaluronic acid|mesh-list
65162327|NCT02793739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65162328|NCT02793739|Immunologic Factors|immunologic factors|mesh-ancestor
65162329|NCT02793739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162330|NCT02793739|Viscosupplements|viscosupplements|mesh-ancestor
65162331|NCT02793739|Protective Agents|protective agents|mesh-ancestor
65162332|NCT02793505|Metformin|metformin|mesh-list
65162333|NCT02793505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65162334|NCT02793505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162335|NCT02793193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65162336|NCT02793193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65162337|NCT02793193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65162338|NCT02793193|Antitubercular Agents|antitubercular agents|mesh-ancestor
65162339|NCT04234321|Mitogens|mitogens|mesh-list
65162340|NCT04234321|Mitosis Modulators|mitosis modulators|mesh-ancestor
65162341|NCT04234321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162342|NCT02797717|Prednisone|prednisone|mesh-list
65162343|NCT02797717|Cyclophosphamide|cyclophosphamide|mesh-list
65162344|NCT02797717|Dacarbazine|dacarbazine|mesh-list
65162346|NCT02797717|Etoposide|etoposide|mesh-list
65162348|NCT02797717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65162349|NCT02797717|Immunologic Factors|immunologic factors|mesh-ancestor
65162350|NCT02797717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162351|NCT02797717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65162352|NCT02797717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65162353|NCT02797717|Alkylating Agents|alkylating agents|mesh-ancestor
65162354|NCT02797717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162355|NCT02797717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162356|NCT02797717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65162357|NCT02797717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65162367|NCT02797717|Tubulin Modulators|tubulin modulators|mesh-ancestor
65162368|NCT02797717|Antimitotic Agents|antimitotic agents|mesh-ancestor
65162369|NCT02797717|Mitosis Modulators|mitosis modulators|mesh-ancestor
65162370|NCT04235569|Enoxaparin|enoxaparin|mesh-list
65162371|NCT04235569|Warfarin|warfarin|mesh-list
65162372|NCT04235569|Enoxaparin sodium|enoxaparin sodium|mesh-list
65162373|NCT04235569|Anticoagulants|anticoagulants|mesh-ancestor
65162374|NCT04235569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65162375|NCT04235569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65162376|NCT04235569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162377|NCT01197378|Cysteamine|cysteamine|mesh-list
65162378|NCT01197378|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
65162379|NCT01197378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162380|NCT02792491|Prednisone|prednisone|mesh-list
65162429|NCT02797249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65162430|NCT02797249|Antifungal Agents|antifungal agents|mesh-ancestor
65162431|NCT02797249|Keratolytic Agents|keratolytic agents|mesh-ancestor
65162500|NCT02796469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65162501|NCT02796469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162502|NCT02796469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162503|NCT02796469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65162504|NCT02796469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65162505|NCT02796469|Protective Agents|protective agents|mesh-ancestor
65162506|NCT02796469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162507|NCT02796469|Vasodilator Agents|vasodilator agents|mesh-ancestor
65162508|NCT02796469|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65162509|NCT02796469|Antioxidants|antioxidants|mesh-ancestor
65162510|NCT02796157|Everolimus|everolimus|mesh-list
65162563|NCT02786407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162564|NCT02786407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65162565|NCT02786407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65162566|NCT03028519|Vitamin D|vitamin d|mesh-list
65162567|NCT03028519|Cholecalciferol|cholecalciferol|mesh-list
65162568|NCT03028519|Vitamins|vitamins|mesh-ancestor
65162569|NCT03028519|Micronutrients|micronutrients|mesh-ancestor
65162570|NCT03028519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162571|NCT03028519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65162572|NCT03028519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65162573|NCT02786641|Cisplatin|cisplatin|mesh-list
65162574|NCT02786641|Docetaxel|docetaxel|mesh-list
65162575|NCT02786641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162576|NCT02786641|Tubulin Modulators|tubulin modulators|mesh-ancestor
65162577|NCT02786641|Antimitotic Agents|antimitotic agents|mesh-ancestor
65162578|NCT02786641|Mitosis Modulators|mitosis modulators|mesh-ancestor
65162579|NCT02786641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162580|NCT02787967|Beclomethasone|beclomethasone|mesh-list
65162581|NCT02787967|Formoterol Fumarate|formoterol fumarate|mesh-list
65162582|NCT02787967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65162583|NCT02787967|Autonomic Agents|autonomic agents|mesh-ancestor
65162584|NCT02787967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65162585|NCT02787967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162586|NCT02787967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65162587|NCT02787967|Respiratory System Agents|respiratory system agents|mesh-ancestor
65162588|NCT02787967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65162589|NCT02787967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65162590|NCT02787967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65162591|NCT02787967|Adrenergic Agents|adrenergic agents|mesh-ancestor
65162592|NCT02787967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65162593|NCT02787967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162594|NCT02787967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65162595|NCT02787967|Glucocorticoids|glucocorticoids|mesh-ancestor
65162596|NCT02787967|Hormones|hormones|mesh-ancestor
65162603|NCT02788123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65162604|NCT02788123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162605|NCT02788123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162606|NCT02788123|Antacids|antacids|mesh-ancestor
65162607|NCT02788123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65162608|NCT02864953|Glyburide|glyburide|mesh-list
65162609|NCT02864953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65162610|NCT02864953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162611|NCT01194804|Eculizumab|eculizumab|mesh-list
65162612|NCT01194804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65162613|NCT01194804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65162614|NCT01194804|Immunologic Factors|immunologic factors|mesh-ancestor
65162615|NCT01194804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162616|NCT02785549|Acetaminophen|acetaminophen|mesh-list
65162617|NCT02785549|Amoxicillin|amoxicillin|mesh-list
65162618|NCT02785549|Clavulanic Acids|clavulanic acids|mesh-list
65162619|NCT02785549|Clavulanic Acid|clavulanic acid|mesh-list
65162620|NCT02785549|Ibuprofen|ibuprofen|mesh-list
65162621|NCT02785549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65162622|NCT02785549|Analgesics|analgesics|mesh-ancestor
65162623|NCT02785549|Sensory System Agents|sensory system agents|mesh-ancestor
65162624|NCT02785549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65162625|NCT02785549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162626|NCT02785549|Antipyretics|antipyretics|mesh-ancestor
65162627|NCT02785549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65162628|NCT02785549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65162629|NCT02785549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65162630|NCT02785549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65162631|NCT02785549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162632|NCT02785549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162633|NCT02785549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65162634|NCT02785549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65162635|NCT02785549|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65162646|NCT02821507|Alkylating Agents|alkylating agents|mesh-ancestor
65162647|NCT02821507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162648|NCT02821507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162649|NCT02821507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65162650|NCT02821507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65162651|NCT02821507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65162652|NCT02821507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65162653|NCT02821507|Antifungal Agents|antifungal agents|mesh-ancestor
65162655|NCT02785393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65162656|NCT02785393|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65162657|NCT02785393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65162658|NCT02785393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65162659|NCT02785393|Adrenergic Agents|adrenergic agents|mesh-ancestor
65162706|NCT02782273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65162707|NCT02782273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65162708|NCT02782273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65162709|NCT02782273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65162710|NCT02782273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65162711|NCT02782273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162712|NCT02782273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162713|NCT05342389|Apatinib|apatinib|mesh-list
65162714|NCT05342389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65162715|NCT05342389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65162716|NCT05342389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162717|NCT05342389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162718|NCT02268175|Prednisone|prednisone|mesh-list
65162719|NCT02268175|Leuprolide|leuprolide|mesh-list
65162720|NCT02268175|Abiraterone Acetate|abiraterone acetate|mesh-list
65162721|NCT02268175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65162723|NCT02268175|Hormones|hormones|mesh-ancestor
65162725|NCT02268175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162763|NCT02782429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65162764|NCT02782429|Anesthetics, General|anesthetics, general|mesh-ancestor
65162765|NCT02782429|Anesthetics|anesthetics|mesh-ancestor
65162766|NCT02782429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65162767|NCT02782429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65162768|NCT02782429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65162769|NCT02782429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65162770|NCT02782429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162771|NCT04229719|Melatonin|melatonin|mesh-list
65162772|NCT04229719|Antioxidants|antioxidants|mesh-ancestor
65162773|NCT04229719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162774|NCT04229719|Protective Agents|protective agents|mesh-ancestor
65162775|NCT04229719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162776|NCT04229719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65162777|NCT01855867|Tenofovir|tenofovir|mesh-list
65162778|NCT01855867|Emtricitabine|emtricitabine|mesh-list
65162779|NCT01855867|Antiviral Agents|antiviral agents|mesh-ancestor
65162780|NCT01855867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65162781|NCT01855867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65162782|NCT01855867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65162783|NCT01855867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162785|NCT01855867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65162815|NCT05341999|Sensory System Agents|sensory system agents|mesh-ancestor
65162816|NCT05341999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65162817|NCT05341999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162818|NCT05341999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65162885|NCT00638131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162886|NCT02780245|Tranexamic Acid|tranexamic acid|mesh-list
65162887|NCT02780245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65162888|NCT02780245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65162889|NCT02780245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162890|NCT02780245|Hemostatics|hemostatics|mesh-ancestor
65162891|NCT02780245|Coagulants|coagulants|mesh-ancestor
65162892|NCT05340985|Vitamin D|vitamin d|mesh-list
65162893|NCT05340985|Ergocalciferols|ergocalciferols|mesh-list
65162894|NCT05340985|Cholecalciferol|cholecalciferol|mesh-list
65162895|NCT05340985|Calcifediol|calcifediol|mesh-list
65162896|NCT05340985|Vitamins|vitamins|mesh-list
65162897|NCT05340985|Dehydrocholesterols|dehydrocholesterols|mesh-list
65162898|NCT05340985|7-dehydrocholesterol|7-dehydrocholesterol|mesh-list
65162899|NCT05340985|Micronutrients|micronutrients|mesh-ancestor
65162900|NCT05340985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162901|NCT05340985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65162902|NCT05340985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65162903|NCT05340985|Provitamins|provitamins|mesh-ancestor
65162904|NCT02784457|Cetrorelix|cetrorelix|mesh-list
65162905|NCT02784457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65162906|NCT02784457|Fertility Agents|fertility agents|mesh-ancestor
65162907|NCT02784457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65162908|NCT02784457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162909|NCT02784457|Hormone Antagonists|hormone antagonists|mesh-ancestor
65162910|NCT02784457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65162911|NCT02780323|Celecoxib|celecoxib|mesh-list
65162912|NCT02780323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65162913|NCT02780323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65162914|NCT02780323|Analgesics|analgesics|mesh-ancestor
65162915|NCT02780323|Sensory System Agents|sensory system agents|mesh-ancestor
65162916|NCT02780323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65162917|NCT02780323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162927|NCT04229407|Vitamins|vitamins|mesh-list
65162928|NCT04229407|Vitamin B Complex|vitamin b complex|mesh-list
65162929|NCT04229407|Micronutrients|micronutrients|mesh-ancestor
65162930|NCT04229407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162931|NCT04231435|Metformin|metformin|mesh-list
65162932|NCT04231435|Digoxin|digoxin|mesh-list
65162933|NCT04231435|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65162934|NCT04231435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65162935|NCT04231435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162936|NCT04231435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65162937|NCT04231435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65162938|NCT04231435|Antimetabolites|antimetabolites|mesh-ancestor
65162939|NCT04231435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162940|NCT04231435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65162941|NCT04231435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65162942|NCT04231435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162943|NCT04231435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65162944|NCT04231435|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65162945|NCT04231435|Protective Agents|protective agents|mesh-ancestor
65162946|NCT05340439|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65162947|NCT05340439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65162948|NCT05340439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65162949|NCT05340439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162950|NCT05340439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65162951|NCT05340439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65162952|NCT05340439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162953|NCT05340439|Cholinergic Agents|cholinergic agents|mesh-ancestor
65162954|NCT05340439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65162955|NCT01194414|Antirheumatic Agents|antirheumatic agents|mesh-list
65162956|NCT05028829|Atorvastatin|atorvastatin|mesh-list
65162957|NCT05028829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65162958|NCT05028829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65162959|NCT05028829|Antimetabolites|antimetabolites|mesh-ancestor
65162960|NCT05028829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162961|NCT05028829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65162963|NCT05028829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65162964|NCT02173405|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65162965|NCT02173405|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65162966|NCT02173405|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65162967|NCT02173405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65162968|NCT02173405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65162969|NCT02173405|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65162970|NCT02173405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65162971|NCT02173405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65162972|NCT02173405|Cholinergic Agents|cholinergic agents|mesh-ancestor
65162973|NCT02173405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65162974|NCT02120365|Anticonvulsants|anticonvulsants|mesh-list
65162975|NCT05322031|Aripiprazole|aripiprazole|mesh-list
65162976|NCT05322031|Antidepressive Agents|antidepressive agents|mesh-ancestor
65162977|NCT05322031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65162978|NCT05322031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65162979|NCT05322031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65162980|NCT05322031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65162981|NCT05322031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163018|NCT05252923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163019|NCT05097079|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
65163020|NCT05097079|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65163021|NCT05097079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65163022|NCT05097079|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65163023|NCT05097079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65163024|NCT05097079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163025|NCT05097079|Cholinergic Agents|cholinergic agents|mesh-ancestor
65163026|NCT05097079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65163027|NCT05097079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163028|NCT05097079|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65163029|NCT05097079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65163030|NCT02779387|Goserelin|goserelin|mesh-list
65163031|NCT02779387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65163032|NCT02779387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163033|NCT04228315|Primaquine|primaquine|mesh-list
65163034|NCT04228315|Antimalarials|antimalarials|mesh-ancestor
65163035|NCT04228315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65163036|NCT04228315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65163037|NCT04228315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65163038|NCT04228393|Mercaptopurine|mercaptopurine|mesh-list
65163039|NCT04228393|Antimetabolites|antimetabolites|mesh-ancestor
65163040|NCT04228393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163041|NCT04228393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65163042|NCT04228393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163043|NCT04228393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65163044|NCT04228393|Immunologic Factors|immunologic factors|mesh-ancestor
65163045|NCT04228393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163064|NCT05279833|Sympatholytics|sympatholytics|mesh-ancestor
65163065|NCT05279833|Autonomic Agents|autonomic agents|mesh-ancestor
65163066|NCT05279833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65163067|NCT01880359|Nimorazole|nimorazole|mesh-list
65163068|NCT01880359|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65163069|NCT01880359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65163070|NCT01880359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65163071|NCT01880359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65163072|NCT05338723|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65163073|NCT05338723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65163074|NCT05338723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65163075|NCT05338723|Antimetabolites|antimetabolites|mesh-ancestor
65163077|NCT05338723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65163127|NCT02776189|Sensory System Agents|sensory system agents|mesh-ancestor
65163128|NCT02776189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65163129|NCT02776189|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65163130|NCT02776189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65163131|NCT02776189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65163132|NCT02776189|Adrenergic Agents|adrenergic agents|mesh-ancestor
65163133|NCT02776189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65163134|NCT02776189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163135|NCT02776189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65163136|NCT02776189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65163137|NCT02776189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65163138|NCT02776189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65163139|NCT02776189|GABA Modulators|gaba modulators|mesh-ancestor
65163140|NCT02776189|GABA Agents|gaba agents|mesh-ancestor
65163141|NCT01194258|Insulin|insulin|mesh-list
65163142|NCT01194258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65163143|NCT01194258|Insulin Glargine|insulin glargine|mesh-list
65163144|NCT01194258|Insulin Aspart|insulin aspart|mesh-list
65163145|NCT01194258|Insulin Lispro|insulin lispro|mesh-list
65163146|NCT01194258|Insulin glulisine|insulin glulisine|mesh-list
65163147|NCT01194258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65163148|NCT01194258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163149|NCT04883437|Obinutuzumab|obinutuzumab|mesh-list
65163150|NCT04883437|Acalabrutinib|acalabrutinib|mesh-list
65163151|NCT04883437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65163177|NCT02777671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163178|NCT02778919|Leuprolide|leuprolide|mesh-list
65163179|NCT02778919|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65163180|NCT02778919|Fertility Agents|fertility agents|mesh-ancestor
65163181|NCT02778919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65163182|NCT02778919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163183|NCT02778919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65163184|NCT02778919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163185|NCT02779153|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65163186|NCT02779153|Hormones|hormones|mesh-ancestor
65163187|NCT02779153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65163188|NCT02779153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163189|NCT04226443|Midazolam|midazolam|mesh-list
65163190|NCT04226443|Remifentanil|remifentanil|mesh-list
65163191|NCT04226443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65163192|NCT04226443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65163195|NCT04226443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65163237|NCT02773927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65163238|NCT02773927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163239|NCT02773459|Capecitabine|capecitabine|mesh-list
65163240|NCT02773459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65163241|NCT02773459|Antimetabolites|antimetabolites|mesh-ancestor
65163242|NCT02773459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163243|NCT02773459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163244|NCT04818229|Moxifloxacin|moxifloxacin|mesh-list
65163245|NCT04818229|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65163246|NCT04818229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65163247|NCT04818229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65163248|NCT04818229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65163249|NCT04818229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65163250|NCT04818229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163251|NCT04818229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163252|NCT04818229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163253|NCT04818229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65163254|NCT04818229|Contraceptive Agents|contraceptive agents|mesh-ancestor
65163255|NCT04818229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65163256|NCT04818229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163257|NCT04818229|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65163258|NCT04818229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65163259|NCT04818229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65163260|NCT04771741|Acetaminophen|acetaminophen|mesh-list
65163285|NCT04771741|Antipyretics|antipyretics|mesh-ancestor
65163286|NCT04771741|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65163287|NCT04771741|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65163288|NCT04771741|Antidepressive Agents|antidepressive agents|mesh-ancestor
65163289|NCT04771741|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65163290|NCT04771741|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65163291|NCT02772601|Metoprolol|metoprolol|mesh-list
65163292|NCT02772601|Midazolam|midazolam|mesh-list
65163293|NCT02772601|Caffeine|caffeine|mesh-list
65163294|NCT02772601|Omeprazole|omeprazole|mesh-list
65163295|NCT02772601|Warfarin|warfarin|mesh-list
65163296|NCT02772601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65163297|NCT02772601|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65163298|NCT02772601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65163299|NCT02772601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163300|NCT02772601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65163301|NCT02772601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65163302|NCT02772601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65163345|NCT02772211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65163346|NCT02772211|Renal Agents|renal agents|mesh-ancestor
65163347|NCT02772211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65163348|NCT02772211|Antitubercular Agents|antitubercular agents|mesh-ancestor
65163349|NCT02772211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65163350|NCT02772211|Antimetabolites|antimetabolites|mesh-ancestor
65163351|NCT04225195|Amphotericin B|amphotericin b|mesh-list
65163352|NCT04225195|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65163353|NCT04225195|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
65163354|NCT04225195|Amebicides|amebicides|mesh-ancestor
65163355|NCT04225195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65163356|NCT04225195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65163357|NCT04225195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65163358|NCT04225195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65163359|NCT04225195|Antifungal Agents|antifungal agents|mesh-ancestor
65163360|NCT04225195|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65163361|NCT04225195|Protease Inhibitors|protease inhibitors|mesh-ancestor
65163362|NCT04225195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163363|NCT04225195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163364|NCT04225195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65163365|NCT04225195|Protective Agents|protective agents|mesh-ancestor
65163366|NCT04225195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163367|NCT04225195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163368|NCT02771509|Mitogens|mitogens|mesh-list
65163369|NCT02771509|Mitosis Modulators|mitosis modulators|mesh-ancestor
65163370|NCT02771509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163371|NCT02696941|Metformin|metformin|mesh-list
65163372|NCT02696941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65163373|NCT02696941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65163374|NCT02696941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163375|NCT02696941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163376|NCT02767375|Fluorouracil|fluorouracil|mesh-list
65163377|NCT02767375|Oxaliplatin|oxaliplatin|mesh-list
64696858|NCT04428359|Vitamin D|vitamin d|mesh-list
65163378|NCT02767375|Antimetabolites|antimetabolites|mesh-ancestor
65163379|NCT02767375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509179|NCT01933984|Dermatologic Agents|dermatologic agents|mesh-ancestor
65163382|NCT02767375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65163383|NCT02767375|Immunologic Factors|immunologic factors|mesh-ancestor
65163384|NCT02767375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163385|NCT02767219|Dexamethasone|dexamethasone|mesh-list
65163386|NCT02767219|Bevacizumab|bevacizumab|mesh-list
65163387|NCT02767219|Fluorouracil|fluorouracil|mesh-list
65163388|NCT02767219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65163389|NCT02767219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163390|NCT02767219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65163391|NCT02767219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65163392|NCT02767219|Growth Substances|growth substances|mesh-ancestor
65163393|NCT02767219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163394|NCT02767219|Growth Inhibitors|growth inhibitors|mesh-ancestor
65163395|NCT02767219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65163396|NCT02767219|Antiemetics|antiemetics|mesh-ancestor
65163397|NCT02767219|Autonomic Agents|autonomic agents|mesh-ancestor
65163442|NCT02762851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163443|NCT02767063|Pioglitazone|pioglitazone|mesh-list
65163444|NCT02767063|Avelumab|avelumab|mesh-list
65163445|NCT02767063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65163446|NCT02767063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163447|NCT02767063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65163448|NCT02767063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163450|NCT04224103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65163451|NCT04224103|Autonomic Agents|autonomic agents|mesh-ancestor
65163452|NCT04224103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65163453|NCT04224103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163454|NCT04224103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65163455|NCT04224103|Respiratory System Agents|respiratory system agents|mesh-ancestor
65163456|NCT04224103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65163457|NCT04224103|Antioxidants|antioxidants|mesh-ancestor
65163458|NCT04224103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163459|NCT04224103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65163460|NCT04224103|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65163461|NCT04224103|Vasodilator Agents|vasodilator agents|mesh-ancestor
65163462|NCT04224103|Gasotransmitters|gasotransmitters|mesh-ancestor
65163463|NCT04224103|Protective Agents|protective agents|mesh-ancestor
65163464|NCT02766439|Etanercept|etanercept|mesh-list
65163497|NCT02765815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163498|NCT02765815|Sensory System Agents|sensory system agents|mesh-ancestor
65163499|NCT02765815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65163500|NCT02765815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65163501|NCT02765815|Narcotics|narcotics|mesh-ancestor
65163502|NCT02765815|Analgesics|analgesics|mesh-ancestor
65163503|NCT02765815|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65163504|NCT02765815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65163505|NCT02765815|Adrenergic Agents|adrenergic agents|mesh-ancestor
65163506|NCT02765815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65163507|NCT02765815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163508|NCT02765815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65163509|NCT02765815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65163510|NCT02765815|Autonomic Agents|autonomic agents|mesh-ancestor
65163511|NCT02765815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65163512|NCT02765815|Respiratory System Agents|respiratory system agents|mesh-ancestor
65163513|NCT02765815|Mydriatics|mydriatics|mesh-ancestor
65163514|NCT02765815|Sympathomimetics|sympathomimetics|mesh-ancestor
65163553|NCT02770261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65163554|NCT02770261|Antimetabolites|antimetabolites|mesh-ancestor
65163555|NCT02770261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163556|NCT02770261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65163557|NCT02770261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65163562|NCT02770105|Caffeine|caffeine|mesh-list
65163620|NCT02769325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65163621|NCT02769325|Cholinergic Agents|cholinergic agents|mesh-ancestor
65163622|NCT02769325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65163623|NCT04224649|Lidocaine|lidocaine|mesh-list
65163624|NCT04224649|Hyaluronic Acid|hyaluronic acid|mesh-list
65163625|NCT04224649|Anesthetics, Local|anesthetics, local|mesh-ancestor
65163626|NCT04224649|Anesthetics|anesthetics|mesh-ancestor
64508411|NCT05447520|Montelukast|montelukast|mesh-list
65163690|NCT00951496|Immunologic Factors|immunologic factors|mesh-ancestor
65163691|NCT02764411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65163692|NCT02764411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65163693|NCT02764411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65163694|NCT02764411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65163695|NCT02764411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65163696|NCT02764411|Adrenergic Agents|adrenergic agents|mesh-ancestor
65163697|NCT02764411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65163698|NCT02764411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163699|NCT02764411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163750|NCT02762617|Tenofovir|tenofovir|mesh-list
65163751|NCT02762617|Antiviral Agents|antiviral agents|mesh-ancestor
65163752|NCT02762617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65163753|NCT02762617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65163754|NCT02762617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65163755|NCT02762617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65163756|NCT02762617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163757|NCT02762617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65163758|NCT02762617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65163759|NCT01192152|Metformin|metformin|mesh-list
65163760|NCT01192152|Saxagliptin|saxagliptin|mesh-list
65163761|NCT01192152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65163762|NCT01192152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163814|NCT02763475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163815|NCT02763475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65163816|NCT02763475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65163817|NCT02763475|Alkylating Agents|alkylating agents|mesh-ancestor
65163818|NCT02763475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65163819|NCT02763475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65163824|NCT02758015|Betaine|betaine|mesh-list
65163883|NCT02757469|Drospirenone|drospirenone|mesh-list
65163884|NCT02757469|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65163885|NCT02757469|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
65163886|NCT02757469|Estradiol|estradiol|mesh-list
65163887|NCT02757469|Estrogens|estrogens|mesh-ancestor
65163888|NCT02757469|Hormones|hormones|mesh-ancestor
65163889|NCT02757469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65163890|NCT02757469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163900|NCT02757469|Diuretics|diuretics|mesh-ancestor
65163950|NCT05357040|Anesthetics, General|anesthetics, general|mesh-ancestor
65163951|NCT05357040|Anesthetics|anesthetics|mesh-ancestor
65163952|NCT05357040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65163953|NCT05357040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65163954|NCT05357040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65163955|NCT05357040|Analgesics|analgesics|mesh-ancestor
65163956|NCT05357040|Sensory System Agents|sensory system agents|mesh-ancestor
65163957|NCT05357040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65163958|NCT00943072|Aflibercept|aflibercept|mesh-list
65163959|NCT00943072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65164015|NCT02199184|Doxorubicin|doxorubicin|mesh-list
65164016|NCT02199184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65164017|NCT02199184|Etoposide|etoposide|mesh-list
65164018|NCT02199184|Vincristine|vincristine|mesh-list
65164019|NCT02199184|Etoposide phosphate|etoposide phosphate|mesh-list
65164020|NCT02199184|Ofatumumab|ofatumumab|mesh-list
65164021|NCT02199184|Podophyllotoxin|podophyllotoxin|mesh-list
65164022|NCT02199184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65164023|NCT02199184|Antibodies|antibodies|mesh-list
65164024|NCT02199184|Immunoglobulins|immunoglobulins|mesh-list
65164025|NCT02199184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65164026|NCT02199184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65164027|NCT02199184|Immunologic Factors|immunologic factors|mesh-ancestor
65164028|NCT02199184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164029|NCT02199184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65164030|NCT02199184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65164031|NCT02199184|Alkylating Agents|alkylating agents|mesh-ancestor
65164040|NCT02199184|Glucocorticoids|glucocorticoids|mesh-ancestor
65164075|NCT02752477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164076|NCT04204096|Vaccines|vaccines|mesh-list
65164077|NCT04204096|Immunologic Factors|immunologic factors|mesh-ancestor
65164078|NCT04204096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164079|NCT05376852|Decitabine|decitabine|mesh-list
65164080|NCT05376852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65164081|NCT05376852|Antimetabolites|antimetabolites|mesh-ancestor
65164082|NCT05376852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164083|NCT05376852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164084|NCT05376852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164085|NCT00061282|Clotrimazole|clotrimazole|mesh-list
65164086|NCT00061282|Miconazole|miconazole|mesh-list
65164087|NCT00061282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65164088|NCT00061282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65164089|NCT00061282|Antifungal Agents|antifungal agents|mesh-ancestor
65164090|NCT00061282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65164091|NCT00061282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65164092|NCT00061282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164093|NCT00061282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164094|NCT00061282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65164095|NCT00061282|Hormone Antagonists|hormone antagonists|mesh-ancestor
65164096|NCT00061282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65164097|NCT00061282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164098|NCT00061282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65164099|NCT00061282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65164100|NCT05657496|Triamcinolone|triamcinolone|mesh-list
65164101|NCT05657496|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65164102|NCT05657496|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65164103|NCT05657496|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65164104|NCT05657496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65164105|NCT05657496|Glucocorticoids|glucocorticoids|mesh-ancestor
65164106|NCT05657496|Hormones|hormones|mesh-ancestor
65164109|NCT05657496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65164114|NCT04268524|Antifungal Agents|antifungal agents|mesh-ancestor
65164115|NCT04268524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65164116|NCT04268524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164117|NCT04268524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65164118|NCT04268524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65164119|NCT02855632|Hormones|hormones|mesh-list
65164120|NCT02855632|Progesterone|progesterone|mesh-list
65164121|NCT02855632|Lenograstim|lenograstim|mesh-list
65164123|NCT02855632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65164124|NCT02855632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164125|NCT02855632|Progestins|progestins|mesh-ancestor
65164126|NCT02855632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65164127|NCT02855632|Immunologic Factors|immunologic factors|mesh-ancestor
65164128|NCT04220281|Nitroglycerin|nitroglycerin|mesh-list
65164129|NCT04220281|Propofol|propofol|mesh-list
65164130|NCT04220281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65164131|NCT04220281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65164132|NCT04220281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164133|NCT04220281|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65164134|NCT04220281|Anesthetics, General|anesthetics, general|mesh-ancestor
65164135|NCT04220281|Anesthetics|anesthetics|mesh-ancestor
65164136|NCT04220281|Vasodilator Agents|vasodilator agents|mesh-ancestor
65164137|NCT02751619|Lidocaine|lidocaine|mesh-list
65164138|NCT02751619|Anesthetics, Local|anesthetics, local|mesh-ancestor
65164166|NCT01734928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65164167|NCT01734928|Growth Substances|growth substances|mesh-ancestor
65164168|NCT01734928|Growth Inhibitors|growth inhibitors|mesh-ancestor
65164169|NCT01734928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65164241|NCT02751307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164242|NCT02751307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65164243|NCT02751307|Serotonin Agents|serotonin agents|mesh-ancestor
65164244|NCT02751307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65164314|NCT01185288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65164315|NCT01185288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65164316|NCT01184118|Fluticasone|fluticasone|mesh-list
65164317|NCT01184118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65164319|NCT01184118|Autonomic Agents|autonomic agents|mesh-ancestor
65164385|NCT01190436|Bisoprolol|bisoprolol|mesh-list
65164386|NCT01190436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65164387|NCT01190436|Sympatholytics|sympatholytics|mesh-ancestor
65164388|NCT01190436|Autonomic Agents|autonomic agents|mesh-ancestor
65164389|NCT01190436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65164392|NCT01190436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65164454|NCT01189500|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65164455|NCT01189500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65164457|NCT01189500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65164458|NCT01189500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164459|NCT01189500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65164460|NCT01189500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164461|NCT01189500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65164462|NCT01189500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65164463|NCT01189500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65164464|NCT01189500|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65164465|NCT01189500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65164472|NCT00938860|Tacrolimus|tacrolimus|mesh-list
65164516|NCT00938392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164517|NCT02851888|Ropivacaine|ropivacaine|mesh-list
65164518|NCT02851888|Anesthetics|anesthetics|mesh-ancestor
65164519|NCT02851888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65164520|NCT02851888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164521|NCT02851888|Anesthetics, Local|anesthetics, local|mesh-ancestor
65164522|NCT02851888|Sensory System Agents|sensory system agents|mesh-ancestor
65164523|NCT02851888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65164524|NCT05381428|Indomethacin|indomethacin|mesh-list
65164525|NCT05381428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65164526|NCT05381428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65164527|NCT05381428|Analgesics|analgesics|mesh-ancestor
65164528|NCT05381428|Sensory System Agents|sensory system agents|mesh-ancestor
65164531|NCT05381428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65164579|NCT01473628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164580|NCT01473628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65164581|NCT05380960|Fibrin fragment D|fibrin fragment d|mesh-list
65164585|NCT05380960|Hemostatics|hemostatics|mesh-ancestor
65164650|NCT04269928|Respiratory System Agents|respiratory system agents|mesh-ancestor
65164651|NCT04269928|Mydriatics|mydriatics|mesh-ancestor
65164652|NCT04269928|Sympathomimetics|sympathomimetics|mesh-ancestor
65164653|NCT04269928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65164654|NCT00950170|Factor VIII|factor viii|mesh-list
65164655|NCT00950170|Coagulants|coagulants|mesh-ancestor
65164656|NCT00604864|Infliximab|infliximab|mesh-list
65164722|NCT01227668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65164723|NCT01227512|Tolvaptan|tolvaptan|mesh-list
65164724|NCT01227512|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65164725|NCT01227512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164726|NCT01227512|Natriuretic Agents|natriuretic agents|mesh-ancestor
65164727|NCT01227512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164728|NCT01227278|Benralizumab|benralizumab|mesh-list
65164729|NCT01227278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65164730|NCT01227278|Respiratory System Agents|respiratory system agents|mesh-ancestor
65164731|NCT01227044|Naltrexone|naltrexone|mesh-list
65164732|NCT01227044|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65164733|NCT01227044|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65164734|NCT01227044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164735|NCT01227044|Sensory System Agents|sensory system agents|mesh-ancestor
65164736|NCT01227044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65164737|NCT01034163|Panobinostat|panobinostat|mesh-list
65164780|NCT02885454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65164781|NCT02885454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65164782|NCT02885454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65164783|NCT02885454|Contraceptive Agents|contraceptive agents|mesh-ancestor
65164784|NCT02885454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65164785|NCT02885454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164786|NCT02885454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65164787|NCT02885454|Estrogens|estrogens|mesh-ancestor
65164788|NCT02885454|Hormones|hormones|mesh-ancestor
65164789|NCT02885454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65164790|NCT02885454|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65164791|NCT02885454|Hormone Antagonists|hormone antagonists|mesh-ancestor
65164844|NCT04301739|Doxorubicin|doxorubicin|mesh-list
65164845|NCT04301739|Epirubicin|epirubicin|mesh-list
65164846|NCT04301739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65164847|NCT04301739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65164848|NCT04301739|Tubulin Modulators|tubulin modulators|mesh-ancestor
65164914|NCT02760901|Respiratory System Agents|respiratory system agents|mesh-ancestor
65164915|NCT02760901|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65164916|NCT02760901|Antioxidants|antioxidants|mesh-ancestor
65164917|NCT02760901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65164918|NCT02760901|Protective Agents|protective agents|mesh-ancestor
65164919|NCT02760901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164920|NCT02760901|Antidotes|antidotes|mesh-ancestor
65164921|NCT02760901|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65164922|NCT02760901|Diuretics|diuretics|mesh-ancestor
65164923|NCT02760901|Natriuretic Agents|natriuretic agents|mesh-ancestor
65164924|NCT02760901|Anticonvulsants|anticonvulsants|mesh-ancestor
65164925|NCT02760901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65164926|NCT02760901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65164927|NCT00635713|Fulvestrant|fulvestrant|mesh-list
65164975|NCT01031979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65164976|NCT01031979|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65164977|NCT01031979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65164978|NCT01031979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65164979|NCT01031979|Adrenergic Agents|adrenergic agents|mesh-ancestor
65164980|NCT01031979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65164982|NCT01031979|Urological Agents|urological agents|mesh-ancestor
65165044|NCT01028391|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65165045|NCT01028391|Protease Inhibitors|protease inhibitors|mesh-ancestor
65165046|NCT01028391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165047|NCT01028391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165048|NCT01179672|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65165049|NCT01179672|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65165050|NCT01179672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65165051|NCT01179672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65165110|NCT01179516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65165118|NCT01179516|Serotonin Agents|serotonin agents|mesh-ancestor
65165182|NCT02750995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165183|NCT01027845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65165184|NCT01027845|Immunologic Factors|immunologic factors|mesh-ancestor
65165185|NCT01027845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165186|NCT04221919|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65165187|NCT04221919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65165188|NCT04221919|Adrenergic Agents|adrenergic agents|mesh-ancestor
65165189|NCT04221919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65165250|NCT02750059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65165251|NCT02750059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65165252|NCT02750059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65165253|NCT02750059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165254|NCT02750059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165255|NCT02750059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65165256|NCT02750059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65165257|NCT02750059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65165258|NCT02750059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65165259|NCT02750059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65165260|NCT02750059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65165261|NCT02750059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65165262|NCT02750059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65165263|NCT02750059|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65165264|NCT02750059|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65165305|NCT02758873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65165306|NCT02758873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165307|NCT02758873|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65165308|NCT02758873|Hormone Antagonists|hormone antagonists|mesh-ancestor
65165309|NCT02758873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65165310|NCT02758873|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65165371|NCT02749123|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65165372|NCT02749123|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65165373|NCT02749123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65165374|NCT02749123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165375|NCT02749123|Antipruritics|antipruritics|mesh-ancestor
65165376|NCT02749123|Dermatologic Agents|dermatologic agents|mesh-ancestor
65165377|NCT00635557|Carboplatin|carboplatin|mesh-list
65165438|NCT02695381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165439|NCT02695381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65165440|NCT02695381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65165512|NCT02644291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165513|NCT01015677|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65165586|NCT02736019|Sensory System Agents|sensory system agents|mesh-ancestor
65165590|NCT02736019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65165660|NCT02735317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65165661|NCT02735317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165662|NCT02735317|Vitamin B Complex|vitamin b complex|mesh-ancestor
65165663|NCT02735317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64808275|NCT01432587|Diflunisal|diflunisal|mesh-list
65165664|NCT02735317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65165665|NCT02735317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65165666|NCT02735317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165667|NCT02735317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165668|NCT02735317|Hematinics|hematinics|mesh-ancestor
65165669|NCT02735317|Anesthetics, Local|anesthetics, local|mesh-ancestor
65165670|NCT02735317|Anesthetics|anesthetics|mesh-ancestor
65165671|NCT02735317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65165672|NCT02735317|Sensory System Agents|sensory system agents|mesh-ancestor
65165673|NCT05554237|Ceftibuten|ceftibuten|mesh-list
65165674|NCT05554237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65165675|NCT05554237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65165676|NCT05544721|Ropivacaine|ropivacaine|mesh-list
65165677|NCT05544721|Anesthetics, Local|anesthetics, local|mesh-ancestor
65165678|NCT05544721|Anesthetics|anesthetics|mesh-ancestor
65165679|NCT05544721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65165680|NCT05544721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165711|NCT02745925|Sensory System Agents|sensory system agents|mesh-ancestor
65165712|NCT02745925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65165713|NCT02745925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165714|NCT02745925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65165715|NCT02745925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65165716|NCT02745925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65165717|NCT02745925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65165718|NCT02745925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165719|NCT04374253|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65165720|NCT04374253|Immunologic Factors|immunologic factors|mesh-ancestor
65165721|NCT04374253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165722|NCT02738905|Rifaximin|rifaximin|mesh-list
65165723|NCT02738905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65165724|NCT02738905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65165725|NCT02738905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65165726|NCT03664687|Zoledronic Acid|zoledronic acid|mesh-list
65165727|NCT03664687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65165728|NCT03664687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165729|NCT02745691|Gefitinib|gefitinib|mesh-list
65165730|NCT02745691|Crizotinib|crizotinib|mesh-list
65165731|NCT02745691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165732|NCT02745691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65165746|NCT00636415|Morphine|morphine|mesh-list
65165766|NCT02737423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165767|NCT02737423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65165768|NCT02737423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65165769|NCT02733679|Metformin|metformin|mesh-list
65165770|NCT02733679|Pioglitazone|pioglitazone|mesh-list
65165771|NCT02733679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65165772|NCT02733679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165773|NCT03289741|Octreotide|octreotide|mesh-list
65165774|NCT03289741|Lanreotide|lanreotide|mesh-list
65165775|NCT03289741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65165776|NCT03289741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65165777|NCT03289741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165778|NCT05473585|Nicotine|nicotine|mesh-list
65165779|NCT05473585|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65165780|NCT05473585|Autonomic Agents|autonomic agents|mesh-ancestor
64699319|NCT04500613|Hormones|hormones|mesh-ancestor
65165828|NCT02743975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65165829|NCT02743975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165830|NCT02743975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65165831|NCT02743975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65165899|NCT03259867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65165900|NCT03259867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65165901|NCT03259867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64514674|NCT02402439|Pancrelipase|pancrelipase|mesh-list
65165902|NCT03259867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165903|NCT03854929|Azithromycin|azithromycin|mesh-list
65165904|NCT03854929|Ciprofloxacin|ciprofloxacin|mesh-list
65165905|NCT03854929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65165906|NCT03854929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65165964|NCT02690389|GABA Agents|gaba agents|mesh-ancestor
65165965|NCT02690389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65165966|NCT02690389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165967|NCT02732197|Thiopental|thiopental|mesh-list
65165968|NCT02732197|Anticonvulsants|anticonvulsants|mesh-ancestor
65165969|NCT02732197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65165970|NCT02732197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65165971|NCT02732197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65165972|NCT02732197|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65165973|NCT02732197|Anesthetics, General|anesthetics, general|mesh-ancestor
65165974|NCT02732197|Anesthetics|anesthetics|mesh-ancestor
65165975|NCT02732197|GABA Modulators|gaba modulators|mesh-ancestor
65165977|NCT02732197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65165978|NCT02732197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65165979|NCT02729935|Parecoxib|parecoxib|mesh-list
65166021|NCT02727205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166022|NCT02721433|Denosumab|denosumab|mesh-list
65166023|NCT02721433|Zoledronic Acid|zoledronic acid|mesh-list
65166024|NCT02721433|Pamidronate|pamidronate|mesh-list
65166094|NCT02728687|Natriuretic Agents|natriuretic agents|mesh-ancestor
65166095|NCT02728687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166096|NCT02728687|Antipruritics|antipruritics|mesh-ancestor
65166097|NCT02728687|Dermatologic Agents|dermatologic agents|mesh-ancestor
65166164|NCT02718547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65166165|NCT02718547|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65166166|NCT02718547|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65166167|NCT02718547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65166168|NCT02725099|Ticagrelor|ticagrelor|mesh-list
65166169|NCT02725099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65166170|NCT02725099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65166171|NCT02725099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65166172|NCT02725099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65166173|NCT02725099|Purinergic Agents|purinergic agents|mesh-ancestor
65166174|NCT02725099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65166175|NCT02725099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166177|NCT01225211|Ivacaftor|ivacaftor|mesh-list
65166224|NCT01224431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65166225|NCT01224431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166226|NCT01224431|Sensory System Agents|sensory system agents|mesh-ancestor
65166227|NCT01224431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166228|NCT01224431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65166229|NCT01224431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65166230|NCT01224431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65166231|NCT01224431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65166233|NCT02716129|Morphine|morphine|mesh-list
65166310|NCT02715193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166311|NCT01223027|Sorafenib|sorafenib|mesh-list
65166312|NCT01223027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166313|NCT01223027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65166314|NCT01223027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65166315|NCT01223027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166316|NCT02714959|Aldesleukin|aldesleukin|mesh-list
65166317|NCT02714959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166318|NCT02714959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65166319|NCT02714959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65166378|NCT05269537|Oxytocics|oxytocics|mesh-ancestor
65166379|NCT05269537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65166380|NCT05269537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65166381|NCT05269537|Sympathomimetics|sympathomimetics|mesh-ancestor
65166382|NCT05269537|Autonomic Agents|autonomic agents|mesh-ancestor
65166383|NCT05269537|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65166384|NCT05269537|Adrenergic Agents|adrenergic agents|mesh-ancestor
65166385|NCT05269537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65166386|NCT05269537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166387|NCT01222715|Sirolimus|sirolimus|mesh-list
65166388|NCT01222715|Cyclophosphamide|cyclophosphamide|mesh-list
65166389|NCT01222715|Bevacizumab|bevacizumab|mesh-list
65166390|NCT01222715|Vinorelbine|vinorelbine|mesh-list
65166391|NCT01222715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65166392|NCT01222715|Antibodies|antibodies|mesh-list
65166393|NCT01222715|Immunoglobulins|immunoglobulins|mesh-list
65166394|NCT01222715|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65166438|NCT02722603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65166439|NCT02722603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65166440|NCT02722603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65166442|NCT02722603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65166512|NCT05260593|Hematinics|hematinics|mesh-ancestor
65166513|NCT02713477|Insulin|insulin|mesh-list
65166514|NCT02713477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65166515|NCT02713477|Insulin Glargine|insulin glargine|mesh-list
65166516|NCT02713477|Lixisenatide|lixisenatide|mesh-list
65166517|NCT02713477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65166518|NCT02713477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166519|NCT01014585|Milnacipran|milnacipran|mesh-list
65166520|NCT01014585|Levomilnacipran|levomilnacipran|mesh-list
65166521|NCT01014585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65166522|NCT01014585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65166523|NCT01014585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65166524|NCT01014585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166525|NCT01014585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65166528|NCT01014585|Analgesics|analgesics|mesh-ancestor
65166573|NCT02712697|Glucocorticoids|glucocorticoids|mesh-ancestor
65166574|NCT02712697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65166575|NCT02712697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166576|NCT02712697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65166577|NCT02712697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166578|NCT01220297|Mycophenolic Acid|mycophenolic acid|mesh-list
65166579|NCT01220297|Sirolimus|sirolimus|mesh-list
65166580|NCT01220297|Cyclophosphamide|cyclophosphamide|mesh-list
65166581|NCT01220297|Carmustine|carmustine|mesh-list
65166582|NCT01220297|Etoposide|etoposide|mesh-list
65166583|NCT01220297|Etoposide phosphate|etoposide phosphate|mesh-list
65166584|NCT01220297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65166585|NCT01220297|Immunologic Factors|immunologic factors|mesh-ancestor
65166636|NCT02708251|Anesthetics, Local|anesthetics, local|mesh-ancestor
65166637|NCT02708251|Anesthetics|anesthetics|mesh-ancestor
65166638|NCT02708251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65166639|NCT02708251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166640|NCT02708251|Sensory System Agents|sensory system agents|mesh-ancestor
65166641|NCT02708251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166642|NCT02708251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65166643|NCT02708251|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65166644|NCT02708251|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65166645|NCT02708251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65166646|NCT02708251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166698|NCT02711449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65166699|NCT02711449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65166700|NCT02711449|Protective Agents|protective agents|mesh-ancestor
65166701|NCT02711449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65166702|NCT02711449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166703|NCT00612079|Sertindole|sertindole|mesh-list
65166704|NCT00612079|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65166705|NCT00612079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65166706|NCT00612079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65166707|NCT00612079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166765|NCT02707315|Antimetabolites|antimetabolites|mesh-ancestor
65166766|NCT02707315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166767|NCT02707315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166768|NCT02707315|Antiviral Agents|antiviral agents|mesh-ancestor
65166769|NCT02707315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65166770|NCT02707315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65166771|NCT02707315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65166772|NCT02707315|Immunologic Factors|immunologic factors|mesh-ancestor
65166773|NCT02707315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166774|NCT00604942|Domperidone|domperidone|mesh-list
65166775|NCT00604942|Esomeprazole|esomeprazole|mesh-list
65166776|NCT00604942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65166777|NCT00604942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65166778|NCT00604942|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65166779|NCT00604942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65166780|NCT00604942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166781|NCT00604942|Antiemetics|antiemetics|mesh-ancestor
65166782|NCT00604942|Autonomic Agents|autonomic agents|mesh-ancestor
65166783|NCT00604942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166784|NCT00604942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166785|NCT00604942|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65166786|NCT00604942|Dopamine Agents|dopamine agents|mesh-ancestor
65166787|NCT00604942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65166788|NCT02711683|3-n-butylphthalide|3-n-butylphthalide|mesh-list
65166789|NCT02711683|Donepezil|donepezil|mesh-list
65166817|NCT02707081|Lidocaine|lidocaine|mesh-list
65166818|NCT02707081|Anesthetics, Local|anesthetics, local|mesh-ancestor
65166819|NCT02707081|Anesthetics|anesthetics|mesh-ancestor
65166820|NCT02707081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65166821|NCT02707081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166822|NCT02707081|Sensory System Agents|sensory system agents|mesh-ancestor
65166823|NCT02707081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166824|NCT02707081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65166825|NCT02707081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65166826|NCT02707081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65166880|NCT02706769|Analgesics|analgesics|mesh-ancestor
65166881|NCT02706769|Sensory System Agents|sensory system agents|mesh-ancestor
65166882|NCT02706769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65166883|NCT02706769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65166884|NCT02706769|Antipyretics|antipyretics|mesh-ancestor
65166885|NCT05044117|Capecitabine|capecitabine|mesh-list
65166886|NCT05044117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65166887|NCT05044117|Antimetabolites|antimetabolites|mesh-ancestor
65166888|NCT05044117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166889|NCT05044117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65166890|NCT03961165|Scopolamine|scopolamine|mesh-list
65166891|NCT03961165|Bromides|bromides|mesh-list
65166892|NCT03961165|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
65166940|NCT03796273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65166941|NCT03796273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65166942|NCT03796273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65166943|NCT03796273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65166944|NCT03796273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65166945|NCT03796273|Hormone Antagonists|hormone antagonists|mesh-ancestor
65166946|NCT03796273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65167005|NCT04300881|Hormone Antagonists|hormone antagonists|mesh-ancestor
65167006|NCT04300881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65167007|NCT04300881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167008|NCT04300881|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65167009|NCT04300881|Diuretics|diuretics|mesh-ancestor
65167010|NCT04300881|Natriuretic Agents|natriuretic agents|mesh-ancestor
65167012|NCT03873493|Venetoclax|venetoclax|mesh-list
65167077|NCT01010217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65167078|NCT01010217|Antimetabolites|antimetabolites|mesh-ancestor
65167079|NCT01010217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65167080|NCT01010217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65167081|NCT01010217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167082|NCT01010217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65167083|NCT01010217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65167084|NCT01010217|Antitubercular Agents|antitubercular agents|mesh-ancestor
65167085|NCT01010217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65167086|NCT04558359|Angiotensin II|angiotensin ii|mesh-list
64512360|NCT04504825|Glucocorticoids|glucocorticoids|mesh-ancestor
64512361|NCT04504825|Hormones|hormones|mesh-ancestor
64512362|NCT04504825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64512363|NCT04504825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64512366|NCT04468984|Navitoclax|navitoclax|mesh-list
65167144|NCT01217957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65167168|NCT00935818|Bupropion|bupropion|mesh-list
65167209|NCT01216163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65167210|NCT01216163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167211|NCT01216163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167212|NCT05260255|Vitamin D|vitamin d|mesh-list
65167213|NCT05260255|Ergocalciferols|ergocalciferols|mesh-list
65167214|NCT05260255|Vitamins|vitamins|mesh-ancestor
65167215|NCT05260255|Micronutrients|micronutrients|mesh-ancestor
65167216|NCT05260255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167219|NCT00612469|Chlorhexidine|chlorhexidine|mesh-list
64512689|NCT04083170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512690|NCT04083170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65167277|NCT04712071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65167278|NCT04712071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65167279|NCT04712071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65167280|NCT04712071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65167281|NCT04712071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167282|NCT05151328|Plecanatide|plecanatide|mesh-list
65167283|NCT05151328|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65167284|NCT05151328|Enzyme Activators|enzyme activators|mesh-ancestor
65167287|NCT00609388|Tacrolimus|tacrolimus|mesh-list
65167340|NCT04188691|Vaccines|vaccines|mesh-list
65167341|NCT04188691|Immunologic Factors|immunologic factors|mesh-ancestor
65167342|NCT04188691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167343|NCT01215851|Moxifloxacin|moxifloxacin|mesh-list
65167344|NCT01215851|Pyrazinamide|pyrazinamide|mesh-list
65167345|NCT01215851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65167346|NCT01215851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65167347|NCT01215851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65167348|NCT01215851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65167349|NCT01215851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167350|NCT01215851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167402|NCT03513211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65167403|NCT04611139|Pembrolizumab|pembrolizumab|mesh-list
65167404|NCT04611139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65167405|NCT04611139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167406|NCT04570501|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
65167407|NCT04570501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65167408|NCT04570501|Vasodilator Agents|vasodilator agents|mesh-ancestor
65167410|NCT05198791|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65167469|NCT00613561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65167470|NCT01009983|Paclitaxel|paclitaxel|mesh-list
65167471|NCT01009983|Carboplatin|carboplatin|mesh-list
65167544|NCT01214915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65167545|NCT01214915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167546|NCT01214915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65167547|NCT01009203|Sirolimus|sirolimus|mesh-list
65167548|NCT01009203|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65167549|NCT01009203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167550|NCT01009203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65167551|NCT01009203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167552|NCT01009203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167553|NCT01009203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65167608|NCT04735861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65167609|NCT04735861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167610|NCT04735861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65167611|NCT04735861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65167612|NCT04735861|Growth Substances|growth substances|mesh-ancestor
65167613|NCT04735861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167614|NCT04735861|Growth Inhibitors|growth inhibitors|mesh-ancestor
65167615|NCT03685747|Vancomycin|vancomycin|mesh-list
65167616|NCT03685747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65167617|NCT03685747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65167618|NCT03651271|Nivolumab|nivolumab|mesh-list
65167676|NCT04177693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65167677|NCT04177693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167678|NCT04177693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65167679|NCT04177693|Hormone Antagonists|hormone antagonists|mesh-ancestor
65167680|NCT04177693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65167681|NCT04177693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167682|NCT04177693|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65167683|NCT04177693|Fertility Agents|fertility agents|mesh-ancestor
65167684|NCT04177693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65167685|NCT04177693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65167686|NCT04177693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65167687|NCT04177693|Antioxidants|antioxidants|mesh-ancestor
65167688|NCT04177693|Protective Agents|protective agents|mesh-ancestor
65167689|NCT04177693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65167690|NCT04177693|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65167691|NCT04177693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65167692|NCT05345119|Sirolimus|sirolimus|mesh-list
65167693|NCT05345119|Methylprednisolone|methylprednisolone|mesh-list
65167696|NCT05345119|Prednisolone|prednisolone|mesh-list
65167734|NCT04074187|Prednisolone phosphate|prednisolone phosphate|mesh-list
65167735|NCT04074187|Immunosuppressive Agents|immunosuppressive agents|mesh-list
65167736|NCT04074187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65167737|NCT04074187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65167803|NCT03909451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167804|NCT03909451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65167805|NCT03909451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167806|NCT03596125|Acetylcysteine|acetylcysteine|mesh-list
65167807|NCT03596125|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65167808|NCT03596125|Antiviral Agents|antiviral agents|mesh-ancestor
65167809|NCT03596125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65167810|NCT03596125|Expectorants|expectorants|mesh-ancestor
65167811|NCT03596125|Respiratory System Agents|respiratory system agents|mesh-ancestor
65167868|NCT02480803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65167869|NCT02480803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167870|NCT02480803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167871|NCT02480803|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65167872|NCT02480803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65167873|NCT02480803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65167874|NCT02480803|Immunologic Factors|immunologic factors|mesh-ancestor
65167936|NCT01210001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65167937|NCT01210001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65167938|NCT01210001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65167939|NCT00624455|Gabapentin|gabapentin|mesh-list
65167940|NCT00624455|Analgesics|analgesics|mesh-ancestor
65167941|NCT00624455|Sensory System Agents|sensory system agents|mesh-ancestor
65167956|NCT01127659|Hormones|hormones|mesh-ancestor
65168006|NCT00848731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168007|NCT00848731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65168008|NCT00848731|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65168009|NCT00848731|Vasodilator Agents|vasodilator agents|mesh-ancestor
65168010|NCT00848731|Gasotransmitters|gasotransmitters|mesh-ancestor
65168011|NCT00848731|Protective Agents|protective agents|mesh-ancestor
65168074|NCT02703649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168075|NCT02703649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65168076|NCT02703649|Hormone Antagonists|hormone antagonists|mesh-ancestor
65168077|NCT02703649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65168078|NCT02703649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168080|NCT02703571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168142|NCT01012713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65168143|NCT01012713|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65168144|NCT01012713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65168145|NCT01012713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810740|NCT01442987|Irbesartan|irbesartan|mesh-list
65168146|NCT01012713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65168147|NCT01012713|Vitamins|vitamins|mesh-ancestor
65168149|NCT01012713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65168150|NCT02698813|Hyaluronic Acid|hyaluronic acid|mesh-list
65168151|NCT02698813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65168152|NCT02698813|Immunologic Factors|immunologic factors|mesh-ancestor
65168205|NCT04738123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168206|NCT04738123|Urological Agents|urological agents|mesh-ancestor
65168207|NCT04738123|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65168208|NCT04738123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65168209|NCT04738123|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65168210|NCT04738123|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65168211|NCT01006707|Ondansetron|ondansetron|mesh-list
65168212|NCT01006707|Antiemetics|antiemetics|mesh-ancestor
65168213|NCT01006707|Autonomic Agents|autonomic agents|mesh-ancestor
65168214|NCT01006707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65168215|NCT01006707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168216|NCT01006707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65168217|NCT01006707|Antipruritics|antipruritics|mesh-ancestor
65168218|NCT01006707|Dermatologic Agents|dermatologic agents|mesh-ancestor
65168265|NCT02549209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65168266|NCT02698267|Itraconazole|itraconazole|mesh-list
65168267|NCT02698267|Antifungal Agents|antifungal agents|mesh-ancestor
65168338|NCT02697955|Adrenergic Agents|adrenergic agents|mesh-ancestor
65168339|NCT02697955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65168340|NCT02697955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168341|NCT02697955|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65168342|NCT02697955|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65168407|NCT04214665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168408|NCT04214665|Vitamin B Complex|vitamin b complex|mesh-ancestor
65168409|NCT04214665|Vitamins|vitamins|mesh-ancestor
65168410|NCT04214665|Micronutrients|micronutrients|mesh-ancestor
65168477|NCT04215523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168478|NCT04215523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65168479|NCT04215523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168482|NCT03151681|Propranolol|propranolol|mesh-list
65168548|NCT02699827|Anesthetics, Local|anesthetics, local|mesh-ancestor
65168549|NCT02705989|Branebrutinib|branebrutinib|mesh-list
65168553|NCT02706067|Orlistat|orlistat|mesh-list
65168620|NCT00616915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168621|NCT02860039|Vaccines|vaccines|mesh-list
65168622|NCT02860039|Immunologic Factors|immunologic factors|mesh-ancestor
65168623|NCT02860039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168624|NCT05410223|Amoxicillin|amoxicillin|mesh-list
65168625|NCT05410223|Clarithromycin|clarithromycin|mesh-list
65168626|NCT05410223|Doxycycline|doxycycline|mesh-list
65168627|NCT05410223|Furazolidone|furazolidone|mesh-list
65168628|NCT05410223|Bismuth|bismuth|mesh-list
65168629|NCT05410223|Antibodies|antibodies|mesh-list
65168630|NCT05410223|Immunoglobulins|immunoglobulins|mesh-list
65168680|NCT02705053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65168681|NCT02705053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168682|NCT01204775|Metformin|metformin|mesh-list
65168683|NCT01204775|Saxagliptin|saxagliptin|mesh-list
65168684|NCT01204775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65168685|NCT01204775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65168686|NCT01204775|Incretins|incretins|mesh-ancestor
65168687|NCT01204775|Hormones|hormones|mesh-ancestor
65168746|NCT01204697|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65168747|NCT01204697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168821|NCT02052193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65168822|NCT02052193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65168823|NCT02052193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168894|NCT04924621|GABA Agents|gaba agents|mesh-ancestor
65168895|NCT04924621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65168896|NCT04924621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65168897|NCT04924621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65168902|NCT04924621|Narcotics|narcotics|mesh-ancestor
65168964|NCT00618397|Anesthetics, General|anesthetics, general|mesh-ancestor
65168966|NCT00618397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64811567|NCT01448174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65168967|NCT00618397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65168968|NCT00618397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65168969|NCT00618397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65168971|NCT04211545|Rabeprazole|rabeprazole|mesh-list
65169029|NCT04160377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65169030|NCT04160377|Antidepressive Agents|antidepressive agents|mesh-ancestor
65169031|NCT04160377|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65169032|NCT04160377|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65169033|NCT04160377|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65169034|NCT01000155|Vorinostat|vorinostat|mesh-list
65169096|NCT00996333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65169097|NCT00996333|Antimetabolites|antimetabolites|mesh-ancestor
65169098|NCT00996333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169099|NCT00996333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169100|NCT00996333|Antiviral Agents|antiviral agents|mesh-ancestor
65169101|NCT00996333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65169102|NCT00996333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169166|NCT04223661|Daratumumab|daratumumab|mesh-list
65169167|NCT04223661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65169168|NCT04223661|Antiemetics|antiemetics|mesh-ancestor
65169169|NCT04223661|Autonomic Agents|autonomic agents|mesh-ancestor
65169170|NCT04223661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65169171|NCT04223661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169172|NCT04223661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65169173|NCT04223661|Glucocorticoids|glucocorticoids|mesh-ancestor
65169174|NCT04223661|Hormones|hormones|mesh-ancestor
65169232|NCT05662189|Exenatide|exenatide|mesh-list
65169233|NCT05662189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65169234|NCT05662189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169235|NCT05662189|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65169236|NCT05662189|Incretins|incretins|mesh-ancestor
65169237|NCT05662189|Hormones|hormones|mesh-ancestor
65169238|NCT05662189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65169239|NCT00629031|Paromomycin|paromomycin|mesh-list
65169240|NCT00629031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65169241|NCT00629031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65169242|NCT00629031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65169243|NCT00629031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65169244|NCT00621361|Etoposide|etoposide|mesh-list
65169294|NCT05368753|Sensory System Agents|sensory system agents|mesh-ancestor
65169295|NCT05368753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65169296|NCT05368753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65169297|NCT05368753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65169298|NCT05368753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65169299|NCT05368753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65169300|NCT05368753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169301|NCT05368675|Buprenorphine|buprenorphine|mesh-list
65169302|NCT05368675|Methadone|methadone|mesh-list
65169303|NCT05368675|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
65169359|NCT05240391|Adrenergic Agents|adrenergic agents|mesh-ancestor
65169360|NCT05240391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65169361|NCT05240391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169362|NCT00628953|Esomeprazole|esomeprazole|mesh-list
65169363|NCT00628953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65169364|NCT00628953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65169365|NCT00628953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65169366|NCT00628953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169367|NCT00628953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169368|NCT04294953|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65169421|NCT02868801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169422|NCT02868801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65169423|NCT02868801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65169424|NCT02868801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65169425|NCT02868801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65169426|NCT02868801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65169427|NCT01002339|Mycophenolic Acid|mycophenolic acid|mesh-list
65169428|NCT01002339|Cyclosporine|cyclosporine|mesh-list
65169488|NCT02471911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65169489|NCT02471911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169490|NCT02471911|Immunologic Factors|immunologic factors|mesh-ancestor
65169491|NCT02471911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169492|NCT02471911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65169493|NCT02471911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65169494|NCT02471911|Antiemetics|antiemetics|mesh-ancestor
65169554|NCT04340947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65169555|NCT04340947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169556|NCT02697331|Progesterone|progesterone|mesh-list
65169557|NCT02697331|Progestins|progestins|mesh-ancestor
65169558|NCT02697331|Hormones|hormones|mesh-ancestor
65169559|NCT02697331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65169560|NCT02697331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169561|NCT04278625|Acetaminophen|acetaminophen|mesh-list
65169562|NCT04278625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65169619|NCT00993915|Atorvastatin|atorvastatin|mesh-list
65169620|NCT00993915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65169621|NCT00993915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65169622|NCT00993915|Antimetabolites|antimetabolites|mesh-ancestor
65169623|NCT00993915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65169624|NCT00993915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65169625|NCT00993915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65169626|NCT00993915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65169627|NCT01202591|Fulvestrant|fulvestrant|mesh-list
65169628|NCT01202591|Exemestane|exemestane|mesh-list
65169629|NCT01202591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65169630|NCT01202591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65169680|NCT02687347|Sensory System Agents|sensory system agents|mesh-ancestor
65169681|NCT02687347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65169682|NCT02687347|Antitussive Agents|antitussive agents|mesh-ancestor
65169683|NCT02687347|Respiratory System Agents|respiratory system agents|mesh-ancestor
65169684|NCT02687425|Pioglitazone|pioglitazone|mesh-list
65169685|NCT02687425|Imatinib Mesylate|imatinib mesylate|mesh-list
65169686|NCT02687425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65169750|NCT05378399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65169751|NCT05378399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65169752|NCT05378399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65169753|NCT04379011|Brivaracetam|brivaracetam|mesh-list
65169754|NCT04379011|Anticonvulsants|anticonvulsants|mesh-ancestor
65169755|NCT02685163|Antioxidants|antioxidants|mesh-list
65169757|NCT02685163|Protective Agents|protective agents|mesh-ancestor
65169820|NCT01200485|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65169821|NCT01200485|Antioxidants|antioxidants|mesh-ancestor
65169895|NCT01199939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65169896|NCT01199939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65169897|NCT01199939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65169898|NCT02688361|Acetylcysteine|acetylcysteine|mesh-list
65169899|NCT02688361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65169900|NCT02688361|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65169901|NCT02688361|Antiviral Agents|antiviral agents|mesh-ancestor
65169964|NCT00638833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65169965|NCT00638833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65169966|NCT00638833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65169967|NCT01198145|Sulfasalazine|sulfasalazine|mesh-list
65169968|NCT01198145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65169969|NCT01198145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65169970|NCT01198145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65169971|NCT01198145|Analgesics|analgesics|mesh-ancestor
65169982|NCT01179048|Hormones|hormones|mesh-ancestor
65170030|NCT01158534|Sensory System Agents|sensory system agents|mesh-ancestor
65170031|NCT01158534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170032|NCT01158534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65170033|NCT01158534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65170034|NCT01158534|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65170035|NCT01158534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65170036|NCT01158534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170037|NCT01158534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170038|NCT02687971|Miltefosine|miltefosine|mesh-list
65170039|NCT02687971|Antifungal Agents|antifungal agents|mesh-ancestor
65170040|NCT02687971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65170041|NCT02687971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170042|NCT02687971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65170043|NCT02687971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65170044|NCT05272878|Irbesartan|irbesartan|mesh-list
65170088|NCT02684071|Alkylating Agents|alkylating agents|mesh-ancestor
64812715|NCT01467115|Vitamins|vitamins|mesh-ancestor
65170089|NCT02684071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170090|NCT02684071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170091|NCT02684071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65170157|NCT04315584|Deoxyglucose|deoxyglucose|mesh-list
65170158|NCT04315584|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64812779|NCT01467401|Insulin Aspart|insulin aspart|mesh-list
65170232|NCT02680951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65170233|NCT02680951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170234|NCT02680951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65170236|NCT02680951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65170237|NCT02680717|Clobetasol|clobetasol|mesh-list
65170238|NCT02680717|Calcipotriene|calcipotriene|mesh-list
65170239|NCT02680717|Tacrolimus|tacrolimus|mesh-list
65170247|NCT02680717|Glucocorticoids|glucocorticoids|mesh-ancestor
65170302|NCT04291755|Ipilimumab|ipilimumab|mesh-list
65170303|NCT04291755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65170304|NCT04291755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170305|NCT04291755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65170306|NCT04291755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170307|NCT04292769|Decitabine|decitabine|mesh-list
65170308|NCT04292769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65170309|NCT04292769|Antimetabolites|antimetabolites|mesh-ancestor
65170310|NCT04292769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170311|NCT04292769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170312|NCT04292769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170313|NCT00640939|Diclofenac|diclofenac|mesh-list
65170365|NCT02682121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65170366|NCT02682121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170367|NCT02683603|Imipenem|imipenem|mesh-list
65170368|NCT02683603|Colistin|colistin|mesh-list
65170437|NCT02869035|Antidepressive Agents|antidepressive agents|mesh-ancestor
65170438|NCT02869035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65170439|NCT02869035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170440|NCT02869035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65170441|NCT02869035|Analgesics|analgesics|mesh-ancestor
65170442|NCT02869035|Sensory System Agents|sensory system agents|mesh-ancestor
65170444|NCT04290819|Caffeine|caffeine|mesh-list
65170508|NCT01195103|GABA Agents|gaba agents|mesh-ancestor
65170509|NCT01195103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65170582|NCT04205916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65170583|NCT04205916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170657|NCT01193153|Serotonin Agents|serotonin agents|mesh-ancestor
65170658|NCT01193153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65170659|NCT01193153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170660|NCT01193153|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65170661|NCT01193153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65170662|NCT01193153|Dopamine Agents|dopamine agents|mesh-ancestor
65170663|NCT02867007|Mogamulizumab|mogamulizumab|mesh-list
65170664|NCT02867007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65170665|NCT04289883|Calcium|calcium|mesh-list
65170668|NCT02865369|Asunaprevir|asunaprevir|mesh-list
65170724|NCT05656079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170725|NCT05656079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65170726|NCT01181921|Galantamine|galantamine|mesh-list
65170727|NCT01181921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65170728|NCT01181921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65170795|NCT02884440|Anesthetics|anesthetics|mesh-ancestor
65170796|NCT02884440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65170797|NCT02884440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170798|NCT02884440|Anesthetics, Local|anesthetics, local|mesh-ancestor
65170799|NCT02884440|Sensory System Agents|sensory system agents|mesh-ancestor
65170800|NCT02884440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65170864|NCT00625014|Dopamine Agents|dopamine agents|mesh-ancestor
65170865|NCT00625014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65170866|NCT00625014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65170867|NCT00625014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65170868|NCT01147848|Fluticasone|fluticasone|mesh-list
65170873|NCT01147848|Autonomic Agents|autonomic agents|mesh-ancestor
65170933|NCT01181531|Vitamins|vitamins|mesh-ancestor
65170934|NCT01181531|Micronutrients|micronutrients|mesh-ancestor
65170935|NCT01181531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65170936|NCT01181531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65170938|NCT01181531|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
65171003|NCT04263844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171004|NCT04263844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65171005|NCT04263844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65171006|NCT04263844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65171007|NCT04263844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65171008|NCT04263844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65171009|NCT04263844|Anesthetics, General|anesthetics, general|mesh-ancestor
65171010|NCT04263844|Anesthetics|anesthetics|mesh-ancestor
65171011|NCT04263844|GABA Modulators|gaba modulators|mesh-ancestor
65171012|NCT04263844|GABA Agents|gaba agents|mesh-ancestor
65171013|NCT00610324|Chlorhexidine|chlorhexidine|mesh-list
65171019|NCT04261036|Ascorbic Acid|ascorbic acid|mesh-list
65171071|NCT01180049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65171072|NCT01180049|Immunologic Factors|immunologic factors|mesh-ancestor
65171073|NCT01180049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171074|NCT01147458|Naproxen|naproxen|mesh-list
65171075|NCT01147458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65171140|NCT01149486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65171141|NCT01149486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65171144|NCT01149486|Natriuretic Agents|natriuretic agents|mesh-ancestor
65171211|NCT00640549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171212|NCT02683369|Iron|iron|mesh-list
65171213|NCT02683369|Trace Elements|trace elements|mesh-ancestor
65171214|NCT02683369|Micronutrients|micronutrients|mesh-ancestor
65171283|NCT01146054|Immunologic Factors|immunologic factors|mesh-ancestor
65171284|NCT01146054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171285|NCT01146054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65171286|NCT00640705|Diclofenac|diclofenac|mesh-list
65171354|NCT00625092|Antidotes|antidotes|mesh-ancestor
65171355|NCT00625092|Protective Agents|protective agents|mesh-ancestor
65171356|NCT00625092|Vitamin B Complex|vitamin b complex|mesh-ancestor
65171357|NCT00625092|Vitamins|vitamins|mesh-ancestor
65171358|NCT00625092|Micronutrients|micronutrients|mesh-ancestor
65171427|NCT00641329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65171428|NCT00641329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65171502|NCT02677519|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65171503|NCT02677519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171504|NCT02677519|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65171508|NCT02677519|Dopamine Agents|dopamine agents|mesh-ancestor
65171576|NCT00975195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65171577|NCT00975195|Autonomic Agents|autonomic agents|mesh-ancestor
65171578|NCT00975195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65171579|NCT00975195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171646|NCT02537353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65171647|NCT02537353|Adrenergic Agents|adrenergic agents|mesh-ancestor
65171648|NCT02537353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65171649|NCT02537353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171717|NCT00610792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171718|NCT00610792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171719|NCT00610870|Atorvastatin|atorvastatin|mesh-list
65171720|NCT00610870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65171721|NCT00610870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65171722|NCT00610870|Antimetabolites|antimetabolites|mesh-ancestor
65171723|NCT00610870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171724|NCT00610870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65171725|NCT00610870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65171726|NCT00610870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171727|NCT01168596|Rasagiline|rasagiline|mesh-list
65171728|NCT01168596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
65171729|NCT01168596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65171731|NCT01168596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65171777|NCT00928408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65171778|NCT00928252|Fluorides|fluorides|mesh-list
65171779|NCT00928252|Cariostatic Agents|cariostatic agents|mesh-ancestor
65171780|NCT00928252|Protective Agents|protective agents|mesh-ancestor
65171781|NCT00928252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171782|NCT02673229|Bacitracin|bacitracin|mesh-list
65171783|NCT02673229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65171784|NCT02673229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65171785|NCT02673229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65171786|NCT00644293|Azithromycin|azithromycin|mesh-list
65171787|NCT00644293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65171788|NCT00644293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65171789|NCT00930982|Ciprofloxacin|ciprofloxacin|mesh-list
65171790|NCT00930982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65171791|NCT00930982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65171792|NCT00930982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65171838|NCT00928018|Methotrexate|methotrexate|mesh-list
65171839|NCT00928018|Tacrolimus|tacrolimus|mesh-list
65171840|NCT00928018|Cyclosporins|cyclosporins|mesh-list
65171841|NCT00928018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65171842|NCT00928018|Abortifacient Agents|abortifacient agents|mesh-ancestor
65171843|NCT00928018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65171863|NCT02672839|Betadex|betadex|mesh-list
65171908|NCT00976989|Mitosis Modulators|mitosis modulators|mesh-ancestor
65171909|NCT00976989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65171910|NCT00976989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65171983|NCT00927472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65171984|NCT00642655|Rituximab|rituximab|mesh-list
65171985|NCT00642655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65171986|NCT00642655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65171987|NCT00642655|Immunologic Factors|immunologic factors|mesh-ancestor
65171988|NCT00642655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172051|NCT00976911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172052|NCT00976911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65172053|NCT05336968|Triamcinolone|triamcinolone|mesh-list
65172054|NCT05336968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65172055|NCT05336968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65172056|NCT05336968|Ketorolac|ketorolac|mesh-list
65172057|NCT05336968|Ropivacaine|ropivacaine|mesh-list
65172058|NCT05336968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65172059|NCT05336968|Anesthetics, Local|anesthetics, local|mesh-ancestor
65172060|NCT05336968|Anesthetics|anesthetics|mesh-ancestor
65172061|NCT05336968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65172062|NCT05336968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172063|NCT05336968|Sensory System Agents|sensory system agents|mesh-ancestor
65172064|NCT05336968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65172066|NCT05336968|Glucocorticoids|glucocorticoids|mesh-ancestor
65172111|NCT00644449|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65172112|NCT00644449|Renal Agents|renal agents|mesh-ancestor
65172113|NCT00644449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65172114|NCT00644449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65172115|NCT00644449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172116|NCT00644449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172179|NCT00976677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172180|NCT00976677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65172181|NCT00976677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65172182|NCT00976677|Growth Substances|growth substances|mesh-ancestor
65172183|NCT00976677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172184|NCT00976677|Growth Inhibitors|growth inhibitors|mesh-ancestor
65172185|NCT00976677|Immunologic Factors|immunologic factors|mesh-ancestor
65172186|NCT00976677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65172187|NCT00976677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172188|NCT05332444|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65172189|NCT05332444|Amoxicillin|amoxicillin|mesh-list
65172190|NCT05332444|Metronidazole|metronidazole|mesh-list
65172191|NCT05332444|Clarithromycin|clarithromycin|mesh-list
65172192|NCT05332444|Levofloxacin|levofloxacin|mesh-list
65172193|NCT05332444|Tetracycline|tetracycline|mesh-list
65172194|NCT05332444|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65172195|NCT05332444|Rabeprazole|rabeprazole|mesh-list
65172196|NCT05332444|Bismuth|bismuth|mesh-list
65172197|NCT05332444|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65172237|NCT04287387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65172238|NCT04287387|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65172239|NCT04287387|Protease Inhibitors|protease inhibitors|mesh-ancestor
65172240|NCT04287387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172241|NCT04287387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172242|NCT04287387|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65172243|NCT04287387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65172244|NCT04287387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65172245|NCT04287387|Immunologic Factors|immunologic factors|mesh-ancestor
65172246|NCT04287387|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65172247|NCT00644605|Sildenafil Citrate|sildenafil citrate|mesh-list
65172248|NCT00644605|Vasodilator Agents|vasodilator agents|mesh-ancestor
65172249|NCT00644605|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65172296|NCT00910195|Antipyretics|antipyretics|mesh-ancestor
65172297|NCT04176367|Nicergoline|nicergoline|mesh-list
65172298|NCT04176367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65172299|NCT04176367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65172300|NCT04176367|Adrenergic Agents|adrenergic agents|mesh-ancestor
65172301|NCT04176367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65172302|NCT04176367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172303|NCT04176367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172304|NCT04176367|Vasodilator Agents|vasodilator agents|mesh-ancestor
65172363|NCT00976209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172364|NCT00976209|Protective Agents|protective agents|mesh-ancestor
65172365|NCT03746301|Rivaroxaban|rivaroxaban|mesh-list
65172366|NCT03746301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65172367|NCT03746301|Antithrombins|antithrombins|mesh-ancestor
65172368|NCT03746301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65172369|NCT03746301|Protease Inhibitors|protease inhibitors|mesh-ancestor
65172370|NCT03746301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172371|NCT03746301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172372|NCT03746301|Anticoagulants|anticoagulants|mesh-ancestor
65172373|NCT00925990|Ribavirin|ribavirin|mesh-list
65172374|NCT00925990|Antimetabolites|antimetabolites|mesh-ancestor
65172375|NCT00925990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172376|NCT00925990|Antiviral Agents|antiviral agents|mesh-ancestor
65172377|NCT00925990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65172378|NCT02670655|Lidocaine|lidocaine|mesh-list
65172379|NCT02670655|Prilocaine|prilocaine|mesh-list
65172380|NCT02670655|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65172381|NCT02670655|Anesthetics, Local|anesthetics, local|mesh-ancestor
65172382|NCT02670655|Anesthetics|anesthetics|mesh-ancestor
65172383|NCT02670655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65172384|NCT02670655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172385|NCT02670655|Sensory System Agents|sensory system agents|mesh-ancestor
65172386|NCT02670655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65172387|NCT02670655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65172388|NCT02670655|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65172389|NCT02670655|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65172390|NCT02670655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65172391|NCT02670655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172392|NCT02670655|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65172405|NCT01131078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172406|NCT01131078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65172407|NCT01131078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65172479|NCT03449901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65172480|NCT03449901|Antimetabolites|antimetabolites|mesh-ancestor
65172481|NCT03449901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172492|NCT00968799|Cisplatin|cisplatin|mesh-list
65172553|NCT02670109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65172554|NCT02670109|Immunologic Factors|immunologic factors|mesh-ancestor
65172555|NCT02670109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172556|NCT02670109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65172558|NCT02670109|Alkylating Agents|alkylating agents|mesh-ancestor
65172623|NCT01175135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65172624|NCT01175135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65172625|NCT01175135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65172626|NCT01175135|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65172628|NCT02669641|Choline|choline|mesh-list
65172692|NCT02667535|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
65172693|NCT02667535|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65172694|NCT02667535|Diuretics|diuretics|mesh-ancestor
65172695|NCT02667535|Natriuretic Agents|natriuretic agents|mesh-ancestor
65172696|NCT02667535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172697|NCT02667535|Vasodilator Agents|vasodilator agents|mesh-ancestor
65172762|NCT02668861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172764|NCT02668861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65172837|NCT00646009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172838|NCT00646009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65172839|NCT00646009|Respiratory System Agents|respiratory system agents|mesh-ancestor
65172840|NCT00646009|Dermatologic Agents|dermatologic agents|mesh-ancestor
65172841|NCT00646009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65172907|NCT02666209|Autonomic Agents|autonomic agents|mesh-ancestor
65172908|NCT02666209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65172909|NCT02666209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65172910|NCT02666209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65172978|NCT02666443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65172979|NCT02666443|Protease Inhibitors|protease inhibitors|mesh-ancestor
65172980|NCT02666443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65172981|NCT02666443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65172982|NCT01130532|Tadalafil|tadalafil|mesh-list
65172983|NCT01130532|Vasodilator Agents|vasodilator agents|mesh-ancestor
65172984|NCT01130532|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65172985|NCT01130532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65173047|NCT02666053|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65173048|NCT02666053|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65173049|NCT02666053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173050|NCT03412773|Sorafenib|sorafenib|mesh-list
65173051|NCT03412773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173052|NCT03412773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65173053|NCT03412773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173054|NCT03412773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173055|NCT04257838|Meropenem|meropenem|mesh-list
65173056|NCT04257838|Tazobactam|tazobactam|mesh-list
65173057|NCT04257838|Piperacillin|piperacillin|mesh-list
65173109|NCT01143714|Dermatologic Agents|dermatologic agents|mesh-ancestor
65173110|NCT04920682|Iodine|iodine|mesh-list
65173111|NCT04920682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65173112|NCT04920682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65173113|NCT04920682|Trace Elements|trace elements|mesh-ancestor
65173114|NCT04920682|Micronutrients|micronutrients|mesh-ancestor
65173181|NCT03395847|Pembrolizumab|pembrolizumab|mesh-list
65173182|NCT03395847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65173183|NCT03395847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173184|NCT03381261|Botulinum Toxins|botulinum toxins|mesh-list
65173185|NCT03381261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65173250|NCT00646321|Hormones|hormones|mesh-ancestor
65173251|NCT00646321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65173252|NCT00646321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65173253|NCT00646321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65173254|NCT00646321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65173255|NCT00646321|Adrenergic Agents|adrenergic agents|mesh-ancestor
65173256|NCT00646321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65173258|NCT00647101|Latanoprost|latanoprost|mesh-list
65173315|NCT04895761|Cyclophosphamide|cyclophosphamide|mesh-list
65173316|NCT04895761|Letrozole|letrozole|mesh-list
65173317|NCT04895761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65173388|NCT04252456|Growth Inhibitors|growth inhibitors|mesh-ancestor
65173389|NCT04252456|Antidotes|antidotes|mesh-ancestor
65173390|NCT04252456|Protective Agents|protective agents|mesh-ancestor
65173391|NCT04252456|Vitamin B Complex|vitamin b complex|mesh-ancestor
65173392|NCT04252456|Vitamins|vitamins|mesh-ancestor
65173393|NCT04252456|Micronutrients|micronutrients|mesh-ancestor
65173394|NCT04252456|Hematinics|hematinics|mesh-ancestor
65173395|NCT02665351|Peramivir|peramivir|mesh-list
65173396|NCT02665351|Antiviral Agents|antiviral agents|mesh-ancestor
65173397|NCT02665351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65173398|NCT02665351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173399|NCT02665351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173449|NCT01220180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173450|NCT01220180|Anticonvulsants|anticonvulsants|mesh-ancestor
65173451|NCT01220180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65173452|NCT01220180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65173453|NCT01220180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173517|NCT02887976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65173518|NCT02887976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173519|NCT02887976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65173520|NCT02887976|Glucocorticoids|glucocorticoids|mesh-ancestor
65173521|NCT02887976|Hormones|hormones|mesh-ancestor
65173522|NCT02887976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65173523|NCT02887976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65173585|NCT01170065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173586|NCT01170065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955755|NCT00410878|Sensory System Agents|sensory system agents|mesh-ancestor
64955756|NCT00410878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64955757|NCT00410995|Naproxen|naproxen|mesh-list
65173589|NCT00966693|Thalidomide|thalidomide|mesh-list
65173652|NCT02664493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65173653|NCT02664493|Glucocorticoids|glucocorticoids|mesh-ancestor
65173654|NCT02664493|Hormones|hormones|mesh-ancestor
65173655|NCT02664493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65173656|NCT02664493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65173723|NCT04174261|Purinergic Agents|purinergic agents|mesh-ancestor
65173724|NCT04174261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65173725|NCT04174261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173726|NCT04174261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173727|NCT00971997|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
65173728|NCT00971997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65173730|NCT01142388|Paclitaxel|paclitaxel|mesh-list
65173792|NCT03809481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65173793|NCT03809481|Protease Inhibitors|protease inhibitors|mesh-ancestor
65173794|NCT03809481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173796|NCT03809481|Anticoagulants|anticoagulants|mesh-ancestor
65173862|NCT00648817|Antiviral Agents|antiviral agents|mesh-ancestor
65173863|NCT00648817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65173864|NCT00648817|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65173865|NCT00648817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65173866|NCT00648817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65173867|NCT00648817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173929|NCT01215032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173930|NCT02663089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65173931|NCT02664103|Cyclophosphamide|cyclophosphamide|mesh-list
65173932|NCT02664103|Capecitabine|capecitabine|mesh-list
65173933|NCT02664103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65173934|NCT02664103|Immunologic Factors|immunologic factors|mesh-ancestor
65173935|NCT02664103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65173936|NCT02664103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65173937|NCT02664103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65173938|NCT02664103|Alkylating Agents|alkylating agents|mesh-ancestor
65173939|NCT02664103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173940|NCT02664103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65173941|NCT02664103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65173942|NCT02664103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65173943|NCT02664103|Antimetabolites|antimetabolites|mesh-ancestor
65173944|NCT02662855|Favipiravir|favipiravir|mesh-list
65173945|NCT02662855|Antiviral Agents|antiviral agents|mesh-ancestor
65173946|NCT02662855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65173947|NCT00648271|Metoprolol|metoprolol|mesh-list
65173948|NCT00648271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65173949|NCT00648271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65173950|NCT00648271|Sympatholytics|sympatholytics|mesh-ancestor
65173981|NCT00648427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65173982|NCT00648427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65173983|NCT00648427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65173984|NCT00648427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65173985|NCT00648427|Serotonin Agents|serotonin agents|mesh-ancestor
65173986|NCT00648427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955823|NCT00039455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65174051|NCT02662309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174052|NCT04032691|Clonidine|clonidine|mesh-list
65174053|NCT04032691|Analgesics|analgesics|mesh-ancestor
65174054|NCT04032691|Sensory System Agents|sensory system agents|mesh-ancestor
65174055|NCT04032691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65174056|NCT04032691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174057|NCT04032691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65174111|NCT04169269|Antithrombins|antithrombins|mesh-ancestor
65174112|NCT04169269|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65174113|NCT04169269|Protease Inhibitors|protease inhibitors|mesh-ancestor
65174114|NCT04169269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174115|NCT04169269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174116|NCT04169269|Anticoagulants|anticoagulants|mesh-ancestor
65174117|NCT04169269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65174118|NCT04169269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65174119|NCT02661373|Cobicistat|cobicistat|mesh-list
65174120|NCT02661373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65174121|NCT02661373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65174122|NCT02661373|Antiviral Agents|antiviral agents|mesh-ancestor
65174123|NCT02661373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65174124|NCT02661373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65174170|NCT01142232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65174171|NCT01142232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65174172|NCT02536807|Hyaluronic Acid|hyaluronic acid|mesh-list
65174173|NCT02536807|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65174174|NCT02536807|Immunologic Factors|immunologic factors|mesh-ancestor
65174175|NCT02536807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174176|NCT02536807|Viscosupplements|viscosupplements|mesh-ancestor
65174177|NCT02536807|Protective Agents|protective agents|mesh-ancestor
65174178|NCT02536495|Docetaxel|docetaxel|mesh-list
65174180|NCT02536495|Tubulin Modulators|tubulin modulators|mesh-ancestor
65174236|NCT04170439|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65174237|NCT04170439|Hormone Antagonists|hormone antagonists|mesh-ancestor
65174238|NCT04170439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65174239|NCT04170439|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65174240|NCT04170439|Fertility Agents|fertility agents|mesh-ancestor
65174241|NCT04170439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65174242|NCT04170439|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65174246|NCT00649363|Ondansetron|ondansetron|mesh-list
65174302|NCT00649441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65174303|NCT00649441|Diuretics|diuretics|mesh-ancestor
65174304|NCT00649441|Natriuretic Agents|natriuretic agents|mesh-ancestor
65174305|NCT00649441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174306|NCT00649441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65174307|NCT00649441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65174374|NCT02658721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65174375|NCT02658721|Adrenergic Agents|adrenergic agents|mesh-ancestor
65174376|NCT04283877|Methylphenidate|methylphenidate|mesh-list
65174447|NCT02652091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65174448|NCT02652091|Immunologic Factors|immunologic factors|mesh-ancestor
65174449|NCT02652091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174450|NCT02652091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65174518|NCT01121484|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65174519|NCT01121484|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65174520|NCT01121484|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65174521|NCT01121484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65174522|NCT01121484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174523|NCT01121484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65174525|NCT01121484|Antidepressive Agents|antidepressive agents|mesh-ancestor
65174583|NCT02651311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65174584|NCT02651311|Narcotics|narcotics|mesh-ancestor
65174585|NCT02651311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65174586|NCT02651311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174587|NCT02651311|Analgesics|analgesics|mesh-ancestor
65174588|NCT02651311|Sensory System Agents|sensory system agents|mesh-ancestor
65174652|NCT00650611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174653|NCT00650611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65174654|NCT00650611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65174655|NCT00650611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65174726|NCT04168099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65174727|NCT04168099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174728|NCT04168099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174729|NCT04283487|Levan|levan|mesh-list
65174739|NCT02657473|Tobramycin|tobramycin|mesh-list
65174800|NCT02652325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65174801|NCT02652325|Trace Elements|trace elements|mesh-ancestor
65174802|NCT02652325|Micronutrients|micronutrients|mesh-ancestor
65174803|NCT02652325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174870|NCT00650923|Alkylating Agents|alkylating agents|mesh-ancestor
65174871|NCT00650923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174872|NCT00650923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65174873|NCT00650923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65174874|NCT00650923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65174875|NCT00650923|Growth Substances|growth substances|mesh-ancestor
65174876|NCT00650923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65174877|NCT00650923|Growth Inhibitors|growth inhibitors|mesh-ancestor
65174937|NCT00625170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65174938|NCT00625170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65174939|NCT00625170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65174940|NCT00625170|Serotonin Agents|serotonin agents|mesh-ancestor
65174941|NCT00625170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65174944|NCT00599755|Gemcitabine|gemcitabine|mesh-list
65175007|NCT02648503|Mydriatics|mydriatics|mesh-ancestor
65175008|NCT02648503|Parasympatholytics|parasympatholytics|mesh-ancestor
65175009|NCT02648503|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65175010|NCT02648503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65175078|NCT02656615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65175080|NCT02656615|Hormone Antagonists|hormone antagonists|mesh-ancestor
65175152|NCT04747912|Dermatologic Agents|dermatologic agents|mesh-ancestor
65175153|NCT04747912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65175154|NCT04747912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65175155|NCT04747912|Immunologic Factors|immunologic factors|mesh-ancestor
65175156|NCT04747912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65175157|NCT04747912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65175158|NCT04747912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65175159|NCT04747912|Tubulin Modulators|tubulin modulators|mesh-ancestor
65175160|NCT04747912|Antimitotic Agents|antimitotic agents|mesh-ancestor
65175161|NCT04747912|Mitosis Modulators|mitosis modulators|mesh-ancestor
65175217|NCT00632086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175292|NCT00910897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65175293|NCT00910897|Growth Substances|growth substances|mesh-ancestor
65175294|NCT00910897|Growth Inhibitors|growth inhibitors|mesh-ancestor
65175295|NCT00651547|Budesonide|budesonide|mesh-list
65175296|NCT00651547|Formoterol Fumarate|formoterol fumarate|mesh-list
65175297|NCT00651547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65175298|NCT00651547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65175299|NCT00651547|Autonomic Agents|autonomic agents|mesh-ancestor
65175300|NCT00651547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65175358|NCT00960531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65175359|NCT00960531|Immunologic Factors|immunologic factors|mesh-ancestor
65175360|NCT00960531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175361|NCT04407754|Inositol|inositol|mesh-list
65175362|NCT04407754|Vitamin B Complex|vitamin b complex|mesh-ancestor
65175429|NCT00957801|Protective Agents|protective agents|mesh-ancestor
65175430|NCT00957801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65175431|NCT00957801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65175432|NCT00957801|Androgens|androgens|mesh-ancestor
65175433|NCT00957801|Anabolic Agents|anabolic agents|mesh-ancestor
65175434|NCT02640469|Chlorhexidine|chlorhexidine|mesh-list
65175501|NCT02955823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65175502|NCT02955823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64818048|NCT01500005|Vitamin D|vitamin d|mesh-list
65175503|NCT02955823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65175504|NCT02955823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65175505|NCT02955823|Growth Substances|growth substances|mesh-ancestor
65175506|NCT02955823|Growth Inhibitors|growth inhibitors|mesh-ancestor
65175508|NCT02646397|Fosinopril|fosinopril|mesh-list
65175567|NCT04829344|Carticaine|carticaine|mesh-list
65175568|NCT04829344|Anesthetics, Local|anesthetics, local|mesh-ancestor
65175569|NCT04829344|Anesthetics|anesthetics|mesh-ancestor
65175570|NCT04829344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65175571|NCT04829344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175638|NCT01167257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65175639|NCT01167257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65175640|NCT01167257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65175641|NCT01167257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175642|NCT01167257|Cholinergic Agents|cholinergic agents|mesh-ancestor
65175643|NCT01167257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65175644|NCT01167257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175706|NCT03421288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175707|NCT03421288|Antidotes|antidotes|mesh-ancestor
65175708|NCT03421288|Protective Agents|protective agents|mesh-ancestor
65175709|NCT03421288|Vitamin B Complex|vitamin b complex|mesh-ancestor
65175778|NCT00652873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65175779|NCT00652873|Dopamine Agonists|dopamine agonists|mesh-ancestor
65175780|NCT00652873|Dopamine Agents|dopamine agents|mesh-ancestor
65175781|NCT00652873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65175784|NCT00652171|Lamotrigine|lamotrigine|mesh-list
65175848|NCT02644057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65175849|NCT02644057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65175850|NCT02644057|Protective Agents|protective agents|mesh-ancestor
65175851|NCT02644057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65175921|NCT02859285|Hormones|hormones|mesh-ancestor
65175922|NCT02859285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65175923|NCT02859285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65175924|NCT04260412|Psyllium|psyllium|mesh-list
65175992|NCT02643823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65175993|NCT02643823|Immunologic Factors|immunologic factors|mesh-ancestor
65175995|NCT02638831|Ketorolac|ketorolac|mesh-list
65176066|NCT04257448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176067|NCT04257448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65176068|NCT04257448|Immunologic Factors|immunologic factors|mesh-ancestor
65176069|NCT04257448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176070|NCT04257448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65176136|NCT01119066|Immunologic Factors|immunologic factors|mesh-ancestor
65176137|NCT01119066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176138|NCT01119066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65176139|NCT01119066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65176207|NCT03770338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176208|NCT03770338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65176209|NCT01198522|Gemcitabine|gemcitabine|mesh-list
65176210|NCT01198522|Antibodies|antibodies|mesh-list
65176278|NCT01135914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176279|NCT01135914|Growth Inhibitors|growth inhibitors|mesh-ancestor
65176280|NCT01135914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176281|NCT00907738|Vorinostat|vorinostat|mesh-list
65176291|NCT01123356|Ofatumumab|ofatumumab|mesh-list
65176350|NCT00632554|Antiemetics|antiemetics|mesh-ancestor
65176351|NCT00632554|Autonomic Agents|autonomic agents|mesh-ancestor
65176352|NCT00632554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65176353|NCT00632554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65176356|NCT03082209|Bevacizumab|bevacizumab|mesh-list
65176424|NCT02860221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176425|NCT02860221|Hemostatics|hemostatics|mesh-ancestor
65176426|NCT02860221|Coagulants|coagulants|mesh-ancestor
65176427|NCT02860221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65176428|NCT02860221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65176429|NCT02860221|Adrenergic Agents|adrenergic agents|mesh-ancestor
65176493|NCT00656695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65176494|NCT00656695|Dermatologic Agents|dermatologic agents|mesh-ancestor
65176495|NCT00656695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65176496|NCT00656695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176566|NCT02856867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65176567|NCT02856867|Immunologic Factors|immunologic factors|mesh-ancestor
65176568|NCT02856867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176569|NCT02856867|Antidotes|antidotes|mesh-ancestor
65176639|NCT02794402|Exenatide|exenatide|mesh-list
65176640|NCT02794402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65176641|NCT02794402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65176642|NCT02794402|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65176711|NCT00948675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65176712|NCT00948675|Tubulin Modulators|tubulin modulators|mesh-ancestor
65176713|NCT00948675|Antimitotic Agents|antimitotic agents|mesh-ancestor
65176714|NCT00948675|Mitosis Modulators|mitosis modulators|mesh-ancestor
65176716|NCT00948675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65176780|NCT02850484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65176781|NCT02850484|Adrenergic Agents|adrenergic agents|mesh-ancestor
65176782|NCT02850484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65176783|NCT02850484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176851|NCT04202224|Antipyretics|antipyretics|mesh-ancestor
65176852|NCT04202224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65176924|NCT02847442|Dopamine Agents|dopamine agents|mesh-ancestor
65176925|NCT02847442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65176926|NCT02847442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176995|NCT00433420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65176996|NCT00433420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65176997|NCT00433420|Immunologic Factors|immunologic factors|mesh-ancestor
65177065|NCT03561376|Petrolatum|petrolatum|mesh-list
65177141|NCT00630981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177210|NCT04410328|Antipyretics|antipyretics|mesh-ancestor
65177211|NCT04410328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65177212|NCT04410328|Vasodilator Agents|vasodilator agents|mesh-ancestor
65177213|NCT02852577|Clonazepam|clonazepam|mesh-list
65177214|NCT02852577|Paroxetine|paroxetine|mesh-list
65177215|NCT02852577|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65177216|NCT02852577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65177217|NCT02852577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65177230|NCT02852577|GABA Agents|gaba agents|mesh-ancestor
65177277|NCT03763162|Ichthammol|ichthammol|mesh-list
65177278|NCT03763162|BB 1101|bb 1101|mesh-list
65177279|NCT03763162|Glycine|glycine|mesh-list
65177280|NCT03763162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65177281|NCT03763162|Antiemetics|antiemetics|mesh-ancestor
65177282|NCT03763162|Autonomic Agents|autonomic agents|mesh-ancestor
65177283|NCT03763162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65177346|NCT00885703|Amebicides|amebicides|mesh-ancestor
65177347|NCT00885703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65177348|NCT00885703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65177349|NCT00885703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65177350|NCT00885703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65177351|NCT00885703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65177352|NCT02642419|Aspirin|aspirin|mesh-list
65177353|NCT02642419|Rivaroxaban|rivaroxaban|mesh-list
65177354|NCT02642419|Clopidogrel|clopidogrel|mesh-list
65177413|NCT00655915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65177414|NCT00655915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65177415|NCT00655915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65177416|NCT00655915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65177483|NCT04475848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65177484|NCT04475848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65177485|NCT04475848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65177558|NCT02634463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65177559|NCT02634463|Antidepressive Agents|antidepressive agents|mesh-ancestor
65177560|NCT02634463|Dopamine Agonists|dopamine agonists|mesh-ancestor
65177561|NCT02634463|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65177629|NCT01236430|Atorvastatin|atorvastatin|mesh-list
65177630|NCT01236430|Ezetimibe|ezetimibe|mesh-list
65177631|NCT01236430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65177632|NCT01236430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65177633|NCT01236430|Antimetabolites|antimetabolites|mesh-ancestor
65177634|NCT01236430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177635|NCT01236430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65177636|NCT01236430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65177638|NCT00726856|Ezetimibe|ezetimibe|mesh-list
65177696|NCT00157924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177697|NCT00157924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65177698|NCT00157924|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65177699|NCT00157924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65177700|NCT00794794|Cetirizine|cetirizine|mesh-list
65177701|NCT00794794|Desloratadine|desloratadine|mesh-list
65177765|NCT02843698|Analgesics|analgesics|mesh-ancestor
65177766|NCT02843698|Sensory System Agents|sensory system agents|mesh-ancestor
65177767|NCT02843698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65177768|NCT02843698|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65177770|NCT02843698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65177834|NCT01212770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65177835|NCT01212770|Immunologic Factors|immunologic factors|mesh-ancestor
65177836|NCT01212770|Leprostatic Agents|leprostatic agents|mesh-ancestor
65177837|NCT01212770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65177838|NCT01212770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65177839|NCT01212770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65177840|NCT01212770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65177904|NCT02633683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65177905|NCT02633683|Antimanic Agents|antimanic agents|mesh-ancestor
65177906|NCT01211522|Haloperidol|haloperidol|mesh-list
65177976|NCT02633761|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65177977|NCT02633761|Hormone Antagonists|hormone antagonists|mesh-ancestor
65177978|NCT02633761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65177979|NCT02633761|Luteolytic Agents|luteolytic agents|mesh-ancestor
65178045|NCT00657163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65178046|NCT00657163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178047|NCT00657163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65178048|NCT00657163|Serotonin Agents|serotonin agents|mesh-ancestor
65178049|NCT00657163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178050|NCT00657163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65178051|NCT00657163|Antidepressive Agents|antidepressive agents|mesh-ancestor
65178052|NCT00657163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65178108|NCT00665743|Sensory System Agents|sensory system agents|mesh-ancestor
65178109|NCT00665743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65178110|NCT00665743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178111|NCT00665743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65178112|NCT00665743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65178113|NCT00665743|Gout Suppressants|gout suppressants|mesh-ancestor
65178178|NCT00666055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178179|NCT00666055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178180|NCT00666055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65178181|NCT00666055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65178182|NCT00666055|Antiviral Agents|antiviral agents|mesh-ancestor
65178183|NCT00666055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65178184|NCT00666055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65178199|NCT00661375|Sorafenib|sorafenib|mesh-list
65178244|NCT02837614|Protease Inhibitors|protease inhibitors|mesh-ancestor
65178245|NCT02837614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178246|NCT02837614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178247|NCT02837614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65178248|NCT02837614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65178314|NCT00661765|Varenicline|varenicline|mesh-list
65178315|NCT00661765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65178316|NCT00661765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65178317|NCT00661765|Cholinergic Agents|cholinergic agents|mesh-ancestor
65178318|NCT00661765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65178319|NCT00661765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178381|NCT02630485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178382|NCT02630485|Vitamin B Complex|vitamin b complex|mesh-ancestor
65178455|NCT02836288|Anesthetics|anesthetics|mesh-ancestor
65178456|NCT02836288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65178468|NCT01208402|Esmolol|esmolol|mesh-list
65178529|NCT00666991|Antimitotic Agents|antimitotic agents|mesh-ancestor
65178530|NCT00666991|Mitosis Modulators|mitosis modulators|mesh-ancestor
65178531|NCT00666991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178532|NCT00667147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65178533|NCT00667147|Paclitaxel|paclitaxel|mesh-list
65178599|NCT02631499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178600|NCT00662233|Cyclophosphamide|cyclophosphamide|mesh-list
65178601|NCT00662233|Ifosfamide|ifosfamide|mesh-list
65178602|NCT00662233|Doxorubicin|doxorubicin|mesh-list
65178603|NCT00662233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65178604|NCT00662233|Etoposide|etoposide|mesh-list
65178605|NCT00662233|Vincristine|vincristine|mesh-list
65178606|NCT00662233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65178607|NCT00662233|Immunologic Factors|immunologic factors|mesh-ancestor
65178666|NCT00894322|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65178667|NCT00894322|Incretins|incretins|mesh-ancestor
65178668|NCT00894322|Hormones|hormones|mesh-ancestor
65178669|NCT00894322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65178670|NCT05323708|Denosumab|denosumab|mesh-list
65178735|NCT00669487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178736|NCT00669487|Antiviral Agents|antiviral agents|mesh-ancestor
65178737|NCT00669487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65178738|NCT00669487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65178739|NCT00669487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65178740|NCT00669487|Antimetabolites|antimetabolites|mesh-ancestor
65178741|NCT00669565|Bavituximab|bavituximab|mesh-list
65178742|NCT00669565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65178802|NCT00670345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65178803|NCT00670345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64821354|NCT01515592|Hormones|hormones|mesh-ancestor
65178804|NCT00670345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65178874|NCT05657015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65178875|NCT02887313|Leucovorin|leucovorin|mesh-list
65178876|NCT02887313|Fluorouracil|fluorouracil|mesh-list
65178877|NCT02887313|Oxaliplatin|oxaliplatin|mesh-list
65178878|NCT02887313|Antimetabolites|antimetabolites|mesh-ancestor
65178947|NCT01188551|Dexmedetomidine|dexmedetomidine|mesh-list
65178948|NCT01188551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65178949|NCT01188551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65178950|NCT01188551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65178952|NCT01188551|Analgesics|analgesics|mesh-ancestor
65179017|NCT02834260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65179018|NCT02834260|Antiemetics|antiemetics|mesh-ancestor
65179019|NCT02834260|Autonomic Agents|autonomic agents|mesh-ancestor
65179020|NCT02834260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65179021|NCT02834260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179022|NCT02834260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65179023|NCT02834260|Glucocorticoids|glucocorticoids|mesh-ancestor
65179024|NCT02834260|Hormones|hormones|mesh-ancestor
65179025|NCT02834260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65179081|NCT02831374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179082|NCT02831218|Aspirin|aspirin|mesh-list
65179083|NCT02831218|Clopidogrel|clopidogrel|mesh-list
65179084|NCT02831218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65179085|NCT02831218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65179086|NCT02831218|Analgesics|analgesics|mesh-ancestor
65179087|NCT02831218|Sensory System Agents|sensory system agents|mesh-ancestor
65179090|NCT02831218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65179147|NCT00891202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179148|NCT02830906|Ondansetron|ondansetron|mesh-list
65179149|NCT02830906|Ramosetron|ramosetron|mesh-list
65179150|NCT02830906|Antiemetics|antiemetics|mesh-ancestor
65179220|NCT02831842|Growth Inhibitors|growth inhibitors|mesh-ancestor
65179221|NCT02830048|Glyburide|glyburide|mesh-list
65179222|NCT02830048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65179223|NCT02830048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179224|NCT02830126|Anesthetics|anesthetics|mesh-list
65179290|NCT02829346|Coagulants|coagulants|mesh-ancestor
65179291|NCT05210764|Ketamine|ketamine|mesh-list
65179292|NCT05210764|Anesthetics|anesthetics|mesh-list
65179293|NCT05210764|Propofol|propofol|mesh-list
65179294|NCT05210764|Sevoflurane|sevoflurane|mesh-list
65179295|NCT05210764|Esketamine|esketamine|mesh-list
65179296|NCT05210764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65179297|NCT05210764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179359|NCT00670813|Modafinil|modafinil|mesh-list
65179360|NCT00670813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65179361|NCT00670813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179362|NCT00670813|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65179363|NCT00670813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65179429|NCT04155697|Ethanol|ethanol|mesh-list
65179430|NCT04155697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65179431|NCT04155697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65179432|NCT04155697|Disinfectants|disinfectants|mesh-ancestor
65179435|NCT00663559|Sunitinib|sunitinib|mesh-list
65179501|NCT00660283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65179502|NCT00660283|Alkylating Agents|alkylating agents|mesh-ancestor
65179503|NCT00660283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179504|NCT00660283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179505|NCT00663949|Captopril|captopril|mesh-list
65179506|NCT00663949|Pentoxifylline|pentoxifylline|mesh-list
65179507|NCT00663949|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65179508|NCT00663949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179510|NCT00663949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65179557|NCT04155229|Respiratory System Agents|respiratory system agents|mesh-ancestor
65179558|NCT04155229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65179559|NCT04155229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65179560|NCT04155229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65179561|NCT00671359|Tedizolid phosphate|tedizolid phosphate|mesh-list
65179562|NCT00671359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65179563|NCT00671359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65179564|NCT04153201|Hydroxychloroquine|hydroxychloroquine|mesh-list
65179565|NCT04153201|Antimalarials|antimalarials|mesh-list
65179566|NCT04153201|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65179567|NCT04153201|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65179568|NCT04153201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65179569|NCT04153201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179617|NCT01104792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65179618|NCT01104792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179619|NCT01104792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65179620|NCT01205126|Oxycodone|oxycodone|mesh-list
65179621|NCT01205126|Hydromorphone|hydromorphone|mesh-list
65179622|NCT01205126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65179623|NCT01205126|Narcotics|narcotics|mesh-ancestor
65179624|NCT01205126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65179684|NCT00665041|Dopamine Agonists|dopamine agonists|mesh-ancestor
65179685|NCT00665041|Dopamine Agents|dopamine agents|mesh-ancestor
65179686|NCT00665041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65179687|NCT00665041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179688|NCT00665041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179755|NCT01109316|Insulin Lispro|insulin lispro|mesh-list
65179756|NCT01109316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65179757|NCT01109316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179758|NCT02825290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65179760|NCT02825290|Luteolytic Agents|luteolytic agents|mesh-ancestor
65179761|NCT02825290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65179762|NCT02825290|Contraceptive Agents|contraceptive agents|mesh-ancestor
65179763|NCT02825290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65179764|NCT02825290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179765|NCT02825290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65179819|NCT01104636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179820|NCT01104636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65179821|NCT04931602|Vitamin D|vitamin d|mesh-list
65179892|NCT00602589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65179893|NCT00602589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65179894|NCT00602589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65179895|NCT00602589|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65179963|NCT00673621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65179964|NCT00673621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65179965|NCT00673621|Adrenergic Agents|adrenergic agents|mesh-ancestor
65180038|NCT01203098|Protease Inhibitors|protease inhibitors|mesh-ancestor
65180039|NCT01203098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180040|NCT05032794|Bisacodyl|bisacodyl|mesh-list
65180041|NCT05032794|Cathartics|cathartics|mesh-ancestor
65180042|NCT05032794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65180043|NCT05032794|Laxatives|laxatives|mesh-ancestor
65180107|NCT02825056|Analgesics|analgesics|mesh-ancestor
65180108|NCT02826772|Androgens|androgens|mesh-list
65180109|NCT02826772|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
65180110|NCT02826772|Hormones|hormones|mesh-ancestor
65180111|NCT02826772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65180112|NCT02826772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180113|NCT02826772|Androgen Antagonists|androgen antagonists|mesh-ancestor
65180114|NCT02826772|Hormone Antagonists|hormone antagonists|mesh-ancestor
65180115|NCT00674011|Bevacizumab|bevacizumab|mesh-list
65180116|NCT00674011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65180117|NCT00674011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180118|NCT00674011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65180119|NCT00674011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65180120|NCT00674011|Growth Substances|growth substances|mesh-ancestor
65180121|NCT00674011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180122|NCT00674011|Growth Inhibitors|growth inhibitors|mesh-ancestor
65180123|NCT00674089|Vitamin A|vitamin a|mesh-list
65180124|NCT00674089|Vitamins|vitamins|mesh-ancestor
65180125|NCT00674089|Micronutrients|micronutrients|mesh-ancestor
65180126|NCT00674089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180165|NCT02824510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65180166|NCT02824510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180167|NCT00674245|Pantoprazole|pantoprazole|mesh-list
65180237|NCT02824354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180238|NCT02824354|Sensory System Agents|sensory system agents|mesh-ancestor
65180239|NCT02824354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65180240|NCT02823496|Sunscreening Agents|sunscreening agents|mesh-list
65180241|NCT02823496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65180242|NCT02823496|Protective Agents|protective agents|mesh-ancestor
65180243|NCT02823496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180244|NCT02823496|Dermatologic Agents|dermatologic agents|mesh-ancestor
65180245|NCT00677755|Misoprostol|misoprostol|mesh-list
65180302|NCT04241458|GABA Agents|gaba agents|mesh-ancestor
65180303|NCT04241458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65180304|NCT04241458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180305|NCT00681343|Alemtuzumab|alemtuzumab|mesh-list
65180375|NCT01200758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65180376|NCT01200758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65180449|NCT00678145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65180524|NCT04148833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180525|NCT04148833|Tubulin Modulators|tubulin modulators|mesh-ancestor
65180526|NCT04148833|Antimitotic Agents|antimitotic agents|mesh-ancestor
65180527|NCT04148833|Mitosis Modulators|mitosis modulators|mesh-ancestor
65180595|NCT02821156|Antioxidants|antioxidants|mesh-ancestor
65180596|NCT02821156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180597|NCT02821156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65180598|NCT02821156|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65180599|NCT02821156|Vasodilator Agents|vasodilator agents|mesh-ancestor
65180600|NCT02821156|Gasotransmitters|gasotransmitters|mesh-ancestor
65180601|NCT02821156|Protective Agents|protective agents|mesh-ancestor
65180602|NCT02820922|Anesthetics|anesthetics|mesh-list
65180662|NCT04745728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180663|NCT04745728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180664|NCT04745728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65180665|NCT04745728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65180666|NCT04745728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65180667|NCT04745728|Glucocorticoids|glucocorticoids|mesh-ancestor
65180671|NCT02818660|Cosyntropin|cosyntropin|mesh-list
65180729|NCT05658640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65180731|NCT05658640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65180732|NCT05658640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65180733|NCT05658640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65180734|NCT05658640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65180735|NCT05658640|Antiemetics|antiemetics|mesh-ancestor
65180736|NCT05658640|Autonomic Agents|autonomic agents|mesh-ancestor
65180799|NCT00684463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65180800|NCT00684463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180801|NCT00684463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65180869|NCT00684853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65180870|NCT00684853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65180871|NCT00684853|Growth Substances|growth substances|mesh-ancestor
65180872|NCT00684853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180873|NCT00684853|Growth Inhibitors|growth inhibitors|mesh-ancestor
65180939|NCT00633802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65180940|NCT00633802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65180941|NCT00633802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65180943|NCT00633802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65181012|NCT01106898|Mitosis Modulators|mitosis modulators|mesh-ancestor
65181013|NCT01106898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181014|NCT01106898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65181015|NCT01106898|Immunologic Factors|immunologic factors|mesh-ancestor
65181016|NCT01106898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181082|NCT04329832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65181158|NCT00634348|Ziprasidone|ziprasidone|mesh-list
65181159|NCT00634348|Antidepressive Agents|antidepressive agents|mesh-ancestor
65181160|NCT00634348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65181176|NCT00680329|Timolol|timolol|mesh-list
65181228|NCT00690313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65181229|NCT00690313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65181230|NCT00690313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65181231|NCT04237480|Vitamin D|vitamin d|mesh-list
65181302|NCT02809768|Hormone Antagonists|hormone antagonists|mesh-ancestor
65181376|NCT02809378|Sensory System Agents|sensory system agents|mesh-ancestor
65181450|NCT00687661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65181451|NCT00687661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181452|NCT00687817|Paclitaxel|paclitaxel|mesh-list
65181453|NCT00687817|Carboplatin|carboplatin|mesh-list
65181454|NCT00687817|Bavituximab|bavituximab|mesh-list
65181455|NCT00687817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65181519|NCT02808676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65181520|NCT00690937|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
65181521|NCT00690937|Sevelamer|sevelamer|mesh-list
65181591|NCT02807116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65181592|NCT02807116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65181593|NCT02807116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65181661|NCT00689845|Cytarabine|cytarabine|mesh-list
65181662|NCT00689845|Prednisone|prednisone|mesh-list
65181663|NCT00689845|Prednisolone|prednisolone|mesh-list
65181664|NCT00689845|Cyclophosphamide|cyclophosphamide|mesh-list
65181665|NCT00689845|Ifosfamide|ifosfamide|mesh-list
65181666|NCT00689845|Rituximab|rituximab|mesh-list
65181667|NCT00689845|Doxorubicin|doxorubicin|mesh-list
65181669|NCT00689845|Methotrexate|methotrexate|mesh-list
65181733|NCT00691405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65181734|NCT00691405|Autonomic Agents|autonomic agents|mesh-ancestor
65181735|NCT00691405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65181736|NCT00691405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65181741|NCT00691405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65181802|NCT00874237|Dopamine Agents|dopamine agents|mesh-ancestor
65181803|NCT00874237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65181804|NCT02805946|Posaconazole|posaconazole|mesh-list
65181805|NCT02805946|Antifungal Agents|antifungal agents|mesh-ancestor
65181806|NCT02805946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65181807|NCT02805946|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64824370|NCT01531309|S 20098|s 20098|mesh-list
65181808|NCT02805946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65181809|NCT02805946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65181871|NCT04032964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65181872|NCT04032964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65181873|NCT04032964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65181874|NCT04032964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65181941|NCT04236310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65181942|NCT04236310|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65181943|NCT04236310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65181944|NCT04236310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182014|NCT02800252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65182015|NCT02800252|Analgesics|analgesics|mesh-ancestor
65182016|NCT02800252|Sensory System Agents|sensory system agents|mesh-ancestor
65182086|NCT01151579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65182087|NCT01151579|Respiratory System Agents|respiratory system agents|mesh-ancestor
65182088|NCT01151579|Tocolytic Agents|tocolytic agents|mesh-ancestor
65182089|NCT01151579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65182155|NCT00692731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182156|NCT00692731|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65182157|NCT00692731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65182227|NCT02798068|Glucocorticoids|glucocorticoids|mesh-ancestor
65182228|NCT02798068|Hormones|hormones|mesh-ancestor
65182240|NCT04135885|Folic Acid|folic acid|mesh-list
65182300|NCT02620423|Pembrolizumab|pembrolizumab|mesh-list
65182301|NCT02620423|Irinotecan|irinotecan|mesh-list
65182302|NCT02620423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65182375|NCT02795572|Pyridoxal|pyridoxal|mesh-list
65182376|NCT02795572|Pyridoxine|pyridoxine|mesh-list
65182377|NCT02795572|Vitamin B Complex|vitamin b complex|mesh-list
65182378|NCT02795572|Micronutrients|micronutrients|mesh-ancestor
65182379|NCT02795572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182380|NCT02795572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65182381|NCT05445778|Bevacizumab|bevacizumab|mesh-list
65182382|NCT05445778|Maytansine|maytansine|mesh-list
65182383|NCT05445778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65182384|NCT05445778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182385|NCT05445778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65182386|NCT05445778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65182387|NCT05445778|Growth Substances|growth substances|mesh-ancestor
65182437|NCT02689960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65182438|NCT01150097|Everolimus|everolimus|mesh-list
65182439|NCT01150097|Tacrolimus|tacrolimus|mesh-list
65182440|NCT01150097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65182441|NCT01150097|Immunologic Factors|immunologic factors|mesh-ancestor
65182442|NCT01150097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182507|NCT00693433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182508|NCT00693433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65182509|NCT00693433|Glucocorticoids|glucocorticoids|mesh-ancestor
65182510|NCT00693433|Hormones|hormones|mesh-ancestor
65182512|NCT00693433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65182575|NCT01148537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65182576|NCT01148537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182577|NCT01148537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65182578|NCT01148537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65182649|NCT03913234|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65182650|NCT03913234|Hormone Antagonists|hormone antagonists|mesh-ancestor
65182652|NCT03913234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182721|NCT00697021|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65182722|NCT00697021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65182723|NCT00697021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65182724|NCT00697021|Antipyretics|antipyretics|mesh-ancestor
65182725|NCT00697021|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65182726|NCT00697021|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65182791|NCT01148225|Adalimumab|adalimumab|mesh-list
65182792|NCT01148225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65182793|NCT01148225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65182794|NCT02788240|Meropenem|meropenem|mesh-list
65182863|NCT02617069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182865|NCT02788552|Thiamine|thiamine|mesh-list
65182866|NCT02788552|Micronutrients|micronutrients|mesh-ancestor
65182867|NCT02788552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65182868|NCT02788552|Vitamin B Complex|vitamin b complex|mesh-ancestor
65182869|NCT01147055|Rifampin|rifampin|mesh-list
65182870|NCT01147055|Crizotinib|crizotinib|mesh-list
65182871|NCT01147055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65182932|NCT00696475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65182933|NCT00696475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65182934|NCT00696475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65182935|NCT00696475|Nootropic Agents|nootropic agents|mesh-ancestor
65182936|NCT00696475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65182937|NCT00696475|Vasodilator Agents|vasodilator agents|mesh-ancestor
65182938|NCT03628066|Letrozole|letrozole|mesh-list
65182939|NCT03628066|Palbociclib|palbociclib|mesh-list
65182940|NCT03628066|Goserelin|goserelin|mesh-list
65182998|NCT04133155|Antiviral Agents|antiviral agents|mesh-ancestor
65182999|NCT04133155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65183000|NCT04133155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65183001|NCT04133155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65183070|NCT01145495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65183071|NCT01145495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65183072|NCT01145495|Growth Substances|growth substances|mesh-ancestor
65183074|NCT03421756|Sirolimus|sirolimus|mesh-list
65183143|NCT02785276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183144|NCT02785276|Sensory System Agents|sensory system agents|mesh-ancestor
65183145|NCT02785276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183146|NCT04316039|Temozolomide|temozolomide|mesh-list
65183148|NCT04316039|Alkylating Agents|alkylating agents|mesh-ancestor
65183212|NCT03071926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183213|NCT02883647|Tenofovir|tenofovir|mesh-list
65183214|NCT02883647|Entecavir|entecavir|mesh-list
65183215|NCT02883647|Antiviral Agents|antiviral agents|mesh-ancestor
65183216|NCT02883647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65183284|NCT01143077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65183285|NCT01143077|Serotonin Agents|serotonin agents|mesh-ancestor
65183286|NCT01143077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65183287|NCT01143077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65183288|NCT01143077|Dopamine Agents|dopamine agents|mesh-ancestor
65183289|NCT02786446|Naproxen|naproxen|mesh-list
65183354|NCT00864721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183356|NCT05308420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65183357|NCT05308420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183425|NCT02786212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65183426|NCT02786212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65183427|NCT02786212|Adrenergic Agents|adrenergic agents|mesh-ancestor
65183428|NCT02786212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65183429|NCT02786212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65183498|NCT01094808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65183499|NCT01094808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183569|NCT04230070|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65183570|NCT04230070|Estrogens|estrogens|mesh-ancestor
65183571|NCT04230070|Hormones|hormones|mesh-ancestor
65183572|NCT04230070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65183573|NCT04230070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183574|NCT04230070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65183575|NCT04230070|Contraceptive Agents|contraceptive agents|mesh-ancestor
65183636|NCT00887536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65183637|NCT00887536|Immunologic Factors|immunologic factors|mesh-ancestor
65183638|NCT00887536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183639|NCT00887536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65183640|NCT00887536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65183641|NCT00887536|Alkylating Agents|alkylating agents|mesh-ancestor
65183703|NCT04229602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65183705|NCT04229602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65183774|NCT01134731|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65183849|NCT04125121|Anesthetics, General|anesthetics, general|mesh-ancestor
65183850|NCT04125121|Anesthetics|anesthetics|mesh-ancestor
65183851|NCT04125121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65183921|NCT01134263|Immunologic Factors|immunologic factors|mesh-ancestor
65183922|NCT01134263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65183923|NCT01199822|Olaratumab|olaratumab|mesh-list
65183995|NCT01092780|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65183996|NCT01092780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65183997|NCT01092780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65183998|NCT01092780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184064|NCT02200978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65184065|NCT02200978|Antimetabolites|antimetabolites|mesh-ancestor
65184066|NCT02200978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184136|NCT04227652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184137|NCT04227652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184138|NCT04227652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65184208|NCT04940572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184209|NCT04940572|GABA Agents|gaba agents|mesh-ancestor
65184210|NCT04940572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65184211|NCT04940572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184212|NCT04940572|Antimanic Agents|antimanic agents|mesh-ancestor
65184213|NCT04940572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65184278|NCT02778178|Anesthetics|anesthetics|mesh-ancestor
64826852|NCT01545479|Captopril|captopril|mesh-list
65184281|NCT02778178|Sensory System Agents|sensory system agents|mesh-ancestor
65184349|NCT02777866|Sensory System Agents|sensory system agents|mesh-ancestor
65184350|NCT02777866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65184351|NCT00626262|Esomeprazole|esomeprazole|mesh-list
65184352|NCT00626262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65184353|NCT00626262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65184420|NCT01076088|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65184421|NCT01076088|Protease Inhibitors|protease inhibitors|mesh-ancestor
65184422|NCT01076088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184423|NCT01076088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184424|NCT02777320|Acetaminophen|acetaminophen|mesh-list
65184425|NCT02777320|Ibuprofen|ibuprofen|mesh-list
64320141|NCT02183701|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64320142|NCT02183701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64320143|NCT02183701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320144|NCT02183701|Diuretics|diuretics|mesh-ancestor
64417226|NCT04819867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64417227|NCT02423343|Nivolumab|nivolumab|mesh-list
64417228|NCT02423343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65184426|NCT02777320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65184427|NCT02777320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65184428|NCT02777320|Analgesics|analgesics|mesh-ancestor
65184429|NCT02777320|Sensory System Agents|sensory system agents|mesh-ancestor
65184430|NCT02777320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64417229|NCT02423343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417230|NCT02423343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65184504|NCT01192178|Xhance|xhance|mesh-list
65184528|NCT04193566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65184529|NCT04193566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65184530|NCT04193566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184599|NCT00950859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65184600|NCT00950859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65184674|NCT01077960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65184675|NCT01077960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184676|NCT04269369|Fluorouracil|fluorouracil|mesh-list
65184746|NCT02772718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65184747|NCT02772718|Immunologic Factors|immunologic factors|mesh-ancestor
65184748|NCT02772718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65184749|NCT00866281|Midostaurin|midostaurin|mesh-list
65184750|NCT00866281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65184819|NCT02770690|Lidocaine|lidocaine|mesh-list
65184820|NCT02770690|Ethyl Chloride|ethyl chloride|mesh-list
65184821|NCT02770690|Anesthetics, Local|anesthetics, local|mesh-ancestor
65184822|NCT02770690|Anesthetics|anesthetics|mesh-ancestor
65184891|NCT02770222|Antitubercular Agents|antitubercular agents|mesh-ancestor
65184892|NCT02770222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65184893|NCT02770222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65184894|NCT02770222|Leprostatic Agents|leprostatic agents|mesh-ancestor
65184895|NCT02770222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65184896|NCT02770222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65184958|NCT02876484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65184959|NCT02876484|Cathartics|cathartics|mesh-ancestor
65184960|NCT02876484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65184961|NCT02876094|Celecoxib|celecoxib|mesh-list
65185032|NCT02768116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65185033|NCT02768116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185106|NCT02617459|Adrenergic Agents|adrenergic agents|mesh-ancestor
65185107|NCT02617459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65185108|NCT02617459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185109|NCT02854995|Triamcinolone|triamcinolone|mesh-list
65185110|NCT02854995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65185111|NCT02854995|Glucocorticoids|glucocorticoids|mesh-ancestor
65185178|NCT01706692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65185179|NCT01706692|Antifungal Agents|antifungal agents|mesh-ancestor
65185180|NCT01706692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65185181|NCT01706692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65185182|NCT01706692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65185183|NCT01706692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65185184|NCT01706692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65185245|NCT02766556|Dexmedetomidine|dexmedetomidine|mesh-list
65185246|NCT02766556|Ropivacaine|ropivacaine|mesh-list
65185247|NCT02766556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65185248|NCT02766556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65185249|NCT02766556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185250|NCT02766556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65185315|NCT01132313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185316|NCT01132313|Antiviral Agents|antiviral agents|mesh-ancestor
65185317|NCT01132313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65185318|NCT05658146|Sulconazole|sulconazole|mesh-list
65185319|NCT05658146|Antifungal Agents|antifungal agents|mesh-ancestor
65185375|NCT02762890|Iodine|iodine|mesh-list
65185386|NCT02762656|Lidocaine|lidocaine|mesh-list
65185387|NCT02762656|Anesthetics, Local|anesthetics, local|mesh-ancestor
65185388|NCT02762656|Anesthetics|anesthetics|mesh-ancestor
65185389|NCT02762656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65185390|NCT02762656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185391|NCT02762656|Sensory System Agents|sensory system agents|mesh-ancestor
65185401|NCT02762344|Heparin|heparin|mesh-list
65185454|NCT00865189|Oxaliplatin|oxaliplatin|mesh-list
65185455|NCT00865189|Levoleucovorin|levoleucovorin|mesh-list
65185456|NCT00865189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65185457|NCT00865189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65185458|NCT00865189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65185471|NCT00865189|Vitamins|vitamins|mesh-ancestor
65185527|NCT01181726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65185528|NCT01181726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185529|NCT01181726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65185530|NCT01181726|Contraceptive Agents|contraceptive agents|mesh-ancestor
65185595|NCT05383131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65185596|NCT05383131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65185597|NCT05383131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65185598|NCT02761486|Aspirin|aspirin|mesh-list
65185601|NCT02761486|Analgesics|analgesics|mesh-ancestor
65185667|NCT01186328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185668|NCT01186328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65185738|NCT02882555|Sensory System Agents|sensory system agents|mesh-ancestor
65185739|NCT02882555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65185740|NCT02882555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65185741|NCT00699361|Pantoprazole|pantoprazole|mesh-list
65185742|NCT00699361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65185806|NCT01128569|Respiratory System Agents|respiratory system agents|mesh-ancestor
65185807|NCT01128569|Dermatologic Agents|dermatologic agents|mesh-ancestor
65185808|NCT01128569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65185810|NCT04582942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65185811|NCT02883179|Lidocaine|lidocaine|mesh-list
65185812|NCT02883179|Prilocaine|prilocaine|mesh-list
65185814|NCT02883179|Anesthetics, Local|anesthetics, local|mesh-ancestor
65185874|NCT01181102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65185875|NCT01181102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65185876|NCT01181102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65185877|NCT01181102|Antithrombins|antithrombins|mesh-ancestor
65185878|NCT01181102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65185879|NCT01181102|Protease Inhibitors|protease inhibitors|mesh-ancestor
65185881|NCT00858637|Bile Acids and Salts|bile acids and salts|mesh-list
65185882|NCT00858637|Simvastatin|simvastatin|mesh-list
65185942|NCT04480918|Antidepressive Agents|antidepressive agents|mesh-ancestor
65185943|NCT04480918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65185944|NCT04222348|Metformin|metformin|mesh-list
65185945|NCT04222348|Insulin Detemir|insulin detemir|mesh-list
65185946|NCT04222348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65185948|NCT04222114|Catumaxomab|catumaxomab|mesh-list
65186013|NCT04221256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65186014|NCT04221256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186015|NCT04221256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65186016|NCT04221256|Serotonin Agents|serotonin agents|mesh-ancestor
65186082|NCT04586920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65186083|NCT04586920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186084|NCT04586920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65186085|NCT04586920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65186086|NCT04586920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65186156|NCT02755714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186231|NCT00939627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65186232|NCT00939627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186233|NCT00939627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186234|NCT05382741|Durvalumab|durvalumab|mesh-list
65186237|NCT04220476|Letrozole|letrozole|mesh-list
65186301|NCT02753140|Cetuximab|cetuximab|mesh-list
65186302|NCT02753140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186303|NCT02753140|Tubulin Modulators|tubulin modulators|mesh-ancestor
65186304|NCT02753140|Antimitotic Agents|antimitotic agents|mesh-ancestor
65186373|NCT01191008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186374|NCT01191008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65186375|NCT01191008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65186376|NCT01076400|Topotecan|topotecan|mesh-list
65186377|NCT01076400|Adavosertib|adavosertib|mesh-list
65186378|NCT01076400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186379|NCT01076400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65186380|NCT01076400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65186381|NCT01076400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65186382|NCT01076400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186436|NCT04115644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186438|NCT04115644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65186510|NCT01127165|Zonisamide|zonisamide|mesh-list
65186511|NCT01127165|Anticonvulsants|anticonvulsants|mesh-ancestor
65186512|NCT01127165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65186513|NCT01127165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65186514|NCT01127165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65186582|NCT00941655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186583|NCT00941655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65186584|NCT00941655|Immunologic Factors|immunologic factors|mesh-ancestor
65186585|NCT00941655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186653|NCT00607503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65186654|NCT00607503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65186655|NCT00607503|Adrenergic Agents|adrenergic agents|mesh-ancestor
65186656|NCT00607503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65186658|NCT04217512|Pantoprazole|pantoprazole|mesh-list
65186723|NCT03141034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186724|NCT00636142|Infliximab|infliximab|mesh-list
65186725|NCT00636142|Dermatologic Agents|dermatologic agents|mesh-ancestor
65186726|NCT00636142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65186727|NCT00636142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65186796|NCT02041234|Linagliptin|linagliptin|mesh-list
65186797|NCT02041234|Canagliflozin|canagliflozin|mesh-list
65186798|NCT02041234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65186799|NCT02041234|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65186800|NCT02041234|Orlistat|orlistat|mesh-list
65186801|NCT02041234|Incretins|incretins|mesh-list
65186802|NCT02041234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65186803|NCT02041234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186804|NCT02041234|Hormones|hormones|mesh-ancestor
65186805|NCT02041234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65186806|NCT02041234|Protease Inhibitors|protease inhibitors|mesh-ancestor
65186853|NCT04406272|Growth Substances|growth substances|mesh-ancestor
65186854|NCT04406272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186928|NCT02744716|Analgesics|analgesics|mesh-ancestor
65186929|NCT02744716|Sensory System Agents|sensory system agents|mesh-ancestor
65186930|NCT02744716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65186931|NCT02744716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65186932|NCT02744716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65186933|NCT02744716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65186996|NCT01071798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65186997|NCT01071798|Immunologic Factors|immunologic factors|mesh-ancestor
65186998|NCT01071798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187070|NCT02739958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65187071|NCT02739880|Hyaluronic Acid|hyaluronic acid|mesh-list
65187072|NCT02739880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65187073|NCT02739880|Immunologic Factors|immunologic factors|mesh-ancestor
65187074|NCT02739880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187075|NCT02739880|Viscosupplements|viscosupplements|mesh-ancestor
65187076|NCT02739880|Protective Agents|protective agents|mesh-ancestor
65187077|NCT01071096|Botulinum Toxins|botulinum toxins|mesh-list
65187078|NCT01071096|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65187079|NCT01071096|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65187080|NCT01071096|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65187081|NCT01071096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65187082|NCT01071096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187083|NCT01071096|Cholinergic Agents|cholinergic agents|mesh-ancestor
65187084|NCT01071096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65187085|NCT01071096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187086|NCT01071096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65187087|NCT01071096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65187088|NCT00856375|Irinotecan|irinotecan|mesh-list
65187089|NCT00856375|Etirinotecan pegol|etirinotecan pegol|mesh-list
65187090|NCT00856375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65187091|NCT00856375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65187092|NCT00856375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187094|NCT00856375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187120|NCT00837577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65187121|NCT00837577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187122|NCT00837577|Incretins|incretins|mesh-ancestor
65187123|NCT00837577|Hormones|hormones|mesh-ancestor
65187131|NCT01070550|Antiviral Agents|antiviral agents|mesh-ancestor
65187192|NCT02613013|Anesthetics|anesthetics|mesh-ancestor
65187193|NCT02613013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65187194|NCT02613013|Sensory System Agents|sensory system agents|mesh-ancestor
65187195|NCT04306510|Antibodies|antibodies|mesh-list
65187196|NCT04306510|Immunoglobulins|immunoglobulins|mesh-list
65187263|NCT04304352|Immunologic Factors|immunologic factors|mesh-ancestor
65187264|NCT04304352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187265|NCT04304352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65187266|NCT04304352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65187330|NCT03633058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65187331|NCT03633058|Anesthetics, General|anesthetics, general|mesh-ancestor
65187332|NCT03633058|Anesthetics|anesthetics|mesh-ancestor
65187333|NCT03633058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65187402|NCT02737228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65187403|NCT02737228|Immunologic Factors|immunologic factors|mesh-ancestor
65187473|NCT00836875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65187474|NCT02732314|Desonide|desonide|mesh-list
65187475|NCT02732314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65187545|NCT02734732|Trimethoprim|trimethoprim|mesh-list
65187546|NCT02734732|Sulfamethoxazole|sulfamethoxazole|mesh-list
65187547|NCT02734732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65187548|NCT02734732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65187549|NCT02734732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65187620|NCT00627354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65187621|NCT00627354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187622|NCT00627354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65187623|NCT00627354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187624|NCT00627354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65187625|NCT00627354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65187689|NCT05433532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187766|NCT00704665|Methocarbamol|methocarbamol|mesh-list
65187767|NCT00704665|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65187768|NCT00704665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187836|NCT02728492|Carboplatin|carboplatin|mesh-list
65187837|NCT02728492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65187838|NCT02728492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187839|NCT02728492|Tubulin Modulators|tubulin modulators|mesh-ancestor
65187840|NCT02728492|Antimitotic Agents|antimitotic agents|mesh-ancestor
65187841|NCT02728492|Mitosis Modulators|mitosis modulators|mesh-ancestor
65187842|NCT02728492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187843|NCT02728492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65187844|NCT02728492|Antimetabolites|antimetabolites|mesh-ancestor
65187901|NCT01042236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187902|NCT01042236|Urological Agents|urological agents|mesh-ancestor
65187903|NCT02725918|Pemetrexed|pemetrexed|mesh-list
65187904|NCT02725918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187905|NCT02725918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65187906|NCT02725918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187907|NCT02725918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65187908|NCT02725918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65187909|NCT00592501|Fluorouracil|fluorouracil|mesh-list
65187910|NCT00592501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187911|NCT00592501|Antimetabolites|antimetabolites|mesh-ancestor
65187912|NCT00592501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187913|NCT00592501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65187914|NCT00592501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65187915|NCT00592501|Immunologic Factors|immunologic factors|mesh-ancestor
65187916|NCT00592501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187917|NCT01040832|Cetuximab|cetuximab|mesh-list
65187918|NCT01040832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65187919|NCT01040832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65187920|NCT02721238|Plasma-lyte 148|plasma-lyte 148|mesh-list
65187921|NCT02721238|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65187922|NCT02721238|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65187923|NCT04304196|TEMPO|tempo|mesh-list
65187924|NCT04304196|Antioxidants|antioxidants|mesh-ancestor
65187925|NCT04304196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65187926|NCT04304196|Protective Agents|protective agents|mesh-ancestor
65187927|NCT04304196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187928|NCT02720770|Hormones|hormones|mesh-list
65187929|NCT02720770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65187930|NCT02720770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65187944|NCT00854581|Antiviral Agents|antiviral agents|mesh-ancestor
65187945|NCT00854581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65187946|NCT00854581|Immunologic Factors|immunologic factors|mesh-ancestor
65187948|NCT00854581|Antimetabolites|antimetabolites|mesh-ancestor
65188017|NCT02719132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65188018|NCT02719132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188019|NCT02718820|Docetaxel|docetaxel|mesh-list
65188020|NCT02718820|Pembrolizumab|pembrolizumab|mesh-list
65188021|NCT02718820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188086|NCT02717572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188087|NCT01121393|Gemcitabine|gemcitabine|mesh-list
65188088|NCT01121393|Afatinib|afatinib|mesh-list
65188089|NCT01121393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188090|NCT01121393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65188091|NCT01121393|Antimetabolites|antimetabolites|mesh-ancestor
65188092|NCT01121393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188093|NCT01121393|Antiviral Agents|antiviral agents|mesh-ancestor
65188094|NCT01121393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65188095|NCT01121393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188096|NCT01121393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65188151|NCT01227616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65188152|NCT04189276|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65188153|NCT04189276|Antiviral Agents|antiviral agents|mesh-ancestor
65188154|NCT04189276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65188155|NCT02714998|Methotrexate|methotrexate|mesh-list
65188156|NCT02714998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65188177|NCT00765310|Vitamins|vitamins|mesh-ancestor
65188221|NCT02714842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65188222|NCT02714842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65188223|NCT02714842|Analgesics|analgesics|mesh-ancestor
65188224|NCT02714842|Sensory System Agents|sensory system agents|mesh-ancestor
65188225|NCT02714842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65188226|NCT02714842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188227|NCT02714842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65188228|NCT02714842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65188229|NCT02714842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65188285|NCT02713282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188286|NCT02713282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65188356|NCT02712346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65188357|NCT04617028|Hydroxyurea|hydroxyurea|mesh-list
65188358|NCT04617028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188359|NCT04617028|Antisickling Agents|antisickling agents|mesh-ancestor
65188360|NCT04617028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188426|NCT02710396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65188427|NCT02710396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188428|NCT02710396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65188499|NCT00611962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503252|NCT01229878|Vitamin D|vitamin d|mesh-list
65188500|NCT00611962|Tubulin Modulators|tubulin modulators|mesh-ancestor
65188501|NCT00611962|Antimitotic Agents|antimitotic agents|mesh-ancestor
65188502|NCT00611962|Mitosis Modulators|mitosis modulators|mesh-ancestor
65188503|NCT00611962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188504|NCT05380713|Cyclophosphamide|cyclophosphamide|mesh-list
65188506|NCT05380713|Tremelimumab|tremelimumab|mesh-list
65188507|NCT05380713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65188508|NCT05380713|Immunologic Factors|immunologic factors|mesh-ancestor
65188509|NCT05380713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188510|NCT05380713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65188511|NCT05380713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65188512|NCT05380713|Alkylating Agents|alkylating agents|mesh-ancestor
65188513|NCT05380713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188514|NCT05380713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188515|NCT05380713|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65188516|NCT05380713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65188517|NCT00606099|Adefovir|adefovir|mesh-list
65188518|NCT00606099|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65188519|NCT00606099|Telbivudine|telbivudine|mesh-list
65188520|NCT00606099|Antiviral Agents|antiviral agents|mesh-ancestor
65188521|NCT00606099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65188522|NCT00606099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65188549|NCT02708446|Luteolytic Agents|luteolytic agents|mesh-ancestor
65188550|NCT02708446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65188551|NCT02708446|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65188552|NCT05378919|Folic Acid|folic acid|mesh-list
65188553|NCT05378919|Leucovorin|leucovorin|mesh-list
65188628|NCT05380479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65188629|NCT05380479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65188630|NCT05380479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188631|NCT05380479|Appetite Stimulants|appetite stimulants|mesh-ancestor
65188632|NCT05380479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65188707|NCT01120691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65188708|NCT01120691|Cholinergic Agents|cholinergic agents|mesh-ancestor
65188709|NCT01120691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65188710|NCT01120691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188711|NCT01120691|Tocolytic Agents|tocolytic agents|mesh-ancestor
65188712|NCT01120691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65188713|NCT01120691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65188714|NCT01120691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65188773|NCT02724904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65188774|NCT02724904|Antimetabolites|antimetabolites|mesh-ancestor
65188775|NCT02724904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65188776|NCT02724904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188777|NCT02724904|Dermatologic Agents|dermatologic agents|mesh-ancestor
64831332|NCT01579461|Mirabegron|mirabegron|mesh-list
65188778|NCT02724904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65188779|NCT02724904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65188780|NCT02724904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65188781|NCT02724904|Immunologic Factors|immunologic factors|mesh-ancestor
65188782|NCT02724904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65188783|NCT02724904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65188784|NCT02724904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65188785|NCT02724904|Alkylating Agents|alkylating agents|mesh-ancestor
65188786|NCT02724904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65188828|NCT02937766|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
65188829|NCT02937766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65188830|NCT02937766|Hormone Antagonists|hormone antagonists|mesh-ancestor
65188831|NCT02937766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65188832|NCT02937766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65188833|NCT02937766|Progestins|progestins|mesh-ancestor
65188834|NCT02937766|Hormones|hormones|mesh-ancestor
65188835|NCT00607971|Renzapride|renzapride|mesh-list
65188836|NCT00607971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65188837|NCT00607971|Serotonin Agents|serotonin agents|mesh-ancestor
65188838|NCT00607971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65188841|NCT02724358|Chlorotrianisene|chlorotrianisene|mesh-list
65188892|NCT01124045|Prednisolone phosphate|prednisolone phosphate|mesh-list
65188893|NCT01124045|Difluprednate|difluprednate|mesh-list
65188894|NCT01124045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65188895|NCT01124045|Glucocorticoids|glucocorticoids|mesh-ancestor
65188896|NCT01124045|Hormones|hormones|mesh-ancestor
65188897|NCT01124045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65188900|NCT01124045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65188960|NCT02723500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65188961|NCT02723500|Anesthetics, General|anesthetics, general|mesh-ancestor
65188962|NCT02723500|Anesthetics|anesthetics|mesh-ancestor
65188965|NCT00934791|Mycophenolic Acid|mycophenolic acid|mesh-list
65189031|NCT01111019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65189032|NCT01111019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189051|NCT01119287|Hormones|hormones|mesh-ancestor
65189102|NCT00636922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189177|NCT01118351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65189178|NCT01118351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65189179|NCT01118351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189180|NCT01110005|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65189246|NCT04120870|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65189247|NCT04120870|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65189248|NCT04120870|Anesthetics, General|anesthetics, general|mesh-ancestor
65189249|NCT04120870|Anesthetics|anesthetics|mesh-ancestor
65189250|NCT04120870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65189251|NCT04120870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65189253|NCT04120870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65189313|NCT01061736|Micronutrients|micronutrients|mesh-ancestor
65189314|NCT02874378|Dexmedetomidine|dexmedetomidine|mesh-list
65189315|NCT02874378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65189316|NCT02874378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65189317|NCT02874378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189318|NCT02874378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65189319|NCT02874378|Analgesics|analgesics|mesh-ancestor
65189378|NCT01040130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65189379|NCT01040130|Autonomic Agents|autonomic agents|mesh-ancestor
65189380|NCT01040130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65189381|NCT01040130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189382|NCT01040130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65189383|NCT01040130|Respiratory System Agents|respiratory system agents|mesh-ancestor
65189445|NCT00613600|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
65189446|NCT00613600|Cathartics|cathartics|mesh-ancestor
65189447|NCT00613600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65189448|NCT04302402|Rifaximin|rifaximin|mesh-list
65189452|NCT03931408|Gentamicins|gentamicins|mesh-list
65189518|NCT03711838|Respiratory System Agents|respiratory system agents|mesh-ancestor
65189519|NCT03711838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65189520|NCT03711838|Antioxidants|antioxidants|mesh-ancestor
65189591|NCT04310579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65189592|NCT04310579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65189593|NCT04310579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65189594|NCT04310579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65189595|NCT04310579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65189596|NCT04310579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65189597|NCT04310579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65189660|NCT02692534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65189661|NCT02692534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65189662|NCT02692534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65189663|NCT02692534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189664|NCT02692534|Dopamine Agents|dopamine agents|mesh-ancestor
65189665|NCT02692534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65189666|NCT00614536|Rabeprazole|rabeprazole|mesh-list
65189667|NCT00614536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65189726|NCT01976182|Methotrexate|methotrexate|mesh-list
65189727|NCT01976182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65189759|NCT00608595|Celecoxib|celecoxib|mesh-list
65189797|NCT01055496|Antiemetics|antiemetics|mesh-ancestor
65189798|NCT01055496|Autonomic Agents|autonomic agents|mesh-ancestor
65189799|NCT01055496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65189800|NCT01055496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65189801|NCT01055496|Glucocorticoids|glucocorticoids|mesh-ancestor
65189802|NCT01055496|Hormones|hormones|mesh-ancestor
65189867|NCT01052844|Antimanic Agents|antimanic agents|mesh-ancestor
65189868|NCT02932618|Factor VIII|factor viii|mesh-list
65189869|NCT02932618|Coagulants|coagulants|mesh-ancestor
65189870|NCT01049412|Insulin Glargine|insulin glargine|mesh-list
65189873|NCT02584426|Cefazolin|cefazolin|mesh-list
65189939|NCT01031628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65189940|NCT00609843|Ethiodized Oil|ethiodized oil|mesh-list
65189941|NCT00609843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65189942|NCT00608673|Betamethasone|betamethasone|mesh-list
65189943|NCT00608673|Betamethasone Valerate|betamethasone valerate|mesh-list
65189944|NCT00608673|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
65190007|NCT00627250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65190008|NCT00627250|Analgesics|analgesics|mesh-ancestor
65190079|NCT00926367|Clindamycin|clindamycin|mesh-list
65190080|NCT00926367|Clindamycin palmitate|clindamycin palmitate|mesh-list
65190081|NCT00926367|Clindamycin phosphate|clindamycin phosphate|mesh-list
65190082|NCT00926367|Adapalene|adapalene|mesh-list
65190083|NCT00926367|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65190084|NCT00926367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65190085|NCT00926367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65190087|NCT00926367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190147|NCT05006417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65190148|NCT05006417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65190149|NCT05006417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190154|NCT05006417|Cholinergic Agents|cholinergic agents|mesh-ancestor
65190216|NCT02549170|Immunoglobulins|immunoglobulins|mesh-list
65190217|NCT02549170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65190218|NCT02549170|Antibodies|antibodies|mesh-list
65190219|NCT02549170|Immunoglobulin G|immunoglobulin g|mesh-list
65190220|NCT02549170|gamma-Globulins|gamma-globulins|mesh-list
65190221|NCT02549170|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65190222|NCT02549170|Immunologic Factors|immunologic factors|mesh-ancestor
65190287|NCT00627666|Levoleucovorin|levoleucovorin|mesh-list
65190288|NCT00627666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65190289|NCT00627666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190290|NCT00627666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65190291|NCT00627666|Abortifacient Agents|abortifacient agents|mesh-ancestor
65190356|NCT04216186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65190357|NCT04216186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190359|NCT04216186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65190429|NCT02698228|Anesthetics|anesthetics|mesh-ancestor
65190430|NCT02698228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65190431|NCT02698228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190432|NCT02698228|Sensory System Agents|sensory system agents|mesh-ancestor
65190452|NCT00193414|Pemetrexed|pemetrexed|mesh-list
65190502|NCT00928707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190503|NCT00928707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190504|NCT00928707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65190505|NCT00928707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65190506|NCT04956705|Vitamin D|vitamin d|mesh-list
65190507|NCT04956705|Calcium|calcium|mesh-list
65190508|NCT04956705|Vitamins|vitamins|mesh-ancestor
65190510|NCT04956705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190511|NCT04956705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65190512|NCT04956705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65190513|NCT02705950|Baclofen|baclofen|mesh-list
65190514|NCT02705950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65190515|NCT02705950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190516|NCT02705950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65190517|NCT02705950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65190518|NCT02705950|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65190560|NCT04258371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190561|NCT00930579|Metformin|metformin|mesh-list
65190562|NCT00930579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65190563|NCT00930579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190564|NCT03367156|Dexamethasone|dexamethasone|mesh-list
65190565|NCT03367156|Dexamethasone acetate|dexamethasone acetate|mesh-list
65190631|NCT02691910|Filaricides|filaricides|mesh-ancestor
65190632|NCT02691910|Antinematodal Agents|antinematodal agents|mesh-ancestor
65190633|NCT02691910|Anthelmintics|anthelmintics|mesh-ancestor
65190634|NCT02705014|Hormones|hormones|mesh-list
65190636|NCT02705014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190705|NCT04214626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65190706|NCT04214626|Alkylating Agents|alkylating agents|mesh-ancestor
65190707|NCT04214626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190713|NCT04214626|Hormones|hormones|mesh-ancestor
65190775|NCT00637078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65190786|NCT00637078|Diuretics|diuretics|mesh-ancestor
65190848|NCT01015638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65190849|NCT01015638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65190850|NCT01015638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65190851|NCT01015638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190853|NCT01015638|Dermatologic Agents|dermatologic agents|mesh-ancestor
65190917|NCT05329857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65190918|NCT05329857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190919|NCT05329857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65190920|NCT05329857|Protease Inhibitors|protease inhibitors|mesh-ancestor
65190921|NCT05329857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65190922|NCT05329857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65190923|NCT04981041|Clopidogrel|clopidogrel|mesh-list
65190924|NCT04981041|Ticagrelor|ticagrelor|mesh-list
65190925|NCT04981041|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65190926|NCT04981041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65190980|NCT01015560|Immunologic Factors|immunologic factors|mesh-ancestor
65190981|NCT01015560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65190982|NCT04253223|Volagidemab|volagidemab|mesh-list
65191053|NCT00833833|Glucocorticoids|glucocorticoids|mesh-ancestor
65191054|NCT00833833|Hormones|hormones|mesh-ancestor
65191055|NCT00833833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65191056|NCT00833833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65191128|NCT02612701|Autonomic Agents|autonomic agents|mesh-ancestor
65191129|NCT02612701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65191130|NCT02612701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191131|NCT02612701|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65191132|NCT02612701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65191133|NCT02612701|Cholinergic Agents|cholinergic agents|mesh-ancestor
65191134|NCT02612701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65191135|NCT02612701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191136|NCT01096667|Ertugliflozin|ertugliflozin|mesh-list
65191137|NCT01096667|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65191193|NCT04559412|Etanercept|etanercept|mesh-list
65191194|NCT04559412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65191195|NCT04559412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65191196|NCT04559412|Analgesics|analgesics|mesh-ancestor
65191197|NCT04559412|Sensory System Agents|sensory system agents|mesh-ancestor
65191198|NCT04559412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65191260|NCT00833755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191261|NCT01021332|Tamsulosin|tamsulosin|mesh-list
65191262|NCT01021332|Solifenacin Succinate|solifenacin succinate|mesh-list
65191263|NCT01021332|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64320867|NCT03534895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65191330|NCT01020786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191331|NCT01020786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191400|NCT04203771|Ibuprofen|ibuprofen|mesh-list
65191401|NCT04203771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65191402|NCT04203771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65191403|NCT04203771|Analgesics|analgesics|mesh-ancestor
65191404|NCT04203771|Sensory System Agents|sensory system agents|mesh-ancestor
65191405|NCT04203771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65191406|NCT04203771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191407|NCT04203771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65191418|NCT01025232|Ranibizumab|ranibizumab|mesh-list
65191469|NCT00832819|Mitosis Modulators|mitosis modulators|mesh-ancestor
65191470|NCT00832819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191471|NCT00832819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65191472|NCT00832819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191473|NCT04820361|Parasympatholytics|parasympatholytics|mesh-list
65191474|NCT04820361|Autonomic Agents|autonomic agents|mesh-ancestor
65191475|NCT04820361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65191476|NCT04820361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191537|NCT04772001|Cisplatin|cisplatin|mesh-list
65191538|NCT04772001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191539|NCT00702091|Ramipril|ramipril|mesh-list
65191540|NCT00702091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65191541|NCT00702091|Protease Inhibitors|protease inhibitors|mesh-ancestor
65191542|NCT00702091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191545|NCT00832585|Alefacept|alefacept|mesh-list
65191606|NCT01104155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65191607|NCT01104155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191608|NCT01104155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191609|NCT02879981|Trimethoprim|trimethoprim|mesh-list
65191610|NCT02879981|Sulfamethoxazole|sulfamethoxazole|mesh-list
65191611|NCT02879981|Phenylpropanolamine|phenylpropanolamine|mesh-list
65191613|NCT02879981|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
65191675|NCT01019694|Respiratory System Agents|respiratory system agents|mesh-ancestor
65191676|NCT01019694|Tocolytic Agents|tocolytic agents|mesh-ancestor
65191677|NCT01019694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65191678|NCT01019694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65191679|NCT01019694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65191680|NCT01019694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65191681|NCT01019694|Adrenergic Agents|adrenergic agents|mesh-ancestor
65191682|NCT01019694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65191683|NCT01019694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65191684|NCT01019694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65191685|NCT01019694|Cholinergic Agents|cholinergic agents|mesh-ancestor
65191695|NCT01095653|Metformin|metformin|mesh-list
65191736|NCT05010876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65191737|NCT05010876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65191738|NCT05010876|Analgesics|analgesics|mesh-ancestor
65191739|NCT05010876|Sensory System Agents|sensory system agents|mesh-ancestor
65191807|NCT04786275|Narcotics|narcotics|mesh-ancestor
65191808|NCT04786275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65191809|NCT04786275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65191877|NCT01017120|Keratolytic Agents|keratolytic agents|mesh-ancestor
65191878|NCT02872038|Cefazolin|cefazolin|mesh-list
65191879|NCT02872038|Ceftazidime|ceftazidime|mesh-list
65191880|NCT02872038|Cefepime|cefepime|mesh-list
65191881|NCT02872038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65191949|NCT04213924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65191950|NCT04213924|Analgesics|analgesics|mesh-ancestor
65191951|NCT04213924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65191952|NCT04213924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65191953|NCT04213924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65191954|NCT04213924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65191955|NCT00616720|Interferons|interferons|mesh-list
65191956|NCT00616720|Aldesleukin|aldesleukin|mesh-list
65191957|NCT00616720|Interferon-gamma|interferon-gamma|mesh-list
65191958|NCT00616720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65191959|NCT00616720|Antiviral Agents|antiviral agents|mesh-ancestor
65191960|NCT00616720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65191961|NCT00616720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65191962|NCT00616720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65191963|NCT01091675|Etoricoxib|etoricoxib|mesh-list
65192012|NCT01091519|Cholinergic Agents|cholinergic agents|mesh-ancestor
65192013|NCT01091519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65192085|NCT05295394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192086|NCT05295394|Antiviral Agents|antiviral agents|mesh-ancestor
65192087|NCT05295394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65192158|NCT00631527|Hormone Antagonists|hormone antagonists|mesh-ancestor
65192159|NCT00631527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65192160|NCT00620620|Zaleplon|zaleplon|mesh-list
65192169|NCT00916383|Donepezil|donepezil|mesh-list
65192229|NCT04209166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65192231|NCT04209166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65192232|NCT04209166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65192233|NCT04766008|Metformin|metformin|mesh-list
65192303|NCT04648540|Antipyretics|antipyretics|mesh-ancestor
65192304|NCT04648540|Anticonvulsants|anticonvulsants|mesh-ancestor
65192305|NCT04648540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65192306|NCT04648540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65192308|NCT04648540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65192376|NCT04208854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192377|NCT01090427|Ustekinumab|ustekinumab|mesh-list
65192378|NCT01090427|Dermatologic Agents|dermatologic agents|mesh-ancestor
65192379|NCT04208776|Propranolol|propranolol|mesh-list
65192380|NCT04208776|Midodrine|midodrine|mesh-list
65192381|NCT04208776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65192447|NCT00621478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65192448|NCT00621478|Anesthetics, General|anesthetics, general|mesh-ancestor
65192449|NCT00621478|Anesthetics|anesthetics|mesh-ancestor
65192450|NCT00621556|Secretin|secretin|mesh-list
65192451|NCT00621556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65192452|NCT00621556|Hormones|hormones|mesh-ancestor
65192453|NCT00621556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65192454|NCT00621556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192455|NCT00618046|Oxcarbazepine|oxcarbazepine|mesh-list
65192456|NCT00618046|Anticonvulsants|anticonvulsants|mesh-ancestor
64949645|NCT00040209|Levodopa|levodopa|mesh-list
65192457|NCT00618046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65192459|NCT00618046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65192460|NCT00618046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192461|NCT00618046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65192462|NCT00618046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65192463|NCT04308551|Aspirin|aspirin|mesh-list
65192464|NCT04308551|Indobufen|indobufen|mesh-list
65192465|NCT04308551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65192466|NCT04308551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65192499|NCT02299414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65192500|NCT01016262|Mesalamine|mesalamine|mesh-list
65192501|NCT01016262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65192571|NCT04188184|Mydriatics|mydriatics|mesh-ancestor
65192572|NCT04188184|Sympathomimetics|sympathomimetics|mesh-ancestor
65192573|NCT04188184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65192574|NCT02296684|Cisplatin|cisplatin|mesh-list
65192575|NCT02296684|Pembrolizumab|pembrolizumab|mesh-list
65192641|NCT01882660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65192642|NCT01882660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192643|NCT01001832|Abatacept|abatacept|mesh-list
65192716|NCT01190930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65192717|NCT01190930|Antimetabolites|antimetabolites|mesh-ancestor
65192718|NCT01190930|Dermatologic Agents|dermatologic agents|mesh-ancestor
65192719|NCT01190930|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65192720|NCT01190930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65192786|NCT00618280|Autonomic Agents|autonomic agents|mesh-ancestor
65192787|NCT00618280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192788|NCT00618280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192789|NCT00618280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65192861|NCT01178138|Adrenergic Agents|adrenergic agents|mesh-ancestor
65192865|NCT01190228|Vaccines|vaccines|mesh-list
65192935|NCT01008696|Lansoprazole|lansoprazole|mesh-list
65192936|NCT01008696|Dexlansoprazole|dexlansoprazole|mesh-list
65192937|NCT01008696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65192938|NCT01008696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65192939|NCT01008696|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65192940|NCT01008696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192941|NCT01008696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192942|NCT01955980|Budesonide|budesonide|mesh-list
65192943|NCT01955980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65192944|NCT01955980|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65192945|NCT01955980|Autonomic Agents|autonomic agents|mesh-ancestor
65192946|NCT01955980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65192947|NCT01955980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65192948|NCT01955980|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65192949|NCT01955980|Respiratory System Agents|respiratory system agents|mesh-ancestor
65192951|NCT01955980|Hormones|hormones|mesh-ancestor
65192995|NCT02870790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65192996|NCT02870790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65192997|NCT02870790|Antiviral Agents|antiviral agents|mesh-ancestor
65192998|NCT02870790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65193069|NCT02691442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65193070|NCT00622648|Enoxaparin|enoxaparin|mesh-list
65193071|NCT00622648|Anticoagulants|anticoagulants|mesh-ancestor
65193072|NCT00622648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65193073|NCT00622648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65193074|NCT00622648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193075|NCT02687854|Vitamin K|vitamin k|mesh-list
65193141|NCT01001208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65193142|NCT01001208|Antimetabolites|antimetabolites|mesh-ancestor
65193143|NCT01001208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193144|NCT01001208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193145|NCT01001208|Dermatologic Agents|dermatologic agents|mesh-ancestor
65193212|NCT01004406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193213|NCT01004406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65193214|NCT01004406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193215|NCT01093612|Copper|copper|mesh-list
65193216|NCT01093612|Trastuzumab|trastuzumab|mesh-list
65193222|NCT01182350|Bevacizumab|bevacizumab|mesh-list
65193284|NCT04521946|Tacrolimus|tacrolimus|mesh-list
65193285|NCT04521946|Thymoglobulin|thymoglobulin|mesh-list
65193286|NCT04521946|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65193287|NCT04521946|Immunoglobulins|immunoglobulins|mesh-list
65193288|NCT04521946|Antibodies|antibodies|mesh-list
65193289|NCT04521946|gamma-Globulins|gamma-globulins|mesh-list
65193290|NCT04521946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65193291|NCT04521946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65193292|NCT04521946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193296|NCT04521946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65193352|NCT04314674|Natriuretic Agents|natriuretic agents|mesh-ancestor
65193353|NCT04314674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193354|NCT00639262|Temozolomide|temozolomide|mesh-list
65193355|NCT00639262|Sorafenib|sorafenib|mesh-list
65193423|NCT02689336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193424|NCT02689336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65193427|NCT03650764|Pembrolizumab|pembrolizumab|mesh-list
65193499|NCT00638482|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65193500|NCT00638482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65193501|NCT00638482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193571|NCT02688400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193572|NCT00639574|Nefopam|nefopam|mesh-list
65193573|NCT00639574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65193574|NCT00639574|Analgesics|analgesics|mesh-ancestor
65193575|NCT00639574|Sensory System Agents|sensory system agents|mesh-ancestor
65193641|NCT00641602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65193642|NCT00641602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193643|NCT00641602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193644|NCT05663944|Sirolimus|sirolimus|mesh-list
65193645|NCT05663944|Liver Extracts|liver extracts|mesh-list
65193646|NCT05663944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65193647|NCT05663944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65193712|NCT04182724|Mitosis Modulators|mitosis modulators|mesh-ancestor
65193713|NCT04182724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193714|NCT04182724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65193716|NCT04184518|Durvalumab|durvalumab|mesh-list
65193783|NCT00641758|Pycnogenols|pycnogenols|mesh-list
65193784|NCT00641758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65193787|NCT00641758|Antioxidants|antioxidants|mesh-ancestor
65193857|NCT04205058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65193858|NCT04205058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65193859|NCT04205058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65193929|NCT00641212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65193930|NCT00641212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65194003|NCT00640744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65194004|NCT00640744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194005|NCT02678104|Chlorhexidine|chlorhexidine|mesh-list
65194025|NCT00996996|Iodine|iodine|mesh-list
65194077|NCT02679040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65194078|NCT05663242|Anesthetics|anesthetics|mesh-list
65194079|NCT05663242|Propofol|propofol|mesh-list
65194080|NCT05663242|Sevoflurane|sevoflurane|mesh-list
65194150|NCT02675530|Ketamine|ketamine|mesh-list
65194151|NCT02675530|Analgesics|analgesics|mesh-ancestor
65194152|NCT02675530|Sensory System Agents|sensory system agents|mesh-ancestor
65194223|NCT01160744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65194224|NCT01160744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194225|NCT01160744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65194226|NCT01160744|Immunologic Factors|immunologic factors|mesh-ancestor
65194227|NCT01160744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194228|NCT01160744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65194294|NCT05351086|Sensory System Agents|sensory system agents|mesh-ancestor
65194295|NCT05351086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65194296|NCT02885168|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
65194297|NCT02885168|Phenylephrine|phenylephrine|mesh-list
65194366|NCT01172288|Respiratory System Agents|respiratory system agents|mesh-ancestor
65194367|NCT01172288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65194368|NCT01172288|Antioxidants|antioxidants|mesh-ancestor
65194370|NCT01172288|Protective Agents|protective agents|mesh-ancestor
65194439|NCT00644176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65194440|NCT04178200|Lidocaine|lidocaine|mesh-list
65194441|NCT04178200|Bupivacaine|bupivacaine|mesh-list
65194442|NCT04178200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65194443|NCT04178200|Anesthetics, Local|anesthetics, local|mesh-ancestor
65194444|NCT04178200|Anesthetics|anesthetics|mesh-ancestor
65194445|NCT04178200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65194507|NCT04176328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65194508|NCT04176328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65194510|NCT04177342|Oxycodone|oxycodone|mesh-list
65194512|NCT04177342|Narcotics|narcotics|mesh-ancestor
65194581|NCT02670616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65194582|NCT02670616|Immunologic Factors|immunologic factors|mesh-ancestor
65194583|NCT02670616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65194653|NCT02667730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65194654|NCT02667730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65194655|NCT02667730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194656|NCT02667730|Gout Suppressants|gout suppressants|mesh-ancestor
65194657|NCT04294992|Ondansetron|ondansetron|mesh-list
65194722|NCT02670304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65194723|NCT02670304|Analgesics|analgesics|mesh-ancestor
65194735|NCT02670304|Antipyretics|antipyretics|mesh-ancestor
65194794|NCT02666170|Micronutrients|micronutrients|mesh-ancestor
65194795|NCT02667262|Analgesics, Opioid|analgesics, opioid|mesh-list
65194796|NCT02667262|Narcotics|narcotics|mesh-ancestor
65194797|NCT02667262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65194799|NCT02667262|Analgesics|analgesics|mesh-ancestor
65194868|NCT02665936|Dexamethasone acetate|dexamethasone acetate|mesh-list
65194869|NCT02665936|Levobupivacaine|levobupivacaine|mesh-list
65194870|NCT02665936|BB 1101|bb 1101|mesh-list
65194871|NCT02665936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65194872|NCT02665936|Antiemetics|antiemetics|mesh-ancestor
65194936|NCT04064476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65194938|NCT04064476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65194939|NCT04064476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65194940|NCT04064476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65194941|NCT04064476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65194942|NCT04064476|Dopamine Agents|dopamine agents|mesh-ancestor
65194943|NCT02669368|Magnesium Sulfate|magnesium sulfate|mesh-list
64837595|NCT01619761|Tacrolimus|tacrolimus|mesh-list
65195003|NCT00646750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65195004|NCT00646750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65195005|NCT00646516|Budesonide|budesonide|mesh-list
65195006|NCT00646516|Formoterol Fumarate|formoterol fumarate|mesh-list
65195007|NCT00646516|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65195008|NCT00646516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65195016|NCT00646516|Hormones|hormones|mesh-ancestor
65195070|NCT00647140|Dopamine Agents|dopamine agents|mesh-ancestor
65195071|NCT00647140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195072|NCT00647140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195076|NCT00647218|Paclitaxel|paclitaxel|mesh-list
65195141|NCT00648778|Dopamine Agents|dopamine agents|mesh-ancestor
65195142|NCT00648778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195143|NCT00648778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195213|NCT02660008|Incretins|incretins|mesh-ancestor
65195214|NCT00649168|Bromocriptine|bromocriptine|mesh-list
65195215|NCT00649168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65195285|NCT00647842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195286|NCT00647842|Analgesics|analgesics|mesh-ancestor
65195287|NCT00647842|Sensory System Agents|sensory system agents|mesh-ancestor
65195288|NCT00647842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195289|NCT00647842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65195290|NCT00647842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65195291|NCT00647842|Anesthetics, General|anesthetics, general|mesh-ancestor
65195292|NCT00647842|Anesthetics|anesthetics|mesh-ancestor
65195293|NCT02662972|Botulinum Toxins|botulinum toxins|mesh-list
65195294|NCT02662972|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65195295|NCT02662972|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65195296|NCT02662972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65195297|NCT02662972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65195298|NCT02662972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195299|NCT02662972|Cholinergic Agents|cholinergic agents|mesh-ancestor
65195300|NCT02662972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195301|NCT02662972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195302|NCT02662972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65195303|NCT02662972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195305|NCT02662894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65195340|NCT02868606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65195341|NCT02868606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65195342|NCT02868606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195343|NCT00647920|Adalimumab|adalimumab|mesh-list
65195344|NCT00647920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65195345|NCT00647920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65195346|NCT00830869|Ixazomib|ixazomib|mesh-list
65195347|NCT00830869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65195348|NCT00830869|Protease Inhibitors|protease inhibitors|mesh-ancestor
65195407|NCT02868372|Povidone-Iodine|povidone-iodine|mesh-list
65195408|NCT02868372|Povidone|povidone|mesh-list
65195409|NCT02868372|Plasma Substitutes|plasma substitutes|mesh-ancestor
65195410|NCT02868372|Blood Substitutes|blood substitutes|mesh-ancestor
65195411|NCT02868372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65195412|NCT02868372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65195413|NCT00629148|Capecitabine|capecitabine|mesh-list
65195414|NCT00629148|Vinorelbine|vinorelbine|mesh-list
65195415|NCT00629148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65195416|NCT00629148|Antimetabolites|antimetabolites|mesh-ancestor
65195417|NCT00629148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65195418|NCT00629148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65195423|NCT01157234|Metoprolol|metoprolol|mesh-list
65195468|NCT00995670|Anesthetics, General|anesthetics, general|mesh-ancestor
65195469|NCT00995670|Anesthetics|anesthetics|mesh-ancestor
65195471|NCT02658838|Heparin|heparin|mesh-list
65195543|NCT04169854|Sensory System Agents|sensory system agents|mesh-ancestor
65195544|NCT04169854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195545|NCT04169854|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65195614|NCT00992394|Sensory System Agents|sensory system agents|mesh-ancestor
65195615|NCT00992394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65195616|NCT00992394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195617|NCT00992394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65195618|NCT00992394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65195619|NCT00992394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65195620|NCT00992394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65195682|NCT00843115|Cholinergic Agents|cholinergic agents|mesh-ancestor
65195683|NCT00843115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65195684|NCT00843115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195685|NCT00843115|Nootropic Agents|nootropic agents|mesh-ancestor
65195686|NCT01156376|Listerine|listerine|mesh-list
65195687|NCT01156376|Fluorides|fluorides|mesh-list
65195688|NCT01156376|Cariostatic Agents|cariostatic agents|mesh-ancestor
65195752|NCT02612233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195753|NCT02612233|Anticonvulsants|anticonvulsants|mesh-ancestor
65195754|NCT02612233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65195755|NCT02612233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65195822|NCT00700687|Celecoxib|celecoxib|mesh-list
65195823|NCT00700687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65195824|NCT00700687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65195825|NCT00700687|Analgesics|analgesics|mesh-ancestor
65195826|NCT00700687|Sensory System Agents|sensory system agents|mesh-ancestor
65195894|NCT00707083|Dermatologic Agents|dermatologic agents|mesh-ancestor
65195966|NCT02658760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65195967|NCT02658760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65195968|NCT02658760|Sensory System Agents|sensory system agents|mesh-ancestor
65196038|NCT00649402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65196039|NCT00649402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65196040|NCT00649402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65196041|NCT00649402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196044|NCT00649402|Vasodilator Agents|vasodilator agents|mesh-ancestor
65196109|NCT00828139|Endothelial Growth Factors|endothelial growth factors|mesh-list
65196110|NCT00828139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65196111|NCT00828139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65196112|NCT00828139|Growth Substances|growth substances|mesh-ancestor
65196113|NCT00828139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196114|NCT00828139|Growth Inhibitors|growth inhibitors|mesh-ancestor
65196115|NCT00828139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196116|NCT00828139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65196117|NCT00828139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65196118|NCT00828139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196119|NCT00828139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196120|NCT04224688|Rozanolixizumab|rozanolixizumab|mesh-list
65196121|NCT04224688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65196122|NCT04224688|Immunologic Factors|immunologic factors|mesh-ancestor
65196123|NCT04224688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196169|NCT04169230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65196170|NCT04201756|Afatinib|afatinib|mesh-list
65196171|NCT04201756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196242|NCT00850993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196243|NCT02657512|Rivaroxaban|rivaroxaban|mesh-list
65196244|NCT02657512|Charcoal|charcoal|mesh-list
65196245|NCT02657512|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65196246|NCT02657512|Antithrombins|antithrombins|mesh-ancestor
65196247|NCT02657512|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65196248|NCT02657512|Protease Inhibitors|protease inhibitors|mesh-ancestor
65196249|NCT02657512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196310|NCT02650102|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65196311|NCT00650182|Fentanyl|fentanyl|mesh-list
65196312|NCT00650182|Naltrexone|naltrexone|mesh-list
65196313|NCT00650182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65196314|NCT00650182|Narcotics|narcotics|mesh-ancestor
65196315|NCT00650182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65196316|NCT00650182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196317|NCT00650182|Analgesics|analgesics|mesh-ancestor
65196318|NCT00650182|Sensory System Agents|sensory system agents|mesh-ancestor
65196319|NCT00650182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65196320|NCT00650182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65196321|NCT00650182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65196322|NCT00650182|Anesthetics, General|anesthetics, general|mesh-ancestor
65196323|NCT00650182|Anesthetics|anesthetics|mesh-ancestor
65196324|NCT00650182|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65196325|NCT00650182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65196326|NCT00910780|Olanzapine|olanzapine|mesh-list
65196327|NCT00910780|Aripiprazole|aripiprazole|mesh-list
65196328|NCT00910780|Antidepressive Agents|antidepressive agents|mesh-ancestor
65196329|NCT00910780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65196330|NCT00910780|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65196331|NCT00910780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65196332|NCT00910780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65196363|NCT02649478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196364|NCT02649478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65196365|NCT02649478|Respiratory System Agents|respiratory system agents|mesh-ancestor
65196366|NCT02649478|Dermatologic Agents|dermatologic agents|mesh-ancestor
65196375|NCT02649478|Hormones|hormones|mesh-ancestor
65196434|NCT02652598|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65196435|NCT02652598|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65196436|NCT02652598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196437|NCT02652598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196507|NCT04166578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196508|NCT04166578|Sensory System Agents|sensory system agents|mesh-ancestor
65196509|NCT04166578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65196510|NCT04166578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65196511|NCT04166578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65196512|NCT04166578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65196574|NCT00827359|Everolimus|everolimus|mesh-list
65196575|NCT00827359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196576|NCT00827359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64839161|NCT01630083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196577|NCT00827359|Immunologic Factors|immunologic factors|mesh-ancestor
65196578|NCT00827359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196579|NCT02641288|Ropivacaine|ropivacaine|mesh-list
65196580|NCT02641288|Anesthetics, Local|anesthetics, local|mesh-ancestor
65196581|NCT02641288|Anesthetics|anesthetics|mesh-ancestor
65196582|NCT02641288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65196583|NCT02641288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196584|NCT02641288|Sensory System Agents|sensory system agents|mesh-ancestor
65196585|NCT02641288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65196586|NCT04165174|Apatinib|apatinib|mesh-list
65196587|NCT04165174|Antibodies|antibodies|mesh-list
65196588|NCT04165174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65196589|NCT04165174|Immunologic Factors|immunologic factors|mesh-ancestor
65196634|NCT00818389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65196635|NCT00818389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196636|NCT00818389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196637|NCT00818389|Antimanic Agents|antimanic agents|mesh-ancestor
65196702|NCT00849901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65196703|NCT00849901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65196705|NCT02641054|Levodopa|levodopa|mesh-list
65196775|NCT00651586|Gatifloxacin|gatifloxacin|mesh-list
65196776|NCT00651586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65196777|NCT00651586|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65196778|NCT00651586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65196787|NCT02640508|Lenvatinib|lenvatinib|mesh-list
65196845|NCT00707551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65196846|NCT00707551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65196847|NCT00707551|Vasodilator Agents|vasodilator agents|mesh-ancestor
65196918|NCT02646904|Respiratory System Agents|respiratory system agents|mesh-ancestor
65196919|NCT00848965|Fluticasone|fluticasone|mesh-list
65196921|NCT00848965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65196922|NCT00848965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65196923|NCT00848965|Autonomic Agents|autonomic agents|mesh-ancestor
65196924|NCT00848965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65196925|NCT00848965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196926|NCT00848965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65196927|NCT00848965|Respiratory System Agents|respiratory system agents|mesh-ancestor
65196928|NCT00848965|Dermatologic Agents|dermatologic agents|mesh-ancestor
65196929|NCT00848965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65196930|NCT00654082|Sildenafil Citrate|sildenafil citrate|mesh-list
65196931|NCT00654082|Vasodilator Agents|vasodilator agents|mesh-ancestor
65196937|NCT00654160|Leucovorin|leucovorin|mesh-list
65196982|NCT01154036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65196983|NCT01154036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65196984|NCT01154036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65196985|NCT00816595|Cyclophosphamide|cyclophosphamide|mesh-list
65196986|NCT00816595|Bevacizumab|bevacizumab|mesh-list
65196987|NCT00816595|Rituximab|rituximab|mesh-list
65196988|NCT00816595|Pentostatin|pentostatin|mesh-list
65196989|NCT00816595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65196990|NCT00816595|Immunologic Factors|immunologic factors|mesh-ancestor
65196991|NCT00816595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65196992|NCT00816595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65196993|NCT00816595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65196994|NCT00816595|Alkylating Agents|alkylating agents|mesh-ancestor
65196995|NCT00816595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65196996|NCT00816595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65196997|NCT00816595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65196998|NCT00816595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65196999|NCT00816595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65197000|NCT00816595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65197001|NCT00816595|Growth Substances|growth substances|mesh-ancestor
65197002|NCT00816595|Growth Inhibitors|growth inhibitors|mesh-ancestor
65197003|NCT00816595|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
65197004|NCT00816595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197005|NCT01166438|Solifenacin Succinate|solifenacin succinate|mesh-list
65197006|NCT01166438|Trospium chloride|trospium chloride|mesh-list
65197030|NCT00707707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197031|NCT00707707|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65197032|NCT00707707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197033|NCT01153958|Metronidazole|metronidazole|mesh-list
65197034|NCT01153958|Chlorquinaldol|chlorquinaldol|mesh-list
65197035|NCT01153958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65197036|NCT01153958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65197037|NCT01153958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65197038|NCT01153958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65197040|NCT00707785|Vitamins|vitamins|mesh-ancestor
65197041|NCT00707785|Micronutrients|micronutrients|mesh-ancestor
65197043|NCT00599638|Pregabalin|pregabalin|mesh-list
65197093|NCT02641990|Exenatide|exenatide|mesh-list
65197094|NCT02641990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65197095|NCT02641990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197096|NCT02641990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65197097|NCT02641990|Incretins|incretins|mesh-ancestor
65197098|NCT02641990|Hormones|hormones|mesh-ancestor
65197099|NCT02641990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65197100|NCT00653380|Doxycycline|doxycycline|mesh-list
65197101|NCT00653380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65197103|NCT00653380|Antimalarials|antimalarials|mesh-ancestor
65197158|NCT02884388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197159|NCT02885948|Naloxone|naloxone|mesh-list
65197160|NCT02885948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65197161|NCT02885948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197162|NCT02885948|Sensory System Agents|sensory system agents|mesh-ancestor
65197163|NCT02885948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65197164|NCT01152788|Dacarbazine|dacarbazine|mesh-list
65197165|NCT01152788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65197166|NCT01152788|Alkylating Agents|alkylating agents|mesh-ancestor
65197167|NCT01152788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197173|NCT00598702|Acetaminophen|acetaminophen|mesh-list
65197222|NCT04187196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65197223|NCT04187196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197224|NCT04187196|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65197225|NCT04187196|Anesthetics, General|anesthetics, general|mesh-ancestor
65197226|NCT04187196|Anesthetics|anesthetics|mesh-ancestor
65197227|NCT04292184|Sodium thiosulfate|sodium thiosulfate|mesh-list
65197228|NCT04292184|Antidotes|antidotes|mesh-ancestor
65197229|NCT04292184|Protective Agents|protective agents|mesh-ancestor
65197290|NCT05297929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65197291|NCT05297929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65197292|NCT05297929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197293|NCT00826111|Eszopiclone|eszopiclone|mesh-list
65197294|NCT00826111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65197295|NCT00826111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65197296|NCT00826111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197297|NCT05269615|Valsartan|valsartan|mesh-list
65197356|NCT00824473|Autonomic Agents|autonomic agents|mesh-ancestor
65197357|NCT00824473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65197358|NCT00824473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197359|NCT00824473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65197360|NCT00824473|Respiratory System Agents|respiratory system agents|mesh-ancestor
65197361|NCT00824473|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65197362|NCT00824473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197363|NCT00824473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197364|NCT00824473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65197365|NCT00824473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65197417|NCT04290858|Antioxidants|antioxidants|mesh-ancestor
65197418|NCT04290858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197419|NCT04290858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65197420|NCT04290858|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65197421|NCT04290858|Vasodilator Agents|vasodilator agents|mesh-ancestor
65197422|NCT04290858|Gasotransmitters|gasotransmitters|mesh-ancestor
65197423|NCT04290858|Protective Agents|protective agents|mesh-ancestor
65197424|NCT05326555|Imidacloprid|imidacloprid|mesh-list
65197425|NCT05326555|Cholinergic Agents|cholinergic agents|mesh-ancestor
65197426|NCT05326555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65197427|NCT05326555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197428|NCT05326555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197430|NCT02610829|Tocopherols|tocopherols|mesh-list
65197431|NCT02610829|Tocotrienols|tocotrienols|mesh-list
65197432|NCT02610829|alpha-Tocopherol|alpha-tocopherol|mesh-list
65197433|NCT02610829|gamma-Tocopherol|gamma-tocopherol|mesh-list
65197434|NCT02610829|Vitamins|vitamins|mesh-ancestor
65197435|NCT02610829|Micronutrients|micronutrients|mesh-ancestor
65197475|NCT00814879|Protease Inhibitors|protease inhibitors|mesh-ancestor
65197476|NCT00814801|Galantamine|galantamine|mesh-list
65197477|NCT00814801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65197478|NCT00814801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65197479|NCT00814801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197480|NCT00814801|Cholinergic Agents|cholinergic agents|mesh-ancestor
65197481|NCT00814801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65197482|NCT00814801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197483|NCT00814801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65197542|NCT05756569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65197543|NCT05756569|Immunologic Factors|immunologic factors|mesh-ancestor
65197544|NCT05756569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197545|NCT04166812|Nitric Oxide|nitric oxide|mesh-list
65197546|NCT04166812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65197547|NCT04166812|Autonomic Agents|autonomic agents|mesh-ancestor
65197548|NCT04166812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65197549|NCT04166812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197550|NCT04166812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65197551|NCT04166812|Respiratory System Agents|respiratory system agents|mesh-ancestor
65197552|NCT04166812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65197609|NCT00709189|Estrogens|estrogens|mesh-ancestor
65197610|NCT00709189|Hormones|hormones|mesh-ancestor
65197611|NCT00709189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65197612|NCT00709189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197613|NCT00709189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65197614|NCT00709189|Contraceptive Agents|contraceptive agents|mesh-ancestor
65197615|NCT00709189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65197616|NCT00709189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65197617|NCT00709189|Hematinics|hematinics|mesh-ancestor
65197618|NCT00709189|Vitamin B Complex|vitamin b complex|mesh-ancestor
65197619|NCT00709189|Vitamins|vitamins|mesh-ancestor
65197620|NCT00709189|Micronutrients|micronutrients|mesh-ancestor
65197621|NCT00709189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65197622|NCT00709189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65197623|NCT00709267|Folic Acid|folic acid|mesh-list
65197624|NCT00709267|Hematinics|hematinics|mesh-ancestor
65197625|NCT00709267|Vitamin B Complex|vitamin b complex|mesh-ancestor
65197669|NCT00652132|Antitubercular Agents|antitubercular agents|mesh-ancestor
65197670|NCT00652132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65197671|NCT00652132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65197672|NCT00652132|Chelating Agents|chelating agents|mesh-ancestor
65197673|NCT00652132|Sequestering Agents|sequestering agents|mesh-ancestor
65197674|NCT00655174|Fluvoxamine|fluvoxamine|mesh-list
65197675|NCT00655174|Sertraline|sertraline|mesh-list
65197676|NCT00655174|Antidepressive Agents|antidepressive agents|mesh-ancestor
65197677|NCT00655174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65197678|NCT00655174|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65197679|NCT00655174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65197680|NCT00655174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65197681|NCT00655174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197682|NCT00655174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65197683|NCT00655174|Serotonin Agents|serotonin agents|mesh-ancestor
65197684|NCT00655174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321742|NCT02205931|Anticonvulsants|anticonvulsants|mesh-list
65197727|NCT02645734|Growth Substances|growth substances|mesh-ancestor
65197728|NCT02645734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197729|NCT02645734|Growth Inhibitors|growth inhibitors|mesh-ancestor
65197730|NCT01133522|Evolocumab|evolocumab|mesh-list
65197797|NCT04163536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65197798|NCT04163536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197799|NCT04163536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65197800|NCT04163536|Glucocorticoids|glucocorticoids|mesh-ancestor
65197801|NCT04163536|Hormones|hormones|mesh-ancestor
65197802|NCT04163536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65197867|NCT02637466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65197868|NCT02637466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65197869|NCT02637466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65197870|NCT02637466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65197936|NCT00656110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65197937|NCT00656110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65197938|NCT00656110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65197939|NCT00656110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65198006|NCT00656266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65198007|NCT00656266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65198008|NCT00656266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198009|NCT00656266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198010|NCT00882310|Gemcitabine|gemcitabine|mesh-list
65198076|NCT00657748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65198077|NCT04161586|Prilocaine|prilocaine|mesh-list
65198078|NCT04161586|Anesthetics, Local|anesthetics, local|mesh-ancestor
65198079|NCT04161586|Anesthetics|anesthetics|mesh-ancestor
65198148|NCT00597766|Anesthetics|anesthetics|mesh-ancestor
65198149|NCT00597766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65198150|NCT00597766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198151|NCT00597766|Sensory System Agents|sensory system agents|mesh-ancestor
65198152|NCT00597766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65198219|NCT02867046|Dexamethasone|dexamethasone|mesh-list
65198220|NCT02867046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65198221|NCT02867046|Antiemetics|antiemetics|mesh-ancestor
65198222|NCT02867046|Autonomic Agents|autonomic agents|mesh-ancestor
65198223|NCT02867046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65198224|NCT02867046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198225|NCT02867046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65198226|NCT02867046|Glucocorticoids|glucocorticoids|mesh-ancestor
65198227|NCT02867046|Hormones|hormones|mesh-ancestor
65198228|NCT02867046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65198229|NCT02867046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65198230|NCT02867046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198231|NCT02865174|Heparin|heparin|mesh-list
65198232|NCT02865174|Enoxaparin|enoxaparin|mesh-list
65198233|NCT02865174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65198235|NCT02865174|Dalteparin|dalteparin|mesh-list
65198236|NCT02865174|Tranylcypromine|tranylcypromine|mesh-list
65198281|NCT04158778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65198282|NCT04158778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65198283|NCT04158778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65198284|NCT04158778|Adrenergic Agents|adrenergic agents|mesh-ancestor
65198285|NCT01132664|Capecitabine|capecitabine|mesh-list
65198286|NCT01132664|Trastuzumab|trastuzumab|mesh-list
65198287|NCT01132664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65198288|NCT01132664|Antimetabolites|antimetabolites|mesh-ancestor
65198289|NCT01132664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198290|NCT01132664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198291|NCT01132664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65198345|NCT01076075|Gliclazide|gliclazide|mesh-list
65198346|NCT01076075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65198347|NCT01076075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198348|NCT01076075|Incretins|incretins|mesh-ancestor
65198349|NCT01076075|Hormones|hormones|mesh-ancestor
65198350|NCT01076075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65198351|NCT01076075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65198352|NCT01076075|Protease Inhibitors|protease inhibitors|mesh-ancestor
65198353|NCT01076075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198355|NCT01076075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65198409|NCT04305743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65198410|NCT04305743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65198411|NCT04305743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198412|NCT04305743|Cholinergic Agents|cholinergic agents|mesh-ancestor
65198413|NCT04305743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65198414|NCT00661180|Sorafenib|sorafenib|mesh-list
65198415|NCT00661180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198477|NCT02631694|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65198478|NCT02631694|Adrenergic Agents|adrenergic agents|mesh-ancestor
65198479|NCT02631694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65198480|NCT02631694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198481|NCT02631694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198485|NCT04305587|Clopidogrel|clopidogrel|mesh-list
65198545|NCT01077713|Antiviral Agents|antiviral agents|mesh-ancestor
65198546|NCT01077713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65198547|NCT01077713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65198548|NCT01077713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65198549|NCT01077713|Immunologic Factors|immunologic factors|mesh-ancestor
65198550|NCT00813709|Interferon beta-1a|interferon beta-1a|mesh-list
65198551|NCT00813709|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65198552|NCT00813709|Immunologic Factors|immunologic factors|mesh-ancestor
65198613|NCT04047576|Glucocorticoids|glucocorticoids|mesh-ancestor
65198614|NCT04047576|Hormones|hormones|mesh-ancestor
65198616|NCT04047576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198686|NCT04868773|Trifluridine|trifluridine|mesh-list
65198687|NCT04868773|Antimetabolites|antimetabolites|mesh-ancestor
65198688|NCT04868773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198689|NCT04868773|Antiviral Agents|antiviral agents|mesh-ancestor
65198758|NCT00878800|Doxorubicin|doxorubicin|mesh-list
65198759|NCT00878800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65198760|NCT00878800|Belinostat|belinostat|mesh-list
65198761|NCT00878800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65198762|NCT00878800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65198763|NCT00878800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65198828|NCT00969618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65198829|NCT00969618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65198830|NCT00969618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65198831|NCT00969618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198832|NCT00969618|Adrenergic Agents|adrenergic agents|mesh-ancestor
64841433|NCT01651715|Antibodies|antibodies|mesh-list
65198833|NCT00969618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65198834|NCT00969618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198835|NCT02864472|Ranibizumab|ranibizumab|mesh-list
65198836|NCT02864472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65198893|NCT00972504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65198894|NCT00972504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65198966|NCT05780489|Estrogens|estrogens|mesh-ancestor
65198967|NCT05780489|Hormones|hormones|mesh-ancestor
65199039|NCT05779410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65199040|NCT05779410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65199041|NCT05779254|Metronidazole|metronidazole|mesh-list
65199042|NCT05779254|Neomycin|neomycin|mesh-list
65199043|NCT05779254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65199044|NCT05779254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65199045|NCT05779254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65199046|NCT05779254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65199047|NCT05779254|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65199048|NCT05779254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199049|NCT05779254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199050|NCT05779059|Ticagrelor|ticagrelor|mesh-list
65199051|NCT05779059|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65199063|NCT05778422|Anesthetics|anesthetics|mesh-list
65199108|NCT05755997|Cerebrolysin|cerebrolysin|mesh-list
65199109|NCT05755997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65199110|NCT05755997|Protective Agents|protective agents|mesh-ancestor
65199111|NCT05755997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65199112|NCT05755997|Nootropic Agents|nootropic agents|mesh-ancestor
65199113|NCT05747794|Paclitaxel|paclitaxel|mesh-list
65199197|NCT05620784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199198|NCT05617859|Lenvatinib|lenvatinib|mesh-list
65199271|NCT05561062|Antimetabolites|antimetabolites|mesh-ancestor
65199272|NCT05561062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199273|NCT05561062|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65199275|NCT05561062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199343|NCT05444946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65199432|NCT05241262|Respiratory System Agents|respiratory system agents|mesh-ancestor
65199433|NCT05241262|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65199543|NCT05027945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65199544|NCT05027945|Antifungal Agents|antifungal agents|mesh-ancestor
65199546|NCT05023070|Anticonvulsants|anticonvulsants|mesh-ancestor
65199631|NCT04879225|Menthol|menthol|mesh-list
65199726|NCT04567784|Cannabidiol|cannabidiol|mesh-list
65199727|NCT04567784|Anticonvulsants|anticonvulsants|mesh-ancestor
65199728|NCT04565288|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65199729|NCT04565288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65199730|NCT04565288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65199798|NCT04252768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65199799|NCT04252768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65199800|NCT04252768|Tubulin Modulators|tubulin modulators|mesh-ancestor
65199801|NCT04252768|Antimitotic Agents|antimitotic agents|mesh-ancestor
65199802|NCT04252768|Mitosis Modulators|mitosis modulators|mesh-ancestor
65199804|NCT04222010|Anesthetics|anesthetics|mesh-list
65199867|NCT04047706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65199868|NCT04047706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65199869|NCT04047706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65199870|NCT04047706|Alkylating Agents|alkylating agents|mesh-ancestor
65199939|NCT03884101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65199940|NCT03884101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200011|NCT03657810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200012|NCT03657810|Antipyretics|antipyretics|mesh-ancestor
65200014|NCT03657810|Narcotics|narcotics|mesh-ancestor
65200084|NCT03409198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65200085|NCT03382548|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65200156|NCT03236987|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65200231|NCT02789982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200232|NCT02789982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200233|NCT02789982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65200238|NCT02684058|Trametinib|trametinib|mesh-list
65200303|NCT02582008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65200304|NCT02582008|Antidepressive Agents|antidepressive agents|mesh-ancestor
65200374|NCT01523977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200375|NCT01523977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65200446|NCT00970632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65200447|NCT00970632|Adrenergic Agents|adrenergic agents|mesh-ancestor
65200450|NCT01144364|Rituximab|rituximab|mesh-list
65200518|NCT00964782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200594|NCT01117766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65200596|NCT01117766|Anticonvulsants|anticonvulsants|mesh-ancestor
65200665|NCT00915525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65200666|NCT00915525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65200669|NCT04669041|Ezetimibe|ezetimibe|mesh-list
65200737|NCT00915681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65200738|NCT01128296|Gemcitabine|gemcitabine|mesh-list
65200739|NCT01128296|Hydroxychloroquine|hydroxychloroquine|mesh-list
65200754|NCT05082909|Probenecid|probenecid|mesh-list
65200812|NCT04539873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65200813|NCT04539873|Tubulin Modulators|tubulin modulators|mesh-ancestor
65200814|NCT04539873|Antimitotic Agents|antimitotic agents|mesh-ancestor
65200815|NCT04539873|Mitosis Modulators|mitosis modulators|mesh-ancestor
65200818|NCT02861040|Vincristine|vincristine|mesh-list
65200882|NCT00659386|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65200954|NCT03537690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65200955|NCT04032184|Chlorhexidine|chlorhexidine|mesh-list
65200956|NCT04032184|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65201027|NCT00666484|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65201028|NCT00666484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65201098|NCT00912093|Analgesics|analgesics|mesh-ancestor
65201099|NCT00912093|Sensory System Agents|sensory system agents|mesh-ancestor
65201100|NCT00912093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65201103|NCT00912093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65201169|NCT03854019|Adrenergic Agents|adrenergic agents|mesh-ancestor
65201170|NCT03854019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65201171|NCT03854019|Antimalarials|antimalarials|mesh-ancestor
65201184|NCT03237702|Carotenoids|carotenoids|mesh-list
65201239|NCT00663442|Dopamine Agents|dopamine agents|mesh-ancestor
65201240|NCT00663442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65201241|NCT00912015|Tramadol|tramadol|mesh-list
65201314|NCT04282746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65201315|NCT04282746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65201316|NCT04282746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65201331|NCT03773445|Golimumab|golimumab|mesh-list
65201389|NCT04284150|Anesthetics|anesthetics|mesh-ancestor
65201459|NCT04283916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65201460|NCT04283916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201461|NCT00911937|Fesoterodine|fesoterodine|mesh-list
65201532|NCT00668044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201533|NCT00668044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201536|NCT02860494|Everolimus|everolimus|mesh-list
65201604|NCT00957528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65201605|NCT00957528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201677|NCT02819856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65201678|NCT02819856|Antioxidants|antioxidants|mesh-ancestor
65201680|NCT02819856|Protective Agents|protective agents|mesh-ancestor
65201750|NCT00911859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65201751|NCT00911859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65201824|NCT00664846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65201825|NCT00664846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65201826|NCT00664846|Analgesics|analgesics|mesh-ancestor
65201827|NCT00664846|Sensory System Agents|sensory system agents|mesh-ancestor
65201828|NCT00664846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65201829|NCT00664846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201830|NCT00664846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65201892|NCT00632385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201893|NCT00632385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201894|NCT00910689|Propranolol|propranolol|mesh-list
65201895|NCT00910689|Nadolol|nadolol|mesh-list
65201896|NCT00910689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65201897|NCT00910689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65201898|NCT00910689|Adrenergic Agents|adrenergic agents|mesh-ancestor
65201899|NCT00910689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65201900|NCT00910689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65201901|NCT00910689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201902|NCT00910689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65201903|NCT00910689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65201904|NCT00910689|Vasodilator Agents|vasodilator agents|mesh-ancestor
65201905|NCT00910689|Sympatholytics|sympatholytics|mesh-ancestor
65201906|NCT00910689|Autonomic Agents|autonomic agents|mesh-ancestor
65201907|NCT00910689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65201908|NCT04164979|Pembrolizumab|pembrolizumab|mesh-list
65201909|NCT04164979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65201950|NCT02609581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65201951|NCT00811135|Bevacizumab|bevacizumab|mesh-list
65201952|NCT00811135|Trastuzumab|trastuzumab|mesh-list
65202022|NCT00910299|Clopidogrel|clopidogrel|mesh-list
65202023|NCT00910299|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65202095|NCT00914017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65202096|NCT00914017|Antimetabolites|antimetabolites|mesh-ancestor
65202097|NCT00914017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202166|NCT00908583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65202167|NCT00908583|Antiemetics|antiemetics|mesh-ancestor
65202168|NCT00908583|Autonomic Agents|autonomic agents|mesh-ancestor
65202170|NCT00908583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65202239|NCT00670618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202240|NCT00677170|Pevonedistat|pevonedistat|mesh-list
65202241|NCT00677170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202242|NCT00677170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202308|NCT00911716|Growth Inhibitors|growth inhibitors|mesh-ancestor
65202309|NCT00911716|Tubulin Modulators|tubulin modulators|mesh-ancestor
65202380|NCT00680758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65202381|NCT00680758|Immunologic Factors|immunologic factors|mesh-ancestor
65202382|NCT00680758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202383|NCT00678106|Dalbavancin|dalbavancin|mesh-list
65202451|NCT02627950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65202452|NCT02627950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202453|NCT02627950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202454|NCT02627950|Antiemetics|antiemetics|mesh-ancestor
65202455|NCT02627950|Autonomic Agents|autonomic agents|mesh-ancestor
65202456|NCT02627950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65202518|NCT05753059|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65202519|NCT05753059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65202520|NCT05753059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65202590|NCT02627560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65202591|NCT02627560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202592|NCT02627560|Hemostatics|hemostatics|mesh-ancestor
65202661|NCT01139762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65202662|NCT01139762|Hormone Antagonists|hormone antagonists|mesh-ancestor
65202663|NCT01139762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65202733|NCT00805207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65202734|NCT00805207|Androgens|androgens|mesh-ancestor
65202735|NCT00805207|Progestins|progestins|mesh-ancestor
65202736|NCT00805675|Tenofovir|tenofovir|mesh-list
65202737|NCT00805675|Telbivudine|telbivudine|mesh-list
65202803|NCT00914095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65202804|NCT00914095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65202876|NCT02856750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65202950|NCT02606539|Dermatologic Agents|dermatologic agents|mesh-ancestor
65202951|NCT02606539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65202960|NCT02606539|Vitamins|vitamins|mesh-ancestor
65203025|NCT05660473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65203026|NCT05660473|Tubulin Modulators|tubulin modulators|mesh-ancestor
65203027|NCT05660473|Antimitotic Agents|antimitotic agents|mesh-ancestor
65203028|NCT05660473|Mitosis Modulators|mitosis modulators|mesh-ancestor
65203029|NCT05660473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65203030|NCT05660473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65203031|NCT05660473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65203093|NCT01254864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203094|NCT01254864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203095|NCT01254864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65203096|NCT01254864|Hormone Antagonists|hormone antagonists|mesh-ancestor
65203097|NCT01254864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65203098|NCT02854722|Calcium, Dietary|calcium, dietary|mesh-list
65203100|NCT02854722|Ergocalciferols|ergocalciferols|mesh-list
65203101|NCT02854722|Cholecalciferol|cholecalciferol|mesh-list
65203102|NCT02854722|Vitamins|vitamins|mesh-list
65203103|NCT02854722|Calcium|calcium|mesh-list
65203159|NCT00907335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203160|NCT00907335|Keratolytic Agents|keratolytic agents|mesh-ancestor
65203161|NCT00907335|Dermatologic Agents|dermatologic agents|mesh-ancestor
65203162|NCT00947154|Aripiprazole|aripiprazole|mesh-list
65203163|NCT00947154|Antidepressive Agents|antidepressive agents|mesh-ancestor
65203230|NCT02857686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203231|NCT03198741|Aspirin|aspirin|mesh-list
65203232|NCT03198741|Clopidogrel|clopidogrel|mesh-list
65203233|NCT03198741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65203299|NCT03525795|Ipilimumab|ipilimumab|mesh-list
65203301|NCT03525795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65203302|NCT03525795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203369|NCT02853864|Anesthetics|anesthetics|mesh-ancestor
65203370|NCT02853864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65203371|NCT02853864|Analgesics|analgesics|mesh-ancestor
65203441|NCT00679666|Riboflavin|riboflavin|mesh-list
65203442|NCT00679666|Vitamins|vitamins|mesh-ancestor
65203443|NCT00679666|Micronutrients|micronutrients|mesh-ancestor
65203444|NCT00679666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203445|NCT00679666|Vitamin B Complex|vitamin b complex|mesh-ancestor
65203446|NCT00679666|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65203447|NCT00679666|Dermatologic Agents|dermatologic agents|mesh-ancestor
65203448|NCT00679744|Pyrimethamine|pyrimethamine|mesh-list
65203449|NCT00679744|Antimalarials|antimalarials|mesh-ancestor
65203450|NCT00679744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65203506|NCT00594646|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65203582|NCT01111526|Panobinostat|panobinostat|mesh-list
65203583|NCT01111526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65203584|NCT01111526|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65203585|NCT01111526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203653|NCT00944658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65203654|NCT00944658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65203655|NCT01110200|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65203656|NCT01110200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65203722|NCT01107626|Tubulin Modulators|tubulin modulators|mesh-ancestor
65203723|NCT01107626|Antimitotic Agents|antimitotic agents|mesh-ancestor
65203796|NCT00904215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203797|NCT00904215|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65203802|NCT05317689|Psilocybin|psilocybin|mesh-list
65203878|NCT04202289|Sulfadiazine|sulfadiazine|mesh-list
65203879|NCT04202289|Silver Sulfadiazine|silver sulfadiazine|mesh-list
65203880|NCT04202289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65203881|NCT04202289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65203952|NCT04413279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65203953|NCT04413279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65203954|NCT04413279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65204024|NCT04202367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65204025|NCT02846493|Dexamethasone|dexamethasone|mesh-list
65204026|NCT02846493|Bromocriptine|bromocriptine|mesh-list
65204096|NCT00625898|Bevacizumab|bevacizumab|mesh-list
65204097|NCT00625898|Carboplatin|carboplatin|mesh-list
65204173|NCT01106534|Analgesics|analgesics|mesh-ancestor
65204174|NCT01106534|Sensory System Agents|sensory system agents|mesh-ancestor
65204175|NCT01106534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65204176|NCT01106534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204177|NCT01106534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65204244|NCT04956302|Daratumumab|daratumumab|mesh-list
65204245|NCT04956302|Panobinostat|panobinostat|mesh-list
65204246|NCT04956302|Ichthammol|ichthammol|mesh-list
65204318|NCT02844309|Immunologic Factors|immunologic factors|mesh-ancestor
65204319|NCT02844309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204320|NCT02844309|Leprostatic Agents|leprostatic agents|mesh-ancestor
65204321|NCT02844309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65204391|NCT05104047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204392|NCT05104047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65204393|NCT05104047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65204394|NCT05104047|Cholinergic Agents|cholinergic agents|mesh-ancestor
65204430|NCT00652431|Niacin|niacin|mesh-list
65204463|NCT00319995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65204464|NCT00319995|Respiratory System Agents|respiratory system agents|mesh-ancestor
65204465|NCT00319995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65204535|NCT00156117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65204536|NCT00156117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65204537|NCT00156117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65204607|NCT00602550|Zidovudine|zidovudine|mesh-list
65204608|NCT00602550|Antimetabolites|antimetabolites|mesh-ancestor
65204609|NCT00602550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65204610|NCT00602550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65204611|NCT00602550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65204612|NCT00602550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65204676|NCT00602862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65204677|NCT00602862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65204822|NCT04268394|Protective Agents|protective agents|mesh-ancestor
65204823|NCT04268394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65204825|NCT04268394|Analgesics|analgesics|mesh-ancestor
65204896|NCT00683176|Choline|choline|mesh-list
65204897|NCT00683176|Fenofibrate|fenofibrate|mesh-list
65204898|NCT00683176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65205043|NCT00684190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65205044|NCT00684190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65205118|NCT05382390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65205119|NCT05382390|Antimetabolites|antimetabolites|mesh-ancestor
65205120|NCT05382390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205121|NCT05382390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205141|NCT00687466|Insulin|insulin|mesh-list
65205188|NCT04138420|Growth Substances|growth substances|mesh-ancestor
65205189|NCT04138420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205190|NCT04138420|Growth Inhibitors|growth inhibitors|mesh-ancestor
65205191|NCT05378646|Interferons|interferons|mesh-list
65205192|NCT05378646|Interferon-gamma|interferon-gamma|mesh-list
65205193|NCT05378646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205278|NCT04138888|Olmesartan|olmesartan|mesh-list
65205335|NCT02625376|Antioxidants|antioxidants|mesh-ancestor
65205336|NCT02625376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205337|NCT02625376|Protective Agents|protective agents|mesh-ancestor
65205338|NCT02625376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205339|NCT02625376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205340|NCT02625376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65205341|NCT04153084|Picosulfate sodium|picosulfate sodium|mesh-list
65205342|NCT04153084|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65205343|NCT04153084|Cathartics|cathartics|mesh-ancestor
65205344|NCT04153084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65205345|NCT04153084|Laxatives|laxatives|mesh-ancestor
65205346|NCT00688948|Alfuzosin|alfuzosin|mesh-list
65205347|NCT00688948|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65205349|NCT00688948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65205396|NCT00874432|Lisinopril|lisinopril|mesh-list
65205397|NCT00874432|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65205398|NCT00874432|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65205399|NCT00874432|Protease Inhibitors|protease inhibitors|mesh-ancestor
65205400|NCT00874432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205401|NCT00874432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65205402|NCT00874432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65205466|NCT00594880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205467|NCT00594880|Antiviral Agents|antiviral agents|mesh-ancestor
65205471|NCT00690118|Pioglitazone|pioglitazone|mesh-list
65205540|NCT04137640|Cyclophosphamide|cyclophosphamide|mesh-list
65205541|NCT04137640|Docetaxel|docetaxel|mesh-list
65205614|NCT00673504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205615|NCT00673504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65205686|NCT00936858|Everolimus|everolimus|mesh-list
65205687|NCT00936858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65205688|NCT00936858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65205758|NCT00936702|Tubulin Modulators|tubulin modulators|mesh-ancestor
65205759|NCT00936702|Antimitotic Agents|antimitotic agents|mesh-ancestor
65205760|NCT00936702|Mitosis Modulators|mitosis modulators|mesh-ancestor
65205761|NCT00936702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205762|NCT00936702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65205826|NCT00674752|Sensory System Agents|sensory system agents|mesh-ancestor
65205827|NCT00674752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65205828|NCT00674752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205829|NCT00674752|Anticonvulsants|anticonvulsants|mesh-ancestor
65205830|NCT00674752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65205831|NCT00674752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65205839|NCT04265274|Copper|copper|mesh-list
65205895|NCT00696826|Protease Inhibitors|protease inhibitors|mesh-ancestor
65205896|NCT00696826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65205897|NCT00696826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65205898|NCT01092182|Prednisone|prednisone|mesh-list
65205899|NCT01092182|Cyclophosphamide|cyclophosphamide|mesh-list
65205900|NCT01092182|Rituximab|rituximab|mesh-list
65205901|NCT01092182|Doxorubicin|doxorubicin|mesh-list
65205964|NCT02623114|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65205965|NCT02623114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65205966|NCT02623114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65205967|NCT02623114|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65205969|NCT02623114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65206032|NCT02621320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65206033|NCT01097330|Amiodarone|amiodarone|mesh-list
65206034|NCT01097330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65206035|NCT01097330|Vasodilator Agents|vasodilator agents|mesh-ancestor
65206102|NCT00675688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65206103|NCT00675688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206104|NCT00675688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65206105|NCT00675688|Hormone Antagonists|hormone antagonists|mesh-ancestor
65206175|NCT04135456|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65206176|NCT04135456|Diuretics|diuretics|mesh-ancestor
65206177|NCT04135456|Natriuretic Agents|natriuretic agents|mesh-ancestor
65206178|NCT04135456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206202|NCT00864682|Lidocaine|lidocaine|mesh-list
65206246|NCT04130230|Autonomic Agents|autonomic agents|mesh-ancestor
65206247|NCT04130230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65206248|NCT04130230|Lipotropic Agents|lipotropic agents|mesh-ancestor
65206319|NCT04933682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65206320|NCT04933682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206321|NCT04933682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206389|NCT01087736|Anticonvulsants|anticonvulsants|mesh-ancestor
65206390|NCT01087736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65206391|NCT01087736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206392|NCT04262388|Durvalumab|durvalumab|mesh-list
65206461|NCT00931632|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65206462|NCT00931632|Vasodilator Agents|vasodilator agents|mesh-ancestor
65206535|NCT00863512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206536|NCT00863512|Tubulin Modulators|tubulin modulators|mesh-ancestor
65206537|NCT00863512|Antimitotic Agents|antimitotic agents|mesh-ancestor
65206538|NCT00863512|Mitosis Modulators|mitosis modulators|mesh-ancestor
65206605|NCT02615782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206678|NCT00867490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65206679|NCT00867490|Vasodilator Agents|vasodilator agents|mesh-ancestor
65206680|NCT00867490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65206681|NCT00867490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65206682|NCT00867490|Diuretics|diuretics|mesh-ancestor
65206683|NCT00867490|Natriuretic Agents|natriuretic agents|mesh-ancestor
65206684|NCT00867490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65206685|NCT00697060|Docetaxel|docetaxel|mesh-list
65206686|NCT00697060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206687|NCT00697060|Tubulin Modulators|tubulin modulators|mesh-ancestor
65206688|NCT00697060|Antimitotic Agents|antimitotic agents|mesh-ancestor
65206689|NCT00697060|Mitosis Modulators|mitosis modulators|mesh-ancestor
65206690|NCT00697060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206691|NCT00867334|Imatinib Mesylate|imatinib mesylate|mesh-list
65206692|NCT00867334|Panitumumab|panitumumab|mesh-list
65206693|NCT00867334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65206694|NCT00867334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65206695|NCT00867334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65206698|NCT00925704|Calcitriol|calcitriol|mesh-list
65206733|NCT00609960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65206734|NCT00609960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65206743|NCT04879134|Emetics|emetics|mesh-ancestor
65206805|NCT04119622|Capecitabine|capecitabine|mesh-list
65206806|NCT04119622|Oxaliplatin|oxaliplatin|mesh-list
65206807|NCT04119622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65206808|NCT04119622|Antimetabolites|antimetabolites|mesh-ancestor
65206809|NCT04119622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65206845|NCT04132570|Budesonide|budesonide|mesh-list
65206874|NCT00860470|Trace Elements|trace elements|mesh-list
65206875|NCT00860470|Folic Acid|folic acid|mesh-list
65206876|NCT00860470|Micronutrients|micronutrients|mesh-list
65206946|NCT04134052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65206947|NCT04134052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65206948|NCT04134052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207018|NCT00923130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207019|NCT00923130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65207091|NCT02876354|Hemostatics|hemostatics|mesh-ancestor
65207092|NCT02876354|Coagulants|coagulants|mesh-ancestor
65207093|NCT00626678|Prednisone|prednisone|mesh-list
65207165|NCT02618824|Antidepressive Agents|antidepressive agents|mesh-ancestor
65207166|NCT02618824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65207167|NCT00610350|Simendan|simendan|mesh-list
65207168|NCT00610350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65207169|NCT00610350|Vasodilator Agents|vasodilator agents|mesh-ancestor
65207170|NCT00610350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65207171|NCT00610350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65207176|NCT01071200|Hormones|hormones|mesh-list
65207231|NCT00857818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65207232|NCT00857818|Dopamine Agents|dopamine agents|mesh-ancestor
65207233|NCT00857818|Antidepressive Agents|antidepressive agents|mesh-ancestor
65207302|NCT00857584|Serotonin Agents|serotonin agents|mesh-ancestor
65207303|NCT00798967|Teduglutide|teduglutide|mesh-list
65207376|NCT00796861|Growth Inhibitors|growth inhibitors|mesh-ancestor
65207377|NCT00796861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65207378|NCT00796861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65207379|NCT00796861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207380|NCT00914563|Lithium Carbonate|lithium carbonate|mesh-list
65207405|NCT00798655|Cisplatin|cisplatin|mesh-list
65207445|NCT00856492|Growth Inhibitors|growth inhibitors|mesh-ancestor
65207446|NCT00856492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65207447|NCT00856492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65207448|NCT00856492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65207516|NCT04115449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65207517|NCT04115449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207519|NCT04133974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65207521|NCT04133974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65207522|NCT04133974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207587|NCT02604823|Antiviral Agents|antiviral agents|mesh-ancestor
65207661|NCT00855166|Hormones|hormones|mesh-ancestor
65207662|NCT00855166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65207663|NCT00855166|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65207664|NCT00855166|Protease Inhibitors|protease inhibitors|mesh-ancestor
65207666|NCT00855166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65207667|NCT00855166|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65207668|NCT00854620|Sorafenib|sorafenib|mesh-list
65207729|NCT02614612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207730|NCT02614612|Antiemetics|antiemetics|mesh-ancestor
65207731|NCT02614612|Autonomic Agents|autonomic agents|mesh-ancestor
65207732|NCT02614612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64324286|NCT05492318|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65207799|NCT00700024|Methyltestosterone|methyltestosterone|mesh-list
65207800|NCT00700024|Testosterone|testosterone|mesh-list
65207801|NCT00700024|Testosterone undecanoate|testosterone undecanoate|mesh-list
65207802|NCT00700024|Testosterone enanthate|testosterone enanthate|mesh-list
65207803|NCT00700024|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65207868|NCT00915577|Interferon-beta|interferon-beta|mesh-list
65207869|NCT00915577|Interferon beta-1a|interferon beta-1a|mesh-list
65207870|NCT00915577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65207945|NCT00529113|Immunologic Factors|immunologic factors|mesh-ancestor
65207946|NCT00529113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65207947|NCT04106557|Gaboxadol|gaboxadol|mesh-list
65208018|NCT02839941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65208019|NCT02839941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208020|NCT02839941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65208021|NCT02839941|Antitubercular Agents|antitubercular agents|mesh-ancestor
65208089|NCT00610506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65208090|NCT00610506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65208091|NCT00610506|Cholinergic Agents|cholinergic agents|mesh-ancestor
65208092|NCT04260828|Aspirin|aspirin|mesh-list
65208093|NCT04260828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65208157|NCT00853372|Trebananib|trebananib|mesh-list
65208158|NCT00853372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
65208159|NCT00853372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208233|NCT00700492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65208234|NCT00700492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208307|NCT00851890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65208308|NCT00851890|Antimetabolites|antimetabolites|mesh-ancestor
65208309|NCT00851890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208310|NCT00592072|Decanoic acid|decanoic acid|mesh-list
65208311|NCT00592072|Antifungal Agents|antifungal agents|mesh-ancestor
65208312|NCT00592072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65208378|NCT04106011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65208379|NCT04106011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208380|NCT04106011|Antimanic Agents|antimanic agents|mesh-ancestor
65208381|NCT02875886|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65208382|NCT02875886|Amiloride|amiloride|mesh-list
65208383|NCT02875886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65208384|NCT02875886|Diuretics|diuretics|mesh-ancestor
65208385|NCT02875886|Natriuretic Agents|natriuretic agents|mesh-ancestor
65208386|NCT02875886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208387|NCT02875886|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65208388|NCT02875886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65208389|NCT02875886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208390|NCT02875886|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65208391|NCT02875886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65208392|NCT02875886|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65208393|NCT02875886|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65208394|NCT00793819|Silodosin|silodosin|mesh-list
65208395|NCT00793819|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65208396|NCT00793819|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65208397|NCT00793819|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65208398|NCT00793819|Adrenergic Agents|adrenergic agents|mesh-ancestor
65208399|NCT00793819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65208400|NCT00793819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208401|NCT00793819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208406|NCT02836821|Rifampin|rifampin|mesh-list
65208423|NCT02836821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65208425|NCT02836743|Antioxidants|antioxidants|mesh-ancestor
65208426|NCT02836743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208494|NCT05304663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208495|NCT05304663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208496|NCT04109755|Pembrolizumab|pembrolizumab|mesh-list
65208497|NCT04109755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65208498|NCT04109755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208563|NCT00892047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65208564|NCT00892047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65208567|NCT00892047|Serotonin Agents|serotonin agents|mesh-ancestor
65208635|NCT02838225|Cyclophosphamide|cyclophosphamide|mesh-list
65208636|NCT02838225|Docetaxel|docetaxel|mesh-list
65208711|NCT02602483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65208712|NCT02602483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65208785|NCT04254744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65208786|NCT04254744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208787|NCT02831361|Metformin|metformin|mesh-list
65208788|NCT02831361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65208789|NCT02831361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208790|NCT04103905|Antibodies|antibodies|mesh-list
65208791|NCT04103905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65208855|NCT00847912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65208856|NCT00847912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65208857|NCT00847912|Immunologic Factors|immunologic factors|mesh-ancestor
65208858|NCT00847912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65208859|NCT00850564|Hormones|hormones|mesh-list
65208860|NCT00850564|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
65208861|NCT00850564|Tesamorelin|tesamorelin|mesh-list
65208922|NCT00848926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65208997|NCT04901676|Leronlimab|leronlimab|mesh-list
65208998|NCT04901676|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65208999|NCT04901676|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65209071|NCT00891735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209072|NCT00891735|Growth Inhibitors|growth inhibitors|mesh-ancestor
64851752|NCT01943825|Vaccines|vaccines|mesh-list
65209073|NCT00891735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65209080|NCT04247373|Ropivacaine|ropivacaine|mesh-list
65209143|NCT02829879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65209144|NCT02829957|Rivaroxaban|rivaroxaban|mesh-list
65209145|NCT02829957|Apixaban|apixaban|mesh-list
65209146|NCT02829957|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65209147|NCT02829957|Antithrombins|antithrombins|mesh-ancestor
65209148|NCT02829957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65209149|NCT02829957|Protease Inhibitors|protease inhibitors|mesh-ancestor
65209150|NCT02829957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65209151|NCT02829957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209210|NCT00835120|Pioglitazone|pioglitazone|mesh-list
65209211|NCT00835120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65209212|NCT00835120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209281|NCT04607460|Dermatologic Agents|dermatologic agents|mesh-ancestor
65209282|NCT04636086|Cholecalciferol|cholecalciferol|mesh-list
65209283|NCT04636086|Vitamin D|vitamin d|mesh-list
65209284|NCT04636086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65209285|NCT04636086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209286|NCT04636086|Vitamins|vitamins|mesh-ancestor
65209287|NCT04636086|Micronutrients|micronutrients|mesh-ancestor
65209288|NCT04636086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65209289|NCT00827242|Tadalafil|tadalafil|mesh-list
65209322|NCT01077284|Febuxostat|febuxostat|mesh-list
65209349|NCT04103125|Viscosupplements|viscosupplements|mesh-ancestor
65209350|NCT04103125|Protective Agents|protective agents|mesh-ancestor
65209351|NCT00826618|Ranibizumab|ranibizumab|mesh-list
65209421|NCT00846040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65209422|NCT00846040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209423|NCT00846040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209424|NCT02611336|Tadalafil|tadalafil|mesh-list
65209491|NCT04309773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65209492|NCT04309773|Antimetabolites|antimetabolites|mesh-ancestor
65209493|NCT04309773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65209563|NCT00915733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65209637|NCT00784927|Growth Substances|growth substances|mesh-ancestor
65209638|NCT00784927|Growth Inhibitors|growth inhibitors|mesh-ancestor
65209639|NCT00637884|Fexofenadine|fexofenadine|mesh-list
65209640|NCT00637884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65209642|NCT00637884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65209707|NCT00845728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209782|NCT00776659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65209857|NCT04102267|Anesthetics|anesthetics|mesh-ancestor
65209858|NCT04102267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65209859|NCT04102267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209860|NCT04102267|Sensory System Agents|sensory system agents|mesh-ancestor
65209861|NCT04102267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65209862|NCT04102267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65209928|NCT00916123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65209929|NCT00916123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209930|NCT00916123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65209931|NCT00916201|Cannabidiol|cannabidiol|mesh-list
65209932|NCT00916201|Anticonvulsants|anticonvulsants|mesh-ancestor
65209933|NCT00833638|Tadalafil|tadalafil|mesh-list
65209934|NCT00833638|Vasodilator Agents|vasodilator agents|mesh-ancestor
65209996|NCT01059812|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
65209997|NCT01059812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65209998|NCT01059812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65209999|NCT00888615|Paclitaxel|paclitaxel|mesh-list
65210000|NCT00888615|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65210066|NCT00887679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65210077|NCT00833482|Ritonavir|ritonavir|mesh-list
65210140|NCT00702442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65210142|NCT00702442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65210143|NCT00702442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65210145|NCT02612272|Betamethasone|betamethasone|mesh-list
65210211|NCT04054674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65210212|NCT04054674|Antifungal Agents|antifungal agents|mesh-ancestor
65210213|NCT04054674|Keratolytic Agents|keratolytic agents|mesh-ancestor
65210227|NCT04099771|Ketamine|ketamine|mesh-list
65210283|NCT02826837|Growth Substances|growth substances|mesh-ancestor
65210285|NCT02826837|Growth Inhibitors|growth inhibitors|mesh-ancestor
65210359|NCT02822157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65210360|NCT02822157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210431|NCT02821689|Analgesics|analgesics|mesh-ancestor
65210432|NCT02821689|Sensory System Agents|sensory system agents|mesh-ancestor
65210436|NCT02821689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65210504|NCT02818881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65210505|NCT02818881|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65210506|NCT02818725|Cisplatin|cisplatin|mesh-list
65210507|NCT02818725|Doxorubicin|doxorubicin|mesh-list
65210508|NCT02818725|Methotrexate|methotrexate|mesh-list
65210509|NCT02818725|Panitumumab|panitumumab|mesh-list
65210534|NCT02818803|Propolis|propolis|mesh-list
65210572|NCT02820051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65210573|NCT02820051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65210574|NCT02820051|Narcotics|narcotics|mesh-ancestor
65210646|NCT02816853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65210647|NCT02816853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210651|NCT02816853|Antiemetics|antiemetics|mesh-ancestor
65210718|NCT05385406|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65210719|NCT05385406|Protective Agents|protective agents|mesh-ancestor
65210720|NCT05385406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65210791|NCT00844480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65210797|NCT04605861|Hormones|hormones|mesh-ancestor
65210865|NCT00820222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65210866|NCT00820222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65210867|NCT00820222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65210868|NCT02815449|Iron|iron|mesh-list
65210869|NCT02815449|Trace Elements|trace elements|mesh-ancestor
65210934|NCT03954366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65210935|NCT03954366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65211007|NCT02812641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65211008|NCT02812641|Immunologic Factors|immunologic factors|mesh-ancestor
65211078|NCT00634413|Budesonide|budesonide|mesh-list
65211079|NCT00634413|Theophylline|theophylline|mesh-list
65211080|NCT00634413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65211081|NCT00634413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65211082|NCT00634413|Autonomic Agents|autonomic agents|mesh-ancestor
65211150|NCT02804841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65211151|NCT02804841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65211152|NCT00634491|Acetazolamide|acetazolamide|mesh-list
65211221|NCT03893175|Antipyretics|antipyretics|mesh-ancestor
65211222|NCT03893175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65211223|NCT03893175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65211224|NCT03893175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65211291|NCT00763555|Calcitriol|calcitriol|mesh-list
65211292|NCT00763555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65211293|NCT00763555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211294|NCT00763555|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65211295|NCT00763555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65211296|NCT00763555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211297|NCT00763555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65211298|NCT00763555|Vitamins|vitamins|mesh-ancestor
65211299|NCT00763555|Micronutrients|micronutrients|mesh-ancestor
65211300|NCT00763555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65211301|NCT02804373|Oxytocin|oxytocin|mesh-list
65211357|NCT05477589|Clofarabine|clofarabine|mesh-list
65211358|NCT05477589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65211359|NCT05477589|Immunologic Factors|immunologic factors|mesh-ancestor
65211360|NCT05477589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211429|NCT00908232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65211430|NCT00908232|Growth Substances|growth substances|mesh-ancestor
65211431|NCT00908232|Growth Inhibitors|growth inhibitors|mesh-ancestor
65211432|NCT00770341|Vancomycin|vancomycin|mesh-list
65211501|NCT00762463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211502|NCT03326310|Azacitidine|azacitidine|mesh-list
65211572|NCT02798055|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65211573|NCT02798055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211574|NCT05331768|Terlipressin|terlipressin|mesh-list
65211648|NCT02630628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65211649|NCT02630628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65211650|NCT02630628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65211651|NCT02630628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65211652|NCT02630628|Antitubercular Agents|antitubercular agents|mesh-ancestor
65211653|NCT02630628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65211654|NCT02630628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65211655|NCT00913588|Fluoxetine|fluoxetine|mesh-list
65211656|NCT00913588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65211657|NCT00913588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65211658|NCT00913588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65211709|NCT00770029|Botulinum Toxins|botulinum toxins|mesh-list
65211710|NCT00770029|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65211711|NCT00770029|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65211786|NCT05804734|Anticoagulants|anticoagulants|mesh-list
65211787|NCT05804734|Vitamins|vitamins|mesh-ancestor
65211788|NCT05804734|Micronutrients|micronutrients|mesh-ancestor
65211789|NCT05804734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211889|NCT05804032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65211890|NCT05804032|Immunologic Factors|immunologic factors|mesh-ancestor
65211965|NCT05803148|Autonomic Agents|autonomic agents|mesh-ancestor
65211966|NCT05803148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65211967|NCT05803148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65211968|NCT05803148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65212036|NCT05802992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65212037|NCT05802992|Immunologic Factors|immunologic factors|mesh-ancestor
65212038|NCT05802992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65212039|NCT05802992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65212040|NCT05802992|Growth Substances|growth substances|mesh-ancestor
65212041|NCT05802992|Growth Inhibitors|growth inhibitors|mesh-ancestor
65212042|NCT05802992|Gout Suppressants|gout suppressants|mesh-ancestor
65212048|NCT05802888|Amoxicillin|amoxicillin|mesh-list
65212107|NCT05801146|Cholinergic Agents|cholinergic agents|mesh-ancestor
65212108|NCT05801146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65212110|NCT05801146|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65212179|NCT05758948|Disinfectants|disinfectants|mesh-ancestor
65212255|NCT05687721|Avelumab|avelumab|mesh-list
65212256|NCT05687721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65212257|NCT05687721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65212258|NCT05684055|Antihypertensive Agents|antihypertensive agents|mesh-list
65212259|NCT05683691|Acetaminophen, aspirin, caffeine drug combination|acetaminophen, aspirin, caffeine drug combination|mesh-list
65212260|NCT05683691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65212261|NCT05683691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65212262|NCT05683691|Analgesics|analgesics|mesh-ancestor
65212263|NCT05683691|Sensory System Agents|sensory system agents|mesh-ancestor
65212264|NCT05683691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65212268|NCT05672901|Estradiol|estradiol|mesh-list
65212320|NCT05627232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65212403|NCT05558124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65212404|NCT05558124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65212405|NCT05558124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65212476|NCT05513469|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
65212477|NCT05513469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65212479|NCT05501548|Ascorbic Acid|ascorbic acid|mesh-list
65212550|NCT05459571|Autonomic Agents|autonomic agents|mesh-ancestor
65212551|NCT05459571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65212552|NCT05459571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65212553|NCT05459571|Glucocorticoids|glucocorticoids|mesh-ancestor
65212620|NCT05355857|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65212697|NCT05226455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212698|NCT05214287|Nitrox|nitrox|mesh-list
65212772|NCT05155709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65212773|NCT05149131|Leuprolide|leuprolide|mesh-list
65212775|NCT05149131|Fertility Agents|fertility agents|mesh-ancestor
65212846|NCT05061017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65212847|NCT05061017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65212919|NCT05017012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65212920|NCT05017012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65212992|NCT04952389|Respiratory System Agents|respiratory system agents|mesh-ancestor
65212994|NCT04952389|Hormones|hormones|mesh-ancestor
65212996|NCT04920617|Cyclophosphamide|cyclophosphamide|mesh-list
65213008|NCT04860804|Aspirin|aspirin|mesh-list
65213065|NCT04703920|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65213066|NCT04703920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213067|NCT04703920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65213071|NCT04700072|Lenvatinib|lenvatinib|mesh-list
65213136|NCT04580121|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65213212|NCT04460872|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65213213|NCT04460872|Androgens|androgens|mesh-ancestor
65213214|NCT04460872|Hormones|hormones|mesh-ancestor
65213286|NCT04305041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213287|NCT04305041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213288|NCT04305041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65213289|NCT04305041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213357|NCT04181359|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65213358|NCT04181359|Vasodilator Agents|vasodilator agents|mesh-ancestor
65213431|NCT04045028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213432|NCT04045028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65213505|NCT03747939|Sensory System Agents|sensory system agents|mesh-ancestor
65213506|NCT03747939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65213507|NCT03747939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213508|NCT03747939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65213575|NCT03597581|Bevacizumab|bevacizumab|mesh-list
65213576|NCT03597581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65213650|NCT03396211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65213651|NCT03386539|Mycophenolic Acid|mycophenolic acid|mesh-list
65213652|NCT03386539|Everolimus|everolimus|mesh-list
65213725|NCT03098836|Hormones|hormones|mesh-ancestor
65213726|NCT03098836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65213735|NCT03078855|Vitamin D|vitamin d|mesh-list
65213800|NCT02877303|Antibodies|antibodies|mesh-list
65213801|NCT02877303|Immunoglobulins|immunoglobulins|mesh-list
65213802|NCT02877303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65213803|NCT02877303|Antibodies, Bispecific|antibodies, bispecific|mesh-list
65213872|NCT02845596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65213876|NCT02775695|Doxycycline|doxycycline|mesh-list
65213949|NCT02256865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65213950|NCT02256865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65213951|NCT02256865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65213952|NCT02256865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65213953|NCT02256865|Anabolic Agents|anabolic agents|mesh-ancestor
65213954|NCT02256865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65214017|NCT01527747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65214018|NCT01439802|Copper|copper|mesh-list
65214092|NCT00760669|Antimetabolites|antimetabolites|mesh-ancestor
65214093|NCT00760669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214094|NCT00760669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65214095|NCT00760669|Dermatologic Agents|dermatologic agents|mesh-ancestor
65214096|NCT00760669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65214165|NCT00769483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214166|NCT00769483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65214167|NCT02794389|Acetylcysteine|acetylcysteine|mesh-list
65214168|NCT02794389|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65214237|NCT04100083|Spironolactone|spironolactone|mesh-list
65214238|NCT04100083|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65214239|NCT04100083|Hormone Antagonists|hormone antagonists|mesh-ancestor
65214243|NCT04100083|Diuretics|diuretics|mesh-ancestor
65214310|NCT02789865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65214311|NCT02789865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65214312|NCT02789865|Renal Agents|renal agents|mesh-ancestor
65214331|NCT02791737|Coal Tar|coal tar|mesh-list
65214384|NCT02789475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65214385|NCT02789475|Antimetabolites|antimetabolites|mesh-ancestor
65214386|NCT02789475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65214387|NCT02789475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65214456|NCT00632580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65214457|NCT00632580|Sensory System Agents|sensory system agents|mesh-ancestor
65214459|NCT03494322|Cetuximab|cetuximab|mesh-list
65214527|NCT02788851|Sympathomimetics|sympathomimetics|mesh-ancestor
65214528|NCT02788851|Autonomic Agents|autonomic agents|mesh-ancestor
65214529|NCT02788851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65214530|NCT02788851|Adrenergic Agents|adrenergic agents|mesh-ancestor
65214531|NCT02788851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65214532|NCT02788851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65214533|NCT02788851|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65214534|NCT02788851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65214594|NCT00905034|Methotrexate|methotrexate|mesh-list
65214595|NCT00905034|Vincristine|vincristine|mesh-list
65214596|NCT00905034|Asparaginase|asparaginase|mesh-list
65214597|NCT00905034|Pegaspargase|pegaspargase|mesh-list
65214600|NCT00905034|Immunologic Factors|immunologic factors|mesh-ancestor
65214666|NCT02611492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65214667|NCT02611492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65214668|NCT02611492|Antimetabolites|antimetabolites|mesh-ancestor
65214670|NCT02611492|Dermatologic Agents|dermatologic agents|mesh-ancestor
65214739|NCT04302584|Sympathomimetics|sympathomimetics|mesh-ancestor
65214740|NCT04302584|Autonomic Agents|autonomic agents|mesh-ancestor
65214741|NCT04302584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65214742|NCT04302584|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65214743|NCT04302584|Hemostatics|hemostatics|mesh-ancestor
65214744|NCT04302584|Coagulants|coagulants|mesh-ancestor
65214745|NCT04302584|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65214746|NCT04302584|Natriuretic Agents|natriuretic agents|mesh-ancestor
65214747|NCT00703144|Tazobactam|tazobactam|mesh-list
65214805|NCT02788305|Oxytocics|oxytocics|mesh-ancestor
65214806|NCT05758012|Oxytocin|oxytocin|mesh-list
65214882|NCT03044613|Antimitotic Agents|antimitotic agents|mesh-ancestor
65214883|NCT03044613|Mitosis Modulators|mitosis modulators|mesh-ancestor
65214884|NCT03044613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65214955|NCT04232007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65214956|NCT02901717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65215028|NCT02785809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65215029|NCT02785809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215030|NCT02785809|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65215103|NCT04202406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65215177|NCT05756764|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65215178|NCT05756764|Appetite Depressants|appetite depressants|mesh-ancestor
65215179|NCT05756764|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65215248|NCT02784795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215323|NCT00759031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65215324|NCT00759031|Antimetabolites|antimetabolites|mesh-ancestor
65215326|NCT00759031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65215398|NCT02601235|Autonomic Agents|autonomic agents|mesh-ancestor
65215399|NCT02601235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65215400|NCT02601235|Nasal Decongestants|nasal decongestants|mesh-ancestor
65215420|NCT02846142|Estradiol|estradiol|mesh-list
65215471|NCT00757705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65215472|NCT00757705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215473|NCT00757705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65215474|NCT00757705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65215475|NCT00757705|Dopamine Agents|dopamine agents|mesh-ancestor
65215477|NCT02845908|Fluorouracil|fluorouracil|mesh-list
65215542|NCT01023308|Glucocorticoids|glucocorticoids|mesh-ancestor
65215543|NCT01023308|Hormones|hormones|mesh-ancestor
65215544|NCT01023308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65215545|NCT01023308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65215546|NCT01023308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215547|NCT01023308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65215548|NCT01023308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215549|NCT01023308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215550|NCT02781909|Ibuprofen|ibuprofen|mesh-list
64858259|NCT01741077|Vitamins|vitamins|mesh-ancestor
65215553|NCT02781909|Analgesics|analgesics|mesh-ancestor
65215605|NCT00903006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65215606|NCT00903006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215607|NCT04097899|Anti-Infective Agents|anti-infective agents|mesh-list
65215608|NCT04097899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65215674|NCT04420884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215675|NCT05341401|Prednisolone|prednisolone|mesh-list
65215748|NCT00634725|Antimetabolites|antimetabolites|mesh-ancestor
65215749|NCT00634725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215750|NCT00634725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65215751|NCT00634725|Antiviral Agents|antiviral agents|mesh-ancestor
65215752|NCT00634725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65215753|NCT00634725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65215819|NCT04887402|Zuclomiphene|zuclomiphene|mesh-list
65215820|NCT04887402|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65215829|NCT04793568|Interferons|interferons|mesh-list
65215893|NCT04570176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65215894|NCT04570176|Adrenergic Agents|adrenergic agents|mesh-ancestor
65215895|NCT04570176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65215966|NCT00747643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65215967|NCT00747643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65215968|NCT00747643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65215969|NCT00627692|Prucalopride|prucalopride|mesh-list
65215970|NCT00627692|Laxatives|laxatives|mesh-ancestor
65215971|NCT00627692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65216034|NCT02599675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65216035|NCT02599675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65216036|NCT02778789|Adalimumab|adalimumab|mesh-list
65216037|NCT02778789|Etanercept|etanercept|mesh-list
65216038|NCT02778789|Golimumab|golimumab|mesh-list
65216105|NCT02779959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65216106|NCT02779959|Dopamine Agents|dopamine agents|mesh-ancestor
65216107|NCT02779959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65216108|NCT02779959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216176|NCT00092742|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65216248|NCT02773017|Sensory System Agents|sensory system agents|mesh-ancestor
65216249|NCT02773017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65216250|NCT02773017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65216320|NCT02840994|Nivolumab|nivolumab|mesh-list
65216321|NCT02840994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65216322|NCT02840994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65216392|NCT01034462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65216468|NCT02774187|Vitamins|vitamins|mesh-ancestor
65216469|NCT02774187|Micronutrients|micronutrients|mesh-ancestor
65216488|NCT02768961|Sofosbuvir|sofosbuvir|mesh-list
65216542|NCT00715611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65216543|NCT00715611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65216618|NCT02767401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65216628|NCT02767401|Antipyretics|antipyretics|mesh-ancestor
65216690|NCT04224441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65216691|NCT04224441|Dopamine Agents|dopamine agents|mesh-ancestor
65216693|NCT02767089|Prednisone|prednisone|mesh-list
65216763|NCT04091815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65216766|NCT00746785|Antiemetics|antiemetics|mesh-ancestor
65216836|NCT02761161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216837|NCT02761161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65216838|NCT02761161|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65216839|NCT02761161|Histamine Antagonists|histamine antagonists|mesh-ancestor
65216907|NCT02765373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65216908|NCT02765373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65216909|NCT02765373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65216910|NCT02765373|Hormone Antagonists|hormone antagonists|mesh-ancestor
65216914|NCT02760615|Losartan|losartan|mesh-list
65216977|NCT02760381|Immunologic Factors|immunologic factors|mesh-ancestor
65216978|NCT02760381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217050|NCT02764515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65217051|NCT02764515|Immunologic Factors|immunologic factors|mesh-ancestor
65217052|NCT02764515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65217053|NCT02764515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65217054|NCT02764749|Phenol|phenol|mesh-list
65217055|NCT02764749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65217056|NCT02764749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65217057|NCT02764749|Disinfectants|disinfectants|mesh-ancestor
65217119|NCT02763969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65217120|NCT02763969|Histamine Antagonists|histamine antagonists|mesh-ancestor
65217121|NCT02763969|Histamine Agents|histamine agents|mesh-ancestor
65217122|NCT02763969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65217123|NCT02763969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65217124|NCT04660929|Pembrolizumab|pembrolizumab|mesh-list
65217125|NCT04660929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65217126|NCT04660929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217186|NCT02757495|Sensory System Agents|sensory system agents|mesh-ancestor
65217187|NCT02757495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65217258|NCT02755545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65217259|NCT02755545|Dermatologic Agents|dermatologic agents|mesh-ancestor
65217266|NCT02695797|Prednisolone|prednisolone|mesh-list
65217334|NCT04090801|Vasodilator Agents|vasodilator agents|mesh-ancestor
65217335|NCT04089631|Capecitabine|capecitabine|mesh-list
65217336|NCT04089631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65217337|NCT04089631|Antimetabolites|antimetabolites|mesh-ancestor
65217405|NCT04219995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65217406|NCT04219995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217407|NCT04544475|Estrogens|estrogens|mesh-list
65217477|NCT04217265|Misoprostol|misoprostol|mesh-list
65217478|NCT04217265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65217479|NCT04217265|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65217480|NCT04217265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65217493|NCT00635973|Gefitinib|gefitinib|mesh-list
65217548|NCT04218513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65217549|NCT04218513|Antioxidants|antioxidants|mesh-ancestor
65217619|NCT02746185|Heparin|heparin|mesh-list
65217620|NCT02746185|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65217621|NCT02746185|Tinzaparin|tinzaparin|mesh-list
65217622|NCT02746185|Dalteparin|dalteparin|mesh-list
65217623|NCT02746185|Rivaroxaban|rivaroxaban|mesh-list
65217624|NCT02746185|Anticoagulants|anticoagulants|mesh-ancestor
65217690|NCT02745717|Cyclosporins|cyclosporins|mesh-list
65217691|NCT02745717|Thymoglobulin|thymoglobulin|mesh-list
65217765|NCT03737253|Hormones|hormones|mesh-ancestor
65217766|NCT03737253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65217767|NCT03737253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217837|NCT02739711|Immunologic Factors|immunologic factors|mesh-ancestor
65217838|NCT02739711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65217839|NCT02739711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65217846|NCT00813592|Pasireotide|pasireotide|mesh-list
65217910|NCT02742675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65217982|NCT02609386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65217983|NCT02609386|Micronutrients|micronutrients|mesh-ancestor
65217984|NCT02609386|Trace Elements|trace elements|mesh-ancestor
65217985|NCT02609386|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65218053|NCT00913822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65218054|NCT00913822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218125|NCT00743509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218126|NCT00743509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65218200|NCT03593655|Antiviral Agents|antiviral agents|mesh-ancestor
65218273|NCT02731911|Autonomic Agents|autonomic agents|mesh-ancestor
65218278|NCT02731911|Hormones|hormones|mesh-ancestor
65218348|NCT02735343|Anesthetics, General|anesthetics, general|mesh-ancestor
65218349|NCT02735343|Anesthetics|anesthetics|mesh-ancestor
65218350|NCT02735343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65218351|NCT02735343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65218416|NCT05430243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65218417|NCT05430243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218418|NCT05430243|Natriuretic Agents|natriuretic agents|mesh-ancestor
65218419|NCT02730117|Cephalosporins|cephalosporins|mesh-list
65218420|NCT02730117|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65218486|NCT02729961|Immunoglobulins|immunoglobulins|mesh-list
65218562|NCT00811954|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65218563|NCT00811954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65218564|NCT00811954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65218630|NCT05757310|Antiviral Agents|antiviral agents|mesh-ancestor
65218631|NCT05757310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65218632|NCT00743119|Dronabinol|dronabinol|mesh-list
65218633|NCT00743119|Hallucinogens|hallucinogens|mesh-ancestor
65218634|NCT00743119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218635|NCT00743119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65218636|NCT00743119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65218637|NCT00743119|Analgesics|analgesics|mesh-ancestor
65218638|NCT00743119|Sensory System Agents|sensory system agents|mesh-ancestor
65218699|NCT00813124|Antimetabolites|antimetabolites|mesh-ancestor
65218700|NCT00813124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218701|NCT00813124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65218702|NCT00813124|Immunologic Factors|immunologic factors|mesh-ancestor
65218703|NCT00813124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218770|NCT02728323|Anesthetics, Local|anesthetics, local|mesh-ancestor
65218771|NCT02728323|Anesthetics|anesthetics|mesh-ancestor
65218772|NCT02728323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65218773|NCT02728323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218774|NCT02728323|Sensory System Agents|sensory system agents|mesh-ancestor
65218776|NCT00811720|Nalmefene|nalmefene|mesh-list
65218836|NCT04770610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65218837|NCT04770610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65218838|NCT02690415|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65218908|NCT02726919|GABA Agonists|gaba agonists|mesh-ancestor
65218909|NCT02726919|GABA Agents|gaba agents|mesh-ancestor
65218910|NCT02726919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65218911|NCT02726919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218912|NCT00590902|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65218978|NCT00590590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65218979|NCT00590590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65218980|NCT00590590|Sensory System Agents|sensory system agents|mesh-ancestor
65218981|NCT00590590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65218982|NCT00590590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65218983|NCT00590590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65218984|NCT00590590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65218985|NCT00590590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65218986|NCT00590590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65218989|NCT00590590|Antiemetics|antiemetics|mesh-ancestor
65219042|NCT02725359|Bupivacaine|bupivacaine|mesh-list
65219043|NCT02725359|Anesthetics, Local|anesthetics, local|mesh-ancestor
65219062|NCT00731731|Vorinostat|vorinostat|mesh-list
65219118|NCT00811252|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65219119|NCT00811252|Serotonin Agents|serotonin agents|mesh-ancestor
65219120|NCT00811252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65219121|NCT00811252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65219122|NCT00811252|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65219123|NCT00811252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65219132|NCT00736957|Tramadol|tramadol|mesh-list
65219191|NCT02723487|Anesthetics, Local|anesthetics, local|mesh-ancestor
65219192|NCT02723487|Anesthetics|anesthetics|mesh-ancestor
65219193|NCT02723487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65219195|NCT02723487|Sensory System Agents|sensory system agents|mesh-ancestor
65219265|NCT02722083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219267|NCT02722083|Dermatologic Agents|dermatologic agents|mesh-ancestor
65219268|NCT02722083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65219269|NCT02722083|Histamine Antagonists|histamine antagonists|mesh-ancestor
65219336|NCT02715687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65219337|NCT02715687|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65219409|NCT04787835|Sensory System Agents|sensory system agents|mesh-ancestor
65219410|NCT04787835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65219411|NCT00730015|Linaclotide|linaclotide|mesh-list
65219483|NCT00248703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219556|NCT00736255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65219571|NCT00808444|Vaccines|vaccines|mesh-list
65219629|NCT02713191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219630|NCT02713191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65219631|NCT02713191|Analgesics|analgesics|mesh-ancestor
65219636|NCT02713191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65219702|NCT02777619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65219703|NCT02777619|Adrenergic Agents|adrenergic agents|mesh-ancestor
65219704|NCT02777619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65219705|NCT02777619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219706|NCT05754424|Insulin Aspart|insulin aspart|mesh-list
65219707|NCT05754424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65219772|NCT00635037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65219773|NCT00635037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219774|NCT00635037|Sensory System Agents|sensory system agents|mesh-ancestor
65219844|NCT02711241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219845|NCT02711241|Vasodilator Agents|vasodilator agents|mesh-ancestor
65219846|NCT02711241|Urological Agents|urological agents|mesh-ancestor
65219847|NCT02711007|Apatinib|apatinib|mesh-list
65219850|NCT02711007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65219914|NCT00729157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219915|NCT00729157|Growth Inhibitors|growth inhibitors|mesh-ancestor
65219916|NCT00729157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65219917|NCT00729157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65219918|NCT00729157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65219919|NCT00729157|Antimetabolites|antimetabolites|mesh-ancestor
65219922|NCT02710305|Lidocaine|lidocaine|mesh-list
65219985|NCT00726895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65219986|NCT00726895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65219987|NCT00726895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65219988|NCT00726895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65219989|NCT00726895|Analgesics|analgesics|mesh-ancestor
65219990|NCT00726895|Sensory System Agents|sensory system agents|mesh-ancestor
65220056|NCT02709603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220057|NCT02709603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65220058|NCT02709603|Mydriatics|mydriatics|mesh-ancestor
65220059|NCT02709603|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65220060|NCT02709603|Cholinergic Agents|cholinergic agents|mesh-ancestor
65220061|NCT02709603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65220062|NCT02709603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220063|NCT02709603|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65220064|NCT02709603|Parasympatholytics|parasympatholytics|mesh-ancestor
65220065|NCT00611793|Bevacizumab|bevacizumab|mesh-list
65220121|NCT00741013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65220122|NCT00741013|Antimetabolites|antimetabolites|mesh-ancestor
65220123|NCT00741013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220124|NCT00741013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65220125|NCT00741013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65220188|NCT00914368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220189|NCT02607982|Paclitaxel|paclitaxel|mesh-list
65220264|NCT04882293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220265|NCT04882293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65220266|NCT04882293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65220267|NCT04882293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220268|NCT02608060|Epoetin Alfa|epoetin alfa|mesh-list
65220269|NCT02608060|Hematinics|hematinics|mesh-ancestor
65220271|NCT04085575|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65220333|NCT05705050|Autonomic Agents|autonomic agents|mesh-ancestor
65220334|NCT05705050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65220338|NCT05705050|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65220407|NCT02607436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65220408|NCT02607436|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65220409|NCT02607436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65220410|NCT02607436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220411|NCT02607436|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65220412|NCT02607436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65220413|NCT02607436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220414|NCT02607436|Antipyretics|antipyretics|mesh-ancestor
65220475|NCT00588952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65220548|NCT04594551|Antibodies|antibodies|mesh-list
65220549|NCT04594551|Immunologic Factors|immunologic factors|mesh-ancestor
65220550|NCT04594551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220623|NCT02607202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220624|NCT03896685|Linezolid|linezolid|mesh-list
65220625|NCT03896685|Bedaquiline|bedaquiline|mesh-list
65220626|NCT03896685|Clofazimine|clofazimine|mesh-list
65220627|NCT03896685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65220628|NCT03896685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65220629|NCT03896685|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65220630|NCT03896685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220690|NCT04114630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220691|NCT04114630|Analgesics|analgesics|mesh-ancestor
65220692|NCT04114630|Sensory System Agents|sensory system agents|mesh-ancestor
65220693|NCT04114630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65220694|NCT04114630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220695|NCT04112212|Vedolizumab|vedolizumab|mesh-list
65220696|NCT04112212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65220697|NCT00914524|Olmesartan|olmesartan|mesh-list
65220698|NCT00914524|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65220699|NCT00914524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65220703|NCT03787095|Cemiplimab|cemiplimab|mesh-list
65220752|NCT04007991|Dopamine Agents|dopamine agents|mesh-ancestor
65220753|NCT04007991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65220754|NCT04007991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65220755|NCT03822507|Cinacalcet|cinacalcet|mesh-list
65220756|NCT03822507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65220757|NCT03822507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65220770|NCT00614679|Heparin|heparin|mesh-list
65220817|NCT00721279|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65220818|NCT00721279|Dopamine Agonists|dopamine agonists|mesh-ancestor
65220891|NCT03245229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65220892|NCT03245229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65220893|NCT03245229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65220894|NCT03462069|Empagliflozin|empagliflozin|mesh-list
65220895|NCT03462069|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
65220898|NCT03462069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65220952|NCT00720343|Choline|choline|mesh-list
65220953|NCT00720343|Lipotropic Agents|lipotropic agents|mesh-ancestor
65220954|NCT00720343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65220955|NCT00720343|Antimetabolites|antimetabolites|mesh-ancestor
65221029|NCT00720109|Antiviral Agents|antiviral agents|mesh-ancestor
65221030|NCT00720109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65221031|NCT00720109|Antidotes|antidotes|mesh-ancestor
65221032|NCT00720109|Protective Agents|protective agents|mesh-ancestor
65221033|NCT00720109|Vitamin B Complex|vitamin b complex|mesh-ancestor
65221034|NCT00720109|Vitamins|vitamins|mesh-ancestor
65221035|NCT00720109|Micronutrients|micronutrients|mesh-ancestor
65221036|NCT00720109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65221037|NCT00720109|Tubulin Modulators|tubulin modulators|mesh-ancestor
65221038|NCT00720109|Antimitotic Agents|antimitotic agents|mesh-ancestor
65221039|NCT00720109|Mitosis Modulators|mitosis modulators|mesh-ancestor
65221040|NCT00720109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65221041|NCT00720109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65221042|NCT00720109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65221043|NCT00720109|Hematinics|hematinics|mesh-ancestor
65221044|NCT00720109|Keratolytic Agents|keratolytic agents|mesh-ancestor
65221045|NCT01705977|Belimumab|belimumab|mesh-list
65221046|NCT01705977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65221047|NCT01705977|Immunologic Factors|immunologic factors|mesh-ancestor
65221048|NCT01705977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221049|NCT02590627|Lumefantrine|lumefantrine|mesh-list
65221050|NCT02590627|Artemether|artemether|mesh-list
65221089|NCT00628160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65221090|NCT00628160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65221091|NCT00628160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221092|NCT00628160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221162|NCT00723229|Acyclovir|acyclovir|mesh-list
65221163|NCT00723229|Antiviral Agents|antiviral agents|mesh-ancestor
65221164|NCT00723229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65221165|NCT01093521|Gallium nitrate|gallium nitrate|mesh-list
65221169|NCT01030718|Dasatinib|dasatinib|mesh-list
65221233|NCT00714493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65221234|NCT01013870|Atorvastatin|atorvastatin|mesh-list
65221235|NCT01013870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65221236|NCT01013870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65221237|NCT01013870|Antimetabolites|antimetabolites|mesh-ancestor
65221304|NCT04301336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65221305|NCT04301336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65221306|NCT04301336|Antimetabolites|antimetabolites|mesh-ancestor
65221307|NCT04301336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221308|NCT04301336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65221376|NCT01010750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65221377|NCT01010750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65221378|NCT01012622|Methylphenidate|methylphenidate|mesh-list
65221379|NCT01012622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65221380|NCT01012622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221381|NCT01012622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65221382|NCT01012622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65221387|NCT00722371|Metformin|metformin|mesh-list
65221441|NCT04114396|Immunologic Factors|immunologic factors|mesh-ancestor
65221442|NCT04114396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221443|NCT00796666|Sildenafil Citrate|sildenafil citrate|mesh-list
65221514|NCT02605798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65221515|NCT00802672|Ciclopirox|ciclopirox|mesh-list
65221516|NCT00802672|Antifungal Agents|antifungal agents|mesh-ancestor
65221517|NCT00802672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65221518|NCT04113772|Nitisinone|nitisinone|mesh-list
65221519|NCT04113772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65221587|NCT04110808|Vasodilator Agents|vasodilator agents|mesh-ancestor
65221664|NCT01016600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65221665|NCT01016600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65221666|NCT01016600|Growth Substances|growth substances|mesh-ancestor
65221667|NCT01016600|Growth Inhibitors|growth inhibitors|mesh-ancestor
65221674|NCT05175235|Nivolumab|nivolumab|mesh-list
65221734|NCT00793624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65221735|NCT00919243|Prednisone|prednisone|mesh-list
65221736|NCT00919243|Allopurinol|allopurinol|mesh-list
65221737|NCT00919243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65221738|NCT00919243|Glucocorticoids|glucocorticoids|mesh-ancestor
65221739|NCT00919243|Hormones|hormones|mesh-ancestor
65221741|NCT00919243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221802|NCT00718315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65221803|NCT00718315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65221876|NCT05137717|Maribavir|maribavir|mesh-list
65221877|NCT05137717|Antiviral Agents|antiviral agents|mesh-ancestor
65221878|NCT05137717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65221879|NCT02643303|Durvalumab|durvalumab|mesh-list
65221949|NCT00789880|Micronutrients|micronutrients|mesh-ancestor
65221950|NCT00789880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65221951|NCT00789880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65221952|NCT00789880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65221953|NCT00915616|Melatonin|melatonin|mesh-list
65221967|NCT00914836|Hormones|hormones|mesh-ancestor
65222016|NCT04106362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222017|NCT04106362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65222018|NCT02603068|Treprostinil|treprostinil|mesh-list
65222019|NCT02603068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65222020|NCT00718081|Sufentanil|sufentanil|mesh-list
65222087|NCT00588094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222088|NCT00588094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65222089|NCT00588094|Alkylating Agents|alkylating agents|mesh-ancestor
65222090|NCT05194735|Aldesleukin|aldesleukin|mesh-list
65222091|NCT05194735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65222157|NCT00919399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65222158|NCT00919399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65222159|NCT00919399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65222160|NCT00919399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65222225|NCT05683171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65222226|NCT05683171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65222227|NCT05683171|Immunologic Factors|immunologic factors|mesh-ancestor
65222228|NCT05683171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222229|NCT05683171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65222230|NCT05683171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65222231|NCT05683171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65222234|NCT02604004|Lamivudine|lamivudine|mesh-list
65222290|NCT04815967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222291|NCT04815967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65222292|NCT04815967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65222293|NCT04815967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65222364|NCT00615381|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65222365|NCT00615381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65222366|NCT00615381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222438|NCT00785512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65222439|NCT00785512|Vasodilator Agents|vasodilator agents|mesh-ancestor
65222440|NCT00785512|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65222441|NCT00785512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65222442|NCT00785512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65222447|NCT02702817|Naproxen|naproxen|mesh-list
65222508|NCT04104334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65222509|NCT04104334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222510|NCT04104334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65222583|NCT03272217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65222584|NCT03272217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65222585|NCT03272217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65222586|NCT03272217|Growth Substances|growth substances|mesh-ancestor
65222587|NCT03272217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222588|NCT03272217|Growth Inhibitors|growth inhibitors|mesh-ancestor
65222589|NCT03262701|Hydrogen Peroxide|hydrogen peroxide|mesh-list
65222656|NCT00775606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222657|NCT00775606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222725|NCT04977271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65222726|NCT04977271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222795|NCT04215159|Antiviral Agents|antiviral agents|mesh-ancestor
65222796|NCT04215159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65222797|NCT04215159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222804|NCT04965493|Rituximab|rituximab|mesh-list
65222870|NCT03236805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65222871|NCT03236805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222872|NCT03236805|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65222873|NCT03236805|Narcotics|narcotics|mesh-ancestor
65222874|NCT02698995|Acetaminophen|acetaminophen|mesh-list
65222875|NCT02698995|Dexamethasone|dexamethasone|mesh-list
65222876|NCT02698995|Lidocaine|lidocaine|mesh-list
65222877|NCT02698995|Morphine|morphine|mesh-list
65222878|NCT02698995|Ropivacaine|ropivacaine|mesh-list
65222879|NCT02698995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65222880|NCT02698995|Antiemetics|antiemetics|mesh-ancestor
65222881|NCT02698995|Autonomic Agents|autonomic agents|mesh-ancestor
65222882|NCT02698995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65222933|NCT02698527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65222934|NCT02698527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65222935|NCT02698527|Sensory System Agents|sensory system agents|mesh-ancestor
65222936|NCT02698527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65222937|NCT02698527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65222938|NCT02698527|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65222939|NCT02698527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65222940|NCT02698527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65222941|NCT02698527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222942|NCT04215237|Atorvastatin|atorvastatin|mesh-list
65222943|NCT04215237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65222944|NCT04215237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65222945|NCT04215237|Antimetabolites|antimetabolites|mesh-ancestor
65222946|NCT04215237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65222947|NCT04215237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65222948|NCT04215237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65222949|NCT04215237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65222987|NCT04213833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65222988|NCT04605991|Insulin Glargine|insulin glargine|mesh-list
65222989|NCT04605991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65222991|NCT00783796|Everolimus|everolimus|mesh-list
65223057|NCT02607891|Anticonvulsants|anticonvulsants|mesh-ancestor
65223058|NCT02607813|Spartalizumab|spartalizumab|mesh-list
65223059|NCT02607813|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65223060|NCT02607813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223061|NCT02607813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223128|NCT00617643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65223129|NCT00617643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65223130|NCT00617643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65223203|NCT04873453|Anticonvulsants|anticonvulsants|mesh-ancestor
65223204|NCT04080349|Misoprostol|misoprostol|mesh-list
65223205|NCT04080349|Dinoprostone|dinoprostone|mesh-list
65223206|NCT04080349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65223207|NCT04080349|Abortifacient Agents|abortifacient agents|mesh-ancestor
65223208|NCT04080349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65223283|NCT05435911|Propofol|propofol|mesh-list
65223284|NCT05435911|Flumazenil|flumazenil|mesh-list
65223285|NCT05435911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65223286|NCT05435911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65223287|NCT05435911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223288|NCT05435911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65223353|NCT00583219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223354|NCT00583219|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65223428|NCT04426669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223429|NCT04426669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65223430|NCT04426669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65223431|NCT04426669|Alkylating Agents|alkylating agents|mesh-ancestor
65223432|NCT04426669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223433|NCT04426669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223436|NCT04426669|Analgesics|analgesics|mesh-ancestor
65223496|NCT05568550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65223497|NCT05568550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223498|NCT05568550|Hormones|hormones|mesh-ancestor
65223499|NCT05568550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65223500|NCT05568550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65223501|NCT02583217|Ketamine|ketamine|mesh-list
65223502|NCT02583217|Remifentanil|remifentanil|mesh-list
65223503|NCT02583217|Propofol|propofol|mesh-list
65223508|NCT02583217|Anesthetics, General|anesthetics, general|mesh-ancestor
65223562|NCT04102072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65223563|NCT04102072|Protective Agents|protective agents|mesh-ancestor
65223564|NCT02875457|Cisplatin|cisplatin|mesh-list
65223565|NCT02875457|Etoposide|etoposide|mesh-list
65223635|NCT04076371|Antidepressive Agents|antidepressive agents|mesh-ancestor
65223636|NCT04076371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65223637|NCT04076371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65223709|NCT01010126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65223710|NCT01010126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65223711|NCT01010126|Antifungal Agents|antifungal agents|mesh-ancestor
65223712|NCT01010126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65223713|NCT03897127|Cytarabine|cytarabine|mesh-list
65223779|NCT00617799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65223780|NCT00617799|Antiviral Agents|antiviral agents|mesh-ancestor
65223781|NCT00617799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65223782|NCT00617877|Losartan|losartan|mesh-list
65223852|NCT01009814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65223927|NCT04297202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65223928|NCT04297202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65223929|NCT04297202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65224000|NCT02601898|Vitamins|vitamins|mesh-ancestor
65224001|NCT02601898|Micronutrients|micronutrients|mesh-ancestor
65224002|NCT00618423|Ketamine|ketamine|mesh-list
65224003|NCT00618423|Analgesics|analgesics|mesh-ancestor
65224004|NCT00618423|Sensory System Agents|sensory system agents|mesh-ancestor
65224005|NCT00618423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65224006|NCT00618423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65224007|NCT00618423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65224008|NCT00618423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65224009|NCT00618423|Anesthetics, General|anesthetics, general|mesh-ancestor
64554991|NCT04197323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64554992|NCT04197323|Vasodilator Agents|vasodilator agents|mesh-ancestor
64554993|NCT04197323|Urological Agents|urological agents|mesh-ancestor
64554994|NCT04196855|Teriparatide|teriparatide|mesh-list
64554995|NCT04196855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64554996|NCT04196855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952332|NCT00395915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554997|NCT04196855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64554998|NCT04196621|Lubricant Eye Drops|lubricant eye drops|mesh-list
64554999|NCT04196621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64555000|NCT04196621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64555001|NCT04196309|Heparin|heparin|mesh-list
64555002|NCT04196309|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64555003|NCT04196309|Tinzaparin|tinzaparin|mesh-list
64555004|NCT04196309|Dalteparin|dalteparin|mesh-list
64555005|NCT04196309|Anticoagulants|anticoagulants|mesh-ancestor
64555006|NCT04196309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64555007|NCT04196309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64725808|NCT00003056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64725809|NCT00003056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64725810|NCT00003056|Antifungal Agents|antifungal agents|mesh-ancestor
64555008|NCT04196309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555010|NCT04196231|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64555011|NCT04196231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64952333|NCT00395915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64952334|NCT00395915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64952335|NCT00395915|Serotonin Agents|serotonin agents|mesh-ancestor
64952336|NCT00395915|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64952337|NCT00395915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64952338|NCT00395915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64952339|NCT00395915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64952340|NCT00029861|Rimonabant|rimonabant|mesh-list
64952341|NCT00029861|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64952342|NCT00029861|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
64952343|NCT00029861|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64952344|NCT00029861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64952345|NCT00029861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952346|NCT00029861|Hormones|hormones|mesh-ancestor
64555012|NCT04196231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555013|NCT03090048|Vitamin A|vitamin a|mesh-list
64555014|NCT03090048|Azithromycin|azithromycin|mesh-list
64555015|NCT03090048|Retinol palmitate|retinol palmitate|mesh-list
64555016|NCT03090048|Vitamins|vitamins|mesh-ancestor
64555017|NCT03090048|Micronutrients|micronutrients|mesh-ancestor
64555018|NCT03090048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952347|NCT00029861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64952348|NCT00029861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952349|NCT00057369|Dalbavancin|dalbavancin|mesh-list
64952350|NCT00057369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64952351|NCT00057369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64952352|NCT00057408|Olanzapine|olanzapine|mesh-list
64952353|NCT00057408|Antipsychotic Agents|antipsychotic agents|mesh-list
64952354|NCT00057408|Antiemetics|antiemetics|mesh-ancestor
64952355|NCT00057408|Autonomic Agents|autonomic agents|mesh-ancestor
64952356|NCT00057408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64555019|NCT03090048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64555020|NCT03090048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64555021|NCT03090048|Antioxidants|antioxidants|mesh-ancestor
64555022|NCT03090048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555023|NCT03090048|Protective Agents|protective agents|mesh-ancestor
64555024|NCT03090048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64555025|NCT03090048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555026|NCT04195997|Heparin|heparin|mesh-list
64555027|NCT04195997|Bivalirudin|bivalirudin|mesh-list
64952357|NCT00057408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952358|NCT00057408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64952359|NCT00057408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64952360|NCT00057408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64555028|NCT04195997|Anticoagulants|anticoagulants|mesh-ancestor
64555029|NCT04195997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64555030|NCT04195997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64555031|NCT04195997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555032|NCT04195997|Antithrombins|antithrombins|mesh-ancestor
64952361|NCT00057408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64952362|NCT00057408|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64509180|NCT01933984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64555033|NCT04195997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64555034|NCT04195997|Protease Inhibitors|protease inhibitors|mesh-ancestor
64555035|NCT04195997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555036|NCT05023122|Vitamin D|vitamin d|mesh-list
64555037|NCT05023122|Cholecalciferol|cholecalciferol|mesh-list
64555038|NCT05023122|Calcium|calcium|mesh-list
64952363|NCT00057408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64952364|NCT00057408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64555039|NCT05023122|Vitamins|vitamins|mesh-ancestor
64555040|NCT05023122|Micronutrients|micronutrients|mesh-ancestor
64555041|NCT05023122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555042|NCT05023122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64555043|NCT05023122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64555044|NCT04195373|Flucytosine|flucytosine|mesh-list
64952365|NCT00057408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952366|NCT00057408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64952367|NCT00057408|Serotonin Agents|serotonin agents|mesh-ancestor
64952368|NCT00030056|Molgramostim|molgramostim|mesh-list
64952369|NCT00030056|Sargramostim|sargramostim|mesh-list
64952373|NCT00057447|Interferons|interferons|mesh-list
64952374|NCT00057447|Interferon-gamma|interferon-gamma|mesh-list
64952375|NCT00057447|Rituximab|rituximab|mesh-list
64952376|NCT00057447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64952377|NCT00057447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952378|NCT00057447|Immunologic Factors|immunologic factors|mesh-ancestor
64952379|NCT00057447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952380|NCT00057447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64952381|NCT00057447|Antiviral Agents|antiviral agents|mesh-ancestor
64555045|NCT04195373|Antifungal Agents|antifungal agents|mesh-ancestor
64555046|NCT04195373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64952385|NCT00030095|Tubulin Modulators|tubulin modulators|mesh-ancestor
64952386|NCT00030095|Antimitotic Agents|antimitotic agents|mesh-ancestor
64952387|NCT00030095|Mitosis Modulators|mitosis modulators|mesh-ancestor
64952388|NCT00030095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952389|NCT00030173|Epothilones|epothilones|mesh-list
64952390|NCT00030173|Desoxyepothilone B|desoxyepothilone b|mesh-list
64952391|NCT00030173|Tubulin Modulators|tubulin modulators|mesh-ancestor
64555048|NCT04195373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555049|NCT04194827|Adalimumab|adalimumab|mesh-list
64555050|NCT04194827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64555051|NCT04194827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64555052|NCT04194905|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64555053|NCT04194905|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64555054|NCT04194905|Levonorgestrel|levonorgestrel|mesh-list
64952392|NCT00030173|Antimitotic Agents|antimitotic agents|mesh-ancestor
64952393|NCT00030173|Mitosis Modulators|mitosis modulators|mesh-ancestor
64952394|NCT00030173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952395|NCT00030173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952396|NCT00057564|Thalidomide|thalidomide|mesh-list
64952397|NCT00057564|Dexamethasone|dexamethasone|mesh-list
64952398|NCT00057564|Dexamethasone acetate|dexamethasone acetate|mesh-list
64555055|NCT04194905|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64555056|NCT04194905|Estradiol|estradiol|mesh-list
64555057|NCT04194905|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64555058|NCT04194905|Estrogens|estrogens|mesh-ancestor
64555059|NCT04194905|Hormones|hormones|mesh-ancestor
64555060|NCT04194905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64555061|NCT04194905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555062|NCT04194905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64555063|NCT04194905|Contraceptive Agents|contraceptive agents|mesh-ancestor
64555064|NCT04194905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64555065|NCT04194905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64320201|NCT04593758|Hydroxychloroquine|hydroxychloroquine|mesh-list
64952400|NCT00057564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64952401|NCT00057564|Antiemetics|antiemetics|mesh-ancestor
64952402|NCT00057564|Autonomic Agents|autonomic agents|mesh-ancestor
64952403|NCT00057564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64952404|NCT00057564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952405|NCT00057564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64725811|NCT00003056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725812|NCT00003056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64725813|NCT00002185|Nelfinavir|nelfinavir|mesh-list
64725814|NCT00002185|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64555067|NCT04194905|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64555068|NCT04194905|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64555069|NCT05017428|Niacinamide|niacinamide|mesh-list
64555070|NCT05017428|Niacin|niacin|mesh-list
64725815|NCT00002185|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64725816|NCT00002185|Protease Inhibitors|protease inhibitors|mesh-ancestor
64725817|NCT00002185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725818|NCT00002185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725819|NCT00002185|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64555071|NCT05017428|Nicotinic Acids|nicotinic acids|mesh-list
64555072|NCT05017428|Vitamin B Complex|vitamin b complex|mesh-ancestor
64555073|NCT05017428|Vitamins|vitamins|mesh-ancestor
64555074|NCT05017428|Micronutrients|micronutrients|mesh-ancestor
64555075|NCT05017428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555076|NCT05017428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64555077|NCT05017428|Antimetabolites|antimetabolites|mesh-ancestor
64555078|NCT05017428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320208|NCT04593758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64320209|NCT05074706|Antibodies|antibodies|mesh-list
64952406|NCT00057564|Glucocorticoids|glucocorticoids|mesh-ancestor
64952407|NCT00057564|Hormones|hormones|mesh-ancestor
64952408|NCT00057564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64952409|NCT00057564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64952410|NCT00057564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555079|NCT05017428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64555080|NCT05017428|Vasodilator Agents|vasodilator agents|mesh-ancestor
64555081|NCT00013611|Aldesleukin|aldesleukin|mesh-list
64555082|NCT00013611|Interleukin-2|interleukin-2|mesh-list
64555083|NCT00013611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952411|NCT00057564|Protease Inhibitors|protease inhibitors|mesh-ancestor
64952412|NCT00057564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952413|NCT00057564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952414|NCT00057564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64555084|NCT00013611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64555086|NCT00013611|Sensory System Agents|sensory system agents|mesh-ancestor
64555087|NCT00013611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64555088|NCT00013611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555089|NCT00013611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64952415|NCT00057564|Immunologic Factors|immunologic factors|mesh-ancestor
64952416|NCT00057564|Leprostatic Agents|leprostatic agents|mesh-ancestor
64952417|NCT00057564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64952418|NCT00057564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64952419|NCT00057564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64555090|NCT00013611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64555091|NCT00013611|Antiviral Agents|antiviral agents|mesh-ancestor
64555092|NCT00013611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64555093|NCT04194515|Metformin|metformin|mesh-list
64555094|NCT04194515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64555095|NCT04194515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555096|NCT03094182|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
64555097|NCT03094182|Hematinics|hematinics|mesh-ancestor
64555098|NCT05017116|Entecavir|entecavir|mesh-list
64555099|NCT05017116|Antiviral Agents|antiviral agents|mesh-ancestor
64555100|NCT05017116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64555101|NCT05022030|Cetuximab|cetuximab|mesh-list
64555102|NCT05022030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64555103|NCT05022030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555104|NCT03845543|Paclitaxel|paclitaxel|mesh-list
64555105|NCT03845543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64555106|NCT03845543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555107|NCT03845543|Tubulin Modulators|tubulin modulators|mesh-ancestor
64555108|NCT03845543|Antimitotic Agents|antimitotic agents|mesh-ancestor
64555109|NCT03845543|Mitosis Modulators|mitosis modulators|mesh-ancestor
64555110|NCT03845543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555111|NCT04192643|Tranexamic Acid|tranexamic acid|mesh-list
64555112|NCT04192643|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64555113|NCT04192643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64320226|NCT02184559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64555120|NCT00010257|Paclitaxel|paclitaxel|mesh-list
64555121|NCT00010257|Carboplatin|carboplatin|mesh-list
64555122|NCT00010257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64555123|NCT00010257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555124|NCT00010257|Tubulin Modulators|tubulin modulators|mesh-ancestor
64555125|NCT00010257|Antimitotic Agents|antimitotic agents|mesh-ancestor
64555126|NCT00010257|Mitosis Modulators|mitosis modulators|mesh-ancestor
64555127|NCT00010257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555128|NCT05022186|Cannabidiol|cannabidiol|mesh-list
64952420|NCT00057564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64952421|NCT00057564|Growth Substances|growth substances|mesh-ancestor
64952422|NCT00057564|Growth Inhibitors|growth inhibitors|mesh-ancestor
64952423|NCT00030368|Paclitaxel|paclitaxel|mesh-list
64952424|NCT00030368|Bortezomib|bortezomib|mesh-list
64952425|NCT00030368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64952426|NCT00030368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952427|NCT00030368|Tubulin Modulators|tubulin modulators|mesh-ancestor
64952428|NCT00030368|Antimitotic Agents|antimitotic agents|mesh-ancestor
64952429|NCT00030368|Mitosis Modulators|mitosis modulators|mesh-ancestor
64952430|NCT00030368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555129|NCT05022186|Tramiprosate|tramiprosate|mesh-list
64555130|NCT05022186|Anticonvulsants|anticonvulsants|mesh-ancestor
64555131|NCT05022186|GABA Agonists|gaba agonists|mesh-ancestor
64555132|NCT05022186|GABA Agents|gaba agents|mesh-ancestor
64555133|NCT05022186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64555134|NCT05022186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555135|NCT05022186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555136|NCT02240043|Hormones|hormones|mesh-list
64555137|NCT02240043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64555138|NCT02240043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555139|NCT03404037|Endostatins|endostatins|mesh-list
64555140|NCT03404037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555141|NCT03404037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64555142|NCT03404037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64555143|NCT03404037|Growth Substances|growth substances|mesh-ancestor
64555144|NCT03404037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952431|NCT00030407|Celecoxib|celecoxib|mesh-list
64952432|NCT00030407|Docetaxel|docetaxel|mesh-list
64952433|NCT00030407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952434|NCT00030407|Tubulin Modulators|tubulin modulators|mesh-ancestor
64952435|NCT00030407|Antimitotic Agents|antimitotic agents|mesh-ancestor
64952436|NCT00030407|Mitosis Modulators|mitosis modulators|mesh-ancestor
64952437|NCT00030407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952438|NCT00030407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64952439|NCT00030407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64952440|NCT00030407|Analgesics|analgesics|mesh-ancestor
64952441|NCT00030407|Sensory System Agents|sensory system agents|mesh-ancestor
64952442|NCT00030407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64952443|NCT00030407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952447|NCT00030407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64952449|NCT00057642|Sertraline|sertraline|mesh-list
64952450|NCT00057642|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64555145|NCT03404037|Growth Inhibitors|growth inhibitors|mesh-ancestor
64555146|NCT02240199|Lidocaine|lidocaine|mesh-list
64555147|NCT02240199|Pregabalin|pregabalin|mesh-list
64555148|NCT02240199|Anesthetics, Local|anesthetics, local|mesh-ancestor
64555149|NCT02240199|Anesthetics|anesthetics|mesh-ancestor
64952455|NCT00057642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64952456|NCT00057642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952457|NCT00057642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64952458|NCT00057642|Serotonin Agents|serotonin agents|mesh-ancestor
64555150|NCT02240199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64555151|NCT02240199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555152|NCT02240199|Sensory System Agents|sensory system agents|mesh-ancestor
64555153|NCT02240199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64555154|NCT02240199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64555155|NCT02240199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64555156|NCT02240199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64555157|NCT02240199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64555158|NCT02240199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555159|NCT02240199|Analgesics|analgesics|mesh-ancestor
64555160|NCT02240199|Anticonvulsants|anticonvulsants|mesh-ancestor
64555161|NCT02240199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64555162|NCT02240199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64555163|NCT02240199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64555164|NCT02240199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64555165|NCT02240199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64555166|NCT04190927|Estradiol|estradiol|mesh-list
64555167|NCT04190927|Progesterone|progesterone|mesh-list
64555168|NCT04190927|Estrogens|estrogens|mesh-ancestor
64555169|NCT04190927|Hormones|hormones|mesh-ancestor
64555170|NCT04190927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64555171|NCT04190927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555174|NCT00919191|Tretinoin|tretinoin|mesh-list
64555175|NCT00919191|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64555176|NCT00919191|Dermatologic Agents|dermatologic agents|mesh-ancestor
64555177|NCT00919191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64555178|NCT00919191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64555179|NCT00919191|Analgesics|analgesics|mesh-ancestor
64555180|NCT00919191|Sensory System Agents|sensory system agents|mesh-ancestor
64555181|NCT00919191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64952459|NCT00057642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952460|NCT00057642|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64952461|NCT00057642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64952462|NCT00030446|Carboplatin|carboplatin|mesh-list
64952463|NCT00030446|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64952464|NCT00030446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725820|NCT00002185|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64725821|NCT00002185|Antiviral Agents|antiviral agents|mesh-ancestor
64725822|NCT00002185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725823|NCT05752279|Plasma-lyte 148|plasma-lyte 148|mesh-list
64555182|NCT00919191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555183|NCT00919191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64555184|NCT00919191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64555185|NCT00919191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555186|NCT00919191|Keratolytic Agents|keratolytic agents|mesh-ancestor
64555187|NCT03962465|Cytarabine|cytarabine|mesh-list
64555188|NCT03962465|Prednisone|prednisone|mesh-list
64555189|NCT03962465|Methotrexate|methotrexate|mesh-list
64555190|NCT03962465|Vincristine|vincristine|mesh-list
64555191|NCT03962465|Daunorubicin|daunorubicin|mesh-list
64555192|NCT03962465|Pegaspargase|pegaspargase|mesh-list
64555193|NCT03962465|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
64555194|NCT03962465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64555195|NCT03962465|Glucocorticoids|glucocorticoids|mesh-ancestor
64555196|NCT03962465|Hormones|hormones|mesh-ancestor
64555197|NCT03962465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64555198|NCT03962465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725824|NCT05752279|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64952465|NCT00030446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64952466|NCT00030446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952467|NCT00030446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952468|NCT00030485|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64952469|NCT00030485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952470|NCT00030485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64952471|NCT00030485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952472|NCT00030485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952473|NCT00057720|Doxorubicin|doxorubicin|mesh-list
64952474|NCT00057720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64952475|NCT00057720|Topotecan|topotecan|mesh-list
64952476|NCT00057720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64555199|NCT03962465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64555200|NCT03962465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555201|NCT03962465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64555202|NCT03962465|Abortifacient Agents|abortifacient agents|mesh-ancestor
64555203|NCT03962465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64555204|NCT03962465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64555205|NCT03962465|Antimetabolites|antimetabolites|mesh-ancestor
64555206|NCT03962465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952477|NCT00057720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952478|NCT00057720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64952479|NCT00057720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64555207|NCT03962465|Dermatologic Agents|dermatologic agents|mesh-ancestor
64555208|NCT03962465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555209|NCT03962465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64555210|NCT03962465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64555211|NCT03962465|Immunologic Factors|immunologic factors|mesh-ancestor
64555212|NCT03962465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64320342|NCT02573012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952480|NCT00057720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952481|NCT00057720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952482|NCT00057720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64952483|NCT00030524|Gefitinib|gefitinib|mesh-list
64952484|NCT00030524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952485|NCT00030524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64555213|NCT03962465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64555215|NCT03962465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64555216|NCT03962465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64555217|NCT03962465|Tubulin Modulators|tubulin modulators|mesh-ancestor
64555218|NCT03962465|Antimitotic Agents|antimitotic agents|mesh-ancestor
64320353|NCT02186275|Vitamin D|vitamin d|mesh-list
64952486|NCT00030524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555219|NCT03962465|Mitosis Modulators|mitosis modulators|mesh-ancestor
64555220|NCT03962465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64320355|NCT02186275|Cholecalciferol|cholecalciferol|mesh-list
64952487|NCT00030524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952488|NCT00030563|Irinotecan|irinotecan|mesh-list
64952489|NCT00030563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64952490|NCT00030563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64952491|NCT00030563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952492|NCT00030563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952493|NCT00030563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555221|NCT03962465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64555222|NCT03962465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64555223|NCT03962465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64555225|NCT05021406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64320357|NCT02186275|Micronutrients|micronutrients|mesh-ancestor
64952494|NCT00030602|Freund's Adjuvant|freund's adjuvant|mesh-list
64952495|NCT00030602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64952496|NCT00030602|Immunologic Factors|immunologic factors|mesh-ancestor
64952497|NCT00030602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952498|NCT00057759|Sildenafil Citrate|sildenafil citrate|mesh-list
64555227|NCT05021406|Adrenergic Agents|adrenergic agents|mesh-ancestor
64555228|NCT05021406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64555229|NCT05021406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555230|NCT05021406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555231|NCT05021406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64555232|NCT05021406|Antioxidants|antioxidants|mesh-ancestor
64555233|NCT05021406|Protective Agents|protective agents|mesh-ancestor
64320361|NCT05117281|Levobupivacaine|levobupivacaine|mesh-list
64320362|NCT05117281|Anesthetics, Local|anesthetics, local|mesh-ancestor
64320363|NCT05117281|Anesthetics|anesthetics|mesh-ancestor
64555234|NCT05021406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64555235|NCT05021406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64555236|NCT05021406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64555237|NCT05021406|Vasodilator Agents|vasodilator agents|mesh-ancestor
64555238|NCT05021406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64555239|NCT05021406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64555241|NCT04766177|Diuretics|diuretics|mesh-ancestor
64555242|NCT04766177|Natriuretic Agents|natriuretic agents|mesh-ancestor
64952499|NCT00057759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555243|NCT04766177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555244|NCT04766177|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64555245|NCT04766177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64555246|NCT04766177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555247|NCT04466280|Hydroxychloroquine|hydroxychloroquine|mesh-list
64555248|NCT04466280|Antimalarials|antimalarials|mesh-ancestor
64555249|NCT04466280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64555250|NCT04466280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64555251|NCT04466280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64555252|NCT04466280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555253|NCT04466280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555254|NCT04466280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64555255|NCT05016180|Ropivacaine|ropivacaine|mesh-list
64555263|NCT03023501|Analgesics|analgesics|mesh-ancestor
64555264|NCT03023501|Sensory System Agents|sensory system agents|mesh-ancestor
64555265|NCT03023501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64555266|NCT03023501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555268|NCT03023501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64952500|NCT00057759|Vasodilator Agents|vasodilator agents|mesh-ancestor
64952501|NCT00057759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64555269|NCT03023501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64555270|NCT03023501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64555271|NCT03023501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64555272|NCT03023501|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64555273|NCT03023501|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64952502|NCT00057759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64952503|NCT00057759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952504|NCT00057759|Urological Agents|urological agents|mesh-ancestor
64952505|NCT00030641|Docetaxel|docetaxel|mesh-list
64952506|NCT00030641|Oblimersen|oblimersen|mesh-list
64952507|NCT00030641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952508|NCT00030641|Tubulin Modulators|tubulin modulators|mesh-ancestor
64952509|NCT00030641|Antimitotic Agents|antimitotic agents|mesh-ancestor
64952510|NCT00030641|Mitosis Modulators|mitosis modulators|mesh-ancestor
64952511|NCT00030641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555274|NCT03023501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64555275|NCT03023501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555276|NCT03023501|Antimanic Agents|antimanic agents|mesh-ancestor
64555277|NCT05015322|Methylprednisolone|methylprednisolone|mesh-list
64555278|NCT05015322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64555279|NCT05015322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64555280|NCT05015322|Prednisolone|prednisolone|mesh-list
64952512|NCT00057798|Gemcitabine|gemcitabine|mesh-list
64952515|NCT00057798|Antimetabolites|antimetabolites|mesh-ancestor
64952526|NCT00057798|Antimitotic Agents|antimitotic agents|mesh-ancestor
64952527|NCT00057798|Mitosis Modulators|mitosis modulators|mesh-ancestor
64952529|NCT02969733|Ketamine|ketamine|mesh-list
64555281|NCT05015322|Prednisolone acetate|prednisolone acetate|mesh-list
64555282|NCT05015322|Bupivacaine|bupivacaine|mesh-list
64555283|NCT05015322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64555284|NCT05015322|Prednisolone phosphate|prednisolone phosphate|mesh-list
64555285|NCT05015322|Anesthetics, Local|anesthetics, local|mesh-ancestor
64555286|NCT05015322|Anesthetics|anesthetics|mesh-ancestor
64555287|NCT05015322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64555288|NCT05015322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555289|NCT05015322|Sensory System Agents|sensory system agents|mesh-ancestor
64320393|NCT04411706|Capecitabine|capecitabine|mesh-list
64320394|NCT04411706|Apatinib|apatinib|mesh-list
64952530|NCT02969733|Analgesics|analgesics|mesh-ancestor
64952531|NCT02969733|Sensory System Agents|sensory system agents|mesh-ancestor
64952532|NCT02969733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64725825|NCT05752279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64725826|NCT00003062|Temozolomide|temozolomide|mesh-list
64725827|NCT00003062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64725828|NCT00003062|Alkylating Agents|alkylating agents|mesh-ancestor
64725829|NCT00003062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555290|NCT05015322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64555291|NCT05015322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64555292|NCT05015322|Antiemetics|antiemetics|mesh-ancestor
64555293|NCT05015322|Autonomic Agents|autonomic agents|mesh-ancestor
64555294|NCT05015322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64725830|NCT00003062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725831|NCT00002191|Albendazole|albendazole|mesh-list
64725832|NCT00002191|Anthelmintics|anthelmintics|mesh-ancestor
64725833|NCT00002191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64555296|NCT05015322|Hormones|hormones|mesh-ancestor
64555297|NCT05015322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64555298|NCT05015322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64555299|NCT05015322|Protective Agents|protective agents|mesh-ancestor
64555300|NCT05015322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64555301|NCT05015322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555302|NCT04195139|Nivolumab|nivolumab|mesh-list
64555303|NCT04195139|Temozolomide|temozolomide|mesh-list
64555304|NCT04195139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64555326|NCT00919503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555327|NCT00919503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64555329|NCT00919503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555330|NCT00919503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555331|NCT00919503|Dermatologic Agents|dermatologic agents|mesh-ancestor
64555332|NCT00919503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320435|NCT02752633|Allopurinol|allopurinol|mesh-list
64555334|NCT00919503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64555335|NCT00919503|Immunologic Factors|immunologic factors|mesh-ancestor
64555336|NCT00919503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64555337|NCT00919503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64555338|NCT00919503|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64725834|NCT00002191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725835|NCT00002191|Anticestodal Agents|anticestodal agents|mesh-ancestor
64725836|NCT00002191|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64725837|NCT00002191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64725838|NCT00002191|Tubulin Modulators|tubulin modulators|mesh-ancestor
64725839|NCT00002191|Antimitotic Agents|antimitotic agents|mesh-ancestor
64725840|NCT00002191|Mitosis Modulators|mitosis modulators|mesh-ancestor
64555339|NCT00919503|Antifungal Agents|antifungal agents|mesh-ancestor
64555340|NCT00919503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64555341|NCT00919503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64555342|NCT00919503|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64555343|NCT00919503|Antitubercular Agents|antitubercular agents|mesh-ancestor
64555344|NCT00919503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64555345|NCT00919503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64555346|NCT00919503|Alkylating Agents|alkylating agents|mesh-ancestor
64555347|NCT00919503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64555348|NCT05020704|Empagliflozin|empagliflozin|mesh-list
64555349|NCT05020704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64555350|NCT05020704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555351|NCT05020704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64555352|NCT05020704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555353|NCT02979665|Ranibizumab|ranibizumab|mesh-list
64555354|NCT02979665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64555355|NCT02979665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64555356|NCT02979665|Growth Substances|growth substances|mesh-ancestor
64555376|NCT04374279|Androgen Antagonists|androgen antagonists|mesh-ancestor
64555377|NCT04374279|Hormone Antagonists|hormone antagonists|mesh-ancestor
64555378|NCT04374279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64555379|NCT04374279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555380|NCT04374279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320484|NCT04766996|Acetaminophen|acetaminophen|mesh-list
64725841|NCT00002191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725842|NCT00002191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952533|NCT02969733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952534|NCT02969733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64555382|NCT03957551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64555383|NCT03957551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555384|NCT02240433|Sorafenib|sorafenib|mesh-list
64555385|NCT02240433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555386|NCT02240433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64555387|NCT02240433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555388|NCT02240433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555389|NCT03403647|Vitamin D|vitamin d|mesh-list
64555390|NCT03403647|Vitamins|vitamins|mesh-ancestor
64555391|NCT03403647|Micronutrients|micronutrients|mesh-ancestor
64555392|NCT03403647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555393|NCT03403647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64555394|NCT05014464|Crizotinib|crizotinib|mesh-list
64555395|NCT05014464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555396|NCT05014464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64555397|NCT05014464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64555398|NCT05014464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555411|NCT00211757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64952535|NCT02969733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64952536|NCT02969733|Anesthetics, General|anesthetics, general|mesh-ancestor
64952537|NCT02969733|Anesthetics|anesthetics|mesh-ancestor
64952538|NCT02969733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64952539|NCT02969733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64952540|NCT02969733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64555412|NCT00211757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555413|NCT00211757|Antimanic Agents|antimanic agents|mesh-ancestor
64555414|NCT00211757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64555415|NCT00211757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64952541|NCT02969733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64952542|NCT02969733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952543|NCT02969733|Anesthetics, Local|anesthetics, local|mesh-ancestor
64952544|NCT02969733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64952545|NCT02969733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64952546|NCT02969733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64952547|NCT02969733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64952548|NCT00030719|Cyclophosphamide|cyclophosphamide|mesh-list
64952550|NCT00030719|Busulfan|busulfan|mesh-list
64952551|NCT00030719|Carboplatin|carboplatin|mesh-list
64952552|NCT00030719|Etoposide|etoposide|mesh-list
64952553|NCT00030719|Vincristine|vincristine|mesh-list
64952554|NCT00030719|Dinutuximab|dinutuximab|mesh-list
64952555|NCT00030719|Isotretinoin|isotretinoin|mesh-list
64952556|NCT00030719|Antibodies|antibodies|mesh-list
64952557|NCT00030719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64952558|NCT00030719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64952559|NCT00030719|Immunologic Factors|immunologic factors|mesh-ancestor
64952560|NCT00030719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952561|NCT00030719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64952562|NCT00030719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64952563|NCT00030719|Alkylating Agents|alkylating agents|mesh-ancestor
64952564|NCT00030719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952568|NCT00030719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64952569|NCT00030719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64555436|NCT04022057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64555438|NCT00921843|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64555439|NCT00921843|Narcotics|narcotics|mesh-ancestor
64555440|NCT00921843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64326813|NCT03134677|Sensory System Agents|sensory system agents|mesh-ancestor
64952570|NCT00030719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725843|NCT00383396|Cyclosporine|cyclosporine|mesh-list
64725844|NCT00383396|Cyclosporins|cyclosporins|mesh-list
64725845|NCT00383396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725846|NCT00383396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725847|NCT00383396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64725848|NCT00383396|Immunologic Factors|immunologic factors|mesh-ancestor
64725849|NCT00383396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725850|NCT00383396|Antifungal Agents|antifungal agents|mesh-ancestor
64952571|NCT00030719|Tubulin Modulators|tubulin modulators|mesh-ancestor
64952572|NCT00030719|Antimitotic Agents|antimitotic agents|mesh-ancestor
64952573|NCT00030719|Mitosis Modulators|mitosis modulators|mesh-ancestor
64952574|NCT00030719|Dermatologic Agents|dermatologic agents|mesh-ancestor
64952575|NCT00030758|Lenograstim|lenograstim|mesh-list
64952576|NCT00030758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64952577|NCT00030758|Immunologic Factors|immunologic factors|mesh-ancestor
64555449|NCT04020653|Artemether|artemether|mesh-list
64555450|NCT04020653|Artemisinins|artemisinins|mesh-list
64555451|NCT04020653|Artemisinin|artemisinin|mesh-list
64555452|NCT04020653|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64326821|NCT02164097|Heparin|heparin|mesh-list
64952578|NCT00030758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952579|NCT04730895|Tretinoin|tretinoin|mesh-list
64952580|NCT04730895|Isotretinoin|isotretinoin|mesh-list
64952581|NCT04730895|Vaccines|vaccines|mesh-list
64952582|NCT04730895|Myeloma Proteins|myeloma proteins|mesh-list
64952583|NCT04730895|Paraproteins|paraproteins|mesh-list
64952584|NCT04730895|Immunologic Factors|immunologic factors|mesh-ancestor
64952585|NCT04730895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952586|NCT04730895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952587|NCT04730895|Keratolytic Agents|keratolytic agents|mesh-ancestor
64952588|NCT04730895|Dermatologic Agents|dermatologic agents|mesh-ancestor
64952589|NCT00030797|Irinotecan|irinotecan|mesh-list
64952601|NCT00030914|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64503407|NCT01601236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64952603|NCT00030914|Medroxyprogesterone|medroxyprogesterone|mesh-list
64952604|NCT00030914|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64952605|NCT00030914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64952606|NCT00030914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64952607|NCT00030914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952608|NCT00030914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64555473|NCT05008458|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64555474|NCT05008458|Natriuretic Agents|natriuretic agents|mesh-ancestor
64555475|NCT05008458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952609|NCT00030914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952610|NCT00030914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64952611|NCT00030914|Antidepressive Agents|antidepressive agents|mesh-ancestor
64952612|NCT00030914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64952613|NCT00030914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64952614|NCT00030914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64952615|NCT00030914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64555492|NCT04029467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952616|NCT00030914|Contraceptive Agents|contraceptive agents|mesh-ancestor
64952617|NCT00030914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64952618|NCT00030914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64952619|NCT00030914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64952620|NCT00030914|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64952621|NCT00030914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64952622|NCT00030914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952623|NCT00058149|Gemcitabine|gemcitabine|mesh-list
64952624|NCT00058149|Oxaliplatin|oxaliplatin|mesh-list
64952625|NCT00058149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64952626|NCT00058149|Antimetabolites|antimetabolites|mesh-ancestor
64509181|NCT01933984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64555499|NCT04029467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64555500|NCT04029467|Adrenergic Agents|adrenergic agents|mesh-ancestor
64555501|NCT04029467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64320597|NCT02187523|Diuretics|diuretics|mesh-ancestor
64952627|NCT00058149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952628|NCT00058149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952629|NCT00058149|Antiviral Agents|antiviral agents|mesh-ancestor
64555502|NCT04029467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555503|NCT03402321|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
64555504|NCT03402321|Hemostatics|hemostatics|mesh-ancestor
64555505|NCT03402321|Coagulants|coagulants|mesh-ancestor
64555506|NCT03402165|Sofosbuvir|sofosbuvir|mesh-list
64555507|NCT03402165|Ledipasvir|ledipasvir|mesh-list
64555508|NCT03402165|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64952630|NCT00058149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64484486|NCT01965431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64484487|NCT01965431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64484488|NCT01965431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484489|NCT01965431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484490|NCT01965431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64555509|NCT03402165|Antiviral Agents|antiviral agents|mesh-ancestor
64555510|NCT03402165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64555511|NCT03402087|Leucovorin|leucovorin|mesh-list
64555512|NCT03402087|Methotrexate|methotrexate|mesh-list
64484523|NCT01973387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64484524|NCT01973231|Liraglutide|liraglutide|mesh-list
64484525|NCT01973231|Lixisenatide|lixisenatide|mesh-list
64484526|NCT01973231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64484527|NCT01973231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484528|NCT01973231|Incretins|incretins|mesh-ancestor
64484529|NCT01973231|Hormones|hormones|mesh-ancestor
64484530|NCT01973231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64484594|NCT03088930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64484595|NCT03088930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484596|NCT03088930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484597|NCT02152696|Methotrexate|methotrexate|mesh-list
64484598|NCT02152696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64484599|NCT02152696|Abortifacient Agents|abortifacient agents|mesh-ancestor
64484600|NCT02152696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64484601|NCT02152696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484602|NCT02152696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64484603|NCT02152696|Antimetabolites|antimetabolites|mesh-ancestor
64555527|NCT03402087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64555528|NCT03402087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64555529|NCT03402087|Antidotes|antidotes|mesh-ancestor
64484745|NCT01970501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64484746|NCT01970501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64484747|NCT01970501|Sympatholytics|sympatholytics|mesh-ancestor
64484969|NCT01702987|Coenzyme Q10|coenzyme q10|mesh-list
64484970|NCT01702987|Atorvastatin|atorvastatin|mesh-list
64484971|NCT01702987|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64484983|NCT00824044|Citalopram|citalopram|mesh-list
64555549|NCT05013060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555550|NCT05008068|Simvastatin|simvastatin|mesh-list
64555551|NCT05008068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64485137|NCT01737931|Antipruritics|antipruritics|mesh-ancestor
64485138|NCT01737931|Dermatologic Agents|dermatologic agents|mesh-ancestor
64485139|NCT01958489|Pravastatin|pravastatin|mesh-list
64485140|NCT01958489|Evacetrapib|evacetrapib|mesh-list
64485141|NCT01958489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64485298|NCT01941095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64485299|NCT01941095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64485416|NCT00835510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64485420|NCT00835510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485566|NCT00841828|Antimitotic Agents|antimitotic agents|mesh-ancestor
64485597|NCT00856024|Antimetabolites|antimetabolites|mesh-ancestor
64485599|NCT00856024|Antiviral Agents|antiviral agents|mesh-ancestor
64485733|NCT00814138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64485734|NCT00860938|Budesonide|budesonide|mesh-list
64485735|NCT00860938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64485893|NCT01718353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485987|NCT00818272|Dermatologic Agents|dermatologic agents|mesh-ancestor
64485988|NCT00818272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64485989|NCT00818272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64486065|NCT01592773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64486066|NCT01592773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64486067|NCT04124965|Rozanolixizumab|rozanolixizumab|mesh-list
64486068|NCT04124965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64486069|NCT04124965|Immunologic Factors|immunologic factors|mesh-ancestor
64486158|NCT01711879|Growth Substances|growth substances|mesh-ancestor
64486159|NCT01711879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486160|NCT01711879|Growth Inhibitors|growth inhibitors|mesh-ancestor
64486231|NCT00871624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64486232|NCT00871624|Analgesics|analgesics|mesh-ancestor
64486233|NCT00871624|Sensory System Agents|sensory system agents|mesh-ancestor
64555636|NCT04028141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64486514|NCT01910441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64486515|NCT01910441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64486516|NCT01910441|Immunologic Factors|immunologic factors|mesh-ancestor
64486517|NCT01910441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64486518|NCT01910441|Protease Inhibitors|protease inhibitors|mesh-ancestor
64486584|NCT01603615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64486585|NCT01603615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486586|NCT01603615|Cholinergic Agents|cholinergic agents|mesh-ancestor
64486617|NCT01921205|Lacosamide|lacosamide|mesh-list
64486686|NCT04088890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64486688|NCT00879190|Ampicillin|ampicillin|mesh-list
64486793|NCT01903031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64486794|NCT01903031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64486795|NCT01903031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64486798|NCT01903031|Hormones|hormones|mesh-ancestor
64486957|NCT03215446|Sevoflurane|sevoflurane|mesh-list
64487038|NCT01919411|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64487039|NCT01919411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64487040|NCT01919411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64487041|NCT01919411|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64487176|NCT03217084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487177|NCT00899470|Metformin|metformin|mesh-list
64487178|NCT00899470|Saxagliptin|saxagliptin|mesh-list
64487267|NCT01838200|BCG Vaccine|bcg vaccine|mesh-list
64487268|NCT01838200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64555700|NCT03022409|Olaparib|olaparib|mesh-list
64487326|NCT03830398|Acetaminophen|acetaminophen|mesh-list
64487327|NCT03830398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64487328|NCT03830398|Analgesics|analgesics|mesh-ancestor
64487329|NCT03830398|Sensory System Agents|sensory system agents|mesh-ancestor
64487330|NCT03830398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64487331|NCT03830398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487332|NCT03830398|Antipyretics|antipyretics|mesh-ancestor
64487333|NCT04405323|Itraconazole|itraconazole|mesh-list
64487335|NCT04405323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64487413|NCT04380298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64487484|NCT03210532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487485|NCT03210532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64487487|NCT03210532|Vasodilator Agents|vasodilator agents|mesh-ancestor
64487556|NCT05372991|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64487557|NCT05372991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64487558|NCT05372991|Cholinergic Agents|cholinergic agents|mesh-ancestor
64487559|NCT05372991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64487670|NCT01725802|Dopamine Agents|dopamine agents|mesh-ancestor
64487671|NCT01725802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64487672|NCT01725802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487675|NCT01725802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487749|NCT01836016|Respiratory System Agents|respiratory system agents|mesh-ancestor
64487750|NCT01836016|Dermatologic Agents|dermatologic agents|mesh-ancestor
64487751|NCT01836016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64487752|NCT01836016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64487753|NCT01836016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64487754|NCT01836016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64487755|NCT01836016|Adrenergic Agents|adrenergic agents|mesh-ancestor
64487845|NCT00913510|Cholinergic Agents|cholinergic agents|mesh-ancestor
64487849|NCT01727050|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64487924|NCT01725100|Antioxidants|antioxidants|mesh-ancestor
64487925|NCT01725412|Thiamine|thiamine|mesh-list
64487926|NCT01725412|Vitamin B Complex|vitamin b complex|mesh-ancestor
64487927|NCT01725412|Vitamins|vitamins|mesh-ancestor
64487928|NCT01725412|Micronutrients|micronutrients|mesh-ancestor
64488036|NCT01729468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64488037|NCT01729468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64488038|NCT01729468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64488057|NCT01714310|Antidepressive Agents|antidepressive agents|mesh-ancestor
64488139|NCT03407404|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64488141|NCT03407404|Anesthetics, General|anesthetics, general|mesh-ancestor
64555793|NCT02242383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555794|NCT02242383|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64714192|NCT02988050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64555795|NCT02242383|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64488290|NCT01712984|Hormone Antagonists|hormone antagonists|mesh-ancestor
64488291|NCT01712984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64488316|NCT01712516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64488317|NCT01712516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64488318|NCT01712516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64488319|NCT01712516|Cholinergic Agents|cholinergic agents|mesh-ancestor
64488383|NCT02241460|Anesthetics|anesthetics|mesh-ancestor
64488384|NCT02241460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64488385|NCT02241460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64555806|NCT03079830|Pirinitramide|pirinitramide|mesh-list
64555807|NCT03079830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64488595|NCT01701362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64488596|NCT01701362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64488597|NCT00919126|Xenon|xenon|mesh-list
64488599|NCT00919126|Anesthetics, General|anesthetics, general|mesh-ancestor
64488707|NCT02242396|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64488708|NCT02242396|Telmisartan|telmisartan|mesh-list
64488709|NCT02242396|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
64488710|NCT02242396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64488711|NCT02242396|Diuretics|diuretics|mesh-ancestor
64488835|NCT02243254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64488836|NCT03402880|Pembrolizumab|pembrolizumab|mesh-list
64488843|NCT01673997|Metoprolol|metoprolol|mesh-list
64488927|NCT01670175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64488928|NCT01670175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488929|NCT02243566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64488930|NCT02243566|Telmisartan|telmisartan|mesh-list
64488931|NCT02243566|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
64488932|NCT02243566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64488933|NCT02243566|Diuretics|diuretics|mesh-ancestor
64488934|NCT02243566|Natriuretic Agents|natriuretic agents|mesh-ancestor
64488935|NCT02243566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488936|NCT02243566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64488937|NCT02243566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64488938|NCT02243566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488958|NCT01988883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64488959|NCT01988883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488960|NCT01988883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488961|NCT01988883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64488962|NCT01988883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64488964|NCT01988883|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64488965|NCT01988883|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64488966|NCT01988883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64489005|NCT01709162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64489006|NCT01709162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489022|NCT04764045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64489023|NCT01698554|Bimatoprost|bimatoprost|mesh-list
64489100|NCT04373044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64489177|NCT03840915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64489178|NCT03748953|Ixazomib|ixazomib|mesh-list
64489184|NCT01567826|Atorvastatin|atorvastatin|mesh-list
64489270|NCT02245126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489271|NCT02245126|Sensory System Agents|sensory system agents|mesh-ancestor
64489273|NCT02245126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64489376|NCT02244190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64489377|NCT02244190|Antiviral Agents|antiviral agents|mesh-ancestor
64489378|NCT02244190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64489381|NCT00926380|Denosumab|denosumab|mesh-list
64489455|NCT04371874|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64489456|NCT04371874|Protease Inhibitors|protease inhibitors|mesh-ancestor
64489568|NCT04763265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64489569|NCT00004143|Alemtuzumab|alemtuzumab|mesh-list
64489572|NCT03705429|Paclitaxel|paclitaxel|mesh-list
64489647|NCT01592240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64489648|NCT03594747|Paclitaxel|paclitaxel|mesh-list
64489649|NCT03594747|Carboplatin|carboplatin|mesh-list
64489650|NCT03594747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64320967|NCT05509244|Acetaminophen|acetaminophen|mesh-list
64489739|NCT01591616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64489740|NCT01591616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489741|NCT01591616|Sensory System Agents|sensory system agents|mesh-ancestor
64555908|NCT02243241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64555909|NCT03076320|Adapalene|adapalene|mesh-list
64555913|NCT03076320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64555914|NCT03076320|Analgesics|analgesics|mesh-ancestor
64555915|NCT03076320|Sensory System Agents|sensory system agents|mesh-ancestor
64320982|NCT05502068|Vitamins|vitamins|mesh-ancestor
64489992|NCT01696058|Autonomic Agents|autonomic agents|mesh-ancestor
64490002|NCT04368520|Vitamin D|vitamin d|mesh-list
64555935|NCT04365309|Antipyretics|antipyretics|mesh-ancestor
64555936|NCT04365231|Azithromycin|azithromycin|mesh-list
64555937|NCT04365231|Hydroxychloroquine|hydroxychloroquine|mesh-list
64555938|NCT04365231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64555939|NCT04365231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64555940|NCT04365231|Antimalarials|antimalarials|mesh-ancestor
64490087|NCT00704769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64490155|NCT01677351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490158|NCT00938704|Glycerol|glycerol|mesh-list
64490231|NCT03553875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64490232|NCT04355416|Curcumin|curcumin|mesh-list
64490244|NCT03777813|Leucovorin|leucovorin|mesh-list
64490339|NCT04359862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64490340|NCT03568383|Pyridoxine|pyridoxine|mesh-list
64490341|NCT03568383|Pyridoxal|pyridoxal|mesh-list
64490343|NCT03568383|Isoniazid|isoniazid|mesh-list
64490458|NCT04601350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490459|NCT04601350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64490460|NCT04601350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64490461|NCT04601350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64490462|NCT04601350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64490586|NCT03422523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490658|NCT02245438|Norinyl|norinyl|mesh-list
64490659|NCT02245438|Estradiol|estradiol|mesh-list
64555983|NCT02243553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64555990|NCT02243553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64555991|NCT02243553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64490802|NCT03031054|Immunologic Factors|immunologic factors|mesh-ancestor
64490803|NCT03031054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490804|NCT03031054|Viscosupplements|viscosupplements|mesh-ancestor
64490910|NCT05099848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64490911|NCT05099848|Immunologic Factors|immunologic factors|mesh-ancestor
64490913|NCT05099848|Antidotes|antidotes|mesh-ancestor
64491129|NCT00953212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64491130|NCT00953212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64491230|NCT01678365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64491312|NCT03019822|Serotonin Agents|serotonin agents|mesh-ancestor
64491313|NCT03019822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64491314|NCT03019822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64491318|NCT00946348|Dronabinol|dronabinol|mesh-list
64556059|NCT02245269|Atorvastatin|atorvastatin|mesh-list
64556060|NCT02245269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64556061|NCT02245269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64556062|NCT02245269|Antimetabolites|antimetabolites|mesh-ancestor
64491472|NCT03085719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64491473|NCT03085719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491474|NCT03080259|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
64491475|NCT03080259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491476|NCT03084861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64491477|NCT03084861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64491478|NCT01006252|Paclitaxel|paclitaxel|mesh-list
64491479|NCT01006252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64491480|NCT01006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491481|NCT01006252|Tubulin Modulators|tubulin modulators|mesh-ancestor
64491483|NCT01006252|Mitosis Modulators|mitosis modulators|mesh-ancestor
64491484|NCT01006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491485|NCT03080805|Capecitabine|capecitabine|mesh-list
64556081|NCT04364139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64556082|NCT04364139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321143|NCT05261971|Analgesics|analgesics|mesh-ancestor
64491544|NCT03088293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64491545|NCT03088293|Dermatologic Agents|dermatologic agents|mesh-ancestor
64491546|NCT03088293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64491547|NCT01008280|Baclofen|baclofen|mesh-list
64491548|NCT01008280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64491549|NCT01008280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491550|NCT01008280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64491551|NCT01008280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64491552|NCT01008280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64491553|NCT01008280|GABA Agonists|gaba agonists|mesh-ancestor
64491554|NCT01008280|GABA Agents|gaba agents|mesh-ancestor
64491555|NCT01008280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64491647|NCT03088371|Sensory System Agents|sensory system agents|mesh-ancestor
64556083|NCT04364139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64491726|NCT05688345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491727|NCT05688345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64491728|NCT05688345|Anesthetics, General|anesthetics, general|mesh-ancestor
64491729|NCT05688345|Anesthetics|anesthetics|mesh-ancestor
64491730|NCT05688345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64491731|NCT05688345|Analgesics|analgesics|mesh-ancestor
64491732|NCT05688345|Sensory System Agents|sensory system agents|mesh-ancestor
64491733|NCT05688345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64491734|NCT05688345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64491735|NCT05688345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64491736|NCT05688345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64491737|NCT05688345|Adrenergic Agents|adrenergic agents|mesh-ancestor
64491738|NCT05688345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64491740|NCT03083457|Anesthetics|anesthetics|mesh-list
64556103|NCT02244255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64556104|NCT02244255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556105|NCT02244255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556106|NCT02244255|Urological Agents|urological agents|mesh-ancestor
64556107|NCT04363827|Hydroxychloroquine|hydroxychloroquine|mesh-list
64556108|NCT04363827|Antimalarials|antimalarials|mesh-ancestor
64556109|NCT04363827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64321169|NCT02206555|Antiviral Agents|antiviral agents|mesh-ancestor
64491820|NCT05678673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64556110|NCT04363827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64556111|NCT04363827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64556112|NCT04363827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556113|NCT04363827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556114|NCT04363827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64491821|NCT05678673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491822|NCT01017250|Bevacizumab|bevacizumab|mesh-list
64491823|NCT01017250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64491840|NCT00812032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64491841|NCT00812032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952631|NCT00058149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952632|NCT00058149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64952633|NCT00058149|Immunologic Factors|immunologic factors|mesh-ancestor
64952634|NCT00058149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952635|NCT00058227|Rituximab|rituximab|mesh-list
64952636|NCT00058227|Fludarabine|fludarabine|mesh-list
64952637|NCT00058227|Fludarabine phosphate|fludarabine phosphate|mesh-list
64952638|NCT00058227|Alvocidib|alvocidib|mesh-list
64420698|NCT03678025|Luteolytic Agents|luteolytic agents|mesh-ancestor
64725856|NCT00002197|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64725857|NCT00002197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64725858|NCT00002197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725859|NCT00002197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333364|NCT03250117|Ropinirole|ropinirole|mesh-list
64491842|NCT00812032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64491843|NCT00812032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64491945|NCT01018420|Tubulin Modulators|tubulin modulators|mesh-ancestor
64491946|NCT01018420|Antimitotic Agents|antimitotic agents|mesh-ancestor
64491947|NCT01018420|Mitosis Modulators|mitosis modulators|mesh-ancestor
64491948|NCT00974350|Bupivacaine|bupivacaine|mesh-list
64491949|NCT00974350|Anesthetics, Local|anesthetics, local|mesh-ancestor
64492031|NCT03371667|Dermatologic Agents|dermatologic agents|mesh-ancestor
64492032|NCT03371667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492033|NCT03371667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64492034|NCT03371667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64492035|NCT03371667|Immunologic Factors|immunologic factors|mesh-ancestor
64492036|NCT03371667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64492037|NCT03371667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64492038|NCT01024738|Chlorhexidine|chlorhexidine|mesh-list
64492039|NCT01024738|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64492040|NCT01024738|Triclosan|triclosan|mesh-list
64492198|NCT01027000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64492199|NCT01027000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64492200|NCT01027000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64492201|NCT01027000|Antifungal Agents|antifungal agents|mesh-ancestor
64492202|NCT05685615|Polymyxins|polymyxins|mesh-list
64492203|NCT05685615|Polymyxin B|polymyxin b|mesh-list
64492204|NCT05685615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64492205|NCT05685615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64492206|NCT01027468|Bevacizumab|bevacizumab|mesh-list
64492279|NCT00980746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64492280|NCT00980746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492386|NCT01897727|Diuretics|diuretics|mesh-ancestor
64492419|NCT01896869|Ipilimumab|ipilimumab|mesh-list
64492466|NCT03262779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492467|NCT03262779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64492468|NCT03262779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492551|NCT03016468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64492552|NCT00997204|Icatibant|icatibant|mesh-list
64492642|NCT04021264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64492643|NCT04021264|Narcotics|narcotics|mesh-ancestor
64492715|NCT04746183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64492775|NCT04197310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492776|NCT04197310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64492777|NCT04197310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492778|NCT05320731|Lidocaine|lidocaine|mesh-list
64492779|NCT05320731|Anesthetics, Local|anesthetics, local|mesh-ancestor
64492780|NCT05320731|Anesthetics|anesthetics|mesh-ancestor
64492866|NCT03016000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64492867|NCT03016000|Growth Substances|growth substances|mesh-ancestor
64492868|NCT03016000|Growth Inhibitors|growth inhibitors|mesh-ancestor
64492937|NCT04613453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64492938|NCT04613453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64492939|NCT04613453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64492940|NCT04613453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492941|NCT04613453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64492942|NCT04613453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64492943|NCT04613453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64493004|NCT03015922|Lenalidomide|lenalidomide|mesh-list
64493109|NCT01882829|Cholinergic Agents|cholinergic agents|mesh-ancestor
64556265|NCT00927849|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64556268|NCT04149587|Brodalumab|brodalumab|mesh-list
64493271|NCT01059682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64493272|NCT01059682|Antimetabolites|antimetabolites|mesh-ancestor
64493285|NCT01892345|Eculizumab|eculizumab|mesh-list
64493350|NCT01062568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556342|NCT04024241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64556343|NCT04024241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64556344|NCT04024241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64556345|NCT04024241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493429|NCT01064830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64493430|NCT01064830|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64493431|NCT01890785|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64493432|NCT01890785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64493433|NCT01890785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493501|NCT01069354|Lidocaine|lidocaine|mesh-list
64493502|NCT01069354|Anesthetics, Local|anesthetics, local|mesh-ancestor
64493581|NCT03013036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64493582|NCT03013036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64493583|NCT03013036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64493584|NCT03013036|GABA Modulators|gaba modulators|mesh-ancestor
64493585|NCT03013036|GABA Agents|gaba agents|mesh-ancestor
64493655|NCT01122160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64493787|NCT01877915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64493788|NCT01877915|Antithrombins|antithrombins|mesh-ancestor
64493789|NCT01877915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64493790|NCT01877915|Protease Inhibitors|protease inhibitors|mesh-ancestor
64493861|NCT03182673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493863|NCT03182673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493941|NCT01082380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64493942|NCT01082380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494049|NCT01090180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64494050|NCT01090180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494137|NCT00635349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64494138|NCT00635349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494139|NCT00635349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494140|NCT00634803|Buprenorphine|buprenorphine|mesh-list
64494141|NCT00634803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64494143|NCT00634803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64494144|NCT00634803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556424|NCT04022525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64556425|NCT04022525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64556426|NCT04022525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64556427|NCT04022525|Immunologic Factors|immunologic factors|mesh-ancestor
64556428|NCT04022525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64556429|NCT04022291|Insulin|insulin|mesh-list
64556430|NCT04022291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64494262|NCT03683524|Protease Inhibitors|protease inhibitors|mesh-ancestor
64494263|NCT03683524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64494264|NCT03683524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64494265|NCT02246842|Immunoglobulins|immunoglobulins|mesh-list
64494266|NCT02246842|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64494267|NCT02246842|Antibodies|antibodies|mesh-list
64494268|NCT02246842|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64494269|NCT02246842|gamma-Globulins|gamma-globulins|mesh-list
64494328|NCT01165840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64494329|NCT00952692|Lapatinib|lapatinib|mesh-list
64494330|NCT00952692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494331|NCT00952692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64494332|NCT00952692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494333|NCT00952692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494334|NCT03535506|Palbociclib|palbociclib|mesh-list
64494335|NCT03535506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494336|NCT03535506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64494337|NCT03535506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494399|NCT01133158|Mitoxantrone|mitoxantrone|mesh-list
64494400|NCT01133158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64494401|NCT01133158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494402|NCT01133158|Immunologic Factors|immunologic factors|mesh-ancestor
64494403|NCT01133158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494404|NCT01133158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64494405|NCT01133158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64494406|NCT01133158|Antiemetics|antiemetics|mesh-ancestor
64494454|NCT01175902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494455|NCT01175902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494456|NCT01175902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64494457|NCT01175902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64494458|NCT01175902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64494459|NCT01175902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64494460|NCT01175902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64494461|NCT01175902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494462|NCT01135186|Verapamil|verapamil|mesh-list
64494463|NCT01135186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64494464|NCT01135186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64556477|NCT03072264|Fluoxetine|fluoxetine|mesh-list
64494532|NCT01175980|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64494534|NCT01175980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494535|NCT04246554|Acetaminophen|acetaminophen|mesh-list
64494536|NCT04246554|Ketorolac|ketorolac|mesh-list
64494537|NCT04246554|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64494538|NCT04246554|Oxycodone|oxycodone|mesh-list
64494539|NCT04246554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64494580|NCT00634179|Bortezomib|bortezomib|mesh-list
64494632|NCT01180036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64494633|NCT01180036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494738|NCT05439798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64556507|NCT04361721|Sensory System Agents|sensory system agents|mesh-ancestor
64556508|NCT04361721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321587|NCT02205151|Amlodipine|amlodipine|mesh-list
64323119|NCT04057131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64323120|NCT04057131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64328537|NCT00449605|Rimonabant|rimonabant|mesh-list
64328731|NCT05149365|Hormones|hormones|mesh-ancestor
64328896|NCT02177825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64328897|NCT02177825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329871|NCT02380053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668600|NCT01695668|Cyclosporins|cyclosporins|mesh-list
64668601|NCT01695668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393952|NCT03169777|Leucovorin|leucovorin|mesh-list
64668602|NCT01695668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668604|NCT01695668|Immunologic Factors|immunologic factors|mesh-ancestor
64668713|NCT01938989|Sympathomimetics|sympathomimetics|mesh-ancestor
64668714|NCT01938989|Autonomic Agents|autonomic agents|mesh-ancestor
64668829|NCT02343120|Zanubrutinib|zanubrutinib|mesh-list
64668887|NCT03129945|Gout Suppressants|gout suppressants|mesh-ancestor
64668888|NCT03129945|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64668918|NCT05482451|Nivolumab|nivolumab|mesh-list
64668956|NCT02342886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64668968|NCT02342886|Antimetabolites|antimetabolites|mesh-ancestor
64669060|NCT05727449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64669061|NCT05727449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669155|NCT01705964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669156|NCT01705964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669157|NCT01705964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64669424|NCT05316935|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64669455|NCT01642238|Aspirin|aspirin|mesh-list
64669529|NCT05736419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64669530|NCT05736419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64669531|NCT05736419|Alkylating Agents|alkylating agents|mesh-ancestor
64669532|NCT05736419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669533|NCT05736419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669534|NCT05736419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64669536|NCT05736419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64669660|NCT01651442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64669661|NCT01651442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669734|NCT04799015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669869|NCT02988843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64669874|NCT01661270|Aflibercept|aflibercept|mesh-list
64669923|NCT01662908|Antithrombins|antithrombins|mesh-ancestor
64669951|NCT05183828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64670026|NCT01667978|Norethindrone Acetate|norethindrone acetate|mesh-list
64670138|NCT00375687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670139|NCT00375687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64670210|NCT02296775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670211|NCT02296775|Immunologic Factors|immunologic factors|mesh-ancestor
64670212|NCT02296775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670213|NCT02296775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64670295|NCT02249936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670342|NCT01683422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670343|NCT01683422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670344|NCT01683422|Antiviral Agents|antiviral agents|mesh-ancestor
64670345|NCT01683422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64670346|NCT01683422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670347|NCT01683422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64670348|NCT01683422|Immunologic Factors|immunologic factors|mesh-ancestor
64670349|NCT01683422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670361|NCT05066061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670362|NCT05066061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64670413|NCT02249546|Protective Agents|protective agents|mesh-ancestor
64670428|NCT02333045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64670429|NCT02333045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64670431|NCT02333045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670439|NCT01684748|Olmesartan|olmesartan|mesh-list
64670504|NCT01685996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64670505|NCT01685996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670601|NCT04499573|Etoposide|etoposide|mesh-list
64670602|NCT04499573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64670721|NCT00376155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64670795|NCT02306759|Anesthetics|anesthetics|mesh-ancestor
64670798|NCT02306759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64670885|NCT01963481|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64670886|NCT01963481|Hormone Antagonists|hormone antagonists|mesh-ancestor
64670888|NCT04436744|Palbociclib|palbociclib|mesh-list
64670975|NCT04153760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64670976|NCT04153760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64556877|NCT04367025|Oxaliplatin|oxaliplatin|mesh-list
64556886|NCT04143581|Empagliflozin|empagliflozin|mesh-list
64556889|NCT04143581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64671175|NCT02067416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671176|NCT02067416|Tubulin Modulators|tubulin modulators|mesh-ancestor
64671184|NCT03258645|Dabigatran|dabigatran|mesh-list
64671297|NCT03496545|Hormone Antagonists|hormone antagonists|mesh-ancestor
64671298|NCT03496545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64671413|NCT01717898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64671498|NCT02400437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64671501|NCT02400437|Hormones|hormones|mesh-ancestor
64671603|NCT01744730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64671604|NCT01744730|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64671688|NCT05718869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671689|NCT05718869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671771|NCT05718323|Niraparib|niraparib|mesh-list
64556964|NCT00936663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64556965|NCT00936663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64671917|NCT01749956|Antimetabolites|antimetabolites|mesh-ancestor
64671918|NCT01749956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671994|NCT02366663|Etoposide|etoposide|mesh-list
64671995|NCT02366663|Melphalan|melphalan|mesh-list
64671996|NCT02366663|Carmustine|carmustine|mesh-list
64672074|NCT02373137|Cholinergic Agents|cholinergic agents|mesh-ancestor
64557043|NCT05582837|Nortriptyline|nortriptyline|mesh-list
64557044|NCT05582837|Anticonvulsants|anticonvulsants|mesh-ancestor
64322086|NCT02396043|Abortifacient Agents|abortifacient agents|mesh-ancestor
64672234|NCT02383043|Anesthetics|anesthetics|mesh-ancestor
64672236|NCT02383043|Sensory System Agents|sensory system agents|mesh-ancestor
64672237|NCT02383043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64672238|NCT01768520|Celecoxib|celecoxib|mesh-list
64672239|NCT01768520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64672240|NCT01768520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64672310|NCT01771952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672311|NCT01771952|Viscosupplements|viscosupplements|mesh-ancestor
64672312|NCT01771952|Protective Agents|protective agents|mesh-ancestor
64672313|NCT02389361|Acetaminophen|acetaminophen|mesh-list
64672314|NCT02389361|Tramadol|tramadol|mesh-list
64672315|NCT02389361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64672316|NCT02389361|Analgesics|analgesics|mesh-ancestor
64672317|NCT02389361|Sensory System Agents|sensory system agents|mesh-ancestor
64672318|NCT02389361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64672319|NCT02389361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672320|NCT02389361|Antipyretics|antipyretics|mesh-ancestor
64672321|NCT02389361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64672382|NCT02236910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672383|NCT04873349|Oleuropein|oleuropein|mesh-list
64672384|NCT04873349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64672385|NCT04873349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64672386|NCT04873349|Vasodilator Agents|vasodilator agents|mesh-ancestor
64672387|NCT01780454|Rituximab|rituximab|mesh-list
64672388|NCT01780454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64672393|NCT04869449|Ketoconazole|ketoconazole|mesh-list
64672475|NCT03785405|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64672476|NCT03785405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672553|NCT04296695|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64672554|NCT04296695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64672660|NCT04071821|Histamine Agents|histamine agents|mesh-ancestor
64672664|NCT03064295|Adenosine|adenosine|mesh-list
64672755|NCT03500289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64672832|NCT01798550|Enoxaparin|enoxaparin|mesh-list
64672833|NCT01798550|Anticoagulants|anticoagulants|mesh-ancestor
64557118|NCT04141553|Diltiazem|diltiazem|mesh-list
64672883|NCT01815008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64672894|NCT01801124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64672895|NCT01801124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672896|NCT01801124|Sensory System Agents|sensory system agents|mesh-ancestor
64672968|NCT03336645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64672969|NCT03336645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64673046|NCT03522441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673047|NCT03530631|Adderall|adderall|mesh-list
64673116|NCT03357393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64673117|NCT03357393|Anesthetics, General|anesthetics, general|mesh-ancestor
64673118|NCT03357393|Anesthetics|anesthetics|mesh-ancestor
64673119|NCT03357393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64673120|NCT03357393|Narcotics|narcotics|mesh-ancestor
64557200|NCT05002686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557201|NCT05002686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64557202|NCT05002686|Antimetabolites|antimetabolites|mesh-ancestor
64557203|NCT03588689|Ropivacaine|ropivacaine|mesh-list
64557204|NCT03588689|Anesthetics, Local|anesthetics, local|mesh-ancestor
64557205|NCT03588689|Anesthetics|anesthetics|mesh-ancestor
64557206|NCT03588689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64557207|NCT03588689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673247|NCT02338362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64673248|NCT02338362|Autonomic Agents|autonomic agents|mesh-ancestor
64673249|NCT02338362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64673250|NCT02338362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673251|NCT02338362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64673252|NCT02338362|Respiratory System Agents|respiratory system agents|mesh-ancestor
64673253|NCT02338362|Dermatologic Agents|dermatologic agents|mesh-ancestor
64673255|NCT02360280|Midazolam|midazolam|mesh-list
64673307|NCT01822886|Romidepsin|romidepsin|mesh-list
64673308|NCT01822886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64557304|NCT03585569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64557305|NCT03585569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64673385|NCT05748236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673386|NCT05748236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64673452|NCT03383523|Praziquantel|praziquantel|mesh-list
64673453|NCT03383523|Emodepside|emodepside|mesh-list
64673588|NCT04392141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673593|NCT00559364|Omeprazole|omeprazole|mesh-list
64557365|NCT05702957|Fertility Agents|fertility agents|mesh-ancestor
64484468|NCT01727713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64484469|NCT01727713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64484470|NCT04658927|Dexamethasone|dexamethasone|mesh-list
64484471|NCT04658927|Prednisone|prednisone|mesh-list
64484472|NCT04658927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64484473|NCT04658927|Antiemetics|antiemetics|mesh-ancestor
64484474|NCT04658927|Autonomic Agents|autonomic agents|mesh-ancestor
64322421|NCT03543683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64673717|NCT02303262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714203|NCT02988050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64714204|NCT02988050|Narcotics|narcotics|mesh-ancestor
64714243|NCT02935699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64673881|NCT00557492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64714271|NCT02841241|Adrenergic Agents|adrenergic agents|mesh-ancestor
64673912|NCT04203225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64673914|NCT04203225|Autonomic Agents|autonomic agents|mesh-ancestor
64673973|NCT03701061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674039|NCT04149405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674045|NCT03717051|Nicotine|nicotine|mesh-list
64714367|NCT03108482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64674138|NCT03054038|Afatinib|afatinib|mesh-list
64674181|NCT04041453|Tubulin Modulators|tubulin modulators|mesh-ancestor
64674182|NCT04041453|Antimitotic Agents|antimitotic agents|mesh-ancestor
64714418|NCT02876900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64674287|NCT03848871|Betamethasone|betamethasone|mesh-list
64674288|NCT03848871|Betamethasone Valerate|betamethasone valerate|mesh-list
64674291|NCT03848871|Calcipotriene|calcipotriene|mesh-list
64714458|NCT03118466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64674346|NCT03852537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64714506|NCT05405270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714507|NCT05405270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674540|NCT03193190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64674545|NCT03193190|Vitamins|vitamins|mesh-ancestor
64674629|NCT02648282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64714556|NCT02946073|Narcotics|narcotics|mesh-ancestor
64714562|NCT02946073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64714563|NCT03071744|Fentanyl|fentanyl|mesh-list
64714564|NCT03071744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64714585|NCT03074630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64714586|NCT03074630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714588|NCT05404334|Hormones|hormones|mesh-ancestor
64714619|NCT03088345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714620|NCT03127514|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64674892|NCT01882868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674893|NCT01882868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674894|NCT01882868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675023|NCT02326272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675024|NCT02326272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64675025|NCT02325414|Zoledronic Acid|zoledronic acid|mesh-list
64675107|NCT01893632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675165|NCT01189071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675245|NCT00552032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64675246|NCT00552032|Dermatologic Agents|dermatologic agents|mesh-ancestor
64675247|NCT00552032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64675248|NCT02429583|Vaccines|vaccines|mesh-list
64675249|NCT02429583|Immunologic Factors|immunologic factors|mesh-ancestor
64675251|NCT02413047|Methotrexate|methotrexate|mesh-list
64675331|NCT03020030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64675332|NCT03020030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675333|NCT03020030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64675414|NCT01048125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675456|NCT01902758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675457|NCT01902758|Vasodilator Agents|vasodilator agents|mesh-ancestor
64675524|NCT02266797|Antiemetics|antiemetics|mesh-ancestor
64675660|NCT03723447|Anesthetics|anesthetics|mesh-ancestor
64675661|NCT03723447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64714897|NCT04468568|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64714898|NCT04468568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64714899|NCT04468568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64714900|NCT04468568|Adrenergic Agents|adrenergic agents|mesh-ancestor
64714901|NCT04468568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64714902|NCT04468568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714903|NCT04468568|Hormone Antagonists|hormone antagonists|mesh-ancestor
64675715|NCT03701295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675716|NCT03701295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675717|NCT03701295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675718|NCT00799773|Rituximab|rituximab|mesh-list
64675719|NCT00799773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64675720|NCT00799773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675721|NCT00799773|Immunologic Factors|immunologic factors|mesh-ancestor
64675722|NCT00799773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675723|NCT00799773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64675724|NCT00765765|Hydroxychloroquine|hydroxychloroquine|mesh-list
64675725|NCT00765765|Antimalarials|antimalarials|mesh-ancestor
64714921|NCT03168308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714922|NCT03168308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64675751|NCT01941615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64675752|NCT01941615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675753|NCT01941615|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64675755|NCT01941615|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64675756|NCT01941615|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64675757|NCT01941615|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64675758|NCT01941615|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
64675759|NCT01941615|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64675760|NCT01941615|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64675761|NCT01901679|Celecoxib|celecoxib|mesh-list
64675762|NCT01901679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64675763|NCT01901679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64714946|NCT03174158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64714947|NCT03174158|Autonomic Agents|autonomic agents|mesh-ancestor
64675805|NCT00642603|Bevacizumab|bevacizumab|mesh-list
64675806|NCT00642603|Capecitabine|capecitabine|mesh-list
64675807|NCT00642603|Oxaliplatin|oxaliplatin|mesh-list
64675808|NCT00642603|Irinotecan|irinotecan|mesh-list
64675809|NCT00642603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64715029|NCT03795350|Adrenergic Agents|adrenergic agents|mesh-ancestor
64715030|NCT03795350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64715031|NCT03795350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64715032|NCT03795350|Anticonvulsants|anticonvulsants|mesh-ancestor
64715033|NCT03795350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64454357|NCT02015195|Ethanol|ethanol|mesh-list
64715046|NCT03624062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715047|NCT05364866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64715069|NCT03122587|Micronutrients|micronutrients|mesh-ancestor
64715070|NCT03122587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675959|NCT01598025|Fludarabine|fludarabine|mesh-list
64676027|NCT00357617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64676028|NCT00357617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64676029|NCT00357617|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64676114|NCT01692171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64676115|NCT01692171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676119|NCT05721755|Paclitaxel|paclitaxel|mesh-list
64676327|NCT00183963|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64676457|NCT00000123|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64676458|NCT00000123|Protective Agents|protective agents|mesh-ancestor
64676460|NCT00380133|Prednisolone|prednisolone|mesh-list
64676519|NCT02681211|Dopamine Agents|dopamine agents|mesh-ancestor
64676520|NCT00000195|Naltrexone|naltrexone|mesh-list
64676521|NCT00000195|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64676605|NCT01692717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64715137|NCT03087578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64715159|NCT02975557|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64715160|NCT02975557|Lubricant Eye Drops|lubricant eye drops|mesh-list
64676731|NCT02322216|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64715227|NCT02002130|Histamine Agents|histamine agents|mesh-ancestor
64676868|NCT00000801|Hormones|hormones|mesh-ancestor
64676869|NCT00000801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64676870|NCT00000801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64676871|NCT00000801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64715274|NCT05113004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64715280|NCT02983981|Desoximetasone|desoximetasone|mesh-list
64676966|NCT00000279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64676967|NCT00000279|Sympatholytics|sympatholytics|mesh-ancestor
64676968|NCT00000279|Autonomic Agents|autonomic agents|mesh-ancestor
64676971|NCT00000279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64677019|NCT05362487|Cholinergic Agents|cholinergic agents|mesh-ancestor
64677020|NCT05362487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64677089|NCT00001827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677090|NCT00001827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677199|NCT05530655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677204|NCT00000921|Prednisone|prednisone|mesh-list
64677228|NCT00000939|Didanosine|didanosine|mesh-list
64677229|NCT00000939|Hydroxyurea|hydroxyurea|mesh-list
64677230|NCT00000939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64677232|NCT00000939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677308|NCT00001893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64677377|NCT00359177|Autonomic Agents|autonomic agents|mesh-ancestor
64677378|NCT00359177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64715503|NCT03347929|Gout Suppressants|gout suppressants|mesh-ancestor
64715504|NCT03347929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64715505|NCT03347929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715525|NCT04736719|Antithrombins|antithrombins|mesh-ancestor
64677596|NCT00002013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64715589|NCT03198884|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64715590|NCT03198884|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64323886|NCT02521285|Antipyretics|antipyretics|mesh-ancestor
64677705|NCT05270057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484376|NCT01729819|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64677877|NCT00002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677878|NCT00002079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64677879|NCT00002079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64677955|NCT00001437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677957|NCT00001437|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64715632|NCT00716755|Risperidone|risperidone|mesh-list
64715633|NCT00716755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64678027|NCT00359567|Serotonin Agents|serotonin agents|mesh-ancestor
64454955|NCT04060342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64715635|NCT00716755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64678143|NCT00001629|Protease Inhibitors|protease inhibitors|mesh-ancestor
64678144|NCT00001629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678145|NCT00001629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678148|NCT00002139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64678220|NCT00002319|Doxorubicin|doxorubicin|mesh-list
64678290|NCT02293902|Methotrexate|methotrexate|mesh-list
64678291|NCT02293902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64678292|NCT02293902|Abortifacient Agents|abortifacient agents|mesh-ancestor
64715714|NCT02076217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64715715|NCT02076217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64715721|NCT02076217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678395|NCT00002367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64678454|NCT00002199|Lamivudine|lamivudine|mesh-list
64678455|NCT00002199|Zidovudine|zidovudine|mesh-list
64678456|NCT00002199|Abacavir|abacavir|mesh-list
64678522|NCT00002409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64715790|NCT03185065|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64715791|NCT03185065|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64715792|NCT03185065|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64678629|NCT00002433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678630|NCT00002433|Antiviral Agents|antiviral agents|mesh-ancestor
64678631|NCT00002433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678695|NCT00002241|Ritonavir|ritonavir|mesh-list
64678696|NCT00002241|Indinavir|indinavir|mesh-list
64678697|NCT00002241|Lamivudine|lamivudine|mesh-list
64678698|NCT00002241|Stavudine|stavudine|mesh-list
64678699|NCT00002241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64678760|NCT04500899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64678770|NCT00002247|Ganciclovir|ganciclovir|mesh-list
64678819|NCT00002481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678828|NCT04862585|Diphenhydramine|diphenhydramine|mesh-list
64678829|NCT04862585|Promethazine|promethazine|mesh-list
64678887|NCT00002487|Immunologic Factors|immunologic factors|mesh-ancestor
64678888|NCT00002487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64678893|NCT00002493|Doxorubicin|doxorubicin|mesh-list
64678952|NCT00002505|Interferon-gamma|interferon-gamma|mesh-list
64678953|NCT00002505|Vaccines|vaccines|mesh-list
64678954|NCT00002505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678955|NCT00002505|Antiviral Agents|antiviral agents|mesh-ancestor
64678956|NCT00002505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64679038|NCT04469075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64679039|NCT04469075|Glucocorticoids|glucocorticoids|mesh-ancestor
64679040|NCT04469075|Hormones|hormones|mesh-ancestor
64679108|NCT00002283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679109|NCT00002283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679110|NCT00002283|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64679113|NCT00002283|Leprostatic Agents|leprostatic agents|mesh-ancestor
64679185|NCT00002547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64679202|NCT00002553|Cobalt|cobalt|mesh-list
64679259|NCT00002565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64679260|NCT00002565|Tubulin Modulators|tubulin modulators|mesh-ancestor
64679261|NCT00002565|Antimitotic Agents|antimitotic agents|mesh-ancestor
64679262|NCT00002565|Mitosis Modulators|mitosis modulators|mesh-ancestor
64679263|NCT00002565|Antiemetics|antiemetics|mesh-ancestor
64679383|NCT00002595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64715953|NCT02157948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64715954|NCT03220958|Diphenhydramine|diphenhydramine|mesh-list
64679546|NCT05806476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679547|NCT05806476|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64679580|NCT05806307|Mydriatics|mydriatics|mesh-ancestor
64679623|NCT05806047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64679624|NCT05806047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679756|NCT05775237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679815|NCT05751044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64679912|NCT05627635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64405259|NCT05057845|Lenvatinib|lenvatinib|mesh-list
64679913|NCT05627635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64679927|NCT05607004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64716050|NCT03228914|Respiratory System Agents|respiratory system agents|mesh-ancestor
64716051|NCT03228914|Mydriatics|mydriatics|mesh-ancestor
64680074|NCT05286814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64680161|NCT05201066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680162|NCT05201066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680163|NCT05201066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680194|NCT05045950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64680195|NCT05045950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64680311|NCT04696146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680312|NCT04696146|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64680513|NCT04220021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64680514|NCT04220021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680524|NCT04186299|Clonidine|clonidine|mesh-list
64680594|NCT04165070|Antimitotic Agents|antimitotic agents|mesh-ancestor
64680595|NCT04165070|Mitosis Modulators|mitosis modulators|mesh-ancestor
64680596|NCT04165070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680833|NCT03555916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64680834|NCT03555916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64680835|NCT03555916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64681014|NCT02624518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681015|NCT02624518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681128|NCT01370811|Analgesics|analgesics|mesh-ancestor
64681129|NCT01370811|Sensory System Agents|sensory system agents|mesh-ancestor
64681130|NCT01370811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64716198|NCT03249272|Vasodilator Agents|vasodilator agents|mesh-ancestor
64716199|NCT03249272|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64681301|NCT00390793|Dasatinib|dasatinib|mesh-list
64681302|NCT00390793|BB 1101|bb 1101|mesh-list
64681303|NCT00390793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64681304|NCT00390793|Immunologic Factors|immunologic factors|mesh-ancestor
64681305|NCT00390793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681386|NCT00002643|Mitosis Modulators|mitosis modulators|mesh-ancestor
64681387|NCT00002643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64681388|NCT00002643|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64681389|NCT00002643|Protective Agents|protective agents|mesh-ancestor
64681471|NCT00002679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64681472|NCT00002679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64681557|NCT00002697|Alkylating Agents|alkylating agents|mesh-ancestor
64681558|NCT04488601|Sirolimus|sirolimus|mesh-list
64681660|NCT05751681|Cetrorelix|cetrorelix|mesh-list
64681661|NCT05751681|Dydrogesterone|dydrogesterone|mesh-list
64681662|NCT05751681|Progestins|progestins|mesh-list
64681663|NCT05751681|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64681664|NCT05751681|Fertility Agents|fertility agents|mesh-ancestor
64681665|NCT05751681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64681666|NCT05751681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681667|NCT05751681|Hormone Antagonists|hormone antagonists|mesh-ancestor
64681668|NCT05751681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64681669|NCT05751681|Hormones|hormones|mesh-ancestor
64681670|NCT02976623|Metronidazole|metronidazole|mesh-list
64681671|NCT02976623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64681672|NCT02976623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64681699|NCT04311671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64681700|NCT04311671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64716248|NCT03478982|GABA Agents|gaba agents|mesh-ancestor
64716249|NCT03478982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64681761|NCT00002757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64681763|NCT00002757|Abortifacient Agents|abortifacient agents|mesh-ancestor
64681856|NCT01632709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681857|NCT01632709|Sensory System Agents|sensory system agents|mesh-ancestor
64681954|NCT03942419|Respiratory System Agents|respiratory system agents|mesh-ancestor
64681955|NCT03942419|Mydriatics|mydriatics|mesh-ancestor
64681970|NCT04343963|Bromides|bromides|mesh-list
64682076|NCT05623761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682080|NCT05614089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64682081|NCT05614089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682082|NCT04231331|Ertugliflozin|ertugliflozin|mesh-list
64682148|NCT00382083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716282|NCT03357614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716290|NCT03357614|Renal Agents|renal agents|mesh-ancestor
64716291|NCT03275870|Hydroxychloroquine|hydroxychloroquine|mesh-list
64716292|NCT03275870|Antimalarials|antimalarials|mesh-ancestor
64716293|NCT03275870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64716294|NCT03275870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64682295|NCT03762317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64716300|NCT02216214|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64716301|NCT02216214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64682427|NCT02975843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682428|NCT02975843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682429|NCT02975843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64682430|NCT02975843|Respiratory System Agents|respiratory system agents|mesh-ancestor
64682431|NCT02975843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64682432|NCT02975843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64682433|NCT02975843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64682499|NCT01656187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64682500|NCT01656187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64682501|NCT01658839|Travoprost|travoprost|mesh-list
64682602|NCT05125029|Cholinergic Agents|cholinergic agents|mesh-ancestor
64682603|NCT05125029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64682676|NCT01602679|Hormones|hormones|mesh-ancestor
64682727|NCT00000333|Benztropine|benztropine|mesh-list
64682728|NCT00000333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64682729|NCT00000333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64716364|NCT03283436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716365|NCT03283436|Sensory System Agents|sensory system agents|mesh-ancestor
64716366|NCT03283436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682893|NCT00000441|Lorazepam|lorazepam|mesh-list
64682894|NCT00000441|Anticonvulsants|anticonvulsants|mesh-ancestor
64682895|NCT00000441|Antiemetics|antiemetics|mesh-ancestor
64682896|NCT00000441|Autonomic Agents|autonomic agents|mesh-ancestor
64682984|NCT02287376|Diclofenac|diclofenac|mesh-list
64682985|NCT02287376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64682996|NCT01928186|Alovudine|alovudine|mesh-list
64683064|NCT01676311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64683065|NCT01676311|Protective Agents|protective agents|mesh-ancestor
64683066|NCT01951118|Donepezil|donepezil|mesh-list
64683067|NCT01951118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64683068|NCT01951118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683074|NCT01951820|Lidocaine|lidocaine|mesh-list
64683140|NCT01701037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64683254|NCT00000627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64683255|NCT00000627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683257|NCT00000627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64683328|NCT04942899|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64683330|NCT04942899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683404|NCT00000723|Antidotes|antidotes|mesh-ancestor
64683405|NCT00000723|Protective Agents|protective agents|mesh-ancestor
64683406|NCT00000723|Vitamin B Complex|vitamin b complex|mesh-ancestor
64683407|NCT00000723|Vitamins|vitamins|mesh-ancestor
64683490|NCT04699383|Protective Agents|protective agents|mesh-ancestor
64683588|NCT04675983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683589|NCT04675983|Antimetabolites|antimetabolites|mesh-ancestor
64683667|NCT01706263|Salicylic Acid|salicylic acid|mesh-list
64683668|NCT01706263|Salicylates|salicylates|mesh-list
64683669|NCT01706263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64683670|NCT01706263|Antifungal Agents|antifungal agents|mesh-ancestor
64683671|NCT01706263|Keratolytic Agents|keratolytic agents|mesh-ancestor
64683672|NCT01706263|Dermatologic Agents|dermatologic agents|mesh-ancestor
64683674|NCT01706263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64683743|NCT05738564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64683744|NCT05738564|Respiratory System Agents|respiratory system agents|mesh-ancestor
64683745|NCT05738564|Mydriatics|mydriatics|mesh-ancestor
64683749|NCT05343572|Plerixafor|plerixafor|mesh-list
64683818|NCT02974439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64683829|NCT03340727|Caffeine|caffeine|mesh-list
64683894|NCT01708525|Deuterium Oxide|deuterium oxide|mesh-list
64683895|NCT01708525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683896|NCT01708525|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64324731|NCT05478356|Atropine|atropine|mesh-list
64716452|NCT02176356|Cholinergic Agents|cholinergic agents|mesh-ancestor
64716453|NCT02176356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64716455|NCT02176356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64684037|NCT00362765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64684038|NCT00362765|Antimetabolites|antimetabolites|mesh-ancestor
64684039|NCT00362765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684040|NCT00362765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64684110|NCT03246347|Docetaxel|docetaxel|mesh-list
64684111|NCT03246347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684112|NCT03246347|Tubulin Modulators|tubulin modulators|mesh-ancestor
64684113|NCT03246347|Antimitotic Agents|antimitotic agents|mesh-ancestor
64716477|NCT03395990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64716478|NCT03395990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324754|NCT01175785|Cyclosporine|cyclosporine|mesh-list
64324757|NCT01175785|Fludarabine|fludarabine|mesh-list
64684215|NCT04964960|Mitosis Modulators|mitosis modulators|mesh-ancestor
64684216|NCT04964960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684217|NCT04964960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64684283|NCT03166761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64684284|NCT03166761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64684348|NCT01710787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64684349|NCT01710787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684350|NCT01710787|Sympathomimetics|sympathomimetics|mesh-ancestor
64684418|NCT01719367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64684419|NCT01719367|Adrenergic Agents|adrenergic agents|mesh-ancestor
64684420|NCT01719367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64684421|NCT01719367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684505|NCT02294630|Respiratory System Agents|respiratory system agents|mesh-ancestor
64684506|NCT01722487|Chlorambucil|chlorambucil|mesh-list
64684507|NCT01722487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64684508|NCT01722487|Alkylating Agents|alkylating agents|mesh-ancestor
64684511|NCT02795858|Octreotide|octreotide|mesh-list
64684566|NCT02318654|Anesthetics|anesthetics|mesh-ancestor
64684567|NCT02318654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64684568|NCT02318654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684635|NCT02247193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716541|NCT03383198|Bupivacaine|bupivacaine|mesh-list
64716556|NCT03523988|Acetaminophen|acetaminophen|mesh-list
64684713|NCT04341935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64684714|NCT04341935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684715|NCT04341935|Incretins|incretins|mesh-ancestor
64684716|NCT04341935|Hormones|hormones|mesh-ancestor
64684722|NCT05317039|Calcium|calcium|mesh-list
64684788|NCT00002919|Dermatologic Agents|dermatologic agents|mesh-ancestor
64684789|NCT00002919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64684790|NCT00002919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64684791|NCT00002919|Immunologic Factors|immunologic factors|mesh-ancestor
64684792|NCT00002919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64684793|NCT00002919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64684809|NCT00383799|Amiodarone|amiodarone|mesh-list
64684810|NCT00383799|Procainamide|procainamide|mesh-list
64684825|NCT04635241|Calcium heparin|calcium heparin|mesh-list
64716568|NCT03523988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64716569|NCT03523988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716570|NCT03525548|Ivacaftor|ivacaftor|mesh-list
64716571|NCT03525548|Elexacaftor|elexacaftor|mesh-list
64716572|NCT03525548|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64716573|NCT03525548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64716574|NCT03525548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64716575|NCT03528512|Fentanyl|fentanyl|mesh-list
64716576|NCT03528512|Midazolam|midazolam|mesh-list
64324843|NCT01354717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64684892|NCT00002943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684893|NCT00002943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64684978|NCT00002967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64684979|NCT00002967|Alkylating Agents|alkylating agents|mesh-ancestor
64684980|NCT00002967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684981|NCT00002967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684982|NCT00002967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64684983|NCT00002967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64684984|NCT00002967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64684985|NCT00002967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64684986|NCT00002967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64716587|NCT03528512|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64685119|NCT03839823|Hormone Antagonists|hormone antagonists|mesh-ancestor
64685120|NCT03839823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64685206|NCT02348385|Amphetamine|amphetamine|mesh-list
64685207|NCT02348385|Dextroamphetamine|dextroamphetamine|mesh-list
64685208|NCT02348385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64685209|NCT02348385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685210|NCT02348385|Sympathomimetics|sympathomimetics|mesh-ancestor
64685211|NCT02348385|Autonomic Agents|autonomic agents|mesh-ancestor
64685212|NCT02348385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64685299|NCT00003111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64685300|NCT00003111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64716627|NCT03537404|Antiviral Agents|antiviral agents|mesh-ancestor
64716628|NCT03537404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64716629|NCT03537404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64716635|NCT03626714|Tacrolimus|tacrolimus|mesh-list
64685423|NCT00003135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64685424|NCT00003135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64685425|NCT00003135|Immunologic Factors|immunologic factors|mesh-ancestor
64685501|NCT04860661|Esketamine|esketamine|mesh-list
64685502|NCT04860661|Antidepressive Agents|antidepressive agents|mesh-ancestor
64685503|NCT04860661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64685504|NCT01740817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64685508|NCT04728217|Factor VIII|factor viii|mesh-list
64685604|NCT01754389|Tacrolimus|tacrolimus|mesh-list
64685605|NCT01754389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64685606|NCT01754389|Abortifacient Agents|abortifacient agents|mesh-ancestor
64685607|NCT01754389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64685608|NCT01754389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716687|NCT02171130|Incretins|incretins|mesh-ancestor
64456000|NCT01784211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64324946|NCT02266537|Urological Agents|urological agents|mesh-ancestor
64685749|NCT01762501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64685750|NCT01762501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64685751|NCT01762501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64685752|NCT01762501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685753|NCT01762501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64685928|NCT05451043|Adrenergic Agents|adrenergic agents|mesh-ancestor
64685929|NCT05451043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64685933|NCT02652169|Amikacin|amikacin|mesh-list
64685995|NCT02041533|Immunologic Factors|immunologic factors|mesh-ancestor
64685996|NCT02041533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686094|NCT01808755|Sulfamethoxazole|sulfamethoxazole|mesh-list
64686095|NCT01808755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64686180|NCT00544115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64686181|NCT00544115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64686182|NCT00544115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64716731|NCT04713956|Fludarabine|fludarabine|mesh-list
64686276|NCT02471651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64686277|NCT02471651|Growth Substances|growth substances|mesh-ancestor
64716767|NCT04374500|Verapamil|verapamil|mesh-list
64716768|NCT04374500|Nitroprusside|nitroprusside|mesh-list
64716769|NCT04374500|Acetylcholine|acetylcholine|mesh-list
64716770|NCT04374500|Vasodilator Agents|vasodilator agents|mesh-list
64716771|NCT04374500|Bradykinin|bradykinin|mesh-list
64716772|NCT04374500|Substance P|substance p|mesh-list
64716784|NCT04370834|Immunoglobulins|immunoglobulins|mesh-list
64686407|NCT02416193|Micronutrients|micronutrients|mesh-ancestor
64686408|NCT02416193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411763|NCT05552651|Paclitaxel|paclitaxel|mesh-list
64686409|NCT02416193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64686410|NCT02416193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64686411|NCT02530151|Clonidine|clonidine|mesh-list
64686502|NCT02419547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64686503|NCT02419547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64686504|NCT02533427|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64686578|NCT05326867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686579|NCT05324995|Celecoxib|celecoxib|mesh-list
64686580|NCT05324995|Epinephrine|epinephrine|mesh-list
64686581|NCT05324995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64686582|NCT05324995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64716817|NCT04352660|Mitomycins|mitomycins|mesh-list
64686649|NCT02535611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64686650|NCT02535611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64686651|NCT02535611|Dopamine Agents|dopamine agents|mesh-ancestor
64686657|NCT01823497|Morphine|morphine|mesh-list
64686723|NCT02487485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686724|NCT02487485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686791|NCT02431637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64686792|NCT02431637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64686793|NCT02545907|Thalidomide|thalidomide|mesh-list
64686813|NCT02545907|Growth Substances|growth substances|mesh-ancestor
64686814|NCT02545907|Growth Inhibitors|growth inhibitors|mesh-ancestor
64686881|NCT01826851|Anesthetics, Local|anesthetics, local|mesh-ancestor
64686882|NCT01826851|Anesthetics|anesthetics|mesh-ancestor
64686982|NCT02504723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686984|NCT02504723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64686985|NCT02504723|Antioxidants|antioxidants|mesh-ancestor
64686986|NCT02504723|Protective Agents|protective agents|mesh-ancestor
64687098|NCT02509481|Anticestodal Agents|anticestodal agents|mesh-ancestor
64687099|NCT02509481|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64687100|NCT02509481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64687101|NCT02509481|Tubulin Modulators|tubulin modulators|mesh-ancestor
64687106|NCT02561897|Warfarin|warfarin|mesh-list
64687171|NCT02974361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64687172|NCT02974361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687240|NCT02576249|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64687241|NCT02576249|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64687242|NCT02576249|Prednisolone|prednisolone|mesh-list
64687243|NCT02576249|Prednisolone acetate|prednisolone acetate|mesh-list
64687244|NCT02576249|Ropivacaine|ropivacaine|mesh-list
64687245|NCT02576249|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64687315|NCT03528941|Antiviral Agents|antiviral agents|mesh-ancestor
64687316|NCT03528941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64687317|NCT03528941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64687318|NCT03528941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64687319|NCT01836133|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64687387|NCT02268955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687388|NCT02268955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64687389|NCT02268955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64687390|NCT02268955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64687391|NCT02268955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687392|NCT02268955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687393|NCT02585843|Spironolactone|spironolactone|mesh-list
64687489|NCT05432466|Celiprolol|celiprolol|mesh-list
64687557|NCT03062059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687558|NCT03062059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687559|NCT03062059|Antiviral Agents|antiviral agents|mesh-ancestor
64687654|NCT02604173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64687655|NCT02604173|Respiratory System Agents|respiratory system agents|mesh-ancestor
64687656|NCT02604173|Glucocorticoids|glucocorticoids|mesh-ancestor
64687657|NCT02604173|Hormones|hormones|mesh-ancestor
64716923|NCT03961100|Entrectinib|entrectinib|mesh-list
64687740|NCT05371301|Antimitotic Agents|antimitotic agents|mesh-ancestor
64687741|NCT05371301|Mitosis Modulators|mitosis modulators|mesh-ancestor
64716924|NCT03961100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64716927|NCT03336853|Hybenx|hybenx|mesh-list
64687799|NCT02647099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64687800|NCT02647099|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64687801|NCT02647099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687802|NCT02647099|Antipyretics|antipyretics|mesh-ancestor
64687803|NCT01843621|Vaccines|vaccines|mesh-list
64687804|NCT01843621|Immunologic Factors|immunologic factors|mesh-ancestor
64687863|NCT01644474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687864|NCT01644474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64687865|NCT01644474|Immunologic Factors|immunologic factors|mesh-ancestor
64687933|NCT03023449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64687934|NCT03023449|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64687935|NCT03023449|Vasodilator Agents|vasodilator agents|mesh-ancestor
64687936|NCT03023449|Gasotransmitters|gasotransmitters|mesh-ancestor
64687937|NCT03023449|Protective Agents|protective agents|mesh-ancestor
64687938|NCT01848067|Prednisone|prednisone|mesh-list
64688025|NCT00551161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688106|NCT00550537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64688107|NCT00550537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64688108|NCT00550537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64688186|NCT05688215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64688187|NCT05688215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688188|NCT05688215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64688287|NCT01866943|Coagulants|coagulants|mesh-ancestor
64688288|NCT01868425|Acetaminophen|acetaminophen|mesh-list
64688347|NCT03123913|Testosterone undecanoate|testosterone undecanoate|mesh-list
64688348|NCT03123913|Testosterone enanthate|testosterone enanthate|mesh-list
64688349|NCT03123913|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64688419|NCT04893629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688420|NCT04893629|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64688421|NCT04893629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64688430|NCT04891991|Infliximab|infliximab|mesh-list
64688489|NCT02641691|Antidotes|antidotes|mesh-ancestor
64688490|NCT02641691|Protective Agents|protective agents|mesh-ancestor
64688491|NCT02641691|Vitamin B Complex|vitamin b complex|mesh-ancestor
64688492|NCT02641691|Vitamins|vitamins|mesh-ancestor
64688493|NCT02641691|Micronutrients|micronutrients|mesh-ancestor
64688494|NCT04047251|Topotecan|topotecan|mesh-list
64688495|NCT04047251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64688566|NCT05588297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64688567|NCT05588297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688568|NCT05588297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64688634|NCT05586971|Gout Suppressants|gout suppressants|mesh-ancestor
64688652|NCT03559049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64688653|NCT03559049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64688655|NCT05559437|Levobupivacaine|levobupivacaine|mesh-list
64688730|NCT05318573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64688731|NCT05318573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688732|NCT05318573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64688733|NCT05318573|Immunologic Factors|immunologic factors|mesh-ancestor
64688745|NCT05303987|Anesthetics|anesthetics|mesh-ancestor
64688804|NCT00367913|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64688805|NCT00367913|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64717093|NCT03473665|Diclofenac|diclofenac|mesh-list
64688891|NCT02205047|Antimetabolites|antimetabolites|mesh-ancestor
64688892|NCT02205047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688893|NCT02205047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64688894|NCT02205047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64688895|NCT02205047|Immunologic Factors|immunologic factors|mesh-ancestor
64688896|NCT02205047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688897|NCT02205047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64688898|NCT01585805|Gemcitabine|gemcitabine|mesh-list
64688899|NCT01585805|Cisplatin|cisplatin|mesh-list
64688900|NCT01585805|Veliparib|veliparib|mesh-list
64717099|NCT03473665|Sensory System Agents|sensory system agents|mesh-ancestor
64688968|NCT02677493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688969|NCT02679911|Ciclopirox|ciclopirox|mesh-list
64688970|NCT02679911|Amorolfine|amorolfine|mesh-list
64688971|NCT02679911|Antifungal Agents|antifungal agents|mesh-ancestor
64688972|NCT02679911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64688973|NCT02680301|Triamcinolone|triamcinolone|mesh-list
64717108|NCT03473665|Gout Suppressants|gout suppressants|mesh-ancestor
64717124|NCT03861338|Analgesics|analgesics|mesh-ancestor
64717125|NCT03861338|Sensory System Agents|sensory system agents|mesh-ancestor
64689029|NCT02697071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64689030|NCT02697071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64689031|NCT02697071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64689032|NCT02697071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717127|NCT03861338|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64717128|NCT00377780|Docetaxel|docetaxel|mesh-list
64717129|NCT00377780|Doxorubicin|doxorubicin|mesh-list
64717130|NCT00377780|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64717131|NCT00377780|Trastuzumab|trastuzumab|mesh-list
64717132|NCT00377780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64717143|NCT00376519|Mycophenolic Acid|mycophenolic acid|mesh-list
64717144|NCT00376519|Cyclophosphamide|cyclophosphamide|mesh-list
64717145|NCT00376519|Fludarabine|fludarabine|mesh-list
64689237|NCT02721641|Trastuzumab|trastuzumab|mesh-list
64689238|NCT02721641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64689239|NCT02721641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689240|NCT03649061|Etanercept|etanercept|mesh-list
64689241|NCT03649061|Leflunomide|leflunomide|mesh-list
64689243|NCT03649061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64717155|NCT00376519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64717156|NCT00376519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64717157|NCT00376519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64325385|NCT02157311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64689341|NCT03445949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64689343|NCT01944319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64689397|NCT05446493|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64689398|NCT05446493|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64689399|NCT05446493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64689400|NCT05446493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689401|NCT05446493|Urological Agents|urological agents|mesh-ancestor
64689402|NCT02863055|Nintedanib|nintedanib|mesh-list
64689403|NCT02863055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689404|NCT02863055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64689482|NCT04739111|Antibodies|antibodies|mesh-list
64689483|NCT04739111|Immunoglobulins|immunoglobulins|mesh-list
64689484|NCT04739111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64689485|NCT04739111|Immunologic Factors|immunologic factors|mesh-ancestor
64689486|NCT04739111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689487|NCT04768231|Rifampin|rifampin|mesh-list
64689488|NCT04768231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64689489|NCT04768231|Antitubercular Agents|antitubercular agents|mesh-ancestor
64689495|NCT04768231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689496|NCT04768231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64689497|NCT04768231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64689498|NCT04768231|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64689499|NCT04768231|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64689500|NCT04768231|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64689501|NCT04768231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64689502|NCT05452187|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64689503|NCT05452187|Immunologic Factors|immunologic factors|mesh-ancestor
64689504|NCT05452187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689505|NCT01889797|Rituximab|rituximab|mesh-list
64717189|NCT04121078|Rifampin|rifampin|mesh-list
64717190|NCT04121078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64717191|NCT04121078|Antitubercular Agents|antitubercular agents|mesh-ancestor
64717192|NCT04121078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64717193|NCT04121078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64717194|NCT04121078|Leprostatic Agents|leprostatic agents|mesh-ancestor
64689527|NCT00369551|Growth Substances|growth substances|mesh-ancestor
64689528|NCT00369551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689529|NCT00369551|Growth Inhibitors|growth inhibitors|mesh-ancestor
64689530|NCT00369551|Immunologic Factors|immunologic factors|mesh-ancestor
64689531|NCT04537793|Ivacaftor|ivacaftor|mesh-list
64689532|NCT04537793|Elexacaftor|elexacaftor|mesh-list
64689533|NCT04537793|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64689534|NCT04537793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64689535|NCT04537793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689536|NCT05451173|Durvalumab|durvalumab|mesh-list
64689537|NCT05451173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64689538|NCT05451173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689539|NCT05437601|Carotenoids|carotenoids|mesh-list
64689544|NCT05449145|Vitamin D|vitamin d|mesh-list
64689577|NCT05448365|Vitamin B 6|vitamin b 6|mesh-list
64689578|NCT05448365|Pyridoxal|pyridoxal|mesh-list
64689579|NCT05448365|Pyridoxine|pyridoxine|mesh-list
64689580|NCT05448365|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
64689581|NCT05448365|Micronutrients|micronutrients|mesh-ancestor
64689582|NCT05448365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689583|NCT05448365|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64689584|NCT05448365|Vitamin B Complex|vitamin b complex|mesh-ancestor
64689585|NCT05448365|Antioxidants|antioxidants|mesh-ancestor
64689650|NCT02661971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689651|NCT02661971|Antimetabolites|antimetabolites|mesh-ancestor
64689652|NCT02661971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64689653|NCT02661971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64689729|NCT04483583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64689730|NCT04483583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689731|NCT04483583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689732|NCT04449965|Povidone-Iodine|povidone-iodine|mesh-list
64689733|NCT04449965|Povidone|povidone|mesh-list
64689734|NCT04449965|Plasma Substitutes|plasma substitutes|mesh-ancestor
64689735|NCT04449965|Blood Substitutes|blood substitutes|mesh-ancestor
64689736|NCT04449965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64689796|NCT02466581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64689797|NCT02466581|Glucocorticoids|glucocorticoids|mesh-ancestor
64689798|NCT02466581|Hormones|hormones|mesh-ancestor
64689799|NCT02466581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64689800|NCT02466581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689803|NCT02466581|Antiemetics|antiemetics|mesh-ancestor
64689892|NCT01953211|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64689893|NCT01953211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64689894|NCT02028221|Metformin|metformin|mesh-list
64689895|NCT02028221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64689896|NCT02028221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689897|NCT05735197|Dapagliflozin|dapagliflozin|mesh-list
64689898|NCT05735197|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64689899|NCT05735197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689962|NCT01211405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689963|NCT01211405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64689964|NCT01211405|Serotonin Agents|serotonin agents|mesh-ancestor
64689965|NCT01211405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64689966|NCT01211405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689967|NCT01211405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64689968|NCT01211405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64689969|NCT01211405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64689970|NCT01211405|Adrenergic Agents|adrenergic agents|mesh-ancestor
64689989|NCT04338191|Vitamins|vitamins|mesh-ancestor
64690021|NCT05454683|Antioxidants|antioxidants|mesh-ancestor
64690022|NCT05454683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690023|NCT05454683|Protective Agents|protective agents|mesh-ancestor
64690024|NCT05454683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690025|NCT05454683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64690026|NCT05193071|Aspirin|aspirin|mesh-list
64690027|NCT05193071|Clopidogrel|clopidogrel|mesh-list
64690117|NCT05062577|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64690118|NCT05062577|GABA Modulators|gaba modulators|mesh-ancestor
64690119|NCT05062577|GABA Agents|gaba agents|mesh-ancestor
64690120|NCT05062577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64690121|NCT05062577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690122|NCT05448989|Atropine|atropine|mesh-list
64690238|NCT03754049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690239|NCT03754049|Protease Inhibitors|protease inhibitors|mesh-ancestor
64690240|NCT03754049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690241|NCT03754049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690242|NCT01901809|Dopamine|dopamine|mesh-list
64690243|NCT01901809|Furosemide|furosemide|mesh-list
64690244|NCT01901809|Diuretics|diuretics|mesh-ancestor
64690261|NCT04947527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690263|NCT05005403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64690334|NCT00370721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690335|NCT00370721|Growth Inhibitors|growth inhibitors|mesh-ancestor
64690336|NCT01909141|Metformin|metformin|mesh-list
64690337|NCT01909141|Pioglitazone|pioglitazone|mesh-list
64690338|NCT01909141|Carbamide Peroxide|carbamide peroxide|mesh-list
64690339|NCT01909141|Letrozole|letrozole|mesh-list
64690340|NCT01909141|Clomiphene|clomiphene|mesh-list
64690341|NCT01909141|Enclomiphene|enclomiphene|mesh-list
64690342|NCT01909141|Zuclomiphene|zuclomiphene|mesh-list
64690343|NCT01909141|Hormones|hormones|mesh-list
64690344|NCT01909141|Estradiol|estradiol|mesh-list
64690345|NCT01909141|Testosterone|testosterone|mesh-list
64690405|NCT04404959|Anesthetics, Local|anesthetics, local|mesh-ancestor
64690406|NCT04404959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64690407|NCT04404959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690408|NCT04404959|Sensory System Agents|sensory system agents|mesh-ancestor
64690409|NCT04404959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690411|NCT04403711|Anesthetics|anesthetics|mesh-list
64690475|NCT01916941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64690476|NCT01916941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690477|NCT01916941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690478|NCT05732701|Oxymetazoline|oxymetazoline|mesh-list
64690479|NCT05732701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64690480|NCT05732701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64690481|NCT05732701|Adrenergic Agents|adrenergic agents|mesh-ancestor
64690482|NCT05732701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64690483|NCT05732701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690484|NCT05732701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690485|NCT05732701|Sympathomimetics|sympathomimetics|mesh-ancestor
64690542|NCT00371501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64690543|NCT00371501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690544|NCT00371501|Antipyretics|antipyretics|mesh-ancestor
64690545|NCT00371501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64690546|NCT00371501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64690651|NCT02287909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64690652|NCT02287909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64690653|NCT02287909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64690654|NCT02287909|Purinergic Agents|purinergic agents|mesh-ancestor
64690655|NCT02287909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64690664|NCT00371579|Antimetabolites|antimetabolites|mesh-ancestor
64690729|NCT01614665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690730|NCT05691829|Pembrolizumab|pembrolizumab|mesh-list
64690734|NCT00371735|Dapsone|dapsone|mesh-list
64690821|NCT02741687|Protease Inhibitors|protease inhibitors|mesh-ancestor
64690822|NCT02741687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690823|NCT02741687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690824|NCT05361499|Amoxicillin|amoxicillin|mesh-list
64690825|NCT05361499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64690826|NCT05361499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64690827|NCT04337099|Tempol|tempol|mesh-list
64690828|NCT04337099|TEMPO|tempo|mesh-list
64690829|NCT04337099|TEMPOL-H|tempol-h|mesh-list
64690830|NCT04337099|Antioxidants|antioxidants|mesh-ancestor
64690831|NCT04337099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690832|NCT04337099|Protective Agents|protective agents|mesh-ancestor
64690833|NCT04337099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690834|NCT04337099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64690835|NCT04337099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690886|NCT05602207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690887|NCT04739761|Trastuzumab|trastuzumab|mesh-list
64690888|NCT04739761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64690889|NCT04739761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690890|NCT05598619|Ascorbic Acid|ascorbic acid|mesh-list
64690891|NCT05598619|Vitamins|vitamins|mesh-ancestor
64690892|NCT05598619|Micronutrients|micronutrients|mesh-ancestor
64690893|NCT05598619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690894|NCT05598619|Antioxidants|antioxidants|mesh-ancestor
64690943|NCT02295553|Ketamine|ketamine|mesh-list
64690944|NCT02295553|Propofol|propofol|mesh-list
64690945|NCT02295553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64690946|NCT02295553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64690947|NCT02295553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690948|NCT02295553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64690949|NCT02295553|Anesthetics, General|anesthetics, general|mesh-ancestor
64690950|NCT02295553|Anesthetics|anesthetics|mesh-ancestor
64690966|NCT05455073|Folic Acid|folic acid|mesh-list
64691005|NCT04669171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64691006|NCT04669171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64691016|NCT05545891|Dopamine Agonists|dopamine agonists|mesh-ancestor
64691017|NCT05545891|Dopamine Agents|dopamine agents|mesh-ancestor
64691018|NCT05545891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64691019|NCT05545891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691020|NCT05545891|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64691028|NCT04757675|Ketamine|ketamine|mesh-list
64691073|NCT05323721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64691103|NCT04566991|Deferoxamine|deferoxamine|mesh-list
64691104|NCT04566991|Siderophores|siderophores|mesh-ancestor
64691105|NCT04566991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64691106|NCT04566991|Chelating Agents|chelating agents|mesh-ancestor
64691107|NCT04566991|Sequestering Agents|sequestering agents|mesh-ancestor
64691108|NCT04566991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691109|NCT04535401|Calcium, Dietary|calcium, dietary|mesh-list
64691110|NCT04535401|Leucovorin|leucovorin|mesh-list
64691175|NCT03860207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691176|NCT03763175|Lovastatin|lovastatin|mesh-list
64691177|NCT03763175|L 647318|l 647318|mesh-list
64691178|NCT03763175|Dihydromevinolin|dihydromevinolin|mesh-list
64691179|NCT03763175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64691180|NCT03763175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64691181|NCT03763175|Antimetabolites|antimetabolites|mesh-ancestor
64691182|NCT03763175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691183|NCT03763175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64691274|NCT02990845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64691275|NCT02990845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691276|NCT02990845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64691277|NCT02990845|Fertility Agents|fertility agents|mesh-ancestor
64691281|NCT02990845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64691346|NCT04265053|Hormone Antagonists|hormone antagonists|mesh-ancestor
64691347|NCT04332497|Ibuprofen|ibuprofen|mesh-list
64691348|NCT04332497|Fentanyl|fentanyl|mesh-list
64691349|NCT04332497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64691350|NCT04332497|Narcotics|narcotics|mesh-ancestor
64691351|NCT04332497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64691352|NCT04332497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691353|NCT04332497|Analgesics|analgesics|mesh-ancestor
64691422|NCT04186247|Metronidazole|metronidazole|mesh-list
64691423|NCT04186247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64691424|NCT04186247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64691519|NCT02316379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416814|NCT04842331|Antioxidants|antioxidants|mesh-ancestor
64691520|NCT02303977|Gemcitabine|gemcitabine|mesh-list
64691521|NCT02303977|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64691522|NCT02303977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64691524|NCT02303977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691525|NCT02303977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691526|NCT02303977|Antiviral Agents|antiviral agents|mesh-ancestor
64691590|NCT02278315|Dexamethasone|dexamethasone|mesh-list
64691591|NCT02278315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64691592|NCT02278315|Antiemetics|antiemetics|mesh-ancestor
64691593|NCT02278315|Autonomic Agents|autonomic agents|mesh-ancestor
64691594|NCT02278315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64691595|NCT02278315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691596|NCT02278315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64691597|NCT02278315|Glucocorticoids|glucocorticoids|mesh-ancestor
64691681|NCT02895035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64691704|NCT02803229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64691705|NCT02803229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691707|NCT02803229|Autonomic Agents|autonomic agents|mesh-ancestor
64691708|NCT02803229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64691709|NCT02803229|Dopamine Agents|dopamine agents|mesh-ancestor
64691710|NCT02803229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64691712|NCT02803229|Adrenergic Agents|adrenergic agents|mesh-ancestor
64691833|NCT04349696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691834|NCT02810873|Copper|copper|mesh-list
64691835|NCT02810873|Deoxyglucose|deoxyglucose|mesh-list
64691836|NCT02810873|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64691837|NCT02810873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64691838|NCT02810873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691839|NCT02810873|Trace Elements|trace elements|mesh-ancestor
64691951|NCT02902913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64691952|NCT02902913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64691953|NCT02902913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64691954|NCT02902913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691955|NCT02902913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691956|NCT03417986|Thiethylperazine|thiethylperazine|mesh-list
64691957|NCT03417986|Antiemetics|antiemetics|mesh-ancestor
64691958|NCT03417986|Autonomic Agents|autonomic agents|mesh-ancestor
64692009|NCT02912195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64692010|NCT02912195|Narcotics|narcotics|mesh-ancestor
64717432|NCT00377468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64717433|NCT00377468|Analgesics|analgesics|mesh-ancestor
64717434|NCT00377468|Sensory System Agents|sensory system agents|mesh-ancestor
64717435|NCT00377468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717436|NCT00377468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64717437|NCT00377468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64325655|NCT02547038|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64692011|NCT02912195|Analgesics|analgesics|mesh-ancestor
64692012|NCT01960075|Fosphenytoin|fosphenytoin|mesh-list
64692114|NCT00374621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692115|NCT00374621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64692116|NCT00374621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64692117|NCT00374621|Oxytocics|oxytocics|mesh-ancestor
64692118|NCT00374621|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64692119|NCT00374621|Diuretics|diuretics|mesh-ancestor
64717438|NCT00377468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64717439|NCT00377468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692183|NCT01969435|Melphalan|melphalan|mesh-list
64692184|NCT01969435|Carmustine|carmustine|mesh-list
64692185|NCT01969435|Etoposide phosphate|etoposide phosphate|mesh-list
64717446|NCT03799484|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64717448|NCT03799484|Anesthetics, Local|anesthetics, local|mesh-ancestor
64717449|NCT03799484|Anesthetics|anesthetics|mesh-ancestor
64692202|NCT01965002|Aspirin|aspirin|mesh-list
64717460|NCT03799484|Cholinergic Agents|cholinergic agents|mesh-ancestor
64717461|NCT03799484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64717462|NCT03799484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64325675|NCT02764697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64692264|NCT02006342|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64692265|NCT02006342|Insulin Glargine|insulin glargine|mesh-list
64692266|NCT02006342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64692267|NCT02006342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692268|NCT01968356|Ethanol|ethanol|mesh-list
64692269|NCT01968356|Chlorhexidine|chlorhexidine|mesh-list
64692270|NCT01968356|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64692272|NCT01968356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64717469|NCT00377546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64717470|NCT00377546|Analgesics|analgesics|mesh-ancestor
64325684|NCT04822337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64692330|NCT02012192|Paclitaxel|paclitaxel|mesh-list
64692331|NCT02012192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64692332|NCT02012192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64692333|NCT02012192|Tubulin Modulators|tubulin modulators|mesh-ancestor
64692337|NCT02066792|Cycloserine|cycloserine|mesh-list
64325691|NCT04822337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64692411|NCT02068820|Fluorophosphate|fluorophosphate|mesh-list
64692412|NCT02068820|Cariostatic Agents|cariostatic agents|mesh-ancestor
64692413|NCT02068820|Protective Agents|protective agents|mesh-ancestor
64692442|NCT01973348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64692443|NCT01973348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64692444|NCT01973348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64692446|NCT02839889|Naloxegol|naloxegol|mesh-list
64692538|NCT02934191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692539|NCT02934191|Antipyretics|antipyretics|mesh-ancestor
64692540|NCT02934191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64692541|NCT02934191|Narcotics|narcotics|mesh-ancestor
64692542|NCT02934191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64692543|NCT02934191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64692544|NCT02934191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64692550|NCT02934191|Antacids|antacids|mesh-ancestor
64692617|NCT02070692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64692618|NCT02070692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692619|NCT02070692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64692720|NCT02345486|Plasma-lyte 148|plasma-lyte 148|mesh-list
64692721|NCT02345486|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64692722|NCT02345486|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64692723|NCT02019758|Fluticasone|fluticasone|mesh-list
64692725|NCT02019758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64692726|NCT02019758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64692727|NCT02019758|Autonomic Agents|autonomic agents|mesh-ancestor
64692728|NCT02019758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692791|NCT01982695|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64692792|NCT01982695|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64692793|NCT01982695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692794|NCT01982695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64692795|NCT01982695|Protease Inhibitors|protease inhibitors|mesh-ancestor
64692857|NCT01985581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64692858|NCT01985581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64692859|NCT01985581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64692860|NCT01985581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64692861|NCT01985581|Adrenergic Agents|adrenergic agents|mesh-ancestor
64692862|NCT01985581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64692863|NCT01985581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692864|NCT01985581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692865|NCT02024204|Fluticasone|fluticasone|mesh-list
64692866|NCT02024204|Xhance|xhance|mesh-list
64692867|NCT02024204|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64692874|NCT02024204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64692875|NCT02024204|Respiratory System Agents|respiratory system agents|mesh-ancestor
64692885|NCT02024204|Hormones|hormones|mesh-ancestor
64692916|NCT02035345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64692917|NCT01986361|Flurbiprofen|flurbiprofen|mesh-list
64692918|NCT01986361|Analgesics|analgesics|mesh-ancestor
64692919|NCT01986361|Sensory System Agents|sensory system agents|mesh-ancestor
64692920|NCT01986361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692921|NCT01986361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692922|NCT01986361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64692929|NCT01983020|Lidocaine|lidocaine|mesh-list
64692982|NCT02352974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64692983|NCT02353754|Morphine|morphine|mesh-list
64692984|NCT02353754|Bupivacaine|bupivacaine|mesh-list
64692985|NCT02353754|Anesthetics, Local|anesthetics, local|mesh-ancestor
64692986|NCT02353754|Anesthetics|anesthetics|mesh-ancestor
64692987|NCT02353754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64692988|NCT02353754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692989|NCT02353754|Sensory System Agents|sensory system agents|mesh-ancestor
64693049|NCT02355158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64693050|NCT02355158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64693051|NCT02355158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64693052|NCT02355158|Adrenergic Agents|adrenergic agents|mesh-ancestor
64693053|NCT02355158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693055|NCT02033876|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64693125|NCT02037230|Adavosertib|adavosertib|mesh-list
64693126|NCT02037230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64693127|NCT02037230|Antimetabolites|antimetabolites|mesh-ancestor
64693128|NCT02037230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693129|NCT02037230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64693130|NCT02037230|Antiviral Agents|antiviral agents|mesh-ancestor
64693131|NCT02037230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64693132|NCT02037230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64693133|NCT02037230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64693134|NCT02037230|Immunologic Factors|immunologic factors|mesh-ancestor
64693156|NCT02877485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64693157|NCT02877485|Immunologic Factors|immunologic factors|mesh-ancestor
64693158|NCT02877485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64693159|NCT02877485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693160|NCT00374387|NuvaRing|nuvaring|mesh-list
64693161|NCT00374387|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64693162|NCT00374387|Contraceptive Agents|contraceptive agents|mesh-ancestor
64693163|NCT00374387|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64693164|NCT00374387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693165|NCT03023891|Prednisone|prednisone|mesh-list
64693166|NCT03023891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64693167|NCT03023891|Glucocorticoids|glucocorticoids|mesh-ancestor
64693168|NCT03023891|Hormones|hormones|mesh-ancestor
64693169|NCT03023891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64418501|NCT05679037|Vitamins|vitamins|mesh-ancestor
64693213|NCT03028103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64717547|NCT05313386|Sensory System Agents|sensory system agents|mesh-ancestor
64717548|NCT05313386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717549|NCT05313386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64717550|NCT05313386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64717551|NCT05313386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64717555|NCT03031340|Pregabalin|pregabalin|mesh-list
64693277|NCT02361476|Autonomic Agents|autonomic agents|mesh-ancestor
64693278|NCT02361476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64693279|NCT02361476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64693280|NCT02361476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64693281|NCT02361476|Adrenergic Agents|adrenergic agents|mesh-ancestor
64693282|NCT02361476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693283|NCT02361476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693284|NCT02363270|Ketamine|ketamine|mesh-list
64717562|NCT03031340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64717563|NCT03031340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717564|NCT03031340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64693349|NCT02965781|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64693350|NCT02965781|Immunologic Factors|immunologic factors|mesh-ancestor
64717565|NCT03031340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64717566|NCT03031340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64717567|NCT03031340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717568|NCT03031340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64717569|NCT03405259|Fluorides|fluorides|mesh-list
64717570|NCT03405259|Fluorides, Topical|fluorides, topical|mesh-list
64717575|NCT03513757|Glycopyrrolate|glycopyrrolate|mesh-list
64717576|NCT03513757|Dexmedetomidine|dexmedetomidine|mesh-list
64717577|NCT03513757|Nitrous Oxide|nitrous oxide|mesh-list
64717578|NCT03513757|Propofol|propofol|mesh-list
64717579|NCT03513757|Sevoflurane|sevoflurane|mesh-list
64693514|NCT02369900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693515|NCT02369900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64693516|NCT03054857|Dexmedetomidine|dexmedetomidine|mesh-list
64717581|NCT03513757|Anesthetics|anesthetics|mesh-ancestor
64717582|NCT03513757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717583|NCT03513757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717584|NCT03513757|Sensory System Agents|sensory system agents|mesh-ancestor
64717585|NCT03513757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693605|NCT02039947|Trametinib|trametinib|mesh-list
64717588|NCT03513757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64717589|NCT03513757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64717590|NCT03513757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717591|NCT03513757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64717592|NCT03513757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64717593|NCT03513757|Anesthetics, General|anesthetics, general|mesh-ancestor
64693757|NCT03068897|Adrenergic Agents|adrenergic agents|mesh-ancestor
64693758|NCT02299297|Tofacitinib|tofacitinib|mesh-list
64693759|NCT02299297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64693760|NCT02299297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64693761|NCT02299297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693763|NCT03069677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64693764|NCT03069677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64693765|NCT03069677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717605|NCT03513757|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64717606|NCT03513757|Cholinergic Agents|cholinergic agents|mesh-ancestor
64717607|NCT03760640|Insulin Lispro|insulin lispro|mesh-list
64717608|NCT03760640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64717609|NCT03760640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693824|NCT00375557|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64693825|NCT00375557|Antidepressive Agents|antidepressive agents|mesh-ancestor
64693881|NCT03086213|Dsuvia|dsuvia|mesh-list
64693894|NCT03086213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693895|NCT03086213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64693896|NCT03086213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64693897|NCT03086213|Anesthetics, General|anesthetics, general|mesh-ancestor
64693898|NCT03086213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64693964|NCT04736927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64693965|NCT04736927|Anesthetics, General|anesthetics, general|mesh-ancestor
64693966|NCT04736927|Anesthetics|anesthetics|mesh-ancestor
64693967|NCT04736927|GABA Modulators|gaba modulators|mesh-ancestor
64693968|NCT04736927|GABA Agents|gaba agents|mesh-ancestor
64693969|NCT04736927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693970|NCT04736927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693971|NCT03810703|Amphetamine|amphetamine|mesh-list
64694039|NCT05185583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64694040|NCT04645121|Carbon Monoxide|carbon monoxide|mesh-list
64694041|NCT04645121|Antimetabolites|antimetabolites|mesh-ancestor
64694050|NCT04603937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694051|NCT04603937|Growth Inhibitors|growth inhibitors|mesh-ancestor
64694052|NCT04603937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694053|NCT02392286|Prednisone|prednisone|mesh-list
64694054|NCT02392286|Methylprednisolone|methylprednisolone|mesh-list
64694055|NCT02392286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64694099|NCT02393378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694100|NCT02393378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694101|NCT02393378|Dermatologic Agents|dermatologic agents|mesh-ancestor
64694102|NCT02393378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64694103|NCT02393378|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64694168|NCT02069041|Immunologic Factors|immunologic factors|mesh-ancestor
64694169|NCT02069041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694170|NCT02069041|Antidotes|antidotes|mesh-ancestor
64694171|NCT02069041|Protective Agents|protective agents|mesh-ancestor
64694173|NCT02069041|Vitamins|vitamins|mesh-ancestor
64694241|NCT02049307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64694242|NCT02049307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694243|NCT00355628|Fentanyl|fentanyl|mesh-list
64694244|NCT00355628|Citric Acid|citric acid|mesh-list
64694245|NCT00355628|Sodium Citrate|sodium citrate|mesh-list
64694275|NCT03717155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64694351|NCT05272826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64694361|NCT03458429|Immunologic Factors|immunologic factors|mesh-ancestor
64694362|NCT03458429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694364|NCT03291197|Anesthetics, Local|anesthetics, local|mesh-ancestor
64694365|NCT03291197|Anesthetics|anesthetics|mesh-ancestor
64694366|NCT03291197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64694367|NCT03291197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694368|NCT03291197|Sensory System Agents|sensory system agents|mesh-ancestor
64694369|NCT03291197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64694370|NCT05638880|Empagliflozin|empagliflozin|mesh-list
64694371|NCT05638880|Valsartan|valsartan|mesh-list
64694372|NCT05638880|Levocetirizine|levocetirizine|mesh-list
64694427|NCT03243461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64694428|NCT03296345|Ketamine|ketamine|mesh-list
64694429|NCT03296345|Analgesics|analgesics|mesh-ancestor
64694430|NCT03296345|Sensory System Agents|sensory system agents|mesh-ancestor
64694431|NCT03296345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64694432|NCT03296345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694433|NCT03296345|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64694434|NCT03296345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64694435|NCT03296345|Anesthetics, General|anesthetics, general|mesh-ancestor
64694436|NCT03296345|Anesthetics|anesthetics|mesh-ancestor
64694477|NCT04630964|Antimetabolites|antimetabolites|mesh-ancestor
64694478|NCT04630964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694492|NCT03138161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64694493|NCT03138161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717700|NCT02892500|Hormones|hormones|mesh-ancestor
64717701|NCT02892500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64717702|NCT02892500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64717703|NCT02892500|Respiratory System Agents|respiratory system agents|mesh-ancestor
64717704|NCT00378872|Tranexamic Acid|tranexamic acid|mesh-list
64717705|NCT00378872|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64717706|NCT00378872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64717708|NCT00378872|Hemostatics|hemostatics|mesh-ancestor
64694649|NCT04776395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694650|NCT04776395|Dermatologic Agents|dermatologic agents|mesh-ancestor
64694651|NCT02342197|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64694652|NCT02342197|Luteolytic Agents|luteolytic agents|mesh-ancestor
64694653|NCT02342197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64694654|NCT02342197|Contraceptive Agents|contraceptive agents|mesh-ancestor
64694722|NCT04624295|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64694723|NCT04624295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64694724|NCT04624295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64694725|NCT04624295|Antipyretics|antipyretics|mesh-ancestor
64694728|NCT03319277|Narcotics|narcotics|mesh-ancestor
64694832|NCT03994874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64694833|NCT03987776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64694834|NCT05722340|Anesthetics|anesthetics|mesh-list
64694911|NCT03220022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64694912|NCT03220022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64694913|NCT03220022|Alkylating Agents|alkylating agents|mesh-ancestor
64694914|NCT03220022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694915|NCT03220022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694916|NCT03220022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64695016|NCT04344782|Bevacizumab|bevacizumab|mesh-list
64695017|NCT04344782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64695018|NCT04344782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695019|NCT04344782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64695020|NCT04344782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64695021|NCT04344782|Growth Substances|growth substances|mesh-ancestor
64695022|NCT04344782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695076|NCT01349192|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64695077|NCT01349192|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64695078|NCT01349192|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64695079|NCT01349192|Renal Agents|renal agents|mesh-ancestor
64695080|NCT01349192|Antimalarials|antimalarials|mesh-ancestor
64695081|NCT01349192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64695082|NCT01349192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64695083|NCT01349192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64695148|NCT02363803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695149|NCT02363803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64695150|NCT02363803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64695151|NCT02363803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64695152|NCT02363803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64695153|NCT02363803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695154|NCT03417193|Analgesics, Opioid|analgesics, opioid|mesh-list
64695211|NCT02376283|Purinergic Agents|purinergic agents|mesh-ancestor
64695212|NCT02376283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64695213|NCT02376283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695214|NCT02376283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695215|NCT00425347|Elotuzumab|elotuzumab|mesh-list
64717801|NCT02614586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64717802|NCT02614586|Antipruritics|antipruritics|mesh-ancestor
64695260|NCT02393677|Ropivacaine|ropivacaine|mesh-list
64695330|NCT03423641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64695331|NCT01112072|Riboflavin|riboflavin|mesh-list
64695332|NCT01112072|Vitamin B Complex|vitamin b complex|mesh-ancestor
64695333|NCT01112072|Vitamins|vitamins|mesh-ancestor
64695334|NCT01112072|Micronutrients|micronutrients|mesh-ancestor
64695335|NCT01112072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695336|NCT01112072|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64695337|NCT01112072|Dermatologic Agents|dermatologic agents|mesh-ancestor
64695338|NCT04825795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64695339|NCT04825795|Protease Inhibitors|protease inhibitors|mesh-ancestor
64695340|NCT04825795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64695397|NCT00003159|Paclitaxel|paclitaxel|mesh-list
64717821|NCT03591458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64717822|NCT03591458|Analgesics|analgesics|mesh-ancestor
64717823|NCT03591458|Sensory System Agents|sensory system agents|mesh-ancestor
64717824|NCT03591458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64326018|NCT01106989|Tetracaine|tetracaine|mesh-list
64695495|NCT00376337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64695496|NCT00376337|Hormone Antagonists|hormone antagonists|mesh-ancestor
64695497|NCT00376337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64695498|NCT00376337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695499|NCT00376337|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64695501|NCT00003165|Doxorubicin|doxorubicin|mesh-list
64717853|NCT01206296|Immunologic Factors|immunologic factors|mesh-ancestor
64717854|NCT01206296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64717855|NCT02593682|Suvorexant|suvorexant|mesh-list
64717856|NCT02593682|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64717857|NCT02593682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64717858|NCT02593682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64695604|NCT00003195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695605|NCT00003195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64695606|NCT00003195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64695607|NCT00003195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64695608|NCT03671109|Piperaquine|piperaquine|mesh-list
64695609|NCT03671109|Artenimol|artenimol|mesh-list
64695675|NCT05552443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695676|NCT01542021|Androgens|androgens|mesh-list
64695677|NCT01542021|Hormones|hormones|mesh-ancestor
64695692|NCT04706897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64695693|NCT04706897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695695|NCT04706897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64695762|NCT00003399|Antiemetics|antiemetics|mesh-ancestor
64695763|NCT00003399|Autonomic Agents|autonomic agents|mesh-ancestor
64695764|NCT00003399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695765|NCT00003399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64695766|NCT00003399|Glucocorticoids|glucocorticoids|mesh-ancestor
64695767|NCT00003399|Hormones|hormones|mesh-ancestor
64695768|NCT00003399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64695769|NCT00003399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64695770|NCT00003399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64695771|NCT00003399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64695772|NCT00003399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64695773|NCT03376061|Tranexamic Acid|tranexamic acid|mesh-list
64695774|NCT03376061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64695775|NCT03376061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64695815|NCT05715788|Respiratory System Agents|respiratory system agents|mesh-ancestor
64695816|NCT05715788|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64695817|NCT05715788|Antioxidants|antioxidants|mesh-ancestor
64695818|NCT05715788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695819|NCT05715788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64695820|NCT05715788|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64695821|NCT05715788|Vasodilator Agents|vasodilator agents|mesh-ancestor
64695824|NCT00003225|Irinotecan|irinotecan|mesh-list
64334690|NCT04464967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695885|NCT05349188|Protective Agents|protective agents|mesh-ancestor
64695886|NCT05349188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695887|NCT05349188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64695888|NCT03441581|Eluxadoline|eluxadoline|mesh-list
64695889|NCT03441581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64695890|NCT02265510|Gemcitabine|gemcitabine|mesh-list
64695891|NCT02265510|Dexamethasone|dexamethasone|mesh-list
64695892|NCT02265510|Paclitaxel|paclitaxel|mesh-list
64695893|NCT02265510|Lenalidomide|lenalidomide|mesh-list
64695894|NCT02265510|Azacitidine|azacitidine|mesh-list
64695895|NCT02265510|Bortezomib|bortezomib|mesh-list
64695963|NCT03256253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695964|NCT03256253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695965|NCT03256253|Anticonvulsants|anticonvulsants|mesh-ancestor
64695966|NCT03256253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64695967|NCT03256253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64695968|NCT03256253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695969|NCT03256253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64696043|NCT00003237|Antimitotic Agents|antimitotic agents|mesh-ancestor
64696044|NCT00003237|Mitosis Modulators|mitosis modulators|mesh-ancestor
64696045|NCT00003237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696046|NCT00003411|Motexafin gadolinium|motexafin gadolinium|mesh-list
64696047|NCT00003411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696048|NCT00003411|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64696147|NCT04530409|Methylprednisolone|methylprednisolone|mesh-list
64696148|NCT04530409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64696149|NCT04530409|Antiemetics|antiemetics|mesh-ancestor
64696150|NCT04530409|Autonomic Agents|autonomic agents|mesh-ancestor
64696151|NCT04530409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64696152|NCT04530409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696153|NCT04530409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64696270|NCT03465787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696271|NCT03465787|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64696272|NCT03465787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64696273|NCT03465787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64696352|NCT05647512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64696353|NCT05647512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696354|NCT05647512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64696355|NCT05647512|Glucocorticoids|glucocorticoids|mesh-ancestor
64696356|NCT05647512|Hormones|hormones|mesh-ancestor
64696358|NCT05647512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64696428|NCT05445440|Antidotes|antidotes|mesh-ancestor
64696429|NCT05445440|Protective Agents|protective agents|mesh-ancestor
64696430|NCT05445440|Vitamin B Complex|vitamin b complex|mesh-ancestor
64696431|NCT05445440|Vitamins|vitamins|mesh-ancestor
64696432|NCT05445440|Micronutrients|micronutrients|mesh-ancestor
64696433|NCT05445440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64696434|NCT05445440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64696435|NCT05445440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64696436|NCT05445440|Analgesics|analgesics|mesh-ancestor
64696501|NCT02259582|Carboplatin|carboplatin|mesh-list
64696502|NCT02259582|Pemetrexed|pemetrexed|mesh-list
64696503|NCT02259582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696504|NCT02259582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696505|NCT02259582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696519|NCT02977208|Sensory System Agents|sensory system agents|mesh-ancestor
64696520|NCT02977208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64696523|NCT02977208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64696569|NCT02259348|Mechlorethamine|mechlorethamine|mesh-list
64696570|NCT02259348|Thiotepa|thiotepa|mesh-list
64696571|NCT02259348|Rituximab|rituximab|mesh-list
64696572|NCT02259348|Fludarabine|fludarabine|mesh-list
64696584|NCT02259348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64717967|NCT02389712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64717968|NCT02389712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64717969|NCT02389712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696673|NCT03463889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64696674|NCT03463889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696675|NCT03472469|Acetaminophen|acetaminophen|mesh-list
64696676|NCT03472469|Ketorolac|ketorolac|mesh-list
64696677|NCT03472469|Naproxen|naproxen|mesh-list
64696678|NCT03472469|Celecoxib|celecoxib|mesh-list
64696679|NCT03472469|Lidocaine|lidocaine|mesh-list
64696680|NCT03472469|Pregabalin|pregabalin|mesh-list
64717972|NCT02389712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696775|NCT03112603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64696776|NCT03112603|Antifungal Agents|antifungal agents|mesh-ancestor
64696777|NCT03112603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64696778|NCT03112603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64696779|NCT03112603|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
64696780|NCT02258334|Vaccines|vaccines|mesh-list
64696781|NCT02258334|Immunologic Factors|immunologic factors|mesh-ancestor
64696782|NCT02258334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696783|NCT03478163|Clindamycin|clindamycin|mesh-list
64696851|NCT05377034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696852|NCT05377034|Growth Inhibitors|growth inhibitors|mesh-ancestor
64696853|NCT03622619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64696854|NCT03622619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64696855|NCT03622619|Lubricant Eye Drops|lubricant eye drops|mesh-list
64696856|NCT03622619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64696857|NCT03622619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64696859|NCT04428359|Vitamins|vitamins|mesh-ancestor
64696860|NCT04428359|Micronutrients|micronutrients|mesh-ancestor
64696861|NCT04428359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696862|NCT04428359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64696863|NCT02257632|Ranibizumab|ranibizumab|mesh-list
64696864|NCT02257632|Aflibercept|aflibercept|mesh-list
64696865|NCT02257632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64696866|NCT02257632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64696867|NCT02257632|Growth Substances|growth substances|mesh-ancestor
64717980|NCT02389712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64717981|NCT02389712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64717982|NCT02389712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64717983|NCT02389712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64717984|NCT02389712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64717985|NCT02389712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64717986|NCT02369744|Tamsulosin|tamsulosin|mesh-list
64717987|NCT02369744|Silodosin|silodosin|mesh-list
64696911|NCT04486352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696912|NCT04486352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64696913|NCT04486352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64696914|NCT04486352|Growth Substances|growth substances|mesh-ancestor
64696915|NCT04486352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696916|NCT04486352|Growth Inhibitors|growth inhibitors|mesh-ancestor
64696917|NCT04486352|Immunologic Factors|immunologic factors|mesh-ancestor
64696918|NCT04486352|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64696994|NCT02973659|Urological Agents|urological agents|mesh-ancestor
64696995|NCT04439396|Ketorolac|ketorolac|mesh-list
64696996|NCT04439396|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64696997|NCT04439396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64696998|NCT04439396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64696999|NCT04439396|Analgesics|analgesics|mesh-ancestor
64697000|NCT04439396|Sensory System Agents|sensory system agents|mesh-ancestor
64697001|NCT04439396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64717996|NCT03577171|Entecavir|entecavir|mesh-list
64697096|NCT04342676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697098|NCT01641822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64697099|NCT01641822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64697100|NCT04398368|Gemcitabine|gemcitabine|mesh-list
64697101|NCT04398368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64697102|NCT04398368|Antimetabolites|antimetabolites|mesh-ancestor
64697103|NCT04398368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697104|NCT04398368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697105|NCT04398368|Antiviral Agents|antiviral agents|mesh-ancestor
64697157|NCT05641818|Micronutrients|micronutrients|mesh-ancestor
64697158|NCT05641818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697159|NCT05641818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64697160|NCT04762082|Tadalafil|tadalafil|mesh-list
64697161|NCT04762082|Vasodilator Agents|vasodilator agents|mesh-ancestor
64697162|NCT04762082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64697163|NCT04762082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64697164|NCT04762082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326228|NCT00955981|Lesinurad|lesinurad|mesh-list
64697263|NCT01639560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697264|NCT04243616|Paclitaxel|paclitaxel|mesh-list
64697265|NCT04243616|Cyclophosphamide|cyclophosphamide|mesh-list
64697266|NCT04243616|Carboplatin|carboplatin|mesh-list
64697267|NCT04243616|Doxorubicin|doxorubicin|mesh-list
64697268|NCT04243616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64697269|NCT04243616|Cemiplimab|cemiplimab|mesh-list
64697270|NCT04243616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64718034|NCT01072526|Cyclosporine|cyclosporine|mesh-list
64697365|NCT02975570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64697366|NCT02975570|Renal Agents|renal agents|mesh-ancestor
64697367|NCT02975570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64697368|NCT02975570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64697369|NCT02975570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64697370|NCT02975570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697371|NCT02975570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697372|NCT02975570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697376|NCT02975570|Antitubercular Agents|antitubercular agents|mesh-ancestor
64697437|NCT05427474|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64697438|NCT05427474|Adrenergic Agents|adrenergic agents|mesh-ancestor
64697439|NCT05427474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64697440|NCT05427474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64697441|NCT05427474|Vasodilator Agents|vasodilator agents|mesh-ancestor
64697442|NCT03667547|Raltegravir Potassium|raltegravir potassium|mesh-list
64697443|NCT03667547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64697444|NCT03667547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64697445|NCT03667547|Antiviral Agents|antiviral agents|mesh-ancestor
64697446|NCT03667547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64697447|NCT03667547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64697448|NCT03667547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64697449|NCT03667547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697450|NCT03667547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697491|NCT04160546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64697492|NCT04160546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64697493|NCT04160546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64697494|NCT04160546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64718054|NCT05312840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718056|NCT05312840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64718057|NCT05312840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718058|NCT05312840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64718082|NCT00378638|Growth Inhibitors|growth inhibitors|mesh-ancestor
64718083|NCT03582553|Naringenin|naringenin|mesh-list
64718084|NCT03582553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64718085|NCT03582553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64718086|NCT03582553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64718087|NCT03582553|Hormone Antagonists|hormone antagonists|mesh-ancestor
64718088|NCT03582553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64718089|NCT03582553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718090|NCT01025492|Fenofibric acid|fenofibric acid|mesh-list
64718091|NCT01025492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64718092|NCT01025492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64718093|NCT01025492|Antimetabolites|antimetabolites|mesh-ancestor
64718094|NCT01025492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718095|NCT01025492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64718096|NCT04331834|Hydroxychloroquine|hydroxychloroquine|mesh-list
64718097|NCT04331834|Antimalarials|antimalarials|mesh-ancestor
64718098|NCT04331834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64718099|NCT04331834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64718100|NCT04331834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64718101|NCT04331834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697540|NCT05122026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64697564|NCT01600716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64697565|NCT01600716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697566|NCT01600716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64697567|NCT01600716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64697568|NCT02975258|Nitric Oxide|nitric oxide|mesh-list
64697569|NCT02975258|Methacholine Chloride|methacholine chloride|mesh-list
64697570|NCT02975258|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64697571|NCT02975258|Autonomic Agents|autonomic agents|mesh-ancestor
64697572|NCT02975258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64697702|NCT00361790|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64697703|NCT00361790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64697704|NCT00361790|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64697705|NCT00361790|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64697706|NCT00361790|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64697707|NCT00361790|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64697708|NCT04570332|Pembrolizumab|pembrolizumab|mesh-list
64334820|NCT02296333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697768|NCT05346666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697769|NCT05346666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64697770|NCT05346666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64697771|NCT05346666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64697772|NCT05346666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64697773|NCT05346666|Anesthetics, General|anesthetics, general|mesh-ancestor
64697774|NCT05346666|Anesthetics|anesthetics|mesh-ancestor
64697835|NCT05369364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64697836|NCT05369364|Antiemetics|antiemetics|mesh-ancestor
64697837|NCT05369364|Autonomic Agents|autonomic agents|mesh-ancestor
64697838|NCT05369364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64697839|NCT05369364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697840|NCT05369364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64697841|NCT05369364|Glucocorticoids|glucocorticoids|mesh-ancestor
64697843|NCT05369364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64697844|NCT05369364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64697927|NCT02974712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64697928|NCT02974712|Anesthetics, General|anesthetics, general|mesh-ancestor
64697929|NCT02974712|Anesthetics|anesthetics|mesh-ancestor
64697930|NCT02974556|Capecitabine|capecitabine|mesh-list
64697931|NCT02974556|Oxaliplatin|oxaliplatin|mesh-list
64697932|NCT02974556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64697933|NCT02974556|Antimetabolites|antimetabolites|mesh-ancestor
64697934|NCT02974556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697935|NCT02974556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697936|NCT04523142|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64697937|NCT04523142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64697938|NCT03557333|Dihydroergotamine|dihydroergotamine|mesh-list
64697939|NCT03557333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64697940|NCT03557333|Dopamine Agonists|dopamine agonists|mesh-ancestor
64697941|NCT03557333|Dopamine Agents|dopamine agents|mesh-ancestor
64697942|NCT03557333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64697943|NCT03557333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697944|NCT03557333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697945|NCT03557333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64697998|NCT04841148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697999|NCT04841148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64698000|NCT04841148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698001|NCT04841148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64698002|NCT04841148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64698003|NCT04830462|Rifampin|rifampin|mesh-list
64698004|NCT04830462|Isoniazid|isoniazid|mesh-list
64698005|NCT04830462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64698006|NCT04830462|Antitubercular Agents|antitubercular agents|mesh-ancestor
64698085|NCT04474470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698086|NCT05330754|Caffeine|caffeine|mesh-list
64698087|NCT05330754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64698088|NCT05330754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698110|NCT04887948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718143|NCT02147834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64718144|NCT02147834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64718145|NCT02147834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718147|NCT00979550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64698187|NCT04023695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64698188|NCT04023695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64698189|NCT04023695|Autonomic Agents|autonomic agents|mesh-ancestor
64698190|NCT04023695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64698191|NCT04023695|Respiratory System Agents|respiratory system agents|mesh-ancestor
64698192|NCT04023695|Mydriatics|mydriatics|mesh-ancestor
64698193|NCT04023695|Sympathomimetics|sympathomimetics|mesh-ancestor
64698194|NCT04023695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64698206|NCT04223843|Respiratory System Agents|respiratory system agents|mesh-ancestor
64698208|NCT04223843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64698209|NCT04223843|Cholinergic Agents|cholinergic agents|mesh-ancestor
64718149|NCT00979550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718150|NCT00979550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718151|NCT00979550|Interferon Inducers|interferon inducers|mesh-ancestor
64334867|NCT03542669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64718152|NCT00966992|Zoledronic Acid|zoledronic acid|mesh-list
64718153|NCT00966992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64698252|NCT03778554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64698253|NCT04810494|Lidocaine|lidocaine|mesh-list
64698254|NCT04810494|Anesthetics, Local|anesthetics, local|mesh-ancestor
64698255|NCT04810494|Anesthetics|anesthetics|mesh-ancestor
64698256|NCT04810494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64698257|NCT04810494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698258|NCT04810494|Sensory System Agents|sensory system agents|mesh-ancestor
64698368|NCT00357721|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64698369|NCT00357721|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64698370|NCT00357721|Protease Inhibitors|protease inhibitors|mesh-ancestor
64698371|NCT00357721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698387|NCT03504410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698388|NCT03504410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64698389|NCT03504410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64698390|NCT03504410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64698391|NCT03504410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698392|NCT03504410|Antiviral Agents|antiviral agents|mesh-ancestor
64698393|NCT03504410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64698394|NCT03504410|Analgesics|analgesics|mesh-ancestor
64698395|NCT03504410|Sensory System Agents|sensory system agents|mesh-ancestor
64698396|NCT03504410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64698474|NCT03541902|Growth Inhibitors|growth inhibitors|mesh-ancestor
64698475|NCT03541902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64698486|NCT02386735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64698487|NCT02386735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698489|NCT02068430|Vitamin B Complex|vitamin b complex|mesh-ancestor
64698490|NCT02068430|Vitamins|vitamins|mesh-ancestor
64698491|NCT02068430|Micronutrients|micronutrients|mesh-ancestor
64698492|NCT02068430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698493|NCT02068430|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64698494|NCT02068430|Dermatologic Agents|dermatologic agents|mesh-ancestor
64698495|NCT03138512|Nivolumab|nivolumab|mesh-list
64698496|NCT03138512|Ipilimumab|ipilimumab|mesh-list
64698501|NCT03137888|Temozolomide|temozolomide|mesh-list
64698533|NCT02444234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698534|NCT02444936|Vaccines|vaccines|mesh-list
64698535|NCT02444936|Immunologic Factors|immunologic factors|mesh-ancestor
64698536|NCT02444936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698537|NCT02445326|Dexamethasone|dexamethasone|mesh-list
64698538|NCT02445326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64698539|NCT02445326|Antiemetics|antiemetics|mesh-ancestor
64698671|NCT01638546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64698672|NCT01638546|Alkylating Agents|alkylating agents|mesh-ancestor
64698673|NCT01638546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698674|NCT01638546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698675|NCT01638546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64698676|NCT01638546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698677|NCT04948489|Norethindrone|norethindrone|mesh-list
64698678|NCT04948489|Norethindrone Acetate|norethindrone acetate|mesh-list
64698679|NCT04948489|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64698680|NCT04948489|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64698681|NCT04948489|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64698776|NCT03012620|Pembrolizumab|pembrolizumab|mesh-list
64698777|NCT03012620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64698778|NCT03012620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698779|NCT05716867|Cystatins|cystatins|mesh-list
64698780|NCT05716867|Salivary Cystatins|salivary cystatins|mesh-list
64698781|NCT05716867|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64698782|NCT05716867|Protease Inhibitors|protease inhibitors|mesh-ancestor
64698783|NCT05716867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698784|NCT05716867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698785|NCT04341584|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64698786|NCT04341584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64698787|NCT01345136|Everolimus|everolimus|mesh-list
64698788|NCT01345136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698846|NCT05215158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64698847|NCT05215158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64698848|NCT05215158|Adrenergic Agents|adrenergic agents|mesh-ancestor
64698849|NCT05215158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64698850|NCT05215158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698851|NCT02454296|Lidocaine|lidocaine|mesh-list
64698852|NCT02454296|Anesthetics, Local|anesthetics, local|mesh-ancestor
64698853|NCT02454296|Anesthetics|anesthetics|mesh-ancestor
64698854|NCT02454296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64698855|NCT02454296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698856|NCT02454296|Sensory System Agents|sensory system agents|mesh-ancestor
64698857|NCT02454296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64698867|NCT03836833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698869|NCT03836833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64698870|NCT03836833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64698871|NCT03836833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64698872|NCT03101748|Paclitaxel|paclitaxel|mesh-list
64698873|NCT03101748|Cyclophosphamide|cyclophosphamide|mesh-list
64698874|NCT03101748|Doxorubicin|doxorubicin|mesh-list
64698875|NCT03101748|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64698876|NCT03101748|Trastuzumab|trastuzumab|mesh-list
64698877|NCT03101748|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64698878|NCT03101748|Daunorubicin|daunorubicin|mesh-list
64698879|NCT03101748|Pertuzumab|pertuzumab|mesh-list
64698880|NCT03101748|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
64698881|NCT03101748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64698882|NCT03101748|Antibodies|antibodies|mesh-list
64698883|NCT03101748|Immunoglobulins|immunoglobulins|mesh-list
64698884|NCT03101748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64698885|NCT03101748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64698886|NCT03101748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698887|NCT03101748|Tubulin Modulators|tubulin modulators|mesh-ancestor
64698888|NCT03101748|Antimitotic Agents|antimitotic agents|mesh-ancestor
64698889|NCT03101748|Mitosis Modulators|mitosis modulators|mesh-ancestor
64698891|NCT03101748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64698898|NCT03101748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64698899|NCT03101748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64698900|NCT03101748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64698901|NCT03101748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718196|NCT03608839|Antiemetics|antiemetics|mesh-ancestor
64718197|NCT03608839|Autonomic Agents|autonomic agents|mesh-ancestor
64718198|NCT03608839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64718199|NCT03608839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698902|NCT05710783|Vaccines|vaccines|mesh-list
64698903|NCT05710783|Immunologic Factors|immunologic factors|mesh-ancestor
64698904|NCT05710783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698905|NCT05710471|Aflibercept|aflibercept|mesh-list
64698906|NCT05710471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64698907|NCT05710471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64698908|NCT05710471|Growth Substances|growth substances|mesh-ancestor
64698909|NCT05710471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334934|NCT02229617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64698986|NCT05679193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334935|NCT02229617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698987|NCT05679193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64698988|NCT05679193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64698989|NCT05679193|Vasodilator Agents|vasodilator agents|mesh-ancestor
64698990|NCT04795752|Cyclosporine|cyclosporine|mesh-list
64698991|NCT04795752|Cyclosporins|cyclosporins|mesh-list
64698992|NCT04795752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698993|NCT04795752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699051|NCT04782804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699052|NCT04227288|Betamethasone|betamethasone|mesh-list
64699053|NCT04227288|Betamethasone Valerate|betamethasone valerate|mesh-list
64699054|NCT04227288|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64699055|NCT04227288|Betamethasone benzoate|betamethasone benzoate|mesh-list
64699056|NCT04227288|Calcipotriene|calcipotriene|mesh-list
64699057|NCT04227288|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64699058|NCT04227288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64699059|NCT04227288|Glucocorticoids|glucocorticoids|mesh-ancestor
64699060|NCT04227288|Hormones|hormones|mesh-ancestor
64699062|NCT04227288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699120|NCT04802382|Fibrin fragment D|fibrin fragment d|mesh-list
64699121|NCT04802382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64699122|NCT04802382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64699123|NCT04802382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699124|NCT04802382|Hemostatics|hemostatics|mesh-ancestor
64699125|NCT04802382|Coagulants|coagulants|mesh-ancestor
64699126|NCT05648916|Celecoxib|celecoxib|mesh-list
64699128|NCT05648916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64699225|NCT05409391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699226|NCT05141149|Gemcitabine|gemcitabine|mesh-list
64699227|NCT05141149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64699228|NCT05141149|Antimetabolites|antimetabolites|mesh-ancestor
64699229|NCT05141149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699230|NCT05141149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699231|NCT05141149|Antiviral Agents|antiviral agents|mesh-ancestor
64699232|NCT05141149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64699233|NCT05141149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64699295|NCT04835623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64699296|NCT04835623|Cyclosporins|cyclosporins|mesh-list
64699297|NCT04835623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64699298|NCT04835623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699299|NCT04835623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64699300|NCT04835623|Immunologic Factors|immunologic factors|mesh-ancestor
64699301|NCT04835623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699302|NCT04835623|Antifungal Agents|antifungal agents|mesh-ancestor
64699303|NCT04835623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64699304|NCT04835623|Dermatologic Agents|dermatologic agents|mesh-ancestor
64699305|NCT04835623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64699306|NCT04835623|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64699307|NCT04835623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64699308|NCT04500613|Dexamethasone|dexamethasone|mesh-list
64699309|NCT04500613|Dexamethasone acetate|dexamethasone acetate|mesh-list
64699310|NCT04500613|Bupivacaine|bupivacaine|mesh-list
64699311|NCT04500613|BB 1101|bb 1101|mesh-list
64699312|NCT04500613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64699313|NCT04500613|Antiemetics|antiemetics|mesh-ancestor
64699314|NCT04500613|Autonomic Agents|autonomic agents|mesh-ancestor
64699315|NCT04500613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699316|NCT04500613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718232|NCT00832520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64718233|NCT00832520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64718234|NCT00832520|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64718235|NCT00832520|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64699329|NCT04500613|Sensory System Agents|sensory system agents|mesh-ancestor
64699330|NCT04833907|Prednisone|prednisone|mesh-list
64699331|NCT04833907|Levetiracetam|levetiracetam|mesh-list
64699351|NCT00360295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64699352|NCT00360295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64699353|NCT04485013|Pembrolizumab|pembrolizumab|mesh-list
64699354|NCT04485013|Cetuximab|cetuximab|mesh-list
64699355|NCT04485013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64699356|NCT04485013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699357|NCT02976727|Vitamin D|vitamin d|mesh-list
64699419|NCT04010305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64699420|NCT04010305|Analgesics|analgesics|mesh-ancestor
64699421|NCT04010305|Sensory System Agents|sensory system agents|mesh-ancestor
64699422|NCT04010305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699423|NCT04010305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64699424|NCT04010305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64699425|NCT04010305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64699426|NCT04010305|Adrenergic Agents|adrenergic agents|mesh-ancestor
64699427|NCT04010305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64699429|NCT00361933|Valganciclovir|valganciclovir|mesh-list
64699497|NCT03926299|Hormones|hormones|mesh-ancestor
64699498|NCT03926299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64699499|NCT03926299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699529|NCT03844633|Medroxyprogesterone|medroxyprogesterone|mesh-list
64699530|NCT03844633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64699531|NCT03844633|Contraceptive Agents|contraceptive agents|mesh-ancestor
64699532|NCT03844633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64699533|NCT03844633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699534|NCT03844633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64699535|NCT03844633|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64699536|NCT03844633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64699537|NCT03844633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699538|NCT03844633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64699539|NCT03844633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64699540|NCT03844633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64699655|NCT03583710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699656|NCT03583710|Keratolytic Agents|keratolytic agents|mesh-ancestor
64699657|NCT03583710|Dermatologic Agents|dermatologic agents|mesh-ancestor
64699658|NCT03583710|Tubulin Modulators|tubulin modulators|mesh-ancestor
64699659|NCT03583710|Antimitotic Agents|antimitotic agents|mesh-ancestor
64699660|NCT03583710|Mitosis Modulators|mitosis modulators|mesh-ancestor
64699661|NCT03583710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64699662|NCT04418154|Paclitaxel|paclitaxel|mesh-list
64699663|NCT04418154|Cyclophosphamide|cyclophosphamide|mesh-list
64699664|NCT04418154|Epirubicin|epirubicin|mesh-list
64699665|NCT04418154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64699666|NCT04418154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64699667|NCT04418154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699769|NCT01634100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64699770|NCT01634100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64699771|NCT01634100|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64699772|NCT01634100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64699801|NCT03661645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64699802|NCT03661645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699803|NCT03661645|Protease Inhibitors|protease inhibitors|mesh-ancestor
64699941|NCT00003423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64699942|NCT00003423|Antiviral Agents|antiviral agents|mesh-ancestor
64699943|NCT00003423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64699944|NCT00003423|Tubulin Modulators|tubulin modulators|mesh-ancestor
64699945|NCT00003423|Antimitotic Agents|antimitotic agents|mesh-ancestor
64699946|NCT00003423|Mitosis Modulators|mitosis modulators|mesh-ancestor
64699947|NCT00003423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64699949|NCT00003273|Cyclophosphamide|cyclophosphamide|mesh-list
64699950|NCT00003273|Temozolomide|temozolomide|mesh-list
64699951|NCT00003273|Thiotepa|thiotepa|mesh-list
64699952|NCT00003273|Carboplatin|carboplatin|mesh-list
64699953|NCT00003273|Methotrexate|methotrexate|mesh-list
64699954|NCT00003273|Etoposide|etoposide|mesh-list
64699955|NCT00003273|Vincristine|vincristine|mesh-list
64699956|NCT00003273|Levoleucovorin|levoleucovorin|mesh-list
64699957|NCT00003273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64699958|NCT00003273|Immunologic Factors|immunologic factors|mesh-ancestor
64700013|NCT00383487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64700014|NCT00383487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700015|NCT00383487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700016|NCT00383487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64700017|NCT00383487|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64700018|NCT00383487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64700019|NCT00383487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64700020|NCT00383487|Vitamins|vitamins|mesh-ancestor
64700021|NCT00383487|Micronutrients|micronutrients|mesh-ancestor
64700022|NCT00383487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64700057|NCT00002805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700059|NCT00002805|Antimetabolites|antimetabolites|mesh-ancestor
64700227|NCT00002829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700228|NCT00002829|Antiviral Agents|antiviral agents|mesh-ancestor
64700229|NCT00002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64700231|NCT03614221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64700232|NCT03614221|Immunologic Factors|immunologic factors|mesh-ancestor
64700233|NCT03614221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700234|NCT03614221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64700235|NCT03614221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700272|NCT00002835|Immunologic Factors|immunologic factors|mesh-ancestor
64700273|NCT00002835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700274|NCT00002835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64700312|NCT00002835|Analgesics|analgesics|mesh-ancestor
64700361|NCT03576001|Anabolic Agents|anabolic agents|mesh-ancestor
64700362|NCT00003519|Cyclophosphamide|cyclophosphamide|mesh-list
64700363|NCT00003519|Docetaxel|docetaxel|mesh-list
64700364|NCT00003519|Doxorubicin|doxorubicin|mesh-list
64700365|NCT00003519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64700366|NCT00003519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64700367|NCT00003519|Immunologic Factors|immunologic factors|mesh-ancestor
64700368|NCT00003519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700369|NCT00003519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64700370|NCT00003519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64718302|NCT05286554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64718303|NCT05286554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718304|NCT05286554|Progestins|progestins|mesh-ancestor
64718305|NCT05286554|Luteolytic Agents|luteolytic agents|mesh-ancestor
64718306|NCT05286554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64718307|NCT05286554|Contraceptive Agents|contraceptive agents|mesh-ancestor
64700506|NCT04530487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64700507|NCT04530487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64700508|NCT04530487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64700509|NCT04530487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700510|NCT04530487|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64700511|NCT04530487|Antifungal Agents|antifungal agents|mesh-ancestor
64700512|NCT04530487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64700513|NCT04530487|Dermatologic Agents|dermatologic agents|mesh-ancestor
64700514|NCT04530487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64700573|NCT00003375|Procarbazine|procarbazine|mesh-list
64700574|NCT00003375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64700575|NCT00003375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700576|NCT00003375|Tubulin Modulators|tubulin modulators|mesh-ancestor
64700577|NCT00003375|Antimitotic Agents|antimitotic agents|mesh-ancestor
64700578|NCT00003375|Mitosis Modulators|mitosis modulators|mesh-ancestor
64700579|NCT00003375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700580|NCT00003375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64700581|NCT00003375|Alkylating Agents|alkylating agents|mesh-ancestor
64718308|NCT05286554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64718309|NCT05286554|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64718310|NCT05286554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64718311|NCT05286554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718312|NCT00379262|Fluorouracil|fluorouracil|mesh-list
64718313|NCT00379262|Capecitabine|capecitabine|mesh-list
64700582|NCT03499249|Acetylcysteine|acetylcysteine|mesh-list
64700583|NCT03499249|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64700594|NCT03498391|Ketamine|ketamine|mesh-list
64700722|NCT00003957|Antiviral Agents|antiviral agents|mesh-ancestor
64335007|NCT03515707|Etoposide|etoposide|mesh-list
64700723|NCT00003957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64700724|NCT00003957|Analgesics|analgesics|mesh-ancestor
64700755|NCT00003963|Mitosis Modulators|mitosis modulators|mesh-ancestor
64700756|NCT00003963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700758|NCT00004845|Rofecoxib|rofecoxib|mesh-list
64700760|NCT00004845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64700866|NCT00003585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700867|NCT00003585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64700868|NCT00003585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700869|NCT00003585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64700870|NCT00003585|Immunologic Factors|immunologic factors|mesh-ancestor
64700871|NCT00003585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700872|NCT00003585|Antiviral Agents|antiviral agents|mesh-ancestor
64700873|NCT00003585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64700884|NCT02975323|Carvedilol|carvedilol|mesh-list
64700933|NCT00004005|Vitamin B Complex|vitamin b complex|mesh-ancestor
64700934|NCT00004005|Vitamins|vitamins|mesh-ancestor
64700935|NCT00004005|Micronutrients|micronutrients|mesh-ancestor
64700936|NCT00003603|Dexamethasone|dexamethasone|mesh-list
64700937|NCT00003603|Prednisolone|prednisolone|mesh-list
64700938|NCT00003603|Cyclophosphamide|cyclophosphamide|mesh-list
64700939|NCT00003603|Melphalan|melphalan|mesh-list
64700940|NCT00003603|Lomustine|lomustine|mesh-list
64700941|NCT00003603|Idarubicin|idarubicin|mesh-list
64700942|NCT00003603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64700976|NCT00004887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64700981|NCT00004893|Interleukin-12|interleukin-12|mesh-list
64701032|NCT00004017|Antibodies|antibodies|mesh-list
64701033|NCT00004017|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64701034|NCT00004017|Immunologic Factors|immunologic factors|mesh-ancestor
64701035|NCT00004017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701036|NCT00003615|Denileukin diftitox|denileukin diftitox|mesh-list
64701037|NCT00003615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701038|NCT00004905|Interferons|interferons|mesh-list
64701039|NCT00004905|Cytarabine|cytarabine|mesh-list
64701040|NCT00004905|Interferon-alpha|interferon-alpha|mesh-list
64701041|NCT00004905|Cyclophosphamide|cyclophosphamide|mesh-list
64701042|NCT00004905|Etoposide|etoposide|mesh-list
64701043|NCT00004905|Idarubicin|idarubicin|mesh-list
64701044|NCT00004905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64701045|NCT00004905|Immunologic Factors|immunologic factors|mesh-ancestor
64701046|NCT00004905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701100|NCT00003627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701101|NCT00003627|Antimetabolites|antimetabolites|mesh-ancestor
64701127|NCT00003633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64701129|NCT00003633|Hormones|hormones|mesh-ancestor
64701130|NCT00003633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64701131|NCT00003633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701132|NCT00003633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64701133|NCT00003633|Analgesics|analgesics|mesh-ancestor
64701134|NCT00003633|Sensory System Agents|sensory system agents|mesh-ancestor
64701135|NCT00003633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64701136|NCT00003633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64701137|NCT00003633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64701138|NCT00003633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701139|NCT00003633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64701140|NCT00003633|Alkylating Agents|alkylating agents|mesh-ancestor
64701141|NCT02363335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64701142|NCT02363335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64701143|NCT02363335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701144|NCT02363335|Incretins|incretins|mesh-ancestor
64701200|NCT00004071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64701201|NCT00004071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701202|NCT00004071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64701236|NCT00003657|Amifostine|amifostine|mesh-list
64701237|NCT00003657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701238|NCT00003657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64701239|NCT00003657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64701240|NCT00003657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64701241|NCT00003657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701242|NCT00003657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701243|NCT00003657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701244|NCT00003657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64701323|NCT00004125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64701324|NCT00004125|Alkylating Agents|alkylating agents|mesh-ancestor
64701325|NCT00004125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64701326|NCT00004125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64701327|NCT00004125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64701328|NCT00004125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64701329|NCT00004125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701330|NCT00004125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64701331|NCT00004125|Hormone Antagonists|hormone antagonists|mesh-ancestor
64701332|NCT00004125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64701333|NCT00004125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64701337|NCT00003675|Topotecan|topotecan|mesh-list
64701401|NCT00004161|Protective Agents|protective agents|mesh-ancestor
64701402|NCT00004161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701403|NCT00004173|Paclitaxel|paclitaxel|mesh-list
64701404|NCT00004173|Oxaliplatin|oxaliplatin|mesh-list
64701405|NCT00004173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64701406|NCT00004173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701407|NCT00004173|Tubulin Modulators|tubulin modulators|mesh-ancestor
64701408|NCT00004173|Antimitotic Agents|antimitotic agents|mesh-ancestor
64701447|NCT00003687|Morphine|morphine|mesh-list
64701544|NCT00004215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701545|NCT00004215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64701546|NCT00004215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64701547|NCT00004215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64701561|NCT00004221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64701562|NCT00004221|Immunologic Factors|immunologic factors|mesh-ancestor
64701563|NCT00004221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701564|NCT00004221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64701565|NCT00004221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64701566|NCT00004221|Alkylating Agents|alkylating agents|mesh-ancestor
64701567|NCT00004221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64701568|NCT00004221|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64701569|NCT00004221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64701570|NCT00004221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64701571|NCT00004221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701572|NCT00003711|Irinotecan|irinotecan|mesh-list
64701573|NCT00003711|Pemetrexed|pemetrexed|mesh-list
64701603|NCT00385359|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64426876|NCT02230527|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64701604|NCT00385359|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64701605|NCT00385359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64701606|NCT00385359|Adrenergic Agents|adrenergic agents|mesh-ancestor
64701607|NCT00385359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64701609|NCT00004233|Leucovorin|leucovorin|mesh-list
64718406|NCT01797380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64718407|NCT01797380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718408|NCT01797380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64718409|NCT01797380|Serotonin Agents|serotonin agents|mesh-ancestor
64718410|NCT01797380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718411|NCT01797380|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64718412|NCT01797380|Antidepressive Agents|antidepressive agents|mesh-ancestor
64335089|NCT03146247|Apremilast|apremilast|mesh-list
64701809|NCT00004323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64701839|NCT00003759|Valrubicin|valrubicin|mesh-list
64701840|NCT00003759|BCG Vaccine|bcg vaccine|mesh-list
64701841|NCT00003759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64701842|NCT00003759|Immunologic Factors|immunologic factors|mesh-ancestor
64701843|NCT00003759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701844|NCT00003759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701845|NCT00003759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64701849|NCT00003765|Carmustine|carmustine|mesh-list
64701902|NCT00003783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701903|NCT00003783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701904|NCT00003783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64701905|NCT00003783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64701906|NCT00003783|Antiemetics|antiemetics|mesh-ancestor
64701907|NCT00003783|Autonomic Agents|autonomic agents|mesh-ancestor
64701908|NCT00003783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64701909|NCT00003783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64701910|NCT00003783|Glucocorticoids|glucocorticoids|mesh-ancestor
64701911|NCT00003783|Hormones|hormones|mesh-ancestor
64701912|NCT00003783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64701973|NCT04712799|Respiratory System Agents|respiratory system agents|mesh-ancestor
64701974|NCT00384969|Sorafenib|sorafenib|mesh-list
64701975|NCT00384969|Everolimus|everolimus|mesh-list
64701976|NCT00384969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701977|NCT00384969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64701978|NCT00384969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701979|NCT00384969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701980|NCT00384969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64701981|NCT00384969|Immunologic Factors|immunologic factors|mesh-ancestor
64702041|NCT00004485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64702042|NCT00004485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64702075|NCT02678312|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64702076|NCT02678312|Protease Inhibitors|protease inhibitors|mesh-ancestor
64702077|NCT02678312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702078|NCT02678312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702079|NCT02678312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64702081|NCT00003843|Irinotecan|irinotecan|mesh-list
64702171|NCT00004665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702172|NCT00363584|Capecitabine|capecitabine|mesh-list
64702173|NCT00363584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64702174|NCT00363584|Antimetabolites|antimetabolites|mesh-ancestor
64702175|NCT00363584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702176|NCT00363584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702177|NCT00003873|Fluorouracil|fluorouracil|mesh-list
64702178|NCT00003873|Eniluracil|eniluracil|mesh-list
64702179|NCT00003873|Antimetabolites|antimetabolites|mesh-ancestor
64945558|NCT05450692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64945559|NCT05447559|Cefazolin|cefazolin|mesh-list
64702180|NCT00003873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702181|NCT00003873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64702182|NCT00003873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702183|NCT00003873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64702270|NCT00004785|Dexamethasone|dexamethasone|mesh-list
64702271|NCT00004785|Methylprednisolone|methylprednisolone|mesh-list
64702272|NCT00004785|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64702273|NCT00004785|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64702274|NCT00004785|Prednisolone|prednisolone|mesh-list
64702275|NCT00004785|Prednisolone acetate|prednisolone acetate|mesh-list
64702276|NCT00004785|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64702277|NCT00004785|Prednisolone phosphate|prednisolone phosphate|mesh-list
64702278|NCT00004785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64702279|NCT00004785|Antiemetics|antiemetics|mesh-ancestor
64702280|NCT00004785|Autonomic Agents|autonomic agents|mesh-ancestor
64702281|NCT00004785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64702367|NCT00005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702368|NCT00005601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64702369|NCT00005601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64702370|NCT00005601|Antiemetics|antiemetics|mesh-ancestor
64702371|NCT00005601|Autonomic Agents|autonomic agents|mesh-ancestor
64702372|NCT00005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64702373|NCT00005601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64702374|NCT00005601|Glucocorticoids|glucocorticoids|mesh-ancestor
64702375|NCT00005601|Hormones|hormones|mesh-ancestor
64702481|NCT03390673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64702482|NCT03390673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702483|NCT03390673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64702484|NCT03390673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64702485|NCT03390673|Growth Substances|growth substances|mesh-ancestor
64702499|NCT00005775|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
64702500|NCT00005775|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64702580|NCT01689987|Alkylating Agents|alkylating agents|mesh-ancestor
64702581|NCT01689987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702582|NCT01689987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702583|NCT01689987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64702584|NCT01689987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64702586|NCT01689987|Autonomic Agents|autonomic agents|mesh-ancestor
64702587|NCT01689987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64702588|NCT01689987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64702679|NCT02420210|Antiemetics|antiemetics|mesh-ancestor
64702680|NCT02420210|Autonomic Agents|autonomic agents|mesh-ancestor
64702681|NCT02420210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64702682|NCT02420210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702683|NCT02420210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64702684|NCT02420210|Glucocorticoids|glucocorticoids|mesh-ancestor
64702685|NCT02420210|Hormones|hormones|mesh-ancestor
64702690|NCT02420210|Alkylating Agents|alkylating agents|mesh-ancestor
64702762|NCT04821375|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64702763|NCT04821375|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64702764|NCT04821375|Hormone Antagonists|hormone antagonists|mesh-ancestor
64702765|NCT04821375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64702766|NCT02488070|Edetic Acid|edetic acid|mesh-list
64702767|NCT02488070|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64702768|NCT02488070|Chelating Agents|chelating agents|mesh-ancestor
64702769|NCT02488070|Sequestering Agents|sequestering agents|mesh-ancestor
64702770|NCT02488070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702771|NCT02488070|Anticoagulants|anticoagulants|mesh-ancestor
64702772|NCT02488070|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64702773|NCT02488070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64702774|NCT04116541|Trametinib|trametinib|mesh-list
64702775|NCT04116541|Dabrafenib|dabrafenib|mesh-list
64702776|NCT04116541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702777|NCT04116541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64702778|NCT04116541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702779|NCT04116541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702780|NCT04822467|Ethanol|ethanol|mesh-list
64702785|NCT03306979|Acetylcysteine|acetylcysteine|mesh-list
64702819|NCT02422940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64702820|NCT02422940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64702821|NCT02422940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718487|NCT01756586|Autonomic Agents|autonomic agents|mesh-ancestor
64718488|NCT01756586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64718489|NCT01756586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718490|NCT01756586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64702918|NCT02420041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64702919|NCT02420041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702920|NCT02420041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64702921|NCT02420041|Glucocorticoids|glucocorticoids|mesh-ancestor
64718494|NCT01756586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64718495|NCT01756586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718496|NCT01756586|Anesthetics, Local|anesthetics, local|mesh-ancestor
64718497|NCT01756586|Anesthetics|anesthetics|mesh-ancestor
64718498|NCT01756586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64718538|NCT01718444|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64718539|NCT01718444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64718540|NCT01718444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718541|NCT01718444|Hormones|hormones|mesh-ancestor
64702940|NCT03091075|Hormones|hormones|mesh-ancestor
64702941|NCT03091075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64702942|NCT03091075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702943|NCT03091075|Anabolic Agents|anabolic agents|mesh-ancestor
64702944|NCT03089905|Dexmedetomidine|dexmedetomidine|mesh-list
64702990|NCT02492750|Dexamethasone|dexamethasone|mesh-list
64702991|NCT02492750|Dexamethasone acetate|dexamethasone acetate|mesh-list
64702992|NCT02492750|Lenalidomide|lenalidomide|mesh-list
64702993|NCT02492750|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64702994|NCT02492750|Ichthammol|ichthammol|mesh-list
64702995|NCT02492750|BB 1101|bb 1101|mesh-list
64702996|NCT02492750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64702997|NCT02492750|Antiemetics|antiemetics|mesh-ancestor
64702998|NCT02492750|Autonomic Agents|autonomic agents|mesh-ancestor
64702999|NCT02492750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64703049|NCT02428478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703050|NCT02428478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703051|NCT02428478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64703052|NCT02428478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64703053|NCT02428478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64703054|NCT02428478|Adrenergic Agents|adrenergic agents|mesh-ancestor
64703055|NCT02428478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703056|NCT02428478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703057|NCT04341493|Hydroxychloroquine|hydroxychloroquine|mesh-list
64703058|NCT04341493|Nitazoxanide|nitazoxanide|mesh-list
64703059|NCT04341493|Antimalarials|antimalarials|mesh-ancestor
64703060|NCT04341493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64703061|NCT04341493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64703062|NCT04341493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64703100|NCT02974244|Hormones|hormones|mesh-ancestor
64703101|NCT02974244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64703109|NCT02436031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64703110|NCT02436031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64703111|NCT02436031|Adrenergic Agents|adrenergic agents|mesh-ancestor
64428382|NCT02302807|Paclitaxel|paclitaxel|mesh-list
64703112|NCT02436031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703113|NCT02436031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703115|NCT02454283|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64703116|NCT02454283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64703117|NCT02454283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64703118|NCT02454283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703119|NCT02454283|Dopamine Agents|dopamine agents|mesh-ancestor
64703120|NCT02454283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703122|NCT02437669|Hydromorphone|hydromorphone|mesh-list
64703152|NCT02533934|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64703153|NCT02533934|Antiviral Agents|antiviral agents|mesh-ancestor
64703154|NCT02533934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64703155|NCT02519023|Acetaminophen|acetaminophen|mesh-list
64703156|NCT02519023|Ibuprofen|ibuprofen|mesh-list
64703157|NCT02519023|Epinephrine|epinephrine|mesh-list
64703158|NCT02519023|Oxycodone|oxycodone|mesh-list
64703159|NCT02519023|Bupivacaine|bupivacaine|mesh-list
64703160|NCT02519023|Anesthetics, Local|anesthetics, local|mesh-ancestor
64703225|NCT02459275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64703226|NCT02459275|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64703227|NCT02459275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64703228|NCT02459275|Dopamine Agents|dopamine agents|mesh-ancestor
64703229|NCT02459275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703230|NCT02459275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703231|NCT02524561|Estradiol|estradiol|mesh-list
64703232|NCT02524561|Progesterone|progesterone|mesh-list
64703233|NCT02524561|Estrogens|estrogens|mesh-ancestor
64703234|NCT02524561|Hormones|hormones|mesh-ancestor
64703239|NCT02431598|Chelating Agents|chelating agents|mesh-ancestor
64703240|NCT02431598|Sequestering Agents|sequestering agents|mesh-ancestor
64703241|NCT02431598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703242|NCT04743739|Cyclosporine|cyclosporine|mesh-list
64703243|NCT04743739|Rituximab|rituximab|mesh-list
64703283|NCT02525653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703284|NCT02431754|Tadalafil|tadalafil|mesh-list
64703285|NCT02431754|Vasodilator Agents|vasodilator agents|mesh-ancestor
64703286|NCT02431754|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64703287|NCT02431754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64703288|NCT02431754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703289|NCT02431754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703351|NCT02464033|Cholecalciferol|cholecalciferol|mesh-list
64703352|NCT02464033|Etanercept|etanercept|mesh-list
64703353|NCT02464033|Vitamins|vitamins|mesh-ancestor
64703354|NCT02464033|Micronutrients|micronutrients|mesh-ancestor
64703355|NCT02464033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703356|NCT02464033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64703357|NCT02464033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64703358|NCT02464033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64703359|NCT02464033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64703360|NCT02464033|Analgesics|analgesics|mesh-ancestor
64703439|NCT02464657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64703440|NCT02464657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64703441|NCT02464657|Immunologic Factors|immunologic factors|mesh-ancestor
64703442|NCT02464657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64703443|NCT02464657|Protective Agents|protective agents|mesh-ancestor
64703444|NCT02464657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64703445|NCT02464657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64703446|NCT02464657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64703447|NCT02464657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703448|NCT02535949|Tranexamic Acid|tranexamic acid|mesh-list
64703449|NCT02535949|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64703450|NCT02535949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64703451|NCT02535949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703452|NCT02535949|Hemostatics|hemostatics|mesh-ancestor
64703453|NCT02535949|Coagulants|coagulants|mesh-ancestor
64703454|NCT02536105|Methylphenidate|methylphenidate|mesh-list
64335497|NCT02302495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64703492|NCT02438540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703493|NCT02506634|Esomeprazole|esomeprazole|mesh-list
64703494|NCT02506634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64703495|NCT02506634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64703496|NCT02506634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64703497|NCT02506634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703505|NCT02541422|Expectorants|expectorants|mesh-ancestor
64703564|NCT02538679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703565|NCT02538679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703566|NCT02538679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64703567|NCT02538679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64428831|NCT02161731|Warfarin|warfarin|mesh-list
64703568|NCT02538679|Autonomic Agents|autonomic agents|mesh-ancestor
64703569|NCT02538679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64703570|NCT02538679|Respiratory System Agents|respiratory system agents|mesh-ancestor
64703571|NCT02538679|Mydriatics|mydriatics|mesh-ancestor
64703572|NCT02538679|Sympathomimetics|sympathomimetics|mesh-ancestor
64703573|NCT02538679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64703585|NCT02551094|Gout Suppressants|gout suppressants|mesh-ancestor
64703586|NCT02551094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64703587|NCT02551094|Tubulin Modulators|tubulin modulators|mesh-ancestor
64703588|NCT02551094|Antimitotic Agents|antimitotic agents|mesh-ancestor
64703589|NCT02551094|Mitosis Modulators|mitosis modulators|mesh-ancestor
64703590|NCT02551094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703592|NCT02513498|Ixazomib|ixazomib|mesh-list
64703632|NCT02516150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64718629|NCT00624650|Coagulants|coagulants|mesh-ancestor
64718630|NCT00624650|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64718631|NCT00624650|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64718632|NCT00377065|Raltegravir Potassium|raltegravir potassium|mesh-list
64718633|NCT00377065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64326790|NCT00838279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64703633|NCT04025060|Caffeine|caffeine|mesh-list
64703637|NCT04025060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703696|NCT04341038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64703697|NCT04341038|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64703698|NCT04341038|Protective Agents|protective agents|mesh-ancestor
64703699|NCT04341038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64703700|NCT04341038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718634|NCT00377065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64718635|NCT00377065|Antiviral Agents|antiviral agents|mesh-ancestor
64718636|NCT00377065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64718637|NCT00377065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64703701|NCT02561702|Mexiletine|mexiletine|mesh-list
64703779|NCT02541565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64703780|NCT02541565|Tubulin Modulators|tubulin modulators|mesh-ancestor
64703781|NCT02541565|Antimitotic Agents|antimitotic agents|mesh-ancestor
64703782|NCT02541565|Mitosis Modulators|mitosis modulators|mesh-ancestor
64703783|NCT04707950|Tranexamic Acid|tranexamic acid|mesh-list
64703784|NCT04707950|Oxytocin|oxytocin|mesh-list
64703785|NCT04707950|Oxytocics|oxytocics|mesh-ancestor
64703786|NCT04707950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64703787|NCT04707950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718642|NCT00377143|Anticoagulants|anticoagulants|mesh-ancestor
64718643|NCT00610532|Probenecid|probenecid|mesh-list
64718644|NCT00610532|Phenytoin|phenytoin|mesh-list
64718645|NCT00610532|Anticonvulsants|anticonvulsants|mesh-ancestor
64718646|NCT00610532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64703791|NCT04707950|Hemostatics|hemostatics|mesh-ancestor
64703834|NCT03169166|Contraceptive Agents|contraceptive agents|mesh-ancestor
64703835|NCT03169166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64703836|NCT03169166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703844|NCT02582840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703845|NCT00364988|Pioglitazone|pioglitazone|mesh-list
64703846|NCT00364988|Losartan|losartan|mesh-list
64703847|NCT00364988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64703848|NCT00364988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703849|NCT00364988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64703850|NCT00364988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64703851|NCT00364988|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64703852|NCT00364988|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64703897|NCT05247554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64703898|NCT05247554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703899|NCT05247554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64703900|NCT05247554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64703901|NCT05247554|Antimalarials|antimalarials|mesh-ancestor
64703911|NCT02596022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64703912|NCT02596022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945569|NCT05438043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64703913|NCT02596022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64703914|NCT02596022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64703915|NCT02596022|Anesthetics, General|anesthetics, general|mesh-ancestor
64703961|NCT02601170|Immunologic Factors|immunologic factors|mesh-ancestor
64703962|NCT02601170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703963|NCT02601170|Viscosupplements|viscosupplements|mesh-ancestor
64703964|NCT02601170|Protective Agents|protective agents|mesh-ancestor
64703965|NCT00366002|Darifenacin|darifenacin|mesh-list
64703966|NCT00366002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64703972|NCT00366002|Urological Agents|urological agents|mesh-ancestor
64703973|NCT00422240|Adapalene|adapalene|mesh-list
64703974|NCT00422240|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
64703975|NCT00422240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64703976|NCT00422240|Dermatologic Agents|dermatologic agents|mesh-ancestor
64703977|NCT00422240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64703978|NCT00422240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64703979|NCT00422240|Analgesics|analgesics|mesh-ancestor
64704020|NCT02607254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64704021|NCT02607254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64704022|NCT02607254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704023|NCT02607254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64704024|NCT02607254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64704025|NCT02607254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64704026|NCT02607254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64704027|NCT02607254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64704028|NCT02611154|Testosterone|testosterone|mesh-list
64704029|NCT02611154|Androgens|androgens|mesh-ancestor
64704030|NCT02611154|Hormones|hormones|mesh-ancestor
64704031|NCT02611154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64704032|NCT02611154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704033|NCT02617784|Oseltamivir|oseltamivir|mesh-list
64704034|NCT02617784|Antiviral Agents|antiviral agents|mesh-ancestor
64704035|NCT02617784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64704040|NCT04936334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704041|NCT00365612|Tenofovir|tenofovir|mesh-list
64704042|NCT00365612|Emtricitabine|emtricitabine|mesh-list
64704043|NCT00365612|Efavirenz|efavirenz|mesh-list
64704044|NCT00365612|Antiviral Agents|antiviral agents|mesh-ancestor
64704045|NCT00365612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64704046|NCT00365612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64704050|NCT00365612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64335612|NCT02344017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704070|NCT02974166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704071|NCT02974166|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64704072|NCT02974166|Antidepressive Agents|antidepressive agents|mesh-ancestor
64704073|NCT02974166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64704074|NCT02974166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64704075|NCT02974166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64704076|NCT02974166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64704077|NCT02974166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64704078|NCT04870034|Palbociclib|palbociclib|mesh-list
64704079|NCT04870034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704080|NCT04870034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64704081|NCT04870034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704082|NCT04870034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704083|NCT05731778|Listerine|listerine|mesh-list
64704084|NCT05731778|Fluorides|fluorides|mesh-list
64704085|NCT05731778|Sodium Fluoride|sodium fluoride|mesh-list
64704086|NCT05731778|Tin Fluorides|tin fluorides|mesh-list
64704087|NCT05731778|Cariostatic Agents|cariostatic agents|mesh-ancestor
64704088|NCT05731778|Protective Agents|protective agents|mesh-ancestor
64704089|NCT05731778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704090|NCT05731778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64704091|NCT05731778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64704092|NCT00422318|Benzbromarone|benzbromarone|mesh-list
64704093|NCT00422318|Uricosuric Agents|uricosuric agents|mesh-ancestor
64704094|NCT00422318|Gout Suppressants|gout suppressants|mesh-ancestor
64704095|NCT00422318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64704096|NCT00422318|Renal Agents|renal agents|mesh-ancestor
64704097|NCT00364754|Tesmilifene|tesmilifene|mesh-list
64704118|NCT04741880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704119|NCT04742504|Benralizumab|benralizumab|mesh-list
64704120|NCT04742504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64704121|NCT04742504|Respiratory System Agents|respiratory system agents|mesh-ancestor
64704122|NCT00365924|Teriparatide|teriparatide|mesh-list
64704123|NCT00365924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64704124|NCT00365924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718671|NCT00378716|Calcium|calcium|mesh-list
64718672|NCT00378716|Levoleucovorin|levoleucovorin|mesh-list
64718673|NCT00378716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64718674|NCT00378716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718675|NCT00378716|Antimetabolites|antimetabolites|mesh-ancestor
64718676|NCT00378716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326826|NCT00717457|Exenatide|exenatide|mesh-list
64704125|NCT00365924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64704126|NCT05360030|Ketamine|ketamine|mesh-list
64704127|NCT05360030|Naloxone|naloxone|mesh-list
64704128|NCT05360030|Analgesics|analgesics|mesh-ancestor
64704129|NCT05360030|Sensory System Agents|sensory system agents|mesh-ancestor
64704130|NCT05360030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64704131|NCT05360030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704132|NCT05360030|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64704133|NCT05360030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64945571|NCT05438043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64945572|NCT05438043|Glucocorticoids|glucocorticoids|mesh-ancestor
64945573|NCT05438043|Hormones|hormones|mesh-ancestor
64945574|NCT05438043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64704150|NCT04158362|Antimitotic Agents|antimitotic agents|mesh-ancestor
64704151|NCT04158362|Mitosis Modulators|mitosis modulators|mesh-ancestor
64704152|NCT04158362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704153|NCT04158362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64704154|NCT04158362|Antimetabolites|antimetabolites|mesh-ancestor
64704155|NCT04158362|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64704156|NCT04158362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64704157|NCT04158362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704213|NCT04799262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704214|NCT00851136|Bevacizumab|bevacizumab|mesh-list
64704215|NCT00851136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64704216|NCT00851136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704217|NCT00851136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64704218|NCT00851136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64704219|NCT00851136|Growth Substances|growth substances|mesh-ancestor
64704220|NCT00851136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704221|NCT00851136|Growth Inhibitors|growth inhibitors|mesh-ancestor
64704222|NCT04798482|Dexmedetomidine|dexmedetomidine|mesh-list
64704223|NCT04798482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64704224|NCT04798482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64704225|NCT04798482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704226|NCT04798482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64704227|NCT04798482|Analgesics|analgesics|mesh-ancestor
64704228|NCT04798482|Sensory System Agents|sensory system agents|mesh-ancestor
64704229|NCT04798482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64335687|NCT02341365|Vitamins|vitamins|mesh-ancestor
64704266|NCT02620904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64704267|NCT00300768|Ivermectin|ivermectin|mesh-list
64704268|NCT00300768|Moxidectin|moxidectin|mesh-list
64704269|NCT00300768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64704270|NCT00300768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64704271|NCT00300768|Anthelmintics|anthelmintics|mesh-ancestor
64704272|NCT00300768|Antinematodal Agents|antinematodal agents|mesh-ancestor
64704274|NCT02621060|Antacids|antacids|mesh-ancestor
64704333|NCT04289792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704334|NCT04289792|Tubulin Modulators|tubulin modulators|mesh-ancestor
64704335|NCT04289792|Antimitotic Agents|antimitotic agents|mesh-ancestor
64704336|NCT04289792|Mitosis Modulators|mitosis modulators|mesh-ancestor
64704337|NCT04289792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704338|NCT04289792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64704339|NCT04289792|Antimetabolites|antimetabolites|mesh-ancestor
64704340|NCT04289792|Antiviral Agents|antiviral agents|mesh-ancestor
64704341|NCT04289792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64704342|NCT04289792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704343|NCT04289792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64704344|NCT04289792|Immunologic Factors|immunologic factors|mesh-ancestor
64704345|NCT04289792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704346|NCT02631590|Gemcitabine|gemcitabine|mesh-list
64704347|NCT02631590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704348|NCT02631590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64704396|NCT02544607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64335758|NCT04771923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64704397|NCT02544607|Anesthetics, General|anesthetics, general|mesh-ancestor
64704398|NCT02544607|Anesthetics|anesthetics|mesh-ancestor
64704399|NCT02544607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64704400|NCT02544607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64704459|NCT02247960|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64704460|NCT02247960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64704461|NCT02473783|Sertraline|sertraline|mesh-list
64704462|NCT02473783|Antidepressive Agents|antidepressive agents|mesh-ancestor
64429730|NCT02112045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64704463|NCT02473783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64704464|NCT02473783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64704465|NCT02473783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64704466|NCT02473783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64704467|NCT02473783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704468|NCT02473783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64704470|NCT02473783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704471|NCT02247804|Timolol|timolol|mesh-list
64704472|NCT02247804|Bimatoprost|bimatoprost|mesh-list
64704473|NCT02247804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64704474|NCT02247804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64704475|NCT02247804|Adrenergic Agents|adrenergic agents|mesh-ancestor
64335804|NCT03148509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64718710|NCT04585490|Cisplatin|cisplatin|mesh-list
64718711|NCT04585490|Carboplatin|carboplatin|mesh-list
64704510|NCT04068272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64704511|NCT04068272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704512|NCT04058756|Spartalizumab|spartalizumab|mesh-list
64704513|NCT04058756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64704517|NCT02243202|Phentermine|phentermine|mesh-list
64704520|NCT02243202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64704574|NCT02560051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64718712|NCT04585490|Pemetrexed|pemetrexed|mesh-list
64718713|NCT04585490|Durvalumab|durvalumab|mesh-list
64718714|NCT04585490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64718715|NCT04585490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64704575|NCT03786770|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64704576|NCT03786770|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64704577|NCT03786770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64704642|NCT02564029|Antiemetics|antiemetics|mesh-ancestor
64945582|NCT05427786|Nicorandil|nicorandil|mesh-list
64704644|NCT02564029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64704645|NCT02564029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704646|NCT02564029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64718716|NCT04585490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718717|NCT04585490|Tubulin Modulators|tubulin modulators|mesh-ancestor
64718718|NCT04585490|Antimitotic Agents|antimitotic agents|mesh-ancestor
64718719|NCT04585490|Mitosis Modulators|mitosis modulators|mesh-ancestor
64718720|NCT04585490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718721|NCT04585490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718722|NCT04585490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64704653|NCT02564029|GABA Agents|gaba agents|mesh-ancestor
64704711|NCT03926624|Idarubicin|idarubicin|mesh-list
64704712|NCT03926624|Cladribine|cladribine|mesh-list
64704713|NCT03926624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704714|NCT03926624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64704715|NCT03926624|Antimetabolites|antimetabolites|mesh-ancestor
64704716|NCT03926624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704717|NCT03926624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64704718|NCT03926624|Immunologic Factors|immunologic factors|mesh-ancestor
64718724|NCT04585490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64718725|NCT04585490|Immunologic Factors|immunologic factors|mesh-ancestor
64458018|NCT00212758|Hormones|hormones|mesh-list
64718726|NCT04585490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704719|NCT03926624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704742|NCT05588102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704743|NCT05588102|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64704744|NCT05588102|Antidepressive Agents|antidepressive agents|mesh-ancestor
64704745|NCT05588102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64704746|NCT05588102|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64704747|NCT05588102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64704748|NCT05588102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704749|NCT05588102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64704750|NCT05588102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64704751|NCT05588102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64704779|NCT00364195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704780|NCT00364195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64704781|NCT02566369|Trifarotene|trifarotene|mesh-list
64704782|NCT02566369|Dermatologic Agents|dermatologic agents|mesh-ancestor
64704783|NCT02569723|Oxaliplatin|oxaliplatin|mesh-list
64704784|NCT02569723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704785|NCT02570425|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64704786|NCT02570425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64704787|NCT02570425|Respiratory System Agents|respiratory system agents|mesh-ancestor
64704788|NCT02571439|Ropivacaine|ropivacaine|mesh-list
64704789|NCT02571439|Anesthetics, Local|anesthetics, local|mesh-ancestor
64704790|NCT02571439|Anesthetics|anesthetics|mesh-ancestor
64704791|NCT02571439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64704792|NCT02571439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704793|NCT02571439|Sensory System Agents|sensory system agents|mesh-ancestor
64484553|NCT04383418|Adrenergic Agents|adrenergic agents|mesh-ancestor
64945583|NCT05427786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64704795|NCT02572609|Ambroxol|ambroxol|mesh-list
64704829|NCT02207634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704830|NCT02207634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64704831|NCT02484859|Metoprolol|metoprolol|mesh-list
64704832|NCT02484859|Remifentanil|remifentanil|mesh-list
64704833|NCT02484859|Tramadol|tramadol|mesh-list
64704834|NCT02484859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64704835|NCT02484859|Narcotics|narcotics|mesh-ancestor
64704836|NCT02484859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64704837|NCT02484859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704838|NCT02484859|Analgesics|analgesics|mesh-ancestor
64704839|NCT02484859|Sensory System Agents|sensory system agents|mesh-ancestor
64704840|NCT02484859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64704853|NCT04341727|Chloroquine|chloroquine|mesh-list
64704895|NCT05587400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64704896|NCT05587400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704897|NCT05587400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64704898|NCT05587400|Respiratory System Agents|respiratory system agents|mesh-ancestor
64704899|NCT05587400|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64704900|NCT05587400|Antioxidants|antioxidants|mesh-ancestor
64704901|NCT05587400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704902|NCT05587400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64704903|NCT05587400|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64704904|NCT05587400|Vasodilator Agents|vasodilator agents|mesh-ancestor
64704905|NCT05587400|Gasotransmitters|gasotransmitters|mesh-ancestor
64704906|NCT05587400|Protective Agents|protective agents|mesh-ancestor
64704957|NCT02587351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64704958|NCT02587351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704959|NCT02587351|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64704960|NCT02587351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64704961|NCT02587351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64704962|NCT02587351|Adrenergic Agents|adrenergic agents|mesh-ancestor
64704963|NCT02587351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64704964|NCT02587351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704965|NCT05553314|Carvedilol|carvedilol|mesh-list
64704966|NCT05553314|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64704967|NCT05553314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64704968|NCT05553314|Adrenergic Agents|adrenergic agents|mesh-ancestor
64704973|NCT05553314|Antioxidants|antioxidants|mesh-ancestor
64718742|NCT04342663|Fluvoxamine|fluvoxamine|mesh-list
64718743|NCT04342663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64945584|NCT05427786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64945585|NCT05427786|Vasodilator Agents|vasodilator agents|mesh-ancestor
64705020|NCT05249023|Histamine Agents|histamine agents|mesh-ancestor
64705021|NCT05249023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64705022|NCT05249023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705023|NCT05249023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705024|NCT02495779|Tenofovir|tenofovir|mesh-list
64705025|NCT02495779|Emtricitabine|emtricitabine|mesh-list
64705026|NCT02495779|Antiviral Agents|antiviral agents|mesh-ancestor
64705027|NCT02495779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64705028|NCT02495779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64705029|NCT02495779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64705030|NCT02495779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705032|NCT02495779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64705081|NCT03019640|Lenalidomide|lenalidomide|mesh-list
64705082|NCT03019640|Etoposide phosphate|etoposide phosphate|mesh-list
64705083|NCT03019640|Melphalan|melphalan|mesh-list
64705084|NCT03019640|Mechlorethamine|mechlorethamine|mesh-list
64705085|NCT03019640|Carmustine|carmustine|mesh-list
64705086|NCT03019640|Podophyllotoxin|podophyllotoxin|mesh-list
64705087|NCT03019640|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64705088|NCT03019640|Antibodies|antibodies|mesh-list
64705089|NCT03019640|Immunoglobulins|immunoglobulins|mesh-list
64705090|NCT03019640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64718744|NCT04342663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64705132|NCT02507011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64705133|NCT02507011|Antioxidants|antioxidants|mesh-ancestor
64718758|NCT04342663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718759|NCT04342663|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64718760|NCT00589550|Interferons|interferons|mesh-list
64705134|NCT02507011|Protective Agents|protective agents|mesh-ancestor
64705135|NCT02507011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64705139|NCT02507011|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64705140|NCT02507011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64430400|NCT02046369|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64705141|NCT02977286|Methylnaltrexone|methylnaltrexone|mesh-list
64705198|NCT02848820|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64705199|NCT02848820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705200|NCT02848820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705201|NCT02848820|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64705202|NCT00534469|Cytarabine|cytarabine|mesh-list
64705203|NCT00534469|Aldesleukin|aldesleukin|mesh-list
64705204|NCT00534469|Etoposide|etoposide|mesh-list
64705205|NCT00534469|Idarubicin|idarubicin|mesh-list
64705206|NCT00534469|Busulfan|busulfan|mesh-list
64718761|NCT00589550|Interferon-alpha|interferon-alpha|mesh-list
64705264|NCT03545035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64705265|NCT03545035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705266|NCT03545035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705267|NCT02589847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64705268|NCT02589847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64705269|NCT02589847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64705270|NCT02589847|Antitubercular Agents|antitubercular agents|mesh-ancestor
64705271|NCT02592421|Dapagliflozin|dapagliflozin|mesh-list
64705325|NCT05673811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705326|NCT04340869|Theobromine|theobromine|mesh-list
64705327|NCT04340869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64705328|NCT04340869|Autonomic Agents|autonomic agents|mesh-ancestor
64705329|NCT04340869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64705330|NCT04340869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705331|NCT04340869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64705332|NCT04340869|Respiratory System Agents|respiratory system agents|mesh-ancestor
64705388|NCT02596867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64705389|NCT02596867|Vasodilator Agents|vasodilator agents|mesh-ancestor
64705390|NCT02597101|Metformin|metformin|mesh-list
64705391|NCT02597101|Saxagliptin|saxagliptin|mesh-list
64705392|NCT02597101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64705393|NCT02597101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705394|NCT02597101|Incretins|incretins|mesh-ancestor
64705395|NCT02597101|Hormones|hormones|mesh-ancestor
64705459|NCT02608177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64705460|NCT02608177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64705461|NCT02608177|Protease Inhibitors|protease inhibitors|mesh-ancestor
64705462|NCT02608177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705463|NCT02608177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705464|NCT02608489|Hyaluronic Acid|hyaluronic acid|mesh-list
64705465|NCT02608489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64705468|NCT02608489|Viscosupplements|viscosupplements|mesh-ancestor
64705520|NCT05528419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64705521|NCT05528419|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64705522|NCT05528419|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64705523|NCT05528419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705525|NCT05731843|Antiviral Agents|antiviral agents|mesh-ancestor
64705526|NCT05731843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64705527|NCT05485831|Cannabidiol|cannabidiol|mesh-list
64705528|NCT05485831|Anticonvulsants|anticonvulsants|mesh-ancestor
64705529|NCT05480293|Ranibizumab|ranibizumab|mesh-list
64705530|NCT05480293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64705531|NCT05480293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64705532|NCT05480293|Growth Substances|growth substances|mesh-ancestor
64705533|NCT05480293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705534|NCT05480293|Growth Inhibitors|growth inhibitors|mesh-ancestor
64705535|NCT05480293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64705575|NCT05384665|Remifentanil|remifentanil|mesh-list
64705576|NCT05384665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64705577|NCT05384665|Narcotics|narcotics|mesh-ancestor
64705578|NCT05384665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64705579|NCT05384665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705580|NCT05384665|Analgesics|analgesics|mesh-ancestor
64705581|NCT05384665|Sensory System Agents|sensory system agents|mesh-ancestor
64705582|NCT05384665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64705583|NCT05384665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64705584|NCT05384665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64705632|NCT05281471|Immunologic Factors|immunologic factors|mesh-ancestor
64705633|NCT05281471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64705634|NCT05281471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64705635|NCT05281471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64705636|NCT05725837|Fluoxetine|fluoxetine|mesh-list
64705637|NCT05725837|Paroxetine|paroxetine|mesh-list
64705638|NCT05725837|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64705639|NCT05725837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64705646|NCT05725837|Antidepressive Agents|antidepressive agents|mesh-ancestor
64705673|NCT04622839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64705674|NCT04622839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705675|NCT04622839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64705676|NCT04622839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64705677|NCT04622839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64705678|NCT04622839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705680|NCT04622839|Antipyretics|antipyretics|mesh-ancestor
64705746|NCT04741165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705747|NCT04741165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705748|NCT02625181|Promethazine|promethazine|mesh-list
64705749|NCT02625181|Diphenhydramine|diphenhydramine|mesh-list
64705750|NCT02625181|Meclizine|meclizine|mesh-list
64705751|NCT02625181|Dexamethasone|dexamethasone|mesh-list
64705752|NCT02625181|Fentanyl|fentanyl|mesh-list
64705753|NCT02625181|Sufentanil|sufentanil|mesh-list
64705754|NCT02625181|Scopolamine|scopolamine|mesh-list
64705755|NCT02625181|Oxymorphone|oxymorphone|mesh-list
64705818|NCT02625181|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64705819|NCT02625181|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64705820|NCT02625181|Dopamine Agents|dopamine agents|mesh-ancestor
64705821|NCT02625181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64705822|NCT02625181|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64705823|NCT02625181|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64705824|NCT02625181|Mydriatics|mydriatics|mesh-ancestor
64705825|NCT02625181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64705880|NCT04159519|Formoterol Fumarate|formoterol fumarate|mesh-list
64705881|NCT04159519|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64705882|NCT04159519|Benralizumab|benralizumab|mesh-list
64705883|NCT04159519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64705884|NCT04159519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64705885|NCT04159519|Autonomic Agents|autonomic agents|mesh-ancestor
64705886|NCT04159519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64705887|NCT04159519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705942|NCT00367393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64705943|NCT00367393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705944|NCT00367393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705945|NCT00367471|Paclitaxel|paclitaxel|mesh-list
64705946|NCT00367471|Carboplatin|carboplatin|mesh-list
64705947|NCT00367471|Trastuzumab|trastuzumab|mesh-list
64705948|NCT00367471|Lapatinib|lapatinib|mesh-list
64705949|NCT00367471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64705950|NCT00367471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64705951|NCT00367471|Tubulin Modulators|tubulin modulators|mesh-ancestor
64705952|NCT00367471|Antimitotic Agents|antimitotic agents|mesh-ancestor
64705953|NCT00367471|Mitosis Modulators|mitosis modulators|mesh-ancestor
64705954|NCT00367471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705999|NCT02239692|Cathartics|cathartics|mesh-ancestor
64706000|NCT02239692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64706001|NCT02641561|Indomethacin|indomethacin|mesh-list
64484558|NCT03414112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64945593|NCT05426525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64706002|NCT02641561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64706003|NCT02641561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64706004|NCT02641561|Analgesics|analgesics|mesh-ancestor
64706005|NCT02641561|Sensory System Agents|sensory system agents|mesh-ancestor
64706006|NCT02641561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706007|NCT02641561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706008|NCT02641561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64706060|NCT02204982|Rituximab|rituximab|mesh-list
64706061|NCT02204982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64706062|NCT02204982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706063|NCT02204982|Immunologic Factors|immunologic factors|mesh-ancestor
64706064|NCT02204982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706072|NCT04074265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706073|NCT04074265|Sensory System Agents|sensory system agents|mesh-ancestor
64706074|NCT04074265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706075|NCT04074265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64945594|NCT05426525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706076|NCT04074265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64706077|NCT04074265|Adrenergic Agents|adrenergic agents|mesh-ancestor
64706078|NCT04074265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64706079|NCT04074265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706080|NCT04074265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64336202|NCT02335203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64706113|NCT03330847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706114|NCT03330847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706115|NCT02237196|Immunologic Factors|immunologic factors|mesh-list
64706116|NCT02237196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706117|NCT04776096|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64706118|NCT04776096|Bepotastine besilate|bepotastine besilate|mesh-list
64706138|NCT04684212|Apixaban|apixaban|mesh-list
64336206|NCT02335203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64706179|NCT03213457|Norethindrone Acetate|norethindrone acetate|mesh-list
64706180|NCT03213457|Estradiol|estradiol|mesh-list
64706181|NCT03213457|Estrogens|estrogens|mesh-ancestor
64706182|NCT03213457|Hormones|hormones|mesh-ancestor
64706183|NCT03213457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64706184|NCT03213457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706185|NCT03213457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64706186|NCT03213457|Contraceptive Agents|contraceptive agents|mesh-ancestor
64706187|NCT03213457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64706188|NCT03213457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64706189|NCT03213457|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64706190|NCT03213457|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64706191|NCT03213457|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64706192|NCT02201940|Sofosbuvir|sofosbuvir|mesh-list
64706193|NCT02201940|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64706194|NCT02201940|Velpatasvir|velpatasvir|mesh-list
64706195|NCT02201940|Antiviral Agents|antiviral agents|mesh-ancestor
64706196|NCT02201940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64706197|NCT05588869|Cyclosporine|cyclosporine|mesh-list
64706198|NCT05588869|Cyclosporins|cyclosporins|mesh-list
64706199|NCT05588869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706204|NCT05588869|Antifungal Agents|antifungal agents|mesh-ancestor
64706205|NCT05588869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64706228|NCT03043807|Tubulin Modulators|tubulin modulators|mesh-ancestor
64706229|NCT03043807|Antimitotic Agents|antimitotic agents|mesh-ancestor
64706230|NCT03043807|Mitosis Modulators|mitosis modulators|mesh-ancestor
64706231|NCT03043807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706232|NCT03043807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64706233|NCT03043807|Fertility Agents|fertility agents|mesh-ancestor
64706234|NCT03043807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64706235|NCT03043807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706236|NCT03043807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64706237|NCT03043807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64706238|NCT03043807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706239|NCT03043807|Hormone Antagonists|hormone antagonists|mesh-ancestor
64706240|NCT03043807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64706241|NCT03043807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64706243|NCT02609828|Tanezumab|tanezumab|mesh-list
64718882|NCT01055756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64718883|NCT01055756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64718884|NCT01055756|Sympathomimetics|sympathomimetics|mesh-ancestor
64327016|NCT00697099|Enoxaparin sodium|enoxaparin sodium|mesh-list
64706294|NCT01632306|Vitamins|vitamins|mesh-ancestor
64706295|NCT01632306|Micronutrients|micronutrients|mesh-ancestor
64706296|NCT02201784|Ropivacaine|ropivacaine|mesh-list
64706297|NCT02201784|Levobupivacaine|levobupivacaine|mesh-list
64706298|NCT02201784|Anesthetics, Local|anesthetics, local|mesh-ancestor
64706299|NCT02201784|Anesthetics|anesthetics|mesh-ancestor
64706380|NCT02302976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64718886|NCT00652574|Dasatinib|dasatinib|mesh-list
64718887|NCT00652574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718888|NCT00652574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64718889|NCT00652574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718890|NCT00652574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718891|NCT01550510|Ascorbic Acid|ascorbic acid|mesh-list
64718892|NCT01550510|Irinotecan|irinotecan|mesh-list
64706381|NCT02302976|Incretins|incretins|mesh-ancestor
64706382|NCT02302976|Hormones|hormones|mesh-ancestor
64706385|NCT02302976|Anesthetics|anesthetics|mesh-ancestor
64706443|NCT02152670|Dopamine Agents|dopamine agents|mesh-ancestor
64706444|NCT02152670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64718893|NCT01550510|Camptothecin|camptothecin|mesh-list
64718894|NCT01550510|Vitamins|vitamins|mesh-ancestor
64718895|NCT01550510|Micronutrients|micronutrients|mesh-ancestor
64718896|NCT01550510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64718897|NCT01550510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64718898|NCT01550510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64718899|NCT01550510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706507|NCT04739774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706509|NCT04739774|Hormone Antagonists|hormone antagonists|mesh-ancestor
64718900|NCT01550510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718901|NCT01550510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64718902|NCT01550510|Antioxidants|antioxidants|mesh-ancestor
64718903|NCT01550510|Protective Agents|protective agents|mesh-ancestor
64706510|NCT04739774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64706511|NCT04739774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706512|NCT04739774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64706568|NCT05441761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64706569|NCT05587621|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
64706570|NCT05587621|Ezetimibe|ezetimibe|mesh-list
64706571|NCT05587621|Evolocumab|evolocumab|mesh-list
64706572|NCT05587621|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64706573|NCT05587621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64706574|NCT05587621|Antimetabolites|antimetabolites|mesh-ancestor
64706575|NCT05587621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706646|NCT02643979|Anesthetics, General|anesthetics, general|mesh-ancestor
64706647|NCT02643979|Anesthetics|anesthetics|mesh-ancestor
64706648|NCT02643979|Analgesics|analgesics|mesh-ancestor
64706649|NCT02643979|Sensory System Agents|sensory system agents|mesh-ancestor
64706650|NCT02643979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706651|NCT02643979|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64706652|NCT02643979|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64706653|NCT02643979|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64706654|NCT02643979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64706655|NCT02643979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706657|NCT05587231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64706658|NCT05587231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706659|NCT05587231|Glucocorticoids|glucocorticoids|mesh-ancestor
64718907|NCT04333225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64718908|NCT04333225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64718909|NCT04333225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64718910|NCT04333225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706660|NCT05587231|Hormones|hormones|mesh-ancestor
64706661|NCT05587231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64706662|NCT05587231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64706663|NCT02667704|Nintedanib|nintedanib|mesh-list
64706664|NCT02667704|Bosentan|bosentan|mesh-list
64706665|NCT02667704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706695|NCT02691416|Propofol|propofol|mesh-list
64706696|NCT02691416|Sevoflurane|sevoflurane|mesh-list
64706697|NCT02691416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64706698|NCT02691416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64706699|NCT02691416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706700|NCT02691416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64706701|NCT02691416|Anesthetics, General|anesthetics, general|mesh-ancestor
64706702|NCT02691416|Anesthetics|anesthetics|mesh-ancestor
64706703|NCT02691416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64706704|NCT02691416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64706705|NCT02650999|Pembrolizumab|pembrolizumab|mesh-list
64706706|NCT02650999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64706707|NCT02650999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706708|NCT05502211|Lidocaine|lidocaine|mesh-list
64706709|NCT05502211|Fentanyl|fentanyl|mesh-list
64706776|NCT02703350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706777|NCT05470465|Oxycodone|oxycodone|mesh-list
64706778|NCT05470465|Citalopram|citalopram|mesh-list
64706779|NCT05470465|Paroxetine|paroxetine|mesh-list
64706780|NCT05470465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64706781|NCT05470465|Narcotics|narcotics|mesh-ancestor
64706782|NCT05470465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64706783|NCT05470465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706784|NCT05470465|Analgesics|analgesics|mesh-ancestor
64706785|NCT05470465|Sensory System Agents|sensory system agents|mesh-ancestor
64706786|NCT05470465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706787|NCT05470465|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64706788|NCT05470465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64706789|NCT05470465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64706790|NCT05470465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706808|NCT02656069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706840|NCT02710981|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64706841|NCT02710981|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64706842|NCT04193228|Carbon Fiber|carbon fiber|mesh-list
64706843|NCT04193228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64706844|NCT04193228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64706845|NCT04738838|Oxytocin|oxytocin|mesh-list
64706846|NCT04738838|Oxytocics|oxytocics|mesh-ancestor
64706850|NCT04739917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64706851|NCT04739917|Immunologic Factors|immunologic factors|mesh-ancestor
64706852|NCT04739917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706853|NCT05343481|Nivolumab|nivolumab|mesh-list
64706900|NCT02659501|Antiemetics|antiemetics|mesh-ancestor
64706901|NCT02659501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64706902|NCT02659501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64706903|NCT02659501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64706904|NCT02659501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64706905|NCT02659501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64706906|NCT02659501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64706907|NCT02659501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64706911|NCT02659501|GABA Agents|gaba agents|mesh-ancestor
64706961|NCT02713178|Bupivacaine|bupivacaine|mesh-list
64706962|NCT02713178|Anesthetics, Local|anesthetics, local|mesh-ancestor
64706963|NCT02713178|Anesthetics|anesthetics|mesh-ancestor
64706964|NCT02713178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64706965|NCT02713178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706966|NCT02713178|Sensory System Agents|sensory system agents|mesh-ancestor
64706967|NCT02713178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64706968|NCT04130438|Nebivolol|nebivolol|mesh-list
64706969|NCT04130438|Diltiazem|diltiazem|mesh-list
64706970|NCT04130438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64706971|NCT04130438|Vasodilator Agents|vasodilator agents|mesh-ancestor
64706972|NCT04130438|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64945601|NCT05423106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706973|NCT04130438|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64706974|NCT04130438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64706975|NCT04130438|Adrenergic Agents|adrenergic agents|mesh-ancestor
64706976|NCT04130438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64706977|NCT04130438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718938|NCT00521924|Immunologic Factors|immunologic factors|mesh-ancestor
64718939|NCT00521924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64718940|NCT00521924|Antifungal Agents|antifungal agents|mesh-ancestor
64718941|NCT00521924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64718942|NCT00521924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64718943|NCT00521924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64718944|NCT00521924|Amebicides|amebicides|mesh-ancestor
64718945|NCT00521924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64327069|NCT02164565|Tranexamic Acid|tranexamic acid|mesh-list
64707017|NCT02714504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64707018|NCT02714504|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64707019|NCT02714504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64707020|NCT02714504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64707021|NCT05221502|Bedaquiline|bedaquiline|mesh-list
64707022|NCT05221502|Diarylquinolines|diarylquinolines|mesh-list
64432272|NCT01650194|Glucocorticoids|glucocorticoids|mesh-ancestor
64707071|NCT02732587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707072|NCT02732587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64707073|NCT02732587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707074|NCT02731820|Vitamin D|vitamin d|mesh-list
64707075|NCT02731820|Cholecalciferol|cholecalciferol|mesh-list
64707076|NCT02731820|Potassium Citrate|potassium citrate|mesh-list
64707077|NCT02731820|Calcium Carbonate|calcium carbonate|mesh-list
64707078|NCT02731820|Calcium|calcium|mesh-list
64707132|NCT00368342|Erythromycin|erythromycin|mesh-list
64707133|NCT00368342|Erythromycin Estolate|erythromycin estolate|mesh-list
64707134|NCT00368342|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64707151|NCT03609008|Respiratory System Agents|respiratory system agents|mesh-ancestor
64707152|NCT03609008|Parasympatholytics|parasympatholytics|mesh-ancestor
64707153|NCT03609008|Vasodilator Agents|vasodilator agents|mesh-ancestor
64707154|NCT02734238|Methyltestosterone|methyltestosterone|mesh-list
64707155|NCT02734238|Testosterone|testosterone|mesh-list
64707156|NCT02734238|Testosterone undecanoate|testosterone undecanoate|mesh-list
64707157|NCT02734238|Testosterone enanthate|testosterone enanthate|mesh-list
64718951|NCT00521924|Sensory System Agents|sensory system agents|mesh-ancestor
64718952|NCT00521924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64718953|NCT00521924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64718954|NCT03927781|Pregabalin|pregabalin|mesh-list
64718955|NCT03927781|Analgesics|analgesics|mesh-ancestor
64707158|NCT02734238|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64707159|NCT02734238|Androgens|androgens|mesh-ancestor
64707160|NCT02734238|Hormones|hormones|mesh-ancestor
64707161|NCT02734238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64707162|NCT02734238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707163|NCT02734238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64707164|NCT02734238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707165|NCT02734238|Anabolic Agents|anabolic agents|mesh-ancestor
64707166|NCT04707547|Nivolumab|nivolumab|mesh-list
64707167|NCT04707547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64707168|NCT04707547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707169|NCT04707547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64707170|NCT04707547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707171|NCT03535376|Valsartan|valsartan|mesh-list
64707172|NCT03535376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64707173|NCT03535376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64707176|NCT02736175|Dexamethasone|dexamethasone|mesh-list
64707185|NCT02736175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64707186|NCT02736175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64707187|NCT02736175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707188|NCT00369356|Prednisone|prednisone|mesh-list
64707189|NCT00369356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64707190|NCT00369356|Glucocorticoids|glucocorticoids|mesh-ancestor
64707194|NCT00369356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64707195|NCT00369356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945603|NCT05423106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64707196|NCT04947085|Ketamine|ketamine|mesh-list
64707197|NCT04947085|Analgesics|analgesics|mesh-ancestor
64707198|NCT04947085|Sensory System Agents|sensory system agents|mesh-ancestor
64707212|NCT04947020|Metformin|metformin|mesh-list
64707243|NCT00367627|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64707244|NCT00367627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64707245|NCT00367627|Tubulin Modulators|tubulin modulators|mesh-ancestor
64707246|NCT00367627|Antimitotic Agents|antimitotic agents|mesh-ancestor
64707247|NCT00367627|Mitosis Modulators|mitosis modulators|mesh-ancestor
64707248|NCT00367627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707249|NCT00367627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707250|NCT05443789|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64707251|NCT05443789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432500|NCT02279719|Sorafenib|sorafenib|mesh-list
64707252|NCT05443789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707254|NCT04738981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64707255|NCT04738981|Immunologic Factors|immunologic factors|mesh-ancestor
64707256|NCT04738981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707314|NCT05448001|Lansoprazole|lansoprazole|mesh-list
64707315|NCT05448001|Dexlansoprazole|dexlansoprazole|mesh-list
64707316|NCT05448001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64707317|NCT05448001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64707318|NCT05448001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64707319|NCT05448001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64707320|NCT05448001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707321|NCT05340673|Petrolatum|petrolatum|mesh-list
64707322|NCT05340673|Mineral Oil|mineral oil|mesh-list
64707323|NCT05340673|Emollients|emollients|mesh-ancestor
64707324|NCT05340673|Dermatologic Agents|dermatologic agents|mesh-ancestor
64707325|NCT05447455|Anesthetics|anesthetics|mesh-list
64707326|NCT05447455|Anesthetics, Local|anesthetics, local|mesh-list
64707327|NCT05447455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64707370|NCT03593317|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64707371|NCT03593317|Diuretics|diuretics|mesh-ancestor
64707372|NCT03593317|Natriuretic Agents|natriuretic agents|mesh-ancestor
64707373|NCT03423121|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
64707374|NCT03423121|Antiviral Agents|antiviral agents|mesh-ancestor
64707375|NCT03423121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64707376|NCT03423121|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64707377|NCT03423121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64707378|NCT05023993|Niacinamide|niacinamide|mesh-list
64707379|NCT05023993|Niacin|niacin|mesh-list
64707380|NCT05023993|Nicotinic Acids|nicotinic acids|mesh-list
64707381|NCT05023993|Vitamin B Complex|vitamin b complex|mesh-ancestor
64707382|NCT05023993|Vitamins|vitamins|mesh-ancestor
64707383|NCT05023993|Micronutrients|micronutrients|mesh-ancestor
64707384|NCT05023993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707385|NCT05023993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64707386|NCT05023993|Antimetabolites|antimetabolites|mesh-ancestor
64707387|NCT05023993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707388|NCT05023993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64707438|NCT05243953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64707439|NCT05243953|Respiratory System Agents|respiratory system agents|mesh-ancestor
64707440|NCT05243953|Parasympatholytics|parasympatholytics|mesh-ancestor
64718972|NCT00379964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64718973|NCT01545518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64718974|NCT01545518|Immunologic Factors|immunologic factors|mesh-ancestor
64718975|NCT01545518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707503|NCT00368498|Teicoplanin|teicoplanin|mesh-list
64707504|NCT00368498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64707505|NCT00368498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64707506|NCT05172817|Adalimumab|adalimumab|mesh-list
64707507|NCT05172817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64707508|NCT05172817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64718977|NCT01526408|Antiviral Agents|antiviral agents|mesh-ancestor
64718978|NCT01526408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64718979|NCT01526408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64718980|NCT01526408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64718981|NCT01526408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707509|NCT05145907|Pembrolizumab|pembrolizumab|mesh-list
64707510|NCT05145907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64707511|NCT05145907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707512|NCT04563325|Ceftriaxone|ceftriaxone|mesh-list
64707513|NCT04563325|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64707531|NCT04545151|Verapamil|verapamil|mesh-list
64707560|NCT04523701|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64707561|NCT04523701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64707562|NCT04338373|Atropine|atropine|mesh-list
64707563|NCT04338373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64707564|NCT04338373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64707565|NCT04338373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64707566|NCT04338373|Autonomic Agents|autonomic agents|mesh-ancestor
64707567|NCT04338373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64707625|NCT05443178|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64707626|NCT05443178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64707627|NCT05443178|Antimetabolites|antimetabolites|mesh-ancestor
64707628|NCT05443178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64707629|NCT05443178|Amebicides|amebicides|mesh-ancestor
64707630|NCT05443178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64707631|NCT05443178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64707632|NCT05443178|Antimalarials|antimalarials|mesh-ancestor
64707633|NCT05443178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64707635|NCT05064319|Analgesics|analgesics|mesh-ancestor
64707636|NCT05064319|Sensory System Agents|sensory system agents|mesh-ancestor
64707637|NCT05064319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64707684|NCT05451290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64707685|NCT05451290|Antimetabolites|antimetabolites|mesh-ancestor
64707686|NCT05451290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707687|NCT05451290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707688|NCT05451290|Antiviral Agents|antiviral agents|mesh-ancestor
64707689|NCT05451290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64707690|NCT05451290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64707691|NCT05451290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64707692|NCT05451290|Immunologic Factors|immunologic factors|mesh-ancestor
64707693|NCT05451290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707694|NCT05451290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64707695|NCT04344860|Tranexamic Acid|tranexamic acid|mesh-list
64707696|NCT04344860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64707700|NCT04344860|Coagulants|coagulants|mesh-ancestor
64707701|NCT00369889|Bevacizumab|bevacizumab|mesh-list
64707702|NCT00369889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64707703|NCT00369889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64707704|NCT00369889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707705|NCT00369889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64707706|NCT00369889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64707707|NCT00369889|Growth Substances|growth substances|mesh-ancestor
64707708|NCT00369889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707709|NCT00369889|Growth Inhibitors|growth inhibitors|mesh-ancestor
64707732|NCT05441150|Sensory System Agents|sensory system agents|mesh-ancestor
64707733|NCT05441150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64707734|NCT05441150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707735|NCT05441150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64707736|NCT05441150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64707737|NCT05441150|Anesthetics, General|anesthetics, general|mesh-ancestor
64707738|NCT05441150|Anesthetics|anesthetics|mesh-ancestor
64707739|NCT05441150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64707740|NCT05441150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64707741|NCT05441150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64707742|NCT05441150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64707744|NCT04270214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64707795|NCT04967443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64707796|NCT04967443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64707797|NCT04967443|Adrenergic Agents|adrenergic agents|mesh-ancestor
64707798|NCT04967443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64707799|NCT04967443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707800|NCT04967443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707801|NCT04697017|Salicylic Acid|salicylic acid|mesh-list
64707802|NCT04697017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64707803|NCT04697017|Antifungal Agents|antifungal agents|mesh-ancestor
64707804|NCT04697017|Keratolytic Agents|keratolytic agents|mesh-ancestor
64707805|NCT04697017|Dermatologic Agents|dermatologic agents|mesh-ancestor
64707817|NCT05450042|Paclitaxel|paclitaxel|mesh-list
64707862|NCT05447702|Paclitaxel|paclitaxel|mesh-list
64707863|NCT05447702|Cyclophosphamide|cyclophosphamide|mesh-list
64945606|NCT05417776|Chelating Agents|chelating agents|mesh-ancestor
64945607|NCT05417776|Sequestering Agents|sequestering agents|mesh-ancestor
64707864|NCT05447702|Apatinib|apatinib|mesh-list
64707865|NCT05447702|Epirubicin|epirubicin|mesh-list
64707866|NCT05447702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64707867|NCT05447702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707868|NCT05447702|Tubulin Modulators|tubulin modulators|mesh-ancestor
64707869|NCT05447702|Antimitotic Agents|antimitotic agents|mesh-ancestor
64707884|NCT05449028|Bismuth|bismuth|mesh-list
64719019|NCT00000764|Interferons|interferons|mesh-list
64719020|NCT00000764|Interferon-alpha|interferon-alpha|mesh-list
64719021|NCT00000764|Interferon alpha-2|interferon alpha-2|mesh-list
64719022|NCT00000764|Isotretinoin|isotretinoin|mesh-list
64719023|NCT00000764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64719024|NCT00000764|Antiviral Agents|antiviral agents|mesh-ancestor
64719025|NCT00000764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719026|NCT00000764|Immunologic Factors|immunologic factors|mesh-ancestor
64719027|NCT00000764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719028|NCT00000764|Dermatologic Agents|dermatologic agents|mesh-ancestor
64719029|NCT03909763|Danazol|danazol|mesh-list
64719030|NCT03909763|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64719031|NCT03909763|Hormone Antagonists|hormone antagonists|mesh-ancestor
64719032|NCT03909763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64719033|NCT03909763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719034|NCT00484718|Celecoxib|celecoxib|mesh-list
64719035|NCT00484718|Oxycodone|oxycodone|mesh-list
64719036|NCT00484718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64719037|NCT00484718|Narcotics|narcotics|mesh-ancestor
64719038|NCT00484718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64327136|NCT00744367|Incretins|incretins|mesh-ancestor
64707921|NCT04793659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64707922|NCT04793659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707923|NCT04793659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64433163|NCT02032875|Antiviral Agents|antiviral agents|mesh-ancestor
64707924|NCT04793659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707925|NCT04793659|Vasodilator Agents|vasodilator agents|mesh-ancestor
64707926|NCT04793659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64707927|NCT04793659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719047|NCT00484718|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64719048|NCT00484718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64719049|NCT00484718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719050|NCT00484718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719051|NCT03665155|Daratumumab|daratumumab|mesh-list
64719052|NCT03665155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64719053|NCT00477230|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64719055|NCT00448682|Docetaxel|docetaxel|mesh-list
64719056|NCT00448682|Oxaliplatin|oxaliplatin|mesh-list
64719057|NCT00448682|Floxuridine|floxuridine|mesh-list
64719058|NCT00448682|Levoleucovorin|levoleucovorin|mesh-list
64719059|NCT00448682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64719065|NCT00448682|Antidotes|antidotes|mesh-ancestor
64719091|NCT00000770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64719092|NCT00000770|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64719093|NCT00000770|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64719094|NCT00368654|Methotrexate|methotrexate|mesh-list
64327191|NCT03071185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707960|NCT05448781|Growth Substances|growth substances|mesh-ancestor
64707961|NCT05448781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707962|NCT05448781|Growth Inhibitors|growth inhibitors|mesh-ancestor
64708016|NCT03233347|Mitosis Modulators|mitosis modulators|mesh-ancestor
64708017|NCT04502966|Immunologic Factors|immunologic factors|mesh-list
64708018|NCT04502966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64708019|NCT04502966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708020|NCT03215719|Cisplatin|cisplatin|mesh-list
64708021|NCT03215719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708022|NCT03134755|Mometasone Furoate|mometasone furoate|mesh-list
64708023|NCT03134755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64708024|NCT03134755|Dermatologic Agents|dermatologic agents|mesh-ancestor
64708025|NCT03134755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64708026|NCT03036488|Paclitaxel|paclitaxel|mesh-list
64708027|NCT03036488|Cyclophosphamide|cyclophosphamide|mesh-list
64708028|NCT03036488|Carboplatin|carboplatin|mesh-list
64708029|NCT03036488|Doxorubicin|doxorubicin|mesh-list
64708030|NCT03036488|Pembrolizumab|pembrolizumab|mesh-list
64708031|NCT03036488|Epirubicin|epirubicin|mesh-list
64337167|NCT02320357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64708086|NCT04417920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708087|NCT04417920|Alkylating Agents|alkylating agents|mesh-ancestor
64484571|NCT03839134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64708088|NCT04417920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708089|NCT04417920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64708090|NCT04417920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708091|NCT02626130|Tremelimumab|tremelimumab|mesh-list
64708092|NCT02626130|Ipilimumab|ipilimumab|mesh-list
64708093|NCT02626130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708094|NCT02626130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64708095|NCT02626130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64708121|NCT03758989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708122|NCT03758989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64708123|NCT03758989|Glucocorticoids|glucocorticoids|mesh-ancestor
64708125|NCT03758989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64708126|NCT03758989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64708127|NCT03758989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64708171|NCT05208944|Cemiplimab|cemiplimab|mesh-list
64708172|NCT05208944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64708173|NCT05208944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708174|NCT01809379|Cisplatin|cisplatin|mesh-list
64708175|NCT01809379|Doxorubicin|doxorubicin|mesh-list
64708176|NCT01809379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708177|NCT01809379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64708178|NCT01809379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64708179|NCT01809379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64708180|NCT01809379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708187|NCT04046575|Paclitaxel|paclitaxel|mesh-list
64708242|NCT02197416|Anticoagulants|anticoagulants|mesh-ancestor
64708243|NCT00370591|Fluticasone|fluticasone|mesh-list
64708244|NCT00370591|Xhance|xhance|mesh-list
64708245|NCT00370591|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64708246|NCT00370591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64708247|NCT00370591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64708248|NCT00370591|Autonomic Agents|autonomic agents|mesh-ancestor
64708249|NCT00370591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64708250|NCT00370591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708251|NCT00370591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64708252|NCT00370591|Respiratory System Agents|respiratory system agents|mesh-ancestor
64708253|NCT00370591|Dermatologic Agents|dermatologic agents|mesh-ancestor
64708271|NCT00371527|Cholinergic Agents|cholinergic agents|mesh-ancestor
64708334|NCT05454332|Purinergic Agents|purinergic agents|mesh-ancestor
64708335|NCT05454332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64708336|NCT03821857|Corticosterone|corticosterone|mesh-list
64708337|NCT03821857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64708338|NCT03924518|Granisetron|granisetron|mesh-list
64708339|NCT03924518|Serotonin|serotonin|mesh-list
64708340|NCT03924518|Antiemetics|antiemetics|mesh-ancestor
64708341|NCT03924518|Autonomic Agents|autonomic agents|mesh-ancestor
64708342|NCT03924518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64708343|NCT03924518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708344|NCT03924518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64708345|NCT03924518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64708346|NCT03924518|Serotonin Agents|serotonin agents|mesh-ancestor
64708347|NCT03924518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64708348|NCT03924518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708349|NCT03924518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64708350|NCT05454085|Bisphenol A|bisphenol a|mesh-list
64708402|NCT02165202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64708403|NCT01628874|Lidocaine|lidocaine|mesh-list
64708404|NCT01628874|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64708405|NCT01628874|Anesthetics, Local|anesthetics, local|mesh-ancestor
64708406|NCT01628874|Anesthetics|anesthetics|mesh-ancestor
64708407|NCT01628874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64708408|NCT01628874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708409|NCT01628874|Sensory System Agents|sensory system agents|mesh-ancestor
64708410|NCT01628874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64708411|NCT01628874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64708412|NCT01628874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64708413|NCT01628874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64708414|NCT01628874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64708415|NCT01628874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708446|NCT02196714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64433690|NCT02412371|Paclitaxel|paclitaxel|mesh-list
64708447|NCT02196714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708448|NCT02196714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64708449|NCT02196714|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64708450|NCT02196714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64708451|NCT02196714|Cholinergic Agents|cholinergic agents|mesh-ancestor
64708452|NCT05453929|Rocuronium|rocuronium|mesh-list
64708514|NCT04766762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64708515|NCT04766762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708516|NCT04766762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64708517|NCT04766762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708518|NCT04766762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64708519|NCT04766762|Histamine Antagonists|histamine antagonists|mesh-ancestor
64708520|NCT04766762|Histamine Agents|histamine agents|mesh-ancestor
64708572|NCT04809662|Interferon Inducers|interferon inducers|mesh-ancestor
64708573|NCT02196324|Serlopitant|serlopitant|mesh-list
64708574|NCT02196324|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64708575|NCT02196324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64708576|NCT02196324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708577|NCT02196324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708578|NCT05450419|Vitamin D|vitamin d|mesh-list
64708579|NCT05450419|Cholecalciferol|cholecalciferol|mesh-list
64708580|NCT05450419|Vitamins|vitamins|mesh-ancestor
64708581|NCT05450419|Micronutrients|micronutrients|mesh-ancestor
64708582|NCT05450419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708583|NCT05450419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64708584|NCT05450419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64708585|NCT05443009|Lidocaine|lidocaine|mesh-list
64708586|NCT05443009|Carticaine|carticaine|mesh-list
64708587|NCT05443009|Anesthetics, Local|anesthetics, local|mesh-ancestor
64708633|NCT04337450|Lamivudine|lamivudine|mesh-list
64708634|NCT04337450|Dolutegravir|dolutegravir|mesh-list
64708635|NCT04337450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64708636|NCT04337450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64708637|NCT04337450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708638|NCT04337450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708639|NCT04337450|Antiviral Agents|antiviral agents|mesh-ancestor
64708640|NCT04337450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64708641|NCT04337450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64708642|NCT04337450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64708643|NCT04337450|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64708644|NCT04337450|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64708645|NCT02740543|Fluticasone|fluticasone|mesh-list
64708647|NCT02740543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64708698|NCT02162862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708699|NCT02162862|Dopamine Agents|dopamine agents|mesh-ancestor
64708700|NCT02162862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64708701|NCT02162862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708702|NCT02162862|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64708703|NCT02162862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64708704|NCT02162862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708705|NCT05277727|Fucoidan|fucoidan|mesh-list
64708706|NCT05277727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64708707|NCT05277727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64708708|NCT05277727|Anticoagulants|anticoagulants|mesh-ancestor
64708709|NCT05277727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708710|NCT02226198|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64708711|NCT02226198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64708712|NCT02226198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64708735|NCT02751385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64708736|NCT02751385|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64708737|NCT02751385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64708738|NCT02751385|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64708739|NCT02751385|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64708750|NCT05349032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64708751|NCT05349032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64708752|NCT05349032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708753|NCT05349032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708754|NCT05349032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708756|NCT05057689|Midazolam|midazolam|mesh-list
64708800|NCT05032183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64708801|NCT05032183|Immunologic Factors|immunologic factors|mesh-ancestor
64708802|NCT05032183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708803|NCT05032183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64708804|NCT05032183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64708805|NCT05032183|Alkylating Agents|alkylating agents|mesh-ancestor
64708806|NCT05032183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708807|NCT05032183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708816|NCT05032183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64708817|NCT05032183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64708856|NCT04737980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64708857|NCT04737980|Sensory System Agents|sensory system agents|mesh-ancestor
64708858|NCT03559868|Digoxin|digoxin|mesh-list
64708859|NCT03559868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64708860|NCT03559868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64708861|NCT03559868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708862|NCT03559868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708863|NCT03559868|Protective Agents|protective agents|mesh-ancestor
64708864|NCT03559868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708865|NCT00371696|Acetaminophen|acetaminophen|mesh-list
64708923|NCT04738045|Antiviral Agents|antiviral agents|mesh-ancestor
64708924|NCT04738045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64708925|NCT04738045|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64708926|NCT04738045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64708927|NCT04738045|Antimetabolites|antimetabolites|mesh-ancestor
64708928|NCT02226120|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64708929|NCT02226120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64708930|NCT02226120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708931|NCT04587973|Dexmedetomidine|dexmedetomidine|mesh-list
64708932|NCT04587973|Ropivacaine|ropivacaine|mesh-list
64708942|NCT04587973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64708943|NCT04587973|Adrenergic Agents|adrenergic agents|mesh-ancestor
64708944|NCT04587973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64708945|NCT04587973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708946|NCT04587973|Anesthetics, Local|anesthetics, local|mesh-ancestor
64708947|NCT04587973|Anesthetics|anesthetics|mesh-ancestor
64708984|NCT01190306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708985|NCT01190306|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64708986|NCT01190306|Dermatologic Agents|dermatologic agents|mesh-ancestor
64708987|NCT02759575|Pembrolizumab|pembrolizumab|mesh-list
64708988|NCT02759575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708989|NCT02759575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64708990|NCT05320718|Ropivacaine|ropivacaine|mesh-list
64708991|NCT05320718|Anesthetics, Local|anesthetics, local|mesh-ancestor
64708992|NCT05320718|Anesthetics|anesthetics|mesh-ancestor
64708993|NCT05320718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64708994|NCT05320718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708995|NCT05320718|Sensory System Agents|sensory system agents|mesh-ancestor
64708996|NCT05320718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64708997|NCT02739698|Paclitaxel|paclitaxel|mesh-list
64708998|NCT02739698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64709053|NCT02192970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64337529|NCT03736265|Protective Agents|protective agents|mesh-ancestor
64709055|NCT02192970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709056|NCT02192970|Growth Inhibitors|growth inhibitors|mesh-ancestor
64709057|NCT05180318|Ketamine|ketamine|mesh-list
64709058|NCT05180318|Esketamine|esketamine|mesh-list
64709059|NCT05180318|Analgesics|analgesics|mesh-ancestor
64709060|NCT05180318|Sensory System Agents|sensory system agents|mesh-ancestor
64709121|NCT04337918|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64709131|NCT02747186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64709132|NCT02747186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64709133|NCT02747186|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64709134|NCT02747186|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64709135|NCT02747186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64709136|NCT02747186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709137|NCT02766517|Capsaicin|capsaicin|mesh-list
64709138|NCT02766517|Antipruritics|antipruritics|mesh-ancestor
64709139|NCT02766517|Dermatologic Agents|dermatologic agents|mesh-ancestor
64709140|NCT02766517|Sensory System Agents|sensory system agents|mesh-ancestor
64709141|NCT02766517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64709142|NCT02766517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709143|NCT04336046|Bupivacaine|bupivacaine|mesh-list
64709144|NCT04336046|Anesthetics, Local|anesthetics, local|mesh-ancestor
64709145|NCT04336046|Anesthetics|anesthetics|mesh-ancestor
64709146|NCT04336046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64709147|NCT04336046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709148|NCT04336046|Sensory System Agents|sensory system agents|mesh-ancestor
64709149|NCT04336046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64709150|NCT05348239|Copper|copper|mesh-list
64709176|NCT00372008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709177|NCT02973763|Aflutinib|aflutinib|mesh-list
64709178|NCT02973763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64709179|NCT02973763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709180|NCT02973763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709181|NCT04337593|Pegaspargase|pegaspargase|mesh-list
64709182|NCT04337593|Basiliximab|basiliximab|mesh-list
64709183|NCT04337593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709184|NCT04337593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64709243|NCT04654988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64709244|NCT04654988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709245|NCT04654988|Antimetabolites|antimetabolites|mesh-ancestor
64709246|NCT04654988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709247|NCT04654988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64709248|NCT04654988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64709249|NCT04654988|Immunologic Factors|immunologic factors|mesh-ancestor
64709250|NCT04654988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64709254|NCT00372710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64709255|NCT00372710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709256|NCT02973776|Clobetasol|clobetasol|mesh-list
64709257|NCT02973776|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64709258|NCT02973776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64709259|NCT02973776|Glucocorticoids|glucocorticoids|mesh-ancestor
64709260|NCT02973776|Hormones|hormones|mesh-ancestor
64709261|NCT02973776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64709262|NCT02973776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709297|NCT04737889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709298|NCT04737889|Dermatologic Agents|dermatologic agents|mesh-ancestor
64709299|NCT04737889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709300|NCT04737889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64709301|NCT04737889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64709302|NCT04737889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64709303|NCT04737889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64709304|NCT04737889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64709305|NCT04737889|Growth Substances|growth substances|mesh-ancestor
64709306|NCT04737889|Growth Inhibitors|growth inhibitors|mesh-ancestor
64709307|NCT04737889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64709308|NCT04737889|Alkylating Agents|alkylating agents|mesh-ancestor
64709309|NCT04191096|Pembrolizumab|pembrolizumab|mesh-list
64709310|NCT04191096|Androgens|androgens|mesh-list
64709311|NCT04191096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64709312|NCT04191096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709313|NCT04191096|Hormones|hormones|mesh-ancestor
64709314|NCT04191096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64709315|NCT04191096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709316|NCT04507022|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64709317|NCT04507022|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64709318|NCT04507022|Estradiol|estradiol|mesh-list
64709319|NCT04507022|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64709320|NCT04507022|Progesterone|progesterone|mesh-list
64709321|NCT04507022|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64709348|NCT00372476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64709349|NCT00372476|Tubulin Modulators|tubulin modulators|mesh-ancestor
64709350|NCT00372476|Antimitotic Agents|antimitotic agents|mesh-ancestor
64709351|NCT00372476|Mitosis Modulators|mitosis modulators|mesh-ancestor
64709352|NCT04737967|Memantine|memantine|mesh-list
64709353|NCT04737967|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64709354|NCT04737967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64709355|NCT04737967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64709356|NCT04737967|Dopamine Agents|dopamine agents|mesh-ancestor
64709357|NCT04737967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64709358|NCT04737967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709359|NCT04737967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709360|NCT04737967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64709361|NCT04737967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64709419|NCT04767074|Appetite Depressants|appetite depressants|mesh-ancestor
64709420|NCT04767074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64709421|NCT04767074|Sympathomimetics|sympathomimetics|mesh-ancestor
64709422|NCT04767074|Autonomic Agents|autonomic agents|mesh-ancestor
64709423|NCT04767074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64945610|NCT05406505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64709424|NCT04767074|Nasal Decongestants|nasal decongestants|mesh-ancestor
64709425|NCT04767074|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64709426|NCT00372307|Pimecrolimus|pimecrolimus|mesh-list
64709427|NCT00372307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64709428|NCT00372307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64709429|NCT00372307|Analgesics|analgesics|mesh-ancestor
64709474|NCT00372632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64709475|NCT00372632|Renal Agents|renal agents|mesh-ancestor
64709476|NCT05125237|Amiloride|amiloride|mesh-list
64709477|NCT05125237|Triamterene|triamterene|mesh-list
64709478|NCT05125237|Diuretics|diuretics|mesh-ancestor
64709479|NCT05125237|Natriuretic Agents|natriuretic agents|mesh-ancestor
64709480|NCT05125237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709481|NCT05125237|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
64709482|NCT05125237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64709543|NCT04737655|Respiratory System Agents|respiratory system agents|mesh-ancestor
64709544|NCT04737655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64709545|NCT04737655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64709546|NCT04737655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64709547|NCT04737655|Adrenergic Agents|adrenergic agents|mesh-ancestor
64709548|NCT04737655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64709549|NCT04737655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709550|NCT04737655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64709551|NCT04737655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64709552|NCT04737655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64709553|NCT04737655|Cholinergic Agents|cholinergic agents|mesh-ancestor
64709554|NCT04737655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64709555|NCT04737655|Glucocorticoids|glucocorticoids|mesh-ancestor
64709556|NCT04737655|Hormones|hormones|mesh-ancestor
64709557|NCT04737655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64709558|NCT05063396|Analgesics, Opioid|analgesics, opioid|mesh-list
64709559|NCT05063396|Anesthetics|anesthetics|mesh-list
64709560|NCT05063396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64709614|NCT04209140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709615|NCT04209140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709616|NCT04209140|Antimanic Agents|antimanic agents|mesh-ancestor
64709617|NCT04209140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64709618|NCT04209140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64709619|NCT04209140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709620|NCT00372541|Ceftriaxone|ceftriaxone|mesh-list
64709623|NCT04762381|Dexamethasone|dexamethasone|mesh-list
64709707|NCT00813566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64709713|NCT02885012|Ambrisentan|ambrisentan|mesh-list
64709714|NCT02885012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64709715|NCT00372853|Tremelimumab|tremelimumab|mesh-list
64709716|NCT00372853|Ipilimumab|ipilimumab|mesh-list
64709717|NCT00372853|Sunitinib|sunitinib|mesh-list
64709718|NCT00372853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709719|NCT00372853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64709720|NCT00372853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64709721|NCT00372853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709722|NCT00372853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64709723|NCT00372853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64709724|NCT00372853|Growth Substances|growth substances|mesh-ancestor
64709759|NCT02892110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64709760|NCT02892110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709761|NCT02892110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709762|NCT02779166|Celecoxib|celecoxib|mesh-list
64709763|NCT02779166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64709764|NCT02779166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64709765|NCT02779166|Analgesics|analgesics|mesh-ancestor
64709766|NCT02779166|Sensory System Agents|sensory system agents|mesh-ancestor
64709767|NCT02779166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64709768|NCT02779166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709769|NCT02779166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64709770|NCT02779166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64709771|NCT02779166|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64709772|NCT02779166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64709773|NCT02779166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709809|NCT02902172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709810|NCT04233229|Insulin|insulin|mesh-list
64709811|NCT04233229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64709812|NCT04233229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709813|NCT04208347|Oxaliplatin|oxaliplatin|mesh-list
64709814|NCT04208347|Apatinib|apatinib|mesh-list
64709815|NCT04208347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709816|NCT04208347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64709817|NCT04208347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709891|NCT02790788|Glucocorticoids|glucocorticoids|mesh-ancestor
64709892|NCT02790788|Hormones|hormones|mesh-ancestor
64709893|NCT02790788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64709894|NCT02790788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64709895|NCT02790788|Protective Agents|protective agents|mesh-ancestor
64709896|NCT02790788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64709897|NCT02790788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709898|NCT02888665|Doxorubicin|doxorubicin|mesh-list
64709908|NCT02781571|Sofosbuvir|sofosbuvir|mesh-list
64709951|NCT00373568|Antifungal Agents|antifungal agents|mesh-ancestor
64709952|NCT00373568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64709953|NCT00373568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709954|NCT00373568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64709955|NCT00373568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64709956|NCT03002012|Fluconazole|fluconazole|mesh-list
64709957|NCT03002012|Sertraline|sertraline|mesh-list
64709958|NCT03002012|Antidepressive Agents|antidepressive agents|mesh-ancestor
64709959|NCT03002012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64709960|NCT03002012|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64710016|NCT03001843|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64710017|NCT03001843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64710018|NCT03001843|Anesthetics, General|anesthetics, general|mesh-ancestor
64710019|NCT03001843|Anesthetics|anesthetics|mesh-ancestor
64710020|NCT03001843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64710021|NCT03001843|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64710022|NCT03001843|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64710023|NCT03001843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64710024|NCT03001843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710028|NCT02786719|Cyclophosphamide|cyclophosphamide|mesh-list
64337719|NCT02580305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64710081|NCT02791945|Protective Agents|protective agents|mesh-ancestor
64710082|NCT02791945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710083|NCT02791945|Antidotes|antidotes|mesh-ancestor
64710084|NCT02793817|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64710085|NCT02793817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64710086|NCT02804594|Acetylcysteine|acetylcysteine|mesh-list
64710087|NCT02804594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64710088|NCT02804594|Antiviral Agents|antiviral agents|mesh-ancestor
64710089|NCT02804594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64710090|NCT02804594|Expectorants|expectorants|mesh-ancestor
64710091|NCT02804594|Respiratory System Agents|respiratory system agents|mesh-ancestor
64710093|NCT02804594|Antioxidants|antioxidants|mesh-ancestor
64710140|NCT02903407|Midazolam|midazolam|mesh-list
64710141|NCT02903407|Dexmedetomidine|dexmedetomidine|mesh-list
64710142|NCT02903407|Propofol|propofol|mesh-list
64710143|NCT02903407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64710144|NCT02903407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64710145|NCT02903407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710146|NCT02903407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64710147|NCT02903407|Anesthetics, General|anesthetics, general|mesh-ancestor
64710148|NCT02903407|Anesthetics|anesthetics|mesh-ancestor
64710149|NCT02903407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64710150|NCT02903407|Analgesics|analgesics|mesh-ancestor
64710151|NCT02903407|Sensory System Agents|sensory system agents|mesh-ancestor
64710152|NCT02903407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710153|NCT02903407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64710154|NCT02903407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64710211|NCT03018223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64710212|NCT03018223|Antitubercular Agents|antitubercular agents|mesh-ancestor
64710213|NCT03018223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64710214|NCT03018223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64710215|NCT03018223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64710216|NCT03018223|Antifungal Agents|antifungal agents|mesh-ancestor
64710217|NCT03018223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64710218|NCT03018925|Golimumab|golimumab|mesh-list
64710219|NCT03018925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64710220|NCT03018925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64710286|NCT02937506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64710287|NCT02937506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64710288|NCT02937506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64710289|NCT02937506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64710290|NCT02937506|GABA Modulators|gaba modulators|mesh-ancestor
64710291|NCT02937506|GABA Agents|gaba agents|mesh-ancestor
64710292|NCT02937506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64710293|NCT02937506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710294|NCT03026803|Capecitabine|capecitabine|mesh-list
64710295|NCT03026803|Oxaliplatin|oxaliplatin|mesh-list
64710296|NCT03026803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64710297|NCT03026803|Antimetabolites|antimetabolites|mesh-ancestor
64710298|NCT03026803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710299|NCT03026803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64710305|NCT03027661|Sensory System Agents|sensory system agents|mesh-ancestor
64710306|NCT03027661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710307|NCT03022526|Fentanyl|fentanyl|mesh-list
64710308|NCT03022526|Bupivacaine|bupivacaine|mesh-list
64337796|NCT02264093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64710338|NCT02941640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710339|NCT02941640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64710340|NCT02941640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710341|NCT02823080|Cetrorelix|cetrorelix|mesh-list
64710342|NCT02823080|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64710343|NCT02823080|Fertility Agents|fertility agents|mesh-ancestor
64710405|NCT03032965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710406|NCT03032965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64710407|NCT03032965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64710408|NCT03032965|Adrenergic Agents|adrenergic agents|mesh-ancestor
64710409|NCT03032965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64710410|NCT03032965|Autonomic Agents|autonomic agents|mesh-ancestor
64710411|NCT03032965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64710412|NCT03032965|Respiratory System Agents|respiratory system agents|mesh-ancestor
64710413|NCT03032965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64710414|NCT03032965|Sympathomimetics|sympathomimetics|mesh-ancestor
64710415|NCT03032965|Protective Agents|protective agents|mesh-ancestor
64710416|NCT02948426|Interferon-gamma|interferon-gamma|mesh-list
64710472|NCT03035929|Hormones|hormones|mesh-ancestor
64945619|NCT05402553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64710473|NCT03035929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64710474|NCT03035929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64710475|NCT03035929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64710476|NCT03035929|Protease Inhibitors|protease inhibitors|mesh-ancestor
64710477|NCT03035929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64710478|NCT03035929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710479|NCT02951702|Vancomycin|vancomycin|mesh-list
64710480|NCT02951702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64710481|NCT02951702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64710482|NCT02831816|Ethanol|ethanol|mesh-list
64710483|NCT02831816|Chlorhexidine|chlorhexidine|mesh-list
64710484|NCT02831816|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64710485|NCT02831816|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64710486|NCT02831816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64710487|NCT02831816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64710488|NCT02831816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710489|NCT02831816|Disinfectants|disinfectants|mesh-ancestor
64710490|NCT02831816|Dermatologic Agents|dermatologic agents|mesh-ancestor
64710491|NCT03036163|Macozinone|macozinone|mesh-list
64710492|NCT03036163|Antitubercular Agents|antitubercular agents|mesh-ancestor
64710493|NCT03036163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64710494|NCT03036163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64710495|NCT02953886|Fluorides|fluorides|mesh-list
64710496|NCT02953886|Cariostatic Agents|cariostatic agents|mesh-ancestor
64710522|NCT00374426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710523|NCT02916745|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
64710524|NCT02916745|Trioxsalen|trioxsalen|mesh-list
64710525|NCT02916745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64710526|NCT02916745|Dermatologic Agents|dermatologic agents|mesh-ancestor
64710527|NCT02916745|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64710528|NCT02954198|Mycophenolic Acid|mycophenolic acid|mesh-list
64710529|NCT02954198|Prednisone|prednisone|mesh-list
64710530|NCT02954198|Methylprednisolone|methylprednisolone|mesh-list
64710531|NCT02954198|Everolimus|everolimus|mesh-list
64710532|NCT02954198|Tacrolimus|tacrolimus|mesh-list
64710533|NCT02954198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64710534|NCT02954198|Glucocorticoids|glucocorticoids|mesh-ancestor
64710578|NCT02956616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710579|NCT02956616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337860|NCT02264171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64710580|NCT02956616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64710581|NCT02956616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64710589|NCT05829603|Hallucinogens|hallucinogens|mesh-ancestor
64710590|NCT05829603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710591|NCT05829603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64710592|NCT05829603|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64710593|NCT05829603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64710595|NCT05829551|Ritonavir|ritonavir|mesh-list
64710639|NCT05829317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710640|NCT05829317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64710641|NCT05829317|Tocolytic Agents|tocolytic agents|mesh-ancestor
64710642|NCT05829317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64710644|NCT05829187|Piperaquine|piperaquine|mesh-list
64710645|NCT05829187|Artenimol|artenimol|mesh-list
64710646|NCT05829187|Antimalarials|antimalarials|mesh-ancestor
64710647|NCT05829187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64710782|NCT05828199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710783|NCT05828199|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64719501|NCT00000902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719502|NCT00000902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719503|NCT00000902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64719504|NCT00000902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64327598|NCT00805129|Everolimus|everolimus|mesh-list
64710784|NCT05828199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64710785|NCT05828199|Anesthetics, General|anesthetics, general|mesh-ancestor
64710786|NCT05828199|Anesthetics|anesthetics|mesh-ancestor
64710787|NCT05828199|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64710788|NCT05828199|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64710790|NCT05828147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64710861|NCT05827497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64710862|NCT05827497|Immunologic Factors|immunologic factors|mesh-ancestor
64710863|NCT05827497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64710864|NCT05827497|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64710865|NCT05827484|Losartan|losartan|mesh-list
64710866|NCT05827484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64710867|NCT05827484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64710929|NCT05821972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64710930|NCT05821972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64710931|NCT05821972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64710932|NCT05821972|Adrenergic Agents|adrenergic agents|mesh-ancestor
64710933|NCT05821972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64710934|NCT05821972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710935|NCT05821972|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64710936|NCT05821972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64711020|NCT05757544|Ganaxolone|ganaxolone|mesh-list
64711083|NCT05709990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711084|NCT05709990|Urological Agents|urological agents|mesh-ancestor
64711085|NCT05707468|Hormones|hormones|mesh-list
64711088|NCT05700903|Leuprolide|leuprolide|mesh-list
64719522|NCT04331600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64719523|NCT04331600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64719525|NCT04331600|Sensory System Agents|sensory system agents|mesh-ancestor
64719526|NCT04331600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719527|NCT04331600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327618|NCT02273635|Analgesics|analgesics|mesh-ancestor
64711089|NCT05700903|Goserelin|goserelin|mesh-list
64711090|NCT05700903|Flutamide|flutamide|mesh-list
64711091|NCT05700903|Bicalutamide|bicalutamide|mesh-list
64711140|NCT05683535|Cholinergic Agents|cholinergic agents|mesh-ancestor
64711141|NCT05683535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64711142|NCT05683535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711143|NCT05678244|Acetaminophen|acetaminophen|mesh-list
64711155|NCT05675800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64711156|NCT05675319|Dexamethasone|dexamethasone|mesh-list
64711157|NCT05675319|Dexamethasone acetate|dexamethasone acetate|mesh-list
64711158|NCT05675319|Lenalidomide|lenalidomide|mesh-list
64711159|NCT05675319|Bortezomib|bortezomib|mesh-list
64711160|NCT05675319|Daratumumab|daratumumab|mesh-list
64338116|NCT02267681|Fentanyl|fentanyl|mesh-list
64711263|NCT05593939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64711264|NCT05593939|Vasodilator Agents|vasodilator agents|mesh-ancestor
64711297|NCT05577845|Ramosetron|ramosetron|mesh-list
64711298|NCT05577845|Antiemetics|antiemetics|mesh-ancestor
64711301|NCT05577845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711302|NCT05577845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64711303|NCT05577845|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64711369|NCT05464680|Chelating Agents|chelating agents|mesh-ancestor
64711370|NCT05464680|Sequestering Agents|sequestering agents|mesh-ancestor
64711371|NCT05464680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945625|NCT05402553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711372|NCT05463744|Insulin|insulin|mesh-list
64711373|NCT05463744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64711374|NCT05463744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64711375|NCT05463744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711376|NCT05462730|Methylprednisolone|methylprednisolone|mesh-list
64711377|NCT05462730|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64719547|NCT00000914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64719548|NCT00000914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64711435|NCT05400369|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64711436|NCT05400369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64711437|NCT05400369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64711438|NCT05400369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64711439|NCT05400369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64711440|NCT05400369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64711441|NCT05400369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711442|NCT05400369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711443|NCT05400369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64711444|NCT05400369|Contraceptive Agents|contraceptive agents|mesh-ancestor
64711445|NCT05400369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64711446|NCT05400369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711512|NCT05374512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711586|NCT05323617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338154|NCT05177939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711587|NCT05323617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64711588|NCT05323617|Immunologic Factors|immunologic factors|mesh-ancestor
64711589|NCT05323617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711590|NCT05323617|Antifungal Agents|antifungal agents|mesh-ancestor
64711591|NCT05323617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64711592|NCT05323617|Dermatologic Agents|dermatologic agents|mesh-ancestor
64711593|NCT05323617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64711594|NCT05323617|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64711595|NCT05323435|Vaccines|vaccines|mesh-list
64711596|NCT05323435|Immunologic Factors|immunologic factors|mesh-ancestor
64711597|NCT05323435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711598|NCT05322252|Misoprostol|misoprostol|mesh-list
64436834|NCT05813600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64711663|NCT05257408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64711664|NCT05257408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64711665|NCT05257408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711666|NCT05257408|Tubulin Modulators|tubulin modulators|mesh-ancestor
64711667|NCT05257408|Antimitotic Agents|antimitotic agents|mesh-ancestor
64711668|NCT05257408|Mitosis Modulators|mitosis modulators|mesh-ancestor
64711669|NCT05257408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945627|NCT05402553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64711798|NCT05084989|Vaccines|vaccines|mesh-list
64711799|NCT05084989|Immunologic Factors|immunologic factors|mesh-ancestor
64711800|NCT05084989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711801|NCT05079828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64711802|NCT05079828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64711803|NCT05079828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711824|NCT05042700|Melatonin|melatonin|mesh-list
64711825|NCT05042700|Antioxidants|antioxidants|mesh-ancestor
64711826|NCT05042700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711827|NCT05042700|Protective Agents|protective agents|mesh-ancestor
64711856|NCT05019222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64711938|NCT04966663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64711939|NCT04966663|Immunologic Factors|immunologic factors|mesh-ancestor
64711940|NCT04966663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711941|NCT04966663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64711942|NCT04966663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64711943|NCT04966663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64711944|NCT04966663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64338200|NCT01255709|Autonomic Agents|autonomic agents|mesh-ancestor
64712094|NCT04724148|Sensory System Agents|sensory system agents|mesh-ancestor
64712095|NCT04724148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64712096|NCT04724148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64712097|NCT04724148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64712098|NCT04724148|Anesthetics, General|anesthetics, general|mesh-ancestor
64712099|NCT04724148|Anesthetics|anesthetics|mesh-ancestor
64712100|NCT04712097|Rituximab|rituximab|mesh-list
64338201|NCT01255709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64712101|NCT04712097|Lenalidomide|lenalidomide|mesh-list
64712103|NCT04712097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712173|NCT04681417|Antimitotic Agents|antimitotic agents|mesh-ancestor
64712174|NCT04681417|Mitosis Modulators|mitosis modulators|mesh-ancestor
64712175|NCT04681417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64712176|NCT04681417|Alkylating Agents|alkylating agents|mesh-ancestor
64712177|NCT04681417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64712191|NCT04670978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64712192|NCT04670978|Growth Substances|growth substances|mesh-ancestor
64712194|NCT04670978|Growth Inhibitors|growth inhibitors|mesh-ancestor
64712325|NCT04505774|Canagliflozin|canagliflozin|mesh-list
64712326|NCT04505774|Ertugliflozin|ertugliflozin|mesh-list
64712327|NCT04505774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64712328|NCT04505774|Heparin|heparin|mesh-list
64712329|NCT04505774|Calcium heparin|calcium heparin|mesh-list
64712330|NCT04505774|Enoxaparin|enoxaparin|mesh-list
64712331|NCT04505774|Dalteparin|dalteparin|mesh-list
64712332|NCT04505774|Tinzaparin|tinzaparin|mesh-list
64712333|NCT04505774|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64712334|NCT04505774|Enoxaparin sodium|enoxaparin sodium|mesh-list
64712347|NCT04505774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64712348|NCT04505774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64945630|NCT05402553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64945631|NCT05379322|Adalimumab|adalimumab|mesh-list
64712353|NCT04503460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64712354|NCT04503460|Autonomic Agents|autonomic agents|mesh-ancestor
64712355|NCT04503460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64712356|NCT04503460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712357|NCT04503460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64712358|NCT04503460|Respiratory System Agents|respiratory system agents|mesh-ancestor
64712359|NCT04503460|Dermatologic Agents|dermatologic agents|mesh-ancestor
64712360|NCT04503460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64712361|NCT04503460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64712362|NCT04503460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64712363|NCT04503460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64712364|NCT04503460|Adrenergic Agents|adrenergic agents|mesh-ancestor
64712365|NCT04503460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64712366|NCT04503460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712367|NCT04503460|Glucocorticoids|glucocorticoids|mesh-ancestor
64712368|NCT04503460|Hormones|hormones|mesh-ancestor
64719620|NCT00000200|Respiratory System Agents|respiratory system agents|mesh-ancestor
64712378|NCT04452877|Dabrafenib|dabrafenib|mesh-list
64712379|NCT04452877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712380|NCT04452877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64712381|NCT04452877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712382|NCT04452877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712383|NCT04414761|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64712384|NCT04414761|Medroxyprogesterone|medroxyprogesterone|mesh-list
64712385|NCT04414761|Cetrorelix|cetrorelix|mesh-list
64712386|NCT04414761|Progesterone|progesterone|mesh-list
64712387|NCT04414761|Dydrogesterone|dydrogesterone|mesh-list
64712388|NCT04414761|Ganirelix|ganirelix|mesh-list
64712389|NCT04414761|Progestins|progestins|mesh-ancestor
64712390|NCT04414761|Hormones|hormones|mesh-ancestor
64712391|NCT04414761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64712392|NCT04414761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712541|NCT04195633|Antifungal Agents|antifungal agents|mesh-ancestor
64712542|NCT04195633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64712553|NCT04169373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712554|NCT04169373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64712555|NCT04167514|Protease Inhibitors|protease inhibitors|mesh-list
64712556|NCT04167514|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64712557|NCT04167514|Protein C Inhibitor|protein c inhibitor|mesh-list
64712558|NCT04167514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712559|NCT04167514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712560|NCT04167514|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64712605|NCT04109066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712606|NCT04109066|Tubulin Modulators|tubulin modulators|mesh-ancestor
64712607|NCT04109066|Antimitotic Agents|antimitotic agents|mesh-ancestor
64719652|NCT00000944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64719653|NCT00000944|Antimetabolites|antimetabolites|mesh-ancestor
64719654|NCT00000944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64719655|NCT00000944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64719656|NCT00000944|Protease Inhibitors|protease inhibitors|mesh-ancestor
64719657|NCT00000950|Pyridoxine|pyridoxine|mesh-list
64719658|NCT00000950|Vitamin B 6|vitamin b 6|mesh-list
64719659|NCT00000950|Rifampin|rifampin|mesh-list
64719660|NCT00000950|Isoniazid|isoniazid|mesh-list
64719661|NCT00000950|Pyrazinamide|pyrazinamide|mesh-list
64719662|NCT00000950|Ethambutol|ethambutol|mesh-list
64327737|NCT00485563|Immunologic Factors|immunologic factors|mesh-ancestor
64327738|NCT00485563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327739|NCT00485563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64327740|NCT00485563|Analgesics|analgesics|mesh-ancestor
64712608|NCT04109066|Mitosis Modulators|mitosis modulators|mesh-ancestor
64712609|NCT04109066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712610|NCT04109066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64712611|NCT04109066|Immunologic Factors|immunologic factors|mesh-ancestor
64712612|NCT04109066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712613|NCT04109066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64712614|NCT04109066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64712615|NCT04109066|Alkylating Agents|alkylating agents|mesh-ancestor
64712616|NCT04109066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64712617|NCT04109066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64712618|NCT04109066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64712635|NCT04100018|Prednisone|prednisone|mesh-list
64712636|NCT04100018|Docetaxel|docetaxel|mesh-list
64712637|NCT04100018|Nivolumab|nivolumab|mesh-list
64712638|NCT04100018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952641|NCT00058227|Immunologic Factors|immunologic factors|mesh-ancestor
64952642|NCT00058227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712659|NCT04093323|Antiviral Agents|antiviral agents|mesh-ancestor
64712660|NCT04093323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64712661|NCT04093323|Immunologic Factors|immunologic factors|mesh-ancestor
64712662|NCT04093323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712663|NCT04093323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64712664|NCT04093323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64712665|NCT04093323|Analgesics|analgesics|mesh-ancestor
64712666|NCT04093323|Sensory System Agents|sensory system agents|mesh-ancestor
64712725|NCT03971474|Pembrolizumab|pembrolizumab|mesh-list
64712726|NCT03971474|Pemetrexed|pemetrexed|mesh-list
64712727|NCT03971474|Ramucirumab|ramucirumab|mesh-list
64712728|NCT03971474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64712729|NCT03971474|Antibodies|antibodies|mesh-list
64719677|NCT00000950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64327749|NCT02170805|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64327750|NCT02170805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64327751|NCT02170805|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64327752|NCT02170805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327753|NCT02170805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327754|NCT02170805|Antithrombins|antithrombins|mesh-ancestor
64712737|NCT03971474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712830|NCT03841617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64327763|NCT00606697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327765|NCT00606697|Autonomic Agents|autonomic agents|mesh-ancestor
64327766|NCT00606697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64327767|NCT00606697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64327768|NCT02404077|Clonidine|clonidine|mesh-list
64327769|NCT02404077|Analgesics|analgesics|mesh-ancestor
64712831|NCT03841617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712832|NCT03827070|Afatinib|afatinib|mesh-list
64712833|NCT03827070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64719707|NCT00000224|Sensory System Agents|sensory system agents|mesh-ancestor
64719708|NCT00000224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64719709|NCT00000224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64719710|NCT04332991|Hydroxychloroquine|hydroxychloroquine|mesh-list
64719711|NCT04332991|Antimalarials|antimalarials|mesh-ancestor
64719712|NCT04332991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64719713|NCT04332991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64719714|NCT04332991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719715|NCT04332991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327770|NCT02404077|Sensory System Agents|sensory system agents|mesh-ancestor
64327771|NCT02404077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64327772|NCT02404077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712837|NCT03820986|Pembrolizumab|pembrolizumab|mesh-list
64712838|NCT03820986|Lenvatinib|lenvatinib|mesh-list
64414911|NCT02418585|Analgesics|analgesics|mesh-ancestor
64952643|NCT00058227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64952646|NCT00058227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952648|NCT00058227|Growth Inhibitors|growth inhibitors|mesh-ancestor
64952649|NCT00058227|Growth Substances|growth substances|mesh-ancestor
64952650|NCT00058227|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64952651|NCT00058227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952652|NCT00031070|Cyclosporine|cyclosporine|mesh-list
64952653|NCT00031070|Lamivudine|lamivudine|mesh-list
64952654|NCT00031070|Zidovudine|zidovudine|mesh-list
64952655|NCT00031070|Efavirenz|efavirenz|mesh-list
64952656|NCT00031070|Abacavir|abacavir|mesh-list
64952657|NCT00031070|Vaccines|vaccines|mesh-list
64952658|NCT00031070|Cyclosporins|cyclosporins|mesh-list
64952659|NCT00031070|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64952660|NCT00031070|Immunologic Factors|immunologic factors|mesh-ancestor
64952661|NCT00031070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952662|NCT00031070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952663|NCT00031070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952664|NCT00031070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64952665|NCT00031070|Antifungal Agents|antifungal agents|mesh-ancestor
64952666|NCT00031070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64952667|NCT00031070|Dermatologic Agents|dermatologic agents|mesh-ancestor
64952668|NCT00031070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64952669|NCT00031070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64952670|NCT00031070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64952671|NCT00031070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64952672|NCT00031070|Antiviral Agents|antiviral agents|mesh-ancestor
64712839|NCT03820986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64712840|NCT03820986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64719738|NCT00000974|Pentamidine|pentamidine|mesh-list
64719739|NCT00000974|Antifungal Agents|antifungal agents|mesh-ancestor
64719740|NCT00000974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719741|NCT00000974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64719742|NCT00000974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64719743|NCT00000974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64719744|NCT00000242|Carbamazepine|carbamazepine|mesh-list
64327784|NCT02174939|Autonomic Agents|autonomic agents|mesh-ancestor
64327785|NCT02174939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64327786|NCT02174939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327787|NCT02174939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64327788|NCT02174939|Respiratory System Agents|respiratory system agents|mesh-ancestor
64327789|NCT02174939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64327790|NCT02174939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64719768|NCT00000992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64327795|NCT02174939|Protective Agents|protective agents|mesh-ancestor
64719778|NCT00000254|Nitrous Oxide|nitrous oxide|mesh-list
64712928|NCT03657602|Levonorgestrel|levonorgestrel|mesh-list
64712929|NCT03657602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64712930|NCT03657602|Contraceptive Agents|contraceptive agents|mesh-ancestor
64712931|NCT03657602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64712932|NCT03657602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712933|NCT03657602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64712934|NCT03657602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64712935|NCT03657602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64719861|NCT00000278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719863|NCT00001028|Pentamidine|pentamidine|mesh-list
64719864|NCT00001028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719865|NCT00001028|Antimalarials|antimalarials|mesh-ancestor
64719866|NCT00001028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64719867|NCT00001028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64719868|NCT00001028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64719869|NCT00001028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719870|NCT00001028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327852|NCT02277847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64719885|NCT00001940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64719886|NCT00001940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64719887|NCT03907033|Bupivacaine|bupivacaine|mesh-list
64713083|NCT03258593|Durvalumab|durvalumab|mesh-list
64713084|NCT03258593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64713085|NCT03258593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713086|NCT03211416|Pembrolizumab|pembrolizumab|mesh-list
64713087|NCT03211416|Sorafenib|sorafenib|mesh-list
64713088|NCT03211416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64713089|NCT03211416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713090|NCT03211416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64713151|NCT03092817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713152|NCT03062358|Pembrolizumab|pembrolizumab|mesh-list
64713153|NCT03062358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64713154|NCT03062358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713155|NCT03049462|Mirabegron|mirabegron|mesh-list
64713156|NCT03049462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713157|NCT03049462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713158|NCT03049462|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64713159|NCT03049462|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64327953|NCT02178683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64327954|NCT02178683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64327955|NCT03170739|Dopamine|dopamine|mesh-list
64327956|NCT03170739|Dexmedetomidine|dexmedetomidine|mesh-list
64327957|NCT03170739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64327961|NCT03170739|Analgesics|analgesics|mesh-ancestor
64713228|NCT03007147|Immunologic Factors|immunologic factors|mesh-ancestor
64713229|NCT03007147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713230|NCT03007147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64713231|NCT03007147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64713232|NCT03007147|Alkylating Agents|alkylating agents|mesh-ancestor
64713233|NCT03007147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713234|NCT03007147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713235|NCT03007147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64459377|NCT01818752|Prednisone|prednisone|mesh-list
64720084|NCT00002012|Immunologic Factors|immunologic factors|mesh-ancestor
64720085|NCT00002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720086|NCT00380354|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
64720087|NCT00380354|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64720120|NCT00001094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720121|NCT00001094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720122|NCT00001094|Antiviral Agents|antiviral agents|mesh-ancestor
64720123|NCT00001094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720183|NCT00001106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720184|NCT00001106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64720185|NCT00001106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720186|NCT00001106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720187|NCT00001106|Antiviral Agents|antiviral agents|mesh-ancestor
64720188|NCT00001106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720250|NCT00000374|Serotonin Agents|serotonin agents|mesh-ancestor
64720251|NCT00000374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64720252|NCT00000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720253|NCT00000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328223|NCT02663271|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64328224|NCT02663271|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64713339|NCT02989597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64713340|NCT02989597|Narcotics|narcotics|mesh-ancestor
64328302|NCT02176499|Telmisartan|telmisartan|mesh-list
64328303|NCT02176499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64328304|NCT02176499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64328305|NCT02176499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64713448|NCT02652195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713522|NCT02404870|Canagliflozin|canagliflozin|mesh-list
64713523|NCT02404870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64713524|NCT02404870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713525|NCT02404870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64713526|NCT02404870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713527|NCT02359565|Pembrolizumab|pembrolizumab|mesh-list
64720405|NCT03782233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720407|NCT00002090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64720439|NCT00002102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64720440|NCT00002102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328334|NCT02403687|Tizanidine|tizanidine|mesh-list
64713564|NCT02194829|Antimetabolites|antimetabolites|mesh-ancestor
64713565|NCT02194829|Antiviral Agents|antiviral agents|mesh-ancestor
64713566|NCT02194829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64713567|NCT02194829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64713621|NCT02107963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64328460|NCT00578773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64328461|NCT00578773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64328462|NCT00578773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64328463|NCT00578773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64328464|NCT00578773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64328465|NCT00578773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328468|NCT02387307|Interferons|interferons|mesh-list
64720664|NCT00000626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64328553|NCT02774239|Immunoglobulin G|immunoglobulin g|mesh-list
64328554|NCT02774239|Immunologic Factors|immunologic factors|mesh-ancestor
64328555|NCT02774239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328556|NCT02280109|Tenofovir|tenofovir|mesh-list
64328557|NCT02280109|Antiviral Agents|antiviral agents|mesh-ancestor
64720721|NCT00002156|Antiviral Agents|antiviral agents|mesh-ancestor
64720722|NCT00002156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64720723|NCT00002156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64720724|NCT00002156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328600|NCT02386449|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64328601|NCT02386449|Diuretics|diuretics|mesh-ancestor
64328602|NCT02386449|Natriuretic Agents|natriuretic agents|mesh-ancestor
64328603|NCT02386449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328604|NCT02386449|Cathartics|cathartics|mesh-ancestor
64328605|NCT02386449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64328606|NCT02386449|Laxatives|laxatives|mesh-ancestor
64328607|NCT02386449|Anticoagulants|anticoagulants|mesh-ancestor
64328608|NCT02386449|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64328609|NCT02386449|Chelating Agents|chelating agents|mesh-ancestor
64720761|NCT00000638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64720762|NCT00000638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64720763|NCT00000638|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64720764|NCT00000638|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64720765|NCT00000638|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64720766|NCT00000638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64720767|NCT00000638|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64720768|NCT00000638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64720769|NCT00000638|Antimetabolites|antimetabolites|mesh-ancestor
64720913|NCT00002198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64720914|NCT00000704|Zalcitabine|zalcitabine|mesh-list
64720915|NCT00000704|Antimetabolites|antimetabolites|mesh-ancestor
64720917|NCT00000704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64713686|NCT01740557|Aldesleukin|aldesleukin|mesh-list
64713687|NCT01740557|Cyclophosphamide|cyclophosphamide|mesh-list
64713688|NCT01740557|Fludarabine|fludarabine|mesh-list
64713689|NCT01740557|Fludarabine phosphate|fludarabine phosphate|mesh-list
64713690|NCT01740557|Interleukin-2|interleukin-2|mesh-list
64713691|NCT01740557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64713692|NCT01740557|Immunologic Factors|immunologic factors|mesh-ancestor
64328851|NCT00443287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64328852|NCT00443287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328853|NCT00443287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64713749|NCT01306019|Busulfan|busulfan|mesh-list
64713807|NCT00329043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713808|NCT00329043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64713809|NCT00329043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64713810|NCT00329043|Growth Substances|growth substances|mesh-ancestor
64713811|NCT00329043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440899|NCT01745380|Autonomic Agents|autonomic agents|mesh-ancestor
64441050|NCT01721746|Alkylating Agents|alkylating agents|mesh-ancestor
64441124|NCT02225353|Progesterone|progesterone|mesh-list
64442492|NCT01637402|Prednisone|prednisone|mesh-list
64494790|NCT05309460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64494791|NCT05309460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494792|NCT05309460|Vasodilator Agents|vasodilator agents|mesh-ancestor
64494793|NCT05309460|Tocolytic Agents|tocolytic agents|mesh-ancestor
64494794|NCT05309460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64494795|NCT05309460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64494796|NCT05309460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64494805|NCT01093690|Metoclopramide|metoclopramide|mesh-list
64494859|NCT05439408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494861|NCT03011476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64494862|NCT03011476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494867|NCT03011476|Nootropic Agents|nootropic agents|mesh-ancestor
64494929|NCT03467178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64494930|NCT03467178|Decitabine|decitabine|mesh-list
64494931|NCT03467178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64494932|NCT03467178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494948|NCT04722822|Vaccines|vaccines|mesh-list
64494979|NCT03461718|Anesthetics, General|anesthetics, general|mesh-ancestor
64494980|NCT03461718|Anesthetics|anesthetics|mesh-ancestor
64494981|NCT03461718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64494982|NCT03461718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64494983|NCT03461718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64494984|NCT03461718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64494985|NCT03461718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494986|NCT03461718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64721244|NCT00002354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64721245|NCT00002354|Antiviral Agents|antiviral agents|mesh-ancestor
64721246|NCT00002354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64721247|NCT00002354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64721248|NCT00002354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64721249|NCT00002354|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64721250|NCT00002354|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64495017|NCT03129594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495018|NCT03129594|Incretins|incretins|mesh-ancestor
64495019|NCT03466632|Dexmedetomidine|dexmedetomidine|mesh-list
64495020|NCT03466632|Propofol|propofol|mesh-list
64495021|NCT03466632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64495024|NCT03466632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64329212|NCT05064449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329213|NCT05064449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64329214|NCT05064449|Hormone Antagonists|hormone antagonists|mesh-ancestor
64329215|NCT05064449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64329252|NCT01645930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329253|NCT01645930|Immunologic Factors|immunologic factors|mesh-ancestor
64329254|NCT01645930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64329255|NCT01645930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64329256|NCT01645930|Growth Substances|growth substances|mesh-ancestor
64495055|NCT03461328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64329262|NCT02190695|Decitabine|decitabine|mesh-list
64721464|NCT02568007|Cyproheptadine|cyproheptadine|mesh-list
64721465|NCT02568007|Antipruritics|antipruritics|mesh-ancestor
64721466|NCT02568007|Dermatologic Agents|dermatologic agents|mesh-ancestor
64721467|NCT02568007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64721468|NCT02568007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64721469|NCT02568007|Histamine Antagonists|histamine antagonists|mesh-ancestor
64721470|NCT02568007|Histamine Agents|histamine agents|mesh-ancestor
64721471|NCT02568007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64495112|NCT01146808|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64495113|NCT01146808|Antiviral Agents|antiviral agents|mesh-ancestor
64495114|NCT01146808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64495115|NCT01146808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64495116|NCT01146808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64495119|NCT02522130|Naproxen|naproxen|mesh-list
64721537|NCT05722262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721538|NCT05722262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64721539|NCT05722262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721540|NCT05709626|Aspirin|aspirin|mesh-list
64721541|NCT05709626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64721542|NCT05709626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64721556|NCT03538015|Carvedilol|carvedilol|mesh-list
64721595|NCT00002426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329431|NCT02384343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329432|NCT05033639|Melatonin|melatonin|mesh-list
64329479|NCT02187107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64329480|NCT02187107|Antiviral Agents|antiviral agents|mesh-ancestor
64329481|NCT02187107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64329482|NCT02285491|Bupivacaine|bupivacaine|mesh-list
64329483|NCT02285491|Anesthetics, Local|anesthetics, local|mesh-ancestor
64329484|NCT02285491|Anesthetics|anesthetics|mesh-ancestor
64495184|NCT01099618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64495185|NCT01099618|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64495187|NCT01099618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418355|NCT05540431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495204|NCT01100242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64495205|NCT01100242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495206|NCT01148836|Ubiquinone|ubiquinone|mesh-list
64495207|NCT01148836|Coenzyme Q10|coenzyme q10|mesh-list
64721733|NCT00002474|Mitoxantrone|mitoxantrone|mesh-list
64721734|NCT00002474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64721735|NCT00002474|Immunologic Factors|immunologic factors|mesh-ancestor
64461026|NCT02405260|Hormones|hormones|mesh-ancestor
64495274|NCT01103440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64495275|NCT01103440|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64495276|NCT01103440|Immunologic Factors|immunologic factors|mesh-ancestor
64495277|NCT01103440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64495278|NCT01103440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721789|NCT02373865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64329543|NCT02381145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64329544|NCT00097357|Enoxaparin|enoxaparin|mesh-list
64329545|NCT00097357|Warfarin|warfarin|mesh-list
64721853|NCT01500109|Analgesics|analgesics|mesh-ancestor
64721854|NCT01500109|Sensory System Agents|sensory system agents|mesh-ancestor
64721855|NCT01500109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64721856|NCT01500109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721857|NCT01500109|Antipyretics|antipyretics|mesh-ancestor
64721859|NCT00002516|Dactinomycin|dactinomycin|mesh-list
64721860|NCT00002516|Cyclophosphamide|cyclophosphamide|mesh-list
64721862|NCT00002516|Doxorubicin|doxorubicin|mesh-list
64721863|NCT00002516|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64721864|NCT00002516|Etoposide|etoposide|mesh-list
64721865|NCT00002516|Vincristine|vincristine|mesh-list
64721866|NCT00002516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64721867|NCT00002516|Immunologic Factors|immunologic factors|mesh-ancestor
64721868|NCT00002516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64721869|NCT00002516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64721871|NCT00002516|Alkylating Agents|alkylating agents|mesh-ancestor
64329640|NCT00069745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64329641|NCT00069745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329642|NCT02192411|Lidocaine|lidocaine|mesh-list
64721913|NCT00002528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64721914|NCT02341495|Vitamin D|vitamin d|mesh-list
64721915|NCT02341495|Cholecalciferol|cholecalciferol|mesh-list
64721916|NCT02341495|Azacitidine|azacitidine|mesh-list
64721917|NCT02341495|Deferasirox|deferasirox|mesh-list
64721918|NCT02341495|Vitamins|vitamins|mesh-ancestor
64721919|NCT02341495|Micronutrients|micronutrients|mesh-ancestor
64329653|NCT02192411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329654|NCT02193893|Coal Tar|coal tar|mesh-list
64329655|NCT02193893|Keratolytic Agents|keratolytic agents|mesh-ancestor
64329668|NCT02384187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64329669|NCT02384187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64329670|NCT02384187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64721950|NCT00002534|Antiemetics|antiemetics|mesh-ancestor
64721960|NCT00002546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64721961|NCT00002546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64721962|NCT00002546|Alkylating Agents|alkylating agents|mesh-ancestor
64721963|NCT00002546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495535|NCT04614714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495536|NCT04614714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64495537|NCT04614714|Vasodilator Agents|vasodilator agents|mesh-ancestor
64495539|NCT01221298|Ribavirin|ribavirin|mesh-list
64495540|NCT01221298|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64495541|NCT01221298|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64495566|NCT01203046|Ertapenem|ertapenem|mesh-list
64495595|NCT04169100|Prednisone|prednisone|mesh-list
64495596|NCT04169100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64495597|NCT04169100|Glucocorticoids|glucocorticoids|mesh-ancestor
64495598|NCT04169100|Hormones|hormones|mesh-ancestor
64495599|NCT04169100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64495600|NCT04169100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495601|NCT04169100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64329789|NCT00312091|Antimetabolites|antimetabolites|mesh-ancestor
64329790|NCT00389779|Guanfacine|guanfacine|mesh-list
64329791|NCT00389779|Darusentan|darusentan|mesh-list
64495693|NCT01158820|Analgesics|analgesics|mesh-ancestor
64495694|NCT01158820|Sensory System Agents|sensory system agents|mesh-ancestor
64495695|NCT01158820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64495696|NCT01158820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64722138|NCT00002582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64722139|NCT00002582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64722140|NCT00002582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64722141|NCT00002582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64722149|NCT00002588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64722198|NCT02234011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722199|NCT00002600|Cyclophosphamide|cyclophosphamide|mesh-list
64722200|NCT00002600|Carboplatin|carboplatin|mesh-list
64722201|NCT00002600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64722281|NCT02110069|Antimitotic Agents|antimitotic agents|mesh-ancestor
64722282|NCT02110069|Mitosis Modulators|mitosis modulators|mesh-ancestor
64722283|NCT02110069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722284|NCT02110069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64722285|NCT02110069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64722286|NCT02110069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64722287|NCT02110069|Antifungal Agents|antifungal agents|mesh-ancestor
64722288|NCT02110069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64722289|NCT02110069|Immunologic Factors|immunologic factors|mesh-ancestor
64495705|NCT01158820|Anesthetics|anesthetics|mesh-ancestor
64495706|NCT01158820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64495707|NCT01158820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64495708|NCT01158820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64495709|NCT01158820|Narcotics|narcotics|mesh-ancestor
64495710|NCT01158820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64495711|NCT01158820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64495728|NCT03707028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495729|NCT03707028|Tubulin Modulators|tubulin modulators|mesh-ancestor
64495730|NCT03707028|Antimitotic Agents|antimitotic agents|mesh-ancestor
64495738|NCT04956042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722425|NCT00002684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722468|NCT00002702|Aldesleukin|aldesleukin|mesh-list
64722469|NCT00002702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722470|NCT00002702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64722471|NCT00002702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64495782|NCT01159054|Niacin|niacin|mesh-list
64495858|NCT01212874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495859|NCT01859741|Carboplatin|carboplatin|mesh-list
64495860|NCT01859741|Etoposide|etoposide|mesh-list
64495861|NCT01859741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495862|NCT01859741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64495863|NCT01859741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64495864|NCT01859741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64495865|NCT01859741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64495866|NCT01859741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495867|NCT01212952|Dexamethasone|dexamethasone|mesh-list
64495868|NCT01212952|Bortezomib|bortezomib|mesh-list
64495869|NCT01212952|Pomalidomide|pomalidomide|mesh-list
64495870|NCT01212952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64495871|NCT01212952|Antiemetics|antiemetics|mesh-ancestor
64495872|NCT01212952|Autonomic Agents|autonomic agents|mesh-ancestor
64495873|NCT01212952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64495874|NCT01212952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495875|NCT01212952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64495876|NCT01212952|Glucocorticoids|glucocorticoids|mesh-ancestor
64495877|NCT01212952|Hormones|hormones|mesh-ancestor
64495878|NCT01212952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64495879|NCT01212952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64722506|NCT00002714|Vinblastine|vinblastine|mesh-list
64722507|NCT00002714|Mechlorethamine|mechlorethamine|mesh-list
64722508|NCT00002714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64722509|NCT00002714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722510|NCT00002714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64722532|NCT00002720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722554|NCT01194427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64722555|NCT01194427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64722556|NCT01194427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64330348|NCT02369133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330349|NCT02369133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330350|NCT02369133|Antipyretics|antipyretics|mesh-ancestor
64330351|NCT02377635|Selenious Acid|selenious acid|mesh-list
64330352|NCT02377635|Sodium Selenite|sodium selenite|mesh-list
64722726|NCT00002756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722727|NCT00002756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64722728|NCT00002756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64722729|NCT00002756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64722730|NCT00002756|Glucocorticoids|glucocorticoids|mesh-ancestor
64722731|NCT00002756|Hormones|hormones|mesh-ancestor
64722732|NCT00002756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64722733|NCT00002756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64722780|NCT05749016|Tubulin Modulators|tubulin modulators|mesh-ancestor
64722781|NCT05749016|Antimitotic Agents|antimitotic agents|mesh-ancestor
64722782|NCT05749016|Mitosis Modulators|mitosis modulators|mesh-ancestor
64722783|NCT05749016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64722784|NCT05749016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64722785|NCT01756573|Bupivacaine|bupivacaine|mesh-list
64722786|NCT01756573|Anesthetics, Local|anesthetics, local|mesh-ancestor
64495959|NCT01230502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64495960|NCT01230502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64495961|NCT01230502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64495962|NCT01230502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495963|NCT03438240|Fentanyl|fentanyl|mesh-list
64496025|NCT04560660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496026|NCT04560660|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64722878|NCT01122511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64722879|NCT01122511|Antiemetics|antiemetics|mesh-ancestor
64722880|NCT01122511|Autonomic Agents|autonomic agents|mesh-ancestor
64722881|NCT01122511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330522|NCT02201459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330523|NCT02368665|Amlodipine|amlodipine|mesh-list
64330524|NCT02368665|Candesartan|candesartan|mesh-list
64496105|NCT01234870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496106|NCT00861705|Paclitaxel|paclitaxel|mesh-list
64496107|NCT00861705|Cyclophosphamide|cyclophosphamide|mesh-list
64496142|NCT03437460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64496143|NCT03437460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64496144|NCT03437460|Analgesics|analgesics|mesh-ancestor
64496145|NCT03437460|Sensory System Agents|sensory system agents|mesh-ancestor
64496146|NCT03437460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496147|NCT03437460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64496148|NCT03437460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64496149|NCT03437460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64722981|NCT05513612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64330598|NCT02202239|Narcotics|narcotics|mesh-ancestor
64330599|NCT02202239|Analgesics|analgesics|mesh-ancestor
64330600|NCT02202239|Sensory System Agents|sensory system agents|mesh-ancestor
64496218|NCT02981290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496219|NCT02981290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496220|NCT03437226|Simendan|simendan|mesh-list
64496221|NCT03437226|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64496222|NCT03437226|Vasodilator Agents|vasodilator agents|mesh-ancestor
64723019|NCT05594407|Narcotics|narcotics|mesh-ancestor
64496264|NCT01238536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64723039|NCT01583647|Vasodilator Agents|vasodilator agents|mesh-ancestor
64723040|NCT01583647|Vitamin B Complex|vitamin b complex|mesh-ancestor
64723042|NCT01583647|Micronutrients|micronutrients|mesh-ancestor
64723043|NCT01583647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723044|NCT04403516|Dexamethasone|dexamethasone|mesh-list
64723045|NCT04403516|Prednisolone|prednisolone|mesh-list
64723046|NCT04403516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64723047|NCT04403516|Methylprednisolone|methylprednisolone|mesh-list
64723048|NCT04403516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64723049|NCT04403516|Prednisolone acetate|prednisolone acetate|mesh-list
64723050|NCT04403516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64723051|NCT04403516|Prednisolone phosphate|prednisolone phosphate|mesh-list
64330664|NCT04547049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330665|NCT04547049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64330666|NCT04547049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64330667|NCT04547049|Antimetabolites|antimetabolites|mesh-ancestor
64330687|NCT05647291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64330688|NCT05647291|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64330689|NCT05647291|Protective Agents|protective agents|mesh-ancestor
64330690|NCT03105765|Ketamine|ketamine|mesh-list
64330691|NCT03105765|Analgesics|analgesics|mesh-ancestor
64330692|NCT03105765|Sensory System Agents|sensory system agents|mesh-ancestor
64330693|NCT03105765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64723070|NCT01555489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723071|NCT01555489|Protective Agents|protective agents|mesh-ancestor
64723072|NCT05243654|Metformin|metformin|mesh-list
64723073|NCT05243654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64723074|NCT05243654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723082|NCT01035073|Analgesics|analgesics|mesh-ancestor
64723106|NCT05296759|Cholinergic Agents|cholinergic agents|mesh-ancestor
64723107|NCT05296759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723108|NCT05296759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723109|NCT05296759|Analgesics|analgesics|mesh-ancestor
64330715|NCT02364531|Abiraterone Acetate|abiraterone acetate|mesh-list
64330716|NCT02364531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330717|NCT02364531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64330718|NCT02364531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64723146|NCT01532635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64723147|NCT01532635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64723148|NCT01532635|Antitubercular Agents|antitubercular agents|mesh-ancestor
64723149|NCT01532635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64723150|NCT01532635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64723151|NCT00986947|Rituximab|rituximab|mesh-list
64723152|NCT00986947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64723153|NCT00986947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723154|NCT00986947|Immunologic Factors|immunologic factors|mesh-ancestor
64723155|NCT00986947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496300|NCT03128736|Esomeprazole|esomeprazole|mesh-list
64496352|NCT04369014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64496353|NCT04369014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496354|NCT04369014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64496356|NCT04369014|Anesthetics, General|anesthetics, general|mesh-ancestor
64496357|NCT03436836|Lidocaine|lidocaine|mesh-list
64496358|NCT03436836|Nalbuphine|nalbuphine|mesh-list
64496359|NCT03436836|Bupivacaine|bupivacaine|mesh-list
64496360|NCT03436836|Anesthetics, Local|anesthetics, local|mesh-ancestor
64496413|NCT03128619|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64496414|NCT03128619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64496415|NCT03128619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64723191|NCT00976339|Vitamins|vitamins|mesh-ancestor
64723192|NCT00976339|Micronutrients|micronutrients|mesh-ancestor
64723193|NCT00976339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723194|NCT00976339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64723195|NCT00976339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64723196|NCT04579640|Vitamin D|vitamin d|mesh-list
64723197|NCT04579640|Vitamins|vitamins|mesh-ancestor
64723198|NCT04579640|Micronutrients|micronutrients|mesh-ancestor
64723199|NCT04579640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723201|NCT00523939|Cytarabine|cytarabine|mesh-list
64496471|NCT01857323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496472|NCT03104439|Nivolumab|nivolumab|mesh-list
64496473|NCT03104439|Ipilimumab|ipilimumab|mesh-list
64496474|NCT03104439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64496475|NCT03104439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723202|NCT00523939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64723203|NCT00523939|Antimetabolites|antimetabolites|mesh-ancestor
64723204|NCT00523939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496539|NCT00632541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64496540|NCT00632541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496541|NCT00632541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496542|NCT01872611|Prednisolone|prednisolone|mesh-list
64496543|NCT01872611|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64496544|NCT01872611|Methylprednisolone|methylprednisolone|mesh-list
64496545|NCT01872611|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64496546|NCT01872611|Prednisolone acetate|prednisolone acetate|mesh-list
64496547|NCT01872611|Nepafenac|nepafenac|mesh-list
64723207|NCT00523939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64723208|NCT00523939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64723209|NCT00523939|Immunologic Factors|immunologic factors|mesh-ancestor
64723210|NCT00523939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723211|NCT00382538|Mifepristone|mifepristone|mesh-list
64330817|NCT05723731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64496548|NCT01872611|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64496552|NCT01872611|Hormones|hormones|mesh-ancestor
64496602|NCT01923597|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
64496603|NCT01923597|Antioxidants|antioxidants|mesh-ancestor
64496604|NCT01923597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496605|NCT01923597|Protective Agents|protective agents|mesh-ancestor
64496606|NCT01923597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496607|NCT01923597|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64496608|NCT01923597|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64496609|NCT01923597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496610|NCT01923597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64496611|NCT05666310|Zoledronic Acid|zoledronic acid|mesh-list
64496612|NCT05666310|Denosumab|denosumab|mesh-list
64496613|NCT05666310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64496614|NCT05666310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496615|NCT00632229|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64496664|NCT01923831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64496665|NCT01923831|Tocolytic Agents|tocolytic agents|mesh-ancestor
64496666|NCT01923831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64496667|NCT01923909|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64496668|NCT01923909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64496669|NCT03086343|Abatacept|abatacept|mesh-list
64496670|NCT03086343|Upadacitinib|upadacitinib|mesh-list
64496671|NCT03086343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64496672|NCT03086343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496673|NCT03086343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496674|NCT03086343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64496675|NCT03086343|Immunologic Factors|immunologic factors|mesh-ancestor
64496676|NCT03086343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496734|NCT03242382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64496735|NCT03242382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496826|NCT03009682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496827|NCT03009682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496828|NCT03431142|Aspirin|aspirin|mesh-list
64496829|NCT03431142|Clopidogrel|clopidogrel|mesh-list
64496830|NCT03431142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64496831|NCT03431142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64496907|NCT00635505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64496908|NCT00635505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64496909|NCT00635505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64496910|NCT00635505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64497013|NCT02199574|Anesthetics|anesthetics|mesh-ancestor
64497014|NCT02199574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64497015|NCT02199574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497016|NCT02199574|Sensory System Agents|sensory system agents|mesh-ancestor
64497017|NCT02199574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64497018|NCT02199652|Prazosin|prazosin|mesh-list
64497019|NCT02199652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64497079|NCT03111537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64497080|NCT03111537|Cholinergic Agents|cholinergic agents|mesh-ancestor
64497081|NCT03111537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723301|NCT05387941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64723302|NCT05387941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497121|NCT01247272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64497122|NCT01247272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64497124|NCT01247272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64497185|NCT03052608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64497186|NCT03052608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497187|NCT03052608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945648|NCT05379322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64497257|NCT01290874|Cholinergic Agents|cholinergic agents|mesh-ancestor
64497259|NCT02977494|Dexamethasone acetate|dexamethasone acetate|mesh-list
64497267|NCT02977494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64497354|NCT01925937|Ubiquinone|ubiquinone|mesh-list
64497355|NCT01925937|Coenzyme Q10|coenzyme q10|mesh-list
64497356|NCT01925937|Atorvastatin|atorvastatin|mesh-list
64497357|NCT01925937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64497358|NCT01925937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64497359|NCT01925937|Antimetabolites|antimetabolites|mesh-ancestor
64497360|NCT01925937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497361|NCT01925937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64497375|NCT03430362|Mydriatics|mydriatics|mesh-ancestor
64497415|NCT00989781|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64497416|NCT00989781|Cosyntropin|cosyntropin|mesh-list
64723371|NCT00476827|Antimitotic Agents|antimitotic agents|mesh-ancestor
64723372|NCT00476827|Mitosis Modulators|mitosis modulators|mesh-ancestor
64723373|NCT00476827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723374|NCT00476827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64723375|NCT00476827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64723459|NCT00314353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64723460|NCT00314353|Antimetabolites|antimetabolites|mesh-ancestor
64723461|NCT00314353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723462|NCT00314353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64723463|NCT00314353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64497615|NCT01253902|Bimatoprost|bimatoprost|mesh-list
64497616|NCT01253902|Travoprost|travoprost|mesh-list
64497617|NCT01253902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64497618|NCT01253902|Latanoprost|latanoprost|mesh-list
64497619|NCT01253902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64497620|NCT01253902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64497621|NCT01253980|Amoxicillin|amoxicillin|mesh-list
64497622|NCT01253980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64497631|NCT03154749|Carboplatin|carboplatin|mesh-list
64497684|NCT00987831|Antiemetics|antiemetics|mesh-ancestor
64497685|NCT00987831|Autonomic Agents|autonomic agents|mesh-ancestor
64497690|NCT00987831|Hormones|hormones|mesh-ancestor
64497744|NCT01887522|Vinblastine|vinblastine|mesh-list
64497745|NCT01887522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64497746|NCT01887522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497747|NCT01887522|Tubulin Modulators|tubulin modulators|mesh-ancestor
64497818|NCT03421314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497819|NCT03421314|Protective Agents|protective agents|mesh-ancestor
64497820|NCT03421314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497821|NCT03421314|Trace Elements|trace elements|mesh-ancestor
64497822|NCT03421314|Micronutrients|micronutrients|mesh-ancestor
64497823|NCT03425994|Emtricitabine|emtricitabine|mesh-list
64497861|NCT02521038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64497862|NCT02521038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64331161|NCT05790239|Dextroamphetamine|dextroamphetamine|mesh-list
64723540|NCT05345990|Immunologic Factors|immunologic factors|mesh-ancestor
64723541|NCT05345990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723542|NCT00019747|Thalidomide|thalidomide|mesh-list
64723543|NCT00019747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64497905|NCT03393741|Paclitaxel|paclitaxel|mesh-list
64497906|NCT03393741|Vinorelbine|vinorelbine|mesh-list
64497907|NCT03393741|Docetaxel|docetaxel|mesh-list
64497920|NCT01352182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497922|NCT00984867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64497923|NCT00984867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497931|NCT01257802|Leuprolide|leuprolide|mesh-list
64723568|NCT00746239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64723569|NCT00746239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64723570|NCT00746239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723571|NCT00746239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723572|NCT00746239|Serotonin Agents|serotonin agents|mesh-ancestor
64723573|NCT00746239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331183|NCT05790161|Caffeine|caffeine|mesh-list
64498055|NCT03029169|Vasodilator Agents|vasodilator agents|mesh-ancestor
64498056|NCT03029169|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64498057|NCT03029169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64498058|NCT03029169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498059|NCT03029169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64498060|NCT03029169|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64498061|NCT03029169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64498062|NCT03029169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64723598|NCT04977674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723599|NCT04977674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723600|NCT04977674|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64723601|NCT04977674|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64723602|NCT04965038|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64723603|NCT04965038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64498115|NCT01354990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498116|NCT01354990|Incretins|incretins|mesh-ancestor
64498117|NCT01354990|Hormones|hormones|mesh-ancestor
64498159|NCT01260688|Dasatinib|dasatinib|mesh-list
64498160|NCT01260688|Cediranib|cediranib|mesh-list
64945651|NCT05379322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64498170|NCT01298128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498172|NCT01298128|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64723654|NCT05286320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723655|NCT00728845|Hydroxychloroquine|hydroxychloroquine|mesh-list
64723656|NCT00728845|Paclitaxel|paclitaxel|mesh-list
64723657|NCT00728845|Bevacizumab|bevacizumab|mesh-list
64723658|NCT00728845|Carboplatin|carboplatin|mesh-list
64331262|NCT05746481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498283|NCT01871285|Sensory System Agents|sensory system agents|mesh-ancestor
64498299|NCT01870973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64498300|NCT01870973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498301|NCT01870973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64498302|NCT01870973|Antitubercular Agents|antitubercular agents|mesh-ancestor
64498303|NCT01870973|Sensory System Agents|sensory system agents|mesh-ancestor
64498304|NCT01870973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498306|NCT01267864|Valproic Acid|valproic acid|mesh-list
64498366|NCT01361620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64498367|NCT01361620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64498368|NCT01361620|Analgesics|analgesics|mesh-ancestor
64498369|NCT01361620|Sensory System Agents|sensory system agents|mesh-ancestor
64498370|NCT01361620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498476|NCT01364584|Incretins|incretins|mesh-ancestor
64498477|NCT01364584|Hormones|hormones|mesh-ancestor
64498478|NCT01364584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64498479|NCT01870583|Iodine|iodine|mesh-list
64498556|NCT01869725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64498557|NCT01869725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64498558|NCT01869725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498622|NCT04602221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64498623|NCT04602221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498687|NCT02201212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498689|NCT01376362|Interferon-gamma|interferon-gamma|mesh-list
64498690|NCT01376362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498787|NCT01316302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64498788|NCT01316302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64723736|NCT04508036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498870|NCT01411696|Dexamethasone|dexamethasone|mesh-list
64331356|NCT05553392|Emollients|emollients|mesh-ancestor
64723764|NCT00000199|Nootropic Agents|nootropic agents|mesh-ancestor
64723765|NCT04485104|Cannabidiol|cannabidiol|mesh-list
64498948|NCT03424746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498949|NCT03424746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64498950|NCT03414918|Clarithromycin|clarithromycin|mesh-list
64498951|NCT03414918|Roxithromycin|roxithromycin|mesh-list
64498952|NCT03414918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64499025|NCT03424356|Propofol|propofol|mesh-list
64499026|NCT03424356|Rocuronium|rocuronium|mesh-list
64499027|NCT03424356|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64499124|NCT03418506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64499125|NCT03418506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64499202|NCT02203630|Norepinephrine|norepinephrine|mesh-list
64499204|NCT02203630|Mydriatics|mydriatics|mesh-ancestor
64499205|NCT02203630|Autonomic Agents|autonomic agents|mesh-ancestor
64499206|NCT02203630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499207|NCT02203630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499208|NCT02203630|Sympathomimetics|sympathomimetics|mesh-ancestor
64499209|NCT02203630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64499222|NCT04593329|Narcotics|narcotics|mesh-ancestor
64499278|NCT03411798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64499279|NCT03408756|Methotrexate|methotrexate|mesh-list
64499280|NCT03408756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64499346|NCT01328782|Analgesics|analgesics|mesh-ancestor
64499347|NCT01328782|Antipyretics|antipyretics|mesh-ancestor
64499348|NCT01328782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64499349|NCT01328782|Narcotics|narcotics|mesh-ancestor
64499350|NCT04447326|Endostar protein|endostar protein|mesh-list
64499351|NCT04447326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64499407|NCT01830881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64499408|NCT01830881|Analgesics|analgesics|mesh-ancestor
64499409|NCT01830881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64499410|NCT01830881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64499411|NCT01830881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64499412|NCT01830881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64499413|NCT01396486|Inositol|inositol|mesh-list
64499414|NCT01396486|Vitamin B Complex|vitamin b complex|mesh-ancestor
64499415|NCT01396486|Vitamins|vitamins|mesh-ancestor
64499416|NCT01396486|Micronutrients|micronutrients|mesh-ancestor
64499417|NCT01396486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499418|NCT01838681|Brexpiprazole|brexpiprazole|mesh-list
64499419|NCT01838681|Serotonin Agents|serotonin agents|mesh-ancestor
64499420|NCT01838681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64723823|NCT00000223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64723825|NCT00000229|Buprenorphine|buprenorphine|mesh-list
64723826|NCT00000229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64723827|NCT00000229|Narcotics|narcotics|mesh-ancestor
64723828|NCT00000229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64723829|NCT00000229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723830|NCT00000229|Analgesics|analgesics|mesh-ancestor
64499466|NCT04447560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499467|NCT03401736|Midazolam|midazolam|mesh-list
64499468|NCT03401736|Dexmedetomidine|dexmedetomidine|mesh-list
64723873|NCT00000259|Analgesics|analgesics|mesh-ancestor
64723874|NCT00000259|Sensory System Agents|sensory system agents|mesh-ancestor
64723875|NCT00000259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64723876|NCT04330664|Adagrasib|adagrasib|mesh-list
64723877|NCT04330664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64723878|NCT00379405|Ritonavir|ritonavir|mesh-list
64723879|NCT00379405|Saquinavir|saquinavir|mesh-list
64499510|NCT02203786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499571|NCT01611857|Vitamins|vitamins|mesh-ancestor
64499572|NCT01611857|Micronutrients|micronutrients|mesh-ancestor
64499573|NCT03393858|Antibodies|antibodies|mesh-list
64499574|NCT03393858|Immunologic Factors|immunologic factors|mesh-ancestor
64499575|NCT03393858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499587|NCT03393702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64499588|NCT03393702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64499589|NCT03393702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499590|NCT03393702|Antimanic Agents|antimanic agents|mesh-ancestor
64499592|NCT01829477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64499653|NCT03399474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64499669|NCT01430182|Methadone|methadone|mesh-list
64499736|NCT04982172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64499737|NCT01837823|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64499738|NCT01837823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64499804|NCT04755972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499805|NCT04755972|Antidotes|antidotes|mesh-ancestor
64499806|NCT01828073|Raltegravir Potassium|raltegravir potassium|mesh-list
64499829|NCT04697693|Analgesics|analgesics|mesh-ancestor
64499882|NCT01335724|Diclofenac|diclofenac|mesh-list
64499883|NCT01335724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64499884|NCT01335724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64499885|NCT01335724|Analgesics|analgesics|mesh-ancestor
64499886|NCT01335724|Sensory System Agents|sensory system agents|mesh-ancestor
64499964|NCT01542502|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64499965|NCT01542502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64499967|NCT01439854|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64499968|NCT01439854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499969|NCT01439854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64500045|NCT01441570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500046|NCT01441570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500047|NCT01441570|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64500048|NCT01441570|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64500049|NCT01441570|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64500115|NCT01546402|Dexamethasone acetate|dexamethasone acetate|mesh-list
64500116|NCT01546402|BB 1101|bb 1101|mesh-list
64500117|NCT01546402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64500118|NCT01546402|Antiemetics|antiemetics|mesh-ancestor
64500119|NCT01546402|Autonomic Agents|autonomic agents|mesh-ancestor
64500120|NCT01546402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500121|NCT01546402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500122|NCT01546402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64500123|NCT01546402|Glucocorticoids|glucocorticoids|mesh-ancestor
64500124|NCT01546402|Hormones|hormones|mesh-ancestor
64500126|NCT01546402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64723968|NCT04295486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64723969|NCT04295486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64723970|NCT04295486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64723972|NCT00000289|Ondansetron|ondansetron|mesh-list
64723973|NCT00000289|Antiemetics|antiemetics|mesh-ancestor
64723974|NCT00000289|Autonomic Agents|autonomic agents|mesh-ancestor
64331546|NCT05276284|Mercaptopurine|mercaptopurine|mesh-list
64723985|NCT00000289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64723986|NCT00000289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64723987|NCT00000289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64723988|NCT00000289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64724021|NCT00000301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64724022|NCT00000301|Analgesics|analgesics|mesh-ancestor
64724023|NCT00000301|Sensory System Agents|sensory system agents|mesh-ancestor
64724024|NCT00000301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64724034|NCT00000313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64500367|NCT02731638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64500368|NCT02731638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64500369|NCT01451632|Irinotecan|irinotecan|mesh-list
64500370|NCT01451632|Cetuximab|cetuximab|mesh-list
64500371|NCT01451632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64500372|NCT01451632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64500373|NCT01451632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500433|NCT01497496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64500434|NCT01497496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64500435|NCT01497496|Growth Substances|growth substances|mesh-ancestor
64500436|NCT01497496|Growth Inhibitors|growth inhibitors|mesh-ancestor
64500437|NCT01497496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500438|NCT01497496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64500439|NCT01497496|Antiemetics|antiemetics|mesh-ancestor
64500440|NCT01497496|Autonomic Agents|autonomic agents|mesh-ancestor
64500441|NCT01497496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500442|NCT01497496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64500443|NCT01497496|Glucocorticoids|glucocorticoids|mesh-ancestor
64500444|NCT01497496|Hormones|hormones|mesh-ancestor
64500445|NCT01497496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64500446|NCT01497496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64500447|NCT01497496|Protective Agents|protective agents|mesh-ancestor
64500448|NCT01497496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64500449|NCT02208310|Vitamin D|vitamin d|mesh-list
64500450|NCT02208310|Ergocalciferols|ergocalciferols|mesh-list
64500452|NCT02208310|Vitamins|vitamins|mesh-list
64500490|NCT01498744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64500491|NCT01498744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64500492|NCT01498744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64500493|NCT01498744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500494|NCT01498744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500495|NCT01498978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64500496|NCT01498978|Ipilimumab|ipilimumab|mesh-list
64500497|NCT01498978|Antibodies|antibodies|mesh-list
64500498|NCT01498978|Immunoglobulins|immunoglobulins|mesh-list
64500499|NCT01498978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64500500|NCT01498978|Immunologic Factors|immunologic factors|mesh-ancestor
64500561|NCT02208466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500562|NCT02208466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64500563|NCT02208466|Serotonin Agents|serotonin agents|mesh-ancestor
64500566|NCT02208466|Antidepressive Agents|antidepressive agents|mesh-ancestor
64500641|NCT03730662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64500642|NCT01509586|Lobeline|lobeline|mesh-list
64500643|NCT01509586|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64500644|NCT01509586|Autonomic Agents|autonomic agents|mesh-ancestor
64500645|NCT01509586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500652|NCT01509586|Respiratory System Agents|respiratory system agents|mesh-ancestor
64500653|NCT01470118|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64500655|NCT01470118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64500656|NCT01470118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64500659|NCT01470118|Anticoagulants|anticoagulants|mesh-ancestor
64500698|NCT01470196|Antiemetics|antiemetics|mesh-ancestor
64500791|NCT05565976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64945675|NCT05329766|Immunologic Factors|immunologic factors|mesh-ancestor
64724126|NCT00000781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724127|NCT00000781|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64724136|NCT00000349|Flupenthixol|flupenthixol|mesh-list
64500927|NCT05173584|Adrenergic Agents|adrenergic agents|mesh-ancestor
64500928|NCT05173584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64501025|NCT03386838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501026|NCT03379974|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64501027|NCT03379974|Hemostatics|hemostatics|mesh-ancestor
64501028|NCT03379974|Coagulants|coagulants|mesh-ancestor
64501029|NCT03379974|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64501030|NCT03379974|Natriuretic Agents|natriuretic agents|mesh-ancestor
64501031|NCT03379974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501032|NCT01570036|Trastuzumab|trastuzumab|mesh-list
64501098|NCT03383406|Ifosfamide|ifosfamide|mesh-list
64501099|NCT03383406|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64501100|NCT03383406|Abortifacient Agents|abortifacient agents|mesh-ancestor
64501142|NCT03383328|Hormones|hormones|mesh-ancestor
64501197|NCT02968446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64501198|NCT02968446|Alkylating Agents|alkylating agents|mesh-ancestor
64501199|NCT02968446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501200|NCT02968446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64501201|NCT02968446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501202|NCT03378960|Omeprazole|omeprazole|mesh-list
64501203|NCT03378960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64501204|NCT03378960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64501205|NCT03378960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64501206|NCT03378960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501207|NCT03378960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501208|NCT02907996|Sofosbuvir|sofosbuvir|mesh-list
64501209|NCT02907996|Antiviral Agents|antiviral agents|mesh-ancestor
64501210|NCT02907996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501211|NCT03383094|Pembrolizumab|pembrolizumab|mesh-list
64501260|NCT01826981|Sofosbuvir|sofosbuvir|mesh-list
64501261|NCT01826981|Antiviral Agents|antiviral agents|mesh-ancestor
64501262|NCT01826981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501263|NCT02247154|Immunoglobulins|immunoglobulins|mesh-list
64501264|NCT02247154|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64501265|NCT02247154|Antibodies|antibodies|mesh-list
64501266|NCT02247154|Immunologic Factors|immunologic factors|mesh-ancestor
64501267|NCT02247154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501268|NCT02728752|gamma-Globulins|gamma-globulins|mesh-list
64501269|NCT02728752|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64501270|NCT02728752|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64501271|NCT02728752|Immunologic Factors|immunologic factors|mesh-ancestor
64501272|NCT02728752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501273|NCT03007810|Hemay005|hemay005|mesh-list
64501274|NCT03007810|Dermatologic Agents|dermatologic agents|mesh-ancestor
64501275|NCT03007810|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64501276|NCT03007810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64501277|NCT03007810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501279|NCT01578772|Telmisartan|telmisartan|mesh-list
64501330|NCT03382314|Vitamin D|vitamin d|mesh-list
64501331|NCT03382314|Bazedoxifene|bazedoxifene|mesh-list
64501332|NCT03382314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64501333|NCT03382314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501334|NCT03382314|Vitamins|vitamins|mesh-ancestor
64501335|NCT03382314|Micronutrients|micronutrients|mesh-ancestor
64501341|NCT03124524|Dienogest|dienogest|mesh-list
64501426|NCT03376932|Tiotropium Bromide|tiotropium bromide|mesh-list
64501427|NCT03376932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64501428|NCT03376932|Autonomic Agents|autonomic agents|mesh-ancestor
64501429|NCT03376932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64501430|NCT03376932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501431|NCT03376932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64501503|NCT02903160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501504|NCT02903160|Hormone Antagonists|hormone antagonists|mesh-ancestor
64501505|NCT02903160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64501506|NCT03376464|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64501507|NCT03376464|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64501571|NCT01581658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501572|NCT01530178|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64501573|NCT01530178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64501574|NCT01530178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501575|NCT01530178|Incretins|incretins|mesh-ancestor
64501576|NCT01530178|Hormones|hormones|mesh-ancestor
64501659|NCT03006952|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64501660|NCT03006952|Protective Agents|protective agents|mesh-ancestor
64501661|NCT03006952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501662|NCT03006952|Vasodilator Agents|vasodilator agents|mesh-ancestor
64501663|NCT03006952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64501664|NCT03006952|Antioxidants|antioxidants|mesh-ancestor
64501728|NCT04129437|Analgesics|analgesics|mesh-ancestor
64501792|NCT03028857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501793|NCT03028857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64501794|NCT03028857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64501795|NCT03028857|Nootropic Agents|nootropic agents|mesh-ancestor
64501796|NCT03062943|Nintedanib|nintedanib|mesh-list
64501805|NCT01536886|Hormones|hormones|mesh-ancestor
64501871|NCT03005860|Sensory System Agents|sensory system agents|mesh-ancestor
64501872|NCT03005860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64501873|NCT03005860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64501874|NCT03005860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64501875|NCT03005860|Anesthetics, General|anesthetics, general|mesh-ancestor
64501876|NCT03005860|Anesthetics|anesthetics|mesh-ancestor
64501939|NCT01594294|Contact Lens Solutions|contact lens solutions|mesh-list
64501940|NCT01594294|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64501941|NCT01594294|Disinfectants|disinfectants|mesh-ancestor
64501942|NCT01594294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501943|NCT03005704|Aspirin|aspirin|mesh-list
64501944|NCT03005704|Ticagrelor|ticagrelor|mesh-list
64501945|NCT03005704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64502034|NCT02217904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64502035|NCT02217904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64502036|NCT05566834|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
64502037|NCT05566834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64502105|NCT03004612|Metformin|metformin|mesh-list
64502106|NCT03004612|Linagliptin|linagliptin|mesh-list
64502107|NCT03004612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64502108|NCT03004612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502109|NCT03004612|Incretins|incretins|mesh-ancestor
64502110|NCT03004612|Hormones|hormones|mesh-ancestor
64502111|NCT03004612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64502205|NCT03000556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64502206|NCT03000556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64502207|NCT03000556|Immunologic Factors|immunologic factors|mesh-ancestor
64502208|NCT03000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502209|NCT03000556|Viscosupplements|viscosupplements|mesh-ancestor
64502210|NCT03000556|Protective Agents|protective agents|mesh-ancestor
64724313|NCT00000841|Antiviral Agents|antiviral agents|mesh-ancestor
64724314|NCT00000841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724315|NCT00000841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64724316|NCT00000841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64724317|NCT00000841|Antimetabolites|antimetabolites|mesh-ancestor
64724318|NCT00000841|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64502281|NCT02998918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64502349|NCT05669872|Ferric Compounds|ferric compounds|mesh-list
64502350|NCT05669872|Hematinics|hematinics|mesh-ancestor
64502351|NCT04861948|Bevacizumab|bevacizumab|mesh-list
64502352|NCT04861948|Carboplatin|carboplatin|mesh-list
64502353|NCT04861948|Pemetrexed|pemetrexed|mesh-list
64502354|NCT04861948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64502355|NCT04861948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502421|NCT02248792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64502422|NCT02248792|Immunologic Factors|immunologic factors|mesh-ancestor
64502423|NCT02248792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64502424|NCT02248792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64502425|NCT03367728|Ropivacaine|ropivacaine|mesh-list
64502426|NCT03367728|Anesthetics, Local|anesthetics, local|mesh-ancestor
64724346|NCT00000847|Protective Agents|protective agents|mesh-ancestor
64724347|NCT04195568|Calcium Carbonate|calcium carbonate|mesh-list
64724348|NCT04195568|Antacids|antacids|mesh-ancestor
64724349|NCT04195568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331906|NCT04495296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64502492|NCT05568160|Sympathomimetics|sympathomimetics|mesh-ancestor
64502546|NCT04119180|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64502547|NCT04119180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64502548|NCT04119180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502549|NCT04119180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64502550|NCT04119180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64502551|NCT04119180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64502552|NCT04119180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64502553|NCT04119180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64502554|NCT04119180|GABA Modulators|gaba modulators|mesh-ancestor
64502555|NCT04119180|GABA Agents|gaba agents|mesh-ancestor
64502556|NCT03358212|Denosumab|denosumab|mesh-list
64502599|NCT04525326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64502600|NCT04525326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64502601|NCT04525326|Growth Substances|growth substances|mesh-ancestor
64502602|NCT04525326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502603|NCT04525326|Growth Inhibitors|growth inhibitors|mesh-ancestor
64502604|NCT03357822|Interferons|interferons|mesh-list
64502605|NCT03357822|Tenofovir|tenofovir|mesh-list
64502606|NCT03357822|Entecavir|entecavir|mesh-list
64502663|NCT02249026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64724410|NCT00000865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64724411|NCT00000865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64724412|NCT00000865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64724413|NCT00000865|Antimetabolites|antimetabolites|mesh-ancestor
64724414|NCT00000469|Aspirin|aspirin|mesh-list
64724428|NCT00000469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724429|NCT00000469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64724430|NCT00000469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64724431|NCT00000469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724432|NCT00000469|Antipyretics|antipyretics|mesh-ancestor
64724433|NCT00000469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64724434|NCT00000469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64502774|NCT03365388|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64502775|NCT03365388|Immunologic Factors|immunologic factors|mesh-ancestor
64502776|NCT03365388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502777|NCT03365388|Viscosupplements|viscosupplements|mesh-ancestor
64502778|NCT03365388|Protective Agents|protective agents|mesh-ancestor
64502779|NCT03123744|Palbociclib|palbociclib|mesh-list
64502840|NCT02519400|Amitriptyline|amitriptyline|mesh-list
64502841|NCT02519400|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64502842|NCT02519400|Antidepressive Agents|antidepressive agents|mesh-ancestor
64502843|NCT02519400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64502844|NCT02519400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64502845|NCT02519400|Analgesics|analgesics|mesh-ancestor
64502846|NCT02519400|Sensory System Agents|sensory system agents|mesh-ancestor
64502847|NCT02519400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502900|NCT03364530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502902|NCT03354624|Mitosis Modulators|mitosis modulators|mesh-ancestor
64502903|NCT03354624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502904|NCT03364218|Acetylcysteine|acetylcysteine|mesh-list
64502905|NCT03364218|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64502906|NCT03364218|Antiviral Agents|antiviral agents|mesh-ancestor
64502907|NCT03364218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64502908|NCT03364218|Expectorants|expectorants|mesh-ancestor
64502909|NCT03364218|Respiratory System Agents|respiratory system agents|mesh-ancestor
64502910|NCT03364218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64724578|NCT00002936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64724579|NCT00002936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724580|NCT00002936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724581|NCT00002936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64724582|NCT00002936|Alkylating Agents|alkylating agents|mesh-ancestor
64724584|NCT00000649|Nevirapine|nevirapine|mesh-list
64724585|NCT00000649|Antimetabolites|antimetabolites|mesh-ancestor
64724586|NCT00000649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724589|NCT00000649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502981|NCT03355716|Narcotics|narcotics|mesh-ancestor
64502982|NCT03355716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64502983|NCT04508400|Dexamethasone|dexamethasone|mesh-list
64502984|NCT04508400|Dexamethasone acetate|dexamethasone acetate|mesh-list
64502985|NCT04508400|Ondansetron|ondansetron|mesh-list
64502986|NCT04508400|Fosaprepitant|fosaprepitant|mesh-list
64502987|NCT04508400|Aprepitant|aprepitant|mesh-list
64503060|NCT04515966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64503061|NCT04515966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64503062|NCT04515966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64503063|NCT04515966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503064|NCT04515966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64503065|NCT04515966|Antiemetics|antiemetics|mesh-ancestor
64503066|NCT04515966|Autonomic Agents|autonomic agents|mesh-ancestor
64503067|NCT04515966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64503068|NCT04515966|Glucocorticoids|glucocorticoids|mesh-ancestor
64503069|NCT04515966|Hormones|hormones|mesh-ancestor
64503070|NCT04515966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64503071|NCT04515966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64503072|NCT04515966|Protective Agents|protective agents|mesh-ancestor
64503073|NCT04515966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64503074|NCT04515966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503075|NCT04504110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64503076|NCT04504110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64503077|NCT04504110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503078|NCT03355248|Acetaminophen|acetaminophen|mesh-list
64503079|NCT03355248|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64503080|NCT03355248|Oxycodone|oxycodone|mesh-list
64503082|NCT03355248|Analgesics|analgesics|mesh-ancestor
64503097|NCT03350334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503099|NCT03350334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503100|NCT03350334|Analgesics|analgesics|mesh-ancestor
64503101|NCT03350334|Sensory System Agents|sensory system agents|mesh-ancestor
64503102|NCT03350334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64503103|NCT03350334|Antidepressive Agents|antidepressive agents|mesh-ancestor
64503104|NCT03350334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64503107|NCT02230696|Xhance|xhance|mesh-list
64503164|NCT02509546|Purinergic Agents|purinergic agents|mesh-ancestor
64503165|NCT02509546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64503166|NCT02509546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503167|NCT03187210|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64503168|NCT03187210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64503169|NCT03187210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503170|NCT03146962|Ascorbic Acid|ascorbic acid|mesh-list
64724703|NCT00000991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64724704|NCT00000991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64724705|NCT00000991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64724706|NCT00000991|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64724707|NCT00000991|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64503192|NCT02989636|Nivolumab|nivolumab|mesh-list
64503250|NCT02518152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64503251|NCT02518152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503253|NCT01229878|Cholecalciferol|cholecalciferol|mesh-list
64503254|NCT01229878|Vitamins|vitamins|mesh-ancestor
64503255|NCT01229878|Micronutrients|micronutrients|mesh-ancestor
64503256|NCT01229878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503257|NCT01229878|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64945764|NCT05222516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945765|NCT05215730|Copper|copper|mesh-list
64945766|NCT05215730|Trace Elements|trace elements|mesh-ancestor
64945767|NCT05215730|Micronutrients|micronutrients|mesh-ancestor
64945768|NCT05215730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945769|NCT05209074|Ivosidenib|ivosidenib|mesh-list
64945770|NCT05209074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945771|NCT05209074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945782|NCT05174065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64945783|NCT05174065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945784|NCT05174065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64945785|NCT05174065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64945829|NCT05083247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64945830|NCT05083247|Antimetabolites|antimetabolites|mesh-ancestor
64945831|NCT05083247|Antiviral Agents|antiviral agents|mesh-ancestor
64945832|NCT05083247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64945833|NCT05083247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945834|NCT05083247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64945880|NCT05022654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945881|NCT05022654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945882|NCT05020457|Paclitaxel|paclitaxel|mesh-list
64945883|NCT05020457|Docetaxel|docetaxel|mesh-list
64945884|NCT05020457|Cisplatin|cisplatin|mesh-list
64945885|NCT05020457|Pemetrexed|pemetrexed|mesh-list
64945886|NCT05020457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64945887|NCT05020457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945888|NCT05020457|Tubulin Modulators|tubulin modulators|mesh-ancestor
64945889|NCT05020457|Antimitotic Agents|antimitotic agents|mesh-ancestor
64945890|NCT05020457|Mitosis Modulators|mitosis modulators|mesh-ancestor
64945891|NCT05020457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724775|NCT00000697|Foscarnet|foscarnet|mesh-list
64945945|NCT04908189|BMS-986165|bms-986165|mesh-list
64945946|NCT04908189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64945947|NCT04908189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64945948|NCT04908189|Analgesics|analgesics|mesh-ancestor
64946015|NCT04846348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64946016|NCT04846348|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64946017|NCT04846348|Histamine Antagonists|histamine antagonists|mesh-ancestor
64946018|NCT04846348|Histamine Agents|histamine agents|mesh-ancestor
64724810|NCT00000703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64724811|NCT00000703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64724812|NCT00000703|Alkylating Agents|alkylating agents|mesh-ancestor
64724813|NCT00000703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724814|NCT00000703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64724815|NCT00000703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64724816|NCT00000703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64946144|NCT04602065|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64946145|NCT04602065|Immunologic Factors|immunologic factors|mesh-ancestor
64946146|NCT04602065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946147|NCT04598815|Sirolimus|sirolimus|mesh-list
64946157|NCT04584112|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64946159|NCT04584112|Carboplatin|carboplatin|mesh-list
64946160|NCT04584112|Doxorubicin|doxorubicin|mesh-list
64946161|NCT04584112|Atezolizumab|atezolizumab|mesh-list
64946162|NCT04584112|Molgramostim|molgramostim|mesh-list
64332371|NCT03020199|Respiratory System Agents|respiratory system agents|mesh-ancestor
64724823|NCT00000703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64724824|NCT00000703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64724825|NCT00000703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64724826|NCT00000703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64724827|NCT00000703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64946267|NCT04435691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64946268|NCT04435691|Antimetabolites|antimetabolites|mesh-ancestor
64946269|NCT04435691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946270|NCT04435691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946271|NCT04435691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946272|NCT04435691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64946273|NCT04376827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64946285|NCT04321993|Antiviral Agents|antiviral agents|mesh-list
64946325|NCT04315948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64946326|NCT04315948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64946327|NCT04315948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64946328|NCT04315948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64946329|NCT04315948|Antimalarials|antimalarials|mesh-ancestor
64724908|NCT00001039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64724909|NCT00001039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64724910|NCT00001039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64946394|NCT04199026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64946395|NCT04199026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64946396|NCT04199026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946397|NCT04199026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725017|NCT00002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725018|NCT00002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64725019|NCT00002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64946423|NCT04171219|Pembrolizumab|pembrolizumab|mesh-list
64946424|NCT04171219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64946425|NCT04171219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946426|NCT04167163|Abaloparatide|abaloparatide|mesh-list
64946427|NCT04167163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64946428|NCT04167163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946429|NCT04134936|Lenalidomide|lenalidomide|mesh-list
64946430|NCT04134936|Immunologic Factors|immunologic factors|mesh-ancestor
64725020|NCT00002323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64725035|NCT00002996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64725036|NCT00002996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64725037|NCT00002996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725038|NCT00001135|Nevirapine|nevirapine|mesh-list
64725039|NCT00001135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64946514|NCT03928314|Mitosis Modulators|mitosis modulators|mesh-ancestor
64946515|NCT03928314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946516|NCT03924414|Zoledronic Acid|zoledronic acid|mesh-list
64946517|NCT03924414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64946518|NCT03924414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946618|NCT03547908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64946619|NCT03547908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64946620|NCT03547908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64946648|NCT03530683|Dexamethasone|dexamethasone|mesh-list
64946698|NCT03476798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946699|NCT03476798|Growth Inhibitors|growth inhibitors|mesh-ancestor
64946700|NCT03476798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64946701|NCT03476798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946702|NCT03476798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946703|NCT03456843|Ascorbic Acid|ascorbic acid|mesh-list
64725116|NCT00002341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64725119|NCT00002347|Zidovudine|zidovudine|mesh-list
64725156|NCT00380575|Natriuretic Agents|natriuretic agents|mesh-ancestor
64725157|NCT00380575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725158|NCT00001963|Chrysarobin|chrysarobin|mesh-list
64725159|NCT00001963|Nitric Oxide|nitric oxide|mesh-list
64725160|NCT00001963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64725161|NCT00001963|Autonomic Agents|autonomic agents|mesh-ancestor
64725162|NCT00001963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64946850|NCT03217747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64946851|NCT03217747|Immunoglobulin G|immunoglobulin g|mesh-list
64946852|NCT03217747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64946853|NCT03217747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946854|NCT03217747|Immunologic Factors|immunologic factors|mesh-ancestor
64946907|NCT03017131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64946908|NCT03017131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64946992|NCT02697448|Anesthetics, General|anesthetics, general|mesh-ancestor
64946993|NCT02697448|Anesthetics|anesthetics|mesh-ancestor
64946994|NCT02697448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64946995|NCT02697448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64946996|NCT02663518|Rituximab|rituximab|mesh-list
64946997|NCT02663518|Nivolumab|nivolumab|mesh-list
64946998|NCT02663518|Immunoglobulin G|immunoglobulin g|mesh-list
64946999|NCT02663518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64725202|NCT00001339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64947064|NCT02438007|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
64947065|NCT02438007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725212|NCT00001993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64725213|NCT00001993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64725214|NCT00001993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64947152|NCT01998971|Sensory System Agents|sensory system agents|mesh-ancestor
64947153|NCT01998971|Antipyretics|antipyretics|mesh-ancestor
64947155|NCT01998971|Alkylating Agents|alkylating agents|mesh-ancestor
64947227|NCT00630032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64947228|NCT00630032|Alkylating Agents|alkylating agents|mesh-ancestor
64947229|NCT00630032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947230|NCT00630032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947231|NCT00630032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64947232|NCT00630032|Tubulin Modulators|tubulin modulators|mesh-ancestor
64947301|NCT05772728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64947302|NCT05772728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947303|NCT05772728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64947304|NCT05772728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64947305|NCT05772676|Aprepitant|aprepitant|mesh-list
64947386|NCT05771480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64947404|NCT05771181|Protective Agents|protective agents|mesh-ancestor
64503307|NCT03352362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64503308|NCT03352362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947405|NCT05771038|Alendronate|alendronate|mesh-list
64947408|NCT05771012|Cyclosporine|cyclosporine|mesh-list
64947484|NCT05750875|Sensory System Agents|sensory system agents|mesh-ancestor
64947485|NCT05750875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64947486|NCT05750875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947487|NCT05750875|Anticonvulsants|anticonvulsants|mesh-ancestor
64947488|NCT05750875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64947489|NCT05750875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64947490|NCT05750875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64947491|NCT05750875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64947492|NCT05750875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64947493|NCT05750875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64947494|NCT05750875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64947495|NCT05750875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725231|NCT00002383|Protease Inhibitors|protease inhibitors|mesh-ancestor
64503310|NCT03352362|Antipyretics|antipyretics|mesh-ancestor
64947573|NCT05689359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64947661|NCT05637606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64947662|NCT05637606|Respiratory System Agents|respiratory system agents|mesh-ancestor
64947663|NCT05637606|Nasal Decongestants|nasal decongestants|mesh-ancestor
64947671|NCT05552508|Benralizumab|benralizumab|mesh-list
64947769|NCT05406401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64947770|NCT05406401|Alkylating Agents|alkylating agents|mesh-ancestor
64486603|NCT01921829|Diuretics|diuretics|mesh-list
64947841|NCT05029622|Contraceptive Agents|contraceptive agents|mesh-ancestor
64947842|NCT05029622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64947843|NCT05029622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947844|NCT05029622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64947847|NCT05010122|Decitabine|decitabine|mesh-list
64947920|NCT04799288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64947921|NCT04799288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64947922|NCT04799288|Immunologic Factors|immunologic factors|mesh-ancestor
64947923|NCT04785118|Scopolamine|scopolamine|mesh-list
64947924|NCT04785118|Ondansetron|ondansetron|mesh-list
64947925|NCT04785118|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64947926|NCT04785118|Antiemetics|antiemetics|mesh-ancestor
64947927|NCT04785118|Autonomic Agents|autonomic agents|mesh-ancestor
64486813|NCT00883168|Xhance|xhance|mesh-list
64947944|NCT04785118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64947945|NCT04785118|Cholinergic Agents|cholinergic agents|mesh-ancestor
64947946|NCT04785118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64947947|NCT04785118|Parasympatholytics|parasympatholytics|mesh-ancestor
64947948|NCT04752163|Leucovorin|leucovorin|mesh-list
64947949|NCT04752163|Cytarabine|cytarabine|mesh-list
64947950|NCT04752163|Voriconazole|voriconazole|mesh-list
64948010|NCT04752163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64948011|NCT04752163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64948012|NCT04752163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64948013|NCT04752163|Hormone Antagonists|hormone antagonists|mesh-ancestor
64948014|NCT04752163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64948015|NCT04752163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64948016|NCT04752163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64948017|NCT04752163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64948018|NCT04735926|Calcifediol|calcifediol|mesh-list
64948019|NCT04735926|Vitamins|vitamins|mesh-ancestor
64486889|NCT03216538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725257|NCT00001357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64725258|NCT00001357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725259|NCT00001381|Suramin|suramin|mesh-list
64725260|NCT00001381|Antinematodal Agents|antinematodal agents|mesh-ancestor
64725261|NCT00001381|Anthelmintics|anthelmintics|mesh-ancestor
64948153|NCT04603183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64948154|NCT04603183|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64487035|NCT01919411|Amoxicillin|amoxicillin|mesh-list
64948155|NCT04580134|Risperidone|risperidone|mesh-list
64948157|NCT04580134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64487109|NCT00898222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948231|NCT04508725|Endothelial Growth Factors|endothelial growth factors|mesh-list
64948232|NCT04508725|Mitosis Modulators|mitosis modulators|mesh-ancestor
64948245|NCT04490057|Cholinergic Agents|cholinergic agents|mesh-ancestor
64948246|NCT04490057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64948247|NCT04490057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948248|NCT04490057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64948249|NCT04490057|Antidepressive Agents|antidepressive agents|mesh-ancestor
64948250|NCT04490057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64948251|NCT04490057|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64948264|NCT04437485|Bupropion|bupropion|mesh-list
64948312|NCT04406649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64948313|NCT04406649|Analgesics|analgesics|mesh-ancestor
64948314|NCT04406649|Sensory System Agents|sensory system agents|mesh-ancestor
64948315|NCT04406649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64948316|NCT04392622|Cisplatin|cisplatin|mesh-list
64948317|NCT04392622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725278|NCT00002023|Antimetabolites|antimetabolites|mesh-ancestor
64725294|NCT00002035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725295|NCT00002035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64332825|NCT01036087|Paclitaxel|paclitaxel|mesh-list
64948384|NCT04210505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64948385|NCT04201262|Ravulizumab|ravulizumab|mesh-list
64725298|NCT00002035|Antiviral Agents|antiviral agents|mesh-ancestor
64725299|NCT00002035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725300|NCT00002035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64725301|NCT00002035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64725302|NCT00002041|Amphotericin B|amphotericin b|mesh-list
64948464|NCT04081389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64948465|NCT04081389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64948466|NCT04081389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64725303|NCT00002041|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64725304|NCT00002041|Amebicides|amebicides|mesh-ancestor
64725305|NCT00002041|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64725306|NCT00002041|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64725307|NCT00002041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725308|NCT00002041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64725309|NCT00002041|Antifungal Agents|antifungal agents|mesh-ancestor
64725310|NCT00002047|Zidovudine|zidovudine|mesh-list
64725311|NCT00002047|Antimetabolites|antimetabolites|mesh-ancestor
64725312|NCT00002047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725313|NCT00002047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64332834|NCT01036087|Tubulin Modulators|tubulin modulators|mesh-ancestor
64948531|NCT03844997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948535|NCT03840967|Niraparib|niraparib|mesh-list
64948595|NCT03589729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64948596|NCT03589729|Antimetabolites|antimetabolites|mesh-ancestor
64725322|NCT00002053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725323|NCT00002053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64725324|NCT00002053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64948686|NCT03390504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948687|NCT03390504|Tubulin Modulators|tubulin modulators|mesh-ancestor
64948688|NCT03390504|Antimitotic Agents|antimitotic agents|mesh-ancestor
64948689|NCT03390504|Mitosis Modulators|mitosis modulators|mesh-ancestor
64948690|NCT03390504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725325|NCT00002053|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64725326|NCT00002059|Inosine Pranobex|inosine pranobex|mesh-list
64725327|NCT00002059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64725328|NCT00002059|Immunologic Factors|immunologic factors|mesh-ancestor
64725329|NCT00002059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948760|NCT03179930|Pembrolizumab|pembrolizumab|mesh-list
64725331|NCT00002059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725332|NCT00002065|Disulfiram|disulfiram|mesh-list
64725333|NCT00002065|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64725334|NCT00002065|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
64725335|NCT00002065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948841|NCT02634294|Immunologic Factors|immunologic factors|mesh-ancestor
64948842|NCT02634294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948843|NCT02586831|Exenatide|exenatide|mesh-list
64725336|NCT00002065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725337|NCT00002071|Epoetin Alfa|epoetin alfa|mesh-list
64725338|NCT00002071|Hematinics|hematinics|mesh-ancestor
64725339|NCT00002395|Topotecan|topotecan|mesh-list
64725347|NCT00002401|Delavirdine|delavirdine|mesh-list
64949007|NCT01013649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949008|NCT01013649|Antiviral Agents|antiviral agents|mesh-ancestor
64949108|NCT00038844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949109|NCT00038844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949110|NCT00038844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64949111|NCT00038844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64949151|NCT00038961|PENTA|penta|mesh-list
64725362|NCT00002407|Nevirapine|nevirapine|mesh-list
64725363|NCT00002407|Stavudine|stavudine|mesh-list
64725364|NCT00002407|Didanosine|didanosine|mesh-list
64725365|NCT00002407|Indinavir|indinavir|mesh-list
64725366|NCT00002407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64725367|NCT00002407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64725368|NCT00002407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725369|NCT00002407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949230|NCT00039117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949231|NCT00019175|Aldesleukin|aldesleukin|mesh-list
64949232|NCT00019175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949233|NCT00019175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64949234|NCT00019175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64949235|NCT00019175|Antiviral Agents|antiviral agents|mesh-ancestor
64949236|NCT00019175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949237|NCT00039156|IDN 5109|idn 5109|mesh-list
64949238|NCT00039156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949239|NCT00019214|Aldesleukin|aldesleukin|mesh-list
64949240|NCT00019214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949241|NCT00019214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64949242|NCT00019214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64949243|NCT00019214|Antiviral Agents|antiviral agents|mesh-ancestor
64949244|NCT00019214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949245|NCT00039234|Aldesleukin|aldesleukin|mesh-list
64949246|NCT00039234|Histamine|histamine|mesh-list
64949247|NCT00039234|Histamine phosphate|histamine phosphate|mesh-list
64949248|NCT00039234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949302|NCT00019409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949303|NCT00019409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64949304|NCT00019409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64949305|NCT00019409|Antiviral Agents|antiviral agents|mesh-ancestor
64949306|NCT00019409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949307|NCT00019409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64949378|NCT00019760|Leucovorin|leucovorin|mesh-list
64949379|NCT00019760|Melphalan|melphalan|mesh-list
64949380|NCT00019760|Floxuridine|floxuridine|mesh-list
64949381|NCT00019760|Calcium|calcium|mesh-list
64949382|NCT00019760|Levoleucovorin|levoleucovorin|mesh-list
64725409|NCT00002419|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64725410|NCT00002419|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64725411|NCT00002419|Protease Inhibitors|protease inhibitors|mesh-ancestor
64725412|NCT00381511|Heparin|heparin|mesh-list
64332924|NCT02257697|Mizoribine|mizoribine|mesh-list
64949447|NCT00039546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64949448|NCT00039546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64949449|NCT00039546|Alkylating Agents|alkylating agents|mesh-ancestor
64949531|NCT00020189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64949532|NCT00039975|Ritonavir|ritonavir|mesh-list
64949533|NCT00039975|Indinavir|indinavir|mesh-list
64949534|NCT00039975|Amlodipine|amlodipine|mesh-list
64949621|NCT00020501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64949622|NCT00020501|Immunologic Factors|immunologic factors|mesh-ancestor
64949623|NCT00020501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64949624|NCT00020501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64949637|NCT00020540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949638|NCT00020540|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64949727|NCT00020774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949728|NCT00020774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949729|NCT00020774|Antiviral Agents|antiviral agents|mesh-ancestor
64949730|NCT00020774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949731|NCT00020774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949732|NCT00020774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64949733|NCT00020774|Immunologic Factors|immunologic factors|mesh-ancestor
64949828|NCT00021281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949829|NCT00021281|Antimetabolites|antimetabolites|mesh-ancestor
64949830|NCT00021281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949831|NCT00021281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64949838|NCT00021281|Antidotes|antidotes|mesh-ancestor
64949904|NCT00041262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949905|NCT00021398|Leucovorin|leucovorin|mesh-list
64949906|NCT00021398|Fluorouracil|fluorouracil|mesh-list
64949907|NCT00021398|Calcium|calcium|mesh-list
64949908|NCT00021398|Levoleucovorin|levoleucovorin|mesh-list
64949909|NCT00021398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64949910|NCT00021398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949911|NCT00021398|Antimetabolites|antimetabolites|mesh-ancestor
64949931|NCT00021554|Antiviral Agents|antiviral agents|mesh-ancestor
64949999|NCT00394628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950000|NCT00394628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950001|NCT00049179|Cytarabine|cytarabine|mesh-list
64950002|NCT00049179|Gemtuzumab|gemtuzumab|mesh-list
64950003|NCT00049179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64950004|NCT00049179|Antimetabolites|antimetabolites|mesh-ancestor
64950005|NCT00049179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950006|NCT00049179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950072|NCT00049374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950073|NCT00049374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64950074|NCT00049374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64950075|NCT00049374|Growth Substances|growth substances|mesh-ancestor
64950076|NCT00049374|Growth Inhibitors|growth inhibitors|mesh-ancestor
64950155|NCT00049569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64950156|NCT00049569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64950157|NCT00049569|Antimetabolites|antimetabolites|mesh-ancestor
64950158|NCT00049569|Dermatologic Agents|dermatologic agents|mesh-ancestor
64950159|NCT00049569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64950223|NCT00049725|Immunologic Factors|immunologic factors|mesh-ancestor
64950234|NCT00397761|Paclitaxel|paclitaxel|mesh-list
64950292|NCT00022646|Pemetrexed|pemetrexed|mesh-list
64950293|NCT00022646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64950294|NCT00022646|Antimetabolites|antimetabolites|mesh-ancestor
64950295|NCT00022646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950296|NCT00022646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950369|NCT00050817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64950370|NCT00050817|Purinergic Agents|purinergic agents|mesh-ancestor
64950371|NCT00050817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64950372|NCT00050817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950373|NCT00050817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950445|NCT00050895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950446|NCT00050895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950447|NCT00050895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64950448|NCT00050895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64950500|NCT00023504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950501|NCT00051051|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
64950502|NCT00051051|Anesthetics, Local|anesthetics, local|mesh-ancestor
64950503|NCT00051051|Anesthetics|anesthetics|mesh-ancestor
64950504|NCT00051051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64950505|NCT00051051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950564|NCT00051285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64950565|NCT00051285|Vasodilator Agents|vasodilator agents|mesh-ancestor
64950566|NCT00051285|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64950567|NCT00051285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64950568|NCT00051285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725513|NCT04329650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64725514|NCT04329650|Prednisolone phosphate|prednisolone phosphate|mesh-list
64725515|NCT04329650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64950630|NCT00023855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950631|NCT00023855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64950632|NCT00023855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64950633|NCT00023855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725521|NCT04329650|Glucocorticoids|glucocorticoids|mesh-ancestor
64725522|NCT04329650|Hormones|hormones|mesh-ancestor
64464794|NCT02384668|Vitamin D|vitamin d|mesh-list
64950695|NCT00024050|Alkylating Agents|alkylating agents|mesh-ancestor
64950696|NCT00024050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725527|NCT04329650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725528|NCT00002443|Zidovudine|zidovudine|mesh-list
64725529|NCT00002443|Indinavir|indinavir|mesh-list
64725530|NCT00002443|Antimetabolites|antimetabolites|mesh-ancestor
64725531|NCT00002443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333055|NCT03532841|Tramadol|tramadol|mesh-list
64950756|NCT00024206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950757|NCT00024206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950758|NCT00024245|Probenecid|probenecid|mesh-list
64333058|NCT03532841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64333059|NCT03532841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333060|NCT03532841|Analgesics|analgesics|mesh-ancestor
64333072|NCT02199431|Itraconazole|itraconazole|mesh-list
64950806|NCT00024440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64950807|NCT00024440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64950808|NCT00024440|Alkylating Agents|alkylating agents|mesh-ancestor
64950809|NCT00024440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950810|NCT00024440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950811|NCT00024440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64950812|NCT00024440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64950814|NCT00024518|Interferons|interferons|mesh-list
64950863|NCT04733066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950864|NCT00052377|Aldesleukin|aldesleukin|mesh-list
64950865|NCT00052377|Interleukin-2|interleukin-2|mesh-list
64950866|NCT00052377|Interleukin-12|interleukin-12|mesh-list
64950867|NCT00052377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950868|NCT00052377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64950869|NCT00052377|Analgesics|analgesics|mesh-ancestor
64950870|NCT00052377|Sensory System Agents|sensory system agents|mesh-ancestor
64950927|NCT00395213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950928|NCT00395213|Sympathomimetics|sympathomimetics|mesh-ancestor
64950929|NCT00395213|Autonomic Agents|autonomic agents|mesh-ancestor
64950930|NCT00395213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64950931|NCT00395213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64950932|NCT00395213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64950933|NCT00395213|Serotonin Agents|serotonin agents|mesh-ancestor
64950934|NCT00395213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64950935|NCT00395213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64950936|NCT00052611|Celecoxib|celecoxib|mesh-list
64950986|NCT00395369|Hemostatics|hemostatics|mesh-ancestor
64950987|NCT00395369|Coagulants|coagulants|mesh-ancestor
64950988|NCT00395369|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64950989|NCT00395369|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64950990|NCT00395369|Protease Inhibitors|protease inhibitors|mesh-ancestor
64950991|NCT00395369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951046|NCT00052923|Alkylating Agents|alkylating agents|mesh-ancestor
64951047|NCT00052923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951048|NCT00052923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951049|NCT00052923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64951050|NCT00052923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64951051|NCT00052923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64951052|NCT00052923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64951116|NCT00025103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951131|NCT00025142|Leucovorin|leucovorin|mesh-list
64951179|NCT00025220|Growth Inhibitors|growth inhibitors|mesh-ancestor
64951180|NCT00025220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951181|NCT00053157|Sargramostim|sargramostim|mesh-list
64951182|NCT00053157|Immunologic Factors|immunologic factors|mesh-ancestor
64951183|NCT00053157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951256|NCT00025337|Micronutrients|micronutrients|mesh-ancestor
64951257|NCT00025376|Bortezomib|bortezomib|mesh-list
64951258|NCT00025376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951259|NCT00025415|Imatinib Mesylate|imatinib mesylate|mesh-list
64951260|NCT00025415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951261|NCT00025415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64951262|NCT00025415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951263|NCT00025415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951264|NCT00025454|Tipifarnib|tipifarnib|mesh-list
64951327|NCT00025649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64951328|NCT00025649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64951329|NCT00025649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64951330|NCT00025649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64951387|NCT00053937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64951388|NCT00053937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64951389|NCT00053937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64951390|NCT00053937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951391|NCT00053976|Methylprednisolone|methylprednisolone|mesh-list
64951392|NCT00053976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64951393|NCT00053976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64951394|NCT00053976|Prednisolone|prednisolone|mesh-list
64951395|NCT00053976|Prednisolone acetate|prednisolone acetate|mesh-list
64725655|NCT00002149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64725656|NCT03868046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64725679|NCT00003032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64503361|NCT04505202|Disinfectants|disinfectants|mesh-ancestor
64503362|NCT04505202|Dermatologic Agents|dermatologic agents|mesh-ancestor
64503363|NCT05585346|Prednisolone|prednisolone|mesh-list
64503364|NCT05585346|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64503365|NCT05585346|Methylprednisolone|methylprednisolone|mesh-list
64503366|NCT05585346|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64503367|NCT05585346|Prednisolone acetate|prednisolone acetate|mesh-list
64503368|NCT05585346|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64725682|NCT00003032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64725683|NCT00003032|Analgesics|analgesics|mesh-ancestor
64725684|NCT00003032|Sensory System Agents|sensory system agents|mesh-ancestor
64725685|NCT00003032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64951496|NCT00054288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951497|NCT00054288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951506|NCT00026273|Leucovorin|leucovorin|mesh-list
64725688|NCT00003032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725689|NCT00002155|Lamivudine|lamivudine|mesh-list
64725690|NCT00002155|Zidovudine|zidovudine|mesh-list
64951570|NCT00026468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951571|NCT00026468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64725693|NCT00002155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64725694|NCT00002155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725695|NCT00002155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725696|NCT00002155|Antiviral Agents|antiviral agents|mesh-ancestor
64951636|NCT00054795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64951637|NCT00054795|Dermatologic Agents|dermatologic agents|mesh-ancestor
64951638|NCT00026819|Rofecoxib|rofecoxib|mesh-list
64951645|NCT00026819|Analgesics|analgesics|mesh-ancestor
64725697|NCT00002155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725698|NCT00002155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64725699|NCT00002155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64725700|NCT00002155|Antimetabolites|antimetabolites|mesh-ancestor
64725701|NCT00002155|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64725702|NCT00002155|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64725703|NCT00002155|Protease Inhibitors|protease inhibitors|mesh-ancestor
64725704|NCT00003038|Suramin|suramin|mesh-list
64951701|NCT00027053|Serotonin Agents|serotonin agents|mesh-ancestor
64725705|NCT00003038|Doxorubicin|doxorubicin|mesh-list
64725706|NCT00003038|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64725707|NCT00003038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64725708|NCT00003038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725709|NCT00003038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64725710|NCT00003038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64725711|NCT00003038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725712|NCT00003038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951834|NCT00027638|Immunologic Factors|immunologic factors|mesh-ancestor
64951836|NCT00027638|Leprostatic Agents|leprostatic agents|mesh-ancestor
64951909|NCT00055965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951910|NCT00027833|Leucovorin|leucovorin|mesh-list
64725713|NCT00003038|Antinematodal Agents|antinematodal agents|mesh-ancestor
64725714|NCT00003038|Anthelmintics|anthelmintics|mesh-ancestor
64725715|NCT00003038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64725716|NCT00003038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725717|NCT00003038|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64725718|NCT00003038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64725719|NCT00003044|Cisplatin|cisplatin|mesh-list
64725721|NCT00002161|Adefovir|adefovir|mesh-list
64951961|NCT00056004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64951962|NCT00056004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951963|NCT00056004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951964|NCT00056004|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64951965|NCT00056004|Hormone Antagonists|hormone antagonists|mesh-ancestor
64951966|NCT00056004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64725735|NCT03805022|Isophosphamide mustard|isophosphamide mustard|mesh-list
64725736|NCT03805022|Dacarbazine|dacarbazine|mesh-list
64725737|NCT03805022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64725738|NCT03805022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725739|NCT03805022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64952033|NCT00056277|Lamotrigine|lamotrigine|mesh-list
64725743|NCT03805022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64725744|NCT03805022|Alkylating Agents|alkylating agents|mesh-ancestor
64725745|NCT05752435|Bleomycin|bleomycin|mesh-list
64725746|NCT05752435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64725747|NCT05752435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952117|NCT00028847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952123|NCT00028886|Melphalan|melphalan|mesh-list
64952187|NCT00028964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64952188|NCT00028964|Immunologic Factors|immunologic factors|mesh-ancestor
64952189|NCT00028964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952190|NCT00028964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64952191|NCT00028964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64952192|NCT00028964|Alkylating Agents|alkylating agents|mesh-ancestor
64952193|NCT00028964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952194|NCT00028964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952201|NCT00423501|Incretins|incretins|mesh-ancestor
64952246|NCT00423696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952247|NCT00423696|Growth Inhibitors|growth inhibitors|mesh-ancestor
64952248|NCT00423696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64952252|NCT00423696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64952312|NCT00395681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952313|NCT00395681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64952314|NCT00395681|Anesthetics, General|anesthetics, general|mesh-ancestor
64952315|NCT00395681|Anesthetics|anesthetics|mesh-ancestor
64952316|NCT00395720|Vaccines|vaccines|mesh-list
64952317|NCT00395720|Immunologic Factors|immunologic factors|mesh-ancestor
64952382|NCT00057447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64952383|NCT00030095|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
64952384|NCT00030095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952451|NCT00057642|Antidepressive Agents|antidepressive agents|mesh-ancestor
64952452|NCT00057642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64952453|NCT00057642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64491315|NCT01678677|Vaccines|vaccines|mesh-list
64952454|NCT00057642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64952516|NCT00057798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952517|NCT00057798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952518|NCT00057798|Antiviral Agents|antiviral agents|mesh-ancestor
64952519|NCT00057798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64952520|NCT00057798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952521|NCT00057798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64952522|NCT00057798|Immunologic Factors|immunologic factors|mesh-ancestor
64952523|NCT00057798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952524|NCT00057798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64952525|NCT00057798|Tubulin Modulators|tubulin modulators|mesh-ancestor
64952565|NCT00030719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952566|NCT00030719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64952567|NCT00030719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64952639|NCT00058227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64952640|NCT00058227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725851|NCT00383396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725852|NCT00383396|Dermatologic Agents|dermatologic agents|mesh-ancestor
64725853|NCT00383396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64725854|NCT00383396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64725855|NCT00002197|Abacavir|abacavir|mesh-list
64952673|NCT00031070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64503408|NCT01601236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503409|NCT05584878|Chitosan|chitosan|mesh-list
64952674|NCT00031070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64952675|NCT00031070|Antimetabolites|antimetabolites|mesh-ancestor
64725861|NCT00002197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64952676|NCT00031070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64952677|NCT00031070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64952678|NCT00031070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64952679|NCT00031070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64952680|NCT00031070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64952681|NCT00031070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64952682|NCT00058305|Vincristine|vincristine|mesh-list
64952683|NCT00058305|Bryostatin 1|bryostatin 1|mesh-list
64952684|NCT00058305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64952685|NCT00058305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952686|NCT00058305|Tubulin Modulators|tubulin modulators|mesh-ancestor
64952687|NCT00058305|Antimitotic Agents|antimitotic agents|mesh-ancestor
64952688|NCT00058305|Mitosis Modulators|mitosis modulators|mesh-ancestor
64952689|NCT00058305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952690|NCT00058305|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64952691|NCT00058305|Immunologic Factors|immunologic factors|mesh-ancestor
64725904|NCT00003080|Analgesics|analgesics|mesh-ancestor
64952692|NCT00058305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952693|NCT00058461|Cytarabine|cytarabine|mesh-list
64952694|NCT00058461|Rituximab|rituximab|mesh-list
64952695|NCT00058461|Carboplatin|carboplatin|mesh-list
64952696|NCT00058461|Methotrexate|methotrexate|mesh-list
64952697|NCT00058461|Etoposide|etoposide|mesh-list
64952698|NCT00058461|Ifosfamide|ifosfamide|mesh-list
64725860|NCT00002197|Antiviral Agents|antiviral agents|mesh-ancestor
64725862|NCT00002197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64725863|NCT00002197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64725864|NCT00003068|Cyclophosphamide|cyclophosphamide|mesh-list
64725865|NCT00003068|Thiotepa|thiotepa|mesh-list
64725866|NCT00003068|Mitoxantrone|mitoxantrone|mesh-list
64725867|NCT00003068|Amifostine|amifostine|mesh-list
64725868|NCT00003068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64725869|NCT00003068|Immunologic Factors|immunologic factors|mesh-ancestor
64725870|NCT00003068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725871|NCT00003068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64725872|NCT00003068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64952699|NCT00058461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64952700|NCT00058461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952701|NCT00058461|Immunologic Factors|immunologic factors|mesh-ancestor
64952702|NCT00058461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952703|NCT00058461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64952704|NCT00058461|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64952705|NCT00058461|Abortifacient Agents|abortifacient agents|mesh-ancestor
64952706|NCT00058461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64952707|NCT00058461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64953157|NCT02968719|Donepezil|donepezil|mesh-list
64952708|NCT00058461|Antimetabolites|antimetabolites|mesh-ancestor
64952709|NCT00058461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952710|NCT00058461|Dermatologic Agents|dermatologic agents|mesh-ancestor
64952711|NCT00058461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952712|NCT00058461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64952713|NCT00058461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64952714|NCT00058461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64952717|NCT00058461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64952719|NCT00058461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64952720|NCT00058461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64952721|NCT00058461|Alkylating Agents|alkylating agents|mesh-ancestor
64952722|NCT00058578|Cyclophosphamide|cyclophosphamide|mesh-list
64952723|NCT00058578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64952724|NCT00058578|Immunologic Factors|immunologic factors|mesh-ancestor
64952725|NCT00058578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952726|NCT00058578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64952727|NCT00058578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64952728|NCT00058578|Alkylating Agents|alkylating agents|mesh-ancestor
64953244|NCT00033059|Tolcapone|tolcapone|mesh-list
64952729|NCT00058578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952730|NCT00058578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952731|NCT00058578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64952732|NCT04711889|Urinastatin|urinastatin|mesh-list
64952733|NCT04711889|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64952734|NCT04711889|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64952735|NCT04711889|Protease Inhibitors|protease inhibitors|mesh-ancestor
64952736|NCT04711889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953308|NCT00060957|Cholinergic Agents|cholinergic agents|mesh-ancestor
64952737|NCT04711889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952738|NCT00031109|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64952739|NCT00031109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64952740|NCT00031109|Immunologic Factors|immunologic factors|mesh-ancestor
64952741|NCT00031109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952742|NCT00031109|Antacids|antacids|mesh-ancestor
64952743|NCT00031109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952744|NCT00031109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64952745|NCT00031148|Mitogens|mitogens|mesh-list
64503410|NCT05584878|Calcium|calcium|mesh-list
64952746|NCT00031148|Mitosis Modulators|mitosis modulators|mesh-ancestor
64952747|NCT00031148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952748|NCT00031187|Docetaxel|docetaxel|mesh-list
64952749|NCT00031187|Doxorubicin|doxorubicin|mesh-list
64952750|NCT00031187|Immunoconjugates|immunoconjugates|mesh-list
64725873|NCT00003068|Alkylating Agents|alkylating agents|mesh-ancestor
64725874|NCT00003068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725875|NCT00003068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333384|NCT02739997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64952751|NCT00031187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952752|NCT00031187|Tubulin Modulators|tubulin modulators|mesh-ancestor
64952753|NCT00031187|Antimitotic Agents|antimitotic agents|mesh-ancestor
64952754|NCT00031187|Mitosis Modulators|mitosis modulators|mesh-ancestor
64952755|NCT00031187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952756|NCT00031187|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64953576|NCT02971397|Antiviral Agents|antiviral agents|mesh-ancestor
64952757|NCT00031187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64952758|NCT00031187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64952759|NCT00031187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952760|NCT00031187|Immunologic Factors|immunologic factors|mesh-ancestor
64953639|NCT00061815|Leucovorin|leucovorin|mesh-list
64952761|NCT00031187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952762|NCT00031343|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64952763|NCT00031343|Antiviral Agents|antiviral agents|mesh-ancestor
64952764|NCT00031343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64952765|NCT00058890|Gabapentin|gabapentin|mesh-list
64952766|NCT00058890|Analgesics|analgesics|mesh-ancestor
64952767|NCT00058890|Sensory System Agents|sensory system agents|mesh-ancestor
64952768|NCT00058890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64952769|NCT00058890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952770|NCT00058890|Anticonvulsants|anticonvulsants|mesh-ancestor
64952771|NCT00058890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64952772|NCT00058890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64726102|NCT00002233|Protease Inhibitors|protease inhibitors|mesh-ancestor
64952773|NCT00058890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64952774|NCT00058890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64952775|NCT00058890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64952776|NCT00058890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64952777|NCT00058890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64952778|NCT00058890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952779|NCT00058890|Antimanic Agents|antimanic agents|mesh-ancestor
64952780|NCT00058929|Treprostinil|treprostinil|mesh-list
64952781|NCT00058929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64952782|NCT00396071|Vildagliptin|vildagliptin|mesh-list
64952783|NCT00396071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64952784|NCT00396071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952785|NCT00396071|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64952797|NCT00058968|Sensory System Agents|sensory system agents|mesh-ancestor
64952798|NCT00058968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64952799|NCT00058968|Antidepressive Agents|antidepressive agents|mesh-ancestor
64952800|NCT00058968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64952801|NCT00058968|Dopamine Agents|dopamine agents|mesh-ancestor
64952802|NCT00396227|Pioglitazone|pioglitazone|mesh-list
64952803|NCT00396227|Rosiglitazone|rosiglitazone|mesh-list
64952804|NCT00396227|Vildagliptin|vildagliptin|mesh-list
64952805|NCT00396227|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
64952806|NCT00396227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64952807|NCT00396227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953928|NCT00062595|Coagulants|coagulants|mesh-ancestor
64952808|NCT00396227|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64952809|NCT00396227|Protease Inhibitors|protease inhibitors|mesh-ancestor
64953982|NCT00062946|Dopamine Agents|dopamine agents|mesh-ancestor
64952810|NCT00396227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952811|NCT00396227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952812|NCT00396344|Hydrocortisone|hydrocortisone|mesh-list
64952813|NCT00396344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64952814|NCT00396344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64952815|NCT00396344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64952816|NCT00396344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64952817|NCT00031499|Azithromycin|azithromycin|mesh-list
64503411|NCT05584878|Caseins|caseins|mesh-list
64952818|NCT00031499|Doxycycline|doxycycline|mesh-list
64491602|NCT01009918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64952819|NCT00031499|Penicillins|penicillins|mesh-list
64952820|NCT00031499|Penicillin G Benzathine|penicillin g benzathine|mesh-list
64952821|NCT00031499|Penicillin G|penicillin g|mesh-list
64952822|NCT00031499|Penicillin G Procaine|penicillin g procaine|mesh-list
64952823|NCT00031499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64952824|NCT00031499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64952825|NCT00031499|Antimalarials|antimalarials|mesh-ancestor
64952826|NCT00031499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64952827|NCT00031499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64725876|NCT00003068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64725877|NCT00003068|Analgesics|analgesics|mesh-ancestor
64954276|NCT00037583|Gemtuzumab|gemtuzumab|mesh-list
64725878|NCT00003068|Sensory System Agents|sensory system agents|mesh-ancestor
64725879|NCT00003068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64725880|NCT00003068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64952828|NCT00059358|Interferons|interferons|mesh-list
64952829|NCT00059358|Ribavirin|ribavirin|mesh-list
64952830|NCT00059358|Interferon-alpha|interferon-alpha|mesh-list
64952831|NCT00059358|Interferon alpha-2|interferon alpha-2|mesh-list
64952832|NCT00059358|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64952833|NCT00059358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952834|NCT00059358|Antiviral Agents|antiviral agents|mesh-ancestor
64952835|NCT00059358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64952836|NCT00059358|Antimetabolites|antimetabolites|mesh-ancestor
64952837|NCT00059358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952838|NCT00059358|Immunologic Factors|immunologic factors|mesh-ancestor
64952839|NCT00059358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952840|NCT00031577|Paclitaxel|paclitaxel|mesh-list
64952841|NCT00031577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64952842|NCT00031577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952843|NCT00031577|Tubulin Modulators|tubulin modulators|mesh-ancestor
64952844|NCT00031577|Antimitotic Agents|antimitotic agents|mesh-ancestor
64952845|NCT00031577|Mitosis Modulators|mitosis modulators|mesh-ancestor
64952846|NCT00031577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952861|NCT00031655|Fludarabine phosphate|fludarabine phosphate|mesh-list
64952862|NCT00031655|Cyclosporins|cyclosporins|mesh-list
64952863|NCT00031655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952864|NCT00031655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64952865|NCT00031655|Antimetabolites|antimetabolites|mesh-ancestor
64952866|NCT00031655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952867|NCT00031655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64952868|NCT00031655|Immunologic Factors|immunologic factors|mesh-ancestor
64952869|NCT00031655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952870|NCT00031655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952871|NCT00031655|Antifungal Agents|antifungal agents|mesh-ancestor
64952872|NCT00031655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64952873|NCT00031655|Dermatologic Agents|dermatologic agents|mesh-ancestor
64952874|NCT00031655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64952875|NCT00031655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64952876|NCT00031655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64952877|NCT00031655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64952878|NCT00031655|Antitubercular Agents|antitubercular agents|mesh-ancestor
64952879|NCT00031655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64952880|NCT00059592|Valacyclovir|valacyclovir|mesh-list
64952881|NCT00059592|Antiviral Agents|antiviral agents|mesh-ancestor
64952882|NCT00059592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64952883|NCT00031733|Interleukin-12|interleukin-12|mesh-list
64952884|NCT00031733|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64952885|NCT00031733|Sargramostim|sargramostim|mesh-list
64952886|NCT00031733|Freund's Adjuvant|freund's adjuvant|mesh-list
64952887|NCT00031733|Aluminum sulfate|aluminum sulfate|mesh-list
64952888|NCT00031733|Immunologic Factors|immunologic factors|mesh-ancestor
64952889|NCT00031733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952890|NCT00031733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952891|NCT00031733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64503412|NCT05584878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64952892|NCT00031733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64952893|NCT00031733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64952894|NCT00031733|Growth Substances|growth substances|mesh-ancestor
64952895|NCT00031733|Growth Inhibitors|growth inhibitors|mesh-ancestor
64503413|NCT05584878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952896|NCT00031733|Antacids|antacids|mesh-ancestor
64952897|NCT00031733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952898|NCT00031733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64952899|NCT02969265|Amlodipine|amlodipine|mesh-list
64952900|NCT02969265|Candesartan cilexetil|candesartan cilexetil|mesh-list
64952901|NCT02969265|Candesartan|candesartan|mesh-list
64952902|NCT02969265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64952903|NCT02969265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64952904|NCT02969265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64952905|NCT02969265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725881|NCT00003068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64725882|NCT00003068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725883|NCT00003068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64725884|NCT00003068|Protective Agents|protective agents|mesh-ancestor
64725885|NCT00003080|Tamoxifen|tamoxifen|mesh-list
64954846|NCT02958501|Cholecalciferol|cholecalciferol|mesh-list
64952906|NCT02969265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64952907|NCT02969265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952910|NCT02969265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64952911|NCT00031811|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64952912|NCT00031811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64952913|NCT00031811|Hormone Antagonists|hormone antagonists|mesh-ancestor
64952914|NCT00031811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64952915|NCT00031811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952916|NCT00031811|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64952917|NCT00031811|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64952918|NCT00031811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64952919|NCT00031850|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64952920|NCT00031850|Goserelin|goserelin|mesh-list
64952921|NCT00031850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64954985|NCT04750772|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64952922|NCT00031850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952923|NCT00031850|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64952924|NCT00031850|Hormone Antagonists|hormone antagonists|mesh-ancestor
64952925|NCT00031850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64952926|NCT00031850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952927|NCT00031850|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64955045|NCT04231643|Hormones|hormones|mesh-ancestor
64952928|NCT00031850|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64952929|NCT00031850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64952930|NCT00059631|Bortezomib|bortezomib|mesh-list
64952931|NCT00059631|Mitoxantrone|mitoxantrone|mesh-list
64952932|NCT00059631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952933|NCT00059631|Analgesics|analgesics|mesh-ancestor
64952934|NCT00059631|Sensory System Agents|sensory system agents|mesh-ancestor
64952935|NCT00059631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64952936|NCT00059631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952937|NCT00059631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64952938|NCT00059631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64952939|NCT00059631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952940|NCT00059631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952941|NCT00031889|Exemestane|exemestane|mesh-list
64952942|NCT00031889|Bicalutamide|bicalutamide|mesh-list
64952943|NCT00031889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955144|NCT03338621|Rifampin|rifampin|mesh-list
64955145|NCT03338621|Isoniazid|isoniazid|mesh-list
64952944|NCT00031889|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64952945|NCT00031889|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64952946|NCT00031889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952947|NCT00031889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952948|NCT00031889|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64952949|NCT00031889|Hormone Antagonists|hormone antagonists|mesh-ancestor
64952950|NCT00031889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64952951|NCT00031889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952952|NCT00031889|Androgen Antagonists|androgen antagonists|mesh-ancestor
64955314|NCT00144703|Sirolimus|sirolimus|mesh-list
64952953|NCT00031928|Mafosfamide|mafosfamide|mesh-list
64952954|NCT00031928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64952955|NCT00031928|Immunologic Factors|immunologic factors|mesh-ancestor
64952956|NCT00031928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952957|NCT00031928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952958|NCT00031967|Melatonin|melatonin|mesh-list
64952959|NCT00031967|Antioxidants|antioxidants|mesh-ancestor
64952960|NCT00031967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952961|NCT00031967|Protective Agents|protective agents|mesh-ancestor
64952962|NCT00031967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952963|NCT00031967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64503536|NCT01603420|Docetaxel|docetaxel|mesh-list
64952964|NCT00059826|Interferons|interferons|mesh-list
64952965|NCT00059826|Interferon-alpha|interferon-alpha|mesh-list
64952966|NCT00059826|Interferon alpha-2|interferon alpha-2|mesh-list
64503414|NCT05584878|Chelating Agents|chelating agents|mesh-ancestor
64952967|NCT00059826|Fluorouracil|fluorouracil|mesh-list
64952968|NCT00059826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725886|NCT00003080|Melphalan|melphalan|mesh-list
64725887|NCT00003080|Thiotepa|thiotepa|mesh-list
64725888|NCT00003080|Mitoxantrone|mitoxantrone|mesh-list
64503587|NCT01691326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725889|NCT00003080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725890|NCT00003080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64725891|NCT00003080|Alkylating Agents|alkylating agents|mesh-ancestor
64725892|NCT00003080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725893|NCT00003080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64725894|NCT00003080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64725895|NCT00003080|Immunologic Factors|immunologic factors|mesh-ancestor
64725896|NCT00003080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725897|NCT00003080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64420714|NCT04424017|Antibodies|antibodies|mesh-list
64725898|NCT00003080|Hormone Antagonists|hormone antagonists|mesh-ancestor
64725899|NCT00003080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64725900|NCT00003080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64725901|NCT00003080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64725902|NCT00003080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64725903|NCT00003080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64725905|NCT00003080|Sensory System Agents|sensory system agents|mesh-ancestor
64503717|NCT01795547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64725906|NCT00003080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64725907|NCT00003080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64725908|NCT00003080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64952969|NCT00059826|Antimetabolites|antimetabolites|mesh-ancestor
64952970|NCT00059826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952971|NCT00059826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64952972|NCT00059826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64952973|NCT00059826|Immunologic Factors|immunologic factors|mesh-ancestor
64952974|NCT00059826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952975|NCT00059826|Antiviral Agents|antiviral agents|mesh-ancestor
64503772|NCT00708552|Donepezil|donepezil|mesh-list
64952976|NCT00059826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64952977|NCT00032045|Ipilimumab|ipilimumab|mesh-list
64952981|NCT00032045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64952982|NCT00032045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952983|NCT00032045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64952984|NCT00032045|Immunologic Factors|immunologic factors|mesh-ancestor
64952985|NCT00032045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952986|NCT00059865|Gemcitabine|gemcitabine|mesh-list
64952987|NCT00059865|Pemetrexed|pemetrexed|mesh-list
64952988|NCT00059865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64952989|NCT00059865|Antimetabolites|antimetabolites|mesh-ancestor
64952990|NCT00059865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952991|NCT00059865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952992|NCT00059865|Antiviral Agents|antiviral agents|mesh-ancestor
64952993|NCT00059865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64952994|NCT00059865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952995|NCT00059865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64952996|NCT00059865|Immunologic Factors|immunologic factors|mesh-ancestor
64725910|NCT00002203|Lamivudine|lamivudine|mesh-list
64725911|NCT00002203|Zidovudine|zidovudine|mesh-list
64725912|NCT00002203|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64725913|NCT00002203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64725914|NCT00002203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64725915|NCT00002203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725916|NCT00002203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725917|NCT00002203|Antiviral Agents|antiviral agents|mesh-ancestor
64725918|NCT00002203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64725919|NCT00002203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64725920|NCT00002203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64725921|NCT00002203|Antimetabolites|antimetabolites|mesh-ancestor
64725922|NCT01568918|Tamsulosin|tamsulosin|mesh-list
64725923|NCT01568918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64725924|NCT01568918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64333431|NCT04467931|Trandolapril|trandolapril|mesh-list
64952997|NCT00059865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952998|NCT00059865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64952999|NCT00059865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64953000|NCT00032084|Bupropion|bupropion|mesh-list
64953001|NCT00032084|Nicotine|nicotine|mesh-list
64953002|NCT00032084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64953003|NCT00032084|Autonomic Agents|autonomic agents|mesh-ancestor
64953004|NCT00032084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64504135|NCT04499118|Antimitotic Agents|antimitotic agents|mesh-ancestor
64953005|NCT00032084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953006|NCT00032084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64953007|NCT00032084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64953008|NCT00032084|Cholinergic Agents|cholinergic agents|mesh-ancestor
64953009|NCT00032084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64953010|NCT00032084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953011|NCT00032084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64420717|NCT05477797|Lenalidomide|lenalidomide|mesh-list
64953012|NCT00032084|Antidepressive Agents|antidepressive agents|mesh-ancestor
64953013|NCT00032084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64953014|NCT00032084|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64953015|NCT00032084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64953016|NCT00032084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64953017|NCT00032084|Dopamine Agents|dopamine agents|mesh-ancestor
64953018|NCT00032084|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64953019|NCT00032084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64953020|NCT00032084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953021|NCT00059904|Aldesleukin|aldesleukin|mesh-list
64953022|NCT00059904|Rituximab|rituximab|mesh-list
64953023|NCT00059904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64953024|NCT00059904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953025|NCT00059904|Immunologic Factors|immunologic factors|mesh-ancestor
64953026|NCT00059904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953027|NCT00059904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64953028|NCT00059904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64953029|NCT00059904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64504335|NCT02728206|Velpatasvir|velpatasvir|mesh-list
64953030|NCT00059904|Antiviral Agents|antiviral agents|mesh-ancestor
64953031|NCT00059904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64953032|NCT00032123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64953033|NCT00032123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953034|NCT00032123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64953035|NCT00032123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953036|NCT00032123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504398|NCT02508402|Autonomic Agents|autonomic agents|mesh-ancestor
64725925|NCT01568918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64725926|NCT01568918|Adrenergic Agents|adrenergic agents|mesh-ancestor
64725927|NCT01568918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64725928|NCT01568918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725929|NCT01568918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725930|NCT01568918|Urological Agents|urological agents|mesh-ancestor
64725931|NCT00003086|Cyclophosphamide|cyclophosphamide|mesh-list
64725932|NCT00003086|Carboplatin|carboplatin|mesh-list
64725933|NCT00003086|Doxorubicin|doxorubicin|mesh-list
64725934|NCT00003086|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64725935|NCT00003086|Fluorouracil|fluorouracil|mesh-list
64725936|NCT00003086|Melphalan|melphalan|mesh-list
64725937|NCT00003086|Ifosfamide|ifosfamide|mesh-list
64725938|NCT00003086|Thiotepa|thiotepa|mesh-list
64725939|NCT00003086|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
64725940|NCT00003086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333452|NCT04467931|Ethacrynic Acid|ethacrynic acid|mesh-list
64953037|NCT00059943|Docetaxel|docetaxel|mesh-list
64953038|NCT00059943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503415|NCT05584878|Sequestering Agents|sequestering agents|mesh-ancestor
64953039|NCT00059943|Tubulin Modulators|tubulin modulators|mesh-ancestor
64953040|NCT00059943|Antimitotic Agents|antimitotic agents|mesh-ancestor
64503416|NCT05584878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953041|NCT00059943|Mitosis Modulators|mitosis modulators|mesh-ancestor
64953042|NCT00059943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953043|NCT00032162|Carboplatin|carboplatin|mesh-list
64953044|NCT00032162|Doxorubicin|doxorubicin|mesh-list
64953045|NCT00032162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64953046|NCT00032162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953050|NCT00032162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953051|NCT00032162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953053|NCT00032279|Immunologic Factors|immunologic factors|mesh-ancestor
64953054|NCT00032279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953055|NCT00060138|Zoledronic Acid|zoledronic acid|mesh-list
64953056|NCT00060138|Antibodies|antibodies|mesh-list
64953057|NCT00060138|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64953058|NCT00060138|Immunologic Factors|immunologic factors|mesh-ancestor
64953059|NCT00060138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953060|NCT00060138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64953061|NCT00032396|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
64953062|NCT00032396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64953063|NCT00032396|Glucocorticoids|glucocorticoids|mesh-ancestor
64953064|NCT00032396|Hormones|hormones|mesh-ancestor
64953065|NCT00032396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64953066|NCT00032396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953067|NCT00060255|Cyclophosphamide|cyclophosphamide|mesh-list
64953068|NCT00060255|Melphalan|melphalan|mesh-list
64953069|NCT00060255|Busulfan|busulfan|mesh-list
64953070|NCT00060255|Thiotepa|thiotepa|mesh-list
64953071|NCT00060255|Carmustine|carmustine|mesh-list
64953072|NCT00060255|Carboplatin|carboplatin|mesh-list
64953073|NCT00060255|Etoposide|etoposide|mesh-list
64953074|NCT00060255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64504819|NCT02235064|Serotonin Agents|serotonin agents|mesh-ancestor
64953075|NCT00060255|Immunologic Factors|immunologic factors|mesh-ancestor
64953076|NCT00060255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953077|NCT00060255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64953078|NCT00060255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64953079|NCT00060255|Alkylating Agents|alkylating agents|mesh-ancestor
64953080|NCT00060255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953081|NCT00060255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953082|NCT00060255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64953083|NCT00060255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64504880|NCT00708162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504881|NCT04930042|Ustekinumab|ustekinumab|mesh-list
64504883|NCT04915768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64725941|NCT00003086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725943|NCT00003086|Immunologic Factors|immunologic factors|mesh-ancestor
64725944|NCT00003086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333466|NCT04467931|Diuretics|diuretics|mesh-ancestor
64953084|NCT00060255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64953085|NCT00060255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64953086|NCT00060255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953087|NCT00060294|Rituximab|rituximab|mesh-list
64953088|NCT00060294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64953089|NCT00060294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953090|NCT00060294|Immunologic Factors|immunologic factors|mesh-ancestor
64953091|NCT00060294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953092|NCT00060294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64953093|NCT00060372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64953094|NCT00060372|Ipilimumab|ipilimumab|mesh-list
64953095|NCT00060372|Antibodies|antibodies|mesh-list
64505086|NCT02245672|Xhance|xhance|mesh-list
64953096|NCT00060372|Immunoglobulins|immunoglobulins|mesh-list
64953097|NCT00060372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64953098|NCT00060372|Immunologic Factors|immunologic factors|mesh-ancestor
64953099|NCT00060372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953100|NCT00060372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953101|NCT00060372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64953102|NCT00060372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953103|NCT00060411|Leucovorin|leucovorin|mesh-list
64505115|NCT03335904|Losartan|losartan|mesh-list
64953104|NCT00060411|Bevacizumab|bevacizumab|mesh-list
64953105|NCT00060411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64953106|NCT00060411|Fluorouracil|fluorouracil|mesh-list
64953107|NCT00060411|Oxaliplatin|oxaliplatin|mesh-list
64953108|NCT00060411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64953109|NCT00060411|Antibodies|antibodies|mesh-list
64953110|NCT00060411|Immunoglobulins|immunoglobulins|mesh-list
64953111|NCT00060411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64953112|NCT00060411|Levoleucovorin|levoleucovorin|mesh-list
64505179|NCT03342300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953113|NCT00060411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953114|NCT00060411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64953115|NCT00060411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64953116|NCT00060411|Growth Substances|growth substances|mesh-ancestor
64953117|NCT00060411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953118|NCT00060411|Growth Inhibitors|growth inhibitors|mesh-ancestor
64953119|NCT00060411|Immunologic Factors|immunologic factors|mesh-ancestor
64953120|NCT00060411|Antimetabolites|antimetabolites|mesh-ancestor
64953124|NCT00060411|Antidotes|antidotes|mesh-ancestor
64953125|NCT00060411|Protective Agents|protective agents|mesh-ancestor
64953126|NCT00060411|Vitamin B Complex|vitamin b complex|mesh-ancestor
64953128|NCT00060411|Micronutrients|micronutrients|mesh-ancestor
64953129|NCT00060411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64953130|NCT00060411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953131|NCT00060450|Nitric Oxide|nitric oxide|mesh-list
64953132|NCT00060450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64953133|NCT00060450|Autonomic Agents|autonomic agents|mesh-ancestor
64953134|NCT00060450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64953135|NCT00060450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953136|NCT00060450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64953137|NCT00060450|Respiratory System Agents|respiratory system agents|mesh-ancestor
64953138|NCT00060450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64953139|NCT00060450|Antioxidants|antioxidants|mesh-ancestor
64953140|NCT00060450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953141|NCT00060450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505320|NCT03339804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64953142|NCT00060450|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64953143|NCT00060450|Vasodilator Agents|vasodilator agents|mesh-ancestor
64953144|NCT00060450|Gasotransmitters|gasotransmitters|mesh-ancestor
64953145|NCT00060450|Protective Agents|protective agents|mesh-ancestor
64953146|NCT00032747|Vasopressins|vasopressins|mesh-list
64953147|NCT00032747|Arginine Vasopressin|arginine vasopressin|mesh-list
64953148|NCT00032747|Hemostatics|hemostatics|mesh-ancestor
64953149|NCT00032747|Coagulants|coagulants|mesh-ancestor
64953150|NCT00032747|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64953151|NCT00032747|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64505415|NCT01722604|Brinzolamide|brinzolamide|mesh-list
64953152|NCT00032747|Natriuretic Agents|natriuretic agents|mesh-ancestor
64953153|NCT00032747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953154|NCT00032786|Natalizumab|natalizumab|mesh-list
64725945|NCT00003086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64505416|NCT01722604|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64505417|NCT01722604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725946|NCT00003086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64725947|NCT00003086|Alkylating Agents|alkylating agents|mesh-ancestor
64725948|NCT00003086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64725949|NCT00003086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64725950|NCT00003086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64725951|NCT00003086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64725952|NCT00003086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64725953|NCT00003086|Antimetabolites|antimetabolites|mesh-ancestor
64725954|NCT00003086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64953155|NCT00032786|Immunologic Factors|immunologic factors|mesh-ancestor
64953156|NCT00032786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953158|NCT02968719|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64953159|NCT02968719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953160|NCT02968719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953161|NCT02968719|Cholinergic Agents|cholinergic agents|mesh-ancestor
64953162|NCT02968719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64953163|NCT02968719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953164|NCT02968719|Nootropic Agents|nootropic agents|mesh-ancestor
64953165|NCT00060489|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64953166|NCT00060489|Antidepressive Agents|antidepressive agents|mesh-ancestor
64953167|NCT00060489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64953168|NCT00060489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64953169|NCT00060489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64953170|NCT00060489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64953171|NCT00060489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953172|NCT00060567|Irinotecan|irinotecan|mesh-list
64953173|NCT00060567|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
64953174|NCT00060567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64953175|NCT00060567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64953176|NCT00060567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953177|NCT00060567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953178|NCT00060567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953179|NCT00060567|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64953180|NCT00032825|Ketoconazole|ketoconazole|mesh-list
64953181|NCT00032825|Docetaxel|docetaxel|mesh-list
64505675|NCT02492178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64953182|NCT00032825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953183|NCT00032825|Tubulin Modulators|tubulin modulators|mesh-ancestor
64953184|NCT00032825|Antimitotic Agents|antimitotic agents|mesh-ancestor
64953185|NCT00032825|Mitosis Modulators|mitosis modulators|mesh-ancestor
64953186|NCT00032825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953187|NCT00032825|Antifungal Agents|antifungal agents|mesh-ancestor
64503417|NCT05584878|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64503418|NCT05584878|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64953188|NCT00032825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64491919|NCT03358563|Docetaxel|docetaxel|mesh-list
64503419|NCT05584878|Antimetabolites|antimetabolites|mesh-ancestor
64505748|NCT02490930|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64953194|NCT00032825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64953196|NCT00032825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64953197|NCT00060645|Sirolimus|sirolimus|mesh-list
64953198|NCT00060645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64953199|NCT00060645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64953200|NCT00060645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64953201|NCT00060645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953202|NCT00060645|Antifungal Agents|antifungal agents|mesh-ancestor
64953203|NCT00060645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64953204|NCT00060645|Immunologic Factors|immunologic factors|mesh-ancestor
64953205|NCT00060645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953206|NCT00060684|Dexamethasone|dexamethasone|mesh-list
64953207|NCT00060684|Rituximab|rituximab|mesh-list
64953208|NCT00060684|Fludarabine|fludarabine|mesh-list
64953209|NCT00060684|Pixantrone|pixantrone|mesh-list
64953210|NCT00060684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64953211|NCT00060684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725956|NCT00003086|Analgesics|analgesics|mesh-ancestor
64725957|NCT00003086|Sensory System Agents|sensory system agents|mesh-ancestor
64725958|NCT00003086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64725959|NCT00003092|Paclitaxel|paclitaxel|mesh-list
64725960|NCT00003092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64725961|NCT00003092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725962|NCT00003092|Tubulin Modulators|tubulin modulators|mesh-ancestor
64725963|NCT00003092|Antimitotic Agents|antimitotic agents|mesh-ancestor
64725964|NCT00003092|Mitosis Modulators|mitosis modulators|mesh-ancestor
64725965|NCT00003092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725966|NCT00381199|Amitriptyline|amitriptyline|mesh-list
64725967|NCT00381199|Nabilone|nabilone|mesh-list
64725968|NCT00381199|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64725969|NCT00381199|Antidepressive Agents|antidepressive agents|mesh-ancestor
64953212|NCT00060684|Immunologic Factors|immunologic factors|mesh-ancestor
64953213|NCT00060684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953214|NCT00060684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64953215|NCT00060684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64953216|NCT00060684|Antiemetics|antiemetics|mesh-ancestor
64953217|NCT00060684|Autonomic Agents|autonomic agents|mesh-ancestor
64953218|NCT00060684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64953219|NCT00060684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64953220|NCT00060684|Glucocorticoids|glucocorticoids|mesh-ancestor
64953221|NCT00060684|Hormones|hormones|mesh-ancestor
64953222|NCT00060684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64953223|NCT00060684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64506003|NCT01808339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506006|NCT01808339|Dermatologic Agents|dermatologic agents|mesh-ancestor
64953224|NCT00060684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953225|NCT00060684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64953226|NCT00060684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64953227|NCT00060684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953228|NCT02971475|Analgesics|analgesics|mesh-list
64953229|NCT02971475|Sensory System Agents|sensory system agents|mesh-ancestor
64953230|NCT02971475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64953231|NCT02971475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953232|NCT00032942|Lofexidine|lofexidine|mesh-list
64953233|NCT00032942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64953234|NCT00032942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64953235|NCT00032942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953236|NCT00032942|Sensory System Agents|sensory system agents|mesh-ancestor
64953237|NCT00032942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64953238|NCT00032942|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64953239|NCT00032942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64953240|NCT00032942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64506041|NCT03833362|Ribavirin|ribavirin|mesh-list
64953241|NCT00032942|Adrenergic Agents|adrenergic agents|mesh-ancestor
64953242|NCT00032942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64953243|NCT00032942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953245|NCT00033059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64953246|NCT00033059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64953247|NCT00033059|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64953248|NCT00033059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953249|NCT00033059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953250|NCT00060918|Metoprolol|metoprolol|mesh-list
64953251|NCT00060918|Carvedilol|carvedilol|mesh-list
64953252|NCT00060918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64953253|NCT00060918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64953254|NCT00060918|Sympatholytics|sympatholytics|mesh-ancestor
64953255|NCT00060918|Autonomic Agents|autonomic agents|mesh-ancestor
64953256|NCT00060918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64725970|NCT00381199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64725971|NCT00381199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64725972|NCT00381199|Analgesics|analgesics|mesh-ancestor
64725973|NCT00381199|Sensory System Agents|sensory system agents|mesh-ancestor
64725974|NCT00381199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64725975|NCT00381199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725976|NCT00381199|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64465261|NCT04124614|Sertraline|sertraline|mesh-list
64725977|NCT00381199|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64506085|NCT02490540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64953263|NCT00060918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953264|NCT00060918|Antioxidants|antioxidants|mesh-ancestor
64953265|NCT00060918|Protective Agents|protective agents|mesh-ancestor
64953266|NCT00060918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64953267|NCT00060918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64953268|NCT00060918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64953269|NCT00060918|Vasodilator Agents|vasodilator agents|mesh-ancestor
64953270|NCT00060918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64953271|NCT00060918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64953273|NCT00033098|Antimetabolites|antimetabolites|mesh-ancestor
64953274|NCT00033098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953275|NCT00033098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953276|NCT02968641|Ritonavir|ritonavir|mesh-list
64953277|NCT02968641|Lonafarnib|lonafarnib|mesh-list
64953278|NCT02968641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64953279|NCT02968641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64953280|NCT02968641|Protease Inhibitors|protease inhibitors|mesh-ancestor
64953281|NCT02968641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953282|NCT02968641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953283|NCT02968641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64953284|NCT02968641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64953285|NCT02968641|Antiviral Agents|antiviral agents|mesh-ancestor
64953286|NCT02968641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64953287|NCT02968641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64953288|NCT02968641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64953289|NCT00033176|Thioctic Acid|thioctic acid|mesh-list
64953290|NCT00033176|Antioxidants|antioxidants|mesh-ancestor
64953291|NCT00033176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506133|NCT02490072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953292|NCT00033176|Protective Agents|protective agents|mesh-ancestor
64953293|NCT00033176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953294|NCT00033176|Vitamin B Complex|vitamin b complex|mesh-ancestor
64953295|NCT00033176|Vitamins|vitamins|mesh-ancestor
64953296|NCT00033176|Micronutrients|micronutrients|mesh-ancestor
64953297|NCT00033215|S 3304|s 3304|mesh-list
64953298|NCT00033215|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
64953299|NCT00033215|Protease Inhibitors|protease inhibitors|mesh-ancestor
64953300|NCT00033215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953301|NCT00033215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953302|NCT00060957|Botulinum Toxins|botulinum toxins|mesh-list
64953303|NCT00060957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64953304|NCT00060957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64953305|NCT00060957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64953306|NCT00060957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64953307|NCT00060957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953309|NCT00060957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64953310|NCT00060957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953311|NCT00060957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64953312|NCT00060957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64953313|NCT00060996|Treprostinil|treprostinil|mesh-list
64953314|NCT00060996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64953315|NCT00033254|Thalidomide|thalidomide|mesh-list
64953316|NCT00033254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64953317|NCT00033254|Immunologic Factors|immunologic factors|mesh-ancestor
64953318|NCT00033254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953319|NCT00033254|Leprostatic Agents|leprostatic agents|mesh-ancestor
64725978|NCT00381199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64725979|NCT00381199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725980|NCT00381199|Adrenergic Agents|adrenergic agents|mesh-ancestor
64725981|NCT00381199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64725982|NCT00381199|Antiemetics|antiemetics|mesh-ancestor
64725983|NCT00381199|Autonomic Agents|autonomic agents|mesh-ancestor
64333505|NCT04467931|Serotonin Agents|serotonin agents|mesh-ancestor
64953320|NCT00033254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64953321|NCT00033254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64953322|NCT00033254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64953323|NCT00033254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64953337|NCT00033332|Zoledronic Acid|zoledronic acid|mesh-list
64953338|NCT00033332|Pamidronate|pamidronate|mesh-list
64953339|NCT00033332|Thalidomide|thalidomide|mesh-list
64953340|NCT00033332|Dexamethasone|dexamethasone|mesh-list
64953341|NCT00033332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64953342|NCT00033332|Antiemetics|antiemetics|mesh-ancestor
64953343|NCT00033332|Autonomic Agents|autonomic agents|mesh-ancestor
64953344|NCT00033332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64953345|NCT00033332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953346|NCT00033332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64953347|NCT00033332|Glucocorticoids|glucocorticoids|mesh-ancestor
64953349|NCT00033332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64953350|NCT00033332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64953351|NCT00033332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953352|NCT00033332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64953353|NCT00033332|Immunologic Factors|immunologic factors|mesh-ancestor
64953354|NCT00033332|Leprostatic Agents|leprostatic agents|mesh-ancestor
64953355|NCT00033332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64953356|NCT00033332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64953357|NCT00033332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64953358|NCT00033332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64953359|NCT00033332|Growth Substances|growth substances|mesh-ancestor
64953360|NCT00033332|Growth Inhibitors|growth inhibitors|mesh-ancestor
64953361|NCT00033332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64953362|NCT00033410|Paclitaxel|paclitaxel|mesh-list
64953363|NCT00033410|Carboplatin|carboplatin|mesh-list
64953364|NCT00033410|Tirapazamine|tirapazamine|mesh-list
64953365|NCT00033410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64953366|NCT00033410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953367|NCT00033410|Tubulin Modulators|tubulin modulators|mesh-ancestor
64953368|NCT00033410|Antimitotic Agents|antimitotic agents|mesh-ancestor
64953369|NCT00033410|Mitosis Modulators|mitosis modulators|mesh-ancestor
64953370|NCT00033410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953371|NCT00061113|Fluoxetine|fluoxetine|mesh-list
64953372|NCT00061113|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64953373|NCT00061113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64953374|NCT00061113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64953375|NCT00061113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953376|NCT00061113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64953377|NCT00061113|Serotonin Agents|serotonin agents|mesh-ancestor
64953378|NCT00061113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953379|NCT00061113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64506191|NCT05373264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64506192|NCT05373264|Diuretics|diuretics|mesh-ancestor
64506193|NCT05373264|Natriuretic Agents|natriuretic agents|mesh-ancestor
64506198|NCT02489760|Adalimumab|adalimumab|mesh-list
64953380|NCT00061113|Antidepressive Agents|antidepressive agents|mesh-ancestor
64953381|NCT00061113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64953397|NCT00033566|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
64953398|NCT00033566|Protease Inhibitors|protease inhibitors|mesh-ancestor
64953399|NCT00033566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953400|NCT00033566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953401|NCT00033605|Octreotide|octreotide|mesh-list
64953402|NCT00033605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64953403|NCT00033605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64953404|NCT00033605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953405|NCT00033644|Doxorubicin|doxorubicin|mesh-list
64953406|NCT00033644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64503422|NCT05584878|Coagulants|coagulants|mesh-ancestor
64503423|NCT01643902|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64953407|NCT00033644|Mitomycins|mitomycins|mesh-list
64725984|NCT00381199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64725985|NCT00381199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64725986|NCT00381199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64725987|NCT00381199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64725988|NCT00002509|Cyclophosphamide|cyclophosphamide|mesh-list
64725989|NCT00002509|Carboplatin|carboplatin|mesh-list
64725990|NCT00002509|Etoposide|etoposide|mesh-list
64725991|NCT00002509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64725992|NCT00002509|Immunologic Factors|immunologic factors|mesh-ancestor
64725993|NCT00002509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64725994|NCT00002509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64725995|NCT00002509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64725996|NCT00002509|Alkylating Agents|alkylating agents|mesh-ancestor
64725997|NCT00002509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725998|NCT00002509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64725999|NCT00002509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64333519|NCT03522649|Leucovorin|leucovorin|mesh-list
64953408|NCT00033644|Mitomycin|mitomycin|mesh-list
64953410|NCT00033644|Sargramostim|sargramostim|mesh-list
64953411|NCT00033644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953412|NCT00033644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64953413|NCT00033644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64953414|NCT00033644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64953415|NCT00033644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953416|NCT00033644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953417|NCT00033644|Immunologic Factors|immunologic factors|mesh-ancestor
64953418|NCT00033644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953419|NCT00033644|Alkylating Agents|alkylating agents|mesh-ancestor
64953420|NCT00033644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64953421|NCT00033644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64953422|NCT00033683|Tamoxifen|tamoxifen|mesh-list
64953423|NCT00033683|Cyclophosphamide|cyclophosphamide|mesh-list
64953424|NCT00033683|Docetaxel|docetaxel|mesh-list
64953425|NCT00033683|Fluorouracil|fluorouracil|mesh-list
64953426|NCT00033683|Methotrexate|methotrexate|mesh-list
64953427|NCT00033683|Epirubicin|epirubicin|mesh-list
64953428|NCT00033683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64953429|NCT00033683|Immunologic Factors|immunologic factors|mesh-ancestor
64953430|NCT00033683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953431|NCT00033683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64953432|NCT00033683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64953433|NCT00033683|Alkylating Agents|alkylating agents|mesh-ancestor
64953434|NCT00033683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953435|NCT00033683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494185|NCT04447534|Analgesics|analgesics|mesh-ancestor
64953436|NCT00033683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64953437|NCT00033683|Tubulin Modulators|tubulin modulators|mesh-ancestor
64953438|NCT00033683|Antimitotic Agents|antimitotic agents|mesh-ancestor
64953439|NCT00033683|Mitosis Modulators|mitosis modulators|mesh-ancestor
64953440|NCT00033683|Antimetabolites|antimetabolites|mesh-ancestor
64953441|NCT00033683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64953445|NCT00033683|Dermatologic Agents|dermatologic agents|mesh-ancestor
64953446|NCT00033683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953447|NCT00033683|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64953448|NCT00033683|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64953449|NCT00033683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64953450|NCT00033683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64953451|NCT00033683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64953452|NCT00033683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64953453|NCT00033683|Hormone Antagonists|hormone antagonists|mesh-ancestor
64726000|NCT00002509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64726001|NCT00002509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64726002|NCT00002509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64726003|NCT00002509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726004|NCT00002515|Carboplatin|carboplatin|mesh-list
64726005|NCT00002515|Topotecan|topotecan|mesh-list
64726006|NCT00002515|Thiotepa|thiotepa|mesh-list
64953454|NCT00033683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64953455|NCT00033683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64953456|NCT00033683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64953457|NCT00033683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64953458|NCT00033683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64953459|NCT00061308|Gemcitabine|gemcitabine|mesh-list
64953460|NCT00061308|Topotecan|topotecan|mesh-list
64953461|NCT00061308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64953462|NCT00061308|Antimetabolites|antimetabolites|mesh-ancestor
64953463|NCT00061308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953464|NCT00061308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953465|NCT00061308|Antiviral Agents|antiviral agents|mesh-ancestor
64953466|NCT00061308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64953467|NCT00061308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953468|NCT00061308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64953469|NCT00061308|Immunologic Factors|immunologic factors|mesh-ancestor
64953470|NCT00061308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953471|NCT00061308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64953472|NCT00061308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64953473|NCT00033722|Folic Acid|folic acid|mesh-list
64953474|NCT00033722|Lometrexol|lometrexol|mesh-list
64953475|NCT00033722|Hematinics|hematinics|mesh-ancestor
64953476|NCT00033722|Vitamin B Complex|vitamin b complex|mesh-ancestor
64953477|NCT00033722|Vitamins|vitamins|mesh-ancestor
64953478|NCT00033722|Micronutrients|micronutrients|mesh-ancestor
64953479|NCT00033722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953480|NCT00033722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64953481|NCT00033722|Antimetabolites|antimetabolites|mesh-ancestor
64503424|NCT01643902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64492222|NCT05086107|Rifabutin|rifabutin|mesh-list
64953482|NCT00033722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953484|NCT00033722|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64953485|NCT00033722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953486|NCT00061425|Epratuzumab|epratuzumab|mesh-list
64953487|NCT00061425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64953488|NCT00061425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953489|NCT00061464|Gemcitabine|gemcitabine|mesh-list
64953490|NCT00061464|Pemetrexed|pemetrexed|mesh-list
64953491|NCT00061464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64953492|NCT00061464|Antimetabolites|antimetabolites|mesh-ancestor
64953493|NCT00061464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953494|NCT00061464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953495|NCT00061464|Antiviral Agents|antiviral agents|mesh-ancestor
64953496|NCT00061464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64953497|NCT00061464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953498|NCT00061464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64953499|NCT00061464|Immunologic Factors|immunologic factors|mesh-ancestor
64953500|NCT00061464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953501|NCT00061464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64953502|NCT00061464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64953503|NCT00061503|Travoprost|travoprost|mesh-list
64953504|NCT00061503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64953505|NCT00061542|Timolol|timolol|mesh-list
64953506|NCT00061542|Betaxolol|betaxolol|mesh-list
64953507|NCT00061542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64506399|NCT02482818|Anticonvulsants|anticonvulsants|mesh-ancestor
64953508|NCT00061542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64953509|NCT00061542|Adrenergic Agents|adrenergic agents|mesh-ancestor
64953510|NCT00061542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64953511|NCT00061542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953512|NCT00061542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506461|NCT01808326|Alkylating Agents|alkylating agents|mesh-ancestor
64953518|NCT00061542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64953519|NCT00061620|Tezacitabine|tezacitabine|mesh-list
64953520|NCT00061620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726007|NCT00002515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506567|NCT02481960|Irinotecan|irinotecan|mesh-list
64726008|NCT00002515|Immunologic Factors|immunologic factors|mesh-ancestor
64726009|NCT00002515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726010|NCT00002515|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64726011|NCT00002515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64726012|NCT00002515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333530|NCT03522649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64953521|NCT00061620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953522|NCT00061620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506653|NCT02479074|Hormones|hormones|mesh-ancestor
64506658|NCT02479074|Antiemetics|antiemetics|mesh-ancestor
64953524|NCT00034151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64953525|NCT00034151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953526|NCT00034151|Tubulin Modulators|tubulin modulators|mesh-ancestor
64953527|NCT00034151|Antimitotic Agents|antimitotic agents|mesh-ancestor
64953528|NCT00034151|Mitosis Modulators|mitosis modulators|mesh-ancestor
64953529|NCT00034151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953530|NCT00034190|Paclitaxel|paclitaxel|mesh-list
64953531|NCT00034190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64953532|NCT00034190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953533|NCT00034190|Tubulin Modulators|tubulin modulators|mesh-ancestor
64953534|NCT00034190|Antimitotic Agents|antimitotic agents|mesh-ancestor
64953535|NCT00034190|Mitosis Modulators|mitosis modulators|mesh-ancestor
64506808|NCT04945824|Autonomic Agents|autonomic agents|mesh-ancestor
64506813|NCT04945824|Hormones|hormones|mesh-ancestor
64953536|NCT00034190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953537|NCT00034229|Felbamate|felbamate|mesh-list
64953538|NCT00034229|Anticonvulsants|anticonvulsants|mesh-ancestor
64953539|NCT00034229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64953540|NCT00034229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64953541|NCT00034229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64953542|NCT00034229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953543|NCT00034229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953544|NCT00034307|Sitaxsentan|sitaxsentan|mesh-list
64953545|NCT00034307|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64953546|NCT00034307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953547|NCT00061776|Capsaicin|capsaicin|mesh-list
64953548|NCT00061776|Antipruritics|antipruritics|mesh-ancestor
64953549|NCT00061776|Dermatologic Agents|dermatologic agents|mesh-ancestor
64953550|NCT00061776|Sensory System Agents|sensory system agents|mesh-ancestor
64953551|NCT00061776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64503425|NCT01643902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64503426|NCT01643902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492278|NCT00980746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64503427|NCT03347994|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
64507099|NCT01783912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953552|NCT00061776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953553|NCT00034346|Paclitaxel|paclitaxel|mesh-list
64953554|NCT00034346|Carboplatin|carboplatin|mesh-list
64953555|NCT00034346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64953556|NCT00034346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953557|NCT00034346|Tubulin Modulators|tubulin modulators|mesh-ancestor
64953558|NCT00034346|Antimitotic Agents|antimitotic agents|mesh-ancestor
64953559|NCT00034346|Mitosis Modulators|mitosis modulators|mesh-ancestor
64507153|NCT04491786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507154|NCT04491786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507169|NCT02470026|Yohimbine|yohimbine|mesh-list
64953560|NCT00034346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953561|NCT00034385|Valganciclovir|valganciclovir|mesh-list
64953562|NCT00034385|Antiviral Agents|antiviral agents|mesh-ancestor
64953563|NCT00034385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64953564|NCT00034463|Folic Acid|folic acid|mesh-list
64953565|NCT00034463|Vitamins|vitamins|mesh-ancestor
64953566|NCT00034463|Micronutrients|micronutrients|mesh-ancestor
64953567|NCT00034463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953568|NCT00034463|Hematinics|hematinics|mesh-ancestor
64953569|NCT00034463|Vitamin B Complex|vitamin b complex|mesh-ancestor
64953570|NCT02971397|Cytarabine|cytarabine|mesh-list
64953571|NCT02971397|Daunorubicin|daunorubicin|mesh-list
64953572|NCT02971397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64953573|NCT02971397|Antimetabolites|antimetabolites|mesh-ancestor
64953574|NCT02971397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953575|NCT02971397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726013|NCT00002515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726014|NCT00002515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64726015|NCT00002515|Alkylating Agents|alkylating agents|mesh-ancestor
64726016|NCT00002515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64726017|NCT00002515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64726018|NCT00002521|Cyclophosphamide|cyclophosphamide|mesh-list
64726019|NCT00002521|Etoposide|etoposide|mesh-list
64726020|NCT00002521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64726021|NCT00002521|Immunologic Factors|immunologic factors|mesh-ancestor
64726022|NCT00002521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726023|NCT00002521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64726024|NCT00002521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64726025|NCT00002521|Alkylating Agents|alkylating agents|mesh-ancestor
64726026|NCT00002521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726027|NCT00002521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333538|NCT02366481|Vitamin K|vitamin k|mesh-list
64953577|NCT02971397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64953578|NCT02971397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64953589|NCT00396500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953590|NCT00396500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953591|NCT00396500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953592|NCT00396500|Anthelmintics|anthelmintics|mesh-ancestor
64953593|NCT00396500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64953594|NCT00396500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64953595|NCT00396500|Anticestodal Agents|anticestodal agents|mesh-ancestor
64953596|NCT00396500|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64953597|NCT00396500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64953598|NCT00396500|Tubulin Modulators|tubulin modulators|mesh-ancestor
64953599|NCT00396500|Antimitotic Agents|antimitotic agents|mesh-ancestor
64953600|NCT00396500|Mitosis Modulators|mitosis modulators|mesh-ancestor
64953601|NCT00034502|Irinotecan|irinotecan|mesh-list
64953602|NCT00034502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64953603|NCT00034502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64953604|NCT00034502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953605|NCT00034502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953606|NCT00034502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953607|NCT00034541|Paclitaxel|paclitaxel|mesh-list
64953608|NCT00034541|Carboplatin|carboplatin|mesh-list
64953609|NCT00034541|Cetuximab|cetuximab|mesh-list
64953610|NCT00034541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64953611|NCT00034541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953612|NCT00034541|Tubulin Modulators|tubulin modulators|mesh-ancestor
64953613|NCT00034541|Antimitotic Agents|antimitotic agents|mesh-ancestor
64953614|NCT00034541|Mitosis Modulators|mitosis modulators|mesh-ancestor
64953615|NCT00034541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953616|NCT00034541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64953617|NCT00034580|Olanzapine|olanzapine|mesh-list
64953618|NCT00034580|Risperidone|risperidone|mesh-list
64953619|NCT00034580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64953620|NCT00034580|Serotonin Agents|serotonin agents|mesh-ancestor
64953621|NCT00034580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64953622|NCT00034580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953623|NCT00034580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492353|NCT02168062|Leuprolide|leuprolide|mesh-list
64953624|NCT00034580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64953625|NCT00034580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64953626|NCT00034580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64953627|NCT00034580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64726029|NCT00002521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64726030|NCT00002521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64726031|NCT00002521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64726032|NCT00002521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726033|NCT00003110|Bleomycin|bleomycin|mesh-list
64726034|NCT00003110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64726035|NCT00003110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726036|NCT00002215|Nelfinavir|nelfinavir|mesh-list
64726037|NCT00002215|Emivirine|emivirine|mesh-list
64726038|NCT00002215|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64726039|NCT00002215|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64726040|NCT00002215|Protease Inhibitors|protease inhibitors|mesh-ancestor
64726041|NCT00002215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726042|NCT00002215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726043|NCT00002215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64507487|NCT02859558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64726044|NCT00002215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64726045|NCT00002215|Antiviral Agents|antiviral agents|mesh-ancestor
64726046|NCT00002215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726047|NCT00002215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64333556|NCT02366247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64503428|NCT03347994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64953628|NCT00034580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64953629|NCT00034580|Dopamine Agents|dopamine agents|mesh-ancestor
64953630|NCT00034580|Antiemetics|antiemetics|mesh-ancestor
64953631|NCT00034580|Autonomic Agents|autonomic agents|mesh-ancestor
64953632|NCT00034580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507535|NCT01862614|Carticaine|carticaine|mesh-list
64953633|NCT00034580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64953634|NCT00034580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64953635|NCT00034580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64953636|NCT00034580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64953637|NCT00034619|Oxaliplatin|oxaliplatin|mesh-list
64953638|NCT00034619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953640|NCT00061815|Fluorouracil|fluorouracil|mesh-list
64953641|NCT00061815|Oxaliplatin|oxaliplatin|mesh-list
64953642|NCT00061815|Cetuximab|cetuximab|mesh-list
64953643|NCT00061815|Antimetabolites|antimetabolites|mesh-ancestor
64953644|NCT00061815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953649|NCT00061815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953650|NCT00061815|Antidotes|antidotes|mesh-ancestor
64953651|NCT00061815|Protective Agents|protective agents|mesh-ancestor
64953652|NCT00061815|Vitamin B Complex|vitamin b complex|mesh-ancestor
64953653|NCT00061815|Vitamins|vitamins|mesh-ancestor
64953654|NCT00061815|Micronutrients|micronutrients|mesh-ancestor
64507626|NCT01869634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507660|NCT01874392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507680|NCT05542264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955470|NCT00203125|Rasagiline|rasagiline|mesh-list
64953655|NCT00061815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64953656|NCT00061854|Soblidotin|soblidotin|mesh-list
64953657|NCT00061854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953658|NCT00034658|Posaconazole|posaconazole|mesh-list
64953659|NCT00034658|Antifungal Agents|antifungal agents|mesh-ancestor
64953660|NCT00034658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64953661|NCT00034658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64953662|NCT00034658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64953663|NCT00034658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64953664|NCT00034658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64953665|NCT00034658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64726048|NCT00002215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64726049|NCT00003116|Cyclosporine|cyclosporine|mesh-list
64726050|NCT00003116|Cyclophosphamide|cyclophosphamide|mesh-list
64726051|NCT00003116|Busulfan|busulfan|mesh-list
64726052|NCT00003116|Cyclosporins|cyclosporins|mesh-list
64726053|NCT00003116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64726054|NCT00003116|Immunologic Factors|immunologic factors|mesh-ancestor
64726055|NCT00003116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726056|NCT00003116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64726057|NCT00003116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64726058|NCT00003116|Alkylating Agents|alkylating agents|mesh-ancestor
64726059|NCT00003116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726060|NCT00003116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726061|NCT00003116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64726062|NCT00003116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726063|NCT00003116|Antifungal Agents|antifungal agents|mesh-ancestor
64726064|NCT00003116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726065|NCT00003116|Dermatologic Agents|dermatologic agents|mesh-ancestor
64726066|NCT00003116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64507803|NCT00550732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726067|NCT00002227|Lamivudine|lamivudine|mesh-list
64726068|NCT00002227|Efavirenz|efavirenz|mesh-list
64726069|NCT00002227|Stavudine|stavudine|mesh-list
64726070|NCT00002227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64726071|NCT00002227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64726072|NCT00002227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726073|NCT00002227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726074|NCT00002227|Antiviral Agents|antiviral agents|mesh-ancestor
64726075|NCT00002227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726076|NCT00002227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64726077|NCT00002227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64726093|NCT00002233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64726094|NCT00002233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726095|NCT00002233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726096|NCT00002233|Antiviral Agents|antiviral agents|mesh-ancestor
64726097|NCT00002233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726098|NCT00002233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64726099|NCT00002233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64953666|NCT00034658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508001|NCT05728008|Ustekinumab|ustekinumab|mesh-list
64953667|NCT00034658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953668|NCT00034658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64953669|NCT00034658|Hormone Antagonists|hormone antagonists|mesh-ancestor
64953670|NCT00034658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64953671|NCT00034658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953672|NCT00398580|Methyltestosterone|methyltestosterone|mesh-list
64953673|NCT00398580|Testosterone|testosterone|mesh-list
64953674|NCT00398580|Testosterone undecanoate|testosterone undecanoate|mesh-list
64953675|NCT00398580|Testosterone enanthate|testosterone enanthate|mesh-list
64953676|NCT00398580|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64953677|NCT00398580|Dutasteride|dutasteride|mesh-list
64953678|NCT00398580|Androgens|androgens|mesh-ancestor
64953679|NCT00398580|Hormones|hormones|mesh-ancestor
64953680|NCT00398580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64726838|NCT00003422|Vitamins|vitamins|mesh-ancestor
64953681|NCT00398580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953682|NCT00398580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64953683|NCT00398580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953684|NCT00398580|Anabolic Agents|anabolic agents|mesh-ancestor
64953685|NCT00398580|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64953686|NCT00398580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64953687|NCT00398580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508275|NCT02467686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508286|NCT05707962|Analgesics|analgesics|mesh-ancestor
64953688|NCT00398580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953689|NCT00398580|Hormone Antagonists|hormone antagonists|mesh-ancestor
64953690|NCT00034697|Temozolomide|temozolomide|mesh-list
64508365|NCT04058470|Hormones|hormones|mesh-ancestor
64953691|NCT00034697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64953692|NCT00034697|Alkylating Agents|alkylating agents|mesh-ancestor
64953693|NCT00034697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953694|NCT00034697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953695|NCT00034736|Levofloxacin|levofloxacin|mesh-list
64953696|NCT00034736|Ofloxacin|ofloxacin|mesh-list
64953697|NCT00034736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64503429|NCT03347994|Alkylating Agents|alkylating agents|mesh-ancestor
64953698|NCT00034736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64953699|NCT00034736|Renal Agents|renal agents|mesh-ancestor
64953700|NCT00034736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64953701|NCT00034736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64953702|NCT00034736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64953703|NCT00034736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953704|NCT00034736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953705|NCT00034736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953706|NCT00034736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64953707|NCT00034736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64953708|NCT02967939|Tenofovir|tenofovir|mesh-list
64953709|NCT02967939|Antiviral Agents|antiviral agents|mesh-ancestor
64953710|NCT02967939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64953711|NCT02967939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64953712|NCT02967939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64953713|NCT02967939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953716|NCT02967939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64953717|NCT00034775|Risperidone|risperidone|mesh-list
64953718|NCT00034775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64953719|NCT00034775|Serotonin Agents|serotonin agents|mesh-ancestor
64953720|NCT00034775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64953721|NCT00034775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953722|NCT00034775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953723|NCT00034775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64726100|NCT00002233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64726101|NCT00002233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64726103|NCT00002233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64726104|NCT00002233|Antitubercular Agents|antitubercular agents|mesh-ancestor
64953724|NCT00034775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64953725|NCT00034775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64953726|NCT00034775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64953727|NCT00034775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64953728|NCT00034775|Dopamine Agents|dopamine agents|mesh-ancestor
64953729|NCT00062127|Thalidomide|thalidomide|mesh-list
64953730|NCT00062127|Irinotecan|irinotecan|mesh-list
64953731|NCT00062127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64953732|NCT00062127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64953733|NCT00062127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953734|NCT00062127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953735|NCT00062127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953736|NCT00062127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64953737|NCT00062127|Immunologic Factors|immunologic factors|mesh-ancestor
64953738|NCT00062127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953739|NCT00062127|Leprostatic Agents|leprostatic agents|mesh-ancestor
64953740|NCT00062127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64953741|NCT00062127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64508931|NCT03832816|Dronabinol|dronabinol|mesh-list
64508932|NCT03832816|Hallucinogens|hallucinogens|mesh-ancestor
64953742|NCT00062127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64953743|NCT00062127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64953744|NCT00062127|Growth Substances|growth substances|mesh-ancestor
64953745|NCT00062127|Growth Inhibitors|growth inhibitors|mesh-ancestor
64953746|NCT00034853|Naproxen|naproxen|mesh-list
64953747|NCT00034853|Meloxicam|meloxicam|mesh-list
64953748|NCT00034853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64953749|NCT00034853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64953750|NCT00034853|Analgesics|analgesics|mesh-ancestor
64953751|NCT00034853|Sensory System Agents|sensory system agents|mesh-ancestor
64953752|NCT00034853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64508982|NCT04127721|Antimetabolites|antimetabolites|mesh-ancestor
64508984|NCT04127721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953753|NCT00034853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953754|NCT00034853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64953755|NCT00034853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64953756|NCT00034853|Gout Suppressants|gout suppressants|mesh-ancestor
64953757|NCT00034853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64953758|NCT00034853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953759|NCT00034853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953760|NCT00034853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64953761|NCT00034892|Olanzapine|olanzapine|mesh-list
64953762|NCT00034892|Risperidone|risperidone|mesh-list
64509040|NCT04122105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953763|NCT00034892|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64953764|NCT00034892|Serotonin Agents|serotonin agents|mesh-ancestor
64953765|NCT00034892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64953766|NCT00034892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953767|NCT00034892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953768|NCT00034892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64953769|NCT00034892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64953770|NCT00034892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64953771|NCT00034892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64953772|NCT00034892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64953773|NCT00034892|Dopamine Agents|dopamine agents|mesh-ancestor
64492493|NCT00992602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953774|NCT00034892|Antiemetics|antiemetics|mesh-ancestor
64503430|NCT03347994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953775|NCT00034892|Autonomic Agents|autonomic agents|mesh-ancestor
64953776|NCT00034892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509173|NCT01933984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64953777|NCT00034892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64953778|NCT00034892|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64953779|NCT00034892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64953780|NCT00034892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64953781|NCT00062205|Imatinib Mesylate|imatinib mesylate|mesh-list
64953782|NCT00062205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953783|NCT00062205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64953789|NCT00035009|Paroxetine|paroxetine|mesh-list
64509249|NCT03829371|Autonomic Agents|autonomic agents|mesh-ancestor
64509264|NCT03829371|Alkylating Agents|alkylating agents|mesh-ancestor
64953790|NCT00035009|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64420779|NCT03383419|Antiviral Agents|antiviral agents|mesh-ancestor
64953791|NCT00035009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64509334|NCT02284126|Vancomycin|vancomycin|mesh-list
64726105|NCT00002233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64726107|NCT00002527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64726108|NCT00002527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64953792|NCT00035009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64953793|NCT00035009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953794|NCT00035009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64953795|NCT00035009|Serotonin Agents|serotonin agents|mesh-ancestor
64953796|NCT00035009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953797|NCT00035009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64509398|NCT03004287|Growth Inhibitors|growth inhibitors|mesh-ancestor
64509399|NCT03004287|Leprostatic Agents|leprostatic agents|mesh-ancestor
64953798|NCT00035009|Antidepressive Agents|antidepressive agents|mesh-ancestor
64953799|NCT00035009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64953800|NCT00035009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64953801|NCT00035009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64953802|NCT00035009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953803|NCT00035009|Antiemetics|antiemetics|mesh-ancestor
64953804|NCT00035009|Autonomic Agents|autonomic agents|mesh-ancestor
64953805|NCT00035009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64953806|NCT00035009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64953807|NCT00035009|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64953808|NCT00062283|Alanosine|alanosine|mesh-list
64953809|NCT00062283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64953810|NCT00062283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953811|NCT00062283|Chelating Agents|chelating agents|mesh-ancestor
64953812|NCT00062283|Sequestering Agents|sequestering agents|mesh-ancestor
64953813|NCT00062283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953814|NCT00035048|Aprepitant|aprepitant|mesh-list
64953815|NCT00035048|Antiemetics|antiemetics|mesh-ancestor
64953816|NCT00035048|Autonomic Agents|autonomic agents|mesh-ancestor
64509545|NCT01945138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64953817|NCT00035048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64953818|NCT00035048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953819|NCT00035048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64953820|NCT00035048|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64953821|NCT00035048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64953822|NCT00035048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953823|NCT00035087|Epothilones|epothilones|mesh-list
64953824|NCT00035087|Epothilone B|epothilone b|mesh-list
64953825|NCT00035087|Tubulin Modulators|tubulin modulators|mesh-ancestor
64953826|NCT00035087|Antimitotic Agents|antimitotic agents|mesh-ancestor
64953827|NCT00035087|Mitosis Modulators|mitosis modulators|mesh-ancestor
64953828|NCT00035087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953829|NCT00035087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953830|NCT00062322|Irinotecan|irinotecan|mesh-list
64953831|NCT00062322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953832|NCT00062322|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64953833|NCT00062322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64953834|NCT00062322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953835|NCT00062322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953836|NCT00035126|Epothilones|epothilones|mesh-list
64953837|NCT00035126|Epothilone B|epothilone b|mesh-list
64953838|NCT00035126|Tubulin Modulators|tubulin modulators|mesh-ancestor
64953839|NCT00035126|Antimitotic Agents|antimitotic agents|mesh-ancestor
64953840|NCT00035126|Mitosis Modulators|mitosis modulators|mesh-ancestor
64953841|NCT00035126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953842|NCT00035126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953843|NCT00035165|Epothilones|epothilones|mesh-list
64953844|NCT00035165|Epothilone B|epothilone b|mesh-list
64953845|NCT00035165|Tubulin Modulators|tubulin modulators|mesh-ancestor
64492567|NCT04263610|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64953846|NCT00035165|Antimitotic Agents|antimitotic agents|mesh-ancestor
64503431|NCT03347994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503432|NCT04966338|Ocrelizumab|ocrelizumab|mesh-list
64953847|NCT00035165|Mitosis Modulators|mitosis modulators|mesh-ancestor
64953848|NCT00035165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953849|NCT00035165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953850|NCT00035204|Galantamine|galantamine|mesh-list
64953855|NCT00035204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64953856|NCT00035204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953857|NCT00035204|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64953858|NCT00035204|Autonomic Agents|autonomic agents|mesh-ancestor
64953859|NCT00035204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64726109|NCT00002527|Analgesics|analgesics|mesh-ancestor
64726110|NCT00002527|Sensory System Agents|sensory system agents|mesh-ancestor
64726111|NCT00002527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64726112|NCT00002527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726113|NCT00002527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64953860|NCT00035204|Nootropic Agents|nootropic agents|mesh-ancestor
64953861|NCT00062478|Camptothecin|camptothecin|mesh-list
64953862|NCT00062478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64955550|NCT00038831|Melphalan|melphalan|mesh-list
64953863|NCT00062478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953864|NCT00062478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64953865|NCT00062478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64953866|NCT00062478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953867|NCT00062478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953868|NCT00035243|Epothilones|epothilones|mesh-list
64953869|NCT00035243|Epothilone B|epothilone b|mesh-list
64953870|NCT00035243|Tubulin Modulators|tubulin modulators|mesh-ancestor
64953871|NCT00035243|Antimitotic Agents|antimitotic agents|mesh-ancestor
64953872|NCT00035243|Mitosis Modulators|mitosis modulators|mesh-ancestor
64953873|NCT00035243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953874|NCT00035243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953876|NCT00035282|Antiemetics|antiemetics|mesh-ancestor
64953877|NCT00035282|Autonomic Agents|autonomic agents|mesh-ancestor
64953878|NCT00035282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64510147|NCT04847193|Xanthohumol|xanthohumol|mesh-list
64953879|NCT00035282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953880|NCT00035282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64953881|NCT00035282|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64953882|NCT00035282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64953883|NCT00035282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953885|NCT00062556|Lovastatin|lovastatin|mesh-list
64953886|NCT00062556|L 647318|l 647318|mesh-list
64953887|NCT00062556|Dihydromevinolin|dihydromevinolin|mesh-list
64953888|NCT00062556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64953889|NCT00062556|Antimetabolites|antimetabolites|mesh-ancestor
64509182|NCT01933984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64953890|NCT00062556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953891|NCT00062556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64953892|NCT00062556|Vasodilator Agents|vasodilator agents|mesh-ancestor
64953893|NCT00062556|Vitamin B Complex|vitamin b complex|mesh-ancestor
64953894|NCT00062556|Vitamins|vitamins|mesh-ancestor
64953895|NCT00062556|Micronutrients|micronutrients|mesh-ancestor
64953896|NCT00062556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953897|NCT00062556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64953898|NCT00062556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64953899|NCT00062556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953900|NCT00035321|Olanzapine|olanzapine|mesh-list
64953901|NCT00035321|Fluoxetine|fluoxetine|mesh-list
64953902|NCT00035321|Antiemetics|antiemetics|mesh-ancestor
64953903|NCT00035321|Autonomic Agents|autonomic agents|mesh-ancestor
64510321|NCT01730729|Cabergoline|cabergoline|mesh-list
64953904|NCT00035321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64953905|NCT00035321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509183|NCT01933984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64953906|NCT00035321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64953907|NCT00035321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64953908|NCT00035321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64953909|NCT00035321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64953910|NCT00035321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64953911|NCT00035321|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64953912|NCT00035321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64953913|NCT00035321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64510533|NCT05826574|Esomeprazole|esomeprazole|mesh-list
64953914|NCT00035321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953915|NCT00035321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64953916|NCT00035321|Serotonin Agents|serotonin agents|mesh-ancestor
64509184|NCT01933984|Adrenergic Agents|adrenergic agents|mesh-ancestor
64953917|NCT00035321|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64953918|NCT00035321|Antidepressive Agents|antidepressive agents|mesh-ancestor
64503433|NCT04966338|Immunologic Factors|immunologic factors|mesh-ancestor
64953919|NCT00035321|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64953924|NCT00062595|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64953925|NCT00062595|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64510717|NCT05825092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953926|NCT00062595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953927|NCT00062595|Hemostatics|hemostatics|mesh-ancestor
64726114|NCT00002527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64726115|NCT00002527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64726116|NCT00002527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64726117|NCT00002527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726118|NCT00002527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64726119|NCT00002527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64953930|NCT00062595|Micronutrients|micronutrients|mesh-ancestor
64953931|NCT00062595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953932|NCT00035360|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64953933|NCT00035360|Antiviral Agents|antiviral agents|mesh-ancestor
64953934|NCT00035360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64953935|NCT00062673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64953936|NCT00062673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64953937|NCT00062673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64953938|NCT00062673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64509197|NCT04126083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64727080|NCT00003440|Trastuzumab|trastuzumab|mesh-list
64510853|NCT05821543|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64953939|NCT00062673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953940|NCT00062673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64953941|NCT00062673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953942|NCT00062673|Analgesics|analgesics|mesh-ancestor
64953943|NCT00062673|Sensory System Agents|sensory system agents|mesh-ancestor
64953944|NCT00062673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64953945|NCT00062673|Antidepressive Agents|antidepressive agents|mesh-ancestor
64953946|NCT00062673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64953947|NCT00062673|Dopamine Agents|dopamine agents|mesh-ancestor
64953948|NCT00035477|Azimilide|azimilide|mesh-list
64953949|NCT00035477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64953950|NCT00035477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64953951|NCT00035477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64953952|NCT00035477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953953|NCT00035477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64953954|NCT00035477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953955|NCT00062712|Sirolimus|sirolimus|mesh-list
64953956|NCT00062712|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64953957|NCT00062712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64953958|NCT00062712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64953959|NCT00062712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64953960|NCT00062712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953961|NCT00062712|Antifungal Agents|antifungal agents|mesh-ancestor
64953962|NCT00062712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64953963|NCT00062712|Immunologic Factors|immunologic factors|mesh-ancestor
64953964|NCT00062712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953965|NCT00062790|Dutasteride|dutasteride|mesh-list
64953966|NCT00062790|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64953967|NCT00062790|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64953968|NCT00062790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953969|NCT00062790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953970|NCT00062790|Hormone Antagonists|hormone antagonists|mesh-ancestor
64953971|NCT00062790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64727097|NCT00003206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727102|NCT00003446|Leucovorin|leucovorin|mesh-list
64953972|NCT00062790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953973|NCT00035516|Epothilones|epothilones|mesh-list
64953974|NCT00035516|Tubulin Modulators|tubulin modulators|mesh-ancestor
64953975|NCT00035516|Antimitotic Agents|antimitotic agents|mesh-ancestor
64511509|NCT05331664|Polymyxins|polymyxins|mesh-list
64953976|NCT00035516|Mitosis Modulators|mitosis modulators|mesh-ancestor
64953977|NCT00035516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953978|NCT00035516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953979|NCT00062946|Fallypride|fallypride|mesh-list
64953980|NCT00062946|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64953981|NCT00062946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64953983|NCT00062946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64953984|NCT00062946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953985|NCT00062946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953986|NCT00063024|Calcium|calcium|mesh-list
64953987|NCT00063024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64953988|NCT00063024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726120|NCT00002527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726121|NCT00002527|Antipyretics|antipyretics|mesh-ancestor
64726122|NCT03688178|Temozolomide|temozolomide|mesh-list
64726123|NCT03688178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64726124|NCT03688178|Alkylating Agents|alkylating agents|mesh-ancestor
64953989|NCT00035984|Exenatide|exenatide|mesh-list
64953998|NCT00063141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64953999|NCT00063141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64954000|NCT00063141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954001|NCT00063141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954002|NCT00063141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954003|NCT00063141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64954005|NCT00036023|Hematinics|hematinics|mesh-ancestor
64954006|NCT00036062|Sivelestat|sivelestat|mesh-list
64954007|NCT00036062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64954008|NCT00036062|Protease Inhibitors|protease inhibitors|mesh-ancestor
64954009|NCT00036062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954010|NCT00036062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954011|NCT00036101|Aripiprazole|aripiprazole|mesh-list
64954012|NCT00036101|Antidepressive Agents|antidepressive agents|mesh-ancestor
64954013|NCT00036101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64954014|NCT00036101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64511979|NCT04903353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64511980|NCT04903353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64954015|NCT00036101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64954016|NCT00036101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64954017|NCT00036101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954018|NCT00036101|Dopamine Agonists|dopamine agonists|mesh-ancestor
64954019|NCT00036101|Dopamine Agents|dopamine agents|mesh-ancestor
64512129|NCT04747314|Dopamine Agents|dopamine agents|mesh-ancestor
64954020|NCT00036101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64954021|NCT00036101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954022|NCT00036101|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64954023|NCT00036101|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64954024|NCT00036101|Serotonin Agents|serotonin agents|mesh-ancestor
64954025|NCT00036101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64954026|NCT00036101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64954027|NCT00036101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64954028|NCT00036101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64954029|NCT00036179|Micafungin|micafungin|mesh-list
64954030|NCT00036179|Antifungal Agents|antifungal agents|mesh-ancestor
64954031|NCT00036179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64954032|NCT00036218|Ropinirole|ropinirole|mesh-list
64954033|NCT00036218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64512209|NCT04677569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64954034|NCT00036218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64954035|NCT00036218|Dopamine Agonists|dopamine agonists|mesh-ancestor
64954036|NCT00036218|Dopamine Agents|dopamine agents|mesh-ancestor
64954037|NCT00036218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64954038|NCT00036218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954039|NCT00036218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954040|NCT00063453|Vitamins|vitamins|mesh-list
64954041|NCT00063453|Vitamin E|vitamin e|mesh-list
64954042|NCT00063453|Tocopherols|tocopherols|mesh-list
64954043|NCT00063453|Tocotrienols|tocotrienols|mesh-list
64954044|NCT00063453|alpha-Tocopherol|alpha-tocopherol|mesh-list
64954045|NCT00063453|Selenium|selenium|mesh-list
64954046|NCT00063453|Micronutrients|micronutrients|mesh-ancestor
64954047|NCT00063453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954048|NCT00063453|Antioxidants|antioxidants|mesh-ancestor
64954049|NCT00063453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954050|NCT00063453|Protective Agents|protective agents|mesh-ancestor
64954051|NCT00063453|Trace Elements|trace elements|mesh-ancestor
64954052|NCT00036335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64954055|NCT00036335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64954056|NCT00036335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954057|NCT00036335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64954058|NCT00036335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420850|NCT02328105|Paclitaxel|paclitaxel|mesh-list
64954060|NCT00036335|Sensory System Agents|sensory system agents|mesh-ancestor
64954061|NCT00036335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64954062|NCT00036335|Antidepressive Agents|antidepressive agents|mesh-ancestor
64954063|NCT00036335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64954064|NCT00036335|Dopamine Agents|dopamine agents|mesh-ancestor
64492790|NCT02808364|Vaccines|vaccines|mesh-list
64954065|NCT00036374|Infliximab|infliximab|mesh-list
64954066|NCT00036374|Dermatologic Agents|dermatologic agents|mesh-ancestor
64726125|NCT03688178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726126|NCT03688178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465407|NCT03822520|Moxifloxacin|moxifloxacin|mesh-list
64726127|NCT00002533|Fluconazole|fluconazole|mesh-list
64954067|NCT00036374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64954068|NCT00036374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64954069|NCT00036452|Ritonavir|ritonavir|mesh-list
64954070|NCT00036452|Lopinavir|lopinavir|mesh-list
64954071|NCT00036452|Tenofovir|tenofovir|mesh-list
64954072|NCT00036452|Emtricitabine|emtricitabine|mesh-list
64954073|NCT00036452|Stavudine|stavudine|mesh-list
64954074|NCT00036452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64954075|NCT00036452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64954076|NCT00036452|Protease Inhibitors|protease inhibitors|mesh-ancestor
64954077|NCT00036452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954078|NCT00036452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954079|NCT00036452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64954080|NCT00036452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64954081|NCT00036452|Antiviral Agents|antiviral agents|mesh-ancestor
64954082|NCT00036452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64954083|NCT00036452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64954084|NCT00036452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64954085|NCT00036452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64954086|NCT00036452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64954087|NCT00036452|Antimetabolites|antimetabolites|mesh-ancestor
64954088|NCT02967276|Metformin|metformin|mesh-list
64954089|NCT02967276|Dexamethasone|dexamethasone|mesh-list
64954090|NCT02967276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64954091|NCT02967276|Antiemetics|antiemetics|mesh-ancestor
64954092|NCT02967276|Autonomic Agents|autonomic agents|mesh-ancestor
64954093|NCT02967276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64954094|NCT02967276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954095|NCT02967276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64954096|NCT02967276|Glucocorticoids|glucocorticoids|mesh-ancestor
64954097|NCT02967276|Hormones|hormones|mesh-ancestor
64954098|NCT02967276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64954099|NCT02967276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64954100|NCT02967276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954101|NCT02967276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64954102|NCT00036491|Rituximab|rituximab|mesh-list
64954103|NCT00036491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64954104|NCT00036491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954105|NCT00036491|Immunologic Factors|immunologic factors|mesh-ancestor
64954106|NCT00036491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954107|NCT00036491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64954108|NCT00063609|Zoledronic Acid|zoledronic acid|mesh-list
64954109|NCT00063609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64954110|NCT00063609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512872|NCT03937830|Durvalumab|durvalumab|mesh-list
64954111|NCT02971319|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
64954112|NCT02971319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64954113|NCT02971319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954114|NCT00036647|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64954115|NCT00036647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954116|NCT00036647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64954117|NCT00036647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954118|NCT00036647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954119|NCT00063687|Oxypurinol|oxypurinol|mesh-list
64954120|NCT00063687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64513082|NCT03533582|Cisplatin|cisplatin|mesh-list
64954121|NCT00063687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954122|NCT00036764|Epothilones|epothilones|mesh-list
64954123|NCT00036764|Epothilone B|epothilone b|mesh-list
64954128|NCT00036764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954130|NCT00063726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954131|NCT00036842|Arsenic Trioxide|arsenic trioxide|mesh-list
64954132|NCT00036842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954133|NCT00036881|Zinc Sulfate|zinc sulfate|mesh-list
64954134|NCT00036881|Astringents|astringents|mesh-ancestor
64954135|NCT00036881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954136|NCT00036881|Dermatologic Agents|dermatologic agents|mesh-ancestor
64954137|NCT00063804|Ritonavir|ritonavir|mesh-list
64954138|NCT00063804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64954139|NCT00063804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64726128|NCT00002533|Antifungal Agents|antifungal agents|mesh-ancestor
64726129|NCT00002533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726130|NCT00002533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64726131|NCT00002533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64726132|NCT00002533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954140|NCT00063804|Protease Inhibitors|protease inhibitors|mesh-ancestor
64954141|NCT00063804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954142|NCT00063804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954143|NCT00063804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64954144|NCT00063804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64954145|NCT00063804|Antiviral Agents|antiviral agents|mesh-ancestor
64954146|NCT00063804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64954147|NCT00063804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64513573|NCT00858273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64513574|NCT00858273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727252|NCT00003968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727253|NCT00003968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727254|NCT00003974|Cyclophosphamide|cyclophosphamide|mesh-list
64727255|NCT00003974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64955611|NCT00203905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954148|NCT00063804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64954149|NCT02967432|Mupirocin|mupirocin|mesh-list
64954150|NCT02967432|Petrolatum|petrolatum|mesh-list
64954151|NCT02967432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64954152|NCT02967432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64954153|NCT02967432|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64954154|NCT02967432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954155|NCT02967432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954156|NCT02967432|Emollients|emollients|mesh-ancestor
64954157|NCT02967432|Dermatologic Agents|dermatologic agents|mesh-ancestor
64954158|NCT00063960|Irinotecan|irinotecan|mesh-list
64954159|NCT00063960|Floxuridine|floxuridine|mesh-list
64954160|NCT00063960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64954161|NCT00063960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64954162|NCT00063960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954163|NCT00063960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954164|NCT00063960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954165|NCT00063960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64954166|NCT00063960|Antimetabolites|antimetabolites|mesh-ancestor
64954167|NCT00064116|Rituximab|rituximab|mesh-list
64954168|NCT00064116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64954169|NCT00064116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954170|NCT00064116|Immunologic Factors|immunologic factors|mesh-ancestor
64727256|NCT00003974|Immunologic Factors|immunologic factors|mesh-ancestor
64727257|NCT00003974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727258|NCT00003974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64466532|NCT02223208|Hormones|hormones|mesh-ancestor
64727259|NCT00003974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64334724|NCT02232035|Autonomic Agents|autonomic agents|mesh-ancestor
64422556|NCT05401279|Antimetabolites|antimetabolites|mesh-ancestor
64954171|NCT00064116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954172|NCT00064116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64954173|NCT00037037|Sargramostim|sargramostim|mesh-list
64954174|NCT00037037|Immunologic Factors|immunologic factors|mesh-ancestor
64954175|NCT00037037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954176|NCT00064194|Vitamin E|vitamin e|mesh-list
64954177|NCT00064194|Selenium|selenium|mesh-list
64954178|NCT00064194|Vitamins|vitamins|mesh-ancestor
64954179|NCT00064194|Micronutrients|micronutrients|mesh-ancestor
64954180|NCT00064194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954181|NCT00064194|Antioxidants|antioxidants|mesh-ancestor
64954182|NCT00064194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954183|NCT00064194|Protective Agents|protective agents|mesh-ancestor
64954184|NCT00064194|Trace Elements|trace elements|mesh-ancestor
64954185|NCT00064233|Dasatinib|dasatinib|mesh-list
64954186|NCT00064233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954187|NCT00064233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64954188|NCT00064233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954189|NCT00064233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954190|NCT02967237|Insulin Glargine|insulin glargine|mesh-list
64954191|NCT02967237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64954192|NCT02967237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954193|NCT00037115|Interferons|interferons|mesh-list
64954194|NCT00037115|Interferon-beta|interferon-beta|mesh-list
64954195|NCT00037115|Interferon beta-1a|interferon beta-1a|mesh-list
64954196|NCT00037115|Methylprednisolone|methylprednisolone|mesh-list
64954205|NCT00037115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954206|NCT00037115|Dermatologic Agents|dermatologic agents|mesh-ancestor
64954207|NCT00037115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954208|NCT00037115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64954209|NCT00037115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64954210|NCT00037115|Immunologic Factors|immunologic factors|mesh-ancestor
64954211|NCT00037115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64954212|NCT00037115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64726133|NCT00002533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726134|NCT00002533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64726135|NCT00002533|Hormone Antagonists|hormone antagonists|mesh-ancestor
64726136|NCT00002533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64954213|NCT00037115|Antiviral Agents|antiviral agents|mesh-ancestor
64954214|NCT00037115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64954215|NCT00037115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64954216|NCT00037115|Antiemetics|antiemetics|mesh-ancestor
64492935|NCT04613453|Anesthetics|anesthetics|mesh-ancestor
64954217|NCT00037115|Autonomic Agents|autonomic agents|mesh-ancestor
64503437|NCT03347916|Sensory System Agents|sensory system agents|mesh-ancestor
64493013|NCT01893827|Naltrexone|naltrexone|mesh-list
64954218|NCT00037115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64954219|NCT00037115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64954220|NCT00037115|Glucocorticoids|glucocorticoids|mesh-ancestor
64954221|NCT00037115|Hormones|hormones|mesh-ancestor
64954222|NCT00037115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64954223|NCT00037115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64954224|NCT00037115|Protective Agents|protective agents|mesh-ancestor
64954225|NCT00037115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64954226|NCT00037154|Saw palmetto extract|saw palmetto extract|mesh-list
64954227|NCT00037154|Urological Agents|urological agents|mesh-ancestor
64954228|NCT00064389|Albuterol|albuterol|mesh-list
64954229|NCT00064389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64954230|NCT00064389|Autonomic Agents|autonomic agents|mesh-ancestor
64954231|NCT00064389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64954232|NCT00064389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954233|NCT00064389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64954234|NCT00064389|Respiratory System Agents|respiratory system agents|mesh-ancestor
64954235|NCT00064389|Tocolytic Agents|tocolytic agents|mesh-ancestor
64954236|NCT00064389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64954237|NCT00064389|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64422581|NCT02954081|Analgesics|analgesics|mesh-ancestor
64954238|NCT00064389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64954239|NCT00064389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64954240|NCT00064389|Adrenergic Agents|adrenergic agents|mesh-ancestor
64954241|NCT00064389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64954242|NCT00064389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954243|NCT00064428|PENTA|penta|mesh-list
64954244|NCT00064428|Fondaparinux|fondaparinux|mesh-list
64954245|NCT00064428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64954246|NCT00064428|Antithrombins|antithrombins|mesh-ancestor
64954247|NCT00064428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64954248|NCT00064428|Protease Inhibitors|protease inhibitors|mesh-ancestor
64954249|NCT00064428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954250|NCT00064428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954251|NCT00064428|Anticoagulants|anticoagulants|mesh-ancestor
64954252|NCT00064428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64954253|NCT00064428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64954254|NCT00064467|Bupropion|bupropion|mesh-list
64954255|NCT00064467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64954256|NCT00064467|Antidepressive Agents|antidepressive agents|mesh-ancestor
64954257|NCT00064467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64954258|NCT00064467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64954259|NCT00064467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64954260|NCT00064467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64954265|NCT00064467|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64954266|NCT00064467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64954267|NCT00064467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954268|NCT00064623|Capsaicin|capsaicin|mesh-list
64954269|NCT00064623|Antipruritics|antipruritics|mesh-ancestor
64954270|NCT00064623|Dermatologic Agents|dermatologic agents|mesh-ancestor
64954271|NCT00064623|Sensory System Agents|sensory system agents|mesh-ancestor
64954272|NCT00064623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64954273|NCT00064623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954274|NCT00037544|Factor VIII|factor viii|mesh-list
64954275|NCT00037544|Coagulants|coagulants|mesh-ancestor
64954277|NCT00037583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64954278|NCT00037583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954279|NCT00064857|Pycnogenols|pycnogenols|mesh-list
64726137|NCT00002533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726138|NCT00002533|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64726139|NCT00002533|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64726141|NCT00002539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64726142|NCT00002539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726143|NCT00002539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64726144|NCT00002539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64726145|NCT00002539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64726146|NCT00002539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726147|NCT00002539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727261|NCT00003974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727262|NCT00003974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727263|NCT00003974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64727264|NCT00002635|Lenograstim|lenograstim|mesh-list
64727265|NCT00002635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64422626|NCT02953457|Tremelimumab|tremelimumab|mesh-list
64726148|NCT00381589|Bromides|bromides|mesh-list
64726149|NCT00381589|Ipratropium|ipratropium|mesh-list
64726150|NCT00381589|Anticonvulsants|anticonvulsants|mesh-ancestor
64726151|NCT00381589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64726152|NCT00381589|Autonomic Agents|autonomic agents|mesh-ancestor
64726153|NCT00381589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64726154|NCT00381589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726155|NCT00381589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64726156|NCT00381589|Respiratory System Agents|respiratory system agents|mesh-ancestor
64726157|NCT00381589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64726158|NCT00381589|Cholinergic Agents|cholinergic agents|mesh-ancestor
64726159|NCT00381589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64726160|NCT00381589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726161|NCT00002239|Ritonavir|ritonavir|mesh-list
64726162|NCT00002239|Amprenavir|amprenavir|mesh-list
64726163|NCT00002239|Abacavir|abacavir|mesh-list
64726164|NCT00002239|Enfuvirtide|enfuvirtide|mesh-list
64726165|NCT00002239|Efavirenz|efavirenz|mesh-list
64726166|NCT00002239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64726167|NCT00002239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64726168|NCT00002239|Protease Inhibitors|protease inhibitors|mesh-ancestor
64726169|NCT00002239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726170|NCT00002239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954280|NCT00064857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64954281|NCT00064857|Immunologic Factors|immunologic factors|mesh-ancestor
64954282|NCT00064857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954283|NCT00064857|Antioxidants|antioxidants|mesh-ancestor
64954284|NCT00064857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954285|NCT00064857|Protective Agents|protective agents|mesh-ancestor
64954286|NCT00064857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64954287|NCT00037622|Dexelvucitabine|dexelvucitabine|mesh-list
64726171|NCT00002239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64726172|NCT00002239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64727266|NCT00002635|Immunologic Factors|immunologic factors|mesh-ancestor
64334731|NCT02232035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64422672|NCT04468061|Pembrolizumab|pembrolizumab|mesh-list
64726173|NCT00002239|Antiviral Agents|antiviral agents|mesh-ancestor
64726174|NCT00002239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726175|NCT00002239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64726176|NCT00002239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64726177|NCT00002239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64954288|NCT00037622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64954289|NCT00037622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64955613|NCT00203905|Antimetabolites|antimetabolites|mesh-ancestor
64955614|NCT00203905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727267|NCT00002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727268|NCT00003242|Paclitaxel|paclitaxel|mesh-list
64727269|NCT00003242|Bryostatin 1|bryostatin 1|mesh-list
64727270|NCT00003242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64727271|NCT00003242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727272|NCT00003242|Tubulin Modulators|tubulin modulators|mesh-ancestor
64954290|NCT00037622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954291|NCT00037622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954292|NCT00037622|Antiviral Agents|antiviral agents|mesh-ancestor
64954293|NCT00037622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64954294|NCT00037622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64954295|NCT00037622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64954296|NCT00037661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64954297|NCT00037661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64954299|NCT04730622|Mitosis Modulators|mitosis modulators|mesh-ancestor
64955615|NCT00203905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64727273|NCT00003242|Antimitotic Agents|antimitotic agents|mesh-ancestor
64727274|NCT00003242|Mitosis Modulators|mitosis modulators|mesh-ancestor
64727275|NCT00003242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727276|NCT00003242|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64727277|NCT00003242|Immunologic Factors|immunologic factors|mesh-ancestor
64954300|NCT04730622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954301|NCT00037700|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64954302|NCT00037700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64954303|NCT00064974|Lenalidomide|lenalidomide|mesh-list
64954304|NCT00064974|Immunologic Factors|immunologic factors|mesh-ancestor
64954305|NCT00064974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954306|NCT00064974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64955616|NCT00203905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64955617|NCT00203905|Immunologic Factors|immunologic factors|mesh-ancestor
64955618|NCT00203905|Antisickling Agents|antisickling agents|mesh-ancestor
64727278|NCT00003242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727279|NCT05665699|Allopurinol|allopurinol|mesh-list
64727280|NCT05665699|Antimetabolites|antimetabolites|mesh-ancestor
64727281|NCT05665699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727282|NCT05665699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954307|NCT00064974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64954308|NCT00064974|Growth Substances|growth substances|mesh-ancestor
64954309|NCT00064974|Growth Inhibitors|growth inhibitors|mesh-ancestor
64954310|NCT00064974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954311|NCT00037817|Celecoxib|celecoxib|mesh-list
64954312|NCT00037817|Decitabine|decitabine|mesh-list
64954313|NCT00037817|Romidepsin|romidepsin|mesh-list
64954314|NCT00037817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64954315|NCT00037817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64954316|NCT00037817|Analgesics|analgesics|mesh-ancestor
64727283|NCT05665699|Gout Suppressants|gout suppressants|mesh-ancestor
64727284|NCT05665699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64727285|NCT05665699|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64727286|NCT05665699|Antioxidants|antioxidants|mesh-ancestor
64727287|NCT05665699|Protective Agents|protective agents|mesh-ancestor
64727288|NCT05665699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727289|NCT05664061|Fluticasone|fluticasone|mesh-list
64955619|NCT00203905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422708|NCT05415709|Cisplatin|cisplatin|mesh-list
64954317|NCT00037817|Sensory System Agents|sensory system agents|mesh-ancestor
64954318|NCT00037817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64954319|NCT00037817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954320|NCT00037817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64954321|NCT00037817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64954322|NCT00037817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64954323|NCT00037817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64954324|NCT00037817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954325|NCT00037817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727290|NCT05664061|Xhance|xhance|mesh-list
64727291|NCT05664061|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64727292|NCT05664061|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64727293|NCT05664061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64955620|NCT00203905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64955621|NCT00072072|Celecoxib|celecoxib|mesh-list
64604554|NCT00845195|Azelastine|azelastine|mesh-list
64954326|NCT00037817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64954327|NCT00037817|Antimetabolites|antimetabolites|mesh-ancestor
64954328|NCT00037817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954329|NCT00037817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64954330|NCT00065130|Insulin|insulin|mesh-list
64954333|NCT00065130|Isophane Insulin, Human|isophane insulin, human|mesh-list
64954334|NCT00065130|Insulin, Isophane|insulin, isophane|mesh-list
64954335|NCT00065130|Isophane insulin, beef|isophane insulin, beef|mesh-list
64954336|NCT00065130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64954337|NCT00065130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954338|NCT00065169|Celecoxib|celecoxib|mesh-list
64954339|NCT00065169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64954340|NCT00065169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64954341|NCT00065169|Analgesics|analgesics|mesh-ancestor
64954342|NCT00065169|Sensory System Agents|sensory system agents|mesh-ancestor
64954343|NCT00065169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64954344|NCT00065169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954345|NCT00065169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64954346|NCT00065169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64954347|NCT00065169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64954348|NCT00065169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64954349|NCT00065169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726178|NCT00002239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64727295|NCT05664061|Autonomic Agents|autonomic agents|mesh-ancestor
64727296|NCT05664061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64727297|NCT05664061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727298|NCT05664061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64726179|NCT00002239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64726180|NCT00002239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64726182|NCT00002239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64726183|NCT00002239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64954350|NCT00065169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954351|NCT00038012|Carboplatin|carboplatin|mesh-list
64954352|NCT00038012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954353|NCT00038051|Lintuzumab|lintuzumab|mesh-list
64954354|NCT00038051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64954355|NCT00038051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727299|NCT05664061|Respiratory System Agents|respiratory system agents|mesh-ancestor
64727300|NCT05664061|Dermatologic Agents|dermatologic agents|mesh-ancestor
64727301|NCT05664061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64955622|NCT00072072|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64494347|NCT01378104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955623|NCT00072072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954356|NCT00038090|Thalidomide|thalidomide|mesh-list
64954357|NCT00038090|Dexamethasone|dexamethasone|mesh-list
64954358|NCT00038090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64954359|NCT00038090|Antiemetics|antiemetics|mesh-ancestor
64954360|NCT00038090|Autonomic Agents|autonomic agents|mesh-ancestor
64954361|NCT00038090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64954362|NCT00038090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954363|NCT00038090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64954364|NCT00038090|Glucocorticoids|glucocorticoids|mesh-ancestor
64503438|NCT03347916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64493089|NCT01882829|Quinidine|quinidine|mesh-list
64954365|NCT00038090|Hormones|hormones|mesh-ancestor
64727302|NCT05664061|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64727303|NCT05664061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64334769|NCT02292667|Morphine|morphine|mesh-list
64503439|NCT03347916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420872|NCT02305797|GABA Agents|gaba agents|mesh-ancestor
64503440|NCT03347916|Anticonvulsants|anticonvulsants|mesh-ancestor
64954366|NCT00038090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64954367|NCT00038090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64954368|NCT00038090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954369|NCT00038090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64954370|NCT00038090|Immunologic Factors|immunologic factors|mesh-ancestor
64954371|NCT00038090|Leprostatic Agents|leprostatic agents|mesh-ancestor
64954372|NCT00038090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64954373|NCT00038090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64727304|NCT05664061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64727305|NCT05664061|Adrenergic Agents|adrenergic agents|mesh-ancestor
64727306|NCT05664061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64727307|NCT05664061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727308|NCT05664061|Glucocorticoids|glucocorticoids|mesh-ancestor
64727309|NCT05664061|Hormones|hormones|mesh-ancestor
64727310|NCT05664061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64727311|NCT05664061|Sympathomimetics|sympathomimetics|mesh-ancestor
64727312|NCT00003248|Rituximab|rituximab|mesh-list
64494350|NCT01131052|Insulin Glargine|insulin glargine|mesh-list
64955626|NCT00072072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954374|NCT00038090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64954375|NCT00038090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64954376|NCT00038090|Growth Substances|growth substances|mesh-ancestor
64954377|NCT00038090|Growth Inhibitors|growth inhibitors|mesh-ancestor
64954378|NCT00065325|Fulvestrant|fulvestrant|mesh-list
64954379|NCT00065325|Exemestane|exemestane|mesh-list
64954380|NCT00065325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64954381|NCT00065325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727314|NCT00003248|Fludarabine phosphate|fludarabine phosphate|mesh-list
64727315|NCT00003248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64422731|NCT04262843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954382|NCT00065325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64954383|NCT00065325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64954384|NCT00065325|Hormone Antagonists|hormone antagonists|mesh-ancestor
64954385|NCT00065325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64954386|NCT00065325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954387|NCT00065325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64954388|NCT00065325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64954389|NCT00065325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727316|NCT00003248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727317|NCT00003248|Immunologic Factors|immunologic factors|mesh-ancestor
64727318|NCT00003248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727319|NCT00003248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64727320|NCT00003248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64727321|NCT00003248|Antimetabolites|antimetabolites|mesh-ancestor
64727322|NCT00003248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727323|NCT00003248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64954390|NCT00065325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954391|NCT00038168|Paclitaxel|paclitaxel|mesh-list
64954392|NCT00038168|Estramustine|estramustine|mesh-list
64954393|NCT00038168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64954394|NCT00038168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954395|NCT00038168|Tubulin Modulators|tubulin modulators|mesh-ancestor
64954396|NCT00038168|Antimitotic Agents|antimitotic agents|mesh-ancestor
64954397|NCT00038168|Mitosis Modulators|mitosis modulators|mesh-ancestor
64955627|NCT00072072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64955628|NCT00072072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64727324|NCT05663905|Ambroxol|ambroxol|mesh-list
64727325|NCT05663905|Expectorants|expectorants|mesh-ancestor
64727326|NCT05663905|Respiratory System Agents|respiratory system agents|mesh-ancestor
64727327|NCT00002641|Doxorubicin|doxorubicin|mesh-list
64727328|NCT00002641|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64727329|NCT00002641|Ifosfamide|ifosfamide|mesh-list
64727330|NCT00002641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64727331|NCT00002641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727332|NCT00002641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64954398|NCT00038168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954399|NCT00038168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64954417|NCT00038207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954419|NCT00398697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64954420|NCT00398697|Antimetabolites|antimetabolites|mesh-ancestor
64954421|NCT00398697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955629|NCT00072072|Analgesics|analgesics|mesh-ancestor
64727333|NCT00002641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64727334|NCT00002641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727335|NCT00002641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727336|NCT00002641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64727338|NCT00003992|Tamoxifen|tamoxifen|mesh-list
64727339|NCT00003992|Paclitaxel|paclitaxel|mesh-list
64727340|NCT00003992|Cyclophosphamide|cyclophosphamide|mesh-list
64727341|NCT00003992|Doxorubicin|doxorubicin|mesh-list
64954422|NCT00398697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954423|NCT00398697|Antiviral Agents|antiviral agents|mesh-ancestor
64726184|NCT00002239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64726185|NCT00002239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64726186|NCT00002239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64726187|NCT00002239|Antitubercular Agents|antitubercular agents|mesh-ancestor
64726188|NCT00002239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64954424|NCT00398697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64954425|NCT00398697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955630|NCT00072072|Sensory System Agents|sensory system agents|mesh-ancestor
64494355|NCT01379274|Azacitidine|azacitidine|mesh-list
64955631|NCT00072072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64955632|NCT00072072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727342|NCT00003992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64727343|NCT00003992|Trastuzumab|trastuzumab|mesh-list
64727344|NCT00003992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64727345|NCT00003992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954426|NCT00398697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64954427|NCT00398697|Immunologic Factors|immunologic factors|mesh-ancestor
64954428|NCT00398697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954429|NCT00038246|Thalidomide|thalidomide|mesh-list
64954430|NCT00038246|Paclitaxel|paclitaxel|mesh-list
64954431|NCT00038246|Estramustine|estramustine|mesh-list
64954432|NCT00038246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64954433|NCT00038246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954434|NCT00038246|Tubulin Modulators|tubulin modulators|mesh-ancestor
64955633|NCT00072072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64955634|NCT00072072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64727347|NCT00003992|Antimitotic Agents|antimitotic agents|mesh-ancestor
64727348|NCT00003992|Mitosis Modulators|mitosis modulators|mesh-ancestor
64605241|NCT02617888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64954435|NCT00038246|Antimitotic Agents|antimitotic agents|mesh-ancestor
64954436|NCT00038246|Mitosis Modulators|mitosis modulators|mesh-ancestor
64954437|NCT00038246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954438|NCT00038246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64954439|NCT00038246|Immunologic Factors|immunologic factors|mesh-ancestor
64954440|NCT00038246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954441|NCT00038246|Leprostatic Agents|leprostatic agents|mesh-ancestor
64954442|NCT00038246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64954443|NCT00038246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64954444|NCT00038246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64954445|NCT00038246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64954446|NCT00038246|Growth Substances|growth substances|mesh-ancestor
64954447|NCT00038246|Growth Inhibitors|growth inhibitors|mesh-ancestor
64954448|NCT00038246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64954449|NCT00038246|Alkylating Agents|alkylating agents|mesh-ancestor
64727349|NCT00003992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727350|NCT00003992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727351|NCT00003992|Immunologic Factors|immunologic factors|mesh-ancestor
64727352|NCT00003992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727353|NCT00003992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64727354|NCT00003992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64955635|NCT00072072|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64954450|NCT00038246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64954451|NCT00398775|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64954452|NCT00398775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64954453|NCT00398814|Sorafenib|sorafenib|mesh-list
64954454|NCT00398814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954455|NCT00398814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64954456|NCT00398814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954459|NCT00065559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64954460|NCT00065559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64954461|NCT00065559|Analgesics|analgesics|mesh-ancestor
64954462|NCT00065559|Sensory System Agents|sensory system agents|mesh-ancestor
64954463|NCT00065559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64727355|NCT00003992|Alkylating Agents|alkylating agents|mesh-ancestor
64727356|NCT00003992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64727357|NCT00003992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64727358|NCT00003992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64727359|NCT00003992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64727360|NCT00003992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727361|NCT00003992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64727362|NCT00003992|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64727363|NCT00003992|Hormone Antagonists|hormone antagonists|mesh-ancestor
64955636|NCT00072072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64955637|NCT00204022|Mycophenolic Acid|mycophenolic acid|mesh-list
64954464|NCT00065559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954465|NCT00065559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64954466|NCT00065559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64954467|NCT00065559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64954468|NCT00065559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64954469|NCT00065559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954470|NCT00065559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954471|NCT00065637|Teriparatide|teriparatide|mesh-list
64954472|NCT00065637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64727364|NCT00003992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64727365|NCT00003992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64727366|NCT00003992|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64727367|NCT00003992|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64727368|NCT00003992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64727369|NCT00003518|Gemcitabine|gemcitabine|mesh-list
64727371|NCT00003518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64727372|NCT00003518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954473|NCT00065637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954474|NCT00065637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64954475|NCT00396578|Vancomycin|vancomycin|mesh-list
64954476|NCT00396578|Gentamicins|gentamicins|mesh-list
64954477|NCT00396578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64954478|NCT00396578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64954479|NCT00396578|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64954480|NCT00396578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954481|NCT00396578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955638|NCT00204022|Azathioprine|azathioprine|mesh-list
64727373|NCT00003518|Tubulin Modulators|tubulin modulators|mesh-ancestor
64727374|NCT00003518|Antimitotic Agents|antimitotic agents|mesh-ancestor
64727375|NCT00003518|Mitosis Modulators|mitosis modulators|mesh-ancestor
64727376|NCT00003518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727377|NCT00003518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64727378|NCT00003518|Antimetabolites|antimetabolites|mesh-ancestor
64727379|NCT00003518|Antiviral Agents|antiviral agents|mesh-ancestor
64727380|NCT00003518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64727381|NCT00003518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954482|NCT00398853|Chromium|chromium|mesh-list
64954483|NCT00398853|Picolinic acid|picolinic acid|mesh-list
64954484|NCT00398853|Trace Elements|trace elements|mesh-ancestor
64954485|NCT00398853|Micronutrients|micronutrients|mesh-ancestor
64954486|NCT00398853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954487|NCT00398853|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64954488|NCT00398853|Chelating Agents|chelating agents|mesh-ancestor
64954489|NCT00398853|Sequestering Agents|sequestering agents|mesh-ancestor
64726189|NCT00383474|Bortezomib|bortezomib|mesh-list
64726190|NCT00383474|Tipifarnib|tipifarnib|mesh-list
64726191|NCT00383474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726192|NCT00002245|Lamivudine|lamivudine|mesh-list
64726193|NCT00002245|Abacavir|abacavir|mesh-list
64726194|NCT00002245|Amprenavir|amprenavir|mesh-list
64954490|NCT00398853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954491|NCT05433896|Dasatinib|dasatinib|mesh-list
64954492|NCT05433896|Omeprazole|omeprazole|mesh-list
64727382|NCT00003518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727383|NCT00003518|Immunologic Factors|immunologic factors|mesh-ancestor
64727384|NCT00003518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727386|NCT00002647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64727387|NCT00002647|Dermatologic Agents|dermatologic agents|mesh-ancestor
64727388|NCT00002653|Prednisone|prednisone|mesh-list
64727389|NCT00002653|Cyclophosphamide|cyclophosphamide|mesh-list
64727390|NCT00002653|Melphalan|melphalan|mesh-list
64727391|NCT00002653|Carmustine|carmustine|mesh-list
64334837|NCT03149913|Antimitotic Agents|antimitotic agents|mesh-ancestor
64954493|NCT05433896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64954494|NCT05433896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64954495|NCT05433896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64954496|NCT05433896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954497|NCT05433896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954498|NCT05433896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954499|NCT05433896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64954500|NCT00069888|Docetaxel|docetaxel|mesh-list
64954501|NCT00069888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727392|NCT00002653|Doxorubicin|doxorubicin|mesh-list
64727393|NCT00002653|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64727394|NCT00002653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727395|NCT00002653|Immunologic Factors|immunologic factors|mesh-ancestor
64727396|NCT00002653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727397|NCT00002653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64727398|NCT00002653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64727399|NCT00002653|Alkylating Agents|alkylating agents|mesh-ancestor
64727400|NCT00002653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727401|NCT00002653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727402|NCT00002653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64727403|NCT00002653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64727404|NCT00002653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64727405|NCT00002653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64727406|NCT00002653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954502|NCT00069888|Tubulin Modulators|tubulin modulators|mesh-ancestor
64954503|NCT00069888|Antimitotic Agents|antimitotic agents|mesh-ancestor
64954504|NCT00069888|Mitosis Modulators|mitosis modulators|mesh-ancestor
64954505|NCT00069888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954506|NCT05433428|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64954507|NCT05433428|Lubricant Eye Drops|lubricant eye drops|mesh-list
64954508|NCT05433428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64954509|NCT00069927|Methylphenidate|methylphenidate|mesh-list
64955641|NCT00204022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64955642|NCT00204022|Antitubercular Agents|antitubercular agents|mesh-ancestor
64955643|NCT00204022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64955644|NCT00204022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64955645|NCT00204022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955646|NCT00204022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955647|NCT00204022|Antimetabolites|antimetabolites|mesh-ancestor
64955648|NCT00204022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64955649|NCT00204022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64955650|NCT00204022|Immunologic Factors|immunologic factors|mesh-ancestor
64955651|NCT00204022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955652|NCT00204022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64727407|NCT00002653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64727408|NCT00002653|Glucocorticoids|glucocorticoids|mesh-ancestor
64727409|NCT00002653|Hormones|hormones|mesh-ancestor
64727410|NCT00002653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64727411|NCT00002653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64727412|NCT00003254|Fluorouracil|fluorouracil|mesh-list
64727413|NCT00003254|Eniluracil|eniluracil|mesh-list
64955653|NCT00204061|Amisulpride|amisulpride|mesh-list
64955654|NCT00204061|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64955655|NCT00204061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64955656|NCT00204061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64955657|NCT00204061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955658|NCT00204061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64955659|NCT00204061|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64955660|NCT00204061|Dopamine Agents|dopamine agents|mesh-ancestor
64954510|NCT00069927|Amphetamine|amphetamine|mesh-list
64954511|NCT00069927|Adderall|adderall|mesh-list
64503441|NCT03347916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64493229|NCT04333407|Aspirin|aspirin|mesh-list
64954512|NCT00069927|Dextroamphetamine|dextroamphetamine|mesh-list
64954513|NCT00069927|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64954514|NCT00069927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954515|NCT00069927|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64954516|NCT00069927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64954517|NCT00069927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64954518|NCT00069927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954519|NCT00069927|Dopamine Agents|dopamine agents|mesh-ancestor
64954520|NCT00069927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64954521|NCT00069927|Sympathomimetics|sympathomimetics|mesh-ancestor
64954522|NCT00069927|Autonomic Agents|autonomic agents|mesh-ancestor
64955661|NCT00204061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64955662|NCT00204061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727415|NCT00003254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727416|NCT00003254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64727417|NCT00003254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727418|NCT00003254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727419|NCT00003254|Immunologic Factors|immunologic factors|mesh-ancestor
64727420|NCT00003254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727421|NCT00003254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727422|NCT00002659|Cisplatin|cisplatin|mesh-list
64727423|NCT00002659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727424|NCT00003998|Paclitaxel|paclitaxel|mesh-list
64727425|NCT00003998|Docetaxel|docetaxel|mesh-list
64727426|NCT00003998|Carboplatin|carboplatin|mesh-list
64727427|NCT00003998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64727428|NCT00003998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727429|NCT00003998|Tubulin Modulators|tubulin modulators|mesh-ancestor
64727430|NCT00003998|Antimitotic Agents|antimitotic agents|mesh-ancestor
64727431|NCT00003998|Mitosis Modulators|mitosis modulators|mesh-ancestor
64727432|NCT00003998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727433|NCT00004004|Procarbazine|procarbazine|mesh-list
64727434|NCT00004004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954523|NCT00069927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64954524|NCT00069927|Adrenergic Agents|adrenergic agents|mesh-ancestor
64954525|NCT00069927|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64954526|NCT00069966|Cytarabine|cytarabine|mesh-list
64954527|NCT00069966|Methylprednisolone|methylprednisolone|mesh-list
64954528|NCT00069966|Rituximab|rituximab|mesh-list
64954535|NCT00069966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64954536|NCT00069966|Antimetabolites|antimetabolites|mesh-ancestor
64727435|NCT00003260|Leucovorin|leucovorin|mesh-list
64954537|NCT00069966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954538|NCT00069966|Antiviral Agents|antiviral agents|mesh-ancestor
64727436|NCT00003260|Fluorouracil|fluorouracil|mesh-list
64727437|NCT00003260|Oxaliplatin|oxaliplatin|mesh-list
64727438|NCT00003260|Irinotecan|irinotecan|mesh-list
64727439|NCT00003260|Calcium|calcium|mesh-list
64727440|NCT00003260|Levoleucovorin|levoleucovorin|mesh-list
64727441|NCT00003260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64955663|NCT00204061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64955664|NCT00204061|Antidepressive Agents|antidepressive agents|mesh-ancestor
64955665|NCT02966652|Methyltestosterone|methyltestosterone|mesh-list
64955666|NCT02966652|Testosterone|testosterone|mesh-list
64955667|NCT02966652|Testosterone undecanoate|testosterone undecanoate|mesh-list
64955668|NCT02966652|Testosterone enanthate|testosterone enanthate|mesh-list
64954539|NCT00069966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64954540|NCT00069966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64954541|NCT00069966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64954542|NCT00069966|Antiemetics|antiemetics|mesh-ancestor
64954543|NCT00069966|Autonomic Agents|autonomic agents|mesh-ancestor
64954544|NCT00069966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64954545|NCT00069966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64954546|NCT00069966|Glucocorticoids|glucocorticoids|mesh-ancestor
64954547|NCT00069966|Hormones|hormones|mesh-ancestor
64954548|NCT00069966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64954549|NCT00069966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64954550|NCT00069966|Protective Agents|protective agents|mesh-ancestor
64955670|NCT02966652|Androgens|androgens|mesh-ancestor
64954551|NCT00069966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64954552|NCT00069966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64954553|NCT00069966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954554|NCT00065871|Contraceptive Agents|contraceptive agents|mesh-list
64954555|NCT00065871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64954556|NCT00065871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954557|NCT00065949|Magnesium Sulfate|magnesium sulfate|mesh-list
64954558|NCT00065949|Analgesics|analgesics|mesh-ancestor
64954559|NCT00065949|Sensory System Agents|sensory system agents|mesh-ancestor
64954560|NCT00065949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64726195|NCT00002245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64726196|NCT00002245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64726197|NCT00002245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726198|NCT00002245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954561|NCT00065949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954562|NCT00065949|Anesthetics|anesthetics|mesh-ancestor
64727442|NCT00003260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727443|NCT00003260|Antimetabolites|antimetabolites|mesh-ancestor
64727444|NCT00003260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334893|NCT03541655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64955671|NCT02966652|Hormones|hormones|mesh-ancestor
64422819|NCT02543801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64422820|NCT02543801|Analgesics|analgesics|mesh-ancestor
64954563|NCT00065949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64954564|NCT00065949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64954565|NCT00065949|Anticonvulsants|anticonvulsants|mesh-ancestor
64954566|NCT00065949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64954567|NCT00065949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64954568|NCT00065949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954569|NCT00065949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64727445|NCT00003260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64727446|NCT00003260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727447|NCT00003260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727448|NCT00003260|Immunologic Factors|immunologic factors|mesh-ancestor
64727449|NCT00003260|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64727450|NCT00003260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64727451|NCT00003260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334900|NCT02296411|Bromides|bromides|mesh-list
64494395|NCT01132846|Natriuretic Agents|natriuretic agents|mesh-ancestor
64955672|NCT02966652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64955673|NCT02966652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954570|NCT00065949|Tocolytic Agents|tocolytic agents|mesh-ancestor
64954571|NCT00065949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64954572|NCT00066027|Doxycycline|doxycycline|mesh-list
64954573|NCT00066027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64954574|NCT00066027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64954575|NCT00066027|Antimalarials|antimalarials|mesh-ancestor
64954576|NCT00066027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64954577|NCT00066027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64954578|NCT00396734|Topiramate|topiramate|mesh-list
64727452|NCT00003260|Antidotes|antidotes|mesh-ancestor
64727453|NCT00003260|Protective Agents|protective agents|mesh-ancestor
64494397|NCT01133158|Rituximab|rituximab|mesh-list
64954579|NCT00396734|Modafinil|modafinil|mesh-list
64954580|NCT00396734|Anticonvulsants|anticonvulsants|mesh-ancestor
64954581|NCT00396734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64954582|NCT00396734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954583|NCT00396734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64503442|NCT03347916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64954584|NCT00396734|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64954585|NCT00396734|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64954586|NCT00396734|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64727455|NCT00003260|Vitamins|vitamins|mesh-ancestor
64727456|NCT00003260|Micronutrients|micronutrients|mesh-ancestor
64727457|NCT00002665|Leucovorin|leucovorin|mesh-list
64727458|NCT00002665|Cytarabine|cytarabine|mesh-list
64727459|NCT00002665|Dexamethasone|dexamethasone|mesh-list
64727460|NCT00002665|Prednisone|prednisone|mesh-list
64727461|NCT00002665|Cyclophosphamide|cyclophosphamide|mesh-list
64727462|NCT00002665|Doxorubicin|doxorubicin|mesh-list
64727463|NCT00002665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64727464|NCT00002665|Methotrexate|methotrexate|mesh-list
64954587|NCT00396734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954589|NCT00070083|Cyclophosphamide|cyclophosphamide|mesh-list
64954590|NCT00070083|Rituximab|rituximab|mesh-list
64954591|NCT00070083|Doxorubicin|doxorubicin|mesh-list
64954592|NCT00070083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64954593|NCT00070083|Vincristine|vincristine|mesh-list
64954594|NCT00070083|Oblimersen|oblimersen|mesh-list
64954595|NCT00070083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64954596|NCT00070083|Immunologic Factors|immunologic factors|mesh-ancestor
64954597|NCT00070083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954598|NCT00070083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64727466|NCT00002665|Vincristine|vincristine|mesh-list
64727467|NCT00002665|Daunorubicin|daunorubicin|mesh-list
64727468|NCT00002665|Asparaginase|asparaginase|mesh-list
64727469|NCT00002665|Mercaptopurine|mercaptopurine|mesh-list
64727470|NCT00002665|Thioguanine|thioguanine|mesh-list
64727471|NCT00002665|Levoleucovorin|levoleucovorin|mesh-list
64727472|NCT00002665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727473|NCT00002665|Immunologic Factors|immunologic factors|mesh-ancestor
64727474|NCT00002665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334915|NCT04581473|Tubulin Modulators|tubulin modulators|mesh-ancestor
64955674|NCT02966652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64955675|NCT02966652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954604|NCT00070083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64954605|NCT00070083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64954606|NCT00070083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64954607|NCT00070083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64954608|NCT00070083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954609|NCT00070083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64954610|NCT00070083|Glucocorticoids|glucocorticoids|mesh-ancestor
64954611|NCT00070083|Hormones|hormones|mesh-ancestor
64727475|NCT00002665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64727476|NCT00002665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64727477|NCT00002665|Alkylating Agents|alkylating agents|mesh-ancestor
64727478|NCT00002665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727479|NCT00002665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727480|NCT00002665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64727481|NCT00002665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64954612|NCT00070083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64954613|NCT00070083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64954614|NCT00070083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64727483|NCT00002665|Autonomic Agents|autonomic agents|mesh-ancestor
64727484|NCT00002665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64727485|NCT00002665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64954615|NCT00070083|Tubulin Modulators|tubulin modulators|mesh-ancestor
64954616|NCT00070083|Antimitotic Agents|antimitotic agents|mesh-ancestor
64954617|NCT00070083|Mitosis Modulators|mitosis modulators|mesh-ancestor
64954618|NCT00070122|Leucovorin|leucovorin|mesh-list
64954619|NCT00070122|Bevacizumab|bevacizumab|mesh-list
64954620|NCT00070122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64954621|NCT00070122|Fluorouracil|fluorouracil|mesh-list
64954622|NCT00070122|Capecitabine|capecitabine|mesh-list
64954623|NCT00070122|Oxaliplatin|oxaliplatin|mesh-list
64954624|NCT00070122|Antibodies|antibodies|mesh-list
64954625|NCT00070122|Immunoglobulins|immunoglobulins|mesh-list
64954626|NCT00070122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64954627|NCT00070122|Levoleucovorin|levoleucovorin|mesh-list
64955676|NCT02966652|Anabolic Agents|anabolic agents|mesh-ancestor
64954628|NCT00070122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954629|NCT00070122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64954630|NCT00070122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64954631|NCT00070122|Growth Substances|growth substances|mesh-ancestor
64954632|NCT00070122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955677|NCT00039026|Exenatide|exenatide|mesh-list
64727486|NCT00002665|Glucocorticoids|glucocorticoids|mesh-ancestor
64727487|NCT00002665|Hormones|hormones|mesh-ancestor
64727488|NCT00002665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64727489|NCT00002665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64727490|NCT00002665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64423034|NCT05411965|Pioglitazone|pioglitazone|mesh-list
64726199|NCT00002245|Antiviral Agents|antiviral agents|mesh-ancestor
64726200|NCT00002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64954633|NCT00070122|Growth Inhibitors|growth inhibitors|mesh-ancestor
64954634|NCT00070122|Immunologic Factors|immunologic factors|mesh-ancestor
64954635|NCT00070122|Antimetabolites|antimetabolites|mesh-ancestor
64954636|NCT00070122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954637|NCT00070122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64954638|NCT00070122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64954639|NCT00070122|Antidotes|antidotes|mesh-ancestor
64954640|NCT00070122|Protective Agents|protective agents|mesh-ancestor
64954641|NCT00070122|Vitamin B Complex|vitamin b complex|mesh-ancestor
64954642|NCT00070122|Vitamins|vitamins|mesh-ancestor
64954643|NCT00070122|Micronutrients|micronutrients|mesh-ancestor
64954644|NCT00070161|Donepezil|donepezil|mesh-list
64727491|NCT00002665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64727492|NCT00002665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64727494|NCT00002665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64727495|NCT00002665|Abortifacient Agents|abortifacient agents|mesh-ancestor
64727496|NCT00002665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64334938|NCT02347059|Levodopa|levodopa|mesh-list
64954645|NCT00070161|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64954646|NCT00070161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954647|NCT00070161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954648|NCT00070161|Cholinergic Agents|cholinergic agents|mesh-ancestor
64954649|NCT00070161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64954650|NCT00070161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954651|NCT00070161|Nootropic Agents|nootropic agents|mesh-ancestor
64954652|NCT00070200|Cyclophosphamide|cyclophosphamide|mesh-list
64954653|NCT00070200|Melphalan|melphalan|mesh-list
64954654|NCT00070200|Doxorubicin|doxorubicin|mesh-list
64954655|NCT00070200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64954656|NCT00070200|Etoposide|etoposide|mesh-list
64955679|NCT00039026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955680|NCT00039026|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64955681|NCT00039026|Incretins|incretins|mesh-ancestor
64727497|NCT00002665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64727498|NCT00002665|Antimetabolites|antimetabolites|mesh-ancestor
64727499|NCT00002665|Dermatologic Agents|dermatologic agents|mesh-ancestor
64727500|NCT00002665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64727501|NCT00002665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64423051|NCT05378737|Exatecan|exatecan|mesh-list
64954657|NCT00070200|Vincristine|vincristine|mesh-list
64503443|NCT03347916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64503444|NCT03347916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64954658|NCT00070200|Topotecan|topotecan|mesh-list
64954659|NCT00070200|Isotretinoin|isotretinoin|mesh-list
64954660|NCT00070200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64954661|NCT00070200|Immunologic Factors|immunologic factors|mesh-ancestor
64954662|NCT00070200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954663|NCT00070200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64954664|NCT00070200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64727502|NCT00002665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64727504|NCT00002665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64727505|NCT00002665|Antidotes|antidotes|mesh-ancestor
64727506|NCT00002665|Protective Agents|protective agents|mesh-ancestor
64727507|NCT00002665|Vitamin B Complex|vitamin b complex|mesh-ancestor
64955682|NCT00039026|Hormones|hormones|mesh-ancestor
64955683|NCT00039026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64954665|NCT00070200|Alkylating Agents|alkylating agents|mesh-ancestor
64954666|NCT00070200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954667|NCT00070200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954669|NCT00070200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64954670|NCT00070200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64954671|NCT00070200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64954672|NCT00070200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954673|NCT00070200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64954674|NCT00070200|Tubulin Modulators|tubulin modulators|mesh-ancestor
64954675|NCT00070200|Antimitotic Agents|antimitotic agents|mesh-ancestor
64954676|NCT00070200|Mitosis Modulators|mitosis modulators|mesh-ancestor
64954677|NCT00070200|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64954678|NCT00070200|Dermatologic Agents|dermatologic agents|mesh-ancestor
64954680|NCT00066339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954681|NCT00066339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64954682|NCT00066339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954683|NCT00066339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954684|NCT00070239|Alvocidib|alvocidib|mesh-list
64727508|NCT00002665|Vitamins|vitamins|mesh-ancestor
64727509|NCT00002665|Micronutrients|micronutrients|mesh-ancestor
64727510|NCT00002665|Tubulin Modulators|tubulin modulators|mesh-ancestor
64727511|NCT00002665|Antimitotic Agents|antimitotic agents|mesh-ancestor
64727512|NCT00002665|Mitosis Modulators|mitosis modulators|mesh-ancestor
64727513|NCT00003536|Methotrexate|methotrexate|mesh-list
64727514|NCT00003536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64423067|NCT01659853|Azelaic acid|azelaic acid|mesh-list
64954685|NCT00070239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64954686|NCT00070239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64954687|NCT00070239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954688|NCT00070239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954689|NCT00070239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954690|NCT00070239|Growth Inhibitors|growth inhibitors|mesh-ancestor
64954691|NCT00070239|Growth Substances|growth substances|mesh-ancestor
64954692|NCT00070239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64727515|NCT00003536|Abortifacient Agents|abortifacient agents|mesh-ancestor
64727516|NCT00003536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64727517|NCT00003536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727518|NCT00003536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64727519|NCT00003536|Antimetabolites|antimetabolites|mesh-ancestor
64955684|NCT00204256|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64954693|NCT00070239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954694|NCT00070278|Gemcitabine|gemcitabine|mesh-list
64954695|NCT00070278|Paclitaxel|paclitaxel|mesh-list
64954696|NCT00070278|Cyclophosphamide|cyclophosphamide|mesh-list
64954697|NCT00070278|Epirubicin|epirubicin|mesh-list
64954698|NCT00070278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64954699|NCT00070278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954700|NCT00070278|Tubulin Modulators|tubulin modulators|mesh-ancestor
64954701|NCT00070278|Antimitotic Agents|antimitotic agents|mesh-ancestor
64954702|NCT00070278|Mitosis Modulators|mitosis modulators|mesh-ancestor
64954703|NCT00070278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954704|NCT00070278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64954705|NCT00070278|Immunologic Factors|immunologic factors|mesh-ancestor
64726201|NCT00002245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64726202|NCT00002245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64726203|NCT00002245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64420934|NCT02304705|Vasodilator Agents|vasodilator agents|mesh-ancestor
64420962|NCT04810559|Antibodies|antibodies|mesh-list
64954706|NCT00070278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954707|NCT00070278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64954708|NCT00070278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64954709|NCT00070278|Alkylating Agents|alkylating agents|mesh-ancestor
64954710|NCT00070278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64954711|NCT00070278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64954712|NCT00070278|Antimetabolites|antimetabolites|mesh-ancestor
64954713|NCT00070278|Antiviral Agents|antiviral agents|mesh-ancestor
64954714|NCT00070278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64954715|NCT00070278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954716|NCT00070278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64954717|NCT00070278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64954718|NCT00070278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64727520|NCT00003536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727521|NCT00003536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727522|NCT00003536|Dermatologic Agents|dermatologic agents|mesh-ancestor
64954719|NCT00066378|Gefitinib|gefitinib|mesh-list
64954720|NCT00066378|Anastrozole|anastrozole|mesh-list
64954721|NCT00066378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954722|NCT00066378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64954723|NCT00066378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954724|NCT00066378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954725|NCT00066378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64954726|NCT00066378|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64954727|NCT00066378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64954728|NCT00066378|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64954729|NCT00066378|Hormone Antagonists|hormone antagonists|mesh-ancestor
64954730|NCT00066378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64503445|NCT03347916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64954731|NCT00066378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954732|NCT00066417|Cyclosporine|cyclosporine|mesh-list
64954733|NCT00066417|Methylprednisolone|methylprednisolone|mesh-list
64954734|NCT00066417|Cyclophosphamide|cyclophosphamide|mesh-list
64954735|NCT00066417|Thiotepa|thiotepa|mesh-list
64954737|NCT00066417|Fludarabine phosphate|fludarabine phosphate|mesh-list
64954738|NCT00066417|Cyclosporins|cyclosporins|mesh-list
64955685|NCT00204256|Hematinics|hematinics|mesh-ancestor
64334966|NCT02296723|Valganciclovir|valganciclovir|mesh-list
64954739|NCT00066417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64954740|NCT00066417|Immunologic Factors|immunologic factors|mesh-ancestor
64954741|NCT00066417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954745|NCT00066417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954746|NCT00066417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954747|NCT00066417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64954748|NCT00066417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64954749|NCT00066417|Antimetabolites|antimetabolites|mesh-ancestor
64954750|NCT00066417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954751|NCT00066417|Antifungal Agents|antifungal agents|mesh-ancestor
64954752|NCT00066417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64494407|NCT01133158|Autonomic Agents|autonomic agents|mesh-ancestor
64955686|NCT00072111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64955687|NCT00072111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64423113|NCT05610085|Levetiracetam|levetiracetam|mesh-list
64954753|NCT00066417|Dermatologic Agents|dermatologic agents|mesh-ancestor
64954754|NCT00066417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64954755|NCT00066417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64954756|NCT00066417|Antiemetics|antiemetics|mesh-ancestor
64954757|NCT00066417|Autonomic Agents|autonomic agents|mesh-ancestor
64954758|NCT00066417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64954759|NCT00066417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64954760|NCT00066417|Glucocorticoids|glucocorticoids|mesh-ancestor
64954761|NCT00066417|Hormones|hormones|mesh-ancestor
64509200|NCT04126083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64727523|NCT00003536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727524|NCT00003536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64727525|NCT00003536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727526|NCT00003536|Immunologic Factors|immunologic factors|mesh-ancestor
64727527|NCT00003536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64727528|NCT00003536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64727529|NCT00003266|Methylphenidate|methylphenidate|mesh-list
64727530|NCT00003266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64334967|NCT02296723|Antiviral Agents|antiviral agents|mesh-ancestor
64955688|NCT00204451|Levonorgestrel|levonorgestrel|mesh-list
64954762|NCT00066417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64727532|NCT00003266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64954763|NCT00066417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64954764|NCT00066417|Protective Agents|protective agents|mesh-ancestor
64954765|NCT00066456|Docetaxel|docetaxel|mesh-list
64954766|NCT00066456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954767|NCT00066456|Tubulin Modulators|tubulin modulators|mesh-ancestor
64954768|NCT00066456|Antimitotic Agents|antimitotic agents|mesh-ancestor
64727533|NCT00003266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64727534|NCT00003266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64334975|NCT02289937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64954769|NCT00066456|Mitosis Modulators|mitosis modulators|mesh-ancestor
64954770|NCT00066456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954771|NCT00070434|Leucovorin|leucovorin|mesh-list
64954772|NCT00070434|Pyridoxine|pyridoxine|mesh-list
64954773|NCT00070434|Fluorouracil|fluorouracil|mesh-list
64954774|NCT00070434|Capecitabine|capecitabine|mesh-list
64954775|NCT00070434|Oxaliplatin|oxaliplatin|mesh-list
64954776|NCT00070434|Irinotecan|irinotecan|mesh-list
64954777|NCT00070434|Levoleucovorin|levoleucovorin|mesh-list
64727535|NCT00003266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727536|NCT00003266|Dopamine Agents|dopamine agents|mesh-ancestor
64727537|NCT00003266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64727538|NCT00003542|Interferons|interferons|mesh-list
64727539|NCT00003542|Interferon-alpha|interferon-alpha|mesh-list
64955689|NCT00204451|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64955690|NCT00204451|Estradiol|estradiol|mesh-list
64955691|NCT00204451|Estrogens|estrogens|mesh-ancestor
64955692|NCT00204451|Hormones|hormones|mesh-ancestor
64955693|NCT00204451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64955694|NCT00204451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955695|NCT00204451|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64955696|NCT00204451|Contraceptive Agents|contraceptive agents|mesh-ancestor
64954778|NCT00070434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954779|NCT00070434|Antimetabolites|antimetabolites|mesh-ancestor
64726204|NCT00002245|Antitubercular Agents|antitubercular agents|mesh-ancestor
64726205|NCT00002245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64726206|NCT00002245|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64726207|NCT00002245|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64954780|NCT00070434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954781|NCT00070434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64954782|NCT00070434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727540|NCT00003542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727541|NCT00003542|Antiviral Agents|antiviral agents|mesh-ancestor
64727542|NCT00003542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64727543|NCT00003542|Immunologic Factors|immunologic factors|mesh-ancestor
64334987|NCT03519061|Glucocorticoids|glucocorticoids|mesh-ancestor
64955697|NCT00204451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64954783|NCT00070434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64954784|NCT00070434|Immunologic Factors|immunologic factors|mesh-ancestor
64954785|NCT00070434|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64954786|NCT00070434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64954787|NCT00070434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954788|NCT00070434|Antidotes|antidotes|mesh-ancestor
64954789|NCT00070434|Protective Agents|protective agents|mesh-ancestor
64954790|NCT00070434|Vitamin B Complex|vitamin b complex|mesh-ancestor
64954791|NCT00070434|Vitamins|vitamins|mesh-ancestor
64954792|NCT00070434|Micronutrients|micronutrients|mesh-ancestor
64954793|NCT05402891|Lithium Carbonate|lithium carbonate|mesh-list
64954794|NCT05402891|Antidepressive Agents|antidepressive agents|mesh-ancestor
64954795|NCT05402891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64954796|NCT05402891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954797|NCT05402891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954798|NCT05402891|Antimanic Agents|antimanic agents|mesh-ancestor
64954799|NCT05402891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64954800|NCT05402891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64954801|NCT05402891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954802|NCT00070473|Pemetrexed|pemetrexed|mesh-list
64954803|NCT00070473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954804|NCT00070473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954805|NCT00070473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954806|NCT00070473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64954807|NCT00070473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64954808|NCT00066612|Irinotecan|irinotecan|mesh-list
64493518|NCT01069510|Spironolactone|spironolactone|mesh-list
64954809|NCT00066612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64954810|NCT00066612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64954811|NCT00066612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954812|NCT00066612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727544|NCT00003542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727546|NCT00004010|Cyclophosphamide|cyclophosphamide|mesh-list
64727547|NCT00004010|Dacarbazine|dacarbazine|mesh-list
64727548|NCT00004010|Doxorubicin|doxorubicin|mesh-list
64955698|NCT00204451|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64955699|NCT00204451|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64954813|NCT00066612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954814|NCT00070551|Cytarabine|cytarabine|mesh-list
64954818|NCT00070551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954819|NCT00070551|Antiviral Agents|antiviral agents|mesh-ancestor
64954820|NCT00070551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64954821|NCT00070551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64954822|NCT00070551|Immunologic Factors|immunologic factors|mesh-ancestor
64954823|NCT00070551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954824|NCT00070629|Paclitaxel|paclitaxel|mesh-list
64727549|NCT00004010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64727550|NCT00004010|Etoposide|etoposide|mesh-list
64727551|NCT00004010|Vincristine|vincristine|mesh-list
64727552|NCT00004010|Bleomycin|bleomycin|mesh-list
64727553|NCT00004010|Vinblastine|vinblastine|mesh-list
64727554|NCT00004010|Procarbazine|procarbazine|mesh-list
64954825|NCT00070629|Docetaxel|docetaxel|mesh-list
64954826|NCT00070629|Cisplatin|cisplatin|mesh-list
64954827|NCT00070629|Carboplatin|carboplatin|mesh-list
64954828|NCT00070629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64954829|NCT00070629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954830|NCT00070629|Tubulin Modulators|tubulin modulators|mesh-ancestor
64954831|NCT00070629|Antimitotic Agents|antimitotic agents|mesh-ancestor
64954832|NCT00070629|Mitosis Modulators|mitosis modulators|mesh-ancestor
64954833|NCT00070629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954834|NCT01349595|Bortezomib|bortezomib|mesh-list
64954835|NCT01349595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954836|NCT05184920|Nicotine|nicotine|mesh-list
64954837|NCT05184920|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64954838|NCT05184920|Autonomic Agents|autonomic agents|mesh-ancestor
64954839|NCT05184920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64727555|NCT00004010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727556|NCT00004010|Immunologic Factors|immunologic factors|mesh-ancestor
64727557|NCT00004010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727558|NCT00004010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64727559|NCT00004010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64727560|NCT00004010|Alkylating Agents|alkylating agents|mesh-ancestor
64727561|NCT00004010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727562|NCT00004010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420987|NCT05092373|Atezolizumab|atezolizumab|mesh-list
64954840|NCT05184920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954841|NCT05184920|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64954842|NCT05184920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64954843|NCT05184920|Cholinergic Agents|cholinergic agents|mesh-ancestor
64954844|NCT05184920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64954845|NCT05184920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954847|NCT02958501|Vitamin D|vitamin d|mesh-list
64727563|NCT00004010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64727564|NCT00004010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64466829|NCT01787500|Cetuximab|cetuximab|mesh-list
64727565|NCT00004010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64335004|NCT02293291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64955700|NCT00204451|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64955701|NCT00204451|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64955702|NCT00204529|Interferons|interferons|mesh-list
64954848|NCT02958501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64954849|NCT02958501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726208|NCT00002245|Protease Inhibitors|protease inhibitors|mesh-ancestor
64726210|NCT00003128|Ifosfamide|ifosfamide|mesh-list
64726211|NCT00003128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64726212|NCT00003128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954850|NCT02958501|Vitamins|vitamins|mesh-ancestor
64954851|NCT02958501|Micronutrients|micronutrients|mesh-ancestor
64954852|NCT02958501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64954853|NCT00066651|Immunotoxins|immunotoxins|mesh-list
64954854|NCT00066651|Immunologic Factors|immunologic factors|mesh-ancestor
64954855|NCT00066651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954856|NCT00398892|Thioctic Acid|thioctic acid|mesh-list
64954857|NCT00398892|Antioxidants|antioxidants|mesh-ancestor
64954858|NCT00398892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954859|NCT00398892|Protective Agents|protective agents|mesh-ancestor
64954860|NCT00398892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954861|NCT00398892|Vitamin B Complex|vitamin b complex|mesh-ancestor
64954862|NCT00398892|Vitamins|vitamins|mesh-ancestor
64954863|NCT00398892|Micronutrients|micronutrients|mesh-ancestor
64954864|NCT05019794|Infigratinib|infigratinib|mesh-list
64954865|NCT05019794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954866|NCT00066768|Gemcitabine|gemcitabine|mesh-list
64954867|NCT00066768|Suramin|suramin|mesh-list
64954868|NCT00066768|Docetaxel|docetaxel|mesh-list
64954869|NCT00066768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64727566|NCT00004010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64727567|NCT00004010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727568|NCT00004010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64727569|NCT00004010|Glucocorticoids|glucocorticoids|mesh-ancestor
64955703|NCT00204529|Interferon-alpha|interferon-alpha|mesh-list
64955704|NCT00204529|Interferon alpha-2|interferon alpha-2|mesh-list
64954870|NCT00066768|Antimetabolites|antimetabolites|mesh-ancestor
64954871|NCT00066768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954872|NCT00066768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954873|NCT00066768|Antiviral Agents|antiviral agents|mesh-ancestor
64954874|NCT00066768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64954875|NCT00066768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954876|NCT00066768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64954877|NCT00066768|Immunologic Factors|immunologic factors|mesh-ancestor
64954878|NCT00066768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954879|NCT00066768|Tubulin Modulators|tubulin modulators|mesh-ancestor
64954880|NCT00066768|Antimitotic Agents|antimitotic agents|mesh-ancestor
64954881|NCT00066768|Mitosis Modulators|mitosis modulators|mesh-ancestor
64954882|NCT00066768|Antinematodal Agents|antinematodal agents|mesh-ancestor
64954883|NCT00066768|Anthelmintics|anthelmintics|mesh-ancestor
64727571|NCT00004010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64727572|NCT00004010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64727573|NCT00004010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64727574|NCT00004010|Tubulin Modulators|tubulin modulators|mesh-ancestor
64727575|NCT00004010|Antimitotic Agents|antimitotic agents|mesh-ancestor
64494423|NCT05396118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64955705|NCT00204529|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64955706|NCT00204529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954884|NCT00066768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64954885|NCT00066768|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64503446|NCT03347916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64503447|NCT03347916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64954886|NCT00066768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64954887|NCT00066846|Leucovorin|leucovorin|mesh-list
64954899|NCT00066846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64954900|NCT00066846|Antimetabolites|antimetabolites|mesh-ancestor
64727576|NCT00004010|Mitosis Modulators|mitosis modulators|mesh-ancestor
64727577|NCT00004016|Interferons|interferons|mesh-list
64727578|NCT00004016|Interferon-gamma|interferon-gamma|mesh-list
64727579|NCT00004016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727580|NCT00004016|Antiviral Agents|antiviral agents|mesh-ancestor
64727581|NCT00004016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64727582|NCT00004022|Aldesleukin|aldesleukin|mesh-list
64727583|NCT00004022|Muromonab-CD3|muromonab-cd3|mesh-list
64727584|NCT00004022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727585|NCT00004022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64727586|NCT00004022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64727587|NCT00004022|Antiviral Agents|antiviral agents|mesh-ancestor
64727588|NCT00004022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64955707|NCT00204529|Antiviral Agents|antiviral agents|mesh-ancestor
64955708|NCT00204529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64955709|NCT00204529|Immunologic Factors|immunologic factors|mesh-ancestor
64955710|NCT00204529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955711|NCT00039104|Zoledronic Acid|zoledronic acid|mesh-list
64423226|NCT05332717|Melatonin|melatonin|mesh-list
64954901|NCT00066846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954902|NCT00066846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64954903|NCT00066846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64954904|NCT00066846|Immunologic Factors|immunologic factors|mesh-ancestor
64954905|NCT00066846|Antidotes|antidotes|mesh-ancestor
64954906|NCT00066846|Protective Agents|protective agents|mesh-ancestor
64954907|NCT00066846|Vitamin B Complex|vitamin b complex|mesh-ancestor
64954908|NCT00066846|Vitamins|vitamins|mesh-ancestor
64954909|NCT00066846|Micronutrients|micronutrients|mesh-ancestor
64954910|NCT00066885|Calcitriol|calcitriol|mesh-list
64954911|NCT00066885|Docetaxel|docetaxel|mesh-list
64954912|NCT00066885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954913|NCT00066885|Tubulin Modulators|tubulin modulators|mesh-ancestor
64727589|NCT00004022|Immunologic Factors|immunologic factors|mesh-ancestor
64727590|NCT00004022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727591|NCT00004022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727593|NCT00381901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64727594|NCT00381901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955712|NCT00039104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64954914|NCT00066885|Antimitotic Agents|antimitotic agents|mesh-ancestor
64954915|NCT00066885|Mitosis Modulators|mitosis modulators|mesh-ancestor
64954916|NCT00066885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954917|NCT00066885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64954918|NCT00066885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420994|NCT05092373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954919|NCT00066885|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64727596|NCT00003278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64727597|NCT00003278|Antiemetics|antiemetics|mesh-ancestor
64727598|NCT00003278|Autonomic Agents|autonomic agents|mesh-ancestor
64727599|NCT00003278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64335034|NCT02298205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64954920|NCT00066885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64954921|NCT00066885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64954922|NCT00066885|Vitamins|vitamins|mesh-ancestor
64727601|NCT00003278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64954923|NCT00066885|Micronutrients|micronutrients|mesh-ancestor
64954924|NCT00066885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64954925|NCT04941521|Exenatide|exenatide|mesh-list
64954926|NCT04941521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64954927|NCT04941521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726213|NCT00003128|Tubulin Modulators|tubulin modulators|mesh-ancestor
64726214|NCT00003128|Antimitotic Agents|antimitotic agents|mesh-ancestor
64727602|NCT00003278|Glucocorticoids|glucocorticoids|mesh-ancestor
64727603|NCT00003278|Hormones|hormones|mesh-ancestor
64727604|NCT00003278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64727605|NCT00003278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64727606|NCT00003278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727607|NCT00004028|Carmustine|carmustine|mesh-list
64727608|NCT00004028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64727609|NCT00004028|Alkylating Agents|alkylating agents|mesh-ancestor
64727610|NCT00004028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727611|NCT00004028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727612|NCT00003554|Prednisone|prednisone|mesh-list
64727613|NCT00003554|Rituximab|rituximab|mesh-list
64727614|NCT00003554|Melphalan|melphalan|mesh-list
64727615|NCT00003554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64727616|NCT00003554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727617|NCT00003554|Immunologic Factors|immunologic factors|mesh-ancestor
64727618|NCT00003554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335043|NCT02346201|Dopamine Agents|dopamine agents|mesh-ancestor
64727619|NCT00003554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64727620|NCT00003554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64727622|NCT00003554|Hormones|hormones|mesh-ancestor
64727623|NCT00003554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64726215|NCT00003128|Mitosis Modulators|mitosis modulators|mesh-ancestor
64333737|NCT03112785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954928|NCT04941521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64954929|NCT04941521|Incretins|incretins|mesh-ancestor
64954930|NCT04941521|Hormones|hormones|mesh-ancestor
64954931|NCT04941521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64954932|NCT02966457|Colistin|colistin|mesh-list
64954933|NCT02966457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64954934|NCT02966457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64954935|NCT00067041|Treprostinil|treprostinil|mesh-list
64727624|NCT00003554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64727625|NCT00003554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64727626|NCT00003554|Alkylating Agents|alkylating agents|mesh-ancestor
64727627|NCT00003554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954936|NCT00067041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64954937|NCT04732364|Bupivacaine|bupivacaine|mesh-list
64954938|NCT04732364|Anesthetics, Local|anesthetics, local|mesh-ancestor
64954939|NCT04732364|Anesthetics|anesthetics|mesh-ancestor
64954940|NCT04732364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64954941|NCT04732364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954942|NCT04732364|Sensory System Agents|sensory system agents|mesh-ancestor
64955713|NCT00039104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954943|NCT04732364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64954944|NCT04732598|Paclitaxel|paclitaxel|mesh-list
64955714|NCT00204568|Doxorubicin|doxorubicin|mesh-list
64955715|NCT00204568|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64727628|NCT00003554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64727629|NCT00003554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727630|NCT00003284|Paclitaxel|paclitaxel|mesh-list
64727631|NCT00003284|Etoposide|etoposide|mesh-list
64727632|NCT00003284|Carboplatin|carboplatin|mesh-list
64727633|NCT00003284|Ifosfamide|ifosfamide|mesh-list
64954945|NCT04732598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64954946|NCT04732598|Bevacizumab|bevacizumab|mesh-list
64954947|NCT04732598|Atezolizumab|atezolizumab|mesh-list
64954948|NCT04732598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64954949|NCT04732598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954950|NCT04732598|Tubulin Modulators|tubulin modulators|mesh-ancestor
64954951|NCT04732598|Antimitotic Agents|antimitotic agents|mesh-ancestor
64954955|NCT04732598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64727634|NCT00003284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64727636|NCT00003284|Tubulin Modulators|tubulin modulators|mesh-ancestor
64727637|NCT00003284|Antimitotic Agents|antimitotic agents|mesh-ancestor
64954956|NCT04732598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64954957|NCT04732598|Growth Substances|growth substances|mesh-ancestor
64954958|NCT04732598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954959|NCT04732598|Growth Inhibitors|growth inhibitors|mesh-ancestor
64503449|NCT03347916|Antimanic Agents|antimanic agents|mesh-ancestor
64954960|NCT00067080|Deferasirox|deferasirox|mesh-list
64954961|NCT00067080|Deferoxamine|deferoxamine|mesh-list
64954962|NCT00067080|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64954963|NCT00067080|Chelating Agents|chelating agents|mesh-ancestor
64727638|NCT00003284|Mitosis Modulators|mitosis modulators|mesh-ancestor
64727639|NCT00003284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466897|NCT01276600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64727640|NCT00003284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64727641|NCT00003284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64727642|NCT00003284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727643|NCT00003284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64727644|NCT00003284|Alkylating Agents|alkylating agents|mesh-ancestor
64727645|NCT00384410|Nabilone|nabilone|mesh-list
64955716|NCT00204568|Trofosfamide|trofosfamide|mesh-list
64955717|NCT00204568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64955718|NCT00204568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727646|NCT00384410|Antiemetics|antiemetics|mesh-ancestor
64727647|NCT00384410|Autonomic Agents|autonomic agents|mesh-ancestor
64727648|NCT00384410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64727649|NCT00384410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727650|NCT00384410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64727651|NCT00384410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64727652|NCT00384410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64335083|NCT02346357|Anesthetics, Local|anesthetics, local|mesh-ancestor
64954964|NCT00067080|Sequestering Agents|sequestering agents|mesh-ancestor
64954965|NCT00067080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954966|NCT00067080|Siderophores|siderophores|mesh-ancestor
64954967|NCT00396851|Metformin|metformin|mesh-list
64954968|NCT00396851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64954969|NCT00396851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954970|NCT00067119|Dipyridamole|dipyridamole|mesh-list
64954971|NCT00067119|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
64954972|NCT00067119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955719|NCT00204568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64727653|NCT00384410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64727654|NCT00384410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64727655|NCT00004040|Interferons|interferons|mesh-list
64727656|NCT00004040|Interferon-alpha|interferon-alpha|mesh-list
64727657|NCT00004040|Rituximab|rituximab|mesh-list
64727658|NCT00004040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64727659|NCT00004040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954973|NCT00067119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64954974|NCT00067119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954975|NCT00067119|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64954976|NCT00067119|Vasodilator Agents|vasodilator agents|mesh-ancestor
64954977|NCT00396929|Paclitaxel|paclitaxel|mesh-list
64954978|NCT00396929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64954979|NCT00396929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954980|NCT00396929|Tubulin Modulators|tubulin modulators|mesh-ancestor
64954981|NCT00396929|Antimitotic Agents|antimitotic agents|mesh-ancestor
64954982|NCT00396929|Mitosis Modulators|mitosis modulators|mesh-ancestor
64954983|NCT00396929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954984|NCT04750772|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
64954986|NCT04750772|Chelating Agents|chelating agents|mesh-ancestor
64954987|NCT04750772|Sequestering Agents|sequestering agents|mesh-ancestor
64954988|NCT04750772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954989|NCT04750772|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64954990|NCT00399165|Methyltestosterone|methyltestosterone|mesh-list
64954991|NCT00399165|Testosterone|testosterone|mesh-list
64954992|NCT00399165|Testosterone undecanoate|testosterone undecanoate|mesh-list
64954993|NCT00399165|Testosterone enanthate|testosterone enanthate|mesh-list
64954994|NCT00399165|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64954995|NCT00399165|Dutasteride|dutasteride|mesh-list
64954996|NCT00399165|Androgens|androgens|mesh-ancestor
64727660|NCT00004040|Immunologic Factors|immunologic factors|mesh-ancestor
64335091|NCT03146247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64955720|NCT00204568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64727661|NCT00004040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727662|NCT00004040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64727663|NCT00004040|Antiviral Agents|antiviral agents|mesh-ancestor
64727664|NCT00004040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64727665|NCT00004046|Exatecan|exatecan|mesh-list
64954997|NCT00399165|Hormones|hormones|mesh-ancestor
64726216|NCT00003128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726217|NCT00003128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64726218|NCT00003128|Alkylating Agents|alkylating agents|mesh-ancestor
64726219|NCT04331197|Letrozole|letrozole|mesh-list
64726220|NCT04331197|Clomiphene|clomiphene|mesh-list
64726221|NCT04331197|Enclomiphene|enclomiphene|mesh-list
64726222|NCT04331197|Zuclomiphene|zuclomiphene|mesh-list
64955721|NCT00204568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727666|NCT00004046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64727667|NCT00004046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64727669|NCT00004046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727670|NCT00004046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727671|NCT00003560|Carboplatin|carboplatin|mesh-list
64726223|NCT04331197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726224|NCT04331197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726225|NCT04331197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64726226|NCT04331197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64726227|NCT04331197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727672|NCT00003560|Docetaxel|docetaxel|mesh-list
64726228|NCT04331197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64954998|NCT00399165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64954999|NCT00399165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955000|NCT00399165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64955001|NCT00399165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955002|NCT00399165|Anabolic Agents|anabolic agents|mesh-ancestor
64955003|NCT00399165|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64955004|NCT00399165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64955005|NCT00399165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955006|NCT00399165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955007|NCT00399165|Hormone Antagonists|hormone antagonists|mesh-ancestor
64955008|NCT00067158|Nicotine|nicotine|mesh-list
64955009|NCT00067158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64727673|NCT00003560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727674|NCT00003560|Tubulin Modulators|tubulin modulators|mesh-ancestor
64727675|NCT00003560|Antimitotic Agents|antimitotic agents|mesh-ancestor
64727676|NCT00003560|Mitosis Modulators|mitosis modulators|mesh-ancestor
64727677|NCT00003560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727678|NCT00003290|Hormones|hormones|mesh-list
64727679|NCT00003290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64727680|NCT00003290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727681|NCT00382213|Olmesartan|olmesartan|mesh-list
64727682|NCT00382213|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64955010|NCT00067158|Autonomic Agents|autonomic agents|mesh-ancestor
64955011|NCT00067158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64955012|NCT00067158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955013|NCT00067158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64955014|NCT00067158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64955015|NCT00067158|Cholinergic Agents|cholinergic agents|mesh-ancestor
64955016|NCT00067158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64955017|NCT00067158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955018|NCT04245722|Cyclophosphamide|cyclophosphamide|mesh-list
64955019|NCT04245722|Rituximab|rituximab|mesh-list
64955020|NCT04245722|Fludarabine|fludarabine|mesh-list
64955021|NCT04245722|Obinutuzumab|obinutuzumab|mesh-list
64955027|NCT04245722|Alkylating Agents|alkylating agents|mesh-ancestor
64727684|NCT00382213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64727685|NCT00382213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64727686|NCT00382213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727687|NCT05748925|Dapagliflozin|dapagliflozin|mesh-list
64727688|NCT05748925|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64423266|NCT05351593|Lenalidomide|lenalidomide|mesh-list
64955028|NCT04245722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955029|NCT04245722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955030|NCT04245722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64955031|NCT04245722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64955032|NCT04231643|Dronabinol|dronabinol|mesh-list
64955033|NCT04231643|Cannabidiol|cannabidiol|mesh-list
64955034|NCT04231643|Hallucinogens|hallucinogens|mesh-ancestor
64503450|NCT05584644|Palbociclib|palbociclib|mesh-list
64955035|NCT04231643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503451|NCT05584644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503452|NCT05584644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64955036|NCT04231643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64955037|NCT04231643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64727689|NCT05748925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727690|NCT05748925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64727691|NCT05748925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727692|NCT00003572|Mycophenolic Acid|mycophenolic acid|mesh-list
64727693|NCT00003572|Tacrolimus|tacrolimus|mesh-list
64727694|NCT00003572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727695|NCT00003572|Immunologic Factors|immunologic factors|mesh-ancestor
64727696|NCT00003572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727697|NCT00003572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64727698|NCT00003572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955723|NCT00204568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727699|NCT00003572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727700|NCT00003572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64727701|NCT00003572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727702|NCT00003572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64727703|NCT00003572|Antitubercular Agents|antitubercular agents|mesh-ancestor
64727704|NCT00003572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64727705|NCT00003572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64727706|NCT05627479|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64727708|NCT00002689|Fluorouracil|fluorouracil|mesh-list
64727709|NCT00002689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64727710|NCT00002689|Antiemetics|antiemetics|mesh-ancestor
64727711|NCT00002689|Autonomic Agents|autonomic agents|mesh-ancestor
64727712|NCT00002689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64727713|NCT00002689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727714|NCT00002689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64727715|NCT00002689|Glucocorticoids|glucocorticoids|mesh-ancestor
64727716|NCT00002689|Hormones|hormones|mesh-ancestor
64727717|NCT00002689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64955038|NCT04231643|Analgesics|analgesics|mesh-ancestor
64955039|NCT04231643|Sensory System Agents|sensory system agents|mesh-ancestor
64955040|NCT04231643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64955041|NCT04231643|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64955042|NCT04231643|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64955043|NCT04231643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64955044|NCT04231643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727718|NCT00002689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64727719|NCT00002689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727720|NCT00002689|Antimetabolites|antimetabolites|mesh-ancestor
64727721|NCT00002689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727722|NCT00002689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64727723|NCT00002689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727724|NCT00002689|Immunologic Factors|immunologic factors|mesh-ancestor
64727725|NCT00003296|Doxorubicin|doxorubicin|mesh-list
64727726|NCT00003296|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64727727|NCT00003296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64727728|NCT00003296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727729|NCT00003296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64727730|NCT00003296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64727731|NCT00003296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727732|NCT00003296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727733|NCT00004064|Oregovomab|oregovomab|mesh-list
64727734|NCT00004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64727735|NCT00004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955046|NCT04231643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64955047|NCT04231643|Anticonvulsants|anticonvulsants|mesh-ancestor
64726229|NCT04331197|Hormone Antagonists|hormone antagonists|mesh-ancestor
64726230|NCT04331197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64726231|NCT04331197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726232|NCT04331197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64726233|NCT04331197|Fertility Agents|fertility agents|mesh-ancestor
64726234|NCT04331197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64955724|NCT00204568|Immunologic Factors|immunologic factors|mesh-ancestor
64955725|NCT00204568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955726|NCT00204568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64727736|NCT00382057|Anastrozole|anastrozole|mesh-list
64727737|NCT00382057|Goserelin|goserelin|mesh-list
64727738|NCT00382057|Testosterone|testosterone|mesh-list
64727739|NCT00382057|Androgens|androgens|mesh-ancestor
64727740|NCT00382057|Hormones|hormones|mesh-ancestor
64727741|NCT00382057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64727742|NCT00382057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727743|NCT00382057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64727744|NCT00382057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726235|NCT04331197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64726236|NCT04331197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64726237|NCT05751733|Sunitinib|sunitinib|mesh-list
64726238|NCT05751733|Imatinib Mesylate|imatinib mesylate|mesh-list
64726239|NCT05751733|Apatinib|apatinib|mesh-list
64726240|NCT05751733|Dasatinib|dasatinib|mesh-list
64726241|NCT05751733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726242|NCT05751733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64726243|NCT05751733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64955727|NCT00204568|Alkylating Agents|alkylating agents|mesh-ancestor
64955728|NCT00072150|Bortezomib|bortezomib|mesh-list
64727745|NCT00382057|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64727746|NCT00382057|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64727747|NCT00382057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727748|NCT00382057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727749|NCT00382057|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64727750|NCT00382057|Hormone Antagonists|hormone antagonists|mesh-ancestor
64727751|NCT00003578|Cytarabine|cytarabine|mesh-list
64727752|NCT00003578|Prednisone|prednisone|mesh-list
64727753|NCT00003578|Cyclophosphamide|cyclophosphamide|mesh-list
64727754|NCT00003578|Melphalan|melphalan|mesh-list
64727755|NCT00003578|Carmustine|carmustine|mesh-list
64727756|NCT00003578|Doxorubicin|doxorubicin|mesh-list
64727757|NCT00003578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64727758|NCT00003578|Etoposide|etoposide|mesh-list
64727759|NCT00003578|Vincristine|vincristine|mesh-list
64727760|NCT00003578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727761|NCT00003578|Immunologic Factors|immunologic factors|mesh-ancestor
64727762|NCT00003578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727763|NCT00003578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64335177|NCT02293525|Morphine|morphine|mesh-list
64726244|NCT05751733|Growth Substances|growth substances|mesh-ancestor
64726245|NCT05751733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726246|NCT05751733|Growth Inhibitors|growth inhibitors|mesh-ancestor
64726247|NCT05751733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64726248|NCT05751733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726249|NCT05751733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726250|NCT00002798|Cytarabine|cytarabine|mesh-list
64726251|NCT00002798|Aldesleukin|aldesleukin|mesh-list
64726252|NCT00002798|Dexamethasone|dexamethasone|mesh-list
64726253|NCT00002798|Hydrocortisone|hydrocortisone|mesh-list
64726254|NCT00002798|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64726255|NCT00002798|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64726256|NCT00002798|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64955048|NCT00071097|Darunavir|darunavir|mesh-list
64955049|NCT00071097|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64955050|NCT00071097|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64955051|NCT00071097|Protease Inhibitors|protease inhibitors|mesh-ancestor
64955052|NCT00071097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727764|NCT00003578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64727765|NCT00003578|Alkylating Agents|alkylating agents|mesh-ancestor
64727766|NCT00003578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727767|NCT00003578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727768|NCT00003578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64727769|NCT00003578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64727770|NCT00003578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64727771|NCT00003578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64727772|NCT00003578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727773|NCT00003578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64727774|NCT00003578|Glucocorticoids|glucocorticoids|mesh-ancestor
64727775|NCT00003578|Hormones|hormones|mesh-ancestor
64335194|NCT02345343|Antithrombins|antithrombins|mesh-ancestor
64955729|NCT00072150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955053|NCT00071097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955054|NCT00071097|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64955055|NCT00071097|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64955056|NCT00071097|Antiviral Agents|antiviral agents|mesh-ancestor
64955057|NCT00071097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64955058|NCT00067353|Fluorides|fluorides|mesh-list
64955059|NCT00067353|Fluorides, Topical|fluorides, topical|mesh-list
64955060|NCT00067353|Cariostatic Agents|cariostatic agents|mesh-ancestor
64955061|NCT00067353|Protective Agents|protective agents|mesh-ancestor
64955062|NCT00067353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955063|NCT00071136|Gemcitabine|gemcitabine|mesh-list
64727776|NCT00003578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64727777|NCT00003578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64727778|NCT00003578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64727779|NCT00003578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64727780|NCT00003578|Antimetabolites|antimetabolites|mesh-ancestor
64727781|NCT00003578|Antiviral Agents|antiviral agents|mesh-ancestor
64727782|NCT00003578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64727783|NCT00003578|Tubulin Modulators|tubulin modulators|mesh-ancestor
64727786|NCT00003584|Prednisone|prednisone|mesh-list
64955064|NCT00071136|Pemetrexed|pemetrexed|mesh-list
64955065|NCT00071136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64955066|NCT00071136|Antimetabolites|antimetabolites|mesh-ancestor
64955067|NCT00071136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726258|NCT00002798|Busulfan|busulfan|mesh-list
64726259|NCT00002798|Methotrexate|methotrexate|mesh-list
64726260|NCT00002798|Fludarabine|fludarabine|mesh-list
64726261|NCT00002798|Fludarabine phosphate|fludarabine phosphate|mesh-list
64726262|NCT00002798|Etoposide|etoposide|mesh-list
64726263|NCT00002798|Etoposide phosphate|etoposide phosphate|mesh-list
64726264|NCT00002798|Daunorubicin|daunorubicin|mesh-list
64333784|NCT03522181|Insulin|insulin|mesh-list
64955068|NCT00071136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727842|NCT00004070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64727843|NCT00004070|Immunologic Factors|immunologic factors|mesh-ancestor
64727844|NCT00004070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727845|NCT00004070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64335251|NCT03149679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64727846|NCT00004070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64727847|NCT00004070|Growth Substances|growth substances|mesh-ancestor
64727848|NCT00004070|Growth Inhibitors|growth inhibitors|mesh-ancestor
64727849|NCT00004070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727850|NCT00004082|Gemcitabine|gemcitabine|mesh-list
64727851|NCT00004082|Carboplatin|carboplatin|mesh-list
64727852|NCT00004082|Docetaxel|docetaxel|mesh-list
64727853|NCT00004082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727854|NCT00004082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64727855|NCT00004082|Antimetabolites|antimetabolites|mesh-ancestor
64727856|NCT00004082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727857|NCT00004082|Antiviral Agents|antiviral agents|mesh-ancestor
64727858|NCT00004082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64727859|NCT00004082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955730|NCT00204646|Carboplatin|carboplatin|mesh-list
64955731|NCT00204646|Etoposide|etoposide|mesh-list
64955732|NCT00204646|Doxorubicin|doxorubicin|mesh-list
64955733|NCT00204646|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64955069|NCT00071136|Antiviral Agents|antiviral agents|mesh-ancestor
64955070|NCT00071136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64955071|NCT00071136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955072|NCT00071136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64955073|NCT00071136|Immunologic Factors|immunologic factors|mesh-ancestor
64955074|NCT00071136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955075|NCT00071136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64955076|NCT00071136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64955077|NCT02970773|Rivaroxaban|rivaroxaban|mesh-list
64955078|NCT02970773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64727860|NCT00004082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727861|NCT00004082|Immunologic Factors|immunologic factors|mesh-ancestor
64727862|NCT00004082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955079|NCT02970773|Antithrombins|antithrombins|mesh-ancestor
64955080|NCT02970773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64955081|NCT02970773|Protease Inhibitors|protease inhibitors|mesh-ancestor
64955082|NCT02970773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955083|NCT02970773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955084|NCT02970773|Anticoagulants|anticoagulants|mesh-ancestor
64955085|NCT00067431|Valproic Acid|valproic acid|mesh-list
64955086|NCT00067431|Anticonvulsants|anticonvulsants|mesh-ancestor
64955087|NCT00067431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955088|NCT00067431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955091|NCT00067431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955092|NCT00067431|Antimanic Agents|antimanic agents|mesh-ancestor
64955093|NCT00067431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64955094|NCT00067431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64494445|NCT01134952|Immunologic Factors|immunologic factors|mesh-ancestor
64727863|NCT00004082|Tubulin Modulators|tubulin modulators|mesh-ancestor
64727864|NCT00004082|Antimitotic Agents|antimitotic agents|mesh-ancestor
64727865|NCT00004082|Mitosis Modulators|mitosis modulators|mesh-ancestor
64727866|NCT00002707|Tamoxifen|tamoxifen|mesh-list
64727867|NCT00002707|Cyclophosphamide|cyclophosphamide|mesh-list
64727869|NCT00002707|Doxorubicin|doxorubicin|mesh-list
64727870|NCT00002707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727871|NCT00002707|Immunologic Factors|immunologic factors|mesh-ancestor
64727872|NCT00002707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727873|NCT00002707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64727874|NCT00002707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64727875|NCT00002707|Alkylating Agents|alkylating agents|mesh-ancestor
64955095|NCT00067431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64955096|NCT00067509|Progesterone|progesterone|mesh-list
64955097|NCT00067509|Estrogens|estrogens|mesh-list
64955098|NCT00067509|Progestins|progestins|mesh-ancestor
64955099|NCT00067509|Hormones|hormones|mesh-ancestor
64955100|NCT00067509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64955101|NCT00067509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955102|NCT01349673|Budesonide|budesonide|mesh-list
64955103|NCT01349673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64955104|NCT01349673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64955736|NCT00204646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64727876|NCT00002707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727877|NCT00002707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727878|NCT00002707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64727879|NCT00002707|Tubulin Modulators|tubulin modulators|mesh-ancestor
64727880|NCT00002707|Antimitotic Agents|antimitotic agents|mesh-ancestor
64727881|NCT00002707|Mitosis Modulators|mitosis modulators|mesh-ancestor
64727882|NCT00002707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64955105|NCT01349673|Autonomic Agents|autonomic agents|mesh-ancestor
64955106|NCT01349673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64955107|NCT01349673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955108|NCT01349673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64955109|NCT01349673|Respiratory System Agents|respiratory system agents|mesh-ancestor
64955110|NCT01349673|Glucocorticoids|glucocorticoids|mesh-ancestor
64955111|NCT01349673|Hormones|hormones|mesh-ancestor
64955112|NCT01349673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64955113|NCT00071253|Valproic Acid|valproic acid|mesh-list
64955114|NCT00071253|Olanzapine|olanzapine|mesh-list
64955115|NCT00071253|Antiemetics|antiemetics|mesh-ancestor
64955737|NCT00204646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64955738|NCT00204646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64727883|NCT00002707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64727884|NCT00002707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64727885|NCT00002707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727886|NCT00002707|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64727887|NCT00002707|Hormone Antagonists|hormone antagonists|mesh-ancestor
64727888|NCT00002707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64727889|NCT00002707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64727890|NCT00002707|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64727891|NCT00002707|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64727892|NCT00002707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64727893|NCT00003596|Fluorouracil|fluorouracil|mesh-list
64727894|NCT00003596|Mitomycins|mitomycins|mesh-list
64727895|NCT00003596|Mitomycin|mitomycin|mesh-list
64727896|NCT00003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727897|NCT00003596|Antimetabolites|antimetabolites|mesh-ancestor
64727898|NCT00003596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727899|NCT00003596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64727900|NCT00003596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727901|NCT00003596|Immunologic Factors|immunologic factors|mesh-ancestor
64335318|NCT03514381|Ifosfamide|ifosfamide|mesh-list
64423347|NCT02522377|Anesthetics|anesthetics|mesh-ancestor
64955116|NCT00071253|Autonomic Agents|autonomic agents|mesh-ancestor
64955117|NCT00071253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64955118|NCT00071253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955119|NCT00071253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64955120|NCT00071253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64955121|NCT00071253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64955122|NCT00071253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64955123|NCT00071253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64727902|NCT00003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727903|NCT00003596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64727904|NCT00003596|Alkylating Agents|alkylating agents|mesh-ancestor
64727905|NCT00003596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64727906|NCT00003596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727908|NCT00002719|Etoposide|etoposide|mesh-list
64727909|NCT00002719|Mitoxantrone|mitoxantrone|mesh-list
64727910|NCT00002719|Idarubicin|idarubicin|mesh-list
64955744|NCT00039182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64955745|NCT00039182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955746|NCT00039182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64955747|NCT00039182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955748|NCT00039182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955124|NCT00071253|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64955125|NCT00071253|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64955126|NCT00071253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64955127|NCT00071253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955128|NCT00071253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64955129|NCT00071253|Serotonin Agents|serotonin agents|mesh-ancestor
64955130|NCT00071253|Anticonvulsants|anticonvulsants|mesh-ancestor
64726265|NCT00002798|Interleukin-2|interleukin-2|mesh-list
64726266|NCT00002798|Asparaginase|asparaginase|mesh-list
64726267|NCT00002798|Idarubicin|idarubicin|mesh-list
64726268|NCT00002798|Thioguanine|thioguanine|mesh-list
64955131|NCT00071253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955132|NCT00071253|GABA Agents|gaba agents|mesh-ancestor
64955133|NCT00071253|Antimanic Agents|antimanic agents|mesh-ancestor
64955134|NCT00067548|EKB 569|ekb 569|mesh-list
64955135|NCT00067548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955136|NCT00067548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64955137|NCT00067548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727911|NCT00002719|Carmustine|carmustine|mesh-list
64727912|NCT00002719|Amsacrine|amsacrine|mesh-list
64727913|NCT00002719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64727914|NCT00002719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727915|NCT00002719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64727916|NCT00002719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64727917|NCT00002719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727918|NCT00002719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727919|NCT00002719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64727920|NCT00002719|Antimetabolites|antimetabolites|mesh-ancestor
64727921|NCT00002719|Antiviral Agents|antiviral agents|mesh-ancestor
64727922|NCT00002719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64727923|NCT00002719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727924|NCT00002719|Immunologic Factors|immunologic factors|mesh-ancestor
64727925|NCT00002719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727926|NCT00002719|Analgesics|analgesics|mesh-ancestor
64727927|NCT00002719|Sensory System Agents|sensory system agents|mesh-ancestor
64727928|NCT00002719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64727929|NCT00002719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64727930|NCT00002719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64955138|NCT00067548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955139|NCT03439865|Ivacaftor|ivacaftor|mesh-list
64955140|NCT03439865|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64955141|NCT03439865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64955142|NCT03439865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955143|NCT03338621|Moxifloxacin|moxifloxacin|mesh-list
64955146|NCT03338621|Pyrazinamide|pyrazinamide|mesh-list
64727931|NCT00002719|Alkylating Agents|alkylating agents|mesh-ancestor
64727933|NCT00003326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64727934|NCT00003326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727935|NCT00003326|Tubulin Modulators|tubulin modulators|mesh-ancestor
64727936|NCT00003326|Antimitotic Agents|antimitotic agents|mesh-ancestor
64727937|NCT00003326|Mitosis Modulators|mitosis modulators|mesh-ancestor
64727938|NCT00003326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727939|NCT00002725|Bryostatin 1|bryostatin 1|mesh-list
64727940|NCT00002725|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64727941|NCT00002725|Immunologic Factors|immunologic factors|mesh-ancestor
64955749|NCT00410878|Hydromorphone|hydromorphone|mesh-list
64955147|NCT03338621|Ethambutol|ethambutol|mesh-list
64955148|NCT03338621|Bedaquiline|bedaquiline|mesh-list
64955149|NCT03338621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64955150|NCT03338621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64955151|NCT03338621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64955152|NCT03338621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64955153|NCT03338621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955154|NCT03338621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955155|NCT03338621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955156|NCT03338621|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64955157|NCT03338621|Antitubercular Agents|antitubercular agents|mesh-ancestor
64955158|NCT03338621|Leprostatic Agents|leprostatic agents|mesh-ancestor
64955159|NCT03338621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64955160|NCT03338621|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64955161|NCT03338621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64955162|NCT03338621|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64955170|NCT00071331|Tolvaptan|tolvaptan|mesh-list
64467199|NCT03800524|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
64727942|NCT00002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727943|NCT00002725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727945|NCT00003602|Etoposide|etoposide|mesh-list
64727946|NCT00003602|Mitoxantrone|mitoxantrone|mesh-list
64727947|NCT00003602|Idarubicin|idarubicin|mesh-list
64727948|NCT00003602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64727949|NCT00003602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955750|NCT00410878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64955171|NCT00071331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64955172|NCT00071331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955173|NCT00071331|Natriuretic Agents|natriuretic agents|mesh-ancestor
64955174|NCT00071331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955175|NCT02544815|Digoxin|digoxin|mesh-list
64955176|NCT02544815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64955177|NCT02544815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64955178|NCT02544815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955179|NCT02544815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727950|NCT00003602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64727952|NCT00003602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727953|NCT00003602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727954|NCT00003602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64727955|NCT00003602|Antimetabolites|antimetabolites|mesh-ancestor
64727956|NCT00003602|Antiviral Agents|antiviral agents|mesh-ancestor
64727957|NCT00003602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64727958|NCT00003602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727959|NCT00003602|Immunologic Factors|immunologic factors|mesh-ancestor
64727960|NCT00003602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727961|NCT00003602|Analgesics|analgesics|mesh-ancestor
64727962|NCT00003602|Sensory System Agents|sensory system agents|mesh-ancestor
64727963|NCT00003602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64727964|NCT00003602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64727965|NCT04609423|Vitamin D|vitamin d|mesh-list
64727966|NCT04609423|Cod Liver Oil|cod liver oil|mesh-list
64727967|NCT04609423|Vitamins|vitamins|mesh-ancestor
64727968|NCT04609423|Micronutrients|micronutrients|mesh-ancestor
64727969|NCT04609423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727970|NCT04609423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64727971|NCT00003332|Gemcitabine|gemcitabine|mesh-list
64727972|NCT00003332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727973|NCT00003332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64955180|NCT02544815|Protective Agents|protective agents|mesh-ancestor
64955181|NCT02544815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955182|NCT00067626|Chromium|chromium|mesh-list
64955183|NCT00067626|Trace Elements|trace elements|mesh-ancestor
64955184|NCT00067626|Micronutrients|micronutrients|mesh-ancestor
64493892|NCT01787409|Vitamin D|vitamin d|mesh-list
64503453|NCT05584644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955185|NCT00067626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955187|NCT00067743|Immunologic Factors|immunologic factors|mesh-ancestor
64727998|NCT00004094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727999|NCT00004094|Tubulin Modulators|tubulin modulators|mesh-ancestor
64728000|NCT00004094|Antimitotic Agents|antimitotic agents|mesh-ancestor
64728001|NCT00004094|Mitosis Modulators|mitosis modulators|mesh-ancestor
64728002|NCT00004094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728003|NCT00004094|Antimetabolites|antimetabolites|mesh-ancestor
64728004|NCT00004094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64728005|NCT00004094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728006|NCT00004094|Immunologic Factors|immunologic factors|mesh-ancestor
64728007|NCT00004094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728008|NCT00004094|Antisickling Agents|antisickling agents|mesh-ancestor
64728009|NCT00004094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728010|NCT00004094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64728011|NCT00004100|Gemcitabine|gemcitabine|mesh-list
64728012|NCT00004100|Vinorelbine|vinorelbine|mesh-list
64728013|NCT00004100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955188|NCT00067743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955189|NCT00067743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64955190|NCT00067743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64955191|NCT00067743|Growth Substances|growth substances|mesh-ancestor
64955192|NCT00067743|Growth Inhibitors|growth inhibitors|mesh-ancestor
64955193|NCT00067743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955194|NCT00396968|Plerixafor|plerixafor|mesh-list
64955195|NCT00396968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64955196|NCT00396968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64955197|NCT00396968|Antiviral Agents|antiviral agents|mesh-ancestor
64955198|NCT00396968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64955199|NCT00067860|Hormones|hormones|mesh-list
64728056|NCT00003626|Antimitotic Agents|antimitotic agents|mesh-ancestor
64728057|NCT00003626|Mitosis Modulators|mitosis modulators|mesh-ancestor
64728058|NCT00003626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728059|NCT00003632|Cytarabine|cytarabine|mesh-list
64728060|NCT00003632|Methotrexate|methotrexate|mesh-list
64728061|NCT00003632|Etoposide|etoposide|mesh-list
64728062|NCT00003632|Melphalan|melphalan|mesh-list
64728063|NCT00003632|Carmustine|carmustine|mesh-list
64423440|NCT05259241|Thrombin|thrombin|mesh-list
64955200|NCT00067860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64955201|NCT00067860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955202|NCT00071448|Insulin|insulin|mesh-list
64955203|NCT00071448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64955204|NCT00071448|Insulin Aspart|insulin aspart|mesh-list
64955205|NCT00071448|Insulin Lispro|insulin lispro|mesh-list
64955206|NCT00071448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64726269|NCT00002798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64726270|NCT00002798|Immunologic Factors|immunologic factors|mesh-ancestor
64955207|NCT00071448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955208|NCT02599324|Paclitaxel|paclitaxel|mesh-list
64955209|NCT02599324|Docetaxel|docetaxel|mesh-list
64955210|NCT02599324|Pembrolizumab|pembrolizumab|mesh-list
64955211|NCT02599324|Cetuximab|cetuximab|mesh-list
64955212|NCT02599324|Everolimus|everolimus|mesh-list
64728064|NCT00003632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64728065|NCT00003632|Abortifacient Agents|abortifacient agents|mesh-ancestor
64728066|NCT00003632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64728067|NCT00003632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728068|NCT00003632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64955751|NCT00410878|Narcotics|narcotics|mesh-ancestor
64955752|NCT00410878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64423441|NCT05259241|Hemostatics|hemostatics|mesh-ancestor
64955213|NCT02599324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64955214|NCT02599324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955215|NCT02599324|Tubulin Modulators|tubulin modulators|mesh-ancestor
64955216|NCT02599324|Antimitotic Agents|antimitotic agents|mesh-ancestor
64955217|NCT02599324|Mitosis Modulators|mitosis modulators|mesh-ancestor
64955218|NCT02599324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955219|NCT02599324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64955220|NCT02599324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64955221|NCT02599324|Immunologic Factors|immunologic factors|mesh-ancestor
64955222|NCT02599324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955223|NCT01331018|Plerixafor|plerixafor|mesh-list
64955224|NCT01331018|Prednisone|prednisone|mesh-list
64955225|NCT01331018|Methylprednisolone|methylprednisolone|mesh-list
64955226|NCT01331018|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64955227|NCT01331018|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64955228|NCT01331018|Prednisolone|prednisolone|mesh-list
64955229|NCT01331018|Prednisolone acetate|prednisolone acetate|mesh-list
64955230|NCT01331018|Cortisone|cortisone|mesh-list
64955231|NCT01331018|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64955242|NCT01331018|Immunologic Factors|immunologic factors|mesh-ancestor
64728069|NCT00003632|Antimetabolites|antimetabolites|mesh-ancestor
64728070|NCT00003632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728071|NCT00003632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728072|NCT00003632|Dermatologic Agents|dermatologic agents|mesh-ancestor
64728073|NCT00003632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728074|NCT00003632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64728075|NCT00003632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728076|NCT00003632|Immunologic Factors|immunologic factors|mesh-ancestor
64335496|NCT02302495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64955243|NCT01331018|Antiemetics|antiemetics|mesh-ancestor
64955244|NCT01331018|Autonomic Agents|autonomic agents|mesh-ancestor
64955245|NCT01331018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64955246|NCT01331018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64955247|NCT01331018|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64955248|NCT01331018|Protective Agents|protective agents|mesh-ancestor
64955249|NCT01331018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64955250|NCT01331018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64955251|NCT01331018|Antiviral Agents|antiviral agents|mesh-ancestor
64955252|NCT01331018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64955253|NCT00067899|Vitamins|vitamins|mesh-list
64955254|NCT00067899|Vitamin E|vitamin e|mesh-list
64955255|NCT00067899|Micronutrients|micronutrients|mesh-ancestor
64955256|NCT00067899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955257|NCT00067899|Antioxidants|antioxidants|mesh-ancestor
64955258|NCT00067899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955259|NCT00067899|Protective Agents|protective agents|mesh-ancestor
64955260|NCT00067938|Lamotrigine|lamotrigine|mesh-list
64955261|NCT00067938|Anticonvulsants|anticonvulsants|mesh-ancestor
64955262|NCT00067938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64955263|NCT00067938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64955264|NCT00067938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955265|NCT00067938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64955266|NCT00067938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955267|NCT00067938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64955268|NCT00067938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64955269|NCT00067938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64728077|NCT00003632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64728078|NCT00003632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64728079|NCT00003632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64728080|NCT00003632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64728081|NCT00003632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64728082|NCT00003632|Antiviral Agents|antiviral agents|mesh-ancestor
64728083|NCT00003632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64728084|NCT00003632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64728085|NCT00003632|Alkylating Agents|alkylating agents|mesh-ancestor
64728086|NCT00003632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64728087|NCT00004112|Prednisone|prednisone|mesh-list
64728088|NCT00004112|Cyclophosphamide|cyclophosphamide|mesh-list
64728089|NCT00004112|Rituximab|rituximab|mesh-list
64728090|NCT00004112|Doxorubicin|doxorubicin|mesh-list
64728091|NCT00004112|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64728092|NCT00004112|Vincristine|vincristine|mesh-list
64335503|NCT03747575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64423468|NCT05256823|Celecoxib|celecoxib|mesh-list
64955270|NCT00067938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64955271|NCT00067938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64955272|NCT02358187|Poly ICLC|poly iclc|mesh-list
64955273|NCT02358187|Interferon Inducers|interferon inducers|mesh-ancestor
64955274|NCT02358187|Immunologic Factors|immunologic factors|mesh-ancestor
64955275|NCT02358187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955276|NCT01809808|Hormones|hormones|mesh-list
64955277|NCT01809808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64955278|NCT01809808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955279|NCT00068055|gamma-Globulins|gamma-globulins|mesh-list
64955280|NCT00068055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64955281|NCT00068055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64955753|NCT00410878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955754|NCT00410878|Analgesics|analgesics|mesh-ancestor
64728093|NCT00004112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728094|NCT00004112|Immunologic Factors|immunologic factors|mesh-ancestor
64728095|NCT00004112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728096|NCT00004112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64728097|NCT00004112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64728098|NCT00004112|Alkylating Agents|alkylating agents|mesh-ancestor
64728099|NCT00004112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728100|NCT00004112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728101|NCT00004112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64728102|NCT00004112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64728103|NCT00004112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64728104|NCT00004112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64728105|NCT00004112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64728106|NCT00004112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728107|NCT00004112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64955282|NCT00068055|Immunologic Factors|immunologic factors|mesh-ancestor
64955283|NCT00068055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955284|NCT01406197|Progesterone|progesterone|mesh-list
64955285|NCT01406197|Progestins|progestins|mesh-ancestor
64955286|NCT01406197|Hormones|hormones|mesh-ancestor
64955287|NCT01406197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64955288|NCT01406197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955289|NCT00038402|Paclitaxel|paclitaxel|mesh-list
64955290|NCT00038402|Cyclophosphamide|cyclophosphamide|mesh-list
64726271|NCT00002798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726272|NCT00002798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64333790|NCT02373033|Hematinics|hematinics|mesh-ancestor
64955291|NCT00038402|Fluorouracil|fluorouracil|mesh-list
64955292|NCT00038402|Trastuzumab|trastuzumab|mesh-list
64955293|NCT00038402|Epirubicin|epirubicin|mesh-list
64955294|NCT00038402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64728109|NCT00004112|Hormones|hormones|mesh-ancestor
64728110|NCT00004112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64728111|NCT00004112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64728112|NCT00004112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64728113|NCT00004112|Tubulin Modulators|tubulin modulators|mesh-ancestor
64955758|NCT00410995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64423520|NCT04243837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955295|NCT00038402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955296|NCT00038402|Tubulin Modulators|tubulin modulators|mesh-ancestor
64955297|NCT00038402|Antimitotic Agents|antimitotic agents|mesh-ancestor
64955301|NCT00038402|Immunologic Factors|immunologic factors|mesh-ancestor
64955302|NCT00038402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955303|NCT00038402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64955304|NCT00038402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64955305|NCT00038402|Alkylating Agents|alkylating agents|mesh-ancestor
64955306|NCT00038402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64728114|NCT00004112|Antimitotic Agents|antimitotic agents|mesh-ancestor
64728115|NCT00004112|Mitosis Modulators|mitosis modulators|mesh-ancestor
64728116|NCT00003350|Paclitaxel|paclitaxel|mesh-list
64728117|NCT00003350|Doxorubicin|doxorubicin|mesh-list
64728118|NCT00003350|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64728119|NCT00003350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64728120|NCT00003350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728121|NCT00003350|Tubulin Modulators|tubulin modulators|mesh-ancestor
64728122|NCT00003350|Antimitotic Agents|antimitotic agents|mesh-ancestor
64728123|NCT00003350|Mitosis Modulators|mitosis modulators|mesh-ancestor
64955307|NCT00038402|Antimetabolites|antimetabolites|mesh-ancestor
64955308|NCT00038402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64955309|NCT00038402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64955310|NCT00038402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64955311|NCT00038402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64955312|NCT00038402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64955313|NCT00038402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955315|NCT00144703|Tacrolimus|tacrolimus|mesh-list
64728124|NCT00003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728125|NCT00003350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64728126|NCT00003350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64728127|NCT00003350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64728128|NCT00003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955316|NCT00144703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64955317|NCT00144703|Immunologic Factors|immunologic factors|mesh-ancestor
64955318|NCT00144703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955319|NCT00144703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64955320|NCT00144703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955321|NCT00144703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955322|NCT00144703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64955323|NCT00144703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64955324|NCT00144703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64955325|NCT00144703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955326|NCT00144703|Antifungal Agents|antifungal agents|mesh-ancestor
64955327|NCT00144820|Hyaluronic Acid|hyaluronic acid|mesh-list
64955328|NCT00144820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64955329|NCT00144820|Immunologic Factors|immunologic factors|mesh-ancestor
64955330|NCT00144820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955331|NCT00144820|Viscosupplements|viscosupplements|mesh-ancestor
64955760|NCT00410995|Analgesics|analgesics|mesh-ancestor
64955761|NCT00410995|Sensory System Agents|sensory system agents|mesh-ancestor
64955762|NCT00410995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64955763|NCT00410995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955764|NCT00410995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64955765|NCT00410995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64955766|NCT00410995|Gout Suppressants|gout suppressants|mesh-ancestor
64955767|NCT00410995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64955768|NCT00410995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955769|NCT00410995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955770|NCT00039338|Cisplatin|cisplatin|mesh-list
64955771|NCT00039338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955772|NCT00072228|Gemcitabine|gemcitabine|mesh-list
64955773|NCT00072228|Soblidotin|soblidotin|mesh-list
64728130|NCT05586373|Ibuprofen|ibuprofen|mesh-list
64728131|NCT05586373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64728132|NCT05586373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64728133|NCT05586373|Analgesics|analgesics|mesh-ancestor
64728134|NCT05586373|Sensory System Agents|sensory system agents|mesh-ancestor
64728135|NCT05586373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64728136|NCT05586373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728137|NCT05586373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64728138|NCT05586373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64728139|NCT05586373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64728140|NCT05586373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728141|NCT05586373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728142|NCT05586373|Antipyretics|antipyretics|mesh-ancestor
64728143|NCT00003356|Aldesleukin|aldesleukin|mesh-list
64728144|NCT00003356|Rituximab|rituximab|mesh-list
64955332|NCT00144820|Protective Agents|protective agents|mesh-ancestor
64955333|NCT00071643|Citalopram|citalopram|mesh-list
64955334|NCT00071643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64494047|NCT01090180|Hormones|hormones|mesh-ancestor
64955335|NCT00071643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64955336|NCT00071643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64955337|NCT00071643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728146|NCT00003356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728147|NCT00003356|Immunologic Factors|immunologic factors|mesh-ancestor
64728148|NCT00003356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728149|NCT00003356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64728150|NCT00003356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64728151|NCT00003356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64728152|NCT00003356|Antiviral Agents|antiviral agents|mesh-ancestor
64728153|NCT00003356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64728154|NCT05582707|Pioglitazone|pioglitazone|mesh-list
64728155|NCT05582707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64728156|NCT05582707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728157|NCT00003638|Cyclophosphamide|cyclophosphamide|mesh-list
64728158|NCT00003638|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
64728159|NCT00003638|Detox adjuvant|detox adjuvant|mesh-list
64728160|NCT00003638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728161|NCT00003638|Immunologic Factors|immunologic factors|mesh-ancestor
64335553|NCT02349399|Hormones|hormones|mesh-ancestor
64955774|NCT00072228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64955775|NCT00072228|Antimetabolites|antimetabolites|mesh-ancestor
64955776|NCT00072228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955777|NCT00072228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955781|NCT00072228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728162|NCT00003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728163|NCT00003638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64728164|NCT00003638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64728165|NCT00003638|Alkylating Agents|alkylating agents|mesh-ancestor
64728166|NCT00003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728167|NCT00003638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728168|NCT00003638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64728169|NCT00003638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64728170|NCT00004142|Fluorouracil|fluorouracil|mesh-list
64728171|NCT00004142|Floxuridine|floxuridine|mesh-list
64728172|NCT00004142|Antimetabolites|antimetabolites|mesh-ancestor
64955338|NCT00071643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64955339|NCT00071643|Serotonin Agents|serotonin agents|mesh-ancestor
64955340|NCT00071643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955341|NCT00071643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64955342|NCT00071643|Antidepressive Agents|antidepressive agents|mesh-ancestor
64955343|NCT00071643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64955344|NCT00144976|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64955345|NCT00144976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955346|NCT00144976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64955783|NCT00072228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955784|NCT00204919|Vitamin D|vitamin d|mesh-list
64955785|NCT00204919|Ergocalciferols|ergocalciferols|mesh-list
64955786|NCT00204919|Vitamins|vitamins|mesh-ancestor
64955787|NCT00204919|Micronutrients|micronutrients|mesh-ancestor
64955788|NCT00204919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955789|NCT00204919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64955790|NCT00204919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64955791|NCT00072267|Topotecan|topotecan|mesh-list
64955792|NCT00072267|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
64955793|NCT00072267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64955794|NCT00072267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64955795|NCT00072267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728174|NCT00004142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64728175|NCT00004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728176|NCT00004142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728177|NCT00004142|Immunologic Factors|immunologic factors|mesh-ancestor
64728178|NCT00004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955347|NCT00144976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955348|NCT00144976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955349|NCT00038480|Ritonavir|ritonavir|mesh-list
64955350|NCT00038480|Lopinavir|lopinavir|mesh-list
64955351|NCT00038480|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64955352|NCT00038480|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64955353|NCT00038480|Protease Inhibitors|protease inhibitors|mesh-ancestor
64955354|NCT00038480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955796|NCT00072267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955797|NCT00072267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955798|NCT00072267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64955799|NCT00039416|Imatinib Mesylate|imatinib mesylate|mesh-list
64955800|NCT00039416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955801|NCT00039416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64955802|NCT00039416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955803|NCT00039416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955804|NCT00072345|Thalidomide|thalidomide|mesh-list
64955805|NCT00072345|Temozolomide|temozolomide|mesh-list
64955806|NCT00072345|Lomustine|lomustine|mesh-list
64955807|NCT00072345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64728180|NCT00002749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728181|NCT00003362|Sargramostim|sargramostim|mesh-list
64728182|NCT00003362|Freund's Adjuvant|freund's adjuvant|mesh-list
64728183|NCT00003362|Immunologic Factors|immunologic factors|mesh-ancestor
64728184|NCT00003362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728185|NCT00003362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64728186|NCT00003650|Cytarabine|cytarabine|mesh-list
64955355|NCT00038480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955356|NCT00038480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64955357|NCT00038480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64955358|NCT00038480|Antiviral Agents|antiviral agents|mesh-ancestor
64955359|NCT00038480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64955360|NCT00038480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64955361|NCT00038480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64726273|NCT00002798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64726275|NCT00002798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955808|NCT00072345|Alkylating Agents|alkylating agents|mesh-ancestor
64955809|NCT00072345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955810|NCT00072345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955811|NCT00072345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728187|NCT00003650|Dexamethasone|dexamethasone|mesh-list
64728188|NCT00003650|Prednisone|prednisone|mesh-list
64728189|NCT00003650|Methylprednisolone|methylprednisolone|mesh-list
64728190|NCT00003650|Cyclophosphamide|cyclophosphamide|mesh-list
64728191|NCT00003650|Methotrexate|methotrexate|mesh-list
64728192|NCT00003650|Etoposide|etoposide|mesh-list
64728193|NCT00003650|Vincristine|vincristine|mesh-list
64728194|NCT00003650|Daunorubicin|daunorubicin|mesh-list
64955819|NCT00072345|Growth Substances|growth substances|mesh-ancestor
64726276|NCT00002798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726277|NCT00002798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64726278|NCT00002798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64726279|NCT00002798|Antiemetics|antiemetics|mesh-ancestor
64726280|NCT00002798|Autonomic Agents|autonomic agents|mesh-ancestor
64726281|NCT00002798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64726282|NCT00002798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64726283|NCT00002798|Glucocorticoids|glucocorticoids|mesh-ancestor
64726284|NCT00002798|Hormones|hormones|mesh-ancestor
64726285|NCT00002798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64726286|NCT00002798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64955362|NCT00202306|Lithium Carbonate|lithium carbonate|mesh-list
64955363|NCT00202306|Antidepressive Agents|antidepressive agents|mesh-ancestor
64955364|NCT00202306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64955365|NCT00202306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955366|NCT00202306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955371|NCT00038519|Ritonavir|ritonavir|mesh-list
64955372|NCT00038519|Saquinavir|saquinavir|mesh-list
64503454|NCT05584644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955820|NCT00072345|Growth Inhibitors|growth inhibitors|mesh-ancestor
64955821|NCT00039455|Trastuzumab|trastuzumab|mesh-list
64728195|NCT00003650|Asparaginase|asparaginase|mesh-list
64728196|NCT00003650|Mitoxantrone|mitoxantrone|mesh-list
64728197|NCT00003650|Mercaptopurine|mercaptopurine|mesh-list
64728198|NCT00003650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728199|NCT00003650|Immunologic Factors|immunologic factors|mesh-ancestor
64728200|NCT00003650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728201|NCT00003650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64728202|NCT00003650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64503455|NCT04892706|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
64503456|NCT04892706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64503457|NCT04892706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64503458|NCT04892706|Analgesics|analgesics|mesh-ancestor
64503459|NCT04892706|Sensory System Agents|sensory system agents|mesh-ancestor
64503460|NCT04892706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64503461|NCT04892706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503463|NCT04892706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64503464|NCT04892706|Dermatologic Agents|dermatologic agents|mesh-ancestor
64728203|NCT00003650|Alkylating Agents|alkylating agents|mesh-ancestor
64728204|NCT00003650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728205|NCT00003650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728206|NCT00003650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64728207|NCT00003650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64728208|NCT00003650|Antiemetics|antiemetics|mesh-ancestor
64728209|NCT00003650|Autonomic Agents|autonomic agents|mesh-ancestor
64728210|NCT00003650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64728211|NCT00003650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64728212|NCT00003650|Glucocorticoids|glucocorticoids|mesh-ancestor
64728213|NCT00003650|Hormones|hormones|mesh-ancestor
64728214|NCT00003650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64728215|NCT00003650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64728216|NCT00003650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64728217|NCT00003650|Abortifacient Agents|abortifacient agents|mesh-ancestor
64728218|NCT00003650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64728219|NCT00003650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64728220|NCT00003650|Antimetabolites|antimetabolites|mesh-ancestor
64728221|NCT00003650|Dermatologic Agents|dermatologic agents|mesh-ancestor
64728222|NCT00003650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335626|NCT03513601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64503465|NCT01821677|Danazol|danazol|mesh-list
64503466|NCT01821677|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64503467|NCT01821677|Hormone Antagonists|hormone antagonists|mesh-ancestor
64503468|NCT01821677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64503469|NCT01821677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503470|NCT03347760|Octreotide|octreotide|mesh-list
64503471|NCT03347760|Edotreotide|edotreotide|mesh-list
64503472|NCT03347760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64503473|NCT03347760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503474|NCT03347760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64503475|NCT03347760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64503476|NCT03347760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503477|NCT03062280|Hydrocortisone|hydrocortisone|mesh-list
64503478|NCT03062280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64503479|NCT00709722|Gusperimus|gusperimus|mesh-list
64503480|NCT00709722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64503481|NCT00709722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503482|NCT00709722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64503483|NCT00709722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503484|NCT00709722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64503485|NCT00709722|Immunologic Factors|immunologic factors|mesh-ancestor
64955827|NCT00039455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728224|NCT00003650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64728225|NCT00003650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64728226|NCT00003650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64728227|NCT00003650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64728228|NCT00003650|Antiviral Agents|antiviral agents|mesh-ancestor
64728229|NCT00003650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64728230|NCT00003650|Tubulin Modulators|tubulin modulators|mesh-ancestor
64728231|NCT00003650|Antimitotic Agents|antimitotic agents|mesh-ancestor
64503486|NCT00709722|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64503487|NCT00709722|Protective Agents|protective agents|mesh-ancestor
64503488|NCT01820585|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64503489|NCT01820585|Anticonvulsants|anticonvulsants|mesh-ancestor
64503490|NCT01820585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64503491|NCT01820585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64726287|NCT00002798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64726289|NCT00002798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64333806|NCT03596281|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64503492|NCT01820585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64503493|NCT01820585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503494|NCT02378298|Methylprednisolone|methylprednisolone|mesh-list
64728266|NCT00002755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64728267|NCT00002755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64728268|NCT00002755|Hormone Antagonists|hormone antagonists|mesh-ancestor
64728269|NCT00002755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64728270|NCT00002755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64728271|NCT00002755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64728272|NCT00002755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64728273|NCT00002755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64728274|NCT00002755|Trace Elements|trace elements|mesh-ancestor
64728275|NCT00002755|Micronutrients|micronutrients|mesh-ancestor
64728276|NCT00002761|Interferons|interferons|mesh-list
64728277|NCT00002761|Cytarabine|cytarabine|mesh-list
64728278|NCT00002761|Interferon-gamma|interferon-gamma|mesh-list
64728279|NCT00002761|Cyclosporine|cyclosporine|mesh-list
64728280|NCT00002761|Cyclophosphamide|cyclophosphamide|mesh-list
64728281|NCT00002761|Busulfan|busulfan|mesh-list
64728282|NCT00002761|Idarubicin|idarubicin|mesh-list
64728283|NCT00002761|Cyclosporins|cyclosporins|mesh-list
64728284|NCT00002761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64335686|NCT02341365|Vitamin D|vitamin d|mesh-list
64728285|NCT00002761|Immunologic Factors|immunologic factors|mesh-ancestor
64728286|NCT00002761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728287|NCT00002761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64728288|NCT00002761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64728289|NCT00002761|Alkylating Agents|alkylating agents|mesh-ancestor
64503495|NCT02378298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64503496|NCT02378298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64503497|NCT02378298|Prednisolone|prednisolone|mesh-list
64503498|NCT02378298|Prednisolone acetate|prednisolone acetate|mesh-list
64503499|NCT02378298|Rituximab|rituximab|mesh-list
64503500|NCT02378298|Methotrexate|methotrexate|mesh-list
64503501|NCT02378298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64503502|NCT02378298|Prednisolone phosphate|prednisolone phosphate|mesh-list
64503503|NCT02378298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64503504|NCT02378298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503505|NCT02378298|Immunologic Factors|immunologic factors|mesh-ancestor
64503506|NCT02378298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503507|NCT02378298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64503508|NCT02378298|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64728303|NCT00002761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64728304|NCT00382135|Tadalafil|tadalafil|mesh-list
64728305|NCT00382135|Vasodilator Agents|vasodilator agents|mesh-ancestor
64728306|NCT00382135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64728307|NCT00382135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64728308|NCT00382135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728309|NCT00382135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728310|NCT00382135|Urological Agents|urological agents|mesh-ancestor
64728311|NCT00003662|Cyclosporine|cyclosporine|mesh-list
64728312|NCT00003662|Methylprednisolone|methylprednisolone|mesh-list
64728313|NCT00003662|Cyclophosphamide|cyclophosphamide|mesh-list
64728314|NCT00003662|Melphalan|melphalan|mesh-list
64728315|NCT00003662|Busulfan|busulfan|mesh-list
64728316|NCT00003662|Cyclosporins|cyclosporins|mesh-list
64728317|NCT00003662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64728318|NCT00003662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728319|NCT00003662|Immunologic Factors|immunologic factors|mesh-ancestor
64728320|NCT00003662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728321|NCT00003662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64728322|NCT00003662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64728323|NCT00003662|Alkylating Agents|alkylating agents|mesh-ancestor
64728324|NCT00003662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728325|NCT00003662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728326|NCT00003662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64728327|NCT00003662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728328|NCT00003662|Antifungal Agents|antifungal agents|mesh-ancestor
64728329|NCT00003662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64728330|NCT00003662|Dermatologic Agents|dermatologic agents|mesh-ancestor
64728331|NCT00003662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64337016|NCT03499639|Ritonavir|ritonavir|mesh-list
64503509|NCT02378298|Abortifacient Agents|abortifacient agents|mesh-ancestor
64503510|NCT02378298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64503511|NCT02378298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64503512|NCT02378298|Antimetabolites|antimetabolites|mesh-ancestor
64503513|NCT02378298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503514|NCT02378298|Dermatologic Agents|dermatologic agents|mesh-ancestor
64503515|NCT02378298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64503516|NCT02378298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64503517|NCT02378298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64503531|NCT02253108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503532|NCT02253108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64503533|NCT02253108|Immunologic Factors|immunologic factors|mesh-ancestor
64503534|NCT02253108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503537|NCT01603420|Methyltestosterone|methyltestosterone|mesh-list
64503538|NCT01603420|Hormones|hormones|mesh-list
64503539|NCT01603420|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64503540|NCT01603420|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64503541|NCT01603420|Androgens|androgens|mesh-list
64503542|NCT01603420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503543|NCT01603420|Tubulin Modulators|tubulin modulators|mesh-ancestor
64955829|NCT00039455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728332|NCT00003662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64728333|NCT00003662|Antiemetics|antiemetics|mesh-ancestor
64728334|NCT00003662|Autonomic Agents|autonomic agents|mesh-ancestor
64728335|NCT00003662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64728336|NCT00003662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64728337|NCT00003662|Glucocorticoids|glucocorticoids|mesh-ancestor
64728338|NCT00003662|Hormones|hormones|mesh-ancestor
64503544|NCT01603420|Antimitotic Agents|antimitotic agents|mesh-ancestor
64503545|NCT01603420|Mitosis Modulators|mitosis modulators|mesh-ancestor
64503546|NCT01603420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503547|NCT01603420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64503548|NCT01603420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503549|NCT01603420|Antioxidants|antioxidants|mesh-ancestor
64503550|NCT01603420|Protective Agents|protective agents|mesh-ancestor
64503551|NCT01603420|Vitamins|vitamins|mesh-ancestor
64503552|NCT01603420|Micronutrients|micronutrients|mesh-ancestor
64503553|NCT01603420|Estrogens|estrogens|mesh-ancestor
64503554|NCT01603420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64503555|NCT01603420|Anabolic Agents|anabolic agents|mesh-ancestor
64955830|NCT00039455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728339|NCT00003662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64728340|NCT00003662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64728341|NCT00003662|Protective Agents|protective agents|mesh-ancestor
64728342|NCT00004154|Fenretinide|fenretinide|mesh-list
64728343|NCT00004154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728344|NCT00004154|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64728345|NCT00004154|Protective Agents|protective agents|mesh-ancestor
64728346|NCT00004154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728347|NCT00002767|Interferons|interferons|mesh-list
64728348|NCT00002767|Interferon-alpha|interferon-alpha|mesh-list
64728349|NCT00002767|Detox adjuvant|detox adjuvant|mesh-list
64728350|NCT00002767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728351|NCT00002767|Antiviral Agents|antiviral agents|mesh-ancestor
64728352|NCT00002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64728353|NCT00002767|Immunologic Factors|immunologic factors|mesh-ancestor
64728354|NCT00002767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728355|NCT00002767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64728356|NCT00002773|Interferons|interferons|mesh-list
64728357|NCT00002773|Interferon-alpha|interferon-alpha|mesh-list
64728358|NCT00002773|Cyclophosphamide|cyclophosphamide|mesh-list
64728359|NCT00002773|Sargramostim|sargramostim|mesh-list
64728360|NCT00002773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728361|NCT00002773|Immunologic Factors|immunologic factors|mesh-ancestor
64728362|NCT00002773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728363|NCT00002773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64728364|NCT00002773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64503556|NCT02064036|Leuprolide|leuprolide|mesh-list
64503557|NCT02064036|Goserelin|goserelin|mesh-list
64503558|NCT02064036|Bicalutamide|bicalutamide|mesh-list
64503559|NCT02064036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64503561|NCT02064036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64503562|NCT02064036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503563|NCT02064036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64503564|NCT02064036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503565|NCT02064036|Androgen Antagonists|androgen antagonists|mesh-ancestor
64503566|NCT02064036|Hormone Antagonists|hormone antagonists|mesh-ancestor
64503567|NCT02064036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64503568|NCT05645484|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64503569|NCT05645484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64503570|NCT05645484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503571|NCT04551300|Sevelamer|sevelamer|mesh-list
64503572|NCT04551300|Chelating Agents|chelating agents|mesh-ancestor
64726290|NCT00002798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64726291|NCT00002798|Antimetabolites|antimetabolites|mesh-ancestor
64726292|NCT00002798|Dermatologic Agents|dermatologic agents|mesh-ancestor
64726293|NCT00002798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726294|NCT00002798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64728384|NCT00004160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728385|NCT00004160|Immunologic Factors|immunologic factors|mesh-ancestor
64728386|NCT00004160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728387|NCT00003368|Irinotecan|irinotecan|mesh-list
64728388|NCT00003368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64728389|NCT00003368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64728390|NCT00003368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728391|NCT00003368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728392|NCT00003368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728394|NCT00003674|Tinzaparin|tinzaparin|mesh-list
64728395|NCT00003674|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64728396|NCT00003674|Anticoagulants|anticoagulants|mesh-ancestor
64728397|NCT00003674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64728398|NCT00003674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64337066|NCT03501901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64726295|NCT00002798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64503573|NCT04551300|Sequestering Agents|sequestering agents|mesh-ancestor
64503574|NCT04551300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503576|NCT04974580|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64503577|NCT04974580|Autonomic Agents|autonomic agents|mesh-ancestor
64503578|NCT04974580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64503579|NCT04974580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503580|NCT04974580|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64503585|NCT01691326|Vaccines|vaccines|mesh-list
64503586|NCT01691326|Immunologic Factors|immunologic factors|mesh-ancestor
64503588|NCT01606852|Dexmedetomidine|dexmedetomidine|mesh-list
64503589|NCT01606852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64955831|NCT00205231|Etanercept|etanercept|mesh-list
64955832|NCT00205231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64955833|NCT00205231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64955834|NCT00205231|Analgesics|analgesics|mesh-ancestor
64955835|NCT00205231|Sensory System Agents|sensory system agents|mesh-ancestor
64728399|NCT00003674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728400|NCT00003380|Doxorubicin|doxorubicin|mesh-list
64728401|NCT00003380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64728402|NCT00003380|Etoposide|etoposide|mesh-list
64728403|NCT00003380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64728404|NCT00003380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728405|NCT00003380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64728406|NCT00003380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64728407|NCT00003380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728408|NCT00003380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728409|NCT00003380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64728410|NCT05557591|Cemiplimab|cemiplimab|mesh-list
64728411|NCT05557591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64728412|NCT05557591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728413|NCT00002779|Fludarabine|fludarabine|mesh-list
64728414|NCT00002779|Fludarabine phosphate|fludarabine phosphate|mesh-list
64728415|NCT00002779|Octreotide|octreotide|mesh-list
64728416|NCT00002779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503590|NCT01606852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64503591|NCT01606852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503592|NCT01606852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64503593|NCT01606852|Analgesics|analgesics|mesh-ancestor
64503594|NCT01606852|Sensory System Agents|sensory system agents|mesh-ancestor
64503595|NCT01606852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64503596|NCT01606852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64503597|NCT01606852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64503598|NCT01606852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64503599|NCT01606852|Adrenergic Agents|adrenergic agents|mesh-ancestor
64728417|NCT00002779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64728418|NCT00002779|Antimetabolites|antimetabolites|mesh-ancestor
64728419|NCT00002779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728420|NCT00002779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728421|NCT00002779|Immunologic Factors|immunologic factors|mesh-ancestor
64728422|NCT00002779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728423|NCT00002779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64728424|NCT00002779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64728425|NCT00003680|Tamoxifen|tamoxifen|mesh-list
64728426|NCT00003680|Cyclophosphamide|cyclophosphamide|mesh-list
64728427|NCT00003680|Thiotepa|thiotepa|mesh-list
64728428|NCT00003680|Fluorouracil|fluorouracil|mesh-list
64728429|NCT00003680|Methotrexate|methotrexate|mesh-list
64728430|NCT00003680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728431|NCT00003680|Immunologic Factors|immunologic factors|mesh-ancestor
64728441|NCT00003680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64728442|NCT00003680|Abortifacient Agents|abortifacient agents|mesh-ancestor
64728443|NCT00003680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64728444|NCT00003680|Dermatologic Agents|dermatologic agents|mesh-ancestor
64728445|NCT00003680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728446|NCT00003680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64728447|NCT00003680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64955836|NCT00205231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64955837|NCT00205231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955838|NCT00205231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64955839|NCT00205231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64337068|NCT03132259|Dexmedetomidine|dexmedetomidine|mesh-list
64503600|NCT01606852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64503601|NCT01606852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503602|NCT01691560|Calcium, Dietary|calcium, dietary|mesh-list
64503603|NCT01691560|Listerine|listerine|mesh-list
64503604|NCT01691560|Calcium|calcium|mesh-list
64503605|NCT01691560|Fluorides|fluorides|mesh-list
64503606|NCT01691560|Sodium Fluoride|sodium fluoride|mesh-list
64503607|NCT01691560|Fluorophosphate|fluorophosphate|mesh-list
64503608|NCT01691560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64503609|NCT01691560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503611|NCT01691560|Cariostatic Agents|cariostatic agents|mesh-ancestor
64503612|NCT01691560|Protective Agents|protective agents|mesh-ancestor
64503613|NCT01691560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64503614|NCT01691560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64503615|NCT03346200|Tamoxifen|tamoxifen|mesh-list
64728450|NCT00003680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64728451|NCT00003680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64728452|NCT00003680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64728453|NCT00003680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64728454|NCT00003680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64955840|NCT00205231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64503616|NCT03346200|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64503617|NCT03346200|Hormone Antagonists|hormone antagonists|mesh-ancestor
64503618|NCT03346200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64503619|NCT03346200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503620|NCT03346200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64503621|NCT03346200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503622|NCT03346200|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64503623|NCT03346200|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64503624|NCT03346200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64728456|NCT00002785|Cobalt|cobalt|mesh-list
64728457|NCT00002785|Cytarabine|cytarabine|mesh-list
64728458|NCT00002785|Cyclosporine|cyclosporine|mesh-list
64728459|NCT00002785|Dexamethasone|dexamethasone|mesh-list
64728460|NCT00002785|Prednisone|prednisone|mesh-list
64728461|NCT00002785|Methylprednisolone|methylprednisolone|mesh-list
64728462|NCT00002785|Hydrocortisone|hydrocortisone|mesh-list
64728463|NCT00002785|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64728464|NCT00002785|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64728465|NCT00002785|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64728466|NCT00002785|Cyclophosphamide|cyclophosphamide|mesh-list
64728467|NCT00002785|Methotrexate|methotrexate|mesh-list
64728468|NCT00002785|Etoposide|etoposide|mesh-list
64955841|NCT00205231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64955842|NCT00205231|Immunologic Factors|immunologic factors|mesh-ancestor
64728469|NCT00002785|Vincristine|vincristine|mesh-list
64728470|NCT00002785|Daunorubicin|daunorubicin|mesh-list
64728471|NCT00002785|Asparaginase|asparaginase|mesh-list
64728472|NCT00002785|Mercaptopurine|mercaptopurine|mesh-list
64728473|NCT00002785|Pegaspargase|pegaspargase|mesh-list
64728474|NCT00002785|Cyclosporins|cyclosporins|mesh-list
64728475|NCT00002785|Levoleucovorin|levoleucovorin|mesh-list
64337073|NCT03132259|Analgesics|analgesics|mesh-ancestor
64503625|NCT01692340|Lycopene|lycopene|mesh-list
64503626|NCT01692340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64503627|NCT01692340|Antioxidants|antioxidants|mesh-ancestor
64503628|NCT01692340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503629|NCT01692340|Protective Agents|protective agents|mesh-ancestor
64503630|NCT01692340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503631|NCT01692340|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64503632|NCT01692340|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64503633|NCT01692340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503634|NCT02517372|Pemirolast|pemirolast|mesh-list
64955843|NCT00072462|Tamoxifen|tamoxifen|mesh-list
64494544|NCT04246554|Antipyretics|antipyretics|mesh-ancestor
64728476|NCT00002785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728477|NCT00002785|Immunologic Factors|immunologic factors|mesh-ancestor
64467735|NCT04780438|Dapagliflozin|dapagliflozin|mesh-list
64728478|NCT00002785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728479|NCT00002785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64728480|NCT00002785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64728481|NCT00002785|Alkylating Agents|alkylating agents|mesh-ancestor
64728482|NCT00002785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728483|NCT00002785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728484|NCT00002785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64728485|NCT00002785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64728487|NCT00002785|Autonomic Agents|autonomic agents|mesh-ancestor
64611348|NCT04364425|Triamcinolone|triamcinolone|mesh-list
64503635|NCT02517372|Histamine Antagonists|histamine antagonists|mesh-ancestor
64503636|NCT02517372|Histamine Agents|histamine agents|mesh-ancestor
64503637|NCT02517372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64726296|NCT00002798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64726297|NCT00002798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64726298|NCT00002798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64726299|NCT00002798|Antiviral Agents|antiviral agents|mesh-ancestor
64726300|NCT00002798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64728488|NCT00002785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64728489|NCT00002785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64728490|NCT00002785|Glucocorticoids|glucocorticoids|mesh-ancestor
64728491|NCT00002785|Hormones|hormones|mesh-ancestor
64728492|NCT00002785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64728493|NCT00002785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64728494|NCT00002785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64728495|NCT00002785|Abortifacient Agents|abortifacient agents|mesh-ancestor
64728496|NCT00002785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64728497|NCT00002785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64728498|NCT00002785|Antimetabolites|antimetabolites|mesh-ancestor
64728499|NCT00002785|Dermatologic Agents|dermatologic agents|mesh-ancestor
64728500|NCT00002785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728501|NCT00002785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64726301|NCT00002798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64726302|NCT00002798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64726303|NCT00002798|Analgesics|analgesics|mesh-ancestor
64726304|NCT00002798|Sensory System Agents|sensory system agents|mesh-ancestor
64726305|NCT00002798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64726306|NCT00002798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64726307|NCT00002251|Ganciclovir|ganciclovir|mesh-list
64726308|NCT00002251|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64726309|NCT00002251|Antiviral Agents|antiviral agents|mesh-ancestor
64726310|NCT00002251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726311|NCT00002251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64726312|NCT00002251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333815|NCT03596281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64503638|NCT02517372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728563|NCT00384566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64728564|NCT00384566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728565|NCT00384566|Antioxidants|antioxidants|mesh-ancestor
64728566|NCT00384566|Protective Agents|protective agents|mesh-ancestor
64728567|NCT00384566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64728568|NCT00384566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64728569|NCT00384566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64728570|NCT00384566|Vasodilator Agents|vasodilator agents|mesh-ancestor
64728571|NCT00384566|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64728572|NCT00384566|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64503639|NCT02517372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503640|NCT02516826|Olmesartan|olmesartan|mesh-list
64955373|NCT00038519|Amprenavir|amprenavir|mesh-list
64955374|NCT00038519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64955375|NCT00038519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64503641|NCT02516826|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64503642|NCT02516826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64503643|NCT02516826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64503644|NCT02516826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64503645|NCT02516826|Antimetabolites|antimetabolites|mesh-ancestor
64503646|NCT02516826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503647|NCT02516826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64503659|NCT01650298|Protease Inhibitors|protease inhibitors|mesh-ancestor
64503660|NCT01650298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728574|NCT05501665|Paclitaxel|paclitaxel|mesh-list
64728575|NCT05501665|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64728576|NCT05501665|Carboplatin|carboplatin|mesh-list
64728577|NCT05501665|Pembrolizumab|pembrolizumab|mesh-list
64728578|NCT05501665|Pemetrexed|pemetrexed|mesh-list
64728579|NCT05501665|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64728580|NCT05501665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64728581|NCT05501665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728582|NCT05501665|Tubulin Modulators|tubulin modulators|mesh-ancestor
64728583|NCT05501665|Antimitotic Agents|antimitotic agents|mesh-ancestor
64728584|NCT05501665|Mitosis Modulators|mitosis modulators|mesh-ancestor
64728585|NCT05501665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728586|NCT05501665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64728587|NCT05501665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728588|NCT05501665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64728589|NCT05501665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64728590|NCT05501665|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64728591|NCT05501665|Antimetabolites|antimetabolites|mesh-ancestor
64728592|NCT05501665|Antiviral Agents|antiviral agents|mesh-ancestor
64728593|NCT05501665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64728594|NCT00004832|Amifampridine|amifampridine|mesh-list
64728595|NCT00004832|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64728596|NCT00004832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64728597|NCT00004832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728598|NCT00004832|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64728599|NCT00004832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64728600|NCT00004832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503661|NCT01650298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503662|NCT01650298|Anticoagulants|anticoagulants|mesh-ancestor
64503663|NCT05583006|Tenofovir|tenofovir|mesh-list
64503664|NCT05583006|Antiviral Agents|antiviral agents|mesh-ancestor
64503665|NCT05583006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64503666|NCT05583006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64503667|NCT05583006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64503668|NCT05583006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728601|NCT00002791|Doxorubicin|doxorubicin|mesh-list
64728602|NCT00002791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64728618|NCT00004190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728619|NCT00004190|Antiviral Agents|antiviral agents|mesh-ancestor
64728620|NCT00004190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64728621|NCT00004190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728622|NCT00004190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728623|NCT00004190|Immunologic Factors|immunologic factors|mesh-ancestor
64728624|NCT00004190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728625|NCT00004196|Interferons|interferons|mesh-list
64728626|NCT00004196|Interferon-alpha|interferon-alpha|mesh-list
64728627|NCT00004196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336029|NCT02300701|Omalizumab|omalizumab|mesh-list
64955846|NCT00072462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64955847|NCT00072462|Hormone Antagonists|hormone antagonists|mesh-ancestor
64728628|NCT00004196|Antiviral Agents|antiviral agents|mesh-ancestor
64728629|NCT00004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64728630|NCT00004196|Immunologic Factors|immunologic factors|mesh-ancestor
64467901|NCT00063232|Metformin|metformin|mesh-list
64728631|NCT00004196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728633|NCT00004838|Antidotes|antidotes|mesh-ancestor
64503669|NCT05583006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503670|NCT05583006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64503671|NCT05583006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64503672|NCT01795937|Itraconazole|itraconazole|mesh-list
64503673|NCT01795937|Atorvastatin|atorvastatin|mesh-list
64503674|NCT01795937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64503675|NCT01795937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64503676|NCT01795937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64503677|NCT01795937|Antimetabolites|antimetabolites|mesh-ancestor
64503678|NCT01795937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503679|NCT01795937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64503680|NCT01795937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64728634|NCT00004838|Protective Agents|protective agents|mesh-ancestor
64955848|NCT00072462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64955849|NCT00072462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728635|NCT00004838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728636|NCT00004838|Chelating Agents|chelating agents|mesh-ancestor
64728637|NCT00004838|Sequestering Agents|sequestering agents|mesh-ancestor
64728638|NCT00004838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728639|NCT00004202|Paclitaxel|paclitaxel|mesh-list
64728640|NCT00004202|Carboplatin|carboplatin|mesh-list
64728641|NCT00004202|Efaproxiral|efaproxiral|mesh-list
64728642|NCT00004202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64337142|NCT03494257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64503681|NCT01795937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64503683|NCT01795937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64503684|NCT01795937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64726313|NCT00002251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726314|NCT00002257|Ganciclovir|ganciclovir|mesh-list
64726315|NCT00002257|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64503685|NCT01795937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64728643|NCT00004202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955850|NCT00072462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64728645|NCT00004202|Antimitotic Agents|antimitotic agents|mesh-ancestor
64728646|NCT00004202|Mitosis Modulators|mitosis modulators|mesh-ancestor
64728647|NCT00004202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728648|NCT00004202|Antisickling Agents|antisickling agents|mesh-ancestor
64728649|NCT00003686|Pilocarpine|pilocarpine|mesh-list
64728650|NCT00003686|Miotics|miotics|mesh-ancestor
64728651|NCT00003686|Autonomic Agents|autonomic agents|mesh-ancestor
64728652|NCT00003686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64728653|NCT00003686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337149|NCT03132181|Empagliflozin|empagliflozin|mesh-list
64503686|NCT01795937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64503687|NCT01795937|Hormone Antagonists|hormone antagonists|mesh-ancestor
64503688|NCT01795937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64503689|NCT01795937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503690|NCT01795937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64503691|NCT04501224|Tenofovir|tenofovir|mesh-list
64503692|NCT04501224|Entecavir|entecavir|mesh-list
64503693|NCT04501224|Antiviral Agents|antiviral agents|mesh-ancestor
64503694|NCT04501224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64503695|NCT04501224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64503696|NCT04501224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64503697|NCT04501224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64503698|NCT04501224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503699|NCT04501224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64503700|NCT04501224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64503701|NCT01817777|Metformin|metformin|mesh-list
64503702|NCT01817777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64503703|NCT01817777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503704|NCT01795547|Aripiprazole|aripiprazole|mesh-list
64503705|NCT01795547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64503706|NCT01795547|Antidepressive Agents|antidepressive agents|mesh-ancestor
64503707|NCT01795547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64503708|NCT01795547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64728654|NCT00003686|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64728655|NCT00003686|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64728656|NCT00003686|Cholinergic Agents|cholinergic agents|mesh-ancestor
64728657|NCT00003686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64728658|NCT00003686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728659|NCT05495035|Dexamethasone|dexamethasone|mesh-list
64728660|NCT05495035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64728661|NCT05495035|Antiemetics|antiemetics|mesh-ancestor
64728662|NCT05495035|Autonomic Agents|autonomic agents|mesh-ancestor
64728663|NCT05495035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64728664|NCT05495035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728665|NCT05495035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64728666|NCT05495035|Glucocorticoids|glucocorticoids|mesh-ancestor
64728667|NCT05495035|Hormones|hormones|mesh-ancestor
64728668|NCT05495035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64728669|NCT05495035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64503709|NCT01795547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64503710|NCT01795547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64503714|NCT01795547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64503715|NCT01795547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503716|NCT01795547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64503718|NCT01795547|Serotonin Agents|serotonin agents|mesh-ancestor
64503719|NCT01795547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64503720|NCT01795547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64503721|NCT01795547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64955851|NCT00072462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728688|NCT00004862|Antiviral Agents|antiviral agents|mesh-ancestor
64728689|NCT00004862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64728690|NCT00004220|Gemcitabine|gemcitabine|mesh-list
64728691|NCT00004220|Oxaliplatin|oxaliplatin|mesh-list
64728692|NCT00004220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64728693|NCT00004220|Antimetabolites|antimetabolites|mesh-ancestor
64728694|NCT00004220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728695|NCT00004220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503722|NCT01795547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64503723|NCT03923556|Neostigmine|neostigmine|mesh-list
64503724|NCT03923556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64503725|NCT03923556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64503726|NCT03923556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503727|NCT03923556|Cholinergic Agents|cholinergic agents|mesh-ancestor
64503728|NCT03923556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64503729|NCT03923556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503730|NCT03923556|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64503731|NCT03923556|Autonomic Agents|autonomic agents|mesh-ancestor
64503732|NCT03923556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64503733|NCT03863184|Rituximab|rituximab|mesh-list
64503734|NCT03863184|Lenalidomide|lenalidomide|mesh-list
64503735|NCT03863184|Acalabrutinib|acalabrutinib|mesh-list
64503736|NCT03863184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64728696|NCT00004220|Antiviral Agents|antiviral agents|mesh-ancestor
64728697|NCT00004220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64728698|NCT00004220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728699|NCT00004220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728700|NCT00004220|Immunologic Factors|immunologic factors|mesh-ancestor
64728701|NCT00004220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728703|NCT00003704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64336104|NCT02335359|Hemostatics|hemostatics|mesh-ancestor
64503737|NCT03863184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503738|NCT03863184|Immunologic Factors|immunologic factors|mesh-ancestor
64503739|NCT03863184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503740|NCT03863184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64503741|NCT03863184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64503742|NCT03863184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64503743|NCT03863184|Growth Substances|growth substances|mesh-ancestor
64503744|NCT03863184|Growth Inhibitors|growth inhibitors|mesh-ancestor
64503745|NCT02516904|Rezafungin|rezafungin|mesh-list
64503746|NCT02516904|Antifungal Agents|antifungal agents|mesh-ancestor
64503747|NCT02516904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64503748|NCT01794845|Docetaxel|docetaxel|mesh-list
64503749|NCT01794845|Cetuximab|cetuximab|mesh-list
64503750|NCT01794845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503751|NCT01794845|Tubulin Modulators|tubulin modulators|mesh-ancestor
64503752|NCT01794845|Antimitotic Agents|antimitotic agents|mesh-ancestor
64503753|NCT01794845|Mitosis Modulators|mitosis modulators|mesh-ancestor
64503754|NCT01794845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503755|NCT01794845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64726316|NCT00002257|Antiviral Agents|antiviral agents|mesh-ancestor
64726317|NCT00002257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726318|NCT00002257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64728705|NCT00003704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467964|NCT00065806|Antimetabolites|antimetabolites|mesh-ancestor
64728706|NCT00003704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728707|NCT00004868|Semaxinib|semaxinib|mesh-list
64955852|NCT00072462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64726319|NCT00002257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333835|NCT02221583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64503757|NCT01794689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64503758|NCT01794689|Narcotics|narcotics|mesh-ancestor
64503759|NCT01794689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64503760|NCT01794689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503761|NCT01794689|Analgesics|analgesics|mesh-ancestor
64503762|NCT01794689|Sensory System Agents|sensory system agents|mesh-ancestor
64503763|NCT01794689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64503764|NCT04587089|Anti-Infective Agents|anti-infective agents|mesh-list
64503765|NCT04587089|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64503766|NCT01817075|Chlorhexidine|chlorhexidine|mesh-list
64503767|NCT01817075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64503768|NCT01817075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64728708|NCT00004868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64728709|NCT00004868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64728710|NCT00004868|Growth Substances|growth substances|mesh-ancestor
64728711|NCT00004868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728712|NCT00004868|Growth Inhibitors|growth inhibitors|mesh-ancestor
64728713|NCT00004868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337188|NCT03132103|Cholecalciferol|cholecalciferol|mesh-list
64503769|NCT01817075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64503770|NCT01817075|Disinfectants|disinfectants|mesh-ancestor
64503771|NCT01817075|Dermatologic Agents|dermatologic agents|mesh-ancestor
64503773|NCT00708552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64503774|NCT00708552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64503775|NCT00708552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503776|NCT00708552|Cholinergic Agents|cholinergic agents|mesh-ancestor
64728714|NCT00004868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64728715|NCT00004868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728716|NCT00004868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728718|NCT00003710|Mitomycins|mitomycins|mesh-list
64728719|NCT00003710|Mitomycin|mitomycin|mesh-list
64728720|NCT00003710|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64728721|NCT00003710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64728722|NCT00003710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728723|NCT00003710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728724|NCT00003710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336121|NCT03511183|Bevacizumab|bevacizumab|mesh-list
64494552|NCT04246554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955853|NCT00072462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64955854|NCT00072462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64503777|NCT00708552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64503778|NCT00708552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503779|NCT00708552|Nootropic Agents|nootropic agents|mesh-ancestor
64503780|NCT02516436|Buprenorphine|buprenorphine|mesh-list
64503783|NCT02516436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64503784|NCT02516436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503785|NCT02516436|Analgesics|analgesics|mesh-ancestor
64503786|NCT02516436|Sensory System Agents|sensory system agents|mesh-ancestor
64503787|NCT02516436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64503788|NCT02516436|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64503790|NCT03347526|Cosyntropin|cosyntropin|mesh-list
64503791|NCT03347526|Anticonvulsants|anticonvulsants|mesh-ancestor
64503792|NCT03347526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64503793|NCT03347526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728726|NCT00003710|Alkylating Agents|alkylating agents|mesh-ancestor
64728727|NCT00003710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64728729|NCT00004232|Prednisone|prednisone|mesh-list
64728730|NCT00004232|Methylprednisolone|methylprednisolone|mesh-list
64728731|NCT00004232|Cyclosporins|cyclosporins|mesh-list
64728732|NCT00004232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64336132|NCT02303587|Prednisolone|prednisolone|mesh-list
64955855|NCT00072462|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64728733|NCT00004232|Glucocorticoids|glucocorticoids|mesh-ancestor
64728734|NCT00004232|Hormones|hormones|mesh-ancestor
64728735|NCT00004232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64728736|NCT00004232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503794|NCT03347526|GABA Agents|gaba agents|mesh-ancestor
64503795|NCT03347526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64503796|NCT03347526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503797|NCT03347526|Hormones|hormones|mesh-ancestor
64503798|NCT03347526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64503799|NCT03347370|Interferons|interferons|mesh-list
64503800|NCT03347370|Interferon-beta|interferon-beta|mesh-list
64503801|NCT03347370|Interferon beta-1a|interferon beta-1a|mesh-list
64503802|NCT03347370|Interferon beta-1b|interferon beta-1b|mesh-list
64503803|NCT03347370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503804|NCT03347370|Antiviral Agents|antiviral agents|mesh-ancestor
64503805|NCT03347370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64503806|NCT03347370|Immunologic Factors|immunologic factors|mesh-ancestor
64503807|NCT03347370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503808|NCT03347370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64503809|NCT02515968|Propofol|propofol|mesh-list
64503810|NCT02515968|Desflurane|desflurane|mesh-list
64503811|NCT02515968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64503812|NCT02515968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64503813|NCT02515968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503814|NCT02515968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64503815|NCT02515968|Anesthetics, General|anesthetics, general|mesh-ancestor
64503816|NCT02515968|Anesthetics|anesthetics|mesh-ancestor
64503817|NCT02515968|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64503818|NCT03345966|Antibodies|antibodies|mesh-list
64503819|NCT03345966|Immunologic Factors|immunologic factors|mesh-ancestor
64503820|NCT03345966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503821|NCT02507700|Bupivacaine|bupivacaine|mesh-list
64503822|NCT02507700|Sevoflurane|sevoflurane|mesh-list
64728737|NCT00004232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64728738|NCT00004232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728739|NCT00004232|Immunologic Factors|immunologic factors|mesh-ancestor
64728740|NCT00004232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337242|NCT02321293|Analgesics|analgesics|mesh-ancestor
64337243|NCT02321293|Sensory System Agents|sensory system agents|mesh-ancestor
64503823|NCT02507700|Anesthetics, Local|anesthetics, local|mesh-ancestor
64503824|NCT02507700|Anesthetics|anesthetics|mesh-ancestor
64503825|NCT02507700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64503826|NCT02507700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726320|NCT00002257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726322|NCT00003134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64503827|NCT02507700|Sensory System Agents|sensory system agents|mesh-ancestor
64503828|NCT02507700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64503829|NCT02507700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64503830|NCT02507700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64503831|NCT02507700|Anesthetics, General|anesthetics, general|mesh-ancestor
64955856|NCT00072462|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64955857|NCT00072462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728741|NCT00004232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728742|NCT00004232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728744|NCT00004232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64728745|NCT00004232|Dermatologic Agents|dermatologic agents|mesh-ancestor
64728746|NCT00004232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64503832|NCT02513004|Clopidogrel|clopidogrel|mesh-list
64503833|NCT02513004|Ticagrelor|ticagrelor|mesh-list
64503835|NCT02513004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64503836|NCT02513004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64503837|NCT02513004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64503838|NCT02513004|Purinergic Agents|purinergic agents|mesh-ancestor
64503839|NCT02513004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64503840|NCT02513004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503841|NCT02513004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503842|NCT04500522|Isoniazid|isoniazid|mesh-list
64503843|NCT04500522|Antitubercular Agents|antitubercular agents|mesh-ancestor
64503844|NCT04500522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64503845|NCT04500522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64503846|NCT04500522|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64503847|NCT04500522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64503848|NCT04500522|Antimetabolites|antimetabolites|mesh-ancestor
64503849|NCT04500522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728747|NCT00004232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64728748|NCT00004232|Antiemetics|antiemetics|mesh-ancestor
64728749|NCT00004232|Autonomic Agents|autonomic agents|mesh-ancestor
64728750|NCT00004232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64728751|NCT00004232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64728752|NCT00004232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64728753|NCT00004232|Protective Agents|protective agents|mesh-ancestor
64728754|NCT05231629|Dexamethasone|dexamethasone|mesh-list
64503850|NCT04500522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64503851|NCT02507232|Temozolomide|temozolomide|mesh-list
64503852|NCT02507232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64503853|NCT02507232|Alkylating Agents|alkylating agents|mesh-ancestor
64503854|NCT02507232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503855|NCT02507232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503858|NCT02506998|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
64503859|NCT02506998|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
64503860|NCT02506998|Histamine Agonists|histamine agonists|mesh-ancestor
64503861|NCT02506998|Histamine Agents|histamine agents|mesh-ancestor
64503862|NCT02506998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64955378|NCT00038519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503863|NCT02506998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503864|NCT02506998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503866|NCT02507076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64503867|NCT02507076|Alkylating Agents|alkylating agents|mesh-ancestor
64503868|NCT02507076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503869|NCT02507076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503870|NCT02507076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64503871|NCT02507076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728755|NCT05231629|Dexamethasone acetate|dexamethasone acetate|mesh-list
64728756|NCT05231629|Melphalan|melphalan|mesh-list
64728757|NCT05231629|Lenalidomide|lenalidomide|mesh-list
64728758|NCT05231629|Bortezomib|bortezomib|mesh-list
64728759|NCT05231629|Daratumumab|daratumumab|mesh-list
64728760|NCT05231629|BB 1101|bb 1101|mesh-list
64728761|NCT05231629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64728762|NCT05231629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64728763|NCT05231629|Antiemetics|antiemetics|mesh-ancestor
64728764|NCT05231629|Autonomic Agents|autonomic agents|mesh-ancestor
64728765|NCT05231629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64728766|NCT05231629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955859|NCT00205426|Natriuretic Agents|natriuretic agents|mesh-ancestor
64503872|NCT02507076|Immunologic Factors|immunologic factors|mesh-ancestor
64503873|NCT02507076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503874|NCT01609348|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64503875|NCT01609348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64503876|NCT01609348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64503877|NCT01609348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64503878|NCT01609348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503879|NCT01609348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64503880|NCT01609348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728767|NCT05231629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64728768|NCT05231629|Glucocorticoids|glucocorticoids|mesh-ancestor
64728770|NCT05231629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64728771|NCT05231629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64728772|NCT05231629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728773|NCT05231629|Protease Inhibitors|protease inhibitors|mesh-ancestor
64728774|NCT05231629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728775|NCT05231629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728776|NCT05231629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64728777|NCT05231629|Alkylating Agents|alkylating agents|mesh-ancestor
64728778|NCT05231629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64728779|NCT05231629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728780|NCT05231629|Immunologic Factors|immunologic factors|mesh-ancestor
64336171|NCT03064113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64337404|NCT02321761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64503881|NCT01609348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64503882|NCT01609348|Antidepressive Agents|antidepressive agents|mesh-ancestor
64503883|NCT01609348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64503884|NCT04500678|Metformin|metformin|mesh-list
64503885|NCT04500678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64503886|NCT04500678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503887|NCT02507154|Cetuximab|cetuximab|mesh-list
64503888|NCT02507154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64503889|NCT02507154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503890|NCT02515734|Leucovorin|leucovorin|mesh-list
64503891|NCT02515734|Bevacizumab|bevacizumab|mesh-list
64503892|NCT02515734|Cetuximab|cetuximab|mesh-list
64503893|NCT02515734|Fluorouracil|fluorouracil|mesh-list
64728781|NCT05231629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64728782|NCT05231629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64728783|NCT05231629|Growth Substances|growth substances|mesh-ancestor
64728784|NCT05231629|Growth Inhibitors|growth inhibitors|mesh-ancestor
64503894|NCT02515734|Oxaliplatin|oxaliplatin|mesh-list
64503895|NCT02515734|Irinotecan|irinotecan|mesh-list
64726323|NCT00003134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64726324|NCT00003134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726325|NCT00003134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726326|NCT00003134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503896|NCT02515734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64503897|NCT02515734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503898|NCT02515734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64503899|NCT02515734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64728786|NCT00004874|Tositumomab I-131|tositumomab i-131|mesh-list
64728787|NCT00004874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64728788|NCT00004874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64728789|NCT00004874|Trace Elements|trace elements|mesh-ancestor
64728790|NCT00004874|Micronutrients|micronutrients|mesh-ancestor
64728791|NCT00004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728792|NCT00004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728793|NCT00004244|Interferons|interferons|mesh-list
64955863|NCT00039494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64503900|NCT02515734|Growth Substances|growth substances|mesh-ancestor
64503901|NCT02515734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503902|NCT02515734|Growth Inhibitors|growth inhibitors|mesh-ancestor
64503903|NCT02515734|Antimetabolites|antimetabolites|mesh-ancestor
64503904|NCT02515734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503905|NCT02515734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64503907|NCT02515734|Immunologic Factors|immunologic factors|mesh-ancestor
64503908|NCT02515734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64503909|NCT02515734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64503910|NCT02515734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64503911|NCT02515734|Antidotes|antidotes|mesh-ancestor
64728794|NCT00004244|Interferon-alpha|interferon-alpha|mesh-list
64728795|NCT00004244|Interleukin-12|interleukin-12|mesh-list
64728796|NCT00004244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728797|NCT00004244|Antiviral Agents|antiviral agents|mesh-ancestor
64728798|NCT00004244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64503912|NCT02515734|Protective Agents|protective agents|mesh-ancestor
64503913|NCT02515734|Vitamin B Complex|vitamin b complex|mesh-ancestor
64503914|NCT02515734|Vitamins|vitamins|mesh-ancestor
64503915|NCT02515734|Micronutrients|micronutrients|mesh-ancestor
64503916|NCT02512536|Botulinum Toxins|botulinum toxins|mesh-list
64503917|NCT02512536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64503918|NCT02512536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64503919|NCT02512536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64503920|NCT02512536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64503921|NCT02512536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503922|NCT02512536|Cholinergic Agents|cholinergic agents|mesh-ancestor
64503923|NCT02512536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64955864|NCT00039494|Alkylating Agents|alkylating agents|mesh-ancestor
64955865|NCT00039494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955866|NCT00039494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955867|NCT00039494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64728799|NCT00004244|Immunologic Factors|immunologic factors|mesh-ancestor
64728800|NCT00004244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728801|NCT00004244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64728802|NCT00004244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64503924|NCT02512536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503925|NCT02512536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64503926|NCT02512536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64503927|NCT02506842|Leucovorin|leucovorin|mesh-list
64503928|NCT02506842|Folic Acid|folic acid|mesh-list
64503929|NCT02506842|Gemcitabine|gemcitabine|mesh-list
64503934|NCT02506842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503935|NCT02506842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64503936|NCT02506842|Antimetabolites|antimetabolites|mesh-ancestor
64955868|NCT00039494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728803|NCT00004244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64728804|NCT00004244|Growth Substances|growth substances|mesh-ancestor
64728805|NCT00004244|Growth Inhibitors|growth inhibitors|mesh-ancestor
64728806|NCT00004880|Vaccines|vaccines|mesh-list
64728807|NCT00004880|Immunologic Factors|immunologic factors|mesh-ancestor
64728808|NCT00004880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728809|NCT00004250|Dactinomycin|dactinomycin|mesh-list
64728810|NCT00004250|Melphalan|melphalan|mesh-list
64728811|NCT00004250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64728812|NCT00004250|Alkylating Agents|alkylating agents|mesh-ancestor
64728813|NCT00004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728814|NCT00004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728815|NCT00004250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64728816|NCT00004250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728817|NCT00004250|Immunologic Factors|immunologic factors|mesh-ancestor
64728818|NCT00004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728819|NCT00004250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64728820|NCT00004250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64728821|NCT00004250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64728822|NCT00004250|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64728823|NCT00004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728824|NCT00004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64728825|NCT00003728|Leucovorin|leucovorin|mesh-list
64728826|NCT00003728|Cytarabine|cytarabine|mesh-list
64728827|NCT00003728|Dexamethasone|dexamethasone|mesh-list
64336205|NCT02335203|Contraceptive Agents|contraceptive agents|mesh-ancestor
64728829|NCT00003728|Prednisolone|prednisolone|mesh-list
64728830|NCT00003728|Hydrocortisone|hydrocortisone|mesh-list
64728831|NCT00003728|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64728832|NCT00003728|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64728833|NCT00003728|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64503937|NCT02506842|Antiviral Agents|antiviral agents|mesh-ancestor
64503938|NCT02506842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64503939|NCT02506842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955379|NCT00038519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64494142|NCT00634803|Narcotics|narcotics|mesh-ancestor
64955380|NCT00038519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64503940|NCT02506842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64503941|NCT02506842|Immunologic Factors|immunologic factors|mesh-ancestor
64503942|NCT02506842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503943|NCT02506842|Antidotes|antidotes|mesh-ancestor
64503944|NCT02506842|Protective Agents|protective agents|mesh-ancestor
64503945|NCT02506842|Vitamin B Complex|vitamin b complex|mesh-ancestor
64503946|NCT02506842|Vitamins|vitamins|mesh-ancestor
64503947|NCT02506842|Micronutrients|micronutrients|mesh-ancestor
64728836|NCT00003728|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64728837|NCT00003728|Methotrexate|methotrexate|mesh-list
64728838|NCT00003728|Etoposide|etoposide|mesh-list
64728839|NCT00003728|Vincristine|vincristine|mesh-list
64728840|NCT00003728|Daunorubicin|daunorubicin|mesh-list
64728841|NCT00003728|Asparaginase|asparaginase|mesh-list
64728842|NCT00003728|Mitoxantrone|mitoxantrone|mesh-list
64728843|NCT00003728|Mercaptopurine|mercaptopurine|mesh-list
64728844|NCT00003728|Thioguanine|thioguanine|mesh-list
64728845|NCT00003728|Vindesine|vindesine|mesh-list
64955869|NCT00205738|Olanzapine|olanzapine|mesh-list
64955870|NCT00205738|Risperidone|risperidone|mesh-list
64728846|NCT00003728|Levoleucovorin|levoleucovorin|mesh-list
64728847|NCT00003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728848|NCT00003728|Immunologic Factors|immunologic factors|mesh-ancestor
64728849|NCT00003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728850|NCT00003728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64728851|NCT00003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64728852|NCT00003728|Alkylating Agents|alkylating agents|mesh-ancestor
64503948|NCT02506842|Hematinics|hematinics|mesh-ancestor
64503949|NCT02512614|Anti-Infective Agents|anti-infective agents|mesh-list
64503950|NCT02512614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64503951|NCT03345498|Entecavir|entecavir|mesh-list
64503952|NCT03345498|Antiviral Agents|antiviral agents|mesh-ancestor
64503953|NCT03345498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64503954|NCT02506686|Meropenem|meropenem|mesh-list
64503955|NCT02506686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64503956|NCT02506686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64503957|NCT04499742|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
64503958|NCT04499742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64503959|NCT04499742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503960|NCT02512380|Docetaxel|docetaxel|mesh-list
64503961|NCT02512380|Oxaliplatin|oxaliplatin|mesh-list
64503962|NCT02512380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503963|NCT02512380|Tubulin Modulators|tubulin modulators|mesh-ancestor
64503964|NCT02512380|Antimitotic Agents|antimitotic agents|mesh-ancestor
64503965|NCT02512380|Mitosis Modulators|mitosis modulators|mesh-ancestor
64726327|NCT00002545|Carmustine|carmustine|mesh-list
64726328|NCT00002545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64726329|NCT00002545|Alkylating Agents|alkylating agents|mesh-ancestor
64726330|NCT00002545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726331|NCT00002545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726332|NCT00002804|Cobalt|cobalt|mesh-list
64726333|NCT00002804|Doxorubicin|doxorubicin|mesh-list
64333847|NCT03500731|Thiotepa|thiotepa|mesh-list
64421103|NCT04282109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64503966|NCT02512380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503967|NCT04497792|Metformin|metformin|mesh-list
64503968|NCT04497792|Empagliflozin|empagliflozin|mesh-list
64503969|NCT04497792|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64503970|NCT04497792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503971|NCT04497792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64728853|NCT00003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728854|NCT00003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728855|NCT00003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64728856|NCT00003728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64728857|NCT00003728|Antiemetics|antiemetics|mesh-ancestor
64728858|NCT00003728|Autonomic Agents|autonomic agents|mesh-ancestor
64728859|NCT00003728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64728860|NCT00003728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64728861|NCT00003728|Glucocorticoids|glucocorticoids|mesh-ancestor
64728862|NCT00003728|Hormones|hormones|mesh-ancestor
64728863|NCT00003728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64728864|NCT00003728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64503972|NCT04497792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503973|NCT03344952|Botulinum Toxins|botulinum toxins|mesh-list
64503974|NCT03344952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64503975|NCT03344952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64503976|NCT03344952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64503977|NCT03344952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64503978|NCT03344952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503979|NCT03344952|Cholinergic Agents|cholinergic agents|mesh-ancestor
64503980|NCT03344952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64503981|NCT03344952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728865|NCT00003728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64728866|NCT00003728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64728868|NCT00003728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728869|NCT00003728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64728870|NCT00003728|Abortifacient Agents|abortifacient agents|mesh-ancestor
64728871|NCT00003728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64728872|NCT00003728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64728934|NCT05477875|Antitussive Agents|antitussive agents|mesh-ancestor
64728935|NCT05477875|Respiratory System Agents|respiratory system agents|mesh-ancestor
64728936|NCT00004256|Sargramostim|sargramostim|mesh-list
64728937|NCT00004256|Immunologic Factors|immunologic factors|mesh-ancestor
64728939|NCT00004262|Motexafin gadolinium|motexafin gadolinium|mesh-list
64728940|NCT00004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728941|NCT00004262|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64728942|NCT00004262|Dermatologic Agents|dermatologic agents|mesh-ancestor
64728943|NCT00004892|Carmustine|carmustine|mesh-list
64728944|NCT00004892|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64728945|NCT00004892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64728946|NCT00004892|Alkylating Agents|alkylating agents|mesh-ancestor
64728947|NCT00004892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728948|NCT00004892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728949|NCT00004892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728950|NCT00004268|Midodrine|midodrine|mesh-list
64728951|NCT00004268|Sympathomimetics|sympathomimetics|mesh-ancestor
64336327|NCT03450343|Antimetabolites|antimetabolites|mesh-ancestor
64503982|NCT03344952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64503984|NCT02515422|Ketamine|ketamine|mesh-list
64503985|NCT02515422|Bupivacaine|bupivacaine|mesh-list
64503986|NCT02515422|Anesthetics, Local|anesthetics, local|mesh-ancestor
64503987|NCT02515422|Anesthetics|anesthetics|mesh-ancestor
64503988|NCT02515422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64503989|NCT02515422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503990|NCT02515422|Sensory System Agents|sensory system agents|mesh-ancestor
64503991|NCT02515422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64503992|NCT02515422|Analgesics|analgesics|mesh-ancestor
64503993|NCT02515422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64503994|NCT02515422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64728952|NCT00004268|Autonomic Agents|autonomic agents|mesh-ancestor
64728953|NCT00004268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64728954|NCT00004268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728955|NCT00004268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64728956|NCT00004268|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64728957|NCT00004268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64728958|NCT00004268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64728959|NCT00004268|Adrenergic Agents|adrenergic agents|mesh-ancestor
64728960|NCT00004268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64728961|NCT00004268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728962|NCT00004274|Estrogens|estrogens|mesh-list
64728963|NCT00004274|Hormones|hormones|mesh-ancestor
64728964|NCT00004274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64728965|NCT00004274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728966|NCT00004904|Methylprednisolone|methylprednisolone|mesh-list
64728967|NCT00004904|Cyclophosphamide|cyclophosphamide|mesh-list
64728968|NCT00004904|Etoposide|etoposide|mesh-list
64728969|NCT00004904|Cladribine|cladribine|mesh-list
64728970|NCT00004904|Tacrolimus|tacrolimus|mesh-list
64728971|NCT00004904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64728972|NCT00004904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728973|NCT00004904|Immunologic Factors|immunologic factors|mesh-ancestor
64728974|NCT00004904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728975|NCT00004904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64728976|NCT00004904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64728977|NCT00004904|Alkylating Agents|alkylating agents|mesh-ancestor
64728978|NCT00004904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503995|NCT02515422|Anesthetics, General|anesthetics, general|mesh-ancestor
64503996|NCT02515422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64503997|NCT02515422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64503998|NCT02515422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64503999|NCT02515422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504000|NCT02506296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64504010|NCT02506140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64504011|NCT02506140|Analgesics|analgesics|mesh-ancestor
64504012|NCT02506140|Sensory System Agents|sensory system agents|mesh-ancestor
64504013|NCT02506140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64504014|NCT02506140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955381|NCT00038519|Antiviral Agents|antiviral agents|mesh-ancestor
64955382|NCT00038519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64955383|NCT00038519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64955384|NCT00038519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64504015|NCT02506140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64504016|NCT02506140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64728987|NCT00004904|Antiemetics|antiemetics|mesh-ancestor
64728988|NCT00004904|Autonomic Agents|autonomic agents|mesh-ancestor
64728989|NCT00004904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64728990|NCT00004904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64728991|NCT00004904|Glucocorticoids|glucocorticoids|mesh-ancestor
64728992|NCT00004904|Hormones|hormones|mesh-ancestor
64728993|NCT00004904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64728994|NCT00004904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64728995|NCT00004904|Protective Agents|protective agents|mesh-ancestor
64728996|NCT00004286|Immunoglobulins|immunoglobulins|mesh-list
64728997|NCT00004286|Antibodies|antibodies|mesh-list
64728998|NCT00004286|gamma-Globulins|gamma-globulins|mesh-list
64728999|NCT00004286|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64729000|NCT00004286|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64729001|NCT00004286|Immunologic Factors|immunologic factors|mesh-ancestor
64729002|NCT00004286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729003|NCT00003746|Cladribine|cladribine|mesh-list
64729004|NCT00003746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729005|NCT00003746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64729006|NCT00003746|Immunologic Factors|immunologic factors|mesh-ancestor
64729007|NCT00003746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729008|NCT00003752|Bexarotene|bexarotene|mesh-list
64729009|NCT00003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729010|NCT00003758|Cytarabine|cytarabine|mesh-list
64729011|NCT00003758|Idarubicin|idarubicin|mesh-list
64729012|NCT00003758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64729013|NCT00003758|Antimetabolites|antimetabolites|mesh-ancestor
64729014|NCT00003758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504017|NCT02506140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64504018|NCT02506140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64504019|NCT02506140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504020|NCT02506140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64504021|NCT02506140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64504022|NCT02506140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504023|NCT02506140|Antipyretics|antipyretics|mesh-ancestor
64504024|NCT02506140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64504025|NCT02506140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64504026|NCT02506140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64504027|NCT02506140|Purinergic Agents|purinergic agents|mesh-ancestor
64504028|NCT02506140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64729017|NCT00003758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64504029|NCT02515188|Acetaminophen|acetaminophen|mesh-list
64726334|NCT00002804|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64726335|NCT00002804|Vincristine|vincristine|mesh-list
64726336|NCT00002804|Ifosfamide|ifosfamide|mesh-list
64726337|NCT00002804|Lenograstim|lenograstim|mesh-list
64726338|NCT00002804|Mesna|mesna|mesh-list
64726339|NCT00002804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64726340|NCT00002804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726341|NCT00002804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64726342|NCT00002804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64726343|NCT00002804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726344|NCT00002804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726345|NCT00002804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64726346|NCT00002804|Immunologic Factors|immunologic factors|mesh-ancestor
64726347|NCT00002804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726348|NCT00002804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64726349|NCT00002804|Tubulin Modulators|tubulin modulators|mesh-ancestor
64726350|NCT00002804|Antimitotic Agents|antimitotic agents|mesh-ancestor
64726351|NCT00002804|Mitosis Modulators|mitosis modulators|mesh-ancestor
64726352|NCT00002804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64729064|NCT00004928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64729065|NCT00004928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729066|NCT00004928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64729067|NCT00004928|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64729068|NCT00004928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64729069|NCT00004928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729070|NCT00004928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64729071|NCT00004928|Vitamins|vitamins|mesh-ancestor
64729072|NCT00004928|Micronutrients|micronutrients|mesh-ancestor
64729073|NCT00004328|Enalapril|enalapril|mesh-list
64729074|NCT00004328|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
64729075|NCT00004328|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64729076|NCT00004328|Protease Inhibitors|protease inhibitors|mesh-ancestor
64729077|NCT00004328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729078|NCT00004328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729079|NCT00004328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64729080|NCT00004328|Chelating Agents|chelating agents|mesh-ancestor
64729081|NCT00004328|Sequestering Agents|sequestering agents|mesh-ancestor
64726353|NCT00002804|Alkylating Agents|alkylating agents|mesh-ancestor
64726354|NCT00002804|Protective Agents|protective agents|mesh-ancestor
64726355|NCT00002804|Trace Elements|trace elements|mesh-ancestor
64333862|NCT02751359|Cannabidiol|cannabidiol|mesh-list
64504030|NCT02515188|Propacetamol|propacetamol|mesh-list
64504031|NCT02515188|Analgesics|analgesics|mesh-ancestor
64504032|NCT02515188|Sensory System Agents|sensory system agents|mesh-ancestor
64504033|NCT02515188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64504034|NCT02515188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729099|NCT00003776|Methotrexate|methotrexate|mesh-list
64729100|NCT00003776|Ifosfamide|ifosfamide|mesh-list
64729101|NCT00003776|Calcium|calcium|mesh-list
64729102|NCT00003776|Levoleucovorin|levoleucovorin|mesh-list
64729103|NCT00003776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729104|NCT00003776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64729105|NCT00003776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64729106|NCT00003776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64729107|NCT00003776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729108|NCT00003776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729125|NCT00003776|Vitamins|vitamins|mesh-ancestor
64504035|NCT02515188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64504036|NCT02515188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64504037|NCT02515188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64504038|NCT02515188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64504039|NCT02515188|Antipyretics|antipyretics|mesh-ancestor
64504040|NCT01696084|Cytarabine|cytarabine|mesh-list
64504041|NCT01696084|Daunorubicin|daunorubicin|mesh-list
64504042|NCT01696084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64504043|NCT01696084|Antimetabolites|antimetabolites|mesh-ancestor
64504044|NCT01696084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504045|NCT01696084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504046|NCT01696084|Antiviral Agents|antiviral agents|mesh-ancestor
64504047|NCT01696084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64504048|NCT01696084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64504049|NCT01696084|Immunologic Factors|immunologic factors|mesh-ancestor
64504050|NCT01696084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504051|NCT01696084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64504052|NCT01696084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64504053|NCT01696084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64504054|NCT01696084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504055|NCT02228824|Nicotine|nicotine|mesh-list
64504056|NCT02228824|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64504057|NCT02228824|Autonomic Agents|autonomic agents|mesh-ancestor
64504058|NCT02228824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64504059|NCT02228824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504060|NCT02228824|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64726356|NCT00002804|Micronutrients|micronutrients|mesh-ancestor
64726358|NCT00002810|Immunologic Factors|immunologic factors|mesh-ancestor
64726359|NCT00002810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726360|NCT00002810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64726361|NCT00002810|Alkylating Agents|alkylating agents|mesh-ancestor
64726362|NCT00002810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726363|NCT00002810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726364|NCT00002810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64726365|NCT00002810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64726367|NCT00003140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726368|NCT00003140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64726369|NCT00003140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64726370|NCT00003140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726371|NCT00003140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726372|NCT00003140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64726373|NCT00003140|Hormone Antagonists|hormone antagonists|mesh-ancestor
64726374|NCT00003140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64726375|NCT00003140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726376|NCT00003392|Paclitaxel|paclitaxel|mesh-list
64726377|NCT00003392|Cyclophosphamide|cyclophosphamide|mesh-list
64726378|NCT00003392|Carboplatin|carboplatin|mesh-list
64726379|NCT00003392|Melphalan|melphalan|mesh-list
64729169|NCT00384800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64729170|NCT00384800|Immunologic Factors|immunologic factors|mesh-ancestor
64729171|NCT00384800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729172|NCT00384800|Leprostatic Agents|leprostatic agents|mesh-ancestor
64729173|NCT00384800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64729174|NCT00384800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64729175|NCT00384800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64729176|NCT00384800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64729177|NCT00384800|Growth Substances|growth substances|mesh-ancestor
64729178|NCT00384800|Growth Inhibitors|growth inhibitors|mesh-ancestor
64729179|NCT00384800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726380|NCT00003392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64504061|NCT02228824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64504062|NCT02228824|Cholinergic Agents|cholinergic agents|mesh-ancestor
64504073|NCT04443036|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64504074|NCT04443036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64504075|NCT04443036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504076|NCT04443036|Tubulin Modulators|tubulin modulators|mesh-ancestor
64504077|NCT04443036|Antimitotic Agents|antimitotic agents|mesh-ancestor
64504078|NCT04443036|Mitosis Modulators|mitosis modulators|mesh-ancestor
64504079|NCT04443036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955887|NCT00205738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64955888|NCT00205738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64729182|NCT00384800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729184|NCT00384878|Fluorouracil|fluorouracil|mesh-list
64729185|NCT00384878|Cetuximab|cetuximab|mesh-list
64729186|NCT00384878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729187|NCT00384878|Antimetabolites|antimetabolites|mesh-ancestor
64729188|NCT00384878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729189|NCT00384878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64729190|NCT00384878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64729191|NCT00384878|Immunologic Factors|immunologic factors|mesh-ancestor
64729192|NCT00384878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729193|NCT00384878|Antidotes|antidotes|mesh-ancestor
64729194|NCT00384878|Protective Agents|protective agents|mesh-ancestor
64729195|NCT00384878|Vitamin B Complex|vitamin b complex|mesh-ancestor
64729196|NCT00384878|Vitamins|vitamins|mesh-ancestor
64729197|NCT00384878|Micronutrients|micronutrients|mesh-ancestor
64729198|NCT00384878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64729199|NCT02972762|Propofol|propofol|mesh-list
64336565|NCT02327091|Vitamins|vitamins|mesh-ancestor
64504080|NCT01653418|Cytarabine|cytarabine|mesh-list
64504081|NCT01653418|Etoposide|etoposide|mesh-list
64504082|NCT01653418|Bortezomib|bortezomib|mesh-list
64504084|NCT01653418|Carmustine|carmustine|mesh-list
64504085|NCT01653418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64504086|NCT01653418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504087|NCT01653418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64504088|NCT01653418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64504089|NCT01653418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504090|NCT01653418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504091|NCT01653418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64729200|NCT02972762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64729201|NCT02972762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64729202|NCT02972762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729203|NCT02972762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64729204|NCT02972762|Anesthetics, General|anesthetics, general|mesh-ancestor
64729206|NCT00004358|Calcitonin|calcitonin|mesh-list
64729207|NCT00004358|Salmon calcitonin|salmon calcitonin|mesh-list
64729208|NCT00004358|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
64729209|NCT00004358|Katacalcin|katacalcin|mesh-list
64729210|NCT00004358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64729211|NCT00004358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729212|NCT00004358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64729213|NCT00004358|Vasodilator Agents|vasodilator agents|mesh-ancestor
64729214|NCT00004364|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64729215|NCT00004364|Hemostatics|hemostatics|mesh-ancestor
64729216|NCT00004364|Coagulants|coagulants|mesh-ancestor
64729217|NCT00004364|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64504092|NCT01653418|Antimetabolites|antimetabolites|mesh-ancestor
64504093|NCT01653418|Antiviral Agents|antiviral agents|mesh-ancestor
64504094|NCT01653418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64504095|NCT01653418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64504096|NCT01653418|Immunologic Factors|immunologic factors|mesh-ancestor
64726381|NCT00003392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726382|NCT00003392|Tubulin Modulators|tubulin modulators|mesh-ancestor
64726383|NCT00003392|Antimitotic Agents|antimitotic agents|mesh-ancestor
64726384|NCT00003392|Mitosis Modulators|mitosis modulators|mesh-ancestor
64955891|NCT00205816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64955892|NCT00205816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64955893|NCT00205816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955894|NCT00205816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955895|NCT00072540|Celecoxib|celecoxib|mesh-list
64729247|NCT00005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729248|NCT00004376|Guanfacine|guanfacine|mesh-list
64729249|NCT00004376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64729250|NCT00004376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64729251|NCT00004376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64729252|NCT00004376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64729253|NCT00004376|Adrenergic Agents|adrenergic agents|mesh-ancestor
64729254|NCT00004376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64729255|NCT00004376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729256|NCT00004376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729257|NCT00005006|Alendronate|alendronate|mesh-list
64729258|NCT00005006|Teriparatide|teriparatide|mesh-list
64729259|NCT00005006|Hormones|hormones|mesh-list
64729260|NCT00005006|Parathyroid Hormone|parathyroid hormone|mesh-list
64729261|NCT00005006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64729262|NCT00005006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729263|NCT00005006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64729264|NCT00005006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64729265|NCT00004382|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
64729266|NCT00004382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337635|NCT02262299|Pirfenidone|pirfenidone|mesh-list
64726385|NCT00003392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726386|NCT00003392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64504097|NCT01653418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504098|NCT01653418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64504099|NCT01653418|Alkylating Agents|alkylating agents|mesh-ancestor
64504100|NCT01653418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64504101|NCT02514642|Clopidogrel|clopidogrel|mesh-list
64504102|NCT02514642|Ticagrelor|ticagrelor|mesh-list
64504103|NCT02514642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64504104|NCT02514642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64504105|NCT02514642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64504106|NCT02514642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64504107|NCT02514642|Purinergic Agents|purinergic agents|mesh-ancestor
64504108|NCT02514642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64729267|NCT00004382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729268|NCT00005012|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64729269|NCT00005012|Antiviral Agents|antiviral agents|mesh-ancestor
64729270|NCT00005012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64729271|NCT00004400|Testosterone|testosterone|mesh-list
64729272|NCT00004400|Androgens|androgens|mesh-ancestor
64729273|NCT00004400|Hormones|hormones|mesh-ancestor
64729274|NCT00004400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64729275|NCT00004400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729276|NCT00003812|Paclitaxel|paclitaxel|mesh-list
64729277|NCT00003812|Etoposide|etoposide|mesh-list
64729278|NCT00003812|Carboplatin|carboplatin|mesh-list
64729279|NCT00003812|Topotecan|topotecan|mesh-list
64729280|NCT00003812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64729282|NCT00003812|Tubulin Modulators|tubulin modulators|mesh-ancestor
64729286|NCT00003812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64729287|NCT00003812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64729288|NCT00003812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729289|NCT00003812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64729290|NCT00005018|Efavirenz|efavirenz|mesh-list
64729291|NCT00005018|Abacavir|abacavir|mesh-list
64729292|NCT00005018|Didanosine|didanosine|mesh-list
64729293|NCT00005018|Hydroxyurea|hydroxyurea|mesh-list
64729294|NCT00005018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64729295|NCT00005018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64729296|NCT00005018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729297|NCT00005018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729298|NCT00005018|Antiviral Agents|antiviral agents|mesh-ancestor
64729299|NCT00005018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64336667|NCT03503227|Analgesics|analgesics|mesh-ancestor
64955896|NCT00072540|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64504109|NCT02514642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504110|NCT02514642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504111|NCT02511210|Anesthetics|anesthetics|mesh-list
64504112|NCT02511210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64504113|NCT02511210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504114|NCT02237950|Metronidazole|metronidazole|mesh-list
64504115|NCT02237950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64504116|NCT02237950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64504117|NCT02237950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64504118|NCT02237950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64504119|NCT02511054|Chloroquine|chloroquine|mesh-list
64504120|NCT02511054|Pyrimethamine|pyrimethamine|mesh-list
64504121|NCT02511054|Amebicides|amebicides|mesh-ancestor
64504122|NCT02511054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64504123|NCT02511054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64504124|NCT02511054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64504125|NCT02511054|Antimalarials|antimalarials|mesh-ancestor
64504126|NCT02511054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64729300|NCT00005018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64729301|NCT00005018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64729302|NCT00005018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64729303|NCT00005018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64729304|NCT00005018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64729305|NCT00005018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64729306|NCT00005018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729307|NCT00005018|Antisickling Agents|antisickling agents|mesh-ancestor
64729308|NCT00005018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64729309|NCT00005018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64729310|NCT00005018|Antimetabolites|antimetabolites|mesh-ancestor
64729311|NCT00003824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64729312|NCT00003824|Ciprofloxacin|ciprofloxacin|mesh-list
64504127|NCT02511054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64504128|NCT02511054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504131|NCT04499118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64504132|NCT04499118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64504133|NCT04499118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504134|NCT04499118|Tubulin Modulators|tubulin modulators|mesh-ancestor
64504136|NCT04499118|Mitosis Modulators|mitosis modulators|mesh-ancestor
64504137|NCT04499118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729314|NCT00003824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64729315|NCT00003824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64729316|NCT00003824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64729317|NCT00003824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729318|NCT00003824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729319|NCT00003824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729320|NCT00003824|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64729321|NCT00003824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64729323|NCT00004406|Parathyroid Hormone|parathyroid hormone|mesh-list
64729324|NCT00004406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64504139|NCT01612546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64504140|NCT01612546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504141|NCT01612546|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64504142|NCT01612546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64504143|NCT01612546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504144|NCT01612546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504145|NCT04499898|Carvedilol|carvedilol|mesh-list
64504146|NCT04499898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64504147|NCT04499898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64504148|NCT04499898|Adrenergic Agents|adrenergic agents|mesh-ancestor
64504149|NCT04499898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64504150|NCT04499898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504151|NCT04499898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504152|NCT04499898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64504153|NCT04499898|Antioxidants|antioxidants|mesh-ancestor
64504154|NCT04499898|Protective Agents|protective agents|mesh-ancestor
64504155|NCT04499898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64504156|NCT04499898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64729427|NCT00005042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64729428|NCT00005042|Growth Substances|growth substances|mesh-ancestor
64729429|NCT00005042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729430|NCT00005042|Growth Inhibitors|growth inhibitors|mesh-ancestor
64729431|NCT00005042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729432|NCT00005042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64729433|NCT00005042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729434|NCT00005042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729435|NCT00004442|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64504157|NCT04499898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64504158|NCT04499898|Vasodilator Agents|vasodilator agents|mesh-ancestor
64504159|NCT04499898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64504160|NCT04499898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64726387|NCT00003392|Immunologic Factors|immunologic factors|mesh-ancestor
64726388|NCT00003392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955385|NCT00038519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64504161|NCT02514330|Dihydrotachysterol|dihydrotachysterol|mesh-list
64955386|NCT00038519|Antitubercular Agents|antitubercular agents|mesh-ancestor
64955387|NCT00038519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64504163|NCT02514330|Micronutrients|micronutrients|mesh-ancestor
64504164|NCT02514330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504165|NCT02514330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64504166|NCT02510976|Prucalopride|prucalopride|mesh-list
64504167|NCT02510976|Laxatives|laxatives|mesh-ancestor
64729468|NCT00005048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64729469|NCT00005048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729470|NCT00005048|Tubulin Modulators|tubulin modulators|mesh-ancestor
64729471|NCT00005048|Antimitotic Agents|antimitotic agents|mesh-ancestor
64729472|NCT00005048|Mitosis Modulators|mitosis modulators|mesh-ancestor
64729474|NCT00005048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64729478|NCT04756765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64729479|NCT04756765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729480|NCT04756765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729481|NCT04756765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729483|NCT00004466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64729484|NCT00004466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64729485|NCT00004466|Antimetabolites|antimetabolites|mesh-ancestor
64729486|NCT00004466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729487|NCT00004466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64729488|NCT00004466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64729489|NCT00004466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729490|NCT00005054|Temozolomide|temozolomide|mesh-list
64729491|NCT00005054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64729492|NCT00005054|Alkylating Agents|alkylating agents|mesh-ancestor
64729493|NCT00005054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729494|NCT00005054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729495|NCT04742101|Azacitidine|azacitidine|mesh-list
64729496|NCT04742101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64729497|NCT04742101|Antimetabolites|antimetabolites|mesh-ancestor
64504168|NCT02510976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64504169|NCT02510976|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64504170|NCT02510976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64504171|NCT02510976|Serotonin Agents|serotonin agents|mesh-ancestor
64504172|NCT02510976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64504173|NCT02510976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504174|NCT02510976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504175|NCT02505516|Metformin|metformin|mesh-list
64504176|NCT02505516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64504177|NCT02505516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504178|NCT02505360|Hyaluronic Acid|hyaluronic acid|mesh-list
64729503|NCT00004478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64729504|NCT00003878|Carmustine|carmustine|mesh-list
64729505|NCT00003878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64729506|NCT00003878|Alkylating Agents|alkylating agents|mesh-ancestor
64729507|NCT00003878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729508|NCT00003878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729509|NCT00005060|Docetaxel|docetaxel|mesh-list
64504179|NCT02505360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64504180|NCT02505360|Immunologic Factors|immunologic factors|mesh-ancestor
64504181|NCT02505360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504182|NCT02505360|Viscosupplements|viscosupplements|mesh-ancestor
64504183|NCT02505360|Protective Agents|protective agents|mesh-ancestor
64504184|NCT04499586|Irinotecan|irinotecan|mesh-list
64504185|NCT04499586|Raltitrexed|raltitrexed|mesh-list
64504186|NCT04499586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64504187|NCT04499586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64504188|NCT04499586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504189|NCT04499586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504190|NCT04499586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504191|NCT04499586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64504192|NCT04499586|Antimetabolites|antimetabolites|mesh-ancestor
64504193|NCT04499586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64504194|NCT02505282|Vitamin K|vitamin k|mesh-list
64504195|NCT02505282|Vitamins|vitamins|mesh-ancestor
64729581|NCT00003914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729582|NCT00005078|Paclitaxel|paclitaxel|mesh-list
64729583|NCT00005078|Carboplatin|carboplatin|mesh-list
64729584|NCT00005078|Tirapazamine|tirapazamine|mesh-list
64729585|NCT00005078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64729586|NCT00005078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336962|NCT04462939|Micronutrients|micronutrients|mesh-list
64729587|NCT00005078|Tubulin Modulators|tubulin modulators|mesh-ancestor
64729588|NCT00005078|Antimitotic Agents|antimitotic agents|mesh-ancestor
64729589|NCT00005078|Mitosis Modulators|mitosis modulators|mesh-ancestor
64729590|NCT00005078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729591|NCT04698031|Aspirin|aspirin|mesh-list
64729592|NCT04698031|Clopidogrel|clopidogrel|mesh-list
64729593|NCT04698031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64729594|NCT04698031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64729595|NCT04698031|Analgesics|analgesics|mesh-ancestor
64729596|NCT04698031|Sensory System Agents|sensory system agents|mesh-ancestor
64729597|NCT04698031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64729598|NCT04698031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729599|NCT04698031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64729600|NCT04698031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64729601|NCT04698031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64729602|NCT04698031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64504196|NCT02505282|Micronutrients|micronutrients|mesh-ancestor
64504197|NCT02505282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504198|NCT02505282|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64504199|NCT02505282|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64504203|NCT01816295|Methyltestosterone|methyltestosterone|mesh-list
64504204|NCT01816295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64504205|NCT01816295|Testosterone|testosterone|mesh-list
64504206|NCT01816295|Testosterone undecanoate|testosterone undecanoate|mesh-list
64729603|NCT04698031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729604|NCT04698031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64729605|NCT04698031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64729606|NCT04698031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729607|NCT04698031|Antipyretics|antipyretics|mesh-ancestor
64729608|NCT04698031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64729609|NCT04698031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64729610|NCT04698031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64729611|NCT04698031|Purinergic Agents|purinergic agents|mesh-ancestor
64729612|NCT04698031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64729613|NCT00003920|Cyclosporine|cyclosporine|mesh-list
64729614|NCT00003920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64729615|NCT00003920|Antibodies|antibodies|mesh-list
64729616|NCT00003920|Immunoglobulins|immunoglobulins|mesh-list
64729617|NCT00003920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64729618|NCT00003920|Cyclosporins|cyclosporins|mesh-list
64729619|NCT00003920|Immunologic Factors|immunologic factors|mesh-ancestor
64729620|NCT00003920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729621|NCT00003920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729622|NCT00003920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729623|NCT00003920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729624|NCT00003920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64729625|NCT00003920|Antifungal Agents|antifungal agents|mesh-ancestor
64729626|NCT00003920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64729627|NCT00003920|Dermatologic Agents|dermatologic agents|mesh-ancestor
64729628|NCT00003920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64729629|NCT00003920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64729631|NCT00003926|Busulfan|busulfan|mesh-list
64729632|NCT00003926|Thiotepa|thiotepa|mesh-list
64729633|NCT00003926|Lenograstim|lenograstim|mesh-list
64729634|NCT00003926|Amifostine|amifostine|mesh-list
64729635|NCT00003926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64504207|NCT01816295|Testosterone enanthate|testosterone enanthate|mesh-list
64504209|NCT01816295|Androgens|androgens|mesh-ancestor
64504210|NCT01816295|Hormones|hormones|mesh-ancestor
64504211|NCT01816295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64504212|NCT01816295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504213|NCT01816295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64504214|NCT01816295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504215|NCT01816295|Anabolic Agents|anabolic agents|mesh-ancestor
64729637|NCT00003926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729638|NCT00003926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64729639|NCT00003926|Alkylating Agents|alkylating agents|mesh-ancestor
64729640|NCT00003926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729641|NCT00003926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729642|NCT00003926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64729643|NCT00003926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64729644|NCT00003926|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64729645|NCT00003926|Protective Agents|protective agents|mesh-ancestor
64729646|NCT05122819|Anesthetics|anesthetics|mesh-list
64729647|NCT05122819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64729648|NCT05122819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729649|NCT00005090|Cyclophosphamide|cyclophosphamide|mesh-list
64729650|NCT00005090|Dacarbazine|dacarbazine|mesh-list
64729651|NCT00005090|Carmustine|carmustine|mesh-list
64729652|NCT00005090|Doxorubicin|doxorubicin|mesh-list
64729653|NCT00005090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64729654|NCT00005090|Etoposide|etoposide|mesh-list
64729655|NCT00005090|Bleomycin|bleomycin|mesh-list
64729656|NCT00005090|Vinblastine|vinblastine|mesh-list
64955912|NCT00206050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64955913|NCT00206050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64729657|NCT00005090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64729658|NCT00005090|Immunologic Factors|immunologic factors|mesh-ancestor
64729659|NCT00005090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729660|NCT00005090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64729661|NCT00005090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64729662|NCT00005090|Alkylating Agents|alkylating agents|mesh-ancestor
64729663|NCT00005090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504216|NCT02514018|Vaccines|vaccines|mesh-list
64504217|NCT02514018|Immunologic Factors|immunologic factors|mesh-ancestor
64504218|NCT02514018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504219|NCT02513862|Heparin|heparin|mesh-list
64504220|NCT02513862|Protamines|protamines|mesh-list
64504221|NCT02513862|Anticoagulants|anticoagulants|mesh-ancestor
64504222|NCT02513862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64504223|NCT02513862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64504224|NCT02513862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504225|NCT02513862|Heparin Antagonists|heparin antagonists|mesh-ancestor
64504226|NCT02513862|Coagulants|coagulants|mesh-ancestor
64729664|NCT00005090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729665|NCT00005090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64729666|NCT00005090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64729667|NCT00005090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64729668|NCT00005090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64729669|NCT00005090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729670|NCT00005090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64729671|NCT00005090|Tubulin Modulators|tubulin modulators|mesh-ancestor
64729672|NCT00005090|Antimitotic Agents|antimitotic agents|mesh-ancestor
64955914|NCT00206050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64729673|NCT00005090|Mitosis Modulators|mitosis modulators|mesh-ancestor
64729674|NCT00004580|Ritonavir|ritonavir|mesh-list
64729675|NCT00004580|Lopinavir|lopinavir|mesh-list
64729676|NCT00004580|Nevirapine|nevirapine|mesh-list
64729677|NCT00004580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64729678|NCT00004580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64729679|NCT00004580|Protease Inhibitors|protease inhibitors|mesh-ancestor
64729680|NCT00004580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729681|NCT00004580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729682|NCT00004580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64729683|NCT00004580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64729684|NCT00004580|Antiviral Agents|antiviral agents|mesh-ancestor
64729685|NCT00004580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64729686|NCT00004580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64729687|NCT00004580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64729688|NCT00004580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64729689|NCT00004580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64729690|NCT00004580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64729691|NCT00004580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64729692|NCT00005096|Docetaxel|docetaxel|mesh-list
64729693|NCT00005096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504227|NCT02510586|Sevoflurane|sevoflurane|mesh-list
64504228|NCT02510586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64504229|NCT02510586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64504230|NCT02510586|Anesthetics, General|anesthetics, general|mesh-ancestor
64504231|NCT02510586|Anesthetics|anesthetics|mesh-ancestor
64504232|NCT02510586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64504233|NCT02510586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504234|NCT01610297|Deferasirox|deferasirox|mesh-list
64726389|NCT00003392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64726390|NCT00003392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64726391|NCT00003392|Alkylating Agents|alkylating agents|mesh-ancestor
64726392|NCT00003392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64726393|NCT00002551|Leucovorin|leucovorin|mesh-list
64726394|NCT00002551|Levamisole|levamisole|mesh-list
64726395|NCT00002551|Fluorouracil|fluorouracil|mesh-list
64504235|NCT01610297|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64504236|NCT01610297|Chelating Agents|chelating agents|mesh-ancestor
64504237|NCT01610297|Sequestering Agents|sequestering agents|mesh-ancestor
64504238|NCT01610297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504239|NCT01660672|Levetiracetam|levetiracetam|mesh-list
64504240|NCT01660672|Anticonvulsants|anticonvulsants|mesh-ancestor
64504241|NCT01660672|Nootropic Agents|nootropic agents|mesh-ancestor
64504242|NCT02505048|Rucaparib|rucaparib|mesh-list
64504243|NCT02505048|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64504244|NCT02505048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504245|NCT02505048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504246|NCT02505048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504247|NCT01793051|Minocycline|minocycline|mesh-list
64504248|NCT01793051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64504249|NCT01793051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64504250|NCT01792115|Vitamins|vitamins|mesh-list
64504251|NCT01792115|Vitamin E|vitamin e|mesh-list
64504252|NCT01792115|Tocopherols|tocopherols|mesh-list
64729696|NCT00005096|Mitosis Modulators|mitosis modulators|mesh-ancestor
64729697|NCT00005096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729698|NCT05396833|Avelumab|avelumab|mesh-list
64729699|NCT05396833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64729700|NCT05396833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729701|NCT00004640|Chlorhexidine|chlorhexidine|mesh-list
64729702|NCT00004640|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64729703|NCT00004640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64729705|NCT05104099|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
64955915|NCT00206050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337847|NCT02264171|Ketoconazole|ketoconazole|mesh-list
64504253|NCT01792115|Tocotrienols|tocotrienols|mesh-list
64504254|NCT01792115|alpha-Tocopherol|alpha-tocopherol|mesh-list
64504255|NCT01792115|Micronutrients|micronutrients|mesh-ancestor
64504256|NCT01792115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504257|NCT01792115|Antioxidants|antioxidants|mesh-ancestor
64504258|NCT01792115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504259|NCT01792115|Protective Agents|protective agents|mesh-ancestor
64504260|NCT01791803|Nicotine|nicotine|mesh-list
64504261|NCT01791803|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64504262|NCT01791803|Autonomic Agents|autonomic agents|mesh-ancestor
64504263|NCT01791803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64729706|NCT05104099|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64729707|NCT05104099|Dermatologic Agents|dermatologic agents|mesh-ancestor
64729708|NCT00004646|Prednisone|prednisone|mesh-list
64729709|NCT00004646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64729710|NCT00004646|Glucocorticoids|glucocorticoids|mesh-ancestor
64729711|NCT00004646|Hormones|hormones|mesh-ancestor
64729712|NCT00004646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64955916|NCT00206050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504264|NCT01791803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504265|NCT01791803|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64504266|NCT01791803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64504267|NCT01791803|Cholinergic Agents|cholinergic agents|mesh-ancestor
64504268|NCT01791803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64504269|NCT01791803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504270|NCT01662856|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64729713|NCT00004646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729714|NCT00004646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64729715|NCT00004646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729716|NCT00005108|Estradiol|estradiol|mesh-list
64729717|NCT00005108|Progesterone|progesterone|mesh-list
64729718|NCT00005108|Estrogens|estrogens|mesh-ancestor
64729719|NCT00005108|Hormones|hormones|mesh-ancestor
64729720|NCT00005108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64729721|NCT00005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729722|NCT00005108|Progestins|progestins|mesh-ancestor
64729723|NCT00004652|Pimozide|pimozide|mesh-list
64729724|NCT00004652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64729725|NCT00004652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64955917|NCT00206089|Ximelagatran|ximelagatran|mesh-list
64955918|NCT00206089|Melagatran|melagatran|mesh-list
64337853|NCT02264171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64421137|NCT05563571|Hormones|hormones|mesh-ancestor
64504271|NCT01662856|Hemostatics|hemostatics|mesh-ancestor
64504272|NCT01662856|Coagulants|coagulants|mesh-ancestor
64504273|NCT04499976|Misoprostol|misoprostol|mesh-list
64504274|NCT04499976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64504275|NCT04499976|Abortifacient Agents|abortifacient agents|mesh-ancestor
64504279|NCT04499976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64504280|NCT04499976|Oxytocics|oxytocics|mesh-ancestor
64504281|NCT01791413|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64504282|NCT01791413|Medroxyprogesterone|medroxyprogesterone|mesh-list
64504283|NCT01791413|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64504284|NCT01791413|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64504285|NCT01791413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64504286|NCT01791413|Contraceptive Agents|contraceptive agents|mesh-ancestor
64504287|NCT01791413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64729726|NCT00004652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64729727|NCT00004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729728|NCT00004652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64729729|NCT00004652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64729730|NCT00004652|Dopamine Agents|dopamine agents|mesh-ancestor
64729731|NCT00004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64729732|NCT00004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729733|NCT00004652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64729734|NCT04641871|Irinotecan|irinotecan|mesh-list
64729735|NCT04641871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64729736|NCT04641871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64729737|NCT04641871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955920|NCT00206089|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64504288|NCT01791413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504289|NCT01791413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64504290|NCT01791413|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64504291|NCT01791413|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64504292|NCT01791413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64504293|NCT01791413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504295|NCT02509806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504296|NCT02509806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64729738|NCT04641871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729739|NCT04641871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729740|NCT04280965|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64729741|NCT04280965|Antidepressive Agents|antidepressive agents|mesh-ancestor
64729742|NCT04280965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64729743|NCT04280965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64729744|NCT04280965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64729745|NCT04280965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64729746|NCT04280965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729747|NCT00005120|Calanolide A|calanolide a|mesh-list
64729748|NCT00005120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64729749|NCT00005120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64729750|NCT00005120|Antiviral Agents|antiviral agents|mesh-ancestor
64729751|NCT00005120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64729752|NCT00004664|Megestrol|megestrol|mesh-list
64729753|NCT00004664|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64729754|NCT00004664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64729755|NCT00004664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64729756|NCT00004664|Contraceptive Agents|contraceptive agents|mesh-ancestor
64729757|NCT00004664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64729758|NCT00004664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729759|NCT00004664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64729760|NCT00004664|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64729761|NCT00004664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64729762|NCT00004664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729763|NCT00004682|Immunoglobulins|immunoglobulins|mesh-list
64504297|NCT02509806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504298|NCT02509806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504299|NCT02509728|Choline|choline|mesh-list
64504300|NCT02509728|Lipotropic Agents|lipotropic agents|mesh-ancestor
64504301|NCT02509728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64504302|NCT02509728|Antimetabolites|antimetabolites|mesh-ancestor
64726396|NCT00002551|Calcium|calcium|mesh-list
64726397|NCT00002551|Levoleucovorin|levoleucovorin|mesh-list
64726398|NCT00002551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64726399|NCT00002551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729764|NCT00004682|Antibodies|antibodies|mesh-list
64729765|NCT00004682|gamma-Globulins|gamma-globulins|mesh-list
64729766|NCT00004682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64337130|NCT02324491|CKD732|ckd732|mesh-list
64729768|NCT00004682|Immunologic Factors|immunologic factors|mesh-ancestor
64729769|NCT00004682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729770|NCT00004688|Mercaptopurine|mercaptopurine|mesh-list
64729771|NCT00004688|Carmustine|carmustine|mesh-list
64729772|NCT00004688|Streptozocin|streptozocin|mesh-list
64729773|NCT00004688|Antimetabolites|antimetabolites|mesh-ancestor
64729774|NCT00004688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729775|NCT00004688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64729776|NCT00004688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729777|NCT00004688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64729778|NCT00004688|Immunologic Factors|immunologic factors|mesh-ancestor
64729779|NCT00004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729780|NCT00004688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64729781|NCT00004688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729782|NCT00004688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64729783|NCT00004688|Alkylating Agents|alkylating agents|mesh-ancestor
64729784|NCT00004688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64729785|NCT00004694|Heparin|heparin|mesh-list
64729786|NCT00004694|Anticoagulants|anticoagulants|mesh-ancestor
64729787|NCT00004694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64729788|NCT00004694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64337875|NCT01470131|Dexamethasone|dexamethasone|mesh-list
64504303|NCT02509728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504304|NCT02509728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64504305|NCT02509728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64504306|NCT02509728|Nootropic Agents|nootropic agents|mesh-ancestor
64504307|NCT02501616|Metformin|metformin|mesh-list
64504308|NCT02501616|Dapagliflozin|dapagliflozin|mesh-list
64504309|NCT02501616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64504310|NCT02501616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504311|NCT02501616|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64504312|NCT02501616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504313|NCT01788215|Doxycycline|doxycycline|mesh-list
64504314|NCT01788215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64955388|NCT00202345|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64504315|NCT01788215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64504316|NCT01788215|Antimalarials|antimalarials|mesh-ancestor
64504317|NCT01788215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64504318|NCT01788215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64504319|NCT01812707|Atorvastatin|atorvastatin|mesh-list
64504320|NCT01812707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64504321|NCT01812707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64504322|NCT01812707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64504323|NCT01812707|Antimetabolites|antimetabolites|mesh-ancestor
64504324|NCT01812707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504325|NCT01812707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64504326|NCT01812707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64504327|NCT01812707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504328|NCT01812707|Immunologic Factors|immunologic factors|mesh-ancestor
64504329|NCT01812707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729789|NCT00004694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729790|NCT04608409|Paclitaxel|paclitaxel|mesh-list
64729791|NCT04608409|Lapatinib|lapatinib|mesh-list
64729792|NCT04608409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64729793|NCT04608409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729794|NCT04608409|Tubulin Modulators|tubulin modulators|mesh-ancestor
64729795|NCT04608409|Antimitotic Agents|antimitotic agents|mesh-ancestor
64729796|NCT04608409|Mitosis Modulators|mitosis modulators|mesh-ancestor
64729797|NCT04608409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729798|NCT04608409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64337159|NCT02320045|Hormones|hormones|mesh-ancestor
64955921|NCT00206089|Protease Inhibitors|protease inhibitors|mesh-ancestor
64955922|NCT00206089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955923|NCT00206089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504330|NCT01787279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64504331|NCT01787279|Antiviral Agents|antiviral agents|mesh-ancestor
64504332|NCT01787279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64504333|NCT02728206|Sofosbuvir|sofosbuvir|mesh-list
64421140|NCT05563571|Protective Agents|protective agents|mesh-ancestor
64504334|NCT02728206|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64504336|NCT02728206|Antiviral Agents|antiviral agents|mesh-ancestor
64504337|NCT02728206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64504338|NCT01811225|Progesterone|progesterone|mesh-list
64504339|NCT01811225|Progestins|progestins|mesh-ancestor
64504340|NCT01811225|Hormones|hormones|mesh-ancestor
64504341|NCT01811225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64729799|NCT04608409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729800|NCT00004700|Mitogens|mitogens|mesh-list
64729801|NCT00004700|Mitosis Modulators|mitosis modulators|mesh-ancestor
64729802|NCT00004700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729803|NCT00004730|Magnesium Sulfate|magnesium sulfate|mesh-list
64729804|NCT00004730|Analgesics|analgesics|mesh-ancestor
64504342|NCT01811225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504343|NCT01809197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64504344|NCT02508870|Azacitidine|azacitidine|mesh-list
64504345|NCT02508870|Atezolizumab|atezolizumab|mesh-list
64504346|NCT02508870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64504347|NCT02508870|Antimetabolites|antimetabolites|mesh-ancestor
64504349|NCT02508870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504350|NCT02508870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504351|NCT01786109|Dronabinol|dronabinol|mesh-list
64504352|NCT01786109|Hallucinogens|hallucinogens|mesh-ancestor
64504353|NCT01786109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729805|NCT00004730|Sensory System Agents|sensory system agents|mesh-ancestor
64729806|NCT00004730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64729807|NCT00004730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729808|NCT00004730|Anesthetics|anesthetics|mesh-ancestor
64729809|NCT00004730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64729810|NCT00004730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64729811|NCT00004730|Anticonvulsants|anticonvulsants|mesh-ancestor
64729812|NCT00004730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64729813|NCT00004730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64729814|NCT00004730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729815|NCT00004730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64729816|NCT00004730|Tocolytic Agents|tocolytic agents|mesh-ancestor
64729817|NCT00004730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64729818|NCT00004736|Lamivudine|lamivudine|mesh-list
64729819|NCT00004736|Zidovudine|zidovudine|mesh-list
64729820|NCT00004736|Stavudine|stavudine|mesh-list
64729821|NCT00004736|Nelfinavir|nelfinavir|mesh-list
64729822|NCT00004736|Isoniazid|isoniazid|mesh-list
64729823|NCT00004736|Pyrazinamide|pyrazinamide|mesh-list
64504354|NCT01786109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64504355|NCT01786109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64504356|NCT01786109|Analgesics|analgesics|mesh-ancestor
64504357|NCT01786109|Sensory System Agents|sensory system agents|mesh-ancestor
64504358|NCT01786109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64504359|NCT01786109|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64504360|NCT01786109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64504362|NCT01786109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504363|NCT01786109|Hormones|hormones|mesh-ancestor
64955924|NCT00206089|Anticoagulants|anticoagulants|mesh-ancestor
64729824|NCT00004736|Ethambutol|ethambutol|mesh-list
64729825|NCT00004736|Rifabutin|rifabutin|mesh-list
64729826|NCT00004736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64729827|NCT00004736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64729828|NCT00004736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729829|NCT00004736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729830|NCT00004736|Antiviral Agents|antiviral agents|mesh-ancestor
64729831|NCT00004736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64729832|NCT00004736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64729833|NCT00004736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64729834|NCT00004736|Antimetabolites|antimetabolites|mesh-ancestor
64729835|NCT00004736|Antitubercular Agents|antitubercular agents|mesh-ancestor
64729836|NCT00004736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64729837|NCT00004736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64729838|NCT00004736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64729839|NCT00004736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64729840|NCT00004736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64729841|NCT00004736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64729842|NCT00004736|Protease Inhibitors|protease inhibitors|mesh-ancestor
64729843|NCT00004736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64729844|NCT00004748|Methotrexate|methotrexate|mesh-list
64729845|NCT00004748|Colchicine|colchicine|mesh-list
64729846|NCT00004748|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64729847|NCT00004748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64729848|NCT00004748|Abortifacient Agents|abortifacient agents|mesh-ancestor
64729849|NCT00004748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64736772|NCT05599919|Gasotransmitters|gasotransmitters|mesh-ancestor
64337888|NCT02264561|Caffeine|caffeine|mesh-list
64955926|NCT00072579|Immunologic Factors|immunologic factors|mesh-ancestor
64955927|NCT00072579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729850|NCT00004748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729851|NCT00004748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64729852|NCT00004748|Antimetabolites|antimetabolites|mesh-ancestor
64729853|NCT00004748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729854|NCT00004748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729855|NCT00004748|Dermatologic Agents|dermatologic agents|mesh-ancestor
64729856|NCT00004748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504364|NCT01786109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64504365|NCT02509104|Tamsulosin|tamsulosin|mesh-list
64504366|NCT02509104|Dutasteride|dutasteride|mesh-list
64504367|NCT02509104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64504368|NCT02509104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64504369|NCT02509104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64504370|NCT02509104|Adrenergic Agents|adrenergic agents|mesh-ancestor
64955928|NCT04732247|Oxytocin|oxytocin|mesh-list
64729865|NCT00004748|Mitosis Modulators|mitosis modulators|mesh-ancestor
64729866|NCT00004748|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64729867|NCT00004748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64729868|NCT04585477|Durvalumab|durvalumab|mesh-list
64729869|NCT04585477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64729870|NCT04585477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729871|NCT00004754|Epoprostenol|epoprostenol|mesh-list
64729872|NCT00004754|Tezosentan|tezosentan|mesh-list
64729873|NCT00004754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64729874|NCT00004754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64729875|NCT00004754|Vasodilator Agents|vasodilator agents|mesh-ancestor
64729876|NCT00005576|Aldesleukin|aldesleukin|mesh-list
64729877|NCT00005576|Interleukin-2|interleukin-2|mesh-list
64729878|NCT00005576|Dinutuximab|dinutuximab|mesh-list
64729879|NCT00005576|Isotretinoin|isotretinoin|mesh-list
64729880|NCT00005576|Antibodies|antibodies|mesh-list
64729881|NCT00005576|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64729882|NCT00005576|Sargramostim|sargramostim|mesh-list
64729883|NCT00005576|Immunologic Factors|immunologic factors|mesh-ancestor
64729884|NCT00005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729885|NCT00005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729886|NCT00005576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64729887|NCT00005576|Analgesics|analgesics|mesh-ancestor
64729888|NCT00005576|Sensory System Agents|sensory system agents|mesh-ancestor
64729889|NCT00005576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64729890|NCT00005576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64729891|NCT00005576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64726400|NCT00002551|Antimetabolites|antimetabolites|mesh-ancestor
64726401|NCT00002551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504371|NCT02509104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64504372|NCT02509104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504373|NCT02509104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504374|NCT02509104|Urological Agents|urological agents|mesh-ancestor
64504375|NCT02509104|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64504376|NCT02509104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64504377|NCT02509104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504378|NCT02509104|Hormone Antagonists|hormone antagonists|mesh-ancestor
64504379|NCT02509104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64504380|NCT02500680|Vaccines|vaccines|mesh-list
64504381|NCT02500680|Immunologic Factors|immunologic factors|mesh-ancestor
64504382|NCT02500680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504383|NCT02500446|Dolutegravir|dolutegravir|mesh-list
64504384|NCT02500446|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64504385|NCT02500446|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64729892|NCT00005576|Antiviral Agents|antiviral agents|mesh-ancestor
64729893|NCT00005576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64729894|NCT00005576|Dermatologic Agents|dermatologic agents|mesh-ancestor
64729895|NCT04562467|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
64729896|NCT04562467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64729897|NCT04562467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64729898|NCT04713163|Vaccines|vaccines|mesh-list
64729899|NCT04713163|Immunologic Factors|immunologic factors|mesh-ancestor
64729900|NCT04713163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729901|NCT00004772|Immunoglobulins|immunoglobulins|mesh-list
64729902|NCT00004772|Antibodies|antibodies|mesh-list
64729903|NCT00004772|gamma-Globulins|gamma-globulins|mesh-list
64729904|NCT00004772|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64337259|NCT02321371|Rifaximin|rifaximin|mesh-list
64615421|NCT03574779|Growth Inhibitors|growth inhibitors|mesh-ancestor
64504386|NCT02500446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504387|NCT02500446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504388|NCT02500446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64504389|NCT02500446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64955389|NCT00202345|Hematinics|hematinics|mesh-ancestor
64504390|NCT02500446|Antiviral Agents|antiviral agents|mesh-ancestor
64504391|NCT02500446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64504392|NCT02500524|Permethrin|permethrin|mesh-list
64504393|NCT02500524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504394|NCT02500524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729907|NCT00004772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729908|NCT04712929|Fluconazole|fluconazole|mesh-list
64729909|NCT04712929|Antifungal Agents|antifungal agents|mesh-ancestor
64729910|NCT04712929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64729911|NCT04712929|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64729912|NCT04712929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64729913|NCT04712929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729914|NCT04712929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729915|NCT04712929|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64729916|NCT04712929|Hormone Antagonists|hormone antagonists|mesh-ancestor
64729917|NCT04712929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64729918|NCT04712929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729919|NCT04712929|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64729920|NCT04712929|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64729921|NCT00004778|Dexamethasone|dexamethasone|mesh-list
64729922|NCT00004778|Betamethasone|betamethasone|mesh-list
64729924|NCT00004778|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
64729925|NCT00004778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64729926|NCT00004778|Antiemetics|antiemetics|mesh-ancestor
64729928|NCT00004778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64729929|NCT00004778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729930|NCT00004778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64729931|NCT00004778|Glucocorticoids|glucocorticoids|mesh-ancestor
64729932|NCT00004778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64729933|NCT00004778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64729934|NCT00004778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729935|NCT00004778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64729936|NCT00004778|Respiratory System Agents|respiratory system agents|mesh-ancestor
64729937|NCT00004784|Methotrexate|methotrexate|mesh-list
64337908|NCT01445795|Ribavirin|ribavirin|mesh-list
64504395|NCT02508402|Dexamethasone|dexamethasone|mesh-list
64504396|NCT02508402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64504397|NCT02508402|Antiemetics|antiemetics|mesh-ancestor
64504399|NCT02508402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64504400|NCT02508402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504401|NCT02508402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64504402|NCT02508402|Glucocorticoids|glucocorticoids|mesh-ancestor
64504403|NCT02508402|Hormones|hormones|mesh-ancestor
64504404|NCT02508402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64504405|NCT02508402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64504406|NCT02508402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504407|NCT02500212|Tacrolimus|tacrolimus|mesh-list
64504408|NCT02500212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64504409|NCT02500212|Immunologic Factors|immunologic factors|mesh-ancestor
64504410|NCT02500212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729938|NCT00004784|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64729939|NCT00004784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64729940|NCT00004784|Abortifacient Agents|abortifacient agents|mesh-ancestor
64729941|NCT00004784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64955929|NCT04732247|Oxytocics|oxytocics|mesh-ancestor
64955930|NCT04732247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64955931|NCT04732247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955932|NCT00206128|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64955933|NCT00206128|Antidepressive Agents|antidepressive agents|mesh-ancestor
64955934|NCT00206128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64955937|NCT00206128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64955938|NCT00206128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729942|NCT00004784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729943|NCT00004784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64729945|NCT00004784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729946|NCT00004784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729947|NCT00004784|Dermatologic Agents|dermatologic agents|mesh-ancestor
64729948|NCT00004784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729949|NCT00004784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64729950|NCT00004784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64729951|NCT00004784|Immunologic Factors|immunologic factors|mesh-ancestor
64729952|NCT00004784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64729953|NCT00004784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64729954|NCT00004784|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64729955|NCT00004784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64729956|NCT00004796|Lactulose|lactulose|mesh-list
64729957|NCT00004796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64729958|NCT00004802|Dichlorphenamide|dichlorphenamide|mesh-list
64504411|NCT02500212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64504412|NCT02500212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504413|NCT02500212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504414|NCT02508168|Metformin|metformin|mesh-list
64504415|NCT02508168|Alogliptin|alogliptin|mesh-list
64504416|NCT02508168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64504417|NCT02508168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504418|NCT02508168|Incretins|incretins|mesh-ancestor
64729961|NCT00004802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729962|NCT00004808|Fluconazole|fluconazole|mesh-list
64729963|NCT00004808|Antifungal Agents|antifungal agents|mesh-ancestor
64729964|NCT00004808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64729965|NCT00004808|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64729966|NCT00004808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64729967|NCT00004808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729968|NCT00004808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729969|NCT00004808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64729970|NCT00004808|Hormone Antagonists|hormone antagonists|mesh-ancestor
64729971|NCT00004808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64729972|NCT00004808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729973|NCT00004808|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64729974|NCT00004808|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64729975|NCT00004814|Glatiramer Acetate|glatiramer acetate|mesh-list
64729976|NCT00004814|(T,G)-A-L|(t,g)-a-l|mesh-list
64955939|NCT00206167|Budesonide|budesonide|mesh-list
64955940|NCT00206167|Formoterol Fumarate|formoterol fumarate|mesh-list
64494613|NCT01179490|Hormones|hormones|mesh-ancestor
64504419|NCT02508168|Hormones|hormones|mesh-ancestor
64504420|NCT02508168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64504435|NCT02508246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504437|NCT01617148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64504438|NCT01617148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64504439|NCT01617148|Growth Substances|growth substances|mesh-ancestor
64504440|NCT01617148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504441|NCT01617148|Growth Inhibitors|growth inhibitors|mesh-ancestor
64504442|NCT01617148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504443|NCT02499978|Dolutegravir|dolutegravir|mesh-list
64504445|NCT02499978|Cobicistat|cobicistat|mesh-list
64504446|NCT02499978|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
64504447|NCT02499978|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64504448|NCT02499978|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64504449|NCT02499978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729977|NCT00004814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64729978|NCT00004814|Immunologic Factors|immunologic factors|mesh-ancestor
64729979|NCT00004814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729980|NCT00004814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64729981|NCT00004814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64729982|NCT00004826|Clozapine|clozapine|mesh-list
64729983|NCT00004826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64729984|NCT00004826|Serotonin Agents|serotonin agents|mesh-ancestor
64729985|NCT00004826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64729986|NCT00004826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729987|NCT00004826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729988|NCT00004826|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64729989|NCT00004826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64337338|NCT02922985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504450|NCT02499978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504451|NCT02499978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64504452|NCT02499978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64504453|NCT02499978|Antiviral Agents|antiviral agents|mesh-ancestor
64504454|NCT02499978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726402|NCT00002551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64726403|NCT00002551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726404|NCT00002551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64726405|NCT00002551|Immunologic Factors|immunologic factors|mesh-ancestor
64726406|NCT00002551|Antidotes|antidotes|mesh-ancestor
64726407|NCT00002551|Protective Agents|protective agents|mesh-ancestor
64726408|NCT00002551|Vitamin B Complex|vitamin b complex|mesh-ancestor
64729990|NCT00004826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64729991|NCT00004826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64729992|NCT00004826|GABA Antagonists|gaba antagonists|mesh-ancestor
64729993|NCT00004826|GABA Agents|gaba agents|mesh-ancestor
64729994|NCT04555603|Pembrolizumab|pembrolizumab|mesh-list
64729995|NCT04555603|Avelumab|avelumab|mesh-list
64729996|NCT04555603|Axitinib|axitinib|mesh-list
64729997|NCT04555603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64729998|NCT04555603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729999|NCT04555603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64730000|NCT04555603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730001|NCT04555603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730002|NCT04552327|Diclofenac|diclofenac|mesh-list
64730003|NCT04552327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64730004|NCT04552327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64730005|NCT04552327|Analgesics|analgesics|mesh-ancestor
64730006|NCT04552327|Sensory System Agents|sensory system agents|mesh-ancestor
64730007|NCT04552327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64730008|NCT04552327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730009|NCT04552327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64730010|NCT04552327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64730011|NCT04552327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64730012|NCT04552327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730013|NCT04552327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504455|NCT02499978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64504456|NCT02499978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64504457|NCT02499978|Protease Inhibitors|protease inhibitors|mesh-ancestor
64504458|NCT02499978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64504459|NCT02499978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64504460|NCT01620190|Paclitaxel|paclitaxel|mesh-list
64504461|NCT01620190|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64504462|NCT01620190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64504463|NCT01620190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730029|NCT00005612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64730031|NCT00005612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64730032|NCT00005612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64730033|NCT00005612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64730034|NCT00005612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730035|NCT00005612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64730039|NCT00005618|Arsenic Trioxide|arsenic trioxide|mesh-list
64730040|NCT00005618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730041|NCT04534153|Fexofenadine|fexofenadine|mesh-list
64730042|NCT04534153|Terfenadine|terfenadine|mesh-list
64730043|NCT04534153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64730044|NCT04534153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64730045|NCT04534153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64337395|NCT02321761|Amantadine|amantadine|mesh-list
64504464|NCT01620190|Tubulin Modulators|tubulin modulators|mesh-ancestor
64504465|NCT01620190|Antimitotic Agents|antimitotic agents|mesh-ancestor
64504466|NCT01620190|Mitosis Modulators|mitosis modulators|mesh-ancestor
64955390|NCT02966847|Anesthetics|anesthetics|mesh-list
64504467|NCT01620190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504468|NCT04498884|Insulin|insulin|mesh-list
64504469|NCT04498884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64504470|NCT04498884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64504471|NCT04498884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504472|NCT01621672|Lenalidomide|lenalidomide|mesh-list
64504473|NCT01621672|Immunologic Factors|immunologic factors|mesh-ancestor
64730046|NCT04534153|Histamine Antagonists|histamine antagonists|mesh-ancestor
64730047|NCT04534153|Histamine Agents|histamine agents|mesh-ancestor
64730048|NCT04534153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64730049|NCT04534153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730050|NCT04534153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730051|NCT00005624|Tacedinaline|tacedinaline|mesh-list
64730052|NCT00005624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
64730053|NCT00005624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730054|NCT00005624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730055|NCT00005624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730056|NCT00385502|Econazole|econazole|mesh-list
64730057|NCT00385502|Antifungal Agents|antifungal agents|mesh-ancestor
64730058|NCT00385502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64730059|NCT00385502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64730060|NCT00385502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64730061|NCT00385502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730062|NCT00385502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730063|NCT00385502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64337408|NCT04674241|Dexmedetomidine|dexmedetomidine|mesh-list
64955945|NCT00206167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494623|NCT01179568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64337973|NCT02265731|Immunologic Factors|immunologic factors|mesh-ancestor
64504474|NCT01621672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504475|NCT01621672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64504476|NCT01621672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64504477|NCT01621672|Growth Substances|growth substances|mesh-ancestor
64504478|NCT01621672|Growth Inhibitors|growth inhibitors|mesh-ancestor
64504479|NCT01621672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504480|NCT03344328|Bortezomib|bortezomib|mesh-list
64504481|NCT03344328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504482|NCT02499822|Ramipril|ramipril|mesh-list
64504483|NCT02499822|Nifedipine|nifedipine|mesh-list
64504484|NCT02499822|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64504493|NCT02499822|Vasodilator Agents|vasodilator agents|mesh-ancestor
64504494|NCT02499822|Tocolytic Agents|tocolytic agents|mesh-ancestor
64504495|NCT02499822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64504496|NCT01663012|Etirinotecan pegol|etirinotecan pegol|mesh-list
64504497|NCT01663012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730065|NCT00385502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64730066|NCT00385502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730067|NCT00005630|Sargramostim|sargramostim|mesh-list
64730068|NCT00005630|Immunologic Factors|immunologic factors|mesh-ancestor
64730069|NCT00005630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730070|NCT00005636|Pemetrexed|pemetrexed|mesh-list
64730071|NCT00005636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730072|NCT00005636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730073|NCT00005636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730074|NCT00005636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64730075|NCT00005636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64730076|NCT00005642|Semaxinib|semaxinib|mesh-list
64730077|NCT00005642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64730078|NCT00005642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64730079|NCT00005642|Growth Substances|growth substances|mesh-ancestor
64730080|NCT00005642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730081|NCT00005642|Growth Inhibitors|growth inhibitors|mesh-ancestor
64730082|NCT00005642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730083|NCT00005642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64730084|NCT00005642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730085|NCT00005642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730086|NCT00005648|Gemcitabine|gemcitabine|mesh-list
64730087|NCT00005648|Tipifarnib|tipifarnib|mesh-list
64730088|NCT00005648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64730089|NCT00005648|Antimetabolites|antimetabolites|mesh-ancestor
64504498|NCT01663012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64504499|NCT01663012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64504500|NCT01663012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504501|NCT01663012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504502|NCT03343548|Magnesium Sulfate|magnesium sulfate|mesh-list
64504503|NCT03343548|Analgesics|analgesics|mesh-ancestor
64504504|NCT03343548|Sensory System Agents|sensory system agents|mesh-ancestor
64504505|NCT03343548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64504507|NCT03343548|Anesthetics|anesthetics|mesh-ancestor
64504508|NCT03343548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64504509|NCT03343548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64504510|NCT03343548|Anticonvulsants|anticonvulsants|mesh-ancestor
64504511|NCT03343548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64504512|NCT03343548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64504513|NCT03343548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504514|NCT03343548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64504515|NCT03343548|Tocolytic Agents|tocolytic agents|mesh-ancestor
64504516|NCT03343548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64504517|NCT02507934|Hyaluronic Acid|hyaluronic acid|mesh-list
64504518|NCT02507934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64504519|NCT02507934|Immunologic Factors|immunologic factors|mesh-ancestor
64504520|NCT02507934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504521|NCT02507934|Viscosupplements|viscosupplements|mesh-ancestor
64504522|NCT02507934|Protective Agents|protective agents|mesh-ancestor
64504523|NCT01622296|Lidocaine|lidocaine|mesh-list
64504524|NCT01622296|Epinephrine|epinephrine|mesh-list
64726410|NCT00002551|Micronutrients|micronutrients|mesh-ancestor
64726411|NCT00002551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64726412|NCT00002551|Antinematodal Agents|antinematodal agents|mesh-ancestor
64726413|NCT00002551|Anthelmintics|anthelmintics|mesh-ancestor
64726414|NCT00002551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64333924|NCT02358057|Alfentanil|alfentanil|mesh-list
64504525|NCT01622296|Anesthetics, Local|anesthetics, local|mesh-list
64504526|NCT01622296|Anesthetics|anesthetics|mesh-list
64504527|NCT01622296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64730156|NCT04456699|Immunologic Factors|immunologic factors|mesh-ancestor
64730157|NCT04456699|Antidotes|antidotes|mesh-ancestor
64730158|NCT04456699|Protective Agents|protective agents|mesh-ancestor
64504528|NCT01622296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504529|NCT01622296|Sensory System Agents|sensory system agents|mesh-ancestor
64504530|NCT01622296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64504531|NCT01622296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64504532|NCT01622296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64504533|NCT01622296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64504534|NCT01622296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64504535|NCT01622296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504537|NCT01622296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64504538|NCT01622296|Adrenergic Agents|adrenergic agents|mesh-ancestor
64730194|NCT00005762|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64730195|NCT00005762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64730196|NCT00005762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64504539|NCT01622296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64504540|NCT01622296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64421149|NCT02717507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504541|NCT01622296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64504542|NCT01622296|Autonomic Agents|autonomic agents|mesh-ancestor
64955391|NCT02966847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64504543|NCT01622296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64504544|NCT01622296|Respiratory System Agents|respiratory system agents|mesh-ancestor
64504545|NCT01622296|Mydriatics|mydriatics|mesh-ancestor
64504546|NCT01622296|Sympathomimetics|sympathomimetics|mesh-ancestor
64504547|NCT01622296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64504548|NCT02728830|Pembrolizumab|pembrolizumab|mesh-list
64504549|NCT02728830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64504560|NCT01705288|Sensory System Agents|sensory system agents|mesh-ancestor
64504561|NCT01705288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64504562|NCT01705288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64504563|NCT01705288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64504564|NCT03343002|Fentanyl|fentanyl|mesh-list
64955946|NCT00206167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64730197|NCT00005762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64730198|NCT00005762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64730199|NCT00005762|Antitubercular Agents|antitubercular agents|mesh-ancestor
64730200|NCT00005762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64730201|NCT00005768|Estrogens|estrogens|mesh-list
64730202|NCT00005768|Hormones|hormones|mesh-ancestor
64730203|NCT00005768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64730204|NCT00005768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730205|NCT00005774|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64730206|NCT00005774|Respiratory System Agents|respiratory system agents|mesh-ancestor
64730207|NCT00005786|Arsenic Trioxide|arsenic trioxide|mesh-list
64730208|NCT00005786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730209|NCT00005792|Etoposide|etoposide|mesh-list
64730210|NCT00005792|Melphalan|melphalan|mesh-list
64337557|NCT02934529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504565|NCT03343002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64504566|NCT03343002|Narcotics|narcotics|mesh-ancestor
64504567|NCT03343002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64504568|NCT03343002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504569|NCT03343002|Analgesics|analgesics|mesh-ancestor
64504570|NCT03343002|Sensory System Agents|sensory system agents|mesh-ancestor
64504571|NCT03343002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64504572|NCT03343002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64504573|NCT03343002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64730211|NCT00005792|Topotecan|topotecan|mesh-list
64730212|NCT00005792|Etoposide phosphate|etoposide phosphate|mesh-list
64730213|NCT00005792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64730214|NCT00005792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730215|NCT00005792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64730216|NCT00005792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64730217|NCT00005792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730218|NCT00005792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730219|NCT00005792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64955947|NCT00206167|Respiratory System Agents|respiratory system agents|mesh-ancestor
64955948|NCT00206167|Glucocorticoids|glucocorticoids|mesh-ancestor
64504574|NCT03343002|Anesthetics, General|anesthetics, general|mesh-ancestor
64504575|NCT03343002|Anesthetics|anesthetics|mesh-ancestor
64504576|NCT03120936|Tenofovir|tenofovir|mesh-list
64504577|NCT03120936|Emtricitabine|emtricitabine|mesh-list
64504578|NCT03120936|Antiviral Agents|antiviral agents|mesh-ancestor
64504579|NCT03120936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64504580|NCT03120936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64504581|NCT03120936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64504582|NCT03120936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504583|NCT03120936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504584|NCT03120936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64504585|NCT03120936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64504587|NCT02234752|Galantamine|galantamine|mesh-list
64504588|NCT02234752|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64504589|NCT02234752|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64504590|NCT02234752|Dopamine Agents|dopamine agents|mesh-ancestor
64504591|NCT02234752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64730220|NCT00005792|Alkylating Agents|alkylating agents|mesh-ancestor
64730221|NCT00005792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64730222|NCT00005792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64730223|NCT00005792|Immunologic Factors|immunologic factors|mesh-ancestor
64730224|NCT00005792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730225|NCT00005792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64730226|NCT00005798|Cyclophosphamide|cyclophosphamide|mesh-list
64730228|NCT00005798|Carboplatin|carboplatin|mesh-list
64730229|NCT00005798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64730230|NCT00005798|Immunologic Factors|immunologic factors|mesh-ancestor
64337578|NCT02638805|Liraglutide|liraglutide|mesh-list
64504592|NCT02234752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504593|NCT02234752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504594|NCT02234752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64504595|NCT02234752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64504596|NCT02234752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64504597|NCT02234752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504598|NCT02234752|Cholinergic Agents|cholinergic agents|mesh-ancestor
64726415|NCT00002551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726416|NCT00002551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64726417|NCT00003146|Melphalan|melphalan|mesh-list
64726418|NCT00003146|Busulfan|busulfan|mesh-list
64726419|NCT00003146|Thiotepa|thiotepa|mesh-list
64726420|NCT00003146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64504599|NCT02234752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64504600|NCT02234752|Autonomic Agents|autonomic agents|mesh-ancestor
64730231|NCT00005798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730232|NCT00005798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64730233|NCT00005798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64730234|NCT00005798|Alkylating Agents|alkylating agents|mesh-ancestor
64730235|NCT00005798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730236|NCT00005798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730237|NCT00005798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64730238|NCT00005804|Cyclophosphamide|cyclophosphamide|mesh-list
64730239|NCT00005804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64730240|NCT00005804|Immunologic Factors|immunologic factors|mesh-ancestor
64730241|NCT00005804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504601|NCT02234752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64504602|NCT02234752|Nootropic Agents|nootropic agents|mesh-ancestor
64504603|NCT01665508|Nebivolol|nebivolol|mesh-list
64504604|NCT01665508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64504605|NCT01665508|Vasodilator Agents|vasodilator agents|mesh-ancestor
64504606|NCT01665508|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64504607|NCT01665508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64504608|NCT01665508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64504609|NCT01665508|Adrenergic Agents|adrenergic agents|mesh-ancestor
64504610|NCT01665508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64955949|NCT00206167|Hormones|hormones|mesh-ancestor
64730253|NCT00005810|Antimitotic Agents|antimitotic agents|mesh-ancestor
64730254|NCT00005810|Mitosis Modulators|mitosis modulators|mesh-ancestor
64730255|NCT00005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730256|NCT00005810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64730257|NCT00005810|Alkylating Agents|alkylating agents|mesh-ancestor
64730258|NCT00005810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64730259|NCT00385970|Leucovorin|leucovorin|mesh-list
64730260|NCT00385970|polysaccharide-K|polysaccharide-k|mesh-list
64730261|NCT00385970|Tegafur|tegafur|mesh-list
64730262|NCT00385970|Calcium|calcium|mesh-list
64730263|NCT00385970|Levoleucovorin|levoleucovorin|mesh-list
64730264|NCT00385970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64730265|NCT00385970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730266|NCT00385970|Antidotes|antidotes|mesh-ancestor
64730267|NCT00385970|Protective Agents|protective agents|mesh-ancestor
64730268|NCT00385970|Vitamin B Complex|vitamin b complex|mesh-ancestor
64504611|NCT01665508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504612|NCT01665508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504613|NCT04498260|Triamcinolone|triamcinolone|mesh-list
64421188|NCT01174199|Vorinostat|vorinostat|mesh-list
64504614|NCT04498260|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64504615|NCT04498260|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64955392|NCT02966847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504621|NCT04498260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730269|NCT00385970|Vitamins|vitamins|mesh-ancestor
64730270|NCT00385970|Micronutrients|micronutrients|mesh-ancestor
64730271|NCT00385970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64730272|NCT00385970|Antimetabolites|antimetabolites|mesh-ancestor
64730273|NCT00385970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730274|NCT00385970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730275|NCT00385970|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64730276|NCT00385970|Immunologic Factors|immunologic factors|mesh-ancestor
64730277|NCT00385970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64730278|NCT00385970|Antiviral Agents|antiviral agents|mesh-ancestor
64730279|NCT00385970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64730280|NCT00385970|Interferon Inducers|interferon inducers|mesh-ancestor
64730281|NCT00385970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64730282|NCT05006677|Vitamin K|vitamin k|mesh-list
64730283|NCT05006677|Anticoagulants|anticoagulants|mesh-list
64730284|NCT05006677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64730285|NCT05006677|Vitamins|vitamins|mesh-ancestor
64730286|NCT05006677|Micronutrients|micronutrients|mesh-ancestor
64730287|NCT05006677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730288|NCT05006677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64730289|NCT05006677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64730290|NCT05006677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730291|NCT05006677|Hemostatics|hemostatics|mesh-ancestor
64504622|NCT04498260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64504623|NCT04498260|Immunologic Factors|immunologic factors|mesh-ancestor
64504624|NCT04498260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504625|NCT04498260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504627|NCT03344094|Interferon-beta|interferon-beta|mesh-list
64504628|NCT03344094|Ocrelizumab|ocrelizumab|mesh-list
64504629|NCT03344094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504630|NCT03344094|Antiviral Agents|antiviral agents|mesh-ancestor
64504631|NCT03344094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64504632|NCT03344094|Immunologic Factors|immunologic factors|mesh-ancestor
64504633|NCT03344094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504634|NCT02498496|Magnesium Sulfate|magnesium sulfate|mesh-list
64504635|NCT02498496|Analgesics|analgesics|mesh-ancestor
64504636|NCT02498496|Sensory System Agents|sensory system agents|mesh-ancestor
64504637|NCT02498496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64504638|NCT02498496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504639|NCT02498496|Anesthetics|anesthetics|mesh-ancestor
64504640|NCT02498496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64504641|NCT02498496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64504642|NCT02498496|Anticonvulsants|anticonvulsants|mesh-ancestor
64504643|NCT02498496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64504644|NCT02498496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64730292|NCT05006677|Coagulants|coagulants|mesh-ancestor
64730293|NCT00386126|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64730294|NCT00386126|Hematinics|hematinics|mesh-ancestor
64730295|NCT05298085|Oxytocin|oxytocin|mesh-list
64730296|NCT05298085|Oxytocics|oxytocics|mesh-ancestor
64730297|NCT05298085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64730298|NCT05298085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504645|NCT02498496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504646|NCT02498496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64504647|NCT02498496|Tocolytic Agents|tocolytic agents|mesh-ancestor
64504648|NCT02498496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64504649|NCT02502708|Cyclophosphamide|cyclophosphamide|mesh-list
64504650|NCT02502708|Temozolomide|temozolomide|mesh-list
64504651|NCT02502708|Etoposide|etoposide|mesh-list
64504652|NCT02502708|Tryptophan|tryptophan|mesh-list
64504653|NCT02502708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64504654|NCT02502708|Immunologic Factors|immunologic factors|mesh-ancestor
64504655|NCT02502708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504656|NCT02502708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64504658|NCT02502708|Alkylating Agents|alkylating agents|mesh-ancestor
64504659|NCT02502708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504660|NCT02502708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504661|NCT02502708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64504662|NCT02502708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64504663|NCT02502708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64504664|NCT02502708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64504665|NCT02502708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730301|NCT05296603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64730302|NCT05296603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730303|NCT05296603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730304|NCT04569890|Hydroxychloroquine|hydroxychloroquine|mesh-list
64730305|NCT04569890|Prednisone|prednisone|mesh-list
64730306|NCT04569890|Certolizumab Pegol|certolizumab pegol|mesh-list
64504666|NCT02502708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64504667|NCT02502708|Antidepressive Agents|antidepressive agents|mesh-ancestor
64504668|NCT02502708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64726421|NCT00003146|Alkylating Agents|alkylating agents|mesh-ancestor
64726422|NCT00003146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726423|NCT00003146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726424|NCT00003146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64504669|NCT01666210|Dexamethasone|dexamethasone|mesh-list
64504670|NCT01666210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64504671|NCT01666210|Antiemetics|antiemetics|mesh-ancestor
64504672|NCT01666210|Autonomic Agents|autonomic agents|mesh-ancestor
64730307|NCT04569890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64730308|NCT04569890|Glucocorticoids|glucocorticoids|mesh-ancestor
64730309|NCT04569890|Hormones|hormones|mesh-ancestor
64730310|NCT04569890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64730311|NCT04569890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730312|NCT04569890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64730313|NCT04569890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730314|NCT04569890|Antimalarials|antimalarials|mesh-ancestor
64730315|NCT04569890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64730316|NCT04569890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64730317|NCT04569890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64955951|NCT00206167|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64338086|NCT01298687|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64504673|NCT01666210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64504674|NCT01666210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504675|NCT01666210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64504676|NCT01666210|Glucocorticoids|glucocorticoids|mesh-ancestor
64504677|NCT01666210|Hormones|hormones|mesh-ancestor
64504678|NCT01666210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64504679|NCT01666210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64504680|NCT01666210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504681|NCT01666912|Contraceptive Agents|contraceptive agents|mesh-list
64504682|NCT01666912|Etonogestrel|etonogestrel|mesh-list
64504683|NCT01666912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64504684|NCT01666912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504685|NCT01666912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64730318|NCT04569890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730319|NCT04569890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730320|NCT04569890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64730321|NCT04569890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64730322|NCT04569890|Immunologic Factors|immunologic factors|mesh-ancestor
64730323|NCT00423163|Voriconazole|voriconazole|mesh-list
64730324|NCT00423163|Micafungin|micafungin|mesh-list
64730325|NCT00423163|Antifungal Agents|antifungal agents|mesh-ancestor
64730326|NCT00423163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64730327|NCT00423163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64730328|NCT00423163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64730329|NCT00423163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730330|NCT00423163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730331|NCT00423163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64730332|NCT00423163|Hormone Antagonists|hormone antagonists|mesh-ancestor
64730333|NCT00423163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64730334|NCT00423163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730335|NCT00423163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64730336|NCT04379635|Paclitaxel|paclitaxel|mesh-list
64730337|NCT04379635|Carboplatin|carboplatin|mesh-list
64730338|NCT04379635|Pemetrexed|pemetrexed|mesh-list
64730339|NCT04379635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64730340|NCT04379635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337669|NCT02262533|Anticoagulants|anticoagulants|mesh-ancestor
64730341|NCT04379635|Tubulin Modulators|tubulin modulators|mesh-ancestor
64730342|NCT04379635|Antimitotic Agents|antimitotic agents|mesh-ancestor
64730343|NCT04379635|Mitosis Modulators|mitosis modulators|mesh-ancestor
64504698|NCT03341988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64504699|NCT02501850|Metformin|metformin|mesh-list
64504700|NCT02501850|Liraglutide|liraglutide|mesh-list
64504701|NCT02501850|Exenatide|exenatide|mesh-list
64504702|NCT02501850|Lixisenatide|lixisenatide|mesh-list
64504703|NCT02501850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64504704|NCT02501850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504705|NCT02501850|Incretins|incretins|mesh-ancestor
64504706|NCT02501850|Hormones|hormones|mesh-ancestor
64504707|NCT02501850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64504708|NCT02501850|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64504709|NCT01709032|Deferasirox|deferasirox|mesh-list
64504710|NCT01709032|Deferiprone|deferiprone|mesh-list
64504711|NCT01709032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64504712|NCT01709032|Chelating Agents|chelating agents|mesh-ancestor
64504713|NCT01709032|Sequestering Agents|sequestering agents|mesh-ancestor
64504714|NCT01709032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504715|NCT02496078|Asunaprevir|asunaprevir|mesh-list
64730348|NCT04568876|Palmidrol|palmidrol|mesh-list
64730349|NCT04568876|Analgesics|analgesics|mesh-ancestor
64730350|NCT04568876|Sensory System Agents|sensory system agents|mesh-ancestor
64730351|NCT04568876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64730352|NCT04568876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730353|NCT04568876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64730354|NCT04568876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64730355|NCT04568876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64730356|NCT04568876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64338107|NCT01262261|Buprenorphine|buprenorphine|mesh-list
64955952|NCT00206167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64955953|NCT00206167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64955954|NCT00206167|Adrenergic Agents|adrenergic agents|mesh-ancestor
64730357|NCT04568876|Antiviral Agents|antiviral agents|mesh-ancestor
64730358|NCT04568876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64730359|NCT04568876|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64730360|NCT04568876|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64730361|NCT04568876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64730362|NCT04568876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504716|NCT02496078|Protease Inhibitors|protease inhibitors|mesh-ancestor
64504717|NCT02496078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504718|NCT02496078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504719|NCT02495922|Dexamethasone|dexamethasone|mesh-list
64504720|NCT02495922|Lenalidomide|lenalidomide|mesh-list
64504721|NCT02495922|Bortezomib|bortezomib|mesh-list
64504722|NCT02495922|Elotuzumab|elotuzumab|mesh-list
64504723|NCT02495922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64504724|NCT02495922|Antiemetics|antiemetics|mesh-ancestor
64504725|NCT02495922|Autonomic Agents|autonomic agents|mesh-ancestor
64504726|NCT02495922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64504727|NCT02495922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504728|NCT02495922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64730363|NCT04568876|Hormones|hormones|mesh-ancestor
64730364|NCT04568876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64730365|NCT04338061|Teriflunomide|teriflunomide|mesh-list
64730366|NCT04338061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64730367|NCT04338061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64730368|NCT04338061|Analgesics|analgesics|mesh-ancestor
64504729|NCT02495922|Glucocorticoids|glucocorticoids|mesh-ancestor
64504730|NCT02495922|Hormones|hormones|mesh-ancestor
64504731|NCT02495922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64504732|NCT02495922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64504733|NCT02495922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504734|NCT02495922|Immunologic Factors|immunologic factors|mesh-ancestor
64504735|NCT02495922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64504736|NCT02495922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64504737|NCT02495922|Growth Substances|growth substances|mesh-ancestor
64504738|NCT02495922|Growth Inhibitors|growth inhibitors|mesh-ancestor
64504740|NCT01709422|Meperidine|meperidine|mesh-list
64955955|NCT00206167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64494634|NCT01180036|Immunologic Factors|immunologic factors|mesh-ancestor
64730369|NCT04338061|Sensory System Agents|sensory system agents|mesh-ancestor
64730370|NCT04338061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64730371|NCT04338061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730372|NCT04338061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64730373|NCT04338061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64730374|NCT04338061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64730375|NCT04338061|Immunologic Factors|immunologic factors|mesh-ancestor
64730376|NCT02210702|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64730377|NCT02210702|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64730378|NCT02210702|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64337715|NCT02580305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64504741|NCT01709422|Propofol|propofol|mesh-list
64504742|NCT01709422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64504743|NCT01709422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64504744|NCT01709422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504745|NCT01709422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64504746|NCT01709422|Anesthetics, General|anesthetics, general|mesh-ancestor
64504747|NCT01709422|Anesthetics|anesthetics|mesh-ancestor
64504750|NCT01709422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64504751|NCT01709422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64504752|NCT01709422|GABA Modulators|gaba modulators|mesh-ancestor
64955956|NCT00206167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955957|NCT00039611|Leucovorin|leucovorin|mesh-list
64955958|NCT00039611|Fluorouracil|fluorouracil|mesh-list
64730379|NCT02210702|Norethindrone|norethindrone|mesh-list
64730380|NCT02210702|Norethindrone Acetate|norethindrone acetate|mesh-list
64730381|NCT02210702|Estradiol|estradiol|mesh-list
64730382|NCT02210702|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64730383|NCT02210702|Estrogens|estrogens|mesh-ancestor
64730384|NCT02210702|Hormones|hormones|mesh-ancestor
64730385|NCT02210702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64730386|NCT02210702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730387|NCT02210702|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64730388|NCT02210702|Contraceptive Agents|contraceptive agents|mesh-ancestor
64730389|NCT02210702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64726425|NCT00003146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64726426|NCT00003146|Immunologic Factors|immunologic factors|mesh-ancestor
64726427|NCT00003146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726428|NCT00003398|Cyclophosphamide|cyclophosphamide|mesh-list
64726429|NCT00003398|Thiotepa|thiotepa|mesh-list
64726430|NCT00003398|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64726431|NCT00003398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64726432|NCT00003398|Immunologic Factors|immunologic factors|mesh-ancestor
64726433|NCT00003398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726434|NCT00003398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64333935|NCT02358057|Adrenergic Agents|adrenergic agents|mesh-ancestor
64504753|NCT01709422|GABA Agents|gaba agents|mesh-ancestor
64504754|NCT01709422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64504755|NCT01709422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504756|NCT01709422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64504757|NCT01709422|Narcotics|narcotics|mesh-ancestor
64504758|NCT01709422|Analgesics|analgesics|mesh-ancestor
64504759|NCT01709422|Sensory System Agents|sensory system agents|mesh-ancestor
64730390|NCT02210702|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64730391|NCT02210702|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64730393|NCT02210702|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64730394|NCT04568096|Tamoxifen|tamoxifen|mesh-list
64730395|NCT04568096|Tretinoin|tretinoin|mesh-list
64730396|NCT04568096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64730397|NCT04568096|Hormone Antagonists|hormone antagonists|mesh-ancestor
64730398|NCT04568096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64730399|NCT04568096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730400|NCT04568096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64730401|NCT04568096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730402|NCT04568096|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64730403|NCT04568096|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64730404|NCT04568096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64730405|NCT04568096|Keratolytic Agents|keratolytic agents|mesh-ancestor
64730406|NCT04568096|Dermatologic Agents|dermatologic agents|mesh-ancestor
64730407|NCT04568018|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64730408|NCT04568018|Respiratory System Agents|respiratory system agents|mesh-ancestor
64730409|NCT02278172|Vitamin D|vitamin d|mesh-list
64730410|NCT02278172|Ergocalciferols|ergocalciferols|mesh-list
64730411|NCT02278172|Cholecalciferol|cholecalciferol|mesh-list
64730412|NCT02278172|Vitamins|vitamins|mesh-list
64730413|NCT02278172|Micronutrients|micronutrients|mesh-ancestor
64730414|NCT02278172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337737|NCT01616303|Paclitaxel|paclitaxel|mesh-list
64955959|NCT00039611|Oxaliplatin|oxaliplatin|mesh-list
64955960|NCT00039611|Calcium|calcium|mesh-list
64955961|NCT00039611|Levoleucovorin|levoleucovorin|mesh-list
64338149|NCT05177939|Hormones|hormones|mesh-ancestor
64504760|NCT01709422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64504761|NCT01669642|Ketamine|ketamine|mesh-list
64504762|NCT01669642|Analgesics|analgesics|mesh-ancestor
64504763|NCT01669642|Sensory System Agents|sensory system agents|mesh-ancestor
64504764|NCT01669642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64504765|NCT01669642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504766|NCT01669642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64504767|NCT01669642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64504768|NCT01669642|Anesthetics, General|anesthetics, general|mesh-ancestor
64504769|NCT01669642|Anesthetics|anesthetics|mesh-ancestor
64504770|NCT01669642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64504771|NCT01669642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64730416|NCT02278172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64730417|NCT04971031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64730418|NCT04971031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64730419|NCT04566224|Pyrithione zinc|pyrithione zinc|mesh-list
64730420|NCT04566224|Keratolytic Agents|keratolytic agents|mesh-ancestor
64730421|NCT04566224|Dermatologic Agents|dermatologic agents|mesh-ancestor
64730422|NCT02210858|Tipifarnib|tipifarnib|mesh-list
64730423|NCT02210858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730424|NCT04564430|Clonidine|clonidine|mesh-list
64730425|NCT04564430|Analgesics|analgesics|mesh-ancestor
64730426|NCT04564430|Sensory System Agents|sensory system agents|mesh-ancestor
64730427|NCT04564430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64730428|NCT04564430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730429|NCT04564430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64730430|NCT04564430|Sympatholytics|sympatholytics|mesh-ancestor
64730431|NCT04564430|Autonomic Agents|autonomic agents|mesh-ancestor
64730432|NCT04564430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64730433|NCT04564430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64730434|NCT04564430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64730435|NCT04564430|Adrenergic Agents|adrenergic agents|mesh-ancestor
64730436|NCT04564430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64730437|NCT04564430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730438|NCT04564040|Acalabrutinib|acalabrutinib|mesh-list
64730439|NCT04564040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730440|NCT04563962|Methamphetamine|methamphetamine|mesh-list
64730441|NCT04563962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64730442|NCT04563962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504772|NCT01669642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64504773|NCT01669642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64504774|NCT01669642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504775|NCT01669720|Aflibercept|aflibercept|mesh-list
64504776|NCT01669720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64504777|NCT01669720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64504778|NCT01669720|Growth Substances|growth substances|mesh-ancestor
64504779|NCT01669720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504780|NCT01669720|Growth Inhibitors|growth inhibitors|mesh-ancestor
64955962|NCT00039611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64730452|NCT04563962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64730453|NCT04563962|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64730454|NCT02211482|Lamivudine|lamivudine|mesh-list
64730455|NCT02211482|Dolutegravir|dolutegravir|mesh-list
64730456|NCT02211482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64730457|NCT02211482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64730458|NCT02211482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730459|NCT02211482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730460|NCT02211482|Antiviral Agents|antiviral agents|mesh-ancestor
64730461|NCT02211482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64730462|NCT02211482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64730463|NCT02211482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64730464|NCT02211482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64730465|NCT02211482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64504781|NCT01669720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504782|NCT01670110|Pasireotide|pasireotide|mesh-list
64504783|NCT01670110|Hormones|hormones|mesh-ancestor
64504784|NCT01670110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64504785|NCT01670110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504786|NCT02245516|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64504787|NCT02245516|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64504788|NCT01677286|Doxycycline|doxycycline|mesh-list
64504789|NCT01677286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64504790|NCT01677286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64504791|NCT01677286|Antimalarials|antimalarials|mesh-ancestor
64504792|NCT01677286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64730467|NCT04929847|Dermatologic Agents|dermatologic agents|mesh-ancestor
64730468|NCT04561934|Fluorides|fluorides|mesh-list
64730469|NCT04561934|Cariostatic Agents|cariostatic agents|mesh-ancestor
64730470|NCT04561934|Protective Agents|protective agents|mesh-ancestor
64730471|NCT04561934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730472|NCT04330495|Hydroxychloroquine|hydroxychloroquine|mesh-list
64730473|NCT04330495|Antimalarials|antimalarials|mesh-ancestor
64730474|NCT04330495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64730475|NCT04330495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64730476|NCT04330495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64730477|NCT04330495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730478|NCT04330495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730479|NCT04330495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64730480|NCT04563260|Palonosetron|palonosetron|mesh-list
64730481|NCT04563260|Antiemetics|antiemetics|mesh-ancestor
64730482|NCT04563260|Autonomic Agents|autonomic agents|mesh-ancestor
64730483|NCT04563260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64730484|NCT04563260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730485|NCT04563260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64730486|NCT04563260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64955963|NCT00039611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504793|NCT01677286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64504794|NCT05710666|Trastuzumab|trastuzumab|mesh-list
64504795|NCT05710666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64504796|NCT05710666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504797|NCT01680172|Ketamine|ketamine|mesh-list
64504798|NCT01680172|Analgesics|analgesics|mesh-ancestor
64504799|NCT01680172|Sensory System Agents|sensory system agents|mesh-ancestor
64504800|NCT01680172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64504801|NCT01680172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504802|NCT01680172|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64504803|NCT01680172|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64504804|NCT01680172|Anesthetics, General|anesthetics, general|mesh-ancestor
64504805|NCT01680172|Anesthetics|anesthetics|mesh-ancestor
64730487|NCT04563260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64730488|NCT04563260|Serotonin Agents|serotonin agents|mesh-ancestor
64730489|NCT04563260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64730490|NCT04563260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730491|NCT04173793|Ezetimibe|ezetimibe|mesh-list
64337833|NCT01495013|Glimepiride|glimepiride|mesh-list
64955966|NCT00039611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64504806|NCT01680172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64726435|NCT00003398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64726436|NCT00003398|Alkylating Agents|alkylating agents|mesh-ancestor
64726437|NCT00003398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726438|NCT00003398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726439|NCT00003398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64726440|NCT00002263|Zidovudine|zidovudine|mesh-list
64726441|NCT00002263|Sargramostim|sargramostim|mesh-list
64726442|NCT00002263|Antimetabolites|antimetabolites|mesh-ancestor
64726443|NCT00002263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726444|NCT00002263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64726445|NCT00002263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64504807|NCT01680172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64504809|NCT01680172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64504810|NCT01680172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730493|NCT04173793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64730494|NCT04173793|Antimetabolites|antimetabolites|mesh-ancestor
64730495|NCT04173793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730496|NCT04173793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64730497|NCT04561466|Bezafibrate|bezafibrate|mesh-list
64730498|NCT04561466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64730499|NCT04561466|Antimetabolites|antimetabolites|mesh-ancestor
64730500|NCT04561466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730501|NCT04561466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64730502|NCT04561856|Dexamethasone|dexamethasone|mesh-list
64730503|NCT04561856|Dexamethasone acetate|dexamethasone acetate|mesh-list
64730504|NCT04561856|BB 1101|bb 1101|mesh-list
64504811|NCT02235064|Sertraline|sertraline|mesh-list
64504812|NCT02235064|Antidepressive Agents|antidepressive agents|mesh-ancestor
64504813|NCT02235064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64504814|NCT02235064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64504815|NCT02235064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64421206|NCT05562869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504816|NCT02235064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64504817|NCT02235064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504818|NCT02235064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64730538|NCT04909801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64730539|NCT00382681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64955967|NCT00039611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730541|NCT04173403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64730542|NCT04173403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64730543|NCT04173403|Antimetabolites|antimetabolites|mesh-ancestor
64730544|NCT04173403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730545|NCT04173403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64730546|NCT03539887|Ketamine|ketamine|mesh-list
64730547|NCT03539887|Analgesics|analgesics|mesh-ancestor
64730548|NCT03539887|Sensory System Agents|sensory system agents|mesh-ancestor
64730549|NCT03539887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64730550|NCT03539887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730551|NCT03539887|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64730552|NCT03539887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64730553|NCT03539887|Anesthetics, General|anesthetics, general|mesh-ancestor
64730554|NCT03539887|Anesthetics|anesthetics|mesh-ancestor
64730555|NCT03539887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64730556|NCT03539887|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64730557|NCT03539887|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64730558|NCT03539887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64730559|NCT03539887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730560|NCT04123717|Acetaminophen|acetaminophen|mesh-list
64730561|NCT04123717|Ibuprofen|ibuprofen|mesh-list
64730562|NCT04123717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64730563|NCT04123717|Analgesics|analgesics|mesh-ancestor
64730564|NCT04123717|Sensory System Agents|sensory system agents|mesh-ancestor
64730565|NCT04123717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64730566|NCT04123717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504820|NCT02235064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504821|NCT05118490|Isoniazid|isoniazid|mesh-list
64504830|NCT05118490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504831|NCT05118490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64504832|NCT05118490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64504833|NCT05118490|Leprostatic Agents|leprostatic agents|mesh-ancestor
64504834|NCT05118490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64504835|NCT05118490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504836|NCT05118490|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64504837|NCT05118490|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64730567|NCT04123717|Antipyretics|antipyretics|mesh-ancestor
64730568|NCT04123717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64730569|NCT04123717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64730570|NCT04123717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64730571|NCT04123717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64730572|NCT04123717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730573|NCT04123717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730574|NCT03472495|Diltiazem|diltiazem|mesh-list
64730575|NCT03472495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64730576|NCT03472495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64730577|NCT03472495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64730583|NCT04094701|Narcotics|narcotics|mesh-ancestor
64730627|NCT00002893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730628|NCT00002893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64730629|NCT00002893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730630|NCT00002893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64730631|NCT00002893|Immunologic Factors|immunologic factors|mesh-ancestor
64730632|NCT00002893|Antidotes|antidotes|mesh-ancestor
64730633|NCT00002893|Protective Agents|protective agents|mesh-ancestor
64730634|NCT00002893|Vitamin B Complex|vitamin b complex|mesh-ancestor
64730635|NCT00002893|Vitamins|vitamins|mesh-ancestor
64730636|NCT00002893|Micronutrients|micronutrients|mesh-ancestor
64730637|NCT00002893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64730638|NCT00002893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730639|NCT03905941|Metformin|metformin|mesh-list
64730640|NCT03905941|Contraceptive Agents|contraceptive agents|mesh-list
64730641|NCT03905941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64730644|NCT03900715|Luspatercept|luspatercept|mesh-list
64504838|NCT05118490|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64955396|NCT00202423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64955397|NCT00202423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504839|NCT05118490|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64504840|NCT05118490|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64504841|NCT05118490|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64504842|NCT01681030|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64504844|NCT01681030|Coagulants|coagulants|mesh-ancestor
64504845|NCT02249416|Ritonavir|ritonavir|mesh-list
64504846|NCT02249416|Zidovudine|zidovudine|mesh-list
64504847|NCT02249416|Tipranavir|tipranavir|mesh-list
64504848|NCT02249416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64504849|NCT02249416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64504850|NCT02249416|Protease Inhibitors|protease inhibitors|mesh-ancestor
64504851|NCT02249416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504852|NCT02249416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504853|NCT02249416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64504854|NCT02249416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64504855|NCT02249416|Antiviral Agents|antiviral agents|mesh-ancestor
64504856|NCT02249416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64504857|NCT02249416|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64504858|NCT02249416|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64504859|NCT02249416|Antimetabolites|antimetabolites|mesh-ancestor
64504860|NCT02249416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64504861|NCT02249416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64504862|NCT01685242|Cetirizine|cetirizine|mesh-list
64504863|NCT01685242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64726446|NCT00002263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726448|NCT00002263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726449|NCT00002263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64726450|NCT00002263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64726451|NCT00002263|Immunologic Factors|immunologic factors|mesh-ancestor
64726452|NCT00002263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504864|NCT01685242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64504865|NCT01685242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64504866|NCT01685242|Histamine Antagonists|histamine antagonists|mesh-ancestor
64504867|NCT01685242|Histamine Agents|histamine agents|mesh-ancestor
64504868|NCT01685242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64730652|NCT03818581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64730653|NCT03818581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730654|NCT00002905|Zidovudine|zidovudine|mesh-list
64730655|NCT00002905|Didanosine|didanosine|mesh-list
64730656|NCT00002905|Cyclophosphamide|cyclophosphamide|mesh-list
64730657|NCT00002905|Prednimustine|prednimustine|mesh-list
64730658|NCT00002905|Doxorubicin|doxorubicin|mesh-list
64730659|NCT00002905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64730660|NCT00002905|Etoposide|etoposide|mesh-list
64730661|NCT00002905|Mitoxantrone|mitoxantrone|mesh-list
64730662|NCT00002905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64730663|NCT00002905|Immunologic Factors|immunologic factors|mesh-ancestor
64730664|NCT00002905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730665|NCT00002905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64494645|NCT01180894|Hematinics|hematinics|mesh-ancestor
64955968|NCT00039611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64730674|NCT00002905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730675|NCT00002905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64730676|NCT00002905|Antimetabolites|antimetabolites|mesh-ancestor
64730677|NCT00002905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64730678|NCT00002905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64730679|NCT00002905|Antiviral Agents|antiviral agents|mesh-ancestor
64730680|NCT00002905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64730681|NCT00002905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64730682|NCT00002905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64730683|NCT00002905|Analgesics|analgesics|mesh-ancestor
64730684|NCT00002905|Sensory System Agents|sensory system agents|mesh-ancestor
64730685|NCT00002905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64504869|NCT01685242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504870|NCT01685242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504871|NCT00708162|Raltegravir Potassium|raltegravir potassium|mesh-list
64504872|NCT00708162|Elvitegravir|elvitegravir|mesh-list
64504873|NCT00708162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64504874|NCT00708162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64504875|NCT00708162|Antiviral Agents|antiviral agents|mesh-ancestor
64504876|NCT00708162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64504877|NCT00708162|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64504878|NCT00708162|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64504879|NCT00708162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504884|NCT04915768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64504885|NCT04915768|Immunologic Factors|immunologic factors|mesh-ancestor
64504886|NCT04915768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504887|NCT04915768|Antacids|antacids|mesh-ancestor
64730703|NCT00383695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64730704|NCT00383851|Temozolomide|temozolomide|mesh-list
64730705|NCT00383851|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
64730706|NCT00383851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64730707|NCT00383851|Alkylating Agents|alkylating agents|mesh-ancestor
64730708|NCT00383851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730709|NCT00383851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730710|NCT00383851|Chelating Agents|chelating agents|mesh-ancestor
64730711|NCT00383851|Sequestering Agents|sequestering agents|mesh-ancestor
64730712|NCT00383851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730713|NCT00383851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64730714|NCT00383851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64955972|NCT00039611|Vitamin B Complex|vitamin b complex|mesh-ancestor
64730715|NCT00383851|Growth Substances|growth substances|mesh-ancestor
64730716|NCT00383851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730717|NCT00383851|Growth Inhibitors|growth inhibitors|mesh-ancestor
64730718|NCT00002923|KRN 5500|krn 5500|mesh-list
64730719|NCT00002923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730720|NCT00002923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64730721|NCT00002923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730722|NCT00002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730723|NCT02636569|Diclofenac|diclofenac|mesh-list
64730724|NCT02636569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64730725|NCT02636569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64504894|NCT04898920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64504895|NCT04898920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504896|NCT04898920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64504897|NCT04898920|Glucocorticoids|glucocorticoids|mesh-ancestor
64504898|NCT04898920|Hormones|hormones|mesh-ancestor
64504899|NCT04898920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64504900|NCT04898920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64504901|NCT04898920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504902|NCT02249884|Carbamide Peroxide|carbamide peroxide|mesh-list
64504903|NCT02249884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64730769|NCT00002941|Immunologic Factors|immunologic factors|mesh-ancestor
64730770|NCT00002941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730771|NCT00002941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64730772|NCT00002941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64730773|NCT00002941|Alkylating Agents|alkylating agents|mesh-ancestor
64730774|NCT00002941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730775|NCT00002941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730776|NCT00002941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64504904|NCT02249884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64504905|NCT01686646|Acetaminophen|acetaminophen|mesh-list
64504906|NCT01686646|Caffeine|caffeine|mesh-list
64504907|NCT01686646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64504908|NCT01686646|Analgesics|analgesics|mesh-ancestor
64504909|NCT01686646|Sensory System Agents|sensory system agents|mesh-ancestor
64504910|NCT01686646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64504911|NCT01686646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504912|NCT01686646|Antipyretics|antipyretics|mesh-ancestor
64504913|NCT01686646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64504914|NCT01686646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64504915|NCT01686646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730778|NCT00002941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64730779|NCT00002941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64730780|NCT00002941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730781|NCT00002953|Paclitaxel|paclitaxel|mesh-list
64730782|NCT00002953|Cyclophosphamide|cyclophosphamide|mesh-list
64730783|NCT00002953|Epirubicin|epirubicin|mesh-list
64730784|NCT00002953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64504916|NCT01686646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504917|NCT01686646|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64504918|NCT01686646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64955398|NCT00202462|Testosterone|testosterone|mesh-list
64504919|NCT01686646|Purinergic Agents|purinergic agents|mesh-ancestor
64504920|NCT01686646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64504922|NCT02495688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64504923|NCT02495688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504924|NCT01688596|Bupivacaine|bupivacaine|mesh-list
64504925|NCT01688596|Anesthetics, Local|anesthetics, local|mesh-ancestor
64504926|NCT01688596|Anesthetics|anesthetics|mesh-ancestor
64504927|NCT01688596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64504928|NCT01688596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504929|NCT01688596|Sensory System Agents|sensory system agents|mesh-ancestor
64504930|NCT01688596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64726453|NCT00002816|Leucovorin|leucovorin|mesh-list
64726454|NCT00002816|Cobalt|cobalt|mesh-list
64726455|NCT00002816|Cytarabine|cytarabine|mesh-list
64726456|NCT00002816|Dexamethasone|dexamethasone|mesh-list
64726457|NCT00002816|Hydrocortisone|hydrocortisone|mesh-list
64726458|NCT00002816|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64726459|NCT00002816|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64504931|NCT02495532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64504932|NCT04869592|Vaccines|vaccines|mesh-list
64504933|NCT04869592|Immunologic Factors|immunologic factors|mesh-ancestor
64504934|NCT04869592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504935|NCT05709652|Ivermectin|ivermectin|mesh-list
64504936|NCT05709652|Selamectin|selamectin|mesh-list
64504937|NCT05709652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64504938|NCT05709652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64504939|NCT01690000|Melatonin|melatonin|mesh-list
64504940|NCT01690000|Antioxidants|antioxidants|mesh-ancestor
64730785|NCT00002953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730786|NCT00002953|Tubulin Modulators|tubulin modulators|mesh-ancestor
64730787|NCT00002953|Antimitotic Agents|antimitotic agents|mesh-ancestor
64730788|NCT00002953|Mitosis Modulators|mitosis modulators|mesh-ancestor
64504941|NCT01690000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504942|NCT01690000|Protective Agents|protective agents|mesh-ancestor
64504943|NCT01690000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504944|NCT01690000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64504945|NCT02495220|Dexmedetomidine|dexmedetomidine|mesh-list
64504946|NCT02495220|Bupivacaine|bupivacaine|mesh-list
64504947|NCT02495220|Anesthetics, Local|anesthetics, local|mesh-ancestor
64504948|NCT02495220|Anesthetics|anesthetics|mesh-ancestor
64730836|NCT03668041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730838|NCT03668041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64730839|NCT03668041|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64730840|NCT03668041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64730841|NCT03668041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64955974|NCT00039611|Micronutrients|micronutrients|mesh-ancestor
64955975|NCT00068289|Bortezomib|bortezomib|mesh-list
64504949|NCT02495220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64504950|NCT02495220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504951|NCT02495220|Sensory System Agents|sensory system agents|mesh-ancestor
64504952|NCT02495220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64504953|NCT02495220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64504954|NCT02495220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64504955|NCT02495220|Analgesics|analgesics|mesh-ancestor
64504956|NCT02495220|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64504967|NCT01690546|Narcotics|narcotics|mesh-ancestor
64504968|NCT01690546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64504969|NCT01690546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504970|NCT01690546|Analgesics|analgesics|mesh-ancestor
64504971|NCT01690546|Sensory System Agents|sensory system agents|mesh-ancestor
64730842|NCT03668041|Serotonin Agents|serotonin agents|mesh-ancestor
64730843|NCT03668041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64730844|NCT03668041|Antidepressive Agents|antidepressive agents|mesh-ancestor
64730846|NCT00002965|Interferon-alpha|interferon-alpha|mesh-list
64730847|NCT00002965|Interferon alpha-2|interferon alpha-2|mesh-list
64730848|NCT00002965|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
64730849|NCT00002965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730850|NCT00002965|Antiviral Agents|antiviral agents|mesh-ancestor
64730851|NCT00002965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64730852|NCT00002965|Immunologic Factors|immunologic factors|mesh-ancestor
64730853|NCT00002965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730854|NCT00002971|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64730855|NCT00002971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730856|NCT00002971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338181|NCT02268149|Hormones|hormones|mesh-ancestor
64504972|NCT01690546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64504973|NCT01690546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64504974|NCT01690546|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64504975|NCT03336918|Lithium Carbonate|lithium carbonate|mesh-list
64504976|NCT03336918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504977|NCT03336918|Antidepressive Agents|antidepressive agents|mesh-ancestor
64504978|NCT03336918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64504979|NCT03336918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504980|NCT03336918|Antimanic Agents|antimanic agents|mesh-ancestor
64504981|NCT03336918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64504982|NCT03336918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64504983|NCT03336918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955976|NCT00068289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955977|NCT00039767|Lepirudin|lepirudin|mesh-list
64955978|NCT00039767|Antithrombins|antithrombins|mesh-ancestor
64955979|NCT00039767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64955980|NCT00039767|Protease Inhibitors|protease inhibitors|mesh-ancestor
64955981|NCT00039767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955982|NCT00039767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955983|NCT00039767|Anticoagulants|anticoagulants|mesh-ancestor
64955984|NCT00039767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64730857|NCT00002971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730858|NCT00002977|Melphalan|melphalan|mesh-list
64730859|NCT00002977|Thiotepa|thiotepa|mesh-list
64730860|NCT00002977|Immunologic Factors|immunologic factors|mesh-ancestor
64730861|NCT00002977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730862|NCT00002977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64730863|NCT00002977|Alkylating Agents|alkylating agents|mesh-ancestor
64504984|NCT02494830|Ketamine|ketamine|mesh-list
64504985|NCT02494830|Analgesics|analgesics|mesh-ancestor
64504986|NCT02494830|Sensory System Agents|sensory system agents|mesh-ancestor
64504987|NCT02494830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64504988|NCT02494830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504989|NCT02494830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64504990|NCT02494830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64504991|NCT02494830|Anesthetics, General|anesthetics, general|mesh-ancestor
64504992|NCT02494830|Anesthetics|anesthetics|mesh-ancestor
64504993|NCT02494830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64504994|NCT02494830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64504995|NCT02494830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64504996|NCT02494830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64504997|NCT02494830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504999|NCT03336840|Promethazine|promethazine|mesh-list
64955985|NCT00039767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64730864|NCT00002977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730866|NCT00002977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64730867|NCT00002977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64730868|NCT00003391|Antibodies|antibodies|mesh-list
64505000|NCT03336840|Diphenhydramine|diphenhydramine|mesh-list
64505001|NCT03336840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64505002|NCT03336840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505003|NCT03336840|Antipruritics|antipruritics|mesh-ancestor
64505004|NCT03336840|Dermatologic Agents|dermatologic agents|mesh-ancestor
64505005|NCT03336840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64726460|NCT00002816|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64726461|NCT00002816|Methotrexate|methotrexate|mesh-list
64726462|NCT00002816|Etoposide|etoposide|mesh-list
64726463|NCT00002816|Vincristine|vincristine|mesh-list
64726464|NCT00002816|Asparaginase|asparaginase|mesh-list
64726465|NCT00002816|Ifosfamide|ifosfamide|mesh-list
64726466|NCT00002816|Idarubicin|idarubicin|mesh-list
64505006|NCT03336840|Histamine Antagonists|histamine antagonists|mesh-ancestor
64505007|NCT03336840|Histamine Agents|histamine agents|mesh-ancestor
64505008|NCT03336840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505009|NCT03336840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505010|NCT03336840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64505011|NCT03336840|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64505012|NCT03336840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64505013|NCT03336840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64955986|NCT00072618|Sulindac sulfone|sulindac sulfone|mesh-list
64730869|NCT00003391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64730870|NCT00003391|Immunologic Factors|immunologic factors|mesh-ancestor
64730871|NCT00003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730872|NCT00003397|Gemcitabine|gemcitabine|mesh-list
64730873|NCT00003397|Dexamethasone|dexamethasone|mesh-list
64730874|NCT00003397|Paclitaxel|paclitaxel|mesh-list
64730875|NCT00003397|Etoposide|etoposide|mesh-list
64730876|NCT00003397|Cyclophosphamide|cyclophosphamide|mesh-list
64730877|NCT00003397|Rituximab|rituximab|mesh-list
64730878|NCT00003397|Melphalan|melphalan|mesh-list
64730879|NCT00003397|Carmustine|carmustine|mesh-list
64730880|NCT00003397|Sargramostim|sargramostim|mesh-list
64730881|NCT00003397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64730882|NCT00003397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338207|NCT02233907|Oxitropium|oxitropium|mesh-list
64505014|NCT03336840|Anesthetics, Local|anesthetics, local|mesh-ancestor
64505015|NCT03336840|Anesthetics|anesthetics|mesh-ancestor
64505016|NCT03336840|Sensory System Agents|sensory system agents|mesh-ancestor
64505017|NCT03336840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64505018|NCT03336840|Antiemetics|antiemetics|mesh-ancestor
64505019|NCT03336840|Autonomic Agents|autonomic agents|mesh-ancestor
64505020|NCT03336840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64505021|NCT02497638|Metformin|metformin|mesh-list
64505022|NCT02497638|Biguanides|biguanides|mesh-list
64505023|NCT02497638|Atorvastatin|atorvastatin|mesh-list
64505031|NCT02497638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64505033|NCT02495064|Mometasone Furoate|mometasone furoate|mesh-list
64505034|NCT02495064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64505035|NCT02495064|Dermatologic Agents|dermatologic agents|mesh-ancestor
64505036|NCT02495064|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64505037|NCT02493192|Meperidine|meperidine|mesh-list
64505038|NCT02493192|Haloperidol|haloperidol|mesh-list
64505039|NCT02493192|Haloperidol decanoate|haloperidol decanoate|mesh-list
64730883|NCT00003397|Tubulin Modulators|tubulin modulators|mesh-ancestor
64730884|NCT00003397|Antimitotic Agents|antimitotic agents|mesh-ancestor
64730885|NCT00003397|Mitosis Modulators|mitosis modulators|mesh-ancestor
64730886|NCT00003397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730887|NCT00003397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64730888|NCT00003397|Immunologic Factors|immunologic factors|mesh-ancestor
64730889|NCT00003397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730890|NCT00003397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64730891|NCT00003397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64730892|NCT00003397|Alkylating Agents|alkylating agents|mesh-ancestor
64730893|NCT00003397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64730894|NCT00003397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64730895|NCT00003397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64730896|NCT00003397|Antiemetics|antiemetics|mesh-ancestor
64730897|NCT00003397|Autonomic Agents|autonomic agents|mesh-ancestor
64505040|NCT02493192|Antiemetics|antiemetics|mesh-ancestor
64505041|NCT02493192|Autonomic Agents|autonomic agents|mesh-ancestor
64505042|NCT02493192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64505043|NCT02493192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505044|NCT02493192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64505045|NCT02493192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64505046|NCT02493192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64505047|NCT02493192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64505048|NCT02493192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64505049|NCT02493192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64505050|NCT02493192|Dopamine Agents|dopamine agents|mesh-ancestor
64505051|NCT02493192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505052|NCT02493192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505053|NCT02493192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64505054|NCT02493192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64505055|NCT02493192|Narcotics|narcotics|mesh-ancestor
64505056|NCT02493192|Analgesics|analgesics|mesh-ancestor
64730898|NCT00003397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64730899|NCT00003397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64730900|NCT00003397|Glucocorticoids|glucocorticoids|mesh-ancestor
64730902|NCT00003397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64730903|NCT00003397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64730904|NCT00003397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64730905|NCT00003397|Antimetabolites|antimetabolites|mesh-ancestor
64730906|NCT00003397|Antiviral Agents|antiviral agents|mesh-ancestor
64730907|NCT00003397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64730908|NCT00003397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730909|NCT00003397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64730910|NCT00003397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64955987|NCT00072618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730911|NCT00003409|Motexafin gadolinium|motexafin gadolinium|mesh-list
64730912|NCT00003409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730913|NCT00003409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64730914|NCT00003409|Dermatologic Agents|dermatologic agents|mesh-ancestor
64730915|NCT00003415|Topotecan|topotecan|mesh-list
64730916|NCT00003415|Amifostine|amifostine|mesh-list
64730917|NCT00003415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64955988|NCT00072618|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64505057|NCT02493192|Sensory System Agents|sensory system agents|mesh-ancestor
64505058|NCT02493192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64505059|NCT02497716|Rivaroxaban|rivaroxaban|mesh-list
64505060|NCT02497716|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64505061|NCT02497716|Antithrombins|antithrombins|mesh-ancestor
64505062|NCT02497716|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64505063|NCT02497716|Protease Inhibitors|protease inhibitors|mesh-ancestor
64505064|NCT02497716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505065|NCT02497716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505067|NCT02238808|Estradiol|estradiol|mesh-list
64505068|NCT02238808|Estrogens|estrogens|mesh-list
64730918|NCT00003415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64730919|NCT00003415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730920|NCT00003415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730921|NCT00003415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730922|NCT00003415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64730923|NCT00003415|Protective Agents|protective agents|mesh-ancestor
64730924|NCT00003415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730925|NCT00002989|Cyclophosphamide|cyclophosphamide|mesh-list
64730927|NCT00002989|Busulfan|busulfan|mesh-list
64730928|NCT00002989|Idarubicin|idarubicin|mesh-list
64730929|NCT00002989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64730930|NCT00002989|Immunologic Factors|immunologic factors|mesh-ancestor
64730931|NCT00002989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730932|NCT00002989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64730933|NCT00002989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64730934|NCT00002989|Alkylating Agents|alkylating agents|mesh-ancestor
64730935|NCT00002989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730936|NCT00002989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730937|NCT00002989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64730938|NCT00002989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64730939|NCT00002989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64505069|NCT02238808|Hormones|hormones|mesh-ancestor
64505070|NCT02238808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64505071|NCT02238808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505072|NCT02497326|Heparin|heparin|mesh-list
64955399|NCT00202462|Androgens|androgens|mesh-ancestor
64505073|NCT02497326|Tramadol|tramadol|mesh-list
64505074|NCT02497326|Anticoagulants|anticoagulants|mesh-ancestor
64505075|NCT02497326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64505076|NCT02497326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64505077|NCT02497326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505078|NCT02497326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64505079|NCT02497326|Narcotics|narcotics|mesh-ancestor
64505080|NCT02497326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64726467|NCT00002816|Pegaspargase|pegaspargase|mesh-list
64726468|NCT00002816|Thioguanine|thioguanine|mesh-list
64726469|NCT00002816|Levoleucovorin|levoleucovorin|mesh-list
64333971|NCT02361177|Oxytocics|oxytocics|mesh-ancestor
64505081|NCT02497326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505082|NCT02497326|Analgesics|analgesics|mesh-ancestor
64505083|NCT02497326|Sensory System Agents|sensory system agents|mesh-ancestor
64505084|NCT02497326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64505085|NCT02245672|Fluticasone|fluticasone|mesh-list
64505087|NCT02245672|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64505088|NCT02245672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64505089|NCT02245672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64505090|NCT02245672|Autonomic Agents|autonomic agents|mesh-ancestor
64421237|NCT04324463|Protease Inhibitors|protease inhibitors|mesh-ancestor
64505091|NCT02245672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64505092|NCT02245672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505114|NCT04305496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955989|NCT00072618|Protective Agents|protective agents|mesh-ancestor
64955990|NCT00072618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730940|NCT00002989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64730941|NCT00002989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730942|NCT00002995|Dactinomycin|dactinomycin|mesh-list
64730943|NCT00002995|Cyclophosphamide|cyclophosphamide|mesh-list
64730944|NCT00002995|Vincristine|vincristine|mesh-list
64730945|NCT00002995|Sargramostim|sargramostim|mesh-list
64730946|NCT00002995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64730947|NCT00002995|Immunologic Factors|immunologic factors|mesh-ancestor
64730948|NCT00002995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730949|NCT00002995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64730950|NCT00002995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64505116|NCT03335904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64505117|NCT03335904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64505118|NCT03335904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64505119|NCT03335904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64505120|NCT03335904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505121|NCT03335826|Anesthetics|anesthetics|mesh-list
64505122|NCT03335826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64505123|NCT03335826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505124|NCT03340740|Cetirizine|cetirizine|mesh-list
64505125|NCT03340740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64505126|NCT03340740|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64505127|NCT03340740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64505128|NCT03340740|Histamine Antagonists|histamine antagonists|mesh-ancestor
64505129|NCT03340740|Histamine Agents|histamine agents|mesh-ancestor
64505130|NCT03340740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505131|NCT03340740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955991|NCT00072618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64955992|NCT00072618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730951|NCT00002995|Alkylating Agents|alkylating agents|mesh-ancestor
64730952|NCT00002995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730953|NCT00002995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730954|NCT00002995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64730955|NCT00002995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64730956|NCT00002995|Tubulin Modulators|tubulin modulators|mesh-ancestor
64730957|NCT00002995|Antimitotic Agents|antimitotic agents|mesh-ancestor
64730958|NCT00002995|Mitosis Modulators|mitosis modulators|mesh-ancestor
64730959|NCT00002995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64730960|NCT00002995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64505132|NCT03340740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505133|NCT03340662|Itraconazole|itraconazole|mesh-list
64505134|NCT03340662|Rifampin|rifampin|mesh-list
64505135|NCT03340662|Fluvoxamine|fluvoxamine|mesh-list
64505136|NCT03340662|Antifungal Agents|antifungal agents|mesh-ancestor
64505137|NCT03340662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64505138|NCT03340662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64505139|NCT03340662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64505140|NCT03340662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505141|NCT03340662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505149|NCT03340662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64505150|NCT03340662|Leprostatic Agents|leprostatic agents|mesh-ancestor
64505151|NCT03340662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64730961|NCT00002995|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64730962|NCT00002995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64730963|NCT00002995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730964|NCT00002995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64730965|NCT01925131|Prednisone|prednisone|mesh-list
64730966|NCT01925131|Cyclophosphamide|cyclophosphamide|mesh-list
64730967|NCT01925131|Vincristine|vincristine|mesh-list
64730968|NCT01925131|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
64730970|NCT01925131|Immunologic Factors|immunologic factors|mesh-ancestor
64730971|NCT01925131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730972|NCT01925131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64730973|NCT01925131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64730974|NCT01925131|Alkylating Agents|alkylating agents|mesh-ancestor
64955993|NCT00072618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955994|NCT00072618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64955995|NCT00072618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64505152|NCT03340662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64505153|NCT03340662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64505154|NCT03340662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64505155|NCT03340662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64505156|NCT03340662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64505157|NCT03340662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64505158|NCT03340662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64505159|NCT03340662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64505160|NCT03340662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64505161|NCT03340662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64505162|NCT03340662|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64505163|NCT03340662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64730975|NCT01925131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730976|NCT01925131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730977|NCT01925131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64730978|NCT01925131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64730979|NCT01925131|Glucocorticoids|glucocorticoids|mesh-ancestor
64730980|NCT01925131|Hormones|hormones|mesh-ancestor
64730981|NCT01925131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64730982|NCT01925131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64955996|NCT00072618|Analgesics|analgesics|mesh-ancestor
64955997|NCT00072618|Sensory System Agents|sensory system agents|mesh-ancestor
64505164|NCT03340662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64505165|NCT03340662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505166|NCT03340662|Serotonin Agents|serotonin agents|mesh-ancestor
64505167|NCT03340662|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64505168|NCT03340662|Antidepressive Agents|antidepressive agents|mesh-ancestor
64505169|NCT03340662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64505170|NCT03340662|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64505171|NCT03342300|Doxorubicin|doxorubicin|mesh-list
64505172|NCT03342300|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64505173|NCT03342300|Pirarubicin|pirarubicin|mesh-list
64730983|NCT01925131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64730984|NCT01925131|Tubulin Modulators|tubulin modulators|mesh-ancestor
64730985|NCT01925131|Antimitotic Agents|antimitotic agents|mesh-ancestor
64730986|NCT01925131|Mitosis Modulators|mitosis modulators|mesh-ancestor
64730987|NCT01925131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64730988|NCT01925131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64730989|NCT00003001|Leucovorin|leucovorin|mesh-list
64730990|NCT00003001|Gemcitabine|gemcitabine|mesh-list
64730991|NCT00003001|Fluorouracil|fluorouracil|mesh-list
64730992|NCT00003001|Calcium|calcium|mesh-list
64730993|NCT00003001|Levoleucovorin|levoleucovorin|mesh-list
64730994|NCT00003001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64730995|NCT00003001|Antimetabolites|antimetabolites|mesh-ancestor
64730996|NCT00003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730997|NCT00003001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730998|NCT00003001|Antiviral Agents|antiviral agents|mesh-ancestor
64730999|NCT00003001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64494674|NCT03188172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731001|NCT00003001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64731002|NCT00003001|Immunologic Factors|immunologic factors|mesh-ancestor
64731003|NCT00003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731004|NCT00003001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64731005|NCT00003001|Antidotes|antidotes|mesh-ancestor
64731006|NCT00003001|Protective Agents|protective agents|mesh-ancestor
64731007|NCT00003001|Vitamin B Complex|vitamin b complex|mesh-ancestor
64731008|NCT00003001|Vitamins|vitamins|mesh-ancestor
64731009|NCT00003001|Micronutrients|micronutrients|mesh-ancestor
64731010|NCT00003421|Prednisolone|prednisolone|mesh-list
64731011|NCT00003421|Doxorubicin|doxorubicin|mesh-list
64731012|NCT00003421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64731013|NCT00003421|Bleomycin|bleomycin|mesh-list
64731014|NCT00003421|Etoposide|etoposide|mesh-list
64731015|NCT00003421|Vincristine|vincristine|mesh-list
64731016|NCT00003421|Dacarbazine|dacarbazine|mesh-list
64505174|NCT03342300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64726470|NCT00002816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64726471|NCT00002816|Antiemetics|antiemetics|mesh-ancestor
64726472|NCT00002816|Autonomic Agents|autonomic agents|mesh-ancestor
64505175|NCT03342300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505176|NCT03342300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64505177|NCT03342300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64505178|NCT03342300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421245|NCT04085237|Anesthetics, Local|anesthetics, local|mesh-ancestor
64505180|NCT01711918|Domperidone|domperidone|mesh-list
64505182|NCT01711918|Autonomic Agents|autonomic agents|mesh-ancestor
64505183|NCT01711918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64505184|NCT01711918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505185|NCT01711918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64505186|NCT01711918|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64505187|NCT01711918|Dopamine Agents|dopamine agents|mesh-ancestor
64505188|NCT01711918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505189|NCT01711918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505190|NCT03120468|Topiramate|topiramate|mesh-list
64505191|NCT03120468|Acetylcysteine|acetylcysteine|mesh-list
64505192|NCT03120468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64505193|NCT03120468|Anticonvulsants|anticonvulsants|mesh-ancestor
64505194|NCT03120468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64505195|NCT03120468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505196|NCT03120468|Antiviral Agents|antiviral agents|mesh-ancestor
64505197|NCT03120468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64505198|NCT03120468|Expectorants|expectorants|mesh-ancestor
64731018|NCT00003421|Procarbazine|procarbazine|mesh-list
64731019|NCT00003421|Chlorambucil|chlorambucil|mesh-list
64731020|NCT00003421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64731021|NCT00003421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731023|NCT00003421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731024|NCT00003421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731025|NCT00003421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955999|NCT00072618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64505199|NCT03120468|Respiratory System Agents|respiratory system agents|mesh-ancestor
64505200|NCT03120468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64505201|NCT03120468|Antioxidants|antioxidants|mesh-ancestor
64505206|NCT01712230|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64505207|NCT01712230|Fertility Agents|fertility agents|mesh-ancestor
64505208|NCT01712230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64505209|NCT01712230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505210|NCT01712230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64505211|NCT01712230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505212|NCT03335436|Gabapentin|gabapentin|mesh-list
64731026|NCT00003421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64731027|NCT00003421|Tubulin Modulators|tubulin modulators|mesh-ancestor
64731028|NCT00003421|Antimitotic Agents|antimitotic agents|mesh-ancestor
64731029|NCT00003421|Mitosis Modulators|mitosis modulators|mesh-ancestor
64956000|NCT00072618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64956001|NCT00039884|Darbepoetin alfa|darbepoetin alfa|mesh-list
64956002|NCT00039884|Hematinics|hematinics|mesh-ancestor
64956003|NCT00206401|Insulin Glargine|insulin glargine|mesh-list
64956004|NCT00206401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64956005|NCT00206401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505213|NCT03335436|Analgesics|analgesics|mesh-ancestor
64505214|NCT03335436|Sensory System Agents|sensory system agents|mesh-ancestor
64505215|NCT03335436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64505216|NCT03335436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955402|NCT00202462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955403|NCT00038558|Doxorubicin|doxorubicin|mesh-list
64955404|NCT00038558|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64955405|NCT00038558|Bleomycin|bleomycin|mesh-list
64955406|NCT00038558|Dacarbazine|dacarbazine|mesh-list
64955407|NCT00038558|Vinblastine|vinblastine|mesh-list
64505217|NCT03335436|Anticonvulsants|anticonvulsants|mesh-ancestor
64505218|NCT03335436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64505219|NCT03335436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64505220|NCT03335436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64505221|NCT03335436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64731030|NCT00003421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64731031|NCT00003421|Glucocorticoids|glucocorticoids|mesh-ancestor
64731032|NCT00003421|Hormones|hormones|mesh-ancestor
64731033|NCT00003421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64731034|NCT00003421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731035|NCT00003421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64731036|NCT00003421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64731037|NCT00003421|Alkylating Agents|alkylating agents|mesh-ancestor
64731038|NCT00003427|Oxaliplatin|oxaliplatin|mesh-list
64731039|NCT00003427|Irinotecan|irinotecan|mesh-list
64731040|NCT00003427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731041|NCT00003427|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64731042|NCT00003427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731043|NCT00003427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731044|NCT00003427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731045|NCT00003439|Interleukin-12|interleukin-12|mesh-list
64731046|NCT00003439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64414895|NCT02418585|Citalopram|citalopram|mesh-list
64505222|NCT03335436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64505223|NCT03335436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64505224|NCT03335436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505225|NCT03335436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505226|NCT03335436|Antimanic Agents|antimanic agents|mesh-ancestor
64505227|NCT02494284|Aspirin|aspirin|mesh-list
64505228|NCT02494284|Clopidogrel|clopidogrel|mesh-list
64505229|NCT02494284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64505230|NCT02494284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64956006|NCT00399204|Metformin|metformin|mesh-list
64731047|NCT00003439|Immunologic Factors|immunologic factors|mesh-ancestor
64731048|NCT00003439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505231|NCT02494284|Analgesics|analgesics|mesh-ancestor
64505232|NCT02494284|Sensory System Agents|sensory system agents|mesh-ancestor
64505233|NCT02494284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64505234|NCT02494284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505235|NCT02494284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64505236|NCT02494284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64505237|NCT02494284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64505238|NCT02494284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64505239|NCT02494284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505240|NCT02494284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64505241|NCT02494284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64505242|NCT02494284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505243|NCT02494284|Antipyretics|antipyretics|mesh-ancestor
64726473|NCT00002816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64726474|NCT00002816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505244|NCT02494284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64505245|NCT02494284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64956007|NCT00399204|Pioglitazone|pioglitazone|mesh-list
64731049|NCT00003439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64731050|NCT00003439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64731051|NCT00003439|Growth Substances|growth substances|mesh-ancestor
64505246|NCT02494284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64505247|NCT02494284|Purinergic Agents|purinergic agents|mesh-ancestor
64505248|NCT02494284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505249|NCT01713400|Sirolimus|sirolimus|mesh-list
64505250|NCT01713400|Ustekinumab|ustekinumab|mesh-list
64505251|NCT01713400|Tacrolimus|tacrolimus|mesh-list
64505252|NCT01713400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64505253|NCT01713400|Immunologic Factors|immunologic factors|mesh-ancestor
64505254|NCT01713400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505255|NCT01713400|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64731052|NCT00003439|Growth Inhibitors|growth inhibitors|mesh-ancestor
64731053|NCT00003439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731054|NCT00003007|Interferons|interferons|mesh-list
64731055|NCT00003007|Interferon-alpha|interferon-alpha|mesh-list
64731056|NCT00003007|Dexamethasone|dexamethasone|mesh-list
64731057|NCT00003007|Cyclophosphamide|cyclophosphamide|mesh-list
64731058|NCT00003007|Melphalan|melphalan|mesh-list
64731059|NCT00003007|Sargramostim|sargramostim|mesh-list
64731060|NCT00003007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64731061|NCT00003007|Immunologic Factors|immunologic factors|mesh-ancestor
64731062|NCT00003007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731063|NCT00003007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64731064|NCT00003007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64731065|NCT00003007|Alkylating Agents|alkylating agents|mesh-ancestor
64731066|NCT00003007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731067|NCT00003007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731068|NCT00003007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64731069|NCT00003007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64731070|NCT00003007|Antiemetics|antiemetics|mesh-ancestor
64731071|NCT00003007|Autonomic Agents|autonomic agents|mesh-ancestor
64731072|NCT00003007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64956009|NCT00399204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956010|NCT00411034|Hydromorphone|hydromorphone|mesh-list
64956011|NCT00411034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64956012|NCT00411034|Narcotics|narcotics|mesh-ancestor
64731073|NCT00003007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64505256|NCT01713400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505257|NCT01713400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505258|NCT01713400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64505259|NCT01713400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64505260|NCT01713400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64505261|NCT01713400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505262|NCT01713400|Antifungal Agents|antifungal agents|mesh-ancestor
64505263|NCT01713400|Dermatologic Agents|dermatologic agents|mesh-ancestor
64505264|NCT04494828|Dexmedetomidine|dexmedetomidine|mesh-list
64505265|NCT04494828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64505266|NCT04494828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64731074|NCT00003007|Glucocorticoids|glucocorticoids|mesh-ancestor
64731075|NCT00003007|Hormones|hormones|mesh-ancestor
64731076|NCT00003007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64731077|NCT00003007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64731078|NCT00003007|Antiviral Agents|antiviral agents|mesh-ancestor
64731079|NCT00003007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64731080|NCT01478035|Phenytoin|phenytoin|mesh-list
64956013|NCT00411034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64956014|NCT00411034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956015|NCT00411034|Analgesics|analgesics|mesh-ancestor
64956016|NCT00411034|Sensory System Agents|sensory system agents|mesh-ancestor
64956017|NCT00411034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64956018|NCT00411073|Darapladib|darapladib|mesh-list
64956020|NCT00411073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956021|NCT00411073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956022|NCT00411190|Acetaminophen|acetaminophen|mesh-list
64956023|NCT00411190|Ibuprofen|ibuprofen|mesh-list
64956024|NCT00411190|Atorvastatin|atorvastatin|mesh-list
64956025|NCT00411190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64956026|NCT00411190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64956027|NCT00411190|Antimetabolites|antimetabolites|mesh-ancestor
64956028|NCT00411190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956029|NCT00411190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64415738|NCT05519111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64415739|NCT05519111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64415740|NCT05519111|Analgesics|analgesics|mesh-ancestor
64415741|NCT05519111|Sensory System Agents|sensory system agents|mesh-ancestor
64415742|NCT05519111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64415743|NCT05519111|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64415744|NCT05519111|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64415745|NCT05519111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505279|NCT01714336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64505280|NCT01714336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64505281|NCT01714336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505282|NCT01714336|Hemostatics|hemostatics|mesh-ancestor
64505283|NCT01714336|Coagulants|coagulants|mesh-ancestor
64955408|NCT00038558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64505285|NCT01716208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505286|NCT00706992|Aldesleukin|aldesleukin|mesh-list
64505287|NCT00706992|Vaccines|vaccines|mesh-list
64505288|NCT00706992|Freund's Adjuvant|freund's adjuvant|mesh-list
64505289|NCT00706992|Immunologic Factors|immunologic factors|mesh-ancestor
64505290|NCT00706992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505291|NCT00706992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505292|NCT00706992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64505293|NCT00706992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64505294|NCT00706992|Antiviral Agents|antiviral agents|mesh-ancestor
64505295|NCT00706992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64415746|NCT05519111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415747|NCT05519111|Hormones|hormones|mesh-ancestor
64415748|NCT05519111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64415749|NCT05531123|Gemcitabine|gemcitabine|mesh-list
64415750|NCT05531123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415751|NCT05531123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64415752|NCT05531123|Antimetabolites|antimetabolites|mesh-ancestor
64415753|NCT05531123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415754|NCT05531123|Antiviral Agents|antiviral agents|mesh-ancestor
64415755|NCT05531123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64731081|NCT01478035|Anticonvulsants|anticonvulsants|mesh-ancestor
64731082|NCT01478035|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64731083|NCT01478035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64731084|NCT01478035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64731086|NCT01478035|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64731108|NCT00003013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64731109|NCT00003013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64731110|NCT00003013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731111|NCT00003013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505296|NCT00706992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64505297|NCT03335124|Vitamins|vitamins|mesh-list
64505298|NCT03335124|Ascorbic Acid|ascorbic acid|mesh-list
64505299|NCT03335124|Thiamine|thiamine|mesh-list
64505300|NCT03335124|Hydrocortisone|hydrocortisone|mesh-list
64505301|NCT03335124|Micronutrients|micronutrients|mesh-ancestor
64505302|NCT03335124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505303|NCT03335124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64505304|NCT03335124|Antioxidants|antioxidants|mesh-ancestor
64505305|NCT03335124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505306|NCT03335124|Protective Agents|protective agents|mesh-ancestor
64505307|NCT03335124|Vitamin B Complex|vitamin b complex|mesh-ancestor
64505308|NCT03339804|Cyclophosphamide|cyclophosphamide|mesh-list
64505309|NCT03339804|Doxorubicin|doxorubicin|mesh-list
64505310|NCT03339804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64505311|NCT03339804|Immunologic Factors|immunologic factors|mesh-ancestor
64731129|NCT00003445|Tubulin Modulators|tubulin modulators|mesh-ancestor
64731130|NCT00003445|Antimitotic Agents|antimitotic agents|mesh-ancestor
64731131|NCT00003445|Mitosis Modulators|mitosis modulators|mesh-ancestor
64731132|NCT00003445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731133|NCT00003451|Interferons|interferons|mesh-list
64731134|NCT00003451|Interferon-alpha|interferon-alpha|mesh-list
64731135|NCT00003451|Interleukin-12|interleukin-12|mesh-list
64731136|NCT00003451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731137|NCT00003451|Antiviral Agents|antiviral agents|mesh-ancestor
64731138|NCT00003451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64731139|NCT00003451|Immunologic Factors|immunologic factors|mesh-ancestor
64731140|NCT00003451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731141|NCT00003451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64731142|NCT00003451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64731143|NCT00003451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64731144|NCT00003451|Growth Substances|growth substances|mesh-ancestor
64731146|NCT00003463|Irinotecan|irinotecan|mesh-list
64731147|NCT00003463|Carmustine|carmustine|mesh-list
64731148|NCT00003463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64731149|NCT00003463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731150|NCT00003463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731151|NCT00003463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731152|NCT00003463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731153|NCT00003463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64731154|NCT00003463|Alkylating Agents|alkylating agents|mesh-ancestor
64731155|NCT00003019|Methotrexate|methotrexate|mesh-list
64731156|NCT00003019|Vinblastine|vinblastine|mesh-list
64731157|NCT00003019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64731158|NCT00003019|Abortifacient Agents|abortifacient agents|mesh-ancestor
64505312|NCT03339804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505313|NCT03339804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64505314|NCT03339804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64505315|NCT03339804|Alkylating Agents|alkylating agents|mesh-ancestor
64505316|NCT03339804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505317|NCT03339804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505318|NCT03339804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64505319|NCT03339804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64505321|NCT03339804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64505322|NCT03339804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505323|NCT02248636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
64505324|NCT02248636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505325|NCT02248636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505326|NCT02248636|Cholinergic Agents|cholinergic agents|mesh-ancestor
64505327|NCT02248636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64726475|NCT00002816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64726476|NCT00002816|Glucocorticoids|glucocorticoids|mesh-ancestor
64726477|NCT00002816|Hormones|hormones|mesh-ancestor
64726478|NCT00002816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64726479|NCT00002816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64726480|NCT00002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726481|NCT00002816|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64726482|NCT00002816|Abortifacient Agents|abortifacient agents|mesh-ancestor
64726483|NCT00002816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64731161|NCT00003019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64731162|NCT00003019|Antimetabolites|antimetabolites|mesh-ancestor
64731163|NCT00003019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731164|NCT00003019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731165|NCT00003019|Dermatologic Agents|dermatologic agents|mesh-ancestor
64726484|NCT00002816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64726485|NCT00002816|Antimetabolites|antimetabolites|mesh-ancestor
64726486|NCT00002816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726487|NCT00002816|Dermatologic Agents|dermatologic agents|mesh-ancestor
64726488|NCT00002816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333981|NCT05055713|Hormones|hormones|mesh-ancestor
64505328|NCT02248636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505329|NCT02491320|Letrozole|letrozole|mesh-list
64505345|NCT02491242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64731166|NCT00003019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731167|NCT00003019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64415964|NCT05506319|Vasopressins|vasopressins|mesh-list
64956030|NCT00411190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64956031|NCT00411190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956032|NCT00411190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64505346|NCT02491242|Antiviral Agents|antiviral agents|mesh-ancestor
64505347|NCT02491242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64505348|NCT03330990|Midazolam|midazolam|mesh-list
64505349|NCT03330990|Entrectinib|entrectinib|mesh-list
64505350|NCT03330990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64505351|NCT03330990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64505352|NCT03330990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64505353|NCT03330990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505354|NCT03330990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64505355|NCT03330990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64505356|NCT03330990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64505357|NCT03330990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64955409|NCT00038558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505358|NCT03330990|Anesthetics, General|anesthetics, general|mesh-ancestor
64505359|NCT03330990|Anesthetics|anesthetics|mesh-ancestor
64505360|NCT03330990|GABA Modulators|gaba modulators|mesh-ancestor
64505361|NCT03330990|GABA Agents|gaba agents|mesh-ancestor
64505362|NCT03330990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505363|NCT03330990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505364|NCT03330990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64505365|NCT03330990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505366|NCT03339024|Oxytocin|oxytocin|mesh-list
64505367|NCT03339024|Oxytocics|oxytocics|mesh-ancestor
64731168|NCT00003019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64731169|NCT00003019|Immunologic Factors|immunologic factors|mesh-ancestor
64731170|NCT00003019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64731171|NCT00003019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64956033|NCT00411190|Analgesics|analgesics|mesh-ancestor
64505368|NCT03339024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64505369|NCT03339024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505370|NCT03330132|Vaccines|vaccines|mesh-list
64505371|NCT03330132|Hemagglutinins|hemagglutinins|mesh-list
64505372|NCT03330132|Immunologic Factors|immunologic factors|mesh-ancestor
64505373|NCT03330132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505374|NCT03330132|Agglutinins|agglutinins|mesh-ancestor
64505375|NCT02492412|Cyclosporine|cyclosporine|mesh-list
64505376|NCT02492412|Cyclosporins|cyclosporins|mesh-list
64505377|NCT02492412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505378|NCT02492412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505379|NCT02492412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64505380|NCT02492412|Immunologic Factors|immunologic factors|mesh-ancestor
64505381|NCT02492412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505382|NCT02492412|Antifungal Agents|antifungal agents|mesh-ancestor
64505383|NCT02492412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64505384|NCT02492412|Dermatologic Agents|dermatologic agents|mesh-ancestor
64505385|NCT02492412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64505386|NCT02492412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64726489|NCT00002816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64731172|NCT00003019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64731173|NCT00003019|Tubulin Modulators|tubulin modulators|mesh-ancestor
64731174|NCT00003019|Antimitotic Agents|antimitotic agents|mesh-ancestor
64731175|NCT00003019|Mitosis Modulators|mitosis modulators|mesh-ancestor
64731176|NCT01120249|Everolimus|everolimus|mesh-list
64956035|NCT00411190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64726490|NCT00002816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64726491|NCT00002816|Immunologic Factors|immunologic factors|mesh-ancestor
64726492|NCT00002816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64726493|NCT00002816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64726494|NCT00002816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64726495|NCT00002816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64726496|NCT00002816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64726497|NCT00002816|Antiviral Agents|antiviral agents|mesh-ancestor
64465775|NCT05024188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64465776|NCT05024188|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64465777|NCT05024188|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64465778|NCT05024188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64465779|NCT05024188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64465780|NCT05024188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731177|NCT01120249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731178|NCT01120249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64731179|NCT01120249|Immunologic Factors|immunologic factors|mesh-ancestor
64731180|NCT01120249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731181|NCT00003493|Dexamethasone|dexamethasone|mesh-list
64731182|NCT00003493|Doxorubicin|doxorubicin|mesh-list
64731183|NCT00003493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64731184|NCT00003493|Vincristine|vincristine|mesh-list
64465781|NCT05024188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465782|NCT05024188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465785|NCT05029960|Brivaracetam|brivaracetam|mesh-list
64726498|NCT00002816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726500|NCT00002816|Protective Agents|protective agents|mesh-ancestor
64726501|NCT00002816|Vitamin B Complex|vitamin b complex|mesh-ancestor
64726502|NCT00002816|Vitamins|vitamins|mesh-ancestor
64726503|NCT00002816|Micronutrients|micronutrients|mesh-ancestor
64726504|NCT00002816|Tubulin Modulators|tubulin modulators|mesh-ancestor
64726505|NCT00002816|Antimitotic Agents|antimitotic agents|mesh-ancestor
64726506|NCT00002816|Mitosis Modulators|mitosis modulators|mesh-ancestor
64726507|NCT00002816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64731185|NCT00003493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64731186|NCT00003493|Antiemetics|antiemetics|mesh-ancestor
64731187|NCT00003493|Autonomic Agents|autonomic agents|mesh-ancestor
64731188|NCT00003493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64731189|NCT00003493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956036|NCT00411190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494710|NCT01185028|Ribavirin|ribavirin|mesh-list
64956038|NCT00411190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64726508|NCT00002816|Alkylating Agents|alkylating agents|mesh-ancestor
64726509|NCT00002816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64726510|NCT00002816|Trace Elements|trace elements|mesh-ancestor
64726511|NCT00002269|Zidovudine|zidovudine|mesh-list
64726512|NCT00002269|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
64505388|NCT03329898|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64505389|NCT03329898|Estradiol|estradiol|mesh-list
64505390|NCT03329898|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64505391|NCT03329898|Dydrogesterone|dydrogesterone|mesh-list
64505392|NCT03329898|Estrogens|estrogens|mesh-ancestor
64505393|NCT03329898|Hormones|hormones|mesh-ancestor
64505394|NCT03329898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64505395|NCT03329898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505396|NCT03329898|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64505397|NCT03329898|Contraceptive Agents|contraceptive agents|mesh-ancestor
64505398|NCT03329898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64505399|NCT03329898|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64731190|NCT00003493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64731191|NCT00003493|Glucocorticoids|glucocorticoids|mesh-ancestor
64731192|NCT00003493|Hormones|hormones|mesh-ancestor
64736774|NCT05599841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64505400|NCT03329898|Progestins|progestins|mesh-ancestor
64726513|NCT00002269|Antimetabolites|antimetabolites|mesh-ancestor
64726514|NCT00002269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726515|NCT00002269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64726516|NCT00002269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64726517|NCT00002269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726518|NCT00002269|Antiviral Agents|antiviral agents|mesh-ancestor
64505401|NCT02492568|Pembrolizumab|pembrolizumab|mesh-list
64505402|NCT02492568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64731193|NCT00003493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64731194|NCT00003493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64731195|NCT00003493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731196|NCT00003493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64731197|NCT00003493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64731198|NCT00003493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731199|NCT00003493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731200|NCT00003493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731201|NCT00003493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64731202|NCT00003493|Tubulin Modulators|tubulin modulators|mesh-ancestor
64731203|NCT00003493|Antimitotic Agents|antimitotic agents|mesh-ancestor
64731204|NCT00003493|Mitosis Modulators|mitosis modulators|mesh-ancestor
64731205|NCT00788125|Carboplatin|carboplatin|mesh-list
64731206|NCT00788125|Etoposide|etoposide|mesh-list
64731207|NCT00788125|Dasatinib|dasatinib|mesh-list
64731208|NCT00788125|Ifosfamide|ifosfamide|mesh-list
64505403|NCT02492568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505404|NCT01722292|Carboplatin|carboplatin|mesh-list
64505406|NCT01722292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505407|NCT01722292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64505408|NCT01722292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64505409|NCT01722292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64505410|NCT01722292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505411|NCT01722292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505412|NCT02493894|Cefazolin|cefazolin|mesh-list
64505413|NCT02493894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64505414|NCT02493894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64505418|NCT01722604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505419|NCT02493738|Itraconazole|itraconazole|mesh-list
64505420|NCT02493738|Antifungal Agents|antifungal agents|mesh-ancestor
64505421|NCT02493738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64731209|NCT00788125|Etoposide phosphate|etoposide phosphate|mesh-list
64731210|NCT00788125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731211|NCT00788125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64731212|NCT00788125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64731213|NCT00788125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731214|NCT00788125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731215|NCT00788125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731216|NCT00788125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64731217|NCT00788125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64731218|NCT00788125|Alkylating Agents|alkylating agents|mesh-ancestor
64731219|NCT00003031|Voriconazole|voriconazole|mesh-list
64731220|NCT00003031|Amphotericin B|amphotericin b|mesh-list
64731221|NCT00003031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64731222|NCT00003031|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
64731223|NCT00003031|Deoxycholic Acid|deoxycholic acid|mesh-list
64731224|NCT00003031|Antifungal Agents|antifungal agents|mesh-ancestor
64731225|NCT00003031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64731226|NCT00003031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64731227|NCT00003031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64731228|NCT00003031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505422|NCT02493738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64505423|NCT02493738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64505424|NCT02493738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505425|NCT02493738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505426|NCT02493738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64505427|NCT02493738|Hormone Antagonists|hormone antagonists|mesh-ancestor
64505428|NCT02493738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64505429|NCT02493738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505430|NCT02493738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64505431|NCT03875638|Levetiracetam|levetiracetam|mesh-list
64505432|NCT03875638|Anticonvulsants|anticonvulsants|mesh-ancestor
64505433|NCT03875638|Nootropic Agents|nootropic agents|mesh-ancestor
64731229|NCT00003031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731230|NCT00003031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64731231|NCT00003031|Hormone Antagonists|hormone antagonists|mesh-ancestor
64731232|NCT00003031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64956039|NCT00411190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64731234|NCT00003031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64731235|NCT00003031|Amebicides|amebicides|mesh-ancestor
64731236|NCT00003031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64731237|NCT00003031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64731238|NCT00003031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64731239|NCT00003031|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64731240|NCT00003031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64731241|NCT00003517|Leuprolide|leuprolide|mesh-list
64731242|NCT00003517|Flutamide|flutamide|mesh-list
64505434|NCT03858322|Paclitaxel|paclitaxel|mesh-list
64505436|NCT03858322|Carboplatin|carboplatin|mesh-list
64505437|NCT03858322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64505438|NCT03858322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505439|NCT03858322|Tubulin Modulators|tubulin modulators|mesh-ancestor
64505440|NCT03858322|Antimitotic Agents|antimitotic agents|mesh-ancestor
64505441|NCT03858322|Mitosis Modulators|mitosis modulators|mesh-ancestor
64505442|NCT03858322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731243|NCT00003517|Bicalutamide|bicalutamide|mesh-list
64731244|NCT00003517|Hormones|hormones|mesh-list
64731245|NCT00003517|Androgen Antagonists|androgen antagonists|mesh-list
64731246|NCT00003517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64731247|NCT00003517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731248|NCT00003517|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64731249|NCT00003517|Fertility Agents|fertility agents|mesh-ancestor
64731250|NCT00003517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64731251|NCT00003517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64731252|NCT00003517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731253|NCT00003517|Hormone Antagonists|hormone antagonists|mesh-ancestor
64731254|NCT00003037|Gemcitabine|gemcitabine|mesh-list
64731255|NCT00003037|Docetaxel|docetaxel|mesh-list
64731256|NCT00003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731257|NCT00003037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64731258|NCT00003037|Antimetabolites|antimetabolites|mesh-ancestor
64731259|NCT00003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731260|NCT00003037|Antiviral Agents|antiviral agents|mesh-ancestor
64731261|NCT00003037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64731262|NCT00003037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731263|NCT00003037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64731264|NCT00003037|Immunologic Factors|immunologic factors|mesh-ancestor
64731265|NCT00003037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731266|NCT00003037|Tubulin Modulators|tubulin modulators|mesh-ancestor
64731267|NCT00003037|Antimitotic Agents|antimitotic agents|mesh-ancestor
64731268|NCT00003037|Mitosis Modulators|mitosis modulators|mesh-ancestor
64731269|NCT00002803|Cyclophosphamide|cyclophosphamide|mesh-list
64731270|NCT00002803|Doxorubicin|doxorubicin|mesh-list
64731271|NCT00002803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64731272|NCT00002803|Vincristine|vincristine|mesh-list
64731273|NCT00002803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64505443|NCT03858322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64505444|NCT03858322|Immunologic Factors|immunologic factors|mesh-ancestor
64505445|NCT03858322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505446|NCT03858322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64505447|NCT03858322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64505448|NCT03858322|Alkylating Agents|alkylating agents|mesh-ancestor
64505449|NCT03858322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64505450|NCT02493582|Apatinib|apatinib|mesh-list
64505451|NCT02493582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505452|NCT02493582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64505453|NCT02493582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505454|NCT02493582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956040|NCT00411190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64956041|NCT00411190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64731279|NCT00002803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731280|NCT00002803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731281|NCT00002803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64731282|NCT00002803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64731283|NCT00002803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64731284|NCT00002803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731285|NCT00002803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731286|NCT00002803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64731287|NCT00002803|Tubulin Modulators|tubulin modulators|mesh-ancestor
64731288|NCT00002803|Antimitotic Agents|antimitotic agents|mesh-ancestor
64505455|NCT05560360|Efavirenz|efavirenz|mesh-list
64505456|NCT05560360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64505457|NCT05560360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64505458|NCT05560360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505459|NCT05560360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505470|NCT03329118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64505471|NCT03329118|Antimetabolites|antimetabolites|mesh-ancestor
64726519|NCT00002269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726521|NCT00002269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64726522|NCT00002275|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64505472|NCT03329118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505473|NCT03329118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64505474|NCT03329118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64505475|NCT03329118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505476|NCT01723384|Naltrexone|naltrexone|mesh-list
64505477|NCT01723384|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64505478|NCT01723384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64505479|NCT01723384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505480|NCT01723384|Sensory System Agents|sensory system agents|mesh-ancestor
64505481|NCT01723384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64505483|NCT02492490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64505484|NCT02492490|Immunologic Factors|immunologic factors|mesh-ancestor
64421265|NCT00560495|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
64421266|NCT00560495|Chelating Agents|chelating agents|mesh-ancestor
64505485|NCT02492490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505486|NCT03337932|Doxycycline|doxycycline|mesh-list
64505487|NCT03337932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64505488|NCT03337932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64505489|NCT03337932|Antimalarials|antimalarials|mesh-ancestor
64505490|NCT03337932|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64505491|NCT03337932|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64505492|NCT02493504|Heparin|heparin|mesh-list
64505493|NCT02493504|Anticoagulants|anticoagulants|mesh-ancestor
64505494|NCT02493504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64505495|NCT02493504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64505496|NCT02493504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505497|NCT00706914|Formoterol Fumarate|formoterol fumarate|mesh-list
64505498|NCT00706914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64505499|NCT00706914|Autonomic Agents|autonomic agents|mesh-ancestor
64505500|NCT00706914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64731289|NCT00002803|Mitosis Modulators|mitosis modulators|mesh-ancestor
64731290|NCT00383929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64731291|NCT00383929|Candesartan|candesartan|mesh-list
64731292|NCT00383929|Candesartan cilexetil|candesartan cilexetil|mesh-list
64731293|NCT00383929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64731294|NCT00383929|Diuretics|diuretics|mesh-ancestor
64731295|NCT00383929|Natriuretic Agents|natriuretic agents|mesh-ancestor
64731296|NCT00383929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731297|NCT00383929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64505501|NCT00706914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505502|NCT00706914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64505503|NCT00706914|Respiratory System Agents|respiratory system agents|mesh-ancestor
64505504|NCT00706914|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64505505|NCT00706914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64505506|NCT00706914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64955410|NCT00038558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64955411|NCT00038558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64505507|NCT00706914|Adrenergic Agents|adrenergic agents|mesh-ancestor
64505508|NCT00706914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505509|NCT00706914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956046|NCT00411229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956047|NCT00411229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731313|NCT00003541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64731314|NCT00003541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64731315|NCT00003541|Alkylating Agents|alkylating agents|mesh-ancestor
64731316|NCT00003541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731317|NCT00003541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731318|NCT00003541|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64505511|NCT03328728|Viscosupplements|viscosupplements|mesh-ancestor
64505512|NCT03328728|Protective Agents|protective agents|mesh-ancestor
64505513|NCT03328728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505514|NCT03328494|Paclitaxel|paclitaxel|mesh-list
64505515|NCT03328494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64505516|NCT03328494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505517|NCT03328494|Tubulin Modulators|tubulin modulators|mesh-ancestor
64505518|NCT03328494|Antimitotic Agents|antimitotic agents|mesh-ancestor
64505519|NCT03328494|Mitosis Modulators|mitosis modulators|mesh-ancestor
64731319|NCT00003541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64956048|NCT00411268|Hydromorphone|hydromorphone|mesh-list
64956049|NCT00411268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64731320|NCT00003541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64731321|NCT00003541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731322|NCT00003541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731323|NCT00003541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64731324|NCT00003541|Glucocorticoids|glucocorticoids|mesh-ancestor
64731325|NCT00003541|Hormones|hormones|mesh-ancestor
64731326|NCT00003541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64731327|NCT00003541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64731328|NCT00003541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64731329|NCT00003541|Tubulin Modulators|tubulin modulators|mesh-ancestor
64731330|NCT00003541|Antimitotic Agents|antimitotic agents|mesh-ancestor
64731331|NCT00003541|Mitosis Modulators|mitosis modulators|mesh-ancestor
64731332|NCT00002809|Cyclophosphamide|cyclophosphamide|mesh-list
64731333|NCT00002809|Methotrexate|methotrexate|mesh-list
64731334|NCT00002809|Tacrolimus|tacrolimus|mesh-list
64731335|NCT00002809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64505520|NCT03328494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505521|NCT02491398|Rituximab|rituximab|mesh-list
64505525|NCT02491398|Immunologic Factors|immunologic factors|mesh-ancestor
64505526|NCT02491398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505527|NCT02491398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64505528|NCT02491398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64505529|NCT02491398|Alkylating Agents|alkylating agents|mesh-ancestor
64505530|NCT02491398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505531|NCT03333018|Bromides|bromides|mesh-list
64505532|NCT03333018|Formoterol Fumarate|formoterol fumarate|mesh-list
64505533|NCT03333018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64505534|NCT03333018|Autonomic Agents|autonomic agents|mesh-ancestor
64505535|NCT03333018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64505536|NCT03333018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505537|NCT03333018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64505538|NCT03333018|Respiratory System Agents|respiratory system agents|mesh-ancestor
64505539|NCT03333018|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64731336|NCT00002809|Sargramostim|sargramostim|mesh-list
64731337|NCT00002809|Immunoglobulins|immunoglobulins|mesh-list
64731338|NCT00002809|Antibodies|antibodies|mesh-list
64731339|NCT00002809|gamma-Globulins|gamma-globulins|mesh-list
64470588|NCT05144542|Autonomic Agents|autonomic agents|mesh-ancestor
64470589|NCT05144542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64470590|NCT05144542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470591|NCT05144542|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64470592|NCT05144542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64470593|NCT05144542|Cholinergic Agents|cholinergic agents|mesh-ancestor
64731340|NCT00002809|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64731341|NCT00002809|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64731342|NCT00002809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64731343|NCT00002809|Immunologic Factors|immunologic factors|mesh-ancestor
64731344|NCT00002809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731345|NCT00002809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64731346|NCT00002809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64731347|NCT00002809|Alkylating Agents|alkylating agents|mesh-ancestor
64731348|NCT00002809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731349|NCT00002809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731350|NCT00002809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64726523|NCT00002275|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64726524|NCT00002275|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64726525|NCT00002275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64726526|NCT00003152|Interferons|interferons|mesh-list
64726527|NCT00003152|Interferon-alpha|interferon-alpha|mesh-list
64726528|NCT00003152|Prednisone|prednisone|mesh-list
64505540|NCT03333018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64505541|NCT03333018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64505542|NCT03333018|Adrenergic Agents|adrenergic agents|mesh-ancestor
64505543|NCT03333018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505544|NCT03333018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505545|NCT03333018|Anticonvulsants|anticonvulsants|mesh-ancestor
64505546|NCT03332940|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
64956050|NCT00411268|Narcotics|narcotics|mesh-ancestor
64956051|NCT00411268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64956052|NCT00411268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956053|NCT00411268|Analgesics|analgesics|mesh-ancestor
64956054|NCT00411268|Sensory System Agents|sensory system agents|mesh-ancestor
64956055|NCT00411268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64956056|NCT00039962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64956057|NCT00039962|Thymalfasin|thymalfasin|mesh-list
64956058|NCT00039962|Antiviral Agents|antiviral agents|mesh-ancestor
64956059|NCT00039962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64956060|NCT00039962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64956061|NCT00039962|Immunologic Factors|immunologic factors|mesh-ancestor
64731351|NCT00002809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64731352|NCT00002809|Abortifacient Agents|abortifacient agents|mesh-ancestor
64731353|NCT00002809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64731354|NCT00002809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64731355|NCT00002809|Antimetabolites|antimetabolites|mesh-ancestor
64731356|NCT00002809|Dermatologic Agents|dermatologic agents|mesh-ancestor
64731357|NCT00002809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731358|NCT00002809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64731359|NCT00002809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64731360|NCT00002809|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64731361|NCT00383539|Vaccines|vaccines|mesh-list
64731362|NCT00383539|Immunologic Factors|immunologic factors|mesh-ancestor
64731363|NCT00383539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731364|NCT00002827|Cobalt|cobalt|mesh-list
64731365|NCT00002827|Doxorubicin|doxorubicin|mesh-list
64414991|NCT04885855|Antiviral Agents|antiviral agents|mesh-ancestor
64505547|NCT03332940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64505548|NCT03332940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505549|NCT01723696|Vitamins|vitamins|mesh-list
64505550|NCT01723696|Ascorbic Acid|ascorbic acid|mesh-list
64505551|NCT01723696|Micronutrients|micronutrients|mesh-ancestor
64505552|NCT01723696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505554|NCT01723696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505555|NCT01723696|Protective Agents|protective agents|mesh-ancestor
64505556|NCT03327558|Mesalamine|mesalamine|mesh-list
64505557|NCT03327558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64505558|NCT03327558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64731366|NCT00002827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64731367|NCT00002827|Bleomycin|bleomycin|mesh-list
64731368|NCT00002827|Etoposide|etoposide|mesh-list
64731369|NCT00002827|Dexrazoxane|dexrazoxane|mesh-list
64731370|NCT00002827|Vincristine|vincristine|mesh-list
64731371|NCT00002827|Razoxane|razoxane|mesh-list
64731372|NCT00002827|Lenograstim|lenograstim|mesh-list
64731373|NCT00002827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64731374|NCT00002827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731375|NCT00002827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64731376|NCT00002827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731377|NCT00002827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731378|NCT00002827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731379|NCT00002827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64956067|NCT00206557|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64956068|NCT00206557|Estradiol|estradiol|mesh-list
64494729|NCT05439798|Dexamethasone acetate|dexamethasone acetate|mesh-list
64956069|NCT00206557|Estrogens|estrogens|mesh-ancestor
64505559|NCT03327558|Analgesics|analgesics|mesh-ancestor
64505560|NCT03327558|Sensory System Agents|sensory system agents|mesh-ancestor
64505561|NCT03327558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64505562|NCT03327558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505563|NCT03327558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64505564|NCT03327558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64505565|NCT02242630|Methylprednisolone|methylprednisolone|mesh-list
64505566|NCT02242630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64731380|NCT00002827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64731382|NCT00002827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731383|NCT00002827|Tubulin Modulators|tubulin modulators|mesh-ancestor
64731384|NCT00002827|Antimitotic Agents|antimitotic agents|mesh-ancestor
64731385|NCT00002827|Mitosis Modulators|mitosis modulators|mesh-ancestor
64731386|NCT00002827|Trace Elements|trace elements|mesh-ancestor
64731387|NCT00002827|Micronutrients|micronutrients|mesh-ancestor
64731388|NCT00002827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64956070|NCT00206557|Hormones|hormones|mesh-ancestor
64731389|NCT00002827|Protective Agents|protective agents|mesh-ancestor
64731390|NCT00384475|Ciclesonide|ciclesonide|mesh-list
64731391|NCT00384475|Glucocorticoids|glucocorticoids|mesh-ancestor
64731392|NCT00384475|Hormones|hormones|mesh-ancestor
64731393|NCT00384475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64731394|NCT00384475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731395|NCT00384475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64731396|NCT00003565|Docetaxel|docetaxel|mesh-list
64731397|NCT00003565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731398|NCT00003565|Tubulin Modulators|tubulin modulators|mesh-ancestor
64731399|NCT00003565|Antimitotic Agents|antimitotic agents|mesh-ancestor
64731400|NCT00003565|Mitosis Modulators|mitosis modulators|mesh-ancestor
64731401|NCT00003565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731402|NCT00003049|Leucovorin|leucovorin|mesh-list
64731403|NCT00003049|Fluorouracil|fluorouracil|mesh-list
64505567|NCT02242630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64505568|NCT02242630|Prednisolone|prednisolone|mesh-list
64505569|NCT02242630|Prednisolone acetate|prednisolone acetate|mesh-list
64505570|NCT02242630|Triamcinolone|triamcinolone|mesh-list
64505571|NCT02242630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64505572|NCT02242630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64505573|NCT02242630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64505574|NCT02242630|Prednisolone phosphate|prednisolone phosphate|mesh-list
64505575|NCT02242630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64505576|NCT02242630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64505577|NCT02242630|Antiemetics|antiemetics|mesh-ancestor
64955412|NCT00038558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955413|NCT00038558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470673|NCT05085808|Trazodone|trazodone|mesh-list
64731413|NCT00003049|Immunologic Factors|immunologic factors|mesh-ancestor
64731414|NCT00003049|Antidotes|antidotes|mesh-ancestor
64731415|NCT00003049|Protective Agents|protective agents|mesh-ancestor
64731416|NCT00003049|Vitamin B Complex|vitamin b complex|mesh-ancestor
64731417|NCT00003049|Vitamins|vitamins|mesh-ancestor
64731418|NCT00003049|Micronutrients|micronutrients|mesh-ancestor
64731419|NCT00003055|Irinotecan|irinotecan|mesh-list
64731420|NCT00003055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731421|NCT00003055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64731422|NCT00003055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731423|NCT00003055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731424|NCT00003055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731425|NCT00002833|Cytarabine|cytarabine|mesh-list
64731426|NCT00002833|Cyclosporine|cyclosporine|mesh-list
64731427|NCT00002833|Methylprednisolone|methylprednisolone|mesh-list
64731428|NCT00002833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64731429|NCT00002833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64415001|NCT05529095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505578|NCT02242630|Autonomic Agents|autonomic agents|mesh-ancestor
64505579|NCT02242630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64505580|NCT02242630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505581|NCT02242630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64505582|NCT02242630|Glucocorticoids|glucocorticoids|mesh-ancestor
64505583|NCT02242630|Hormones|hormones|mesh-ancestor
64505584|NCT02242630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64505585|NCT02242630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64505586|NCT02242630|Protective Agents|protective agents|mesh-ancestor
64731430|NCT00002833|Prednisolone|prednisolone|mesh-list
64731431|NCT00002833|Prednisolone acetate|prednisolone acetate|mesh-list
64731432|NCT00002833|Fludarabine|fludarabine|mesh-list
64731433|NCT00002833|Fludarabine phosphate|fludarabine phosphate|mesh-list
64731434|NCT00002833|Idarubicin|idarubicin|mesh-list
64731435|NCT00002833|Cladribine|cladribine|mesh-list
64731436|NCT00002833|Cyclosporins|cyclosporins|mesh-list
64731437|NCT00002833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64731438|NCT00002833|Prednisolone phosphate|prednisolone phosphate|mesh-list
64731439|NCT00002833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505587|NCT02242630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64505588|NCT02242630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505589|NCT02242630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64505590|NCT02242630|Immunologic Factors|immunologic factors|mesh-ancestor
64505591|NCT02242630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956071|NCT00206557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64505603|NCT03109080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64505604|NCT03109080|Vasodilator Agents|vasodilator agents|mesh-ancestor
64505605|NCT03109080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64731440|NCT00002833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64731441|NCT00002833|Antimetabolites|antimetabolites|mesh-ancestor
64731442|NCT00002833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731443|NCT00002833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64731444|NCT00002833|Immunologic Factors|immunologic factors|mesh-ancestor
64731445|NCT00002833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731446|NCT00002833|Antiviral Agents|antiviral agents|mesh-ancestor
64731447|NCT00002833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64731448|NCT00002833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731449|NCT00002833|Antifungal Agents|antifungal agents|mesh-ancestor
64731450|NCT00002833|Dermatologic Agents|dermatologic agents|mesh-ancestor
64731451|NCT00002833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64731452|NCT00002833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64731453|NCT00002833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64505606|NCT03109080|Purinergic Agonists|purinergic agonists|mesh-ancestor
64505607|NCT03109080|Purinergic Agents|purinergic agents|mesh-ancestor
64505608|NCT03109080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505609|NCT03109158|Cetuximab|cetuximab|mesh-list
64505610|NCT03109158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64505611|NCT03109158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505612|NCT03324828|Hydroxyzine|hydroxyzine|mesh-list
64505613|NCT03324828|Antipruritics|antipruritics|mesh-ancestor
64726530|NCT00003152|Vincristine|vincristine|mesh-list
64726531|NCT00003152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64726532|NCT00003152|Immunologic Factors|immunologic factors|mesh-ancestor
64726533|NCT00003152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731455|NCT00002833|Autonomic Agents|autonomic agents|mesh-ancestor
64731456|NCT00002833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64731457|NCT00002833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64731458|NCT00002833|Glucocorticoids|glucocorticoids|mesh-ancestor
64731459|NCT00002833|Hormones|hormones|mesh-ancestor
64731460|NCT00002833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64731461|NCT00002833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64731462|NCT00002833|Protective Agents|protective agents|mesh-ancestor
64731463|NCT00002833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64731464|NCT00002833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64731465|NCT00002833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64731466|NCT00002833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731467|NCT00003061|Cytarabine|cytarabine|mesh-list
64731468|NCT00003061|Methotrexate|methotrexate|mesh-list
64731469|NCT00003061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64731470|NCT00003061|Abortifacient Agents|abortifacient agents|mesh-ancestor
64731471|NCT00003061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64956072|NCT00206557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726534|NCT00003152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64726535|NCT00003152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64726536|NCT00003152|Alkylating Agents|alkylating agents|mesh-ancestor
64726537|NCT00003152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726538|NCT00003152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726539|NCT00003152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64726540|NCT00003152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64726541|NCT00003152|Glucocorticoids|glucocorticoids|mesh-ancestor
64726542|NCT00003152|Hormones|hormones|mesh-ancestor
64726543|NCT00003152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64726544|NCT00003152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64726545|NCT00003152|Antiviral Agents|antiviral agents|mesh-ancestor
64726546|NCT00003152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726547|NCT00003152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64726548|NCT00003152|Tubulin Modulators|tubulin modulators|mesh-ancestor
64731472|NCT00003061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731473|NCT00003061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64731474|NCT00003061|Antimetabolites|antimetabolites|mesh-ancestor
64731475|NCT00003061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726549|NCT00003152|Antimitotic Agents|antimitotic agents|mesh-ancestor
64726550|NCT00003152|Mitosis Modulators|mitosis modulators|mesh-ancestor
64726551|NCT05751421|Meloxicam|meloxicam|mesh-list
64726552|NCT05751421|Bupivacaine|bupivacaine|mesh-list
64726553|NCT05751421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64505614|NCT03324828|Dermatologic Agents|dermatologic agents|mesh-ancestor
64505615|NCT03324828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64505616|NCT03324828|Histamine Antagonists|histamine antagonists|mesh-ancestor
64505617|NCT03324828|Histamine Agents|histamine agents|mesh-ancestor
64505618|NCT03324828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505619|NCT03324828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505620|NCT03324828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505621|NCT03332316|Dexamethasone|dexamethasone|mesh-list
64505622|NCT03332316|Dexamethasone acetate|dexamethasone acetate|mesh-list
64505623|NCT03332316|Ropivacaine|ropivacaine|mesh-list
64505624|NCT03332316|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64505625|NCT03332316|BB 1101|bb 1101|mesh-list
64505626|NCT03332316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64505627|NCT03332316|Antiemetics|antiemetics|mesh-ancestor
64505628|NCT03332316|Autonomic Agents|autonomic agents|mesh-ancestor
64505630|NCT03332316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505631|NCT03332316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64505632|NCT03332316|Glucocorticoids|glucocorticoids|mesh-ancestor
64505633|NCT03332316|Hormones|hormones|mesh-ancestor
64505634|NCT03332316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64505635|NCT03332316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64505636|NCT03332316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505637|NCT03332316|Anesthetics, Local|anesthetics, local|mesh-ancestor
64505638|NCT03332316|Anesthetics|anesthetics|mesh-ancestor
64505639|NCT03332316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64505640|NCT03332316|Sensory System Agents|sensory system agents|mesh-ancestor
64726554|NCT05751421|Anesthetics, Local|anesthetics, local|mesh-ancestor
64726555|NCT05751421|Anesthetics|anesthetics|mesh-ancestor
64726556|NCT05751421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64505641|NCT03332316|Protease Inhibitors|protease inhibitors|mesh-ancestor
64731476|NCT00003061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731477|NCT00003061|Dermatologic Agents|dermatologic agents|mesh-ancestor
64731478|NCT00003061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470739|NCT05063097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470740|NCT05059470|Pembrolizumab|pembrolizumab|mesh-list
64470741|NCT05059470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64470742|NCT05059470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470743|NCT05048797|Carboplatin|carboplatin|mesh-list
64956076|NCT00206557|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64415028|NCT03051373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505642|NCT03332316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505643|NCT03332316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505644|NCT03327168|Adenosine|adenosine|mesh-list
64505645|NCT03327168|Analgesics|analgesics|mesh-ancestor
64505646|NCT03327168|Sensory System Agents|sensory system agents|mesh-ancestor
64505647|NCT03327168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64505648|NCT03327168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505649|NCT03327168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64505650|NCT03327168|Vasodilator Agents|vasodilator agents|mesh-ancestor
64955414|NCT00038558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64955415|NCT00038558|Alkylating Agents|alkylating agents|mesh-ancestor
64505651|NCT03327168|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64955416|NCT00038558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64470744|NCT05048797|Pembrolizumab|pembrolizumab|mesh-list
64470745|NCT05048797|Trastuzumab|trastuzumab|mesh-list
64470746|NCT05048797|Pemetrexed|pemetrexed|mesh-list
64470747|NCT05048797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470748|NCT05048797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64956077|NCT00206557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64956078|NCT00068484|Bortezomib|bortezomib|mesh-list
64956079|NCT00068484|Topotecan|topotecan|mesh-list
64955417|NCT00038558|Tubulin Modulators|tubulin modulators|mesh-ancestor
64505665|NCT02492178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64505666|NCT02492178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64505667|NCT02492178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64505668|NCT02492178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505670|NCT02492178|Schistosomicides|schistosomicides|mesh-ancestor
64505671|NCT02492178|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64505672|NCT02492178|Anthelmintics|anthelmintics|mesh-ancestor
64470750|NCT05048797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731479|NCT00003061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64731480|NCT00003061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64731481|NCT00003061|Immunologic Factors|immunologic factors|mesh-ancestor
64731482|NCT00003061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64731483|NCT00003061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64731484|NCT00003061|Antiviral Agents|antiviral agents|mesh-ancestor
64731485|NCT00003061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64731486|NCT00003577|Cyclophosphamide|cyclophosphamide|mesh-list
64731487|NCT00003577|Fluorouracil|fluorouracil|mesh-list
64731488|NCT00003577|Methotrexate|methotrexate|mesh-list
64731489|NCT00003577|Epirubicin|epirubicin|mesh-list
64731490|NCT00003577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64731491|NCT00003577|Immunologic Factors|immunologic factors|mesh-ancestor
64731492|NCT00003577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418384|NCT01666951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418422|NCT05550415|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64731493|NCT00003577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64731494|NCT00003577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64731495|NCT00003577|Alkylating Agents|alkylating agents|mesh-ancestor
64731496|NCT00003577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731497|NCT00003577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731498|NCT00003577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64731499|NCT00003577|Antimetabolites|antimetabolites|mesh-ancestor
64731500|NCT00003577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64731501|NCT00003577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64731502|NCT00003577|Abortifacient Agents|abortifacient agents|mesh-ancestor
64598077|NCT00687713|Bupropion|bupropion|mesh-list
64505673|NCT02492178|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64505674|NCT02492178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505676|NCT02492178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64505677|NCT02492178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64505678|NCT02492178|Analgesics|analgesics|mesh-ancestor
64505679|NCT02492178|Sensory System Agents|sensory system agents|mesh-ancestor
64505680|NCT03679624|Daratumumab|daratumumab|mesh-list
64505681|NCT03679624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505682|NCT04494126|Tranexamic Acid|tranexamic acid|mesh-list
64505683|NCT04494126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64505684|NCT04494126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64505685|NCT04494126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505686|NCT04494126|Hemostatics|hemostatics|mesh-ancestor
64505687|NCT04494126|Coagulants|coagulants|mesh-ancestor
64505688|NCT01730872|Prednisolone|prednisolone|mesh-list
64505689|NCT01730872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64505690|NCT01730872|Methylprednisolone|methylprednisolone|mesh-list
64505691|NCT01730872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64956080|NCT00068484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731503|NCT00003577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64731504|NCT00003577|Dermatologic Agents|dermatologic agents|mesh-ancestor
64731505|NCT00003577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731506|NCT00003577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64731507|NCT00003577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64731508|NCT00003577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64622034|NCT01452698|Lansoprazole|lansoprazole|mesh-list
64505692|NCT01730872|Prednisolone acetate|prednisolone acetate|mesh-list
64505693|NCT01730872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64505694|NCT01730872|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64505695|NCT01730872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64505696|NCT01730872|Prednisolone phosphate|prednisolone phosphate|mesh-list
64505697|NCT01730872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64505698|NCT01730872|Glucocorticoids|glucocorticoids|mesh-ancestor
64505699|NCT01730872|Hormones|hormones|mesh-ancestor
64956081|NCT00068484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64731509|NCT00003577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64731510|NCT00003577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731511|NCT00002839|Fluorouracil|fluorouracil|mesh-list
64509201|NCT04126083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509202|NCT01935622|Doxycycline|doxycycline|mesh-list
64509203|NCT01935622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64509204|NCT01935622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64509205|NCT01935622|Antimalarials|antimalarials|mesh-ancestor
64509206|NCT01935622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64509207|NCT01935622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64509208|NCT03010917|Ethanol|ethanol|mesh-list
64956082|NCT00068484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64956083|NCT00068484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731512|NCT00002839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731513|NCT00002839|Antimetabolites|antimetabolites|mesh-ancestor
64731514|NCT00002839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731515|NCT00002839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64731516|NCT00002839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64731517|NCT00002839|Immunologic Factors|immunologic factors|mesh-ancestor
64505700|NCT01730872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64505701|NCT01730872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505702|NCT01730872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64505703|NCT01730872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505704|NCT01730872|Antiemetics|antiemetics|mesh-ancestor
64505706|NCT01730872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64505707|NCT01730872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64505708|NCT01730872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64505709|NCT01730872|Protective Agents|protective agents|mesh-ancestor
64505711|NCT02491086|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64505712|NCT02491086|Autonomic Agents|autonomic agents|mesh-ancestor
64505713|NCT02491086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64505714|NCT02491086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505715|NCT02491086|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64505716|NCT02491086|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64505717|NCT02491086|Cholinergic Agents|cholinergic agents|mesh-ancestor
64505718|NCT02491086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505727|NCT05469412|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64505728|NCT05469412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64505729|NCT05469412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64726557|NCT05751421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726558|NCT05751421|Sensory System Agents|sensory system agents|mesh-ancestor
64731518|NCT00002839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731519|NCT00003583|Etoposide|etoposide|mesh-list
64731520|NCT00003583|Amifostine|amifostine|mesh-list
64731521|NCT00003583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731522|NCT00003583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64731523|NCT00003583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64731524|NCT00003583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731525|NCT00003583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731526|NCT00003583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731527|NCT00003583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64731528|NCT00003583|Protective Agents|protective agents|mesh-ancestor
64731529|NCT00003583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731530|NCT00002845|Aldesleukin|aldesleukin|mesh-list
64731531|NCT00002845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731532|NCT00002845|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64731533|NCT00002845|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64731534|NCT00002845|Antiviral Agents|antiviral agents|mesh-ancestor
64731535|NCT00002845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64731536|NCT00003067|Aldesleukin|aldesleukin|mesh-list
64731537|NCT00003067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731538|NCT00003067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64731539|NCT00003067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64731540|NCT00003067|Antiviral Agents|antiviral agents|mesh-ancestor
64731542|NCT00003589|Gemcitabine|gemcitabine|mesh-list
64726559|NCT05751421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64505730|NCT05469412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505731|NCT05469412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64505732|NCT05469412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64505733|NCT05469412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64505734|NCT05469412|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64505735|NCT05469412|Anesthetics, General|anesthetics, general|mesh-ancestor
64505737|NCT05469412|GABA Modulators|gaba modulators|mesh-ancestor
64505738|NCT05469412|GABA Agents|gaba agents|mesh-ancestor
64505739|NCT05469412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505740|NCT05469412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505741|NCT03331692|Anesthetics|anesthetics|mesh-list
64505742|NCT03331692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64505743|NCT03331692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505744|NCT04826692|Metformin|metformin|mesh-list
64731546|NCT00003589|Tubulin Modulators|tubulin modulators|mesh-ancestor
64731547|NCT00003589|Antimitotic Agents|antimitotic agents|mesh-ancestor
64731548|NCT00003589|Mitosis Modulators|mitosis modulators|mesh-ancestor
64731549|NCT00003589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731550|NCT00003589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64731551|NCT00003589|Antimetabolites|antimetabolites|mesh-ancestor
64731552|NCT00003589|Antiviral Agents|antiviral agents|mesh-ancestor
64505745|NCT04826692|Biguanides|biguanides|mesh-list
64505746|NCT04826692|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64505747|NCT04826692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505749|NCT02490930|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64505750|NCT02490930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505751|NCT02490930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64505752|NCT02490930|Immunologic Factors|immunologic factors|mesh-ancestor
64505753|NCT02490930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505754|NCT04825990|Pembrolizumab|pembrolizumab|mesh-list
64505755|NCT04825990|Olaparib|olaparib|mesh-list
64505756|NCT04825990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64505757|NCT04825990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505758|NCT04825990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64505759|NCT04825990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505760|NCT04825990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956085|NCT00206596|Sargramostim|sargramostim|mesh-list
64731553|NCT00003589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64731554|NCT00003589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731555|NCT00003589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64731556|NCT00003589|Immunologic Factors|immunologic factors|mesh-ancestor
64731557|NCT00003589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731558|NCT00003595|Prednisone|prednisone|mesh-list
64731559|NCT00003595|Cyclophosphamide|cyclophosphamide|mesh-list
64731560|NCT00003595|Rituximab|rituximab|mesh-list
64731561|NCT00003595|Doxorubicin|doxorubicin|mesh-list
64731562|NCT00003595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64731563|NCT00003595|Vincristine|vincristine|mesh-list
64731564|NCT00003595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64415051|NCT04895137|Bevacizumab|bevacizumab|mesh-list
64505762|NCT03331302|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64505763|NCT03331302|Anesthetics, General|anesthetics, general|mesh-ancestor
64505764|NCT03331302|Anesthetics|anesthetics|mesh-ancestor
64505765|NCT03331302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64505766|NCT03331302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505767|NCT01738672|Nitrous Oxide|nitrous oxide|mesh-list
64505768|NCT01738672|Entonox|entonox|mesh-list
64505769|NCT01738672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64505770|NCT01738672|Anesthetics, General|anesthetics, general|mesh-ancestor
64731566|NCT00003595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731567|NCT00003595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64731568|NCT00003595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64731569|NCT00003595|Alkylating Agents|alkylating agents|mesh-ancestor
64731570|NCT00003595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731571|NCT00003595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731572|NCT00003595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64731573|NCT00003595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64731574|NCT00003595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64731575|NCT00003595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64731576|NCT00003595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731577|NCT00003595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731578|NCT00003595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64731579|NCT00003595|Glucocorticoids|glucocorticoids|mesh-ancestor
64731580|NCT00003595|Hormones|hormones|mesh-ancestor
64736776|NCT01645709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64505771|NCT01738672|Anesthetics|anesthetics|mesh-ancestor
64505772|NCT01738672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64505773|NCT01738672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505774|NCT01738672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64505775|NCT01738672|Analgesics|analgesics|mesh-ancestor
64505776|NCT01738672|Sensory System Agents|sensory system agents|mesh-ancestor
64505777|NCT01738672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64956086|NCT00206596|Immunologic Factors|immunologic factors|mesh-ancestor
64731581|NCT00003595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64731582|NCT00003595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64731583|NCT00003595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64731584|NCT00003595|Tubulin Modulators|tubulin modulators|mesh-ancestor
64731585|NCT00003595|Antimitotic Agents|antimitotic agents|mesh-ancestor
64731586|NCT00003595|Mitosis Modulators|mitosis modulators|mesh-ancestor
64731587|NCT00003073|Cytarabine|cytarabine|mesh-list
64731588|NCT00003073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64731589|NCT00003073|Antimetabolites|antimetabolites|mesh-ancestor
64731614|NCT00003601|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64731615|NCT00003601|Protective Agents|protective agents|mesh-ancestor
64731616|NCT00003601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731617|NCT00002869|Interferons|interferons|mesh-list
64731618|NCT00002869|Cytarabine|cytarabine|mesh-list
64731619|NCT00002869|Interferon-alpha|interferon-alpha|mesh-list
64731620|NCT00002869|Hydroxyurea|hydroxyurea|mesh-list
64731621|NCT00002869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731622|NCT00002869|Antiviral Agents|antiviral agents|mesh-ancestor
64505778|NCT01738672|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64505779|NCT02488512|Edotreotide|edotreotide|mesh-list
64505780|NCT02488512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64505781|NCT02488512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505782|NCT01808651|Fluoxetine|fluoxetine|mesh-list
64505783|NCT01808651|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64505784|NCT01808651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64505785|NCT01808651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64505788|NCT01808651|Serotonin Agents|serotonin agents|mesh-ancestor
64505789|NCT01808651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505790|NCT01808651|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64505791|NCT01808651|Antidepressive Agents|antidepressive agents|mesh-ancestor
64505792|NCT01808651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64505793|NCT01808651|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64505794|NCT01808651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64505795|NCT01808651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505796|NCT02488590|Bronchodilator Agents|bronchodilator agents|mesh-list
64956087|NCT00206596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494765|NCT02189122|Bradykinin|bradykinin|mesh-list
64956088|NCT00206635|Interferons|interferons|mesh-list
64956089|NCT00206635|Interferon-beta|interferon-beta|mesh-list
64731623|NCT00002869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64731624|NCT00002869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64731625|NCT00002869|Antimetabolites|antimetabolites|mesh-ancestor
64731626|NCT00002869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731627|NCT00002869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64731628|NCT00002869|Immunologic Factors|immunologic factors|mesh-ancestor
64731629|NCT00002869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731630|NCT00002869|Antisickling Agents|antisickling agents|mesh-ancestor
64731631|NCT00002869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731632|NCT00002869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64731633|NCT00002875|Cyclophosphamide|cyclophosphamide|mesh-list
64731634|NCT00002875|Lomustine|lomustine|mesh-list
64731635|NCT00002875|Cisplatin|cisplatin|mesh-list
64731636|NCT00002875|Vincristine|vincristine|mesh-list
64731637|NCT00002875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64731638|NCT00002875|Immunologic Factors|immunologic factors|mesh-ancestor
64731639|NCT00002875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505797|NCT02488590|Autonomic Agents|autonomic agents|mesh-ancestor
64505798|NCT02488590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64726560|NCT05751421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64726561|NCT05751421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64726562|NCT05751421|Analgesics|analgesics|mesh-ancestor
64726563|NCT05751421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64726564|NCT05751421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64731640|NCT00002875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64731641|NCT00002875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64731642|NCT00002875|Alkylating Agents|alkylating agents|mesh-ancestor
64731643|NCT00002875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731644|NCT00002875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731645|NCT00002875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64731646|NCT00002875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64731647|NCT00002875|Tubulin Modulators|tubulin modulators|mesh-ancestor
64731648|NCT00002875|Antimitotic Agents|antimitotic agents|mesh-ancestor
64731649|NCT00002875|Mitosis Modulators|mitosis modulators|mesh-ancestor
64731650|NCT00003613|Carmustine|carmustine|mesh-list
64731651|NCT00003613|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64731652|NCT00003613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64731653|NCT00003613|Alkylating Agents|alkylating agents|mesh-ancestor
64731654|NCT00003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731655|NCT00003613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731656|NCT00003613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731657|NCT00002881|Suramin|suramin|mesh-list
64731658|NCT00002881|Hydrocortisone|hydrocortisone|mesh-list
64731659|NCT00002881|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64731660|NCT00002881|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64731661|NCT00002881|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64731662|NCT00002881|Leuprolide|leuprolide|mesh-list
64731663|NCT00002881|Goserelin|goserelin|mesh-list
64731664|NCT00002881|Flutamide|flutamide|mesh-list
64726565|NCT05751421|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64334070|NCT02294305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64505799|NCT02488590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505800|NCT02488590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64505801|NCT02488590|Respiratory System Agents|respiratory system agents|mesh-ancestor
64505802|NCT05316376|Paclitaxel|paclitaxel|mesh-list
64505803|NCT05316376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64505804|NCT05316376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64955418|NCT00038558|Antimitotic Agents|antimitotic agents|mesh-ancestor
64505805|NCT05316376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505806|NCT05316376|Tubulin Modulators|tubulin modulators|mesh-ancestor
64505807|NCT05316376|Antimitotic Agents|antimitotic agents|mesh-ancestor
64505808|NCT05316376|Mitosis Modulators|mitosis modulators|mesh-ancestor
64505809|NCT05316376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505810|NCT01743976|Donepezil|donepezil|mesh-list
64956090|NCT00206635|Interferon beta-1b|interferon beta-1b|mesh-list
64731665|NCT00002881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64731666|NCT00002881|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64731667|NCT00002881|Fertility Agents|fertility agents|mesh-ancestor
64731668|NCT00002881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64731669|NCT00002881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731670|NCT00002881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64731671|NCT00002881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731672|NCT00002881|Androgen Antagonists|androgen antagonists|mesh-ancestor
64731673|NCT00002881|Hormone Antagonists|hormone antagonists|mesh-ancestor
64731674|NCT00002881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64731675|NCT00002881|Antinematodal Agents|antinematodal agents|mesh-ancestor
64731676|NCT00002881|Anthelmintics|anthelmintics|mesh-ancestor
64731677|NCT00002881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64731678|NCT00002881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64505811|NCT01743976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64505812|NCT01743976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505813|NCT01743976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505814|NCT01743976|Cholinergic Agents|cholinergic agents|mesh-ancestor
64505815|NCT01743976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505816|NCT01743976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505817|NCT01743976|Nootropic Agents|nootropic agents|mesh-ancestor
64505818|NCT05315830|Vaccines|vaccines|mesh-list
64505819|NCT05315830|Immunologic Factors|immunologic factors|mesh-ancestor
64505820|NCT05315830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505821|NCT05463822|Botulinum Toxins|botulinum toxins|mesh-list
64731679|NCT00002881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64731680|NCT00002881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64731681|NCT00003091|Interferons|interferons|mesh-list
64731682|NCT00003091|Interferon-alpha|interferon-alpha|mesh-list
64731683|NCT00003091|Aldesleukin|aldesleukin|mesh-list
64731684|NCT00003091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731685|NCT00003091|Antiviral Agents|antiviral agents|mesh-ancestor
64513656|NCT01457859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64470964|NCT04918823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64956091|NCT00206635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505822|NCT05463822|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64505823|NCT05463822|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64505824|NCT05463822|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64505825|NCT05463822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64505826|NCT05463822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505827|NCT05463822|Cholinergic Agents|cholinergic agents|mesh-ancestor
64505828|NCT05463822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505829|NCT05463822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505830|NCT05463822|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64470965|NCT04918823|Immunologic Factors|immunologic factors|mesh-ancestor
64470966|NCT04918823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470967|NCT04918823|Antifungal Agents|antifungal agents|mesh-ancestor
64470968|NCT04918823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64470969|NCT04918823|Dermatologic Agents|dermatologic agents|mesh-ancestor
64470970|NCT04918823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64470971|NCT04918823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64956092|NCT00206635|Antiviral Agents|antiviral agents|mesh-ancestor
64470972|NCT04918823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64505831|NCT05463822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64505832|NCT04639960|Risperidone|risperidone|mesh-list
64505833|NCT04639960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64505834|NCT04639960|Serotonin Agents|serotonin agents|mesh-ancestor
64505835|NCT04639960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505836|NCT04639960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505837|NCT04639960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505838|NCT04639960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64505839|NCT04639960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64505840|NCT04639960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64505841|NCT04639960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64505842|NCT04639960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64505843|NCT04639960|Dopamine Agents|dopamine agents|mesh-ancestor
64505844|NCT04579120|Corticosterone|corticosterone|mesh-list
64505845|NCT04579120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64505846|NCT03109314|Donepezil|donepezil|mesh-list
64505847|NCT03109314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64505848|NCT03109314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505849|NCT03109314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505850|NCT03109314|Cholinergic Agents|cholinergic agents|mesh-ancestor
64470974|NCT04912492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64470975|NCT04912492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64470976|NCT04912492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64470977|NCT04912492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956093|NCT00206635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64956094|NCT00206635|Immunologic Factors|immunologic factors|mesh-ancestor
64956095|NCT00206635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470978|NCT04909073|Afatinib|afatinib|mesh-list
64470979|NCT04909073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470980|NCT04909073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64505851|NCT03109314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505852|NCT03109314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505854|NCT04566016|Anesthetics|anesthetics|mesh-list
64505855|NCT04566016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64505856|NCT04566016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505874|NCT03322878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726566|NCT05751421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64956096|NCT00206635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64470981|NCT04909073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64470982|NCT04909073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64470983|NCT04887259|Interleukin-2|interleukin-2|mesh-list
64726568|NCT05751421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726569|NCT00002822|Cyclophosphamide|cyclophosphamide|mesh-list
64726570|NCT00002822|Ifosfamide|ifosfamide|mesh-list
64726571|NCT00002822|Carboplatin|carboplatin|mesh-list
64726572|NCT00002822|Doxorubicin|doxorubicin|mesh-list
64726573|NCT00002822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64726574|NCT00002822|Etoposide|etoposide|mesh-list
64726575|NCT00002822|Vincristine|vincristine|mesh-list
64726576|NCT00002822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64726577|NCT00002822|Immunologic Factors|immunologic factors|mesh-ancestor
64726578|NCT00002822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64470984|NCT04887259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64470985|NCT04887259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64470986|NCT04887259|Analgesics|analgesics|mesh-ancestor
64470987|NCT04887259|Sensory System Agents|sensory system agents|mesh-ancestor
64956097|NCT00206674|Sargramostim|sargramostim|mesh-list
64956098|NCT00206674|Immunologic Factors|immunologic factors|mesh-ancestor
64731687|NCT00003091|Immunologic Factors|immunologic factors|mesh-ancestor
64731688|NCT00003091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731689|NCT00003091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64726579|NCT00002822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64726580|NCT00002822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64726581|NCT00002822|Alkylating Agents|alkylating agents|mesh-ancestor
64726582|NCT00002822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726583|NCT00002822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726584|NCT00002822|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64726585|NCT00002822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64726586|NCT00002822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64726587|NCT00002822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64726588|NCT00002822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726589|NCT00002822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64726590|NCT00002822|Tubulin Modulators|tubulin modulators|mesh-ancestor
64726591|NCT00002822|Antimitotic Agents|antimitotic agents|mesh-ancestor
64726592|NCT00002822|Mitosis Modulators|mitosis modulators|mesh-ancestor
64726593|NCT00002281|Zidovudine|zidovudine|mesh-list
64726594|NCT00002281|Epoetin Alfa|epoetin alfa|mesh-list
64956099|NCT00206674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956100|NCT00206713|Sargramostim|sargramostim|mesh-list
64731690|NCT00003091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64731691|NCT00003619|Vitamin E|vitamin e|mesh-list
64731692|NCT00003619|Cytarabine|cytarabine|mesh-list
64731693|NCT00003619|Fludarabine|fludarabine|mesh-list
64731694|NCT00003619|Fludarabine phosphate|fludarabine phosphate|mesh-list
64731695|NCT00003619|Etoposide|etoposide|mesh-list
64731696|NCT00003619|Busulfan|busulfan|mesh-list
64731697|NCT00003619|Topotecan|topotecan|mesh-list
64726595|NCT00002281|Antimetabolites|antimetabolites|mesh-ancestor
64505875|NCT03322878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64505876|NCT03322878|Tocolytic Agents|tocolytic agents|mesh-ancestor
64505877|NCT03322878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64505878|NCT03322800|Ziresovir|ziresovir|mesh-list
64955419|NCT00038558|Mitosis Modulators|mitosis modulators|mesh-ancestor
64505879|NCT03322800|Antiviral Agents|antiviral agents|mesh-ancestor
64505880|NCT03322800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64505881|NCT03320460|Clobetasol|clobetasol|mesh-list
64505882|NCT03320460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64505883|NCT03320460|Glucocorticoids|glucocorticoids|mesh-ancestor
64505884|NCT03320460|Hormones|hormones|mesh-ancestor
64505885|NCT03320460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64731698|NCT00003619|Isotretinoin|isotretinoin|mesh-list
64731700|NCT00003619|Micronutrients|micronutrients|mesh-ancestor
64731701|NCT00003619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731702|NCT00003619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731703|NCT00003619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64731704|NCT00003619|Antimetabolites|antimetabolites|mesh-ancestor
64505886|NCT03320460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505887|NCT04471714|Baclofen|baclofen|mesh-list
64505888|NCT04471714|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64505889|NCT04471714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505890|NCT04471714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64726596|NCT00002281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726597|NCT00002281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64726598|NCT00002281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64726599|NCT00002281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726600|NCT00002281|Antiviral Agents|antiviral agents|mesh-ancestor
64726601|NCT00002281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726602|NCT00002281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64731705|NCT00003619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731706|NCT00003619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64731707|NCT00003619|Immunologic Factors|immunologic factors|mesh-ancestor
64731708|NCT00003619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64731709|NCT00003619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64731710|NCT00003619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731711|NCT00003619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731712|NCT00003619|Antiviral Agents|antiviral agents|mesh-ancestor
64731713|NCT00003619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64731714|NCT00003619|Alkylating Agents|alkylating agents|mesh-ancestor
64731715|NCT00003619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64731716|NCT00003619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64731717|NCT00003619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64731718|NCT00003619|Antioxidants|antioxidants|mesh-ancestor
64731719|NCT00003619|Protective Agents|protective agents|mesh-ancestor
64731720|NCT00003619|Dermatologic Agents|dermatologic agents|mesh-ancestor
64731721|NCT00002887|Etoposide|etoposide|mesh-list
64726603|NCT00002281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64726604|NCT00002281|Hematinics|hematinics|mesh-ancestor
64726605|NCT00002287|Zidovudine|zidovudine|mesh-list
64726606|NCT00002287|Antimetabolites|antimetabolites|mesh-ancestor
64726607|NCT00002287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726608|NCT00002287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64505891|NCT04471714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64505892|NCT04471714|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64505893|NCT04471714|GABA Agonists|gaba agonists|mesh-ancestor
64505894|NCT04471714|GABA Agents|gaba agents|mesh-ancestor
64505895|NCT04471714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64509209|NCT03010917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64731722|NCT00002887|Vinorelbine|vinorelbine|mesh-list
64731723|NCT00002887|Hydroxyurea|hydroxyurea|mesh-list
64731724|NCT00002887|Vinblastine|vinblastine|mesh-list
64731725|NCT00002887|Vindesine|vindesine|mesh-list
64731726|NCT00002887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731727|NCT00002887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64731728|NCT00002887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64505896|NCT04471714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505897|NCT05315206|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64505898|NCT05315206|Nootropic Agents|nootropic agents|mesh-ancestor
64505899|NCT03325686|Vitamin D|vitamin d|mesh-list
64505900|NCT03325686|Vitamins|vitamins|mesh-ancestor
64505901|NCT03325686|Micronutrients|micronutrients|mesh-ancestor
64505902|NCT03325686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505903|NCT03325686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64505904|NCT05315128|Methotrexate|methotrexate|mesh-list
64505905|NCT05315128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64505906|NCT05315128|Abortifacient Agents|abortifacient agents|mesh-ancestor
64505907|NCT05315128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64731830|NCT00003955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731831|NCT00003955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731832|NCT00003955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64731833|NCT00003955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64731834|NCT00003955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731835|NCT00003955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731836|NCT00003955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64731837|NCT00003955|Tubulin Modulators|tubulin modulators|mesh-ancestor
64731838|NCT00003955|Antimitotic Agents|antimitotic agents|mesh-ancestor
64731839|NCT00003955|Mitosis Modulators|mitosis modulators|mesh-ancestor
64731840|NCT00003955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64731841|NCT00003955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64731842|NCT00003955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64731843|NCT00003955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64731844|NCT00003955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64731873|NCT00003643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731874|NCT00003643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64731875|NCT00003961|Sargramostim|sargramostim|mesh-list
64731876|NCT00003961|Immunologic Factors|immunologic factors|mesh-ancestor
64731877|NCT00003961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731878|NCT00003661|Cyclosporine|cyclosporine|mesh-list
64731879|NCT00003661|Methylprednisolone|methylprednisolone|mesh-list
64731881|NCT00003661|Busulfan|busulfan|mesh-list
64731882|NCT00003661|Cyclosporins|cyclosporins|mesh-list
64731883|NCT00003661|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64505908|NCT05315128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505909|NCT05315128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64505910|NCT05315128|Antimetabolites|antimetabolites|mesh-ancestor
64505911|NCT05315128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505912|NCT05315128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505928|NCT03322488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64505929|NCT03322488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64505930|NCT03322488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320167|NCT02184091|Antiviral Agents|antiviral agents|mesh-ancestor
64320168|NCT02184091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64320169|NCT02184091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64320170|NCT02184091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64320171|NCT02184091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64320172|NCT02184091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64320173|NCT02184247|Theophylline|theophylline|mesh-list
64320174|NCT02184247|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64731887|NCT00003661|Immunologic Factors|immunologic factors|mesh-ancestor
64731888|NCT00003661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731889|NCT00003661|Antifungal Agents|antifungal agents|mesh-ancestor
64731890|NCT00003661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64731891|NCT00003661|Dermatologic Agents|dermatologic agents|mesh-ancestor
64731892|NCT00003661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64731893|NCT00003661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64731894|NCT00003661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64731895|NCT00003661|Antiemetics|antiemetics|mesh-ancestor
64731896|NCT00003661|Autonomic Agents|autonomic agents|mesh-ancestor
64731897|NCT00003661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421187|NCT01174199|Sirolimus|sirolimus|mesh-list
64505931|NCT03322488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505932|NCT03322488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505933|NCT03322488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64505934|NCT03322488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64505935|NCT01808573|Capecitabine|capecitabine|mesh-list
64505936|NCT01808573|Lapatinib|lapatinib|mesh-list
64505937|NCT01808573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64505938|NCT01808573|Antimetabolites|antimetabolites|mesh-ancestor
64505939|NCT01808573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505940|NCT01808573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505941|NCT01808573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64505942|NCT01808573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505943|NCT01746940|Cocaine|cocaine|mesh-list
64505944|NCT01746940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64505945|NCT01746940|Anesthetics, Local|anesthetics, local|mesh-ancestor
64320175|NCT02184247|Autonomic Agents|autonomic agents|mesh-ancestor
64320176|NCT02184247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64320177|NCT02184247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731901|NCT00003661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64731902|NCT00003661|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64731903|NCT00003661|Protective Agents|protective agents|mesh-ancestor
64731904|NCT00003661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731905|NCT00003661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64731906|NCT00003661|Alkylating Agents|alkylating agents|mesh-ancestor
64731907|NCT00003661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64731908|NCT00003967|Etoposide|etoposide|mesh-list
64731909|NCT00003967|Topotecan|topotecan|mesh-list
64731910|NCT00003967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64731911|NCT00003967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731912|NCT00003967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64731913|NCT00003967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731914|NCT00003967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731915|NCT00003967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731916|NCT00003967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64731917|NCT00003115|Hydromorphone|hydromorphone|mesh-list
64731918|NCT00003115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64731919|NCT00003115|Narcotics|narcotics|mesh-ancestor
64731920|NCT00003115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64471292|NCT04615013|Paclitaxel|paclitaxel|mesh-list
64471293|NCT04615013|Docetaxel|docetaxel|mesh-list
64471294|NCT04615013|Carboplatin|carboplatin|mesh-list
64471295|NCT04615013|Fluorouracil|fluorouracil|mesh-list
64471296|NCT04615013|Capecitabine|capecitabine|mesh-list
64471297|NCT04615013|Oxaliplatin|oxaliplatin|mesh-list
64505946|NCT01746940|Anesthetics|anesthetics|mesh-ancestor
64505947|NCT01746940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64505948|NCT01746940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505949|NCT01746940|Sensory System Agents|sensory system agents|mesh-ancestor
64505950|NCT01746940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64955420|NCT00038597|Lonafarnib|lonafarnib|mesh-list
64505951|NCT01746940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64726609|NCT00002287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64505952|NCT01746940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64471298|NCT04615013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64471299|NCT04615013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64471300|NCT04615013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421286|NCT04038437|Venetoclax|venetoclax|mesh-list
64320179|NCT02184247|Respiratory System Agents|respiratory system agents|mesh-ancestor
64320180|NCT02184247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64320181|NCT02184247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320182|NCT02184247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471301|NCT04615013|Tubulin Modulators|tubulin modulators|mesh-ancestor
64471302|NCT04615013|Antimitotic Agents|antimitotic agents|mesh-ancestor
64471303|NCT04615013|Mitosis Modulators|mitosis modulators|mesh-ancestor
64505953|NCT01746940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64505954|NCT01746940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64505955|NCT01746940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505956|NCT01746940|Dopamine Agents|dopamine agents|mesh-ancestor
64505957|NCT01746940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505959|NCT01747330|Pancrelipase|pancrelipase|mesh-list
64505960|NCT01747330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64505961|NCT02990962|Triamcinolone|triamcinolone|mesh-list
64505962|NCT02990962|Lidocaine|lidocaine|mesh-list
64505963|NCT02990962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64505964|NCT02990962|Glucocorticoids|glucocorticoids|mesh-ancestor
64505965|NCT02990962|Hormones|hormones|mesh-ancestor
64505966|NCT02990962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64505967|NCT02990962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320183|NCT02184247|Vasodilator Agents|vasodilator agents|mesh-ancestor
64320184|NCT02184247|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64320185|NCT02184247|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64320186|NCT02184247|Purinergic Agents|purinergic agents|mesh-ancestor
64471304|NCT04615013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471305|NCT04615013|Antimetabolites|antimetabolites|mesh-ancestor
64471306|NCT04615013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64471307|NCT04615013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64471308|NCT04615013|Immunologic Factors|immunologic factors|mesh-ancestor
64471309|NCT04615013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731956|NCT00003679|Cyclophosphamide|cyclophosphamide|mesh-list
64731957|NCT00003679|Docetaxel|docetaxel|mesh-list
64505968|NCT02990962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505969|NCT02990962|Anesthetics, Local|anesthetics, local|mesh-ancestor
64505970|NCT02990962|Anesthetics|anesthetics|mesh-ancestor
64505971|NCT02990962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64505972|NCT02990962|Sensory System Agents|sensory system agents|mesh-ancestor
64505975|NCT02990962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64505976|NCT02990962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64505977|NCT02990962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64505978|NCT03322098|Atropine|atropine|mesh-list
64505979|NCT03322098|Glycopyrrolate|glycopyrrolate|mesh-list
64505980|NCT03322098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64731958|NCT00003679|Doxorubicin|doxorubicin|mesh-list
64731959|NCT00003679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64731960|NCT00003679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64731961|NCT00003679|Immunologic Factors|immunologic factors|mesh-ancestor
64731962|NCT00003679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731963|NCT00003679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64731964|NCT00003679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64731965|NCT00003679|Alkylating Agents|alkylating agents|mesh-ancestor
64731966|NCT00003679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731967|NCT00003679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731968|NCT00003679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64731969|NCT00003679|Tubulin Modulators|tubulin modulators|mesh-ancestor
64731970|NCT00003679|Antimitotic Agents|antimitotic agents|mesh-ancestor
64731971|NCT00003679|Mitosis Modulators|mitosis modulators|mesh-ancestor
64731972|NCT00003679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64731973|NCT00003679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64731974|NCT00003679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731975|NCT00003679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731976|NCT00003679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64731977|NCT00003679|Hormone Antagonists|hormone antagonists|mesh-ancestor
64731978|NCT00003679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64731979|NCT00003679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64731980|NCT00003679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64731981|NCT00003679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64731982|NCT00003679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64731983|NCT00003985|KRN 7000|krn 7000|mesh-list
64731984|NCT00003985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64731985|NCT00003985|Immunologic Factors|immunologic factors|mesh-ancestor
64505981|NCT03322098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64505982|NCT03322098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64505983|NCT03322098|Autonomic Agents|autonomic agents|mesh-ancestor
64505984|NCT03322098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64505985|NCT03322098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505986|NCT03322098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64505987|NCT03322098|Respiratory System Agents|respiratory system agents|mesh-ancestor
64505988|NCT03322098|Mydriatics|mydriatics|mesh-ancestor
64505989|NCT03322098|Parasympatholytics|parasympatholytics|mesh-ancestor
64505990|NCT03322098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64505991|NCT03322098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64505992|NCT03322098|Cholinergic Agents|cholinergic agents|mesh-ancestor
64505993|NCT03322098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505994|NCT03322098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505995|NCT03319680|Dialysis Solutions|dialysis solutions|mesh-list
64505996|NCT03319680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64731989|NCT00384553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64731990|NCT00384553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731991|NCT00384553|Immunologic Factors|immunologic factors|mesh-ancestor
64731992|NCT00384553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731993|NCT00384553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64731994|NCT00003991|Aldesleukin|aldesleukin|mesh-list
64731995|NCT00003991|Histamine|histamine|mesh-list
64731996|NCT00003991|Histamine phosphate|histamine phosphate|mesh-list
64731997|NCT00003991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731998|NCT00003991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64731999|NCT00003991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64320189|NCT04292756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64320190|NCT04292756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64320191|NCT04292756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64320192|NCT04292756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64320193|NCT04292756|Glucocorticoids|glucocorticoids|mesh-ancestor
64320194|NCT04292756|Hormones|hormones|mesh-ancestor
64320195|NCT04292756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64505997|NCT01808339|Fluticasone|fluticasone|mesh-list
64505998|NCT01808339|Xhance|xhance|mesh-list
64505999|NCT01808339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64506000|NCT01808339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64506001|NCT01808339|Autonomic Agents|autonomic agents|mesh-ancestor
64506004|NCT01808339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64506005|NCT01808339|Respiratory System Agents|respiratory system agents|mesh-ancestor
64506007|NCT01808339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64506008|NCT01749904|Timolol|timolol|mesh-list
64506009|NCT01749904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64506010|NCT01749904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64506011|NCT01749904|Adrenergic Agents|adrenergic agents|mesh-ancestor
64506012|NCT01749904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64732001|NCT00003991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64732002|NCT00003991|Histamine Agonists|histamine agonists|mesh-ancestor
64732003|NCT00003991|Histamine Agents|histamine agents|mesh-ancestor
64732004|NCT00003991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64732005|NCT00003991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732006|NCT00003991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732007|NCT00003997|Irofulven|irofulven|mesh-list
64732008|NCT00003997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64732009|NCT00003997|Alkylating Agents|alkylating agents|mesh-ancestor
64732010|NCT00003997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732011|NCT00003997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732012|NCT00384631|Bevacizumab|bevacizumab|mesh-list
64732013|NCT00384631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64732014|NCT00384631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732015|NCT00384631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64732016|NCT00384631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64320196|NCT04292756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320197|NCT04292756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64320198|NCT04292756|Immunologic Factors|immunologic factors|mesh-ancestor
64320199|NCT04292756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509210|NCT03010917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64509211|NCT03010917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64509212|NCT03010917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509213|NCT02979561|Warfarin|warfarin|mesh-list
64509214|NCT02979561|Dabigatran|dabigatran|mesh-list
64509215|NCT02979561|Anticoagulants|anticoagulants|mesh-ancestor
64509216|NCT02979561|Antithrombins|antithrombins|mesh-ancestor
64509217|NCT02979561|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64509218|NCT02979561|Protease Inhibitors|protease inhibitors|mesh-ancestor
64509219|NCT02979561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732017|NCT00384631|Growth Substances|growth substances|mesh-ancestor
64732018|NCT00384631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732019|NCT00384631|Growth Inhibitors|growth inhibitors|mesh-ancestor
64732020|NCT00003127|Paclitaxel|paclitaxel|mesh-list
64320200|NCT04292756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320202|NCT04593758|Antimalarials|antimalarials|mesh-ancestor
64320203|NCT04593758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64320204|NCT04593758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64320205|NCT04593758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64732021|NCT00003127|Carboplatin|carboplatin|mesh-list
64732022|NCT00003127|Amifostine|amifostine|mesh-list
64506013|NCT01749904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506014|NCT01749904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506015|NCT01749904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64506016|NCT01749904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64506017|NCT02484768|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
64506018|NCT02484768|Hematinics|hematinics|mesh-ancestor
64506019|NCT03316326|Oxaliplatin|oxaliplatin|mesh-list
64506020|NCT03316326|Irinotecan|irinotecan|mesh-list
64506021|NCT03316326|Tegafur|tegafur|mesh-list
64506022|NCT03316326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506023|NCT03316326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64506024|NCT03316326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64732023|NCT00003127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64732024|NCT00003127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732025|NCT00003127|Tubulin Modulators|tubulin modulators|mesh-ancestor
64732026|NCT00003127|Antimitotic Agents|antimitotic agents|mesh-ancestor
64732027|NCT00003127|Mitosis Modulators|mitosis modulators|mesh-ancestor
64732028|NCT00003127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732029|NCT00003127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64732030|NCT00003127|Protective Agents|protective agents|mesh-ancestor
64732031|NCT00003127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732032|NCT00004003|Gemcitabine|gemcitabine|mesh-list
64732033|NCT00004003|Fluorouracil|fluorouracil|mesh-list
64320206|NCT04593758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732034|NCT00004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732035|NCT00004003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64732036|NCT00004003|Antimetabolites|antimetabolites|mesh-ancestor
64506025|NCT03316326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506026|NCT03316326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726611|NCT00002287|Antiviral Agents|antiviral agents|mesh-ancestor
64726612|NCT00002287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726613|NCT00002287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64726614|NCT00002287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64726615|NCT00002828|Fluorouracil|fluorouracil|mesh-list
64726616|NCT00002828|Raltitrexed|raltitrexed|mesh-list
64726617|NCT00002828|Antimetabolites|antimetabolites|mesh-ancestor
64726618|NCT00002828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726619|NCT00002828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64726620|NCT00002828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726621|NCT00002828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64726622|NCT00002828|Immunologic Factors|immunologic factors|mesh-ancestor
64726623|NCT00002828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726624|NCT00002828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64726625|NCT00002828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726626|NCT00003410|Motexafin gadolinium|motexafin gadolinium|mesh-list
64726627|NCT00003410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732037|NCT00004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732038|NCT00004003|Antiviral Agents|antiviral agents|mesh-ancestor
64732039|NCT00004003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64732040|NCT00004003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732041|NCT00004003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732042|NCT00004003|Immunologic Factors|immunologic factors|mesh-ancestor
64732043|NCT00004003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732044|NCT00004009|Tipifarnib|tipifarnib|mesh-list
64732045|NCT00004009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320207|NCT04593758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732046|NCT00003133|Gemcitabine|gemcitabine|mesh-list
64732047|NCT00003133|Paclitaxel|paclitaxel|mesh-list
64732048|NCT00003133|Doxorubicin|doxorubicin|mesh-list
64732049|NCT00003133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64732050|NCT00003133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64732051|NCT00003133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732052|NCT00003133|Tubulin Modulators|tubulin modulators|mesh-ancestor
64732053|NCT00003133|Antimitotic Agents|antimitotic agents|mesh-ancestor
64732054|NCT00003133|Mitosis Modulators|mitosis modulators|mesh-ancestor
64732055|NCT00003133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732056|NCT00003133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64732057|NCT00003133|Antimetabolites|antimetabolites|mesh-ancestor
64726628|NCT00003410|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64726629|NCT00003410|Dermatologic Agents|dermatologic agents|mesh-ancestor
64726630|NCT05751265|Paclitaxel|paclitaxel|mesh-list
64334116|NCT02356965|Anesthetics|anesthetics|mesh-ancestor
64506027|NCT03316326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64955421|NCT00038597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506028|NCT03316326|Antimetabolites|antimetabolites|mesh-ancestor
64506029|NCT02487732|Ticagrelor|ticagrelor|mesh-list
64506030|NCT02487732|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64506031|NCT02487732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64732058|NCT00003133|Antiviral Agents|antiviral agents|mesh-ancestor
64320210|NCT05074706|Immunoglobulin G|immunoglobulin g|mesh-list
64320211|NCT05074706|Immunologic Factors|immunologic factors|mesh-ancestor
64320212|NCT05074706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320213|NCT02181205|Bupivacaine|bupivacaine|mesh-list
64320214|NCT02181205|Anesthetics, Local|anesthetics, local|mesh-ancestor
64320215|NCT02181205|Anesthetics|anesthetics|mesh-ancestor
64320216|NCT02181205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64732059|NCT00003133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64732060|NCT00003133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732061|NCT00003133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732062|NCT00003133|Immunologic Factors|immunologic factors|mesh-ancestor
64732063|NCT00003133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732064|NCT00003133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64732065|NCT00003133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64732066|NCT00003133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64732067|NCT00003691|Paclitaxel|paclitaxel|mesh-list
64732068|NCT00003691|Doxorubicin|doxorubicin|mesh-list
64732069|NCT00003691|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64732070|NCT00003691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64732071|NCT00003691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732072|NCT00003691|Tubulin Modulators|tubulin modulators|mesh-ancestor
64732073|NCT00003691|Antimitotic Agents|antimitotic agents|mesh-ancestor
64732074|NCT00003691|Mitosis Modulators|mitosis modulators|mesh-ancestor
64732075|NCT00003691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732076|NCT00003691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64732077|NCT00003691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64732078|NCT00003691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64732079|NCT00003691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732080|NCT00003139|Pilocarpine|pilocarpine|mesh-list
64732081|NCT00003139|Miotics|miotics|mesh-ancestor
64506032|NCT02487732|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64506033|NCT02487732|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64506034|NCT02487732|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64506035|NCT02487732|Purinergic Agents|purinergic agents|mesh-ancestor
64506036|NCT02487732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64506037|NCT02487732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506038|NCT02487732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506039|NCT03833362|Interferons|interferons|mesh-list
64506042|NCT03833362|Interferon-alpha|interferon-alpha|mesh-list
64506043|NCT03833362|Interferon alpha-2|interferon alpha-2|mesh-list
64732082|NCT00003139|Autonomic Agents|autonomic agents|mesh-ancestor
64320217|NCT02181205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320218|NCT02181205|Sensory System Agents|sensory system agents|mesh-ancestor
64320219|NCT02181205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64320220|NCT02184559|Ropivacaine|ropivacaine|mesh-list
64732083|NCT00003139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64732084|NCT00003139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732085|NCT00003139|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64732086|NCT00003139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64732087|NCT00003139|Cholinergic Agents|cholinergic agents|mesh-ancestor
64732088|NCT00003139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64732089|NCT00003139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732090|NCT00003697|Vadimezan|vadimezan|mesh-list
64732091|NCT00003697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732092|NCT02972983|Daptomycin|daptomycin|mesh-list
64732093|NCT02972983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64732094|NCT02972983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64732095|NCT00003709|Carbendazim|carbendazim|mesh-list
64732096|NCT00003709|Antinematodal Agents|antinematodal agents|mesh-ancestor
64732097|NCT00003709|Anthelmintics|anthelmintics|mesh-ancestor
64732098|NCT00003709|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64732099|NCT00003709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64732100|NCT00003145|Cyclosporine|cyclosporine|mesh-list
64732101|NCT00003145|Mycophenolic Acid|mycophenolic acid|mesh-list
64732102|NCT00003145|Fludarabine|fludarabine|mesh-list
64732103|NCT00003145|Fludarabine phosphate|fludarabine phosphate|mesh-list
64732104|NCT00003145|Cyclosporins|cyclosporins|mesh-list
64732105|NCT00003145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732106|NCT00003145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64506044|NCT03833362|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64506045|NCT03833362|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64506046|NCT03833362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506052|NCT03833362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506053|NCT03833362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506054|NCT03833362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64506055|NCT03833362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64506056|NCT03833362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64506057|NCT03833362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64506058|NCT03833362|Antimetabolites|antimetabolites|mesh-ancestor
64506059|NCT03833362|Immunologic Factors|immunologic factors|mesh-ancestor
64506060|NCT03833362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506061|NCT05463588|Methamphetamine|methamphetamine|mesh-list
64506062|NCT05463588|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64506063|NCT05463588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732107|NCT00003145|Antimetabolites|antimetabolites|mesh-ancestor
64732108|NCT00003145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64471503|NCT04463394|Hemostatics|hemostatics|mesh-ancestor
64732109|NCT00003145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732110|NCT00003145|Immunologic Factors|immunologic factors|mesh-ancestor
64732111|NCT00003145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732112|NCT00003145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732113|NCT00003145|Antifungal Agents|antifungal agents|mesh-ancestor
64732114|NCT00003145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64732115|NCT00003145|Dermatologic Agents|dermatologic agents|mesh-ancestor
64732116|NCT00003145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64732117|NCT00003145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64732118|NCT00003145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64732119|NCT00003145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64732120|NCT00003145|Antitubercular Agents|antitubercular agents|mesh-ancestor
64732121|NCT00003145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64732122|NCT00004039|Interferons|interferons|mesh-list
64732123|NCT00004039|Interferon-alpha|interferon-alpha|mesh-list
64732124|NCT00004039|Prednisone|prednisone|mesh-list
64732125|NCT00004039|Cyclophosphamide|cyclophosphamide|mesh-list
64732126|NCT00004039|Rituximab|rituximab|mesh-list
64732127|NCT00004039|Doxorubicin|doxorubicin|mesh-list
64506064|NCT05463588|Sympathomimetics|sympathomimetics|mesh-ancestor
64726631|NCT05751265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64726632|NCT05751265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726633|NCT05751265|Tubulin Modulators|tubulin modulators|mesh-ancestor
64726634|NCT05751265|Antimitotic Agents|antimitotic agents|mesh-ancestor
64726635|NCT05751265|Mitosis Modulators|mitosis modulators|mesh-ancestor
64726636|NCT05751265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726638|NCT00384020|Paroxetine|paroxetine|mesh-list
64726639|NCT00384020|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64320224|NCT02184559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320225|NCT02184559|Sensory System Agents|sensory system agents|mesh-ancestor
64732142|NCT00004039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64732143|NCT00004039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732144|NCT00004039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64732145|NCT00004039|Glucocorticoids|glucocorticoids|mesh-ancestor
64732146|NCT00004039|Hormones|hormones|mesh-ancestor
64732147|NCT00004039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64422256|NCT02301975|Xhance|xhance|mesh-list
64320227|NCT02185651|Miglustat|miglustat|mesh-list
64320228|NCT02185651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320229|NCT02185651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320230|NCT02185651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64320231|NCT02185651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64320232|NCT02185651|Antiviral Agents|antiviral agents|mesh-ancestor
64726640|NCT00384020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64506065|NCT05463588|Autonomic Agents|autonomic agents|mesh-ancestor
64506066|NCT05463588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64506067|NCT05463588|Dopamine Agents|dopamine agents|mesh-ancestor
64506068|NCT05463588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64506069|NCT05463588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506070|NCT05463588|Adrenergic Agents|adrenergic agents|mesh-ancestor
64506071|NCT05463588|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64506072|NCT05463588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64320233|NCT02185651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64320234|NCT02185651|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64320235|NCT02185651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64320236|NCT02185651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320237|NCT02181361|Aspirin|aspirin|mesh-list
64320238|NCT02181361|Hirudins|hirudins|mesh-list
64320239|NCT02181361|Warfarin|warfarin|mesh-list
64320240|NCT02181361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64320242|NCT02181361|Analgesics|analgesics|mesh-ancestor
64320243|NCT02181361|Sensory System Agents|sensory system agents|mesh-ancestor
64320244|NCT02181361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64320245|NCT02181361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320246|NCT02181361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64320247|NCT02181361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64320248|NCT02181361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64320249|NCT02181361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64320250|NCT02181361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320251|NCT02181361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64732148|NCT00004039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64732149|NCT00004039|Antiviral Agents|antiviral agents|mesh-ancestor
64732150|NCT00004039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64732151|NCT00004039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64732152|NCT00004039|Tubulin Modulators|tubulin modulators|mesh-ancestor
64732153|NCT00004039|Antimitotic Agents|antimitotic agents|mesh-ancestor
64320252|NCT02181361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64320253|NCT02181361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320254|NCT02181361|Antipyretics|antipyretics|mesh-ancestor
64320255|NCT02181361|Anticoagulants|anticoagulants|mesh-ancestor
64506073|NCT05463588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64506074|NCT05463588|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64506076|NCT02490774|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64506077|NCT02490774|Contraceptive Agents|contraceptive agents|mesh-ancestor
64506078|NCT02490774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64506079|NCT02490774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506080|NCT02490774|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64732154|NCT00004039|Mitosis Modulators|mitosis modulators|mesh-ancestor
64732155|NCT00003151|Amoxicillin|amoxicillin|mesh-list
64732156|NCT00003151|Metronidazole|metronidazole|mesh-list
64732157|NCT00003151|Clarithromycin|clarithromycin|mesh-list
64732158|NCT00003151|Tetracycline|tetracycline|mesh-list
64732159|NCT00003151|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
64732160|NCT00003151|Omeprazole|omeprazole|mesh-list
64732161|NCT00003151|Bismuth|bismuth|mesh-list
64732162|NCT00003151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64732163|NCT00003151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64732164|NCT00003151|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64732165|NCT00003151|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64732166|NCT00003151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64732167|NCT00003151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64732168|NCT00003151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64732169|NCT00003151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732170|NCT00003151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732171|NCT00003151|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64732172|NCT00003151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64732173|NCT00003151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64732174|NCT00003151|Antacids|antacids|mesh-ancestor
64732175|NCT00004045|Exatecan|exatecan|mesh-list
64732176|NCT00004045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64732177|NCT00004045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64732178|NCT00004045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732179|NCT00004045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732180|NCT00004045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732181|NCT00003715|Interferons|interferons|mesh-list
64732182|NCT00003715|Interferon-alpha|interferon-alpha|mesh-list
64732183|NCT00003715|Cyclophosphamide|cyclophosphamide|mesh-list
64732184|NCT00003715|Vaccines|vaccines|mesh-list
64732185|NCT00003715|BCG Vaccine|bcg vaccine|mesh-list
64506081|NCT02490774|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64506082|NCT02490774|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64506083|NCT02490540|Sufentanil|sufentanil|mesh-list
64506084|NCT02490540|Dsuvia|dsuvia|mesh-list
64421416|NCT05466175|Prednisone|prednisone|mesh-list
64506086|NCT02490540|Narcotics|narcotics|mesh-ancestor
64506087|NCT02490540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64506088|NCT02490540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506089|NCT02490540|Analgesics|analgesics|mesh-ancestor
64506090|NCT02490540|Sensory System Agents|sensory system agents|mesh-ancestor
64320256|NCT02181361|Antithrombins|antithrombins|mesh-ancestor
64320257|NCT02181361|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64320258|NCT02181361|Protease Inhibitors|protease inhibitors|mesh-ancestor
64320259|NCT05060276|Immunoconjugates|immunoconjugates|mesh-list
64320260|NCT05060276|Immunologic Factors|immunologic factors|mesh-ancestor
64320261|NCT05060276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320262|NCT02184637|Lumefantrine|lumefantrine|mesh-list
64320263|NCT02184637|Artemether|artemether|mesh-list
64320264|NCT02184637|Piperaquine|piperaquine|mesh-list
64320265|NCT02184637|Artenimol|artenimol|mesh-list
64732186|NCT00003715|Immunologic Factors|immunologic factors|mesh-ancestor
64732187|NCT00003715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732188|NCT00003715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732189|NCT00003715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64732190|NCT00003715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64732191|NCT00003715|Alkylating Agents|alkylating agents|mesh-ancestor
64732192|NCT00003715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732193|NCT00003715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732194|NCT00003715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64732195|NCT00003715|Antiviral Agents|antiviral agents|mesh-ancestor
64732196|NCT00003715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64732197|NCT00003715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64732198|NCT00004051|Irinotecan|irinotecan|mesh-list
64732199|NCT00004051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64506091|NCT02490540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64506092|NCT02490540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64506093|NCT02490540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64506094|NCT02490540|Anesthetics, General|anesthetics, general|mesh-ancestor
64506095|NCT02490540|Anesthetics|anesthetics|mesh-ancestor
64506096|NCT02484300|Melatonin|melatonin|mesh-list
64506097|NCT02484300|Antioxidants|antioxidants|mesh-ancestor
64506098|NCT02484300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955422|NCT00038597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955423|NCT00202618|Amlodipine|amlodipine|mesh-list
64955424|NCT00202618|Valsartan|valsartan|mesh-list
64955425|NCT00202618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64955426|NCT00202618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64955427|NCT00202618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64506099|NCT02484300|Protective Agents|protective agents|mesh-ancestor
64506100|NCT02484300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506101|NCT02484300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64506102|NCT02727660|Budesonide|budesonide|mesh-list
64732222|NCT00003727|Antimetabolites|antimetabolites|mesh-ancestor
64732223|NCT00003727|Antiviral Agents|antiviral agents|mesh-ancestor
64732224|NCT00003727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64732225|NCT00003727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732226|NCT00003727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64732227|NCT00003727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64732228|NCT00003727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64732229|NCT00003157|Gemcitabine|gemcitabine|mesh-list
64732230|NCT00003157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732231|NCT00003157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64732232|NCT00003157|Antimetabolites|antimetabolites|mesh-ancestor
64732233|NCT00003157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732234|NCT00003157|Antiviral Agents|antiviral agents|mesh-ancestor
64732235|NCT00003157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64732236|NCT00003157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320266|NCT02184637|Tafenoquine|tafenoquine|mesh-list
64320267|NCT02184637|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64320268|NCT02184637|Antimalarials|antimalarials|mesh-ancestor
64320269|NCT02184637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64320270|NCT02184637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64320271|NCT02184637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64320272|NCT04870424|Colchicine|colchicine|mesh-list
64320273|NCT04870424|Gout Suppressants|gout suppressants|mesh-ancestor
64320274|NCT04870424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64320275|NCT04870424|Tubulin Modulators|tubulin modulators|mesh-ancestor
64320276|NCT04870424|Antimitotic Agents|antimitotic agents|mesh-ancestor
64732237|NCT00003157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732238|NCT00003157|Immunologic Factors|immunologic factors|mesh-ancestor
64732239|NCT00003157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732240|NCT00004057|Paclitaxel|paclitaxel|mesh-list
64732241|NCT00004057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64732242|NCT00004057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732243|NCT00004057|Tubulin Modulators|tubulin modulators|mesh-ancestor
64732244|NCT00004057|Antimitotic Agents|antimitotic agents|mesh-ancestor
64732245|NCT00004057|Mitosis Modulators|mitosis modulators|mesh-ancestor
64732246|NCT00004057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732247|NCT00004063|Gemcitabine|gemcitabine|mesh-list
64732248|NCT00004063|Interferons|interferons|mesh-list
64732249|NCT00004063|Interferon-alpha|interferon-alpha|mesh-list
64506103|NCT02727660|Formoterol Fumarate|formoterol fumarate|mesh-list
64506104|NCT02727660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64506105|NCT02727660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64506106|NCT02727660|Autonomic Agents|autonomic agents|mesh-ancestor
64506107|NCT02727660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64506108|NCT02727660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506109|NCT02727660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64506110|NCT02727660|Respiratory System Agents|respiratory system agents|mesh-ancestor
64506120|NCT02490072|Dexmedetomidine|dexmedetomidine|mesh-list
64506121|NCT02490072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64506122|NCT02490072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64726642|NCT00384020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726643|NCT00384020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64726644|NCT00384020|Serotonin Agents|serotonin agents|mesh-ancestor
64726645|NCT00384020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732257|NCT00004063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732258|NCT00004063|Immunologic Factors|immunologic factors|mesh-ancestor
64732259|NCT00004063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732260|NCT00003733|Paclitaxel|paclitaxel|mesh-list
64732261|NCT00003733|Carboplatin|carboplatin|mesh-list
64732262|NCT00003733|Topotecan|topotecan|mesh-list
64732263|NCT00003733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64732264|NCT00003733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732265|NCT00003733|Tubulin Modulators|tubulin modulators|mesh-ancestor
64732266|NCT00003733|Antimitotic Agents|antimitotic agents|mesh-ancestor
64506123|NCT02490072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506124|NCT02490072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64506125|NCT02490072|Analgesics|analgesics|mesh-ancestor
64506126|NCT02490072|Sensory System Agents|sensory system agents|mesh-ancestor
64506127|NCT02490072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64506128|NCT02490072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64506129|NCT02490072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64506130|NCT02490072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64732308|NCT00004087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64320286|NCT03536845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64320287|NCT02256709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64320288|NCT02181985|Heparin|heparin|mesh-list
64320289|NCT02181985|Enoxaparin|enoxaparin|mesh-list
64320290|NCT02181985|Tenecteplase|tenecteplase|mesh-list
64320291|NCT02181985|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64320292|NCT02181985|Abciximab|abciximab|mesh-list
64320293|NCT02181985|Anticoagulants|anticoagulants|mesh-ancestor
64320294|NCT02181985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64320295|NCT02181985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64732313|NCT00004087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732314|NCT00004087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732316|NCT00003757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64732317|NCT00003757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732318|NCT00003757|Immunologic Factors|immunologic factors|mesh-ancestor
64732319|NCT00003757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732320|NCT00003757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64732321|NCT00003175|Fluorouracil|fluorouracil|mesh-list
64732322|NCT00003175|Antimetabolites|antimetabolites|mesh-ancestor
64320296|NCT02181985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320297|NCT02181985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64320298|NCT05514080|Insulin|insulin|mesh-list
64320299|NCT05514080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64506131|NCT02490072|Adrenergic Agents|adrenergic agents|mesh-ancestor
64506132|NCT02490072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64421430|NCT02546323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64506134|NCT02483598|Buspirone|buspirone|mesh-list
64506135|NCT02483598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64506136|NCT02483598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64506137|NCT02483598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64506138|NCT02483598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506139|NCT02483598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64506140|NCT02483598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64506141|NCT02483598|Serotonin Agents|serotonin agents|mesh-ancestor
64506142|NCT02483598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64732326|NCT00003175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732327|NCT00003175|Immunologic Factors|immunologic factors|mesh-ancestor
64732328|NCT00003175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732329|NCT00004099|Leucovorin|leucovorin|mesh-list
64732330|NCT00004099|Fluorouracil|fluorouracil|mesh-list
64732331|NCT00004099|Calcium|calcium|mesh-list
64732332|NCT00004099|Levoleucovorin|levoleucovorin|mesh-list
64732333|NCT00004099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732334|NCT00004099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64732335|NCT00004099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732336|NCT00004099|Antimetabolites|antimetabolites|mesh-ancestor
64732337|NCT00004099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732339|NCT00004099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732341|NCT00004099|Antidotes|antidotes|mesh-ancestor
64732342|NCT00004099|Protective Agents|protective agents|mesh-ancestor
64732343|NCT00004099|Vitamin B Complex|vitamin b complex|mesh-ancestor
64732344|NCT00004099|Vitamins|vitamins|mesh-ancestor
64732345|NCT00004099|Micronutrients|micronutrients|mesh-ancestor
64732346|NCT00003763|Folic Acid|folic acid|mesh-list
64732347|NCT00003763|Hematinics|hematinics|mesh-ancestor
64732348|NCT00003763|Vitamin B Complex|vitamin b complex|mesh-ancestor
64732349|NCT00003763|Vitamins|vitamins|mesh-ancestor
64732350|NCT00003763|Micronutrients|micronutrients|mesh-ancestor
64732351|NCT00003763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732352|NCT00003181|Aldesleukin|aldesleukin|mesh-list
64732353|NCT00003181|Vinblastine|vinblastine|mesh-list
64732354|NCT00003181|Sargramostim|sargramostim|mesh-list
64732355|NCT00003181|Immunologic Factors|immunologic factors|mesh-ancestor
64732356|NCT00003181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732357|NCT00003181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506143|NCT02483598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506144|NCT03321318|Cholecalciferol|cholecalciferol|mesh-list
64506145|NCT03321318|Vitamin D|vitamin d|mesh-list
64506146|NCT03321318|Bazedoxifene|bazedoxifene|mesh-list
64506147|NCT03321318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64506148|NCT03321318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506149|NCT03321318|Vitamins|vitamins|mesh-ancestor
64506150|NCT03321318|Micronutrients|micronutrients|mesh-ancestor
64506151|NCT03321318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64506152|NCT03321318|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64320316|NCT05513924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64320317|NCT05513924|Immunologic Factors|immunologic factors|mesh-ancestor
64320318|NCT05513924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320319|NCT05513924|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64320320|NCT02186119|Ranibizumab|ranibizumab|mesh-list
64732359|NCT00003181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64732360|NCT00003181|Antiviral Agents|antiviral agents|mesh-ancestor
64732361|NCT00003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64732362|NCT00003181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64732363|NCT00003181|Tubulin Modulators|tubulin modulators|mesh-ancestor
64732364|NCT00003181|Antimitotic Agents|antimitotic agents|mesh-ancestor
64732365|NCT00003181|Mitosis Modulators|mitosis modulators|mesh-ancestor
64732366|NCT00003181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732367|NCT00004105|Paclitaxel|paclitaxel|mesh-list
64732368|NCT00004105|Vinorelbine|vinorelbine|mesh-list
64732369|NCT00004105|Estramustine|estramustine|mesh-list
64732370|NCT00004105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64732371|NCT00004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732372|NCT00004105|Tubulin Modulators|tubulin modulators|mesh-ancestor
64506153|NCT03321318|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64506154|NCT03321318|Hormone Antagonists|hormone antagonists|mesh-ancestor
64506155|NCT03321318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64506156|NCT01784861|Everolimus|everolimus|mesh-list
64506157|NCT01784861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506158|NCT01784861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64506159|NCT01784861|Immunologic Factors|immunologic factors|mesh-ancestor
64506160|NCT01784861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506161|NCT03318744|Aspirin|aspirin|mesh-list
64506162|NCT03318744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64506163|NCT03318744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64506164|NCT03318744|Analgesics|analgesics|mesh-ancestor
64506165|NCT03318744|Sensory System Agents|sensory system agents|mesh-ancestor
64506166|NCT03318744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64506167|NCT03318744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955428|NCT00202618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506168|NCT03318744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64506169|NCT03318744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64506170|NCT03318744|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64506171|NCT03318744|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64506174|NCT03318744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64506175|NCT03318744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506176|NCT03318744|Antipyretics|antipyretics|mesh-ancestor
64506177|NCT02489604|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64506178|NCT02489604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64506179|NCT02489604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506180|NCT01751386|Baclofen|baclofen|mesh-list
64506181|NCT01751386|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64506182|NCT01751386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506183|NCT01751386|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64506184|NCT01751386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64320321|NCT02186119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64320322|NCT02186119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64320323|NCT02186119|Growth Substances|growth substances|mesh-ancestor
64320324|NCT02186119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320325|NCT02186119|Growth Inhibitors|growth inhibitors|mesh-ancestor
64320326|NCT02186119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320327|NCT02185261|Interferons|interferons|mesh-list
64320328|NCT02185261|Interferon-alpha|interferon-alpha|mesh-list
64320329|NCT02185261|Interferon alpha-2|interferon alpha-2|mesh-list
64320330|NCT02185261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320331|NCT02185261|Antiviral Agents|antiviral agents|mesh-ancestor
64320332|NCT02185261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64732374|NCT00004105|Mitosis Modulators|mitosis modulators|mesh-ancestor
64732375|NCT00004105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732376|NCT00004105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64732377|NCT00004105|Alkylating Agents|alkylating agents|mesh-ancestor
64732379|NCT00003187|Cytarabine|cytarabine|mesh-list
64726646|NCT00384020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64726647|NCT00384020|Antidepressive Agents|antidepressive agents|mesh-ancestor
64726648|NCT00384020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64726649|NCT00384020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64726650|NCT00384020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64726651|NCT00384020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726652|NCT05725213|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
64726653|NCT05725213|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64506185|NCT01751386|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64506186|NCT01751386|GABA Agonists|gaba agonists|mesh-ancestor
64506187|NCT01751386|GABA Agents|gaba agents|mesh-ancestor
64320333|NCT02185261|Immunologic Factors|immunologic factors|mesh-ancestor
64320334|NCT02185261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320335|NCT02573012|Prednisone|prednisone|mesh-list
64732388|NCT00003187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64732389|NCT00003187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64732390|NCT00003187|Alkylating Agents|alkylating agents|mesh-ancestor
64732391|NCT00003187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732392|NCT00003187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320336|NCT02573012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64320337|NCT02573012|Glucocorticoids|glucocorticoids|mesh-ancestor
64506188|NCT01751386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64506189|NCT01751386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506190|NCT05373264|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64506194|NCT05373264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506195|NCT05373264|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64506196|NCT05373264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64506197|NCT05373264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506199|NCT02489760|Etanercept|etanercept|mesh-list
64506200|NCT02489760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64506201|NCT02489760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64506202|NCT02489760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64506203|NCT02489760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64506204|NCT02489760|Analgesics|analgesics|mesh-ancestor
64732393|NCT00003187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64732394|NCT00003187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64732395|NCT00003187|Abortifacient Agents|abortifacient agents|mesh-ancestor
64732396|NCT00003187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64732397|NCT00003187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64732398|NCT00003187|Antimetabolites|antimetabolites|mesh-ancestor
64732399|NCT00003187|Dermatologic Agents|dermatologic agents|mesh-ancestor
64732400|NCT00003187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732401|NCT00003187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64732402|NCT00003187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64506205|NCT02489760|Sensory System Agents|sensory system agents|mesh-ancestor
64506206|NCT02489760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64506207|NCT02489760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506208|NCT02489760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64506209|NCT02489760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64506210|NCT02489760|Immunologic Factors|immunologic factors|mesh-ancestor
64506211|NCT01752712|Oxytocin|oxytocin|mesh-list
64506212|NCT01752712|Oxytocics|oxytocics|mesh-ancestor
64506213|NCT01752712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64506214|NCT01752712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506215|NCT05127928|Vitamins|vitamins|mesh-list
64506216|NCT05127928|Ascorbic Acid|ascorbic acid|mesh-list
64506217|NCT05127928|Vitamin E|vitamin e|mesh-list
64506218|NCT05127928|Tocopherols|tocopherols|mesh-list
64732438|NCT00003781|Antimitotic Agents|antimitotic agents|mesh-ancestor
64732439|NCT00003781|Mitosis Modulators|mitosis modulators|mesh-ancestor
64732440|NCT00003781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732441|NCT00003193|Paclitaxel|paclitaxel|mesh-list
64732442|NCT00003193|Amifostine|amifostine|mesh-list
64732443|NCT00003193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64732444|NCT00003193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732445|NCT00003193|Tubulin Modulators|tubulin modulators|mesh-ancestor
64732446|NCT00003193|Antimitotic Agents|antimitotic agents|mesh-ancestor
64732447|NCT00003193|Mitosis Modulators|mitosis modulators|mesh-ancestor
64732448|NCT00003193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732449|NCT00003193|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64732450|NCT00003193|Protective Agents|protective agents|mesh-ancestor
64732451|NCT00003193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732452|NCT00004135|Cyclophosphamide|cyclophosphamide|mesh-list
64732453|NCT00004135|Fludarabine|fludarabine|mesh-list
64732454|NCT00004135|Fludarabine phosphate|fludarabine phosphate|mesh-list
64732455|NCT00004135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732456|NCT00004135|Immunologic Factors|immunologic factors|mesh-ancestor
64732457|NCT00004135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732458|NCT00004135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64732459|NCT00004135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64320343|NCT04128176|Omalizumab|omalizumab|mesh-list
64506219|NCT05127928|Micronutrients|micronutrients|mesh-ancestor
64506220|NCT05127928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506221|NCT05127928|Antioxidants|antioxidants|mesh-ancestor
64506222|NCT05127928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506224|NCT02483130|Acetylcysteine|acetylcysteine|mesh-list
64506225|NCT02483130|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64506226|NCT02483130|Antiviral Agents|antiviral agents|mesh-ancestor
64506227|NCT02483130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64506228|NCT02483130|Expectorants|expectorants|mesh-ancestor
64506229|NCT02483130|Respiratory System Agents|respiratory system agents|mesh-ancestor
64506230|NCT02483130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64506231|NCT02483130|Antioxidants|antioxidants|mesh-ancestor
64506232|NCT02483130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506233|NCT02483130|Protective Agents|protective agents|mesh-ancestor
64320344|NCT04128176|Rituximab|rituximab|mesh-list
64320345|NCT04128176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64320346|NCT04128176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320347|NCT04128176|Immunologic Factors|immunologic factors|mesh-ancestor
64732460|NCT00004135|Alkylating Agents|alkylating agents|mesh-ancestor
64732461|NCT00004135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732462|NCT00004135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732463|NCT00004135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64732464|NCT00004135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64732465|NCT00004135|Antimetabolites|antimetabolites|mesh-ancestor
64732466|NCT00004141|Dacarbazine|dacarbazine|mesh-list
64732467|NCT00004141|Molgramostim|molgramostim|mesh-list
64732468|NCT00004141|Sargramostim|sargramostim|mesh-list
64732469|NCT00004141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732470|NCT00004141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64732471|NCT00004141|Alkylating Agents|alkylating agents|mesh-ancestor
64732472|NCT00004141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732473|NCT00004141|Immunologic Factors|immunologic factors|mesh-ancestor
64732474|NCT00004141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732475|NCT02972905|Nemiralisib|nemiralisib|mesh-list
64732476|NCT02972905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64732477|NCT02972905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64415201|NCT04389073|Alkylating Agents|alkylating agents|mesh-ancestor
64506234|NCT02483130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506235|NCT02483130|Antidotes|antidotes|mesh-ancestor
64506236|NCT03318354|Olmesartan|olmesartan|mesh-list
64506237|NCT03318354|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64506238|NCT03318354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64506239|NCT03318354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64506240|NCT03318354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64955429|NCT00202618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64732478|NCT02972905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732480|NCT00003799|Fluorouracil|fluorouracil|mesh-list
64732481|NCT00003799|Oxaliplatin|oxaliplatin|mesh-list
64732482|NCT00003799|Calcium|calcium|mesh-list
64732483|NCT00003799|Levoleucovorin|levoleucovorin|mesh-list
64732484|NCT00003799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64732485|NCT00003799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732486|NCT00003799|Antimetabolites|antimetabolites|mesh-ancestor
64471807|NCT04094961|BB 1101|bb 1101|mesh-list
64732487|NCT00003799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320348|NCT04128176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320349|NCT04128176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64320350|NCT04128176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64320351|NCT04128176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64320352|NCT04128176|Respiratory System Agents|respiratory system agents|mesh-ancestor
64320354|NCT02186275|Ergocalciferols|ergocalciferols|mesh-list
64732488|NCT00003799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64732489|NCT00003799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732490|NCT00003799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64955430|NCT00202618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726654|NCT05725213|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64726655|NCT05725213|Dermatologic Agents|dermatologic agents|mesh-ancestor
64726656|NCT00002557|Leucovorin|leucovorin|mesh-list
64726657|NCT00002557|Doxorubicin|doxorubicin|mesh-list
64726658|NCT00002557|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64726659|NCT00002557|Etoposide|etoposide|mesh-list
64726660|NCT00002557|Methotrexate|methotrexate|mesh-list
64726661|NCT00002557|Calcium|calcium|mesh-list
64506245|NCT05113186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732491|NCT00003799|Immunologic Factors|immunologic factors|mesh-ancestor
64732493|NCT00003799|Protective Agents|protective agents|mesh-ancestor
64732494|NCT00003799|Vitamin B Complex|vitamin b complex|mesh-ancestor
64732495|NCT00003799|Vitamins|vitamins|mesh-ancestor
64732496|NCT00003799|Micronutrients|micronutrients|mesh-ancestor
64732497|NCT00003205|Bryostatin 1|bryostatin 1|mesh-list
64732498|NCT00003205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64320356|NCT02186275|Vitamins|vitamins|mesh-list
64732499|NCT00003205|Immunologic Factors|immunologic factors|mesh-ancestor
64732500|NCT00003205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732501|NCT00003205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732502|NCT00003211|Cyclophosphamide|cyclophosphamide|mesh-list
64732503|NCT00003211|Vincristine|vincristine|mesh-list
64732505|NCT00003211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732506|NCT00003211|Immunologic Factors|immunologic factors|mesh-ancestor
64732507|NCT00003211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732508|NCT00003211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64732509|NCT00003211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64732510|NCT00003211|Alkylating Agents|alkylating agents|mesh-ancestor
64732511|NCT00003211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732512|NCT00003211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732513|NCT00003211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64732514|NCT00003211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64320358|NCT02186275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320359|NCT02186275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64320360|NCT02186275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64732516|NCT00003211|Antimitotic Agents|antimitotic agents|mesh-ancestor
64506246|NCT05113186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506247|NCT05093140|Prednisone|prednisone|mesh-list
64506248|NCT05093140|Cyclophosphamide|cyclophosphamide|mesh-list
64506249|NCT05093140|Vincristine|vincristine|mesh-list
64506250|NCT05093140|Doxorubicin|doxorubicin|mesh-list
64506251|NCT05093140|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64506252|NCT05093140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64506253|NCT05093140|Immunologic Factors|immunologic factors|mesh-ancestor
64506254|NCT05093140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506255|NCT05093140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64506256|NCT05093140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64506257|NCT05093140|Alkylating Agents|alkylating agents|mesh-ancestor
64506258|NCT05093140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506259|NCT05093140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732535|NCT00004159|Mitosis Modulators|mitosis modulators|mesh-ancestor
64732536|NCT00004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732537|NCT00004159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64732538|NCT00004159|Antimetabolites|antimetabolites|mesh-ancestor
64732539|NCT00004159|Antiviral Agents|antiviral agents|mesh-ancestor
64732540|NCT00004159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64732541|NCT00004159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320364|NCT05117281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64320365|NCT05117281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320366|NCT05117281|Sensory System Agents|sensory system agents|mesh-ancestor
64320367|NCT05117281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64320368|NCT05519072|Ciprofloxacin|ciprofloxacin|mesh-list
64506260|NCT05093140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64506261|NCT05093140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64506263|NCT05093140|Hormones|hormones|mesh-ancestor
64506264|NCT05093140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64506265|NCT05093140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64506266|NCT05093140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64506267|NCT05093140|Tubulin Modulators|tubulin modulators|mesh-ancestor
64506268|NCT05093140|Antimitotic Agents|antimitotic agents|mesh-ancestor
64506269|NCT05093140|Mitosis Modulators|mitosis modulators|mesh-ancestor
64506270|NCT05093140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64506271|NCT05093140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64732542|NCT00004159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732543|NCT00004159|Immunologic Factors|immunologic factors|mesh-ancestor
64732544|NCT00004159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732546|NCT00003811|Bleomycin|bleomycin|mesh-list
64732547|NCT00003811|Amifostine|amifostine|mesh-list
64732548|NCT00003811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320369|NCT05519072|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64320371|NCT05519072|Fosfomycin|fosfomycin|mesh-list
64320372|NCT05519072|Nitrofurantoin|nitrofurantoin|mesh-list
64320373|NCT05519072|Trimethoprim|trimethoprim|mesh-list
64320374|NCT05519072|Sulfamethoxazole|sulfamethoxazole|mesh-list
64320375|NCT05519072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64506272|NCT05093140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64506273|NCT05093140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506274|NCT03315312|Fluorides|fluorides|mesh-list
64506275|NCT03315312|Fluorides, Topical|fluorides, topical|mesh-list
64506276|NCT03315312|Cariostatic Agents|cariostatic agents|mesh-ancestor
64506277|NCT03315312|Protective Agents|protective agents|mesh-ancestor
64506278|NCT03315312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506279|NCT00705666|Ribavirin|ribavirin|mesh-list
64506280|NCT00705666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64732549|NCT00003811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64732550|NCT00003811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64732551|NCT00003811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64732552|NCT00003811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732553|NCT00003811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732554|NCT00003811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64732555|NCT00003811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64732556|NCT00003811|Protective Agents|protective agents|mesh-ancestor
64732557|NCT00003811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320376|NCT05519072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64320377|NCT05519072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64320378|NCT05519072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64320379|NCT05519072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506281|NCT00705666|Antimetabolites|antimetabolites|mesh-ancestor
64421693|NCT05482763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64421694|NCT05482763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64421695|NCT05482763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421696|NCT05482763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506282|NCT00705666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506283|NCT00705666|Antiviral Agents|antiviral agents|mesh-ancestor
64732558|NCT00004177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64732559|NCT00004177|Antibodies|antibodies|mesh-list
64732560|NCT00004177|Immunoglobulins|immunoglobulins|mesh-list
64732561|NCT00004177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64732562|NCT00004177|Immunologic Factors|immunologic factors|mesh-ancestor
64732563|NCT00004177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732564|NCT00004177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732565|NCT00003817|Ondansetron|ondansetron|mesh-list
64732566|NCT00003817|Granisetron|granisetron|mesh-list
64732567|NCT00003817|Tropisetron|tropisetron|mesh-list
64732568|NCT00003817|Dolasetron|dolasetron|mesh-list
64732569|NCT00003817|Antiemetics|antiemetics|mesh-ancestor
64732570|NCT00003817|Autonomic Agents|autonomic agents|mesh-ancestor
64732571|NCT00003817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64732572|NCT00003817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732573|NCT00003817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64732574|NCT00003817|Antipruritics|antipruritics|mesh-ancestor
64732575|NCT00003817|Dermatologic Agents|dermatologic agents|mesh-ancestor
64732576|NCT00003817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64732577|NCT00003817|Serotonin Agents|serotonin agents|mesh-ancestor
64732578|NCT00003817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64732579|NCT00003817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320380|NCT05519072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320381|NCT05519072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320382|NCT05519072|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64732580|NCT00003817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64732581|NCT00003817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64732582|NCT00003817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64732583|NCT00003817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64506284|NCT00705666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64506285|NCT04955236|Fentanyl|fentanyl|mesh-list
64506286|NCT04955236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64506287|NCT04955236|Narcotics|narcotics|mesh-ancestor
64506288|NCT04955236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64506289|NCT04955236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506290|NCT04955236|Analgesics|analgesics|mesh-ancestor
64506291|NCT04955236|Sensory System Agents|sensory system agents|mesh-ancestor
64732584|NCT00003817|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64732585|NCT00003817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64732586|NCT00003829|Cyclophosphamide|cyclophosphamide|mesh-list
64732587|NCT00003829|Fludarabine|fludarabine|mesh-list
64732588|NCT00003829|Fludarabine phosphate|fludarabine phosphate|mesh-list
64732589|NCT00003829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732590|NCT00003829|Immunologic Factors|immunologic factors|mesh-ancestor
64732591|NCT00003829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732592|NCT00003829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64732593|NCT00003829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64732594|NCT00003829|Alkylating Agents|alkylating agents|mesh-ancestor
64732595|NCT00003829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732596|NCT00003829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732597|NCT00003829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64732598|NCT00003829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64732599|NCT00003829|Antimetabolites|antimetabolites|mesh-ancestor
64732600|NCT04329403|Adapalene|adapalene|mesh-list
64732601|NCT04329403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64732602|NCT04329403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64732603|NCT04329403|Analgesics|analgesics|mesh-ancestor
64732604|NCT04329403|Sensory System Agents|sensory system agents|mesh-ancestor
64732605|NCT04329403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64732606|NCT04329403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732607|NCT04329403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64732608|NCT04329403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64732609|NCT04329403|Dermatologic Agents|dermatologic agents|mesh-ancestor
64732610|NCT00003217|Cytarabine|cytarabine|mesh-list
64732611|NCT00003217|Dexamethasone|dexamethasone|mesh-list
64732612|NCT00003217|Cyclophosphamide|cyclophosphamide|mesh-list
64732613|NCT00003217|Doxorubicin|doxorubicin|mesh-list
64732614|NCT00003217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64732615|NCT00003217|Methotrexate|methotrexate|mesh-list
64506292|NCT04955236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64506293|NCT04955236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64506294|NCT04955236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64506295|NCT04955236|Anesthetics, General|anesthetics, general|mesh-ancestor
64506296|NCT04955236|Anesthetics|anesthetics|mesh-ancestor
64506297|NCT03957304|Dexmedetomidine|dexmedetomidine|mesh-list
64506298|NCT03957304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64506299|NCT03957304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64506300|NCT03957304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506301|NCT03957304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64506303|NCT03957304|Sensory System Agents|sensory system agents|mesh-ancestor
64506304|NCT03957304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64506305|NCT03957304|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64506306|NCT03957304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64506307|NCT03957304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64732617|NCT00003217|Lenograstim|lenograstim|mesh-list
64732618|NCT00003217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732619|NCT00003217|Immunologic Factors|immunologic factors|mesh-ancestor
64732620|NCT00003217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732621|NCT00003217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64320387|NCT05519072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64726663|NCT00002557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64726664|NCT00002557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726665|NCT00002557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64726666|NCT00002557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64726667|NCT00002557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506308|NCT03957304|Adrenergic Agents|adrenergic agents|mesh-ancestor
64506309|NCT03957304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64732622|NCT00003217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64732623|NCT00003217|Alkylating Agents|alkylating agents|mesh-ancestor
64732624|NCT00003217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732625|NCT00003217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732626|NCT00003217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64732627|NCT00003217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64732628|NCT00003217|Antiemetics|antiemetics|mesh-ancestor
64732629|NCT00003217|Autonomic Agents|autonomic agents|mesh-ancestor
64732630|NCT00003217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64732631|NCT00003217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64732632|NCT00003217|Glucocorticoids|glucocorticoids|mesh-ancestor
64732633|NCT00003217|Hormones|hormones|mesh-ancestor
64732634|NCT00003217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64471957|NCT03975647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732635|NCT00003217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64732636|NCT00003217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64320395|NCT04411706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64320399|NCT04411706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64320400|NCT04411706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732637|NCT00003217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64732638|NCT00003217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64732639|NCT00003217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732640|NCT00003217|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64732641|NCT00003217|Abortifacient Agents|abortifacient agents|mesh-ancestor
64506310|NCT03957304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506311|NCT03320928|Methotrexate|methotrexate|mesh-list
64955431|NCT00202618|Vasodilator Agents|vasodilator agents|mesh-ancestor
64506320|NCT03320928|Dermatologic Agents|dermatologic agents|mesh-ancestor
64506321|NCT03320928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506322|NCT03320928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64506323|NCT03320928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64506324|NCT03320928|Immunologic Factors|immunologic factors|mesh-ancestor
64320402|NCT05518994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64320403|NCT05518994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320404|NCT05518994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64320405|NCT05518994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64732647|NCT00003217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64732648|NCT00003217|Antiviral Agents|antiviral agents|mesh-ancestor
64732649|NCT00003217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64732650|NCT00003217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64732651|NCT00003217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64732652|NCT00003217|Tubulin Modulators|tubulin modulators|mesh-ancestor
64732653|NCT00003217|Antimitotic Agents|antimitotic agents|mesh-ancestor
64320406|NCT05518994|Growth Substances|growth substances|mesh-ancestor
64320407|NCT05518994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320408|NCT05518994|Growth Inhibitors|growth inhibitors|mesh-ancestor
64320409|NCT02256943|Amitriptyline|amitriptyline|mesh-list
64320410|NCT02256943|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64320411|NCT02256943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64320412|NCT02256943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64320413|NCT02256943|Cholinergic Agents|cholinergic agents|mesh-ancestor
64320414|NCT02256943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64320415|NCT02256943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320416|NCT02256943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320417|NCT02256943|Urological Agents|urological agents|mesh-ancestor
64320418|NCT02256943|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64320419|NCT02256943|Antidepressive Agents|antidepressive agents|mesh-ancestor
64320420|NCT02256943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64320421|NCT02256943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64320422|NCT02256943|Analgesics|analgesics|mesh-ancestor
64320423|NCT02256943|Sensory System Agents|sensory system agents|mesh-ancestor
64320424|NCT02256943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64320425|NCT02256943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64506325|NCT03320928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64506326|NCT03320928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64506327|NCT02488902|Mefloquine|mefloquine|mesh-list
64506328|NCT02488902|Tafenoquine|tafenoquine|mesh-list
64506329|NCT02488902|Antimalarials|antimalarials|mesh-ancestor
64506330|NCT02488902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64506331|NCT02488902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64506332|NCT02488902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64506333|NCT02253160|Lenograstim|lenograstim|mesh-list
64506334|NCT02253160|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64506335|NCT02253160|Immunologic Factors|immunologic factors|mesh-ancestor
64506336|NCT02253160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506337|NCT02254252|Nicorandil|nicorandil|mesh-list
64506338|NCT02254252|Nitroglycerin|nitroglycerin|mesh-list
64506339|NCT02254252|Vasodilator Agents|vasodilator agents|mesh-ancestor
64506340|NCT02254252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64732654|NCT00003217|Mitosis Modulators|mitosis modulators|mesh-ancestor
64732656|NCT00004183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64732657|NCT00004183|Antimetabolites|antimetabolites|mesh-ancestor
64732658|NCT00004183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732659|NCT00004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732660|NCT00003223|Fenretinide|fenretinide|mesh-list
64732661|NCT00003223|Retinamide|retinamide|mesh-list
64732662|NCT00003223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732663|NCT00003223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64320426|NCT02256943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64320427|NCT02256943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64320428|NCT02256943|Adrenergic Agents|adrenergic agents|mesh-ancestor
64320429|NCT05059951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64320430|NCT05059951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320431|NCT05059951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506341|NCT02254252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64506342|NCT02254252|Vitamin B Complex|vitamin b complex|mesh-ancestor
64506343|NCT02254252|Vitamins|vitamins|mesh-ancestor
64506344|NCT02254252|Micronutrients|micronutrients|mesh-ancestor
64506345|NCT02254252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506346|NCT03315078|Busulfan|busulfan|mesh-list
64506347|NCT03315078|Alkylating Agents|alkylating agents|mesh-ancestor
64506348|NCT03315078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506349|NCT03315078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64506350|NCT03315078|Immunologic Factors|immunologic factors|mesh-ancestor
64506351|NCT03315078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506352|NCT03315078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64506353|NCT03315078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506354|NCT03315078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64732664|NCT00003223|Protective Agents|protective agents|mesh-ancestor
64732665|NCT00003223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732666|NCT00004189|Cisplatin|cisplatin|mesh-list
64732667|NCT00004189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732668|NCT00003229|Aldesleukin|aldesleukin|mesh-list
64732669|NCT00003229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732670|NCT00003229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64732671|NCT00003229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64732672|NCT00003229|Antiviral Agents|antiviral agents|mesh-ancestor
64732673|NCT00003229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64732674|NCT00003835|Leucovorin|leucovorin|mesh-list
64732675|NCT00003835|Fluorouracil|fluorouracil|mesh-list
64732676|NCT00003835|Irinotecan|irinotecan|mesh-list
64732677|NCT00003835|Calcium|calcium|mesh-list
64732678|NCT00003835|Levoleucovorin|levoleucovorin|mesh-list
64732679|NCT00003835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64732680|NCT00003835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320433|NCT02186899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64320434|NCT02186899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320436|NCT02752633|Febuxostat|febuxostat|mesh-list
64320437|NCT02752633|Antimetabolites|antimetabolites|mesh-ancestor
64320438|NCT02752633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320439|NCT02752633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320440|NCT02752633|Gout Suppressants|gout suppressants|mesh-ancestor
64320441|NCT02752633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64732681|NCT00003835|Antimetabolites|antimetabolites|mesh-ancestor
64732682|NCT00003835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732683|NCT00003835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64732684|NCT00003835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506355|NCT02255110|Doxorubicin|doxorubicin|mesh-list
64506356|NCT02255110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64506357|NCT02255110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506358|NCT02255110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64506359|NCT02255110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64506360|NCT02255110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506361|NCT02255110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506362|NCT03320694|Insulin|insulin|mesh-list
64732689|NCT00003835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732690|NCT00003835|Antidotes|antidotes|mesh-ancestor
64732691|NCT00003835|Protective Agents|protective agents|mesh-ancestor
64320442|NCT02752633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64320444|NCT02752633|Protective Agents|protective agents|mesh-ancestor
64320445|NCT02752633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320446|NCT02191189|Nevirapine|nevirapine|mesh-list
64320447|NCT02191189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64732692|NCT00003835|Vitamin B Complex|vitamin b complex|mesh-ancestor
64506363|NCT03320694|Metformin|metformin|mesh-list
64506364|NCT03320694|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64506365|NCT03320694|Isophane Insulin, Human|isophane insulin, human|mesh-list
64506366|NCT03320694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64506367|NCT03320694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506368|NCT02482740|Tamoxifen|tamoxifen|mesh-list
64506369|NCT02482740|Letrozole|letrozole|mesh-list
64506370|NCT02482740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506371|NCT02482740|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64506372|NCT02482740|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64506373|NCT02482740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506374|NCT02482740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506375|NCT02482740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64506376|NCT02482740|Hormone Antagonists|hormone antagonists|mesh-ancestor
64320448|NCT02191189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64320449|NCT02191189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320450|NCT02191189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320451|NCT02191189|Antiviral Agents|antiviral agents|mesh-ancestor
64320452|NCT02191189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64320453|NCT02191189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64732693|NCT00003835|Vitamins|vitamins|mesh-ancestor
64732694|NCT00003835|Micronutrients|micronutrients|mesh-ancestor
64732695|NCT00003847|Doxorubicin|doxorubicin|mesh-list
64732696|NCT00003847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64732697|NCT00003847|Vincristine|vincristine|mesh-list
64732698|NCT00003847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64415250|NCT05524259|Folic Acid|folic acid|mesh-list
64506377|NCT02482740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64506378|NCT02482740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506379|NCT02482740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64726668|NCT00002557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726669|NCT00002557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64726670|NCT00002557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320454|NCT02191189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64320455|NCT02191189|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64320456|NCT02191189|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64320457|NCT05512520|Capecitabine|capecitabine|mesh-list
64320458|NCT05512520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64320459|NCT05512520|Antimetabolites|antimetabolites|mesh-ancestor
64320460|NCT05512520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320461|NCT05512520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320462|NCT02187133|Rituximab|rituximab|mesh-list
64320463|NCT02187133|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64320464|NCT02187133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64320465|NCT02187133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320466|NCT02187133|Immunologic Factors|immunologic factors|mesh-ancestor
64732699|NCT00003847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732700|NCT00003847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64732701|NCT00003847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64732702|NCT00003847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732703|NCT00003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732704|NCT00003847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64732705|NCT00003847|Tubulin Modulators|tubulin modulators|mesh-ancestor
64732706|NCT00003847|Antimitotic Agents|antimitotic agents|mesh-ancestor
64732707|NCT00003847|Mitosis Modulators|mitosis modulators|mesh-ancestor
64732708|NCT00004195|Eniluracil|eniluracil|mesh-list
64732709|NCT00004195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732710|NCT00004195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732711|NCT00003853|Esorubicin|esorubicin|mesh-list
64732712|NCT00003853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64732713|NCT00003853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732714|NCT00385021|Leucovorin|leucovorin|mesh-list
64472032|NCT03892785|Abortifacient Agents|abortifacient agents|mesh-ancestor
64726671|NCT00002557|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64726672|NCT00002557|Abortifacient Agents|abortifacient agents|mesh-ancestor
64726673|NCT00002557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64726674|NCT00002557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64726675|NCT00002557|Antimetabolites|antimetabolites|mesh-ancestor
64726676|NCT00002557|Dermatologic Agents|dermatologic agents|mesh-ancestor
64726677|NCT00002557|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64506380|NCT02482740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64506386|NCT03315000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64506387|NCT03315000|Autonomic Agents|autonomic agents|mesh-ancestor
64732715|NCT00385021|Fluorouracil|fluorouracil|mesh-list
64732716|NCT00385021|Oxaliplatin|oxaliplatin|mesh-list
64732717|NCT00385021|Bevacizumab|bevacizumab|mesh-list
64732718|NCT00385021|Antimetabolites|antimetabolites|mesh-ancestor
64320467|NCT02187133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320468|NCT02187133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64320469|NCT02187133|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64320470|NCT02187133|Alkylating Agents|alkylating agents|mesh-ancestor
64320471|NCT02187133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320472|NCT04411862|Choline|choline|mesh-list
64320473|NCT04411862|Lipotropic Agents|lipotropic agents|mesh-ancestor
64320474|NCT04411862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64320475|NCT04411862|Antimetabolites|antimetabolites|mesh-ancestor
64320476|NCT04411862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732719|NCT00385021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732720|NCT00385021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64732721|NCT00385021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424728|NCT02494921|Hormones|hormones|mesh-ancestor
64320477|NCT04411862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64320478|NCT04411862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64320480|NCT02187211|Minocycline|minocycline|mesh-list
64320481|NCT02187211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64320482|NCT02187211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64320483|NCT04766996|Aspirin|aspirin|mesh-list
64506388|NCT03315000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64506389|NCT03315000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955432|NCT00202618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64506390|NCT03315000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64506391|NCT03315000|Respiratory System Agents|respiratory system agents|mesh-ancestor
64506392|NCT03315000|Dermatologic Agents|dermatologic agents|mesh-ancestor
64506393|NCT03315000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64506395|NCT02482818|Analgesics|analgesics|mesh-ancestor
64506396|NCT02482818|Sensory System Agents|sensory system agents|mesh-ancestor
64506397|NCT02482818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421770|NCT03907475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64506398|NCT02482818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506400|NCT02482818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64506401|NCT02482818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64506402|NCT02482818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506403|NCT02482818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64506404|NCT02482818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64732722|NCT00385021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732723|NCT00385021|Immunologic Factors|immunologic factors|mesh-ancestor
64732724|NCT00385021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732725|NCT00385021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64732726|NCT00385021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64732727|NCT00385021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64732728|NCT00385021|Growth Substances|growth substances|mesh-ancestor
64732729|NCT00385021|Growth Inhibitors|growth inhibitors|mesh-ancestor
64732730|NCT00385021|Antidotes|antidotes|mesh-ancestor
64732731|NCT00385021|Protective Agents|protective agents|mesh-ancestor
64732732|NCT00385021|Vitamin B Complex|vitamin b complex|mesh-ancestor
64732733|NCT00385021|Vitamins|vitamins|mesh-ancestor
64732734|NCT00385021|Micronutrients|micronutrients|mesh-ancestor
64732735|NCT00003235|Paclitaxel|paclitaxel|mesh-list
64732736|NCT00003235|Carboplatin|carboplatin|mesh-list
64732737|NCT00003235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64732738|NCT00003235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732739|NCT00003235|Tubulin Modulators|tubulin modulators|mesh-ancestor
64732740|NCT00003235|Antimitotic Agents|antimitotic agents|mesh-ancestor
64732741|NCT00003235|Mitosis Modulators|mitosis modulators|mesh-ancestor
64320485|NCT04766996|Prednisone|prednisone|mesh-list
64320486|NCT04766996|Meloxicam|meloxicam|mesh-list
64320487|NCT04766996|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64320488|NCT04766996|Diclofenac|diclofenac|mesh-list
64320489|NCT04766996|Lidocaine|lidocaine|mesh-list
64320490|NCT04766996|Pregabalin|pregabalin|mesh-list
64320491|NCT04766996|Tramadol|tramadol|mesh-list
64320492|NCT04766996|Bupivacaine|bupivacaine|mesh-list
64506405|NCT02482818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64506406|NCT02482818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64506407|NCT02482818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64506408|NCT02989870|Sorafenib|sorafenib|mesh-list
64506409|NCT02989870|Bavituximab|bavituximab|mesh-list
64506410|NCT02989870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506411|NCT02989870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64506412|NCT02989870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506413|NCT02989870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732742|NCT00003235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732743|NCT00004201|Gemcitabine|gemcitabine|mesh-list
64732744|NCT00004201|Carboplatin|carboplatin|mesh-list
64732745|NCT00004201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320495|NCT04766996|Tranexamic Acid|tranexamic acid|mesh-list
64320496|NCT04766996|Anesthetics, Local|anesthetics, local|mesh-ancestor
64320497|NCT04766996|Anesthetics|anesthetics|mesh-ancestor
64320498|NCT04766996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64320499|NCT04766996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320500|NCT04766996|Sensory System Agents|sensory system agents|mesh-ancestor
64320501|NCT04766996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64320502|NCT04766996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64320503|NCT04766996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64320504|NCT04766996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64320505|NCT04766996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64320506|NCT04766996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320507|NCT04766996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64320508|NCT04766996|Glucocorticoids|glucocorticoids|mesh-ancestor
64320509|NCT04766996|Hormones|hormones|mesh-ancestor
64320510|NCT04766996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64320511|NCT04766996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64320512|NCT04766996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320513|NCT04766996|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64320514|NCT04766996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64320515|NCT04766996|Anesthetics, General|anesthetics, general|mesh-ancestor
64320516|NCT04766996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64320517|NCT04766996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64320518|NCT04766996|Analgesics|analgesics|mesh-ancestor
64506414|NCT02989870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64506415|NCT02480088|Palonosetron|palonosetron|mesh-list
64506416|NCT02480088|Ramosetron|ramosetron|mesh-list
64506417|NCT02480088|Antiemetics|antiemetics|mesh-ancestor
64506418|NCT02480088|Autonomic Agents|autonomic agents|mesh-ancestor
64506419|NCT02480088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64506420|NCT02480088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506421|NCT02480088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64506422|NCT02480088|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64506423|NCT02480088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64732746|NCT00004201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64732747|NCT00004201|Antimetabolites|antimetabolites|mesh-ancestor
64732748|NCT00004201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732749|NCT00004201|Antiviral Agents|antiviral agents|mesh-ancestor
64732750|NCT00004201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64732751|NCT00004201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732752|NCT00004201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732753|NCT00004201|Immunologic Factors|immunologic factors|mesh-ancestor
64732754|NCT00004201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732755|NCT00003241|Phenylacetic acid|phenylacetic acid|mesh-list
64732756|NCT00003241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64732757|NCT00003241|Antimetabolites|antimetabolites|mesh-ancestor
64732758|NCT00003241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732759|NCT00003241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732760|NCT00003859|Cyclophosphamide|cyclophosphamide|mesh-list
64732761|NCT00003859|Carboplatin|carboplatin|mesh-list
64320519|NCT04766996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64320520|NCT04766996|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64320521|NCT04766996|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64506424|NCT02480088|Serotonin Agents|serotonin agents|mesh-ancestor
64506425|NCT02480088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64506426|NCT02480088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506427|NCT01807624|Phenylephrine|phenylephrine|mesh-list
64506428|NCT01807624|Oxymetazoline|oxymetazoline|mesh-list
64506429|NCT01807624|Tetracaine|tetracaine|mesh-list
64506430|NCT01807624|Anesthetics, Local|anesthetics, local|mesh-ancestor
64506431|NCT01807624|Anesthetics|anesthetics|mesh-ancestor
64506432|NCT01807624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64506433|NCT01807624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506434|NCT01807624|Sensory System Agents|sensory system agents|mesh-ancestor
64732763|NCT00003859|Vincristine|vincristine|mesh-list
64732764|NCT00003859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732765|NCT00003859|Immunologic Factors|immunologic factors|mesh-ancestor
64732766|NCT00003859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320522|NCT04766996|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64320523|NCT04766996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64320524|NCT04766996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320525|NCT04766996|Antipyretics|antipyretics|mesh-ancestor
64415286|NCT05533073|Narcotics|narcotics|mesh-ancestor
64506435|NCT01807624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64506436|NCT01807624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64726679|NCT00002557|Immunologic Factors|immunologic factors|mesh-ancestor
64726680|NCT00002557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64726681|NCT00002557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64506437|NCT01807624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64506438|NCT01807624|Adrenergic Agents|adrenergic agents|mesh-ancestor
64506439|NCT01807624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64506440|NCT01807624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732767|NCT00003859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64732768|NCT00003859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64732769|NCT00003859|Alkylating Agents|alkylating agents|mesh-ancestor
64732770|NCT00003859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732771|NCT00003859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732772|NCT00003859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64732773|NCT00003859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64732774|NCT00003859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64732775|NCT00003859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64732776|NCT00003859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732777|NCT00003859|Tubulin Modulators|tubulin modulators|mesh-ancestor
64320526|NCT04766996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64320527|NCT04766996|Anticonvulsants|anticonvulsants|mesh-ancestor
64320528|NCT04766996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64320529|NCT04766996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64320530|NCT04766996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64320531|NCT04766996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64732778|NCT00003859|Antimitotic Agents|antimitotic agents|mesh-ancestor
64732779|NCT00003859|Mitosis Modulators|mitosis modulators|mesh-ancestor
64732781|NCT00003865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64732782|NCT00003865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732783|NCT00003865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64732784|NCT00003865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64732785|NCT00003865|Hormone Antagonists|hormone antagonists|mesh-ancestor
64732786|NCT00003865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64732787|NCT00003865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627233|NCT00002416|Lamivudine|lamivudine|mesh-list
64506441|NCT01807624|Sympathomimetics|sympathomimetics|mesh-ancestor
64506442|NCT01807624|Autonomic Agents|autonomic agents|mesh-ancestor
64506443|NCT01807624|Nasal Decongestants|nasal decongestants|mesh-ancestor
64506444|NCT01807624|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64506445|NCT01807624|Respiratory System Agents|respiratory system agents|mesh-ancestor
64506446|NCT01807624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64506448|NCT01807624|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64506449|NCT01807624|Protective Agents|protective agents|mesh-ancestor
64506450|NCT02486640|Interferons|interferons|mesh-list
64955434|NCT00202696|Nalmefene|nalmefene|mesh-list
64955435|NCT00202696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64955436|NCT00202696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955437|NCT00202696|Sensory System Agents|sensory system agents|mesh-ancestor
64955438|NCT00202696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64955439|NCT00038636|Ritonavir|ritonavir|mesh-list
64506456|NCT02486640|Immunologic Factors|immunologic factors|mesh-ancestor
64506457|NCT02486640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732788|NCT00003865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64732789|NCT00004207|Daunorubicin|daunorubicin|mesh-list
64320532|NCT04766996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64320533|NCT04766996|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64320534|NCT04766996|Hemostatics|hemostatics|mesh-ancestor
64320535|NCT04766996|Coagulants|coagulants|mesh-ancestor
64494193|NCT01044862|Letrozole|letrozole|mesh-list
64955440|NCT00038636|Lopinavir|lopinavir|mesh-list
64955441|NCT00038636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64506458|NCT02486640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64506459|NCT01808326|Chlorambucil|chlorambucil|mesh-list
64506460|NCT01808326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64421806|NCT05481281|Analgesics|analgesics|mesh-ancestor
64506462|NCT01808326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506463|NCT01808326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506464|NCT03317730|Oxycodone|oxycodone|mesh-list
64320536|NCT04766996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64320537|NCT04766996|Narcotics|narcotics|mesh-ancestor
64320538|NCT04766996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64320539|NCT04766996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64320540|NCT04766996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64320541|NCT02191423|Oxytocin|oxytocin|mesh-list
64320542|NCT02191423|Oxytocics|oxytocics|mesh-ancestor
64320543|NCT02191423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64320544|NCT02191423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320545|NCT05509946|Celecoxib|celecoxib|mesh-list
64732790|NCT00004207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732791|NCT00004207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64732792|NCT00004207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732793|NCT00004207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64732794|NCT00004207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64732796|NCT00003871|Vaccines|vaccines|mesh-list
64732797|NCT00003871|Immunologic Factors|immunologic factors|mesh-ancestor
64732798|NCT00003871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732799|NCT00004219|Granisetron|granisetron|mesh-list
64732800|NCT00004219|Antiemetics|antiemetics|mesh-ancestor
64732801|NCT00004219|Autonomic Agents|autonomic agents|mesh-ancestor
64732802|NCT00004219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64732803|NCT00004219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732804|NCT00004219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64506465|NCT03317730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64506466|NCT03317730|Narcotics|narcotics|mesh-ancestor
64506467|NCT03317730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64506468|NCT03317730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506469|NCT03317730|Analgesics|analgesics|mesh-ancestor
64506470|NCT03317730|Sensory System Agents|sensory system agents|mesh-ancestor
64506471|NCT03317730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64506472|NCT02486484|Aflibercept|aflibercept|mesh-list
64506473|NCT02486484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64506474|NCT02486484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64506475|NCT02486484|Growth Substances|growth substances|mesh-ancestor
64506476|NCT02486484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506477|NCT02486484|Growth Inhibitors|growth inhibitors|mesh-ancestor
64506478|NCT02486484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506479|NCT03317652|Nitroprusside|nitroprusside|mesh-list
64506480|NCT03317652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64506481|NCT03317652|Vasodilator Agents|vasodilator agents|mesh-ancestor
64506482|NCT03317652|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64320547|NCT05509946|Analgesics|analgesics|mesh-ancestor
64320548|NCT05509946|Sensory System Agents|sensory system agents|mesh-ancestor
64320549|NCT05509946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64320550|NCT05509946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320551|NCT05509946|Anticonvulsants|anticonvulsants|mesh-ancestor
64320552|NCT05509946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64732806|NCT00004219|Serotonin Agents|serotonin agents|mesh-ancestor
64732807|NCT00004219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64732808|NCT00004219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732809|NCT00003877|Paclitaxel|paclitaxel|mesh-list
64732810|NCT00003877|Cyclophosphamide|cyclophosphamide|mesh-list
64732811|NCT00003877|Carboplatin|carboplatin|mesh-list
64732812|NCT00003877|Thiotepa|thiotepa|mesh-list
64732813|NCT00003877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64732814|NCT00003877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732815|NCT00003877|Tubulin Modulators|tubulin modulators|mesh-ancestor
64732816|NCT00003877|Antimitotic Agents|antimitotic agents|mesh-ancestor
64732817|NCT00003877|Mitosis Modulators|mitosis modulators|mesh-ancestor
64732818|NCT00003877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732819|NCT00003877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732820|NCT00003877|Immunologic Factors|immunologic factors|mesh-ancestor
64320556|NCT05509946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64506483|NCT03317652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506484|NCT02479854|Montelukast|montelukast|mesh-list
64506485|NCT02479854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64506486|NCT02479854|Respiratory System Agents|respiratory system agents|mesh-ancestor
64506487|NCT02479854|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64506488|NCT02479854|Hormone Antagonists|hormone antagonists|mesh-ancestor
64506489|NCT02479854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64732821|NCT00003877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732822|NCT00003877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64732823|NCT00003877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64732824|NCT00003877|Alkylating Agents|alkylating agents|mesh-ancestor
64732825|NCT00003877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64732826|NCT00003883|Itraconazole|itraconazole|mesh-list
64732827|NCT00003883|Fluconazole|fluconazole|mesh-list
64320562|NCT05509946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64320563|NCT05509946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64320564|NCT05509946|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64320565|NCT05509946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64320566|NCT05509946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506490|NCT02479854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506491|NCT02479854|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64506492|NCT02479854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64506493|NCT02479854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506494|NCT01809106|Fentanyl|fentanyl|mesh-list
64506495|NCT01809106|Morphine|morphine|mesh-list
64506496|NCT01809106|Oxycodone|oxycodone|mesh-list
64506497|NCT01809106|Buprenorphine|buprenorphine|mesh-list
64506498|NCT01809106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64506499|NCT01809106|Narcotics|narcotics|mesh-ancestor
64732828|NCT00003883|Antifungal Agents|antifungal agents|mesh-ancestor
64732829|NCT00003883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64732830|NCT00003883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64320567|NCT04304209|Capecitabine|capecitabine|mesh-list
64320568|NCT04304209|Oxaliplatin|oxaliplatin|mesh-list
64320569|NCT04304209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64320570|NCT04304209|Antimetabolites|antimetabolites|mesh-ancestor
64320571|NCT04304209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320572|NCT04304209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320573|NCT02187367|Cyclophosphamide|cyclophosphamide|mesh-list
64320574|NCT02187367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64506500|NCT01809106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64506501|NCT01809106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726691|NCT00003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64506502|NCT01809106|Analgesics|analgesics|mesh-ancestor
64506503|NCT01809106|Sensory System Agents|sensory system agents|mesh-ancestor
64506504|NCT01809106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64506505|NCT01809106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64506506|NCT01809106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64506507|NCT01809106|Anesthetics, General|anesthetics, general|mesh-ancestor
64506508|NCT01809106|Anesthetics|anesthetics|mesh-ancestor
64506509|NCT01809106|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64506510|NCT03804580|Osimertinib|osimertinib|mesh-list
64506511|NCT03804580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506543|NCT01766440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64506544|NCT01766440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506545|NCT01766440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64506546|NCT01766440|Vitamins|vitamins|mesh-ancestor
64506547|NCT01766440|Micronutrients|micronutrients|mesh-ancestor
64506548|NCT01766440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64506549|NCT02479620|Dexamethasone|dexamethasone|mesh-list
64506550|NCT02479620|Dexamethasone acetate|dexamethasone acetate|mesh-list
64506551|NCT02479620|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64732831|NCT00003883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64732832|NCT00003883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732833|NCT00003883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732834|NCT00003883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64732835|NCT00003883|Hormone Antagonists|hormone antagonists|mesh-ancestor
64732836|NCT00003883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64732837|NCT00003883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320575|NCT02187367|Immunologic Factors|immunologic factors|mesh-ancestor
64320576|NCT02187367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320577|NCT02187367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64320578|NCT02187367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64320579|NCT02187367|Alkylating Agents|alkylating agents|mesh-ancestor
64320580|NCT02187367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320581|NCT02187367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506552|NCT02479620|BB 1101|bb 1101|mesh-list
64506553|NCT02479620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64506559|NCT02479620|Glucocorticoids|glucocorticoids|mesh-ancestor
64506561|NCT02479620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64506562|NCT02479620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64506563|NCT02479620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506564|NCT02479620|Protease Inhibitors|protease inhibitors|mesh-ancestor
64506565|NCT02479620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732838|NCT00003883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64320582|NCT02187367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64320583|NCT02187445|Budesonide|budesonide|mesh-list
64320584|NCT02187445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64320585|NCT02187445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64320586|NCT02187445|Autonomic Agents|autonomic agents|mesh-ancestor
64320587|NCT02187445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64320588|NCT02187445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320589|NCT02187445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64320590|NCT02187445|Respiratory System Agents|respiratory system agents|mesh-ancestor
64415303|NCT04050553|Incretins|incretins|mesh-ancestor
64506566|NCT02479620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506568|NCT02481960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64506569|NCT02481960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64506570|NCT02481960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506571|NCT02481960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506572|NCT02481960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506581|NCT02725866|Ritonavir|ritonavir|mesh-list
64506582|NCT02725866|Ribavirin|ribavirin|mesh-list
64506583|NCT02725866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64506584|NCT02725866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64506585|NCT02725866|Protease Inhibitors|protease inhibitors|mesh-ancestor
64506586|NCT02725866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506587|NCT02725866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506588|NCT02725866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64732839|NCT00003883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64732840|NCT00003883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64732841|NCT04225819|Vitamin D|vitamin d|mesh-list
64732842|NCT04225819|Cholecalciferol|cholecalciferol|mesh-list
64732843|NCT04225819|Vitamins|vitamins|mesh-ancestor
64732844|NCT04225819|Micronutrients|micronutrients|mesh-ancestor
64732845|NCT04225819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320591|NCT02187445|Glucocorticoids|glucocorticoids|mesh-ancestor
64320593|NCT02187445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64506589|NCT02725866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64506590|NCT02725866|Antiviral Agents|antiviral agents|mesh-ancestor
64506591|NCT02725866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64506592|NCT02725866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64506593|NCT02725866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64506594|NCT02725866|Antimetabolites|antimetabolites|mesh-ancestor
64506595|NCT02481726|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64506596|NCT02481726|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64726692|NCT00003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726693|NCT00003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
64726694|NCT00003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
64726695|NCT00003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
64334190|NCT02352987|Analgesics|analgesics|mesh-ancestor
64506597|NCT02481726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506599|NCT03314298|Anastrozole|anastrozole|mesh-list
64732846|NCT04225819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64732847|NCT04225819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64732849|NCT00003253|Antineoplastic Agents|antineoplastic agents|mesh-list
64732850|NCT00003253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64320596|NCT02187523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64320598|NCT02187523|Natriuretic Agents|natriuretic agents|mesh-ancestor
64320599|NCT02187523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320600|NCT02187523|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64506600|NCT03314298|Testosterone|testosterone|mesh-list
64506601|NCT03314298|Testosterone undecanoate|testosterone undecanoate|mesh-list
64506602|NCT03314298|Testosterone enanthate|testosterone enanthate|mesh-list
64506603|NCT03314298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64506604|NCT03314298|Androgens|androgens|mesh-ancestor
64506605|NCT03314298|Hormones|hormones|mesh-ancestor
64506606|NCT03314298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64955443|NCT00038636|Protease Inhibitors|protease inhibitors|mesh-ancestor
64955444|NCT00038636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732851|NCT00003253|Tubulin Modulators|tubulin modulators|mesh-ancestor
64732852|NCT00003253|Antimitotic Agents|antimitotic agents|mesh-ancestor
64732853|NCT00003253|Mitosis Modulators|mitosis modulators|mesh-ancestor
64732854|NCT00003253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732855|NCT00004237|Cyclophosphamide|cyclophosphamide|mesh-list
64320601|NCT02187523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64320602|NCT02187523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320603|NCT02187523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64320604|NCT02187523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64320605|NCT02187679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64320607|NCT02187679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64415309|NCT03946891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415320|NCT03849625|Aspirin|aspirin|mesh-list
64955445|NCT00038636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506607|NCT03314298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506608|NCT03314298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64506609|NCT03314298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506610|NCT03314298|Anabolic Agents|anabolic agents|mesh-ancestor
64506611|NCT03314298|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64506612|NCT03314298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64506613|NCT03314298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506614|NCT03314298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506615|NCT03314298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64506616|NCT03314298|Hormone Antagonists|hormone antagonists|mesh-ancestor
64506617|NCT02479308|Moxifloxacin|moxifloxacin|mesh-list
64506618|NCT02479308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64506619|NCT02479308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64506620|NCT02479308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64320608|NCT02187679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64320609|NCT02187679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320610|NCT02187679|Cholinergic Agents|cholinergic agents|mesh-ancestor
64320611|NCT02187679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64732857|NCT00004237|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64732858|NCT00004237|Vinorelbine|vinorelbine|mesh-list
64732859|NCT00004237|Epirubicin|epirubicin|mesh-list
64320612|NCT02187679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320613|NCT02187679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64320620|NCT05507606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320621|NCT05507606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64506621|NCT02479308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64506637|NCT02485548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64506638|NCT02485548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64506639|NCT02485548|Immunologic Factors|immunologic factors|mesh-ancestor
64506640|NCT02485548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506641|NCT02485548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64506642|NCT02485548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506643|NCT02479074|Prednisolone|prednisolone|mesh-list
64506644|NCT02479074|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64506645|NCT02479074|Methylprednisolone|methylprednisolone|mesh-list
64506646|NCT02479074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64506647|NCT02479074|Prednisolone acetate|prednisolone acetate|mesh-list
64732860|NCT00004237|Mitoxantrone|mitoxantrone|mesh-list
64732861|NCT00004237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732862|NCT00004237|Immunologic Factors|immunologic factors|mesh-ancestor
64732863|NCT00004237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732864|NCT00004237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64472181|NCT03720522|Purinergic Agonists|purinergic agonists|mesh-ancestor
64732865|NCT00004237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64732866|NCT00004237|Alkylating Agents|alkylating agents|mesh-ancestor
64732867|NCT00004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732868|NCT00004237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732869|NCT00004237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64320622|NCT05507606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64320623|NCT05507606|Growth Substances|growth substances|mesh-ancestor
64320624|NCT05507606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320625|NCT05507606|Growth Inhibitors|growth inhibitors|mesh-ancestor
64732870|NCT00004237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64732871|NCT00004237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64732872|NCT00004237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64732873|NCT00004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732874|NCT00004237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64732875|NCT00004237|Tubulin Modulators|tubulin modulators|mesh-ancestor
64732876|NCT00004237|Antimitotic Agents|antimitotic agents|mesh-ancestor
64732877|NCT00004237|Mitosis Modulators|mitosis modulators|mesh-ancestor
64732878|NCT00004237|Analgesics|analgesics|mesh-ancestor
64506648|NCT02479074|Montelukast|montelukast|mesh-list
64506649|NCT02479074|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64506650|NCT02479074|Prednisolone phosphate|prednisolone phosphate|mesh-list
64506651|NCT02479074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64506652|NCT02479074|Glucocorticoids|glucocorticoids|mesh-ancestor
64506654|NCT02479074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64506655|NCT02479074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732879|NCT00004237|Sensory System Agents|sensory system agents|mesh-ancestor
64732880|NCT00004237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64320626|NCT05507606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320627|NCT05507606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320628|NCT05507606|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64320629|NCT05507606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64320630|NCT05507606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64320632|NCT02191657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64320633|NCT02191657|Chelating Agents|chelating agents|mesh-ancestor
64732881|NCT00003259|Vinorelbine|vinorelbine|mesh-list
64732882|NCT00003259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64732883|NCT00003259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732884|NCT00003259|Tubulin Modulators|tubulin modulators|mesh-ancestor
64732885|NCT00003259|Antimitotic Agents|antimitotic agents|mesh-ancestor
64732886|NCT00003259|Mitosis Modulators|mitosis modulators|mesh-ancestor
64506656|NCT02479074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64506657|NCT02479074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506659|NCT02479074|Autonomic Agents|autonomic agents|mesh-ancestor
64506660|NCT02479074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64506661|NCT02479074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64506662|NCT02479074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64506663|NCT02479074|Protective Agents|protective agents|mesh-ancestor
64506664|NCT02479074|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64506665|NCT02479074|Respiratory System Agents|respiratory system agents|mesh-ancestor
64506666|NCT02479074|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64506667|NCT02479074|Hormone Antagonists|hormone antagonists|mesh-ancestor
64506668|NCT02479074|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64506669|NCT02479074|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64506670|NCT02479074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506671|NCT02481180|T0001|t0001|mesh-list
64320634|NCT02191657|Sequestering Agents|sequestering agents|mesh-ancestor
64320635|NCT02191657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320636|NCT02191891|Afatinib|afatinib|mesh-list
64320637|NCT02191891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320638|NCT02191891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64320639|NCT02191891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732887|NCT00003259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732889|NCT00003913|Cyclophosphamide|cyclophosphamide|mesh-list
64732890|NCT00003913|Busulfan|busulfan|mesh-list
64732891|NCT00003913|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64732892|NCT00003913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732893|NCT00003913|Immunologic Factors|immunologic factors|mesh-ancestor
64732894|NCT00003913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732895|NCT00003913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64732896|NCT00003913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64506673|NCT02481180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506674|NCT02481180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64506675|NCT02481180|Immunologic Factors|immunologic factors|mesh-ancestor
64506676|NCT02480946|Methotrexate|methotrexate|mesh-list
64726696|NCT00003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726697|NCT00003158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64726698|NCT00003158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64726699|NCT00003158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732897|NCT00003913|Alkylating Agents|alkylating agents|mesh-ancestor
64732898|NCT00003913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732899|NCT00003913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732900|NCT00003913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64732901|NCT00003913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64732902|NCT00003913|Antiemetics|antiemetics|mesh-ancestor
64732903|NCT00003913|Autonomic Agents|autonomic agents|mesh-ancestor
64320640|NCT02191891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320641|NCT05507372|Pimozide|pimozide|mesh-list
64320642|NCT05507372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64320643|NCT05507372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64320644|NCT05507372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64320645|NCT05507372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726700|NCT05751187|Folic Acid|folic acid|mesh-list
64506677|NCT02480946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64506678|NCT02480946|Abortifacient Agents|abortifacient agents|mesh-ancestor
64506679|NCT02480946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64955446|NCT00038636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64506698|NCT02480634|Zoledronic Acid|zoledronic acid|mesh-list
64506699|NCT02480634|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64506700|NCT02480634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506701|NCT03399292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64506702|NCT03399292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64506703|NCT02726022|Ribavirin|ribavirin|mesh-list
64506704|NCT02726022|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64506705|NCT02726022|Antimetabolites|antimetabolites|mesh-ancestor
64732904|NCT00003913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64732905|NCT00003913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64732906|NCT00003913|Glucocorticoids|glucocorticoids|mesh-ancestor
64732907|NCT00003913|Hormones|hormones|mesh-ancestor
64732908|NCT00003913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64732909|NCT00003913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64732910|NCT00003913|Protective Agents|protective agents|mesh-ancestor
64732911|NCT00004243|Docetaxel|docetaxel|mesh-list
64732912|NCT00004243|Oxaliplatin|oxaliplatin|mesh-list
64732913|NCT00004243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732914|NCT00004243|Tubulin Modulators|tubulin modulators|mesh-ancestor
64732915|NCT00004243|Antimitotic Agents|antimitotic agents|mesh-ancestor
64732916|NCT00004243|Mitosis Modulators|mitosis modulators|mesh-ancestor
64732917|NCT00004243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732918|NCT00004249|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
64732919|NCT00004249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64732920|NCT00004249|Immunologic Factors|immunologic factors|mesh-ancestor
64732921|NCT00004249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732922|NCT00003925|Leucovorin|leucovorin|mesh-list
64732923|NCT00003925|Gemcitabine|gemcitabine|mesh-list
64732924|NCT00003925|Tegafur|tegafur|mesh-list
64732925|NCT00003925|Calcium|calcium|mesh-list
64732926|NCT00003925|Levoleucovorin|levoleucovorin|mesh-list
64732927|NCT00003925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64732928|NCT00003925|Antimetabolites|antimetabolites|mesh-ancestor
64320646|NCT05507372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64320647|NCT05507372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64320648|NCT05507372|Dopamine Agents|dopamine agents|mesh-ancestor
64320649|NCT05507372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64506706|NCT02726022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506707|NCT02726022|Antiviral Agents|antiviral agents|mesh-ancestor
64506708|NCT02726022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64506709|NCT02478294|Warfarin|warfarin|mesh-list
64506710|NCT02478294|Anticoagulants|anticoagulants|mesh-list
64506711|NCT01770652|Deferiprone|deferiprone|mesh-list
64506712|NCT01770652|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64506713|NCT01770652|Chelating Agents|chelating agents|mesh-ancestor
64506714|NCT01770652|Sequestering Agents|sequestering agents|mesh-ancestor
64506715|NCT01770652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320650|NCT05507372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732929|NCT00003925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732930|NCT00003925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732931|NCT00003925|Antiviral Agents|antiviral agents|mesh-ancestor
64320651|NCT05507372|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64320652|NCT02192203|Diclofenac|diclofenac|mesh-list
64320653|NCT02192203|Menthol|menthol|mesh-list
64320654|NCT02192203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64320655|NCT02192203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64320656|NCT02192203|Analgesics|analgesics|mesh-ancestor
64506716|NCT03316482|Leuprolide|leuprolide|mesh-list
64506717|NCT03316482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64506718|NCT03316482|Fertility Agents|fertility agents|mesh-ancestor
64506719|NCT03316482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64506720|NCT03316482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506721|NCT03316482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64506722|NCT03316482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506723|NCT01771666|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
64506724|NCT01771666|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64506725|NCT01771666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506726|NCT01772758|Antioxidants|antioxidants|mesh-list
64732932|NCT00003925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64732934|NCT00003925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732935|NCT00003925|Immunologic Factors|immunologic factors|mesh-ancestor
64732936|NCT00003925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732937|NCT00003925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64732938|NCT00003925|Antidotes|antidotes|mesh-ancestor
64732939|NCT00003925|Protective Agents|protective agents|mesh-ancestor
64732940|NCT00003925|Vitamin B Complex|vitamin b complex|mesh-ancestor
64472332|NCT03530124|Immunologic Factors|immunologic factors|mesh-ancestor
64732941|NCT00003925|Vitamins|vitamins|mesh-ancestor
64732942|NCT00003925|Micronutrients|micronutrients|mesh-ancestor
64732943|NCT00004255|Methylprednisolone|methylprednisolone|mesh-list
64732944|NCT00004255|Cyclophosphamide|cyclophosphamide|mesh-list
64732945|NCT00004255|Fludarabine|fludarabine|mesh-list
64732946|NCT00004255|Fludarabine phosphate|fludarabine phosphate|mesh-list
64732947|NCT00004255|Tacrolimus|tacrolimus|mesh-list
64732948|NCT00004255|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64732949|NCT00004255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732950|NCT00004255|Immunologic Factors|immunologic factors|mesh-ancestor
64732951|NCT00004255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732953|NCT00004255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64732954|NCT00004255|Alkylating Agents|alkylating agents|mesh-ancestor
64415335|NCT03849625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506727|NCT01772758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506728|NCT01772758|Protective Agents|protective agents|mesh-ancestor
64506729|NCT01772758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506730|NCT02485080|Sofosbuvir|sofosbuvir|mesh-list
64506731|NCT02485080|Simeprevir|simeprevir|mesh-list
64506732|NCT02485080|Antiviral Agents|antiviral agents|mesh-ancestor
64506740|NCT02480400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64506741|NCT02480400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64506742|NCT02480400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732955|NCT00004255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732956|NCT00004255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732957|NCT00004255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64732958|NCT00004255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64732959|NCT00004255|Antimetabolites|antimetabolites|mesh-ancestor
64732960|NCT00004255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64732961|NCT00004255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732962|NCT00004255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64732963|NCT00004255|Antiemetics|antiemetics|mesh-ancestor
64732964|NCT00004255|Autonomic Agents|autonomic agents|mesh-ancestor
64732965|NCT00004255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64732966|NCT00004255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64320658|NCT02192203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64320659|NCT02192203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320660|NCT02192203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64320661|NCT02192203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64320662|NCT02192203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64732967|NCT00004255|Glucocorticoids|glucocorticoids|mesh-ancestor
64732968|NCT00004255|Hormones|hormones|mesh-ancestor
64732969|NCT00004255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64732970|NCT00004255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64732971|NCT00004255|Protective Agents|protective agents|mesh-ancestor
64732972|NCT00004261|Antibodies|antibodies|mesh-list
64732973|NCT00004261|Immunologic Factors|immunologic factors|mesh-ancestor
64732974|NCT00004261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415338|NCT03612973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64506743|NCT02480400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64506744|NCT02480400|Serotonin Agents|serotonin agents|mesh-ancestor
64506746|NCT02480400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64506747|NCT02480400|Antidepressive Agents|antidepressive agents|mesh-ancestor
64506748|NCT02480400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64506749|NCT02480400|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64506750|NCT02480400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64506751|NCT02480400|Parasympatholytics|parasympatholytics|mesh-ancestor
64955448|NCT00038636|Antiviral Agents|antiviral agents|mesh-ancestor
64506753|NCT02480400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64955449|NCT00038636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64506754|NCT02480400|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64506755|NCT02480400|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64320663|NCT02192203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320664|NCT02192203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320665|NCT02192203|Antipruritics|antipruritics|mesh-ancestor
64320666|NCT02192203|Dermatologic Agents|dermatologic agents|mesh-ancestor
64320668|NCT02257021|Tipranavir|tipranavir|mesh-list
64320669|NCT02257021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64320670|NCT02257021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64732976|NCT00003283|Octreotide|octreotide|mesh-list
64732977|NCT00003283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64732978|NCT00003283|Glucocorticoids|glucocorticoids|mesh-ancestor
64732979|NCT00003283|Hormones|hormones|mesh-ancestor
64732980|NCT00003283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64732981|NCT00003283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732982|NCT00003283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64732983|NCT00003283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732984|NCT00003283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64732985|NCT00004297|Diazepam|diazepam|mesh-list
64732986|NCT00004297|Lorazepam|lorazepam|mesh-list
64732987|NCT00004297|Anticonvulsants|anticonvulsants|mesh-ancestor
64732988|NCT00004297|Antiemetics|antiemetics|mesh-ancestor
64506756|NCT02480400|Cholinergic Agents|cholinergic agents|mesh-ancestor
64506758|NCT02725710|Analgesics|analgesics|mesh-ancestor
64506759|NCT02725710|Sensory System Agents|sensory system agents|mesh-ancestor
64506760|NCT02725710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64506761|NCT02725710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506762|NCT02725710|Anticonvulsants|anticonvulsants|mesh-ancestor
64506763|NCT02725710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64506764|NCT02725710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64506765|NCT02725710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64726701|NCT05751187|Vitamin B 12|vitamin b 12|mesh-list
64726702|NCT05751187|Dexamethasone|dexamethasone|mesh-list
64726703|NCT05751187|Bevacizumab|bevacizumab|mesh-list
64726704|NCT05751187|Pembrolizumab|pembrolizumab|mesh-list
64726705|NCT05751187|Carboplatin|carboplatin|mesh-list
64506766|NCT02725710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64732989|NCT00004297|Autonomic Agents|autonomic agents|mesh-ancestor
64732990|NCT00004297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64732991|NCT00004297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732992|NCT00004297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64732993|NCT00004297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64732994|NCT00004297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64732995|NCT00004297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64732996|NCT00004297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64732997|NCT00004297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64506767|NCT02725710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64506768|NCT02725710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64506769|NCT02725710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64506770|NCT02725710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506771|NCT02725710|Antimanic Agents|antimanic agents|mesh-ancestor
64506772|NCT02256358|Midazolam|midazolam|mesh-list
64506773|NCT02256358|Ketamine|ketamine|mesh-list
64506774|NCT02256358|Analgesics|analgesics|mesh-ancestor
64320674|NCT02257021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64320675|NCT02257021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64320676|NCT02257021|Antiviral Agents|antiviral agents|mesh-ancestor
64320677|NCT02257021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64320678|NCT02257021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64320679|NCT02257021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64320680|NCT03536065|Analgesics, Opioid|analgesics, opioid|mesh-list
64732998|NCT00004297|GABA Modulators|gaba modulators|mesh-ancestor
64733000|NCT00004297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64733001|NCT00004297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733002|NCT00004297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64733003|NCT00004297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64733004|NCT00004297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64733005|NCT00004297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64733006|NCT00004297|Anesthetics, General|anesthetics, general|mesh-ancestor
64733007|NCT00004297|Anesthetics|anesthetics|mesh-ancestor
64733008|NCT00004855|Ritonavir|ritonavir|mesh-list
64733009|NCT00004855|Lopinavir|lopinavir|mesh-list
64733010|NCT00004855|Lamivudine|lamivudine|mesh-list
64733011|NCT00004855|Nevirapine|nevirapine|mesh-list
64733012|NCT00004855|Abacavir|abacavir|mesh-list
64733013|NCT00004855|Stavudine|stavudine|mesh-list
64733014|NCT00004855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64733015|NCT00004855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64733016|NCT00004855|Protease Inhibitors|protease inhibitors|mesh-ancestor
64733017|NCT00004855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506775|NCT02256358|Sensory System Agents|sensory system agents|mesh-ancestor
64506776|NCT02256358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64506777|NCT02256358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506778|NCT02256358|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64506779|NCT02256358|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64506780|NCT02256358|Anesthetics, General|anesthetics, general|mesh-ancestor
64506781|NCT02256358|Anesthetics|anesthetics|mesh-ancestor
64506782|NCT02256358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64506783|NCT02256358|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64733018|NCT00004855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733019|NCT00004855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64733020|NCT00004855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64733021|NCT00004855|Antiviral Agents|antiviral agents|mesh-ancestor
64733022|NCT00004855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64733023|NCT00004855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64427112|NCT02217501|Aspirin|aspirin|mesh-list
64320682|NCT03536065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64320684|NCT03536065|Analgesics|analgesics|mesh-ancestor
64320685|NCT03536065|Sensory System Agents|sensory system agents|mesh-ancestor
64320686|NCT03536065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64320687|NCT02192827|Dexamethasone|dexamethasone|mesh-list
64320688|NCT02192827|Dexamethasone acetate|dexamethasone acetate|mesh-list
64320689|NCT02192827|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64415343|NCT03049345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506784|NCT02256358|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64506785|NCT02256358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64506786|NCT02256358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506787|NCT02256358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64506788|NCT02256358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64506789|NCT02256358|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64506790|NCT02256358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64506791|NCT02256358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64506792|NCT02256358|GABA Modulators|gaba modulators|mesh-ancestor
64506793|NCT02256358|GABA Agents|gaba agents|mesh-ancestor
64733024|NCT00004855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64733025|NCT00004855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64733026|NCT00004855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64733027|NCT00004855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64733028|NCT00004855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64733029|NCT00004855|Antimetabolites|antimetabolites|mesh-ancestor
64733030|NCT00003289|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
64733031|NCT00003289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320690|NCT02192827|BB 1101|bb 1101|mesh-list
64320691|NCT02192827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64320692|NCT02192827|Antiemetics|antiemetics|mesh-ancestor
64733032|NCT00003289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64733033|NCT00003289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733034|NCT00003289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733035|NCT00004861|Gemcitabine|gemcitabine|mesh-list
64733036|NCT00004861|Tacedinaline|tacedinaline|mesh-list
64506794|NCT01825408|Azithromycin|azithromycin|mesh-list
64506795|NCT01825408|Doxycycline|doxycycline|mesh-list
64506796|NCT01825408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64506797|NCT01825408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64506798|NCT01825408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64506799|NCT01825408|Antimalarials|antimalarials|mesh-ancestor
64506803|NCT01825408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506804|NCT01825408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506805|NCT04945824|Dexamethasone|dexamethasone|mesh-list
64506806|NCT04945824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64506807|NCT04945824|Antiemetics|antiemetics|mesh-ancestor
64506809|NCT04945824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64506810|NCT04945824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506811|NCT04945824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64506812|NCT04945824|Glucocorticoids|glucocorticoids|mesh-ancestor
64506814|NCT04945824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64506815|NCT04945824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64506816|NCT04945824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506817|NCT04937634|Melphalan|melphalan|mesh-list
64506818|NCT04937634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64733037|NCT00004861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64733038|NCT00004861|Antimetabolites|antimetabolites|mesh-ancestor
64320693|NCT02192827|Autonomic Agents|autonomic agents|mesh-ancestor
64320694|NCT02192827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64320695|NCT02192827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733039|NCT00004861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733040|NCT00004861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733041|NCT00004861|Antiviral Agents|antiviral agents|mesh-ancestor
64733042|NCT00004861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64733043|NCT00004861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733044|NCT00004861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64733045|NCT00004861|Immunologic Factors|immunologic factors|mesh-ancestor
64415349|NCT05526911|Tenofovir|tenofovir|mesh-list
64506819|NCT04937634|Alkylating Agents|alkylating agents|mesh-ancestor
64506820|NCT04937634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506821|NCT04937634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506822|NCT04937634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64506823|NCT04937634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64506824|NCT04937634|Immunologic Factors|immunologic factors|mesh-ancestor
64506825|NCT04937634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955450|NCT00038636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64733046|NCT00004861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320699|NCT02192827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64320700|NCT02192827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64320701|NCT02192827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733047|NCT00004861|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64733048|NCT00004315|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64733049|NCT00004315|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64733050|NCT00004315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64733051|NCT04074343|Irinotecan|irinotecan|mesh-list
64733052|NCT04074343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64733053|NCT04074343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64733054|NCT04074343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733055|NCT04074343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733056|NCT04074343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733057|NCT00003301|Irinotecan|irinotecan|mesh-list
64733058|NCT00003301|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64320704|NCT02192827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320705|NCT02188225|Fluoxetine|fluoxetine|mesh-list
64320706|NCT02188225|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64320707|NCT02188225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64320708|NCT02188225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64733059|NCT00003301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64733060|NCT00003301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733061|NCT00003301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733062|NCT00003301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733064|NCT00003307|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64733065|NCT00003307|Protective Agents|protective agents|mesh-ancestor
64733066|NCT00003307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733067|NCT00004327|Octreotide|octreotide|mesh-list
64733068|NCT00004327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64733069|NCT00004327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64733070|NCT00004327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733071|NCT00003313|Paclitaxel|paclitaxel|mesh-list
64955451|NCT00038636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64506826|NCT02262130|Omalizumab|omalizumab|mesh-list
64506827|NCT02262130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64506828|NCT02262130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64506829|NCT02262130|Respiratory System Agents|respiratory system agents|mesh-ancestor
64506830|NCT04913610|Ivermectin|ivermectin|mesh-list
64506831|NCT04913610|Albendazole|albendazole|mesh-list
64506832|NCT04913610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64726707|NCT05751187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64726708|NCT05751187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506833|NCT04913610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64506834|NCT04913610|Anthelmintics|anthelmintics|mesh-ancestor
64506835|NCT04913610|Anticestodal Agents|anticestodal agents|mesh-ancestor
64506836|NCT04913610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64733074|NCT00003313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64733075|NCT00003313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733076|NCT00003313|Tubulin Modulators|tubulin modulators|mesh-ancestor
64733077|NCT00003313|Antimitotic Agents|antimitotic agents|mesh-ancestor
64733078|NCT00003313|Mitosis Modulators|mitosis modulators|mesh-ancestor
64320709|NCT02188225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320710|NCT02188225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64320711|NCT02188225|Serotonin Agents|serotonin agents|mesh-ancestor
64320712|NCT02188225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320713|NCT02188225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64506837|NCT04913610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64506838|NCT04913610|Tubulin Modulators|tubulin modulators|mesh-ancestor
64506839|NCT04913610|Antimitotic Agents|antimitotic agents|mesh-ancestor
64506840|NCT04913610|Mitosis Modulators|mitosis modulators|mesh-ancestor
64506841|NCT04913610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506842|NCT04913610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506843|NCT04887870|Pembrolizumab|pembrolizumab|mesh-list
64506844|NCT04887870|Nivolumab|nivolumab|mesh-list
64506845|NCT04887870|Ipilimumab|ipilimumab|mesh-list
64506846|NCT04887870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64506847|NCT04887870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506848|NCT04887870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64506849|NCT04887870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506850|NCT01827358|Calcium, Dietary|calcium, dietary|mesh-list
64506851|NCT01827358|Mupirocin|mupirocin|mesh-list
64506852|NCT01827358|Calcium|calcium|mesh-list
64733079|NCT00003313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733080|NCT00003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733081|NCT00003313|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64733082|NCT00003313|Protective Agents|protective agents|mesh-ancestor
64733083|NCT00004867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64733084|NCT00004867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64733085|NCT00004867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733086|NCT00004873|Docetaxel|docetaxel|mesh-list
64733087|NCT00004873|Fluorouracil|fluorouracil|mesh-list
64320714|NCT02188225|Antidepressive Agents|antidepressive agents|mesh-ancestor
64320715|NCT02188225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64320716|NCT02188225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64320717|NCT02188225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64320718|NCT02188225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320719|NCT04535089|Lidocaine|lidocaine|mesh-list
64320720|NCT04535089|Dexmedetomidine|dexmedetomidine|mesh-list
64733088|NCT00004873|Epirubicin|epirubicin|mesh-list
64733089|NCT00004873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733090|NCT00004873|Tubulin Modulators|tubulin modulators|mesh-ancestor
64472407|NCT03410030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64733091|NCT00004873|Antimitotic Agents|antimitotic agents|mesh-ancestor
64733092|NCT00004873|Mitosis Modulators|mitosis modulators|mesh-ancestor
64733093|NCT00004873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733094|NCT00004873|Antimetabolites|antimetabolites|mesh-ancestor
64320721|NCT04535089|Anesthetics, Local|anesthetics, local|mesh-ancestor
64320722|NCT04535089|Anesthetics|anesthetics|mesh-ancestor
64320723|NCT04535089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64320724|NCT04535089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506853|NCT01827358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64506854|NCT01827358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506855|NCT01827358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64506856|NCT01827358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64506857|NCT01827358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64506858|NCT01827358|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64506859|NCT01827358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506860|NCT01827358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506861|NCT01780324|Lidocaine|lidocaine|mesh-list
64506862|NCT01780324|Anesthetics, Local|anesthetics, local|mesh-ancestor
64506863|NCT01780324|Anesthetics|anesthetics|mesh-ancestor
64506864|NCT01780324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64506865|NCT01780324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506866|NCT01780324|Sensory System Agents|sensory system agents|mesh-ancestor
64506867|NCT01780324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64506868|NCT01780324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64506883|NCT02472600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64506884|NCT02472600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64733095|NCT00004873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64733096|NCT00004873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64733097|NCT00004873|Immunologic Factors|immunologic factors|mesh-ancestor
64472484|NCT03245892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64733170|NCT00003343|Glucocorticoids|glucocorticoids|mesh-ancestor
64733172|NCT00003343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64733173|NCT00003343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733174|NCT00003343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64733175|NCT00003343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733176|NCT00003343|Analgesics|analgesics|mesh-ancestor
64733177|NCT00003343|Sensory System Agents|sensory system agents|mesh-ancestor
64733178|NCT00003343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64733179|NCT00003343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64733180|NCT00003343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64320726|NCT04535089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64320727|NCT04535089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64320728|NCT04535089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64320729|NCT04535089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64320730|NCT04535089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64320731|NCT04535089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320732|NCT04535089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64320733|NCT04535089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64320734|NCT04535089|Analgesics|analgesics|mesh-ancestor
64733182|NCT00003343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506885|NCT04858776|Dexamethasone|dexamethasone|mesh-list
64506886|NCT04858776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64506887|NCT04858776|Antiemetics|antiemetics|mesh-ancestor
64506888|NCT04858776|Autonomic Agents|autonomic agents|mesh-ancestor
64506889|NCT04858776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64506890|NCT04858776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506891|NCT04858776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64506892|NCT04858776|Glucocorticoids|glucocorticoids|mesh-ancestor
64733183|NCT00003343|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
64733184|NCT00003343|Protease Inhibitors|protease inhibitors|mesh-ancestor
64733185|NCT00004903|Interferons|interferons|mesh-list
64733186|NCT00004903|Cytarabine|cytarabine|mesh-list
64733187|NCT00004903|Interferon-alpha|interferon-alpha|mesh-list
64733188|NCT00004903|Cyclophosphamide|cyclophosphamide|mesh-list
64733189|NCT00004903|Melphalan|melphalan|mesh-list
64733190|NCT00004903|Etoposide|etoposide|mesh-list
64733191|NCT00004903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64320735|NCT04535089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64320736|NCT04535089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64320737|NCT04535089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64320738|NCT04535089|Adrenergic Agents|adrenergic agents|mesh-ancestor
64733192|NCT00004903|Immunologic Factors|immunologic factors|mesh-ancestor
64733193|NCT00004903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733194|NCT00004903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64733195|NCT00004903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64733196|NCT00004903|Alkylating Agents|alkylating agents|mesh-ancestor
64733197|NCT00004903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320739|NCT04535089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64509220|NCT02979561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509221|NCT01937026|Probenecid|probenecid|mesh-list
64509222|NCT01937026|Uricosuric Agents|uricosuric agents|mesh-ancestor
64509223|NCT01937026|Gout Suppressants|gout suppressants|mesh-ancestor
64726890|NCT00002870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64726891|NCT00002870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64726892|NCT00002870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64726893|NCT00002870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64726894|NCT00002870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726896|NCT00002581|Cyclophosphamide|cyclophosphamide|mesh-list
64726897|NCT00002581|Fluorouracil|fluorouracil|mesh-list
64509224|NCT01937026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64509226|NCT03672292|Voriconazole|voriconazole|mesh-list
64509227|NCT03672292|Ibrexafungerp|ibrexafungerp|mesh-list
64509228|NCT03672292|Antifungal Agents|antifungal agents|mesh-ancestor
64509229|NCT03672292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64509230|NCT03672292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64509231|NCT03672292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64509232|NCT03672292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509233|NCT03672292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320741|NCT02188537|Dexamethasone|dexamethasone|mesh-list
64320742|NCT02188537|Bortezomib|bortezomib|mesh-list
64320743|NCT02188537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64733198|NCT00004903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733199|NCT00004903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64733200|NCT00004903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64733201|NCT00004903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64733202|NCT00004903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64733204|NCT00004903|Antiviral Agents|antiviral agents|mesh-ancestor
64733205|NCT00004903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64733206|NCT00004903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64733207|NCT00004903|Antimetabolites|antimetabolites|mesh-ancestor
64733208|NCT00004357|Methylprednisolone|methylprednisolone|mesh-list
64733209|NCT00004357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64506894|NCT04858776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64506895|NCT04858776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64506896|NCT04858776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506897|NCT01781806|Tenofovir|tenofovir|mesh-list
64506898|NCT01781806|Emtricitabine|emtricitabine|mesh-list
64506899|NCT01781806|Antiviral Agents|antiviral agents|mesh-ancestor
64955452|NCT00202813|Anti-Infective Agents|anti-infective agents|mesh-list
64955453|NCT00202813|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64506900|NCT01781806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64733210|NCT00004357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64733211|NCT00004357|Prednisolone|prednisolone|mesh-list
64733212|NCT00004357|Prednisolone acetate|prednisolone acetate|mesh-list
64320744|NCT02188537|Antiemetics|antiemetics|mesh-ancestor
64320745|NCT02188537|Autonomic Agents|autonomic agents|mesh-ancestor
64320746|NCT02188537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64320747|NCT02188537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320748|NCT02188537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64733214|NCT00004357|Prednisolone phosphate|prednisolone phosphate|mesh-list
64733215|NCT00004357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64733216|NCT00004357|Antiemetics|antiemetics|mesh-ancestor
64733217|NCT00004357|Autonomic Agents|autonomic agents|mesh-ancestor
64733218|NCT00004357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64733219|NCT00004357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733220|NCT00004357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64733221|NCT00004357|Glucocorticoids|glucocorticoids|mesh-ancestor
64733222|NCT00004357|Hormones|hormones|mesh-ancestor
64733223|NCT00004357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64733224|NCT00004357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64733225|NCT00004357|Protective Agents|protective agents|mesh-ancestor
64733226|NCT00004357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64733227|NCT00004357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733228|NCT00004363|Chlorpropamide|chlorpropamide|mesh-list
64733229|NCT00004363|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64733230|NCT00004363|Hemostatics|hemostatics|mesh-ancestor
64733231|NCT00004363|Coagulants|coagulants|mesh-ancestor
64733232|NCT00004363|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64320749|NCT02188537|Glucocorticoids|glucocorticoids|mesh-ancestor
64320750|NCT02188537|Hormones|hormones|mesh-ancestor
64320751|NCT02188537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64733234|NCT00004363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733235|NCT00004363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64733236|NCT04069117|Letrozole|letrozole|mesh-list
64733237|NCT04069117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733238|NCT04069117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64733239|NCT04069117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64733240|NCT04069117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733241|NCT04069117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320752|NCT02188537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64320753|NCT02188537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320754|NCT02188537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64506901|NCT01781806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64506902|NCT01781806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64506903|NCT01781806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506904|NCT01781806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506905|NCT01781806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64506906|NCT01781806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64506907|NCT02477514|Tedizolid|tedizolid|mesh-list
64506908|NCT02477514|Tedizolid phosphate|tedizolid phosphate|mesh-list
64506909|NCT02477514|Midazolam|midazolam|mesh-list
64506910|NCT02477514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64506911|NCT02477514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64506912|NCT02477514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64733242|NCT04069117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64733243|NCT04069117|Hormone Antagonists|hormone antagonists|mesh-ancestor
64733244|NCT04069117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64733246|NCT00004921|Paclitaxel|paclitaxel|mesh-list
64733315|NCT00003367|Vitamins|vitamins|mesh-ancestor
64733316|NCT00003367|Micronutrients|micronutrients|mesh-ancestor
64472640|NCT03060434|Sensory System Agents|sensory system agents|mesh-ancestor
64733317|NCT00003367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733318|NCT00003367|Antioxidants|antioxidants|mesh-ancestor
64320758|NCT02188537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320759|NCT02188537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64320760|NCT02188537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64320761|NCT02188537|Antiviral Agents|antiviral agents|mesh-ancestor
64320762|NCT02188537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64320763|NCT03535051|Tacrolimus|tacrolimus|mesh-list
64733319|NCT00003367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733322|NCT00003379|Cisplatin|cisplatin|mesh-list
64733323|NCT00003379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64733324|NCT00003379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733325|NCT00003379|Tubulin Modulators|tubulin modulators|mesh-ancestor
64733326|NCT00003379|Antimitotic Agents|antimitotic agents|mesh-ancestor
64733327|NCT00003379|Mitosis Modulators|mitosis modulators|mesh-ancestor
64733328|NCT00003379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733329|NCT00003385|Paclitaxel|paclitaxel|mesh-list
64733330|NCT00003385|Carboplatin|carboplatin|mesh-list
64733331|NCT00003385|Doxorubicin|doxorubicin|mesh-list
64733332|NCT00003385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64320764|NCT03535051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64320765|NCT03535051|Immunologic Factors|immunologic factors|mesh-ancestor
64320766|NCT03535051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320767|NCT03535051|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64320768|NCT03535051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726709|NCT05751187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64726710|NCT05751187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64726711|NCT05751187|Growth Substances|growth substances|mesh-ancestor
64726712|NCT05751187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726713|NCT05751187|Growth Inhibitors|growth inhibitors|mesh-ancestor
64726714|NCT05751187|Vitamins|vitamins|mesh-ancestor
64726715|NCT05751187|Micronutrients|micronutrients|mesh-ancestor
64726716|NCT05751187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64506913|NCT02477514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64506914|NCT02477514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506915|NCT02477514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64506916|NCT02477514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64506917|NCT02477514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64506918|NCT02477514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64506919|NCT02477514|Anesthetics, General|anesthetics, general|mesh-ancestor
64506920|NCT02477514|Anesthetics|anesthetics|mesh-ancestor
64506921|NCT02477514|GABA Modulators|gaba modulators|mesh-ancestor
64506922|NCT02477514|GABA Agents|gaba agents|mesh-ancestor
64506923|NCT02477514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64506924|NCT02477514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506925|NCT02477514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64733333|NCT00003385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64733334|NCT00003385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733335|NCT00003385|Tubulin Modulators|tubulin modulators|mesh-ancestor
64733336|NCT00003385|Antimitotic Agents|antimitotic agents|mesh-ancestor
64733337|NCT00003385|Mitosis Modulators|mitosis modulators|mesh-ancestor
64733338|NCT00003385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733339|NCT00003385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64733340|NCT00003385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64733341|NCT00003385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64733342|NCT00003385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733343|NCT00004381|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
64733344|NCT00004381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733345|NCT00004381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733346|NCT00005005|Alendronate|alendronate|mesh-list
64320769|NCT03535051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320771|NCT02188615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320772|NCT02188615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64320773|NCT02188615|Tubulin Modulators|tubulin modulators|mesh-ancestor
64733347|NCT00005005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64733348|NCT00005005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733349|NCT00004393|Risperidone|risperidone|mesh-list
64415365|NCT05526911|GABA Agents|gaba agents|mesh-ancestor
64506926|NCT02477514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64506927|NCT02477514|Antimetabolites|antimetabolites|mesh-ancestor
64506928|NCT02477514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64506960|NCT02472054|Immunologic Factors|immunologic factors|mesh-ancestor
64506961|NCT02472054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506962|NCT02472054|Antifungal Agents|antifungal agents|mesh-ancestor
64506963|NCT02472054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64506964|NCT02472054|Dermatologic Agents|dermatologic agents|mesh-ancestor
64320774|NCT02188615|Antimitotic Agents|antimitotic agents|mesh-ancestor
64320775|NCT02188615|Mitosis Modulators|mitosis modulators|mesh-ancestor
64320776|NCT02188615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320778|NCT02188771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64320779|NCT02188771|Immunologic Factors|immunologic factors|mesh-ancestor
64320780|NCT02188771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320781|NCT02188771|Viscosupplements|viscosupplements|mesh-ancestor
64320782|NCT02188771|Protective Agents|protective agents|mesh-ancestor
64320783|NCT02194075|Fluvoxamine|fluvoxamine|mesh-list
64320784|NCT02194075|Methylphenidate|methylphenidate|mesh-list
64320785|NCT02194075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64320786|NCT02194075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320787|NCT02194075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64320788|NCT02194075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64320789|NCT02194075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64320790|NCT02194075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320791|NCT02194075|Dopamine Agents|dopamine agents|mesh-ancestor
64320792|NCT02194075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64733350|NCT00004393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64733351|NCT00004393|Serotonin Agents|serotonin agents|mesh-ancestor
64733352|NCT00004393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64320793|NCT02194075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64320794|NCT02194075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64506965|NCT02472054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64506966|NCT02472054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64506967|NCT02472054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64506968|NCT02472054|Glucocorticoids|glucocorticoids|mesh-ancestor
64506970|NCT02472054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64506971|NCT02472054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64506972|NCT02472054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506973|NCT02472054|Antiemetics|antiemetics|mesh-ancestor
64506990|NCT02475876|Clindamycin phosphate|clindamycin phosphate|mesh-list
64506991|NCT02475876|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64506992|NCT02475876|Trimethoprim|trimethoprim|mesh-list
64506993|NCT02475876|Sulfamethoxazole|sulfamethoxazole|mesh-list
64320795|NCT02194075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64320796|NCT02194075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64320797|NCT02194075|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64320798|NCT02194075|Serotonin Agents|serotonin agents|mesh-ancestor
64320799|NCT02194075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64320800|NCT02194075|Antidepressive Agents|antidepressive agents|mesh-ancestor
64320801|NCT02194075|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64320802|NCT02194075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64320803|NCT02194075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320804|NCT02194075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64320805|NCT04270747|Aflibercept|aflibercept|mesh-list
64320806|NCT04270747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64733361|NCT00004399|Magnesium Sulfate|magnesium sulfate|mesh-list
64733362|NCT00004399|Nimodipine|nimodipine|mesh-list
64733363|NCT00004399|Analgesics|analgesics|mesh-ancestor
64733364|NCT00004399|Sensory System Agents|sensory system agents|mesh-ancestor
64733365|NCT00004399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64733366|NCT00004399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733367|NCT00004399|Anesthetics|anesthetics|mesh-ancestor
64320807|NCT04270747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64320809|NCT04270747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320810|NCT04270747|Growth Inhibitors|growth inhibitors|mesh-ancestor
64320811|NCT04270747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506994|NCT02475876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64506995|NCT02475876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64506996|NCT02475876|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64506997|NCT02475876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506998|NCT02475876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506999|NCT02475876|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64507000|NCT02475876|Renal Agents|renal agents|mesh-ancestor
64507001|NCT02475876|Antimalarials|antimalarials|mesh-ancestor
64507002|NCT02475876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64320820|NCT02562716|Pancreatin|pancreatin|mesh-list
64320821|NCT02562716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64320822|NCT02562716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320823|NCT02562716|Tubulin Modulators|tubulin modulators|mesh-ancestor
64320824|NCT02562716|Antimitotic Agents|antimitotic agents|mesh-ancestor
64733368|NCT00004399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64733369|NCT00004399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64733370|NCT00004399|Anticonvulsants|anticonvulsants|mesh-ancestor
64733371|NCT00004399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64733372|NCT00004399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64733373|NCT00004399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733374|NCT00004399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64320826|NCT02562716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320827|NCT02562716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64320828|NCT02562716|Antimetabolites|antimetabolites|mesh-ancestor
64320829|NCT02562716|Antiviral Agents|antiviral agents|mesh-ancestor
64320830|NCT02562716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64320831|NCT02562716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320832|NCT02562716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64320833|NCT02562716|Immunologic Factors|immunologic factors|mesh-ancestor
64415376|NCT05526911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64507003|NCT02475876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64507004|NCT02475876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64507005|NCT02475876|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64507006|NCT02475876|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64507007|NCT02475876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64507008|NCT02472210|Botulinum Toxins|botulinum toxins|mesh-list
64507009|NCT02472210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64507010|NCT02472210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64507011|NCT02472210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507012|NCT02472210|Cholinergic Agents|cholinergic agents|mesh-ancestor
64507013|NCT02472210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64733375|NCT00004399|Tocolytic Agents|tocolytic agents|mesh-ancestor
64733376|NCT00004399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64733377|NCT00004399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64733378|NCT00004399|Vasodilator Agents|vasodilator agents|mesh-ancestor
64733379|NCT00004423|Aminosalicylic Acid|aminosalicylic acid|mesh-list
64733380|NCT00004423|Antitubercular Agents|antitubercular agents|mesh-ancestor
64733381|NCT00004423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64733382|NCT00004423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64733383|NCT00005017|Ritonavir|ritonavir|mesh-list
64733384|NCT00005017|Amprenavir|amprenavir|mesh-list
64733385|NCT00005017|Lamivudine|lamivudine|mesh-list
64733386|NCT00005017|Abacavir|abacavir|mesh-list
64733387|NCT00005017|Stavudine|stavudine|mesh-list
64733388|NCT00005017|Efavirenz|efavirenz|mesh-list
64733389|NCT00005017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64733390|NCT00005017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64733391|NCT00005017|Protease Inhibitors|protease inhibitors|mesh-ancestor
64733392|NCT00005017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320834|NCT02562716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320835|NCT02562716|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64733393|NCT00005017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733394|NCT00005017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64733395|NCT00005017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64507014|NCT02472210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507015|NCT01783054|Gemcitabine|gemcitabine|mesh-list
64507016|NCT01783054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64507017|NCT01783054|Antimetabolites|antimetabolites|mesh-ancestor
64507018|NCT01783054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726718|NCT05751187|Autonomic Agents|autonomic agents|mesh-ancestor
64726719|NCT05751187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64726720|NCT05751187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64726721|NCT05751187|Glucocorticoids|glucocorticoids|mesh-ancestor
64726722|NCT05751187|Hormones|hormones|mesh-ancestor
64726723|NCT05751187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64507019|NCT01783054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507020|NCT01783054|Antiviral Agents|antiviral agents|mesh-ancestor
64733396|NCT00005017|Antiviral Agents|antiviral agents|mesh-ancestor
64733397|NCT00005017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64733398|NCT00005017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64733399|NCT00005017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64733400|NCT00005017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64320836|NCT02562716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64320837|NCT02562716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64733401|NCT00005017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64733402|NCT00005017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64733403|NCT00005017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64733404|NCT00005017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64733405|NCT00005017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64733406|NCT00005017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64733407|NCT00005017|Antimetabolites|antimetabolites|mesh-ancestor
64507021|NCT01783054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64507022|NCT01783054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507023|NCT01783054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64507024|NCT01783054|Immunologic Factors|immunologic factors|mesh-ancestor
64507025|NCT01783054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507026|NCT05397600|Bimatoprost|bimatoprost|mesh-list
64507027|NCT05397600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64507028|NCT02725008|Dexamethasone|dexamethasone|mesh-list
64507062|NCT02471820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64507063|NCT02471820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507064|NCT02471820|Protease Inhibitors|protease inhibitors|mesh-ancestor
64507065|NCT02471820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507066|NCT02471820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507067|NCT02471820|Immunologic Factors|immunologic factors|mesh-ancestor
64507068|NCT02471820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64733408|NCT00005017|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64733409|NCT00005017|Antitubercular Agents|antitubercular agents|mesh-ancestor
64733410|NCT00005017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64733411|NCT00005023|Sargramostim|sargramostim|mesh-list
64733412|NCT00005023|Immunologic Factors|immunologic factors|mesh-ancestor
64733413|NCT00005023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733415|NCT00005029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64733416|NCT00005029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64733417|NCT00005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733418|NCT00005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733419|NCT00005029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320838|NCT02193217|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64320839|NCT02193217|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64507069|NCT02471820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64507070|NCT02471820|Growth Substances|growth substances|mesh-ancestor
64507071|NCT02471820|Growth Inhibitors|growth inhibitors|mesh-ancestor
64507084|NCT01833130|Botulinum Toxins|botulinum toxins|mesh-list
64507085|NCT01833130|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64507086|NCT01833130|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64507087|NCT01833130|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64507088|NCT01833130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64507089|NCT01833130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507090|NCT01833130|Cholinergic Agents|cholinergic agents|mesh-ancestor
64320840|NCT02193217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320841|NCT02193217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64733420|NCT00005035|Oxaliplatin|oxaliplatin|mesh-list
64733421|NCT00005035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733422|NCT00004429|Hormones|hormones|mesh-list
64733423|NCT00004429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64733424|NCT00004429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733425|NCT00005041|Tipifarnib|tipifarnib|mesh-list
64507091|NCT01833130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64507092|NCT01833130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507093|NCT01833130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64507094|NCT01833130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507096|NCT01783912|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64507097|NCT01783912|Autonomic Agents|autonomic agents|mesh-ancestor
64507098|NCT01783912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507100|NCT01783912|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64507101|NCT01783912|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64507102|NCT01783912|Cholinergic Agents|cholinergic agents|mesh-ancestor
64507103|NCT01783912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64507104|NCT01783912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507105|NCT05583708|Pembrolizumab|pembrolizumab|mesh-list
64733426|NCT00005041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733427|NCT00004441|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
64733428|NCT00004441|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64733429|NCT00004441|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64733430|NCT00004441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64733431|NCT00004441|Antiviral Agents|antiviral agents|mesh-ancestor
64733432|NCT00004441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64733433|NCT00004465|Shiga Toxins|shiga toxins|mesh-list
64733434|NCT00004465|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64733435|NCT00004465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733436|NCT00004465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733437|NCT00005569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
64733438|NCT00005569|Protease Inhibitors|protease inhibitors|mesh-list
64733439|NCT00005569|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
64733440|NCT00005569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733441|NCT00005569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733442|NCT00005569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64733443|NCT00005569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64733444|NCT00005569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64733445|NCT00005569|Antiviral Agents|antiviral agents|mesh-ancestor
64733446|NCT00005569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64320847|NCT03534973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64320848|NCT03534973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320849|NCT03534973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320850|NCT03534973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64733447|NCT00005569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64733448|NCT00005575|Imipramine|imipramine|mesh-list
64733449|NCT00005575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64733450|NCT00005575|Antidepressive Agents|antidepressive agents|mesh-ancestor
64733451|NCT00005575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64733452|NCT00005575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64733453|NCT00005575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64507106|NCT05583708|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64507107|NCT05583708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64507108|NCT05583708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507109|NCT05583708|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64507110|NCT05583708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507111|NCT01783990|Hydroxyurea|hydroxyurea|mesh-list
64507112|NCT01783990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507113|NCT01783990|Antisickling Agents|antisickling agents|mesh-ancestor
64507114|NCT01783990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507115|NCT01783990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507116|NCT01783990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64507117|NCT01833988|Pancrelipase|pancrelipase|mesh-list
64507118|NCT01833988|Pancreatin|pancreatin|mesh-list
64320851|NCT03534973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64320852|NCT03534973|Purinergic Agents|purinergic agents|mesh-ancestor
64320853|NCT03534973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64320855|NCT03534895|Anesthetics|anesthetics|mesh-ancestor
64320856|NCT03534895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64320857|NCT03534895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320858|NCT03534895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64320859|NCT03534895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64320860|NCT03534895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64320861|NCT03534895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64320862|NCT03534895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64472793|NCT02661035|Immunologic Factors|immunologic factors|mesh-ancestor
64733466|NCT00005059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733467|NCT00005065|Paclitaxel|paclitaxel|mesh-list
64733468|NCT00005065|Carboplatin|carboplatin|mesh-list
64733469|NCT00005065|Motexafin gadolinium|motexafin gadolinium|mesh-list
64733470|NCT00005065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64733471|NCT00005065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733472|NCT00005065|Tubulin Modulators|tubulin modulators|mesh-ancestor
64733473|NCT00005065|Antimitotic Agents|antimitotic agents|mesh-ancestor
64733474|NCT00005065|Mitosis Modulators|mitosis modulators|mesh-ancestor
64733475|NCT00005065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733476|NCT00005065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64733477|NCT00005065|Dermatologic Agents|dermatologic agents|mesh-ancestor
64733478|NCT00386191|Clopidogrel|clopidogrel|mesh-list
64733479|NCT00386191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64507119|NCT01833988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64507120|NCT05363436|Oxycodone|oxycodone|mesh-list
64507121|NCT05363436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64507122|NCT05363436|Narcotics|narcotics|mesh-ancestor
64494205|NCT01044862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955456|NCT00071838|Immunologic Factors|immunologic factors|mesh-ancestor
64955457|NCT00071838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726724|NCT05751187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64726725|NCT05751187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726726|NCT05751187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726727|NCT05751187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64726728|NCT05751187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64726729|NCT05751187|Hematinics|hematinics|mesh-ancestor
64726730|NCT05751187|Vitamin B Complex|vitamin b complex|mesh-ancestor
64726731|NCT00003416|Interferons|interferons|mesh-list
64726732|NCT00003416|Interferon-alpha|interferon-alpha|mesh-list
64726733|NCT00003416|Dexamethasone|dexamethasone|mesh-list
64726734|NCT00003416|Melphalan|melphalan|mesh-list
64726735|NCT00003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64726736|NCT00003416|Antiemetics|antiemetics|mesh-ancestor
64507123|NCT05363436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64507124|NCT05363436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320863|NCT03534895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64320864|NCT03534895|Anesthetics, General|anesthetics, general|mesh-ancestor
64320866|NCT03534895|GABA Agents|gaba agents|mesh-ancestor
64733480|NCT00386191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64733481|NCT00386191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64733482|NCT00386191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64733483|NCT00386191|Purinergic Agents|purinergic agents|mesh-ancestor
64429509|NCT05138549|Vitamins|vitamins|mesh-ancestor
64320868|NCT03534895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320869|NCT03535753|Decitabine|decitabine|mesh-list
64320870|NCT03535753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64320871|NCT03535753|Antimetabolites|antimetabolites|mesh-ancestor
64320872|NCT03535753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320873|NCT03535753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507125|NCT05363436|Analgesics|analgesics|mesh-ancestor
64507126|NCT05363436|Sensory System Agents|sensory system agents|mesh-ancestor
64507127|NCT05363436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507128|NCT03582774|Edetic Acid|edetic acid|mesh-list
64507129|NCT03582774|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64507133|NCT03582774|Anticoagulants|anticoagulants|mesh-ancestor
64507134|NCT03582774|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64507135|NCT03582774|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64507136|NCT01784614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64507138|NCT02474706|Cefoxitin|cefoxitin|mesh-list
64507139|NCT02474706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64507140|NCT02474706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64507141|NCT01784770|Azithromycin|azithromycin|mesh-list
64733484|NCT00386191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64733485|NCT00386191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733486|NCT00386191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733487|NCT00386269|Codeine|codeine|mesh-list
64733488|NCT00386269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64733489|NCT00386269|Narcotics|narcotics|mesh-ancestor
64733490|NCT00386269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64733491|NCT00386269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733492|NCT00386269|Analgesics|analgesics|mesh-ancestor
64733493|NCT00386269|Sensory System Agents|sensory system agents|mesh-ancestor
64733494|NCT00386269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64733495|NCT00386269|Antitussive Agents|antitussive agents|mesh-ancestor
64320875|NCT02189395|Insulin|insulin|mesh-list
64320876|NCT02189395|Insulin Lispro|insulin lispro|mesh-list
64320877|NCT02189395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64320878|NCT02189395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64320879|NCT02189395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415407|NCT05231941|Lidocaine|lidocaine|mesh-list
64507142|NCT01784770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64507143|NCT01784770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64507144|NCT02471274|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
64507145|NCT02471274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64507146|NCT02471274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507147|NCT02471274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64507148|NCT02471274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507149|NCT04491786|Gabapentin|gabapentin|mesh-list
64507150|NCT04491786|Nefopam|nefopam|mesh-list
64507151|NCT04491786|Analgesics|analgesics|mesh-ancestor
64507152|NCT04491786|Sensory System Agents|sensory system agents|mesh-ancestor
64507155|NCT04491786|Anticonvulsants|anticonvulsants|mesh-ancestor
64733496|NCT00386269|Respiratory System Agents|respiratory system agents|mesh-ancestor
64733497|NCT00005581|Paclitaxel|paclitaxel|mesh-list
64733498|NCT00005581|Cyclophosphamide|cyclophosphamide|mesh-list
64733499|NCT00005581|Fluorouracil|fluorouracil|mesh-list
64733500|NCT00005581|Epirubicin|epirubicin|mesh-list
64733501|NCT00005581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64733502|NCT00005581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733503|NCT00005581|Tubulin Modulators|tubulin modulators|mesh-ancestor
64733504|NCT00005581|Antimitotic Agents|antimitotic agents|mesh-ancestor
64733505|NCT00005581|Mitosis Modulators|mitosis modulators|mesh-ancestor
64733506|NCT00005581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733507|NCT00005581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64733508|NCT00005581|Immunologic Factors|immunologic factors|mesh-ancestor
64733509|NCT00005581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320881|NCT03535519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64320882|NCT03535519|Abortifacient Agents|abortifacient agents|mesh-ancestor
64320883|NCT03535519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64320884|NCT03535519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507156|NCT04491786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64507157|NCT04491786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64507158|NCT04491786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64507159|NCT04491786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64507160|NCT04491786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64507161|NCT04491786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64507162|NCT04491786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64507163|NCT04491786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507164|NCT04491786|Antimanic Agents|antimanic agents|mesh-ancestor
64507165|NCT04491786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64507166|NCT01786252|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64507167|NCT01786252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64733510|NCT00005581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64733511|NCT00005581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64733512|NCT00005581|Alkylating Agents|alkylating agents|mesh-ancestor
64733513|NCT00005581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64733514|NCT00005581|Antimetabolites|antimetabolites|mesh-ancestor
64733515|NCT00005581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64733516|NCT00005581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64733517|NCT00005581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64733518|NCT00005581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64733519|NCT00005581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733520|NCT00005077|Oxaliplatin|oxaliplatin|mesh-list
64733521|NCT00005077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733522|NCT00004489|Cholecalciferol|cholecalciferol|mesh-list
64733524|NCT00004489|Alendronate|alendronate|mesh-list
64733525|NCT00004489|Calcium Carbonate|calcium carbonate|mesh-list
64733526|NCT00004489|Calcium|calcium|mesh-list
64733527|NCT00004489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64733528|NCT00004489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733529|NCT00004489|Vitamins|vitamins|mesh-ancestor
64507168|NCT01786252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507170|NCT02470026|Mydriatics|mydriatics|mesh-ancestor
64507171|NCT02470026|Autonomic Agents|autonomic agents|mesh-ancestor
64507172|NCT02470026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507173|NCT02470026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726737|NCT00003416|Autonomic Agents|autonomic agents|mesh-ancestor
64726738|NCT00003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64726739|NCT00003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726740|NCT00003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64726741|NCT00003416|Glucocorticoids|glucocorticoids|mesh-ancestor
64726742|NCT00003416|Hormones|hormones|mesh-ancestor
64507174|NCT02470026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64507175|NCT02470026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64507176|NCT02470026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64507177|NCT02470026|Adrenergic Agents|adrenergic agents|mesh-ancestor
64507178|NCT02470026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64507179|NCT02470026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733530|NCT00004489|Micronutrients|micronutrients|mesh-ancestor
64733531|NCT00004489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64733532|NCT00004489|Antacids|antacids|mesh-ancestor
64733533|NCT00004489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733534|NCT00004489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64472868|NCT02444429|Methylprednisolone|methylprednisolone|mesh-list
64733535|NCT00005593|Carboplatin|carboplatin|mesh-list
64320887|NCT03535519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320889|NCT03535519|Dermatologic Agents|dermatologic agents|mesh-ancestor
64320890|NCT03535519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320891|NCT03535519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64733537|NCT00005593|Fludarabine phosphate|fludarabine phosphate|mesh-list
64733538|NCT00005593|Topotecan|topotecan|mesh-list
64733539|NCT00005593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733540|NCT00005593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64733541|NCT00005593|Antimetabolites|antimetabolites|mesh-ancestor
64733542|NCT00005593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733543|NCT00005593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64733544|NCT00005593|Immunologic Factors|immunologic factors|mesh-ancestor
64733545|NCT00005593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733546|NCT00005593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64733547|NCT00005593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64733548|NCT00005593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733549|NCT00004495|Folic Acid|folic acid|mesh-list
64733550|NCT00004495|Pyridoxine|pyridoxine|mesh-list
64733551|NCT00004495|Vitamin B 12|vitamin b 12|mesh-list
64733552|NCT00004495|Hydroxocobalamin|hydroxocobalamin|mesh-list
64507180|NCT02470026|Urological Agents|urological agents|mesh-ancestor
64507181|NCT01840072|Antihypertensive Agents|antihypertensive agents|mesh-list
64507182|NCT01807949|Ivacaftor|ivacaftor|mesh-list
64507183|NCT01807949|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64507184|NCT01807949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64507185|NCT01807949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507186|NCT02989558|Aspirin|aspirin|mesh-list
64507187|NCT02989558|Clopidogrel|clopidogrel|mesh-list
64733553|NCT00004495|Hematinics|hematinics|mesh-ancestor
64733554|NCT00004495|Vitamin B Complex|vitamin b complex|mesh-ancestor
64733555|NCT00004495|Vitamins|vitamins|mesh-ancestor
64320892|NCT03535519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64320893|NCT03535519|Immunologic Factors|immunologic factors|mesh-ancestor
64320894|NCT03535519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64320895|NCT03535519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64320896|NCT02194153|Tenecteplase|tenecteplase|mesh-list
64320897|NCT02194153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64733556|NCT00004495|Micronutrients|micronutrients|mesh-ancestor
64733557|NCT00004495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733558|NCT00005089|Prednisone|prednisone|mesh-list
64733559|NCT00005089|Cyclophosphamide|cyclophosphamide|mesh-list
64733560|NCT00005089|Rituximab|rituximab|mesh-list
64733561|NCT00005089|Doxorubicin|doxorubicin|mesh-list
64733562|NCT00005089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64733563|NCT00005089|Vincristine|vincristine|mesh-list
64733564|NCT00005089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64733565|NCT00005089|Immunologic Factors|immunologic factors|mesh-ancestor
64733566|NCT00005089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733567|NCT00005089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64733568|NCT00005089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64733569|NCT00005089|Alkylating Agents|alkylating agents|mesh-ancestor
64733570|NCT00005089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733571|NCT00005089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733572|NCT00005089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64733573|NCT00005089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64733574|NCT00005089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64733575|NCT00005089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64733576|NCT00005089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64733577|NCT00005089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733578|NCT00005089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64733579|NCT00005089|Glucocorticoids|glucocorticoids|mesh-ancestor
64733580|NCT00005089|Hormones|hormones|mesh-ancestor
64733581|NCT00005089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64733582|NCT00005089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64733583|NCT00005089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64733584|NCT00005089|Tubulin Modulators|tubulin modulators|mesh-ancestor
64320898|NCT02194153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64320899|NCT02194153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320900|NCT02194231|Trabectedin|trabectedin|mesh-list
64320904|NCT02194231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320906|NCT04292054|Tazobactam|tazobactam|mesh-list
64320907|NCT04292054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64320908|NCT04292054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64507189|NCT02989558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64507191|NCT02989558|Analgesics|analgesics|mesh-ancestor
64507192|NCT02989558|Sensory System Agents|sensory system agents|mesh-ancestor
64507193|NCT02989558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507194|NCT02989558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955458|NCT00202852|Infliximab|infliximab|mesh-list
64507195|NCT02989558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64320909|NCT04292054|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64320910|NCT04292054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733586|NCT00005089|Mitosis Modulators|mitosis modulators|mesh-ancestor
64733587|NCT00005599|Paclitaxel|paclitaxel|mesh-list
64733588|NCT00005599|Bryostatin 1|bryostatin 1|mesh-list
64733589|NCT00005599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64733590|NCT00005599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733591|NCT00005599|Tubulin Modulators|tubulin modulators|mesh-ancestor
64733592|NCT00005599|Antimitotic Agents|antimitotic agents|mesh-ancestor
64733593|NCT00005599|Mitosis Modulators|mitosis modulators|mesh-ancestor
64733594|NCT00005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733595|NCT00005599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64733596|NCT00005599|Immunologic Factors|immunologic factors|mesh-ancestor
64733597|NCT00005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733598|NCT00004567|Mycophenolic Acid|mycophenolic acid|mesh-list
64733599|NCT00004567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64733600|NCT00004567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733601|NCT00004567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64733602|NCT00004567|Antitubercular Agents|antitubercular agents|mesh-ancestor
64733603|NCT00004567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64733604|NCT00004567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64733605|NCT00004567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733606|NCT00004567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733607|NCT00005107|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
64733608|NCT00005107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320911|NCT04292054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320912|NCT04291508|Acetaminophen|acetaminophen|mesh-list
64320913|NCT04291508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733619|NCT00005113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733620|NCT00005113|Antifungal Agents|antifungal agents|mesh-ancestor
64733621|NCT00005113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64733622|NCT00005113|Dermatologic Agents|dermatologic agents|mesh-ancestor
64733623|NCT00005113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64733624|NCT00005113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64733625|NCT00005113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64320916|NCT04291508|Sensory System Agents|sensory system agents|mesh-ancestor
64320917|NCT04291508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507197|NCT02989558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64507198|NCT02989558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64507199|NCT02989558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507200|NCT02989558|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64507213|NCT01806779|Autonomic Agents|autonomic agents|mesh-ancestor
64507214|NCT01806779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507215|NCT01806779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507216|NCT01806779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64507217|NCT01806779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64507218|NCT01806779|Cholinergic Agents|cholinergic agents|mesh-ancestor
64320924|NCT02933671|Sensory System Agents|sensory system agents|mesh-ancestor
64320925|NCT02933671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64320926|NCT05509478|Lenvatinib|lenvatinib|mesh-list
64320927|NCT05509478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64733633|NCT00004573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733634|NCT00005623|Cyproterone Acetate|cyproterone acetate|mesh-list
64733635|NCT00005623|Cyproterone|cyproterone|mesh-list
64733636|NCT00005623|Androgen Antagonists|androgen antagonists|mesh-ancestor
64733637|NCT00005623|Hormone Antagonists|hormone antagonists|mesh-ancestor
64320928|NCT05509478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320929|NCT05509478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64320930|NCT05509478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507219|NCT01806779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64507220|NCT01806779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507221|NCT01806779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64507222|NCT01806779|Antidepressive Agents|antidepressive agents|mesh-ancestor
64507223|NCT01806779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64507224|NCT01806779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64320931|NCT05509478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320932|NCT02194309|Amlodipine|amlodipine|mesh-list
64320933|NCT02194309|Telmisartan|telmisartan|mesh-list
64733638|NCT00005623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64733639|NCT00005623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733640|NCT00005623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733641|NCT00005623|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64733642|NCT00005623|Contraceptive Agents|contraceptive agents|mesh-ancestor
64507225|NCT01806779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64507226|NCT01806779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64507227|NCT01806779|Dopamine Agents|dopamine agents|mesh-ancestor
64507228|NCT01806779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64507229|NCT01806779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64507230|NCT01806779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507231|NCT01878526|Domperidone|domperidone|mesh-list
64507232|NCT01878526|Antiemetics|antiemetics|mesh-ancestor
64507233|NCT01878526|Autonomic Agents|autonomic agents|mesh-ancestor
64320934|NCT02194309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64320935|NCT02194309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64320936|NCT02194309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64320937|NCT02194309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320938|NCT02194309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64320939|NCT02194309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320940|NCT02194309|Vasodilator Agents|vasodilator agents|mesh-ancestor
64733643|NCT00005623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64733645|NCT00005119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64733646|NCT00005119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733647|NCT00004585|Lamivudine|lamivudine|mesh-list
64733648|NCT00004585|Zidovudine|zidovudine|mesh-list
64733649|NCT00004585|Efavirenz|efavirenz|mesh-list
64733650|NCT00004585|Abacavir|abacavir|mesh-list
64733651|NCT00004585|Dideoxynucleosides|dideoxynucleosides|mesh-list
64733652|NCT00004585|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64733653|NCT00004585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64733654|NCT00004585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64733655|NCT00004585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733656|NCT00004585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733657|NCT00004585|Antiviral Agents|antiviral agents|mesh-ancestor
64733658|NCT00004585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64733659|NCT00004585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64320941|NCT02194309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64507234|NCT01878526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507235|NCT01878526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507236|NCT01878526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64507237|NCT01878526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64507238|NCT01878526|Dopamine Agents|dopamine agents|mesh-ancestor
64507239|NCT01878526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64507240|NCT01878526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507241|NCT01878604|Hypolipidemic Agents|hypolipidemic agents|mesh-list
64507242|NCT01878604|Antimetabolites|antimetabolites|mesh-ancestor
64507243|NCT01878604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507244|NCT01878604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64507245|NCT02266810|Mometasone Furoate|mometasone furoate|mesh-list
64507246|NCT02266810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64507247|NCT02266810|Dermatologic Agents|dermatologic agents|mesh-ancestor
64507248|NCT02266810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64726743|NCT00003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64726744|NCT00003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64726745|NCT00003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726746|NCT00003416|Antiviral Agents|antiviral agents|mesh-ancestor
64726747|NCT00003416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726748|NCT00003416|Immunologic Factors|immunologic factors|mesh-ancestor
64334231|NCT02352597|Clomiphene|clomiphene|mesh-list
64733660|NCT00004585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64733661|NCT00004585|Antimetabolites|antimetabolites|mesh-ancestor
64733662|NCT00004585|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64733663|NCT00004585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64733664|NCT00004585|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64733665|NCT00004585|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64733666|NCT00004585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64733667|NCT00004585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64733668|NCT00005635|Paclitaxel|paclitaxel|mesh-list
64733669|NCT00005635|Trastuzumab|trastuzumab|mesh-list
64733670|NCT00005635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64733671|NCT00005635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733672|NCT00005635|Tubulin Modulators|tubulin modulators|mesh-ancestor
64733673|NCT00005635|Antimitotic Agents|antimitotic agents|mesh-ancestor
64733674|NCT00005635|Mitosis Modulators|mitosis modulators|mesh-ancestor
64733675|NCT00005635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733676|NCT00005635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64733677|NCT00005641|Leucovorin|leucovorin|mesh-list
64733678|NCT00005641|Cyclosporine|cyclosporine|mesh-list
64733679|NCT00005641|Methylprednisolone|methylprednisolone|mesh-list
64415440|NCT05522231|Axitinib|axitinib|mesh-list
64415480|NCT03044665|Antimetabolites|antimetabolites|mesh-ancestor
64507249|NCT01806623|Fluconazole|fluconazole|mesh-list
64507250|NCT01806623|Antifungal Agents|antifungal agents|mesh-ancestor
64507251|NCT01806623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64507252|NCT01806623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64507253|NCT01806623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64507254|NCT01806623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507255|NCT01806623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507256|NCT01806623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64507257|NCT01806623|Hormone Antagonists|hormone antagonists|mesh-ancestor
64507258|NCT01806623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64507260|NCT01806623|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64507261|NCT01806623|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64507262|NCT01806545|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
64507296|NCT05211570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64507297|NCT05211570|Antimetabolites|antimetabolites|mesh-ancestor
64320942|NCT02194309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64320943|NCT04392505|Durvalumab|durvalumab|mesh-list
64320944|NCT04392505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64320945|NCT04392505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320946|NCT05502458|Propofol|propofol|mesh-list
64733680|NCT00005641|Cyclophosphamide|cyclophosphamide|mesh-list
64733681|NCT00005641|Busulfan|busulfan|mesh-list
64733682|NCT00005641|Methotrexate|methotrexate|mesh-list
64733683|NCT00005641|Cyclosporins|cyclosporins|mesh-list
64733684|NCT00005641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64507298|NCT05211570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507299|NCT05211570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507300|NCT05211570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507301|NCT03099564|Pembrolizumab|pembrolizumab|mesh-list
64507334|NCT01798264|Hormones|hormones|mesh-ancestor
64507335|NCT01798264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64507336|NCT05326984|Metformin|metformin|mesh-list
64507337|NCT05326984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64507338|NCT05326984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507339|NCT01800838|Silicon|silicon|mesh-list
64507340|NCT01800838|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
64507341|NCT01800838|Trace Elements|trace elements|mesh-ancestor
64507342|NCT01800838|Micronutrients|micronutrients|mesh-ancestor
64507343|NCT01800838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507344|NCT01800838|Antimalarials|antimalarials|mesh-ancestor
64507360|NCT01782131|Hormone Antagonists|hormone antagonists|mesh-ancestor
64507361|NCT01782131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64507362|NCT01782131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507363|NCT01782131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64507364|NCT01782131|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64507365|NCT01782131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64507366|NCT01782131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64507367|NCT01781975|Imatinib Mesylate|imatinib mesylate|mesh-list
64507368|NCT01781975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507369|NCT01781975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64320947|NCT05502458|Desflurane|desflurane|mesh-list
64320948|NCT05502458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64320949|NCT05502458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64320950|NCT05502458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320951|NCT05502458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64320952|NCT05502458|Anesthetics, General|anesthetics, general|mesh-ancestor
64320953|NCT05502458|Anesthetics|anesthetics|mesh-ancestor
64733686|NCT00005641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64733687|NCT00005641|Immunologic Factors|immunologic factors|mesh-ancestor
64733688|NCT00005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733689|NCT00005641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64733690|NCT00005641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64733691|NCT00005641|Alkylating Agents|alkylating agents|mesh-ancestor
64733692|NCT00005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733693|NCT00005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733694|NCT00005641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64733695|NCT00005641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64733696|NCT00005641|Abortifacient Agents|abortifacient agents|mesh-ancestor
64733697|NCT00005641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64733698|NCT00005641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64733700|NCT00005641|Dermatologic Agents|dermatologic agents|mesh-ancestor
64507370|NCT01781975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507371|NCT01781975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507372|NCT01855360|Doxycycline|doxycycline|mesh-list
64507373|NCT01855360|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
64507374|NCT01855360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64507375|NCT01855360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64507376|NCT01855360|Antimalarials|antimalarials|mesh-ancestor
64507377|NCT01855360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64507378|NCT01855360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64507379|NCT01855360|Antiviral Agents|antiviral agents|mesh-ancestor
64507380|NCT01855360|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64507381|NCT01855360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64507382|NCT04351126|Fludrocortisone|fludrocortisone|mesh-list
64507383|NCT04351126|Bromocriptine|bromocriptine|mesh-list
64507384|NCT04351126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64507385|NCT04351126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64507386|NCT04351126|Hormone Antagonists|hormone antagonists|mesh-ancestor
64507387|NCT04351126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64507388|NCT04351126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304158|NCT04926844|Midazolam|midazolam|mesh-list
64726749|NCT00003416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64726750|NCT00003416|Alkylating Agents|alkylating agents|mesh-ancestor
64726751|NCT00003416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726752|NCT00003416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64726753|NCT00003416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64726754|NCT00002569|Vincristine|vincristine|mesh-list
64726755|NCT00002569|Lomustine|lomustine|mesh-list
64726756|NCT00002569|Procarbazine|procarbazine|mesh-list
64334240|NCT02352597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507389|NCT04351126|Dopamine Agonists|dopamine agonists|mesh-ancestor
64507390|NCT04351126|Dopamine Agents|dopamine agents|mesh-ancestor
64507391|NCT04351126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64507392|NCT04351126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507393|NCT04351126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64507394|NCT01804673|Fentanyl|fentanyl|mesh-list
64507395|NCT01804673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64507396|NCT01804673|Narcotics|narcotics|mesh-ancestor
64507397|NCT01804673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64507398|NCT01804673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507399|NCT01804673|Analgesics|analgesics|mesh-ancestor
64507400|NCT01804673|Sensory System Agents|sensory system agents|mesh-ancestor
64507401|NCT01804673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507402|NCT01804673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64507403|NCT01804673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65495211|NCT00911820|Tubulin Modulators|tubulin modulators|mesh-ancestor
64507404|NCT01804673|Anesthetics, General|anesthetics, general|mesh-ancestor
64507405|NCT01804673|Anesthetics|anesthetics|mesh-ancestor
64507422|NCT05302336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64306830|NCT02071043|Oxaliplatin|oxaliplatin|mesh-list
64507423|NCT05302336|Tubulin Modulators|tubulin modulators|mesh-ancestor
64507424|NCT05302336|Antimitotic Agents|antimitotic agents|mesh-ancestor
64507425|NCT05302336|Mitosis Modulators|mitosis modulators|mesh-ancestor
64507426|NCT05302336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64507427|NCT05302336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64507428|NCT05302336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64507429|NCT05302336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507430|NCT01804036|Zolpidem|zolpidem|mesh-list
64507431|NCT01804036|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64309095|NCT03204045|Anesthetics|anesthetics|mesh-ancestor
64507432|NCT01804036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64507433|NCT01804036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64507434|NCT01804036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507435|NCT01804036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64507436|NCT01804036|GABA Agonists|gaba agonists|mesh-ancestor
64507437|NCT01804036|GABA Agents|gaba agents|mesh-ancestor
64507438|NCT01804036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64507439|NCT01804036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507440|NCT01857232|Dexamethasone|dexamethasone|mesh-list
64507441|NCT01857232|Ondansetron|ondansetron|mesh-list
64507442|NCT01857232|Fosaprepitant|fosaprepitant|mesh-list
64507443|NCT01857232|Aprepitant|aprepitant|mesh-list
64507444|NCT01857232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64507445|NCT01857232|Antiemetics|antiemetics|mesh-ancestor
64507446|NCT01857232|Autonomic Agents|autonomic agents|mesh-ancestor
64507447|NCT01857232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507448|NCT01857232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507449|NCT01857232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64507450|NCT01857232|Glucocorticoids|glucocorticoids|mesh-ancestor
64507451|NCT01857232|Hormones|hormones|mesh-ancestor
64507452|NCT01857232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64507453|NCT01857232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64507454|NCT01857232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507455|NCT01857232|Antipruritics|antipruritics|mesh-ancestor
64507456|NCT01857232|Dermatologic Agents|dermatologic agents|mesh-ancestor
64507457|NCT01857232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64507458|NCT01857232|Serotonin Agents|serotonin agents|mesh-ancestor
64421947|NCT05479487|Apatinib|apatinib|mesh-list
64507459|NCT01857232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64507460|NCT01857232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507461|NCT01857232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64507484|NCT02859558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64390218|NCT02426983|Antitussive Agents|antitussive agents|mesh-ancestor
64397579|NCT03097211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397580|NCT03097211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397640|NCT05054465|Navitoclax|navitoclax|mesh-list
64726757|NCT00002569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64726758|NCT00002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726759|NCT00002569|Tubulin Modulators|tubulin modulators|mesh-ancestor
64726760|NCT00002569|Antimitotic Agents|antimitotic agents|mesh-ancestor
64726761|NCT00002569|Mitosis Modulators|mitosis modulators|mesh-ancestor
64726762|NCT00002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726763|NCT00002569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64398335|NCT01949662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507485|NCT02859558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507486|NCT02859558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507488|NCT02859558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64507489|NCT02859558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64507490|NCT02859558|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64507491|NCT01860586|Bevacizumab|bevacizumab|mesh-list
64507492|NCT01860586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64507493|NCT01860586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507494|NCT01860586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64507495|NCT01860586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64507496|NCT01860586|Growth Substances|growth substances|mesh-ancestor
64507497|NCT01860586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507498|NCT01860586|Growth Inhibitors|growth inhibitors|mesh-ancestor
64507499|NCT00705432|Ribavirin|ribavirin|mesh-list
64507500|NCT00705432|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64507501|NCT00705432|Antimetabolites|antimetabolites|mesh-ancestor
64507502|NCT00705432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507503|NCT00705432|Antiviral Agents|antiviral agents|mesh-ancestor
64507504|NCT00705432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64507505|NCT00704964|Ribavirin|ribavirin|mesh-list
64399997|NCT05002517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64399999|NCT05002517|Prednisolone acetate|prednisolone acetate|mesh-list
64400000|NCT05002517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64400087|NCT04654429|Ondansetron|ondansetron|mesh-list
64507506|NCT00704964|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64507507|NCT00704964|Interferon-alpha|interferon-alpha|mesh-list
64507508|NCT00704964|Antimetabolites|antimetabolites|mesh-ancestor
64400230|NCT02578069|Sirolimus|sirolimus|mesh-list
64507509|NCT00704964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507510|NCT00704964|Antiviral Agents|antiviral agents|mesh-ancestor
64507511|NCT00704964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64400390|NCT04991207|Bosentan|bosentan|mesh-list
64507516|NCT00704808|Alkylating Agents|alkylating agents|mesh-ancestor
64507517|NCT00704808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507518|NCT00704808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507519|NCT05305794|Insulin|insulin|mesh-list
64507520|NCT05305794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64507521|NCT05305794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64507522|NCT05305794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507523|NCT02474316|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64507524|NCT02474316|Antiviral Agents|antiviral agents|mesh-ancestor
64507525|NCT02474316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64507526|NCT01862536|Tadalafil|tadalafil|mesh-list
64507527|NCT01862536|Vasodilator Agents|vasodilator agents|mesh-ancestor
64507528|NCT01862536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64507529|NCT01862536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64507530|NCT01862536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067011|NCT00273338|Vitamins|vitamins|mesh-ancestor
64507531|NCT01862536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507532|NCT01862536|Urological Agents|urological agents|mesh-ancestor
65067097|NCT00314379|Vitamin E|vitamin e|mesh-list
64507533|NCT01862614|Epinephrine|epinephrine|mesh-list
64507534|NCT01862614|Racepinephrine|racepinephrine|mesh-list
64507536|NCT01862614|Epinephryl borate|epinephryl borate|mesh-list
64507537|NCT01862614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64507538|NCT01862614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64507539|NCT01862614|Adrenergic Agents|adrenergic agents|mesh-ancestor
64507540|NCT01862614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64507541|NCT01862614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507542|NCT01862614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507543|NCT01862614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65067435|NCT00308880|Hemostatics|hemostatics|mesh-ancestor
64507544|NCT01862614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64507545|NCT01862614|Autonomic Agents|autonomic agents|mesh-ancestor
64507546|NCT01862614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507547|NCT01862614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64507548|NCT01862614|Respiratory System Agents|respiratory system agents|mesh-ancestor
64726764|NCT00002569|Alkylating Agents|alkylating agents|mesh-ancestor
64726765|NCT00002840|Vincristine|vincristine|mesh-list
64726766|NCT00002840|Lomustine|lomustine|mesh-list
64726767|NCT00002840|Procarbazine|procarbazine|mesh-list
64726768|NCT00002840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64726769|NCT00002840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726770|NCT00002840|Tubulin Modulators|tubulin modulators|mesh-ancestor
64334255|NCT03521167|Ketamine|ketamine|mesh-list
64507549|NCT01862614|Mydriatics|mydriatics|mesh-ancestor
64507550|NCT01862614|Sympathomimetics|sympathomimetics|mesh-ancestor
64507551|NCT01862614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64507552|NCT01862614|Anesthetics, Local|anesthetics, local|mesh-ancestor
64507553|NCT01862614|Anesthetics|anesthetics|mesh-ancestor
64507554|NCT01862614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65067966|NCT00310128|Hormones|hormones|mesh-ancestor
64507555|NCT01862614|Sensory System Agents|sensory system agents|mesh-ancestor
64507556|NCT05166876|Brequinar|brequinar|mesh-list
64507557|NCT05166876|Dipyridamole|dipyridamole|mesh-list
65068023|NCT00280007|Bevacizumab|bevacizumab|mesh-list
64507558|NCT05166876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64507560|NCT05166876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068167|NCT00310596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507561|NCT05166876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64955464|NCT00202891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65068240|NCT00416858|Antimetabolites|antimetabolites|mesh-ancestor
64955465|NCT00202891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64507562|NCT05166876|Vasodilator Agents|vasodilator agents|mesh-ancestor
64507563|NCT05166876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507564|NCT05166876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64507565|NCT05166876|Immunologic Factors|immunologic factors|mesh-ancestor
64507566|NCT05166876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507567|NCT02470650|Ritonavir|ritonavir|mesh-list
64507568|NCT02470650|Darunavir|darunavir|mesh-list
64507569|NCT02470650|Tenofovir|tenofovir|mesh-list
64507570|NCT02470650|Lamivudine|lamivudine|mesh-list
64507571|NCT02470650|Emtricitabine|emtricitabine|mesh-list
64507572|NCT02470650|Abacavir|abacavir|mesh-list
64507573|NCT02470650|Cobicistat|cobicistat|mesh-list
64507574|NCT02470650|Rilpivirine|rilpivirine|mesh-list
64507575|NCT02470650|Elvitegravir|elvitegravir|mesh-list
64507576|NCT02470650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65495478|NCT01967238|Vaccines|vaccines|mesh-list
64507577|NCT02470650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64507578|NCT02470650|Protease Inhibitors|protease inhibitors|mesh-ancestor
64507579|NCT02470650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507580|NCT02470650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507581|NCT02470650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64507582|NCT02470650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64507583|NCT02470650|Antiviral Agents|antiviral agents|mesh-ancestor
64507584|NCT02470650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64507616|NCT00704418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507617|NCT00704418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507619|NCT00704418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64507620|NCT01869634|Ritonavir|ritonavir|mesh-list
64507621|NCT01869634|Darunavir|darunavir|mesh-list
64507622|NCT01869634|Emtricitabine|emtricitabine|mesh-list
64507623|NCT01869634|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65495959|NCT03984214|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65495963|NCT03984214|Hormones|hormones|mesh-ancestor
64507624|NCT01869634|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64507625|NCT01869634|Protease Inhibitors|protease inhibitors|mesh-ancestor
64507682|NCT05542264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65496034|NCT04113538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64507683|NCT05542264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64507684|NCT05542264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64507685|NCT05542264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64507686|NCT05542264|Dopamine Agents|dopamine agents|mesh-ancestor
64507687|NCT05542264|Antiemetics|antiemetics|mesh-ancestor
64507688|NCT05542264|Autonomic Agents|autonomic agents|mesh-ancestor
64507689|NCT05542264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496171|NCT01257048|Hormones|hormones|mesh-ancestor
64507690|NCT05542264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64507691|NCT05542264|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64507692|NCT05542264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64507693|NCT05542264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64507694|NCT05542264|Antidepressive Agents|antidepressive agents|mesh-ancestor
64507695|NCT05542264|Dopamine Agonists|dopamine agonists|mesh-ancestor
64726771|NCT00002840|Antimitotic Agents|antimitotic agents|mesh-ancestor
64726772|NCT00002840|Mitosis Modulators|mitosis modulators|mesh-ancestor
64726773|NCT00002840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496455|NCT03892512|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64726774|NCT00002840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65496525|NCT03892122|Anesthetics|anesthetics|mesh-ancestor
64726775|NCT00002840|Alkylating Agents|alkylating agents|mesh-ancestor
64726776|NCT00002846|Aldesleukin|aldesleukin|mesh-list
64726777|NCT00002846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726778|NCT00002846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64726779|NCT00002846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64726780|NCT00002846|Antiviral Agents|antiviral agents|mesh-ancestor
64507696|NCT05542264|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64507697|NCT05542264|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64507698|NCT05542264|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65496739|NCT01260714|Mitosis Modulators|mitosis modulators|mesh-ancestor
64507699|NCT05542264|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64507700|NCT03314064|Dolutegravir|dolutegravir|mesh-list
64507701|NCT03314064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64507702|NCT03314064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64507703|NCT03314064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507704|NCT03314064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507705|NCT03314064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65497091|NCT03760068|Insulin Aspart|insulin aspart|mesh-list
64507706|NCT03314064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64507707|NCT03314064|Antiviral Agents|antiviral agents|mesh-ancestor
64507708|NCT03314064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64507709|NCT00552058|Certolizumab Pegol|certolizumab pegol|mesh-list
64507710|NCT00552058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64507711|NCT00552058|Immunologic Factors|immunologic factors|mesh-ancestor
65497232|NCT01162824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65497300|NCT01158846|Protease Inhibitors|protease inhibitors|mesh-ancestor
65497373|NCT01161186|Antimetabolites|antimetabolites|mesh-ancestor
64507712|NCT00552058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507713|NCT00552058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64507714|NCT02473302|Tocopherols|tocopherols|mesh-list
65497518|NCT01269528|Protective Agents|protective agents|mesh-ancestor
64955469|NCT00202969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507715|NCT02473302|Vitamin E|vitamin e|mesh-list
65497598|NCT01280682|Rituximab|rituximab|mesh-list
64507745|NCT03108300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64507746|NCT03108300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507747|NCT03108300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65497737|NCT01281696|Growth Inhibitors|growth inhibitors|mesh-ancestor
64507748|NCT03108300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64507750|NCT03313752|Dapagliflozin|dapagliflozin|mesh-list
64507751|NCT03313752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64507752|NCT03313752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507753|NCT03313752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65497954|NCT05834244|Antimetabolites|antimetabolites|mesh-ancestor
64507754|NCT03313752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507755|NCT02473146|Gemtuzumab|gemtuzumab|mesh-list
64507756|NCT02473146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64507757|NCT02473146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507758|NCT02989012|Oseltamivir|oseltamivir|mesh-list
64507759|NCT02989012|Antiviral Agents|antiviral agents|mesh-ancestor
64507760|NCT02989012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64507772|NCT03832894|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64507774|NCT03832894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64507775|NCT03832894|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64507776|NCT03832894|Progestins|progestins|mesh-ancestor
64507777|NCT02989324|Misoprostol|misoprostol|mesh-list
64507778|NCT02989324|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64507779|NCT02989324|Abortifacient Agents|abortifacient agents|mesh-ancestor
65498317|NCT05651711|KHK4083|khk4083|mesh-list
64507780|NCT02989324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64507781|NCT02989324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498454|NCT05578976|Rituximab|rituximab|mesh-list
64507782|NCT02989324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64507783|NCT02989324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64507784|NCT02989324|Oxytocics|oxytocics|mesh-ancestor
64507785|NCT03686124|Nivolumab|nivolumab|mesh-list
65498531|NCT05470283|Cyclophosphamide|cyclophosphamide|mesh-list
64507786|NCT03686124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64955471|NCT00203125|Tyramine|tyramine|mesh-list
64955472|NCT00203125|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64507789|NCT03686124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726784|NCT05720767|Antifungal Agents|antifungal agents|mesh-ancestor
64726785|NCT05720767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65498970|NCT04938830|Palivizumab|palivizumab|mesh-list
64726786|NCT05720767|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64726787|NCT05720767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64726788|NCT05720767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726789|NCT05720767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726790|NCT05720767|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64726791|NCT05720767|Hormone Antagonists|hormone antagonists|mesh-ancestor
64726792|NCT05720767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65499339|NCT04464798|Immunologic Factors|immunologic factors|mesh-ancestor
64726793|NCT05720767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726794|NCT05720767|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64726795|NCT05720767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64726796|NCT05720767|Antitubercular Agents|antitubercular agents|mesh-ancestor
64726797|NCT05720767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64726798|NCT05720767|Leprostatic Agents|leprostatic agents|mesh-ancestor
64726799|NCT05720767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64726800|NCT05720767|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65499556|NCT04201873|Laxatives|laxatives|mesh-ancestor
64726801|NCT05720767|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64466097|NCT02514382|Bortezomib|bortezomib|mesh-list
64955473|NCT00203125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507790|NCT00550732|Posaconazole|posaconazole|mesh-list
64507791|NCT00550732|Antifungal Agents|antifungal agents|mesh-ancestor
64507792|NCT00550732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64507793|NCT00550732|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64507794|NCT00550732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65499848|NCT03516812|Hormones|hormones|mesh-ancestor
64507795|NCT00550732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65499922|NCT03282123|Hallucinogens|hallucinogens|mesh-ancestor
64507796|NCT00550732|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65499989|NCT03178552|Immunologic Factors|immunologic factors|mesh-ancestor
64507797|NCT00550732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64507798|NCT00550732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509234|NCT03672292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64507799|NCT00550732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500141|NCT02668770|Ipilimumab|ipilimumab|mesh-list
64507800|NCT00550732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64507801|NCT00550732|Hormone Antagonists|hormone antagonists|mesh-ancestor
64507802|NCT00550732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64507807|NCT03311022|Nefopam|nefopam|mesh-list
64507808|NCT03311022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64507809|NCT03311022|Analgesics|analgesics|mesh-ancestor
64507810|NCT03311022|Sensory System Agents|sensory system agents|mesh-ancestor
64509235|NCT03672292|Hormone Antagonists|hormone antagonists|mesh-ancestor
64507811|NCT03311022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507812|NCT03311022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507813|NCT03313206|Pembrolizumab|pembrolizumab|mesh-list
64507814|NCT03313206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64507815|NCT03313206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726802|NCT05720767|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64726803|NCT05720767|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64726804|NCT05720767|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64726805|NCT05720767|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64726806|NCT05751031|Raltegravir Potassium|raltegravir potassium|mesh-list
64726807|NCT05751031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64726808|NCT05751031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65500640|NCT00042406|Zanolimumab|zanolimumab|mesh-list
64507817|NCT00550420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64507818|NCT00550420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507819|NCT00559936|Bevacizumab|bevacizumab|mesh-list
64507820|NCT00559936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64507821|NCT00559936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507846|NCT03312582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068612|NCT00283790|Zolpidem|zolpidem|mesh-list
64507848|NCT04350580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64507849|NCT04350580|Antibodies|antibodies|mesh-list
64507850|NCT04350580|Immunologic Factors|immunologic factors|mesh-ancestor
64507851|NCT04350580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507852|NCT00558064|Amlodipine|amlodipine|mesh-list
64507853|NCT00558064|Telmisartan|telmisartan|mesh-list
64507854|NCT00558064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
64507855|NCT00558064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64507856|NCT00558064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64507857|NCT00558064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64507858|NCT00558064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507859|NCT00558064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64507860|NCT00558064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507861|NCT00558064|Vasodilator Agents|vasodilator agents|mesh-ancestor
64507862|NCT00558064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64507863|NCT00558064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64507864|NCT03312426|Linrodostat|linrodostat|mesh-list
65068894|NCT00285155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64955474|NCT00203125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507865|NCT03312426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068971|NCT00319488|Glucocorticoids|glucocorticoids|mesh-ancestor
65069042|NCT00319683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507866|NCT03312426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507867|NCT03309618|Valsartan|valsartan|mesh-list
65069128|NCT00319878|Cyclosporine|cyclosporine|mesh-list
64507868|NCT03309618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65069187|NCT00320034|Tocolytic Agents|tocolytic agents|mesh-ancestor
64507869|NCT03309618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64507887|NCT00557440|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64507888|NCT00557440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64507889|NCT00557440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64507890|NCT00557440|Autonomic Agents|autonomic agents|mesh-ancestor
64507891|NCT00557440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507892|NCT00557440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507893|NCT00557440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64507894|NCT00557440|Respiratory System Agents|respiratory system agents|mesh-ancestor
64507895|NCT00557440|Dermatologic Agents|dermatologic agents|mesh-ancestor
64507896|NCT00557440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64507897|NCT00557440|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64507898|NCT00557440|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64507899|NCT00557440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64507900|NCT00557440|Adrenergic Agents|adrenergic agents|mesh-ancestor
64507901|NCT00557440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64507902|NCT00557440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507903|NCT00557440|Glucocorticoids|glucocorticoids|mesh-ancestor
64507904|NCT00557440|Hormones|hormones|mesh-ancestor
65069316|NCT00287105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069321|NCT00313599|Paclitaxel|paclitaxel|mesh-list
64507905|NCT00557440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64507906|NCT00557440|Sympathomimetics|sympathomimetics|mesh-ancestor
64507907|NCT03311178|Dobutamine|dobutamine|mesh-list
64507908|NCT03311178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64507909|NCT03311178|Sympathomimetics|sympathomimetics|mesh-ancestor
64507910|NCT03311178|Autonomic Agents|autonomic agents|mesh-ancestor
64507911|NCT03311178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507912|NCT03311178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507913|NCT03311178|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64726809|NCT05751031|Antiviral Agents|antiviral agents|mesh-ancestor
65069609|NCT00288158|Renal Agents|renal agents|mesh-ancestor
64726810|NCT05751031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726811|NCT05751031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64726812|NCT05751031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64507914|NCT03311178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64507915|NCT03311178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64507916|NCT03311178|Adrenergic Agents|adrenergic agents|mesh-ancestor
64507917|NCT03311178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64507918|NCT03311178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069898|NCT00289445|Mitomycins|mitomycins|mesh-list
64507919|NCT03311178|Protective Agents|protective agents|mesh-ancestor
64507920|NCT02469012|Ribavirin|ribavirin|mesh-list
64507921|NCT02469012|Sofosbuvir|sofosbuvir|mesh-list
64507922|NCT02469012|Ledipasvir|ledipasvir|mesh-list
64507923|NCT02469012|Antimetabolites|antimetabolites|mesh-ancestor
65070045|NCT00290264|Glucocorticoids|glucocorticoids|mesh-ancestor
64507924|NCT02469012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507925|NCT02469012|Antiviral Agents|antiviral agents|mesh-ancestor
64507951|NCT03303378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507952|NCT03303378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64507953|NCT04491474|Lidocaine|lidocaine|mesh-list
64507954|NCT04491474|Anesthetics, Local|anesthetics, local|mesh-ancestor
64507955|NCT04491474|Anesthetics|anesthetics|mesh-ancestor
64507956|NCT04491474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64507957|NCT04491474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507958|NCT04491474|Sensory System Agents|sensory system agents|mesh-ancestor
64507959|NCT04491474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507960|NCT04491474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64507961|NCT04491474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65070460|NCT00304551|Ribavirin|ribavirin|mesh-list
64507962|NCT04491474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65070562|NCT00293072|Rituximab|rituximab|mesh-list
64507963|NCT04491474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64507964|NCT04491474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507965|NCT03308682|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
64507966|NCT03308682|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65070634|NCT00293657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64507967|NCT03308682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070706|NCT00294008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64507969|NCT03308604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507970|NCT05176288|Palbociclib|palbociclib|mesh-list
64507971|NCT05176288|Avelumab|avelumab|mesh-list
64507972|NCT05176288|Axitinib|axitinib|mesh-list
65070848|NCT00294593|Leucovorin|leucovorin|mesh-list
64507973|NCT05176288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070920|NCT00295178|Daptomycin|daptomycin|mesh-list
64507974|NCT05176288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64507975|NCT05176288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507992|NCT00553306|Sensory System Agents|sensory system agents|mesh-ancestor
64507993|NCT00553306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507994|NCT00553306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64507995|NCT00553306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64507996|NCT00553306|Antiviral Agents|antiviral agents|mesh-ancestor
64507997|NCT00553306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64507998|NCT02722044|Adalimumab|adalimumab|mesh-list
64507999|NCT02722044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64422072|NCT05424835|Antimetabolites|antimetabolites|mesh-ancestor
64508000|NCT02722044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64508002|NCT05728008|Tofacitinib|tofacitinib|mesh-list
64508003|NCT05728008|Dermatologic Agents|dermatologic agents|mesh-ancestor
64508004|NCT05728008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64508005|NCT05728008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508006|NCT05728008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508007|NCT02988700|Bupivacaine|bupivacaine|mesh-list
64508008|NCT02988700|Anesthetics, Local|anesthetics, local|mesh-ancestor
65071352|NCT04231773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64508010|NCT02988700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64508011|NCT02988700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955476|NCT00203125|Protective Agents|protective agents|mesh-ancestor
64508012|NCT02988700|Sensory System Agents|sensory system agents|mesh-ancestor
64508013|NCT02988700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64508014|NCT03308214|Imipenem|imipenem|mesh-list
64508015|NCT03308214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64508016|NCT03308214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64508017|NCT03308136|Lidocaine|lidocaine|mesh-list
64508018|NCT03308136|Anesthetics, Local|anesthetics, local|mesh-list
64508019|NCT03308136|Anesthetics|anesthetics|mesh-list
64508020|NCT03308136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65071494|NCT00298883|Mycophenolic Acid|mycophenolic acid|mesh-list
64508021|NCT03308136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508022|NCT03308136|Sensory System Agents|sensory system agents|mesh-ancestor
64726813|NCT05751031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071713|NCT00300794|Ketamine|ketamine|mesh-list
64726814|NCT05751031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726815|NCT00002852|Paclitaxel|paclitaxel|mesh-list
64726816|NCT00002852|Carboplatin|carboplatin|mesh-list
64726817|NCT00002852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65072004|NCT00302549|Immunologic Factors|immunologic factors|mesh-ancestor
64726818|NCT00002852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726819|NCT00002852|Tubulin Modulators|tubulin modulators|mesh-ancestor
64508023|NCT03308136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64508024|NCT03308136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64508025|NCT03308136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64508026|NCT03308136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64508027|NCT03308136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64508028|NCT03308136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508029|NCT02466984|Metoclopramide|metoclopramide|mesh-list
64508030|NCT02466984|Antiemetics|antiemetics|mesh-ancestor
64508031|NCT02466984|Autonomic Agents|autonomic agents|mesh-ancestor
64508032|NCT02466984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64508033|NCT02466984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508071|NCT04927312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64955479|NCT00203125|Autonomic Agents|autonomic agents|mesh-ancestor
64955480|NCT00203125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64955481|NCT00203125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64955482|NCT00203125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64508087|NCT03307590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64508088|NCT03307590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64508089|NCT03307590|Adrenergic Agents|adrenergic agents|mesh-ancestor
64508090|NCT03307590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64508091|NCT03307590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072968|NCT00451139|Artemether|artemether|mesh-list
64508093|NCT03302208|Analgesics|analgesics|mesh-ancestor
64508094|NCT03302208|Sensory System Agents|sensory system agents|mesh-ancestor
65073033|NCT00451646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64508095|NCT03302208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64508096|NCT03302208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508097|NCT03302208|Anticonvulsants|anticonvulsants|mesh-ancestor
64508098|NCT03302208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64508099|NCT03302208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65073248|NCT00452270|Xylometazoline|xylometazoline|mesh-list
64508100|NCT03302208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073321|NCT00452855|Analgesics|analgesics|mesh-ancestor
64508101|NCT03302208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64508102|NCT03302208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64508103|NCT03302208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64508104|NCT03302208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64508105|NCT03302208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64508106|NCT03307512|Insulin|insulin|mesh-list
64508107|NCT03307512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64508108|NCT03307512|Insulin Lispro|insulin lispro|mesh-list
64508109|NCT03307512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65073550|NCT00322062|Ascorbic Acid|ascorbic acid|mesh-list
64508110|NCT03307512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073615|NCT00336765|XL647|xl647|mesh-list
64508111|NCT02466828|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64508112|NCT02466828|Hematinics|hematinics|mesh-ancestor
64508113|NCT02466828|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64508114|NCT02466828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64508115|NCT02721966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65073760|NCT00337545|Everolimus|everolimus|mesh-list
64508116|NCT02721966|Immunologic Factors|immunologic factors|mesh-ancestor
64508117|NCT02721966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508118|NCT00553462|Paclitaxel|paclitaxel|mesh-list
64508119|NCT00553462|Carboplatin|carboplatin|mesh-list
64508120|NCT00553462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64508121|NCT00553462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64508122|NCT00553462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64508123|NCT00553462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508124|NCT00553462|Tubulin Modulators|tubulin modulators|mesh-ancestor
64508125|NCT00553462|Antimitotic Agents|antimitotic agents|mesh-ancestor
64508126|NCT00553462|Mitosis Modulators|mitosis modulators|mesh-ancestor
64508149|NCT03306732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508150|NCT00553150|Everolimus|everolimus|mesh-list
64508151|NCT00553150|Temozolomide|temozolomide|mesh-list
64508152|NCT00553150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508153|NCT00553150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64508154|NCT00553150|Immunologic Factors|immunologic factors|mesh-ancestor
64726820|NCT00002852|Antimitotic Agents|antimitotic agents|mesh-ancestor
64726821|NCT00002852|Mitosis Modulators|mitosis modulators|mesh-ancestor
64726822|NCT00002852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726823|NCT00003422|Leucovorin|leucovorin|mesh-list
64726824|NCT00003422|Fluorouracil|fluorouracil|mesh-list
64726825|NCT00003422|Calcium|calcium|mesh-list
64726826|NCT00003422|Levoleucovorin|levoleucovorin|mesh-list
65073977|NCT00341250|Antacids|antacids|mesh-ancestor
64726827|NCT00003422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65074035|NCT00309218|Prednisolone phosphate|prednisolone phosphate|mesh-list
64726828|NCT00003422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716164|NCT03245762|Oxytocin|oxytocin|mesh-list
64726829|NCT00003422|Antimetabolites|antimetabolites|mesh-ancestor
65074196|NCT00309881|Hormones|hormones|mesh-ancestor
64726830|NCT00003422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074331|NCT00310778|Atenolol|atenolol|mesh-list
64726831|NCT00003422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64716463|NCT03591068|Xhance|xhance|mesh-list
64726832|NCT00003422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508155|NCT00553150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508156|NCT00553150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65074559|NCT00343005|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64508157|NCT00553150|Alkylating Agents|alkylating agents|mesh-ancestor
64508158|NCT00553150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074624|NCT00343161|Magnesium trisilicate|magnesium trisilicate|mesh-list
65074698|NCT00343278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65074699|NCT00343317|Cefoxitin|cefoxitin|mesh-list
65074772|NCT00419042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508161|NCT02468232|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64508162|NCT02468232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64508163|NCT02468232|Protease Inhibitors|protease inhibitors|mesh-ancestor
64508164|NCT02468232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074949|NCT00348387|Vaccines|vaccines|mesh-list
64508165|NCT02468232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508166|NCT02468232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64508167|NCT02468232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64508168|NCT02246920|Fluticasone|fluticasone|mesh-list
64508170|NCT02246920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64508171|NCT02246920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65075144|NCT02960126|Antipyretics|antipyretics|mesh-ancestor
64508172|NCT02246920|Autonomic Agents|autonomic agents|mesh-ancestor
64508173|NCT02246920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64508174|NCT02246920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508175|NCT02246920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64508176|NCT02246920|Respiratory System Agents|respiratory system agents|mesh-ancestor
65075285|NCT00315965|Gasotransmitters|gasotransmitters|mesh-ancestor
64508177|NCT02246920|Dermatologic Agents|dermatologic agents|mesh-ancestor
64508178|NCT02246920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64508179|NCT04630834|Acetaminophen|acetaminophen|mesh-list
64508180|NCT04630834|Ibuprofen|ibuprofen|mesh-list
64508198|NCT03301350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508199|NCT03301350|Tubulin Modulators|tubulin modulators|mesh-ancestor
65075502|NCT00317096|Rituximab|rituximab|mesh-list
64508200|NCT03301350|Antimitotic Agents|antimitotic agents|mesh-ancestor
64508201|NCT03301350|Mitosis Modulators|mitosis modulators|mesh-ancestor
64508202|NCT03301350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508203|NCT03301350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64508204|NCT03301350|Immunologic Factors|immunologic factors|mesh-ancestor
64508205|NCT03301350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508206|NCT03301350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64508207|NCT03301350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64508208|NCT03301350|Alkylating Agents|alkylating agents|mesh-ancestor
64508209|NCT03301350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64508210|NCT03301350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64508211|NCT03301350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64508212|NCT03301350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64508213|NCT03301350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508215|NCT05722704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64508216|NCT05722704|Antifungal Agents|antifungal agents|mesh-ancestor
64508217|NCT05722704|Keratolytic Agents|keratolytic agents|mesh-ancestor
64508218|NCT05722704|Dermatologic Agents|dermatologic agents|mesh-ancestor
64508219|NCT02722278|Methyltestosterone|methyltestosterone|mesh-list
64508220|NCT02722278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64508221|NCT02722278|Testosterone|testosterone|mesh-list
64508222|NCT02722278|Testosterone undecanoate|testosterone undecanoate|mesh-list
64726833|NCT00003422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64726834|NCT00003422|Immunologic Factors|immunologic factors|mesh-ancestor
64726835|NCT00003422|Antidotes|antidotes|mesh-ancestor
64726836|NCT00003422|Protective Agents|protective agents|mesh-ancestor
64726837|NCT00003422|Vitamin B Complex|vitamin b complex|mesh-ancestor
64508223|NCT02722278|Testosterone enanthate|testosterone enanthate|mesh-list
64508224|NCT02722278|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64508225|NCT02722278|Androgens|androgens|mesh-ancestor
64508226|NCT02722278|Hormones|hormones|mesh-ancestor
64508227|NCT02722278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64508228|NCT02722278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508229|NCT02722278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64508230|NCT02722278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508231|NCT02722278|Anabolic Agents|anabolic agents|mesh-ancestor
64508232|NCT03300960|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64508234|NCT03300960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65076080|NCT00346749|Xhance|xhance|mesh-list
64508236|NCT03300960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64508237|NCT03300960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508238|NCT03300960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65076218|NCT00347295|Estazolam|estazolam|mesh-list
64508239|NCT03300960|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64508247|NCT02485444|Oxytocics|oxytocics|mesh-ancestor
64508248|NCT02485444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64508249|NCT02485444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508250|NCT04443010|Temozolomide|temozolomide|mesh-list
65076292|NCT00352092|Sirolimus|sirolimus|mesh-list
65076365|NCT00352521|Growth Substances|growth substances|mesh-ancestor
64508251|NCT04443010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64508252|NCT04443010|Alkylating Agents|alkylating agents|mesh-ancestor
65076518|NCT00323375|Amebicides|amebicides|mesh-ancestor
65076582|NCT00353340|Antidotes|antidotes|mesh-ancestor
64508253|NCT04443010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508254|NCT04443010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508255|NCT04490694|Lenvatinib|lenvatinib|mesh-list
64508256|NCT04490694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508257|NCT04490694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64508258|NCT04490694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508259|NCT04490694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508260|NCT04601584|Antibodies|antibodies|mesh-list
64508261|NCT04601584|Immunoglobulins|immunoglobulins|mesh-list
64508262|NCT04601584|Immunologic Factors|immunologic factors|mesh-ancestor
64508263|NCT04601584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508264|NCT02359474|Trabectedin|trabectedin|mesh-list
64508265|NCT02359474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64508266|NCT02359474|Alkylating Agents|alkylating agents|mesh-ancestor
64508267|NCT02359474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508268|NCT02359474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508270|NCT02467686|Exemestane|exemestane|mesh-list
64508271|NCT02467686|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64508272|NCT02467686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64508273|NCT02467686|Hormone Antagonists|hormone antagonists|mesh-ancestor
64508274|NCT02467686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64508276|NCT02467686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64508277|NCT02467686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077313|NCT00427128|Fluoxetine|fluoxetine|mesh-list
64508278|NCT02467686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64508279|NCT02467686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64508280|NCT02467686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65077458|NCT00432510|Immunologic Factors|immunologic factors|mesh-ancestor
64508281|NCT02467686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64508282|NCT02467686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508283|NCT02467686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508284|NCT05707962|Magnesium Sulfate|magnesium sulfate|mesh-list
64508285|NCT05707962|Neuroprotective Agents|neuroprotective agents|mesh-list
64508287|NCT05707962|Sensory System Agents|sensory system agents|mesh-ancestor
64508288|NCT05707962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64508289|NCT05707962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508290|NCT05707962|Anesthetics|anesthetics|mesh-ancestor
64508291|NCT05707962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64508292|NCT05707962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64508293|NCT05707962|Anticonvulsants|anticonvulsants|mesh-ancestor
64508294|NCT05707962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64726839|NCT00003422|Micronutrients|micronutrients|mesh-ancestor
64726840|NCT00003176|Temozolomide|temozolomide|mesh-list
64726841|NCT00003176|Carmustine|carmustine|mesh-list
64726842|NCT00003176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64508295|NCT05707962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65077888|NCT04703127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65077960|NCT02244125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64508296|NCT05707962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078039|NCT04704297|Analgesics|analgesics|mesh-ancestor
64508297|NCT05707962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64508298|NCT05707962|Tocolytic Agents|tocolytic agents|mesh-ancestor
64508299|NCT05707962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64508300|NCT05707962|Protective Agents|protective agents|mesh-ancestor
64508301|NCT01993810|Paclitaxel|paclitaxel|mesh-list
64508302|NCT01993810|Etoposide|etoposide|mesh-list
65078268|NCT00329381|Omalizumab|omalizumab|mesh-list
64508303|NCT01993810|Podophyllotoxin|podophyllotoxin|mesh-list
64508304|NCT01993810|Cisplatin|cisplatin|mesh-list
64508305|NCT01993810|Carboplatin|carboplatin|mesh-list
64508306|NCT01993810|Pemetrexed|pemetrexed|mesh-list
64508307|NCT01993810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64508308|NCT01993810|Etoposide phosphate|etoposide phosphate|mesh-list
64508322|NCT01993810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64508329|NCT05698680|Prednisolone|prednisolone|mesh-list
64508330|NCT05698680|Colchicine|colchicine|mesh-list
64508331|NCT05698680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64508332|NCT05698680|Glucocorticoids|glucocorticoids|mesh-ancestor
64508333|NCT05698680|Hormones|hormones|mesh-ancestor
64508334|NCT05698680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64508335|NCT05698680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508336|NCT05698680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64508337|NCT05698680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508338|NCT05698680|Gout Suppressants|gout suppressants|mesh-ancestor
64508339|NCT05698680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64508340|NCT05698680|Tubulin Modulators|tubulin modulators|mesh-ancestor
64508341|NCT05698680|Antimitotic Agents|antimitotic agents|mesh-ancestor
64508342|NCT05698680|Mitosis Modulators|mitosis modulators|mesh-ancestor
64508343|NCT05698680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508345|NCT04058470|Cyclophosphamide|cyclophosphamide|mesh-list
64508346|NCT04058470|Rituximab|rituximab|mesh-list
64508347|NCT04058470|Doxorubicin|doxorubicin|mesh-list
64508348|NCT04058470|Vincristine|vincristine|mesh-list
64508349|NCT04058470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64508350|NCT04058470|Immunologic Factors|immunologic factors|mesh-ancestor
65078827|NCT00332306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64508351|NCT04058470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508352|NCT04058470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64508353|NCT04058470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64508354|NCT04058470|Alkylating Agents|alkylating agents|mesh-ancestor
65078896|NCT00332774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64508355|NCT04058470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508356|NCT04058470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508357|NCT04058470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64508358|NCT04058470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64508359|NCT04058470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64508360|NCT04058470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64508361|NCT04058470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64508362|NCT04058470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508363|NCT04058470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64508364|NCT04058470|Glucocorticoids|glucocorticoids|mesh-ancestor
64508366|NCT04058470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64508367|NCT04058470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64508368|NCT04058470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64508369|NCT04058470|Tubulin Modulators|tubulin modulators|mesh-ancestor
65079035|NCT00333281|Tadalafil|tadalafil|mesh-list
64508370|NCT04058470|Antimitotic Agents|antimitotic agents|mesh-ancestor
64508371|NCT04058470|Mitosis Modulators|mitosis modulators|mesh-ancestor
64508392|NCT05456256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508393|NCT05456256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64508394|NCT05456256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64508395|NCT02720484|Nivolumab|nivolumab|mesh-list
64508396|NCT02720484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65079249|NCT00438087|Hormones|hormones|mesh-ancestor
64508397|NCT02720484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508398|NCT02720484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65079317|NCT00334685|Sensory System Agents|sensory system agents|mesh-ancestor
64508399|NCT02720484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508423|NCT05438550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64508424|NCT05411484|Doxycycline|doxycycline|mesh-list
64508425|NCT05411484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64508426|NCT05411484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64508427|NCT05411484|Antimalarials|antimalarials|mesh-ancestor
64508428|NCT05411484|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64508429|NCT05411484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64508430|NCT05639946|Brivaracetam|brivaracetam|mesh-list
64508431|NCT05639946|Anticonvulsants|anticonvulsants|mesh-ancestor
64508432|NCT03299712|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
64508433|NCT03299712|Vasodilator Agents|vasodilator agents|mesh-ancestor
64508434|NCT03299712|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64508435|NCT03299712|Protective Agents|protective agents|mesh-ancestor
64508436|NCT03299712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508437|NCT05327556|Epinephrine|epinephrine|mesh-list
64508438|NCT05327556|Racepinephrine|racepinephrine|mesh-list
64508439|NCT05327556|Epinephryl borate|epinephryl borate|mesh-list
64508440|NCT05327556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64508441|NCT05327556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64508442|NCT05327556|Adrenergic Agents|adrenergic agents|mesh-ancestor
64508443|NCT05327556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64508444|NCT05327556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508445|NCT05327556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508446|NCT05327556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64508447|NCT05327556|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65079824|NCT00444717|Pitavastatin|pitavastatin|mesh-list
64508448|NCT05327556|Autonomic Agents|autonomic agents|mesh-ancestor
64508449|NCT05327556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64508450|NCT05327556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64955484|NCT00203125|Adrenergic Agents|adrenergic agents|mesh-ancestor
64955485|NCT00203125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64955486|NCT00203164|Rasagiline|rasagiline|mesh-list
64955487|NCT00203164|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64955488|NCT00203164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494230|NCT01048606|Hormones|hormones|mesh-ancestor
64508451|NCT05327556|Respiratory System Agents|respiratory system agents|mesh-ancestor
64508452|NCT05327556|Mydriatics|mydriatics|mesh-ancestor
64508453|NCT05327556|Sympathomimetics|sympathomimetics|mesh-ancestor
64508454|NCT05327556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64508455|NCT02466438|Tazobactam|tazobactam|mesh-list
64508456|NCT02466438|Piperacillin|piperacillin|mesh-list
64508457|NCT02466438|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64508458|NCT02466438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64508459|NCT02466438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64508460|NCT02466438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64508461|NCT02466438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508462|NCT02466438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508463|NCT05587062|Aflibercept|aflibercept|mesh-list
64508464|NCT05587062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64508465|NCT05587062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64422086|NCT02551055|Paclitaxel|paclitaxel|mesh-list
64726851|NCT00002858|Immunologic Factors|immunologic factors|mesh-ancestor
64726852|NCT00002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726853|NCT00002858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64334340|NCT03521713|Epoetin Alfa|epoetin alfa|mesh-list
64508478|NCT02463006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508479|NCT02463006|Adrenergic Agents|adrenergic agents|mesh-ancestor
64508480|NCT02463006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64508481|NCT02463006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64508482|NCT02463006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64508483|NCT02463006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64508484|NCT04779216|Alendronate|alendronate|mesh-list
64508485|NCT04779216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64723102|NCT05296759|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64508486|NCT04779216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508487|NCT05216328|Magnesium Hydroxide|magnesium hydroxide|mesh-list
64508488|NCT05216328|Antacids|antacids|mesh-ancestor
64508489|NCT05216328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508490|NCT05216328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65081209|NCT00347165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508491|NCT02466204|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64508492|NCT02466204|Hormones|hormones|mesh-ancestor
64508493|NCT02466204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64508494|NCT02466204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508495|NCT02715804|Gemcitabine|gemcitabine|mesh-list
64508496|NCT02715804|Paclitaxel|paclitaxel|mesh-list
64508497|NCT02715804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64508498|NCT02715804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508499|NCT02715804|Tubulin Modulators|tubulin modulators|mesh-ancestor
65081418|NCT00449280|Sirolimus|sirolimus|mesh-list
64508500|NCT02715804|Antimitotic Agents|antimitotic agents|mesh-ancestor
64508501|NCT02715804|Mitosis Modulators|mitosis modulators|mesh-ancestor
64508502|NCT02715804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508503|NCT02715804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64508504|NCT02715804|Antimetabolites|antimetabolites|mesh-ancestor
64508505|NCT02715804|Antiviral Agents|antiviral agents|mesh-ancestor
64508506|NCT02715804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65081568|NCT00456027|Antacids|antacids|mesh-ancestor
64508507|NCT02715804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508508|NCT02715804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64508509|NCT02715804|Immunologic Factors|immunologic factors|mesh-ancestor
64508510|NCT02715804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508511|NCT04745130|Cetuximab|cetuximab|mesh-list
64508512|NCT04745130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64508513|NCT04745130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508514|NCT02462304|Bevacizumab|bevacizumab|mesh-list
64508515|NCT02462304|Ranibizumab|ranibizumab|mesh-list
64508516|NCT02462304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65081862|NCT00421538|Nadroparin|nadroparin|mesh-list
64508517|NCT02462304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508518|NCT02462304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64508519|NCT02462304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64508520|NCT02462304|Growth Substances|growth substances|mesh-ancestor
65081996|NCT00352196|Risperidone|risperidone|mesh-list
64508521|NCT02462304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508522|NCT02462304|Growth Inhibitors|growth inhibitors|mesh-ancestor
64955489|NCT00203164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508523|NCT03501576|Vaccines|vaccines|mesh-list
64508524|NCT03501576|Immunologic Factors|immunologic factors|mesh-ancestor
64508525|NCT03501576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508534|NCT04645212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64508535|NCT04645212|Growth Substances|growth substances|mesh-ancestor
64508536|NCT04645212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082227|NCT00353717|Paclitaxel|paclitaxel|mesh-list
64508537|NCT04645212|Growth Inhibitors|growth inhibitors|mesh-ancestor
64508538|NCT04645212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082286|NCT00354146|Tipifarnib|tipifarnib|mesh-list
64508540|NCT04489446|Vasodilator Agents|vasodilator agents|mesh-ancestor
65082370|NCT00354458|Rolofylline|rolofylline|mesh-list
64508541|NCT04489446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64508542|NCT04489446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64508543|NCT04489446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508544|NCT04489446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508545|NCT04489446|Urological Agents|urological agents|mesh-ancestor
64508546|NCT02717754|Oseltamivir|oseltamivir|mesh-list
64508547|NCT02717754|Antiviral Agents|antiviral agents|mesh-ancestor
65082579|NCT00426491|Misoprostol|misoprostol|mesh-list
64508548|NCT02717754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64508549|NCT02717754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508550|NCT02717754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508551|NCT04497168|Citalopram|citalopram|mesh-list
64726854|NCT00002858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65082727|NCT00459771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64726856|NCT00002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726857|NCT00002858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726858|NCT00002858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64726859|NCT00002858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64726860|NCT00002858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64508552|NCT04497168|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64508553|NCT04497168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64508554|NCT04497168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65082943|NCT00460473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64508555|NCT04497168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508556|NCT04497168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64508557|NCT04497168|Serotonin Agents|serotonin agents|mesh-ancestor
64508558|NCT04497168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508559|NCT04497168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64508560|NCT04497168|Antidepressive Agents|antidepressive agents|mesh-ancestor
64508561|NCT04497168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64508562|NCT04608474|Evolocumab|evolocumab|mesh-list
65083162|NCT00430079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508563|NCT04608474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
65083232|NCT00430196|Anticonvulsants|anticonvulsants|mesh-ancestor
64508564|NCT04608474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64508565|NCT04608474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64508566|NCT04608474|Antimetabolites|antimetabolites|mesh-ancestor
64725600|NCT00002461|Cyclophosphamide|cyclophosphamide|mesh-list
64508567|NCT04608474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083524|NCT00462657|Dimercaprol|dimercaprol|mesh-list
64508568|NCT04608474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64508569|NCT04608474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508570|NCT02717130|Aripiprazole|aripiprazole|mesh-list
65083674|NCT00463203|Bevacizumab|bevacizumab|mesh-list
64508571|NCT02717130|Antidepressive Agents|antidepressive agents|mesh-ancestor
64508572|NCT02717130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64508573|NCT02717130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64508574|NCT02717130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64508575|NCT02717130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64508576|NCT02717130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508577|NCT02717130|Dopamine Agonists|dopamine agonists|mesh-ancestor
64508578|NCT02717130|Dopamine Agents|dopamine agents|mesh-ancestor
65083744|NCT00463359|Imiquimod|imiquimod|mesh-list
64508579|NCT02717130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64508580|NCT02717130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508581|NCT02717130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64508582|NCT02717130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64508583|NCT02717130|Serotonin Agents|serotonin agents|mesh-ancestor
64508584|NCT02717130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64508585|NCT02717130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65084028|NCT04702685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64508586|NCT02717130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64508587|NCT02717130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64508588|NCT02256696|Rifampin|rifampin|mesh-list
64508589|NCT02256696|Rifabutin|rifabutin|mesh-list
64508590|NCT02256696|Isoniazid|isoniazid|mesh-list
64508591|NCT02256696|Pyrazinamide|pyrazinamide|mesh-list
64508592|NCT02256696|Ethambutol|ethambutol|mesh-list
65084175|NCT03272802|Antioxidants|antioxidants|mesh-ancestor
64508593|NCT02256696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64508594|NCT02256696|Antitubercular Agents|antitubercular agents|mesh-ancestor
64508601|NCT02256696|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64508602|NCT02256696|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64508603|NCT02256696|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64508604|NCT02256696|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65084393|NCT00465543|Rosmarinic acid|rosmarinic acid|mesh-list
64508605|NCT02256696|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64508606|NCT02256696|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64508607|NCT02256696|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64508608|NCT02256696|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64508610|NCT02256696|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64508611|NCT04936230|Atezolizumab|atezolizumab|mesh-list
64508612|NCT04936230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64508613|NCT04936230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508614|NCT04936230|Immunologic Factors|immunologic factors|mesh-ancestor
65084674|NCT00437762|Cholinergic Agents|cholinergic agents|mesh-ancestor
64508615|NCT04936230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508616|NCT01773473|Insulin|insulin|mesh-list
64508617|NCT01773473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64726861|NCT00002858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64726862|NCT00002858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726863|NCT00002858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64508618|NCT01773473|Insulin Lispro|insulin lispro|mesh-list
64508619|NCT01773473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65084842|NCT00474591|PENTA|penta|mesh-list
64508620|NCT01773473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508621|NCT01779869|Regadenoson|regadenoson|mesh-list
64508622|NCT01779869|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
65084977|NCT00475527|Omeprazole|omeprazole|mesh-list
64508623|NCT01779869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64508624|NCT01779869|Purinergic Agonists|purinergic agonists|mesh-ancestor
64508625|NCT01779869|Purinergic Agents|purinergic agents|mesh-ancestor
65085109|NCT00476034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64508626|NCT01779869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64508627|NCT01779869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508628|NCT01779869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508629|NCT01772537|Propofol|propofol|mesh-list
64508630|NCT01772537|Isoflurane|isoflurane|mesh-list
64508631|NCT01772537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64508632|NCT01772537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65085324|NCT00440336|Latanoprost|latanoprost|mesh-list
64508633|NCT01772537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508634|NCT01772537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65085402|NCT00438789|Eculizumab|eculizumab|mesh-list
64508635|NCT01772537|Anesthetics, General|anesthetics, general|mesh-ancestor
64508636|NCT01772537|Anesthetics|anesthetics|mesh-ancestor
64508637|NCT01772537|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64508638|NCT01772147|Fluticasone|fluticasone|mesh-list
64508639|NCT01772147|Xhance|xhance|mesh-list
64508640|NCT01772147|Bromides|bromides|mesh-list
64508641|NCT01772147|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65085537|NCT00441740|Antiviral Agents|antiviral agents|mesh-ancestor
64508642|NCT01772147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64508643|NCT01772147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64508644|NCT01772147|Autonomic Agents|autonomic agents|mesh-ancestor
64508645|NCT01772147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64508646|NCT01772147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085689|NCT00442637|Bevacizumab|bevacizumab|mesh-list
64508647|NCT01772147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64508648|NCT01772147|Respiratory System Agents|respiratory system agents|mesh-ancestor
64508649|NCT01772147|Dermatologic Agents|dermatologic agents|mesh-ancestor
64508650|NCT01772147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64508651|NCT01772147|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64508652|NCT01772147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64508653|NCT01772147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64508654|NCT01772147|Adrenergic Agents|adrenergic agents|mesh-ancestor
64508655|NCT01772147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64508656|NCT01772147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508657|NCT01772147|Anticonvulsants|anticonvulsants|mesh-ancestor
64508658|NCT01606787|Mannitol|mannitol|mesh-list
64508659|NCT01606787|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64508660|NCT01606787|Diuretics|diuretics|mesh-ancestor
64508672|NCT01777997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64508673|NCT01777997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508674|NCT01777997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508675|NCT01777997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64508676|NCT01777997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64508677|NCT01770353|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64508678|NCT01770353|Hematinics|hematinics|mesh-ancestor
64508680|NCT01770353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64508681|NCT01777763|Posaconazole|posaconazole|mesh-list
64508682|NCT01777763|Antifungal Agents|antifungal agents|mesh-ancestor
64508683|NCT01777763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64508684|NCT01777763|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64508685|NCT01777763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64508686|NCT01777763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64508687|NCT01777763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64508688|NCT01777763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64508689|NCT01777763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508690|NCT01777763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508691|NCT01777763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64508692|NCT01777763|Hormone Antagonists|hormone antagonists|mesh-ancestor
64508693|NCT01777763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65086175|NCT00445055|Antiemetics|antiemetics|mesh-ancestor
64508694|NCT01777763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508696|NCT01769339|Hydrocortisone|hydrocortisone|mesh-list
64508697|NCT01769339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64508698|NCT01769339|Antifungal Agents|antifungal agents|mesh-ancestor
64508699|NCT01769339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726865|NCT00002864|Octreotide|octreotide|mesh-list
64726866|NCT00002864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64422117|NCT05469893|Dexamethasone|dexamethasone|mesh-list
64508700|NCT01769339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65086321|NCT00454259|Analgesics|analgesics|mesh-ancestor
64508701|NCT01769339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64508702|NCT01769339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508703|NCT01769339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508704|NCT01769339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64508705|NCT01769339|Hormone Antagonists|hormone antagonists|mesh-ancestor
65086538|NCT00443235|Prednisone|prednisone|mesh-list
65086612|NCT00480597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508706|NCT01769339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64508707|NCT01769339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508708|NCT01769339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64508709|NCT01769339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64508710|NCT01777139|Ezogabine|ezogabine|mesh-list
64508711|NCT01777139|Anticonvulsants|anticonvulsants|mesh-ancestor
65086757|NCT00457145|Ranibizumab|ranibizumab|mesh-list
64508712|NCT01777139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65086822|NCT00457808|Immunologic Factors|immunologic factors|mesh-ancestor
64508713|NCT01777139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508714|NCT01768637|Aspirin|aspirin|mesh-list
64508715|NCT01768637|Clopidogrel|clopidogrel|mesh-list
64508716|NCT01768637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64508717|NCT01768637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64508718|NCT01768637|Analgesics|analgesics|mesh-ancestor
64508719|NCT01768637|Sensory System Agents|sensory system agents|mesh-ancestor
64508720|NCT01768637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64508721|NCT01768637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508722|NCT01768637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64508723|NCT01768637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65087188|NCT00495651|Isoniazid|isoniazid|mesh-list
64508724|NCT01768637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64508740|NCT01886872|Immunoglobulins|immunoglobulins|mesh-list
64508741|NCT01886872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64508742|NCT01886872|Immunologic Factors|immunologic factors|mesh-ancestor
64508743|NCT01886872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508744|NCT01886872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508745|NCT01886872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64508746|NCT01886872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64955491|NCT00203164|Protective Agents|protective agents|mesh-ancestor
64955492|NCT00203164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508747|NCT01886872|Alkylating Agents|alkylating agents|mesh-ancestor
64508748|NCT01886872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508750|NCT01768559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64508751|NCT01768559|Metformin|metformin|mesh-list
65087560|NCT00463268|Vitamins|vitamins|mesh-ancestor
64508752|NCT01768559|Insulin Glargine|insulin glargine|mesh-list
64508753|NCT01768559|Insulin glulisine|insulin glulisine|mesh-list
64508754|NCT01768559|Lixisenatide|lixisenatide|mesh-list
64729923|NCT00004778|Hormones|hormones|mesh-list
64508755|NCT01768559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64508756|NCT01768559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508757|NCT00983619|Rituximab|rituximab|mesh-list
65087849|NCT03272321|Oxytocin|oxytocin|mesh-list
64508758|NCT00983619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64730144|NCT04456699|Levoleucovorin|levoleucovorin|mesh-list
64508759|NCT00983619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508760|NCT00983619|Immunologic Factors|immunologic factors|mesh-ancestor
64508761|NCT00983619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508762|NCT00983619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64508763|NCT00653068|Calcium, Dietary|calcium, dietary|mesh-list
64508764|NCT00653068|Leucovorin|leucovorin|mesh-list
64508765|NCT00653068|Folic Acid|folic acid|mesh-list
64508766|NCT00653068|Cyclophosphamide|cyclophosphamide|mesh-list
64508767|NCT00653068|Thiotepa|thiotepa|mesh-list
64508768|NCT00653068|Cisplatin|cisplatin|mesh-list
64508769|NCT00653068|Carboplatin|carboplatin|mesh-list
64508770|NCT00653068|Methotrexate|methotrexate|mesh-list
64508771|NCT00653068|Etoposide|etoposide|mesh-list
64508772|NCT00653068|Vincristine|vincristine|mesh-list
64508773|NCT00653068|Etoposide phosphate|etoposide phosphate|mesh-list
64508774|NCT00653068|Podophyllotoxin|podophyllotoxin|mesh-list
64508775|NCT00653068|Lenograstim|lenograstim|mesh-list
64508776|NCT00653068|Calcium|calcium|mesh-list
64508777|NCT00653068|Levoleucovorin|levoleucovorin|mesh-list
64508778|NCT00653068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64508779|NCT00653068|Immunologic Factors|immunologic factors|mesh-ancestor
64508780|NCT00653068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508781|NCT00653068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64508782|NCT00653068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64508783|NCT00653068|Alkylating Agents|alkylating agents|mesh-ancestor
64508784|NCT00653068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508818|NCT05608785|Antimetabolites|antimetabolites|mesh-ancestor
64726867|NCT00002864|Hormone Antagonists|hormone antagonists|mesh-ancestor
65088650|NCT00492687|Tamoxifen|tamoxifen|mesh-list
64726868|NCT00002864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64726869|NCT00002864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726870|NCT00002864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65088719|NCT00473720|Antimitotic Agents|antimitotic agents|mesh-ancestor
64508819|NCT05608785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508820|NCT05608785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088794|NCT00493077|Interferons|interferons|mesh-list
64508821|NCT03037437|Hydroxychloroquine|hydroxychloroquine|mesh-list
64508823|NCT03037437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508874|NCT03024489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64508876|NCT03024489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64508877|NCT03024489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508878|NCT03024489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508879|NCT01775189|Naltrexone|naltrexone|mesh-list
64508880|NCT01775189|Oxycodone|oxycodone|mesh-list
64508881|NCT01775189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64508882|NCT01775189|Narcotics|narcotics|mesh-ancestor
64508883|NCT01775189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65089156|NCT01244100|Analgesics|analgesics|mesh-ancestor
64508884|NCT01775189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508885|NCT01775189|Analgesics|analgesics|mesh-ancestor
64508886|NCT01775189|Sensory System Agents|sensory system agents|mesh-ancestor
64508887|NCT01775189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64508888|NCT01775189|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65089301|NCT00469937|Lithium Carbonate|lithium carbonate|mesh-list
64508889|NCT01775189|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64508890|NCT04551963|Clarithromycin|clarithromycin|mesh-list
64508891|NCT04551963|Fluconazole|fluconazole|mesh-list
64508892|NCT04551963|Voriconazole|voriconazole|mesh-list
64508893|NCT04551963|Zanubrutinib|zanubrutinib|mesh-list
64508894|NCT04551963|Diltiazem|diltiazem|mesh-list
64508895|NCT04551963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64508896|NCT04551963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64508897|NCT04551963|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64508898|NCT04551963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089513|NCT00600535|Hormone Antagonists|hormone antagonists|mesh-ancestor
64508899|NCT04551963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508900|NCT04551963|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64508901|NCT04551963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64508902|NCT04551963|Antifungal Agents|antifungal agents|mesh-ancestor
64508907|NCT04551963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508908|NCT04551963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64508909|NCT04551963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64508911|NCT04551963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64508912|NCT04551963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64508913|NCT04551963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64508914|NCT04551963|Vasodilator Agents|vasodilator agents|mesh-ancestor
64508915|NCT04551963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508916|NCT04551963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64508917|NCT01881412|Fluticasone|fluticasone|mesh-list
64508918|NCT01881412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65089645|NCT00601042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65089719|NCT00601432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089724|NCT00475514|Frovatriptan|frovatriptan|mesh-list
64508919|NCT01881412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65089794|NCT00601159|Gemcitabine|gemcitabine|mesh-list
64508920|NCT01881412|Autonomic Agents|autonomic agents|mesh-ancestor
64508921|NCT01881412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64508922|NCT01881412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955495|NCT00203281|Daclizumab|daclizumab|mesh-list
64508923|NCT01881412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64508924|NCT01881412|Respiratory System Agents|respiratory system agents|mesh-ancestor
64508925|NCT01881412|Dermatologic Agents|dermatologic agents|mesh-ancestor
64955496|NCT00203281|Immunoglobulins|immunoglobulins|mesh-list
64508926|NCT01881412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64508927|NCT03043053|Oxytocin|oxytocin|mesh-list
64508928|NCT03043053|Oxytocics|oxytocics|mesh-ancestor
64508929|NCT03043053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65090166|NCT00503412|Cediranib|cediranib|mesh-list
64508930|NCT03043053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508933|NCT03832816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508934|NCT03832816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64508935|NCT03832816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64508936|NCT03832816|Analgesics|analgesics|mesh-ancestor
64508937|NCT03832816|Sensory System Agents|sensory system agents|mesh-ancestor
64508938|NCT03832816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64726872|NCT00002864|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64726873|NCT00002864|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64334361|NCT04465123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64508939|NCT03832816|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65090380|NCT05645302|Lidocaine|lidocaine|mesh-list
64508940|NCT03832816|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64508941|NCT03832816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65090435|NCT04325776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508942|NCT03832816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508943|NCT03832816|Hormones|hormones|mesh-ancestor
65090582|NCT01247337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508944|NCT03832816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64508945|NCT04231084|Epoprostenol|epoprostenol|mesh-list
64508946|NCT04231084|Nitric Oxide|nitric oxide|mesh-list
64508947|NCT04231084|Vasodilator Agents|vasodilator agents|mesh-list
64508948|NCT04231084|Tezosentan|tezosentan|mesh-list
65090803|NCT01248117|Growth Inhibitors|growth inhibitors|mesh-ancestor
64508949|NCT04231084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64508950|NCT04231084|Autonomic Agents|autonomic agents|mesh-ancestor
64508951|NCT04231084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64508952|NCT04231084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508953|NCT04231084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64508954|NCT04231084|Respiratory System Agents|respiratory system agents|mesh-ancestor
64508955|NCT04231084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64508956|NCT04231084|Antioxidants|antioxidants|mesh-ancestor
64508957|NCT04231084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508958|NCT04231084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65091242|NCT01312909|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65091316|NCT00482261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65091394|NCT04518540|Vitamins|vitamins|mesh-ancestor
64508959|NCT04231084|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64508960|NCT04231084|Gasotransmitters|gasotransmitters|mesh-ancestor
64508961|NCT04231084|Protective Agents|protective agents|mesh-ancestor
64508962|NCT04231084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64508963|NCT04231084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64508964|NCT01884844|Vitamin D|vitamin d|mesh-list
65091608|NCT04517214|Gemcitabine|gemcitabine|mesh-list
64508965|NCT01884844|Cholecalciferol|cholecalciferol|mesh-list
64508966|NCT01884844|Vitamins|vitamins|mesh-ancestor
64508967|NCT01884844|Micronutrients|micronutrients|mesh-ancestor
65091677|NCT00482963|Levonorgestrel|levonorgestrel|mesh-list
64508968|NCT01884844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091746|NCT00483158|Renal Agents|renal agents|mesh-ancestor
64508969|NCT01884844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64508970|NCT01884844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64508971|NCT04123587|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64508972|NCT04123587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508977|NCT04127721|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64508978|NCT04127721|Abortifacient Agents|abortifacient agents|mesh-ancestor
64508979|NCT04127721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64508980|NCT04127721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508981|NCT04127721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64508983|NCT04127721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508985|NCT04127721|Dermatologic Agents|dermatologic agents|mesh-ancestor
64508986|NCT04127721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508987|NCT04127721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64508988|NCT04127721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64508989|NCT04127721|Immunologic Factors|immunologic factors|mesh-ancestor
64508990|NCT04127721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64508991|NCT04127721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64508992|NCT04127721|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64508993|NCT04127721|Alkylating Agents|alkylating agents|mesh-ancestor
64508994|NCT04127721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64508995|NCT04127721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64508996|NCT04123743|Sunscreening Agents|sunscreening agents|mesh-list
64508997|NCT04123743|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64508998|NCT04123743|Protective Agents|protective agents|mesh-ancestor
64508999|NCT04123743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509000|NCT04123743|Dermatologic Agents|dermatologic agents|mesh-ancestor
64509002|NCT02996721|Cholecalciferol|cholecalciferol|mesh-list
64509003|NCT02996721|Vitamins|vitamins|mesh-ancestor
64509004|NCT02996721|Micronutrients|micronutrients|mesh-ancestor
64509005|NCT02996721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509006|NCT02996721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64509007|NCT02996721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64726874|NCT00002864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64726875|NCT00002864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64466155|NCT04757506|Naltrexone|naltrexone|mesh-list
64726877|NCT00002870|Thiotepa|thiotepa|mesh-list
64726878|NCT00002870|Fluorouracil|fluorouracil|mesh-list
64726879|NCT00002870|Epirubicin|epirubicin|mesh-list
65092614|NCT01302067|Urological Agents|urological agents|mesh-ancestor
64726880|NCT00002870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64726881|NCT00002870|Immunologic Factors|immunologic factors|mesh-ancestor
64509008|NCT04122885|Oxaliplatin|oxaliplatin|mesh-list
64509009|NCT04122885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509010|NCT03926338|Celecoxib|celecoxib|mesh-list
64509011|NCT03926338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
64509012|NCT03926338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64509013|NCT03926338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64509014|NCT03926338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64509015|NCT03926338|Analgesics|analgesics|mesh-ancestor
64509016|NCT03926338|Sensory System Agents|sensory system agents|mesh-ancestor
64509017|NCT03926338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509018|NCT03926338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509019|NCT03926338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64509020|NCT03926338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64509021|NCT03926338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64509022|NCT03926338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509023|NCT03926338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509024|NCT03926338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509025|NCT04126941|Calcium|calcium|mesh-list
64509026|NCT04126941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64509027|NCT04126941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509028|NCT02506192|Prednisone|prednisone|mesh-list
64509029|NCT02506192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64509030|NCT02506192|Glucocorticoids|glucocorticoids|mesh-ancestor
64509031|NCT02506192|Hormones|hormones|mesh-ancestor
64509032|NCT02506192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64509033|NCT02506192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509034|NCT02506192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64509035|NCT02506192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509036|NCT04122105|Sildenafil Citrate|sildenafil citrate|mesh-list
64509037|NCT04122105|Vasodilator Agents|vasodilator agents|mesh-ancestor
64509038|NCT04122105|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64509039|NCT04122105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64509041|NCT04122105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509042|NCT04122105|Urological Agents|urological agents|mesh-ancestor
64509043|NCT02270632|Methotrexate|methotrexate|mesh-list
64509048|NCT02270632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64509050|NCT02270632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509051|NCT02270632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509052|NCT02270632|Dermatologic Agents|dermatologic agents|mesh-ancestor
64509053|NCT02270632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509054|NCT02270632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64509055|NCT02270632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64509056|NCT02270632|Immunologic Factors|immunologic factors|mesh-ancestor
64509057|NCT02270632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64509058|NCT02270632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64509059|NCT04127019|Paclitaxel|paclitaxel|mesh-list
64509060|NCT04127019|Docetaxel|docetaxel|mesh-list
64509061|NCT04127019|Cyclophosphamide|cyclophosphamide|mesh-list
64509062|NCT04127019|Fluorouracil|fluorouracil|mesh-list
64509063|NCT04127019|Epirubicin|epirubicin|mesh-list
64509064|NCT04127019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64509065|NCT04127019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509066|NCT04127019|Tubulin Modulators|tubulin modulators|mesh-ancestor
64509067|NCT04127019|Antimitotic Agents|antimitotic agents|mesh-ancestor
64509068|NCT04127019|Mitosis Modulators|mitosis modulators|mesh-ancestor
64509069|NCT04127019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509070|NCT04127019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64509071|NCT04127019|Immunologic Factors|immunologic factors|mesh-ancestor
64726882|NCT00002870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726883|NCT00002870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64726884|NCT00002870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64509072|NCT04127019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955498|NCT00203281|gamma-Globulins|gamma-globulins|mesh-list
64509073|NCT04127019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64509074|NCT04127019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64509075|NCT04127019|Alkylating Agents|alkylating agents|mesh-ancestor
64509076|NCT04127019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64509077|NCT04127019|Antimetabolites|antimetabolites|mesh-ancestor
64509078|NCT04127019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64509079|NCT04127019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64509080|NCT04127019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64509081|NCT04127019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64509082|NCT04127019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509083|NCT02076646|Interleukin-2|interleukin-2|mesh-list
64509084|NCT02076646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509085|NCT02076646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64509086|NCT02076646|Analgesics|analgesics|mesh-ancestor
64509087|NCT02076646|Sensory System Agents|sensory system agents|mesh-ancestor
64509088|NCT02076646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509089|NCT02076646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509090|NCT04121091|Pramipexole|pramipexole|mesh-list
64509091|NCT04121091|Antioxidants|antioxidants|mesh-ancestor
65093949|NCT02274506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64509092|NCT04121091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509093|NCT04121091|Protective Agents|protective agents|mesh-ancestor
64509094|NCT04121091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094094|NCT00494156|Aspirin|aspirin|mesh-list
64509095|NCT04121091|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64509096|NCT04121091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64509097|NCT04121091|Dopamine Agonists|dopamine agonists|mesh-ancestor
64509098|NCT04121091|Dopamine Agents|dopamine agents|mesh-ancestor
65094171|NCT00494429|Morphine|morphine|mesh-list
64509099|NCT04121091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64509100|NCT03283605|Durvalumab|durvalumab|mesh-list
64509101|NCT03283605|Tremelimumab|tremelimumab|mesh-list
64509102|NCT03283605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64509103|NCT03283605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509104|NCT01896544|Cholecalciferol|cholecalciferol|mesh-list
64509105|NCT01896544|Vitamin D|vitamin d|mesh-list
64509106|NCT01896544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64509107|NCT01896544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509108|NCT01896544|Vitamins|vitamins|mesh-ancestor
64509109|NCT01896544|Micronutrients|micronutrients|mesh-ancestor
64509110|NCT01896544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64509111|NCT04120623|Insulin Aspart|insulin aspart|mesh-list
64509112|NCT04120623|Dapagliflozin|dapagliflozin|mesh-list
64509113|NCT04120623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64509114|NCT04120623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509115|NCT04120623|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65094598|NCT05145543|Anesthetics, General|anesthetics, general|mesh-ancestor
64509120|NCT01931878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509121|NCT01931878|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65094669|NCT00503321|polysaccharide-K|polysaccharide-k|mesh-list
64509122|NCT01931878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65094739|NCT05148195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64509123|NCT01931878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509125|NCT01931878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64509127|NCT01932112|Analgesics|analgesics|mesh-ancestor
64509128|NCT01932112|Sensory System Agents|sensory system agents|mesh-ancestor
64509129|NCT01932112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65094887|NCT05146713|Disinfectants|disinfectants|mesh-ancestor
64509130|NCT01932112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509131|NCT01932112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64509132|NCT01932112|Vasodilator Agents|vasodilator agents|mesh-ancestor
64509133|NCT01932112|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64509134|NCT01932112|Purinergic Agonists|purinergic agonists|mesh-ancestor
64509135|NCT01932112|Purinergic Agents|purinergic agents|mesh-ancestor
64509136|NCT01932112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64509137|NCT01932112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509138|NCT04120311|Dexamethasone|dexamethasone|mesh-list
64509139|NCT04120311|Dexamethasone acetate|dexamethasone acetate|mesh-list
64509140|NCT04120311|BB 1101|bb 1101|mesh-list
64509141|NCT04120311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64509142|NCT04120311|Antiemetics|antiemetics|mesh-ancestor
64509143|NCT04120311|Autonomic Agents|autonomic agents|mesh-ancestor
64726885|NCT00002870|Alkylating Agents|alkylating agents|mesh-ancestor
64726886|NCT00002870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726887|NCT00002870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726888|NCT00002870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64726889|NCT00002870|Antimetabolites|antimetabolites|mesh-ancestor
64509144|NCT04120311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509145|NCT04120311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509146|NCT04120311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64509147|NCT04120311|Glucocorticoids|glucocorticoids|mesh-ancestor
64509148|NCT04120311|Hormones|hormones|mesh-ancestor
64955499|NCT00203281|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64509149|NCT04120311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64509150|NCT04120311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64509151|NCT04120311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509152|NCT04120311|Protease Inhibitors|protease inhibitors|mesh-ancestor
64509153|NCT04120311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509154|NCT04120311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509155|NCT01897402|Vaccines|vaccines|mesh-list
64509156|NCT01897402|Immunologic Factors|immunologic factors|mesh-ancestor
64509157|NCT01897402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509158|NCT01897792|Vitamins|vitamins|mesh-list
64509159|NCT01897792|Ascorbic Acid|ascorbic acid|mesh-list
64509160|NCT01897792|Vitamin E|vitamin e|mesh-list
64509161|NCT01897792|Tocopherols|tocopherols|mesh-list
64509162|NCT01897792|Tocotrienols|tocotrienols|mesh-list
64509163|NCT01897792|alpha-Tocopherol|alpha-tocopherol|mesh-list
64509164|NCT01897792|Micronutrients|micronutrients|mesh-ancestor
64509165|NCT01897792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509166|NCT01897792|Antioxidants|antioxidants|mesh-ancestor
64509167|NCT01897792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509168|NCT01897792|Protective Agents|protective agents|mesh-ancestor
64562599|NCT01225263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64562600|NCT01225263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562629|NCT01227993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64562631|NCT01227993|Urological Agents|urological agents|mesh-ancestor
64562632|NCT01155999|Tobramycin|tobramycin|mesh-list
64562633|NCT01155999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64562634|NCT01155999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64934764|NCT03187080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934765|NCT03187080|Sensory System Agents|sensory system agents|mesh-ancestor
64934766|NCT03187080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64934767|NCT00081484|Epoetin Alfa|epoetin alfa|mesh-list
64934768|NCT00081484|Hematinics|hematinics|mesh-ancestor
64934769|NCT00390260|Acetaminophen|acetaminophen|mesh-list
64934771|NCT00390260|Hydrocodone|hydrocodone|mesh-list
64934772|NCT00390260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64934773|NCT00390260|Analgesics|analgesics|mesh-ancestor
64934774|NCT00390260|Sensory System Agents|sensory system agents|mesh-ancestor
64934775|NCT00390260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64934776|NCT00390260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528787|NCT01531153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528788|NCT01531153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528789|NCT01531153|Cholinergic Agents|cholinergic agents|mesh-ancestor
64528790|NCT01531153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64528791|NCT01531153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528792|NCT01531153|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64934777|NCT00390260|Antipyretics|antipyretics|mesh-ancestor
64934778|NCT00390260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934779|NCT00390260|Respiratory System Agents|respiratory system agents|mesh-ancestor
64934780|NCT00390260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64934781|NCT00390260|Narcotics|narcotics|mesh-ancestor
64650848|NCT01395329|Acetylcholine|acetylcholine|mesh-list
64934825|NCT00399685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64934826|NCT00399685|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64934827|NCT00399685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64934828|NCT00399685|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64934829|NCT00399685|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64934830|NCT00399685|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64934831|NCT00399685|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64934857|NCT03152097|Protective Agents|protective agents|mesh-ancestor
64934858|NCT03152097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934859|NCT03152097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934860|NCT00082186|Bosentan|bosentan|mesh-list
64934861|NCT00082186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64934862|NCT00082186|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64934863|NCT00082186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934864|NCT00082225|Antibodies|antibodies|mesh-list
64934865|NCT00082225|Immunologic Factors|immunologic factors|mesh-ancestor
64934866|NCT00082225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934867|NCT03152058|Certolizumab Pegol|certolizumab pegol|mesh-list
64934868|NCT03152058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64934869|NCT03152058|Immunologic Factors|immunologic factors|mesh-ancestor
64934870|NCT03152058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934871|NCT03152058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64934872|NCT00082537|Caspofungin|caspofungin|mesh-list
64934873|NCT00082537|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64934874|NCT00082537|Antifungal Agents|antifungal agents|mesh-ancestor
64934875|NCT00082537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64934876|NCT00082537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934877|NCT00082537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934878|NCT00082537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64934914|NCT00083005|Alkylating Agents|alkylating agents|mesh-ancestor
64934915|NCT00083005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64934917|NCT00083083|Etoposide|etoposide|mesh-list
64934918|NCT00083083|Vinorelbine|vinorelbine|mesh-list
64934919|NCT00083083|Vinblastine|vinblastine|mesh-list
64934920|NCT00083083|Docetaxel|docetaxel|mesh-list
64934921|NCT00083083|Carboplatin|carboplatin|mesh-list
64562635|NCT03275597|Durvalumab|durvalumab|mesh-list
64562636|NCT03275597|Tremelimumab|tremelimumab|mesh-list
64562637|NCT03275597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64562638|NCT03275597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562639|NCT01228149|Acetazolamide|acetazolamide|mesh-list
64562640|NCT01228149|Anticonvulsants|anticonvulsants|mesh-ancestor
64934922|NCT00083083|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64934943|NCT03151863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64934944|NCT03151863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64934945|NCT03151863|Adrenergic Agents|adrenergic agents|mesh-ancestor
64528794|NCT01531153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64528796|NCT03027973|Tranexamic Acid|tranexamic acid|mesh-list
64528797|NCT03027973|Ulipristal acetate|ulipristal acetate|mesh-list
64528798|NCT03027973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64528799|NCT03027973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64528800|NCT03027973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528801|NCT03027973|Hemostatics|hemostatics|mesh-ancestor
64934946|NCT03151863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64934947|NCT03151863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934948|NCT03151863|Narcotics|narcotics|mesh-ancestor
64934949|NCT00083161|Cyclophosphamide|cyclophosphamide|mesh-list
64934950|NCT00083161|Etoposide|etoposide|mesh-list
64934955|NCT00083161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64934956|NCT00083161|Alkylating Agents|alkylating agents|mesh-ancestor
64934957|NCT00083161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934958|NCT00083161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934959|NCT00083161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64934960|NCT00083161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64934961|NCT00083161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64934962|NCT00083161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64934963|NCT00083161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934964|NCT00083278|Ipilimumab|ipilimumab|mesh-list
64934965|NCT00083278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64934966|NCT00083278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934967|NCT00083278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64934968|NCT00083278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934969|NCT00083434|Epoetin Alfa|epoetin alfa|mesh-list
64934970|NCT00083434|Hematinics|hematinics|mesh-ancestor
64934971|NCT00083590|Huperzine A|huperzine a|mesh-list
64934972|NCT00083590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64934973|NCT00083590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934974|NCT00083590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934975|NCT00083590|Cholinergic Agents|cholinergic agents|mesh-ancestor
64935003|NCT00083668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64935004|NCT00083668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64935005|NCT00083668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64935006|NCT00083668|Serotonin Agents|serotonin agents|mesh-ancestor
64935007|NCT00083668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64935008|NCT00083668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935009|NCT00083668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64935010|NCT00083668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64935011|NCT00083668|Dopamine Agents|dopamine agents|mesh-ancestor
64935012|NCT00083707|Thalidomide|thalidomide|mesh-list
64935013|NCT00083707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64935014|NCT00083707|Immunologic Factors|immunologic factors|mesh-ancestor
64935015|NCT00083707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935016|NCT00083707|Leprostatic Agents|leprostatic agents|mesh-ancestor
64935017|NCT00083707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64935018|NCT00083707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64935019|NCT00083707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64935020|NCT00083707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64935047|NCT03151668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64935048|NCT03151668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64935049|NCT03151668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64935050|NCT03151668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64935051|NCT03151668|Adrenergic Agents|adrenergic agents|mesh-ancestor
64935052|NCT03151668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64935053|NCT03151668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935054|NCT05568082|Itraconazole|itraconazole|mesh-list
64562641|NCT01228149|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64562642|NCT01228149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562643|NCT01228149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562644|NCT01228149|Diuretics|diuretics|mesh-ancestor
64562674|NCT04986839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64562675|NCT04986839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562676|NCT04986839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562677|NCT04968587|Dialysis Solutions|dialysis solutions|mesh-list
64562678|NCT04968587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64562679|NCT02192541|Aflibercept|aflibercept|mesh-list
64562680|NCT02192541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64562681|NCT02192541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64562682|NCT02192541|Growth Substances|growth substances|mesh-ancestor
64562683|NCT02192541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935055|NCT05568082|Antifungal Agents|antifungal agents|mesh-ancestor
64528802|NCT03027973|Coagulants|coagulants|mesh-ancestor
64528803|NCT03027973|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64528804|NCT03027973|Contraceptive Agents|contraceptive agents|mesh-ancestor
64528805|NCT03027973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64528806|NCT03027973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528807|NCT03027973|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64528808|NCT01529749|Raltegravir Potassium|raltegravir potassium|mesh-list
64528809|NCT01529749|Losartan|losartan|mesh-list
64528810|NCT01529749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64528811|NCT01529749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64528812|NCT01529749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64528813|NCT01529749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64528814|NCT01529749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528815|NCT01529749|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64935056|NCT05568082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64935057|NCT05568082|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64935058|NCT05568082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64935062|NCT05568082|Hormone Antagonists|hormone antagonists|mesh-ancestor
64935063|NCT05568082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64935064|NCT05568082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935065|NCT05568082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64935066|NCT05567653|Sulfalene|sulfalene|mesh-list
64935067|NCT05567653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64935068|NCT05567653|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64935069|NCT05567653|Renal Agents|renal agents|mesh-ancestor
64935070|NCT05567653|Antimalarials|antimalarials|mesh-ancestor
64935106|NCT00135499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935107|NCT00135499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935108|NCT00135499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64935109|NCT00135499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64935110|NCT00135499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64935111|NCT00135499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64935112|NCT00135499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64935134|NCT00135577|Alvimopan|alvimopan|mesh-list
64935135|NCT00135577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64935136|NCT00135733|Alefacept|alefacept|mesh-list
64935137|NCT00135733|Dermatologic Agents|dermatologic agents|mesh-ancestor
64935138|NCT00135733|Immunologic Factors|immunologic factors|mesh-ancestor
64935139|NCT00135733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935140|NCT04061798|Heparin|heparin|mesh-list
64935141|NCT04061798|Anticoagulants|anticoagulants|mesh-ancestor
64935142|NCT04061798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64935143|NCT04061798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64935144|NCT04061798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562684|NCT02192541|Growth Inhibitors|growth inhibitors|mesh-ancestor
64562685|NCT02192541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562686|NCT01156701|Zanamivir|zanamivir|mesh-list
64562687|NCT01156701|Antiviral Agents|antiviral agents|mesh-ancestor
64562688|NCT01156701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64562689|NCT01156701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562721|NCT02984657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562722|NCT01158651|Everolimus|everolimus|mesh-list
64619561|NCT00982280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64562723|NCT01158651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935145|NCT00135811|Cyclosporine|cyclosporine|mesh-list
64935146|NCT00135811|Dexamethasone|dexamethasone|mesh-list
64935147|NCT00135811|Cyclosporins|cyclosporins|mesh-list
64935148|NCT00135811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64935149|NCT00135811|Antiemetics|antiemetics|mesh-ancestor
64935150|NCT00135811|Autonomic Agents|autonomic agents|mesh-ancestor
64935151|NCT00135811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64935152|NCT00135811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935154|NCT00135811|Glucocorticoids|glucocorticoids|mesh-ancestor
64935155|NCT00135811|Hormones|hormones|mesh-ancestor
64935156|NCT00135811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64935157|NCT00135811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64528817|NCT01529749|Antiviral Agents|antiviral agents|mesh-ancestor
64528818|NCT01529749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64528819|NCT01529749|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64528820|NCT01529749|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64528821|NCT01529749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528822|NCT01529515|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64528823|NCT01529515|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64528824|NCT01529515|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64528825|NCT01529515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64528826|NCT04101721|Aflibercept|aflibercept|mesh-list
64528827|NCT04101721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64528828|NCT04101721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64528829|NCT04101721|Growth Substances|growth substances|mesh-ancestor
64528830|NCT04101721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528831|NCT04101721|Growth Inhibitors|growth inhibitors|mesh-ancestor
64935158|NCT00135811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935159|NCT00135811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935160|NCT00135811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935161|NCT00135811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64935162|NCT00135811|Immunologic Factors|immunologic factors|mesh-ancestor
64935163|NCT00135811|Antifungal Agents|antifungal agents|mesh-ancestor
64935164|NCT00135811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64935165|NCT00135811|Dermatologic Agents|dermatologic agents|mesh-ancestor
64935166|NCT00135811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64935167|NCT00135811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64935168|NCT00135928|Lenograstim|lenograstim|mesh-list
64935169|NCT00135928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64935194|NCT00135967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935196|NCT00135967|Autonomic Agents|autonomic agents|mesh-ancestor
64935204|NCT00136045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64935205|NCT00136045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935206|NCT00136045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935207|NCT00136201|Tigecycline|tigecycline|mesh-list
64935208|NCT00136201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64935209|NCT00136201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64935210|NCT00136201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64935211|NCT00136201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935212|NCT00136201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935213|NCT03151239|Niacinamide|niacinamide|mesh-list
64935214|NCT03151239|Vitamin B Complex|vitamin b complex|mesh-ancestor
64935216|NCT03151239|Micronutrients|micronutrients|mesh-ancestor
64935217|NCT03151239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935218|NCT00136396|Rituximab|rituximab|mesh-list
64562724|NCT01158651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64562725|NCT01158651|Immunologic Factors|immunologic factors|mesh-ancestor
64562726|NCT01158651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562727|NCT04852679|Lanreotide|lanreotide|mesh-list
64562760|NCT04775225|Anesthetics, Local|anesthetics, local|mesh-ancestor
64562761|NCT04775225|Anesthetics|anesthetics|mesh-ancestor
64562762|NCT04775225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64562763|NCT04775225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562764|NCT04775225|Sensory System Agents|sensory system agents|mesh-ancestor
64562765|NCT04775225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64562766|NCT04775225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64562767|NCT04775225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64484224|NCT01751113|Respiratory System Agents|respiratory system agents|mesh-ancestor
64562803|NCT03239561|JNJ-64326067|jnj-64326067|mesh-list
64562804|NCT03239561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64562805|NCT03239561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562806|NCT04746365|Hydroxychloroquine|hydroxychloroquine|mesh-list
64562807|NCT04746365|Ivermectin|ivermectin|mesh-list
64562808|NCT04746365|Antimalarials|antimalarials|mesh-ancestor
64562809|NCT04746365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64619627|NCT03011905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935219|NCT00136396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64935243|NCT00404053|Clopidogrel|clopidogrel|mesh-list
64935244|NCT00404053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64935245|NCT00404053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64935246|NCT00404053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64528832|NCT04101721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528833|NCT01528969|Sorbitol|sorbitol|mesh-list
64528834|NCT01528969|Cathartics|cathartics|mesh-ancestor
64528835|NCT01528969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64528836|NCT01514201|Temozolomide|temozolomide|mesh-list
64528837|NCT01514201|Veliparib|veliparib|mesh-list
64528838|NCT01514201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64528839|NCT01514201|Alkylating Agents|alkylating agents|mesh-ancestor
64528840|NCT01514201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528841|NCT01514201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528842|NCT01514201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64528843|NCT01514201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528844|NCT02666664|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
64528845|NCT02666664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64935247|NCT00404053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64935248|NCT00404053|Purinergic Agents|purinergic agents|mesh-ancestor
64935249|NCT00404053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64935250|NCT00404053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935251|NCT00404053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935253|NCT03991130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64935254|NCT03991130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935255|NCT03991130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64935256|NCT03991130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935257|NCT00136747|Memantine|memantine|mesh-list
64935258|NCT00136747|Bupropion|bupropion|mesh-list
64935259|NCT00136747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64562810|NCT04746365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64562840|NCT02984345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562841|NCT01232205|Micronutrients|micronutrients|mesh-list
64562842|NCT01232205|Trace Elements|trace elements|mesh-list
64484225|NCT01751113|Dermatologic Agents|dermatologic agents|mesh-ancestor
64562843|NCT01232205|Antioxidants|antioxidants|mesh-list
64517115|NCT03258372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64517116|NCT03258372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64517117|NCT03258372|Hormone Antagonists|hormone antagonists|mesh-ancestor
64517118|NCT03258372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64517119|NCT03258372|Luteolytic Agents|luteolytic agents|mesh-ancestor
64517120|NCT03258372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64517121|NCT03258372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64517122|NCT02456454|Valproic Acid|valproic acid|mesh-list
64517123|NCT02456454|Risperidone|risperidone|mesh-list
64517124|NCT02456454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64517125|NCT02456454|Serotonin Agents|serotonin agents|mesh-ancestor
64517126|NCT02456454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64517127|NCT02456454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517128|NCT02456454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517129|NCT02456454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64517130|NCT02456454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64517131|NCT02456454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64517132|NCT02456454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64517133|NCT02456454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64517134|NCT02456454|Dopamine Agents|dopamine agents|mesh-ancestor
64619682|NCT01178281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64562844|NCT01232205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619683|NCT01178281|Leprostatic Agents|leprostatic agents|mesh-ancestor
64935260|NCT00136747|Antidepressive Agents|antidepressive agents|mesh-ancestor
64935261|NCT00136747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64935262|NCT00136747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64935263|NCT00136747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64935264|NCT00136747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64935265|NCT00136747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935266|NCT00136747|Dopamine Agents|dopamine agents|mesh-ancestor
64935267|NCT00136747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64935268|NCT00136747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935269|NCT00136747|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64935270|NCT00136747|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64935303|NCT00393198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64650877|NCT00882206|Decitabine|decitabine|mesh-list
64562845|NCT01232205|Protective Agents|protective agents|mesh-ancestor
64562846|NCT01232205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562847|NCT04584125|Riboflavin|riboflavin|mesh-list
64562848|NCT04584125|Flavin Mononucleotide|flavin mononucleotide|mesh-list
64562849|NCT04584125|Dextrans|dextrans|mesh-list
64562850|NCT04584125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64562851|NCT04584125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64562852|NCT04584125|Vitamin B Complex|vitamin b complex|mesh-ancestor
64562853|NCT04584125|Vitamins|vitamins|mesh-ancestor
64562854|NCT04584125|Micronutrients|micronutrients|mesh-ancestor
64562855|NCT04584125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562856|NCT04584125|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64562928|NCT01237197|Hormones|hormones|mesh-ancestor
64562929|NCT01237197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64562930|NCT01237353|Rabeprazole|rabeprazole|mesh-list
64562931|NCT01237353|Betaine|betaine|mesh-list
64562932|NCT01237353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64562933|NCT01237353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64562934|NCT01237353|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64562935|NCT01237353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562936|NCT01237353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562937|NCT01237353|Lipotropic Agents|lipotropic agents|mesh-ancestor
64562970|NCT03010761|Antidepressive Agents|antidepressive agents|mesh-ancestor
64562971|NCT03010761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64562972|NCT03010761|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64562973|NCT03010761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562974|NCT01243593|Anesthetics|anesthetics|mesh-list
64562975|NCT01243593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64562976|NCT01243593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562977|NCT04362761|Ivacaftor|ivacaftor|mesh-list
64563008|NCT05632211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517136|NCT02456454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935340|NCT00136981|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64935341|NCT00136981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935343|NCT00137020|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64935344|NCT00137020|Serotonin Agents|serotonin agents|mesh-ancestor
64935345|NCT00137020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64935346|NCT00137020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935347|NCT00137020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935348|NCT00137020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64935349|NCT00137020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64528847|NCT02666664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528848|NCT02666664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64528849|NCT02666664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517137|NCT02456454|GABA Agents|gaba agents|mesh-ancestor
64517138|NCT02456454|Antimanic Agents|antimanic agents|mesh-ancestor
64517139|NCT03258294|Melatonin|melatonin|mesh-list
64517140|NCT03258294|Antioxidants|antioxidants|mesh-ancestor
64563009|NCT01246401|Naltrexone|naltrexone|mesh-list
64528850|NCT02666664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64528851|NCT02666664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528852|NCT01528735|Ribavirin|ribavirin|mesh-list
64528853|NCT01528735|Antimetabolites|antimetabolites|mesh-ancestor
64528854|NCT01528735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528855|NCT01528735|Antiviral Agents|antiviral agents|mesh-ancestor
64528856|NCT01528735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64528857|NCT02386488|Vortioxetine|vortioxetine|mesh-list
64528858|NCT02386488|Antidepressive Agents|antidepressive agents|mesh-ancestor
64528859|NCT02386488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64528860|NCT02386488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64528861|NCT02386488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64935350|NCT00137020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64935351|NCT00137020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64935352|NCT00137020|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64935353|NCT00137020|Dopamine Agents|dopamine agents|mesh-ancestor
64935354|NCT00137059|Acetaminophen|acetaminophen|mesh-list
64935355|NCT00137059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64935356|NCT00137059|Analgesics|analgesics|mesh-ancestor
64935357|NCT00137059|Sensory System Agents|sensory system agents|mesh-ancestor
64935358|NCT00137059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64935359|NCT00137059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935379|NCT03151044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935380|NCT03151044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64935381|NCT03151044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64935382|NCT03151044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64935383|NCT03151044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64935384|NCT03151044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935385|NCT03151044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935386|NCT00137410|Celecoxib|celecoxib|mesh-list
64935387|NCT00137410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64935388|NCT00137410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64935389|NCT00137410|Analgesics|analgesics|mesh-ancestor
64935390|NCT00137410|Sensory System Agents|sensory system agents|mesh-ancestor
64935391|NCT00137410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64935392|NCT00137410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935393|NCT00137410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64935394|NCT00137410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64935395|NCT00137410|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64935396|NCT00137410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64935408|NCT03151005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64528864|NCT02386488|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64528865|NCT02386488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64528866|NCT02386488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64528867|NCT02386488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528868|NCT02386488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64935410|NCT03151005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64935411|NCT03151005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64935412|NCT00137527|Anesthetics|anesthetics|mesh-list
64935413|NCT00137527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64935414|NCT00137527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935415|NCT00137566|Acetaminophen|acetaminophen|mesh-list
64935451|NCT00137995|Etoposide phosphate|etoposide phosphate|mesh-list
64935452|NCT00137995|Melphalan|melphalan|mesh-list
64935453|NCT00137995|Ifosfamide|ifosfamide|mesh-list
64935454|NCT00137995|Carboplatin|carboplatin|mesh-list
64935455|NCT00137995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64935456|NCT00137995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935457|NCT00137995|Immunologic Factors|immunologic factors|mesh-ancestor
64935458|NCT00137995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935495|NCT00138229|Alkylating Agents|alkylating agents|mesh-ancestor
64935516|NCT03150810|Alkylating Agents|alkylating agents|mesh-ancestor
64935517|NCT03150810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935518|NCT03150810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935520|NCT00138541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64563010|NCT01246401|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64563011|NCT01246401|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64563012|NCT01246401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563013|NCT01246401|Sensory System Agents|sensory system agents|mesh-ancestor
64563014|NCT01246401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563015|NCT05627375|Anticoagulants|anticoagulants|mesh-list
64563016|NCT01281501|Scopolamine|scopolamine|mesh-list
64563017|NCT01281501|Pantoprazole|pantoprazole|mesh-list
64563018|NCT01281501|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
64563019|NCT01281501|Antacids|antacids|mesh-list
64563045|NCT01246713|Acetaminophen|acetaminophen|mesh-list
64563046|NCT01246713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64563047|NCT01246713|Analgesics|analgesics|mesh-ancestor
64563048|NCT01246713|Sensory System Agents|sensory system agents|mesh-ancestor
64563049|NCT01246713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563050|NCT01246713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563051|NCT01246713|Antipyretics|antipyretics|mesh-ancestor
64563052|NCT01246791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64563053|NCT01246791|Norethindrone|norethindrone|mesh-list
64563054|NCT01246791|Norinyl|norinyl|mesh-list
64563055|NCT01246791|Estradiol|estradiol|mesh-list
64563056|NCT01246791|Estrogens|estrogens|mesh-ancestor
64935521|NCT00138541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935522|NCT00138541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64935523|NCT00138541|Protease Inhibitors|protease inhibitors|mesh-ancestor
64935524|NCT00138541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935525|NCT00138541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935526|NCT00138580|Vildagliptin|vildagliptin|mesh-list
64935527|NCT00138580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64935528|NCT00138580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935529|NCT00138580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64935530|NCT00138580|Protease Inhibitors|protease inhibitors|mesh-ancestor
64935531|NCT00138580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935532|NCT00138580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935533|NCT03150771|Aripiprazole|aripiprazole|mesh-list
64935534|NCT03150771|Antidepressive Agents|antidepressive agents|mesh-ancestor
64935535|NCT03150771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64935536|NCT03150771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64935537|NCT03150771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64935538|NCT03150771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64935539|NCT03150771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935540|NCT03150771|Dopamine Agonists|dopamine agonists|mesh-ancestor
64935541|NCT03150771|Dopamine Agents|dopamine agents|mesh-ancestor
64935542|NCT03150771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64935543|NCT03150771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935544|NCT03150771|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64935545|NCT03150771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64935546|NCT03150771|Serotonin Agents|serotonin agents|mesh-ancestor
64528869|NCT02386488|Serotonin Agents|serotonin agents|mesh-ancestor
64528870|NCT02386488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64528871|NCT02386488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64528872|NCT02386488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64528873|NCT02386488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64528874|NCT02661594|Moxifloxacin|moxifloxacin|mesh-list
64528875|NCT02661594|Amisulpride|amisulpride|mesh-list
64528876|NCT02661594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64563057|NCT01246791|Hormones|hormones|mesh-ancestor
64563058|NCT01246791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64563059|NCT01246791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563060|NCT01246791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64563061|NCT01246791|Contraceptive Agents|contraceptive agents|mesh-ancestor
64563062|NCT01246791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64563063|NCT01246791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64563064|NCT01246791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64563065|NCT01246791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64563066|NCT01246791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64563067|NCT01246791|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64563068|NCT05345639|Ropivacaine|ropivacaine|mesh-list
64563069|NCT05345639|Anesthetics|anesthetics|mesh-ancestor
64563104|NCT04176419|Celecoxib|celecoxib|mesh-list
64563105|NCT04176419|Lidocaine|lidocaine|mesh-list
64563106|NCT04176419|Ketamine|ketamine|mesh-list
64563107|NCT04176419|Gabapentin|gabapentin|mesh-list
64563108|NCT04176419|Anesthetics, Local|anesthetics, local|mesh-ancestor
64563109|NCT04176419|Anesthetics|anesthetics|mesh-ancestor
64563110|NCT04176419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64563111|NCT04176419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563112|NCT04176419|Sensory System Agents|sensory system agents|mesh-ancestor
64563144|NCT04165967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528877|NCT02661594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64528878|NCT02661594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64528879|NCT02661594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64528880|NCT02661594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528881|NCT02661594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528882|NCT02661594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528883|NCT02661594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528884|NCT02661594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64528885|NCT02661594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64528886|NCT02661594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64528887|NCT02661594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64528888|NCT02661594|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64528889|NCT02661594|Dopamine Agents|dopamine agents|mesh-ancestor
64528890|NCT02661594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64528891|NCT02661594|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64528892|NCT02661594|Antidepressive Agents|antidepressive agents|mesh-ancestor
64528893|NCT02386566|Natalizumab|natalizumab|mesh-list
64528894|NCT02386566|Immunologic Factors|immunologic factors|mesh-ancestor
64935575|NCT03893825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935576|NCT03893825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935577|NCT03893825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64935578|NCT03893825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64935579|NCT03893825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64935580|NCT03893825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64935581|NCT03893825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64935582|NCT03893825|Dopamine Agents|dopamine agents|mesh-ancestor
64935583|NCT00138970|Mycophenolic Acid|mycophenolic acid|mesh-list
64935584|NCT00138970|Cyclosporine|cyclosporine|mesh-list
64935585|NCT00138970|Prednisolone|prednisolone|mesh-list
64563145|NCT04165967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64563146|NCT04165967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563147|NCT03211949|Mepivacaine|mepivacaine|mesh-list
64563148|NCT03211949|Anesthetics, Local|anesthetics, local|mesh-ancestor
64563149|NCT03211949|Anesthetics|anesthetics|mesh-ancestor
64563150|NCT03211949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64563151|NCT03211949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563152|NCT03211949|Sensory System Agents|sensory system agents|mesh-ancestor
64563153|NCT03211949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563186|NCT01288521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64563188|NCT00632749|Cytarabine|cytarabine|mesh-list
64563189|NCT00632749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64563190|NCT00632749|Antimetabolites|antimetabolites|mesh-ancestor
64563191|NCT00632749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563192|NCT00632749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563230|NCT03934307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563266|NCT01289457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64563267|NCT01289457|Antimetabolites|antimetabolites|mesh-ancestor
64517141|NCT03258294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517142|NCT03258294|Protective Agents|protective agents|mesh-ancestor
64517143|NCT03258294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517144|NCT03258294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64619960|NCT01218997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935586|NCT00138970|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64935587|NCT00138970|Methylprednisolone|methylprednisolone|mesh-list
64935588|NCT00138970|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64935589|NCT00138970|Prednisolone acetate|prednisolone acetate|mesh-list
64935590|NCT00138970|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64935591|NCT00138970|Prednisolone phosphate|prednisolone phosphate|mesh-list
64935592|NCT00138970|Daclizumab|daclizumab|mesh-list
64935593|NCT00138970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64935594|NCT00138970|Glucocorticoids|glucocorticoids|mesh-ancestor
64935595|NCT00138970|Hormones|hormones|mesh-ancestor
64935596|NCT00138970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64528895|NCT02386566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528896|NCT01528345|Fulvestrant|fulvestrant|mesh-list
64528897|NCT01528345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64528898|NCT01528345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528899|NCT01528345|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64650905|NCT00882206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64935604|NCT00138970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64935605|NCT00138970|Protective Agents|protective agents|mesh-ancestor
64935638|NCT03890666|Tocolytic Agents|tocolytic agents|mesh-ancestor
64935639|NCT03890666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64935640|NCT03890666|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64935641|NCT03890666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64935642|NCT03890666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64517145|NCT03265782|Acetaminophen|acetaminophen|mesh-list
64563268|NCT01289457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563269|NCT01289457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64563270|NCT01289457|Immunologic Factors|immunologic factors|mesh-ancestor
64563307|NCT03810287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563308|NCT03810287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563309|NCT03810287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64563310|NCT03810287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64563311|NCT03810287|Dopamine Agents|dopamine agents|mesh-ancestor
64563312|NCT03810287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64563313|NCT03810287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563342|NCT01251393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64563343|NCT01251393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563344|NCT00631969|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
64563345|NCT00631969|Vasodilator Agents|vasodilator agents|mesh-ancestor
64563346|NCT00631969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64563347|NCT00631969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64935643|NCT03890666|Adrenergic Agents|adrenergic agents|mesh-ancestor
64935644|NCT03890666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64935645|NCT03890666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935646|NCT00139165|Budesonide|budesonide|mesh-list
64935647|NCT00139165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64935670|NCT00139243|Antidotes|antidotes|mesh-ancestor
64935671|NCT00139243|Protective Agents|protective agents|mesh-ancestor
64935672|NCT00139243|Vitamin B Complex|vitamin b complex|mesh-ancestor
64935673|NCT00139243|Vitamins|vitamins|mesh-ancestor
64935674|NCT00139243|Micronutrients|micronutrients|mesh-ancestor
64935675|NCT00139243|Tubulin Modulators|tubulin modulators|mesh-ancestor
64935676|NCT00139243|Antimitotic Agents|antimitotic agents|mesh-ancestor
64935677|NCT00139243|Mitosis Modulators|mitosis modulators|mesh-ancestor
64935678|NCT00139282|Squalamine|squalamine|mesh-list
64935679|NCT00139282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64935680|NCT00139282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64935681|NCT00139282|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64935682|NCT00139282|Protective Agents|protective agents|mesh-ancestor
64935683|NCT00139282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935684|NCT00139282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935685|NCT00139282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64935686|NCT00139282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64935687|NCT00139282|Growth Substances|growth substances|mesh-ancestor
64935688|NCT00139282|Growth Inhibitors|growth inhibitors|mesh-ancestor
64935689|NCT03861767|Metformin|metformin|mesh-list
64935690|NCT03861767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64935691|NCT03861767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935692|NCT00139360|Bevacizumab|bevacizumab|mesh-list
64935693|NCT00139360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64935694|NCT00139360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935695|NCT00139360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64935696|NCT00139360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64935697|NCT00139360|Growth Substances|growth substances|mesh-ancestor
64935698|NCT00139360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935699|NCT00139360|Growth Inhibitors|growth inhibitors|mesh-ancestor
64935700|NCT00139516|Nicotine|nicotine|mesh-list
64935721|NCT00139555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935722|NCT03844412|Lidocaine|lidocaine|mesh-list
64935723|NCT03844412|Nortriptyline|nortriptyline|mesh-list
64935724|NCT03844412|Estradiol|estradiol|mesh-list
64935725|NCT03844412|Anesthetics, Local|anesthetics, local|mesh-ancestor
64563348|NCT00631969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563349|NCT00631969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563350|NCT00631969|Urological Agents|urological agents|mesh-ancestor
64563352|NCT01255137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563353|NCT01255137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64563354|NCT01255137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563355|NCT01255137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563356|NCT03253133|Oxaliplatin|oxaliplatin|mesh-list
64935726|NCT03844412|Anesthetics|anesthetics|mesh-ancestor
64935727|NCT03844412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64935728|NCT03844412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935729|NCT03844412|Sensory System Agents|sensory system agents|mesh-ancestor
64935730|NCT03844412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64935731|NCT03844412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64935732|NCT03844412|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64935733|NCT03844412|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64935734|NCT03844412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64935735|NCT03844412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935736|NCT03844412|Estrogens|estrogens|mesh-ancestor
64528900|NCT01528345|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64528901|NCT01528345|Hormone Antagonists|hormone antagonists|mesh-ancestor
64528902|NCT01528345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64935738|NCT03844412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64935739|NCT03844412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64935740|NCT03844412|Antidepressive Agents|antidepressive agents|mesh-ancestor
64935741|NCT03844412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64935742|NCT03844412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64935743|NCT03844412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64935744|NCT03844412|Adrenergic Agents|adrenergic agents|mesh-ancestor
64935745|NCT03844412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64935746|NCT00139633|Carboplatin|carboplatin|mesh-list
64935747|NCT00139633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935748|NCT00139711|Docetaxel|docetaxel|mesh-list
64935749|NCT00139711|Irinotecan|irinotecan|mesh-list
64935750|NCT00139711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935751|NCT00139711|Tubulin Modulators|tubulin modulators|mesh-ancestor
64935752|NCT00139711|Antimitotic Agents|antimitotic agents|mesh-ancestor
64935753|NCT00139711|Mitosis Modulators|mitosis modulators|mesh-ancestor
64935777|NCT03837977|Antidotes|antidotes|mesh-ancestor
64935778|NCT03837977|Protective Agents|protective agents|mesh-ancestor
64935779|NCT03837977|Vitamin B Complex|vitamin b complex|mesh-ancestor
64935781|NCT03837977|Micronutrients|micronutrients|mesh-ancestor
64935782|NCT03837977|Hematinics|hematinics|mesh-ancestor
64935783|NCT00404326|Hydralazine|hydralazine|mesh-list
64935784|NCT00404326|Valproic Acid|valproic acid|mesh-list
64935785|NCT00404326|Anticonvulsants|anticonvulsants|mesh-ancestor
64935786|NCT00404326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935787|NCT00404326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935788|NCT00404326|GABA Agents|gaba agents|mesh-ancestor
64935789|NCT00404326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64935790|NCT00404326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935791|NCT00404326|Antimanic Agents|antimanic agents|mesh-ancestor
64935792|NCT00404326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64935793|NCT00404326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64935794|NCT00404326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64935795|NCT00404326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64935796|NCT00404326|Vasodilator Agents|vasodilator agents|mesh-ancestor
64935797|NCT00139750|Varenicline|varenicline|mesh-list
64935798|NCT00139750|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64935799|NCT00139750|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64935800|NCT00139750|Cholinergic Agents|cholinergic agents|mesh-ancestor
64935801|NCT00139750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64935802|NCT00139750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935803|NCT00139750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935804|NCT00139867|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64935805|NCT00139867|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64563357|NCT03253133|Oxycodone|oxycodone|mesh-list
64563358|NCT03253133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563359|NCT03253133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64563360|NCT03253133|Narcotics|narcotics|mesh-ancestor
64563361|NCT03253133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64563396|NCT00631657|Adrenergic Agents|adrenergic agents|mesh-ancestor
64563397|NCT00631657|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64563398|NCT00631657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64563399|NCT00631657|Serotonin Agents|serotonin agents|mesh-ancestor
64563400|NCT00631657|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64563401|NCT01257087|Insulin|insulin|mesh-list
64563426|NCT00630877|Sensory System Agents|sensory system agents|mesh-ancestor
64563427|NCT00630877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563428|NCT00630877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563429|NCT00630877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64563430|NCT00630877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64563431|NCT00630877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64563432|NCT00630877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64563433|NCT00630877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563434|NCT00630877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64563435|NCT00630877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64563436|NCT00630877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563437|NCT00630877|Antipyretics|antipyretics|mesh-ancestor
64563438|NCT00630877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64563439|NCT00630877|Antimetabolites|antimetabolites|mesh-ancestor
64563440|NCT00630877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64563444|NCT00630877|Micronutrients|micronutrients|mesh-ancestor
64517156|NCT03265782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517157|NCT03265782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517158|NCT03265782|Antipyretics|antipyretics|mesh-ancestor
64517159|NCT03798054|Insulin|insulin|mesh-list
64563483|NCT02307149|Ipilimumab|ipilimumab|mesh-list
64563484|NCT02307149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64563485|NCT02307149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563486|NCT02307149|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64563487|NCT02307149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563488|NCT02134301|Oritavancin|oritavancin|mesh-list
64563489|NCT02134301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64563490|NCT02134301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64563491|NCT04397393|Midazolam|midazolam|mesh-list
64563492|NCT04397393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64935806|NCT00139867|Immunologic Factors|immunologic factors|mesh-ancestor
64935807|NCT00139867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935830|NCT00140062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64935831|NCT00140062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64935832|NCT00140101|Paclitaxel|paclitaxel|mesh-list
64935833|NCT00140101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64935834|NCT00140101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935835|NCT00140101|Tubulin Modulators|tubulin modulators|mesh-ancestor
64935836|NCT00140101|Antimitotic Agents|antimitotic agents|mesh-ancestor
64935837|NCT00140101|Mitosis Modulators|mitosis modulators|mesh-ancestor
64935838|NCT00140101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935839|NCT03150420|Sodium thiosulfate|sodium thiosulfate|mesh-list
64935840|NCT03150420|Antidotes|antidotes|mesh-ancestor
64528909|NCT01511939|Sensory System Agents|sensory system agents|mesh-ancestor
64485025|NCT01722097|Rocuronium|rocuronium|mesh-list
64935841|NCT03150420|Protective Agents|protective agents|mesh-ancestor
64935842|NCT03150420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935843|NCT03150420|Antioxidants|antioxidants|mesh-ancestor
64935844|NCT03150420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935938|NCT00140803|Glucocorticoids|glucocorticoids|mesh-ancestor
64935939|NCT00140803|Hormones|hormones|mesh-ancestor
64935940|NCT00140803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64650927|NCT00885638|Incretins|incretins|mesh-ancestor
64650928|NCT00885638|Hormones|hormones|mesh-ancestor
64935948|NCT00140920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64935949|NCT00140920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64935950|NCT00140920|Analgesics|analgesics|mesh-ancestor
64935951|NCT00140920|Sensory System Agents|sensory system agents|mesh-ancestor
64935967|NCT00140998|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64935968|NCT00140998|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64935969|NCT00140998|Estradiol|estradiol|mesh-list
64935970|NCT00140998|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64935971|NCT00140998|Estrogens|estrogens|mesh-ancestor
64935972|NCT00140998|Hormones|hormones|mesh-ancestor
64935973|NCT00140998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64935974|NCT00140998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704469|NCT02473783|Serotonin Agents|serotonin agents|mesh-ancestor
64935975|NCT00140998|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64935976|NCT00140998|Contraceptive Agents|contraceptive agents|mesh-ancestor
64935977|NCT00140998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64935978|NCT00140998|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64935980|NCT00141154|Loxoprofen|loxoprofen|mesh-list
64935981|NCT00141154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64935982|NCT00141154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64935983|NCT00141154|Analgesics|analgesics|mesh-ancestor
64528911|NCT01511939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528912|NCT01511939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64563493|NCT04397393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64563494|NCT04397393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64563495|NCT04397393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563496|NCT04397393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64563530|NCT00630331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563531|NCT04555291|Ropivacaine|ropivacaine|mesh-list
64563532|NCT04555291|Anesthetics, Local|anesthetics, local|mesh-ancestor
64563533|NCT04555291|Anesthetics|anesthetics|mesh-ancestor
64563534|NCT04555291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64563535|NCT04555291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563536|NCT04555291|Sensory System Agents|sensory system agents|mesh-ancestor
64563537|NCT04555291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563538|NCT04275115|Midazolam|midazolam|mesh-list
64563539|NCT04275115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64563642|NCT00667121|Hormone Antagonists|hormone antagonists|mesh-ancestor
64563643|NCT00667121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64563644|NCT00667121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64563645|NCT00667121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563646|NCT00667121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64563647|NCT00667121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64563648|NCT00667121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64563649|NCT00667121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64563650|NCT04828343|Rozanolixizumab|rozanolixizumab|mesh-list
64563651|NCT04828343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64563652|NCT04828343|Immunologic Factors|immunologic factors|mesh-ancestor
64563653|NCT04828343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563654|NCT04276649|Calcium Carbonate|calcium carbonate|mesh-list
64563655|NCT04276649|Antacids|antacids|mesh-ancestor
64528913|NCT01511939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64528914|NCT01511939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528915|NCT01511939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528916|NCT01576705|Leucovorin|leucovorin|mesh-list
64528917|NCT01576705|Folic Acid|folic acid|mesh-list
64528918|NCT01576705|Hormones|hormones|mesh-list
64528919|NCT01576705|Levoleucovorin|levoleucovorin|mesh-list
64528920|NCT01576705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64528921|NCT01576705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528922|NCT01576705|Antidotes|antidotes|mesh-ancestor
64528923|NCT01576705|Protective Agents|protective agents|mesh-ancestor
64528924|NCT01576705|Vitamin B Complex|vitamin b complex|mesh-ancestor
64935984|NCT00141154|Sensory System Agents|sensory system agents|mesh-ancestor
64935985|NCT00141154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64935986|NCT00141154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935987|NCT00141154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64935988|NCT00141154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64563656|NCT04276649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563683|NCT04346407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64563684|NCT04346407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563685|NCT04346407|Hormones|hormones|mesh-ancestor
64563686|NCT04346407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64563687|NCT04397549|Morphine|morphine|mesh-list
64517160|NCT03798054|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64517161|NCT03798054|Metformin|metformin|mesh-list
64517162|NCT03798054|Insulin Glargine|insulin glargine|mesh-list
64517163|NCT03798054|Lixisenatide|lixisenatide|mesh-list
64517164|NCT03798054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64563688|NCT04397549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64563689|NCT04397549|Narcotics|narcotics|mesh-ancestor
64563690|NCT04397549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64563691|NCT04397549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563692|NCT04397549|Analgesics|analgesics|mesh-ancestor
64563693|NCT04397549|Sensory System Agents|sensory system agents|mesh-ancestor
64563694|NCT04397549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563695|NCT03080441|Midodrine|midodrine|mesh-list
64563696|NCT03080441|Sympathomimetics|sympathomimetics|mesh-ancestor
64620265|NCT02569242|Nivolumab|nivolumab|mesh-list
64620266|NCT02569242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64563697|NCT03080441|Autonomic Agents|autonomic agents|mesh-ancestor
64935989|NCT00141154|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64935990|NCT00141154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64935991|NCT00141154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935992|NCT00141154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935993|NCT03709706|Pembrolizumab|pembrolizumab|mesh-list
64935994|NCT03709706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64935995|NCT03709706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935996|NCT00141193|Celecoxib|celecoxib|mesh-list
64935997|NCT00141193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64935998|NCT00141193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64935999|NCT00141193|Analgesics|analgesics|mesh-ancestor
64936000|NCT00141193|Sensory System Agents|sensory system agents|mesh-ancestor
64936001|NCT00141193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64936002|NCT00141193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936003|NCT00141193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64936004|NCT00141193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64936005|NCT00141193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64936006|NCT00141193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64936007|NCT00141193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936008|NCT00141193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936009|NCT00141232|Atorvastatin|atorvastatin|mesh-list
64936043|NCT00404404|Paclitaxel|paclitaxel|mesh-list
64936084|NCT00141427|Sensory System Agents|sensory system agents|mesh-ancestor
64936108|NCT00141544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936110|NCT00141544|Androgens|androgens|mesh-ancestor
64936111|NCT00141583|Candesartan|candesartan|mesh-list
64936112|NCT00141583|Enalapril|enalapril|mesh-list
64936113|NCT00141583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64936114|NCT00141583|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64563698|NCT03080441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563699|NCT03080441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563700|NCT03080441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64563701|NCT03080441|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64563739|NCT01925911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563741|NCT01925911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64936115|NCT00141583|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64936116|NCT00141583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936117|NCT00141583|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64528925|NCT01576705|Vitamins|vitamins|mesh-ancestor
64528926|NCT01576705|Micronutrients|micronutrients|mesh-ancestor
64528927|NCT01576705|Hematinics|hematinics|mesh-ancestor
64528928|NCT02666430|Insulin Glargine|insulin glargine|mesh-list
64528929|NCT02666430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64528930|NCT02666430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528931|NCT02382666|Rolapitant|rolapitant|mesh-list
64528932|NCT02382666|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64528933|NCT02382666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64528934|NCT02382666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528935|NCT02382666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528936|NCT00145041|Vincristine|vincristine|mesh-list
64528937|NCT00145041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64528938|NCT00145041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936118|NCT00141583|Protease Inhibitors|protease inhibitors|mesh-ancestor
64936119|NCT00141583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936120|NCT00141700|Rituximab|rituximab|mesh-list
64936121|NCT00141700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64936122|NCT00141700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936123|NCT00141700|Immunologic Factors|immunologic factors|mesh-ancestor
64936124|NCT00141700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936125|NCT00141700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64936126|NCT03555149|Bevacizumab|bevacizumab|mesh-list
64936127|NCT03555149|Atezolizumab|atezolizumab|mesh-list
64936128|NCT03555149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64936129|NCT03555149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936130|NCT03555149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64936131|NCT03555149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64936132|NCT03555149|Growth Substances|growth substances|mesh-ancestor
64936133|NCT03555149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936134|NCT03555149|Growth Inhibitors|growth inhibitors|mesh-ancestor
64936155|NCT00142051|Vasodilator Agents|vasodilator agents|mesh-ancestor
64936156|NCT00142051|Gasotransmitters|gasotransmitters|mesh-ancestor
64936157|NCT00142051|Protective Agents|protective agents|mesh-ancestor
64936158|NCT00142129|Bortezomib|bortezomib|mesh-list
64936159|NCT00142129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936160|NCT02825979|Sotalol|sotalol|mesh-list
64936161|NCT02825979|Flecainide|flecainide|mesh-list
64936162|NCT02825979|Dronedarone|dronedarone|mesh-list
64936163|NCT02825979|Propafenone|propafenone|mesh-list
64936164|NCT02825979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64936165|NCT02825979|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64936166|NCT02825979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64936167|NCT02825979|Adrenergic Agents|adrenergic agents|mesh-ancestor
64936168|NCT02825979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64936169|NCT02825979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936170|NCT02825979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936171|NCT02825979|Sympatholytics|sympatholytics|mesh-ancestor
64936172|NCT02825979|Autonomic Agents|autonomic agents|mesh-ancestor
64936173|NCT02825979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64936174|NCT02825979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64936175|NCT02825979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64936176|NCT02825979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64936177|NCT00142207|Pyrimethamine|pyrimethamine|mesh-list
64936178|NCT00142207|Sulfadoxine|sulfadoxine|mesh-list
64936179|NCT00142207|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64528939|NCT00145041|Tubulin Modulators|tubulin modulators|mesh-ancestor
64528940|NCT00145041|Antimitotic Agents|antimitotic agents|mesh-ancestor
64528941|NCT00145041|Mitosis Modulators|mitosis modulators|mesh-ancestor
64563742|NCT01925911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64563743|NCT01925911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64563811|NCT02393183|Selenium|selenium|mesh-list
64563812|NCT02393183|Antioxidants|antioxidants|mesh-list
64563813|NCT02393183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563814|NCT02393183|Protective Agents|protective agents|mesh-ancestor
64563815|NCT02393183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563816|NCT02393183|Trace Elements|trace elements|mesh-ancestor
64563817|NCT02393183|Micronutrients|micronutrients|mesh-ancestor
64563818|NCT05599295|Oritavancin|oritavancin|mesh-list
64563819|NCT05599295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64563820|NCT05599295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64563821|NCT03554291|Famotidine|famotidine|mesh-list
64563822|NCT03554291|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64620391|NCT04120922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64563823|NCT03554291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64563854|NCT02392637|Antiviral Agents|antiviral agents|mesh-ancestor
64563855|NCT02392637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64528942|NCT00145041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528943|NCT04123561|Dexamethasone|dexamethasone|mesh-list
64528944|NCT04123561|Dexamethasone acetate|dexamethasone acetate|mesh-list
64936186|NCT00142207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936187|NCT00142207|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64936188|NCT00142207|Renal Agents|renal agents|mesh-ancestor
64936189|NCT00142246|Amodiaquine|amodiaquine|mesh-list
64936215|NCT00142480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64936216|NCT00142480|Growth Substances|growth substances|mesh-ancestor
64936217|NCT00142480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936218|NCT00142480|Growth Inhibitors|growth inhibitors|mesh-ancestor
64936219|NCT00142480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64936220|NCT00142480|Antimetabolites|antimetabolites|mesh-ancestor
64936221|NCT00142480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936222|NCT02806050|Letrozole|letrozole|mesh-list
64936223|NCT02806050|Palbociclib|palbociclib|mesh-list
64936224|NCT02806050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936225|NCT02806050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64936226|NCT02806050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64936227|NCT02806050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936228|NCT02806050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936229|NCT02806050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64936230|NCT02806050|Hormone Antagonists|hormone antagonists|mesh-ancestor
64936231|NCT02806050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64936232|NCT02806050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936233|NCT02806050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64936234|NCT02781792|Temozolomide|temozolomide|mesh-list
64936235|NCT02781792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64936236|NCT02781792|Alkylating Agents|alkylating agents|mesh-ancestor
64936256|NCT00142948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936257|NCT00142948|Sensory System Agents|sensory system agents|mesh-ancestor
64936258|NCT00142948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64936259|NCT02780427|Dexmedetomidine|dexmedetomidine|mesh-list
64936260|NCT02780427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64936261|NCT02780427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64936262|NCT02780427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936263|NCT02780427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64936265|NCT02780427|Sensory System Agents|sensory system agents|mesh-ancestor
64563856|NCT02392637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563857|NCT02392637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64563858|NCT02392637|Immunologic Factors|immunologic factors|mesh-ancestor
64563859|NCT02392637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563860|NCT05600881|Methylphenidate|methylphenidate|mesh-list
64563861|NCT05600881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64563862|NCT05600881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563863|NCT05600881|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64563864|NCT05600881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64563865|NCT05600881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64563866|NCT05600881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563867|NCT05600881|Dopamine Agents|dopamine agents|mesh-ancestor
64936266|NCT02780427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64936267|NCT02780427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64936268|NCT02780427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64936269|NCT02780427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64936270|NCT02780427|Adrenergic Agents|adrenergic agents|mesh-ancestor
64936271|NCT02780427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64936272|NCT02780427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936273|NCT00142987|Tegaserod|tegaserod|mesh-list
64936274|NCT00142987|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64936275|NCT00142987|Serotonin Agents|serotonin agents|mesh-ancestor
64936276|NCT00142987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64936277|NCT00142987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936278|NCT00142987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936279|NCT00143026|Levodopa|levodopa|mesh-list
64936280|NCT00143026|Carbidopa|carbidopa|mesh-list
64936281|NCT00143026|Entacapone|entacapone|mesh-list
64936282|NCT00143026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64936283|NCT00143026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64936284|NCT00143026|Dopamine Agents|dopamine agents|mesh-ancestor
64936285|NCT00143026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64936286|NCT00143026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528951|NCT04123561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528952|NCT04123561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64528953|NCT04123561|Glucocorticoids|glucocorticoids|mesh-ancestor
64528954|NCT04123561|Hormones|hormones|mesh-ancestor
64528955|NCT04123561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64528956|NCT04123561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64528957|NCT04123561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528958|NCT04123561|Protease Inhibitors|protease inhibitors|mesh-ancestor
64528959|NCT04123561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936304|NCT00143065|Immunologic Factors|immunologic factors|mesh-ancestor
64936305|NCT00143065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936306|NCT00143065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64936307|NCT02554383|Amoxicillin|amoxicillin|mesh-list
64936308|NCT02554383|Clavulanic Acid|clavulanic acid|mesh-list
64936309|NCT02554383|Clavulanic Acids|clavulanic acids|mesh-list
64936310|NCT02554383|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64936311|NCT02554383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64936312|NCT02554383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64936313|NCT02554383|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64936314|NCT02554383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936315|NCT02554383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936316|NCT00143104|Insulin|insulin|mesh-list
64936317|NCT00143104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64936318|NCT00143104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936319|NCT00143143|Pregabalin|pregabalin|mesh-list
64936320|NCT00143143|Analgesics|analgesics|mesh-ancestor
64936321|NCT00143143|Sensory System Agents|sensory system agents|mesh-ancestor
64936322|NCT00143143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563932|NCT03133325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563934|NCT00638963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64563935|NCT00638963|Alkylating Agents|alkylating agents|mesh-ancestor
64563936|NCT00638963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563937|NCT00638963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563938|NCT04278677|Melatonin|melatonin|mesh-list
64563939|NCT04278677|Antioxidants|antioxidants|mesh-ancestor
64563967|NCT01927315|Fenofibrate|fenofibrate|mesh-list
64563968|NCT01927315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64563969|NCT01927315|Antimetabolites|antimetabolites|mesh-ancestor
64563970|NCT01927315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563971|NCT01927315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64563972|NCT00636155|Cyclophosphamide|cyclophosphamide|mesh-list
64563975|NCT00636155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64563976|NCT00636155|Immunologic Factors|immunologic factors|mesh-ancestor
64563977|NCT00636155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563978|NCT00636155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64620511|NCT04128254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620513|NCT04128254|Anticoagulants|anticoagulants|mesh-ancestor
64936323|NCT00143143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936324|NCT00143143|Anticonvulsants|anticonvulsants|mesh-ancestor
64936325|NCT00143143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64936326|NCT00143143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64936327|NCT00143143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936328|NCT00143143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64936329|NCT00143143|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64936330|NCT00143143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64936331|NCT00143143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64936332|NCT00143143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64936333|NCT00143221|Sildenafil Citrate|sildenafil citrate|mesh-list
64936334|NCT00143221|Vasodilator Agents|vasodilator agents|mesh-ancestor
64936335|NCT00143221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64936336|NCT00143221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64936337|NCT00143221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936338|NCT00143221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936339|NCT00143221|Urological Agents|urological agents|mesh-ancestor
64936340|NCT00143260|Sildenafil Citrate|sildenafil citrate|mesh-list
64936341|NCT00143260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936342|NCT00143260|Vasodilator Agents|vasodilator agents|mesh-ancestor
64936343|NCT00143260|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64936344|NCT00143260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64936345|NCT00143260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528960|NCT04123561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528962|NCT01510769|Lesinurad|lesinurad|mesh-list
64528963|NCT01510769|Gout Suppressants|gout suppressants|mesh-ancestor
64650979|NCT02203019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64650980|NCT02203019|Narcotics|narcotics|mesh-ancestor
64650982|NCT05000450|Cyclophosphamide|cyclophosphamide|mesh-list
64936369|NCT02972216|Mitosis Modulators|mitosis modulators|mesh-ancestor
64936370|NCT02972216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936372|NCT04726345|Terfenadine|terfenadine|mesh-list
64936373|NCT04726345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64936374|NCT04726345|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64936375|NCT04726345|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64563979|NCT00636155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64563980|NCT00636155|Alkylating Agents|alkylating agents|mesh-ancestor
64517165|NCT03798054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64517166|NCT03798054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517167|NCT03798054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517168|NCT03265470|Fentanyl|fentanyl|mesh-list
64517169|NCT03265470|Dexmedetomidine|dexmedetomidine|mesh-list
64517170|NCT03265470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64517171|NCT03265470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64563981|NCT00636155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563982|NCT00636155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564017|NCT04127851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64936376|NCT04726345|Histamine Antagonists|histamine antagonists|mesh-ancestor
64936377|NCT04726345|Histamine Agents|histamine agents|mesh-ancestor
64936378|NCT04726345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64936379|NCT04726345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936380|NCT04726345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936381|NCT00143533|Cefpodoxime|cefpodoxime|mesh-list
64936382|NCT00143533|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
64936383|NCT00143533|Irinotecan|irinotecan|mesh-list
64936384|NCT00143533|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64936385|NCT00143533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64936386|NCT00143533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936387|NCT00143533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936388|NCT00143533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936389|NCT00143533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64936390|NCT00143533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64936391|NCT00143572|Hydroxyurea|hydroxyurea|mesh-list
64936392|NCT00143572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936393|NCT00143572|Antisickling Agents|antisickling agents|mesh-ancestor
64936394|NCT00143572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936395|NCT00143572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936396|NCT00143572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64936397|NCT00393315|Paclitaxel|paclitaxel|mesh-list
64936398|NCT00393315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64936399|NCT00393315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936400|NCT00393315|Tubulin Modulators|tubulin modulators|mesh-ancestor
64936401|NCT00393315|Antimitotic Agents|antimitotic agents|mesh-ancestor
64936402|NCT00393315|Mitosis Modulators|mitosis modulators|mesh-ancestor
64936403|NCT00393315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936404|NCT00143689|Ritonavir|ritonavir|mesh-list
64936405|NCT00143689|Lopinavir|lopinavir|mesh-list
64936438|NCT00143806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936439|NCT00143806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64936440|NCT00143806|Immunologic Factors|immunologic factors|mesh-ancestor
64936441|NCT00143806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936442|NCT00143806|Antifungal Agents|antifungal agents|mesh-ancestor
64936443|NCT00143806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64936444|NCT00143806|Dermatologic Agents|dermatologic agents|mesh-ancestor
64936445|NCT00143806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64936446|NCT00143806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64650988|NCT05000450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64650989|NCT05000450|Alkylating Agents|alkylating agents|mesh-ancestor
64936467|NCT00144157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64650993|NCT00886262|Vasopressins|vasopressins|mesh-list
64528978|NCT02382354|Sensory System Agents|sensory system agents|mesh-ancestor
64528979|NCT02382354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64528980|NCT01510145|Travoprost|travoprost|mesh-list
64528981|NCT01510145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64528982|NCT03027167|Aspirin|aspirin|mesh-list
64564018|NCT04127851|Dermatologic Agents|dermatologic agents|mesh-ancestor
64564019|NCT04127851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64564052|NCT05602129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64564053|NCT05602129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564054|NCT05609929|Omeprazole|omeprazole|mesh-list
64564055|NCT05609929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64564056|NCT05609929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64564057|NCT05609929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64564058|NCT05609929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64564059|NCT05609929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564060|NCT01928563|Udenafil|udenafil|mesh-list
64564061|NCT01928563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64528983|NCT03027167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64528984|NCT03027167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64528985|NCT03027167|Analgesics|analgesics|mesh-ancestor
64945396|NCT05664789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64528986|NCT03027167|Sensory System Agents|sensory system agents|mesh-ancestor
64936470|NCT00144157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64936471|NCT00144157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64936472|NCT00144157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64936473|NCT00144157|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64936474|NCT00144157|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64936475|NCT00144196|Tiotropium Bromide|tiotropium bromide|mesh-list
64936476|NCT00144196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64936477|NCT00144196|Autonomic Agents|autonomic agents|mesh-ancestor
64936478|NCT00144196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64936479|NCT00144196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936480|NCT00144196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64936481|NCT00144196|Respiratory System Agents|respiratory system agents|mesh-ancestor
64936482|NCT00144196|Parasympatholytics|parasympatholytics|mesh-ancestor
64936483|NCT00144196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64936484|NCT00144196|Cholinergic Agents|cholinergic agents|mesh-ancestor
64936485|NCT00144196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64936486|NCT00144196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936487|NCT03276572|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64936488|NCT03276572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64936489|NCT03276572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936490|NCT00144274|Ambroxol|ambroxol|mesh-list
64936491|NCT00144274|Expectorants|expectorants|mesh-ancestor
64936492|NCT00144274|Respiratory System Agents|respiratory system agents|mesh-ancestor
64936493|NCT00144352|Pyrimethamine|pyrimethamine|mesh-list
64936494|NCT00144352|Sulfadoxine|sulfadoxine|mesh-list
64936495|NCT00144352|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64936496|NCT00144352|Antimalarials|antimalarials|mesh-ancestor
64936497|NCT00144352|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64936498|NCT00144352|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64936499|NCT00144352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64936533|NCT00404794|Methylprednisolone|methylprednisolone|mesh-list
64936534|NCT00404794|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64936535|NCT00404794|Prednisolone acetate|prednisolone acetate|mesh-list
64936536|NCT00404794|Tacrolimus|tacrolimus|mesh-list
64936537|NCT00404794|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64936538|NCT00404794|Prednisolone phosphate|prednisolone phosphate|mesh-list
64936539|NCT00404794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64936540|NCT00404794|Immunologic Factors|immunologic factors|mesh-ancestor
64936541|NCT00404794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936570|NCT03191786|Antimetabolites|antimetabolites|mesh-ancestor
64936571|NCT03191786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936572|NCT03191786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651001|NCT00887510|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64936573|NCT03191786|Antiviral Agents|antiviral agents|mesh-ancestor
64528987|NCT03027167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64528988|NCT03027167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564062|NCT01928563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64564063|NCT01928563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586301|NCT00365261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64564094|NCT04394377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64564095|NCT04394377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64564096|NCT04394377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564097|NCT04394377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64564099|NCT04394377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64564100|NCT04394377|Protease Inhibitors|protease inhibitors|mesh-ancestor
64564101|NCT04394377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528989|NCT03027167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64528990|NCT03027167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64528991|NCT03027167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64528992|NCT03027167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64651002|NCT00887510|Trandolapril|trandolapril|mesh-list
64651003|NCT00887510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64936578|NCT03191786|Tubulin Modulators|tubulin modulators|mesh-ancestor
64936579|NCT03191786|Antimitotic Agents|antimitotic agents|mesh-ancestor
64936580|NCT03191786|Mitosis Modulators|mitosis modulators|mesh-ancestor
64936582|NCT00404833|Prednisolone|prednisolone|mesh-list
64936583|NCT00404833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64936584|NCT00404833|Methylprednisolone|methylprednisolone|mesh-list
64936585|NCT00404833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64936586|NCT00404833|Prednisolone acetate|prednisolone acetate|mesh-list
64936587|NCT00404833|Chlorambucil|chlorambucil|mesh-list
64936588|NCT00404833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64936609|NCT00404833|Protective Agents|protective agents|mesh-ancestor
64936610|NCT00404833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64936611|NCT00404833|Alkylating Agents|alkylating agents|mesh-ancestor
64936613|NCT05595109|Antioxidants|antioxidants|mesh-ancestor
64936614|NCT05595109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936615|NCT05595109|Protective Agents|protective agents|mesh-ancestor
64936616|NCT05595109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936617|NCT01940094|Prednisone|prednisone|mesh-list
64936618|NCT01940094|Glucocorticoids|glucocorticoids|mesh-list
64936619|NCT01940094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64936620|NCT01940094|Hormones|hormones|mesh-ancestor
64936621|NCT01940094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64936622|NCT01940094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936623|NCT01940094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64936624|NCT01940094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936625|NCT03128021|Milnacipran|milnacipran|mesh-list
64936626|NCT03128021|Citalopram|citalopram|mesh-list
64936627|NCT03128021|Levomilnacipran|levomilnacipran|mesh-list
64936628|NCT03128021|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64936629|NCT03128021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64936630|NCT03128021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64936631|NCT03128021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936632|NCT03128021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64936633|NCT03128021|Serotonin Agents|serotonin agents|mesh-ancestor
64936634|NCT03128021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936635|NCT03128021|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64936636|NCT03128021|Antidepressive Agents|antidepressive agents|mesh-ancestor
64936637|NCT03128021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64936638|NCT03128021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64936639|NCT03128021|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64529001|NCT02382198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64651009|NCT00887510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651010|NCT00887510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64651011|NCT00887510|Protease Inhibitors|protease inhibitors|mesh-ancestor
64651012|NCT00887510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651013|NCT03313778|Pembrolizumab|pembrolizumab|mesh-list
64651014|NCT03313778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64564102|NCT02984293|Atorvastatin|atorvastatin|mesh-list
64564103|NCT02984293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64564104|NCT02984293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64564105|NCT02984293|Antimetabolites|antimetabolites|mesh-ancestor
64564106|NCT02984293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564107|NCT02984293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64564108|NCT02984293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64564109|NCT02984293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64564110|NCT01929187|Amorolfine|amorolfine|mesh-list
64564138|NCT04396223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64564139|NCT04396223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64564141|NCT04396067|Isotretinoin|isotretinoin|mesh-list
64564142|NCT04396067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564143|NCT04396067|Keratolytic Agents|keratolytic agents|mesh-ancestor
64564144|NCT04396067|Dermatologic Agents|dermatologic agents|mesh-ancestor
64564145|NCT05608213|Lenvatinib|lenvatinib|mesh-list
64564146|NCT05608213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564147|NCT05608213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64564148|NCT05608213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64564149|NCT05608213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564150|NCT04124107|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64564151|NCT04124107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64564152|NCT04124107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564153|NCT03015259|Budesonide|budesonide|mesh-list
64564154|NCT03015259|Formoterol Fumarate|formoterol fumarate|mesh-list
64564155|NCT03015259|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64564156|NCT03015259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64564157|NCT03015259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64564187|NCT04127227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564189|NCT04127227|Antiviral Agents|antiviral agents|mesh-ancestor
64564190|NCT04127227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64620759|NCT03829592|Misoprostol|misoprostol|mesh-list
64564191|NCT04127227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620761|NCT03829592|Abortifacient Agents|abortifacient agents|mesh-ancestor
64651015|NCT03313778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376322|NCT04146207|Prednisone|prednisone|mesh-list
64651016|NCT01431989|Amoxicillin|amoxicillin|mesh-list
64936750|NCT01807455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64936751|NCT01807455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64936752|NCT01807455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64564192|NCT04127227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64517172|NCT03265470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517173|NCT03265470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64517174|NCT03265470|Analgesics|analgesics|mesh-ancestor
64517175|NCT03265470|Sensory System Agents|sensory system agents|mesh-ancestor
64517176|NCT03265470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517177|NCT03265470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64517178|NCT03265470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64517179|NCT03265470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64517180|NCT03265470|Adrenergic Agents|adrenergic agents|mesh-ancestor
64564193|NCT04127227|Immunologic Factors|immunologic factors|mesh-ancestor
64564194|NCT04127227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564195|NCT04274803|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64564196|NCT04274803|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64564197|NCT04274803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64564198|NCT04274803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64564199|NCT03292861|Mycophenolic Acid|mycophenolic acid|mesh-list
64564201|NCT03292861|Tacrolimus|tacrolimus|mesh-list
64564229|NCT03267277|Sodium thiosulfate|sodium thiosulfate|mesh-list
64564230|NCT03267277|Antidotes|antidotes|mesh-ancestor
64564231|NCT03267277|Protective Agents|protective agents|mesh-ancestor
64564232|NCT03267277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564233|NCT03267277|Antioxidants|antioxidants|mesh-ancestor
64620802|NCT02969798|Hormones|hormones|mesh-ancestor
64936753|NCT01807455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64936754|NCT01807455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936755|NCT05594017|Scopolamine|scopolamine|mesh-list
64936756|NCT05594017|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64936757|NCT05594017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64936758|NCT05594017|Antiemetics|antiemetics|mesh-ancestor
64936759|NCT05594017|Autonomic Agents|autonomic agents|mesh-ancestor
64936760|NCT05594017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64936761|NCT05594017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936762|NCT05594017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64936763|NCT05594017|Mydriatics|mydriatics|mesh-ancestor
64936764|NCT05594017|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64936765|NCT05594017|Cholinergic Agents|cholinergic agents|mesh-ancestor
64936766|NCT05594017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64936767|NCT05594017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936768|NCT05594017|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64936769|NCT05594017|Parasympatholytics|parasympatholytics|mesh-ancestor
64936770|NCT05586724|Norethindrone|norethindrone|mesh-list
64936771|NCT05586724|Norethindrone Acetate|norethindrone acetate|mesh-list
64936772|NCT05586724|Progesterone|progesterone|mesh-list
64936773|NCT05586724|Estrogens|estrogens|mesh-list
64936774|NCT05586724|Progestins|progestins|mesh-ancestor
64936775|NCT05586724|Hormones|hormones|mesh-ancestor
64936776|NCT05586724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64936777|NCT05586724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936778|NCT05586724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64936779|NCT05586724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64936806|NCT01807377|Anesthetics, General|anesthetics, general|mesh-ancestor
64564234|NCT03267277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564235|NCT03267277|Antitubercular Agents|antitubercular agents|mesh-ancestor
64564236|NCT03267277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64564237|NCT03267277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64564238|NCT03267277|Chelating Agents|chelating agents|mesh-ancestor
64564239|NCT03267277|Sequestering Agents|sequestering agents|mesh-ancestor
64564240|NCT00634049|Isavuconazole|isavuconazole|mesh-list
64564241|NCT00634049|Antifungal Agents|antifungal agents|mesh-ancestor
64564242|NCT00634049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64564243|NCT04123249|Propofol|propofol|mesh-list
64564244|NCT04123249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
64564245|NCT04123249|Anesthetics|anesthetics|mesh-list
64564246|NCT04123249|Sevoflurane|sevoflurane|mesh-list
64936808|NCT01807377|GABA Modulators|gaba modulators|mesh-ancestor
64936809|NCT01807377|GABA Agents|gaba agents|mesh-ancestor
64936810|NCT01807377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64936811|NCT01807377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936812|NCT03090737|Nivolumab|nivolumab|mesh-list
64936813|NCT03090737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64936814|NCT03090737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936815|NCT03090737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64936816|NCT03090737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936817|NCT02972255|Meropenem|meropenem|mesh-list
64936818|NCT02972255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64936819|NCT02972255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64936820|NCT05468671|Remifentanil|remifentanil|mesh-list
64936821|NCT05468671|Oxycodone|oxycodone|mesh-list
64936822|NCT05468671|Propofol|propofol|mesh-list
64936823|NCT05468671|Rocuronium|rocuronium|mesh-list
64936824|NCT05468671|Flumazenil|flumazenil|mesh-list
64936825|NCT05468671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64936826|NCT05468671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64936827|NCT05468671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936828|NCT05468671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64936864|NCT05461807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529009|NCT02382432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64529010|NCT02382432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651020|NCT03247088|Cyclophosphamide|cyclophosphamide|mesh-list
64936909|NCT01806948|Ramosetron|ramosetron|mesh-list
64936934|NCT02958163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936936|NCT00424138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64936937|NCT00424138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936938|NCT02985866|Pancrelipase|pancrelipase|mesh-list
64936939|NCT02985866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64936940|NCT01806792|Cholecalciferol|cholecalciferol|mesh-list
64936941|NCT01806792|Risedronic Acid|risedronic acid|mesh-list
64936942|NCT01806792|Etidronic Acid|etidronic acid|mesh-list
64936943|NCT01806792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64936944|NCT01806792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936945|NCT01806792|Vitamins|vitamins|mesh-ancestor
64936946|NCT01806792|Micronutrients|micronutrients|mesh-ancestor
64936947|NCT01806792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64936948|NCT01806792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64936949|NCT01806792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64936950|NCT01806792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936951|NCT05228431|Capecitabine|capecitabine|mesh-list
64936952|NCT05228431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64936953|NCT05228431|Antimetabolites|antimetabolites|mesh-ancestor
64936954|NCT05228431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936955|NCT05228431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936956|NCT05227456|Etonogestrel|etonogestrel|mesh-list
64936957|NCT05227456|Desogestrel|desogestrel|mesh-list
64936958|NCT05227456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64936986|NCT01806753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64564247|NCT04123249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64564272|NCT04274413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564274|NCT04274257|Rituximab|rituximab|mesh-list
64620914|NCT05394233|Bevacizumab|bevacizumab|mesh-list
64936987|NCT01806753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64936988|NCT01806753|GABA Modulators|gaba modulators|mesh-ancestor
64936989|NCT01806753|GABA Agents|gaba agents|mesh-ancestor
64936990|NCT01806753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64936991|NCT01806753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936992|NCT05197075|Darunavir|darunavir|mesh-list
64936993|NCT05197075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64936994|NCT05197075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64936995|NCT05197075|Protease Inhibitors|protease inhibitors|mesh-ancestor
64936996|NCT05197075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936997|NCT05197075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936998|NCT05197075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64936999|NCT05197075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64937000|NCT05197075|Antiviral Agents|antiviral agents|mesh-ancestor
64937001|NCT05197075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64937002|NCT05175430|Paroxetine|paroxetine|mesh-list
64937003|NCT05175430|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
64937004|NCT05175430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64937023|NCT01806675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937024|NCT01806675|Glycine Agents|glycine agents|mesh-ancestor
64937025|NCT01806675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64937026|NCT01806675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937027|NCT02762981|Paclitaxel|paclitaxel|mesh-list
64937028|NCT02762981|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64651033|NCT03247088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937033|NCT02762981|Mitosis Modulators|mitosis modulators|mesh-ancestor
64937034|NCT02762981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937035|NCT05065567|Droperidol|droperidol|mesh-list
64937036|NCT05065567|Haloperidol|haloperidol|mesh-list
64937037|NCT05065567|Ondansetron|ondansetron|mesh-list
64937038|NCT05065567|Haloperidol decanoate|haloperidol decanoate|mesh-list
64937039|NCT05065567|Antiemetics|antiemetics|mesh-ancestor
64937040|NCT05065567|Autonomic Agents|autonomic agents|mesh-ancestor
64937041|NCT05065567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64937042|NCT05065567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937043|NCT05065567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64937044|NCT05065567|Antipruritics|antipruritics|mesh-ancestor
64937045|NCT05065567|Dermatologic Agents|dermatologic agents|mesh-ancestor
64937046|NCT05065567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64937047|NCT05065567|Serotonin Agents|serotonin agents|mesh-ancestor
64937048|NCT05065567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64937049|NCT05065567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937050|NCT05065567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64937051|NCT05065567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64937052|NCT05065567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64937053|NCT05065567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64937054|NCT05065567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64937055|NCT05065567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64937056|NCT05065567|Dopamine Agents|dopamine agents|mesh-ancestor
64937057|NCT05065567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64937058|NCT05065567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64937083|NCT04958044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64937084|NCT04958044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937086|NCT04953754|Antioxidants|antioxidants|mesh-ancestor
64937087|NCT04953754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937088|NCT04953754|Protective Agents|protective agents|mesh-ancestor
64937089|NCT04953754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937090|NCT04953754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64937091|NCT04871308|Dexmedetomidine|dexmedetomidine|mesh-list
64937092|NCT04871308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64937093|NCT04871308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64937094|NCT04871308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937095|NCT04871308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64937096|NCT04871308|Analgesics|analgesics|mesh-ancestor
64937097|NCT04871308|Sensory System Agents|sensory system agents|mesh-ancestor
64937098|NCT04871308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64564275|NCT04274257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64564276|NCT04274257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564277|NCT04274257|Immunologic Factors|immunologic factors|mesh-ancestor
64564278|NCT04274257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564279|NCT04274257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64564280|NCT03128879|Venetoclax|venetoclax|mesh-list
64564281|NCT03128879|Acalabrutinib|acalabrutinib|mesh-list
64564282|NCT03128879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564283|NCT03831815|Rocuronium|rocuronium|mesh-list
64564284|NCT03831815|Cisatracurium|cisatracurium|mesh-list
64564285|NCT03831815|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64564286|NCT03831815|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64564287|NCT03831815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64564288|NCT03831815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64564289|NCT03831815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564290|NCT00632099|Progesterone|progesterone|mesh-list
64564291|NCT00632099|Progestins|progestins|mesh-ancestor
64564292|NCT00632099|Hormones|hormones|mesh-ancestor
64564293|NCT00632099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64564294|NCT00632099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564295|NCT03827629|Naloxone|naloxone|mesh-list
64937099|NCT04871308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64937100|NCT04871308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64937101|NCT04871308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64937102|NCT04871308|Adrenergic Agents|adrenergic agents|mesh-ancestor
64937103|NCT04871308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64937104|NCT04871308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937105|NCT04861051|Ketamine|ketamine|mesh-list
64937106|NCT04861051|Analgesics|analgesics|mesh-ancestor
64937129|NCT01806363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64937131|NCT04846855|Anesthetics, Local|anesthetics, local|mesh-list
64937132|NCT04846855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64937133|NCT04846855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651044|NCT01397591|Bortezomib|bortezomib|mesh-list
64529027|NCT04298463|Vancomycin|vancomycin|mesh-list
64529028|NCT04298463|Daptomycin|daptomycin|mesh-list
64937138|NCT01806324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64937139|NCT01806324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64937140|NCT01806324|Antimetabolites|antimetabolites|mesh-ancestor
64937141|NCT01806324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937142|NCT01806324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64937143|NCT01806324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64937144|NCT01806324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937145|NCT01806324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64937146|NCT01806324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64937147|NCT01806324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64937148|NCT01806324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64937149|NCT02964403|Indomethacin|indomethacin|mesh-list
64937150|NCT02964403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64937151|NCT02964403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64937152|NCT02964403|Analgesics|analgesics|mesh-ancestor
64937153|NCT02964403|Sensory System Agents|sensory system agents|mesh-ancestor
64937154|NCT02964403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64937187|NCT00405262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64564296|NCT03827629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64564297|NCT03827629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564324|NCT04124887|Caseins|caseins|mesh-list
64564325|NCT04124887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64564326|NCT04124887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937188|NCT00405262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64937189|NCT00405262|Analgesics|analgesics|mesh-ancestor
64937190|NCT00405262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64937191|NCT00405262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64937192|NCT00405262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64937193|NCT00405262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937221|NCT00393471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64937223|NCT00393471|Analgesics|analgesics|mesh-ancestor
64937224|NCT00393471|Sensory System Agents|sensory system agents|mesh-ancestor
64937225|NCT00393471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64937226|NCT00393471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937227|NCT00393471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64937228|NCT00393471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64937229|NCT00393471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64937230|NCT00393471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64937231|NCT00393471|Immunologic Factors|immunologic factors|mesh-ancestor
64937232|NCT02647892|Lidocaine|lidocaine|mesh-list
64937233|NCT02647892|Anesthetics, Local|anesthetics, local|mesh-ancestor
64937234|NCT02647892|Anesthetics|anesthetics|mesh-ancestor
64937235|NCT02647892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64651054|NCT03855332|Urological Agents|urological agents|mesh-ancestor
64651055|NCT03855332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64937236|NCT02647892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651056|NCT03855332|Autonomic Agents|autonomic agents|mesh-ancestor
64651057|NCT03855332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64651058|NCT03855332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651059|NCT03855332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64651060|NCT03855332|Respiratory System Agents|respiratory system agents|mesh-ancestor
64319408|NCT02174575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64319410|NCT03751397|Cystatins|cystatins|mesh-list
64937266|NCT01806090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64937267|NCT01806090|Purinergic Agents|purinergic agents|mesh-ancestor
64937268|NCT01806090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64937269|NCT01806090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937270|NCT01806090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937272|NCT02505893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64937273|NCT02505893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64937274|NCT02505893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64937275|NCT02505893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937276|NCT02505893|Antifungal Agents|antifungal agents|mesh-ancestor
64937277|NCT02505893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64529030|NCT04298463|Dalbavancin|dalbavancin|mesh-list
64529031|NCT04298463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64529032|NCT04298463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64529033|NCT02381964|Coenzyme Q10|coenzyme q10|mesh-list
64529034|NCT02381964|Vitamins|vitamins|mesh-ancestor
64529035|NCT02381964|Micronutrients|micronutrients|mesh-ancestor
64529036|NCT02381964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529037|NCT01509053|Aripiprazole|aripiprazole|mesh-list
64529038|NCT01509053|Antidepressive Agents|antidepressive agents|mesh-ancestor
64529039|NCT01509053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64529040|NCT01509053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64529041|NCT01509053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64529042|NCT01509053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64529043|NCT01509053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529044|NCT01509053|Dopamine Agonists|dopamine agonists|mesh-ancestor
64529045|NCT01509053|Dopamine Agents|dopamine agents|mesh-ancestor
64937278|NCT02505893|Immunologic Factors|immunologic factors|mesh-ancestor
64937279|NCT02505893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937280|NCT04341181|Trastuzumab|trastuzumab|mesh-list
64937281|NCT04341181|Pertuzumab|pertuzumab|mesh-list
64937282|NCT04341181|Avelumab|avelumab|mesh-list
64937283|NCT04341181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64937284|NCT04341181|Atezolizumab|atezolizumab|mesh-list
64937285|NCT04341181|Niraparib|niraparib|mesh-list
64937286|NCT04341181|Axitinib|axitinib|mesh-list
64937287|NCT04341181|Vemurafenib|vemurafenib|mesh-list
64564327|NCT04124887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64517181|NCT03265470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64517182|NCT03265470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564328|NCT04124887|Cariostatic Agents|cariostatic agents|mesh-ancestor
64564329|NCT04124887|Protective Agents|protective agents|mesh-ancestor
64564330|NCT04124887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64564331|NCT04124887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64564332|NCT04124887|Chelating Agents|chelating agents|mesh-ancestor
64937288|NCT04341181|Maytansine|maytansine|mesh-list
64937289|NCT04341181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64937324|NCT04234048|Keratolytic Agents|keratolytic agents|mesh-ancestor
64937325|NCT04234048|Dermatologic Agents|dermatologic agents|mesh-ancestor
64937327|NCT01805817|Drospirenone|drospirenone|mesh-list
64937328|NCT01805817|Levonorgestrel|levonorgestrel|mesh-list
64937329|NCT01805817|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64937330|NCT01805817|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
64937331|NCT01805817|Estradiol|estradiol|mesh-list
64937332|NCT01805817|Estrogens|estrogens|mesh-ancestor
64937353|NCT00405418|Insulin|insulin|mesh-list
64937354|NCT00405418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64937355|NCT00405418|Insulin Glargine|insulin glargine|mesh-list
64937356|NCT00405418|Insulin Detemir|insulin detemir|mesh-list
64937357|NCT00405418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64937358|NCT00405418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937359|NCT02157077|Aflibercept|aflibercept|mesh-list
64937360|NCT02157077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64937361|NCT02157077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64937362|NCT02157077|Growth Substances|growth substances|mesh-ancestor
64937363|NCT02157077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937364|NCT02157077|Growth Inhibitors|growth inhibitors|mesh-ancestor
64937365|NCT02157077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937366|NCT01805700|Caffeine|caffeine|mesh-list
64937367|NCT01805700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64937368|NCT01805700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937369|NCT01805700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64529046|NCT01509053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64529047|NCT01509053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529048|NCT01509053|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64529049|NCT01509053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64529050|NCT01509053|Serotonin Agents|serotonin agents|mesh-ancestor
64529051|NCT01509053|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64529052|NCT01509053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64529053|NCT01509053|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64529054|NCT01509053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64529055|NCT01560403|Teduglutide|teduglutide|mesh-list
64529056|NCT01560403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64529057|NCT01560403|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64529058|NCT01560403|Protective Agents|protective agents|mesh-ancestor
64529059|NCT01560403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529060|NCT02100579|Bupivacaine|bupivacaine|mesh-list
64529061|NCT02100579|Anesthetics, Local|anesthetics, local|mesh-ancestor
64529062|NCT02100579|Anesthetics|anesthetics|mesh-ancestor
64529063|NCT02100579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64529064|NCT02100579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529065|NCT02100579|Sensory System Agents|sensory system agents|mesh-ancestor
64529066|NCT02100579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64529067|NCT04251351|Acetaminophen|acetaminophen|mesh-list
64529068|NCT04251351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64529069|NCT04251351|Analgesics|analgesics|mesh-ancestor
64529070|NCT04251351|Sensory System Agents|sensory system agents|mesh-ancestor
64529071|NCT04251351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64529072|NCT04251351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529073|NCT04251351|Antipyretics|antipyretics|mesh-ancestor
64529074|NCT02390700|Golimumab|golimumab|mesh-list
64529075|NCT02390700|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64937378|NCT04033276|Antibodies|antibodies|mesh-list
64937379|NCT04033276|gamma-Globulins|gamma-globulins|mesh-list
64564333|NCT04124887|Sequestering Agents|sequestering agents|mesh-ancestor
64564334|NCT04124887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564335|NCT04121767|Warfarin|warfarin|mesh-list
64564336|NCT04121767|Edoxaban|edoxaban|mesh-list
64564337|NCT04121767|Anticoagulants|anticoagulants|mesh-ancestor
64564338|NCT04121767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64564339|NCT04121767|Antithrombins|antithrombins|mesh-ancestor
64564340|NCT04121767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64564341|NCT04121767|Protease Inhibitors|protease inhibitors|mesh-ancestor
64564342|NCT04121767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64564343|NCT04121767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564344|NCT04121689|Caseins|caseins|mesh-list
64564345|NCT04121689|Chelating Agents|chelating agents|mesh-ancestor
64564346|NCT04121689|Sequestering Agents|sequestering agents|mesh-ancestor
64564372|NCT03098485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64937380|NCT04033276|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64937381|NCT04033276|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64937382|NCT04033276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64937383|NCT04033276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937384|NCT04033276|Immunologic Factors|immunologic factors|mesh-ancestor
64937385|NCT04033276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937386|NCT04033276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64937406|NCT03781063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64937407|NCT03781063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937408|NCT03781063|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64529076|NCT02390700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64529077|NCT02390700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64529078|NCT02390700|Immunologic Factors|immunologic factors|mesh-ancestor
64529079|NCT02390700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529080|NCT00284739|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64529081|NCT00284739|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64529082|NCT00284739|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64529083|NCT00284739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529084|NCT01527487|Cyclophosphamide|cyclophosphamide|mesh-list
64651067|NCT02335580|Somatostatin|somatostatin|mesh-list
64651068|NCT02335580|Hormones|hormones|mesh-ancestor
64651069|NCT02335580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64651070|NCT02335580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651071|NCT02476968|Olaparib|olaparib|mesh-list
64651072|NCT02476968|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64651073|NCT02476968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937419|NCT01805544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937420|NCT01805544|Anticoagulants|anticoagulants|mesh-ancestor
64937422|NCT03770767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64937423|NCT03770767|Insulin Aspart|insulin aspart|mesh-list
64937424|NCT03770767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64937425|NCT03770767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937426|NCT01903421|Fentanyl|fentanyl|mesh-list
64937427|NCT01903421|Bupivacaine|bupivacaine|mesh-list
64937428|NCT01903421|Anesthetics|anesthetics|mesh-list
64937429|NCT01903421|Propofol|propofol|mesh-list
64937430|NCT01903421|Sevoflurane|sevoflurane|mesh-list
64937431|NCT01903421|Isoflurane|isoflurane|mesh-list
64937432|NCT01903421|Anesthetics, Local|anesthetics, local|mesh-ancestor
64937433|NCT01903421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64937434|NCT01903421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937435|NCT01903421|Sensory System Agents|sensory system agents|mesh-ancestor
64937436|NCT01903421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64937437|NCT01903421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64937438|NCT01903421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64937439|NCT01903421|Anesthetics, General|anesthetics, general|mesh-ancestor
64564373|NCT03098485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64564374|NCT03098485|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64564375|NCT03098485|Renal Agents|renal agents|mesh-ancestor
64564376|NCT03098485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64564377|NCT03098485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64564378|NCT03098485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64564379|NCT03098485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564380|NCT03098485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564381|NCT03098485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64564382|NCT03098485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64564383|NCT04121533|Vitamin D|vitamin d|mesh-list
64564384|NCT04121533|Cholecalciferol|cholecalciferol|mesh-list
64564385|NCT04121533|Vitamins|vitamins|mesh-ancestor
64564386|NCT04121533|Micronutrients|micronutrients|mesh-ancestor
64937440|NCT01903421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64937441|NCT01903421|Narcotics|narcotics|mesh-ancestor
64937442|NCT01903421|Analgesics|analgesics|mesh-ancestor
64937462|NCT01902173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937464|NCT01902173|Antioxidants|antioxidants|mesh-ancestor
64937465|NCT01723839|Cyclophosphamide|cyclophosphamide|mesh-list
64937466|NCT01723839|Rituximab|rituximab|mesh-list
64937467|NCT01723839|Fludarabine|fludarabine|mesh-list
64937468|NCT01723839|Lenalidomide|lenalidomide|mesh-list
64937469|NCT01723839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64937470|NCT01723839|Immunologic Factors|immunologic factors|mesh-ancestor
64937471|NCT01723839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937472|NCT01723839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64937473|NCT01723839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64937474|NCT01723839|Alkylating Agents|alkylating agents|mesh-ancestor
64937475|NCT01723839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937476|NCT01723839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937477|NCT01723839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64937478|NCT01723839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64937479|NCT01723839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64937480|NCT01723839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64529087|NCT01527487|Immunologic Factors|immunologic factors|mesh-ancestor
64529088|NCT01527487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529089|NCT01527487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64529090|NCT01527487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64529092|NCT01527487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529093|NCT01527487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651074|NCT02476968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937481|NCT01723839|Growth Substances|growth substances|mesh-ancestor
64937482|NCT01723839|Growth Inhibitors|growth inhibitors|mesh-ancestor
64937483|NCT03421483|Folic Acid|folic acid|mesh-list
64937484|NCT03421483|Hematinics|hematinics|mesh-ancestor
64937496|NCT03341143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937497|NCT01878617|Gemcitabine|gemcitabine|mesh-list
64937498|NCT01878617|Cyclophosphamide|cyclophosphamide|mesh-list
64937499|NCT01878617|Vincristine|vincristine|mesh-list
64937517|NCT01878617|Antimitotic Agents|antimitotic agents|mesh-ancestor
64937518|NCT01878617|Mitosis Modulators|mitosis modulators|mesh-ancestor
64937519|NCT01878617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64937520|NCT01878617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64937521|NCT03205696|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64937522|NCT03205696|Antiviral Agents|antiviral agents|mesh-ancestor
64937523|NCT03205696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64937524|NCT00405496|Difluprednate|difluprednate|mesh-list
64937525|NCT00405496|Glucocorticoids|glucocorticoids|mesh-ancestor
64937526|NCT00405496|Hormones|hormones|mesh-ancestor
64937527|NCT00405496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64937528|NCT00405496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564387|NCT04121533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564388|NCT04121533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64564389|NCT04121533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64564390|NCT03822091|Terlipressin|terlipressin|mesh-list
64564391|NCT03822091|Norepinephrine|norepinephrine|mesh-list
64564392|NCT03822091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64564393|NCT03822091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64564429|NCT03064867|Ifosfamide|ifosfamide|mesh-list
64564456|NCT03824665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64564457|NCT03824665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64621297|NCT05563350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64937529|NCT00405535|Glycine|glycine|mesh-list
64937530|NCT00405535|Glycine Agents|glycine agents|mesh-ancestor
64937531|NCT00405535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64937532|NCT00405535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937533|NCT00405535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937534|NCT00405574|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
64937535|NCT00405574|Chelating Agents|chelating agents|mesh-ancestor
64937536|NCT00405574|Sequestering Agents|sequestering agents|mesh-ancestor
64937537|NCT00405574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937538|NCT00405574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937539|NCT00405574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64937540|NCT00405574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64937541|NCT00405574|Growth Substances|growth substances|mesh-ancestor
64937542|NCT00405574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937543|NCT00405574|Growth Inhibitors|growth inhibitors|mesh-ancestor
64937544|NCT00405574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937545|NCT02993029|Celecoxib|celecoxib|mesh-list
64706055|NCT04146571|Ensartinib|ensartinib|mesh-list
64937546|NCT02993029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64937547|NCT02993029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64937548|NCT02993029|Analgesics|analgesics|mesh-ancestor
64937549|NCT02993029|Sensory System Agents|sensory system agents|mesh-ancestor
64937550|NCT02993029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64937551|NCT02993029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937552|NCT02993029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64937553|NCT02993029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64937554|NCT02993029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64937576|NCT01646034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64937577|NCT01646034|Immunologic Factors|immunologic factors|mesh-ancestor
64937578|NCT01646034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937579|NCT01646034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64529094|NCT01527487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64529095|NCT01527487|Tubulin Modulators|tubulin modulators|mesh-ancestor
64529096|NCT01527487|Antimitotic Agents|antimitotic agents|mesh-ancestor
64529097|NCT01527487|Mitosis Modulators|mitosis modulators|mesh-ancestor
64529099|NCT05030298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64529100|NCT05030298|Alkylating Agents|alkylating agents|mesh-ancestor
64529101|NCT05030298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529110|NCT00149643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64529111|NCT00149643|Serotonin Agents|serotonin agents|mesh-ancestor
64937580|NCT01646034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64937581|NCT01646034|Alkylating Agents|alkylating agents|mesh-ancestor
64937582|NCT01646034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64937583|NCT01646034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64937584|NCT01646034|Antimetabolites|antimetabolites|mesh-ancestor
64937585|NCT01646034|Antiviral Agents|antiviral agents|mesh-ancestor
64937586|NCT01646034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64937587|NCT01646034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937588|NCT01646034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64937589|NCT01646034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64937590|NCT01646034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64564458|NCT03824665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64564459|NCT03824665|Anesthetics, General|anesthetics, general|mesh-ancestor
64564460|NCT03824665|Anesthetics|anesthetics|mesh-ancestor
64564461|NCT04120831|Abatacept|abatacept|mesh-list
64564462|NCT04120831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564463|NCT04120831|Immunologic Factors|immunologic factors|mesh-ancestor
64564464|NCT04120831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564465|NCT04120831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64564466|NCT04120831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64564467|NCT04120831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564468|NCT04120831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64564469|NCT00631163|Deferasirox|deferasirox|mesh-list
64564470|NCT00631163|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64937591|NCT01628640|Interferons|interferons|mesh-list
64937592|NCT01628640|Interferon-beta|interferon-beta|mesh-list
64937593|NCT01628640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937594|NCT01628640|Antiviral Agents|antiviral agents|mesh-ancestor
64937595|NCT01628640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64937596|NCT01628640|Immunologic Factors|immunologic factors|mesh-ancestor
64937597|NCT01628640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937599|NCT02638519|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64937600|NCT02638519|Anesthetics, General|anesthetics, general|mesh-ancestor
64937601|NCT02638519|Anesthetics|anesthetics|mesh-ancestor
64937602|NCT02638519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64937603|NCT02638519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937604|NCT00391313|Chloroquine|chloroquine|mesh-list
64937605|NCT00391313|Amebicides|amebicides|mesh-ancestor
64937606|NCT00391313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64937607|NCT00391313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64937608|NCT00391313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64937609|NCT00391313|Antimalarials|antimalarials|mesh-ancestor
64937610|NCT00391313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64937611|NCT01466517|Ibuprofen|ibuprofen|mesh-list
64937642|NCT00062816|Ribavirin|ribavirin|mesh-list
64937643|NCT00062816|Antimetabolites|antimetabolites|mesh-ancestor
64937644|NCT00062816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937645|NCT00062816|Antiviral Agents|antiviral agents|mesh-ancestor
64937646|NCT00062816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64937647|NCT00048113|Alicaforsen|alicaforsen|mesh-list
64937648|NCT00048113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64937649|NCT00048113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64529112|NCT00149643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529113|NCT00149643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64529114|NCT00149643|Antidepressive Agents|antidepressive agents|mesh-ancestor
64529115|NCT00149643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64529116|NCT00149643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64529117|NCT00149643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64529118|NCT00149643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529120|NCT02381730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64529121|NCT02381730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64529122|NCT02381730|Growth Substances|growth substances|mesh-ancestor
64529123|NCT02381730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529124|NCT02381730|Growth Inhibitors|growth inhibitors|mesh-ancestor
64529125|NCT02381730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529126|NCT00149799|Citalopram|citalopram|mesh-list
64529127|NCT00149799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64529128|NCT00149799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64937650|NCT00048113|Immunologic Factors|immunologic factors|mesh-ancestor
64651099|NCT03808610|Alkylating Agents|alkylating agents|mesh-ancestor
64937683|NCT01466205|Dihydrexidine|dihydrexidine|mesh-list
64937684|NCT01466205|Dopamine Agonists|dopamine agonists|mesh-ancestor
64937685|NCT01466205|Dopamine Agents|dopamine agents|mesh-ancestor
64937686|NCT01466205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64937687|NCT01466205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564471|NCT00631163|Chelating Agents|chelating agents|mesh-ancestor
64564472|NCT00631163|Sequestering Agents|sequestering agents|mesh-ancestor
64564473|NCT00631163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564474|NCT02677051|Sulforaphane|sulforaphane|mesh-list
64564475|NCT02677051|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64564476|NCT02677051|Protective Agents|protective agents|mesh-ancestor
64564477|NCT02677051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564478|NCT02677051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564514|NCT03014167|Anticestodal Agents|anticestodal agents|mesh-ancestor
64564515|NCT03014167|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64517183|NCT03265470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64517184|NCT03265470|Narcotics|narcotics|mesh-ancestor
64517185|NCT03265470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64517186|NCT03265470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64517187|NCT03265470|Anesthetics, General|anesthetics, general|mesh-ancestor
64517188|NCT03265470|Anesthetics|anesthetics|mesh-ancestor
64517189|NCT02019940|Riluzole|riluzole|mesh-list
64517190|NCT02019940|Anticonvulsants|anticonvulsants|mesh-ancestor
64517191|NCT02019940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64517192|NCT02019940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64937688|NCT01466205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937689|NCT01466127|Oxytocin|oxytocin|mesh-list
64937690|NCT01466127|Oxytocics|oxytocics|mesh-ancestor
64937691|NCT01466127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64937692|NCT01466127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937693|NCT00009191|Sertraline|sertraline|mesh-list
64937694|NCT00009191|Antidepressive Agents|antidepressive agents|mesh-ancestor
64937695|NCT00009191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64937696|NCT00009191|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64937697|NCT00009191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64937698|NCT00009191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64937699|NCT00009191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706223|NCT03043807|Docetaxel|docetaxel|mesh-list
64937700|NCT00009191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64937701|NCT00009191|Serotonin Agents|serotonin agents|mesh-ancestor
64937702|NCT00009191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937703|NCT01466088|Donepezil|donepezil|mesh-list
64937704|NCT01466088|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64937705|NCT01466088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529130|NCT00149799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529131|NCT00149799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64529132|NCT00149799|Serotonin Agents|serotonin agents|mesh-ancestor
64529133|NCT00149799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529134|NCT00149799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64529135|NCT00149799|Antidepressive Agents|antidepressive agents|mesh-ancestor
64529136|NCT00149799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64529137|NCT02390544|Melphalan|melphalan|mesh-list
64529138|NCT02390544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64529139|NCT02390544|Alkylating Agents|alkylating agents|mesh-ancestor
64529140|NCT02390544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529141|NCT02390544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529142|NCT02390544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64529143|NCT02390544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64651107|NCT03808610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64651108|NCT03808610|Glucocorticoids|glucocorticoids|mesh-ancestor
64651109|NCT03808610|Hormones|hormones|mesh-ancestor
64517193|NCT02019940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64517194|NCT02019940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517195|NCT02019940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517196|NCT02019940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64517197|NCT02019940|Protective Agents|protective agents|mesh-ancestor
64621487|NCT04281420|Niacin|niacin|mesh-list
64651110|NCT03808610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64651111|NCT03808610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64651112|NCT03808610|Protease Inhibitors|protease inhibitors|mesh-ancestor
64651113|NCT03808610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651114|NCT03808610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64651115|NCT03808610|Abortifacient Agents|abortifacient agents|mesh-ancestor
64651116|NCT03808610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64651117|NCT03808610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64937738|NCT00009620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64937739|NCT00009620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937741|NCT00009620|GABA Agents|gaba agents|mesh-ancestor
64937742|NCT00009620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64937743|NCT00009620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64937767|NCT01465893|Micronutrients|micronutrients|mesh-ancestor
64937768|NCT01465893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937769|NCT01465893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64937770|NCT01465893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64937771|NCT00009776|Cyclosporine|cyclosporine|mesh-list
64937772|NCT00009776|Paclitaxel|paclitaxel|mesh-list
64937773|NCT00009776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64937774|NCT00009776|Antibodies|antibodies|mesh-list
64937776|NCT00009776|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64937777|NCT00009776|Cyclosporins|cyclosporins|mesh-list
64937778|NCT00009776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64937779|NCT00009776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937780|NCT00009776|Tubulin Modulators|tubulin modulators|mesh-ancestor
64937781|NCT00009776|Antimitotic Agents|antimitotic agents|mesh-ancestor
64937782|NCT00009776|Mitosis Modulators|mitosis modulators|mesh-ancestor
64937783|NCT00009776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937784|NCT00009776|Immunologic Factors|immunologic factors|mesh-ancestor
64937785|NCT00009776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937786|NCT00009776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937787|NCT00009776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64529152|NCT01790997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64529153|NCT01790997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529155|NCT01790997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64529156|NCT01790997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64529157|NCT01790997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64529158|NCT01790997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529159|NCT01790997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64529160|NCT01790997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64529161|NCT01790997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529162|NCT01790997|Antipyretics|antipyretics|mesh-ancestor
64529163|NCT01790997|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64529164|NCT01790997|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64529165|NCT01790997|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64529166|NCT01790997|Purinergic Agents|purinergic agents|mesh-ancestor
64529167|NCT01790997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64529168|NCT02385474|Fluorides|fluorides|mesh-list
64529169|NCT02385474|Cariostatic Agents|cariostatic agents|mesh-ancestor
64529170|NCT02385474|Protective Agents|protective agents|mesh-ancestor
64529171|NCT02385474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529172|NCT02390310|Lidocaine|lidocaine|mesh-list
64529173|NCT02390310|Prilocaine|prilocaine|mesh-list
64529174|NCT02390310|Anesthetics|anesthetics|mesh-list
64529175|NCT02390310|Anesthetics, Local|anesthetics, local|mesh-ancestor
64529176|NCT02390310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64529177|NCT02390310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529178|NCT02390310|Sensory System Agents|sensory system agents|mesh-ancestor
64529179|NCT02390310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64529180|NCT02390310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64517198|NCT01229943|Bevacizumab|bevacizumab|mesh-list
64517199|NCT01229943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64517200|NCT01229943|Everolimus|everolimus|mesh-list
64564516|NCT03014167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64564517|NCT03014167|Tubulin Modulators|tubulin modulators|mesh-ancestor
64564518|NCT03014167|Antimitotic Agents|antimitotic agents|mesh-ancestor
64564519|NCT03014167|Mitosis Modulators|mitosis modulators|mesh-ancestor
64564520|NCT03014167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529181|NCT02390310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64529182|NCT02390310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64529183|NCT02390310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64529184|NCT02390310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937789|NCT00009776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64937790|NCT00009776|Dermatologic Agents|dermatologic agents|mesh-ancestor
64937791|NCT00009776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64937792|NCT00009776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64937793|NCT00009815|Leucovorin|leucovorin|mesh-list
64937794|NCT00009815|Etoposide|etoposide|mesh-list
64937795|NCT00009815|Tegafur|tegafur|mesh-list
64937796|NCT00009815|Calcium|calcium|mesh-list
64937797|NCT00009815|Levoleucovorin|levoleucovorin|mesh-list
64937798|NCT00009815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64937799|NCT00009815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937827|NCT00009854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937828|NCT00009893|Leucovorin|leucovorin|mesh-list
64937829|NCT00009893|Gemcitabine|gemcitabine|mesh-list
64937830|NCT00009893|Fluorouracil|fluorouracil|mesh-list
64937831|NCT00009893|Calcium|calcium|mesh-list
64937832|NCT00009893|Levoleucovorin|levoleucovorin|mesh-list
64937833|NCT00009893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64937834|NCT00009893|Antimetabolites|antimetabolites|mesh-ancestor
64937835|NCT00009893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937836|NCT00009893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937837|NCT00009893|Antiviral Agents|antiviral agents|mesh-ancestor
64937838|NCT00009893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64937839|NCT00009893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937840|NCT00009893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64937841|NCT00009893|Immunologic Factors|immunologic factors|mesh-ancestor
64937842|NCT00009893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937843|NCT00009893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64937844|NCT00009893|Antidotes|antidotes|mesh-ancestor
64937845|NCT00009893|Protective Agents|protective agents|mesh-ancestor
64937846|NCT00009893|Vitamin B Complex|vitamin b complex|mesh-ancestor
64937877|NCT00010049|Imatinib Mesylate|imatinib mesylate|mesh-list
64937878|NCT00010049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937879|NCT00010049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64937880|NCT00010049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937881|NCT00010049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937882|NCT00010088|Leucovorin|leucovorin|mesh-list
64937883|NCT00010088|Gemcitabine|gemcitabine|mesh-list
64937884|NCT00010088|Fluorouracil|fluorouracil|mesh-list
64937885|NCT00010088|Calcium|calcium|mesh-list
64937886|NCT00010088|Levoleucovorin|levoleucovorin|mesh-list
64937887|NCT00010088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64937888|NCT00010088|Antimetabolites|antimetabolites|mesh-ancestor
64937910|NCT01465503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937911|NCT01465503|Antithrombins|antithrombins|mesh-ancestor
64937912|NCT01465503|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64937913|NCT01465503|Protease Inhibitors|protease inhibitors|mesh-ancestor
64937914|NCT01465503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937915|NCT00010166|Gemcitabine|gemcitabine|mesh-list
64937916|NCT00010166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64937917|NCT00010166|Antimetabolites|antimetabolites|mesh-ancestor
64937918|NCT00010166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937919|NCT00010166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937920|NCT00010166|Antiviral Agents|antiviral agents|mesh-ancestor
64937921|NCT00010166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64937922|NCT00010166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937923|NCT00010166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64937924|NCT00010166|Immunologic Factors|immunologic factors|mesh-ancestor
64564582|NCT01920113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64564583|NCT01920113|Narcotics|narcotics|mesh-ancestor
64564584|NCT01920191|Poly ICLC|poly iclc|mesh-list
64564585|NCT01920191|Interferon Inducers|interferon inducers|mesh-ancestor
64564586|NCT01920191|Immunologic Factors|immunologic factors|mesh-ancestor
64937925|NCT00010166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651127|NCT03808610|Mitosis Modulators|mitosis modulators|mesh-ancestor
64529208|NCT00326781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529209|NCT02385396|Folic Acid|folic acid|mesh-list
64529210|NCT02385396|Inositol|inositol|mesh-list
64484449|NCT01741532|Chelating Agents|chelating agents|mesh-ancestor
64529211|NCT02385396|Hematinics|hematinics|mesh-ancestor
64529212|NCT02385396|Vitamin B Complex|vitamin b complex|mesh-ancestor
64529213|NCT02385396|Vitamins|vitamins|mesh-ancestor
64529214|NCT02385396|Micronutrients|micronutrients|mesh-ancestor
64529215|NCT02385396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529216|NCT05445414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64529217|NCT05445414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64529218|NCT02979405|Phenylephrine|phenylephrine|mesh-list
64529219|NCT02979405|Oxymetazoline|oxymetazoline|mesh-list
64529220|NCT02979405|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64529221|NCT02979405|Mydriatics|mydriatics|mesh-ancestor
64529222|NCT02979405|Autonomic Agents|autonomic agents|mesh-ancestor
64529223|NCT02979405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64529224|NCT02979405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529225|NCT02979405|Sympathomimetics|sympathomimetics|mesh-ancestor
64529226|NCT02979405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64529227|NCT02979405|Nasal Decongestants|nasal decongestants|mesh-ancestor
64529228|NCT02979405|Respiratory System Agents|respiratory system agents|mesh-ancestor
64529229|NCT02979405|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64706434|NCT02152670|Raclopride|raclopride|mesh-list
64937926|NCT01465152|Metformin|metformin|mesh-list
64937927|NCT01465152|Repaglinide|repaglinide|mesh-list
64937928|NCT01465152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64937929|NCT01465152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937930|NCT01465113|Vitamin D|vitamin d|mesh-list
64937931|NCT01465113|Ergocalciferols|ergocalciferols|mesh-list
64937932|NCT01465113|Cholecalciferol|cholecalciferol|mesh-list
64937933|NCT01465113|Vitamins|vitamins|mesh-list
64937934|NCT01465113|Metformin|metformin|mesh-list
64937935|NCT01465113|Omeprazole|omeprazole|mesh-list
64937936|NCT01465113|Micronutrients|micronutrients|mesh-ancestor
64937937|NCT01465113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937938|NCT01465113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64937939|NCT01465113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64937940|NCT01465113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64529232|NCT02979405|Adrenergic Agents|adrenergic agents|mesh-ancestor
64529233|NCT02979405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64529234|NCT02979405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529235|NCT02979405|Protective Agents|protective agents|mesh-ancestor
64529237|NCT01791231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64529238|NCT01791231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529239|NCT01791231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64937941|NCT01465113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64937942|NCT01465113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64937943|NCT01465113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64937944|NCT01465113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937945|NCT01465113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938006|NCT01464840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64938007|NCT01464840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64938008|NCT01464801|Resveratrol|resveratrol|mesh-list
64938009|NCT01464801|Antioxidants|antioxidants|mesh-ancestor
64938010|NCT01464801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651136|NCT04981860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64651137|NCT01432145|Methotrexate|methotrexate|mesh-list
64938020|NCT01464723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64938021|NCT01464723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64938022|NCT01464723|Growth Substances|growth substances|mesh-ancestor
64938055|NCT01464528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938056|NCT01464528|Viscosupplements|viscosupplements|mesh-ancestor
64938057|NCT01464528|Protective Agents|protective agents|mesh-ancestor
64938058|NCT00393744|Amoxicillin|amoxicillin|mesh-list
64938059|NCT00393744|Pristinamycin|pristinamycin|mesh-list
64938060|NCT00393744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64564587|NCT01920191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564588|NCT01920269|Mitomycins|mitomycins|mesh-list
64564589|NCT01920269|Mitomycin|mitomycin|mesh-list
64564590|NCT01920269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64564591|NCT01920269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938061|NCT00393744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64938062|NCT01280994|Xenon|xenon|mesh-list
64938063|NCT01280994|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64938064|NCT01280994|Anesthetics, General|anesthetics, general|mesh-ancestor
64938065|NCT01280994|Anesthetics|anesthetics|mesh-ancestor
64938086|NCT00011297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64938087|NCT00011297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64938088|NCT00011297|GABA Modulators|gaba modulators|mesh-ancestor
64938089|NCT00011297|GABA Agents|gaba agents|mesh-ancestor
64938090|NCT00011375|Rolipram|rolipram|mesh-list
64938091|NCT00011375|Antidepressive Agents|antidepressive agents|mesh-ancestor
64938092|NCT00011375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64938093|NCT00011375|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64938094|NCT00011375|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64938095|NCT00011375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938096|NCT00011375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938097|NCT00847938|Neostigmine|neostigmine|mesh-list
64938098|NCT00847938|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64529240|NCT01791231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529241|NCT01791309|Panitumumab|panitumumab|mesh-list
64529242|NCT01791309|Vemurafenib|vemurafenib|mesh-list
64529243|NCT01791309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64529244|NCT01791309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529245|NCT01791309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64529246|NCT01791309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529247|NCT01791309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529248|NCT00329433|Heparin|heparin|mesh-list
64529249|NCT00329433|Desirudin|desirudin|mesh-list
64529250|NCT00329433|Anticoagulants|anticoagulants|mesh-ancestor
64529251|NCT00329433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64529252|NCT00329433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64529253|NCT00329433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529254|NCT03105960|Chlorhexidine|chlorhexidine|mesh-list
64529255|NCT03105960|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64529256|NCT03105960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64529257|NCT03105960|Disinfectants|disinfectants|mesh-ancestor
64529258|NCT02389842|Palbociclib|palbociclib|mesh-list
64529259|NCT02389842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529260|NCT02389842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64529261|NCT02389842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529262|NCT02389842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938099|NCT00847938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938100|NCT00847938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938101|NCT00847938|Cholinergic Agents|cholinergic agents|mesh-ancestor
64938102|NCT00847938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64938103|NCT00847938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938104|NCT00847938|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64938105|NCT00847938|Autonomic Agents|autonomic agents|mesh-ancestor
64938106|NCT00847938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64651144|NCT01432145|Antimetabolites|antimetabolites|mesh-ancestor
64938110|NCT00847899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938112|NCT00847860|Cilostazol|cilostazol|mesh-list
64938113|NCT00847860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64938114|NCT00847860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64938115|NCT00847860|Analgesics|analgesics|mesh-ancestor
64938116|NCT00847860|Sensory System Agents|sensory system agents|mesh-ancestor
64938117|NCT00847860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64938118|NCT00847860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938119|NCT00847860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64938140|NCT00847821|Hormone Antagonists|hormone antagonists|mesh-ancestor
64938141|NCT00847821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64938142|NCT00847821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938143|NCT00847821|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64938144|NCT00847821|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64529263|NCT05233332|Vemurafenib|vemurafenib|mesh-list
64564592|NCT01920269|Alkylating Agents|alkylating agents|mesh-ancestor
64621768|NCT01143181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64529264|NCT05233332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529265|NCT05233332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64529266|NCT05233332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529267|NCT05233332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529268|NCT04932096|Melatonin|melatonin|mesh-list
64529269|NCT04932096|Antioxidants|antioxidants|mesh-ancestor
64938145|NCT00847821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64938146|NCT00847587|Contraceptive Agents|contraceptive agents|mesh-list
64938147|NCT00847587|Etonogestrel|etonogestrel|mesh-list
64938148|NCT00847587|Desogestrel|desogestrel|mesh-list
64938149|NCT00847587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64938150|NCT00847587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706656|NCT05587231|Fluorometholone|fluorometholone|mesh-list
64938151|NCT00847587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64938152|NCT00847587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64938153|NCT00847587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64938154|NCT00847587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64938155|NCT00847587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64938156|NCT00847587|Progestins|progestins|mesh-ancestor
64938158|NCT00847587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64938159|NCT00011765|Fluoxetine|fluoxetine|mesh-list
64938160|NCT00011765|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64938161|NCT00011765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64938162|NCT00011765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64938163|NCT00011765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938164|NCT00011765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64938165|NCT00011765|Serotonin Agents|serotonin agents|mesh-ancestor
64938166|NCT00011765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938167|NCT00011765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64938168|NCT00011765|Antidepressive Agents|antidepressive agents|mesh-ancestor
64938169|NCT00011765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64938170|NCT00011765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64938190|NCT00011921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64938191|NCT00011921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938192|NCT00011921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64938193|NCT00011921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64938194|NCT00011921|Alkylating Agents|alkylating agents|mesh-ancestor
64938195|NCT00011960|Paclitaxel|paclitaxel|mesh-list
64938196|NCT00011960|Cisplatin|cisplatin|mesh-list
64938197|NCT00011960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64938198|NCT00011960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938199|NCT00011960|Tubulin Modulators|tubulin modulators|mesh-ancestor
64938200|NCT00011960|Antimitotic Agents|antimitotic agents|mesh-ancestor
64938201|NCT00011960|Mitosis Modulators|mitosis modulators|mesh-ancestor
64938202|NCT00011960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938203|NCT00847314|Methyltestosterone|methyltestosterone|mesh-list
64938204|NCT00847314|Testosterone|testosterone|mesh-list
64938205|NCT00847314|Testosterone undecanoate|testosterone undecanoate|mesh-list
64938206|NCT00847314|Testosterone enanthate|testosterone enanthate|mesh-list
64938207|NCT00847314|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64938217|NCT00011999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64938218|NCT00011999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938219|NCT00011999|Tubulin Modulators|tubulin modulators|mesh-ancestor
64938220|NCT00011999|Antimitotic Agents|antimitotic agents|mesh-ancestor
64938221|NCT00011999|Mitosis Modulators|mitosis modulators|mesh-ancestor
64938222|NCT00011999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938223|NCT00012038|Irofulven|irofulven|mesh-list
64529270|NCT04932096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529271|NCT04932096|Protective Agents|protective agents|mesh-ancestor
64529272|NCT04932096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529273|NCT04932096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64529274|NCT00289653|Nicotine|nicotine|mesh-list
64529275|NCT00289653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64529276|NCT00289653|Autonomic Agents|autonomic agents|mesh-ancestor
64529277|NCT00289653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64529278|NCT00289653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529279|NCT00289653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64529280|NCT00289653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64529281|NCT00289653|Cholinergic Agents|cholinergic agents|mesh-ancestor
64529282|NCT00289653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64564593|NCT01920269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564594|NCT01920269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64564595|NCT01920269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64564596|NCT02921893|Dexamethasone|dexamethasone|mesh-list
64564597|NCT02921893|Dexamethasone acetate|dexamethasone acetate|mesh-list
64564598|NCT02921893|Lenalidomide|lenalidomide|mesh-list
64564599|NCT02921893|Ixazomib|ixazomib|mesh-list
64564600|NCT02921893|Ichthammol|ichthammol|mesh-list
64621842|NCT01188109|Gemcitabine|gemcitabine|mesh-list
64564601|NCT02921893|BB 1101|bb 1101|mesh-list
64529283|NCT00289653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529284|NCT00291135|Letrozole|letrozole|mesh-list
64945397|NCT05664789|Antioxidants|antioxidants|mesh-ancestor
64485399|NCT00835198|Dapsone|dapsone|mesh-list
64529285|NCT00291135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529286|NCT00291135|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64529287|NCT00291135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64529288|NCT00291135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529289|NCT00291135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529290|NCT00291135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64529291|NCT00291135|Hormone Antagonists|hormone antagonists|mesh-ancestor
64529292|NCT00291135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64529293|NCT00291135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529294|NCT02103855|Abatacept|abatacept|mesh-list
64529295|NCT02103855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64938224|NCT00012038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64938225|NCT00012038|Alkylating Agents|alkylating agents|mesh-ancestor
64938226|NCT00012038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938227|NCT00012038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938228|NCT00012116|Temozolomide|temozolomide|mesh-list
64938259|NCT00012194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938261|NCT00012311|Ifosfamide|ifosfamide|mesh-list
64938262|NCT00012311|Thiotepa|thiotepa|mesh-list
64938263|NCT00012311|Carboplatin|carboplatin|mesh-list
64938264|NCT00012311|Docetaxel|docetaxel|mesh-list
64938265|NCT00012311|Doxorubicin|doxorubicin|mesh-list
64938266|NCT00012311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64938267|NCT00012311|Fluorouracil|fluorouracil|mesh-list
64938268|NCT00012311|Methotrexate|methotrexate|mesh-list
64938269|NCT00012311|Etoposide|etoposide|mesh-list
64938270|NCT00012311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64529296|NCT02103855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529298|NCT02103855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64651157|NCT01432379|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64651158|NCT01432379|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64651159|NCT01432379|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64651160|NCT01432379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64529313|NCT03706053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529315|NCT01504841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64529316|NCT01504841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64529317|NCT01504841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529318|NCT01504841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938299|NCT00012350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938300|NCT00846963|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64938301|NCT00846963|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64938302|NCT00846963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64938303|NCT00012389|Oxaliplatin|oxaliplatin|mesh-list
64938304|NCT00012389|Irinotecan|irinotecan|mesh-list
64938305|NCT00012389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938306|NCT00012389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64938307|NCT00012389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64938308|NCT00012389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938309|NCT00012389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938310|NCT00846885|Sumatriptan|sumatriptan|mesh-list
64938311|NCT00846885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64938312|NCT00846885|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64564602|NCT02921893|Glycine|glycine|mesh-list
64564603|NCT02921893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64564604|NCT02921893|Antiemetics|antiemetics|mesh-ancestor
64564605|NCT02921893|Autonomic Agents|autonomic agents|mesh-ancestor
64938313|NCT00846885|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64938336|NCT00012467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938337|NCT00012467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64938338|NCT00012467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64938339|NCT00012467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64938340|NCT00012467|Amebicides|amebicides|mesh-ancestor
64938341|NCT00012467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64938342|NCT00012467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64938343|NCT00012467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64938344|NCT00012467|Antimetabolites|antimetabolites|mesh-ancestor
64938345|NCT00012506|Etanercept|etanercept|mesh-list
64529320|NCT01504841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64529321|NCT00330915|Pemetrexed|pemetrexed|mesh-list
64529322|NCT00330915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529323|NCT00330915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529324|NCT00330915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529325|NCT00330915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64529326|NCT00330915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64938346|NCT00012506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64938347|NCT00012506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64938348|NCT00012506|Analgesics|analgesics|mesh-ancestor
64938349|NCT00012506|Sensory System Agents|sensory system agents|mesh-ancestor
64938350|NCT00012506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64938351|NCT00012506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938352|NCT00012506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64651165|NCT01432379|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64938358|NCT00012584|Methylphenidate|methylphenidate|mesh-list
64938359|NCT00012584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64938360|NCT00012584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938361|NCT00012584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64938362|NCT00012584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64938363|NCT00012584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64938364|NCT00012584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938422|NCT00846651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64938423|NCT00846651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938424|NCT00846651|Protective Agents|protective agents|mesh-ancestor
64938425|NCT00846612|Bevacizumab|bevacizumab|mesh-list
64938426|NCT00846612|Doxorubicin|doxorubicin|mesh-list
64938427|NCT00846612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64938428|NCT00846612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938429|NCT00846612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64938430|NCT00846612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64938431|NCT00846612|Growth Substances|growth substances|mesh-ancestor
64938432|NCT00846612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938433|NCT00846612|Growth Inhibitors|growth inhibitors|mesh-ancestor
64938434|NCT00846612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64938435|NCT00846612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64938436|NCT00846612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64938437|NCT00846612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938438|NCT00846612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938439|NCT00012857|Acetaminophen|acetaminophen|mesh-list
64938440|NCT00012857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64938441|NCT00012857|Analgesics|analgesics|mesh-ancestor
64938442|NCT00012857|Sensory System Agents|sensory system agents|mesh-ancestor
64938443|NCT00012857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64938444|NCT00012857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938445|NCT00012857|Antipyretics|antipyretics|mesh-ancestor
64938446|NCT00394056|Paroxetine|paroxetine|mesh-list
64938447|NCT00394056|Vestipitant|vestipitant|mesh-list
64706954|NCT02665273|Bupivacaine|bupivacaine|mesh-list
64938448|NCT00394056|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64938449|NCT00394056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64938450|NCT00394056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64938451|NCT00394056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938469|NCT00846339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938471|NCT00846339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64564640|NCT01293825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64564641|NCT01293825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64564642|NCT01293825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64564643|NCT01293825|Dopamine Agents|dopamine agents|mesh-ancestor
64938472|NCT00846339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938473|NCT00846339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64938474|NCT00846339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64938475|NCT00846339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529327|NCT03026933|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64529328|NCT03026933|Calcium|calcium|mesh-list
64651179|NCT00890162|Adrenergic Agents|adrenergic agents|mesh-ancestor
64529329|NCT03026933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64529330|NCT03026933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529331|NCT03026933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64529332|NCT03026933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64529333|NCT03026933|Antimetabolites|antimetabolites|mesh-ancestor
64529334|NCT03026933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529335|NCT03026933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64529336|NCT03026933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64529337|NCT03026933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529338|NCT01502423|Adalimumab|adalimumab|mesh-list
64529339|NCT01502423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64938476|NCT00846144|Copper|copper|mesh-list
64938477|NCT00846144|Copper Sulfate|copper sulfate|mesh-list
64938478|NCT00846144|Trace Elements|trace elements|mesh-ancestor
64938479|NCT00846144|Micronutrients|micronutrients|mesh-ancestor
64938480|NCT00846144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938481|NCT00846144|Antidotes|antidotes|mesh-ancestor
64938491|NCT00845988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64938492|NCT00845988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64938493|NCT00845988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938494|NCT00845988|Dopamine Agonists|dopamine agonists|mesh-ancestor
64938495|NCT00845988|Dopamine Agents|dopamine agents|mesh-ancestor
64938496|NCT00845988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64938497|NCT00845988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938498|NCT00845988|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64938499|NCT00845988|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64938500|NCT00845988|Serotonin Agents|serotonin agents|mesh-ancestor
64938501|NCT00845988|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64938502|NCT00845988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64938503|NCT00845988|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64938504|NCT00845988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64938505|NCT00845910|Bevacizumab|bevacizumab|mesh-list
64938506|NCT00845910|Docetaxel|docetaxel|mesh-list
64938519|NCT00845910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64938521|NCT00680628|Enoxaparin|enoxaparin|mesh-list
64938522|NCT00680628|Tenecteplase|tenecteplase|mesh-list
64938524|NCT00680628|Anticoagulants|anticoagulants|mesh-ancestor
64938525|NCT00680628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64938526|NCT00680628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64938527|NCT00680628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938528|NCT00013520|Lamivudine|lamivudine|mesh-list
64938529|NCT00013520|Zidovudine|zidovudine|mesh-list
64938530|NCT00013520|Efavirenz|efavirenz|mesh-list
64938531|NCT00013520|Nevirapine|nevirapine|mesh-list
64938532|NCT00013520|Abacavir|abacavir|mesh-list
64938533|NCT00013520|Dideoxynucleosides|dideoxynucleosides|mesh-list
64938534|NCT00013520|Didanosine|didanosine|mesh-list
64938535|NCT00013520|Stavudine|stavudine|mesh-list
64938536|NCT00013520|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64938537|NCT00013520|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64938538|NCT00013520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64938539|NCT00013520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64529340|NCT01502423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64529342|NCT04861584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529343|NCT04861584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64529344|NCT04861584|Antimetabolites|antimetabolites|mesh-ancestor
64529345|NCT04861584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529346|NCT04861584|Antiviral Agents|antiviral agents|mesh-ancestor
64529347|NCT04861584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64529348|NCT04861584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529349|NCT04861584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64529350|NCT04861584|Immunologic Factors|immunologic factors|mesh-ancestor
64564644|NCT03009513|Glimepiride|glimepiride|mesh-list
64564645|NCT03009513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64564704|NCT01921361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64529351|NCT04861584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529352|NCT02388750|Palonosetron|palonosetron|mesh-list
64529353|NCT02388750|Antiemetics|antiemetics|mesh-ancestor
64529354|NCT02388750|Autonomic Agents|autonomic agents|mesh-ancestor
64529355|NCT02388750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714116|NCT03043274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529356|NCT02388750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529357|NCT02388750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64529358|NCT02388750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64529359|NCT02388750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64529360|NCT02388750|Serotonin Agents|serotonin agents|mesh-ancestor
64529361|NCT02388750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64938540|NCT00013520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938541|NCT00013520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938546|NCT00013520|Antimetabolites|antimetabolites|mesh-ancestor
64938547|NCT00013520|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64938548|NCT00013520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64938549|NCT00013520|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64938550|NCT00013520|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64938551|NCT00013520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64938552|NCT00013520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64938553|NCT00013520|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64938554|NCT00013520|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64938555|NCT00013520|Protease Inhibitors|protease inhibitors|mesh-ancestor
64938556|NCT00013598|Pioglitazone|pioglitazone|mesh-list
64938557|NCT00013598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64938558|NCT00013598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938559|NCT00277017|Interferons|interferons|mesh-list
64938560|NCT00277017|Thalidomide|thalidomide|mesh-list
64938561|NCT00277017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938562|NCT00277017|Antiviral Agents|antiviral agents|mesh-ancestor
64938563|NCT00277017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64938564|NCT00277017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64938565|NCT00277017|Immunologic Factors|immunologic factors|mesh-ancestor
64529362|NCT02388750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529363|NCT02388594|Cyclophosphamide|cyclophosphamide|mesh-list
64529364|NCT02388594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64529365|NCT02388594|Immunologic Factors|immunologic factors|mesh-ancestor
64529366|NCT02388594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529367|NCT02388594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64938566|NCT00277017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938567|NCT00277017|Leprostatic Agents|leprostatic agents|mesh-ancestor
64938568|NCT00277017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64938569|NCT00277017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64938570|NCT00277017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64938599|NCT00276900|Serotonin Agents|serotonin agents|mesh-ancestor
64938600|NCT00276900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938601|NCT00276861|Gemcitabine|gemcitabine|mesh-list
64938602|NCT00276861|Oxaliplatin|oxaliplatin|mesh-list
64938603|NCT00276861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64938604|NCT00276861|Antimetabolites|antimetabolites|mesh-ancestor
64938605|NCT00276861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938606|NCT00276861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938607|NCT00276861|Antiviral Agents|antiviral agents|mesh-ancestor
64938608|NCT00276861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64938609|NCT00276861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938610|NCT00276861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64938611|NCT00276861|Immunologic Factors|immunologic factors|mesh-ancestor
64938612|NCT00276861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938614|NCT00013871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64938635|NCT00276705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64938636|NCT00276705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64938637|NCT00276705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64938638|NCT00276705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64938639|NCT00276705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938640|NCT00276705|Leprostatic Agents|leprostatic agents|mesh-ancestor
64938641|NCT00276705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64938642|NCT00276705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64564706|NCT01921361|Adrenergic Agents|adrenergic agents|mesh-ancestor
64564707|NCT01921361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64564708|NCT01921361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564709|NCT01921361|Anesthetics, Local|anesthetics, local|mesh-ancestor
64564710|NCT01921361|Anesthetics|anesthetics|mesh-ancestor
64564711|NCT04121455|Bevacizumab|bevacizumab|mesh-list
64517203|NCT01229943|Antibodies|antibodies|mesh-list
64517204|NCT01229943|Immunoglobulins|immunoglobulins|mesh-list
64517205|NCT01229943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64517206|NCT01229943|Immunoglobulin G|immunoglobulin g|mesh-list
64517207|NCT01229943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938643|NCT00276705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64938644|NCT00276705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64938645|NCT00276705|Growth Substances|growth substances|mesh-ancestor
64938646|NCT00276705|Growth Inhibitors|growth inhibitors|mesh-ancestor
64938647|NCT00276666|Vincristine|vincristine|mesh-list
64938648|NCT00276666|Lomustine|lomustine|mesh-list
64938649|NCT00276666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938650|NCT00276666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64938651|NCT00276666|Tubulin Modulators|tubulin modulators|mesh-ancestor
64938652|NCT00276666|Antimitotic Agents|antimitotic agents|mesh-ancestor
64938653|NCT00276666|Mitosis Modulators|mitosis modulators|mesh-ancestor
64938654|NCT00276666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651190|NCT00890162|Sympathomimetics|sympathomimetics|mesh-ancestor
64938660|NCT00014066|Dermatologic Agents|dermatologic agents|mesh-ancestor
64938661|NCT00014066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938662|NCT00014105|Carboplatin|carboplatin|mesh-list
64938663|NCT00014105|Temozolomide|temozolomide|mesh-list
64938664|NCT00014105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938665|NCT00014105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64938666|NCT00014105|Alkylating Agents|alkylating agents|mesh-ancestor
64938667|NCT00014105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938668|NCT00014144|Gefitinib|gefitinib|mesh-list
64938690|NCT00276549|Gemcitabine|gemcitabine|mesh-list
64938691|NCT00276549|Docetaxel|docetaxel|mesh-list
64938692|NCT00276549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64938693|NCT00276549|Antimetabolites|antimetabolites|mesh-ancestor
64938694|NCT00276549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938695|NCT00276549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938696|NCT00276549|Antiviral Agents|antiviral agents|mesh-ancestor
64529369|NCT02388594|Alkylating Agents|alkylating agents|mesh-ancestor
64529370|NCT02388594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529371|NCT02388594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529372|NCT02388594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64529373|NCT01500317|Oxycodone|oxycodone|mesh-list
64529374|NCT01500317|Tapentadol|tapentadol|mesh-list
64529375|NCT01500317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64529376|NCT01500317|Narcotics|narcotics|mesh-ancestor
64529377|NCT01500317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64529378|NCT01500317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529379|NCT01500317|Analgesics|analgesics|mesh-ancestor
64529380|NCT01500317|Sensory System Agents|sensory system agents|mesh-ancestor
64529381|NCT01500317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64529382|NCT01500317|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64529383|NCT01500317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64529384|NCT01500317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64529385|NCT01500317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529386|NCT01500317|Adrenergic Agents|adrenergic agents|mesh-ancestor
64938697|NCT00276549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64938698|NCT00276549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938699|NCT00276549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64938700|NCT00276549|Immunologic Factors|immunologic factors|mesh-ancestor
64938701|NCT00276549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938702|NCT00276549|Tubulin Modulators|tubulin modulators|mesh-ancestor
64938703|NCT00276549|Antimitotic Agents|antimitotic agents|mesh-ancestor
64938704|NCT00276549|Mitosis Modulators|mitosis modulators|mesh-ancestor
64517208|NCT01229943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64938705|NCT00014183|Gefitinib|gefitinib|mesh-list
64938706|NCT00014183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938707|NCT00014183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64938708|NCT00014183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938709|NCT00014183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938710|NCT00014261|Interferons|interferons|mesh-list
64938711|NCT00014261|Interferon-alpha|interferon-alpha|mesh-list
64938712|NCT00014261|Interferon alpha-2|interferon alpha-2|mesh-list
64938713|NCT00014261|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64938714|NCT00014261|Temozolomide|temozolomide|mesh-list
64938715|NCT00014261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938716|NCT00014261|Antiviral Agents|antiviral agents|mesh-ancestor
64938717|NCT00014261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64938718|NCT00014261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64938719|NCT00014261|Alkylating Agents|alkylating agents|mesh-ancestor
64938720|NCT00014261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938721|NCT00014261|Immunologic Factors|immunologic factors|mesh-ancestor
64938722|NCT00014261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938723|NCT00014339|Prednisone|prednisone|mesh-list
64938724|NCT00014339|Melphalan|melphalan|mesh-list
64938742|NCT00014456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938743|NCT00014456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938744|NCT00014456|Antiviral Agents|antiviral agents|mesh-ancestor
64938745|NCT00014456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64529401|NCT00332163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64529403|NCT02379000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64529404|NCT02379000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64529405|NCT02379000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64707253|NCT04738981|Basiliximab|basiliximab|mesh-list
64938748|NCT00014456|Immunologic Factors|immunologic factors|mesh-ancestor
64938749|NCT00014456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938750|NCT00014456|Tubulin Modulators|tubulin modulators|mesh-ancestor
64529407|NCT02379000|Glucocorticoids|glucocorticoids|mesh-ancestor
64529408|NCT02379000|Hormones|hormones|mesh-ancestor
64529409|NCT02379000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64529410|NCT02379000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529411|NCT02379000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64529412|NCT02379000|Immunologic Factors|immunologic factors|mesh-ancestor
64529413|NCT02379000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529414|NCT02379000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529415|NCT00333177|Risperidone|risperidone|mesh-list
64529416|NCT00333177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64529417|NCT00333177|Serotonin Agents|serotonin agents|mesh-ancestor
64529418|NCT00333177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64529419|NCT00333177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529420|NCT00333177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938751|NCT00014456|Antimitotic Agents|antimitotic agents|mesh-ancestor
64938752|NCT00014456|Mitosis Modulators|mitosis modulators|mesh-ancestor
64938754|NCT00276393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64938755|NCT00276393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938756|NCT00014534|Gemcitabine|gemcitabine|mesh-list
64938757|NCT00014534|Doxorubicin|doxorubicin|mesh-list
64938758|NCT00014534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64938759|NCT00014534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938760|NCT00014534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64938761|NCT00014534|Antimetabolites|antimetabolites|mesh-ancestor
64938762|NCT00014534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938763|NCT00014534|Antiviral Agents|antiviral agents|mesh-ancestor
64938764|NCT00014534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64938765|NCT00014534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938771|NCT00014534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64938773|NCT00014573|Paclitaxel|paclitaxel|mesh-list
64938774|NCT00014573|Cyclophosphamide|cyclophosphamide|mesh-list
64938775|NCT00014573|Carmustine|carmustine|mesh-list
64938776|NCT00014573|Sargramostim|sargramostim|mesh-list
64938777|NCT00014573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64938778|NCT00014573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938779|NCT00014573|Tubulin Modulators|tubulin modulators|mesh-ancestor
64938780|NCT00014573|Antimitotic Agents|antimitotic agents|mesh-ancestor
64938803|NCT00276315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64938804|NCT00276315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64938806|NCT00276276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64938807|NCT00276276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64938808|NCT00276276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517209|NCT01229943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64622284|NCT04423926|Hormones|hormones|mesh-ancestor
64938809|NCT00276276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938810|NCT00276276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938811|NCT00014651|Vapreotide|vapreotide|mesh-list
64938812|NCT00014651|Analgesics|analgesics|mesh-ancestor
64938813|NCT00014651|Sensory System Agents|sensory system agents|mesh-ancestor
64938814|NCT00014651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64938815|NCT00014651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938816|NCT00014651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938817|NCT00014690|Topotecan|topotecan|mesh-list
64529422|NCT00333177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64529423|NCT00333177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64529424|NCT00333177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64529425|NCT00333177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64529426|NCT00333177|Dopamine Agents|dopamine agents|mesh-ancestor
64529427|NCT02379156|Midodrine|midodrine|mesh-list
64529428|NCT02379156|Sympathomimetics|sympathomimetics|mesh-ancestor
64529429|NCT02379156|Autonomic Agents|autonomic agents|mesh-ancestor
64529430|NCT02379156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64529431|NCT02379156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529432|NCT02379156|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64529433|NCT02379156|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64529434|NCT02379156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64529435|NCT02379156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64529436|NCT02379156|Adrenergic Agents|adrenergic agents|mesh-ancestor
64938818|NCT00014690|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64938819|NCT00014690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64938820|NCT00014690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938821|NCT00014690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938822|NCT00014690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707332|NCT00369733|Hematinics|hematinics|mesh-ancestor
64938824|NCT00014729|Dermatologic Agents|dermatologic agents|mesh-ancestor
64938825|NCT00276198|Vitamin D|vitamin d|mesh-list
64938826|NCT00276198|Vitamin A|vitamin a|mesh-list
64938827|NCT00276198|Vitamins|vitamins|mesh-ancestor
64938828|NCT00276198|Micronutrients|micronutrients|mesh-ancestor
64938829|NCT00276198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938830|NCT00276198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64938831|NCT00276081|Gabapentin|gabapentin|mesh-list
64938832|NCT00276081|Estrogens|estrogens|mesh-list
64938850|NCT00276003|Irinotecan|irinotecan|mesh-list
64938851|NCT00276003|Allopurinol|allopurinol|mesh-list
64938852|NCT00276003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64938853|NCT00276003|Antimetabolites|antimetabolites|mesh-ancestor
64938854|NCT00276003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938855|NCT00276003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938856|NCT00276003|Antiviral Agents|antiviral agents|mesh-ancestor
64938857|NCT00276003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64938858|NCT00276003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938859|NCT00276003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64938860|NCT00276003|Immunologic Factors|immunologic factors|mesh-ancestor
64938861|NCT00276003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651202|NCT01433081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64938869|NCT00275925|Oxcarbazepine|oxcarbazepine|mesh-list
64938870|NCT00275925|Anticonvulsants|anticonvulsants|mesh-ancestor
64938871|NCT00275925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64938872|NCT00275925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64938873|NCT00275925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64938874|NCT00275925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938875|NCT00275925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64938876|NCT00275925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64938877|NCT00015041|Buprenorphine|buprenorphine|mesh-list
64529437|NCT02379156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64529438|NCT02379156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529439|NCT00335283|Lansoprazole|lansoprazole|mesh-list
64529440|NCT00335283|Dexlansoprazole|dexlansoprazole|mesh-list
64529441|NCT00335283|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64529442|NCT00335283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64529443|NCT00335283|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64529444|NCT00335283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529445|NCT00335283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529446|NCT01500083|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64529447|NCT01500083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64622342|NCT00379600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529448|NCT01500083|Alkylating Agents|alkylating agents|mesh-ancestor
64529449|NCT01500083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529450|NCT01500083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529452|NCT02779257|Pasireotide|pasireotide|mesh-list
64529453|NCT02779257|Hormones|hormones|mesh-ancestor
64529454|NCT02779257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64529455|NCT02779257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529456|NCT02779257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64938878|NCT00015041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64938879|NCT00015041|Narcotics|narcotics|mesh-ancestor
64938880|NCT00015041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64938881|NCT00015041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938882|NCT00015041|Analgesics|analgesics|mesh-ancestor
64938883|NCT00015041|Sensory System Agents|sensory system agents|mesh-ancestor
64938884|NCT00015041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64938885|NCT00015041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64938886|NCT00015080|Naltrexone|naltrexone|mesh-list
64938887|NCT00015080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64938888|NCT00015080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64938889|NCT00015080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938905|NCT00015275|Cocaine|cocaine|mesh-list
64938906|NCT00015275|Anesthetics, Local|anesthetics, local|mesh-ancestor
64938907|NCT00015275|Anesthetics|anesthetics|mesh-ancestor
64938908|NCT00015275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64938909|NCT00015275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938910|NCT00015275|Sensory System Agents|sensory system agents|mesh-ancestor
64938911|NCT00015275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64938912|NCT00015275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64938913|NCT00015275|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64938914|NCT00015275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64938915|NCT00015275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64938916|NCT00015275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938917|NCT00015275|Dopamine Agents|dopamine agents|mesh-ancestor
64938918|NCT00015275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64938919|NCT00275730|Indomethacin|indomethacin|mesh-list
64938920|NCT00275730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64938921|NCT00275730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64938922|NCT00275730|Analgesics|analgesics|mesh-ancestor
64938923|NCT00275730|Sensory System Agents|sensory system agents|mesh-ancestor
64938925|NCT00275730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938926|NCT00275730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64938927|NCT00275730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64938928|NCT00275730|Gout Suppressants|gout suppressants|mesh-ancestor
64938929|NCT00275730|Tocolytic Agents|tocolytic agents|mesh-ancestor
64938930|NCT00275730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64938931|NCT00275730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64938932|NCT00275730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938933|NCT00275730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938934|NCT00275652|Lamivudine|lamivudine|mesh-list
64938935|NCT00275652|Telbivudine|telbivudine|mesh-list
64938936|NCT00275652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64938937|NCT00275652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64938938|NCT00275652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938939|NCT00275652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938940|NCT00275652|Antiviral Agents|antiviral agents|mesh-ancestor
64938941|NCT00275652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64938942|NCT00275652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64938943|NCT00275652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64938944|NCT00275613|Rituximab|rituximab|mesh-list
64938945|NCT00275613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64938946|NCT00275613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938966|NCT00015548|Autonomic Agents|autonomic agents|mesh-ancestor
64938967|NCT00015548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64938968|NCT00015548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64938969|NCT00015548|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64938970|NCT00015548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64938971|NCT00015548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64938972|NCT00015548|Antidepressive Agents|antidepressive agents|mesh-ancestor
64938973|NCT00015548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64938974|NCT00275535|Mycophenolic Acid|mycophenolic acid|mesh-list
64938976|NCT00275535|Prednisone|prednisone|mesh-list
64938977|NCT00275535|Tacrolimus|tacrolimus|mesh-list
64517210|NCT01229943|Growth Substances|growth substances|mesh-ancestor
64517211|NCT01229943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517212|NCT01229943|Growth Inhibitors|growth inhibitors|mesh-ancestor
64938978|NCT00275535|Thymoglobulin|thymoglobulin|mesh-list
64938979|NCT00275535|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64938980|NCT00275535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64938981|NCT00275535|Glucocorticoids|glucocorticoids|mesh-ancestor
64938982|NCT00275535|Hormones|hormones|mesh-ancestor
64938983|NCT00275535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64938984|NCT00275535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938985|NCT00275535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64938986|NCT00275535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938987|NCT00275535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64938988|NCT00275535|Immunologic Factors|immunologic factors|mesh-ancestor
64938989|NCT00275535|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64938990|NCT00275535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938991|NCT00275535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938992|NCT00275535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64938993|NCT00275535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64938994|NCT00275535|Antitubercular Agents|antitubercular agents|mesh-ancestor
64938995|NCT00275535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64938996|NCT00275535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64938997|NCT00275535|Antifungal Agents|antifungal agents|mesh-ancestor
64938998|NCT00015626|Metformin|metformin|mesh-list
64938999|NCT00015626|Pioglitazone|pioglitazone|mesh-list
64939000|NCT00015626|Rosiglitazone|rosiglitazone|mesh-list
64939001|NCT00015626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64939002|NCT00015626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939031|NCT00275418|Beta Carotene|beta carotene|mesh-list
64939032|NCT00275418|Carotenoids|carotenoids|mesh-list
64939033|NCT00275418|Antioxidants|antioxidants|mesh-ancestor
64939034|NCT00275418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939035|NCT00275418|Protective Agents|protective agents|mesh-ancestor
64939036|NCT00275418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939037|NCT00275418|Provitamins|provitamins|mesh-ancestor
64939038|NCT00275418|Vitamins|vitamins|mesh-ancestor
64939039|NCT00275418|Micronutrients|micronutrients|mesh-ancestor
64939040|NCT01784159|Aspirin|aspirin|mesh-list
64939041|NCT01784159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64939042|NCT01784159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64939043|NCT01784159|Analgesics|analgesics|mesh-ancestor
64939044|NCT01784159|Sensory System Agents|sensory system agents|mesh-ancestor
64939045|NCT01784159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64939046|NCT01784159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939047|NCT01784159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64707558|NCT04523701|SMOFlipid|smoflipid|mesh-list
64939048|NCT01784159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64939049|NCT01784159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64939050|NCT01784159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64939051|NCT01784159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939052|NCT01784159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64939053|NCT01784159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64939054|NCT01784159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939056|NCT00015821|Thalidomide|thalidomide|mesh-list
64939057|NCT00015821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64939058|NCT00015821|Immunologic Factors|immunologic factors|mesh-ancestor
64939059|NCT00015821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939060|NCT00015821|Leprostatic Agents|leprostatic agents|mesh-ancestor
64939061|NCT00015821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64939090|NCT00015860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64939091|NCT00015860|Tubulin Modulators|tubulin modulators|mesh-ancestor
64939092|NCT00015860|Antimitotic Agents|antimitotic agents|mesh-ancestor
64939093|NCT00015860|Mitosis Modulators|mitosis modulators|mesh-ancestor
64939094|NCT00015860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939095|NCT00015860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64939096|NCT00015860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939097|NCT00015860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64651221|NCT01515995|Analgesics|analgesics|mesh-ancestor
64651225|NCT01515995|Anesthetics|anesthetics|mesh-ancestor
64939141|NCT00275106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64529471|NCT02371590|Lenalidomide|lenalidomide|mesh-list
64529472|NCT02371590|Obinutuzumab|obinutuzumab|mesh-list
64529473|NCT02371590|Immunologic Factors|immunologic factors|mesh-ancestor
64517213|NCT01229943|Immunologic Factors|immunologic factors|mesh-ancestor
64517214|NCT01229943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64622496|NCT01350232|Antimetabolites|antimetabolites|mesh-ancestor
64529474|NCT02371590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529475|NCT02371590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64529476|NCT02371590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64529477|NCT02371590|Growth Substances|growth substances|mesh-ancestor
64529478|NCT02371590|Growth Inhibitors|growth inhibitors|mesh-ancestor
64529479|NCT02371590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529480|NCT02371590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64529481|NCT00298155|Ketoconazole|ketoconazole|mesh-list
64529482|NCT00298155|Goserelin|goserelin|mesh-list
64529483|NCT00298155|Bicalutamide|bicalutamide|mesh-list
64529484|NCT00298155|Dutasteride|dutasteride|mesh-list
64529485|NCT00298155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64529486|NCT00298155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529487|NCT00298155|Antifungal Agents|antifungal agents|mesh-ancestor
64529488|NCT00298155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64529489|NCT00298155|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64529490|NCT00298155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64529491|NCT00298155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529492|NCT00298155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529493|NCT00298155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64529494|NCT00298155|Hormone Antagonists|hormone antagonists|mesh-ancestor
64939142|NCT00275106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64939144|NCT00275106|Dermatologic Agents|dermatologic agents|mesh-ancestor
64939145|NCT00275106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64939146|NCT00275106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64939147|NCT00275106|Antiviral Agents|antiviral agents|mesh-ancestor
64939148|NCT00275106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64939149|NCT00275106|Antidotes|antidotes|mesh-ancestor
64939150|NCT00275106|Protective Agents|protective agents|mesh-ancestor
64939151|NCT00275106|Vitamin B Complex|vitamin b complex|mesh-ancestor
64939152|NCT00275106|Vitamins|vitamins|mesh-ancestor
64939153|NCT00275106|Micronutrients|micronutrients|mesh-ancestor
64939174|NCT00274989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64939175|NCT00274989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939176|NCT00274989|Immunologic Factors|immunologic factors|mesh-ancestor
64939177|NCT00274989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939178|NCT00274989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64939179|NCT00274989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64939180|NCT00274989|Alkylating Agents|alkylating agents|mesh-ancestor
64939181|NCT00274989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939182|NCT00015977|Interleukin-12|interleukin-12|mesh-list
64939183|NCT00015977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64939184|NCT00015977|Immunologic Factors|immunologic factors|mesh-ancestor
64939185|NCT00015977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939186|NCT00015977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64529495|NCT00298155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64529496|NCT00298155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529497|NCT00298155|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64376543|NCT02452151|Infliximab|infliximab|mesh-list
64939196|NCT01678586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939197|NCT01678586|Anticonvulsants|anticonvulsants|mesh-ancestor
64939198|NCT01678586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64939199|NCT01678586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64939200|NCT01678586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64939201|NCT01678586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64939202|NCT01678586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64939203|NCT01678586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64939204|NCT01678586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64939205|NCT01678586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294216|NCT02478645|Ramosetron|ramosetron|mesh-list
64939206|NCT01678586|Antimanic Agents|antimanic agents|mesh-ancestor
64939207|NCT01678586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64939240|NCT00016016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939242|NCT00016016|Antiviral Agents|antiviral agents|mesh-ancestor
64939243|NCT00016016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64939244|NCT00016016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64939245|NCT00016016|Immunologic Factors|immunologic factors|mesh-ancestor
64939246|NCT00016016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517215|NCT01229943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64517216|NCT01229943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64517217|NCT02020408|Raclopride|raclopride|mesh-list
64517218|NCT02020408|Amphetamine|amphetamine|mesh-list
64517219|NCT02020408|Dextroamphetamine|dextroamphetamine|mesh-list
64517220|NCT02020408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64939247|NCT00016016|Analgesics|analgesics|mesh-ancestor
64939248|NCT00016016|Sensory System Agents|sensory system agents|mesh-ancestor
64939249|NCT00016016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64939250|NCT00016016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64939251|NCT00016016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64939252|NCT00016016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939253|NCT00016016|Growth Inhibitors|growth inhibitors|mesh-ancestor
64939280|NCT00016094|Growth Substances|growth substances|mesh-ancestor
64939281|NCT00016094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939282|NCT00016094|Growth Inhibitors|growth inhibitors|mesh-ancestor
64939283|NCT00016094|Immunologic Factors|immunologic factors|mesh-ancestor
64939284|NCT00130338|Rivastigmine|rivastigmine|mesh-list
64939285|NCT00130338|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64939286|NCT00130338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939287|NCT00130338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939288|NCT00130338|Cholinergic Agents|cholinergic agents|mesh-ancestor
64651242|NCT01519271|Cholinergic Agents|cholinergic agents|mesh-ancestor
64939294|NCT00016133|Fluorouracil|fluorouracil|mesh-list
64939295|NCT00016133|Vaccines|vaccines|mesh-list
64939296|NCT00016133|BCG Vaccine|bcg vaccine|mesh-list
64939297|NCT00016133|Calcium|calcium|mesh-list
64939298|NCT00016133|Levoleucovorin|levoleucovorin|mesh-list
64939299|NCT00016133|Immunologic Factors|immunologic factors|mesh-ancestor
64939300|NCT00016133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939319|NCT00016172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939320|NCT00016172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939321|NCT00130221|Chlorhexidine|chlorhexidine|mesh-list
64939322|NCT00130221|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64939323|NCT00130221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64939324|NCT00130221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64939325|NCT00130221|Disinfectants|disinfectants|mesh-ancestor
64939326|NCT00130221|Dermatologic Agents|dermatologic agents|mesh-ancestor
64939327|NCT01470716|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64939328|NCT01470716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939329|NCT01470716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64939330|NCT01470716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939331|NCT01470716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939332|NCT00394368|Fluticasone|fluticasone|mesh-list
64939334|NCT00394368|Beclomethasone|beclomethasone|mesh-list
64939335|NCT00394368|Formoterol Fumarate|formoterol fumarate|mesh-list
64939336|NCT00394368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64939337|NCT00394368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64939338|NCT00394368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64939339|NCT00394368|Autonomic Agents|autonomic agents|mesh-ancestor
64939340|NCT00394368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64939341|NCT00394368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939342|NCT00394368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64939343|NCT00394368|Respiratory System Agents|respiratory system agents|mesh-ancestor
64939344|NCT00394368|Dermatologic Agents|dermatologic agents|mesh-ancestor
64939345|NCT00394368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64529500|NCT01499849|Dexamethasone|dexamethasone|mesh-list
64529501|NCT01499849|Granisetron|granisetron|mesh-list
64529502|NCT01499849|Rolapitant|rolapitant|mesh-list
64529503|NCT01499849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64529504|NCT01499849|Antiemetics|antiemetics|mesh-ancestor
64529505|NCT01499849|Autonomic Agents|autonomic agents|mesh-ancestor
64529506|NCT01499849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64529507|NCT01499849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529508|NCT01499849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64529509|NCT01499849|Glucocorticoids|glucocorticoids|mesh-ancestor
64529510|NCT01499849|Hormones|hormones|mesh-ancestor
64529511|NCT01499849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64529512|NCT01499849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64529513|NCT01499849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529514|NCT01499849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64529515|NCT01499849|Serotonin Agents|serotonin agents|mesh-ancestor
64517221|NCT02020408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517222|NCT02020408|Sympathomimetics|sympathomimetics|mesh-ancestor
64517223|NCT02020408|Autonomic Agents|autonomic agents|mesh-ancestor
64517224|NCT02020408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64564712|NCT04121455|Pembrolizumab|pembrolizumab|mesh-list
64294226|NCT03829579|Esketamine|esketamine|mesh-list
64939346|NCT00394368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64939347|NCT00394368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64939348|NCT00394368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64939349|NCT00394368|Adrenergic Agents|adrenergic agents|mesh-ancestor
64939350|NCT00394368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64939351|NCT00394368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939352|NCT00394368|Glucocorticoids|glucocorticoids|mesh-ancestor
64939353|NCT00394368|Hormones|hormones|mesh-ancestor
64939354|NCT00394368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64939355|NCT01441349|Simvastatin|simvastatin|mesh-list
64939356|NCT01441349|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64939383|NCT00130065|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64939385|NCT00130065|Vitamin B Complex|vitamin b complex|mesh-ancestor
64939386|NCT00130065|Vitamins|vitamins|mesh-ancestor
64939387|NCT00130065|Micronutrients|micronutrients|mesh-ancestor
64939388|NCT00130065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939389|NCT00130065|Antimalarials|antimalarials|mesh-ancestor
64939390|NCT00130065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64939397|NCT00130065|Renal Agents|renal agents|mesh-ancestor
64939398|NCT00016328|Sirolimus|sirolimus|mesh-list
64939399|NCT00016328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64939400|NCT00016328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64939401|NCT00016328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64939402|NCT00016328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939403|NCT00016328|Antifungal Agents|antifungal agents|mesh-ancestor
64939404|NCT00016328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64939405|NCT00016328|Immunologic Factors|immunologic factors|mesh-ancestor
64939424|NCT00016367|Antiviral Agents|antiviral agents|mesh-ancestor
64939425|NCT00016367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64939426|NCT00016367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939427|NCT00016367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64529516|NCT01499849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64529517|NCT01499849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529518|NCT01499849|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64529519|NCT01880541|Anesthetics|anesthetics|mesh-list
64294237|NCT01362296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939428|NCT00016367|Immunologic Factors|immunologic factors|mesh-ancestor
64939429|NCT00016367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939430|NCT00016367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64939431|NCT00129948|Troxacitabine|troxacitabine|mesh-list
64939432|NCT00129948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939433|NCT00129948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64939434|NCT00129948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64939435|NCT00129948|Antiviral Agents|antiviral agents|mesh-ancestor
64939436|NCT00129948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64939437|NCT00016406|Paclitaxel|paclitaxel|mesh-list
64939438|NCT00016406|Cyclophosphamide|cyclophosphamide|mesh-list
64939439|NCT00016406|Doxorubicin|doxorubicin|mesh-list
64939440|NCT00016406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64939441|NCT00016406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939442|NCT00016406|Tubulin Modulators|tubulin modulators|mesh-ancestor
64939443|NCT00016406|Antimitotic Agents|antimitotic agents|mesh-ancestor
64939444|NCT00016406|Mitosis Modulators|mitosis modulators|mesh-ancestor
64939445|NCT00016406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939446|NCT00016406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64939447|NCT00016406|Immunologic Factors|immunologic factors|mesh-ancestor
64939448|NCT00016406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939449|NCT00016406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64939450|NCT00016406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64939451|NCT00016406|Alkylating Agents|alkylating agents|mesh-ancestor
64939452|NCT00016406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64939453|NCT00016406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64939454|NCT00016406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64939455|NCT00016406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64564713|NCT04121455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64564714|NCT04121455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564715|NCT04121455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64564716|NCT04121455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64564717|NCT04121455|Growth Substances|growth substances|mesh-ancestor
64564718|NCT04121455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564719|NCT04121455|Growth Inhibitors|growth inhibitors|mesh-ancestor
64564721|NCT01921673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564722|NCT01921673|Tubulin Modulators|tubulin modulators|mesh-ancestor
64564723|NCT01921673|Antimitotic Agents|antimitotic agents|mesh-ancestor
64564724|NCT01921673|Mitosis Modulators|mitosis modulators|mesh-ancestor
64564725|NCT01921673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564726|NCT01921985|Terlipressin|terlipressin|mesh-list
64564755|NCT03828019|Cyclosporins|cyclosporins|mesh-list
64564756|NCT03828019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64564757|NCT03828019|Abortifacient Agents|abortifacient agents|mesh-ancestor
64564758|NCT03828019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64622709|NCT02534038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64939456|NCT00016406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939457|NCT00129870|Oxaliplatin|oxaliplatin|mesh-list
64939458|NCT00129870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939459|NCT00016445|Hormones|hormones|mesh-list
64939460|NCT00016445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64939461|NCT00016445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939480|NCT00129597|Ketamine|ketamine|mesh-list
64939481|NCT00129597|Analgesics|analgesics|mesh-ancestor
64939482|NCT00129597|Sensory System Agents|sensory system agents|mesh-ancestor
64939483|NCT00129597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64939484|NCT00129597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939485|NCT00129597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64939486|NCT00129597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64939487|NCT00129597|Anesthetics, General|anesthetics, general|mesh-ancestor
64939488|NCT00129597|Anesthetics|anesthetics|mesh-ancestor
64939489|NCT00129597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64651255|NCT01436279|Contraceptive Agents|contraceptive agents|mesh-ancestor
64939501|NCT00016601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64939502|NCT00016601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64939503|NCT00016601|Protease Inhibitors|protease inhibitors|mesh-ancestor
64939504|NCT00016601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939505|NCT00016601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939507|NCT00016601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64939508|NCT00016601|Antiviral Agents|antiviral agents|mesh-ancestor
64939509|NCT00016601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64939510|NCT00016601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64529520|NCT01880541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64529521|NCT01880541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529522|NCT00298233|Oseltamivir|oseltamivir|mesh-list
64529523|NCT00298233|Antiviral Agents|antiviral agents|mesh-ancestor
64529524|NCT00298233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64529525|NCT00298233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529526|NCT00298233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529527|NCT02376972|Rifaximin|rifaximin|mesh-list
64529528|NCT02376972|Metronidazole|metronidazole|mesh-list
64529529|NCT02376972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64529530|NCT02376972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64529531|NCT02376972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64564759|NCT03828019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564760|NCT03828019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64564761|NCT03828019|Antimetabolites|antimetabolites|mesh-ancestor
64564762|NCT03828019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529532|NCT02376972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64294242|NCT01362296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64294243|NCT01362296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294244|NCT01338415|Bosentan|bosentan|mesh-list
64294248|NCT04353128|Melatonin|melatonin|mesh-list
64939511|NCT00016601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64939512|NCT00016601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64939513|NCT00016601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64939514|NCT00016601|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64939515|NCT00016601|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64939516|NCT00016601|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64939517|NCT00016601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64939538|NCT00129519|Interferon Inducers|interferon inducers|mesh-ancestor
64939539|NCT00016835|Metronidazole|metronidazole|mesh-list
64939540|NCT00016835|Doxycycline|doxycycline|mesh-list
64939541|NCT00016835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64939542|NCT00016835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64939543|NCT00016835|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64939544|NCT00016835|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64939545|NCT00016835|Antimalarials|antimalarials|mesh-ancestor
64939546|NCT00016874|Paclitaxel|paclitaxel|mesh-list
64939547|NCT00016874|Cisplatin|cisplatin|mesh-list
64939548|NCT00016874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64939549|NCT00016874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939550|NCT00016874|Tubulin Modulators|tubulin modulators|mesh-ancestor
64939551|NCT00016874|Antimitotic Agents|antimitotic agents|mesh-ancestor
64939552|NCT00016874|Mitosis Modulators|mitosis modulators|mesh-ancestor
64939553|NCT00016874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939554|NCT00016952|Leucovorin|leucovorin|mesh-list
64939555|NCT00016952|Fluorouracil|fluorouracil|mesh-list
64939556|NCT00016952|Irinotecan|irinotecan|mesh-list
64939557|NCT00016952|Calcium|calcium|mesh-list
64939558|NCT00016952|Levoleucovorin|levoleucovorin|mesh-list
64939559|NCT00016952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64939560|NCT00016952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939566|NCT00016952|Immunologic Factors|immunologic factors|mesh-ancestor
64939567|NCT00016952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64939568|NCT00016952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64939569|NCT00016952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939571|NCT00016952|Protective Agents|protective agents|mesh-ancestor
64939572|NCT00016952|Vitamin B Complex|vitamin b complex|mesh-ancestor
64939604|NCT00017069|Antiemetics|antiemetics|mesh-ancestor
64529533|NCT02376972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64529534|NCT02378532|Chloroquine|chloroquine|mesh-list
64529535|NCT02378532|Temozolomide|temozolomide|mesh-list
64529536|NCT02378532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64529537|NCT02378532|Alkylating Agents|alkylating agents|mesh-ancestor
64529538|NCT02378532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529539|NCT02378532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529540|NCT02378532|Amebicides|amebicides|mesh-ancestor
64529541|NCT02378532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64529542|NCT02378532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64529543|NCT02378532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64529544|NCT02378532|Antimalarials|antimalarials|mesh-ancestor
64529545|NCT02378532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64529547|NCT01498679|Xhance|xhance|mesh-list
64529548|NCT01498679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64529549|NCT01498679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64529550|NCT01498679|Autonomic Agents|autonomic agents|mesh-ancestor
64529551|NCT01498679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64939605|NCT00017069|Autonomic Agents|autonomic agents|mesh-ancestor
64939606|NCT00017069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64939607|NCT00017069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939608|NCT00017069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64939609|NCT00017069|Glucocorticoids|glucocorticoids|mesh-ancestor
64939610|NCT00017069|Hormones|hormones|mesh-ancestor
64939611|NCT00017069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64939612|NCT00017069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64564763|NCT03828019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564764|NCT03828019|Dermatologic Agents|dermatologic agents|mesh-ancestor
64564765|NCT03828019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64564766|NCT03828019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64939613|NCT00017069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939633|NCT00017108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64939634|NCT00017108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64939635|NCT00017108|Antimetabolites|antimetabolites|mesh-ancestor
64939636|NCT00129246|Naltrexone|naltrexone|mesh-list
64939637|NCT00129246|Bupropion|bupropion|mesh-list
64939638|NCT00129246|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64939639|NCT00129246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64939640|NCT00129246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939641|NCT00129246|Sensory System Agents|sensory system agents|mesh-ancestor
64939642|NCT00129246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64939643|NCT00129246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64939644|NCT00129246|Antidepressive Agents|antidepressive agents|mesh-ancestor
64939645|NCT00129246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64939646|NCT00129246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64939647|NCT00129246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64939648|NCT00129246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64939649|NCT00129246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939650|NCT00129246|Dopamine Agents|dopamine agents|mesh-ancestor
64939651|NCT00129246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64939652|NCT00129246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64939653|NCT00129246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64939654|NCT00129246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939656|NCT00017147|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64939657|NCT00017147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64939658|NCT00017147|Alkylating Agents|alkylating agents|mesh-ancestor
64939659|NCT00017147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939660|NCT00017147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939661|NCT00017147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939662|NCT00129207|Bortezomib|bortezomib|mesh-list
64939666|NCT00129168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64939667|NCT00129168|Antimetabolites|antimetabolites|mesh-ancestor
64939680|NCT00129090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64939681|NCT00129090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939682|NCT00129090|Immunologic Factors|immunologic factors|mesh-ancestor
64939683|NCT00129090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939684|NCT00129090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64939685|NCT00017186|Gemcitabine|gemcitabine|mesh-list
64939686|NCT00017186|Epirubicin|epirubicin|mesh-list
64939687|NCT00017186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64939688|NCT00017186|Antimetabolites|antimetabolites|mesh-ancestor
64939689|NCT00017186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939690|NCT00017186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939691|NCT00017186|Antiviral Agents|antiviral agents|mesh-ancestor
64939692|NCT00017186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64939693|NCT00017186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939694|NCT00017186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64939695|NCT00017186|Immunologic Factors|immunologic factors|mesh-ancestor
64939696|NCT00017186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939697|NCT00017186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64939698|NCT00017186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64939699|NCT00017186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64939700|NCT00017225|Cyclophosphamide|cyclophosphamide|mesh-list
64939701|NCT00017225|Melphalan|melphalan|mesh-list
64939702|NCT00017225|Ifosfamide|ifosfamide|mesh-list
64939703|NCT00017225|Dacarbazine|dacarbazine|mesh-list
64939704|NCT00017225|Carboplatin|carboplatin|mesh-list
64939705|NCT00017225|Doxorubicin|doxorubicin|mesh-list
64939706|NCT00017225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64939707|NCT00017225|Etoposide|etoposide|mesh-list
64939708|NCT00017225|Vincristine|vincristine|mesh-list
64939709|NCT00017225|Tretinoin|tretinoin|mesh-list
64939710|NCT00017225|Vindesine|vindesine|mesh-list
64939711|NCT00017225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64939712|NCT00017225|Immunologic Factors|immunologic factors|mesh-ancestor
64939713|NCT00017225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939714|NCT00017225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64939715|NCT00017225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64939716|NCT00017225|Alkylating Agents|alkylating agents|mesh-ancestor
64564767|NCT03828019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64939717|NCT00017225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939718|NCT00017225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939719|NCT00017225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64939720|NCT00017225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64939721|NCT00017225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64939722|NCT00017225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64939723|NCT00017225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939724|NCT00017225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64939725|NCT00017225|Tubulin Modulators|tubulin modulators|mesh-ancestor
64708230|NCT03236935|Pembrolizumab|pembrolizumab|mesh-list
64939726|NCT00017225|Antimitotic Agents|antimitotic agents|mesh-ancestor
64939727|NCT00017225|Mitosis Modulators|mitosis modulators|mesh-ancestor
64939728|NCT00017225|Keratolytic Agents|keratolytic agents|mesh-ancestor
64939729|NCT00017225|Dermatologic Agents|dermatologic agents|mesh-ancestor
64939730|NCT00128934|Levonorgestrel|levonorgestrel|mesh-list
64939731|NCT00128934|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64939763|NCT00017303|Antimitotic Agents|antimitotic agents|mesh-ancestor
64939764|NCT00017303|Mitosis Modulators|mitosis modulators|mesh-ancestor
64939765|NCT00017303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939767|NCT00017342|Bryostatin 1|bryostatin 1|mesh-list
64939768|NCT00017342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64651276|NCT01437449|Tubulin Modulators|tubulin modulators|mesh-ancestor
64939769|NCT00017342|Antimetabolites|antimetabolites|mesh-ancestor
64651277|NCT01437449|Antimitotic Agents|antimitotic agents|mesh-ancestor
64529562|NCT01000467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64939772|NCT00017342|Antiviral Agents|antiviral agents|mesh-ancestor
64939800|NCT00017381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64939801|NCT00017381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64939802|NCT00128700|Temozolomide|temozolomide|mesh-list
64939803|NCT00128700|Vatalanib|vatalanib|mesh-list
64939804|NCT00128700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64939805|NCT00128700|Alkylating Agents|alkylating agents|mesh-ancestor
64939806|NCT00128700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939807|NCT00128700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939808|NCT00128700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64939809|NCT00128700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939810|NCT00017459|Vinorelbine|vinorelbine|mesh-list
64939811|NCT00017459|Tirapazamine|tirapazamine|mesh-list
64939812|NCT00017459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939813|NCT00017459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64939814|NCT00017459|Tubulin Modulators|tubulin modulators|mesh-ancestor
64939815|NCT00017459|Antimitotic Agents|antimitotic agents|mesh-ancestor
64939816|NCT00017459|Mitosis Modulators|mitosis modulators|mesh-ancestor
64939817|NCT00017459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939818|NCT00128622|Denileukin diftitox|denileukin diftitox|mesh-list
64939819|NCT00128622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939853|NCT00017576|Calcitriol|calcitriol|mesh-list
64939854|NCT00017576|Carboplatin|carboplatin|mesh-list
64939855|NCT00017576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939856|NCT00017576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64939857|NCT00017576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939876|NCT00017654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939877|NCT00017654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939878|NCT00017654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64939879|NCT00017654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939880|NCT00017654|Antifungal Agents|antifungal agents|mesh-ancestor
64939881|NCT00017654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64939882|NCT00017654|Dermatologic Agents|dermatologic agents|mesh-ancestor
64939883|NCT00017654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64939884|NCT00017654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64939886|NCT00017654|Autonomic Agents|autonomic agents|mesh-ancestor
64939887|NCT00017654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64939888|NCT00017654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64939889|NCT00017654|Glucocorticoids|glucocorticoids|mesh-ancestor
64939890|NCT00017654|Hormones|hormones|mesh-ancestor
64939891|NCT00017654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64939892|NCT00017654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64939893|NCT00017654|Protective Agents|protective agents|mesh-ancestor
64939894|NCT00394485|Tiotropium Bromide|tiotropium bromide|mesh-list
64939895|NCT00394485|Procaterol|procaterol|mesh-list
64939896|NCT00394485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64939897|NCT00394485|Autonomic Agents|autonomic agents|mesh-ancestor
64939898|NCT00394485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64564768|NCT03828019|Immunologic Factors|immunologic factors|mesh-ancestor
64517225|NCT02020408|Dopamine Agents|dopamine agents|mesh-ancestor
64517226|NCT02020408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64517227|NCT02020408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517228|NCT02020408|Adrenergic Agents|adrenergic agents|mesh-ancestor
64939899|NCT00394485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939900|NCT00394485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64939901|NCT00394485|Respiratory System Agents|respiratory system agents|mesh-ancestor
64939902|NCT00394485|Parasympatholytics|parasympatholytics|mesh-ancestor
64939903|NCT00394485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64939904|NCT00394485|Cholinergic Agents|cholinergic agents|mesh-ancestor
64939905|NCT00394485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64939906|NCT00394485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939907|NCT00394485|Sympathomimetics|sympathomimetics|mesh-ancestor
64939908|NCT00394485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64939909|NCT00394485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64939910|NCT00394485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64651283|NCT00836888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529567|NCT00198315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64529568|NCT00198315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529570|NCT01559389|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64529571|NCT01559389|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64529572|NCT01559389|Cholinergic Agents|cholinergic agents|mesh-ancestor
64529573|NCT01559389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64529574|NCT01559389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529575|NCT01559389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529576|NCT01559389|Urological Agents|urological agents|mesh-ancestor
64529577|NCT01526551|Vaccines|vaccines|mesh-list
64529578|NCT01526551|Immunologic Factors|immunologic factors|mesh-ancestor
64529579|NCT01526551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529580|NCT04540692|Paclitaxel|paclitaxel|mesh-list
64529581|NCT04540692|Docetaxel|docetaxel|mesh-list
64294280|NCT05124938|Hormones|hormones|mesh-list
64294283|NCT02259985|Itasetron|itasetron|mesh-list
64939925|NCT00128427|Colchicine|colchicine|mesh-list
64939926|NCT00128427|Gout Suppressants|gout suppressants|mesh-ancestor
64939927|NCT00128427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64939928|NCT00128427|Tubulin Modulators|tubulin modulators|mesh-ancestor
64939929|NCT00128427|Antimitotic Agents|antimitotic agents|mesh-ancestor
64939930|NCT00128427|Mitosis Modulators|mitosis modulators|mesh-ancestor
64939931|NCT00128427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939932|NCT00128427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939933|NCT00128310|Gemcitabine|gemcitabine|mesh-list
64939934|NCT00128310|Vinorelbine|vinorelbine|mesh-list
64939935|NCT00128310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64939936|NCT00128310|Antimetabolites|antimetabolites|mesh-ancestor
64939937|NCT00128310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939938|NCT00128310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939939|NCT00128310|Antiviral Agents|antiviral agents|mesh-ancestor
64939940|NCT00128310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64939941|NCT00128310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939942|NCT00128310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64939943|NCT00128310|Immunologic Factors|immunologic factors|mesh-ancestor
64939944|NCT00128310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939945|NCT00128310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64939946|NCT00128310|Tubulin Modulators|tubulin modulators|mesh-ancestor
64939947|NCT00128310|Antimitotic Agents|antimitotic agents|mesh-ancestor
64939948|NCT00128310|Mitosis Modulators|mitosis modulators|mesh-ancestor
64939949|NCT00006099|Antibodies|antibodies|mesh-list
64939950|NCT00006099|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64939951|NCT00006099|Immunologic Factors|immunologic factors|mesh-ancestor
64939952|NCT00006099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939953|NCT00018603|Guanfacine|guanfacine|mesh-list
64939954|NCT00018603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64939955|NCT00018603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64939956|NCT00018603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64939957|NCT00018603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64939958|NCT00018603|Adrenergic Agents|adrenergic agents|mesh-ancestor
64939959|NCT00018603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64939960|NCT00018603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529582|NCT04540692|Cyclophosphamide|cyclophosphamide|mesh-list
64517229|NCT02020408|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64623056|NCT02134912|Pemetrexed|pemetrexed|mesh-list
64529583|NCT04540692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64529584|NCT04540692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529585|NCT04540692|Tubulin Modulators|tubulin modulators|mesh-ancestor
64529586|NCT04540692|Antimitotic Agents|antimitotic agents|mesh-ancestor
64529587|NCT04540692|Mitosis Modulators|mitosis modulators|mesh-ancestor
64529588|NCT04540692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529589|NCT04540692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64529590|NCT04540692|Immunologic Factors|immunologic factors|mesh-ancestor
64529591|NCT04540692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529592|NCT04540692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64529593|NCT04540692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64529594|NCT04540692|Alkylating Agents|alkylating agents|mesh-ancestor
64651290|NCT00889226|Atorvastatin|atorvastatin|mesh-list
64939962|NCT00018642|Haloperidol|haloperidol|mesh-list
64939963|NCT00018642|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64939964|NCT00018642|Haloperidol decanoate|haloperidol decanoate|mesh-list
64939965|NCT00018642|Antidepressive Agents|antidepressive agents|mesh-ancestor
64939966|NCT00018642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64939967|NCT00018642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64939968|NCT00018642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64939969|NCT00018642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64939970|NCT00018642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939971|NCT00018642|Antiemetics|antiemetics|mesh-ancestor
64939972|NCT00018642|Autonomic Agents|autonomic agents|mesh-ancestor
64939973|NCT00018642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64939974|NCT00018642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64939975|NCT00018642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64940007|NCT00018161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940009|NCT00018161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64940010|NCT00018161|Cholinergic Agents|cholinergic agents|mesh-ancestor
64940011|NCT00018161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64940012|NCT00018161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940013|NCT00018161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64940014|NCT00018161|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
64940015|NCT00018161|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64940034|NCT00018200|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64940035|NCT00018200|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64940036|NCT00018200|Adrenergic Agents|adrenergic agents|mesh-ancestor
64940037|NCT00018200|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64940038|NCT00018200|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64940039|NCT00018200|Parasympatholytics|parasympatholytics|mesh-ancestor
64940040|NCT00018200|Autonomic Agents|autonomic agents|mesh-ancestor
64940041|NCT00018200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64940042|NCT00018200|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64940043|NCT00018200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64940044|NCT00018200|Cholinergic Agents|cholinergic agents|mesh-ancestor
64529602|NCT00343083|Antimitotic Agents|antimitotic agents|mesh-ancestor
64529603|NCT00343083|Mitosis Modulators|mitosis modulators|mesh-ancestor
64529604|NCT00343083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529605|NCT00343083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64529607|NCT00343785|Cyclophosphamide|cyclophosphamide|mesh-list
64529608|NCT00343785|Methotrexate|methotrexate|mesh-list
64529609|NCT00343785|Cyclosporins|cyclosporins|mesh-list
64529610|NCT00343785|Thymoglobulin|thymoglobulin|mesh-list
64529611|NCT00343785|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64529612|NCT00343785|Immunoglobulins|immunoglobulins|mesh-list
64529613|NCT00343785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64529614|NCT00343785|Immunologic Factors|immunologic factors|mesh-ancestor
64529615|NCT00343785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529616|NCT00343785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64529617|NCT00343785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64529618|NCT00343785|Alkylating Agents|alkylating agents|mesh-ancestor
64529619|NCT00343785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529620|NCT00343785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529621|NCT00343785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64529622|NCT00343785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64529623|NCT00343785|Abortifacient Agents|abortifacient agents|mesh-ancestor
64529624|NCT00343785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64529625|NCT00343785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64529626|NCT00343785|Antimetabolites|antimetabolites|mesh-ancestor
64529627|NCT00343785|Dermatologic Agents|dermatologic agents|mesh-ancestor
64564769|NCT03828019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64564770|NCT03828019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64564771|NCT03828019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64564772|NCT03828019|Antifungal Agents|antifungal agents|mesh-ancestor
64564773|NCT03828019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64564774|NCT03828019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64564775|NCT03111485|Levodopa|levodopa|mesh-list
64940045|NCT00018200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64940046|NCT00018200|Dopamine Agents|dopamine agents|mesh-ancestor
64940047|NCT00018759|Paroxetine|paroxetine|mesh-list
64940048|NCT00018759|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64940053|NCT00018759|Serotonin Agents|serotonin agents|mesh-ancestor
64940054|NCT00018759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940055|NCT00018759|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64940056|NCT00018759|Antidepressive Agents|antidepressive agents|mesh-ancestor
64940057|NCT00018759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64940058|NCT00018759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64940059|NCT00018759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64940060|NCT00018759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64940062|NCT04734353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64940063|NCT04734353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64940064|NCT04734353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64940065|NCT04734353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64529629|NCT00343785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64529630|NCT00343785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64529631|NCT00343785|Antifungal Agents|antifungal agents|mesh-ancestor
64529632|NCT00343785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64529633|NCT00343785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64529634|NCT00343863|Dexamethasone|dexamethasone|mesh-list
64529635|NCT00343863|Cyclophosphamide|cyclophosphamide|mesh-list
64529636|NCT00343863|Doxorubicin|doxorubicin|mesh-list
64529637|NCT00343863|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64529638|NCT00343863|Ondansetron|ondansetron|mesh-list
64529639|NCT00343863|Palonosetron|palonosetron|mesh-list
64529640|NCT00343863|Antiemetics|antiemetics|mesh-list
64940066|NCT04734353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64940091|NCT00018954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64940092|NCT00018954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64940093|NCT00018954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64940094|NCT00018954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64940095|NCT00018954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64940096|NCT00018954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64940097|NCT00018954|Glucocorticoids|glucocorticoids|mesh-ancestor
64940098|NCT00018954|Hormones|hormones|mesh-ancestor
64945555|NCT05450692|Antimitotic Agents|antimitotic agents|mesh-ancestor
64708646|NCT02740543|Xhance|xhance|mesh-list
64940099|NCT00018954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64940100|NCT00018954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64940101|NCT00018954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64940102|NCT00018954|Abortifacient Agents|abortifacient agents|mesh-ancestor
64940103|NCT00018954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64940104|NCT00018954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64940105|NCT00018954|Antimetabolites|antimetabolites|mesh-ancestor
64940106|NCT00018954|Dermatologic Agents|dermatologic agents|mesh-ancestor
64940107|NCT00018954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64940108|NCT00018954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64940109|NCT00018954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64940110|NCT00018954|Antiviral Agents|antiviral agents|mesh-ancestor
64940111|NCT00018954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64940112|NCT00018954|Tubulin Modulators|tubulin modulators|mesh-ancestor
64940113|NCT00018954|Antimitotic Agents|antimitotic agents|mesh-ancestor
64940114|NCT00018954|Mitosis Modulators|mitosis modulators|mesh-ancestor
64940115|NCT00018278|Donepezil|donepezil|mesh-list
64940116|NCT00018278|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64940117|NCT00018278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64940126|NCT00019032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940128|NCT00019071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940129|NCT00019071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64564810|NCT01922375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64564811|NCT01922375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64564812|NCT01922375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64940130|NCT00019071|Immunologic Factors|immunologic factors|mesh-ancestor
64940131|NCT00019071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940132|NCT04734119|Anesthetics|anesthetics|mesh-list
64940133|NCT04734119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64940134|NCT04734119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940135|NCT00018356|Testosterone|testosterone|mesh-list
64940136|NCT00018356|Androgens|androgens|mesh-ancestor
64940137|NCT00018356|Hormones|hormones|mesh-ancestor
64940144|NCT00019188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64940145|NCT00019188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64940146|NCT00019188|Growth Substances|growth substances|mesh-ancestor
64529641|NCT00343863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64529642|NCT00343863|Immunologic Factors|immunologic factors|mesh-ancestor
64529643|NCT00343863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529644|NCT00343863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64529645|NCT00343863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64529646|NCT00343863|Alkylating Agents|alkylating agents|mesh-ancestor
64529647|NCT00343863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529648|NCT00343863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529649|NCT00343863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64529650|NCT00343863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64529651|NCT00343863|Autonomic Agents|autonomic agents|mesh-ancestor
64529652|NCT00343863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64529653|NCT00343863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64529654|NCT00343863|Glucocorticoids|glucocorticoids|mesh-ancestor
64529655|NCT00343863|Hormones|hormones|mesh-ancestor
64529656|NCT00343863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64529657|NCT00343863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64529658|NCT00343863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64529659|NCT00343863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64529660|NCT00343863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64529661|NCT00343863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529662|NCT00343863|Antipruritics|antipruritics|mesh-ancestor
64529663|NCT00343863|Dermatologic Agents|dermatologic agents|mesh-ancestor
64529664|NCT00343863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64529665|NCT00343863|Serotonin Agents|serotonin agents|mesh-ancestor
64529666|NCT00343863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64529667|NCT00343863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64529668|NCT00343863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64529669|NCT00343863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64529670|NCT00343863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64529671|NCT00343863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64529672|NCT00343863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64529673|NCT00344175|Simvastatin|simvastatin|mesh-list
64294354|NCT04500548|Ipilimumab|ipilimumab|mesh-list
64940147|NCT00019188|Growth Inhibitors|growth inhibitors|mesh-ancestor
64940148|NCT00019188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940149|NCT00019227|Calcium|calcium|mesh-list
64940150|NCT00019227|Daclizumab|daclizumab|mesh-list
64940151|NCT00019227|Pentetic Acid|pentetic acid|mesh-list
64940152|NCT00019227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64529674|NCT00344175|Pitavastatin|pitavastatin|mesh-list
64529675|NCT00344175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64529676|NCT00344175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64529677|NCT00344175|Antimetabolites|antimetabolites|mesh-ancestor
64529678|NCT00344175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529679|NCT00344175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64529680|NCT00344175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64294389|NCT00094016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64940153|NCT00019227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940154|NCT00019227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64940155|NCT00019227|Immunologic Factors|immunologic factors|mesh-ancestor
64940156|NCT00019227|Antidotes|antidotes|mesh-ancestor
64940157|NCT00019227|Protective Agents|protective agents|mesh-ancestor
64940158|NCT00019227|Chelating Agents|chelating agents|mesh-ancestor
64940159|NCT00019227|Sequestering Agents|sequestering agents|mesh-ancestor
64940160|NCT00019227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940161|NCT00019227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64940162|NCT04734041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64940163|NCT00019344|Alvocidib|alvocidib|mesh-list
64564813|NCT01922375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64564841|NCT03108131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564842|NCT01922687|Amlodipine|amlodipine|mesh-list
64564843|NCT01922687|Atorvastatin|atorvastatin|mesh-list
64564844|NCT01922687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64564845|NCT01922687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64940170|NCT00019344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940171|NCT00019383|Aldesleukin|aldesleukin|mesh-list
64940172|NCT00019383|Sargramostim|sargramostim|mesh-list
64940173|NCT00019383|Freund's Adjuvant|freund's adjuvant|mesh-list
64940174|NCT00019383|Immunologic Factors|immunologic factors|mesh-ancestor
64940175|NCT00019383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940176|NCT00019383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940178|NCT00019383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64940179|NCT00019383|Antiviral Agents|antiviral agents|mesh-ancestor
64940180|NCT00019383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64940181|NCT00019383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64940182|NCT00019422|Carboplatin|carboplatin|mesh-list
64940183|NCT00019422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940184|NCT00018551|Folic Acid|folic acid|mesh-list
64940185|NCT00018551|Hematinics|hematinics|mesh-ancestor
64940186|NCT00018551|Vitamin B Complex|vitamin b complex|mesh-ancestor
64940187|NCT00018551|Vitamins|vitamins|mesh-ancestor
64940207|NCT00019539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64940208|NCT00019539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940209|NCT00019539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64940210|NCT00019539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64940211|NCT00019539|Growth Substances|growth substances|mesh-ancestor
64940212|NCT00019539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940213|NCT00019539|Growth Inhibitors|growth inhibitors|mesh-ancestor
64940214|NCT00019539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64940215|NCT00019539|Immunologic Factors|immunologic factors|mesh-ancestor
64940216|NCT00019539|Leprostatic Agents|leprostatic agents|mesh-ancestor
64940217|NCT00019539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64940218|NCT00019539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64940219|NCT00019695|Alendronate|alendronate|mesh-list
64940220|NCT00019695|Ketoconazole|ketoconazole|mesh-list
64940221|NCT00019695|Antifungal Agents|antifungal agents|mesh-ancestor
64940222|NCT00019695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64940223|NCT00019695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64940224|NCT00019695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64940225|NCT00019695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64940226|NCT00019695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940227|NCT00019695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64940228|NCT00019695|Hormone Antagonists|hormone antagonists|mesh-ancestor
64940229|NCT00019695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64940230|NCT00019695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294394|NCT05134298|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64529681|NCT00344175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529682|NCT00345033|Aripiprazole|aripiprazole|mesh-list
64529683|NCT00345033|Antidepressive Agents|antidepressive agents|mesh-ancestor
64529684|NCT00345033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64529685|NCT00345033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64529686|NCT00345033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64529687|NCT00345033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64529688|NCT00345033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529689|NCT00345033|Dopamine Agonists|dopamine agonists|mesh-ancestor
64529690|NCT00345033|Dopamine Agents|dopamine agents|mesh-ancestor
64529691|NCT00345033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64529692|NCT00345033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529693|NCT00345033|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64529694|NCT00345033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64529695|NCT00345033|Serotonin Agents|serotonin agents|mesh-ancestor
64529696|NCT00345033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64529697|NCT00345033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64529698|NCT00345033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64529699|NCT00345033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64529700|NCT00345969|Testosterone|testosterone|mesh-list
64651313|NCT00837590|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
64564846|NCT01922687|Antimetabolites|antimetabolites|mesh-ancestor
64564847|NCT01922687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940234|NCT00019734|Vaccines|vaccines|mesh-list
64940235|NCT00019734|Immunologic Factors|immunologic factors|mesh-ancestor
64940236|NCT00019734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940237|NCT00019734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940238|NCT00019734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64940253|NCT03370406|Antimetabolites|antimetabolites|mesh-ancestor
64940254|NCT03370406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940255|NCT03370406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64940256|NCT03370406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940257|NCT03370406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64940258|NCT03370406|Immunologic Factors|immunologic factors|mesh-ancestor
64940259|NCT03370406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940260|NCT03370406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64940261|NCT03370406|Interferon Inducers|interferon inducers|mesh-ancestor
64940262|NCT00019812|Paclitaxel|paclitaxel|mesh-list
64940263|NCT00019812|Trastuzumab|trastuzumab|mesh-list
64940264|NCT00019812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64940265|NCT00019812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940266|NCT00019812|Tubulin Modulators|tubulin modulators|mesh-ancestor
64940267|NCT00019812|Antimitotic Agents|antimitotic agents|mesh-ancestor
64940268|NCT00019812|Mitosis Modulators|mitosis modulators|mesh-ancestor
64940269|NCT00019812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940270|NCT00019812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64940271|NCT03326063|Ifetroban|ifetroban|mesh-list
64940272|NCT03326063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64940273|NCT00019890|Sargramostim|sargramostim|mesh-list
64529701|NCT00345969|Androgens|androgens|mesh-ancestor
64529702|NCT00345969|Hormones|hormones|mesh-ancestor
64529703|NCT00345969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64529704|NCT00345969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529705|NCT01498445|Decitabine|decitabine|mesh-list
64529706|NCT01498445|Dasatinib|dasatinib|mesh-list
64529707|NCT01498445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64529708|NCT01498445|Antimetabolites|antimetabolites|mesh-ancestor
64529709|NCT01498445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529710|NCT01498445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529711|NCT01498445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529712|NCT01498445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64529713|NCT01525615|Tiotropium Bromide|tiotropium bromide|mesh-list
64529714|NCT01525615|Olodaterol|olodaterol|mesh-list
64529715|NCT01525615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64529716|NCT01525615|Autonomic Agents|autonomic agents|mesh-ancestor
64529717|NCT01525615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64529718|NCT01525615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940274|NCT00019890|Immunologic Factors|immunologic factors|mesh-ancestor
64940275|NCT00019890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940276|NCT00019968|Melphalan|melphalan|mesh-list
64940277|NCT00019968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64940278|NCT00019968|Alkylating Agents|alkylating agents|mesh-ancestor
64940279|NCT00019968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940280|NCT00019968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940281|NCT00019968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64940282|NCT00019968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64940283|NCT00019968|Immunologic Factors|immunologic factors|mesh-ancestor
64940284|NCT00019968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940285|NCT00020007|Paclitaxel|paclitaxel|mesh-list
64940286|NCT00020007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64940287|NCT00020007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940288|NCT00020007|Tubulin Modulators|tubulin modulators|mesh-ancestor
64940289|NCT00020007|Antimitotic Agents|antimitotic agents|mesh-ancestor
64940290|NCT00020007|Mitosis Modulators|mitosis modulators|mesh-ancestor
64940291|NCT00020007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940292|NCT00142454|Imiquimod|imiquimod|mesh-list
64940293|NCT00142454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64940294|NCT00142454|Immunologic Factors|immunologic factors|mesh-ancestor
64940295|NCT00142454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940296|NCT00142454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940335|NCT05576675|Sensory System Agents|sensory system agents|mesh-ancestor
64940336|NCT05576675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64940337|NCT05576675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64564848|NCT01922687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64564849|NCT01922687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64564850|NCT01922687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64940338|NCT05576675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64940339|NCT05576675|Anesthetics, General|anesthetics, general|mesh-ancestor
64940340|NCT05576675|Anesthetics|anesthetics|mesh-ancestor
64940341|NCT00020358|Aldesleukin|aldesleukin|mesh-list
64940342|NCT00020358|Freund's Adjuvant|freund's adjuvant|mesh-list
64940343|NCT00020358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940344|NCT00020358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64294431|NCT02036125|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64529719|NCT01525615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64529720|NCT01525615|Respiratory System Agents|respiratory system agents|mesh-ancestor
64529722|NCT01525615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64484196|NCT04795336|Protective Agents|protective agents|mesh-ancestor
64529723|NCT01525615|Cholinergic Agents|cholinergic agents|mesh-ancestor
64529724|NCT01525615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64529725|NCT01525615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294433|NCT02036125|Prednisolone|prednisolone|mesh-list
64940345|NCT00020358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64940346|NCT00020358|Antiviral Agents|antiviral agents|mesh-ancestor
64940382|NCT00020631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940383|NCT00020670|Vaccines|vaccines|mesh-list
64940384|NCT00020670|Immunologic Factors|immunologic factors|mesh-ancestor
64940385|NCT00020670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940386|NCT05576324|Ivacaftor|ivacaftor|mesh-list
64940387|NCT05576324|Elexacaftor|elexacaftor|mesh-list
64940414|NCT00020787|Cisplatin|cisplatin|mesh-list
64940415|NCT00020787|Fluorouracil|fluorouracil|mesh-list
64940416|NCT00020787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940417|NCT00020787|Antimetabolites|antimetabolites|mesh-ancestor
64940418|NCT00020787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940419|NCT00020787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64940420|NCT00020787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64940421|NCT00020787|Immunologic Factors|immunologic factors|mesh-ancestor
64940422|NCT00020787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940423|NCT00020865|Levofloxacin|levofloxacin|mesh-list
64940424|NCT00020865|Ofloxacin|ofloxacin|mesh-list
64940425|NCT00020865|Cefepime|cefepime|mesh-list
64940426|NCT00020865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64940427|NCT00020865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64940428|NCT00020865|Renal Agents|renal agents|mesh-ancestor
64940429|NCT00020865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64940430|NCT00020865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64940431|NCT00020865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64940432|NCT00020865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64940433|NCT00020865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940434|NCT00020865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940435|NCT00020865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64940436|NCT00020865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64940437|NCT00020943|Leucovorin|leucovorin|mesh-list
64940448|NCT00020943|Levoleucovorin|levoleucovorin|mesh-list
64940449|NCT00020943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64940450|NCT00020943|Immunologic Factors|immunologic factors|mesh-ancestor
64940451|NCT00020943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940452|NCT00020943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64940453|NCT00020943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64940454|NCT00020943|Alkylating Agents|alkylating agents|mesh-ancestor
64940455|NCT00020943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940456|NCT00020943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940457|NCT00020943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64940458|NCT00020943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64940459|NCT00020943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64940467|NCT00020943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64940468|NCT00020943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64529726|NCT00309465|Insulin|insulin|mesh-list
64529727|NCT00309465|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64529728|NCT00309465|Insulin Glargine|insulin glargine|mesh-list
64529729|NCT00309465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64529730|NCT00309465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529731|NCT01791699|Moxonidine|moxonidine|mesh-list
64529732|NCT01791699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64529733|NCT00302133|Naltrexone|naltrexone|mesh-list
64564851|NCT01922687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64564852|NCT01922687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64564853|NCT01922687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64564854|NCT01922687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64564855|NCT01922687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529734|NCT00302133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64529735|NCT00302133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64294440|NCT02036125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64940470|NCT00020943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64940471|NCT00020943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64940472|NCT00020943|Antimetabolites|antimetabolites|mesh-ancestor
64940473|NCT00020943|Dermatologic Agents|dermatologic agents|mesh-ancestor
64940474|NCT00020943|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64940475|NCT00020943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64940476|NCT00020943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64940477|NCT00020943|Antiviral Agents|antiviral agents|mesh-ancestor
64940478|NCT00020943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64940479|NCT00020943|Antidotes|antidotes|mesh-ancestor
64940480|NCT00020943|Protective Agents|protective agents|mesh-ancestor
64940481|NCT00020943|Vitamin B Complex|vitamin b complex|mesh-ancestor
64940482|NCT00020943|Vitamins|vitamins|mesh-ancestor
64940483|NCT00020943|Micronutrients|micronutrients|mesh-ancestor
64940484|NCT00020943|Tubulin Modulators|tubulin modulators|mesh-ancestor
64940485|NCT00020943|Antimitotic Agents|antimitotic agents|mesh-ancestor
64940486|NCT00020943|Mitosis Modulators|mitosis modulators|mesh-ancestor
64940487|NCT00021060|Paclitaxel|paclitaxel|mesh-list
64940488|NCT00021060|Bevacizumab|bevacizumab|mesh-list
64940489|NCT00021060|Carboplatin|carboplatin|mesh-list
64940490|NCT00021060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64940491|NCT00021060|Antibodies|antibodies|mesh-list
64940492|NCT00021060|Immunoglobulins|immunoglobulins|mesh-list
64940493|NCT00021060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64940494|NCT00021060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64940495|NCT00021060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940496|NCT00021060|Tubulin Modulators|tubulin modulators|mesh-ancestor
64940497|NCT00021060|Antimitotic Agents|antimitotic agents|mesh-ancestor
64940498|NCT00021060|Mitosis Modulators|mitosis modulators|mesh-ancestor
64940499|NCT00021060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940500|NCT00021060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64940501|NCT00021060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64940502|NCT00021060|Growth Substances|growth substances|mesh-ancestor
64940503|NCT00021060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940504|NCT00021060|Growth Inhibitors|growth inhibitors|mesh-ancestor
64940528|NCT00021138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64940529|NCT00021138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940531|NCT00021138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64940532|NCT00021138|Cholinergic Agents|cholinergic agents|mesh-ancestor
64940533|NCT00021138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64940534|NCT00021138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940535|NCT05574179|Midazolam|midazolam|mesh-list
64940536|NCT05574179|Dexmedetomidine|dexmedetomidine|mesh-list
64940537|NCT05574179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64940538|NCT05574179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64940539|NCT05574179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940540|NCT05574179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64940541|NCT05574179|Analgesics|analgesics|mesh-ancestor
64940545|NCT05574179|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64940546|NCT05574179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64940547|NCT05574179|Adrenergic Agents|adrenergic agents|mesh-ancestor
64940548|NCT05574179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64529737|NCT00302133|Sensory System Agents|sensory system agents|mesh-ancestor
64529738|NCT00302133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64529739|NCT01525225|Metformin|metformin|mesh-list
64529740|NCT01525225|Saxagliptin|saxagliptin|mesh-list
64529741|NCT01525225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64529742|NCT01525225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529743|NCT01525225|Incretins|incretins|mesh-ancestor
64529744|NCT01525225|Hormones|hormones|mesh-ancestor
64529745|NCT01525225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64529746|NCT01525225|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64564856|NCT01922687|Vasodilator Agents|vasodilator agents|mesh-ancestor
64564858|NCT01922765|Metronidazole|metronidazole|mesh-list
64564859|NCT01922765|Clarithromycin|clarithromycin|mesh-list
64564860|NCT01922765|Rabeprazole|rabeprazole|mesh-list
64564861|NCT01922765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64564862|NCT01922765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64564889|NCT01923077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64564890|NCT01923077|Antimetabolites|antimetabolites|mesh-ancestor
64564891|NCT01923077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564892|NCT01923077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64564893|NCT01923077|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64564894|NCT01923077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529747|NCT01525225|Protease Inhibitors|protease inhibitors|mesh-ancestor
64529748|NCT01525225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529749|NCT01525225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529750|NCT00304161|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64529751|NCT00304161|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64294448|NCT02036125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64940549|NCT05574179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940550|NCT05574179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64940551|NCT05574179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64940552|NCT05574179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64709047|NCT02768558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64940553|NCT05574179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64940554|NCT05574179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64940579|NCT00021333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940580|NCT00021333|Tubulin Modulators|tubulin modulators|mesh-ancestor
64940581|NCT00021333|Antimitotic Agents|antimitotic agents|mesh-ancestor
64940582|NCT00021333|Mitosis Modulators|mitosis modulators|mesh-ancestor
64940583|NCT00021333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940584|NCT00021372|Paclitaxel|paclitaxel|mesh-list
64940585|NCT00021372|Estramustine|estramustine|mesh-list
64940586|NCT00021372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64940587|NCT00021372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940588|NCT00021372|Tubulin Modulators|tubulin modulators|mesh-ancestor
64940589|NCT00021372|Antimitotic Agents|antimitotic agents|mesh-ancestor
64940590|NCT00021372|Mitosis Modulators|mitosis modulators|mesh-ancestor
64940591|NCT00021372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940592|NCT00021372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64940593|NCT00021372|Alkylating Agents|alkylating agents|mesh-ancestor
64940594|NCT00021372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64940595|NCT00392093|Estrogens|estrogens|mesh-list
64940596|NCT00392093|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64940597|NCT00392093|Hormones|hormones|mesh-ancestor
64940598|NCT00392093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64940599|NCT00392093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940600|NCT00021450|Goserelin|goserelin|mesh-list
64940601|NCT00021450|Bicalutamide|bicalutamide|mesh-list
64940602|NCT00021450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64940603|NCT00021450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940604|NCT00021450|Androgen Antagonists|androgen antagonists|mesh-ancestor
64940605|NCT00021450|Hormone Antagonists|hormone antagonists|mesh-ancestor
64940606|NCT00021450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64940634|NCT00021528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940635|NCT00021528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64529752|NCT00304161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64529753|NCT00304161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64529754|NCT00304161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529755|NCT00304161|Adrenergic Agents|adrenergic agents|mesh-ancestor
64529756|NCT00304161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64564895|NCT01269801|Botulinum Toxins|botulinum toxins|mesh-list
64564896|NCT01269801|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64564897|NCT01269801|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64564898|NCT01269801|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64564899|NCT01269801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64564900|NCT01269801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529757|NCT00304161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940636|NCT00021528|Serotonin Agents|serotonin agents|mesh-ancestor
64940637|NCT00021528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651336|NCT00837902|Adrenergic Agents|adrenergic agents|mesh-ancestor
64940642|NCT00021528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64940643|NCT00021528|Histamine Antagonists|histamine antagonists|mesh-ancestor
64940645|NCT00021528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64940646|NCT00021528|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64940647|NCT00021528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64940648|NCT00021528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64940649|NCT00021528|Adrenergic Agents|adrenergic agents|mesh-ancestor
64940650|NCT00021528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64940651|NCT00021528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64940652|NCT00021528|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64940684|NCT00021996|Sensory System Agents|sensory system agents|mesh-ancestor
64940685|NCT00021996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64940686|NCT00021996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940687|NCT00021996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64940688|NCT00021996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64940689|NCT00022074|Gabapentin|gabapentin|mesh-list
64940690|NCT00022074|Analgesics|analgesics|mesh-ancestor
64940691|NCT00022074|Sensory System Agents|sensory system agents|mesh-ancestor
64940692|NCT00022074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64940693|NCT00022074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940694|NCT00022074|Anticonvulsants|anticonvulsants|mesh-ancestor
64940695|NCT00022074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64940696|NCT00022074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64940729|NCT00022230|Cyclophosphamide|cyclophosphamide|mesh-list
64940730|NCT00022230|Doxorubicin|doxorubicin|mesh-list
64940731|NCT00022230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64940732|NCT00022230|Sargramostim|sargramostim|mesh-list
64940733|NCT00022230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64940734|NCT00022230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940735|NCT00022230|Tubulin Modulators|tubulin modulators|mesh-ancestor
64940736|NCT00022230|Antimitotic Agents|antimitotic agents|mesh-ancestor
64940737|NCT00022230|Mitosis Modulators|mitosis modulators|mesh-ancestor
64940772|NCT00022464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64940773|NCT00022464|Immunologic Factors|immunologic factors|mesh-ancestor
64940774|NCT00022464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940807|NCT00022620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64940808|NCT00022620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940809|NCT00022620|Tubulin Modulators|tubulin modulators|mesh-ancestor
64940810|NCT00022620|Antimitotic Agents|antimitotic agents|mesh-ancestor
64940811|NCT00022620|Mitosis Modulators|mitosis modulators|mesh-ancestor
64940812|NCT00022620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940813|NCT00022737|Leucovorin|leucovorin|mesh-list
64940814|NCT00022737|Cytarabine|cytarabine|mesh-list
64940815|NCT00022737|Cyclosporine|cyclosporine|mesh-list
64940816|NCT00022737|Dexamethasone|dexamethasone|mesh-list
64940817|NCT00022737|Cyclophosphamide|cyclophosphamide|mesh-list
64940818|NCT00022737|Ifosfamide|ifosfamide|mesh-list
64940819|NCT00022737|Methotrexate|methotrexate|mesh-list
64940820|NCT00022737|Etoposide|etoposide|mesh-list
64940845|NCT00022737|Hormones|hormones|mesh-ancestor
64529759|NCT02660580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64529761|NCT01524991|Gemcitabine|gemcitabine|mesh-list
64529762|NCT01524991|Ipilimumab|ipilimumab|mesh-list
64529763|NCT01524991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529764|NCT01524991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64529765|NCT01524991|Antimetabolites|antimetabolites|mesh-ancestor
64529766|NCT01524991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529767|NCT01524991|Antiviral Agents|antiviral agents|mesh-ancestor
64529768|NCT01524991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64294473|NCT05704933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64564901|NCT01269801|Cholinergic Agents|cholinergic agents|mesh-ancestor
64564902|NCT01269801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64564903|NCT01269801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564904|NCT01269801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64564905|NCT01269801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64564906|NCT01297335|Clonidine|clonidine|mesh-list
64294474|NCT05704933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651339|NCT00891176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64940846|NCT00022737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64940847|NCT00022737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64940848|NCT00022737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64940849|NCT00022737|Abortifacient Agents|abortifacient agents|mesh-ancestor
64940856|NCT00022737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64945556|NCT05450692|Mitosis Modulators|mitosis modulators|mesh-ancestor
64940857|NCT00022737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64940858|NCT00022737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64940859|NCT00022737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64940860|NCT00022737|Antiviral Agents|antiviral agents|mesh-ancestor
64940861|NCT00022737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64940862|NCT00022737|Antidotes|antidotes|mesh-ancestor
64940863|NCT00022737|Protective Agents|protective agents|mesh-ancestor
64940864|NCT00022737|Vitamin B Complex|vitamin b complex|mesh-ancestor
64940865|NCT00022737|Vitamins|vitamins|mesh-ancestor
64940866|NCT00022737|Micronutrients|micronutrients|mesh-ancestor
64940867|NCT00022737|Tubulin Modulators|tubulin modulators|mesh-ancestor
64940868|NCT00022737|Antimitotic Agents|antimitotic agents|mesh-ancestor
64940869|NCT00022737|Mitosis Modulators|mitosis modulators|mesh-ancestor
64940870|NCT00022737|Antifungal Agents|antifungal agents|mesh-ancestor
64940871|NCT00022737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64940872|NCT00022737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64940895|NCT05512754|Sensory System Agents|sensory system agents|mesh-ancestor
64940896|NCT05512754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64940897|NCT05512754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940898|NCT05512754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64940899|NCT05512754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64940900|NCT05512754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64940901|NCT05512754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64940902|NCT05512754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940903|NCT02971878|Thioctic Acid|thioctic acid|mesh-list
64940904|NCT02971878|Acetylcarnitine|acetylcarnitine|mesh-list
64940905|NCT02971878|Acetylcysteine|acetylcysteine|mesh-list
64940906|NCT02971878|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64940907|NCT02971878|Antioxidants|antioxidants|mesh-ancestor
64940908|NCT02971878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940909|NCT02971878|Protective Agents|protective agents|mesh-ancestor
64940910|NCT02971878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940911|NCT02971878|Vitamin B Complex|vitamin b complex|mesh-ancestor
64940913|NCT02971878|Micronutrients|micronutrients|mesh-ancestor
64940914|NCT02971878|Nootropic Agents|nootropic agents|mesh-ancestor
64940915|NCT02971878|Antiviral Agents|antiviral agents|mesh-ancestor
64940916|NCT02971878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64940917|NCT02971878|Expectorants|expectorants|mesh-ancestor
64529769|NCT01524991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529770|NCT01524991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64529771|NCT01524991|Immunologic Factors|immunologic factors|mesh-ancestor
64529772|NCT01524991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529773|NCT01524991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64529774|NCT01524991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64529775|NCT04039230|Talazoparib|talazoparib|mesh-list
64529776|NCT04039230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64529777|NCT04039230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529778|NCT04039230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529779|NCT04039230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529780|NCT01524913|Hyaluronic Acid|hyaluronic acid|mesh-list
64529781|NCT01524913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64529782|NCT01524913|Immunologic Factors|immunologic factors|mesh-ancestor
64529783|NCT01524913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529784|NCT01524913|Viscosupplements|viscosupplements|mesh-ancestor
64529785|NCT01524913|Protective Agents|protective agents|mesh-ancestor
64564907|NCT01297335|Analgesics|analgesics|mesh-ancestor
64564967|NCT01929941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64564968|NCT01929941|Antimetabolites|antimetabolites|mesh-ancestor
64564969|NCT01929941|Antiviral Agents|antiviral agents|mesh-ancestor
64529786|NCT02376192|Phenylephrine|phenylephrine|mesh-list
64529787|NCT02376192|Oxymetazoline|oxymetazoline|mesh-list
64529788|NCT02376192|Ephedrine|ephedrine|mesh-list
64529789|NCT02376192|Bupivacaine|bupivacaine|mesh-list
64529790|NCT02376192|Anesthetics, Local|anesthetics, local|mesh-ancestor
64529791|NCT02376192|Anesthetics|anesthetics|mesh-ancestor
64529792|NCT02376192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64651345|NCT00839540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64940918|NCT02971878|Respiratory System Agents|respiratory system agents|mesh-ancestor
64940919|NCT02971878|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64940920|NCT02971878|Antidotes|antidotes|mesh-ancestor
64940921|NCT00023166|Paclitaxel|paclitaxel|mesh-list
64940922|NCT00023166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64940923|NCT00023166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940924|NCT00023166|Tubulin Modulators|tubulin modulators|mesh-ancestor
64940925|NCT00023166|Antimitotic Agents|antimitotic agents|mesh-ancestor
64940926|NCT00023166|Mitosis Modulators|mitosis modulators|mesh-ancestor
64940927|NCT00023166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940962|NCT00023244|Sulfamethoxazole|sulfamethoxazole|mesh-list
64940963|NCT00023244|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64940964|NCT00023244|Prednisone|prednisone|mesh-list
64940965|NCT00023244|Methylprednisolone|methylprednisolone|mesh-list
64940966|NCT00023244|Tacrolimus|tacrolimus|mesh-list
64940967|NCT00023244|Cyclosporins|cyclosporins|mesh-list
64940968|NCT00023244|Basiliximab|basiliximab|mesh-list
64940969|NCT00023244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64940997|NCT00023244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64940998|NCT00023244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64940999|NCT00023244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64529797|NCT02376192|Mydriatics|mydriatics|mesh-ancestor
64529798|NCT02376192|Autonomic Agents|autonomic agents|mesh-ancestor
64529799|NCT02376192|Sympathomimetics|sympathomimetics|mesh-ancestor
64529800|NCT02376192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64529801|NCT02376192|Nasal Decongestants|nasal decongestants|mesh-ancestor
64941000|NCT00023244|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64941001|NCT00023244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64941002|NCT00023283|Buprenorphine|buprenorphine|mesh-list
64941003|NCT00023283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64941004|NCT00023283|Narcotics|narcotics|mesh-ancestor
64941005|NCT00023283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64941006|NCT00023283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941007|NCT00023283|Analgesics|analgesics|mesh-ancestor
64941008|NCT00023283|Sensory System Agents|sensory system agents|mesh-ancestor
64941009|NCT00023283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64941010|NCT00023283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64941011|NCT00023361|Rifabutin|rifabutin|mesh-list
64941012|NCT00023361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64941013|NCT00023361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64941014|NCT00023361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64941015|NCT00023361|Antitubercular Agents|antitubercular agents|mesh-ancestor
64941016|NCT00023400|Nelfinavir|nelfinavir|mesh-list
64941017|NCT00023400|Rifabutin|rifabutin|mesh-list
64941041|NCT00023751|Calcium|calcium|mesh-list
64941042|NCT00023751|Levoleucovorin|levoleucovorin|mesh-list
64941043|NCT00023751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64941044|NCT00023751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941045|NCT00023751|Antimetabolites|antimetabolites|mesh-ancestor
64941046|NCT00023751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941047|NCT00023751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64941048|NCT00023751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941049|NCT00023751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64941050|NCT00023751|Immunologic Factors|immunologic factors|mesh-ancestor
64941051|NCT00023751|Antidotes|antidotes|mesh-ancestor
64941052|NCT00023751|Protective Agents|protective agents|mesh-ancestor
64941053|NCT00023751|Vitamin B Complex|vitamin b complex|mesh-ancestor
64941054|NCT00023751|Vitamins|vitamins|mesh-ancestor
64941055|NCT00023751|Micronutrients|micronutrients|mesh-ancestor
64941056|NCT00023790|Silicon|silicon|mesh-list
64941057|NCT00023790|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
64941058|NCT00023790|Trace Elements|trace elements|mesh-ancestor
64941059|NCT00023790|Micronutrients|micronutrients|mesh-ancestor
64941060|NCT00023790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564970|NCT01929941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64564971|NCT01929941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64564972|NCT01929941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64564973|NCT01929941|Immunologic Factors|immunologic factors|mesh-ancestor
64941061|NCT00023790|Antimalarials|antimalarials|mesh-ancestor
64941062|NCT00023790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64941063|NCT00023790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64941064|NCT00023790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64941065|NCT00023790|Antiviral Agents|antiviral agents|mesh-ancestor
64941066|NCT00023790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64941067|NCT00023790|Dermatologic Agents|dermatologic agents|mesh-ancestor
64941068|NCT02971982|Dexamethasone|dexamethasone|mesh-list
64651352|NCT02964182|Nicotine|nicotine|mesh-list
64941100|NCT00023829|Androgen Antagonists|androgen antagonists|mesh-ancestor
64941101|NCT00023829|Hormone Antagonists|hormone antagonists|mesh-ancestor
64941102|NCT00023829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941103|NCT00023829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64941104|NCT00023868|Leucovorin|leucovorin|mesh-list
64941105|NCT00023868|Doxorubicin|doxorubicin|mesh-list
64941106|NCT00023868|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64941107|NCT00023868|Fluorouracil|fluorouracil|mesh-list
64941108|NCT00023868|Irinotecan|irinotecan|mesh-list
64941109|NCT00023868|Mitomycins|mitomycins|mesh-list
64941110|NCT00023868|Mitomycin|mitomycin|mesh-list
64941111|NCT00023868|Levoleucovorin|levoleucovorin|mesh-list
64941112|NCT00023868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941113|NCT00023868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64941114|NCT00023868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64941115|NCT00023868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64529802|NCT02376192|Respiratory System Agents|respiratory system agents|mesh-ancestor
64529803|NCT02376192|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64529804|NCT02376192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64529805|NCT02376192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64529806|NCT02376192|Adrenergic Agents|adrenergic agents|mesh-ancestor
64529807|NCT02376192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64529808|NCT02376192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529809|NCT02376192|Protective Agents|protective agents|mesh-ancestor
64529810|NCT02376192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64529811|NCT02037126|Diphenhydramine|diphenhydramine|mesh-list
64529813|NCT02037126|Psilocybin|psilocybin|mesh-list
64529814|NCT02037126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64529815|NCT02037126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64529816|NCT02037126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64294513|NCT05121038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294514|NCT05121038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64294515|NCT05121038|Immunologic Factors|immunologic factors|mesh-ancestor
64941116|NCT00023868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941117|NCT00023868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941118|NCT00023868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941119|NCT00023868|Antimetabolites|antimetabolites|mesh-ancestor
64941120|NCT00023868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64941121|NCT00023868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64941122|NCT00023868|Immunologic Factors|immunologic factors|mesh-ancestor
64941123|NCT00023868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64941124|NCT00023868|Antidotes|antidotes|mesh-ancestor
64941155|NCT00024141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941156|NCT00024141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64941157|NCT00024141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941158|NCT00024141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64941159|NCT00024141|Immunologic Factors|immunologic factors|mesh-ancestor
64941160|NCT00024141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941161|NCT00024141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64941162|NCT00024141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64941163|NCT00024141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941164|NCT05239286|Anesthetics|anesthetics|mesh-list
64941165|NCT05239286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64941166|NCT05239286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941167|NCT00024180|Romidepsin|romidepsin|mesh-list
64941168|NCT00024180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64941169|NCT00024180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941170|NCT00024297|Warfarin|warfarin|mesh-list
64941171|NCT00024297|Anticoagulants|anticoagulants|mesh-ancestor
64941199|NCT00024492|Mitoxantrone|mitoxantrone|mesh-list
64941200|NCT00024492|Analgesics|analgesics|mesh-ancestor
64564974|NCT01929941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564975|NCT01920737|Leucovorin|leucovorin|mesh-list
64517230|NCT02020408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64941201|NCT00024492|Sensory System Agents|sensory system agents|mesh-ancestor
64941202|NCT00024492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64941211|NCT00024531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64529817|NCT02037126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529818|NCT02037126|Anesthetics, Local|anesthetics, local|mesh-ancestor
64529819|NCT02037126|Anesthetics|anesthetics|mesh-ancestor
64529820|NCT02037126|Sensory System Agents|sensory system agents|mesh-ancestor
64529821|NCT02037126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64529822|NCT02037126|Antiemetics|antiemetics|mesh-ancestor
64529823|NCT02037126|Autonomic Agents|autonomic agents|mesh-ancestor
64529824|NCT02037126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64529825|NCT02037126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64529826|NCT02037126|Histamine Antagonists|histamine antagonists|mesh-ancestor
64294529|NCT05097794|Natriuretic Agents|natriuretic agents|mesh-ancestor
64294534|NCT02036281|Substance P|substance p|mesh-list
64941212|NCT00024531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941213|NCT00024531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64941214|NCT00024531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64941215|NCT00024531|Antimetabolites|antimetabolites|mesh-ancestor
64941216|NCT00024531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941241|NCT00025038|Immunologic Factors|immunologic factors|mesh-ancestor
64941242|NCT00025038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941244|NCT00025038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64941245|NCT00025038|Alkylating Agents|alkylating agents|mesh-ancestor
64941246|NCT00025038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941247|NCT00025038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941248|NCT00025038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64941249|NCT00025038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64941250|NCT00025038|Antimetabolites|antimetabolites|mesh-ancestor
64941251|NCT00025038|Antiviral Agents|antiviral agents|mesh-ancestor
64941252|NCT00025038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64941253|NCT00025038|Dermatologic Agents|dermatologic agents|mesh-ancestor
64941254|NCT05055830|Acetaminophen|acetaminophen|mesh-list
64941255|NCT05055830|Methadone|methadone|mesh-list
64941256|NCT05055830|Caffeine|caffeine|mesh-list
64941257|NCT05055830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64941258|NCT05055830|Analgesics|analgesics|mesh-ancestor
64941259|NCT05055830|Sensory System Agents|sensory system agents|mesh-ancestor
64941260|NCT05055830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64941261|NCT05055830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941262|NCT05055830|Antipyretics|antipyretics|mesh-ancestor
64941263|NCT05055830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64941264|NCT05055830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64941265|NCT05055830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941266|NCT05055830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941267|NCT05055830|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64941268|NCT05055830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64941269|NCT05055830|Purinergic Agents|purinergic agents|mesh-ancestor
64941270|NCT05055830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64941271|NCT05055830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64941289|NCT05051891|Cyclophosphamide|cyclophosphamide|mesh-list
64941290|NCT05051891|Vincristine|vincristine|mesh-list
64941291|NCT05051891|Rituximab|rituximab|mesh-list
64941292|NCT05051891|Doxorubicin|doxorubicin|mesh-list
64941293|NCT05051891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64941294|NCT05051891|Immunologic Factors|immunologic factors|mesh-ancestor
64941295|NCT05051891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941296|NCT05051891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64941297|NCT05051891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64941298|NCT05051891|Alkylating Agents|alkylating agents|mesh-ancestor
64941299|NCT05051891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941304|NCT05051891|Hormones|hormones|mesh-ancestor
64941305|NCT05051891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64529827|NCT02037126|Histamine Agents|histamine agents|mesh-ancestor
64529828|NCT02037126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64529829|NCT02037126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529830|NCT02037126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64529831|NCT02037126|Antipruritics|antipruritics|mesh-ancestor
64529832|NCT02037126|Dermatologic Agents|dermatologic agents|mesh-ancestor
64517231|NCT02020408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64517232|NCT02020408|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64564976|NCT01920737|Cytarabine|cytarabine|mesh-list
64564977|NCT01920737|Dexamethasone|dexamethasone|mesh-list
64564978|NCT01920737|Prednisone|prednisone|mesh-list
64564979|NCT01920737|Cyclophosphamide|cyclophosphamide|mesh-list
64564980|NCT01920737|Methotrexate|methotrexate|mesh-list
64564981|NCT01920737|Vincristine|vincristine|mesh-list
64564982|NCT01920737|Daunorubicin|daunorubicin|mesh-list
64564983|NCT01920737|Asparaginase|asparaginase|mesh-list
64564984|NCT01920737|Mercaptopurine|mercaptopurine|mesh-list
64564985|NCT01920737|Pegaspargase|pegaspargase|mesh-list
64564986|NCT01920737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64564987|NCT01920737|Immunologic Factors|immunologic factors|mesh-ancestor
64564988|NCT01920737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564989|NCT01920737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64565021|NCT01920737|Tubulin Modulators|tubulin modulators|mesh-ancestor
64565022|NCT01920737|Antimitotic Agents|antimitotic agents|mesh-ancestor
64565023|NCT01920737|Mitosis Modulators|mitosis modulators|mesh-ancestor
64565024|NCT01920737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64565025|NCT01920737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64565026|NCT01920737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64565027|NCT01922843|Calcitriol|calcitriol|mesh-list
64565028|NCT01922843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64565029|NCT01922843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565030|NCT01922843|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64565031|NCT01922843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64565032|NCT01922843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565033|NCT01922843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64565071|NCT01279317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64565072|NCT01279317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64565074|NCT01304589|Levomilnacipran|levomilnacipran|mesh-list
64565107|NCT01926197|Vitamin B Complex|vitamin b complex|mesh-ancestor
64565108|NCT01926197|Vitamins|vitamins|mesh-ancestor
64565118|NCT01925027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64565152|NCT01307007|Blood Substitutes|blood substitutes|mesh-ancestor
64565153|NCT01307007|Hematinics|hematinics|mesh-ancestor
64565155|NCT02197455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64565156|NCT02197455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565157|NCT02197455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529833|NCT02037126|Hallucinogens|hallucinogens|mesh-ancestor
64529834|NCT02037126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64529835|NCT02375880|Gemcitabine|gemcitabine|mesh-list
64529836|NCT02375880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529837|NCT02375880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64529838|NCT02375880|Antimetabolites|antimetabolites|mesh-ancestor
64294536|NCT02036281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64941306|NCT05051891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64941307|NCT05051891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64941308|NCT05051891|Tubulin Modulators|tubulin modulators|mesh-ancestor
64941309|NCT05051891|Antimitotic Agents|antimitotic agents|mesh-ancestor
64941310|NCT05051891|Mitosis Modulators|mitosis modulators|mesh-ancestor
64941311|NCT05051891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64941312|NCT05051891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64941313|NCT05051891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64941314|NCT05051891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64941315|NCT05051891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941316|NCT00025116|Gefitinib|gefitinib|mesh-list
64941317|NCT00025116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941318|NCT00025116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64941319|NCT00025116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941320|NCT00025116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941321|NCT00025194|Estramustine|estramustine|mesh-list
64941322|NCT00025194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64941323|NCT00025194|Alkylating Agents|alkylating agents|mesh-ancestor
64941324|NCT00025194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941325|NCT00025194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941326|NCT00025194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64941327|NCT00025272|Carboplatin|carboplatin|mesh-list
64941328|NCT00025272|Etoposide|etoposide|mesh-list
64941329|NCT00025272|Topotecan|topotecan|mesh-list
64941350|NCT00025350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64941351|NCT00025350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941352|NCT00025350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941354|NCT00025389|Bevacizumab|bevacizumab|mesh-list
64941355|NCT00025389|Carboplatin|carboplatin|mesh-list
64941356|NCT00025389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64941357|NCT00025389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941358|NCT00025389|Tubulin Modulators|tubulin modulators|mesh-ancestor
64941359|NCT00025389|Antimitotic Agents|antimitotic agents|mesh-ancestor
64941360|NCT00025389|Mitosis Modulators|mitosis modulators|mesh-ancestor
64941361|NCT00025389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941362|NCT00025389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64941363|NCT00025389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64941364|NCT00025389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64941365|NCT00025389|Growth Substances|growth substances|mesh-ancestor
64941366|NCT00025389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941367|NCT00025389|Growth Inhibitors|growth inhibitors|mesh-ancestor
64941368|NCT00025428|Cyclophosphamide|cyclophosphamide|mesh-list
64941369|NCT00025428|Carboplatin|carboplatin|mesh-list
64941370|NCT00025428|Doxorubicin|doxorubicin|mesh-list
64941371|NCT00025428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64941372|NCT00025428|Etoposide|etoposide|mesh-list
64941373|NCT00025428|Vincristine|vincristine|mesh-list
64941374|NCT00025428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64941375|NCT00025428|Immunologic Factors|immunologic factors|mesh-ancestor
64941376|NCT00025428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529839|NCT02375880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529840|NCT02375880|Antiviral Agents|antiviral agents|mesh-ancestor
64651370|NCT02684006|Axitinib|axitinib|mesh-list
64941381|NCT00025428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941382|NCT00025428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64941410|NCT04964414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64565158|NCT03101501|Mitomycins|mitomycins|mesh-list
64565159|NCT03101501|Mitomycin|mitomycin|mesh-list
64565160|NCT03101501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64565161|NCT03101501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624095|NCT02658890|Nivolumab|nivolumab|mesh-list
64941411|NCT04964414|Respiratory System Agents|respiratory system agents|mesh-ancestor
64941413|NCT04964414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64941414|NCT00025545|Cyclophosphamide|cyclophosphamide|mesh-list
64941415|NCT00025545|Methotrexate|methotrexate|mesh-list
64941416|NCT00025545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64941417|NCT00025545|Immunologic Factors|immunologic factors|mesh-ancestor
64941418|NCT00025545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941419|NCT00025545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64941420|NCT00025545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64941421|NCT00025545|Alkylating Agents|alkylating agents|mesh-ancestor
64941422|NCT00025545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941423|NCT00025545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941424|NCT00025545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64941425|NCT00025545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64941426|NCT00025545|Abortifacient Agents|abortifacient agents|mesh-ancestor
64941427|NCT00025545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64941428|NCT00025545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64941429|NCT00025545|Antimetabolites|antimetabolites|mesh-ancestor
64941458|NCT00025623|Mitosis Modulators|mitosis modulators|mesh-ancestor
64941459|NCT00025740|Clonazepam|clonazepam|mesh-list
64941460|NCT00025740|Paroxetine|paroxetine|mesh-list
64941461|NCT00025740|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64941462|NCT00025740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64941463|NCT00025740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64941464|NCT00025740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941465|NCT00025740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64941466|NCT00025740|Serotonin Agents|serotonin agents|mesh-ancestor
64941467|NCT00025740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941468|NCT00025740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64941469|NCT00025740|Antidepressive Agents|antidepressive agents|mesh-ancestor
64941470|NCT00025740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64941471|NCT00025740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64941472|NCT00025740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64941473|NCT00025740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941474|NCT00025740|Anticonvulsants|anticonvulsants|mesh-ancestor
64941475|NCT00025740|GABA Modulators|gaba modulators|mesh-ancestor
64941476|NCT00025740|GABA Agents|gaba agents|mesh-ancestor
64941496|NCT00026052|Anticonvulsants|anticonvulsants|mesh-ancestor
64941497|NCT00026052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64941498|NCT00026052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64941499|NCT00026052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64941500|NCT00026052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941501|NCT00026052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941502|NCT00026052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64941503|NCT00026052|Protective Agents|protective agents|mesh-ancestor
64941504|NCT00026091|Fenretinide|fenretinide|mesh-list
64941505|NCT00026091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941506|NCT00026091|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64941507|NCT00026091|Protective Agents|protective agents|mesh-ancestor
64941508|NCT00026091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941509|NCT00026130|Gemcitabine|gemcitabine|mesh-list
64941510|NCT00026130|Fluorouracil|fluorouracil|mesh-list
64651374|NCT02684006|Growth Substances|growth substances|mesh-ancestor
64529859|NCT02369250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64529860|NCT02369250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64529861|NCT02369250|Antimetabolites|antimetabolites|mesh-ancestor
64529862|NCT02369250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294553|NCT04635644|Analgesics|analgesics|mesh-ancestor
64294554|NCT04635644|Sensory System Agents|sensory system agents|mesh-ancestor
64941511|NCT00026130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64941512|NCT00026130|Antimetabolites|antimetabolites|mesh-ancestor
64941513|NCT00026130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941514|NCT00026130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941515|NCT00026130|Antiviral Agents|antiviral agents|mesh-ancestor
64941516|NCT00026130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64565162|NCT03101501|Alkylating Agents|alkylating agents|mesh-ancestor
64565195|NCT03100253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64565196|NCT03100253|Analgesics|analgesics|mesh-ancestor
64565197|NCT03100253|Sensory System Agents|sensory system agents|mesh-ancestor
64941517|NCT00026130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941518|NCT00026130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64941519|NCT00026130|Immunologic Factors|immunologic factors|mesh-ancestor
64941520|NCT00026130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941521|NCT00026169|Imatinib Mesylate|imatinib mesylate|mesh-list
64941522|NCT00026169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941523|NCT00026169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64941524|NCT00026169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941525|NCT00026169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941526|NCT04808414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64941527|NCT04808414|Polymyxins|polymyxins|mesh-list
64941528|NCT04808414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64941529|NCT00026286|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64941530|NCT00026286|Medroxyprogesterone|medroxyprogesterone|mesh-list
64941531|NCT00026286|Estrogens|estrogens|mesh-list
64941532|NCT00026286|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64941533|NCT00026286|Hormones|hormones|mesh-ancestor
64941568|NCT00026364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64941570|NCT00026403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941571|NCT00026403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64941572|NCT00026403|Antimetabolites|antimetabolites|mesh-ancestor
64941599|NCT00026520|Immunologic Factors|immunologic factors|mesh-ancestor
64941600|NCT00026520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941601|NCT00026520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64941602|NCT00026520|Leprostatic Agents|leprostatic agents|mesh-ancestor
64941603|NCT00026520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64941604|NCT00026520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64941605|NCT00026520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64941606|NCT00026520|Growth Substances|growth substances|mesh-ancestor
64941607|NCT00026520|Growth Inhibitors|growth inhibitors|mesh-ancestor
64529863|NCT02369250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64529864|NCT02369250|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64529865|NCT02369250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529867|NCT04645602|Lenvatinib|lenvatinib|mesh-list
64529868|NCT04645602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64529869|NCT04645602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294571|NCT02036983|Anesthetics, Local|anesthetics, local|mesh-list
64941608|NCT00026637|Sertraline|sertraline|mesh-list
64941609|NCT00026637|Antidepressive Agents|antidepressive agents|mesh-ancestor
64941610|NCT00026637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64941615|NCT00026637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64941616|NCT00026637|Serotonin Agents|serotonin agents|mesh-ancestor
64941617|NCT00026637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941618|NCT04657094|Acalabrutinib|acalabrutinib|mesh-list
64941619|NCT04657094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941620|NCT04610684|Carboplatin|carboplatin|mesh-list
64941621|NCT04610684|Etoposide|etoposide|mesh-list
64941653|NCT04473482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64941654|NCT04473482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64941655|NCT04473482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64941656|NCT04473482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941657|NCT00027300|Natalizumab|natalizumab|mesh-list
64941658|NCT00027300|Immunologic Factors|immunologic factors|mesh-ancestor
64941659|NCT00027300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941660|NCT00395382|Alendronate|alendronate|mesh-list
64941661|NCT00395382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64941662|NCT00395382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941663|NCT00027339|Ritonavir|ritonavir|mesh-list
64941664|NCT00027339|Lopinavir|lopinavir|mesh-list
64941665|NCT00027339|Indinavir|indinavir|mesh-list
64941686|NCT04206488|Protective Agents|protective agents|mesh-ancestor
64941687|NCT04206488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941688|NCT00027495|Curcumin|curcumin|mesh-list
64941689|NCT00027495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64941690|NCT00027495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64941691|NCT00027495|Analgesics|analgesics|mesh-ancestor
64941692|NCT00027495|Sensory System Agents|sensory system agents|mesh-ancestor
64941693|NCT00027495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64941694|NCT00027495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565198|NCT03100253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565199|NCT03100253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565200|NCT03100253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64941695|NCT00027495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64941696|NCT00027495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64941697|NCT00027495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941698|NCT00027495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941699|NCT00027495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941700|NCT00027534|Metronidazole|metronidazole|mesh-list
64941701|NCT00027534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64941702|NCT00027534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64941703|NCT00027534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64941704|NCT00027534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64941705|NCT00027573|Cyclophosphamide|cyclophosphamide|mesh-list
64941706|NCT00027573|Methotrexate|methotrexate|mesh-list
64941707|NCT00027573|Fludarabine|fludarabine|mesh-list
64941708|NCT00027573|Fludarabine phosphate|fludarabine phosphate|mesh-list
64941709|NCT00027573|Tacrolimus|tacrolimus|mesh-list
64941710|NCT00027573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64941711|NCT00027573|Immunologic Factors|immunologic factors|mesh-ancestor
64941712|NCT00027573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941713|NCT00027573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64941714|NCT00027573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64941715|NCT00027573|Alkylating Agents|alkylating agents|mesh-ancestor
64941716|NCT00027573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941717|NCT00027573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941718|NCT00027573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64529871|NCT04645602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529872|NCT04645602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529873|NCT02368860|Capecitabine|capecitabine|mesh-list
64529874|NCT02368860|Oxaliplatin|oxaliplatin|mesh-list
64529875|NCT02368860|Irinotecan|irinotecan|mesh-list
64529876|NCT02368860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64529877|NCT02368860|Antimetabolites|antimetabolites|mesh-ancestor
64529878|NCT02368860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529879|NCT02368860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529880|NCT02368860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64529881|NCT02368860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64529882|NCT02368860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529883|NCT02375646|Heparin|heparin|mesh-list
64529884|NCT02375646|Enoxaparin|enoxaparin|mesh-list
64529885|NCT02375646|Warfarin|warfarin|mesh-list
64941737|NCT00027612|Alkylating Agents|alkylating agents|mesh-ancestor
64941738|NCT04137887|Vaccines|vaccines|mesh-list
64941739|NCT04137887|Immunologic Factors|immunologic factors|mesh-ancestor
64941740|NCT04137887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941741|NCT00027690|Gefitinib|gefitinib|mesh-list
64941742|NCT00027690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941743|NCT00027690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64941744|NCT00027690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941745|NCT00027690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941746|NCT04137536|Antibodies|antibodies|mesh-list
64941747|NCT04137536|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64941748|NCT04137536|Immunologic Factors|immunologic factors|mesh-ancestor
64941749|NCT04137536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941750|NCT00027768|Ethiodized Oil|ethiodized oil|mesh-list
64941751|NCT00027768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941752|NCT00027807|Aldesleukin|aldesleukin|mesh-list
64941753|NCT00027807|Molgramostim|molgramostim|mesh-list
64941754|NCT00027807|Sargramostim|sargramostim|mesh-list
64941755|NCT00027807|Immunologic Factors|immunologic factors|mesh-ancestor
64941756|NCT00027807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941757|NCT00027807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941758|NCT00027807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64941759|NCT00027807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64941760|NCT00027807|Antiviral Agents|antiviral agents|mesh-ancestor
64941761|NCT00027807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64941762|NCT00392522|Nitrous Oxide|nitrous oxide|mesh-list
64941763|NCT00392522|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64941764|NCT00392522|Anesthetics, General|anesthetics, general|mesh-ancestor
64941765|NCT00392522|Anesthetics|anesthetics|mesh-ancestor
64941766|NCT00392522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64941767|NCT00392522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941768|NCT00392522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64941769|NCT00392522|Analgesics|analgesics|mesh-ancestor
64565201|NCT03100253|Immunologic Factors|immunologic factors|mesh-ancestor
64565202|NCT03100253|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64941770|NCT00392522|Sensory System Agents|sensory system agents|mesh-ancestor
64941771|NCT00392522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64941772|NCT00027885|Cyclophosphamide|cyclophosphamide|mesh-list
64941773|NCT00027885|Bevacizumab|bevacizumab|mesh-list
64529888|NCT02375646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64529889|NCT02375646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529890|NCT01524289|Anacetrapib|anacetrapib|mesh-list
64529891|NCT01524289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64529892|NCT01524289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64529893|NCT01524289|Antimetabolites|antimetabolites|mesh-ancestor
64529894|NCT01524289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529895|NCT01524289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64529896|NCT01498289|Leucovorin|leucovorin|mesh-list
64529897|NCT01498289|Docetaxel|docetaxel|mesh-list
64529898|NCT01498289|Fluorouracil|fluorouracil|mesh-list
64529899|NCT01498289|Oxaliplatin|oxaliplatin|mesh-list
64529900|NCT01498289|Irinotecan|irinotecan|mesh-list
64529901|NCT01498289|Calcium|calcium|mesh-list
64941774|NCT00027885|Docetaxel|docetaxel|mesh-list
64941775|NCT00027885|Doxorubicin|doxorubicin|mesh-list
64941776|NCT00027885|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64941777|NCT00027885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64941778|NCT00027885|Immunologic Factors|immunologic factors|mesh-ancestor
64941779|NCT00027885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941780|NCT00027885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64941781|NCT00027885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64941782|NCT00027885|Alkylating Agents|alkylating agents|mesh-ancestor
64941810|NCT00027924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941811|NCT00027924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941812|NCT00027924|Dermatologic Agents|dermatologic agents|mesh-ancestor
64941813|NCT00027924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941821|NCT00027924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64941822|NCT00027924|Alkylating Agents|alkylating agents|mesh-ancestor
64941823|NCT00027924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64941824|NCT00027924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64941825|NCT04022876|Carboplatin|carboplatin|mesh-list
64941826|NCT04022876|Pemetrexed|pemetrexed|mesh-list
64941827|NCT04022876|Topotecan|topotecan|mesh-list
64941828|NCT04022876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941829|NCT04022876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941830|NCT04022876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941856|NCT00395499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64941857|NCT00395499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941858|NCT00395499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941859|NCT00395499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64941860|NCT00395499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64941861|NCT00395499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64941862|NCT00395499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64941863|NCT00395499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64941864|NCT00395499|Dopamine Agents|dopamine agents|mesh-ancestor
64941865|NCT03960125|Imipramine|imipramine|mesh-list
64941866|NCT03960125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64941867|NCT03960125|Antidepressive Agents|antidepressive agents|mesh-ancestor
64941868|NCT03960125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64941869|NCT03960125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64941870|NCT03960125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64941871|NCT03960125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64941872|NCT03960125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529902|NCT01498289|Levoleucovorin|levoleucovorin|mesh-list
64529903|NCT01498289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529904|NCT01498289|Tubulin Modulators|tubulin modulators|mesh-ancestor
64529905|NCT01498289|Antimitotic Agents|antimitotic agents|mesh-ancestor
64529906|NCT01498289|Mitosis Modulators|mitosis modulators|mesh-ancestor
64529907|NCT01498289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529908|NCT01498289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64529909|NCT01498289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529910|NCT01498289|Antimetabolites|antimetabolites|mesh-ancestor
64529911|NCT01498289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64529912|NCT01498289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64529913|NCT01498289|Immunologic Factors|immunologic factors|mesh-ancestor
64529914|NCT01498289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64565203|NCT01924091|Dapivirine|dapivirine|mesh-list
64565204|NCT01924091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64565205|NCT01924091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64565236|NCT01924325|Protease Inhibitors|protease inhibitors|mesh-ancestor
64565238|NCT01924481|Theobromine|theobromine|mesh-list
64565239|NCT01924481|Caffeine|caffeine|mesh-list
64565240|NCT01924481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64565241|NCT01924481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565242|NCT01924481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64517233|NCT02020408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64624376|NCT02627846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64517234|NCT02020408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64529915|NCT01498289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64529916|NCT01498289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529917|NCT01498289|Antidotes|antidotes|mesh-ancestor
64529918|NCT01498289|Protective Agents|protective agents|mesh-ancestor
64529919|NCT01498289|Vitamin B Complex|vitamin b complex|mesh-ancestor
64529920|NCT01498289|Vitamins|vitamins|mesh-ancestor
64529921|NCT01498289|Micronutrients|micronutrients|mesh-ancestor
64529922|NCT02364882|Sildenafil Citrate|sildenafil citrate|mesh-list
64529923|NCT02364882|Vasodilator Agents|vasodilator agents|mesh-ancestor
64529924|NCT02364882|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64529925|NCT02364882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64529926|NCT02364882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529927|NCT02364882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294607|NCT02475135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64294610|NCT05161754|Hemostatics|hemostatics|mesh-list
64941873|NCT03960125|Adrenergic Agents|adrenergic agents|mesh-ancestor
64941874|NCT03960125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64941875|NCT03960125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941876|NCT00395655|Hydralazine|hydralazine|mesh-list
64941877|NCT00395655|Valproic Acid|valproic acid|mesh-list
64941878|NCT00395655|Anticonvulsants|anticonvulsants|mesh-ancestor
64941918|NCT03959969|Narcotics|narcotics|mesh-ancestor
64941919|NCT03959969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64941920|NCT00028314|Ritonavir|ritonavir|mesh-list
64941921|NCT00028314|Lopinavir|lopinavir|mesh-list
64941922|NCT00028314|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64941924|NCT00028314|Abacavir|abacavir|mesh-list
64941925|NCT00028314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64529928|NCT02364882|Urological Agents|urological agents|mesh-ancestor
64529929|NCT02364804|Aprepitant|aprepitant|mesh-list
64529930|NCT02364804|Antiemetics|antiemetics|mesh-ancestor
64529931|NCT02364804|Autonomic Agents|autonomic agents|mesh-ancestor
64529932|NCT02364804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64529933|NCT02364804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529934|NCT02364804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64529935|NCT02364804|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64529936|NCT02364804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64529937|NCT02364804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529938|NCT01524133|Sertraline|sertraline|mesh-list
64529939|NCT01524133|Antidepressive Agents|antidepressive agents|mesh-ancestor
64529940|NCT01524133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64529941|NCT01524133|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64529942|NCT01524133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64529943|NCT01524133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64529944|NCT01524133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529945|NCT01524133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64529946|NCT01524133|Serotonin Agents|serotonin agents|mesh-ancestor
64529947|NCT01524133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529948|NCT02368470|Gemifloxacin|gemifloxacin|mesh-list
64529949|NCT02368470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64529950|NCT02368470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64529951|NCT02368470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529952|NCT02368470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529953|NCT02368470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64517235|NCT02020408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64517236|NCT02020408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64517237|NCT02020408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64517238|NCT01219257|Adalimumab|adalimumab|mesh-list
64517239|NCT01219257|Etanercept|etanercept|mesh-list
64529954|NCT02368470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64529955|NCT02368470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529956|NCT04561206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64529957|NCT04561206|Nivolumab|nivolumab|mesh-list
64941926|NCT00028314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64941956|NCT03959852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64941957|NCT03959852|Anesthetics, General|anesthetics, general|mesh-ancestor
64941959|NCT03959852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64941960|NCT03959852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64941961|NCT03959852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64941962|NCT03959852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64941963|NCT03959852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941964|NCT03959852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64941965|NCT03959852|Narcotics|narcotics|mesh-ancestor
64529958|NCT04561206|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64529959|NCT04561206|Antibodies|antibodies|mesh-list
64529960|NCT04561206|Immunoglobulins|immunoglobulins|mesh-list
64529961|NCT04561206|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64529962|NCT04561206|Immunoconjugates|immunoconjugates|mesh-list
64529963|NCT04561206|Immunologic Factors|immunologic factors|mesh-ancestor
64529964|NCT04561206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529965|NCT04561206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529966|NCT04561206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64529967|NCT04561206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651413|NCT01203722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64529968|NCT04110301|Lenalidomide|lenalidomide|mesh-list
64529969|NCT04110301|Antibodies|antibodies|mesh-list
64529970|NCT04110301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64294664|NCT05714553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64294665|NCT05714553|Antidotes|antidotes|mesh-ancestor
64294666|NCT05714553|Protective Agents|protective agents|mesh-ancestor
64294667|NCT05714553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294668|NCT05714553|Vitamin B Complex|vitamin b complex|mesh-ancestor
64941966|NCT03959852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64941994|NCT00028665|Etoposide|etoposide|mesh-list
64941995|NCT00028665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64941996|NCT00028665|Immunologic Factors|immunologic factors|mesh-ancestor
64941997|NCT00028665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941998|NCT00028665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64941999|NCT00028665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64942000|NCT00028665|Alkylating Agents|alkylating agents|mesh-ancestor
64942001|NCT00028665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942002|NCT00028665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942003|NCT00028665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64942004|NCT00028665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64942005|NCT00028665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64942006|NCT00028665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64942007|NCT00028665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64942008|NCT00028665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942009|NCT03959540|Levodopa|levodopa|mesh-list
64942010|NCT03959540|Opicapone|opicapone|mesh-list
64942011|NCT03959540|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64942012|NCT03959540|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64942013|NCT03959540|Dopamine Agents|dopamine agents|mesh-ancestor
64942014|NCT03959540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64942015|NCT03959540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942016|NCT03959540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942017|NCT03959540|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64942040|NCT03959501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942041|NCT03959501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529976|NCT04110301|Growth Inhibitors|growth inhibitors|mesh-ancestor
64529977|NCT04110301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529978|NCT05800600|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64529979|NCT05800600|Hematinics|hematinics|mesh-ancestor
64529980|NCT05800587|Gemcitabine|gemcitabine|mesh-list
64529981|NCT05800587|Paclitaxel|paclitaxel|mesh-list
64517240|NCT01219257|Golimumab|golimumab|mesh-list
64517241|NCT01219257|Infliximab|infliximab|mesh-list
64517242|NCT01219257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64517243|NCT01219257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64517244|NCT01219257|Dermatologic Agents|dermatologic agents|mesh-ancestor
64565243|NCT01924481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565244|NCT01924481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565245|NCT01924481|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64565246|NCT01924481|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64565247|NCT01924481|Purinergic Agents|purinergic agents|mesh-ancestor
64565248|NCT01924481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64565249|NCT01924481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64565278|NCT01925729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64565279|NCT01925729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565280|NCT01925729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64565281|NCT01925729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64565282|NCT01925729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64565283|NCT01925729|Mydriatics|mydriatics|mesh-ancestor
64565284|NCT01925729|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64565285|NCT01925729|Protective Agents|protective agents|mesh-ancestor
64565286|NCT01925729|Histamine Agonists|histamine agonists|mesh-ancestor
64565287|NCT01925729|Histamine Agents|histamine agents|mesh-ancestor
64565288|NCT01926587|Azacitidine|azacitidine|mesh-list
64529982|NCT05800587|Etoposide|etoposide|mesh-list
64529983|NCT05800587|Docetaxel|docetaxel|mesh-list
64529984|NCT05800587|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64529985|NCT05800587|Carboplatin|carboplatin|mesh-list
64529986|NCT05800587|Irinotecan|irinotecan|mesh-list
64529987|NCT05800587|Pemetrexed|pemetrexed|mesh-list
64529988|NCT05800587|Topotecan|topotecan|mesh-list
64529989|NCT05800587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64529990|NCT05800587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529991|NCT05800587|Tubulin Modulators|tubulin modulators|mesh-ancestor
64529992|NCT05800587|Antimitotic Agents|antimitotic agents|mesh-ancestor
64529993|NCT05800587|Mitosis Modulators|mitosis modulators|mesh-ancestor
64529994|NCT05800587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529995|NCT05800587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64529996|NCT05800587|Antimetabolites|antimetabolites|mesh-ancestor
64294679|NCT05256056|Bupivacaine|bupivacaine|mesh-list
64294680|NCT05256056|Anesthetics, Local|anesthetics, local|mesh-ancestor
64294681|NCT05256056|Anesthetics|anesthetics|mesh-ancestor
64294682|NCT05256056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64942042|NCT03959501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64942043|NCT00028782|Etanidazole|etanidazole|mesh-list
64942044|NCT00028782|Imidazole|imidazole|mesh-list
64942045|NCT00028782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942046|NCT00028782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942047|NCT00028782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942048|NCT00028821|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
64942057|NCT00028821|Mitosis Modulators|mitosis modulators|mesh-ancestor
64942058|NCT00028821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942059|NCT03959384|Poractant alfa|poractant alfa|mesh-list
64942060|NCT03959384|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
64942061|NCT03959384|Respiratory System Agents|respiratory system agents|mesh-ancestor
64565289|NCT01926587|ON 01910|on 01910|mesh-list
64565290|NCT01926587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64565291|NCT01926587|Antimetabolites|antimetabolites|mesh-ancestor
64624570|NCT02221310|Gemtuzumab|gemtuzumab|mesh-list
64942062|NCT00028860|Gemcitabine|gemcitabine|mesh-list
64942063|NCT00028860|Paclitaxel|paclitaxel|mesh-list
64942064|NCT00028860|Carboplatin|carboplatin|mesh-list
64942065|NCT00028860|Ifosfamide|ifosfamide|mesh-list
64942066|NCT00028860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64942067|NCT00028860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942068|NCT00028860|Tubulin Modulators|tubulin modulators|mesh-ancestor
64942069|NCT00028860|Antimitotic Agents|antimitotic agents|mesh-ancestor
64529998|NCT05800587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64529999|NCT05800587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530000|NCT05800587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64530001|NCT05800587|Immunologic Factors|immunologic factors|mesh-ancestor
64530002|NCT05800587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530003|NCT05800587|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64530004|NCT05800587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64530005|NCT05800587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64530006|NCT05800587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64530007|NCT05800587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64530009|NCT05800418|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64530010|NCT05800418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530011|NCT05800418|Immunologic Factors|immunologic factors|mesh-ancestor
64530012|NCT05800418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530013|NCT05800366|Prednisone|prednisone|mesh-list
64530014|NCT05800366|Methylprednisolone|methylprednisolone|mesh-list
64530015|NCT05800366|Prednisolone|prednisolone|mesh-list
64530016|NCT05800366|Cyclophosphamide|cyclophosphamide|mesh-list
64530017|NCT05800366|Rituximab|rituximab|mesh-list
64530018|NCT05800366|Doxorubicin|doxorubicin|mesh-list
64942070|NCT00028860|Mitosis Modulators|mitosis modulators|mesh-ancestor
64942089|NCT00028899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942090|NCT00028899|Antiviral Agents|antiviral agents|mesh-ancestor
64942091|NCT00028899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64942092|NCT00028899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64942093|NCT00028899|Immunologic Factors|immunologic factors|mesh-ancestor
64942094|NCT00028899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942095|NCT00028899|Analgesics|analgesics|mesh-ancestor
64942096|NCT00028899|Sensory System Agents|sensory system agents|mesh-ancestor
64942097|NCT00028899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64942098|NCT00028899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64942099|NCT00028899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64942100|NCT00028899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942101|NCT00028899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64942102|NCT03959306|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64942103|NCT03959306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942104|NCT00028938|Paclitaxel|paclitaxel|mesh-list
64942105|NCT00028938|Carboplatin|carboplatin|mesh-list
64942106|NCT00028938|Epoetin Alfa|epoetin alfa|mesh-list
64942107|NCT00028938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64942108|NCT00028938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651427|NCT03008057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942109|NCT00028938|Tubulin Modulators|tubulin modulators|mesh-ancestor
64942110|NCT00028938|Antimitotic Agents|antimitotic agents|mesh-ancestor
64942111|NCT00028938|Mitosis Modulators|mitosis modulators|mesh-ancestor
64942112|NCT00028938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942113|NCT00028938|Hematinics|hematinics|mesh-ancestor
64942114|NCT00029250|Allicin|allicin|mesh-list
64651430|NCT01542125|Lidocaine|lidocaine|mesh-list
64942120|NCT00029250|Antioxidants|antioxidants|mesh-ancestor
64530020|NCT05800366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64530021|NCT05800366|Immunologic Factors|immunologic factors|mesh-ancestor
64530022|NCT05800366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530023|NCT05800366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64530024|NCT05800366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64530025|NCT05800366|Alkylating Agents|alkylating agents|mesh-ancestor
64530026|NCT05800366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484198|NCT04795336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64530027|NCT05800366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530028|NCT05800366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64530029|NCT05800366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64294722|NCT02814175|Adalimumab|adalimumab|mesh-list
64942121|NCT00029250|Protective Agents|protective agents|mesh-ancestor
64565292|NCT01926587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565293|NCT01926587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565294|NCT01926587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565295|NCT01926587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64942122|NCT00029250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942123|NCT00029250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64942124|NCT00029250|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64942125|NCT03959150|Capecitabine|capecitabine|mesh-list
64942126|NCT03959150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64942127|NCT03959150|Antimetabolites|antimetabolites|mesh-ancestor
64942156|NCT00029523|Immunologic Factors|immunologic factors|mesh-ancestor
64942157|NCT00029523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64942158|NCT00029523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64942159|NCT00029523|Antiviral Agents|antiviral agents|mesh-ancestor
64942160|NCT00029523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64942161|NCT00392717|Atorvastatin|atorvastatin|mesh-list
64942162|NCT00392717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64942163|NCT00392717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64942164|NCT00392717|Antimetabolites|antimetabolites|mesh-ancestor
64942165|NCT00392717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942166|NCT00392717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64942167|NCT00392717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64942168|NCT00392717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942169|NCT00029679|Borage oil|borage oil|mesh-list
64942170|NCT00029679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64942171|NCT03958799|Vaccines|vaccines|mesh-list
64942203|NCT00395772|Antithrombins|antithrombins|mesh-ancestor
64942204|NCT00395772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64942205|NCT00395772|Protease Inhibitors|protease inhibitors|mesh-ancestor
64942206|NCT00395772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942207|NCT00395772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64942208|NCT00395772|Hemostatics|hemostatics|mesh-ancestor
64942209|NCT00395772|Coagulants|coagulants|mesh-ancestor
64942210|NCT00029874|Minocycline|minocycline|mesh-list
64942211|NCT00029874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64942212|NCT00029874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64942213|NCT00030030|Silymarin|silymarin|mesh-list
64942214|NCT00030030|Antioxidants|antioxidants|mesh-ancestor
64942231|NCT00030069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64942232|NCT00030069|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64942233|NCT00030069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64942234|NCT00030069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942235|NCT00030069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64942237|NCT00030069|Micronutrients|micronutrients|mesh-ancestor
64942238|NCT00030069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64942239|NCT03958097|Antibodies|antibodies|mesh-list
64942240|NCT03958097|Immunologic Factors|immunologic factors|mesh-ancestor
64942241|NCT03958097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942242|NCT00030342|Interferons|interferons|mesh-list
64942243|NCT00030342|Interferon-alpha|interferon-alpha|mesh-list
64942244|NCT00030342|Fluorouracil|fluorouracil|mesh-list
64530030|NCT05800366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64530031|NCT05800366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64530032|NCT05800366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64530033|NCT05800366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530034|NCT05800366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64942265|NCT00030420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64942267|NCT00030420|Analgesics|analgesics|mesh-ancestor
64942268|NCT00030420|Sensory System Agents|sensory system agents|mesh-ancestor
64942269|NCT00030420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64942270|NCT00030420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942271|NCT00030420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64942272|NCT00030420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64942291|NCT00030498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942292|NCT00030498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64942293|NCT00030498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530054|NCT05800340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530055|NCT05800340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64530056|NCT05800340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64530057|NCT05800301|Neurotransmitter Agents|neurotransmitter agents|mesh-list
64530058|NCT05800301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565328|NCT03430661|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64565329|NCT03430661|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64565330|NCT03430661|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64565331|NCT03430661|Purinergic Agents|purinergic agents|mesh-ancestor
64565332|NCT03430661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64565333|NCT03430661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565334|NCT03430661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565335|NCT01927835|Vaccines|vaccines|mesh-list
64565362|NCT01307397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64565363|NCT01307397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530059|NCT05800301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530060|NCT05800288|Propofol|propofol|mesh-list
64530061|NCT05800288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64530062|NCT05800288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64530063|NCT05800288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530064|NCT05800288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64530065|NCT05800288|Anesthetics, General|anesthetics, general|mesh-ancestor
64530066|NCT05800288|Anesthetics|anesthetics|mesh-ancestor
64530067|NCT05800275|Capecitabine|capecitabine|mesh-list
64530068|NCT05800275|Trastuzumab|trastuzumab|mesh-list
64294749|NCT02474667|Mitosis Modulators|mitosis modulators|mesh-ancestor
64294753|NCT03096080|XL647|xl647|mesh-list
64942304|NCT00030537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942305|NCT00030576|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64942306|NCT00030576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942307|NCT00030576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64942308|NCT00030576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942309|NCT00030576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942310|NCT00030615|Decitabine|decitabine|mesh-list
64942311|NCT00030615|Azacitidine|azacitidine|mesh-list
64942312|NCT00030615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64942313|NCT00030615|Antimetabolites|antimetabolites|mesh-ancestor
64942314|NCT00030615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942315|NCT00030615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942316|NCT00030615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942317|NCT03857087|Edetic Acid|edetic acid|mesh-list
64942318|NCT03857087|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64942319|NCT03857087|Chelating Agents|chelating agents|mesh-ancestor
64942320|NCT03857087|Sequestering Agents|sequestering agents|mesh-ancestor
64942321|NCT03857087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942322|NCT03857087|Anticoagulants|anticoagulants|mesh-ancestor
64942323|NCT03857087|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64942324|NCT03857087|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64942325|NCT00030654|Ketoconazole|ketoconazole|mesh-list
64942326|NCT00030654|Vinblastine|vinblastine|mesh-list
64942327|NCT00030654|Docetaxel|docetaxel|mesh-list
64942328|NCT00030654|Doxorubicin|doxorubicin|mesh-list
64942359|NCT03852407|Fludarabine|fludarabine|mesh-list
64942360|NCT03852407|Thymoglobulin|thymoglobulin|mesh-list
64942363|NCT03852407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942365|NCT03852407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64942366|NCT03852407|Alkylating Agents|alkylating agents|mesh-ancestor
64942367|NCT03852407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942368|NCT03852407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942369|NCT03852407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64942370|NCT00030693|Metronidazole|metronidazole|mesh-list
64942371|NCT00030693|Vaccines|vaccines|mesh-list
64942372|NCT00030693|Immunologic Factors|immunologic factors|mesh-ancestor
64942408|NCT00030732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942409|NCT00030732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64942410|NCT00030732|Immunologic Factors|immunologic factors|mesh-ancestor
64942434|NCT03779789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64942435|NCT03779789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942436|NCT03779789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64565364|NCT01307397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565365|NCT01929161|Oxytocin|oxytocin|mesh-list
64565366|NCT01929161|Oxytocics|oxytocics|mesh-ancestor
64565367|NCT01929161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64565368|NCT01929161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565369|NCT03373877|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
64565370|NCT03373877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565371|NCT04552535|Afatinib|afatinib|mesh-list
64565372|NCT04552535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565373|NCT04552535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64565374|NCT04552535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565375|NCT04552535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565376|NCT02197767|Rituximab|rituximab|mesh-list
64565377|NCT02197767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64565378|NCT02197767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64517245|NCT01219257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64517246|NCT01219257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64517247|NCT01219257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64517248|NCT01219257|Analgesics|analgesics|mesh-ancestor
64517249|NCT01219257|Sensory System Agents|sensory system agents|mesh-ancestor
64517250|NCT01219257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517251|NCT01219257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517252|NCT01219257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64517253|NCT01219257|Immunologic Factors|immunologic factors|mesh-ancestor
64942437|NCT03779789|Serotonin Agents|serotonin agents|mesh-ancestor
64942438|NCT03779789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942439|NCT03779789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64942440|NCT03779789|Antidepressive Agents|antidepressive agents|mesh-ancestor
64942441|NCT03779789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64651476|NCT05310344|Growth Substances|growth substances|mesh-ancestor
64530125|NCT05799924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530133|NCT05799820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64942456|NCT00030888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64942457|NCT00030888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942458|NCT00030888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942459|NCT00030966|Natalizumab|natalizumab|mesh-list
64942460|NCT00030966|Immunologic Factors|immunologic factors|mesh-ancestor
64942461|NCT00030966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942462|NCT03715205|Pembrolizumab|pembrolizumab|mesh-list
64942490|NCT03559985|Analgesics|analgesics|mesh-ancestor
64942491|NCT03559985|Sensory System Agents|sensory system agents|mesh-ancestor
64942492|NCT03559985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64942493|NCT03559985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942494|NCT03559985|Antipyretics|antipyretics|mesh-ancestor
64942495|NCT04711863|Fluvoxamine|fluvoxamine|mesh-list
64942496|NCT04711863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64942497|NCT04711863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64942498|NCT04711863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64517254|NCT01219257|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64517255|NCT01615887|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64624833|NCT03244020|Aspirin|aspirin|mesh-list
64942499|NCT04711863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942500|NCT04711863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64942501|NCT04711863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64942502|NCT04711863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64942503|NCT04711863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64942504|NCT04711863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942505|NCT04711863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64942506|NCT04711863|Serotonin Agents|serotonin agents|mesh-ancestor
64942507|NCT04711863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64942508|NCT04711863|Antidepressive Agents|antidepressive agents|mesh-ancestor
64942527|NCT04712058|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64942528|NCT04712058|Antiviral Agents|antiviral agents|mesh-ancestor
64942529|NCT04712058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64942530|NCT04712058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64942531|NCT04712058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64942532|NCT04712058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942533|NCT04712058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651500|NCT03215498|Insulin Aspart|insulin aspart|mesh-list
64651501|NCT03215498|Insulin, Long-Acting|insulin, long-acting|mesh-list
64530154|NCT05799729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64530155|NCT05799729|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64530156|NCT05799729|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64530157|NCT05799729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64294843|NCT02474511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64942542|NCT00393107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64942543|NCT00393107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64942544|NCT00393107|Alkylating Agents|alkylating agents|mesh-ancestor
64942545|NCT00393107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942546|NCT00393107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942547|NCT00393107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64942548|NCT00393107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64942549|NCT04711668|Lidocaine|lidocaine|mesh-list
64942550|NCT04711668|Ketamine|ketamine|mesh-list
64942551|NCT04711668|Anesthetics, Local|anesthetics, local|mesh-ancestor
64942552|NCT04711668|Anesthetics|anesthetics|mesh-ancestor
64942553|NCT04711668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64942554|NCT04711668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942555|NCT04711668|Sensory System Agents|sensory system agents|mesh-ancestor
64942556|NCT04711668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64942557|NCT04711668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64942558|NCT04711668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64942559|NCT04711668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64942560|NCT04711668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64942561|NCT04711668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942580|NCT00031317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942581|NCT00031317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64386459|NCT01729091|Lenalidomide|lenalidomide|mesh-list
64942589|NCT00031317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942590|NCT00031317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64942591|NCT00031317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64942592|NCT00031317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64942593|NCT00031317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64942594|NCT00031317|GABA Antagonists|gaba antagonists|mesh-ancestor
64942595|NCT00031317|GABA Agents|gaba agents|mesh-ancestor
64942649|NCT03152123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64942650|NCT03152123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942652|NCT00031473|Antimetabolites|antimetabolites|mesh-ancestor
64942653|NCT00031473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942654|NCT00031473|Antiviral Agents|antiviral agents|mesh-ancestor
64942655|NCT00031473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64942656|NCT00031629|Gemcitabine|gemcitabine|mesh-list
64942657|NCT00031629|Docetaxel|docetaxel|mesh-list
64942658|NCT00031629|Lenograstim|lenograstim|mesh-list
64942659|NCT00031629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64942660|NCT00031629|Antimetabolites|antimetabolites|mesh-ancestor
64317708|NCT04482543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64517256|NCT01615887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64517257|NCT01615887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517258|NCT01615887|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64517259|NCT01615887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64517260|NCT01615887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64517261|NCT01615887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517262|NCT01615887|Dopamine Agents|dopamine agents|mesh-ancestor
64565379|NCT02197767|Immunologic Factors|immunologic factors|mesh-ancestor
64565380|NCT02197767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565415|NCT05607641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64565416|NCT05607641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64565417|NCT05607641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64565418|NCT05607641|Analgesics|analgesics|mesh-ancestor
64565419|NCT05607641|Sensory System Agents|sensory system agents|mesh-ancestor
64565420|NCT05607641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565421|NCT05607641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565422|NCT05607641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64942661|NCT00031629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942662|NCT00031629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942663|NCT00031629|Antiviral Agents|antiviral agents|mesh-ancestor
64942664|NCT00031629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64942665|NCT00031629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942666|NCT00031629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64942667|NCT00031629|Immunologic Factors|immunologic factors|mesh-ancestor
64942668|NCT00031629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942669|NCT00031629|Tubulin Modulators|tubulin modulators|mesh-ancestor
64942670|NCT00031629|Antimitotic Agents|antimitotic agents|mesh-ancestor
64942671|NCT00031629|Mitosis Modulators|mitosis modulators|mesh-ancestor
64530194|NCT05799378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530195|NCT05799378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530196|NCT05799378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64530197|NCT05799300|Anesthetics|anesthetics|mesh-list
64530198|NCT05799300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64530199|NCT05799300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530200|NCT05799144|Pembrolizumab|pembrolizumab|mesh-list
64530202|NCT05799144|Immunologic Factors|immunologic factors|mesh-ancestor
64530203|NCT05799144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530204|NCT05799144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64530205|NCT05799144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530206|NCT05799105|Omeprazole|omeprazole|mesh-list
64530207|NCT05799105|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64530208|NCT05799105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64530209|NCT05799105|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64530210|NCT05799105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651544|NCT01549223|Carboprost|carboprost|mesh-list
64530245|NCT05798819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64530246|NCT05798819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64530247|NCT05798819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64530248|NCT05798819|Growth Substances|growth substances|mesh-ancestor
64530249|NCT05798819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942672|NCT00031629|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64942674|NCT03152084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64942675|NCT03152084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942676|NCT03152084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64565423|NCT05607641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64565424|NCT05607641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64565453|NCT04161599|Cefuroxime axetil|cefuroxime axetil|mesh-list
64565454|NCT04161599|Picosulfate sodium|picosulfate sodium|mesh-list
64942677|NCT03152084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942679|NCT00031707|Megestrol Acetate|megestrol acetate|mesh-list
64942680|NCT00031707|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64942681|NCT00031707|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64942682|NCT00031707|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64942683|NCT00031707|Contraceptive Agents|contraceptive agents|mesh-ancestor
64942701|NCT00031785|Contraceptive Agents|contraceptive agents|mesh-ancestor
64942702|NCT00031785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64942703|NCT00031785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942704|NCT00031785|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64942705|NCT00031785|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64942706|NCT00031785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64942707|NCT00031785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942708|NCT00031785|Appetite Stimulants|appetite stimulants|mesh-ancestor
64942709|NCT00031785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64942710|NCT03151772|Metformin|metformin|mesh-list
64942711|NCT03151772|Disulfiram|disulfiram|mesh-list
64942712|NCT03151772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64942713|NCT03151772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942714|NCT03151772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64942715|NCT03151772|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
64942716|NCT03151772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942717|NCT03151772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942718|NCT02971644|Cobalt|cobalt|mesh-list
64942719|NCT02971644|Trace Elements|trace elements|mesh-ancestor
64942720|NCT02971644|Micronutrients|micronutrients|mesh-ancestor
64942721|NCT02971644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942722|NCT00031824|Cyclosporine|cyclosporine|mesh-list
64942723|NCT00031824|Hydroxychloroquine|hydroxychloroquine|mesh-list
64942724|NCT00031824|Prednisone|prednisone|mesh-list
64942725|NCT00031824|Tacrolimus|tacrolimus|mesh-list
64942726|NCT00031824|Cyclosporins|cyclosporins|mesh-list
64942727|NCT00031824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64942728|NCT00031824|Glucocorticoids|glucocorticoids|mesh-ancestor
64942729|NCT00031824|Hormones|hormones|mesh-ancestor
64942730|NCT00031824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64942731|NCT00031824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942732|NCT00031824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64942733|NCT00031824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942734|NCT00031824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64942735|NCT00031824|Immunologic Factors|immunologic factors|mesh-ancestor
64942736|NCT00031824|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64942737|NCT00031824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942738|NCT00031824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942739|NCT00031824|Antifungal Agents|antifungal agents|mesh-ancestor
64942740|NCT00031824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64942759|NCT03151616|Cholinergic Antagonists|cholinergic antagonists|mesh-list
64942760|NCT03151616|Cholinergic Agents|cholinergic agents|mesh-ancestor
64942761|NCT03151616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64942786|NCT00031941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942788|NCT00031941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64942789|NCT00031941|Growth Substances|growth substances|mesh-ancestor
64942790|NCT00031941|Growth Inhibitors|growth inhibitors|mesh-ancestor
64942791|NCT00031941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942792|NCT00031980|Cyclosporine|cyclosporine|mesh-list
64942793|NCT00031980|Cyclosporins|cyclosporins|mesh-list
64942794|NCT00031980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942795|NCT00031980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651569|NCT01550471|Beclomethasone|beclomethasone|mesh-list
64651571|NCT01550471|Glucocorticoids|glucocorticoids|mesh-ancestor
64711307|NCT05570825|Pembrolizumab|pembrolizumab|mesh-list
64942820|NCT03151499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64942821|NCT00032019|Prednisone|prednisone|mesh-list
64942822|NCT00032019|Cyclophosphamide|cyclophosphamide|mesh-list
64942823|NCT00032019|Rituximab|rituximab|mesh-list
64942824|NCT00032019|Doxorubicin|doxorubicin|mesh-list
64942825|NCT00032019|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64942826|NCT00032019|Etoposide|etoposide|mesh-list
64942827|NCT00032019|Vincristine|vincristine|mesh-list
64942828|NCT00032019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64565455|NCT04161599|Magnesium Oxide|magnesium oxide|mesh-list
64565456|NCT04161599|Citric Acid|citric acid|mesh-list
64565457|NCT04161599|Sodium Citrate|sodium citrate|mesh-list
64942829|NCT00032019|Immunologic Factors|immunologic factors|mesh-ancestor
64942830|NCT00032019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942831|NCT00032019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64942832|NCT00032019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64942833|NCT00032019|Alkylating Agents|alkylating agents|mesh-ancestor
64942834|NCT00032019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942835|NCT00032019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942836|NCT00032019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64942837|NCT00032019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64942838|NCT00032019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64942839|NCT00032019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64530257|NCT05798793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530258|NCT05798728|Misoprostol|misoprostol|mesh-list
64530259|NCT05798728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64530260|NCT05798728|Abortifacient Agents|abortifacient agents|mesh-ancestor
64530261|NCT05798728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64530262|NCT05798728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530263|NCT05798728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64530264|NCT05798728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64530265|NCT05798728|Oxytocics|oxytocics|mesh-ancestor
64530266|NCT05798715|Metformin|metformin|mesh-list
64530267|NCT05798715|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64530268|NCT05798715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64530269|NCT05798715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530270|NCT05798715|Incretins|incretins|mesh-ancestor
64294960|NCT00071552|Dermatologic Agents|dermatologic agents|mesh-ancestor
64942840|NCT00032019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64942841|NCT00032019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942842|NCT00032019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64942843|NCT00032019|Glucocorticoids|glucocorticoids|mesh-ancestor
64942844|NCT00032019|Hormones|hormones|mesh-ancestor
64942845|NCT00032019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64942846|NCT00032019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64942847|NCT00032019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64942848|NCT00032019|Tubulin Modulators|tubulin modulators|mesh-ancestor
64942894|NCT00032136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942896|NCT03151343|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64942897|NCT03151343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942898|NCT03151343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64942899|NCT03151343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942900|NCT00032175|Gemcitabine|gemcitabine|mesh-list
64942901|NCT00032175|Capecitabine|capecitabine|mesh-list
64942902|NCT00032175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64942903|NCT00032175|Antimetabolites|antimetabolites|mesh-ancestor
64942904|NCT00032175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942905|NCT00032175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530271|NCT05798715|Hormones|hormones|mesh-ancestor
64530272|NCT05798715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64530273|NCT05798715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64530274|NCT05798715|Protease Inhibitors|protease inhibitors|mesh-ancestor
64530275|NCT05798715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530276|NCT05798715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530277|NCT05796167|Pimavanserin|pimavanserin|mesh-list
64530278|NCT05796167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64530279|NCT05796167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64530280|NCT05796167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64530281|NCT05796167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64530282|NCT05796167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64530283|NCT05796167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530284|NCT05796167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64651593|NCT03215264|Antimalarials|antimalarials|mesh-ancestor
64942907|NCT00032175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64942908|NCT00032175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942909|NCT00032175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64942910|NCT00032175|Immunologic Factors|immunologic factors|mesh-ancestor
64942911|NCT00032175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942912|NCT04712279|Hydroxychloroquine|hydroxychloroquine|mesh-list
64942914|NCT04712279|Antimalarials|antimalarials|mesh-ancestor
64565458|NCT04161599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625116|NCT00000298|Naloxone|naloxone|mesh-list
64942926|NCT03150914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64942927|NCT03150914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64942928|NCT03150914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942929|NCT03150914|Antifungal Agents|antifungal agents|mesh-ancestor
64942930|NCT03150914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64942931|NCT03150914|Immunologic Factors|immunologic factors|mesh-ancestor
64942932|NCT03150914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942933|NCT00032799|Natalizumab|natalizumab|mesh-list
64942934|NCT00032799|Immunologic Factors|immunologic factors|mesh-ancestor
64942935|NCT00032799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942936|NCT03150836|Durvalumab|durvalumab|mesh-list
64942937|NCT03150836|Tremelimumab|tremelimumab|mesh-list
64942938|NCT03150836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64942939|NCT03150836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942940|NCT00032838|Yohimbine|yohimbine|mesh-list
64942941|NCT00032838|Mydriatics|mydriatics|mesh-ancestor
64942942|NCT00032838|Autonomic Agents|autonomic agents|mesh-ancestor
64942943|NCT00032838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64942944|NCT00032838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942945|NCT00032838|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64942946|NCT00032838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64942947|NCT00032838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64942948|NCT00032838|Adrenergic Agents|adrenergic agents|mesh-ancestor
64530292|NCT05795491|Clotrimazole|clotrimazole|mesh-list
64530293|NCT05795491|Miconazole|miconazole|mesh-list
64530294|NCT05795491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64530295|NCT05795491|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64530296|NCT05795491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64530297|NCT05795491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530298|NCT05795491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530299|NCT05795491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64942949|NCT00032838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64942950|NCT00032838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942951|NCT00032838|Urological Agents|urological agents|mesh-ancestor
64942952|NCT03150797|Melatonin|melatonin|mesh-list
64942953|NCT03150797|Antioxidants|antioxidants|mesh-ancestor
64942954|NCT03150797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942955|NCT03150797|Protective Agents|protective agents|mesh-ancestor
64942956|NCT03150797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942957|NCT03150797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64942958|NCT03150680|Clopidogrel|clopidogrel|mesh-list
64942959|NCT03150680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64942960|NCT03150680|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64942961|NCT03150680|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64942962|NCT03150680|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64942963|NCT03150680|Purinergic Agents|purinergic agents|mesh-ancestor
64942964|NCT03150680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64942965|NCT03150680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942966|NCT03150680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942967|NCT00396396|Acetylcysteine|acetylcysteine|mesh-list
64651602|NCT01447511|Rifampin|rifampin|mesh-list
64943005|NCT00033033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943006|NCT00033033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64943007|NCT00033033|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64943008|NCT00033033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64943009|NCT00033033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64943010|NCT00033033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943011|NCT00033033|Adrenergic Agents|adrenergic agents|mesh-ancestor
64943012|NCT00033033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64943013|NCT03150368|Docetaxel|docetaxel|mesh-list
64943014|NCT03150368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530301|NCT05795491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64530302|NCT05795491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530303|NCT05795491|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64530304|NCT05795491|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64530305|NCT05795491|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64530306|NCT05795491|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64530307|NCT05789381|Magnesium Sulfate|magnesium sulfate|mesh-list
64530308|NCT05789381|Analgesics|analgesics|mesh-ancestor
64565459|NCT04161599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64565460|NCT04161599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64565461|NCT04161599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64565462|NCT04161599|Cathartics|cathartics|mesh-ancestor
64565463|NCT04161599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64565464|NCT04161599|Anticoagulants|anticoagulants|mesh-ancestor
64565465|NCT04161599|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64565466|NCT04161599|Chelating Agents|chelating agents|mesh-ancestor
64565467|NCT04161599|Sequestering Agents|sequestering agents|mesh-ancestor
64565468|NCT04161599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565469|NCT04161599|Antacids|antacids|mesh-ancestor
64565470|NCT04759235|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64565471|NCT04759235|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64565493|NCT05601167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64565494|NCT05601167|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64565495|NCT05601167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64625188|NCT01227655|Levodopa|levodopa|mesh-list
64530309|NCT05789381|Sensory System Agents|sensory system agents|mesh-ancestor
64530310|NCT05789381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64530311|NCT05789381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943039|NCT00033111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943040|NCT00033111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943053|NCT00033267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64943054|NCT00033267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64943055|NCT00033267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943056|NCT00033267|Antifungal Agents|antifungal agents|mesh-ancestor
64943057|NCT00033267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64943058|NCT00033267|Immunologic Factors|immunologic factors|mesh-ancestor
64943059|NCT00033267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943060|NCT00033306|Irinotecan|irinotecan|mesh-list
64530318|NCT05789381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530319|NCT05789381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64530320|NCT05789381|Tocolytic Agents|tocolytic agents|mesh-ancestor
64530329|NCT05787600|Dermatologic Agents|dermatologic agents|mesh-ancestor
64530330|NCT05777135|Propofol|propofol|mesh-list
64530331|NCT05777135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64530332|NCT05777135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64530333|NCT05777135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530334|NCT05777135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64530335|NCT05777135|Anesthetics, General|anesthetics, general|mesh-ancestor
64530336|NCT05777135|Anesthetics|anesthetics|mesh-ancestor
64530337|NCT05771883|Lenalidomide|lenalidomide|mesh-list
64530338|NCT05771883|Immunologic Factors|immunologic factors|mesh-ancestor
64530339|NCT05771883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530340|NCT05771883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64295026|NCT04646967|Acetaminophen|acetaminophen|mesh-list
64943142|NCT00033696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64651640|NCT04380818|Azithromycin|azithromycin|mesh-list
64651641|NCT04380818|Hydroxychloroquine|hydroxychloroquine|mesh-list
64943186|NCT02971410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64943187|NCT02971410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64943188|NCT02971410|Antimetabolites|antimetabolites|mesh-ancestor
64943189|NCT02971410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943190|NCT02971410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64943191|NCT02971410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64943192|NCT02971410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943193|NCT02035397|Botulinum Toxins|botulinum toxins|mesh-list
64943194|NCT02035397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64943195|NCT02035397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64565496|NCT05605613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64565497|NCT05605613|Antibodies|antibodies|mesh-list
64625242|NCT02725424|Docetaxel|docetaxel|mesh-list
64943201|NCT02035397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943202|NCT02035397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64943203|NCT02035397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64943205|NCT00034047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64943207|NCT00034047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64943208|NCT00034047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943209|NCT00034086|Ritonavir|ritonavir|mesh-list
64943210|NCT00034086|Lopinavir|lopinavir|mesh-list
64943211|NCT00034086|Tenofovir|tenofovir|mesh-list
64530370|NCT05730816|Anesthetics|anesthetics|mesh-ancestor
64530371|NCT05730816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64486542|NCT01908803|Hormones|hormones|mesh-ancestor
64530372|NCT05730816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64530373|NCT05730816|Anticonvulsants|anticonvulsants|mesh-ancestor
64530374|NCT05730816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64530375|NCT05730816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64530376|NCT05730816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530377|NCT05730816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64530378|NCT05730816|Tocolytic Agents|tocolytic agents|mesh-ancestor
64530379|NCT05730816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64295059|NCT05341323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64295065|NCT04622865|Quercetin|quercetin|mesh-list
64943233|NCT00034086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64943234|NCT00034086|Antimetabolites|antimetabolites|mesh-ancestor
64943235|NCT00034125|Tamoxifen|tamoxifen|mesh-list
64943236|NCT00034125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64943237|NCT00034125|Hormone Antagonists|hormone antagonists|mesh-ancestor
64943238|NCT00034125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64943239|NCT00034125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943240|NCT00034125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64943241|NCT00034125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943242|NCT00034125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64943243|NCT00034125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64943244|NCT00034125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64943245|NCT00034164|Paclitaxel|paclitaxel|mesh-list
64943246|NCT00034164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64943247|NCT00034164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943248|NCT00034164|Tubulin Modulators|tubulin modulators|mesh-ancestor
64943249|NCT00034164|Antimitotic Agents|antimitotic agents|mesh-ancestor
64943250|NCT00034164|Mitosis Modulators|mitosis modulators|mesh-ancestor
64943251|NCT00034164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943252|NCT00034242|Immunoglobulins|immunoglobulins|mesh-list
64943253|NCT00034242|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64943254|NCT00034242|Antibodies|antibodies|mesh-list
64943255|NCT00034242|gamma-Globulins|gamma-globulins|mesh-list
64943256|NCT00034242|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64943257|NCT00034242|Immunologic Factors|immunologic factors|mesh-ancestor
64943258|NCT00034242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943259|NCT01807325|Pancrelipase|pancrelipase|mesh-list
64943260|NCT01807325|Pancreatin|pancreatin|mesh-list
64943261|NCT01807325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64943262|NCT01807286|Dexamethasone|dexamethasone|mesh-list
64943263|NCT01807286|Melphalan|melphalan|mesh-list
64943264|NCT01807286|Pomalidomide|pomalidomide|mesh-list
64943265|NCT01807286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64943266|NCT01807286|Antiemetics|antiemetics|mesh-ancestor
64530392|NCT05702333|Epinephrine|epinephrine|mesh-list
64295074|NCT02473185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64295077|NCT02473185|Dopamine Agents|dopamine agents|mesh-ancestor
64943270|NCT01807286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64943271|NCT01807286|Glucocorticoids|glucocorticoids|mesh-ancestor
64943272|NCT01807286|Hormones|hormones|mesh-ancestor
64943273|NCT01807286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64943274|NCT01807286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64943275|NCT01807286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943276|NCT01807286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64943277|NCT01807286|Alkylating Agents|alkylating agents|mesh-ancestor
64943278|NCT01807286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943293|NCT00034359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64943294|NCT00034359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64943295|NCT00034593|Gemcitabine|gemcitabine|mesh-list
64565498|NCT05605613|Immunologic Factors|immunologic factors|mesh-ancestor
64517263|NCT01615887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64517264|NCT04389801|Deferoxamine|deferoxamine|mesh-list
64517265|NCT04389801|Siderophores|siderophores|mesh-ancestor
64943296|NCT00034593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64943297|NCT00034593|Antimetabolites|antimetabolites|mesh-ancestor
64943298|NCT00034593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943299|NCT00034593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943300|NCT00034593|Antiviral Agents|antiviral agents|mesh-ancestor
64943301|NCT00034593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64943302|NCT00034593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943303|NCT00034593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64943304|NCT00034593|Immunologic Factors|immunologic factors|mesh-ancestor
64943305|NCT00034593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943306|NCT00034632|Posaconazole|posaconazole|mesh-list
64943307|NCT00034632|Antifungal Agents|antifungal agents|mesh-ancestor
64943308|NCT00034632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64943309|NCT00034632|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64943310|NCT00034632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64943311|NCT00034632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64943312|NCT00034632|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64943313|NCT00034632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64943314|NCT00034632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943315|NCT00034632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943316|NCT00034632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64943317|NCT00034632|Hormone Antagonists|hormone antagonists|mesh-ancestor
64943318|NCT00034632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64943319|NCT00034632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943320|NCT00034671|Posaconazole|posaconazole|mesh-list
64943321|NCT00034671|Antifungal Agents|antifungal agents|mesh-ancestor
64943322|NCT00034671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64943323|NCT00034671|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64943324|NCT00034671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64943325|NCT00034671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64943326|NCT00034671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64943327|NCT00034671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64943367|NCT00034749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64943368|NCT00034749|Serotonin Agents|serotonin agents|mesh-ancestor
64943369|NCT00034749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64943370|NCT00034749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943371|NCT00034749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943372|NCT00034749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64943373|NCT00034749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64943374|NCT00034749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64943375|NCT00034749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64943376|NCT00034749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64943377|NCT00034749|Dopamine Agents|dopamine agents|mesh-ancestor
64943378|NCT00034788|Becaplermin|becaplermin|mesh-list
64943379|NCT00034788|Anticoagulants|anticoagulants|mesh-ancestor
64943380|NCT00034788|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
64943381|NCT00034788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64943382|NCT00034788|Growth Substances|growth substances|mesh-ancestor
64943383|NCT00034788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943384|NCT00034866|Tipranavir|tipranavir|mesh-list
64943418|NCT01806311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64943420|NCT00034944|Antiemetics|antiemetics|mesh-ancestor
64943421|NCT00034944|Autonomic Agents|autonomic agents|mesh-ancestor
64943422|NCT00034944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64943423|NCT00034944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943424|NCT00034944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64943425|NCT00034944|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64943426|NCT00034944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64943427|NCT00034944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530421|NCT05684744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530422|NCT05684744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64530424|NCT05684744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530425|NCT05684744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530426|NCT05684744|Dermatologic Agents|dermatologic agents|mesh-ancestor
64530427|NCT05684744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530428|NCT05684744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64517266|NCT04389801|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64517267|NCT04389801|Chelating Agents|chelating agents|mesh-ancestor
64565499|NCT05605613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565500|NCT05605613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530429|NCT05684744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64530430|NCT05684744|Immunologic Factors|immunologic factors|mesh-ancestor
64530431|NCT05684744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64530432|NCT05684744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64943445|NCT00034983|Antidepressive Agents|antidepressive agents|mesh-ancestor
64943446|NCT00034983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64943447|NCT00034983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64943448|NCT00034983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64943449|NCT00034983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943450|NCT00034983|Antiemetics|antiemetics|mesh-ancestor
64943451|NCT00034983|Autonomic Agents|autonomic agents|mesh-ancestor
64943452|NCT00034983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64943453|NCT00034983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64943454|NCT00034983|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64943455|NCT00035061|Pemetrexed|pemetrexed|mesh-list
64943456|NCT00035061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943457|NCT00035061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943458|NCT00035061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943459|NCT00035061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64943460|NCT00035061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64943461|NCT00393497|Bevacizumab|bevacizumab|mesh-list
64943462|NCT00393497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64943463|NCT00393497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943464|NCT00393497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64943476|NCT00035139|Methylphenidate|methylphenidate|mesh-list
64943477|NCT00035139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64943478|NCT00035139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943479|NCT00035139|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64943480|NCT00035139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64530436|NCT05671913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64530437|NCT05671913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530438|NCT05671913|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64530439|NCT05671913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64530440|NCT05671913|Anesthetics, General|anesthetics, general|mesh-ancestor
64530441|NCT05671913|Anesthetics|anesthetics|mesh-ancestor
64530442|NCT05671913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64530443|NCT05671913|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64714118|NCT03054805|Magnesium Oxide|magnesium oxide|mesh-list
64943497|NCT00035256|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64943498|NCT00035256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64943499|NCT00035256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943500|NCT00035256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64943501|NCT00035256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64943502|NCT00035256|Hormone Antagonists|hormone antagonists|mesh-ancestor
64530458|NCT05668936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64530459|NCT05668936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530460|NCT05668936|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64530461|NCT05668936|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64530462|NCT05668936|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64530479|NCT05657990|Urological Agents|urological agents|mesh-ancestor
64530480|NCT05649722|Treprostinil|treprostinil|mesh-list
64530481|NCT05649722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64530482|NCT05645900|Vaccines|vaccines|mesh-list
64530483|NCT05645900|Immunologic Factors|immunologic factors|mesh-ancestor
64530484|NCT05645900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530485|NCT05633381|Temozolomide|temozolomide|mesh-list
64530486|NCT05633381|Trabectedin|trabectedin|mesh-list
64530487|NCT05633381|Olaparib|olaparib|mesh-list
64943503|NCT00035256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64943504|NCT00035256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64943505|NCT00035256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64943506|NCT00035295|Aprepitant|aprepitant|mesh-list
64943507|NCT00035295|Antiemetics|antiemetics|mesh-ancestor
64943508|NCT00035295|Autonomic Agents|autonomic agents|mesh-ancestor
64943509|NCT00035295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565501|NCT05605613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565502|NCT05602259|Dimercaprol|dimercaprol|mesh-list
64565503|NCT05602259|Chelating Agents|chelating agents|mesh-ancestor
64943510|NCT00035295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943511|NCT00035295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64943512|NCT00035295|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64943513|NCT00035295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64530489|NCT05633381|Alkylating Agents|alkylating agents|mesh-ancestor
64530490|NCT05633381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530491|NCT05633381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530492|NCT05633381|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64530493|NCT05633381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530494|NCT05627752|Docetaxel|docetaxel|mesh-list
64530495|NCT05627752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530496|NCT05627752|Tubulin Modulators|tubulin modulators|mesh-ancestor
64530497|NCT05627752|Antimitotic Agents|antimitotic agents|mesh-ancestor
64530498|NCT05627752|Mitosis Modulators|mitosis modulators|mesh-ancestor
64530499|NCT05627752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530500|NCT05613088|Paclitaxel|paclitaxel|mesh-list
64530501|NCT05613088|Doxorubicin|doxorubicin|mesh-list
64530502|NCT05613088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64530503|NCT05613088|Topotecan|topotecan|mesh-list
64530504|NCT05613088|Farletuzumab|farletuzumab|mesh-list
64530505|NCT05613088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64530506|NCT05613088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530507|NCT05613088|Tubulin Modulators|tubulin modulators|mesh-ancestor
64530508|NCT05613088|Antimitotic Agents|antimitotic agents|mesh-ancestor
64651771|NCT02476422|Analgesics|analgesics|mesh-ancestor
64943525|NCT00035451|Adrenergic Agents|adrenergic agents|mesh-ancestor
64943526|NCT00035451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64943541|NCT00035490|Azimilide|azimilide|mesh-list
64943542|NCT00035490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64943543|NCT00035490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64943544|NCT00035490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64530516|NCT05609942|Azacitidine|azacitidine|mesh-list
64530517|NCT05609942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64530518|NCT05609942|Antimetabolites|antimetabolites|mesh-ancestor
64530519|NCT05609942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530520|NCT05609942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530521|NCT05609942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530522|NCT05590676|Metformin|metformin|mesh-list
64530523|NCT05590676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64530524|NCT05590676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530525|NCT05577481|Antidepressive Agents|antidepressive agents|mesh-list
64530526|NCT05577481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64530527|NCT05576350|Ethanol|ethanol|mesh-list
64530528|NCT05576350|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64530529|NCT05576350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64530530|NCT05576350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64530531|NCT05576350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530532|NCT05559814|Peppermint oil|peppermint oil|mesh-list
64530533|NCT05559814|Antiemetics|antiemetics|mesh-ancestor
64530534|NCT05559814|Autonomic Agents|autonomic agents|mesh-ancestor
64530535|NCT05559814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64530536|NCT05559814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530537|NCT05559814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64530538|NCT05559814|Parasympatholytics|parasympatholytics|mesh-ancestor
64530539|NCT05558007|Tadalafil|tadalafil|mesh-list
64530540|NCT05558007|Vasodilator Agents|vasodilator agents|mesh-ancestor
64530541|NCT05558007|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64530542|NCT05558007|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64295215|NCT05192798|Paclitaxel|paclitaxel|mesh-list
64943545|NCT00035490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943546|NCT00035490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64943547|NCT00035490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943548|NCT00035607|Darbepoetin alfa|darbepoetin alfa|mesh-list
64943549|NCT00035607|Hematinics|hematinics|mesh-ancestor
64530555|NCT05556616|Growth Inhibitors|growth inhibitors|mesh-ancestor
64530556|NCT05556616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530557|NCT05544136|Carboplatin|carboplatin|mesh-list
64530558|NCT05544136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530559|NCT05539027|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64530560|NCT05539027|N-Methylaspartate|n-methylaspartate|mesh-list
64530561|NCT05539027|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
64565504|NCT05602259|Sequestering Agents|sequestering agents|mesh-ancestor
64565505|NCT05602259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565506|NCT04393883|Pembrolizumab|pembrolizumab|mesh-list
64565507|NCT04393883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64565508|NCT04393883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565509|NCT03032783|Mycophenolic Acid|mycophenolic acid|mesh-list
64565510|NCT03032783|Cyclophosphamide|cyclophosphamide|mesh-list
64565511|NCT03032783|Tacrolimus|tacrolimus|mesh-list
64530562|NCT05539027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64530563|NCT05539027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64530564|NCT05539027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530565|NCT05539027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295240|NCT03108807|Fibrin fragment D|fibrin fragment d|mesh-list
64943566|NCT04732377|Dexmedetomidine|dexmedetomidine|mesh-list
64943567|NCT04732377|Bupivacaine|bupivacaine|mesh-list
64943568|NCT04732377|Anesthetics, Local|anesthetics, local|mesh-ancestor
64943570|NCT04732377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64943571|NCT04732377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943572|NCT04732377|Sensory System Agents|sensory system agents|mesh-ancestor
64943573|NCT04732377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64943574|NCT04732377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64943575|NCT04732377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64943576|NCT04732377|Analgesics|analgesics|mesh-ancestor
64651800|NCT00893984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64943579|NCT04732377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64943580|NCT04732377|Adrenergic Agents|adrenergic agents|mesh-ancestor
64943581|NCT04732377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64943582|NCT04732377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943583|NCT01805726|Dexmedetomidine|dexmedetomidine|mesh-list
64943584|NCT01805726|Alfentanil|alfentanil|mesh-list
64943585|NCT01805726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64943586|NCT01805726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64943587|NCT01805726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943588|NCT01805726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64943601|NCT01805726|Anesthetics, General|anesthetics, general|mesh-ancestor
64943602|NCT01805726|Anesthetics|anesthetics|mesh-ancestor
64943603|NCT00035958|Prednisone|prednisone|mesh-list
64943604|NCT00035958|Etanercept|etanercept|mesh-list
64943605|NCT00035958|Methotrexate|methotrexate|mesh-list
64943606|NCT00035958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64530566|NCT05513586|Immunoglobulins|immunoglobulins|mesh-list
64530567|NCT05513586|Immunologic Factors|immunologic factors|mesh-ancestor
64530568|NCT05513586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530569|NCT05505292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64530570|NCT05505292|Lifitegrast|lifitegrast|mesh-list
64530571|NCT05505292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64530572|NCT05492994|Carbon Monoxide|carbon monoxide|mesh-list
64530573|NCT05492994|Antimetabolites|antimetabolites|mesh-ancestor
64530574|NCT05492994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530575|NCT05492994|Gasotransmitters|gasotransmitters|mesh-ancestor
64530576|NCT05492994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64530577|NCT05492994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530578|NCT05491317|Pembrolizumab|pembrolizumab|mesh-list
64530579|NCT05491317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64530580|NCT05491317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530582|NCT05477953|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64530583|NCT05477953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64530584|NCT05477953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64943607|NCT00035958|Glucocorticoids|glucocorticoids|mesh-ancestor
64943608|NCT00035958|Hormones|hormones|mesh-ancestor
64943609|NCT00035958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64943610|NCT00035958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943611|NCT00035958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64943612|NCT00035958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943613|NCT00035958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64943614|NCT00035958|Abortifacient Agents|abortifacient agents|mesh-ancestor
64943615|NCT00035958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64943616|NCT00035958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64565512|NCT03032783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64565513|NCT03032783|Immunologic Factors|immunologic factors|mesh-ancestor
64565514|NCT03032783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943617|NCT00035958|Antimetabolites|antimetabolites|mesh-ancestor
64943618|NCT00035958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943619|NCT00035958|Dermatologic Agents|dermatologic agents|mesh-ancestor
64943620|NCT00035958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943621|NCT00035958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64943622|NCT00035958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64943623|NCT00035958|Immunologic Factors|immunologic factors|mesh-ancestor
64943624|NCT00035958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64943625|NCT00035958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64943626|NCT00035958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64943627|NCT00035958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64943628|NCT00035958|Analgesics|analgesics|mesh-ancestor
64943629|NCT00035958|Sensory System Agents|sensory system agents|mesh-ancestor
64943630|NCT00035958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64943631|NCT00035958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64943632|NCT01805687|Zileuton|zileuton|mesh-list
64943633|NCT01805687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64943634|NCT01805687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64943635|NCT01805687|Analgesics|analgesics|mesh-ancestor
64943636|NCT01805687|Sensory System Agents|sensory system agents|mesh-ancestor
64943637|NCT01805687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64943638|NCT01805687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943639|NCT01805687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64943640|NCT01805687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64712136|NCT04702893|Nintedanib|nintedanib|mesh-list
64943642|NCT01805687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943643|NCT01805687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943645|NCT01805687|Hormone Antagonists|hormone antagonists|mesh-ancestor
64943646|NCT01805687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64943647|NCT00035997|Zoledronic Acid|zoledronic acid|mesh-list
64943648|NCT00035997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64943649|NCT00035997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943650|NCT01805570|Ticagrelor|ticagrelor|mesh-list
64943671|NCT00036114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64943672|NCT00036114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64943673|NCT00036114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64943674|NCT00036114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943675|NCT00036114|Dopamine Agonists|dopamine agonists|mesh-ancestor
64943676|NCT00036114|Dopamine Agents|dopamine agents|mesh-ancestor
64943677|NCT00036114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64943678|NCT00036114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943679|NCT00036114|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64943680|NCT00036114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64943681|NCT00036114|Serotonin Agents|serotonin agents|mesh-ancestor
64943682|NCT00036114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64943683|NCT00036114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64943684|NCT00036114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64943685|NCT00036114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64943686|NCT01805453|Losartan|losartan|mesh-list
64943687|NCT01805453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64943688|NCT01805453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64943689|NCT01805453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64943690|NCT01805453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64943691|NCT01805453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943692|NCT00036153|Methotrexate|methotrexate|mesh-list
64943693|NCT00036153|Tacrolimus|tacrolimus|mesh-list
64943694|NCT00036153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64943695|NCT00036153|Abortifacient Agents|abortifacient agents|mesh-ancestor
64943696|NCT00036153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64943697|NCT00036153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943698|NCT00036153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64943699|NCT00036153|Antimetabolites|antimetabolites|mesh-ancestor
64943700|NCT00036153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943701|NCT00036153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943704|NCT00036153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64943705|NCT00036153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64565515|NCT03032783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64565516|NCT03032783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64565517|NCT03032783|Alkylating Agents|alkylating agents|mesh-ancestor
64565518|NCT03032783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565519|NCT03032783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64625672|NCT00000430|Alendronate|alendronate|mesh-list
64943706|NCT00036153|Immunologic Factors|immunologic factors|mesh-ancestor
64943707|NCT00036153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64943708|NCT00036153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64943709|NCT00036153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64943711|NCT00036231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64943712|NCT00036231|Hormones|hormones|mesh-ancestor
64943713|NCT00036231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64943714|NCT00036231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943715|NCT00036309|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64943716|NCT00036309|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64943717|NCT00036309|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64943718|NCT00036309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64943719|NCT00036309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943720|NCT00036309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64943721|NCT00036309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943722|NCT00036309|Analgesics|analgesics|mesh-ancestor
64530600|NCT05459129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64530601|NCT05459129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530603|NCT05459129|Antimitotic Agents|antimitotic agents|mesh-ancestor
64530604|NCT05459129|Mitosis Modulators|mitosis modulators|mesh-ancestor
64530605|NCT05459129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530606|NCT05438420|Pembrolizumab|pembrolizumab|mesh-list
64530607|NCT05438420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64530608|NCT05438420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530609|NCT05419466|Melatonin|melatonin|mesh-list
64530610|NCT05419466|Antioxidants|antioxidants|mesh-ancestor
64943723|NCT00036309|Sensory System Agents|sensory system agents|mesh-ancestor
64943724|NCT00036309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64943725|NCT00036309|Antidepressive Agents|antidepressive agents|mesh-ancestor
64943726|NCT00036309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64943727|NCT00036309|Dopamine Agents|dopamine agents|mesh-ancestor
64943728|NCT00036348|Aripiprazole|aripiprazole|mesh-list
64943729|NCT00036348|Antidepressive Agents|antidepressive agents|mesh-ancestor
64943730|NCT00036348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64943731|NCT00036348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64943732|NCT00036348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64943733|NCT00036348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64943734|NCT00036348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943735|NCT00036348|Dopamine Agonists|dopamine agonists|mesh-ancestor
64943736|NCT00036348|Dopamine Agents|dopamine agents|mesh-ancestor
64943737|NCT00036348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64943738|NCT00036348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943739|NCT00036348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64943740|NCT00036348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64943741|NCT00036348|Serotonin Agents|serotonin agents|mesh-ancestor
64943742|NCT00036348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64943743|NCT00036348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64943744|NCT00036348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64943760|NCT01466465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64943761|NCT01466465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64943762|NCT00036504|Insulin Lispro|insulin lispro|mesh-list
64943763|NCT00036504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64943764|NCT00036504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943765|NCT00036543|Atrasentan|atrasentan|mesh-list
64943766|NCT00036543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943767|NCT00036543|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64943768|NCT00036543|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64943769|NCT00036543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943770|NCT01466231|Everolimus|everolimus|mesh-list
64943771|NCT01466231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565520|NCT03032783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64565521|NCT03032783|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64565522|NCT03032783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943772|NCT01466231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64943773|NCT01466231|Immunologic Factors|immunologic factors|mesh-ancestor
64943774|NCT01466231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943775|NCT00036582|Clozapine|clozapine|mesh-list
64943776|NCT00036582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64943777|NCT00036582|Serotonin Agents|serotonin agents|mesh-ancestor
64530611|NCT05419466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530612|NCT05419466|Protective Agents|protective agents|mesh-ancestor
64530613|NCT05419466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530614|NCT05419466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64530616|NCT05418556|Clopidogrel|clopidogrel|mesh-list
64530617|NCT05418556|Ticagrelor|ticagrelor|mesh-list
64530618|NCT05418556|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64530619|NCT05418556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64530620|NCT05418556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64530621|NCT05418556|Analgesics|analgesics|mesh-ancestor
64530622|NCT05418556|Sensory System Agents|sensory system agents|mesh-ancestor
64943778|NCT00036582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64943779|NCT00036582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943780|NCT00036582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943782|NCT00036582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64943783|NCT00036582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64943784|NCT00036582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64943785|NCT00036582|GABA Antagonists|gaba antagonists|mesh-ancestor
64943787|NCT01466114|Norethindrone|norethindrone|mesh-list
64943788|NCT01466114|Norethindrone Acetate|norethindrone acetate|mesh-list
64943789|NCT01466114|Progestins|progestins|mesh-list
64943790|NCT01466114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64943791|NCT01466114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64943792|NCT01466114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64943793|NCT01466114|Contraceptive Agents|contraceptive agents|mesh-ancestor
64943794|NCT01466114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64943795|NCT01466114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943796|NCT01466114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64943797|NCT01466114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64943798|NCT01466114|Hormones|hormones|mesh-ancestor
64943799|NCT01466114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64943800|NCT00036777|Carboplatin|carboplatin|mesh-list
64943801|NCT00036777|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
64943802|NCT00036777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943803|NCT00036777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64943804|NCT00036777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530635|NCT05418556|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64530636|NCT05418556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64530637|NCT05418556|Purinergic Agents|purinergic agents|mesh-ancestor
64530638|NCT05418556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64530639|NCT05400109|Cyclophosphamide|cyclophosphamide|mesh-list
64530640|NCT05400109|Fludarabine|fludarabine|mesh-list
64295321|NCT04398914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64295322|NCT04398914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295323|NCT04398914|Tubulin Modulators|tubulin modulators|mesh-ancestor
64943805|NCT00036777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943817|NCT01465919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64943818|NCT01465919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64943819|NCT01465919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64943820|NCT01465919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64943821|NCT01465919|Adrenergic Agents|adrenergic agents|mesh-ancestor
64943822|NCT01465919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64943823|NCT01465919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64943824|NCT01465919|Serotonin Agents|serotonin agents|mesh-ancestor
64943825|NCT01465919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64943826|NCT00396513|Metformin|metformin|mesh-list
64943827|NCT00396513|Simvastatin|simvastatin|mesh-list
64943828|NCT00396513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64943829|NCT00396513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943830|NCT00396513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64943859|NCT01465685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943861|NCT01465685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64565523|NCT03032783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64565524|NCT03032783|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64565525|NCT03032783|Antitubercular Agents|antitubercular agents|mesh-ancestor
64943862|NCT01465685|Hallucinogens|hallucinogens|mesh-ancestor
64943863|NCT01465685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64943864|NCT01465685|Serotonin Agents|serotonin agents|mesh-ancestor
64530644|NCT05400109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530645|NCT05400109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64530646|NCT05400109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64530647|NCT05400109|Alkylating Agents|alkylating agents|mesh-ancestor
64530648|NCT05400109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530649|NCT05400109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530650|NCT05400109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64530651|NCT05400109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64530652|NCT05400109|Antimetabolites|antimetabolites|mesh-ancestor
64530653|NCT05386472|Ritonavir|ritonavir|mesh-list
64943894|NCT01465412|Sensory System Agents|sensory system agents|mesh-ancestor
64943895|NCT01465412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64943896|NCT01465412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943897|NCT01465412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64943898|NCT01465412|Vasodilator Agents|vasodilator agents|mesh-ancestor
64943899|NCT01465412|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64943900|NCT01465412|Purinergic Agonists|purinergic agonists|mesh-ancestor
64943901|NCT01465412|Purinergic Agents|purinergic agents|mesh-ancestor
64943902|NCT01465412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64943903|NCT01465412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943904|NCT01465373|Progesterone|progesterone|mesh-list
64943905|NCT01465373|Progestins|progestins|mesh-ancestor
64943906|NCT01465373|Hormones|hormones|mesh-ancestor
64943907|NCT01465373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64943908|NCT01465373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943909|NCT01465256|Aspirin|aspirin|mesh-list
64530658|NCT05386472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530659|NCT05386472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64530660|NCT05386472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64530661|NCT05386472|Antiviral Agents|antiviral agents|mesh-ancestor
64530662|NCT05386472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64530663|NCT05386472|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64530664|NCT05386472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64530665|NCT05382481|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64530666|NCT05382481|Dalteparin|dalteparin|mesh-list
64530667|NCT05382481|Anticoagulants|anticoagulants|mesh-ancestor
64530668|NCT05382481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64295341|NCT02807623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651846|NCT01533077|Opicapone|opicapone|mesh-list
64530675|NCT05353283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64530676|NCT05353283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530677|NCT05353283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530678|NCT05353283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64530679|NCT05353283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64943910|NCT01465256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64530681|NCT05338320|Morphine|morphine|mesh-list
64530682|NCT05338320|Anesthetics|anesthetics|mesh-ancestor
64530683|NCT05338320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64530684|NCT05338320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530685|NCT05338320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64530686|NCT05338320|Narcotics|narcotics|mesh-ancestor
64530687|NCT05338320|Analgesics|analgesics|mesh-ancestor
64530688|NCT05338320|Sensory System Agents|sensory system agents|mesh-ancestor
64530689|NCT05338320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64530690|NCT05338320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64530691|NCT05338320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64530692|NCT05338320|Anesthetics, General|anesthetics, general|mesh-ancestor
64530693|NCT05329545|Immunoconjugates|immunoconjugates|mesh-list
64530694|NCT05329545|Immunologic Factors|immunologic factors|mesh-ancestor
64530695|NCT05329545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530696|NCT05327023|Mycophenolic Acid|mycophenolic acid|mesh-list
64530697|NCT05327023|Sirolimus|sirolimus|mesh-list
64530698|NCT05327023|Cyclophosphamide|cyclophosphamide|mesh-list
64530699|NCT05327023|Busulfan|busulfan|mesh-list
64530700|NCT05327023|Fludarabine|fludarabine|mesh-list
64530737|NCT05301062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530738|NCT05262387|Insulin Lispro|insulin lispro|mesh-list
64565558|NCT02981173|Psilocybin|psilocybin|mesh-list
64565559|NCT02981173|Hallucinogens|hallucinogens|mesh-ancestor
64625898|NCT01151761|Cisplatin|cisplatin|mesh-list
64530739|NCT05262387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64530740|NCT05262387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530741|NCT05256069|Propranolol|propranolol|mesh-list
64530742|NCT05256069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64530743|NCT05256069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64530744|NCT05256069|Adrenergic Agents|adrenergic agents|mesh-ancestor
64530745|NCT05256069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64530746|NCT05256069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530747|NCT05256069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530748|NCT05256069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64530802|NCT05169593|Infliximab|infliximab|mesh-list
64530803|NCT05169593|Ustekinumab|ustekinumab|mesh-list
64530804|NCT05169593|Vedolizumab|vedolizumab|mesh-list
64651859|NCT01534013|Insulin|insulin|mesh-list
64943920|NCT01465256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943921|NCT01465256|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64943922|NCT01465256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64943923|NCT01465256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943924|NCT01465256|Antipyretics|antipyretics|mesh-ancestor
64943925|NCT00037479|Ceftriaxone|ceftriaxone|mesh-list
64943926|NCT00037479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64943927|NCT00037479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64943928|NCT01464983|Aspirin|aspirin|mesh-list
64943929|NCT01464983|Ibuprofen|ibuprofen|mesh-list
64943930|NCT01464983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64943943|NCT01464983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943944|NCT01464983|Antipyretics|antipyretics|mesh-ancestor
64943946|NCT00037518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64943947|NCT00037518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943948|NCT00037518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64943949|NCT00037518|Hormone Antagonists|hormone antagonists|mesh-ancestor
64943950|NCT00037518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64943951|NCT01464944|Aspirin|aspirin|mesh-list
64943952|NCT01464944|Acetaminophen|acetaminophen|mesh-list
64943953|NCT01464944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64943954|NCT01464944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64943955|NCT01464944|Analgesics|analgesics|mesh-ancestor
64943956|NCT01464944|Sensory System Agents|sensory system agents|mesh-ancestor
64943957|NCT01464944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64943958|NCT01464944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651865|NCT01534013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64943972|NCT00037596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943973|NCT00037596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943974|NCT00037596|Antiviral Agents|antiviral agents|mesh-ancestor
64943975|NCT00037596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64943976|NCT00037596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64943977|NCT00037596|Immunologic Factors|immunologic factors|mesh-ancestor
64943978|NCT00037596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943979|NCT00037596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64943980|NCT00037635|Cinacalcet|cinacalcet|mesh-list
64943981|NCT00037635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64943982|NCT00037635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943983|NCT00037635|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64943984|NCT00037635|Hormone Antagonists|hormone antagonists|mesh-ancestor
64943985|NCT00037635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64943986|NCT00037674|Topiramate|topiramate|mesh-list
64943987|NCT00037674|Anticonvulsants|anticonvulsants|mesh-ancestor
64943988|NCT00037674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64943989|NCT00037674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943990|NCT00037752|Sibutramine|sibutramine|mesh-list
64943991|NCT00037752|Antidepressive Agents|antidepressive agents|mesh-ancestor
64943992|NCT00037752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64943993|NCT00037752|Appetite Depressants|appetite depressants|mesh-ancestor
64944000|NCT01464671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944002|NCT01464671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64944003|NCT01464671|Protease Inhibitors|protease inhibitors|mesh-ancestor
64944004|NCT01464671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944005|NCT00037869|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64651880|NCT01833728|Analgesics|analgesics|mesh-ancestor
64651881|NCT01833728|Sensory System Agents|sensory system agents|mesh-ancestor
64565560|NCT02981173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565561|NCT02981173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64565562|NCT04125745|CXA-10|cxa-10|mesh-list
64565563|NCT04125745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64651882|NCT01833728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64944017|NCT00393731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64944018|NCT00393731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64530828|NCT05145413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64530829|NCT05145413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530830|NCT05145413|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64530831|NCT05145413|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64530833|NCT05145413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64530834|NCT05145413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530835|NCT05145413|Urological Agents|urological agents|mesh-ancestor
64530836|NCT05145413|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64530837|NCT05145413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64530838|NCT05145413|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64530839|NCT05145413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64295486|NCT02053519|Vitamin D|vitamin d|mesh-list
64944020|NCT00038025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944021|NCT00038025|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
64944022|NCT00038025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944023|NCT00038025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944024|NCT00393770|Acetylcarnitine|acetylcarnitine|mesh-list
64944025|NCT00393770|Vitamin B Complex|vitamin b complex|mesh-ancestor
64944026|NCT00393770|Vitamins|vitamins|mesh-ancestor
64944027|NCT00393770|Micronutrients|micronutrients|mesh-ancestor
64944028|NCT00393770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944029|NCT00393770|Nootropic Agents|nootropic agents|mesh-ancestor
64944030|NCT00038064|Darbepoetin alfa|darbepoetin alfa|mesh-list
64944031|NCT00038064|Hematinics|hematinics|mesh-ancestor
64944032|NCT00038181|Thalidomide|thalidomide|mesh-list
64944033|NCT00038181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64944034|NCT00038181|Immunologic Factors|immunologic factors|mesh-ancestor
64944035|NCT00038181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944036|NCT00038181|Leprostatic Agents|leprostatic agents|mesh-ancestor
64944037|NCT00038181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64944038|NCT00038181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64944039|NCT00038181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64944040|NCT00038181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64944041|NCT00038181|Growth Substances|growth substances|mesh-ancestor
64944042|NCT00038181|Growth Inhibitors|growth inhibitors|mesh-ancestor
64944043|NCT00038181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944044|NCT00038220|Ritonavir|ritonavir|mesh-list
64944045|NCT00038220|Lopinavir|lopinavir|mesh-list
64944046|NCT00038220|Tenofovir|tenofovir|mesh-list
64944047|NCT00038220|Lamivudine|lamivudine|mesh-list
64944048|NCT00038220|Efavirenz|efavirenz|mesh-list
64944049|NCT00038220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64651892|NCT03219788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64651893|NCT03219788|Narcotics|narcotics|mesh-ancestor
64651894|NCT03219788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64651895|NCT03219788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651896|NCT03219788|Analgesics|analgesics|mesh-ancestor
64651897|NCT03219788|Sensory System Agents|sensory system agents|mesh-ancestor
64651898|NCT03219788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64651899|NCT03219710|Dexamethasone|dexamethasone|mesh-list
64651900|NCT03219710|Ondansetron|ondansetron|mesh-list
64651901|NCT03219710|Olanzapine|olanzapine|mesh-list
64651902|NCT03219710|Aprepitant|aprepitant|mesh-list
64944054|NCT00038220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64944055|NCT00038220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64944056|NCT00038220|Antiviral Agents|antiviral agents|mesh-ancestor
64944057|NCT00038220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64944058|NCT00038220|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64944079|NCT05433480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64944080|NCT05433480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944081|NCT05433480|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64944082|NCT05433480|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64944083|NCT05433480|Hormone Antagonists|hormone antagonists|mesh-ancestor
64944084|NCT05433480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64944085|NCT05433480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944086|NCT00847262|Amlodipine|amlodipine|mesh-list
64944087|NCT00847262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64565564|NCT04393805|Heparin|heparin|mesh-list
64565565|NCT04393805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64565566|NCT04393805|Tinzaparin|tinzaparin|mesh-list
64565567|NCT04393805|Dalteparin|dalteparin|mesh-list
64565568|NCT04393805|Anticoagulants|anticoagulants|mesh-ancestor
64565569|NCT04393805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64944088|NCT00847262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64530840|NCT05108688|Sumatriptan|sumatriptan|mesh-list
64530841|NCT05108688|Mirtazapine|mirtazapine|mesh-list
64530842|NCT05108688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64530843|NCT05108688|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64530844|NCT05108688|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64530845|NCT05108688|Serotonin Agents|serotonin agents|mesh-ancestor
64530846|NCT05108688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64530847|NCT05108688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530848|NCT05108688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530849|NCT05108688|Antidepressive Agents|antidepressive agents|mesh-ancestor
64530850|NCT05108688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64530851|NCT05108688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64530852|NCT05108688|Histamine Antagonists|histamine antagonists|mesh-ancestor
64530861|NCT05108688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64530862|NCT05108688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64530863|NCT05108688|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64530864|NCT05104723|Tofacitinib|tofacitinib|mesh-list
64530865|NCT05104723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64530866|NCT05104723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530867|NCT05104723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530868|NCT05084053|Immunoglobulins|immunoglobulins|mesh-list
64530869|NCT05084053|Immunologic Factors|immunologic factors|mesh-ancestor
64530870|NCT05084053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530871|NCT05039801|Paclitaxel|paclitaxel|mesh-list
64530872|NCT05039801|Bevacizumab|bevacizumab|mesh-list
64530873|NCT05039801|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64530874|NCT05039801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64530875|NCT05039801|Endothelial Growth Factors|endothelial growth factors|mesh-list
64944089|NCT00847262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64944090|NCT00847262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944091|NCT00847262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64944092|NCT00847262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944093|NCT00847262|Vasodilator Agents|vasodilator agents|mesh-ancestor
64944094|NCT00847223|Tipifarnib|tipifarnib|mesh-list
64944095|NCT00847223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944096|NCT05433207|Eldecalcitol|eldecalcitol|mesh-list
64944097|NCT05433207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64944098|NCT05433207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944099|NCT00847106|Daclizumab|daclizumab|mesh-list
64944100|NCT00847106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64944101|NCT00847106|Immunologic Factors|immunologic factors|mesh-ancestor
64944102|NCT00847106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944103|NCT00396669|Bupropion|bupropion|mesh-list
64944104|NCT00396669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64530877|NCT05039801|Immunoglobulins|immunoglobulins|mesh-list
64530878|NCT05039801|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64530879|NCT05039801|Immunoglobulin G|immunoglobulin g|mesh-list
64530880|NCT05039801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64530881|NCT05039801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944105|NCT00396669|Antidepressive Agents|antidepressive agents|mesh-ancestor
64944106|NCT00396669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64944107|NCT00396669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64944108|NCT00396669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64944109|NCT00396669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64944110|NCT00396669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944132|NCT00396747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944133|NCT00396747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64944135|NCT00396747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944136|NCT00396747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944137|NCT00396747|Dermatologic Agents|dermatologic agents|mesh-ancestor
64944138|NCT00396747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944139|NCT00396747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64565570|NCT04393805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64944140|NCT00396747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64944141|NCT00396747|Immunologic Factors|immunologic factors|mesh-ancestor
64944142|NCT00396747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64944143|NCT00396747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64944144|NCT00396747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64944145|NCT00396747|Antiemetics|antiemetics|mesh-ancestor
64944146|NCT00396747|Autonomic Agents|autonomic agents|mesh-ancestor
64944147|NCT00396747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64944148|NCT00396747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64944149|NCT00396747|Glucocorticoids|glucocorticoids|mesh-ancestor
64944150|NCT00396747|Hormones|hormones|mesh-ancestor
64944151|NCT00396747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64944152|NCT00396747|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64944153|NCT00396747|Protective Agents|protective agents|mesh-ancestor
64944154|NCT00396747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64944155|NCT00846950|Lorazepam|lorazepam|mesh-list
64944156|NCT00846950|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
64944157|NCT00846950|Anticonvulsants|anticonvulsants|mesh-ancestor
64944158|NCT00846950|Antiemetics|antiemetics|mesh-ancestor
64944159|NCT00846950|Autonomic Agents|autonomic agents|mesh-ancestor
64944160|NCT00846950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64944161|NCT00846950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944162|NCT00846950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64944163|NCT00846950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64944164|NCT00846950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64944175|NCT05432934|Dexamethasone|dexamethasone|mesh-list
64944176|NCT05432934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64530892|NCT05022901|Melphalan|melphalan|mesh-list
64530893|NCT05022901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64530894|NCT05022901|Alkylating Agents|alkylating agents|mesh-ancestor
64530895|NCT05022901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530896|NCT05022901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530897|NCT05022901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64530898|NCT05022901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64530899|NCT05022901|Immunologic Factors|immunologic factors|mesh-ancestor
64530900|NCT05022901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530910|NCT04985500|Bupivacaine|bupivacaine|mesh-list
64530911|NCT04985500|Anesthetics, Local|anesthetics, local|mesh-ancestor
64530912|NCT04985500|Anesthetics|anesthetics|mesh-ancestor
64530920|NCT04973670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64530921|NCT04973670|Protease Inhibitors|protease inhibitors|mesh-ancestor
64530922|NCT04973670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530923|NCT04973670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530924|NCT04967248|Fulvestrant|fulvestrant|mesh-list
64530925|NCT04967248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64530926|NCT04967248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530927|NCT04967248|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64944177|NCT05432934|Antiemetics|antiemetics|mesh-ancestor
64944178|NCT05432934|Autonomic Agents|autonomic agents|mesh-ancestor
64944179|NCT05432934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64944180|NCT05432934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944181|NCT05432934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64944182|NCT05432934|Glucocorticoids|glucocorticoids|mesh-ancestor
64944183|NCT05432934|Hormones|hormones|mesh-ancestor
64944184|NCT05432934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64944185|NCT05432934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64944186|NCT05432934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944187|NCT00846911|Moxifloxacin|moxifloxacin|mesh-list
64944188|NCT00846911|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64944189|NCT00846911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64944190|NCT00846911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64944191|NCT00846911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64944192|NCT00846911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64944193|NCT00846911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944194|NCT00846911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944195|NCT00846911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530928|NCT04967248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64530929|NCT04967248|Hormone Antagonists|hormone antagonists|mesh-ancestor
64530930|NCT04967248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64530931|NCT04967248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530932|NCT04929626|Magnesium Sulfate|magnesium sulfate|mesh-list
64530933|NCT04929626|Albuterol|albuterol|mesh-list
64565619|NCT05793892|Anesthetics|anesthetics|mesh-ancestor
64565620|NCT05793892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64565621|NCT05793892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565622|NCT05793892|Sensory System Agents|sensory system agents|mesh-ancestor
64565671|NCT05793060|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64565672|NCT05793060|BB 1101|bb 1101|mesh-list
64565673|NCT05793060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64565674|NCT05793060|Antiemetics|antiemetics|mesh-ancestor
64565675|NCT05793060|Autonomic Agents|autonomic agents|mesh-ancestor
64530934|NCT04929626|Analgesics|analgesics|mesh-ancestor
64530935|NCT04929626|Sensory System Agents|sensory system agents|mesh-ancestor
64530936|NCT04929626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64530937|NCT04929626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530938|NCT04929626|Anesthetics|anesthetics|mesh-ancestor
64530939|NCT04929626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64530940|NCT04929626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64530941|NCT04929626|Anticonvulsants|anticonvulsants|mesh-ancestor
64530942|NCT04929626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64530943|NCT04929626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64530944|NCT04929626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530945|NCT04929626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64530946|NCT04929626|Tocolytic Agents|tocolytic agents|mesh-ancestor
64530947|NCT04929626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64530948|NCT04929626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64530949|NCT04929626|Autonomic Agents|autonomic agents|mesh-ancestor
64530950|NCT04929626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64530951|NCT04929626|Respiratory System Agents|respiratory system agents|mesh-ancestor
64530952|NCT04929626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64530953|NCT04929626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64530954|NCT04929626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64295573|NCT02415400|Hemostatics|hemostatics|mesh-ancestor
64944196|NCT00846911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64944197|NCT00846911|Contraceptive Agents|contraceptive agents|mesh-ancestor
64944198|NCT00846911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64944199|NCT00846911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944205|NCT00846872|Secretagogues|secretagogues|mesh-list
64944206|NCT00846872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64944207|NCT00846872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944208|NCT00846872|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64944209|NCT00846872|Diuretics|diuretics|mesh-ancestor
64944210|NCT00846872|Natriuretic Agents|natriuretic agents|mesh-ancestor
64944211|NCT05432778|Letermovir|letermovir|mesh-list
64530956|NCT04929626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64530957|NCT04908202|BMS-986165|bms-986165|mesh-list
64530958|NCT04908202|Dermatologic Agents|dermatologic agents|mesh-ancestor
64530959|NCT04908202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64530960|NCT04908202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530961|NCT04908202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530962|NCT04905316|Durvalumab|durvalumab|mesh-list
64530963|NCT04905316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64530964|NCT04905316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530965|NCT04879849|Pembrolizumab|pembrolizumab|mesh-list
64530966|NCT04879849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64530967|NCT04879849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530968|NCT04835805|Nivolumab|nivolumab|mesh-list
64530969|NCT04835805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64530970|NCT04835805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530971|NCT04835805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64530972|NCT04835805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530973|NCT04826198|Olaparib|olaparib|mesh-list
64530974|NCT04826198|Niraparib|niraparib|mesh-list
64530975|NCT04826198|Rucaparib|rucaparib|mesh-list
64530976|NCT04826198|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64530977|NCT04826198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944212|NCT05432778|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64944213|NCT05432778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565676|NCT05793060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565677|NCT05793060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565678|NCT05793060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64565679|NCT05793060|Glucocorticoids|glucocorticoids|mesh-ancestor
64565680|NCT05793060|Hormones|hormones|mesh-ancestor
64944214|NCT05432778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944215|NCT05432778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944216|NCT05432778|Antiviral Agents|antiviral agents|mesh-ancestor
64944217|NCT05432778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64944218|NCT00846755|Propylthiouracil|propylthiouracil|mesh-list
64944219|NCT00846755|Antimetabolites|antimetabolites|mesh-ancestor
64944220|NCT00846755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944221|NCT00846755|Antithyroid Agents|antithyroid agents|mesh-ancestor
64944222|NCT00846755|Hormone Antagonists|hormone antagonists|mesh-ancestor
64944223|NCT00846755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64944224|NCT00846755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944225|NCT00846716|Pioglitazone|pioglitazone|mesh-list
64944226|NCT00846716|Biguanides|biguanides|mesh-list
64944246|NCT05428683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64944247|NCT05428683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64944248|NCT05428683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944249|NCT05428683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944250|NCT05428683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944251|NCT05428683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944252|NCT05428683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64944254|NCT05428683|Hormones|hormones|mesh-ancestor
64944255|NCT05428683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64944256|NCT05424549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64944257|NCT05424549|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64944258|NCT00846443|Cisplatin|cisplatin|mesh-list
64944259|NCT00846443|Pemetrexed|pemetrexed|mesh-list
64530978|NCT04826198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530979|NCT04826198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530980|NCT04808934|Rivaroxaban|rivaroxaban|mesh-list
64530981|NCT04808934|Apixaban|apixaban|mesh-list
64530982|NCT04808934|Dabigatran|dabigatran|mesh-list
64530983|NCT04808934|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64530984|NCT04808934|Antithrombins|antithrombins|mesh-ancestor
64530985|NCT04808934|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64530986|NCT04808934|Protease Inhibitors|protease inhibitors|mesh-ancestor
64944263|NCT00846443|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64944264|NCT00846443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64944265|NCT00846326|Fluticasone|fluticasone|mesh-list
64944266|NCT00846326|Xhance|xhance|mesh-list
64944267|NCT00846326|Phenylephrine|phenylephrine|mesh-list
64944268|NCT00846326|Oxymetazoline|oxymetazoline|mesh-list
64944269|NCT00846326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64944270|NCT00846326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64944271|NCT00846326|Autonomic Agents|autonomic agents|mesh-ancestor
64944272|NCT00846326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64944273|NCT00846326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944274|NCT00846326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64944275|NCT00846326|Respiratory System Agents|respiratory system agents|mesh-ancestor
64944276|NCT00846326|Dermatologic Agents|dermatologic agents|mesh-ancestor
64944277|NCT00846326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64944278|NCT00846326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64944279|NCT00846326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64944280|NCT00846326|Adrenergic Agents|adrenergic agents|mesh-ancestor
64944281|NCT00846326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64944282|NCT00846326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944283|NCT00846326|Sympathomimetics|sympathomimetics|mesh-ancestor
64944284|NCT00846326|Nasal Decongestants|nasal decongestants|mesh-ancestor
64944295|NCT00846248|Chromium|chromium|mesh-list
64944296|NCT00846248|Trace Elements|trace elements|mesh-ancestor
64944297|NCT00846248|Micronutrients|micronutrients|mesh-ancestor
64944298|NCT00846248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944299|NCT00846131|Sorafenib|sorafenib|mesh-list
64944300|NCT00846131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944301|NCT00846131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64944302|NCT00846131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944303|NCT00846131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565681|NCT05793060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64565682|NCT05793060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64565683|NCT05793060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565684|NCT05793060|Protease Inhibitors|protease inhibitors|mesh-ancestor
64565685|NCT05793060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626322|NCT00000658|Gout Suppressants|gout suppressants|mesh-ancestor
64944304|NCT05116059|Amphotericin B|amphotericin b|mesh-list
64944305|NCT05116059|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64944306|NCT05116059|Amebicides|amebicides|mesh-ancestor
64944307|NCT05116059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64944308|NCT05116059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64944309|NCT05116059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64944310|NCT05116059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64944311|NCT05116059|Antifungal Agents|antifungal agents|mesh-ancestor
64944313|NCT00845936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64944314|NCT00845936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944315|NCT00277082|Camptothecin|camptothecin|mesh-list
64944316|NCT00277082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64944317|NCT00277082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944318|NCT00277082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64944319|NCT00277082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64944320|NCT00277082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944321|NCT00277082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944322|NCT04888377|Aspirin|aspirin|mesh-list
64944323|NCT04888377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64530988|NCT04808934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530989|NCT04808934|Anticoagulants|anticoagulants|mesh-ancestor
64530990|NCT04795245|Afatinib|afatinib|mesh-list
64530991|NCT04795245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530992|NCT04795245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64530993|NCT04795245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530994|NCT04795245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530995|NCT04754230|Tranexamic Acid|tranexamic acid|mesh-list
64530996|NCT04754230|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64530997|NCT04754230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64530998|NCT04754230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530999|NCT04754230|Hemostatics|hemostatics|mesh-ancestor
64531000|NCT04754230|Coagulants|coagulants|mesh-ancestor
64651929|NCT00899600|Ketamine|ketamine|mesh-list
64944336|NCT04888377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944338|NCT00277043|Paclitaxel|paclitaxel|mesh-list
64944339|NCT00277043|Docetaxel|docetaxel|mesh-list
64944340|NCT00277043|Taxane|taxane|mesh-list
64944341|NCT00277043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64944342|NCT00277043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944343|NCT00277043|Tubulin Modulators|tubulin modulators|mesh-ancestor
64944344|NCT00277043|Antimitotic Agents|antimitotic agents|mesh-ancestor
64944345|NCT00277043|Mitosis Modulators|mitosis modulators|mesh-ancestor
64944346|NCT00277043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944347|NCT00276965|Lithium Carbonate|lithium carbonate|mesh-list
64944348|NCT00276965|Sertraline|sertraline|mesh-list
64944349|NCT00276965|Antidepressive Agents|antidepressive agents|mesh-ancestor
64944350|NCT00276965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64944364|NCT00276926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64944365|NCT00276926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944366|NCT00276926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944368|NCT00396786|Rivaroxaban|rivaroxaban|mesh-list
64944369|NCT00396786|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64944370|NCT00396786|Antithrombins|antithrombins|mesh-ancestor
64944371|NCT00396786|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64944372|NCT00396786|Protease Inhibitors|protease inhibitors|mesh-ancestor
64944373|NCT00396786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944374|NCT00396786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944375|NCT00396786|Anticoagulants|anticoagulants|mesh-ancestor
64944376|NCT00396786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64944377|NCT00396786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64944378|NCT00276848|Vidarabine|vidarabine|mesh-list
64944379|NCT00276848|Cyclophosphamide|cyclophosphamide|mesh-list
64944380|NCT00276848|Fludarabine|fludarabine|mesh-list
64944381|NCT00276848|Fludarabine phosphate|fludarabine phosphate|mesh-list
64565686|NCT05793060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565687|NCT05793060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64565688|NCT05793060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64565689|NCT05793060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64565690|NCT05793060|Analgesics|analgesics|mesh-ancestor
64565691|NCT05793060|Sensory System Agents|sensory system agents|mesh-ancestor
64565692|NCT05793060|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64944382|NCT00276848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64944383|NCT00276848|Immunologic Factors|immunologic factors|mesh-ancestor
64531002|NCT04738942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64531003|NCT04733118|Trastuzumab|trastuzumab|mesh-list
64531004|NCT04733118|Pertuzumab|pertuzumab|mesh-list
64531005|NCT04733118|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64531006|NCT04733118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64531007|NCT04733118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531008|NCT04733118|Tubulin Modulators|tubulin modulators|mesh-ancestor
64531009|NCT04733118|Antimitotic Agents|antimitotic agents|mesh-ancestor
64531010|NCT04733118|Mitosis Modulators|mitosis modulators|mesh-ancestor
64531011|NCT04733118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531012|NCT04717414|Luspatercept|luspatercept|mesh-list
64531013|NCT04717414|Hematinics|hematinics|mesh-ancestor
64531014|NCT04699461|Idelalisib|idelalisib|mesh-list
64531015|NCT04699461|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
64651934|NCT00899600|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64531016|NCT04699461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531022|NCT04677543|Ethambutol|ethambutol|mesh-list
64944384|NCT00276848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944385|NCT00276848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64712952|NCT03632369|Xenon|xenon|mesh-list
64944386|NCT00276848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64944387|NCT00276848|Alkylating Agents|alkylating agents|mesh-ancestor
64944388|NCT00276848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944389|NCT00276848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944390|NCT00276848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64944391|NCT00276848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64944392|NCT00276848|Antimetabolites|antimetabolites|mesh-ancestor
64944393|NCT00276848|Antiviral Agents|antiviral agents|mesh-ancestor
64944394|NCT00276848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64944395|NCT00276809|Cytarabine|cytarabine|mesh-list
64944396|NCT00276809|Dexamethasone|dexamethasone|mesh-list
64944397|NCT00276809|Cyclophosphamide|cyclophosphamide|mesh-list
64944398|NCT00276809|Melphalan|melphalan|mesh-list
64944399|NCT00276809|Carmustine|carmustine|mesh-list
64944400|NCT00276809|Fludarabine|fludarabine|mesh-list
64944401|NCT00276809|Fludarabine phosphate|fludarabine phosphate|mesh-list
64944402|NCT00276809|Etoposide|etoposide|mesh-list
64944403|NCT00276809|Alemtuzumab|alemtuzumab|mesh-list
64944404|NCT00276809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64944405|NCT00276809|Immunologic Factors|immunologic factors|mesh-ancestor
64944406|NCT00276809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944407|NCT00276809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64944408|NCT00276809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64944409|NCT00276809|Alkylating Agents|alkylating agents|mesh-ancestor
64944410|NCT00276809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944411|NCT00276809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944445|NCT00276731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944447|NCT00276731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64944448|NCT00276731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64944449|NCT00276731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64944450|NCT00276731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64944451|NCT00276731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944452|NCT00276731|Tubulin Modulators|tubulin modulators|mesh-ancestor
64531023|NCT04677543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64531024|NCT04677543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64531025|NCT04677543|Antitubercular Agents|antitubercular agents|mesh-ancestor
64531026|NCT04659928|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64531027|NCT04659928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64531028|NCT04659928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64531029|NCT04653337|Norepinephrine|norepinephrine|mesh-list
64517268|NCT04389801|Sequestering Agents|sequestering agents|mesh-ancestor
64517269|NCT04389801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517270|NCT01606995|Rivaroxaban|rivaroxaban|mesh-list
64517271|NCT01606995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64531030|NCT04653337|Serotonin|serotonin|mesh-list
64531031|NCT04653337|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
64531032|NCT04653337|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64531033|NCT04653337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64531034|NCT04653337|Adrenergic Agents|adrenergic agents|mesh-ancestor
64531035|NCT04653337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64531036|NCT04653337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531037|NCT04653337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531038|NCT04653337|Sympathomimetics|sympathomimetics|mesh-ancestor
64531039|NCT04653337|Autonomic Agents|autonomic agents|mesh-ancestor
64531040|NCT04653337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64295663|NCT02476929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64295664|NCT02726997|Paclitaxel|paclitaxel|mesh-list
64944466|NCT00276575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64944467|NCT00276575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64944468|NCT00276575|Growth Substances|growth substances|mesh-ancestor
64944469|NCT00276575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944470|NCT00276575|Growth Inhibitors|growth inhibitors|mesh-ancestor
64944471|NCT00276575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64944472|NCT00276575|Immunologic Factors|immunologic factors|mesh-ancestor
64944473|NCT00276575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64651948|NCT01554371|Cyclophosphamide|cyclophosphamide|mesh-list
64944479|NCT00276536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944480|NCT00276536|Antiviral Agents|antiviral agents|mesh-ancestor
64944481|NCT00276536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64944482|NCT00276536|Immunologic Factors|immunologic factors|mesh-ancestor
64944483|NCT00276536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944484|NCT00276497|Pioglitazone|pioglitazone|mesh-list
64944485|NCT00276497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64944486|NCT00276497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944487|NCT04430790|Doxapram|doxapram|mesh-list
64944488|NCT04430790|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64944489|NCT04430790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944490|NCT04430790|Respiratory System Agents|respiratory system agents|mesh-ancestor
64944491|NCT04393389|Paclitaxel|paclitaxel|mesh-list
64944492|NCT04393389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64944493|NCT04393389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944494|NCT04393389|Tubulin Modulators|tubulin modulators|mesh-ancestor
64944495|NCT04393389|Antimitotic Agents|antimitotic agents|mesh-ancestor
64944496|NCT04393389|Mitosis Modulators|mitosis modulators|mesh-ancestor
64944497|NCT04393389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944498|NCT00041340|Imatinib Mesylate|imatinib mesylate|mesh-list
64944499|NCT00041340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531041|NCT04653337|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64531042|NCT04653337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64531043|NCT04653337|Serotonin Agents|serotonin agents|mesh-ancestor
64531044|NCT04653337|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64531045|NCT04653337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64531046|NCT04561739|Sirolimus|sirolimus|mesh-list
64531047|NCT04561739|Paclitaxel|paclitaxel|mesh-list
64531048|NCT04561739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64531049|NCT04561739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531050|NCT04561739|Tubulin Modulators|tubulin modulators|mesh-ancestor
64531051|NCT04561739|Antimitotic Agents|antimitotic agents|mesh-ancestor
64531052|NCT04561739|Mitosis Modulators|mitosis modulators|mesh-ancestor
64531053|NCT04561739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531054|NCT04561739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64531055|NCT04561739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64531056|NCT04561739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64531057|NCT04561739|Antifungal Agents|antifungal agents|mesh-ancestor
64531058|NCT04561739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64531059|NCT04561739|Immunologic Factors|immunologic factors|mesh-ancestor
64531060|NCT04561739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531061|NCT04539626|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64531062|NCT04539626|Estradiol|estradiol|mesh-list
64531063|NCT04539626|Estrogens|estrogens|mesh-list
64531064|NCT04539626|Hormones|hormones|mesh-ancestor
64517272|NCT01606995|Antithrombins|antithrombins|mesh-ancestor
64517273|NCT01606995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64517274|NCT01606995|Protease Inhibitors|protease inhibitors|mesh-ancestor
64517275|NCT01606995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517276|NCT01606995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517277|NCT01606995|Anticoagulants|anticoagulants|mesh-ancestor
64531065|NCT04539626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64531066|NCT04539626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531067|NCT04539626|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64531068|NCT04539626|Contraceptive Agents|contraceptive agents|mesh-ancestor
64531069|NCT04539626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64531070|NCT04539626|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64531071|NCT04539626|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64531072|NCT04539626|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64531073|NCT04521348|Antibodies|antibodies|mesh-list
64531074|NCT04521348|Immunoglobulins|immunoglobulins|mesh-list
64531075|NCT04521348|Immunologic Factors|immunologic factors|mesh-ancestor
64484201|NCT00809848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64944500|NCT00041340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64944501|NCT00041340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531076|NCT04521348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531077|NCT04512534|Antibodies|antibodies|mesh-list
64531128|NCT04436731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64531129|NCT04436731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531130|NCT04436731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64531131|NCT04436731|Analgesics|analgesics|mesh-ancestor
64531132|NCT04436731|Sensory System Agents|sensory system agents|mesh-ancestor
64944506|NCT00276185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944507|NCT00276185|Cholinergic Agents|cholinergic agents|mesh-ancestor
64944508|NCT00276185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64944509|NCT00276185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944511|NCT00276146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64944512|NCT00276146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944513|NCT00276146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944514|NCT00276146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64944515|NCT00276146|Vasodilator Agents|vasodilator agents|mesh-ancestor
64944530|NCT00276068|Sensory System Agents|sensory system agents|mesh-ancestor
64944531|NCT00276068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64944532|NCT00276068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64944533|NCT00276068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64944534|NCT00276068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64944535|NCT00276068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64944536|NCT00276068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944537|NCT00276068|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64944539|NCT00276068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64944540|NCT00276068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944541|NCT00276068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64944542|NCT00276068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64944543|NCT00276068|Adrenergic Agents|adrenergic agents|mesh-ancestor
64944544|NCT00276068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64944545|NCT00276029|Etanercept|etanercept|mesh-list
64944546|NCT00276029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64944547|NCT00276029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64944548|NCT00276029|Analgesics|analgesics|mesh-ancestor
64944549|NCT00276029|Sensory System Agents|sensory system agents|mesh-ancestor
64944550|NCT00276029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64944551|NCT00276029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944552|NCT00276029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64944553|NCT00276029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64944554|NCT00276029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64944555|NCT00276029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64944556|NCT00276029|Immunologic Factors|immunologic factors|mesh-ancestor
64944557|NCT00397059|Citalopram|citalopram|mesh-list
64944558|NCT00397059|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64944559|NCT00397059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64944560|NCT00397059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64517278|NCT03257670|Lidocaine|lidocaine|mesh-list
64517279|NCT03257670|Anesthetics, Local|anesthetics, local|mesh-ancestor
64517280|NCT03257670|Anesthetics|anesthetics|mesh-ancestor
64517281|NCT03257670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64517282|NCT03257670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517283|NCT03257670|Sensory System Agents|sensory system agents|mesh-ancestor
64565693|NCT05793060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64626616|NCT00002320|Lamivudine|lamivudine|mesh-list
64944561|NCT00397059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944562|NCT00397059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64944563|NCT00397059|Serotonin Agents|serotonin agents|mesh-ancestor
64944564|NCT00397059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944565|NCT00397059|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64944566|NCT00397059|Antidepressive Agents|antidepressive agents|mesh-ancestor
64944567|NCT00397059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64944568|NCT04149210|Fluorometholone|fluorometholone|mesh-list
64944569|NCT04149210|Lubricant Eye Drops|lubricant eye drops|mesh-list
64944570|NCT04149210|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64531133|NCT04436731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64531134|NCT04436731|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64531135|NCT04436731|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64531136|NCT04436731|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64531137|NCT04436731|Adrenergic Agents|adrenergic agents|mesh-ancestor
64531138|NCT04436731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64531139|NCT04436731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531140|NCT04436731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64531141|NCT04436731|Mydriatics|mydriatics|mesh-ancestor
64944572|NCT04149210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64944573|NCT04149210|Glucocorticoids|glucocorticoids|mesh-ancestor
64944575|NCT04149210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64944576|NCT04149210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944590|NCT00397098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64944591|NCT00397098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64944592|NCT00397098|Adrenergic Agents|adrenergic agents|mesh-ancestor
64944593|NCT00397098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64944594|NCT00397098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944595|NCT00397098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944597|NCT00275834|Anticonvulsants|anticonvulsants|mesh-ancestor
64944598|NCT00275834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64944599|NCT00275834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64944600|NCT00275834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944601|NCT00275834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64944602|NCT00275834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944603|NCT00397176|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64944604|NCT00397176|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64944605|NCT00397176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64944606|NCT00397176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64944607|NCT00397176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944608|NCT00397176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64944609|NCT00397176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944610|NCT00397176|Antidepressive Agents|antidepressive agents|mesh-ancestor
64944611|NCT00397176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64944612|NCT04061421|Decitabine|decitabine|mesh-list
64944613|NCT04061421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64944614|NCT04061421|Antimetabolites|antimetabolites|mesh-ancestor
64944615|NCT04061421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944616|NCT04061421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944617|NCT04061421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944618|NCT00275756|Timolol|timolol|mesh-list
64944619|NCT00275756|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64944620|NCT00275756|Dorzolamide|dorzolamide|mesh-list
64944621|NCT00275756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64944622|NCT00275756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64944623|NCT00275756|Adrenergic Agents|adrenergic agents|mesh-ancestor
64565694|NCT05793060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64565695|NCT05793060|Adrenergic Agents|adrenergic agents|mesh-ancestor
64565696|NCT05793060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64565697|NCT05792995|Pembrolizumab|pembrolizumab|mesh-list
64565698|NCT05792995|Nivolumab|nivolumab|mesh-list
64565699|NCT05792995|Durvalumab|durvalumab|mesh-list
64565700|NCT05792995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64565701|NCT05792995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565702|NCT05792995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64565703|NCT05792995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565704|NCT05792878|Interferons|interferons|mesh-list
64565705|NCT05792878|Interferon-alpha|interferon-alpha|mesh-list
64565706|NCT05792878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626678|NCT00002188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626680|NCT00002332|Thymopentin|thymopentin|mesh-list
64944624|NCT00275756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64944625|NCT00275756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944626|NCT00275756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944627|NCT00275756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64295740|NCT02054299|Fenoterol|fenoterol|mesh-list
64531147|NCT04436731|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64531148|NCT04436731|Protective Agents|protective agents|mesh-ancestor
64531149|NCT04436731|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64531150|NCT04436731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64531151|NCT04436731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64531152|NCT04423068|Contraceptive Agents|contraceptive agents|mesh-list
64531153|NCT04423068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64531154|NCT04423068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531155|NCT04420598|Trastuzumab|trastuzumab|mesh-list
64295741|NCT02054299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64295742|NCT02054299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64944628|NCT00275756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64944629|NCT00275756|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64944630|NCT00275756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64944631|NCT00275756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64944632|NCT00275756|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64944633|NCT00275756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944648|NCT00275600|Micronutrients|micronutrients|mesh-ancestor
64944649|NCT00275600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944650|NCT00275600|Antioxidants|antioxidants|mesh-ancestor
64944651|NCT00275600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944652|NCT00275600|Protective Agents|protective agents|mesh-ancestor
64944654|NCT00275522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64944655|NCT00275522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64944656|NCT00275522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64944657|NCT00275522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944658|NCT00275522|Antifungal Agents|antifungal agents|mesh-ancestor
64944659|NCT00275522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64944660|NCT00275522|Immunologic Factors|immunologic factors|mesh-ancestor
64944661|NCT00275522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944662|NCT03828201|Levofloxacin|levofloxacin|mesh-list
64944663|NCT03828201|Ofloxacin|ofloxacin|mesh-list
64944664|NCT03828201|Linezolid|linezolid|mesh-list
64944665|NCT03828201|Bedaquiline|bedaquiline|mesh-list
64944666|NCT03828201|Clofazimine|clofazimine|mesh-list
64944667|NCT03828201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64944668|NCT03828201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64944669|NCT03828201|Renal Agents|renal agents|mesh-ancestor
64944670|NCT03828201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64944671|NCT03828201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64944672|NCT03828201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64944673|NCT03828201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565707|NCT05792878|Antiviral Agents|antiviral agents|mesh-ancestor
64565708|NCT05792878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64565709|NCT05792878|Immunologic Factors|immunologic factors|mesh-ancestor
64565710|NCT05792878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626745|NCT04756622|Antidotes|antidotes|mesh-ancestor
64944674|NCT03828201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944675|NCT03828201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944676|NCT03828201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64944677|NCT03828201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64944678|NCT03828201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64944679|NCT03828201|Antitubercular Agents|antitubercular agents|mesh-ancestor
64944680|NCT03828201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64944681|NCT03828201|Leprostatic Agents|leprostatic agents|mesh-ancestor
64713202|NCT03007147|Ifosfamide|ifosfamide|mesh-list
64944683|NCT00275444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64944684|NCT00275444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64944685|NCT00275444|Antiviral Agents|antiviral agents|mesh-ancestor
64944686|NCT00275444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64531156|NCT04420598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64531158|NCT04411654|Sirolimus|sirolimus|mesh-list
64531159|NCT04411654|Prednisone|prednisone|mesh-list
64531160|NCT04411654|Methylprednisolone|methylprednisolone|mesh-list
64531161|NCT04411654|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64531162|NCT04411654|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64531163|NCT04411654|Prednisolone|prednisolone|mesh-list
64944687|NCT00275405|Allyl sulfide|allyl sulfide|mesh-list
64944688|NCT00275405|Antioxidants|antioxidants|mesh-ancestor
64944689|NCT00275405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944690|NCT00275405|Protective Agents|protective agents|mesh-ancestor
64944691|NCT00275405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944692|NCT00275405|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64944693|NCT00275405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944694|NCT00275405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64944695|NCT00275405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944696|NCT03533946|Rucaparib|rucaparib|mesh-list
64944697|NCT03533946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64944698|NCT03533946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944699|NCT03533946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944700|NCT03533946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944701|NCT00275249|Levorphanol|levorphanol|mesh-list
64944713|NCT00041535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944715|NCT00041535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64944716|NCT00041535|Antiviral Agents|antiviral agents|mesh-ancestor
64944717|NCT00041535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64944718|NCT00041535|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64944723|NCT00041574|Autonomic Agents|autonomic agents|mesh-ancestor
64944724|NCT00041574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64944725|NCT00041574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944726|NCT00041574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64944727|NCT00041574|Respiratory System Agents|respiratory system agents|mesh-ancestor
64944728|NCT00041574|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64944729|NCT00041574|Antioxidants|antioxidants|mesh-ancestor
64944730|NCT00041574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944731|NCT00041574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64944732|NCT00041574|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64944733|NCT00041574|Vasodilator Agents|vasodilator agents|mesh-ancestor
64944734|NCT00041574|Gasotransmitters|gasotransmitters|mesh-ancestor
64944735|NCT00041574|Protective Agents|protective agents|mesh-ancestor
64944736|NCT00275132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64944737|NCT00275132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944738|NCT00275132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64944739|NCT00275132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944740|NCT00275132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944741|NCT00275093|Sirolimus|sirolimus|mesh-list
64944742|NCT00275093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64944743|NCT00275093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64944744|NCT00275093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64944745|NCT00275093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944746|NCT00275093|Antifungal Agents|antifungal agents|mesh-ancestor
64944747|NCT00275093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64565711|NCT05792761|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64565712|NCT05792761|Antiviral Agents|antiviral agents|mesh-ancestor
64565713|NCT05792761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64565714|NCT05792748|Hemostatics|hemostatics|mesh-list
64944748|NCT00275093|Immunologic Factors|immunologic factors|mesh-ancestor
64944749|NCT00275093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944750|NCT00041652|Labetuzumab|labetuzumab|mesh-list
64944751|NCT00041652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64944752|NCT00041652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944753|NCT03430596|Pramipexole|pramipexole|mesh-list
64944754|NCT03430596|Trihexyphenidyl|trihexyphenidyl|mesh-list
64944755|NCT03430596|Antioxidants|antioxidants|mesh-ancestor
64944756|NCT03430596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531164|NCT04411654|Prednisolone acetate|prednisolone acetate|mesh-list
64531165|NCT04411654|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64531166|NCT04411654|Prednisolone phosphate|prednisolone phosphate|mesh-list
64531167|NCT04411654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64531168|NCT04411654|Glucocorticoids|glucocorticoids|mesh-ancestor
64531170|NCT04411654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64531171|NCT04411654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531172|NCT04411654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64531173|NCT04411654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531174|NCT04411654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64295760|NCT02054299|Vitamins|vitamins|mesh-ancestor
64944757|NCT03430596|Protective Agents|protective agents|mesh-ancestor
64944758|NCT03430596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944759|NCT03430596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64944760|NCT03430596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64944761|NCT03430596|Dopamine Agonists|dopamine agonists|mesh-ancestor
64944762|NCT03430596|Dopamine Agents|dopamine agents|mesh-ancestor
64944763|NCT03430596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64944764|NCT03430596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64944765|NCT03430596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64944776|NCT00275054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944778|NCT00275054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64944779|NCT00275054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64944780|NCT03208179|Azithromycin|azithromycin|mesh-list
64944781|NCT03208179|Pyrimethamine|pyrimethamine|mesh-list
64944782|NCT03208179|Piperaquine|piperaquine|mesh-list
64944783|NCT03208179|Sulfadoxine|sulfadoxine|mesh-list
64944784|NCT03208179|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64944785|NCT03208179|Artenimol|artenimol|mesh-list
64944786|NCT03208179|Artemisinins|artemisinins|mesh-list
64944787|NCT03208179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64944788|NCT03208179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64944789|NCT03208179|Antimalarials|antimalarials|mesh-ancestor
64944790|NCT03208179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64944811|NCT00275015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944812|NCT00275015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944813|NCT00275015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64944814|NCT00275015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64944815|NCT00275015|Antiemetics|antiemetics|mesh-ancestor
64944816|NCT00275015|Autonomic Agents|autonomic agents|mesh-ancestor
64944817|NCT00275015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64944818|NCT00275015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64944819|NCT00275015|Glucocorticoids|glucocorticoids|mesh-ancestor
64944820|NCT00275015|Hormones|hormones|mesh-ancestor
64531175|NCT04411654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64531176|NCT04411654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64531177|NCT04411654|Antifungal Agents|antifungal agents|mesh-ancestor
64531178|NCT04411654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64531179|NCT04411654|Immunologic Factors|immunologic factors|mesh-ancestor
64531180|NCT04411654|Antiemetics|antiemetics|mesh-ancestor
64531181|NCT04411654|Autonomic Agents|autonomic agents|mesh-ancestor
64944821|NCT00275015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64944822|NCT00275015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64944823|NCT00275015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64944824|NCT00275015|Antimetabolites|antimetabolites|mesh-ancestor
64944825|NCT00275015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64944826|NCT00275015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64944827|NCT00275015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64944828|NCT00275015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944829|NCT00275015|Antiviral Agents|antiviral agents|mesh-ancestor
64565715|NCT05792748|Coagulants|coagulants|mesh-ancestor
64565716|NCT05792644|Crizotinib|crizotinib|mesh-list
64565717|NCT05792644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565718|NCT05792644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64565747|NCT05792111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565748|NCT05792111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64565749|NCT05792111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64944830|NCT00275015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64944831|NCT00274976|Alemtuzumab|alemtuzumab|mesh-list
64944840|NCT00130403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64944842|NCT03062826|Clopidogrel|clopidogrel|mesh-list
64944844|NCT03062826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64944845|NCT03062826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64944846|NCT03062826|Analgesics|analgesics|mesh-ancestor
64944847|NCT03062826|Sensory System Agents|sensory system agents|mesh-ancestor
64944848|NCT03062826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64944849|NCT03062826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944850|NCT03062826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64944851|NCT03062826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64944858|NCT03062826|Antipyretics|antipyretics|mesh-ancestor
64944859|NCT03062826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64944860|NCT03062826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64944861|NCT03062826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64944862|NCT03062826|Purinergic Agents|purinergic agents|mesh-ancestor
64944863|NCT03062826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64944864|NCT00130364|Pimecrolimus|pimecrolimus|mesh-list
64944865|NCT00130364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64944866|NCT00130364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64944867|NCT00130364|Analgesics|analgesics|mesh-ancestor
64944868|NCT00130364|Sensory System Agents|sensory system agents|mesh-ancestor
64944869|NCT00130364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64944870|NCT00130364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944871|NCT00130364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64944872|NCT00130364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64944873|NCT00130364|Dermatologic Agents|dermatologic agents|mesh-ancestor
64944874|NCT00130364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64944875|NCT00130364|Immunologic Factors|immunologic factors|mesh-ancestor
64944876|NCT00130364|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64944877|NCT00130364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944878|NCT00130364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944879|NCT00130325|Isoniazid|isoniazid|mesh-list
64944880|NCT00130325|Antitubercular Agents|antitubercular agents|mesh-ancestor
64944881|NCT00130325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64944882|NCT00130325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64944883|NCT00130325|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64944884|NCT00130325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64944885|NCT00130325|Antimetabolites|antimetabolites|mesh-ancestor
64944886|NCT00130325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944887|NCT00130325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64944888|NCT00041691|Labetuzumab|labetuzumab|mesh-list
64531182|NCT04411654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64531183|NCT04411654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64531184|NCT04411654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64487263|NCT01830478|Growth Substances|growth substances|mesh-ancestor
64531185|NCT04411654|Protective Agents|protective agents|mesh-ancestor
64531186|NCT04386057|Hydroxychloroquine|hydroxychloroquine|mesh-list
64531187|NCT04386057|Antimalarials|antimalarials|mesh-ancestor
64531188|NCT04386057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64531189|NCT04386057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64531190|NCT04386057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64531191|NCT04386057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531192|NCT04386057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531193|NCT04386057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64531194|NCT04381832|Docetaxel|docetaxel|mesh-list
64531195|NCT04381832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531196|NCT04381832|Tubulin Modulators|tubulin modulators|mesh-ancestor
64531197|NCT04381832|Antimitotic Agents|antimitotic agents|mesh-ancestor
64531198|NCT04381832|Mitosis Modulators|mitosis modulators|mesh-ancestor
64295773|NCT02054299|Tocolytic Agents|tocolytic agents|mesh-ancestor
64626955|NCT02168855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64626956|NCT02168855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565750|NCT05792111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64565751|NCT05792111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64565752|NCT05792111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565753|NCT05792111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64565754|NCT05792111|Glucocorticoids|glucocorticoids|mesh-ancestor
64565755|NCT05792111|Hormones|hormones|mesh-ancestor
64565756|NCT05792111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64565757|NCT05789732|Tadalafil|tadalafil|mesh-list
64944889|NCT00041691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64944890|NCT00041691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944891|NCT00394394|Enalapril|enalapril|mesh-list
64944892|NCT00394394|Amiloride|amiloride|mesh-list
64944893|NCT00394394|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64944894|NCT00394394|Protease Inhibitors|protease inhibitors|mesh-ancestor
64944895|NCT00394394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944896|NCT00394394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944910|NCT00130091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944911|NCT00130091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64944913|NCT00130091|Autonomic Agents|autonomic agents|mesh-ancestor
64944914|NCT00130091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64944921|NCT00130013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64944922|NCT00130013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64944924|NCT00129857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64944925|NCT00129857|Antiemetics|antiemetics|mesh-ancestor
64944926|NCT00129857|Autonomic Agents|autonomic agents|mesh-ancestor
64944927|NCT00129857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64944928|NCT00129857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944929|NCT00129857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64944930|NCT00129857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64944931|NCT00129857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64944932|NCT00129857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64944933|NCT00129857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944934|NCT00129857|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64944935|NCT00129857|Protective Agents|protective agents|mesh-ancestor
64944936|NCT00129818|Famciclovir|famciclovir|mesh-list
64944937|NCT00129818|Antiviral Agents|antiviral agents|mesh-ancestor
64944938|NCT00129818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64944939|NCT00129818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64944940|NCT00129818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531205|NCT04364230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531206|NCT04364230|Interferon Inducers|interferon inducers|mesh-ancestor
64531207|NCT04303858|Atezolizumab|atezolizumab|mesh-list
64531208|NCT04303858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531209|NCT04268706|Fludarabine|fludarabine|mesh-list
64944941|NCT00129818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944942|NCT00129506|Methotrexate|methotrexate|mesh-list
64944943|NCT00129506|Misoprostol|misoprostol|mesh-list
64944944|NCT00129506|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64944945|NCT00129506|Abortifacient Agents|abortifacient agents|mesh-ancestor
64944946|NCT00129506|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64944947|NCT00129506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944948|NCT00129506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64944949|NCT00129506|Antimetabolites|antimetabolites|mesh-ancestor
64944950|NCT00129506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944951|NCT00129506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944952|NCT00129506|Dermatologic Agents|dermatologic agents|mesh-ancestor
64944953|NCT00129506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944954|NCT00129506|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64944955|NCT00129506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64565758|NCT05789732|Silodosin|silodosin|mesh-list
64565759|NCT05789732|Vasodilator Agents|vasodilator agents|mesh-ancestor
64565760|NCT05789732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64565761|NCT05789732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64565762|NCT05789732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565763|NCT05789732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517284|NCT03257670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517285|NCT03257670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64517286|NCT03257670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64517287|NCT03257670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64517288|NCT03257670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64565786|NCT05783817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565788|NCT05783817|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64565789|NCT05783817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64565790|NCT05783817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64565791|NCT05783817|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64565793|NCT05778617|Expectorants|expectorants|mesh-ancestor
64565794|NCT05778617|Respiratory System Agents|respiratory system agents|mesh-ancestor
64565795|NCT05767047|Apremilast|apremilast|mesh-list
64944956|NCT00129506|Immunologic Factors|immunologic factors|mesh-ancestor
64944982|NCT00712881|Trastuzumab|trastuzumab|mesh-list
64944983|NCT00712881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64944984|NCT00712881|Immunologic Factors|immunologic factors|mesh-ancestor
64944985|NCT00712881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944986|NCT00712881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64944987|NCT00712881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64944988|NCT00712881|Alkylating Agents|alkylating agents|mesh-ancestor
64944989|NCT00712881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944990|NCT00712881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944991|NCT00712881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64944992|NCT00712881|Tubulin Modulators|tubulin modulators|mesh-ancestor
64944993|NCT00712881|Antimitotic Agents|antimitotic agents|mesh-ancestor
64944994|NCT00712881|Mitosis Modulators|mitosis modulators|mesh-ancestor
64944995|NCT00712881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64944996|NCT00712881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64944997|NCT00712881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64944998|NCT00712881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944999|NCT00712881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64945000|NCT00042003|Decitabine|decitabine|mesh-list
64945001|NCT00042003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64652002|NCT01537835|Anti-Infective Agents|anti-infective agents|mesh-list
64531210|NCT04268706|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64531211|NCT04268706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531212|NCT04268706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531213|NCT04268706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64531214|NCT04268706|Alkylating Agents|alkylating agents|mesh-ancestor
64531215|NCT04267926|Ubiquinone|ubiquinone|mesh-list
64531216|NCT04267926|Micronutrients|micronutrients|mesh-ancestor
64295805|NCT03945591|Cyclophosphamide|cyclophosphamide|mesh-list
64945041|NCT00470223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945042|NCT00470223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64945043|NCT00470223|Antimetabolites|antimetabolites|mesh-ancestor
64565796|NCT05767047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64565797|NCT05767047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64565798|NCT05767047|Analgesics|analgesics|mesh-ancestor
64565799|NCT05767047|Sensory System Agents|sensory system agents|mesh-ancestor
64565800|NCT05767047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565801|NCT05767047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565802|NCT05767047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64565803|NCT05767047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64565804|NCT05767047|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64565805|NCT05767047|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64565806|NCT05767047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565807|NCT05767047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565808|NCT05761080|Amoxicillin|amoxicillin|mesh-list
64565809|NCT05761080|Clavulanic Acids|clavulanic acids|mesh-list
64565810|NCT05761080|Clavulanic Acid|clavulanic acid|mesh-list
64565811|NCT05761080|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64565812|NCT05761080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64565813|NCT05761080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64565814|NCT05761080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565840|NCT05700669|Olaparib|olaparib|mesh-list
64565841|NCT05700669|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64565842|NCT05700669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565843|NCT05700669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565844|NCT05700669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565845|NCT05686564|Choline|choline|mesh-list
64565846|NCT05686564|Lipotropic Agents|lipotropic agents|mesh-ancestor
64565847|NCT05686564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64565848|NCT05686564|Antimetabolites|antimetabolites|mesh-ancestor
64565849|NCT05686564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565850|NCT05686564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64565851|NCT05686564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64565894|NCT05642026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565895|NCT05642026|Sensory System Agents|sensory system agents|mesh-ancestor
64565931|NCT05558137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565932|NCT05549505|Anastrozole|anastrozole|mesh-list
64565933|NCT05549505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64565934|NCT05549505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565935|NCT05549505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64565936|NCT05549505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64565937|NCT05549505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565938|NCT05549505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517289|NCT03257670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517290|NCT03265002|Psyllium|psyllium|mesh-list
64517291|NCT03265002|Calcium polycarbophil|calcium polycarbophil|mesh-list
64517292|NCT03265002|Cathartics|cathartics|mesh-ancestor
64517293|NCT03265002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64517294|NCT03265002|Antidiarrheals|antidiarrheals|mesh-ancestor
64517295|NCT03257514|Thioctic Acid|thioctic acid|mesh-list
64517296|NCT03257514|Antioxidants|antioxidants|mesh-ancestor
64517297|NCT03257514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565939|NCT05549505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64565940|NCT05549505|Hormone Antagonists|hormone antagonists|mesh-ancestor
64565941|NCT05549505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64565962|NCT05463224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64565963|NCT05463224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627114|NCT04998617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64945044|NCT00470223|Dermatologic Agents|dermatologic agents|mesh-ancestor
64945045|NCT00470223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64945046|NCT00470223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64945047|NCT00470223|Immunologic Factors|immunologic factors|mesh-ancestor
64945048|NCT00470223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64945049|NCT00470223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64945050|NCT00470223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64945051|NCT00470223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64945052|NCT00470223|Alkylating Agents|alkylating agents|mesh-ancestor
64945053|NCT00470223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64945054|NCT00103389|Docetaxel|docetaxel|mesh-list
64945055|NCT00103389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945056|NCT00103389|Tubulin Modulators|tubulin modulators|mesh-ancestor
64945065|NCT00128804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945066|NCT00128804|Protective Agents|protective agents|mesh-ancestor
64945067|NCT00128804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945068|NCT00128804|Provitamins|provitamins|mesh-ancestor
64945069|NCT00128804|Vitamins|vitamins|mesh-ancestor
64945070|NCT00128804|Micronutrients|micronutrients|mesh-ancestor
64945071|NCT00097851|Docetaxel|docetaxel|mesh-list
64945072|NCT00097851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945073|NCT00097851|Tubulin Modulators|tubulin modulators|mesh-ancestor
64945074|NCT00097851|Antimitotic Agents|antimitotic agents|mesh-ancestor
64945075|NCT00097851|Mitosis Modulators|mitosis modulators|mesh-ancestor
64565964|NCT05463224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565965|NCT05456932|Iron|iron|mesh-list
64565966|NCT05456932|Ferrous fumarate|ferrous fumarate|mesh-list
64565967|NCT05456932|Ferric maltol|ferric maltol|mesh-list
64565968|NCT05456932|Trace Elements|trace elements|mesh-ancestor
64565969|NCT05456932|Micronutrients|micronutrients|mesh-ancestor
64565970|NCT05456932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565971|NCT05456932|Hematinics|hematinics|mesh-ancestor
64565972|NCT05447780|Anesthetics|anesthetics|mesh-list
64565973|NCT05447780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64565974|NCT05447780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565975|NCT05419011|Vaccines|vaccines|mesh-list
64565976|NCT05419011|Immunologic Factors|immunologic factors|mesh-ancestor
64565977|NCT05419011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565978|NCT05413343|Ceftazidime|ceftazidime|mesh-list
64565979|NCT05413343|Avibactam|avibactam|mesh-list
64565980|NCT05413343|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
64565981|NCT05413343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64565982|NCT05413343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64565983|NCT05413343|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64565984|NCT05413343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565985|NCT05413343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565986|NCT05403502|Insulin|insulin|mesh-list
64565987|NCT05403502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64565988|NCT05403502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565989|NCT05392946|Dexamethasone|dexamethasone|mesh-list
64945076|NCT00097851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945077|NCT00038376|Interferons|interferons|mesh-list
64945078|NCT00038376|Interferon-alpha|interferon-alpha|mesh-list
64945079|NCT00038376|Interferon alpha-2|interferon alpha-2|mesh-list
64945080|NCT00038376|Isotretinoin|isotretinoin|mesh-list
64945081|NCT00038376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945082|NCT00038376|Antiviral Agents|antiviral agents|mesh-ancestor
64945083|NCT00038376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64652012|NCT01556633|Oseltamivir|oseltamivir|mesh-list
64945088|NCT00128531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64945089|NCT00128531|Fertility Agents|fertility agents|mesh-ancestor
64945090|NCT00128531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64945091|NCT00128531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945092|NCT00128531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64945093|NCT00128531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945095|NCT00038454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64945096|NCT00038454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64945097|NCT00038454|Analgesics|analgesics|mesh-ancestor
64945098|NCT00038454|Sensory System Agents|sensory system agents|mesh-ancestor
64945099|NCT00038454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64945100|NCT00038454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945101|NCT00038454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64945102|NCT00038454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64945103|NCT00128453|Colchicine|colchicine|mesh-list
64945104|NCT00128453|Gout Suppressants|gout suppressants|mesh-ancestor
64945105|NCT00128453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64565990|NCT05392946|Dexamethasone acetate|dexamethasone acetate|mesh-list
64565991|NCT05392946|Bortezomib|bortezomib|mesh-list
64565992|NCT05392946|Daratumumab|daratumumab|mesh-list
64565993|NCT05392946|Ichthammol|ichthammol|mesh-list
64565994|NCT05392946|BB 1101|bb 1101|mesh-list
64565995|NCT05392946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64565996|NCT05392946|Antiemetics|antiemetics|mesh-ancestor
64565997|NCT05392946|Autonomic Agents|autonomic agents|mesh-ancestor
64565998|NCT05392946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565999|NCT05392946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566030|NCT05372133|Narcotics|narcotics|mesh-ancestor
64566031|NCT05372133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64566032|NCT05372133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566033|NCT05372133|Analgesics|analgesics|mesh-ancestor
64566034|NCT05372133|Sensory System Agents|sensory system agents|mesh-ancestor
64566035|NCT05372133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64566042|NCT05351554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64566043|NCT05351554|Immunologic Factors|immunologic factors|mesh-ancestor
64566044|NCT05351554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566045|NCT05341115|Leuprolide|leuprolide|mesh-list
64566046|NCT05341115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64566047|NCT05341115|Fertility Agents|fertility agents|mesh-ancestor
64566079|NCT05292664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64566080|NCT05292664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64566081|NCT05292664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566082|NCT05292664|Protease Inhibitors|protease inhibitors|mesh-ancestor
64945106|NCT00128453|Tubulin Modulators|tubulin modulators|mesh-ancestor
64945107|NCT00128453|Antimitotic Agents|antimitotic agents|mesh-ancestor
64945108|NCT00128453|Mitosis Modulators|mitosis modulators|mesh-ancestor
64531217|NCT04267926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531218|NCT04223609|Oxycodone|oxycodone|mesh-list
64531219|NCT04223609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64531220|NCT04223609|Narcotics|narcotics|mesh-ancestor
64531221|NCT04223609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64531222|NCT04223609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531223|NCT04223609|Analgesics|analgesics|mesh-ancestor
64531224|NCT04223609|Sensory System Agents|sensory system agents|mesh-ancestor
64531225|NCT04223609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64531226|NCT04120415|Vedolizumab|vedolizumab|mesh-list
64531227|NCT04120415|Vaccines|vaccines|mesh-list
64531228|NCT04120415|Immunologic Factors|immunologic factors|mesh-ancestor
64531229|NCT04120415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531230|NCT04120415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64531231|NCT04118920|Insulin|insulin|mesh-list
64531232|NCT04118920|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64295816|NCT01955499|Lenalidomide|lenalidomide|mesh-list
64945109|NCT00128453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945110|NCT00128453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945111|NCT00128414|Colchicine|colchicine|mesh-list
64945112|NCT00128414|Gout Suppressants|gout suppressants|mesh-ancestor
64945113|NCT00128414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64517298|NCT03257514|Protective Agents|protective agents|mesh-ancestor
64517299|NCT03257514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517300|NCT03257514|Vitamin B Complex|vitamin b complex|mesh-ancestor
64517301|NCT03257514|Vitamins|vitamins|mesh-ancestor
64517302|NCT03257514|Micronutrients|micronutrients|mesh-ancestor
64517303|NCT04781751|Insulin|insulin|mesh-list
64517304|NCT04781751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64517305|NCT04781751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517306|NCT04643379|Carboplatin|carboplatin|mesh-list
64517307|NCT04643379|Pembrolizumab|pembrolizumab|mesh-list
64517308|NCT04643379|Olaparib|olaparib|mesh-list
64517309|NCT04643379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566083|NCT05292664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566084|NCT05292664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566085|NCT05292664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64566086|NCT05292664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64566087|NCT05292664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64566088|NCT05292664|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64566089|NCT05292664|Abortifacient Agents|abortifacient agents|mesh-ancestor
64566090|NCT05292664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64566091|NCT05292664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64566093|NCT05292664|Dermatologic Agents|dermatologic agents|mesh-ancestor
64566094|NCT05292664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64566095|NCT05292664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64566096|NCT05292664|Immunologic Factors|immunologic factors|mesh-ancestor
64566097|NCT05292664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64566127|NCT05275907|Amlodipine|amlodipine|mesh-list
64627270|NCT01897454|Antidotes|antidotes|mesh-ancestor
64945114|NCT00128414|Tubulin Modulators|tubulin modulators|mesh-ancestor
64945115|NCT00128414|Antimitotic Agents|antimitotic agents|mesh-ancestor
64945116|NCT00128414|Mitosis Modulators|mitosis modulators|mesh-ancestor
64945117|NCT00128414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945118|NCT00128414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945119|NCT00038493|Temozolomide|temozolomide|mesh-list
64945120|NCT00038493|Lonafarnib|lonafarnib|mesh-list
64945121|NCT00038493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64945122|NCT00038493|Alkylating Agents|alkylating agents|mesh-ancestor
64945123|NCT00038493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945124|NCT00038493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945125|NCT00038493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945126|NCT00038532|Ritonavir|ritonavir|mesh-list
64945152|NCT00038571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945153|NCT05770687|Dapagliflozin|dapagliflozin|mesh-list
64945154|NCT05770687|Empagliflozin|empagliflozin|mesh-list
64945155|NCT05770687|Ertugliflozin|ertugliflozin|mesh-list
64945156|NCT05770687|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64945157|NCT05770687|Ipragliflozin|ipragliflozin|mesh-list
64945158|NCT05770687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945159|NCT05770687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64566128|NCT05275907|Chlorthalidone|chlorthalidone|mesh-list
64566129|NCT05275907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64566130|NCT05275907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64566131|NCT05275907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64566132|NCT05275907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566133|NCT05275907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64566134|NCT05275907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566135|NCT05275907|Vasodilator Agents|vasodilator agents|mesh-ancestor
64566136|NCT05275907|Diuretics|diuretics|mesh-ancestor
64566137|NCT05275907|Natriuretic Agents|natriuretic agents|mesh-ancestor
64566138|NCT05275907|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64566139|NCT05269628|Dronabinol|dronabinol|mesh-list
64566140|NCT05269628|Cannabidiol|cannabidiol|mesh-list
64566141|NCT05269628|Anticonvulsants|anticonvulsants|mesh-ancestor
64566142|NCT05269628|Hallucinogens|hallucinogens|mesh-ancestor
64566143|NCT05269628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566144|NCT05269628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64566210|NCT05161195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566211|NCT05161195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64566212|NCT05161195|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64566213|NCT05161195|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64566214|NCT05161195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64566215|NCT05161195|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64566216|NCT05132075|Docetaxel|docetaxel|mesh-list
64566217|NCT05132075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566218|NCT05132075|Tubulin Modulators|tubulin modulators|mesh-ancestor
64566219|NCT05132075|Antimitotic Agents|antimitotic agents|mesh-ancestor
64566220|NCT05132075|Mitosis Modulators|mitosis modulators|mesh-ancestor
64566221|NCT05132075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566222|NCT05128344|Vigabatrin|vigabatrin|mesh-list
64566223|NCT05128344|Anticonvulsants|anticonvulsants|mesh-ancestor
64566224|NCT05128344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627317|NCT01460654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945160|NCT05770687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945161|NCT05770375|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
64945162|NCT05770375|Hallucinogens|hallucinogens|mesh-ancestor
64945163|NCT05770375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945164|NCT05770375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64945171|NCT05770375|Adrenergic Agents|adrenergic agents|mesh-ancestor
64945172|NCT05770323|Uric Acid|uric acid|mesh-list
64945173|NCT05770323|Antioxidants|antioxidants|mesh-ancestor
64993387|NCT02408861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64566225|NCT05128344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566226|NCT05128344|GABA Agents|gaba agents|mesh-ancestor
64566227|NCT05128344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64517310|NCT04643379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64517311|NCT04643379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64517313|NCT04643379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517314|NCT04781439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64517315|NCT04781439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64517316|NCT03261024|Nickel|nickel|mesh-list
64517317|NCT03261024|Trace Elements|trace elements|mesh-ancestor
64517318|NCT03261024|Micronutrients|micronutrients|mesh-ancestor
64517319|NCT03261024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517320|NCT04777383|Atropine|atropine|mesh-list
64517321|NCT04777383|Phenylephrine|phenylephrine|mesh-list
64517322|NCT04777383|Oxymetazoline|oxymetazoline|mesh-list
64517323|NCT04777383|Norepinephrine|norepinephrine|mesh-list
64517324|NCT04777383|Acetylcholine|acetylcholine|mesh-list
64517325|NCT04777383|Neostigmine|neostigmine|mesh-list
64517326|NCT04777383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64517327|NCT04777383|Mydriatics|mydriatics|mesh-ancestor
64517328|NCT04777383|Autonomic Agents|autonomic agents|mesh-ancestor
64627356|NCT01444040|Travoprost|travoprost|mesh-list
64945174|NCT05770323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945175|NCT05770323|Protective Agents|protective agents|mesh-ancestor
64531233|NCT04118920|Lubricant Eye Drops|lubricant eye drops|mesh-list
64531234|NCT04118920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64531235|NCT04118920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531236|NCT04118920|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64531237|NCT04118920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64531239|NCT04111458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531240|NCT04111458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64531241|NCT04111458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531242|NCT04111458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531243|NCT04100135|Clopidogrel|clopidogrel|mesh-list
64531244|NCT04100135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64295824|NCT02058979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64295825|NCT02058979|Cefazolin|cefazolin|mesh-list
64295826|NCT02058979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64945203|NCT05769725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945204|NCT05769725|Tubulin Modulators|tubulin modulators|mesh-ancestor
64945205|NCT05769725|Antimitotic Agents|antimitotic agents|mesh-ancestor
64945206|NCT05769725|Mitosis Modulators|mitosis modulators|mesh-ancestor
64713741|NCT01517100|Hormones|hormones|mesh-ancestor
64945207|NCT05769725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945208|NCT05769660|Temozolomide|temozolomide|mesh-list
64945209|NCT05769660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64945210|NCT05769660|Alkylating Agents|alkylating agents|mesh-ancestor
64945211|NCT05769660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945212|NCT05769660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945213|NCT05769569|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64945214|NCT05769569|Antiviral Agents|antiviral agents|mesh-ancestor
64945215|NCT05769569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64945216|NCT05769530|Dexmedetomidine|dexmedetomidine|mesh-list
64945217|NCT05769530|Nalbuphine|nalbuphine|mesh-list
64945218|NCT05769530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64945219|NCT05769530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64517329|NCT04777383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517330|NCT04777383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566228|NCT05128344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566229|NCT05117242|Pembrolizumab|pembrolizumab|mesh-list
64566230|NCT05117242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64566231|NCT05117242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566232|NCT05093296|Naltrexone|naltrexone|mesh-list
64566233|NCT05093296|Oxytocin|oxytocin|mesh-list
64566234|NCT05093296|Oxytocics|oxytocics|mesh-ancestor
64566235|NCT05093296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64566236|NCT05093296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566237|NCT05093296|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64566238|NCT05093296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64566239|NCT05093296|Sensory System Agents|sensory system agents|mesh-ancestor
64566240|NCT05093296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64566241|NCT05071833|Peppermint oil|peppermint oil|mesh-list
64566242|NCT05071833|Antiemetics|antiemetics|mesh-ancestor
64566243|NCT05071833|Autonomic Agents|autonomic agents|mesh-ancestor
64566244|NCT05071833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64566245|NCT05071833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566246|NCT05071833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64566247|NCT05071833|Parasympatholytics|parasympatholytics|mesh-ancestor
64566248|NCT05050136|Volixibat|volixibat|mesh-list
64566249|NCT05050136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64566250|NCT05023369|Dexamethasone|dexamethasone|mesh-list
64945220|NCT05769530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945221|NCT05769530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64945222|NCT05769530|Analgesics|analgesics|mesh-ancestor
64945223|NCT05769530|Sensory System Agents|sensory system agents|mesh-ancestor
64945224|NCT05769530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64945236|NCT05769478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945238|NCT05769478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64945239|NCT05769478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945240|NCT05769309|Fentanyl|fentanyl|mesh-list
64945241|NCT05769309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64945242|NCT05769309|Narcotics|narcotics|mesh-ancestor
64945243|NCT05769309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64945244|NCT05769309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945245|NCT05769309|Analgesics|analgesics|mesh-ancestor
64945246|NCT05769309|Sensory System Agents|sensory system agents|mesh-ancestor
64945247|NCT05769309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64945248|NCT05769309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64945249|NCT05769309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64945250|NCT05769309|Anesthetics, General|anesthetics, general|mesh-ancestor
64945251|NCT05769309|Anesthetics|anesthetics|mesh-ancestor
64945252|NCT05769153|Aflibercept|aflibercept|mesh-list
64945253|NCT05769153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64945254|NCT05769153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64945255|NCT05769153|Growth Substances|growth substances|mesh-ancestor
64945256|NCT05769153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531249|NCT04100135|Purinergic Agents|purinergic agents|mesh-ancestor
64531250|NCT04100135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64566251|NCT05023369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64566252|NCT05023369|Antiemetics|antiemetics|mesh-ancestor
64566253|NCT05023369|Autonomic Agents|autonomic agents|mesh-ancestor
64566254|NCT05023369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64566255|NCT05023369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566256|NCT05023369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64566315|NCT04812548|Azacitidine|azacitidine|mesh-list
64566316|NCT04812548|Venetoclax|venetoclax|mesh-list
64566317|NCT04812548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64566319|NCT04812548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566320|NCT04812548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566321|NCT04812548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566322|NCT04785950|Levonorgestrel|levonorgestrel|mesh-list
64517331|NCT04777383|Sympathomimetics|sympathomimetics|mesh-ancestor
64517332|NCT04777383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64517333|NCT04777383|Nasal Decongestants|nasal decongestants|mesh-ancestor
64517334|NCT04777383|Respiratory System Agents|respiratory system agents|mesh-ancestor
64517335|NCT04777383|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64627466|NCT00002440|Abacavir|abacavir|mesh-list
64531251|NCT04100135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531252|NCT04100135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531254|NCT04083144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64531255|NCT04083144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64531256|NCT04083144|Cholinergic Agents|cholinergic agents|mesh-ancestor
64531257|NCT04083144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64531258|NCT04083144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714120|NCT03054805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531259|NCT04083144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531260|NCT04055818|Niacinamide|niacinamide|mesh-list
64945260|NCT05769049|Immunologic Factors|immunologic factors|mesh-ancestor
64945261|NCT05769049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945262|NCT05768997|Darbepoetin alfa|darbepoetin alfa|mesh-list
64945263|NCT05768997|Hematinics|hematinics|mesh-ancestor
64945264|NCT05768945|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64945265|NCT05768945|Protease Inhibitors|protease inhibitors|mesh-ancestor
64945266|NCT05768945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945267|NCT05768945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945268|NCT05768945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64945269|NCT05768945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945270|NCT05765305|Chromium|chromium|mesh-list
64945271|NCT05765305|Letrozole|letrozole|mesh-list
64945272|NCT05765305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945273|NCT05765305|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64945274|NCT05765305|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64945275|NCT05765305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945276|NCT05765305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945277|NCT05765305|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64945278|NCT05765305|Hormone Antagonists|hormone antagonists|mesh-ancestor
64945279|NCT05765305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64945280|NCT05765305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945281|NCT05765305|Trace Elements|trace elements|mesh-ancestor
64945282|NCT05765305|Micronutrients|micronutrients|mesh-ancestor
64945283|NCT05762146|Perphenazine|perphenazine|mesh-list
64945284|NCT05762146|Riociguat|riociguat|mesh-list
64945285|NCT05762146|Propylthiouracil|propylthiouracil|mesh-list
64945286|NCT05762146|Enzyme Activators|enzyme activators|mesh-ancestor
64517336|NCT04777383|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64517337|NCT04777383|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64517338|NCT04777383|Adrenergic Agents|adrenergic agents|mesh-ancestor
64517339|NCT04777383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64517340|NCT04777383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517341|NCT04777383|Protective Agents|protective agents|mesh-ancestor
64517342|NCT04777383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64517343|NCT04777383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64517344|NCT04777383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64517345|NCT04777383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64517346|NCT04777383|Parasympatholytics|parasympatholytics|mesh-ancestor
64517347|NCT04777383|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64517348|NCT04777383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64517349|NCT04777383|Cholinergic Agents|cholinergic agents|mesh-ancestor
64517350|NCT04777383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64517351|NCT04777383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566323|NCT04785950|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64566324|NCT04785950|Contraceptive Agents|contraceptive agents|mesh-ancestor
64566325|NCT04785950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64566326|NCT04785950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566327|NCT04785950|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64566328|NCT04785950|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64566329|NCT04785950|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64566330|NCT04781881|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64566331|NCT04781881|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64566332|NCT04781881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566407|NCT04577755|Pomalidomide|pomalidomide|mesh-list
64566408|NCT04577755|Immunologic Factors|immunologic factors|mesh-ancestor
64566409|NCT04577755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566410|NCT04577755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64566411|NCT04577755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64566412|NCT04577755|Growth Substances|growth substances|mesh-ancestor
64627520|NCT00002446|Posaconazole|posaconazole|mesh-list
64945287|NCT05762146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945295|NCT05762146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64945297|NCT05762146|Antithyroid Agents|antithyroid agents|mesh-ancestor
64945298|NCT05762146|Hormone Antagonists|hormone antagonists|mesh-ancestor
64945299|NCT05762146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64566413|NCT04577755|Growth Inhibitors|growth inhibitors|mesh-ancestor
64566450|NCT04469868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566451|NCT04469868|Analgesics|analgesics|mesh-ancestor
64566452|NCT04469868|Sensory System Agents|sensory system agents|mesh-ancestor
64566453|NCT04469868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64566482|NCT04385277|Temozolomide|temozolomide|mesh-list
64566483|NCT04385277|Tretinoin|tretinoin|mesh-list
64566484|NCT04385277|Dinutuximab|dinutuximab|mesh-list
64566485|NCT04385277|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64566486|NCT04385277|Isotretinoin|isotretinoin|mesh-list
64566487|NCT04385277|Sargramostim|sargramostim|mesh-list
64566488|NCT04385277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64566489|NCT04385277|Vitamins|vitamins|mesh-ancestor
64566490|NCT04385277|Micronutrients|micronutrients|mesh-ancestor
64566491|NCT04385277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517352|NCT04777383|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64517353|NCT04777383|Vasodilator Agents|vasodilator agents|mesh-ancestor
64517354|NCT04777383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64627580|NCT00002452|Indinavir|indinavir|mesh-list
64945300|NCT05760612|Trastuzumab|trastuzumab|mesh-list
64945301|NCT05760612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64945302|NCT05760612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945303|NCT05760144|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64531262|NCT04055818|Nicotinic Acids|nicotinic acids|mesh-list
64531263|NCT04055818|Decitabine|decitabine|mesh-list
64531264|NCT04055818|Tetrahydrouridine|tetrahydrouridine|mesh-list
64531265|NCT04055818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64531266|NCT04055818|Antimetabolites|antimetabolites|mesh-ancestor
64531267|NCT04055818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531268|NCT04055818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531269|NCT04055818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531270|NCT04055818|Vitamin B Complex|vitamin b complex|mesh-ancestor
64531271|NCT04055818|Vitamins|vitamins|mesh-ancestor
64652035|NCT01834898|Narcotics|narcotics|mesh-ancestor
64945307|NCT05760144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64945308|NCT05760144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945309|NCT05760144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64945310|NCT05760144|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64945311|NCT05760144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64945312|NCT05760144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945314|NCT05744674|Anesthetics, Local|anesthetics, local|mesh-ancestor
64945315|NCT05744674|Anesthetics|anesthetics|mesh-ancestor
64945316|NCT05744674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64945317|NCT05744674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945318|NCT05744674|Sensory System Agents|sensory system agents|mesh-ancestor
64945319|NCT05744674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64945320|NCT05742594|Lazertinib|lazertinib|mesh-list
64945321|NCT05742594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64945322|NCT05742594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945323|NCT05742594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945324|NCT05736978|Azacitidine|azacitidine|mesh-list
64945325|NCT05736978|Venetoclax|venetoclax|mesh-list
64945326|NCT05736978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64945327|NCT05736978|Antimetabolites|antimetabolites|mesh-ancestor
64945328|NCT05736978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945329|NCT05736978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945330|NCT05736978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945331|NCT05736965|Azacitidine|azacitidine|mesh-list
64945332|NCT05736965|Venetoclax|venetoclax|mesh-list
64945333|NCT05736965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64945334|NCT05736965|Antimetabolites|antimetabolites|mesh-ancestor
64517355|NCT03257124|Osimertinib|osimertinib|mesh-list
64517356|NCT03257124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566492|NCT04385277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64566493|NCT04385277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64566494|NCT04385277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566495|NCT04385277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566496|NCT04385277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566497|NCT04385277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64566498|NCT04385277|Alkylating Agents|alkylating agents|mesh-ancestor
64566499|NCT04385277|Immunologic Factors|immunologic factors|mesh-ancestor
64566500|NCT04385277|Keratolytic Agents|keratolytic agents|mesh-ancestor
64566501|NCT04385277|Dermatologic Agents|dermatologic agents|mesh-ancestor
64566502|NCT04385277|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64566503|NCT04363697|Dapagliflozin|dapagliflozin|mesh-list
64566504|NCT04363697|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64566541|NCT04265105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64566542|NCT04265105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64566544|NCT04265105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64566545|NCT04265105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566554|NCT04246229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566555|NCT04239703|Antibodies|antibodies|mesh-list
64566556|NCT04239703|Immunologic Factors|immunologic factors|mesh-ancestor
64566557|NCT04239703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566558|NCT04208178|Trastuzumab|trastuzumab|mesh-list
64566559|NCT04208178|Pertuzumab|pertuzumab|mesh-list
64566560|NCT04208178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64566561|NCT04208178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566562|NCT04148911|Paclitaxel|paclitaxel|mesh-list
64566563|NCT04148911|Atezolizumab|atezolizumab|mesh-list
64566564|NCT04148911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64566565|NCT04148911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566566|NCT04148911|Tubulin Modulators|tubulin modulators|mesh-ancestor
64566567|NCT04148911|Antimitotic Agents|antimitotic agents|mesh-ancestor
64566568|NCT04148911|Mitosis Modulators|mitosis modulators|mesh-ancestor
64566569|NCT04148911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566648|NCT03841058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64566649|NCT03841058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566650|NCT03731923|Liver Extracts|liver extracts|mesh-list
64566651|NCT03731923|Hematinics|hematinics|mesh-ancestor
64566652|NCT03723564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64566653|NCT03714308|Aflibercept|aflibercept|mesh-list
64566654|NCT03714308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64566655|NCT03714308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64566656|NCT03714308|Growth Substances|growth substances|mesh-ancestor
64566657|NCT03714308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566658|NCT03714308|Growth Inhibitors|growth inhibitors|mesh-ancestor
64566659|NCT03714308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566660|NCT03688789|Hydrocortisone|hydrocortisone|mesh-list
64566661|NCT03688789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64566693|NCT03492775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64566695|NCT03385304|Chlorhexidine|chlorhexidine|mesh-list
64566696|NCT03385304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64566697|NCT03385304|Povidone-Iodine|povidone-iodine|mesh-list
64566698|NCT03385304|Povidone|povidone|mesh-list
64566699|NCT03385304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64627661|NCT01004705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64945335|NCT05736965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945336|NCT05736965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945337|NCT05736965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945338|NCT05706727|Phenylephrine|phenylephrine|mesh-list
64945339|NCT05706727|Oxymetazoline|oxymetazoline|mesh-list
64945340|NCT05706727|Mephentermine|mephentermine|mesh-list
64945341|NCT05706727|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64945342|NCT05706727|Mydriatics|mydriatics|mesh-ancestor
64945343|NCT05706727|Autonomic Agents|autonomic agents|mesh-ancestor
64945344|NCT05706727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64945345|NCT05706727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945346|NCT05706727|Sympathomimetics|sympathomimetics|mesh-ancestor
64945347|NCT05706727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64945348|NCT05706727|Nasal Decongestants|nasal decongestants|mesh-ancestor
64945349|NCT05706727|Respiratory System Agents|respiratory system agents|mesh-ancestor
64945350|NCT05706727|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64945351|NCT05706727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64945352|NCT05706727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64531275|NCT04055818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64531276|NCT04055818|Vasodilator Agents|vasodilator agents|mesh-ancestor
64531277|NCT04047953|Paclitaxel|paclitaxel|mesh-list
64531278|NCT04047953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64531279|NCT04047953|Oxaliplatin|oxaliplatin|mesh-list
64531280|NCT04047953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64295871|NCT02058199|Rivaroxaban|rivaroxaban|mesh-list
64945353|NCT05706727|Adrenergic Agents|adrenergic agents|mesh-ancestor
64945354|NCT05706727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64557564|NCT04405193|Antidotes|antidotes|mesh-ancestor
64557565|NCT05227833|Pantoprazole|pantoprazole|mesh-list
64557566|NCT05227833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64557567|NCT05227833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64557568|NCT05227833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64557569|NCT05227833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557570|NCT05227833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557571|NCT05083299|Sarpogrelate|sarpogrelate|mesh-list
64557577|NCT05083299|Serotonin Agents|serotonin agents|mesh-ancestor
64566700|NCT03385304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64566701|NCT03385304|Disinfectants|disinfectants|mesh-ancestor
64566702|NCT03385304|Dermatologic Agents|dermatologic agents|mesh-ancestor
64566703|NCT03385304|Trace Elements|trace elements|mesh-ancestor
64566704|NCT03385304|Micronutrients|micronutrients|mesh-ancestor
64566728|NCT03237780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566729|NCT03237780|Tubulin Modulators|tubulin modulators|mesh-ancestor
64517357|NCT03257124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64517359|NCT03257124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517360|NCT02089113|Dexamethasone|dexamethasone|mesh-list
64517361|NCT02089113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64517362|NCT02089113|Antiemetics|antiemetics|mesh-ancestor
64517363|NCT02089113|Autonomic Agents|autonomic agents|mesh-ancestor
64517364|NCT02089113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517365|NCT02089113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517366|NCT02089113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64517367|NCT02089113|Glucocorticoids|glucocorticoids|mesh-ancestor
64557578|NCT05083299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64557579|NCT05083299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557580|NCT05701475|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64557581|NCT05701475|Dermatologic Agents|dermatologic agents|mesh-ancestor
64557582|NCT03035253|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64557583|NCT03035253|Immunologic Factors|immunologic factors|mesh-ancestor
64557584|NCT03035253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557585|NCT04405271|Tenofovir|tenofovir|mesh-list
64557586|NCT04405271|Emtricitabine|emtricitabine|mesh-list
64557587|NCT04405271|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64557588|NCT04405271|Antiviral Agents|antiviral agents|mesh-ancestor
64557589|NCT04405271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64557590|NCT04405271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64557591|NCT04405271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64557592|NCT04405271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557593|NCT04405271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557594|NCT04405271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64557595|NCT04405271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64557596|NCT03034941|Metformin|metformin|mesh-list
64557597|NCT03034941|Liraglutide|liraglutide|mesh-list
64557598|NCT03034941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64557599|NCT03034941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557600|NCT03034941|Incretins|incretins|mesh-ancestor
64557601|NCT03034941|Hormones|hormones|mesh-ancestor
64557602|NCT03034941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64557603|NCT03030105|Scopolamine|scopolamine|mesh-list
64557604|NCT03030105|Donepezil|donepezil|mesh-list
64557605|NCT03030105|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64557606|NCT03030105|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64557607|NCT03030105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557608|NCT03030105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557609|NCT03030105|Cholinergic Agents|cholinergic agents|mesh-ancestor
64557610|NCT03030105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64557611|NCT03030105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557612|NCT03030105|Nootropic Agents|nootropic agents|mesh-ancestor
64557613|NCT03030105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64557614|NCT03030105|Antiemetics|antiemetics|mesh-ancestor
64557615|NCT03030105|Autonomic Agents|autonomic agents|mesh-ancestor
64557616|NCT03030105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64557617|NCT03030105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64557618|NCT03030105|Mydriatics|mydriatics|mesh-ancestor
64557619|NCT03030105|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64557620|NCT03030105|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64517368|NCT02089113|Hormones|hormones|mesh-ancestor
64517369|NCT02089113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64517370|NCT02089113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64517371|NCT02089113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566730|NCT03237780|Antimitotic Agents|antimitotic agents|mesh-ancestor
64566731|NCT03237780|Mitosis Modulators|mitosis modulators|mesh-ancestor
64566732|NCT03237780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566734|NCT03185819|Esketamine|esketamine|mesh-list
64566735|NCT03185819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64566736|NCT03185819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64566737|NCT03185819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64566738|NCT03185819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566739|NCT03185819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64566740|NCT03185819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64566741|NCT03185819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64566742|NCT03185819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64566743|NCT03185819|Anesthetics, General|anesthetics, general|mesh-ancestor
64566744|NCT03185819|Anesthetics|anesthetics|mesh-ancestor
64566745|NCT03185819|GABA Modulators|gaba modulators|mesh-ancestor
64566746|NCT03185819|GABA Agents|gaba agents|mesh-ancestor
64566747|NCT03185819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64566748|NCT03185819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566749|NCT03185819|Antidepressive Agents|antidepressive agents|mesh-ancestor
64566750|NCT03173248|Azacitidine|azacitidine|mesh-list
64566751|NCT03173248|Ivosidenib|ivosidenib|mesh-list
64566771|NCT03152786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64566772|NCT03152786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566773|NCT03152786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566774|NCT03152786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64566846|NCT02756962|Immunologic Factors|immunologic factors|mesh-ancestor
64566847|NCT02756962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566848|NCT02728037|Lidocaine|lidocaine|mesh-list
64566849|NCT02728037|Magnesium Sulfate|magnesium sulfate|mesh-list
64557621|NCT03030105|Parasympatholytics|parasympatholytics|mesh-ancestor
64557622|NCT03067896|Magnesium Sulfate|magnesium sulfate|mesh-list
64557623|NCT03067896|Dexmedetomidine|dexmedetomidine|mesh-list
64484386|NCT01729819|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64531281|NCT04047953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531282|NCT04047953|Tubulin Modulators|tubulin modulators|mesh-ancestor
64531283|NCT04047953|Antimitotic Agents|antimitotic agents|mesh-ancestor
64531284|NCT04047953|Mitosis Modulators|mitosis modulators|mesh-ancestor
64566850|NCT02728037|Anesthetics, Local|anesthetics, local|mesh-ancestor
64566851|NCT02728037|Anesthetics|anesthetics|mesh-ancestor
64566852|NCT02728037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64566853|NCT02728037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566854|NCT02728037|Sensory System Agents|sensory system agents|mesh-ancestor
64566880|NCT02275780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566881|NCT02275780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566882|NCT02275780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64566883|NCT02275780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64566884|NCT02275780|Antiviral Agents|antiviral agents|mesh-ancestor
64566885|NCT02275780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64566886|NCT02275780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64531285|NCT04047953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531286|NCT04039607|Nivolumab|nivolumab|mesh-list
64531287|NCT04039607|Ipilimumab|ipilimumab|mesh-list
64531288|NCT04039607|Sorafenib|sorafenib|mesh-list
64531289|NCT04039607|Lenvatinib|lenvatinib|mesh-list
64531290|NCT04039607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64531291|NCT04039607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531292|NCT04039607|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64531293|NCT04039607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531294|NCT04039607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64531295|NCT04039607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531296|NCT04029688|Cytarabine|cytarabine|mesh-list
64531297|NCT04029688|Cyclophosphamide|cyclophosphamide|mesh-list
64531298|NCT04029688|Fludarabine|fludarabine|mesh-list
64531299|NCT04029688|Topotecan|topotecan|mesh-list
64484394|NCT00811564|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64484395|NCT00811564|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64484396|NCT00811564|Adrenergic Agents|adrenergic agents|mesh-ancestor
64484397|NCT00811564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64484398|NCT00811564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484399|NCT00811564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64484400|NCT00811564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64484401|NCT00811564|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64484402|NCT00811564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64484403|NCT00811564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64484404|NCT05394298|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64484405|NCT05394298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64484406|NCT05394298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64484407|NCT05394298|Antitubercular Agents|antitubercular agents|mesh-ancestor
64484408|NCT04520776|Meloxicam|meloxicam|mesh-list
64484409|NCT04520776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64484410|NCT04520776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64484411|NCT04520776|Analgesics|analgesics|mesh-ancestor
64484412|NCT04520776|Sensory System Agents|sensory system agents|mesh-ancestor
64484413|NCT04520776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484414|NCT04520776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484415|NCT04520776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64484416|NCT04520776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64484417|NCT04520776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64484418|NCT04520776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64484419|NCT04520776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484420|NCT04520776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484421|NCT01709084|Tenofovir|tenofovir|mesh-list
64295894|NCT03314025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64531302|NCT04029688|Immunologic Factors|immunologic factors|mesh-ancestor
64531303|NCT04029688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531304|NCT04029688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64531305|NCT04029688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64531306|NCT04029688|Alkylating Agents|alkylating agents|mesh-ancestor
64566887|NCT02275780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64517373|NCT04780659|Immunologic Factors|immunologic factors|mesh-ancestor
64517374|NCT04780659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517375|NCT03260634|Voriconazole|voriconazole|mesh-list
64517376|NCT03260634|Antifungal Agents|antifungal agents|mesh-ancestor
64566888|NCT02275780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64566889|NCT02275780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64566890|NCT02158091|Cyclophosphamide|cyclophosphamide|mesh-list
64566891|NCT02158091|Rituximab|rituximab|mesh-list
64566892|NCT02158091|Fludarabine|fludarabine|mesh-list
64566893|NCT02158091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64566894|NCT02158091|Immunologic Factors|immunologic factors|mesh-ancestor
64566895|NCT02158091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566896|NCT02158091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64566897|NCT02158091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64566898|NCT02158091|Alkylating Agents|alkylating agents|mesh-ancestor
64566899|NCT02158091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566900|NCT02158091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566901|NCT02158091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64566932|NCT00545077|Growth Substances|growth substances|mesh-ancestor
64566933|NCT00545077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566934|NCT00545077|Growth Inhibitors|growth inhibitors|mesh-ancestor
64566935|NCT00545077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64566936|NCT00545077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64566937|NCT00545077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531307|NCT04029688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531308|NCT04029688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531309|NCT04029688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64531310|NCT04029688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64295895|NCT03314025|Adrenergic Agents|adrenergic agents|mesh-ancestor
64484423|NCT01709084|Efavirenz|efavirenz|mesh-list
64484424|NCT01709084|Rilpivirine|rilpivirine|mesh-list
64484425|NCT01709084|Antiviral Agents|antiviral agents|mesh-ancestor
64484426|NCT01709084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64484427|NCT01709084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64484428|NCT01709084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64484429|NCT01709084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484430|NCT01709084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484431|NCT01709084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64484444|NCT01776307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484445|NCT01776307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64484446|NCT01776307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64484447|NCT01741532|Deferiprone|deferiprone|mesh-list
64484448|NCT01741532|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64453598|NCT01959529|Insulin Glargine|insulin glargine|mesh-list
64453599|NCT01959529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64453600|NCT01959529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652056|NCT03212456|Sensory System Agents|sensory system agents|mesh-ancestor
64566938|NCT00545077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566939|NCT00545077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64566940|NCT00545077|Hormone Antagonists|hormone antagonists|mesh-ancestor
64566941|NCT00545077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64566942|NCT00545077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64566943|NCT00545077|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64566944|NCT00251433|Docetaxel|docetaxel|mesh-list
64566945|NCT00251433|Trastuzumab|trastuzumab|mesh-list
64566946|NCT00251433|Lapatinib|lapatinib|mesh-list
64566947|NCT00251433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566948|NCT00251433|Tubulin Modulators|tubulin modulators|mesh-ancestor
64566974|NCT00129935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566975|NCT00129935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64566976|NCT00129935|Tubulin Modulators|tubulin modulators|mesh-ancestor
64566977|NCT00129935|Antimitotic Agents|antimitotic agents|mesh-ancestor
64627935|NCT00002524|Abortifacient Agents|abortifacient agents|mesh-ancestor
64453614|NCT04681469|Niraparib|niraparib|mesh-list
64453615|NCT04681469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64453616|NCT04681469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453617|NCT04681469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453618|NCT04681469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453619|NCT01986751|Clonidine|clonidine|mesh-list
64453620|NCT01986751|Ropivacaine|ropivacaine|mesh-list
64453621|NCT01986751|Anesthetics, Local|anesthetics, local|mesh-ancestor
64453622|NCT01986751|Anesthetics|anesthetics|mesh-ancestor
64453623|NCT01986751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64453624|NCT01986751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453625|NCT01986751|Sensory System Agents|sensory system agents|mesh-ancestor
64453626|NCT01986751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64453627|NCT01986751|Analgesics|analgesics|mesh-ancestor
64453628|NCT01986751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64453629|NCT01986751|Sympatholytics|sympatholytics|mesh-ancestor
64453630|NCT01986751|Autonomic Agents|autonomic agents|mesh-ancestor
64453631|NCT01986751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64453632|NCT01986751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64453633|NCT01986751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64453634|NCT01986751|Adrenergic Agents|adrenergic agents|mesh-ancestor
64531311|NCT04029688|Antimetabolites|antimetabolites|mesh-ancestor
64531312|NCT04029688|Antiviral Agents|antiviral agents|mesh-ancestor
64531313|NCT04029688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64531314|NCT04029688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64531315|NCT04029688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64531316|NCT04029688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531317|NCT03983850|Mycophenolic Acid|mycophenolic acid|mesh-list
64531318|NCT03983850|Sirolimus|sirolimus|mesh-list
64531319|NCT03983850|Cyclophosphamide|cyclophosphamide|mesh-list
64453635|NCT01986751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64453636|NCT01986751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453637|NCT01438060|Aripiprazole|aripiprazole|mesh-list
64453638|NCT01438060|Antidepressive Agents|antidepressive agents|mesh-ancestor
64453639|NCT01438060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64453640|NCT01438060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64453641|NCT01438060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64453642|NCT01438060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64453653|NCT01438060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64453655|NCT01444300|4-Aminopyridine|4-aminopyridine|mesh-list
64453656|NCT01444300|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64453657|NCT01444300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64453658|NCT01444300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566978|NCT00129935|Mitosis Modulators|mitosis modulators|mesh-ancestor
64566979|NCT00129935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64566980|NCT00129935|Antimetabolites|antimetabolites|mesh-ancestor
64566981|NCT00129935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64566982|NCT00129935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64566983|NCT00129935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64566984|NCT00129935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566985|NCT02760667|Cisplatin|cisplatin|mesh-list
64566986|NCT02760667|Carboplatin|carboplatin|mesh-list
64566987|NCT02760667|Docetaxel|docetaxel|mesh-list
64566988|NCT02760667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566989|NCT02760667|Tubulin Modulators|tubulin modulators|mesh-ancestor
64566990|NCT02760667|Antimitotic Agents|antimitotic agents|mesh-ancestor
64566991|NCT02760667|Mitosis Modulators|mitosis modulators|mesh-ancestor
64566992|NCT02760667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566993|NCT04127357|Fluorides|fluorides|mesh-list
64627994|NCT01344200|Analgesics|analgesics|mesh-ancestor
64453659|NCT01443364|Certolizumab Pegol|certolizumab pegol|mesh-list
64453660|NCT01443364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64453661|NCT01443364|Immunologic Factors|immunologic factors|mesh-ancestor
64453662|NCT01443364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652066|NCT03217838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453663|NCT01443364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64453664|NCT02020577|Cetuximab|cetuximab|mesh-list
64453670|NCT02020577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453672|NCT02020031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64453674|NCT02030405|Ixazomib|ixazomib|mesh-list
64453675|NCT02030405|Proteasome Inhibitors|proteasome inhibitors|mesh-list
64453676|NCT02030405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453677|NCT02030405|Protease Inhibitors|protease inhibitors|mesh-ancestor
64453678|NCT02030405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453679|NCT02030405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453681|NCT01975376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64453682|NCT01975376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64453683|NCT01975376|Antimetabolites|antimetabolites|mesh-ancestor
64453684|NCT01975376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453685|NCT01975376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64453686|NCT01443130|Chloroquine|chloroquine|mesh-list
64453687|NCT01443130|Pyrimethamine|pyrimethamine|mesh-list
64453688|NCT01443130|Sulfadoxine|sulfadoxine|mesh-list
64453689|NCT01443130|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64453690|NCT01443130|Amebicides|amebicides|mesh-ancestor
64453691|NCT01443130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64453692|NCT01443130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64453693|NCT01443130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64453694|NCT01443130|Antimalarials|antimalarials|mesh-ancestor
64453695|NCT01443130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64453696|NCT01443130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64453697|NCT01443130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453698|NCT01443130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453699|NCT01443130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64453700|NCT01443130|Renal Agents|renal agents|mesh-ancestor
64453701|NCT04066192|Brexpiprazole|brexpiprazole|mesh-list
64453702|NCT04066192|Serotonin Agents|serotonin agents|mesh-ancestor
64453703|NCT04066192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64453704|NCT04066192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453705|NCT04066192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453706|NCT04066192|Dopamine Agonists|dopamine agonists|mesh-ancestor
64531321|NCT03983850|Fludarabine|fludarabine|mesh-list
64531322|NCT03983850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64531323|NCT03983850|Immunologic Factors|immunologic factors|mesh-ancestor
64566994|NCT04127357|Cariostatic Agents|cariostatic agents|mesh-ancestor
64566995|NCT04127357|Protective Agents|protective agents|mesh-ancestor
64566996|NCT04127357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566997|NCT02713945|Simvastatin|simvastatin|mesh-list
64566998|NCT02713945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64567026|NCT02660905|Ledipasvir|ledipasvir|mesh-list
64567027|NCT02660905|Antiviral Agents|antiviral agents|mesh-ancestor
64567028|NCT02660905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64567029|NCT02660905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64567030|NCT02660905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64567031|NCT02660905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567032|NCT02660905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567033|NCT02660905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64567034|NCT02660905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64517377|NCT03260634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64517378|NCT03260634|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64517379|NCT03260634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64517380|NCT03260634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567035|NCT03822715|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64567036|NCT03822715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64567037|NCT03822715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567038|NCT03822715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567039|NCT03822715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64531324|NCT03983850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531325|NCT03983850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64453707|NCT04066192|Dopamine Agents|dopamine agents|mesh-ancestor
64453723|NCT01959139|Antidotes|antidotes|mesh-ancestor
64453724|NCT01959139|Protective Agents|protective agents|mesh-ancestor
64453725|NCT01959139|Vitamin B Complex|vitamin b complex|mesh-ancestor
64453726|NCT01959139|Vitamins|vitamins|mesh-ancestor
64453727|NCT01959139|Micronutrients|micronutrients|mesh-ancestor
64453728|NCT01436500|Ifetroban|ifetroban|mesh-list
64453729|NCT01436500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64453730|NCT01958827|Adalimumab|adalimumab|mesh-list
64453731|NCT01958827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64453732|NCT01958827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64453733|NCT04670653|Mometasone Furoate|mometasone furoate|mesh-list
64453734|NCT04670653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64453735|NCT04670653|Dermatologic Agents|dermatologic agents|mesh-ancestor
64453736|NCT04670653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64453737|NCT01436110|Fluticasone|fluticasone|mesh-list
64453739|NCT01436110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64453740|NCT01436110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64453741|NCT01436110|Autonomic Agents|autonomic agents|mesh-ancestor
64453742|NCT01436110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64453743|NCT01436110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453744|NCT01436110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64453745|NCT01436110|Respiratory System Agents|respiratory system agents|mesh-ancestor
64453746|NCT01436110|Dermatologic Agents|dermatologic agents|mesh-ancestor
64453747|NCT01436110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64453748|NCT01619852|Lidocaine|lidocaine|mesh-list
64453749|NCT01619852|Anesthetics, Local|anesthetics, local|mesh-ancestor
64453750|NCT01619852|Anesthetics|anesthetics|mesh-ancestor
64567040|NCT03822715|Hormone Antagonists|hormone antagonists|mesh-ancestor
64567041|NCT03822715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64567064|NCT01450345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64567065|NCT01450345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64567066|NCT01450345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64567067|NCT01450345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64567069|NCT03822559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64567070|NCT03822559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64567071|NCT03822559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64567072|NCT03822559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64567073|NCT03822559|Adrenergic Agents|adrenergic agents|mesh-ancestor
64567074|NCT03822559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64567075|NCT03822559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567076|NCT03822559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628118|NCT05750056|Narcotics|narcotics|mesh-ancestor
64439479|NCT01942161|Aripiprazole|aripiprazole|mesh-list
64453758|NCT01619852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64453759|NCT01619852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453762|NCT04069936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64453763|NCT04069936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453764|NCT04069936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64453765|NCT04069936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453766|NCT04069936|Vasodilator Agents|vasodilator agents|mesh-ancestor
64453767|NCT04069936|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64453768|NCT04069936|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64453769|NCT04069936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453770|NCT04069936|Urological Agents|urological agents|mesh-ancestor
64453800|NCT04666129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64453801|NCT04666129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453802|NCT04666129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64453804|NCT04666129|Autonomic Agents|autonomic agents|mesh-ancestor
64453805|NCT04666129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64453806|NCT04666129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64453807|NCT04666129|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64453808|NCT04666129|Protective Agents|protective agents|mesh-ancestor
64453809|NCT04666129|Androgen Antagonists|androgen antagonists|mesh-ancestor
64453810|NCT04666129|Hormone Antagonists|hormone antagonists|mesh-ancestor
64453811|NCT04666051|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64453812|NCT04666051|Hemostatics|hemostatics|mesh-ancestor
64453813|NCT04666051|Coagulants|coagulants|mesh-ancestor
64453814|NCT01965704|Ondansetron|ondansetron|mesh-list
64453815|NCT01965704|Antiemetics|antiemetics|mesh-ancestor
64453816|NCT01965704|Autonomic Agents|autonomic agents|mesh-ancestor
64453817|NCT01965704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64531326|NCT03983850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64531327|NCT03983850|Alkylating Agents|alkylating agents|mesh-ancestor
64531328|NCT03983850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531329|NCT03983850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531330|NCT03983850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64531331|NCT03983850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64531332|NCT03983850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64531333|NCT03983850|Antitubercular Agents|antitubercular agents|mesh-ancestor
64531334|NCT03983850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64531335|NCT03983850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64531336|NCT03983850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531337|NCT03983850|Antifungal Agents|antifungal agents|mesh-ancestor
64567077|NCT03822559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64567078|NCT03822559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64567079|NCT01647828|Gemcitabine|gemcitabine|mesh-list
64567080|NCT01647828|Paclitaxel|paclitaxel|mesh-list
64567081|NCT01647828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64567082|NCT01647828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567083|NCT01647828|Tubulin Modulators|tubulin modulators|mesh-ancestor
64567084|NCT01647828|Antimitotic Agents|antimitotic agents|mesh-ancestor
64567085|NCT01647828|Mitosis Modulators|mitosis modulators|mesh-ancestor
64567086|NCT01647828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567087|NCT01647828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64567088|NCT01647828|Antimetabolites|antimetabolites|mesh-ancestor
64567089|NCT01647828|Antiviral Agents|antiviral agents|mesh-ancestor
64567090|NCT01647828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64567091|NCT01647828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567092|NCT01647828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64567093|NCT01647828|Immunologic Factors|immunologic factors|mesh-ancestor
64567119|NCT04273321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64567120|NCT04273321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64567121|NCT04273321|Protective Agents|protective agents|mesh-ancestor
64567122|NCT04273321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64567123|NCT04273321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567124|NCT02654119|Paclitaxel|paclitaxel|mesh-list
64567125|NCT02654119|Cyclophosphamide|cyclophosphamide|mesh-list
64567126|NCT02654119|Trastuzumab|trastuzumab|mesh-list
64567127|NCT02654119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64567128|NCT02654119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64567130|NCT02654119|Immunoglobulins|immunoglobulins|mesh-list
64567131|NCT02654119|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64567132|NCT02654119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64567133|NCT02654119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567134|NCT02654119|Tubulin Modulators|tubulin modulators|mesh-ancestor
64567135|NCT02654119|Antimitotic Agents|antimitotic agents|mesh-ancestor
64567143|NCT02654119|Alkylating Agents|alkylating agents|mesh-ancestor
64517381|NCT03260634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517383|NCT03260634|Hormone Antagonists|hormone antagonists|mesh-ancestor
64517384|NCT03260634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64517385|NCT03260634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517386|NCT03260634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64517387|NCT04777227|Lidocaine|lidocaine|mesh-list
64517388|NCT04777227|Anesthetics, Local|anesthetics, local|mesh-ancestor
64517389|NCT04777227|Anesthetics|anesthetics|mesh-ancestor
64517390|NCT04777227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64517391|NCT04777227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517392|NCT04777227|Sensory System Agents|sensory system agents|mesh-ancestor
64517393|NCT04777227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517394|NCT04777227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64517395|NCT04777227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64517396|NCT04777227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64517397|NCT04777227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64517398|NCT04777227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517399|NCT03260556|Pirfenidone|pirfenidone|mesh-list
64517400|NCT03260556|Analgesics|analgesics|mesh-ancestor
64517401|NCT03260556|Sensory System Agents|sensory system agents|mesh-ancestor
64517402|NCT03260556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517403|NCT03260556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567168|NCT01454011|Testosterone enanthate|testosterone enanthate|mesh-list
64567169|NCT01454011|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64567171|NCT01454011|Hormones|hormones|mesh-ancestor
64567172|NCT01454011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64567173|NCT01454011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567174|NCT01454011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64567175|NCT01454011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567176|NCT01454011|Anabolic Agents|anabolic agents|mesh-ancestor
64567185|NCT04976088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64567186|NCT04976088|Analgesics|analgesics|mesh-ancestor
64567187|NCT04976088|Sensory System Agents|sensory system agents|mesh-ancestor
64567188|NCT04976088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64567189|NCT04976088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567190|NCT04976088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64567191|NCT04976088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64567192|NCT04976088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64517404|NCT03260556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64517405|NCT03260556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64517406|NCT03260556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64517407|NCT03260556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64517408|NCT03260556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567199|NCT04975932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64567200|NCT04975932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567201|NCT04975932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64567203|NCT04968132|Analgesics, Opioid|analgesics, opioid|mesh-list
64567204|NCT04968132|Narcotics|narcotics|mesh-ancestor
64567205|NCT04968132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64567206|NCT04968132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567207|NCT04968132|Analgesics|analgesics|mesh-ancestor
64567208|NCT04968132|Sensory System Agents|sensory system agents|mesh-ancestor
64567209|NCT04968132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64567211|NCT03829111|Ipilimumab|ipilimumab|mesh-list
64567212|NCT03829111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64567213|NCT03829111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567214|NCT03829111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64567215|NCT03829111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567216|NCT01454479|Lapatinib|lapatinib|mesh-list
64567217|NCT01454479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567218|NCT01454479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64567219|NCT01454479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531339|NCT03981900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64531340|NCT03981900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531341|NCT03981900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531342|NCT03961971|Spartalizumab|spartalizumab|mesh-list
64531343|NCT03961971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64295917|NCT03313869|Micronutrients|micronutrients|mesh-ancestor
64295919|NCT03313869|Antioxidants|antioxidants|mesh-ancestor
64453822|NCT01965704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64567220|NCT01454479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567221|NCT03061032|Ribavirin|ribavirin|mesh-list
64567222|NCT03061032|Sofosbuvir|sofosbuvir|mesh-list
64567223|NCT03061032|Ledipasvir|ledipasvir|mesh-list
64567224|NCT03061032|Antimetabolites|antimetabolites|mesh-ancestor
64567225|NCT03061032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567226|NCT03061032|Antiviral Agents|antiviral agents|mesh-ancestor
64567227|NCT03061032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64567228|NCT02911831|Tranexamic Acid|tranexamic acid|mesh-list
64567229|NCT02911831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64567230|NCT02911831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64567231|NCT02911831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567232|NCT02911831|Hemostatics|hemostatics|mesh-ancestor
64567233|NCT02911831|Coagulants|coagulants|mesh-ancestor
64567234|NCT03061734|Acetaminophen|acetaminophen|mesh-list
64567235|NCT03061734|Naltrexone|naltrexone|mesh-list
64567236|NCT03061734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64567237|NCT03061734|Analgesics|analgesics|mesh-ancestor
64567238|NCT03061734|Sensory System Agents|sensory system agents|mesh-ancestor
64567239|NCT03061734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64567240|NCT03061734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567241|NCT03061734|Antipyretics|antipyretics|mesh-ancestor
64567242|NCT03061734|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64567243|NCT03061734|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64567244|NCT03061656|Cyclophosphamide|cyclophosphamide|mesh-list
64567245|NCT03061656|Melphalan|melphalan|mesh-list
64567246|NCT03061656|Thiotepa|thiotepa|mesh-list
64567247|NCT03061656|Carboplatin|carboplatin|mesh-list
64567248|NCT03061656|Etoposide|etoposide|mesh-list
64567249|NCT03061656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64567250|NCT03061656|Immunologic Factors|immunologic factors|mesh-ancestor
64567251|NCT03061656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567252|NCT03061656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64567253|NCT03061656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64567254|NCT03061656|Alkylating Agents|alkylating agents|mesh-ancestor
64567256|NCT03061656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64517409|NCT02712996|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64517410|NCT02712996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64517411|NCT02712996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517412|NCT02712996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64517413|NCT02712996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64517414|NCT02712996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64517415|NCT02712996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517416|NCT02712996|Dopamine Agents|dopamine agents|mesh-ancestor
64517417|NCT02712996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64517418|NCT03252366|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
64517419|NCT03252366|Hemostatics|hemostatics|mesh-ancestor
64517420|NCT03252366|Coagulants|coagulants|mesh-ancestor
64517421|NCT04346277|Antibodies|antibodies|mesh-list
64517422|NCT04346277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64517423|NCT04346277|Immunologic Factors|immunologic factors|mesh-ancestor
64517424|NCT04346277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517425|NCT03573960|Lenvatinib|lenvatinib|mesh-list
64517426|NCT03573960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64517427|NCT03573960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64517428|NCT03573960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517429|NCT03573960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517430|NCT04780347|Paclitaxel|paclitaxel|mesh-list
64567263|NCT02906761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64567292|NCT02905591|Protective Agents|protective agents|mesh-ancestor
64567293|NCT01455025|Plerixafor|plerixafor|mesh-list
64567294|NCT01455025|Lenograstim|lenograstim|mesh-list
64567295|NCT01455025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64567296|NCT01455025|Immunologic Factors|immunologic factors|mesh-ancestor
64567297|NCT01455025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567298|NCT01455025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64567299|NCT01455025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64567300|NCT01455025|Antiviral Agents|antiviral agents|mesh-ancestor
64567301|NCT01455025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64567302|NCT03060798|Desflurane|desflurane|mesh-list
64567303|NCT03060798|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64567304|NCT03060798|Anesthetics, General|anesthetics, general|mesh-ancestor
64567305|NCT03060798|Anesthetics|anesthetics|mesh-ancestor
64453823|NCT01965704|Serotonin Agents|serotonin agents|mesh-ancestor
64567308|NCT04426890|Omalizumab|omalizumab|mesh-list
64567309|NCT04426890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64567310|NCT04426890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64567311|NCT04426890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64567312|NCT04426890|Respiratory System Agents|respiratory system agents|mesh-ancestor
64567338|NCT04963998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567339|NCT03148327|Durvalumab|durvalumab|mesh-list
64567340|NCT03148327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64567341|NCT03148327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567342|NCT01451905|Liraglutide|liraglutide|mesh-list
64567343|NCT01451905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64567344|NCT01451905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567345|NCT01451905|Incretins|incretins|mesh-ancestor
64567346|NCT01451905|Hormones|hormones|mesh-ancestor
64567347|NCT01451905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64517432|NCT04780347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64517433|NCT04780347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64517434|NCT04780347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64517435|NCT04780347|Tubulin Modulators|tubulin modulators|mesh-ancestor
64567348|NCT01455649|Cyclosporine|cyclosporine|mesh-list
64567349|NCT01455649|Everolimus|everolimus|mesh-list
64567350|NCT01455649|Tacrolimus|tacrolimus|mesh-list
64567351|NCT01455649|Cyclosporins|cyclosporins|mesh-list
64567352|NCT01455649|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
64567353|NCT01455649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64567354|NCT01455649|Immunologic Factors|immunologic factors|mesh-ancestor
64567355|NCT01455649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567356|NCT01455649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567357|NCT01455649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567358|NCT01455649|Antifungal Agents|antifungal agents|mesh-ancestor
64567359|NCT01455649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64567360|NCT01455649|Dermatologic Agents|dermatologic agents|mesh-ancestor
64567361|NCT01455649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64567362|NCT01455649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567363|NCT04974294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64567364|NCT04974294|Immunologic Factors|immunologic factors|mesh-ancestor
64567397|NCT02637583|Immunologic Factors|immunologic factors|mesh-ancestor
64567398|NCT02637583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567399|NCT04954560|Losartan|losartan|mesh-list
64567400|NCT04954560|Eprosartan|eprosartan|mesh-list
64567401|NCT04954560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64567402|NCT04954560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64567403|NCT04954560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64567404|NCT04954560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64567405|NCT04954560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567406|NCT04954560|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
64567407|NCT01456117|Pioglitazone|pioglitazone|mesh-list
64567408|NCT01456117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64567409|NCT01456117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567410|NCT04962672|Anesthetics|anesthetics|mesh-list
64567411|NCT04962672|Propofol|propofol|mesh-list
64567412|NCT04962672|Sevoflurane|sevoflurane|mesh-list
64567413|NCT04962672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64567447|NCT01452685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567448|NCT01452685|Androgen Antagonists|androgen antagonists|mesh-ancestor
64567449|NCT01452685|Hormone Antagonists|hormone antagonists|mesh-ancestor
64567450|NCT01452685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64567483|NCT00988169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567484|NCT02967133|Paclitaxel|paclitaxel|mesh-list
64567485|NCT02967133|Nivolumab|nivolumab|mesh-list
64567486|NCT02967133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64567487|NCT02967133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567488|NCT02967133|Tubulin Modulators|tubulin modulators|mesh-ancestor
64567489|NCT02967133|Antimitotic Agents|antimitotic agents|mesh-ancestor
64567490|NCT02967133|Mitosis Modulators|mitosis modulators|mesh-ancestor
64567491|NCT02967133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567492|NCT02967133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64567493|NCT02967133|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64567494|NCT04961970|Leucovorin|leucovorin|mesh-list
64567528|NCT01311687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64567529|NCT01311687|Growth Substances|growth substances|mesh-ancestor
64453824|NCT01965704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64453825|NCT01965704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453826|NCT01965704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64453827|NCT01965704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64453828|NCT01965704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64567530|NCT01311687|Growth Inhibitors|growth inhibitors|mesh-ancestor
64567532|NCT00988091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64567533|NCT00988091|Immunologic Factors|immunologic factors|mesh-ancestor
64567534|NCT00988091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567535|NCT00988091|Viscosupplements|viscosupplements|mesh-ancestor
64567536|NCT00988091|Protective Agents|protective agents|mesh-ancestor
64567537|NCT04965324|Anesthetics|anesthetics|mesh-list
64567538|NCT04965324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64567567|NCT03828643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64567568|NCT03828643|Immunologic Factors|immunologic factors|mesh-ancestor
64567569|NCT03828643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517436|NCT04780347|Antimitotic Agents|antimitotic agents|mesh-ancestor
64517437|NCT04780347|Mitosis Modulators|mitosis modulators|mesh-ancestor
64517438|NCT04780347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517439|NCT04780347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64517440|NCT04780347|Antimetabolites|antimetabolites|mesh-ancestor
64517441|NCT02455596|Interferons|interferons|mesh-list
64517442|NCT02455596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64517443|NCT02455596|Antiviral Agents|antiviral agents|mesh-ancestor
64517444|NCT02455596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64628414|NCT05445856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628415|NCT05445856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64453829|NCT01965704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64453830|NCT01965704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64453839|NCT02003365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64453841|NCT02003365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64453842|NCT02003365|Immunologic Factors|immunologic factors|mesh-ancestor
64453843|NCT02003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453844|NCT02003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453845|NCT01975220|Metformin|metformin|mesh-list
64453846|NCT01975220|Empagliflozin|empagliflozin|mesh-list
64453847|NCT01975220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64453848|NCT01975220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453849|NCT01975220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64453850|NCT01975220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453851|NCT01974752|Dacarbazine|dacarbazine|mesh-list
64453852|NCT01974752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64453853|NCT01974752|Alkylating Agents|alkylating agents|mesh-ancestor
64453854|NCT01974752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531344|NCT03961971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531345|NCT03961971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531346|NCT03958877|Interferons|interferons|mesh-list
64531347|NCT03958877|Interferon-beta|interferon-beta|mesh-list
64531348|NCT03958877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531349|NCT03958877|Antiviral Agents|antiviral agents|mesh-ancestor
64531350|NCT03958877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64531351|NCT03958877|Immunologic Factors|immunologic factors|mesh-ancestor
64531352|NCT03958877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531353|NCT03954067|Pembrolizumab|pembrolizumab|mesh-list
64531354|NCT03954067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64531355|NCT03954067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531356|NCT03953300|Benralizumab|benralizumab|mesh-list
64517445|NCT02455440|Propofol|propofol|mesh-list
64517446|NCT02455440|Sevoflurane|sevoflurane|mesh-list
64517447|NCT02455440|Esmolol|esmolol|mesh-list
64517448|NCT02455440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64517449|NCT02455440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64517450|NCT02455440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517451|NCT02455440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64517452|NCT02455440|Anesthetics, General|anesthetics, general|mesh-ancestor
64517453|NCT02455440|Anesthetics|anesthetics|mesh-ancestor
64517454|NCT02455440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64517455|NCT02455440|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64567570|NCT01346397|Cyclosporine|cyclosporine|mesh-list
64567571|NCT01346397|Tacrolimus|tacrolimus|mesh-list
64567572|NCT01346397|Cyclosporins|cyclosporins|mesh-list
64567573|NCT01346397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64567574|NCT01346397|Immunologic Factors|immunologic factors|mesh-ancestor
64567575|NCT01346397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567576|NCT01346397|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64567577|NCT01346397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567578|NCT01346397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567579|NCT01346397|Antifungal Agents|antifungal agents|mesh-ancestor
64567580|NCT01346397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64567581|NCT01346397|Dermatologic Agents|dermatologic agents|mesh-ancestor
64567582|NCT01346397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64567619|NCT01457131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64567649|NCT03059316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64567650|NCT03059316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64567651|NCT03059316|Adrenergic Agents|adrenergic agents|mesh-ancestor
64567652|NCT03059316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64567653|NCT03059316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567654|NCT03059316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567655|NCT03059316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64567656|NCT03059316|Sympathomimetics|sympathomimetics|mesh-ancestor
64567657|NCT03059316|Autonomic Agents|autonomic agents|mesh-ancestor
64567658|NCT03059316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628469|NCT00002548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64531357|NCT03953300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64531358|NCT03953300|Respiratory System Agents|respiratory system agents|mesh-ancestor
64531359|NCT03941288|Cannabidiol|cannabidiol|mesh-list
64531360|NCT03941288|Anticonvulsants|anticonvulsants|mesh-ancestor
64567659|NCT03059316|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64567660|NCT03059316|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64567661|NCT01312389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
64567662|NCT01312389|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64567663|NCT01312389|Immunologic Factors|immunologic factors|mesh-ancestor
64567664|NCT01312389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567700|NCT01314417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64567701|NCT01314417|Antimetabolites|antimetabolites|mesh-ancestor
64567702|NCT01314417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567703|NCT01314417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64517457|NCT02455440|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64517458|NCT02455440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64517459|NCT02455440|Adrenergic Agents|adrenergic agents|mesh-ancestor
64517460|NCT02455440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64517461|NCT02455440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517462|NCT03260166|Niacinamide|niacinamide|mesh-list
64517463|NCT03260166|Niacin|niacin|mesh-list
64517464|NCT03260166|Nicotinic Acids|nicotinic acids|mesh-list
64517465|NCT03260166|Vitamin B Complex|vitamin b complex|mesh-ancestor
64517466|NCT03260166|Vitamins|vitamins|mesh-ancestor
64517467|NCT03260166|Micronutrients|micronutrients|mesh-ancestor
64517468|NCT03260166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517469|NCT03260166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64567704|NCT01314417|Dermatologic Agents|dermatologic agents|mesh-ancestor
64567737|NCT01890889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567739|NCT04951752|Ropivacaine|ropivacaine|mesh-list
64567860|NCT04942002|Antiemetics|antiemetics|mesh-ancestor
64567861|NCT04942002|Autonomic Agents|autonomic agents|mesh-ancestor
64567862|NCT04942002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64567863|NCT04942002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567864|NCT04942002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64567865|NCT04942002|Glucocorticoids|glucocorticoids|mesh-ancestor
64567866|NCT04942002|Hormones|hormones|mesh-ancestor
64567867|NCT04942002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64567868|NCT04942002|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64567869|NCT04942002|Protective Agents|protective agents|mesh-ancestor
64567870|NCT04942002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64567871|NCT04942002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567872|NCT01891435|Acetaminophen|acetaminophen|mesh-list
64567873|NCT01891435|Diclofenac|diclofenac|mesh-list
64567874|NCT01891435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64567875|NCT01891435|Analgesics|analgesics|mesh-ancestor
64567876|NCT01891435|Sensory System Agents|sensory system agents|mesh-ancestor
64567877|NCT01891435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64567911|NCT01891513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64567912|NCT01891513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64517470|NCT03260166|Antimetabolites|antimetabolites|mesh-ancestor
64517471|NCT03260166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517472|NCT03260166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64517473|NCT03260166|Vasodilator Agents|vasodilator agents|mesh-ancestor
64517474|NCT03260010|Fosfomycin|fosfomycin|mesh-list
64517475|NCT03260010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64517476|NCT03260010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64517477|NCT00992901|Atropine|atropine|mesh-list
64517478|NCT00992901|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64517479|NCT00992901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64517480|NCT00992901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64517481|NCT00992901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64517482|NCT00992901|Autonomic Agents|autonomic agents|mesh-ancestor
64517483|NCT00992901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628534|NCT00002566|Ifosfamide|ifosfamide|mesh-list
64531361|NCT03925727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64531362|NCT03925727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64295936|NCT01673984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64453855|NCT01974752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453856|NCT01999946|Naltrexone|naltrexone|mesh-list
64453857|NCT01999946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64453858|NCT01999946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64517484|NCT00992901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567913|NCT01891513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64567937|NCT04421196|Sensory System Agents|sensory system agents|mesh-ancestor
64567938|NCT04421196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64567939|NCT01459315|Dolutegravir|dolutegravir|mesh-list
64567940|NCT01459315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64567941|NCT01459315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64567942|NCT01459315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567943|NCT01459315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567944|NCT01459315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64567945|NCT01459315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64567946|NCT01459315|Antiviral Agents|antiviral agents|mesh-ancestor
64567947|NCT01459315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64567948|NCT04948788|Gemcitabine|gemcitabine|mesh-list
64567949|NCT04948788|Oxaliplatin|oxaliplatin|mesh-list
64567950|NCT04948788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64567951|NCT04948788|Antimetabolites|antimetabolites|mesh-ancestor
64567952|NCT04948788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567953|NCT04948788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453859|NCT01999946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453860|NCT01999946|Sensory System Agents|sensory system agents|mesh-ancestor
64453861|NCT01999946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64453862|NCT01958281|Sofosbuvir|sofosbuvir|mesh-list
64453863|NCT01958281|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64453864|NCT01958281|Antiviral Agents|antiviral agents|mesh-ancestor
64453865|NCT01958281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64453866|NCT02002975|Pioglitazone|pioglitazone|mesh-list
64453867|NCT02002975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64453868|NCT02002975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453869|NCT02001181|Tofacitinib|tofacitinib|mesh-list
64453870|NCT02001181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64453871|NCT02001181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453872|NCT02001181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453873|NCT04176055|Haloperidol|haloperidol|mesh-list
64453874|NCT04176055|Haloperidol decanoate|haloperidol decanoate|mesh-list
64453875|NCT04176055|Antiemetics|antiemetics|mesh-ancestor
64453876|NCT04176055|Autonomic Agents|autonomic agents|mesh-ancestor
64453877|NCT04176055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64453878|NCT04176055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453887|NCT04176055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453888|NCT04176055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64453904|NCT04659044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531363|NCT03899155|Nivolumab|nivolumab|mesh-list
64531364|NCT03899155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64531365|NCT03899155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531366|NCT03899155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64531367|NCT03899155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531368|NCT03864419|Prednisone|prednisone|mesh-list
64531369|NCT03864419|Cyclophosphamide|cyclophosphamide|mesh-list
64531370|NCT03864419|Rituximab|rituximab|mesh-list
64531371|NCT03864419|Doxorubicin|doxorubicin|mesh-list
64531372|NCT03864419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64531373|NCT03864419|Methotrexate|methotrexate|mesh-list
64531374|NCT03864419|Etoposide|etoposide|mesh-list
64567954|NCT04948788|Antiviral Agents|antiviral agents|mesh-ancestor
64567955|NCT04948788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64567956|NCT04948788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567957|NCT04948788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64567958|NCT04948788|Immunologic Factors|immunologic factors|mesh-ancestor
64567959|NCT04948788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567960|NCT02865811|Doxorubicin|doxorubicin|mesh-list
64567961|NCT02865811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64567962|NCT02865811|Pembrolizumab|pembrolizumab|mesh-list
64567963|NCT02865811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64567964|NCT02865811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568035|NCT01459627|Purinergic Agents|purinergic agents|mesh-ancestor
64568036|NCT01459627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64568037|NCT01459627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568038|NCT01459627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568068|NCT04937946|Anesthetics, General|anesthetics, general|mesh-ancestor
64568069|NCT04937946|Anesthetics|anesthetics|mesh-ancestor
64568070|NCT05160987|Midazolam|midazolam|mesh-list
64568071|NCT05160987|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64568072|NCT05160987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64568073|NCT05160987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64568074|NCT05160987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568075|NCT05160987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64568076|NCT05160987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64568077|NCT05160987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64517485|NCT00992901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64517486|NCT00992901|Respiratory System Agents|respiratory system agents|mesh-ancestor
64517487|NCT00992901|Mydriatics|mydriatics|mesh-ancestor
64517488|NCT00992901|Parasympatholytics|parasympatholytics|mesh-ancestor
64517489|NCT00992901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64517490|NCT00992901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64517491|NCT00992901|Cholinergic Agents|cholinergic agents|mesh-ancestor
64517495|NCT00992901|Hormones|hormones|mesh-ancestor
64568083|NCT05160987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64568084|NCT05160987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568085|NCT01892995|Ketamine|ketamine|mesh-list
64568086|NCT01892995|Analgesics|analgesics|mesh-ancestor
64568120|NCT01359735|Bacitracin|bacitracin|mesh-list
64568121|NCT01359735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64568122|NCT01359735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64568123|NCT01359735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64568124|NCT01361217|Midazolam|midazolam|mesh-list
64568125|NCT01361217|Dextromethorphan|dextromethorphan|mesh-list
64568126|NCT01361217|Caffeine|caffeine|mesh-list
64568127|NCT01361217|Fluoxetine|fluoxetine|mesh-list
64568160|NCT01361217|Antidepressive Agents|antidepressive agents|mesh-ancestor
64568161|NCT01361217|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64568162|NCT01361217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64568163|NCT01361217|Antitussive Agents|antitussive agents|mesh-ancestor
64568164|NCT01361217|Respiratory System Agents|respiratory system agents|mesh-ancestor
64568165|NCT01361217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64568166|NCT01361217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64568167|NCT01361217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64568168|NCT01361217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64568169|NCT01361217|Antimetabolites|antimetabolites|mesh-ancestor
64568193|NCT02869789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64568194|NCT02869789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568195|NCT04945434|Methamphetamine|methamphetamine|mesh-list
64568196|NCT04945434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64568197|NCT04945434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568198|NCT04945434|Sympathomimetics|sympathomimetics|mesh-ancestor
64568199|NCT04945434|Autonomic Agents|autonomic agents|mesh-ancestor
64517506|NCT04776135|Edaravone|edaravone|mesh-list
64517507|NCT04776135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64517508|NCT04776135|Antioxidants|antioxidants|mesh-ancestor
64517509|NCT04776135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517510|NCT04776135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64517511|NCT04776135|Protective Agents|protective agents|mesh-ancestor
64517512|NCT04776135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517513|NCT03474276|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64517514|NCT03474276|Azithromycin|azithromycin|mesh-list
64517515|NCT03474276|Albendazole|albendazole|mesh-list
64517516|NCT03474276|Antiparasitic Agents|antiparasitic agents|mesh-list
64517517|NCT03474276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64517518|NCT03474276|Anthelmintics|anthelmintics|mesh-ancestor
64517519|NCT03474276|Anticestodal Agents|anticestodal agents|mesh-ancestor
64517520|NCT03474276|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64517521|NCT03474276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64517522|NCT03474276|Tubulin Modulators|tubulin modulators|mesh-ancestor
64517523|NCT03474276|Antimitotic Agents|antimitotic agents|mesh-ancestor
64517524|NCT03474276|Mitosis Modulators|mitosis modulators|mesh-ancestor
64517525|NCT03474276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517526|NCT03474276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568211|NCT04408560|Acetaminophen|acetaminophen|mesh-list
64568212|NCT04408560|Analgesics|analgesics|mesh-list
64568213|NCT04408560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64568214|NCT04408560|Sensory System Agents|sensory system agents|mesh-ancestor
64568215|NCT04408560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568216|NCT04408560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568217|NCT04408560|Antipyretics|antipyretics|mesh-ancestor
64568218|NCT04844905|Ivermectin|ivermectin|mesh-list
64568219|NCT04844905|Piperaquine|piperaquine|mesh-list
64568220|NCT04844905|Artenimol|artenimol|mesh-list
64568221|NCT04844905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64568222|NCT04844905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64568255|NCT04944966|Antimalarials|antimalarials|mesh-ancestor
64568256|NCT04944966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64568257|NCT04944966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64568258|NCT04944966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64531375|NCT03864419|Vincristine|vincristine|mesh-list
64531376|NCT03864419|Daunorubicin|daunorubicin|mesh-list
64531377|NCT03864419|Podophyllotoxin|podophyllotoxin|mesh-list
64531378|NCT03864419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64531379|NCT03864419|Antibodies|antibodies|mesh-list
64531380|NCT03864419|Immunoglobulins|immunoglobulins|mesh-list
64568259|NCT04955262|Nivolumab|nivolumab|mesh-list
64568260|NCT04955262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64568291|NCT02792257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64568292|NCT02792257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64568293|NCT02792257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568294|NCT02792257|Hormones|hormones|mesh-ancestor
64517527|NCT04779255|Acetaminophen|acetaminophen|mesh-list
64517528|NCT04779255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517529|NCT04779255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64517530|NCT04779255|Analgesics|analgesics|mesh-ancestor
64517532|NCT04779255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517533|NCT04779255|Antipyretics|antipyretics|mesh-ancestor
64517534|NCT04779567|Acetaminophen|acetaminophen|mesh-list
64517535|NCT04779567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64517536|NCT04779567|Analgesics|analgesics|mesh-ancestor
64517537|NCT04779567|Sensory System Agents|sensory system agents|mesh-ancestor
64517538|NCT04779567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628738|NCT04194554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64531381|NCT03864419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64531382|NCT03864419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64453906|NCT04659044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64453907|NCT01999868|Abatacept|abatacept|mesh-list
64453908|NCT01999868|Ustekinumab|ustekinumab|mesh-list
64453909|NCT01999868|Immunoglobulins|immunoglobulins|mesh-list
64453910|NCT01999868|Immunologic Factors|immunologic factors|mesh-ancestor
64453911|NCT01999868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945362|NCT05697783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453912|NCT01999868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64453913|NCT01999868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453914|NCT01999868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453915|NCT01999868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64453916|NCT01999868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64453917|NCT01999868|Dermatologic Agents|dermatologic agents|mesh-ancestor
64453918|NCT03511963|Bevacizumab|bevacizumab|mesh-list
64453919|NCT03511963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64453920|NCT03511963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453921|NCT03511963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64453922|NCT03511963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64453923|NCT03511963|Growth Substances|growth substances|mesh-ancestor
64453924|NCT03511963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453925|NCT03511963|Growth Inhibitors|growth inhibitors|mesh-ancestor
64453926|NCT01999322|Insulin|insulin|mesh-list
64453927|NCT01999322|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64453928|NCT01999322|Insulin Aspart|insulin aspart|mesh-list
64453929|NCT01999322|Insulin, Long-Acting|insulin, long-acting|mesh-list
64453930|NCT01999322|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64453931|NCT01999322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64453932|NCT01999322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453933|NCT01964924|Trametinib|trametinib|mesh-list
64453934|NCT01964924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453935|NCT01964924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64453936|NCT01964924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453937|NCT01964924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453938|NCT01964378|Morphine|morphine|mesh-list
64453939|NCT01964378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64453940|NCT01964378|Narcotics|narcotics|mesh-ancestor
64453941|NCT01964378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64517539|NCT04779567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517540|NCT04779567|Antipyretics|antipyretics|mesh-ancestor
64517541|NCT02352844|Everolimus|everolimus|mesh-list
64517542|NCT02352844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568295|NCT02792257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64568296|NCT01893385|Vitamin D|vitamin d|mesh-list
64568297|NCT01893385|Vitamins|vitamins|mesh-ancestor
64568298|NCT01893385|Micronutrients|micronutrients|mesh-ancestor
64568299|NCT01893385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568300|NCT01893385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64568301|NCT04935450|Dimercaprol|dimercaprol|mesh-list
64568302|NCT04935450|Chelating Agents|chelating agents|mesh-ancestor
64568303|NCT04935450|Sequestering Agents|sequestering agents|mesh-ancestor
64568328|NCT01364259|Protective Agents|protective agents|mesh-ancestor
64568329|NCT01364259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568330|NCT01321437|Axitinib|axitinib|mesh-list
64568331|NCT01321437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568332|NCT01321437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64568333|NCT01321437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568334|NCT01321437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568335|NCT01365585|Sildenafil Citrate|sildenafil citrate|mesh-list
64568336|NCT01365585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517547|NCT03255642|Melatonin|melatonin|mesh-list
64517548|NCT03255642|Antioxidants|antioxidants|mesh-ancestor
64517549|NCT03255642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517550|NCT03255642|Protective Agents|protective agents|mesh-ancestor
64568463|NCT01893541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568464|NCT01893541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568465|NCT01893541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64568466|NCT01893541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64568467|NCT01893541|Vasodilator Agents|vasodilator agents|mesh-ancestor
64568468|NCT02849899|Vildagliptin|vildagliptin|mesh-list
64568469|NCT02849899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64568470|NCT02849899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568471|NCT02849899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64568472|NCT02849899|Protease Inhibitors|protease inhibitors|mesh-ancestor
64568473|NCT02849899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568474|NCT02849899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568475|NCT02771197|Pembrolizumab|pembrolizumab|mesh-list
64568476|NCT02771197|Fludarabine|fludarabine|mesh-list
64568502|NCT01369875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64568503|NCT02620189|Adalimumab|adalimumab|mesh-list
64568504|NCT02620189|Etanercept|etanercept|mesh-list
64531388|NCT03864419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531389|NCT03864419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531390|NCT03864419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64531391|NCT03864419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64531392|NCT03864419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64531393|NCT03864419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64295972|NCT03313479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64295973|NCT03313479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453944|NCT01964378|Sensory System Agents|sensory system agents|mesh-ancestor
64453945|NCT01964378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64453946|NCT01442038|Ranolazine|ranolazine|mesh-list
64453947|NCT01442038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64453948|NCT01442038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64453949|NCT01442038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453950|NCT01998919|Gemcitabine|gemcitabine|mesh-list
64453951|NCT01998919|Carboplatin|carboplatin|mesh-list
64453952|NCT01998919|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64453964|NCT01964300|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64453965|NCT01964300|Antiviral Agents|antiviral agents|mesh-ancestor
64453966|NCT01964300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64453967|NCT01972724|Metformin|metformin|mesh-list
64453968|NCT01972724|Pioglitazone|pioglitazone|mesh-list
64453969|NCT01972724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64453970|NCT01972724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453971|NCT01441960|Rocuronium|rocuronium|mesh-list
64453972|NCT01441960|Succinylcholine|succinylcholine|mesh-list
64453973|NCT01441960|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64453974|NCT01441960|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64453975|NCT01441960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64453976|NCT01441960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64453977|NCT01441960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453978|NCT01441960|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
64568505|NCT02620189|Certolizumab Pegol|certolizumab pegol|mesh-list
64568506|NCT02620189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64568507|NCT02620189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64568508|NCT02620189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64568509|NCT02620189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64568510|NCT02620189|Analgesics|analgesics|mesh-ancestor
64568511|NCT02620189|Sensory System Agents|sensory system agents|mesh-ancestor
64568512|NCT02620189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568513|NCT02620189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568514|NCT02620189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64568515|NCT02620189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64568516|NCT02620189|Immunologic Factors|immunologic factors|mesh-ancestor
64568518|NCT02763319|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64568519|NCT02763319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64568520|NCT02763319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568521|NCT02763319|Immunologic Factors|immunologic factors|mesh-ancestor
64568522|NCT02763319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568523|NCT02763319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64568524|NCT02763319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64568525|NCT02763319|Alkylating Agents|alkylating agents|mesh-ancestor
64628869|NCT00002662|Mitosis Modulators|mitosis modulators|mesh-ancestor
64453979|NCT01955707|Natalizumab|natalizumab|mesh-list
64453980|NCT01955707|Immunologic Factors|immunologic factors|mesh-ancestor
64453981|NCT01955707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453982|NCT01435798|Dextromethorphan|dextromethorphan|mesh-list
64453983|NCT01435798|Antitussive Agents|antitussive agents|mesh-ancestor
64453984|NCT01435798|Respiratory System Agents|respiratory system agents|mesh-ancestor
64453985|NCT01435798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64453986|NCT01435798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64453987|NCT01435798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64453988|NCT01435798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453989|NCT01435798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453990|NCT01441414|Axitinib|axitinib|mesh-list
64453991|NCT01441414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453992|NCT01441414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64453993|NCT01441414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453994|NCT01441414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453995|NCT01954927|Gabapentin|gabapentin|mesh-list
64453996|NCT01954927|Analgesics|analgesics|mesh-ancestor
64453997|NCT01954927|Sensory System Agents|sensory system agents|mesh-ancestor
64453998|NCT01954927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64531395|NCT03864419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64531396|NCT03864419|Glucocorticoids|glucocorticoids|mesh-ancestor
64531397|NCT03864419|Hormones|hormones|mesh-ancestor
64531398|NCT03864419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64531399|NCT03864419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64531400|NCT03864419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64531406|NCT03864419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64295985|NCT03313401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453999|NCT01954927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454001|NCT01954927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64454002|NCT01954927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64568554|NCT04920708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64568555|NCT04920708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568556|NCT04920708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64568557|NCT04920708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568558|NCT04920708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568559|NCT02594371|Paclitaxel|paclitaxel|mesh-list
64568560|NCT02594371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64568561|NCT02594371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64568562|NCT02594371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568563|NCT02594371|Tubulin Modulators|tubulin modulators|mesh-ancestor
64568564|NCT02594371|Antimitotic Agents|antimitotic agents|mesh-ancestor
64568565|NCT02594371|Mitosis Modulators|mitosis modulators|mesh-ancestor
64568566|NCT02594371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568567|NCT02197065|Atorvastatin|atorvastatin|mesh-list
64568568|NCT02197065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64568569|NCT02197065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64568570|NCT02197065|Antimetabolites|antimetabolites|mesh-ancestor
64568620|NCT02588443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568621|NCT02588443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64568623|NCT02588443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517551|NCT03255642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517552|NCT03255642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64517553|NCT03255642|Anticonvulsants|anticonvulsants|mesh-ancestor
64517554|NCT03255642|GABA Modulators|gaba modulators|mesh-ancestor
64517555|NCT03255642|GABA Agents|gaba agents|mesh-ancestor
64517556|NCT03255642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64517557|NCT03562377|Vaccines|vaccines|mesh-list
64517558|NCT03562377|Immunologic Factors|immunologic factors|mesh-ancestor
64517559|NCT03562377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517560|NCT02352922|Bupivacaine|bupivacaine|mesh-list
64517561|NCT02352922|Anesthetics, Local|anesthetics, local|mesh-ancestor
64517562|NCT02352922|Anesthetics|anesthetics|mesh-ancestor
64517563|NCT02352922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64517564|NCT02352922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628922|NCT00002680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64628923|NCT00002680|Hormone Antagonists|hormone antagonists|mesh-ancestor
64454003|NCT01954927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64454004|NCT01954927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64517565|NCT02352922|Sensory System Agents|sensory system agents|mesh-ancestor
64517566|NCT02352922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517567|NCT03255330|Dipyrone|dipyrone|mesh-list
64568624|NCT02741323|Maraviroc|maraviroc|mesh-list
64568625|NCT02741323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64568626|NCT02741323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64568627|NCT02741323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568628|NCT02741323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64568629|NCT02741323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64568630|NCT02741323|Antiviral Agents|antiviral agents|mesh-ancestor
64568631|NCT02741323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64568632|NCT02741323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64568633|NCT02582359|Cytarabine|cytarabine|mesh-list
64628961|NCT05293210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64454005|NCT01954927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64454006|NCT01954927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64454007|NCT01954927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64454008|NCT01954927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454009|NCT01954927|Antimanic Agents|antimanic agents|mesh-ancestor
64454010|NCT01953913|Afatinib|afatinib|mesh-list
64454011|NCT01953913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64454012|NCT01953913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64454013|NCT01953913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454014|NCT01953913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454024|NCT01996826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64454026|NCT01996826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64454027|NCT01996826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64454028|NCT01996826|Growth Substances|growth substances|mesh-ancestor
64454029|NCT01996826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454030|NCT01996826|Growth Inhibitors|growth inhibitors|mesh-ancestor
64454031|NCT01996826|Laxatives|laxatives|mesh-ancestor
64454032|NCT01996826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64454033|NCT01621178|Insulin|insulin|mesh-list
64454034|NCT01621178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64454035|NCT01621178|Insulin Glargine|insulin glargine|mesh-list
64454036|NCT01621178|Insulin Lispro|insulin lispro|mesh-list
64454037|NCT01621178|Dulaglutide|dulaglutide|mesh-list
64454038|NCT01621178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64454039|NCT01621178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454040|NCT01962974|Golimumab|golimumab|mesh-list
64454041|NCT01962974|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64454042|NCT01962974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64454043|NCT01962974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64454044|NCT01962974|Immunologic Factors|immunologic factors|mesh-ancestor
64454045|NCT01962974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454046|NCT01962896|Sirolimus|sirolimus|mesh-list
64454047|NCT01962896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64454048|NCT01962896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64454049|NCT01962896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64454050|NCT01962896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454051|NCT01962896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454052|NCT01962896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64454053|NCT01962896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64454054|NCT01962896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64454055|NCT01962896|Antifungal Agents|antifungal agents|mesh-ancestor
64531407|NCT03864419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64531408|NCT03864419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64531410|NCT03864419|Antimitotic Agents|antimitotic agents|mesh-ancestor
64531411|NCT03864419|Mitosis Modulators|mitosis modulators|mesh-ancestor
64454056|NCT01962896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64454057|NCT01962896|Immunologic Factors|immunologic factors|mesh-ancestor
64568634|NCT02582359|Daunorubicin|daunorubicin|mesh-list
64568635|NCT02582359|Ixazomib|ixazomib|mesh-list
64568636|NCT02582359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64568637|NCT02582359|Antimetabolites|antimetabolites|mesh-ancestor
64568638|NCT02582359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568639|NCT02582359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568640|NCT02582359|Antiviral Agents|antiviral agents|mesh-ancestor
64568641|NCT02582359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64568642|NCT02582359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64568643|NCT02582359|Immunologic Factors|immunologic factors|mesh-ancestor
64568644|NCT02582359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568645|NCT02582359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64568646|NCT02582359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64568647|NCT02582359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64568648|NCT02582359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568649|NCT02582359|Protease Inhibitors|protease inhibitors|mesh-ancestor
64568650|NCT00227253|Hormones|hormones|mesh-list
64568651|NCT00227253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64568652|NCT00227253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568653|NCT05021809|Calcium|calcium|mesh-list
64568654|NCT05021809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64568655|NCT05021809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568656|NCT02730715|Thymoglobulin|thymoglobulin|mesh-list
64568657|NCT02730715|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64568658|NCT02730715|Basiliximab|basiliximab|mesh-list
64568659|NCT02730715|Immunologic Factors|immunologic factors|mesh-ancestor
64568660|NCT02730715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568661|NCT02730715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64568662|NCT04919460|Tolonium Chloride|tolonium chloride|mesh-list
64568663|NCT04919460|Hemostatics|hemostatics|mesh-ancestor
64568664|NCT04919460|Coagulants|coagulants|mesh-ancestor
64568665|NCT04919460|Heparin Antagonists|heparin antagonists|mesh-ancestor
64517568|NCT03255330|Gabapentin|gabapentin|mesh-list
64517569|NCT03255330|Tramadol|tramadol|mesh-list
64568699|NCT01327677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64568700|NCT01327677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568701|NCT01327677|Analgesics|analgesics|mesh-ancestor
64568702|NCT01327677|Sensory System Agents|sensory system agents|mesh-ancestor
64568703|NCT01327677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568704|NCT01327677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64568705|NCT01327677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64568706|NCT01327677|Anesthetics, General|anesthetics, general|mesh-ancestor
64568707|NCT01327677|Anesthetics|anesthetics|mesh-ancestor
64568708|NCT03054480|Botulinum Toxins|botulinum toxins|mesh-list
64568709|NCT03054480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64568710|NCT03054480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64568711|NCT03054480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64568712|NCT03054480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64568713|NCT03054480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568714|NCT03054480|Cholinergic Agents|cholinergic agents|mesh-ancestor
64454058|NCT01962896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454059|NCT01970462|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64454060|NCT01970462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64454061|NCT01970462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454063|NCT01970462|Hormones|hormones|mesh-ancestor
64454064|NCT01970462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64454065|NCT01970462|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64454066|NCT01970462|Protease Inhibitors|protease inhibitors|mesh-ancestor
64454067|NCT01970462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454077|NCT01968980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64454078|NCT01968980|Antimetabolites|antimetabolites|mesh-ancestor
64454079|NCT01968980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454088|NCT01946438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454090|NCT01618214|Biphasic Insulins|biphasic insulins|mesh-list
64454091|NCT01618214|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64454092|NCT01618214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64454093|NCT01618214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454094|NCT01917656|Metformin|metformin|mesh-list
64454095|NCT01917656|Liraglutide|liraglutide|mesh-list
64454096|NCT01917656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64454097|NCT01917656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454098|NCT01917656|Incretins|incretins|mesh-ancestor
64454099|NCT01917656|Hormones|hormones|mesh-ancestor
64454100|NCT01917656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64454101|NCT02018861|Rituximab|rituximab|mesh-list
64454102|NCT02018861|Carboplatin|carboplatin|mesh-list
64454103|NCT02018861|Etoposide|etoposide|mesh-list
64454104|NCT02018861|Ifosfamide|ifosfamide|mesh-list
64454105|NCT02018861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64454106|NCT02018861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64454107|NCT02018861|Immunologic Factors|immunologic factors|mesh-ancestor
64454108|NCT02018861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454109|NCT02018861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64454110|NCT02018861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64454111|NCT02018861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64454112|NCT02018861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64454113|NCT02018861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454114|NCT02018861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454115|NCT02018861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64454116|NCT02018861|Alkylating Agents|alkylating agents|mesh-ancestor
64454117|NCT02017535|Fluoxetine|fluoxetine|mesh-list
64454118|NCT02017535|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64568715|NCT03054480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64568716|NCT03054480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568717|NCT03054480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64568718|NCT03054480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568720|NCT04918914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64568751|NCT04918524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64568752|NCT04918524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568753|NCT04918524|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64568754|NCT04918524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64568756|NCT04918524|Antipyretics|antipyretics|mesh-ancestor
64568757|NCT04918524|Anticoagulants|anticoagulants|mesh-ancestor
64568758|NCT04918524|Antimalarials|antimalarials|mesh-ancestor
64568759|NCT04918524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64568760|NCT04918524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64568761|NCT04918524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64568762|NCT01328379|4-Aminopyridine|4-aminopyridine|mesh-list
64568763|NCT01328379|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64568764|NCT01328379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64568765|NCT01328379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568766|NCT05586763|Promethazine|promethazine|mesh-list
64568799|NCT02552641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64517585|NCT03255330|Narcotics|narcotics|mesh-ancestor
64517586|NCT03255330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64517587|NCT03255330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64517588|NCT03255330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64517589|NCT03255330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64517590|NCT03255330|Antipyretics|antipyretics|mesh-ancestor
64517591|NCT02353780|Etanercept|etanercept|mesh-list
64568851|NCT02542969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568852|NCT02414269|Cyclophosphamide|cyclophosphamide|mesh-list
64568853|NCT02414269|Pembrolizumab|pembrolizumab|mesh-list
64568876|NCT03054168|Hormones|hormones|mesh-ancestor
64568877|NCT03054168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64568878|NCT03054168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568879|NCT03054168|Androgens|androgens|mesh-ancestor
64568880|NCT03054168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64568881|NCT03054168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568882|NCT02518945|Dapagliflozin|dapagliflozin|mesh-list
64568883|NCT02518945|Liraglutide|liraglutide|mesh-list
64568884|NCT02518945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64568885|NCT02518945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568886|NCT02518945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64568887|NCT02518945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568888|NCT02518945|Incretins|incretins|mesh-ancestor
64568889|NCT02518945|Hormones|hormones|mesh-ancestor
64568890|NCT02518945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64568891|NCT02390869|Rituximab|rituximab|mesh-list
64568892|NCT02390869|Lenalidomide|lenalidomide|mesh-list
64568893|NCT02390869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64568894|NCT02390869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568895|NCT02390869|Immunologic Factors|immunologic factors|mesh-ancestor
64568896|NCT02390869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517593|NCT02353780|Abatacept|abatacept|mesh-list
64517594|NCT02353780|Infliximab|infliximab|mesh-list
64517595|NCT02353780|Certolizumab Pegol|certolizumab pegol|mesh-list
64517596|NCT02353780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64517597|NCT02353780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64568940|NCT02489695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568941|NCT02489695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64568942|NCT02489695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568943|NCT02489695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568944|NCT03053388|Nitric Oxide|nitric oxide|mesh-list
64568945|NCT03053388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64568946|NCT03053388|Autonomic Agents|autonomic agents|mesh-ancestor
64568947|NCT03053388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568948|NCT03053388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568949|NCT03053388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64568950|NCT03053388|Respiratory System Agents|respiratory system agents|mesh-ancestor
64568984|NCT04926480|Anesthetics|anesthetics|mesh-list
64568985|NCT04926480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64629168|NCT00002722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454119|NCT02017535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64454120|NCT02017535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64454121|NCT02017535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454122|NCT02017535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64454123|NCT02017535|Serotonin Agents|serotonin agents|mesh-ancestor
64454124|NCT02017535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454125|NCT02017535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64454126|NCT02017535|Antidepressive Agents|antidepressive agents|mesh-ancestor
64454128|NCT02017535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64531418|NCT03859427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64531419|NCT03859427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531421|NCT03859427|Glucocorticoids|glucocorticoids|mesh-ancestor
64531422|NCT03859427|Hormones|hormones|mesh-ancestor
64531423|NCT03859427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64531424|NCT03859427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64531425|NCT03859427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531426|NCT03859427|Immunologic Factors|immunologic factors|mesh-ancestor
64531427|NCT03859427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64531428|NCT03859427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64531429|NCT03859427|Growth Substances|growth substances|mesh-ancestor
64531430|NCT03859427|Growth Inhibitors|growth inhibitors|mesh-ancestor
64531431|NCT03856671|Metronidazole|metronidazole|mesh-list
64296000|NCT03313323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296001|NCT05302232|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64454129|NCT02017535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64454130|NCT02017535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454131|NCT01944098|Lidocaine|lidocaine|mesh-list
64454132|NCT01944098|Anesthetics, Local|anesthetics, local|mesh-ancestor
64454133|NCT01944098|Anesthetics|anesthetics|mesh-ancestor
64454134|NCT01944098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64454135|NCT01944098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454136|NCT01944098|Sensory System Agents|sensory system agents|mesh-ancestor
64454137|NCT01944098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64454138|NCT01944098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64568986|NCT04926480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568987|NCT02484391|Thioctic Acid|thioctic acid|mesh-list
64568988|NCT02484391|Cytarabine|cytarabine|mesh-list
64568989|NCT02484391|Mitoxantrone|mitoxantrone|mesh-list
64568990|NCT02484391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64569020|NCT03053622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64569021|NCT02380573|Methylene Blue|methylene blue|mesh-list
64569022|NCT02380573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569023|NCT02380573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569024|NCT02461537|Mitoxantrone|mitoxantrone|mesh-list
64569025|NCT02461537|Analgesics|analgesics|mesh-ancestor
64569026|NCT02461537|Sensory System Agents|sensory system agents|mesh-ancestor
64569027|NCT02461537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64569028|NCT02461537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569029|NCT02461537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569030|NCT02461537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64569031|NCT02461537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64569032|NCT02461537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569035|NCT05028673|Antacids|antacids|mesh-list
64569222|NCT03056118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569223|NCT03056118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64569224|NCT03056118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64569225|NCT03056118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569226|NCT03056118|Antipyretics|antipyretics|mesh-ancestor
64569227|NCT03056118|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64569247|NCT00987467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569248|NCT00987467|Antifungal Agents|antifungal agents|mesh-ancestor
64569249|NCT00987467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64569250|NCT00987467|Dermatologic Agents|dermatologic agents|mesh-ancestor
64569251|NCT00987467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64569252|NCT00987467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64569253|NCT01332357|Fluticasone|fluticasone|mesh-list
64569254|NCT01332357|Xhance|xhance|mesh-list
64569255|NCT01332357|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64569256|NCT01332357|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64569257|NCT01332357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64569258|NCT01332357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64569259|NCT01332357|Autonomic Agents|autonomic agents|mesh-ancestor
64569260|NCT01332357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64569261|NCT01332357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569262|NCT01332357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64569263|NCT01332357|Respiratory System Agents|respiratory system agents|mesh-ancestor
64569264|NCT01332357|Dermatologic Agents|dermatologic agents|mesh-ancestor
64294510|NCT05121038|Antimetabolites|antimetabolites|mesh-ancestor
64569265|NCT01332357|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64569266|NCT01332357|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64569267|NCT01332357|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64569268|NCT01332357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64569269|NCT01332357|Adrenergic Agents|adrenergic agents|mesh-ancestor
64569270|NCT01332357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64569271|NCT01332357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569272|NCT01332357|Glucocorticoids|glucocorticoids|mesh-ancestor
64569273|NCT01332357|Hormones|hormones|mesh-ancestor
64569274|NCT01332357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64454139|NCT01944098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64454140|NCT01944098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64454141|NCT01944098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64569275|NCT01332357|Sympathomimetics|sympathomimetics|mesh-ancestor
64569276|NCT04914936|Rifampin|rifampin|mesh-list
64569277|NCT04914936|Acalabrutinib|acalabrutinib|mesh-list
64569278|NCT04914936|Omeprazole|omeprazole|mesh-list
64569279|NCT04914936|Calcium Carbonate|calcium carbonate|mesh-list
64569280|NCT04914936|Calcium|calcium|mesh-list
64569281|NCT04914936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64569310|NCT03054948|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64569311|NCT03054948|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64569312|NCT03054948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64569313|NCT00986921|Mifepristone|mifepristone|mesh-list
64569314|NCT00986921|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64569315|NCT00986921|Abortifacient Agents|abortifacient agents|mesh-ancestor
64569316|NCT00986921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64454142|NCT01944098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454143|NCT04624178|Nivolumab|nivolumab|mesh-list
64454144|NCT04624178|Rucaparib|rucaparib|mesh-list
64454145|NCT04624178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64454146|NCT04624178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64454181|NCT01914926|Autonomic Agents|autonomic agents|mesh-ancestor
64454182|NCT01914926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64454183|NCT01914926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454184|NCT01914926|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64454185|NCT01914926|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64454201|NCT05119166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64454202|NCT05119166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64454203|NCT05119166|Vitamin B Complex|vitamin b complex|mesh-ancestor
64531438|NCT03856671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531439|NCT03856671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531440|NCT03728972|Pembrolizumab|pembrolizumab|mesh-list
64531441|NCT03728972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64454204|NCT05119166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64454206|NCT05119166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454207|NCT05119166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64454208|NCT05119166|Vasodilator Agents|vasodilator agents|mesh-ancestor
64454209|NCT01942148|Aripiprazole|aripiprazole|mesh-list
64454210|NCT01942148|Antidepressive Agents|antidepressive agents|mesh-ancestor
64454211|NCT01942148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64454212|NCT01942148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64454213|NCT01942148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64454214|NCT01942148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64454215|NCT01942148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454216|NCT01942148|Dopamine Agonists|dopamine agonists|mesh-ancestor
64454217|NCT01942148|Dopamine Agents|dopamine agents|mesh-ancestor
64454218|NCT01942148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64454219|NCT01942148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454220|NCT01942148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64454221|NCT01942148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64454222|NCT01942148|Serotonin Agents|serotonin agents|mesh-ancestor
64454223|NCT01942148|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64454224|NCT01942148|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64454225|NCT01942148|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64454226|NCT01942148|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64454228|NCT02030015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454229|NCT02030015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454230|NCT02030015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64454231|NCT02030015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64454232|NCT02030015|Antiviral Agents|antiviral agents|mesh-ancestor
64454233|NCT02030015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64454234|NCT02030015|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64454239|NCT02029235|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64569317|NCT00986921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569318|NCT00986921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64569319|NCT00986921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64569320|NCT00986921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64569321|NCT00986921|Contraceptive Agents|contraceptive agents|mesh-ancestor
64569322|NCT00986921|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64569323|NCT00986921|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64569324|NCT00986921|Hormone Antagonists|hormone antagonists|mesh-ancestor
64569350|NCT01384539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64569351|NCT01384539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454241|NCT02029235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64454242|NCT02029235|Analgesics|analgesics|mesh-ancestor
64454243|NCT02029235|Sensory System Agents|sensory system agents|mesh-ancestor
64454244|NCT02029235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64454257|NCT02029235|Respiratory System Agents|respiratory system agents|mesh-ancestor
64454258|NCT01617434|Liraglutide|liraglutide|mesh-list
64454259|NCT01617434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64454260|NCT01617434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454261|NCT01617434|Incretins|incretins|mesh-ancestor
64454262|NCT01617434|Hormones|hormones|mesh-ancestor
64454263|NCT01617434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64454264|NCT04623398|Lithium Carbonate|lithium carbonate|mesh-list
64454265|NCT04623398|Antidepressive Agents|antidepressive agents|mesh-ancestor
64454266|NCT04623398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64454267|NCT04623398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454268|NCT04623398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454269|NCT04623398|Antimanic Agents|antimanic agents|mesh-ancestor
64454270|NCT04623398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64454271|NCT04623398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64454272|NCT04623398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454273|NCT01940900|Ranibizumab|ranibizumab|mesh-list
64454274|NCT01940900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64454275|NCT01940900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64454276|NCT01940900|Growth Substances|growth substances|mesh-ancestor
64454277|NCT01940900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454278|NCT01940900|Growth Inhibitors|growth inhibitors|mesh-ancestor
64454279|NCT01940900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64454281|NCT01911260|Sequestering Agents|sequestering agents|mesh-ancestor
64531443|NCT03728361|Nivolumab|nivolumab|mesh-list
64531444|NCT03728361|Temozolomide|temozolomide|mesh-list
64531445|NCT03728361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64531446|NCT03728361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531447|NCT03728361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64531448|NCT03728361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531449|NCT03728361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64531450|NCT03728361|Alkylating Agents|alkylating agents|mesh-ancestor
64531451|NCT03662685|Coal Tar|coal tar|mesh-list
64531452|NCT03662685|Keratolytic Agents|keratolytic agents|mesh-ancestor
64531453|NCT03662685|Dermatologic Agents|dermatologic agents|mesh-ancestor
64531454|NCT03617328|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64531455|NCT03617328|Poly ICLC|poly iclc|mesh-list
64531456|NCT03617328|Immunologic Factors|immunologic factors|mesh-ancestor
64531457|NCT03617328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454282|NCT01911260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454283|NCT02015819|Leucovorin|leucovorin|mesh-list
64454284|NCT02015819|Flucytosine|flucytosine|mesh-list
64454285|NCT02015819|Calcium|calcium|mesh-list
64454286|NCT02015819|Levoleucovorin|levoleucovorin|mesh-list
64945363|NCT05697783|Analgesics|analgesics|mesh-ancestor
64454287|NCT02015819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64454288|NCT02015819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454290|NCT02015819|Protective Agents|protective agents|mesh-ancestor
64454291|NCT02015819|Vitamin B Complex|vitamin b complex|mesh-ancestor
64454292|NCT02015819|Vitamins|vitamins|mesh-ancestor
64569353|NCT01384539|Micronutrients|micronutrients|mesh-ancestor
64569354|NCT01384539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64517604|NCT02353780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64517605|NCT02353780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64517606|NCT02353780|Immunologic Factors|immunologic factors|mesh-ancestor
64517607|NCT02353780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64517608|NCT02353780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517609|NCT02353780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569355|NCT01384539|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64569356|NCT01384539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64629417|NCT04330300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629418|NCT04330300|Vasodilator Agents|vasodilator agents|mesh-ancestor
64454293|NCT02015819|Micronutrients|micronutrients|mesh-ancestor
64454294|NCT02015819|Antifungal Agents|antifungal agents|mesh-ancestor
64454295|NCT02015819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64454296|NCT02015819|Antimetabolites|antimetabolites|mesh-ancestor
64454297|NCT02015819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454298|NCT01939496|Canagliflozin|canagliflozin|mesh-list
64454299|NCT01939496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64454300|NCT01939496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454301|NCT01939496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64454302|NCT01939496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454303|NCT01939028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64454304|NCT01938716|Gemcitabine|gemcitabine|mesh-list
64454343|NCT04678895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64454345|NCT04683965|Pemetrexed|pemetrexed|mesh-list
64454346|NCT04683965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64454347|NCT04683965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64454348|NCT04683965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64454349|NCT04683965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64531458|NCT03617328|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64531459|NCT03617328|Interferon Inducers|interferon inducers|mesh-ancestor
64531465|NCT03493854|Paclitaxel|paclitaxel|mesh-list
64531466|NCT03493854|Docetaxel|docetaxel|mesh-list
64531467|NCT03493854|Cyclophosphamide|cyclophosphamide|mesh-list
64531468|NCT03493854|Doxorubicin|doxorubicin|mesh-list
64531469|NCT03493854|Trastuzumab|trastuzumab|mesh-list
64531470|NCT03493854|Pertuzumab|pertuzumab|mesh-list
64531471|NCT03493854|Hormones|hormones|mesh-list
64531472|NCT03493854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64531473|NCT03493854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531474|NCT03493854|Tubulin Modulators|tubulin modulators|mesh-ancestor
64531475|NCT03493854|Antimitotic Agents|antimitotic agents|mesh-ancestor
64531476|NCT03493854|Mitosis Modulators|mitosis modulators|mesh-ancestor
64531477|NCT03493854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531478|NCT03493854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64531479|NCT03493854|Immunologic Factors|immunologic factors|mesh-ancestor
64531480|NCT03493854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531481|NCT03493854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64531482|NCT03493854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64531483|NCT03493854|Alkylating Agents|alkylating agents|mesh-ancestor
64296040|NCT03304431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454350|NCT04683965|Growth Substances|growth substances|mesh-ancestor
64454351|NCT04683965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454352|NCT04683965|Growth Inhibitors|growth inhibitors|mesh-ancestor
64454353|NCT04683965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454363|NCT02015195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64454364|NCT02015195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454365|NCT02015195|Sensory System Agents|sensory system agents|mesh-ancestor
64454366|NCT02015195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64454367|NCT02015195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64569357|NCT01384539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569358|NCT01384539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64569359|NCT03399981|Natalizumab|natalizumab|mesh-list
64569360|NCT03399981|Immunologic Factors|immunologic factors|mesh-ancestor
64569361|NCT03399981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569362|NCT04902222|Morphine|morphine|mesh-list
64569363|NCT04902222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64569364|NCT04902222|Narcotics|narcotics|mesh-ancestor
64569365|NCT04902222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64569366|NCT04902222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569367|NCT04902222|Analgesics|analgesics|mesh-ancestor
64569368|NCT04902222|Sensory System Agents|sensory system agents|mesh-ancestor
64569369|NCT04902222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64569371|NCT04904406|Abacavir|abacavir|mesh-list
64569372|NCT04904406|Dolutegravir|dolutegravir|mesh-list
64569373|NCT04904406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64569399|NCT02337985|Alkylating Agents|alkylating agents|mesh-ancestor
64569400|NCT02337985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454368|NCT02015195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64454369|NCT02015195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64454370|NCT02015195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64454371|NCT02015195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454372|NCT02015195|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64454373|NCT02015195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64454374|NCT02015195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64454375|NCT02015195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64454376|NCT02015195|Immunologic Factors|immunologic factors|mesh-ancestor
64454377|NCT02015195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64454378|NCT02015195|Protective Agents|protective agents|mesh-ancestor
64454379|NCT02015195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531484|NCT03493854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64531485|NCT03493854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64531486|NCT03493854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64531487|NCT03493854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64531488|NCT03493854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531489|NCT03493854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64714121|NCT03054805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64531496|NCT03478878|Antioxidants|antioxidants|mesh-ancestor
64454389|NCT02025725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64454390|NCT02025725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454391|NCT02025179|Teriparatide|teriparatide|mesh-list
64454392|NCT02025179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64454393|NCT02025179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454394|NCT02025179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64454395|NCT02013791|Cyclosporine|cyclosporine|mesh-list
64454396|NCT02013791|Cyclosporins|cyclosporins|mesh-list
64454397|NCT02013791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454398|NCT02013791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454399|NCT02013791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64454400|NCT02013791|Immunologic Factors|immunologic factors|mesh-ancestor
64454401|NCT02013791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454402|NCT02013791|Antifungal Agents|antifungal agents|mesh-ancestor
64454403|NCT02013791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64454404|NCT02013791|Dermatologic Agents|dermatologic agents|mesh-ancestor
64454405|NCT02013791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64454406|NCT02013791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64569401|NCT02337985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569402|NCT02337985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64569403|NCT02337985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64569404|NCT02337985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64569405|NCT02337985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64569406|NCT02337985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64569407|NCT02337985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569408|NCT02337985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64569409|NCT02337985|Glucocorticoids|glucocorticoids|mesh-ancestor
64569410|NCT02337985|Hormones|hormones|mesh-ancestor
64569411|NCT02337985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64569412|NCT02337985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64569413|NCT02337985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64569414|NCT02337985|Tubulin Modulators|tubulin modulators|mesh-ancestor
64569415|NCT02337985|Antimitotic Agents|antimitotic agents|mesh-ancestor
64569416|NCT02337985|Mitosis Modulators|mitosis modulators|mesh-ancestor
64569417|NCT02429557|Midodrine|midodrine|mesh-list
64569418|NCT02429557|Sympathomimetics|sympathomimetics|mesh-ancestor
64569419|NCT02429557|Autonomic Agents|autonomic agents|mesh-ancestor
64569420|NCT02429557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64569421|NCT02429557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569422|NCT02429557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64569423|NCT02429557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64569447|NCT04346329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64569448|NCT04346329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64569449|NCT04346329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569450|NCT04346329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569451|NCT04346329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64569453|NCT02422381|Pembrolizumab|pembrolizumab|mesh-list
64569454|NCT02422381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64569455|NCT02422381|Antimetabolites|antimetabolites|mesh-ancestor
64454407|NCT02024867|Trimethoprim|trimethoprim|mesh-list
64454408|NCT02024867|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64454409|NCT02024867|Sulfamethoxazole|sulfamethoxazole|mesh-list
64454410|NCT02024867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64454411|NCT02024867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64454412|NCT02024867|Renal Agents|renal agents|mesh-ancestor
64454413|NCT02024867|Antimalarials|antimalarials|mesh-ancestor
64454414|NCT02024867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64454415|NCT02024867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64454416|NCT02024867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64454417|NCT02024867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569456|NCT02422381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569457|NCT02422381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569458|NCT02422381|Antiviral Agents|antiviral agents|mesh-ancestor
64569459|NCT02422381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64569460|NCT02422381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569461|NCT02422381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64569462|NCT02422381|Immunologic Factors|immunologic factors|mesh-ancestor
64569463|NCT02422381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569464|NCT02422381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64569465|NCT04883736|Tretinoin|tretinoin|mesh-list
64517610|NCT02353780|Dermatologic Agents|dermatologic agents|mesh-ancestor
64517612|NCT03176472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64517613|NCT03176472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64517614|NCT03176472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454418|NCT02024867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454419|NCT02024867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64454420|NCT02024867|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64454447|NCT01979185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454448|NCT01979185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64454449|NCT01979185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64454450|NCT01979185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454451|NCT01946425|Vaccines|vaccines|mesh-list
64454452|NCT01946425|Immunologic Factors|immunologic factors|mesh-ancestor
64454453|NCT01946425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454454|NCT01959698|Rituximab|rituximab|mesh-list
64454455|NCT01959698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64454456|NCT01959698|Carboplatin|carboplatin|mesh-list
64454457|NCT01959698|Etoposide|etoposide|mesh-list
64454458|NCT01959698|Etoposide phosphate|etoposide phosphate|mesh-list
64454459|NCT01959698|Ifosfamide|ifosfamide|mesh-list
64454460|NCT01959698|Isophosphamide mustard|isophosphamide mustard|mesh-list
64454461|NCT01959698|Podophyllotoxin|podophyllotoxin|mesh-list
64454462|NCT01959698|Antibodies|antibodies|mesh-list
64454463|NCT01959698|Immunoglobulins|immunoglobulins|mesh-list
64454469|NCT01959698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64454470|NCT01959698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64454482|NCT04650698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64531497|NCT03478878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531498|NCT03478878|Protective Agents|protective agents|mesh-ancestor
64531499|NCT03478878|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64531500|NCT03478878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296063|NCT04335968|Protective Agents|protective agents|mesh-ancestor
64296066|NCT04266938|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64454483|NCT04650698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64454484|NCT04650698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454485|NCT04650698|Hemostatics|hemostatics|mesh-ancestor
64454486|NCT04650698|Coagulants|coagulants|mesh-ancestor
64454487|NCT01910402|Ritonavir|ritonavir|mesh-list
64454488|NCT01910402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64454489|NCT01910402|Tenofovir|tenofovir|mesh-list
64454490|NCT01910402|Lamivudine|lamivudine|mesh-list
64454491|NCT01910402|Emtricitabine|emtricitabine|mesh-list
64454492|NCT01910402|Dolutegravir|dolutegravir|mesh-list
64454493|NCT01910402|Abacavir|abacavir|mesh-list
64454494|NCT01910402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64454495|NCT01910402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64454496|NCT01910402|Protease Inhibitors|protease inhibitors|mesh-ancestor
64454497|NCT01910402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454498|NCT01910402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454499|NCT01910402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64454500|NCT01910402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64569466|NCT04883736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569467|NCT04883736|Keratolytic Agents|keratolytic agents|mesh-ancestor
64569468|NCT04883736|Dermatologic Agents|dermatologic agents|mesh-ancestor
64569469|NCT02312557|Pembrolizumab|pembrolizumab|mesh-list
64569470|NCT02312557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64569471|NCT02312557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569472|NCT01387815|Adalimumab|adalimumab|mesh-list
64569473|NCT01387815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64569474|NCT01387815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64569475|NCT04883034|Analgesics|analgesics|mesh-list
64569476|NCT04883034|Sensory System Agents|sensory system agents|mesh-ancestor
64569477|NCT04883034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64569497|NCT02394769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64569498|NCT02394769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64569499|NCT02394769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569500|NCT02394769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64569501|NCT02394769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64569502|NCT02394769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569503|NCT02394769|Antipyretics|antipyretics|mesh-ancestor
64569504|NCT01334229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64569505|NCT01334229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64569506|NCT01334229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569507|NCT01334229|Incretins|incretins|mesh-ancestor
64569508|NCT01334229|Hormones|hormones|mesh-ancestor
64569509|NCT01334229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64569510|NCT01334229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64569511|NCT01334229|Protease Inhibitors|protease inhibitors|mesh-ancestor
64569512|NCT01334229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569513|NCT01334229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569514|NCT01390077|Nitisinone|nitisinone|mesh-list
64629649|NCT04349722|Scopolamine|scopolamine|mesh-list
64454501|NCT01910402|Antiviral Agents|antiviral agents|mesh-ancestor
64454502|NCT01910402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64454503|NCT01910402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64454504|NCT01910402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64454505|NCT01910402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64454508|NCT01910402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64454509|NCT01937312|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64454510|NCT01937312|Travoprost|travoprost|mesh-list
64454511|NCT01937312|Brinzolamide|brinzolamide|mesh-list
64454512|NCT01937312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64454513|NCT01937312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64945364|NCT05697783|Sensory System Agents|sensory system agents|mesh-ancestor
64454514|NCT01937312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64454515|NCT01937312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64569515|NCT01390077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569516|NCT01390077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569517|NCT02292979|Doxorubicin|doxorubicin|mesh-list
64569518|NCT02292979|Bleomycin|bleomycin|mesh-list
64569519|NCT02292979|Dacarbazine|dacarbazine|mesh-list
64569520|NCT02292979|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64569521|NCT02292979|Vinblastine|vinblastine|mesh-list
64569522|NCT02292979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64569523|NCT02292979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569524|NCT02292979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64569525|NCT02292979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64569526|NCT02292979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569527|NCT02292979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569528|NCT02292979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64569529|NCT02292979|Alkylating Agents|alkylating agents|mesh-ancestor
64569530|NCT02292979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64569531|NCT02292979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64569532|NCT02292979|Tubulin Modulators|tubulin modulators|mesh-ancestor
64569533|NCT02292979|Antimitotic Agents|antimitotic agents|mesh-ancestor
64569564|NCT01404429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294817|NCT04495088|Leucovorin|leucovorin|mesh-list
64569565|NCT01404429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64569566|NCT01404429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64569567|NCT01404429|Immunologic Factors|immunologic factors|mesh-ancestor
64569568|NCT01404429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64569569|NCT01404429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64569570|NCT03051906|Cetuximab|cetuximab|mesh-list
64569571|NCT03051906|Durvalumab|durvalumab|mesh-list
64569572|NCT03051906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64569573|NCT03051906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569574|NCT01390233|Dinoprostone|dinoprostone|mesh-list
64569575|NCT01390233|Oxytocics|oxytocics|mesh-ancestor
64569576|NCT01390233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64454516|NCT01937312|Adrenergic Agents|adrenergic agents|mesh-ancestor
64454517|NCT01937312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64454518|NCT01937312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454519|NCT01937312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454520|NCT01937312|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64454521|NCT01937312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454522|NCT01909934|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64454523|NCT01909934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64454524|NCT01909934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64454526|NCT01935128|Tacrolimus|tacrolimus|mesh-list
64569607|NCT01391013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64569608|NCT01891747|Bevacizumab|bevacizumab|mesh-list
64517615|NCT03176472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517616|NCT03246360|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64517617|NCT03246360|Cloxacillin|cloxacillin|mesh-list
64517618|NCT03246360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64569609|NCT01891747|Temozolomide|temozolomide|mesh-list
64569610|NCT01891747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64569611|NCT01891747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569612|NCT01891747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64569613|NCT01891747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64569614|NCT01891747|Growth Substances|growth substances|mesh-ancestor
64569615|NCT01891747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569616|NCT01891747|Growth Inhibitors|growth inhibitors|mesh-ancestor
64569617|NCT01891747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64569618|NCT01891747|Alkylating Agents|alkylating agents|mesh-ancestor
64569619|NCT01891747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569620|NCT04899570|Prednisone|prednisone|mesh-list
64569644|NCT04899570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569645|NCT04899570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64569646|NCT04899570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64569647|NCT04899570|Tubulin Modulators|tubulin modulators|mesh-ancestor
64569648|NCT04899570|Antimitotic Agents|antimitotic agents|mesh-ancestor
64569649|NCT04899570|Mitosis Modulators|mitosis modulators|mesh-ancestor
64569650|NCT02274415|Vaccines|vaccines|mesh-list
64629730|NCT00383032|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64454527|NCT01935128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64454528|NCT01935128|Immunologic Factors|immunologic factors|mesh-ancestor
64454529|NCT01935128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454530|NCT01935128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64454531|NCT01935128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454532|NCT01935128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454533|NCT01935128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64454534|NCT01934972|Cycloserine|cycloserine|mesh-list
64531521|NCT03464045|Empagliflozin|empagliflozin|mesh-list
64531522|NCT03464045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64531523|NCT03464045|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64531524|NCT03464045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531525|NCT03464045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64531526|NCT03464045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454559|NCT01977937|Sensory System Agents|sensory system agents|mesh-ancestor
64454560|NCT01977937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64454561|NCT01977937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454563|NCT01977937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64454564|NCT01977937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64454565|NCT01977937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64454566|NCT01977937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64569651|NCT02274415|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64569652|NCT02274415|Immunologic Factors|immunologic factors|mesh-ancestor
64569653|NCT02274415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569654|NCT03049878|Acetaminophen|acetaminophen|mesh-list
64569655|NCT03049878|Codeine|codeine|mesh-list
64569656|NCT03049878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64569657|NCT03049878|Analgesics|analgesics|mesh-ancestor
64569658|NCT03049878|Sensory System Agents|sensory system agents|mesh-ancestor
64569659|NCT03049878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64569660|NCT03049878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569661|NCT03049878|Antipyretics|antipyretics|mesh-ancestor
64569662|NCT03049878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64569663|NCT03049878|Narcotics|narcotics|mesh-ancestor
64569664|NCT03049878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64569665|NCT03049878|Antitussive Agents|antitussive agents|mesh-ancestor
64569666|NCT03049878|Respiratory System Agents|respiratory system agents|mesh-ancestor
64569667|NCT01391325|Allopurinol|allopurinol|mesh-list
64629778|NCT02169869|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64454567|NCT01977937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64454568|NCT01977937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64454569|NCT01977937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64454570|NCT01977937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454571|NCT01977937|Antimanic Agents|antimanic agents|mesh-ancestor
64454572|NCT01951105|Naproxen|naproxen|mesh-list
64454573|NCT01951105|Levodopa|levodopa|mesh-list
64454574|NCT01951105|Carbidopa|carbidopa|mesh-list
64454575|NCT01951105|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64454576|NCT01951105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64454577|NCT01951105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64454599|NCT01958918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64454600|NCT01958918|Growth Substances|growth substances|mesh-ancestor
64454601|NCT01958918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454602|NCT01958918|Growth Inhibitors|growth inhibitors|mesh-ancestor
64454603|NCT01958918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64454604|NCT01945489|Botulinum Toxins|botulinum toxins|mesh-list
64454605|NCT01945489|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64454606|NCT01945489|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64454607|NCT01945489|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64454608|NCT01945489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64454609|NCT01945489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454610|NCT01945489|Cholinergic Agents|cholinergic agents|mesh-ancestor
64454611|NCT01945489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64454612|NCT01945489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454613|NCT01945489|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64454614|NCT01945489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64454615|NCT01934894|Lapatinib|lapatinib|mesh-list
64454616|NCT01934894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64454617|NCT01934894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64454618|NCT01934894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454619|NCT01934894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454620|NCT01950169|Vitamin D|vitamin d|mesh-list
64454621|NCT01950169|Cholecalciferol|cholecalciferol|mesh-list
64454622|NCT01950169|Risedronic Acid|risedronic acid|mesh-list
64454623|NCT01950169|Diphosphonates|diphosphonates|mesh-list
64454624|NCT01950169|Calcium|calcium|mesh-list
64454625|NCT01950169|Vitamins|vitamins|mesh-ancestor
64531535|NCT03391934|Leucovorin|leucovorin|mesh-list
64531536|NCT03391934|Fluorouracil|fluorouracil|mesh-list
64531537|NCT03391934|Irinotecan|irinotecan|mesh-list
64531538|NCT03391934|Cetuximab|cetuximab|mesh-list
64569668|NCT01391325|Antimetabolites|antimetabolites|mesh-ancestor
64569669|NCT01391325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569670|NCT01391325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569671|NCT01391325|Gout Suppressants|gout suppressants|mesh-ancestor
64569672|NCT01391325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64569705|NCT04891458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64569706|NCT04891458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569707|NCT04891458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64569708|NCT04891458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64569709|NCT04891458|Anesthetics, General|anesthetics, general|mesh-ancestor
64569710|NCT04891458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64569711|NCT04891458|Analgesics|analgesics|mesh-ancestor
64569712|NCT04891458|Sensory System Agents|sensory system agents|mesh-ancestor
64569713|NCT04891458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64569714|NCT04891458|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64569785|NCT01894711|Trastuzumab|trastuzumab|mesh-list
64569786|NCT01894711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64569787|NCT01894711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569788|NCT00985439|Celecoxib|celecoxib|mesh-list
64569805|NCT04412148|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64569806|NCT04412148|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64569807|NCT04412148|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64569808|NCT04412148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64569809|NCT04412148|Glucocorticoids|glucocorticoids|mesh-ancestor
64569810|NCT04412148|Hormones|hormones|mesh-ancestor
64569811|NCT04412148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64569812|NCT04412148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569813|NCT04412148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64569814|NCT04412148|Immunologic Factors|immunologic factors|mesh-ancestor
64569815|NCT04412148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517619|NCT02354092|Anesthetics|anesthetics|mesh-list
64517620|NCT02354092|Anesthetics, Local|anesthetics, local|mesh-list
64517621|NCT02354092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64517622|NCT02354092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629845|NCT04896658|Hormones|hormones|mesh-ancestor
64531539|NCT03391934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531540|NCT03391934|Antimetabolites|antimetabolites|mesh-ancestor
64531541|NCT03391934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531542|NCT03391934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64517623|NCT02354092|Sensory System Agents|sensory system agents|mesh-ancestor
64517624|NCT02354092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517625|NCT00907101|Adapalene|adapalene|mesh-list
64517626|NCT00907101|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
64517627|NCT00907101|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64517628|NCT00907101|Dermatologic Agents|dermatologic agents|mesh-ancestor
64569816|NCT04412148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569817|NCT04890522|Gemcitabine|gemcitabine|mesh-list
64569818|NCT04890522|Fluorouracil|fluorouracil|mesh-list
64531543|NCT03391934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531544|NCT03391934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64531545|NCT03391934|Immunologic Factors|immunologic factors|mesh-ancestor
64531546|NCT03391934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64531547|NCT03391934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64531548|NCT03391934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531549|NCT03391934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64531550|NCT03391934|Antidotes|antidotes|mesh-ancestor
64454656|NCT01977625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64454657|NCT01977625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454658|NCT01977625|Dopamine Agents|dopamine agents|mesh-ancestor
64454659|NCT01977625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64454660|NCT01995071|Ribavirin|ribavirin|mesh-list
64454661|NCT01995071|Antimetabolites|antimetabolites|mesh-ancestor
64454662|NCT01995071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454663|NCT01995071|Antiviral Agents|antiviral agents|mesh-ancestor
64454664|NCT01995071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64454665|NCT01994837|Venetoclax|venetoclax|mesh-list
64454666|NCT01994837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64454667|NCT02010593|Dapivirine|dapivirine|mesh-list
64454668|NCT02010593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64454669|NCT02010593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64454670|NCT02010593|Antiviral Agents|antiviral agents|mesh-ancestor
64454671|NCT02010593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64454672|NCT01994291|Ranibizumab|ranibizumab|mesh-list
64454673|NCT01994291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64454674|NCT01994291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64454675|NCT01994291|Growth Substances|growth substances|mesh-ancestor
64454676|NCT01994291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454677|NCT01994291|Growth Inhibitors|growth inhibitors|mesh-ancestor
64454678|NCT01994291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64454679|NCT04667039|Ranibizumab|ranibizumab|mesh-list
64454708|NCT01993667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454709|NCT01934192|Metoclopramide|metoclopramide|mesh-list
64454710|NCT01934192|Antiemetics|antiemetics|mesh-ancestor
64454711|NCT01934192|Autonomic Agents|autonomic agents|mesh-ancestor
64454712|NCT01934192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64454713|NCT01934192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531551|NCT03391934|Protective Agents|protective agents|mesh-ancestor
64531552|NCT03391934|Vitamin B Complex|vitamin b complex|mesh-ancestor
64531553|NCT03391934|Vitamins|vitamins|mesh-ancestor
64531554|NCT03391934|Micronutrients|micronutrients|mesh-ancestor
64531555|NCT03333343|Gefitinib|gefitinib|mesh-list
64531556|NCT03333343|Trametinib|trametinib|mesh-list
64531557|NCT03333343|Nazartinib|nazartinib|mesh-list
64531558|NCT03333343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531559|NCT03333343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64531560|NCT03333343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531561|NCT03333343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714122|NCT00374101|Omeprazole|omeprazole|mesh-list
64531562|NCT03326947|Docetaxel|docetaxel|mesh-list
64531563|NCT03326947|Fluorouracil|fluorouracil|mesh-list
64531564|NCT03326947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531565|NCT03326947|Tubulin Modulators|tubulin modulators|mesh-ancestor
64531566|NCT03326947|Antimitotic Agents|antimitotic agents|mesh-ancestor
64531567|NCT03326947|Mitosis Modulators|mitosis modulators|mesh-ancestor
64531568|NCT03326947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531569|NCT03326947|Antimetabolites|antimetabolites|mesh-ancestor
64454714|NCT01934192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64454715|NCT01934192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64569819|NCT04890522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569820|NCT04890522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64569821|NCT04890522|Antimetabolites|antimetabolites|mesh-ancestor
64569822|NCT04890522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569823|NCT04890522|Antiviral Agents|antiviral agents|mesh-ancestor
64569824|NCT04890522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64569825|NCT04890522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569826|NCT04890522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64569827|NCT04890522|Immunologic Factors|immunologic factors|mesh-ancestor
64569828|NCT04890522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569829|NCT01525069|Gemcitabine|gemcitabine|mesh-list
64569830|NCT01525069|Dexamethasone|dexamethasone|mesh-list
64569831|NCT01525069|Oxaliplatin|oxaliplatin|mesh-list
64569832|NCT01525069|Floxuridine|floxuridine|mesh-list
64569833|NCT01525069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64569834|NCT01525069|Antiemetics|antiemetics|mesh-ancestor
64569862|NCT02249065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569863|NCT02249065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295110|NCT02472886|Sofosbuvir|sofosbuvir|mesh-list
64569865|NCT00983957|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64569866|NCT00983957|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64569867|NCT00983957|Contraceptive Agents|contraceptive agents|mesh-ancestor
64569868|NCT00983957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64569869|NCT00983957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454716|NCT01934192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64454717|NCT01934192|Dopamine Agents|dopamine agents|mesh-ancestor
64454718|NCT01934192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64454719|NCT01934192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454720|NCT01933880|Methylphenidate|methylphenidate|mesh-list
64454721|NCT01933880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64454740|NCT01933334|Sensory System Agents|sensory system agents|mesh-ancestor
64454751|NCT01932788|Micronutrients|micronutrients|mesh-ancestor
64454752|NCT01932788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454753|NCT01932788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64454754|NCT01932788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64454755|NCT01908140|Fluticasone|fluticasone|mesh-list
64454756|NCT01908140|Bromides|bromides|mesh-list
64454757|NCT01908140|Formoterol Fumarate|formoterol fumarate|mesh-list
64454758|NCT01908140|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64454759|NCT01908140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64454760|NCT01908140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64454761|NCT01908140|Autonomic Agents|autonomic agents|mesh-ancestor
64454762|NCT01908140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64454763|NCT01908140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454764|NCT01908140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64454765|NCT01908140|Respiratory System Agents|respiratory system agents|mesh-ancestor
64454766|NCT01908140|Dermatologic Agents|dermatologic agents|mesh-ancestor
64454767|NCT01908140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64454768|NCT01908140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64569870|NCT00983957|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64569871|NCT00983957|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64569872|NCT00983957|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64569873|NCT00983957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64569874|NCT00983957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64569875|NCT00983957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64569876|NCT00983957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64569877|NCT00983957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569878|NCT00983957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569905|NCT03074045|Estradiol|estradiol|mesh-list
64569906|NCT03074045|Estrogens|estrogens|mesh-ancestor
64569907|NCT03074045|Hormones|hormones|mesh-ancestor
64569908|NCT03074045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64569909|NCT03074045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569910|NCT03074045|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64569911|NCT03074045|Contraceptive Agents|contraceptive agents|mesh-ancestor
64454769|NCT01908140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64531570|NCT03326947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64531571|NCT03326947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64531572|NCT03326947|Immunologic Factors|immunologic factors|mesh-ancestor
64531573|NCT03326947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531574|NCT03304639|Pembrolizumab|pembrolizumab|mesh-list
64531575|NCT03304639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64531576|NCT03304639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531578|NCT03289234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64531579|NCT03289234|Antioxidants|antioxidants|mesh-ancestor
64531580|NCT03289234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531581|NCT03289234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64531582|NCT03289234|Protective Agents|protective agents|mesh-ancestor
64531583|NCT03289234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531584|NCT03289208|Edaravone|edaravone|mesh-list
64531585|NCT03289208|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64531586|NCT03289208|Antioxidants|antioxidants|mesh-ancestor
64531587|NCT03289208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531588|NCT03289208|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64531589|NCT03289208|Protective Agents|protective agents|mesh-ancestor
64531590|NCT03289208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531591|NCT03244059|Belimumab|belimumab|mesh-list
64531592|NCT03244059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64531593|NCT03244059|Immunologic Factors|immunologic factors|mesh-ancestor
64531594|NCT03244059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531595|NCT03217812|Prednisone|prednisone|mesh-list
64531596|NCT03217812|Bortezomib|bortezomib|mesh-list
64531597|NCT03217812|Melphalan|melphalan|mesh-list
64531598|NCT03217812|Daratumumab|daratumumab|mesh-list
64531599|NCT03217812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64531600|NCT03217812|Glucocorticoids|glucocorticoids|mesh-ancestor
64531601|NCT03217812|Hormones|hormones|mesh-ancestor
64454770|NCT01908140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64454771|NCT01908140|Adrenergic Agents|adrenergic agents|mesh-ancestor
64454772|NCT01908140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64454773|NCT01908140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454774|NCT01908140|Anticonvulsants|anticonvulsants|mesh-ancestor
64454775|NCT02008565|Loperamide|loperamide|mesh-list
64454776|NCT02008565|Antidiarrheals|antidiarrheals|mesh-list
64454790|NCT01906346|Anesthetics|anesthetics|mesh-ancestor
64454791|NCT01906346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64531602|NCT03217812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64569912|NCT03074045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64569913|NCT03074045|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64569914|NCT03074045|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64569915|NCT03074045|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64569916|NCT03074045|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64569917|NCT03074045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64569918|NCT03074045|Hormone Antagonists|hormone antagonists|mesh-ancestor
64569919|NCT03074045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64569920|NCT03074045|Diuretics|diuretics|mesh-ancestor
64517629|NCT00907101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64517631|NCT00907101|Analgesics|analgesics|mesh-ancestor
64517632|NCT00907101|Sensory System Agents|sensory system agents|mesh-ancestor
64517633|NCT00907101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517634|NCT00907101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517635|NCT00907101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64517636|NCT00907101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64517637|NCT03245970|Atenolol|atenolol|mesh-list
64517638|NCT03245970|Labetalol|labetalol|mesh-list
64517639|NCT03245970|Nifedipine|nifedipine|mesh-list
64517640|NCT03245970|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64517641|NCT03245970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64517642|NCT03245970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517643|NCT03245970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64517644|NCT03245970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517645|NCT03245970|Vasodilator Agents|vasodilator agents|mesh-ancestor
64517646|NCT03245970|Tocolytic Agents|tocolytic agents|mesh-ancestor
64531603|NCT03217812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531604|NCT03217812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64531605|NCT03217812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531606|NCT03217812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64531607|NCT03217812|Alkylating Agents|alkylating agents|mesh-ancestor
64531608|NCT03217812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531609|NCT03217812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64531610|NCT03217812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64531611|NCT03217812|Immunologic Factors|immunologic factors|mesh-ancestor
64296166|NCT00703677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454795|NCT01906346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64454796|NCT01906346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64454797|NCT01906346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64454798|NCT01906346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64454799|NCT01906346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454801|NCT01906346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64454803|NCT04645004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64454804|NCT04645004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64454806|NCT04645004|Sensory System Agents|sensory system agents|mesh-ancestor
64517647|NCT03245970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64517648|NCT03245970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64517649|NCT03245970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64517650|NCT03245970|Sympatholytics|sympatholytics|mesh-ancestor
64517651|NCT03245970|Autonomic Agents|autonomic agents|mesh-ancestor
64517652|NCT03245970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714090|NCT03054103|Sensory System Agents|sensory system agents|mesh-ancestor
64569921|NCT03074045|Natriuretic Agents|natriuretic agents|mesh-ancestor
64569922|NCT02248597|Mycophenolic Acid|mycophenolic acid|mesh-list
64569923|NCT02248597|Cyclophosphamide|cyclophosphamide|mesh-list
64569924|NCT02248597|Busulfan|busulfan|mesh-list
64569925|NCT02248597|Fludarabine|fludarabine|mesh-list
64569926|NCT02248597|Fludarabine phosphate|fludarabine phosphate|mesh-list
64569927|NCT02248597|Tacrolimus|tacrolimus|mesh-list
64569928|NCT02248597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64569929|NCT02248597|Immunologic Factors|immunologic factors|mesh-ancestor
64569930|NCT02248597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569962|NCT04126811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64569963|NCT04126811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64569964|NCT01406223|Bupropion|bupropion|mesh-list
64630108|NCT03187834|Amoxicillin|amoxicillin|mesh-list
64454807|NCT04645004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64454808|NCT04645004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454809|NCT04645004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64454810|NCT04645004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64454811|NCT04645004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64454812|NCT04645004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64454813|NCT04645004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454814|NCT04645004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64454815|NCT04645004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64454816|NCT04645004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454817|NCT04645004|Antipyretics|antipyretics|mesh-ancestor
64454819|NCT01929980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64454820|NCT04630808|Latanoprost|latanoprost|mesh-list
64454821|NCT04630808|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64454822|NCT04630808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64454823|NCT01363076|Ketorolac|ketorolac|mesh-list
64454824|NCT01363076|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64454825|NCT01363076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64454826|NCT01363076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64454827|NCT01363076|Analgesics|analgesics|mesh-ancestor
64454828|NCT01363076|Sensory System Agents|sensory system agents|mesh-ancestor
64454829|NCT01363076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64454830|NCT01363076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454831|NCT01363076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64454832|NCT01363076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64454833|NCT01363076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64454834|NCT01363076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454835|NCT01363076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454836|NCT01929044|Anisodamine|anisodamine|mesh-list
64454837|NCT01929044|Scopolamine|scopolamine|mesh-list
64454838|NCT01929044|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64454839|NCT01929044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64454840|NCT01929044|Antiemetics|antiemetics|mesh-ancestor
64454854|NCT01929044|Adrenergic Agents|adrenergic agents|mesh-ancestor
64454855|NCT01929044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64454856|NCT01929044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64569965|NCT01406223|Nicotine|nicotine|mesh-list
64569966|NCT01406223|Varenicline|varenicline|mesh-list
64569967|NCT01406223|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64569968|NCT01406223|Autonomic Agents|autonomic agents|mesh-ancestor
64569969|NCT01406223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64569970|NCT01406223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569971|NCT01406223|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64569972|NCT01406223|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64569973|NCT01406223|Cholinergic Agents|cholinergic agents|mesh-ancestor
64570005|NCT04881474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570006|NCT04881474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570007|NCT00981149|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64570008|NCT00981149|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64517653|NCT03245970|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64517654|NCT03245970|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64517655|NCT03245970|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64517656|NCT03245970|Adrenergic Agents|adrenergic agents|mesh-ancestor
64517657|NCT03245970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64570009|NCT00981149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64570010|NCT00981149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64454857|NCT01929044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64454858|NCT01929044|Analgesics|analgesics|mesh-ancestor
64531612|NCT03129555|Rivaroxaban|rivaroxaban|mesh-list
64531613|NCT03129555|Apixaban|apixaban|mesh-list
64531614|NCT03129555|Edoxaban|edoxaban|mesh-list
64531615|NCT03129555|Dabigatran|dabigatran|mesh-list
64531616|NCT03129555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64531617|NCT03129555|Antithrombins|antithrombins|mesh-ancestor
64531618|NCT03129555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64531619|NCT03129555|Protease Inhibitors|protease inhibitors|mesh-ancestor
64531627|NCT03129490|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64531628|NCT03129490|Antithrombins|antithrombins|mesh-ancestor
64531629|NCT03129490|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64531630|NCT03129490|Protease Inhibitors|protease inhibitors|mesh-ancestor
64531631|NCT03129490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531632|NCT03129490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531633|NCT03129490|Anticoagulants|anticoagulants|mesh-ancestor
64531634|NCT03122522|Nivolumab|nivolumab|mesh-list
64531635|NCT03122522|Ipilimumab|ipilimumab|mesh-list
64531636|NCT03122522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64531637|NCT03122522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531638|NCT03122522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64531639|NCT03122522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487725|NCT01723150|Renal Agents|renal agents|mesh-ancestor
64531640|NCT03078946|Midazolam|midazolam|mesh-list
64531641|NCT03078946|Dexmedetomidine|dexmedetomidine|mesh-list
64531642|NCT03078946|Morphine|morphine|mesh-list
64531643|NCT03078946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64531644|NCT03078946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64531645|NCT03078946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531646|NCT03078946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64296177|NCT05426252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64454859|NCT01929044|Sensory System Agents|sensory system agents|mesh-ancestor
64454860|NCT01929044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64454861|NCT01929044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64570011|NCT00981149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570012|NCT00981149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64570013|NCT00981149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570014|NCT00981149|Analgesics|analgesics|mesh-ancestor
64570034|NCT01907191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570035|NCT01907191|Sensory System Agents|sensory system agents|mesh-ancestor
64570036|NCT01907191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64570037|NCT01395537|Paclitaxel|paclitaxel|mesh-list
64570038|NCT01395537|Carboplatin|carboplatin|mesh-list
64570039|NCT01395537|Lapatinib|lapatinib|mesh-list
64570040|NCT01395537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64570041|NCT01395537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570042|NCT01395537|Tubulin Modulators|tubulin modulators|mesh-ancestor
64570043|NCT01395537|Antimitotic Agents|antimitotic agents|mesh-ancestor
64570044|NCT01395537|Mitosis Modulators|mitosis modulators|mesh-ancestor
64570045|NCT01395537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570046|NCT01395537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64570047|NCT01395537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570048|NCT04898712|Tranexamic Acid|tranexamic acid|mesh-list
64570049|NCT04898712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64570050|NCT04898712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64570051|NCT04898712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570052|NCT04898712|Hemostatics|hemostatics|mesh-ancestor
64570053|NCT04898712|Coagulants|coagulants|mesh-ancestor
64570054|NCT04898556|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64570055|NCT04898556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64570056|NCT04898556|Immunologic Factors|immunologic factors|mesh-ancestor
64454862|NCT01929044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64454863|NCT01929044|Vasodilator Agents|vasodilator agents|mesh-ancestor
64531647|NCT03078946|Analgesics|analgesics|mesh-ancestor
64531648|NCT03078946|Sensory System Agents|sensory system agents|mesh-ancestor
64531649|NCT03078946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64531650|NCT03078946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64531651|NCT03078946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64531652|NCT03078946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64531653|NCT03078946|Adrenergic Agents|adrenergic agents|mesh-ancestor
64531654|NCT03078946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64531655|NCT03078946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531656|NCT03078946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64531657|NCT03078946|Narcotics|narcotics|mesh-ancestor
64531658|NCT03078946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64531659|NCT03078946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64531660|NCT03078946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64531661|NCT03078946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64531662|NCT03078946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64531663|NCT03078946|Anesthetics, General|anesthetics, general|mesh-ancestor
64531664|NCT03078946|Anesthetics|anesthetics|mesh-ancestor
64531665|NCT03078946|GABA Modulators|gaba modulators|mesh-ancestor
64570057|NCT04898556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570058|NCT02317549|Tranexamic Acid|tranexamic acid|mesh-list
64570059|NCT02317549|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64570096|NCT01897441|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64570097|NCT01897441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64570098|NCT01897441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570099|NCT01897441|Tubulin Modulators|tubulin modulators|mesh-ancestor
64570100|NCT01897441|Antimitotic Agents|antimitotic agents|mesh-ancestor
64570123|NCT01411137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570124|NCT04430556|Sertraline|sertraline|mesh-list
64570125|NCT04430556|Antidepressive Agents|antidepressive agents|mesh-ancestor
64570126|NCT04430556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64570127|NCT04430556|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64570128|NCT04430556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64570129|NCT04430556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64570130|NCT04430556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570131|NCT04430556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64570132|NCT04430556|Serotonin Agents|serotonin agents|mesh-ancestor
64570133|NCT04430556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570134|NCT04897854|Folfirinox|folfirinox|mesh-list
64570135|NCT04897854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570136|NCT01892527|Cetuximab|cetuximab|mesh-list
64570137|NCT01892527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64570138|NCT01892527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570139|NCT02213575|Minocycline|minocycline|mesh-list
64570140|NCT02213575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64570141|NCT02213575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64570142|NCT01399827|Methylphenidate|methylphenidate|mesh-list
64570143|NCT01399827|Amphetamine|amphetamine|mesh-list
64570144|NCT01399827|Adderall|adderall|mesh-list
64570145|NCT01399827|Dextroamphetamine|dextroamphetamine|mesh-list
64570146|NCT01399827|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
64570147|NCT01399827|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64570148|NCT01399827|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64517666|NCT02454348|Adrenergic Agents|adrenergic agents|mesh-ancestor
64517667|NCT02454348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64517668|NCT02454348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517669|NCT02454348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517670|NCT02454348|Sympathomimetics|sympathomimetics|mesh-ancestor
64517671|NCT02454348|Autonomic Agents|autonomic agents|mesh-ancestor
64517672|NCT02454348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517673|NCT02454348|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64570149|NCT01399827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570150|NCT01399827|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64570184|NCT02196961|Nivolumab|nivolumab|mesh-list
64570185|NCT02196961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64570213|NCT02166463|Prednisolone|prednisolone|mesh-list
64570214|NCT02166463|Prednisolone acetate|prednisolone acetate|mesh-list
64570215|NCT02166463|Cortisone|cortisone|mesh-list
64570216|NCT02166463|Cyclophosphamide|cyclophosphamide|mesh-list
64570217|NCT02166463|Doxorubicin|doxorubicin|mesh-list
64570218|NCT02166463|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64570219|NCT02166463|Etoposide|etoposide|mesh-list
64570220|NCT02166463|Vincristine|vincristine|mesh-list
64570221|NCT02166463|Etoposide phosphate|etoposide phosphate|mesh-list
64570222|NCT02166463|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64570223|NCT02166463|Bleomycin|bleomycin|mesh-list
64570224|NCT02166463|Podophyllotoxin|podophyllotoxin|mesh-list
64570225|NCT02166463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64296211|NCT02714894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64454864|NCT01929044|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64454865|NCT01929044|Antioxidants|antioxidants|mesh-ancestor
64454866|NCT01929044|Protective Agents|protective agents|mesh-ancestor
64454867|NCT01957202|Levocabastine|levocabastine|mesh-list
64454868|NCT01957202|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64454869|NCT01957202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64454870|NCT01957202|Histamine Antagonists|histamine antagonists|mesh-ancestor
64454871|NCT01957202|Histamine Agents|histamine agents|mesh-ancestor
64454872|NCT01957202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64454873|NCT01957202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454874|NCT01957202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454875|NCT01616654|Tazarotene|tazarotene|mesh-list
64454876|NCT01616654|Trifarotene|trifarotene|mesh-list
64454877|NCT01616654|Dermatologic Agents|dermatologic agents|mesh-ancestor
64454878|NCT01616654|Keratolytic Agents|keratolytic agents|mesh-ancestor
64454879|NCT01902290|Brodalumab|brodalumab|mesh-list
64454880|NCT01902290|Dermatologic Agents|dermatologic agents|mesh-ancestor
64454881|NCT01467466|Acetylcysteine|acetylcysteine|mesh-list
64454890|NCT01467466|Protective Agents|protective agents|mesh-ancestor
64454891|NCT01467466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454892|NCT01467466|Antidotes|antidotes|mesh-ancestor
64454893|NCT01441180|Sofosbuvir|sofosbuvir|mesh-list
64454894|NCT01441180|Ribavirin|ribavirin|mesh-list
64454895|NCT01441180|Antiviral Agents|antiviral agents|mesh-ancestor
64454896|NCT01441180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64570226|NCT02166463|Antibodies|antibodies|mesh-list
64570227|NCT02166463|Immunoglobulins|immunoglobulins|mesh-list
64570228|NCT02166463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64570229|NCT02166463|Immunoconjugates|immunoconjugates|mesh-list
64570230|NCT02166463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64570231|NCT02166463|Prednisolone phosphate|prednisolone phosphate|mesh-list
64570232|NCT02166463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64570233|NCT02166463|Immunologic Factors|immunologic factors|mesh-ancestor
64570234|NCT02166463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570235|NCT02166463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64570269|NCT03049176|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64570270|NCT03049176|Antiviral Agents|antiviral agents|mesh-ancestor
64570271|NCT03049176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64570272|NCT03049176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64570273|NCT03049176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64570274|NCT03049176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570275|NCT03049176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570307|NCT04888728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64570308|NCT04888728|Serotonin Agents|serotonin agents|mesh-ancestor
64570309|NCT04888728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570310|NCT04888728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64517675|NCT02454348|Coagulants|coagulants|mesh-ancestor
64517676|NCT02454348|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64517677|NCT02454348|Natriuretic Agents|natriuretic agents|mesh-ancestor
64517678|NCT02455908|Aldesleukin|aldesleukin|mesh-list
64517679|NCT02455908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64517680|NCT02455908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64517681|NCT02455908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64517682|NCT02455908|Antiviral Agents|antiviral agents|mesh-ancestor
64517683|NCT02455908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64517684|NCT03245658|Nabiximols|nabiximols|mesh-list
64570338|NCT01428973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64570339|NCT01428973|Immunologic Factors|immunologic factors|mesh-ancestor
64570340|NCT01428973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570341|NCT01421797|Dexamethasone|dexamethasone|mesh-list
64570342|NCT01421797|Cosyntropin|cosyntropin|mesh-list
64570343|NCT01421797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64570344|NCT01421797|Antiemetics|antiemetics|mesh-ancestor
64570345|NCT01421797|Autonomic Agents|autonomic agents|mesh-ancestor
64570346|NCT01421797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64570347|NCT01421797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570348|NCT01421797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64570349|NCT01421797|Glucocorticoids|glucocorticoids|mesh-ancestor
64570350|NCT01421797|Hormones|hormones|mesh-ancestor
64570351|NCT01421797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64570352|NCT01421797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64570353|NCT01421797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570354|NCT01475643|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64570355|NCT01475643|Prednisolone|prednisolone|mesh-list
64570356|NCT01475643|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64570357|NCT01475643|Methylprednisolone|methylprednisolone|mesh-list
64570358|NCT01475643|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64570359|NCT01475643|Prednisolone acetate|prednisolone acetate|mesh-list
64570360|NCT01475643|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64570361|NCT01475643|Prednisolone phosphate|prednisolone phosphate|mesh-list
64570362|NCT01475643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64570363|NCT01475643|Glucocorticoids|glucocorticoids|mesh-ancestor
64570364|NCT01475643|Hormones|hormones|mesh-ancestor
64570365|NCT01475643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64570366|NCT01475643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570399|NCT04395222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517689|NCT03245424|Ivosidenib|ivosidenib|mesh-list
64517691|NCT03245424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517692|NCT03245424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517693|NCT03251040|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64517694|NCT03251040|Hemostatics|hemostatics|mesh-ancestor
64517695|NCT03251040|Coagulants|coagulants|mesh-ancestor
64517696|NCT04754763|Propolis|propolis|mesh-list
64517697|NCT04754763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64517698|NCT02454894|Lidocaine|lidocaine|mesh-list
64517699|NCT02454894|Anesthetics, Local|anesthetics, local|mesh-ancestor
64517700|NCT02454894|Anesthetics|anesthetics|mesh-ancestor
64570442|NCT04393025|Purinergic Agents|purinergic agents|mesh-ancestor
64570443|NCT04393025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64570444|NCT01419067|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64570445|NCT01419067|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64570446|NCT01419067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570448|NCT05580445|Conteltinib|conteltinib|mesh-list
64570449|NCT05580445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64570470|NCT02143219|Irinotecan|irinotecan|mesh-list
64570471|NCT02143219|Oxaliplatin|oxaliplatin|mesh-list
64570472|NCT02143219|Levoleucovorin|levoleucovorin|mesh-list
64570473|NCT02143219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64570474|NCT02143219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64570475|NCT02143219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570476|NCT02143219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570477|NCT02143219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570485|NCT04122911|Temozolomide|temozolomide|mesh-list
64570486|NCT04122911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64570487|NCT04122911|Alkylating Agents|alkylating agents|mesh-ancestor
64570488|NCT04122911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570489|NCT04122911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570491|NCT04122599|Antioxidants|antioxidants|mesh-ancestor
64570492|NCT04122599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570493|NCT04122599|Protective Agents|protective agents|mesh-ancestor
64570494|NCT04122599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630400|NCT02189317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570501|NCT03048474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64570502|NCT03048474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570503|NCT03048474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64570504|NCT03048474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570505|NCT04121975|Endostar protein|endostar protein|mesh-list
64570506|NCT04121975|Endostatins|endostatins|mesh-list
64570507|NCT04121975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570508|NCT04121975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64570509|NCT04121975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64570510|NCT04121975|Growth Substances|growth substances|mesh-ancestor
64570511|NCT04121975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570512|NCT04121975|Growth Inhibitors|growth inhibitors|mesh-ancestor
64570513|NCT02139319|Botulinum Toxins|botulinum toxins|mesh-list
64570559|NCT01476345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570560|NCT04121039|Apatinib|apatinib|mesh-list
64570561|NCT04121039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570562|NCT04121039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64570563|NCT04121039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517701|NCT02454894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64517702|NCT02454894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517703|NCT02454894|Sensory System Agents|sensory system agents|mesh-ancestor
64517704|NCT02454894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517705|NCT02454894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64517706|NCT02454894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64570564|NCT04121039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570565|NCT01401543|Tadalafil|tadalafil|mesh-list
64570566|NCT01401543|Vasodilator Agents|vasodilator agents|mesh-ancestor
64570567|NCT01401543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64570568|NCT01401543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64570569|NCT01401543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570570|NCT01401543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570660|NCT05205252|Autonomic Agents|autonomic agents|mesh-ancestor
64570661|NCT05205252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64570662|NCT05205252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570663|NCT05205252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64570664|NCT05205252|Glucocorticoids|glucocorticoids|mesh-ancestor
64570665|NCT05205252|Hormones|hormones|mesh-ancestor
64570666|NCT05205252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64570667|NCT05205252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64570714|NCT02980835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64570715|NCT02980835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570716|NCT02980835|Anesthetics, Local|anesthetics, local|mesh-ancestor
64570717|NCT02980835|Anesthetics|anesthetics|mesh-ancestor
64570718|NCT02980835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64570719|NCT02980835|Sensory System Agents|sensory system agents|mesh-ancestor
64570720|NCT02980835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64570721|NCT02980835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64570722|NCT02980835|Adrenergic Agents|adrenergic agents|mesh-ancestor
64570723|NCT02980835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64570724|NCT02980835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570725|NCT02980835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64570726|NCT02980835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64570727|NCT02980835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64570859|NCT03825809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64570860|NCT03825809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64570920|NCT03824171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64570922|NCT03824171|Vitamins|vitamins|mesh-ancestor
64570923|NCT03824171|Micronutrients|micronutrients|mesh-ancestor
64570924|NCT03824171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64570925|NCT03824171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64570926|NCT03824171|Hormone Antagonists|hormone antagonists|mesh-ancestor
64570927|NCT03824171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64570928|NCT03824171|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64570929|NCT03824171|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64570930|NCT02079181|Fluorides|fluorides|mesh-list
64570959|NCT01895257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570961|NCT01895257|Vitamins|vitamins|mesh-ancestor
64570962|NCT01895257|Micronutrients|micronutrients|mesh-ancestor
64570963|NCT01895257|Antimetabolites|antimetabolites|mesh-ancestor
64570964|NCT01895257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570965|NCT01895257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64570966|NCT01895257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570967|NCT01895257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64570968|NCT01895257|Immunologic Factors|immunologic factors|mesh-ancestor
64570969|NCT02064673|Curcumin|curcumin|mesh-list
64570970|NCT02064673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64570971|NCT02064673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64570972|NCT02064673|Analgesics|analgesics|mesh-ancestor
64570973|NCT02064673|Sensory System Agents|sensory system agents|mesh-ancestor
64570974|NCT02064673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64570975|NCT02064673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571012|NCT02863991|TIC10 compound|tic10 compound|mesh-list
64571018|NCT02860091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571019|NCT02860091|Sensory System Agents|sensory system agents|mesh-ancestor
64571020|NCT02860091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64571021|NCT02858219|Botulinum Toxins|botulinum toxins|mesh-list
64571022|NCT02858219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64571023|NCT02858219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64571024|NCT02858219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64571025|NCT02858219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64571083|NCT00988247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64571084|NCT00988247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571085|NCT00988247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64571086|NCT00988247|Respiratory System Agents|respiratory system agents|mesh-ancestor
64571087|NCT02832401|Caffeine|caffeine|mesh-list
64571088|NCT02832401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64571089|NCT02832401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571178|NCT04875702|Antimetabolites|antimetabolites|mesh-ancestor
64517712|NCT03250962|Antimetabolites|antimetabolites|mesh-ancestor
64517713|NCT03250962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517714|NCT03250962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64517715|NCT03250962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517716|NCT03245190|Chiauranib|chiauranib|mesh-list
64517717|NCT03245190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64517718|NCT03245190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64571179|NCT04875702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571180|NCT04875702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571181|NCT04875702|Gout Suppressants|gout suppressants|mesh-ancestor
64571182|NCT04875702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64571183|NCT04875702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64454897|NCT01441180|Antimetabolites|antimetabolites|mesh-ancestor
64454898|NCT01441180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454899|NCT01441102|Dextromethorphan|dextromethorphan|mesh-list
64454900|NCT01441102|Antitussive Agents|antitussive agents|mesh-ancestor
64531667|NCT03036566|Lithium Carbonate|lithium carbonate|mesh-list
64531668|NCT03036566|Antidepressive Agents|antidepressive agents|mesh-ancestor
64531669|NCT03036566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64531670|NCT03036566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531671|NCT03036566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531672|NCT03036566|Antimanic Agents|antimanic agents|mesh-ancestor
64531673|NCT03036566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64531674|NCT03036566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64531675|NCT03036566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531676|NCT03010228|Aluminum sulfate|aluminum sulfate|mesh-list
64531677|NCT03010228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64531678|NCT03010228|Immunologic Factors|immunologic factors|mesh-ancestor
64571184|NCT04875702|Antioxidants|antioxidants|mesh-ancestor
64571185|NCT04875702|Protective Agents|protective agents|mesh-ancestor
64571186|NCT04875702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571216|NCT04864314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64571217|NCT04864314|Antioxidants|antioxidants|mesh-ancestor
64571218|NCT04864314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571219|NCT04864314|Protective Agents|protective agents|mesh-ancestor
64571220|NCT04864314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571222|NCT04874844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64571223|NCT04874844|Immunologic Factors|immunologic factors|mesh-ancestor
64571224|NCT04874844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571226|NCT02740985|Durvalumab|durvalumab|mesh-list
64571227|NCT02740985|Abiraterone Acetate|abiraterone acetate|mesh-list
64571228|NCT02740985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571229|NCT02740985|Tubulin Modulators|tubulin modulators|mesh-ancestor
64571230|NCT02740985|Antimitotic Agents|antimitotic agents|mesh-ancestor
64571231|NCT02740985|Mitosis Modulators|mitosis modulators|mesh-ancestor
64586305|NCT00426517|Alemtuzumab|alemtuzumab|mesh-list
64571264|NCT02612064|Cariostatic Agents|cariostatic agents|mesh-ancestor
64571265|NCT02612064|Protective Agents|protective agents|mesh-ancestor
64571266|NCT02612064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571267|NCT04553003|Prednisone|prednisone|mesh-list
64571268|NCT04553003|Methylprednisolone|methylprednisolone|mesh-list
64571269|NCT04553003|Choline|choline|mesh-list
64571270|NCT04553003|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
64571271|NCT04553003|Glucocorticoids|glucocorticoids|mesh-list
64571272|NCT04553003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64571273|NCT04553003|Hormones|hormones|mesh-ancestor
64571358|NCT03821987|Alkylating Agents|alkylating agents|mesh-ancestor
64571469|NCT04391621|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64571470|NCT04391621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64571471|NCT04391621|Glucocorticoids|glucocorticoids|mesh-ancestor
64571472|NCT04391621|Hormones|hormones|mesh-ancestor
64571473|NCT04391621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64571474|NCT04391621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571475|NCT04391621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64517719|NCT03245190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517720|NCT03245190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517721|NCT04774029|Lidocaine|lidocaine|mesh-list
64517722|NCT04774029|Anesthetics, Local|anesthetics, local|mesh-ancestor
64517723|NCT04774029|Anesthetics|anesthetics|mesh-ancestor
64517724|NCT04774029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64517725|NCT04774029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517726|NCT04774029|Sensory System Agents|sensory system agents|mesh-ancestor
64517727|NCT04774029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517728|NCT04774029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64517729|NCT04774029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64517730|NCT04774029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64517731|NCT04774029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64517732|NCT04774029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517733|NCT03245346|Anesthetics|anesthetics|mesh-list
64517734|NCT03245346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64517735|NCT03245346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517737|NCT03244956|Dabrafenib|dabrafenib|mesh-list
64517738|NCT03244956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64517739|NCT03244956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64517740|NCT03244956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517741|NCT03244956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517742|NCT03244488|Mecamylamine|mecamylamine|mesh-list
64517743|NCT03244488|Scopolamine|scopolamine|mesh-list
64517744|NCT03244488|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64517745|NCT03244488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64517746|NCT03244488|Antiemetics|antiemetics|mesh-ancestor
64531679|NCT03010228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531680|NCT03006302|Cyclophosphamide|cyclophosphamide|mesh-list
64531681|NCT03006302|Pembrolizumab|pembrolizumab|mesh-list
64531682|NCT03006302|Immunologic Factors|immunologic factors|mesh-ancestor
64531683|NCT03006302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517747|NCT03244488|Autonomic Agents|autonomic agents|mesh-ancestor
64517748|NCT03244488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517749|NCT03244488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517750|NCT03244488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64517751|NCT03244488|Mydriatics|mydriatics|mesh-ancestor
64517752|NCT03244488|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64517753|NCT03244488|Cholinergic Agents|cholinergic agents|mesh-ancestor
64517754|NCT03244488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64571476|NCT04391621|Immunologic Factors|immunologic factors|mesh-ancestor
64571477|NCT04391621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571478|NCT04391621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571479|NCT01669122|Nicotine|nicotine|mesh-list
64517757|NCT03244488|Parasympatholytics|parasympatholytics|mesh-ancestor
64517758|NCT03244488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64517759|NCT03244488|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
64517760|NCT03244488|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64517762|NCT01969708|Aflibercept|aflibercept|mesh-list
64517763|NCT01969708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64517764|NCT01969708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64517765|NCT01969708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64517766|NCT01969708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64517767|NCT01969708|Growth Substances|growth substances|mesh-ancestor
64517768|NCT01969708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517769|NCT01969708|Growth Inhibitors|growth inhibitors|mesh-ancestor
64517770|NCT03254784|BMS-986165|bms-986165|mesh-list
64517771|NCT03254784|Dermatologic Agents|dermatologic agents|mesh-ancestor
64571529|NCT01450865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64571530|NCT01450865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571532|NCT01308619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64571533|NCT01308619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64571534|NCT01308619|Antimalarials|antimalarials|mesh-ancestor
64571535|NCT01308619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64571536|NCT01308619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64571567|NCT04758689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571568|NCT04758689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64571569|NCT04758689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64630631|NCT00003388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64296235|NCT03303495|Growth Substances|growth substances|mesh-ancestor
64454901|NCT01441102|Respiratory System Agents|respiratory system agents|mesh-ancestor
64571570|NCT04758689|Immunologic Factors|immunologic factors|mesh-ancestor
64571571|NCT04758689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64571572|NCT04758689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64571573|NCT01451333|Efavirenz|efavirenz|mesh-list
64571574|NCT01451333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64571575|NCT01451333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64571576|NCT01451333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571577|NCT01451333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571578|NCT01451333|Antiviral Agents|antiviral agents|mesh-ancestor
64571579|NCT01451333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64571580|NCT01451333|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64571635|NCT05417113|Anesthetics|anesthetics|mesh-ancestor
64571636|NCT05417113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64571637|NCT05417113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571638|NCT05417113|Sensory System Agents|sensory system agents|mesh-ancestor
64571639|NCT05417113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64571640|NCT01452113|Vildagliptin|vildagliptin|mesh-list
64571641|NCT01452113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64571642|NCT01452113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630670|NCT04348370|Immunologic Factors|immunologic factors|mesh-ancestor
64630671|NCT04348370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454902|NCT01441102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64454903|NCT01441102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64454916|NCT04069156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64454917|NCT04069156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64454918|NCT04069156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454919|NCT04069156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64454920|NCT04069156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64454921|NCT04069156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454922|NCT04069156|Antipyretics|antipyretics|mesh-ancestor
64454923|NCT04061980|Nivolumab|nivolumab|mesh-list
64454924|NCT04061980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64454925|NCT04061980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64454926|NCT04061980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64454927|NCT04061980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454928|NCT01467076|Alprostadil|alprostadil|mesh-list
64454929|NCT01467076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64454930|NCT01467076|Vasodilator Agents|vasodilator agents|mesh-ancestor
64454931|NCT01467076|Urological Agents|urological agents|mesh-ancestor
64454932|NCT01466062|Palivizumab|palivizumab|mesh-list
64454933|NCT01466062|Antiviral Agents|antiviral agents|mesh-ancestor
64454934|NCT01466062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64454935|NCT04504864|Aspirin|aspirin|mesh-list
64454936|NCT04504864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64454937|NCT04504864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64454938|NCT04504864|Analgesics|analgesics|mesh-ancestor
64454939|NCT04504864|Sensory System Agents|sensory system agents|mesh-ancestor
64454941|NCT04504864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454942|NCT04504864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64454943|NCT04504864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64454944|NCT04504864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64454945|NCT04504864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64571643|NCT01452113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64571644|NCT01452113|Protease Inhibitors|protease inhibitors|mesh-ancestor
64571645|NCT01452113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571646|NCT01452113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571647|NCT02022709|Fluvoxamine|fluvoxamine|mesh-list
64571648|NCT02022709|Sertraline|sertraline|mesh-list
64571649|NCT02022709|Fluoxetine|fluoxetine|mesh-list
64571650|NCT02022709|Paroxetine|paroxetine|mesh-list
64517773|NCT03254784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517774|NCT03254784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517775|NCT03243864|Ceftazidime|ceftazidime|mesh-list
64517776|NCT03243864|Avibactam|avibactam|mesh-list
64517777|NCT03243864|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
64517778|NCT03243864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64517779|NCT03243864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64517780|NCT03243864|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64517781|NCT03243864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517782|NCT03243864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517783|NCT03250494|Dexamethasone|dexamethasone|mesh-list
64517784|NCT03250494|Dexamethasone acetate|dexamethasone acetate|mesh-list
64517785|NCT03250494|BB 1101|bb 1101|mesh-list
64517786|NCT03250494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64517787|NCT03250494|Antiemetics|antiemetics|mesh-ancestor
64517788|NCT03250494|Autonomic Agents|autonomic agents|mesh-ancestor
64517789|NCT03250494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64630725|NCT00003412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64517790|NCT03250494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454946|NCT04504864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454947|NCT04504864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64454948|NCT04504864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64454949|NCT04504864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454950|NCT04504864|Antipyretics|antipyretics|mesh-ancestor
64454951|NCT04060342|Gemcitabine|gemcitabine|mesh-list
64454952|NCT04060342|Paclitaxel|paclitaxel|mesh-list
64454953|NCT04060342|Pembrolizumab|pembrolizumab|mesh-list
64454954|NCT04060342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64454956|NCT04060342|Tubulin Modulators|tubulin modulators|mesh-ancestor
64454957|NCT04060342|Antimitotic Agents|antimitotic agents|mesh-ancestor
64454958|NCT04060342|Mitosis Modulators|mitosis modulators|mesh-ancestor
64454959|NCT04060342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454960|NCT04060342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64454961|NCT04060342|Antimetabolites|antimetabolites|mesh-ancestor
64454962|NCT04060342|Antiviral Agents|antiviral agents|mesh-ancestor
64454963|NCT04060342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64454964|NCT04060342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454965|NCT04060342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64454966|NCT04060342|Immunologic Factors|immunologic factors|mesh-ancestor
64454982|NCT01435018|Emtricitabine|emtricitabine|mesh-list
64454984|NCT01435018|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64517791|NCT03250494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64517792|NCT03250494|Glucocorticoids|glucocorticoids|mesh-ancestor
64517793|NCT03250494|Hormones|hormones|mesh-ancestor
64517794|NCT03250494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64517795|NCT03250494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64571976|NCT01458041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64571977|NCT01458041|Vasodilator Agents|vasodilator agents|mesh-ancestor
64571979|NCT02610816|Xhance|xhance|mesh-list
64571980|NCT02610816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64571981|NCT02610816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64571982|NCT02610816|Autonomic Agents|autonomic agents|mesh-ancestor
64571983|NCT02610816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64571984|NCT02610816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571985|NCT02610816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64571986|NCT02610816|Respiratory System Agents|respiratory system agents|mesh-ancestor
64571987|NCT02610816|Dermatologic Agents|dermatologic agents|mesh-ancestor
64571988|NCT02610816|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64571989|NCT00332605|Acetylcysteine|acetylcysteine|mesh-list
64571990|NCT00332605|Naltrexone|naltrexone|mesh-list
64571991|NCT00332605|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64571992|NCT00332605|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64571993|NCT00332605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64571994|NCT00332605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571995|NCT00332605|Sensory System Agents|sensory system agents|mesh-ancestor
64571996|NCT00332605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64572029|NCT01458977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572030|NCT01458977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572031|NCT01458977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64572032|NCT01458977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64572033|NCT02508311|Albuterol|albuterol|mesh-list
64572034|NCT02508311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64517799|NCT03250494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517800|NCT03254628|Misoprostol|misoprostol|mesh-list
64517801|NCT03254628|Oxytocin|oxytocin|mesh-list
64517802|NCT03254628|Oxytocics|oxytocics|mesh-ancestor
64517803|NCT03254628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64517804|NCT03254628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517805|NCT03254628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64517806|NCT03254628|Abortifacient Agents|abortifacient agents|mesh-ancestor
64517807|NCT03254628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64572035|NCT02508311|Autonomic Agents|autonomic agents|mesh-ancestor
64572036|NCT02508311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64572037|NCT02508311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572038|NCT02508311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64572099|NCT00198991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572100|NCT00198991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64572101|NCT00198991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64572102|NCT00198991|Alkylating Agents|alkylating agents|mesh-ancestor
64572103|NCT00198991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454985|NCT01435018|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64454986|NCT01435018|Paclitaxel|paclitaxel|mesh-list
64454987|NCT01435018|Etoposide|etoposide|mesh-list
64454988|NCT01435018|Vincristine|vincristine|mesh-list
64454989|NCT01435018|Bleomycin|bleomycin|mesh-list
64454990|NCT01435018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64454991|NCT01435018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64454992|NCT01435018|Tubulin Modulators|tubulin modulators|mesh-ancestor
64454993|NCT01435018|Antimitotic Agents|antimitotic agents|mesh-ancestor
64454994|NCT01435018|Mitosis Modulators|mitosis modulators|mesh-ancestor
64454995|NCT01435018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454996|NCT01435018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64454997|NCT01435018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64454998|NCT01435018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454999|NCT01435018|Antiviral Agents|antiviral agents|mesh-ancestor
64455000|NCT01435018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64455001|NCT01435018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64455002|NCT01435018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64455003|NCT01435018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64455004|NCT01435018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64455005|NCT01435018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64652203|NCT01561703|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64652204|NCT01561703|Cephalexin|cephalexin|mesh-list
64652205|NCT01561703|Cefdinir|cefdinir|mesh-list
64531697|NCT02927249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64531698|NCT02927249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531699|NCT02927249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64531700|NCT02927249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64531701|NCT02927249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64531702|NCT02927249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64531703|NCT02927249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531704|NCT02927249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64531705|NCT02927249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64531706|NCT02927249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531707|NCT02927249|Antipyretics|antipyretics|mesh-ancestor
64531708|NCT02918864|Oxytocin|oxytocin|mesh-list
64531709|NCT02918864|Oxytocics|oxytocics|mesh-ancestor
64714123|NCT00374101|Pantoprazole|pantoprazole|mesh-list
64531715|NCT02890368|Immunoglobulin G|immunoglobulin g|mesh-list
64572104|NCT00198991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572105|NCT00198991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64572106|NCT00198991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64572107|NCT00198991|Antiemetics|antiemetics|mesh-ancestor
64572108|NCT00198991|Autonomic Agents|autonomic agents|mesh-ancestor
64572109|NCT00198991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64572110|NCT00198991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64572111|NCT00198991|Glucocorticoids|glucocorticoids|mesh-ancestor
64572112|NCT00198991|Hormones|hormones|mesh-ancestor
64572113|NCT00198991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64572114|NCT00198991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64517808|NCT03254628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64517809|NCT01970176|Tadalafil|tadalafil|mesh-list
64517810|NCT01970176|Vasodilator Agents|vasodilator agents|mesh-ancestor
64517811|NCT01970176|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64517812|NCT01970176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64517813|NCT01970176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572115|NCT00198991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64572116|NCT00198991|Abortifacient Agents|abortifacient agents|mesh-ancestor
64572117|NCT00198991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64297350|NCT04823403|Nivolumab|nivolumab|mesh-list
64572118|NCT00198991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64572119|NCT00198991|Antimetabolites|antimetabolites|mesh-ancestor
64572120|NCT00198991|Dermatologic Agents|dermatologic agents|mesh-ancestor
64630841|NCT04777838|Adrenergic Agents|adrenergic agents|mesh-ancestor
64630842|NCT00003424|Tamoxifen|tamoxifen|mesh-list
64630843|NCT00003424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64630844|NCT00003424|Hormone Antagonists|hormone antagonists|mesh-ancestor
64630845|NCT00003424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64630846|NCT00003424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630847|NCT00003424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64630848|NCT00003424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630849|NCT00003424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64630850|NCT00003424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64531716|NCT02890368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531717|NCT02890368|Antiviral Agents|antiviral agents|mesh-ancestor
64531718|NCT02890368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64531719|NCT02890368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64531720|NCT02890368|Immunologic Factors|immunologic factors|mesh-ancestor
64572121|NCT00198991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572187|NCT01542255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572188|NCT01542255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572189|NCT01542255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64572190|NCT01542255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64572192|NCT01542255|Antimitotic Agents|antimitotic agents|mesh-ancestor
64572193|NCT01542255|Mitosis Modulators|mitosis modulators|mesh-ancestor
64572194|NCT01456481|Midodrine|midodrine|mesh-list
64572195|NCT01456481|Sympathomimetics|sympathomimetics|mesh-ancestor
64572196|NCT01456481|Autonomic Agents|autonomic agents|mesh-ancestor
64572197|NCT01456481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64572198|NCT01456481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572199|NCT01456481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64572230|NCT04776655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572231|NCT04776655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64572233|NCT04776655|Immunologic Factors|immunologic factors|mesh-ancestor
64572234|NCT04776655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64572235|NCT04776655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64572236|NCT04776655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572237|NCT04776655|Antidotes|antidotes|mesh-ancestor
64572238|NCT04776655|Protective Agents|protective agents|mesh-ancestor
64572239|NCT04776655|Vitamin B Complex|vitamin b complex|mesh-ancestor
64572240|NCT04776655|Vitamins|vitamins|mesh-ancestor
64572241|NCT04776655|Micronutrients|micronutrients|mesh-ancestor
64572242|NCT01455233|Moxifloxacin|moxifloxacin|mesh-list
64572243|NCT01455233|Besifloxacin|besifloxacin|mesh-list
64572244|NCT01455233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64630880|NCT00003004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630881|NCT00003004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64630882|NCT00003004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630883|NCT04776512|Bupivacaine|bupivacaine|mesh-list
64630884|NCT04776512|Anesthetics, Local|anesthetics, local|mesh-ancestor
64630885|NCT04776512|Anesthetics|anesthetics|mesh-ancestor
64630886|NCT04776512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64531721|NCT02890368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531722|NCT02890368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531728|NCT02754141|Nivolumab|nivolumab|mesh-list
64531729|NCT02754141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64531730|NCT02754141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531731|NCT02754141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64586306|NCT00426517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64572508|NCT01421355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64572509|NCT01421355|Protease Inhibitors|protease inhibitors|mesh-ancestor
64572510|NCT01421355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572511|NCT01421355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572512|NCT01421355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64572513|NCT01421355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64572514|NCT01421355|Antiviral Agents|antiviral agents|mesh-ancestor
64572515|NCT01421355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64572516|NCT04844957|Vitamin D|vitamin d|mesh-list
64630920|NCT00003436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64630921|NCT00003436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64572517|NCT04844957|Ergocalciferols|ergocalciferols|mesh-list
64572518|NCT04844957|Cholecalciferol|cholecalciferol|mesh-list
64572519|NCT04844957|Vitamins|vitamins|mesh-list
64572520|NCT04844957|Micronutrients|micronutrients|mesh-ancestor
64572521|NCT04844957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572522|NCT04844957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64572523|NCT04844957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64572524|NCT04782115|RC28-E protein|rc28-e protein|mesh-list
64572525|NCT04782115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64572526|NCT04782115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64572527|NCT04782115|Growth Substances|growth substances|mesh-ancestor
64572528|NCT04782115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572529|NCT04782115|Growth Inhibitors|growth inhibitors|mesh-ancestor
64572555|NCT04848246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64531732|NCT02754141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455010|NCT01435018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64455011|NCT01435018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64455012|NCT01419184|Vancomycin|vancomycin|mesh-list
64455013|NCT01419184|Daptomycin|daptomycin|mesh-list
64455014|NCT01419184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64455015|NCT01419184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64455016|NCT01417156|Nintedanib|nintedanib|mesh-list
64455017|NCT01417156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455018|NCT01417156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64455019|NCT01417156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455020|NCT01417156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455021|NCT01417078|Diazepam|diazepam|mesh-list
64455022|NCT01417078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64455023|NCT01417078|Anticonvulsants|anticonvulsants|mesh-ancestor
64531735|NCT02659059|Carboplatin|carboplatin|mesh-list
64531736|NCT02659059|Nivolumab|nivolumab|mesh-list
64531737|NCT02659059|Pemetrexed|pemetrexed|mesh-list
64531738|NCT02659059|Ipilimumab|ipilimumab|mesh-list
64531739|NCT02659059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64455024|NCT01417078|Antiemetics|antiemetics|mesh-ancestor
64455025|NCT01417078|Autonomic Agents|autonomic agents|mesh-ancestor
64455026|NCT01417078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64455027|NCT01417078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455051|NCT01902134|Narcotics|narcotics|mesh-ancestor
64572556|NCT04848246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64572557|NCT04848246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64572558|NCT04848246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64572559|NCT04848246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517814|NCT01970176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517815|NCT01970176|Urological Agents|urological agents|mesh-ancestor
64517816|NCT02024386|Riociguat|riociguat|mesh-list
64517817|NCT02024386|Enzyme Activators|enzyme activators|mesh-ancestor
64517818|NCT02024386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517819|NCT03250338|Cytarabine|cytarabine|mesh-list
64517820|NCT03250338|Fludarabine|fludarabine|mesh-list
64517821|NCT03250338|Mitoxantrone|mitoxantrone|mesh-list
64517822|NCT03250338|Idarubicin|idarubicin|mesh-list
64517823|NCT03250338|Crenolanib|crenolanib|mesh-list
64517824|NCT03250338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64517825|NCT03250338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64517826|NCT03250338|Antimetabolites|antimetabolites|mesh-ancestor
64517827|NCT03250338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517828|NCT03250338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64572560|NCT04848246|Dopamine Agents|dopamine agents|mesh-ancestor
64572561|NCT04848246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64572562|NCT04848246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572563|NCT04848246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64572564|NCT04848246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64572565|NCT04848246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630963|NCT00003016|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64630964|NCT00003016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64455052|NCT01902134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64455053|NCT01902134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455054|NCT01902134|Analgesics|analgesics|mesh-ancestor
64455055|NCT01902134|Sensory System Agents|sensory system agents|mesh-ancestor
64455056|NCT01902134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64455057|NCT01902134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64455058|NCT01902134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64455059|NCT01902134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64455060|NCT01902134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64455061|NCT01954082|Inositol|inositol|mesh-list
64455071|NCT01417000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64455072|NCT01417000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64455073|NCT01417000|Alkylating Agents|alkylating agents|mesh-ancestor
64455074|NCT01417000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455075|NCT01417000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455076|NCT01417000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64455077|NCT01417000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64455079|NCT01415986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572566|NCT04842071|Listerine|listerine|mesh-list
64572568|NCT04842071|Sodium Fluoride|sodium fluoride|mesh-list
64572569|NCT04842071|Cariostatic Agents|cariostatic agents|mesh-ancestor
64297796|NCT02066077|Propofol|propofol|mesh-list
64572570|NCT04842071|Protective Agents|protective agents|mesh-ancestor
64572571|NCT04842071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572572|NCT04842071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64572573|NCT04842071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64572574|NCT04038619|Loperamide|loperamide|mesh-list
64572575|NCT04038619|Antidiarrheals|antidiarrheals|mesh-list
64572576|NCT04038619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64572577|NCT04774627|Olaparib|olaparib|mesh-list
64572578|NCT04774627|Niraparib|niraparib|mesh-list
64572607|NCT01545141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64572609|NCT01545141|Analgesics|analgesics|mesh-ancestor
64572610|NCT01545141|Sensory System Agents|sensory system agents|mesh-ancestor
64572611|NCT01545141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64572612|NCT01545141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64572613|NCT01545141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64572614|NCT01545141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64572615|NCT01545141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64572616|NCT01545141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572617|NCT01545141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572618|NCT01545141|Interferon Inducers|interferon inducers|mesh-ancestor
64572619|NCT02849639|Scopolamine|scopolamine|mesh-list
64572620|NCT02849639|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64572621|NCT02849639|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64572622|NCT02849639|Antiemetics|antiemetics|mesh-ancestor
64572623|NCT02849639|Autonomic Agents|autonomic agents|mesh-ancestor
64572624|NCT02849639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64572625|NCT02849639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572626|NCT02849639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64572627|NCT02849639|Mydriatics|mydriatics|mesh-ancestor
64572628|NCT02849639|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64572723|NCT04859556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64572724|NCT04859556|Adrenergic Agents|adrenergic agents|mesh-ancestor
64572725|NCT04859556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64455080|NCT01415986|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64455081|NCT01415986|Dermatologic Agents|dermatologic agents|mesh-ancestor
64455082|NCT01415518|Budesonide|budesonide|mesh-list
64455083|NCT01415518|Theophylline|theophylline|mesh-list
64455084|NCT01415518|Formoterol Fumarate|formoterol fumarate|mesh-list
64572726|NCT04859556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572727|NCT04859556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572728|NCT04781335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64517830|NCT03250338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517831|NCT03250338|Antiviral Agents|antiviral agents|mesh-ancestor
64517832|NCT03250338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64517833|NCT03250338|Analgesics|analgesics|mesh-ancestor
64517834|NCT03250338|Sensory System Agents|sensory system agents|mesh-ancestor
64517835|NCT03250338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517836|NCT03250338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64517837|NCT03250338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64517838|NCT03250338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517839|NCT03250338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64517840|NCT01971580|Ambrisentan|ambrisentan|mesh-list
64517841|NCT01971580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64517842|NCT00354562|Docetaxel|docetaxel|mesh-list
64631051|NCT00383890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517843|NCT00354562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64517844|NCT00354562|Tubulin Modulators|tubulin modulators|mesh-ancestor
64517845|NCT00354562|Antimitotic Agents|antimitotic agents|mesh-ancestor
64517846|NCT00354562|Mitosis Modulators|mitosis modulators|mesh-ancestor
64517847|NCT00354562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517848|NCT03250104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64517849|NCT03250104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64517850|NCT00838383|Sitaxsentan|sitaxsentan|mesh-list
64517851|NCT00838383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64631052|NCT00003046|Interleukin-12|interleukin-12|mesh-list
64455096|NCT01415518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64455097|NCT01415518|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64455098|NCT01415518|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64455099|NCT01415518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64455100|NCT01415518|Adrenergic Agents|adrenergic agents|mesh-ancestor
64455101|NCT01415518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64455102|NCT01415518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455103|NCT01415518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64455104|NCT01415518|Cholinergic Agents|cholinergic agents|mesh-ancestor
64455105|NCT01415518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64455106|NCT01415518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455107|NCT01415518|Vasodilator Agents|vasodilator agents|mesh-ancestor
64455108|NCT01415518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64455109|NCT01415518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64455110|NCT01415518|Purinergic Agents|purinergic agents|mesh-ancestor
64455112|NCT01393600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64455113|NCT01393600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64455114|NCT01393600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64517852|NCT00838383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572729|NCT04781335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64572730|NCT04781335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64572731|NCT04781335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64572732|NCT04773301|Ropivacaine|ropivacaine|mesh-list
64572733|NCT04773301|Levobupivacaine|levobupivacaine|mesh-list
64572734|NCT04773301|Anesthetics, Local|anesthetics, local|mesh-ancestor
64572735|NCT04773301|Anesthetics|anesthetics|mesh-ancestor
64572736|NCT04773301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64572820|NCT04855110|Anticoagulants|anticoagulants|mesh-ancestor
64572821|NCT01485393|Dexmedetomidine|dexmedetomidine|mesh-list
64572822|NCT01485393|Zolpidem|zolpidem|mesh-list
64572823|NCT01485393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64572849|NCT04772521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572852|NCT04772287|Vinorelbine|vinorelbine|mesh-list
64572853|NCT04772287|Docetaxel|docetaxel|mesh-list
64572854|NCT04772287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64572855|NCT04772287|Cisplatin|cisplatin|mesh-list
64572856|NCT04772287|Carboplatin|carboplatin|mesh-list
64572857|NCT04772287|Pemetrexed|pemetrexed|mesh-list
64572858|NCT04772287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64572859|NCT04772287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572860|NCT04772287|Tubulin Modulators|tubulin modulators|mesh-ancestor
64572861|NCT04772287|Antimitotic Agents|antimitotic agents|mesh-ancestor
64572862|NCT04772287|Mitosis Modulators|mitosis modulators|mesh-ancestor
64572863|NCT04772287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572864|NCT04772287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64517854|NCT02355886|Analgesics|analgesics|mesh-ancestor
64517855|NCT02355886|Sensory System Agents|sensory system agents|mesh-ancestor
64517856|NCT02355886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517857|NCT02355886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945366|NCT05697783|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64455115|NCT01393600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455116|NCT01393600|Adrenergic Agents|adrenergic agents|mesh-ancestor
64455117|NCT01393600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64455118|NCT01393600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455121|NCT04767178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64531741|NCT02659059|Tubulin Modulators|tubulin modulators|mesh-ancestor
64531742|NCT02659059|Antimitotic Agents|antimitotic agents|mesh-ancestor
64531743|NCT02659059|Mitosis Modulators|mitosis modulators|mesh-ancestor
64531744|NCT02659059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531745|NCT02659059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64531746|NCT02659059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64531747|NCT02659059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531748|NCT02659059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64517858|NCT02355886|Anticonvulsants|anticonvulsants|mesh-ancestor
64517859|NCT02355886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64572865|NCT04772287|Antimetabolites|antimetabolites|mesh-ancestor
64631143|NCT00384436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64572866|NCT04772287|Antiviral Agents|antiviral agents|mesh-ancestor
64572867|NCT04772287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64572868|NCT04772287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572869|NCT04772287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64572870|NCT04772287|Immunologic Factors|immunologic factors|mesh-ancestor
64572871|NCT04772287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572872|NCT04772287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64572904|NCT04854252|Sensory System Agents|sensory system agents|mesh-ancestor
64572905|NCT04854252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64572906|NCT04854252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64572907|NCT04854252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64572909|NCT04854252|Anesthetics|anesthetics|mesh-ancestor
64572910|NCT03040830|Progesterone|progesterone|mesh-list
64572911|NCT03040830|Progestins|progestins|mesh-ancestor
64572913|NCT03040830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64572949|NCT01890863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64572950|NCT01890863|Autonomic Agents|autonomic agents|mesh-ancestor
64572951|NCT01890863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64298172|NCT02076685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64573004|NCT04374474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64631144|NCT00384436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631151|NCT00003562|Carboplatin|carboplatin|mesh-list
64573005|NCT04374474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573006|NCT04374474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64573007|NCT04374474|Respiratory System Agents|respiratory system agents|mesh-ancestor
64573008|NCT04374474|Glucocorticoids|glucocorticoids|mesh-ancestor
64573009|NCT04374474|Hormones|hormones|mesh-ancestor
64586307|NCT00426517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64573070|NCT01427595|Progestins|progestins|mesh-ancestor
64531749|NCT02659059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64531750|NCT02632344|Pembrolizumab|pembrolizumab|mesh-list
64531751|NCT02632344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64531752|NCT02632344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455122|NCT04767178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64455123|NCT04767178|Analgesics|analgesics|mesh-ancestor
64455124|NCT04767178|Sensory System Agents|sensory system agents|mesh-ancestor
64455125|NCT04767178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652226|NCT01839734|Lubiprostone|lubiprostone|mesh-list
64573071|NCT01427595|Hormones|hormones|mesh-ancestor
64573072|NCT01427595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64573073|NCT04390061|Hydroxychloroquine|hydroxychloroquine|mesh-list
64573074|NCT04390061|Tofacitinib|tofacitinib|mesh-list
64573076|NCT04390061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64573077|NCT04390061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64573078|NCT04390061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64573079|NCT04390061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573080|NCT04390061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573081|NCT04390061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64573082|NCT04390061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64573083|NCT01892813|Bupropion|bupropion|mesh-list
64573084|NCT01892813|Nicotine|nicotine|mesh-list
64573144|NCT04753489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573145|NCT04753489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573146|NCT04753489|Anticoagulants|anticoagulants|mesh-ancestor
64573147|NCT04769557|Acetaminophen|acetaminophen|mesh-list
64573148|NCT04769557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64573149|NCT04769557|Analgesics|analgesics|mesh-ancestor
64573150|NCT04769557|Sensory System Agents|sensory system agents|mesh-ancestor
64573151|NCT04769557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573152|NCT04769557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573153|NCT04769557|Antipyretics|antipyretics|mesh-ancestor
64573154|NCT05606497|Dexamethasone|dexamethasone|mesh-list
64573155|NCT05606497|Betamethasone|betamethasone|mesh-list
64573156|NCT05606497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64573157|NCT05606497|Antiemetics|antiemetics|mesh-ancestor
64573158|NCT05606497|Autonomic Agents|autonomic agents|mesh-ancestor
64631186|NCT00003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573212|NCT05606107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573214|NCT00053989|Methylprednisolone|methylprednisolone|mesh-list
64573215|NCT00053989|Cyclophosphamide|cyclophosphamide|mesh-list
64573216|NCT00053989|Fludarabine|fludarabine|mesh-list
64573217|NCT00053989|Fludarabine phosphate|fludarabine phosphate|mesh-list
64573218|NCT00053989|Tacrolimus|tacrolimus|mesh-list
64517860|NCT02355886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64517862|NCT02355886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64517866|NCT02355886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517867|NCT02355886|Antimanic Agents|antimanic agents|mesh-ancestor
64517868|NCT03247413|Dexamethasone|dexamethasone|mesh-list
64517869|NCT03247413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64517870|NCT03247413|Antiemetics|antiemetics|mesh-ancestor
64517871|NCT03247413|Autonomic Agents|autonomic agents|mesh-ancestor
64517872|NCT03247413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517873|NCT03247413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517874|NCT03247413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64517875|NCT03247413|Glucocorticoids|glucocorticoids|mesh-ancestor
64517876|NCT03247413|Hormones|hormones|mesh-ancestor
64517877|NCT03247413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64517878|NCT03247413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64517879|NCT03247413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64517880|NCT02356198|Hydromorphone|hydromorphone|mesh-list
64631221|NCT00003088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64573219|NCT00053989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64573220|NCT00053989|Sargramostim|sargramostim|mesh-list
64573221|NCT00053989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64573223|NCT00053989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573224|NCT00053989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64573225|NCT00053989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64573226|NCT00053989|Alkylating Agents|alkylating agents|mesh-ancestor
64573227|NCT00053989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573228|NCT00053989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573229|NCT00053989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64573230|NCT00053989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64573231|NCT00053989|Antimetabolites|antimetabolites|mesh-ancestor
64573232|NCT00053989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64631222|NCT00003088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64455142|NCT01432600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455143|NCT01432600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455144|NCT01432600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64455145|NCT01432600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64455157|NCT01432600|Growth Inhibitors|growth inhibitors|mesh-ancestor
64455158|NCT01432444|Aripiprazole|aripiprazole|mesh-list
64455159|NCT01432444|Antidepressive Agents|antidepressive agents|mesh-ancestor
64573233|NCT00053989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573234|NCT00053989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64573235|NCT00053989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64573236|NCT00053989|Antitubercular Agents|antitubercular agents|mesh-ancestor
64517881|NCT02356198|Bupivacaine|bupivacaine|mesh-list
64517882|NCT02356198|Anesthetics, Local|anesthetics, local|mesh-ancestor
64517883|NCT02356198|Anesthetics|anesthetics|mesh-ancestor
64517884|NCT02356198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64517885|NCT02356198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517886|NCT02356198|Sensory System Agents|sensory system agents|mesh-ancestor
64517887|NCT02356198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517888|NCT02356198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64517889|NCT02356198|Narcotics|narcotics|mesh-ancestor
64517890|NCT02356198|Analgesics|analgesics|mesh-ancestor
64517891|NCT03254004|Pembrolizumab|pembrolizumab|mesh-list
64517892|NCT03254004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64517893|NCT03254004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64517894|NCT04778865|Vitamin D|vitamin d|mesh-list
64517895|NCT04778865|Ergocalciferols|ergocalciferols|mesh-list
64517896|NCT04778865|Cholecalciferol|cholecalciferol|mesh-list
64517897|NCT04778865|Vitamins|vitamins|mesh-list
64517898|NCT04778865|Micronutrients|micronutrients|mesh-ancestor
64517899|NCT04778865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517900|NCT04778865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64517901|NCT04778865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64517902|NCT02025634|Acetaminophen|acetaminophen|mesh-list
64631262|NCT05358704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64455160|NCT01432444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64455161|NCT01432444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64455162|NCT01432444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64455163|NCT01432444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64455164|NCT01432444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455165|NCT01432444|Dopamine Agonists|dopamine agonists|mesh-ancestor
64455166|NCT01432444|Dopamine Agents|dopamine agents|mesh-ancestor
64455167|NCT01432444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64455168|NCT01432444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455169|NCT01432444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64455170|NCT01432444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64455171|NCT01432444|Serotonin Agents|serotonin agents|mesh-ancestor
64455172|NCT01432444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64455173|NCT01432444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64455174|NCT01432444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64455175|NCT01432444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64455176|NCT01415440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64455177|NCT01415440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64531753|NCT02386800|Panobinostat|panobinostat|mesh-list
64531754|NCT02386800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531755|NCT02386800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64531756|NCT02386800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517903|NCT02025634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64517904|NCT02025634|Analgesics|analgesics|mesh-ancestor
64517905|NCT02025634|Sensory System Agents|sensory system agents|mesh-ancestor
64517906|NCT02025634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517907|NCT02025634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517908|NCT02025634|Antipyretics|antipyretics|mesh-ancestor
64517909|NCT04773951|Antibodies|antibodies|mesh-list
64517910|NCT04773951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64517911|NCT04773951|Immunologic Factors|immunologic factors|mesh-ancestor
64517912|NCT04773951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517913|NCT04773717|Ascorbic Acid|ascorbic acid|mesh-list
64517914|NCT04773717|Antioxidants|antioxidants|mesh-ancestor
64517915|NCT04773717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517916|NCT04773717|Protective Agents|protective agents|mesh-ancestor
64631311|NCT00003130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64631312|NCT00003130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631313|NCT00003130|Tubulin Modulators|tubulin modulators|mesh-ancestor
64631314|NCT00003130|Antimitotic Agents|antimitotic agents|mesh-ancestor
64631315|NCT00003130|Mitosis Modulators|mitosis modulators|mesh-ancestor
64631316|NCT00003130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517918|NCT04773717|Vitamins|vitamins|mesh-ancestor
64517919|NCT04773717|Micronutrients|micronutrients|mesh-ancestor
64517920|NCT04444167|Lenvatinib|lenvatinib|mesh-list
64517921|NCT04444167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64517922|NCT04444167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64517923|NCT04444167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517924|NCT04444167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631317|NCT00058370|Vincristine|vincristine|mesh-list
64631318|NCT00058370|Lomustine|lomustine|mesh-list
64517925|NCT03243006|Acetaminophen|acetaminophen|mesh-list
64631319|NCT00058370|Antibodies|antibodies|mesh-list
64631320|NCT00058370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64531757|NCT02386800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531758|NCT02081378|Niacinamide|niacinamide|mesh-list
64531759|NCT02081378|Imatinib Mesylate|imatinib mesylate|mesh-list
64531760|NCT02081378|Dasatinib|dasatinib|mesh-list
64296316|NCT03308253|Tobramycin|tobramycin|mesh-list
64455178|NCT01415440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455179|NCT01415440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64455180|NCT01415440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64455181|NCT01415440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64455182|NCT01415440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455184|NCT01415440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64455185|NCT01431976|Lamotrigine|lamotrigine|mesh-list
64455194|NCT01431976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64517926|NCT03243006|Tramadol|tramadol|mesh-list
64573237|NCT00053989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64573238|NCT00053989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64573239|NCT00053989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64573240|NCT00053989|Antiemetics|antiemetics|mesh-ancestor
64573241|NCT00053989|Autonomic Agents|autonomic agents|mesh-ancestor
64573270|NCT02713997|Protein C Inhibitor|protein c inhibitor|mesh-list
64573271|NCT02713997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64573272|NCT02713997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64573274|NCT02713997|Sensory System Agents|sensory system agents|mesh-ancestor
64573275|NCT02713997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573276|NCT02713997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573277|NCT02713997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64573278|NCT02713997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64573279|NCT02713997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64573280|NCT02713997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64573281|NCT02713997|Immunologic Factors|immunologic factors|mesh-ancestor
64573282|NCT02713997|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64573283|NCT02713997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64573284|NCT02713997|Protease Inhibitors|protease inhibitors|mesh-ancestor
64573285|NCT02713997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573286|NCT02713997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573398|NCT03040752|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64573399|NCT03040752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64573432|NCT03038958|Sensory System Agents|sensory system agents|mesh-ancestor
64573433|NCT03038958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573434|NCT04840290|Paclitaxel|paclitaxel|mesh-list
64573435|NCT04840290|Carboplatin|carboplatin|mesh-list
64573436|NCT04840290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64573437|NCT04840290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573438|NCT04840290|Tubulin Modulators|tubulin modulators|mesh-ancestor
64573471|NCT01431573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64573472|NCT01431573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573473|NCT01431573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573474|NCT01431573|Antimanic Agents|antimanic agents|mesh-ancestor
64631350|NCT00062738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64455195|NCT01431976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64455196|NCT01431976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64455198|NCT01413958|Phenylephrine|phenylephrine|mesh-list
64631388|NCT00064844|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64573475|NCT01431573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64573476|NCT01431573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64573477|NCT01431573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573478|NCT04843644|Propolis|propolis|mesh-list
64573479|NCT04843644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64573480|NCT02588105|Leucovorin|leucovorin|mesh-list
64573481|NCT02588105|Folic Acid|folic acid|mesh-list
64573530|NCT01490073|Vasodilator Agents|vasodilator agents|mesh-ancestor
64573531|NCT04839666|Propofol|propofol|mesh-list
64573532|NCT04839666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64573533|NCT04839666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64573534|NCT04839666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573535|NCT04839666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64573536|NCT04839666|Anesthetics, General|anesthetics, general|mesh-ancestor
64573537|NCT04839666|Anesthetics|anesthetics|mesh-ancestor
64573538|NCT03008109|Endostatins|endostatins|mesh-list
64573539|NCT03008109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573540|NCT03008109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64573541|NCT03008109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64517929|NCT03243006|Sensory System Agents|sensory system agents|mesh-ancestor
64517930|NCT03243006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517931|NCT03243006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517932|NCT03243006|Antipyretics|antipyretics|mesh-ancestor
64517933|NCT03243006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64517934|NCT03243006|Narcotics|narcotics|mesh-ancestor
64517935|NCT03243006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64517936|NCT03249402|Levonorgestrel|levonorgestrel|mesh-list
64573542|NCT03008109|Growth Substances|growth substances|mesh-ancestor
64573543|NCT03008109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573544|NCT03008109|Growth Inhibitors|growth inhibitors|mesh-ancestor
64573545|NCT02562443|ON 01910|on 01910|mesh-list
64573546|NCT02562443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573547|NCT02562443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64573548|NCT02562443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573549|NCT02562443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573550|NCT04843098|Paclitaxel|paclitaxel|mesh-list
64573551|NCT04843098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64455199|NCT01413958|Oxymetazoline|oxymetazoline|mesh-list
64631425|NCT05174312|Natriuretic Agents|natriuretic agents|mesh-ancestor
64573553|NCT04843098|Tubulin Modulators|tubulin modulators|mesh-ancestor
64573554|NCT04843098|Antimitotic Agents|antimitotic agents|mesh-ancestor
64573555|NCT04843098|Mitosis Modulators|mitosis modulators|mesh-ancestor
64573556|NCT04843098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573557|NCT01490931|Ketorolac|ketorolac|mesh-list
64573558|NCT01490931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64573587|NCT01491633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64573588|NCT01491633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573589|NCT01491633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573590|NCT01433913|Metformin|metformin|mesh-list
64573591|NCT01433913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64573592|NCT01433913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573593|NCT02535533|Selenium|selenium|mesh-list
64573594|NCT02535533|Axitinib|axitinib|mesh-list
64573595|NCT02535533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573596|NCT02535533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64573597|NCT02535533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573598|NCT02535533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573599|NCT02535533|Antioxidants|antioxidants|mesh-ancestor
64573600|NCT02535533|Protective Agents|protective agents|mesh-ancestor
64573601|NCT02535533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573602|NCT02535533|Trace Elements|trace elements|mesh-ancestor
64573603|NCT02535533|Micronutrients|micronutrients|mesh-ancestor
64573604|NCT04839198|Nicotine|nicotine|mesh-list
64573761|NCT03038334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64573762|NCT03038334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64573763|NCT03038334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573764|NCT03038334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64573765|NCT03038334|Tocolytic Agents|tocolytic agents|mesh-ancestor
64573766|NCT03038334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64573767|NCT01441245|Furosemide|furosemide|mesh-list
64573768|NCT01441245|Diuretics|diuretics|mesh-ancestor
64573769|NCT01441245|Natriuretic Agents|natriuretic agents|mesh-ancestor
64631426|NCT05174312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573770|NCT01441245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573771|NCT01441245|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64573772|NCT01441245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64573773|NCT01441245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573774|NCT02298257|Doxorubicin|doxorubicin|mesh-list
64573775|NCT02298257|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64573776|NCT02298257|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64573777|NCT02298257|Dacarbazine|dacarbazine|mesh-list
64573778|NCT02298257|Vinblastine|vinblastine|mesh-list
64573779|NCT02298257|Antibodies|antibodies|mesh-list
64573780|NCT02298257|Immunoglobulins|immunoglobulins|mesh-list
64517937|NCT03249402|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64517938|NCT03249402|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64517939|NCT03249402|Estradiol|estradiol|mesh-list
64517940|NCT03249402|Estrogens|estrogens|mesh-ancestor
64517941|NCT03249402|Hormones|hormones|mesh-ancestor
64517942|NCT03249402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64517943|NCT03249402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517944|NCT03249402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64517945|NCT03249402|Contraceptive Agents|contraceptive agents|mesh-ancestor
64517946|NCT03249402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64517947|NCT03249402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64517948|NCT03249402|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64517949|NCT03249402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64517950|NCT03249402|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64517951|NCT03249402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64517952|NCT03242460|Dexamethasone|dexamethasone|mesh-list
64517953|NCT03242460|Cyclophosphamide|cyclophosphamide|mesh-list
64517954|NCT03242460|Pomalidomide|pomalidomide|mesh-list
64517955|NCT03242460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64517956|NCT03242460|Immunologic Factors|immunologic factors|mesh-ancestor
64517957|NCT03242460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517958|NCT03242460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64573781|NCT02298257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64573782|NCT02298257|Immunoconjugates|immunoconjugates|mesh-list
64573783|NCT02298257|Immunologic Factors|immunologic factors|mesh-ancestor
64455200|NCT01413958|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64455201|NCT01413958|Mydriatics|mydriatics|mesh-ancestor
64455202|NCT01413958|Autonomic Agents|autonomic agents|mesh-ancestor
64455203|NCT01413958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64455204|NCT01413958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455205|NCT01413958|Sympathomimetics|sympathomimetics|mesh-ancestor
64455206|NCT01413958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64455207|NCT01413958|Nasal Decongestants|nasal decongestants|mesh-ancestor
64455220|NCT01413958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64573784|NCT02298257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573785|NCT02298257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64573786|NCT02298257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573787|NCT02298257|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64573788|NCT02298257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64573789|NCT02298257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573851|NCT01441401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64573852|NCT01441401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64573853|NCT01441401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64631507|NCT00003610|Dermatologic Agents|dermatologic agents|mesh-ancestor
64631508|NCT00003610|Sensory System Agents|sensory system agents|mesh-ancestor
64573854|NCT01441401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64573855|NCT01441401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64573919|NCT03060473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573920|NCT03060473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573922|NCT03039426|Bupivacaine|bupivacaine|mesh-list
64573923|NCT03039426|Anesthetics, Local|anesthetics, local|mesh-ancestor
64573924|NCT03039426|Anesthetics|anesthetics|mesh-ancestor
64573925|NCT03039426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64573926|NCT03039426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573927|NCT03039426|Sensory System Agents|sensory system agents|mesh-ancestor
64573928|NCT03039426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573929|NCT03039426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64573930|NCT03039426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64573931|NCT03039426|Analgesics|analgesics|mesh-ancestor
64573932|NCT03039426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64573933|NCT03039426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64573934|NCT03039426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64573935|NCT03039426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517959|NCT03242460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64517960|NCT03242460|Alkylating Agents|alkylating agents|mesh-ancestor
64517961|NCT03242460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517962|NCT03242460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64517963|NCT03242460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64517964|NCT03242460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64517965|NCT03242460|Antiemetics|antiemetics|mesh-ancestor
64517967|NCT03242460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517968|NCT03242460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64517969|NCT03242460|Glucocorticoids|glucocorticoids|mesh-ancestor
64517970|NCT03242460|Hormones|hormones|mesh-ancestor
64517971|NCT03242460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64517972|NCT03242460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64517973|NCT03242460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64517974|NCT03242460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64517975|NCT03242460|Growth Substances|growth substances|mesh-ancestor
64517976|NCT03242460|Growth Inhibitors|growth inhibitors|mesh-ancestor
64517977|NCT03242616|Pemetrexed|pemetrexed|mesh-list
64517978|NCT03242616|Vinorelbine|vinorelbine|mesh-list
64517979|NCT03242616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64517980|NCT03242616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517981|NCT03242616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517982|NCT03242616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64573936|NCT03039426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573938|NCT02205515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573939|NCT02205515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64573968|NCT01447017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64573969|NCT01447017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64455221|NCT01413958|Histamine Antagonists|histamine antagonists|mesh-ancestor
64455222|NCT01413958|Histamine Agents|histamine agents|mesh-ancestor
64455223|NCT01413178|Melphalan|melphalan|mesh-list
64455224|NCT01413178|Busulfan|busulfan|mesh-list
64455225|NCT01413178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64455226|NCT01413178|Alkylating Agents|alkylating agents|mesh-ancestor
64455227|NCT01413178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455228|NCT01413178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455229|NCT01413178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64455230|NCT01413178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64455231|NCT01413178|Immunologic Factors|immunologic factors|mesh-ancestor
64455232|NCT01413178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455233|NCT01412944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64455234|NCT01412944|Immunologic Factors|immunologic factors|mesh-ancestor
64455235|NCT01412944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455236|NCT03025906|Valproic Acid|valproic acid|mesh-list
64455237|NCT03025906|Phenobarbital|phenobarbital|mesh-list
64455238|NCT03025906|Anticonvulsants|anticonvulsants|mesh-ancestor
64455239|NCT03025906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455240|NCT03025906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455241|NCT03025906|GABA Agents|gaba agents|mesh-ancestor
64455242|NCT03025906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64455243|NCT03025906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455244|NCT03025906|Antimanic Agents|antimanic agents|mesh-ancestor
64455245|NCT03025906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64455246|NCT03025906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64455247|NCT03025906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64455248|NCT03025906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64531762|NCT02081378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64531763|NCT02081378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531764|NCT02081378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573970|NCT01894295|Vitamin D|vitamin d|mesh-list
64573971|NCT01894295|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
64573972|NCT01894295|Vitamins|vitamins|mesh-ancestor
64573973|NCT01894295|Micronutrients|micronutrients|mesh-ancestor
64573974|NCT01894295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573975|NCT01894295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64573976|NCT02169089|Spironolactone|spironolactone|mesh-list
64573977|NCT02169089|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64573978|NCT02169089|Hormone Antagonists|hormone antagonists|mesh-ancestor
64573979|NCT02169089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64573980|NCT02169089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573981|NCT02169089|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64573982|NCT02169089|Diuretics|diuretics|mesh-ancestor
64573983|NCT02169089|Natriuretic Agents|natriuretic agents|mesh-ancestor
64573984|NCT04788186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64573985|NCT04788186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64574014|NCT02140151|Ranibizumab|ranibizumab|mesh-list
64574015|NCT02140151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64574016|NCT02140151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64574017|NCT02140151|Growth Substances|growth substances|mesh-ancestor
64517983|NCT03242616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64517984|NCT03242616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64517985|NCT03242616|Tubulin Modulators|tubulin modulators|mesh-ancestor
64517987|NCT03242616|Mitosis Modulators|mitosis modulators|mesh-ancestor
64631599|NCT00003160|Tubulin Modulators|tubulin modulators|mesh-ancestor
64531765|NCT02081378|Vitamin B Complex|vitamin b complex|mesh-ancestor
64531766|NCT02081378|Vitamins|vitamins|mesh-ancestor
64531767|NCT02081378|Micronutrients|micronutrients|mesh-ancestor
64531768|NCT02081378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531769|NCT01997840|Dexamethasone|dexamethasone|mesh-list
64296324|NCT02467023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64455249|NCT03025906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64455250|NCT03025906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64455251|NCT03025906|GABA Modulators|gaba modulators|mesh-ancestor
64455252|NCT03025906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64455253|NCT03025906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64455254|NCT03025906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64455289|NCT01797081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64455290|NCT01797081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455291|NCT01797081|Cholinergic Agents|cholinergic agents|mesh-ancestor
64455292|NCT01797081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64455293|NCT01797081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455294|NCT01797081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64455295|NCT01797081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64455296|NCT01794117|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64455297|NCT01794117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64455299|NCT01765569|Digoxin|digoxin|mesh-list
64455300|NCT01765569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64455301|NCT01765569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64517988|NCT01748825|Adavosertib|adavosertib|mesh-list
64517989|NCT01748825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517990|NCT01748825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517991|NCT05605587|Leflunomide|leflunomide|mesh-list
64517992|NCT05605587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517993|NCT05605587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574018|NCT02140151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574019|NCT02140151|Growth Inhibitors|growth inhibitors|mesh-ancestor
64574020|NCT02140151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574022|NCT02135315|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64574023|NCT02135315|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64574024|NCT02135315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64574025|NCT02135315|Diuretics|diuretics|mesh-ancestor
64574026|NCT02135315|Natriuretic Agents|natriuretic agents|mesh-ancestor
64574027|NCT02135315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574028|NCT02135315|Vasodilator Agents|vasodilator agents|mesh-ancestor
64574029|NCT02135315|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64574030|NCT02135315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574032|NCT02117297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64574033|NCT02117297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574067|NCT02113553|Contraceptive Agents|contraceptive agents|mesh-ancestor
64574068|NCT02113553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64574069|NCT02113553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574070|NCT02113553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64574071|NCT02113553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64574072|NCT02113553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574074|NCT02101775|Adavosertib|adavosertib|mesh-list
64574109|NCT04274933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574121|NCT02603952|Oseltamivir|oseltamivir|mesh-list
64574122|NCT02603952|MEDI8852|medi8852|mesh-list
64574123|NCT02603952|Antiviral Agents|antiviral agents|mesh-ancestor
64631651|NCT00002812|Antimitotic Agents|antimitotic agents|mesh-ancestor
64574124|NCT02603952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64574125|NCT02603952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64574153|NCT01501929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574158|NCT01501929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64574159|NCT01501929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574160|NCT01501929|Vasodilator Agents|vasodilator agents|mesh-ancestor
64574161|NCT01501929|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64574162|NCT01501929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64574163|NCT01501929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64574164|NCT05618496|Hyaluronic Acid|hyaluronic acid|mesh-list
64574165|NCT05618496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64574166|NCT05618496|Immunologic Factors|immunologic factors|mesh-ancestor
64574167|NCT05618496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631689|NCT00003172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574168|NCT05618496|Viscosupplements|viscosupplements|mesh-ancestor
64574169|NCT05618496|Protective Agents|protective agents|mesh-ancestor
64574170|NCT02049593|Irinotecan|irinotecan|mesh-list
64574171|NCT02049593|Temozolomide|temozolomide|mesh-list
64574252|NCT01517243|Growth Inhibitors|growth inhibitors|mesh-ancestor
64574253|NCT01517243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64574254|NCT01517243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64574255|NCT01517243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574256|NCT01517243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64574257|NCT01517243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64455302|NCT01765569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455303|NCT01765569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455304|NCT01765569|Protective Agents|protective agents|mesh-ancestor
64455305|NCT01765569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455306|NCT01765569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455307|NCT01765569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64455308|NCT04414605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64455309|NCT04414605|Immunologic Factors|immunologic factors|mesh-ancestor
64455310|NCT04414605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531770|NCT01997840|Dexamethasone acetate|dexamethasone acetate|mesh-list
64531771|NCT01997840|Pomalidomide|pomalidomide|mesh-list
64652256|NCT01837394|Antiemetics|antiemetics|mesh-ancestor
64652257|NCT01837394|Autonomic Agents|autonomic agents|mesh-ancestor
64531782|NCT01997840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64531783|NCT01997840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64531784|NCT01997840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531785|NCT01997840|Protease Inhibitors|protease inhibitors|mesh-ancestor
64531786|NCT01997840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531787|NCT01997840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531788|NCT01997840|Immunologic Factors|immunologic factors|mesh-ancestor
64531789|NCT01997840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64531790|NCT01997840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64531791|NCT01997840|Growth Substances|growth substances|mesh-ancestor
64531792|NCT01997840|Growth Inhibitors|growth inhibitors|mesh-ancestor
64531793|NCT01997840|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64296334|NCT02467023|Narcotics|narcotics|mesh-ancestor
64455311|NCT01609023|Rituximab|rituximab|mesh-list
64455312|NCT01609023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64455313|NCT01609023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455314|NCT01609023|Immunologic Factors|immunologic factors|mesh-ancestor
64455315|NCT01609023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455316|NCT01609023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64631743|NCT00003640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517995|NCT05605587|Immunologic Factors|immunologic factors|mesh-ancestor
64517996|NCT05605587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517997|NCT03253224|Magnesium Sulfate|magnesium sulfate|mesh-list
64517998|NCT03253224|Analgesics|analgesics|mesh-ancestor
64517999|NCT03253224|Sensory System Agents|sensory system agents|mesh-ancestor
64518000|NCT03253224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64518001|NCT03253224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518002|NCT03253224|Anesthetics|anesthetics|mesh-ancestor
64518003|NCT03253224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64518004|NCT03253224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64518005|NCT03253224|Anticonvulsants|anticonvulsants|mesh-ancestor
64518006|NCT03253224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64518007|NCT03253224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64518008|NCT03253224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574258|NCT01517243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64574259|NCT01517243|Antifungal Agents|antifungal agents|mesh-ancestor
64574260|NCT01517243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64455317|NCT01765179|Methyltestosterone|methyltestosterone|mesh-list
64455318|NCT01765179|Testosterone|testosterone|mesh-list
64455319|NCT01765179|Testosterone undecanoate|testosterone undecanoate|mesh-list
64455320|NCT01765179|Testosterone enanthate|testosterone enanthate|mesh-list
64455321|NCT01765179|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64455322|NCT01765179|Androgens|androgens|mesh-ancestor
64455323|NCT01765179|Hormones|hormones|mesh-ancestor
64455324|NCT01765179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64455325|NCT01765179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455326|NCT01765179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64455327|NCT01765179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455328|NCT01765179|Anabolic Agents|anabolic agents|mesh-ancestor
64455329|NCT01793883|Laninamivir|laninamivir|mesh-list
64455330|NCT01793883|Zanamivir|zanamivir|mesh-list
64455331|NCT01793883|Antiviral Agents|antiviral agents|mesh-ancestor
64455343|NCT01953692|Growth Substances|growth substances|mesh-ancestor
64455344|NCT01953692|Growth Inhibitors|growth inhibitors|mesh-ancestor
64455345|NCT01791153|Prednisone|prednisone|mesh-list
64455346|NCT01791153|Methotrexate|methotrexate|mesh-list
64531795|NCT01853826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531796|NCT01853826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64531797|NCT01853826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531798|NCT01853826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531799|NCT01505569|Etoposide|etoposide|mesh-list
64531800|NCT01505569|Carboplatin|carboplatin|mesh-list
64531801|NCT01505569|Melphalan|melphalan|mesh-list
64531802|NCT01505569|Busulfan|busulfan|mesh-list
64531803|NCT01505569|Ifosfamide|ifosfamide|mesh-list
64531804|NCT01505569|Thiotepa|thiotepa|mesh-list
64531805|NCT01505569|Lenograstim|lenograstim|mesh-list
64531806|NCT01505569|Mesna|mesna|mesh-list
64531807|NCT01505569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64531808|NCT01505569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531809|NCT01505569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531810|NCT01505569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64531811|NCT01505569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64531812|NCT01505569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531813|NCT01505569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64531814|NCT01505569|Alkylating Agents|alkylating agents|mesh-ancestor
64455350|NCT01791153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64574261|NCT01517243|Immunologic Factors|immunologic factors|mesh-ancestor
64574262|NCT00055237|Bevacizumab|bevacizumab|mesh-list
64574263|NCT00055237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64574264|NCT00055237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574265|NCT00055237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64574266|NCT00055237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64574267|NCT00055237|Growth Substances|growth substances|mesh-ancestor
64574268|NCT00055237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574269|NCT00055237|Growth Inhibitors|growth inhibitors|mesh-ancestor
64574270|NCT04836156|Cyclophosphamide|cyclophosphamide|mesh-list
64574325|NCT01502787|Protease Inhibitors|protease inhibitors|mesh-ancestor
64574326|NCT01502787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64574327|NCT04363164|Methyltestosterone|methyltestosterone|mesh-list
64574328|NCT04363164|Testosterone|testosterone|mesh-list
64574329|NCT04363164|Testosterone undecanoate|testosterone undecanoate|mesh-list
64574330|NCT04363164|Testosterone enanthate|testosterone enanthate|mesh-list
64574331|NCT04363164|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64574332|NCT04363164|Androgens|androgens|mesh-ancestor
64574333|NCT04363164|Hormones|hormones|mesh-ancestor
64574334|NCT04363164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64574335|NCT04363164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574336|NCT04363164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64574337|NCT04363164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455351|NCT01791153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455352|NCT01791153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64455353|NCT01791153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455354|NCT01791153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64455355|NCT01791153|Abortifacient Agents|abortifacient agents|mesh-ancestor
64455356|NCT01791153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64455357|NCT01791153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64455358|NCT01791153|Antimetabolites|antimetabolites|mesh-ancestor
64455359|NCT01791153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455360|NCT01791153|Dermatologic Agents|dermatologic agents|mesh-ancestor
64455361|NCT01791153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455362|NCT01791153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64455363|NCT01791153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64455364|NCT01791153|Immunologic Factors|immunologic factors|mesh-ancestor
64455365|NCT01791153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64455366|NCT01791153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64455367|NCT01926782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64455368|NCT01926782|Immunologic Factors|immunologic factors|mesh-ancestor
64455369|NCT01926782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455370|NCT01926626|Moclobemide|moclobemide|mesh-list
64455372|NCT01926626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64455373|NCT01926626|Autonomic Agents|autonomic agents|mesh-ancestor
64455374|NCT01926626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64531819|NCT01505569|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64531820|NCT01505569|Protective Agents|protective agents|mesh-ancestor
64531821|NCT01500551|Tofacitinib|tofacitinib|mesh-list
64531822|NCT01500551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64531823|NCT01500551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531824|NCT01500551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574338|NCT04363164|Anabolic Agents|anabolic agents|mesh-ancestor
64574339|NCT04829916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64574340|NCT04835922|Anesthetics|anesthetics|mesh-list
64631854|NCT00003658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64574341|NCT04835922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64574342|NCT04835922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574343|NCT00153985|Fludarabine|fludarabine|mesh-list
64574344|NCT00153985|Alemtuzumab|alemtuzumab|mesh-list
64574345|NCT00153985|Busulfan|busulfan|mesh-list
64574346|NCT00153985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574347|NCT00153985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574348|NCT00153985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64574440|NCT01576809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64574441|NCT01576809|Nasal Decongestants|nasal decongestants|mesh-ancestor
64574442|NCT01576809|Respiratory System Agents|respiratory system agents|mesh-ancestor
64574443|NCT01576809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64574444|NCT01576809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64574479|NCT00161473|Adrenergic Agents|adrenergic agents|mesh-ancestor
64574480|NCT00161473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64518009|NCT03253224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64631855|NCT00003658|Immunologic Factors|immunologic factors|mesh-ancestor
64531825|NCT02375178|Biguanides|biguanides|mesh-list
64531826|NCT02375178|Chlorhexidine|chlorhexidine|mesh-list
64531827|NCT02375178|Polihexanide|polihexanide|mesh-list
64531828|NCT02375178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64531829|NCT02375178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64531830|NCT02375178|Disinfectants|disinfectants|mesh-ancestor
64531831|NCT02375178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64531832|NCT02375178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484203|NCT01730053|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64531833|NCT02375100|Acetaminophen|acetaminophen|mesh-list
64531834|NCT02375100|Tramadol|tramadol|mesh-list
64531835|NCT02375100|Analgesics|analgesics|mesh-list
64531836|NCT02375100|Bupivacaine|bupivacaine|mesh-list
64531837|NCT02375100|Anesthetics, Local|anesthetics, local|mesh-ancestor
64531838|NCT02375100|Anesthetics|anesthetics|mesh-ancestor
64531839|NCT02375100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64531840|NCT02375100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296379|NCT02058433|Paclitaxel|paclitaxel|mesh-list
64455375|NCT01926626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455376|NCT01926626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64455377|NCT01926626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64455378|NCT01926626|Cholinergic Agents|cholinergic agents|mesh-ancestor
64455379|NCT01926626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64455380|NCT01926626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455381|NCT01926626|Antidepressive Agents|antidepressive agents|mesh-ancestor
64455382|NCT01926626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64455383|NCT01926626|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64455384|NCT01926626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455385|NCT01900730|Valproic Acid|valproic acid|mesh-list
64455386|NCT01900730|Anticonvulsants|anticonvulsants|mesh-ancestor
64455387|NCT01900730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652290|NCT01837628|Emollients|emollients|mesh-ancestor
64455420|NCT01431274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455421|NCT01431274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64455422|NCT01431274|Respiratory System Agents|respiratory system agents|mesh-ancestor
64518011|NCT03253224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64518012|NCT00789399|PENTA|penta|mesh-list
64518013|NCT00789399|Fondaparinux|fondaparinux|mesh-list
64518014|NCT00789399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64518015|NCT00789399|Antithrombins|antithrombins|mesh-ancestor
64518016|NCT00789399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64518017|NCT00789399|Protease Inhibitors|protease inhibitors|mesh-ancestor
64518018|NCT00789399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518019|NCT00789399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518020|NCT00789399|Anticoagulants|anticoagulants|mesh-ancestor
64518021|NCT00789399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64518022|NCT00789399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64518023|NCT01720667|Levetiracetam|levetiracetam|mesh-list
64518024|NCT01720667|Phenobarbital|phenobarbital|mesh-list
64518025|NCT01720667|Anticonvulsants|anticonvulsants|mesh-ancestor
64518026|NCT01720667|Nootropic Agents|nootropic agents|mesh-ancestor
64518027|NCT01720667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64518028|NCT01720667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64518029|NCT01720667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518030|NCT01720667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64518036|NCT01720667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64518037|NCT01720667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64518038|NCT01720667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64518039|NCT04773093|Lidocaine|lidocaine|mesh-list
64518040|NCT04773093|Anesthetics, Local|anesthetics, local|mesh-ancestor
64518041|NCT04773093|Anesthetics|anesthetics|mesh-ancestor
64518042|NCT04773093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64518043|NCT04773093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518044|NCT04773093|Sensory System Agents|sensory system agents|mesh-ancestor
64518045|NCT04773093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64518046|NCT04773093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64574481|NCT00161473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574482|NCT00161473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574483|NCT01319981|Cytarabine|cytarabine|mesh-list
64574484|NCT01319981|Dexamethasone|dexamethasone|mesh-list
64574485|NCT01319981|Methylprednisolone|methylprednisolone|mesh-list
64574552|NCT00065611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64574553|NCT00065611|Glucocorticoids|glucocorticoids|mesh-ancestor
64574555|NCT00065611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64518050|NCT04773093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518052|NCT01720043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518053|NCT02455362|Morphine|morphine|mesh-list
64574556|NCT00065611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64574557|NCT00065611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574558|NCT00066781|Gemcitabine|gemcitabine|mesh-list
64631951|NCT02308202|Perindopril|perindopril|mesh-list
64574559|NCT00066781|Irinotecan|irinotecan|mesh-list
64574560|NCT00066781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64574561|NCT00066781|Antimetabolites|antimetabolites|mesh-ancestor
64574562|NCT00066781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574563|NCT00066781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574564|NCT00066781|Antiviral Agents|antiviral agents|mesh-ancestor
64574565|NCT00066781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64574579|NCT01189643|Growth Substances|growth substances|mesh-ancestor
64574580|NCT01189643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574581|NCT01189643|Growth Inhibitors|growth inhibitors|mesh-ancestor
64574582|NCT01189643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64574583|NCT01189643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64574584|NCT01189643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64574585|NCT01189643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574586|NCT01189643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64574587|NCT01189643|Alkylating Agents|alkylating agents|mesh-ancestor
64574588|NCT01431755|Lidocaine|lidocaine|mesh-list
64574589|NCT01431755|Hyaluronic Acid|hyaluronic acid|mesh-list
64574591|NCT01431755|Anesthetics|anesthetics|mesh-ancestor
64574611|NCT00066937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64574612|NCT00066937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64586308|NCT00426517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64574645|NCT01061411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64574647|NCT01061411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574648|NCT01061411|Growth Inhibitors|growth inhibitors|mesh-ancestor
64574649|NCT01061411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64574650|NCT01061411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64574651|NCT01061411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574652|NCT01061411|Anticoagulants|anticoagulants|mesh-ancestor
64574653|NCT01061411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64574889|NCT04834752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574890|NCT04834752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64574891|NCT04834752|Histamine Antagonists|histamine antagonists|mesh-ancestor
64574892|NCT04834752|Histamine Agents|histamine agents|mesh-ancestor
64574916|NCT04198727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631987|NCT03233204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64574918|NCT00437255|Betamethasone|betamethasone|mesh-list
64574919|NCT00437255|Betamethasone Valerate|betamethasone valerate|mesh-list
64574920|NCT00437255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64574921|NCT00437255|Betamethasone benzoate|betamethasone benzoate|mesh-list
64574922|NCT00437255|Clobetasol|clobetasol|mesh-list
64574923|NCT00437255|Calcipotriene|calcipotriene|mesh-list
64574924|NCT00437255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64574925|NCT00437255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64518064|NCT03253068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64518065|NCT03253068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518066|NCT04772781|Ibuprofen|ibuprofen|mesh-list
64518067|NCT04772781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64518068|NCT04772781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64518069|NCT04772781|Analgesics|analgesics|mesh-ancestor
64518070|NCT04772781|Sensory System Agents|sensory system agents|mesh-ancestor
64518071|NCT04772781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64518072|NCT04772781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518073|NCT04772781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64518074|NCT04772781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64518075|NCT04772781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64518076|NCT04772781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518077|NCT04772781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518083|NCT01718483|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64455423|NCT01431274|Parasympatholytics|parasympatholytics|mesh-ancestor
64531842|NCT02375100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64531843|NCT02375100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64531844|NCT02375100|Antipyretics|antipyretics|mesh-ancestor
64531845|NCT02375100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64531846|NCT02375100|Narcotics|narcotics|mesh-ancestor
64531847|NCT02364258|Atorvastatin|atorvastatin|mesh-list
64531848|NCT02364258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64531849|NCT02364258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64455424|NCT01431274|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64455425|NCT01431274|Cholinergic Agents|cholinergic agents|mesh-ancestor
64455426|NCT01431274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64455427|NCT01431274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455428|NCT01991795|Ticagrelor|ticagrelor|mesh-list
64455429|NCT01991795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64518084|NCT01718483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64518085|NCT01718483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518086|NCT01718483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64518087|NCT01718483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64518088|NCT01718483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64518089|NCT01718483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518090|NCT01718483|Dopamine Agents|dopamine agents|mesh-ancestor
64518091|NCT01718483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64518092|NCT03241914|Megestrol|megestrol|mesh-list
64518093|NCT03241914|Megestrol Acetate|megestrol acetate|mesh-list
64518094|NCT03241914|Levonorgestrel|levonorgestrel|mesh-list
64518095|NCT03241914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64518096|NCT03241914|Contraceptive Agents|contraceptive agents|mesh-ancestor
64518097|NCT03241914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64574926|NCT00437255|Glucocorticoids|glucocorticoids|mesh-ancestor
64574927|NCT00437255|Hormones|hormones|mesh-ancestor
64574928|NCT00437255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64574929|NCT00437255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574930|NCT00437255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64574931|NCT00437255|Respiratory System Agents|respiratory system agents|mesh-ancestor
64574932|NCT00437255|Dermatologic Agents|dermatologic agents|mesh-ancestor
64574933|NCT02324673|Cannabidiol|cannabidiol|mesh-list
64574934|NCT02324673|Anticonvulsants|anticonvulsants|mesh-ancestor
64574935|NCT00373217|Paclitaxel|paclitaxel|mesh-list
64574936|NCT00373217|Carboplatin|carboplatin|mesh-list
64574937|NCT00373217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64574938|NCT00373217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574940|NCT00373217|Antimitotic Agents|antimitotic agents|mesh-ancestor
64574941|NCT00373217|Mitosis Modulators|mitosis modulators|mesh-ancestor
64518098|NCT03241914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518099|NCT03241914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64518100|NCT03241914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64632051|NCT00002878|Hormones|hormones|mesh-ancestor
64455430|NCT01991795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64455431|NCT01991795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64455432|NCT01991795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64455433|NCT01991795|Purinergic Agents|purinergic agents|mesh-ancestor
64455434|NCT01991795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64455435|NCT01991795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455436|NCT01991795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455437|NCT02076100|Ruzasvir|ruzasvir|mesh-list
64518101|NCT03241914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64574968|NCT01579305|Sensory System Agents|sensory system agents|mesh-ancestor
64574969|NCT01579305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64574970|NCT01579305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64574971|NCT01579305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64574972|NCT01579305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64574973|NCT01579305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64574974|NCT01579305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574975|NCT00212147|Nitrous Oxide|nitrous oxide|mesh-list
64574976|NCT00212147|Anesthetics|anesthetics|mesh-list
64574977|NCT00212147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64574978|NCT00212147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574979|NCT00212147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64574980|NCT00212147|Anesthetics, General|anesthetics, general|mesh-ancestor
64574981|NCT00212147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64574982|NCT00212147|Analgesics|analgesics|mesh-ancestor
64574983|NCT00212147|Sensory System Agents|sensory system agents|mesh-ancestor
64574984|NCT00212147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64574985|NCT04820010|Insulin|insulin|mesh-list
64574986|NCT04820010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64574987|NCT04820010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574988|NCT01454102|Gemcitabine|gemcitabine|mesh-list
64574989|NCT01454102|Paclitaxel|paclitaxel|mesh-list
64574990|NCT01454102|Bevacizumab|bevacizumab|mesh-list
64574991|NCT01454102|Carboplatin|carboplatin|mesh-list
64575017|NCT01454102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64575018|NCT01454102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64575019|NCT04819776|Iloperidone|iloperidone|mesh-list
64632076|NCT00003682|Methylprednisolone|methylprednisolone|mesh-list
64632077|NCT00003682|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64632078|NCT00003682|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64575032|NCT04192253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575033|NCT04825938|Paclitaxel|paclitaxel|mesh-list
64575034|NCT04825938|Carboplatin|carboplatin|mesh-list
64575035|NCT04825938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64575036|NCT04825938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575037|NCT04825938|Tubulin Modulators|tubulin modulators|mesh-ancestor
64575038|NCT04825938|Antimitotic Agents|antimitotic agents|mesh-ancestor
64575039|NCT04825938|Mitosis Modulators|mitosis modulators|mesh-ancestor
64575040|NCT04825938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575041|NCT04826016|Paclitaxel|paclitaxel|mesh-list
64575042|NCT04826016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64575129|NCT01512225|Antiemetics|antiemetics|mesh-ancestor
64575130|NCT01512225|Autonomic Agents|autonomic agents|mesh-ancestor
64575131|NCT01512225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64575132|NCT01512225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575133|NCT01512225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64575134|NCT01512225|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64575135|NCT01512225|Dopamine Agents|dopamine agents|mesh-ancestor
64575136|NCT01512225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64632107|NCT00003688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575137|NCT01472445|Vitamin D|vitamin d|mesh-list
64575138|NCT01472445|Cholecalciferol|cholecalciferol|mesh-list
64575139|NCT01472445|Vitamins|vitamins|mesh-ancestor
64575140|NCT01472445|Micronutrients|micronutrients|mesh-ancestor
64575141|NCT01472445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575142|NCT01472445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64575143|NCT01472445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64518102|NCT03241914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64518103|NCT03241914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64518104|NCT03241914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518119|NCT03249168|Dopamine Agents|dopamine agents|mesh-ancestor
64632136|NCT00003934|Dermatologic Agents|dermatologic agents|mesh-ancestor
64518120|NCT03248856|Triamcinolone|triamcinolone|mesh-list
64632137|NCT00003934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632138|NCT00003934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64518121|NCT03248856|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64518122|NCT03248856|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64518123|NCT03248856|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64518124|NCT03248856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64518125|NCT03248856|Glucocorticoids|glucocorticoids|mesh-ancestor
64518126|NCT03248856|Hormones|hormones|mesh-ancestor
64575144|NCT04782089|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64575145|NCT04782089|Antibodies|antibodies|mesh-list
64575146|NCT04782089|Immunologic Factors|immunologic factors|mesh-ancestor
64575147|NCT04782089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575148|NCT04782089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575149|NCT04782089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575150|NCT04782089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575151|NCT02604342|Docetaxel|docetaxel|mesh-list
64575152|NCT02604342|Pemetrexed|pemetrexed|mesh-list
64575153|NCT02604342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632139|NCT00003934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64575154|NCT02604342|Tubulin Modulators|tubulin modulators|mesh-ancestor
64575155|NCT02604342|Antimitotic Agents|antimitotic agents|mesh-ancestor
64575156|NCT02604342|Mitosis Modulators|mitosis modulators|mesh-ancestor
64575157|NCT02604342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575158|NCT02604342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575192|NCT05565573|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64575193|NCT05565573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64575194|NCT05565573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575196|NCT04389359|Antimalarials|antimalarials|mesh-ancestor
64575197|NCT04389359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64575198|NCT04389359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64518127|NCT03248856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64632140|NCT00003934|Immunologic Factors|immunologic factors|mesh-ancestor
64632141|NCT00003934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64455438|NCT02076100|Antiviral Agents|antiviral agents|mesh-ancestor
64455439|NCT02076100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64455440|NCT01411774|Cycloserine|cycloserine|mesh-list
64455441|NCT01411774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64518128|NCT03248856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518129|NCT03248856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64518130|NCT03248856|Immunologic Factors|immunologic factors|mesh-ancestor
64518131|NCT03248856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518132|NCT03248856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518133|NCT03241602|Lidocaine|lidocaine|mesh-list
64518134|NCT03241602|Anesthetics, Local|anesthetics, local|mesh-ancestor
64518135|NCT03241602|Anesthetics|anesthetics|mesh-ancestor
64518136|NCT03241602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64575199|NCT04389359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64575290|NCT04815408|Carboplatin|carboplatin|mesh-list
64575291|NCT04815408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64575292|NCT04815408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64575331|NCT04817982|Hormones|hormones|mesh-ancestor
64575364|NCT04779047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64575365|NCT04779047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64575366|NCT04779047|Antimetabolites|antimetabolites|mesh-ancestor
64575367|NCT04427826|Morphine|morphine|mesh-list
64575368|NCT04427826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64575369|NCT04427826|Narcotics|narcotics|mesh-ancestor
64632177|NCT00003946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64455468|NCT01410448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64455469|NCT01410448|Antitubercular Agents|antitubercular agents|mesh-ancestor
64455470|NCT01410448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64455471|NCT04037176|Omalizumab|omalizumab|mesh-list
64455472|NCT04037176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64455473|NCT04037176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64455474|NCT04037176|Respiratory System Agents|respiratory system agents|mesh-ancestor
64455475|NCT01430104|Teriparatide|teriparatide|mesh-list
64455476|NCT01430104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64455477|NCT01430104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455478|NCT01430104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64455479|NCT01990859|Ipilimumab|ipilimumab|mesh-list
64455480|NCT01990859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64455481|NCT01990859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455482|NCT01990859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64455483|NCT01990859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455484|NCT02093897|Factor VIII|factor viii|mesh-list
64455485|NCT02093897|Coagulants|coagulants|mesh-ancestor
64455486|NCT01976845|Midazolam|midazolam|mesh-list
64455487|NCT01976845|Propofol|propofol|mesh-list
64455488|NCT01976845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64455489|NCT01976845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64455490|NCT01976845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455504|NCT01989689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64455505|NCT01989689|Analgesics|analgesics|mesh-ancestor
64455506|NCT01989689|Sensory System Agents|sensory system agents|mesh-ancestor
64455507|NCT01989689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64455508|NCT01989689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652297|NCT04972656|Ambrisentan|ambrisentan|mesh-list
64531850|NCT02364258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64531851|NCT02364258|Antimetabolites|antimetabolites|mesh-ancestor
64531852|NCT02364258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531853|NCT02364258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64575370|NCT04427826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64575371|NCT04427826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575372|NCT04427826|Analgesics|analgesics|mesh-ancestor
64575373|NCT04427826|Sensory System Agents|sensory system agents|mesh-ancestor
64575393|NCT01515345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64575394|NCT01515345|Purinergic Agents|purinergic agents|mesh-ancestor
64575395|NCT01515345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64575396|NCT01515345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575397|NCT01515345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575398|NCT01492400|Dexamethasone|dexamethasone|mesh-list
64575399|NCT01492400|Ranibizumab|ranibizumab|mesh-list
64575400|NCT01492400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64575401|NCT01492400|Antiemetics|antiemetics|mesh-ancestor
64575402|NCT01492400|Autonomic Agents|autonomic agents|mesh-ancestor
64575403|NCT01492400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64575404|NCT01492400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575405|NCT01492400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64575406|NCT01492400|Glucocorticoids|glucocorticoids|mesh-ancestor
64575407|NCT01492400|Hormones|hormones|mesh-ancestor
64575408|NCT01492400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64575409|NCT01492400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64575410|NCT01492400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575411|NCT01492400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64575412|NCT01492400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64575413|NCT01492400|Growth Substances|growth substances|mesh-ancestor
64575414|NCT01492400|Growth Inhibitors|growth inhibitors|mesh-ancestor
64575415|NCT00168337|Dexamethasone|dexamethasone|mesh-list
64575416|NCT00168337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64575417|NCT00168337|Antiemetics|antiemetics|mesh-ancestor
64575418|NCT00168337|Autonomic Agents|autonomic agents|mesh-ancestor
64575419|NCT00168337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64575420|NCT00168337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575421|NCT00168337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64575422|NCT00168337|Glucocorticoids|glucocorticoids|mesh-ancestor
64575423|NCT00168337|Hormones|hormones|mesh-ancestor
64575424|NCT00168337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64575426|NCT00168337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575456|NCT00073957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64575457|NCT00073957|Antimetabolites|antimetabolites|mesh-ancestor
64518137|NCT03241602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518138|NCT03241602|Sensory System Agents|sensory system agents|mesh-ancestor
64518139|NCT03241602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64518140|NCT03241602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64518141|NCT03241602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64518142|NCT03241602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64518143|NCT03241602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64518144|NCT03241602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518145|NCT00734877|Thalidomide|thalidomide|mesh-list
64518146|NCT00734877|Dexamethasone|dexamethasone|mesh-list
64518147|NCT00734877|Dexamethasone acetate|dexamethasone acetate|mesh-list
64518148|NCT00734877|Cyclophosphamide|cyclophosphamide|mesh-list
64518149|NCT00734877|Melphalan|melphalan|mesh-list
64518150|NCT00734877|Cisplatin|cisplatin|mesh-list
64518151|NCT00734877|Etoposide|etoposide|mesh-list
64518152|NCT00734877|Etoposide phosphate|etoposide phosphate|mesh-list
64518153|NCT00734877|Doxorubicin|doxorubicin|mesh-list
64518154|NCT00734877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64518155|NCT00734877|Bortezomib|bortezomib|mesh-list
64518156|NCT00734877|BB 1101|bb 1101|mesh-list
64575458|NCT00073957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575459|NCT00073957|Antiviral Agents|antiviral agents|mesh-ancestor
64575460|NCT00073957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64575461|NCT00073957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64575462|NCT04354428|Folic Acid|folic acid|mesh-list
64575463|NCT04354428|Ascorbic Acid|ascorbic acid|mesh-list
64632271|NCT00003958|Vincristine|vincristine|mesh-list
64575464|NCT04354428|Ritonavir|ritonavir|mesh-list
64575465|NCT04354428|Lopinavir|lopinavir|mesh-list
64575466|NCT04354428|Azithromycin|azithromycin|mesh-list
64575467|NCT04354428|Hydroxychloroquine|hydroxychloroquine|mesh-list
64575468|NCT04354428|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64575598|NCT00074815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64575599|NCT00074815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575600|NCT00074815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64575601|NCT00074815|Serotonin Agents|serotonin agents|mesh-ancestor
64575602|NCT00074815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575603|NCT00074815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64575604|NCT00074815|Antidepressive Agents|antidepressive agents|mesh-ancestor
64575605|NCT00074815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64575606|NCT00074815|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64575607|NCT00074815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64575608|NCT00074815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575609|NCT00074815|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64575610|NCT00074815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64575611|NCT00074815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64575612|NCT00074815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64518157|NCT00734877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64518158|NCT00734877|Immunologic Factors|immunologic factors|mesh-ancestor
64518159|NCT00734877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518160|NCT00734877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64518161|NCT00734877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64518162|NCT00734877|Alkylating Agents|alkylating agents|mesh-ancestor
64518163|NCT00734877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518164|NCT00734877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518165|NCT00734877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64518166|NCT00734877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64518168|NCT00734877|Autonomic Agents|autonomic agents|mesh-ancestor
64518169|NCT00734877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64518170|NCT00734877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64518171|NCT00734877|Glucocorticoids|glucocorticoids|mesh-ancestor
64518172|NCT00734877|Hormones|hormones|mesh-ancestor
64518173|NCT00734877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64518174|NCT00734877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64518175|NCT00734877|Protease Inhibitors|protease inhibitors|mesh-ancestor
64518176|NCT00734877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632304|NCT00003268|Cytarabine|cytarabine|mesh-list
64531854|NCT02364258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64518177|NCT00734877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64518178|NCT00734877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64518179|NCT00734877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64518180|NCT00734877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64518181|NCT00734877|Leprostatic Agents|leprostatic agents|mesh-ancestor
64518182|NCT00734877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64518183|NCT00734877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64518184|NCT00734877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64518185|NCT00734877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64575613|NCT00074815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64575614|NCT00074815|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64575683|NCT02592876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575684|NCT02592876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64575685|NCT02592876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64575686|NCT02592876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64575687|NCT02592876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64575688|NCT02592876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575689|NCT02592876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575690|NCT02592876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64575691|NCT02592876|Alkylating Agents|alkylating agents|mesh-ancestor
64575692|NCT00585559|Acetaminophen|acetaminophen|mesh-list
64575693|NCT00585559|Acetylcysteine|acetylcysteine|mesh-list
64518187|NCT00734877|Growth Inhibitors|growth inhibitors|mesh-ancestor
64518189|NCT02357290|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64518190|NCT02357290|Antiviral Agents|antiviral agents|mesh-ancestor
64518191|NCT02357290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64518192|NCT02357290|Expectorants|expectorants|mesh-ancestor
64518193|NCT02357290|Respiratory System Agents|respiratory system agents|mesh-ancestor
64518194|NCT02357290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64518195|NCT02357290|Antioxidants|antioxidants|mesh-ancestor
64518196|NCT02357290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518197|NCT02357290|Protective Agents|protective agents|mesh-ancestor
64575821|NCT01520727|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64575822|NCT01520727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586309|NCT00426517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575893|NCT05331131|Ketamine|ketamine|mesh-list
64575894|NCT05331131|Analgesics|analgesics|mesh-ancestor
64575928|NCT01527045|Cyclosporine|cyclosporine|mesh-list
64575929|NCT01527045|Mycophenolic Acid|mycophenolic acid|mesh-list
64575978|NCT01972919|Immunologic Factors|immunologic factors|mesh-ancestor
64575979|NCT01972919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575980|NCT03440567|Rituximab|rituximab|mesh-list
64575981|NCT03440567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64575982|NCT03440567|Avelumab|avelumab|mesh-list
64575983|NCT03440567|Carboplatin|carboplatin|mesh-list
64575984|NCT03440567|Etoposide|etoposide|mesh-list
64575985|NCT03440567|Ifosfamide|ifosfamide|mesh-list
64575986|NCT03440567|Isophosphamide mustard|isophosphamide mustard|mesh-list
64575987|NCT03440567|Etoposide phosphate|etoposide phosphate|mesh-list
64575988|NCT03440567|Antibodies|antibodies|mesh-list
64575989|NCT03440567|Immunoglobulins|immunoglobulins|mesh-list
64575990|NCT03440567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64575991|NCT03440567|Immunoglobulin G|immunoglobulin g|mesh-list
64575992|NCT03440567|Immunologic Factors|immunologic factors|mesh-ancestor
64575993|NCT03440567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575994|NCT03440567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632385|NCT00086138|Sertraline|sertraline|mesh-list
64531855|NCT02364258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531856|NCT02367924|Trabectedin|trabectedin|mesh-list
64531857|NCT02367924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64531858|NCT02367924|Alkylating Agents|alkylating agents|mesh-ancestor
64531859|NCT02367924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531860|NCT02367924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531861|NCT02375022|Endostar protein|endostar protein|mesh-list
64531862|NCT02375022|Endostatins|endostatins|mesh-list
64487945|NCT03834766|Amphetamine|amphetamine|mesh-list
64531863|NCT02375022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64531864|NCT02375022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64531865|NCT02375022|Growth Substances|growth substances|mesh-ancestor
64531866|NCT02375022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531867|NCT02375022|Growth Inhibitors|growth inhibitors|mesh-ancestor
64531868|NCT02375022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531869|NCT01497899|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64531870|NCT01497899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64531871|NCT01497899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64531872|NCT01497899|Antiviral Agents|antiviral agents|mesh-ancestor
64531873|NCT01497899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64531874|NCT01497275|Rituximab|rituximab|mesh-list
64531875|NCT01497275|Bortezomib|bortezomib|mesh-list
64531876|NCT01497275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64531877|NCT01497275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531878|NCT01497275|Immunologic Factors|immunologic factors|mesh-ancestor
64531879|NCT01497275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531880|NCT01497275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64455520|NCT01989455|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64455521|NCT01989455|Chelating Agents|chelating agents|mesh-ancestor
64455522|NCT01989455|Sequestering Agents|sequestering agents|mesh-ancestor
64576027|NCT01530243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632432|NCT00003730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64576028|NCT01530243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576029|NCT01530243|Urological Agents|urological agents|mesh-ancestor
64576030|NCT01530243|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64576031|NCT01530243|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64576032|NCT01530243|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64576033|NCT01530243|Adrenergic Agents|adrenergic agents|mesh-ancestor
64576089|NCT00078559|Protective Agents|protective agents|mesh-ancestor
64576090|NCT00078559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64576091|NCT00078559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64576092|NCT00078559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64576093|NCT00078559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64576094|NCT00078559|Anesthetics, Local|anesthetics, local|mesh-ancestor
64576095|NCT00078559|Anesthetics|anesthetics|mesh-ancestor
64576096|NCT00078559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64455523|NCT01989455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455524|NCT01987895|Vancomycin|vancomycin|mesh-list
64455525|NCT01987895|Oxazolidinones|oxazolidinones|mesh-list
64455526|NCT01987895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64455527|NCT01987895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64531882|NCT01557517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64531883|NCT01557517|Glucocorticoids|glucocorticoids|mesh-ancestor
64531885|NCT01557517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64531886|NCT01557517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531887|NCT02363556|Misoprostol|misoprostol|mesh-list
64531888|NCT02363556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64531889|NCT02363556|Abortifacient Agents|abortifacient agents|mesh-ancestor
64531890|NCT02363556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64531891|NCT02363556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531892|NCT02363556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64531893|NCT02363556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64531894|NCT02363556|Oxytocics|oxytocics|mesh-ancestor
64531902|NCT01557283|Sensory System Agents|sensory system agents|mesh-ancestor
64531903|NCT01557283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64531904|NCT01557283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531905|NCT01557283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64531907|NCT01557283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64531908|NCT01557283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64531909|NCT01557283|Immunologic Factors|immunologic factors|mesh-ancestor
64531910|NCT02374632|Octreotide|octreotide|mesh-list
64296445|NCT01333501|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64455528|NCT01987895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64455529|NCT01987895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455530|NCT01987895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455531|NCT01618669|Regadenoson|regadenoson|mesh-list
64455532|NCT01618669|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64455533|NCT01618669|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64455534|NCT01618669|Purinergic Agonists|purinergic agonists|mesh-ancestor
64455535|NCT01618669|Purinergic Agents|purinergic agents|mesh-ancestor
64455536|NCT01618669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64455537|NCT01618669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455538|NCT01618669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455539|NCT01390948|Bevacizumab|bevacizumab|mesh-list
64531911|NCT02374632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64632491|NCT00003742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64576097|NCT00078559|Histamine Antagonists|histamine antagonists|mesh-ancestor
64576098|NCT00078559|Histamine Agents|histamine agents|mesh-ancestor
64576099|NCT00078559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64576100|NCT00078559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64518202|NCT02477202|Contraceptive Agents|contraceptive agents|mesh-ancestor
64518203|NCT02477202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64518204|NCT02477202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518205|NCT02477202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64518206|NCT02477202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64518207|NCT02477202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64518209|NCT00687765|Iniparib|iniparib|mesh-list
64518210|NCT00687765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64518211|NCT00687765|Alkylating Agents|alkylating agents|mesh-ancestor
64576101|NCT00078559|Antipruritics|antipruritics|mesh-ancestor
64576102|NCT00078559|Dermatologic Agents|dermatologic agents|mesh-ancestor
64576103|NCT00078559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64576104|NCT00078559|Renal Agents|renal agents|mesh-ancestor
64576133|NCT00078715|Adrenergic Agents|adrenergic agents|mesh-ancestor
64576134|NCT00078715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64576135|NCT00078715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576136|NCT00078715|Urological Agents|urological agents|mesh-ancestor
64576137|NCT04805034|Antiviral Agents|antiviral agents|mesh-list
64576138|NCT04805034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64576139|NCT01530399|Tranexamic Acid|tranexamic acid|mesh-list
64632492|NCT00003742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64531912|NCT02374632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64531913|NCT02374632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531914|NCT02363400|Cisplatin|cisplatin|mesh-list
64531915|NCT02363400|Epirubicin|epirubicin|mesh-list
64531916|NCT02363400|Mitomycins|mitomycins|mesh-list
64531917|NCT02363400|Mitomycin|mitomycin|mesh-list
64531918|NCT02363400|Tegafur|tegafur|mesh-list
64531919|NCT02363400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531920|NCT02363400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64531921|NCT02363400|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64531922|NCT02363400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64531923|NCT02363400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531924|NCT02363400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531925|NCT02363400|Alkylating Agents|alkylating agents|mesh-ancestor
64531926|NCT02363400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64531927|NCT02363400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64531928|NCT02363400|Antimetabolites|antimetabolites|mesh-ancestor
64296476|NCT03307863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64455540|NCT01390948|Temozolomide|temozolomide|mesh-list
64455541|NCT01390948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64455542|NCT01390948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455543|NCT01390948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64455544|NCT01390948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64455545|NCT01390948|Growth Substances|growth substances|mesh-ancestor
64576140|NCT01530399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64576141|NCT01530399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64576142|NCT01530399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576143|NCT01530399|Hemostatics|hemostatics|mesh-ancestor
64576144|NCT01530399|Coagulants|coagulants|mesh-ancestor
64576145|NCT01531803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64576146|NCT02596620|Amoxicillin|amoxicillin|mesh-list
64576147|NCT02596620|Metronidazole|metronidazole|mesh-list
64576148|NCT02596620|Levofloxacin|levofloxacin|mesh-list
64576149|NCT02596620|Esomeprazole|esomeprazole|mesh-list
64576150|NCT02596620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64576151|NCT02596620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64576185|NCT03001089|Fludrocortisone|fludrocortisone|mesh-list
64576186|NCT03001089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64576187|NCT01533207|Gemcitabine|gemcitabine|mesh-list
64632541|NCT00089024|Antiviral Agents|antiviral agents|mesh-ancestor
64576188|NCT01533207|Docetaxel|docetaxel|mesh-list
64576189|NCT01533207|Doxorubicin|doxorubicin|mesh-list
64576190|NCT01533207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64576191|NCT01533207|Lenograstim|lenograstim|mesh-list
64576192|NCT01533207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64576265|NCT01535001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576266|NCT01535001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576268|NCT03000777|Antioxidants|antioxidants|mesh-ancestor
64576296|NCT04426734|Glucocorticoids|glucocorticoids|mesh-ancestor
64576297|NCT04426734|Hormones|hormones|mesh-ancestor
64576298|NCT04426734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64576299|NCT04426734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64576300|NCT04426734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576301|NCT04426734|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64576302|NCT04426734|Protective Agents|protective agents|mesh-ancestor
64576303|NCT03006081|Aflibercept|aflibercept|mesh-list
64576304|NCT03006081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64518213|NCT00687765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518214|NCT00687765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64518215|NCT00687765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518216|NCT03248544|Vitamin D|vitamin d|mesh-list
64518217|NCT03248544|Cholecalciferol|cholecalciferol|mesh-list
64518218|NCT03248544|Vitamins|vitamins|mesh-ancestor
64518219|NCT03248544|Micronutrients|micronutrients|mesh-ancestor
64518220|NCT03248544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518221|NCT03248544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64518222|NCT03248544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64518223|NCT00984399|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64518224|NCT00984399|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64518225|NCT00984399|Estradiol|estradiol|mesh-list
64518226|NCT00984399|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64518227|NCT00984399|Estrogens|estrogens|mesh-ancestor
64518228|NCT00984399|Hormones|hormones|mesh-ancestor
64518229|NCT00984399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64518230|NCT00984399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518231|NCT00984399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64518232|NCT00984399|Contraceptive Agents|contraceptive agents|mesh-ancestor
64518233|NCT00984399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64518234|NCT00984399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64576344|NCT02999841|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64576345|NCT01537029|Cyclophosphamide|cyclophosphamide|mesh-list
64576346|NCT01537029|Doxorubicin|doxorubicin|mesh-list
64576347|NCT01537029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64576348|NCT01537029|Immunologic Factors|immunologic factors|mesh-ancestor
64632573|NCT00089102|Irinotecan|irinotecan|mesh-list
64632574|NCT00089102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64632575|NCT00089102|Antimetabolites|antimetabolites|mesh-ancestor
64576349|NCT01537029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576350|NCT01537029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64576351|NCT01537029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64576352|NCT01537029|Alkylating Agents|alkylating agents|mesh-ancestor
64576353|NCT01537029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576354|NCT01537029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576356|NCT01537029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64576357|NCT01537029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64576358|NCT01537029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64576359|NCT01537029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576360|NCT01667562|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64576361|NCT01667562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576362|NCT01667562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64576395|NCT02980965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64576396|NCT02980965|Immunologic Factors|immunologic factors|mesh-ancestor
64576397|NCT02980965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576398|NCT02980965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64576399|NCT02980965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64576400|NCT02980965|Alkylating Agents|alkylating agents|mesh-ancestor
64632609|NCT00003328|Porfiromycin|porfiromycin|mesh-list
64632610|NCT00003328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64632611|NCT00003328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632612|NCT00004024|Aldesleukin|aldesleukin|mesh-list
64632613|NCT00004024|Sargramostim|sargramostim|mesh-list
64632614|NCT00004024|Muromonab-CD3|muromonab-cd3|mesh-list
64632616|NCT00004024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632617|NCT00004024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576401|NCT02980965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576402|NCT02980965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576403|NCT02980965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64576404|NCT02980965|Tubulin Modulators|tubulin modulators|mesh-ancestor
64576405|NCT02980965|Antimitotic Agents|antimitotic agents|mesh-ancestor
64576406|NCT02980965|Mitosis Modulators|mitosis modulators|mesh-ancestor
64576407|NCT02980965|Antimetabolites|antimetabolites|mesh-ancestor
64576408|NCT02980965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64576437|NCT01538745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64576439|NCT04803240|Hyaluronic Acid|hyaluronic acid|mesh-list
64576440|NCT04803240|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64576441|NCT04803240|Immunologic Factors|immunologic factors|mesh-ancestor
64576442|NCT04803240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576443|NCT04803240|Viscosupplements|viscosupplements|mesh-ancestor
64632618|NCT00004024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64632623|NCT00003334|Paclitaxel|paclitaxel|mesh-list
64455546|NCT01390948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455547|NCT01390948|Growth Inhibitors|growth inhibitors|mesh-ancestor
64576444|NCT04803240|Protective Agents|protective agents|mesh-ancestor
64576446|NCT04803474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64576447|NCT04803474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576448|NCT01539135|Methylene Blue|methylene blue|mesh-list
64576449|NCT01539135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576450|NCT01539135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576451|NCT04426578|Perhexiline|perhexiline|mesh-list
64576452|NCT04426578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64576453|NCT04426578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64576484|NCT05350371|Pirfenidone|pirfenidone|mesh-list
64576485|NCT05350371|Analgesics|analgesics|mesh-ancestor
64576486|NCT05350371|Sensory System Agents|sensory system agents|mesh-ancestor
64576487|NCT05350371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576488|NCT05350371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576489|NCT05350371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64576490|NCT05350371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64576491|NCT05350371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64576492|NCT05350371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64576493|NCT05350371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576495|NCT04794738|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64576496|NCT04794738|Narcotics|narcotics|mesh-ancestor
64576497|NCT04794738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64576532|NCT04793256|Fluorides, Topical|fluorides, topical|mesh-list
64576533|NCT04793256|Cariostatic Agents|cariostatic agents|mesh-ancestor
64576534|NCT04793256|Protective Agents|protective agents|mesh-ancestor
64576535|NCT04793256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576536|NCT04793256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64576537|NCT04793256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632652|NCT04771754|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64586310|NCT00426517|Antifungal Agents|antifungal agents|mesh-ancestor
64576570|NCT05672355|Immunologic Factors|immunologic factors|mesh-ancestor
64576571|NCT05672355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576572|NCT03004521|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64576573|NCT03004521|Antidepressive Agents|antidepressive agents|mesh-ancestor
64576574|NCT03004521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64576575|NCT03004521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64576576|NCT03004521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64576577|NCT03004521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64357954|NCT03375463|Hormones|hormones|mesh-ancestor
64576578|NCT03004521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576579|NCT04792710|Metronidazole|metronidazole|mesh-list
64301782|NCT02127775|Lesinurad|lesinurad|mesh-list
64576608|NCT04814433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64518271|NCT03248700|Retinol acetate|retinol acetate|mesh-list
64576609|NCT04814433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64576610|NCT04814433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64576611|NCT04814433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632689|NCT00003340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64576612|NCT04814433|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64576613|NCT04814433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64576614|NCT04814433|Hemostatics|hemostatics|mesh-ancestor
64576615|NCT04814433|Coagulants|coagulants|mesh-ancestor
64576616|NCT04814433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64576617|NCT04814433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64576618|NCT04814433|Adrenergic Agents|adrenergic agents|mesh-ancestor
64576619|NCT04814433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64576620|NCT04814433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64576621|NCT04814433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64576622|NCT04814433|Autonomic Agents|autonomic agents|mesh-ancestor
64576623|NCT04814433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64576624|NCT04814433|Respiratory System Agents|respiratory system agents|mesh-ancestor
64576625|NCT04814433|Mydriatics|mydriatics|mesh-ancestor
64576626|NCT04814433|Sympathomimetics|sympathomimetics|mesh-ancestor
64576627|NCT04814433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64576661|NCT02248155|Dopamine Agonists|dopamine agonists|mesh-ancestor
64576662|NCT02248155|Dopamine Agents|dopamine agents|mesh-ancestor
64576663|NCT02248155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64576664|NCT02597946|Paclitaxel|paclitaxel|mesh-list
64576665|NCT02597946|Afatinib|afatinib|mesh-list
64576666|NCT02597946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64576738|NCT02597478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64576739|NCT02597478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576740|NCT02597478|Analgesics|analgesics|mesh-ancestor
64576741|NCT02597478|Sensory System Agents|sensory system agents|mesh-ancestor
64576742|NCT02597478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576743|NCT02597478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64576744|NCT02597478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64576745|NCT02597478|Anesthetics, General|anesthetics, general|mesh-ancestor
64576746|NCT02597478|Anesthetics|anesthetics|mesh-ancestor
64576747|NCT02219997|Methamphetamine|methamphetamine|mesh-list
64576748|NCT02219997|beta-Endorphin|beta-endorphin|mesh-list
64576749|NCT02219997|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64576750|NCT02219997|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64576751|NCT02219997|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64576752|NCT02219997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576753|NCT02219997|Sympathomimetics|sympathomimetics|mesh-ancestor
64576754|NCT02219997|Autonomic Agents|autonomic agents|mesh-ancestor
64576824|NCT04339101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64576825|NCT04339101|Immunologic Factors|immunologic factors|mesh-ancestor
64518273|NCT03248700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576911|NCT04197687|Trastuzumab|trastuzumab|mesh-list
64576912|NCT04197687|Pertuzumab|pertuzumab|mesh-list
64576913|NCT04197687|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64576914|NCT04197687|Maytansine|maytansine|mesh-list
64576915|NCT04197687|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
64576916|NCT04197687|Vaccines|vaccines|mesh-list
64576917|NCT04197687|Antibodies|antibodies|mesh-list
64576918|NCT04197687|Immunoglobulins|immunoglobulins|mesh-list
64576919|NCT04197687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64576920|NCT04197687|Sargramostim|sargramostim|mesh-list
64576921|NCT04197687|Immunoconjugates|immunoconjugates|mesh-list
64576922|NCT04197687|Immunologic Factors|immunologic factors|mesh-ancestor
64576923|NCT04197687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576924|NCT04197687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576925|NCT04197687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64576926|NCT04197687|Tubulin Modulators|tubulin modulators|mesh-ancestor
64576957|NCT04788654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64576959|NCT04788654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576961|NCT04788654|Analgesics|analgesics|mesh-ancestor
64576962|NCT04788654|Sensory System Agents|sensory system agents|mesh-ancestor
64576963|NCT04788654|Antipyretics|antipyretics|mesh-ancestor
64576964|NCT04788654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64576965|NCT04788654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64576966|NCT04788654|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64576967|NCT04788654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64576968|NCT04788654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576969|NCT04788654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576970|NCT04785768|Morphine|morphine|mesh-list
64576971|NCT04785768|Hydromorphone|hydromorphone|mesh-list
64455548|NCT01390948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64455549|NCT01390948|Alkylating Agents|alkylating agents|mesh-ancestor
64455550|NCT01390948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455551|NCT03842722|Protoporphyrin IX|protoporphyrin ix|mesh-list
64455565|NCT01940887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64455566|NCT01940887|Growth Substances|growth substances|mesh-ancestor
64455567|NCT01940887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455568|NCT01940887|Growth Inhibitors|growth inhibitors|mesh-ancestor
64455570|NCT01925612|Cyclophosphamide|cyclophosphamide|mesh-list
64455571|NCT01925612|Rituximab|rituximab|mesh-list
64455572|NCT01925612|Doxorubicin|doxorubicin|mesh-list
64455573|NCT01925612|Vincristine|vincristine|mesh-list
64531934|NCT00350025|Antimitotic Agents|antimitotic agents|mesh-ancestor
64531935|NCT00350025|Mitosis Modulators|mitosis modulators|mesh-ancestor
64531936|NCT00350025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714124|NCT00374101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64531937|NCT00350025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64531938|NCT01496807|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64531939|NCT01496807|Ipilimumab|ipilimumab|mesh-list
64531940|NCT01496807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64577010|NCT03002649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64577011|NCT03002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577012|NCT04785222|Dexmedetomidine|dexmedetomidine|mesh-list
64577013|NCT04785222|Bupivacaine|bupivacaine|mesh-list
64518277|NCT03248700|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64518278|NCT03248700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518279|NCT03248700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64518280|NCT03248700|Immunologic Factors|immunologic factors|mesh-ancestor
64518281|NCT03238482|Fluticasone|fluticasone|mesh-list
64518283|NCT03238482|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64518284|NCT03238482|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64518285|NCT03238482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64577014|NCT04785222|Anesthetics, Local|anesthetics, local|mesh-ancestor
64577015|NCT04785222|Anesthetics|anesthetics|mesh-ancestor
64577016|NCT04785222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64577017|NCT04785222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577018|NCT04785222|Sensory System Agents|sensory system agents|mesh-ancestor
64577019|NCT04785222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64577020|NCT04785222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64577021|NCT04785222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64577052|NCT04808622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577053|NCT02247687|Raltegravir Potassium|raltegravir potassium|mesh-list
64577054|NCT02247687|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
64577055|NCT02247687|Protease Inhibitors|protease inhibitors|mesh-list
64577056|NCT02247687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64577057|NCT02247687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64577058|NCT02247687|Antiviral Agents|antiviral agents|mesh-ancestor
64577059|NCT02247687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632810|NCT00004048|Antibodies|antibodies|mesh-list
64531941|NCT01496807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531942|NCT01496807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64531943|NCT01496807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531944|NCT01496807|Antiviral Agents|antiviral agents|mesh-ancestor
64531945|NCT01496807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64531946|NCT02374320|Bupivacaine|bupivacaine|mesh-list
64531947|NCT02374320|Anesthetics, Local|anesthetics, local|mesh-ancestor
64531948|NCT02374320|Anesthetics|anesthetics|mesh-ancestor
64531949|NCT02374320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64531950|NCT02374320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531951|NCT02374320|Sensory System Agents|sensory system agents|mesh-ancestor
64531952|NCT02374320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64531953|NCT01496183|Olanzapine|olanzapine|mesh-list
64531954|NCT01496183|Antiemetics|antiemetics|mesh-ancestor
64531955|NCT01496183|Autonomic Agents|autonomic agents|mesh-ancestor
64296494|NCT04656470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64455590|NCT01925612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64455591|NCT01925612|Glucocorticoids|glucocorticoids|mesh-ancestor
64455592|NCT01925612|Hormones|hormones|mesh-ancestor
64577060|NCT02247687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64577061|NCT02247687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64577062|NCT02247687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577063|NCT02247687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577096|NCT00083551|Alkylating Agents|alkylating agents|mesh-ancestor
64577097|NCT00083551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577098|NCT00083551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577099|NCT00083551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64577100|NCT00083551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64577101|NCT00083551|Antiemetics|antiemetics|mesh-ancestor
64577102|NCT00083551|Autonomic Agents|autonomic agents|mesh-ancestor
64577103|NCT00083551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64577104|NCT00083551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64577105|NCT00083551|Glucocorticoids|glucocorticoids|mesh-ancestor
64577106|NCT00083551|Hormones|hormones|mesh-ancestor
64577107|NCT00083551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64577108|NCT00083551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64577109|NCT00083551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64302317|NCT03260283|Narcotics|narcotics|mesh-ancestor
64577110|NCT00083551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64577111|NCT00083551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64577112|NCT00083551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577170|NCT01490918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64577171|NCT01490918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577172|NCT01490918|Incretins|incretins|mesh-ancestor
64577173|NCT01490918|Hormones|hormones|mesh-ancestor
64632837|NCT00004060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455593|NCT01925612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64455594|NCT01925612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64455595|NCT01925612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64455596|NCT01925612|Tubulin Modulators|tubulin modulators|mesh-ancestor
64455597|NCT01925612|Antimitotic Agents|antimitotic agents|mesh-ancestor
64531975|NCT01495793|Dopamine Agonists|dopamine agonists|mesh-ancestor
64455606|NCT02093663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64455607|NCT02093663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64455608|NCT01408888|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64455609|NCT01408888|Dulaglutide|dulaglutide|mesh-list
64455610|NCT01408888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64455611|NCT01408888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455612|NCT01408888|Incretins|incretins|mesh-ancestor
64455613|NCT01408888|Hormones|hormones|mesh-ancestor
64455614|NCT01408888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64455650|NCT01390402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455651|NCT01390402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64455652|NCT01390402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64455653|NCT01390402|Immunologic Factors|immunologic factors|mesh-ancestor
64577174|NCT01490918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64577175|NCT01490918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64577176|NCT01490918|Protease Inhibitors|protease inhibitors|mesh-ancestor
64577177|NCT01490918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577178|NCT01490918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577179|NCT01490918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64577180|NCT02230995|Metformin|metformin|mesh-list
64577181|NCT02230995|Empagliflozin|empagliflozin|mesh-list
64577182|NCT02230995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64577183|NCT02230995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577184|NCT02230995|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64577185|NCT02230995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302398|NCT03069950|Antidotes|antidotes|mesh-ancestor
64577186|NCT02995083|Methylprednisolone|methylprednisolone|mesh-list
64518286|NCT03238482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64518287|NCT03238482|Autonomic Agents|autonomic agents|mesh-ancestor
64632885|NCT00004066|Mitosis Modulators|mitosis modulators|mesh-ancestor
64632886|NCT00003370|Irofulven|irofulven|mesh-list
64632887|NCT00003370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64518288|NCT03238482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64518289|NCT03238482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518290|NCT03238482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64518291|NCT03238482|Respiratory System Agents|respiratory system agents|mesh-ancestor
64518292|NCT03238482|Dermatologic Agents|dermatologic agents|mesh-ancestor
64518293|NCT03238482|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64518294|NCT03238482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64518295|NCT03238482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64577187|NCT02995083|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64577188|NCT02995083|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64577189|NCT02995083|Prednisolone|prednisolone|mesh-list
64577230|NCT03794388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64577231|NCT03794388|Antipruritics|antipruritics|mesh-ancestor
64577232|NCT03794388|Dermatologic Agents|dermatologic agents|mesh-ancestor
64577233|NCT04426422|Metformin|metformin|mesh-list
64577234|NCT04426422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64577235|NCT04426422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577236|NCT05471700|Azacitidine|azacitidine|mesh-list
64577237|NCT05471700|Venetoclax|venetoclax|mesh-list
64577238|NCT05471700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64577239|NCT05471700|Antimetabolites|antimetabolites|mesh-ancestor
64577240|NCT05471700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577241|NCT05471700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577242|NCT05471700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577271|NCT05466318|Antiviral Agents|antiviral agents|mesh-ancestor
64577272|NCT05466318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64577273|NCT05466318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577274|NCT05466318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64577275|NCT05466318|Immunologic Factors|immunologic factors|mesh-ancestor
64577276|NCT05466318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577277|NCT05466318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64577278|NCT05466318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64577279|NCT05466318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64577280|NCT05466318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64577281|NCT05466318|Alkylating Agents|alkylating agents|mesh-ancestor
64577282|NCT05466318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64577283|NCT04928664|Bupivacaine|bupivacaine|mesh-list
64577284|NCT04928664|Anesthetics, Local|anesthetics, local|mesh-ancestor
64577285|NCT04928664|Anesthetics|anesthetics|mesh-ancestor
64577286|NCT04928664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64577287|NCT04928664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577288|NCT04928664|Sensory System Agents|sensory system agents|mesh-ancestor
64577289|NCT04928664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64577290|NCT01633827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64577291|NCT01633827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64632919|NCT00003382|Gemcitabine|gemcitabine|mesh-list
64455654|NCT01390402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64455655|NCT01390402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64455656|NCT01390402|Antiviral Agents|antiviral agents|mesh-ancestor
64455657|NCT01390402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64455691|NCT02093351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64577320|NCT00081263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577321|NCT00081263|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64577322|NCT03138603|Metoprolol|metoprolol|mesh-list
64577323|NCT03138603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64577324|NCT03138603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64518296|NCT03238482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64518297|NCT03238482|Adrenergic Agents|adrenergic agents|mesh-ancestor
64518298|NCT03238482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64632957|NCT00004852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64518299|NCT03238482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518301|NCT03238482|Hormones|hormones|mesh-ancestor
64518302|NCT03238482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64577325|NCT03138603|Sympatholytics|sympatholytics|mesh-ancestor
64577326|NCT03138603|Autonomic Agents|autonomic agents|mesh-ancestor
64577327|NCT03138603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64577328|NCT03138603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577329|NCT03138603|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64577330|NCT03138603|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64577331|NCT03138603|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64577332|NCT03138603|Adrenergic Agents|adrenergic agents|mesh-ancestor
64577333|NCT03138603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64577334|NCT03138603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577335|NCT05087381|Cyproheptadine|cyproheptadine|mesh-list
64577336|NCT05087381|Niclosamide|niclosamide|mesh-list
64577363|NCT05087381|Dermatologic Agents|dermatologic agents|mesh-ancestor
64577364|NCT05087381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64577365|NCT05087381|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64577366|NCT05087381|Histamine Antagonists|histamine antagonists|mesh-ancestor
64577367|NCT05087381|Histamine Agents|histamine agents|mesh-ancestor
64577368|NCT05087381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64577369|NCT05087381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64577370|NCT05087381|Expectorants|expectorants|mesh-ancestor
64632958|NCT00004852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64455692|NCT02093351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455693|NCT02093351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64652343|NCT03210038|Anesthetics|anesthetics|mesh-ancestor
64531983|NCT02374008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64531985|NCT02374008|Autonomic Agents|autonomic agents|mesh-ancestor
64531986|NCT02374008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64531987|NCT02374008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531988|NCT02374008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64577371|NCT05087381|Respiratory System Agents|respiratory system agents|mesh-ancestor
64577372|NCT05611710|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64577373|NCT05611710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64577374|NCT00080483|Methyltestosterone|methyltestosterone|mesh-list
64577375|NCT00080483|Testosterone|testosterone|mesh-list
64577376|NCT00080483|Testosterone undecanoate|testosterone undecanoate|mesh-list
64577377|NCT00080483|Testosterone enanthate|testosterone enanthate|mesh-list
64577378|NCT00080483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64577379|NCT00080483|Androgens|androgens|mesh-ancestor
64577381|NCT00080483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64577382|NCT00080483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577383|NCT00080483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64577384|NCT00080483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577419|NCT00089141|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64577420|NCT00089141|Antitubercular Agents|antitubercular agents|mesh-ancestor
64632998|NCT02972866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64577421|NCT00089141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64577422|NCT00089141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64577423|NCT00089141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577424|NCT00089141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577425|NCT02227329|Ethanol|ethanol|mesh-list
64577426|NCT02227329|Heparin|heparin|mesh-list
64577427|NCT02227329|Calcium heparin|calcium heparin|mesh-list
64577428|NCT02227329|Anticoagulants|anticoagulants|mesh-ancestor
64577452|NCT03172897|Dexmedetomidine|dexmedetomidine|mesh-list
64577453|NCT03172897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64577454|NCT03172897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64577455|NCT03172897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577456|NCT03172897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64577457|NCT03172897|Analgesics|analgesics|mesh-ancestor
64577458|NCT03172897|Sensory System Agents|sensory system agents|mesh-ancestor
64531989|NCT02374008|Glucocorticoids|glucocorticoids|mesh-ancestor
64531990|NCT02374008|Hormones|hormones|mesh-ancestor
64531991|NCT02374008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64531992|NCT02374008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64531993|NCT02374008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531994|NCT02374008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531995|NCT02374008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531996|NCT02374008|Anesthetics, Local|anesthetics, local|mesh-ancestor
64531997|NCT02374008|Anesthetics|anesthetics|mesh-ancestor
64531998|NCT02374008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64531999|NCT02374008|Sensory System Agents|sensory system agents|mesh-ancestor
64532000|NCT02374008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64577459|NCT03172897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64577460|NCT03172897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64577461|NCT03172897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64577462|NCT03172897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64577463|NCT03172897|Adrenergic Agents|adrenergic agents|mesh-ancestor
64577464|NCT03172897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64577465|NCT03172897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577466|NCT00086723|Captopril|captopril|mesh-list
64577467|NCT00086723|Plasminogen|plasminogen|mesh-list
64518304|NCT02454504|Neostigmine|neostigmine|mesh-list
64518305|NCT02454504|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64518306|NCT02454504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577468|NCT00086723|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64577469|NCT00086723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64577470|NCT00086723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64577471|NCT00086723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577472|NCT00086723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64577473|NCT00086723|Protease Inhibitors|protease inhibitors|mesh-ancestor
64577474|NCT00086723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577505|NCT00088621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64577506|NCT00088621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64577507|NCT00088621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577589|NCT04714541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64577590|NCT04714541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64577591|NCT04714541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64577592|NCT04714541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577593|NCT02414724|Gemcitabine|gemcitabine|mesh-list
64577594|NCT02414724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64577595|NCT02414724|Antimetabolites|antimetabolites|mesh-ancestor
64577596|NCT02414724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577597|NCT02414724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577598|NCT02414724|Antiviral Agents|antiviral agents|mesh-ancestor
64577599|NCT02414724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64577600|NCT02414724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577601|NCT02414724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64577602|NCT02414724|Immunologic Factors|immunologic factors|mesh-ancestor
64577603|NCT02414724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577604|NCT00187681|Metformin|metformin|mesh-list
64577605|NCT00187681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64577606|NCT00187681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577607|NCT00083759|Natalizumab|natalizumab|mesh-list
64577608|NCT00083759|Immunologic Factors|immunologic factors|mesh-ancestor
64577609|NCT00083759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577610|NCT02412228|Dexamethasone|dexamethasone|mesh-list
64577611|NCT02412228|Cyclophosphamide|cyclophosphamide|mesh-list
64577612|NCT02412228|Ixazomib|ixazomib|mesh-list
64577613|NCT02412228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64518307|NCT02454504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518308|NCT02454504|Cholinergic Agents|cholinergic agents|mesh-ancestor
64518309|NCT02454504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64518310|NCT02454504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518311|NCT02454504|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64518312|NCT02454504|Autonomic Agents|autonomic agents|mesh-ancestor
64518313|NCT02454504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64518315|NCT03240822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64532001|NCT02374008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64532002|NCT02374008|Analgesics|analgesics|mesh-ancestor
64455715|NCT01940497|Antimitotic Agents|antimitotic agents|mesh-ancestor
64455716|NCT01940497|Mitosis Modulators|mitosis modulators|mesh-ancestor
64455717|NCT01940497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455718|NCT01940497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64455719|NCT01940497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64455720|NCT01940497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64518316|NCT03240822|Tacrolimus|tacrolimus|mesh-list
64518317|NCT03240822|Immunologic Factors|immunologic factors|mesh-ancestor
64518318|NCT03240822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518319|NCT03240822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64518320|NCT03240822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64577646|NCT03693807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577647|NCT03693807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64577648|NCT03693807|Immunologic Factors|immunologic factors|mesh-ancestor
64577649|NCT03693807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577650|NCT03693807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64577651|NCT03693807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64633108|NCT00004876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577652|NCT03693807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64577653|NCT01646151|Bimatoprost|bimatoprost|mesh-list
64577654|NCT01646151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64577655|NCT03692481|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64577687|NCT02233101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64577688|NCT02233101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577689|NCT02233101|Hemostatics|hemostatics|mesh-ancestor
64577690|NCT02233101|Coagulants|coagulants|mesh-ancestor
64577691|NCT00089011|Mycophenolic Acid|mycophenolic acid|mesh-list
64577692|NCT00089011|Fludarabine|fludarabine|mesh-list
64577693|NCT00089011|Fludarabine phosphate|fludarabine phosphate|mesh-list
64577694|NCT00089011|Tacrolimus|tacrolimus|mesh-list
64577695|NCT00089011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577696|NCT00089011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64577697|NCT00089011|Antimetabolites|antimetabolites|mesh-ancestor
64577698|NCT00089011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577728|NCT00189475|Montelukast|montelukast|mesh-list
64577729|NCT00189475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64577730|NCT00189475|Respiratory System Agents|respiratory system agents|mesh-ancestor
64577731|NCT00189475|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64577732|NCT00189475|Hormone Antagonists|hormone antagonists|mesh-ancestor
64577733|NCT00189475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64577734|NCT00189475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577735|NCT00189475|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64577736|NCT00189475|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64577737|NCT00189475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633148|NCT00003868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633149|NCT00003868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577738|NCT00091273|Sargramostim|sargramostim|mesh-list
64577739|NCT00091273|Freund's Adjuvant|freund's adjuvant|mesh-list
64577740|NCT00091273|Immunologic Factors|immunologic factors|mesh-ancestor
64577741|NCT00091273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577765|NCT04589208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577767|NCT04589208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64577768|NCT04589208|Anesthetics, General|anesthetics, general|mesh-ancestor
64577769|NCT04589208|Anesthetics|anesthetics|mesh-ancestor
64577770|NCT04589208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64577771|NCT04589208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64577772|NCT04589208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64577773|NCT04589208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64577774|NCT04589208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518322|NCT03240822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518323|NCT03238560|Montelukast|montelukast|mesh-list
64518324|NCT03238560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64518325|NCT03238560|Respiratory System Agents|respiratory system agents|mesh-ancestor
64518326|NCT03238560|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64518327|NCT03238560|Hormone Antagonists|hormone antagonists|mesh-ancestor
64518328|NCT03238560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64518329|NCT03238560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518330|NCT03238560|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64518331|NCT03238560|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64518332|NCT03238560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518333|NCT04486092|Valproic Acid|valproic acid|mesh-list
64518334|NCT04486092|Anticonvulsants|anticonvulsants|mesh-ancestor
64518335|NCT04486092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455721|NCT01940497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455722|NCT01940497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64455724|NCT01987505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64455725|NCT01987505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455726|NCT01987505|Immunologic Factors|immunologic factors|mesh-ancestor
64455727|NCT01987505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455728|NCT01987505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64455729|NCT01923896|Cycloserine|cycloserine|mesh-list
64455730|NCT01923896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64518336|NCT04486092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518337|NCT04486092|GABA Agents|gaba agents|mesh-ancestor
64518338|NCT04486092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64518339|NCT04486092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577775|NCT00193453|Gemcitabine|gemcitabine|mesh-list
64577776|NCT00193453|Docetaxel|docetaxel|mesh-list
64577777|NCT00193453|Cetuximab|cetuximab|mesh-list
64577778|NCT00193453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64577779|NCT00193453|Antimetabolites|antimetabolites|mesh-ancestor
64577780|NCT00193453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577781|NCT00193453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303004|NCT05635370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64577782|NCT00193453|Antiviral Agents|antiviral agents|mesh-ancestor
64577783|NCT00193453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64577784|NCT00193453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577785|NCT00193453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64577786|NCT00193453|Immunologic Factors|immunologic factors|mesh-ancestor
64577787|NCT00193453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577788|NCT00193453|Tubulin Modulators|tubulin modulators|mesh-ancestor
64577789|NCT00193453|Antimitotic Agents|antimitotic agents|mesh-ancestor
64577790|NCT00193453|Mitosis Modulators|mitosis modulators|mesh-ancestor
64577791|NCT00193453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64577792|NCT05614518|Methylene diphosphonate|methylene diphosphonate|mesh-list
64577825|NCT05614440|Sensory System Agents|sensory system agents|mesh-ancestor
64577826|NCT05614440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64577827|NCT05613192|Vitamin D|vitamin d|mesh-list
64577828|NCT05613192|Cholecalciferol|cholecalciferol|mesh-list
64577829|NCT05613192|Vitamins|vitamins|mesh-ancestor
64577830|NCT05613192|Micronutrients|micronutrients|mesh-ancestor
64577831|NCT05613192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577866|NCT00194779|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64577867|NCT00194779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64577868|NCT00194779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64577869|NCT00194779|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64577870|NCT00194779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64577871|NCT00194779|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64577872|NCT00194779|Hormone Antagonists|hormone antagonists|mesh-ancestor
64577873|NCT00194779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64577874|NCT00194779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64577875|NCT00194779|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64577876|NCT00194779|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64577877|NCT00194779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64577878|NCT05474664|Camostat|camostat|mesh-list
64577879|NCT05474664|Protease Inhibitors|protease inhibitors|mesh-ancestor
64577880|NCT05474664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577881|NCT05474664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633222|NCT00004900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577882|NCT05474664|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64577883|NCT05474664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64577884|NCT02096575|Nitrous Oxide|nitrous oxide|mesh-list
64577885|NCT02096575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64577886|NCT02096575|Anesthetics, General|anesthetics, general|mesh-ancestor
64577887|NCT02096575|Anesthetics|anesthetics|mesh-ancestor
64577888|NCT02096575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64577889|NCT02096575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577890|NCT02096575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64577891|NCT02096575|Analgesics|analgesics|mesh-ancestor
64577892|NCT02096575|Sensory System Agents|sensory system agents|mesh-ancestor
64577924|NCT00089609|Growth Substances|growth substances|mesh-ancestor
64577925|NCT00089609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577926|NCT00089609|Growth Inhibitors|growth inhibitors|mesh-ancestor
64577927|NCT00089609|Tubulin Modulators|tubulin modulators|mesh-ancestor
64455731|NCT01923896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64455732|NCT01923896|Renal Agents|renal agents|mesh-ancestor
64455733|NCT01923896|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64652370|NCT01464359|Alkylating Agents|alkylating agents|mesh-ancestor
64532009|NCT04505280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532010|NCT04505280|Sensory System Agents|sensory system agents|mesh-ancestor
64532011|NCT04505280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64532013|NCT04505280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64577928|NCT00089609|Antimitotic Agents|antimitotic agents|mesh-ancestor
64577929|NCT00089609|Mitosis Modulators|mitosis modulators|mesh-ancestor
64577930|NCT00089609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577931|NCT00089609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64577932|NCT00089609|Glucocorticoids|glucocorticoids|mesh-ancestor
64577934|NCT00089609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64577935|NCT00089609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64577970|NCT00095875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64577971|NCT00095875|Immunologic Factors|immunologic factors|mesh-ancestor
64577972|NCT00095875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577973|NCT03086993|Gemcitabine|gemcitabine|mesh-list
64577975|NCT03086993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577976|NCT03086993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64577977|NCT03086993|Antimetabolites|antimetabolites|mesh-ancestor
64577978|NCT03086993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577979|NCT03086993|Antiviral Agents|antiviral agents|mesh-ancestor
64578009|NCT04089072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578010|NCT04089072|Protective Agents|protective agents|mesh-ancestor
64578011|NCT04089072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578012|NCT00006227|Paclitaxel|paclitaxel|mesh-list
64578013|NCT00006227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64578014|NCT00006227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578015|NCT00006227|Tubulin Modulators|tubulin modulators|mesh-ancestor
64578016|NCT00006227|Antimitotic Agents|antimitotic agents|mesh-ancestor
64578017|NCT00006227|Mitosis Modulators|mitosis modulators|mesh-ancestor
64578018|NCT00006227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578019|NCT00097669|Folic Acid|folic acid|mesh-list
64578020|NCT00097669|Hematinics|hematinics|mesh-ancestor
64578021|NCT00097669|Vitamin B Complex|vitamin b complex|mesh-ancestor
64518346|NCT03238638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518347|NCT00668655|Metronidazole|metronidazole|mesh-list
64518348|NCT00668655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64518349|NCT00668655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64578023|NCT00097669|Micronutrients|micronutrients|mesh-ancestor
64578024|NCT00097669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578025|NCT05612880|Androgens|androgens|mesh-list
64578045|NCT03908736|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64578046|NCT03908736|Chelating Agents|chelating agents|mesh-ancestor
64578048|NCT03908736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578049|NCT05468892|Trifluridine|trifluridine|mesh-list
64578050|NCT05468892|Panitumumab|panitumumab|mesh-list
64578051|NCT05468892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64578052|NCT05468892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578053|NCT05468892|Antimetabolites|antimetabolites|mesh-ancestor
64578054|NCT05468892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578055|NCT05468892|Antiviral Agents|antiviral agents|mesh-ancestor
64578056|NCT05468892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64578057|NCT00200161|Temozolomide|temozolomide|mesh-list
64578058|NCT00200161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64633302|NCT00004132|Ifosfamide|ifosfamide|mesh-list
64578059|NCT00200161|Alkylating Agents|alkylating agents|mesh-ancestor
64578060|NCT00200161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578061|NCT00200161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578062|NCT00016913|Paclitaxel|paclitaxel|mesh-list
64578063|NCT00016913|Carboplatin|carboplatin|mesh-list
64578064|NCT00016913|Leuprolide|leuprolide|mesh-list
64578065|NCT00016913|Goserelin|goserelin|mesh-list
64578066|NCT00016913|Estramustine|estramustine|mesh-list
64578067|NCT00016913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64578068|NCT00016913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578069|NCT00016913|Tubulin Modulators|tubulin modulators|mesh-ancestor
64578070|NCT00016913|Antimitotic Agents|antimitotic agents|mesh-ancestor
64578071|NCT00016913|Mitosis Modulators|mitosis modulators|mesh-ancestor
64578072|NCT00016913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578073|NCT00016913|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64578074|NCT00016913|Fertility Agents|fertility agents|mesh-ancestor
64578075|NCT00016913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64578076|NCT00016913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578077|NCT00016913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64532014|NCT04505280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64532015|NCT04505280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64532016|NCT04505280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532017|NCT02366676|Hyaluronic Acid|hyaluronic acid|mesh-list
64532018|NCT02366676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64532019|NCT02366676|Immunologic Factors|immunologic factors|mesh-ancestor
64532020|NCT02366676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532021|NCT02366676|Viscosupplements|viscosupplements|mesh-ancestor
64532022|NCT02366676|Protective Agents|protective agents|mesh-ancestor
64532023|NCT02373384|Allopurinol|allopurinol|mesh-list
64578078|NCT00016913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64578079|NCT00016913|Alkylating Agents|alkylating agents|mesh-ancestor
64578080|NCT00023309|Lamivudine|lamivudine|mesh-list
64578081|NCT00023309|Adefovir|adefovir|mesh-list
64578105|NCT02440581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64578107|NCT01359150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64578108|NCT01359150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578109|NCT01359150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578111|NCT00098371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578112|NCT00098371|Growth Inhibitors|growth inhibitors|mesh-ancestor
64578113|NCT00098371|Growth Substances|growth substances|mesh-ancestor
64578114|NCT00098371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578115|NCT00098371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64578116|NCT00098371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578117|NCT00098371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578118|NCT04745988|Leucovorin|leucovorin|mesh-list
64578119|NCT04745988|Docetaxel|docetaxel|mesh-list
64578120|NCT04745988|Pembrolizumab|pembrolizumab|mesh-list
64578121|NCT04745988|Fluorouracil|fluorouracil|mesh-list
64578122|NCT04745988|Oxaliplatin|oxaliplatin|mesh-list
64578123|NCT04745988|Lenvatinib|lenvatinib|mesh-list
64578124|NCT04745988|Levoleucovorin|levoleucovorin|mesh-list
64578125|NCT04745988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578126|NCT04745988|Tubulin Modulators|tubulin modulators|mesh-ancestor
64578127|NCT04745988|Antimitotic Agents|antimitotic agents|mesh-ancestor
64578128|NCT04745988|Mitosis Modulators|mitosis modulators|mesh-ancestor
64578129|NCT04745988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633344|NCT05776940|BB 1101|bb 1101|mesh-list
64633347|NCT05776940|Antiemetics|antiemetics|mesh-ancestor
64532024|NCT02373384|Potassium Citrate|potassium citrate|mesh-list
64532025|NCT02373384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532026|NCT02373384|Antimetabolites|antimetabolites|mesh-ancestor
64532027|NCT02373384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532028|NCT02373384|Gout Suppressants|gout suppressants|mesh-ancestor
64532029|NCT02373384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64532030|NCT02373384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64455735|NCT01923896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64455736|NCT01923896|Antimetabolites|antimetabolites|mesh-ancestor
64455737|NCT01923896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455738|NCT01938625|Cyclosporine|cyclosporine|mesh-list
64455740|NCT01938625|Simeprevir|simeprevir|mesh-list
64455741|NCT01938625|Tacrolimus|tacrolimus|mesh-list
64455742|NCT01938625|Cyclosporins|cyclosporins|mesh-list
64455743|NCT01938625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64455744|NCT01938625|Immunologic Factors|immunologic factors|mesh-ancestor
64455745|NCT01938625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455746|NCT01938625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64455747|NCT01938625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455748|NCT01938625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578165|NCT04351191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64578166|NCT04351191|Amebicides|amebicides|mesh-ancestor
64578167|NCT01469000|Pemetrexed|pemetrexed|mesh-list
64578168|NCT01469000|Gefitinib|gefitinib|mesh-list
64578169|NCT01469000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518350|NCT00668655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64518351|NCT00668655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64578207|NCT01490060|Aprepitant|aprepitant|mesh-list
64578208|NCT01490060|BB 1101|bb 1101|mesh-list
64578209|NCT01490060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64578210|NCT01490060|Antiemetics|antiemetics|mesh-ancestor
64578211|NCT01490060|Autonomic Agents|autonomic agents|mesh-ancestor
64578212|NCT01490060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64578225|NCT01490060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64578226|NCT01490060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64455749|NCT01938625|Antifungal Agents|antifungal agents|mesh-ancestor
64455750|NCT01938625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64455751|NCT01938625|Dermatologic Agents|dermatologic agents|mesh-ancestor
64455752|NCT01938625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64455753|NCT01938625|Antimetabolites|antimetabolites|mesh-ancestor
64455754|NCT01938625|Antiviral Agents|antiviral agents|mesh-ancestor
64455755|NCT01938625|Protease Inhibitors|protease inhibitors|mesh-ancestor
64455756|NCT01975675|Sofosbuvir|sofosbuvir|mesh-list
64532032|NCT02373384|Protective Agents|protective agents|mesh-ancestor
64532033|NCT02373384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532034|NCT02373384|Diuretics|diuretics|mesh-ancestor
64532035|NCT02373384|Natriuretic Agents|natriuretic agents|mesh-ancestor
64532036|NCT02373384|Expectorants|expectorants|mesh-ancestor
64532037|NCT02373384|Respiratory System Agents|respiratory system agents|mesh-ancestor
64532038|NCT01494467|Azelaic acid|azelaic acid|mesh-list
64532039|NCT01494467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532040|NCT01494467|Dermatologic Agents|dermatologic agents|mesh-ancestor
64532041|NCT02881086|Cytarabine|cytarabine|mesh-list
64532042|NCT02881086|Dexamethasone|dexamethasone|mesh-list
64532043|NCT02881086|Prednisolone|prednisolone|mesh-list
64532044|NCT02881086|Cyclophosphamide|cyclophosphamide|mesh-list
64532045|NCT02881086|Rituximab|rituximab|mesh-list
64532046|NCT02881086|Methotrexate|methotrexate|mesh-list
64532047|NCT02881086|Fludarabine|fludarabine|mesh-list
64532048|NCT02881086|Vincristine|vincristine|mesh-list
64532049|NCT02881086|Doxorubicin|doxorubicin|mesh-list
64532050|NCT02881086|Daunorubicin|daunorubicin|mesh-list
64532051|NCT02881086|Asparaginase|asparaginase|mesh-list
64532052|NCT02881086|Mercaptopurine|mercaptopurine|mesh-list
64532053|NCT02881086|Idarubicin|idarubicin|mesh-list
64532054|NCT02881086|Pegaspargase|pegaspargase|mesh-list
64532055|NCT02881086|Vindesine|vindesine|mesh-list
64532056|NCT02881086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64532062|NCT02881086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532063|NCT02881086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296608|NCT03324932|Denosumab|denosumab|mesh-list
64455757|NCT01975675|Antiviral Agents|antiviral agents|mesh-ancestor
64455758|NCT01975675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64455759|NCT01975285|Dexamethasone|dexamethasone|mesh-list
64455760|NCT01975285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64455761|NCT01975285|Antiemetics|antiemetics|mesh-ancestor
64455762|NCT01975285|Autonomic Agents|autonomic agents|mesh-ancestor
64455763|NCT01975285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64455764|NCT01975285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455765|NCT01975285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64455766|NCT01975285|Glucocorticoids|glucocorticoids|mesh-ancestor
64455767|NCT01975285|Hormones|hormones|mesh-ancestor
64455768|NCT01975285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64455784|NCT01915303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64532065|NCT02881086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64532067|NCT02881086|Antiemetics|antiemetics|mesh-ancestor
64532068|NCT02881086|Autonomic Agents|autonomic agents|mesh-ancestor
64532069|NCT02881086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64578227|NCT01490060|Tubulin Modulators|tubulin modulators|mesh-ancestor
64578228|NCT01490060|Antimitotic Agents|antimitotic agents|mesh-ancestor
64578229|NCT01490060|Mitosis Modulators|mitosis modulators|mesh-ancestor
64578230|NCT01490060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64578231|NCT01490060|Alkylating Agents|alkylating agents|mesh-ancestor
64578232|NCT01490060|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64578233|NCT01490060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64578234|NCT04090736|Azacitidine|azacitidine|mesh-list
64578235|NCT04090736|Pevonedistat|pevonedistat|mesh-list
64578236|NCT04090736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64578237|NCT04090736|Antimetabolites|antimetabolites|mesh-ancestor
64578238|NCT04090736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578239|NCT04090736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578240|NCT04090736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303459|NCT02138383|Antimetabolites|antimetabolites|mesh-ancestor
64578241|NCT05557344|Acetaminophen|acetaminophen|mesh-list
64578242|NCT05557344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64578243|NCT05557344|Analgesics|analgesics|mesh-ancestor
64578244|NCT05557344|Sensory System Agents|sensory system agents|mesh-ancestor
64578245|NCT05557344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64578246|NCT05557344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578247|NCT05557344|Antipyretics|antipyretics|mesh-ancestor
64578248|NCT00101413|Sorafenib|sorafenib|mesh-list
64578249|NCT00101413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578250|NCT00101413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64578251|NCT00101413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578252|NCT00101413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578253|NCT01246869|Deoxyglucose|deoxyglucose|mesh-list
64578303|NCT03085680|Curcumin|curcumin|mesh-list
64578304|NCT03085680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64578305|NCT03085680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64578306|NCT03085680|Analgesics|analgesics|mesh-ancestor
64578307|NCT03085680|Sensory System Agents|sensory system agents|mesh-ancestor
64578308|NCT03085680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64578309|NCT03085680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578310|NCT03085680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64578311|NCT03085680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64578312|NCT03085680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578313|NCT03085680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578314|NCT03085680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578315|NCT01468844|Minocycline|minocycline|mesh-list
64578316|NCT01468844|Bevacizumab|bevacizumab|mesh-list
64578330|NCT01451606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64518352|NCT02454426|Vortioxetine|vortioxetine|mesh-list
64518353|NCT02454426|Antidepressive Agents|antidepressive agents|mesh-ancestor
64518354|NCT02454426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64518355|NCT02454426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64633487|NCT05775939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64532070|NCT02881086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64532071|NCT02881086|Glucocorticoids|glucocorticoids|mesh-ancestor
64532072|NCT02881086|Hormones|hormones|mesh-ancestor
64736756|NCT00616343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455785|NCT01915303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455786|NCT01915303|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64455787|NCT01915303|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64455788|NCT01915303|Dopamine Agonists|dopamine agonists|mesh-ancestor
64455789|NCT01915303|Dopamine Agents|dopamine agents|mesh-ancestor
64455790|NCT01915303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64455791|NCT01915303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455792|NCT01987427|Phentermine|phentermine|mesh-list
64455793|NCT01987427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64455794|NCT01987427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455795|NCT01987427|Appetite Depressants|appetite depressants|mesh-ancestor
64455796|NCT01987427|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64455797|NCT01987427|Sympathomimetics|sympathomimetics|mesh-ancestor
64455798|NCT01987427|Autonomic Agents|autonomic agents|mesh-ancestor
64455799|NCT01987427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64455800|NCT01987427|Adrenergic Agents|adrenergic agents|mesh-ancestor
64455801|NCT01987427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64455802|NCT01987427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455803|NCT01937299|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64455804|NCT01937299|Travoprost|travoprost|mesh-list
64455805|NCT01937299|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64455806|NCT01937299|Brinzolamide|brinzolamide|mesh-list
64455807|NCT01937299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64455808|NCT01937299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64455809|NCT01937299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64455810|NCT01937299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64455811|NCT01937299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64455812|NCT01937299|Adrenergic Agents|adrenergic agents|mesh-ancestor
64455813|NCT01937299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64455814|NCT01937299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455815|NCT01937299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518356|NCT02454426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64633540|NCT05775536|Sensory System Agents|sensory system agents|mesh-ancestor
64633541|NCT05775536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64518357|NCT02454426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64518358|NCT02454426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518359|NCT02454426|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64518360|NCT02454426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64578331|NCT01451606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64578332|NCT01451606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64578333|NCT01451606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64578334|NCT01451606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578335|NCT01451606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64578336|NCT01451606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578337|NCT01451606|Analgesics|analgesics|mesh-ancestor
64578338|NCT01451606|Sensory System Agents|sensory system agents|mesh-ancestor
64578339|NCT01451606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64578340|NCT01451606|Antidepressive Agents|antidepressive agents|mesh-ancestor
64578341|NCT01451606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64578342|NCT01451606|Dopamine Agents|dopamine agents|mesh-ancestor
64578343|NCT05556720|Vaccines|vaccines|mesh-list
64578344|NCT05556720|Immunologic Factors|immunologic factors|mesh-ancestor
64578345|NCT05556720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578346|NCT00204373|Lansoprazole|lansoprazole|mesh-list
64578347|NCT00204373|Dexlansoprazole|dexlansoprazole|mesh-list
64578348|NCT00204373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64578349|NCT00204373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64578350|NCT00204373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64578351|NCT00204373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455816|NCT01937299|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64455817|NCT01937299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455818|NCT01606761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64455819|NCT01606761|Immunologic Factors|immunologic factors|mesh-ancestor
64455820|NCT01606761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455821|NCT01597557|Magnesium Sulfate|magnesium sulfate|mesh-list
64455822|NCT01597557|Analgesics|analgesics|mesh-ancestor
64455823|NCT01597557|Sensory System Agents|sensory system agents|mesh-ancestor
64652395|NCT01838252|Viscosupplements|viscosupplements|mesh-ancestor
64455855|NCT01789203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64455856|NCT01789203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64455857|NCT01789203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64455858|NCT01789203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455859|NCT01789203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455860|NCT01789203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455861|NCT01789203|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64578352|NCT00204373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578353|NCT01655043|Regadenoson|regadenoson|mesh-list
64578354|NCT01655043|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64578355|NCT01655043|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64578356|NCT01655043|Purinergic Agonists|purinergic agonists|mesh-ancestor
64578357|NCT01655043|Purinergic Agents|purinergic agents|mesh-ancestor
64578358|NCT01655043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64578359|NCT01655043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633586|NCT05774964|Metronidazole|metronidazole|mesh-list
64578360|NCT01655043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578361|NCT00473343|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
64578362|NCT00473343|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64578363|NCT00473343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64578364|NCT00473343|Dermatologic Agents|dermatologic agents|mesh-ancestor
64578365|NCT00003927|Paclitaxel|paclitaxel|mesh-list
64578366|NCT00003927|Cyclophosphamide|cyclophosphamide|mesh-list
64578367|NCT00003927|Doxorubicin|doxorubicin|mesh-list
64578368|NCT00003927|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64578369|NCT00003927|Amifostine|amifostine|mesh-list
64578370|NCT00003927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64578371|NCT00003927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578372|NCT00003927|Tubulin Modulators|tubulin modulators|mesh-ancestor
64578373|NCT00003927|Antimitotic Agents|antimitotic agents|mesh-ancestor
64578374|NCT00003927|Mitosis Modulators|mitosis modulators|mesh-ancestor
64578375|NCT00003927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578376|NCT00003927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64578377|NCT00003927|Immunologic Factors|immunologic factors|mesh-ancestor
64578398|NCT01660191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64578399|NCT01660191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64578400|NCT01660191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578401|NCT00033917|Indomethacin|indomethacin|mesh-list
64578403|NCT00033917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64518369|NCT03238092|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64518371|NCT03238092|Estradiol|estradiol|mesh-list
64578406|NCT00033917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64578407|NCT00033917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578408|NCT00033917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64578409|NCT00033917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64578410|NCT00033917|Gout Suppressants|gout suppressants|mesh-ancestor
64578411|NCT00033917|Tocolytic Agents|tocolytic agents|mesh-ancestor
64578412|NCT00033917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64578413|NCT00033917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64578414|NCT00033917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578415|NCT00033917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578416|NCT00036569|Interferons|interferons|mesh-list
64578417|NCT00036569|Interferon-alpha|interferon-alpha|mesh-list
64578418|NCT00036569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578419|NCT00036569|Antiviral Agents|antiviral agents|mesh-ancestor
64578420|NCT00036569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64532073|NCT02881086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64532074|NCT02881086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64532075|NCT02881086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64532076|NCT02881086|Abortifacient Agents|abortifacient agents|mesh-ancestor
64532077|NCT02881086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64532078|NCT02881086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64532079|NCT02881086|Antimetabolites|antimetabolites|mesh-ancestor
64532080|NCT02881086|Dermatologic Agents|dermatologic agents|mesh-ancestor
64532081|NCT02881086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532082|NCT02881086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64532083|NCT02881086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64532084|NCT02881086|Antiviral Agents|antiviral agents|mesh-ancestor
64532085|NCT02881086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64532086|NCT02881086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64532087|NCT02881086|Tubulin Modulators|tubulin modulators|mesh-ancestor
64532088|NCT02881086|Antimitotic Agents|antimitotic agents|mesh-ancestor
64296636|NCT01003028|Remifentanil|remifentanil|mesh-list
64455862|NCT01789203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64455864|NCT01789047|Amantadine|amantadine|mesh-list
64455865|NCT01789047|Anticonvulsants|anticonvulsants|mesh-ancestor
64455866|NCT01789047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64455867|NCT01789047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455868|NCT01789047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64455869|NCT01789047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64455870|NCT01789047|Antiviral Agents|antiviral agents|mesh-ancestor
64455871|NCT01789047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64455872|NCT01789047|Dopamine Agents|dopamine agents|mesh-ancestor
64455873|NCT01789047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64455874|NCT01789047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455875|NCT01789047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64455876|NCT01789047|Analgesics|analgesics|mesh-ancestor
64455877|NCT01789047|Sensory System Agents|sensory system agents|mesh-ancestor
64455878|NCT01789047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64455879|NCT01617187|Olanzapine|olanzapine|mesh-list
64455880|NCT01617187|Asenapine|asenapine|mesh-list
64455902|NCT01759407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455903|NCT01759407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64455904|NCT01759407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64455905|NCT01759407|Autonomic Agents|autonomic agents|mesh-ancestor
64455906|NCT01759407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64455907|NCT01759407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64578421|NCT00036569|Immunologic Factors|immunologic factors|mesh-ancestor
64578422|NCT00036569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578424|NCT01660893|Oxymetazoline|oxymetazoline|mesh-list
64578425|NCT01660893|Tetracaine|tetracaine|mesh-list
64578426|NCT01660893|Anesthetics, Local|anesthetics, local|mesh-ancestor
64578427|NCT01660893|Anesthetics|anesthetics|mesh-ancestor
64578428|NCT01660893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64578429|NCT01660893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578430|NCT01660893|Sensory System Agents|sensory system agents|mesh-ancestor
64578431|NCT01660893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64455908|NCT01759407|Respiratory System Agents|respiratory system agents|mesh-ancestor
64455909|NCT01759407|Mydriatics|mydriatics|mesh-ancestor
64455910|NCT01759407|Sympathomimetics|sympathomimetics|mesh-ancestor
64455911|NCT01759407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64455912|NCT01787331|Itraconazole|itraconazole|mesh-list
64455913|NCT01787331|Antifungal Agents|antifungal agents|mesh-ancestor
64455914|NCT01787331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64455915|NCT01787331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64455916|NCT01787331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64455917|NCT01787331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455918|NCT01787331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455919|NCT01787331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64532092|NCT02881086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64532093|NCT03922542|Riboflavin|riboflavin|mesh-list
64532094|NCT03922542|Vitamin B Complex|vitamin b complex|mesh-ancestor
64532095|NCT03922542|Vitamins|vitamins|mesh-ancestor
64455923|NCT01787331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64455924|NCT01787097|Formoterol Fumarate|formoterol fumarate|mesh-list
64455925|NCT01787097|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64455926|NCT01787097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64455927|NCT01787097|Autonomic Agents|autonomic agents|mesh-ancestor
64455929|NCT01787097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455930|NCT01787097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64455931|NCT01787097|Respiratory System Agents|respiratory system agents|mesh-ancestor
64455957|NCT01973569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64455958|NCT01973569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455959|NCT01951586|Zoledronic Acid|zoledronic acid|mesh-list
64455961|NCT01951586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64455962|NCT01951586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455963|NCT04643678|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64455964|NCT04643678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64455965|NCT04641728|Pembrolizumab|pembrolizumab|mesh-list
64455966|NCT04641728|Olaparib|olaparib|mesh-list
64455967|NCT04641728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64455968|NCT04641728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455969|NCT04641728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64455970|NCT04641728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455971|NCT04641728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455972|NCT01756833|Doxycycline|doxycycline|mesh-list
64455973|NCT01756833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64455974|NCT01756833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64455975|NCT01756833|Antimalarials|antimalarials|mesh-ancestor
64455976|NCT01756833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64455977|NCT01756833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64455996|NCT01784523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455997|NCT01784523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455998|NCT01784523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64456001|NCT01784211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456002|NCT01783821|Budesonide|budesonide|mesh-list
64456003|NCT01783821|Formoterol Fumarate|formoterol fumarate|mesh-list
64456004|NCT01783821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64456005|NCT01783821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64456006|NCT01783821|Autonomic Agents|autonomic agents|mesh-ancestor
64456007|NCT01783821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456008|NCT01783821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578432|NCT01660893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64578433|NCT01660893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64578461|NCT01946373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64578462|NCT01946373|Immunologic Factors|immunologic factors|mesh-ancestor
64578463|NCT01946373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578464|NCT01946373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64578465|NCT01946373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64578466|NCT01946373|Alkylating Agents|alkylating agents|mesh-ancestor
64578467|NCT01946373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578468|NCT01946373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578469|NCT01946373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64578470|NCT01946373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64578472|NCT01946373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64578473|NCT01946373|Analgesics|analgesics|mesh-ancestor
64578474|NCT01946373|Sensory System Agents|sensory system agents|mesh-ancestor
64578475|NCT01946373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64578476|NCT01662297|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64578477|NCT01662297|Trazodone|trazodone|mesh-list
64578478|NCT01662297|Antidepressive Agents|antidepressive agents|mesh-ancestor
64578479|NCT01662297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64578480|NCT01662297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64578481|NCT01662297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64578482|NCT01662297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64578483|NCT01662297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578505|NCT00040937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64578506|NCT00040937|Immunologic Factors|immunologic factors|mesh-ancestor
64578507|NCT00040937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518372|NCT03238092|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64518373|NCT03238092|Testosterone|testosterone|mesh-list
64518374|NCT03238092|Estrogens|estrogens|mesh-ancestor
64518375|NCT03238092|Hormones|hormones|mesh-ancestor
64518376|NCT03238092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64578508|NCT00040937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64633766|NCT05429970|Anesthetics, General|anesthetics, general|mesh-ancestor
64456009|NCT01783821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64456010|NCT01783821|Respiratory System Agents|respiratory system agents|mesh-ancestor
64456011|NCT01783821|Glucocorticoids|glucocorticoids|mesh-ancestor
64456012|NCT01783821|Hormones|hormones|mesh-ancestor
64456013|NCT01783821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64578509|NCT00040937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64578510|NCT00040937|Alkylating Agents|alkylating agents|mesh-ancestor
64578511|NCT00040937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578512|NCT00040937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578513|NCT00040937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64578514|NCT00040937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64578515|NCT00040937|Antiemetics|antiemetics|mesh-ancestor
64578516|NCT00040937|Autonomic Agents|autonomic agents|mesh-ancestor
64578517|NCT00040937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64578518|NCT00040937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64578519|NCT00040937|Glucocorticoids|glucocorticoids|mesh-ancestor
64578520|NCT00040937|Hormones|hormones|mesh-ancestor
64578521|NCT00040937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64578522|NCT00040937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64578523|NCT00040937|Leprostatic Agents|leprostatic agents|mesh-ancestor
64578524|NCT00040937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64578525|NCT00040937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64578526|NCT00040937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64578527|NCT00040937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64578528|NCT00040937|Growth Substances|growth substances|mesh-ancestor
64578529|NCT00040937|Growth Inhibitors|growth inhibitors|mesh-ancestor
64578530|NCT04756895|Vancomycin|vancomycin|mesh-list
64578531|NCT04756895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64578532|NCT04756895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64578533|NCT02234115|Leuprolide|leuprolide|mesh-list
64578534|NCT02234115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64578535|NCT02234115|Fertility Agents|fertility agents|mesh-ancestor
64578536|NCT02234115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64578574|NCT01664559|Sensory System Agents|sensory system agents|mesh-ancestor
64633837|NCT05297851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64578619|NCT00048737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64578620|NCT00048737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64578671|NCT01605903|Sensory System Agents|sensory system agents|mesh-ancestor
64578672|NCT01605903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64578673|NCT01605903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578674|NCT01605903|Antipyretics|antipyretics|mesh-ancestor
64578675|NCT01605903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64578676|NCT01605903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64578677|NCT01605903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64578678|NCT01605903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64578679|NCT01605903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578680|NCT01605903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578681|NCT00048893|Metronidazole|metronidazole|mesh-list
64578682|NCT00048893|Paclitaxel|paclitaxel|mesh-list
64578683|NCT00048893|Cyclophosphamide|cyclophosphamide|mesh-list
64578684|NCT00048893|Doxorubicin|doxorubicin|mesh-list
64578685|NCT00048893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64518377|NCT03238092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518378|NCT03238092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64518379|NCT03238092|Contraceptive Agents|contraceptive agents|mesh-ancestor
64518380|NCT03238092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64518381|NCT03238092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64518382|NCT03238092|Androgens|androgens|mesh-ancestor
64518383|NCT03247998|Remifentanil|remifentanil|mesh-list
64633838|NCT05297851|Antimetabolites|antimetabolites|mesh-ancestor
64456014|NCT01783821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64456015|NCT01783821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64456016|NCT01783821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64456017|NCT01783821|Adrenergic Agents|adrenergic agents|mesh-ancestor
64456018|NCT01783821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64456019|NCT01783821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456020|NCT01608087|Bevacizumab|bevacizumab|mesh-list
64456021|NCT01608087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64456022|NCT01608087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456023|NCT01608087|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64456024|NCT01608087|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64532097|NCT03922542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532098|NCT03922542|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64532099|NCT03922542|Dermatologic Agents|dermatologic agents|mesh-ancestor
64532100|NCT01493687|Azelaic acid|azelaic acid|mesh-list
64532101|NCT01493687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532102|NCT01493687|Dermatologic Agents|dermatologic agents|mesh-ancestor
64532103|NCT02362308|Eplerenone|eplerenone|mesh-list
64456029|NCT01912963|Pertuzumab|pertuzumab|mesh-list
64456030|NCT01912963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64456031|NCT01912963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456032|NCT01912807|Ondansetron|ondansetron|mesh-list
64456033|NCT01912807|Antiemetics|antiemetics|mesh-ancestor
64578686|NCT00048893|Fludarabine|fludarabine|mesh-list
64578687|NCT00048893|Fludarabine phosphate|fludarabine phosphate|mesh-list
64303912|NCT03068234|Pirfenidone|pirfenidone|mesh-list
64578688|NCT00048893|Vaccines|vaccines|mesh-list
64578689|NCT00048893|Sargramostim|sargramostim|mesh-list
64578690|NCT00048893|Immunologic Factors|immunologic factors|mesh-ancestor
64578691|NCT00048893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578692|NCT00048893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64578693|NCT00048893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578694|NCT00048893|Tubulin Modulators|tubulin modulators|mesh-ancestor
64578695|NCT00048893|Antimitotic Agents|antimitotic agents|mesh-ancestor
64578696|NCT00048893|Mitosis Modulators|mitosis modulators|mesh-ancestor
64578697|NCT00048893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578698|NCT00048893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64578699|NCT00048893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64578700|NCT00048893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64578701|NCT00048893|Alkylating Agents|alkylating agents|mesh-ancestor
64578702|NCT00048893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64578703|NCT00048893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64578704|NCT00048893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64578705|NCT00048893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64578706|NCT00048893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578707|NCT00048893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64578708|NCT00048893|Antimetabolites|antimetabolites|mesh-ancestor
64578709|NCT00048893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64578710|NCT00048893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64578711|NCT00048893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64578712|NCT00048893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64578763|NCT01931033|Oxytocics|oxytocics|mesh-ancestor
64578764|NCT01931033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64578766|NCT01671423|Prednisone|prednisone|mesh-list
64578767|NCT01671423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64578768|NCT01671423|Glucocorticoids|glucocorticoids|mesh-ancestor
64578769|NCT01671423|Hormones|hormones|mesh-ancestor
64633888|NCT05180006|Growth Inhibitors|growth inhibitors|mesh-ancestor
64456038|NCT01912807|Antipruritics|antipruritics|mesh-ancestor
64456039|NCT01912807|Dermatologic Agents|dermatologic agents|mesh-ancestor
64456040|NCT01912807|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64456041|NCT01912807|Serotonin Agents|serotonin agents|mesh-ancestor
64456042|NCT01912807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64456043|NCT01912807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456044|NCT01912807|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64578770|NCT01671423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64578771|NCT01671423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578772|NCT01671423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64578773|NCT01671423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578774|NCT02092181|Mirabegron|mirabegron|mesh-list
64578775|NCT02092181|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64578776|NCT02092181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64578777|NCT02092181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64578778|NCT02092181|Adrenergic Agents|adrenergic agents|mesh-ancestor
64578779|NCT02092181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64578780|NCT02092181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578781|NCT02092181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578782|NCT02092181|Urological Agents|urological agents|mesh-ancestor
64578783|NCT01672827|Flutemetamol|flutemetamol|mesh-list
64578784|NCT01672827|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64578785|NCT01672827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578786|NCT01700907|Sevoflurane|sevoflurane|mesh-list
64578787|NCT01700907|Desflurane|desflurane|mesh-list
64578788|NCT01700907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64456045|NCT01912807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64456046|NCT01912807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64456047|NCT01912807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64456048|NCT01912807|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64456049|NCT01782885|Acetaminophen|acetaminophen|mesh-list
64456050|NCT01782885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64456051|NCT01782885|Analgesics|analgesics|mesh-ancestor
64456052|NCT01782885|Sensory System Agents|sensory system agents|mesh-ancestor
64456053|NCT01782885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456054|NCT01782885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456055|NCT01782885|Antipyretics|antipyretics|mesh-ancestor
64456056|NCT01754493|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64456057|NCT01754493|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64456058|NCT01754493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64456059|NCT01754493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64456060|NCT01754493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456061|NCT01754493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64456062|NCT01754493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456063|NCT01754493|Analgesics|analgesics|mesh-ancestor
64456064|NCT01754493|Sensory System Agents|sensory system agents|mesh-ancestor
64456065|NCT01754493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456066|NCT01754493|Antidepressive Agents|antidepressive agents|mesh-ancestor
64456067|NCT01754493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64456068|NCT01754493|Dopamine Agents|dopamine agents|mesh-ancestor
64456069|NCT01972789|Ranibizumab|ranibizumab|mesh-list
64456070|NCT01972789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64456071|NCT01972789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64456072|NCT01972789|Growth Substances|growth substances|mesh-ancestor
64456073|NCT01972789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456074|NCT01972789|Growth Inhibitors|growth inhibitors|mesh-ancestor
64456075|NCT01972789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456076|NCT01910389|Tadalafil|tadalafil|mesh-list
64456077|NCT01910389|Vasodilator Agents|vasodilator agents|mesh-ancestor
64456078|NCT01910389|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64578789|NCT01700907|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64578790|NCT01700907|Anesthetics, General|anesthetics, general|mesh-ancestor
64578791|NCT01700907|Anesthetics|anesthetics|mesh-ancestor
64578792|NCT01700907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64578793|NCT01700907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578795|NCT03089567|Fluorides|fluorides|mesh-list
64578796|NCT03089567|Sodium Fluoride|sodium fluoride|mesh-list
64518384|NCT03247998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64518385|NCT03247998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518387|NCT03247998|Narcotics|narcotics|mesh-ancestor
64518388|NCT03247998|Analgesics|analgesics|mesh-ancestor
64518389|NCT03247998|Sensory System Agents|sensory system agents|mesh-ancestor
64518390|NCT03247998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456079|NCT01910389|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64456080|NCT01910389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64456081|NCT01910389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456082|NCT01910389|Urological Agents|urological agents|mesh-ancestor
64456083|NCT01970995|Menthol|menthol|mesh-list
64456084|NCT01970995|Antipruritics|antipruritics|mesh-ancestor
64456085|NCT01970995|Dermatologic Agents|dermatologic agents|mesh-ancestor
64456086|NCT01932697|Docetaxel|docetaxel|mesh-list
64456087|NCT01932697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456088|NCT01932697|Tubulin Modulators|tubulin modulators|mesh-ancestor
64456089|NCT01932697|Antimitotic Agents|antimitotic agents|mesh-ancestor
64456090|NCT01932697|Mitosis Modulators|mitosis modulators|mesh-ancestor
64456091|NCT01932697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652416|NCT02498418|Rifaximin|rifaximin|mesh-list
64532112|NCT02362308|Natriuretic Agents|natriuretic agents|mesh-ancestor
64532113|NCT02362308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64532114|NCT02362308|Hormones|hormones|mesh-ancestor
64532115|NCT02366208|Adefovir|adefovir|mesh-list
64532116|NCT02366208|Thymalfasin|thymalfasin|mesh-list
64532117|NCT02366208|Antiviral Agents|antiviral agents|mesh-ancestor
64296669|NCT03104270|Elotuzumab|elotuzumab|mesh-list
64456094|NCT01970527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456095|NCT01970527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64456096|NCT01970527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456097|NCT01408576|Epratuzumab|epratuzumab|mesh-list
64456098|NCT01408576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64456099|NCT01408576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456100|NCT01427920|Insulin Aspart|insulin aspart|mesh-list
64456101|NCT01427920|Biphasic Insulins|biphasic insulins|mesh-list
64456102|NCT01427920|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64456119|NCT01427608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456120|NCT01427608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64456121|NCT01427608|Serotonin Agents|serotonin agents|mesh-ancestor
64456122|NCT01427608|Antidepressive Agents|antidepressive agents|mesh-ancestor
64456123|NCT01408030|Bevacizumab|bevacizumab|mesh-list
64456124|NCT01408030|Tranexamic Acid|tranexamic acid|mesh-list
64456125|NCT01408030|Endothelial Growth Factors|endothelial growth factors|mesh-list
64456126|NCT01408030|Estrogens|estrogens|mesh-list
64456127|NCT01408030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64456128|NCT01408030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456129|NCT01408030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64456130|NCT01408030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64456131|NCT01408030|Growth Substances|growth substances|mesh-ancestor
64456132|NCT01408030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456133|NCT01408030|Growth Inhibitors|growth inhibitors|mesh-ancestor
64456134|NCT01408030|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64456135|NCT01408030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64456136|NCT01408030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456137|NCT01408030|Hemostatics|hemostatics|mesh-ancestor
64456138|NCT01408030|Coagulants|coagulants|mesh-ancestor
64456139|NCT01408030|Hormones|hormones|mesh-ancestor
64518391|NCT03248076|Fentanyl|fentanyl|mesh-list
64518392|NCT03248076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64634046|NCT04802161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64518393|NCT03248076|Narcotics|narcotics|mesh-ancestor
64518394|NCT03248076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64518395|NCT03248076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518396|NCT03248076|Analgesics|analgesics|mesh-ancestor
64578797|NCT03089567|Cariostatic Agents|cariostatic agents|mesh-ancestor
64578798|NCT03089567|Protective Agents|protective agents|mesh-ancestor
64578799|NCT03089567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578800|NCT03089567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64578801|NCT03089567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64578802|NCT03431987|Ethanol|ethanol|mesh-list
64578803|NCT03431987|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64578804|NCT03431987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64578805|NCT03431987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64578806|NCT03431987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578807|NCT01612221|Acetylcysteine|acetylcysteine|mesh-list
64578808|NCT01612221|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64578809|NCT01612221|Antiviral Agents|antiviral agents|mesh-ancestor
64578810|NCT01612221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64578811|NCT01612221|Expectorants|expectorants|mesh-ancestor
64578812|NCT01612221|Respiratory System Agents|respiratory system agents|mesh-ancestor
64578813|NCT01612221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64578814|NCT01612221|Antioxidants|antioxidants|mesh-ancestor
64578815|NCT01612221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578848|NCT01701375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578849|NCT01701375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456140|NCT01408030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64456141|NCT02985424|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64456142|NCT02985424|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64456143|NCT02985424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456144|NCT01897532|Linagliptin|linagliptin|mesh-list
64456145|NCT01897532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64456146|NCT01897532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456147|NCT01897532|Incretins|incretins|mesh-ancestor
64456148|NCT01897532|Hormones|hormones|mesh-ancestor
64456149|NCT01897532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64456150|NCT01897532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64456151|NCT01897532|Protease Inhibitors|protease inhibitors|mesh-ancestor
64456152|NCT01897532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64456153|NCT01897532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532118|NCT02366208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64532119|NCT02366208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64532120|NCT02366208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64532121|NCT02366208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578851|NCT05556408|Succinylcholine|succinylcholine|mesh-list
64578852|NCT05556408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64578853|NCT05556408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64578854|NCT05556408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578855|NCT05556408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64578856|NCT05556408|Anesthetics, General|anesthetics, general|mesh-ancestor
64578857|NCT05556408|Anesthetics|anesthetics|mesh-ancestor
64578875|NCT00054353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578876|NCT00054353|Antifungal Agents|antifungal agents|mesh-ancestor
64578877|NCT00054353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64578878|NCT00054353|Dermatologic Agents|dermatologic agents|mesh-ancestor
64578879|NCT00054353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64578880|NCT00054353|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64578881|NCT00054353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64578882|NCT00054353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64578883|NCT00054353|Antitubercular Agents|antitubercular agents|mesh-ancestor
64578884|NCT00054353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64578885|NCT00054353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64578886|NCT00054353|Alkylating Agents|alkylating agents|mesh-ancestor
64578887|NCT00054353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64578889|NCT00208975|Rituximab|rituximab|mesh-list
64578890|NCT00208975|Fludarabine|fludarabine|mesh-list
64578891|NCT00208975|Mitoxantrone|mitoxantrone|mesh-list
64578892|NCT00208975|Sargramostim|sargramostim|mesh-list
64578893|NCT00208975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64578894|NCT00208975|Immunologic Factors|immunologic factors|mesh-ancestor
64578895|NCT00208975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578896|NCT00208975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64518398|NCT03248076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64518399|NCT03248076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64518400|NCT03248076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64634092|NCT04733157|Tranexamic Acid|tranexamic acid|mesh-list
64652419|NCT02498418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64456157|NCT04641026|Protective Agents|protective agents|mesh-ancestor
64456158|NCT04641026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456159|NCT04173416|Analgesics, Opioid|analgesics, opioid|mesh-list
64456160|NCT04173416|Narcotics|narcotics|mesh-ancestor
64456193|NCT01406938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456195|NCT01405924|Fosaprepitant|fosaprepitant|mesh-list
64456196|NCT01405924|Aprepitant|aprepitant|mesh-list
64456197|NCT01405924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64456198|NCT01405924|Antiemetics|antiemetics|mesh-ancestor
64456199|NCT01405924|Autonomic Agents|autonomic agents|mesh-ancestor
64456200|NCT01405924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456224|NCT01426438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518401|NCT03248076|Anesthetics, General|anesthetics, general|mesh-ancestor
64518402|NCT03248076|Anesthetics|anesthetics|mesh-ancestor
64518404|NCT03240120|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64518405|NCT03240120|Dalteparin|dalteparin|mesh-list
64518406|NCT03240120|Dabigatran|dabigatran|mesh-list
64518407|NCT03240120|Antithrombins|antithrombins|mesh-ancestor
64518408|NCT03240120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64518409|NCT03240120|Protease Inhibitors|protease inhibitors|mesh-ancestor
64518410|NCT03240120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518411|NCT03240120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518412|NCT03240120|Anticoagulants|anticoagulants|mesh-ancestor
64518413|NCT03240120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64518414|NCT03240120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64578897|NCT00208975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64578898|NCT00208975|Alkylating Agents|alkylating agents|mesh-ancestor
64578899|NCT00208975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578900|NCT00208975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578901|NCT00208975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64578902|NCT00208975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64578903|NCT00208975|Analgesics|analgesics|mesh-ancestor
64578904|NCT00208975|Sensory System Agents|sensory system agents|mesh-ancestor
64578905|NCT00208975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64578906|NCT00208975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64578907|NCT00208975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64578908|NCT00208975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578909|NCT01702233|Dexamethasone|dexamethasone|mesh-list
64578910|NCT01702233|Dexamethasone acetate|dexamethasone acetate|mesh-list
64578911|NCT01702233|BB 1101|bb 1101|mesh-list
64578912|NCT01702233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64578913|NCT01702233|Antiemetics|antiemetics|mesh-ancestor
64578914|NCT01702233|Autonomic Agents|autonomic agents|mesh-ancestor
64578915|NCT01702233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64578916|NCT01702233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578952|NCT01757418|Immunologic Factors|immunologic factors|mesh-ancestor
64578953|NCT01757418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578954|NCT00217399|Sorafenib|sorafenib|mesh-list
64634174|NCT04643405|Immunologic Factors|immunologic factors|mesh-ancestor
64579029|NCT00218023|Dopamine Agents|dopamine agents|mesh-ancestor
64579030|NCT00218023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64579031|NCT00218023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579032|NCT00218023|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64579033|NCT00218023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579034|NCT00218023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64579035|NCT00218023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64579036|NCT00218023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64579037|NCT00218023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64579039|NCT00054665|Cyclophosphamide|cyclophosphamide|mesh-list
64579110|NCT00476190|Antiviral Agents|antiviral agents|mesh-ancestor
64579111|NCT00476190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64579112|NCT00476190|Tubulin Modulators|tubulin modulators|mesh-ancestor
64518416|NCT03237936|Cyclosporins|cyclosporins|mesh-list
64518417|NCT03237936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518418|NCT03237936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518419|NCT03237936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64518420|NCT03237936|Immunologic Factors|immunologic factors|mesh-ancestor
64518421|NCT03237936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579139|NCT00221299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64579140|NCT00221299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579142|NCT00221299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64579143|NCT00221299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579144|NCT00221299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64579145|NCT00221299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64579147|NCT05554848|Dexmedetomidine|dexmedetomidine|mesh-list
64579148|NCT05554848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64579182|NCT01666782|Vaccines|vaccines|mesh-list
64579183|NCT01666782|Immunologic Factors|immunologic factors|mesh-ancestor
64579184|NCT01666782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579185|NCT00058019|Epothilones|epothilones|mesh-list
64634176|NCT04633122|Sunitinib|sunitinib|mesh-list
64456225|NCT01426438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64456226|NCT01426438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64456227|NCT01426438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64456228|NCT01426438|Antipyretics|antipyretics|mesh-ancestor
64456229|NCT01426438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64456230|NCT01426438|Antimetabolites|antimetabolites|mesh-ancestor
64579186|NCT00058019|Epothilone B|epothilone b|mesh-list
64579187|NCT00058019|Tubulin Modulators|tubulin modulators|mesh-ancestor
64579188|NCT00058019|Antimitotic Agents|antimitotic agents|mesh-ancestor
64579189|NCT00058019|Mitosis Modulators|mitosis modulators|mesh-ancestor
64579215|NCT00061373|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64579216|NCT00061373|Dalteparin|dalteparin|mesh-list
64579217|NCT00061373|Eptifibatide|eptifibatide|mesh-list
64579218|NCT00061373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64579219|NCT00061373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64579220|NCT00061373|Analgesics|analgesics|mesh-ancestor
64579221|NCT00061373|Sensory System Agents|sensory system agents|mesh-ancestor
64579222|NCT00061373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64579223|NCT00061373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579224|NCT00061373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64579225|NCT00061373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64579226|NCT00061373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64579227|NCT00061373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64579228|NCT00061373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579229|NCT00061373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64579230|NCT00061373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64579231|NCT00061373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579232|NCT00061373|Antipyretics|antipyretics|mesh-ancestor
64579233|NCT00061373|Anticoagulants|anticoagulants|mesh-ancestor
64579234|NCT01897337|Aprepitant|aprepitant|mesh-list
64579235|NCT01897337|Antiemetics|antiemetics|mesh-ancestor
64579236|NCT01897337|Autonomic Agents|autonomic agents|mesh-ancestor
64579237|NCT01897337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64579238|NCT01897337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579239|NCT01897337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64579304|NCT00117715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64579305|NCT00117715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579306|NCT00117715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64579307|NCT00117715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579308|NCT00117715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456231|NCT01426438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64456232|NCT01426438|Vasodilator Agents|vasodilator agents|mesh-ancestor
64456233|NCT01426438|Vitamin B Complex|vitamin b complex|mesh-ancestor
64456234|NCT01426438|Vitamins|vitamins|mesh-ancestor
64456235|NCT01426438|Micronutrients|micronutrients|mesh-ancestor
64456236|NCT01782495|Ritonavir|ritonavir|mesh-list
64456237|NCT01782495|Ribavirin|ribavirin|mesh-list
64456238|NCT01782495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64579309|NCT00117715|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64579310|NCT00117715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64579311|NCT00117715|Purinergic Agents|purinergic agents|mesh-ancestor
64579312|NCT00117715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64579332|NCT00227617|Immunologic Factors|immunologic factors|mesh-ancestor
64579333|NCT00227617|Antidotes|antidotes|mesh-ancestor
64579334|NCT00227617|Protective Agents|protective agents|mesh-ancestor
64579335|NCT00227617|Vitamin B Complex|vitamin b complex|mesh-ancestor
64579336|NCT00227617|Vitamins|vitamins|mesh-ancestor
64579337|NCT00227617|Micronutrients|micronutrients|mesh-ancestor
64579338|NCT00228943|Tryptophan|tryptophan|mesh-list
64579339|NCT00228943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64579340|NCT00228943|Antidepressive Agents|antidepressive agents|mesh-ancestor
64518424|NCT03237936|Dermatologic Agents|dermatologic agents|mesh-ancestor
64518425|NCT03237936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64518426|NCT03237936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64518427|NCT02759835|Osimertinib|osimertinib|mesh-list
64518428|NCT02759835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518429|NCT02759835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64518430|NCT02759835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579341|NCT00228943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64579342|NCT01439282|Capecitabine|capecitabine|mesh-list
64579343|NCT01439282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64579344|NCT01439282|Antimetabolites|antimetabolites|mesh-ancestor
64579345|NCT01439282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579346|NCT01439282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579347|NCT01879085|Gemcitabine|gemcitabine|mesh-list
64579348|NCT01879085|Docetaxel|docetaxel|mesh-list
64579349|NCT01879085|Vorinostat|vorinostat|mesh-list
64579350|NCT01879085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64579351|NCT01879085|Antimetabolites|antimetabolites|mesh-ancestor
64579367|NCT01439204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579368|NCT01439204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64579369|NCT01439204|Immunologic Factors|immunologic factors|mesh-ancestor
64579370|NCT01439204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579461|NCT01676415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579462|NCT01676415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64579463|NCT01676415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579465|NCT01676415|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64579466|NCT05547516|Gemcitabine|gemcitabine|mesh-list
64579467|NCT05547516|Epirubicin|epirubicin|mesh-list
64579468|NCT05547516|Mitomycins|mitomycins|mesh-list
64579469|NCT05547516|Mitomycin|mitomycin|mesh-list
64579470|NCT05547516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64579471|NCT05547516|Antimetabolites|antimetabolites|mesh-ancestor
64579472|NCT05547516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579473|NCT05547516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579474|NCT05547516|Antiviral Agents|antiviral agents|mesh-ancestor
64579475|NCT05547516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64579476|NCT05547516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579477|NCT05547516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64579478|NCT05547516|Immunologic Factors|immunologic factors|mesh-ancestor
64579479|NCT05547516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579480|NCT05547516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64579503|NCT01707381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64579504|NCT01707381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64579505|NCT05552586|Melatonin|melatonin|mesh-list
64579506|NCT05552586|Antioxidants|antioxidants|mesh-ancestor
64579507|NCT05552586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579508|NCT05552586|Protective Agents|protective agents|mesh-ancestor
64579509|NCT05552586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518431|NCT02759835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518432|NCT03247920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64634303|NCT04140526|Pembrolizumab|pembrolizumab|mesh-list
64518433|NCT03247920|Amoxicillin|amoxicillin|mesh-list
64518434|NCT03247920|Clavulanic Acid|clavulanic acid|mesh-list
64518441|NCT03239964|Dexamethasone|dexamethasone|mesh-list
64518442|NCT03239964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64518443|NCT03239964|Antiemetics|antiemetics|mesh-ancestor
64518444|NCT03239964|Autonomic Agents|autonomic agents|mesh-ancestor
64518445|NCT03239964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64518446|NCT03239964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518447|NCT03239964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64518448|NCT03239964|Glucocorticoids|glucocorticoids|mesh-ancestor
64518449|NCT03239964|Hormones|hormones|mesh-ancestor
64518450|NCT03239964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64518451|NCT03239964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64518452|NCT03239964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518453|NCT03239886|Imatinib Mesylate|imatinib mesylate|mesh-list
64518454|NCT03239886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518455|NCT03239886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64518456|NCT03239886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518457|NCT03239886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518458|NCT03102723|Cangrelor|cangrelor|mesh-list
64518459|NCT03102723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64518460|NCT03102723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64518461|NCT03102723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64579510|NCT05552586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64579511|NCT00069329|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64579512|NCT00069329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64579513|NCT00072449|Rituximab|rituximab|mesh-list
64579514|NCT00072449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64579515|NCT00072449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579516|NCT00072449|Immunologic Factors|immunologic factors|mesh-ancestor
64579517|NCT00072449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579518|NCT00072449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64579519|NCT04756661|Misoprostol|misoprostol|mesh-list
64579520|NCT04756661|Oxytocin|oxytocin|mesh-list
64456239|NCT01782495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64456240|NCT01782495|Protease Inhibitors|protease inhibitors|mesh-ancestor
64456241|NCT01782495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64456242|NCT01782495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456243|NCT01782495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64456244|NCT01782495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64456245|NCT01782495|Antiviral Agents|antiviral agents|mesh-ancestor
64456246|NCT01782495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64456247|NCT01782495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64456248|NCT01782495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64518463|NCT03102723|Purinergic Agents|purinergic agents|mesh-ancestor
64518464|NCT03102723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64518465|NCT03102723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518466|NCT03102723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518468|NCT03237312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64579521|NCT04756661|Carbetocin|carbetocin|mesh-list
64579522|NCT04756661|Oxytocics|oxytocics|mesh-ancestor
64579523|NCT04756661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64579524|NCT04756661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456249|NCT01782495|Antimetabolites|antimetabolites|mesh-ancestor
64456250|NCT01922102|Ranibizumab|ranibizumab|mesh-list
64456251|NCT01922102|Verteporfin|verteporfin|mesh-list
64456252|NCT01922102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64456281|NCT01405456|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64456282|NCT01405456|Diuretics|diuretics|mesh-ancestor
64456283|NCT01405456|Natriuretic Agents|natriuretic agents|mesh-ancestor
64456284|NCT01405456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64456285|NCT01404208|Cycloserine|cycloserine|mesh-list
64456286|NCT01404208|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64456287|NCT01404208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64456288|NCT01404208|Renal Agents|renal agents|mesh-ancestor
64456289|NCT01404208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64456290|NCT01404208|Antitubercular Agents|antitubercular agents|mesh-ancestor
64456291|NCT01404208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64456292|NCT01404208|Antimetabolites|antimetabolites|mesh-ancestor
64456293|NCT01404208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456294|NCT01617668|Paclitaxel|paclitaxel|mesh-list
64456328|NCT01424644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456329|NCT01403116|Methyltestosterone|methyltestosterone|mesh-list
64456330|NCT01403116|Testosterone|testosterone|mesh-list
64456331|NCT01403116|Testosterone undecanoate|testosterone undecanoate|mesh-list
64532125|NCT02366208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532126|NCT02373462|Olmesartan|olmesartan|mesh-list
64532127|NCT02373462|Antihypertensive Agents|antihypertensive agents|mesh-list
64532128|NCT02373462|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64532129|NCT02373462|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64532130|NCT02373462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296691|NCT04064918|Timolol|timolol|mesh-list
64456356|NCT01894568|Meglitinide|meglitinide|mesh-list
64456357|NCT01894568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456358|NCT01920152|Hyaluronic Acid|hyaluronic acid|mesh-list
64456359|NCT01920152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64456360|NCT01920152|Immunologic Factors|immunologic factors|mesh-ancestor
64456361|NCT01920152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456362|NCT01920152|Viscosupplements|viscosupplements|mesh-ancestor
64456363|NCT01920152|Protective Agents|protective agents|mesh-ancestor
64456364|NCT01752933|Guadecitabine|guadecitabine|mesh-list
64456365|NCT01752933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456366|NCT01752855|Adalimumab|adalimumab|mesh-list
64456367|NCT01752855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64456368|NCT01752855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64456369|NCT01402492|Naltrexone|naltrexone|mesh-list
64456370|NCT01402492|Buprenorphine|buprenorphine|mesh-list
64484477|NCT04658927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64456371|NCT01402492|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64456372|NCT01402492|Naloxone|naloxone|mesh-list
64456373|NCT01402492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64456374|NCT01402492|Narcotics|narcotics|mesh-ancestor
64456375|NCT01402492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64456376|NCT01402492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456377|NCT01402492|Analgesics|analgesics|mesh-ancestor
64456378|NCT01402492|Sensory System Agents|sensory system agents|mesh-ancestor
64456379|NCT01402492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456380|NCT01402492|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64456381|NCT01402492|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64456382|NCT01894256|Olaparib|olaparib|mesh-list
64579525|NCT04756661|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64579526|NCT04756661|Abortifacient Agents|abortifacient agents|mesh-ancestor
64579527|NCT04756661|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64579528|NCT04756661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64579529|NCT01708629|Ustekinumab|ustekinumab|mesh-list
64579530|NCT01708629|Brodalumab|brodalumab|mesh-list
64579531|NCT01708629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64579532|NCT01708629|Dermatologic Agents|dermatologic agents|mesh-ancestor
64579533|NCT01708629|Immunologic Factors|immunologic factors|mesh-ancestor
64579567|NCT00074165|Alkylating Agents|alkylating agents|mesh-ancestor
64579568|NCT00074165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579569|NCT00074165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579570|NCT00074165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64579571|NCT00074165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64579572|NCT00074165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64579573|NCT00074165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64579574|NCT00074165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64579575|NCT00074165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579604|NCT00075335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64579605|NCT00075335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64579606|NCT00075335|Antiviral Agents|antiviral agents|mesh-ancestor
64579607|NCT00075335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64579608|NCT01680549|Gabapentin|gabapentin|mesh-list
64579609|NCT01680549|Analgesics|analgesics|mesh-ancestor
64579610|NCT01680549|Sensory System Agents|sensory system agents|mesh-ancestor
64579611|NCT01680549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64579612|NCT01680549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579613|NCT01680549|Anticonvulsants|anticonvulsants|mesh-ancestor
64579614|NCT01680549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64579615|NCT01680549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64579616|NCT01680549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64579617|NCT01680549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64579618|NCT01680549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64579619|NCT01680549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64456383|NCT01894256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64456384|NCT01894256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64456385|NCT01894256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456386|NCT01894256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456387|NCT01780935|Ranibizumab|ranibizumab|mesh-list
64456388|NCT01780935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64456389|NCT01780935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64579620|NCT01680549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64579621|NCT01680549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579623|NCT01466348|Acetaminophen|acetaminophen|mesh-list
64579624|NCT01466348|Caffeine|caffeine|mesh-list
64579625|NCT01466348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64579626|NCT01466348|Analgesics|analgesics|mesh-ancestor
64579627|NCT01466348|Sensory System Agents|sensory system agents|mesh-ancestor
64579660|NCT00120523|Analgesics|analgesics|mesh-ancestor
64579661|NCT00120523|Sensory System Agents|sensory system agents|mesh-ancestor
64579662|NCT00120523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64579663|NCT00120523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579664|NCT00120523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64579666|NCT00120523|Dermatologic Agents|dermatologic agents|mesh-ancestor
64579667|NCT00120523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64634495|NCT02856594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64579668|NCT00120523|Immunologic Factors|immunologic factors|mesh-ancestor
64579669|NCT00120523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64579738|NCT05698524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579739|NCT05698524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518469|NCT03237312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518471|NCT00057681|Risperidone|risperidone|mesh-list
64518472|NCT00057681|Lithium Carbonate|lithium carbonate|mesh-list
64518473|NCT00057681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64518474|NCT00057681|Serotonin Agents|serotonin agents|mesh-ancestor
64518475|NCT00057681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64518476|NCT00057681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518477|NCT00057681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518478|NCT00057681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64634499|NCT02856594|Analgesics|analgesics|mesh-ancestor
64456390|NCT01780935|Growth Substances|growth substances|mesh-ancestor
64456391|NCT01780935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456392|NCT01780935|Growth Inhibitors|growth inhibitors|mesh-ancestor
64456406|NCT01422382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64456407|NCT01422382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64456408|NCT01422382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64456409|NCT01422382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456410|NCT01422382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64456411|NCT01422382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456412|NCT01422382|Vasodilator Agents|vasodilator agents|mesh-ancestor
64456413|NCT01422382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64456414|NCT01422382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64456415|NCT01422382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64456416|NCT01422382|Antimetabolites|antimetabolites|mesh-ancestor
64456417|NCT01422382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64456418|NCT01422382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64518479|NCT00057681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64518480|NCT00057681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64518481|NCT00057681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64518482|NCT00057681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64518483|NCT00057681|Dopamine Agents|dopamine agents|mesh-ancestor
64579740|NCT05698524|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64579773|NCT00124579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64579774|NCT00124579|Glucocorticoids|glucocorticoids|mesh-ancestor
64579776|NCT00124579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64579777|NCT00124579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64579778|NCT00124579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579779|NCT00124579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64579780|NCT00124579|Immunologic Factors|immunologic factors|mesh-ancestor
64579781|NCT00124579|Leprostatic Agents|leprostatic agents|mesh-ancestor
64579782|NCT00124579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64579783|NCT00124579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64579784|NCT00124579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64579819|NCT00125515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579820|NCT00125515|Sensory System Agents|sensory system agents|mesh-ancestor
64579821|NCT00125515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64532131|NCT01523587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64532132|NCT01523587|Afatinib|afatinib|mesh-list
64532133|NCT01523587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532134|NCT01523587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64532135|NCT01523587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532136|NCT01523587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532137|NCT00310401|Albuterol|albuterol|mesh-list
64532138|NCT00310401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64532146|NCT00310401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64532147|NCT00310401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64532149|NCT00310401|Adrenergic Agents|adrenergic agents|mesh-ancestor
64532150|NCT00310401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64456419|NCT01401322|Lenalidomide|lenalidomide|mesh-list
64456420|NCT01401322|Immunologic Factors|immunologic factors|mesh-ancestor
64456421|NCT01401322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456422|NCT01401322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64456423|NCT01401322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64456424|NCT01401322|Growth Substances|growth substances|mesh-ancestor
64456425|NCT01401322|Growth Inhibitors|growth inhibitors|mesh-ancestor
64456426|NCT01401322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456427|NCT01401010|Doripenem|doripenem|mesh-list
64456428|NCT01401010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64456429|NCT01401010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64456430|NCT01400932|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64456431|NCT01400932|Dermatologic Agents|dermatologic agents|mesh-ancestor
64456432|NCT01890746|Cytarabine|cytarabine|mesh-list
64456433|NCT01890746|Daunorubicin|daunorubicin|mesh-list
64456434|NCT01890746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64456435|NCT01890746|Antimetabolites|antimetabolites|mesh-ancestor
64456436|NCT01890746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456437|NCT01890746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456438|NCT01890746|Antiviral Agents|antiviral agents|mesh-ancestor
64456439|NCT01890746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64456440|NCT01890746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64456441|NCT01890746|Immunologic Factors|immunologic factors|mesh-ancestor
64579822|NCT00125515|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64579823|NCT00125515|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64579859|NCT04753177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64579861|NCT04753177|Tubulin Modulators|tubulin modulators|mesh-ancestor
64579862|NCT04753177|Antimitotic Agents|antimitotic agents|mesh-ancestor
64579863|NCT04753177|Mitosis Modulators|mitosis modulators|mesh-ancestor
64579890|NCT01691313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579892|NCT01691313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64579893|NCT01691313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579894|NCT00079001|Vitamin D|vitamin d|mesh-list
64579895|NCT00079001|Zoledronic Acid|zoledronic acid|mesh-list
64579896|NCT00079001|Calcium|calcium|mesh-list
64634599|NCT02106988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579897|NCT00079001|Androgens|androgens|mesh-list
64579898|NCT00079001|Vitamins|vitamins|mesh-ancestor
64579899|NCT00079001|Micronutrients|micronutrients|mesh-ancestor
64579900|NCT00079001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579901|NCT00079001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64579902|NCT00079001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64579903|NCT00079001|Hormones|hormones|mesh-ancestor
64579904|NCT00079001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64579905|NCT05234307|Nivolumab|nivolumab|mesh-list
64579906|NCT05234307|Adenosine|adenosine|mesh-list
64580003|NCT05168475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64580004|NCT05168475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580005|NCT05168475|Immunologic Factors|immunologic factors|mesh-ancestor
64580006|NCT05168475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580007|NCT05168475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64580008|NCT05168475|Dermatologic Agents|dermatologic agents|mesh-ancestor
64580009|NCT05168475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64518484|NCT00057681|Antidepressive Agents|antidepressive agents|mesh-ancestor
64456442|NCT01890746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456443|NCT01890746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64456444|NCT01890746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64456445|NCT01890746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64456447|NCT01422304|Atropine|atropine|mesh-list
64456448|NCT01422304|Glycopyrrolate|glycopyrrolate|mesh-list
64456449|NCT01422304|Neostigmine|neostigmine|mesh-list
64456450|NCT01422304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64456451|NCT01422304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64456452|NCT01422304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64456453|NCT01422304|Autonomic Agents|autonomic agents|mesh-ancestor
64456454|NCT01422304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64532151|NCT00310401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518485|NCT00057681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518486|NCT00057681|Antimanic Agents|antimanic agents|mesh-ancestor
64518487|NCT00057681|Anticonvulsants|anticonvulsants|mesh-ancestor
64518488|NCT00057681|GABA Agents|gaba agents|mesh-ancestor
64518489|NCT03234816|Norepinephrine|norepinephrine|mesh-list
64518490|NCT03234816|Bupivacaine|bupivacaine|mesh-list
64518491|NCT03234816|Anesthetics, Local|anesthetics, local|mesh-ancestor
64518492|NCT03234816|Anesthetics|anesthetics|mesh-ancestor
64518493|NCT03234816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64518494|NCT03234816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518495|NCT03234816|Sensory System Agents|sensory system agents|mesh-ancestor
64518496|NCT03234816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64518497|NCT03234816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64518498|NCT03234816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64518499|NCT03234816|Adrenergic Agents|adrenergic agents|mesh-ancestor
64518500|NCT03234816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64518501|NCT03234816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518502|NCT03234816|Sympathomimetics|sympathomimetics|mesh-ancestor
64518503|NCT03234816|Autonomic Agents|autonomic agents|mesh-ancestor
64518504|NCT03234816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64518505|NCT03247452|Ascorbic Acid|ascorbic acid|mesh-list
64518506|NCT03247452|Antioxidants|antioxidants|mesh-ancestor
64518507|NCT03247452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518508|NCT03247452|Protective Agents|protective agents|mesh-ancestor
64518509|NCT03247452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518510|NCT03247452|Vitamins|vitamins|mesh-ancestor
64518511|NCT03247452|Micronutrients|micronutrients|mesh-ancestor
64580010|NCT03088709|Mycophenolic Acid|mycophenolic acid|mesh-list
64580011|NCT03088709|Cyclophosphamide|cyclophosphamide|mesh-list
64580012|NCT03088709|Tacrolimus|tacrolimus|mesh-list
64580013|NCT03088709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64580014|NCT03088709|Immunologic Factors|immunologic factors|mesh-ancestor
64580029|NCT03139305|Glucagon|glucagon|mesh-list
64580045|NCT00084149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580046|NCT00084149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64580047|NCT00084149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64518512|NCT03247140|Amlodipine|amlodipine|mesh-list
64518513|NCT03247140|Telmisartan|telmisartan|mesh-list
64518514|NCT03247140|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
64518515|NCT03247140|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64518516|NCT03247140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64518517|NCT03247140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64518518|NCT03247140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64518519|NCT03247140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518520|NCT03247140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64518521|NCT03247140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518522|NCT03247140|Vasodilator Agents|vasodilator agents|mesh-ancestor
64580048|NCT00084149|Antiviral Agents|antiviral agents|mesh-ancestor
64580049|NCT00084149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64580050|NCT00084149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64580051|NCT00084149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64580052|NCT00084149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64580054|NCT00084149|Antimetabolites|antimetabolites|mesh-ancestor
64586311|NCT00426517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64580185|NCT00252967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580186|NCT00252967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64580187|NCT00252967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64580188|NCT00252967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580189|NCT00088985|Trastuzumab|trastuzumab|mesh-list
64580190|NCT00088985|Vinorelbine|vinorelbine|mesh-list
64580191|NCT00088985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64580192|NCT00088985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580193|NCT00088985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64580194|NCT00088985|Tubulin Modulators|tubulin modulators|mesh-ancestor
64580195|NCT00088985|Antimitotic Agents|antimitotic agents|mesh-ancestor
64518524|NCT03247140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64518525|NCT03247140|Antimetabolites|antimetabolites|mesh-ancestor
64518526|NCT03247140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64518527|NCT03247140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64518528|NCT03247140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518529|NCT03247140|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64518530|NCT03247140|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64518532|NCT03237546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64518533|NCT03237546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518534|NCT03247296|Ribavirin|ribavirin|mesh-list
64518535|NCT03247296|Sofosbuvir|sofosbuvir|mesh-list
64518536|NCT03247296|Antimetabolites|antimetabolites|mesh-ancestor
64736754|NCT00616343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64580233|NCT00159263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64580264|NCT02926833|Atezolizumab|atezolizumab|mesh-list
64580265|NCT02926833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64580266|NCT02926833|Immunologic Factors|immunologic factors|mesh-ancestor
64580267|NCT02926833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580268|NCT02926833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64532153|NCT00310791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64532154|NCT00310791|Hormones|hormones|mesh-list
64532155|NCT00310791|Estradiol|estradiol|mesh-list
64532156|NCT00310791|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64532157|NCT00310791|Estrogens|estrogens|mesh-list
64532158|NCT00310791|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64532159|NCT00310791|Progestins|progestins|mesh-list
64532160|NCT00310791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64532161|NCT00310791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532162|NCT00310791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64532163|NCT00310791|Contraceptive Agents|contraceptive agents|mesh-ancestor
64296716|NCT03300609|Tetrahydrofolates|tetrahydrofolates|mesh-list
64580269|NCT02926833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64580270|NCT02926833|Alkylating Agents|alkylating agents|mesh-ancestor
64580271|NCT02926833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580272|NCT02926833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580273|NCT02926833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64580274|NCT00096161|Cyclosporine|cyclosporine|mesh-list
64580308|NCT01898039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580309|NCT01898039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64580310|NCT00099047|Celecoxib|celecoxib|mesh-list
64580311|NCT00099047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64580312|NCT00099047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64580313|NCT00099047|Analgesics|analgesics|mesh-ancestor
64580314|NCT00099047|Sensory System Agents|sensory system agents|mesh-ancestor
64580315|NCT00099047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64586312|NCT00426517|Immunologic Factors|immunologic factors|mesh-ancestor
64580345|NCT00253513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580346|NCT00253513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64580349|NCT05033847|Immunologic Factors|immunologic factors|mesh-ancestor
64580350|NCT05033847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580351|NCT04963725|Ustekinumab|ustekinumab|mesh-list
64580352|NCT04963725|Dermatologic Agents|dermatologic agents|mesh-ancestor
64580353|NCT02098993|Heparin|heparin|mesh-list
64580354|NCT02098993|Calcium heparin|calcium heparin|mesh-list
64518551|NCT03237624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64518552|NCT03237624|Antimetabolites|antimetabolites|mesh-ancestor
64580400|NCT04908579|Anesthetics, Local|anesthetics, local|mesh-ancestor
64580401|NCT04908579|Anesthetics|anesthetics|mesh-ancestor
64580402|NCT04908579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64580434|NCT02096081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580435|NCT02096081|Cholinergic Agents|cholinergic agents|mesh-ancestor
64580436|NCT02096081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64580437|NCT02096081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580438|NCT02096081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64580439|NCT02096081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64580440|NCT02240589|Memantine|memantine|mesh-list
64580441|NCT02240589|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64580473|NCT00258349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580474|NCT00258349|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64580475|NCT00258349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580476|NCT00258349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580477|NCT01713621|Artefenomel|artefenomel|mesh-list
64580478|NCT01713621|Antimalarials|antimalarials|mesh-ancestor
64580479|NCT01713621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64580480|NCT01713621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64580481|NCT01713621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64580482|NCT05165485|Tiotropium Bromide|tiotropium bromide|mesh-list
64580483|NCT05165485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64580534|NCT01716195|Paclitaxel|paclitaxel|mesh-list
64580535|NCT01716195|Carboplatin|carboplatin|mesh-list
64580536|NCT01716195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64580557|NCT01717053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64580558|NCT01717053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580559|NCT01717053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64580560|NCT01717053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580561|NCT01717053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580562|NCT01717053|Hormone Antagonists|hormone antagonists|mesh-ancestor
64580563|NCT01717053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64580564|NCT01666314|Prednisone|prednisone|mesh-list
64580565|NCT01666314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64580566|NCT01666314|Glucocorticoids|glucocorticoids|mesh-ancestor
64580568|NCT01666314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64580569|NCT01666314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580570|NCT01666314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64580571|NCT01666314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580572|NCT01717209|Epoprostenol|epoprostenol|mesh-list
64580573|NCT01717209|Nitric Oxide|nitric oxide|mesh-list
64580574|NCT01717209|Tezosentan|tezosentan|mesh-list
64580575|NCT01717209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64580576|NCT01717209|Autonomic Agents|autonomic agents|mesh-ancestor
64580577|NCT01717209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64580578|NCT01717209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580579|NCT01717209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64580580|NCT01717209|Respiratory System Agents|respiratory system agents|mesh-ancestor
64580581|NCT01717209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64580582|NCT01717209|Antioxidants|antioxidants|mesh-ancestor
64580583|NCT01717209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580584|NCT01717209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64580585|NCT01717209|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64580586|NCT01717209|Vasodilator Agents|vasodilator agents|mesh-ancestor
64580587|NCT01717209|Gasotransmitters|gasotransmitters|mesh-ancestor
64634791|NCT00109395|Midazolam|midazolam|mesh-list
64296717|NCT03300609|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
64456455|NCT01422304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456456|NCT01422304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64456474|NCT01387516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64456475|NCT01387516|Cholinergic Agents|cholinergic agents|mesh-ancestor
64456476|NCT01387516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64580588|NCT01717209|Protective Agents|protective agents|mesh-ancestor
64580589|NCT01717209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64580590|NCT01717209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64580591|NCT05535738|Fluticasone|fluticasone|mesh-list
64580664|NCT01062451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64586313|NCT00426517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580726|NCT04425642|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64580727|NCT04425642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64580728|NCT04425642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64580729|NCT04425642|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64580730|NCT04425642|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64580731|NCT04425642|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64580732|NCT04425642|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64580733|NCT00266851|Azithromycin|azithromycin|mesh-list
64580734|NCT00266851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64580735|NCT00266851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64580736|NCT00015847|Interferons|interferons|mesh-list
64580737|NCT00015847|Interferon-alpha|interferon-alpha|mesh-list
64580738|NCT00015847|Imatinib Mesylate|imatinib mesylate|mesh-list
64580739|NCT00015847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580740|NCT00015847|Antiviral Agents|antiviral agents|mesh-ancestor
64580741|NCT00015847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64518561|NCT03234660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64518562|NCT03234660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580780|NCT00017563|Docetaxel|docetaxel|mesh-list
64580858|NCT01721967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64580859|NCT01721967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64580860|NCT01721967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580861|NCT04026451|Propofol|propofol|mesh-list
64580862|NCT04026451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64580863|NCT04026451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64580864|NCT04026451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580865|NCT04026451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64580866|NCT04026451|Anesthetics, General|anesthetics, general|mesh-ancestor
64580867|NCT04026451|Anesthetics|anesthetics|mesh-ancestor
64580868|NCT01722435|Opiate Alkaloids|opiate alkaloids|mesh-list
64580869|NCT01722435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64580870|NCT01722435|Narcotics|narcotics|mesh-ancestor
64580871|NCT01722435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64580872|NCT01722435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580873|NCT01722435|Analgesics|analgesics|mesh-ancestor
64580874|NCT01722435|Sensory System Agents|sensory system agents|mesh-ancestor
64580875|NCT01722435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64580876|NCT00029107|Rituximab|rituximab|mesh-list
64580877|NCT00029107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64580878|NCT00029107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580879|NCT00029107|Immunologic Factors|immunologic factors|mesh-ancestor
64580880|NCT00029107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580899|NCT03861702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64580900|NCT03861702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64580902|NCT03861702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580903|NCT03861702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580904|NCT03723252|Dapagliflozin|dapagliflozin|mesh-list
64580905|NCT03723252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64580906|NCT03723252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580907|NCT03723252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64580908|NCT03723252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580909|NCT05538702|Menthol|menthol|mesh-list
64580910|NCT05538702|Antipruritics|antipruritics|mesh-ancestor
64580911|NCT05538702|Dermatologic Agents|dermatologic agents|mesh-ancestor
64580912|NCT00271219|Buprenorphine|buprenorphine|mesh-list
64634894|NCT00004162|Antimetabolites|antimetabolites|mesh-ancestor
64580916|NCT00271219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64580917|NCT00271219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580918|NCT00271219|Analgesics|analgesics|mesh-ancestor
64580919|NCT00271219|Sensory System Agents|sensory system agents|mesh-ancestor
64518564|NCT03234660|Analgesics|analgesics|mesh-ancestor
64518565|NCT03234660|Sensory System Agents|sensory system agents|mesh-ancestor
64518566|NCT03234660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64518567|NCT03234660|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64518568|NCT03234660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64518569|NCT03234660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64580920|NCT00271219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64580921|NCT00271219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64580922|NCT00271219|Antitussive Agents|antitussive agents|mesh-ancestor
64580923|NCT00271219|Respiratory System Agents|respiratory system agents|mesh-ancestor
64580924|NCT03340506|Trametinib|trametinib|mesh-list
64580925|NCT03340506|Dabrafenib|dabrafenib|mesh-list
64580926|NCT03340506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580927|NCT03340506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64580928|NCT03340506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580929|NCT03340506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580930|NCT02240667|Vitamin K|vitamin k|mesh-list
64580931|NCT02240667|Dabigatran|dabigatran|mesh-list
64580932|NCT02240667|Phenprocoumon|phenprocoumon|mesh-list
64580933|NCT02240667|Vitamins|vitamins|mesh-ancestor
64580934|NCT02240667|Micronutrients|micronutrients|mesh-ancestor
64580935|NCT02240667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580936|NCT02240667|Antithrombins|antithrombins|mesh-ancestor
64580937|NCT02240667|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64580938|NCT02240667|Protease Inhibitors|protease inhibitors|mesh-ancestor
64580939|NCT02240667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580958|NCT00272311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64580959|NCT00272311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64580960|NCT00272311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580961|NCT00272311|Antipyretics|antipyretics|mesh-ancestor
64634909|NCT00004174|Paclitaxel|paclitaxel|mesh-list
64456477|NCT01387516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652440|NCT02472366|Hormones|hormones|mesh-ancestor
64456487|NCT01421134|Adrenergic Agents|adrenergic agents|mesh-ancestor
64456488|NCT01421134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64456489|NCT01421134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456490|NCT01421134|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64580962|NCT00038857|Fludarabine|fludarabine|mesh-list
64580963|NCT00038857|Fludarabine phosphate|fludarabine phosphate|mesh-list
64580965|NCT00038857|Thiotepa|thiotepa|mesh-list
64580966|NCT00038857|Thymoglobulin|thymoglobulin|mesh-list
64580967|NCT00038857|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64580968|NCT00038857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580969|NCT00038857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64580970|NCT00038857|Antimetabolites|antimetabolites|mesh-ancestor
64580971|NCT00038857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580972|NCT00038857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64580973|NCT00038857|Immunologic Factors|immunologic factors|mesh-ancestor
64580974|NCT00038857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580975|NCT00038857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64580976|NCT00038857|Alkylating Agents|alkylating agents|mesh-ancestor
64580977|NCT00038857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64580978|NCT03097068|Ranibizumab|ranibizumab|mesh-list
64580979|NCT03097068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64580980|NCT03097068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64580981|NCT03097068|Growth Substances|growth substances|mesh-ancestor
64580982|NCT03097068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580983|NCT03097068|Growth Inhibitors|growth inhibitors|mesh-ancestor
64580984|NCT03097068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580985|NCT01729845|Cytarabine|cytarabine|mesh-list
64580986|NCT01729845|Etoposide|etoposide|mesh-list
64580987|NCT01729845|Podophyllotoxin|podophyllotoxin|mesh-list
64580988|NCT01729845|Mitoxantrone|mitoxantrone|mesh-list
64580989|NCT01729845|Etoposide phosphate|etoposide phosphate|mesh-list
64580990|NCT01729845|Decitabine|decitabine|mesh-list
64580991|NCT01729845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64580992|NCT01729845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581063|NCT02502006|Analgesics|analgesics|mesh-ancestor
64581064|NCT02502006|Sensory System Agents|sensory system agents|mesh-ancestor
64581092|NCT03520491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581093|NCT03520491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64581094|NCT03520491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581097|NCT05588934|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64581098|NCT05588934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581099|NCT05588934|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64581100|NCT05588934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581101|NCT05588934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581102|NCT05588934|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64581103|NCT05588934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64581104|NCT05588934|Purinergic Agents|purinergic agents|mesh-ancestor
64581105|NCT05588934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64581106|NCT02243007|Gemcitabine|gemcitabine|mesh-list
64581107|NCT02243007|Paclitaxel|paclitaxel|mesh-list
64581108|NCT02243007|Capecitabine|capecitabine|mesh-list
64581109|NCT02243007|Folfirinox|folfirinox|mesh-list
64581122|NCT02243007|Immunologic Factors|immunologic factors|mesh-ancestor
64581123|NCT02243007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581124|NCT05536596|Hydroxocobalamin|hydroxocobalamin|mesh-list
64581125|NCT05536596|Vitamin B 12|vitamin b 12|mesh-list
64581126|NCT05536596|Melatonin|melatonin|mesh-list
64581127|NCT05536596|Antioxidants|antioxidants|mesh-ancestor
64581128|NCT05536596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581129|NCT05536596|Protective Agents|protective agents|mesh-ancestor
64581153|NCT05536284|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64581154|NCT05536284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64581155|NCT05536284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64581156|NCT05536284|Adrenergic Agents|adrenergic agents|mesh-ancestor
64581157|NCT05536284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64581158|NCT05536284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581159|NCT05536128|Olaparib|olaparib|mesh-list
64581160|NCT05536128|Fulvestrant|fulvestrant|mesh-list
64581161|NCT05536128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64581162|NCT05536128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581163|NCT05536128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581164|NCT05536128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581165|NCT05536128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64518575|NCT04485780|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64518576|NCT04485780|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64518577|NCT04485780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64518578|NCT04485780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518579|NCT04485780|Cholinergic Agents|cholinergic agents|mesh-ancestor
64518580|NCT04485780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64581166|NCT05536128|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64581167|NCT05536128|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64581168|NCT05536128|Hormone Antagonists|hormone antagonists|mesh-ancestor
64581169|NCT05536128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64581170|NCT05536128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581210|NCT01739361|Sensory System Agents|sensory system agents|mesh-ancestor
64634991|NCT00004192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64634992|NCT00004192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64581214|NCT01743729|Lifitegrast|lifitegrast|mesh-list
64581227|NCT01744821|Cholecalciferol|cholecalciferol|mesh-list
64581228|NCT01744821|Vitamins|vitamins|mesh-ancestor
64581229|NCT01744821|Micronutrients|micronutrients|mesh-ancestor
64581230|NCT01744821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581231|NCT01744821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64581232|NCT01744821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64581233|NCT04369365|Azithromycin|azithromycin|mesh-list
64581234|NCT04369365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64581235|NCT04369365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64581236|NCT01745055|Methotrexate|methotrexate|mesh-list
64581237|NCT01745055|Tofacitinib|tofacitinib|mesh-list
64581238|NCT01745055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64581239|NCT01745055|Abortifacient Agents|abortifacient agents|mesh-ancestor
64581240|NCT01745055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64581241|NCT01745055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581242|NCT01745055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64581278|NCT05302011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581280|NCT04769271|Tea Tree Oil|tea tree oil|mesh-list
64581349|NCT00106535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64581350|NCT01748799|Ethanol|ethanol|mesh-list
64581351|NCT01748799|Nabiximols|nabiximols|mesh-list
64581352|NCT01748799|Dronabinol|dronabinol|mesh-list
64581353|NCT01748799|Cannabidiol|cannabidiol|mesh-list
64581354|NCT01748799|Peppermint oil|peppermint oil|mesh-list
64581355|NCT01748799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64581356|NCT01748799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64581357|NCT01748799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64581358|NCT01748799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518591|NCT00059475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64518592|NCT00059475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518593|NCT00059475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64518594|NCT00059475|Immunologic Factors|immunologic factors|mesh-ancestor
64518595|NCT00059475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64518596|NCT00059475|Antiviral Agents|antiviral agents|mesh-ancestor
64518597|NCT00059475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64518598|NCT00059475|Interferon Inducers|interferon inducers|mesh-ancestor
64581370|NCT01748799|Hormones|hormones|mesh-ancestor
64581371|NCT01748799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64581372|NCT01748799|Antiemetics|antiemetics|mesh-ancestor
64581373|NCT01748799|Autonomic Agents|autonomic agents|mesh-ancestor
64581374|NCT01748799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64581375|NCT01748799|Parasympatholytics|parasympatholytics|mesh-ancestor
64581376|NCT04107051|Nalmefene|nalmefene|mesh-list
64581377|NCT04107051|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64581378|NCT04107051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581379|NCT04107051|Sensory System Agents|sensory system agents|mesh-ancestor
64581380|NCT04107051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581381|NCT05696886|Meperidine|meperidine|mesh-list
64581382|NCT05696886|Tramadol|tramadol|mesh-list
64581383|NCT05696886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64581384|NCT05696886|Narcotics|narcotics|mesh-ancestor
64581385|NCT05696886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64581419|NCT05156268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64581420|NCT05156268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581421|NCT05156268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64581422|NCT05156268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581423|NCT05156268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581424|NCT01749501|Rocuronium|rocuronium|mesh-list
64581425|NCT01749501|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64581458|NCT03899103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581502|NCT05299866|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64518601|NCT02453802|Tranylcypromine|tranylcypromine|mesh-list
64518602|NCT02453802|Rivaroxaban|rivaroxaban|mesh-list
64518603|NCT02453802|Tranexamic Acid|tranexamic acid|mesh-list
64518604|NCT02453802|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64518605|NCT02453802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64635082|NCT00005026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518606|NCT02453802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581504|NCT05299866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581541|NCT02250807|Sofosbuvir|sofosbuvir|mesh-list
64581542|NCT02250807|Simeprevir|simeprevir|mesh-list
64581543|NCT02250807|Antiviral Agents|antiviral agents|mesh-ancestor
64581672|NCT05162742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581673|NCT04303026|Zoledronic Acid|zoledronic acid|mesh-list
64581736|NCT00116207|Antioxidants|antioxidants|mesh-list
64581737|NCT00116207|Antimetabolites|antimetabolites|mesh-ancestor
64581738|NCT00116207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581739|NCT00116207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581740|NCT00116207|Gout Suppressants|gout suppressants|mesh-ancestor
64581741|NCT00116207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64581742|NCT00116207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64581743|NCT00116207|Protective Agents|protective agents|mesh-ancestor
64581744|NCT00116207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581745|NCT00116207|Vitamin B Complex|vitamin b complex|mesh-ancestor
64581746|NCT00116207|Vitamins|vitamins|mesh-ancestor
64581747|NCT00116207|Micronutrients|micronutrients|mesh-ancestor
64581748|NCT04129398|Letermovir|letermovir|mesh-list
64581749|NCT04129398|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64581750|NCT04129398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581751|NCT04129398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581752|NCT04129398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581784|NCT03453489|Tryptophan|tryptophan|mesh-list
64581785|NCT03453489|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64581786|NCT03453489|Antidepressive Agents|antidepressive agents|mesh-ancestor
64581787|NCT03453489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64581788|NCT04284839|Warfarin|warfarin|mesh-list
64581789|NCT04284839|Rivaroxaban|rivaroxaban|mesh-list
64581790|NCT04284839|Dabigatran|dabigatran|mesh-list
64581791|NCT04284839|Apixaban|apixaban|mesh-list
64581792|NCT04284839|Edoxaban|edoxaban|mesh-list
64581793|NCT04284839|Anticoagulants|anticoagulants|mesh-ancestor
64581794|NCT04284839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64581795|NCT04284839|Antithrombins|antithrombins|mesh-ancestor
64581796|NCT04284839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64581797|NCT04284839|Protease Inhibitors|protease inhibitors|mesh-ancestor
64581798|NCT04284839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581799|NCT04284839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581800|NCT05656248|Cytarabine|cytarabine|mesh-list
64581801|NCT05656248|Hydrocortisone|hydrocortisone|mesh-list
64581802|NCT05656248|Methotrexate|methotrexate|mesh-list
64581803|NCT05656248|Daunorubicin|daunorubicin|mesh-list
64581804|NCT05656248|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64581805|NCT05656248|Abortifacient Agents|abortifacient agents|mesh-ancestor
64581806|NCT05656248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64581807|NCT05656248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518609|NCT02453802|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64518610|NCT02453802|Antithrombins|antithrombins|mesh-ancestor
64518611|NCT02453802|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64518612|NCT02453802|Protease Inhibitors|protease inhibitors|mesh-ancestor
64518613|NCT02453802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518614|NCT02453802|Anticoagulants|anticoagulants|mesh-ancestor
64581872|NCT00125957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581873|NCT00125957|Dopamine Agents|dopamine agents|mesh-ancestor
64581874|NCT00125957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64581875|NCT00125957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581876|NCT00125957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64581877|NCT00125957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64581878|NCT00125957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581879|NCT00183443|Valproic Acid|valproic acid|mesh-list
64581880|NCT00183443|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64581881|NCT00183443|Antidepressive Agents|antidepressive agents|mesh-ancestor
64581882|NCT00183443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64581883|NCT00183443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64581884|NCT00183443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64581885|NCT00183443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64581942|NCT00041119|Paclitaxel|paclitaxel|mesh-list
64581943|NCT00041119|Cyclophosphamide|cyclophosphamide|mesh-list
64581944|NCT00041119|Doxorubicin|doxorubicin|mesh-list
64581945|NCT00041119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64581946|NCT00041119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64581947|NCT00041119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581948|NCT00041119|Tubulin Modulators|tubulin modulators|mesh-ancestor
64581949|NCT00041119|Antimitotic Agents|antimitotic agents|mesh-ancestor
64581950|NCT00041119|Mitosis Modulators|mitosis modulators|mesh-ancestor
64581951|NCT00041119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581952|NCT00041119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64581953|NCT00041119|Immunologic Factors|immunologic factors|mesh-ancestor
64581954|NCT00041119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581955|NCT00041119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64581956|NCT00041119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64581957|NCT00041119|Alkylating Agents|alkylating agents|mesh-ancestor
64581958|NCT00041119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64581959|NCT00041119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64582021|NCT00551460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64582023|NCT00551460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64456491|NCT01421134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64456492|NCT01421134|Serotonin Agents|serotonin agents|mesh-ancestor
64456493|NCT01421134|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64456494|NCT01421134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64456495|NCT01421134|Dopamine Agents|dopamine agents|mesh-ancestor
64456496|NCT01894022|Ambrisentan|ambrisentan|mesh-list
64582024|NCT00551460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582025|NCT00551460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64582026|NCT00551460|Antimetabolites|antimetabolites|mesh-ancestor
64518620|NCT02453802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64518621|NCT02453802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518622|NCT02028676|Lamivudine|lamivudine|mesh-list
64518623|NCT02028676|Zidovudine|zidovudine|mesh-list
64518624|NCT02028676|Efavirenz|efavirenz|mesh-list
64518625|NCT02028676|Nevirapine|nevirapine|mesh-list
64518626|NCT02028676|Abacavir|abacavir|mesh-list
64518627|NCT02028676|Dideoxynucleosides|dideoxynucleosides|mesh-list
64518628|NCT02028676|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64518629|NCT02028676|Trimethoprim|trimethoprim|mesh-list
64518630|NCT02028676|Sulfamethoxazole|sulfamethoxazole|mesh-list
64518631|NCT02028676|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64518632|NCT02028676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64518633|NCT02028676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64518634|NCT02028676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582027|NCT00551460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582028|NCT00551460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582029|NCT00551460|Dermatologic Agents|dermatologic agents|mesh-ancestor
64582030|NCT00551460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582031|NCT00551460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64582032|NCT00551460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64582033|NCT00551460|Immunologic Factors|immunologic factors|mesh-ancestor
64582034|NCT00551460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64582035|NCT00551460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64582036|NCT00551460|Keratolytic Agents|keratolytic agents|mesh-ancestor
64456497|NCT01894022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64456500|NCT01386970|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64456501|NCT01386970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64456502|NCT01386970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64456503|NCT01386970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64456504|NCT01386970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456505|NCT01386970|Antiviral Agents|antiviral agents|mesh-ancestor
64456506|NCT01386970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64456507|NCT01386970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64456508|NCT01386970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64456509|NCT01386970|Antimetabolites|antimetabolites|mesh-ancestor
64456510|NCT01385566|Vaccines|vaccines|mesh-list
64456511|NCT01385566|Immunologic Factors|immunologic factors|mesh-ancestor
64456512|NCT01385566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456546|NCT01865084|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64456547|NCT01865084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64456548|NCT01865084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64714125|NCT00374101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64582037|NCT00551460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64582038|NCT04751227|Modafinil|modafinil|mesh-list
64582039|NCT04751227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64582093|NCT00044005|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64582095|NCT00044005|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64582096|NCT00044005|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64582097|NCT00044005|Dopamine Agents|dopamine agents|mesh-ancestor
64582098|NCT02989701|Plerixafor|plerixafor|mesh-list
64582204|NCT05534802|Urinastatin|urinastatin|mesh-list
64582205|NCT05534802|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64582206|NCT05534802|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64582240|NCT04123873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64582241|NCT04123873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64582242|NCT04123873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582243|NCT04123873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64582244|NCT04123873|Analgesics|analgesics|mesh-ancestor
64582245|NCT04123873|Sensory System Agents|sensory system agents|mesh-ancestor
64582246|NCT04123873|Antipyretics|antipyretics|mesh-ancestor
64582247|NCT04123873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64582248|NCT04123873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64582249|NCT04123873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64582250|NCT04123873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582301|NCT02256189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582303|NCT00193037|Doxorubicin|doxorubicin|mesh-list
64582304|NCT00193037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64582305|NCT00193037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64488247|NCT03406546|Narcotics|narcotics|mesh-ancestor
64532164|NCT00310791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64532165|NCT00310791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64532166|NCT00310791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64532167|NCT00310791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64532168|NCT00310791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64532169|NCT00310791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64532170|NCT00310791|Immunologic Factors|immunologic factors|mesh-ancestor
64532172|NCT02362152|Fluorouracil|fluorouracil|mesh-list
64532173|NCT02362152|Imiquimod|imiquimod|mesh-list
64532174|NCT02362152|Antimetabolites|antimetabolites|mesh-ancestor
64532175|NCT02362152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532176|NCT02362152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64532177|NCT02362152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532178|NCT02362152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64532179|NCT02362152|Immunologic Factors|immunologic factors|mesh-ancestor
64532180|NCT02362152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532181|NCT02362152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64532182|NCT02362152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64532183|NCT02362152|Analgesics|analgesics|mesh-ancestor
64532184|NCT02362152|Sensory System Agents|sensory system agents|mesh-ancestor
64532185|NCT02362152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64582306|NCT00193037|Tubulin Modulators|tubulin modulators|mesh-ancestor
64582307|NCT00193037|Antimitotic Agents|antimitotic agents|mesh-ancestor
64582308|NCT00193037|Mitosis Modulators|mitosis modulators|mesh-ancestor
64518636|NCT02028676|Antiviral Agents|antiviral agents|mesh-ancestor
64518637|NCT02028676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64518638|NCT02028676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64518639|NCT02028676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64518640|NCT02028676|Antimetabolites|antimetabolites|mesh-ancestor
64518641|NCT02028676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64518642|NCT02028676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64518643|NCT02028676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64518644|NCT02028676|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64518645|NCT02028676|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64518646|NCT02028676|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64518647|NCT02028676|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64518648|NCT02028676|Renal Agents|renal agents|mesh-ancestor
64518649|NCT02028676|Antimalarials|antimalarials|mesh-ancestor
64518650|NCT02028676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64518651|NCT02028676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64582309|NCT00193037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582310|NCT00193037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64582311|NCT00193037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64582312|NCT00193037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64582366|NCT02783859|Amoxicillin|amoxicillin|mesh-list
64582367|NCT02783859|Clavulanic Acids|clavulanic acids|mesh-list
64582368|NCT02783859|Clavulanic Acid|clavulanic acid|mesh-list
64582369|NCT02783859|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64582370|NCT02783859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64582371|NCT02783859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64582372|NCT02783859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582373|NCT02783859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582374|NCT02783859|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64582375|NCT01765803|Thioridazine|thioridazine|mesh-list
64582376|NCT01765803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64582377|NCT01765803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64582380|NCT01765803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64582381|NCT01765803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64582382|NCT01765803|Dopamine Agents|dopamine agents|mesh-ancestor
64582383|NCT01765803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64582384|NCT01765803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582385|NCT02566395|Cyclophosphamide|cyclophosphamide|mesh-list
64582386|NCT02566395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64582387|NCT02566395|Immunologic Factors|immunologic factors|mesh-ancestor
64582388|NCT02566395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582389|NCT02566395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64582390|NCT02566395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64582391|NCT02566395|Alkylating Agents|alkylating agents|mesh-ancestor
64582392|NCT02566395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582393|NCT02566395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582394|NCT02566395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64582395|NCT01811355|Mexiletine|mexiletine|mesh-list
64582396|NCT01811355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64518652|NCT02028676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64518653|NCT02028676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64518654|NCT02028676|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64518655|NCT02028676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64518656|NCT03233880|Azithromycin|azithromycin|mesh-list
64518657|NCT03233880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64518658|NCT03233880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64582423|NCT01465802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582424|NCT01813149|Clonidine|clonidine|mesh-list
64582425|NCT01813149|Phenylephrine|phenylephrine|mesh-list
64582426|NCT01813149|Oxymetazoline|oxymetazoline|mesh-list
64582427|NCT01813149|Anesthetics|anesthetics|mesh-list
64296732|NCT03300609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64456549|NCT01865084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456550|NCT01865084|Urological Agents|urological agents|mesh-ancestor
64456581|NCT01385098|Cholecalciferol|cholecalciferol|mesh-list
64456582|NCT01385098|Vitamins|vitamins|mesh-list
64456583|NCT01385098|Calcium|calcium|mesh-list
64456584|NCT01385098|Micronutrients|micronutrients|mesh-ancestor
64456585|NCT01385098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456586|NCT01385098|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64456587|NCT01385098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64456588|NCT01398514|Citalopram|citalopram|mesh-list
64456589|NCT01398514|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64456590|NCT01398514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64456591|NCT01398514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64456592|NCT01398514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456593|NCT01398514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64456594|NCT01398514|Serotonin Agents|serotonin agents|mesh-ancestor
64582428|NCT01813149|Anesthetics, Local|anesthetics, local|mesh-list
64582429|NCT01813149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64582430|NCT01813149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582431|NCT01813149|Sensory System Agents|sensory system agents|mesh-ancestor
64582432|NCT01813149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64582433|NCT01813149|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64582434|NCT01813149|Mydriatics|mydriatics|mesh-ancestor
64582435|NCT01813149|Autonomic Agents|autonomic agents|mesh-ancestor
64582436|NCT01813149|Sympathomimetics|sympathomimetics|mesh-ancestor
64582437|NCT01813149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64582438|NCT01813149|Nasal Decongestants|nasal decongestants|mesh-ancestor
64582439|NCT01813149|Respiratory System Agents|respiratory system agents|mesh-ancestor
64582440|NCT01813149|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64582441|NCT01813149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64582443|NCT01813149|Adrenergic Agents|adrenergic agents|mesh-ancestor
64582467|NCT00137969|Glucocorticoids|glucocorticoids|mesh-ancestor
64582468|NCT00137969|Hormones|hormones|mesh-ancestor
64582469|NCT00137969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64582470|NCT00137969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64582471|NCT00137969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64582472|NCT00137969|Analgesics|analgesics|mesh-ancestor
64582473|NCT00137969|Sensory System Agents|sensory system agents|mesh-ancestor
64582474|NCT00137969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64582475|NCT00137969|Antipyretics|antipyretics|mesh-ancestor
64635367|NCT00005068|Vitamins|vitamins|mesh-ancestor
64456595|NCT01398514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456596|NCT01398514|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64532186|NCT02362152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64532188|NCT02362152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64532189|NCT02362152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532190|NCT02362152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64532191|NCT02362152|Interferon Inducers|interferon inducers|mesh-ancestor
64532192|NCT01493531|Allopurinol|allopurinol|mesh-list
64532193|NCT01493531|Lesinurad|lesinurad|mesh-list
64532194|NCT01493531|Antimetabolites|antimetabolites|mesh-ancestor
64532195|NCT01493531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296755|NCT03300531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64456597|NCT01398514|Antidepressive Agents|antidepressive agents|mesh-ancestor
64456598|NCT01398514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64456600|NCT03025282|Betamethasone Valerate|betamethasone valerate|mesh-list
64456601|NCT03025282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64456602|NCT03025282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64456603|NCT03025282|Glucocorticoids|glucocorticoids|mesh-ancestor
64456626|NCT01777581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456627|NCT01777581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64456628|NCT01777581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456629|NCT01777581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64456630|NCT01777581|Analgesics|analgesics|mesh-ancestor
64456631|NCT01777581|Sensory System Agents|sensory system agents|mesh-ancestor
64582476|NCT00137969|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64635418|NCT00005086|Antiviral Agents|antiviral agents|mesh-ancestor
64635419|NCT00005086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64582477|NCT00137969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64582478|NCT00137969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64582479|NCT00137969|Anesthetics, Local|anesthetics, local|mesh-ancestor
64582480|NCT00137969|Anesthetics|anesthetics|mesh-ancestor
64582481|NCT00137969|Antiemetics|antiemetics|mesh-ancestor
64582482|NCT00137969|Autonomic Agents|autonomic agents|mesh-ancestor
64582483|NCT00137969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64582484|NCT00137969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64582485|NCT00137969|Histamine Antagonists|histamine antagonists|mesh-ancestor
64582486|NCT00137969|Histamine Agents|histamine agents|mesh-ancestor
64582487|NCT00137969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64582488|NCT00137969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582489|NCT00137969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64582490|NCT00137969|Antipruritics|antipruritics|mesh-ancestor
64582491|NCT00137969|Dermatologic Agents|dermatologic agents|mesh-ancestor
64582492|NCT01437878|Iloprost|iloprost|mesh-list
64582493|NCT01437878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64582494|NCT01437878|Vasodilator Agents|vasodilator agents|mesh-ancestor
64582523|NCT01465178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582524|NCT01465178|Vitamins|vitamins|mesh-ancestor
64582525|NCT01465178|Micronutrients|micronutrients|mesh-ancestor
64582526|NCT01465178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64582527|NCT00138203|Vorinostat|vorinostat|mesh-list
64582528|NCT00138203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582529|NCT00138203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64582530|NCT00138203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582531|NCT00138203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582532|NCT01732809|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64518673|NCT00061893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518674|NCT00061893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518675|NCT00061893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64518676|NCT00061893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64518677|NCT00061893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64518678|NCT00061893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64518679|NCT00061893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582536|NCT01732809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582537|NCT01732809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64582538|NCT01732809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64582573|NCT01445678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64582574|NCT01445678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64582575|NCT02193191|Plerixafor|plerixafor|mesh-list
64582576|NCT02193191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64582577|NCT02193191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64582578|NCT02193191|Antiviral Agents|antiviral agents|mesh-ancestor
64582601|NCT01818063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64582602|NCT01818063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582603|NCT01818063|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64582604|NCT04273139|Venetoclax|venetoclax|mesh-list
64635449|NCT00101036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582605|NCT04273139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582606|NCT01465022|Estrogens|estrogens|mesh-list
64582607|NCT01465022|Progestins|progestins|mesh-list
64582608|NCT01465022|Hormones|hormones|mesh-ancestor
64582609|NCT01465022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64582610|NCT01465022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582611|NCT02258217|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64582612|NCT02258217|Hormones|hormones|mesh-ancestor
64582613|NCT02258217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64582614|NCT02258217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582615|NCT03714828|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
64582616|NCT03714828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64582617|NCT03714828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582618|NCT01464788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64582619|NCT01464788|Argatroban|argatroban|mesh-list
64582621|NCT01464788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64582622|NCT01464788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582623|NCT01464788|Antithrombins|antithrombins|mesh-ancestor
64582624|NCT01464788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64518680|NCT00061893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64518681|NCT00061893|Tubulin Modulators|tubulin modulators|mesh-ancestor
64518682|NCT00061893|Antimitotic Agents|antimitotic agents|mesh-ancestor
64518683|NCT00061893|Mitosis Modulators|mitosis modulators|mesh-ancestor
64518684|NCT00061893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64518685|NCT00061893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64518686|NCT00061893|Analgesics|analgesics|mesh-ancestor
64518687|NCT00061893|Sensory System Agents|sensory system agents|mesh-ancestor
64518688|NCT00061893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64518689|NCT00061893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64518690|NCT00061893|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64518691|NCT00061893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64518692|NCT02957019|Rituximab|rituximab|mesh-list
64518693|NCT02957019|Interleukin-2|interleukin-2|mesh-list
64518694|NCT02957019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64582625|NCT01464788|Protease Inhibitors|protease inhibitors|mesh-ancestor
64582626|NCT01464788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582627|NCT01464788|Anticoagulants|anticoagulants|mesh-ancestor
64582628|NCT01464788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64582629|NCT01444898|Exenatide|exenatide|mesh-list
64582630|NCT01444898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64582652|NCT00201773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64582653|NCT00201773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64582654|NCT00201773|Hormone Antagonists|hormone antagonists|mesh-ancestor
64582655|NCT00201773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64582656|NCT00256217|Anastrozole|anastrozole|mesh-list
64582657|NCT00256217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64582658|NCT00256217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582659|NCT00256217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64582660|NCT00256217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64582661|NCT00256217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635520|NCT00005110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64582664|NCT00256217|Hormone Antagonists|hormone antagonists|mesh-ancestor
64582665|NCT00256217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64582666|NCT00256217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582668|NCT05643066|Propofol|propofol|mesh-list
64582669|NCT05643066|Esketamine|esketamine|mesh-list
64582670|NCT05643066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64582671|NCT05643066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64307876|NCT04939766|Insulin|insulin|mesh-list
64582672|NCT05643066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582673|NCT05643066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64582674|NCT05643066|Anesthetics, General|anesthetics, general|mesh-ancestor
64582675|NCT05643066|Anesthetics|anesthetics|mesh-ancestor
64582676|NCT05643066|Analgesics|analgesics|mesh-ancestor
64582677|NCT05643066|Sensory System Agents|sensory system agents|mesh-ancestor
64582678|NCT05643066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64582679|NCT05643066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64582680|NCT05643066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64582681|NCT05643066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64582715|NCT00257309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582716|NCT00257309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64582717|NCT00257309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64582719|NCT01444742|Clofarabine|clofarabine|mesh-list
64582720|NCT01444742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64582721|NCT01444742|Antimetabolites|antimetabolites|mesh-ancestor
64582748|NCT00257933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64582749|NCT00257933|Glucocorticoids|glucocorticoids|mesh-ancestor
64582750|NCT00257933|Hormones|hormones|mesh-ancestor
64582765|NCT01819935|Linezolid|linezolid|mesh-list
64582766|NCT01819935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64582767|NCT01819935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64582768|NCT01819935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64582769|NCT01819935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582770|NCT01819935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582771|NCT01821105|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64582772|NCT01821105|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64582805|NCT00210353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64582806|NCT00210353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582807|NCT00210353|Immunologic Factors|immunologic factors|mesh-ancestor
64582808|NCT00210353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582809|NCT00210353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64582810|NCT00210353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64582811|NCT00210353|Alkylating Agents|alkylating agents|mesh-ancestor
64582812|NCT00210353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582848|NCT01774149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64582849|NCT01774149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64582850|NCT01774149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64582851|NCT01774149|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64582852|NCT01774149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64582853|NCT01774149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64582890|NCT01436162|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64582891|NCT01436162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582892|NCT01436162|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64582893|NCT01436162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64582923|NCT03440112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582924|NCT03440112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582925|NCT03440112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64582926|NCT03440112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64582927|NCT03440112|Antidotes|antidotes|mesh-ancestor
64582936|NCT01775865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64582937|NCT01775865|Analgesics|analgesics|mesh-ancestor
64518702|NCT02957019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64518704|NCT02028754|Ofloxacin|ofloxacin|mesh-list
64518705|NCT02028754|Prednisolone|prednisolone|mesh-list
64518706|NCT02028754|Prednisolone acetate|prednisolone acetate|mesh-list
64518707|NCT02028754|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64518708|NCT02028754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64518709|NCT02028754|Glucocorticoids|glucocorticoids|mesh-ancestor
64518710|NCT02028754|Hormones|hormones|mesh-ancestor
64518711|NCT02028754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64518712|NCT02028754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456632|NCT01777581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456633|NCT01777581|Antidepressive Agents|antidepressive agents|mesh-ancestor
64456634|NCT01777581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64456635|NCT01864148|Interferons|interferons|mesh-list
64456636|NCT01864148|Interferon-beta|interferon-beta|mesh-list
64456637|NCT01864148|Interferon beta-1a|interferon beta-1a|mesh-list
64456638|NCT01864148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456639|NCT01864148|Antiviral Agents|antiviral agents|mesh-ancestor
64456640|NCT01864148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64456641|NCT01864148|Immunologic Factors|immunologic factors|mesh-ancestor
64456642|NCT01864148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456643|NCT01864148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64456644|NCT01890122|Metformin|metformin|mesh-list
64456645|NCT01890122|Alogliptin|alogliptin|mesh-list
64456646|NCT01890122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64456647|NCT01890122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456648|NCT01890122|Incretins|incretins|mesh-ancestor
64456649|NCT01890122|Hormones|hormones|mesh-ancestor
64456650|NCT01890122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64456651|NCT01890122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64456652|NCT01890122|Protease Inhibitors|protease inhibitors|mesh-ancestor
64456653|NCT01890122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64456686|NCT01777269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456688|NCT01777269|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64456689|NCT01777269|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64456690|NCT01777269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64456691|NCT01777269|Hormone Antagonists|hormone antagonists|mesh-ancestor
64456728|NCT01775475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456729|NCT01775475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64456730|NCT01775475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64456731|NCT01775475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64456732|NCT01775475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64456733|NCT01775475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64456734|NCT01775475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64532197|NCT01493531|Gout Suppressants|gout suppressants|mesh-ancestor
64532198|NCT01493531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64532199|NCT01493531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64532200|NCT01493531|Antioxidants|antioxidants|mesh-ancestor
64532201|NCT01493531|Protective Agents|protective agents|mesh-ancestor
64532202|NCT01493531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532203|NCT01493531|Uricosuric Agents|uricosuric agents|mesh-ancestor
64532204|NCT01493531|Renal Agents|renal agents|mesh-ancestor
64532205|NCT02105415|Ketamine|ketamine|mesh-list
64532206|NCT02105415|Propofol|propofol|mesh-list
64532207|NCT02105415|Etomidate|etomidate|mesh-list
64532208|NCT02105415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64532209|NCT02105415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64532210|NCT02105415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532211|NCT02105415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64532212|NCT02105415|Anesthetics, General|anesthetics, general|mesh-ancestor
64532213|NCT02105415|Anesthetics|anesthetics|mesh-ancestor
64532214|NCT02105415|Analgesics|analgesics|mesh-ancestor
64532215|NCT02105415|Sensory System Agents|sensory system agents|mesh-ancestor
64532216|NCT02105415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64582938|NCT01775865|Sensory System Agents|sensory system agents|mesh-ancestor
64582939|NCT01775865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64582940|NCT01775865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582941|NCT01775865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64582942|NCT01775865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64582970|NCT01879371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582971|NCT01879371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64582972|NCT01879371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64582973|NCT01879371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64582974|NCT01879371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582975|NCT01879371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582976|NCT01879371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64582977|NCT01879371|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64582978|NCT01879371|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64582979|NCT01879371|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64582980|NCT01879371|Purinergic Agents|purinergic agents|mesh-ancestor
64635645|NCT00004420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582981|NCT01879371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64582982|NCT03276468|Atezolizumab|atezolizumab|mesh-list
64582983|NCT03276468|Venetoclax|venetoclax|mesh-list
64582984|NCT03276468|Obinutuzumab|obinutuzumab|mesh-list
64582985|NCT03276468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582986|NCT03276468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64582987|NCT01442714|Lenalidomide|lenalidomide|mesh-list
64582988|NCT01442714|Azacitidine|azacitidine|mesh-list
64582989|NCT01442714|Immunologic Factors|immunologic factors|mesh-ancestor
64583013|NCT05501574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583014|NCT05501574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583015|NCT01435928|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64583016|NCT01435928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64532217|NCT02105415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64296770|NCT02809820|Metoprolol|metoprolol|mesh-list
64456735|NCT01775475|Glucocorticoids|glucocorticoids|mesh-ancestor
64456737|NCT01775475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64456738|NCT01775475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64456739|NCT01775475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64456768|NCT01774305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456770|NCT01397422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64456771|NCT01397422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64456772|NCT01397422|Antiviral Agents|antiviral agents|mesh-ancestor
64456773|NCT01397422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64456774|NCT01397422|Dopamine Agents|dopamine agents|mesh-ancestor
64456775|NCT01397422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64583017|NCT01435928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64583018|NCT01435928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64583019|NCT01435928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583020|NCT01435928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64583021|NCT01435928|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64583022|NCT01435928|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64583023|NCT01435928|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64583024|NCT01435928|Adrenergic Agents|adrenergic agents|mesh-ancestor
64583025|NCT01435928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64583026|NCT01435928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583027|NCT01435928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64583028|NCT01435928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64583029|NCT01435928|Serotonin Agents|serotonin agents|mesh-ancestor
64583030|NCT01435928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64583031|NCT01435928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64583032|NCT01435928|Dopamine Agents|dopamine agents|mesh-ancestor
64583033|NCT01828515|Hydrocortisone|hydrocortisone|mesh-list
64583034|NCT01828515|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
64583035|NCT01828515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64583036|NCT01828515|Antidepressive Agents|antidepressive agents|mesh-ancestor
64583037|NCT01828515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64583059|NCT00216125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583060|NCT00216125|Tubulin Modulators|tubulin modulators|mesh-ancestor
64518714|NCT02028754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518715|NCT02028754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64518716|NCT02028754|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64518717|NCT02028754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64583069|NCT01781403|Temozolomide|temozolomide|mesh-list
64583070|NCT01781403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64583071|NCT01781403|Antimetabolites|antimetabolites|mesh-ancestor
64583072|NCT01781403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583073|NCT01781403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583074|NCT01781403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64583075|NCT01781403|Alkylating Agents|alkylating agents|mesh-ancestor
64583076|NCT00218387|Modafinil|modafinil|mesh-list
64583077|NCT00218387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64583078|NCT00218387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583079|NCT00218387|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64583080|NCT00218387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64583081|NCT00218387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64583082|NCT00218387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583083|NCT00218465|Glycine|glycine|mesh-list
64583084|NCT00218465|Glycine Agents|glycine agents|mesh-ancestor
64583085|NCT00218465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64583086|NCT00218465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583087|NCT00218465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583088|NCT01898585|Vemurafenib|vemurafenib|mesh-list
64583089|NCT01898585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583114|NCT01782963|Bortezomib|bortezomib|mesh-list
64583115|NCT01782963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64583116|NCT01782963|Antiemetics|antiemetics|mesh-ancestor
64583117|NCT01782963|Autonomic Agents|autonomic agents|mesh-ancestor
64583118|NCT01782963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583119|NCT01782963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583120|NCT01782963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64583121|NCT01782963|Glucocorticoids|glucocorticoids|mesh-ancestor
64583122|NCT01782963|Hormones|hormones|mesh-ancestor
64583123|NCT01782963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64583124|NCT01782963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64583125|NCT01782963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583126|NCT01782963|Immunologic Factors|immunologic factors|mesh-ancestor
64635721|NCT00004450|Thalidomide|thalidomide|mesh-list
64456776|NCT01397422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456777|NCT01397422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456778|NCT01397422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64583127|NCT01782963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64518727|NCT02453490|Fluorouracil|fluorouracil|mesh-list
64518728|NCT02453490|Raltitrexed|raltitrexed|mesh-list
64518729|NCT02453490|Antimetabolites|antimetabolites|mesh-ancestor
64518730|NCT02453490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518731|NCT02453490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64518732|NCT02453490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518733|NCT02453490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64518734|NCT02453490|Immunologic Factors|immunologic factors|mesh-ancestor
64518735|NCT02453490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635760|NCT00005764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64583128|NCT01782963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64583129|NCT01782963|Growth Substances|growth substances|mesh-ancestor
64583130|NCT01782963|Growth Inhibitors|growth inhibitors|mesh-ancestor
64583131|NCT01829217|Sunitinib|sunitinib|mesh-list
64583132|NCT01829217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583133|NCT01829217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64583134|NCT01829217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64583135|NCT01829217|Growth Substances|growth substances|mesh-ancestor
64583136|NCT01829217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456779|NCT01397422|Analgesics|analgesics|mesh-ancestor
64456780|NCT01397422|Sensory System Agents|sensory system agents|mesh-ancestor
64456781|NCT01397422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456782|NCT01736475|Factor VIII|factor viii|mesh-list
64456783|NCT01736475|BAX 855|bax 855|mesh-list
64456784|NCT01736475|Coagulants|coagulants|mesh-ancestor
64456785|NCT01863680|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64456786|NCT01863680|Hormones|hormones|mesh-list
64456787|NCT01863680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64456819|NCT04590404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456820|NCT04590404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64456821|NCT04590404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64456822|NCT04590404|Cholinergic Agents|cholinergic agents|mesh-ancestor
64456823|NCT04590404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64456824|NCT04590404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652461|NCT03217136|Renal Agents|renal agents|mesh-ancestor
64532227|NCT01523275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532228|NCT01523275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64532230|NCT00304707|Bupropion|bupropion|mesh-list
64532231|NCT00304707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64532232|NCT00304707|Antidepressive Agents|antidepressive agents|mesh-ancestor
64532233|NCT00304707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64532234|NCT00304707|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64532235|NCT00304707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64532236|NCT00304707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64532237|NCT00304707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532238|NCT00304707|Dopamine Agents|dopamine agents|mesh-ancestor
64532239|NCT00304707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64532240|NCT00304707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532241|NCT00304707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64532242|NCT00304707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64532243|NCT00304707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532244|NCT04409483|Ritonavir|ritonavir|mesh-list
64583137|NCT01829217|Growth Inhibitors|growth inhibitors|mesh-ancestor
64583138|NCT01829217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64583139|NCT01829217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583140|NCT01829217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635813|NCT00004486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583163|NCT01829919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64583164|NCT01829919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64583165|NCT01829919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64583166|NCT01829919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583167|NCT01829919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64583168|NCT01829919|Serotonin Agents|serotonin agents|mesh-ancestor
64583169|NCT01829919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583170|NCT01829919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64583171|NCT01829919|Antidepressive Agents|antidepressive agents|mesh-ancestor
64583172|NCT01829919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64583173|NCT01829919|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64583174|NCT01829919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64583175|NCT01829919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583176|NCT02097641|Plasma-lyte 148|plasma-lyte 148|mesh-list
64583177|NCT02097641|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64583178|NCT02097641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64583179|NCT00274781|Arsenic Trioxide|arsenic trioxide|mesh-list
64583181|NCT00274781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583182|NCT00274781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64583183|NCT00226577|Gemcitabine|gemcitabine|mesh-list
64583185|NCT00226577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64583186|NCT00226577|Antimetabolites|antimetabolites|mesh-ancestor
64583187|NCT00226577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583188|NCT00226577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583189|NCT00226577|Antiviral Agents|antiviral agents|mesh-ancestor
64583190|NCT00226577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64583191|NCT00226577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583192|NCT00226577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64583193|NCT00226577|Immunologic Factors|immunologic factors|mesh-ancestor
64583213|NCT00280241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532245|NCT04409483|Lopinavir|lopinavir|mesh-list
64296792|NCT05717049|Theophylline|theophylline|mesh-list
64583214|NCT00280241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583215|NCT00280241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64635849|NCT01290445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64583216|NCT00280241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64583217|NCT01899755|Adalimumab|adalimumab|mesh-list
64583218|NCT01899755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64583219|NCT01899755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64583220|NCT01899755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64583221|NCT01899833|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
64583222|NCT01899833|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64518736|NCT02453490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64518737|NCT02453490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518738|NCT01974700|Levetiracetam|levetiracetam|mesh-list
64518739|NCT01974700|Anticonvulsants|anticonvulsants|mesh-ancestor
64518740|NCT01974700|Nootropic Agents|nootropic agents|mesh-ancestor
64518741|NCT04753203|Capecitabine|capecitabine|mesh-list
64518742|NCT04753203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64518743|NCT04753203|Antimetabolites|antimetabolites|mesh-ancestor
64518744|NCT04753203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518745|NCT04753203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518746|NCT03236610|Tenofovir|tenofovir|mesh-list
64518747|NCT03236610|Entecavir|entecavir|mesh-list
64518748|NCT03236610|Antiviral Agents|antiviral agents|mesh-ancestor
64518749|NCT03236610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64518750|NCT03236610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64518751|NCT03236610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64518752|NCT03236610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518753|NCT03236610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518754|NCT03236610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64518755|NCT03236610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64518756|NCT05287893|Pyronaridine|pyronaridine|mesh-list
64635855|NCT00005782|Lenograstim|lenograstim|mesh-list
64456825|NCT01885208|Exenatide|exenatide|mesh-list
64456826|NCT01885208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64456827|NCT01885208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456828|NCT01885208|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64456829|NCT01885208|Incretins|incretins|mesh-ancestor
64456830|NCT01885208|Hormones|hormones|mesh-ancestor
64456856|NCT01747551|Aflibercept|aflibercept|mesh-list
64456857|NCT01747551|Antimetabolites|antimetabolites|mesh-ancestor
64456858|NCT01747551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456859|NCT01747551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64456860|NCT01747551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456861|NCT01747551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64456862|NCT01747551|Immunologic Factors|immunologic factors|mesh-ancestor
64456863|NCT01747551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518757|NCT05287893|Antimalarials|antimalarials|mesh-ancestor
64583223|NCT01899833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583224|NCT00229619|Rituximab|rituximab|mesh-list
64583225|NCT00229619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64583226|NCT00229619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583227|NCT00229619|Immunologic Factors|immunologic factors|mesh-ancestor
64583228|NCT00229619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583229|NCT00229619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64583230|NCT00281021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64583231|NCT00281021|Digoxin|digoxin|mesh-list
64583232|NCT00281021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583233|NCT00281021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64583234|NCT00281021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583235|NCT00281021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583236|NCT00281021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64583237|NCT00281021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64583238|NCT00281021|Protective Agents|protective agents|mesh-ancestor
64583239|NCT00281021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583240|NCT01786161|Vancomycin|vancomycin|mesh-list
64583241|NCT01786161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64583242|NCT01786161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64583243|NCT01786239|Risperidone|risperidone|mesh-list
64583244|NCT01786239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64583245|NCT01786239|Serotonin Agents|serotonin agents|mesh-ancestor
64583246|NCT01786239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64583247|NCT01786239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583248|NCT01786239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583249|NCT01786239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64583273|NCT02261727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64456864|NCT01747551|Antidotes|antidotes|mesh-ancestor
64456865|NCT01747551|Protective Agents|protective agents|mesh-ancestor
64532246|NCT04409483|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64532247|NCT04409483|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64532248|NCT04409483|Protease Inhibitors|protease inhibitors|mesh-ancestor
64532249|NCT04409483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532250|NCT04409483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532251|NCT04409483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64532252|NCT04409483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64532253|NCT04409483|Antiviral Agents|antiviral agents|mesh-ancestor
64296814|NCT01673594|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64296820|NCT02786498|Vitamin D|vitamin d|mesh-list
64456866|NCT01747551|Vitamin B Complex|vitamin b complex|mesh-ancestor
64456868|NCT01747551|Micronutrients|micronutrients|mesh-ancestor
64456869|NCT01747551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64456870|NCT01747551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64456871|NCT01747551|Growth Substances|growth substances|mesh-ancestor
64456872|NCT01747551|Growth Inhibitors|growth inhibitors|mesh-ancestor
64583274|NCT02261727|Autonomic Agents|autonomic agents|mesh-ancestor
64583275|NCT02261727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583276|NCT02261727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64583277|NCT02261727|Respiratory System Agents|respiratory system agents|mesh-ancestor
64518759|NCT05287893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64518760|NCT05287893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64635938|NCT00004582|Protease Inhibitors|protease inhibitors|mesh-ancestor
64518761|NCT02357758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64518762|NCT02357758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64518763|NCT01552434|Sirolimus|sirolimus|mesh-list
64518764|NCT01552434|Bevacizumab|bevacizumab|mesh-list
64518765|NCT01552434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64518766|NCT01552434|Cetuximab|cetuximab|mesh-list
64583278|NCT02261727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64583279|NCT02261727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583280|NCT02261727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583281|NCT02261727|Vasodilator Agents|vasodilator agents|mesh-ancestor
64583282|NCT02261727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64583283|NCT02261727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64583284|NCT02261727|Purinergic Agents|purinergic agents|mesh-ancestor
64583285|NCT02261727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64583286|NCT02261805|Doxorubicin|doxorubicin|mesh-list
64583287|NCT02261805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64583288|NCT02261805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583289|NCT02261805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64583290|NCT02261805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64583291|NCT02261805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583292|NCT02261805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583293|NCT05300841|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64583294|NCT05300841|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64583297|NCT05300841|Dydrogesterone|dydrogesterone|mesh-list
64583330|NCT01789905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583331|NCT01790685|Dexamethasone|dexamethasone|mesh-list
64583332|NCT01790685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64583333|NCT01790685|Antiemetics|antiemetics|mesh-ancestor
64583334|NCT01790685|Autonomic Agents|autonomic agents|mesh-ancestor
64583335|NCT01790685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583336|NCT01790685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583337|NCT01790685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64583338|NCT01790685|Glucocorticoids|glucocorticoids|mesh-ancestor
64583339|NCT01790685|Hormones|hormones|mesh-ancestor
64583340|NCT01790685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64583341|NCT01790685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64583342|NCT01790685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583343|NCT01838655|Nitisinone|nitisinone|mesh-list
64583344|NCT01838655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64308548|NCT04485429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64583345|NCT01838655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583346|NCT00050089|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64583347|NCT00050089|Antiviral Agents|antiviral agents|mesh-ancestor
64583348|NCT00050089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64583350|NCT00282971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64583351|NCT00282971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583352|NCT01791465|Exenatide|exenatide|mesh-list
64583353|NCT01791465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64583354|NCT01791465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518769|NCT01552434|Antibodies|antibodies|mesh-list
64583493|NCT00287053|GABA Agents|gaba agents|mesh-ancestor
64583494|NCT00287053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64583495|NCT00287053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583496|NCT00287053|Antimanic Agents|antimanic agents|mesh-ancestor
64583497|NCT00287053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64583498|NCT00287053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64583499|NCT00287053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64583500|NCT01435460|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64583501|NCT01435460|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64583502|NCT01435460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64583503|NCT01435460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64583504|NCT01435460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64583506|NCT01435460|Sensory System Agents|sensory system agents|mesh-ancestor
64583507|NCT01435460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583508|NCT01435460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583509|NCT01435460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64583510|NCT01435460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64583511|NCT01435460|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64583512|NCT01435460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64583513|NCT01435460|Histamine Antagonists|histamine antagonists|mesh-ancestor
64583514|NCT01435460|Histamine Agents|histamine agents|mesh-ancestor
64583515|NCT01435460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64583516|NCT01435460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583517|NCT00236951|Epoetin Alfa|epoetin alfa|mesh-list
64583557|NCT00288067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64583558|NCT00288067|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64583559|NCT00288067|Protective Agents|protective agents|mesh-ancestor
64583561|NCT00285779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64583562|NCT00285779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64583563|NCT00285779|Analgesics|analgesics|mesh-ancestor
64583564|NCT00285779|Sensory System Agents|sensory system agents|mesh-ancestor
64583565|NCT00285779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583575|NCT04827537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64583576|NCT04827537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64583577|NCT04728087|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
64583578|NCT04728087|Hemostatics|hemostatics|mesh-ancestor
64583579|NCT04728087|Coagulants|coagulants|mesh-ancestor
64518773|NCT01552434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518774|NCT01552434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64518775|NCT01552434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64518776|NCT01552434|Growth Substances|growth substances|mesh-ancestor
64518777|NCT01552434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518778|NCT01552434|Growth Inhibitors|growth inhibitors|mesh-ancestor
64518779|NCT01552434|Immunologic Factors|immunologic factors|mesh-ancestor
64518780|NCT01552434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64518781|NCT01552434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64518782|NCT01552434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64518783|NCT01552434|Antifungal Agents|antifungal agents|mesh-ancestor
64518784|NCT01552434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64518785|NCT01552434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518786|NCT01552434|Anticonvulsants|anticonvulsants|mesh-ancestor
64518787|NCT01552434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518788|NCT01552434|GABA Agents|gaba agents|mesh-ancestor
64518800|NCT02357836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518801|NCT02357836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64518802|NCT02357836|Hormone Antagonists|hormone antagonists|mesh-ancestor
64518803|NCT02357836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64518804|NCT02357836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518805|NCT02357836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64518806|NCT02359006|Minocycline|minocycline|mesh-list
64518807|NCT02359006|Tetracycline|tetracycline|mesh-list
64518808|NCT02359006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64518809|NCT02359006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64518810|NCT02359006|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64518811|NCT02359006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518812|NCT02359006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518813|NCT04485702|Midazolam|midazolam|mesh-list
64518814|NCT04485702|Ketamine|ketamine|mesh-list
64518815|NCT04485702|Analgesics|analgesics|mesh-ancestor
64518816|NCT04485702|Sensory System Agents|sensory system agents|mesh-ancestor
64518817|NCT04485702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64518818|NCT04485702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518819|NCT04485702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64518820|NCT04485702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64456873|NCT01859390|Antioxidants|antioxidants|mesh-list
64456874|NCT01859390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456875|NCT01859390|Protective Agents|protective agents|mesh-ancestor
64456876|NCT01859390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456877|NCT01746225|Paclitaxel|paclitaxel|mesh-list
64456878|NCT01746225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64456879|NCT01746225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652468|NCT01720238|Entecavir|entecavir|mesh-list
64456918|NCT01383928|Immunologic Factors|immunologic factors|mesh-ancestor
64456919|NCT01383928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64456920|NCT01383928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64456921|NCT01383928|Growth Substances|growth substances|mesh-ancestor
64456922|NCT01383928|Growth Inhibitors|growth inhibitors|mesh-ancestor
64456923|NCT01383928|Protease Inhibitors|protease inhibitors|mesh-ancestor
64456924|NCT01383928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64456939|NCT05368012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64456940|NCT05368012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456942|NCT05368012|Anesthetics|anesthetics|mesh-ancestor
64456943|NCT05368012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64456944|NCT05368012|Sensory System Agents|sensory system agents|mesh-ancestor
64456945|NCT01606137|Nabiximols|nabiximols|mesh-list
64456946|NCT01606137|Analgesics|analgesics|mesh-ancestor
64456947|NCT01606137|Sensory System Agents|sensory system agents|mesh-ancestor
64456948|NCT01606137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456949|NCT01606137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456950|NCT01382446|Chlorhexidine|chlorhexidine|mesh-list
64456951|NCT01382446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64456952|NCT01382446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64456953|NCT01382446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64456954|NCT01382446|Disinfectants|disinfectants|mesh-ancestor
64456955|NCT01382446|Dermatologic Agents|dermatologic agents|mesh-ancestor
64518821|NCT04485702|Anesthetics, General|anesthetics, general|mesh-ancestor
64518822|NCT04485702|Anesthetics|anesthetics|mesh-ancestor
64518823|NCT04485702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64518824|NCT04485702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64583630|NCT01650701|Growth Inhibitors|growth inhibitors|mesh-ancestor
64636102|NCT00102518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64583631|NCT01650701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64583632|NCT01650701|Alkylating Agents|alkylating agents|mesh-ancestor
64583633|NCT01650701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583635|NCT00290329|Immunologic Factors|immunologic factors|mesh-ancestor
64583636|NCT00290329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583638|NCT04058678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64583658|NCT00291655|Nootropic Agents|nootropic agents|mesh-ancestor
64583659|NCT01846455|Promethazine|promethazine|mesh-list
64583660|NCT01846455|Diphenhydramine|diphenhydramine|mesh-list
64456956|NCT01381900|Metformin|metformin|mesh-list
64456957|NCT01381900|Canagliflozin|canagliflozin|mesh-list
64456958|NCT01381900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64456959|NCT01381900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456960|NCT01381900|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64456961|NCT01381900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456962|NCT01744197|Lidocaine|lidocaine|mesh-list
64456963|NCT01744197|Tetracaine|tetracaine|mesh-list
64456964|NCT01744197|Anesthetics, Local|anesthetics, local|mesh-ancestor
64456965|NCT01744197|Anesthetics|anesthetics|mesh-ancestor
64456966|NCT01744197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64532255|NCT04409483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64532256|NCT04409483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64532257|NCT02365740|Insulin|insulin|mesh-list
64532258|NCT02365740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64532259|NCT02365740|Hormones|hormones|mesh-list
64532260|NCT02365740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64532261|NCT02365740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532262|NCT02365740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64532263|NCT02437110|Ritonavir|ritonavir|mesh-list
64532264|NCT02437110|Darunavir|darunavir|mesh-list
64532265|NCT02437110|Tenofovir|tenofovir|mesh-list
64532266|NCT02437110|Dolutegravir|dolutegravir|mesh-list
64532267|NCT02437110|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64532268|NCT02437110|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64532269|NCT02437110|Protease Inhibitors|protease inhibitors|mesh-ancestor
64532270|NCT02437110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532271|NCT02437110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532272|NCT02437110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64532273|NCT02437110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64532274|NCT02437110|Antiviral Agents|antiviral agents|mesh-ancestor
64532275|NCT02437110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64532276|NCT02437110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64532277|NCT02437110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64532278|NCT02437110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64296823|NCT02786498|Micronutrients|micronutrients|mesh-ancestor
64456967|NCT01744197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456973|NCT01744197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64456974|NCT01744197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456975|NCT04565301|Dexamethasone|dexamethasone|mesh-list
64456976|NCT04565301|Neostigmine|neostigmine|mesh-list
64456977|NCT04565301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64456978|NCT04565301|Antiemetics|antiemetics|mesh-ancestor
64456979|NCT04565301|Autonomic Agents|autonomic agents|mesh-ancestor
64456980|NCT04565301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583661|NCT01846455|Buprenorphine|buprenorphine|mesh-list
64583662|NCT01846455|Naloxone|naloxone|mesh-list
64583663|NCT01846455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64583664|NCT01846455|Narcotics|narcotics|mesh-ancestor
64583665|NCT01846455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64583666|NCT01846455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583667|NCT01846455|Analgesics|analgesics|mesh-ancestor
64583668|NCT01846455|Sensory System Agents|sensory system agents|mesh-ancestor
64518826|NCT04485702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64518827|NCT04485702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518828|NCT04485702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64518829|NCT04485702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64518830|NCT04485702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64518831|NCT04485702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64518832|NCT04485702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64518833|NCT04485702|GABA Modulators|gaba modulators|mesh-ancestor
64518834|NCT04485702|GABA Agents|gaba agents|mesh-ancestor
64636164|NCT01402375|Respiratory System Agents|respiratory system agents|mesh-ancestor
64518835|NCT00068367|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64518836|NCT00068367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518837|NCT00068367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64518838|NCT00068367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518839|NCT00068367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518840|NCT03233412|Imiquimod|imiquimod|mesh-list
64518841|NCT03233412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64518842|NCT03233412|Immunologic Factors|immunologic factors|mesh-ancestor
64518843|NCT03233412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518844|NCT03233412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518845|NCT03233412|Interferon Inducers|interferon inducers|mesh-ancestor
64518846|NCT01976416|Hydroxyurea|hydroxyurea|mesh-list
64518847|NCT01976416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518848|NCT01976416|Antisickling Agents|antisickling agents|mesh-ancestor
64456981|NCT04565301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456982|NCT04565301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64456983|NCT04565301|Glucocorticoids|glucocorticoids|mesh-ancestor
64456984|NCT04565301|Hormones|hormones|mesh-ancestor
64457011|NCT01743027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457013|NCT01380730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64457014|NCT01380730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64532280|NCT02437110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64532281|NCT02437110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64532282|NCT05267847|Anesthetics|anesthetics|mesh-list
64532283|NCT05267847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64532284|NCT05267847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583669|NCT01846455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583670|NCT01846455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64583671|NCT01846455|Antipruritics|antipruritics|mesh-ancestor
64583672|NCT01846455|Dermatologic Agents|dermatologic agents|mesh-ancestor
64583673|NCT01846455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64583674|NCT01846455|Histamine Antagonists|histamine antagonists|mesh-ancestor
64583675|NCT01846455|Histamine Agents|histamine agents|mesh-ancestor
64583676|NCT01846455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64583677|NCT01846455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583678|NCT01846455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64583679|NCT01846455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64583680|NCT01846455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64583681|NCT01846455|Anesthetics, Local|anesthetics, local|mesh-ancestor
64583682|NCT01846455|Anesthetics|anesthetics|mesh-ancestor
64583683|NCT01846455|Antiemetics|antiemetics|mesh-ancestor
64583684|NCT01846455|Autonomic Agents|autonomic agents|mesh-ancestor
64583685|NCT01846455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64583686|NCT03366415|Gemcitabine|gemcitabine|mesh-list
64583687|NCT03366415|Cisplatin|cisplatin|mesh-list
64583688|NCT03366415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583689|NCT03366415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64583690|NCT03366415|Antimetabolites|antimetabolites|mesh-ancestor
64583691|NCT03366415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583692|NCT03366415|Antiviral Agents|antiviral agents|mesh-ancestor
64583693|NCT03366415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64583694|NCT03366415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518849|NCT01976416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518850|NCT01976416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518851|NCT01976416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64518852|NCT01976572|Candesartan|candesartan|mesh-list
64518853|NCT01976572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64518854|NCT01976572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64518855|NCT01976572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64518856|NCT01976572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518857|NCT01976650|Dexamethasone|dexamethasone|mesh-list
64518858|NCT01976650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64532285|NCT05267457|Vanadium|vanadium|mesh-list
64518861|NCT01976650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64518862|NCT01976650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518863|NCT01976650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64518864|NCT01976650|Glucocorticoids|glucocorticoids|mesh-ancestor
64636247|NCT01409239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518865|NCT01976650|Hormones|hormones|mesh-ancestor
64518866|NCT01976650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64518867|NCT01976650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64518868|NCT01976650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518869|NCT01978600|Timolol|timolol|mesh-list
64518870|NCT01978600|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64518871|NCT01978600|Brinzolamide|brinzolamide|mesh-list
64518872|NCT01978600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518873|NCT01978600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518874|NCT01978600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64518875|NCT01978600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64518876|NCT01978600|Adrenergic Agents|adrenergic agents|mesh-ancestor
64518877|NCT01978600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64583724|NCT01847001|Alkylating Agents|alkylating agents|mesh-ancestor
64583725|NCT01847001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64583726|NCT01847001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64583727|NCT01847001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64583728|NCT01847001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64583729|NCT01847001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583730|NCT01847001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64583731|NCT01847001|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64583732|NCT01847001|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64583733|NCT01847001|Adrenergic Agents|adrenergic agents|mesh-ancestor
64583734|NCT01847001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64583735|NCT01847001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64583736|NCT01847001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64583737|NCT01847001|Vasodilator Agents|vasodilator agents|mesh-ancestor
64583738|NCT01847469|Zonisamide|zonisamide|mesh-list
64518878|NCT01978600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518879|NCT01978600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64518883|NCT01978600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64518884|NCT01978600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64518885|NCT03236220|Acetylcysteine|acetylcysteine|mesh-list
64518886|NCT03236220|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64518887|NCT03236220|Antiviral Agents|antiviral agents|mesh-ancestor
64518888|NCT03236220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64518889|NCT03236220|Expectorants|expectorants|mesh-ancestor
64518890|NCT03236220|Respiratory System Agents|respiratory system agents|mesh-ancestor
64518891|NCT03236220|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64518892|NCT03236220|Antioxidants|antioxidants|mesh-ancestor
64518893|NCT03236220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518894|NCT03236220|Protective Agents|protective agents|mesh-ancestor
64518895|NCT03236220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518896|NCT03236220|Antidotes|antidotes|mesh-ancestor
64518897|NCT03232632|Flutemetamol|flutemetamol|mesh-list
64518898|NCT03232632|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64518899|NCT03232632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518900|NCT01747499|Azacitidine|azacitidine|mesh-list
64518901|NCT01747499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64518906|NCT00071721|Valproic Acid|valproic acid|mesh-list
64518927|NCT05606055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518928|NCT05606055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64518929|NCT05606055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64518930|NCT03232710|Aripiprazole|aripiprazole|mesh-list
64518931|NCT03232710|Antidepressive Agents|antidepressive agents|mesh-ancestor
64518932|NCT03232710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64518933|NCT03232710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64518934|NCT03232710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64636285|NCT01411501|Citric Acid|citric acid|mesh-list
64532286|NCT05267457|Trace Elements|trace elements|mesh-ancestor
64532287|NCT05267457|Micronutrients|micronutrients|mesh-ancestor
64296849|NCT02163356|Antimitotic Agents|antimitotic agents|mesh-ancestor
64457015|NCT01380730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64457016|NCT01380730|Antimetabolites|antimetabolites|mesh-ancestor
64457017|NCT01380730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457018|NCT01380730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64457019|NCT01380730|Immunologic Factors|immunologic factors|mesh-ancestor
64457020|NCT01380730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457021|NCT04010968|Venetoclax|venetoclax|mesh-list
64457022|NCT04010968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457023|NCT01395784|Pioglitazone|pioglitazone|mesh-list
64457024|NCT01395784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64457025|NCT01395784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457026|NCT01380184|Sirolimus|sirolimus|mesh-list
64457027|NCT01380184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64457028|NCT01380184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64457029|NCT01380184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64457030|NCT01380184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457031|NCT01380184|Antifungal Agents|antifungal agents|mesh-ancestor
64518935|NCT03232710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64518936|NCT03232710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518937|NCT03232710|Dopamine Agonists|dopamine agonists|mesh-ancestor
64518938|NCT03232710|Dopamine Agents|dopamine agents|mesh-ancestor
64518939|NCT03232710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64518940|NCT03232710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518941|NCT03232710|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64518942|NCT03232710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64518943|NCT03232710|Serotonin Agents|serotonin agents|mesh-ancestor
64518944|NCT03232710|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64518945|NCT03232710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64518946|NCT03232710|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64518947|NCT03232710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64518948|NCT01896609|Interferons|interferons|mesh-list
64518949|NCT01896609|Ribavirin|ribavirin|mesh-list
64518950|NCT01896609|Interferon-alpha|interferon-alpha|mesh-list
64518951|NCT01896609|Interferon alpha-2|interferon alpha-2|mesh-list
64518952|NCT01896609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64518953|NCT01896609|Nitazoxanide|nitazoxanide|mesh-list
64518954|NCT01896609|Complement Factor H|complement factor h|mesh-list
64518955|NCT01896609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518956|NCT01896609|Antiviral Agents|antiviral agents|mesh-ancestor
64518957|NCT01896609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64518958|NCT01896609|Antimetabolites|antimetabolites|mesh-ancestor
64518959|NCT01896609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518960|NCT01896609|Immunologic Factors|immunologic factors|mesh-ancestor
64457051|NCT01741545|Antimetabolites|antimetabolites|mesh-ancestor
64457052|NCT01741545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457053|NCT01884350|Apixaban|apixaban|mesh-list
64457054|NCT01884350|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64457055|NCT01884350|Antithrombins|antithrombins|mesh-ancestor
64457056|NCT01884350|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64457057|NCT01884350|Protease Inhibitors|protease inhibitors|mesh-ancestor
64457058|NCT01884350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457059|NCT01884350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457060|NCT01884350|Anticoagulants|anticoagulants|mesh-ancestor
64457061|NCT01614795|Sirolimus|sirolimus|mesh-list
64457062|NCT01614795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64457063|NCT01614795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64457064|NCT01614795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64457065|NCT01614795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64457066|NCT01614795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457067|NCT01614795|Antifungal Agents|antifungal agents|mesh-ancestor
64457068|NCT01614795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64457069|NCT01614795|Immunologic Factors|immunologic factors|mesh-ancestor
64457070|NCT01614795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457071|NCT01834586|Anesthetics|anesthetics|mesh-list
64457072|NCT01834586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64518965|NCT03232554|Iron|iron|mesh-list
64518966|NCT03232554|Trace Elements|trace elements|mesh-ancestor
64518967|NCT03232554|Micronutrients|micronutrients|mesh-ancestor
64518968|NCT03232554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518969|NCT03232398|Warfarin|warfarin|mesh-list
64518970|NCT03232398|Apixaban|apixaban|mesh-list
64518971|NCT03232398|Anticoagulants|anticoagulants|mesh-ancestor
64518972|NCT03232398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64583739|NCT01847469|Anticonvulsants|anticonvulsants|mesh-ancestor
64518976|NCT03232398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518977|NCT03232398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518978|NCT02362048|Pembrolizumab|pembrolizumab|mesh-list
64518979|NCT02362048|Acalabrutinib|acalabrutinib|mesh-list
64518980|NCT02362048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64518981|NCT02362048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518982|NCT00158223|Pimozide|pimozide|mesh-list
64518983|NCT00158223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64518984|NCT00158223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64518985|NCT00158223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64518986|NCT00158223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518987|NCT00158223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64518988|NCT00158223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64518989|NCT00158223|Dopamine Agents|dopamine agents|mesh-ancestor
64518990|NCT00158223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64518991|NCT00158223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518993|NCT03228576|Everolimus|everolimus|mesh-list
64584071|NCT00299741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64584072|NCT00299741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584073|NCT00299741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584074|NCT00328861|Aldesleukin|aldesleukin|mesh-list
64584075|NCT00328861|Cyclophosphamide|cyclophosphamide|mesh-list
64584076|NCT00328861|Fludarabine|fludarabine|mesh-list
64584077|NCT00328861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64584078|NCT00328861|Immunologic Factors|immunologic factors|mesh-ancestor
64584079|NCT00328861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584080|NCT00328861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64584081|NCT00328861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64584082|NCT00328861|Alkylating Agents|alkylating agents|mesh-ancestor
64584083|NCT00328861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584084|NCT00328861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584085|NCT00328861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64584087|NCT00328861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64584088|NCT00328861|Antiviral Agents|antiviral agents|mesh-ancestor
64584117|NCT04350645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584119|NCT04350645|Coagulants|coagulants|mesh-ancestor
64584120|NCT00330733|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
64584121|NCT00330733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64584122|NCT00330733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64584123|NCT00330733|Analgesics|analgesics|mesh-ancestor
64584124|NCT00330733|Sensory System Agents|sensory system agents|mesh-ancestor
64584125|NCT00330733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64584126|NCT00330733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584127|NCT00330733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64584128|NCT00330733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64584129|NCT01861665|Bupivacaine|bupivacaine|mesh-list
64584131|NCT01861665|Anesthetics|anesthetics|mesh-ancestor
64519023|NCT03232320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519024|NCT03232320|Cholinergic Agents|cholinergic agents|mesh-ancestor
64519025|NCT03232320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64519026|NCT02364076|Pembrolizumab|pembrolizumab|mesh-list
64519027|NCT02364076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64519028|NCT02364076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519029|NCT02453022|Omeprazole|omeprazole|mesh-list
64519030|NCT02453022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64519031|NCT02453022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64519032|NCT02453022|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64519033|NCT02453022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519034|NCT02453022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519035|NCT00163293|Ciclesonide|ciclesonide|mesh-list
64584165|NCT00251303|Anticonvulsants|anticonvulsants|mesh-ancestor
64584166|NCT00251303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64584167|NCT00251303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64584168|NCT00251303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64584169|NCT00251303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584170|NCT00251303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584171|NCT00251303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64584172|NCT00251303|Protective Agents|protective agents|mesh-ancestor
64584173|NCT00303823|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
64309386|NCT02150473|Adalimumab|adalimumab|mesh-list
64584174|NCT00303823|Antioxidants|antioxidants|mesh-ancestor
64584175|NCT00303823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584176|NCT00303823|Protective Agents|protective agents|mesh-ancestor
64584177|NCT00303823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584178|NCT00303823|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64584179|NCT00303823|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64584180|NCT00303823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584181|NCT00303823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64584219|NCT00559845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64584220|NCT00559845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64584221|NCT00559845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64584222|NCT00559845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584223|NCT00304187|Erythromycin|erythromycin|mesh-list
64584224|NCT00304187|Erythromycin Estolate|erythromycin estolate|mesh-list
64584225|NCT00304187|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64584226|NCT00304187|Erythromycin stearate|erythromycin stearate|mesh-list
64584227|NCT00304187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64584228|NCT00304187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64584229|NCT00304187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64584291|NCT01790555|Hallucinogens|hallucinogens|mesh-ancestor
64519038|NCT00163293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64519039|NCT00163293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519041|NCT02365870|Rotigotine|rotigotine|mesh-list
64519042|NCT02365870|Dopamine Agonists|dopamine agonists|mesh-ancestor
64519043|NCT02365870|Dopamine Agents|dopamine agents|mesh-ancestor
64519044|NCT02365870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64519045|NCT02365870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519046|NCT02365870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519047|NCT03228108|Amoxicillin|amoxicillin|mesh-list
64584292|NCT01790555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64584327|NCT00336817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584328|NCT00337987|Prednisone|prednisone|mesh-list
64584329|NCT00337987|Cyclophosphamide|cyclophosphamide|mesh-list
64584330|NCT00337987|Vincristine|vincristine|mesh-list
64584331|NCT00337987|Doxorubicin|doxorubicin|mesh-list
64584332|NCT00337987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64584476|NCT00342355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64584477|NCT00342355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64584478|NCT00342355|Protease Inhibitors|protease inhibitors|mesh-ancestor
64584479|NCT00342355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585501|NCT00360685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64585502|NCT00360685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64585503|NCT00360685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64585504|NCT00360685|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64585759|NCT04523961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64585760|NCT04523961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64585761|NCT04523961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64585762|NCT04523961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64585763|NCT04523961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64636506|NCT03015857|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64585764|NCT04523961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585765|NCT04523961|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64585767|NCT01792505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64585768|NCT01792505|Immunologic Factors|immunologic factors|mesh-ancestor
64585769|NCT01792505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585770|NCT01792505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586142|NCT00418093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64884639|NCT04722835|Adrenergic Agents|adrenergic agents|mesh-ancestor
64884640|NCT04722835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64884641|NCT04722835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884642|NCT04722835|Chelating Agents|chelating agents|mesh-ancestor
64884643|NCT04722835|Sequestering Agents|sequestering agents|mesh-ancestor
64884644|NCT04561115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64884645|NCT04561115|Immunologic Factors|immunologic factors|mesh-ancestor
64884646|NCT04561115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884647|NCT04538053|Cefazolin|cefazolin|mesh-list
64884648|NCT04538053|Cephalexin|cephalexin|mesh-list
64884649|NCT04538053|Floxacillin|floxacillin|mesh-list
64457073|NCT01834586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457074|NCT01614093|Oxytocin|oxytocin|mesh-list
64457075|NCT01614093|Oxytocics|oxytocics|mesh-ancestor
64457086|NCT01834274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457114|NCT01738503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532288|NCT05267457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532289|NCT00351039|Bevacizumab|bevacizumab|mesh-list
64532290|NCT00351039|Pemetrexed|pemetrexed|mesh-list
64532291|NCT00351039|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64532292|NCT00351039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64532293|NCT00351039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532294|NCT00351039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64532295|NCT00351039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64532296|NCT00351039|Growth Substances|growth substances|mesh-ancestor
64532297|NCT00351039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532298|NCT00351039|Growth Inhibitors|growth inhibitors|mesh-ancestor
64532299|NCT00351039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296864|NCT02021006|Amoxicillin|amoxicillin|mesh-list
64457116|NCT01738503|Sensory System Agents|sensory system agents|mesh-ancestor
64457117|NCT01738503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64457118|NCT01738503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64457119|NCT01738191|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64457120|NCT01738191|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64457121|NCT01738191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64457122|NCT01738191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64884650|NCT04538053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64884651|NCT04538053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64884652|NCT04487990|Heparin|heparin|mesh-list
64884653|NCT04487990|Calcium heparin|calcium heparin|mesh-list
64636558|NCT04780061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64884654|NCT04487990|Anticoagulants|anticoagulants|mesh-ancestor
64884655|NCT04487990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64884656|NCT04487990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64884657|NCT04487990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884658|NCT04476979|Dexamethasone|dexamethasone|mesh-list
64519050|NCT03228108|Clavulanic Acids|clavulanic acids|mesh-list
64519051|NCT03228108|Clavulanic Acid|clavulanic acid|mesh-list
64519052|NCT03228108|Fosfomycin|fosfomycin|mesh-list
64519053|NCT03228108|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64519054|NCT03228108|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
64519055|NCT03228108|Trimethoprim|trimethoprim|mesh-list
64519056|NCT03228108|Sulfamethoxazole|sulfamethoxazole|mesh-list
64519057|NCT03228108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64519058|NCT03228108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64519059|NCT03228108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64519060|NCT03228108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64519061|NCT03228108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519062|NCT03228108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519063|NCT03228108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64884659|NCT04476979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64884660|NCT04476979|Antiemetics|antiemetics|mesh-ancestor
64653196|NCT01045694|Lidocaine|lidocaine|mesh-list
64884661|NCT04476979|Autonomic Agents|autonomic agents|mesh-ancestor
64884662|NCT04476979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64884663|NCT04476979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884664|NCT04476979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64884665|NCT04476979|Glucocorticoids|glucocorticoids|mesh-ancestor
64636586|NCT01072643|Sensory System Agents|sensory system agents|mesh-ancestor
64636587|NCT01072643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64636588|NCT01072643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64884708|NCT04411940|Dopamine Agents|dopamine agents|mesh-ancestor
64884709|NCT04411940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64884710|NCT04411940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884849|NCT03333005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64884850|NCT03333005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64884851|NCT03333005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64884867|NCT03148366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64884868|NCT03148366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64884869|NCT03148366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884870|NCT03148366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884871|NCT03148366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64884872|NCT03148366|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64884873|NCT03148366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64884874|NCT03148366|Antacids|antacids|mesh-ancestor
64884875|NCT03148366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64884876|NCT03122496|Durvalumab|durvalumab|mesh-list
64884877|NCT03122496|Tremelimumab|tremelimumab|mesh-list
64884878|NCT03122496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64884879|NCT03122496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64884880|NCT03118232|Chlorhexidine|chlorhexidine|mesh-list
64519064|NCT03228108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64519065|NCT03228108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64519066|NCT03228108|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64519067|NCT03228108|Renal Agents|renal agents|mesh-ancestor
64519068|NCT03228108|Antimalarials|antimalarials|mesh-ancestor
64519069|NCT03228108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64519070|NCT03228108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64519071|NCT03228108|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64519084|NCT03228030|Vitamins|vitamins|mesh-ancestor
64519085|NCT03228030|Micronutrients|micronutrients|mesh-ancestor
64519086|NCT03228030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519087|NCT01717313|Metformin|metformin|mesh-list
64519088|NCT01717313|Glimepiride|glimepiride|mesh-list
64519089|NCT01717313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64519090|NCT01717313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884881|NCT03118232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64884882|NCT03118232|Povidone-Iodine|povidone-iodine|mesh-list
64884883|NCT03118232|Povidone|povidone|mesh-list
64884884|NCT03118232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64884885|NCT03118232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64884886|NCT03118232|Disinfectants|disinfectants|mesh-ancestor
64884887|NCT03118232|Dermatologic Agents|dermatologic agents|mesh-ancestor
64884888|NCT03118232|Plasma Substitutes|plasma substitutes|mesh-ancestor
64884889|NCT03118232|Blood Substitutes|blood substitutes|mesh-ancestor
64884890|NCT03073694|Melphalan|melphalan|mesh-list
64884891|NCT03073694|Mitomycins|mitomycins|mesh-list
64884892|NCT03073694|Mitomycin|mitomycin|mesh-list
64884893|NCT03073694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64884894|NCT03073694|Alkylating Agents|alkylating agents|mesh-ancestor
64884895|NCT03073694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884896|NCT03073694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64884897|NCT03073694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64884898|NCT03073694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64884899|NCT03073694|Immunologic Factors|immunologic factors|mesh-ancestor
64884900|NCT03073694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884901|NCT03073694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64884902|NCT03073694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64884903|NCT03073694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884904|NCT03069703|Rituximab|rituximab|mesh-list
64519091|NCT01717313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64519092|NCT01717313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64519093|NCT01717313|Immunologic Factors|immunologic factors|mesh-ancestor
64519094|NCT00081861|Bevacizumab|bevacizumab|mesh-list
64519095|NCT00081861|Rituximab|rituximab|mesh-list
64519096|NCT00081861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64519097|NCT00081861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64884907|NCT03069703|Immunologic Factors|immunologic factors|mesh-ancestor
64884908|NCT03069703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884909|NCT03069703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64884910|NCT02955082|Carboplatin|carboplatin|mesh-list
64884941|NCT02053363|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64884942|NCT02053363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64884943|NCT02053363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884944|NCT02053363|Hemostatics|hemostatics|mesh-ancestor
64884945|NCT02053363|Coagulants|coagulants|mesh-ancestor
64884946|NCT01100775|Galantamine|galantamine|mesh-list
64884947|NCT01100775|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64884948|NCT01100775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884949|NCT01100775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884950|NCT01100775|Cholinergic Agents|cholinergic agents|mesh-ancestor
64884951|NCT01100775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64884952|NCT01100775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884953|NCT01100775|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64884954|NCT01100775|Autonomic Agents|autonomic agents|mesh-ancestor
64636653|NCT00166166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64885211|NCT04733534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885212|NCT04733534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885213|NCT04733534|Antioxidants|antioxidants|mesh-ancestor
64885214|NCT04733534|Protective Agents|protective agents|mesh-ancestor
64636654|NCT00166166|Vasodilator Agents|vasodilator agents|mesh-ancestor
64885215|NCT04733534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885216|NCT04725864|Progesterone|progesterone|mesh-list
64885217|NCT04725864|Progestins|progestins|mesh-ancestor
64885218|NCT04725864|Hormones|hormones|mesh-ancestor
64885454|NCT03032406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64885455|NCT03032406|Immunologic Factors|immunologic factors|mesh-ancestor
64885456|NCT03032406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885457|NCT03032406|Antimalarials|antimalarials|mesh-ancestor
64885458|NCT03032406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64885459|NCT03032406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64885460|NCT03032406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64885461|NCT03032406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885462|NCT03032406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885463|NCT03032406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64885464|NCT02897063|Midodrine|midodrine|mesh-list
64636695|NCT01111331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64885465|NCT02897063|Droxidopa|droxidopa|mesh-list
64885466|NCT02897063|Sympathomimetics|sympathomimetics|mesh-ancestor
64885467|NCT02897063|Autonomic Agents|autonomic agents|mesh-ancestor
64885468|NCT02897063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64885469|NCT02897063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885642|NCT00572169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64885643|NCT00572169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64885644|NCT00572169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64885645|NCT00572169|Growth Substances|growth substances|mesh-ancestor
64885646|NCT00572169|Growth Inhibitors|growth inhibitors|mesh-ancestor
64885647|NCT00323856|Factor VIII|factor viii|mesh-list
64885648|NCT00323856|Coagulants|coagulants|mesh-ancestor
64885649|NCT05415150|Fibrinolytic Agents|fibrinolytic agents|mesh-list
64885650|NCT05415150|Eptifibatide|eptifibatide|mesh-list
64885651|NCT05415150|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64885652|NCT05415150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64885653|NCT05415150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885654|NCT05414942|Analgesics, Opioid|analgesics, opioid|mesh-list
64885655|NCT05414942|Narcotics|narcotics|mesh-ancestor
64885656|NCT05414942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64885657|NCT05414942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885658|NCT05414942|Analgesics|analgesics|mesh-ancestor
64519099|NCT00081861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64519100|NCT00081861|Growth Substances|growth substances|mesh-ancestor
64519101|NCT00081861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519102|NCT00081861|Growth Inhibitors|growth inhibitors|mesh-ancestor
64519103|NCT00081861|Immunologic Factors|immunologic factors|mesh-ancestor
64519104|NCT00081861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64519105|NCT03120234|Fentanyl|fentanyl|mesh-list
64519106|NCT03120234|Dexmedetomidine|dexmedetomidine|mesh-list
64519107|NCT03120234|Ketamine|ketamine|mesh-list
64519108|NCT03120234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64519109|NCT03120234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64519110|NCT03120234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457123|NCT01738191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457124|NCT01738191|Adrenergic Agents|adrenergic agents|mesh-ancestor
64457125|NCT01738191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64457126|NCT01738191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457127|NCT01737879|Epoetin Alfa|epoetin alfa|mesh-list
64457128|NCT01737879|Hematinics|hematinics|mesh-ancestor
64636736|NCT02176031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64636737|NCT02176031|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64636738|NCT02176031|Protective Agents|protective agents|mesh-ancestor
64636739|NCT02176031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64636740|NCT02176031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636741|NCT02176031|Immunologic Factors|immunologic factors|mesh-ancestor
64636742|NCT03013361|Bupivacaine|bupivacaine|mesh-list
64636743|NCT03013361|Ropivacaine|ropivacaine|mesh-list
64636744|NCT03013361|Anesthetics, Local|anesthetics, local|mesh-ancestor
64519111|NCT03120234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64519112|NCT03120234|Analgesics|analgesics|mesh-ancestor
64519113|NCT03120234|Sensory System Agents|sensory system agents|mesh-ancestor
64519114|NCT03120234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64519115|NCT03120234|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64519116|NCT03120234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64885659|NCT05414942|Sensory System Agents|sensory system agents|mesh-ancestor
64885660|NCT05414942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64885661|NCT05414721|Anesthetics|anesthetics|mesh-list
64885662|NCT05414721|Desflurane|desflurane|mesh-list
64885663|NCT05414721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64885664|NCT05414721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885665|NCT05414721|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64885666|NCT05414721|Anesthetics, General|anesthetics, general|mesh-ancestor
64885667|NCT05414669|Allopurinol|allopurinol|mesh-list
64885668|NCT05414669|Antimetabolites|antimetabolites|mesh-ancestor
64885669|NCT05414669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885670|NCT05414669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885671|NCT05414669|Gout Suppressants|gout suppressants|mesh-ancestor
64885672|NCT05414669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64885673|NCT05414669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64885674|NCT05414669|Antioxidants|antioxidants|mesh-ancestor
64885675|NCT05414669|Protective Agents|protective agents|mesh-ancestor
64885676|NCT05414669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885677|NCT05414474|Ascorbic Acid|ascorbic acid|mesh-list
64885678|NCT05414474|Antioxidants|antioxidants|mesh-ancestor
64885679|NCT05414474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636745|NCT03013361|Anesthetics|anesthetics|mesh-ancestor
64885681|NCT05414474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885682|NCT05414474|Vitamins|vitamins|mesh-ancestor
64885683|NCT05414474|Micronutrients|micronutrients|mesh-ancestor
64885684|NCT05414292|Sirolimus|sirolimus|mesh-list
64885685|NCT05414292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64885686|NCT05414292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64885715|NCT05413902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64885716|NCT05413902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64885718|NCT05413902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64885719|NCT05413902|Antipyretics|antipyretics|mesh-ancestor
64885720|NCT05413902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64885721|NCT05413902|Antiemetics|antiemetics|mesh-ancestor
64885722|NCT05413902|Autonomic Agents|autonomic agents|mesh-ancestor
64885772|NCT05413746|Protective Agents|protective agents|mesh-ancestor
64885773|NCT05413746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885774|NCT05409365|Antibodies|antibodies|mesh-list
64885775|NCT05409365|Immunoglobulins|immunoglobulins|mesh-list
64885776|NCT05409365|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64885777|NCT05409365|Immunologic Factors|immunologic factors|mesh-ancestor
64885778|NCT05409365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885779|NCT05397587|Vaccines|vaccines|mesh-list
64885780|NCT05397587|Immunologic Factors|immunologic factors|mesh-ancestor
64885781|NCT05397587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885782|NCT05378880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64885783|NCT05378880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64885784|NCT05356936|Vitamin D|vitamin d|mesh-list
64885785|NCT05356936|Cholecalciferol|cholecalciferol|mesh-list
64519131|NCT03230682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64519133|NCT03227484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64885866|NCT05105282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64885867|NCT05067387|Dronabinol|dronabinol|mesh-list
64636798|NCT01114997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64636799|NCT01114997|Adrenergic Agents|adrenergic agents|mesh-ancestor
64636800|NCT01114997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64885868|NCT05067387|Hallucinogens|hallucinogens|mesh-ancestor
64885869|NCT05067387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885870|NCT05067387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64885871|NCT05067387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64885872|NCT05067387|Analgesics|analgesics|mesh-ancestor
64885873|NCT05067387|Sensory System Agents|sensory system agents|mesh-ancestor
64885874|NCT05067387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64885875|NCT05067387|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64885876|NCT05067387|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64885877|NCT05067387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64885878|NCT05067387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885879|NCT05067387|Hormones|hormones|mesh-ancestor
64885880|NCT05067387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64885881|NCT05005455|Bevacizumab|bevacizumab|mesh-list
64885882|NCT05005455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64519140|NCT04555577|Alkylating Agents|alkylating agents|mesh-ancestor
64519141|NCT04555577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519142|NCT04555577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519143|NCT04555577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64885883|NCT05005455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885884|NCT05005455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64885885|NCT05005455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64885886|NCT05005455|Growth Substances|growth substances|mesh-ancestor
64885887|NCT05005455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885888|NCT05005455|Growth Inhibitors|growth inhibitors|mesh-ancestor
64885889|NCT04910386|Gemcitabine|gemcitabine|mesh-list
64885890|NCT04910386|Cisplatin|cisplatin|mesh-list
64457129|NCT01605825|4-Aminopyridine|4-aminopyridine|mesh-list
64457130|NCT01605825|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64457131|NCT01605825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64457164|NCT04609761|Immunoglobulins|immunoglobulins|mesh-list
64457165|NCT04609761|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64457166|NCT04609761|Antibodies|antibodies|mesh-list
64457167|NCT04609761|gamma-Globulins|gamma-globulins|mesh-list
64457168|NCT04609761|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64457169|NCT04609761|Immunologic Factors|immunologic factors|mesh-ancestor
64885891|NCT04910386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885892|NCT04910386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64885893|NCT04910386|Antimetabolites|antimetabolites|mesh-ancestor
64885894|NCT04910386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885895|NCT04910386|Antiviral Agents|antiviral agents|mesh-ancestor
64885896|NCT04910386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64885897|NCT04910386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885898|NCT04910386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64885899|NCT04910386|Immunologic Factors|immunologic factors|mesh-ancestor
64885900|NCT04910386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885901|NCT04875715|Hydroquinone|hydroquinone|mesh-list
64636840|NCT01317901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64636841|NCT01317901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64636842|NCT01317901|Alkylating Agents|alkylating agents|mesh-ancestor
64636843|NCT01317901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636844|NCT03008551|Metformin|metformin|mesh-list
64636845|NCT03008551|Empagliflozin|empagliflozin|mesh-list
64885902|NCT04875715|Antioxidants|antioxidants|mesh-ancestor
64885903|NCT04875715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885904|NCT04875715|Protective Agents|protective agents|mesh-ancestor
64885905|NCT04875715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885906|NCT04875715|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64885907|NCT04757662|Tadalafil|tadalafil|mesh-list
64885908|NCT04757662|Vasodilator Agents|vasodilator agents|mesh-ancestor
64885909|NCT04757662|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64885910|NCT04757662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64885929|NCT04636034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64885930|NCT04547946|Trametinib|trametinib|mesh-list
64885931|NCT04547946|Dabrafenib|dabrafenib|mesh-list
64885932|NCT04547946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885933|NCT04547946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64885934|NCT04547946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885935|NCT04547946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457170|NCT04609761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457171|NCT01858532|Atrasentan|atrasentan|mesh-list
64457172|NCT01858532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457173|NCT01858532|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64457174|NCT01858532|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64457175|NCT01858532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457176|NCT04613960|Magnesium Sulfate|magnesium sulfate|mesh-list
64457199|NCT04599140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885936|NCT04524663|Camostat|camostat|mesh-list
64885937|NCT04524663|Protease Inhibitors|protease inhibitors|mesh-ancestor
64885938|NCT04524663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885939|NCT04524663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885940|NCT04524663|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64885941|NCT04524663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64885942|NCT04435795|Ciclesonide|ciclesonide|mesh-list
64885943|NCT04435795|Glucocorticoids|glucocorticoids|mesh-ancestor
64885944|NCT04435795|Hormones|hormones|mesh-ancestor
64885945|NCT04435795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64885946|NCT04435795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885947|NCT04435795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64885948|NCT04350593|Dapagliflozin|dapagliflozin|mesh-list
64885949|NCT04350593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64885950|NCT04350593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885951|NCT04350593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64885952|NCT04350593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636882|NCT02539368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64636883|NCT01425307|Hydroxyurea|hydroxyurea|mesh-list
64636884|NCT01425307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636885|NCT01425307|Antisickling Agents|antisickling agents|mesh-ancestor
64636886|NCT01425307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636887|NCT01425307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636889|NCT01035749|Vaccines|vaccines|mesh-list
64885953|NCT04222283|Emtricitabine|emtricitabine|mesh-list
64885954|NCT04222283|Antiviral Agents|antiviral agents|mesh-ancestor
64885955|NCT04222283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64885956|NCT04222283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64885957|NCT04222283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64519154|NCT02038894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64519155|NCT01375374|Lacosamide|lacosamide|mesh-list
64519156|NCT01375374|Levetiracetam|levetiracetam|mesh-list
64885965|NCT04131504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64885966|NCT04131504|Dermatologic Agents|dermatologic agents|mesh-ancestor
64885986|NCT03891667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885987|NCT03891667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885988|NCT03859635|Bupivacaine|bupivacaine|mesh-list
64885989|NCT03859635|Anesthetics, Local|anesthetics, local|mesh-ancestor
64885990|NCT03859635|Anesthetics|anesthetics|mesh-ancestor
64885991|NCT03859635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64885992|NCT03859635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885993|NCT03859635|Sensory System Agents|sensory system agents|mesh-ancestor
64885994|NCT03859635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64885995|NCT03783013|Lycopene|lycopene|mesh-list
64885996|NCT03783013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64885997|NCT03783013|Antioxidants|antioxidants|mesh-ancestor
64885998|NCT03783013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885999|NCT03783013|Protective Agents|protective agents|mesh-ancestor
64886000|NCT03783013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886001|NCT03783013|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64886002|NCT03783013|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64886003|NCT03783013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886004|NCT03762473|Tacrolimus|tacrolimus|mesh-list
64886005|NCT03762473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64886006|NCT03762473|Immunologic Factors|immunologic factors|mesh-ancestor
64886007|NCT03762473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886008|NCT03762473|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64886009|NCT03762473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886010|NCT03762473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886011|NCT03726229|Cholic Acids|cholic acids|mesh-list
64886012|NCT03726229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64886013|NCT03712228|Antibodies|antibodies|mesh-list
64886014|NCT03712228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64886017|NCT03626922|Folic Acid|folic acid|mesh-list
64886025|NCT03626922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886053|NCT03578276|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64886054|NCT03578276|Methylprednisolone|methylprednisolone|mesh-list
64886055|NCT03578276|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64886056|NCT03578276|Prednisolone acetate|prednisolone acetate|mesh-list
64886057|NCT03578276|Bromfenac|bromfenac|mesh-list
64886058|NCT03578276|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64886059|NCT03578276|Prednisolone phosphate|prednisolone phosphate|mesh-list
64886060|NCT03578276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64886061|NCT03578276|Glucocorticoids|glucocorticoids|mesh-ancestor
64886062|NCT03578276|Hormones|hormones|mesh-ancestor
64886063|NCT03578276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64519158|NCT01375374|Nootropic Agents|nootropic agents|mesh-ancestor
64519159|NCT01375374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64519160|NCT01375374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64636947|NCT01427881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519161|NCT01375374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64519162|NCT01375374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519163|NCT04348786|Amoxicillin|amoxicillin|mesh-list
64519164|NCT04348786|Doxycycline|doxycycline|mesh-list
64519165|NCT04348786|Levofloxacin|levofloxacin|mesh-list
64519166|NCT04348786|Ofloxacin|ofloxacin|mesh-list
64519167|NCT04348786|Esomeprazole|esomeprazole|mesh-list
64886064|NCT03578276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886065|NCT03578276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64886066|NCT03578276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886067|NCT03578276|Antiemetics|antiemetics|mesh-ancestor
64886068|NCT03578276|Autonomic Agents|autonomic agents|mesh-ancestor
64886069|NCT03578276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64886070|NCT03578276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64886071|NCT03578276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64886090|NCT03532477|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64886091|NCT03532477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64886100|NCT03491267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886101|NCT03491267|Keratolytic Agents|keratolytic agents|mesh-ancestor
64886102|NCT03491267|Dermatologic Agents|dermatologic agents|mesh-ancestor
64886103|NCT03174184|Amoxicillin|amoxicillin|mesh-list
64886104|NCT03174184|Rifampin|rifampin|mesh-list
64886105|NCT03174184|Meropenem|meropenem|mesh-list
64886106|NCT03174184|Clavulanic Acid|clavulanic acid|mesh-list
64886107|NCT03174184|Clavulanic Acids|clavulanic acids|mesh-list
64886108|NCT03174184|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64886109|NCT03174184|Rifamycins|rifamycins|mesh-list
64886110|NCT03174184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64886111|NCT03174184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64886112|NCT03174184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64886113|NCT03174184|Antitubercular Agents|antitubercular agents|mesh-ancestor
64636982|NCT01319851|Dermatologic Agents|dermatologic agents|mesh-ancestor
64886114|NCT03174184|Leprostatic Agents|leprostatic agents|mesh-ancestor
64886115|NCT03174184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64886116|NCT03174184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886117|NCT03174184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886118|NCT03174184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64886119|NCT03174184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64886120|NCT03174184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64457200|NCT04599140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64457201|NCT04599140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457203|NCT01857206|Immunologic Factors|immunologic factors|mesh-ancestor
64457204|NCT01857206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457205|NCT01882088|Psyllium|psyllium|mesh-list
64457206|NCT01882088|Cathartics|cathartics|mesh-ancestor
64457207|NCT01882088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64457208|NCT01722669|Quercetin|quercetin|mesh-list
64457209|NCT01722669|Antioxidants|antioxidants|mesh-ancestor
64457219|NCT01707147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64457220|NCT01707147|Protease Inhibitors|protease inhibitors|mesh-ancestor
64532300|NCT00351039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532301|NCT00351039|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64532302|NCT00351039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64532303|NCT00351039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64532306|NCT02373072|Autonomic Agents|autonomic agents|mesh-ancestor
64532307|NCT02373072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64532308|NCT02373072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532309|NCT02373072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64532310|NCT02372916|Ranibizumab|ranibizumab|mesh-list
64532311|NCT02372916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64532312|NCT02372916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64532313|NCT02372916|Growth Substances|growth substances|mesh-ancestor
64296870|NCT02021006|Trimethoprim|trimethoprim|mesh-list
64296871|NCT02021006|Sulfamethoxazole|sulfamethoxazole|mesh-list
64296875|NCT02021006|Renal Agents|renal agents|mesh-ancestor
64457221|NCT01707147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457222|NCT01707147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457223|NCT01876251|Docetaxel|docetaxel|mesh-list
64457224|NCT01876251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457225|NCT01876251|Tubulin Modulators|tubulin modulators|mesh-ancestor
64457226|NCT01876251|Antimitotic Agents|antimitotic agents|mesh-ancestor
64886121|NCT03174184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64886122|NCT03174184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64886123|NCT03174184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64886124|NCT03174184|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64886136|NCT02971761|Pembrolizumab|pembrolizumab|mesh-list
64886137|NCT02971761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64886138|NCT02971761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886139|NCT02959697|Lidocaine|lidocaine|mesh-list
64886140|NCT02959697|Anesthetics, Local|anesthetics, local|mesh-ancestor
64886141|NCT02959697|Anesthetics|anesthetics|mesh-ancestor
64886142|NCT02959697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64886143|NCT02959697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886144|NCT02959697|Sensory System Agents|sensory system agents|mesh-ancestor
64519168|NCT04348786|Bismuth|bismuth|mesh-list
64519169|NCT04348786|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
64519170|NCT04348786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64519171|NCT04348786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64886145|NCT02959697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64886146|NCT02959697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64886147|NCT02959697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64886148|NCT02959697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64886149|NCT02959697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64886150|NCT02959697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886151|NCT02900560|Pembrolizumab|pembrolizumab|mesh-list
64886152|NCT02900560|Azacitidine|azacitidine|mesh-list
64886153|NCT02900560|Cc-486|cc-486|mesh-list
64886154|NCT02900560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64886155|NCT02900560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886156|NCT02900560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64886157|NCT02900560|Antimetabolites|antimetabolites|mesh-ancestor
64886158|NCT02900560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886159|NCT02900560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886160|NCT02877550|Venetoclax|venetoclax|mesh-list
64886161|NCT02877550|Obinutuzumab|obinutuzumab|mesh-list
64886162|NCT02877550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457227|NCT01876251|Mitosis Modulators|mitosis modulators|mesh-ancestor
64457261|NCT01875237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64457262|NCT01875237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64457263|NCT01875237|Glucocorticoids|glucocorticoids|mesh-ancestor
64886163|NCT02877550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64637076|NCT00176228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64886164|NCT02775812|Pembrolizumab|pembrolizumab|mesh-list
64886165|NCT02775812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886166|NCT02775812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64886167|NCT02679170|Crizotinib|crizotinib|mesh-list
64886168|NCT02679170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886169|NCT02679170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64886170|NCT02679170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886171|NCT02679170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886172|NCT02640534|Metformin|metformin|mesh-list
64886173|NCT02640534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64886174|NCT02640534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886175|NCT02518009|Estrogens|estrogens|mesh-list
64886176|NCT02518009|Androgens|androgens|mesh-list
64886177|NCT02518009|Hormones|hormones|mesh-ancestor
64886178|NCT02518009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64886179|NCT02518009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886180|NCT02238496|Sirolimus|sirolimus|mesh-list
64886181|NCT02238496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64886182|NCT02238496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64886183|NCT02238496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64886184|NCT02238496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886185|NCT02238496|Antifungal Agents|antifungal agents|mesh-ancestor
64886186|NCT02238496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64886187|NCT02238496|Immunologic Factors|immunologic factors|mesh-ancestor
64886203|NCT01968213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886204|NCT01968213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886205|NCT01968213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886206|NCT01503632|Mercaptopurine|mercaptopurine|mesh-list
64886207|NCT01503632|Antimetabolites|antimetabolites|mesh-ancestor
64637077|NCT00176306|Levofloxacin|levofloxacin|mesh-list
64637078|NCT00176306|Ofloxacin|ofloxacin|mesh-list
64457264|NCT01875237|Hormones|hormones|mesh-ancestor
64457265|NCT01875237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64457266|NCT01875237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64457267|NCT01875237|Protective Agents|protective agents|mesh-ancestor
64457268|NCT01875237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64457289|NCT01721109|Antiviral Agents|antiviral agents|mesh-ancestor
64457290|NCT01721109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64457291|NCT01874145|Glatiramer Acetate|glatiramer acetate|mesh-list
64457292|NCT01874145|(T,G)-A-L|(t,g)-a-l|mesh-list
64457293|NCT01874145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64457294|NCT01874145|Immunologic Factors|immunologic factors|mesh-ancestor
64886208|NCT01503632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886209|NCT01503632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64886210|NCT01503632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886211|NCT01503632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64886212|NCT01503632|Immunologic Factors|immunologic factors|mesh-ancestor
64886213|NCT01503632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886214|NCT01503632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64886215|NCT01503632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886216|NCT01498458|Capecitabine|capecitabine|mesh-list
64886217|NCT01498458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64886218|NCT01498458|Antimetabolites|antimetabolites|mesh-ancestor
64886219|NCT01498458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886220|NCT01498458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886221|NCT01427712|Pancrelipase|pancrelipase|mesh-list
64886222|NCT01427712|Pancreatin|pancreatin|mesh-list
64886223|NCT01427712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64886224|NCT01369147|Clevidipine|clevidipine|mesh-list
64519173|NCT04348786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64519174|NCT04348786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64519175|NCT04348786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519176|NCT04348786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519177|NCT04348786|Antimalarials|antimalarials|mesh-ancestor
64519178|NCT04348786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64519179|NCT04348786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64519180|NCT04348786|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64519181|NCT04348786|Renal Agents|renal agents|mesh-ancestor
64519182|NCT04348786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64637123|NCT00176852|Alkylating Agents|alkylating agents|mesh-ancestor
64457295|NCT01874145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457296|NCT01874145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64457297|NCT01874145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64457298|NCT04415385|Apatinib|apatinib|mesh-list
64457299|NCT04415385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457300|NCT04415385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64457301|NCT04415385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457302|NCT04415385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457303|NCT01720797|Chlorhexidine|chlorhexidine|mesh-list
64457304|NCT01720797|Anesthetics|anesthetics|mesh-list
64457305|NCT01720797|Anesthetics, Local|anesthetics, local|mesh-list
64457306|NCT01720797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64457307|NCT01720797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457308|NCT01720797|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64457309|NCT01720797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64457310|NCT01720797|Disinfectants|disinfectants|mesh-ancestor
64457311|NCT01720797|Sensory System Agents|sensory system agents|mesh-ancestor
64532323|NCT01572727|Tubulin Modulators|tubulin modulators|mesh-ancestor
64532324|NCT01572727|Antimitotic Agents|antimitotic agents|mesh-ancestor
64519183|NCT04348786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64519184|NCT04348786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519185|NCT04348786|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64519186|NCT04348786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64886225|NCT01369147|Propofol|propofol|mesh-list
64886226|NCT01369147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64886227|NCT01369147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64886228|NCT01369147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886229|NCT01369147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64532325|NCT01572727|Mitosis Modulators|mitosis modulators|mesh-ancestor
64532326|NCT01572727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457313|NCT01831466|Tofacitinib|tofacitinib|mesh-list
64457314|NCT01831466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64457315|NCT01831466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457316|NCT01831466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457317|NCT01881230|Gemcitabine|gemcitabine|mesh-list
64457318|NCT01881230|Paclitaxel|paclitaxel|mesh-list
64457319|NCT01881230|Carboplatin|carboplatin|mesh-list
64457320|NCT01881230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64457321|NCT01881230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457355|NCT01880528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64457356|NCT01880528|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64457357|NCT01880528|Protective Agents|protective agents|mesh-ancestor
64457386|NCT01828034|Antimetabolites|antimetabolites|mesh-ancestor
64457387|NCT01828034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457388|NCT01828034|Antiviral Agents|antiviral agents|mesh-ancestor
64457389|NCT01828034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64457390|NCT01828034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457391|NCT01828034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64457392|NCT01828034|Immunologic Factors|immunologic factors|mesh-ancestor
64457393|NCT01828034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457394|NCT01853696|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64457395|NCT01853696|Prednisolone|prednisolone|mesh-list
64457396|NCT01853696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64457397|NCT01853696|Methylprednisolone|methylprednisolone|mesh-list
64457398|NCT01853696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64457399|NCT01853696|Prednisolone acetate|prednisolone acetate|mesh-list
64457400|NCT01853696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64457401|NCT01853696|Prednisolone phosphate|prednisolone phosphate|mesh-list
64457402|NCT01853696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64457403|NCT01853696|Glucocorticoids|glucocorticoids|mesh-ancestor
64457404|NCT01853696|Hormones|hormones|mesh-ancestor
64457422|NCT01719861|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64457423|NCT01719861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64457424|NCT01719861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64457425|NCT01719861|Adrenergic Agents|adrenergic agents|mesh-ancestor
64457426|NCT01719861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64457427|NCT01719861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457428|NCT01853618|Tremelimumab|tremelimumab|mesh-list
64457429|NCT01853618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457431|NCT01719783|Immunologic Factors|immunologic factors|mesh-ancestor
64457432|NCT01719783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457433|NCT01719237|Ropivacaine|ropivacaine|mesh-list
64457434|NCT01719237|Chloroprocaine|chloroprocaine|mesh-list
64457435|NCT01719237|Anesthetics, Local|anesthetics, local|mesh-ancestor
64457436|NCT01719237|Anesthetics|anesthetics|mesh-ancestor
64457437|NCT01719237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64457438|NCT01719237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457439|NCT01719237|Sensory System Agents|sensory system agents|mesh-ancestor
64457440|NCT01719237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64457441|NCT01878890|Efavirenz|efavirenz|mesh-list
64532328|NCT02359266|Cholecalciferol|cholecalciferol|mesh-list
64532329|NCT02359266|Vitamins|vitamins|mesh-ancestor
64532330|NCT02359266|Micronutrients|micronutrients|mesh-ancestor
64532331|NCT02359266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532340|NCT02359500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886230|NCT01369147|Anesthetics, General|anesthetics, general|mesh-ancestor
64886231|NCT01369147|Anesthetics|anesthetics|mesh-ancestor
64886232|NCT01369147|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64886233|NCT01369147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64886234|NCT01369147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886235|NCT01369147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64886236|NCT01197066|Certolizumab Pegol|certolizumab pegol|mesh-list
64886237|NCT01197066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64886238|NCT01197066|Immunologic Factors|immunologic factors|mesh-ancestor
64886239|NCT01197066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886240|NCT01197066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64886241|NCT01079780|Irinotecan|irinotecan|mesh-list
64886242|NCT01079780|Cetuximab|cetuximab|mesh-list
64886243|NCT01079780|Ramucirumab|ramucirumab|mesh-list
64886244|NCT01079780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64654774|NCT01640171|Ketorolac|ketorolac|mesh-list
64886245|NCT01079780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64886246|NCT01079780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886264|NCT01945840|Hormones|hormones|mesh-list
64886265|NCT01945840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64886266|NCT01945840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886267|NCT01945879|Heparin|heparin|mesh-list
64886268|NCT01945879|Enoxaparin|enoxaparin|mesh-list
64886269|NCT01945879|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64886270|NCT01945879|Tinzaparin|tinzaparin|mesh-list
64886271|NCT01945879|Dalteparin|dalteparin|mesh-list
64886272|NCT01945879|Anticoagulants|anticoagulants|mesh-ancestor
64637227|NCT01080677|Adrenergic Agents|adrenergic agents|mesh-ancestor
64532342|NCT02372526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532343|NCT02372526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296897|NCT03867110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457442|NCT01878890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64457443|NCT01878890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64457444|NCT01878890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457445|NCT01878890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457446|NCT01878890|Antiviral Agents|antiviral agents|mesh-ancestor
64457447|NCT01878890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64457448|NCT01878890|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64457449|NCT01878890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64457450|NCT01878890|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64457451|NCT01878890|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64457452|NCT01878890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64457453|NCT01878890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64457454|NCT01827332|Oxytocin|oxytocin|mesh-list
64457455|NCT01827332|Oxytocics|oxytocics|mesh-ancestor
64457456|NCT01827332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64457457|NCT01827332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457479|NCT01705587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64637277|NCT01381471|Fluticasone|fluticasone|mesh-list
64886273|NCT01945879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64886274|NCT01945879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64886275|NCT01945879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886276|NCT01945892|Dexamethasone|dexamethasone|mesh-list
64886277|NCT01945892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64886278|NCT01945892|Antiemetics|antiemetics|mesh-ancestor
64886279|NCT01945892|Autonomic Agents|autonomic agents|mesh-ancestor
64886280|NCT01945892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64886281|NCT01945892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886282|NCT01945892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64886283|NCT01945892|Glucocorticoids|glucocorticoids|mesh-ancestor
64886284|NCT01945892|Hormones|hormones|mesh-ancestor
64886285|NCT01945892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64637278|NCT01381471|Xhance|xhance|mesh-list
64519188|NCT04348786|Antidiarrheals|antidiarrheals|mesh-ancestor
64519189|NCT02369068|Triamcinolone|triamcinolone|mesh-list
64519190|NCT02369068|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64519191|NCT02369068|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64519192|NCT02369068|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64519193|NCT02369068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64519194|NCT02369068|Glucocorticoids|glucocorticoids|mesh-ancestor
64519196|NCT02369068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64519197|NCT02369068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519198|NCT02369068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64519199|NCT02369068|Immunologic Factors|immunologic factors|mesh-ancestor
64519200|NCT02369068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519201|NCT02369068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64519202|NCT02369068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64519203|NCT02369068|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64519204|NCT02369068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64886292|NCT01945983|Norepinephrine|norepinephrine|mesh-list
64886293|NCT01945983|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64886294|NCT01945983|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64886295|NCT01945983|Adrenergic Agents|adrenergic agents|mesh-ancestor
64886296|NCT01945983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64886297|NCT01945983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886298|NCT01945983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886299|NCT01945983|Sympathomimetics|sympathomimetics|mesh-ancestor
64886300|NCT01945983|Autonomic Agents|autonomic agents|mesh-ancestor
64886301|NCT01945983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64886302|NCT01945983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64886303|NCT01946009|Cidofovir|cidofovir|mesh-list
64886304|NCT01946009|Antiviral Agents|antiviral agents|mesh-ancestor
64457480|NCT01705509|Ranolazine|ranolazine|mesh-list
64457481|NCT01705509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64457482|NCT01705509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64457483|NCT01705509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457484|NCT01853072|Prednisolone|prednisolone|mesh-list
64457485|NCT01853072|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64457486|NCT01853072|Methylprednisolone|methylprednisolone|mesh-list
64457487|NCT01853072|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64513624|NCT01457001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457488|NCT01853072|Prednisolone acetate|prednisolone acetate|mesh-list
64457490|NCT01853072|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64457491|NCT01853072|Prednisolone phosphate|prednisolone phosphate|mesh-list
64457492|NCT01853072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64457493|NCT01853072|Glucocorticoids|glucocorticoids|mesh-ancestor
64457494|NCT01853072|Hormones|hormones|mesh-ancestor
64457495|NCT01853072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64457496|NCT01853072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457497|NCT01853072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64532344|NCT02372526|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64532345|NCT02372526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64532346|NCT02985697|Midazolam|midazolam|mesh-list
64532347|NCT02985697|Dexmedetomidine|dexmedetomidine|mesh-list
64532348|NCT02985697|Nitrous Oxide|nitrous oxide|mesh-list
64532349|NCT02985697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64532350|NCT02985697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64532351|NCT02985697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532352|NCT02985697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64532353|NCT02985697|Analgesics|analgesics|mesh-ancestor
64532354|NCT02985697|Sensory System Agents|sensory system agents|mesh-ancestor
64532355|NCT02985697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64532356|NCT02985697|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64532357|NCT02985697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64532358|NCT02985697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64532359|NCT02985697|Adrenergic Agents|adrenergic agents|mesh-ancestor
64457498|NCT01853072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457499|NCT01853072|Antiemetics|antiemetics|mesh-ancestor
64457500|NCT01853072|Autonomic Agents|autonomic agents|mesh-ancestor
64457501|NCT01853072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64457502|NCT01853072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64457503|NCT01853072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64457504|NCT01853072|Protective Agents|protective agents|mesh-ancestor
64457505|NCT01853072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64945371|NCT05697783|Respiratory System Agents|respiratory system agents|mesh-ancestor
64457506|NCT01853072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64457507|NCT01853072|Analgesics|analgesics|mesh-ancestor
64457508|NCT01853072|Sensory System Agents|sensory system agents|mesh-ancestor
64457538|NCT01827254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64457540|NCT01827254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457541|NCT01827254|Growth Inhibitors|growth inhibitors|mesh-ancestor
64886305|NCT01946009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64886335|NCT01946295|Histamine Agents|histamine agents|mesh-ancestor
64886336|NCT01946295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64886337|NCT01946295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886338|NCT01946295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886339|NCT01946386|Betamethasone|betamethasone|mesh-list
64886340|NCT01946386|Betamethasone Valerate|betamethasone valerate|mesh-list
64886341|NCT01946386|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64886342|NCT01946386|Betamethasone benzoate|betamethasone benzoate|mesh-list
64886343|NCT01946386|Clobetasol|clobetasol|mesh-list
64886344|NCT01946386|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64519210|NCT02452632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64519211|NCT02452632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519212|NCT02371252|Alendronate|alendronate|mesh-list
64519213|NCT02371252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64519214|NCT02371252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519215|NCT03221946|Diclofenac|diclofenac|mesh-list
64519216|NCT03221946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64519217|NCT03221946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64519218|NCT03221946|Analgesics|analgesics|mesh-ancestor
64519219|NCT03221946|Sensory System Agents|sensory system agents|mesh-ancestor
64637373|NCT01118273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64637374|NCT01118273|Gout Suppressants|gout suppressants|mesh-ancestor
64519220|NCT03221946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64519221|NCT03221946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886345|NCT01946386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64886346|NCT01946386|Glucocorticoids|glucocorticoids|mesh-ancestor
64886347|NCT01946386|Hormones|hormones|mesh-ancestor
64886348|NCT01946386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64886349|NCT01946386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886373|NCT01946555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64886375|NCT01946555|Analgesics|analgesics|mesh-ancestor
64886376|NCT01946555|Sensory System Agents|sensory system agents|mesh-ancestor
64886377|NCT01946555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64637379|NCT01118273|Anesthetics|anesthetics|mesh-ancestor
64457542|NCT01827254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64457543|NCT01827254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457544|NCT01827254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886378|NCT01946555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64886379|NCT01946555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64886380|NCT01946555|Anesthetics, General|anesthetics, general|mesh-ancestor
64886381|NCT01946555|Anesthetics|anesthetics|mesh-ancestor
64886382|NCT01946555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64886383|NCT01946555|Antitussive Agents|antitussive agents|mesh-ancestor
64886384|NCT01946555|Respiratory System Agents|respiratory system agents|mesh-ancestor
64886385|NCT01946555|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64886386|NCT01946555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64886387|NCT01946555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64886388|NCT01946555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886389|NCT01946555|Adrenergic Agents|adrenergic agents|mesh-ancestor
64886390|NCT01946555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64886391|NCT01946568|Dalbavancin|dalbavancin|mesh-list
64886392|NCT01946568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64637415|NCT01439815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64886393|NCT01946568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64886394|NCT01946594|Acetaminophen|acetaminophen|mesh-list
64886395|NCT01946594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64654923|NCT01600703|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64886396|NCT01946594|Analgesics|analgesics|mesh-ancestor
64886397|NCT01946594|Sensory System Agents|sensory system agents|mesh-ancestor
64886398|NCT01946594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64886399|NCT01946594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886400|NCT01946594|Antipyretics|antipyretics|mesh-ancestor
64886401|NCT01946607|Citalopram|citalopram|mesh-list
64886402|NCT01946607|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64886403|NCT01946607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64886414|NCT01946620|Autonomic Agents|autonomic agents|mesh-ancestor
64886415|NCT01946620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64886416|NCT01946620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886417|NCT01946620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64886418|NCT01946620|Respiratory System Agents|respiratory system agents|mesh-ancestor
64886419|NCT01946620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64886420|NCT01946620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64457545|NCT01824602|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64457546|NCT01824602|Anticonvulsants|anticonvulsants|mesh-ancestor
64457547|NCT01824602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64457548|NCT01824602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64886421|NCT01946620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64886422|NCT01946620|Adrenergic Agents|adrenergic agents|mesh-ancestor
64886423|NCT01946620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64886424|NCT01946620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886425|NCT01946906|Rifaximin|rifaximin|mesh-list
64519222|NCT03221946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64519224|NCT03221946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64519225|NCT03221946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519226|NCT03221946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519227|NCT03229746|Hydroxychloroquine|hydroxychloroquine|mesh-list
64519228|NCT03229746|Vincristine|vincristine|mesh-list
64519229|NCT03229746|Azathioprine|azathioprine|mesh-list
64519230|NCT03229746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64519231|NCT03229746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519232|NCT03229746|Tubulin Modulators|tubulin modulators|mesh-ancestor
64519233|NCT03229746|Antimitotic Agents|antimitotic agents|mesh-ancestor
64886426|NCT01946906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64886427|NCT01946906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64886428|NCT01946906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64886429|NCT01946971|Lansoprazole|lansoprazole|mesh-list
64886430|NCT01946971|Dexlansoprazole|dexlansoprazole|mesh-list
64886431|NCT01946971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64637454|NCT01384591|Expectorants|expectorants|mesh-ancestor
64637455|NCT01384591|Respiratory System Agents|respiratory system agents|mesh-ancestor
64886432|NCT01946971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64886433|NCT01946971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64886434|NCT01946971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886435|NCT01946971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886436|NCT01946984|Diclofenac|diclofenac|mesh-list
64886437|NCT01946984|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
64886438|NCT01946984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64886439|NCT01946984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64886440|NCT01946984|Analgesics|analgesics|mesh-ancestor
64886441|NCT01946984|Sensory System Agents|sensory system agents|mesh-ancestor
64886442|NCT01946984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64886443|NCT01946984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886447|NCT01946984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886448|NCT01946984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886449|NCT01947010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64886450|NCT01947010|Immunologic Factors|immunologic factors|mesh-ancestor
64886451|NCT01947010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886452|NCT01947062|Cyclophosphamide|cyclophosphamide|mesh-list
64886453|NCT01947062|Cisplatin|cisplatin|mesh-list
64886454|NCT01947062|Etoposide|etoposide|mesh-list
64886455|NCT01947062|Etoposide phosphate|etoposide phosphate|mesh-list
64886456|NCT01947062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64886457|NCT01947062|Immunologic Factors|immunologic factors|mesh-ancestor
64886458|NCT01947062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886459|NCT01947062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64886460|NCT01947062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64886461|NCT01947062|Alkylating Agents|alkylating agents|mesh-ancestor
64637493|NCT00265850|Vitamins|vitamins|mesh-ancestor
64637494|NCT00265850|Micronutrients|micronutrients|mesh-ancestor
64457549|NCT01824602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64457550|NCT01824602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457552|NCT01704651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64457572|NCT01876082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64457573|NCT01876082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64532365|NCT02985697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64532366|NCT02985697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64532368|NCT02985697|Anesthetics|anesthetics|mesh-ancestor
64532369|NCT02985697|GABA Modulators|gaba modulators|mesh-ancestor
64532370|NCT02985697|GABA Agents|gaba agents|mesh-ancestor
64532371|NCT02985697|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64532372|NCT02372760|Lidocaine|lidocaine|mesh-list
64532373|NCT02372760|Anesthetics|anesthetics|mesh-list
64532374|NCT02372760|Anesthetics, Local|anesthetics, local|mesh-ancestor
64532375|NCT02372760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64532376|NCT02372760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532377|NCT02372760|Sensory System Agents|sensory system agents|mesh-ancestor
64532378|NCT02372760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64532379|NCT02372760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64532380|NCT02372760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64532381|NCT02372760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64532382|NCT02372760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64532383|NCT02372760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532384|NCT00352911|Mifepristone|mifepristone|mesh-list
64532385|NCT00352911|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64532386|NCT00352911|Abortifacient Agents|abortifacient agents|mesh-ancestor
64532387|NCT00352911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64532388|NCT00352911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296933|NCT01187810|Antiviral Agents|antiviral agents|mesh-ancestor
64457575|NCT01876082|Antimitotic Agents|antimitotic agents|mesh-ancestor
64457576|NCT01876082|Mitosis Modulators|mitosis modulators|mesh-ancestor
64457577|NCT01716585|Ribavirin|ribavirin|mesh-list
64457578|NCT01716585|Antimetabolites|antimetabolites|mesh-ancestor
64457579|NCT01716585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457580|NCT01716585|Antiviral Agents|antiviral agents|mesh-ancestor
64457581|NCT01716585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64457583|NCT01852292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64457592|NCT01715805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64457593|NCT01715805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64457594|NCT01715805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64886462|NCT01947062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886463|NCT01947062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886464|NCT01947062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64886487|NCT01947114|Narcotics|narcotics|mesh-ancestor
64886488|NCT01947192|Chlorhexidine|chlorhexidine|mesh-list
64886489|NCT01947192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64886490|NCT01947192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64886491|NCT01947192|Disinfectants|disinfectants|mesh-ancestor
64886492|NCT01947205|Acetaminophen|acetaminophen|mesh-list
64886493|NCT01947205|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
64886494|NCT01947205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64886495|NCT01947205|Analgesics|analgesics|mesh-ancestor
64886496|NCT01947205|Sensory System Agents|sensory system agents|mesh-ancestor
64886497|NCT01947205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64886498|NCT01947205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519234|NCT03229746|Mitosis Modulators|mitosis modulators|mesh-ancestor
64519235|NCT03229746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519236|NCT03229746|Antimalarials|antimalarials|mesh-ancestor
64519237|NCT03229746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64519238|NCT03229746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64519239|NCT03229746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64519240|NCT03229746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519241|NCT03229746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64519242|NCT03229746|Antimetabolites|antimetabolites|mesh-ancestor
64519243|NCT03229746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64519244|NCT03229746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64519245|NCT03229746|Immunologic Factors|immunologic factors|mesh-ancestor
64519246|NCT03229746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519247|NCT02040298|Clemastine|clemastine|mesh-list
64519248|NCT02040298|Antipruritics|antipruritics|mesh-ancestor
64519249|NCT02040298|Dermatologic Agents|dermatologic agents|mesh-ancestor
64637564|NCT01336933|Hormones|hormones|mesh-ancestor
64457595|NCT01715805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457596|NCT01852214|Ticagrelor|ticagrelor|mesh-list
64457597|NCT01852214|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64457598|NCT01852214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64457599|NCT01852214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64457600|NCT01852214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64457601|NCT01852214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64532389|NCT00352911|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64532390|NCT00352911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64532391|NCT00352911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64532392|NCT00352911|Contraceptive Agents|contraceptive agents|mesh-ancestor
64532393|NCT00352911|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64519250|NCT02040298|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64519251|NCT02040298|Histamine Antagonists|histamine antagonists|mesh-ancestor
64519252|NCT02040298|Histamine Agents|histamine agents|mesh-ancestor
64519253|NCT02040298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64519254|NCT02040298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519255|NCT02040298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519256|NCT02040298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64519257|NCT03229668|Pregabalin|pregabalin|mesh-list
64519258|NCT03229668|Analgesics|analgesics|mesh-ancestor
64519259|NCT03229668|Sensory System Agents|sensory system agents|mesh-ancestor
64886499|NCT01947205|Antipyretics|antipyretics|mesh-ancestor
64886500|NCT01947205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64886501|NCT01947205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64886502|NCT01947205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64886503|NCT01947309|Lenalidomide|lenalidomide|mesh-list
64886504|NCT01947309|Immunologic Factors|immunologic factors|mesh-ancestor
64886505|NCT01947309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886506|NCT01947309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64886507|NCT01947309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64886508|NCT01947309|Growth Substances|growth substances|mesh-ancestor
64886509|NCT01947309|Growth Inhibitors|growth inhibitors|mesh-ancestor
64637597|NCT00176930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637598|NCT00176930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64886510|NCT01947309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886511|NCT01947465|Vaccines|vaccines|mesh-list
64886512|NCT01947465|Immunologic Factors|immunologic factors|mesh-ancestor
64886513|NCT01947465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886514|NCT01947556|Insulin Aspart|insulin aspart|mesh-list
64886515|NCT01947556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64886516|NCT01947556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886517|NCT01947608|Ceritinib|ceritinib|mesh-list
64886518|NCT01947608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886551|NCT01947803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886576|NCT01947933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64886577|NCT01947933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64886578|NCT01947933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64886579|NCT01947933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64886580|NCT01947959|Rivaroxaban|rivaroxaban|mesh-list
64886581|NCT01947959|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64886582|NCT01947959|Antithrombins|antithrombins|mesh-ancestor
64886583|NCT01947959|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64886584|NCT01947959|Protease Inhibitors|protease inhibitors|mesh-ancestor
64886585|NCT01947959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886586|NCT01947959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886587|NCT01947959|Anticoagulants|anticoagulants|mesh-ancestor
64886588|NCT01947985|Rivaroxaban|rivaroxaban|mesh-list
64886589|NCT01947985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64886590|NCT01947985|Antithrombins|antithrombins|mesh-ancestor
64886591|NCT01947985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64886592|NCT01947985|Protease Inhibitors|protease inhibitors|mesh-ancestor
64886593|NCT01947985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886594|NCT01947985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886595|NCT01947985|Anticoagulants|anticoagulants|mesh-ancestor
64886596|NCT01947998|Warfarin|warfarin|mesh-list
64886597|NCT01947998|Rivaroxaban|rivaroxaban|mesh-list
64886598|NCT01947998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64886599|NCT01947998|Anticoagulants|anticoagulants|mesh-ancestor
64886600|NCT01947998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64886601|NCT01947998|Antithrombins|antithrombins|mesh-ancestor
64886602|NCT01947998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64886603|NCT01947998|Protease Inhibitors|protease inhibitors|mesh-ancestor
64886604|NCT01947998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886605|NCT01947998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886606|NCT01948011|Racecadotril|racecadotril|mesh-list
64886607|NCT01948011|Thiorphan|thiorphan|mesh-list
64886608|NCT01948011|Antidiarrheals|antidiarrheals|mesh-ancestor
64886609|NCT01948011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64532394|NCT00352911|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64532395|NCT00352911|Hormone Antagonists|hormone antagonists|mesh-ancestor
64532396|NCT00352911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64532397|NCT00352911|Luteolytic Agents|luteolytic agents|mesh-ancestor
64532398|NCT00352911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64532399|NCT00352911|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64532401|NCT00353301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64532402|NCT00353301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532403|NCT00353301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64532404|NCT00353301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886610|NCT01948011|Protease Inhibitors|protease inhibitors|mesh-ancestor
64886611|NCT01948011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886632|NCT01948128|Vitamins|vitamins|mesh-list
64886633|NCT01948128|Micronutrients|micronutrients|mesh-ancestor
64886634|NCT01948128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886635|NCT01948128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64637674|NCT01121939|Growth Inhibitors|growth inhibitors|mesh-ancestor
64886636|NCT01948128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64886637|NCT01948232|Perindopril|perindopril|mesh-list
64886638|NCT01948232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64886639|NCT01948232|Protease Inhibitors|protease inhibitors|mesh-ancestor
64886640|NCT01948232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886641|NCT01948232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886642|NCT01948232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64886643|NCT01948245|Taurolidine|taurolidine|mesh-list
64886644|NCT01948245|Heparin|heparin|mesh-list
64886645|NCT01948245|Calcium heparin|calcium heparin|mesh-list
64886646|NCT01948245|Anticoagulants|anticoagulants|mesh-ancestor
64886647|NCT01948245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886648|NCT01948245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64886649|NCT01948245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64886650|NCT01948245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64886651|NCT01948245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64886652|NCT01948245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886653|NCT01948336|Dexmedetomidine|dexmedetomidine|mesh-list
64886654|NCT01948336|Ketamine|ketamine|mesh-list
64886655|NCT01948336|Propofol|propofol|mesh-list
64519268|NCT03229668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64637677|NCT03013751|Udenafil|udenafil|mesh-list
64296955|NCT03449888|Purinergic Agents|purinergic agents|mesh-ancestor
64296956|NCT03449888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64457602|NCT01852214|Purinergic Agents|purinergic agents|mesh-ancestor
64457603|NCT01852214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64457604|NCT01852214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457605|NCT01852214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457639|NCT01393990|Anesthetics|anesthetics|mesh-ancestor
64457640|NCT01393990|GABA Modulators|gaba modulators|mesh-ancestor
64457641|NCT01393990|GABA Agents|gaba agents|mesh-ancestor
64457642|NCT01393990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64457643|NCT01393990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457644|NCT01393990|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64457645|NCT01393990|Hormone Antagonists|hormone antagonists|mesh-ancestor
64457646|NCT01393990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64457647|NCT01393990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64457648|NCT01393990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457649|NCT01393990|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64457671|NCT05364190|Canagliflozin|canagliflozin|mesh-list
64519269|NCT03229668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64519270|NCT03229668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64637722|NCT00182000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637723|NCT01092923|Sevoflurane|sevoflurane|mesh-list
64519272|NCT03230058|Natamycin|natamycin|mesh-list
64519273|NCT03230058|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64519274|NCT03230058|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64637724|NCT01092923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64519275|NCT03230058|Antifungal Agents|antifungal agents|mesh-ancestor
64519276|NCT03230058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64519277|NCT03230058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64886656|NCT01948336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64886657|NCT01948336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64886658|NCT01948336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886659|NCT01948336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64886660|NCT01948336|Anesthetics, General|anesthetics, general|mesh-ancestor
64886661|NCT01948336|Anesthetics|anesthetics|mesh-ancestor
64886662|NCT01948336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64886663|NCT01948336|Analgesics|analgesics|mesh-ancestor
64886664|NCT01948336|Sensory System Agents|sensory system agents|mesh-ancestor
64886665|NCT01948336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64886666|NCT01948336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64886676|NCT01948362|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64886677|NCT01948362|Protective Agents|protective agents|mesh-ancestor
64886678|NCT01948362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886679|NCT01948362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886680|NCT01948401|Prednisolone|prednisolone|mesh-list
64886681|NCT01948401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64886682|NCT01948401|Glucocorticoids|glucocorticoids|mesh-ancestor
64886683|NCT01948401|Hormones|hormones|mesh-ancestor
64886684|NCT01948401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64886685|NCT01948401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886686|NCT01948401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64886687|NCT01948401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457672|NCT05364190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64457673|NCT05364190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457674|NCT05364190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64457675|NCT05364190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457676|NCT00210964|Linezolid|linezolid|mesh-list
64886688|NCT01948583|Hyaluronic Acid|hyaluronic acid|mesh-list
64886689|NCT01948583|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64886690|NCT01948583|Immunologic Factors|immunologic factors|mesh-ancestor
64886691|NCT01948583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886692|NCT01948583|Viscosupplements|viscosupplements|mesh-ancestor
64886693|NCT01948583|Protective Agents|protective agents|mesh-ancestor
64886694|NCT01948648|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
64886695|NCT01948648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64886696|NCT01948648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64655223|NCT01652495|Hormones|hormones|mesh-ancestor
64886697|NCT01948648|Antimetabolites|antimetabolites|mesh-ancestor
64886698|NCT01948648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886699|NCT01948648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64886700|NCT01948765|Propofol|propofol|mesh-list
64886701|NCT01948765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64886702|NCT01948765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64886703|NCT01948765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886704|NCT01948765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64886705|NCT01948765|Anesthetics, General|anesthetics, general|mesh-ancestor
64886706|NCT01948765|Anesthetics|anesthetics|mesh-ancestor
64886707|NCT01948804|Letrozole|letrozole|mesh-list
64886708|NCT01948804|Clomiphene|clomiphene|mesh-list
64457677|NCT00210964|Ceftazidime|ceftazidime|mesh-list
64457678|NCT00210964|Ceftobiprole|ceftobiprole|mesh-list
64457679|NCT00210964|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
64457680|NCT00210964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64457681|NCT00210964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64457682|NCT00210964|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64457683|NCT00210964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457684|NCT00210964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532408|NCT00353301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64532409|NCT00353301|Antifungal Agents|antifungal agents|mesh-ancestor
64457691|NCT03997786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64457692|NCT03997786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457693|NCT03997786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64457694|NCT03997786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64457695|NCT03997786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64457696|NCT03997786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64457697|NCT03997786|Immunologic Factors|immunologic factors|mesh-ancestor
64457698|NCT05630638|Dolutegravir|dolutegravir|mesh-list
64457699|NCT05630638|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64457700|NCT05630638|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64457701|NCT05630638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457702|NCT05630638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457703|NCT05630638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64457704|NCT05630638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64457705|NCT05630638|Antiviral Agents|antiviral agents|mesh-ancestor
64457706|NCT05630638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64457707|NCT03593434|Xenon|xenon|mesh-list
64457726|NCT03598426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457727|NCT03598426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64457729|NCT03598426|Hormones|hormones|mesh-ancestor
64443462|NCT01907217|Anesthetics|anesthetics|mesh-ancestor
64457730|NCT03598426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64457731|NCT03598426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64457732|NCT03598426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886709|NCT01948804|Cetrorelix|cetrorelix|mesh-list
64886710|NCT01948804|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64886711|NCT01948804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886712|NCT01948804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64886713|NCT01948804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64886714|NCT01948804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886715|NCT01948804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886716|NCT01948804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64886717|NCT01948804|Hormone Antagonists|hormone antagonists|mesh-ancestor
64886718|NCT01948804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64519278|NCT03230058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64519279|NCT03230058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519280|NCT03230058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519281|NCT03230058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64519282|NCT03230058|Hormone Antagonists|hormone antagonists|mesh-ancestor
64519283|NCT03230058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64519284|NCT03230058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519285|NCT03230058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64519286|NCT03230058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64519287|NCT03230058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64519288|NCT03230136|Anesthetics|anesthetics|mesh-list
64519289|NCT03230136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64519290|NCT03230136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519291|NCT03229824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
64519292|NCT03229824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64519293|NCT00081939|Thalidomide|thalidomide|mesh-list
64519294|NCT00081939|Bortezomib|bortezomib|mesh-list
64519295|NCT00081939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519296|NCT00081939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64886719|NCT01948804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886720|NCT01948804|Hormones|hormones|mesh-ancestor
64886721|NCT01948804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64637816|NCT01047527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457734|NCT03989362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64457735|NCT03989362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457736|NCT03989362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64886722|NCT01948804|Fertility Agents|fertility agents|mesh-ancestor
64886723|NCT01948804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64886724|NCT01948804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64886725|NCT01948804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64886726|NCT01948817|Deferasirox|deferasirox|mesh-list
64886727|NCT01948817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64886728|NCT01948817|Chelating Agents|chelating agents|mesh-ancestor
64886729|NCT01948817|Sequestering Agents|sequestering agents|mesh-ancestor
64886730|NCT01948817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886746|NCT01948921|Sensory System Agents|sensory system agents|mesh-ancestor
64886747|NCT01948921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64886748|NCT01948921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64886749|NCT01948960|Everolimus|everolimus|mesh-list
64886750|NCT01948960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886751|NCT01948960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64886752|NCT01948960|Immunologic Factors|immunologic factors|mesh-ancestor
64886753|NCT01948960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886754|NCT01948999|Anesthetics|anesthetics|mesh-list
64886755|NCT01948999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64637859|NCT01094717|Tazarotene|tazarotene|mesh-list
64457737|NCT03989362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457738|NCT03599596|Pyrimethamine|pyrimethamine|mesh-list
64457739|NCT03599596|Sulfadoxine|sulfadoxine|mesh-list
64457740|NCT03599596|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64457741|NCT03599596|Antimalarials|antimalarials|mesh-ancestor
64457742|NCT03599596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64457743|NCT03599596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64457744|NCT03599596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64457745|NCT03599596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64457746|NCT03599596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457747|NCT03599596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457748|NCT03599596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64457749|NCT03599596|Renal Agents|renal agents|mesh-ancestor
64457750|NCT04407130|Doxycycline|doxycycline|mesh-list
64457751|NCT04407130|Ivermectin|ivermectin|mesh-list
64457752|NCT04407130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64457753|NCT04407130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64457754|NCT04407130|Antimalarials|antimalarials|mesh-ancestor
64457755|NCT04407130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64457756|NCT04407130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64457757|NCT03599284|Clopidogrel|clopidogrel|mesh-list
64457758|NCT03599284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64457759|NCT03599284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64457760|NCT03599284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64457761|NCT03599284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64457762|NCT03599284|Purinergic Agents|purinergic agents|mesh-ancestor
64457763|NCT03599284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64652539|NCT01725776|Protective Agents|protective agents|mesh-ancestor
64457791|NCT03024502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64457792|NCT03024502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64457793|NCT03024502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532410|NCT00353301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64532411|NCT00353301|Immunologic Factors|immunologic factors|mesh-ancestor
64532412|NCT00353301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532413|NCT02372604|Cetirizine|cetirizine|mesh-list
64532414|NCT02372604|Levocetirizine|levocetirizine|mesh-list
64886756|NCT01948999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886757|NCT01949038|Alprazolam|alprazolam|mesh-list
64886758|NCT01949038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64886759|NCT01949038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64886760|NCT01949038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886761|NCT01949038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64886762|NCT01949038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64886763|NCT01949038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64886764|NCT01949038|GABA Modulators|gaba modulators|mesh-ancestor
64886765|NCT01949038|GABA Agents|gaba agents|mesh-ancestor
64519297|NCT00081939|Immunologic Factors|immunologic factors|mesh-ancestor
64519298|NCT00081939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519299|NCT00081939|Leprostatic Agents|leprostatic agents|mesh-ancestor
64519300|NCT00081939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64519301|NCT00081939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64519302|NCT00081939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64519303|NCT00081939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64519304|NCT00081939|Growth Substances|growth substances|mesh-ancestor
64519305|NCT00081939|Growth Inhibitors|growth inhibitors|mesh-ancestor
64519306|NCT02373124|N-Methylaspartate|n-methylaspartate|mesh-list
64637911|NCT01100255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64532415|NCT02372604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64532416|NCT02372604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64532417|NCT02372604|Histamine Antagonists|histamine antagonists|mesh-ancestor
64532418|NCT02372604|Histamine Agents|histamine agents|mesh-ancestor
64532419|NCT02372604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64532420|NCT02372604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532421|NCT02372604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532422|NCT02372604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64532423|NCT01792323|Insulin Lispro|insulin lispro|mesh-list
64532424|NCT01792323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64532425|NCT01792323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532426|NCT02358642|Lisinopril|lisinopril|mesh-list
64532427|NCT02358642|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64532428|NCT02358642|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64532429|NCT02358642|Protease Inhibitors|protease inhibitors|mesh-ancestor
64532430|NCT02358642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532431|NCT02358642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64532432|NCT02358642|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64532433|NCT02358642|Protective Agents|protective agents|mesh-ancestor
64532434|NCT02358642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532435|NCT03160248|Apremilast|apremilast|mesh-list
64532436|NCT03160248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64532437|NCT03160248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64532438|NCT03160248|Analgesics|analgesics|mesh-ancestor
64532439|NCT03160248|Sensory System Agents|sensory system agents|mesh-ancestor
64532440|NCT03160248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64532441|NCT03160248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532442|NCT03160248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64532443|NCT03160248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64532444|NCT03160248|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64532445|NCT03160248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64532447|NCT03160248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532448|NCT01522651|Dronedarone|dronedarone|mesh-list
64519307|NCT02373124|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
64519309|NCT02373124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64519310|NCT02373124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519311|NCT02373124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519312|NCT03221634|Pembrolizumab|pembrolizumab|mesh-list
64886766|NCT01949038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64637965|NCT02246855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637966|NCT05272397|Methylphenidate|methylphenidate|mesh-list
64637973|NCT05272397|Dopamine Agents|dopamine agents|mesh-ancestor
64532449|NCT01522651|Ranolazine|ranolazine|mesh-list
64532450|NCT01522651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64532451|NCT01522651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64532452|NCT01522651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297017|NCT03103568|Chlorzoxazone|chlorzoxazone|mesh-list
64457794|NCT03024502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457795|NCT03024502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64457796|NCT03024502|Hormone Antagonists|hormone antagonists|mesh-ancestor
64457797|NCT03024502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64457798|NCT03024502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457799|NCT03024502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64457800|NCT03024502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64457801|NCT03024580|Tamoxifen|tamoxifen|mesh-list
64457802|NCT03024580|Letrozole|letrozole|mesh-list
64457804|NCT03024580|Anastrozole|anastrozole|mesh-list
64457805|NCT03024580|Exemestane|exemestane|mesh-list
64457806|NCT03024580|Megestrol|megestrol|mesh-list
64457807|NCT03024580|Megestrol Acetate|megestrol acetate|mesh-list
64457808|NCT03024580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457809|NCT03024580|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64457810|NCT03024580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64457811|NCT03024580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457812|NCT03024580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457813|NCT03024580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64457814|NCT03024580|Hormone Antagonists|hormone antagonists|mesh-ancestor
64652550|NCT05564819|Acetaminophen|acetaminophen|mesh-list
64457848|NCT05633758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457850|NCT03978442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64457851|NCT03978442|Antidepressive Agents|antidepressive agents|mesh-ancestor
64457852|NCT03978442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64457853|NCT03978442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64457854|NCT03978442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64457879|NCT04003948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64457880|NCT04003948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64457881|NCT04003948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457882|NCT03598582|Epoetin Alfa|epoetin alfa|mesh-list
64457883|NCT03598582|Hematinics|hematinics|mesh-ancestor
64457885|NCT03593668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64457886|NCT03593668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457887|NCT03598348|Capecitabine|capecitabine|mesh-list
64457888|NCT03598348|Apatinib|apatinib|mesh-list
64457889|NCT03598348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64457890|NCT03598348|Antimetabolites|antimetabolites|mesh-ancestor
64457891|NCT03598348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457892|NCT03598348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457893|NCT03598348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64457894|NCT03598348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457895|NCT03976258|Naltrexone|naltrexone|mesh-list
64457896|NCT03976258|Buprenorphine|buprenorphine|mesh-list
64457897|NCT03976258|Methadone|methadone|mesh-list
64457898|NCT03976258|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64457899|NCT03976258|Heroin|heroin|mesh-list
64457900|NCT03976258|Naloxone|naloxone|mesh-list
64457901|NCT03976258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64457902|NCT03976258|Narcotics|narcotics|mesh-ancestor
64457903|NCT03976258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64886767|NCT01949038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886768|NCT01949064|Salicylic Acid|salicylic acid|mesh-list
64886769|NCT01949064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64886770|NCT01949064|Antifungal Agents|antifungal agents|mesh-ancestor
64886771|NCT01949064|Keratolytic Agents|keratolytic agents|mesh-ancestor
64886772|NCT01949064|Dermatologic Agents|dermatologic agents|mesh-ancestor
64886773|NCT01949129|Cyclophosphamide|cyclophosphamide|mesh-list
64886774|NCT01949129|Busulfan|busulfan|mesh-list
64886775|NCT01949129|Thiotepa|thiotepa|mesh-list
64886776|NCT01949129|Treosulfan|treosulfan|mesh-list
64886777|NCT01949129|Fludarabine|fludarabine|mesh-list
64886778|NCT01949129|Etoposide|etoposide|mesh-list
64886779|NCT01949129|Thymoglobulin|thymoglobulin|mesh-list
64886780|NCT01949129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64886781|NCT01949129|Immunoglobulins|immunoglobulins|mesh-list
64886782|NCT01949129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64886783|NCT01949129|Immunologic Factors|immunologic factors|mesh-ancestor
64886784|NCT01949129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886785|NCT01949129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64886786|NCT01949129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64886787|NCT01949129|Alkylating Agents|alkylating agents|mesh-ancestor
64886788|NCT01949129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638028|NCT00136760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64886789|NCT01949129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886790|NCT01949129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64886810|NCT01949233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64886811|NCT01949233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886812|NCT01949363|Cefixime|cefixime|mesh-list
64886813|NCT01949363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64886814|NCT01949363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64886815|NCT01949454|Fluorometholone|fluorometholone|mesh-list
64886816|NCT01949454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64886817|NCT01949454|Lubricant Eye Drops|lubricant eye drops|mesh-list
64886818|NCT01949454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64886819|NCT01949454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64457904|NCT03976258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457905|NCT03976258|Analgesics|analgesics|mesh-ancestor
64457906|NCT03976258|Sensory System Agents|sensory system agents|mesh-ancestor
64457907|NCT03976258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64457931|NCT04003246|Immunologic Factors|immunologic factors|mesh-ancestor
64532453|NCT01522651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64532455|NCT02372292|Diuretics|diuretics|mesh-ancestor
64886820|NCT01949454|Glucocorticoids|glucocorticoids|mesh-ancestor
64886821|NCT01949454|Hormones|hormones|mesh-ancestor
64886822|NCT01949454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64886823|NCT01949454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886824|NCT01949454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64886825|NCT01949519|Lycopene|lycopene|mesh-list
64886826|NCT01949519|Docetaxel|docetaxel|mesh-list
64886827|NCT01949519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886828|NCT01949519|Tubulin Modulators|tubulin modulators|mesh-ancestor
64886829|NCT01949519|Antimitotic Agents|antimitotic agents|mesh-ancestor
64886830|NCT01949519|Mitosis Modulators|mitosis modulators|mesh-ancestor
64519314|NCT03221634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64519315|NCT03221634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519316|NCT05003037|Carboplatin|carboplatin|mesh-list
64519317|NCT05003037|Pemetrexed|pemetrexed|mesh-list
64519318|NCT05003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519319|NCT05003037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519320|NCT05003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519321|NCT05003037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64519322|NCT05003037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64519323|NCT02374060|Dexamethasone|dexamethasone|mesh-list
64519324|NCT02374060|Triamcinolone|triamcinolone|mesh-list
64519325|NCT02374060|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64532526|NCT01554163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532527|NCT02360826|Simvastatin|simvastatin|mesh-list
64532528|NCT02360826|Pravastatin|pravastatin|mesh-list
64532529|NCT02360826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64532530|NCT02360826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64532531|NCT02360826|Antimetabolites|antimetabolites|mesh-ancestor
64532532|NCT02360826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532533|NCT02360826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64532534|NCT02360826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64532535|NCT02360826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532536|NCT03818607|Eculizumab|eculizumab|mesh-list
64532537|NCT03818607|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64532538|NCT03818607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64297095|NCT03299829|Sequestering Agents|sequestering agents|mesh-ancestor
64457932|NCT04003246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457933|NCT00218296|Lobeline|lobeline|mesh-list
64457934|NCT00218296|Nicotine|nicotine|mesh-list
64457935|NCT00218296|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64457936|NCT00218296|Autonomic Agents|autonomic agents|mesh-ancestor
64457937|NCT00218296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64457938|NCT00218296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457939|NCT00218296|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64457940|NCT00218296|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64457941|NCT00218296|Cholinergic Agents|cholinergic agents|mesh-ancestor
64457942|NCT00218296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64457943|NCT00218296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457944|NCT00218296|Respiratory System Agents|respiratory system agents|mesh-ancestor
64457945|NCT00217672|Bevacizumab|bevacizumab|mesh-list
64457946|NCT00217672|Docetaxel|docetaxel|mesh-list
64457947|NCT00217672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64457948|NCT00217672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886831|NCT01949519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886832|NCT01949519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64886833|NCT01949519|Antioxidants|antioxidants|mesh-ancestor
64886834|NCT01949519|Protective Agents|protective agents|mesh-ancestor
64886835|NCT01949519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886836|NCT01949519|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64886837|NCT01949519|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64886838|NCT01949571|Mirtazapine|mirtazapine|mesh-list
64886839|NCT01949571|Antidepressive Agents|antidepressive agents|mesh-ancestor
64886840|NCT01949571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64886841|NCT01949571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64886842|NCT01949571|Histamine Antagonists|histamine antagonists|mesh-ancestor
64886843|NCT01949571|Histamine Agents|histamine agents|mesh-ancestor
64886844|NCT01949571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64886845|NCT01949571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886846|NCT01949571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886864|NCT01949766|Protective Agents|protective agents|mesh-ancestor
64886865|NCT01949766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886866|NCT01949766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886867|NCT01949805|Interferon alpha-2|interferon alpha-2|mesh-list
64886868|NCT01949805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64886869|NCT01949805|Hydroxyurea|hydroxyurea|mesh-list
64886870|NCT01949805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886871|NCT01949805|Antisickling Agents|antisickling agents|mesh-ancestor
64886872|NCT01949805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886873|NCT01949805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886874|NCT01949805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64886875|NCT01949805|Antiviral Agents|antiviral agents|mesh-ancestor
64886876|NCT01949805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64886877|NCT01949818|Prednisone|prednisone|mesh-list
64886878|NCT01949818|Prednisolone|prednisolone|mesh-list
64886879|NCT01949818|Cyclophosphamide|cyclophosphamide|mesh-list
64886880|NCT01949818|Doxorubicin|doxorubicin|mesh-list
64886881|NCT01949818|Vincristine|vincristine|mesh-list
64886882|NCT01949818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64886883|NCT01949818|Immunologic Factors|immunologic factors|mesh-ancestor
64457949|NCT00217672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64457958|NCT00216736|Dexamethasone|dexamethasone|mesh-list
64457959|NCT00216736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64457960|NCT00216736|Antiemetics|antiemetics|mesh-ancestor
64886884|NCT01949818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638159|NCT01474915|Glucocorticoids|glucocorticoids|mesh-ancestor
64886885|NCT01949818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64886886|NCT01949818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64886887|NCT01949818|Alkylating Agents|alkylating agents|mesh-ancestor
64886888|NCT01949818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886889|NCT01949818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886890|NCT01949818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64886891|NCT01949818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64886892|NCT01949818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64886893|NCT01949818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64886894|NCT01949818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886895|NCT01949818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64519326|NCT02374060|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64519327|NCT02374060|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64519328|NCT02374060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64519330|NCT02374060|Autonomic Agents|autonomic agents|mesh-ancestor
64519331|NCT02374060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64519332|NCT02374060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519333|NCT02374060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64886896|NCT01949818|Glucocorticoids|glucocorticoids|mesh-ancestor
64886897|NCT01949818|Hormones|hormones|mesh-ancestor
64886898|NCT01949818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64886899|NCT01949818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64886900|NCT01949818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64638160|NCT01474915|Hormones|hormones|mesh-ancestor
64457961|NCT00216736|Autonomic Agents|autonomic agents|mesh-ancestor
64457984|NCT00215644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64457985|NCT00215644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457986|NCT00213148|Anastrozole|anastrozole|mesh-list
64457987|NCT00213148|Citric Acid|citric acid|mesh-list
64457988|NCT00213148|Sodium Citrate|sodium citrate|mesh-list
64457989|NCT00213148|Clomiphene|clomiphene|mesh-list
64457990|NCT00213148|Enclomiphene|enclomiphene|mesh-list
64457991|NCT00213148|Zuclomiphene|zuclomiphene|mesh-list
64457992|NCT00213148|Anticoagulants|anticoagulants|mesh-ancestor
64457993|NCT00213148|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64457994|NCT00213148|Chelating Agents|chelating agents|mesh-ancestor
64457995|NCT00213148|Sequestering Agents|sequestering agents|mesh-ancestor
64457996|NCT00213148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457997|NCT00213148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64457998|NCT00213148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886901|NCT01949818|Tubulin Modulators|tubulin modulators|mesh-ancestor
64886902|NCT01949818|Antimitotic Agents|antimitotic agents|mesh-ancestor
64886939|NCT01950182|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64886940|NCT01950182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64886941|NCT01950182|Antimetabolites|antimetabolites|mesh-ancestor
64886942|NCT01950182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886943|NCT01950182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886972|NCT01950416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64638200|NCT01391299|Botulinum Toxins|botulinum toxins|mesh-list
64638201|NCT01391299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64638202|NCT01391299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64638203|NCT01391299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64638204|NCT01391299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64638205|NCT01391299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638206|NCT01391299|Cholinergic Agents|cholinergic agents|mesh-ancestor
64638207|NCT01391299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64886973|NCT01950416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64886974|NCT01950416|Purinergic Agents|purinergic agents|mesh-ancestor
64886975|NCT01950416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64886976|NCT01950416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886977|NCT01950416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886978|NCT01950481|Ceritinib|ceritinib|mesh-list
64886979|NCT01950481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886980|NCT01950481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64886981|NCT01950481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457999|NCT00213148|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64458000|NCT00213148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64532539|NCT03818607|Immunologic Factors|immunologic factors|mesh-ancestor
64532540|NCT03818607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532541|NCT02361060|Atropine|atropine|mesh-list
64532542|NCT02361060|Neostigmine|neostigmine|mesh-list
64532543|NCT02361060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64532544|NCT02361060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64532545|NCT02361060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64532546|NCT02361060|Autonomic Agents|autonomic agents|mesh-ancestor
64532547|NCT02361060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64532548|NCT02361060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532549|NCT02361060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64532550|NCT02361060|Respiratory System Agents|respiratory system agents|mesh-ancestor
64532551|NCT02361060|Mydriatics|mydriatics|mesh-ancestor
64532552|NCT02361060|Parasympatholytics|parasympatholytics|mesh-ancestor
64532553|NCT02361060|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64532554|NCT02361060|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64532555|NCT02361060|Cholinergic Agents|cholinergic agents|mesh-ancestor
64532556|NCT02361060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64532557|NCT02361060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458001|NCT00213148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458002|NCT00213148|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64886982|NCT01950481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638250|NCT05156060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64886983|NCT01950494|Hand Sanitizers|hand sanitizers|mesh-list
64886984|NCT01950494|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64886985|NCT01950494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64886997|NCT01950507|Respiratory System Agents|respiratory system agents|mesh-ancestor
64886999|NCT01950507|Hormones|hormones|mesh-ancestor
64887000|NCT01950507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64887001|NCT01950507|Antifungal Agents|antifungal agents|mesh-ancestor
64887002|NCT01950507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64887003|NCT01950507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64887004|NCT01950507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64887005|NCT01950507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887006|NCT01950507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887007|NCT01950507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64887008|NCT01950507|Hormone Antagonists|hormone antagonists|mesh-ancestor
64887009|NCT01950507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64887010|NCT01950507|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64887011|NCT01950507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64887012|NCT01950546|Fluorides|fluorides|mesh-list
64887013|NCT01950546|Cariostatic Agents|cariostatic agents|mesh-ancestor
64519334|NCT02374060|Glucocorticoids|glucocorticoids|mesh-ancestor
64519336|NCT02374060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64519337|NCT02374060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64519338|NCT02374060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519339|NCT02374060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64887014|NCT01950546|Protective Agents|protective agents|mesh-ancestor
64887015|NCT01950546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887030|NCT01950793|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64887031|NCT01950793|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64887032|NCT01950793|Hyaluronic Acid|hyaluronic acid|mesh-list
64887033|NCT01950793|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64887034|NCT01950793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64887035|NCT01950793|Glucocorticoids|glucocorticoids|mesh-ancestor
64887036|NCT01950793|Hormones|hormones|mesh-ancestor
64887037|NCT01950793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64887038|NCT01950793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887039|NCT01950793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64887040|NCT01950793|Immunologic Factors|immunologic factors|mesh-ancestor
64887041|NCT01950793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887042|NCT01950793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887043|NCT01950793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64887044|NCT01950793|Viscosupplements|viscosupplements|mesh-ancestor
64887045|NCT01950793|Protective Agents|protective agents|mesh-ancestor
64887046|NCT01950884|Ezetimibe|ezetimibe|mesh-list
64887047|NCT01950884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64887048|NCT01950884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64887049|NCT01950884|Antimetabolites|antimetabolites|mesh-ancestor
64586281|NCT00426283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64887059|NCT01950949|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
64887060|NCT01950949|Plasma Substitutes|plasma substitutes|mesh-ancestor
64887061|NCT01950949|Blood Substitutes|blood substitutes|mesh-ancestor
64887062|NCT01951001|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64887063|NCT01951001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64887064|NCT01951027|Lenograstim|lenograstim|mesh-list
64458003|NCT00213148|Hormone Antagonists|hormone antagonists|mesh-ancestor
64458004|NCT00213148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64458005|NCT00213148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458006|NCT00213148|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64458007|NCT00213148|Fertility Agents|fertility agents|mesh-ancestor
64458008|NCT00213148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64458009|NCT00213148|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64458010|NCT00213148|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64458011|NCT01704261|Metformin|metformin|mesh-list
64458012|NCT01704261|Glimepiride|glimepiride|mesh-list
64458013|NCT01704261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64458044|NCT04198636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458045|NCT04414995|Acetaminophen|acetaminophen|mesh-list
64458046|NCT04414995|Ibuprofen|ibuprofen|mesh-list
64458047|NCT04414995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64458048|NCT04414995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64458049|NCT04414995|Analgesics|analgesics|mesh-ancestor
64458057|NCT04414995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458077|NCT01875848|Buprenorphine|buprenorphine|mesh-list
64458078|NCT01875848|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64458079|NCT01875848|Naloxone|naloxone|mesh-list
64458080|NCT01875848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64887065|NCT01951027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64887066|NCT01951027|Immunologic Factors|immunologic factors|mesh-ancestor
64887067|NCT01951027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887068|NCT01951053|Citalopram|citalopram|mesh-list
64887069|NCT01951053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64887070|NCT01951053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64887071|NCT01951053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64887072|NCT01951053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887073|NCT01951053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64887075|NCT01951053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458081|NCT01875848|Narcotics|narcotics|mesh-ancestor
64458082|NCT01875848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64458083|NCT01875848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458084|NCT01875848|Analgesics|analgesics|mesh-ancestor
64532558|NCT02361060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64532559|NCT02361060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532560|NCT02361060|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64532561|NCT02360982|Fentanyl|fentanyl|mesh-list
64532562|NCT02360982|Propofol|propofol|mesh-list
64532563|NCT02360982|Bupivacaine|bupivacaine|mesh-list
64532564|NCT02360982|Rocuronium|rocuronium|mesh-list
64532565|NCT02360982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64532566|NCT02360982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64532567|NCT02360982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532568|NCT02360982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64532569|NCT02360982|Anesthetics, General|anesthetics, general|mesh-ancestor
64532570|NCT02360982|Anesthetics|anesthetics|mesh-ancestor
64532571|NCT02360982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64532572|NCT02360982|Narcotics|narcotics|mesh-ancestor
64532573|NCT02360982|Analgesics|analgesics|mesh-ancestor
64532574|NCT02360982|Sensory System Agents|sensory system agents|mesh-ancestor
64532575|NCT02360982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64532576|NCT02360982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64297129|NCT02471404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64458085|NCT01875848|Sensory System Agents|sensory system agents|mesh-ancestor
64458086|NCT01875848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458087|NCT01875848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64458088|NCT03591172|Propolis|propolis|mesh-list
64458089|NCT03591172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64458090|NCT04197622|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64458091|NCT04197622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64458092|NCT04197622|Diuretics|diuretics|mesh-ancestor
64458093|NCT04197622|Natriuretic Agents|natriuretic agents|mesh-ancestor
64458094|NCT04197622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458095|NCT04197622|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64458096|NCT04197622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64458097|NCT04197622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458099|NCT03595930|Xhance|xhance|mesh-list
64458100|NCT03595930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64458101|NCT03595930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64458102|NCT03595930|Autonomic Agents|autonomic agents|mesh-ancestor
64458103|NCT03595930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458104|NCT03595930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458105|NCT03595930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64458106|NCT03595930|Respiratory System Agents|respiratory system agents|mesh-ancestor
64458107|NCT03595930|Dermatologic Agents|dermatologic agents|mesh-ancestor
64458108|NCT03595930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64945372|NCT05686408|Tianeptine|tianeptine|mesh-list
64458109|NCT03595852|Cefazolin|cefazolin|mesh-list
64458110|NCT03595852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64458111|NCT03595852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64458112|NCT04191382|Letrozole|letrozole|mesh-list
64458113|NCT04191382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458114|NCT04191382|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64458115|NCT04191382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64458116|NCT04191382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887076|NCT01951053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64887077|NCT01951053|Antidepressive Agents|antidepressive agents|mesh-ancestor
64887078|NCT01951053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64887079|NCT01951079|Digoxin|digoxin|mesh-list
64887080|NCT01951079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64887081|NCT01951079|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64532578|NCT02360982|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64532579|NCT02360982|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64532580|NCT02360982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64532581|NCT01790139|Simethicone|simethicone|mesh-list
64532582|NCT01790139|Antifoaming Agents|antifoaming agents|mesh-ancestor
64532583|NCT01790139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532584|NCT01790139|Emollients|emollients|mesh-ancestor
64532585|NCT01790139|Dermatologic Agents|dermatologic agents|mesh-ancestor
64532586|NCT03786237|ON 01910|on 01910|mesh-list
64532587|NCT03786237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532588|NCT03786237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64532589|NCT03786237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532590|NCT03786237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532592|NCT01553851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532593|NCT01553851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64532594|NCT01553851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532595|NCT01553851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532596|NCT02358018|Edotreotide|edotreotide|mesh-list
64532597|NCT02358018|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64532598|NCT02358018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532599|NCT01552915|Methylphenidate|methylphenidate|mesh-list
64458175|NCT04022200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64458176|NCT04022200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458177|NCT04022200|Tubulin Modulators|tubulin modulators|mesh-ancestor
64458178|NCT04022200|Antimitotic Agents|antimitotic agents|mesh-ancestor
64458179|NCT04022200|Mitosis Modulators|mitosis modulators|mesh-ancestor
64458180|NCT04022200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458181|NCT04552743|Plerixafor|plerixafor|mesh-list
64458182|NCT04552743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64458183|NCT04552743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64458184|NCT04552743|Antiviral Agents|antiviral agents|mesh-ancestor
64458185|NCT04552743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64458186|NCT03590080|Methylprednisolone|methylprednisolone|mesh-list
64458187|NCT03590080|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64458188|NCT03590080|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64458189|NCT03590080|Prednisolone|prednisolone|mesh-list
64458190|NCT03590080|Prednisolone acetate|prednisolone acetate|mesh-list
64458191|NCT03590080|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64458192|NCT03590080|Prednisolone phosphate|prednisolone phosphate|mesh-list
64458193|NCT03590080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64458194|NCT03590080|Antiemetics|antiemetics|mesh-ancestor
64458195|NCT03590080|Autonomic Agents|autonomic agents|mesh-ancestor
64458196|NCT03590080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458197|NCT03590080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458198|NCT03590080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64458199|NCT03590080|Glucocorticoids|glucocorticoids|mesh-ancestor
64458200|NCT03590080|Hormones|hormones|mesh-ancestor
64458201|NCT03590080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64458202|NCT03590080|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64458203|NCT03590080|Protective Agents|protective agents|mesh-ancestor
64532601|NCT01552915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64532602|NCT01552915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532603|NCT01552915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64532604|NCT01552915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64532605|NCT01552915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64297169|NCT04160936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458204|NCT03590080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64458205|NCT03590080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458206|NCT03971422|Rozanolixizumab|rozanolixizumab|mesh-list
64458207|NCT03971422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64458208|NCT03971422|Immunologic Factors|immunologic factors|mesh-ancestor
64458216|NCT04021108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887082|NCT01951079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887083|NCT01951079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887084|NCT01951079|Protective Agents|protective agents|mesh-ancestor
64519341|NCT02374060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519342|NCT02374060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519343|NCT03221166|Thalidomide|thalidomide|mesh-list
64458244|NCT03970720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458246|NCT04028830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64458247|NCT04028830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64458248|NCT04028830|Antitubercular Agents|antitubercular agents|mesh-ancestor
64458250|NCT04194658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458251|NCT04194658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64458252|NCT04194658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64458253|NCT04194658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458254|NCT04194658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458255|NCT04194658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64458256|NCT04194658|Hormone Antagonists|hormone antagonists|mesh-ancestor
64458257|NCT04194658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64458258|NCT04194658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458259|NCT04028518|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64458260|NCT04028518|Plasminogen|plasminogen|mesh-list
64458285|NCT04027972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64458286|NCT04191928|Apixaban|apixaban|mesh-list
64458287|NCT04191928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64458288|NCT04191928|Antithrombins|antithrombins|mesh-ancestor
64458289|NCT04191928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64458290|NCT04191928|Protease Inhibitors|protease inhibitors|mesh-ancestor
64458291|NCT04191928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458292|NCT04191928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458293|NCT04191928|Anticoagulants|anticoagulants|mesh-ancestor
64458294|NCT04199494|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64458295|NCT04199494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64458296|NCT04027192|Midazolam|midazolam|mesh-list
64458297|NCT04027192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64458298|NCT04027192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64458299|NCT04027192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64458300|NCT04027192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458301|NCT04027192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64458302|NCT04027192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64458303|NCT04027192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64458304|NCT04027192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64458305|NCT04027192|Anesthetics, General|anesthetics, general|mesh-ancestor
64458306|NCT04027192|Anesthetics|anesthetics|mesh-ancestor
64458307|NCT04027192|GABA Modulators|gaba modulators|mesh-ancestor
64458308|NCT04027192|GABA Agents|gaba agents|mesh-ancestor
64458309|NCT04027192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64458310|NCT04027192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458311|NCT04406506|Erythromycin|erythromycin|mesh-list
64458332|NCT03828292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64458334|NCT03828292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532606|NCT01552915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532608|NCT01552915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64532609|NCT02352714|Lidocaine|lidocaine|mesh-list
64532610|NCT02352714|Anesthetics, Local|anesthetics, local|mesh-ancestor
64532611|NCT02352714|Anesthetics|anesthetics|mesh-ancestor
64532612|NCT02352714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64532613|NCT02352714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458335|NCT03828292|Immunologic Factors|immunologic factors|mesh-ancestor
64458336|NCT03828292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64458337|NCT03828292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64458338|NCT03828292|Growth Substances|growth substances|mesh-ancestor
64458339|NCT03828292|Growth Inhibitors|growth inhibitors|mesh-ancestor
64458340|NCT04191694|Ondansetron|ondansetron|mesh-list
64458341|NCT04191694|Antiemetics|antiemetics|mesh-ancestor
64652582|NCT01568255|Vitamins|vitamins|mesh-ancestor
64458350|NCT04191694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64458351|NCT04191694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519344|NCT03221166|Infliximab|infliximab|mesh-list
64638531|NCT01898624|Mirabegron|mirabegron|mesh-list
64519345|NCT03221166|Dermatologic Agents|dermatologic agents|mesh-ancestor
64519346|NCT03221166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64887085|NCT01951079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887086|NCT01951144|Lorazepam|lorazepam|mesh-list
64887087|NCT01951144|PF-06372865|pf-06372865|mesh-list
64887088|NCT01951144|Anticonvulsants|anticonvulsants|mesh-ancestor
64887089|NCT01951144|Antiemetics|antiemetics|mesh-ancestor
64887090|NCT01951144|Autonomic Agents|autonomic agents|mesh-ancestor
64887091|NCT01951144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64887092|NCT01951144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887093|NCT01951144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64887094|NCT01951144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64887095|NCT01951144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64887096|NCT01951144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64458352|NCT04191694|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64458353|NCT04191694|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64458354|NCT04191694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64458355|NCT04191694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64458356|NCT04191694|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64458357|NCT04026022|Fentanyl|fentanyl|mesh-list
64458358|NCT04026022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64458359|NCT04026022|Narcotics|narcotics|mesh-ancestor
64458360|NCT04026022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64458361|NCT04026022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458362|NCT04026022|Analgesics|analgesics|mesh-ancestor
64458363|NCT04026022|Sensory System Agents|sensory system agents|mesh-ancestor
64458364|NCT04026022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458365|NCT04026022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64458397|NCT04020016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64458398|NCT04020016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458399|NCT04020016|Analgesics|analgesics|mesh-ancestor
64458400|NCT04020016|Sensory System Agents|sensory system agents|mesh-ancestor
64458401|NCT04020016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458402|NCT01874054|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64458403|NCT01874054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64458404|NCT01874054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64458405|NCT01874054|Alkylating Agents|alkylating agents|mesh-ancestor
64458406|NCT01874054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458407|NCT01874054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458408|NCT01874054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64458409|NCT04029610|Lidocaine|lidocaine|mesh-list
64458410|NCT04029610|Epinephrine|epinephrine|mesh-list
64458411|NCT04029610|Racepinephrine|racepinephrine|mesh-list
64458412|NCT04029610|Epinephryl borate|epinephryl borate|mesh-list
64458413|NCT04029610|Anesthetics, Local|anesthetics, local|mesh-ancestor
64458432|NCT04029610|Respiratory System Agents|respiratory system agents|mesh-ancestor
64458433|NCT04029610|Mydriatics|mydriatics|mesh-ancestor
64458434|NCT04029610|Sympathomimetics|sympathomimetics|mesh-ancestor
64458435|NCT04029610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64458436|NCT04026880|Methyltestosterone|methyltestosterone|mesh-list
64458437|NCT04026880|Testosterone|testosterone|mesh-list
64458438|NCT04026880|Testosterone undecanoate|testosterone undecanoate|mesh-list
64458439|NCT04026880|Testosterone enanthate|testosterone enanthate|mesh-list
64458440|NCT04026880|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64458441|NCT04026880|Androgens|androgens|mesh-ancestor
64458443|NCT04026880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64532614|NCT02352714|Sensory System Agents|sensory system agents|mesh-ancestor
64532615|NCT02352714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64532616|NCT02352714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64887097|NCT01951144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64887098|NCT01951144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64887099|NCT01951144|GABA Modulators|gaba modulators|mesh-ancestor
64887100|NCT01951144|GABA Agents|gaba agents|mesh-ancestor
64887101|NCT01951144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64887102|NCT01951144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887103|NCT01951209|Rifaximin|rifaximin|mesh-list
64887104|NCT01951209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64887105|NCT01951209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64887106|NCT01951209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64887107|NCT01951404|Allopurinol|allopurinol|mesh-list
64887108|NCT01951404|Antimetabolites|antimetabolites|mesh-ancestor
64887109|NCT01951404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887110|NCT01951404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887111|NCT01951404|Gout Suppressants|gout suppressants|mesh-ancestor
64887112|NCT01951404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64887113|NCT01951404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64887114|NCT01951404|Antioxidants|antioxidants|mesh-ancestor
64887115|NCT01951404|Protective Agents|protective agents|mesh-ancestor
64887136|NCT01951430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64887137|NCT01951430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64887138|NCT01951430|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64887139|NCT01951430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64887140|NCT01951430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64887141|NCT01951430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64887142|NCT01951430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64887143|NCT01951430|Renal Agents|renal agents|mesh-ancestor
64887144|NCT01951430|Antimalarials|antimalarials|mesh-ancestor
64887145|NCT01951482|Bevacizumab|bevacizumab|mesh-list
64887146|NCT01951482|Cisplatin|cisplatin|mesh-list
64887147|NCT01951482|Pemetrexed|pemetrexed|mesh-list
64655675|NCT03031184|Serotonin Agents|serotonin agents|mesh-ancestor
64887148|NCT01951482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64887149|NCT01951482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887159|NCT01951508|Methylphenidate|methylphenidate|mesh-list
64887160|NCT01951508|Modafinil|modafinil|mesh-list
64887161|NCT01951508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64887162|NCT01951508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887163|NCT01951508|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64887164|NCT01951508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64887165|NCT01951508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64887166|NCT01951508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887180|NCT01951560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64519347|NCT03221166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64519348|NCT03221166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64519349|NCT03221166|Immunologic Factors|immunologic factors|mesh-ancestor
64519350|NCT03221166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519351|NCT03221166|Leprostatic Agents|leprostatic agents|mesh-ancestor
64519352|NCT03221166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64519353|NCT03221166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64519354|NCT03221166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64519355|NCT03221166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64519356|NCT03221166|Growth Substances|growth substances|mesh-ancestor
64519357|NCT03221166|Growth Inhibitors|growth inhibitors|mesh-ancestor
64519358|NCT03221166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887195|NCT01951729|Atropine|atropine|mesh-list
64887196|NCT01951729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64887197|NCT01951729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64887198|NCT01951729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64519376|NCT04484688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519377|NCT04484688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64519378|NCT04484688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64519379|NCT04484688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64519380|NCT04484688|Adrenergic Agents|adrenergic agents|mesh-ancestor
64519446|NCT03220464|Interferon-gamma|interferon-gamma|mesh-list
64519447|NCT03220464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519448|NCT03220464|Antiviral Agents|antiviral agents|mesh-ancestor
64519449|NCT03220464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64519450|NCT03206658|Spironolactone|spironolactone|mesh-list
64887199|NCT01951729|Autonomic Agents|autonomic agents|mesh-ancestor
64887200|NCT01951729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64887201|NCT01951729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887202|NCT01951729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64887203|NCT01951729|Respiratory System Agents|respiratory system agents|mesh-ancestor
64887204|NCT01951729|Mydriatics|mydriatics|mesh-ancestor
64887211|NCT01951846|Nintedanib|nintedanib|mesh-list
64887245|NCT01951911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64887246|NCT01951911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64887247|NCT01951911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64887248|NCT01951911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64887249|NCT01951911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887250|NCT01951924|Immunoglobulins|immunoglobulins|mesh-list
64887251|NCT01951924|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64887252|NCT01951924|Antibodies|antibodies|mesh-list
64887253|NCT01951924|Immunoglobulin G|immunoglobulin g|mesh-list
64887254|NCT01951924|Immunologic Factors|immunologic factors|mesh-ancestor
64887255|NCT01951924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887256|NCT01952314|Naftopidil|naftopidil|mesh-list
64887257|NCT01952314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64887258|NCT01952314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64887259|NCT01952314|Adrenergic Agents|adrenergic agents|mesh-ancestor
64887260|NCT01952314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64887263|NCT01952314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64887289|NCT01952626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64887290|NCT01952626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64887291|NCT01952626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64887292|NCT01952652|Naproxen|naproxen|mesh-list
64887323|NCT01952756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64887324|NCT01952756|Protective Agents|protective agents|mesh-ancestor
64887325|NCT01952756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64887326|NCT01952756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64887327|NCT01952756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887328|NCT01952769|Pidilizumab|pidilizumab|mesh-list
64887329|NCT01952769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64887330|NCT01952769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887331|NCT01952886|Ondansetron|ondansetron|mesh-list
64887332|NCT01952886|Granisetron|granisetron|mesh-list
64887333|NCT01952886|Antiemetics|antiemetics|mesh-ancestor
64887334|NCT01952886|Autonomic Agents|autonomic agents|mesh-ancestor
64887354|NCT01952951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64887355|NCT01952951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887356|NCT01952951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64887357|NCT01952951|Immunologic Factors|immunologic factors|mesh-ancestor
64887358|NCT01952951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887385|NCT01953406|Alkylating Agents|alkylating agents|mesh-ancestor
64887386|NCT01953406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64887387|NCT01953406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887388|NCT01953419|Pemetrexed|pemetrexed|mesh-list
64887389|NCT01953419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887390|NCT01953419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887391|NCT01953419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887412|NCT01953536|Vitamins|vitamins|mesh-ancestor
64887413|NCT01953536|Micronutrients|micronutrients|mesh-ancestor
64887414|NCT01953536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887415|NCT01953679|Ulipristal acetate|ulipristal acetate|mesh-list
64887416|NCT01953679|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64887417|NCT01953679|Contraceptive Agents|contraceptive agents|mesh-ancestor
64887418|NCT01953679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64887419|NCT01953679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887420|NCT01953679|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64887421|NCT01953731|Rifampin|rifampin|mesh-list
64887422|NCT01953731|Palbociclib|palbociclib|mesh-list
64887423|NCT01953731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887424|NCT01953731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64887425|NCT01953731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887427|NCT01953731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64887442|NCT01953744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64887443|NCT01953744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64887444|NCT01953744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64887445|NCT01953744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887478|NCT01953770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64887479|NCT01953770|Antimetabolites|antimetabolites|mesh-ancestor
64887480|NCT01953770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887481|NCT01953770|Dermatologic Agents|dermatologic agents|mesh-ancestor
64887482|NCT01953770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887483|NCT01953770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64887484|NCT01953770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64887485|NCT01953770|Immunologic Factors|immunologic factors|mesh-ancestor
64887486|NCT01953770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64887487|NCT01953770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64887508|NCT01953835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887525|NCT01953887|Tamsulosin|tamsulosin|mesh-list
64887556|NCT01953978|Narcotics|narcotics|mesh-ancestor
64887557|NCT01953978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64887558|NCT01953978|Analgesics|analgesics|mesh-ancestor
64887559|NCT01953978|Sensory System Agents|sensory system agents|mesh-ancestor
64887560|NCT01953978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64887561|NCT01953978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64887562|NCT01953978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64887563|NCT01953978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64887564|NCT01953978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887565|NCT01953978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887566|NCT01953978|Antipyretics|antipyretics|mesh-ancestor
64887567|NCT01954030|Bevacizumab|bevacizumab|mesh-list
64887568|NCT01954030|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
64887569|NCT01954030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64887570|NCT01954030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887571|NCT01954030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64887572|NCT01954030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64887573|NCT01954030|Growth Substances|growth substances|mesh-ancestor
64887574|NCT01954030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887575|NCT01954030|Growth Inhibitors|growth inhibitors|mesh-ancestor
64887576|NCT01954030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64887610|NCT01954186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64887611|NCT01954186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887612|NCT01954238|Rivaroxaban|rivaroxaban|mesh-list
64887613|NCT01954238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64887614|NCT01954238|Antithrombins|antithrombins|mesh-ancestor
64887615|NCT01954238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64887616|NCT01954238|Protease Inhibitors|protease inhibitors|mesh-ancestor
64887617|NCT01954238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887618|NCT01954238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887619|NCT01954238|Anticoagulants|anticoagulants|mesh-ancestor
64887620|NCT01954290|Mannitol|mannitol|mesh-list
64887621|NCT01954290|Conivaptan|conivaptan|mesh-list
64887622|NCT01954290|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64887623|NCT01954290|Diuretics|diuretics|mesh-ancestor
64887624|NCT01954290|Natriuretic Agents|natriuretic agents|mesh-ancestor
64887625|NCT01954290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887626|NCT01954290|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64887627|NCT01954290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887628|NCT01954355|Paclitaxel|paclitaxel|mesh-list
64887629|NCT01954355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64887630|NCT01954355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887631|NCT01954355|Tubulin Modulators|tubulin modulators|mesh-ancestor
64887632|NCT01954355|Antimitotic Agents|antimitotic agents|mesh-ancestor
64887633|NCT01954355|Mitosis Modulators|mitosis modulators|mesh-ancestor
64887634|NCT01954355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887635|NCT01954368|Sufentanil|sufentanil|mesh-list
64887636|NCT01954368|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64887637|NCT01954368|Narcotics|narcotics|mesh-ancestor
64887638|NCT01954368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64887639|NCT01954368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887640|NCT01954368|Analgesics|analgesics|mesh-ancestor
64887641|NCT01954368|Sensory System Agents|sensory system agents|mesh-ancestor
64887642|NCT01954368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64887643|NCT01954368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64887644|NCT01954368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64887651|NCT01954693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887652|NCT01954732|Metformin|metformin|mesh-list
64887653|NCT01954732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64887654|NCT01954732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887655|NCT01954784|Cyclosporine|cyclosporine|mesh-list
64887657|NCT01954784|Fludarabine|fludarabine|mesh-list
64887695|NCT01954992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887696|NCT01955057|Carbon Monoxide|carbon monoxide|mesh-list
64887697|NCT01955057|Antimetabolites|antimetabolites|mesh-ancestor
64887698|NCT01955057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887767|NCT01955187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64887768|NCT01955187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64887769|NCT01955187|Glucocorticoids|glucocorticoids|mesh-ancestor
64887770|NCT01955187|Hormones|hormones|mesh-ancestor
64638802|NCT03660683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64887771|NCT01955187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64887772|NCT01955187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64887773|NCT01955187|Protective Agents|protective agents|mesh-ancestor
64887774|NCT01955187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64887775|NCT01955200|Cilostazol|cilostazol|mesh-list
64887776|NCT01955200|Clopidogrel|clopidogrel|mesh-list
64887777|NCT01955200|Ticagrelor|ticagrelor|mesh-list
64887778|NCT01955200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64638803|NCT03660683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64887779|NCT01955200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64887780|NCT01955200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64638804|NCT03660683|Protease Inhibitors|protease inhibitors|mesh-ancestor
64887781|NCT01955200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64887782|NCT01955200|Purinergic Agents|purinergic agents|mesh-ancestor
64638805|NCT03660683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638806|NCT01177709|Metformin|metformin|mesh-list
64638807|NCT01177709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64638808|NCT01177709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887783|NCT01955200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64887797|NCT01955200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64887798|NCT01955200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887815|NCT01955408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887817|NCT01955421|Gefitinib|gefitinib|mesh-list
64887818|NCT01955421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887819|NCT01955421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64887820|NCT01955421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887821|NCT01955421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887886|NCT01955759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64656423|NCT04337177|Temozolomide|temozolomide|mesh-list
64887887|NCT01955759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64887888|NCT01955759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64887889|NCT01955759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64887890|NCT01955759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64887892|NCT01955759|Sympatholytics|sympatholytics|mesh-ancestor
64887893|NCT01955759|Autonomic Agents|autonomic agents|mesh-ancestor
64887894|NCT01955759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64887951|NCT01956487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64887952|NCT01956487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64887953|NCT01956487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64887954|NCT01956487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887956|NCT01956591|Parasympatholytics|parasympatholytics|mesh-ancestor
64887957|NCT01956591|Autonomic Agents|autonomic agents|mesh-ancestor
64887958|NCT01956591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64887959|NCT01956591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887960|NCT01956591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64888059|NCT01957189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888060|NCT01957189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888061|NCT01957189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888062|NCT01957189|Urological Agents|urological agents|mesh-ancestor
64888063|NCT01957189|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64888064|NCT01957189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64519594|NCT02046382|Sensory System Agents|sensory system agents|mesh-ancestor
64519595|NCT02046382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64888158|NCT01957839|Cabergoline|cabergoline|mesh-list
64888159|NCT01957839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64888160|NCT01957839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64888161|NCT01957839|Dopamine Agonists|dopamine agonists|mesh-ancestor
64888162|NCT01957839|Dopamine Agents|dopamine agents|mesh-ancestor
64519599|NCT03205176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64519600|NCT03205176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519601|NCT03205176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519602|NCT03205176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519603|NCT02046772|Morphine|morphine|mesh-list
64519604|NCT02046772|Bupivacaine|bupivacaine|mesh-list
64519605|NCT02046772|Anesthetics, Local|anesthetics, local|mesh-ancestor
64519606|NCT02046772|Anesthetics|anesthetics|mesh-ancestor
64519607|NCT02046772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64519608|NCT02046772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519609|NCT02046772|Sensory System Agents|sensory system agents|mesh-ancestor
64519610|NCT02046772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64519611|NCT02046772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64519612|NCT02046772|Narcotics|narcotics|mesh-ancestor
64519613|NCT02046772|Analgesics|analgesics|mesh-ancestor
64888275|NCT01958944|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64888276|NCT01958944|Vasodilator Agents|vasodilator agents|mesh-ancestor
64888277|NCT01958944|Gasotransmitters|gasotransmitters|mesh-ancestor
64888278|NCT01958944|Protective Agents|protective agents|mesh-ancestor
64888279|NCT01958996|Idarubicin|idarubicin|mesh-list
64888280|NCT01958996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64888281|NCT01958996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888282|NCT01958996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64888283|NCT01958996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64888284|NCT01958996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64888332|NCT01959191|Aspirin|aspirin|mesh-list
64888361|NCT01959399|Antimetabolites|antimetabolites|mesh-ancestor
64888362|NCT01959399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888363|NCT01959399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64519615|NCT00178503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64519616|NCT00178503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519617|NCT00178503|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64519618|NCT00178503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64519619|NCT00178503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64519620|NCT00178503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519622|NCT00178503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64519623|NCT02376010|Warfarin|warfarin|mesh-list
64519624|NCT02376010|Rivaroxaban|rivaroxaban|mesh-list
64519625|NCT02376010|Anticoagulants|anticoagulants|mesh-ancestor
64519626|NCT02376010|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64519627|NCT02376010|Antithrombins|antithrombins|mesh-ancestor
64519628|NCT02376010|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64519629|NCT02376010|Protease Inhibitors|protease inhibitors|mesh-ancestor
64519630|NCT02376010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519631|NCT02376010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519632|NCT00085293|Decitabine|decitabine|mesh-list
64888364|NCT01959399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64888365|NCT01959399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64888366|NCT01959399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64532617|NCT02352714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64532618|NCT02352714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64458444|NCT04026880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458445|NCT04026880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64458446|NCT04026880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458447|NCT04026880|Anabolic Agents|anabolic agents|mesh-ancestor
64458448|NCT04024384|Daratumumab|daratumumab|mesh-list
64458449|NCT04024384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458450|NCT01849562|Ribavirin|ribavirin|mesh-list
64458451|NCT01849562|Odalasvir|odalasvir|mesh-list
64458452|NCT01849562|Antimetabolites|antimetabolites|mesh-ancestor
64458453|NCT01849562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458454|NCT01849562|Antiviral Agents|antiviral agents|mesh-ancestor
64458462|NCT04023760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458463|NCT04023760|Anticoagulants|anticoagulants|mesh-ancestor
64458464|NCT04026958|Clarithromycin|clarithromycin|mesh-list
64458465|NCT04026958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64458466|NCT04026958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64458467|NCT04026958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64458468|NCT04026958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458469|NCT04026958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458501|NCT04195204|Tropisetron|tropisetron|mesh-list
64458502|NCT04195204|Antiemetics|antiemetics|mesh-ancestor
64458503|NCT04195204|Autonomic Agents|autonomic agents|mesh-ancestor
64458504|NCT04195204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458505|NCT04195204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458506|NCT04195204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64888367|NCT01959399|Immunologic Factors|immunologic factors|mesh-ancestor
64888368|NCT01959399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888369|NCT01959438|Selenious Acid|selenious acid|mesh-list
64888370|NCT01959438|Sodium Selenite|sodium selenite|mesh-list
64888371|NCT01959438|Trace Elements|trace elements|mesh-ancestor
64888372|NCT01959438|Micronutrients|micronutrients|mesh-ancestor
64888373|NCT01959438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888374|NCT01959451|Clopidogrel|clopidogrel|mesh-list
64888375|NCT01959451|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64888376|NCT01959451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64888377|NCT01959451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64888406|NCT01959828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64888407|NCT01959828|Respiratory System Agents|respiratory system agents|mesh-ancestor
64888408|NCT01959828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64888409|NCT01959828|Antioxidants|antioxidants|mesh-ancestor
64888410|NCT01959828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888411|NCT01959828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888412|NCT01959828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64888413|NCT01959828|Vasodilator Agents|vasodilator agents|mesh-ancestor
64888414|NCT01959828|Gasotransmitters|gasotransmitters|mesh-ancestor
64888415|NCT01959828|Protective Agents|protective agents|mesh-ancestor
64888416|NCT01959854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64888442|NCT01960205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888443|NCT01960205|Incretins|incretins|mesh-ancestor
64888444|NCT01960205|Hormones|hormones|mesh-ancestor
64888445|NCT01960205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64888446|NCT01960205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64888447|NCT01960205|Protease Inhibitors|protease inhibitors|mesh-ancestor
64888448|NCT01960205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638962|NCT00301028|Paclitaxel|paclitaxel|mesh-list
64458507|NCT04195204|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64458508|NCT04195204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64458509|NCT04195204|Serotonin Agents|serotonin agents|mesh-ancestor
64458510|NCT04195204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64458525|NCT04023292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64458526|NCT04023292|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64458527|NCT04023292|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64458528|NCT04023292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64458530|NCT03022240|Propofol|propofol|mesh-list
64458531|NCT03022240|Sevoflurane|sevoflurane|mesh-list
64458532|NCT03022240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64458533|NCT03022240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64458534|NCT03022240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458535|NCT03022240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64458536|NCT03022240|Anesthetics, General|anesthetics, general|mesh-ancestor
64458537|NCT03022240|Anesthetics|anesthetics|mesh-ancestor
64458538|NCT03022240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64458539|NCT03022240|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64458540|NCT03022240|Antiemetics|antiemetics|mesh-ancestor
64458541|NCT03022240|Autonomic Agents|autonomic agents|mesh-ancestor
64458542|NCT03022240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458543|NCT03022240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64458544|NCT03022240|Antipruritics|antipruritics|mesh-ancestor
64458545|NCT03022240|Dermatologic Agents|dermatologic agents|mesh-ancestor
64458546|NCT03022240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64458548|NCT03022240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64458549|NCT03022240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458550|NCT03022240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64458551|NCT03022240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64458552|NCT03022240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64458553|NCT03022240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64532619|NCT02352714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64532620|NCT02352714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532621|NCT03911557|Durvalumab|durvalumab|mesh-list
64532622|NCT03911557|Tremelimumab|tremelimumab|mesh-list
64532623|NCT03911557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64532624|NCT03911557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532625|NCT00356031|Bevacizumab|bevacizumab|mesh-list
64532626|NCT00356031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64532627|NCT00356031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532628|NCT00356031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64532629|NCT00356031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64532630|NCT00356031|Growth Substances|growth substances|mesh-ancestor
64532631|NCT00356031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532632|NCT00356031|Growth Inhibitors|growth inhibitors|mesh-ancestor
64532633|NCT02038842|Vaccines|vaccines|mesh-list
64532634|NCT02038842|Immunologic Factors|immunologic factors|mesh-ancestor
64532635|NCT02038842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532645|NCT02360592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458554|NCT02704390|Methylphenidate|methylphenidate|mesh-list
64458555|NCT02704390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64458556|NCT02704390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458557|NCT02704390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64458558|NCT02704390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64458559|NCT02704390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64458560|NCT02704390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458561|NCT02704390|Dopamine Agents|dopamine agents|mesh-ancestor
64458562|NCT02704390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888449|NCT01960205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888450|NCT01960283|Methotrexate|methotrexate|mesh-list
64888451|NCT01960283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64888452|NCT01960283|Abortifacient Agents|abortifacient agents|mesh-ancestor
64888453|NCT01960283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64888454|NCT01960283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639030|NCT00239642|Iron|iron|mesh-list
64458563|NCT04147390|Mycophenolic Acid|mycophenolic acid|mesh-list
64458564|NCT04147390|Tacrolimus|tacrolimus|mesh-list
64458565|NCT04147390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64458567|NCT04147390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458568|NCT04147390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64458569|NCT04147390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458570|NCT04147390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458597|NCT01611974|Maribavir|maribavir|mesh-list
64458598|NCT01611974|Antiviral Agents|antiviral agents|mesh-ancestor
64458599|NCT01611974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64458600|NCT01871870|Pancrelipase|pancrelipase|mesh-list
64458601|NCT01871870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64297214|NCT00794846|Histamine Agents|histamine agents|mesh-ancestor
64532646|NCT02360592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64532647|NCT02360592|Analgesics|analgesics|mesh-ancestor
64532648|NCT02360592|Sensory System Agents|sensory system agents|mesh-ancestor
64532649|NCT02360592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64532651|NCT02360202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64532652|NCT02360202|Glucocorticoids|glucocorticoids|mesh-ancestor
64532653|NCT02360202|Hormones|hormones|mesh-ancestor
64532654|NCT02360202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64532655|NCT02360202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532656|NCT00322101|Cyclosporine|cyclosporine|mesh-list
64532657|NCT00322101|Mycophenolic Acid|mycophenolic acid|mesh-list
64532658|NCT00322101|Cyclophosphamide|cyclophosphamide|mesh-list
64532659|NCT00322101|Busulfan|busulfan|mesh-list
64532660|NCT00322101|Methotrexate|methotrexate|mesh-list
64532661|NCT00322101|Fludarabine|fludarabine|mesh-list
64532662|NCT00322101|Fludarabine phosphate|fludarabine phosphate|mesh-list
64532663|NCT00322101|Tacrolimus|tacrolimus|mesh-list
64532664|NCT00322101|Cyclosporins|cyclosporins|mesh-list
64532665|NCT00322101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64532666|NCT00322101|Immunologic Factors|immunologic factors|mesh-ancestor
64532667|NCT00322101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532668|NCT00322101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64532669|NCT00322101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64532670|NCT00322101|Alkylating Agents|alkylating agents|mesh-ancestor
64532671|NCT00322101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532672|NCT00322101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532673|NCT00322101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64532674|NCT00322101|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64532675|NCT00322101|Abortifacient Agents|abortifacient agents|mesh-ancestor
64532676|NCT00322101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64532677|NCT00322101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64532678|NCT00322101|Antimetabolites|antimetabolites|mesh-ancestor
64532679|NCT00322101|Dermatologic Agents|dermatologic agents|mesh-ancestor
64532680|NCT00322101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297232|NCT02060851|Iron|iron|mesh-list
64458602|NCT02080780|Clarithromycin|clarithromycin|mesh-list
64652598|NCT01569191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64458603|NCT02080780|Diltiazem|diltiazem|mesh-list
64532687|NCT00322101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64532688|NCT00322101|Antitubercular Agents|antitubercular agents|mesh-ancestor
64532689|NCT00322101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64532690|NCT02360046|Hydrocortisone|hydrocortisone|mesh-list
64532691|NCT02360046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64532692|NCT01552681|Immunoglobulins|immunoglobulins|mesh-list
64532693|NCT01552681|Immunologic Factors|immunologic factors|mesh-ancestor
64458606|NCT02080780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64458607|NCT02080780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458608|NCT02080780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458609|NCT02080780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64458610|NCT02080780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64888455|NCT01960283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64888456|NCT01960283|Antimetabolites|antimetabolites|mesh-ancestor
64888457|NCT01960283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888458|NCT01960283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888459|NCT01960283|Dermatologic Agents|dermatologic agents|mesh-ancestor
64888460|NCT01960283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64888461|NCT01960283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64888462|NCT01960283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64888463|NCT01960283|Immunologic Factors|immunologic factors|mesh-ancestor
64888464|NCT01960283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64458611|NCT02080780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64458612|NCT02080780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64458613|NCT02080780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64458614|NCT02080780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64458615|NCT02080780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458616|NCT02080780|Vasodilator Agents|vasodilator agents|mesh-ancestor
64458618|NCT01871558|Vildagliptin|vildagliptin|mesh-list
64458638|NCT01711359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64458640|NCT01711359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64458641|NCT01711359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64458642|NCT01711359|Hematinics|hematinics|mesh-ancestor
64458643|NCT01711359|Vitamin B Complex|vitamin b complex|mesh-ancestor
64458644|NCT01711359|Vitamins|vitamins|mesh-ancestor
64458645|NCT01711359|Micronutrients|micronutrients|mesh-ancestor
64458646|NCT04149964|Acetaminophen|acetaminophen|mesh-list
64458647|NCT04149964|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64458648|NCT04149964|Oxycodone|oxycodone|mesh-list
64458649|NCT04149964|Hydrocodone|hydrocodone|mesh-list
64458650|NCT04149964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64458651|NCT04149964|Analgesics|analgesics|mesh-ancestor
64458652|NCT04149964|Sensory System Agents|sensory system agents|mesh-ancestor
64458653|NCT04149964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458654|NCT04149964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458655|NCT04149964|Antipyretics|antipyretics|mesh-ancestor
64458656|NCT04149964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64458657|NCT04149964|Narcotics|narcotics|mesh-ancestor
64458658|NCT04149964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64458659|NCT04149964|Antitussive Agents|antitussive agents|mesh-ancestor
64458660|NCT04149964|Respiratory System Agents|respiratory system agents|mesh-ancestor
64458661|NCT04149964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64458662|NCT04149964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64458663|NCT04149964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64458664|NCT04140136|Tocotrienols|tocotrienols|mesh-list
64458665|NCT04140136|Vitamin E|vitamin e|mesh-list
64458666|NCT04140136|Tocopherols|tocopherols|mesh-list
64458667|NCT04140136|Antioxidants|antioxidants|mesh-ancestor
64458668|NCT04140136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458669|NCT04140136|Protective Agents|protective agents|mesh-ancestor
64458670|NCT04140136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458671|NCT04140136|Vitamins|vitamins|mesh-ancestor
64458672|NCT04140136|Micronutrients|micronutrients|mesh-ancestor
64458691|NCT03929224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64458692|NCT03929224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64458693|NCT03928288|Cabergoline|cabergoline|mesh-list
64532694|NCT01552681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532695|NCT02352402|Ticagrelor|ticagrelor|mesh-list
64532696|NCT02352402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64532701|NCT02352402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64532702|NCT02352402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532703|NCT02352402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532704|NCT02357472|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64532705|NCT02357472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64532706|NCT02357472|Immunologic Factors|immunologic factors|mesh-ancestor
64297262|NCT03299517|Anesthetics, Local|anesthetics, local|mesh-ancestor
64297263|NCT03299517|Anesthetics|anesthetics|mesh-ancestor
64458694|NCT03928288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64458695|NCT03928288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64888465|NCT01960283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64888466|NCT01960426|Adalimumab|adalimumab|mesh-list
64888467|NCT01960426|Infliximab|infliximab|mesh-list
64888468|NCT01960426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64888469|NCT01960426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64888470|NCT01960426|Dermatologic Agents|dermatologic agents|mesh-ancestor
64888471|NCT01960426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64639165|NCT00248612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64519656|NCT02450838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519657|NCT02450838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64519658|NCT03214302|Tenofovir|tenofovir|mesh-list
64519659|NCT03214302|Antiviral Agents|antiviral agents|mesh-ancestor
64519660|NCT03214302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64519661|NCT03214302|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64458696|NCT03928288|Dopamine Agonists|dopamine agonists|mesh-ancestor
64458697|NCT03928288|Dopamine Agents|dopamine agents|mesh-ancestor
64458698|NCT03928288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64458699|NCT03928288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458700|NCT03928288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458702|NCT04146610|Immunoconjugates|immunoconjugates|mesh-list
64458703|NCT04146610|Immunologic Factors|immunologic factors|mesh-ancestor
64458704|NCT04146610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458705|NCT04146376|Tranexamic Acid|tranexamic acid|mesh-list
64458706|NCT04146376|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64458707|NCT04146376|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64458708|NCT04146376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458709|NCT04146376|Hemostatics|hemostatics|mesh-ancestor
64458710|NCT04146376|Coagulants|coagulants|mesh-ancestor
64458711|NCT01710657|Lacosamide|lacosamide|mesh-list
64458712|NCT01710657|Anticonvulsants|anticonvulsants|mesh-ancestor
64458713|NCT01710657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64458714|NCT01710657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64458715|NCT01710657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64458716|NCT01710657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458717|NCT04145518|Naproxen|naproxen|mesh-list
64458718|NCT04145518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64458719|NCT04145518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64458720|NCT04145518|Analgesics|analgesics|mesh-ancestor
64458721|NCT04145518|Sensory System Agents|sensory system agents|mesh-ancestor
64458722|NCT04145518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458723|NCT04145518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458724|NCT04145518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64458725|NCT04145518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64458726|NCT04145518|Gout Suppressants|gout suppressants|mesh-ancestor
64458727|NCT04145518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64458728|NCT04145518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458765|NCT04405960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458784|NCT03944434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64458785|NCT03944434|Contraceptive Agents|contraceptive agents|mesh-ancestor
64458786|NCT03944434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64458787|NCT03944434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64458788|NCT03944434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557634|NCT03067896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64532707|NCT02357472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532709|NCT00322335|Anticoagulants|anticoagulants|mesh-ancestor
64532710|NCT00322335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64532711|NCT00322335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64532712|NCT00322335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532713|NCT04337970|Axitinib|axitinib|mesh-list
64532714|NCT04337970|Talazoparib|talazoparib|mesh-list
64297274|NCT03299517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64519662|NCT03214302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64519663|NCT03214302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519664|NCT03214302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519665|NCT03214302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64519666|NCT03214302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64888472|NCT01960543|Fentanyl|fentanyl|mesh-list
64888473|NCT01960543|Bupivacaine|bupivacaine|mesh-list
64888474|NCT01960543|Levobupivacaine|levobupivacaine|mesh-list
64458789|NCT03944434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458791|NCT03944434|Hormone Antagonists|hormone antagonists|mesh-ancestor
64458792|NCT03944434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64458793|NCT03944356|Trametinib|trametinib|mesh-list
64458794|NCT03944356|Dabrafenib|dabrafenib|mesh-list
64458795|NCT03944356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458796|NCT03944356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64458797|NCT03944356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458805|NCT03920722|Rituximab|rituximab|mesh-list
64458806|NCT03920722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64458807|NCT03920722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458808|NCT03920722|Immunologic Factors|immunologic factors|mesh-ancestor
64458809|NCT03920722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458810|NCT03920722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64458811|NCT05580094|Anesthetics|anesthetics|mesh-list
64458812|NCT05580094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64458813|NCT05580094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458814|NCT05589766|Niacinamide|niacinamide|mesh-list
64458815|NCT05589766|Niacin|niacin|mesh-list
64458816|NCT05589766|Nicotinic Acids|nicotinic acids|mesh-list
64458817|NCT05589766|Vitamin B Complex|vitamin b complex|mesh-ancestor
64458818|NCT05589766|Vitamins|vitamins|mesh-ancestor
64458819|NCT05589766|Micronutrients|micronutrients|mesh-ancestor
64458820|NCT05589766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458821|NCT05589766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64458846|NCT01710501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458847|NCT01710501|Immunologic Factors|immunologic factors|mesh-ancestor
64458848|NCT01710501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513627|NCT02846883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64458849|NCT05583058|Hormones|hormones|mesh-list
64458850|NCT05583058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64458851|NCT05583058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458852|NCT01700829|Midazolam|midazolam|mesh-list
64458853|NCT01700829|Ketamine|ketamine|mesh-list
64458854|NCT01700829|Analgesics|analgesics|mesh-ancestor
64458855|NCT01700829|Sensory System Agents|sensory system agents|mesh-ancestor
64458856|NCT01700829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458857|NCT01700829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458858|NCT01700829|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64458859|NCT01700829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64458860|NCT01700829|Anesthetics, General|anesthetics, general|mesh-ancestor
64458861|NCT01700829|Anesthetics|anesthetics|mesh-ancestor
64458862|NCT01700829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64458863|NCT01700829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64458864|NCT01700829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64458865|NCT01700829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64458866|NCT01700829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458867|NCT01700829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64458868|NCT01700829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64458869|NCT01700829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64532715|NCT04337970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532716|NCT04337970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64532717|NCT04337970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532718|NCT04337970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532719|NCT04337970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64532720|NCT03153852|Glycolic acid|glycolic acid|mesh-list
64532721|NCT03153852|Keratolytic Agents|keratolytic agents|mesh-ancestor
64532722|NCT03153852|Dermatologic Agents|dermatologic agents|mesh-ancestor
64532723|NCT04751175|Dexamethasone|dexamethasone|mesh-list
64888475|NCT01960543|Anesthetics, Local|anesthetics, local|mesh-ancestor
64888476|NCT01960543|Anesthetics|anesthetics|mesh-ancestor
64888477|NCT01960543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64888478|NCT01960543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888479|NCT01960543|Sensory System Agents|sensory system agents|mesh-ancestor
64888480|NCT01960543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64657021|NCT01061528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64888481|NCT01960543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64888512|NCT01960647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888513|NCT01960647|Tubulin Modulators|tubulin modulators|mesh-ancestor
64888514|NCT01960647|Antimitotic Agents|antimitotic agents|mesh-ancestor
64888515|NCT01960647|Mitosis Modulators|mitosis modulators|mesh-ancestor
64888516|NCT01960647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888517|NCT01960764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64888518|NCT01960764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64888519|NCT01960829|Everolimus|everolimus|mesh-list
64888520|NCT01960829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888521|NCT01960829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64888522|NCT01960829|Immunologic Factors|immunologic factors|mesh-ancestor
64888523|NCT01960829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888524|NCT01961154|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64639293|NCT01480297|Sodium Salicylate|sodium salicylate|mesh-list
64639296|NCT01480297|Analgesics|analgesics|mesh-ancestor
64532724|NCT04751175|Ketamine|ketamine|mesh-list
64532725|NCT04751175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64532726|NCT04751175|Antiemetics|antiemetics|mesh-ancestor
64532727|NCT04751175|Autonomic Agents|autonomic agents|mesh-ancestor
64532728|NCT04751175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64532729|NCT04751175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532730|NCT04751175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64532731|NCT04751175|Glucocorticoids|glucocorticoids|mesh-ancestor
64532732|NCT04751175|Hormones|hormones|mesh-ancestor
64532733|NCT04751175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64458873|NCT01700829|GABA Agents|gaba agents|mesh-ancestor
64458890|NCT04144192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458893|NCT01710345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64458894|NCT01710345|Narcotics|narcotics|mesh-ancestor
64458895|NCT01710345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64458896|NCT01710345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458897|NCT01710345|Analgesics|analgesics|mesh-ancestor
64458898|NCT01710345|Sensory System Agents|sensory system agents|mesh-ancestor
64458899|NCT01710345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458900|NCT01710345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64458901|NCT01710345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64458902|NCT01710345|Anesthetics, General|anesthetics, general|mesh-ancestor
64458903|NCT01710345|Anesthetics|anesthetics|mesh-ancestor
64458904|NCT03022006|Grazoprevir|grazoprevir|mesh-list
64458905|NCT03022006|Antiviral Agents|antiviral agents|mesh-ancestor
64458906|NCT03022006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64458908|NCT04143256|Antipruritics|antipruritics|mesh-ancestor
64458909|NCT04143256|Dermatologic Agents|dermatologic agents|mesh-ancestor
64458910|NCT04143412|Ramipril|ramipril|mesh-list
64458911|NCT04143412|Eplerenone|eplerenone|mesh-list
64639345|NCT01460875|Interferon-alpha|interferon-alpha|mesh-list
64888525|NCT01961154|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64888526|NCT01961154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64888527|NCT01961154|Respiratory System Agents|respiratory system agents|mesh-ancestor
64888554|NCT01961336|Testosterone|testosterone|mesh-list
64888555|NCT01961336|Androgens|androgens|mesh-ancestor
64888556|NCT01961336|Hormones|hormones|mesh-ancestor
64888557|NCT01961336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64888558|NCT01961336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888560|NCT01961388|Acarbose|acarbose|mesh-list
64888561|NCT01961388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64888562|NCT01961388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888563|NCT01961388|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64888564|NCT01961388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64888565|NCT01961388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888566|NCT01961414|Aflibercept|aflibercept|mesh-list
64888567|NCT01961414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64888568|NCT01961414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64888569|NCT01961414|Growth Substances|growth substances|mesh-ancestor
64888570|NCT01961414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888571|NCT01961414|Growth Inhibitors|growth inhibitors|mesh-ancestor
64888572|NCT01961414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888573|NCT01961453|Isosorbide|isosorbide|mesh-list
64888574|NCT01961453|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64888575|NCT01961453|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64888586|NCT01961635|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64888587|NCT01961635|Histamine Antagonists|histamine antagonists|mesh-ancestor
64519667|NCT00085839|Paclitaxel|paclitaxel|mesh-list
64519668|NCT00085839|Carboplatin|carboplatin|mesh-list
64519669|NCT00085839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64519671|NCT00085839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888599|NCT01961739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888600|NCT01961739|Sensory System Agents|sensory system agents|mesh-ancestor
64888601|NCT01961739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64888602|NCT01961739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64639378|NCT01482091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64888603|NCT01961739|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64888604|NCT01961739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64888605|NCT01961739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64888606|NCT01961739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888607|NCT01961752|Triamcinolone|triamcinolone|mesh-list
64888608|NCT01961752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64888609|NCT01961752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64888610|NCT01961752|Bupivacaine|bupivacaine|mesh-list
64458912|NCT04143412|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64458913|NCT04143412|Protease Inhibitors|protease inhibitors|mesh-ancestor
64458914|NCT04143412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458915|NCT04143412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532739|NCT04751175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64532740|NCT04751175|Anesthetics, General|anesthetics, general|mesh-ancestor
64532741|NCT04751175|Anesthetics|anesthetics|mesh-ancestor
64532742|NCT04751175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64532743|NCT04751175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64532744|NCT04751175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64532745|NCT04751175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64532746|NCT04751175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532747|NCT01792557|Phenol|phenol|mesh-list
64532748|NCT01792557|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64532749|NCT01792557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64532750|NCT01792557|Disinfectants|disinfectants|mesh-ancestor
64532751|NCT01792557|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64532752|NCT01792557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64532753|NCT01792713|Sertaconazole|sertaconazole|mesh-list
64532754|NCT01792713|Antifungal Agents|antifungal agents|mesh-ancestor
64297309|NCT02062255|Aspirin|aspirin|mesh-list
64458916|NCT04143412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64458917|NCT04143412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64458918|NCT04143412|Hormone Antagonists|hormone antagonists|mesh-ancestor
64458919|NCT04143412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64458920|NCT04143412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458921|NCT04143412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64458923|NCT04143412|Natriuretic Agents|natriuretic agents|mesh-ancestor
64458924|NCT05582278|Lenvatinib|lenvatinib|mesh-list
64458925|NCT05582278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64458926|NCT05582278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458927|NCT05582278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64458928|NCT05582278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458929|NCT05582278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458930|NCT01710033|Tofacitinib|tofacitinib|mesh-list
64458931|NCT01710033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64458932|NCT01710033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652624|NCT01468337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64458954|NCT01822496|Dermatologic Agents|dermatologic agents|mesh-ancestor
64458962|NCT03588988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458963|NCT03588988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64458964|NCT03588988|Analgesics|analgesics|mesh-ancestor
64458965|NCT03588988|Sensory System Agents|sensory system agents|mesh-ancestor
64458966|NCT03588988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458967|NCT03588988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64458968|NCT03588988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64888611|NCT01961752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64888612|NCT01961752|Anesthetics, Local|anesthetics, local|mesh-ancestor
64888613|NCT01961752|Anesthetics|anesthetics|mesh-ancestor
64888614|NCT01961752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64888615|NCT01961752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888616|NCT01961752|Sensory System Agents|sensory system agents|mesh-ancestor
64888617|NCT01961752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64888618|NCT01961752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64888619|NCT01961752|Glucocorticoids|glucocorticoids|mesh-ancestor
64888620|NCT01961752|Hormones|hormones|mesh-ancestor
64888621|NCT01961752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64888622|NCT01961752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64888623|NCT01961752|Immunologic Factors|immunologic factors|mesh-ancestor
64888624|NCT01961752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458969|NCT03588988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64458970|NCT03588988|Adrenergic Agents|adrenergic agents|mesh-ancestor
64458971|NCT03588988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64458972|NCT03588988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458973|NCT04414137|Daptomycin|daptomycin|mesh-list
64458974|NCT04414137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64458975|NCT04414137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64458976|NCT01821560|Baclofen|baclofen|mesh-list
64458977|NCT01821560|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64532755|NCT01792713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64532756|NCT02352168|Budesonide|budesonide|mesh-list
64532757|NCT02352168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64532758|NCT02352168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64532759|NCT02352168|Autonomic Agents|autonomic agents|mesh-ancestor
64532760|NCT02352168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64297324|NCT02062255|Antipyretics|antipyretics|mesh-ancestor
64458978|NCT01821560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458979|NCT01821560|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64458980|NCT01821560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458981|NCT01821560|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64458982|NCT01821560|GABA Agonists|gaba agonists|mesh-ancestor
64458983|NCT01821560|GABA Agents|gaba agents|mesh-ancestor
64458984|NCT01821560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64459009|NCT01846442|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64459010|NCT01846442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64459011|NCT01846442|Immunologic Factors|immunologic factors|mesh-ancestor
64945374|NCT05686408|Antidepressive Agents|antidepressive agents|mesh-ancestor
64459012|NCT01846442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459014|NCT01709721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64459015|NCT01709721|Narcotics|narcotics|mesh-ancestor
64459016|NCT01709721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64459017|NCT01709721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459018|NCT01709721|Analgesics|analgesics|mesh-ancestor
64459019|NCT01709721|Sensory System Agents|sensory system agents|mesh-ancestor
64459020|NCT01709721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459021|NCT01866657|Phenylephrine|phenylephrine|mesh-list
64459022|NCT01866657|Dopamine|dopamine|mesh-list
64459023|NCT01866657|Ephedrine|ephedrine|mesh-list
64459024|NCT01866657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64459025|NCT01866657|Propofol|propofol|mesh-list
64459026|NCT01866657|Sevoflurane|sevoflurane|mesh-list
64459027|NCT01866657|Anesthetics|anesthetics|mesh-ancestor
64459028|NCT01866657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64459029|NCT01866657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459062|NCT03584152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64459063|NCT03584152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64459064|NCT03584152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459065|NCT03589690|Thioctic Acid|thioctic acid|mesh-list
64459066|NCT03589690|Antioxidants|antioxidants|mesh-ancestor
64888625|NCT01961752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888626|NCT01961830|Arbekacin|arbekacin|mesh-list
64888627|NCT01961830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64888628|NCT01961843|Prednisone|prednisone|mesh-list
64888629|NCT01961843|Abiraterone Acetate|abiraterone acetate|mesh-list
64888630|NCT01961843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64657171|NCT05070650|Respiratory System Agents|respiratory system agents|mesh-ancestor
64888632|NCT01961843|Hormones|hormones|mesh-ancestor
64888633|NCT01961843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64888634|NCT01961843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888635|NCT01961843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64639503|NCT00335504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64639504|NCT00335504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639505|NCT00335504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64639506|NCT01183169|Ribavirin|ribavirin|mesh-list
64639507|NCT01183169|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64639508|NCT01183169|Antimetabolites|antimetabolites|mesh-ancestor
64639509|NCT01183169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639510|NCT01183169|Antiviral Agents|antiviral agents|mesh-ancestor
64639511|NCT01183169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64459067|NCT03589690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459068|NCT03589690|Protective Agents|protective agents|mesh-ancestor
64459069|NCT03589690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459070|NCT03589690|Vitamin B Complex|vitamin b complex|mesh-ancestor
64459071|NCT03589690|Vitamins|vitamins|mesh-ancestor
64459092|NCT01699815|Antipyretics|antipyretics|mesh-ancestor
64459101|NCT03589222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64459102|NCT03589222|Glucocorticoids|glucocorticoids|mesh-ancestor
64459103|NCT03589222|Hormones|hormones|mesh-ancestor
64459104|NCT03589222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64459105|NCT03589222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64459106|NCT03589222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459107|NCT03589066|Rotigotine|rotigotine|mesh-list
64459108|NCT03589066|Dopamine Agonists|dopamine agonists|mesh-ancestor
64459109|NCT03589066|Dopamine Agents|dopamine agents|mesh-ancestor
64459110|NCT03589066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64459111|NCT03589066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459112|NCT03589066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459113|NCT03020368|Diclofenac|diclofenac|mesh-list
64459114|NCT03020368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64459115|NCT03020368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64459116|NCT03020368|Analgesics|analgesics|mesh-ancestor
64459117|NCT03020368|Sensory System Agents|sensory system agents|mesh-ancestor
64532761|NCT02352168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532762|NCT02352168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64532763|NCT02352168|Respiratory System Agents|respiratory system agents|mesh-ancestor
64532764|NCT02352168|Glucocorticoids|glucocorticoids|mesh-ancestor
64532765|NCT02352168|Hormones|hormones|mesh-ancestor
64714126|NCT00374101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64532766|NCT02352168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64532767|NCT02357004|Carvedilol|carvedilol|mesh-list
64532768|NCT02357004|Chlorthalidone|chlorthalidone|mesh-list
64532769|NCT02357004|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64532770|NCT02357004|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64888636|NCT01961843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888637|NCT01961843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64888638|NCT01961843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64888644|NCT01961856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64888645|NCT01961856|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64888646|NCT01961856|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64888647|NCT01961856|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64888648|NCT01961856|Purinergic Agents|purinergic agents|mesh-ancestor
64639579|NCT01222091|Propranolol|propranolol|mesh-list
64639580|NCT01222091|Remifentanil|remifentanil|mesh-list
64639581|NCT01222091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64639582|NCT01222091|Narcotics|narcotics|mesh-ancestor
64639583|NCT01222091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64639584|NCT01222091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639586|NCT01222091|Sensory System Agents|sensory system agents|mesh-ancestor
64639587|NCT01222091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639588|NCT01222091|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64639589|NCT01222091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64639590|NCT01222091|Adrenergic Agents|adrenergic agents|mesh-ancestor
64639591|NCT01222091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64639593|NCT01222091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64532771|NCT02357004|Adrenergic Agents|adrenergic agents|mesh-ancestor
64532772|NCT02357004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64532773|NCT02357004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532774|NCT02357004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532775|NCT02357004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64532776|NCT02357004|Antioxidants|antioxidants|mesh-ancestor
64532777|NCT02357004|Protective Agents|protective agents|mesh-ancestor
64532778|NCT02357004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64532779|NCT02357004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64297325|NCT02739542|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64459118|NCT03020368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459119|NCT03020368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459120|NCT03020368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64459121|NCT03020368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64459122|NCT03020368|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64459123|NCT03020368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64459156|NCT03585556|Prednisolone|prednisolone|mesh-list
64459157|NCT03585556|Ranibizumab|ranibizumab|mesh-list
64459158|NCT03585556|Aflibercept|aflibercept|mesh-list
64459159|NCT03585556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459160|NCT03585556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64459169|NCT03585556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64459170|NCT05702398|Vitamins|vitamins|mesh-list
64459171|NCT05702398|Vitamin A|vitamin a|mesh-list
64459172|NCT05702398|Niacin|niacin|mesh-list
64459173|NCT05702398|Niacinamide|niacinamide|mesh-list
64459174|NCT05702398|Nicotinic Acids|nicotinic acids|mesh-list
64459175|NCT05702398|Micronutrients|micronutrients|mesh-ancestor
64459176|NCT05702398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459177|NCT05702398|Vitamin B Complex|vitamin b complex|mesh-ancestor
64459178|NCT05702398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459179|NCT05702398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64459180|NCT05702398|Antimetabolites|antimetabolites|mesh-ancestor
64888649|NCT01961856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888650|NCT01961856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888651|NCT01961856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888652|NCT01961947|Vaccines|vaccines|mesh-list
64459181|NCT05702398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64532785|NCT02357004|Natriuretic Agents|natriuretic agents|mesh-ancestor
64297347|NCT00398294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64459190|NCT02335294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64459191|NCT02335294|Narcotics|narcotics|mesh-ancestor
64459192|NCT02335294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64459193|NCT02335294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459194|NCT02335294|Analgesics|analgesics|mesh-ancestor
64459195|NCT02335294|Sensory System Agents|sensory system agents|mesh-ancestor
64459196|NCT02335294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459197|NCT01698801|Dexamethasone|dexamethasone|mesh-list
64459198|NCT01698801|Lenalidomide|lenalidomide|mesh-list
64459199|NCT01698801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64459200|NCT01698801|Antiemetics|antiemetics|mesh-ancestor
64459201|NCT01698801|Autonomic Agents|autonomic agents|mesh-ancestor
64459202|NCT01698801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459203|NCT01698801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459204|NCT01698801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64459205|NCT01698801|Glucocorticoids|glucocorticoids|mesh-ancestor
64459206|NCT01698801|Hormones|hormones|mesh-ancestor
64459207|NCT01698801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64459208|NCT01698801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64459209|NCT01698801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459210|NCT01698801|Immunologic Factors|immunologic factors|mesh-ancestor
64459211|NCT01698801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64459212|NCT01698801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64459213|NCT01698801|Growth Substances|growth substances|mesh-ancestor
64459214|NCT01698801|Growth Inhibitors|growth inhibitors|mesh-ancestor
64459215|NCT03735628|Nivolumab|nivolumab|mesh-list
64459216|NCT03735628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64459217|NCT03735628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459218|NCT03735628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64459219|NCT03735628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459220|NCT01682811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64459221|NCT01682811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64459222|NCT01682811|Dermatologic Agents|dermatologic agents|mesh-ancestor
64459223|NCT03580018|Tranexamic Acid|tranexamic acid|mesh-list
64459224|NCT03580018|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64459225|NCT03580018|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64459226|NCT03580018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459227|NCT03580018|Hemostatics|hemostatics|mesh-ancestor
64459228|NCT03580018|Coagulants|coagulants|mesh-ancestor
64459229|NCT03584854|Carboprost|carboprost|mesh-list
64459230|NCT03584854|Dinoprost|dinoprost|mesh-list
64459248|NCT03584698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64459249|NCT03584698|Analgesics|analgesics|mesh-ancestor
64459250|NCT03584698|Sensory System Agents|sensory system agents|mesh-ancestor
64459251|NCT03584698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459252|NCT03584698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64459253|NCT03584698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64459254|NCT03584698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64652650|NCT03409250|Ranibizumab|ranibizumab|mesh-list
64459262|NCT03587038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459264|NCT03582124|Panitumumab|panitumumab|mesh-list
64459265|NCT03582124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64459266|NCT03582124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459267|NCT01682031|Selenium|selenium|mesh-list
64532786|NCT02357004|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64532788|NCT01570387|Dexamethasone acetate|dexamethasone acetate|mesh-list
64532789|NCT01570387|Pomalidomide|pomalidomide|mesh-list
64532790|NCT01570387|BB 1101|bb 1101|mesh-list
64532791|NCT01570387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64532792|NCT01570387|Antiemetics|antiemetics|mesh-ancestor
64532793|NCT01570387|Autonomic Agents|autonomic agents|mesh-ancestor
64532794|NCT01570387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64532795|NCT01570387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532796|NCT01570387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64532797|NCT01570387|Glucocorticoids|glucocorticoids|mesh-ancestor
64532798|NCT01570387|Hormones|hormones|mesh-ancestor
64519673|NCT00085839|Antimitotic Agents|antimitotic agents|mesh-ancestor
64519674|NCT00085839|Mitosis Modulators|mitosis modulators|mesh-ancestor
64519675|NCT00085839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519676|NCT00085839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64519677|NCT00085839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519678|NCT03204474|Lacosamide|lacosamide|mesh-list
64519679|NCT03204474|Anticonvulsants|anticonvulsants|mesh-ancestor
64888653|NCT01961947|Immunologic Factors|immunologic factors|mesh-ancestor
64888654|NCT01961947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639704|NCT00343460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64639705|NCT00343460|Glucocorticoids|glucocorticoids|mesh-ancestor
64888655|NCT01962116|Heparin|heparin|mesh-list
64888656|NCT01962116|Calcium heparin|calcium heparin|mesh-list
64888657|NCT01962116|Anticoagulants|anticoagulants|mesh-ancestor
64888658|NCT01962116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888659|NCT01962116|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64888660|NCT01962116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64888661|NCT01962181|Methylphenidate|methylphenidate|mesh-list
64888662|NCT01962181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64888663|NCT01962181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888664|NCT01962181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64888665|NCT01962181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64888697|NCT01962376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888698|NCT01962454|Methyltestosterone|methyltestosterone|mesh-list
64888699|NCT01962454|Testosterone|testosterone|mesh-list
64888700|NCT01962454|Testosterone undecanoate|testosterone undecanoate|mesh-list
64888701|NCT01962454|Testosterone enanthate|testosterone enanthate|mesh-list
64888702|NCT01962454|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64888703|NCT01962454|Androgens|androgens|mesh-ancestor
64888704|NCT01962454|Hormones|hormones|mesh-ancestor
64888706|NCT01962454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888707|NCT01962454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64888708|NCT01962454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888709|NCT01962454|Anabolic Agents|anabolic agents|mesh-ancestor
64557518|NCT03067974|Analgesics|analgesics|mesh-ancestor
64557519|NCT03067974|Sensory System Agents|sensory system agents|mesh-ancestor
64557520|NCT03067974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64557521|NCT03067974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557522|NCT03067974|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64519680|NCT03204474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64519681|NCT03204474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64639726|NCT01192139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64532799|NCT01570387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64532800|NCT01570387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64532801|NCT01570387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532802|NCT01570387|Protease Inhibitors|protease inhibitors|mesh-ancestor
64532803|NCT01570387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532804|NCT01570387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532805|NCT01570387|Immunologic Factors|immunologic factors|mesh-ancestor
64532806|NCT01570387|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64459268|NCT01682031|Antioxidants|antioxidants|mesh-ancestor
64459269|NCT01682031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459270|NCT01682031|Protective Agents|protective agents|mesh-ancestor
64459271|NCT01682031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459272|NCT01682031|Trace Elements|trace elements|mesh-ancestor
64459273|NCT01682031|Micronutrients|micronutrients|mesh-ancestor
64459274|NCT03020134|Ritonavir|ritonavir|mesh-list
64459275|NCT03020134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64459276|NCT03020134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64459277|NCT03020134|Protease Inhibitors|protease inhibitors|mesh-ancestor
64459278|NCT03020134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64459279|NCT03020134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459280|NCT03020134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64459281|NCT03020134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64459282|NCT03020134|Antiviral Agents|antiviral agents|mesh-ancestor
64459283|NCT03020134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64459284|NCT03020134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64459285|NCT03020134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64459286|NCT03020056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64459287|NCT03020056|Antioxidants|antioxidants|mesh-list
64459288|NCT03020056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64459322|NCT03584074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64459323|NCT03584074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64459324|NCT03584074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64459325|NCT03584074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519682|NCT03204474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64519683|NCT03204474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519684|NCT03204318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64519685|NCT03204318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64557523|NCT03067974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64557524|NCT03067974|Anesthetics, General|anesthetics, general|mesh-ancestor
64557525|NCT03067974|Anesthetics|anesthetics|mesh-ancestor
64557526|NCT03067974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64557527|NCT03067974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64557528|NCT03067974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64557529|NCT03067974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64557551|NCT03582137|Cannabidiol|cannabidiol|mesh-list
64557552|NCT03582137|Anticonvulsants|anticonvulsants|mesh-ancestor
64557553|NCT04405193|Acetylcysteine|acetylcysteine|mesh-list
64459358|NCT01567527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64459359|NCT01567527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64459360|NCT01567527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64459361|NCT03159988|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
64459362|NCT03159988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64459363|NCT03159988|Vasodilator Agents|vasodilator agents|mesh-ancestor
64459364|NCT05701540|Esomeprazole|esomeprazole|mesh-list
64652657|NCT01569815|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64652660|NCT01469585|Doxycycline|doxycycline|mesh-list
64532818|NCT01570309|Micronutrients|micronutrients|mesh-ancestor
64297377|NCT03451370|Bevacizumab|bevacizumab|mesh-list
64297378|NCT03451370|Capecitabine|capecitabine|mesh-list
64297379|NCT03451370|Oxaliplatin|oxaliplatin|mesh-list
64459366|NCT05701540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64459367|NCT05701540|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64459368|NCT05701540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64459369|NCT05701540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459370|NCT03159598|Urethane|urethane|mesh-list
64459396|NCT03582280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459397|NCT03582280|Antacids|antacids|mesh-ancestor
64459398|NCT03582280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459399|NCT03582280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64459400|NCT03159754|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64459401|NCT03159754|Metronidazole|metronidazole|mesh-list
64459402|NCT03159754|Ciprofloxacin|ciprofloxacin|mesh-list
64459403|NCT03159754|Tazobactam|tazobactam|mesh-list
64459404|NCT03159754|Piperacillin|piperacillin|mesh-list
64459405|NCT03159754|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64459406|NCT03159754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64459407|NCT03159754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64459408|NCT03159754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64459409|NCT03159754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64459410|NCT03159754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64459411|NCT03159754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64459412|NCT03159754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459413|NCT03159754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459414|NCT03159754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64459415|NCT03159754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64459416|NCT03159754|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64459417|NCT05701384|Lazertinib|lazertinib|mesh-list
64459418|NCT05701384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64459419|NCT05701384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64459420|NCT05701384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459441|NCT03158584|Analgesics|analgesics|mesh-ancestor
64459442|NCT03158584|Sensory System Agents|sensory system agents|mesh-ancestor
64459443|NCT03158584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459444|NCT04765228|Doxorubicin|doxorubicin|mesh-list
64557554|NCT04405193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64639843|NCT00352976|Mycophenolic Acid|mycophenolic acid|mesh-list
64888714|NCT01962831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64888715|NCT01962831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888716|NCT01963039|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
64888717|NCT01963039|Vasodilator Agents|vasodilator agents|mesh-ancestor
64888718|NCT01963039|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64888719|NCT01963039|Protective Agents|protective agents|mesh-ancestor
64888720|NCT01963039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888722|NCT01963182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64888723|NCT01963182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64888724|NCT01963182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64888725|NCT01963182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888726|NCT01963182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888727|NCT01963221|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64888728|NCT01963221|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64888729|NCT01963221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888730|NCT01963299|Clonidine|clonidine|mesh-list
64888731|NCT01963299|Ropivacaine|ropivacaine|mesh-list
64888732|NCT01963299|Anesthetics, Local|anesthetics, local|mesh-ancestor
64888733|NCT01963299|Anesthetics|anesthetics|mesh-ancestor
64888734|NCT01963299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64888735|NCT01963299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888736|NCT01963299|Sensory System Agents|sensory system agents|mesh-ancestor
64459445|NCT04765228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64459446|NCT04765228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64459447|NCT04765228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459448|NCT04765228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64459449|NCT04765228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64459450|NCT04765228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64459451|NCT04765228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459452|NCT05696626|Fulvestrant|fulvestrant|mesh-list
64459453|NCT05696626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64459454|NCT05696626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459455|NCT05696626|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64459456|NCT05696626|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64532819|NCT01570309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64532820|NCT02356146|Tacrolimus|tacrolimus|mesh-list
64532829|NCT01519921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64532830|NCT01519765|Misoprostol|misoprostol|mesh-list
64532831|NCT01519765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64532832|NCT01519765|Abortifacient Agents|abortifacient agents|mesh-ancestor
64297389|NCT03451370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459457|NCT05696626|Hormone Antagonists|hormone antagonists|mesh-ancestor
64459458|NCT05696626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64459459|NCT05696626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459460|NCT01818596|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64459461|NCT01818596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64888737|NCT01963299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64888738|NCT01963299|Analgesics|analgesics|mesh-ancestor
64888739|NCT01963299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64888740|NCT01963299|Sympatholytics|sympatholytics|mesh-ancestor
64888741|NCT01963299|Autonomic Agents|autonomic agents|mesh-ancestor
64888742|NCT01963299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64888743|NCT01963299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64459462|NCT01818596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64459463|NCT01818596|Antiviral Agents|antiviral agents|mesh-ancestor
64459464|NCT01818596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64459465|NCT04140448|Ranibizumab|ranibizumab|mesh-list
64459466|NCT04140448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64459467|NCT04140448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64459468|NCT04140448|Growth Substances|growth substances|mesh-ancestor
64459469|NCT04140448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459503|NCT04140058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64459504|NCT04140058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64459505|NCT04140058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64459506|NCT04146298|Cyclophosphamide|cyclophosphamide|mesh-list
64459507|NCT04146298|Fludarabine|fludarabine|mesh-list
64459508|NCT04146298|Antibodies|antibodies|mesh-list
64459509|NCT04146298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64459510|NCT04146298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64459511|NCT04146298|Immunologic Factors|immunologic factors|mesh-ancestor
64459512|NCT04146298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459535|NCT04551196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459536|NCT04551196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459538|NCT04551196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64459539|NCT04551196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64459540|NCT04551196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64459541|NCT04551196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64459542|NCT04551196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64459543|NCT04551196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459544|NCT01923298|Estradiol|estradiol|mesh-list
64459545|NCT01923298|Estrogens|estrogens|mesh-ancestor
64459546|NCT01923298|Hormones|hormones|mesh-ancestor
64459547|NCT01923298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64459548|NCT01923298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459549|NCT04417192|Pembrolizumab|pembrolizumab|mesh-list
64459550|NCT04417192|Olaparib|olaparib|mesh-list
64459551|NCT04417192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64459552|NCT04417192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459553|NCT04417192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64459554|NCT04417192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532833|NCT01519765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64532834|NCT01519765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532835|NCT01519765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64532836|NCT01519765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64532837|NCT01519765|Oxytocics|oxytocics|mesh-ancestor
64532838|NCT03147066|Flurbiprofen|flurbiprofen|mesh-list
64532839|NCT03147066|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
64459555|NCT04417192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459556|NCT05212246|Imiquimod|imiquimod|mesh-list
64459557|NCT05212246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64513630|NCT01457469|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64459595|NCT01671904|Venetoclax|venetoclax|mesh-list
64459596|NCT01671904|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64459597|NCT01671904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64459598|NCT01671904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459599|NCT01671904|Immunologic Factors|immunologic factors|mesh-ancestor
64459600|NCT01671904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459601|NCT01671904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64459602|NCT01671904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64459603|NCT01671904|Alkylating Agents|alkylating agents|mesh-ancestor
64459604|NCT01671904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459605|NCT01671982|Tenofovir|tenofovir|mesh-list
64459606|NCT01671982|Antiviral Agents|antiviral agents|mesh-ancestor
64459629|NCT04027894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64888753|NCT01963325|Antimitotic Agents|antimitotic agents|mesh-ancestor
64888754|NCT01963325|Mitosis Modulators|mitosis modulators|mesh-ancestor
64888755|NCT01963325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888756|NCT01963390|Testosterone|testosterone|mesh-list
64888757|NCT01963390|Androgens|androgens|mesh-ancestor
64888758|NCT01963390|Hormones|hormones|mesh-ancestor
64888759|NCT01963390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64888760|NCT01963390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888761|NCT01963416|Micronutrients|micronutrients|mesh-list
64888762|NCT01963416|Trace Elements|trace elements|mesh-list
64888763|NCT01963416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888764|NCT01963442|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64888765|NCT01963442|Lactams|lactams|mesh-list
64888766|NCT01963442|beta-Lactams|beta-lactams|mesh-list
64888767|NCT01963442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64888768|NCT01963442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64459630|NCT04027894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64459631|NCT02564068|Oxytocin|oxytocin|mesh-list
64459632|NCT02564068|Oxytocics|oxytocics|mesh-ancestor
64459633|NCT02564068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64459634|NCT02564068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459635|NCT03154528|Vitamin D|vitamin d|mesh-list
64459636|NCT03154528|Vitamins|vitamins|mesh-ancestor
64459637|NCT03154528|Micronutrients|micronutrients|mesh-ancestor
64459638|NCT03154528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459639|NCT03154528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64459640|NCT03154372|Metronidazole|metronidazole|mesh-list
64459641|NCT03154372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64459642|NCT03154372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64459643|NCT03154372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64459644|NCT03154372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64459645|NCT01676506|Ranibizumab|ranibizumab|mesh-list
64459646|NCT01676506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64459647|NCT01676506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64459648|NCT01676506|Growth Substances|growth substances|mesh-ancestor
64459649|NCT01676506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459650|NCT01676506|Growth Inhibitors|growth inhibitors|mesh-ancestor
64459651|NCT01676506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459652|NCT03154294|Paclitaxel|paclitaxel|mesh-list
64459653|NCT03154294|Serabelisib|serabelisib|mesh-list
64459654|NCT03154294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64459655|NCT03154294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459656|NCT03154294|Tubulin Modulators|tubulin modulators|mesh-ancestor
64459657|NCT03154294|Antimitotic Agents|antimitotic agents|mesh-ancestor
64459658|NCT03154294|Mitosis Modulators|mitosis modulators|mesh-ancestor
64459659|NCT03154294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459684|NCT01672450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459685|NCT01854268|Capsaicin|capsaicin|mesh-list
64459686|NCT01854268|Antipruritics|antipruritics|mesh-ancestor
64459687|NCT01854268|Dermatologic Agents|dermatologic agents|mesh-ancestor
64459688|NCT01854268|Sensory System Agents|sensory system agents|mesh-ancestor
64459689|NCT01854268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459690|NCT01854268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459691|NCT01672606|Rocuronium|rocuronium|mesh-list
64532840|NCT03147066|Dezocine|dezocine|mesh-list
64532841|NCT03147066|Analgesics|analgesics|mesh-ancestor
64532842|NCT03147066|Sensory System Agents|sensory system agents|mesh-ancestor
64532843|NCT03147066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64532844|NCT03147066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532845|NCT03147066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64532846|NCT03147066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64888769|NCT01963442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64888770|NCT01963442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64888771|NCT01963442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888772|NCT01963546|Dexmedetomidine|dexmedetomidine|mesh-list
64519686|NCT03204318|Norethindrone|norethindrone|mesh-list
64519687|NCT03204318|Norethindrone Acetate|norethindrone acetate|mesh-list
64519688|NCT03204318|Estradiol|estradiol|mesh-list
64519689|NCT03204318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64519690|NCT03204318|Relugolix|relugolix|mesh-list
64519691|NCT03204318|Estrogens|estrogens|mesh-ancestor
64519692|NCT03204318|Hormones|hormones|mesh-ancestor
64519693|NCT03204318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64519694|NCT03204318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519695|NCT03204318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64519696|NCT03204318|Contraceptive Agents|contraceptive agents|mesh-ancestor
64519697|NCT03204318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64519698|NCT03204318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64519699|NCT03204318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64519700|NCT03204318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64519701|NCT03204318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64519702|NCT03204318|Androgen Antagonists|androgen antagonists|mesh-ancestor
64888773|NCT01963546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64888774|NCT01963546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888775|NCT01963546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64888776|NCT01963546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64888777|NCT01963546|Analgesics|analgesics|mesh-ancestor
64888778|NCT01963546|Sensory System Agents|sensory system agents|mesh-ancestor
64888779|NCT01963546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64888780|NCT01963546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64888781|NCT01963546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64888782|NCT01963546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64888783|NCT01963546|Adrenergic Agents|adrenergic agents|mesh-ancestor
64888784|NCT01963546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888785|NCT01963546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888786|NCT01963559|Lidocaine|lidocaine|mesh-list
64888787|NCT01963559|Prilocaine|prilocaine|mesh-list
64640030|NCT00316862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532847|NCT03147066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64888788|NCT01963559|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64888789|NCT01963559|Anesthetics, Local|anesthetics, local|mesh-ancestor
64888790|NCT01963559|Anesthetics|anesthetics|mesh-ancestor
64640071|NCT00980460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532848|NCT03147066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64532849|NCT03147066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64532850|NCT03147066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652685|NCT02497404|Alemtuzumab|alemtuzumab|mesh-list
64297415|NCT05060198|Lumefantrine|lumefantrine|mesh-list
64459692|NCT01672606|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64459693|NCT01672606|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64459694|NCT01672606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64459695|NCT01672606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459696|NCT01672606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459697|NCT01594281|Ranibizumab|ranibizumab|mesh-list
64459698|NCT01594281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64459699|NCT01594281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64459700|NCT01594281|Growth Substances|growth substances|mesh-ancestor
64459701|NCT01594281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459702|NCT01594281|Growth Inhibitors|growth inhibitors|mesh-ancestor
64459703|NCT01594281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459704|NCT04964050|Captopril, hydrochlorothiazide drug combination|captopril, hydrochlorothiazide drug combination|mesh-list
64459705|NCT04964050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64459706|NCT04964050|Protease Inhibitors|protease inhibitors|mesh-ancestor
64459707|NCT04964050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64459708|NCT04964050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459720|NCT02386774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64459721|NCT02386774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459722|NCT02386774|Sensory System Agents|sensory system agents|mesh-ancestor
64459723|NCT02386774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459725|NCT03526900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459726|NCT03420742|Midazolam|midazolam|mesh-list
64459727|NCT03420742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64459728|NCT03420742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64459729|NCT03420742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64459730|NCT03420742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459731|NCT03420742|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64459732|NCT03420742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64459733|NCT03420742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64459734|NCT03420742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64459735|NCT03420742|Anesthetics, General|anesthetics, general|mesh-ancestor
64459736|NCT03420742|Anesthetics|anesthetics|mesh-ancestor
64459737|NCT03420742|GABA Modulators|gaba modulators|mesh-ancestor
64459738|NCT03420742|GABA Agents|gaba agents|mesh-ancestor
64459739|NCT03420742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64532853|NCT03147066|Narcotics|narcotics|mesh-ancestor
64532854|NCT03147066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64532855|NCT02351622|Dexamethasone|dexamethasone|mesh-list
64532856|NCT02351622|Caffeic acid|caffeic acid|mesh-list
64532857|NCT02351622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64532858|NCT02351622|Antiemetics|antiemetics|mesh-ancestor
64532859|NCT02351622|Autonomic Agents|autonomic agents|mesh-ancestor
64532860|NCT02351622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64532861|NCT02351622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532862|NCT02351622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64532863|NCT02351622|Glucocorticoids|glucocorticoids|mesh-ancestor
64532864|NCT02351622|Hormones|hormones|mesh-ancestor
64532865|NCT02351622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64532866|NCT02351622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64532867|NCT02351622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459740|NCT03420742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459741|NCT01818284|Plerixafor|plerixafor|mesh-list
64459742|NCT01818284|Lenograstim|lenograstim|mesh-list
64459743|NCT01818284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64459744|NCT01818284|Immunologic Factors|immunologic factors|mesh-ancestor
64459745|NCT01818284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459746|NCT01818284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64459747|NCT01818284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64459748|NCT01818284|Antiviral Agents|antiviral agents|mesh-ancestor
64459749|NCT01818284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64459752|NCT02081014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64888791|NCT01963559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64888792|NCT01963559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888793|NCT01963559|Sensory System Agents|sensory system agents|mesh-ancestor
64888794|NCT01963559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64888795|NCT01963559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64888796|NCT01963559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64888797|NCT01963559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64888798|NCT01963559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64888799|NCT01963559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888800|NCT01963559|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64888801|NCT01963663|Metformin|metformin|mesh-list
64888802|NCT01963663|Pioglitazone|pioglitazone|mesh-list
64888803|NCT01963663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64888804|NCT01963663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888805|NCT01963702|Capecitabine|capecitabine|mesh-list
64888806|NCT01963702|Oxaliplatin|oxaliplatin|mesh-list
64888807|NCT01963702|Docetaxel|docetaxel|mesh-list
64640145|NCT05334654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64459754|NCT02081014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64459755|NCT02081014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459756|NCT02081014|Incretins|incretins|mesh-ancestor
64459757|NCT05418010|Natalizumab|natalizumab|mesh-list
64459758|NCT05418010|Immunologic Factors|immunologic factors|mesh-ancestor
64459759|NCT05418010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459760|NCT03025594|Ketorolac|ketorolac|mesh-list
64459761|NCT03025594|Epinephrine|epinephrine|mesh-list
64945376|NCT05672225|Dexmedetomidine|dexmedetomidine|mesh-list
64459762|NCT03025594|Levobupivacaine|levobupivacaine|mesh-list
64459763|NCT03025594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64459764|NCT03025594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64459765|NCT03025594|Adrenergic Agents|adrenergic agents|mesh-ancestor
64459766|NCT03025594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64459767|NCT03025594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459768|NCT03025594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459769|NCT03025594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64459770|NCT03025594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64459771|NCT03025594|Autonomic Agents|autonomic agents|mesh-ancestor
64459785|NCT03025594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64459786|NCT03025594|Anesthetics, Local|anesthetics, local|mesh-ancestor
64459787|NCT03025594|Anesthetics|anesthetics|mesh-ancestor
64459788|NCT03025594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64459789|NCT04404946|Phenylephrine|phenylephrine|mesh-list
64459790|NCT04404946|Oxymetazoline|oxymetazoline|mesh-list
64459791|NCT04404946|Norepinephrine|norepinephrine|mesh-list
64459792|NCT04404946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64459793|NCT04404946|Mydriatics|mydriatics|mesh-ancestor
64459794|NCT04404946|Autonomic Agents|autonomic agents|mesh-ancestor
64459795|NCT04404946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459796|NCT04404946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532868|NCT02351622|Antioxidants|antioxidants|mesh-ancestor
64532869|NCT02351622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532870|NCT02351622|Protective Agents|protective agents|mesh-ancestor
64532871|NCT01552603|Pancrelipase|pancrelipase|mesh-list
64532872|NCT01552603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64532873|NCT02348190|Heparin|heparin|mesh-list
64532874|NCT02348190|Anticoagulants|anticoagulants|mesh-ancestor
64532875|NCT02348190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64532876|NCT02348190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64888808|NCT01963702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64888831|NCT01963754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888832|NCT01963754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888833|NCT01963754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64888834|NCT01963754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64519703|NCT03204318|Hormone Antagonists|hormone antagonists|mesh-ancestor
64519704|NCT03204006|Dexmedetomidine|dexmedetomidine|mesh-list
64519705|NCT03204006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64519706|NCT03204006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64519707|NCT03204006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519708|NCT03204006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64519709|NCT03204006|Analgesics|analgesics|mesh-ancestor
64519710|NCT03204006|Sensory System Agents|sensory system agents|mesh-ancestor
64519711|NCT03204006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64519712|NCT03204006|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64519713|NCT03204006|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64519714|NCT03204006|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64519715|NCT03204006|Adrenergic Agents|adrenergic agents|mesh-ancestor
64519716|NCT03204006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64519717|NCT03204006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519718|NCT03226080|Rocuronium|rocuronium|mesh-list
64519719|NCT03226080|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64519720|NCT03226080|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64519721|NCT03226080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64519722|NCT03226080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64519723|NCT03226080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888835|NCT01963754|Autonomic Agents|autonomic agents|mesh-ancestor
64888836|NCT01963754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64888837|NCT01963754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64888838|NCT01963754|Respiratory System Agents|respiratory system agents|mesh-ancestor
64888839|NCT01963754|Mydriatics|mydriatics|mesh-ancestor
64640213|NCT05366868|Metformin|metformin|mesh-list
64532877|NCT02348190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532878|NCT01552369|Valganciclovir|valganciclovir|mesh-list
64532879|NCT01552369|Antiviral Agents|antiviral agents|mesh-ancestor
64532880|NCT01552369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64532881|NCT02351232|Liraglutide|liraglutide|mesh-list
64532882|NCT02351232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64532883|NCT02351232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532884|NCT02351232|Incretins|incretins|mesh-ancestor
64888840|NCT01963754|Sympathomimetics|sympathomimetics|mesh-ancestor
64888841|NCT01963754|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64888842|NCT01963754|Anesthetics, Local|anesthetics, local|mesh-ancestor
64888843|NCT01963754|Sensory System Agents|sensory system agents|mesh-ancestor
64888844|NCT01963832|Fluoxetine|fluoxetine|mesh-list
64888845|NCT01963832|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64888846|NCT01963832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64888847|NCT01963832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64888848|NCT01963832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888849|NCT01963832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888850|NCT01963832|Serotonin Agents|serotonin agents|mesh-ancestor
64532885|NCT02351232|Hormones|hormones|mesh-ancestor
64532886|NCT02351232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64532887|NCT02355756|Maxadilan protein, insect|maxadilan protein, insect|mesh-list
64297440|NCT02464761|Dermatologic Agents|dermatologic agents|mesh-ancestor
64459797|NCT04404946|Sympathomimetics|sympathomimetics|mesh-ancestor
64459798|NCT04404946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64459799|NCT04404946|Nasal Decongestants|nasal decongestants|mesh-ancestor
64459800|NCT04404946|Respiratory System Agents|respiratory system agents|mesh-ancestor
64459801|NCT04404946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64459802|NCT04404946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64459803|NCT04404946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64459804|NCT04404946|Adrenergic Agents|adrenergic agents|mesh-ancestor
64459805|NCT04404946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64459806|NCT04404946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459807|NCT04404946|Protective Agents|protective agents|mesh-ancestor
64459809|NCT01673542|Prilocaine|prilocaine|mesh-list
64459810|NCT01673542|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64459811|NCT01673542|Anesthetics, Local|anesthetics, local|mesh-ancestor
64459812|NCT01673542|Anesthetics|anesthetics|mesh-ancestor
64459813|NCT01673542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64652695|NCT02497404|Alkylating Agents|alkylating agents|mesh-ancestor
64459814|NCT01673542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459815|NCT01673542|Sensory System Agents|sensory system agents|mesh-ancestor
64459833|NCT02738866|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64459834|NCT02738866|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64459835|NCT02738866|Hormone Antagonists|hormone antagonists|mesh-ancestor
64459836|NCT02738866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64459837|NCT02738866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459838|NCT02738866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64532888|NCT02355756|Vasodilator Agents|vasodilator agents|mesh-ancestor
64532889|NCT03150030|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64532890|NCT03150030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532891|NCT02355678|Acetaminophen|acetaminophen|mesh-list
64532892|NCT02355678|Dexamethasone|dexamethasone|mesh-list
64532893|NCT02355678|Propacetamol|propacetamol|mesh-list
64532894|NCT02355678|Tramadol|tramadol|mesh-list
64532895|NCT02355678|Anesthetics|anesthetics|mesh-list
64532896|NCT02355678|Anesthetics, Local|anesthetics, local|mesh-list
64297462|NCT02462499|Diuretics|diuretics|mesh-ancestor
64459840|NCT02738866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459841|NCT04587128|Irinotecan|irinotecan|mesh-list
64459842|NCT04587128|Cetuximab|cetuximab|mesh-list
64459843|NCT04587128|Panitumumab|panitumumab|mesh-list
64459844|NCT04587128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64459845|NCT04587128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64459846|NCT04587128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64459847|NCT04587128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459848|NCT04587128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459849|NCT04587128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64459850|NCT01817582|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64459851|NCT01817582|Cyclosporine|cyclosporine|mesh-list
64459852|NCT01817582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64459853|NCT01817582|Lubricant Eye Drops|lubricant eye drops|mesh-list
64888851|NCT01963832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888852|NCT01963832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64888853|NCT01963832|Antidepressive Agents|antidepressive agents|mesh-ancestor
64888854|NCT01963832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64888855|NCT01963832|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64888856|NCT01963832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64888857|NCT01963832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64888858|NCT01963910|Mannitol|mannitol|mesh-list
64888859|NCT01963910|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64888860|NCT01963910|Diuretics|diuretics|mesh-ancestor
64888861|NCT01963910|Natriuretic Agents|natriuretic agents|mesh-ancestor
64888882|NCT01964001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888883|NCT01964027|Irinotecan|irinotecan|mesh-list
64519725|NCT03225924|Cyclophosphamide|cyclophosphamide|mesh-list
64519726|NCT03225924|Rituximab|rituximab|mesh-list
64519727|NCT03225924|Doxorubicin|doxorubicin|mesh-list
64519728|NCT03225924|Vincristine|vincristine|mesh-list
64519729|NCT03225924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64640309|NCT00392678|Analgesics|analgesics|mesh-ancestor
64459854|NCT01817582|Cyclosporins|cyclosporins|mesh-list
64459855|NCT01817582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64459856|NCT01817582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459857|NCT01817582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64459858|NCT01817582|Immunologic Factors|immunologic factors|mesh-ancestor
64459859|NCT01817582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459860|NCT01817582|Antifungal Agents|antifungal agents|mesh-ancestor
64459861|NCT01817582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64459862|NCT01817582|Dermatologic Agents|dermatologic agents|mesh-ancestor
64459863|NCT01817582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64459864|NCT01817582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64459865|NCT01817582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64459866|NCT01817582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64459867|NCT01594125|Nintedanib|nintedanib|mesh-list
64459868|NCT01594125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459869|NCT01594125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64459870|NCT01594125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64459871|NCT01594125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459872|NCT01592409|Dronabinol|dronabinol|mesh-list
64459873|NCT01592409|Hallucinogens|hallucinogens|mesh-ancestor
64459874|NCT01592409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459875|NCT01592409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64459876|NCT01592409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64459877|NCT01592409|Analgesics|analgesics|mesh-ancestor
64459878|NCT01592409|Sensory System Agents|sensory system agents|mesh-ancestor
64459879|NCT01592409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459880|NCT01592409|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64459881|NCT01592409|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64459882|NCT01592409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64459883|NCT01592409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459916|NCT04603508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64459917|NCT04603508|Antimetabolites|antimetabolites|mesh-ancestor
64459923|NCT04603508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64459924|NCT01674166|Prucalopride|prucalopride|mesh-list
64459925|NCT01674166|Laxatives|laxatives|mesh-ancestor
64459959|NCT01065532|Antimitotic Agents|antimitotic agents|mesh-ancestor
64459960|NCT01065532|Mitosis Modulators|mitosis modulators|mesh-ancestor
64532898|NCT02355678|Antiemetics|antiemetics|mesh-ancestor
64532899|NCT02355678|Autonomic Agents|autonomic agents|mesh-ancestor
64532900|NCT02355678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64519730|NCT03225924|Immunologic Factors|immunologic factors|mesh-ancestor
64519731|NCT03225924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519732|NCT03225924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64888884|NCT01964027|Epirubicin|epirubicin|mesh-list
64888885|NCT01964027|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64532901|NCT02355678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532902|NCT02355678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64532903|NCT02355678|Glucocorticoids|glucocorticoids|mesh-ancestor
64532904|NCT02355678|Hormones|hormones|mesh-ancestor
64532905|NCT02355678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64532906|NCT02355678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64532907|NCT02355678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532908|NCT02355678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64532909|NCT02355678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64532910|NCT02355678|Analgesics|analgesics|mesh-ancestor
64532911|NCT02355678|Sensory System Agents|sensory system agents|mesh-ancestor
64532912|NCT02355678|Antipyretics|antipyretics|mesh-ancestor
64532913|NCT02355678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64532914|NCT02355678|Narcotics|narcotics|mesh-ancestor
64532915|NCT02355678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64532916|NCT02355678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64532917|NCT02351310|Betamethasone|betamethasone|mesh-list
64532918|NCT02351310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64488997|NCT01745757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64459961|NCT01065532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459962|NCT01065532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64459963|NCT01065532|Immunologic Factors|immunologic factors|mesh-ancestor
64459980|NCT01674868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64459982|NCT01674868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64459983|NCT01674868|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64459984|NCT01674868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64459985|NCT01674868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64459986|NCT01674946|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
64459987|NCT01674946|Bile Acids and Salts|bile acids and salts|mesh-list
64459989|NCT01674946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64459990|NCT01675024|Rotigotine|rotigotine|mesh-list
64459991|NCT01675024|Dopamine Agonists|dopamine agonists|mesh-ancestor
64459992|NCT01675024|Dopamine Agents|dopamine agents|mesh-ancestor
64459993|NCT01675024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64459994|NCT01675024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459995|NCT01675024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459996|NCT03883828|Chlorhexidine|chlorhexidine|mesh-list
64459997|NCT03883828|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64459998|NCT03883828|Mupirocin|mupirocin|mesh-list
64459999|NCT03883828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64460000|NCT03883828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64460001|NCT03883828|Disinfectants|disinfectants|mesh-ancestor
64460002|NCT03883828|Dermatologic Agents|dermatologic agents|mesh-ancestor
64460003|NCT03883828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64460004|NCT03883828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64460005|NCT03883828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460006|NCT03883828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532920|NCT02351310|Hormones|hormones|mesh-ancestor
64532921|NCT02351310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64532922|NCT02351310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532923|NCT02351310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64532924|NCT02351310|Respiratory System Agents|respiratory system agents|mesh-ancestor
64532925|NCT02347878|Aprepitant|aprepitant|mesh-list
64532926|NCT02347878|Antiemetics|antiemetics|mesh-ancestor
64532927|NCT02347878|Autonomic Agents|autonomic agents|mesh-ancestor
64652703|NCT04205994|Tolcapone|tolcapone|mesh-list
64532934|NCT02355522|Lidocaine|lidocaine|mesh-list
64460007|NCT02081950|Enoxaparin|enoxaparin|mesh-list
64460008|NCT02081950|Enoxaparin sodium|enoxaparin sodium|mesh-list
64460009|NCT02081950|Anticoagulants|anticoagulants|mesh-ancestor
64460010|NCT02081950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64460011|NCT02081950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64460012|NCT02081950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460013|NCT01675648|Lofexidine|lofexidine|mesh-list
64460014|NCT01675648|Clonidine|clonidine|mesh-list
64460015|NCT01675648|Diazepam|diazepam|mesh-list
64460016|NCT01675648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64888886|NCT01964027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64888887|NCT01964027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64888888|NCT01964027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888889|NCT01964027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888890|NCT01964027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64888891|NCT01964027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64888892|NCT01964040|Dexmedetomidine|dexmedetomidine|mesh-list
64888893|NCT01964040|Bupivacaine|bupivacaine|mesh-list
64888894|NCT01964040|Anesthetics, Local|anesthetics, local|mesh-ancestor
64888895|NCT01964040|Anesthetics|anesthetics|mesh-ancestor
64888896|NCT01964040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64888897|NCT01964040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888898|NCT01964040|Sensory System Agents|sensory system agents|mesh-ancestor
64888899|NCT01964040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64888900|NCT01964040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64640439|NCT02277782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640443|NCT02277782|Narcotics|narcotics|mesh-ancestor
64460017|NCT01675648|Anticonvulsants|anticonvulsants|mesh-ancestor
64460018|NCT01675648|Antiemetics|antiemetics|mesh-ancestor
64460019|NCT01675648|Autonomic Agents|autonomic agents|mesh-ancestor
64460020|NCT01675648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64460048|NCT03871348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460050|NCT01566435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64460051|NCT01566435|Fluorouracil|fluorouracil|mesh-list
64460052|NCT01566435|Cetuximab|cetuximab|mesh-list
64460053|NCT01566435|Antibodies|antibodies|mesh-list
64460054|NCT01566435|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64460055|NCT01566435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64460056|NCT01566435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460057|NCT01566435|Tubulin Modulators|tubulin modulators|mesh-ancestor
64460058|NCT01566435|Antimitotic Agents|antimitotic agents|mesh-ancestor
64460059|NCT01566435|Mitosis Modulators|mitosis modulators|mesh-ancestor
64460060|NCT01566435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460061|NCT01566435|Immunologic Factors|immunologic factors|mesh-ancestor
64460062|NCT01566435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460063|NCT01566435|Antimetabolites|antimetabolites|mesh-ancestor
64460064|NCT01566435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64460065|NCT01566435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64460066|NCT01566435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64460068|NCT01675804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64460089|NCT04768023|Micronutrients|micronutrients|mesh-ancestor
64460090|NCT04768023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460091|NCT04768023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64460092|NCT03861988|Ketamine|ketamine|mesh-list
64460093|NCT03861988|Analgesics|analgesics|mesh-ancestor
64460094|NCT03861988|Sensory System Agents|sensory system agents|mesh-ancestor
64460095|NCT03861988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64460096|NCT03861988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460097|NCT03861988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64532935|NCT02355522|Anesthetics, Local|anesthetics, local|mesh-ancestor
64532936|NCT02355522|Anesthetics|anesthetics|mesh-ancestor
64532937|NCT02355522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64532938|NCT02355522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532939|NCT02355522|Sensory System Agents|sensory system agents|mesh-ancestor
64532940|NCT02355522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64532941|NCT02355522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64532942|NCT02355522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64888901|NCT01964040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64888902|NCT01964040|Analgesics|analgesics|mesh-ancestor
64888903|NCT01964040|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64640498|NCT00396266|Plerixafor|plerixafor|mesh-list
64532943|NCT02355522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64532944|NCT02355522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64532945|NCT02355522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532946|NCT02355054|Choline|choline|mesh-list
64532947|NCT02355054|Lipotropic Agents|lipotropic agents|mesh-ancestor
64532948|NCT02355054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64297505|NCT05059418|GABA Modulators|gaba modulators|mesh-ancestor
64297506|NCT05059418|GABA Agents|gaba agents|mesh-ancestor
64460098|NCT03861988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64460099|NCT03861988|Anesthetics, General|anesthetics, general|mesh-ancestor
64460100|NCT03861988|Anesthetics|anesthetics|mesh-ancestor
64652707|NCT04205994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460108|NCT03755440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460109|NCT03749902|Misoprostol|misoprostol|mesh-list
64460110|NCT03749902|Oxytocin|oxytocin|mesh-list
64460111|NCT03749902|Oxytocics|oxytocics|mesh-ancestor
64460112|NCT03749902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64460113|NCT03749902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460114|NCT03749902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64460115|NCT03749902|Abortifacient Agents|abortifacient agents|mesh-ancestor
64513631|NCT01457469|Autonomic Agents|autonomic agents|mesh-ancestor
64460116|NCT03749902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64460117|NCT03749902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64460118|NCT01565889|Ritonavir|ritonavir|mesh-list
64460119|NCT01565889|Ribavirin|ribavirin|mesh-list
64460120|NCT01565889|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64460121|NCT01565889|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64460146|NCT01591863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64460147|NCT01591785|Retapamulin|retapamulin|mesh-list
64460148|NCT01591785|Petrolatum|petrolatum|mesh-list
64460149|NCT01591785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64460150|NCT01591785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64460151|NCT01591785|Emollients|emollients|mesh-ancestor
64460152|NCT01591785|Dermatologic Agents|dermatologic agents|mesh-ancestor
64460153|NCT03660046|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64460154|NCT03660046|Levonorgestrel|levonorgestrel|mesh-list
64460155|NCT03660046|Medroxyprogesterone|medroxyprogesterone|mesh-list
64460156|NCT03660046|Etonogestrel|etonogestrel|mesh-list
64460157|NCT03660046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64460158|NCT03660046|Contraceptive Agents|contraceptive agents|mesh-ancestor
64460159|NCT03660046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64460160|NCT03660046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460161|NCT03660046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64460162|NCT03660046|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64460163|NCT03660046|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64532949|NCT02355054|Antimetabolites|antimetabolites|mesh-ancestor
64532950|NCT02355054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532951|NCT02355054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64532952|NCT02355054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64532953|NCT02355054|Nootropic Agents|nootropic agents|mesh-ancestor
64532955|NCT04478448|Antiviral Agents|antiviral agents|mesh-ancestor
64460164|NCT03660046|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64460165|NCT03660046|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64460166|NCT03660046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64460167|NCT03660046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460168|NCT03654040|Cyclophosphamide|cyclophosphamide|mesh-list
64460169|NCT03654040|Everolimus|everolimus|mesh-list
64460170|NCT03654040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64460171|NCT03654040|Immunologic Factors|immunologic factors|mesh-ancestor
64460172|NCT03654040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460173|NCT03654040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64460194|NCT01695135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64460195|NCT01695135|Glucocorticoids|glucocorticoids|mesh-ancestor
64460197|NCT01695135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64460199|NCT01695135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64460200|NCT01695135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460201|NCT01695135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64460202|NCT01695135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460203|NCT01695135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888904|NCT01964040|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64888905|NCT01964040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64888906|NCT01964040|Adrenergic Agents|adrenergic agents|mesh-ancestor
64888907|NCT01964040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888908|NCT01964040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888909|NCT01964079|Losartan|losartan|mesh-list
64460204|NCT01695135|Hormone Antagonists|hormone antagonists|mesh-ancestor
64460205|NCT01695135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64460206|NCT01590771|Metformin|metformin|mesh-list
64460207|NCT01590771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64460218|NCT01590771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460219|NCT01590771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64460220|NCT01590771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64460221|NCT01590771|Immunologic Factors|immunologic factors|mesh-ancestor
64460222|NCT04764058|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
64460223|NCT04764058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64460224|NCT04764058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64460225|NCT04764058|Protease Inhibitors|protease inhibitors|mesh-ancestor
64460226|NCT04764058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460227|NCT04764058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460258|NCT01693185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64460259|NCT01693185|Anesthetics, General|anesthetics, general|mesh-ancestor
64460261|NCT01693185|GABA Modulators|gaba modulators|mesh-ancestor
64460262|NCT01693185|GABA Agents|gaba agents|mesh-ancestor
64460263|NCT01693185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64460264|NCT01693185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460265|NCT01693185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64460266|NCT01693185|Narcotics|narcotics|mesh-ancestor
64460267|NCT01693185|Analgesics|analgesics|mesh-ancestor
64460268|NCT01693185|Sensory System Agents|sensory system agents|mesh-ancestor
64460269|NCT01693185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64460270|NCT03825796|Cytarabine|cytarabine|mesh-list
64460271|NCT03825796|Daunorubicin|daunorubicin|mesh-list
64460272|NCT03825796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64460273|NCT03825796|Antimetabolites|antimetabolites|mesh-ancestor
64460274|NCT03825796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460275|NCT03825796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532957|NCT04478526|Norepinephrine|norepinephrine|mesh-list
64532958|NCT04478526|Serotonin|serotonin|mesh-list
64532959|NCT04478526|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
64460304|NCT03630640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460305|NCT03630640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64460306|NCT03630640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460307|NCT03820726|Nintedanib|nintedanib|mesh-list
64460308|NCT03820726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460309|NCT03820726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64460310|NCT03820726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460311|NCT03820726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460312|NCT03625726|Thrombin|thrombin|mesh-list
64460313|NCT03625726|Hemostatics|hemostatics|mesh-ancestor
64460314|NCT03625726|Coagulants|coagulants|mesh-ancestor
64460315|NCT03814954|Epinephrine|epinephrine|mesh-list
64460316|NCT03814954|Albuterol|albuterol|mesh-list
64460317|NCT03814954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64460318|NCT03814954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64460319|NCT03814954|Adrenergic Agents|adrenergic agents|mesh-ancestor
64460320|NCT03814954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64460321|NCT03814954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460322|NCT03814954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460323|NCT03814954|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64460350|NCT03619252|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64460351|NCT03619252|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64460352|NCT03619252|Immunologic Factors|immunologic factors|mesh-ancestor
64460353|NCT03619252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460354|NCT03619252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64460355|NCT03807856|Dabigatran|dabigatran|mesh-list
64460356|NCT03807856|Antithrombins|antithrombins|mesh-ancestor
64460357|NCT03807856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64460363|NCT03806530|Ropinirole|ropinirole|mesh-list
64460364|NCT03806530|Analgesics|analgesics|mesh-ancestor
64888910|NCT01964079|Amlodipine|amlodipine|mesh-list
64888911|NCT01964079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64888912|NCT01964079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64640647|NCT00373334|Histamine Agents|histamine agents|mesh-ancestor
64460365|NCT03806530|Sensory System Agents|sensory system agents|mesh-ancestor
64460366|NCT03806530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64460367|NCT03806530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460369|NCT03806530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64460370|NCT03806530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64460371|NCT03806530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64460372|NCT03806530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64460373|NCT03806530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64460374|NCT03806530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64460395|NCT00003910|Cyclophosphamide|cyclophosphamide|mesh-list
64460396|NCT00003910|Methotrexate|methotrexate|mesh-list
64460397|NCT00003910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64460398|NCT00003910|Immunologic Factors|immunologic factors|mesh-ancestor
64460399|NCT00003910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460400|NCT00003910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64460401|NCT00003910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64460402|NCT00003910|Alkylating Agents|alkylating agents|mesh-ancestor
64460403|NCT00003910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460404|NCT00003910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460405|NCT00003910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64460406|NCT00003910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64460407|NCT00003910|Glucocorticoids|glucocorticoids|mesh-ancestor
64460408|NCT00003910|Hormones|hormones|mesh-ancestor
64460409|NCT00003910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64460410|NCT00003910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64460411|NCT00003910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64460412|NCT00003910|Abortifacient Agents|abortifacient agents|mesh-ancestor
64460413|NCT00003910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64460414|NCT00003910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64460415|NCT00003910|Antimetabolites|antimetabolites|mesh-ancestor
64460416|NCT00003910|Dermatologic Agents|dermatologic agents|mesh-ancestor
64460417|NCT00003910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460418|NCT00003910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64532960|NCT04478526|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
64532961|NCT04478526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64532962|NCT04478526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64532963|NCT04478526|Adrenergic Agents|adrenergic agents|mesh-ancestor
64532964|NCT04478526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64532965|NCT04478526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532966|NCT04478526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297536|NCT02063425|Fluoxetine|fluoxetine|mesh-list
64460419|NCT00003910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64460420|NCT01561989|Vitamin D|vitamin d|mesh-list
64460421|NCT01561989|Cholecalciferol|cholecalciferol|mesh-list
64460422|NCT01561989|Vaccines|vaccines|mesh-list
64460423|NCT01561989|Immunologic Factors|immunologic factors|mesh-ancestor
64460424|NCT01561989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460425|NCT01561989|Vitamins|vitamins|mesh-ancestor
64460426|NCT01561989|Micronutrients|micronutrients|mesh-ancestor
64460427|NCT01561989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64460428|NCT01561989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64460429|NCT00004054|Paclitaxel|paclitaxel|mesh-list
64460430|NCT00004054|Etoposide|etoposide|mesh-list
64460431|NCT00004054|Bicalutamide|bicalutamide|mesh-list
64460432|NCT00004054|Flutamide|flutamide|mesh-list
64460464|NCT03802240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64460465|NCT03802240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64460466|NCT03710122|Vancomycin|vancomycin|mesh-list
64460467|NCT03710122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64460468|NCT03710122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64460469|NCT01587651|Ticagrelor|ticagrelor|mesh-list
64460470|NCT01587651|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64460471|NCT01587651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64460506|NCT03606538|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
64460534|NCT00779116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64460535|NCT00779116|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64460536|NCT00779116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64888913|NCT01964079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64888914|NCT01964079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888915|NCT01964079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64888916|NCT01964079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888917|NCT01964079|Vasodilator Agents|vasodilator agents|mesh-ancestor
64888918|NCT01964079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64888919|NCT01964079|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64888928|NCT01964170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888929|NCT01964183|Mirabegron|mirabegron|mesh-list
64888930|NCT01964183|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64888931|NCT01964183|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64888932|NCT01964183|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64888933|NCT01964183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64888934|NCT01964183|Adrenergic Agents|adrenergic agents|mesh-ancestor
64888935|NCT01964183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888936|NCT01964183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460537|NCT00779116|Histamine Antagonists|histamine antagonists|mesh-ancestor
64460538|NCT00779116|Histamine Agents|histamine agents|mesh-ancestor
64460539|NCT00779116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64460540|NCT00779116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460541|NCT00779116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460542|NCT00779116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64460543|NCT00779116|Cholinergic Agents|cholinergic agents|mesh-ancestor
64460544|NCT01691781|Lisinopril|lisinopril|mesh-list
64460545|NCT01691781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64460546|NCT01691781|Protease Inhibitors|protease inhibitors|mesh-ancestor
64460547|NCT01691781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460548|NCT01691781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460549|NCT01691781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64460550|NCT01691781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64460551|NCT01691781|Protective Agents|protective agents|mesh-ancestor
64460552|NCT01691781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460553|NCT04112043|Niacinamide|niacinamide|mesh-list
64460554|NCT04112043|Niacin|niacin|mesh-list
64460555|NCT04112043|Nicotinic Acids|nicotinic acids|mesh-list
64460556|NCT04112043|Vitamin B Complex|vitamin b complex|mesh-ancestor
64460557|NCT04112043|Vitamins|vitamins|mesh-ancestor
64460558|NCT04112043|Micronutrients|micronutrients|mesh-ancestor
64532968|NCT04478526|Autonomic Agents|autonomic agents|mesh-ancestor
64532969|NCT04478526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64532970|NCT04478526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64532971|NCT04478526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64532972|NCT04478526|Serotonin Agents|serotonin agents|mesh-ancestor
64532973|NCT04478526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64532974|NCT04478526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64532975|NCT01552057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64532976|NCT01552057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64460559|NCT04112043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460560|NCT04112043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64460561|NCT04112043|Antimetabolites|antimetabolites|mesh-ancestor
64460562|NCT04112043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460589|NCT01560507|Autonomic Agents|autonomic agents|mesh-ancestor
64460590|NCT01560507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64460591|NCT01560507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460592|NCT01560507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64460593|NCT01560507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64888937|NCT01964183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888938|NCT01964183|Urological Agents|urological agents|mesh-ancestor
64888939|NCT01964183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64888940|NCT01964183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64888941|NCT01964183|Cholinergic Agents|cholinergic agents|mesh-ancestor
64888942|NCT01964248|Lidocaine|lidocaine|mesh-list
64888943|NCT01964248|Prilocaine|prilocaine|mesh-list
64888944|NCT01964248|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64888945|NCT01964248|Anesthetics, Local|anesthetics, local|mesh-ancestor
64888946|NCT01964248|Anesthetics|anesthetics|mesh-ancestor
64888947|NCT01964248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64888948|NCT01964248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888949|NCT01964248|Sensory System Agents|sensory system agents|mesh-ancestor
64519733|NCT03225924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64519734|NCT03225924|Alkylating Agents|alkylating agents|mesh-ancestor
64519735|NCT03225924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519736|NCT03225924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519737|NCT03225924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64519738|NCT03225924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64519739|NCT03225924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64519740|NCT03225924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64519741|NCT03225924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64519742|NCT03225924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519743|NCT03225924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64460594|NCT01560507|Cholinergic Agents|cholinergic agents|mesh-ancestor
64460595|NCT01560507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64460596|NCT01560507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460597|NCT01560507|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64460598|NCT01560507|Antidepressive Agents|antidepressive agents|mesh-ancestor
64460599|NCT01560507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64460600|NCT01560507|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64460601|NCT01560507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64460602|NCT01560507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64460603|NCT01560507|Dopamine Agents|dopamine agents|mesh-ancestor
64460604|NCT01560507|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64460605|NCT01560507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64460606|NCT01560507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460607|NCT03694834|Pembrolizumab|pembrolizumab|mesh-list
64460643|NCT01584843|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64460645|NCT01584843|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64460646|NCT01584843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64460647|NCT01584843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460648|NCT01584843|Cholinergic Agents|cholinergic agents|mesh-ancestor
64460649|NCT01584843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64460650|NCT01584843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460651|NCT01584843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64460652|NCT01584843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64460653|NCT03580408|Nivolumab|nivolumab|mesh-list
64640825|NCT05300802|Adrenergic Agents|adrenergic agents|mesh-ancestor
64519745|NCT03225924|Hormones|hormones|mesh-ancestor
64519746|NCT03225924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64519747|NCT03225924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64519748|NCT03225924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64519749|NCT03225924|Tubulin Modulators|tubulin modulators|mesh-ancestor
64519750|NCT03225924|Antimitotic Agents|antimitotic agents|mesh-ancestor
64519751|NCT03225924|Mitosis Modulators|mitosis modulators|mesh-ancestor
64519752|NCT03119532|Metronidazole|metronidazole|mesh-list
64519753|NCT03119532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64519754|NCT03119532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64519755|NCT03119532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64519756|NCT03119532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64519758|NCT02404168|Anticonvulsants|anticonvulsants|mesh-list
64519759|NCT02404168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64519760|NCT02404168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64519761|NCT02404168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519762|NCT02404168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64519763|NCT02404168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519775|NCT02051452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519776|NCT02051452|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64519777|NCT02051452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64519778|NCT02051452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64519779|NCT02051452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888950|NCT01964248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64640826|NCT05300802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888951|NCT01964248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64888952|NCT01964248|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64888953|NCT01964248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64460672|NCT03775096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64460673|NCT03775096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64460675|NCT03774394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64460676|NCT03774394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64460677|NCT03774394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64460678|NCT03774394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64532977|NCT01552057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64532978|NCT01552057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64532979|NCT01552057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532980|NCT01552057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888954|NCT01964248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64640867|NCT05299398|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64888955|NCT01964248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888956|NCT01964248|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64888957|NCT01964287|Leucovorin|leucovorin|mesh-list
64888958|NCT01964287|Gemcitabine|gemcitabine|mesh-list
64888959|NCT01964287|Paclitaxel|paclitaxel|mesh-list
64888960|NCT01964287|Oxaliplatin|oxaliplatin|mesh-list
64888961|NCT01964287|Irinotecan|irinotecan|mesh-list
64888962|NCT01964287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64888963|NCT01964287|Folfirinox|folfirinox|mesh-list
64888964|NCT01964287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64888965|NCT01964287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888966|NCT01964287|Tubulin Modulators|tubulin modulators|mesh-ancestor
64888967|NCT01964287|Antimitotic Agents|antimitotic agents|mesh-ancestor
64888968|NCT01964287|Mitosis Modulators|mitosis modulators|mesh-ancestor
64640869|NCT01793480|Methadone|methadone|mesh-list
64532981|NCT01552057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532982|NCT01552057|Analgesics|analgesics|mesh-ancestor
64532983|NCT01552057|Sensory System Agents|sensory system agents|mesh-ancestor
64532984|NCT01552057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64532985|NCT01552057|Antidepressive Agents|antidepressive agents|mesh-ancestor
64532986|NCT01552057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64532987|NCT01552057|Dopamine Agents|dopamine agents|mesh-ancestor
64532988|NCT02350686|Capecitabine|capecitabine|mesh-list
64297549|NCT02063425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297550|NCT05071118|Pregabalin|pregabalin|mesh-list
64460679|NCT03774394|Purinergic Agents|purinergic agents|mesh-ancestor
64460680|NCT03774394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64460681|NCT03774394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460682|NCT03774394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460683|NCT03772834|Methylphenidate|methylphenidate|mesh-list
64460684|NCT03772834|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64460685|NCT03772834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460686|NCT03772834|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64460687|NCT03772834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64460688|NCT03772834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64460689|NCT03772834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460690|NCT03772834|Dopamine Agents|dopamine agents|mesh-ancestor
64460691|NCT03772834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64460692|NCT03675256|Vaccines|vaccines|mesh-list
64460693|NCT03675256|Immunologic Factors|immunologic factors|mesh-ancestor
64460694|NCT03675256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460695|NCT03766750|Dapagliflozin|dapagliflozin|mesh-list
64460696|NCT03766750|Linagliptin|linagliptin|mesh-list
64460697|NCT03766750|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64460698|NCT03766750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460699|NCT03766750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64460700|NCT03766750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460701|NCT03766750|Incretins|incretins|mesh-ancestor
64460702|NCT03766750|Hormones|hormones|mesh-ancestor
64460703|NCT03766750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64460740|NCT04761952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64460741|NCT04761952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460742|NCT04761952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64460743|NCT04761952|Immunologic Factors|immunologic factors|mesh-ancestor
64460744|NCT04761952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460745|NCT03673072|Gemcitabine|gemcitabine|mesh-list
64460746|NCT03673072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888969|NCT01964287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888970|NCT01964287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64888971|NCT01964287|Antimetabolites|antimetabolites|mesh-ancestor
64888972|NCT01964287|Antiviral Agents|antiviral agents|mesh-ancestor
64888973|NCT01964287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64640928|NCT00379574|Bortezomib|bortezomib|mesh-list
64888974|NCT01964287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64888975|NCT01964287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64888976|NCT01964287|Immunologic Factors|immunologic factors|mesh-ancestor
64888977|NCT01964287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888978|NCT01964287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64888979|NCT01964287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64888980|NCT01964287|Antidotes|antidotes|mesh-ancestor
64888981|NCT01964287|Protective Agents|protective agents|mesh-ancestor
64460747|NCT03673072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64460748|NCT03673072|Antimetabolites|antimetabolites|mesh-ancestor
64460749|NCT03673072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460750|NCT03673072|Antiviral Agents|antiviral agents|mesh-ancestor
64460751|NCT03673072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64532989|NCT02350686|Oxaliplatin|oxaliplatin|mesh-list
64714127|NCT00374101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532990|NCT02350686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64532991|NCT02350686|Antimetabolites|antimetabolites|mesh-ancestor
64532992|NCT02350686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532993|NCT02350686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532994|NCT03159078|Imipenem|imipenem|mesh-list
64532995|NCT03159078|Polymyxins|polymyxins|mesh-list
64532996|NCT03159078|Polymyxin B|polymyxin b|mesh-list
64532997|NCT03159078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64532998|NCT03159078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64532999|NCT01551745|Bevacizumab|bevacizumab|mesh-list
64533000|NCT01551745|Vaccines|vaccines|mesh-list
64533001|NCT01551745|Immunologic Factors|immunologic factors|mesh-ancestor
64533002|NCT01551745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533003|NCT01551745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64533004|NCT01551745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533005|NCT01551745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64533006|NCT01551745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64533007|NCT01551745|Growth Substances|growth substances|mesh-ancestor
64533008|NCT01551745|Growth Inhibitors|growth inhibitors|mesh-ancestor
64460789|NCT01690299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460810|NCT00723736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460811|NCT00723736|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64460812|NCT00723736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64460813|NCT00723736|Histamine Antagonists|histamine antagonists|mesh-ancestor
64460814|NCT00723736|Histamine Agents|histamine agents|mesh-ancestor
64460816|NCT00305344|Immunologic Factors|immunologic factors|mesh-ancestor
64460817|NCT00305344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460819|NCT01690143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64460820|NCT01690143|Alkylating Agents|alkylating agents|mesh-ancestor
64460821|NCT01690143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460822|NCT01690143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460823|NCT01690143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64460824|NCT01690143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64460825|NCT01690143|Immunologic Factors|immunologic factors|mesh-ancestor
64460826|NCT01690143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460827|NCT05347498|Febuxostat|febuxostat|mesh-list
64460828|NCT05347498|Gout Suppressants|gout suppressants|mesh-ancestor
64460829|NCT05347498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64460830|NCT03553186|Tranexamic Acid|tranexamic acid|mesh-list
64460831|NCT03553186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64888982|NCT01964287|Vitamin B Complex|vitamin b complex|mesh-ancestor
64888983|NCT01964287|Vitamins|vitamins|mesh-ancestor
64888984|NCT01964287|Micronutrients|micronutrients|mesh-ancestor
64888985|NCT01964365|Fenofibric acid|fenofibric acid|mesh-list
64888986|NCT01964365|Fenofibrate|fenofibrate|mesh-list
64888987|NCT01964365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64889041|NCT01964534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889042|NCT01964573|Rotigotine|rotigotine|mesh-list
64889043|NCT01964573|Dopamine Agonists|dopamine agonists|mesh-ancestor
64889044|NCT01964573|Dopamine Agents|dopamine agents|mesh-ancestor
64889045|NCT01964573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64889046|NCT01964573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889047|NCT01964573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889048|NCT01964586|Lidocaine|lidocaine|mesh-list
64889049|NCT01964586|Epinephrine|epinephrine|mesh-list
64889050|NCT01964586|Racepinephrine|racepinephrine|mesh-list
64889051|NCT01964586|Dexmedetomidine|dexmedetomidine|mesh-list
64889052|NCT01964586|Epinephryl borate|epinephryl borate|mesh-list
64889053|NCT01964586|Anesthetics, Local|anesthetics, local|mesh-ancestor
64889054|NCT01964586|Anesthetics|anesthetics|mesh-ancestor
64889055|NCT01964586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64889056|NCT01964586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889057|NCT01964586|Sensory System Agents|sensory system agents|mesh-ancestor
64889058|NCT01964586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889059|NCT01964586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64889060|NCT01964586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64889061|NCT01964586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64889062|NCT01964586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64640990|NCT00407888|Alkylating Agents|alkylating agents|mesh-ancestor
64640991|NCT00407888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64460832|NCT03553186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64460833|NCT03553186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460834|NCT03553186|Hemostatics|hemostatics|mesh-ancestor
64460835|NCT03553186|Coagulants|coagulants|mesh-ancestor
64460836|NCT01677364|Oxytocin|oxytocin|mesh-list
64460837|NCT01677364|Oxytocics|oxytocics|mesh-ancestor
64460838|NCT01677364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64533018|NCT02350530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533019|NCT02350530|Growth Inhibitors|growth inhibitors|mesh-ancestor
64533020|NCT02350530|Antimetabolites|antimetabolites|mesh-ancestor
64533021|NCT02350530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533022|NCT02350530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64533023|NCT02350530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64533024|NCT02350530|Immunologic Factors|immunologic factors|mesh-ancestor
64533025|NCT02350530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64460874|NCT03559348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460875|NCT03559348|Antiviral Agents|antiviral agents|mesh-ancestor
64889063|NCT01964586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641038|NCT05255406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889064|NCT01964586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64889065|NCT01964586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64889066|NCT01964586|Analgesics|analgesics|mesh-ancestor
64519781|NCT02051452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64519782|NCT00180687|Bupivacaine|bupivacaine|mesh-list
64519783|NCT00180687|Coal Tar|coal tar|mesh-list
64519784|NCT00180687|Anesthetics, Local|anesthetics, local|mesh-ancestor
64519785|NCT00180687|Anesthetics|anesthetics|mesh-ancestor
64519786|NCT00180687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64519787|NCT00180687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519788|NCT00180687|Sensory System Agents|sensory system agents|mesh-ancestor
64519789|NCT00180687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64519790|NCT00180687|Keratolytic Agents|keratolytic agents|mesh-ancestor
64519791|NCT00180687|Dermatologic Agents|dermatologic agents|mesh-ancestor
64519792|NCT00087633|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64519793|NCT00087633|Antiviral Agents|antiviral agents|mesh-ancestor
64519794|NCT00087633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64519795|NCT02384044|Listerine|listerine|mesh-list
64519796|NCT02384044|Sodium Fluoride|sodium fluoride|mesh-list
64641039|NCT05255406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460876|NCT03559348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64460877|NCT03559348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460878|NCT03559348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64460879|NCT03559348|Immunologic Factors|immunologic factors|mesh-ancestor
64460880|NCT03559348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460881|NCT03559348|Antidotes|antidotes|mesh-ancestor
64460882|NCT03559348|Protective Agents|protective agents|mesh-ancestor
64460883|NCT03559348|Vitamin B Complex|vitamin b complex|mesh-ancestor
64460884|NCT03559348|Vitamins|vitamins|mesh-ancestor
64460885|NCT03559348|Micronutrients|micronutrients|mesh-ancestor
64460886|NCT04762030|Paclitaxel|paclitaxel|mesh-list
64460887|NCT04762030|Carboplatin|carboplatin|mesh-list
64460888|NCT04762030|Durvalumab|durvalumab|mesh-list
64460889|NCT04762030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64460890|NCT04762030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460922|NCT03088306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64460923|NCT03088306|Anesthetics, General|anesthetics, general|mesh-ancestor
64460924|NCT03088306|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64460925|NCT03088306|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64460926|NCT03088306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64460927|NCT03088306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460928|NCT03088306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64460929|NCT03088306|Narcotics|narcotics|mesh-ancestor
64460930|NCT03088306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64460931|NCT03088306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64460932|NCT03088306|Antipyretics|antipyretics|mesh-ancestor
64460933|NCT03088306|Anticonvulsants|anticonvulsants|mesh-ancestor
64460934|NCT03088306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64460935|NCT03088306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64460957|NCT01677598|Ustekinumab|ustekinumab|mesh-list
64460958|NCT01677598|Dermatologic Agents|dermatologic agents|mesh-ancestor
64460960|NCT01677754|Rivastigmine|rivastigmine|mesh-list
64460961|NCT01677754|Donepezil|donepezil|mesh-list
64460962|NCT01677754|Galantamine|galantamine|mesh-list
64460963|NCT01677754|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64519797|NCT02384044|Cariostatic Agents|cariostatic agents|mesh-ancestor
64641094|NCT05254626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519798|NCT02384044|Protective Agents|protective agents|mesh-ancestor
64519799|NCT02384044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519800|NCT02384044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64519801|NCT02384044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64519802|NCT02384200|Vancomycin|vancomycin|mesh-list
64889067|NCT01964586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64889068|NCT01964586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64889069|NCT01964586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64889070|NCT01964586|Adrenergic Agents|adrenergic agents|mesh-ancestor
64889071|NCT01964586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64889072|NCT01964586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64889073|NCT01964586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64641097|NCT05254236|Vaccines|vaccines|mesh-list
64889074|NCT01964586|Autonomic Agents|autonomic agents|mesh-ancestor
64889075|NCT01964586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64889076|NCT01964586|Respiratory System Agents|respiratory system agents|mesh-ancestor
64889077|NCT01964586|Mydriatics|mydriatics|mesh-ancestor
64460964|NCT01677754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460965|NCT01677754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460966|NCT01677754|Cholinergic Agents|cholinergic agents|mesh-ancestor
64460967|NCT01677754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64460968|NCT01677754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460969|NCT01677754|Nootropic Agents|nootropic agents|mesh-ancestor
64533030|NCT01569841|Insulin Glargine|insulin glargine|mesh-list
64533031|NCT01569841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64460970|NCT01677754|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64460971|NCT01677754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64460972|NCT01677754|Dopamine Agents|dopamine agents|mesh-ancestor
64460973|NCT01677754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64460974|NCT01677754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64460975|NCT01677754|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64460976|NCT01677754|Autonomic Agents|autonomic agents|mesh-ancestor
64460977|NCT01677754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64460978|NCT01677754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64460979|NCT01677754|Protective Agents|protective agents|mesh-ancestor
64460980|NCT01670500|Cyclophosphamide|cyclophosphamide|mesh-list
64460981|NCT01670500|Cisplatin|cisplatin|mesh-list
64460982|NCT01670500|Doxorubicin|doxorubicin|mesh-list
64460983|NCT01670500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64460984|NCT01670500|Immunologic Factors|immunologic factors|mesh-ancestor
64460985|NCT01670500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460986|NCT01670500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64460987|NCT01670500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64460988|NCT01670500|Alkylating Agents|alkylating agents|mesh-ancestor
64461003|NCT03525574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461005|NCT02402920|Carboplatin|carboplatin|mesh-list
64461006|NCT02402920|Pembrolizumab|pembrolizumab|mesh-list
64461007|NCT02402920|Etoposide|etoposide|mesh-list
64461008|NCT02402920|Etoposide phosphate|etoposide phosphate|mesh-list
64461009|NCT02402920|Podophyllotoxin|podophyllotoxin|mesh-list
64461010|NCT02402920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461011|NCT02402920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64461012|NCT02402920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64461013|NCT02402920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64461014|NCT02402920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64461015|NCT02402920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889078|NCT01964586|Sympathomimetics|sympathomimetics|mesh-ancestor
64889090|NCT01964781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64641149|NCT05189756|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64657631|NCT03013400|Ebselen|ebselen|mesh-list
64889092|NCT01964781|Sensory System Agents|sensory system agents|mesh-ancestor
64889093|NCT01964781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889094|NCT01964781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64889095|NCT01964781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64889096|NCT01964781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889097|NCT01964781|Hemostatics|hemostatics|mesh-ancestor
64889098|NCT01964781|Coagulants|coagulants|mesh-ancestor
64889099|NCT01964781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64889100|NCT01964781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64889101|NCT01964781|Adrenergic Agents|adrenergic agents|mesh-ancestor
64889102|NCT01964781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64889103|NCT01964781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64889104|NCT01964781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64641152|NCT02111798|Bupropion|bupropion|mesh-list
64461016|NCT02402920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461017|NCT02402920|Keratolytic Agents|keratolytic agents|mesh-ancestor
64461018|NCT02402920|Dermatologic Agents|dermatologic agents|mesh-ancestor
64461019|NCT02402920|Tubulin Modulators|tubulin modulators|mesh-ancestor
64461020|NCT02402920|Antimitotic Agents|antimitotic agents|mesh-ancestor
64461021|NCT02402920|Mitosis Modulators|mitosis modulators|mesh-ancestor
64461022|NCT02405260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64461023|NCT02405260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64461024|NCT02405260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461025|NCT02405260|Incretins|incretins|mesh-ancestor
64461027|NCT02405260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64461028|NCT02405260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64461029|NCT02405260|Protease Inhibitors|protease inhibitors|mesh-ancestor
64461030|NCT02405260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461031|NCT02405260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461032|NCT03519646|Eliglustat|eliglustat|mesh-list
64461033|NCT03519646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461034|NCT03519646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461035|NCT02984722|Metformin|metformin|mesh-list
64461036|NCT02984722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64461037|NCT02984722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461038|NCT02401750|Naltrexone|naltrexone|mesh-list
64461039|NCT02401750|Oxycodone|oxycodone|mesh-list
64461040|NCT02401750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64461042|NCT02401750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64461043|NCT02401750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461044|NCT02401750|Analgesics|analgesics|mesh-ancestor
64461045|NCT02401750|Sensory System Agents|sensory system agents|mesh-ancestor
64461046|NCT02401750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64461047|NCT02401750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64461048|NCT02401750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64461049|NCT03087136|polysaccharide-K|polysaccharide-k|mesh-list
64533032|NCT01569841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533033|NCT01550965|Adalimumab|adalimumab|mesh-list
64533034|NCT01550965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64533035|NCT01550965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64461076|NCT03502018|Anesthetics|anesthetics|mesh-ancestor
64461077|NCT03502018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64461078|NCT03502018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889105|NCT01964781|Autonomic Agents|autonomic agents|mesh-ancestor
64889106|NCT01964781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64889107|NCT01964781|Respiratory System Agents|respiratory system agents|mesh-ancestor
64889108|NCT01964781|Mydriatics|mydriatics|mesh-ancestor
64889109|NCT01964781|Sympathomimetics|sympathomimetics|mesh-ancestor
64519803|NCT02384200|Gentamicins|gentamicins|mesh-list
64519804|NCT02384200|Ceftriaxone|ceftriaxone|mesh-list
64519806|NCT02384200|Nitrofurantoin|nitrofurantoin|mesh-list
64519807|NCT02384200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64519808|NCT02384200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64519809|NCT02384200|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64519810|NCT02384200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641210|NCT05290116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461079|NCT03502018|Sensory System Agents|sensory system agents|mesh-ancestor
64461080|NCT03502018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64461081|NCT01689207|Aztreonam|aztreonam|mesh-list
64461082|NCT01689207|Avibactam|avibactam|mesh-list
64461083|NCT01689207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64461084|NCT01689207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64461085|NCT01689207|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64461086|NCT01689207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461087|NCT01689207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461088|NCT00089284|Rituximab|rituximab|mesh-list
64461089|NCT00089284|Motexafin gadolinium|motexafin gadolinium|mesh-list
64461090|NCT00089284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64461091|NCT00089284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461092|NCT00089284|Immunologic Factors|immunologic factors|mesh-ancestor
64461093|NCT00089284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461094|NCT00089284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64461095|NCT00089284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64461096|NCT00089284|Dermatologic Agents|dermatologic agents|mesh-ancestor
64461097|NCT01688973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64461098|NCT01688973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461099|NCT01688973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64461100|NCT01688973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461131|NCT03085654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64461132|NCT03085654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461133|NCT00087568|Ribavirin|ribavirin|mesh-list
64461134|NCT00087568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64461135|NCT00087568|Antimetabolites|antimetabolites|mesh-ancestor
64461136|NCT00087568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461137|NCT00087568|Antiviral Agents|antiviral agents|mesh-ancestor
64461138|NCT00087568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64461139|NCT05346562|Cannabidiol|cannabidiol|mesh-list
64461140|NCT05346562|Anticonvulsants|anticonvulsants|mesh-ancestor
64461141|NCT04402762|Enoxaparin|enoxaparin|mesh-list
64461142|NCT04402762|Enoxaparin sodium|enoxaparin sodium|mesh-list
64461143|NCT04402762|Anticoagulants|anticoagulants|mesh-ancestor
64461144|NCT04402762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64461145|NCT04402762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64461181|NCT00084838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64461182|NCT00084838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64461183|NCT00084838|Alkylating Agents|alkylating agents|mesh-ancestor
64461184|NCT00084838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461185|NCT00084838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461186|NCT00084838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64461187|NCT00084838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64461188|NCT00084838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64461189|NCT00084838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64461210|NCT00084838|Tubulin Modulators|tubulin modulators|mesh-ancestor
64461211|NCT00084838|Antimitotic Agents|antimitotic agents|mesh-ancestor
64461212|NCT00084838|Mitosis Modulators|mitosis modulators|mesh-ancestor
64461213|NCT00084838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64461214|NCT00084838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64519811|NCT02384200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461215|NCT00084838|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64461216|NCT00084838|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64461217|NCT01558089|Etanercept|etanercept|mesh-list
64461218|NCT01558089|Methotrexate|methotrexate|mesh-list
64461219|NCT01558089|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64461220|NCT01558089|Abortifacient Agents|abortifacient agents|mesh-ancestor
64461221|NCT01558089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64461222|NCT01558089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461223|NCT01558089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64461224|NCT01558089|Antimetabolites|antimetabolites|mesh-ancestor
64461225|NCT01558089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533037|NCT05265819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64533038|NCT05265819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533039|NCT02353494|Piperaquine|piperaquine|mesh-list
64533040|NCT02353494|Artenimol|artenimol|mesh-list
64533041|NCT02353494|Antimalarials|antimalarials|mesh-ancestor
64484205|NCT01730053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64533042|NCT02353494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64533043|NCT02353494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64461231|NCT01558089|Immunologic Factors|immunologic factors|mesh-ancestor
64461232|NCT01558089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64461233|NCT01558089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64461234|NCT01558089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64461235|NCT01558089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64461236|NCT01558089|Analgesics|analgesics|mesh-ancestor
64461237|NCT01558089|Sensory System Agents|sensory system agents|mesh-ancestor
64461238|NCT01558089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64461239|NCT01558089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64461240|NCT01558089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64461241|NCT00084682|Romidepsin|romidepsin|mesh-list
64461242|NCT00084682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64461243|NCT00084682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461244|NCT01556997|Amlodipine|amlodipine|mesh-list
64461270|NCT00082810|Fulvestrant|fulvestrant|mesh-list
64461271|NCT00082810|Tipifarnib|tipifarnib|mesh-list
64461272|NCT00082810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64461273|NCT00082810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461274|NCT00082810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64461275|NCT00082810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64461276|NCT00082810|Hormone Antagonists|hormone antagonists|mesh-ancestor
64461277|NCT00082810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64461278|NCT00082810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461279|NCT03480334|Nivolumab|nivolumab|mesh-list
64461280|NCT03480334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64461281|NCT03480334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461282|NCT03480334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64461283|NCT03480334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461284|NCT03085030|Antioxidants|antioxidants|mesh-list
64461285|NCT03085030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461286|NCT03085030|Protective Agents|protective agents|mesh-ancestor
64461287|NCT03085030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461288|NCT03443128|Vinorelbine|vinorelbine|mesh-list
64461289|NCT03443128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64461298|NCT03437746|Prednisolone|prednisolone|mesh-list
64461299|NCT03437746|Prednisolone acetate|prednisolone acetate|mesh-list
64461300|NCT03437746|Anesthetics|anesthetics|mesh-list
64461301|NCT03437746|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64461302|NCT03437746|Prednisolone phosphate|prednisolone phosphate|mesh-list
64461303|NCT03437746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64461304|NCT03437746|Antiemetics|antiemetics|mesh-ancestor
64461305|NCT03437746|Autonomic Agents|autonomic agents|mesh-ancestor
64461306|NCT03437746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64461307|NCT03437746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461308|NCT03437746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64461309|NCT03437746|Glucocorticoids|glucocorticoids|mesh-ancestor
64461310|NCT03437746|Hormones|hormones|mesh-ancestor
64461311|NCT03437746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64461312|NCT03437746|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64461313|NCT03437746|Protective Agents|protective agents|mesh-ancestor
64461314|NCT03437746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64461315|NCT03437746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519812|NCT02384200|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64519813|NCT02384200|Renal Agents|renal agents|mesh-ancestor
64519814|NCT02051686|Tranexamic Acid|tranexamic acid|mesh-list
64519815|NCT02051686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64461316|NCT03437746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64533044|NCT02353494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64533045|NCT02353260|Docetaxel|docetaxel|mesh-list
64533046|NCT02353260|Fluorouracil|fluorouracil|mesh-list
64533047|NCT02353260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533048|NCT02353260|Tubulin Modulators|tubulin modulators|mesh-ancestor
64533049|NCT02353260|Antimitotic Agents|antimitotic agents|mesh-ancestor
64533050|NCT02353260|Mitosis Modulators|mitosis modulators|mesh-ancestor
64533051|NCT02353260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533052|NCT02353260|Antimetabolites|antimetabolites|mesh-ancestor
64533053|NCT02353260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64533054|NCT02353260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64533055|NCT02353260|Immunologic Factors|immunologic factors|mesh-ancestor
64533064|NCT00323739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64533066|NCT00323739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64297610|NCT05069870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64461317|NCT03479476|Metformin|metformin|mesh-list
64461318|NCT03479476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64461319|NCT03479476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461320|NCT00080938|Temozolomide|temozolomide|mesh-list
64461321|NCT00080938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64461322|NCT00080938|Alkylating Agents|alkylating agents|mesh-ancestor
64461323|NCT00080938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461324|NCT00080938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461325|NCT03084250|Tenofovir|tenofovir|mesh-list
64461326|NCT03084250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64461327|NCT03084250|Entecavir|entecavir|mesh-list
64461328|NCT03084250|Adefovir|adefovir|mesh-list
64461329|NCT03084250|Antiviral Agents|antiviral agents|mesh-ancestor
64461330|NCT03084250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64461331|NCT03084250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64461332|NCT03084250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64461333|NCT03084250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461334|NCT03084250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461335|NCT03084250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64461336|NCT03084250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64461337|NCT01688037|Tetrabenazine|tetrabenazine|mesh-list
64461338|NCT01688037|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64461339|NCT01688037|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64461340|NCT01688037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64461341|NCT01688037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945379|NCT05672225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461343|NCT01688037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64461344|NCT01688037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461346|NCT03084328|Vitamins|vitamins|mesh-ancestor
64533067|NCT00323739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64533069|NCT00323739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533070|NCT00323739|Growth Inhibitors|growth inhibitors|mesh-ancestor
64533071|NCT00323739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64533072|NCT00323739|Immunologic Factors|immunologic factors|mesh-ancestor
64533073|NCT02350218|Alprostadil|alprostadil|mesh-list
64533074|NCT02350218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64533075|NCT02350218|Vasodilator Agents|vasodilator agents|mesh-ancestor
64533076|NCT02350218|Urological Agents|urological agents|mesh-ancestor
64533077|NCT00390429|Docetaxel|docetaxel|mesh-list
64533078|NCT00390429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64533079|NCT00390429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533080|NCT00390429|Tubulin Modulators|tubulin modulators|mesh-ancestor
64533081|NCT00390429|Antimitotic Agents|antimitotic agents|mesh-ancestor
64533082|NCT00390429|Mitosis Modulators|mitosis modulators|mesh-ancestor
64533083|NCT00390429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533084|NCT00390429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64533085|NCT00390429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533086|NCT02349828|Acyclovir|acyclovir|mesh-list
64533087|NCT02349828|Antiviral Agents|antiviral agents|mesh-ancestor
64533088|NCT02349828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64533089|NCT02353182|Dexmedetomidine|dexmedetomidine|mesh-list
64533090|NCT02353182|Remifentanil|remifentanil|mesh-list
64519816|NCT02051686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64519817|NCT02051686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519818|NCT02051686|Hemostatics|hemostatics|mesh-ancestor
64519819|NCT02051686|Coagulants|coagulants|mesh-ancestor
64519820|NCT00182793|Cyclophosphamide|cyclophosphamide|mesh-list
64519821|NCT00182793|Melphalan|melphalan|mesh-list
64519822|NCT00182793|Thiotepa|thiotepa|mesh-list
64519823|NCT00182793|Carboplatin|carboplatin|mesh-list
64519824|NCT00182793|Trastuzumab|trastuzumab|mesh-list
64519825|NCT00182793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64519826|NCT00182793|Immunologic Factors|immunologic factors|mesh-ancestor
64519827|NCT00182793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519828|NCT00182793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64519829|NCT00182793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64519830|NCT00182793|Alkylating Agents|alkylating agents|mesh-ancestor
64519831|NCT00182793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519832|NCT00182793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519833|NCT00182793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64641421|NCT00456014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64652772|NCT01728272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64533091|NCT02353182|Bupivacaine|bupivacaine|mesh-list
64533092|NCT02353182|Ropivacaine|ropivacaine|mesh-list
64533093|NCT02353182|Anesthetics, Local|anesthetics, local|mesh-ancestor
64533094|NCT02353182|Anesthetics|anesthetics|mesh-ancestor
64652774|NCT03835286|Ascorbic Acid|ascorbic acid|mesh-list
64533115|NCT02349516|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64533116|NCT02349516|Protective Agents|protective agents|mesh-ancestor
64533117|NCT02349516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533118|NCT02349516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297675|NCT02056899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461347|NCT03084328|Micronutrients|micronutrients|mesh-ancestor
64461348|NCT03084328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461349|NCT03084328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64461350|NCT03435718|Albendazole|albendazole|mesh-list
64461351|NCT03435718|Oxfendazole|oxfendazole|mesh-list
64461352|NCT03435718|Anthelmintics|anthelmintics|mesh-ancestor
64461353|NCT03435718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64461354|NCT03435718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64461355|NCT03435718|Anticestodal Agents|anticestodal agents|mesh-ancestor
64461356|NCT03435718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64461357|NCT03435718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64461420|NCT03471442|Sensory System Agents|sensory system agents|mesh-ancestor
64461421|NCT03471442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64461422|NCT01679392|Ropivacaine|ropivacaine|mesh-list
64461423|NCT01679392|Anesthetics, Local|anesthetics, local|mesh-ancestor
64461424|NCT01679392|Anesthetics|anesthetics|mesh-ancestor
64461425|NCT01679392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64461426|NCT01679392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461427|NCT01679392|Sensory System Agents|sensory system agents|mesh-ancestor
64461428|NCT01679392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64461429|NCT03083080|Epinephrine|epinephrine|mesh-list
64461430|NCT03083080|Ropivacaine|ropivacaine|mesh-list
64461431|NCT03083080|Anesthetics, Local|anesthetics, local|mesh-ancestor
64461432|NCT03083080|Anesthetics|anesthetics|mesh-ancestor
64461433|NCT03083080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64461434|NCT03083080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461435|NCT03083080|Sensory System Agents|sensory system agents|mesh-ancestor
64461436|NCT03083080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889110|NCT01964781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64889111|NCT01964846|Curcumin|curcumin|mesh-list
64889112|NCT01964846|Resveratrol|resveratrol|mesh-list
64889113|NCT01964846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64889114|NCT01964846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64889115|NCT01964846|Analgesics|analgesics|mesh-ancestor
64889116|NCT01964846|Sensory System Agents|sensory system agents|mesh-ancestor
64889117|NCT01964846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64461437|NCT03083080|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64461438|NCT03083080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64461439|NCT03083080|Adrenergic Agents|adrenergic agents|mesh-ancestor
64461440|NCT03083080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64461441|NCT03083080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461442|NCT03083080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64461443|NCT03083080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64461444|NCT03083080|Autonomic Agents|autonomic agents|mesh-ancestor
64461445|NCT03083080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64461446|NCT03083080|Respiratory System Agents|respiratory system agents|mesh-ancestor
64461468|NCT03435250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64461469|NCT03435250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461470|NCT03435250|Tubulin Modulators|tubulin modulators|mesh-ancestor
64461471|NCT03435250|Antimitotic Agents|antimitotic agents|mesh-ancestor
64461472|NCT03435250|Mitosis Modulators|mitosis modulators|mesh-ancestor
64461473|NCT03435250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461474|NCT03435250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64461475|NCT03435250|Antimetabolites|antimetabolites|mesh-ancestor
64461476|NCT03435250|Antiviral Agents|antiviral agents|mesh-ancestor
64652780|NCT03835286|Protective Agents|protective agents|mesh-ancestor
64533120|NCT02349516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64533121|NCT02349516|Growth Substances|growth substances|mesh-ancestor
64533122|NCT02349516|Growth Inhibitors|growth inhibitors|mesh-ancestor
64533123|NCT02349594|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64533124|NCT02349594|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64533125|NCT02349594|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64533126|NCT02349594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64533127|NCT02346084|Maraviroc|maraviroc|mesh-list
64533128|NCT02346084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64533129|NCT02346084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64533130|NCT02346084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533131|NCT02346084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64533132|NCT02346084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64533133|NCT02346084|Antiviral Agents|antiviral agents|mesh-ancestor
64297685|NCT02056899|Antimanic Agents|antimanic agents|mesh-ancestor
64461484|NCT01679860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461485|NCT01679860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64461486|NCT01679860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461487|NCT05346952|Carboplatin|carboplatin|mesh-list
64461489|NCT05346952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461490|NCT05346952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461491|NCT05346952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461492|NCT05346952|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64461493|NCT05346952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64461494|NCT03081442|Misoprostol|misoprostol|mesh-list
64461495|NCT03081442|Contraceptive Agents|contraceptive agents|mesh-list
64461496|NCT03081442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64461497|NCT03081442|Abortifacient Agents|abortifacient agents|mesh-ancestor
64945380|NCT05672225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64461498|NCT03081442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64461499|NCT03081442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461500|NCT03081442|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64461501|NCT03081442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64461502|NCT03081442|Oxytocics|oxytocics|mesh-ancestor
64461503|NCT03431194|Midodrine|midodrine|mesh-list
64461504|NCT03431194|Sympathomimetics|sympathomimetics|mesh-ancestor
64461524|NCT03080740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461525|NCT03080740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889118|NCT01964846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889119|NCT01964846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64889120|NCT01964846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64889121|NCT01964846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889122|NCT01964846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641541|NCT00462332|Vidarabine|vidarabine|mesh-list
64461526|NCT03081832|Oxytocin|oxytocin|mesh-list
64461527|NCT03081832|Oxytocics|oxytocics|mesh-ancestor
64461528|NCT03081832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64461529|NCT03081832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461530|NCT05345938|Mitoxantrone|mitoxantrone|mesh-list
64461531|NCT05345938|Analgesics|analgesics|mesh-ancestor
64461532|NCT05345938|Sensory System Agents|sensory system agents|mesh-ancestor
64461533|NCT05345938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64461534|NCT05345938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461535|NCT05345938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461536|NCT05345938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64461537|NCT05345938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64461538|NCT05345938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461539|NCT05345938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461540|NCT03080350|Fentanyl|fentanyl|mesh-list
64461541|NCT03080350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64461542|NCT03080350|Narcotics|narcotics|mesh-ancestor
64461543|NCT03080350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64461544|NCT03080350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533134|NCT02346084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64533135|NCT02346084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64652791|NCT01728740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64533136|NCT03149250|Hemostatics|hemostatics|mesh-list
64533140|NCT00391443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64533141|NCT00391443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533142|NCT02343432|Triamcinolone|triamcinolone|mesh-list
64461545|NCT03080350|Analgesics|analgesics|mesh-ancestor
64461546|NCT03080350|Sensory System Agents|sensory system agents|mesh-ancestor
64461547|NCT03080350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64461548|NCT03080350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64461549|NCT03080350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64461550|NCT03080350|Anesthetics, General|anesthetics, general|mesh-ancestor
64461551|NCT03080350|Anesthetics|anesthetics|mesh-ancestor
64461552|NCT03080194|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64461553|NCT03080194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64461554|NCT03080194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64461555|NCT03080194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64461556|NCT03080194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461557|NCT03080194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64461558|NCT03080194|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64461559|NCT03080194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64461582|NCT03323866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64461583|NCT03323866|Dermatologic Agents|dermatologic agents|mesh-ancestor
64461584|NCT03323866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64461585|NCT05688670|Ropivacaine|ropivacaine|mesh-list
64461586|NCT05688670|Anesthetics|anesthetics|mesh-ancestor
64461587|NCT05688670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64461588|NCT05688670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461589|NCT05688670|Anesthetics, Local|anesthetics, local|mesh-ancestor
64461590|NCT05688670|Sensory System Agents|sensory system agents|mesh-ancestor
64461591|NCT05688670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64461592|NCT05684848|Resveratrol|resveratrol|mesh-list
64461593|NCT05684848|Antioxidants|antioxidants|mesh-ancestor
64461594|NCT05684848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461595|NCT05684848|Protective Agents|protective agents|mesh-ancestor
64461596|NCT05684848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461597|NCT05684848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461598|NCT05684848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64461599|NCT03366298|Epinephrine|epinephrine|mesh-list
64461600|NCT03366298|Racepinephrine|racepinephrine|mesh-list
64461601|NCT03366298|Epinephryl borate|epinephryl borate|mesh-list
64461602|NCT03366298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64461603|NCT03366298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64461604|NCT03366298|Adrenergic Agents|adrenergic agents|mesh-ancestor
64519834|NCT00182793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64519835|NCT00183339|Fluoxetine|fluoxetine|mesh-list
64519836|NCT00183339|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64519837|NCT00183339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64519838|NCT00183339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64519839|NCT00183339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641613|NCT00528398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461605|NCT03366298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64461606|NCT03366298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461607|NCT03366298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461608|NCT03366298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64461609|NCT03366298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64461610|NCT03366298|Autonomic Agents|autonomic agents|mesh-ancestor
64461611|NCT03366298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64461642|NCT03386578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64461643|NCT03386578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64461644|NCT03386578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461645|NCT03386578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461646|NCT03386578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64461647|NCT03386578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64461648|NCT05688202|Acetaminophen|acetaminophen|mesh-list
64461649|NCT05688202|Lidocaine|lidocaine|mesh-list
64945381|NCT05672225|Analgesics|analgesics|mesh-ancestor
64461669|NCT05688124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64461670|NCT05688124|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64461671|NCT05688124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533143|NCT02343432|Bupivacaine|bupivacaine|mesh-list
64533144|NCT02343432|Anesthetics, Local|anesthetics, local|mesh-ancestor
64533145|NCT02343432|Anesthetics|anesthetics|mesh-ancestor
64533146|NCT02343432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64533147|NCT02343432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533148|NCT02343432|Sensory System Agents|sensory system agents|mesh-ancestor
64533149|NCT02343432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652798|NCT01728818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64533150|NCT02343432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64533151|NCT02343432|Glucocorticoids|glucocorticoids|mesh-ancestor
64533160|NCT02349282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64533161|NCT02349282|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64533163|NCT02349204|Anticonvulsants|anticonvulsants|mesh-ancestor
64533164|NCT02349204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64297709|NCT02461719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64297710|NCT02461719|Immunologic Factors|immunologic factors|mesh-ancestor
64297718|NCT04322643|Pembrolizumab|pembrolizumab|mesh-list
64461672|NCT05688124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461693|NCT01842620|Metformin|metformin|mesh-list
64461694|NCT01842620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64461695|NCT01842620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461696|NCT05687500|Glyburide|glyburide|mesh-list
64461697|NCT05687500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64461698|NCT05687500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461730|NCT03356860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64461731|NCT03356860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64461732|NCT03356860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461733|NCT01931839|Ivacaftor|ivacaftor|mesh-list
64461734|NCT01931839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64461735|NCT01931839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64461736|NCT01931839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461737|NCT01842308|Melphalan|melphalan|mesh-list
64461738|NCT01842308|Mechlorethamine|mechlorethamine|mesh-list
64461739|NCT01842308|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64461740|NCT01842308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64461763|NCT01841762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461765|NCT03301636|Pembrolizumab|pembrolizumab|mesh-list
64461766|NCT03301636|Nivolumab|nivolumab|mesh-list
64461767|NCT03301636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64461768|NCT03301636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889123|NCT01964846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889124|NCT01964846|Antioxidants|antioxidants|mesh-ancestor
64889125|NCT01964846|Protective Agents|protective agents|mesh-ancestor
64461769|NCT03301636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64461770|NCT03301636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533175|NCT02345616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533176|NCT02345616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64533177|NCT02345616|Respiratory System Agents|respiratory system agents|mesh-ancestor
64533178|NCT02345616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64533179|NCT02345616|Antioxidants|antioxidants|mesh-ancestor
64297732|NCT02796391|Nicotine|nicotine|mesh-list
64461771|NCT04760860|Prazosin|prazosin|mesh-list
64461772|NCT04760860|Terazosin|terazosin|mesh-list
64461773|NCT04760860|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64461774|NCT04760860|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64461775|NCT04760860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64461776|NCT04760860|Adrenergic Agents|adrenergic agents|mesh-ancestor
64461777|NCT04760860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64461778|NCT04760860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461779|NCT04760860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461780|NCT04760860|Urological Agents|urological agents|mesh-ancestor
64461781|NCT04760860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64461783|NCT04602494|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64461784|NCT04602494|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64461785|NCT04602494|Cholinergic Agents|cholinergic agents|mesh-ancestor
64461786|NCT04602494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64461787|NCT04602494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461788|NCT04602494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652800|NCT01728818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461789|NCT05640232|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64461870|NCT05305924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64461871|NCT05305924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461873|NCT05548582|Ibuprofen|ibuprofen|mesh-list
64461874|NCT05548582|Oxycodone|oxycodone|mesh-list
64461875|NCT05548582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64461900|NCT01839188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533180|NCT02345616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533181|NCT02345616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64533182|NCT02345616|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64533183|NCT02345616|Vasodilator Agents|vasodilator agents|mesh-ancestor
64533184|NCT02345616|Gasotransmitters|gasotransmitters|mesh-ancestor
64533185|NCT02345616|Protective Agents|protective agents|mesh-ancestor
64533187|NCT00391989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533188|NCT00391989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64533189|NCT00391989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533190|NCT00391989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533191|NCT03148704|Palonosetron|palonosetron|mesh-list
64533192|NCT03148704|Antiemetics|antiemetics|mesh-ancestor
64533193|NCT03148704|Autonomic Agents|autonomic agents|mesh-ancestor
64533194|NCT03148704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484206|NCT01730053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64484207|NCT01730053|Antimetabolites|antimetabolites|mesh-ancestor
64461901|NCT05223088|Oxaliplatin|oxaliplatin|mesh-list
64461902|NCT05223088|Apatinib|apatinib|mesh-list
64461903|NCT05223088|Tegafur|tegafur|mesh-list
64461904|NCT05223088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461905|NCT05223088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64461906|NCT05223088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461907|NCT05223088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461908|NCT05223088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64461909|NCT05223088|Antimetabolites|antimetabolites|mesh-ancestor
64461910|NCT01838876|Cariprazine|cariprazine|mesh-list
64461911|NCT01838876|Antidepressive Agents|antidepressive agents|mesh-list
64461912|NCT01838876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64461913|NCT01838876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64461914|NCT01838876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64461915|NCT01838876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64461916|NCT01838876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461917|NCT03279250|Prednisone|prednisone|mesh-list
64461918|NCT03279250|Cortisone|cortisone|mesh-list
64461919|NCT03279250|Abiraterone Acetate|abiraterone acetate|mesh-list
64889126|NCT01964846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64889127|NCT01964911|Ropivacaine|ropivacaine|mesh-list
64889128|NCT01964911|Anesthetics, Local|anesthetics, local|mesh-ancestor
64889129|NCT01964911|Anesthetics|anesthetics|mesh-ancestor
64889130|NCT01964911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64889131|NCT01964911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889132|NCT01964911|Sensory System Agents|sensory system agents|mesh-ancestor
64889133|NCT01964911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889134|NCT01965041|Aflibercept|aflibercept|mesh-list
64889135|NCT01965041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64889136|NCT01965041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64889137|NCT01965041|Growth Substances|growth substances|mesh-ancestor
64889138|NCT01965041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889139|NCT01965041|Growth Inhibitors|growth inhibitors|mesh-ancestor
64889140|NCT01965041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889141|NCT01965080|Exemestane|exemestane|mesh-list
64889142|NCT01965080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889143|NCT01965080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64889149|NCT01965080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64889150|NCT01965080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889151|NCT01965275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64889152|NCT01965275|Gefitinib|gefitinib|mesh-list
64461920|NCT03279250|Hormones|hormones|mesh-list
64461921|NCT03279250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64461922|NCT03279250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64461923|NCT03279250|Glucocorticoids|glucocorticoids|mesh-ancestor
64461924|NCT03279250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64461982|NCT05139004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64461983|NCT05139004|Mitosis Modulators|mitosis modulators|mesh-ancestor
64461985|NCT05139004|Sequestering Agents|sequestering agents|mesh-ancestor
64461986|NCT01811186|Oxycodone|oxycodone|mesh-list
64461987|NCT01811186|Naloxone|naloxone|mesh-list
64461988|NCT01811186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64461989|NCT01811186|Narcotics|narcotics|mesh-ancestor
64461990|NCT01811186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64461991|NCT01811186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461992|NCT01811186|Analgesics|analgesics|mesh-ancestor
64461993|NCT01811186|Sensory System Agents|sensory system agents|mesh-ancestor
64461994|NCT01811186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64461995|NCT01811186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64461996|NCT04630756|Acalabrutinib|acalabrutinib|mesh-list
64461997|NCT04630756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461998|NCT01866098|Naltrexone|naltrexone|mesh-list
64461999|NCT01866098|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64462000|NCT01866098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64533203|NCT01795287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64297765|NCT02067949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462001|NCT01866098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462002|NCT01866098|Sensory System Agents|sensory system agents|mesh-ancestor
64462003|NCT01866098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462004|NCT04885972|Triamcinolone|triamcinolone|mesh-list
64462005|NCT04885972|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64462006|NCT04885972|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64462007|NCT04885972|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64889153|NCT01965275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889154|NCT01965275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64889155|NCT01965275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889156|NCT01965275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889157|NCT01965301|Diphenhydramine|diphenhydramine|mesh-list
64889158|NCT01965301|Promethazine|promethazine|mesh-list
64889159|NCT01965301|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64889160|NCT01965301|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64889161|NCT01965301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64889162|NCT01965301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889163|NCT01965301|Anesthetics, Local|anesthetics, local|mesh-ancestor
64889164|NCT01965301|Anesthetics|anesthetics|mesh-ancestor
64889165|NCT01965301|Sensory System Agents|sensory system agents|mesh-ancestor
64657708|NCT00363285|Androgen Antagonists|androgen antagonists|mesh-ancestor
64889166|NCT01965301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889167|NCT01965301|Antiemetics|antiemetics|mesh-ancestor
64889168|NCT01965301|Autonomic Agents|autonomic agents|mesh-ancestor
64889169|NCT01965301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64889170|NCT01965301|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64889171|NCT01965301|Histamine Antagonists|histamine antagonists|mesh-ancestor
64889172|NCT01965301|Histamine Agents|histamine agents|mesh-ancestor
64889173|NCT01965301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64889174|NCT01965301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889175|NCT01965301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64889176|NCT01965301|Antipruritics|antipruritics|mesh-ancestor
64889177|NCT01965301|Dermatologic Agents|dermatologic agents|mesh-ancestor
64641804|NCT00466310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64462008|NCT04885972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64462009|NCT04885972|Glucocorticoids|glucocorticoids|mesh-ancestor
64462010|NCT04885972|Hormones|hormones|mesh-ancestor
64462011|NCT04885972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64462032|NCT03985540|Dopamine Agents|dopamine agents|mesh-ancestor
64462033|NCT03985540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64462034|NCT03985540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462035|NCT03985540|Adrenergic Agents|adrenergic agents|mesh-ancestor
64462036|NCT03985540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64462037|NCT03985540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64462038|NCT03985540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64462039|NCT03985540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64462040|NCT04858360|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64462041|NCT04858360|Anesthetics, Local|anesthetics, local|mesh-ancestor
64462042|NCT04858360|Anesthetics|anesthetics|mesh-ancestor
64462043|NCT04858360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64462044|NCT04858360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462045|NCT04858360|Sensory System Agents|sensory system agents|mesh-ancestor
64462046|NCT04858360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462047|NCT04858360|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64889178|NCT01965353|Dexamethasone|dexamethasone|mesh-list
64889179|NCT01965353|Lenalidomide|lenalidomide|mesh-list
64889181|NCT01965353|Panobinostat|panobinostat|mesh-list
64889182|NCT01965353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64889183|NCT01965353|Antiemetics|antiemetics|mesh-ancestor
64889184|NCT01965353|Autonomic Agents|autonomic agents|mesh-ancestor
64889185|NCT01965353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889186|NCT01965353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889187|NCT01965353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64889188|NCT01965353|Glucocorticoids|glucocorticoids|mesh-ancestor
64889189|NCT01965353|Hormones|hormones|mesh-ancestor
64462048|NCT01865552|Etanercept|etanercept|mesh-list
64462049|NCT01865552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64462050|NCT01865552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64462051|NCT01865552|Analgesics|analgesics|mesh-ancestor
64462052|NCT01865552|Sensory System Agents|sensory system agents|mesh-ancestor
64462053|NCT01865552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462054|NCT01865552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462055|NCT01865552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64462056|NCT01865552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64462057|NCT01865552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64462058|NCT01865552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64462059|NCT01865552|Immunologic Factors|immunologic factors|mesh-ancestor
64462060|NCT04830592|Pembrolizumab|pembrolizumab|mesh-list
64462061|NCT04830592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64462062|NCT04830592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462063|NCT01809314|Epoetin Alfa|epoetin alfa|mesh-list
64462064|NCT01809314|Hematinics|hematinics|mesh-ancestor
64462065|NCT03943498|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64462095|NCT04413734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64462096|NCT04413734|Antimetabolites|antimetabolites|mesh-ancestor
64462097|NCT04413734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462098|NCT04413734|Antiviral Agents|antiviral agents|mesh-ancestor
64945382|NCT05672225|Sensory System Agents|sensory system agents|mesh-ancestor
64462099|NCT04413734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64533204|NCT01795287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533205|NCT04976283|Pioglitazone|pioglitazone|mesh-list
64652813|NCT03407300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533216|NCT02345304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64533217|NCT02345304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64533218|NCT02345304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533219|NCT02345304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64533220|NCT02345304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64533221|NCT02345304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64533222|NCT02345304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64533223|NCT02345304|Anesthetics, General|anesthetics, general|mesh-ancestor
64297775|NCT02068339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462100|NCT04413734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462101|NCT04413734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64462102|NCT04413734|Immunologic Factors|immunologic factors|mesh-ancestor
64462103|NCT04413734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462104|NCT03229798|Sumatriptan|sumatriptan|mesh-list
64462105|NCT03229798|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64462106|NCT03229798|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64462107|NCT03229798|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64462108|NCT03229798|Serotonin Agents|serotonin agents|mesh-ancestor
64462109|NCT03229798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64462145|NCT03615742|Respiratory System Agents|respiratory system agents|mesh-ancestor
64462147|NCT03615742|Hormones|hormones|mesh-ancestor
64462148|NCT03615742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64462149|NCT01363297|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
64462178|NCT03199924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64462179|NCT03199924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64462180|NCT03199924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64462181|NCT03199924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64641934|NCT00471848|Thymoglobulin|thymoglobulin|mesh-list
64519841|NCT00183339|Serotonin Agents|serotonin agents|mesh-ancestor
64519842|NCT00183339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519843|NCT00183339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64519844|NCT00183339|Antidepressive Agents|antidepressive agents|mesh-ancestor
64519845|NCT00183339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64889190|NCT01965353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64889191|NCT01965353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64889192|NCT01965353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889193|NCT01965353|Immunologic Factors|immunologic factors|mesh-ancestor
64889194|NCT01965353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64889195|NCT01965353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64889196|NCT01965353|Growth Substances|growth substances|mesh-ancestor
64889197|NCT01965353|Growth Inhibitors|growth inhibitors|mesh-ancestor
64889198|NCT01965353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64889199|NCT01965353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889200|NCT01965353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889201|NCT01965405|Bupropion|bupropion|mesh-list
64889202|NCT01965405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64462182|NCT03199924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462183|NCT03199924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64462184|NCT03199924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64462185|NCT03199924|Analgesics|analgesics|mesh-ancestor
64462186|NCT03199924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64462187|NCT03199924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64462188|NCT03199924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462189|NCT03199924|Anticonvulsants|anticonvulsants|mesh-ancestor
64462190|NCT03199924|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64462191|NCT03199924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64462192|NCT03199924|Tocolytic Agents|tocolytic agents|mesh-ancestor
64462193|NCT03199924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64462194|NCT03199300|Trastuzumab|trastuzumab|mesh-list
64533225|NCT02345304|GABA Modulators|gaba modulators|mesh-ancestor
64533226|NCT02345304|GABA Agents|gaba agents|mesh-ancestor
64533227|NCT02345304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64533228|NCT02345304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533229|NCT02345304|Anticoagulants|anticoagulants|mesh-ancestor
64533230|NCT02345304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64533231|NCT02345304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64533232|NCT02345304|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64533233|NCT02345304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533234|NCT02345304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64533235|NCT02345304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64533236|NCT02345304|Protective Agents|protective agents|mesh-ancestor
64533237|NCT01569295|Rituximab|rituximab|mesh-list
64533238|NCT01569295|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64533239|NCT01569295|Idelalisib|idelalisib|mesh-list
64462228|NCT04407442|Azacitidine|azacitidine|mesh-list
64462229|NCT04407442|Daratumumab|daratumumab|mesh-list
64462230|NCT04407442|Ichthammol|ichthammol|mesh-list
64462231|NCT04407442|BB 1101|bb 1101|mesh-list
64462232|NCT04407442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64462233|NCT04407442|Antiemetics|antiemetics|mesh-ancestor
64462234|NCT04407442|Autonomic Agents|autonomic agents|mesh-ancestor
64462235|NCT04407442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462236|NCT04407442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889203|NCT01965405|Antidepressive Agents|antidepressive agents|mesh-ancestor
64641991|NCT00419666|Micronutrients|micronutrients|mesh-ancestor
64889204|NCT01965405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64889205|NCT01965405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64889206|NCT01965405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64889207|NCT01965405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64889208|NCT01965405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889209|NCT01965405|Dopamine Agents|dopamine agents|mesh-ancestor
64889210|NCT01965405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64889211|NCT01965405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889226|NCT01965522|Protective Agents|protective agents|mesh-ancestor
64889227|NCT01965522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64889229|NCT01965587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64889230|NCT01965587|Contraceptive Agents|contraceptive agents|mesh-ancestor
64889231|NCT01965587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64889232|NCT01965587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889233|NCT01965587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64889234|NCT01965587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64889235|NCT01965587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64889236|NCT01965626|Oseltamivir|oseltamivir|mesh-list
64889237|NCT01965626|Dexamethasone|dexamethasone|mesh-list
64889238|NCT01965626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64889239|NCT01965626|Antiemetics|antiemetics|mesh-ancestor
64657782|NCT02385708|Disinfectants|disinfectants|mesh-ancestor
64889240|NCT01965626|Autonomic Agents|autonomic agents|mesh-ancestor
64889241|NCT01965626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889242|NCT01965626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889243|NCT01965626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64462237|NCT04407442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64462238|NCT04407442|Glucocorticoids|glucocorticoids|mesh-ancestor
64462239|NCT04407442|Hormones|hormones|mesh-ancestor
64462240|NCT04407442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64462275|NCT01808612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64462276|NCT01808612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64462277|NCT01808612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64462278|NCT01808612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462279|NCT01908829|Solifenacin Succinate|solifenacin succinate|mesh-list
64462280|NCT01908829|Mirabegron|mirabegron|mesh-list
64462308|NCT01773122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462310|NCT01773122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64462311|NCT01808534|Isophosphamide mustard|isophosphamide mustard|mesh-list
64462313|NCT01808534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64462314|NCT01808534|Alkylating Agents|alkylating agents|mesh-ancestor
64462315|NCT01808534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462316|NCT01808534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889244|NCT01965626|Glucocorticoids|glucocorticoids|mesh-ancestor
64889245|NCT01965626|Hormones|hormones|mesh-ancestor
64889246|NCT01965626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64889247|NCT01965626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64889248|NCT01965626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889249|NCT01965626|Antiviral Agents|antiviral agents|mesh-ancestor
64889250|NCT01965626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64889251|NCT01965626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889252|NCT01965626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462317|NCT03221140|Anti-Infective Agents|anti-infective agents|mesh-list
64462318|NCT03221140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64462319|NCT03218800|Ertapenem|ertapenem|mesh-list
64462320|NCT03218800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64462321|NCT03218800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64462322|NCT01802216|Minocycline|minocycline|mesh-list
64462323|NCT01802216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64945383|NCT05672225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462324|NCT01802216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64462325|NCT03621904|Tamoxifen|tamoxifen|mesh-list
64533242|NCT01569295|Immunologic Factors|immunologic factors|mesh-ancestor
64533243|NCT01569295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533244|NCT01569295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64533245|NCT01569295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64533246|NCT01569295|Alkylating Agents|alkylating agents|mesh-ancestor
64533247|NCT01569295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533248|NCT01569295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533249|NCT03112278|Salicylic Acid|salicylic acid|mesh-list
64533250|NCT03112278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64533251|NCT03112278|Antifungal Agents|antifungal agents|mesh-ancestor
64533252|NCT03112278|Keratolytic Agents|keratolytic agents|mesh-ancestor
64533253|NCT03112278|Dermatologic Agents|dermatologic agents|mesh-ancestor
64533254|NCT02345148|Esketamine|esketamine|mesh-list
64533255|NCT02345148|Antidepressive Agents|antidepressive agents|mesh-ancestor
64533256|NCT02345148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64533257|NCT00394329|Beclomethasone|beclomethasone|mesh-list
64533258|NCT00394329|Albuterol|albuterol|mesh-list
64533259|NCT00394329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64533260|NCT00394329|Autonomic Agents|autonomic agents|mesh-ancestor
64533261|NCT00394329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64297813|NCT02069197|Orlistat|orlistat|mesh-list
64297814|NCT02069197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652831|NCT01722968|Growth Inhibitors|growth inhibitors|mesh-ancestor
64462351|NCT03588754|Vasodilator Agents|vasodilator agents|mesh-ancestor
64652832|NCT04379180|Bosentan|bosentan|mesh-list
64462361|NCT01604343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64462362|NCT01604343|Immunologic Factors|immunologic factors|mesh-ancestor
64462363|NCT01604343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462364|NCT01801436|Bortezomib|bortezomib|mesh-list
64462365|NCT01801436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462366|NCT01771250|Insulin|insulin|mesh-list
64462367|NCT01771250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64462368|NCT01771250|Insulin Glargine|insulin glargine|mesh-list
64462369|NCT01771250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64462370|NCT01771250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462371|NCT03568708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64462372|NCT03568708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64462373|NCT03568708|Estradiol|estradiol|mesh-list
64462374|NCT03568708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64462408|NCT04305106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64462410|NCT04305106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462411|NCT04305106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462412|NCT04305106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64462413|NCT04305106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64462414|NCT01770392|Rifampin|rifampin|mesh-list
64462415|NCT01770392|Nintedanib|nintedanib|mesh-list
64462416|NCT01770392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64462435|NCT01603641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64462436|NCT01603641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64889253|NCT01965730|Aminocaproic Acid|aminocaproic acid|mesh-list
64889254|NCT01965730|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64889255|NCT01965730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64889256|NCT01965730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889257|NCT01965730|Hemostatics|hemostatics|mesh-ancestor
64889258|NCT01965730|Coagulants|coagulants|mesh-ancestor
64889259|NCT01965925|Modafinil|modafinil|mesh-list
64889260|NCT01965925|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64889261|NCT01965925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889262|NCT01965925|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64889263|NCT01965925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64519846|NCT00183339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64519847|NCT00183339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64519848|NCT00183339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519849|NCT00183729|Memantine|memantine|mesh-list
64519850|NCT00183729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64519851|NCT00183729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64519852|NCT00183729|Dopamine Agents|dopamine agents|mesh-ancestor
64519853|NCT00183729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64889264|NCT01965925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64889265|NCT01965925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889266|NCT01965977|Bortezomib|bortezomib|mesh-list
64889267|NCT01965977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889268|NCT01966055|Solithromycin|solithromycin|mesh-list
64889310|NCT01966276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64889311|NCT01966276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64889312|NCT01966276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64889313|NCT01966276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889314|NCT01966276|Dopamine Agents|dopamine agents|mesh-ancestor
64889315|NCT01966276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64889316|NCT01966289|Cyclophosphamide|cyclophosphamide|mesh-list
64889317|NCT01966289|Guadecitabine|guadecitabine|mesh-list
64889318|NCT01966289|Immunologic Factors|immunologic factors|mesh-ancestor
64533262|NCT00394329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533263|NCT00394329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64533264|NCT00394329|Respiratory System Agents|respiratory system agents|mesh-ancestor
64533265|NCT00394329|Tocolytic Agents|tocolytic agents|mesh-ancestor
64533266|NCT00394329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64533267|NCT00394329|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64533268|NCT00394329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64533269|NCT00394329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64533270|NCT00394329|Adrenergic Agents|adrenergic agents|mesh-ancestor
64533271|NCT00394329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64533272|NCT00394329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533273|NCT00394329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64533274|NCT00394329|Glucocorticoids|glucocorticoids|mesh-ancestor
64533275|NCT00394329|Hormones|hormones|mesh-ancestor
64533276|NCT00394329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64533277|NCT03146052|Simethicone|simethicone|mesh-list
64533278|NCT03146052|Bisacodyl|bisacodyl|mesh-list
64533279|NCT03146052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533280|NCT03146052|Cathartics|cathartics|mesh-ancestor
64533281|NCT03146052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64533282|NCT03146052|Laxatives|laxatives|mesh-ancestor
64533283|NCT03146052|Antifoaming Agents|antifoaming agents|mesh-ancestor
64533284|NCT03146052|Emollients|emollients|mesh-ancestor
64533285|NCT03146052|Dermatologic Agents|dermatologic agents|mesh-ancestor
64533286|NCT01549951|Prednisone|prednisone|mesh-list
64297834|NCT02069431|Oxytocin|oxytocin|mesh-list
64462437|NCT01603641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462439|NCT01603641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64462440|NCT01603641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462441|NCT01603641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64462442|NCT01603641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462443|NCT03492112|Sofosbuvir|sofosbuvir|mesh-list
64462444|NCT03492112|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64462445|NCT03492112|Velpatasvir|velpatasvir|mesh-list
64462446|NCT03492112|Antiviral Agents|antiviral agents|mesh-ancestor
64462447|NCT03492112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64462448|NCT01556763|Antipsychotic Agents|antipsychotic agents|mesh-list
64533298|NCT03148314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533299|NCT03148314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64533300|NCT03148314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64533301|NCT03148314|Oxytocics|oxytocics|mesh-ancestor
64533302|NCT01517893|Simvastatin|simvastatin|mesh-list
64533303|NCT01517893|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64533304|NCT01517893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64533305|NCT01517893|Antimetabolites|antimetabolites|mesh-ancestor
64533306|NCT01517893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533307|NCT01517893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64533308|NCT01517893|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64533309|NCT01517893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533310|NCT02344992|Insulin Lispro|insulin lispro|mesh-list
64533311|NCT02344992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64533312|NCT02344992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533313|NCT01489891|Lidocaine|lidocaine|mesh-list
64533314|NCT01489891|Anesthetics, Local|anesthetics, local|mesh-ancestor
64533315|NCT01489891|Anesthetics|anesthetics|mesh-ancestor
64533316|NCT01489891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64533328|NCT03148002|Lactulose|lactulose|mesh-list
64533329|NCT03148002|Sennosides|sennosides|mesh-list
64889319|NCT01966289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889320|NCT01966289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64889321|NCT01966289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64889322|NCT01966289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64889323|NCT01966289|Alkylating Agents|alkylating agents|mesh-ancestor
64889324|NCT01966289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889325|NCT01966289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889326|NCT01966289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64889327|NCT01966302|Beraprost|beraprost|mesh-list
64889328|NCT01966302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64889329|NCT01966302|Vasodilator Agents|vasodilator agents|mesh-ancestor
64889330|NCT01966341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64889331|NCT01966341|Laxatives|laxatives|mesh-list
64889358|NCT01966575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64889359|NCT01966575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889361|NCT01966575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64519854|NCT00183729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519855|NCT00183729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519856|NCT00183729|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64519857|NCT00183729|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64519858|NCT00186069|Magnesium Sulfate|magnesium sulfate|mesh-list
64519859|NCT00186069|Analgesics|analgesics|mesh-ancestor
64519860|NCT00186069|Sensory System Agents|sensory system agents|mesh-ancestor
64519861|NCT00186069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64519862|NCT00186069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519863|NCT00186069|Anesthetics|anesthetics|mesh-ancestor
64519864|NCT00186069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64519865|NCT00186069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64519866|NCT00186069|Anticonvulsants|anticonvulsants|mesh-ancestor
64519867|NCT00186069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64519868|NCT00186069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64519869|NCT00186069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642194|NCT00546104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64533330|NCT03148002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64533331|NCT03148002|Laxatives|laxatives|mesh-ancestor
64533332|NCT02342184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64533333|NCT02342184|Immunologic Factors|immunologic factors|mesh-ancestor
64533334|NCT02342184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642236|NCT00551174|Ibandronic Acid|ibandronic acid|mesh-list
64519870|NCT00186069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64519871|NCT00186069|Tocolytic Agents|tocolytic agents|mesh-ancestor
64642237|NCT00551174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64519872|NCT00186069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64519873|NCT01742897|Fentanyl|fentanyl|mesh-list
64519874|NCT01742897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64519875|NCT01742897|Narcotics|narcotics|mesh-ancestor
64519876|NCT01742897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64519877|NCT01742897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519878|NCT01742897|Analgesics|analgesics|mesh-ancestor
64519879|NCT01742897|Sensory System Agents|sensory system agents|mesh-ancestor
64519880|NCT01742897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889362|NCT01966627|Liver Extracts|liver extracts|mesh-list
64889363|NCT01966627|Hematinics|hematinics|mesh-ancestor
64889364|NCT01966653|Fosfomycin|fosfomycin|mesh-list
64889365|NCT01966653|Nitrofurantoin|nitrofurantoin|mesh-list
64889366|NCT01966653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64889367|NCT01966653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64889368|NCT01966653|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64889369|NCT01966653|Renal Agents|renal agents|mesh-ancestor
64642238|NCT00551174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533335|NCT00396201|Plerixafor|plerixafor|mesh-list
64462465|NCT04397458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462466|NCT04397458|Anesthetics, Local|anesthetics, local|mesh-ancestor
64462467|NCT04397458|Anesthetics|anesthetics|mesh-ancestor
64462468|NCT04397458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64462476|NCT04398316|Sensory System Agents|sensory system agents|mesh-ancestor
64462477|NCT04398316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462478|NCT04398316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64462479|NCT04398316|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64462480|NCT04398316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64462481|NCT04398316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64462482|NCT04398316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462483|NCT04398316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64462484|NCT04398316|Narcotics|narcotics|mesh-ancestor
64462485|NCT04398316|Analgesics|analgesics|mesh-ancestor
64462486|NCT01576575|Rifampin|rifampin|mesh-list
64462487|NCT01576575|Ketoconazole|ketoconazole|mesh-list
64462488|NCT01576575|Buprenorphine|buprenorphine|mesh-list
64462489|NCT01576575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64462490|NCT01576575|Narcotics|narcotics|mesh-ancestor
64462491|NCT01576575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64462492|NCT01576575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462493|NCT01576575|Analgesics|analgesics|mesh-ancestor
64462494|NCT01576575|Sensory System Agents|sensory system agents|mesh-ancestor
64462495|NCT01576575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462496|NCT01576575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64462497|NCT01576575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64462498|NCT01576575|Antitubercular Agents|antitubercular agents|mesh-ancestor
64462499|NCT01576575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64462500|NCT01576575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64462501|NCT01576575|Leprostatic Agents|leprostatic agents|mesh-ancestor
64462502|NCT01576575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64462503|NCT01576575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889370|NCT01966692|Fluticasone|fluticasone|mesh-list
64642292|NCT00432458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889371|NCT01966692|Xhance|xhance|mesh-list
64889372|NCT01966692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64889373|NCT01966692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64889374|NCT01966692|Autonomic Agents|autonomic agents|mesh-ancestor
64889375|NCT01966692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889376|NCT01966692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889377|NCT01966692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64889378|NCT01966692|Respiratory System Agents|respiratory system agents|mesh-ancestor
64889390|NCT01966783|Glucocorticoids|glucocorticoids|mesh-ancestor
64889391|NCT01966783|Hormones|hormones|mesh-ancestor
64889392|NCT01966783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64519881|NCT01742897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64519882|NCT01742897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64519883|NCT01742897|Anesthetics, General|anesthetics, general|mesh-ancestor
64642302|NCT01482715|Rucaparib|rucaparib|mesh-list
64462504|NCT01576575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462505|NCT01576575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64462506|NCT01576575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64462507|NCT01576575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64462508|NCT01576575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64462509|NCT01576575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64462510|NCT01576575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64462511|NCT01576575|Antifungal Agents|antifungal agents|mesh-ancestor
64462512|NCT01576575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64462513|NCT01576575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64462514|NCT01576575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64533340|NCT03145896|Vitamin D|vitamin d|mesh-list
64533341|NCT03145896|Vitamins|vitamins|mesh-ancestor
64533342|NCT03145896|Micronutrients|micronutrients|mesh-ancestor
64533343|NCT03145896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533344|NCT03145896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64533345|NCT02341872|Calcium|calcium|mesh-list
64533346|NCT02341872|Fluorides|fluorides|mesh-list
64533347|NCT02341872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64533348|NCT02341872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533349|NCT02341872|Cariostatic Agents|cariostatic agents|mesh-ancestor
64462515|NCT01576575|Hormone Antagonists|hormone antagonists|mesh-ancestor
64462516|NCT01576575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64462522|NCT05051566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462523|NCT05051566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462525|NCT01576341|Hematinics|hematinics|mesh-ancestor
64462526|NCT04276090|Dexamethasone|dexamethasone|mesh-list
64462527|NCT04276090|Floxuridine|floxuridine|mesh-list
64462528|NCT04276090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64462529|NCT04276090|Antiemetics|antiemetics|mesh-ancestor
64462530|NCT04276090|Autonomic Agents|autonomic agents|mesh-ancestor
64462531|NCT04276090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462532|NCT04276090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462533|NCT04276090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64462561|NCT01892722|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64462562|NCT01892722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462563|NCT01892722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64462565|NCT04398004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64462566|NCT04398004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64462567|NCT04398004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64519885|NCT04554485|Blinatumomab|blinatumomab|mesh-list
64519886|NCT04554485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519887|NCT01741259|Meperidine|meperidine|mesh-list
64519888|NCT01741259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64519889|NCT01741259|Narcotics|narcotics|mesh-ancestor
64519890|NCT01741259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64519891|NCT01741259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519892|NCT01741259|Analgesics|analgesics|mesh-ancestor
64519893|NCT01741259|Sensory System Agents|sensory system agents|mesh-ancestor
64519894|NCT01741259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64519895|NCT01741259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64519896|NCT01715129|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64519897|NCT01715129|Luteolytic Agents|luteolytic agents|mesh-ancestor
64519898|NCT01715129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64519899|NCT01715129|Contraceptive Agents|contraceptive agents|mesh-ancestor
64519900|NCT01715129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64889393|NCT01966783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64889394|NCT01966783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64889395|NCT01966783|Analgesics|analgesics|mesh-ancestor
64889396|NCT01966783|Sensory System Agents|sensory system agents|mesh-ancestor
64889397|NCT01966783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64889398|NCT01966822|Ritonavir|ritonavir|mesh-list
64642353|NCT03007927|Dexamethasone|dexamethasone|mesh-list
64462568|NCT04398004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462569|NCT04398004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462570|NCT04398004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64462571|NCT04398004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64462572|NCT01687413|Cisplatin|cisplatin|mesh-list
64462573|NCT01687413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462574|NCT01555671|Meperidine|meperidine|mesh-list
64462575|NCT01555671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64462576|NCT01555671|Narcotics|narcotics|mesh-ancestor
64462577|NCT01555671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64462578|NCT01555671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462605|NCT01801280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64462606|NCT01801280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64462607|NCT01769456|Tenofovir|tenofovir|mesh-list
64462608|NCT01769456|Emtricitabine|emtricitabine|mesh-list
64462609|NCT01769456|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64462610|NCT01769456|Antiviral Agents|antiviral agents|mesh-ancestor
64462611|NCT01769456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64462612|NCT01769456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64462613|NCT01769456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64462614|NCT01769456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462615|NCT01769456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462616|NCT01769456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64462617|NCT01769456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64462618|NCT01769378|Glimepiride|glimepiride|mesh-list
64462619|NCT01769378|Dulaglutide|dulaglutide|mesh-list
64533350|NCT02341872|Protective Agents|protective agents|mesh-ancestor
64533351|NCT00360399|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64533353|NCT00360399|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64533354|NCT00360399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64889399|NCT01966822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
64889400|NCT01966822|Dolutegravir|dolutegravir|mesh-list
64889401|NCT01966822|Protease Inhibitors|protease inhibitors|mesh-list
64889402|NCT01966822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64889403|NCT01966822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889404|NCT01966822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889405|NCT01966822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64889406|NCT01966822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64889407|NCT01966822|Antiviral Agents|antiviral agents|mesh-ancestor
64889408|NCT01966822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64889409|NCT01966822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64889410|NCT01966822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64889411|NCT01966822|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64889412|NCT01966822|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64889413|NCT01966913|Bevacizumab|bevacizumab|mesh-list
64889414|NCT01966913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64889415|NCT01966913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889416|NCT01966913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64642406|NCT05090358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64889417|NCT01966913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64889418|NCT01966913|Growth Substances|growth substances|mesh-ancestor
64889419|NCT01966913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889420|NCT01966913|Growth Inhibitors|growth inhibitors|mesh-ancestor
64889421|NCT01967017|Lidocaine|lidocaine|mesh-list
64889422|NCT01967017|Anesthetics, Local|anesthetics, local|mesh-ancestor
64889423|NCT01967017|Anesthetics|anesthetics|mesh-ancestor
64889424|NCT01967017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64889425|NCT01967017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533355|NCT00360399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64533356|NCT00360399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533357|NCT00360399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64533358|NCT00360399|Serotonin Agents|serotonin agents|mesh-ancestor
64533359|NCT00360399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533360|NCT00360399|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64533361|NCT00360399|Antidepressive Agents|antidepressive agents|mesh-ancestor
64297928|NCT02069977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64462620|NCT01769378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64462621|NCT01769378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64945384|NCT05672225|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64462622|NCT01769378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462623|NCT01769378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64462624|NCT01769378|Immunologic Factors|immunologic factors|mesh-ancestor
64462654|NCT01968967|Antimetabolites|antimetabolites|mesh-ancestor
64462662|NCT01930045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64462663|NCT01930045|Antiviral Agents|antiviral agents|mesh-ancestor
64889426|NCT01967017|Sensory System Agents|sensory system agents|mesh-ancestor
64889427|NCT01967017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64519901|NCT01715129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519902|NCT01715129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64519903|NCT01715129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64462664|NCT01930045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64462665|NCT01930045|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64462666|NCT01930045|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64462667|NCT01930045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462668|NCT01930045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462669|NCT01930045|Antacids|antacids|mesh-ancestor
64462692|NCT01798706|Lixisenatide|lixisenatide|mesh-list
64462693|NCT01798706|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64462694|NCT01798706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462695|NCT01767194|Sirolimus|sirolimus|mesh-list
64462696|NCT01767194|Irinotecan|irinotecan|mesh-list
64462697|NCT01767194|Camptothecin|camptothecin|mesh-list
64462698|NCT01767194|Temozolomide|temozolomide|mesh-list
64462699|NCT01767194|Dinutuximab|dinutuximab|mesh-list
64462700|NCT01767194|Sargramostim|sargramostim|mesh-list
64462701|NCT01767194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64462702|NCT01767194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64462703|NCT01767194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462704|NCT01767194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462705|NCT01767194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462706|NCT01767194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64462707|NCT01767194|Alkylating Agents|alkylating agents|mesh-ancestor
64462708|NCT01767194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64462709|NCT01767194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64462710|NCT01767194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64462711|NCT01767194|Antifungal Agents|antifungal agents|mesh-ancestor
64462712|NCT01767194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64462713|NCT01767194|Immunologic Factors|immunologic factors|mesh-ancestor
64462714|NCT01767194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462715|NCT01767194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64462716|NCT01575873|Denosumab|denosumab|mesh-list
64533362|NCT00360399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64714128|NCT00374101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533363|NCT00360399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64533364|NCT00360399|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64533365|NCT00360399|Analgesics|analgesics|mesh-ancestor
64533366|NCT00360399|Sensory System Agents|sensory system agents|mesh-ancestor
64533367|NCT00360399|Dopamine Agents|dopamine agents|mesh-ancestor
64533368|NCT02341794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64533369|NCT02341794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64533370|NCT02341794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64533371|NCT02341794|Antimetabolites|antimetabolites|mesh-ancestor
64533372|NCT02341794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533373|NCT02341794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64533374|NCT02341794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64533375|NCT02341794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533376|NCT02344602|Febuxostat|febuxostat|mesh-list
64533377|NCT02344602|Gout Suppressants|gout suppressants|mesh-ancestor
64533378|NCT02344602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64533379|NCT02348268|Analgesics|analgesics|mesh-list
64533380|NCT02348268|Sensory System Agents|sensory system agents|mesh-ancestor
64533381|NCT02348268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64533382|NCT02348268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533383|NCT02348346|Titanium dioxide|titanium dioxide|mesh-list
64533384|NCT02348346|Sunscreening Agents|sunscreening agents|mesh-ancestor
64462717|NCT01575873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64462718|NCT01575873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462719|NCT04276636|Calcium Carbonate|calcium carbonate|mesh-list
64462746|NCT01575561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64462747|NCT01575561|Serotonin Agents|serotonin agents|mesh-ancestor
64462748|NCT01575561|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64462749|NCT01575561|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64462750|NCT01575561|Dopamine Agents|dopamine agents|mesh-ancestor
64513634|NCT01457469|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64519904|NCT01715129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519906|NCT02387554|Amlodipine|amlodipine|mesh-list
64519907|NCT02387554|Chlorthalidone|chlorthalidone|mesh-list
64519908|NCT02387554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64519909|NCT02387554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64519910|NCT02387554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64519911|NCT02387554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519912|NCT02387554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64519913|NCT02387554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519914|NCT02387554|Vasodilator Agents|vasodilator agents|mesh-ancestor
64519915|NCT02387554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64519916|NCT02387554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64519917|NCT02387554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64889428|NCT01967017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64889429|NCT01967017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64889430|NCT01967017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64889431|NCT01967017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64889432|NCT01967017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889433|NCT01967095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64889434|NCT01967095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889435|NCT01967095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64889436|NCT01967095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462752|NCT03021460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64462753|NCT03021460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462754|NCT04397770|Temozolomide|temozolomide|mesh-list
64462756|NCT04397770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64462757|NCT04397770|Alkylating Agents|alkylating agents|mesh-ancestor
64462758|NCT04397770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533385|NCT02348346|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64533386|NCT02348346|Protective Agents|protective agents|mesh-ancestor
64533387|NCT02348346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533388|NCT02348346|Dermatologic Agents|dermatologic agents|mesh-ancestor
64533389|NCT02348346|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64533391|NCT00361257|Tetracycline|tetracycline|mesh-list
64533392|NCT00361257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64533393|NCT00361257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64533394|NCT00361257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64533395|NCT00361257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533396|NCT00361257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533397|NCT02341404|Hydroxyflutamide|hydroxyflutamide|mesh-list
64533398|NCT02341404|Androgen Antagonists|androgen antagonists|mesh-ancestor
64533399|NCT02341404|Hormone Antagonists|hormone antagonists|mesh-ancestor
64533400|NCT02341404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64462759|NCT04397770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462760|NCT04397770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64462761|NCT04397770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462762|NCT03082846|Temozolomide|temozolomide|mesh-list
64462763|NCT03082846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64889437|NCT01967095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889438|NCT01967199|Paclitaxel|paclitaxel|mesh-list
64889439|NCT01967199|Everolimus|everolimus|mesh-list
64889440|NCT01967199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64889441|NCT01967199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889442|NCT01967199|Tubulin Modulators|tubulin modulators|mesh-ancestor
64889466|NCT01967381|Autonomic Agents|autonomic agents|mesh-ancestor
64889467|NCT01967381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889468|NCT01967381|Dopamine Agents|dopamine agents|mesh-ancestor
64889469|NCT01967381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64889470|NCT01967381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889471|NCT01967381|Adrenergic Agents|adrenergic agents|mesh-ancestor
64889472|NCT01967381|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64889473|NCT01967381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64889474|NCT01967381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64889475|NCT01967381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64889476|NCT01967459|Cholecalciferol|cholecalciferol|mesh-list
64462764|NCT03082846|Alkylating Agents|alkylating agents|mesh-ancestor
64462765|NCT03082846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462766|NCT03082846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462767|NCT02397226|Anesthetics|anesthetics|mesh-list
64462768|NCT02397226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64462769|NCT02397226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462770|NCT05249920|Edaravone|edaravone|mesh-list
64462771|NCT05249920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64462772|NCT05249920|Antioxidants|antioxidants|mesh-ancestor
64462773|NCT05249920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462803|NCT01574703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462804|NCT01574703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64462805|NCT01574703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64462806|NCT01574703|Cholinergic Agents|cholinergic agents|mesh-ancestor
64462807|NCT01574703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64462808|NCT01574703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462809|NCT01574703|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64462810|NCT01574703|Antidepressive Agents|antidepressive agents|mesh-ancestor
64462811|NCT01574703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64462812|NCT01574703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64462813|NCT01574703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64462814|NCT01574703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64652893|NCT01578317|Vaccines|vaccines|mesh-list
64462821|NCT01686633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64462844|NCT03141424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64462845|NCT03141424|Autonomic Agents|autonomic agents|mesh-ancestor
64462846|NCT03141424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462847|NCT03141424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462848|NCT03141424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64462849|NCT03141424|Respiratory System Agents|respiratory system agents|mesh-ancestor
64533401|NCT02341404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533403|NCT02341638|Itraconazole|itraconazole|mesh-list
64533404|NCT02341638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64533405|NCT02341638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64533406|NCT02341638|Analgesics|analgesics|mesh-ancestor
64533407|NCT02341638|Sensory System Agents|sensory system agents|mesh-ancestor
64533408|NCT02341638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64533409|NCT02341638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889477|NCT01967459|Vitamin D|vitamin d|mesh-list
64889478|NCT01967459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64889479|NCT01967459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889480|NCT01967459|Vitamins|vitamins|mesh-ancestor
64533410|NCT02341638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64533411|NCT02341638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64533412|NCT02341638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64533413|NCT02341638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64533414|NCT02341638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533415|NCT02341638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64533416|NCT02341638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64533417|NCT02341638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533418|NCT02341638|Antipyretics|antipyretics|mesh-ancestor
64297979|NCT02412670|Cisplatin|cisplatin|mesh-list
64462850|NCT03141424|Dermatologic Agents|dermatologic agents|mesh-ancestor
64462851|NCT03141424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64462852|NCT03141424|Glucocorticoids|glucocorticoids|mesh-ancestor
64462853|NCT03141424|Hormones|hormones|mesh-ancestor
64462854|NCT03141424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64462855|NCT03614494|Piroxicam|piroxicam|mesh-list
64462856|NCT03614494|Levonorgestrel|levonorgestrel|mesh-list
64462857|NCT03614494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64462858|NCT03614494|Contraceptive Agents|contraceptive agents|mesh-ancestor
64462859|NCT03614494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64462860|NCT03614494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462861|NCT03614494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64462862|NCT03614494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64462863|NCT03614494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64462864|NCT03614494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64462865|NCT03614494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64462866|NCT03614494|Analgesics|analgesics|mesh-ancestor
64462867|NCT03614494|Sensory System Agents|sensory system agents|mesh-ancestor
64462868|NCT03614494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462869|NCT03614494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64462870|NCT03614494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64462871|NCT03614494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64462872|NCT03614494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462873|NCT03614494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462874|NCT03028155|Oxaliplatin|oxaliplatin|mesh-list
64462875|NCT03028155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462876|NCT04276480|Tazobactam|tazobactam|mesh-list
64462877|NCT04276480|Piperacillin|piperacillin|mesh-list
64462902|NCT01573767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64462903|NCT01573767|Respiratory System Agents|respiratory system agents|mesh-ancestor
64462904|NCT01573767|Dermatologic Agents|dermatologic agents|mesh-ancestor
64462905|NCT01573767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64462906|NCT04396990|Prednisolone|prednisolone|mesh-list
64462907|NCT04396990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64462908|NCT04396990|Glucocorticoids|glucocorticoids|mesh-ancestor
64462909|NCT04396990|Hormones|hormones|mesh-ancestor
64533419|NCT02341638|Antifungal Agents|antifungal agents|mesh-ancestor
64533420|NCT02341638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64533421|NCT02341638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64652905|NCT01723670|Flurbiprofen|flurbiprofen|mesh-list
64533434|NCT02337192|Dermatologic Agents|dermatologic agents|mesh-ancestor
64297998|NCT02412670|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64462910|NCT04396990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64462911|NCT04396990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462912|NCT04396990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64462913|NCT04396990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462915|NCT03133546|Osimertinib|osimertinib|mesh-list
64462916|NCT03133546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64462917|NCT03133546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462918|NCT03133546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64462919|NCT03133546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64462920|NCT03133546|Growth Substances|growth substances|mesh-ancestor
64462921|NCT03133546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462922|NCT03133546|Growth Inhibitors|growth inhibitors|mesh-ancestor
64462923|NCT03133546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64462924|NCT03133546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462925|NCT03133546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889481|NCT01967459|Micronutrients|micronutrients|mesh-ancestor
64889482|NCT01967459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64889483|NCT01967472|Artesunate|artesunate|mesh-list
64889484|NCT01967472|Lumefantrine|lumefantrine|mesh-list
64889485|NCT01967472|Artemether|artemether|mesh-list
64889486|NCT01967472|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64519919|NCT02387554|Natriuretic Agents|natriuretic agents|mesh-ancestor
64519920|NCT02387554|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64519921|NCT02387710|Tiagabine|tiagabine|mesh-list
64519922|NCT02387710|Anticonvulsants|anticonvulsants|mesh-ancestor
64519923|NCT02387710|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
64519924|NCT02387710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64519925|NCT02387710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64519926|NCT02387710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519927|NCT02387710|GABA Agents|gaba agents|mesh-ancestor
64519928|NCT02387710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64519929|NCT02387710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519930|NCT01740791|Velpatasvir|velpatasvir|mesh-list
64642704|NCT05028348|Elotuzumab|elotuzumab|mesh-list
64462926|NCT01551303|Oxytocin|oxytocin|mesh-list
64462927|NCT01551303|Oxytocics|oxytocics|mesh-ancestor
64462960|NCT01550289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462961|NCT01968031|Istradefylline|istradefylline|mesh-list
64462962|NCT01968031|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
64462963|NCT01968031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64462964|NCT01968031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64462965|NCT01968031|Purinergic Agents|purinergic agents|mesh-ancestor
64462966|NCT01968031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64462967|NCT01968031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462985|NCT03911739|Buprenorphine|buprenorphine|mesh-list
64462986|NCT03911739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64462987|NCT03911739|Narcotics|narcotics|mesh-ancestor
64462988|NCT03911739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64462989|NCT03911739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462990|NCT03911739|Analgesics|analgesics|mesh-ancestor
64462991|NCT03911739|Sensory System Agents|sensory system agents|mesh-ancestor
64462992|NCT03911739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462993|NCT03911739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64462994|NCT01549041|Asenapine|asenapine|mesh-list
64462995|NCT01549041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64462996|NCT01549041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64533435|NCT02337192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64533436|NCT02337192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64533437|NCT02337192|Analgesics|analgesics|mesh-ancestor
64533438|NCT02337192|Sensory System Agents|sensory system agents|mesh-ancestor
64714129|NCT00373789|Botulinum Toxins|botulinum toxins|mesh-list
64533439|NCT02337192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64533440|NCT02337192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533441|NCT02337192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64533442|NCT02337192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64463021|NCT01548573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64463022|NCT01548573|Immunologic Factors|immunologic factors|mesh-ancestor
64463023|NCT01548573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463024|NCT01548573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64463025|NCT01548573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64463026|NCT01548573|Alkylating Agents|alkylating agents|mesh-ancestor
64463027|NCT01548573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519931|NCT01740791|Antiviral Agents|antiviral agents|mesh-ancestor
64519932|NCT01740791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64519933|NCT01740401|Cyclophosphamide|cyclophosphamide|mesh-list
64519935|NCT01740401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64519936|NCT01740401|Immunologic Factors|immunologic factors|mesh-ancestor
64519937|NCT01740401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519938|NCT01740401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64519939|NCT01740401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64519940|NCT01740401|Alkylating Agents|alkylating agents|mesh-ancestor
64519941|NCT01740401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519942|NCT01740401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519943|NCT01740401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64519944|NCT01740401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64519945|NCT01740401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64889487|NCT01967472|Amodiaquine|amodiaquine|mesh-list
64889488|NCT01967472|Antimalarials|antimalarials|mesh-ancestor
64889489|NCT01967472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64463028|NCT01548573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463054|NCT01518153|Methotrexate|methotrexate|mesh-list
64463055|NCT01518153|Fludarabine phosphate|fludarabine phosphate|mesh-list
64463056|NCT01518153|Fludarabine|fludarabine|mesh-list
64463057|NCT01518153|Melphalan|melphalan|mesh-list
64463058|NCT01518153|Alemtuzumab|alemtuzumab|mesh-list
64463059|NCT01518153|Tacrolimus|tacrolimus|mesh-list
64463060|NCT01518153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64463061|NCT01518153|Abortifacient Agents|abortifacient agents|mesh-ancestor
64463062|NCT01518153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64463063|NCT01518153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463064|NCT01518153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64463065|NCT01518153|Antimetabolites|antimetabolites|mesh-ancestor
64463066|NCT01518153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463067|NCT01518153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463068|NCT01518153|Dermatologic Agents|dermatologic agents|mesh-ancestor
64463069|NCT01518153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64463070|NCT01518153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64463071|NCT01518153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64298028|NCT02071927|Azacitidine|azacitidine|mesh-list
64463076|NCT01518153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64463077|NCT01518153|Alkylating Agents|alkylating agents|mesh-ancestor
64463078|NCT01518153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64463107|NCT01548417|Contraceptive Agents|contraceptive agents|mesh-ancestor
64463108|NCT01548417|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64463109|NCT01548417|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64463110|NCT01548417|Hormone Antagonists|hormone antagonists|mesh-ancestor
64463111|NCT01548417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64463112|NCT01548417|Luteolytic Agents|luteolytic agents|mesh-ancestor
64463113|NCT01548417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64463114|NCT01548417|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64463115|NCT01546857|Gabapentin|gabapentin|mesh-list
64463116|NCT01546857|Analgesics|analgesics|mesh-ancestor
64463117|NCT01546857|Sensory System Agents|sensory system agents|mesh-ancestor
64463118|NCT01546857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64463119|NCT01546857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463120|NCT01546857|Anticonvulsants|anticonvulsants|mesh-ancestor
64463121|NCT01546857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64463122|NCT01546857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64463151|NCT01515189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463152|NCT01546623|Leuprolide|leuprolide|mesh-list
64889490|NCT01967472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64889491|NCT01967472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64889492|NCT01967472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889521|NCT01967524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64889522|NCT01967524|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64889523|NCT01967758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64642821|NCT05021094|Progestins|progestins|mesh-ancestor
64463153|NCT01546623|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64463154|NCT01546623|Fertility Agents|fertility agents|mesh-ancestor
64463155|NCT01546623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64463156|NCT01546623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463157|NCT01546623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64463158|NCT01546623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463159|NCT00636610|Bevacizumab|bevacizumab|mesh-list
64463160|NCT00636610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64463161|NCT00636610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463162|NCT00636610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64463163|NCT00636610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64463164|NCT00636610|Growth Substances|growth substances|mesh-ancestor
64463188|NCT01923376|Lactulose|lactulose|mesh-list
64463189|NCT01923376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64463190|NCT01923376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64463191|NCT01923376|Laxatives|laxatives|mesh-ancestor
64463192|NCT05245786|Copper|copper|mesh-list
64463193|NCT05245786|Antibodies|antibodies|mesh-list
64463194|NCT05245786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64463195|NCT05245786|Immunologic Factors|immunologic factors|mesh-ancestor
64463196|NCT05245786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463197|NCT05245786|Trace Elements|trace elements|mesh-ancestor
64463198|NCT05245786|Micronutrients|micronutrients|mesh-ancestor
64463199|NCT00634504|Leucovorin|leucovorin|mesh-list
64513636|NCT01457469|Cholinergic Agents|cholinergic agents|mesh-ancestor
64463200|NCT00634504|Methotrexate|methotrexate|mesh-list
64463201|NCT00634504|Levoleucovorin|levoleucovorin|mesh-list
64533460|NCT02343666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533462|NCT02343666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64533463|NCT02343666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64533464|NCT02343666|Antiviral Agents|antiviral agents|mesh-ancestor
64533465|NCT02343666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64533466|NCT02343666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533467|NCT02332356|Adalimumab|adalimumab|mesh-list
64533468|NCT02332356|Azathioprine|azathioprine|mesh-list
64533469|NCT02332356|Infliximab|infliximab|mesh-list
64533470|NCT02332356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64463206|NCT00634504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64463207|NCT00634504|Antimetabolites|antimetabolites|mesh-ancestor
64463208|NCT00634504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463209|NCT00634504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463210|NCT00634504|Dermatologic Agents|dermatologic agents|mesh-ancestor
64463211|NCT00634504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64463212|NCT00634504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64463213|NCT00634504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64463214|NCT00634504|Immunologic Factors|immunologic factors|mesh-ancestor
64463215|NCT00634504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64463239|NCT05241496|Anesthetics|anesthetics|mesh-ancestor
64463240|NCT05241496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64463241|NCT05241496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463242|NCT05241496|Sensory System Agents|sensory system agents|mesh-ancestor
64463243|NCT05241496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64463244|NCT05241496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64463245|NCT05241496|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64463246|NCT05241496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64463247|NCT05241496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64463248|NCT05241496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463249|NCT01545375|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64463250|NCT01545375|Immunologic Factors|immunologic factors|mesh-ancestor
64463251|NCT01545375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463252|NCT01539837|Deferiprone|deferiprone|mesh-list
64463253|NCT01539837|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64463254|NCT01539837|Chelating Agents|chelating agents|mesh-ancestor
64463255|NCT01539837|Sequestering Agents|sequestering agents|mesh-ancestor
64889525|NCT01967758|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64889526|NCT01967758|Trimethoprim|trimethoprim|mesh-list
64889527|NCT01967758|Sulfamethoxazole|sulfamethoxazole|mesh-list
64889528|NCT01967758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64463256|NCT01539837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463257|NCT03156790|Asparaginase|asparaginase|mesh-list
64463258|NCT03156790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463259|NCT03153202|Pembrolizumab|pembrolizumab|mesh-list
64463260|NCT03153202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64463261|NCT03153202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463262|NCT04410081|Lazertinib|lazertinib|mesh-list
64463263|NCT04410081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64463264|NCT04410081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64463265|NCT04410081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463266|NCT01923844|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64463267|NCT01923844|Beractant|beractant|mesh-list
64463294|NCT01924234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64463295|NCT01924234|Narcotics|narcotics|mesh-ancestor
64463296|NCT01924234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64463297|NCT01924234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533471|NCT02332356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64533472|NCT02332356|Dermatologic Agents|dermatologic agents|mesh-ancestor
64533473|NCT02332356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64533482|NCT02340936|Immunologic Factors|immunologic factors|mesh-ancestor
64533483|NCT02340936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298051|NCT02072083|Anesthetics, General|anesthetics, general|mesh-ancestor
64463299|NCT01924234|Sensory System Agents|sensory system agents|mesh-ancestor
64463300|NCT01924234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64463301|NCT00630058|Interferon-alpha|interferon-alpha|mesh-list
64463302|NCT00630058|Interferon alpha-2|interferon alpha-2|mesh-list
64463303|NCT00630058|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
64463304|NCT00630058|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64463305|NCT00630058|Antiviral Agents|antiviral agents|mesh-ancestor
64463306|NCT00630058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64463307|NCT00630058|Immunologic Factors|immunologic factors|mesh-ancestor
64463308|NCT00630058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463309|NCT00630058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463310|NCT01927198|Verinurad|verinurad|mesh-list
64463311|NCT01927198|Gout Suppressants|gout suppressants|mesh-ancestor
64463312|NCT01927198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64463313|NCT01924468|Haloperidol|haloperidol|mesh-list
64463314|NCT01924468|Haloperidol decanoate|haloperidol decanoate|mesh-list
64463315|NCT01924468|Methylphenidate|methylphenidate|mesh-list
64463316|NCT01924468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64463317|NCT01924468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463343|NCT01924624|Leprostatic Agents|leprostatic agents|mesh-ancestor
64463344|NCT01924624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64463345|NCT01924624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64463346|NCT01924624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64463347|NCT01924624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64463348|NCT01924624|Growth Substances|growth substances|mesh-ancestor
64463349|NCT01924624|Growth Inhibitors|growth inhibitors|mesh-ancestor
64463350|NCT01924624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463352|NCT01929382|Interferon-gamma|interferon-gamma|mesh-list
64463353|NCT01929382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463355|NCT01929382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64463356|NCT00989950|Methylphenidate|methylphenidate|mesh-list
64463357|NCT00989950|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64463358|NCT00989950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463359|NCT00989950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64463360|NCT00989950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64463361|NCT00989950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64463362|NCT00989950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463363|NCT00989950|Dopamine Agents|dopamine agents|mesh-ancestor
64463364|NCT00989950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64463365|NCT03121456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64463394|NCT01905943|Alkylating Agents|alkylating agents|mesh-ancestor
64463395|NCT01905943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463396|NCT01905943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533484|NCT02340936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64533485|NCT02340936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64889529|NCT01967758|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64889530|NCT01967758|Renal Agents|renal agents|mesh-ancestor
64889531|NCT01967758|Antimalarials|antimalarials|mesh-ancestor
64889532|NCT01967758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64889533|NCT01967758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64889534|NCT01967758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64889535|NCT01967758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519947|NCT01740323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64519948|NCT01740323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64519949|NCT01740323|Analgesics|analgesics|mesh-ancestor
64519950|NCT01740323|Sensory System Agents|sensory system agents|mesh-ancestor
64519951|NCT01740323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64519952|NCT01740323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519953|NCT01740323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64519954|NCT01740323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64519955|NCT01740323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519956|NCT01740323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519957|NCT01740323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519958|NCT00090051|Cyclophosphamide|cyclophosphamide|mesh-list
64519959|NCT00090051|Rituximab|rituximab|mesh-list
64519960|NCT00090051|Fludarabine|fludarabine|mesh-list
64519961|NCT00090051|Fludarabine phosphate|fludarabine phosphate|mesh-list
64519962|NCT00090051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64519963|NCT00090051|Immunologic Factors|immunologic factors|mesh-ancestor
64889564|NCT01967875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64889565|NCT01967875|Antimetabolites|antimetabolites|mesh-ancestor
64889566|NCT01967927|Imidazole|imidazole|mesh-list
64889567|NCT01967927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889568|NCT01967927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889569|NCT01967979|Itraconazole|itraconazole|mesh-list
64889570|NCT01967979|Fluoxetine|fluoxetine|mesh-list
64642956|NCT01493947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64642957|NCT01493947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64533486|NCT02340936|Growth Substances|growth substances|mesh-ancestor
64533487|NCT02340936|Growth Inhibitors|growth inhibitors|mesh-ancestor
64533488|NCT02340936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533489|NCT02332044|Bepotastine besilate|bepotastine besilate|mesh-list
64533490|NCT02332044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64533491|NCT02337036|Tacrolimus|tacrolimus|mesh-list
64533492|NCT02337036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64533493|NCT02337036|Immunologic Factors|immunologic factors|mesh-ancestor
64533494|NCT02337036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533495|NCT02337036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64533496|NCT02337036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64463402|NCT01929031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64889571|NCT01967979|Antifungal Agents|antifungal agents|mesh-ancestor
64643000|NCT04214886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889572|NCT01967979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64889573|NCT01967979|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64889574|NCT01967979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64889575|NCT01967979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889576|NCT01967979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889577|NCT01967979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64889610|NCT01968005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64889611|NCT01968005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889612|NCT01968018|Acetaminophen|acetaminophen|mesh-list
64889613|NCT01968018|Tramadol|tramadol|mesh-list
64889614|NCT01968018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64889615|NCT01968018|Analgesics|analgesics|mesh-ancestor
64889624|NCT01968044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64889625|NCT01968044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889626|NCT01968044|Incretins|incretins|mesh-ancestor
64889627|NCT01968044|Hormones|hormones|mesh-ancestor
64889628|NCT01968044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64889629|NCT01968044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64889630|NCT01968044|Protease Inhibitors|protease inhibitors|mesh-ancestor
64889631|NCT01968044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64463404|NCT01929031|Sensory System Agents|sensory system agents|mesh-ancestor
64463405|NCT01929031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64463406|NCT01929031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463407|NCT01929031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64463408|NCT01929031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64463409|NCT01929031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64463435|NCT01920334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463436|NCT03096418|Paclitaxel|paclitaxel|mesh-list
64463437|NCT03096418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64463438|NCT03096418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463439|NCT03096418|Tubulin Modulators|tubulin modulators|mesh-ancestor
64463440|NCT03096418|Antimitotic Agents|antimitotic agents|mesh-ancestor
64463441|NCT03096418|Mitosis Modulators|mitosis modulators|mesh-ancestor
64463442|NCT03096418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463443|NCT00986986|Niacin|niacin|mesh-list
64463444|NCT00986986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64463445|NCT00986986|Antimetabolites|antimetabolites|mesh-ancestor
64463446|NCT00986986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463447|NCT00986986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64463448|NCT00986986|Vasodilator Agents|vasodilator agents|mesh-ancestor
64463449|NCT00986986|Vitamin B Complex|vitamin b complex|mesh-ancestor
64463450|NCT00986986|Vitamins|vitamins|mesh-ancestor
64463451|NCT00986986|Micronutrients|micronutrients|mesh-ancestor
64463452|NCT00986986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463453|NCT01928719|Nicotine|nicotine|mesh-list
64463454|NCT01928719|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64463455|NCT01928719|Autonomic Agents|autonomic agents|mesh-ancestor
64463456|NCT01928719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64463457|NCT01928719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463492|NCT03118492|Alkylating Agents|alkylating agents|mesh-ancestor
64889632|NCT01968044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889633|NCT01968083|Vaccines|vaccines|mesh-list
64889634|NCT01968083|Immunologic Factors|immunologic factors|mesh-ancestor
64889635|NCT01968083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889636|NCT01968161|Asenapine|asenapine|mesh-list
64889637|NCT01968161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64889638|NCT01968161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64889639|NCT01968161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64889640|NCT01968161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889641|NCT01968161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64889642|NCT01968200|Enalapril|enalapril|mesh-list
64519964|NCT00090051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519965|NCT00090051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64519966|NCT00090051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64519967|NCT00090051|Alkylating Agents|alkylating agents|mesh-ancestor
64519968|NCT00090051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519969|NCT00090051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519970|NCT00090051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64519971|NCT00090051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64519972|NCT00090051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64519973|NCT00090051|Antimetabolites|antimetabolites|mesh-ancestor
64519974|NCT01740089|Ribavirin|ribavirin|mesh-list
64519975|NCT01740089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64519976|NCT01740089|Antimetabolites|antimetabolites|mesh-ancestor
64519977|NCT01740089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519978|NCT01740089|Antiviral Agents|antiviral agents|mesh-ancestor
64519979|NCT01740089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64519980|NCT01739933|Dexmedetomidine|dexmedetomidine|mesh-list
64519981|NCT01739933|Propofol|propofol|mesh-list
64519982|NCT01739933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64519983|NCT01739933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64643062|NCT05009862|Aspirin|aspirin|mesh-list
64463493|NCT03118492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463494|NCT03118492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463495|NCT03118492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64463496|NCT03118492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64463497|NCT03118492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64463498|NCT03118492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64463499|NCT03118492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64463500|NCT03118492|Antitubercular Agents|antitubercular agents|mesh-ancestor
64463524|NCT01925638|Ketoconazole|ketoconazole|mesh-list
64533499|NCT02336568|Oxytocics|oxytocics|mesh-ancestor
64533500|NCT02336568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64519984|NCT01739933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519985|NCT01739933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64519986|NCT01739933|Anesthetics, General|anesthetics, general|mesh-ancestor
64519987|NCT01739933|Anesthetics|anesthetics|mesh-ancestor
64889643|NCT01968200|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64889644|NCT01968200|Protease Inhibitors|protease inhibitors|mesh-ancestor
64889645|NCT01968200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889646|NCT01968200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889647|NCT01968200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64533501|NCT02336568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533502|NCT05253768|Glycerol|glycerol|mesh-list
64533503|NCT05253768|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64533504|NCT05253768|Protective Agents|protective agents|mesh-ancestor
64533505|NCT05253768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533506|NCT04630938|Lidocaine|lidocaine|mesh-list
64533507|NCT04630938|Morphine|morphine|mesh-list
64533508|NCT04630938|Anesthetics, Local|anesthetics, local|mesh-ancestor
64533509|NCT04630938|Anesthetics|anesthetics|mesh-ancestor
64533510|NCT04630938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64533511|NCT04630938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533512|NCT04630938|Sensory System Agents|sensory system agents|mesh-ancestor
64533513|NCT04630938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64533514|NCT04630938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64714130|NCT00373789|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64533515|NCT04630938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64463525|NCT01925638|Antifungal Agents|antifungal agents|mesh-ancestor
64463526|NCT01925638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64463527|NCT01925638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64463531|NCT01925638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64463532|NCT01925638|Hormone Antagonists|hormone antagonists|mesh-ancestor
64463533|NCT01925638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64463534|NCT01925638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463535|NCT01925638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64463536|NCT00985738|Dutasteride|dutasteride|mesh-list
64463537|NCT00985738|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64463538|NCT00985738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64463539|NCT00985738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64463540|NCT00985738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463541|NCT00985738|Hormone Antagonists|hormone antagonists|mesh-ancestor
64463542|NCT00985738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64463543|NCT00985738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463544|NCT00985504|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64463545|NCT00985504|Citalopram|citalopram|mesh-list
64463546|NCT00985504|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64463547|NCT00985504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64463548|NCT00985504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64463549|NCT00985504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463550|NCT00985504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64463551|NCT00985504|Serotonin Agents|serotonin agents|mesh-ancestor
64463576|NCT04275388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64463577|NCT04275388|Protease Inhibitors|protease inhibitors|mesh-ancestor
64463578|NCT04275388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64463579|NCT04275388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463580|NCT04275388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64463581|NCT04275388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64463582|NCT04275388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64533516|NCT04630938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64533517|NCT04630938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64533518|NCT04630938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298100|NCT02071069|Irinotecan|irinotecan|mesh-list
64463583|NCT04275388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64889648|NCT01968239|Ranibizumab|ranibizumab|mesh-list
64889649|NCT01968239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64889650|NCT01968239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64463584|NCT04275388|Immunologic Factors|immunologic factors|mesh-ancestor
64463585|NCT04275388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463586|NCT01921426|Avasopasem manganese|avasopasem manganese|mesh-list
64463587|NCT01921426|Antioxidants|antioxidants|mesh-ancestor
64463588|NCT01921426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463589|NCT01921426|Protective Agents|protective agents|mesh-ancestor
64463590|NCT01921426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463591|NCT01921582|Methylphenidate|methylphenidate|mesh-list
64463592|NCT01921582|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64449332|NCT01832727|Hormones|hormones|mesh-ancestor
64463593|NCT01921582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463594|NCT01921582|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64463595|NCT01921582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64463596|NCT01921582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64463597|NCT01921582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463598|NCT01921582|Dopamine Agents|dopamine agents|mesh-ancestor
64463599|NCT01921582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64463600|NCT00985426|Vaccines|vaccines|mesh-list
64463601|NCT00985426|Immunologic Factors|immunologic factors|mesh-ancestor
64463602|NCT00985426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463634|NCT00984568|Dermatologic Agents|dermatologic agents|mesh-ancestor
64463635|NCT00984568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64463636|NCT00984568|Antimetabolites|antimetabolites|mesh-ancestor
64463637|NCT00984568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463638|NCT00984568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64463639|NCT00984568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64463640|NCT00984568|Immunologic Factors|immunologic factors|mesh-ancestor
64463641|NCT00984568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64463642|NCT00984568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64463643|NCT00984568|Analgesics|analgesics|mesh-ancestor
64652974|NCT03405584|Amoxicillin|amoxicillin|mesh-list
64463678|NCT01890265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463679|NCT01890265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463680|NCT01890265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64463681|NCT01890265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64463682|NCT01890265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463684|NCT01890265|Sensory System Agents|sensory system agents|mesh-ancestor
64463685|NCT01890265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64463686|NCT01890265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64463687|NCT01890265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64463688|NCT01890265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64463689|NCT01890265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64463690|NCT01926652|Amlodipine|amlodipine|mesh-list
64463691|NCT01926652|Candesartan|candesartan|mesh-list
64463692|NCT01926652|Candesartan cilexetil|candesartan cilexetil|mesh-list
64463693|NCT01926652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64463694|NCT01926652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64463695|NCT01926652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64463696|NCT01926652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463697|NCT01926652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64463698|NCT01926652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463699|NCT01926652|Vasodilator Agents|vasodilator agents|mesh-ancestor
64463700|NCT01926652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64463729|NCT01890109|Sensory System Agents|sensory system agents|mesh-ancestor
64463730|NCT01890109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64533519|NCT04630938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64533520|NCT04630938|Narcotics|narcotics|mesh-ancestor
64533521|NCT04630938|Analgesics|analgesics|mesh-ancestor
64533523|NCT04594746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64533524|NCT04594746|Vasodilator Agents|vasodilator agents|mesh-ancestor
64298105|NCT02071069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463731|NCT01890109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463732|NCT03069976|Metronidazole|metronidazole|mesh-list
64463733|NCT03069976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64463734|NCT03069976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64463735|NCT03069976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64463736|NCT03069976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64463737|NCT00982930|Tobramycin|tobramycin|mesh-list
64889651|NCT01968239|Growth Substances|growth substances|mesh-ancestor
64889652|NCT01968239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889653|NCT01968239|Growth Inhibitors|growth inhibitors|mesh-ancestor
64889654|NCT01968239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889655|NCT01968395|Caspofungin|caspofungin|mesh-list
64889656|NCT01968395|Antifungal Agents|antifungal agents|mesh-ancestor
64463738|NCT00982930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64463739|NCT00982930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64463740|NCT03088540|Gemcitabine|gemcitabine|mesh-list
64463741|NCT03088540|Paclitaxel|paclitaxel|mesh-list
64463742|NCT03088540|Carboplatin|carboplatin|mesh-list
64463743|NCT03088540|Pemetrexed|pemetrexed|mesh-list
64463744|NCT03088540|Cemiplimab|cemiplimab|mesh-list
64463745|NCT03088540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64463746|NCT03088540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463747|NCT03088540|Tubulin Modulators|tubulin modulators|mesh-ancestor
64463748|NCT03088540|Antimitotic Agents|antimitotic agents|mesh-ancestor
64463749|NCT03088540|Mitosis Modulators|mitosis modulators|mesh-ancestor
64463776|NCT00980044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64463777|NCT03049306|Propranolol|propranolol|mesh-list
64463778|NCT03049306|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64463779|NCT03049306|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64463780|NCT03049306|Adrenergic Agents|adrenergic agents|mesh-ancestor
64463781|NCT03049306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64463782|NCT03049306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463783|NCT03049306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463784|NCT03049306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64463785|NCT03049306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64463794|NCT05601700|Mitosis Modulators|mitosis modulators|mesh-ancestor
64463795|NCT05601700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463796|NCT05601700|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64463797|NCT05601700|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64463798|NCT05601700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64463799|NCT05601700|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64463836|NCT01903837|ALKS-33|alks-33|mesh-list
64463837|NCT01903837|Antiemetics|antiemetics|mesh-ancestor
64463838|NCT01903837|Autonomic Agents|autonomic agents|mesh-ancestor
64463839|NCT01903837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64463840|NCT01903837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463864|NCT00982696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64463865|NCT00982696|Mitosis Modulators|mitosis modulators|mesh-ancestor
64463866|NCT00982696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463867|NCT00982696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64463868|NCT00981526|Telmisartan|telmisartan|mesh-list
64463870|NCT00981526|Clozapine|clozapine|mesh-list
64463871|NCT00981526|Antiemetics|antiemetics|mesh-ancestor
64463872|NCT00981526|Autonomic Agents|autonomic agents|mesh-ancestor
64463873|NCT00981526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64463874|NCT00981526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463875|NCT00981526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64463876|NCT00981526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64463877|NCT00981526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64463878|NCT00981526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64463879|NCT00981526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64533525|NCT04594746|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64533526|NCT04594746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64533527|NCT04594746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533528|NCT04594746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64533529|NCT04594746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64533530|NCT04594746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64533531|NCT04594746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533532|NCT04594746|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64533533|NCT04594746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64463880|NCT00981526|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64463881|NCT00981526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64463882|NCT00981526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64463883|NCT00981526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463884|NCT00981526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64463885|NCT00981526|Serotonin Agents|serotonin agents|mesh-ancestor
64889657|NCT01968395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64889658|NCT01968395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889659|NCT01968395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889660|NCT01968486|Ranibizumab|ranibizumab|mesh-list
64889661|NCT01968486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64889662|NCT01968486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64889663|NCT01968486|Growth Substances|growth substances|mesh-ancestor
64889664|NCT01968486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889665|NCT01968486|Growth Inhibitors|growth inhibitors|mesh-ancestor
64889666|NCT01968486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463886|NCT00981526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64463887|NCT00981526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64463888|NCT00981526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64463889|NCT00981526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64463890|NCT00981526|GABA Antagonists|gaba antagonists|mesh-ancestor
64463909|NCT05607940|Analgesics|analgesics|mesh-ancestor
64463910|NCT05607940|Sensory System Agents|sensory system agents|mesh-ancestor
64463911|NCT05607940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64463912|NCT05607940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463913|NCT05607940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64463914|NCT05607940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64463915|NCT04394728|Trabectedin|trabectedin|mesh-list
64463916|NCT04394728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64463917|NCT04394728|Alkylating Agents|alkylating agents|mesh-ancestor
64463918|NCT04394728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463919|NCT04394728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463920|NCT05600608|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
64463927|NCT01616173|Autonomic Agents|autonomic agents|mesh-ancestor
64463928|NCT01616173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64463929|NCT01616173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463930|NCT01616173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64463931|NCT01616173|Glucocorticoids|glucocorticoids|mesh-ancestor
64463933|NCT01616173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64463934|NCT01616173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64463935|NCT01616173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463936|NCT01616173|Protease Inhibitors|protease inhibitors|mesh-ancestor
64463937|NCT01616173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64463938|NCT01616173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463939|NCT05609500|Warfarin|warfarin|mesh-list
64463940|NCT05609500|Anticoagulants|anticoagulants|mesh-ancestor
64463941|NCT03044314|Nitric Oxide|nitric oxide|mesh-list
64463942|NCT03044314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64463943|NCT03044314|Autonomic Agents|autonomic agents|mesh-ancestor
64463944|NCT03044314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64463945|NCT03044314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463946|NCT03044314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64463980|NCT05608564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64463982|NCT05608564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64463983|NCT05608564|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64533534|NCT04594746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64533536|NCT02790138|Vedolizumab|vedolizumab|mesh-list
64533537|NCT02790138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64533538|NCT02790138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64533539|NCT02790138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64533540|NCT02790138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64533541|NCT02790138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298119|NCT02072785|Antimitotic Agents|antimitotic agents|mesh-ancestor
64463984|NCT05608564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64463985|NCT05608564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463986|NCT03036904|Prednisone|prednisone|mesh-list
64463987|NCT03036904|Cyclophosphamide|cyclophosphamide|mesh-list
64463988|NCT03036904|Rituximab|rituximab|mesh-list
64463989|NCT03036904|Doxorubicin|doxorubicin|mesh-list
64463990|NCT03036904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64519988|NCT01739933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64519989|NCT01739933|Analgesics|analgesics|mesh-ancestor
64519990|NCT01739933|Sensory System Agents|sensory system agents|mesh-ancestor
64519991|NCT01739933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64519992|NCT01739933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64519993|NCT01739933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64519994|NCT01739933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64519995|NCT01739933|Adrenergic Agents|adrenergic agents|mesh-ancestor
64519996|NCT01739933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64519997|NCT01739933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519998|NCT00094497|Doxorubicin|doxorubicin|mesh-list
64519999|NCT00094497|Etoposide|etoposide|mesh-list
64520000|NCT00094497|Mitotane|mitotane|mesh-list
64520001|NCT00094497|Streptozocin|streptozocin|mesh-list
64520002|NCT00094497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520003|NCT00094497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64520004|NCT00094497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64520005|NCT00094497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64341073|NCT05025800|Rituximab|rituximab|mesh-list
64889667|NCT01968564|Curcumin|curcumin|mesh-list
64889668|NCT01968564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64889669|NCT01968564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64889670|NCT01968564|Analgesics|analgesics|mesh-ancestor
64889671|NCT01968564|Sensory System Agents|sensory system agents|mesh-ancestor
64889672|NCT01968564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889673|NCT01968564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889674|NCT01968564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64889675|NCT01968564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64889676|NCT01968564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889677|NCT01968564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889678|NCT01968564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643399|NCT04946370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64889704|NCT01968759|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64889705|NCT01968759|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64889706|NCT01968759|Chelating Agents|chelating agents|mesh-ancestor
64889707|NCT01968759|Sequestering Agents|sequestering agents|mesh-ancestor
64889708|NCT01968798|Aspirin|aspirin|mesh-list
64889709|NCT01968798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64889710|NCT01968798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64889711|NCT01968798|Analgesics|analgesics|mesh-ancestor
64889712|NCT01968798|Sensory System Agents|sensory system agents|mesh-ancestor
64889713|NCT01968798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889714|NCT01968798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520006|NCT00094497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520007|NCT00094497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520008|NCT00094497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64520009|NCT00094497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64520010|NCT00094887|Nitric Oxide|nitric oxide|mesh-list
64520011|NCT00094887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64520012|NCT00094887|Autonomic Agents|autonomic agents|mesh-ancestor
64520013|NCT00094887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520014|NCT00094887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520015|NCT00094887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64520016|NCT00094887|Respiratory System Agents|respiratory system agents|mesh-ancestor
64520017|NCT00094887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64889715|NCT01968798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64889716|NCT01968798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64889717|NCT01968798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64889718|NCT01968798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64889719|NCT01968798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889720|NCT01968798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64889726|NCT01968850|Vitamins|vitamins|mesh-ancestor
64889734|NCT01968915|Antimitotic Agents|antimitotic agents|mesh-ancestor
64889735|NCT01968915|Mitosis Modulators|mitosis modulators|mesh-ancestor
64889736|NCT01968915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889737|NCT01969006|Bupivacaine|bupivacaine|mesh-list
64889738|NCT01969006|Anesthetics, Local|anesthetics, local|mesh-ancestor
64889739|NCT01969006|Anesthetics|anesthetics|mesh-ancestor
64889740|NCT01969006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64889741|NCT01969006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889742|NCT01969006|Sensory System Agents|sensory system agents|mesh-ancestor
64889743|NCT01969006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889744|NCT01969019|Prednisone|prednisone|mesh-list
64889745|NCT01969019|Methylprednisolone|methylprednisolone|mesh-list
64889746|NCT01969019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64889747|NCT01969019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64889768|NCT01969032|Cyclophosphamide|cyclophosphamide|mesh-list
64643432|NCT02125292|Sensory System Agents|sensory system agents|mesh-ancestor
64889769|NCT01969032|Carboplatin|carboplatin|mesh-list
64889770|NCT01969032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64889771|NCT01969032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889772|NCT01969032|Tubulin Modulators|tubulin modulators|mesh-ancestor
64889773|NCT01969032|Antimitotic Agents|antimitotic agents|mesh-ancestor
64889774|NCT01969032|Mitosis Modulators|mitosis modulators|mesh-ancestor
64889775|NCT01969032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643437|NCT05079698|177Lu-PSMA-617|177lu-psma-617|mesh-list
64463991|NCT03036904|Etoposide|etoposide|mesh-list
64463992|NCT03036904|Vincristine|vincristine|mesh-list
64464012|NCT03036904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64464013|NCT03036904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64464014|NCT03036904|Tubulin Modulators|tubulin modulators|mesh-ancestor
64464015|NCT03036904|Antimitotic Agents|antimitotic agents|mesh-ancestor
64464016|NCT03036904|Mitosis Modulators|mitosis modulators|mesh-ancestor
64464017|NCT05604898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64464018|NCT05604898|Antibodies|antibodies|mesh-list
64464019|NCT05604898|Immunoglobulins|immunoglobulins|mesh-list
64464020|NCT05604898|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64464021|NCT05604898|Immunologic Factors|immunologic factors|mesh-ancestor
64464022|NCT05604898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464023|NCT05604898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464024|NCT05606692|Propofol|propofol|mesh-list
64464025|NCT05606692|Sevoflurane|sevoflurane|mesh-list
64464026|NCT05606692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64464027|NCT05606692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64464028|NCT05606692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464029|NCT05606692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64464030|NCT05606692|Anesthetics, General|anesthetics, general|mesh-ancestor
64464032|NCT05606692|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64464033|NCT05606692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64464034|NCT04392700|Tenofovir|tenofovir|mesh-list
64464035|NCT04392700|Entecavir|entecavir|mesh-list
64464036|NCT04392700|Antiviral Agents|antiviral agents|mesh-ancestor
64464037|NCT04392700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64464038|NCT04392700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64464071|NCT03827278|Amphotericin B|amphotericin b|mesh-list
64889776|NCT01969032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64889777|NCT01969032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64889778|NCT01969032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64889779|NCT01969032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889780|NCT01969032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64889781|NCT01969032|Antimetabolites|antimetabolites|mesh-ancestor
64889782|NCT01969032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64889783|NCT01969032|Immunologic Factors|immunologic factors|mesh-ancestor
64520019|NCT00094887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520020|NCT00094887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64520021|NCT00094887|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64520022|NCT00094887|Vasodilator Agents|vasodilator agents|mesh-ancestor
64520023|NCT00094887|Gasotransmitters|gasotransmitters|mesh-ancestor
64520024|NCT00094887|Protective Agents|protective agents|mesh-ancestor
64520025|NCT01712399|Mavrilimumab|mavrilimumab|mesh-list
64520026|NCT01712399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64520027|NCT00097695|Icatibant|icatibant|mesh-list
64520028|NCT00097695|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64520029|NCT00097695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64520030|NCT00097695|Analgesics|analgesics|mesh-ancestor
64520031|NCT00097695|Sensory System Agents|sensory system agents|mesh-ancestor
64520032|NCT00097695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520033|NCT00097695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520034|NCT00097695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64520035|NCT00097695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64520036|NCT00097695|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
64520037|NCT00097695|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
64464072|NCT03827278|Antifungal Agents|antifungal agents|mesh-ancestor
64464073|NCT03827278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64464074|NCT03827278|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64464075|NCT03827278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64464076|NCT03827278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464077|NCT03827278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464078|NCT03827278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64464079|NCT03827278|Hormone Antagonists|hormone antagonists|mesh-ancestor
64464080|NCT03827278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64533542|NCT02790138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533543|NCT02790138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533544|NCT02790138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64533545|NCT02790138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64533546|NCT02790138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64464081|NCT03827278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464082|NCT03827278|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64464083|NCT03827278|Amebicides|amebicides|mesh-ancestor
64889784|NCT01969032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889785|NCT01969032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64889786|NCT01969032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64889787|NCT01969032|Alkylating Agents|alkylating agents|mesh-ancestor
64889788|NCT01969032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64889790|NCT01969071|Dobutamine|dobutamine|mesh-list
64889791|NCT01969071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64889792|NCT01969071|Vasodilator Agents|vasodilator agents|mesh-ancestor
64889793|NCT01969071|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64889794|NCT01969071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64889795|NCT01969071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889796|NCT01969071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889797|NCT01969071|Protective Agents|protective agents|mesh-ancestor
64889798|NCT01969071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889799|NCT01969071|Sympathomimetics|sympathomimetics|mesh-ancestor
64889800|NCT01969071|Autonomic Agents|autonomic agents|mesh-ancestor
64889801|NCT01969071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889813|NCT01969149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889814|NCT01969149|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64889815|NCT01969149|Hormones|hormones|mesh-ancestor
64889816|NCT01969149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64889817|NCT01969318|Metformin|metformin|mesh-list
64889818|NCT01969318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64889819|NCT01969318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889820|NCT01969357|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64889821|NCT01969357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64889822|NCT01969357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889823|NCT01969357|Incretins|incretins|mesh-ancestor
64464084|NCT03827278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64464085|NCT03827278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64464086|NCT03827278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64464087|NCT01513473|Insulin|insulin|mesh-list
64464088|NCT01513473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64464089|NCT01513473|Insulin Aspart|insulin aspart|mesh-list
64464090|NCT01513473|Insulin Detemir|insulin detemir|mesh-list
64464091|NCT01513473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64464092|NCT01513473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464093|NCT03109990|Dexmedetomidine|dexmedetomidine|mesh-list
64464094|NCT03109990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64464095|NCT03109990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64464096|NCT03109990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464097|NCT03109990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64464098|NCT03109990|Analgesics|analgesics|mesh-ancestor
64464099|NCT03109990|Sensory System Agents|sensory system agents|mesh-ancestor
64464132|NCT03825328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464133|NCT03825328|Tubulin Modulators|tubulin modulators|mesh-ancestor
64464134|NCT03825328|Antimitotic Agents|antimitotic agents|mesh-ancestor
64464135|NCT03825328|Mitosis Modulators|mitosis modulators|mesh-ancestor
64889824|NCT01969357|Hormones|hormones|mesh-ancestor
64643583|NCT01511809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889825|NCT01969357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64889826|NCT01969357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64889827|NCT01969357|Protease Inhibitors|protease inhibitors|mesh-ancestor
64520038|NCT00097695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520039|NCT00097695|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64520040|NCT00097695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64520041|NCT00097695|Immunologic Factors|immunologic factors|mesh-ancestor
64520042|NCT02096679|Osimertinib|osimertinib|mesh-list
64520043|NCT02096679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520044|NCT02096679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64520045|NCT02096679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520046|NCT02096679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520047|NCT00099021|Pioglitazone|pioglitazone|mesh-list
64643584|NCT01511809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64520048|NCT00099021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64520049|NCT00099021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520050|NCT00195039|Antibodies|antibodies|mesh-list
64889828|NCT01969357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889829|NCT01969357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889830|NCT01969617|Naltrexone|naltrexone|mesh-list
64889831|NCT01969617|Nalmefene|nalmefene|mesh-list
64889832|NCT01969617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64889833|NCT01969617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889834|NCT01969617|Sensory System Agents|sensory system agents|mesh-ancestor
64889835|NCT01969617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889836|NCT01969617|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64889837|NCT01969656|Calcitriol|calcitriol|mesh-list
64889838|NCT01969656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64889839|NCT01969656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889840|NCT01969656|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64889841|NCT01969656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64464136|NCT03825328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464137|NCT03825328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64464138|NCT03825328|Antimetabolites|antimetabolites|mesh-ancestor
64464139|NCT03825328|Antiviral Agents|antiviral agents|mesh-ancestor
64464140|NCT03825328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64464141|NCT03825328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889842|NCT01969656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889843|NCT01969656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64889844|NCT01969656|Vitamins|vitamins|mesh-ancestor
64889845|NCT01969656|Micronutrients|micronutrients|mesh-ancestor
64889846|NCT01969656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64889847|NCT01969669|Ketoconazole|ketoconazole|mesh-list
64889848|NCT01969669|Venetoclax|venetoclax|mesh-list
64889849|NCT01969669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889850|NCT01969669|Antifungal Agents|antifungal agents|mesh-ancestor
64889851|NCT01969669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64889852|NCT01969669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64643624|NCT01553539|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
64889853|NCT01969669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64889854|NCT01969669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889855|NCT01969669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889856|NCT01969669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64643625|NCT01553539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64464142|NCT03825328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64464176|NCT03043924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464177|NCT03043924|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64464178|NCT03043924|Contraceptive Agents|contraceptive agents|mesh-ancestor
64464217|NCT03824002|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64464218|NCT03824002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64464219|NCT03824002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464220|NCT03823846|Flurbiprofen|flurbiprofen|mesh-list
64464221|NCT03823846|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
64464222|NCT03823846|Parecoxib|parecoxib|mesh-list
64464223|NCT03823846|Dezocine|dezocine|mesh-list
64464224|NCT03823846|Analgesics|analgesics|mesh-ancestor
64464225|NCT03823846|Sensory System Agents|sensory system agents|mesh-ancestor
64464226|NCT03823846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64464227|NCT03823846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464228|NCT03823846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64464229|NCT03823846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64464230|NCT03823846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64464231|NCT03823846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64464258|NCT02810704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64464259|NCT02810704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464260|NCT02810704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64464262|NCT02810704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64464263|NCT02810704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64464264|NCT02810704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464265|NCT02810704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64533547|NCT02339844|Aripiprazole|aripiprazole|mesh-list
64533548|NCT02339844|Antidepressive Agents|antidepressive agents|mesh-ancestor
64533549|NCT02339844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64533550|NCT02339844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64533551|NCT02339844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64298131|NCT02071303|Tramadol|tramadol|mesh-list
64464266|NCT02810704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64464267|NCT02810704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464268|NCT02810704|Antipyretics|antipyretics|mesh-ancestor
64464269|NCT02810704|Anticoagulants|anticoagulants|mesh-ancestor
64464270|NCT02810704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64464271|NCT02810704|Antithrombins|antithrombins|mesh-ancestor
64464272|NCT02810704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64464273|NCT02810704|Protease Inhibitors|protease inhibitors|mesh-ancestor
64464274|NCT02735902|Aspirin|aspirin|mesh-list
64889857|NCT01969669|Hormone Antagonists|hormone antagonists|mesh-ancestor
64889858|NCT01969669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64889859|NCT01969669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889860|NCT01969669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64889861|NCT01969682|Rifampin|rifampin|mesh-list
64889862|NCT01969682|Venetoclax|venetoclax|mesh-list
64889863|NCT01969682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889864|NCT01969682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64889865|NCT01969682|Antitubercular Agents|antitubercular agents|mesh-ancestor
64889866|NCT01969682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64889871|NCT01969682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889872|NCT01969682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64889873|NCT01969682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64889874|NCT01969682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64889875|NCT01969682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64889876|NCT01969682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64889877|NCT01969682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64520051|NCT00195039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64520052|NCT00195039|Immunologic Factors|immunologic factors|mesh-ancestor
64520053|NCT00195039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520054|NCT04645719|Magnesium Sulfate|magnesium sulfate|mesh-list
64520055|NCT04645719|Analgesics|analgesics|mesh-ancestor
64341460|NCT00821249|Hormones|hormones|mesh-ancestor
64889879|NCT01969695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889880|NCT01969773|Botulinum Toxins|botulinum toxins|mesh-list
64889881|NCT01969773|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64889882|NCT01969773|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64889883|NCT01969773|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64889884|NCT01969773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64889885|NCT01969773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889886|NCT01969773|Cholinergic Agents|cholinergic agents|mesh-ancestor
64889887|NCT01969773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64889888|NCT01969773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889889|NCT01969773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64889890|NCT01969773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889891|NCT01969877|Cetuximab|cetuximab|mesh-list
64464275|NCT02735902|Vitamin K|vitamin k|mesh-list
64889892|NCT01969877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889893|NCT01969877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64889894|NCT01969903|Dexmedetomidine|dexmedetomidine|mesh-list
64889895|NCT01969903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64889896|NCT01969903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64889897|NCT01969903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889898|NCT01969903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64889899|NCT01969903|Analgesics|analgesics|mesh-ancestor
64889900|NCT01969903|Sensory System Agents|sensory system agents|mesh-ancestor
64889901|NCT01969903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889902|NCT01969903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64889903|NCT01969903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64889904|NCT01969903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64889905|NCT01969903|Adrenergic Agents|adrenergic agents|mesh-ancestor
64889906|NCT01969903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64889907|NCT01969903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889908|NCT01969942|Melphalan|melphalan|mesh-list
64889909|NCT01969942|Busulfan|busulfan|mesh-list
64889910|NCT01969942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64643720|NCT00562328|Rituximab|rituximab|mesh-list
64464276|NCT02735902|Anticoagulants|anticoagulants|mesh-list
64464277|NCT02735902|Vitamins|vitamins|mesh-ancestor
64464278|NCT02735902|Micronutrients|micronutrients|mesh-ancestor
64464279|NCT02735902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464315|NCT04273282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464316|NCT04273282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64464317|NCT04273282|Glucocorticoids|glucocorticoids|mesh-ancestor
64464318|NCT04273282|Hormones|hormones|mesh-ancestor
64464319|NCT04273282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64464357|NCT01455532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64464358|NCT01455532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464359|NCT01455532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64464360|NCT01455532|Immunologic Factors|immunologic factors|mesh-ancestor
64464361|NCT01455532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464388|NCT02542696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464389|NCT02542696|Autonomic Agents|autonomic agents|mesh-ancestor
64464390|NCT02542696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64464391|NCT02542696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64464392|NCT02542696|Dopamine Agonists|dopamine agonists|mesh-ancestor
64464393|NCT02542696|Dopamine Agents|dopamine agents|mesh-ancestor
64464394|NCT02542696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64464395|NCT02542696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464396|NCT01456468|Tretinoin|tretinoin|mesh-list
64464397|NCT01456468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464398|NCT01456468|Keratolytic Agents|keratolytic agents|mesh-ancestor
64464399|NCT01456468|Dermatologic Agents|dermatologic agents|mesh-ancestor
64464404|NCT01456546|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64464405|NCT01456546|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64464406|NCT01456546|Purinergic Agents|purinergic agents|mesh-ancestor
64464407|NCT01456546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64464408|NCT01456546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464409|NCT01456546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464410|NCT01456546|Antimalarials|antimalarials|mesh-ancestor
64464411|NCT01456546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64889911|NCT01969942|Alkylating Agents|alkylating agents|mesh-ancestor
64889912|NCT01969942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889913|NCT01969942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889914|NCT01969942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64889915|NCT01969942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64889916|NCT01969942|Immunologic Factors|immunologic factors|mesh-ancestor
64889917|NCT01969942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889918|NCT01969955|Paclitaxel|paclitaxel|mesh-list
64889919|NCT01969955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64889920|NCT01969955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64889921|NCT01969955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889922|NCT01969955|Tubulin Modulators|tubulin modulators|mesh-ancestor
64889923|NCT01969955|Antimitotic Agents|antimitotic agents|mesh-ancestor
64889924|NCT01969955|Mitosis Modulators|mitosis modulators|mesh-ancestor
64889925|NCT01969955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889926|NCT01970046|Metformin|metformin|mesh-list
64889927|NCT01970046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64889928|NCT01970046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889929|NCT01970059|Metoprolol|metoprolol|mesh-list
64889930|NCT01970059|Carvedilol|carvedilol|mesh-list
64889931|NCT01970059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64889932|NCT01970059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64889933|NCT01970059|Sympatholytics|sympatholytics|mesh-ancestor
64889934|NCT01970059|Autonomic Agents|autonomic agents|mesh-ancestor
64889946|NCT01970059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64889947|NCT01970059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64889949|NCT01970059|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64889950|NCT01970059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64889951|NCT01970072|Midazolam|midazolam|mesh-list
64889952|NCT01970072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64889953|NCT01970072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64520057|NCT04645719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520058|NCT04645719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520059|NCT04645719|Anesthetics|anesthetics|mesh-ancestor
64520060|NCT04645719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64520061|NCT04645719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64520062|NCT04645719|Anticonvulsants|anticonvulsants|mesh-ancestor
64520064|NCT04645719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64520065|NCT04645719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520066|NCT04645719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64520067|NCT04645719|Tocolytic Agents|tocolytic agents|mesh-ancestor
64520068|NCT04645719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64520069|NCT02054338|Gemcitabine|gemcitabine|mesh-list
64520070|NCT02054338|Paclitaxel|paclitaxel|mesh-list
64889954|NCT01970072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64889955|NCT01970072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889956|NCT01970072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64889957|NCT01970072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64889958|NCT01970072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64889959|NCT01970072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64889960|NCT01970072|Anesthetics, General|anesthetics, general|mesh-ancestor
64889961|NCT01970072|Anesthetics|anesthetics|mesh-ancestor
64889962|NCT01970072|GABA Modulators|gaba modulators|mesh-ancestor
64889963|NCT01970072|GABA Agents|gaba agents|mesh-ancestor
64889964|NCT01970072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64889965|NCT01970072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889966|NCT01970202|Enoxaparin|enoxaparin|mesh-list
64889967|NCT01970202|Enoxaparin sodium|enoxaparin sodium|mesh-list
64889968|NCT01970202|Anticoagulants|anticoagulants|mesh-ancestor
64889969|NCT01970202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64889970|NCT01970202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64889971|NCT01970202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889972|NCT01970215|Atorvastatin|atorvastatin|mesh-list
64889973|NCT01970215|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64889974|NCT01970215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64889975|NCT01970215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64889976|NCT01970215|Antimetabolites|antimetabolites|mesh-ancestor
64889977|NCT01970215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643811|NCT00634166|Mafenide|mafenide|mesh-list
64464437|NCT01457716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64464438|NCT01457716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464440|NCT02880982|Cholecalciferol|cholecalciferol|mesh-list
64464441|NCT02880982|Vitamins|vitamins|mesh-ancestor
64464442|NCT02880982|Micronutrients|micronutrients|mesh-ancestor
64464443|NCT02880982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464444|NCT02880982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64464445|NCT02880982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64464446|NCT01458964|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64464447|NCT01458964|Antidepressive Agents|antidepressive agents|mesh-ancestor
64464448|NCT01458964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64889978|NCT01970215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64889979|NCT01970215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64889980|NCT01970215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889981|NCT01970280|Enoxaparin|enoxaparin|mesh-list
64889982|NCT01970280|Anticoagulants|anticoagulants|mesh-ancestor
64889983|NCT01970280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64889984|NCT01970280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64889985|NCT01970280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889986|NCT01970358|Poly ICLC|poly iclc|mesh-list
64889987|NCT01970358|Interferon Inducers|interferon inducers|mesh-ancestor
64889988|NCT01970358|Immunologic Factors|immunologic factors|mesh-ancestor
64889989|NCT01970358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889990|NCT01970449|Vaccines|vaccines|mesh-list
64889991|NCT01970449|Immunologic Factors|immunologic factors|mesh-ancestor
64889992|NCT01970449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889993|NCT01970553|Gemcitabine|gemcitabine|mesh-list
64889994|NCT01970553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64889995|NCT01970553|Antimetabolites|antimetabolites|mesh-ancestor
64890004|NCT01970579|Paclitaxel|paclitaxel|mesh-list
64520071|NCT02054338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64520072|NCT02054338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520073|NCT02054338|Tubulin Modulators|tubulin modulators|mesh-ancestor
64464449|NCT01458964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64464450|NCT01458964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64464451|NCT01458964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64464452|NCT01458964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464453|NCT01459198|Vaccines|vaccines|mesh-list
64533552|NCT02339844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64533553|NCT02339844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533554|NCT02339844|Dopamine Agonists|dopamine agonists|mesh-ancestor
64533555|NCT02339844|Dopamine Agents|dopamine agents|mesh-ancestor
64533556|NCT02339844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64298136|NCT02071303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64464454|NCT01459198|Immunologic Factors|immunologic factors|mesh-ancestor
64464455|NCT01459198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464456|NCT02490904|Eplerenone|eplerenone|mesh-list
64464457|NCT02490904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64464458|NCT02490904|Hormone Antagonists|hormone antagonists|mesh-ancestor
64464459|NCT02490904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64464481|NCT02873806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64464482|NCT02873806|Glucocorticoids|glucocorticoids|mesh-ancestor
64464483|NCT02873806|Hormones|hormones|mesh-ancestor
64464484|NCT02873806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64464485|NCT02873806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64464486|NCT02873806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464487|NCT02873806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64464488|NCT02873806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64464489|NCT02873806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64464490|NCT01890772|Vitamin D|vitamin d|mesh-list
64464491|NCT01890772|Ribavirin|ribavirin|mesh-list
64464492|NCT01890772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64464493|NCT01890772|Vitamins|vitamins|mesh-ancestor
64464494|NCT01890772|Micronutrients|micronutrients|mesh-ancestor
64464495|NCT01890772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520074|NCT02054338|Antimitotic Agents|antimitotic agents|mesh-ancestor
64520075|NCT02054338|Mitosis Modulators|mitosis modulators|mesh-ancestor
64520076|NCT02054338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643908|NCT00566540|Tubulin Modulators|tubulin modulators|mesh-ancestor
64520077|NCT02054338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64890005|NCT01970579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64890006|NCT01970579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890007|NCT01970579|Tubulin Modulators|tubulin modulators|mesh-ancestor
64890008|NCT01970579|Antimitotic Agents|antimitotic agents|mesh-ancestor
64890009|NCT01970579|Mitosis Modulators|mitosis modulators|mesh-ancestor
64890010|NCT01970579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890011|NCT01970748|Propranolol|propranolol|mesh-list
64890012|NCT01970748|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64890013|NCT01970748|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64890014|NCT01970748|Adrenergic Agents|adrenergic agents|mesh-ancestor
64890015|NCT01970748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64890016|NCT01970748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890017|NCT01970748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890018|NCT01970748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64890019|NCT01970748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64890020|NCT01970748|Vasodilator Agents|vasodilator agents|mesh-ancestor
64890021|NCT01970800|Hormones|hormones|mesh-list
64890022|NCT01970800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64890023|NCT01970800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890024|NCT01970904|Ribavirin|ribavirin|mesh-list
64890025|NCT01970904|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64890026|NCT01970904|Antimetabolites|antimetabolites|mesh-ancestor
64890027|NCT01970904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890028|NCT01970904|Antiviral Agents|antiviral agents|mesh-ancestor
64890029|NCT01970904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64643909|NCT00566540|Antimitotic Agents|antimitotic agents|mesh-ancestor
64890030|NCT01970917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64890039|NCT01971034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890040|NCT01971034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64890041|NCT01971034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890042|NCT01971047|Insulin|insulin|mesh-list
64890043|NCT01971047|Insulin Lispro|insulin lispro|mesh-list
64890044|NCT01971047|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64890045|NCT01971047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64890046|NCT01971047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890047|NCT01971190|Aflibercept|aflibercept|mesh-list
64890048|NCT01971190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64890049|NCT01971190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64890050|NCT01971190|Growth Substances|growth substances|mesh-ancestor
64890051|NCT01971190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890052|NCT01971190|Growth Inhibitors|growth inhibitors|mesh-ancestor
64890053|NCT01971190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890054|NCT01971242|Exenatide|exenatide|mesh-list
64890055|NCT01971242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64890056|NCT01971242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890057|NCT01971242|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64890058|NCT01971242|Incretins|incretins|mesh-ancestor
64890059|NCT01971242|Hormones|hormones|mesh-ancestor
64890060|NCT01971242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64890061|NCT01971268|Cimetidine|cimetidine|mesh-list
64520078|NCT02054338|Antimetabolites|antimetabolites|mesh-ancestor
64520079|NCT02054338|Antiviral Agents|antiviral agents|mesh-ancestor
64890081|NCT01971281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64890082|NCT01971281|Antimetabolites|antimetabolites|mesh-ancestor
64890083|NCT01971281|Antiviral Agents|antiviral agents|mesh-ancestor
64890084|NCT01971281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64890085|NCT01971281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890086|NCT01971281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64890087|NCT01971281|Immunologic Factors|immunologic factors|mesh-ancestor
64890088|NCT01971281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890089|NCT01971411|Calcium, Dietary|calcium, dietary|mesh-list
64890090|NCT01971411|Vitamin D|vitamin d|mesh-list
64464496|NCT01890772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64464497|NCT01890772|Antimetabolites|antimetabolites|mesh-ancestor
64464498|NCT01890772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464499|NCT01890772|Antiviral Agents|antiviral agents|mesh-ancestor
64464500|NCT01890772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64464501|NCT01891084|Acetaminophen|acetaminophen|mesh-list
64464502|NCT01891084|Ibuprofen|ibuprofen|mesh-list
64890091|NCT01971411|Ergocalciferols|ergocalciferols|mesh-list
64890092|NCT01971411|Cholecalciferol|cholecalciferol|mesh-list
64890093|NCT01971411|Vitamins|vitamins|mesh-list
64890094|NCT01971411|Calcium|calcium|mesh-list
64890095|NCT01971411|Micronutrients|micronutrients|mesh-ancestor
64890096|NCT01971411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890097|NCT01971411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64890098|NCT01971411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64890099|NCT01971424|Magnesium Oxide|magnesium oxide|mesh-list
64890100|NCT01971424|Antacids|antacids|mesh-ancestor
64890101|NCT01971424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890102|NCT01971424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64890103|NCT01971450|Iloprost|iloprost|mesh-list
64890104|NCT01971450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64890105|NCT01971450|Vasodilator Agents|vasodilator agents|mesh-ancestor
64890139|NCT01971632|Naloxone|naloxone|mesh-list
64890140|NCT01971632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64890141|NCT01971632|Narcotics|narcotics|mesh-ancestor
64890142|NCT01971632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64890143|NCT01971632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890144|NCT01971632|Analgesics|analgesics|mesh-ancestor
64890145|NCT01971632|Sensory System Agents|sensory system agents|mesh-ancestor
64890146|NCT01971632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64890147|NCT01971632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64890148|NCT01971658|Thalidomide|thalidomide|mesh-list
64890149|NCT01971658|Dexamethasone|dexamethasone|mesh-list
64890150|NCT01971658|Cyclophosphamide|cyclophosphamide|mesh-list
64890151|NCT01971658|Bortezomib|bortezomib|mesh-list
64890152|NCT01971658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64890153|NCT01971658|Immunologic Factors|immunologic factors|mesh-ancestor
64890154|NCT01971658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890155|NCT01971658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64890156|NCT01971658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64890157|NCT01971658|Alkylating Agents|alkylating agents|mesh-ancestor
64890158|NCT01971658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890159|NCT01971658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890160|NCT01971658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64890161|NCT01971658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64890164|NCT01971658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64890165|NCT01971658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64890166|NCT01971658|Glucocorticoids|glucocorticoids|mesh-ancestor
64890167|NCT01971658|Hormones|hormones|mesh-ancestor
64890180|NCT01971684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890181|NCT01971684|Immunologic Factors|immunologic factors|mesh-ancestor
64890182|NCT01971684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890183|NCT01971684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64890184|NCT01971684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64890185|NCT01971684|Antitubercular Agents|antitubercular agents|mesh-ancestor
64890186|NCT01971684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64890187|NCT01971684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64890188|NCT01971684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890189|NCT01971684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890190|NCT01971684|Antifungal Agents|antifungal agents|mesh-ancestor
64890191|NCT01971684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64890192|NCT01971684|Antimetabolites|antimetabolites|mesh-ancestor
64890193|NCT01971684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64520081|NCT02054338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520082|NCT02054338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64520083|NCT02054338|Immunologic Factors|immunologic factors|mesh-ancestor
64520084|NCT02054338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520085|NCT00198081|Celecoxib|celecoxib|mesh-list
64520086|NCT00198081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
64520087|NCT00198081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64520088|NCT00198081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64520089|NCT00198081|Analgesics|analgesics|mesh-ancestor
64520090|NCT00198081|Sensory System Agents|sensory system agents|mesh-ancestor
64520091|NCT00198081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520092|NCT00198081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520093|NCT00198081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64520094|NCT00198081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64520095|NCT00198081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64520096|NCT00198081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644022|NCT02429570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64464503|NCT01891084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64464504|NCT01891084|Analgesics|analgesics|mesh-ancestor
64464505|NCT01891084|Sensory System Agents|sensory system agents|mesh-ancestor
64464506|NCT01891084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64464507|NCT01891084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520097|NCT00198081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520098|NCT00100659|Interferons|interferons|mesh-list
64520099|NCT00100659|Ribavirin|ribavirin|mesh-list
64520100|NCT00100659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520101|NCT00100659|Antiviral Agents|antiviral agents|mesh-ancestor
64520102|NCT00100659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64520103|NCT00100659|Antimetabolites|antimetabolites|mesh-ancestor
64520104|NCT00100659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520105|NCT00101361|Oxandrolone|oxandrolone|mesh-list
64520106|NCT00101361|Androgens|androgens|mesh-ancestor
64520107|NCT00101361|Hormones|hormones|mesh-ancestor
64520108|NCT00101361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64520109|NCT00101361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520110|NCT00101361|Anabolic Agents|anabolic agents|mesh-ancestor
64520111|NCT03225690|Morphine|morphine|mesh-list
64520112|NCT03225690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64520113|NCT03225690|Narcotics|narcotics|mesh-ancestor
64520114|NCT03225690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64520116|NCT03225690|Analgesics|analgesics|mesh-ancestor
64520119|NCT02389738|Temozolomide|temozolomide|mesh-list
64520120|NCT02389738|Regadenoson|regadenoson|mesh-list
64520121|NCT02389738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64520122|NCT02389738|Alkylating Agents|alkylating agents|mesh-ancestor
64520123|NCT02389738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890194|NCT01971684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64890195|NCT01971801|Vitamin D|vitamin d|mesh-list
64890196|NCT01971801|Cholecalciferol|cholecalciferol|mesh-list
64890197|NCT01971801|Vitamins|vitamins|mesh-ancestor
64890198|NCT01971801|Micronutrients|micronutrients|mesh-ancestor
64644062|NCT05389046|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64644070|NCT02184416|Everolimus|everolimus|mesh-list
64464508|NCT01891084|Antipyretics|antipyretics|mesh-ancestor
64464509|NCT01891084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64464510|NCT01891084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64653012|NCT01725152|GABA Modulators|gaba modulators|mesh-ancestor
64464514|NCT01891084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464515|NCT01891708|Bevacizumab|bevacizumab|mesh-list
64464516|NCT01891708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64464546|NCT01892332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64464547|NCT01892332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464548|NCT01892332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64464549|NCT01892332|Narcotics|narcotics|mesh-ancestor
64464550|NCT01892332|Analgesics|analgesics|mesh-ancestor
64464551|NCT01892332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64464552|NCT01892332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64464553|NCT01892332|Anesthetics, General|anesthetics, general|mesh-ancestor
64890199|NCT01971801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890200|NCT01971801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64890201|NCT01971801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64890202|NCT01971814|Infliximab|infliximab|mesh-list
64890203|NCT01971814|Dermatologic Agents|dermatologic agents|mesh-ancestor
64890204|NCT01971814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64890205|NCT01971814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64890206|NCT01971918|Antibodies|antibodies|mesh-list
64890207|NCT01971918|Immunologic Factors|immunologic factors|mesh-ancestor
64890208|NCT01971918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890209|NCT01972113|Vitamins|vitamins|mesh-list
64890210|NCT01972113|Vitamin K|vitamin k|mesh-list
64658775|NCT02581839|BB 1101|bb 1101|mesh-list
64890211|NCT01972113|Vitamin K 2|vitamin k 2|mesh-list
64890212|NCT01972113|Vitamin MK 7|vitamin mk 7|mesh-list
64890213|NCT01972113|Micronutrients|micronutrients|mesh-ancestor
64890214|NCT01972113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890215|NCT01972113|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64890216|NCT01972113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64890217|NCT01972113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890218|NCT01972113|Hemostatics|hemostatics|mesh-ancestor
64890219|NCT01972113|Coagulants|coagulants|mesh-ancestor
64890220|NCT01972230|Remifentanil|remifentanil|mesh-list
64890221|NCT01972230|Sevoflurane|sevoflurane|mesh-list
64890222|NCT01972230|Propofol|propofol|mesh-list
64890223|NCT01972230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64890224|NCT01972230|Narcotics|narcotics|mesh-ancestor
64890225|NCT01972230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64890226|NCT01972230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890227|NCT01972230|Analgesics|analgesics|mesh-ancestor
64890228|NCT01972230|Sensory System Agents|sensory system agents|mesh-ancestor
64890229|NCT01972230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64890230|NCT01972230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64890239|NCT01972269|Anesthetics, Local|anesthetics, local|mesh-ancestor
64890240|NCT01972269|Anesthetics|anesthetics|mesh-ancestor
64890241|NCT01972269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64890242|NCT01972269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890243|NCT01972269|Sensory System Agents|sensory system agents|mesh-ancestor
64464554|NCT01892488|Sultamicillin|sultamicillin|mesh-list
64464555|NCT01892488|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
64464556|NCT01892488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64890244|NCT01972269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64890245|NCT01972269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64890246|NCT01972269|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64890247|NCT01972269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64890248|NCT01972269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64890249|NCT01972269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890250|NCT01972269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64890251|NCT01972269|Narcotics|narcotics|mesh-ancestor
64890252|NCT01972269|Analgesics|analgesics|mesh-ancestor
64890253|NCT01972269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64890254|NCT01972269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64890255|NCT01972269|Anesthetics, General|anesthetics, general|mesh-ancestor
64890256|NCT01972373|Bevacizumab|bevacizumab|mesh-list
64890257|NCT01972373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64890258|NCT01972373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890259|NCT01972373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64890260|NCT01972373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64890261|NCT01972373|Growth Substances|growth substances|mesh-ancestor
64890262|NCT01972373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520124|NCT02389738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520125|NCT02389738|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64520126|NCT02389738|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64520127|NCT02389738|Purinergic Agonists|purinergic agonists|mesh-ancestor
64520128|NCT02389738|Purinergic Agents|purinergic agents|mesh-ancestor
64520129|NCT02389738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64520130|NCT02389738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520131|NCT00200343|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64520132|NCT00200343|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64644176|NCT01571557|Hormones|hormones|mesh-ancestor
64464557|NCT01892488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64464558|NCT01892488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464559|NCT01892488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464560|NCT02809690|Clevudine|clevudine|mesh-list
64464562|NCT02809690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64464563|NCT01892644|Deferasirox|deferasirox|mesh-list
64464564|NCT01892644|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64513638|NCT01457469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464590|NCT01615939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64533557|NCT02339844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533558|NCT02339844|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64533559|NCT02339844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64533560|NCT02339844|Serotonin Agents|serotonin agents|mesh-ancestor
64533561|NCT02339844|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64520133|NCT00200343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64520134|NCT00201123|Interferons|interferons|mesh-list
64520135|NCT00201123|Interferon-gamma|interferon-gamma|mesh-list
64520136|NCT00201123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520137|NCT00201123|Antiviral Agents|antiviral agents|mesh-ancestor
64520138|NCT00201123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64520139|NCT01712009|Loratadine|loratadine|mesh-list
64520140|NCT01712009|Naproxen|naproxen|mesh-list
64520141|NCT01712009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64890263|NCT01972373|Growth Inhibitors|growth inhibitors|mesh-ancestor
64890264|NCT01972490|Bevacizumab|bevacizumab|mesh-list
64890265|NCT01972490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64890266|NCT01972490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890267|NCT01972490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64890268|NCT01972490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64890269|NCT01972490|Growth Substances|growth substances|mesh-ancestor
64890270|NCT01972490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890271|NCT01972490|Growth Inhibitors|growth inhibitors|mesh-ancestor
64890272|NCT01972503|Oxaliplatin|oxaliplatin|mesh-list
64890273|NCT01972503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890274|NCT01972620|Bupivacaine|bupivacaine|mesh-list
64533562|NCT02339844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64464591|NCT02789878|Prednisone|prednisone|mesh-list
64464592|NCT02789878|Goserelin|goserelin|mesh-list
64464593|NCT02789878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64464594|NCT02789878|Glucocorticoids|glucocorticoids|mesh-ancestor
64464595|NCT02789878|Hormones|hormones|mesh-ancestor
64464596|NCT02789878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64464597|NCT02789878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464598|NCT02789878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64464599|NCT02789878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464600|NCT01901185|Etanercept|etanercept|mesh-list
64464601|NCT01901185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64464602|NCT01901185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64464603|NCT01901185|Analgesics|analgesics|mesh-ancestor
64464604|NCT01901185|Sensory System Agents|sensory system agents|mesh-ancestor
64464605|NCT01901185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64464606|NCT01901185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464607|NCT01901185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64464608|NCT01901185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64464609|NCT01901185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64464610|NCT01901185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64464611|NCT01901185|Immunologic Factors|immunologic factors|mesh-ancestor
64464612|NCT01893424|Dronabinol|dronabinol|mesh-list
64464640|NCT02788708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464641|NCT02788708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64464642|NCT02788708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464644|NCT01888003|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64464645|NCT01888003|Hematinics|hematinics|mesh-ancestor
64464646|NCT02784496|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
64464647|NCT02784496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64464648|NCT02784496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464649|NCT02784496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464650|NCT02780128|Ceritinib|ceritinib|mesh-list
64464651|NCT02780128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464652|NCT02780128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64464653|NCT02780128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890275|NCT01972620|Anesthetics, Local|anesthetics, local|mesh-ancestor
64890276|NCT01972620|Anesthetics|anesthetics|mesh-ancestor
64890277|NCT01972620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64890278|NCT01972620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890279|NCT01972620|Sensory System Agents|sensory system agents|mesh-ancestor
64890280|NCT01972620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64890281|NCT01972711|Amisulpride|amisulpride|mesh-list
64890282|NCT01972711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64890283|NCT01972711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64890284|NCT01972711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64890285|NCT01972711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557557|NCT04405193|Expectorants|expectorants|mesh-ancestor
64890286|NCT01972711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64644244|NCT05092412|Etoposide|etoposide|mesh-list
64644245|NCT05092412|Durvalumab|durvalumab|mesh-list
64890287|NCT01972711|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64890288|NCT01972711|Dopamine Agents|dopamine agents|mesh-ancestor
64890289|NCT01972711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64890290|NCT01972711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890291|NCT01972711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64890292|NCT01972711|Antidepressive Agents|antidepressive agents|mesh-ancestor
64890293|NCT01972763|Ranibizumab|ranibizumab|mesh-list
64890294|NCT01972763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64890295|NCT01972763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64890296|NCT01972763|Growth Substances|growth substances|mesh-ancestor
64890297|NCT01972763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644246|NCT05092412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464654|NCT02780128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464655|NCT02773732|Ciprofloxacin|ciprofloxacin|mesh-list
64464656|NCT02773732|Etoposide|etoposide|mesh-list
64653015|NCT02980913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64464696|NCT02720068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64464698|NCT02720068|Antimetabolites|antimetabolites|mesh-ancestor
64464699|NCT02720068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464700|NCT02720068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64464701|NCT02720068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64464702|NCT02720068|Immunologic Factors|immunologic factors|mesh-ancestor
64464703|NCT02720068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64464704|NCT02720068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64464705|NCT02720068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464706|NCT02720068|Antidotes|antidotes|mesh-ancestor
64464707|NCT02720068|Protective Agents|protective agents|mesh-ancestor
64464708|NCT02720068|Vitamin B Complex|vitamin b complex|mesh-ancestor
64464735|NCT01893658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64464736|NCT01893658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533564|NCT02339844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64533565|NCT00397839|Ibandronic Acid|ibandronic acid|mesh-list
64533566|NCT00397839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64890317|NCT01972906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64890318|NCT01972906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890319|NCT01972906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890320|NCT01972984|Anastrozole|anastrozole|mesh-list
64520143|NCT01712009|Analgesics|analgesics|mesh-ancestor
64520144|NCT01712009|Sensory System Agents|sensory system agents|mesh-ancestor
64520145|NCT01712009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64644295|NCT04866602|Antimetabolites|antimetabolites|mesh-ancestor
64533567|NCT00397839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533568|NCT02331576|Fentanyl|fentanyl|mesh-list
64533569|NCT02331576|Ropivacaine|ropivacaine|mesh-list
64533570|NCT02331576|Anesthetics, Local|anesthetics, local|mesh-ancestor
64533571|NCT02331576|Anesthetics|anesthetics|mesh-ancestor
64533572|NCT02331576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64533573|NCT02331576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533574|NCT02331576|Sensory System Agents|sensory system agents|mesh-ancestor
64533575|NCT02331576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64533576|NCT02331576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64533577|NCT02331576|Narcotics|narcotics|mesh-ancestor
64533578|NCT02331576|Analgesics|analgesics|mesh-ancestor
64533579|NCT02331576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64533580|NCT02331576|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64533581|NCT02331576|Anesthetics, General|anesthetics, general|mesh-ancestor
64533582|NCT00400803|Gemcitabine|gemcitabine|mesh-list
64533583|NCT00400803|Bevacizumab|bevacizumab|mesh-list
64298148|NCT02076529|Antiemetics|antiemetics|mesh-ancestor
64464737|NCT01893658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64464738|NCT01893658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64464739|NCT01893658|Respiratory System Agents|respiratory system agents|mesh-ancestor
64464740|NCT02703610|Acetaminophen|acetaminophen|mesh-list
64464741|NCT02703610|Ibuprofen|ibuprofen|mesh-list
64464742|NCT02703610|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64464743|NCT02703610|Oxycodone|oxycodone|mesh-list
64464744|NCT02703610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64464745|NCT02703610|Analgesics|analgesics|mesh-ancestor
64464746|NCT02703610|Sensory System Agents|sensory system agents|mesh-ancestor
64464747|NCT02703610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64464748|NCT02703610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464749|NCT02703610|Antipyretics|antipyretics|mesh-ancestor
64464750|NCT02703610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64464751|NCT02703610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64464752|NCT02703610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64464753|NCT02703610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64464754|NCT02703610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464755|NCT02703610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464756|NCT02703610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64464757|NCT02703610|Narcotics|narcotics|mesh-ancestor
64464786|NCT02684032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464789|NCT02684032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64464791|NCT02388178|Cariostatic Agents|cariostatic agents|mesh-ancestor
64464792|NCT02388178|Protective Agents|protective agents|mesh-ancestor
64464793|NCT02388178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464795|NCT02384668|Cholecalciferol|cholecalciferol|mesh-list
64464796|NCT02384668|Vitamins|vitamins|mesh-ancestor
64464797|NCT02384668|Micronutrients|micronutrients|mesh-ancestor
64464798|NCT02384668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533584|NCT00400803|Carboplatin|carboplatin|mesh-list
64533585|NCT00400803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64533586|NCT00400803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533587|NCT00400803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64714131|NCT00373789|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64533588|NCT00400803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64533589|NCT00400803|Growth Substances|growth substances|mesh-ancestor
64533590|NCT00400803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533591|NCT00400803|Growth Inhibitors|growth inhibitors|mesh-ancestor
64533592|NCT00400803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64533593|NCT00400803|Antimetabolites|antimetabolites|mesh-ancestor
64533594|NCT00400803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533595|NCT00400803|Antiviral Agents|antiviral agents|mesh-ancestor
64520146|NCT01712009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520147|NCT01712009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64520148|NCT01712009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64520149|NCT01712009|Gout Suppressants|gout suppressants|mesh-ancestor
64890321|NCT01972984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64890322|NCT01972984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890323|NCT01972984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64890324|NCT01972984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64890325|NCT01972984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890326|NCT01972984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890327|NCT01972984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64890328|NCT01972984|Hormone Antagonists|hormone antagonists|mesh-ancestor
64890329|NCT01972984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64890330|NCT01972984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890331|NCT01973010|Ibuprofen|ibuprofen|mesh-list
64890332|NCT01973010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64890333|NCT01973010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64890334|NCT01973010|Analgesics|analgesics|mesh-ancestor
64890335|NCT01973010|Sensory System Agents|sensory system agents|mesh-ancestor
64890336|NCT01973010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64644360|NCT01533259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64890337|NCT01973010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644361|NCT01533259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64890338|NCT01973010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64890339|NCT01973010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64890340|NCT01973010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64890341|NCT01973010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890342|NCT01973010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533596|NCT00400803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64533597|NCT00400803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533598|NCT00400803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64533599|NCT00400803|Immunologic Factors|immunologic factors|mesh-ancestor
64533601|NCT04681443|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64533602|NCT04681443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64533603|NCT04681443|Disinfectants|disinfectants|mesh-ancestor
64533604|NCT04681443|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64533605|NCT04681443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64533606|NCT02339142|Methylprednisolone|methylprednisolone|mesh-list
64533607|NCT02339142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64533608|NCT02339142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64533609|NCT02339142|Prednisolone|prednisolone|mesh-list
64464799|NCT02384668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64464800|NCT02384668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64464801|NCT01898923|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64890343|NCT01973101|Gemcitabine|gemcitabine|mesh-list
64890344|NCT01973101|Cisplatin|cisplatin|mesh-list
64890345|NCT01973101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890346|NCT01973101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64890347|NCT01973101|Antimetabolites|antimetabolites|mesh-ancestor
64890348|NCT01973101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890349|NCT01973101|Antiviral Agents|antiviral agents|mesh-ancestor
64890350|NCT01973101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64890360|NCT01973140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890362|NCT01973140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890363|NCT01973309|Paclitaxel|paclitaxel|mesh-list
64890364|NCT01973309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64890365|NCT01973309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890366|NCT01973309|Tubulin Modulators|tubulin modulators|mesh-ancestor
64890367|NCT01973309|Antimitotic Agents|antimitotic agents|mesh-ancestor
64890368|NCT01973309|Mitosis Modulators|mitosis modulators|mesh-ancestor
64890369|NCT01973309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890370|NCT01973322|Vaccines|vaccines|mesh-list
64890371|NCT01973322|Complement Factor H|complement factor h|mesh-list
64890372|NCT01973322|Immunologic Factors|immunologic factors|mesh-ancestor
64890373|NCT01973322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890374|NCT01973322|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64890375|NCT01973322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64644408|NCT05245448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64464802|NCT01898923|Laxatives|laxatives|mesh-ancestor
64464803|NCT01898923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64464804|NCT01924429|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64464805|NCT01924429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64464840|NCT05604586|Respiratory System Agents|respiratory system agents|mesh-ancestor
64464841|NCT05604586|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64464842|NCT05604586|Antioxidants|antioxidants|mesh-ancestor
64464843|NCT05604586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464844|NCT05604586|Protective Agents|protective agents|mesh-ancestor
64464876|NCT05603884|Azacitidine|azacitidine|mesh-list
64464877|NCT05603884|Venetoclax|venetoclax|mesh-list
64464878|NCT05603884|Mitoxantrone|mitoxantrone|mesh-list
64464879|NCT05603884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64464880|NCT05603884|Antimetabolites|antimetabolites|mesh-ancestor
64464881|NCT05603884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464882|NCT05603884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464883|NCT05603884|Antiviral Agents|antiviral agents|mesh-ancestor
64464884|NCT05603884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64533611|NCT02339142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64533612|NCT02339142|Prednisolone phosphate|prednisolone phosphate|mesh-list
64533613|NCT02339142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64533614|NCT02339142|Antiemetics|antiemetics|mesh-ancestor
64533615|NCT02339142|Autonomic Agents|autonomic agents|mesh-ancestor
64533616|NCT02339142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64533617|NCT02339142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533618|NCT02339142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64533619|NCT02339142|Glucocorticoids|glucocorticoids|mesh-ancestor
64890376|NCT01973400|Tocotrienols|tocotrienols|mesh-list
64890377|NCT01973400|Vitamin E|vitamin e|mesh-list
64890378|NCT01973400|Tocopherols|tocopherols|mesh-list
64890379|NCT01973400|Antioxidants|antioxidants|mesh-ancestor
64890380|NCT01973400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890381|NCT01973400|Protective Agents|protective agents|mesh-ancestor
64890382|NCT01973400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890383|NCT01973400|Vitamins|vitamins|mesh-ancestor
64890384|NCT01973400|Micronutrients|micronutrients|mesh-ancestor
64890385|NCT01973504|Chrysarobin|chrysarobin|mesh-list
64890386|NCT01973504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64890387|NCT01973504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64520150|NCT01712009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64520151|NCT01712009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520152|NCT01712009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520153|NCT01712009|Antipruritics|antipruritics|mesh-ancestor
64520154|NCT01712009|Dermatologic Agents|dermatologic agents|mesh-ancestor
64520155|NCT01712009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64520156|NCT01712009|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64520157|NCT01712009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64520158|NCT01712009|Histamine Antagonists|histamine antagonists|mesh-ancestor
64520159|NCT01712009|Histamine Agents|histamine agents|mesh-ancestor
64520160|NCT01712009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64520161|NCT03212352|Misoprostol|misoprostol|mesh-list
64520162|NCT03212352|Mifepristone|mifepristone|mesh-list
64520163|NCT03212352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64533620|NCT02339142|Hormones|hormones|mesh-ancestor
64533621|NCT02339142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64464885|NCT05603884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64464886|NCT05603884|Immunologic Factors|immunologic factors|mesh-ancestor
64464919|NCT01896895|Botulinum Toxins|botulinum toxins|mesh-list
64464920|NCT01896895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64464923|NCT01896895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64464924|NCT01896895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64464948|NCT04127500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464950|NCT03017326|Carboplatin|carboplatin|mesh-list
64464951|NCT03017326|Doxorubicin|doxorubicin|mesh-list
64464952|NCT03017326|Fluorouracil|fluorouracil|mesh-list
64464953|NCT03017326|Oxaliplatin|oxaliplatin|mesh-list
64464954|NCT03017326|Irinotecan|irinotecan|mesh-list
64464955|NCT03017326|Etoposide|etoposide|mesh-list
64464956|NCT03017326|Vincristine|vincristine|mesh-list
64464957|NCT03017326|Sorafenib|sorafenib|mesh-list
64464958|NCT03017326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464959|NCT03017326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64464960|NCT03017326|Antimetabolites|antimetabolites|mesh-ancestor
64464961|NCT03017326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464962|NCT03017326|Antiviral Agents|antiviral agents|mesh-ancestor
64464963|NCT03017326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64464964|NCT03017326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464965|NCT03017326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64464966|NCT03017326|Immunologic Factors|immunologic factors|mesh-ancestor
64520164|NCT03212352|Abortifacient Agents|abortifacient agents|mesh-ancestor
64520165|NCT03212352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64890388|NCT01973504|Analgesics|analgesics|mesh-ancestor
64890389|NCT01973504|Sensory System Agents|sensory system agents|mesh-ancestor
64890390|NCT01973504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64890391|NCT01973504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890392|NCT01973504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64890393|NCT01973504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64890394|NCT01973517|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64890395|NCT01973517|Hematinics|hematinics|mesh-ancestor
64890396|NCT01973517|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64890397|NCT01973517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64890398|NCT01973660|Tamoxifen|tamoxifen|mesh-list
64890399|NCT01973660|Paclitaxel|paclitaxel|mesh-list
64890400|NCT01973660|Trastuzumab|trastuzumab|mesh-list
64890401|NCT01973660|Letrozole|letrozole|mesh-list
64890402|NCT01973660|Lapatinib|lapatinib|mesh-list
64890403|NCT01973660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64890404|NCT01973660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890405|NCT01973660|Tubulin Modulators|tubulin modulators|mesh-ancestor
64890406|NCT01973660|Antimitotic Agents|antimitotic agents|mesh-ancestor
64890407|NCT01973660|Mitosis Modulators|mitosis modulators|mesh-ancestor
64890408|NCT01973660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890409|NCT01973660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64890410|NCT01973660|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64890411|NCT01973660|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64890412|NCT01973660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890413|NCT01973660|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64890414|NCT01973660|Hormone Antagonists|hormone antagonists|mesh-ancestor
64890415|NCT01973660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64890416|NCT01973660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890440|NCT01973790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64890441|NCT01973816|Cyproterone Acetate|cyproterone acetate|mesh-list
64890442|NCT01973816|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64464967|NCT03017326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464968|NCT03017326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64464969|NCT03017326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64464970|NCT03017326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64464971|NCT03017326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64464995|NCT03012880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464996|NCT03012880|Immunologic Factors|immunologic factors|mesh-ancestor
64464997|NCT03012880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64890443|NCT01973816|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64890444|NCT01973816|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64890446|NCT01973816|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64890447|NCT01973816|Cyproterone|cyproterone|mesh-list
64890448|NCT01973816|Estrogens|estrogens|mesh-ancestor
64890449|NCT01973816|Hormones|hormones|mesh-ancestor
64890450|NCT01973816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64890451|NCT01973816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890452|NCT01973816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64890453|NCT01973816|Contraceptive Agents|contraceptive agents|mesh-ancestor
64890454|NCT01973816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64520166|NCT03212352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520167|NCT03212352|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64890455|NCT01973816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64890456|NCT01973816|Androgen Antagonists|androgen antagonists|mesh-ancestor
64890457|NCT01973816|Hormone Antagonists|hormone antagonists|mesh-ancestor
64890458|NCT01973816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890459|NCT01973816|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64890460|NCT01973816|Luteolytic Agents|luteolytic agents|mesh-ancestor
64890461|NCT01973816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64890462|NCT01973842|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64890463|NCT01973842|Luteolytic Agents|luteolytic agents|mesh-ancestor
64890475|NCT01973855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64890477|NCT01973868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64890478|NCT01973868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890479|NCT01973920|Insulin|insulin|mesh-list
64890480|NCT01973920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64890481|NCT01973920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890482|NCT01973933|Metformin|metformin|mesh-list
64890501|NCT01974024|Antiemetics|antiemetics|mesh-ancestor
64890502|NCT01974024|Autonomic Agents|autonomic agents|mesh-ancestor
64890503|NCT01974024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64890504|NCT01974024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890505|NCT01974024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64890506|NCT01974024|Glucocorticoids|glucocorticoids|mesh-ancestor
64890507|NCT01974024|Hormones|hormones|mesh-ancestor
64890508|NCT01974024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64890509|NCT01974024|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64890510|NCT01974024|Protective Agents|protective agents|mesh-ancestor
64890511|NCT01974024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64890512|NCT01974024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890513|NCT01974037|Capsaicin|capsaicin|mesh-list
64890514|NCT01974037|Antipruritics|antipruritics|mesh-ancestor
64890515|NCT01974037|Dermatologic Agents|dermatologic agents|mesh-ancestor
64890516|NCT01974037|Sensory System Agents|sensory system agents|mesh-ancestor
64890517|NCT01974037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64890518|NCT01974037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890519|NCT01974167|Alfacalcidol|alfacalcidol|mesh-list
64890520|NCT01974167|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
64890521|NCT01974167|Eldecalcitol|eldecalcitol|mesh-list
64890522|NCT01974167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64890523|NCT01974167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890524|NCT01974167|Vitamins|vitamins|mesh-ancestor
64464998|NCT03012880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64464999|NCT03012880|Growth Substances|growth substances|mesh-ancestor
64465000|NCT03012880|Growth Inhibitors|growth inhibitors|mesh-ancestor
64465001|NCT03012880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465002|NCT03012880|Protease Inhibitors|protease inhibitors|mesh-ancestor
64465003|NCT03012880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465004|NCT03012880|Dermatologic Agents|dermatologic agents|mesh-ancestor
64465005|NCT03012880|Glycine Agents|glycine agents|mesh-ancestor
64465006|NCT03012880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64465007|NCT04126330|Vitamin D|vitamin d|mesh-list
64465008|NCT04126330|Vitamins|vitamins|mesh-ancestor
64465009|NCT04126330|Micronutrients|micronutrients|mesh-ancestor
64465010|NCT04126330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465011|NCT04126330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64465012|NCT04126720|Vitamin E|vitamin e|mesh-list
64465013|NCT04126720|Vitamins|vitamins|mesh-ancestor
64465014|NCT04126720|Micronutrients|micronutrients|mesh-ancestor
64513640|NCT01457547|Vaccines|vaccines|mesh-list
64465015|NCT04126720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465016|NCT04126720|Antioxidants|antioxidants|mesh-ancestor
64533622|NCT02339142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64533623|NCT02339142|Protective Agents|protective agents|mesh-ancestor
64533624|NCT02339142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64533625|NCT02339142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533626|NCT00362817|Carboplatin|carboplatin|mesh-list
64533627|NCT00362817|Temozolomide|temozolomide|mesh-list
64533628|NCT00362817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533629|NCT00362817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64298211|NCT02071537|Antimalarials|antimalarials|mesh-ancestor
64298212|NCT02071537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64890525|NCT01974167|Micronutrients|micronutrients|mesh-ancestor
64890526|NCT01974258|Vemurafenib|vemurafenib|mesh-list
64890527|NCT01974258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890528|NCT01974258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64890548|NCT01974375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64890549|NCT01974375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890550|NCT01974375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890551|NCT01974375|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64890552|NCT01974375|Hormone Antagonists|hormone antagonists|mesh-ancestor
64890553|NCT01974375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64520168|NCT03212352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64520169|NCT03212352|Oxytocics|oxytocics|mesh-ancestor
64520170|NCT03212352|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64520171|NCT03212352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64520172|NCT03212352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64520173|NCT03212352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64520174|NCT03212352|Contraceptive Agents|contraceptive agents|mesh-ancestor
64520175|NCT03212352|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64520176|NCT03212352|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64520177|NCT03212352|Hormone Antagonists|hormone antagonists|mesh-ancestor
64520178|NCT03212352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64520179|NCT03212352|Luteolytic Agents|luteolytic agents|mesh-ancestor
64520180|NCT03212352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64520181|NCT03212352|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64520183|NCT00201825|Capecitabine|capecitabine|mesh-list
64520184|NCT00201825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520185|NCT00201825|Tubulin Modulators|tubulin modulators|mesh-ancestor
64520186|NCT00201825|Antimitotic Agents|antimitotic agents|mesh-ancestor
64520187|NCT00201825|Mitosis Modulators|mitosis modulators|mesh-ancestor
64890554|NCT01974375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890555|NCT01974375|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64890556|NCT01974375|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64890557|NCT01974401|Chlorhexidine|chlorhexidine|mesh-list
64890558|NCT01974401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64890563|NCT01974518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64890564|NCT01974518|Immunologic Factors|immunologic factors|mesh-ancestor
64890565|NCT01974518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890566|NCT01974518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64890567|NCT01974518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64890568|NCT01974518|Alkylating Agents|alkylating agents|mesh-ancestor
64890569|NCT01974518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890570|NCT01974518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890571|NCT01974518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64890572|NCT01974518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64890573|NCT01974622|Verteporfin|verteporfin|mesh-list
64890574|NCT01974622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64890575|NCT01974622|Dermatologic Agents|dermatologic agents|mesh-ancestor
64890576|NCT01974648|Remifentanil|remifentanil|mesh-list
64890577|NCT01974648|Propofol|propofol|mesh-list
64890578|NCT01974648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64890579|NCT01974648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64890580|NCT01974648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890581|NCT01974648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64890582|NCT01974648|Anesthetics, General|anesthetics, general|mesh-ancestor
64890594|NCT01974843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890595|NCT01974843|Sensory System Agents|sensory system agents|mesh-ancestor
64644668|NCT04545008|Antioxidants|antioxidants|mesh-ancestor
64465017|NCT04126720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465018|NCT04126720|Protective Agents|protective agents|mesh-ancestor
64465019|NCT04126252|Sildenafil Citrate|sildenafil citrate|mesh-list
64465020|NCT04126252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465021|NCT04126252|Vasodilator Agents|vasodilator agents|mesh-ancestor
64465022|NCT04126252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64465023|NCT04126252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64465024|NCT04126252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465025|NCT04126252|Urological Agents|urological agents|mesh-ancestor
64465026|NCT04125862|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64465057|NCT03007732|Estrogens|estrogens|mesh-ancestor
64465058|NCT03007732|Anabolic Agents|anabolic agents|mesh-ancestor
64465059|NCT03007420|Lidocaine|lidocaine|mesh-list
64465060|NCT03007420|Anesthetics, Local|anesthetics, local|mesh-ancestor
64465061|NCT03007420|Anesthetics|anesthetics|mesh-ancestor
64465062|NCT03007420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64653030|NCT01724138|Chelating Agents|chelating agents|mesh-ancestor
64465090|NCT04393246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64465091|NCT04393246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465092|NCT04393246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64465094|NCT04124302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64465095|NCT04124302|Insulin Aspart|insulin aspart|mesh-list
64465096|NCT04124302|Insulin Lispro|insulin lispro|mesh-list
64465097|NCT04124302|Insulin glulisine|insulin glulisine|mesh-list
64465098|NCT04124302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64465099|NCT04124302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465100|NCT04124068|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64465101|NCT04124068|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64465102|NCT04124068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64465103|NCT04411069|Droperidol|droperidol|mesh-list
64890596|NCT01974843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64890597|NCT01974934|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64520188|NCT00201825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520189|NCT00201825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64520191|NCT02390050|Bexagliflozin|bexagliflozin|mesh-list
64520192|NCT02390050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64520193|NCT02390050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520194|NCT01711853|Dabigatran|dabigatran|mesh-list
64520195|NCT01711853|Antithrombins|antithrombins|mesh-ancestor
64520196|NCT01711853|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64520197|NCT01711853|Protease Inhibitors|protease inhibitors|mesh-ancestor
64520198|NCT01711853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520199|NCT01711853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520200|NCT01711853|Anticoagulants|anticoagulants|mesh-ancestor
64520201|NCT00202449|Prazosin|prazosin|mesh-list
64520202|NCT00202449|Paroxetine|paroxetine|mesh-list
64890598|NCT01974934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64890599|NCT01974934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64890600|NCT01974934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64890601|NCT01974934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890602|NCT01974934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64890603|NCT01974934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890604|NCT01974934|Antidepressive Agents|antidepressive agents|mesh-ancestor
64890605|NCT01974934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64890606|NCT01975012|Rilpivirine|rilpivirine|mesh-list
64890607|NCT01975012|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64890608|NCT01975012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64890609|NCT01975012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890610|NCT01975012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890611|NCT01975012|Antiviral Agents|antiviral agents|mesh-ancestor
64890612|NCT01975012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64890613|NCT01975012|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64890614|NCT01975012|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64890615|NCT01975051|Miltefosine|miltefosine|mesh-list
64465104|NCT04411069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64465105|NCT04411069|Antiemetics|antiemetics|mesh-ancestor
64465106|NCT04411069|Autonomic Agents|autonomic agents|mesh-ancestor
64465107|NCT04411069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64890616|NCT01975051|Antifungal Agents|antifungal agents|mesh-ancestor
64890617|NCT01975051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64890618|NCT01975051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890619|NCT01975051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64890620|NCT01975051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64890622|NCT01975129|Oxytocics|oxytocics|mesh-ancestor
64890623|NCT01975129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64890624|NCT01975129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890625|NCT01975142|Trastuzumab|trastuzumab|mesh-list
64890626|NCT01975142|Maytansine|maytansine|mesh-list
64890627|NCT01975142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64890628|NCT01975142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890629|NCT01975142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64890630|NCT01975142|Tubulin Modulators|tubulin modulators|mesh-ancestor
64890631|NCT01975142|Antimitotic Agents|antimitotic agents|mesh-ancestor
64890632|NCT01975142|Mitosis Modulators|mitosis modulators|mesh-ancestor
64890633|NCT01975142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890634|NCT01975194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64890635|NCT01975194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64890636|NCT01975194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64890637|NCT01975194|Antimetabolites|antimetabolites|mesh-ancestor
64890638|NCT01975194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890639|NCT01975194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64890640|NCT01975194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64520204|NCT00202449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64520205|NCT00202449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64520206|NCT00202449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520207|NCT00202449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64520208|NCT00202449|Serotonin Agents|serotonin agents|mesh-ancestor
64520209|NCT00202449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520210|NCT00202449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64520211|NCT00202449|Antidepressive Agents|antidepressive agents|mesh-ancestor
64520212|NCT00202449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64520213|NCT00202449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64520214|NCT00202449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64465108|NCT04411069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520215|NCT00202449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520216|NCT00202449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64520217|NCT00202449|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64890641|NCT01975194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890642|NCT01975259|Glucagon|glucagon|mesh-list
64890643|NCT01975259|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
64890644|NCT01975259|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64890645|NCT01975259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64890646|NCT01975259|Hormones|hormones|mesh-ancestor
64890678|NCT01975441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890679|NCT01975441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890681|NCT01975441|Antinematodal Agents|antinematodal agents|mesh-ancestor
64890682|NCT01975441|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64890683|NCT01975441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890684|NCT01975454|Capecitabine|capecitabine|mesh-list
64890685|NCT01975454|Oxaliplatin|oxaliplatin|mesh-list
64890686|NCT01975454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64890687|NCT01975454|Antimetabolites|antimetabolites|mesh-ancestor
64890688|NCT01975454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890715|NCT01975727|BB 1101|bb 1101|mesh-list
64890716|NCT01975727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64890717|NCT01975727|Antiemetics|antiemetics|mesh-ancestor
64890718|NCT01975727|Autonomic Agents|autonomic agents|mesh-ancestor
64890719|NCT01975727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64890720|NCT01975727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890721|NCT01975727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64890722|NCT01975727|Glucocorticoids|glucocorticoids|mesh-ancestor
64890723|NCT01975727|Hormones|hormones|mesh-ancestor
64890724|NCT01975727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64890725|NCT01975727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64890726|NCT01975727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890727|NCT01975727|Protease Inhibitors|protease inhibitors|mesh-ancestor
64890728|NCT01975727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890729|NCT01975727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890730|NCT01975753|Fentanyl|fentanyl|mesh-list
64890731|NCT01975753|Morphine|morphine|mesh-list
64890735|NCT01975753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890736|NCT01975753|Analgesics|analgesics|mesh-ancestor
64890737|NCT01975753|Sensory System Agents|sensory system agents|mesh-ancestor
64890756|NCT01975961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64520218|NCT00202449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64520219|NCT00202449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64520220|NCT00202449|Adrenergic Agents|adrenergic agents|mesh-ancestor
64520221|NCT03203304|Nivolumab|nivolumab|mesh-list
64520222|NCT03203304|Ipilimumab|ipilimumab|mesh-list
64890758|NCT01975961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890759|NCT01975961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64890760|NCT01975961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64890761|NCT01975961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890762|NCT01975961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64890763|NCT01975961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64890764|NCT01975961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64890765|NCT01976078|Midazolam|midazolam|mesh-list
64890766|NCT01976078|Esomeprazole|esomeprazole|mesh-list
64890767|NCT01976078|Ranitidine|ranitidine|mesh-list
64890768|NCT01976078|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
64890769|NCT01976078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64890770|NCT01976078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64890771|NCT01976078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64890772|NCT01976078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890773|NCT01976078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64890774|NCT01976078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64890775|NCT01976078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64890776|NCT01976078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64890777|NCT01976078|Anesthetics, General|anesthetics, general|mesh-ancestor
64890778|NCT01976078|Anesthetics|anesthetics|mesh-ancestor
64890779|NCT01976078|GABA Modulators|gaba modulators|mesh-ancestor
64890780|NCT01976078|GABA Agents|gaba agents|mesh-ancestor
64890781|NCT01976078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64890782|NCT01976078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890783|NCT01976078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64890784|NCT01976078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64890785|NCT01976078|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64890787|NCT01976078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64890788|NCT01976078|Histamine Antagonists|histamine antagonists|mesh-ancestor
64890789|NCT01976078|Histamine Agents|histamine agents|mesh-ancestor
64890790|NCT01976143|Etirinotecan pegol|etirinotecan pegol|mesh-list
64890791|NCT01976143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890792|NCT01976143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64890793|NCT01976143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64890794|NCT01976143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890795|NCT01976143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890796|NCT01976195|Thalidomide|thalidomide|mesh-list
64890815|NCT01976195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64890816|NCT01976195|Growth Substances|growth substances|mesh-ancestor
64890817|NCT01976195|Growth Inhibitors|growth inhibitors|mesh-ancestor
64890818|NCT01976208|Omalizumab|omalizumab|mesh-list
64890819|NCT01976208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64890820|NCT01976208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64890821|NCT01976208|Respiratory System Agents|respiratory system agents|mesh-ancestor
64890822|NCT01976520|Vaccines|vaccines|mesh-list
64890823|NCT01976520|Immunologic Factors|immunologic factors|mesh-ancestor
64890824|NCT01976520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890825|NCT01976611|Botulinum Toxins|botulinum toxins|mesh-list
64890826|NCT01976611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64890827|NCT01976611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64890828|NCT01976611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64890829|NCT01976611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64890830|NCT01976611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890831|NCT01976611|Cholinergic Agents|cholinergic agents|mesh-ancestor
64890832|NCT01976611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64890833|NCT01976611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890834|NCT01976611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64890835|NCT01976611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64890836|NCT01976676|Folic Acid|folic acid|mesh-list
64890837|NCT01976676|Hematinics|hematinics|mesh-ancestor
64890838|NCT01976676|Vitamin B Complex|vitamin b complex|mesh-ancestor
64890839|NCT01976676|Vitamins|vitamins|mesh-ancestor
64890840|NCT01976676|Micronutrients|micronutrients|mesh-ancestor
64890841|NCT01976676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890842|NCT01976780|Artesunate|artesunate|mesh-list
64890843|NCT01976780|Lumefantrine|lumefantrine|mesh-list
64520223|NCT03203304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64520224|NCT03203304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520225|NCT03203304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64520226|NCT03203304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520227|NCT03225456|Oxytocin|oxytocin|mesh-list
64520228|NCT03225456|Oxytocics|oxytocics|mesh-ancestor
64520229|NCT03225456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64520230|NCT03225456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520231|NCT05545072|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64520232|NCT05545072|Immunologic Factors|immunologic factors|mesh-ancestor
64520233|NCT05545072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520234|NCT00203229|Lamotrigine|lamotrigine|mesh-list
64520235|NCT00203229|Anticonvulsants|anticonvulsants|mesh-ancestor
64520236|NCT00203229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64520237|NCT00203229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64520238|NCT00203229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520239|NCT00203229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64520240|NCT00203229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520241|NCT00203229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64520242|NCT00203229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64520243|NCT00203229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64520244|NCT00203229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64520245|NCT00203229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64520246|NCT00203931|Pemetrexed|pemetrexed|mesh-list
64520247|NCT00203931|Cetuximab|cetuximab|mesh-list
64520248|NCT00203931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520249|NCT00203931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520250|NCT00203931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890844|NCT01976780|Artemether|artemether|mesh-list
64890845|NCT01976780|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64890846|NCT01976780|Mefloquine|mefloquine|mesh-list
64890847|NCT01976780|Antimalarials|antimalarials|mesh-ancestor
64890848|NCT01976780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64890849|NCT01976780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64890850|NCT01976780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64890851|NCT01976780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644904|NCT03722966|Nicotine|nicotine|mesh-list
64465109|NCT04411069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64890852|NCT01976780|Antiviral Agents|antiviral agents|mesh-ancestor
64890853|NCT01976780|Schistosomicides|schistosomicides|mesh-ancestor
64890854|NCT01976780|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64890891|NCT01977300|Risperidone|risperidone|mesh-list
64890909|NCT01977300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64890910|NCT01977300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64890911|NCT01977300|Antidepressive Agents|antidepressive agents|mesh-ancestor
64890912|NCT01977300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890913|NCT01977300|Antimanic Agents|antimanic agents|mesh-ancestor
64890914|NCT01977300|Anticonvulsants|anticonvulsants|mesh-ancestor
64890915|NCT01977300|GABA Agents|gaba agents|mesh-ancestor
64520252|NCT00203931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64520253|NCT00203931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64520254|NCT02412982|Enoxaparin|enoxaparin|mesh-list
64520255|NCT02412982|Enoxaparin sodium|enoxaparin sodium|mesh-list
64890916|NCT01977339|Bupivacaine|bupivacaine|mesh-list
64890917|NCT01977339|Anesthetics, Local|anesthetics, local|mesh-ancestor
64890918|NCT01977339|Anesthetics|anesthetics|mesh-ancestor
64890919|NCT01977339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64890920|NCT01977339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890921|NCT01977339|Sensory System Agents|sensory system agents|mesh-ancestor
64890922|NCT01977339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64890923|NCT01977378|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64890924|NCT01977378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64890925|NCT01977378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64890926|NCT01977378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64890927|NCT01977378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64890928|NCT01977378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890929|NCT01977378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64890930|NCT01977378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890931|NCT01977378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64890932|NCT01977378|Antidepressive Agents|antidepressive agents|mesh-ancestor
64890933|NCT01977378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64465110|NCT04411069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64465111|NCT04411069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64465112|NCT04411069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64465113|NCT04411069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64465114|NCT04411069|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64465115|NCT04411069|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64465117|NCT04411069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64890934|NCT01977417|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
64890935|NCT01977417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64890936|NCT01977417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64890937|NCT01977417|Analgesics|analgesics|mesh-ancestor
64890938|NCT01977417|Sensory System Agents|sensory system agents|mesh-ancestor
64890939|NCT01977417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64890940|NCT01977417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890941|NCT01977417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64890942|NCT01977417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64890943|NCT01977430|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64890944|NCT01977430|Furosemide|furosemide|mesh-list
64890945|NCT01977430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64890946|NCT01977430|Diuretics|diuretics|mesh-ancestor
64890947|NCT01977430|Natriuretic Agents|natriuretic agents|mesh-ancestor
64890982|NCT01978041|Cariostatic Agents|cariostatic agents|mesh-ancestor
64890983|NCT01978041|Protective Agents|protective agents|mesh-ancestor
64890984|NCT01978041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890985|NCT01978301|Triamcinolone|triamcinolone|mesh-list
64890986|NCT01978301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64890987|NCT01978301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64890988|NCT01978301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64891000|NCT01978405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891002|NCT01978405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891003|NCT01978405|Vitamin B Complex|vitamin b complex|mesh-ancestor
64891004|NCT01978405|Vitamins|vitamins|mesh-ancestor
64891005|NCT01978405|Micronutrients|micronutrients|mesh-ancestor
64891006|NCT01978418|Albuterol|albuterol|mesh-list
64891007|NCT01978418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64891008|NCT01978418|Autonomic Agents|autonomic agents|mesh-ancestor
64891009|NCT01978418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64891010|NCT01978418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891011|NCT01978418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64891012|NCT01978418|Respiratory System Agents|respiratory system agents|mesh-ancestor
64891013|NCT01978418|Tocolytic Agents|tocolytic agents|mesh-ancestor
64644979|NCT03007303|Antidepressive Agents|antidepressive agents|mesh-ancestor
64891014|NCT01978418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64465118|NCT04411069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465119|NCT03003130|Hyaluronic Acid|hyaluronic acid|mesh-list
64465120|NCT03003130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64465121|NCT03003130|Immunologic Factors|immunologic factors|mesh-ancestor
64891015|NCT01978418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64891016|NCT01978418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64891017|NCT01978418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64891018|NCT01978418|Adrenergic Agents|adrenergic agents|mesh-ancestor
64891019|NCT01978418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64891020|NCT01978418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891021|NCT01978457|Propranolol|propranolol|mesh-list
64891022|NCT01978457|Cocaine|cocaine|mesh-list
64891023|NCT01978457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64520256|NCT02412982|Anticoagulants|anticoagulants|mesh-ancestor
64520257|NCT02412982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64520258|NCT02412982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64520259|NCT02412982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645020|NCT00619190|Dopamine Agonists|dopamine agonists|mesh-ancestor
64533630|NCT00362817|Alkylating Agents|alkylating agents|mesh-ancestor
64533631|NCT00362817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533633|NCT02330952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64533634|NCT02330952|Glucocorticoids|glucocorticoids|mesh-ancestor
64533635|NCT02330952|Hormones|hormones|mesh-ancestor
64298219|NCT02071537|Filaricides|filaricides|mesh-ancestor
64465122|NCT03003130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465123|NCT03003130|Viscosupplements|viscosupplements|mesh-ancestor
64465124|NCT03003130|Protective Agents|protective agents|mesh-ancestor
64465125|NCT01884571|Mycophenolic Acid|mycophenolic acid|mesh-list
64465126|NCT01884571|Prednisone|prednisone|mesh-list
64465127|NCT01884571|Methylprednisolone|methylprednisolone|mesh-list
64465158|NCT01884337|Protease Inhibitors|protease inhibitors|mesh-ancestor
64465159|NCT01884337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465160|NCT01884337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465161|NCT01884337|Anticoagulants|anticoagulants|mesh-ancestor
64465162|NCT04123288|ACT-709478|act-709478|mesh-list
64465163|NCT04123288|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64465164|NCT04123288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64465165|NCT04123288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465166|NCT04123288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64465167|NCT04123288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465168|NCT04123210|Vitamin A|vitamin a|mesh-list
64513641|NCT01457547|Pentetic Acid|pentetic acid|mesh-list
64465170|NCT04123210|Micronutrients|micronutrients|mesh-ancestor
64465171|NCT04123210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465207|NCT01921387|Cytarabine|cytarabine|mesh-list
64465255|NCT04129216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64465256|NCT04129216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465257|NCT04129216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64465258|NCT04129216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64465259|NCT04129216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64465260|NCT04129216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64465285|NCT02980510|Leucovorin|leucovorin|mesh-list
64465286|NCT02980510|Folic Acid|folic acid|mesh-list
64465287|NCT02980510|Oxaliplatin|oxaliplatin|mesh-list
64465288|NCT02980510|Irinotecan|irinotecan|mesh-list
64465289|NCT02980510|Panitumumab|panitumumab|mesh-list
64465290|NCT02980510|Fluorouracil|fluorouracil|mesh-list
64465291|NCT02980510|Levoleucovorin|levoleucovorin|mesh-list
64465292|NCT02980510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465293|NCT02980510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64465294|NCT02980510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64465295|NCT02980510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465296|NCT02980510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465297|NCT02980510|Antidotes|antidotes|mesh-ancestor
64465298|NCT02980510|Protective Agents|protective agents|mesh-ancestor
64465299|NCT02980510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520260|NCT03203616|Trastuzumab|trastuzumab|mesh-list
64891024|NCT01978457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64891025|NCT01978457|Adrenergic Agents|adrenergic agents|mesh-ancestor
64891026|NCT01978457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64891027|NCT01978457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891028|NCT01978457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891029|NCT01978457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64891030|NCT01978457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64891031|NCT01978457|Vasodilator Agents|vasodilator agents|mesh-ancestor
64891032|NCT01978457|Anesthetics, Local|anesthetics, local|mesh-ancestor
64891033|NCT01978457|Anesthetics|anesthetics|mesh-ancestor
64891034|NCT01978457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64891035|NCT01978457|Sensory System Agents|sensory system agents|mesh-ancestor
64891036|NCT01978457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659571|NCT04246047|Bortezomib|bortezomib|mesh-list
64891037|NCT01978457|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64891038|NCT01978457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64891039|NCT01978457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64891040|NCT01978457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64891041|NCT01978457|Dopamine Agents|dopamine agents|mesh-ancestor
64891043|NCT01978483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64891044|NCT01978483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891045|NCT01978496|Eletriptan|eletriptan|mesh-list
64891046|NCT01978496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64891047|NCT01978496|Serotonin Agents|serotonin agents|mesh-ancestor
64891048|NCT01978496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64891049|NCT01978496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891050|NCT01978496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891062|NCT01978678|Autonomic Agents|autonomic agents|mesh-ancestor
64891078|NCT01978782|Citalopram|citalopram|mesh-list
64891079|NCT01978782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64891080|NCT01978782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64891081|NCT01978782|Antiviral Agents|antiviral agents|mesh-ancestor
64891082|NCT01978782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64891083|NCT01978782|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64891084|NCT01978782|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64891085|NCT01978782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64891086|NCT01978782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891087|NCT01978782|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64891088|NCT01978782|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64891089|NCT01978782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64891090|NCT01978782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64891091|NCT01978782|Serotonin Agents|serotonin agents|mesh-ancestor
64891092|NCT01978782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891093|NCT01978782|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64891094|NCT01978782|Antidepressive Agents|antidepressive agents|mesh-ancestor
64891095|NCT01978782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64891096|NCT01978873|Ascorbic Acid|ascorbic acid|mesh-list
64520261|NCT03203616|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64520262|NCT03203616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64520263|NCT03203616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891097|NCT01978873|Methyltestosterone|methyltestosterone|mesh-list
64891098|NCT01978873|Androgens|androgens|mesh-list
64891099|NCT01978873|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64891100|NCT01978873|Hormones|hormones|mesh-ancestor
64891101|NCT01978873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64891102|NCT01978873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891103|NCT01978873|Antioxidants|antioxidants|mesh-ancestor
64891104|NCT01978873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891105|NCT01978873|Protective Agents|protective agents|mesh-ancestor
64891106|NCT01978873|Vitamins|vitamins|mesh-ancestor
64891107|NCT01978873|Micronutrients|micronutrients|mesh-ancestor
64891120|NCT01979341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64891122|NCT01979354|Morphine|morphine|mesh-list
64891123|NCT01979354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64891124|NCT01979354|Narcotics|narcotics|mesh-ancestor
64891125|NCT01979354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64891126|NCT01979354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891127|NCT01979354|Analgesics|analgesics|mesh-ancestor
64891128|NCT01979354|Sensory System Agents|sensory system agents|mesh-ancestor
64891129|NCT01979354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64891130|NCT01979406|Vaccines|vaccines|mesh-list
64891131|NCT01979406|Immunologic Factors|immunologic factors|mesh-ancestor
64891132|NCT01979406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891133|NCT01979510|Acetaminophen|acetaminophen|mesh-list
64891134|NCT01979510|Etoricoxib|etoricoxib|mesh-list
64891135|NCT01979510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64891136|NCT01979510|Analgesics|analgesics|mesh-ancestor
64891137|NCT01979510|Sensory System Agents|sensory system agents|mesh-ancestor
64465300|NCT02980510|Vitamin B Complex|vitamin b complex|mesh-ancestor
64533636|NCT02330952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64533637|NCT02330952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533638|NCT02330952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64533639|NCT02330952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533640|NCT02338830|Progesterone|progesterone|mesh-list
64533641|NCT02338830|Progestins|progestins|mesh-ancestor
64533642|NCT02338830|Hormones|hormones|mesh-ancestor
64533643|NCT02338830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64533644|NCT02338830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533645|NCT00364377|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64533646|NCT00364377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64533647|NCT00364377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533648|NCT00364377|Incretins|incretins|mesh-ancestor
64465310|NCT03829696|Mifepristone|mifepristone|mesh-list
64465311|NCT03829696|Ulipristal acetate|ulipristal acetate|mesh-list
64465312|NCT03829696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64465313|NCT03829696|Abortifacient Agents|abortifacient agents|mesh-ancestor
64465314|NCT03829696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64465348|NCT02972398|Respiratory System Agents|respiratory system agents|mesh-ancestor
64465349|NCT02972398|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64465350|NCT02972398|Antioxidants|antioxidants|mesh-ancestor
64465351|NCT02972398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465352|NCT02972398|Protective Agents|protective agents|mesh-ancestor
64465378|NCT03828682|Hormones|hormones|mesh-ancestor
64465379|NCT03828682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64465380|NCT03828682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465381|NCT03828682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64465382|NCT03828682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465383|NCT03828682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64465384|NCT03828682|Immunologic Factors|immunologic factors|mesh-ancestor
64465385|NCT03828682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64465386|NCT03828682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465387|NCT03828682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465388|NCT03828682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64465389|NCT03828682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64465390|NCT03828682|Antitubercular Agents|antitubercular agents|mesh-ancestor
64465391|NCT03828682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64465392|NCT03828682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64465393|NCT03828682|Antiemetics|antiemetics|mesh-ancestor
64465394|NCT03828682|Autonomic Agents|autonomic agents|mesh-ancestor
64465395|NCT03828682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64891138|NCT01979510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64891139|NCT01979510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891140|NCT01979510|Antipyretics|antipyretics|mesh-ancestor
64891141|NCT01979510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64891142|NCT01979510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64891143|NCT01979510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64891144|NCT01979510|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64891145|NCT01979510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64891146|NCT01979510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64891147|NCT01979510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891148|NCT01979653|Midazolam|midazolam|mesh-list
64891149|NCT01979653|Dexmedetomidine|dexmedetomidine|mesh-list
64891150|NCT01979653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64891151|NCT01979653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64645202|NCT02174822|Sensory System Agents|sensory system agents|mesh-ancestor
64465396|NCT03828682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64465397|NCT03828682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64465398|NCT03828682|Protective Agents|protective agents|mesh-ancestor
64465399|NCT03483649|Bevacizumab|bevacizumab|mesh-list
64465400|NCT03483649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64533651|NCT00364377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64533652|NCT00364377|Protease Inhibitors|protease inhibitors|mesh-ancestor
64533653|NCT00364377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533654|NCT00364377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533655|NCT04175886|Tofacitinib|tofacitinib|mesh-list
64465401|NCT03483649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465402|NCT03483649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64465403|NCT03483649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64465404|NCT03483649|Growth Substances|growth substances|mesh-ancestor
64465429|NCT01894477|Busulfan|busulfan|mesh-list
64465430|NCT01894477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465431|NCT01894477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64465432|NCT01894477|Antimetabolites|antimetabolites|mesh-ancestor
64465433|NCT01894477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465434|NCT01894477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64465435|NCT01894477|Immunologic Factors|immunologic factors|mesh-ancestor
64465436|NCT01894477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653059|NCT03001271|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
64465439|NCT01894477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64465440|NCT04391998|Metronidazole|metronidazole|mesh-list
64465441|NCT04391998|Albendazole|albendazole|mesh-list
64465442|NCT04391998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64465443|NCT04391998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64465444|NCT04391998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64465445|NCT04391998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64465446|NCT04391998|Anthelmintics|anthelmintics|mesh-ancestor
64465447|NCT04391998|Anticestodal Agents|anticestodal agents|mesh-ancestor
64465448|NCT04391998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64465449|NCT04391998|Tubulin Modulators|tubulin modulators|mesh-ancestor
64465450|NCT04391998|Antimitotic Agents|antimitotic agents|mesh-ancestor
64465451|NCT04391998|Mitosis Modulators|mitosis modulators|mesh-ancestor
64465452|NCT04391998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465453|NCT04391998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465454|NCT03820180|Fluticasone|fluticasone|mesh-list
64465455|NCT03820180|Xhance|xhance|mesh-list
64465456|NCT03820180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64465479|NCT01894243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465480|NCT01894243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465481|NCT01894243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465482|NCT01450384|Pemetrexed|pemetrexed|mesh-list
64891152|NCT01979653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645261|NCT00626210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891153|NCT01979653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64891154|NCT01979653|Analgesics|analgesics|mesh-ancestor
64891155|NCT01979653|Sensory System Agents|sensory system agents|mesh-ancestor
64891156|NCT01979653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64891157|NCT01979653|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64891158|NCT01979653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64891159|NCT01979653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64891160|NCT01979653|Adrenergic Agents|adrenergic agents|mesh-ancestor
64891161|NCT01979653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64891162|NCT01979653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891163|NCT01979653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64891164|NCT01979653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64891165|NCT01979653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64891166|NCT01979653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64891167|NCT01979653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64891168|NCT01979653|Anesthetics, General|anesthetics, general|mesh-ancestor
64891169|NCT01979653|Anesthetics|anesthetics|mesh-ancestor
64520264|NCT03203616|Tubulin Modulators|tubulin modulators|mesh-ancestor
64520265|NCT03203616|Antimitotic Agents|antimitotic agents|mesh-ancestor
64520266|NCT03203616|Mitosis Modulators|mitosis modulators|mesh-ancestor
64520267|NCT03203616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520268|NCT02450214|Ketamine|ketamine|mesh-list
64520269|NCT02450214|Analgesics|analgesics|mesh-ancestor
64520270|NCT02450214|Sensory System Agents|sensory system agents|mesh-ancestor
64520271|NCT02450214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520272|NCT02450214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520273|NCT02450214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64520274|NCT02450214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64520275|NCT02450214|Anesthetics, General|anesthetics, general|mesh-ancestor
64520276|NCT02450214|Anesthetics|anesthetics|mesh-ancestor
64520277|NCT02450214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64465483|NCT01450384|Sorafenib|sorafenib|mesh-list
64465484|NCT01450384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465485|NCT01450384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465486|NCT01450384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465487|NCT01450384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64465488|NCT01450384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64465489|NCT01450384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64465490|NCT01450462|Vitamin D|vitamin d|mesh-list
64645303|NCT03006835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64520278|NCT02450214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64520279|NCT02450214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64520280|NCT02450214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64520281|NCT02450214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520282|NCT02450682|Warfarin|warfarin|mesh-list
64520283|NCT02450682|Apixaban|apixaban|mesh-list
64520284|NCT02450682|Anticoagulants|anticoagulants|mesh-ancestor
64891170|NCT01979653|GABA Modulators|gaba modulators|mesh-ancestor
64891171|NCT01979653|GABA Agents|gaba agents|mesh-ancestor
64891172|NCT01979679|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64891173|NCT01979679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64891174|NCT01979679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64891175|NCT01979679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64891176|NCT01979679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891177|NCT01979679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64891178|NCT01979679|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64891179|NCT01979679|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64891180|NCT01979679|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64891181|NCT01979679|Adrenergic Agents|adrenergic agents|mesh-ancestor
64891182|NCT01979679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64891183|NCT01979679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891184|NCT01979679|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64891185|NCT01979679|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64891200|NCT01980069|Neostigmine|neostigmine|mesh-list
64891201|NCT01980069|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64891202|NCT01980069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64891203|NCT01980069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891204|NCT01980069|Cholinergic Agents|cholinergic agents|mesh-ancestor
64891205|NCT01980069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64891206|NCT01980069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891207|NCT01980069|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64891208|NCT01980069|Autonomic Agents|autonomic agents|mesh-ancestor
64891209|NCT01980069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64891210|NCT01980082|Cefazolin|cefazolin|mesh-list
64891211|NCT01980082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64891212|NCT01980082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64891213|NCT01980277|Paclitaxel|paclitaxel|mesh-list
64891214|NCT01980277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64891215|NCT01980277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891216|NCT01980277|Tubulin Modulators|tubulin modulators|mesh-ancestor
64520285|NCT02450682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64520287|NCT02450682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64520288|NCT02450682|Protease Inhibitors|protease inhibitors|mesh-ancestor
64520289|NCT02450682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520290|NCT02450682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520291|NCT03202836|Tocolytic Agents|tocolytic agents|mesh-list
64645339|NCT05134363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64645340|NCT05134363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645341|NCT03006679|Meropenem|meropenem|mesh-list
64520292|NCT03202836|Progesterone|progesterone|mesh-list
64891217|NCT01980277|Antimitotic Agents|antimitotic agents|mesh-ancestor
64891218|NCT01980277|Mitosis Modulators|mitosis modulators|mesh-ancestor
64891219|NCT01980277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891220|NCT01980303|Esketamine|esketamine|mesh-list
64891221|NCT01980303|Antidepressive Agents|antidepressive agents|mesh-ancestor
64891222|NCT01980303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64891223|NCT01980316|Heparin|heparin|mesh-list
64891224|NCT01980316|Calcium heparin|calcium heparin|mesh-list
64891225|NCT01980316|Argatroban|argatroban|mesh-list
64891226|NCT01980316|Anticoagulants|anticoagulants|mesh-ancestor
64645342|NCT03006679|Tazobactam|tazobactam|mesh-list
64645343|NCT03006679|Piperacillin|piperacillin|mesh-list
64465491|NCT01450462|Cholecalciferol|cholecalciferol|mesh-list
64465493|NCT01450462|Micronutrients|micronutrients|mesh-ancestor
64465494|NCT01450462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465495|NCT01450462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64465496|NCT01450462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64465497|NCT01450774|Beclomethasone|beclomethasone|mesh-list
64465498|NCT01450774|Formoterol Fumarate|formoterol fumarate|mesh-list
64465499|NCT01450774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64465500|NCT01450774|Autonomic Agents|autonomic agents|mesh-ancestor
64465501|NCT01450774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64465502|NCT01450774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465503|NCT01450774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64465504|NCT01450774|Respiratory System Agents|respiratory system agents|mesh-ancestor
64465505|NCT01450774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64465506|NCT01450774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64465507|NCT01450774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64465542|NCT01451710|Prednisolone|prednisolone|mesh-list
64465543|NCT01451710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64465544|NCT01451710|Methylprednisolone|methylprednisolone|mesh-list
64533656|NCT04175886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64533657|NCT04175886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533659|NCT02338674|Tenofovir|tenofovir|mesh-list
64533729|NCT04417179|Anesthetics, Local|anesthetics, local|mesh-ancestor
64533730|NCT04417179|Anesthetics|anesthetics|mesh-ancestor
64645388|NCT02247505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64891227|NCT01980316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64891228|NCT01980316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64891229|NCT01980316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891230|NCT01980316|Antithrombins|antithrombins|mesh-ancestor
64891231|NCT01980316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64891232|NCT01980316|Protease Inhibitors|protease inhibitors|mesh-ancestor
64891233|NCT01980316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64891234|NCT01980316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64891235|NCT01980329|Maraviroc|maraviroc|mesh-list
64891236|NCT01980329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64891237|NCT01980329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64891238|NCT01980329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891239|NCT01980329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64891240|NCT01980329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64891241|NCT01980329|Antiviral Agents|antiviral agents|mesh-ancestor
64533731|NCT04417179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64533732|NCT04417179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533733|NCT04417179|Sensory System Agents|sensory system agents|mesh-ancestor
64533734|NCT04417179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64533735|NCT02330796|Bucillamine|bucillamine|mesh-list
64298319|NCT03298347|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64465545|NCT01451710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64465546|NCT01451710|Prednisolone acetate|prednisolone acetate|mesh-list
64465547|NCT01451710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64465569|NCT03553810|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64465570|NCT03553810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465571|NCT01452100|Prednisone|prednisone|mesh-list
64465572|NCT01452100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64465573|NCT01452100|Glucocorticoids|glucocorticoids|mesh-ancestor
64465574|NCT01452100|Hormones|hormones|mesh-ancestor
64465575|NCT01452100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64465576|NCT01452100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653069|NCT03001193|Oxytocin|oxytocin|mesh-list
64465584|NCT01452568|Salicylates|salicylates|mesh-list
64465586|NCT01452568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64465587|NCT01452568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64465588|NCT01452568|Analgesics|analgesics|mesh-ancestor
64465589|NCT01452568|Sensory System Agents|sensory system agents|mesh-ancestor
64465590|NCT01452568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64465591|NCT01452568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465592|NCT01452568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64465593|NCT01452568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64465594|NCT01452568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64465595|NCT01452568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64465596|NCT01452568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465597|NCT01452568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64465598|NCT01452568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64465599|NCT01452568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465617|NCT01452880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64465618|NCT01452880|Narcotics|narcotics|mesh-ancestor
64465619|NCT01452880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64465620|NCT01452880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465621|NCT01452880|Analgesics|analgesics|mesh-ancestor
64465622|NCT01452880|Sensory System Agents|sensory system agents|mesh-ancestor
64465623|NCT01452880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64465624|NCT01453192|Raltegravir Potassium|raltegravir potassium|mesh-list
64891242|NCT01980329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64891243|NCT01980329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64891244|NCT01980407|Leucovorin|leucovorin|mesh-list
64891245|NCT01980407|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
64891246|NCT01980407|Oxaliplatin|oxaliplatin|mesh-list
64891247|NCT01980407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891248|NCT01980407|Antidotes|antidotes|mesh-ancestor
64891273|NCT01980498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891274|NCT01980498|Analgesics|analgesics|mesh-ancestor
64891275|NCT01980498|Sensory System Agents|sensory system agents|mesh-ancestor
64891276|NCT01980498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64891277|NCT01980498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64891278|NCT01980498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64891279|NCT01980498|Anesthetics, General|anesthetics, general|mesh-ancestor
64891280|NCT01980498|Anesthetics|anesthetics|mesh-ancestor
64891281|NCT01980550|Nicotine|nicotine|mesh-list
64891282|NCT01980550|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64891283|NCT01980550|Autonomic Agents|autonomic agents|mesh-ancestor
64891284|NCT01980550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64891285|NCT01980550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891286|NCT01980550|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64891287|NCT01980550|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64891288|NCT01980550|Cholinergic Agents|cholinergic agents|mesh-ancestor
64891289|NCT01980550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64891290|NCT01980550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891291|NCT01980615|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64645446|NCT00683930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64465625|NCT01453192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64465626|NCT01453192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64465627|NCT01453192|Antiviral Agents|antiviral agents|mesh-ancestor
64465628|NCT01453192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64465629|NCT01453192|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64465630|NCT01453192|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64465631|NCT01453192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465632|NCT01453192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465633|NCT01453426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64465634|NCT01453426|Dermatologic Agents|dermatologic agents|mesh-ancestor
64465635|NCT01453426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64465636|NCT01453426|Immunologic Factors|immunologic factors|mesh-ancestor
64465637|NCT01453426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465638|NCT01453504|Everolimus|everolimus|mesh-list
64465639|NCT01453504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465640|NCT01453504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64945387|NCT05672225|Adrenergic Agents|adrenergic agents|mesh-ancestor
64533737|NCT02330796|Gout Suppressants|gout suppressants|mesh-ancestor
64533738|NCT02330796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64533739|NCT02330796|Tubulin Modulators|tubulin modulators|mesh-ancestor
64533740|NCT02330796|Antimitotic Agents|antimitotic agents|mesh-ancestor
64533741|NCT02330796|Mitosis Modulators|mitosis modulators|mesh-ancestor
64891292|NCT01980615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64891293|NCT01980615|Respiratory System Agents|respiratory system agents|mesh-ancestor
64891294|NCT01980667|Cisplatin|cisplatin|mesh-list
64891295|NCT01980667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891296|NCT01980680|Estradiol|estradiol|mesh-list
64891297|NCT01980680|Progesterone|progesterone|mesh-list
64891298|NCT01980680|Estrogens|estrogens|mesh-ancestor
64891299|NCT01980680|Hormones|hormones|mesh-ancestor
64891319|NCT01980745|Antinematodal Agents|antinematodal agents|mesh-ancestor
64891320|NCT01980745|Anthelmintics|anthelmintics|mesh-ancestor
64891321|NCT01980810|Paclitaxel|paclitaxel|mesh-list
64520293|NCT03202836|Progestins|progestins|mesh-ancestor
64520294|NCT03202836|Hormones|hormones|mesh-ancestor
64520295|NCT03202836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64520296|NCT03202836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520297|NCT03202836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64520298|NCT03203070|Dipyrone|dipyrone|mesh-list
64520299|NCT03203070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64520300|NCT03203070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64520301|NCT03203070|Analgesics|analgesics|mesh-ancestor
64520302|NCT03203070|Sensory System Agents|sensory system agents|mesh-ancestor
64645494|NCT04451863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64645504|NCT00251576|Heparin|heparin|mesh-list
64533742|NCT02330796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533743|NCT02330796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533744|NCT02330796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64465641|NCT01453504|Immunologic Factors|immunologic factors|mesh-ancestor
64465642|NCT01453504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465643|NCT01453582|Propolis|propolis|mesh-list
64465644|NCT01453582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64465645|NCT01453738|Plasma-lyte 148|plasma-lyte 148|mesh-list
64465646|NCT01453738|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64465647|NCT01453738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64465648|NCT04847752|Aspirin|aspirin|mesh-list
64465649|NCT04847752|Warfarin|warfarin|mesh-list
64465650|NCT04847752|Rivaroxaban|rivaroxaban|mesh-list
64465651|NCT04847752|Dabigatran|dabigatran|mesh-list
64465652|NCT04847752|Anticoagulants|anticoagulants|mesh-list
64465653|NCT04847752|Clopidogrel|clopidogrel|mesh-list
64465654|NCT04847752|Atorvastatin|atorvastatin|mesh-list
64465655|NCT04847752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64465660|NCT04847752|Analgesics|analgesics|mesh-ancestor
64465686|NCT04847206|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
64465687|NCT04847206|3,4-Methylenedioxyamphetamine|3,4-methylenedioxyamphetamine|mesh-list
64465689|NCT04847206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465690|NCT04847206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64465691|NCT04847206|Serotonin Agents|serotonin agents|mesh-ancestor
64465692|NCT04847206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64465693|NCT04847206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465694|NCT04847206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64645543|NCT04386811|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64520303|NCT03203070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520304|NCT03203070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520305|NCT03203070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64520339|NCT00354874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520340|NCT00354874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64520341|NCT00354874|Respiratory System Agents|respiratory system agents|mesh-ancestor
64520342|NCT00354874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64520343|NCT00354874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64520344|NCT00354874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64891322|NCT01980810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64891323|NCT01980810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64891324|NCT01980810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891325|NCT01980810|Tubulin Modulators|tubulin modulators|mesh-ancestor
64891326|NCT01980810|Antimitotic Agents|antimitotic agents|mesh-ancestor
64891327|NCT01980810|Mitosis Modulators|mitosis modulators|mesh-ancestor
64891328|NCT01980810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891330|NCT01980849|Anticoagulants|anticoagulants|mesh-ancestor
64891331|NCT01980849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64891332|NCT01980849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64891333|NCT01980849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891334|NCT01980966|Oseltamivir|oseltamivir|mesh-list
64891335|NCT01980966|Antiviral Agents|antiviral agents|mesh-ancestor
64891336|NCT01980966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64891337|NCT01980966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64891338|NCT01980966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891339|NCT01980979|Treprostinil|treprostinil|mesh-list
64891340|NCT01980979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64891341|NCT01981031|Insulin Lispro|insulin lispro|mesh-list
64891342|NCT01981031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64465695|NCT04847206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64465696|NCT04847206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64465697|NCT04847206|Adrenergic Agents|adrenergic agents|mesh-ancestor
64465698|NCT02864914|Empagliflozin|empagliflozin|mesh-list
64465699|NCT02864914|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64465700|NCT02864914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64465701|NCT02864914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465702|NCT02864914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64465703|NCT02864914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465704|NCT02864914|Protease Inhibitors|protease inhibitors|mesh-ancestor
64465705|NCT02864914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465706|NCT04840264|Docetaxel|docetaxel|mesh-list
64465707|NCT04840264|Fluorouracil|fluorouracil|mesh-list
64891343|NCT01981031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891344|NCT01981278|Tapentadol|tapentadol|mesh-list
64891345|NCT01981278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64891346|NCT01981278|Narcotics|narcotics|mesh-ancestor
64891347|NCT01981278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64891348|NCT01981278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891349|NCT01981278|Analgesics|analgesics|mesh-ancestor
64891350|NCT01981278|Sensory System Agents|sensory system agents|mesh-ancestor
64891351|NCT01981278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64891352|NCT01981278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64891353|NCT01981278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64891354|NCT01981278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64891355|NCT01981278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891370|NCT01981330|Protective Agents|protective agents|mesh-ancestor
64891371|NCT01981369|Dexmedetomidine|dexmedetomidine|mesh-list
64891372|NCT01981369|Propofol|propofol|mesh-list
64891373|NCT01981369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64891374|NCT01981369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64891375|NCT01981369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891376|NCT01981369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64891377|NCT01981369|Anesthetics, General|anesthetics, general|mesh-ancestor
64891378|NCT01981369|Anesthetics|anesthetics|mesh-ancestor
64891379|NCT01981369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64891380|NCT01981369|Analgesics|analgesics|mesh-ancestor
64891381|NCT01981369|Sensory System Agents|sensory system agents|mesh-ancestor
64891382|NCT01981369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64891383|NCT01981369|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64891384|NCT01981369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64891385|NCT01981369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64891386|NCT01981369|Adrenergic Agents|adrenergic agents|mesh-ancestor
64891387|NCT01981369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64891388|NCT01981369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891389|NCT01981447|Lacosamide|lacosamide|mesh-list
64891390|NCT01981447|Anticonvulsants|anticonvulsants|mesh-ancestor
64891391|NCT01981447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64645587|NCT00630734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64645588|NCT00630734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64891392|NCT01981447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64891393|NCT01981447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64891394|NCT01981447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891395|NCT01981460|Methylene Blue|methylene blue|mesh-list
64891396|NCT01981460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520345|NCT00354874|Adrenergic Agents|adrenergic agents|mesh-ancestor
64520346|NCT00354874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64520347|NCT00354874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520349|NCT03209466|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64520350|NCT03209466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64520351|NCT03209466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64520352|NCT03209466|Disinfectants|disinfectants|mesh-ancestor
64520353|NCT03209466|Dermatologic Agents|dermatologic agents|mesh-ancestor
64520354|NCT03834688|Rituximab|rituximab|mesh-list
64520355|NCT03834688|Venetoclax|venetoclax|mesh-list
64891397|NCT01981460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891398|NCT01981499|Cetirizine|cetirizine|mesh-list
64891399|NCT01981499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64645623|NCT02248753|Digoxin|digoxin|mesh-list
64891400|NCT01981499|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64891401|NCT01981499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64891402|NCT01981499|Histamine Antagonists|histamine antagonists|mesh-ancestor
64891403|NCT01981499|Histamine Agents|histamine agents|mesh-ancestor
64891404|NCT01981499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64891405|NCT01981499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891406|NCT01981499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891407|NCT01981525|Metformin|metformin|mesh-list
64891408|NCT01981525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64891409|NCT01981525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891410|NCT01981707|Choline|choline|mesh-list
64891411|NCT01981707|Lipotropic Agents|lipotropic agents|mesh-ancestor
64891412|NCT01981707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64891413|NCT01981707|Antimetabolites|antimetabolites|mesh-ancestor
64645624|NCT02248753|Amiodarone|amiodarone|mesh-list
64465731|NCT04841434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64465732|NCT04841434|Immunologic Factors|immunologic factors|mesh-ancestor
64465733|NCT04841434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64465734|NCT04841434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64465735|NCT04840342|Amlodipine|amlodipine|mesh-list
64465736|NCT04840342|Eplerenone|eplerenone|mesh-list
64465737|NCT04840342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64465738|NCT04840342|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64465739|NCT04840342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64891414|NCT01981707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891415|NCT01981707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64891416|NCT01981707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64891432|NCT01981811|Dopamine Agonists|dopamine agonists|mesh-ancestor
64891434|NCT01981811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64891435|NCT01981811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891436|NCT01981811|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64891437|NCT01981811|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64891438|NCT01981811|Serotonin Agents|serotonin agents|mesh-ancestor
64465740|NCT04840342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465741|NCT04840342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64465742|NCT04840342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465743|NCT04840342|Vasodilator Agents|vasodilator agents|mesh-ancestor
64465744|NCT04840342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64465745|NCT04840342|Hormone Antagonists|hormone antagonists|mesh-ancestor
64465746|NCT04840342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64533745|NCT02330796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64533746|NCT02330796|Analgesics|analgesics|mesh-ancestor
64533747|NCT02330796|Sensory System Agents|sensory system agents|mesh-ancestor
64533748|NCT02330796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64533749|NCT02330796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533750|NCT02330796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64533751|NCT02330796|Antioxidants|antioxidants|mesh-ancestor
64533752|NCT02330796|Protective Agents|protective agents|mesh-ancestor
64533753|NCT02330640|Clopidogrel|clopidogrel|mesh-list
64533754|NCT02330640|Ticagrelor|ticagrelor|mesh-list
64533755|NCT02330640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64533756|NCT02330640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64533757|NCT02330640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64533758|NCT02330640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64533759|NCT02330640|Purinergic Agents|purinergic agents|mesh-ancestor
64533760|NCT02330640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64533761|NCT02330640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533762|NCT02330640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533763|NCT02335398|Methadone|methadone|mesh-list
64533764|NCT02335398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64533765|NCT02335398|Narcotics|narcotics|mesh-ancestor
64533766|NCT02335398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64533767|NCT02335398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533768|NCT02335398|Analgesics|analgesics|mesh-ancestor
64533769|NCT02335398|Sensory System Agents|sensory system agents|mesh-ancestor
64533770|NCT02335398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64465754|NCT02849470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465755|NCT05021926|Lidocaine|lidocaine|mesh-list
64465756|NCT05021926|Hyaluronic Acid|hyaluronic acid|mesh-list
64465757|NCT05021926|Anesthetics, Local|anesthetics, local|mesh-ancestor
64465788|NCT04390594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64465789|NCT04390594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64465790|NCT04390594|Analgesics|analgesics|mesh-ancestor
64465791|NCT04390594|Sensory System Agents|sensory system agents|mesh-ancestor
64465792|NCT04390594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64465793|NCT04390594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465794|NCT04390594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64465795|NCT04390594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64465796|NCT04390594|Anticoagulants|anticoagulants|mesh-ancestor
64465797|NCT04390594|Protease Inhibitors|protease inhibitors|mesh-ancestor
64465798|NCT04390594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533771|NCT02335398|Antitussive Agents|antitussive agents|mesh-ancestor
64533772|NCT02335398|Respiratory System Agents|respiratory system agents|mesh-ancestor
64533773|NCT02338206|Hormones|hormones|mesh-list
64533774|NCT02338206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64533775|NCT02338206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891439|NCT01981811|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64891440|NCT01981811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64891441|NCT01981811|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64891442|NCT01981811|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64891443|NCT01981889|Prednisone|prednisone|mesh-list
64891444|NCT01981889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64891445|NCT01981889|Glucocorticoids|glucocorticoids|mesh-ancestor
64891446|NCT01981889|Hormones|hormones|mesh-ancestor
64891447|NCT01981889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64891448|NCT01981889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891449|NCT01981889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64891450|NCT01981889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891451|NCT01981941|Gabapentin|gabapentin|mesh-list
64891452|NCT01981941|Analgesics|analgesics|mesh-ancestor
64891453|NCT01981941|Sensory System Agents|sensory system agents|mesh-ancestor
64891454|NCT01981941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64891455|NCT01981941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891456|NCT01981941|Anticonvulsants|anticonvulsants|mesh-ancestor
64891457|NCT01981941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64891458|NCT01981941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64891459|NCT01981941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64891460|NCT01981941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64891461|NCT01981941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64891462|NCT01981941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64891463|NCT01981941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64891464|NCT01981941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520356|NCT03834688|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64520357|NCT03834688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64520358|NCT03834688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520359|NCT03834688|Immunologic Factors|immunologic factors|mesh-ancestor
64520360|NCT03834688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520361|NCT03834688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64520362|NCT03834688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64520363|NCT03834688|Alkylating Agents|alkylating agents|mesh-ancestor
64891467|NCT01982019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64891468|NCT01982019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891469|NCT01982071|Micafungin|micafungin|mesh-list
64891470|NCT01982071|Antifungal Agents|antifungal agents|mesh-ancestor
64891471|NCT01982071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64891472|NCT01982097|Sorafenib|sorafenib|mesh-list
64891473|NCT01982097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891474|NCT01982097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64891475|NCT01982097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64891476|NCT01982097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891511|NCT01982578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64891513|NCT01982734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64891514|NCT01982734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64891515|NCT01982734|Analgesics|analgesics|mesh-ancestor
64891516|NCT01982734|Sensory System Agents|sensory system agents|mesh-ancestor
64891535|NCT01982799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64645766|NCT03977233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891536|NCT01982799|Analgesics|analgesics|mesh-ancestor
64891537|NCT01982799|Sensory System Agents|sensory system agents|mesh-ancestor
64891538|NCT01982799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64891539|NCT01982799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891540|NCT01982799|Antipyretics|antipyretics|mesh-ancestor
64891541|NCT01982799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64891542|NCT01982799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64891543|NCT01982799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64645771|NCT03977233|Vitamins|vitamins|mesh-ancestor
64533776|NCT02338050|Immunotoxin HA22|immunotoxin ha22|mesh-list
64533777|NCT02338050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533778|NCT02330406|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64533779|NCT02330406|Anagliptin|anagliptin|mesh-list
64533780|NCT02330406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64533781|NCT02330406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533782|NCT02330406|Incretins|incretins|mesh-ancestor
64533783|NCT02330406|Hormones|hormones|mesh-ancestor
64298361|NCT03298191|Analgesics|analgesics|mesh-ancestor
64465799|NCT04390594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465800|NCT04390594|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64465801|NCT04390594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64465802|NCT04390594|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64465803|NCT04390594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64465804|NCT04390594|Immunologic Factors|immunologic factors|mesh-ancestor
64465814|NCT05024422|Pyridoxine|pyridoxine|mesh-list
64465815|NCT05024422|Vitamin B 6|vitamin b 6|mesh-list
64465816|NCT05024422|Cabergoline|cabergoline|mesh-list
64465817|NCT05024422|Vitamins|vitamins|mesh-ancestor
64465818|NCT05024422|Micronutrients|micronutrients|mesh-ancestor
64465819|NCT05024422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465820|NCT05024422|Vitamin B Complex|vitamin b complex|mesh-ancestor
64891544|NCT01982799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64891545|NCT01982799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64891546|NCT01982799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891547|NCT01982799|Gout Suppressants|gout suppressants|mesh-ancestor
64891548|NCT01982799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64891549|NCT01982799|Narcotics|narcotics|mesh-ancestor
64891550|NCT01982799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64891551|NCT01982799|Antitussive Agents|antitussive agents|mesh-ancestor
64891552|NCT01982799|Respiratory System Agents|respiratory system agents|mesh-ancestor
64891553|NCT01982864|Gentamicins|gentamicins|mesh-list
64891554|NCT01982864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64891555|NCT01982864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64891556|NCT01982864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64891557|NCT01982864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64891558|NCT01982864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891559|NCT01982929|Epinephrine|epinephrine|mesh-list
64891560|NCT01982929|Bupivacaine|bupivacaine|mesh-list
64891561|NCT01982929|Anesthetics, Local|anesthetics, local|mesh-ancestor
64645814|NCT02221219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64645815|NCT02221219|Analgesics|analgesics|mesh-ancestor
64891562|NCT01982929|Anesthetics|anesthetics|mesh-ancestor
64891563|NCT01982929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64891564|NCT01982929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891565|NCT01982929|Sensory System Agents|sensory system agents|mesh-ancestor
64891566|NCT01982929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64660108|NCT01239212|Levetiracetam|levetiracetam|mesh-list
64891567|NCT01982929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64520368|NCT00354952|Azithromycin|azithromycin|mesh-list
64520369|NCT00354952|Clarithromycin|clarithromycin|mesh-list
64465821|NCT05024422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64465822|NCT05024422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64465823|NCT05024422|Dopamine Agonists|dopamine agonists|mesh-ancestor
64465824|NCT05024422|Dopamine Agents|dopamine agents|mesh-ancestor
64465825|NCT05024422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64465826|NCT05024422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465827|NCT02819596|Durvalumab|durvalumab|mesh-list
64465828|NCT02819596|Tremelimumab|tremelimumab|mesh-list
64465852|NCT02668666|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64465853|NCT02668666|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64465854|NCT02668666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64465855|NCT02668666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64465856|NCT02668666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465857|NCT02668666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465859|NCT05586568|Rifampin|rifampin|mesh-list
64465860|NCT05586568|Esomeprazole|esomeprazole|mesh-list
64465861|NCT05586568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64465862|NCT05586568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64645862|NCT00594308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520370|NCT00354952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64520371|NCT00354952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64520372|NCT00354952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64520373|NCT00354952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520374|NCT00354952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520375|NCT00354952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64891568|NCT01982929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64891569|NCT01982929|Adrenergic Agents|adrenergic agents|mesh-ancestor
64891570|NCT01982929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64891571|NCT01982929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891572|NCT01982929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64891591|NCT01983137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465863|NCT05586568|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64465864|NCT05586568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465865|NCT05586568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465869|NCT05586568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64465871|NCT05586568|Hormone Antagonists|hormone antagonists|mesh-ancestor
64465872|NCT05586568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64465873|NCT05586568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465874|NCT05586568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64465875|NCT05586568|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64465876|NCT05586568|Antitubercular Agents|antitubercular agents|mesh-ancestor
64465904|NCT02632708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64533784|NCT02330406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64533785|NCT02330406|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64533786|NCT02330406|Protease Inhibitors|protease inhibitors|mesh-ancestor
64533787|NCT02330406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533788|NCT02330406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533789|NCT03906708|Carbon Monoxide|carbon monoxide|mesh-list
64533790|NCT03906708|Antimetabolites|antimetabolites|mesh-ancestor
64533791|NCT03906708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533792|NCT03906708|Gasotransmitters|gasotransmitters|mesh-ancestor
64533793|NCT03906708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64533794|NCT03906708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533795|NCT02337972|Povidone-Iodine|povidone-iodine|mesh-list
64533796|NCT02337972|Povidone|povidone|mesh-list
64533798|NCT02337972|Blood Substitutes|blood substitutes|mesh-ancestor
64465905|NCT02632708|Immunologic Factors|immunologic factors|mesh-ancestor
64465906|NCT02632708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465907|NCT02632708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64465908|NCT02632708|Analgesics|analgesics|mesh-ancestor
64465909|NCT02632708|Sensory System Agents|sensory system agents|mesh-ancestor
64465910|NCT02632708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64465911|NCT02624908|Canagliflozin|canagliflozin|mesh-list
64465912|NCT02624908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64465913|NCT02624908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465914|NCT02624908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64465915|NCT02624908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465916|NCT02614534|Mitomycins|mitomycins|mesh-list
64465917|NCT02614534|Mitomycin|mitomycin|mesh-list
64465918|NCT02614534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64465919|NCT02614534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465920|NCT02614534|Alkylating Agents|alkylating agents|mesh-ancestor
64465921|NCT02614534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465922|NCT02614534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64465937|NCT04757818|Cetylpyridinium|cetylpyridinium|mesh-list
64645922|NCT00597818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891593|NCT01983137|Sensory System Agents|sensory system agents|mesh-ancestor
64891594|NCT01983137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64891595|NCT01983137|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64891596|NCT01983371|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64891597|NCT01983371|Hematinics|hematinics|mesh-ancestor
64891598|NCT01983371|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64891599|NCT01983371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64891600|NCT01983384|Anesthetics|anesthetics|mesh-list
64891601|NCT01983384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64891602|NCT01983384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891603|NCT01983449|Dexamethasone|dexamethasone|mesh-list
64891604|NCT01983449|Dexamethasone acetate|dexamethasone acetate|mesh-list
64891605|NCT01983449|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64891606|NCT01983449|BB 1101|bb 1101|mesh-list
64891607|NCT01983449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64891608|NCT01983449|Antiemetics|antiemetics|mesh-ancestor
64891609|NCT01983449|Autonomic Agents|autonomic agents|mesh-ancestor
64891610|NCT01983449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64891611|NCT01983449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891612|NCT01983449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64891613|NCT01983449|Glucocorticoids|glucocorticoids|mesh-ancestor
64891614|NCT01983449|Hormones|hormones|mesh-ancestor
64891615|NCT01983449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64891616|NCT01983449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64891617|NCT01983449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891618|NCT01983449|Protease Inhibitors|protease inhibitors|mesh-ancestor
64891619|NCT01983449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64891620|NCT01983449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891621|NCT01983475|Denosumab|denosumab|mesh-list
64891622|NCT01983475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64891623|NCT01983475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891624|NCT01983501|Tucatinib|tucatinib|mesh-list
64645934|NCT01790282|Estradiol|estradiol|mesh-list
64465938|NCT04757818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64465939|NCT04757818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64465940|NCT02559778|Eflornithine|eflornithine|mesh-list
64465941|NCT02559778|Sorafenib|sorafenib|mesh-list
64465942|NCT02559778|Dasatinib|dasatinib|mesh-list
64465943|NCT02559778|Vorinostat|vorinostat|mesh-list
64465944|NCT02559778|Ceritinib|ceritinib|mesh-list
64465945|NCT02559778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465946|NCT02559778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64891625|NCT01983501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891626|NCT01983501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891627|NCT01983501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64891628|NCT01983501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64891629|NCT01983514|Oxytocin|oxytocin|mesh-list
64891630|NCT01983514|Oxytocics|oxytocics|mesh-ancestor
64891657|NCT01983657|Molgramostim|molgramostim|mesh-list
64891658|NCT01983657|Sargramostim|sargramostim|mesh-list
64891659|NCT01983657|Immunologic Factors|immunologic factors|mesh-ancestor
64891660|NCT01983657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891661|NCT01983657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891662|NCT01983722|Stiripentol|stiripentol|mesh-list
64891663|NCT01983722|Anticonvulsants|anticonvulsants|mesh-ancestor
64891664|NCT01983735|Niacin|niacin|mesh-list
64891665|NCT01983735|Amlodipine|amlodipine|mesh-list
64891666|NCT01983735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64891667|NCT01983735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64891668|NCT01983735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64520376|NCT00354952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64520377|NCT04943848|Iodine|iodine|mesh-list
64520378|NCT04943848|Vaccines|vaccines|mesh-list
64520379|NCT04943848|Immunologic Factors|immunologic factors|mesh-ancestor
64520380|NCT04943848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520381|NCT04943848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64520382|NCT04943848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64520383|NCT04943848|Trace Elements|trace elements|mesh-ancestor
64520384|NCT04943848|Micronutrients|micronutrients|mesh-ancestor
64520385|NCT01706939|Carboplatin|carboplatin|mesh-list
64520386|NCT01706939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520387|NCT04938232|Nivolumab|nivolumab|mesh-list
64520388|NCT04938232|Ipilimumab|ipilimumab|mesh-list
64520389|NCT04938232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64520390|NCT04938232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520391|NCT04938232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64520392|NCT04938232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520393|NCT03209232|Infliximab|infliximab|mesh-list
64645967|NCT00639158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64465947|NCT02559778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465948|NCT02559778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465949|NCT02559778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64465950|NCT02559778|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64465951|NCT02559778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64520394|NCT03209232|Dermatologic Agents|dermatologic agents|mesh-ancestor
64520395|NCT03209232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64520396|NCT03209232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64520397|NCT04485312|Chlorhexidine|chlorhexidine|mesh-list
64891669|NCT01983735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891670|NCT01983735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64891671|NCT01983735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891672|NCT01983735|Vasodilator Agents|vasodilator agents|mesh-ancestor
64891673|NCT01983735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64891674|NCT01983735|Antimetabolites|antimetabolites|mesh-ancestor
64891675|NCT01983735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64891676|NCT01983735|Vitamin B Complex|vitamin b complex|mesh-ancestor
64891677|NCT01983735|Vitamins|vitamins|mesh-ancestor
64891678|NCT01983735|Micronutrients|micronutrients|mesh-ancestor
64891679|NCT01983761|Vidarabine|vidarabine|mesh-list
64891680|NCT01983761|Mycophenolic Acid|mycophenolic acid|mesh-list
64891690|NCT01983761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64891692|NCT01983761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891693|NCT01983761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64891694|NCT01983761|Antiviral Agents|antiviral agents|mesh-ancestor
64891695|NCT01983761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64465952|NCT02559778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64465953|NCT02559778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64465954|NCT02559778|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64465955|NCT02556424|Dexamethasone|dexamethasone|mesh-list
64465956|NCT02556424|Triamcinolone|triamcinolone|mesh-list
64465957|NCT02556424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64465958|NCT02556424|Antiemetics|antiemetics|mesh-ancestor
64465959|NCT02556424|Autonomic Agents|autonomic agents|mesh-ancestor
64465960|NCT02556424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64465961|NCT02556424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465962|NCT02556424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64533803|NCT02335164|Immunologic Factors|immunologic factors|mesh-ancestor
64533804|NCT02335164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533805|NCT00365859|Aripiprazole|aripiprazole|mesh-list
64533806|NCT00365859|Antidepressive Agents|antidepressive agents|mesh-ancestor
64533807|NCT00365859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64533808|NCT00365859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64533809|NCT00365859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64533810|NCT00365859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64533811|NCT00365859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533812|NCT00365859|Dopamine Agonists|dopamine agonists|mesh-ancestor
64533813|NCT00365859|Dopamine Agents|dopamine agents|mesh-ancestor
64465963|NCT02556424|Glucocorticoids|glucocorticoids|mesh-ancestor
64465964|NCT02556424|Hormones|hormones|mesh-ancestor
64465965|NCT02556424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64465966|NCT02556424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64465967|NCT02556424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465968|NCT02543944|Clonidine|clonidine|mesh-list
64465969|NCT02543944|Naltrexone|naltrexone|mesh-list
64465970|NCT02543944|Buprenorphine|buprenorphine|mesh-list
64465971|NCT02543944|Gabapentin|gabapentin|mesh-list
64465972|NCT02543944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64465973|NCT02543944|Narcotics|narcotics|mesh-ancestor
64465974|NCT02543944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64465975|NCT02543944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891696|NCT01983761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64891697|NCT01983761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64891698|NCT01983761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64891699|NCT01983761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64891700|NCT01983761|Antitubercular Agents|antitubercular agents|mesh-ancestor
64891701|NCT01983761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64891702|NCT01983761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64891703|NCT01983761|Alkylating Agents|alkylating agents|mesh-ancestor
64891704|NCT01983761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64891705|NCT01983800|Midazolam|midazolam|mesh-list
64891706|NCT01983800|Propofol|propofol|mesh-list
64891707|NCT01983800|Isoflurane|isoflurane|mesh-list
64891708|NCT01983800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64891709|NCT01983800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64891710|NCT01983800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891711|NCT01983800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64520398|NCT04485312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64520399|NCT04485312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64520400|NCT04485312|Disinfectants|disinfectants|mesh-ancestor
64520401|NCT01709903|Fluticasone|fluticasone|mesh-list
64520402|NCT01709903|Xhance|xhance|mesh-list
64891712|NCT01983800|Anesthetics, General|anesthetics, general|mesh-ancestor
64891713|NCT01983800|Anesthetics|anesthetics|mesh-ancestor
64891714|NCT01983800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64891715|NCT01983800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64891716|NCT01983800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64891717|NCT01983800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64891718|NCT01983800|GABA Modulators|gaba modulators|mesh-ancestor
64891719|NCT01983800|GABA Agents|gaba agents|mesh-ancestor
64891720|NCT01983800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64891721|NCT01983800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891722|NCT01983800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64891723|NCT01983943|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
64891724|NCT01983943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64891725|NCT01983943|Antioxidants|antioxidants|mesh-ancestor
64891726|NCT01983943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891727|NCT01983943|Protective Agents|protective agents|mesh-ancestor
64891728|NCT01983943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465976|NCT02543944|Analgesics|analgesics|mesh-ancestor
64891729|NCT01983943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64891730|NCT01984008|Picosulfate sodium|picosulfate sodium|mesh-list
64891731|NCT01984008|Magnesium Oxide|magnesium oxide|mesh-list
64891732|NCT01984008|Citric Acid|citric acid|mesh-list
64891733|NCT01984008|Sodium Citrate|sodium citrate|mesh-list
64891734|NCT01984008|Anticoagulants|anticoagulants|mesh-ancestor
64891735|NCT01984008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64891736|NCT01984008|Chelating Agents|chelating agents|mesh-ancestor
64891737|NCT01984008|Sequestering Agents|sequestering agents|mesh-ancestor
64891738|NCT01984008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891739|NCT01984008|Cathartics|cathartics|mesh-ancestor
64891740|NCT01984008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64891741|NCT01984008|Antacids|antacids|mesh-ancestor
64891797|NCT01984177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891798|NCT01984255|Ipilimumab|ipilimumab|mesh-list
64891799|NCT01984255|Bavituximab|bavituximab|mesh-list
64891800|NCT01984255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64891801|NCT01984255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891802|NCT01984255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64891803|NCT01984255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891804|NCT01984372|Insulin|insulin|mesh-list
64891805|NCT01984372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64891806|NCT01984372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891807|NCT01984463|Fentanyl|fentanyl|mesh-list
64891808|NCT01984463|Morphine|morphine|mesh-list
64891809|NCT01984463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64891810|NCT01984463|Narcotics|narcotics|mesh-ancestor
64891811|NCT01984463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64891812|NCT01984463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891813|NCT01984463|Analgesics|analgesics|mesh-ancestor
64891814|NCT01984463|Sensory System Agents|sensory system agents|mesh-ancestor
64891829|NCT01984606|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64891831|NCT01984606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64891832|NCT01984606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891833|NCT01984606|Incretins|incretins|mesh-ancestor
64891834|NCT01984606|Hormones|hormones|mesh-ancestor
64520409|NCT01709903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520410|NCT01709903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520411|NCT01709903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64520412|NCT01709903|Respiratory System Agents|respiratory system agents|mesh-ancestor
64520413|NCT01709903|Dermatologic Agents|dermatologic agents|mesh-ancestor
64520414|NCT01709903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64520415|NCT01709903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64520416|NCT01709903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64520417|NCT01709903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64520418|NCT01709903|Adrenergic Agents|adrenergic agents|mesh-ancestor
64520419|NCT01709903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64520420|NCT01709903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891867|NCT01984931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64891868|NCT01984931|Dopamine Agents|dopamine agents|mesh-ancestor
64891869|NCT01984931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64646136|NCT00651482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64891870|NCT01984931|Parasympatholytics|parasympatholytics|mesh-ancestor
64891871|NCT01984931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64891872|NCT01984931|Serotonin Agents|serotonin agents|mesh-ancestor
64891873|NCT01984931|Antifoaming Agents|antifoaming agents|mesh-ancestor
64891874|NCT01984931|Emollients|emollients|mesh-ancestor
64891875|NCT01984931|Dermatologic Agents|dermatologic agents|mesh-ancestor
64891876|NCT01984931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64891877|NCT01984931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64646161|NCT02997800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891939|NCT01985477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64891940|NCT01985477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64891941|NCT01985477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891942|NCT01985477|Immunologic Factors|immunologic factors|mesh-ancestor
64891943|NCT01985477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64891944|NCT01985477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64891945|NCT01985477|Growth Substances|growth substances|mesh-ancestor
64891946|NCT01985477|Growth Inhibitors|growth inhibitors|mesh-ancestor
64891947|NCT01985477|Keratolytic Agents|keratolytic agents|mesh-ancestor
64891948|NCT01985477|Dermatologic Agents|dermatologic agents|mesh-ancestor
64891949|NCT01985594|Nifedipine|nifedipine|mesh-list
64891950|NCT01985594|Progesterone|progesterone|mesh-list
64520422|NCT01709903|Hormones|hormones|mesh-ancestor
64520423|NCT01709903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64520424|NCT01709903|Sympathomimetics|sympathomimetics|mesh-ancestor
64520425|NCT01709903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64520426|NCT01709903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64520427|NCT01709903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64520428|NCT01709903|Cholinergic Agents|cholinergic agents|mesh-ancestor
64646162|NCT02997800|Analgesics|analgesics|mesh-ancestor
64520429|NCT03202446|Cyclophosphamide|cyclophosphamide|mesh-list
64520430|NCT03202446|Chitosan|chitosan|mesh-list
64891951|NCT01985594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64891952|NCT01985594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64891953|NCT01985594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891954|NCT01985594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64891955|NCT01985594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891956|NCT01985594|Vasodilator Agents|vasodilator agents|mesh-ancestor
64891957|NCT01985594|Tocolytic Agents|tocolytic agents|mesh-ancestor
64891958|NCT01985594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64891959|NCT01985594|Progestins|progestins|mesh-ancestor
64891960|NCT01985594|Hormones|hormones|mesh-ancestor
64891971|NCT01985724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64891972|NCT01985724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64891973|NCT01985724|Alkylating Agents|alkylating agents|mesh-ancestor
64891974|NCT01985724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891975|NCT01985724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891976|NCT01985724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64891977|NCT01985724|Tubulin Modulators|tubulin modulators|mesh-ancestor
64891978|NCT01985724|Antimitotic Agents|antimitotic agents|mesh-ancestor
64891979|NCT01985724|Mitosis Modulators|mitosis modulators|mesh-ancestor
64891980|NCT01985724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64891981|NCT01985724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64891982|NCT01985724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64891983|NCT01985724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64891984|NCT01985724|Antimetabolites|antimetabolites|mesh-ancestor
64891985|NCT01985724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64646198|NCT01362998|Fentanyl|fentanyl|mesh-list
64520454|NCT05718934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64520455|NCT05718934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520456|NCT05718934|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64520457|NCT05718934|Autonomic Agents|autonomic agents|mesh-ancestor
64520458|NCT05718934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520459|NCT05718934|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64520460|NCT05718934|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64646212|NCT02998268|Carboplatin|carboplatin|mesh-list
64520461|NCT05718934|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64520462|NCT03208764|Nitric Oxide|nitric oxide|mesh-list
64892022|NCT01985828|Androgens|androgens|mesh-list
64520472|NCT03208764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64520473|NCT03208764|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64520474|NCT03208764|Vasodilator Agents|vasodilator agents|mesh-ancestor
64520475|NCT03208764|Gasotransmitters|gasotransmitters|mesh-ancestor
64520476|NCT03208764|Protective Agents|protective agents|mesh-ancestor
64520477|NCT05718856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64520478|NCT05718856|Antibodies|antibodies|mesh-list
64520479|NCT05718856|Immunoglobulins|immunoglobulins|mesh-list
64520480|NCT05718856|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64520481|NCT05718856|Immunologic Factors|immunologic factors|mesh-ancestor
64520482|NCT05718856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520483|NCT05718856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520484|NCT03208998|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64520485|NCT03208998|Antiviral Agents|antiviral agents|mesh-ancestor
64520486|NCT03208998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64520487|NCT05718466|Bevacizumab|bevacizumab|mesh-list
64520488|NCT05718466|Carboplatin|carboplatin|mesh-list
64520489|NCT05718466|Irinotecan|irinotecan|mesh-list
64520490|NCT05718466|Etoposide|etoposide|mesh-list
64892023|NCT01985828|Hormones|hormones|mesh-ancestor
64892024|NCT01985828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64892025|NCT01985828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892026|NCT01985841|Cyclophosphamide|cyclophosphamide|mesh-list
64892027|NCT01985841|Docetaxel|docetaxel|mesh-list
64892037|NCT01985841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64892038|NCT01985841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64892039|NCT01985841|Tubulin Modulators|tubulin modulators|mesh-ancestor
64892040|NCT01985841|Antimitotic Agents|antimitotic agents|mesh-ancestor
64892041|NCT01985841|Mitosis Modulators|mitosis modulators|mesh-ancestor
64892042|NCT01985841|Antimetabolites|antimetabolites|mesh-ancestor
64892043|NCT01985841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64892044|NCT01985841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64892045|NCT01985841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64892046|NCT01985841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64892047|NCT01985841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64892048|NCT01985854|Propofol|propofol|mesh-list
64892049|NCT01985854|Desflurane|desflurane|mesh-list
64892050|NCT01985854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64892051|NCT01985854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64892052|NCT01985854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892055|NCT01985854|Anesthetics|anesthetics|mesh-ancestor
64892104|NCT01986283|Oxycodone|oxycodone|mesh-list
64892105|NCT01986283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64892120|NCT01986309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64892121|NCT01986309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64892122|NCT01986309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64892123|NCT01986309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892124|NCT01986322|Vaccines|vaccines|mesh-list
64892125|NCT01986322|Immunologic Factors|immunologic factors|mesh-ancestor
64892126|NCT01986322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892127|NCT01986426|Pembrolizumab|pembrolizumab|mesh-list
64892128|NCT01986426|Ipilimumab|ipilimumab|mesh-list
64892129|NCT01986426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64892130|NCT01986426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64892131|NCT01986426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64892132|NCT01986426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892133|NCT01986465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64892134|NCT01986465|Methylprednisolone|methylprednisolone|mesh-list
64892153|NCT01986556|Lesinurad|lesinurad|mesh-list
64892154|NCT01986556|Gout Suppressants|gout suppressants|mesh-ancestor
64892155|NCT01986556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64892156|NCT01986556|Uricosuric Agents|uricosuric agents|mesh-ancestor
64892157|NCT01986556|Renal Agents|renal agents|mesh-ancestor
64892158|NCT01986582|Phenylephrine|phenylephrine|mesh-list
64892159|NCT01986582|Oxymetazoline|oxymetazoline|mesh-list
64892160|NCT01986582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64892161|NCT01986582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64892162|NCT01986582|Adrenergic Agents|adrenergic agents|mesh-ancestor
64892163|NCT01986582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64892164|NCT01986582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892165|NCT01986582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892166|NCT01986582|Sympathomimetics|sympathomimetics|mesh-ancestor
64892167|NCT01986582|Autonomic Agents|autonomic agents|mesh-ancestor
64892178|NCT01986608|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64520530|NCT05718232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520531|NCT05718232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64520532|NCT05718232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520533|NCT05718232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520534|NCT00355966|Misoprostol|misoprostol|mesh-list
64520535|NCT00355966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64892179|NCT01986608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64892208|NCT01986764|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64892209|NCT01986764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64892210|NCT01986764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64892211|NCT01986764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892212|NCT01986764|Dopamine Agents|dopamine agents|mesh-ancestor
64892213|NCT01986764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64892214|NCT01986777|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64892215|NCT01986777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64892216|NCT01986777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892217|NCT01986777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64892218|NCT01986777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64520567|NCT02451774|Vasodilator Agents|vasodilator agents|mesh-ancestor
64520568|NCT02451774|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64520570|NCT00355576|Minocycline|minocycline|mesh-list
64520571|NCT00355576|Celecoxib|celecoxib|mesh-list
64892270|NCT01987128|Ropivacaine|ropivacaine|mesh-list
64892271|NCT01987128|Anesthetics, Local|anesthetics, local|mesh-ancestor
64892272|NCT01987128|Anesthetics|anesthetics|mesh-ancestor
64520572|NCT00355576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64520573|NCT00355576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64520574|NCT00355576|Analgesics|analgesics|mesh-ancestor
64520575|NCT00355576|Sensory System Agents|sensory system agents|mesh-ancestor
64520576|NCT00355576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520577|NCT00355576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520578|NCT00355576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64520579|NCT00355576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64520580|NCT00355576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64520599|NCT02451852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520600|NCT00421642|Adalimumab|adalimumab|mesh-list
64520601|NCT00421642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64520602|NCT00421642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64520603|NCT03200964|Anesthetics|anesthetics|mesh-list
64520604|NCT03200964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64520605|NCT03200964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520606|NCT04484844|Listerine|listerine|mesh-list
64520607|NCT04484844|Fluorides|fluorides|mesh-list
64520608|NCT04484844|Sodium Fluoride|sodium fluoride|mesh-list
64520609|NCT04484844|Cariostatic Agents|cariostatic agents|mesh-ancestor
64520610|NCT04484844|Protective Agents|protective agents|mesh-ancestor
64520611|NCT04484844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520612|NCT04484844|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64520613|NCT04484844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64520614|NCT03119454|Betamethasone|betamethasone|mesh-list
64520615|NCT03119454|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
64520616|NCT03119454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64520617|NCT03119454|Glucocorticoids|glucocorticoids|mesh-ancestor
64520618|NCT03119454|Hormones|hormones|mesh-ancestor
64520637|NCT04485156|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64520638|NCT04485156|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64520639|NCT04485156|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64520640|NCT04485156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64892385|NCT01988506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892387|NCT01988545|Glucagon|glucagon|mesh-list
64892388|NCT01988545|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64892389|NCT01988545|Incretins|incretins|mesh-ancestor
64892390|NCT01988545|Hormones|hormones|mesh-ancestor
64892391|NCT01988545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64892392|NCT01988545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892393|NCT01988545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64892394|NCT01988545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64892395|NCT01988545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64892396|NCT01988610|Mifepristone|mifepristone|mesh-list
64892397|NCT01988610|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64892398|NCT01988610|Abortifacient Agents|abortifacient agents|mesh-ancestor
64892399|NCT01988610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64892400|NCT01988610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892401|NCT01988610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64892402|NCT01988610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64892403|NCT01988610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64892404|NCT01988610|Contraceptive Agents|contraceptive agents|mesh-ancestor
64520649|NCT04637620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64520650|NCT04637620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64520651|NCT04637620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520652|NCT04637620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64520653|NCT04637620|Serotonin Agents|serotonin agents|mesh-ancestor
64892424|NCT01988831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64892425|NCT01988831|Vasodilator Agents|vasodilator agents|mesh-ancestor
64892438|NCT01989000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892439|NCT01989000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64892441|NCT01989000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64892442|NCT01989000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64892443|NCT01989000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64892444|NCT01989000|Immunologic Factors|immunologic factors|mesh-ancestor
64892445|NCT01989000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892446|NCT01989052|Lomustine|lomustine|mesh-list
64892447|NCT01989052|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
64892448|NCT01989052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64892449|NCT01989052|Alkylating Agents|alkylating agents|mesh-ancestor
64892450|NCT01989052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892456|NCT01989078|Losartan|losartan|mesh-list
64520657|NCT00355108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64520658|NCT00355108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520659|NCT00355108|Hemostatics|hemostatics|mesh-ancestor
64520660|NCT00355108|Coagulants|coagulants|mesh-ancestor
64520661|NCT05271604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64520662|NCT05271604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520663|NCT05271604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520664|NCT04614766|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64520665|NCT04614766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520666|NCT04614766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64520667|NCT03200886|Triamcinolone|triamcinolone|mesh-list
64520668|NCT03200886|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64520669|NCT03200886|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64520670|NCT03200886|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64892481|NCT01989312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892482|NCT01989312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64892483|NCT01989312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64520672|NCT03200886|Glucocorticoids|glucocorticoids|mesh-ancestor
64520673|NCT03200886|Hormones|hormones|mesh-ancestor
64520674|NCT03200886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64520675|NCT03200886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520676|NCT03200886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64520677|NCT03200886|Immunologic Factors|immunologic factors|mesh-ancestor
64520678|NCT03200886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520679|NCT03200886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520681|NCT05717764|Mitoxantrone|mitoxantrone|mesh-list
64520682|NCT05717764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64520683|NCT05717764|Antimetabolites|antimetabolites|mesh-ancestor
64520684|NCT05717764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520685|NCT05717764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520686|NCT05717764|Analgesics|analgesics|mesh-ancestor
64520687|NCT05717764|Sensory System Agents|sensory system agents|mesh-ancestor
64520694|NCT03118830|Cetrorelix|cetrorelix|mesh-list
64520711|NCT03223506|Analgesics|analgesics|mesh-ancestor
64520712|NCT03223506|Sensory System Agents|sensory system agents|mesh-ancestor
64892569|NCT01989897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64892570|NCT01989897|Disinfectants|disinfectants|mesh-ancestor
64892571|NCT01989897|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64892572|NCT01989897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64892573|NCT01989923|Nicotine|nicotine|mesh-list
64892574|NCT01989923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64892575|NCT01989923|Autonomic Agents|autonomic agents|mesh-ancestor
64892576|NCT01989923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64892577|NCT01989923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892578|NCT01989923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64892579|NCT01989923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64892580|NCT01989923|Cholinergic Agents|cholinergic agents|mesh-ancestor
64892581|NCT01989923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64892582|NCT01989923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892583|NCT01989936|Eletriptan|eletriptan|mesh-list
64892584|NCT01989936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64892585|NCT01989936|Serotonin Agents|serotonin agents|mesh-ancestor
64892586|NCT01989936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64892587|NCT01989936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892588|NCT01989936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892589|NCT01990079|Bupropion|bupropion|mesh-list
64892590|NCT01990079|Nicotine|nicotine|mesh-list
64520719|NCT04535362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520720|NCT04535362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520721|NCT04535362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64520722|NCT04535362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64520723|NCT04535362|Cholinergic Agents|cholinergic agents|mesh-ancestor
64520724|NCT04535362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64520725|NCT04535362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520726|NCT03223896|Naloxone|naloxone|mesh-list
64520727|NCT03223896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64520728|NCT03223896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520729|NCT03223896|Sensory System Agents|sensory system agents|mesh-ancestor
64520730|NCT03223896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520731|NCT05716516|Estradiol|estradiol|mesh-list
64892624|NCT01990144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64892625|NCT01990144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64661144|NCT02618343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64892626|NCT01990144|Immunologic Factors|immunologic factors|mesh-ancestor
64892627|NCT01990144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520739|NCT02447796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64520740|NCT02447796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520741|NCT02447796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64520742|NCT02447796|Anesthetics, General|anesthetics, general|mesh-ancestor
64520743|NCT02447796|Anesthetics|anesthetics|mesh-ancestor
64892660|NCT01990690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892661|NCT01990755|Chlordesmethyldiazepam|chlordesmethyldiazepam|mesh-list
64892662|NCT01990755|Olanzapine|olanzapine|mesh-list
64892663|NCT01990755|Antiemetics|antiemetics|mesh-ancestor
64892664|NCT01990755|Autonomic Agents|autonomic agents|mesh-ancestor
64892665|NCT01990755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64892666|NCT01990755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892667|NCT01990755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64892668|NCT01990755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64892669|NCT01990755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64892671|NCT01990755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64520747|NCT02447796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520748|NCT02447796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64520749|NCT02447796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64520750|NCT02447796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64520751|NCT02447796|Adrenergic Agents|adrenergic agents|mesh-ancestor
64520752|NCT02447796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64520753|NCT02447796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892746|NCT01991119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64892747|NCT01991119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64892748|NCT01991119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892749|NCT01991145|Epoetin Alfa|epoetin alfa|mesh-list
64892750|NCT01991145|Hematinics|hematinics|mesh-ancestor
64892751|NCT01991158|Gemcitabine|gemcitabine|mesh-list
64892752|NCT01991158|Dexamethasone|dexamethasone|mesh-list
64892753|NCT01991158|Methotrexate|methotrexate|mesh-list
64892754|NCT01991158|Pegaspargase|pegaspargase|mesh-list
64892755|NCT01991158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64892756|NCT01991158|Antiemetics|antiemetics|mesh-ancestor
64892757|NCT01991158|Autonomic Agents|autonomic agents|mesh-ancestor
64892821|NCT01991327|Fertility Agents|fertility agents|mesh-ancestor
64892822|NCT01991327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64892823|NCT01991327|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64892824|NCT01991327|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64520755|NCT05225116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520756|NCT05225116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64520757|NCT05225116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520758|NCT05225116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520759|NCT03838042|Nivolumab|nivolumab|mesh-list
64520760|NCT03838042|Entinostat|entinostat|mesh-list
64520761|NCT03838042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64520762|NCT03838042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520766|NCT03838042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520780|NCT03222960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520781|NCT03222960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64520782|NCT05681260|Cytarabine|cytarabine|mesh-list
64520783|NCT05681260|Dexamethasone|dexamethasone|mesh-list
64520784|NCT05681260|Dexamethasone acetate|dexamethasone acetate|mesh-list
64520785|NCT05681260|Prednisone|prednisone|mesh-list
64520786|NCT05681260|Cyclophosphamide|cyclophosphamide|mesh-list
64520787|NCT05681260|Ifosfamide|ifosfamide|mesh-list
64520788|NCT05681260|Doxorubicin|doxorubicin|mesh-list
64520789|NCT05681260|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64646524|NCT02979392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520790|NCT05681260|Methotrexate|methotrexate|mesh-list
64520791|NCT05681260|Etoposide|etoposide|mesh-list
64892862|NCT01991873|Antimetabolites|antimetabolites|mesh-ancestor
64892863|NCT01991873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892864|NCT01991873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64892865|NCT01991873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64892866|NCT01991873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64892867|NCT01991873|Immunologic Factors|immunologic factors|mesh-ancestor
64892868|NCT01991873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892869|NCT01991873|Antidotes|antidotes|mesh-ancestor
64892872|NCT01991873|Vitamins|vitamins|mesh-ancestor
64892909|NCT01992211|Metformin|metformin|mesh-list
64892910|NCT01992211|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64892911|NCT01992211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64892912|NCT01992211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520792|NCT05681260|Vincristine|vincristine|mesh-list
64520793|NCT05681260|Bortezomib|bortezomib|mesh-list
64520794|NCT05681260|Daunorubicin|daunorubicin|mesh-list
64520795|NCT05681260|Asparaginase|asparaginase|mesh-list
64520796|NCT05681260|Mercaptopurine|mercaptopurine|mesh-list
64520797|NCT05681260|Vindesine|vindesine|mesh-list
64520798|NCT05681260|Pegaspargase|pegaspargase|mesh-list
64520799|NCT05681260|BB 1101|bb 1101|mesh-list
64520800|NCT05681260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64520801|NCT05681260|Immunologic Factors|immunologic factors|mesh-ancestor
64520802|NCT05681260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520803|NCT05681260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64520804|NCT05681260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64892915|NCT01992211|Antimetabolites|antimetabolites|mesh-ancestor
64892997|NCT01992796|Irbesartan|irbesartan|mesh-list
64892998|NCT01992796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64892999|NCT01992796|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64520809|NCT05681260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64520810|NCT05681260|Antiemetics|antiemetics|mesh-ancestor
64520811|NCT05681260|Autonomic Agents|autonomic agents|mesh-ancestor
64520812|NCT05681260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520813|NCT05681260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64520814|NCT05681260|Glucocorticoids|glucocorticoids|mesh-ancestor
64520815|NCT05681260|Hormones|hormones|mesh-ancestor
64893000|NCT01992796|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64893001|NCT01992796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893002|NCT01992900|Piperaquine|piperaquine|mesh-list
64893003|NCT01992900|Artenimol|artenimol|mesh-list
64893004|NCT01992900|Artemisinins|artemisinins|mesh-list
64893005|NCT01992900|Antimalarials|antimalarials|mesh-ancestor
64893006|NCT01992900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64893007|NCT01992900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64893008|NCT01992900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64893009|NCT01993134|Cefazolin|cefazolin|mesh-list
64646558|NCT01292447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64893012|NCT01993173|Vaccines|vaccines|mesh-list
64893058|NCT01993459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64893059|NCT01993459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893060|NCT01993459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64893061|NCT01993459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64893062|NCT01993459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64893063|NCT01993459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64893064|NCT01993459|Anesthetics, General|anesthetics, general|mesh-ancestor
64893065|NCT01993459|Anesthetics|anesthetics|mesh-ancestor
64893066|NCT01993459|GABA Modulators|gaba modulators|mesh-ancestor
64893067|NCT01993459|GABA Agents|gaba agents|mesh-ancestor
64893068|NCT01993459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64893069|NCT01993459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893070|NCT01993472|Andrographolide|andrographolide|mesh-list
64893071|NCT01993472|Capecitabine|capecitabine|mesh-list
64893072|NCT01993472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64893073|NCT01993472|Antimetabolites|antimetabolites|mesh-ancestor
64893074|NCT01993472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520816|NCT05681260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64520817|NCT05681260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64520818|NCT05681260|Protease Inhibitors|protease inhibitors|mesh-ancestor
64520819|NCT05681260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520820|NCT05681260|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64893130|NCT01993979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893165|NCT01994356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64893166|NCT01994356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893168|NCT01994460|Ethambutol|ethambutol|mesh-list
64893169|NCT01994460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64893170|NCT01994460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64893200|NCT01994668|Anticonvulsants|anticonvulsants|mesh-ancestor
64893201|NCT01994668|Antiemetics|antiemetics|mesh-ancestor
64893202|NCT01994668|Autonomic Agents|autonomic agents|mesh-ancestor
64893203|NCT01994668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893204|NCT01994668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893205|NCT01994668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64893206|NCT01994668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64893207|NCT01994668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64893208|NCT01994668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64893209|NCT01994668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64893210|NCT01994668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64893211|NCT01994668|GABA Modulators|gaba modulators|mesh-ancestor
64893212|NCT01994668|GABA Agents|gaba agents|mesh-ancestor
64893213|NCT01994668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64893228|NCT01994759|Autonomic Agents|autonomic agents|mesh-ancestor
64893229|NCT01994759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893230|NCT01994759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893231|NCT01994759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64893232|NCT01994759|Glucocorticoids|glucocorticoids|mesh-ancestor
64893233|NCT01994759|Hormones|hormones|mesh-ancestor
64893247|NCT01994941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64893248|NCT01994941|Purinergic Agents|purinergic agents|mesh-ancestor
64893249|NCT01994941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64893250|NCT01994941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646623|NCT00667004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64893251|NCT01994941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893252|NCT01994967|Bupivacaine|bupivacaine|mesh-list
64893253|NCT01994967|Levobupivacaine|levobupivacaine|mesh-list
64893260|NCT01995006|Dipyrone|dipyrone|mesh-list
64520855|NCT03199950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64520856|NCT05156632|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64520857|NCT05156632|Vaccines|vaccines|mesh-list
64520858|NCT05156632|Immunologic Factors|immunologic factors|mesh-ancestor
64520859|NCT05156632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520860|NCT05156632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64520861|NCT05156632|Antacids|antacids|mesh-ancestor
64520862|NCT05156632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893355|NCT01995331|Dermatologic Agents|dermatologic agents|mesh-ancestor
64893356|NCT01995331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64893357|NCT01995370|Aspirin|aspirin|mesh-list
64893358|NCT01995370|Cilostazol|cilostazol|mesh-list
64893359|NCT01995370|Clopidogrel|clopidogrel|mesh-list
64893360|NCT01995370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64893361|NCT01995370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64520887|NCT02447094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64520888|NCT02447094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64520889|NCT02447094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520890|NCT02446860|Nivolumab|nivolumab|mesh-list
64520891|NCT02446860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64520892|NCT02446860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520893|NCT02446860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64520894|NCT02446860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520895|NCT02449746|Immunoglobulins|immunoglobulins|mesh-list
64520896|NCT02449746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64520897|NCT02449746|Antibodies|antibodies|mesh-list
64520898|NCT02449746|gamma-Globulins|gamma-globulins|mesh-list
64520899|NCT02449746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64520900|NCT02449746|Immunologic Factors|immunologic factors|mesh-ancestor
64520901|NCT02449746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520902|NCT02446782|Clindamycin|clindamycin|mesh-list
64520903|NCT02446782|Cefazolin|cefazolin|mesh-list
64520920|NCT04745260|Anesthetics, General|anesthetics, general|mesh-ancestor
64520921|NCT04745260|Anesthetics|anesthetics|mesh-ancestor
64520922|NCT04745260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64520923|NCT04745260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64520924|NCT04745260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64520925|NCT04745260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64520926|NCT04745260|GABA Modulators|gaba modulators|mesh-ancestor
64520927|NCT04745260|GABA Agents|gaba agents|mesh-ancestor
64520928|NCT04745260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64893374|NCT01995370|Antipyretics|antipyretics|mesh-ancestor
64893375|NCT01995370|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64893376|NCT01995370|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64893377|NCT01995370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64893378|NCT01995370|Purinergic Agents|purinergic agents|mesh-ancestor
64893379|NCT01995370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64893380|NCT01995370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64646663|NCT02995304|Sensory System Agents|sensory system agents|mesh-ancestor
64893381|NCT01995370|Autonomic Agents|autonomic agents|mesh-ancestor
64893382|NCT01995370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64893383|NCT01995370|Respiratory System Agents|respiratory system agents|mesh-ancestor
64893384|NCT01995370|Vasodilator Agents|vasodilator agents|mesh-ancestor
64893385|NCT01995370|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64893386|NCT01995370|Protective Agents|protective agents|mesh-ancestor
64557558|NCT04405193|Respiratory System Agents|respiratory system agents|mesh-ancestor
64893387|NCT01995370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64893388|NCT01995370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64893389|NCT01995656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64893394|NCT01995734|Hormones|hormones|mesh-ancestor
64893438|NCT01996150|Sodium Hypochlorite|sodium hypochlorite|mesh-list
64893439|NCT01996150|Eusol|eusol|mesh-list
64893440|NCT01996150|Disinfectants|disinfectants|mesh-ancestor
64893441|NCT01996150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64893442|NCT01996189|Insulin|insulin|mesh-list
64893443|NCT01996189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64893444|NCT01996189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893445|NCT01996306|Leucovorin|leucovorin|mesh-list
64893468|NCT01996306|Vitamins|vitamins|mesh-ancestor
64893469|NCT01996306|Micronutrients|micronutrients|mesh-ancestor
64893470|NCT01996358|Rocuronium|rocuronium|mesh-list
64893471|NCT01996358|Succinylcholine|succinylcholine|mesh-list
64893472|NCT01996358|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64893473|NCT01996358|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64893474|NCT01996358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64520969|NCT03199170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64646703|NCT03830684|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
64520970|NCT03199170|Narcotics|narcotics|mesh-ancestor
64646704|NCT03830684|Hormone Antagonists|hormone antagonists|mesh-ancestor
64520971|NCT03199170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64520972|NCT03199170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520973|NCT03199170|Analgesics|analgesics|mesh-ancestor
64520974|NCT03199170|Sensory System Agents|sensory system agents|mesh-ancestor
64520975|NCT03199170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520976|NCT03118128|Metformin|metformin|mesh-list
64520977|NCT03118128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64520978|NCT03118128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520979|NCT05100472|Androgens|androgens|mesh-list
64520980|NCT05100472|Hormones|hormones|mesh-ancestor
64520981|NCT05100472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64520982|NCT05100472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520983|NCT05087914|Naproxen|naproxen|mesh-list
64520984|NCT05087914|Levodopa|levodopa|mesh-list
64520985|NCT05087914|Carbidopa|carbidopa|mesh-list
64520986|NCT05087914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64520987|NCT05087914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64520988|NCT05087914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64520989|NCT05087914|Analgesics|analgesics|mesh-ancestor
64520990|NCT05087914|Sensory System Agents|sensory system agents|mesh-ancestor
64520991|NCT05087914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520992|NCT05087914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520993|NCT05087914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64893483|NCT01996384|Sensory System Agents|sensory system agents|mesh-ancestor
64893484|NCT01996384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893485|NCT01996384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64893486|NCT01996384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64521000|NCT05087914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64521002|NCT05087914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64521003|NCT05087914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64521004|NCT05087914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64521005|NCT05087914|Immunologic Factors|immunologic factors|mesh-ancestor
64521006|NCT05087914|Dopamine Agonists|dopamine agonists|mesh-ancestor
64521007|NCT03194724|Vitamin A|vitamin a|mesh-list
64521008|NCT03194724|Vitamins|vitamins|mesh-ancestor
64521009|NCT03194724|Micronutrients|micronutrients|mesh-ancestor
64521010|NCT03194724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521011|NCT05637970|Hemostatics|hemostatics|mesh-list
64521012|NCT05637970|Coagulants|coagulants|mesh-ancestor
64521013|NCT03198702|Botulinum Toxins|botulinum toxins|mesh-list
64521014|NCT03198702|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64521015|NCT03198702|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64521016|NCT03198702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64521017|NCT03198702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64521018|NCT03198702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521020|NCT03198702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64521021|NCT03198702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893532|NCT01996475|Autonomic Agents|autonomic agents|mesh-ancestor
64893533|NCT01996475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893534|NCT01996475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64893535|NCT01996475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64893536|NCT01996475|Cholinergic Agents|cholinergic agents|mesh-ancestor
64893537|NCT01996488|Olanzapine|olanzapine|mesh-list
64893538|NCT01996488|Antiemetics|antiemetics|mesh-ancestor
64893539|NCT01996488|Autonomic Agents|autonomic agents|mesh-ancestor
64893540|NCT01996488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893554|NCT01996501|Antiemetics|antiemetics|mesh-ancestor
64893555|NCT01996501|Autonomic Agents|autonomic agents|mesh-ancestor
64893556|NCT01996501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893557|NCT01996501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893558|NCT01996501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64893559|NCT01996501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64893560|NCT01996501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64893580|NCT01996683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893581|NCT01996683|Siderophores|siderophores|mesh-ancestor
64893582|NCT01996696|Metformin|metformin|mesh-list
64893583|NCT01996696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64893584|NCT01996696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893585|NCT01996735|Ticagrelor|ticagrelor|mesh-list
64893586|NCT01996735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64893587|NCT01996735|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64893588|NCT01996735|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64893589|NCT01996735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64893590|NCT01996735|Purinergic Agents|purinergic agents|mesh-ancestor
64893591|NCT01996735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64893592|NCT01996735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893593|NCT01996735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893594|NCT01996761|Cerebrolysin|cerebrolysin|mesh-list
64893598|NCT01996761|Nootropic Agents|nootropic agents|mesh-ancestor
64893623|NCT01997099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64893624|NCT01997099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893625|NCT01997112|Acetaminophen|acetaminophen|mesh-list
64893626|NCT01997112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64893627|NCT01997112|Analgesics|analgesics|mesh-ancestor
64893628|NCT01997112|Sensory System Agents|sensory system agents|mesh-ancestor
64893629|NCT01997112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893630|NCT01997112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893631|NCT01997112|Antipyretics|antipyretics|mesh-ancestor
64893632|NCT01997138|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64893633|NCT01997138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64893634|NCT01997164|Aflibercept|aflibercept|mesh-list
64893635|NCT01997164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64521102|NCT03192618|Levoleucovorin|levoleucovorin|mesh-list
64521103|NCT03192618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64521104|NCT03192618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521105|NCT03192618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521106|NCT03192618|Antidotes|antidotes|mesh-ancestor
64521107|NCT03192618|Protective Agents|protective agents|mesh-ancestor
64521108|NCT03192618|Vitamin B Complex|vitamin b complex|mesh-ancestor
64893652|NCT01997203|Antiviral Agents|antiviral agents|mesh-ancestor
64893653|NCT01997203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64893654|NCT01997203|Antimetabolites|antimetabolites|mesh-ancestor
64893655|NCT01997203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521131|NCT02444364|Hormones|hormones|mesh-ancestor
64521132|NCT02444364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64521133|NCT02444364|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64521134|NCT02444364|Protease Inhibitors|protease inhibitors|mesh-ancestor
64521135|NCT02444364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521136|NCT02444364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521138|NCT05039476|Vitamins|vitamins|mesh-ancestor
64521139|NCT05039476|Micronutrients|micronutrients|mesh-ancestor
64521140|NCT05039476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521141|NCT00356356|Etanercept|etanercept|mesh-list
64521142|NCT00356356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64521143|NCT00356356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64521144|NCT00356356|Analgesics|analgesics|mesh-ancestor
64521145|NCT00356356|Sensory System Agents|sensory system agents|mesh-ancestor
64521146|NCT00356356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64521147|NCT00356356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521148|NCT00356356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64521149|NCT00356356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64521150|NCT00356356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64893696|NCT01997658|Prednisolone phosphate|prednisolone phosphate|mesh-list
64893697|NCT01997658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64521156|NCT02443818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64521157|NCT02443818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521158|NCT02443818|Antifungal Agents|antifungal agents|mesh-ancestor
64646828|NCT01244711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521159|NCT02443818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64521160|NCT02443818|Immunologic Factors|immunologic factors|mesh-ancestor
64521161|NCT02443818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521162|NCT01705691|Paclitaxel|paclitaxel|mesh-list
64521163|NCT01705691|Cyclophosphamide|cyclophosphamide|mesh-list
64521164|NCT01705691|Doxorubicin|doxorubicin|mesh-list
64521165|NCT01705691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64521166|NCT01705691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521167|NCT01705691|Tubulin Modulators|tubulin modulators|mesh-ancestor
64521168|NCT01705691|Antimitotic Agents|antimitotic agents|mesh-ancestor
64521169|NCT01705691|Mitosis Modulators|mitosis modulators|mesh-ancestor
64521170|NCT01705691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521171|NCT01705691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64477307|NCT01441635|Progestins|progestins|mesh-ancestor
64521172|NCT01705691|Immunologic Factors|immunologic factors|mesh-ancestor
64521173|NCT01705691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521174|NCT01705691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64893698|NCT01997658|Antiemetics|antiemetics|mesh-ancestor
64893699|NCT01997658|Autonomic Agents|autonomic agents|mesh-ancestor
64893700|NCT01997658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893701|NCT01997658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893702|NCT01997658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64893703|NCT01997658|Glucocorticoids|glucocorticoids|mesh-ancestor
64893704|NCT01997658|Hormones|hormones|mesh-ancestor
64893705|NCT01997658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64893719|NCT01997775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893720|NCT01997788|Morphine|morphine|mesh-list
64893721|NCT01997788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64893722|NCT01997788|Narcotics|narcotics|mesh-ancestor
64893723|NCT01997788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64893756|NCT01997983|Botulinum Toxins|botulinum toxins|mesh-list
64893757|NCT01997983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64893758|NCT01997983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64893759|NCT01997983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893760|NCT01997983|Cholinergic Agents|cholinergic agents|mesh-ancestor
64893761|NCT01997983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64893762|NCT01997983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521175|NCT01705691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64521176|NCT01705691|Alkylating Agents|alkylating agents|mesh-ancestor
64521177|NCT01705691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64521178|NCT01705691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64521179|NCT01705691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64521180|NCT01705691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64521181|NCT01705691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521182|NCT02450058|Paclitaxel|paclitaxel|mesh-list
64521183|NCT02450058|Cyclophosphamide|cyclophosphamide|mesh-list
64521184|NCT02450058|Fluorouracil|fluorouracil|mesh-list
64521185|NCT02450058|Epirubicin|epirubicin|mesh-list
64521186|NCT02450058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64521187|NCT02450058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521188|NCT02450058|Tubulin Modulators|tubulin modulators|mesh-ancestor
64521189|NCT02450058|Antimitotic Agents|antimitotic agents|mesh-ancestor
64521190|NCT02450058|Mitosis Modulators|mitosis modulators|mesh-ancestor
64893764|NCT01998113|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64893765|NCT01998113|Metformin|metformin|mesh-list
64893788|NCT01998217|Remifentanil|remifentanil|mesh-list
64893789|NCT01998217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64893790|NCT01998217|Narcotics|narcotics|mesh-ancestor
64893791|NCT01998217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64893792|NCT01998217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893793|NCT01998217|Analgesics|analgesics|mesh-ancestor
64893794|NCT01998217|Sensory System Agents|sensory system agents|mesh-ancestor
64893795|NCT01998217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893796|NCT01998217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64893797|NCT01998217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64893798|NCT01998217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64893799|NCT01998217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64893800|NCT01998217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64893801|NCT01998217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64893802|NCT01998217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893803|NCT01998295|Lumefantrine|lumefantrine|mesh-list
64893804|NCT01998295|Artemether|artemether|mesh-list
64893805|NCT01998295|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64893806|NCT01998295|Antimalarials|antimalarials|mesh-ancestor
64893807|NCT01998295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64893808|NCT01998295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64893809|NCT01998295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64893810|NCT01998308|Hyaluronic Acid|hyaluronic acid|mesh-list
64893811|NCT01998308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64893812|NCT01998308|Immunologic Factors|immunologic factors|mesh-ancestor
64893813|NCT01998308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893814|NCT01998308|Viscosupplements|viscosupplements|mesh-ancestor
64893815|NCT01998308|Protective Agents|protective agents|mesh-ancestor
64893816|NCT01998347|Paclitaxel|paclitaxel|mesh-list
64893817|NCT01998347|Fluorouracil|fluorouracil|mesh-list
64893818|NCT01998347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64893819|NCT01998347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64893820|NCT01998347|Tubulin Modulators|tubulin modulators|mesh-ancestor
64521208|NCT02445066|Vitamin D|vitamin d|mesh-list
64521210|NCT02445066|Vitamins|vitamins|mesh-ancestor
64521211|NCT02445066|Micronutrients|micronutrients|mesh-ancestor
64521245|NCT02443194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64714091|NCT03054103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64477377|NCT04415983|Metronidazole|metronidazole|mesh-list
64521246|NCT02443194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521247|NCT02443194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64521248|NCT02443194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521249|NCT02443194|Analgesics|analgesics|mesh-ancestor
64521250|NCT02443194|Sensory System Agents|sensory system agents|mesh-ancestor
64521251|NCT02443194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64521252|NCT02443194|Antidepressive Agents|antidepressive agents|mesh-ancestor
64521253|NCT02443194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64521254|NCT02443194|Dopamine Agents|dopamine agents|mesh-ancestor
64521255|NCT03193944|Vitamin D|vitamin d|mesh-list
64521256|NCT03193944|Ergocalciferols|ergocalciferols|mesh-list
64521257|NCT03193944|Cholecalciferol|cholecalciferol|mesh-list
64521258|NCT03193944|Vitamins|vitamins|mesh-list
64521263|NCT00357604|Ritonavir|ritonavir|mesh-list
64893851|NCT01998503|Immunologic Factors|immunologic factors|mesh-ancestor
64893852|NCT01998503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64893853|NCT01998503|Alkylating Agents|alkylating agents|mesh-ancestor
64893854|NCT01998503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893855|NCT01998503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64893856|NCT01998503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64893857|NCT01998685|Fentanyl|fentanyl|mesh-list
64893858|NCT01998685|Midazolam|midazolam|mesh-list
64893859|NCT01998685|Remifentanil|remifentanil|mesh-list
64893860|NCT01998685|Propofol|propofol|mesh-list
64893861|NCT01998685|Sevoflurane|sevoflurane|mesh-list
64893862|NCT01998685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64893863|NCT01998685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64893864|NCT01998685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893865|NCT01998685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64893866|NCT01998685|Anesthetics, General|anesthetics, general|mesh-ancestor
64893867|NCT01998685|Anesthetics|anesthetics|mesh-ancestor
64893868|NCT01998685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64893869|NCT01998685|Narcotics|narcotics|mesh-ancestor
64893870|NCT01998685|Analgesics|analgesics|mesh-ancestor
64893871|NCT01998685|Sensory System Agents|sensory system agents|mesh-ancestor
64893872|NCT01998685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893904|NCT01998763|Vitamin D|vitamin d|mesh-list
64521317|NCT03193788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521318|NCT03193788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521319|NCT03193788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714092|NCT03054103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64477450|NCT02076243|Tubulin Modulators|tubulin modulators|mesh-ancestor
64521320|NCT03193788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64521321|NCT03193788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64893907|NCT01998763|Micronutrients|micronutrients|mesh-ancestor
64893977|NCT01999647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893978|NCT01999673|Docetaxel|docetaxel|mesh-list
64893979|NCT01999673|Bavituximab|bavituximab|mesh-list
64893980|NCT01999673|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64893981|NCT01999673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64893982|NCT01999673|Tubulin Modulators|tubulin modulators|mesh-ancestor
64893983|NCT01999673|Antimitotic Agents|antimitotic agents|mesh-ancestor
64893984|NCT01999673|Mitosis Modulators|mitosis modulators|mesh-ancestor
64893985|NCT01999673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893986|NCT01999673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64893987|NCT01999673|Immunologic Factors|immunologic factors|mesh-ancestor
64893988|NCT01999673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893989|NCT01999686|Metformin|metformin|mesh-list
64894013|NCT01999907|Cholecalciferol|cholecalciferol|mesh-list
64894014|NCT01999907|Vitamins|vitamins|mesh-list
64894015|NCT01999907|Micronutrients|micronutrients|mesh-ancestor
64894016|NCT01999907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894017|NCT01999907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64894018|NCT01999907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64894019|NCT01999933|Cisplatin|cisplatin|mesh-list
64894020|NCT01999933|Docetaxel|docetaxel|mesh-list
64894021|NCT01999933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894022|NCT01999933|Tubulin Modulators|tubulin modulators|mesh-ancestor
64894023|NCT01999933|Antimitotic Agents|antimitotic agents|mesh-ancestor
64894024|NCT01999933|Mitosis Modulators|mitosis modulators|mesh-ancestor
64646968|NCT02992496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894025|NCT01999933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894026|NCT02000102|Aflibercept|aflibercept|mesh-list
64894027|NCT02000102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64894039|NCT02000193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64894040|NCT02000193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894041|NCT02000206|Ketamine|ketamine|mesh-list
64894042|NCT02000206|Alfentanil|alfentanil|mesh-list
64894043|NCT02000206|Propofol|propofol|mesh-list
64894058|NCT02000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64894059|NCT02000206|Narcotics|narcotics|mesh-ancestor
64894060|NCT02000336|Prednisolone|prednisolone|mesh-list
64894061|NCT02000336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64894062|NCT02000336|Glucocorticoids|glucocorticoids|mesh-ancestor
64894063|NCT02000336|Hormones|hormones|mesh-ancestor
64894064|NCT02000336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64894065|NCT02000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894066|NCT02000336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64894067|NCT02000336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894068|NCT02000375|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64894069|NCT02000375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64894070|NCT02000375|Immunologic Factors|immunologic factors|mesh-ancestor
64894071|NCT02000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894072|NCT02000388|Ketorolac|ketorolac|mesh-list
64894073|NCT02000388|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64894074|NCT02000388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64894075|NCT02000388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64894076|NCT02000388|Analgesics|analgesics|mesh-ancestor
64894077|NCT02000388|Sensory System Agents|sensory system agents|mesh-ancestor
64894078|NCT02000388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894079|NCT02000388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894080|NCT02000388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64894081|NCT02000388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64894082|NCT02000388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64894083|NCT02000388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64894084|NCT02000388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894095|NCT02000401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64894096|NCT02000401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64894097|NCT02000401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894098|NCT02000414|Daptomycin|daptomycin|mesh-list
64894099|NCT02000414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64894100|NCT02000414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64894101|NCT02000674|Rocuronium|rocuronium|mesh-list
64894102|NCT02000674|Succinylcholine|succinylcholine|mesh-list
64894109|NCT02000700|Canagliflozin|canagliflozin|mesh-list
64894110|NCT02000700|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64894111|NCT02000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894115|NCT02000726|Citalopram|citalopram|mesh-list
64521372|NCT05165550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64521373|NCT04166669|Itraconazole|itraconazole|mesh-list
64521374|NCT04166669|Rifampin|rifampin|mesh-list
64521375|NCT04166669|Antifungal Agents|antifungal agents|mesh-ancestor
64521376|NCT04166669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64521377|NCT04166669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64521378|NCT04166669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64521379|NCT04166669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521380|NCT04166669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521381|NCT04166669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64521382|NCT04166669|Hormone Antagonists|hormone antagonists|mesh-ancestor
64521383|NCT04166669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64521384|NCT04166669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521385|NCT04166669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64521386|NCT04166669|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64521387|NCT04166669|Antitubercular Agents|antitubercular agents|mesh-ancestor
64521388|NCT04166669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64521389|NCT04166669|Leprostatic Agents|leprostatic agents|mesh-ancestor
64521390|NCT04166669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64894143|NCT02001012|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64894144|NCT02001012|Amebicides|amebicides|mesh-ancestor
64894145|NCT02001012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64894146|NCT02001012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64894147|NCT02001012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64894148|NCT02001012|Antimalarials|antimalarials|mesh-ancestor
64894149|NCT02001012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64894150|NCT02001012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64894151|NCT02001012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64894152|NCT02001012|Analgesics|analgesics|mesh-ancestor
64894153|NCT02001012|Sensory System Agents|sensory system agents|mesh-ancestor
64894154|NCT02001012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894155|NCT02001012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894156|NCT02001012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64894157|NCT02001012|Filaricides|filaricides|mesh-ancestor
64894158|NCT02001012|Antinematodal Agents|antinematodal agents|mesh-ancestor
64894159|NCT02001012|Anthelmintics|anthelmintics|mesh-ancestor
64894160|NCT02001103|Memantine|memantine|mesh-list
64894161|NCT02001103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64894162|NCT02001103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64894163|NCT02001103|Dopamine Agents|dopamine agents|mesh-ancestor
64647063|NCT02992340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894164|NCT02001103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64894165|NCT02001103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894166|NCT02001103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894167|NCT02001103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64894168|NCT02001103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64894169|NCT02001168|Docetaxel|docetaxel|mesh-list
64894196|NCT02001259|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64894197|NCT02001259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64894198|NCT02001259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64894199|NCT02001259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894200|NCT02001272|Paclitaxel|paclitaxel|mesh-list
64894201|NCT02001272|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64894202|NCT02001272|Carboplatin|carboplatin|mesh-list
64894203|NCT02001272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64894204|NCT02001272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894205|NCT02001272|Tubulin Modulators|tubulin modulators|mesh-ancestor
64894206|NCT02001272|Antimitotic Agents|antimitotic agents|mesh-ancestor
64894207|NCT02001272|Mitosis Modulators|mitosis modulators|mesh-ancestor
64894208|NCT02001272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894209|NCT02001285|Remifentanil|remifentanil|mesh-list
64894210|NCT02001285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64894211|NCT02001285|Narcotics|narcotics|mesh-ancestor
64894212|NCT02001285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64894213|NCT02001285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894214|NCT02001285|Analgesics|analgesics|mesh-ancestor
64894215|NCT02001285|Sensory System Agents|sensory system agents|mesh-ancestor
64521406|NCT03193710|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64521407|NCT03193710|Narcotics|narcotics|mesh-ancestor
64521408|NCT03193710|Analgesics|analgesics|mesh-ancestor
64521409|NCT03193710|Sensory System Agents|sensory system agents|mesh-ancestor
64521410|NCT03193710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64521411|NCT03193710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64521412|NCT03193710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64521413|NCT01704599|Vitamins|vitamins|mesh-list
64521414|NCT01704599|Folic Acid|folic acid|mesh-list
64521415|NCT01704599|Vitamin B 12|vitamin b 12|mesh-list
64521416|NCT01704599|Pyridoxine|pyridoxine|mesh-list
64521417|NCT01704599|Vitamin B 6|vitamin b 6|mesh-list
64521418|NCT01704599|Vitamin B Complex|vitamin b complex|mesh-list
64521419|NCT01704599|Adalimumab|adalimumab|mesh-list
64521420|NCT01704599|Micronutrients|micronutrients|mesh-ancestor
64521421|NCT01704599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521422|NCT01704599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64521423|NCT01704599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64521424|NCT01704599|Hematinics|hematinics|mesh-ancestor
64521425|NCT03196362|Metformin|metformin|mesh-list
64521426|NCT03196362|Pioglitazone|pioglitazone|mesh-list
64894216|NCT02001285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894217|NCT02001298|Nitroprusside|nitroprusside|mesh-list
64894218|NCT02001298|Remifentanil|remifentanil|mesh-list
64894240|NCT02001363|Hormones|hormones|mesh-ancestor
64894241|NCT02001363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64894242|NCT02001428|Piperaquine|piperaquine|mesh-list
64894243|NCT02001428|Artenimol|artenimol|mesh-list
64894249|NCT02001506|Epirubicin|epirubicin|mesh-list
64894250|NCT02001506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894251|NCT02001506|Tubulin Modulators|tubulin modulators|mesh-ancestor
64894252|NCT02001506|Antimitotic Agents|antimitotic agents|mesh-ancestor
64894253|NCT02001506|Mitosis Modulators|mitosis modulators|mesh-ancestor
64894254|NCT02001506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894255|NCT02001506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64894256|NCT02001506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64894257|NCT02001506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64894258|NCT02001506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64894259|NCT02001571|Abiraterone Acetate|abiraterone acetate|mesh-list
64894260|NCT02001571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894261|NCT02001571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64894262|NCT02001571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64894263|NCT02001571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894264|NCT02001571|Hormone Antagonists|hormone antagonists|mesh-ancestor
64894265|NCT02001571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64894266|NCT02001571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894267|NCT02001571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64894268|NCT02001584|Memantine|memantine|mesh-list
64894269|NCT02001584|Baclofen|baclofen|mesh-list
64894270|NCT02001584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64894271|NCT02001584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64894272|NCT02001584|Dopamine Agents|dopamine agents|mesh-ancestor
64894273|NCT02001584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64894287|NCT02001740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64521427|NCT03196362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64521428|NCT03196362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521429|NCT02449278|Prednisone|prednisone|mesh-list
64894288|NCT02001740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894289|NCT02001740|Sensory System Agents|sensory system agents|mesh-ancestor
64894290|NCT02001740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894291|NCT02001740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64894292|NCT02001740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64662794|NCT01825655|Histamine Antagonists|histamine antagonists|mesh-ancestor
64894293|NCT02001740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64894294|NCT02001740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64894295|NCT02001740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894296|NCT02001818|Interferons|interferons|mesh-list
64894297|NCT02001818|Interferon-alpha|interferon-alpha|mesh-list
64894298|NCT02001818|Interferon alpha-2|interferon alpha-2|mesh-list
64894299|NCT02001818|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64894300|NCT02001818|Imatinib Mesylate|imatinib mesylate|mesh-list
64894301|NCT02001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894302|NCT02001818|Antiviral Agents|antiviral agents|mesh-ancestor
64647165|NCT01271894|Antiviral Agents|antiviral agents|mesh-ancestor
64894303|NCT02001818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64894304|NCT02001818|Immunologic Factors|immunologic factors|mesh-ancestor
64894305|NCT02001818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894306|NCT02001818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64894307|NCT02001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64894308|NCT02001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894309|NCT02001857|Hemostatics|hemostatics|mesh-list
64894310|NCT02001857|Coagulants|coagulants|mesh-ancestor
64894311|NCT02001883|Policosanol|policosanol|mesh-list
64894312|NCT02001883|Atorvastatin|atorvastatin|mesh-list
64894313|NCT02001883|Simvastatin|simvastatin|mesh-list
64894314|NCT02001883|Red yeast rice|red yeast rice|mesh-list
64894315|NCT02001883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64521448|NCT02449278|Hormones|hormones|mesh-ancestor
64521452|NCT02449278|Tubulin Modulators|tubulin modulators|mesh-ancestor
64521453|NCT02449278|Antimitotic Agents|antimitotic agents|mesh-ancestor
64521454|NCT02449278|Mitosis Modulators|mitosis modulators|mesh-ancestor
64521455|NCT03388788|CGP 12177|cgp 12177|mesh-list
64521456|NCT03388788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64521457|NCT03388788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64521458|NCT03388788|Adrenergic Agents|adrenergic agents|mesh-ancestor
64521459|NCT03388788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64521460|NCT03388788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521461|NCT03388788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521462|NCT03388788|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64521463|NCT03388788|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64521464|NCT03599518|Gefitinib|gefitinib|mesh-list
64521465|NCT03599518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521466|NCT03599518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64521467|NCT03599518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521468|NCT03599518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894364|NCT02001948|Sensory System Agents|sensory system agents|mesh-ancestor
64894365|NCT02001948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894366|NCT02001948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64894367|NCT02001948|Narcotics|narcotics|mesh-ancestor
64647213|NCT00737204|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64894368|NCT02001948|Analgesics|analgesics|mesh-ancestor
64894369|NCT02001974|Paclitaxel|paclitaxel|mesh-list
64894370|NCT02001974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64894372|NCT02001974|Tubulin Modulators|tubulin modulators|mesh-ancestor
64521544|NCT05721586|Sodium Fluoride|sodium fluoride|mesh-list
64521545|NCT05721586|Cariostatic Agents|cariostatic agents|mesh-ancestor
64521546|NCT05721586|Protective Agents|protective agents|mesh-ancestor
64521547|NCT05721586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521548|NCT05721586|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64521549|NCT05721586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64521550|NCT03295396|TIC10 compound|tic10 compound|mesh-list
64521551|NCT03295396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521552|NCT02978482|Durvalumab|durvalumab|mesh-list
64521553|NCT02978482|Tremelimumab|tremelimumab|mesh-list
64521554|NCT02978482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64521555|NCT02978482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64521556|NCT02978482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521557|NCT02978482|Immunologic Factors|immunologic factors|mesh-ancestor
64521558|NCT02978482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521559|NCT00357682|Aspirin|aspirin|mesh-list
64521560|NCT00357682|Esomeprazole|esomeprazole|mesh-list
64521561|NCT00357682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64521562|NCT00357682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64521563|NCT00357682|Analgesics|analgesics|mesh-ancestor
64894426|NCT02002195|Protective Agents|protective agents|mesh-ancestor
64894427|NCT02002195|Vitamin B Complex|vitamin b complex|mesh-ancestor
64894428|NCT02002195|Vitamins|vitamins|mesh-ancestor
64894429|NCT02002195|Micronutrients|micronutrients|mesh-ancestor
64894439|NCT02002260|Levonorgestrel|levonorgestrel|mesh-list
64894440|NCT02002260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64894441|NCT02002260|Contraceptive Agents|contraceptive agents|mesh-list
64894442|NCT02002260|Contraceptives, Oral|contraceptives, oral|mesh-list
64894443|NCT02002260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64662952|NCT01416584|Methadone|methadone|mesh-list
64894444|NCT02002260|Estradiol|estradiol|mesh-list
64894445|NCT02002260|Estrogens|estrogens|mesh-ancestor
64894446|NCT02002260|Hormones|hormones|mesh-ancestor
64945484|NCT05595603|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64894447|NCT02002260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64894458|NCT02002286|Contraceptive Agents|contraceptive agents|mesh-ancestor
64894459|NCT02002286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64894460|NCT02002286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64894461|NCT02002286|Immunologic Factors|immunologic factors|mesh-ancestor
64521564|NCT00357682|Sensory System Agents|sensory system agents|mesh-ancestor
64521565|NCT00357682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64521566|NCT00357682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521567|NCT00357682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64521568|NCT00357682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64521569|NCT00357682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64521570|NCT00357682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64894462|NCT02002286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64894463|NCT02002286|Alkylating Agents|alkylating agents|mesh-ancestor
64894464|NCT02002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894465|NCT02002286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894466|NCT02002312|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
64894467|NCT02002312|Chelating Agents|chelating agents|mesh-ancestor
64894468|NCT02002312|Sequestering Agents|sequestering agents|mesh-ancestor
64894469|NCT02002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894470|NCT02002325|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64894471|NCT02002325|Plasminogen|plasminogen|mesh-list
64894472|NCT02002325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64894473|NCT02002325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64894474|NCT02002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894475|NCT02002377|Aflibercept|aflibercept|mesh-list
64894476|NCT02002377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64894477|NCT02002377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64894478|NCT02002377|Growth Substances|growth substances|mesh-ancestor
64894479|NCT02002377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894480|NCT02002377|Growth Inhibitors|growth inhibitors|mesh-ancestor
64894481|NCT02002377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894482|NCT02002390|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64894488|NCT02002403|Danazol|danazol|mesh-list
64894490|NCT02002403|Hormone Antagonists|hormone antagonists|mesh-ancestor
64894491|NCT02002403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64894492|NCT02002403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894510|NCT02002598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64894511|NCT02002598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64894513|NCT02002598|Protease Inhibitors|protease inhibitors|mesh-ancestor
64894514|NCT02002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64894515|NCT02002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894516|NCT02002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64894517|NCT02002598|Alkylating Agents|alkylating agents|mesh-ancestor
64894518|NCT02002611|Warfarin|warfarin|mesh-list
64894519|NCT02002611|Anticoagulants|anticoagulants|mesh-ancestor
64894520|NCT02002663|Methylprednisolone|methylprednisolone|mesh-list
64894521|NCT02002663|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64894522|NCT02002663|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64894523|NCT02002663|Prednisolone|prednisolone|mesh-list
64894524|NCT02002663|Prednisolone acetate|prednisolone acetate|mesh-list
64894525|NCT02002663|Morphine|morphine|mesh-list
64894526|NCT02002663|Ropivacaine|ropivacaine|mesh-list
64894527|NCT02002663|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64894528|NCT02002663|Prednisolone phosphate|prednisolone phosphate|mesh-list
64894529|NCT02002663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64894571|NCT02002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894572|NCT02002754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64894573|NCT02002754|Respiratory System Agents|respiratory system agents|mesh-ancestor
64894575|NCT02002806|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64894576|NCT02002806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64894577|NCT02002806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64894578|NCT02002806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894579|NCT02002858|Nicotine|nicotine|mesh-list
64894580|NCT02002858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64894581|NCT02002858|Autonomic Agents|autonomic agents|mesh-ancestor
64894582|NCT02002858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894583|NCT02002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894584|NCT02002858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64894585|NCT02002858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64894586|NCT02002858|Cholinergic Agents|cholinergic agents|mesh-ancestor
64894587|NCT02002858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64894588|NCT02002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894589|NCT02002923|Botulinum Toxins|botulinum toxins|mesh-list
64894590|NCT02002923|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64894593|NCT02002923|Cholinergic Agents|cholinergic agents|mesh-ancestor
64894648|NCT02003664|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64894649|NCT02003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894650|NCT02003664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64894651|NCT02003664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894674|NCT02003885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64894675|NCT02003885|Anesthetics, General|anesthetics, general|mesh-ancestor
64894676|NCT02003885|Anesthetics|anesthetics|mesh-ancestor
64894677|NCT02003885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64894678|NCT02003885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894679|NCT02004067|Cyclosporine|cyclosporine|mesh-list
64894680|NCT02004067|Castor Oil|castor oil|mesh-list
64894681|NCT02004067|Cyclosporins|cyclosporins|mesh-list
64894682|NCT02004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64894683|NCT02004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894684|NCT02004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64521585|NCT00105027|Hormones|hormones|mesh-ancestor
64647344|NCT01273454|Hydromorphone|hydromorphone|mesh-list
64521586|NCT00105027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64521587|NCT00105027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521588|NCT00105027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64521589|NCT00105027|Immunologic Factors|immunologic factors|mesh-ancestor
64521590|NCT00105027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521591|NCT00105027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521592|NCT03145012|Ranitidine|ranitidine|mesh-list
64521593|NCT03145012|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
64521594|NCT03145012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64521595|NCT03145012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64521596|NCT03145012|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64521597|NCT03145012|Histamine Antagonists|histamine antagonists|mesh-ancestor
64521598|NCT03145012|Histamine Agents|histamine agents|mesh-ancestor
64521599|NCT03145012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64521600|NCT03145012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521601|NCT03145012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521602|NCT03832660|Valsartan|valsartan|mesh-list
64521603|NCT03832660|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64894743|NCT02004314|Antimalarials|antimalarials|mesh-ancestor
64894744|NCT02004314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64894745|NCT02004418|Choline|choline|mesh-list
64894746|NCT02004418|Lipotropic Agents|lipotropic agents|mesh-ancestor
64894747|NCT02004418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64521604|NCT03832660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64521605|NCT03832660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64521606|NCT03832660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64521607|NCT03832660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521608|NCT03132532|Paclitaxel|paclitaxel|mesh-list
64521609|NCT03132532|Etoposide|etoposide|mesh-list
64521610|NCT03132532|Podophyllotoxin|podophyllotoxin|mesh-list
64521611|NCT03132532|Cisplatin|cisplatin|mesh-list
64521612|NCT03132532|Carboplatin|carboplatin|mesh-list
64521613|NCT03132532|Pemetrexed|pemetrexed|mesh-list
64521614|NCT03132532|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64521615|NCT03132532|Etoposide phosphate|etoposide phosphate|mesh-list
64521616|NCT03132532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64521617|NCT03132532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521618|NCT03132532|Tubulin Modulators|tubulin modulators|mesh-ancestor
64521619|NCT03132532|Antimitotic Agents|antimitotic agents|mesh-ancestor
64521620|NCT03132532|Mitosis Modulators|mitosis modulators|mesh-ancestor
64521621|NCT03132532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521622|NCT03132532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64521623|NCT03132532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64521624|NCT03132532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521625|NCT03132532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64521626|NCT03132532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64521627|NCT03132532|Keratolytic Agents|keratolytic agents|mesh-ancestor
64521628|NCT03132532|Dermatologic Agents|dermatologic agents|mesh-ancestor
64521629|NCT00030147|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64521631|NCT00030147|Estrogens|estrogens|mesh-ancestor
64521632|NCT00030147|Hormones|hormones|mesh-ancestor
64521633|NCT00030147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64521639|NCT00030147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64521651|NCT03107416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521652|NCT03107416|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64521653|NCT03107416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64521654|NCT03107416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521655|NCT02439996|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64521656|NCT02439996|gamma-Globulins|gamma-globulins|mesh-list
64521657|NCT02439996|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64894789|NCT02004782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64894790|NCT02004782|Glucocorticoids|glucocorticoids|mesh-ancestor
64894792|NCT02004782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64894793|NCT02004782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894794|NCT02004782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64894795|NCT02004782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894796|NCT02004860|Ciclopirox|ciclopirox|mesh-list
64894797|NCT02004860|Tacrolimus|tacrolimus|mesh-list
64894798|NCT02004860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64647398|NCT00744380|Analgesics|analgesics|mesh-ancestor
64894799|NCT02004860|Immunologic Factors|immunologic factors|mesh-ancestor
64894800|NCT02004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521737|NCT02425774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64521738|NCT02425774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521739|NCT02425774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521740|NCT02420002|Nitrous Oxide|nitrous oxide|mesh-list
64521741|NCT02420002|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64521742|NCT02420002|Anesthetics, General|anesthetics, general|mesh-ancestor
64521743|NCT02420002|Anesthetics|anesthetics|mesh-ancestor
64521744|NCT02420002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64521745|NCT02420002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521746|NCT02420002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64521747|NCT02420002|Analgesics|analgesics|mesh-ancestor
64521748|NCT02420002|Sensory System Agents|sensory system agents|mesh-ancestor
64521749|NCT02420002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894826|NCT02005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894827|NCT02005107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64894838|NCT02005120|Growth Substances|growth substances|mesh-ancestor
64894865|NCT02005419|Metformin|metformin|mesh-list
64894866|NCT02005419|Gemcitabine|gemcitabine|mesh-list
64894867|NCT02005419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64894868|NCT02005419|Antimetabolites|antimetabolites|mesh-ancestor
64894869|NCT02005419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894870|NCT02005419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894871|NCT02005419|Antiviral Agents|antiviral agents|mesh-ancestor
64894872|NCT02005419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64894873|NCT02005419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64894874|NCT02005419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64894878|NCT02005523|RNS60|rns60|mesh-list
64521800|NCT03117894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521801|NCT03117894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64894928|NCT02005653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894929|NCT02005653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894930|NCT02005653|Filaricides|filaricides|mesh-ancestor
64894931|NCT02005653|Antinematodal Agents|antinematodal agents|mesh-ancestor
64894932|NCT02005653|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64894933|NCT02005653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64894934|NCT02005718|Cholecalciferol|cholecalciferol|mesh-list
64894935|NCT02005718|Vitamin D|vitamin d|mesh-list
64894936|NCT02005718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64894937|NCT02005718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894938|NCT02005718|Vitamins|vitamins|mesh-ancestor
64894939|NCT02005718|Micronutrients|micronutrients|mesh-ancestor
64894940|NCT02005718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64894941|NCT02005757|Mizoribine|mizoribine|mesh-list
64894942|NCT02005757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64894943|NCT02005757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64894944|NCT02005757|Analgesics|analgesics|mesh-ancestor
64894998|NCT02005848|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64894999|NCT02005848|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64895000|NCT02006043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64895001|NCT02006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895026|NCT02006277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64895027|NCT02006277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895028|NCT02006355|Ropivacaine|ropivacaine|mesh-list
64895029|NCT02006355|Anesthetics, Local|anesthetics, local|mesh-ancestor
64895030|NCT02006355|Anesthetics|anesthetics|mesh-ancestor
64895031|NCT02006355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64895032|NCT02006355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895033|NCT02006355|Sensory System Agents|sensory system agents|mesh-ancestor
64895034|NCT02006355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895035|NCT02006485|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64895036|NCT02006485|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64895037|NCT02006485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64895038|NCT02006485|Alkylating Agents|alkylating agents|mesh-ancestor
64895043|NCT02006498|Silymarin|silymarin|mesh-list
64895073|NCT02006914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895074|NCT02006914|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64895075|NCT02006914|Chelating Agents|chelating agents|mesh-ancestor
64895076|NCT02006914|Sequestering Agents|sequestering agents|mesh-ancestor
64895077|NCT02006914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895078|NCT02006966|Lidocaine|lidocaine|mesh-list
64895079|NCT02006966|Anesthetics, Local|anesthetics, local|mesh-ancestor
64895080|NCT02006966|Anesthetics|anesthetics|mesh-ancestor
64895081|NCT02006966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64895082|NCT02006966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895083|NCT02006966|Sensory System Agents|sensory system agents|mesh-ancestor
64895084|NCT02006966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895085|NCT02006966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64895086|NCT02006966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64895087|NCT02006966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64895088|NCT02006966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64895089|NCT02006966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895090|NCT02007005|Viscum album peptide|viscum album peptide|mesh-list
64895091|NCT02007005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895092|NCT02007005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64895093|NCT02007005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64895094|NCT02007005|Antiviral Agents|antiviral agents|mesh-ancestor
64521893|NCT05717062|Varespladib methyl|varespladib methyl|mesh-list
64521894|NCT05717062|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
64521895|NCT05717062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521896|NCT05717062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521897|NCT00215787|Lansoprazole|lansoprazole|mesh-list
64521898|NCT00215787|Dexlansoprazole|dexlansoprazole|mesh-list
64521899|NCT00215787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64521900|NCT00215787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64521901|NCT00215787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64521902|NCT00215787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64895148|NCT02007408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895179|NCT02007798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64895180|NCT02007798|Adrenergic Agents|adrenergic agents|mesh-ancestor
64895181|NCT02007798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64895182|NCT02007798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895183|NCT02007837|Aspirin|aspirin|mesh-list
64521908|NCT05716906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521909|NCT05716906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64521910|NCT00216099|Folic Acid|folic acid|mesh-list
64521911|NCT00216099|Vitamin B 12|vitamin b 12|mesh-list
64521912|NCT00216099|Hydroxocobalamin|hydroxocobalamin|mesh-list
64521913|NCT00216099|Pemetrexed|pemetrexed|mesh-list
64521914|NCT00216099|Vitamins|vitamins|mesh-ancestor
64521915|NCT00216099|Micronutrients|micronutrients|mesh-ancestor
64521916|NCT00216099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521917|NCT00216099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521918|NCT00216099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64895230|NCT02007928|Antidepressive Agents|antidepressive agents|mesh-ancestor
64895231|NCT02007928|Dopamine Agonists|dopamine agonists|mesh-ancestor
64895232|NCT02007928|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64895233|NCT02007928|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64895234|NCT02007928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64895235|NCT02007928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64895236|NCT02008006|Cytarabine|cytarabine|mesh-list
64895237|NCT02008006|Etoposide|etoposide|mesh-list
64521924|NCT04565925|Sildenafil Citrate|sildenafil citrate|mesh-list
64521925|NCT04565925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521926|NCT04565925|Vasodilator Agents|vasodilator agents|mesh-ancestor
64521927|NCT04565925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64521928|NCT04565925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64895295|NCT02008162|Adrenergic Agents|adrenergic agents|mesh-ancestor
64895296|NCT02008201|Vitamin D|vitamin d|mesh-list
64895297|NCT02008201|Vitamins|vitamins|mesh-ancestor
64895298|NCT02008201|Micronutrients|micronutrients|mesh-ancestor
64895299|NCT02008201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895300|NCT02008201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64895301|NCT02008214|Pentoxifylline|pentoxifylline|mesh-list
64895302|NCT02008214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64895303|NCT02008214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64895304|NCT02008214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521931|NCT00039195|Prednisone|prednisone|mesh-list
64521932|NCT00039195|Cyclophosphamide|cyclophosphamide|mesh-list
64521933|NCT00039195|Ifosfamide|ifosfamide|mesh-list
64521934|NCT00039195|Rituximab|rituximab|mesh-list
64521935|NCT00039195|Carboplatin|carboplatin|mesh-list
64521936|NCT00039195|Doxorubicin|doxorubicin|mesh-list
64521937|NCT00039195|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64521938|NCT00039195|Etoposide|etoposide|mesh-list
64895356|NCT02008747|Anticonvulsants|anticonvulsants|mesh-ancestor
64895357|NCT02008747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64895358|NCT02008747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64895359|NCT02008747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895360|NCT02008747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64895361|NCT02008747|Tocolytic Agents|tocolytic agents|mesh-ancestor
64895362|NCT02008747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64895363|NCT02008786|Ramipril|ramipril|mesh-list
64895364|NCT02008786|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64895365|NCT02008786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64895366|NCT02008786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64895367|NCT02008786|Antimetabolites|antimetabolites|mesh-ancestor
64895368|NCT02008786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895369|NCT02008786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64895370|NCT02008786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64895371|NCT02008786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64895397|NCT02008981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895398|NCT02008981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64895399|NCT02008981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64895400|NCT02008981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64895401|NCT02008981|Antipyretics|antipyretics|mesh-ancestor
64895402|NCT02008981|Antioxidants|antioxidants|mesh-ancestor
64895404|NCT02009007|Phenylephrine|phenylephrine|mesh-list
64895421|NCT02009007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895433|NCT02009202|Cathartics|cathartics|mesh-ancestor
64895434|NCT02009202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64895435|NCT02009215|Piperaquine|piperaquine|mesh-list
64895436|NCT02009215|Artenimol|artenimol|mesh-list
64895437|NCT02009215|Antimalarials|antimalarials|mesh-ancestor
64895438|NCT02009215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64895439|NCT02009215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64895440|NCT02009215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64895441|NCT05778838|Midodrine|midodrine|mesh-list
64895442|NCT05778838|Sympathomimetics|sympathomimetics|mesh-ancestor
64895443|NCT05778838|Autonomic Agents|autonomic agents|mesh-ancestor
64895444|NCT05778838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895445|NCT05778838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895446|NCT05778838|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64895447|NCT05778838|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64895448|NCT05778838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64895449|NCT05778838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64895450|NCT05778838|Adrenergic Agents|adrenergic agents|mesh-ancestor
64895451|NCT05778838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64521939|NCT00039195|Vincristine|vincristine|mesh-list
64521940|NCT00039195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64895466|NCT05778591|Sensory System Agents|sensory system agents|mesh-ancestor
64895467|NCT05778591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895468|NCT05778591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64895469|NCT05778461|N-Methylaspartate|n-methylaspartate|mesh-list
64895470|NCT05778461|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
64895471|NCT05778461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64895472|NCT05778461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64895473|NCT05778461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895474|NCT05778461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895475|NCT05778305|Dexmedetomidine|dexmedetomidine|mesh-list
64895476|NCT05778305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64895573|NCT05777369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64895574|NCT05777369|Tubulin Modulators|tubulin modulators|mesh-ancestor
64895575|NCT05777369|Antimitotic Agents|antimitotic agents|mesh-ancestor
64895576|NCT05777369|Mitosis Modulators|mitosis modulators|mesh-ancestor
64895578|NCT05777369|Sensory System Agents|sensory system agents|mesh-ancestor
64895612|NCT05741086|Evolocumab|evolocumab|mesh-list
64895613|NCT05741086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64895614|NCT05741086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64895615|NCT05741086|Antimetabolites|antimetabolites|mesh-ancestor
64895616|NCT05741086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895617|NCT05741086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64895618|NCT05741086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64895642|NCT05707273|Alkylating Agents|alkylating agents|mesh-ancestor
64521977|NCT00218439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521978|NCT00218439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64521979|NCT00218439|Antidepressive Agents|antidepressive agents|mesh-ancestor
64895646|NCT05706259|Vitamin D|vitamin d|mesh-list
64895688|NCT05616390|Growth Substances|growth substances|mesh-ancestor
64895689|NCT05616390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895690|NCT05616390|Growth Inhibitors|growth inhibitors|mesh-ancestor
64895691|NCT05613413|Pembrolizumab|pembrolizumab|mesh-list
64895692|NCT05613413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64895693|NCT05613413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895694|NCT05597150|Magnesium citrate|magnesium citrate|mesh-list
64895695|NCT05597150|Cathartics|cathartics|mesh-ancestor
64895696|NCT05597150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64895697|NCT05595460|Carboplatin|carboplatin|mesh-list
64895698|NCT05595460|Etoposide|etoposide|mesh-list
64895699|NCT05595460|Atezolizumab|atezolizumab|mesh-list
64895704|NCT05595460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64895734|NCT05587894|Antiviral Agents|antiviral agents|mesh-ancestor
64895735|NCT05587894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64895736|NCT05587894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64895737|NCT05587894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64895738|NCT05587894|Antimetabolites|antimetabolites|mesh-ancestor
64895739|NCT05548270|Scopolamine|scopolamine|mesh-list
64895740|NCT05548270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64895750|NCT05548270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895751|NCT05548270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64895752|NCT05534620|Fludarabine|fludarabine|mesh-list
64895753|NCT05534620|Treosulfan|treosulfan|mesh-list
64522005|NCT00358384|Calcipotriene|calcipotriene|mesh-list
64522006|NCT00358384|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64522007|NCT00358384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64522008|NCT00358384|Glucocorticoids|glucocorticoids|mesh-ancestor
64522009|NCT00358384|Hormones|hormones|mesh-ancestor
64522010|NCT00358384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64522011|NCT00358384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522012|NCT00358384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64522013|NCT00358384|Respiratory System Agents|respiratory system agents|mesh-ancestor
64522014|NCT00358384|Dermatologic Agents|dermatologic agents|mesh-ancestor
64522015|NCT02959060|Rifampin|rifampin|mesh-list
64895758|NCT05514197|Ascorbic Acid|ascorbic acid|mesh-list
64895783|NCT05455424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64895784|NCT05455424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895785|NCT05455424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895786|NCT05447286|Oxycodone|oxycodone|mesh-list
64895787|NCT05447286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64895788|NCT05447286|Narcotics|narcotics|mesh-ancestor
64895789|NCT05447286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64895790|NCT05447286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895791|NCT05447286|Analgesics|analgesics|mesh-ancestor
64895792|NCT05447286|Sensory System Agents|sensory system agents|mesh-ancestor
64895793|NCT05447286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895794|NCT05410158|Ketamine|ketamine|mesh-list
64895795|NCT05410158|Analgesics|analgesics|mesh-ancestor
64895796|NCT05410158|Sensory System Agents|sensory system agents|mesh-ancestor
64895798|NCT05410158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895799|NCT05410158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64895800|NCT05410158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64895801|NCT05410158|Anesthetics, General|anesthetics, general|mesh-ancestor
64895802|NCT05410158|Anesthetics|anesthetics|mesh-ancestor
64895803|NCT05410158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64895804|NCT05410158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64522017|NCT02959060|Antitubercular Agents|antitubercular agents|mesh-ancestor
64895837|NCT05185947|Tubulin Modulators|tubulin modulators|mesh-ancestor
64895838|NCT05185947|Antimitotic Agents|antimitotic agents|mesh-ancestor
64895839|NCT05185947|Mitosis Modulators|mitosis modulators|mesh-ancestor
64895840|NCT05185947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895841|NCT05139238|Labetalol|labetalol|mesh-list
64895842|NCT05139238|Nifedipine|nifedipine|mesh-list
64895843|NCT05139238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64895844|NCT05139238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64895845|NCT05139238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895846|NCT05139238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64895847|NCT05139238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895848|NCT05139238|Vasodilator Agents|vasodilator agents|mesh-ancestor
64895849|NCT05139238|Tocolytic Agents|tocolytic agents|mesh-ancestor
64895850|NCT05139238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64895851|NCT05139238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64895852|NCT05139238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64895853|NCT05139238|Adrenergic Agents|adrenergic agents|mesh-ancestor
64895854|NCT05139238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64895855|NCT05139238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64895856|NCT05139238|Sympathomimetics|sympathomimetics|mesh-ancestor
64895857|NCT05139238|Autonomic Agents|autonomic agents|mesh-ancestor
64895858|NCT05139238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895859|NCT05139238|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64895860|NCT05139238|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64895861|NCT05138068|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
64895862|NCT05138068|Hallucinogens|hallucinogens|mesh-ancestor
64522029|NCT02959060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64522031|NCT00109005|Immunologic Factors|immunologic factors|mesh-ancestor
64522032|NCT00109005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522033|NCT00109005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64522034|NCT00109005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64522035|NCT00109005|Growth Substances|growth substances|mesh-ancestor
64522036|NCT00109005|Growth Inhibitors|growth inhibitors|mesh-ancestor
64895863|NCT05138068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647710|NCT00245102|Sorafenib|sorafenib|mesh-list
64895895|NCT05091905|Anesthetics, Local|anesthetics, local|mesh-list
64895896|NCT05091905|Anesthetics|anesthetics|mesh-list
64895897|NCT05091905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64895898|NCT05091905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895899|NCT05091905|Sensory System Agents|sensory system agents|mesh-ancestor
64895900|NCT05091905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895901|NCT05085873|Midazolam|midazolam|mesh-list
64895902|NCT05085873|Sodium Oxybate|sodium oxybate|mesh-list
64895903|NCT05085873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64895904|NCT05085873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64895905|NCT05085873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64895906|NCT05085873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895922|NCT04983589|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64895923|NCT04983589|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64895924|NCT04983589|Cholinergic Agents|cholinergic agents|mesh-ancestor
64895927|NCT04975334|Naloxone|naloxone|mesh-list
64522045|NCT05547100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64522046|NCT05547100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64522047|NCT05547100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64522048|NCT05547100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64522049|NCT05547100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64522050|NCT05547100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64522051|NCT05547100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64895963|NCT04789408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895964|NCT04789408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895965|NCT04789408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64895966|NCT04782830|Midodrine|midodrine|mesh-list
64895977|NCT04782830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895978|NCT04782830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64895979|NCT04782830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64895980|NCT04782830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64895981|NCT04782830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64895982|NCT04771000|Ambrisentan|ambrisentan|mesh-list
64895983|NCT04771000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64895984|NCT04711109|Denosumab|denosumab|mesh-list
64895985|NCT04711109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64895986|NCT04711109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895987|NCT04699123|Pembrolizumab|pembrolizumab|mesh-list
64522056|NCT00109473|Prednisone|prednisone|mesh-list
64522057|NCT00109473|Hormones|hormones|mesh-list
64522058|NCT00109473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64522059|NCT00109473|Glucocorticoids|glucocorticoids|mesh-ancestor
64522060|NCT00109473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64522061|NCT00109473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522062|NCT00109473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64522063|NCT00109473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522064|NCT05136976|Rituximab|rituximab|mesh-list
64522065|NCT05136976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64896015|NCT04567420|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64896016|NCT04567420|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64896017|NCT04567420|Hormone Antagonists|hormone antagonists|mesh-ancestor
64664540|NCT02371746|Travoprost|travoprost|mesh-list
64896018|NCT04567420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64896019|NCT04567420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896020|NCT04567420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64896021|NCT04567420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64896022|NCT04567420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896023|NCT04565483|Benralizumab|benralizumab|mesh-list
64896024|NCT04565483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64896025|NCT04565483|Respiratory System Agents|respiratory system agents|mesh-ancestor
64896026|NCT04558281|Ropivacaine|ropivacaine|mesh-list
64896027|NCT04558281|Anesthetics, Local|anesthetics, local|mesh-ancestor
64896050|NCT04461587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896051|NCT04461587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64896075|NCT04278833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64896076|NCT04278833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64896077|NCT04278833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896113|NCT04200911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64896114|NCT04200911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64896115|NCT04200911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522066|NCT05136976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522067|NCT05136976|Immunologic Factors|immunologic factors|mesh-ancestor
64714095|NCT03054103|Anesthetics, General|anesthetics, general|mesh-ancestor
64522068|NCT05136976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522069|NCT05136976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64522070|NCT00044655|Olanzapine|olanzapine|mesh-list
64522071|NCT00044655|Risperidone|risperidone|mesh-list
64522072|NCT00044655|Aripiprazole|aripiprazole|mesh-list
64522073|NCT00044655|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64522074|NCT00044655|Ziprasidone|ziprasidone|mesh-list
64522075|NCT00044655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64522076|NCT00044655|Serotonin Agents|serotonin agents|mesh-ancestor
64522077|NCT00044655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64522078|NCT00044655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896167|NCT04057898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64896168|NCT04057898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896169|NCT04057898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64896170|NCT04057898|Respiratory System Agents|respiratory system agents|mesh-ancestor
64896199|NCT03994731|Abortifacient Agents|abortifacient agents|mesh-ancestor
64522088|NCT00044655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64522090|NCT00044655|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64522091|NCT00044655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64522092|NCT00044655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64522093|NCT00044655|Antidepressive Agents|antidepressive agents|mesh-ancestor
64522094|NCT00044655|Dopamine Agonists|dopamine agonists|mesh-ancestor
64522095|NCT00044655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64522096|NCT00044655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64522097|NCT00044655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64522098|NCT00044655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64522099|NCT05130892|Tranilast|tranilast|mesh-list
64522100|NCT05130892|Colchicine|colchicine|mesh-list
64522101|NCT05130892|Gout Suppressants|gout suppressants|mesh-ancestor
64522102|NCT05130892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64522103|NCT05130892|Tubulin Modulators|tubulin modulators|mesh-ancestor
64522104|NCT05130892|Antimitotic Agents|antimitotic agents|mesh-ancestor
64522105|NCT05130892|Mitosis Modulators|mitosis modulators|mesh-ancestor
64522106|NCT05130892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522107|NCT05130892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896200|NCT03994731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64896201|NCT03994731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896202|NCT03994731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64896203|NCT03994731|Antimetabolites|antimetabolites|mesh-ancestor
64896205|NCT03994731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896238|NCT03984357|Antibodies|antibodies|mesh-list
64896239|NCT03984357|Antibodies, Blocking|antibodies, blocking|mesh-list
64896240|NCT03984357|Immunologic Factors|immunologic factors|mesh-ancestor
64896241|NCT03984357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896242|NCT03984357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664795|NCT00369993|Xhance|xhance|mesh-list
64896244|NCT03984357|Antimetabolites|antimetabolites|mesh-ancestor
64896245|NCT03984357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896246|NCT03984357|Antiviral Agents|antiviral agents|mesh-ancestor
64896247|NCT03984357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64896248|NCT03984357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64896249|NCT03984357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64522108|NCT05130892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64522109|NCT05130892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64522110|NCT05130892|Analgesics|analgesics|mesh-ancestor
64522111|NCT05130892|Sensory System Agents|sensory system agents|mesh-ancestor
64522112|NCT05130892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64522113|NCT05130892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522114|NCT05130892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64522115|NCT05130892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64896274|NCT03829683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896275|NCT03829683|Antioxidants|antioxidants|mesh-ancestor
64896276|NCT03829683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896277|NCT03829683|Protective Agents|protective agents|mesh-ancestor
64896291|NCT03737968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64896293|NCT03737968|Immunologic Factors|immunologic factors|mesh-ancestor
64896294|NCT03737968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896295|NCT03725202|Upadacitinib|upadacitinib|mesh-list
64896296|NCT03725202|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64896297|NCT03725202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64896298|NCT03725202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522130|NCT05312242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522131|NCT00223665|Leuprolide|leuprolide|mesh-list
64522132|NCT00223665|Flutamide|flutamide|mesh-list
64522133|NCT00223665|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64522134|NCT00223665|Fertility Agents|fertility agents|mesh-ancestor
64522135|NCT00223665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64522136|NCT00223665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522137|NCT00223665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64896323|NCT03556202|Analgesics|analgesics|mesh-ancestor
64896324|NCT03556202|Sensory System Agents|sensory system agents|mesh-ancestor
64896325|NCT03556202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64896326|NCT03556202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896327|NCT03556202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64896328|NCT03556202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64896329|NCT03556202|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64896330|NCT03556202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64896331|NCT03480438|Blinatumomab|blinatumomab|mesh-list
64896332|NCT03480438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896333|NCT03463876|Apatinib|apatinib|mesh-list
64522150|NCT00223821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522151|NCT00223821|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64522152|NCT00223821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64522153|NCT00223821|Cholinergic Agents|cholinergic agents|mesh-ancestor
64896391|NCT03329508|Antioxidants|antioxidants|mesh-ancestor
64896392|NCT03329508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896393|NCT03329508|Protective Agents|protective agents|mesh-ancestor
64896394|NCT03329508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896395|NCT03329508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64896396|NCT03329508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64896427|NCT03289039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896428|NCT03281304|Tofacitinib|tofacitinib|mesh-list
64896429|NCT03281304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64522162|NCT00359164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64522164|NCT00359164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522165|NCT00359164|Growth Inhibitors|growth inhibitors|mesh-ancestor
64522166|NCT00359164|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64522167|NCT00359164|Dermatologic Agents|dermatologic agents|mesh-ancestor
64522168|NCT00224289|Latanoprost|latanoprost|mesh-list
64522169|NCT00224289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64522170|NCT00224289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64522171|NCT05117476|Pembrolizumab|pembrolizumab|mesh-list
64522172|NCT05117476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64522173|NCT05117476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522174|NCT00045435|Cyclosporine|cyclosporine|mesh-list
64522175|NCT00045435|Mycophenolic Acid|mycophenolic acid|mesh-list
64522176|NCT00045435|Fludarabine|fludarabine|mesh-list
64522177|NCT00045435|Fludarabine phosphate|fludarabine phosphate|mesh-list
64522178|NCT00045435|Cyclosporins|cyclosporins|mesh-list
64522179|NCT00045435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522180|NCT00045435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64522181|NCT00045435|Antimetabolites|antimetabolites|mesh-ancestor
64522182|NCT00045435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522183|NCT00045435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64522184|NCT00045435|Immunologic Factors|immunologic factors|mesh-ancestor
64522185|NCT00045435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522186|NCT00045435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64896434|NCT03233711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896435|NCT03233711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64896436|NCT03233711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896437|NCT03153319|Adalimumab|adalimumab|mesh-list
64896438|NCT03153319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64896439|NCT03153319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64896466|NCT02768701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64896468|NCT02726711|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
64896469|NCT02726711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64896470|NCT02726711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64896471|NCT02726711|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
64522193|NCT00045435|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64522194|NCT00045435|Antitubercular Agents|antitubercular agents|mesh-ancestor
64522195|NCT00045435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64522197|NCT00111657|Gout Suppressants|gout suppressants|mesh-ancestor
64522198|NCT00111657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64522199|NCT05292586|Beclomethasone|beclomethasone|mesh-list
64522200|NCT05292586|Formoterol Fumarate|formoterol fumarate|mesh-list
64522201|NCT05292586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64522202|NCT05292586|Autonomic Agents|autonomic agents|mesh-ancestor
64522203|NCT05292586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64522204|NCT05292586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896484|NCT02725060|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64522223|NCT02097303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64522224|NCT02097303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522225|NCT02097303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64522226|NCT02097303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522227|NCT02097303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64522228|NCT02097303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522229|NCT02097303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522230|NCT02097303|Hormone Antagonists|hormone antagonists|mesh-ancestor
64522231|NCT02097303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64522233|NCT00703326|Ramucirumab|ramucirumab|mesh-list
64522234|NCT00703326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522235|NCT00703326|Tubulin Modulators|tubulin modulators|mesh-ancestor
64647960|NCT01214057|Anesthetics, General|anesthetics, general|mesh-ancestor
64647961|NCT01214057|Anesthetics|anesthetics|mesh-ancestor
64647962|NCT01214057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64647963|NCT01214057|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64647964|NCT01214057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64647965|NCT01214057|Narcotics|narcotics|mesh-ancestor
64647966|NCT01214057|Analgesics|analgesics|mesh-ancestor
64647967|NCT01214057|Sensory System Agents|sensory system agents|mesh-ancestor
64647968|NCT01214057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64647969|NCT03809546|Dronabinol|dronabinol|mesh-list
64647970|NCT03809546|Hallucinogens|hallucinogens|mesh-ancestor
64896485|NCT02725060|Mydriatics|mydriatics|mesh-ancestor
64896486|NCT02725060|Autonomic Agents|autonomic agents|mesh-ancestor
64896487|NCT02725060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64896488|NCT02725060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896520|NCT02649998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896521|NCT02649998|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64896542|NCT02432963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665059|NCT05454345|Rifampin|rifampin|mesh-list
64896544|NCT02358538|Neurosteroids|neurosteroids|mesh-ancestor
64896545|NCT02358538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64896546|NCT02358538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896547|NCT02358538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896548|NCT02358538|GABA Modulators|gaba modulators|mesh-ancestor
64896549|NCT02358538|GABA Agents|gaba agents|mesh-ancestor
64896550|NCT02349906|Treosulfan|treosulfan|mesh-list
64896551|NCT02349906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64896552|NCT02349906|Alkylating Agents|alkylating agents|mesh-ancestor
64896553|NCT02349906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896554|NCT02349906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896555|NCT02336087|Metformin|metformin|mesh-list
64896556|NCT02336087|Gemcitabine|gemcitabine|mesh-list
64896557|NCT02336087|Paclitaxel|paclitaxel|mesh-list
64896558|NCT02336087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64896559|NCT02336087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64896582|NCT02197234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64896583|NCT02197234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64896584|NCT02197234|Antimetabolites|antimetabolites|mesh-ancestor
64896585|NCT02197234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896586|NCT02197234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64896587|NCT02197234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64896588|NCT02197234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64896589|NCT02197234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896590|NCT02197234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64896591|NCT02157883|Itraconazole|itraconazole|mesh-list
64896592|NCT02157883|Osimertinib|osimertinib|mesh-list
64896593|NCT02157883|Antifungal Agents|antifungal agents|mesh-ancestor
64896594|NCT02157883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64896595|NCT02157883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64896596|NCT02157883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64896597|NCT02157883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64896598|NCT02157883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896628|NCT02048150|Antibodies|antibodies|mesh-list
64896668|NCT01476839|Cytarabine|cytarabine|mesh-list
64896681|NCT01476839|Antimetabolites|antimetabolites|mesh-ancestor
64896682|NCT01476839|Antiviral Agents|antiviral agents|mesh-ancestor
64896683|NCT01476839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64896684|NCT01476839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64896685|NCT01476839|Immunologic Factors|immunologic factors|mesh-ancestor
64896686|NCT01476839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896687|NCT01476839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64896688|NCT01476839|Alkylating Agents|alkylating agents|mesh-ancestor
64896689|NCT01476839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64896690|NCT01332097|Prednisone|prednisone|mesh-list
64896691|NCT01332097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64896692|NCT01332097|Glucocorticoids|glucocorticoids|mesh-ancestor
64896693|NCT01332097|Hormones|hormones|mesh-ancestor
64896694|NCT01332097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64896695|NCT01332097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896696|NCT01332097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64896697|NCT01332097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896699|NCT01163357|Fludarabine|fludarabine|mesh-list
64896700|NCT01163357|Fludarabine phosphate|fludarabine phosphate|mesh-list
64896701|NCT01163357|Bortezomib|bortezomib|mesh-list
64896726|NCT00976963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64896727|NCT00976963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64896728|NCT00967005|Acetylcysteine|acetylcysteine|mesh-list
64896729|NCT00967005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64896730|NCT00967005|Antiviral Agents|antiviral agents|mesh-ancestor
64896731|NCT00967005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64896732|NCT00967005|Expectorants|expectorants|mesh-ancestor
64896733|NCT00967005|Respiratory System Agents|respiratory system agents|mesh-ancestor
64896734|NCT00967005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64896735|NCT00967005|Antioxidants|antioxidants|mesh-ancestor
64896736|NCT00967005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896737|NCT00967005|Protective Agents|protective agents|mesh-ancestor
64896738|NCT00967005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522282|NCT00047697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522283|NCT00047697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522284|NCT00047697|Cholinergic Agents|cholinergic agents|mesh-ancestor
64522285|NCT00047697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64522286|NCT00047697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896744|NCT00863369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896745|NCT00863369|Immunologic Factors|immunologic factors|mesh-ancestor
64896746|NCT00863369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896747|NCT00863369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64896748|NCT00863369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64896749|NCT00863369|Antimetabolites|antimetabolites|mesh-ancestor
64896750|NCT00863369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896751|NCT00863369|Antiviral Agents|antiviral agents|mesh-ancestor
64896752|NCT00863369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64896777|NCT00538031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64896778|NCT00538031|Immunologic Factors|immunologic factors|mesh-ancestor
64896779|NCT00538031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896780|NCT00538031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64896781|NCT00538031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64896782|NCT00538031|Alkylating Agents|alkylating agents|mesh-ancestor
64896783|NCT00538031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896784|NCT00538031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896785|NCT00538031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64896786|NCT00538031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64896787|NCT00538031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64896788|NCT00538031|Analgesics|analgesics|mesh-ancestor
64896789|NCT00538031|Sensory System Agents|sensory system agents|mesh-ancestor
64896824|NCT02009280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64896825|NCT02009280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64896826|NCT02009306|Fentanyl|fentanyl|mesh-list
64896827|NCT02009306|Midazolam|midazolam|mesh-list
64896828|NCT02009306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64896829|NCT02009306|Narcotics|narcotics|mesh-ancestor
64896830|NCT02009306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64896831|NCT02009306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896832|NCT02009306|Analgesics|analgesics|mesh-ancestor
64896833|NCT02009306|Sensory System Agents|sensory system agents|mesh-ancestor
64522287|NCT00047697|Nootropic Agents|nootropic agents|mesh-ancestor
64522288|NCT05094154|Penicillins|penicillins|mesh-list
64522289|NCT05094154|Cephalosporins|cephalosporins|mesh-list
64522290|NCT05094154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64522291|NCT05094154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64522306|NCT02437812|Metformin|metformin|mesh-list
64522307|NCT02437812|Paclitaxel|paclitaxel|mesh-list
64522308|NCT02437812|Carboplatin|carboplatin|mesh-list
64896834|NCT02009306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64896835|NCT02009306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64896836|NCT02009306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64896837|NCT02009306|Anesthetics, General|anesthetics, general|mesh-ancestor
64896838|NCT02009306|Anesthetics|anesthetics|mesh-ancestor
64896839|NCT02009306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64896840|NCT02009306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64896841|NCT02009306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64896842|NCT02009306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64896843|NCT02009306|GABA Modulators|gaba modulators|mesh-ancestor
64896844|NCT02009306|GABA Agents|gaba agents|mesh-ancestor
64896845|NCT02009306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64896846|NCT02009306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896847|NCT02009410|Pancrelipase|pancrelipase|mesh-list
64896849|NCT02009410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64896850|NCT02009436|Azacitidine|azacitidine|mesh-list
64896851|NCT02009436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64896852|NCT02009436|Antimetabolites|antimetabolites|mesh-ancestor
64896853|NCT02009436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896860|NCT02009462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896861|NCT02009488|Canagliflozin|canagliflozin|mesh-list
64896862|NCT02009488|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64896863|NCT02009488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896864|NCT02009488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64896881|NCT02009592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64896882|NCT02009592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64896883|NCT02009592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64896884|NCT02009618|Rifaximin|rifaximin|mesh-list
64896885|NCT02009618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64896886|NCT02009618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64896887|NCT02009618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64896888|NCT02009631|Veliparib|veliparib|mesh-list
64896889|NCT02009631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64896890|NCT02009631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64896891|NCT02009631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896892|NCT02009631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896893|NCT02009709|Riboflavin|riboflavin|mesh-list
64522328|NCT00112593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522329|NCT00112593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522330|NCT00112593|Antifungal Agents|antifungal agents|mesh-ancestor
64522331|NCT00112593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64522332|NCT00112593|Dermatologic Agents|dermatologic agents|mesh-ancestor
64522333|NCT00112593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64522334|NCT00112593|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64522335|NCT00112593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64896914|NCT02009943|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64896915|NCT02009943|Hematinics|hematinics|mesh-ancestor
64896916|NCT02010164|Coenzyme Q10|coenzyme q10|mesh-list
64896917|NCT02010164|Ubiquinone|ubiquinone|mesh-list
64896918|NCT02010164|Vitamins|vitamins|mesh-ancestor
64896919|NCT02010164|Micronutrients|micronutrients|mesh-ancestor
64896920|NCT02010164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896921|NCT02010411|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64896922|NCT02010411|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64896923|NCT02010411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64896924|NCT02010411|Protease Inhibitors|protease inhibitors|mesh-ancestor
64896949|NCT02010827|Glucagon|glucagon|mesh-list
64896960|NCT02010944|Solifenacin Succinate|solifenacin succinate|mesh-list
64896961|NCT02010944|Mirabegron|mirabegron|mesh-list
64896962|NCT02010944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64896963|NCT02010944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64896964|NCT02010944|Cholinergic Agents|cholinergic agents|mesh-ancestor
64896965|NCT02010944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64896966|NCT02010944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896967|NCT02010944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896968|NCT02010944|Urological Agents|urological agents|mesh-ancestor
64896969|NCT02010944|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64896970|NCT02010944|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64896971|NCT02010944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64896972|NCT02010944|Adrenergic Agents|adrenergic agents|mesh-ancestor
64896973|NCT02010957|Etomidate|etomidate|mesh-list
64896974|NCT02010957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64896975|NCT02010957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64896976|NCT02010957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896977|NCT02010957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64896978|NCT02010957|Anesthetics, General|anesthetics, general|mesh-ancestor
64897054|NCT02011633|Antimetabolites|antimetabolites|mesh-ancestor
64897055|NCT02011633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897056|NCT02011633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64897057|NCT02011633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64897058|NCT02011633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897059|NCT02011659|Ramosetron|ramosetron|mesh-list
64897060|NCT02011659|Antiemetics|antiemetics|mesh-ancestor
64897061|NCT02011659|Autonomic Agents|autonomic agents|mesh-ancestor
64897062|NCT02011659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64897063|NCT02011659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648178|NCT01250717|Androgen Antagonists|androgen antagonists|mesh-ancestor
64897064|NCT02011659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64897065|NCT02011659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64897066|NCT02011659|Serotonin Agents|serotonin agents|mesh-ancestor
64897067|NCT02011659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64897068|NCT02011659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897069|NCT02011737|Naftopidil|naftopidil|mesh-list
64897070|NCT02011737|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64897071|NCT02011737|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64665581|NCT02346240|Analgesics|analgesics|mesh-ancestor
64897108|NCT02011841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64897109|NCT02011841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64897110|NCT02011841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64897111|NCT02011880|Corylifolin|corylifolin|mesh-list
64897112|NCT02011880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64897113|NCT02011880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897114|NCT02011880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897115|NCT02011880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64897116|NCT02011880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64897117|NCT02011880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897118|NCT02011906|Vitamins|vitamins|mesh-list
64897119|NCT02011906|Vitamin E|vitamin e|mesh-list
64897120|NCT02011906|Tocopherols|tocopherols|mesh-list
64897121|NCT02011906|Tocotrienols|tocotrienols|mesh-list
64897122|NCT02011906|alpha-Tocopherol|alpha-tocopherol|mesh-list
64897123|NCT02011906|Micronutrients|micronutrients|mesh-ancestor
64897124|NCT02011906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897125|NCT02011906|Antioxidants|antioxidants|mesh-ancestor
64897126|NCT02011906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897127|NCT02011906|Protective Agents|protective agents|mesh-ancestor
64897128|NCT02011958|Amphotericin B|amphotericin b|mesh-list
64897129|NCT02011958|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64897130|NCT02011958|Miltefosine|miltefosine|mesh-list
64897131|NCT02011958|Amebicides|amebicides|mesh-ancestor
64897132|NCT02011958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64648223|NCT00782756|Alkylating Agents|alkylating agents|mesh-ancestor
64522407|NCT02429466|Azacitidine|azacitidine|mesh-list
64522408|NCT02429466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522409|NCT02429466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64522410|NCT02429466|Antimetabolites|antimetabolites|mesh-ancestor
64897174|NCT02012075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64897175|NCT02012075|Vasodilator Agents|vasodilator agents|mesh-ancestor
64897176|NCT02012075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64897177|NCT02012075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64897178|NCT02012088|Prednisone|prednisone|mesh-list
64897180|NCT02012088|Rituximab|rituximab|mesh-list
64522439|NCT02437032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64522440|NCT02437032|Fertility Agents|fertility agents|mesh-ancestor
64522441|NCT02437032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64522442|NCT02437032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522443|NCT05232994|Metformin|metformin|mesh-list
64897217|NCT02012166|Octreotide|octreotide|mesh-list
64897218|NCT02012166|Glucagon|glucagon|mesh-list
64897219|NCT02012166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64897220|NCT02012166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897221|NCT02012166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64897222|NCT02012166|Hormones|hormones|mesh-ancestor
64897223|NCT02012166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64522446|NCT05232994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522447|NCT05232994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64522448|NCT05232994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64522449|NCT05232994|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64522450|NCT05232994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897224|NCT02012166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64897225|NCT02012166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897226|NCT02012244|Fentanyl|fentanyl|mesh-list
64897227|NCT02012244|Anesthetics|anesthetics|mesh-list
64897228|NCT02012244|Anesthetics, Local|anesthetics, local|mesh-list
64897229|NCT02012244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64897230|NCT02012244|Narcotics|narcotics|mesh-ancestor
64897231|NCT02012244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64897232|NCT02012244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897233|NCT02012244|Analgesics|analgesics|mesh-ancestor
64897234|NCT02012244|Sensory System Agents|sensory system agents|mesh-ancestor
64897235|NCT02012244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64897236|NCT02012244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64897237|NCT02012244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64897238|NCT02012244|Anesthetics, General|anesthetics, general|mesh-ancestor
64897262|NCT02012387|Vaccines|vaccines|mesh-list
64897263|NCT02012387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64897264|NCT02012387|Immunologic Factors|immunologic factors|mesh-ancestor
64897265|NCT02012387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897266|NCT02012387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64897267|NCT02012387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64897268|NCT02012387|Respiratory System Agents|respiratory system agents|mesh-ancestor
64897269|NCT02012465|Insulin|insulin|mesh-list
64897270|NCT02012465|Insulin Glargine|insulin glargine|mesh-list
64897271|NCT02012465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64897272|NCT02012465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897273|NCT02012517|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64897274|NCT02012517|Cefazolin|cefazolin|mesh-list
64897275|NCT02012517|Cephalexin|cephalexin|mesh-list
64897276|NCT02012517|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64897277|NCT02012517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64897278|NCT02012517|Antitubercular Agents|antitubercular agents|mesh-ancestor
64897279|NCT02012556|Tesamorelin|tesamorelin|mesh-list
64897280|NCT02012556|Growth Substances|growth substances|mesh-ancestor
64897281|NCT02012556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897282|NCT02012569|Hemostatics|hemostatics|mesh-list
64897283|NCT02012569|Coagulants|coagulants|mesh-ancestor
64897284|NCT02012595|Donepezil|donepezil|mesh-list
64897285|NCT02012595|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64897286|NCT02012595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897287|NCT02012595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897288|NCT02012595|Cholinergic Agents|cholinergic agents|mesh-ancestor
64897289|NCT02012595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64897290|NCT02012595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897291|NCT02012595|Nootropic Agents|nootropic agents|mesh-ancestor
64897300|NCT02012777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64897301|NCT02012777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897302|NCT02012777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897303|NCT02012777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64897304|NCT02012777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64897305|NCT02012777|Vasodilator Agents|vasodilator agents|mesh-ancestor
64897317|NCT02012933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897319|NCT02012946|Dobutamine|dobutamine|mesh-list
64897320|NCT02012946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64897321|NCT02012946|Vasodilator Agents|vasodilator agents|mesh-ancestor
64897322|NCT02012946|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64897323|NCT02012946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64897324|NCT02012946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897325|NCT02012946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897326|NCT02012946|Protective Agents|protective agents|mesh-ancestor
64897327|NCT02012946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897328|NCT02012946|Sympathomimetics|sympathomimetics|mesh-ancestor
64897329|NCT02012946|Autonomic Agents|autonomic agents|mesh-ancestor
64897330|NCT02012946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64897331|NCT02012946|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64897332|NCT02012946|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64897333|NCT02012946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64897334|NCT02012946|Adrenergic Agents|adrenergic agents|mesh-ancestor
64897335|NCT02012946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64897336|NCT02012998|Vaccines|vaccines|mesh-list
64897337|NCT02012998|Immunologic Factors|immunologic factors|mesh-ancestor
64897360|NCT02013102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897361|NCT02013102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522462|NCT02436798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64522463|NCT02436798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522464|NCT02436798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64522465|NCT02436798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64522466|NCT02436798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64522467|NCT02436798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64522468|NCT02436798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64522469|NCT03185130|Diphenhydramine|diphenhydramine|mesh-list
64522470|NCT03185130|Promethazine|promethazine|mesh-list
64522471|NCT03185130|Prochlorperazine|prochlorperazine|mesh-list
64522472|NCT03185130|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64522473|NCT03185130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64522474|NCT03185130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64522475|NCT03185130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522476|NCT03185130|Anesthetics, Local|anesthetics, local|mesh-ancestor
64522477|NCT03185130|Anesthetics|anesthetics|mesh-ancestor
64522478|NCT03185130|Sensory System Agents|sensory system agents|mesh-ancestor
64522480|NCT03185130|Antiemetics|antiemetics|mesh-ancestor
64897366|NCT02013115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64897385|NCT02013219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64897386|NCT02013219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897387|NCT02013219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897388|NCT02013232|Aripiprazole|aripiprazole|mesh-list
64897389|NCT02013232|Antidepressive Agents|antidepressive agents|mesh-ancestor
64897390|NCT02013232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64897391|NCT02013232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64897392|NCT02013232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64897393|NCT02013232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64897394|NCT02013232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897395|NCT02013232|Dopamine Agonists|dopamine agonists|mesh-ancestor
64897396|NCT02013232|Dopamine Agents|dopamine agents|mesh-ancestor
64897397|NCT02013232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64897398|NCT02013232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897399|NCT02013232|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64897400|NCT02013232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64522524|NCT00358696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64522525|NCT00358696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64522526|NCT05050942|Octreotide|octreotide|mesh-list
64522527|NCT05050942|Lanreotide|lanreotide|mesh-list
64897439|NCT02013453|Immunologic Factors|immunologic factors|mesh-ancestor
64897440|NCT02013453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897441|NCT02013453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897442|NCT02013453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64897443|NCT02013453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64897444|NCT02013453|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64897445|NCT02013453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64897446|NCT02013453|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64897447|NCT02013570|Dexmedetomidine|dexmedetomidine|mesh-list
64897448|NCT02013570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64897449|NCT02013570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64897450|NCT02013570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897451|NCT02013570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64897453|NCT02013570|Sensory System Agents|sensory system agents|mesh-ancestor
64897454|NCT02013570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64897455|NCT02013570|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64522538|NCT00360178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64522539|NCT00360178|Candesartan|candesartan|mesh-list
64522540|NCT00360178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64522541|NCT00360178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64522542|NCT00360178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64897482|NCT02013986|Propofol|propofol|mesh-list
64897483|NCT02013986|Etomidate|etomidate|mesh-list
64897484|NCT02013986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64897485|NCT02013986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64897486|NCT02013986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897497|NCT02013986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522552|NCT00421720|Sufentanil|sufentanil|mesh-list
64522557|NCT00421720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522558|NCT00421720|Analgesics|analgesics|mesh-ancestor
64522559|NCT00421720|Sensory System Agents|sensory system agents|mesh-ancestor
64522560|NCT00421720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64522561|NCT00421720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64522562|NCT00421720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64522563|NCT00421720|Anesthetics, General|anesthetics, general|mesh-ancestor
64522564|NCT00421720|Anesthetics|anesthetics|mesh-ancestor
64522565|NCT05383456|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64522566|NCT05383456|Antiviral Agents|antiviral agents|mesh-ancestor
64522567|NCT05383456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64522568|NCT05008276|Dextrans|dextrans|mesh-list
64522569|NCT05008276|Anticoagulants|anticoagulants|mesh-ancestor
64360277|NCT05638399|Denosumab|denosumab|mesh-list
64897533|NCT02014428|Viscosupplements|viscosupplements|mesh-ancestor
64897534|NCT02014428|Protective Agents|protective agents|mesh-ancestor
64897536|NCT02014454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64897537|NCT02014454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64522596|NCT04469842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522597|NCT04469842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64522598|NCT04469842|Immunologic Factors|immunologic factors|mesh-ancestor
64522599|NCT04469842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64897587|NCT02014558|Anesthetics|anesthetics|mesh-ancestor
64897588|NCT02014558|GABA Modulators|gaba modulators|mesh-ancestor
64897589|NCT02014558|GABA Agents|gaba agents|mesh-ancestor
64897590|NCT02014558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64897591|NCT02014558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897592|NCT02014558|Antifungal Agents|antifungal agents|mesh-ancestor
64897621|NCT02014714|Anesthetics, General|anesthetics, general|mesh-ancestor
64897623|NCT02014727|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64897624|NCT02014727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64897625|NCT02014727|Immunologic Factors|immunologic factors|mesh-ancestor
64897626|NCT02014727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897627|NCT02014727|Antacids|antacids|mesh-ancestor
64897628|NCT02014727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897629|NCT02014727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64897630|NCT02014753|Cobalt|cobalt|mesh-list
64897631|NCT02014753|Chromium|chromium|mesh-list
64897632|NCT02014753|Everolimus|everolimus|mesh-list
64522600|NCT04469842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522601|NCT04469842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522602|NCT04469842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64522607|NCT04469842|Antimetabolites|antimetabolites|mesh-ancestor
64897679|NCT02015299|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64897680|NCT02015299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64897692|NCT02015312|Diuretics|diuretics|mesh-ancestor
64897693|NCT02015312|Natriuretic Agents|natriuretic agents|mesh-ancestor
64897694|NCT02015312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897695|NCT02015312|Trace Elements|trace elements|mesh-ancestor
64897696|NCT02015312|Micronutrients|micronutrients|mesh-ancestor
64897697|NCT02015312|Antioxidants|antioxidants|mesh-ancestor
64897698|NCT02015312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897699|NCT02015312|Protective Agents|protective agents|mesh-ancestor
64897700|NCT02015312|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64897701|NCT02015312|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64897702|NCT02015312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897703|NCT02015312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64897704|NCT02015403|Acetylcysteine|acetylcysteine|mesh-list
64897705|NCT02015403|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64897706|NCT02015403|Antiviral Agents|antiviral agents|mesh-ancestor
64897707|NCT02015403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64897708|NCT02015403|Expectorants|expectorants|mesh-ancestor
64897709|NCT02015403|Respiratory System Agents|respiratory system agents|mesh-ancestor
64897710|NCT02015403|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64897711|NCT02015403|Antioxidants|antioxidants|mesh-ancestor
64897712|NCT02015403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897713|NCT02015403|Protective Agents|protective agents|mesh-ancestor
64897714|NCT02015403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897715|NCT02015403|Antidotes|antidotes|mesh-ancestor
64897716|NCT02015494|Hemagglutinins|hemagglutinins|mesh-list
64897717|NCT02015494|Immunologic Factors|immunologic factors|mesh-ancestor
64897718|NCT02015494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897719|NCT02015494|Agglutinins|agglutinins|mesh-ancestor
64897720|NCT02015507|Ciprofloxacin|ciprofloxacin|mesh-list
64648456|NCT00794144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64522633|NCT04394416|Imatinib Mesylate|imatinib mesylate|mesh-list
64522634|NCT04394416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522635|NCT04394416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64522636|NCT04394416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522637|NCT04394416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522638|NCT04887298|Annamycin|annamycin|mesh-list
64522639|NCT04887298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64897721|NCT02015507|Ivacaftor|ivacaftor|mesh-list
64897722|NCT02015507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64897723|NCT02015507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64897724|NCT02015507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64897725|NCT02015507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64897726|NCT02015507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897727|NCT02015507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897728|NCT02015507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897729|NCT02015507|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64897730|NCT02015507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64897731|NCT02015507|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64897732|NCT02015507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64897733|NCT02015559|Protective Agents|protective agents|mesh-list
64897757|NCT02015728|Everolimus|everolimus|mesh-list
64897758|NCT02015728|Temozolomide|temozolomide|mesh-list
64897759|NCT02015728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64897760|NCT02015728|Sorafenib|sorafenib|mesh-list
64897761|NCT02015728|Dasatinib|dasatinib|mesh-list
64648478|NCT01309451|Glucocorticoids|glucocorticoids|mesh-ancestor
64897762|NCT02015728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64897763|NCT02015728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897764|NCT02015728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64897765|NCT02015728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64897807|NCT02016157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897808|NCT02016157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897809|NCT02016196|Rifaximin|rifaximin|mesh-list
64897810|NCT02016196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64897811|NCT02016196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64897812|NCT02016196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64897813|NCT02016209|Paclitaxel|paclitaxel|mesh-list
64897826|NCT02016261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64897827|NCT02016261|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64897828|NCT02016261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64897829|NCT02016261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64897830|NCT02016261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897831|NCT02016261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64897832|NCT02016261|Serotonin Agents|serotonin agents|mesh-ancestor
64897833|NCT02016261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64897834|NCT02016261|Antidepressive Agents|antidepressive agents|mesh-ancestor
64897835|NCT02016261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64897836|NCT02016261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64897862|NCT02016365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64897863|NCT02016391|Dexmedetomidine|dexmedetomidine|mesh-list
64897864|NCT02016391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64897865|NCT02016391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64897866|NCT02016391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897867|NCT02016391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64897868|NCT02016391|Analgesics|analgesics|mesh-ancestor
64897869|NCT02016391|Sensory System Agents|sensory system agents|mesh-ancestor
64897870|NCT02016391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64897871|NCT02016391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64897872|NCT02016391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64897873|NCT02016391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64897874|NCT02016391|Adrenergic Agents|adrenergic agents|mesh-ancestor
64897898|NCT02016443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897900|NCT02016443|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64897901|NCT02016443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64897902|NCT02016443|Parasympatholytics|parasympatholytics|mesh-ancestor
64897903|NCT02016443|Autonomic Agents|autonomic agents|mesh-ancestor
64897904|NCT02016443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64897905|NCT02016443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64897906|NCT02016443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64897907|NCT02016443|Adrenergic Agents|adrenergic agents|mesh-ancestor
64897908|NCT02016443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64897909|NCT02016443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522696|NCT00226239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64522697|NCT00227019|Vitamins|vitamins|mesh-list
64522698|NCT00227019|Folic Acid|folic acid|mesh-list
64522699|NCT00227019|Vitamin B 12|vitamin b 12|mesh-list
64522700|NCT00227019|Vitamin B Complex|vitamin b complex|mesh-list
64522701|NCT00227019|Dexamethasone|dexamethasone|mesh-list
64522702|NCT00227019|Bevacizumab|bevacizumab|mesh-list
64522703|NCT00227019|Pemetrexed|pemetrexed|mesh-list
64522704|NCT00227019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64522705|NCT00227019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522706|NCT00227019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64522707|NCT00227019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64897925|NCT02016664|Ketamine|ketamine|mesh-list
64898071|NCT02018055|Purinergic Agents|purinergic agents|mesh-ancestor
64898072|NCT02018055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64898073|NCT02018081|Levofloxacin|levofloxacin|mesh-list
64898074|NCT02018081|Ofloxacin|ofloxacin|mesh-list
64898075|NCT02018081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64898076|NCT02018081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64898077|NCT02018081|Renal Agents|renal agents|mesh-ancestor
64898078|NCT02018081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64898079|NCT02018081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64898142|NCT02018289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64898143|NCT02018289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64898144|NCT02018289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64898145|NCT02018289|Antimetabolites|antimetabolites|mesh-ancestor
64898146|NCT02018289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898147|NCT02018289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64898148|NCT02018328|Curcumin|curcumin|mesh-list
64898149|NCT02018328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64898150|NCT02018328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64898242|NCT02018874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64898243|NCT02018874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64898244|NCT02018874|Immunologic Factors|immunologic factors|mesh-ancestor
64898245|NCT02018874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898246|NCT02018965|Vitamins|vitamins|mesh-list
64898247|NCT02018965|Niacin|niacin|mesh-list
64898248|NCT02018965|Niacinamide|niacinamide|mesh-list
64898258|NCT02018991|Everolimus|everolimus|mesh-list
64898381|NCT02019524|Sargramostim|sargramostim|mesh-list
64898382|NCT02019524|Immunologic Factors|immunologic factors|mesh-ancestor
64898383|NCT02019524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898384|NCT02019524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898385|NCT02019524|Hematinics|hematinics|mesh-ancestor
64898386|NCT02019524|Vitamins|vitamins|mesh-ancestor
64898387|NCT02019524|Micronutrients|micronutrients|mesh-ancestor
64898388|NCT02019784|Rifaximin|rifaximin|mesh-list
64898389|NCT02019784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64898390|NCT02019784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64898391|NCT02019784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64898392|NCT02019797|Desflurane|desflurane|mesh-list
64898393|NCT02019797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64898394|NCT02019797|Anesthetics, General|anesthetics, general|mesh-ancestor
64898395|NCT02019797|Anesthetics|anesthetics|mesh-ancestor
64898396|NCT02019797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64898397|NCT02019797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898398|NCT02019810|Dobutamine|dobutamine|mesh-list
64898399|NCT02019810|Norepinephrine|norepinephrine|mesh-list
64898400|NCT02019810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64898401|NCT02019810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64522761|NCT04276792|Sensory System Agents|sensory system agents|mesh-ancestor
64522762|NCT04276792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64522763|NCT00053703|Olanzapine|olanzapine|mesh-list
64522764|NCT00053703|Risperidone|risperidone|mesh-list
64522765|NCT00053703|Molindone|molindone|mesh-list
64522766|NCT00053703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64522767|NCT00053703|Serotonin Agents|serotonin agents|mesh-ancestor
64522768|NCT00053703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64522769|NCT00053703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522770|NCT00053703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898402|NCT02019810|Adrenergic Agents|adrenergic agents|mesh-ancestor
64898403|NCT02019810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64898404|NCT02019810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898405|NCT02019810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898415|NCT02019836|Vitamins|vitamins|mesh-ancestor
64898416|NCT02019836|Micronutrients|micronutrients|mesh-ancestor
64898417|NCT02019836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898418|NCT02019836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64898419|NCT02020005|Nicotine|nicotine|mesh-list
64898420|NCT02020005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64898421|NCT02020005|Autonomic Agents|autonomic agents|mesh-ancestor
64898422|NCT02020005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898423|NCT02020005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898424|NCT02020005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64898425|NCT02020005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64898441|NCT02020122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64898442|NCT02020122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64898443|NCT02020122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64898444|NCT02020122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64898445|NCT02020122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64898446|NCT02020122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64898447|NCT02020122|Antidepressive Agents|antidepressive agents|mesh-ancestor
64898448|NCT02020122|Dopamine Agents|dopamine agents|mesh-ancestor
64898450|NCT02020161|Idarubicin|idarubicin|mesh-list
64898451|NCT02020161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64898452|NCT02020161|Abortifacient Agents|abortifacient agents|mesh-ancestor
64898453|NCT02020161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64898454|NCT02020161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898455|NCT02020161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64898456|NCT02020161|Antimetabolites|antimetabolites|mesh-ancestor
64898458|NCT02020161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522778|NCT00053703|Autonomic Agents|autonomic agents|mesh-ancestor
64522779|NCT00053703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64522780|NCT00053703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64478883|NCT03597867|Nepafenac|nepafenac|mesh-list
64522781|NCT00053703|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64522782|NCT00053703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64522783|NCT00053703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64522784|NCT02975440|Rifampin|rifampin|mesh-list
64522785|NCT02975440|Midazolam|midazolam|mesh-list
64522786|NCT02975440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64522787|NCT02975440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64522788|NCT02975440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64522789|NCT02975440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898560|NCT02021097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898561|NCT02021097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64898562|NCT02021097|Contraceptive Agents|contraceptive agents|mesh-ancestor
64898563|NCT02021097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64898564|NCT02021097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64898565|NCT02021097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64898566|NCT02021097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64898567|NCT02021097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64898568|NCT02021110|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64898569|NCT02021110|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64898598|NCT02021240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64898600|NCT02021240|Autonomic Agents|autonomic agents|mesh-ancestor
64898601|NCT02021240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898602|NCT02021240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898603|NCT02021240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64898604|NCT02021240|Glucocorticoids|glucocorticoids|mesh-ancestor
64898605|NCT02021240|Hormones|hormones|mesh-ancestor
64898606|NCT02021240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64898607|NCT02021240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64522820|NCT04267120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522821|NCT04267120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64522822|NCT04267120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522823|NCT04267120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522824|NCT04265872|Pembrolizumab|pembrolizumab|mesh-list
64522825|NCT04265872|Bortezomib|bortezomib|mesh-list
64898650|NCT02021825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64898651|NCT02021825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898652|NCT02021851|Dexamethasone|dexamethasone|mesh-list
64898653|NCT02021851|Dexamethasone acetate|dexamethasone acetate|mesh-list
64898654|NCT02021851|Ondansetron|ondansetron|mesh-list
64898655|NCT02021851|Aprepitant|aprepitant|mesh-list
64898656|NCT02021851|BB 1101|bb 1101|mesh-list
64898657|NCT02021851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64898658|NCT02021851|Antiemetics|antiemetics|mesh-ancestor
64898659|NCT02021851|Autonomic Agents|autonomic agents|mesh-ancestor
64898660|NCT02021851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898662|NCT02021851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64898711|NCT02022241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64898712|NCT02022241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898713|NCT02022241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64898714|NCT02022241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64898715|NCT02022241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898716|NCT02022254|Metformin|metformin|mesh-list
64898717|NCT02022254|Warfarin|warfarin|mesh-list
64898718|NCT02022254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64898719|NCT02022254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898720|NCT02022254|Anticoagulants|anticoagulants|mesh-ancestor
64898721|NCT02022293|Atorvastatin|atorvastatin|mesh-list
64898742|NCT02022358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64898743|NCT02022358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64898744|NCT02022358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64898745|NCT02022358|Immunologic Factors|immunologic factors|mesh-ancestor
64898746|NCT02022358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64898747|NCT02022358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64898748|NCT02022358|Antidotes|antidotes|mesh-ancestor
64898749|NCT02022358|Protective Agents|protective agents|mesh-ancestor
64898750|NCT02022358|Vitamin B Complex|vitamin b complex|mesh-ancestor
64898751|NCT02022358|Vitamins|vitamins|mesh-ancestor
64898752|NCT02022358|Micronutrients|micronutrients|mesh-ancestor
64898753|NCT02022358|Hematinics|hematinics|mesh-ancestor
64898754|NCT02022475|Vitamin D|vitamin d|mesh-list
64898755|NCT02022475|Cholecalciferol|cholecalciferol|mesh-list
64898756|NCT02022475|Vitamins|vitamins|mesh-ancestor
64898757|NCT02022475|Micronutrients|micronutrients|mesh-ancestor
64522849|NCT00233103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64522850|NCT00233103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522851|NCT00233103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64522852|NCT00233103|Serotonin Agents|serotonin agents|mesh-ancestor
64522853|NCT00233103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522854|NCT00703014|Progesterone|progesterone|mesh-list
64714097|NCT03054103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64648703|NCT03801746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64522855|NCT00703014|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64522856|NCT00703014|Ganirelix|ganirelix|mesh-list
64522857|NCT00703014|Progestins|progestins|mesh-ancestor
64522858|NCT00703014|Hormones|hormones|mesh-ancestor
64522859|NCT00703014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64522860|NCT00703014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522861|NCT00703014|Hormone Antagonists|hormone antagonists|mesh-ancestor
64522862|NCT02433522|Rituximab|rituximab|mesh-list
64522863|NCT02433522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64898776|NCT02022488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898801|NCT02022527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64898802|NCT02022527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64898803|NCT02022527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522868|NCT00118131|Docetaxel|docetaxel|mesh-list
64522874|NCT02433912|Acetaminophen|acetaminophen|mesh-list
64522875|NCT02433912|Chlorhexidine|chlorhexidine|mesh-list
64522876|NCT02433912|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64522877|NCT02433912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64522878|NCT02433912|Analgesics|analgesics|mesh-ancestor
64522879|NCT02433912|Sensory System Agents|sensory system agents|mesh-ancestor
64522880|NCT02433912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64522881|NCT02433912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522882|NCT02433912|Antipyretics|antipyretics|mesh-ancestor
64522883|NCT02433912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64522884|NCT02433912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64522885|NCT02433912|Disinfectants|disinfectants|mesh-ancestor
64522886|NCT02433912|Dermatologic Agents|dermatologic agents|mesh-ancestor
64522887|NCT02436486|Moxifloxacin|moxifloxacin|mesh-list
64898827|NCT02022722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898828|NCT02022722|Sensory System Agents|sensory system agents|mesh-ancestor
64898829|NCT02022722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898830|NCT02022722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64898843|NCT02022852|Antimetabolites|antimetabolites|mesh-ancestor
64898844|NCT02022852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898845|NCT02022852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898847|NCT02022917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64898848|NCT02022917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898849|NCT02022917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64898850|NCT02022917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64898851|NCT02022917|Growth Substances|growth substances|mesh-ancestor
64898869|NCT02023021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64898870|NCT02023021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898871|NCT02023021|Tubulin Modulators|tubulin modulators|mesh-ancestor
64898872|NCT02023021|Antimitotic Agents|antimitotic agents|mesh-ancestor
64898873|NCT02023021|Mitosis Modulators|mitosis modulators|mesh-ancestor
64898874|NCT02023021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898875|NCT02023021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64898876|NCT02023021|Antimetabolites|antimetabolites|mesh-ancestor
64898877|NCT02023021|Antiviral Agents|antiviral agents|mesh-ancestor
64898878|NCT02023021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64898879|NCT02023021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64898880|NCT02023021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64898881|NCT02023021|Immunologic Factors|immunologic factors|mesh-ancestor
64898882|NCT02023021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898883|NCT02023047|Nifedipine|nifedipine|mesh-list
64898884|NCT02023047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64898885|NCT02023047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64898887|NCT02023047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64898933|NCT02023359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64898934|NCT02023359|Hormone Antagonists|hormone antagonists|mesh-ancestor
64522894|NCT02436486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522896|NCT04342858|Fluorides|fluorides|mesh-list
64522897|NCT04342858|Sodium Fluoride|sodium fluoride|mesh-list
64522898|NCT04342858|Fluorides, Topical|fluorides, topical|mesh-list
64522899|NCT04342858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522900|NCT04342858|Cariostatic Agents|cariostatic agents|mesh-ancestor
64522901|NCT04342858|Protective Agents|protective agents|mesh-ancestor
64898935|NCT02023359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64898936|NCT02023424|Glatiramer Acetate|glatiramer acetate|mesh-list
64898937|NCT02023424|(T,G)-A-L|(t,g)-a-l|mesh-list
64898938|NCT02023424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64898939|NCT02023424|Immunologic Factors|immunologic factors|mesh-ancestor
64898940|NCT02023424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898941|NCT02023424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64898942|NCT02023424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64898943|NCT02023450|Ritonavir|ritonavir|mesh-list
64898944|NCT02023450|Saquinavir|saquinavir|mesh-list
64898945|NCT02023450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64898946|NCT02023450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64898947|NCT02023450|Protease Inhibitors|protease inhibitors|mesh-ancestor
64898948|NCT02023450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64898949|NCT02023450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898950|NCT02023450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64898951|NCT02023450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64898952|NCT02023450|Antiviral Agents|antiviral agents|mesh-ancestor
64898953|NCT02023450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64898954|NCT02023450|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64898955|NCT02023450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64898956|NCT02023554|Azithromycin|azithromycin|mesh-list
64898957|NCT02023554|Theophylline|theophylline|mesh-list
64898986|NCT02023684|Anesthetics|anesthetics|mesh-ancestor
64898987|NCT02023684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64898988|NCT02023684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898996|NCT02023710|Paclitaxel|paclitaxel|mesh-list
64899054|NCT02024009|Immunologic Factors|immunologic factors|mesh-ancestor
64899055|NCT02024009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899056|NCT02024009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64899057|NCT02024009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64522925|NCT00255177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64522946|NCT00361114|Antimalarials|antimalarials|mesh-ancestor
64522947|NCT00361114|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64522948|NCT00361114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64522949|NCT00361114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64362238|NCT02476825|Xhance|xhance|mesh-list
64522968|NCT05442580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64522969|NCT05442580|Immunologic Factors|immunologic factors|mesh-ancestor
64522970|NCT05442580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522971|NCT05442580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64522972|NCT05442580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64522973|NCT05442580|Alkylating Agents|alkylating agents|mesh-ancestor
64899244|NCT02024984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64899245|NCT02024984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64899315|NCT02025361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64899338|NCT02025465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899340|NCT02025465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64899341|NCT02025465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64899342|NCT02025465|Vasodilator Agents|vasodilator agents|mesh-ancestor
64899343|NCT02025491|Amphotericin B|amphotericin b|mesh-list
64899344|NCT02025491|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64899345|NCT02025491|Amebicides|amebicides|mesh-ancestor
64899346|NCT02025491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64899412|NCT02025881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899413|NCT02025881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899414|NCT02025881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64899415|NCT02025881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64899416|NCT02025881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64899417|NCT02025881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64899419|NCT02025998|Ibudilast|ibudilast|mesh-list
64899546|NCT02026817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899547|NCT02026817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64899548|NCT02026817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64899549|NCT02026817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899550|NCT02026856|Selenious Acid|selenious acid|mesh-list
64899551|NCT02026856|Sodium Selenite|sodium selenite|mesh-list
64899552|NCT02026856|Trace Elements|trace elements|mesh-ancestor
64899553|NCT02026856|Micronutrients|micronutrients|mesh-ancestor
64899554|NCT02026856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899555|NCT02026869|Metformin|metformin|mesh-list
64899556|NCT02026869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64899557|NCT02026869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899558|NCT02026921|Carboplatin|carboplatin|mesh-list
64899559|NCT02026921|Docetaxel|docetaxel|mesh-list
64899560|NCT02026921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899561|NCT02026921|Tubulin Modulators|tubulin modulators|mesh-ancestor
64899568|NCT02026973|Fulvestrant|fulvestrant|mesh-list
64899640|NCT02027337|Contraceptive Agents|contraceptive agents|mesh-ancestor
64899641|NCT02027337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64899642|NCT02027337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899643|NCT02027337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64899644|NCT02027337|Estrogens|estrogens|mesh-ancestor
64899645|NCT02027337|Hormones|hormones|mesh-ancestor
64899647|NCT02027337|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64899724|NCT02027922|Protective Agents|protective agents|mesh-ancestor
64899725|NCT02027922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899726|NCT02027961|Durvalumab|durvalumab|mesh-list
64899727|NCT02027961|Trametinib|trametinib|mesh-list
64668373|NCT01915823|Xhance|xhance|mesh-list
64523055|NCT04614610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64523056|NCT04614610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64523057|NCT04614610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64523058|NCT04614610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64523059|NCT04614610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64523060|NCT04614610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523061|NCT02428218|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64899887|NCT02028910|Dermatologic Agents|dermatologic agents|mesh-ancestor
64899888|NCT02028910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64899889|NCT02028910|Serotonin Agents|serotonin agents|mesh-ancestor
64899890|NCT02028910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64899891|NCT02028910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899993|NCT02029573|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64899994|NCT02029573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523062|NCT02428218|Dermatologic Agents|dermatologic agents|mesh-ancestor
64523063|NCT02428218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64523064|NCT02428218|Immunologic Factors|immunologic factors|mesh-ancestor
64523065|NCT02428218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523066|NCT04606576|Insulin|insulin|mesh-list
64523067|NCT04606576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64523068|NCT04606576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64523069|NCT04606576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523082|NCT02428062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523083|NCT02428062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64523084|NCT02428062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64523085|NCT02428062|Autonomic Agents|autonomic agents|mesh-ancestor
64523087|NCT02428062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64900105|NCT02031367|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64900106|NCT02031367|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64900107|NCT02031367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64900108|NCT02031367|Glucocorticoids|glucocorticoids|mesh-ancestor
64900109|NCT02031367|Hormones|hormones|mesh-ancestor
64900110|NCT02031367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64900244|NCT02039453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64900245|NCT02039453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900246|NCT02039453|Analgesics|analgesics|mesh-ancestor
64900247|NCT02039453|Sensory System Agents|sensory system agents|mesh-ancestor
64900248|NCT02039453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64900249|NCT02039453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64900250|NCT02039453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64900251|NCT02039453|Anesthetics, General|anesthetics, general|mesh-ancestor
64900252|NCT02039453|Anesthetics|anesthetics|mesh-ancestor
64900253|NCT02039492|Spironolactone|spironolactone|mesh-list
64900276|NCT02040142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64523148|NCT00361894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64900453|NCT02040883|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64900454|NCT02040883|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64900455|NCT02040883|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64900456|NCT02040883|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64900457|NCT02040883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64900458|NCT02040909|Propofol|propofol|mesh-list
64900459|NCT02040909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64900460|NCT02040909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64900461|NCT02040909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900462|NCT02040909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64900463|NCT02040909|Anesthetics, General|anesthetics, general|mesh-ancestor
64900464|NCT02040909|Anesthetics|anesthetics|mesh-ancestor
64900465|NCT02040935|Trastuzumab|trastuzumab|mesh-list
64900466|NCT02040935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64523202|NCT00362752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64523203|NCT00362752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64523204|NCT00362752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523205|NCT00362752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523206|NCT00362752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523207|NCT00362752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64523208|NCT00362752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64523210|NCT00118209|Cyclophosphamide|cyclophosphamide|mesh-list
64900512|NCT02041351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900513|NCT02041455|Amitriptyline|amitriptyline|mesh-list
64900514|NCT02041455|Melatonin|melatonin|mesh-list
64900515|NCT02041455|Antioxidants|antioxidants|mesh-ancestor
64900621|NCT02042612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900622|NCT02042638|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64900644|NCT02042690|Autonomic Agents|autonomic agents|mesh-ancestor
64900645|NCT02042690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64900705|NCT02043288|Gemcitabine|gemcitabine|mesh-list
64900706|NCT02043288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64900707|NCT02043288|Antimetabolites|antimetabolites|mesh-ancestor
64900708|NCT02043288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900709|NCT02043288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900710|NCT02043288|Antiviral Agents|antiviral agents|mesh-ancestor
64900711|NCT02043288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64900712|NCT02043288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900713|NCT02043288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64900819|NCT02044146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64900820|NCT02044146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900853|NCT02044250|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64900854|NCT02044250|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64900855|NCT02044250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64901024|NCT02045693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901025|NCT02045693|Analgesics|analgesics|mesh-ancestor
64523321|NCT01682759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523322|NCT01682759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64523323|NCT01682759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64523324|NCT01682759|Immunologic Factors|immunologic factors|mesh-ancestor
64523325|NCT01682681|Topiramate|topiramate|mesh-list
64523326|NCT01682681|Anticonvulsants|anticonvulsants|mesh-ancestor
64901179|NCT02046486|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64523361|NCT02126553|Growth Inhibitors|growth inhibitors|mesh-ancestor
64523362|NCT02126553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523364|NCT01703741|Androgens|androgens|mesh-ancestor
64523365|NCT01703741|Hormones|hormones|mesh-ancestor
64523366|NCT01703741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64523367|NCT01703741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714099|NCT03054103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64523384|NCT02430714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523385|NCT02425254|Acetaminophen|acetaminophen|mesh-list
64523386|NCT02425254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64523387|NCT02425254|Analgesics|analgesics|mesh-ancestor
64901282|NCT02046915|Pomalidomide|pomalidomide|mesh-list
64901283|NCT02046915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64901284|NCT02046915|Immunologic Factors|immunologic factors|mesh-ancestor
64523403|NCT02426736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64901411|NCT00005823|Tretinoin|tretinoin|mesh-list
64901412|NCT00005823|Thioguanine|thioguanine|mesh-list
64901413|NCT00005823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64901414|NCT00005823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901516|NCT00005850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64901517|NCT00005853|Etanercept|etanercept|mesh-list
64901518|NCT00005853|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64901519|NCT00005853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64901520|NCT00005853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64523458|NCT02425878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523459|NCT02425878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64523460|NCT02425722|Linaclotide|linaclotide|mesh-list
64670182|NCT05293509|Antiemetics|antiemetics|mesh-ancestor
64901652|NCT00005898|Glucocorticoids|glucocorticoids|mesh-ancestor
64901653|NCT00005898|Hormones|hormones|mesh-ancestor
64901654|NCT00005898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64901655|NCT00005898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64901656|NCT00005898|Protective Agents|protective agents|mesh-ancestor
64901657|NCT00386412|Valganciclovir|valganciclovir|mesh-list
64901658|NCT00386412|Antiviral Agents|antiviral agents|mesh-ancestor
64523516|NCT01703117|Protective Agents|protective agents|mesh-ancestor
64523517|NCT01702961|Cytarabine|cytarabine|mesh-list
64523518|NCT01702961|Etoposide|etoposide|mesh-list
64523519|NCT01702961|Rituximab|rituximab|mesh-list
64523520|NCT01702961|Melphalan|melphalan|mesh-list
64523521|NCT01702961|Carmustine|carmustine|mesh-list
64523522|NCT01702961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64523523|NCT01702961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523524|NCT01702961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64523525|NCT01702961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64901723|NCT00005940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64901754|NCT00005943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64901755|NCT00005943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64901756|NCT00005943|Antiviral Agents|antiviral agents|mesh-ancestor
64901757|NCT00005943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64901758|NCT00005946|Cyclophosphamide|cyclophosphamide|mesh-list
64901759|NCT00005946|Etoposide|etoposide|mesh-list
64901760|NCT00005946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64901761|NCT00005946|Immunologic Factors|immunologic factors|mesh-ancestor
64523532|NCT01702961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64523533|NCT01702961|Immunologic Factors|immunologic factors|mesh-ancestor
64523534|NCT01702961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523535|NCT01702961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64523554|NCT01702025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64523555|NCT01702025|Purinergic Agents|purinergic agents|mesh-ancestor
64523556|NCT01702025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64523566|NCT01592747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64523567|NCT01592747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523568|NCT01592747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523569|NCT01592747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64523570|NCT01592747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64523571|NCT02425488|Coal Tar|coal tar|mesh-list
64901956|NCT00005988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901957|NCT00005988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523580|NCT03117192|Dermatologic Agents|dermatologic agents|mesh-ancestor
64523582|NCT04768439|Ergocalciferols|ergocalciferols|mesh-list
64523583|NCT04768439|Cholecalciferol|cholecalciferol|mesh-list
64523584|NCT04768439|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
64523585|NCT04768439|Calcitriol|calcitriol|mesh-list
64902080|NCT00006015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902081|NCT00006015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64902082|NCT00006015|Immunologic Factors|immunologic factors|mesh-ancestor
64902119|NCT00386646|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64523651|NCT03106818|Anesthetics, Local|anesthetics, local|mesh-list
64523652|NCT03106818|Anesthetics|anesthetics|mesh-list
64523653|NCT03106818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64523654|NCT03106818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523655|NCT03106818|Sensory System Agents|sensory system agents|mesh-ancestor
64523656|NCT03106818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64523657|NCT03106818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64523658|NCT03106818|Analgesics|analgesics|mesh-ancestor
64523672|NCT01592045|Aldesleukin|aldesleukin|mesh-list
64523673|NCT01592045|Molgramostim|molgramostim|mesh-list
64902349|NCT00386997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64902375|NCT04921722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902376|NCT04921722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64902377|NCT04921722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902378|NCT04921722|Antifungal Agents|antifungal agents|mesh-ancestor
64902379|NCT04921722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64902380|NCT04921722|Immunologic Factors|immunologic factors|mesh-ancestor
64902381|NCT04921722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902382|NCT04910568|Dexamethasone|dexamethasone|mesh-list
64523693|NCT01590797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523694|NCT01590797|Incretins|incretins|mesh-ancestor
64523695|NCT01590797|Hormones|hormones|mesh-ancestor
64523696|NCT01590797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64523697|NCT01590797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64902540|NCT03869736|Anesthetics, General|anesthetics, general|mesh-ancestor
64902541|NCT03869736|Anesthetics|anesthetics|mesh-ancestor
64902542|NCT03869736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64902543|NCT03869736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902544|NCT03869736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64902575|NCT03741933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902576|NCT03741933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902577|NCT03568656|Atezolizumab|atezolizumab|mesh-list
64902578|NCT03568656|Olaparib|olaparib|mesh-list
64902579|NCT03568656|Abiraterone Acetate|abiraterone acetate|mesh-list
64523720|NCT02415270|Autonomic Agents|autonomic agents|mesh-ancestor
64523721|NCT02415270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64523723|NCT02415270|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64902744|NCT00006045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902745|NCT00006045|Analgesics|analgesics|mesh-ancestor
64649057|NCT03800264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64523739|NCT03178422|Autonomic Agents|autonomic agents|mesh-ancestor
64523740|NCT03178422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64523741|NCT03178422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523742|NCT03178422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64523743|NCT03178422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64523744|NCT03178422|Cholinergic Agents|cholinergic agents|mesh-ancestor
64902749|NCT00006048|Gemcitabine|gemcitabine|mesh-list
64523756|NCT02414880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523757|NCT02414880|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64523758|NCT02414880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523759|NCT02414880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902970|NCT00006129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902971|NCT00006132|Acyclovir|acyclovir|mesh-list
64902972|NCT00006132|Antiviral Agents|antiviral agents|mesh-ancestor
64902973|NCT00006132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902974|NCT00006135|Acyclovir|acyclovir|mesh-list
64902975|NCT00006135|Antiviral Agents|antiviral agents|mesh-ancestor
64902976|NCT00006135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902977|NCT00006144|Ritonavir|ritonavir|mesh-list
64902978|NCT00006144|Lopinavir|lopinavir|mesh-list
64902979|NCT00006144|Emtricitabine|emtricitabine|mesh-list
64902980|NCT00006144|Stavudine|stavudine|mesh-list
64902981|NCT00006144|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64902982|NCT00006144|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64902983|NCT00006144|Protease Inhibitors|protease inhibitors|mesh-ancestor
64902984|NCT00006144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902985|NCT00006144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523797|NCT02414802|Heparin|heparin|mesh-list
64903040|NCT00006195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64903041|NCT00006195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64903068|NCT00006204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64903069|NCT00006204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64903070|NCT00006204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64903071|NCT00006204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64903072|NCT00006204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903073|NCT00006204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64903074|NCT00006204|Serotonin Agents|serotonin agents|mesh-ancestor
64903075|NCT00006204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64903076|NCT00006204|Antidepressive Agents|antidepressive agents|mesh-ancestor
64903077|NCT00006204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64903078|NCT00006204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64903079|NCT00006204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64903080|NCT00006204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903081|NCT00006216|Ganciclovir|ganciclovir|mesh-list
64903082|NCT00006216|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64903083|NCT00006216|Antiviral Agents|antiviral agents|mesh-ancestor
64903084|NCT00006216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64903085|NCT00006216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64671607|NCT02033993|Paclitaxel|paclitaxel|mesh-list
64903086|NCT00006216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903112|NCT00006228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64903121|NCT03751800|Hormones|hormones|mesh-ancestor
64903122|NCT03751800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64903123|NCT03751800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903124|NCT03751800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64903125|NCT03751800|Contraceptive Agents|contraceptive agents|mesh-ancestor
64903126|NCT03751800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64903127|NCT03751800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64903128|NCT03751800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64903129|NCT03751800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64903130|NCT03751800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64903131|NCT03751800|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64903132|NCT03751800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64903133|NCT03751800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903134|NCT03751800|Hormone Antagonists|hormone antagonists|mesh-ancestor
64903135|NCT00006240|Dexamethasone|dexamethasone|mesh-list
64903136|NCT00006240|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64903137|NCT00006240|Sargramostim|sargramostim|mesh-list
64903157|NCT00006243|Immunologic Factors|immunologic factors|mesh-ancestor
64903158|NCT00006243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903185|NCT00006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903186|NCT00006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903187|NCT00006252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64903188|NCT00006252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64903189|NCT00006252|Antimetabolites|antimetabolites|mesh-ancestor
64903190|NCT00006258|Cyclophosphamide|cyclophosphamide|mesh-list
64903191|NCT00006258|Methotrexate|methotrexate|mesh-list
64903192|NCT00006258|Etoposide|etoposide|mesh-list
64903193|NCT00006258|Vincristine|vincristine|mesh-list
64903194|NCT00006258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64903195|NCT00006258|Immunologic Factors|immunologic factors|mesh-ancestor
64903213|NCT00006258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64903214|NCT00006258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64903215|NCT00006258|Tubulin Modulators|tubulin modulators|mesh-ancestor
64903216|NCT00006258|Antimitotic Agents|antimitotic agents|mesh-ancestor
64903217|NCT00006258|Mitosis Modulators|mitosis modulators|mesh-ancestor
64903218|NCT00006261|Cyclophosphamide|cyclophosphamide|mesh-list
64523906|NCT01587989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523907|NCT01587989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64523908|NCT01587989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64523909|NCT01587989|Immunologic Factors|immunologic factors|mesh-ancestor
64523910|NCT01587989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64523911|NCT01587989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64523912|NCT01697969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64523913|NCT01697969|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64523914|NCT01697969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64903369|NCT00005830|Doxorubicin|doxorubicin|mesh-list
64903370|NCT00005830|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64903371|NCT00005830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903372|NCT00005830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64903373|NCT00005830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64903374|NCT00005830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64903375|NCT00005830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903376|NCT00005830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903377|NCT00005833|Tipifarnib|tipifarnib|mesh-list
64903378|NCT00005833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903379|NCT00005836|Oxaliplatin|oxaliplatin|mesh-list
64903380|NCT00005836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903381|NCT00006330|Digoxin|digoxin|mesh-list
64903382|NCT00006330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64903383|NCT00006330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64557560|NCT04405193|Antioxidants|antioxidants|mesh-ancestor
64903384|NCT00006330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903385|NCT00006330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903414|NCT00005851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523946|NCT01697579|Antipruritics|antipruritics|mesh-ancestor
64649164|NCT00802100|Metformin|metformin|mesh-list
64523947|NCT01697579|Dermatologic Agents|dermatologic agents|mesh-ancestor
64523948|NCT01697579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64523949|NCT01697579|Serotonin Agents|serotonin agents|mesh-ancestor
64523950|NCT01697579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64523951|NCT01697579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523952|NCT01697579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64523953|NCT01697579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64523954|NCT01697579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64523955|NCT01697579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64523956|NCT01697579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64523957|NCT01697579|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64523958|NCT01697579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64523959|NCT01586195|Vemurafenib|vemurafenib|mesh-list
64523960|NCT01586195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903516|NCT00005866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64903668|NCT00005935|Immunologic Factors|immunologic factors|mesh-ancestor
64903669|NCT00005935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903670|NCT00005935|Antifungal Agents|antifungal agents|mesh-ancestor
64903671|NCT00005935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64903672|NCT00005935|Dermatologic Agents|dermatologic agents|mesh-ancestor
64903673|NCT00005935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64903674|NCT00005935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64903699|NCT00005938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64903757|NCT00387699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64903758|NCT00387699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64903759|NCT00387699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64903760|NCT00387699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903940|NCT00005998|Etoposide|etoposide|mesh-list
64524016|NCT02442700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64524017|NCT02442700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64524018|NCT02442700|Antimetabolites|antimetabolites|mesh-ancestor
64524019|NCT02442700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524020|NCT02442700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524021|NCT02442700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64524023|NCT00619528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64524024|NCT00619528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64524025|NCT00568672|Olanzapine|olanzapine|mesh-list
64903941|NCT00005998|Mitoxantrone|mitoxantrone|mesh-list
64903942|NCT00005998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64524029|NCT00568672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524030|NCT00568672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64524031|NCT00568672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64524032|NCT00568672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64524033|NCT00568672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64524034|NCT00568672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64904167|NCT00006040|Etoposide|etoposide|mesh-list
64524044|NCT02448862|Narcotics|narcotics|mesh-ancestor
64524045|NCT02448862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64524046|NCT02448862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524047|NCT02448862|Sensory System Agents|sensory system agents|mesh-ancestor
64524048|NCT02448862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524049|NCT02448862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64524050|NCT02448862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64524108|NCT02452060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524109|NCT01696955|Cetuximab|cetuximab|mesh-list
64524112|NCT02452528|Diphenhydramine|diphenhydramine|mesh-list
64524129|NCT02452528|Anesthetics|anesthetics|mesh-ancestor
64524130|NCT02452528|Sensory System Agents|sensory system agents|mesh-ancestor
64524131|NCT02452528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524132|NCT02452528|Antiemetics|antiemetics|mesh-ancestor
64524133|NCT02452528|Autonomic Agents|autonomic agents|mesh-ancestor
64524134|NCT02452528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64904358|NCT03996148|Propofol|propofol|mesh-list
64904460|NCT05546320|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64904461|NCT05546320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64904498|NCT05401786|Ipilimumab|ipilimumab|mesh-list
64904601|NCT00006459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64904602|NCT00006459|Antimetabolites|antimetabolites|mesh-ancestor
64904603|NCT00006459|Antiviral Agents|antiviral agents|mesh-ancestor
64904699|NCT04513522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64904700|NCT04513522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904701|NCT04513522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64904702|NCT04513522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524206|NCT02418676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64524207|NCT02418676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524208|NCT02419638|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64524209|NCT02419638|Dermatologic Agents|dermatologic agents|mesh-ancestor
64524210|NCT02419638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64524211|NCT02419638|Immunologic Factors|immunologic factors|mesh-ancestor
64904855|NCT03003325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904856|NCT03003325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64904857|NCT03003325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64904858|NCT03003325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904859|NCT03003325|Antipyretics|antipyretics|mesh-ancestor
64904860|NCT02966548|Nivolumab|nivolumab|mesh-list
64904861|NCT02966548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64904961|NCT00006669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64904962|NCT00006669|Alkylating Agents|alkylating agents|mesh-ancestor
64904963|NCT00006669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904964|NCT00006669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904965|NCT00006669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64904966|NCT00006669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64904967|NCT00006669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64904968|NCT00006669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64904973|NCT00006669|Hormones|hormones|mesh-ancestor
64905141|NCT00006055|Cyclosporins|cyclosporins|mesh-list
64905142|NCT00006055|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64905143|NCT00006055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64905144|NCT00006055|Immunologic Factors|immunologic factors|mesh-ancestor
64905330|NCT00006124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64905331|NCT00006124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905333|NCT00006127|Amifostine|amifostine|mesh-list
64905370|NCT00006154|Abacavir|abacavir|mesh-list
64905580|NCT00006247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905582|NCT00006250|Fludarabine|fludarabine|mesh-list
64905583|NCT00006250|Fludarabine phosphate|fludarabine phosphate|mesh-list
64905584|NCT00006250|Mitoxantrone|mitoxantrone|mesh-list
64905585|NCT00006250|Chlorambucil|chlorambucil|mesh-list
64905586|NCT00006250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64905587|NCT00006250|Antiemetics|antiemetics|mesh-ancestor
64905588|NCT00006250|Autonomic Agents|autonomic agents|mesh-ancestor
64905759|NCT00387868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905760|NCT00387868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64905761|NCT00387868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64905762|NCT00387868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64524287|NCT02703636|Rivastigmine|rivastigmine|mesh-list
64524309|NCT02466958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524310|NCT02466958|Antidepressive Agents|antidepressive agents|mesh-ancestor
64905986|NCT00008073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905987|NCT00008073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64905988|NCT00008073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64905989|NCT00006397|Ritonavir|ritonavir|mesh-list
64905990|NCT00006397|Indinavir|indinavir|mesh-list
64905991|NCT00006397|Didanosine|didanosine|mesh-list
64905992|NCT00006397|Stavudine|stavudine|mesh-list
64905993|NCT00006397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64906102|NCT00006451|Immunologic Factors|immunologic factors|mesh-ancestor
64906103|NCT00006451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906104|NCT00006451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64906105|NCT00006451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64906137|NCT00006454|Tubulin Modulators|tubulin modulators|mesh-ancestor
64906138|NCT00006454|Antimitotic Agents|antimitotic agents|mesh-ancestor
64906270|NCT00006493|Rosiglitazone|rosiglitazone|mesh-list
64906271|NCT00006493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64906272|NCT00006493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906273|NCT00008463|Interferons|interferons|mesh-list
64906274|NCT00008463|Ribavirin|ribavirin|mesh-list
64906275|NCT00008463|Interferon-alpha|interferon-alpha|mesh-list
64906276|NCT00008463|Interferon alpha-2|interferon alpha-2|mesh-list
64524379|NCT02412930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524381|NCT02412930|Narcotics|narcotics|mesh-ancestor
64524382|NCT02412930|Analgesics|analgesics|mesh-ancestor
64524383|NCT02432716|Insulin|insulin|mesh-list
64524384|NCT02432716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64524385|NCT02432716|Insulin glulisine|insulin glulisine|mesh-list
64906442|NCT00007852|Cytarabine|cytarabine|mesh-list
64524393|NCT02418624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524394|NCT02440204|Remifentanil|remifentanil|mesh-list
64524395|NCT02440204|Sevoflurane|sevoflurane|mesh-list
64524396|NCT02440204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64524397|NCT02440204|Narcotics|narcotics|mesh-ancestor
64524398|NCT02440204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64524399|NCT02440204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524400|NCT02440204|Analgesics|analgesics|mesh-ancestor
64524401|NCT02440204|Sensory System Agents|sensory system agents|mesh-ancestor
64906561|NCT00008242|Thalidomide|thalidomide|mesh-list
64906727|NCT05638633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64906729|NCT05638633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906952|NCT00388479|Alvimopan|alvimopan|mesh-list
64907077|NCT00000499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907078|NCT00000499|Diuretics|diuretics|mesh-ancestor
64907079|NCT00000499|Natriuretic Agents|natriuretic agents|mesh-ancestor
64907080|NCT00000499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64907081|NCT00000499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64907197|NCT00000556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64907230|NCT00000559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64907231|NCT00000559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64907232|NCT00000559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64907233|NCT00000559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64907234|NCT00000559|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64907235|NCT00000559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64907236|NCT00000559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64907273|NCT00000625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907274|NCT00000625|Antiviral Agents|antiviral agents|mesh-ancestor
64907311|NCT00000640|Leprostatic Agents|leprostatic agents|mesh-ancestor
64907469|NCT00000742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64907470|NCT00000742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907471|NCT00000742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907472|NCT00000742|Antiviral Agents|antiviral agents|mesh-ancestor
64907474|NCT00000742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64907691|NCT00000892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64907692|NCT00000892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907693|NCT00000895|Azithromycin|azithromycin|mesh-list
64907694|NCT00000895|Nevirapine|nevirapine|mesh-list
64907695|NCT00000895|Nelfinavir|nelfinavir|mesh-list
64907842|NCT00000952|Antiviral Agents|antiviral agents|mesh-ancestor
64907843|NCT00000952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907989|NCT00001045|Nevirapine|nevirapine|mesh-list
64907990|NCT00001045|Didanosine|didanosine|mesh-list
64907991|NCT00001045|Antimetabolites|antimetabolites|mesh-ancestor
64524479|NCT03175926|Autonomic Agents|autonomic agents|mesh-ancestor
64908045|NCT00001075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64908152|NCT00001165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64524572|NCT02411604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524573|NCT02411604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908426|NCT00001720|Alendronate|alendronate|mesh-list
64908608|NCT00000375|Adrenergic Agents|adrenergic agents|mesh-ancestor
64908609|NCT00000375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64908928|NCT00423475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908929|NCT00000516|Enalapril|enalapril|mesh-list
64908930|NCT00000516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64908935|NCT05049616|Nifedipine|nifedipine|mesh-list
64909066|NCT00000555|Micronutrients|micronutrients|mesh-ancestor
64909067|NCT00000555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649344|NCT03984188|Purinergic Agents|purinergic agents|mesh-ancestor
64524640|NCT03177174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64524641|NCT03177174|Tubulin Modulators|tubulin modulators|mesh-ancestor
64524642|NCT03177174|Antimitotic Agents|antimitotic agents|mesh-ancestor
64909212|NCT00390091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64909233|NCT04601077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64909234|NCT04601077|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64909235|NCT04601077|Vasodilator Agents|vasodilator agents|mesh-ancestor
64524650|NCT03177252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524651|NCT03177252|Sensory System Agents|sensory system agents|mesh-ancestor
64524652|NCT03177252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524653|NCT03177252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64714102|NCT03054103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64524654|NCT03177252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64524655|NCT03177252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64909310|NCT00000645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909390|NCT00000672|Didanosine|didanosine|mesh-list
64909403|NCT04321954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909404|NCT04321954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909405|NCT00000675|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
64909406|NCT00000675|Immunologic Factors|immunologic factors|mesh-ancestor
64909407|NCT00000675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909408|NCT00000678|Zidovudine|zidovudine|mesh-list
64909409|NCT00000678|Zalcitabine|zalcitabine|mesh-list
64909410|NCT00000678|Antimetabolites|antimetabolites|mesh-ancestor
64909411|NCT00000678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909412|NCT00000678|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64909413|NCT00000678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64909442|NCT00000681|Zidovudine|zidovudine|mesh-list
64524684|NCT03174288|Spironolactone|spironolactone|mesh-list
64524685|NCT03174288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64909605|NCT00000720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909606|NCT04142983|Vaccines|vaccines|mesh-list
64909607|NCT04142983|Immunologic Factors|immunologic factors|mesh-ancestor
64909608|NCT04142983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524760|NCT02405910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524761|NCT02405910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64524762|NCT02405910|Antimetabolites|antimetabolites|mesh-ancestor
64524763|NCT02405910|Antiviral Agents|antiviral agents|mesh-ancestor
64524764|NCT02405910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909674|NCT04038346|Analgesics|analgesics|mesh-ancestor
64909707|NCT00000747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64909708|NCT00000747|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64909709|NCT00000747|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64909710|NCT00000753|Zidovudine|zidovudine|mesh-list
64909711|NCT00000753|Didanosine|didanosine|mesh-list
64524818|NCT03173898|Anesthetics|anesthetics|mesh-list
64524819|NCT03173898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64524820|NCT03173898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524821|NCT02408172|Metoprolol|metoprolol|mesh-list
64524822|NCT02408172|Amlodipine|amlodipine|mesh-list
64524823|NCT02408172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64524824|NCT02408172|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64910056|NCT03211741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64910057|NCT03211741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64910058|NCT03211741|Growth Substances|growth substances|mesh-ancestor
64910238|NCT02419495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910239|NCT02419495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64910241|NCT02419495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910242|NCT02419495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64910243|NCT02419495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64910244|NCT02419495|Alkylating Agents|alkylating agents|mesh-ancestor
64910245|NCT02419495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64910246|NCT02419495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64910247|NCT02419495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64910248|NCT02419495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64910249|NCT02419495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910250|NCT02419495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64910252|NCT02419495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64910338|NCT00001002|Antiviral Agents|antiviral agents|mesh-ancestor
64910339|NCT00001002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910340|NCT00001002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64910341|NCT00001002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64910342|NCT00005819|Paclitaxel|paclitaxel|mesh-list
64910343|NCT00005819|Fenretinide|fenretinide|mesh-list
64910344|NCT00005819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64910516|NCT00005834|Immunologic Factors|immunologic factors|mesh-ancestor
64910517|NCT00005834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910518|NCT00005834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64910519|NCT00005834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64910520|NCT00005834|Alkylating Agents|alkylating agents|mesh-ancestor
64910522|NCT00005834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910647|NCT00005855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910648|NCT00005855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910649|NCT00005855|Antisickling Agents|antisickling agents|mesh-ancestor
64910650|NCT00001074|Didanosine|didanosine|mesh-list
64910790|NCT00005870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64910791|NCT00005870|Antimetabolites|antimetabolites|mesh-ancestor
64910816|NCT00008866|Antisickling Agents|antisickling agents|mesh-ancestor
64910817|NCT00008866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910818|NCT00008866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910819|NCT00008866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64910821|NCT00008866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64910822|NCT00008866|Antiviral Agents|antiviral agents|mesh-ancestor
64910823|NCT00008866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910824|NCT00008866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64910825|NCT00008866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64910826|NCT00001119|Ritonavir|ritonavir|mesh-list
64910827|NCT00001119|Indinavir|indinavir|mesh-list
64910828|NCT00001119|Amprenavir|amprenavir|mesh-list
64910920|NCT00001146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64910921|NCT00001146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64910922|NCT00009646|Indomethacin|indomethacin|mesh-list
64910923|NCT00009646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64910989|NCT00009880|Fluorouracil|fluorouracil|mesh-list
64910990|NCT00009880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64910991|NCT00009880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910992|NCT00009880|Tubulin Modulators|tubulin modulators|mesh-ancestor
64910993|NCT00009880|Antimitotic Agents|antimitotic agents|mesh-ancestor
64910994|NCT00009880|Mitosis Modulators|mitosis modulators|mesh-ancestor
64910995|NCT00009880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910996|NCT00009880|Antimetabolites|antimetabolites|mesh-ancestor
64911163|NCT00010699|Vitamin E|vitamin e|mesh-list
64911164|NCT00010699|Vitamins|vitamins|mesh-ancestor
64911202|NCT00005921|Caspofungin|caspofungin|mesh-list
64911203|NCT00005921|Antifungal Agents|antifungal agents|mesh-ancestor
64911236|NCT00001212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64911237|NCT00001212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64911239|NCT00001212|Hormones|hormones|mesh-ancestor
64911493|NCT00005963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911495|NCT00013585|Antidepressive Agents|antidepressive agents|mesh-ancestor
64911496|NCT00013585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64911497|NCT00013585|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64911498|NCT00013585|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64911499|NCT00013585|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64911638|NCT00014287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64911639|NCT00014287|Antimetabolites|antimetabolites|mesh-ancestor
64911640|NCT00014287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911669|NCT00014404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64911670|NCT00014404|Analgesics|analgesics|mesh-ancestor
64911671|NCT00014404|Sensory System Agents|sensory system agents|mesh-ancestor
64911672|NCT00014404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524999|NCT04481802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64525000|NCT04481802|Immunologic Factors|immunologic factors|mesh-ancestor
64525001|NCT04481802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525002|NCT04481802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525003|NCT04481802|Antiviral Agents|antiviral agents|mesh-ancestor
64525004|NCT04481802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64525005|NCT04481802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64525006|NCT02551822|Neurotransmitter Agents|neurotransmitter agents|mesh-list
64525007|NCT02551822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525008|NCT02551822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525010|NCT02407314|Ticagrelor|ticagrelor|mesh-list
64525011|NCT02407314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64525012|NCT02407314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64525013|NCT02407314|Analgesics|analgesics|mesh-ancestor
64525014|NCT02407314|Sensory System Agents|sensory system agents|mesh-ancestor
64525015|NCT02407314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64911765|NCT00005987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64911766|NCT00005987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64911800|NCT00005990|Topotecan|topotecan|mesh-list
64911801|NCT00005990|Tipifarnib|tipifarnib|mesh-list
64911802|NCT00005990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64649498|NCT01275365|Methyltestosterone|methyltestosterone|mesh-list
64525031|NCT02407080|Interferons|interferons|mesh-list
64525032|NCT02407080|Interferon-alpha|interferon-alpha|mesh-list
64525033|NCT02407080|Interferon alpha-2|interferon alpha-2|mesh-list
64525034|NCT02407080|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64525035|NCT02407080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525036|NCT02407080|Antiviral Agents|antiviral agents|mesh-ancestor
64525037|NCT02407080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64525038|NCT02407080|Immunologic Factors|immunologic factors|mesh-ancestor
64912042|NCT00016198|Immunologic Factors|immunologic factors|mesh-ancestor
64912043|NCT00016198|Antidotes|antidotes|mesh-ancestor
64912044|NCT00016198|Protective Agents|protective agents|mesh-ancestor
64912045|NCT00016198|Vitamin B Complex|vitamin b complex|mesh-ancestor
64912046|NCT00016198|Vitamins|vitamins|mesh-ancestor
64912047|NCT00016198|Micronutrients|micronutrients|mesh-ancestor
64912194|NCT00016939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912195|NCT00016939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64912196|NCT00016939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912197|NCT00016939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912198|NCT00386672|Calcium, Dietary|calcium, dietary|mesh-list
64912200|NCT00386672|Ergocalciferols|ergocalciferols|mesh-list
64912201|NCT00386672|Cholecalciferol|cholecalciferol|mesh-list
64912202|NCT00386672|Vitamins|vitamins|mesh-list
64912325|NCT04734418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64912326|NCT04734418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912327|NCT04734418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64912328|NCT04734418|Narcotics|narcotics|mesh-ancestor
64912329|NCT00006032|Etoposide|etoposide|mesh-list
64912330|NCT00006032|Topotecan|topotecan|mesh-list
64912331|NCT00006032|Ifosfamide|ifosfamide|mesh-list
64525119|NCT03168594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64525120|NCT02563834|Insulin|insulin|mesh-list
64525121|NCT02563834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64525122|NCT02563834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525123|NCT02564926|Dapagliflozin|dapagliflozin|mesh-list
64525124|NCT02564926|Glimepiride|glimepiride|mesh-list
64525125|NCT02564926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64525146|NCT02567968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64525147|NCT02567968|Purinergic Agents|purinergic agents|mesh-ancestor
64525148|NCT02567968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64525149|NCT02571634|Fentanyl|fentanyl|mesh-list
64525150|NCT02571634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64525151|NCT02571634|Narcotics|narcotics|mesh-ancestor
64525154|NCT02571634|Analgesics|analgesics|mesh-ancestor
64912661|NCT00018382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64912662|NCT00018382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912663|NCT00018460|Vitamins|vitamins|mesh-list
64912664|NCT00018460|Vitamin B Complex|vitamin b complex|mesh-list
64912665|NCT00018460|Micronutrients|micronutrients|mesh-ancestor
64912761|NCT00001644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64912789|NCT00001656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64912790|NCT00001656|GABA Antagonists|gaba antagonists|mesh-ancestor
64912791|NCT00001656|GABA Agents|gaba agents|mesh-ancestor
64912792|NCT05573191|Lidocaine|lidocaine|mesh-list
64912793|NCT05573191|Anesthetics, Local|anesthetics, local|mesh-ancestor
64912794|NCT05573191|Anesthetics|anesthetics|mesh-ancestor
64912797|NCT05573191|Sensory System Agents|sensory system agents|mesh-ancestor
64912897|NCT05367271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64912898|NCT05367271|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64912899|NCT05679401|Cyclophosphamide|cyclophosphamide|mesh-list
64912900|NCT05679401|Glucocorticoids|glucocorticoids|mesh-list
64913136|NCT04752475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913137|NCT04752475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64913138|NCT04752475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64913140|NCT05641467|Methamphetamine|methamphetamine|mesh-list
64913268|NCT00392470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913269|NCT00392470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913270|NCT00392470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64913271|NCT05470517|Ceftriaxone|ceftriaxone|mesh-list
64525281|NCT03970252|Calcium|calcium|mesh-list
64525303|NCT03970252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64913371|NCT04733521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913372|NCT05640726|Leucovorin|leucovorin|mesh-list
64913373|NCT05640726|Bevacizumab|bevacizumab|mesh-list
64913374|NCT05640726|Fluorouracil|fluorouracil|mesh-list
64913375|NCT05640726|Oxaliplatin|oxaliplatin|mesh-list
64913376|NCT05640726|Calcium|calcium|mesh-list
64649566|NCT00845000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64913552|NCT05637567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64913553|NCT05637567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64913580|NCT03508726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525316|NCT03169764|Nivolumab|nivolumab|mesh-list
64913735|NCT03912818|Durvalumab|durvalumab|mesh-list
64913736|NCT03912818|Daunorubicin|daunorubicin|mesh-list
64913844|NCT03150316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913845|NCT03150316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64913846|NCT03150316|Glucocorticoids|glucocorticoids|mesh-ancestor
64914027|NCT04650581|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64914059|NCT01806805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64914061|NCT00387413|Niacinamide|niacinamide|mesh-list
64914062|NCT00387413|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64914063|NCT00387413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64914064|NCT00387413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64914096|NCT01806571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64914097|NCT01806571|Immunologic Factors|immunologic factors|mesh-ancestor
64914098|NCT01806571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914099|NCT01806571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64914100|NCT01806571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64914101|NCT01806571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64914102|NCT01806571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914104|NCT04590248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64682571|NCT00000309|Dopamine Agents|dopamine agents|mesh-ancestor
64914196|NCT05437887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64914197|NCT05437887|Anticoagulants|anticoagulants|mesh-ancestor
64914224|NCT04474223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64914405|NCT05361720|Nivolumab|nivolumab|mesh-list
64914407|NCT05361720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64914408|NCT05361720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914409|NCT05361720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64914506|NCT00847834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64914507|NCT00847834|Irbesartan|irbesartan|mesh-list
64914508|NCT00847834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64914509|NCT00847834|Diuretics|diuretics|mesh-ancestor
64914510|NCT00847834|Natriuretic Agents|natriuretic agents|mesh-ancestor
64914511|NCT00847834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914512|NCT00847834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64914573|NCT05321160|Sevoflurane|sevoflurane|mesh-list
64914574|NCT05321160|Esketamine|esketamine|mesh-list
64914575|NCT05321160|Analgesics|analgesics|mesh-ancestor
64914576|NCT05321160|Sensory System Agents|sensory system agents|mesh-ancestor
64914577|NCT05321160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64914578|NCT05321160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914579|NCT05321160|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64914580|NCT05321160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64914683|NCT00846703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64914684|NCT00846703|Antimetabolites|antimetabolites|mesh-ancestor
64914685|NCT00846703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914686|NCT00846703|Dermatologic Agents|dermatologic agents|mesh-ancestor
64914687|NCT00846703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914838|NCT00276835|Interleukin-2|interleukin-2|mesh-list
64914839|NCT00276835|Genistein|genistein|mesh-list
64914840|NCT00276835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914841|NCT00276835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64914842|NCT00276835|Analgesics|analgesics|mesh-ancestor
64914843|NCT00276835|Sensory System Agents|sensory system agents|mesh-ancestor
64914844|NCT00276835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64914950|NCT00276601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64914951|NCT00276601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64914952|NCT00276601|Immunologic Factors|immunologic factors|mesh-ancestor
64914978|NCT00276406|Cholinergic Agents|cholinergic agents|mesh-ancestor
64914979|NCT00276406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64914980|NCT00276406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914981|NCT00389883|Anesthetics|anesthetics|mesh-list
64914982|NCT00389883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64915088|NCT03152318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64915118|NCT02979977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915120|NCT05424757|Laxatives|laxatives|mesh-ancestor
64915121|NCT05424757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64915122|NCT02921555|Prednisone|prednisone|mesh-list
64915123|NCT02921555|Methylprednisolone|methylprednisolone|mesh-list
64915124|NCT02921555|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64915126|NCT02921555|Prednisolone|prednisolone|mesh-list
64915256|NCT04554862|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64915257|NCT04554862|Magnesium Sulfate|magnesium sulfate|mesh-list
64915258|NCT04554862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64915259|NCT04554862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64915260|NCT04554862|Analgesics|analgesics|mesh-ancestor
64915261|NCT04554862|Sensory System Agents|sensory system agents|mesh-ancestor
64915403|NCT02832544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915404|NCT02832544|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64915405|NCT02832544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64915406|NCT02832544|Hemostatics|hemostatics|mesh-ancestor
64915407|NCT02832544|Coagulants|coagulants|mesh-ancestor
64915410|NCT00006044|Hormones|hormones|mesh-ancestor
64649644|NCT01331213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64915585|NCT00006056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64915586|NCT00084370|Celecoxib|celecoxib|mesh-list
64915587|NCT00084370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64915588|NCT00084370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64915589|NCT00084370|Analgesics|analgesics|mesh-ancestor
64915621|NCT00084565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64915675|NCT00084877|Irinotecan|irinotecan|mesh-list
64915765|NCT04729348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64915766|NCT04729348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915767|NCT04729348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64915768|NCT04729348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915797|NCT00006080|Protective Agents|protective agents|mesh-ancestor
64915798|NCT00006080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915799|NCT00085462|Aldesleukin|aldesleukin|mesh-list
64915800|NCT00085462|Cyclophosphamide|cyclophosphamide|mesh-list
64915801|NCT00085462|Fludarabine|fludarabine|mesh-list
64915802|NCT00085462|Fludarabine phosphate|fludarabine phosphate|mesh-list
64525497|NCT02402400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525498|NCT02402400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525499|NCT02610868|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
64525500|NCT02610868|Botulinum Toxins|botulinum toxins|mesh-list
64525501|NCT02610868|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64525540|NCT00365638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64915810|NCT00085462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915811|NCT00085462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64915812|NCT00085462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64915888|NCT00086125|Sirolimus|sirolimus|mesh-list
64916019|NCT00087100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916020|NCT00087100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916021|NCT00087100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916022|NCT00087100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64916023|NCT00087100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64916024|NCT00006113|Interferons|interferons|mesh-list
64916038|NCT00087217|Paclitaxel|paclitaxel|mesh-list
64916172|NCT00006125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64916173|NCT00006125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916197|NCT00088036|Antiemetics|antiemetics|mesh-ancestor
64916198|NCT00088036|Autonomic Agents|autonomic agents|mesh-ancestor
64916199|NCT00088036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64916381|NCT00089050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916382|NCT00089050|Antifungal Agents|antifungal agents|mesh-ancestor
64916383|NCT00089050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64916384|NCT00089050|Dermatologic Agents|dermatologic agents|mesh-ancestor
64916385|NCT00089050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64916386|NCT00089050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64649688|NCT01362959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64916530|NCT00390156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916531|NCT00089401|Melphalan|melphalan|mesh-list
64916532|NCT00089401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64916533|NCT00089401|Alkylating Agents|alkylating agents|mesh-ancestor
64916561|NCT00089518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64916562|NCT00089518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916563|NCT00089557|Capsaicin|capsaicin|mesh-list
64916564|NCT00089557|Antipruritics|antipruritics|mesh-ancestor
64916565|NCT00089557|Dermatologic Agents|dermatologic agents|mesh-ancestor
64525609|NCT02974270|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64525610|NCT02974270|Fertility Agents|fertility agents|mesh-ancestor
64525611|NCT02974270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64525612|NCT02974270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916662|NCT00091156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64525625|NCT03167268|Protective Agents|protective agents|mesh-ancestor
64525626|NCT03167268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525627|NCT03167268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64525628|NCT03167268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64525629|NCT03167268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525630|NCT04544098|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64525631|NCT04544098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64916901|NCT00093028|Growth Inhibitors|growth inhibitors|mesh-ancestor
64916902|NCT00093067|Daptomycin|daptomycin|mesh-list
64916903|NCT00093067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64916935|NCT00093262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64916936|NCT00093262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916937|NCT00093301|Simendan|simendan|mesh-list
64916938|NCT00093301|Dobutamine|dobutamine|mesh-list
64916939|NCT00093301|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64916940|NCT00093301|Vasodilator Agents|vasodilator agents|mesh-ancestor
64916978|NCT00006230|Rubitecan|rubitecan|mesh-list
64649718|NCT03608696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64917032|NCT00093925|Nicardipine|nicardipine|mesh-list
64917033|NCT00093925|Clevidipine|clevidipine|mesh-list
64917034|NCT00093925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64917035|NCT00093925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64917036|NCT00093925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917073|NCT00006245|Growth Inhibitors|growth inhibitors|mesh-ancestor
64917074|NCT00006245|Growth Substances|growth substances|mesh-ancestor
64917075|NCT00006245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917076|NCT00006245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64917285|NCT00095524|Dopamine Agonists|dopamine agonists|mesh-ancestor
64917286|NCT00095524|Dopamine Agents|dopamine agents|mesh-ancestor
64917312|NCT04476030|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64917313|NCT04476030|Citalopram|citalopram|mesh-list
64917314|NCT04476030|Sertraline|sertraline|mesh-list
64917315|NCT04476030|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64917316|NCT04476030|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64917317|NCT04476030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64525690|NCT02393664|Propofol|propofol|mesh-list
64917372|NCT00095914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525736|NCT02393586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525737|NCT02393586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64525738|NCT02393586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64917549|NCT00097084|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64917550|NCT00097084|Insulin Glargine|insulin glargine|mesh-list
64917723|NCT04290546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64917724|NCT04290546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917725|NCT04290546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917726|NCT00098683|Amifostine|amifostine|mesh-list
64917727|NCT00098683|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64525769|NCT03103750|Calcitriol|calcitriol|mesh-list
64917857|NCT00099619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64917858|NCT00006359|Androgen Antagonists|androgen antagonists|mesh-list
64917859|NCT00006359|Hormone Antagonists|hormone antagonists|mesh-ancestor
64525774|NCT03103750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64525800|NCT02397330|Narcotics|narcotics|mesh-ancestor
64525801|NCT02397330|Analgesics|analgesics|mesh-ancestor
64525802|NCT03081052|Nitric Oxide|nitric oxide|mesh-list
64525803|NCT03081052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64525804|NCT03081052|Autonomic Agents|autonomic agents|mesh-ancestor
64525805|NCT03081052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64525806|NCT03081052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917914|NCT00099970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64917915|NCT00099970|Growth Substances|growth substances|mesh-ancestor
64918014|NCT00006374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64918015|NCT00006374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64918016|NCT00006374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918017|NCT00006374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64918018|NCT00100750|Gemcitabine|gemcitabine|mesh-list
64918019|NCT00100750|Tipifarnib|tipifarnib|mesh-list
64918020|NCT00100750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64918021|NCT00100750|Antimetabolites|antimetabolites|mesh-ancestor
64918022|NCT00100750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918023|NCT00100750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918024|NCT00100750|Antiviral Agents|antiviral agents|mesh-ancestor
64918180|NCT00006398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918181|NCT00006398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64918182|NCT00006398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64918183|NCT00006398|Adrenergic Agents|adrenergic agents|mesh-ancestor
64918184|NCT00006398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64918268|NCT03991884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64918269|NCT03991884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64918270|NCT03991884|Tubulin Modulators|tubulin modulators|mesh-ancestor
64649773|NCT03637400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64918271|NCT03991884|Antimitotic Agents|antimitotic agents|mesh-ancestor
64918272|NCT03991884|Mitosis Modulators|mitosis modulators|mesh-ancestor
64918273|NCT03991884|Keratolytic Agents|keratolytic agents|mesh-ancestor
64918274|NCT03991884|Dermatologic Agents|dermatologic agents|mesh-ancestor
64918276|NCT00101764|Triamcinolone|triamcinolone|mesh-list
64918373|NCT00006428|Sensory System Agents|sensory system agents|mesh-ancestor
64918374|NCT00006428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64918375|NCT00006428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918376|NCT00006428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64918377|NCT00006428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64918378|NCT00006428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64918379|NCT00006428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918510|NCT00103597|Autonomic Agents|autonomic agents|mesh-ancestor
64918511|NCT00103597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64918512|NCT00103597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918513|NCT00103597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64918514|NCT00103597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64918515|NCT00103597|Dopamine Agents|dopamine agents|mesh-ancestor
64918516|NCT00103597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64525882|NCT01695239|Adalimumab|adalimumab|mesh-list
64525898|NCT01587352|Vorinostat|vorinostat|mesh-list
64525899|NCT01587352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918744|NCT00105352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64918745|NCT00105352|Hormones|hormones|mesh-ancestor
64918774|NCT00006473|Oxaliplatin|oxaliplatin|mesh-list
64918992|NCT03746106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64918993|NCT03746106|Vitamin B Complex|vitamin b complex|mesh-ancestor
64918994|NCT03746106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64918995|NCT03746106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64918996|NCT03746106|Renal Agents|renal agents|mesh-ancestor
64918997|NCT03746106|Antimalarials|antimalarials|mesh-ancestor
64919046|NCT03683667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919047|NCT00006578|Ritonavir|ritonavir|mesh-list
64919048|NCT00006578|Amprenavir|amprenavir|mesh-list
64919049|NCT00006578|Lamivudine|lamivudine|mesh-list
64919050|NCT00006578|Abacavir|abacavir|mesh-list
64919051|NCT00006578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64919195|NCT00006734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64919196|NCT00006734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64919197|NCT00006734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64919224|NCT00108316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64919225|NCT00108316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919227|NCT00108316|Serotonin Agents|serotonin agents|mesh-ancestor
64919364|NCT00006929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919365|NCT00006929|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64919393|NCT03595917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919395|NCT00109408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64919531|NCT03434262|Gemcitabine|gemcitabine|mesh-list
64919532|NCT03434262|Trametinib|trametinib|mesh-list
64919533|NCT03434262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64919534|NCT03434262|Antimetabolites|antimetabolites|mesh-ancestor
64919535|NCT03434262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919536|NCT03434262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919640|NCT00111163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64919641|NCT00111163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919642|NCT00111163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919643|NCT00111163|Antiviral Agents|antiviral agents|mesh-ancestor
64919644|NCT00111163|Schistosomicides|schistosomicides|mesh-ancestor
64919733|NCT00111943|Tenofovir|tenofovir|mesh-list
64919734|NCT00111943|Antiviral Agents|antiviral agents|mesh-ancestor
64526062|NCT03167112|Micronutrients|micronutrients|mesh-ancestor
64526063|NCT01578785|Glatiramer Acetate|glatiramer acetate|mesh-list
64526064|NCT01578785|(T,G)-A-L|(t,g)-a-l|mesh-list
64526065|NCT01578785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64526066|NCT01578785|Immunologic Factors|immunologic factors|mesh-ancestor
64526067|NCT01578785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526068|NCT01578785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64919742|NCT00401596|Omalizumab|omalizumab|mesh-list
64526080|NCT01578551|Paclitaxel|paclitaxel|mesh-list
64526081|NCT01578551|Bevacizumab|bevacizumab|mesh-list
64526082|NCT01578551|Carboplatin|carboplatin|mesh-list
64919804|NCT00007436|Tenofovir|tenofovir|mesh-list
64919805|NCT00007436|Antiviral Agents|antiviral agents|mesh-ancestor
64919826|NCT00112528|Gemcitabine|gemcitabine|mesh-list
64919827|NCT00112528|Bevacizumab|bevacizumab|mesh-list
64919828|NCT00112528|Oxaliplatin|oxaliplatin|mesh-list
64919829|NCT00112528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64919830|NCT00112528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919831|NCT00112528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64919832|NCT00112528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64919833|NCT00112528|Growth Substances|growth substances|mesh-ancestor
64919835|NCT00112528|Growth Inhibitors|growth inhibitors|mesh-ancestor
64482173|NCT04149171|Tranexamic Acid|tranexamic acid|mesh-list
64526084|NCT01578551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526085|NCT01578551|Tubulin Modulators|tubulin modulators|mesh-ancestor
64526086|NCT01578551|Antimitotic Agents|antimitotic agents|mesh-ancestor
64526087|NCT01578551|Mitosis Modulators|mitosis modulators|mesh-ancestor
64526088|NCT01578551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526104|NCT01692197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64920046|NCT00007826|Antibodies|antibodies|mesh-list
64920047|NCT00007826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64920048|NCT00007826|BCG Vaccine|bcg vaccine|mesh-list
64920049|NCT00007826|Aluminum sulfate|aluminum sulfate|mesh-list
64920074|NCT00113698|Protease Inhibitors|protease inhibitors|mesh-ancestor
64920075|NCT00113698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920076|NCT00113698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920078|NCT00113737|Fluoxetine|fluoxetine|mesh-list
64526122|NCT03166644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64526123|NCT03166644|Narcotics|narcotics|mesh-ancestor
64920178|NCT00007982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64920179|NCT00007982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920181|NCT00114205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920182|NCT00114205|Tubulin Modulators|tubulin modulators|mesh-ancestor
64920183|NCT00114205|Antimitotic Agents|antimitotic agents|mesh-ancestor
64920281|NCT00008060|Irinotecan|irinotecan|mesh-list
64920282|NCT00008060|Calcium|calcium|mesh-list
64920283|NCT00008060|Levoleucovorin|levoleucovorin|mesh-list
64920284|NCT00008060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64920309|NCT00114868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920310|NCT03034200|TIC10 compound|tic10 compound|mesh-list
64920311|NCT03034200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920312|NCT00114946|Bevacizumab|bevacizumab|mesh-list
64920313|NCT00114946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64920314|NCT00114946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920377|NCT00115102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64526199|NCT04782258|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64526200|NCT04782258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526201|NCT04782258|Natriuretic Agents|natriuretic agents|mesh-ancestor
64526202|NCT04782258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526203|NCT02653144|Dexamethasone|dexamethasone|mesh-list
64526204|NCT02653144|Dexmedetomidine|dexmedetomidine|mesh-list
64526205|NCT02653144|Ropivacaine|ropivacaine|mesh-list
64526206|NCT02653144|Anesthetics|anesthetics|mesh-list
64526207|NCT02653144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64526208|NCT02653144|Antiemetics|antiemetics|mesh-ancestor
64526209|NCT02653144|Autonomic Agents|autonomic agents|mesh-ancestor
64526210|NCT02653144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526211|NCT02653144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526212|NCT02653144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64526213|NCT02653144|Glucocorticoids|glucocorticoids|mesh-ancestor
64920560|NCT00008411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920561|NCT04727671|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64920562|NCT04727671|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64920563|NCT04727671|Cetrorelix|cetrorelix|mesh-list
64920564|NCT04727671|Menotropins|menotropins|mesh-list
64920565|NCT04727671|Luteolytic Agents|luteolytic agents|mesh-ancestor
64920566|NCT04727671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64920567|NCT04727671|Contraceptive Agents|contraceptive agents|mesh-ancestor
64920568|NCT04727671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64920569|NCT04727671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920570|NCT04727671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64526267|NCT01587079|Cholinergic Agents|cholinergic agents|mesh-ancestor
64526268|NCT01587079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64526269|NCT01587079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526270|NCT03028909|Oseltamivir|oseltamivir|mesh-list
64526272|NCT03028909|Antiviral Agents|antiviral agents|mesh-ancestor
64920789|NCT00117403|Coenzyme Q10|coenzyme q10|mesh-list
64920790|NCT00117403|Ubiquinone|ubiquinone|mesh-list
64920791|NCT00117403|Micronutrients|micronutrients|mesh-ancestor
64920792|NCT00117403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920793|NCT00117403|Antioxidants|antioxidants|mesh-ancestor
64920794|NCT00117403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526317|NCT04739566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920930|NCT00118222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920931|NCT00118261|Leucovorin|leucovorin|mesh-list
64920932|NCT00118261|Bevacizumab|bevacizumab|mesh-list
64920933|NCT00118261|Fluorouracil|fluorouracil|mesh-list
64920934|NCT00118261|Oxaliplatin|oxaliplatin|mesh-list
64920935|NCT00118261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64920936|NCT00118261|Calcium|calcium|mesh-list
64920959|NCT00118300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64921024|NCT02706873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921025|NCT02706873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64921026|NCT02706873|Antimetabolites|antimetabolites|mesh-ancestor
64921027|NCT02706873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921028|NCT02706873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921029|NCT02706873|Dermatologic Agents|dermatologic agents|mesh-ancestor
64921030|NCT02706873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526351|NCT02662036|Bupivacaine|bupivacaine|mesh-list
64526373|NCT00121251|Sorafenib|sorafenib|mesh-list
64526374|NCT00121251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64526375|NCT00121251|Antimetabolites|antimetabolites|mesh-ancestor
64526376|NCT00121251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921296|NCT00121030|Epoetin Alfa|epoetin alfa|mesh-list
64921297|NCT00121030|Darbepoetin alfa|darbepoetin alfa|mesh-list
64921298|NCT00121030|Hematinics|hematinics|mesh-ancestor
64921299|NCT00121069|Citalopram|citalopram|mesh-list
64921300|NCT00121069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64921301|NCT00121069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64921302|NCT00121069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64921303|NCT00121069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921304|NCT00121069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64921342|NCT00121381|Pimecrolimus|pimecrolimus|mesh-list
64921424|NCT04705948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64921425|NCT04705948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921426|NCT04705948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64921427|NCT04705948|Anticonvulsants|anticonvulsants|mesh-ancestor
64921428|NCT04705948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64921433|NCT00121888|Paroxetine|paroxetine|mesh-list
64526441|NCT02666950|Antiviral Agents|antiviral agents|mesh-ancestor
64526442|NCT02666950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64526443|NCT02666950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64526444|NCT02666950|Immunologic Factors|immunologic factors|mesh-ancestor
64526445|NCT02666950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526446|NCT02666950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526447|NCT02668432|Amiodarone|amiodarone|mesh-list
64921722|NCT00009204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64921723|NCT00009204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64921724|NCT00009204|Dopamine Agents|dopamine agents|mesh-ancestor
64921725|NCT00394459|Anesthetics|anesthetics|mesh-list
64921726|NCT00394459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64921727|NCT00394459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921728|NCT05638919|Antiviral Agents|antiviral agents|mesh-list
64921729|NCT05638919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921730|NCT00394498|Lenograstim|lenograstim|mesh-list
64921731|NCT00394498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64921732|NCT00394498|Immunologic Factors|immunologic factors|mesh-ancestor
64921734|NCT00394537|Labetalol|labetalol|mesh-list
64921867|NCT00009750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64921868|NCT00009750|Antibodies|antibodies|mesh-list
64921869|NCT00009750|Immunoglobulins|immunoglobulins|mesh-list
64921870|NCT00009750|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64921871|NCT00009750|Cyclosporins|cyclosporins|mesh-list
64921910|NCT00019123|Growth Substances|growth substances|mesh-ancestor
64922052|NCT00019864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64922053|NCT00019864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922054|NCT00019864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922055|NCT00019864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64922056|NCT00019864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922057|NCT00019864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64922058|NCT00019864|Abortifacient Agents|abortifacient agents|mesh-ancestor
64922059|NCT00019864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64922195|NCT00020527|Caspofungin|caspofungin|mesh-list
64922196|NCT00020527|Antifungal Agents|antifungal agents|mesh-ancestor
64922197|NCT00020527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64922198|NCT00020527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922199|NCT00020527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922200|NCT00020566|Dactinomycin|dactinomycin|mesh-list
64922201|NCT00020566|Doxorubicin|doxorubicin|mesh-list
64922233|NCT00010062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64526521|NCT00367978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922325|NCT00020917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64690773|NCT05417659|Niacin|niacin|mesh-list
64922326|NCT00020917|Immunologic Factors|immunologic factors|mesh-ancestor
64922327|NCT00020917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64922328|NCT00020917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64922329|NCT00020917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922330|NCT00020917|Antidotes|antidotes|mesh-ancestor
64922331|NCT00020917|Protective Agents|protective agents|mesh-ancestor
64922332|NCT00020917|Vitamin B Complex|vitamin b complex|mesh-ancestor
64922333|NCT00020917|Vitamins|vitamins|mesh-ancestor
64922334|NCT00020917|Micronutrients|micronutrients|mesh-ancestor
64922369|NCT00021112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64922370|NCT00021112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64922372|NCT00021112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922657|NCT00022399|Celecoxib|celecoxib|mesh-list
64922658|NCT00022399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64922659|NCT00022399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64922660|NCT00022399|Analgesics|analgesics|mesh-ancestor
64526524|NCT00367978|Protease Inhibitors|protease inhibitors|mesh-ancestor
64526525|NCT00367978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526526|NCT00368056|Eszopiclone|eszopiclone|mesh-list
64526527|NCT00368056|Zopiclone|zopiclone|mesh-list
64922827|NCT00023218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64922857|NCT02024607|Fluorouracil|fluorouracil|mesh-list
64922858|NCT02024607|Capecitabine|capecitabine|mesh-list
64922860|NCT02024607|Irinotecan|irinotecan|mesh-list
64922993|NCT00000176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64922994|NCT00000176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922995|NCT00000179|Haloperidol|haloperidol|mesh-list
64922996|NCT00000179|Haloperidol decanoate|haloperidol decanoate|mesh-list
64922997|NCT00000179|Trazodone|trazodone|mesh-list
64526615|NCT04707508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64526616|NCT04707508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64526617|NCT04707508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64526618|NCT04707508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526619|NCT05145400|Dexamethasone|dexamethasone|mesh-list
64923044|NCT00000191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64923046|NCT00000191|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64923191|NCT00024193|Alkylating Agents|alkylating agents|mesh-ancestor
64923192|NCT00024193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923224|NCT00024271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64923225|NCT00024271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64923226|NCT00024271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64923227|NCT00024271|Alkylating Agents|alkylating agents|mesh-ancestor
64923228|NCT00024271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64923230|NCT00024310|Paclitaxel|paclitaxel|mesh-list
64923231|NCT00024310|Lometrexol|lometrexol|mesh-list
64923232|NCT00024310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64923233|NCT00024310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526639|NCT01567865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526640|NCT05049226|Vaccines|vaccines|mesh-list
64526641|NCT05049226|Immunologic Factors|immunologic factors|mesh-ancestor
64526642|NCT05049226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526643|NCT05044936|Cannabidiol|cannabidiol|mesh-list
64526644|NCT05044936|Anticonvulsants|anticonvulsants|mesh-ancestor
64526645|NCT05005000|Triamcinolone|triamcinolone|mesh-list
64526646|NCT05005000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64923400|NCT00025285|Immunologic Factors|immunologic factors|mesh-ancestor
64923401|NCT00025285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923402|NCT00025285|Leprostatic Agents|leprostatic agents|mesh-ancestor
64923616|NCT00025636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64692058|NCT02823431|Lidocaine|lidocaine|mesh-list
64923617|NCT00025636|Alkylating Agents|alkylating agents|mesh-ancestor
64923618|NCT00025636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923619|NCT00025636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923712|NCT00026182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923713|NCT00026182|Immunologic Factors|immunologic factors|mesh-ancestor
64923714|NCT00026182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923715|NCT00026182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64923716|NCT00026182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64923717|NCT00026182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64923743|NCT00026338|Antiviral Agents|antiviral agents|mesh-ancestor
64526730|NCT01566773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64526731|NCT01566773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526732|NCT01566773|Anticonvulsants|anticonvulsants|mesh-ancestor
64526733|NCT04134442|Bupivacaine|bupivacaine|mesh-list
64526734|NCT04134442|Anesthetics, Local|anesthetics, local|mesh-ancestor
64526735|NCT04134442|Anesthetics|anesthetics|mesh-ancestor
64526736|NCT04134442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64526737|NCT04134442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526738|NCT04134442|Sensory System Agents|sensory system agents|mesh-ancestor
64526739|NCT04134442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526740|NCT04116437|Zanubrutinib|zanubrutinib|mesh-list
64526741|NCT04116437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923861|NCT00000428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923862|NCT00000428|Adrenergic Agents|adrenergic agents|mesh-ancestor
64923863|NCT00000428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64923865|NCT00027391|Oxandrolone|oxandrolone|mesh-list
64923866|NCT00027391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64923867|NCT00027391|Autonomic Agents|autonomic agents|mesh-ancestor
64923892|NCT00000461|Vasodilator Agents|vasodilator agents|mesh-ancestor
64923965|NCT00000464|Mexiletine|mexiletine|mesh-list
64923966|NCT00000464|Procainamide|procainamide|mesh-list
64923967|NCT00000464|Imipramine|imipramine|mesh-list
64923968|NCT00000464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64923993|NCT00000464|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64923994|NCT00000464|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64526793|NCT03417388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64526814|NCT03382834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526815|NCT03382834|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64924232|NCT00028132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924233|NCT00028132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64924234|NCT00028132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64924235|NCT00028171|Tacrolimus|tacrolimus|mesh-list
64924236|NCT00028171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64924237|NCT00028171|Immunologic Factors|immunologic factors|mesh-ancestor
64924238|NCT00028171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924242|NCT00012090|Goserelin|goserelin|mesh-list
64924452|NCT00028717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924453|NCT00028717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64924454|NCT00028717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64924455|NCT00028717|Alkylating Agents|alkylating agents|mesh-ancestor
64924456|NCT00028717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924457|NCT00028717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924588|NCT01803555|Adrenergic Agents|adrenergic agents|mesh-ancestor
64924589|NCT01803555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64924590|NCT01803555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924591|NCT00028990|Paclitaxel|paclitaxel|mesh-list
64924592|NCT00028990|Bevacizumab|bevacizumab|mesh-list
64924593|NCT00028990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64924594|NCT00028990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924595|NCT00028990|Tubulin Modulators|tubulin modulators|mesh-ancestor
64924724|NCT00029770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924725|NCT00029770|Antipyretics|antipyretics|mesh-ancestor
64924726|NCT00029770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64526885|NCT03295240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64526886|NCT03295240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64526890|NCT03293368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64526915|NCT04341844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526916|NCT01561313|Adalimumab|adalimumab|mesh-list
64924852|NCT00000518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64924853|NCT00000518|Sympatholytics|sympatholytics|mesh-ancestor
64924854|NCT00000518|Autonomic Agents|autonomic agents|mesh-ancestor
64924855|NCT00000518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64924856|NCT00000518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64924857|NCT00000518|Antimalarials|antimalarials|mesh-ancestor
64924858|NCT00000518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64924859|NCT00000518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64925022|NCT00000539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925023|NCT00000539|Provitamins|provitamins|mesh-ancestor
64925025|NCT00030979|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64925026|NCT00030979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925027|NCT00030979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925028|NCT00030979|Cholinergic Agents|cholinergic agents|mesh-ancestor
64925029|NCT00030979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64925030|NCT00030979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526960|NCT01374906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64526961|NCT01374906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526962|NCT03228394|Ganaxolone|ganaxolone|mesh-list
64526963|NCT03228394|Neurosteroids|neurosteroids|mesh-ancestor
64925118|NCT00000563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64925119|NCT00000563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925120|NCT00031564|Aldesleukin|aldesleukin|mesh-list
64925121|NCT00031564|Interleukin-2|interleukin-2|mesh-list
64925122|NCT00031564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925123|NCT00031564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925124|NCT00031564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64925125|NCT00031564|Analgesics|analgesics|mesh-ancestor
64925126|NCT00031564|Sensory System Agents|sensory system agents|mesh-ancestor
64526969|NCT00362596|Acyclovir|acyclovir|mesh-list
64526992|NCT03013504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526993|NCT03013504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526994|NCT03013504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64925292|NCT00032149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925293|NCT00032149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64925294|NCT00032149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64925295|NCT00032149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64925296|NCT00032149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64925297|NCT00032149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925298|NCT00032149|Tubulin Modulators|tubulin modulators|mesh-ancestor
64925299|NCT00032149|Antimitotic Agents|antimitotic agents|mesh-ancestor
64527065|NCT02678286|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64527066|NCT02678286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64527067|NCT02678286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527068|NCT02678286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527069|NCT03164694|Carboplatin|carboplatin|mesh-list
64527070|NCT03164694|Pemetrexed|pemetrexed|mesh-list
64527071|NCT03164694|Apatinib|apatinib|mesh-list
64527072|NCT03164694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527078|NCT04775550|Dexamethasone|dexamethasone|mesh-list
64925422|NCT00000611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925423|NCT00000611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64925424|NCT00000611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64925425|NCT00000611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64925426|NCT00032968|Buprenorphine|buprenorphine|mesh-list
64925506|NCT00000620|Chlorthalidone|chlorthalidone|mesh-list
64925507|NCT00000620|Diltiazem|diltiazem|mesh-list
64925508|NCT00000620|Benazepril|benazepril|mesh-list
64925509|NCT00000620|Hydralazine|hydralazine|mesh-list
64925510|NCT00000620|Antihypertensive Agents|antihypertensive agents|mesh-list
64925511|NCT00000620|Reserpine|reserpine|mesh-list
64925512|NCT00000620|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
64925513|NCT00000620|Hydrochlorothiazide-triamterene|hydrochlorothiazide-triamterene|mesh-list
64925514|NCT00000620|Triamterene|triamterene|mesh-list
64925613|NCT02971696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64925614|NCT02971696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925615|NCT02971696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925616|NCT00033436|Niacinamide|niacinamide|mesh-list
64925617|NCT00033436|Niacin|niacin|mesh-list
64925742|NCT00000644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925743|NCT00000644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64925744|NCT00000644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64925746|NCT02971423|Sulbactam|sulbactam|mesh-list
64925747|NCT02971423|Cilastatin|cilastatin|mesh-list
64925769|NCT00033982|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64925770|NCT00033982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64925771|NCT00033982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64925772|NCT00033982|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64925773|NCT00033982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64925774|NCT00033982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925775|NCT00033982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925780|NCT00034060|Etanercept|etanercept|mesh-list
64527186|NCT01557569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925946|NCT00014040|Nitric Oxide|nitric oxide|mesh-list
64925947|NCT00014040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64925948|NCT00014040|Autonomic Agents|autonomic agents|mesh-ancestor
64925949|NCT00014040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64925950|NCT00014040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925951|NCT00014040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64925952|NCT00014040|Respiratory System Agents|respiratory system agents|mesh-ancestor
64925954|NCT00014040|Antioxidants|antioxidants|mesh-ancestor
64527202|NCT01537783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926051|NCT00034801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64926052|NCT00034801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64926053|NCT00034801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64926054|NCT00034801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64926055|NCT00034801|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64926056|NCT00034801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64926057|NCT00034801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64926064|NCT00014196|Docetaxel|docetaxel|mesh-list
64527224|NCT01555931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64527225|NCT01555931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527226|NCT01555931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64926114|NCT00000689|Dermatologic Agents|dermatologic agents|mesh-ancestor
64926115|NCT00000689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64926116|NCT00000689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64926117|NCT00000689|Antiviral Agents|antiviral agents|mesh-ancestor
64926118|NCT00000689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926218|NCT00035035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64926219|NCT00035035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64926220|NCT00000719|Zidovudine|zidovudine|mesh-list
64926221|NCT00000719|Zalcitabine|zalcitabine|mesh-list
64926242|NCT00035074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926243|NCT00035074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64926244|NCT00035074|Antimetabolites|antimetabolites|mesh-ancestor
64926245|NCT00035074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926246|NCT00035074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926247|NCT00035074|Dermatologic Agents|dermatologic agents|mesh-ancestor
64926248|NCT00035074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926254|NCT00035113|Epothilones|epothilones|mesh-list
64926347|NCT00014430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64926349|NCT00014430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64926350|NCT00014430|Tubulin Modulators|tubulin modulators|mesh-ancestor
64926351|NCT00014430|Antimitotic Agents|antimitotic agents|mesh-ancestor
64926352|NCT00014430|Mitosis Modulators|mitosis modulators|mesh-ancestor
64926353|NCT00014430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926354|NCT00035425|Vancomycin|vancomycin|mesh-list
64926355|NCT00035425|Linezolid|linezolid|mesh-list
64926356|NCT00035425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64926357|NCT00035425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64527263|NCT01555463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527264|NCT01555463|Dermatologic Agents|dermatologic agents|mesh-ancestor
64926471|NCT00035620|Lenograstim|lenograstim|mesh-list
64926472|NCT00035620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64926473|NCT00035620|Immunologic Factors|immunologic factors|mesh-ancestor
64926474|NCT00035620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926475|NCT00014547|BBR 3464|bbr 3464|mesh-list
64926476|NCT00014547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926477|NCT02971306|Acetylcysteine|acetylcysteine|mesh-list
64527277|NCT01537081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64527278|NCT01537081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527279|NCT01537081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527280|NCT01537081|Appetite Depressants|appetite depressants|mesh-ancestor
64527281|NCT01537081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64527282|NCT01537081|Sympathomimetics|sympathomimetics|mesh-ancestor
64527283|NCT01537081|Autonomic Agents|autonomic agents|mesh-ancestor
64527284|NCT01537081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64527285|NCT01537081|Nasal Decongestants|nasal decongestants|mesh-ancestor
64527286|NCT01537081|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64527287|NCT01555073|Celecoxib|celecoxib|mesh-list
64527288|NCT01555073|Pregabalin|pregabalin|mesh-list
64527289|NCT01555073|Analgesics|analgesics|mesh-ancestor
64527290|NCT01555073|Sensory System Agents|sensory system agents|mesh-ancestor
64527291|NCT01555073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64527292|NCT01555073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527294|NCT01555073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64926506|NCT04732390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64926507|NCT04732390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926508|NCT04732390|Sensory System Agents|sensory system agents|mesh-ancestor
64926509|NCT04732390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64926510|NCT04732390|Analgesics|analgesics|mesh-ancestor
64926511|NCT04732390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64926512|NCT04732390|Anticonvulsants|anticonvulsants|mesh-ancestor
64926513|NCT04732390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64926514|NCT04732390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64527299|NCT01555073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64527300|NCT01555073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64527301|NCT01555073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64527302|NCT01555073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64527309|NCT01582243|Vildagliptin|vildagliptin|mesh-list
64527349|NCT04410211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64527350|NCT04410211|Anesthetics, General|anesthetics, general|mesh-ancestor
64527351|NCT04410211|Anesthetics|anesthetics|mesh-ancestor
64926549|NCT00014625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527388|NCT01581307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527390|NCT01581307|Immunologic Factors|immunologic factors|mesh-ancestor
64527391|NCT01581307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527393|NCT01581307|Protective Agents|protective agents|mesh-ancestor
64527394|NCT01581307|Vitamin B Complex|vitamin b complex|mesh-ancestor
64527395|NCT01581307|Vitamins|vitamins|mesh-ancestor
64527396|NCT01581307|Micronutrients|micronutrients|mesh-ancestor
64527397|NCT01581307|Hematinics|hematinics|mesh-ancestor
64527398|NCT01580995|Valacyclovir|valacyclovir|mesh-list
64527399|NCT01580995|Antiviral Agents|antiviral agents|mesh-ancestor
64527400|NCT01580995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64527401|NCT01553279|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64527402|NCT01553279|Immunologic Factors|immunologic factors|mesh-ancestor
64527403|NCT01553279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527404|NCT01562743|Rotigotine|rotigotine|mesh-list
64926636|NCT00000794|Antidotes|antidotes|mesh-ancestor
64926637|NCT00000794|Protective Agents|protective agents|mesh-ancestor
64926638|NCT00000794|Vitamin B Complex|vitamin b complex|mesh-ancestor
64926640|NCT00000794|Micronutrients|micronutrients|mesh-ancestor
64926641|NCT00000794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64926642|NCT00000794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926643|NCT00000794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64926644|NCT00000794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926645|NCT00000794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926681|NCT00391638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926768|NCT00036868|Cyclophosphamide|cyclophosphamide|mesh-list
64926769|NCT00036868|Fluorouracil|fluorouracil|mesh-list
64926800|NCT00036985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64926801|NCT00036985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64926802|NCT00036985|Immunologic Factors|immunologic factors|mesh-ancestor
64926896|NCT00000893|Efavirenz|efavirenz|mesh-list
64927012|NCT00038077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64927014|NCT00038077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64927015|NCT00038077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527415|NCT03028571|Autonomic Agents|autonomic agents|mesh-ancestor
64527416|NCT03028571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64527417|NCT03028571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527418|NCT03028571|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64927160|NCT00396682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64927161|NCT00396721|Sirolimus|sirolimus|mesh-list
64527422|NCT03028571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527424|NCT01535443|Bromfenac|bromfenac|mesh-list
64527425|NCT01535443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64527444|NCT01535287|Adrenergic Agents|adrenergic agents|mesh-ancestor
64527445|NCT01535287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64927327|NCT00001001|Antiviral Agents|antiviral agents|mesh-ancestor
64927328|NCT00001001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927329|NCT00001001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64927330|NCT00001001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64927331|NCT05076877|Metformin|metformin|mesh-list
64927332|NCT05076877|Midazolam|midazolam|mesh-list
64927333|NCT05076877|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64927334|NCT05076877|Lazertinib|lazertinib|mesh-list
64927335|NCT05076877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64927336|NCT05076877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927337|NCT05076877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64927338|NCT05076877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64927339|NCT05076877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64927340|NCT05076877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64927367|NCT00396760|Hemostatics|hemostatics|mesh-ancestor
64927368|NCT00396760|Coagulants|coagulants|mesh-ancestor
64927369|NCT00396760|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64927370|NCT00396760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64927371|NCT00396760|Protease Inhibitors|protease inhibitors|mesh-ancestor
64527450|NCT01549613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64527451|NCT04106219|Cyclophosphamide|cyclophosphamide|mesh-list
64527452|NCT04106219|Topotecan|topotecan|mesh-list
64527453|NCT04106219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64527454|NCT04106219|Immunologic Factors|immunologic factors|mesh-ancestor
64527468|NCT01546883|Dabigatran|dabigatran|mesh-list
64927517|NCT00015873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64927518|NCT00015873|Glucocorticoids|glucocorticoids|mesh-ancestor
64927519|NCT00015873|Hormones|hormones|mesh-ancestor
64927520|NCT00015873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64927521|NCT00015873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64927522|NCT00015912|Interferons|interferons|mesh-list
64927523|NCT00015912|Interferon-alpha|interferon-alpha|mesh-list
64927524|NCT00015912|Interferon alpha-2|interferon alpha-2|mesh-list
64927700|NCT00016224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927701|NCT00016263|Dacarbazine|dacarbazine|mesh-list
64927702|NCT00016263|Oblimersen|oblimersen|mesh-list
64927703|NCT00016263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64927704|NCT00016263|Alkylating Agents|alkylating agents|mesh-ancestor
64927705|NCT00016263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927706|NCT00016263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927707|NCT00016302|Leucovorin|leucovorin|mesh-list
64927708|NCT00016302|Cytarabine|cytarabine|mesh-list
64927709|NCT00016302|Dexamethasone|dexamethasone|mesh-list
64927797|NCT00016341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64927798|NCT00016341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64927799|NCT00016341|Appetite Stimulants|appetite stimulants|mesh-ancestor
64927800|NCT00016341|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64927801|NCT00001181|Testolactone|testolactone|mesh-list
64927802|NCT00001181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64927803|NCT00001181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527527|NCT01540487|Metformin|metformin|mesh-list
64527542|NCT01539317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527543|NCT01539317|Sensory System Agents|sensory system agents|mesh-ancestor
64527544|NCT01539317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64527545|NCT01539317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64527546|NCT01539317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64527547|NCT01539317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64527548|NCT01539317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64527562|NCT01539083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527563|NCT01539083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64527564|NCT01539083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64527565|NCT01539083|Antiemetics|antiemetics|mesh-ancestor
64527566|NCT01539083|Autonomic Agents|autonomic agents|mesh-ancestor
64527567|NCT01539083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64927920|NCT02347111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64927921|NCT02347111|Adrenergic Agents|adrenergic agents|mesh-ancestor
64927922|NCT02347111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64696334|NCT02263326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927923|NCT02347111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927924|NCT02347111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927925|NCT02347111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64927926|NCT02347111|Sympatholytics|sympatholytics|mesh-ancestor
64927927|NCT02347111|Autonomic Agents|autonomic agents|mesh-ancestor
64927928|NCT02347111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64927929|NCT02347111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64927930|NCT02347111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64927964|NCT00016887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64927966|NCT00016887|Antiemetics|antiemetics|mesh-ancestor
64928055|NCT00038896|Antidepressive Agents|antidepressive agents|mesh-ancestor
64928056|NCT00038896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64928057|NCT00038935|Factor VIII|factor viii|mesh-list
64928093|NCT00039169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928094|NCT00001304|Vitamin D|vitamin d|mesh-list
64928095|NCT00001304|Calcitriol|calcitriol|mesh-list
64928096|NCT00001304|Calcium|calcium|mesh-list
64928097|NCT00001304|Parathyroid Hormone|parathyroid hormone|mesh-list
64928098|NCT00001304|Hormones|hormones|mesh-list
64928099|NCT00001304|Vitamins|vitamins|mesh-ancestor
64928100|NCT00001304|Micronutrients|micronutrients|mesh-ancestor
64928101|NCT00001304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928129|NCT00039208|Vitamins|vitamins|mesh-ancestor
64928130|NCT00039208|Micronutrients|micronutrients|mesh-ancestor
64928131|NCT00017121|Sargramostim|sargramostim|mesh-list
64928132|NCT00017121|Immunologic Factors|immunologic factors|mesh-ancestor
64928133|NCT00017121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928134|NCT00039286|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64928135|NCT00039286|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64928136|NCT00039286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928137|NCT00039364|Imatinib Mesylate|imatinib mesylate|mesh-list
64928272|NCT00039988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64928273|NCT00039988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64928301|NCT00040066|Sensory System Agents|sensory system agents|mesh-ancestor
64928302|NCT00040066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64928303|NCT00040066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64928304|NCT00040066|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64527572|NCT01539083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64527573|NCT01539083|Leprostatic Agents|leprostatic agents|mesh-ancestor
64527574|NCT01539083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64527575|NCT01539083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64527576|NCT01539083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64527577|NCT01539083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64928401|NCT00040690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64928402|NCT00040690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64928403|NCT00040690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64928404|NCT00040690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928405|NCT00040690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64928556|NCT00001436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928557|NCT00001436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64928558|NCT00001436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928582|NCT00041704|Anidulafungin|anidulafungin|mesh-list
64928583|NCT00041704|Antifungal Agents|antifungal agents|mesh-ancestor
64928584|NCT00041704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64928585|NCT00017472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64928695|NCT02970643|Serotonin Agents|serotonin agents|mesh-ancestor
64928696|NCT02970643|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64928697|NCT02970643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64928729|NCT00042562|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64527597|NCT01536587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64527599|NCT01536587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64527600|NCT01536587|Adrenergic Agents|adrenergic agents|mesh-ancestor
64527601|NCT01536587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64527615|NCT01534637|Fluorouracil|fluorouracil|mesh-list
64527616|NCT01534637|Capecitabine|capecitabine|mesh-list
64527617|NCT01534637|Aprepitant|aprepitant|mesh-list
64527618|NCT01534637|Antiemetics|antiemetics|mesh-list
64527619|NCT01534637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64527620|NCT01534637|Antimetabolites|antimetabolites|mesh-ancestor
64527621|NCT01534637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527622|NCT01534637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527623|NCT01534637|Antiviral Agents|antiviral agents|mesh-ancestor
64928873|NCT00043147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928874|NCT00043147|Antiemetics|antiemetics|mesh-ancestor
64928875|NCT00043147|Autonomic Agents|autonomic agents|mesh-ancestor
64928876|NCT00043147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64928877|NCT00043147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64928878|NCT00043147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64928879|NCT00043147|Protective Agents|protective agents|mesh-ancestor
64928880|NCT00043147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64928882|NCT00017862|Reslizumab|reslizumab|mesh-list
64928963|NCT00043576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928964|NCT00043576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64928965|NCT00043576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928966|NCT00043576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64928967|NCT00043576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64527689|NCT02677116|Ifosfamide|ifosfamide|mesh-list
64527690|NCT02677116|Olaratumab|olaratumab|mesh-list
64929102|NCT00044278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64929103|NCT00044278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64929104|NCT00044278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64929105|NCT00044395|Ruboxistaurin|ruboxistaurin|mesh-list
64527696|NCT02677116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527697|NCT02677116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64527698|NCT02677116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64527699|NCT02677116|Tubulin Modulators|tubulin modulators|mesh-ancestor
64527700|NCT02677116|Antimitotic Agents|antimitotic agents|mesh-ancestor
64527701|NCT02677116|Mitosis Modulators|mitosis modulators|mesh-ancestor
64929174|NCT00397501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64929175|NCT00397501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929176|NCT00397501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64527704|NCT02689518|Aflibercept|aflibercept|mesh-list
64527705|NCT02689518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64527706|NCT02689518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64527707|NCT02689518|Growth Substances|growth substances|mesh-ancestor
64527737|NCT03164304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64527738|NCT02689284|Pembrolizumab|pembrolizumab|mesh-list
64527739|NCT02689284|Margetuximab|margetuximab|mesh-list
64527740|NCT02689284|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64527741|NCT02689284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64527742|NCT02689284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527743|NCT02689284|Immunologic Factors|immunologic factors|mesh-ancestor
64527744|NCT02689284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527745|NCT03165396|Propofol|propofol|mesh-list
64527746|NCT03165396|Sevoflurane|sevoflurane|mesh-list
64929324|NCT00045175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64929325|NCT00045292|Valacyclovir|valacyclovir|mesh-list
64929326|NCT00045292|Acyclovir|acyclovir|mesh-list
64929327|NCT00045292|Antiviral Agents|antiviral agents|mesh-ancestor
64929328|NCT00045292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64929329|NCT00045370|Interferons|interferons|mesh-list
64929330|NCT00045370|Interferon-alpha|interferon-alpha|mesh-list
64929331|NCT00045370|Sirolimus|sirolimus|mesh-list
64929332|NCT00045370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929363|NCT00045448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929499|NCT00045916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64929500|NCT00045916|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64929501|NCT00045916|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64929572|NCT00046267|Niacin|niacin|mesh-list
64929582|NCT00046306|Antioxidants|antioxidants|mesh-list
64945551|NCT05450692|Docetaxel|docetaxel|mesh-list
64945552|NCT05450692|Durvalumab|durvalumab|mesh-list
64929583|NCT00046306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929584|NCT00046306|Protective Agents|protective agents|mesh-ancestor
64929585|NCT00046306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929586|NCT00046345|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64929587|NCT00046345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64527819|NCT03163914|Mydriatics|mydriatics|mesh-ancestor
64929668|NCT00001766|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64929669|NCT00001766|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64929670|NCT00001766|Protease Inhibitors|protease inhibitors|mesh-ancestor
64929671|NCT00001766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929672|NCT00001766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929673|NCT00001766|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64929674|NCT00001766|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64929675|NCT00001766|Antiviral Agents|antiviral agents|mesh-ancestor
64929676|NCT00001766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64929677|NCT00001766|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64929752|NCT04733781|Lidocaine|lidocaine|mesh-list
64929837|NCT00047476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929838|NCT00047476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64929839|NCT00047476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64929840|NCT00047476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64929841|NCT00047476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929842|NCT00047476|Dopamine Agents|dopamine agents|mesh-ancestor
64929843|NCT00047476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64929844|NCT00047554|Travoprost|travoprost|mesh-list
64929848|NCT00047632|Interferons|interferons|mesh-list
64929949|NCT00048607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929950|NCT00048607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64929951|NCT00048607|Serotonin Agents|serotonin agents|mesh-ancestor
64929982|NCT00048763|Protective Agents|protective agents|mesh-ancestor
64929983|NCT00048763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64929984|NCT00048763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64929985|NCT00048763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930075|NCT05576181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64930076|NCT05576181|Immunologic Factors|immunologic factors|mesh-ancestor
64930077|NCT05576181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930078|NCT05576181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64930088|NCT00049348|Gemcitabine|gemcitabine|mesh-list
64930229|NCT00050245|Rituximab|rituximab|mesh-list
64930230|NCT00050245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64930231|NCT00050245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930232|NCT00050245|Immunologic Factors|immunologic factors|mesh-ancestor
64930233|NCT00050245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930234|NCT00050245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64930235|NCT00050362|Rofecoxib|rofecoxib|mesh-list
64930236|NCT00050362|Bupivacaine|bupivacaine|mesh-list
64930237|NCT00050362|Anesthetics, Local|anesthetics, local|mesh-ancestor
64930238|NCT00050362|Anesthetics|anesthetics|mesh-ancestor
64930239|NCT00050362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64930240|NCT00050362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930241|NCT00050362|Sensory System Agents|sensory system agents|mesh-ancestor
64930272|NCT00050440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64930274|NCT00050440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930275|NCT00050479|Celecoxib|celecoxib|mesh-list
64930276|NCT00050479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64930277|NCT00050479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64930278|NCT00050479|Analgesics|analgesics|mesh-ancestor
64930279|NCT00050479|Sensory System Agents|sensory system agents|mesh-ancestor
64930280|NCT00050479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64930281|NCT00050479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930282|NCT00050479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64930283|NCT00050479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64930284|NCT00050479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64930285|NCT00050479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64930315|NCT00050830|Anesthetics, Local|anesthetics, local|mesh-ancestor
64930316|NCT00050830|Anesthetics|anesthetics|mesh-ancestor
64930317|NCT00050830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64930318|NCT00050830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930319|NCT00050830|Sensory System Agents|sensory system agents|mesh-ancestor
64930320|NCT00050830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64930321|NCT00050830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930322|NCT00050830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64930323|NCT00050830|Protective Agents|protective agents|mesh-ancestor
64930324|NCT00050947|Oxcarbazepine|oxcarbazepine|mesh-list
64930325|NCT00050947|Anticonvulsants|anticonvulsants|mesh-ancestor
64650524|NCT02512302|Antidotes|antidotes|mesh-ancestor
64930326|NCT00050947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64930327|NCT00050947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64930328|NCT00050947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64930361|NCT05639777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64527924|NCT02671500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64527925|NCT02671266|Oxytocin|oxytocin|mesh-list
64527926|NCT02671266|Oxytocics|oxytocics|mesh-ancestor
64527927|NCT02671266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64527928|NCT02671266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930483|NCT00052273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64930484|NCT00052273|Antimetabolites|antimetabolites|mesh-ancestor
64930485|NCT00052273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930486|NCT00052273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930487|NCT00052312|Paclitaxel|paclitaxel|mesh-list
64930557|NCT00052468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930558|NCT00052468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64930559|NCT00052468|Immunologic Factors|immunologic factors|mesh-ancestor
64930560|NCT00052468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930561|NCT00052507|Bortezomib|bortezomib|mesh-list
64930585|NCT00052585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64930586|NCT00052780|Temozolomide|temozolomide|mesh-list
64930587|NCT00052780|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64930588|NCT00052780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64930589|NCT00052780|Alkylating Agents|alkylating agents|mesh-ancestor
64930683|NCT00053287|Antimetabolites|antimetabolites|mesh-ancestor
64930684|NCT00053287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930685|NCT00053287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64930686|NCT00053287|Immunologic Factors|immunologic factors|mesh-ancestor
64930687|NCT00053287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930757|NCT05626478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64930758|NCT05626478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930759|NCT05626478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930760|NCT05626478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930761|NCT05626478|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64930762|NCT05626478|Protective Agents|protective agents|mesh-ancestor
64930763|NCT05626478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64930764|NCT05626478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64930765|NCT05626478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64930852|NCT00054184|Docetaxel|docetaxel|mesh-list
64930853|NCT00054184|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
64930854|NCT00054184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64930855|NCT00054184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528037|NCT02135874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64528038|NCT02135874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64528039|NCT02135874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64528040|NCT01531673|Ivacaftor|ivacaftor|mesh-list
64528043|NCT01531673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528045|NCT01531205|Goserelin|goserelin|mesh-list
64528046|NCT01531205|Bicalutamide|bicalutamide|mesh-list
64528047|NCT01531205|Androgens|androgens|mesh-list
64931199|NCT00056329|Vitamins|vitamins|mesh-ancestor
64931200|NCT00056329|Micronutrients|micronutrients|mesh-ancestor
64931201|NCT00056329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931202|NCT00056329|Antioxidants|antioxidants|mesh-ancestor
64931203|NCT00056329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931204|NCT00056329|Protective Agents|protective agents|mesh-ancestor
64931222|NCT00056446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931289|NCT05410197|Gemcitabine|gemcitabine|mesh-list
64931290|NCT05410197|Lenvatinib|lenvatinib|mesh-list
64931291|NCT05410197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931292|NCT05410197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64931293|NCT05410197|Antimetabolites|antimetabolites|mesh-ancestor
64931294|NCT05410197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931295|NCT05410197|Antiviral Agents|antiviral agents|mesh-ancestor
64931433|NCT00058084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64931434|NCT00058084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931435|NCT00058084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931436|NCT00058084|Tubulin Modulators|tubulin modulators|mesh-ancestor
64931437|NCT00058084|Antimitotic Agents|antimitotic agents|mesh-ancestor
64528138|NCT00242619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528139|NCT01899027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64528140|NCT01899027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64528141|NCT01899027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64528142|NCT01899027|Antimetabolites|antimetabolites|mesh-ancestor
64528143|NCT01899027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528144|NCT01899027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64931659|NCT00060112|Antimetabolites|antimetabolites|mesh-ancestor
64931660|NCT00060112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931661|NCT00060112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931662|NCT00060112|Antiviral Agents|antiviral agents|mesh-ancestor
64931663|NCT00060112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931664|NCT00060112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931665|NCT00060112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64931666|NCT00060112|Immunologic Factors|immunologic factors|mesh-ancestor
64931667|NCT00060112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931710|NCT05105685|Hormones|hormones|mesh-list
64931908|NCT00061477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64650650|NCT02518464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931910|NCT02968342|Progestins|progestins|mesh-ancestor
64931911|NCT02968342|Hormones|hormones|mesh-ancestor
64931912|NCT02968342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64931913|NCT02968342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931914|NCT02968303|Vemurafenib|vemurafenib|mesh-list
64931915|NCT02968303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931916|NCT02968303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64931917|NCT02968303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931918|NCT02968303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931940|NCT00061594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64931941|NCT00061594|Growth Substances|growth substances|mesh-ancestor
64931942|NCT00061594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931943|NCT00061594|Growth Inhibitors|growth inhibitors|mesh-ancestor
64931944|NCT00061594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931945|NCT00061711|Hormones|hormones|mesh-list
64931946|NCT00061711|Phytoestrogens|phytoestrogens|mesh-list
64931947|NCT00061711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64932004|NCT00398554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64932005|NCT00398554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64932006|NCT00398554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932007|NCT00398554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64932008|NCT00398554|Glucocorticoids|glucocorticoids|mesh-ancestor
64932145|NCT00062296|Immunologic Factors|immunologic factors|mesh-ancestor
64932146|NCT00062296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932147|NCT00062296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64932148|NCT00062296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64932149|NCT00062296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64932150|NCT00062296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64932151|NCT00062296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932186|NCT00062803|Anticoagulants|anticoagulants|mesh-ancestor
64932319|NCT00064207|Antiviral Agents|antiviral agents|mesh-ancestor
64932320|NCT00064207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64932321|NCT00064207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932322|NCT00064207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64932323|NCT00064207|Immunologic Factors|immunologic factors|mesh-ancestor
64932324|NCT00064207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932325|NCT00064246|Rituximab|rituximab|mesh-list
64932326|NCT00064246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64932327|NCT00064246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64932328|NCT00064246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528240|NCT00249249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528241|NCT01522235|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64528242|NCT01522235|gamma-Globulins|gamma-globulins|mesh-list
64528243|NCT01522235|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64528254|NCT00125931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64528255|NCT00125931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64932498|NCT00065923|Topiramate|topiramate|mesh-list
64528276|NCT01521923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64528277|NCT01521923|Immunologic Factors|immunologic factors|mesh-ancestor
64528278|NCT01521923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64528279|NCT01521923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64528280|NCT05240781|Sirolimus|sirolimus|mesh-list
64528370|NCT03027635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528371|NCT03027635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528372|NCT03027635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64528373|NCT03027635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64528374|NCT01520363|Dextromethorphan|dextromethorphan|mesh-list
64528375|NCT01520363|Antitussive Agents|antitussive agents|mesh-ancestor
64528376|NCT01520363|Respiratory System Agents|respiratory system agents|mesh-ancestor
64528377|NCT01520363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64528378|NCT01520363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64528415|NCT01561963|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64528416|NCT01561963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64528418|NCT01561963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64528449|NCT01534351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64932867|NCT00068848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64932868|NCT00068848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932909|NCT02966587|Durvalumab|durvalumab|mesh-list
64933008|NCT00070213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933009|NCT00070213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64933010|NCT00070213|Immunologic Factors|immunologic factors|mesh-ancestor
64933011|NCT00070213|Antidotes|antidotes|mesh-ancestor
64933012|NCT00070213|Protective Agents|protective agents|mesh-ancestor
64933013|NCT00070213|Vitamin B Complex|vitamin b complex|mesh-ancestor
64933014|NCT00070213|Vitamins|vitamins|mesh-ancestor
64933041|NCT00070447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64933043|NCT00070447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64933109|NCT00071188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64933110|NCT00071188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933111|NCT00071188|Tubulin Modulators|tubulin modulators|mesh-ancestor
64933112|NCT00071188|Antimitotic Agents|antimitotic agents|mesh-ancestor
64933198|NCT00390065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64933199|NCT00390065|Autonomic Agents|autonomic agents|mesh-ancestor
64528503|NCT03113448|Sensory System Agents|sensory system agents|mesh-ancestor
64528504|NCT03113448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64528505|NCT03113448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528506|NCT01533493|Memantine|memantine|mesh-list
64528507|NCT01533493|Methylphenidate|methylphenidate|mesh-list
64528508|NCT01533493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64528509|NCT01533493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528510|NCT01533493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64528517|NCT01533493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64528518|NCT01533493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64528519|NCT01533493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64528520|NCT02388048|Ofatumumab|ofatumumab|mesh-list
64528521|NCT02388048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528522|NCT02387892|Vitamin D|vitamin d|mesh-list
64528523|NCT02387892|Cholecalciferol|cholecalciferol|mesh-list
64528524|NCT02387892|Vitamins|vitamins|mesh-ancestor
64528585|NCT01790529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64933480|NCT00072943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64933481|NCT04834349|Pembrolizumab|pembrolizumab|mesh-list
64933482|NCT04834349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64933483|NCT04834349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933484|NCT00072982|Borage oil|borage oil|mesh-list
64933485|NCT00072982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64933486|NCT03959124|Memantine|memantine|mesh-list
64933487|NCT03959124|Rivastigmine|rivastigmine|mesh-list
64933490|NCT03959124|Dopamine Agents|dopamine agents|mesh-ancestor
64933613|NCT00073879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64933614|NCT00074074|Infliximab|infliximab|mesh-list
64528605|NCT04641507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528606|NCT04641507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528607|NCT04641507|Urological Agents|urological agents|mesh-ancestor
64528617|NCT04489173|Antiviral Agents|antiviral agents|mesh-ancestor
64528618|NCT04489173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64528619|NCT00512070|Olanzapine|olanzapine|mesh-list
64528620|NCT00512070|Melatonin|melatonin|mesh-list
64528621|NCT00512070|Antioxidants|antioxidants|mesh-ancestor
64528622|NCT00512070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933818|NCT00075595|Protective Agents|protective agents|mesh-ancestor
64933819|NCT00075595|Vitamin B Complex|vitamin b complex|mesh-ancestor
64933820|NCT00075595|Vitamins|vitamins|mesh-ancestor
64933821|NCT00075595|Micronutrients|micronutrients|mesh-ancestor
64933822|NCT00075634|Cyclophosphamide|cyclophosphamide|mesh-list
64933823|NCT00075634|Doxorubicin|doxorubicin|mesh-list
64933824|NCT00075634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64933825|NCT00075634|Decitabine|decitabine|mesh-list
64933826|NCT00075634|Azacitidine|azacitidine|mesh-list
64933827|NCT00075634|Lenograstim|lenograstim|mesh-list
64933863|NCT00075712|Paclitaxel|paclitaxel|mesh-list
64933889|NCT00075868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64933890|NCT00075868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933891|NCT00075907|Ritonavir|ritonavir|mesh-list
64933892|NCT00075907|Lopinavir|lopinavir|mesh-list
64933893|NCT00075907|Efavirenz|efavirenz|mesh-list
64933894|NCT00075907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64933895|NCT00075907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64933896|NCT00075907|Protease Inhibitors|protease inhibitors|mesh-ancestor
64933897|NCT00075907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933922|NCT00076414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64933923|NCT00076414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933924|NCT00076414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933925|NCT00399256|Acetylcysteine|acetylcysteine|mesh-list
64933926|NCT00399256|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64933927|NCT00399256|Antiviral Agents|antiviral agents|mesh-ancestor
64933928|NCT00399256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64933929|NCT00399256|Expectorants|expectorants|mesh-ancestor
64933930|NCT00399256|Respiratory System Agents|respiratory system agents|mesh-ancestor
64933931|NCT00399256|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64934013|NCT03951207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934014|NCT03951207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64934015|NCT03951207|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64934016|NCT03951207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64934017|NCT03951207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64934018|NCT03951207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934019|NCT03951207|Vasodilator Agents|vasodilator agents|mesh-ancestor
64934127|NCT03766581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64934128|NCT03766581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64934130|NCT03766581|Antipyretics|antipyretics|mesh-ancestor
64934131|NCT03766581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64934132|NCT03766581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64934133|NCT03766581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64934172|NCT00078247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934208|NCT00078793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64934209|NCT00078793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64934210|NCT00078793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64934211|NCT00078793|Immunologic Factors|immunologic factors|mesh-ancestor
64934213|NCT00078832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64934214|NCT00078832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934248|NCT00078910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64702743|NCT01761877|Sulindac|sulindac|mesh-list
64934251|NCT00078988|Carboplatin|carboplatin|mesh-list
64934331|NCT04472429|Mitosis Modulators|mitosis modulators|mesh-ancestor
64934332|NCT04472429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934333|NCT03647124|Lenalidomide|lenalidomide|mesh-list
64934334|NCT03647124|Immunologic Factors|immunologic factors|mesh-ancestor
64934335|NCT03647124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934336|NCT03647124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64934337|NCT03647124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64934341|NCT00079144|Aldesleukin|aldesleukin|mesh-list
64528744|NCT01518257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64528745|NCT01518257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64528746|NCT02391636|Oxytocin|oxytocin|mesh-list
64934374|NCT00079222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64934375|NCT00079261|Gemcitabine|gemcitabine|mesh-list
64934376|NCT00079261|Prednisone|prednisone|mesh-list
64934377|NCT00079261|Cyclophosphamide|cyclophosphamide|mesh-list
64934378|NCT00079261|Doxorubicin|doxorubicin|mesh-list
64934379|NCT00079261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64934380|NCT00079261|Vincristine|vincristine|mesh-list
64528758|NCT02383212|Pemetrexed|pemetrexed|mesh-list
64528759|NCT02383212|Cemiplimab|cemiplimab|mesh-list
64528760|NCT02383212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64528761|NCT02383212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528762|NCT02383212|Tubulin Modulators|tubulin modulators|mesh-ancestor
64528763|NCT02383212|Antimitotic Agents|antimitotic agents|mesh-ancestor
64528764|NCT02383212|Mitosis Modulators|mitosis modulators|mesh-ancestor
64528765|NCT02383212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528766|NCT02383212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64934482|NCT00079885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64934483|NCT00079885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64934578|NCT00080158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64934579|NCT00080158|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64934580|NCT00080197|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
64934581|NCT00080197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934582|NCT00080197|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64934583|NCT00080197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934584|NCT00080197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934585|NCT00080275|Niacin|niacin|mesh-list
64934586|NCT00080275|Simvastatin|simvastatin|mesh-list
64934587|NCT00080275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64934676|NCT00080743|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64934677|NCT00080743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64934678|NCT00080743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64934679|NCT00080743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934680|NCT04423367|Dexamethasone|dexamethasone|mesh-list
64934681|NCT04423367|Bortezomib|bortezomib|mesh-list
64934682|NCT04423367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64934683|NCT04423367|Antiemetics|antiemetics|mesh-ancestor
64934684|NCT04423367|Autonomic Agents|autonomic agents|mesh-ancestor
64934685|NCT04423367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64934686|NCT04423367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934687|NCT04423367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64934688|NCT04423367|Glucocorticoids|glucocorticoids|mesh-ancestor
64934689|NCT04423367|Hormones|hormones|mesh-ancestor
64934690|NCT04423367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64934782|NCT00390260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64934783|NCT00390260|Antitussive Agents|antitussive agents|mesh-ancestor
64934784|NCT00390260|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64934785|NCT00390260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64934786|NCT00390260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934787|NCT00390260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64934788|NCT00390260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64934789|NCT00390260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64934790|NCT00081757|Thalidomide|thalidomide|mesh-list
64934791|NCT00081757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64934792|NCT00081757|Immunologic Factors|immunologic factors|mesh-ancestor
64934824|NCT00399685|Antiviral Agents|antiviral agents|mesh-ancestor
64934951|NCT00083161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64934952|NCT00083161|Immunologic Factors|immunologic factors|mesh-ancestor
64934953|NCT00083161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934954|NCT00083161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64935059|NCT05568082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935060|NCT05568082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935061|NCT05568082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64935197|NCT00135967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64935198|NCT00135967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64935199|NCT00135967|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64935200|NCT00135967|Protective Agents|protective agents|mesh-ancestor
64935201|NCT00136045|Rotigotine|rotigotine|mesh-list
64935202|NCT00136045|Dopamine Agonists|dopamine agonists|mesh-ancestor
64935203|NCT00136045|Dopamine Agents|dopamine agents|mesh-ancestor
64935215|NCT03151239|Vitamins|vitamins|mesh-ancestor
64935304|NCT00393198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64935305|NCT00393198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64935306|NCT00393198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64935307|NCT00393198|Abortifacient Agents|abortifacient agents|mesh-ancestor
64935308|NCT00393198|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64935309|NCT00393198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64935310|NCT00393198|Oxytocics|oxytocics|mesh-ancestor
64935311|NCT03968822|Lidocaine|lidocaine|mesh-list
64935312|NCT03968822|Bupivacaine|bupivacaine|mesh-list
64935313|NCT03968822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64935339|NCT00136981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64935397|NCT00137410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935398|NCT00137410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935399|NCT03151005|Metformin|metformin|mesh-list
64935400|NCT03151005|Liraglutide|liraglutide|mesh-list
64935401|NCT03151005|Exenatide|exenatide|mesh-list
64935402|NCT03151005|Contraceptive Agents|contraceptive agents|mesh-list
64935403|NCT03151005|Contraceptives, Oral|contraceptives, oral|mesh-list
64935404|NCT03151005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64935405|NCT03151005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935406|NCT03151005|Incretins|incretins|mesh-ancestor
64935407|NCT03151005|Hormones|hormones|mesh-ancestor
64935409|NCT03151005|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64935564|NCT03150732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64935565|NCT03150732|Narcotics|narcotics|mesh-ancestor
64935566|NCT03150732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64935567|NCT03150732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935568|NCT03150732|Analgesics|analgesics|mesh-ancestor
64935569|NCT03150732|Sensory System Agents|sensory system agents|mesh-ancestor
64935570|NCT03150732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64935571|NCT03893825|Risperidone|risperidone|mesh-list
64935572|NCT03893825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64935573|NCT03893825|Serotonin Agents|serotonin agents|mesh-ancestor
64935574|NCT03893825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64935597|NCT00138970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935598|NCT00138970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64935599|NCT00138970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935600|NCT00138970|Antiemetics|antiemetics|mesh-ancestor
64935601|NCT00138970|Autonomic Agents|autonomic agents|mesh-ancestor
64935602|NCT00138970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64935603|NCT00138970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64528903|NCT01528345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528904|NCT01511939|Diclofenac|diclofenac|mesh-list
64528905|NCT01511939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64528906|NCT01511939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64528907|NCT01511939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64528908|NCT01511939|Analgesics|analgesics|mesh-ancestor
64935737|NCT03844412|Hormones|hormones|mesh-ancestor
64935845|NCT03150420|Antitubercular Agents|antitubercular agents|mesh-ancestor
64935846|NCT03150420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64935847|NCT03150420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64935848|NCT03150420|Chelating Agents|chelating agents|mesh-ancestor
64935849|NCT03150420|Sequestering Agents|sequestering agents|mesh-ancestor
64935850|NCT00140218|Pramipexole|pramipexole|mesh-list
64935851|NCT00140218|Antioxidants|antioxidants|mesh-ancestor
64935852|NCT00140218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935853|NCT00140218|Protective Agents|protective agents|mesh-ancestor
64935854|NCT00140218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935855|NCT00140218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64935856|NCT00140218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64935857|NCT00140218|Dopamine Agonists|dopamine agonists|mesh-ancestor
64935858|NCT00140218|Dopamine Agents|dopamine agents|mesh-ancestor
64935888|NCT00140530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64935889|NCT00140530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935890|NCT00140530|Tubulin Modulators|tubulin modulators|mesh-ancestor
64935891|NCT00140530|Antimitotic Agents|antimitotic agents|mesh-ancestor
64935892|NCT00140530|Mitosis Modulators|mitosis modulators|mesh-ancestor
64935893|NCT00140530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935894|NCT00140530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64935895|NCT00140530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64935896|NCT00140530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64935897|NCT00140530|Antifungal Agents|antifungal agents|mesh-ancestor
64935898|NCT00140530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64935899|NCT00140530|Immunologic Factors|immunologic factors|mesh-ancestor
64935900|NCT00140530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935901|NCT00140569|Interferons|interferons|mesh-list
64935902|NCT00140569|Fludarabine|fludarabine|mesh-list
64935903|NCT00140569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935932|NCT00140764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64935933|NCT00140764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64935934|NCT00140764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64935935|NCT00140803|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64935936|NCT00140803|Verteporfin|verteporfin|mesh-list
64935937|NCT00140803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64935941|NCT00140803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935942|NCT00140803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64935943|NCT00140803|Immunologic Factors|immunologic factors|mesh-ancestor
64935944|NCT00140803|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64935945|NCT00140803|Dermatologic Agents|dermatologic agents|mesh-ancestor
64935946|NCT00140920|Diclofenac|diclofenac|mesh-list
64935947|NCT00140920|Rofecoxib|rofecoxib|mesh-list
64936044|NCT00404404|Bevacizumab|bevacizumab|mesh-list
64936045|NCT00404404|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64936046|NCT00404404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64936082|NCT00141427|Pregabalin|pregabalin|mesh-list
64936083|NCT00141427|Analgesics|analgesics|mesh-ancestor
64936109|NCT00141544|Anabolic Agents|anabolic agents|mesh-ancestor
64936180|NCT00142207|Antimalarials|antimalarials|mesh-ancestor
64936181|NCT00142207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64936182|NCT00142207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64936183|NCT00142207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64936184|NCT00142207|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64936185|NCT00142207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936287|NCT00143026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936302|NCT00143065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64936303|NCT00143065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528945|NCT04123561|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64528947|NCT04123561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64528948|NCT04123561|Antiemetics|antiemetics|mesh-ancestor
64528949|NCT04123561|Autonomic Agents|autonomic agents|mesh-ancestor
64528950|NCT04123561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64528964|NCT01510769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64528965|NCT01510769|Uricosuric Agents|uricosuric agents|mesh-ancestor
64528966|NCT01510769|Renal Agents|renal agents|mesh-ancestor
64528967|NCT02382354|Remifentanil|remifentanil|mesh-list
64528968|NCT02382354|Propofol|propofol|mesh-list
64528969|NCT02382354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64528970|NCT02382354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64936346|NCT00143260|Urological Agents|urological agents|mesh-ancestor
64936363|NCT00143377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936365|NCT02972216|Docetaxel|docetaxel|mesh-list
64936366|NCT02972216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936367|NCT02972216|Tubulin Modulators|tubulin modulators|mesh-ancestor
64936368|NCT02972216|Antimitotic Agents|antimitotic agents|mesh-ancestor
64936371|NCT04726345|Fexofenadine|fexofenadine|mesh-list
64936469|NCT00144157|Antiviral Agents|antiviral agents|mesh-ancestor
64528971|NCT02382354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528972|NCT02382354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64528973|NCT02382354|Anesthetics, General|anesthetics, general|mesh-ancestor
64528974|NCT02382354|Anesthetics|anesthetics|mesh-ancestor
64528975|NCT02382354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64528976|NCT02382354|Narcotics|narcotics|mesh-ancestor
64528977|NCT02382354|Analgesics|analgesics|mesh-ancestor
64528993|NCT03027167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528994|NCT03027167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64528995|NCT03027167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64528996|NCT03027167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528997|NCT03027167|Antipyretics|antipyretics|mesh-ancestor
64528998|NCT02382198|Glycopyrrolate|glycopyrrolate|mesh-list
64528999|NCT02382198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64936574|NCT03191786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64936575|NCT03191786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936576|NCT03191786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64936577|NCT03191786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64936581|NCT00404833|Mycophenolic Acid|mycophenolic acid|mesh-list
64529002|NCT02382198|Cholinergic Agents|cholinergic agents|mesh-ancestor
64529003|NCT02382198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64529004|NCT02382198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529005|NCT02382198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529006|NCT02382432|Meperidine|meperidine|mesh-list
64529007|NCT02382432|Dexmedetomidine|dexmedetomidine|mesh-list
64936746|NCT01807455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64936747|NCT01807455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936749|NCT01807455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64529011|NCT02382432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64529012|NCT02382432|Analgesics|analgesics|mesh-ancestor
64529013|NCT02382432|Sensory System Agents|sensory system agents|mesh-ancestor
64936866|NCT03079427|Gemcitabine|gemcitabine|mesh-list
64936867|NCT03079427|Cisplatin|cisplatin|mesh-list
64936868|NCT03079427|Capecitabine|capecitabine|mesh-list
64705371|NCT02593903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64936869|NCT03079427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936905|NCT00425425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64936906|NCT00425425|Immunologic Factors|immunologic factors|mesh-ancestor
64936907|NCT00425425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936908|NCT00425425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64529014|NCT02382432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64529015|NCT02382432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64529016|NCT02382432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64529017|NCT02382432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64529018|NCT02382432|Adrenergic Agents|adrenergic agents|mesh-ancestor
64529019|NCT02382432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64937029|NCT02762981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64937030|NCT02762981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937031|NCT02762981|Tubulin Modulators|tubulin modulators|mesh-ancestor
64937032|NCT02762981|Antimitotic Agents|antimitotic agents|mesh-ancestor
64937134|NCT04846855|Sensory System Agents|sensory system agents|mesh-ancestor
64937135|NCT04846855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64937136|NCT01806324|Losartan|losartan|mesh-list
64937137|NCT01806324|Atorvastatin|atorvastatin|mesh-list
64529020|NCT02382432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529023|NCT02382432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64529024|NCT00145587|Antibodies|antibodies|mesh-list
64529025|NCT00145587|Immunologic Factors|immunologic factors|mesh-ancestor
64529026|NCT00145587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937259|NCT02593175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937261|NCT02593175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937262|NCT01806090|Clopidogrel|clopidogrel|mesh-list
64937263|NCT01806090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64937264|NCT01806090|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64937265|NCT01806090|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64937271|NCT02505893|Sirolimus|sirolimus|mesh-list
64937370|NCT01805700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937371|NCT01805700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937372|NCT01805700|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64937373|NCT01805700|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64937374|NCT01805700|Purinergic Agents|purinergic agents|mesh-ancestor
64937375|NCT01805700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64937376|NCT04033276|Rituximab|rituximab|mesh-list
64937377|NCT04033276|Immunoglobulins|immunoglobulins|mesh-list
64529086|NCT01527487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64937409|NCT03781063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64937410|NCT03781063|Hormone Antagonists|hormone antagonists|mesh-ancestor
64937411|NCT03781063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64937412|NCT03781063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937413|NCT01805544|Rivaroxaban|rivaroxaban|mesh-list
64937414|NCT01805544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64937415|NCT01805544|Antithrombins|antithrombins|mesh-ancestor
64937416|NCT01805544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64937417|NCT01805544|Protease Inhibitors|protease inhibitors|mesh-ancestor
64937418|NCT01805544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937421|NCT03770767|Insulin|insulin|mesh-list
64937485|NCT03421483|Vitamin B Complex|vitamin b complex|mesh-ancestor
64937486|NCT03421483|Vitamins|vitamins|mesh-ancestor
64937487|NCT03421483|Micronutrients|micronutrients|mesh-ancestor
64937488|NCT03421483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937489|NCT03363217|Trametinib|trametinib|mesh-list
64937490|NCT03363217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937491|NCT03363217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64937492|NCT03363217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937493|NCT03363217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937494|NCT03341143|Pembrolizumab|pembrolizumab|mesh-list
64937495|NCT03341143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64529102|NCT05030298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529103|NCT01506947|Darbepoetin alfa|darbepoetin alfa|mesh-list
64529104|NCT01506947|Hematinics|hematinics|mesh-ancestor
64529105|NCT00149643|Fluoxetine|fluoxetine|mesh-list
64529106|NCT00149643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64529107|NCT00149643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64529108|NCT00149643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64529109|NCT00149643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937651|NCT00048113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937652|NCT01466361|Nicotine|nicotine|mesh-list
64937672|NCT00001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937674|NCT00001832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64937675|NCT00001832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64937676|NCT00001832|Analgesics|analgesics|mesh-ancestor
64937677|NCT00001832|Sensory System Agents|sensory system agents|mesh-ancestor
64937678|NCT00001832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64937679|NCT00001832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64937680|NCT01466244|Cetuximab|cetuximab|mesh-list
64937681|NCT01466244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937682|NCT01466244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64529144|NCT02390544|Immunologic Factors|immunologic factors|mesh-ancestor
64529145|NCT02390544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529146|NCT01790997|Aspirin|aspirin|mesh-list
64529147|NCT01790997|Clopidogrel|clopidogrel|mesh-list
64529148|NCT01790997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64529149|NCT01790997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64529150|NCT01790997|Analgesics|analgesics|mesh-ancestor
64529151|NCT01790997|Sensory System Agents|sensory system agents|mesh-ancestor
64937740|NCT00009620|GABA Modulators|gaba modulators|mesh-ancestor
64529191|NCT02381184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529192|NCT02381184|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64529193|NCT02381184|Fertility Agents|fertility agents|mesh-ancestor
64529194|NCT02381184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64529195|NCT02381184|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64529196|NCT02381184|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64529197|NCT02381028|Emollients|emollients|mesh-list
64529198|NCT02381028|Dermatologic Agents|dermatologic agents|mesh-ancestor
64937788|NCT00009776|Antifungal Agents|antifungal agents|mesh-ancestor
64529200|NCT00326781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64529201|NCT00326781|Autonomic Agents|autonomic agents|mesh-ancestor
64529202|NCT00326781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64529203|NCT00326781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529204|NCT00326781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64529205|NCT00326781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64529206|NCT00326781|Cholinergic Agents|cholinergic agents|mesh-ancestor
64529207|NCT00326781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64938011|NCT01464801|Protective Agents|protective agents|mesh-ancestor
64938012|NCT01464801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938013|NCT01464801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938014|NCT01464801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64938015|NCT01464762|Bedaquiline|bedaquiline|mesh-list
64938016|NCT01464762|Antitubercular Agents|antitubercular agents|mesh-ancestor
64938017|NCT01464762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64938018|NCT01464762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64938019|NCT01464723|Ranibizumab|ranibizumab|mesh-list
64938107|NCT00847899|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|mesh-list
64938108|NCT00847899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64938109|NCT00847899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938111|NCT00847860|Aspirin|aspirin|mesh-list
64938208|NCT00847314|Androgens|androgens|mesh-ancestor
64938209|NCT00847314|Hormones|hormones|mesh-ancestor
64938210|NCT00847314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64938211|NCT00847314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938212|NCT00847314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64938213|NCT00847314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938214|NCT00847314|Anabolic Agents|anabolic agents|mesh-ancestor
64938215|NCT00011999|Paclitaxel|paclitaxel|mesh-list
64938216|NCT00011999|Cisplatin|cisplatin|mesh-list
64529299|NCT02103855|Immunologic Factors|immunologic factors|mesh-ancestor
64529300|NCT02103855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529301|NCT02103855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64529302|NCT03706053|Midodrine|midodrine|mesh-list
64529303|NCT03706053|Sympathomimetics|sympathomimetics|mesh-ancestor
64529304|NCT03706053|Autonomic Agents|autonomic agents|mesh-ancestor
64529305|NCT03706053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64529306|NCT03706053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529307|NCT03706053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64529308|NCT03706053|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64529309|NCT03706053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64529310|NCT03706053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64529311|NCT03706053|Adrenergic Agents|adrenergic agents|mesh-ancestor
64529312|NCT03706053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64938353|NCT00012506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64938354|NCT00012506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64938355|NCT00012506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64938356|NCT00012506|Immunologic Factors|immunologic factors|mesh-ancestor
64938357|NCT00012584|Fluvoxamine|fluvoxamine|mesh-list
64938482|NCT00846144|Protective Agents|protective agents|mesh-ancestor
64938483|NCT00846144|Emetics|emetics|mesh-ancestor
64938484|NCT00846144|Autonomic Agents|autonomic agents|mesh-ancestor
64938485|NCT00846144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64938486|NCT00846144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64938487|NCT00845988|Aripiprazole|aripiprazole|mesh-list
64938488|NCT00845988|Antidepressive Agents|antidepressive agents|mesh-ancestor
64938489|NCT00845988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64938490|NCT00845988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64938542|NCT00013520|Antiviral Agents|antiviral agents|mesh-ancestor
64938543|NCT00013520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64938544|NCT00013520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64938545|NCT00013520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64938655|NCT00276666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64938656|NCT00276666|Alkylating Agents|alkylating agents|mesh-ancestor
64938657|NCT00014066|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
64938658|NCT00014066|Hematoporphyrins|hematoporphyrins|mesh-list
64938659|NCT00014066|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64938746|NCT00014456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938747|NCT00014456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64529387|NCT01500317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64529388|NCT02379546|Desflurane|desflurane|mesh-list
64529389|NCT02379546|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64529390|NCT02379546|Anesthetics, General|anesthetics, general|mesh-ancestor
64529391|NCT02379546|Anesthetics|anesthetics|mesh-ancestor
64529392|NCT02379546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64529393|NCT02379546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529394|NCT00332163|Irinotecan|irinotecan|mesh-list
64529395|NCT00332163|Panitumumab|panitumumab|mesh-list
64529396|NCT00332163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64529397|NCT00332163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64529398|NCT00332163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529399|NCT00332163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529400|NCT00332163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529402|NCT02379000|Triamcinolone|triamcinolone|mesh-list
64938766|NCT00014534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64938767|NCT00014534|Immunologic Factors|immunologic factors|mesh-ancestor
64938768|NCT00014534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938769|NCT00014534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64938770|NCT00014534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64938772|NCT00014573|Aldesleukin|aldesleukin|mesh-list
64938862|NCT00276003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64938863|NCT00276003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64938864|NCT00276003|Gout Suppressants|gout suppressants|mesh-ancestor
64938865|NCT00276003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64938866|NCT00276003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64938867|NCT00276003|Antioxidants|antioxidants|mesh-ancestor
64938868|NCT00276003|Protective Agents|protective agents|mesh-ancestor
64529451|NCT02779257|Diazoxide|diazoxide|mesh-list
64938924|NCT00275730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484195|NCT04795336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529457|NCT02779257|Vasodilator Agents|vasodilator agents|mesh-ancestor
64529458|NCT00295503|Bevacizumab|bevacizumab|mesh-list
64529459|NCT00295503|Pemetrexed|pemetrexed|mesh-list
64529460|NCT00295503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64529461|NCT00295503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529462|NCT00295503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64939003|NCT00015665|Voriconazole|voriconazole|mesh-list
64529463|NCT00295503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64529464|NCT00295503|Growth Substances|growth substances|mesh-ancestor
64529465|NCT00295503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529466|NCT00295503|Growth Inhibitors|growth inhibitors|mesh-ancestor
64529467|NCT00295503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529468|NCT00295503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529469|NCT00295503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64939004|NCT00015665|Antifungal Agents|antifungal agents|mesh-ancestor
64939005|NCT00015665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64939023|NCT00275457|Dopamine Agents|dopamine agents|mesh-ancestor
64939024|NCT00275457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64939025|NCT00015704|Aldesleukin|aldesleukin|mesh-list
64939026|NCT00015704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939027|NCT00015704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64939028|NCT00015704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64939029|NCT00015704|Antiviral Agents|antiviral agents|mesh-ancestor
64939030|NCT00015704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64939098|NCT00015860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64939099|NCT00015860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64939100|NCT00015899|Lonafarnib|lonafarnib|mesh-list
64939101|NCT00015899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939102|NCT00015899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939103|NCT00275106|Leucovorin|leucovorin|mesh-list
64939104|NCT00275106|Cytarabine|cytarabine|mesh-list
64939105|NCT00275106|Dexamethasone|dexamethasone|mesh-list
64939106|NCT00275106|Prednisolone|prednisolone|mesh-list
64939107|NCT00275106|Cyclophosphamide|cyclophosphamide|mesh-list
64939108|NCT00275106|Doxorubicin|doxorubicin|mesh-list
64939109|NCT00275106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64939187|NCT00015977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64939188|NCT00015977|Growth Substances|growth substances|mesh-ancestor
64939189|NCT00015977|Growth Inhibitors|growth inhibitors|mesh-ancestor
64939190|NCT00015977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939191|NCT01678586|Diphenhydramine|diphenhydramine|mesh-list
64939192|NCT01678586|Gabapentin|gabapentin|mesh-list
64939193|NCT01678586|Analgesics|analgesics|mesh-ancestor
64939194|NCT01678586|Sensory System Agents|sensory system agents|mesh-ancestor
64939195|NCT01678586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64939289|NCT00130338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64939290|NCT00130338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939291|NCT00130338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64939292|NCT00130338|Protective Agents|protective agents|mesh-ancestor
64939293|NCT00016133|Leucovorin|leucovorin|mesh-list
64939391|NCT00130065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64939392|NCT00130065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64939393|NCT00130065|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64939394|NCT00130065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939395|NCT00130065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939396|NCT00130065|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64939490|NCT00129597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64939491|NCT00129597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64939492|NCT00129597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64939493|NCT00129597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939494|NCT00016601|Ritonavir|ritonavir|mesh-list
64939495|NCT00016601|Nelfinavir|nelfinavir|mesh-list
64939496|NCT00016601|Indinavir|indinavir|mesh-list
64939497|NCT00016601|Nevirapine|nevirapine|mesh-list
64939498|NCT00016601|Efavirenz|efavirenz|mesh-list
64939499|NCT00016601|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64939500|NCT00016601|Medroxyprogesterone|medroxyprogesterone|mesh-list
64939561|NCT00016952|Antimetabolites|antimetabolites|mesh-ancestor
64939562|NCT00016952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939563|NCT00016952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64939564|NCT00016952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939565|NCT00016952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64939570|NCT00016952|Antidotes|antidotes|mesh-ancestor
64939663|NCT00129207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529552|NCT01498679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529553|NCT01498679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64529554|NCT01498679|Respiratory System Agents|respiratory system agents|mesh-ancestor
64529556|NCT01498679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64529557|NCT01000467|Probucol|probucol|mesh-list
64939664|NCT00129168|Cytarabine|cytarabine|mesh-list
64939665|NCT00129168|Daunorubicin|daunorubicin|mesh-list
64939770|NCT00017342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939771|NCT00017342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529558|NCT01000467|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64529559|NCT01000467|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64529561|NCT01000467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529563|NCT01000467|Antioxidants|antioxidants|mesh-ancestor
64939922|NCT00128466|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64939924|NCT00128466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529565|NCT01000467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529566|NCT00198315|Bleomycin|bleomycin|mesh-list
64529569|NCT01559389|Solifenacin Succinate|solifenacin succinate|mesh-list
64529595|NCT04540692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64529597|NCT00343083|Carboplatin|carboplatin|mesh-list
64529598|NCT00343083|Cetuximab|cetuximab|mesh-list
64529599|NCT00343083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64529600|NCT00343083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529601|NCT00343083|Tubulin Modulators|tubulin modulators|mesh-ancestor
64939961|NCT00018603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940049|NCT00018759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64940050|NCT00018759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64940051|NCT00018759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940052|NCT00018759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64940061|NCT04734353|Ticagrelor|ticagrelor|mesh-list
64940138|NCT00018356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64940139|NCT00018356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940140|NCT00019188|Interleukin-12|interleukin-12|mesh-list
64940141|NCT00019188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64940142|NCT00019188|Immunologic Factors|immunologic factors|mesh-ancestor
64940143|NCT00019188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940164|NCT00019344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940165|NCT00019344|Growth Inhibitors|growth inhibitors|mesh-ancestor
64940166|NCT00019344|Growth Substances|growth substances|mesh-ancestor
64940167|NCT00019344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940168|NCT00019344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64940169|NCT00019344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294395|NCT05134298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64940231|NCT00019695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64940232|NCT00019695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64940233|NCT00019734|Aldesleukin|aldesleukin|mesh-list
64940297|NCT00142454|Interferon Inducers|interferon inducers|mesh-ancestor
64940298|NCT00020046|Thalidomide|thalidomide|mesh-list
64940299|NCT00020046|Docetaxel|docetaxel|mesh-list
64940300|NCT00020046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940332|NCT05576675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64940333|NCT05576675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940334|NCT05576675|Analgesics|analgesics|mesh-ancestor
64940460|NCT00020943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64940461|NCT00020943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64940462|NCT00020943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64940463|NCT00020943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64940464|NCT00020943|Glucocorticoids|glucocorticoids|mesh-ancestor
64940465|NCT00020943|Hormones|hormones|mesh-ancestor
64940466|NCT00020943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64940469|NCT00020943|Abortifacient Agents|abortifacient agents|mesh-ancestor
64940542|NCT05574179|Sensory System Agents|sensory system agents|mesh-ancestor
64940543|NCT05574179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64940544|NCT05574179|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64940638|NCT00021528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64940639|NCT00021528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64940640|NCT00021528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64940641|NCT00021528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64940644|NCT00021528|Histamine Agents|histamine agents|mesh-ancestor
64940850|NCT00022737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64940851|NCT00022737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64940852|NCT00022737|Antimetabolites|antimetabolites|mesh-ancestor
64940853|NCT00022737|Dermatologic Agents|dermatologic agents|mesh-ancestor
64940854|NCT00022737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64940855|NCT00022737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64529793|NCT02376192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529794|NCT02376192|Sensory System Agents|sensory system agents|mesh-ancestor
64529795|NCT02376192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64941069|NCT02971982|Dexamethasone acetate|dexamethasone acetate|mesh-list
64941070|NCT02971982|Cyclophosphamide|cyclophosphamide|mesh-list
64941071|NCT02971982|Rituximab|rituximab|mesh-list
64941072|NCT02971982|Bortezomib|bortezomib|mesh-list
64941073|NCT02971982|BB 1101|bb 1101|mesh-list
64941098|NCT00023829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64941099|NCT00023829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941203|NCT00024492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941204|NCT00024492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941205|NCT00024492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64941206|NCT00024492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64941207|NCT00024492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941208|NCT00024492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941209|NCT00024531|Atorvastatin|atorvastatin|mesh-list
64941210|NCT00024531|Calcium|calcium|mesh-list
64941300|NCT05051891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941301|NCT05051891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64941302|NCT05051891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64941303|NCT05051891|Glucocorticoids|glucocorticoids|mesh-ancestor
64529841|NCT02375880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64529842|NCT02375880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64529843|NCT02375880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64529844|NCT02375880|Immunologic Factors|immunologic factors|mesh-ancestor
64941377|NCT00025428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64941378|NCT00025428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64941379|NCT00025428|Alkylating Agents|alkylating agents|mesh-ancestor
64941380|NCT00025428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941412|NCT04964414|Hormones|hormones|mesh-ancestor
64529846|NCT01524679|Interferons|interferons|mesh-list
64529847|NCT01524679|Interferon-alpha|interferon-alpha|mesh-list
64529848|NCT01524679|Interferon alpha-2|interferon alpha-2|mesh-list
64529849|NCT01524679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64529850|NCT01524679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64529851|NCT01524679|Antiviral Agents|antiviral agents|mesh-ancestor
64529852|NCT01524679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64529853|NCT01524679|Immunologic Factors|immunologic factors|mesh-ancestor
64529854|NCT01524679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529855|NCT02365272|Amikacin|amikacin|mesh-list
64529856|NCT02365272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64529857|NCT02365272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64529858|NCT02369250|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64941611|NCT00026637|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64941612|NCT00026637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64941613|NCT00026637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64941614|NCT00026637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64529886|NCT02375646|Anticoagulants|anticoagulants|mesh-ancestor
64529887|NCT02375646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64941732|NCT00027612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64941733|NCT00027612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941734|NCT00027612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941735|NCT00027612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941736|NCT00027612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64941814|NCT00027924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64941815|NCT00027924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64941816|NCT00027924|Immunologic Factors|immunologic factors|mesh-ancestor
64941817|NCT00027924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64941818|NCT00027924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64941819|NCT00027924|Antifungal Agents|antifungal agents|mesh-ancestor
64941820|NCT00027924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64941879|NCT00395655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941912|NCT03959969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64941913|NCT03959969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64941914|NCT03959969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64941915|NCT03959969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941916|NCT03959969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941917|NCT03959969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64529971|NCT04110301|Immunologic Factors|immunologic factors|mesh-ancestor
64529972|NCT04110301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64529973|NCT04110301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64529974|NCT04110301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64294663|NCT05714553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941967|NCT00028431|Ipilimumab|ipilimumab|mesh-list
64942049|NCT00028821|Estradiol|estradiol|mesh-list
64942050|NCT00028821|Estrogens|estrogens|mesh-ancestor
64942051|NCT00028821|Hormones|hormones|mesh-ancestor
64942052|NCT00028821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64942053|NCT00028821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942054|NCT00028821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942055|NCT00028821|Tubulin Modulators|tubulin modulators|mesh-ancestor
64942056|NCT00028821|Antimitotic Agents|antimitotic agents|mesh-ancestor
64942115|NCT00029250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64942116|NCT00029250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64942117|NCT00029250|Antimetabolites|antimetabolites|mesh-ancestor
64942118|NCT00029250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942119|NCT00029250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64530035|NCT05800366|Glucocorticoids|glucocorticoids|mesh-ancestor
64530037|NCT05800366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64530038|NCT05800366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64530039|NCT05800366|Antiemetics|antiemetics|mesh-ancestor
64530040|NCT05800366|Autonomic Agents|autonomic agents|mesh-ancestor
64530041|NCT05800366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64530042|NCT05800366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64530043|NCT05800366|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64530044|NCT05800366|Protective Agents|protective agents|mesh-ancestor
64530045|NCT05800340|Paclitaxel|paclitaxel|mesh-list
64530046|NCT05800340|Carboplatin|carboplatin|mesh-list
64530047|NCT05800340|Pemetrexed|pemetrexed|mesh-list
64942245|NCT00030342|Sargramostim|sargramostim|mesh-list
64942246|NCT00030342|Antimetabolites|antimetabolites|mesh-ancestor
64942247|NCT00030342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942248|NCT00030342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64942249|NCT00030342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942250|NCT00030342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64942251|NCT00030342|Immunologic Factors|immunologic factors|mesh-ancestor
64942252|NCT00030342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942253|NCT00030342|Antiviral Agents|antiviral agents|mesh-ancestor
64942254|NCT00030342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64942255|NCT00030381|Esorubicin|esorubicin|mesh-list
64942256|NCT00030381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64942257|NCT00030381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942258|NCT00030420|Celecoxib|celecoxib|mesh-list
64942259|NCT00030420|Docetaxel|docetaxel|mesh-list
64942260|NCT00030420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942261|NCT00030420|Tubulin Modulators|tubulin modulators|mesh-ancestor
64942262|NCT00030420|Antimitotic Agents|antimitotic agents|mesh-ancestor
64942263|NCT00030420|Mitosis Modulators|mitosis modulators|mesh-ancestor
64942264|NCT00030420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942266|NCT00030420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64942294|NCT00030498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942295|NCT03873857|Venetoclax|venetoclax|mesh-list
64942296|NCT03873857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942297|NCT03866408|Pioglitazone|pioglitazone|mesh-list
64942298|NCT03866408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64942299|NCT03866408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710780|NCT05828199|Adrenergic Agents|adrenergic agents|mesh-ancestor
64942300|NCT00030537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64942301|NCT00030537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942302|NCT00030537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64942303|NCT00030537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530048|NCT05800340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64530049|NCT05800340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530051|NCT05800340|Antimitotic Agents|antimitotic agents|mesh-ancestor
64530052|NCT05800340|Mitosis Modulators|mitosis modulators|mesh-ancestor
64530053|NCT05800340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942361|NCT03852407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64530069|NCT05800275|Tucatinib|tucatinib|mesh-list
64530070|NCT05800275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64530071|NCT05800275|Antimetabolites|antimetabolites|mesh-ancestor
64530072|NCT05800275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530073|NCT05800275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530074|NCT05800275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64530075|NCT05800275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64530076|NCT05800275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530078|NCT05800106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530079|NCT05800106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64530080|NCT05800106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64530081|NCT05800106|Growth Substances|growth substances|mesh-ancestor
64530082|NCT05800106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530083|NCT05800106|Growth Inhibitors|growth inhibitors|mesh-ancestor
64530084|NCT05800106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64530085|NCT05800106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530086|NCT05800106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530087|NCT05800080|Oxaliplatin|oxaliplatin|mesh-list
64530088|NCT05800080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530089|NCT05800054|Docetaxel|docetaxel|mesh-list
64530090|NCT05800054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530091|NCT05800054|Tubulin Modulators|tubulin modulators|mesh-ancestor
64294770|NCT01335997|Vitamin B Complex|vitamin b complex|mesh-ancestor
64294771|NCT01335997|Vitamins|vitamins|mesh-ancestor
64942362|NCT03852407|Immunologic Factors|immunologic factors|mesh-ancestor
64942364|NCT03852407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64942442|NCT03779789|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64942443|NCT03779789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64942444|NCT03779789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530092|NCT05800054|Antimitotic Agents|antimitotic agents|mesh-ancestor
64530093|NCT05800054|Mitosis Modulators|mitosis modulators|mesh-ancestor
64530094|NCT05800054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530095|NCT05800041|Cyclophosphamide|cyclophosphamide|mesh-list
64530096|NCT05800041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64530097|NCT05800041|Immunologic Factors|immunologic factors|mesh-ancestor
64530098|NCT05800041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530099|NCT05800041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64530100|NCT05800041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64530101|NCT05800041|Alkylating Agents|alkylating agents|mesh-ancestor
64530102|NCT05800041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530103|NCT05800041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530104|NCT05800041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64530106|NCT05800015|Carboplatin|carboplatin|mesh-list
64530107|NCT05800015|Pemetrexed|pemetrexed|mesh-list
64530108|NCT05800015|Cemiplimab|cemiplimab|mesh-list
64530109|NCT05800015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64530110|NCT05800015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530111|NCT05800015|Tubulin Modulators|tubulin modulators|mesh-ancestor
64530112|NCT05800015|Antimitotic Agents|antimitotic agents|mesh-ancestor
64530113|NCT05800015|Mitosis Modulators|mitosis modulators|mesh-ancestor
64530114|NCT05800015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530115|NCT05800015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530116|NCT05800015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64530117|NCT05800015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64530118|NCT05800015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64530119|NCT05799924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64530120|NCT05799924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64530121|NCT05799924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64530122|NCT05799924|Analgesics|analgesics|mesh-ancestor
64530123|NCT05799924|Sensory System Agents|sensory system agents|mesh-ancestor
64530124|NCT05799924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64530134|NCT05799820|Growth Substances|growth substances|mesh-ancestor
64530135|NCT05799820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530136|NCT05799820|Growth Inhibitors|growth inhibitors|mesh-ancestor
64530137|NCT05799820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64530138|NCT05799820|Antimetabolites|antimetabolites|mesh-ancestor
64294834|NCT04495088|Micronutrients|micronutrients|mesh-ancestor
64294836|NCT04717154|Nivolumab|nivolumab|mesh-list
64942445|NCT03779789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64942446|NCT03779789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64942447|NCT03779789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64942448|NCT03779789|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64942449|NCT03779789|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64710938|NCT05821972|Anesthetics|anesthetics|mesh-ancestor
64942450|NCT03779789|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64942451|NCT03779789|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64942452|NCT03779789|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64942453|NCT03779789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64942454|NCT00030888|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
64942455|NCT00030888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942534|NCT04712058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64942535|NCT04712058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64942536|NCT00393107|Cyclophosphamide|cyclophosphamide|mesh-list
64942538|NCT00393107|Fludarabine|fludarabine|mesh-list
64942539|NCT00393107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64942540|NCT00393107|Immunologic Factors|immunologic factors|mesh-ancestor
64942541|NCT00393107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530139|NCT05799820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530141|NCT05799755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530142|NCT05799755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64530143|NCT05799755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530144|NCT05799755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530145|NCT05799729|Ketamine|ketamine|mesh-list
64530146|NCT05799729|Analgesics|analgesics|mesh-ancestor
64530147|NCT05799729|Sensory System Agents|sensory system agents|mesh-ancestor
64530148|NCT05799729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64530149|NCT05799729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484450|NCT01741532|Sequestering Agents|sequestering agents|mesh-ancestor
64530150|NCT05799729|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64530151|NCT05799729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64530152|NCT05799729|Anesthetics, General|anesthetics, general|mesh-ancestor
64530153|NCT05799729|Anesthetics|anesthetics|mesh-ancestor
64294842|NCT02474511|Anesthetics|anesthetics|mesh-list
64942583|NCT00031317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942584|NCT00031317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64942585|NCT00031317|Antidepressive Agents|antidepressive agents|mesh-ancestor
64942586|NCT00031317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64942587|NCT00031317|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64530158|NCT05799729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530160|NCT05799612|Interferon-alpha|interferon-alpha|mesh-list
64530161|NCT05799612|Interferon alpha-2|interferon alpha-2|mesh-list
64530162|NCT05799612|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64530163|NCT05799612|Paclitaxel|paclitaxel|mesh-list
64530164|NCT05799612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64530165|NCT05799612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530166|NCT05799612|Tubulin Modulators|tubulin modulators|mesh-ancestor
64530167|NCT05799612|Antimitotic Agents|antimitotic agents|mesh-ancestor
64530168|NCT05799612|Mitosis Modulators|mitosis modulators|mesh-ancestor
64530169|NCT05799612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530170|NCT05799612|Antiviral Agents|antiviral agents|mesh-ancestor
64530171|NCT05799612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64530172|NCT05799612|Immunologic Factors|immunologic factors|mesh-ancestor
64530173|NCT05799612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530174|NCT05799521|Glycine|glycine|mesh-list
64530175|NCT05799521|Glycine Agents|glycine agents|mesh-ancestor
64530176|NCT05799521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64530177|NCT05799521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530178|NCT05799521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530179|NCT05799469|Cisplatin|cisplatin|mesh-list
64530180|NCT05799469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530181|NCT05799443|Irinotecan|irinotecan|mesh-list
64530182|NCT05799443|Cetuximab|cetuximab|mesh-list
64530183|NCT05799443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64530184|NCT05799443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64530185|NCT05799443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294863|NCT02474433|Oxytocics|oxytocics|mesh-ancestor
64942588|NCT00031317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64942596|NCT00396045|Lenalidomide|lenalidomide|mesh-list
64942597|NCT00396045|Immunologic Factors|immunologic factors|mesh-ancestor
64942598|NCT00396045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942599|NCT00396045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64942600|NCT00396045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64942601|NCT00396045|Growth Substances|growth substances|mesh-ancestor
64942602|NCT00396045|Growth Inhibitors|growth inhibitors|mesh-ancestor
64942603|NCT00396045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942604|NCT00396240|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64530186|NCT05799443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530187|NCT05799443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530188|NCT05799443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64530189|NCT05799378|Hydroxychloroquine|hydroxychloroquine|mesh-list
64530190|NCT05799378|Antimalarials|antimalarials|mesh-ancestor
64530191|NCT05799378|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64530192|NCT05799378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64530193|NCT05799378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64942605|NCT00396240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64942606|NCT00396240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64942607|NCT00396240|Antimetabolites|antimetabolites|mesh-ancestor
64942608|NCT00396240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942609|NCT00396240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64942610|NCT00396240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64942611|NCT00396240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942612|NCT00031395|Clonidine|clonidine|mesh-list
64942613|NCT00031395|Methylphenidate|methylphenidate|mesh-list
64942614|NCT00031395|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64942615|NCT00031395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942616|NCT00031395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64942625|NCT00031395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64942626|NCT00031395|Sympatholytics|sympatholytics|mesh-ancestor
64942627|NCT00031395|Autonomic Agents|autonomic agents|mesh-ancestor
64942628|NCT00031395|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64942629|NCT00031395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64942630|NCT00031395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64651530|NCT03838328|Hemostatics|hemostatics|mesh-ancestor
64465977|NCT02543944|Sensory System Agents|sensory system agents|mesh-ancestor
64465978|NCT02543944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64942631|NCT00031395|Adrenergic Agents|adrenergic agents|mesh-ancestor
64942632|NCT00031434|Valganciclovir|valganciclovir|mesh-list
64942633|NCT00031434|Ganciclovir|ganciclovir|mesh-list
64942634|NCT00031434|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64942635|NCT00031434|Antiviral Agents|antiviral agents|mesh-ancestor
64942636|NCT00031434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64942637|NCT00031434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64942638|NCT00031434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942639|NCT00031434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942640|NCT03152123|Phentermine|phentermine|mesh-list
64942641|NCT03152123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64942642|NCT03152123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942643|NCT03152123|Appetite Depressants|appetite depressants|mesh-ancestor
64942644|NCT03152123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64942645|NCT03152123|Sympathomimetics|sympathomimetics|mesh-ancestor
64942646|NCT03152123|Autonomic Agents|autonomic agents|mesh-ancestor
64942647|NCT03152123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64942648|NCT03152123|Adrenergic Agents|adrenergic agents|mesh-ancestor
64942651|NCT00031473|Ribavirin|ribavirin|mesh-list
64530211|NCT05799105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530212|NCT05799079|Decitabine|decitabine|mesh-list
64530213|NCT05799079|Venetoclax|venetoclax|mesh-list
64530214|NCT05799079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64530215|NCT05799079|Antimetabolites|antimetabolites|mesh-ancestor
64530216|NCT05799079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530219|NCT05799053|Peppermint oil|peppermint oil|mesh-list
64942673|NCT03152084|Dapagliflozin|dapagliflozin|mesh-list
64942762|NCT03151616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942763|NCT03151616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942764|NCT00031902|Prednisolone|prednisolone|mesh-list
64942765|NCT00031902|Rituximab|rituximab|mesh-list
64942766|NCT00031902|Vincristine|vincristine|mesh-list
64942767|NCT00031902|Bleomycin|bleomycin|mesh-list
64942768|NCT00031902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64942769|NCT00031902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942770|NCT00031902|Immunologic Factors|immunologic factors|mesh-ancestor
64942771|NCT00031902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530250|NCT05798819|Growth Inhibitors|growth inhibitors|mesh-ancestor
64530251|NCT05798793|Cisplatin|cisplatin|mesh-list
64530252|NCT05798793|Docetaxel|docetaxel|mesh-list
64530253|NCT05798793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530254|NCT05798793|Tubulin Modulators|tubulin modulators|mesh-ancestor
64530255|NCT05798793|Antimitotic Agents|antimitotic agents|mesh-ancestor
64530256|NCT05798793|Mitosis Modulators|mitosis modulators|mesh-ancestor
64294953|NCT00071552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64942772|NCT00031902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64942773|NCT00031902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64942774|NCT00031902|Tubulin Modulators|tubulin modulators|mesh-ancestor
64942775|NCT00031902|Antimitotic Agents|antimitotic agents|mesh-ancestor
64942776|NCT00031902|Mitosis Modulators|mitosis modulators|mesh-ancestor
64942777|NCT00031902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942778|NCT00031902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64942779|NCT00031902|Glucocorticoids|glucocorticoids|mesh-ancestor
64942780|NCT00031902|Hormones|hormones|mesh-ancestor
64942781|NCT00031902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64942782|NCT00031902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64942783|NCT00031902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64942784|NCT00031941|Lenalidomide|lenalidomide|mesh-list
64942785|NCT00031941|Immunologic Factors|immunologic factors|mesh-ancestor
64942787|NCT00031941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64942796|NCT00031980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64942806|NCT03151499|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64942808|NCT03151499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64942809|NCT03151499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64942810|NCT03151499|Leprostatic Agents|leprostatic agents|mesh-ancestor
64942811|NCT03151499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64942812|NCT03151499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942813|NCT03151499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942814|NCT03151499|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64942815|NCT03151499|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64942816|NCT03151499|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64942817|NCT03151499|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64942818|NCT03151499|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64942819|NCT03151499|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64942849|NCT00032019|Antimitotic Agents|antimitotic agents|mesh-ancestor
64942850|NCT00032019|Mitosis Modulators|mitosis modulators|mesh-ancestor
64942851|NCT03151460|Dopamine|dopamine|mesh-list
64942852|NCT03151460|Dopamine Agents|dopamine agents|mesh-list
64942853|NCT03151460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64942854|NCT03151460|Sympathomimetics|sympathomimetics|mesh-ancestor
64942855|NCT03151460|Autonomic Agents|autonomic agents|mesh-ancestor
64942856|NCT03151460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64942857|NCT03151460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942858|NCT03151460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64942859|NCT03151460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942860|NCT03151460|Protective Agents|protective agents|mesh-ancestor
64942861|NCT00032097|Motexafin gadolinium|motexafin gadolinium|mesh-list
64942884|NCT00032136|Hormone Antagonists|hormone antagonists|mesh-ancestor
64942885|NCT00032136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64942886|NCT00032136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942887|NCT00032136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64942888|NCT00032136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942889|NCT00032136|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64942890|NCT00032136|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64942891|NCT00032136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64942892|NCT00032136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64942893|NCT00032136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64530285|NCT05796167|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64530286|NCT05796167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64530287|NCT05796167|Serotonin Agents|serotonin agents|mesh-ancestor
64530288|NCT05796167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64530289|NCT05796167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530290|NCT05795491|Fluconazole|fluconazole|mesh-list
64294970|NCT04767711|Hormones|hormones|mesh-ancestor
64942906|NCT00032175|Antiviral Agents|antiviral agents|mesh-ancestor
64942913|NCT04712279|Ivermectin|ivermectin|mesh-list
64942968|NCT00396396|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64942969|NCT00396396|Antiviral Agents|antiviral agents|mesh-ancestor
64942970|NCT00396396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64942971|NCT00396396|Expectorants|expectorants|mesh-ancestor
64942972|NCT00396396|Respiratory System Agents|respiratory system agents|mesh-ancestor
64942973|NCT00396396|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64942974|NCT00396396|Antioxidants|antioxidants|mesh-ancestor
64942975|NCT00396396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942976|NCT00396396|Protective Agents|protective agents|mesh-ancestor
64942977|NCT00396396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942978|NCT00396396|Antidotes|antidotes|mesh-ancestor
64942989|NCT00032955|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64942991|NCT03150524|Nimodipine|nimodipine|mesh-list
64942992|NCT03150524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64942993|NCT03150524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64942994|NCT03150524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64942995|NCT03150524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942996|NCT03150524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64942997|NCT03150524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942998|NCT03150524|Vasodilator Agents|vasodilator agents|mesh-ancestor
64942999|NCT03150524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64943000|NCT00033033|Reserpine|reserpine|mesh-list
64943001|NCT00033033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64943002|NCT00033033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64943003|NCT00033033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64943004|NCT00033033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64530312|NCT05789381|Anesthetics|anesthetics|mesh-ancestor
64530313|NCT05789381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64530314|NCT05789381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64530315|NCT05789381|Anticonvulsants|anticonvulsants|mesh-ancestor
64530316|NCT05789381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64530317|NCT05789381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64943015|NCT03150368|Tubulin Modulators|tubulin modulators|mesh-ancestor
64943016|NCT03150368|Antimitotic Agents|antimitotic agents|mesh-ancestor
64943017|NCT03150368|Mitosis Modulators|mitosis modulators|mesh-ancestor
64943018|NCT03150368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943019|NCT00033072|Selegiline|selegiline|mesh-list
64943020|NCT00033072|Antidepressive Agents|antidepressive agents|mesh-ancestor
64943021|NCT00033072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64943022|NCT00033072|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64943023|NCT00033072|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64943024|NCT00033072|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64943025|NCT00033072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943026|NCT00033072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943027|NCT00033072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64943028|NCT00033072|Protective Agents|protective agents|mesh-ancestor
64943029|NCT00033072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943030|NCT03150290|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64943031|NCT03150290|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64943032|NCT03150290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943033|NCT00033111|Cabergoline|cabergoline|mesh-list
64943034|NCT00033111|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64943035|NCT00033111|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64943036|NCT00033111|Dopamine Agonists|dopamine agonists|mesh-ancestor
64943037|NCT00033111|Dopamine Agents|dopamine agents|mesh-ancestor
64943038|NCT00033111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64943041|NCT00033189|Ubiquinone|ubiquinone|mesh-list
64530321|NCT05789381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64530322|NCT05788627|Lactulose|lactulose|mesh-list
64530323|NCT05788627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64530324|NCT05787600|Chlorhexidine|chlorhexidine|mesh-list
64530325|NCT05787600|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64484199|NCT00809848|Bimatoprost|bimatoprost|mesh-list
64530326|NCT05787600|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64530327|NCT05787600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64295013|NCT03770546|Glucocorticoids|glucocorticoids|mesh-ancestor
64943061|NCT00033306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64943062|NCT00033306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64943063|NCT00033306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943064|NCT00033306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943065|NCT00033306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943066|NCT02984384|Aspirin|aspirin|mesh-list
64943067|NCT02984384|Heparin|heparin|mesh-list
64943068|NCT02984384|Enoxaparin|enoxaparin|mesh-list
64943069|NCT02984384|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64943070|NCT02984384|Tinzaparin|tinzaparin|mesh-list
64943071|NCT02984384|Dalteparin|dalteparin|mesh-list
64943072|NCT02984384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64943073|NCT02984384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64943074|NCT02984384|Analgesics|analgesics|mesh-ancestor
64943075|NCT02984384|Sensory System Agents|sensory system agents|mesh-ancestor
64943076|NCT02984384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64943077|NCT02984384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943078|NCT02984384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64943079|NCT02984384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64943080|NCT02984384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64943081|NCT02984384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64943082|NCT02984384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465979|NCT02543944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64465980|NCT02543944|Anticonvulsants|anticonvulsants|mesh-ancestor
64465981|NCT02543944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64465982|NCT02543944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64465983|NCT02543944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64465984|NCT02543944|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64465985|NCT02543944|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64465986|NCT02543944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64466015|NCT02531308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466017|NCT02531308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64466018|NCT02531308|Alkylating Agents|alkylating agents|mesh-ancestor
64466019|NCT02531308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466020|NCT02531308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466021|NCT02531308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64943083|NCT02984384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64943084|NCT02984384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64943085|NCT02984384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943086|NCT02984384|Antipyretics|antipyretics|mesh-ancestor
64943087|NCT02984384|Anticoagulants|anticoagulants|mesh-ancestor
64943088|NCT00033345|Indole-3-carbinol|indole-3-carbinol|mesh-list
64943089|NCT00033345|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64943090|NCT00033345|Protective Agents|protective agents|mesh-ancestor
64943091|NCT00033345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943092|NCT00033345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943093|NCT02823821|Dialysis Solutions|dialysis solutions|mesh-list
64943094|NCT02823821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64943095|NCT00033423|Rituximab|rituximab|mesh-list
64943096|NCT00033423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64943097|NCT00033423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943098|NCT00033423|Immunologic Factors|immunologic factors|mesh-ancestor
64943099|NCT00033423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943100|NCT00033423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64943101|NCT00033462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64943102|NCT00033462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943103|NCT00033462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64943104|NCT00033462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943105|NCT00033462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943106|NCT00393263|Clobetasol|clobetasol|mesh-list
64943107|NCT00393263|Pimecrolimus|pimecrolimus|mesh-list
64943137|NCT00033696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943138|NCT00033696|Tubulin Modulators|tubulin modulators|mesh-ancestor
64943139|NCT00033696|Antimitotic Agents|antimitotic agents|mesh-ancestor
64943140|NCT00033696|Mitosis Modulators|mitosis modulators|mesh-ancestor
64943141|NCT00033696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943143|NCT00033696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64943144|NCT00033696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943145|NCT00033696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64943146|NCT02548559|Cannabidiol|cannabidiol|mesh-list
64943147|NCT02548559|Anticonvulsants|anticonvulsants|mesh-ancestor
64943148|NCT00033735|Fluorouracil|fluorouracil|mesh-list
64943149|NCT00033735|Irofulven|irofulven|mesh-list
64943150|NCT00033735|Antimetabolites|antimetabolites|mesh-ancestor
64943151|NCT00033735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943162|NCT00033813|Histamine Agents|histamine agents|mesh-ancestor
64943163|NCT00033813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64943164|NCT00033813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943165|NCT00033813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943166|NCT00033813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64943167|NCT00033813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64943168|NCT00033813|Respiratory System Agents|respiratory system agents|mesh-ancestor
64943169|NCT00033891|Infliximab|infliximab|mesh-list
64943170|NCT00033891|Dermatologic Agents|dermatologic agents|mesh-ancestor
64943171|NCT00033891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64943172|NCT00033891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64943173|NCT02271893|Dextromethorphan|dextromethorphan|mesh-list
64943174|NCT02271893|Antitussive Agents|antitussive agents|mesh-ancestor
64943175|NCT02271893|Respiratory System Agents|respiratory system agents|mesh-ancestor
64943176|NCT02271893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64943177|NCT02271893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64943178|NCT02271893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64943179|NCT02271893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943180|NCT02271893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943181|NCT02149823|Oxytocin|oxytocin|mesh-list
64943182|NCT02149823|Oxytocics|oxytocics|mesh-ancestor
64943183|NCT02149823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64943184|NCT02149823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943185|NCT02971410|Simvastatin|simvastatin|mesh-list
64943196|NCT02035397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64943197|NCT02035397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64943198|NCT02035397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530341|NCT05771883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64530342|NCT05771883|Growth Substances|growth substances|mesh-ancestor
64530343|NCT05771883|Growth Inhibitors|growth inhibitors|mesh-ancestor
64530344|NCT05771883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530345|NCT05767892|Carboplatin|carboplatin|mesh-list
64530346|NCT05767892|Pemetrexed|pemetrexed|mesh-list
64530347|NCT05767892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530348|NCT05767892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530349|NCT05767892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530350|NCT05767892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64530351|NCT05767892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64530352|NCT05759754|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64530353|NCT05759754|Protease Inhibitors|protease inhibitors|mesh-ancestor
64530354|NCT05759754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530355|NCT05759754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530356|NCT05753956|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
64530357|NCT05753956|Hallucinogens|hallucinogens|mesh-ancestor
64530358|NCT05753956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530359|NCT05753956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64530360|NCT05753956|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64530361|NCT05753956|Serotonin Agents|serotonin agents|mesh-ancestor
64530362|NCT05753956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64530363|NCT05753956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295035|NCT04646967|Sensory System Agents|sensory system agents|mesh-ancestor
64295036|NCT04646967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64295037|NCT04646967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64943199|NCT02035397|Cholinergic Agents|cholinergic agents|mesh-ancestor
64943200|NCT02035397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64943206|NCT00034047|Fertility Agents|fertility agents|mesh-ancestor
64943212|NCT00034086|Lamivudine|lamivudine|mesh-list
64943213|NCT00034086|Zidovudine|zidovudine|mesh-list
64943214|NCT00034086|Didanosine|didanosine|mesh-list
64943215|NCT00034086|Stavudine|stavudine|mesh-list
64943216|NCT00034086|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64943217|NCT00034086|Vaccines|vaccines|mesh-list
64943230|NCT00034086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64943231|NCT00034086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64943232|NCT00034086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64530364|NCT05753956|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64530365|NCT05730816|Magnesium Sulfate|magnesium sulfate|mesh-list
64530366|NCT05730816|Analgesics|analgesics|mesh-ancestor
64530367|NCT05730816|Sensory System Agents|sensory system agents|mesh-ancestor
64530368|NCT05730816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64530369|NCT05730816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943267|NCT01807286|Autonomic Agents|autonomic agents|mesh-ancestor
64943268|NCT01807286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64943269|NCT01807286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530381|NCT05723874|BI 425809|bi 425809|mesh-list
64530382|NCT05723874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64530383|NCT05723874|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64530384|NCT05723874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530385|NCT05723874|Nootropic Agents|nootropic agents|mesh-ancestor
64530386|NCT05713760|Tirbanibulin|tirbanibulin|mesh-list
64530387|NCT05713760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530388|NCT05713760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530389|NCT05702333|Simendan|simendan|mesh-list
64530390|NCT05702333|Dobutamine|dobutamine|mesh-list
64530391|NCT05702333|Dopamine|dopamine|mesh-list
64943328|NCT00034671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530394|NCT05702333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64530395|NCT05702333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64530396|NCT05702333|Adrenergic Agents|adrenergic agents|mesh-ancestor
64530397|NCT05702333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64530398|NCT05702333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530399|NCT05702333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530400|NCT05702333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64530401|NCT05702333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64530402|NCT05702333|Autonomic Agents|autonomic agents|mesh-ancestor
64530403|NCT05702333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64530404|NCT05702333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64530405|NCT05702333|Respiratory System Agents|respiratory system agents|mesh-ancestor
64530406|NCT05702333|Mydriatics|mydriatics|mesh-ancestor
64530407|NCT05702333|Sympathomimetics|sympathomimetics|mesh-ancestor
64530408|NCT05702333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64530409|NCT05702333|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64530410|NCT05702333|Vasodilator Agents|vasodilator agents|mesh-ancestor
64530411|NCT05702333|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64530412|NCT05702333|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64530413|NCT05702333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295086|NCT02445586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943329|NCT00034671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943330|NCT00034671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64943331|NCT00034671|Hormone Antagonists|hormone antagonists|mesh-ancestor
64943332|NCT00034671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64943333|NCT00034671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943334|NCT01806857|Quinidine|quinidine|mesh-list
64651685|NCT01831700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64651686|NCT01831700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651687|NCT01831700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64651689|NCT01831700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651690|NCT01831700|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64466022|NCT02531308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64466023|NCT02531308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64466024|NCT02531308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64943335|NCT01806857|Dextromethorphan|dextromethorphan|mesh-list
64943336|NCT01806857|Antitussive Agents|antitussive agents|mesh-ancestor
64943347|NCT01806857|Antimalarials|antimalarials|mesh-ancestor
64943348|NCT01806857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64943349|NCT01806857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64943350|NCT01806857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64943351|NCT01806857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943352|NCT01806857|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64943353|NCT01806857|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64943354|NCT01806857|Cholinergic Agents|cholinergic agents|mesh-ancestor
64943355|NCT01806857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64943356|NCT01806857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64943357|NCT01806857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64943358|NCT01806857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64943359|NCT01806857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64943361|NCT00034710|Antipruritics|antipruritics|mesh-ancestor
64943362|NCT00034710|Dermatologic Agents|dermatologic agents|mesh-ancestor
64943363|NCT00034710|Sensory System Agents|sensory system agents|mesh-ancestor
64943364|NCT00034710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64530415|NCT05702333|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64530416|NCT05702333|Dopamine Agents|dopamine agents|mesh-ancestor
64530417|NCT05684744|Methotrexate|methotrexate|mesh-list
64530418|NCT05684744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64530419|NCT05684744|Abortifacient Agents|abortifacient agents|mesh-ancestor
64530420|NCT05684744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64295107|NCT02472873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64295112|NCT02472886|Ledipasvir|ledipasvir|mesh-list
64943365|NCT00034710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943366|NCT00034749|Risperidone|risperidone|mesh-list
64943385|NCT00034866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
64943386|NCT00034866|Protease Inhibitors|protease inhibitors|mesh-list
64943387|NCT00034866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64943388|NCT00034866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64943389|NCT00034866|Antiviral Agents|antiviral agents|mesh-ancestor
64943390|NCT00034866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64943391|NCT00034866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943392|NCT00034866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943393|NCT00034866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64943394|NCT00034905|Risperidone|risperidone|mesh-list
64943395|NCT00034905|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64943396|NCT00034905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64943397|NCT00034905|Serotonin Agents|serotonin agents|mesh-ancestor
64943398|NCT00034905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64943405|NCT00034905|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64943407|NCT00034905|Antidepressive Agents|antidepressive agents|mesh-ancestor
64943408|NCT01806311|Amlodipine|amlodipine|mesh-list
64943409|NCT01806311|Candesartan|candesartan|mesh-list
64943410|NCT01806311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64943411|NCT01806311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64943412|NCT01806311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64943413|NCT01806311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943414|NCT01806311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64943415|NCT01806311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943416|NCT01806311|Vasodilator Agents|vasodilator agents|mesh-ancestor
64943417|NCT01806311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64943419|NCT00034944|Aprepitant|aprepitant|mesh-list
64530433|NCT05671913|Ketamine|ketamine|mesh-list
64530434|NCT05671913|Analgesics|analgesics|mesh-ancestor
64530435|NCT05671913|Sensory System Agents|sensory system agents|mesh-ancestor
64295115|NCT04570839|Nivolumab|nivolumab|mesh-list
64943428|NCT01806272|Vitamin B 12|vitamin b 12|mesh-list
64943429|NCT01806272|Hydroxocobalamin|hydroxocobalamin|mesh-list
64943430|NCT01806272|Vitamins|vitamins|mesh-ancestor
64943431|NCT01806272|Micronutrients|micronutrients|mesh-ancestor
64943432|NCT01806272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943433|NCT01806272|Vitamin B Complex|vitamin b complex|mesh-ancestor
64943434|NCT01806272|Hematinics|hematinics|mesh-ancestor
64943435|NCT00034983|Aprepitant|aprepitant|mesh-list
64943436|NCT00034983|Paroxetine|paroxetine|mesh-list
64943437|NCT00034983|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64943438|NCT00034983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64943439|NCT00034983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64943440|NCT00034983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943441|NCT00034983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64943442|NCT00034983|Serotonin Agents|serotonin agents|mesh-ancestor
64943443|NCT00034983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943444|NCT00034983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64530444|NCT05671913|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64530445|NCT05671913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64530446|NCT05671913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530447|NCT05668936|Moxifloxacin|moxifloxacin|mesh-list
64530448|NCT05668936|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64530449|NCT05668936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64530450|NCT05668936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64530451|NCT05668936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64530452|NCT05668936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64530453|NCT05668936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530454|NCT05668936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530455|NCT05668936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530456|NCT05668936|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64530457|NCT05668936|Contraceptive Agents|contraceptive agents|mesh-ancestor
64295129|NCT02472652|Aripiprazole|aripiprazole|mesh-list
64943481|NCT00035139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64943482|NCT00035139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943483|NCT00035139|Dopamine Agents|dopamine agents|mesh-ancestor
64943484|NCT00035139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64943485|NCT00035178|Argatroban|argatroban|mesh-list
64943486|NCT00035178|Antithrombins|antithrombins|mesh-ancestor
64943487|NCT00035178|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64943488|NCT00035178|Protease Inhibitors|protease inhibitors|mesh-ancestor
64943489|NCT00035178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943490|NCT00035178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943491|NCT00035178|Anticoagulants|anticoagulants|mesh-ancestor
64943492|NCT00035178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64943493|NCT00393614|Levetiracetam|levetiracetam|mesh-list
64943494|NCT00393614|Anticonvulsants|anticonvulsants|mesh-ancestor
64943495|NCT00393614|Nootropic Agents|nootropic agents|mesh-ancestor
64943496|NCT00035256|Teriparatide|teriparatide|mesh-list
64530463|NCT05668676|Prednisone|prednisone|mesh-list
64530464|NCT05668676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64530465|NCT05668676|Glucocorticoids|glucocorticoids|mesh-ancestor
64530466|NCT05668676|Hormones|hormones|mesh-ancestor
64530467|NCT05668676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64530468|NCT05668676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530469|NCT05668676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64530470|NCT05668676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530471|NCT05657990|Tamsulosin|tamsulosin|mesh-list
64530472|NCT05657990|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64484200|NCT00809848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64530473|NCT05657990|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64530474|NCT05657990|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64530475|NCT05657990|Adrenergic Agents|adrenergic agents|mesh-ancestor
64530476|NCT05657990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64530477|NCT05657990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530478|NCT05657990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530509|NCT05613088|Mitosis Modulators|mitosis modulators|mesh-ancestor
64530510|NCT05613088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530511|NCT05613088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64530512|NCT05613088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64530513|NCT05613088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64530514|NCT05613088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530515|NCT05613088|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64943514|NCT00035295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943515|NCT01806116|Decitabine|decitabine|mesh-list
64943516|NCT01806116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64943517|NCT01806116|Antimetabolites|antimetabolites|mesh-ancestor
64943518|NCT01806116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943519|NCT01806116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943520|NCT01806116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943521|NCT00035451|Sotalol|sotalol|mesh-list
64943522|NCT00035451|Azimilide|azimilide|mesh-list
64943523|NCT00035451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64943524|NCT00035451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64943550|NCT02971254|Sevoflurane|sevoflurane|mesh-list
64943551|NCT02971254|Desflurane|desflurane|mesh-list
64943552|NCT02971254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64943553|NCT02971254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64943554|NCT02971254|Anesthetics, General|anesthetics, general|mesh-ancestor
64943555|NCT02971254|Anesthetics|anesthetics|mesh-ancestor
64943556|NCT02971254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64943557|NCT02971254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943558|NCT01805882|Sofosbuvir|sofosbuvir|mesh-list
64943559|NCT01805882|Ledipasvir|ledipasvir|mesh-list
64943560|NCT01805882|Antiviral Agents|antiviral agents|mesh-ancestor
64943561|NCT01805882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64943562|NCT00035802|Topiramate|topiramate|mesh-list
64943563|NCT00035802|Anticonvulsants|anticonvulsants|mesh-ancestor
64943564|NCT00035802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64943565|NCT00035802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530543|NCT05558007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64530544|NCT05558007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530545|NCT05558007|Urological Agents|urological agents|mesh-ancestor
64530546|NCT05556616|Lenalidomide|lenalidomide|mesh-list
64530547|NCT05556616|Pomalidomide|pomalidomide|mesh-list
64530548|NCT05556616|Bortezomib|bortezomib|mesh-list
64530549|NCT05556616|Daratumumab|daratumumab|mesh-list
64530550|NCT05556616|Immunologic Factors|immunologic factors|mesh-ancestor
64530551|NCT05556616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530552|NCT05556616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64530553|NCT05556616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64530554|NCT05556616|Growth Substances|growth substances|mesh-ancestor
64943577|NCT04732377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64943578|NCT04732377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64530585|NCT05477953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64530586|NCT05468320|Prednisone|prednisone|mesh-list
64530587|NCT05468320|Prednisolone|prednisolone|mesh-list
64530588|NCT05468320|Antibodies|antibodies|mesh-list
64530589|NCT05468320|Immunologic Factors|immunologic factors|mesh-ancestor
64530590|NCT05468320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530591|NCT05468320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530592|NCT05468320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64943644|NCT01805687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64530593|NCT05468320|Glucocorticoids|glucocorticoids|mesh-ancestor
64530594|NCT05468320|Hormones|hormones|mesh-ancestor
64530595|NCT05468320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64530596|NCT05468320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64530598|NCT05459129|Carboplatin|carboplatin|mesh-list
64530599|NCT05459129|Atezolizumab|atezolizumab|mesh-list
64530602|NCT05459129|Tubulin Modulators|tubulin modulators|mesh-ancestor
64530623|NCT05418556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64530624|NCT05418556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530625|NCT05418556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64530626|NCT05418556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64530627|NCT05418556|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64530628|NCT05418556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64530629|NCT05418556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530630|NCT05418556|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64530631|NCT05418556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64530632|NCT05418556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295299|NCT02049073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943781|NCT00036582|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64943831|NCT00396513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64943832|NCT00396513|Antimetabolites|antimetabolites|mesh-ancestor
64943833|NCT00396513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943834|NCT00396513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64943835|NCT00396513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64943836|NCT00396513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943837|NCT00036855|Rituximab|rituximab|mesh-list
64943838|NCT00036855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64943839|NCT00036855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64943840|NCT00036855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943841|NCT00036855|Immunologic Factors|immunologic factors|mesh-ancestor
64943842|NCT00036855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943843|NCT00036855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64943844|NCT00036894|Lenalidomide|lenalidomide|mesh-list
64943845|NCT00036894|Immunologic Factors|immunologic factors|mesh-ancestor
64943846|NCT00036894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943847|NCT00036894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64943848|NCT00036894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64943849|NCT00036894|Growth Substances|growth substances|mesh-ancestor
64943850|NCT00036894|Growth Inhibitors|growth inhibitors|mesh-ancestor
64943851|NCT00036894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943852|NCT01465685|Methylphenidate|methylphenidate|mesh-list
64943853|NCT01465685|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
64943854|NCT01465685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64943855|NCT01465685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943856|NCT01465685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64943857|NCT01465685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64943858|NCT01465685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64943860|NCT01465685|Dopamine Agents|dopamine agents|mesh-ancestor
64530654|NCT05386472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64530655|NCT05386472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64530656|NCT05386472|Protease Inhibitors|protease inhibitors|mesh-ancestor
64530657|NCT05386472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943865|NCT01465685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64943866|NCT01465685|Adrenergic Agents|adrenergic agents|mesh-ancestor
64943867|NCT00037011|Antibodies|antibodies|mesh-list
64943868|NCT00037011|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64943877|NCT00037050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64943879|NCT00037050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943880|NCT00037089|Tegafur|tegafur|mesh-list
64943881|NCT00037089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64943882|NCT00037089|Antimetabolites|antimetabolites|mesh-ancestor
64943883|NCT00037089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943884|NCT00037089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943885|NCT01465568|Denosumab|denosumab|mesh-list
64943886|NCT01465568|Diphosphonates|diphosphonates|mesh-list
64943887|NCT01465568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64943888|NCT01465568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943889|NCT00037206|Anidulafungin|anidulafungin|mesh-list
64943890|NCT00037206|Antifungal Agents|antifungal agents|mesh-ancestor
64943891|NCT00037206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64943892|NCT01465412|Adenosine|adenosine|mesh-list
64943893|NCT01465412|Analgesics|analgesics|mesh-ancestor
64295342|NCT02807623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295343|NCT05137964|Vitamin D|vitamin d|mesh-list
64295344|NCT05137964|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
64295345|NCT05137964|Vitamins|vitamins|mesh-ancestor
64295346|NCT05137964|Micronutrients|micronutrients|mesh-ancestor
64295347|NCT05137964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295348|NCT05137964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64295349|NCT04374578|Dulaglutide|dulaglutide|mesh-list
64295350|NCT04374578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64295351|NCT04374578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295352|NCT02470923|Nicotine|nicotine|mesh-list
64530669|NCT05382481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64530670|NCT05382481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530671|NCT05353283|Tenofovir|tenofovir|mesh-list
64530672|NCT05353283|Antiviral Agents|antiviral agents|mesh-ancestor
64530673|NCT05353283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64530674|NCT05353283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64530805|NCT05169593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64530806|NCT05169593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64530807|NCT05169593|Dermatologic Agents|dermatologic agents|mesh-ancestor
64530808|NCT05169593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64530809|NCT05162937|Antibodies|antibodies|mesh-list
64530810|NCT05162937|Immunologic Factors|immunologic factors|mesh-ancestor
64530811|NCT05162937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530812|NCT05152147|Fluorouracil|fluorouracil|mesh-list
64530813|NCT05152147|Capecitabine|capecitabine|mesh-list
64530814|NCT05152147|Oxaliplatin|oxaliplatin|mesh-list
64530815|NCT05152147|Trastuzumab|trastuzumab|mesh-list
64530816|NCT05152147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64530817|NCT05152147|Antimetabolites|antimetabolites|mesh-ancestor
64530818|NCT05152147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530819|NCT05152147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64295458|NCT03561415|Hormone Antagonists|hormone antagonists|mesh-ancestor
64943911|NCT01465256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64943912|NCT01465256|Analgesics|analgesics|mesh-ancestor
64943913|NCT01465256|Sensory System Agents|sensory system agents|mesh-ancestor
64943914|NCT01465256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64943915|NCT01465256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943916|NCT01465256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64943917|NCT01465256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64943918|NCT01465256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64943919|NCT01465256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64530820|NCT05152147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64530822|NCT05152147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530823|NCT05152147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64530824|NCT05145413|Xanomeline|xanomeline|mesh-list
64530825|NCT05145413|Trospium chloride|trospium chloride|mesh-list
64530826|NCT05145413|Parasympatholytics|parasympatholytics|mesh-ancestor
64530827|NCT05145413|Autonomic Agents|autonomic agents|mesh-ancestor
64295473|NCT02477007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295474|NCT02477007|Antipyretics|antipyretics|mesh-ancestor
64295475|NCT02052973|Propolis|propolis|mesh-list
64943959|NCT01464944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64943960|NCT01464944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64943961|NCT01464944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64943962|NCT01464944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64943963|NCT01464944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943964|NCT01464944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64943965|NCT01464944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64943966|NCT01464944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943967|NCT01464944|Antipyretics|antipyretics|mesh-ancestor
64943968|NCT00037596|Cytarabine|cytarabine|mesh-list
64943969|NCT00037596|Gemtuzumab|gemtuzumab|mesh-list
64943970|NCT00037596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64943971|NCT00037596|Antimetabolites|antimetabolites|mesh-ancestor
64944006|NCT00037869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944007|NCT00037869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944008|NCT00037869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944009|NCT00037869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64944010|NCT00393731|Misoprostol|misoprostol|mesh-list
64944011|NCT00393731|Oxytocin|oxytocin|mesh-list
64944012|NCT00393731|Oxytocics|oxytocics|mesh-ancestor
64944013|NCT00393731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64944014|NCT00393731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944015|NCT00393731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64944016|NCT00393731|Abortifacient Agents|abortifacient agents|mesh-ancestor
64944019|NCT00038025|Pentostatin|pentostatin|mesh-list
64944050|NCT00038220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64944051|NCT00038220|Protease Inhibitors|protease inhibitors|mesh-ancestor
64944052|NCT00038220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944053|NCT00038220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712596|NCT04109729|Nivolumab|nivolumab|mesh-list
64530882|NCT05039801|Tubulin Modulators|tubulin modulators|mesh-ancestor
64530883|NCT05039801|Antimitotic Agents|antimitotic agents|mesh-ancestor
64530884|NCT05039801|Mitosis Modulators|mitosis modulators|mesh-ancestor
64530885|NCT05039801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64530886|NCT05039801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64530887|NCT05039801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64530888|NCT05039801|Growth Substances|growth substances|mesh-ancestor
64530889|NCT05039801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530890|NCT05039801|Growth Inhibitors|growth inhibitors|mesh-ancestor
64530891|NCT05039801|Immunologic Factors|immunologic factors|mesh-ancestor
64295524|NCT02056249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64530913|NCT04985500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64530914|NCT04985500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64530915|NCT04985500|Sensory System Agents|sensory system agents|mesh-ancestor
64530916|NCT04985500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64530917|NCT04978493|Ustekinumab|ustekinumab|mesh-list
64530918|NCT04978493|Dermatologic Agents|dermatologic agents|mesh-ancestor
64530919|NCT04973670|Sivelestat|sivelestat|mesh-list
64944200|NCT00846911|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64944201|NCT00846911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64944202|NCT00846911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64944203|NCT00846872|Mannitol|mannitol|mesh-list
64944204|NCT00846872|Hormones|hormones|mesh-list
64530987|NCT04808934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295620|NCT02802865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64295621|NCT02802865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64944260|NCT00846443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944261|NCT00846443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944262|NCT00846443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531001|NCT04738942|Vedolizumab|vedolizumab|mesh-list
64944324|NCT04888377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64944325|NCT04888377|Analgesics|analgesics|mesh-ancestor
64944326|NCT04888377|Sensory System Agents|sensory system agents|mesh-ancestor
64944327|NCT04888377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64944328|NCT04888377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944329|NCT04888377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64944330|NCT04888377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64944331|NCT04888377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64944332|NCT04888377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64944333|NCT04888377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944334|NCT04888377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64944335|NCT04888377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64944337|NCT04888377|Antipyretics|antipyretics|mesh-ancestor
64531017|NCT04699461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531018|NCT04699461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531019|NCT04699461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64531020|NCT04677543|Azithromycin|azithromycin|mesh-list
64531021|NCT04677543|Amikacin|amikacin|mesh-list
64944474|NCT00276575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944475|NCT00276575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944476|NCT00276536|Interferons|interferons|mesh-list
64944477|NCT00276536|Interferon-alpha|interferon-alpha|mesh-list
64944478|NCT00276536|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
64295717|NCT02057263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64295719|NCT05550909|Artesunate|artesunate|mesh-list
64944502|NCT00041340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944503|NCT00276185|Botulinum Toxins|botulinum toxins|mesh-list
64944504|NCT00276185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64944505|NCT00276185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64944510|NCT00276146|Dipyridamole|dipyridamole|mesh-list
64531142|NCT04436731|Autonomic Agents|autonomic agents|mesh-ancestor
64531143|NCT04436731|Sympathomimetics|sympathomimetics|mesh-ancestor
64531144|NCT04436731|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64531145|NCT04436731|Nasal Decongestants|nasal decongestants|mesh-ancestor
64531146|NCT04436731|Respiratory System Agents|respiratory system agents|mesh-ancestor
64944571|NCT04149210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64944574|NCT04149210|Hormones|hormones|mesh-ancestor
64944634|NCT00275639|Losartan|losartan|mesh-list
64944643|NCT03957057|Micronutrients|micronutrients|mesh-ancestor
64944644|NCT03957057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944645|NCT03957057|Hematinics|hematinics|mesh-ancestor
64944646|NCT00275600|Vitamin E|vitamin e|mesh-list
64944647|NCT00275600|Vitamins|vitamins|mesh-ancestor
64944653|NCT00275522|Sirolimus|sirolimus|mesh-list
64944719|NCT00041535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64944720|NCT00041535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944721|NCT00041574|Nitric Oxide|nitric oxide|mesh-list
64944722|NCT00041574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64944791|NCT03208179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64944792|NCT03208179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64944793|NCT03208179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944794|NCT03208179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944795|NCT03208179|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64944796|NCT03208179|Renal Agents|renal agents|mesh-ancestor
64944797|NCT00275015|Cytarabine|cytarabine|mesh-list
64944798|NCT00275015|Dexamethasone|dexamethasone|mesh-list
64944799|NCT00275015|Cyclophosphamide|cyclophosphamide|mesh-list
64944800|NCT00275015|Melphalan|melphalan|mesh-list
64944801|NCT00275015|Carmustine|carmustine|mesh-list
64944802|NCT00275015|Fludarabine|fludarabine|mesh-list
64944803|NCT00275015|Fludarabine phosphate|fludarabine phosphate|mesh-list
64944804|NCT00275015|Etoposide|etoposide|mesh-list
64944805|NCT00275015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64944806|NCT00275015|Immunologic Factors|immunologic factors|mesh-ancestor
64944807|NCT00275015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944808|NCT00275015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64944809|NCT00275015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64944810|NCT00275015|Alkylating Agents|alkylating agents|mesh-ancestor
64944852|NCT03062826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64944853|NCT03062826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64944854|NCT03062826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944855|NCT03062826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64944856|NCT03062826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64944857|NCT03062826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944915|NCT00130091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64944916|NCT00130091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64944917|NCT00130091|Adrenergic Agents|adrenergic agents|mesh-ancestor
64944918|NCT00130091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64944919|NCT00130091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944920|NCT00130013|Amoxicillin|amoxicillin|mesh-list
64944923|NCT00129857|HU 211|hu 211|mesh-list
64945002|NCT00042003|Antimetabolites|antimetabolites|mesh-ancestor
64945003|NCT00042003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945004|NCT00042003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945027|NCT00470223|Doxorubicin|doxorubicin|mesh-list
64945028|NCT00470223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64945029|NCT00470223|Methotrexate|methotrexate|mesh-list
64945031|NCT00470223|Ifosfamide|ifosfamide|mesh-list
64945032|NCT00470223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945033|NCT00470223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64945034|NCT00470223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64945035|NCT00470223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64945036|NCT00470223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945037|NCT00470223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945038|NCT00470223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64945039|NCT00470223|Abortifacient Agents|abortifacient agents|mesh-ancestor
64945040|NCT00470223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64945084|NCT00038376|Immunologic Factors|immunologic factors|mesh-ancestor
64945085|NCT00038376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945086|NCT00038376|Dermatologic Agents|dermatologic agents|mesh-ancestor
64945087|NCT00128531|Leuprolide|leuprolide|mesh-list
64945094|NCT00038454|Chrysarobin|chrysarobin|mesh-list
64945165|NCT05770375|Serotonin Agents|serotonin agents|mesh-ancestor
64945166|NCT05770375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64945167|NCT05770375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945168|NCT05770375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64945169|NCT05770375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64945170|NCT05770375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64945257|NCT05769153|Growth Inhibitors|growth inhibitors|mesh-ancestor
64945258|NCT05769153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945259|NCT05769049|Vaccines|vaccines|mesh-list
64531245|NCT04100135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64531246|NCT04100135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64531247|NCT04100135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64531248|NCT04100135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64531261|NCT04055818|Niacin|niacin|mesh-list
64531272|NCT04055818|Micronutrients|micronutrients|mesh-ancestor
64531273|NCT04055818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531274|NCT04055818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64295860|NCT03310593|Cannabidiol|cannabidiol|mesh-list
64945304|NCT05760144|Etonogestrel|etonogestrel|mesh-list
64945305|NCT05760144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64945306|NCT05760144|Contraceptive Agents|contraceptive agents|mesh-ancestor
64945313|NCT05744674|Ropivacaine|ropivacaine|mesh-list
64557572|NCT05083299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64557573|NCT05083299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64557574|NCT05083299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557575|NCT05083299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64557576|NCT05083299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64531300|NCT04029688|Venetoclax|venetoclax|mesh-list
64531301|NCT04029688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64484387|NCT01729819|Natriuretic Agents|natriuretic agents|mesh-ancestor
64484388|NCT00811564|Timolol|timolol|mesh-list
64484389|NCT00811564|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64484390|NCT00811564|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64484391|NCT00811564|Latanoprost|latanoprost|mesh-list
64484392|NCT00811564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64484393|NCT00811564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453601|NCT02033369|Pramipexole|pramipexole|mesh-list
64453602|NCT02033369|Antioxidants|antioxidants|mesh-ancestor
64453603|NCT02033369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439329|NCT01777282|Hormones|hormones|mesh-ancestor
64453604|NCT02033369|Protective Agents|protective agents|mesh-ancestor
64453605|NCT02033369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453606|NCT02033369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64453607|NCT02033369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64453608|NCT02033369|Dopamine Agonists|dopamine agonists|mesh-ancestor
64453609|NCT02033369|Dopamine Agents|dopamine agents|mesh-ancestor
64453610|NCT02033369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64453611|NCT02032901|Sofosbuvir|sofosbuvir|mesh-list
64453612|NCT02032901|Antiviral Agents|antiviral agents|mesh-ancestor
64453613|NCT02032901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64453665|NCT02020577|Afatinib|afatinib|mesh-list
64453666|NCT02020577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64453667|NCT02020577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453668|NCT02020577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64453669|NCT02020577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453671|NCT02020031|Vancomycin|vancomycin|mesh-list
64453751|NCT01619852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64453752|NCT01619852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453753|NCT01619852|Sensory System Agents|sensory system agents|mesh-ancestor
64453754|NCT01619852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64453755|NCT01619852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64453756|NCT01619852|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64453757|NCT01619852|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64453761|NCT04069936|Tadalafil|tadalafil|mesh-list
64453831|NCT02003365|Triamcinolone|triamcinolone|mesh-list
64453832|NCT02003365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64453833|NCT02003365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64945361|NCT05697783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64453835|NCT02003365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64453836|NCT02003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64453837|NCT02003365|Glucocorticoids|glucocorticoids|mesh-ancestor
64453840|NCT02003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453879|NCT04176055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64453880|NCT04176055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64453881|NCT04176055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64453882|NCT04176055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64453883|NCT04176055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64453884|NCT04176055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64453885|NCT04176055|Dopamine Agents|dopamine agents|mesh-ancestor
64453886|NCT04176055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64453903|NCT04659044|Immunologic Factors|immunologic factors|mesh-ancestor
64453942|NCT01964378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453943|NCT01964378|Analgesics|analgesics|mesh-ancestor
64531383|NCT03864419|Immunologic Factors|immunologic factors|mesh-ancestor
64531384|NCT03864419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531385|NCT03864419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64531386|NCT03864419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64531387|NCT03864419|Alkylating Agents|alkylating agents|mesh-ancestor
64531394|NCT03864419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531401|NCT03864419|Abortifacient Agents|abortifacient agents|mesh-ancestor
64531402|NCT03864419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64531403|NCT03864419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64531404|NCT03864419|Antimetabolites|antimetabolites|mesh-ancestor
64531405|NCT03864419|Dermatologic Agents|dermatologic agents|mesh-ancestor
64454000|NCT01954927|Anticonvulsants|anticonvulsants|mesh-ancestor
64454068|NCT01970462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454069|NCT01995266|Asunaprevir|asunaprevir|mesh-list
64454070|NCT01995266|Protease Inhibitors|protease inhibitors|mesh-ancestor
64454071|NCT01995266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454072|NCT01995266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454073|NCT01969058|Isotretinoin|isotretinoin|mesh-list
64454074|NCT01969058|Dermatologic Agents|dermatologic agents|mesh-ancestor
64454075|NCT01968980|Bococizumab|bococizumab|mesh-list
64454076|NCT01968980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64531432|NCT03856671|Neomycin|neomycin|mesh-list
64531433|NCT03856671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64531434|NCT03856671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64531435|NCT03856671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64531436|NCT03856671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64531437|NCT03856671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64454235|NCT02030015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64454236|NCT02030015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454237|NCT02029235|Acetaminophen|acetaminophen|mesh-list
64454238|NCT02029235|Ibuprofen|ibuprofen|mesh-list
64454240|NCT02029235|Hydrocodone|hydrocodone|mesh-list
64454330|NCT02015663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64454331|NCT02015663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64454333|NCT02028767|Empagliflozin|empagliflozin|mesh-list
64454334|NCT02028767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64454335|NCT02028767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454336|NCT02028767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64454337|NCT02028767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454338|NCT04678895|Naltrexone|naltrexone|mesh-list
64454339|NCT04678895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64454340|NCT04678895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64454341|NCT04678895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454342|NCT04678895|Sensory System Agents|sensory system agents|mesh-ancestor
64454344|NCT04683965|Bevacizumab|bevacizumab|mesh-list
64454380|NCT02025725|Metoclopramide|metoclopramide|mesh-list
64454381|NCT02025725|Antiemetics|antiemetics|mesh-ancestor
64454382|NCT02025725|Autonomic Agents|autonomic agents|mesh-ancestor
64454383|NCT02025725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64454384|NCT02025725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454385|NCT02025725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64454386|NCT02025725|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64454387|NCT02025725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64454388|NCT02025725|Dopamine Agents|dopamine agents|mesh-ancestor
64296060|NCT04335968|Melatonin|melatonin|mesh-list
64454464|NCT01959698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64454465|NCT01959698|Immunologic Factors|immunologic factors|mesh-ancestor
64454466|NCT01959698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454467|NCT01959698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64454468|NCT01959698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64531527|NCT03464045|Protease Inhibitors|protease inhibitors|mesh-ancestor
64531528|NCT03464045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296081|NCT04490967|Salicylates|salicylates|mesh-list
64454535|NCT01934972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64454536|NCT01934972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64454556|NCT01978093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454558|NCT01977937|Analgesics|analgesics|mesh-ancestor
64454562|NCT01977937|Anticonvulsants|anticonvulsants|mesh-ancestor
64454626|NCT01950169|Micronutrients|micronutrients|mesh-ancestor
64454627|NCT01950169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454628|NCT01950169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64454629|NCT01950169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64454630|NCT01950169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64454652|NCT01977625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64454653|NCT01977625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454655|NCT01977625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64454741|NCT01933334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64454742|NCT01933334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454743|NCT01933334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64454744|NCT01933334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64454745|NCT01933334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64454747|NCT01933334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64454748|NCT01932788|Vitamin D|vitamin d|mesh-list
64454749|NCT01932788|Cholecalciferol|cholecalciferol|mesh-list
64454750|NCT01932788|Vitamins|vitamins|mesh-list
64454792|NCT01906346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454793|NCT01906346|Sensory System Agents|sensory system agents|mesh-ancestor
64454794|NCT01906346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64454805|NCT04645004|Analgesics|analgesics|mesh-ancestor
64531620|NCT03129555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531621|NCT03129555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531622|NCT03129555|Anticoagulants|anticoagulants|mesh-ancestor
64531623|NCT03129490|Rivaroxaban|rivaroxaban|mesh-list
64531624|NCT03129490|Apixaban|apixaban|mesh-list
64531625|NCT03129490|Edoxaban|edoxaban|mesh-list
64531626|NCT03129490|Dabigatran|dabigatran|mesh-list
64454882|NCT01467466|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64454883|NCT01467466|Antiviral Agents|antiviral agents|mesh-ancestor
64454884|NCT01467466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64454885|NCT01467466|Expectorants|expectorants|mesh-ancestor
64454886|NCT01467466|Respiratory System Agents|respiratory system agents|mesh-ancestor
64454887|NCT01467466|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64454888|NCT01467466|Antioxidants|antioxidants|mesh-ancestor
64454889|NCT01467466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454940|NCT04504864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64531684|NCT03006302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64531685|NCT03006302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64531686|NCT03006302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64531687|NCT03006302|Alkylating Agents|alkylating agents|mesh-ancestor
64531688|NCT03006302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531689|NCT03006302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531690|NCT03006302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64531691|NCT03006302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64531692|NCT02927249|Aspirin|aspirin|mesh-list
64531693|NCT02927249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64455006|NCT01435018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64455007|NCT01435018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64455008|NCT01435018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64455009|NCT01435018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64531694|NCT02927249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64531695|NCT02927249|Analgesics|analgesics|mesh-ancestor
64531696|NCT02927249|Sensory System Agents|sensory system agents|mesh-ancestor
64455062|NCT01954082|Vitamin B Complex|vitamin b complex|mesh-ancestor
64455063|NCT01954082|Vitamins|vitamins|mesh-ancestor
64455064|NCT01954082|Micronutrients|micronutrients|mesh-ancestor
64455065|NCT01954082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455066|NCT01417000|Cyclophosphamide|cyclophosphamide|mesh-list
64455067|NCT01417000|Pancrelipase|pancrelipase|mesh-list
64455068|NCT01417000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64455069|NCT01417000|Immunologic Factors|immunologic factors|mesh-ancestor
64455070|NCT01417000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455078|NCT01415986|Temoporfin|temoporfin|mesh-list
64455126|NCT04767178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455127|NCT04767178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64455128|NCT04767178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64455129|NCT04767178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64455130|NCT04767178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455131|NCT04767178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455132|NCT04767178|Antipyretics|antipyretics|mesh-ancestor
64455133|NCT01432600|Dexamethasone|dexamethasone|mesh-list
64455134|NCT01432600|Cyclophosphamide|cyclophosphamide|mesh-list
64455135|NCT01432600|Pomalidomide|pomalidomide|mesh-list
64455136|NCT01432600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64455137|NCT01432600|Immunologic Factors|immunologic factors|mesh-ancestor
64455138|NCT01432600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455139|NCT01432600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64455140|NCT01432600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64455141|NCT01432600|Alkylating Agents|alkylating agents|mesh-ancestor
64455186|NCT01431976|Anticonvulsants|anticonvulsants|mesh-ancestor
64455187|NCT01431976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64455188|NCT01431976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64455189|NCT01431976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455190|NCT01431976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64455191|NCT01431976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455192|NCT01431976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64455193|NCT01431976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64455197|NCT01413958|Loratadine|loratadine|mesh-list
64455255|NCT04053712|Glucagon|glucagon|mesh-list
64455256|NCT04053712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64455257|NCT04053712|Hormones|hormones|mesh-ancestor
64455258|NCT04053712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64455259|NCT04053712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455260|NCT01798485|Docetaxel|docetaxel|mesh-list
64455261|NCT01798485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455262|NCT01798485|Tubulin Modulators|tubulin modulators|mesh-ancestor
64945367|NCT05697783|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64455263|NCT01798485|Antimitotic Agents|antimitotic agents|mesh-ancestor
64455264|NCT01798485|Mitosis Modulators|mitosis modulators|mesh-ancestor
64455265|NCT01798485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455266|NCT01767519|Solifenacin Succinate|solifenacin succinate|mesh-list
64455267|NCT01767519|Botulinum Toxins|botulinum toxins|mesh-list
64455278|NCT01767519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64455279|NCT01767519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64455280|NCT01767519|Urological Agents|urological agents|mesh-ancestor
64455281|NCT04581603|Topiramate|topiramate|mesh-list
64455282|NCT04581603|Anticonvulsants|anticonvulsants|mesh-ancestor
64455283|NCT04581603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64455284|NCT04581603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455285|NCT01797081|Botulinum Toxins|botulinum toxins|mesh-list
64455286|NCT01797081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64455287|NCT01797081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64455288|NCT01797081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64455298|NCT01765569|Vemurafenib|vemurafenib|mesh-list
64531772|NCT01997840|Ricolinostat|ricolinostat|mesh-list
64531773|NCT01997840|BB 1101|bb 1101|mesh-list
64531774|NCT01997840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64531775|NCT01997840|Antiemetics|antiemetics|mesh-ancestor
64531776|NCT01997840|Autonomic Agents|autonomic agents|mesh-ancestor
64531777|NCT01997840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64531778|NCT01997840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531779|NCT01997840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64531780|NCT01997840|Glucocorticoids|glucocorticoids|mesh-ancestor
64531781|NCT01997840|Hormones|hormones|mesh-ancestor
64531794|NCT01853826|Afatinib|afatinib|mesh-list
64531815|NCT01505569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64531816|NCT01505569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64531817|NCT01505569|Immunologic Factors|immunologic factors|mesh-ancestor
64296359|NCT02055703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455347|NCT01791153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64455348|NCT01791153|Glucocorticoids|glucocorticoids|mesh-ancestor
64455349|NCT01791153|Hormones|hormones|mesh-ancestor
64455371|NCT01926626|Nicotine|nicotine|mesh-list
64455388|NCT01900730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455389|NCT01900730|GABA Agents|gaba agents|mesh-ancestor
64455390|NCT01900730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64455391|NCT01900730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455392|NCT01900730|Antimanic Agents|antimanic agents|mesh-ancestor
64455393|NCT01900730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64455418|NCT01431274|Autonomic Agents|autonomic agents|mesh-ancestor
64455419|NCT01431274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64455509|NCT01989689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64455510|NCT01989689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64455511|NCT01989689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64455512|NCT01989689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64455513|NCT01989689|Immunologic Factors|immunologic factors|mesh-ancestor
64455514|NCT01942993|Vemurafenib|vemurafenib|mesh-list
64455515|NCT01942993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455516|NCT01942993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64455517|NCT01942993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455518|NCT01942993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455519|NCT01989455|Deferiprone|deferiprone|mesh-list
64531895|NCT01497197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64531896|NCT01497197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64531897|NCT01497197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531898|NCT01557283|Etanercept|etanercept|mesh-list
64531899|NCT01557283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64531900|NCT01557283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64531901|NCT01557283|Analgesics|analgesics|mesh-ancestor
64531906|NCT01557283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64455574|NCT01925612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64455575|NCT01925612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64455576|NCT01925612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64455577|NCT01925612|Immunologic Factors|immunologic factors|mesh-ancestor
64455578|NCT01925612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455579|NCT01925612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64455580|NCT01925612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64455581|NCT01925612|Alkylating Agents|alkylating agents|mesh-ancestor
64455582|NCT01925612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455583|NCT01925612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455584|NCT01925612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64455585|NCT01925612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64455586|NCT01925612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64455587|NCT01925612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64455588|NCT01925612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64455589|NCT01925612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531929|NCT00350025|Paclitaxel|paclitaxel|mesh-list
64531930|NCT00350025|Cetuximab|cetuximab|mesh-list
64531931|NCT00350025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64531932|NCT00350025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531933|NCT00350025|Tubulin Modulators|tubulin modulators|mesh-ancestor
64455598|NCT01925612|Mitosis Modulators|mitosis modulators|mesh-ancestor
64455599|NCT02093663|Mesalamine|mesalamine|mesh-list
64455600|NCT02093663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64455601|NCT02093663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64455602|NCT02093663|Analgesics|analgesics|mesh-ancestor
64455603|NCT02093663|Sensory System Agents|sensory system agents|mesh-ancestor
64455604|NCT02093663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64455605|NCT02093663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531957|NCT01496183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531958|NCT01496183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64531959|NCT01496183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64531960|NCT01496183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64531961|NCT01496183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64531962|NCT01496183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64531963|NCT01496183|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64531964|NCT01496183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64531965|NCT01496183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64531966|NCT01496183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531967|NCT01496183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64531968|NCT01496183|Serotonin Agents|serotonin agents|mesh-ancestor
64531969|NCT03278106|Trifluridine|trifluridine|mesh-list
64531970|NCT03278106|Antimetabolites|antimetabolites|mesh-ancestor
64531971|NCT03278106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531972|NCT03278106|Antiviral Agents|antiviral agents|mesh-ancestor
64531973|NCT03278106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64531974|NCT01495793|Rotigotine|rotigotine|mesh-list
64455694|NCT02093351|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64455695|NCT02093351|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64455696|NCT02093351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64455697|NCT02093351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64455698|NCT02078284|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
64455699|NCT02078284|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64455710|NCT01940497|Doxorubicin|doxorubicin|mesh-list
64455711|NCT01940497|Trastuzumab|trastuzumab|mesh-list
64455712|NCT01940497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64455713|NCT01940497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455714|NCT01940497|Tubulin Modulators|tubulin modulators|mesh-ancestor
64531976|NCT01495793|Dopamine Agents|dopamine agents|mesh-ancestor
64531977|NCT01495793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64531978|NCT01495793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531979|NCT01495793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531981|NCT02374008|Ketorolac|ketorolac|mesh-list
64531982|NCT02374008|Ropivacaine|ropivacaine|mesh-list
64531984|NCT02374008|Antiemetics|antiemetics|mesh-ancestor
64455734|NCT01923896|Antitubercular Agents|antitubercular agents|mesh-ancestor
64532003|NCT02374008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64532004|NCT02374008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64532005|NCT04505280|Lidocaine|lidocaine|mesh-list
64532006|NCT04505280|Anesthetics, Local|anesthetics, local|mesh-ancestor
64532007|NCT04505280|Anesthetics|anesthetics|mesh-ancestor
64532008|NCT04505280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64532057|NCT02881086|Immunologic Factors|immunologic factors|mesh-ancestor
64532058|NCT02881086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532059|NCT02881086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64532060|NCT02881086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64532061|NCT02881086|Alkylating Agents|alkylating agents|mesh-ancestor
64455824|NCT01597557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64455825|NCT01597557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455826|NCT01597557|Anesthetics|anesthetics|mesh-ancestor
64455827|NCT01597557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64455828|NCT01597557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64455829|NCT01597557|Anticonvulsants|anticonvulsants|mesh-ancestor
64455854|NCT01789203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64455920|NCT01787331|Hormone Antagonists|hormone antagonists|mesh-ancestor
64455921|NCT01787331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64455922|NCT01787331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532089|NCT02881086|Mitosis Modulators|mitosis modulators|mesh-ancestor
64488188|NCT02240212|Paclitaxel|paclitaxel|mesh-list
64532090|NCT02881086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64532091|NCT02881086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64456025|NCT01608087|Growth Substances|growth substances|mesh-ancestor
64456026|NCT01608087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456027|NCT01608087|Growth Inhibitors|growth inhibitors|mesh-ancestor
64456028|NCT01912963|Trastuzumab|trastuzumab|mesh-list
64532096|NCT03922542|Micronutrients|micronutrients|mesh-ancestor
64456093|NCT01970527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64532105|NCT02362308|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
64532106|NCT02362308|Mineralocorticoids|mineralocorticoids|mesh-list
64532107|NCT02362308|Hormone Antagonists|hormone antagonists|mesh-ancestor
64532108|NCT02362308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64532109|NCT02362308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532110|NCT02362308|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64532111|NCT02362308|Diuretics|diuretics|mesh-ancestor
64532122|NCT02366208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532123|NCT02366208|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64532124|NCT02366208|Immunologic Factors|immunologic factors|mesh-ancestor
64456154|NCT04641026|Deuterium Oxide|deuterium oxide|mesh-list
64456155|NCT04641026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456156|NCT04641026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64456332|NCT01403116|Testosterone enanthate|testosterone enanthate|mesh-list
64456333|NCT01403116|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64456349|NCT01753401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456350|NCT01894568|Insulin|insulin|mesh-list
64456351|NCT01894568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64456352|NCT01894568|Insulin Glargine|insulin glargine|mesh-list
64456353|NCT01894568|Pioglitazone|pioglitazone|mesh-list
64456354|NCT01894568|Biguanides|biguanides|mesh-list
64456355|NCT01894568|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64532139|NCT00310401|Autonomic Agents|autonomic agents|mesh-ancestor
64532140|NCT00310401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64532141|NCT00310401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532142|NCT00310401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64532143|NCT00310401|Respiratory System Agents|respiratory system agents|mesh-ancestor
64532144|NCT00310401|Tocolytic Agents|tocolytic agents|mesh-ancestor
64532145|NCT00310401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64532148|NCT00310401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64456478|NCT01421134|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64456479|NCT01421134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64456480|NCT01421134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64456481|NCT01421134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64456482|NCT01421134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456483|NCT01421134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64456484|NCT01421134|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64456485|NCT01421134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64456486|NCT01421134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64456499|NCT01386970|Zidovudine|zidovudine|mesh-list
64456575|NCT01399372|Tubulin Modulators|tubulin modulators|mesh-ancestor
64456576|NCT01399372|Antimitotic Agents|antimitotic agents|mesh-ancestor
64456577|NCT01399372|Mitosis Modulators|mitosis modulators|mesh-ancestor
64456578|NCT01385098|Calcium, Dietary|calcium, dietary|mesh-list
64456579|NCT01385098|Vitamin D|vitamin d|mesh-list
64456580|NCT01385098|Ergocalciferols|ergocalciferols|mesh-list
64456692|NCT01777269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64456722|NCT01775475|Immunologic Factors|immunologic factors|mesh-ancestor
64456723|NCT01775475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456724|NCT01775475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64456725|NCT01775475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64456726|NCT01775475|Alkylating Agents|alkylating agents|mesh-ancestor
64456727|NCT01775475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532218|NCT02105415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64532219|NCT02105415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64532221|NCT02105415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532223|NCT01523275|Mitomycin|mitomycin|mesh-list
64532224|NCT01523275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64532225|NCT01523275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532226|NCT01523275|Alkylating Agents|alkylating agents|mesh-ancestor
64532229|NCT01523275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64456880|NCT01746225|Tubulin Modulators|tubulin modulators|mesh-ancestor
64456881|NCT01746225|Antimitotic Agents|antimitotic agents|mesh-ancestor
64456912|NCT01383928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64456913|NCT01383928|Glucocorticoids|glucocorticoids|mesh-ancestor
64456914|NCT01383928|Hormones|hormones|mesh-ancestor
64456915|NCT01383928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64456916|NCT01383928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64456917|NCT01383928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456968|NCT01744197|Sensory System Agents|sensory system agents|mesh-ancestor
64456969|NCT01744197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456970|NCT01744197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64456971|NCT01744197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64456972|NCT01744197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64457076|NCT01614093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64457077|NCT01614093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457078|NCT04559607|Apatinib|apatinib|mesh-list
64457079|NCT04559607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457080|NCT04559607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64457081|NCT04559607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457082|NCT04559607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457083|NCT01834274|Metformin|metformin|mesh-list
64457084|NCT01834274|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64457085|NCT01834274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64457087|NCT01834274|Incretins|incretins|mesh-ancestor
64457210|NCT01722669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457212|NCT01722669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457213|NCT01707147|Linagliptin|linagliptin|mesh-list
64457214|NCT01707147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64457215|NCT01707147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457216|NCT01707147|Incretins|incretins|mesh-ancestor
64457217|NCT01707147|Hormones|hormones|mesh-ancestor
64457218|NCT01707147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64532305|NCT02373072|Antiemetics|antiemetics|mesh-ancestor
64457312|NCT01720797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64532314|NCT02372916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532315|NCT02372916|Growth Inhibitors|growth inhibitors|mesh-ancestor
64532316|NCT02372916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532317|NCT02361528|Sargramostim|sargramostim|mesh-list
64532318|NCT02361528|Immunologic Factors|immunologic factors|mesh-ancestor
64532319|NCT02361528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532321|NCT01572727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64532322|NCT01572727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532332|NCT02359266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64532333|NCT02359266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64532334|NCT02359500|Octreotide|octreotide|mesh-list
64532335|NCT02359500|Edotreotide|edotreotide|mesh-list
64532336|NCT02359500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64532337|NCT02359500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64532338|NCT02359500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532339|NCT02359500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64532341|NCT02372526|Orlistat|orlistat|mesh-list
64532360|NCT02985697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64532361|NCT02985697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532362|NCT02985697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64532363|NCT02985697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64532364|NCT02985697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64296912|NCT03102398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457551|NCT01704651|Alvimopan|alvimopan|mesh-list
64457584|NCT01852292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457585|NCT01852292|Tubulin Modulators|tubulin modulators|mesh-ancestor
64457586|NCT01852292|Antimitotic Agents|antimitotic agents|mesh-ancestor
64457587|NCT01852292|Mitosis Modulators|mitosis modulators|mesh-ancestor
64457588|NCT01852292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457589|NCT01715805|Cariprazine|cariprazine|mesh-list
64457590|NCT01715805|Antidepressive Agents|antidepressive agents|mesh-list
64457591|NCT01715805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64457685|NCT03997786|Etanercept|etanercept|mesh-list
64457686|NCT03997786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64457687|NCT03997786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64457688|NCT03997786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64457689|NCT03997786|Analgesics|analgesics|mesh-ancestor
64457690|NCT03997786|Sensory System Agents|sensory system agents|mesh-ancestor
64532405|NCT00353301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532406|NCT00353301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64532407|NCT00353301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64457764|NCT03599284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457789|NCT03024502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64457790|NCT03024502|Antifungal Agents|antifungal agents|mesh-ancestor
64457815|NCT03024580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64457847|NCT05633758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64457849|NCT03978442|Bupropion|bupropion|mesh-list
64457950|NCT00217672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64457951|NCT00217672|Growth Substances|growth substances|mesh-ancestor
64457952|NCT00217672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457953|NCT00217672|Growth Inhibitors|growth inhibitors|mesh-ancestor
64457954|NCT00217672|Tubulin Modulators|tubulin modulators|mesh-ancestor
64457955|NCT00217672|Antimitotic Agents|antimitotic agents|mesh-ancestor
64457956|NCT00217672|Mitosis Modulators|mitosis modulators|mesh-ancestor
64457957|NCT00217672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458050|NCT04414995|Sensory System Agents|sensory system agents|mesh-ancestor
64458051|NCT04414995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458052|NCT04414995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458053|NCT04414995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64458054|NCT04414995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64458055|NCT04414995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64458056|NCT04414995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458058|NCT04414995|Antipyretics|antipyretics|mesh-ancestor
64458151|NCT03956056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64458152|NCT03956056|Antiviral Agents|antiviral agents|mesh-ancestor
64458153|NCT03956056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64458154|NCT01867671|Immunologic Factors|immunologic factors|mesh-list
64458155|NCT01867671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458174|NCT04022200|Paclitaxel|paclitaxel|mesh-list
64532577|NCT02360982|Anesthetics, Local|anesthetics, local|mesh-ancestor
64458209|NCT03971422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458210|NCT04028362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
64458211|NCT04028362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64458212|NCT04028362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458213|NCT04028362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458214|NCT04021108|Nivolumab|nivolumab|mesh-list
64458215|NCT04021108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64458342|NCT04191694|Autonomic Agents|autonomic agents|mesh-ancestor
64458343|NCT04191694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458344|NCT04191694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458345|NCT04191694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64458346|NCT04191694|Antipruritics|antipruritics|mesh-ancestor
64458347|NCT04191694|Dermatologic Agents|dermatologic agents|mesh-ancestor
64458348|NCT04191694|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64458349|NCT04191694|Serotonin Agents|serotonin agents|mesh-ancestor
64458455|NCT01849562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64458456|NCT04023760|Apixaban|apixaban|mesh-list
64458457|NCT04023760|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64458458|NCT04023760|Antithrombins|antithrombins|mesh-ancestor
64458459|NCT04023760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64458460|NCT04023760|Protease Inhibitors|protease inhibitors|mesh-ancestor
64458461|NCT04023760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532636|NCT02360592|Interferons|interferons|mesh-list
64532637|NCT02360592|Interferon-alpha|interferon-alpha|mesh-list
64532638|NCT02360592|Interferon alpha-2|interferon alpha-2|mesh-list
64532639|NCT02360592|Entecavir|entecavir|mesh-list
64532640|NCT02360592|Interleukin-2|interleukin-2|mesh-list
64532641|NCT02360592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532642|NCT02360592|Antiviral Agents|antiviral agents|mesh-ancestor
64532643|NCT02360592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64532644|NCT02360592|Immunologic Factors|immunologic factors|mesh-ancestor
64458604|NCT02080780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64458605|NCT02080780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64532681|NCT00322101|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64532682|NCT00322101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64532683|NCT00322101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64532684|NCT00322101|Antifungal Agents|antifungal agents|mesh-ancestor
64532685|NCT00322101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64532686|NCT00322101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64458617|NCT01871558|Metformin|metformin|mesh-list
64532697|NCT02352402|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64532698|NCT02352402|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64532699|NCT02352402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64532700|NCT02352402|Purinergic Agents|purinergic agents|mesh-ancestor
64458798|NCT03944356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458799|NCT01701063|Ribavirin|ribavirin|mesh-list
64458800|NCT01701063|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64458801|NCT01701063|Antimetabolites|antimetabolites|mesh-ancestor
64458802|NCT01701063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458803|NCT01701063|Antiviral Agents|antiviral agents|mesh-ancestor
64458804|NCT01701063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64532734|NCT04751175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64532735|NCT04751175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64532736|NCT04751175|Analgesics|analgesics|mesh-ancestor
64532737|NCT04751175|Sensory System Agents|sensory system agents|mesh-ancestor
64532738|NCT04751175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64458870|NCT01700829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64458871|NCT01700829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64458872|NCT01700829|GABA Modulators|gaba modulators|mesh-ancestor
64458907|NCT04143256|Menthol|menthol|mesh-list
64458955|NCT01867047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64458956|NCT01867047|Protease Inhibitors|protease inhibitors|mesh-ancestor
64458957|NCT01867047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458958|NCT01867047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458959|NCT03588988|Dexmedetomidine|dexmedetomidine|mesh-list
64458960|NCT03588988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64458961|NCT03588988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64459093|NCT03589222|Dexamethasone|dexamethasone|mesh-list
64459094|NCT03589222|Bortezomib|bortezomib|mesh-list
64459095|NCT03589222|Daratumumab|daratumumab|mesh-list
64459096|NCT03589222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64459097|NCT03589222|Antiemetics|antiemetics|mesh-ancestor
64459098|NCT03589222|Autonomic Agents|autonomic agents|mesh-ancestor
64459099|NCT03589222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459100|NCT03589222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459182|NCT05702398|Vasodilator Agents|vasodilator agents|mesh-ancestor
64459183|NCT01709409|Poractant alfa|poractant alfa|mesh-list
64459184|NCT01709409|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
64459185|NCT01709409|Respiratory System Agents|respiratory system agents|mesh-ancestor
64459186|NCT01698879|Gemtuzumab|gemtuzumab|mesh-list
64459187|NCT01698879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64459188|NCT01698879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459189|NCT02335294|Morphine|morphine|mesh-list
64532780|NCT02357004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64532781|NCT02357004|Vasodilator Agents|vasodilator agents|mesh-ancestor
64532782|NCT02357004|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64532783|NCT02357004|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64532784|NCT02357004|Diuretics|diuretics|mesh-ancestor
64459255|NCT03584698|Antimetabolites|antimetabolites|mesh-ancestor
64459256|NCT03584698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459257|NCT03584698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64459258|NCT03584698|Dermatologic Agents|dermatologic agents|mesh-ancestor
64459259|NCT03587038|Temozolomide|temozolomide|mesh-list
64459260|NCT03587038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64459261|NCT03587038|Alkylating Agents|alkylating agents|mesh-ancestor
64459263|NCT03587038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459365|NCT05701540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64532807|NCT01570387|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64532808|NCT01570387|Growth Substances|growth substances|mesh-ancestor
64532809|NCT01570387|Growth Inhibitors|growth inhibitors|mesh-ancestor
64532810|NCT02348424|Solithromycin|solithromycin|mesh-list
64532811|NCT02348424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64532812|NCT02348424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64532813|NCT01570309|Ergocalciferols|ergocalciferols|mesh-list
64532814|NCT01570309|Vitamin D|vitamin d|mesh-list
64532815|NCT01570309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64532816|NCT01570309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532817|NCT01570309|Vitamins|vitamins|mesh-ancestor
64532821|NCT02356146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64532822|NCT02356146|Immunologic Factors|immunologic factors|mesh-ancestor
64532823|NCT02356146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532824|NCT02356146|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64532825|NCT02356146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64532826|NCT02356146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532827|NCT01519921|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64532828|NCT01519921|Antiviral Agents|antiviral agents|mesh-ancestor
64459558|NCT05212246|Immunologic Factors|immunologic factors|mesh-ancestor
64459559|NCT05212246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459560|NCT05212246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459561|NCT05212246|Interferon Inducers|interferon inducers|mesh-ancestor
64459562|NCT04297618|Lifitegrast|lifitegrast|mesh-list
64459563|NCT04297618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64459594|NCT01671904|Obinutuzumab|obinutuzumab|mesh-list
64532851|NCT03147066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64532852|NCT03147066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64297409|NCT04435028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297410|NCT04435028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64297411|NCT03945812|Lenograstim|lenograstim|mesh-list
64297412|NCT03945812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64459750|NCT02081014|Glucagon|glucagon|mesh-list
64459751|NCT02081014|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64459753|NCT02081014|Hormones|hormones|mesh-ancestor
64459816|NCT01673542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459817|NCT01673542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64459828|NCT01610492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459829|NCT02738866|Fulvestrant|fulvestrant|mesh-list
64459830|NCT02738866|Palbociclib|palbociclib|mesh-list
64459831|NCT02738866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64459832|NCT02738866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459918|NCT04603508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459919|NCT04603508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64459920|NCT04603508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64459921|NCT04603508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64459922|NCT04603508|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64532928|NCT02347878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64532929|NCT02347878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532930|NCT02347878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64532931|NCT02347878|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64532932|NCT02347878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64532933|NCT02347878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460101|NCT03861988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64460102|NCT03861988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64460103|NCT03861988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64460104|NCT03861988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64460105|NCT03861988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460106|NCT03755440|Antibodies|antibodies|mesh-list
64460107|NCT03755440|Immunologic Factors|immunologic factors|mesh-ancestor
64460208|NCT01590771|Glimepiride|glimepiride|mesh-list
64460209|NCT01590771|Gliclazide|gliclazide|mesh-list
64460210|NCT01590771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64460211|NCT01590771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460212|NCT01590771|Incretins|incretins|mesh-ancestor
64460213|NCT01590771|Hormones|hormones|mesh-ancestor
64460214|NCT01590771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64460215|NCT01590771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64460217|NCT01590771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460358|NCT03807856|Protease Inhibitors|protease inhibitors|mesh-ancestor
64460359|NCT03807856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460360|NCT03807856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460361|NCT03807856|Anticoagulants|anticoagulants|mesh-ancestor
64460362|NCT03806530|Gabapentin|gabapentin|mesh-list
64460507|NCT03606538|Hallucinogens|hallucinogens|mesh-ancestor
64460508|NCT03606538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460528|NCT03797326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460529|NCT03797326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64460530|NCT03797326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460531|NCT03797326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460532|NCT00779116|Cetirizine|cetirizine|mesh-list
64460533|NCT00779116|Desloratadine|desloratadine|mesh-list
64460635|NCT03676192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64460637|NCT03676192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64460638|NCT03676192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64460639|NCT03676192|Growth Substances|growth substances|mesh-ancestor
64460640|NCT03676192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460641|NCT03676192|Growth Inhibitors|growth inhibitors|mesh-ancestor
64460642|NCT01584843|Botulinum Toxins|botulinum toxins|mesh-list
64460644|NCT01584843|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64460704|NCT03766750|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64460734|NCT04761952|Infliximab|infliximab|mesh-list
64460735|NCT04761952|Dermatologic Agents|dermatologic agents|mesh-ancestor
64460736|NCT04761952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64460737|NCT04761952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64460738|NCT04761952|Antimetabolites|antimetabolites|mesh-ancestor
64460739|NCT04761952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460839|NCT01677364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460840|NCT03563248|Nivolumab|nivolumab|mesh-list
64460841|NCT03563248|Folfirinox|folfirinox|mesh-list
64460842|NCT03563248|Losartan|losartan|mesh-list
64460843|NCT03563248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64460844|NCT03563248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533010|NCT02350530|Fluorouracil|fluorouracil|mesh-list
64533011|NCT02350530|Oxaliplatin|oxaliplatin|mesh-list
64533012|NCT02350530|Irinotecan|irinotecan|mesh-list
64533013|NCT02350530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64533014|NCT02350530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533015|NCT02350530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64533016|NCT02350530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64533017|NCT02350530|Growth Substances|growth substances|mesh-ancestor
64533026|NCT02350530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64533027|NCT02350530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533028|NCT01569841|Insulin|insulin|mesh-list
64533029|NCT01569841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64533036|NCT05265819|Hormones|hormones|mesh-list
64461050|NCT03087136|Antibodies|antibodies|mesh-list
64461226|NCT01558089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461227|NCT01558089|Dermatologic Agents|dermatologic agents|mesh-ancestor
64461228|NCT01558089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461229|NCT01558089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64461230|NCT01558089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64533056|NCT02353260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533057|NCT03158610|Capecitabine|capecitabine|mesh-list
64533058|NCT03158610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64533059|NCT03158610|Antimetabolites|antimetabolites|mesh-ancestor
64533060|NCT03158610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533061|NCT03158610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533062|NCT00323739|Bevacizumab|bevacizumab|mesh-list
64533063|NCT00323739|Everolimus|everolimus|mesh-list
64533095|NCT02353182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64533096|NCT02353182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533097|NCT02353182|Sensory System Agents|sensory system agents|mesh-ancestor
64533098|NCT02353182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64533099|NCT02353182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64533100|NCT02353182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64533110|NCT02349516|Squalamine|squalamine|mesh-list
64533111|NCT02349516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64533112|NCT02349516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64533113|NCT02349516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64533114|NCT02349516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64461477|NCT03435250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64461478|NCT03435250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461479|NCT03435250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64461480|NCT03435250|Immunologic Factors|immunologic factors|mesh-ancestor
64461481|NCT03435250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461483|NCT01679860|Immunologic Factors|immunologic factors|mesh-list
64533119|NCT02349516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64533137|NCT03149250|Coagulants|coagulants|mesh-ancestor
64533138|NCT00391443|Bosentan|bosentan|mesh-list
64533139|NCT00391443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64533152|NCT02343432|Hormones|hormones|mesh-ancestor
64533153|NCT02343432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64533154|NCT02349282|Vitamin D|vitamin d|mesh-list
64533155|NCT02349282|Cholecalciferol|cholecalciferol|mesh-list
64533156|NCT02349282|Calcifediol|calcifediol|mesh-list
64533157|NCT02349282|Vitamins|vitamins|mesh-ancestor
64533158|NCT02349282|Micronutrients|micronutrients|mesh-ancestor
64533159|NCT02349282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533162|NCT02349204|Zaleplon|zaleplon|mesh-list
64461833|NCT04621435|Copper|copper|mesh-list
64461865|NCT05305924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64461866|NCT05305924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461867|NCT05305924|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64461868|NCT05305924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64461869|NCT05305924|Hormone Antagonists|hormone antagonists|mesh-ancestor
64461872|NCT05548582|Acetaminophen|acetaminophen|mesh-list
64533195|NCT03148704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533196|NCT03148704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64533197|NCT03148704|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64533198|NCT03148704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64533199|NCT03148704|Serotonin Agents|serotonin agents|mesh-ancestor
64533200|NCT03148704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64533201|NCT03148704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533202|NCT01795287|Anesthetics|anesthetics|mesh-list
64533206|NCT04976283|Empagliflozin|empagliflozin|mesh-list
64533207|NCT04976283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64533208|NCT04976283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533209|NCT04976283|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64533210|NCT04976283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533211|NCT02345304|Digoxin|digoxin|mesh-list
64533212|NCT02345304|Midazolam|midazolam|mesh-list
64533213|NCT02345304|Omeprazole|omeprazole|mesh-list
64533214|NCT02345304|Warfarin|warfarin|mesh-list
64533215|NCT02345304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64533224|NCT02345304|Anesthetics|anesthetics|mesh-ancestor
64533240|NCT01569295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64533241|NCT01569295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462222|NCT03642028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462223|NCT03642028|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64462224|NCT03642028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64462225|NCT03642028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462227|NCT04407442|Dexamethasone acetate|dexamethasone acetate|mesh-list
64462353|NCT01808144|Lesinurad|lesinurad|mesh-list
64462354|NCT01808144|Gout Suppressants|gout suppressants|mesh-ancestor
64462355|NCT01808144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64462356|NCT01808144|Uricosuric Agents|uricosuric agents|mesh-ancestor
64462357|NCT01808144|Renal Agents|renal agents|mesh-ancestor
64462358|NCT02085070|Pembrolizumab|pembrolizumab|mesh-list
64462359|NCT02085070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64462360|NCT02085070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462449|NCT01556763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64462450|NCT01556763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64462451|NCT01556763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462452|NCT01556763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64462453|NCT04397458|Dexamethasone|dexamethasone|mesh-list
64462454|NCT04397458|Bupivacaine|bupivacaine|mesh-list
64462455|NCT04397458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64462456|NCT04397458|Antiemetics|antiemetics|mesh-ancestor
64462457|NCT04397458|Autonomic Agents|autonomic agents|mesh-ancestor
64462458|NCT04397458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462459|NCT04397458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462460|NCT04397458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64462461|NCT04397458|Glucocorticoids|glucocorticoids|mesh-ancestor
64533287|NCT01549951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64533288|NCT01549951|Glucocorticoids|glucocorticoids|mesh-ancestor
64533289|NCT01549951|Hormones|hormones|mesh-ancestor
64533290|NCT01549951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64533291|NCT01549951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489373|NCT02244190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533292|NCT01549951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64533293|NCT01549951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533294|NCT03148314|Misoprostol|misoprostol|mesh-list
64533295|NCT03148314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64533296|NCT03148314|Abortifacient Agents|abortifacient agents|mesh-ancestor
64533297|NCT03148314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64533336|NCT00396201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64533337|NCT00396201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64533338|NCT00396201|Antiviral Agents|antiviral agents|mesh-ancestor
64297906|NCT02463825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64297907|NCT02463825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64297908|NCT02463825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64462462|NCT04397458|Hormones|hormones|mesh-ancestor
64462463|NCT04397458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64462464|NCT04397458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64462517|NCT01576575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64462518|NCT05051566|Esomeprazole|esomeprazole|mesh-list
64462519|NCT05051566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64462520|NCT05051566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64462521|NCT05051566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64462524|NCT01576341|Epoetin Alfa|epoetin alfa|mesh-list
64462655|NCT01968967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462656|NCT01968967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64462657|NCT01806662|Ustekinumab|ustekinumab|mesh-list
64462658|NCT01806662|Dermatologic Agents|dermatologic agents|mesh-ancestor
64462659|NCT01930045|Raltegravir Potassium|raltegravir potassium|mesh-list
64462660|NCT01930045|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
64462661|NCT01930045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64462720|NCT04276636|Antacids|antacids|mesh-ancestor
64462739|NCT01575561|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64462740|NCT01575561|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64462741|NCT01575561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64462742|NCT01575561|Adrenergic Agents|adrenergic agents|mesh-ancestor
64462743|NCT01575561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64462744|NCT01575561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462745|NCT01575561|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64462815|NCT01574703|Dopamine Agents|dopamine agents|mesh-ancestor
64462816|NCT01574703|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64462817|NCT01574703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64462818|NCT01574703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462819|NCT01686633|Fluticasone|fluticasone|mesh-list
64462820|NCT01686633|Xhance|xhance|mesh-list
64533422|NCT02341638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64533423|NCT02341638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64533424|NCT02341638|Hormone Antagonists|hormone antagonists|mesh-ancestor
64533425|NCT02341638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64533426|NCT02341638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64533427|NCT02337192|Chlorhexidine|chlorhexidine|mesh-list
64533428|NCT02337192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64533429|NCT02337192|Curcumin|curcumin|mesh-list
64533430|NCT02337192|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64533431|NCT02337192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64533432|NCT02337192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64533433|NCT02337192|Disinfectants|disinfectants|mesh-ancestor
64462914|NCT03133546|Bevacizumab|bevacizumab|mesh-list
64533443|NCT02337192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533444|NCT02337192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298015|NCT02070133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64462997|NCT01549041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64462998|NCT01549041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463000|NCT04106115|Durvalumab|durvalumab|mesh-list
64463001|NCT04106115|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64463002|NCT04106115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64463003|NCT04106115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463004|NCT04106115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64463005|NCT04106115|Immunologic Factors|immunologic factors|mesh-ancestor
64463006|NCT04106115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463007|NCT01907815|Trametinib|trametinib|mesh-list
64463008|NCT01907815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463009|NCT01907815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64463010|NCT01907815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64463011|NCT01907815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463012|NCT01548573|Thalidomide|thalidomide|mesh-list
64463013|NCT01548573|Dexamethasone|dexamethasone|mesh-list
64463014|NCT01548573|Cyclophosphamide|cyclophosphamide|mesh-list
64463015|NCT01548573|Melphalan|melphalan|mesh-list
64463016|NCT01548573|Doxorubicin|doxorubicin|mesh-list
64463017|NCT01548573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64463018|NCT01548573|Etoposide|etoposide|mesh-list
64463019|NCT01548573|Etoposide phosphate|etoposide phosphate|mesh-list
64463020|NCT01548573|Bortezomib|bortezomib|mesh-list
64463072|NCT01518153|Immunologic Factors|immunologic factors|mesh-ancestor
64463073|NCT01518153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64463074|NCT01518153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64533445|NCT02337192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533446|NCT02337192|Respiratory System Agents|respiratory system agents|mesh-ancestor
64533447|NCT03111966|Grazoprevir|grazoprevir|mesh-list
64533448|NCT03111966|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
64533449|NCT03111966|Antiviral Agents|antiviral agents|mesh-ancestor
64533450|NCT03111966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64533451|NCT02343666|Plerixafor|plerixafor|mesh-list
64533452|NCT02343666|Carmustine|carmustine|mesh-list
64533453|NCT02343666|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64533454|NCT02343666|Lenograstim|lenograstim|mesh-list
64533455|NCT02343666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64463202|NCT00634504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64463203|NCT00634504|Abortifacient Agents|abortifacient agents|mesh-ancestor
64463204|NCT00634504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64463205|NCT00634504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533457|NCT02343666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533458|NCT02343666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64533459|NCT02343666|Alkylating Agents|alkylating agents|mesh-ancestor
64533461|NCT02343666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533474|NCT02332356|Antimetabolites|antimetabolites|mesh-ancestor
64533475|NCT02332356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533476|NCT02332356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64533477|NCT02332356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533478|NCT02332356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64533479|NCT02332356|Immunologic Factors|immunologic factors|mesh-ancestor
64533480|NCT02332356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533481|NCT02340936|Lenalidomide|lenalidomide|mesh-list
64533497|NCT02337036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463397|NCT01905943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64463398|NCT01905943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64463399|NCT01929031|Ibuprofen|ibuprofen|mesh-list
64463400|NCT01929031|Caffeine|caffeine|mesh-list
64463401|NCT01929031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64463403|NCT01929031|Analgesics|analgesics|mesh-ancestor
64463528|NCT01925638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64463529|NCT01925638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64463530|NCT01925638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463644|NCT00984568|Sensory System Agents|sensory system agents|mesh-ancestor
64463645|NCT00984568|Antitubercular Agents|antitubercular agents|mesh-ancestor
64463646|NCT00984568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64463647|NCT00984568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64463648|NCT02984176|Simethicone|simethicone|mesh-list
64463675|NCT01890265|Immunoglobulin G|immunoglobulin g|mesh-list
64463676|NCT01890265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64463677|NCT01890265|Immunologic Factors|immunologic factors|mesh-ancestor
64463786|NCT03049306|Vasodilator Agents|vasodilator agents|mesh-ancestor
64463787|NCT05601700|Paclitaxel|paclitaxel|mesh-list
64463788|NCT05601700|Carboplatin|carboplatin|mesh-list
64463789|NCT05601700|Letrozole|letrozole|mesh-list
64463790|NCT05601700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64463791|NCT05601700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463792|NCT05601700|Tubulin Modulators|tubulin modulators|mesh-ancestor
64463793|NCT05601700|Antimitotic Agents|antimitotic agents|mesh-ancestor
64463921|NCT05600608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463922|NCT01616173|Dexamethasone|dexamethasone|mesh-list
64463923|NCT01616173|Dexamethasone acetate|dexamethasone acetate|mesh-list
64463924|NCT01616173|BB 1101|bb 1101|mesh-list
64463925|NCT01616173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64463926|NCT01616173|Antiemetics|antiemetics|mesh-ancestor
64463932|NCT01616173|Hormones|hormones|mesh-ancestor
64464039|NCT04392700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64464040|NCT04392700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464041|NCT04392700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464042|NCT04392700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64464043|NCT04392700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64464044|NCT03828058|Tacrolimus|tacrolimus|mesh-list
64464045|NCT03828058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64464046|NCT03828058|Immunologic Factors|immunologic factors|mesh-ancestor
64464047|NCT03828058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464067|NCT02983630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64464068|NCT02983630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64464070|NCT03827278|Voriconazole|voriconazole|mesh-list
64464179|NCT03043924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64464180|NCT03043924|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64464181|NCT03043924|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64464182|NCT03043924|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64464183|NCT03043924|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64464216|NCT03824002|Insulin, Long-Acting|insulin, long-acting|mesh-list
64464400|NCT01456546|Proguanil|proguanil|mesh-list
64464401|NCT01456546|Clopidogrel|clopidogrel|mesh-list
64464402|NCT01456546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64464403|NCT01456546|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64464511|NCT01891084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64464512|NCT01891084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64464513|NCT01891084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464657|NCT02773732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64464658|NCT02773732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464659|NCT02773732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64464660|NCT02773732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64464661|NCT02773732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464693|NCT02720068|Levoleucovorin|levoleucovorin|mesh-list
64464694|NCT02720068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64464695|NCT02720068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464697|NCT02720068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464787|NCT02684032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64464788|NCT02684032|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64464790|NCT02388178|Fluorides|fluorides|mesh-list
64464921|NCT01896895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64464922|NCT01896895|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64465063|NCT03007420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465064|NCT03007420|Sensory System Agents|sensory system agents|mesh-ancestor
64465065|NCT03007420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64465066|NCT03007420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64465067|NCT03007420|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64465068|NCT03007420|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64465088|NCT04393246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64465089|NCT04393246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465093|NCT04124302|Insulin|insulin|mesh-list
64465208|NCT01921387|Etoposide|etoposide|mesh-list
64465209|NCT01921387|Podophyllotoxin|podophyllotoxin|mesh-list
64465210|NCT01921387|Etoposide phosphate|etoposide phosphate|mesh-list
64465211|NCT01921387|Melphalan|melphalan|mesh-list
64465212|NCT01921387|Mechlorethamine|mechlorethamine|mesh-list
64465213|NCT01921387|Carmustine|carmustine|mesh-list
64465214|NCT01921387|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64465215|NCT01921387|Antibodies|antibodies|mesh-list
64465243|NCT04129996|Mitosis Modulators|mitosis modulators|mesh-ancestor
64465244|NCT04129996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465245|NCT04129216|Tamoxifen|tamoxifen|mesh-list
64465246|NCT04129216|Letrozole|letrozole|mesh-list
64465247|NCT04129216|Exemestane|exemestane|mesh-list
64465248|NCT04129216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513642|NCT01457547|Immunologic Factors|immunologic factors|mesh-ancestor
64465249|NCT04129216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465250|NCT04129216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64465251|NCT04129216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64465252|NCT04129216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465253|NCT04129216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64465254|NCT04129216|Hormone Antagonists|hormone antagonists|mesh-ancestor
64465284|NCT01895335|Immunologic Factors|immunologic factors|mesh-ancestor
64533649|NCT00364377|Hormones|hormones|mesh-ancestor
64533650|NCT00364377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64465301|NCT02980510|Vitamins|vitamins|mesh-ancestor
64465302|NCT02980510|Micronutrients|micronutrients|mesh-ancestor
64465303|NCT02980510|Hematinics|hematinics|mesh-ancestor
64465304|NCT02980510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64465305|NCT02980510|Antimetabolites|antimetabolites|mesh-ancestor
64465306|NCT02980510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64465307|NCT02980510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64465308|NCT02980510|Immunologic Factors|immunologic factors|mesh-ancestor
64465309|NCT03829696|Misoprostol|misoprostol|mesh-list
64465437|NCT01894477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64465438|NCT01894477|Alkylating Agents|alkylating agents|mesh-ancestor
64465577|NCT01452100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64465578|NCT01452100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465579|NCT01452334|BMS-936559|bms-936559|mesh-list
64465580|NCT01452334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64465581|NCT01452334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465582|NCT01452568|Aspirin|aspirin|mesh-list
64465583|NCT01452568|Salicylic Acid|salicylic acid|mesh-list
64465585|NCT01452568|Warfarin|warfarin|mesh-list
64465656|NCT04847752|Evolocumab|evolocumab|mesh-list
64465657|NCT04847752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
64465658|NCT04847752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64465659|NCT04847752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64465747|NCT04840342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64465748|NCT04840342|Diuretics|diuretics|mesh-ancestor
64465749|NCT04840342|Natriuretic Agents|natriuretic agents|mesh-ancestor
64465750|NCT02849470|Complement Factor H|complement factor h|mesh-list
64465751|NCT02849470|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64465752|NCT02849470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64465753|NCT02849470|Immunologic Factors|immunologic factors|mesh-ancestor
64465866|NCT05586568|Antifungal Agents|antifungal agents|mesh-ancestor
64465867|NCT05586568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64465868|NCT05586568|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64465870|NCT05586568|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64533799|NCT02337972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64533800|NCT02337972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64533802|NCT02335164|Agglutinins|agglutinins|mesh-ancestor
64466025|NCT02531308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64466026|NCT02531308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64466027|NCT02531308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466028|NCT02531308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64466029|NCT02531308|Glucocorticoids|glucocorticoids|mesh-ancestor
64466030|NCT02531308|Hormones|hormones|mesh-ancestor
64466031|NCT02531308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64466032|NCT02531308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64466033|NCT02531308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64466055|NCT02523976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466137|NCT02493322|Chlorthalidone|chlorthalidone|mesh-list
64466056|NCT02523976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64466057|NCT02523976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64466058|NCT02523976|Antiemetics|antiemetics|mesh-ancestor
64466195|NCT02420860|Growth Substances|growth substances|mesh-ancestor
64533814|NCT00365859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64489923|NCT01696214|Hormones|hormones|mesh-ancestor
64533815|NCT00365859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533816|NCT00365859|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64533817|NCT00365859|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64533818|NCT00365859|Serotonin Agents|serotonin agents|mesh-ancestor
64533819|NCT00365859|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64533820|NCT00365859|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64533821|NCT00365859|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64533822|NCT00365859|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64533823|NCT02337426|Temozolomide|temozolomide|mesh-list
64533824|NCT02337426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64533825|NCT02337426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64533826|NCT02337426|Alkylating Agents|alkylating agents|mesh-ancestor
64533827|NCT02337426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466059|NCT02523976|Autonomic Agents|autonomic agents|mesh-ancestor
64466060|NCT02523976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64466061|NCT02523976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64466062|NCT02523976|Glucocorticoids|glucocorticoids|mesh-ancestor
64466063|NCT02523976|Hormones|hormones|mesh-ancestor
64466064|NCT02523976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64466065|NCT02523976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64466066|NCT02523976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64466067|NCT02523976|Abortifacient Agents|abortifacient agents|mesh-ancestor
64466068|NCT02523976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64466069|NCT02523976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64466070|NCT02523976|Antimetabolites|antimetabolites|mesh-ancestor
64466071|NCT02523976|Dermatologic Agents|dermatologic agents|mesh-ancestor
64466509|NCT02223208|Prednisone|prednisone|mesh-list
64466072|NCT02523976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466073|NCT02523976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64466074|NCT02523976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64466075|NCT02523976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64466076|NCT02523976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64466077|NCT02523976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64466078|NCT02523976|Antiviral Agents|antiviral agents|mesh-ancestor
64466079|NCT02523976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64466080|NCT02523976|Tubulin Modulators|tubulin modulators|mesh-ancestor
64466081|NCT02523976|Antimitotic Agents|antimitotic agents|mesh-ancestor
64466082|NCT02523976|Mitosis Modulators|mitosis modulators|mesh-ancestor
64466083|NCT02523976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64466084|NCT02523976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64466085|NCT02523976|Analgesics|analgesics|mesh-ancestor
64466086|NCT02523976|Sensory System Agents|sensory system agents|mesh-ancestor
64466087|NCT02523040|Lenalidomide|lenalidomide|mesh-list
64533914|NCT02334150|Anesthetics|anesthetics|mesh-ancestor
64466088|NCT02523040|Immunologic Factors|immunologic factors|mesh-ancestor
64466089|NCT02523040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466118|NCT02495896|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64466120|NCT02495896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64466121|NCT02495896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466122|NCT02495896|Tubulin Modulators|tubulin modulators|mesh-ancestor
64466123|NCT02495896|Antimitotic Agents|antimitotic agents|mesh-ancestor
64466621|NCT01865110|Prednisone|prednisone|mesh-list
64466124|NCT02495896|Mitosis Modulators|mitosis modulators|mesh-ancestor
64466125|NCT02495896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466126|NCT02495896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64466127|NCT02495896|Antimetabolites|antimetabolites|mesh-ancestor
64466128|NCT02495896|Antiviral Agents|antiviral agents|mesh-ancestor
64533828|NCT02337426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533829|NCT02337426|Dermatologic Agents|dermatologic agents|mesh-ancestor
64533830|NCT02337426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64533831|NCT02337426|Immunologic Factors|immunologic factors|mesh-ancestor
64533832|NCT02337426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533833|NCT03664830|Plerixafor|plerixafor|mesh-list
64466716|NCT01810588|Tacrolimus|tacrolimus|mesh-list
64466717|NCT01810588|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64533834|NCT03664830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64533835|NCT03664830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64533951|NCT03111342|Lidocaine|lidocaine|mesh-list
64533836|NCT03664830|Antiviral Agents|antiviral agents|mesh-ancestor
64533837|NCT03664830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64533838|NCT00407355|Ranibizumab|ranibizumab|mesh-list
64533839|NCT00407355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64533840|NCT00407355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64533841|NCT00407355|Growth Substances|growth substances|mesh-ancestor
64533842|NCT00407355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533843|NCT00407355|Growth Inhibitors|growth inhibitors|mesh-ancestor
64533844|NCT00407355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466859|NCT02108158|Cholinergic Agents|cholinergic agents|mesh-ancestor
64466860|NCT02108158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64298425|NCT02078167|Policosanol|policosanol|mesh-list
64466129|NCT02495896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64466130|NCT02495896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466131|NCT02495896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64466132|NCT02495896|Immunologic Factors|immunologic factors|mesh-ancestor
64466133|NCT02495896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466134|NCT02493322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64466135|NCT02493322|Olmesartan|olmesartan|mesh-list
64466136|NCT02493322|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64466143|NCT02493322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64466144|NCT02493322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466145|NCT02493322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64466146|NCT02493322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64466147|NCT04757974|Fostemsavir|fostemsavir|mesh-list
64466148|NCT04757974|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64466149|NCT04757974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64466150|NCT04757974|Antiviral Agents|antiviral agents|mesh-ancestor
64466151|NCT04757974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64467186|NCT00410956|Growth Inhibitors|growth inhibitors|mesh-ancestor
64466152|NCT04757974|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64466153|NCT04757974|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64466154|NCT04757974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466156|NCT04757506|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64466157|NCT04757506|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64466158|NCT04757506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466159|NCT04757506|Sensory System Agents|sensory system agents|mesh-ancestor
64466160|NCT04757506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64466161|NCT02477644|Olaparib|olaparib|mesh-list
64467262|NCT04776772|Immunologic Factors|immunologic factors|mesh-ancestor
64467263|NCT04776772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466162|NCT02477644|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64466163|NCT02477644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466164|NCT02477644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466165|NCT02477644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466166|NCT02466334|Calcitonin|calcitonin|mesh-list
64466167|NCT02466334|Salmon calcitonin|salmon calcitonin|mesh-list
64466168|NCT02466334|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
64466169|NCT02466334|Katacalcin|katacalcin|mesh-list
64466170|NCT02466334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64466171|NCT02466334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466172|NCT02466334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64466173|NCT02466334|Vasodilator Agents|vasodilator agents|mesh-ancestor
64533845|NCT02334462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64533846|NCT02334462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64533847|NCT02334462|Immunologic Factors|immunologic factors|mesh-ancestor
64533848|NCT02334462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533849|NCT02334462|Antacids|antacids|mesh-ancestor
64533850|NCT02334462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533851|NCT02334462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64533852|NCT03144882|Curcumin|curcumin|mesh-list
64533853|NCT03144882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64533854|NCT03144882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64533855|NCT03144882|Analgesics|analgesics|mesh-ancestor
64533856|NCT03144882|Sensory System Agents|sensory system agents|mesh-ancestor
64533857|NCT03144882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64533858|NCT03144882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533859|NCT03144882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64533860|NCT03144882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64533861|NCT03144882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533862|NCT03144882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298436|NCT02078323|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64466174|NCT02460874|Glyburide|glyburide|mesh-list
64466175|NCT02460874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64466176|NCT02460874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466177|NCT02443324|Pembrolizumab|pembrolizumab|mesh-list
64466178|NCT02443324|Ramucirumab|ramucirumab|mesh-list
64466179|NCT02443324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64466180|NCT02443324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467631|NCT00637624|Antiviral Agents|antiviral agents|mesh-ancestor
64466181|NCT01894048|Beclomethasone|beclomethasone|mesh-list
64466182|NCT01894048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64466183|NCT01894048|Glucocorticoids|glucocorticoids|mesh-ancestor
64466184|NCT01894048|Hormones|hormones|mesh-ancestor
64466185|NCT01894048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64466186|NCT01894048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466187|NCT01894048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64466188|NCT01894048|Respiratory System Agents|respiratory system agents|mesh-ancestor
64466189|NCT02420860|Lenalidomide|lenalidomide|mesh-list
64467670|NCT04781686|Mitosis Modulators|mitosis modulators|mesh-ancestor
64466190|NCT02420860|Elotuzumab|elotuzumab|mesh-list
64466191|NCT02420860|Immunologic Factors|immunologic factors|mesh-ancestor
64466192|NCT02420860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466193|NCT02420860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64466194|NCT02420860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64466196|NCT02420860|Growth Inhibitors|growth inhibitors|mesh-ancestor
64466197|NCT02420860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466198|NCT02420314|Ascorbic Acid|ascorbic acid|mesh-list
64466199|NCT02420314|Paclitaxel|paclitaxel|mesh-list
64534099|NCT03142620|Clavulanic Acid|clavulanic acid|mesh-list
64466200|NCT02420314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64466201|NCT02420314|Carboplatin|carboplatin|mesh-list
64466202|NCT02420314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64466203|NCT02420314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466204|NCT02420314|Tubulin Modulators|tubulin modulators|mesh-ancestor
64466205|NCT02420314|Antimitotic Agents|antimitotic agents|mesh-ancestor
64466206|NCT02420314|Mitosis Modulators|mitosis modulators|mesh-ancestor
64466207|NCT02420314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466208|NCT02420314|Vitamins|vitamins|mesh-ancestor
64534121|NCT03110952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466243|NCT04746040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466244|NCT04746040|Glucocorticoids|glucocorticoids|mesh-ancestor
64466245|NCT04746040|Hormones|hormones|mesh-ancestor
64533863|NCT03144882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533864|NCT01793259|Methotrexate|methotrexate|mesh-list
64533865|NCT01793259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64533866|NCT01793259|Abortifacient Agents|abortifacient agents|mesh-ancestor
64533867|NCT01793259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64533868|NCT01793259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533869|NCT01793259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64956148|NCT00068523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64533870|NCT01793259|Antimetabolites|antimetabolites|mesh-ancestor
64466246|NCT04746040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64466247|NCT04746040|Sympathomimetics|sympathomimetics|mesh-ancestor
64466248|NCT02400814|Atezolizumab|atezolizumab|mesh-list
64466249|NCT02400814|Antibodies|antibodies|mesh-list
64466250|NCT02400814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64466251|NCT02400814|Immunologic Factors|immunologic factors|mesh-ancestor
64466275|NCT02022280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64466276|NCT02022280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64466278|NCT02022280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956287|NCT00072930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956288|NCT00072930|Tubulin Modulators|tubulin modulators|mesh-ancestor
64956289|NCT00072930|Antimitotic Agents|antimitotic agents|mesh-ancestor
64956290|NCT00072930|Mitosis Modulators|mitosis modulators|mesh-ancestor
64956294|NCT00072930|Hormones|hormones|mesh-ancestor
64466279|NCT02363374|Leucovorin|leucovorin|mesh-list
64466280|NCT02363374|Folic Acid|folic acid|mesh-list
64466281|NCT02363374|Fluorouracil|fluorouracil|mesh-list
64466282|NCT02363374|Oxaliplatin|oxaliplatin|mesh-list
64466283|NCT02363374|Levoleucovorin|levoleucovorin|mesh-list
64466284|NCT02363374|Antimetabolites|antimetabolites|mesh-ancestor
64466285|NCT02363374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466286|NCT02363374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64466287|NCT02363374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466288|NCT02363374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64466289|NCT02363374|Immunologic Factors|immunologic factors|mesh-ancestor
64466290|NCT02363374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956333|NCT00424606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64466291|NCT02363374|Antidotes|antidotes|mesh-ancestor
64466292|NCT02363374|Protective Agents|protective agents|mesh-ancestor
64466293|NCT02363374|Vitamin B Complex|vitamin b complex|mesh-ancestor
64466294|NCT02363374|Vitamins|vitamins|mesh-ancestor
64466295|NCT02363374|Micronutrients|micronutrients|mesh-ancestor
64466296|NCT02363374|Hematinics|hematinics|mesh-ancestor
64466297|NCT01511445|Silicon|silicon|mesh-list
64466298|NCT01511445|Trace Elements|trace elements|mesh-ancestor
64466299|NCT01511445|Micronutrients|micronutrients|mesh-ancestor
64466300|NCT01511445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466301|NCT02362594|Pembrolizumab|pembrolizumab|mesh-list
64466302|NCT02362594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64466303|NCT02362594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466304|NCT02344186|Liraglutide|liraglutide|mesh-list
64466313|NCT01537887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64466314|NCT01537887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64466315|NCT01537887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64466316|NCT01537887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466317|NCT01537887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466318|NCT01537887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466319|NCT01537887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64466320|NCT01537887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64466321|NCT01537887|Antimetabolites|antimetabolites|mesh-ancestor
64466322|NCT01537887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64466323|NCT02305264|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64466324|NCT02305264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64466325|NCT02305264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466326|NCT02297698|Trastuzumab|trastuzumab|mesh-list
64466327|NCT02297698|Sargramostim|sargramostim|mesh-list
64466328|NCT02297698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64466329|NCT02297698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466330|NCT02297698|Immunologic Factors|immunologic factors|mesh-ancestor
64466331|NCT02297698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466332|NCT01487577|Mycophenolic Acid|mycophenolic acid|mesh-list
64466333|NCT01487577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64466334|NCT01487577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466335|NCT01487577|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64466336|NCT01487577|Antitubercular Agents|antitubercular agents|mesh-ancestor
64533871|NCT01793259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533872|NCT01793259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533873|NCT01793259|Dermatologic Agents|dermatologic agents|mesh-ancestor
64533874|NCT01793259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956703|NCT00209716|Docetaxel|docetaxel|mesh-list
64533875|NCT01793259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64533876|NCT01793259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64533877|NCT01793259|Immunologic Factors|immunologic factors|mesh-ancestor
64533878|NCT01793259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64466337|NCT01487577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64466338|NCT01487577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64466339|NCT01487577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466340|NCT01487577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466341|NCT01928056|Montelukast|montelukast|mesh-list
64466342|NCT01928056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64466343|NCT01928056|Respiratory System Agents|respiratory system agents|mesh-ancestor
64466344|NCT01928056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64466345|NCT01928056|Hormone Antagonists|hormone antagonists|mesh-ancestor
64466346|NCT01928056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64466347|NCT01928056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466348|NCT01928056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64466349|NCT01928056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64466350|NCT01928056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466351|NCT05585866|Anesthetics|anesthetics|mesh-list
64466352|NCT05585866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64466353|NCT05585866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466354|NCT01992952|Fulvestrant|fulvestrant|mesh-list
64466355|NCT01992952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64466356|NCT01992952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466357|NCT01992952|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64466358|NCT01992952|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64466359|NCT01992952|Hormone Antagonists|hormone antagonists|mesh-ancestor
64466360|NCT01992952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64466361|NCT01992952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466362|NCT01928134|Calcium Carbonate|calcium carbonate|mesh-list
64466363|NCT01928134|Calcium|calcium|mesh-list
64466372|NCT02285140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64466373|NCT04756882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64466374|NCT04756882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64466375|NCT04756882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64466376|NCT04756882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64957021|NCT00210769|Dopamine Agents|dopamine agents|mesh-ancestor
64466377|NCT04756882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466378|NCT04756882|Cholinergic Agents|cholinergic agents|mesh-ancestor
64466379|NCT04756882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64466380|NCT04756882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466381|NCT04756882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64466382|NCT04756882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64466383|NCT04756492|Cyclosporine|cyclosporine|mesh-list
64466384|NCT04756492|Antifungal Agents|antifungal agents|mesh-ancestor
64466385|NCT04756492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64466386|NCT04756492|Dermatologic Agents|dermatologic agents|mesh-ancestor
64466387|NCT04756492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466388|NCT04756492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466389|NCT04756492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64466390|NCT04756492|Immunologic Factors|immunologic factors|mesh-ancestor
64466391|NCT04756492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466392|NCT04756492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64466393|NCT04756492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64466394|NCT01536951|Moxifloxacin|moxifloxacin|mesh-list
64466395|NCT01536951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64466396|NCT01536951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64466397|NCT01536951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64957285|NCT00213694|Analgesics|analgesics|mesh-ancestor
64466398|NCT01536951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64466399|NCT01536951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533879|NCT01793259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64533880|NCT02329626|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64533881|NCT02329626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64533882|NCT02329626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533883|NCT03111810|Prednisolone|prednisolone|mesh-list
64957345|NCT00214435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64533884|NCT03111810|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64533885|NCT03111810|Methylprednisolone|methylprednisolone|mesh-list
64533886|NCT03111810|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64714132|NCT00373789|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64533887|NCT03111810|Prednisolone acetate|prednisolone acetate|mesh-list
64533888|NCT03111810|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64533889|NCT03111810|Prednisolone phosphate|prednisolone phosphate|mesh-list
64533890|NCT03111810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64466400|NCT01536951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466401|NCT01536951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466402|NCT04767633|Magnesium Sulfate|magnesium sulfate|mesh-list
64466403|NCT04767633|Analgesics|analgesics|mesh-ancestor
64466404|NCT04767633|Sensory System Agents|sensory system agents|mesh-ancestor
64466405|NCT04767633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64466406|NCT04767633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466407|NCT04767633|Anesthetics|anesthetics|mesh-ancestor
64466408|NCT04767633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64466409|NCT04767633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64466410|NCT04767633|Anticonvulsants|anticonvulsants|mesh-ancestor
64466411|NCT04767633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64466412|NCT04767633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64713972|NCT02837744|Hemostatics|hemostatics|mesh-list
64466413|NCT04767633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957697|NCT00216658|Anesthetics|anesthetics|mesh-ancestor
64466414|NCT04767633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64466415|NCT04767633|Tocolytic Agents|tocolytic agents|mesh-ancestor
64466416|NCT04767633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64466417|NCT02257138|Decitabine|decitabine|mesh-list
64534384|NCT05287035|Antiemetics|antiemetics|mesh-ancestor
64466418|NCT02257138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64466419|NCT02257138|Antimetabolites|antimetabolites|mesh-ancestor
64466420|NCT02257138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466421|NCT02257138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466422|NCT02257138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466423|NCT01928914|Moxifloxacin|moxifloxacin|mesh-list
64466424|NCT01928914|Tafenoquine|tafenoquine|mesh-list
64466425|NCT01928914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64466426|NCT01928914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64466431|NCT01928914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466433|NCT01928914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64466434|NCT01928914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64466435|NCT02249104|Adapalene|adapalene|mesh-list
64466436|NCT02249104|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
64466437|NCT02249104|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64466438|NCT02249104|Dermatologic Agents|dermatologic agents|mesh-ancestor
64466439|NCT02249104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64466440|NCT02249104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64466441|NCT02249104|Analgesics|analgesics|mesh-ancestor
64466442|NCT02249104|Sensory System Agents|sensory system agents|mesh-ancestor
64466443|NCT02249104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64466444|NCT02249104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466445|NCT02249104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64466446|NCT02249104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64466447|NCT01927744|Docetaxel|docetaxel|mesh-list
64466448|NCT01927744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64466449|NCT01927744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466450|NCT01927744|Tubulin Modulators|tubulin modulators|mesh-ancestor
64533891|NCT03111810|Glucocorticoids|glucocorticoids|mesh-ancestor
64653102|NCT01583543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533893|NCT03111810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64533894|NCT03111810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533895|NCT03111810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64958423|NCT00397319|Hormones|hormones|mesh-list
64533896|NCT03111810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533897|NCT03111810|Antiemetics|antiemetics|mesh-ancestor
64533898|NCT03111810|Autonomic Agents|autonomic agents|mesh-ancestor
64533899|NCT03111810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64533900|NCT03111810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64533901|NCT03111810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64533902|NCT03111810|Protective Agents|protective agents|mesh-ancestor
64533903|NCT02334150|Sufentanil|sufentanil|mesh-list
64298485|NCT02083315|Morphine|morphine|mesh-list
64466451|NCT01927744|Antimitotic Agents|antimitotic agents|mesh-ancestor
64466452|NCT01927744|Mitosis Modulators|mitosis modulators|mesh-ancestor
64513644|NCT01457547|Antidotes|antidotes|mesh-ancestor
64513645|NCT01457547|Protective Agents|protective agents|mesh-ancestor
64958628|NCT00124150|Tocolytic Agents|tocolytic agents|mesh-ancestor
64466453|NCT01927744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466454|NCT01927744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64466455|NCT01927744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466456|NCT01929070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64466457|NCT01929070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64466458|NCT01929070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64466459|NCT01929070|Antimetabolites|antimetabolites|mesh-ancestor
64958737|NCT00124384|Modafinil|modafinil|mesh-list
64466460|NCT01929070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466461|NCT01929070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64466462|NCT01929070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64466463|NCT01929070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466464|NCT01536561|Tositumomab I-131|tositumomab i-131|mesh-list
64466465|NCT01536561|Antibodies|antibodies|mesh-list
64466466|NCT01536561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64958856|NCT00043355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958879|NCT00125554|Metyrapone|metyrapone|mesh-list
64466467|NCT01536561|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
64466468|NCT01536561|Immunologic Factors|immunologic factors|mesh-ancestor
64466469|NCT01536561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466470|NCT01536561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466471|NCT02236312|Botulinum Toxins|botulinum toxins|mesh-list
64466472|NCT02236312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64466473|NCT02236312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64466474|NCT02236312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64466475|NCT02236312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64466476|NCT02236312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466477|NCT02236312|Cholinergic Agents|cholinergic agents|mesh-ancestor
64466478|NCT02236312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64466479|NCT02236312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466480|NCT02236312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64466481|NCT02236312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64466482|NCT01916278|Lidocaine|lidocaine|mesh-list
64466483|NCT01916278|Anesthetics, Local|anesthetics, local|mesh-ancestor
64466484|NCT01916278|Anesthetics|anesthetics|mesh-ancestor
64466485|NCT01916278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64466486|NCT01916278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466487|NCT01916278|Sensory System Agents|sensory system agents|mesh-ancestor
64466488|NCT01916278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64466489|NCT01916278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64959169|NCT00126646|Immunotoxins|immunotoxins|mesh-list
64466490|NCT01916278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64466491|NCT01916278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64466492|NCT01916278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64466503|NCT04409691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64533904|NCT02334150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64533905|NCT02334150|Narcotics|narcotics|mesh-ancestor
64533906|NCT02334150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64533907|NCT02334150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533908|NCT02334150|Analgesics|analgesics|mesh-ancestor
64466504|NCT04409691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466505|NCT04409691|Antifungal Agents|antifungal agents|mesh-ancestor
64466506|NCT04409691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64466507|NCT04409691|Immunologic Factors|immunologic factors|mesh-ancestor
64466508|NCT04409691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466510|NCT02223208|Cyclophosphamide|cyclophosphamide|mesh-list
64466511|NCT02223208|Doxorubicin|doxorubicin|mesh-list
64466512|NCT02223208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64466513|NCT02223208|Etoposide|etoposide|mesh-list
64466514|NCT02223208|Etoposide phosphate|etoposide phosphate|mesh-list
64466515|NCT02223208|Romidepsin|romidepsin|mesh-list
64466516|NCT02223208|Vincristine|vincristine|mesh-list
64466517|NCT02223208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64466518|NCT02223208|Immunologic Factors|immunologic factors|mesh-ancestor
64466519|NCT02223208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466520|NCT02223208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64466521|NCT02223208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64466522|NCT02223208|Alkylating Agents|alkylating agents|mesh-ancestor
64466523|NCT02223208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466524|NCT02223208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466525|NCT02223208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64959459|NCT00044291|Estrogen Antagonists|estrogen antagonists|mesh-list
64513646|NCT01457547|Chelating Agents|chelating agents|mesh-ancestor
64513647|NCT01457547|Sequestering Agents|sequestering agents|mesh-ancestor
64466526|NCT02223208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64466527|NCT02223208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64466528|NCT02223208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64466529|NCT02223208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466530|NCT02223208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64466533|NCT02223208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64466534|NCT02223208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64466535|NCT02223208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64466536|NCT02223208|Tubulin Modulators|tubulin modulators|mesh-ancestor
64466537|NCT02223208|Antimitotic Agents|antimitotic agents|mesh-ancestor
64466538|NCT02223208|Mitosis Modulators|mitosis modulators|mesh-ancestor
64466539|NCT02219776|Chlorhexidine|chlorhexidine|mesh-list
64466540|NCT02219776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64466541|NCT02219776|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64466542|NCT02219776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64466543|NCT02219776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64466544|NCT02219776|Disinfectants|disinfectants|mesh-ancestor
64466545|NCT02219776|Dermatologic Agents|dermatologic agents|mesh-ancestor
64466546|NCT01487265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64466547|NCT01487265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959696|NCT00074841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64959697|NCT00074841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466548|NCT01487265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64466549|NCT01487265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466550|NCT01487265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466551|NCT01516606|Clarithromycin|clarithromycin|mesh-list
64466552|NCT01516606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64466553|NCT01516606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64466554|NCT01516606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64466555|NCT01516606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466556|NCT01516606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466557|NCT01516606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64534701|NCT01482767|Interferons|interferons|mesh-list
64466570|NCT01508325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64466571|NCT01508325|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64466572|NCT01508325|Sympatholytics|sympatholytics|mesh-ancestor
64466573|NCT01508325|Autonomic Agents|autonomic agents|mesh-ancestor
64960004|NCT00075231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64466574|NCT01508325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64466575|NCT01508325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466576|NCT01508325|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64466577|NCT01508325|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64466578|NCT01508325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64466579|NCT01508325|Adrenergic Agents|adrenergic agents|mesh-ancestor
64466580|NCT01508325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64533909|NCT02334150|Sensory System Agents|sensory system agents|mesh-ancestor
64533910|NCT02334150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64533911|NCT02334150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64533912|NCT02334150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64533913|NCT02334150|Anesthetics, General|anesthetics, general|mesh-ancestor
64533915|NCT02326428|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64533916|NCT02326428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64960271|NCT01409161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64533917|NCT02326428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64533918|NCT02326428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533919|NCT04477590|Metformin|metformin|mesh-list
64533920|NCT04477590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64533921|NCT04477590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533922|NCT02333838|Fludarabine|fludarabine|mesh-list
64533923|NCT02333838|Fludarabine phosphate|fludarabine phosphate|mesh-list
64533924|NCT02333838|Busulfan|busulfan|mesh-list
64533925|NCT02333838|Thiotepa|thiotepa|mesh-list
64533926|NCT02333838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533927|NCT02333838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64533928|NCT02333838|Antimetabolites|antimetabolites|mesh-ancestor
64533929|NCT02333838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533930|NCT02333838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64533931|NCT02333838|Immunologic Factors|immunologic factors|mesh-ancestor
64533932|NCT02333838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533933|NCT02333838|Alkylating Agents|alkylating agents|mesh-ancestor
64466581|NCT01508325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466582|NCT01514344|Rituximab|rituximab|mesh-list
64466583|NCT01514344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64466584|NCT01514344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466585|NCT01514344|Immunologic Factors|immunologic factors|mesh-ancestor
64466586|NCT01514344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466587|NCT01514344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64466588|NCT01506856|Paclitaxel|paclitaxel|mesh-list
64466589|NCT01506856|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64466590|NCT01506856|Carboplatin|carboplatin|mesh-list
64466591|NCT01506856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64466592|NCT01506856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466593|NCT01506856|Tubulin Modulators|tubulin modulators|mesh-ancestor
64466594|NCT01506856|Antimitotic Agents|antimitotic agents|mesh-ancestor
64466595|NCT01506856|Mitosis Modulators|mitosis modulators|mesh-ancestor
64466596|NCT01506856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466597|NCT02191930|Cyclophosphamide|cyclophosphamide|mesh-list
64466598|NCT02191930|Doxorubicin|doxorubicin|mesh-list
64466599|NCT02191930|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64466600|NCT02191930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64466601|NCT02191930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64466602|NCT02191930|Immunologic Factors|immunologic factors|mesh-ancestor
64466603|NCT02191930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466604|NCT02191930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64466605|NCT02191930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64533934|NCT02333838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64533935|NCT02333838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64533937|NCT02326584|Daunorubicin|daunorubicin|mesh-list
64533938|NCT02326584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64533939|NCT02326584|Antimetabolites|antimetabolites|mesh-ancestor
64466606|NCT02191930|Alkylating Agents|alkylating agents|mesh-ancestor
64466607|NCT02191930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960882|NCT00047021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64960884|NCT00133627|Ketotifen|ketotifen|mesh-list
64466608|NCT02191930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466609|NCT02191930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64466610|NCT02191930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64466611|NCT02191930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64466612|NCT02191930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64466613|NCT02191930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466614|NCT02191930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64466616|NCT01536015|Dopamine Agonists|dopamine agonists|mesh-ancestor
64466617|NCT01536015|Dopamine Agents|dopamine agents|mesh-ancestor
64466618|NCT01536015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64466619|NCT01536015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466620|NCT01536015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466622|NCT01865110|Rituximab|rituximab|mesh-list
64466647|NCT01865110|Tubulin Modulators|tubulin modulators|mesh-ancestor
64466648|NCT01865110|Antimitotic Agents|antimitotic agents|mesh-ancestor
64466649|NCT01865110|Mitosis Modulators|mitosis modulators|mesh-ancestor
64466650|NCT01865110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64466651|NCT01865110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64466652|NCT01865110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64466653|NCT01865110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961095|NCT00134290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64466654|NCT01484691|Budesonide|budesonide|mesh-list
64466655|NCT01484691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64466656|NCT01484691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64466657|NCT01484691|Autonomic Agents|autonomic agents|mesh-ancestor
64466658|NCT01484691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64466659|NCT01484691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466660|NCT01484691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64466661|NCT01484691|Respiratory System Agents|respiratory system agents|mesh-ancestor
64961175|NCT00134485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961177|NCT00047294|Celecoxib|celecoxib|mesh-list
64466662|NCT01484691|Glucocorticoids|glucocorticoids|mesh-ancestor
64466663|NCT01484691|Hormones|hormones|mesh-ancestor
64466664|NCT01484691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64466665|NCT01464034|Dexamethasone|dexamethasone|mesh-list
64466666|NCT01464034|Pomalidomide|pomalidomide|mesh-list
64466667|NCT01464034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64466668|NCT01464034|Antiemetics|antiemetics|mesh-ancestor
64466669|NCT01464034|Autonomic Agents|autonomic agents|mesh-ancestor
64466670|NCT01464034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64466671|NCT01464034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466672|NCT01464034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64466687|NCT01535235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466688|NCT01535235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64466689|NCT01535235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64466690|NCT01535235|Protective Agents|protective agents|mesh-ancestor
64466691|NCT01535235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466692|NCT02317744|Naltrexone|naltrexone|mesh-list
64466693|NCT02317744|Bupropion|bupropion|mesh-list
64961380|NCT00081276|Cisplatin|cisplatin|mesh-list
64466694|NCT02317744|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64466695|NCT02317744|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64466696|NCT02317744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466697|NCT02317744|Sensory System Agents|sensory system agents|mesh-ancestor
64466698|NCT02317744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64466699|NCT02317744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64534877|NCT00442689|Contraceptive Agents|contraceptive agents|mesh-ancestor
64466700|NCT02317744|Antidepressive Agents|antidepressive agents|mesh-ancestor
64466701|NCT02317744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64466702|NCT02317744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64466703|NCT02317744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64466704|NCT02317744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64466705|NCT02317744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466706|NCT02317744|Dopamine Agents|dopamine agents|mesh-ancestor
64299488|NCT02103205|Iron|iron|mesh-list
64466707|NCT02317744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64533940|NCT02326584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533941|NCT02326584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64533942|NCT02326584|Antiviral Agents|antiviral agents|mesh-ancestor
64452408|NCT01991197|Gliclazide|gliclazide|mesh-list
64713973|NCT02837744|Coagulants|coagulants|mesh-ancestor
64466708|NCT02317744|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64466709|NCT02317744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64466710|NCT02317744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466711|NCT01810588|Mycophenolic Acid|mycophenolic acid|mesh-list
64466713|NCT01810588|Fludarabine|fludarabine|mesh-list
64466714|NCT01810588|Fludarabine phosphate|fludarabine phosphate|mesh-list
64466715|NCT01810588|Melphalan|melphalan|mesh-list
64466718|NCT01810588|Thymoglobulin|thymoglobulin|mesh-list
64466719|NCT01810588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64466720|NCT01810588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466721|NCT01810588|Immunologic Factors|immunologic factors|mesh-ancestor
64466722|NCT01810588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466723|NCT01810588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64466724|NCT01810588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64466725|NCT01810588|Antimetabolites|antimetabolites|mesh-ancestor
64466726|NCT01810588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466737|NCT01810588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64466739|NCT02144584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64466740|NCT02144584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64466741|NCT02144584|Dopamine Agents|dopamine agents|mesh-ancestor
64466742|NCT02144584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64961815|NCT04725682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64961816|NCT04725682|Immunologic Factors|immunologic factors|mesh-ancestor
64466743|NCT02144584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466744|NCT02144584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466745|NCT02144584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64466746|NCT02144584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64466747|NCT05577442|Trastuzumab|trastuzumab|mesh-list
64466748|NCT05577442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64513649|NCT01457547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64466749|NCT05577442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466750|NCT01895764|Adalimumab|adalimumab|mesh-list
64466751|NCT01895764|Methotrexate|methotrexate|mesh-list
64961919|NCT00147979|Calcium heparin|calcium heparin|mesh-list
64466752|NCT01895764|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64466753|NCT01895764|Abortifacient Agents|abortifacient agents|mesh-ancestor
64466754|NCT01895764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64466755|NCT01895764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466756|NCT01895764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64466757|NCT01895764|Antimetabolites|antimetabolites|mesh-ancestor
64466758|NCT01895764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466759|NCT01895764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466760|NCT01895764|Dermatologic Agents|dermatologic agents|mesh-ancestor
64466761|NCT01895764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466762|NCT01895764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64466763|NCT01895764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64466764|NCT01895764|Immunologic Factors|immunologic factors|mesh-ancestor
64466765|NCT01895764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64466766|NCT01895764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64466767|NCT01895764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64466768|NCT01415752|Rituximab|rituximab|mesh-list
64466769|NCT01415752|Lenalidomide|lenalidomide|mesh-list
64466770|NCT01415752|Bortezomib|bortezomib|mesh-list
64466771|NCT01415752|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64466772|NCT01415752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64466773|NCT01415752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466774|NCT01415752|Immunologic Factors|immunologic factors|mesh-ancestor
64466775|NCT01415752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466776|NCT01415752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64466777|NCT01415752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64466778|NCT01415752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64466779|NCT01415752|Growth Substances|growth substances|mesh-ancestor
64466780|NCT01415752|Growth Inhibitors|growth inhibitors|mesh-ancestor
64466781|NCT01415752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64535017|NCT01483651|Insulin|insulin|mesh-list
64466782|NCT01415752|Alkylating Agents|alkylating agents|mesh-ancestor
64466783|NCT01415752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466784|NCT01894360|Belimumab|belimumab|mesh-list
64533944|NCT02326584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64533945|NCT02326584|Immunologic Factors|immunologic factors|mesh-ancestor
64533946|NCT02326584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533947|NCT02326584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64533948|NCT02326584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64535025|NCT01464307|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64533949|NCT02326584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64533950|NCT02326584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533952|NCT03111342|Anesthetics, Local|anesthetics, local|mesh-ancestor
64533953|NCT03111342|Anesthetics|anesthetics|mesh-ancestor
64533954|NCT03111342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64533955|NCT03111342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533956|NCT03111342|Sensory System Agents|sensory system agents|mesh-ancestor
64533957|NCT03111342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64533958|NCT03111342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64535047|NCT01482169|Vasodilator Agents|vasodilator agents|mesh-ancestor
64533959|NCT03111342|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64533960|NCT03111342|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64533961|NCT03111342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64466785|NCT01894360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64466786|NCT01894360|Immunologic Factors|immunologic factors|mesh-ancestor
64466787|NCT01894360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466788|NCT01483599|Adalimumab|adalimumab|mesh-list
64466789|NCT01483599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64466820|NCT02086786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466821|NCT02086786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466822|NCT02086786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64535094|NCT01472081|Nivolumab|nivolumab|mesh-list
64466823|NCT02086786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64466824|NCT02086786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64466825|NCT02086786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64466826|NCT02086786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64466827|NCT02086786|Dopamine Agents|dopamine agents|mesh-ancestor
64466828|NCT01787500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64466830|NCT01787500|Irinotecan|irinotecan|mesh-list
64466831|NCT01787500|Camptothecin|camptothecin|mesh-list
64466832|NCT01787500|Vemurafenib|vemurafenib|mesh-list
64466842|NCT01787500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466843|NCT01787500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64466844|NCT01787500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64466845|NCT01782352|Vitamin D|vitamin d|mesh-list
64466846|NCT01782352|Ergocalciferols|ergocalciferols|mesh-list
64466847|NCT01782352|Cholecalciferol|cholecalciferol|mesh-list
64466848|NCT01782352|Vitamins|vitamins|mesh-list
64466849|NCT01782352|Micronutrients|micronutrients|mesh-ancestor
64466850|NCT01782352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466851|NCT01782352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64466852|NCT01782352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64466853|NCT02108158|Botulinum Toxins|botulinum toxins|mesh-list
64466854|NCT02108158|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64466855|NCT02108158|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64466856|NCT02108158|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64713974|NCT02918617|Fluorides|fluorides|mesh-list
64466857|NCT02108158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64533962|NCT03111342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963047|NCT00050180|GABA Agents|gaba agents|mesh-ancestor
64535115|NCT01471379|Milnacipran|milnacipran|mesh-list
64533963|NCT03111420|Clopidogrel|clopidogrel|mesh-list
64533964|NCT03111420|Ticagrelor|ticagrelor|mesh-list
64533965|NCT03111420|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64533966|NCT03111420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64533967|NCT03111420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64533968|NCT03111420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64533969|NCT03111420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64533970|NCT03111420|Purinergic Agents|purinergic agents|mesh-ancestor
64533971|NCT03111420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64533972|NCT03111420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533973|NCT03111420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533974|NCT02333682|Vitamin D|vitamin d|mesh-list
64533975|NCT02333682|Cholecalciferol|cholecalciferol|mesh-list
64533976|NCT02333682|Calcifediol|calcifediol|mesh-list
64533977|NCT02333682|Vitamins|vitamins|mesh-ancestor
64963154|NCT00153088|Telmisartan|telmisartan|mesh-list
64533978|NCT02333682|Micronutrients|micronutrients|mesh-ancestor
64533979|NCT02333682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533980|NCT02333682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64533981|NCT02333682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64533982|NCT02328456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64533983|NCT02328456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64466858|NCT02108158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466861|NCT02108158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466862|NCT02108158|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64466863|NCT02108158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64466864|NCT01895218|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
64466865|NCT01895218|Hematinics|hematinics|mesh-ancestor
64466866|NCT01895998|Albuterol|albuterol|mesh-list
64466867|NCT01895998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64466868|NCT01895998|Autonomic Agents|autonomic agents|mesh-ancestor
64466869|NCT01895998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64466870|NCT01895998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466871|NCT01895998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64466872|NCT01895998|Respiratory System Agents|respiratory system agents|mesh-ancestor
64466873|NCT01895998|Tocolytic Agents|tocolytic agents|mesh-ancestor
64466874|NCT01895998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64466875|NCT01895998|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64466876|NCT01895998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64466877|NCT01895998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64466878|NCT01895998|Adrenergic Agents|adrenergic agents|mesh-ancestor
64466879|NCT01895998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64466880|NCT01895998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466881|NCT02073994|Ivosidenib|ivosidenib|mesh-list
64466882|NCT02073994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466883|NCT02073994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466884|NCT02073994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466885|NCT01895296|Pasireotide|pasireotide|mesh-list
64466886|NCT01895296|Hormones|hormones|mesh-ancestor
64533984|NCT02326350|Aspirin|aspirin|mesh-list
64533985|NCT02326350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64533986|NCT02326350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64533987|NCT02326350|Analgesics|analgesics|mesh-ancestor
64533988|NCT02326350|Sensory System Agents|sensory system agents|mesh-ancestor
64533989|NCT02326350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64533990|NCT02326350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64533991|NCT02326350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64533992|NCT02326350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64298580|NCT02084953|Moxifloxacin|moxifloxacin|mesh-list
64466887|NCT01895296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64466888|NCT01895296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466889|NCT01276600|Tenofovir|tenofovir|mesh-list
64466890|NCT01276600|Emtricitabine|emtricitabine|mesh-list
64466891|NCT01276600|Antiviral Agents|antiviral agents|mesh-ancestor
64466892|NCT01276600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64466893|NCT01276600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64466894|NCT01276600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64466895|NCT01276600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466896|NCT01276600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466929|NCT01659658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466930|NCT01659658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64466931|NCT01659658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64713975|NCT02918617|Cariostatic Agents|cariostatic agents|mesh-ancestor
64466932|NCT01659658|Antiemetics|antiemetics|mesh-ancestor
64466933|NCT01659658|Autonomic Agents|autonomic agents|mesh-ancestor
64466934|NCT01659658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64466935|NCT01659658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64466936|NCT01659658|Glucocorticoids|glucocorticoids|mesh-ancestor
64466937|NCT01659658|Hormones|hormones|mesh-ancestor
64466938|NCT01659658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64466939|NCT01659658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64466940|NCT01659658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64466955|NCT01639690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64535301|NCT03331731|Pembrolizumab|pembrolizumab|mesh-list
64466956|NCT01639690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466957|NCT01639690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64466958|NCT01621906|Alovudine|alovudine|mesh-list
64466959|NCT01621906|Antiviral Agents|antiviral agents|mesh-ancestor
64466960|NCT01621906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64466961|NCT01615510|Tapentadol|tapentadol|mesh-list
64466962|NCT01615510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64466963|NCT01615510|Narcotics|narcotics|mesh-ancestor
64466964|NCT01615510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64466965|NCT01615510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466966|NCT01615510|Analgesics|analgesics|mesh-ancestor
64466967|NCT01615510|Sensory System Agents|sensory system agents|mesh-ancestor
64466968|NCT01615510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64466969|NCT01615510|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64963892|NCT00406978|Growth Substances|growth substances|mesh-ancestor
64963913|NCT00157729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963916|NCT00157729|Vitamins|vitamins|mesh-ancestor
64466970|NCT01615510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64466971|NCT01615510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64466972|NCT01615510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466973|NCT01615510|Adrenergic Agents|adrenergic agents|mesh-ancestor
64466974|NCT01615510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64466975|NCT00530062|Albuterol|albuterol|mesh-list
64466976|NCT00530062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64466977|NCT00530062|Autonomic Agents|autonomic agents|mesh-ancestor
64466978|NCT00530062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64466979|NCT00530062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466980|NCT00530062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64466981|NCT00530062|Respiratory System Agents|respiratory system agents|mesh-ancestor
64466982|NCT00530062|Tocolytic Agents|tocolytic agents|mesh-ancestor
64964183|NCT00044538|Taxane|taxane|mesh-list
64466983|NCT00530062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64533993|NCT02326350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64533994|NCT02326350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64533995|NCT02326350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64533996|NCT02326350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64533997|NCT02326350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64533998|NCT02326350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64533999|NCT02326350|Antipyretics|antipyretics|mesh-ancestor
64534000|NCT02326194|Vaccines|vaccines|mesh-list
64298591|NCT02085109|Theobromine|theobromine|mesh-list
64466984|NCT00530062|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64466985|NCT00530062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64466986|NCT00530062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64466987|NCT00530062|Adrenergic Agents|adrenergic agents|mesh-ancestor
64503086|NCT03355248|Antipyretics|antipyretics|mesh-ancestor
64466988|NCT00530062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64466989|NCT00530062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466990|NCT04283656|Tenofovir|tenofovir|mesh-list
64466991|NCT04283656|Lamivudine|lamivudine|mesh-list
64466992|NCT04283656|Spironolactone|spironolactone|mesh-list
64466993|NCT04283656|Estradiol|estradiol|mesh-list
64466994|NCT04283656|Antiviral Agents|antiviral agents|mesh-ancestor
64466995|NCT04283656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64466996|NCT04283656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64466997|NCT04283656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64466998|NCT04283656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466999|NCT04283656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467000|NCT04283656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64467001|NCT04283656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64467024|NCT01209364|Glucocorticoids|glucocorticoids|mesh-ancestor
64964636|NCT00053105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64467026|NCT01209364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64467027|NCT01209364|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64467028|NCT01209364|Protective Agents|protective agents|mesh-ancestor
64467029|NCT01209364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64467030|NCT01209364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467031|NCT05080192|Fenofibrate|fenofibrate|mesh-list
64467032|NCT05080192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64467033|NCT05080192|Antimetabolites|antimetabolites|mesh-ancestor
64467034|NCT05080192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467035|NCT05080192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64467036|NCT00479128|Gemcitabine|gemcitabine|mesh-list
64467037|NCT00479128|Doxorubicin|doxorubicin|mesh-list
64467038|NCT00479128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64467039|NCT00479128|Bortezomib|bortezomib|mesh-list
64467040|NCT00479128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64467041|NCT00479128|Antimetabolites|antimetabolites|mesh-ancestor
64467042|NCT00479128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467043|NCT00479128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467044|NCT00479128|Antiviral Agents|antiviral agents|mesh-ancestor
64467045|NCT00479128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64467046|NCT00479128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467047|NCT00479128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64467048|NCT00479128|Immunologic Factors|immunologic factors|mesh-ancestor
64467049|NCT00479128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467050|NCT00479128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64467051|NCT00479128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64467052|NCT00479128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64467053|NCT00472966|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
64467054|NCT00472966|Tretinoin|tretinoin|mesh-list
64467083|NCT01547260|Antimetabolites|antimetabolites|mesh-ancestor
64467084|NCT01547260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467085|NCT01547260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467086|NCT01547260|Antiviral Agents|antiviral agents|mesh-ancestor
64467087|NCT01547260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64467088|NCT01547260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467089|NCT01547260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64467090|NCT01547260|Immunologic Factors|immunologic factors|mesh-ancestor
64467091|NCT01547260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534001|NCT02326194|Immunologic Factors|immunologic factors|mesh-ancestor
64534002|NCT02326194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534003|NCT02326038|Methylphenidate|methylphenidate|mesh-list
64534004|NCT02326038|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64534005|NCT02326038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534006|NCT02326038|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64534007|NCT02326038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64298598|NCT02085109|Vasodilator Agents|vasodilator agents|mesh-ancestor
64467092|NCT01547260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64467093|NCT01547260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64467094|NCT01547260|Growth Substances|growth substances|mesh-ancestor
64467095|NCT01547260|Growth Inhibitors|growth inhibitors|mesh-ancestor
64467096|NCT04205266|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64467097|NCT04205266|Hematinics|hematinics|mesh-ancestor
64467098|NCT04205266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64467099|NCT04205266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64467130|NCT04755322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467131|NCT04755322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64467132|NCT04755322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64467133|NCT04755322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467134|NCT04755322|Antipyretics|antipyretics|mesh-ancestor
64467135|NCT04755322|Antimalarials|antimalarials|mesh-ancestor
64467136|NCT04755322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64467137|NCT04755322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64467138|NCT04755322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64965133|NCT00165139|Mitosis Modulators|mitosis modulators|mesh-ancestor
64965134|NCT00165139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64965135|NCT00165139|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64965136|NCT00053807|Interferons|interferons|mesh-list
64965137|NCT00053807|Interferon-alpha|interferon-alpha|mesh-list
64965138|NCT00053807|Aldesleukin|aldesleukin|mesh-list
64965139|NCT00053807|Fluorouracil|fluorouracil|mesh-list
64965140|NCT00053807|Antimetabolites|antimetabolites|mesh-ancestor
64965141|NCT00053807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965142|NCT00053807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64965143|NCT00053807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965144|NCT00053807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64965145|NCT00053807|Immunologic Factors|immunologic factors|mesh-ancestor
64965146|NCT00053807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965147|NCT00053807|Antiviral Agents|antiviral agents|mesh-ancestor
64965148|NCT00053807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64965149|NCT00053807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64965150|NCT00053807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64965151|NCT00165178|Leucovorin|leucovorin|mesh-list
64965152|NCT00165178|Cytarabine|cytarabine|mesh-list
64965153|NCT00165178|Dexamethasone|dexamethasone|mesh-list
64965154|NCT00165178|Prednisone|prednisone|mesh-list
64965155|NCT00165178|Hydrocortisone|hydrocortisone|mesh-list
64965156|NCT00165178|Doxorubicin|doxorubicin|mesh-list
64965157|NCT00165178|Methotrexate|methotrexate|mesh-list
64965193|NCT00165178|Vitamins|vitamins|mesh-ancestor
64467139|NCT04755322|Hematinics|hematinics|mesh-ancestor
64467140|NCT04755322|Vitamin B Complex|vitamin b complex|mesh-ancestor
64467141|NCT04755322|Vitamins|vitamins|mesh-ancestor
64467142|NCT04755322|Micronutrients|micronutrients|mesh-ancestor
64467143|NCT00436540|Clobetasol|clobetasol|mesh-list
64467144|NCT00436540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64467145|NCT00436540|Glucocorticoids|glucocorticoids|mesh-ancestor
64467169|NCT00412594|Immunologic Factors|immunologic factors|mesh-ancestor
64467170|NCT00412594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467171|NCT00412594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467172|NCT00412594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64467173|NCT00412594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64965238|NCT00165373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64965240|NCT00165373|Growth Substances|growth substances|mesh-ancestor
64467174|NCT00412594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64467175|NCT00412594|Antimetabolites|antimetabolites|mesh-ancestor
64467176|NCT00412594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467177|NCT00410956|Dexamethasone|dexamethasone|mesh-list
64467178|NCT00410956|Bevacizumab|bevacizumab|mesh-list
64467179|NCT00410956|Floxuridine|floxuridine|mesh-list
64467180|NCT00410956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64467181|NCT00410956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467182|NCT00410956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64467183|NCT00410956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64467184|NCT00410956|Growth Substances|growth substances|mesh-ancestor
64467185|NCT00410956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467187|NCT00410956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64467188|NCT00410956|Antiemetics|antiemetics|mesh-ancestor
64467189|NCT00410956|Autonomic Agents|autonomic agents|mesh-ancestor
64467190|NCT00410956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64467191|NCT00410956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64467192|NCT00410956|Glucocorticoids|glucocorticoids|mesh-ancestor
64467193|NCT00410956|Hormones|hormones|mesh-ancestor
64965486|NCT00054548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965487|NCT00054548|Tubulin Modulators|tubulin modulators|mesh-ancestor
64467194|NCT00410956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64467195|NCT00410956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64467196|NCT00410956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64504294|NCT02509806|Apatinib|apatinib|mesh-list
64467197|NCT00410956|Antimetabolites|antimetabolites|mesh-ancestor
64467207|NCT04634578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64467208|NCT04634578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64467209|NCT04634578|Growth Substances|growth substances|mesh-ancestor
64467210|NCT04634578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467211|NCT04634578|Growth Inhibitors|growth inhibitors|mesh-ancestor
64467212|NCT01066858|Tenofovir|tenofovir|mesh-list
64534008|NCT02326038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64534009|NCT02326038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534011|NCT02326038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64534012|NCT00970866|Folic Acid|folic acid|mesh-list
64534013|NCT00970866|Micronutrients|micronutrients|mesh-list
64534014|NCT00970866|Trace Elements|trace elements|mesh-list
64534015|NCT00970866|Hematinics|hematinics|mesh-ancestor
64467213|NCT01066858|Antiviral Agents|antiviral agents|mesh-ancestor
64467214|NCT01066858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64467215|NCT01066858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64467216|NCT01066858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64535603|NCT00462423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64535604|NCT00462423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535605|NCT00462423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64535606|NCT00462423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64535607|NCT00462423|Growth Substances|growth substances|mesh-ancestor
64535608|NCT00462423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535609|NCT00462423|Growth Inhibitors|growth inhibitors|mesh-ancestor
64535610|NCT00462735|Fluorouracil|fluorouracil|mesh-list
64535611|NCT00462735|Cetuximab|cetuximab|mesh-list
64467217|NCT01066858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467218|NCT01066858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467219|NCT01066858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64467220|NCT01066858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64467221|NCT04777552|Diazepam|diazepam|mesh-list
64467222|NCT04777552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64467223|NCT04777552|Anticonvulsants|anticonvulsants|mesh-ancestor
64467224|NCT04777552|Antiemetics|antiemetics|mesh-ancestor
64467225|NCT04777552|Autonomic Agents|autonomic agents|mesh-ancestor
64467226|NCT04777552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64467227|NCT04777552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467228|NCT04777552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64467229|NCT04777552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64467230|NCT04777552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64467231|NCT04777552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64467232|NCT04777552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64467233|NCT04777552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64467234|NCT04777552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64467235|NCT04777552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64467236|NCT04777552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64467237|NCT04777552|Anesthetics, General|anesthetics, general|mesh-ancestor
64467238|NCT04777552|Anesthetics|anesthetics|mesh-ancestor
64467239|NCT04777552|GABA Modulators|gaba modulators|mesh-ancestor
64467240|NCT04777552|GABA Agents|gaba agents|mesh-ancestor
64966019|NCT00170404|Folic Acid|folic acid|mesh-list
64467241|NCT04777552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64467242|NCT04777552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467243|NCT01506609|Paclitaxel|paclitaxel|mesh-list
64467244|NCT01506609|Carboplatin|carboplatin|mesh-list
64467245|NCT01506609|Temozolomide|temozolomide|mesh-list
64467246|NCT01506609|Veliparib|veliparib|mesh-list
64467247|NCT01506609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64467252|NCT01506609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467254|NCT01506609|Alkylating Agents|alkylating agents|mesh-ancestor
64966156|NCT00055562|Growth Substances|growth substances|mesh-ancestor
64467255|NCT01506609|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64467256|NCT01506609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467257|NCT03027219|Alprostadil|alprostadil|mesh-list
64467258|NCT03027219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64467259|NCT03027219|Vasodilator Agents|vasodilator agents|mesh-ancestor
64467260|NCT03027219|Urological Agents|urological agents|mesh-ancestor
64467261|NCT04776772|Complement System Proteins|complement system proteins|mesh-list
64467264|NCT01506453|Gabapentin|gabapentin|mesh-list
64467265|NCT01506453|Analgesics|analgesics|mesh-ancestor
64467266|NCT01506453|Sensory System Agents|sensory system agents|mesh-ancestor
64467267|NCT01506453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64467268|NCT01506453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467269|NCT01506453|Anticonvulsants|anticonvulsants|mesh-ancestor
64467270|NCT01506453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64467271|NCT01506453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64467272|NCT01506453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64467273|NCT01506453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64535961|NCT01460381|Antimalarials|antimalarials|mesh-ancestor
64966263|NCT00171808|Letrozole|letrozole|mesh-list
64467274|NCT01506453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64467275|NCT01506453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64467276|NCT01506453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64534016|NCT00970866|Vitamin B Complex|vitamin b complex|mesh-ancestor
64534017|NCT00970866|Vitamins|vitamins|mesh-ancestor
64534018|NCT00970866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534019|NCT03145584|Bupivacaine|bupivacaine|mesh-list
64534020|NCT03145584|Anesthetics, Local|anesthetics, local|mesh-ancestor
64534021|NCT03145584|Anesthetics|anesthetics|mesh-ancestor
64534022|NCT03145584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64534023|NCT03145584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534024|NCT03145584|Sensory System Agents|sensory system agents|mesh-ancestor
64534025|NCT03145584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64534026|NCT03145194|Ticagrelor|ticagrelor|mesh-list
64534027|NCT03145194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64534028|NCT03145194|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64534029|NCT03145194|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64298617|NCT02085577|Acetaminophen|acetaminophen|mesh-list
64467277|NCT01506453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467278|NCT01506453|Antimanic Agents|antimanic agents|mesh-ancestor
64467279|NCT04389580|Tamoxifen|tamoxifen|mesh-list
64467280|NCT04389580|Isotretinoin|isotretinoin|mesh-list
64467281|NCT04389580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64467282|NCT04389580|Hormone Antagonists|hormone antagonists|mesh-ancestor
64467283|NCT04389580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64467284|NCT04389580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467285|NCT04389580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64467286|NCT04389580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467287|NCT04389580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64966417|NCT00045864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64467288|NCT04389580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64467289|NCT04389580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64467290|NCT04389580|Dermatologic Agents|dermatologic agents|mesh-ancestor
64467291|NCT00199108|Dexamethasone|dexamethasone|mesh-list
64467292|NCT00199108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64467293|NCT00199108|Antiemetics|antiemetics|mesh-ancestor
64467294|NCT00199108|Autonomic Agents|autonomic agents|mesh-ancestor
64467295|NCT00199108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64966479|NCT00173875|Gefitinib|gefitinib|mesh-list
64467296|NCT00199108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467297|NCT00199108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64467298|NCT00199108|Glucocorticoids|glucocorticoids|mesh-ancestor
64467299|NCT00199108|Hormones|hormones|mesh-ancestor
64467300|NCT00199108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64467301|NCT00199108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64467302|NCT00199108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467303|NCT01504971|Rabeprazole|rabeprazole|mesh-list
64467304|NCT01504971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64467305|NCT01504971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64467306|NCT01504971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64467307|NCT01504971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467308|NCT01504971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467309|NCT00954226|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64467310|NCT00954226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467311|NCT00954226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64467312|NCT00954226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467313|NCT00954226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467314|NCT04753918|Ethiodized Oil|ethiodized oil|mesh-list
64467315|NCT04753918|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
64467344|NCT00936832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467345|NCT00936832|Antidotes|antidotes|mesh-ancestor
64467346|NCT00936832|Protective Agents|protective agents|mesh-ancestor
64534030|NCT03145194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64534031|NCT03145194|Purinergic Agents|purinergic agents|mesh-ancestor
64966673|NCT00046176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64966674|NCT00046176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64534032|NCT03145194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64534033|NCT03145194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534034|NCT03145194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534036|NCT05076942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534037|NCT03143946|Vitamins|vitamins|mesh-list
64534038|NCT03143946|Micronutrients|micronutrients|mesh-ancestor
64534039|NCT03143946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534040|NCT02039700|Lesinurad|lesinurad|mesh-list
64966807|NCT00175903|Antimanic Agents|antimanic agents|mesh-ancestor
64534041|NCT02039700|Gout Suppressants|gout suppressants|mesh-ancestor
64534042|NCT02039700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64534043|NCT02039700|Uricosuric Agents|uricosuric agents|mesh-ancestor
64534044|NCT02039700|Renal Agents|renal agents|mesh-ancestor
64534045|NCT05076474|Orlistat|orlistat|mesh-list
64534046|NCT05076474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534047|NCT05076474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534048|NCT05076474|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64534049|NCT05076474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64534050|NCT02328144|Metronidazole|metronidazole|mesh-list
64534051|NCT02328144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64298629|NCT02085577|Anesthetics, General|anesthetics, general|mesh-ancestor
64298631|NCT02085577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64467347|NCT00936832|Vitamin B Complex|vitamin b complex|mesh-ancestor
64467348|NCT00936832|Vitamins|vitamins|mesh-ancestor
64467349|NCT00936832|Micronutrients|micronutrients|mesh-ancestor
64467350|NCT00936832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64467351|NCT00936832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64467352|NCT00936832|Growth Substances|growth substances|mesh-ancestor
64467353|NCT00936832|Growth Inhibitors|growth inhibitors|mesh-ancestor
64467354|NCT00936832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64467356|NCT01479621|Xhance|xhance|mesh-list
64467357|NCT01479621|Albuterol|albuterol|mesh-list
64467358|NCT01479621|Adrenergic Agonists|adrenergic agonists|mesh-list
64467359|NCT01479621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64467360|NCT01479621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64467361|NCT01479621|Autonomic Agents|autonomic agents|mesh-ancestor
64467362|NCT01479621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64467363|NCT01479621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467364|NCT01479621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64467365|NCT01479621|Respiratory System Agents|respiratory system agents|mesh-ancestor
64467366|NCT01479621|Dermatologic Agents|dermatologic agents|mesh-ancestor
64467389|NCT02319304|Antimetabolites|antimetabolites|mesh-ancestor
64467390|NCT02319304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467391|NCT02319304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64467392|NCT02319304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467393|NCT02319304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64467394|NCT02319304|Immunologic Factors|immunologic factors|mesh-ancestor
64467395|NCT02319304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467397|NCT02319304|Protective Agents|protective agents|mesh-ancestor
64467398|NCT02319304|Vitamin B Complex|vitamin b complex|mesh-ancestor
64467399|NCT02319304|Vitamins|vitamins|mesh-ancestor
64467400|NCT02319304|Micronutrients|micronutrients|mesh-ancestor
64467401|NCT00885664|Ritonavir|ritonavir|mesh-list
64534052|NCT02328144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64534053|NCT02328144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64534054|NCT02328144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64534055|NCT02327676|Emtricitabine|emtricitabine|mesh-list
64534056|NCT02327676|Antiviral Agents|antiviral agents|mesh-ancestor
64534057|NCT02327676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64467402|NCT00885664|Lopinavir|lopinavir|mesh-list
64467403|NCT00885664|Tenofovir|tenofovir|mesh-list
64467404|NCT00885664|Emtricitabine|emtricitabine|mesh-list
64467405|NCT00885664|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64536432|NCT01453205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64467406|NCT00885664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64467407|NCT00885664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64467408|NCT00885664|Protease Inhibitors|protease inhibitors|mesh-ancestor
64467409|NCT00885664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467410|NCT00885664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467411|NCT00885664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64467412|NCT00885664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64467413|NCT00885664|Antiviral Agents|antiviral agents|mesh-ancestor
64467414|NCT00885664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64467415|NCT00885664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64467416|NCT00885664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64467417|NCT00885664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64467437|NCT04784104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64467439|NCT04784104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64467440|NCT04784104|Respiratory System Agents|respiratory system agents|mesh-ancestor
64467441|NCT04784104|Mydriatics|mydriatics|mesh-ancestor
64467442|NCT04784104|Sympathomimetics|sympathomimetics|mesh-ancestor
64467443|NCT04784104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64467444|NCT00880594|Desipramine|desipramine|mesh-list
64467445|NCT00880594|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64467446|NCT00880594|Antidepressive Agents|antidepressive agents|mesh-ancestor
64467447|NCT00880594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64467448|NCT00880594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467449|NCT00880594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467450|NCT00880594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64467451|NCT00880594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64467452|NCT00880594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64467453|NCT00880594|Adrenergic Agents|adrenergic agents|mesh-ancestor
64467454|NCT00880594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64467455|NCT00880594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467456|NCT04783870|Dapagliflozin|dapagliflozin|mesh-list
64467457|NCT04783870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64467458|NCT04783870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967222|NCT00179062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64467459|NCT04783870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64467460|NCT04783870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467461|NCT00878254|Leucovorin|leucovorin|mesh-list
64467462|NCT00878254|Cytarabine|cytarabine|mesh-list
64467463|NCT00878254|Cyclophosphamide|cyclophosphamide|mesh-list
64467464|NCT00878254|Ifosfamide|ifosfamide|mesh-list
64467465|NCT00878254|Rituximab|rituximab|mesh-list
64467466|NCT00878254|Doxorubicin|doxorubicin|mesh-list
64467467|NCT00878254|Methotrexate|methotrexate|mesh-list
64467468|NCT00878254|Etoposide|etoposide|mesh-list
64467469|NCT00878254|Vincristine|vincristine|mesh-list
64467470|NCT00878254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64467471|NCT00878254|Immunologic Factors|immunologic factors|mesh-ancestor
64467472|NCT00878254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467473|NCT00878254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64467497|NCT00878254|Vitamin B Complex|vitamin b complex|mesh-ancestor
64467498|NCT00878254|Vitamins|vitamins|mesh-ancestor
64467499|NCT00878254|Micronutrients|micronutrients|mesh-ancestor
64467500|NCT00878254|Tubulin Modulators|tubulin modulators|mesh-ancestor
64467501|NCT00878254|Antimitotic Agents|antimitotic agents|mesh-ancestor
64467502|NCT00878254|Mitosis Modulators|mitosis modulators|mesh-ancestor
64467504|NCT04783636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64467506|NCT04783636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64467507|NCT04783636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467508|NCT04783636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64467509|NCT04783636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467510|NCT00820846|Vaccines|vaccines|mesh-list
64653198|NCT01045694|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64534058|NCT02327676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64534059|NCT02327676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64534060|NCT02327676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534061|NCT02327676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534062|NCT02327676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64467511|NCT00820846|Immunologic Factors|immunologic factors|mesh-ancestor
64467512|NCT00820846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467513|NCT03364348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64467514|NCT03364348|Trastuzumab|trastuzumab|mesh-list
64467515|NCT03364348|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64467516|NCT03364348|Maytansine|maytansine|mesh-list
64467517|NCT03364348|Antibodies|antibodies|mesh-list
64467518|NCT03364348|Immunoglobulins|immunoglobulins|mesh-list
64467519|NCT03364348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64467520|NCT03364348|Immunoconjugates|immunoconjugates|mesh-list
64467521|NCT03364348|Immunoglobulin G|immunoglobulin g|mesh-list
64467522|NCT03364348|Immunologic Factors|immunologic factors|mesh-ancestor
64467523|NCT03364348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467524|NCT03364348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467525|NCT03364348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64467526|NCT03364348|Tubulin Modulators|tubulin modulators|mesh-ancestor
64467552|NCT04782388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64467553|NCT04782388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64467554|NCT04782388|GABA Modulators|gaba modulators|mesh-ancestor
64467555|NCT04782388|GABA Agents|gaba agents|mesh-ancestor
64467556|NCT04782388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64967465|NCT00181597|Hydrocortisone|hydrocortisone|mesh-list
64467557|NCT04782388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467558|NCT04782076|Dabigatran|dabigatran|mesh-list
64467559|NCT04782076|Antithrombins|antithrombins|mesh-ancestor
64467560|NCT04782076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64467561|NCT04782076|Protease Inhibitors|protease inhibitors|mesh-ancestor
64467562|NCT04782076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467563|NCT04782076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467564|NCT04782076|Anticoagulants|anticoagulants|mesh-ancestor
64536710|NCT01577186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64467565|NCT04782310|Pregabalin|pregabalin|mesh-list
64467566|NCT04782310|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64467567|NCT04782310|Analgesics|analgesics|mesh-ancestor
64467568|NCT04782310|Sensory System Agents|sensory system agents|mesh-ancestor
64467569|NCT04782310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64467570|NCT04782310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467571|NCT04782310|Anticonvulsants|anticonvulsants|mesh-ancestor
64467572|NCT04782310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64467573|NCT04782310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64467574|NCT04782310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467575|NCT04782310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64467603|NCT03300544|Antidotes|antidotes|mesh-ancestor
64467604|NCT03300544|Protective Agents|protective agents|mesh-ancestor
64967573|NCT00182455|Topiramate|topiramate|mesh-list
64467605|NCT03300544|Vitamin B Complex|vitamin b complex|mesh-ancestor
64467607|NCT03300544|Micronutrients|micronutrients|mesh-ancestor
64467608|NCT03300544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64467609|NCT03249844|Methylprednisolone|methylprednisolone|mesh-list
64467610|NCT03249844|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64467611|NCT03249844|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64467612|NCT03249844|Prednisolone|prednisolone|mesh-list
64467613|NCT03249844|Prednisolone acetate|prednisolone acetate|mesh-list
64467614|NCT03249844|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64467615|NCT03249844|Prednisolone phosphate|prednisolone phosphate|mesh-list
64713977|NCT02918617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467616|NCT03249844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64467617|NCT03249844|Antiemetics|antiemetics|mesh-ancestor
64467618|NCT03249844|Autonomic Agents|autonomic agents|mesh-ancestor
64467619|NCT03249844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64467620|NCT03249844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467621|NCT03249844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64467622|NCT03249844|Glucocorticoids|glucocorticoids|mesh-ancestor
64467623|NCT03249844|Hormones|hormones|mesh-ancestor
64467627|NCT03249844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64467629|NCT00637624|Acetylcysteine|acetylcysteine|mesh-list
64467630|NCT00637624|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64534064|NCT02333058|Treosulfan|treosulfan|mesh-list
64534065|NCT02333058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64534066|NCT02333058|Alkylating Agents|alkylating agents|mesh-ancestor
64534067|NCT02333058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534068|NCT02333058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534069|NCT03111186|Acetaminophen|acetaminophen|mesh-list
64534070|NCT03111186|Ibuprofen|ibuprofen|mesh-list
64534071|NCT03111186|Oxycodone|oxycodone|mesh-list
64534072|NCT03111186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64534073|NCT03111186|Analgesics|analgesics|mesh-ancestor
64534074|NCT03111186|Sensory System Agents|sensory system agents|mesh-ancestor
64534075|NCT03111186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64534076|NCT03111186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534077|NCT03111186|Antipyretics|antipyretics|mesh-ancestor
64534078|NCT03111186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64534079|NCT03111186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64534080|NCT03111186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64534081|NCT03111186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64534082|NCT03111186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967831|NCT00184171|Hormones|hormones|mesh-ancestor
64534083|NCT03111186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534084|NCT03111186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64534085|NCT03111186|Narcotics|narcotics|mesh-ancestor
64467632|NCT00637624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64467633|NCT00637624|Expectorants|expectorants|mesh-ancestor
64467634|NCT00637624|Respiratory System Agents|respiratory system agents|mesh-ancestor
64467635|NCT00637624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64467636|NCT00637624|Antioxidants|antioxidants|mesh-ancestor
64467637|NCT00637624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467638|NCT00637624|Protective Agents|protective agents|mesh-ancestor
64467639|NCT00637624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467640|NCT00637624|Antidotes|antidotes|mesh-ancestor
64467641|NCT01479465|Leucovorin|leucovorin|mesh-list
64467642|NCT01479465|Fluorouracil|fluorouracil|mesh-list
64467643|NCT01479465|Irinotecan|irinotecan|mesh-list
64467644|NCT01479465|Antimetabolites|antimetabolites|mesh-ancestor
64536824|NCT01449929|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64467645|NCT01479465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467646|NCT01479465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64467647|NCT01479465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467648|NCT01479465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64467649|NCT01479465|Immunologic Factors|immunologic factors|mesh-ancestor
64467650|NCT01479465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467651|NCT01479465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64467652|NCT01479465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64467653|NCT01479465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467654|NCT01479465|Antidotes|antidotes|mesh-ancestor
64467655|NCT01479465|Protective Agents|protective agents|mesh-ancestor
64467656|NCT01479465|Vitamin B Complex|vitamin b complex|mesh-ancestor
64467657|NCT01479465|Vitamins|vitamins|mesh-ancestor
64467658|NCT01479465|Micronutrients|micronutrients|mesh-ancestor
64536873|NCT01451515|Antiviral Agents|antiviral agents|mesh-ancestor
64467659|NCT02428192|Nivolumab|nivolumab|mesh-list
64467660|NCT02428192|Ipilimumab|ipilimumab|mesh-list
64467661|NCT02428192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64534086|NCT03111186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64534087|NCT02332512|Apatinib|apatinib|mesh-list
64534088|NCT02332512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534089|NCT02332512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64534090|NCT02332512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467662|NCT02428192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467663|NCT02428192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64968004|NCT00185224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64467664|NCT02428192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467665|NCT04781686|Docetaxel|docetaxel|mesh-list
64467666|NCT04781686|Apatinib|apatinib|mesh-list
64467667|NCT04781686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467668|NCT04781686|Tubulin Modulators|tubulin modulators|mesh-ancestor
64467669|NCT04781686|Antimitotic Agents|antimitotic agents|mesh-ancestor
64467671|NCT04781686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467672|NCT04781686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64467673|NCT04781686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467674|NCT02390284|Timolol|timolol|mesh-list
64467675|NCT02390284|Bimatoprost|bimatoprost|mesh-list
64467676|NCT02390284|Travoprost|travoprost|mesh-list
64467677|NCT02390284|Dorzolamide|dorzolamide|mesh-list
64467678|NCT02390284|Acetazolamide|acetazolamide|mesh-list
64467679|NCT02390284|Methazolamide|methazolamide|mesh-list
64467680|NCT02390284|Latanoprost|latanoprost|mesh-list
64467691|NCT02390284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64467693|NCT02390284|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64467694|NCT02390284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467695|NCT02390284|Diuretics|diuretics|mesh-ancestor
64467696|NCT02390284|Natriuretic Agents|natriuretic agents|mesh-ancestor
64467697|NCT04780750|Docetaxel|docetaxel|mesh-list
64968168|NCT00409201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64467698|NCT04780750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467699|NCT04780750|Tubulin Modulators|tubulin modulators|mesh-ancestor
64467700|NCT04780750|Antimitotic Agents|antimitotic agents|mesh-ancestor
64467701|NCT04780750|Mitosis Modulators|mitosis modulators|mesh-ancestor
64467702|NCT04780750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467703|NCT04780984|Bromides|bromides|mesh-list
64467704|NCT04780984|Tiotropium Bromide|tiotropium bromide|mesh-list
64467705|NCT04780984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64467706|NCT04780984|Autonomic Agents|autonomic agents|mesh-ancestor
64467707|NCT04780984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64467708|NCT04780984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467709|NCT04780984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64467710|NCT04780984|Respiratory System Agents|respiratory system agents|mesh-ancestor
64467711|NCT04780984|Parasympatholytics|parasympatholytics|mesh-ancestor
64467712|NCT04780984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64467713|NCT04780984|Cholinergic Agents|cholinergic agents|mesh-ancestor
64467714|NCT04780984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64467715|NCT04780984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467716|NCT04780984|Anticonvulsants|anticonvulsants|mesh-ancestor
64467717|NCT02090374|Vitamin D|vitamin d|mesh-list
64467718|NCT02090374|Poly ICLC|poly iclc|mesh-list
64467719|NCT02090374|Vitamins|vitamins|mesh-ancestor
64467720|NCT02090374|Micronutrients|micronutrients|mesh-ancestor
64467721|NCT02090374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467722|NCT02090374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64467723|NCT02090374|Interferon Inducers|interferon inducers|mesh-ancestor
64467724|NCT02090374|Immunologic Factors|immunologic factors|mesh-ancestor
64467725|NCT02222740|Hydrocodone|hydrocodone|mesh-list
64467726|NCT02222740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64467727|NCT02222740|Narcotics|narcotics|mesh-ancestor
64467728|NCT02222740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64467729|NCT02222740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467730|NCT02222740|Analgesics|analgesics|mesh-ancestor
64467731|NCT02222740|Sensory System Agents|sensory system agents|mesh-ancestor
64467732|NCT02222740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64467733|NCT02222740|Antitussive Agents|antitussive agents|mesh-ancestor
64467734|NCT02222740|Respiratory System Agents|respiratory system agents|mesh-ancestor
64467736|NCT04780438|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64467737|NCT04780438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467738|NCT04780438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64968252|NCT00187057|Glucocorticoids|glucocorticoids|mesh-ancestor
64968253|NCT00187057|Hormones|hormones|mesh-ancestor
64536963|NCT02073487|Paclitaxel|paclitaxel|mesh-list
64467739|NCT04780438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467740|NCT04779892|Infliximab|infliximab|mesh-list
64534091|NCT02332512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534092|NCT02327754|FYX-051|fyx-051|mesh-list
64534093|NCT02327754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534094|NCT02327754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534095|NCT03142620|Vitamin D|vitamin d|mesh-list
64534096|NCT03142620|Cholecalciferol|cholecalciferol|mesh-list
64534097|NCT03142620|Amoxicillin|amoxicillin|mesh-list
64534098|NCT03142620|Clarithromycin|clarithromycin|mesh-list
64653223|NCT01586975|Aspirin|aspirin|mesh-list
64534100|NCT03142620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64534101|NCT03142620|Esomeprazole|esomeprazole|mesh-list
64534102|NCT03142620|Vitamins|vitamins|mesh-ancestor
64534103|NCT03142620|Micronutrients|micronutrients|mesh-ancestor
64534104|NCT03142620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534105|NCT03142620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64534106|NCT03142620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64467741|NCT04779892|Dermatologic Agents|dermatologic agents|mesh-ancestor
64467742|NCT04779892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64467743|NCT04779892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64467744|NCT04389424|Tamoxifen|tamoxifen|mesh-list
64467745|NCT04389424|Anastrozole|anastrozole|mesh-list
64467746|NCT04389424|Exemestane|exemestane|mesh-list
64467761|NCT04771390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467762|NCT04771390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467763|NCT04779502|Chlorhexidine|chlorhexidine|mesh-list
64467764|NCT04779502|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64467765|NCT04779502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64467766|NCT04779502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64467767|NCT04779502|Disinfectants|disinfectants|mesh-ancestor
64467768|NCT04779502|Dermatologic Agents|dermatologic agents|mesh-ancestor
64467769|NCT05411380|Capecitabine|capecitabine|mesh-list
64467770|NCT05411380|Letrozole|letrozole|mesh-list
64467771|NCT05411380|Fulvestrant|fulvestrant|mesh-list
64467772|NCT05411380|Anastrozole|anastrozole|mesh-list
64467773|NCT05411380|Exemestane|exemestane|mesh-list
64467774|NCT05411380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64467775|NCT05411380|Antimetabolites|antimetabolites|mesh-ancestor
64467776|NCT05411380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467777|NCT05411380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467778|NCT05411380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64467779|NCT05411380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64467780|NCT05411380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467781|NCT05411380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64467782|NCT05411380|Hormone Antagonists|hormone antagonists|mesh-ancestor
64467783|NCT05411380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64467784|NCT05411380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467785|NCT05411380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64467786|NCT05411380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64467787|NCT04779580|Anesthetics|anesthetics|mesh-list
64467788|NCT04779580|Anesthetics, Local|anesthetics, local|mesh-list
64467789|NCT04779580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64467790|NCT04779580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467791|NCT04779580|Sensory System Agents|sensory system agents|mesh-ancestor
64467792|NCT04779580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64467796|NCT04770688|Osimertinib|osimertinib|mesh-list
64467797|NCT04770688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467798|NCT04770688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64467799|NCT04770688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467800|NCT04770688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534107|NCT03142620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64534108|NCT03142620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64534109|NCT03142620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64534110|NCT03142620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64534111|NCT03142620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64490201|NCT04361422|Isotretinoin|isotretinoin|mesh-list
64534112|NCT03142620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534113|NCT03142620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534114|NCT03142620|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64534115|NCT03142620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64534116|NCT03142620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64534117|NCT03142620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64534118|NCT03110952|alpha-Tocopherol|alpha-tocopherol|mesh-list
64534120|NCT03110952|Immunologic Factors|immunologic factors|mesh-ancestor
64653231|NCT01586975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64534122|NCT03110952|Antioxidants|antioxidants|mesh-ancestor
64534123|NCT03110952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298707|NCT02085967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467801|NCT05390476|Capecitabine|capecitabine|mesh-list
64467802|NCT05390476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64467824|NCT00054028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64467825|NCT00054028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64467826|NCT00054028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64467827|NCT00054028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64467828|NCT00058240|Alvocidib|alvocidib|mesh-list
64467829|NCT00058240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467830|NCT00058240|Growth Inhibitors|growth inhibitors|mesh-ancestor
64467831|NCT00058240|Growth Substances|growth substances|mesh-ancestor
64467832|NCT00058240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467833|NCT00058240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64467834|NCT00058240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467835|NCT00058240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467836|NCT00060346|Prednisone|prednisone|mesh-list
64467837|NCT00060346|Cyclophosphamide|cyclophosphamide|mesh-list
64467838|NCT00060346|Rituximab|rituximab|mesh-list
64467839|NCT00060346|Doxorubicin|doxorubicin|mesh-list
64467840|NCT00060346|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64467841|NCT00060346|Vincristine|vincristine|mesh-list
64467842|NCT00060346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64467843|NCT00060346|Immunologic Factors|immunologic factors|mesh-ancestor
64467844|NCT00060346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467845|NCT00060346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64467846|NCT00060346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64956104|NCT00040040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64956105|NCT00040040|Antidepressive Agents|antidepressive agents|mesh-ancestor
64537076|NCT00297063|Rosiglitazone|rosiglitazone|mesh-list
64956106|NCT00040040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64956107|NCT00040040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64956108|NCT00040040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64956109|NCT00040040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64956110|NCT00040040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956111|NCT00040040|Dopamine Agents|dopamine agents|mesh-ancestor
64956112|NCT00040040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64956131|NCT00068523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534124|NCT03110952|Protective Agents|protective agents|mesh-ancestor
64534125|NCT03110952|Vitamins|vitamins|mesh-ancestor
64534126|NCT03110952|Micronutrients|micronutrients|mesh-ancestor
64534127|NCT03143244|Ketorolac|ketorolac|mesh-list
64534128|NCT03143244|Midazolam|midazolam|mesh-list
64534129|NCT03143244|Dexmedetomidine|dexmedetomidine|mesh-list
64534130|NCT03143244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64537088|NCT01553318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64537089|NCT01572740|Liraglutide|liraglutide|mesh-list
64968638|NCT00189358|Gefitinib|gefitinib|mesh-list
64968692|NCT00189748|Tacrolimus|tacrolimus|mesh-list
64534131|NCT03143244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64534132|NCT03143244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534133|NCT03143244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64534134|NCT03143244|Analgesics|analgesics|mesh-ancestor
64534135|NCT03143244|Sensory System Agents|sensory system agents|mesh-ancestor
64956132|NCT00068523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64956133|NCT00068523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64956134|NCT00068523|Antimetabolites|antimetabolites|mesh-ancestor
64956135|NCT00068523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956136|NCT00068523|Antifungal Agents|antifungal agents|mesh-ancestor
64956137|NCT00068523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64956138|NCT00068523|Dermatologic Agents|dermatologic agents|mesh-ancestor
64956139|NCT00068523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64956140|NCT00068523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64956141|NCT00068523|Antiemetics|antiemetics|mesh-ancestor
64956142|NCT00068523|Autonomic Agents|autonomic agents|mesh-ancestor
64956143|NCT00068523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64956144|NCT00068523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64956145|NCT00068523|Glucocorticoids|glucocorticoids|mesh-ancestor
64956146|NCT00068523|Hormones|hormones|mesh-ancestor
64653239|NCT01586975|Antipyretics|antipyretics|mesh-ancestor
64968796|NCT00190294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64956147|NCT00068523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64956149|NCT00068523|Protective Agents|protective agents|mesh-ancestor
64956150|NCT00040157|Dexelvucitabine|dexelvucitabine|mesh-list
64956151|NCT00040157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64956152|NCT00040157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64956153|NCT00040157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956154|NCT00040157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956155|NCT00040157|Antiviral Agents|antiviral agents|mesh-ancestor
64956156|NCT00040157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64956157|NCT00040157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64956158|NCT00040157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64956159|NCT00206947|Ziprasidone|ziprasidone|mesh-list
64956160|NCT00206947|Donepezil|donepezil|mesh-list
64956161|NCT00206947|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64956162|NCT00206947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956163|NCT00206947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968922|NCT00190840|Pemetrexed|pemetrexed|mesh-list
64956164|NCT00206947|Cholinergic Agents|cholinergic agents|mesh-ancestor
64956165|NCT00206947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64956166|NCT00206947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956167|NCT00206947|Nootropic Agents|nootropic agents|mesh-ancestor
64968982|NCT02922894|Serotonin Agents|serotonin agents|mesh-ancestor
64956168|NCT00206947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64956169|NCT00206947|Serotonin Agents|serotonin agents|mesh-ancestor
64969044|NCT00191503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64956200|NCT00206986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956202|NCT00207064|Antidepressive Agents|antidepressive agents|mesh-ancestor
64956203|NCT00207064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64956204|NCT00207064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64956205|NCT00207064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64956206|NCT00207064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64956207|NCT00207064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956208|NCT00040274|Dexelvucitabine|dexelvucitabine|mesh-list
64956209|NCT00040274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64956210|NCT00040274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64956211|NCT00040274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956248|NCT00207688|Dermatologic Agents|dermatologic agents|mesh-ancestor
64956249|NCT00207688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64534136|NCT03143244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64534137|NCT03143244|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64534138|NCT03143244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64534139|NCT03143244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64534140|NCT03143244|Adrenergic Agents|adrenergic agents|mesh-ancestor
64534141|NCT03143244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64969264|NCT00192712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64534142|NCT03143244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534143|NCT03143244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64534144|NCT03143244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64534145|NCT03143244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64534146|NCT03143244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64534147|NCT03143244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64956250|NCT00207688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64956273|NCT00040469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64956274|NCT00040469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64956275|NCT00207844|Selenium|selenium|mesh-list
64956276|NCT00207844|Selenious Acid|selenious acid|mesh-list
64956277|NCT00207844|Sodium Selenite|sodium selenite|mesh-list
64956278|NCT00207844|Antioxidants|antioxidants|mesh-ancestor
64956279|NCT00207844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956280|NCT00207844|Protective Agents|protective agents|mesh-ancestor
64956281|NCT00207844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956282|NCT00207844|Trace Elements|trace elements|mesh-ancestor
64969471|NCT00060359|Antimitotic Agents|antimitotic agents|mesh-ancestor
64956283|NCT00207844|Micronutrients|micronutrients|mesh-ancestor
64956284|NCT00072930|Zoledronic Acid|zoledronic acid|mesh-list
64956285|NCT00072930|Prednisone|prednisone|mesh-list
64956286|NCT00072930|Docetaxel|docetaxel|mesh-list
64956291|NCT00072930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956292|NCT00072930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64956293|NCT00072930|Glucocorticoids|glucocorticoids|mesh-ancestor
64956295|NCT00072930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64956296|NCT00072930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956297|NCT00072930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64956298|NCT00072930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64956299|NCT00411307|Hydromorphone|hydromorphone|mesh-list
64956300|NCT00411307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64956301|NCT00411307|Narcotics|narcotics|mesh-ancestor
64956306|NCT00411307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64956308|NCT00040508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64956309|NCT00040508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969646|NCT00084240|Amebicides|amebicides|mesh-ancestor
64956310|NCT00040508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64956311|NCT00040508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956312|NCT00040508|Antifungal Agents|antifungal agents|mesh-ancestor
64956313|NCT00040508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64956314|NCT00040508|Immunologic Factors|immunologic factors|mesh-ancestor
64956315|NCT00040508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956316|NCT00424411|Insulin|insulin|mesh-list
64956317|NCT00424411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64956318|NCT00424411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64956319|NCT00424411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956320|NCT00072969|Daclizumab|daclizumab|mesh-list
64956321|NCT00072969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64969812|NCT00060554|PENTA|penta|mesh-list
64534148|NCT03143244|Anesthetics, General|anesthetics, general|mesh-ancestor
64534150|NCT03143244|GABA Modulators|gaba modulators|mesh-ancestor
64534151|NCT03143244|GABA Agents|gaba agents|mesh-ancestor
64534152|NCT03143244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64534153|NCT03143244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64534154|NCT03143244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64534155|NCT03143244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64534156|NCT03143244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534157|NCT03838692|Ponatinib|ponatinib|mesh-list
64534158|NCT03838692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534159|NCT03838692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64534160|NCT03838692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534161|NCT03838692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534162|NCT03774186|Pancrelipase|pancrelipase|mesh-list
64534163|NCT03774186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64534164|NCT03505944|Venetoclax|venetoclax|mesh-list
64534165|NCT03505944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534166|NCT01489189|Ranibizumab|ranibizumab|mesh-list
64534167|NCT01489189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64298749|NCT02091973|Everolimus|everolimus|mesh-list
64956322|NCT00072969|Immunologic Factors|immunologic factors|mesh-ancestor
64956323|NCT00072969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956324|NCT00424606|Docetaxel|docetaxel|mesh-list
64956325|NCT00424606|Epirubicin|epirubicin|mesh-list
64956326|NCT00424606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956327|NCT00424606|Tubulin Modulators|tubulin modulators|mesh-ancestor
64956328|NCT00424606|Antimitotic Agents|antimitotic agents|mesh-ancestor
64969988|NCT00084591|Capecitabine|capecitabine|mesh-list
64956329|NCT00424606|Mitosis Modulators|mitosis modulators|mesh-ancestor
64956330|NCT00424606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956331|NCT00424606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64495008|NCT03467022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956332|NCT00424606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64956334|NCT00424606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956335|NCT00208039|Calfactant|calfactant|mesh-list
64956336|NCT00208039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
64956337|NCT00208039|Respiratory System Agents|respiratory system agents|mesh-ancestor
64956338|NCT02962921|Insulin|insulin|mesh-list
64956339|NCT02962921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64956340|NCT02962921|Insulin Lispro|insulin lispro|mesh-list
64956341|NCT02962921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64956342|NCT02962921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956343|NCT00040586|Interleukin-2|interleukin-2|mesh-list
64956344|NCT00040586|Antibodies|antibodies|mesh-list
64956345|NCT00040586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64956346|NCT00040586|Immunologic Factors|immunologic factors|mesh-ancestor
64956347|NCT00040586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956348|NCT00040586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956349|NCT00040586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64956350|NCT00040586|Analgesics|analgesics|mesh-ancestor
64956351|NCT00040586|Sensory System Agents|sensory system agents|mesh-ancestor
64956352|NCT00040586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64956353|NCT00208117|Sertraline|sertraline|mesh-list
64956354|NCT00208117|Simvastatin|simvastatin|mesh-list
64956355|NCT00208117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64956356|NCT00208117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64956357|NCT00208117|Antimetabolites|antimetabolites|mesh-ancestor
64534168|NCT01489189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64537695|NCT01572038|Paclitaxel|paclitaxel|mesh-list
64534169|NCT01489189|Growth Substances|growth substances|mesh-ancestor
64534170|NCT01489189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534171|NCT01489189|Growth Inhibitors|growth inhibitors|mesh-ancestor
64534172|NCT01489189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534173|NCT01549873|Propofol|propofol|mesh-list
64534174|NCT01549873|Desflurane|desflurane|mesh-list
64970448|NCT00061178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64956358|NCT00208117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956359|NCT00208117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64956360|NCT00208117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64956361|NCT00208117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956362|NCT00208117|Antidepressive Agents|antidepressive agents|mesh-ancestor
64956363|NCT00208117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64956364|NCT00208117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64956386|NCT00040625|Pemetrexed|pemetrexed|mesh-list
64956387|NCT00040625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956388|NCT00040625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956389|NCT00040625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956390|NCT00040625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64956391|NCT00040625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64956392|NCT00208195|Valproic Acid|valproic acid|mesh-list
64956393|NCT00208195|Anticonvulsants|anticonvulsants|mesh-ancestor
64956394|NCT00208195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956395|NCT00208195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956396|NCT00208195|GABA Agents|gaba agents|mesh-ancestor
64956397|NCT00208195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64956398|NCT00208195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956399|NCT00208195|Antimanic Agents|antimanic agents|mesh-ancestor
64956400|NCT00208195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64956401|NCT00208195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64956402|NCT00208195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64956403|NCT00208234|Omalizumab|omalizumab|mesh-list
64956404|NCT00208234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64956405|NCT00208234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64495082|NCT03466242|Ketamine|ketamine|mesh-list
64956406|NCT00208234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64956407|NCT00208234|Respiratory System Agents|respiratory system agents|mesh-ancestor
64956408|NCT00208234|Immunologic Factors|immunologic factors|mesh-ancestor
64956409|NCT00208234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956410|NCT00208273|Letrozole|letrozole|mesh-list
64378564|NCT04485689|Capsaicin|capsaicin|mesh-list
64509578|NCT02918721|Anesthetics|anesthetics|mesh-ancestor
64956411|NCT00208273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956412|NCT00208273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64956413|NCT00208273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64956414|NCT00208273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956440|NCT00068952|Carmustine|carmustine|mesh-list
64956441|NCT00068952|Lomustine|lomustine|mesh-list
64956442|NCT00068952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64956443|NCT00068952|Alkylating Agents|alkylating agents|mesh-ancestor
64956444|NCT00068952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956445|NCT00068952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956446|NCT00040820|Oxaliplatin|oxaliplatin|mesh-list
64956447|NCT00040820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956448|NCT00208546|Bevacizumab|bevacizumab|mesh-list
64956449|NCT00208546|Cetuximab|cetuximab|mesh-list
64956450|NCT00208546|Capecitabine|capecitabine|mesh-list
64956451|NCT00208546|Oxaliplatin|oxaliplatin|mesh-list
64956452|NCT00208546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64956453|NCT00208546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956454|NCT00208546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64956455|NCT00208546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64956456|NCT00208546|Growth Substances|growth substances|mesh-ancestor
64956457|NCT00208546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956458|NCT00208546|Growth Inhibitors|growth inhibitors|mesh-ancestor
64956459|NCT00208546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64956460|NCT00208546|Antimetabolites|antimetabolites|mesh-ancestor
64956461|NCT00208546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956462|NCT00208585|Sertraline|sertraline|mesh-list
64956485|NCT00208702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64534175|NCT01549873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64534176|NCT01549873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64534177|NCT01549873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534178|NCT01549873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64534179|NCT01549873|Anesthetics, General|anesthetics, general|mesh-ancestor
64534180|NCT01549873|Anesthetics|anesthetics|mesh-ancestor
64534181|NCT01549873|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64971288|NCT00224809|Diuretics|diuretics|mesh-ancestor
64534182|NCT04106401|Carbon Monoxide|carbon monoxide|mesh-list
64534183|NCT04106401|Antimetabolites|antimetabolites|mesh-ancestor
64534184|NCT04106401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534185|NCT04106401|Gasotransmitters|gasotransmitters|mesh-ancestor
64714133|NCT00373789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64534186|NCT04106401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64534187|NCT04106401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534188|NCT01488487|Everolimus|everolimus|mesh-list
64534189|NCT01488487|Pasireotide|pasireotide|mesh-list
64534190|NCT01488487|Somatostatin|somatostatin|mesh-list
64534191|NCT01488487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534192|NCT01488487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64534193|NCT01488487|Immunologic Factors|immunologic factors|mesh-ancestor
64534194|NCT01488487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534195|NCT01488487|Hormones|hormones|mesh-ancestor
64534196|NCT01488487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64534197|NCT03027115|Tamsulosin|tamsulosin|mesh-list
64298772|NCT03557437|Metronidazole|metronidazole|mesh-list
64956486|NCT00208702|Serotonin Agents|serotonin agents|mesh-ancestor
64956487|NCT00208702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956488|NCT00208741|Tiagabine|tiagabine|mesh-list
64956489|NCT00208741|Anticonvulsants|anticonvulsants|mesh-ancestor
64956490|NCT00208741|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
64956491|NCT00208741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64956492|NCT00208741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64956493|NCT00208741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971664|NCT00062660|Tipranavir|tipranavir|mesh-list
64956494|NCT00208741|GABA Agents|gaba agents|mesh-ancestor
64956495|NCT00208741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64956496|NCT00208741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956497|NCT00399048|Hydromorphone|hydromorphone|mesh-list
64956498|NCT00399048|Oxycodone|oxycodone|mesh-list
64956499|NCT00399048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64956500|NCT00399048|Narcotics|narcotics|mesh-ancestor
64956501|NCT00399048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64956502|NCT00399048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956503|NCT00399048|Analgesics|analgesics|mesh-ancestor
64956504|NCT00399048|Sensory System Agents|sensory system agents|mesh-ancestor
64956505|NCT00399048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64956506|NCT00208819|Valproic Acid|valproic acid|mesh-list
64956507|NCT00208819|Olanzapine|olanzapine|mesh-list
64956508|NCT00208819|Risperidone|risperidone|mesh-list
64956509|NCT00208819|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64956510|NCT00208819|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64971782|NCT00227110|Pioglitazone|pioglitazone|mesh-list
64956511|NCT00208819|Serotonin Agents|serotonin agents|mesh-ancestor
64534198|NCT03027115|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64534199|NCT03027115|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64534200|NCT03027115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64298789|NCT03557437|Expectorants|expectorants|mesh-ancestor
64956512|NCT00208819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64956515|NCT00208819|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64510633|NCT05825781|Pertuzumab|pertuzumab|mesh-list
64956516|NCT00208819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64956517|NCT00208819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64956518|NCT00208819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64956519|NCT00208819|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64956520|NCT00208819|Dopamine Agents|dopamine agents|mesh-ancestor
64956521|NCT00208819|Antiemetics|antiemetics|mesh-ancestor
64956522|NCT00208819|Autonomic Agents|autonomic agents|mesh-ancestor
64956523|NCT00208819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64956524|NCT00208819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64956525|NCT00208819|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64956526|NCT00208819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64956527|NCT00208819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64956528|NCT00208819|Antidepressive Agents|antidepressive agents|mesh-ancestor
64956529|NCT00208819|Anticonvulsants|anticonvulsants|mesh-ancestor
64956530|NCT00208819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956531|NCT00208819|GABA Agents|gaba agents|mesh-ancestor
64956532|NCT00208819|Antimanic Agents|antimanic agents|mesh-ancestor
64956534|NCT00208858|Anticonvulsants|anticonvulsants|mesh-ancestor
64956535|NCT00208858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64956536|NCT00208858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956537|NCT00041015|Etoposide|etoposide|mesh-list
64956538|NCT00041015|Topotecan|topotecan|mesh-list
64538044|NCT04514211|Propofol|propofol|mesh-list
64956539|NCT00041015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956540|NCT00041015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64956541|NCT00041015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64956542|NCT00041015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64956543|NCT00041015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956544|NCT00041015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956545|NCT00041015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64956546|NCT00073047|Daclizumab|daclizumab|mesh-list
64956547|NCT00073047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64956548|NCT00073047|Immunologic Factors|immunologic factors|mesh-ancestor
64956549|NCT00073047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495157|NCT03460860|Protective Agents|protective agents|mesh-ancestor
64495158|NCT03460860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495160|NCT03460860|Micronutrients|micronutrients|mesh-ancestor
64495161|NCT03460860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64495162|NCT03460860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64495163|NCT03460860|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64956551|NCT00208897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64956552|NCT00208897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64538074|NCT00574587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64956553|NCT00208897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64956554|NCT00208897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956555|NCT00208897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64956556|NCT00208897|Serotonin Agents|serotonin agents|mesh-ancestor
64956557|NCT00208897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956558|NCT00208897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64956559|NCT00208897|Antidepressive Agents|antidepressive agents|mesh-ancestor
64956560|NCT00208897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64956561|NCT00208897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64956562|NCT00208897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64956563|NCT00208897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956564|NCT00208936|Fluorouracil|fluorouracil|mesh-list
64956565|NCT00208936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956566|NCT00208936|Antimetabolites|antimetabolites|mesh-ancestor
64956567|NCT00208936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956568|NCT00208936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64956569|NCT00208936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64972216|NCT02967341|Ciprofloxacin|ciprofloxacin|mesh-list
64956570|NCT00208936|Immunologic Factors|immunologic factors|mesh-ancestor
64956571|NCT00208936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956572|NCT00209014|Thalidomide|thalidomide|mesh-list
64956573|NCT00209014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64956574|NCT00209014|Immunologic Factors|immunologic factors|mesh-ancestor
64534201|NCT03027115|Adrenergic Agents|adrenergic agents|mesh-ancestor
64534202|NCT03027115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64534203|NCT03027115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534204|NCT03027115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534205|NCT03027115|Urological Agents|urological agents|mesh-ancestor
64534206|NCT03026881|Paclitaxel|paclitaxel|mesh-list
64534207|NCT03026881|Apatinib|apatinib|mesh-list
64534208|NCT03026881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64534209|NCT03026881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534210|NCT03026881|Tubulin Modulators|tubulin modulators|mesh-ancestor
64534211|NCT03026881|Antimitotic Agents|antimitotic agents|mesh-ancestor
64534212|NCT03026881|Mitosis Modulators|mitosis modulators|mesh-ancestor
64534213|NCT03026881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956575|NCT00209014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538183|NCT00579111|Fludarabine|fludarabine|mesh-list
64956576|NCT00209014|Leprostatic Agents|leprostatic agents|mesh-ancestor
64956577|NCT00209014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64956578|NCT00209014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64956612|NCT00209209|Vincristine|vincristine|mesh-list
64956613|NCT00209209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64956614|NCT00209209|Immunologic Factors|immunologic factors|mesh-ancestor
64956615|NCT00209209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956616|NCT00209209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64956617|NCT00209209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64956618|NCT00209209|Alkylating Agents|alkylating agents|mesh-ancestor
64956619|NCT00209209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956620|NCT00209209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495234|NCT01101880|Cytarabine|cytarabine|mesh-list
64495235|NCT01101880|Clofarabine|clofarabine|mesh-list
64956641|NCT00041093|Antimitotic Agents|antimitotic agents|mesh-ancestor
64956642|NCT00041093|Mitosis Modulators|mitosis modulators|mesh-ancestor
64956643|NCT00041093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956645|NCT00399087|Docetaxel|docetaxel|mesh-list
64956646|NCT00399087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956647|NCT00399087|Tubulin Modulators|tubulin modulators|mesh-ancestor
64956648|NCT00399087|Antimitotic Agents|antimitotic agents|mesh-ancestor
64956649|NCT00399087|Mitosis Modulators|mitosis modulators|mesh-ancestor
64956650|NCT00399087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972471|NCT00230815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972472|NCT00230815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64956651|NCT00399087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64956652|NCT00399087|Glucocorticoids|glucocorticoids|mesh-ancestor
64956653|NCT00399087|Hormones|hormones|mesh-ancestor
64956654|NCT00399087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64956655|NCT00399087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956656|NCT00399087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64956657|NCT00209482|Metformin|metformin|mesh-list
64956658|NCT00209482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64956659|NCT00209482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956660|NCT00041171|Docetaxel|docetaxel|mesh-list
64956661|NCT00041171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956662|NCT00041171|Tubulin Modulators|tubulin modulators|mesh-ancestor
64956663|NCT00041171|Antimitotic Agents|antimitotic agents|mesh-ancestor
64956664|NCT00041171|Mitosis Modulators|mitosis modulators|mesh-ancestor
64956665|NCT00041171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956666|NCT00209521|Propofol|propofol|mesh-list
64956667|NCT00209521|Fospropofol|fospropofol|mesh-list
64956668|NCT00209521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64956669|NCT00209521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64956670|NCT00209521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956671|NCT00209521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64956672|NCT00209521|Anesthetics, General|anesthetics, general|mesh-ancestor
64956673|NCT00209521|Anesthetics|anesthetics|mesh-ancestor
64956677|NCT00209599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534214|NCT03026881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64534216|NCT01516879|Atorvastatin|atorvastatin|mesh-list
64534217|NCT01516879|Ezetimibe|ezetimibe|mesh-list
64534218|NCT01516879|Evolocumab|evolocumab|mesh-list
64534219|NCT01516879|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64534220|NCT01516879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64534221|NCT01516879|Antimetabolites|antimetabolites|mesh-ancestor
64534222|NCT01516879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534223|NCT01516879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64534224|NCT01516879|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64534225|NCT01516879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534226|NCT01515865|Midodrine|midodrine|mesh-list
64534227|NCT01515865|Sympathomimetics|sympathomimetics|mesh-ancestor
64534228|NCT01515865|Autonomic Agents|autonomic agents|mesh-ancestor
64534229|NCT01515865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64534230|NCT01515865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534231|NCT01515865|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64534232|NCT01515865|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64538323|NCT01534208|Enclomiphene|enclomiphene|mesh-list
64534233|NCT01515865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64534234|NCT01515865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64534235|NCT01515865|Adrenergic Agents|adrenergic agents|mesh-ancestor
64534236|NCT01515865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64534237|NCT01515865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534238|NCT01547299|Leuprolide|leuprolide|mesh-list
64534239|NCT01547299|Dutasteride|dutasteride|mesh-list
64534240|NCT01547299|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64534241|NCT01547299|Fertility Agents|fertility agents|mesh-ancestor
64298810|NCT02086903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64972970|NCT00233623|Vitamins|vitamins|mesh-ancestor
64972973|NCT00233662|Alefacept|alefacept|mesh-list
64956678|NCT00209638|Irinotecan|irinotecan|mesh-list
64956679|NCT00209638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64956680|NCT00209638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64956681|NCT00209638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956682|NCT00209638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956683|NCT00209638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956684|NCT00399126|Paclitaxel|paclitaxel|mesh-list
64956685|NCT00399126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64956686|NCT00399126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956687|NCT00399126|Tubulin Modulators|tubulin modulators|mesh-ancestor
64956688|NCT00399126|Antimitotic Agents|antimitotic agents|mesh-ancestor
64956689|NCT00399126|Mitosis Modulators|mitosis modulators|mesh-ancestor
64956690|NCT00399126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956691|NCT00209677|Gemcitabine|gemcitabine|mesh-list
64956692|NCT00209677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64956693|NCT00209677|Antimetabolites|antimetabolites|mesh-ancestor
64973071|NCT00076284|Aplaviroc|aplaviroc|mesh-list
64956694|NCT00209677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534242|NCT01547299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64534243|NCT01547299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534244|NCT01547299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64534245|NCT01547299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534246|NCT01547299|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64534247|NCT01547299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64298836|NCT02092363|Paclitaxel|paclitaxel|mesh-list
64956695|NCT00209677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956696|NCT00209677|Antiviral Agents|antiviral agents|mesh-ancestor
64956697|NCT00209677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64956698|NCT00209677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956699|NCT00209677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64956700|NCT00209677|Immunologic Factors|immunologic factors|mesh-ancestor
64956701|NCT00209677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956702|NCT00209716|Cisplatin|cisplatin|mesh-list
64956704|NCT00209716|Fluorouracil|fluorouracil|mesh-list
64956705|NCT00209716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956706|NCT00209716|Tubulin Modulators|tubulin modulators|mesh-ancestor
64956707|NCT00209716|Antimitotic Agents|antimitotic agents|mesh-ancestor
64956708|NCT00209716|Mitosis Modulators|mitosis modulators|mesh-ancestor
64956709|NCT00209716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956710|NCT00209716|Antimetabolites|antimetabolites|mesh-ancestor
64956711|NCT00209716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64956712|NCT00209716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64956713|NCT00209716|Immunologic Factors|immunologic factors|mesh-ancestor
64956714|NCT00209716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956715|NCT00209755|Ribavirin|ribavirin|mesh-list
64538500|NCT01532414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538506|NCT01441973|Elotuzumab|elotuzumab|mesh-list
64956716|NCT00209755|Antimetabolites|antimetabolites|mesh-ancestor
64956717|NCT00209755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956718|NCT00209755|Antiviral Agents|antiviral agents|mesh-ancestor
64956719|NCT00209755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64956720|NCT00209794|Pyrimethamine|pyrimethamine|mesh-list
64956721|NCT00209794|Sulfadoxine|sulfadoxine|mesh-list
64956722|NCT00209794|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64956723|NCT00209794|Antimalarials|antimalarials|mesh-ancestor
64956724|NCT00209794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64956725|NCT00209794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64956726|NCT00209794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64956727|NCT00209794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64956728|NCT00209794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956729|NCT00209794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956730|NCT00209794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64956731|NCT00209794|Renal Agents|renal agents|mesh-ancestor
64956732|NCT00209833|Cytarabine|cytarabine|mesh-list
64956733|NCT00209833|Fludarabine|fludarabine|mesh-list
64956734|NCT00209833|Etoposide|etoposide|mesh-list
64956735|NCT00209833|Idarubicin|idarubicin|mesh-list
64956736|NCT00209833|Daunorubicin|daunorubicin|mesh-list
64973436|NCT00236782|Estradiol|estradiol|mesh-list
64956737|NCT00209833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956738|NCT00209833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64956739|NCT00209833|Antimetabolites|antimetabolites|mesh-ancestor
64956740|NCT00209833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956741|NCT00209833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64956742|NCT00209833|Immunologic Factors|immunologic factors|mesh-ancestor
64956743|NCT00209833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956744|NCT00209833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64538621|NCT01440803|Teriparatide|teriparatide|mesh-list
64956745|NCT00209833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64956746|NCT00209833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64495393|NCT01199146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495394|NCT01199146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64495395|NCT01199146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64495396|NCT01199146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495397|NCT01199146|Hormone Antagonists|hormone antagonists|mesh-ancestor
64495398|NCT01199146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64495399|NCT01199146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956752|NCT00041210|Doxorubicin|doxorubicin|mesh-list
64956753|NCT00041210|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64534248|NCT01547299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534249|NCT01547299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534250|NCT01547299|Hormone Antagonists|hormone antagonists|mesh-ancestor
64534251|NCT01547299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64534252|NCT04072107|Capecitabine|capecitabine|mesh-list
64534253|NCT04072107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64534254|NCT04072107|Antimetabolites|antimetabolites|mesh-ancestor
64538762|NCT00669279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534255|NCT04072107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534256|NCT04072107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534257|NCT00411411|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64534258|NCT00411411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64534259|NCT00411411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534260|NCT00411411|Incretins|incretins|mesh-ancestor
64534261|NCT00411411|Hormones|hormones|mesh-ancestor
64534262|NCT00411411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64534263|NCT00411411|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64534264|NCT00411411|Protease Inhibitors|protease inhibitors|mesh-ancestor
64534265|NCT00411411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534266|NCT00411411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534267|NCT01794273|Phenylephrine|phenylephrine|mesh-list
64534268|NCT01794273|Oxymetazoline|oxymetazoline|mesh-list
64534269|NCT01794273|Ephedrine|ephedrine|mesh-list
64534270|NCT01794273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64956754|NCT00041210|Bleomycin|bleomycin|mesh-list
64956755|NCT00041210|Etoposide|etoposide|mesh-list
64956756|NCT00041210|Vincristine|vincristine|mesh-list
64956757|NCT00041210|Dacarbazine|dacarbazine|mesh-list
64495006|NCT03467022|Vitamins|vitamins|mesh-ancestor
64956758|NCT00041210|Vinblastine|vinblastine|mesh-list
64956759|NCT00041210|Mechlorethamine|mechlorethamine|mesh-list
64956760|NCT00041210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64956761|NCT00041210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956762|NCT00041210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64956763|NCT00041210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64956764|NCT00041210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956765|NCT00041210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956766|NCT00041210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64956767|NCT00041210|Glucocorticoids|glucocorticoids|mesh-ancestor
64956768|NCT00041210|Hormones|hormones|mesh-ancestor
64956769|NCT00041210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64956770|NCT00041210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956771|NCT00041210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64956772|NCT00041210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64956773|NCT00041210|Tubulin Modulators|tubulin modulators|mesh-ancestor
64956774|NCT00041210|Antimitotic Agents|antimitotic agents|mesh-ancestor
64956775|NCT00041210|Mitosis Modulators|mitosis modulators|mesh-ancestor
64956776|NCT00041210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64956777|NCT00041210|Alkylating Agents|alkylating agents|mesh-ancestor
64538948|NCT01439945|Antacids|antacids|mesh-ancestor
64538949|NCT01439945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956778|NCT00209872|Lidocaine|lidocaine|mesh-list
64956779|NCT00209872|Ketamine|ketamine|mesh-list
64956780|NCT00209872|Gabapentin|gabapentin|mesh-list
64956781|NCT00209872|Esketamine|esketamine|mesh-list
64534271|NCT01794273|Mydriatics|mydriatics|mesh-ancestor
64534272|NCT01794273|Autonomic Agents|autonomic agents|mesh-ancestor
64534273|NCT01794273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64534274|NCT01794273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534275|NCT01794273|Sympathomimetics|sympathomimetics|mesh-ancestor
64512747|NCT04019964|Nivolumab|nivolumab|mesh-list
64534276|NCT01794273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64534277|NCT01794273|Nasal Decongestants|nasal decongestants|mesh-ancestor
64534278|NCT01794273|Respiratory System Agents|respiratory system agents|mesh-ancestor
64534279|NCT01794273|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64534280|NCT01794273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64534281|NCT01794273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64534282|NCT01794273|Adrenergic Agents|adrenergic agents|mesh-ancestor
64534283|NCT01794273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64534284|NCT01794273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653318|NCT01591733|Capecitabine|capecitabine|mesh-list
64534285|NCT01794273|Protective Agents|protective agents|mesh-ancestor
64538998|NCT01439555|Simvastatin|simvastatin|mesh-list
64534286|NCT01794273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64956782|NCT00209872|Anesthetics, Local|anesthetics, local|mesh-ancestor
64956783|NCT00209872|Anesthetics|anesthetics|mesh-ancestor
64956784|NCT00209872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64956785|NCT00209872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956885|NCT00073164|GABA Agents|gaba agents|mesh-ancestor
64956886|NCT00073164|Antimanic Agents|antimanic agents|mesh-ancestor
64956887|NCT00210301|Modafinil|modafinil|mesh-list
64956888|NCT00210301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64539051|NCT00639717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956889|NCT00210301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956890|NCT00210301|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64956891|NCT00210301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64956892|NCT00210301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64539125|NCT01419535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64956893|NCT00210301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956894|NCT00210340|Rituximab|rituximab|mesh-list
64956895|NCT00210340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64956896|NCT00210340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956897|NCT00210340|Immunologic Factors|immunologic factors|mesh-ancestor
64956898|NCT00210340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956899|NCT00210340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64956900|NCT00411541|Dexamethasone|dexamethasone|mesh-list
64956901|NCT00411541|Vincristine|vincristine|mesh-list
64956902|NCT00411541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64956903|NCT00411541|Antiemetics|antiemetics|mesh-ancestor
64956960|NCT00041327|Glucocorticoids|glucocorticoids|mesh-ancestor
64956961|NCT00041327|Hormones|hormones|mesh-ancestor
64956962|NCT00041327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64512908|NCT03889756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64956963|NCT00041327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64956964|NCT00041327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64974012|NCT00076674|Levodopa|levodopa|mesh-list
64956965|NCT00041327|Antiviral Agents|antiviral agents|mesh-ancestor
64956966|NCT00041327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64956967|NCT00041327|Tubulin Modulators|tubulin modulators|mesh-ancestor
64956968|NCT00041327|Antimitotic Agents|antimitotic agents|mesh-ancestor
64956969|NCT00041327|Mitosis Modulators|mitosis modulators|mesh-ancestor
64974107|NCT00240058|Antioxidants|antioxidants|mesh-ancestor
64956970|NCT00041327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64956971|NCT00041327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64956972|NCT00041327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64956973|NCT00041327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64956974|NCT00041327|Antimetabolites|antimetabolites|mesh-ancestor
64956975|NCT00210457|Lanreotide|lanreotide|mesh-list
64956976|NCT00210457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956977|NCT00210496|Topiramate|topiramate|mesh-list
64974196|NCT00240760|Dopamine Agents|dopamine agents|mesh-ancestor
64956978|NCT00210496|Almotriptan|almotriptan|mesh-list
64534287|NCT02109939|Psychotropic Drugs|psychotropic drugs|mesh-list
64534288|NCT01795599|Mifepristone|mifepristone|mesh-list
64534289|NCT01795599|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64534290|NCT01795599|Abortifacient Agents|abortifacient agents|mesh-ancestor
64534291|NCT01795599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64534292|NCT01795599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534293|NCT01795599|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64298881|NCT02093299|Clopidogrel|clopidogrel|mesh-list
64956979|NCT00210496|Anticonvulsants|anticonvulsants|mesh-ancestor
64956980|NCT00210496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64495681|NCT04963530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64956981|NCT00210496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956982|NCT00210496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64956983|NCT00210496|Serotonin Agents|serotonin agents|mesh-ancestor
64539636|NCT01414855|Immunologic Factors|immunologic factors|mesh-ancestor
64956984|NCT00210496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64956985|NCT00210496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956986|NCT00210535|Topiramate|topiramate|mesh-list
64513362|NCT02511028|Hematinics|hematinics|mesh-ancestor
64956987|NCT00210535|Anticonvulsants|anticonvulsants|mesh-ancestor
64956988|NCT00210535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64956989|NCT00210535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956990|NCT00210574|Topiramate|topiramate|mesh-list
64957018|NCT00210769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957019|NCT00210769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64957020|NCT00210769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64653341|NCT03005405|Adrenergic Agents|adrenergic agents|mesh-ancestor
64957023|NCT00210808|Anticonvulsants|anticonvulsants|mesh-ancestor
64957024|NCT00210808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64957025|NCT00210808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957026|NCT00210847|Acetaminophen|acetaminophen|mesh-list
64957027|NCT00210847|Tramadol|tramadol|mesh-list
64957028|NCT00210847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64957029|NCT00210847|Analgesics|analgesics|mesh-ancestor
64974407|NCT00066482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64974408|NCT00066482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64974409|NCT00066482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957030|NCT00210847|Sensory System Agents|sensory system agents|mesh-ancestor
64957031|NCT00210847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957032|NCT00210847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957033|NCT00210847|Antipyretics|antipyretics|mesh-ancestor
64957034|NCT00210847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64957035|NCT00210847|Narcotics|narcotics|mesh-ancestor
64957036|NCT00210847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64957037|NCT00210886|Levofloxacin|levofloxacin|mesh-list
64957038|NCT00210886|Ofloxacin|ofloxacin|mesh-list
64957061|NCT00211276|Denileukin diftitox|denileukin diftitox|mesh-list
64957062|NCT00211276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957063|NCT00211315|Anecortave|anecortave|mesh-list
64957064|NCT00211315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64957065|NCT00211315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64974501|NCT00066716|Sensory System Agents|sensory system agents|mesh-ancestor
64974502|NCT00066716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64974503|NCT00066716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974504|NCT00066716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64957066|NCT00211315|Growth Substances|growth substances|mesh-ancestor
64957067|NCT00211315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957068|NCT00211315|Growth Inhibitors|growth inhibitors|mesh-ancestor
64957069|NCT00211315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957070|NCT00211354|Anecortave|anecortave|mesh-list
64957071|NCT00211354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64957072|NCT00211354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64957073|NCT00211354|Growth Substances|growth substances|mesh-ancestor
64974567|NCT00066872|Imiquimod|imiquimod|mesh-list
64974568|NCT00066872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64974569|NCT00066872|Immunologic Factors|immunologic factors|mesh-ancestor
64974570|NCT00066872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957074|NCT00211354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957075|NCT00211354|Growth Inhibitors|growth inhibitors|mesh-ancestor
64957076|NCT00211354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957077|NCT00211393|Ketoconazole|ketoconazole|mesh-list
64957078|NCT00211393|Antifungal Agents|antifungal agents|mesh-ancestor
64957079|NCT00211393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64957080|NCT00211393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64957081|NCT00211393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64957082|NCT00211393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957083|NCT00211393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957084|NCT00211393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64957085|NCT00211393|Hormone Antagonists|hormone antagonists|mesh-ancestor
64957086|NCT00211393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64534294|NCT01795599|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64534295|NCT01795599|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64534296|NCT01795599|Contraceptive Agents|contraceptive agents|mesh-ancestor
64534297|NCT01795599|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64957087|NCT00211393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957088|NCT00211393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64957089|NCT00211432|Anecortave|anecortave|mesh-list
64957090|NCT00211432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64957091|NCT00211432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64957092|NCT00211432|Growth Substances|growth substances|mesh-ancestor
64957123|NCT00211744|Anticonvulsants|anticonvulsants|mesh-ancestor
64957124|NCT00211744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64957125|NCT00211744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957126|NCT00211939|Atorvastatin|atorvastatin|mesh-list
64957127|NCT00211939|Calcium|calcium|mesh-list
64957128|NCT00211939|Sevelamer|sevelamer|mesh-list
64957129|NCT00211939|Calcium acetate|calcium acetate|mesh-list
64495757|NCT02521662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64957130|NCT00211939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64957131|NCT00211939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957132|NCT00211939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64957133|NCT00211939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64957134|NCT00211939|Antimetabolites|antimetabolites|mesh-ancestor
64957135|NCT00211939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957153|NCT00212017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957154|NCT00212095|Ketoconazole|ketoconazole|mesh-list
64957155|NCT00212095|Docetaxel|docetaxel|mesh-list
64957156|NCT00212095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957157|NCT00212095|Tubulin Modulators|tubulin modulators|mesh-ancestor
64957158|NCT00212095|Antimitotic Agents|antimitotic agents|mesh-ancestor
64957159|NCT00212095|Mitosis Modulators|mitosis modulators|mesh-ancestor
64957160|NCT00212095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957161|NCT00212095|Antifungal Agents|antifungal agents|mesh-ancestor
64957162|NCT00212095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64957163|NCT00212095|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64957164|NCT00212095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64957165|NCT00212095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957166|NCT00212095|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64957167|NCT00212095|Hormone Antagonists|hormone antagonists|mesh-ancestor
64957168|NCT00212095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64957169|NCT00212095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957170|NCT00212095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64957171|NCT00212173|Sibutramine|sibutramine|mesh-list
64957172|NCT00212173|Antidepressive Agents|antidepressive agents|mesh-ancestor
64957173|NCT00212173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64957174|NCT00212173|Appetite Depressants|appetite depressants|mesh-ancestor
64957175|NCT00212173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64957176|NCT00212212|Selenium|selenium|mesh-list
64957177|NCT00212212|Antioxidants|antioxidants|mesh-ancestor
64957178|NCT00212212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957179|NCT00212212|Protective Agents|protective agents|mesh-ancestor
64957180|NCT00212212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957181|NCT00212212|Trace Elements|trace elements|mesh-ancestor
64957182|NCT00212212|Micronutrients|micronutrients|mesh-ancestor
64957183|NCT00212290|Pioglitazone|pioglitazone|mesh-list
64957184|NCT00212290|Nateglinide|nateglinide|mesh-list
64957185|NCT00212290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64957186|NCT00212290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957187|NCT00073203|Paroxetine|paroxetine|mesh-list
64957188|NCT00073203|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64957189|NCT00073203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64957195|NCT00073203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64957196|NCT00073203|Antidepressive Agents|antidepressive agents|mesh-ancestor
64957197|NCT00073203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64957198|NCT00073203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64957199|NCT00073203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64957200|NCT00073203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957201|NCT00411736|Azithromycin|azithromycin|mesh-list
64957202|NCT00411736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64534298|NCT01795599|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64534299|NCT01795599|Hormone Antagonists|hormone antagonists|mesh-ancestor
64534300|NCT01795599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64534301|NCT01795599|Luteolytic Agents|luteolytic agents|mesh-ancestor
64534302|NCT01795599|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64974862|NCT00245206|Antiemetics|antiemetics|mesh-ancestor
64974863|NCT00245206|Autonomic Agents|autonomic agents|mesh-ancestor
64534303|NCT01795599|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64534304|NCT01794351|Resveratrol|resveratrol|mesh-list
64534305|NCT01794351|Antioxidants|antioxidants|mesh-ancestor
64534306|NCT01794351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534307|NCT01794351|Protective Agents|protective agents|mesh-ancestor
64534308|NCT01794351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534309|NCT01794351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534310|NCT01794351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64534311|NCT04409431|Epinephrine|epinephrine|mesh-list
64534312|NCT04409431|Racepinephrine|racepinephrine|mesh-list
64534313|NCT04409431|Epinephryl borate|epinephryl borate|mesh-list
64298893|NCT00454753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957203|NCT00411736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64495837|NCT01212484|Carbidopa|carbidopa|mesh-list
64957204|NCT00212602|Aprepitant|aprepitant|mesh-list
64957205|NCT00212602|Fosaprepitant|fosaprepitant|mesh-list
64957206|NCT00212602|Antiemetics|antiemetics|mesh-ancestor
64957207|NCT00212602|Autonomic Agents|autonomic agents|mesh-ancestor
64957208|NCT00212602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957209|NCT00212602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957210|NCT00212602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64957211|NCT00212602|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64957212|NCT00212602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957213|NCT00212602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957214|NCT00212680|Landiolol|landiolol|mesh-list
64957215|NCT00212680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64957216|NCT00212680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64957217|NCT00212680|Adrenergic Agents|adrenergic agents|mesh-ancestor
64957218|NCT00212680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64974923|NCT00245596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957219|NCT00212680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957220|NCT00212680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957221|NCT00212680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64957222|NCT00212875|Epoetin Alfa|epoetin alfa|mesh-list
64957223|NCT00212875|Hematinics|hematinics|mesh-ancestor
64957224|NCT00213070|Miglitol|miglitol|mesh-list
64957225|NCT00213070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957226|NCT00213070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957227|NCT00213070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64957228|NCT00213070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957229|NCT00213070|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64957230|NCT00213109|Miglitol|miglitol|mesh-list
64957231|NCT00213109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957232|NCT00213109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974973|NCT00245791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64974974|NCT00400647|Mycophenolic Acid|mycophenolic acid|mesh-list
64974983|NCT00245908|Azithromycin|azithromycin|mesh-list
64957233|NCT00213109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64957234|NCT00213109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957235|NCT00213109|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64957236|NCT00213226|Dexamethasone|dexamethasone|mesh-list
64957237|NCT00213226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64957238|NCT00213226|Antiemetics|antiemetics|mesh-ancestor
64957239|NCT00213226|Autonomic Agents|autonomic agents|mesh-ancestor
64957240|NCT00213226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957241|NCT00213226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534314|NCT04409431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64534315|NCT04409431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64534316|NCT04409431|Adrenergic Agents|adrenergic agents|mesh-ancestor
64534317|NCT04409431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64534318|NCT04409431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534319|NCT04409431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534320|NCT04409431|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64534321|NCT04409431|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64534322|NCT04409431|Autonomic Agents|autonomic agents|mesh-ancestor
64534323|NCT04409431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64534324|NCT04409431|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64539821|NCT01435577|Analgesics|analgesics|mesh-ancestor
64957242|NCT00213226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64957243|NCT00213226|Glucocorticoids|glucocorticoids|mesh-ancestor
64957244|NCT00213226|Hormones|hormones|mesh-ancestor
64957245|NCT00213226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64957246|NCT00213226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64957247|NCT00213226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957248|NCT00213265|Vaccines|vaccines|mesh-list
64957249|NCT00213265|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64957250|NCT00213265|Immunologic Factors|immunologic factors|mesh-ancestor
64957251|NCT00213265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957252|NCT00213538|Methotrexate|methotrexate|mesh-list
64957253|NCT00213538|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64957254|NCT00213538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64957255|NCT00213538|Abortifacient Agents|abortifacient agents|mesh-ancestor
64957269|NCT00213577|Botulinum Toxins|botulinum toxins|mesh-list
64957270|NCT00213577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64957271|NCT00213577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64957272|NCT00213577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957273|NCT00213577|Cholinergic Agents|cholinergic agents|mesh-ancestor
64957274|NCT00213577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957275|NCT00213577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495904|NCT00493896|Anticoagulants|anticoagulants|mesh-ancestor
64957276|NCT00213694|Celecoxib|celecoxib|mesh-list
64957277|NCT00213694|Docetaxel|docetaxel|mesh-list
64653359|NCT03005483|Gabapentin|gabapentin|mesh-list
64957278|NCT00213694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957279|NCT00213694|Tubulin Modulators|tubulin modulators|mesh-ancestor
64957280|NCT00213694|Antimitotic Agents|antimitotic agents|mesh-ancestor
64957281|NCT00213694|Mitosis Modulators|mitosis modulators|mesh-ancestor
64304603|NCT03546283|Cardiac Glycosides|cardiac glycosides|mesh-list
64975141|NCT00246610|Nelfinavir|nelfinavir|mesh-list
64957282|NCT00213694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957283|NCT00213694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64957284|NCT00213694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64957286|NCT00213694|Sensory System Agents|sensory system agents|mesh-ancestor
64957287|NCT00213694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957288|NCT00213694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957289|NCT00213694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64957290|NCT00213694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64957291|NCT00213694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64957292|NCT00213694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64957293|NCT00213694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957294|NCT00214084|Allopurinol|allopurinol|mesh-list
64957295|NCT00214084|Antimetabolites|antimetabolites|mesh-ancestor
64957296|NCT00214084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957297|NCT00214084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957298|NCT00214084|Gout Suppressants|gout suppressants|mesh-ancestor
64957299|NCT00214084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64957300|NCT00214084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64957301|NCT00214084|Antioxidants|antioxidants|mesh-ancestor
64957302|NCT00214084|Protective Agents|protective agents|mesh-ancestor
64534325|NCT04409431|Respiratory System Agents|respiratory system agents|mesh-ancestor
64534326|NCT04409431|Mydriatics|mydriatics|mesh-ancestor
64534327|NCT04409431|Sympathomimetics|sympathomimetics|mesh-ancestor
64534328|NCT04409431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64534329|NCT01794507|Dexamethasone|dexamethasone|mesh-list
64534330|NCT01794507|Bortezomib|bortezomib|mesh-list
64534331|NCT01794507|Venetoclax|venetoclax|mesh-list
64534332|NCT01794507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64534333|NCT01794507|Antiemetics|antiemetics|mesh-ancestor
64534334|NCT01794507|Autonomic Agents|autonomic agents|mesh-ancestor
64534335|NCT01794507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64534336|NCT01794507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534337|NCT01794507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64534338|NCT01794507|Glucocorticoids|glucocorticoids|mesh-ancestor
64534339|NCT01794507|Hormones|hormones|mesh-ancestor
64534340|NCT01794507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64534341|NCT01794507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64534342|NCT01794507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534343|NCT00412425|Palonosetron|palonosetron|mesh-list
64534344|NCT00412425|Antiemetics|antiemetics|mesh-ancestor
64534345|NCT00412425|Autonomic Agents|autonomic agents|mesh-ancestor
64298922|NCT02094001|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64957303|NCT00214084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957304|NCT00214240|Immunoglobulins|immunoglobulins|mesh-list
64957305|NCT00214240|Antibodies|antibodies|mesh-list
64957306|NCT00214240|gamma-Globulins|gamma-globulins|mesh-list
64957307|NCT00214240|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64957308|NCT00214240|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64957309|NCT00214240|Immunologic Factors|immunologic factors|mesh-ancestor
64957310|NCT00214240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957311|NCT00214318|Metoprolol|metoprolol|mesh-list
64957312|NCT00214318|Carvedilol|carvedilol|mesh-list
64957313|NCT00214318|Terbutaline|terbutaline|mesh-list
64957314|NCT00214318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64957315|NCT00214318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64957316|NCT00214318|Sympatholytics|sympatholytics|mesh-ancestor
64957337|NCT00214318|Sympathomimetics|sympathomimetics|mesh-ancestor
64957338|NCT00214318|Tocolytic Agents|tocolytic agents|mesh-ancestor
64957339|NCT00214318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64957340|NCT00214318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64957341|NCT00214318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64957342|NCT00214318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64957343|NCT00214435|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64957344|NCT00214435|Antiviral Agents|antiviral agents|mesh-ancestor
64957346|NCT00214552|Rabeprazole|rabeprazole|mesh-list
64957347|NCT00214552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64957348|NCT00214552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64957349|NCT00214552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64495978|NCT03438240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64495988|NCT01160848|Ethanol|ethanol|mesh-list
64957350|NCT00214552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957351|NCT00214552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957352|NCT00069459|Bupropion|bupropion|mesh-list
64957353|NCT00069459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64957354|NCT00069459|Antidepressive Agents|antidepressive agents|mesh-ancestor
64957355|NCT00069459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64534346|NCT00412425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64534347|NCT00412425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534348|NCT00412425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64534349|NCT00412425|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64534350|NCT00412425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64534352|NCT00412425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64534353|NCT00412425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534354|NCT01492361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
64534355|NCT01492361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64534356|NCT01492361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64298943|NCT02094313|Atorvastatin|atorvastatin|mesh-list
64957356|NCT00069459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64957357|NCT00069459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64957358|NCT00069459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64957359|NCT00069459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957360|NCT00069459|Dopamine Agents|dopamine agents|mesh-ancestor
64957361|NCT00069459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957362|NCT00069459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957363|NCT00069459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64957364|NCT00069459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64957365|NCT00069459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957391|NCT00214864|Docetaxel|docetaxel|mesh-list
64957392|NCT00214864|Capecitabine|capecitabine|mesh-list
64957393|NCT00214864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957394|NCT00214864|Tubulin Modulators|tubulin modulators|mesh-ancestor
64957395|NCT00214864|Antimitotic Agents|antimitotic agents|mesh-ancestor
64957396|NCT00214864|Mitosis Modulators|mitosis modulators|mesh-ancestor
64957397|NCT00214864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957398|NCT00214864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64957399|NCT00214864|Antimetabolites|antimetabolites|mesh-ancestor
64957400|NCT00214942|Fentanyl|fentanyl|mesh-list
64975291|NCT00248209|Dopamine Agents|dopamine agents|mesh-ancestor
64957401|NCT00214942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64957402|NCT00214942|Narcotics|narcotics|mesh-ancestor
64957403|NCT00214942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64957404|NCT00214942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957405|NCT00214942|Analgesics|analgesics|mesh-ancestor
64957406|NCT00214942|Sensory System Agents|sensory system agents|mesh-ancestor
64957407|NCT00214942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957408|NCT00214942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64957409|NCT00214942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64957410|NCT00214942|Anesthetics, General|anesthetics, general|mesh-ancestor
64957411|NCT00214942|Anesthetics|anesthetics|mesh-ancestor
64957431|NCT00214981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957432|NCT00397241|Timolol|timolol|mesh-list
64957433|NCT00397241|Dorzolamide|dorzolamide|mesh-list
64957434|NCT00397241|Latanoprost|latanoprost|mesh-list
64957435|NCT00397241|Lubricant Eye Drops|lubricant eye drops|mesh-list
64957436|NCT00397241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64957437|NCT00397241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64957438|NCT00397241|Adrenergic Agents|adrenergic agents|mesh-ancestor
64957439|NCT00397241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957440|NCT00397241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653374|NCT01593215|Yohimbine|yohimbine|mesh-list
64957441|NCT00397241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957442|NCT00397241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64957443|NCT00397241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64957444|NCT00397241|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64957445|NCT00397241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64957446|NCT00397241|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64534358|NCT05287503|Expectorants|expectorants|mesh-ancestor
64534359|NCT05287503|Respiratory System Agents|respiratory system agents|mesh-ancestor
64534360|NCT00415857|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64534361|NCT00415857|Imatinib Mesylate|imatinib mesylate|mesh-list
64534362|NCT00415857|Vaccines|vaccines|mesh-list
64534363|NCT00415857|Sargramostim|sargramostim|mesh-list
64534364|NCT00415857|Immunologic Factors|immunologic factors|mesh-ancestor
64298953|NCT02094391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957447|NCT00397241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957448|NCT00073320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64957449|NCT00073320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64957450|NCT00073320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64957451|NCT00073320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64957452|NCT00073320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957453|NCT00073320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64957454|NCT00073320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64957455|NCT00073320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64957456|NCT00073320|Serotonin Agents|serotonin agents|mesh-ancestor
64957457|NCT00073320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957458|NCT00073320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957459|NCT00073320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64957460|NCT00073320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64957461|NCT00073320|Dopamine Agents|dopamine agents|mesh-ancestor
64957462|NCT00215176|Modafinil|modafinil|mesh-list
64957463|NCT00215176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64957464|NCT00215176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957487|NCT00215371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957488|NCT00215371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64957489|NCT00215371|Respiratory System Agents|respiratory system agents|mesh-ancestor
64957490|NCT00215371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64957491|NCT00215371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64957492|NCT00215371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64957493|NCT00215371|Adrenergic Agents|adrenergic agents|mesh-ancestor
64957494|NCT00215371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957495|NCT00215371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957496|NCT00215410|Formoterol Fumarate|formoterol fumarate|mesh-list
64957497|NCT00215410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64957499|NCT00215410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957500|NCT00215410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957501|NCT00215410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64957502|NCT00215410|Respiratory System Agents|respiratory system agents|mesh-ancestor
64957503|NCT00215410|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64957504|NCT00215410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64957505|NCT00215410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64957506|NCT00215410|Adrenergic Agents|adrenergic agents|mesh-ancestor
64957507|NCT00215410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957508|NCT00215410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957509|NCT00215449|Formoterol Fumarate|formoterol fumarate|mesh-list
64957510|NCT00215449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64957511|NCT00215449|Autonomic Agents|autonomic agents|mesh-ancestor
64957512|NCT00215449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957513|NCT00215449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957547|NCT00215995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64957548|NCT00216034|polysaccharide-K|polysaccharide-k|mesh-list
64957549|NCT00216034|Tegafur|tegafur|mesh-list
64957550|NCT00216034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64957551|NCT00216034|Antimetabolites|antimetabolites|mesh-ancestor
64957552|NCT00216034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957553|NCT00216034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957572|NCT00216112|Imatinib Mesylate|imatinib mesylate|mesh-list
64957573|NCT00216112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957574|NCT00216112|Tubulin Modulators|tubulin modulators|mesh-ancestor
64957575|NCT00216112|Antimitotic Agents|antimitotic agents|mesh-ancestor
64411323|NCT04426097|Iodine|iodine|mesh-list
64957576|NCT00216112|Mitosis Modulators|mitosis modulators|mesh-ancestor
64534365|NCT00415857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975340|NCT00249106|Vaccines|vaccines|mesh-list
64534366|NCT00415857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534367|NCT00415857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64534368|NCT00415857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534369|NCT00415857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534370|NCT00415857|Antiviral Agents|antiviral agents|mesh-ancestor
64534371|NCT00415857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64957577|NCT00216112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957578|NCT00216112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64957579|NCT00216112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957580|NCT00216151|Zoledronic Acid|zoledronic acid|mesh-list
64957581|NCT00216151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64957582|NCT00216151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957583|NCT00216190|Midazolam|midazolam|mesh-list
64957584|NCT00216190|Dexmedetomidine|dexmedetomidine|mesh-list
64957585|NCT00216190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64957586|NCT00216190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64957587|NCT00216190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957588|NCT00216190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64957589|NCT00216190|Analgesics|analgesics|mesh-ancestor
64957590|NCT00216190|Sensory System Agents|sensory system agents|mesh-ancestor
64957591|NCT00216190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957592|NCT00216190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64957593|NCT00216190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64957594|NCT00216190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64957595|NCT00216190|Adrenergic Agents|adrenergic agents|mesh-ancestor
64957596|NCT00216190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957597|NCT00216190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957598|NCT00216190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64957599|NCT00216190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64957600|NCT00216190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64957601|NCT00216190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64957602|NCT00216190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64957603|NCT00216190|Anesthetics, General|anesthetics, general|mesh-ancestor
64957604|NCT00216190|Anesthetics|anesthetics|mesh-ancestor
64957605|NCT00216190|GABA Modulators|gaba modulators|mesh-ancestor
64957606|NCT00216190|GABA Agents|gaba agents|mesh-ancestor
64957607|NCT00216268|Ribavirin|ribavirin|mesh-list
64957608|NCT00216268|Antimetabolites|antimetabolites|mesh-ancestor
64957609|NCT00216268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957610|NCT00216268|Antiviral Agents|antiviral agents|mesh-ancestor
64957611|NCT00216268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64957645|NCT00216502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496280|NCT01238536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64496291|NCT03437070|Olaratumab|olaratumab|mesh-list
64957647|NCT00216502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957648|NCT00216502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957649|NCT00216502|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64957650|NCT00216502|Autonomic Agents|autonomic agents|mesh-ancestor
64957651|NCT00216502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957652|NCT00216502|Nootropic Agents|nootropic agents|mesh-ancestor
64957653|NCT00216541|Epoetin Alfa|epoetin alfa|mesh-list
64957682|NCT00216619|Topiramate|topiramate|mesh-list
64957683|NCT00216619|Anticonvulsants|anticonvulsants|mesh-ancestor
64957684|NCT00216619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64957685|NCT00216619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957686|NCT00216658|Fentanyl|fentanyl|mesh-list
64957687|NCT00216658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64957688|NCT00216658|Narcotics|narcotics|mesh-ancestor
64957689|NCT00216658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64957690|NCT00216658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957691|NCT00216658|Analgesics|analgesics|mesh-ancestor
64957692|NCT00216658|Sensory System Agents|sensory system agents|mesh-ancestor
64957693|NCT00216658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957694|NCT00216658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64957695|NCT00216658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64957696|NCT00216658|Anesthetics, General|anesthetics, general|mesh-ancestor
64534373|NCT03491631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534374|NCT03491631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64534375|NCT03491631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534376|NCT03491631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534377|NCT04271007|Mometasone Furoate|mometasone furoate|mesh-list
64534378|NCT04271007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64534379|NCT04271007|Dermatologic Agents|dermatologic agents|mesh-ancestor
64534380|NCT04271007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64534381|NCT05287035|Dexamethasone|dexamethasone|mesh-list
64534382|NCT05287035|Dexamethasone acetate|dexamethasone acetate|mesh-list
64534383|NCT05287035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64957698|NCT00216697|Bortezomib|bortezomib|mesh-list
64957699|NCT00216697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957700|NCT00216775|Interferons|interferons|mesh-list
64957701|NCT00216775|Ribavirin|ribavirin|mesh-list
64957725|NCT00216931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64957726|NCT00216931|Vasodilator Agents|vasodilator agents|mesh-ancestor
64957727|NCT00217009|Furocoumarins|furocoumarins|mesh-list
64957728|NCT00217009|Dermatologic Agents|dermatologic agents|mesh-ancestor
64957729|NCT00217009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64957730|NCT00217048|Yohimbine|yohimbine|mesh-list
64957731|NCT00217048|Mydriatics|mydriatics|mesh-ancestor
64957732|NCT00217048|Autonomic Agents|autonomic agents|mesh-ancestor
64957733|NCT00217048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957734|NCT00217048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957735|NCT00217048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64957736|NCT00217048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64957737|NCT00217048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64957738|NCT00217048|Adrenergic Agents|adrenergic agents|mesh-ancestor
64957739|NCT00217048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957740|NCT00217048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957741|NCT00217048|Urological Agents|urological agents|mesh-ancestor
64957742|NCT00217204|Pancrelipase|pancrelipase|mesh-list
64957743|NCT00217204|Pancreatin|pancreatin|mesh-list
64957744|NCT00217204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64957745|NCT00412126|Insulin|insulin|mesh-list
64957746|NCT00412126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64957747|NCT00412126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957748|NCT00412204|Bromides|bromides|mesh-list
64957749|NCT00412204|Tiotropium Bromide|tiotropium bromide|mesh-list
64957750|NCT00412204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64957751|NCT00412204|Autonomic Agents|autonomic agents|mesh-ancestor
64957752|NCT00412204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957753|NCT00412204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957754|NCT00412204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64957786|NCT00217243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957787|NCT00217243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64957788|NCT00217243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64957789|NCT00217243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64957790|NCT00217243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64957791|NCT00217243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957792|NCT00217282|Gemcitabine|gemcitabine|mesh-list
64957793|NCT00217282|Bevacizumab|bevacizumab|mesh-list
64957794|NCT00217282|Oxaliplatin|oxaliplatin|mesh-list
64957795|NCT00217282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64957814|NCT00217477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957815|NCT00217477|Antiviral Agents|antiviral agents|mesh-ancestor
64957816|NCT00217477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64957817|NCT00217477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957818|NCT00217477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64957819|NCT00217477|Immunologic Factors|immunologic factors|mesh-ancestor
64957820|NCT00217477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957821|NCT00217516|Selenium|selenium|mesh-list
64957822|NCT00217516|Antioxidants|antioxidants|mesh-ancestor
64534385|NCT05287035|Autonomic Agents|autonomic agents|mesh-ancestor
64534386|NCT05287035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64534387|NCT05287035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534388|NCT05287035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64534389|NCT05287035|Glucocorticoids|glucocorticoids|mesh-ancestor
64534390|NCT05287035|Hormones|hormones|mesh-ancestor
64534391|NCT05287035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64534392|NCT05287035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64534393|NCT05287035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534394|NCT00416793|Carboplatin|carboplatin|mesh-list
64534395|NCT00416793|Bortezomib|bortezomib|mesh-list
64957823|NCT00217516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957824|NCT00217516|Protective Agents|protective agents|mesh-ancestor
64957825|NCT00217516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957826|NCT00217516|Trace Elements|trace elements|mesh-ancestor
64957827|NCT00217516|Micronutrients|micronutrients|mesh-ancestor
64957828|NCT00217555|Gemcitabine|gemcitabine|mesh-list
64957829|NCT00217555|Topotecan|topotecan|mesh-list
64957830|NCT00217555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64957831|NCT00217555|Antimetabolites|antimetabolites|mesh-ancestor
64975435|NCT00249847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975444|NCT00249886|Citalopram|citalopram|mesh-list
64957832|NCT00217555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957833|NCT00217555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957834|NCT00217555|Antiviral Agents|antiviral agents|mesh-ancestor
64957835|NCT00217555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64957836|NCT00217555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957837|NCT00217555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64957838|NCT00217555|Immunologic Factors|immunologic factors|mesh-ancestor
64957839|NCT00217555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957840|NCT00217555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64957841|NCT00217555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64957842|NCT00217711|Capecitabine|capecitabine|mesh-list
64957843|NCT00217711|Oxaliplatin|oxaliplatin|mesh-list
64957844|NCT00217711|Irinotecan|irinotecan|mesh-list
64957845|NCT00217711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64957846|NCT00217711|Antimetabolites|antimetabolites|mesh-ancestor
64957847|NCT00217711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957848|NCT00217711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957849|NCT00217711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64957850|NCT00217711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64957851|NCT00217711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957852|NCT00217789|Dimercaprol|dimercaprol|mesh-list
64957878|NCT00218101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64957879|NCT00218101|Narcotics|narcotics|mesh-ancestor
64957880|NCT00218101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64957881|NCT00218101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957882|NCT00218101|Analgesics|analgesics|mesh-ancestor
64957883|NCT00218101|Sensory System Agents|sensory system agents|mesh-ancestor
64957884|NCT00218101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957885|NCT00218101|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64957886|NCT00218140|Nicotine|nicotine|mesh-list
64957887|NCT00218140|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64957888|NCT00218140|Autonomic Agents|autonomic agents|mesh-ancestor
64957889|NCT00218140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957890|NCT00218140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957891|NCT00218140|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64957892|NCT00218140|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64957893|NCT00218140|Cholinergic Agents|cholinergic agents|mesh-ancestor
64957894|NCT00218140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957895|NCT00218140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957896|NCT00042029|Aprepitant|aprepitant|mesh-list
64957897|NCT00042029|Antiemetics|antiemetics|mesh-ancestor
64957898|NCT00042029|Autonomic Agents|autonomic agents|mesh-ancestor
64957899|NCT00042029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64534396|NCT00416793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534397|NCT00417417|Rilonacept|rilonacept|mesh-list
64534398|NCT00417417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64534399|NCT00419445|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
64534400|NCT00419445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64957900|NCT00042029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957901|NCT00042029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64957927|NCT00218374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957928|NCT00218374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957929|NCT00218374|Antimanic Agents|antimanic agents|mesh-ancestor
64957930|NCT00218413|Vaccines|vaccines|mesh-list
64957931|NCT00218413|Immunologic Factors|immunologic factors|mesh-ancestor
64957932|NCT00218413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957933|NCT00042068|Meloxicam|meloxicam|mesh-list
64957934|NCT00042068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64957935|NCT00042068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64957936|NCT00042068|Analgesics|analgesics|mesh-ancestor
64957937|NCT00042068|Sensory System Agents|sensory system agents|mesh-ancestor
64957938|NCT00042068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957939|NCT00042068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957940|NCT00042068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64957941|NCT00042068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64957942|NCT00042068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64957943|NCT00042068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64957944|NCT00042068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496577|NCT03432312|Nicotine|nicotine|mesh-list
64957945|NCT00042068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957946|NCT00218530|Lofexidine|lofexidine|mesh-list
64957947|NCT00218530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64957948|NCT00218530|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64957979|NCT00412321|Siltuximab|siltuximab|mesh-list
64957980|NCT00412321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957981|NCT00219232|Rivastigmine|rivastigmine|mesh-list
64957982|NCT00219232|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64957983|NCT00219232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957984|NCT00219232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957985|NCT00219232|Cholinergic Agents|cholinergic agents|mesh-ancestor
64957986|NCT00219232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957987|NCT00219232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957988|NCT00219232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64957989|NCT00219232|Protective Agents|protective agents|mesh-ancestor
64957990|NCT00219271|Zoledronic Acid|zoledronic acid|mesh-list
64496727|NCT03274752|Antidepressive Agents|antidepressive agents|mesh-ancestor
64958021|NCT00219466|Dermatologic Agents|dermatologic agents|mesh-ancestor
64958022|NCT00219466|Sunscreening Agents|sunscreening agents|mesh-ancestor
64958023|NCT00219466|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64958024|NCT00042302|Paclitaxel|paclitaxel|mesh-list
64958025|NCT00042302|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64958026|NCT00042302|Carboplatin|carboplatin|mesh-list
64958027|NCT00042302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64958028|NCT00042302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958029|NCT00042302|Tubulin Modulators|tubulin modulators|mesh-ancestor
64958030|NCT00042302|Antimitotic Agents|antimitotic agents|mesh-ancestor
64958031|NCT00042302|Mitosis Modulators|mitosis modulators|mesh-ancestor
64958032|NCT00042302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958033|NCT00219700|Ibuprofen|ibuprofen|mesh-list
64975454|NCT00249886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64975455|NCT00249964|Paclitaxel|paclitaxel|mesh-list
64958034|NCT00219700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64958035|NCT00219700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64958061|NCT00219778|Abortifacient Agents|abortifacient agents|mesh-ancestor
64958062|NCT00219778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64958063|NCT00219778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958064|NCT00219778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64958065|NCT00219778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64958066|NCT00219778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64958067|NCT00219778|Contraceptive Agents|contraceptive agents|mesh-ancestor
64958068|NCT00219778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64958069|NCT00219778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64958070|NCT00219778|Hormone Antagonists|hormone antagonists|mesh-ancestor
64958071|NCT00219778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64534401|NCT00419445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64534402|NCT00419445|Cholinergic Agents|cholinergic agents|mesh-ancestor
64534403|NCT00419445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64534404|NCT00419445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534405|NCT00419445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534406|NCT00420459|Aripiprazole|aripiprazole|mesh-list
64534407|NCT00420459|Antidepressive Agents|antidepressive agents|mesh-ancestor
64534408|NCT00420459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64534409|NCT00420459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64534410|NCT00420459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64534411|NCT00420459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64534412|NCT00420459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534413|NCT00420459|Dopamine Agonists|dopamine agonists|mesh-ancestor
64534414|NCT00420459|Dopamine Agents|dopamine agents|mesh-ancestor
64534415|NCT00420459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64534416|NCT00420459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534417|NCT00420459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64534418|NCT00420459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64534419|NCT00420459|Serotonin Agents|serotonin agents|mesh-ancestor
64534420|NCT00420459|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64534421|NCT00420459|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64534422|NCT00420459|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64534423|NCT00420459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64534424|NCT00420771|Gabapentin|gabapentin|mesh-list
64534425|NCT00420771|Analgesics|analgesics|mesh-ancestor
64534426|NCT00420771|Sensory System Agents|sensory system agents|mesh-ancestor
64975536|NCT00068432|Sensory System Agents|sensory system agents|mesh-ancestor
64534427|NCT00420771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64534428|NCT00420771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534429|NCT00420771|Anticonvulsants|anticonvulsants|mesh-ancestor
64534430|NCT00420771|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64534431|NCT00420771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64298993|NCT02098837|Dolutegravir|dolutegravir|mesh-list
64958072|NCT00219778|Luteolytic Agents|luteolytic agents|mesh-ancestor
64958073|NCT00219778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64958074|NCT00219778|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64958075|NCT00219856|Propofol|propofol|mesh-list
64958076|NCT00219856|Desflurane|desflurane|mesh-list
64958077|NCT00219856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64958078|NCT00219856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64958079|NCT00219856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958080|NCT00219856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64534432|NCT00420771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64534433|NCT00420771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64534434|NCT00420771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64534435|NCT00420771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64534436|NCT00420771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64534437|NCT00420771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958081|NCT00219856|Anesthetics, General|anesthetics, general|mesh-ancestor
64958083|NCT00219856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64958084|NCT00042458|Pramlintide|pramlintide|mesh-list
64958109|NCT00220051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64958110|NCT00220051|Antimetabolites|antimetabolites|mesh-ancestor
64958111|NCT00220051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958112|NCT00220051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958113|NCT00077415|Gemcitabine|gemcitabine|mesh-list
64958114|NCT00077415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64958115|NCT00077415|Antimetabolites|antimetabolites|mesh-ancestor
64958116|NCT00077415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958117|NCT00077415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958118|NCT00077415|Antiviral Agents|antiviral agents|mesh-ancestor
64958119|NCT00077415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64958120|NCT00077415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958121|NCT00077415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64958122|NCT00077415|Immunologic Factors|immunologic factors|mesh-ancestor
64958123|NCT00077415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958124|NCT00042536|Naltrexone|naltrexone|mesh-list
64958125|NCT00042536|Yohimbine|yohimbine|mesh-list
64958126|NCT00042536|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64958127|NCT00042536|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64958128|NCT00042536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958129|NCT00042536|Sensory System Agents|sensory system agents|mesh-ancestor
64958130|NCT00042536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64958131|NCT00042536|Mydriatics|mydriatics|mesh-ancestor
64958132|NCT00042536|Autonomic Agents|autonomic agents|mesh-ancestor
64958133|NCT00042536|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64958134|NCT00042536|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64958135|NCT00042536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64958136|NCT00042536|Adrenergic Agents|adrenergic agents|mesh-ancestor
64958137|NCT00042536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64413407|NCT04948801|Velpatasvir|velpatasvir|mesh-list
64975586|NCT00250354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975587|NCT00250354|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64958162|NCT00042575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64958163|NCT00042575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958164|NCT00042575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64958165|NCT00042575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958166|NCT00042575|Analgesics|analgesics|mesh-ancestor
64958167|NCT00042575|Sensory System Agents|sensory system agents|mesh-ancestor
64958168|NCT00042575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64958169|NCT00042575|Antidepressive Agents|antidepressive agents|mesh-ancestor
64958170|NCT00042575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64958171|NCT00042575|Dopamine Agents|dopamine agents|mesh-ancestor
64958172|NCT00220285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64958173|NCT00220285|Immunologic Factors|immunologic factors|mesh-ancestor
64958174|NCT00220285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958175|NCT00077454|Temozolomide|temozolomide|mesh-list
64958176|NCT00077454|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64958177|NCT00077454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64958178|NCT00077454|Alkylating Agents|alkylating agents|mesh-ancestor
64958179|NCT00077454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958180|NCT00077454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958181|NCT00077454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64958182|NCT00077454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958183|NCT00220324|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
64958204|NCT00042653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64958205|NCT00042653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534438|NCT00420771|Antimanic Agents|antimanic agents|mesh-ancestor
64534439|NCT00426153|Octreotide|octreotide|mesh-list
64534440|NCT00426153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64534441|NCT00426153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64534442|NCT00426153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534443|NCT04750317|Tofacitinib|tofacitinib|mesh-list
64534444|NCT04750317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64534445|NCT04750317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534446|NCT04750317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534447|NCT01996449|Amlodipine|amlodipine|mesh-list
64534448|NCT01996449|Eplerenone|eplerenone|mesh-list
64534449|NCT01996449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64534450|NCT01996449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64534451|NCT01996449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64534452|NCT01996449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534453|NCT01996449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64534454|NCT01996449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534455|NCT01996449|Vasodilator Agents|vasodilator agents|mesh-ancestor
64534456|NCT01996449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64534457|NCT01996449|Hormone Antagonists|hormone antagonists|mesh-ancestor
64534458|NCT01996449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64534459|NCT01996449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64534460|NCT01996449|Diuretics|diuretics|mesh-ancestor
64534461|NCT01996449|Natriuretic Agents|natriuretic agents|mesh-ancestor
64534462|NCT00426855|Bortezomib|bortezomib|mesh-list
64534463|NCT00426855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64534464|NCT00426855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534465|NCT00426855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64534466|NCT00426855|Alkylating Agents|alkylating agents|mesh-ancestor
64534467|NCT00426855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534468|NCT01491737|Trastuzumab|trastuzumab|mesh-list
64534469|NCT01491737|Pertuzumab|pertuzumab|mesh-list
64534470|NCT01491737|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64534476|NCT01491737|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64534477|NCT01491737|Hormone Antagonists|hormone antagonists|mesh-ancestor
64534478|NCT01491737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64534479|NCT01491737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534480|NCT00427557|Rituximab|rituximab|mesh-list
64534481|NCT00427557|Fludarabine|fludarabine|mesh-list
64534482|NCT00427557|Fludarabine phosphate|fludarabine phosphate|mesh-list
64534483|NCT00427557|Melphalan|melphalan|mesh-list
64299069|NCT02718417|Paclitaxel|paclitaxel|mesh-list
64958206|NCT00042653|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64958207|NCT00042653|Hormone Antagonists|hormone antagonists|mesh-ancestor
64958208|NCT00042653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64958209|NCT00073593|Heparin|heparin|mesh-list
64958210|NCT00073593|Bivalirudin|bivalirudin|mesh-list
64958211|NCT00073593|Protamines|protamines|mesh-list
64975650|NCT00250861|Antiviral Agents|antiviral agents|mesh-ancestor
64975651|NCT00250861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64958212|NCT00073593|Anticoagulants|anticoagulants|mesh-ancestor
64958213|NCT00073593|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64958214|NCT00073593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64958215|NCT00073593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958216|NCT00073593|Antithrombins|antithrombins|mesh-ancestor
64958217|NCT00073593|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64958218|NCT00073593|Protease Inhibitors|protease inhibitors|mesh-ancestor
64958219|NCT00073593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958220|NCT00073593|Heparin Antagonists|heparin antagonists|mesh-ancestor
64958221|NCT00073593|Coagulants|coagulants|mesh-ancestor
64958222|NCT00220480|Citalopram|citalopram|mesh-list
64958223|NCT00220480|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64958224|NCT00220480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64958225|NCT00220480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64958226|NCT00220480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958227|NCT00220480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64958228|NCT00220480|Serotonin Agents|serotonin agents|mesh-ancestor
64958229|NCT00220480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958230|NCT00220480|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64958231|NCT00220480|Antidepressive Agents|antidepressive agents|mesh-ancestor
64958232|NCT00220480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64958233|NCT00220675|Epoetin Alfa|epoetin alfa|mesh-list
64958234|NCT00220675|Hematinics|hematinics|mesh-ancestor
64958235|NCT00042731|Lycopene|lycopene|mesh-list
64958236|NCT00042731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64958265|NCT00220909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64958266|NCT00220909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64958267|NCT00220909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64958268|NCT00220909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958269|NCT00220909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958270|NCT00220987|Insulin|insulin|mesh-list
64958271|NCT00220987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64958272|NCT00220987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64958273|NCT00220987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958274|NCT02966067|Anesthetics|anesthetics|mesh-list
64958275|NCT02966067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64958276|NCT02966067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64958277|NCT02966067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958278|NCT00221026|Methoxsalen|methoxsalen|mesh-list
64958279|NCT00221026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64958280|NCT00221026|Dermatologic Agents|dermatologic agents|mesh-ancestor
64958281|NCT00042809|Paclitaxel|paclitaxel|mesh-list
64958282|NCT00042809|Trastuzumab|trastuzumab|mesh-list
64958283|NCT00042809|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64958284|NCT00042809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64958285|NCT00042809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958309|NCT00042848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958310|NCT00221260|Anesthetics|anesthetics|mesh-list
64958311|NCT00221260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64958312|NCT00221260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958313|NCT00402259|Esomeprazole|esomeprazole|mesh-list
64958314|NCT00402259|Omeprazole|omeprazole|mesh-list
64958315|NCT00402259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64534484|NCT00427557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64534485|NCT00427557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534486|NCT00427557|Immunologic Factors|immunologic factors|mesh-ancestor
64534487|NCT00427557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958316|NCT00402259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64958317|NCT00402259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64958318|NCT00402259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958319|NCT00402259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958320|NCT02965677|Paclitaxel|paclitaxel|mesh-list
64958321|NCT02965677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64958322|NCT02965677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958323|NCT02965677|Tubulin Modulators|tubulin modulators|mesh-ancestor
64653415|NCT03005171|Anesthetics|anesthetics|mesh-ancestor
64539934|NCT04973826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64958324|NCT02965677|Antimitotic Agents|antimitotic agents|mesh-ancestor
64958325|NCT02965677|Mitosis Modulators|mitosis modulators|mesh-ancestor
64958326|NCT02965677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958327|NCT00402376|Carvedilol|carvedilol|mesh-list
64958328|NCT00402376|Perindopril|perindopril|mesh-list
64958329|NCT00402376|Pravastatin|pravastatin|mesh-list
64958330|NCT00402376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64958331|NCT00402376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64958332|NCT00402376|Adrenergic Agents|adrenergic agents|mesh-ancestor
64958333|NCT00402376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64958362|NCT00122746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958363|NCT00122785|Dexamethasone|dexamethasone|mesh-list
64958364|NCT00122785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64958365|NCT00122785|Antiemetics|antiemetics|mesh-ancestor
64958366|NCT00122785|Autonomic Agents|autonomic agents|mesh-ancestor
64958367|NCT00122785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64958368|NCT00122785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958369|NCT00122785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64958370|NCT00122785|Glucocorticoids|glucocorticoids|mesh-ancestor
64958372|NCT00122785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64958373|NCT00122785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64958374|NCT00122785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958375|NCT00122824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64958376|NCT00122824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64958385|NCT00122824|Antidepressive Agents|antidepressive agents|mesh-ancestor
64958386|NCT00122824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64958387|NCT00122824|Dopamine Agents|dopamine agents|mesh-ancestor
64958388|NCT00077532|Ipilimumab|ipilimumab|mesh-list
64958389|NCT00077532|Freund's Adjuvant|freund's adjuvant|mesh-list
64958390|NCT00077532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64497035|NCT01927029|Hormones|hormones|mesh-ancestor
64958391|NCT00077532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958392|NCT00077532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64958393|NCT00077532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958394|NCT00077532|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64958396|NCT00077532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958397|NCT00122863|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64958398|NCT00122863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64958399|NCT00122863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64958400|NCT00122863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64958401|NCT00122863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958402|NCT00122863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64958403|NCT00122863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958404|NCT00122863|Analgesics|analgesics|mesh-ancestor
64958405|NCT00122863|Sensory System Agents|sensory system agents|mesh-ancestor
64958406|NCT00122863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64958407|NCT00122863|Antidepressive Agents|antidepressive agents|mesh-ancestor
64958408|NCT00122863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64958409|NCT00122863|Dopamine Agents|dopamine agents|mesh-ancestor
64958410|NCT00042926|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
64958411|NCT00042926|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64958412|NCT00042926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958413|NCT00122941|Micronutrients|micronutrients|mesh-list
64958414|NCT00122941|Trace Elements|trace elements|mesh-list
64958415|NCT00122941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958416|NCT00077688|Paclitaxel|paclitaxel|mesh-list
64534488|NCT00427557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64534489|NCT00427557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64534490|NCT00427557|Antimetabolites|antimetabolites|mesh-ancestor
64534491|NCT00427557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534492|NCT00427557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64299082|NCT05067530|Paclitaxel|paclitaxel|mesh-list
64958417|NCT00077688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64958418|NCT00077688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958419|NCT00077688|Tubulin Modulators|tubulin modulators|mesh-ancestor
64958420|NCT00077688|Antimitotic Agents|antimitotic agents|mesh-ancestor
64958421|NCT00077688|Mitosis Modulators|mitosis modulators|mesh-ancestor
64958422|NCT00077688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958424|NCT00397319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64958425|NCT00397319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958426|NCT02965443|Dapagliflozin|dapagliflozin|mesh-list
64958427|NCT02965443|Saxagliptin|saxagliptin|mesh-list
64958428|NCT02965443|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64958429|NCT02965443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958430|NCT02965443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64958431|NCT02965443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958432|NCT02965443|Incretins|incretins|mesh-ancestor
64958433|NCT02965443|Hormones|hormones|mesh-ancestor
64958434|NCT02965443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64958435|NCT02965443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64958436|NCT02965443|Protease Inhibitors|protease inhibitors|mesh-ancestor
64958437|NCT02965443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958438|NCT00042965|Gemcitabine|gemcitabine|mesh-list
64958439|NCT00042965|Capecitabine|capecitabine|mesh-list
64958463|NCT00123175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958464|NCT00123175|Hormones|hormones|mesh-ancestor
64958465|NCT00123175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64958466|NCT00123253|Tesamorelin|tesamorelin|mesh-list
64958467|NCT00123253|Growth Substances|growth substances|mesh-ancestor
64958468|NCT00123253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958469|NCT00077727|Galantamine|galantamine|mesh-list
64958470|NCT00077727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64958471|NCT00077727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975691|NCT00103701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958472|NCT00077727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958473|NCT00077727|Cholinergic Agents|cholinergic agents|mesh-ancestor
64958474|NCT00077727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64958475|NCT00077727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958476|NCT00077727|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64958477|NCT00077727|Autonomic Agents|autonomic agents|mesh-ancestor
64958478|NCT00077727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64958479|NCT00077727|Nootropic Agents|nootropic agents|mesh-ancestor
64958480|NCT00123292|Plasminogen|plasminogen|mesh-list
64958481|NCT00123292|Fibrinolysin|fibrinolysin|mesh-list
64958482|NCT00123292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64958483|NCT00123292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64958484|NCT00123292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958485|NCT00043004|Leucovorin|leucovorin|mesh-list
64958486|NCT00043004|Bevacizumab|bevacizumab|mesh-list
64958507|NCT00043004|Vitamins|vitamins|mesh-ancestor
64958508|NCT00043004|Micronutrients|micronutrients|mesh-ancestor
64958509|NCT00123331|Cyclosporine|cyclosporine|mesh-list
64958510|NCT00123331|Sirolimus|sirolimus|mesh-list
64958511|NCT00123331|Cyclosporins|cyclosporins|mesh-list
64958512|NCT00123331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958513|NCT00123331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958514|NCT00123331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64958515|NCT00123331|Immunologic Factors|immunologic factors|mesh-ancestor
64958516|NCT00123331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958517|NCT00123331|Antifungal Agents|antifungal agents|mesh-ancestor
64958518|NCT00123331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64958519|NCT00123331|Dermatologic Agents|dermatologic agents|mesh-ancestor
64958520|NCT00123331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64958521|NCT00123331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64958522|NCT00123331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64534494|NCT00427557|Alkylating Agents|alkylating agents|mesh-ancestor
64534495|NCT00427557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64534496|NCT01487863|Abiraterone Acetate|abiraterone acetate|mesh-list
64534497|NCT01487863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534498|NCT01487863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64534499|NCT01487863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534500|NCT01487863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534501|NCT01487863|Hormone Antagonists|hormone antagonists|mesh-ancestor
64534502|NCT01487863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64299084|NCT05067530|Palbociclib|palbociclib|mesh-list
64958523|NCT00123331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64958524|NCT00123331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958525|NCT00123370|Modafinil|modafinil|mesh-list
64958526|NCT00123370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64958527|NCT00123370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958528|NCT00123370|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64958529|NCT00123370|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64958530|NCT00123370|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64958531|NCT00123370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958532|NCT00043043|Celecoxib|celecoxib|mesh-list
64958533|NCT00043043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64958534|NCT00043043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64958535|NCT00043043|Analgesics|analgesics|mesh-ancestor
64958536|NCT00043043|Sensory System Agents|sensory system agents|mesh-ancestor
64975737|NCT00100113|Dopamine Agents|dopamine agents|mesh-ancestor
64958537|NCT00043043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64958538|NCT00043043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958539|NCT00043043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64958540|NCT00043043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64958541|NCT00043043|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64958570|NCT00123916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64958571|NCT00073827|Albuterol|albuterol|mesh-list
64958572|NCT00073827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64958573|NCT00073827|Autonomic Agents|autonomic agents|mesh-ancestor
64958574|NCT00073827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64958575|NCT00073827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958576|NCT00073827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64958577|NCT00073827|Respiratory System Agents|respiratory system agents|mesh-ancestor
64958578|NCT00073827|Tocolytic Agents|tocolytic agents|mesh-ancestor
64958579|NCT00073827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64958580|NCT00073827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64958581|NCT00073827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64958582|NCT00073827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64958583|NCT00073827|Adrenergic Agents|adrenergic agents|mesh-ancestor
64958584|NCT00073827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64958585|NCT00073827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958586|NCT02970539|Paclitaxel|paclitaxel|mesh-list
64975765|NCT02966522|Hormones|hormones|mesh-ancestor
64958587|NCT02970539|Ramucirumab|ramucirumab|mesh-list
64958588|NCT02970539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64958608|NCT00124111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64958609|NCT00124111|Abortifacient Agents|abortifacient agents|mesh-ancestor
64958610|NCT00124111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64958611|NCT00124111|Dermatologic Agents|dermatologic agents|mesh-ancestor
64958613|NCT00124111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64958614|NCT00124111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64958615|NCT00124150|Magnesium Sulfate|magnesium sulfate|mesh-list
64958616|NCT00124150|Analgesics|analgesics|mesh-ancestor
64958617|NCT00124150|Sensory System Agents|sensory system agents|mesh-ancestor
64958618|NCT00124150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64958619|NCT00124150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958620|NCT00124150|Anesthetics|anesthetics|mesh-ancestor
64534503|NCT01487863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534504|NCT01487863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64534505|NCT04088305|Vancomycin|vancomycin|mesh-list
64534506|NCT04088305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64534507|NCT04088305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64534508|NCT00427791|Rituximab|rituximab|mesh-list
64534509|NCT00427791|Etoposide|etoposide|mesh-list
64534510|NCT00427791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64534511|NCT00427791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958621|NCT00124150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64958622|NCT00124150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64958623|NCT00124150|Anticonvulsants|anticonvulsants|mesh-ancestor
64958624|NCT00124150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64958625|NCT00124150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64958626|NCT00124150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958627|NCT00124150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64958629|NCT00124150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64958630|NCT02958046|Domperidone|domperidone|mesh-list
64958631|NCT02958046|Lansoprazole|lansoprazole|mesh-list
64958632|NCT02958046|Dexlansoprazole|dexlansoprazole|mesh-list
64958633|NCT02958046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64958634|NCT02958046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64958635|NCT02958046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64958636|NCT02958046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958637|NCT02958046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958638|NCT02958046|Antiemetics|antiemetics|mesh-ancestor
64958639|NCT02958046|Autonomic Agents|autonomic agents|mesh-ancestor
64958640|NCT02958046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64958641|NCT02958046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958642|NCT02958046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64958643|NCT02958046|Dopamine Agents|dopamine agents|mesh-ancestor
64958644|NCT02958046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64958672|NCT00077844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64958673|NCT00077844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64958674|NCT00077844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958675|NCT00043121|Leucovorin|leucovorin|mesh-list
64958676|NCT00043121|Fluorouracil|fluorouracil|mesh-list
64958677|NCT00043121|Capecitabine|capecitabine|mesh-list
64958678|NCT00043121|Oxaliplatin|oxaliplatin|mesh-list
64958679|NCT00043121|Calcium|calcium|mesh-list
64958680|NCT00043121|Levoleucovorin|levoleucovorin|mesh-list
64958681|NCT00043121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64958682|NCT00043121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958683|NCT00043121|Antimetabolites|antimetabolites|mesh-ancestor
64958684|NCT00043121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497324|NCT04395105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64497325|NCT04395105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497326|NCT04072770|Caseins|caseins|mesh-list
64958685|NCT00043121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64958686|NCT00043121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958687|NCT00043121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64958688|NCT00043121|Immunologic Factors|immunologic factors|mesh-ancestor
64958689|NCT00043121|Antidotes|antidotes|mesh-ancestor
64958690|NCT00043121|Protective Agents|protective agents|mesh-ancestor
64958691|NCT00043121|Vitamin B Complex|vitamin b complex|mesh-ancestor
64958692|NCT00043121|Vitamins|vitamins|mesh-ancestor
64975830|NCT00251602|Cholinergic Agents|cholinergic agents|mesh-ancestor
64958716|NCT04727476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64958717|NCT04727476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958719|NCT04727476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64958720|NCT00124306|Amitriptyline|amitriptyline|mesh-list
64958721|NCT00124306|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64958722|NCT00124306|Antidepressive Agents|antidepressive agents|mesh-ancestor
64958723|NCT00124306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64958724|NCT00124306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64958725|NCT00124306|Analgesics|analgesics|mesh-ancestor
64958726|NCT00124306|Sensory System Agents|sensory system agents|mesh-ancestor
64534512|NCT00427791|Immunologic Factors|immunologic factors|mesh-ancestor
64534513|NCT00427791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534514|NCT00427791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64534515|NCT00427791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64534516|NCT00427791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64534517|NCT00427791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64534518|NCT00427791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534519|NCT00427791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534520|NCT01487161|Triamcinolone|triamcinolone|mesh-list
64534521|NCT01487161|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64534522|NCT01487161|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64534524|NCT01487161|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64534525|NCT01487161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64534526|NCT01487161|Glucocorticoids|glucocorticoids|mesh-ancestor
64534527|NCT01487161|Hormones|hormones|mesh-ancestor
64534528|NCT01487161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64534529|NCT01487161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534530|NCT01487161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64534531|NCT01487161|Immunologic Factors|immunologic factors|mesh-ancestor
64534532|NCT01487161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299104|NCT05003895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958727|NCT00124306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64958728|NCT00124306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958729|NCT00124306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64958730|NCT00124306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64958731|NCT00124306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64958732|NCT00124306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958733|NCT00124306|Adrenergic Agents|adrenergic agents|mesh-ancestor
64958734|NCT00124306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64958735|NCT00043199|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
64958736|NCT00043199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958738|NCT00124384|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64958739|NCT00124384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958740|NCT00124384|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64975960|NCT00252655|Immunologic Factors|immunologic factors|mesh-ancestor
64958764|NCT00043277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64958765|NCT00043277|Protease Inhibitors|protease inhibitors|mesh-ancestor
64958766|NCT00043277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958767|NCT00043277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958768|NCT00043277|Anticoagulants|anticoagulants|mesh-ancestor
64958769|NCT00074022|Docetaxel|docetaxel|mesh-list
64958770|NCT00074022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958771|NCT00074022|Tubulin Modulators|tubulin modulators|mesh-ancestor
64958772|NCT00074022|Antimitotic Agents|antimitotic agents|mesh-ancestor
64958773|NCT00074022|Mitosis Modulators|mitosis modulators|mesh-ancestor
64958774|NCT00074022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958775|NCT00124813|Thalidomide|thalidomide|mesh-list
64958776|NCT00124813|Idarubicin|idarubicin|mesh-list
64958777|NCT00124813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64958778|NCT00124813|Immunologic Factors|immunologic factors|mesh-ancestor
64534533|NCT01487161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534535|NCT00429507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64534536|NCT00429507|Analgesics|analgesics|mesh-ancestor
64534537|NCT00429507|Sensory System Agents|sensory system agents|mesh-ancestor
64534538|NCT00429507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64958779|NCT00124813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958780|NCT00124813|Leprostatic Agents|leprostatic agents|mesh-ancestor
64958781|NCT00124813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64958782|NCT00124813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64958783|NCT00124813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64958784|NCT00124813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64958785|NCT00124813|Growth Substances|growth substances|mesh-ancestor
64958786|NCT00124813|Growth Inhibitors|growth inhibitors|mesh-ancestor
64958787|NCT00124813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958788|NCT00124813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64958789|NCT00124813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64958816|NCT00124969|Vasodilator Agents|vasodilator agents|mesh-ancestor
64958817|NCT00043316|Interferons|interferons|mesh-list
64958818|NCT00043316|Interferon-gamma|interferon-gamma|mesh-list
64958819|NCT00043316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958820|NCT00043316|Antiviral Agents|antiviral agents|mesh-ancestor
64958821|NCT00043316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64958822|NCT00077961|Alemtuzumab|alemtuzumab|mesh-list
64976022|NCT00253162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64976024|NCT00253162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64958823|NCT00077961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64958824|NCT00077961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958825|NCT00125008|Vaccines|vaccines|mesh-list
64958826|NCT00125008|Immunologic Factors|immunologic factors|mesh-ancestor
64958827|NCT00125008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958828|NCT00125047|Vaccines|vaccines|mesh-list
64958829|NCT00125047|Immunologic Factors|immunologic factors|mesh-ancestor
64958830|NCT00125047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497552|NCT01253824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64958832|NCT00078000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958833|NCT00078000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64958854|NCT00043355|Interferons|interferons|mesh-list
64958855|NCT00043355|Interferon-gamma|interferon-gamma|mesh-list
64958857|NCT00043355|Antiviral Agents|antiviral agents|mesh-ancestor
64958858|NCT00043355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64958859|NCT00125398|Fospropofol|fospropofol|mesh-list
64958860|NCT00125398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64958861|NCT00125398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64958862|NCT00125398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958863|NCT04729998|Rivaroxaban|rivaroxaban|mesh-list
64958864|NCT04729998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64958865|NCT04729998|Antithrombins|antithrombins|mesh-ancestor
64958866|NCT04729998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64958867|NCT04729998|Protease Inhibitors|protease inhibitors|mesh-ancestor
64958868|NCT04729998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958869|NCT04729998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958870|NCT04729998|Anticoagulants|anticoagulants|mesh-ancestor
64958871|NCT00125437|Spironolactone|spironolactone|mesh-list
64958872|NCT00125437|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64958873|NCT00125437|Hormone Antagonists|hormone antagonists|mesh-ancestor
64958874|NCT00125437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64958875|NCT00125437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958876|NCT00125437|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64958877|NCT00125437|Diuretics|diuretics|mesh-ancestor
64958878|NCT00125437|Natriuretic Agents|natriuretic agents|mesh-ancestor
64958880|NCT00125554|Antimetabolites|antimetabolites|mesh-ancestor
64958881|NCT00125554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958882|NCT00125554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958883|NCT00043394|Trastuzumab|trastuzumab|mesh-list
64534539|NCT00429507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534540|NCT01794897|Valacyclovir|valacyclovir|mesh-list
64534541|NCT01794897|Antiviral Agents|antiviral agents|mesh-ancestor
64534542|NCT01794897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64534543|NCT01794975|Ketamine|ketamine|mesh-list
64534544|NCT01794975|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64534545|NCT01794975|Analgesics|analgesics|mesh-ancestor
64534546|NCT01794975|Sensory System Agents|sensory system agents|mesh-ancestor
64534547|NCT01794975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64534548|NCT01794975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534549|NCT01794975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64534550|NCT01794975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64534551|NCT01794975|Anesthetics, General|anesthetics, general|mesh-ancestor
64534552|NCT01794975|Anesthetics|anesthetics|mesh-ancestor
64534553|NCT01794975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64534554|NCT01794975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64534555|NCT01794975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64534556|NCT01794975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64534557|NCT01794975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534558|NCT01794975|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64534559|NCT01794975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64534560|NCT01794975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64534561|NCT01794975|Adrenergic Agents|adrenergic agents|mesh-ancestor
64534562|NCT05285787|Vitamin MK 7|vitamin mk 7|mesh-list
64534563|NCT05285787|Hemostatics|hemostatics|mesh-ancestor
64534564|NCT05285787|Coagulants|coagulants|mesh-ancestor
64534565|NCT01491035|Vortioxetine|vortioxetine|mesh-list
64534566|NCT01491035|Antidepressive Agents|antidepressive agents|mesh-ancestor
64534567|NCT01491035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64534568|NCT01491035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64534569|NCT01491035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64534570|NCT01491035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64534571|NCT01491035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299132|NCT00701727|Ezetimibe|ezetimibe|mesh-list
64534576|NCT01491035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64534577|NCT01491035|Serotonin Agents|serotonin agents|mesh-ancestor
64534578|NCT01491035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64534579|NCT01491035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64653455|NCT05566301|Clopidogrel|clopidogrel|mesh-list
64534580|NCT01491035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64534581|NCT01491035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64534583|NCT00375999|Epirubicin|epirubicin|mesh-list
64534584|NCT00375999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534585|NCT00375999|Tubulin Modulators|tubulin modulators|mesh-ancestor
64534586|NCT00375999|Antimitotic Agents|antimitotic agents|mesh-ancestor
64534587|NCT00375999|Mitosis Modulators|mitosis modulators|mesh-ancestor
64534588|NCT00375999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534589|NCT00375999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64534590|NCT00375999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64534591|NCT00375999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64958884|NCT00043394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64958885|NCT00043394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958886|NCT00125671|Warfarin|warfarin|mesh-list
64958914|NCT00125905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64958915|NCT00125905|Cholinergic Agents|cholinergic agents|mesh-ancestor
64958916|NCT00125905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64958917|NCT00125905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958918|NCT00125905|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64958919|NCT00125905|Antidepressive Agents|antidepressive agents|mesh-ancestor
64958920|NCT00125905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64958921|NCT00125905|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64958922|NCT00125905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64958923|NCT00125905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64958924|NCT00125905|Dopamine Agents|dopamine agents|mesh-ancestor
64958925|NCT00125905|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64958926|NCT00125905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64958927|NCT00125905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958928|NCT00078117|Buprenorphine|buprenorphine|mesh-list
64958929|NCT00078117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64958930|NCT00078117|Narcotics|narcotics|mesh-ancestor
64958931|NCT00078117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64958956|NCT00125983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64958957|NCT00125983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958958|NCT00125983|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64958959|NCT00125983|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64958960|NCT00126022|Tedisamil|tedisamil|mesh-list
64958961|NCT00126022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64958962|NCT00126022|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64958963|NCT00126022|Protective Agents|protective agents|mesh-ancestor
64958964|NCT00126022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958965|NCT00402454|Rifampin|rifampin|mesh-list
64958966|NCT00402454|Isoniazid|isoniazid|mesh-list
64958967|NCT00402454|Pyrazinamide|pyrazinamide|mesh-list
64958968|NCT00402454|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64958969|NCT00402454|Antitubercular Agents|antitubercular agents|mesh-ancestor
64958970|NCT00402454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64958971|NCT00402454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64958972|NCT00402454|Leprostatic Agents|leprostatic agents|mesh-ancestor
64958973|NCT00402454|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64958974|NCT00402454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958975|NCT00402454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534593|NCT04409327|Dactolisib|dactolisib|mesh-list
64534594|NCT04409327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534595|NCT01488071|Vortioxetine|vortioxetine|mesh-list
64534596|NCT01488071|S 20098|s 20098|mesh-list
64534597|NCT01488071|Antidepressive Agents|antidepressive agents|mesh-ancestor
64534598|NCT01488071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64534599|NCT01488071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64534600|NCT01488071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64534601|NCT01488071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64976117|NCT00253552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64976118|NCT00253591|Vinorelbine|vinorelbine|mesh-list
64534602|NCT01488071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534603|NCT01488071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64958976|NCT00402454|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64497625|NCT00988533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64958977|NCT00402454|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64958978|NCT00402454|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64958979|NCT00402454|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64958980|NCT00402454|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64959018|NCT00043589|Donepezil|donepezil|mesh-list
64959019|NCT00043589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64959038|NCT00399399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64959039|NCT00126100|Lenograstim|lenograstim|mesh-list
64959040|NCT00126100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64959041|NCT00126100|Immunologic Factors|immunologic factors|mesh-ancestor
64959042|NCT00126100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959044|NCT00126139|Anticoagulants|anticoagulants|mesh-ancestor
64959045|NCT00126139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64959046|NCT00074100|Amonafide|amonafide|mesh-list
64959047|NCT00074100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959048|NCT00074100|Antiviral Agents|antiviral agents|mesh-ancestor
64959049|NCT00074100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64959050|NCT00074100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497701|NCT03608358|Incretins|incretins|mesh-ancestor
64959051|NCT00074100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959053|NCT00126256|Fluorouracil|fluorouracil|mesh-list
64959054|NCT00126256|Oxaliplatin|oxaliplatin|mesh-list
64959055|NCT00126256|Irinotecan|irinotecan|mesh-list
64959056|NCT00126256|Antimetabolites|antimetabolites|mesh-ancestor
64959057|NCT00126256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959058|NCT00126256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64959059|NCT00126256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959060|NCT00126256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64959061|NCT00126256|Immunologic Factors|immunologic factors|mesh-ancestor
64959062|NCT00126256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959063|NCT00126256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64959064|NCT00126256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64959065|NCT00126256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959066|NCT00126256|Antidotes|antidotes|mesh-ancestor
64959067|NCT00126256|Protective Agents|protective agents|mesh-ancestor
64959068|NCT00126256|Vitamin B Complex|vitamin b complex|mesh-ancestor
64959069|NCT00126256|Vitamins|vitamins|mesh-ancestor
64959070|NCT00126256|Micronutrients|micronutrients|mesh-ancestor
64959071|NCT00043667|Daclizumab|daclizumab|mesh-list
64959072|NCT00043667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64959073|NCT00043667|Immunologic Factors|immunologic factors|mesh-ancestor
64959074|NCT00043667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959075|NCT00074139|Cyclophosphamide|cyclophosphamide|mesh-list
64959076|NCT00074139|Docetaxel|docetaxel|mesh-list
64959077|NCT00074139|Doxorubicin|doxorubicin|mesh-list
64959111|NCT00126412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959112|NCT00126412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959113|NCT00126412|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64959114|NCT00043706|Antibodies|antibodies|mesh-list
64534604|NCT01488071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64534605|NCT01488071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64534606|NCT01488071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534607|NCT01488071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64534609|NCT01488071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64534610|NCT01488071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64534611|NCT01488071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64534612|NCT01488071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64534613|NCT01488071|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64534614|NCT01485887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64534615|NCT01485887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64534616|NCT01485887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64534617|NCT01485887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64534618|NCT01485887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534619|NCT01485887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64959115|NCT00043706|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64959151|NCT00074178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64959152|NCT00074178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64959167|NCT00126646|Antibodies|antibodies|mesh-list
64959168|NCT00126646|Immunoconjugates|immunoconjugates|mesh-list
64959170|NCT00126646|Immunologic Factors|immunologic factors|mesh-ancestor
64959171|NCT00126646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959172|NCT00126763|Fentanyl|fentanyl|mesh-list
64959173|NCT00126763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64959174|NCT00126763|Narcotics|narcotics|mesh-ancestor
64959175|NCT00126763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64959176|NCT00126763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959177|NCT00126763|Analgesics|analgesics|mesh-ancestor
64959178|NCT00126763|Sensory System Agents|sensory system agents|mesh-ancestor
64959179|NCT00126763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64959180|NCT00126763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64959181|NCT00126763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64959182|NCT00126763|Anesthetics, General|anesthetics, general|mesh-ancestor
64959183|NCT00126763|Anesthetics|anesthetics|mesh-ancestor
64959184|NCT00402571|Acetaminophen|acetaminophen|mesh-list
64959185|NCT00402571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64959186|NCT00402571|Analgesics|analgesics|mesh-ancestor
64959187|NCT00402571|Sensory System Agents|sensory system agents|mesh-ancestor
64959188|NCT00402571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64959189|NCT00402571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959190|NCT00402571|Antipyretics|antipyretics|mesh-ancestor
64959191|NCT00126880|Lamivudine|lamivudine|mesh-list
64959192|NCT00126880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64959193|NCT00126880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64959194|NCT00126880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959195|NCT00126880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959196|NCT00126880|Antiviral Agents|antiviral agents|mesh-ancestor
64959197|NCT00126880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64959198|NCT00126880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64959199|NCT00126880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64959200|NCT02965911|Fenofibrate|fenofibrate|mesh-list
64959201|NCT02965911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64976227|NCT00254800|Incretins|incretins|mesh-ancestor
64959202|NCT02965911|Antimetabolites|antimetabolites|mesh-ancestor
64534620|NCT01485887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534621|NCT01485887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64534622|NCT01485887|Antidepressive Agents|antidepressive agents|mesh-ancestor
64534623|NCT01485887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64534624|NCT01484951|Timolol|timolol|mesh-list
64959203|NCT02965911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959204|NCT02965911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64959205|NCT00127075|Estradiol|estradiol|mesh-list
64959206|NCT00127075|Estrogens|estrogens|mesh-ancestor
64959207|NCT00127075|Hormones|hormones|mesh-ancestor
64959208|NCT00127075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64959209|NCT00127075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959210|NCT00127114|Amantadine|amantadine|mesh-list
64959211|NCT00127114|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64959212|NCT00127114|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64959213|NCT00127114|Antiviral Agents|antiviral agents|mesh-ancestor
64959214|NCT00127114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64959234|NCT00399477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64959235|NCT00399477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64959237|NCT00399477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64959238|NCT00399477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959239|NCT00399477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959240|NCT00399477|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64959241|NCT00399477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959242|NCT00399477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64959243|NCT00399477|Protective Agents|protective agents|mesh-ancestor
64959244|NCT00399477|Antioxidants|antioxidants|mesh-ancestor
64959245|NCT00399477|Dopamine Agonists|dopamine agonists|mesh-ancestor
64959246|NCT00127270|Darifenacin|darifenacin|mesh-list
64959247|NCT00127270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64959248|NCT00127270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64959249|NCT00127270|Cholinergic Agents|cholinergic agents|mesh-ancestor
64959250|NCT00127270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64959251|NCT00127270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959252|NCT00127270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959253|NCT00127270|Urological Agents|urological agents|mesh-ancestor
64959254|NCT00043823|Bevacizumab|bevacizumab|mesh-list
64959255|NCT00043823|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64959256|NCT00043823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64959257|NCT00043823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959258|NCT00043823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64959259|NCT00043823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64959260|NCT00043823|Growth Substances|growth substances|mesh-ancestor
64959261|NCT00043823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959262|NCT00043823|Growth Inhibitors|growth inhibitors|mesh-ancestor
64959263|NCT00043823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64959264|NCT00043823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976230|NCT00254800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64959265|NCT00043823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959266|NCT00074334|Immunotoxins|immunotoxins|mesh-list
64959267|NCT00074334|Immunologic Factors|immunologic factors|mesh-ancestor
64959268|NCT00074334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959269|NCT00127387|Etanercept|etanercept|mesh-list
64959297|NCT00127504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64959298|NCT00127504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64959299|NCT00127504|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64959300|NCT00127504|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64959301|NCT00127504|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64959302|NCT00127504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64959303|NCT00043901|Lamotrigine|lamotrigine|mesh-list
64959304|NCT00043901|Anticonvulsants|anticonvulsants|mesh-ancestor
64959305|NCT00043901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64959306|NCT00043901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64959307|NCT00043901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959308|NCT00043901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64959309|NCT00043901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959310|NCT00043901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64959311|NCT00043901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64959312|NCT00043901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64534625|NCT01484951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64534626|NCT01484951|Brinzolamide|brinzolamide|mesh-list
64534627|NCT01484951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64534628|NCT01484951|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64534629|NCT01484951|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64534630|NCT01484951|Adrenergic Agents|adrenergic agents|mesh-ancestor
64534631|NCT01484951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64959313|NCT00043901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64959314|NCT00043901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64959326|NCT00127777|Sensory System Agents|sensory system agents|mesh-ancestor
64959327|NCT00127777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64959328|NCT00399633|Sumatriptan|sumatriptan|mesh-list
64959329|NCT00399633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64959330|NCT00399633|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64959331|NCT00399633|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64959332|NCT00399633|Serotonin Agents|serotonin agents|mesh-ancestor
64959333|NCT00399633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64959334|NCT00399633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959335|NCT00399633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959337|NCT04726657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64959338|NCT04726657|Insulin, Isophane|insulin, isophane|mesh-list
64959339|NCT04726657|Isophane Insulin, Human|isophane insulin, human|mesh-list
64976275|NCT00254917|Immunologic Factors|immunologic factors|mesh-ancestor
64540078|NCT03025867|Niraparib|niraparib|mesh-list
64959340|NCT04726657|Isophane insulin, beef|isophane insulin, beef|mesh-list
64959341|NCT04726657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64959342|NCT04726657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959343|NCT00402610|Rifampin|rifampin|mesh-list
64959344|NCT00402610|Isoniazid|isoniazid|mesh-list
64959345|NCT00402610|Pyrazinamide|pyrazinamide|mesh-list
64959346|NCT00402610|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64959347|NCT00402610|Antitubercular Agents|antitubercular agents|mesh-ancestor
64498002|NCT03032601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959348|NCT00402610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64959349|NCT00402610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64959350|NCT00402610|Leprostatic Agents|leprostatic agents|mesh-ancestor
64959351|NCT00402610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64959352|NCT00402610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959353|NCT00402610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959354|NCT00402610|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64959355|NCT00402610|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64959356|NCT00402610|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64959357|NCT00402610|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64959358|NCT00402610|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64959359|NCT00402610|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64959360|NCT00402610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64959361|NCT00402610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64959362|NCT00402610|Antimetabolites|antimetabolites|mesh-ancestor
64959363|NCT00402610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64959364|NCT00402766|Dexamethasone|dexamethasone|mesh-list
64959365|NCT00402766|Cisplatin|cisplatin|mesh-list
64959366|NCT00402766|Pemetrexed|pemetrexed|mesh-list
64959367|NCT00402766|Imatinib Mesylate|imatinib mesylate|mesh-list
64959368|NCT00402766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64959369|NCT00402766|Antiemetics|antiemetics|mesh-ancestor
64959370|NCT00402766|Autonomic Agents|autonomic agents|mesh-ancestor
64959371|NCT00402766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64959372|NCT00402766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959373|NCT00402766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64959374|NCT00402766|Glucocorticoids|glucocorticoids|mesh-ancestor
64959375|NCT00402766|Hormones|hormones|mesh-ancestor
64959376|NCT00402766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64959377|NCT00402766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64959401|NCT00127972|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64959402|NCT00127972|Antimetabolites|antimetabolites|mesh-ancestor
64959403|NCT00043940|Bivalirudin|bivalirudin|mesh-list
64959404|NCT00043940|Antithrombins|antithrombins|mesh-ancestor
64959405|NCT00043940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64959406|NCT00043940|Protease Inhibitors|protease inhibitors|mesh-ancestor
64959407|NCT00043940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534632|NCT01484951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534633|NCT01484951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534634|NCT01484951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64534635|NCT01484951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64534636|NCT01484951|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64534637|NCT01484951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534639|NCT01484873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64534640|NCT01484873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534641|NCT01484873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64534642|NCT01484873|Incretins|incretins|mesh-ancestor
64534643|NCT01484873|Hormones|hormones|mesh-ancestor
64299229|NCT04150640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64959408|NCT00043940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959409|NCT00043940|Anticoagulants|anticoagulants|mesh-ancestor
64959410|NCT04711434|Antibodies|antibodies|mesh-list
64959411|NCT04711434|Immunologic Factors|immunologic factors|mesh-ancestor
64959412|NCT04711434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959413|NCT00128245|Pimecrolimus|pimecrolimus|mesh-list
64959414|NCT00128245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64959415|NCT00128245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64959416|NCT00128245|Analgesics|analgesics|mesh-ancestor
64959417|NCT00128245|Sensory System Agents|sensory system agents|mesh-ancestor
64959418|NCT00128245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64959419|NCT00128245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959420|NCT00128245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64959421|NCT00128245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64959422|NCT00128245|Dermatologic Agents|dermatologic agents|mesh-ancestor
64959423|NCT00128245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64498148|NCT01297348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959425|NCT00128245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64959426|NCT00128245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653495|NCT01045460|Cyclophosphamide|cyclophosphamide|mesh-list
64959460|NCT00044291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
64959461|NCT00044291|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
64959462|NCT00044291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64959463|NCT00044291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959464|NCT00044291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959465|NCT00044291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64959466|NCT00044291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64959467|NCT00044291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959468|NCT00044291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959469|NCT00044291|Hormone Antagonists|hormone antagonists|mesh-ancestor
64959499|NCT05519917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64959500|NCT05519917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959501|NCT05519917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959503|NCT00078390|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
64959504|NCT00078390|Protease Inhibitors|protease inhibitors|mesh-ancestor
64959505|NCT00078390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959506|NCT00078390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959507|NCT00044486|Posaconazole|posaconazole|mesh-list
64959508|NCT00044486|Antifungal Agents|antifungal agents|mesh-ancestor
64959509|NCT00044486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64959510|NCT00044486|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64959511|NCT00044486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64959512|NCT00044486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64959513|NCT00044486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64959514|NCT00044486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64959515|NCT00044486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534648|NCT00379197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64534649|NCT00379197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64534650|NCT00379197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534651|NCT00379197|Sensory System Agents|sensory system agents|mesh-ancestor
64534652|NCT00379197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64534653|NCT01513759|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64534654|NCT01513759|Plasminogen|plasminogen|mesh-list
64534655|NCT01513759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64299242|NCT05054114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64976304|NCT00255268|Goserelin|goserelin|mesh-list
64959516|NCT00044486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959537|NCT05417425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64959538|NCT05417425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64959539|NCT05417425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959541|NCT00397475|Vitamin D|vitamin d|mesh-list
64959542|NCT00397475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64959543|NCT00397475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959544|NCT00397475|Vitamins|vitamins|mesh-ancestor
64959545|NCT00397475|Micronutrients|micronutrients|mesh-ancestor
64959546|NCT00397475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64959547|NCT00074607|Gemcitabine|gemcitabine|mesh-list
64959548|NCT00074607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64959549|NCT00074607|Antimetabolites|antimetabolites|mesh-ancestor
64959550|NCT00074607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959551|NCT00074607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959552|NCT00074607|Antiviral Agents|antiviral agents|mesh-ancestor
64959553|NCT00074607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64959554|NCT00074607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959555|NCT00074607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64959556|NCT00074607|Immunologic Factors|immunologic factors|mesh-ancestor
64959557|NCT00074607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959558|NCT05305885|Pemetrexed|pemetrexed|mesh-list
64959559|NCT05305885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959560|NCT05305885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959561|NCT05305885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959562|NCT05305885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64959563|NCT05305885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64959564|NCT00044564|IDN 5109|idn 5109|mesh-list
64959565|NCT00044564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959603|NCT00044681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64959604|NCT00044681|Dopamine Agents|dopamine agents|mesh-ancestor
64959605|NCT05002465|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64959606|NCT05002465|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64959607|NCT05002465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959609|NCT00044720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64959610|NCT00044720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64959611|NCT00044720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64959612|NCT00044720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540099|NCT01412879|Alkylating Agents|alkylating agents|mesh-ancestor
64976390|NCT00070148|Hormones|hormones|mesh-ancestor
64959643|NCT00078858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959644|NCT00078858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64959645|NCT00078858|Antimetabolites|antimetabolites|mesh-ancestor
64959646|NCT00078858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959647|NCT00078858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64534656|NCT01513759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64534657|NCT01513759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534658|NCT01484561|Tofacitinib|tofacitinib|mesh-list
64534659|NCT01484561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64534660|NCT01484561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534661|NCT01484561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534662|NCT01483625|Tiotropium Bromide|tiotropium bromide|mesh-list
64534663|NCT01483625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64534664|NCT01483625|Autonomic Agents|autonomic agents|mesh-ancestor
64534665|NCT01483625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64534666|NCT01483625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534667|NCT01483625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64534668|NCT01483625|Respiratory System Agents|respiratory system agents|mesh-ancestor
64534669|NCT01483625|Parasympatholytics|parasympatholytics|mesh-ancestor
64534670|NCT01483625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64534671|NCT01483625|Cholinergic Agents|cholinergic agents|mesh-ancestor
64534672|NCT01483625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64299254|NCT02097511|Metoprolol|metoprolol|mesh-list
64959648|NCT00078858|Immunologic Factors|immunologic factors|mesh-ancestor
64959649|NCT00078858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959650|NCT00078858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959651|NCT00078858|Antifungal Agents|antifungal agents|mesh-ancestor
64959652|NCT00078858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64959653|NCT00078858|Dermatologic Agents|dermatologic agents|mesh-ancestor
64959654|NCT00078858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64959655|NCT00078858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64959679|NCT00074841|Azithromycin|azithromycin|mesh-list
64959680|NCT00074841|Chloroquine|chloroquine|mesh-list
64959681|NCT00074841|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64959682|NCT00074841|Pyrimethamine|pyrimethamine|mesh-list
64959683|NCT00074841|Sulfadoxine|sulfadoxine|mesh-list
64959684|NCT00074841|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64959685|NCT00074841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64959686|NCT00074841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64959687|NCT00074841|Amebicides|amebicides|mesh-ancestor
64959688|NCT00074841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64959689|NCT00074841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64959690|NCT00074841|Antimalarials|antimalarials|mesh-ancestor
64959691|NCT00074841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64959692|NCT00074841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64959693|NCT00074841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64959694|NCT00074841|Analgesics|analgesics|mesh-ancestor
64959695|NCT00074841|Sensory System Agents|sensory system agents|mesh-ancestor
64959698|NCT00074841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64959699|NCT00074841|Filaricides|filaricides|mesh-ancestor
64959700|NCT00074841|Antinematodal Agents|antinematodal agents|mesh-ancestor
64959701|NCT00074841|Anthelmintics|anthelmintics|mesh-ancestor
64959702|NCT00074841|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64959703|NCT00074841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959704|NCT00074841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959735|NCT04457557|Ropivacaine|ropivacaine|mesh-list
64959736|NCT04457557|Anesthetics, Local|anesthetics, local|mesh-list
64959737|NCT04457557|Anesthetics|anesthetics|mesh-list
64959738|NCT04457557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64534673|NCT01483625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534674|NCT01485991|Simeprevir|simeprevir|mesh-list
64534675|NCT01485991|Antiviral Agents|antiviral agents|mesh-ancestor
64534676|NCT01485991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64534677|NCT01485991|Protease Inhibitors|protease inhibitors|mesh-ancestor
64534678|NCT01485991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534679|NCT01485991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534680|NCT00379821|Azithromycin|azithromycin|mesh-list
64959739|NCT04457557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959740|NCT04457557|Sensory System Agents|sensory system agents|mesh-ancestor
64959741|NCT04457557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64959742|NCT00044876|Ulipristal acetate|ulipristal acetate|mesh-list
64959743|NCT00044876|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64959744|NCT00044876|Contraceptive Agents|contraceptive agents|mesh-ancestor
64959745|NCT00044876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64959775|NCT04321408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959776|NCT04321408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64959777|NCT04321408|Protective Agents|protective agents|mesh-ancestor
64959778|NCT04321408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64959780|NCT04321408|Sensory System Agents|sensory system agents|mesh-ancestor
64959781|NCT04321408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64959782|NCT00079053|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64959783|NCT00079053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959784|NCT00079053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64959785|NCT00079053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959816|NCT00044954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64959817|NCT00044954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64959818|NCT00044954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64959819|NCT00044954|Antitubercular Agents|antitubercular agents|mesh-ancestor
64959820|NCT00044954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64959821|NCT00079092|Thalidomide|thalidomide|mesh-list
64959822|NCT00079092|Procarbazine|procarbazine|mesh-list
64959823|NCT00079092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64959824|NCT00079092|Immunologic Factors|immunologic factors|mesh-ancestor
64959825|NCT00079092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959826|NCT00079092|Leprostatic Agents|leprostatic agents|mesh-ancestor
64959827|NCT00079092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64959828|NCT00079092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64959829|NCT00079092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64959846|NCT04162210|Dexamethasone|dexamethasone|mesh-list
64959847|NCT04162210|Pomalidomide|pomalidomide|mesh-list
64959848|NCT04162210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64959849|NCT04162210|Antiemetics|antiemetics|mesh-ancestor
64959850|NCT04162210|Autonomic Agents|autonomic agents|mesh-ancestor
64959851|NCT04162210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64959852|NCT04162210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653525|NCT05014919|Serotonin Agents|serotonin agents|mesh-ancestor
64959853|NCT04162210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64959854|NCT04162210|Glucocorticoids|glucocorticoids|mesh-ancestor
64959856|NCT04162210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64959857|NCT04162210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64959858|NCT04162210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959859|NCT04162210|Immunologic Factors|immunologic factors|mesh-ancestor
64959860|NCT04162210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64959861|NCT04162210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64959862|NCT04162210|Growth Substances|growth substances|mesh-ancestor
64959863|NCT04162210|Growth Inhibitors|growth inhibitors|mesh-ancestor
64959864|NCT00079131|Oblimersen|oblimersen|mesh-list
64959865|NCT00079131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959866|NCT00045149|Aldesleukin|aldesleukin|mesh-list
64959867|NCT00045149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959868|NCT00045149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64959869|NCT00045149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64959870|NCT00045149|Antiviral Agents|antiviral agents|mesh-ancestor
64959871|NCT00045149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64959872|NCT00045188|Imatinib Mesylate|imatinib mesylate|mesh-list
64959873|NCT00045188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534681|NCT00379821|Artesunate|artesunate|mesh-list
64534682|NCT00379821|Chloroquine|chloroquine|mesh-list
64534683|NCT00379821|Atovaquone|atovaquone|mesh-list
64534684|NCT00379821|Proguanil|proguanil|mesh-list
64534685|NCT00379821|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
64534686|NCT00379821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64534687|NCT00379821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64534688|NCT00379821|Antimalarials|antimalarials|mesh-ancestor
64534689|NCT00379821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64534690|NCT00379821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64534691|NCT00379821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534692|NCT00379821|Antiviral Agents|antiviral agents|mesh-ancestor
64534693|NCT00379821|Schistosomicides|schistosomicides|mesh-ancestor
64534694|NCT00379821|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64534695|NCT00379821|Anthelmintics|anthelmintics|mesh-ancestor
64534696|NCT00379821|Amebicides|amebicides|mesh-ancestor
64534697|NCT00379821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64534698|NCT00379821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534699|NCT00379821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534700|NCT00379821|Antimetabolites|antimetabolites|mesh-ancestor
64959874|NCT00045188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64959875|NCT00045188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959876|NCT00045188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959877|NCT00403156|Ranibizumab|ranibizumab|mesh-list
64959878|NCT00403156|Imatinib Mesylate|imatinib mesylate|mesh-list
64959879|NCT00403156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64959880|NCT00403156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64959881|NCT00403156|Growth Substances|growth substances|mesh-ancestor
64959882|NCT00403156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959883|NCT00403156|Growth Inhibitors|growth inhibitors|mesh-ancestor
64959884|NCT00403156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959885|NCT00403156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64959886|NCT00403156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959887|NCT00403156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959888|NCT00045227|Docetaxel|docetaxel|mesh-list
64959889|NCT00045227|Vaccines|vaccines|mesh-list
64959907|NCT04065451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959909|NCT04065451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64959910|NCT04065451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64959911|NCT04065451|Autonomic Agents|autonomic agents|mesh-ancestor
64959912|NCT04065451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64959913|NCT04065451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64959914|NCT04065451|Respiratory System Agents|respiratory system agents|mesh-ancestor
64959915|NCT04065451|Mydriatics|mydriatics|mesh-ancestor
64959916|NCT04065451|Sympathomimetics|sympathomimetics|mesh-ancestor
64959917|NCT04065451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64959918|NCT00045266|Aflibercept|aflibercept|mesh-list
64959919|NCT00045266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64959920|NCT00045266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64959921|NCT00045266|Growth Substances|growth substances|mesh-ancestor
64959922|NCT00045266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959923|NCT00045266|Growth Inhibitors|growth inhibitors|mesh-ancestor
64959924|NCT00045266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959925|NCT03953131|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
64959926|NCT03953131|Chelating Agents|chelating agents|mesh-ancestor
64959927|NCT03953131|Sequestering Agents|sequestering agents|mesh-ancestor
64534702|NCT01482767|Ribavirin|ribavirin|mesh-list
64534703|NCT01482767|Interferon-alpha|interferon-alpha|mesh-list
64534704|NCT01482767|Interferon alpha-2|interferon alpha-2|mesh-list
64534705|NCT01482767|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64534706|NCT01482767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534707|NCT01482767|Antiviral Agents|antiviral agents|mesh-ancestor
64534708|NCT01482767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64534709|NCT01482767|Antimetabolites|antimetabolites|mesh-ancestor
64534710|NCT01482767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534711|NCT01482767|Immunologic Factors|immunologic factors|mesh-ancestor
64534712|NCT01482767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534713|NCT00435591|Conivaptan|conivaptan|mesh-list
64534714|NCT00435591|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64534715|NCT00435591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534716|NCT00435591|Natriuretic Agents|natriuretic agents|mesh-ancestor
64534717|NCT00435591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534718|NCT00439335|Vaccines|vaccines|mesh-list
64534719|NCT00439335|Immunologic Factors|immunologic factors|mesh-ancestor
64534720|NCT00439335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534721|NCT01545817|Everolimus|everolimus|mesh-list
64534722|NCT01545817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534723|NCT01545817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64534724|NCT01545817|Immunologic Factors|immunologic factors|mesh-ancestor
64959928|NCT03953131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959929|NCT03948568|Tamoxifen|tamoxifen|mesh-list
64959930|NCT03948568|Letrozole|letrozole|mesh-list
64959931|NCT03948568|Anastrozole|anastrozole|mesh-list
64959932|NCT03948568|Exemestane|exemestane|mesh-list
64959933|NCT03948568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959934|NCT03948568|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64959935|NCT03948568|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64959936|NCT03948568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959937|NCT03948568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959938|NCT03948568|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64959939|NCT03948568|Hormone Antagonists|hormone antagonists|mesh-ancestor
64959940|NCT03948568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64959941|NCT03948568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959942|NCT03948568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64498600|NCT01369888|Fludarabine|fludarabine|mesh-list
64959943|NCT03948568|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64959944|NCT03948568|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64959978|NCT00075192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959979|NCT00075192|Androgen Antagonists|androgen antagonists|mesh-ancestor
64959980|NCT00075192|Hormone Antagonists|hormone antagonists|mesh-ancestor
64959981|NCT00075192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64959982|NCT03739411|Temozolomide|temozolomide|mesh-list
64959983|NCT03739411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64959984|NCT03739411|Alkylating Agents|alkylating agents|mesh-ancestor
64534725|NCT01545817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534727|NCT01512979|Linagliptin|linagliptin|mesh-list
64534728|NCT01512979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64534729|NCT01512979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534730|NCT01512979|Incretins|incretins|mesh-ancestor
64534731|NCT01512979|Hormones|hormones|mesh-ancestor
64534732|NCT01512979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64534733|NCT01512979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64534734|NCT01512979|Protease Inhibitors|protease inhibitors|mesh-ancestor
64534735|NCT01512979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534736|NCT01512979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534737|NCT00383565|Romidepsin|romidepsin|mesh-list
64959985|NCT03739411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959986|NCT03739411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959987|NCT00045461|Carboplatin|carboplatin|mesh-list
64960003|NCT00075231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960005|NCT00075231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64960006|NCT00075231|Antiviral Agents|antiviral agents|mesh-ancestor
64960007|NCT00075231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64960008|NCT00075231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64960009|NCT00075231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64960010|NCT00075231|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64960011|NCT00075231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64960012|NCT00075231|Antimetabolites|antimetabolites|mesh-ancestor
64976476|NCT00415285|Antimitotic Agents|antimitotic agents|mesh-ancestor
64960013|NCT00075231|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64498678|NCT01611935|Coagulants|coagulants|mesh-ancestor
64960014|NCT00075231|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64960015|NCT00075231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64960016|NCT00075231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64960017|NCT00075231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64960018|NCT00403312|Nicotine|nicotine|mesh-list
64960019|NCT00403312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64960020|NCT00403312|Autonomic Agents|autonomic agents|mesh-ancestor
64960021|NCT00403312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64960022|NCT00403312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960023|NCT00403312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64960024|NCT00403312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64960025|NCT00403312|Cholinergic Agents|cholinergic agents|mesh-ancestor
64960026|NCT00403312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64960027|NCT00403312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960028|NCT00079170|Docetaxel|docetaxel|mesh-list
64960029|NCT00079170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960030|NCT00079170|Tubulin Modulators|tubulin modulators|mesh-ancestor
64960031|NCT00079170|Antimitotic Agents|antimitotic agents|mesh-ancestor
64960032|NCT00079170|Mitosis Modulators|mitosis modulators|mesh-ancestor
64960033|NCT00079170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960034|NCT00045500|Prednisone|prednisone|mesh-list
64960035|NCT00045500|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
64960036|NCT00045500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64960037|NCT00045500|Glucocorticoids|glucocorticoids|mesh-ancestor
64960038|NCT00045500|Hormones|hormones|mesh-ancestor
64960039|NCT00045500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64960040|NCT00045500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960041|NCT00045500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64960042|NCT00045500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960043|NCT00045500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64960044|NCT00045500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534738|NCT00383565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64534739|NCT00383565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534740|NCT01512745|Apatinib|apatinib|mesh-list
64534741|NCT01512745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534742|NCT01512745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64534743|NCT01512745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534744|NCT01512745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534745|NCT01478321|Bevacizumab|bevacizumab|mesh-list
64534746|NCT01478321|Temozolomide|temozolomide|mesh-list
64534747|NCT01478321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64534748|NCT01478321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534749|NCT01478321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64299338|NCT05066516|Incretins|incretins|mesh-ancestor
64960045|NCT00045500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960046|NCT00045539|Leucovorin|leucovorin|mesh-list
64960070|NCT00045539|Vitamins|vitamins|mesh-ancestor
64960071|NCT00045539|Micronutrients|micronutrients|mesh-ancestor
64960072|NCT00045539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64960073|NCT00045539|Alkylating Agents|alkylating agents|mesh-ancestor
64960074|NCT00045539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64960075|NCT00079248|Progesterone|progesterone|mesh-list
64960076|NCT00079248|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64960077|NCT00079248|Estrogens|estrogens|mesh-list
64960078|NCT00079248|Progestins|progestins|mesh-ancestor
64960079|NCT00079248|Hormones|hormones|mesh-ancestor
64960080|NCT00079248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64960081|NCT00079248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960082|NCT00045617|Etoposide|etoposide|mesh-list
64960083|NCT00045617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64960084|NCT00045617|Vaccines|vaccines|mesh-list
64960085|NCT00045617|Antibodies|antibodies|mesh-list
64960086|NCT00045617|Immunoglobulins|immunoglobulins|mesh-list
64960087|NCT00045617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64960088|NCT00045617|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
64960089|NCT00045617|Immunologic Factors|immunologic factors|mesh-ancestor
64960090|NCT00045617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960091|NCT00045617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960092|NCT00045617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64960093|NCT00045617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64960094|NCT00045617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64960095|NCT00045617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960096|NCT00045617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960097|NCT03442309|Fluorides|fluorides|mesh-list
64960098|NCT03442309|Fluorides, Topical|fluorides, topical|mesh-list
64960099|NCT03442309|Cariostatic Agents|cariostatic agents|mesh-ancestor
64960135|NCT00079287|Mitosis Modulators|mitosis modulators|mesh-ancestor
64960136|NCT00079287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960137|NCT00079287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64960138|NCT00079287|Antimetabolites|antimetabolites|mesh-ancestor
64960139|NCT00079287|Antiviral Agents|antiviral agents|mesh-ancestor
64960140|NCT00079287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64960141|NCT00079287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960172|NCT00045773|Serotonin Agents|serotonin agents|mesh-ancestor
64960173|NCT00045773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960174|NCT02839915|Leucovorin|leucovorin|mesh-list
64960175|NCT02839915|Folic Acid|folic acid|mesh-list
64960176|NCT02839915|Levoleucovorin|levoleucovorin|mesh-list
64960177|NCT02839915|Antidotes|antidotes|mesh-ancestor
64960178|NCT02839915|Protective Agents|protective agents|mesh-ancestor
64960179|NCT02839915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960180|NCT02839915|Vitamin B Complex|vitamin b complex|mesh-ancestor
64960181|NCT02839915|Vitamins|vitamins|mesh-ancestor
64960182|NCT02839915|Micronutrients|micronutrients|mesh-ancestor
64960183|NCT02839915|Hematinics|hematinics|mesh-ancestor
64534750|NCT01478321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64534751|NCT01478321|Growth Substances|growth substances|mesh-ancestor
64534752|NCT01478321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534753|NCT01478321|Growth Inhibitors|growth inhibitors|mesh-ancestor
64960184|NCT00045812|Ezetimibe|ezetimibe|mesh-list
64960185|NCT00045812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64960186|NCT00045812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64960187|NCT00045812|Antimetabolites|antimetabolites|mesh-ancestor
64960215|NCT02580838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960216|NCT02580838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64960217|NCT02580838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64960218|NCT02580838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960219|NCT02580838|Cholinergic Agents|cholinergic agents|mesh-ancestor
64960220|NCT02580838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64960221|NCT00403429|Capecitabine|capecitabine|mesh-list
64960222|NCT00403429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64960223|NCT00403429|Antimetabolites|antimetabolites|mesh-ancestor
64976530|NCT00070304|Gemcitabine|gemcitabine|mesh-list
64960224|NCT00403429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960225|NCT00403429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960226|NCT00403624|Oxaliplatin|oxaliplatin|mesh-list
64960227|NCT00403624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960228|NCT00079560|Dronabinol|dronabinol|mesh-list
64960229|NCT00079560|Hallucinogens|hallucinogens|mesh-ancestor
64960230|NCT00079560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960231|NCT00079560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64960232|NCT00079560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64960233|NCT00079560|Analgesics|analgesics|mesh-ancestor
64960264|NCT01409161|Keratolytic Agents|keratolytic agents|mesh-ancestor
64960265|NCT01409161|Dermatologic Agents|dermatologic agents|mesh-ancestor
64960266|NCT01409161|Antioxidants|antioxidants|mesh-ancestor
64960267|NCT01409161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960268|NCT01409161|Protective Agents|protective agents|mesh-ancestor
64960269|NCT01409161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64960270|NCT01409161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64960272|NCT00079638|Niacin|niacin|mesh-list
64960273|NCT00079638|Atorvastatin|atorvastatin|mesh-list
64960274|NCT00079638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64960275|NCT00079638|Simvastatin|simvastatin|mesh-list
64960276|NCT00079638|Ezetimibe|ezetimibe|mesh-list
64960277|NCT00079638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64960309|NCT00130468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960310|NCT00130468|Viscosupplements|viscosupplements|mesh-ancestor
64960311|NCT00130468|Protective Agents|protective agents|mesh-ancestor
64960312|NCT00130507|Capecitabine|capecitabine|mesh-list
64960313|NCT00130507|Trastuzumab|trastuzumab|mesh-list
64960314|NCT00130507|Vinorelbine|vinorelbine|mesh-list
64960315|NCT00130507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64960316|NCT00130507|Antimetabolites|antimetabolites|mesh-ancestor
64960317|NCT00130507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960337|NCT00130546|Immunologic Factors|immunologic factors|mesh-ancestor
64960338|NCT00130546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960340|NCT00130585|Vitamin B Complex|vitamin b complex|mesh-list
64960341|NCT00130585|Hematinics|hematinics|mesh-ancestor
64960342|NCT00130585|Vitamins|vitamins|mesh-ancestor
64960343|NCT00130585|Micronutrients|micronutrients|mesh-ancestor
64960344|NCT00130585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960345|NCT00079755|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64960346|NCT00079755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64960347|NCT00079755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960348|NCT00130702|Gefitinib|gefitinib|mesh-list
64960349|NCT00130702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960350|NCT00130702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64960351|NCT00130702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960352|NCT00130702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960353|NCT00130819|Buprenorphine|buprenorphine|mesh-list
64960354|NCT00130819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64960355|NCT00130819|Narcotics|narcotics|mesh-ancestor
64960356|NCT00130819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64960357|NCT00130819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534755|NCT01478321|Alkylating Agents|alkylating agents|mesh-ancestor
64534756|NCT01478321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534757|NCT01544491|Everolimus|everolimus|mesh-list
64534758|NCT01544491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534759|NCT01544491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64960358|NCT00130819|Analgesics|analgesics|mesh-ancestor
64960359|NCT00130819|Sensory System Agents|sensory system agents|mesh-ancestor
64960360|NCT00130819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64960361|NCT00130819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64960362|NCT00130858|Carboplatin|carboplatin|mesh-list
64960363|NCT00130858|Topotecan|topotecan|mesh-list
64960364|NCT00130858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960365|NCT00130858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64960366|NCT00130858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64960367|NCT00130858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960368|NCT00130858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960369|NCT00130897|Sunitinib|sunitinib|mesh-list
64960370|NCT00130897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960371|NCT00130897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64960372|NCT00130897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64960373|NCT00130897|Growth Substances|growth substances|mesh-ancestor
64960392|NCT00079872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64960394|NCT00046358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64960395|NCT00046358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64960396|NCT00046358|Analgesics|analgesics|mesh-ancestor
64960397|NCT00046358|Sensory System Agents|sensory system agents|mesh-ancestor
64960398|NCT00046358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64960399|NCT00046358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960400|NCT00046358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64960401|NCT00046358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64960402|NCT00046358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64960403|NCT00046358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960404|NCT00046358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960405|NCT00130936|Carboplatin|carboplatin|mesh-list
64960406|NCT00130936|Capecitabine|capecitabine|mesh-list
64960407|NCT00130936|Epirubicin|epirubicin|mesh-list
64960408|NCT00130936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960409|NCT00130936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64960410|NCT00130936|Antimetabolites|antimetabolites|mesh-ancestor
64960411|NCT00130936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960412|NCT00130936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64960413|NCT00130936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64960414|NCT00130936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64960415|NCT00130936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960416|NCT00130975|Candesartan|candesartan|mesh-list
64960417|NCT00130975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64960418|NCT00130975|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64960419|NCT00130975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64960420|NCT00130975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960421|NCT00131053|Cytarabine|cytarabine|mesh-list
64960422|NCT00131053|Dexamethasone|dexamethasone|mesh-list
64960423|NCT00131053|Prednisolone|prednisolone|mesh-list
64960424|NCT00131053|Hydrocortisone|hydrocortisone|mesh-list
64960425|NCT00131053|Cyclophosphamide|cyclophosphamide|mesh-list
64960458|NCT00131053|Antiviral Agents|antiviral agents|mesh-ancestor
64960459|NCT00131053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64960460|NCT00131053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64960461|NCT00131053|Tubulin Modulators|tubulin modulators|mesh-ancestor
64960462|NCT00131053|Antimitotic Agents|antimitotic agents|mesh-ancestor
64960463|NCT00131053|Mitosis Modulators|mitosis modulators|mesh-ancestor
64960464|NCT00079911|Valacyclovir|valacyclovir|mesh-list
64960465|NCT00079911|Antiviral Agents|antiviral agents|mesh-ancestor
64960466|NCT00079911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64960467|NCT00397592|Hormones|hormones|mesh-list
64960486|NCT00079989|Tigecycline|tigecycline|mesh-list
64960487|NCT00079989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64960488|NCT00079989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64960489|NCT00079989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64534760|NCT01544491|Immunologic Factors|immunologic factors|mesh-ancestor
64534761|NCT01544491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534763|NCT00383643|Zolpidem|zolpidem|mesh-list
64534764|NCT00383643|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64960490|NCT00079989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960491|NCT00079989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960493|NCT00131482|Hemostatics|hemostatics|mesh-ancestor
64960494|NCT00131482|Coagulants|coagulants|mesh-ancestor
64960495|NCT00397709|Rifampin|rifampin|mesh-list
64960496|NCT00397709|Isoniazid|isoniazid|mesh-list
64960497|NCT00397709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64960498|NCT00397709|Antitubercular Agents|antitubercular agents|mesh-ancestor
64960499|NCT00397709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64960500|NCT00397709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64960501|NCT00397709|Leprostatic Agents|leprostatic agents|mesh-ancestor
64960502|NCT00397709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64960503|NCT00397709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960504|NCT00397709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960505|NCT00397709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64960506|NCT00397709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64960507|NCT00397709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64960508|NCT00397709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64960509|NCT00397709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64960510|NCT00397709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64960511|NCT00397709|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64960512|NCT00397709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64960513|NCT00397709|Antimetabolites|antimetabolites|mesh-ancestor
64960514|NCT00397709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64960515|NCT00131521|Acetylcysteine|acetylcysteine|mesh-list
64960516|NCT00131521|Antiviral Agents|antiviral agents|mesh-ancestor
64960517|NCT00131521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64960518|NCT00131521|Expectorants|expectorants|mesh-ancestor
64960519|NCT00131521|Respiratory System Agents|respiratory system agents|mesh-ancestor
64960534|NCT00131716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64960535|NCT00131716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64960536|NCT00131716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64960537|NCT00131716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960538|NCT00131716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960539|NCT00131716|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64960540|NCT00131716|Renal Agents|renal agents|mesh-ancestor
64960541|NCT00131755|Diazoxide|diazoxide|mesh-list
64960542|NCT00131755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64499203|NCT02203630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64499220|NCT04593329|Tramadol|tramadol|mesh-list
64960543|NCT00131755|Vasodilator Agents|vasodilator agents|mesh-ancestor
64960544|NCT00080145|Risperidone|risperidone|mesh-list
64960545|NCT00080145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64960546|NCT00080145|Serotonin Agents|serotonin agents|mesh-ancestor
64960547|NCT00080145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64960548|NCT00080145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960549|NCT00080145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960550|NCT00080145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64960551|NCT00080145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64960552|NCT00080145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64960553|NCT00080145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64960554|NCT00080145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64960555|NCT00080145|Dopamine Agents|dopamine agents|mesh-ancestor
64960556|NCT00403663|Fentanyl|fentanyl|mesh-list
64960557|NCT00403663|Morphine|morphine|mesh-list
64960558|NCT00403663|Bupivacaine|bupivacaine|mesh-list
64960559|NCT00403663|Anesthetics, Local|anesthetics, local|mesh-ancestor
64960560|NCT00403663|Anesthetics|anesthetics|mesh-ancestor
64960561|NCT00403663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64960562|NCT00403663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960563|NCT00403663|Sensory System Agents|sensory system agents|mesh-ancestor
64960564|NCT00403663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64960565|NCT00403663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64960566|NCT00403663|Narcotics|narcotics|mesh-ancestor
64960567|NCT00403663|Analgesics|analgesics|mesh-ancestor
64960568|NCT00403663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64960569|NCT00403663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64534765|NCT00383643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64534766|NCT00383643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64976579|NCT00256711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64534767|NCT00383643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534768|NCT00383643|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64534769|NCT00383643|GABA Agonists|gaba agonists|mesh-ancestor
64534770|NCT00383643|GABA Agents|gaba agents|mesh-ancestor
64534771|NCT00383643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64299365|NCT02465866|Histamine Agents|histamine agents|mesh-ancestor
64299370|NCT05052008|Erenumab|erenumab|mesh-list
64960570|NCT00403663|Anesthetics, General|anesthetics, general|mesh-ancestor
64960571|NCT00403780|Pregabalin|pregabalin|mesh-list
64960572|NCT00403780|Analgesics|analgesics|mesh-ancestor
64960573|NCT00403780|Sensory System Agents|sensory system agents|mesh-ancestor
64960574|NCT00403780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64960575|NCT00403780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960576|NCT00403780|Anticonvulsants|anticonvulsants|mesh-ancestor
64960577|NCT00403780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64960578|NCT00403780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64960608|NCT00046553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64960609|NCT00046553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64960611|NCT00131989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960612|NCT00131989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64960613|NCT00131989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960614|NCT00131989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960615|NCT00132067|Vorinostat|vorinostat|mesh-list
64960616|NCT00132067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960617|NCT00132067|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64960618|NCT00132067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960619|NCT00132067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960620|NCT00132106|Phentolamine|phentolamine|mesh-list
64960637|NCT00132184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64960639|NCT00132379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960640|NCT00132379|Tubulin Modulators|tubulin modulators|mesh-ancestor
64960641|NCT00132379|Antimitotic Agents|antimitotic agents|mesh-ancestor
64960642|NCT00132379|Mitosis Modulators|mitosis modulators|mesh-ancestor
64960643|NCT00132379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960644|NCT00132418|Etanercept|etanercept|mesh-list
64960645|NCT00132418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64960646|NCT00132418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64960647|NCT00132418|Analgesics|analgesics|mesh-ancestor
64960648|NCT00132418|Sensory System Agents|sensory system agents|mesh-ancestor
64960649|NCT00132418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64960650|NCT00132418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960651|NCT00132418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64960652|NCT00132418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64960653|NCT00132418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64960654|NCT00132418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64960655|NCT00132418|Immunologic Factors|immunologic factors|mesh-ancestor
64960656|NCT00132535|Chloroquine|chloroquine|mesh-list
64960657|NCT00132535|Pyrimethamine|pyrimethamine|mesh-list
64960658|NCT00132535|Sulfadoxine|sulfadoxine|mesh-list
64960659|NCT00132535|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64960660|NCT00132535|Amebicides|amebicides|mesh-ancestor
64960661|NCT00132535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64960662|NCT00132535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64960663|NCT00132535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64960664|NCT00132535|Antimalarials|antimalarials|mesh-ancestor
64960665|NCT00132535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64960666|NCT00132535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64960667|NCT00132535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960668|NCT00132535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960669|NCT00132535|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64960670|NCT00132535|Renal Agents|renal agents|mesh-ancestor
64960671|NCT00132613|Bleomycin|bleomycin|mesh-list
64960672|NCT00132613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64534772|NCT00383643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534773|NCT00383643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64534774|NCT00383643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64534775|NCT00383643|Anesthetics, General|anesthetics, general|mesh-ancestor
64534776|NCT00383643|Anesthetics|anesthetics|mesh-ancestor
64960673|NCT00132613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960675|NCT00132652|Telbivudine|telbivudine|mesh-list
64960676|NCT00132652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64960677|NCT00132652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64960678|NCT00132652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960696|NCT00080418|Tubulin Modulators|tubulin modulators|mesh-ancestor
64960697|NCT00080418|Antimitotic Agents|antimitotic agents|mesh-ancestor
64960698|NCT00080418|Mitosis Modulators|mitosis modulators|mesh-ancestor
64960699|NCT00080418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960700|NCT00132925|Triamcinolone|triamcinolone|mesh-list
64960701|NCT00132925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64960702|NCT00132925|Glucocorticoids|glucocorticoids|mesh-ancestor
64960703|NCT00132925|Hormones|hormones|mesh-ancestor
64960704|NCT00132925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64960705|NCT00132925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960706|NCT00133003|Abciximab|abciximab|mesh-list
64960707|NCT00133003|Anticoagulants|anticoagulants|mesh-ancestor
64960708|NCT00133003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64960709|NCT00046787|Lurtotecan|lurtotecan|mesh-list
64960710|NCT00046787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960711|NCT00133042|Omalizumab|omalizumab|mesh-list
64960712|NCT00133042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64960713|NCT00133042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64960714|NCT00133042|Respiratory System Agents|respiratory system agents|mesh-ancestor
64960715|NCT00080457|Sitaxsentan|sitaxsentan|mesh-list
64960716|NCT00080457|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64960717|NCT00080457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960718|NCT00133081|Anticonvulsants|anticonvulsants|mesh-list
64960719|NCT00133198|Pramipexole|pramipexole|mesh-list
64960720|NCT00133198|Antioxidants|antioxidants|mesh-ancestor
64960721|NCT00133198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960722|NCT00133198|Protective Agents|protective agents|mesh-ancestor
64960723|NCT00133198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960724|NCT00133198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64960725|NCT00133198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64960726|NCT00133198|Dopamine Agonists|dopamine agonists|mesh-ancestor
64960727|NCT00133198|Dopamine Agents|dopamine agents|mesh-ancestor
64960728|NCT00133198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64960729|NCT00046826|Thalidomide|thalidomide|mesh-list
64960730|NCT00046826|Docetaxel|docetaxel|mesh-list
64960731|NCT00046826|Estramustine|estramustine|mesh-list
64960732|NCT00046826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960733|NCT00046826|Tubulin Modulators|tubulin modulators|mesh-ancestor
64960734|NCT00046826|Antimitotic Agents|antimitotic agents|mesh-ancestor
64960735|NCT00046826|Mitosis Modulators|mitosis modulators|mesh-ancestor
64960736|NCT00046826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960757|NCT00133237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960758|NCT00133237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64960759|NCT00133237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64976604|NCT00256828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64960760|NCT00133237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64960761|NCT00133237|Antifungal Agents|antifungal agents|mesh-ancestor
64960762|NCT00133237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64960763|NCT00133237|Immunologic Factors|immunologic factors|mesh-ancestor
64960764|NCT00133237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960765|NCT00399672|Interferons|interferons|mesh-list
64960766|NCT00399672|Ribavirin|ribavirin|mesh-list
64960767|NCT00399672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960768|NCT00399672|Antiviral Agents|antiviral agents|mesh-ancestor
64960769|NCT00399672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64960770|NCT00399672|Antimetabolites|antimetabolites|mesh-ancestor
64499430|NCT01398280|Aminocaproic Acid|aminocaproic acid|mesh-list
64960771|NCT00399672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960772|NCT00133276|Citalopram|citalopram|mesh-list
64960773|NCT00133276|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64534777|NCT00439413|Selegiline|selegiline|mesh-list
64534778|NCT00439413|Antidepressive Agents|antidepressive agents|mesh-ancestor
64534779|NCT00439413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64534780|NCT00439413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64534781|NCT00439413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64534782|NCT00439413|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64534783|NCT00439413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534784|NCT00439413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534785|NCT00439413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64534786|NCT00439413|Protective Agents|protective agents|mesh-ancestor
64534787|NCT00439413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534788|NCT01477853|Metformin|metformin|mesh-list
64534789|NCT01477853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64534790|NCT01477853|Glimepiride|glimepiride|mesh-list
64534791|NCT01477853|Atorvastatin|atorvastatin|mesh-list
64534792|NCT01477853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64534793|NCT01477853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534794|NCT01477853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64534795|NCT01477853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64534796|NCT01477853|Antimetabolites|antimetabolites|mesh-ancestor
64534797|NCT01477853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960774|NCT00133276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64960775|NCT00133276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64960776|NCT00133276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960777|NCT00133276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64960778|NCT00133276|Serotonin Agents|serotonin agents|mesh-ancestor
64960779|NCT00133276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960780|NCT00133276|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64960781|NCT00133276|Antidepressive Agents|antidepressive agents|mesh-ancestor
64960782|NCT00133276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64960783|NCT00133315|Adalimumab|adalimumab|mesh-list
64960784|NCT00133315|Etanercept|etanercept|mesh-list
64960785|NCT00133315|Infliximab|infliximab|mesh-list
64960786|NCT00133315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64960787|NCT00133315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64960788|NCT00133315|Dermatologic Agents|dermatologic agents|mesh-ancestor
64653582|NCT03003611|Anesthetics|anesthetics|mesh-list
64960809|NCT00133354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64960810|NCT00133354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960811|NCT00133354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64960812|NCT00133354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960813|NCT00133354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64960814|NCT00133354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64960815|NCT00133354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960816|NCT00133354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960817|NCT00133354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64960818|NCT00133354|Hormone Antagonists|hormone antagonists|mesh-ancestor
64960819|NCT00133393|Pentoxifylline|pentoxifylline|mesh-list
64960820|NCT00133393|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64960821|NCT00133393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960822|NCT00133393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960823|NCT00133393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64960824|NCT00133393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64534798|NCT01477853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64534799|NCT01477853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64534800|NCT01477853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534801|NCT01477853|Incretins|incretins|mesh-ancestor
64534802|NCT01477853|Hormones|hormones|mesh-ancestor
64534803|NCT01477853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64534804|NCT01477853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64299399|NCT03290859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64960825|NCT00133393|Protective Agents|protective agents|mesh-ancestor
64960826|NCT00133393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960827|NCT00133393|Vasodilator Agents|vasodilator agents|mesh-ancestor
64960828|NCT00133393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64960829|NCT00133393|Antioxidants|antioxidants|mesh-ancestor
64960830|NCT00046904|Etanercept|etanercept|mesh-list
64960831|NCT00046904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64960832|NCT00046904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64960833|NCT00046904|Analgesics|analgesics|mesh-ancestor
64960834|NCT00046904|Sensory System Agents|sensory system agents|mesh-ancestor
64960835|NCT00046904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64960836|NCT00046904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960837|NCT00046904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64960838|NCT00046904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64960839|NCT00046904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64960840|NCT00046904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64960841|NCT00046904|Immunologic Factors|immunologic factors|mesh-ancestor
64960842|NCT00403897|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64960843|NCT00403897|Laxatives|laxatives|mesh-ancestor
64960858|NCT00080613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960859|NCT00080613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960860|NCT00080613|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64960861|NCT00080613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64960862|NCT00080613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960863|NCT00080613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960864|NCT00080613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64960865|NCT00080613|Hormone Antagonists|hormone antagonists|mesh-ancestor
64960866|NCT00047021|Cytarabine|cytarabine|mesh-list
64960867|NCT00047021|Mitoxantrone|mitoxantrone|mesh-list
64960868|NCT00047021|Sargramostim|sargramostim|mesh-list
64960869|NCT00047021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64960870|NCT00047021|Antimetabolites|antimetabolites|mesh-ancestor
64960871|NCT00047021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960872|NCT00047021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960873|NCT00047021|Antiviral Agents|antiviral agents|mesh-ancestor
64960874|NCT00047021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64960875|NCT00047021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64960876|NCT00047021|Immunologic Factors|immunologic factors|mesh-ancestor
64960877|NCT00047021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960878|NCT00047021|Analgesics|analgesics|mesh-ancestor
64960879|NCT00047021|Sensory System Agents|sensory system agents|mesh-ancestor
64960880|NCT00047021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64960881|NCT00047021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64960883|NCT00047021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960885|NCT00133627|Antipruritics|antipruritics|mesh-ancestor
64960886|NCT00133627|Dermatologic Agents|dermatologic agents|mesh-ancestor
64960887|NCT00133627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64960888|NCT00133627|Histamine Antagonists|histamine antagonists|mesh-ancestor
64960889|NCT00133627|Histamine Agents|histamine agents|mesh-ancestor
64960890|NCT00133627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64976650|NCT00070538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960891|NCT00133627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960892|NCT00133627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960893|NCT00133627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64960894|NCT00133744|Folic Acid|folic acid|mesh-list
64960895|NCT00133744|Vitamin B Complex|vitamin b complex|mesh-list
64960896|NCT00133744|Vitamins|vitamins|mesh-ancestor
64960897|NCT00133744|Micronutrients|micronutrients|mesh-ancestor
64534805|NCT01477853|Protease Inhibitors|protease inhibitors|mesh-ancestor
64534806|NCT01477853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64534807|NCT01477853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64534808|NCT01477853|Immunologic Factors|immunologic factors|mesh-ancestor
64534809|NCT00440505|Nicotine|nicotine|mesh-list
64534810|NCT00440505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64534811|NCT00440505|Autonomic Agents|autonomic agents|mesh-ancestor
64960898|NCT00133744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960899|NCT00133744|Hematinics|hematinics|mesh-ancestor
64960900|NCT00080808|Phentolamine|phentolamine|mesh-list
64960901|NCT00080808|Sildenafil Citrate|sildenafil citrate|mesh-list
64960902|NCT00080808|Alprostadil|alprostadil|mesh-list
64960903|NCT00080808|Papaverine|papaverine|mesh-list
64960927|NCT00047099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64960929|NCT00047099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960930|NCT00047099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960931|NCT00047099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64960932|NCT00047099|Tubulin Modulators|tubulin modulators|mesh-ancestor
64960933|NCT00047099|Antimitotic Agents|antimitotic agents|mesh-ancestor
64960934|NCT00047099|Mitosis Modulators|mitosis modulators|mesh-ancestor
64960935|NCT00047099|Antimetabolites|antimetabolites|mesh-ancestor
64960936|NCT00047099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64960937|NCT00047099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64960938|NCT00047099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64960939|NCT00047099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64960940|NCT00047099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960941|NCT00047099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64960942|NCT00047099|Hormone Antagonists|hormone antagonists|mesh-ancestor
64960943|NCT00047099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64960944|NCT00047099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64960945|NCT00047099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64960946|NCT00047099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64960947|NCT00047099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64960948|NCT00133822|Risperidone|risperidone|mesh-list
64960949|NCT00133822|Sertraline|sertraline|mesh-list
64960950|NCT00133822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64960951|NCT00133822|Serotonin Agents|serotonin agents|mesh-ancestor
64960952|NCT00133822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64960967|NCT00133861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64960968|NCT00133861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960969|NCT00133861|Cholinergic Agents|cholinergic agents|mesh-ancestor
64960970|NCT00133861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64960971|NCT00133861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960972|NCT00134095|Irinotecan|irinotecan|mesh-list
64960973|NCT00134095|Tegafur|tegafur|mesh-list
64653607|NCT03401294|Antidotes|antidotes|mesh-ancestor
64960974|NCT00134095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64960975|NCT00134095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64960976|NCT00134095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960977|NCT00134095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960978|NCT00134095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960979|NCT00134095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64960980|NCT00134095|Antimetabolites|antimetabolites|mesh-ancestor
64960981|NCT00047138|Dactinomycin|dactinomycin|mesh-list
64960982|NCT00047138|Cyclophosphamide|cyclophosphamide|mesh-list
64960983|NCT00047138|Carboplatin|carboplatin|mesh-list
64960984|NCT00047138|Doxorubicin|doxorubicin|mesh-list
64960985|NCT00047138|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64960986|NCT00047138|Etoposide|etoposide|mesh-list
64960987|NCT00047138|Vincristine|vincristine|mesh-list
64960988|NCT00047138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64960989|NCT00047138|Immunologic Factors|immunologic factors|mesh-ancestor
64960990|NCT00047138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960991|NCT00047138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64960992|NCT00047138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64960993|NCT00047138|Alkylating Agents|alkylating agents|mesh-ancestor
64960994|NCT00047138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499668|NCT01430182|Morphine|morphine|mesh-list
64960995|NCT00047138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960996|NCT00047138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64534812|NCT00440505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64534813|NCT00440505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534814|NCT00440505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64534815|NCT00440505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64534816|NCT00440505|Cholinergic Agents|cholinergic agents|mesh-ancestor
64534817|NCT00440505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64534818|NCT00440505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534819|NCT00441285|Albendazole|albendazole|mesh-list
64960997|NCT00047138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64960998|NCT00047138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64960999|NCT00047138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64961000|NCT00047138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961001|NCT00047138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64961002|NCT00047138|Tubulin Modulators|tubulin modulators|mesh-ancestor
64961003|NCT00047138|Antimitotic Agents|antimitotic agents|mesh-ancestor
64961004|NCT00047138|Mitosis Modulators|mitosis modulators|mesh-ancestor
64961005|NCT00047138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64961006|NCT00047138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64961007|NCT00047138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64961008|NCT00047138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64961009|NCT00080847|Prednisone|prednisone|mesh-list
64961010|NCT00080847|Cyclophosphamide|cyclophosphamide|mesh-list
64961011|NCT00080847|Rituximab|rituximab|mesh-list
64961040|NCT00134173|Torcetrapib|torcetrapib|mesh-list
64961041|NCT00134173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64961042|NCT00134173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64961043|NCT00134173|Antimetabolites|antimetabolites|mesh-ancestor
64961044|NCT00134173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961045|NCT00134173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64976709|NCT00257257|Hormones|hormones|mesh-ancestor
64961046|NCT00134173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64961047|NCT00134173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961048|NCT00047177|Oxaliplatin|oxaliplatin|mesh-list
64961049|NCT00047177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961050|NCT00080886|Cytarabine|cytarabine|mesh-list
64961051|NCT00080886|Rituximab|rituximab|mesh-list
64961052|NCT00080886|Etoposide|etoposide|mesh-list
64961053|NCT00080886|Melphalan|melphalan|mesh-list
64961054|NCT00080886|Carmustine|carmustine|mesh-list
64961055|NCT00080886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64961056|NCT00080886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961057|NCT00080886|Immunologic Factors|immunologic factors|mesh-ancestor
64961058|NCT00080886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961088|NCT00134212|Mydriatics|mydriatics|mesh-ancestor
64961089|NCT00134212|Sympathomimetics|sympathomimetics|mesh-ancestor
64961090|NCT00134212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64961091|NCT00134212|Vasodilator Agents|vasodilator agents|mesh-ancestor
64961092|NCT00134212|Dopamine Agonists|dopamine agonists|mesh-ancestor
64961093|NCT00134212|Dopamine Agents|dopamine agents|mesh-ancestor
64961094|NCT00134290|Metformin|metformin|mesh-list
64961096|NCT00134290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961097|NCT00047216|Tipifarnib|tipifarnib|mesh-list
64961098|NCT00047216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961099|NCT00080925|Cytarabine|cytarabine|mesh-list
64961100|NCT00080925|Cyclosporine|cyclosporine|mesh-list
64961101|NCT00080925|Prednisone|prednisone|mesh-list
64961122|NCT00080925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64961123|NCT00080925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64961124|NCT00080925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961125|NCT00080925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64961126|NCT00080925|Glucocorticoids|glucocorticoids|mesh-ancestor
64961127|NCT00080925|Hormones|hormones|mesh-ancestor
64961128|NCT00080925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64961129|NCT00080925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64961130|NCT00080925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64961131|NCT00080925|Antimetabolites|antimetabolites|mesh-ancestor
64961132|NCT00080925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64961133|NCT00080925|Antiviral Agents|antiviral agents|mesh-ancestor
64961134|NCT00080925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64534821|NCT00441285|Anthelmintics|anthelmintics|mesh-ancestor
64534822|NCT00441285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64534823|NCT00441285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64534824|NCT00441285|Anticestodal Agents|anticestodal agents|mesh-ancestor
64534825|NCT00441285|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64534826|NCT00441285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64534827|NCT00441285|Tubulin Modulators|tubulin modulators|mesh-ancestor
64534828|NCT00441285|Antimitotic Agents|antimitotic agents|mesh-ancestor
64534829|NCT00441285|Mitosis Modulators|mitosis modulators|mesh-ancestor
64534830|NCT00441285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534831|NCT00441285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534832|NCT01796613|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64534833|NCT01796613|Desogestrel|desogestrel|mesh-list
64534834|NCT01796613|Etonogestrel|etonogestrel|mesh-list
64299417|NCT02102815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64961135|NCT00080925|Tubulin Modulators|tubulin modulators|mesh-ancestor
64961136|NCT00080925|Antimitotic Agents|antimitotic agents|mesh-ancestor
64961137|NCT00080925|Mitosis Modulators|mitosis modulators|mesh-ancestor
64961138|NCT00080925|Antifungal Agents|antifungal agents|mesh-ancestor
64961139|NCT00080925|Dermatologic Agents|dermatologic agents|mesh-ancestor
64961140|NCT00080925|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64961141|NCT04705831|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64961142|NCT04705831|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64961143|NCT04705831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64961144|NCT04705831|Immunologic Factors|immunologic factors|mesh-ancestor
64961145|NCT04705831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961146|NCT00047255|Carboplatin|carboplatin|mesh-list
64961147|NCT00047255|Docetaxel|docetaxel|mesh-list
64961148|NCT00047255|Trastuzumab|trastuzumab|mesh-list
64961149|NCT00047255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961150|NCT00047255|Tubulin Modulators|tubulin modulators|mesh-ancestor
64961151|NCT00047255|Antimitotic Agents|antimitotic agents|mesh-ancestor
64961152|NCT00047255|Mitosis Modulators|mitosis modulators|mesh-ancestor
64961153|NCT00047255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961154|NCT00047255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64961155|NCT00134368|Etanercept|etanercept|mesh-list
64961156|NCT00134368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64961157|NCT00134368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64961172|NCT00134485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961174|NCT00134485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64961176|NCT00047294|Thalidomide|thalidomide|mesh-list
64961178|NCT00047294|Temozolomide|temozolomide|mesh-list
64961179|NCT00047294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64961180|NCT00047294|Alkylating Agents|alkylating agents|mesh-ancestor
64961181|NCT00047294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961182|NCT00047294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961183|NCT00047294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64961184|NCT00047294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64961185|NCT00047294|Analgesics|analgesics|mesh-ancestor
64961186|NCT00047294|Sensory System Agents|sensory system agents|mesh-ancestor
64961187|NCT00047294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64961188|NCT00047294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961189|NCT00047294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64961190|NCT00047294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64961191|NCT00047294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64961192|NCT00047294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64961193|NCT00047294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534836|NCT01796613|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64534837|NCT01796613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64534838|NCT01796613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64534839|NCT01796613|Contraceptive Agents|contraceptive agents|mesh-ancestor
64961194|NCT00047294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64961195|NCT00047294|Immunologic Factors|immunologic factors|mesh-ancestor
64961196|NCT00047294|Leprostatic Agents|leprostatic agents|mesh-ancestor
64961197|NCT00047294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64961198|NCT00047294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64961199|NCT00047294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64961200|NCT00047294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64961201|NCT00047294|Growth Substances|growth substances|mesh-ancestor
64961202|NCT00047294|Growth Inhibitors|growth inhibitors|mesh-ancestor
64961203|NCT00042822|Romidepsin|romidepsin|mesh-list
64961204|NCT00042822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64961205|NCT00042822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961206|NCT00134641|Gemcitabine|gemcitabine|mesh-list
64961207|NCT00134641|Vinorelbine|vinorelbine|mesh-list
64961208|NCT00134641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64961209|NCT00134641|Antimetabolites|antimetabolites|mesh-ancestor
64961210|NCT00134641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961211|NCT00134641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961212|NCT00134641|Antiviral Agents|antiviral agents|mesh-ancestor
64961213|NCT00134641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64961214|NCT00134641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961215|NCT00134641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64961216|NCT00134641|Immunologic Factors|immunologic factors|mesh-ancestor
64961217|NCT00134641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961244|NCT00081042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976750|NCT00070655|Anticoagulants|anticoagulants|mesh-ancestor
64961245|NCT00047333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64961246|NCT00047333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961247|NCT00047333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64961248|NCT00047333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961249|NCT00047333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961250|NCT00134875|Buprenorphine|buprenorphine|mesh-list
64961251|NCT00134875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64961252|NCT00134875|Naloxone|naloxone|mesh-list
64961253|NCT00134875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64961254|NCT00134875|Narcotics|narcotics|mesh-ancestor
64961255|NCT00134875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64961256|NCT00134875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961257|NCT00134875|Analgesics|analgesics|mesh-ancestor
64961258|NCT00134875|Sensory System Agents|sensory system agents|mesh-ancestor
64961259|NCT00134875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64961260|NCT00134875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64961261|NCT00134914|Buprenorphine|buprenorphine|mesh-list
64961262|NCT00134914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64961287|NCT00042861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961288|NCT00042861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64961289|NCT00042861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961290|NCT00042861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64961291|NCT00042861|Immunologic Factors|immunologic factors|mesh-ancestor
64961292|NCT00042861|Antidotes|antidotes|mesh-ancestor
64961293|NCT00042861|Protective Agents|protective agents|mesh-ancestor
64961294|NCT00042861|Vitamin B Complex|vitamin b complex|mesh-ancestor
64961295|NCT00042861|Vitamins|vitamins|mesh-ancestor
64961296|NCT00042861|Micronutrients|micronutrients|mesh-ancestor
64961297|NCT00042861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64961298|NCT00042861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961300|NCT00134992|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64961301|NCT00134992|Methylprednisolone|methylprednisolone|mesh-list
64961302|NCT00134992|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64961303|NCT00134992|Prednisolone acetate|prednisolone acetate|mesh-list
64961304|NCT00134992|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64961305|NCT00134992|Prednisolone phosphate|prednisolone phosphate|mesh-list
64961306|NCT00134992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64961307|NCT00134992|Glucocorticoids|glucocorticoids|mesh-ancestor
64961308|NCT00134992|Hormones|hormones|mesh-ancestor
64961309|NCT00134992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64534840|NCT01796613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64534841|NCT01796613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534842|NCT01796613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64534844|NCT01796613|Hormones|hormones|mesh-ancestor
64534845|NCT01796613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64534846|NCT01796613|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64534847|NCT01796613|Progestins|progestins|mesh-ancestor
64534848|NCT00442611|Abatacept|abatacept|mesh-list
64534849|NCT00442611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64534850|NCT00442611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534851|NCT00442611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534852|NCT00442611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64534853|NCT00442611|Immunologic Factors|immunologic factors|mesh-ancestor
64534854|NCT00442611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534855|NCT00442611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64299442|NCT05043350|Loratadine|loratadine|mesh-list
64961310|NCT00134992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961311|NCT00134992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64961312|NCT00134992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961313|NCT00134992|Antiemetics|antiemetics|mesh-ancestor
64961314|NCT00134992|Autonomic Agents|autonomic agents|mesh-ancestor
64961315|NCT00134992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64961343|NCT00047450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961344|NCT00047450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64961345|NCT00047450|Serotonin Agents|serotonin agents|mesh-ancestor
64976792|NCT00401115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64961346|NCT00047450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961347|NCT00047450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64961348|NCT00047450|Antidepressive Agents|antidepressive agents|mesh-ancestor
64961349|NCT00047450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64961350|NCT00081237|Oxaliplatin|oxaliplatin|mesh-list
64961351|NCT00081237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961352|NCT00145171|Apomorphine|apomorphine|mesh-list
64961354|NCT00145171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961355|NCT00145171|Autonomic Agents|autonomic agents|mesh-ancestor
64961356|NCT00145171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64961357|NCT00145171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64961358|NCT00145171|Dopamine Agonists|dopamine agonists|mesh-ancestor
64961359|NCT00145171|Dopamine Agents|dopamine agents|mesh-ancestor
64961360|NCT00145171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64961361|NCT00145171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961362|NCT00145210|Atenolol|atenolol|mesh-list
64961363|NCT00145210|Nebivolol|nebivolol|mesh-list
64961376|NCT00145210|Vasodilator Agents|vasodilator agents|mesh-ancestor
64961377|NCT00145210|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64961378|NCT00145210|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64961379|NCT00145210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64961381|NCT00081276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961382|NCT00145405|Octreotide|octreotide|mesh-list
64961383|NCT00145405|Lanreotide|lanreotide|mesh-list
64961384|NCT00145405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64961385|NCT00145405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64961386|NCT00145405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961387|NCT00145444|Olanzapine|olanzapine|mesh-list
64961388|NCT00145444|Ziprasidone|ziprasidone|mesh-list
64961389|NCT00145444|Antiemetics|antiemetics|mesh-ancestor
64961390|NCT00145444|Autonomic Agents|autonomic agents|mesh-ancestor
64961391|NCT00145444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64534857|NCT01511107|Clavulanic Acid|clavulanic acid|mesh-list
64534858|NCT01511107|Clavulanic Acids|clavulanic acids|mesh-list
64534859|NCT01511107|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64534860|NCT01511107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64534861|NCT01511107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64534862|NCT01511107|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64534863|NCT01511107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534864|NCT01511107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534865|NCT00387621|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64534866|NCT00387621|Natriuretic Agents|natriuretic agents|mesh-ancestor
64534867|NCT00387621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534868|NCT00442689|Flutamide|flutamide|mesh-list
64534869|NCT00442689|Drospirenone|drospirenone|mesh-list
64534870|NCT00442689|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64534871|NCT00442689|Estradiol|estradiol|mesh-list
64534872|NCT00442689|Estrogens|estrogens|mesh-ancestor
64534873|NCT00442689|Hormones|hormones|mesh-ancestor
64534874|NCT00442689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64534875|NCT00442689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961392|NCT00145444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961393|NCT00145444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64961394|NCT00145444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64961395|NCT00145444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64961396|NCT00145444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64961397|NCT00145444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64961398|NCT00145444|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64961399|NCT00145444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64961400|NCT00145444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64961401|NCT00145444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961402|NCT00145444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64961403|NCT00145444|Serotonin Agents|serotonin agents|mesh-ancestor
64961404|NCT00145444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64961405|NCT00145444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64961406|NCT00145444|Dopamine Agents|dopamine agents|mesh-ancestor
64961407|NCT00145483|Sildenafil Citrate|sildenafil citrate|mesh-list
64961408|NCT00145483|Vasodilator Agents|vasodilator agents|mesh-ancestor
64961409|NCT00145483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64961410|NCT00145483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64961411|NCT00145483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961412|NCT00145483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961413|NCT00145483|Urological Agents|urological agents|mesh-ancestor
64961414|NCT00145522|Tibolone|tibolone|mesh-list
64961415|NCT00145522|Estradiol|estradiol|mesh-list
64961416|NCT00145522|Dydrogesterone|dydrogesterone|mesh-list
64961417|NCT00145522|Estrogens|estrogens|mesh-ancestor
64961418|NCT00145522|Hormones|hormones|mesh-ancestor
64961419|NCT00145522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64961420|NCT00145522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961421|NCT00145522|Progestins|progestins|mesh-ancestor
64961454|NCT00145639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961455|NCT00145639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64961456|NCT00145639|Alkylating Agents|alkylating agents|mesh-ancestor
64961457|NCT00047567|Zonisamide|zonisamide|mesh-list
64534876|NCT00442689|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64534878|NCT00442689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64534879|NCT00442689|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64534880|NCT00442689|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64534881|NCT00442689|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64534882|NCT00442689|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64534883|NCT00442689|Hormone Antagonists|hormone antagonists|mesh-ancestor
64534884|NCT00442689|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64534885|NCT00442689|Diuretics|diuretics|mesh-ancestor
64534886|NCT00442689|Natriuretic Agents|natriuretic agents|mesh-ancestor
64534887|NCT00442689|Androgen Antagonists|androgen antagonists|mesh-ancestor
64534888|NCT00442689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64961458|NCT00047567|Anticonvulsants|anticonvulsants|mesh-ancestor
64961459|NCT00047567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64961460|NCT00047567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64961461|NCT00047567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961462|NCT00047567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64961463|NCT00047567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961485|NCT00146068|Antiviral Agents|antiviral agents|mesh-ancestor
64961486|NCT00146068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64961487|NCT00081471|Darbepoetin alfa|darbepoetin alfa|mesh-list
64961488|NCT00081471|Hematinics|hematinics|mesh-ancestor
64961489|NCT00047645|Interferons|interferons|mesh-list
64961490|NCT00047645|Interferon-gamma|interferon-gamma|mesh-list
64540141|NCT03143010|Analgesics|analgesics|mesh-ancestor
64961491|NCT00047645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961492|NCT00047645|Antiviral Agents|antiviral agents|mesh-ancestor
64961493|NCT00047645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64961494|NCT00146146|Letrozole|letrozole|mesh-list
64961495|NCT00146146|Methyltestosterone|methyltestosterone|mesh-list
64961496|NCT00146146|Dutasteride|dutasteride|mesh-list
64961497|NCT00146146|Testosterone|testosterone|mesh-list
64961498|NCT00146146|Testosterone undecanoate|testosterone undecanoate|mesh-list
64961499|NCT00146146|Testosterone enanthate|testosterone enanthate|mesh-list
64961500|NCT00146146|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64961501|NCT00146146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961502|NCT00146146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64961503|NCT00146146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64961504|NCT00146146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961505|NCT00146146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961506|NCT00146146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64961507|NCT00146146|Hormone Antagonists|hormone antagonists|mesh-ancestor
64961508|NCT00146146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64961509|NCT00146146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961510|NCT00146146|Androgens|androgens|mesh-ancestor
64961511|NCT00146146|Hormones|hormones|mesh-ancestor
64961512|NCT00146146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64961513|NCT00146146|Anabolic Agents|anabolic agents|mesh-ancestor
64976878|NCT00258271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961514|NCT00146146|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64961515|NCT00146224|Epoetin Alfa|epoetin alfa|mesh-list
64961516|NCT00146224|Hematinics|hematinics|mesh-ancestor
64961517|NCT00081549|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
64961543|NCT00081588|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64961544|NCT00081588|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64961545|NCT00081588|Protease Inhibitors|protease inhibitors|mesh-ancestor
64961546|NCT00081588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961547|NCT00081588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961548|NCT00081588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64961549|NCT00081588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64961550|NCT00081588|Antiviral Agents|antiviral agents|mesh-ancestor
64534889|NCT00442689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534891|NCT01484977|Anticonvulsants|anticonvulsants|mesh-ancestor
64534892|NCT01484977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64534893|NCT01484977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64534894|NCT01484977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64534895|NCT01484977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534896|NCT00442767|Insulin|insulin|mesh-list
64653663|NCT02248259|BI 409306|bi 409306|mesh-list
64534897|NCT00442767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64534898|NCT00442767|Pramlintide|pramlintide|mesh-list
64534899|NCT00442767|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
64534900|NCT00442767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64534901|NCT00442767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961551|NCT00081588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64961552|NCT00146458|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64961553|NCT00146458|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64961554|NCT00146458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961555|NCT00047723|Minocycline|minocycline|mesh-list
64961556|NCT00047723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64961557|NCT00047723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64961558|NCT00146497|Budesonide|budesonide|mesh-list
64961559|NCT00146497|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64961560|NCT00146497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64961561|NCT00146497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64961562|NCT00146497|Autonomic Agents|autonomic agents|mesh-ancestor
64961563|NCT00146497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64961564|NCT00146497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961565|NCT00146497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64961566|NCT00146497|Respiratory System Agents|respiratory system agents|mesh-ancestor
64961567|NCT00146497|Glucocorticoids|glucocorticoids|mesh-ancestor
64961586|NCT00146575|Immunologic Factors|immunologic factors|mesh-ancestor
64961587|NCT00146575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961588|NCT00146614|Sirolimus|sirolimus|mesh-list
64961589|NCT00146614|Methotrexate|methotrexate|mesh-list
64961590|NCT00146614|Tacrolimus|tacrolimus|mesh-list
64961591|NCT00146614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64961592|NCT00146614|Abortifacient Agents|abortifacient agents|mesh-ancestor
64961593|NCT00146614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64961594|NCT00146614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500255|NCT03390972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64961595|NCT00146614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64961596|NCT00146614|Antimetabolites|antimetabolites|mesh-ancestor
64961597|NCT00146614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961598|NCT00146614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961599|NCT00146614|Dermatologic Agents|dermatologic agents|mesh-ancestor
64961600|NCT00146614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961601|NCT00146614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64961602|NCT00146614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64961603|NCT00146614|Immunologic Factors|immunologic factors|mesh-ancestor
64961604|NCT00146614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64961605|NCT00146614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64961606|NCT00146614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64961607|NCT00146614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64961608|NCT00146614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64540158|NCT01430611|Vaccines|vaccines|mesh-list
64961609|NCT00146614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64961610|NCT00146614|Antifungal Agents|antifungal agents|mesh-ancestor
64961611|NCT00047762|Bevacizumab|bevacizumab|mesh-list
64961612|NCT00047762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64961613|NCT00047762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64961614|NCT00047762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961615|NCT00047762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64534902|NCT00442767|Appetite Depressants|appetite depressants|mesh-ancestor
64534903|NCT00442767|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64534904|NCT00442767|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
64534905|NCT00442767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534907|NCT00445263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64534908|NCT00445263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64534909|NCT00445263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534910|NCT00445263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64534911|NCT00389493|Risperidone|risperidone|mesh-list
64534912|NCT00389493|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64534913|NCT00389493|Serotonin Agents|serotonin agents|mesh-ancestor
64534914|NCT00389493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64534915|NCT00389493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534916|NCT00389493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534917|NCT00389493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64534918|NCT00389493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64534919|NCT00389493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64534920|NCT00389493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64534921|NCT00389493|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64534922|NCT00389493|Dopamine Agents|dopamine agents|mesh-ancestor
64534924|NCT04388709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534925|NCT04388709|Antiviral Agents|antiviral agents|mesh-ancestor
64534926|NCT04388709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64534927|NCT00389805|Pemetrexed|pemetrexed|mesh-list
64534928|NCT00389805|Bortezomib|bortezomib|mesh-list
64534929|NCT00389805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534930|NCT00389805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534931|NCT00389805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299512|NCT02408068|Hormones|hormones|mesh-ancestor
64961616|NCT00047762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64961617|NCT00047762|Growth Substances|growth substances|mesh-ancestor
64961618|NCT00047762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961619|NCT00047762|Growth Inhibitors|growth inhibitors|mesh-ancestor
64961620|NCT00047762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64961621|NCT00047762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961622|NCT00047762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961648|NCT00405730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961650|NCT00405769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64961651|NCT00405769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64540168|NCT03140826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961652|NCT00405769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64534932|NCT00389805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64534933|NCT00389805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64534935|NCT00456807|Immunologic Factors|immunologic factors|mesh-ancestor
64534936|NCT00456807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534937|NCT00456885|Exenatide|exenatide|mesh-list
64534938|NCT00456885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64534939|NCT00456885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534940|NCT00456885|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64534941|NCT00456885|Incretins|incretins|mesh-ancestor
64534942|NCT00456885|Hormones|hormones|mesh-ancestor
64534943|NCT00456885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64299530|NCT05050604|Antimetabolites|antimetabolites|mesh-ancestor
64299532|NCT05050604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64961653|NCT00405769|Antimetabolites|antimetabolites|mesh-ancestor
64961654|NCT00405769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961655|NCT00405769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961656|NCT00405769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64961657|NCT00047801|Docetaxel|docetaxel|mesh-list
64961658|NCT00047801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961659|NCT00047801|Tubulin Modulators|tubulin modulators|mesh-ancestor
64961660|NCT00047801|Antimitotic Agents|antimitotic agents|mesh-ancestor
64961661|NCT00047801|Mitosis Modulators|mitosis modulators|mesh-ancestor
64961662|NCT00047801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961663|NCT00146731|Artesunate|artesunate|mesh-list
64961664|NCT00146731|Amodiaquine|amodiaquine|mesh-list
64961665|NCT00146731|Dapsone|dapsone|mesh-list
64961666|NCT00146731|Chlorproguanil|chlorproguanil|mesh-list
64961667|NCT00146731|Antimalarials|antimalarials|mesh-ancestor
64961668|NCT00146731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64961669|NCT00146731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64961670|NCT00146731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64961671|NCT00146731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961672|NCT00146731|Antiviral Agents|antiviral agents|mesh-ancestor
64961673|NCT00146731|Schistosomicides|schistosomicides|mesh-ancestor
64961706|NCT00146926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64961707|NCT00146926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64961708|NCT00146926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64961709|NCT00146926|Sympathomimetics|sympathomimetics|mesh-ancestor
64961710|NCT00146926|Autonomic Agents|autonomic agents|mesh-ancestor
64961711|NCT00146926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64961712|NCT00146926|Adrenergic Agents|adrenergic agents|mesh-ancestor
64961713|NCT00147004|Hydrocortisone|hydrocortisone|mesh-list
64976978|NCT00259051|Omeprazole|omeprazole|mesh-list
64961714|NCT00147004|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64653676|NCT04526951|Aspirin|aspirin|mesh-list
64961736|NCT04732104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961737|NCT04732104|Sensory System Agents|sensory system agents|mesh-ancestor
64961738|NCT04732104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64961739|NCT04732104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64961740|NCT04732104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64961741|NCT04732104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64961742|NCT04732104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64961743|NCT04732104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961744|NCT04732104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64961745|NCT04732104|Respiratory System Agents|respiratory system agents|mesh-ancestor
64961746|NCT00147355|Acetaminophen|acetaminophen|mesh-list
64961747|NCT00147355|Ibuprofen|ibuprofen|mesh-list
64500401|NCT01492582|Immunologic Factors|immunologic factors|mesh-ancestor
64961749|NCT00147355|Ondansetron|ondansetron|mesh-list
64961750|NCT00147355|Metoclopramide|metoclopramide|mesh-list
64961751|NCT00147355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64961752|NCT00147355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64961753|NCT00147355|Analgesics|analgesics|mesh-ancestor
64961754|NCT00147355|Sensory System Agents|sensory system agents|mesh-ancestor
64534945|NCT01475825|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64534946|NCT01475825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64534947|NCT01475825|Antimetabolites|antimetabolites|mesh-ancestor
64534948|NCT01475825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534949|NCT01475825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64534950|NCT00457197|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64534951|NCT00457197|Antidepressive Agents|antidepressive agents|mesh-ancestor
64534952|NCT00457197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64534953|NCT00457197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64534954|NCT00457197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64534955|NCT00457197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64534956|NCT00457197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534957|NCT01484431|Tadalafil|tadalafil|mesh-list
64534958|NCT01484431|Vasodilator Agents|vasodilator agents|mesh-ancestor
64961755|NCT00147355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64961756|NCT00147355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961757|NCT00147355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64961758|NCT00147355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64961759|NCT00147355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64961760|NCT00147355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961761|NCT00147355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961762|NCT00147355|Antipyretics|antipyretics|mesh-ancestor
64961763|NCT00147355|Antiemetics|antiemetics|mesh-ancestor
64961764|NCT00147355|Autonomic Agents|autonomic agents|mesh-ancestor
64961765|NCT00147355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64961766|NCT00147355|Antipruritics|antipruritics|mesh-ancestor
64961767|NCT00147355|Dermatologic Agents|dermatologic agents|mesh-ancestor
64961768|NCT00147355|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64961769|NCT00147355|Serotonin Agents|serotonin agents|mesh-ancestor
64961796|NCT00048152|Dermatologic Agents|dermatologic agents|mesh-ancestor
64961797|NCT00048152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64961798|NCT00048152|Immunologic Factors|immunologic factors|mesh-ancestor
64961799|NCT00048152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961800|NCT00048152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64961801|NCT00048152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64961803|NCT00147394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64961804|NCT00147394|Serotonin Agents|serotonin agents|mesh-ancestor
64961805|NCT00147394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64961806|NCT00147394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961807|NCT00147394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961808|NCT00147394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64961809|NCT00147394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64961810|NCT00147394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64961811|NCT00147394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64961812|NCT00147394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64961813|NCT00147394|Dopamine Agents|dopamine agents|mesh-ancestor
64961814|NCT04725682|Tacrolimus|tacrolimus|mesh-list
64977005|NCT00104988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961817|NCT04725682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961818|NCT04725682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64961819|NCT04725682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961838|NCT00048230|Bortezomib|bortezomib|mesh-list
64961839|NCT00048230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961840|NCT00147589|Eplerenone|eplerenone|mesh-list
64961841|NCT00147589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64961842|NCT00147589|Hormone Antagonists|hormone antagonists|mesh-ancestor
64961843|NCT00147589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64961844|NCT00147589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534959|NCT01484431|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64534960|NCT01484431|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64534961|NCT01484431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534962|NCT01484431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961845|NCT00147589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64961846|NCT00147589|Diuretics|diuretics|mesh-ancestor
64961847|NCT00147589|Natriuretic Agents|natriuretic agents|mesh-ancestor
64961848|NCT00147589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64961850|NCT00397332|Dermatologic Agents|dermatologic agents|mesh-ancestor
64961851|NCT00397332|Immunologic Factors|immunologic factors|mesh-ancestor
64961852|NCT00397332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961853|NCT00147628|Sildenafil Citrate|sildenafil citrate|mesh-list
64961854|NCT00147628|Citric Acid|citric acid|mesh-list
64961855|NCT00147628|Sodium Citrate|sodium citrate|mesh-list
64961856|NCT00147628|Anticoagulants|anticoagulants|mesh-ancestor
64961857|NCT00147628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64961858|NCT00147628|Chelating Agents|chelating agents|mesh-ancestor
64961859|NCT00147628|Sequestering Agents|sequestering agents|mesh-ancestor
64961860|NCT00147628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961861|NCT00147628|Vasodilator Agents|vasodilator agents|mesh-ancestor
64961862|NCT00147628|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64961863|NCT00147628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64961864|NCT00147628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961865|NCT00147628|Urological Agents|urological agents|mesh-ancestor
64961866|NCT00147667|Erythromycin|erythromycin|mesh-list
64961867|NCT00147667|Erythromycin Estolate|erythromycin estolate|mesh-list
64961868|NCT00147667|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64961869|NCT00147667|Erythromycin stearate|erythromycin stearate|mesh-list
64961870|NCT00147667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64961871|NCT00147667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64961872|NCT00147667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64961873|NCT00147667|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64961874|NCT00147667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961900|NCT00147901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961901|NCT00147901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64961902|NCT00147901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64961903|NCT00147901|Alkylating Agents|alkylating agents|mesh-ancestor
64961904|NCT00147901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961905|NCT00147901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961906|NCT00147901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64961907|NCT00147901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64961908|NCT02957851|Nitrous Oxide|nitrous oxide|mesh-list
64961909|NCT02957851|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64961910|NCT02957851|Anesthetics, General|anesthetics, general|mesh-ancestor
64961911|NCT02957851|Anesthetics|anesthetics|mesh-ancestor
64961912|NCT02957851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64961913|NCT02957851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961914|NCT02957851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64961915|NCT02957851|Analgesics|analgesics|mesh-ancestor
64961916|NCT02957851|Sensory System Agents|sensory system agents|mesh-ancestor
64961917|NCT02957851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64961920|NCT00147979|Anticoagulants|anticoagulants|mesh-ancestor
64961921|NCT00147979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64961922|NCT00147979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64961944|NCT00081822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64961945|NCT00081822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64961946|NCT00081822|Immunologic Factors|immunologic factors|mesh-ancestor
64961947|NCT00081822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961948|NCT00048425|Simendan|simendan|mesh-list
64961949|NCT00048425|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64961950|NCT00048425|Vasodilator Agents|vasodilator agents|mesh-ancestor
64961951|NCT00048425|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64961952|NCT00048425|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64961953|NCT00048425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961954|NCT00048425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961955|NCT00048425|Protective Agents|protective agents|mesh-ancestor
64961956|NCT00048425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961957|NCT00148135|Gemcitabine|gemcitabine|mesh-list
64534963|NCT01484431|Urological Agents|urological agents|mesh-ancestor
64534965|NCT00445887|Norgestrel|norgestrel|mesh-list
64534966|NCT00445887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64534967|NCT00445887|Contraceptive Agents|contraceptive agents|mesh-ancestor
64534968|NCT00445887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64534969|NCT00445887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534970|NCT00445887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64534971|NCT00445887|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64534972|NCT00445887|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64534973|NCT00445887|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64961958|NCT00148135|Carboplatin|carboplatin|mesh-list
64961959|NCT00148135|Capecitabine|capecitabine|mesh-list
64961960|NCT00148135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961961|NCT00148135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64961962|NCT00148135|Antimetabolites|antimetabolites|mesh-ancestor
64961963|NCT00148135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961964|NCT00148135|Antiviral Agents|antiviral agents|mesh-ancestor
64961965|NCT00148135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64961966|NCT00148135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961967|NCT00148135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64961968|NCT00148135|Immunologic Factors|immunologic factors|mesh-ancestor
64961969|NCT00148135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961970|NCT00399711|Metformin|metformin|mesh-list
64961971|NCT00399711|Rosiglitazone|rosiglitazone|mesh-list
64961972|NCT00399711|Repaglinide|repaglinide|mesh-list
64961973|NCT00399711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64961974|NCT00399711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961975|NCT00148252|Mycophenolic Acid|mycophenolic acid|mesh-list
64961976|NCT00148252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64962005|NCT00405808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64962006|NCT00405808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962007|NCT00081900|N(1),N(11)-diethylnorspermine|n(1),n(11)-diethylnorspermine|mesh-list
64962008|NCT00081900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64962009|NCT00081900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962010|NCT00405847|Dexmedetomidine|dexmedetomidine|mesh-list
64962011|NCT00405847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64962012|NCT00405847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64962013|NCT00405847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962014|NCT00405847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64962015|NCT00405847|Analgesics|analgesics|mesh-ancestor
64962016|NCT00405847|Sensory System Agents|sensory system agents|mesh-ancestor
64962017|NCT00405847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962018|NCT00405847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64962019|NCT00405847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64962020|NCT00405847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64962052|NCT00043134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962053|NCT00148564|Olanzapine|olanzapine|mesh-list
64962054|NCT00148564|Ziprasidone|ziprasidone|mesh-list
64962055|NCT00148564|Antiemetics|antiemetics|mesh-ancestor
64962056|NCT00148564|Autonomic Agents|autonomic agents|mesh-ancestor
64962057|NCT00148564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962058|NCT00148564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962074|NCT00148603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64962075|NCT00148603|Respiratory System Agents|respiratory system agents|mesh-ancestor
64962076|NCT00148603|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64962077|NCT00148603|Hormone Antagonists|hormone antagonists|mesh-ancestor
64962078|NCT00148603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64962079|NCT00148603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962080|NCT00148603|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64962081|NCT00148603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64962082|NCT00148603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534975|NCT01473953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64534976|NCT01473953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534978|NCT01473953|Hormones|hormones|mesh-ancestor
64534979|NCT01473953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64534980|NCT00457977|Vaccines|vaccines|mesh-list
64534981|NCT00457977|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64534982|NCT00457977|Immunologic Factors|immunologic factors|mesh-ancestor
64962083|NCT00048659|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
64962084|NCT00048659|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64962085|NCT00048659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962086|NCT00148681|Paclitaxel|paclitaxel|mesh-list
64962087|NCT00148681|Vinorelbine|vinorelbine|mesh-list
64962088|NCT00148681|Cyclophosphamide|cyclophosphamide|mesh-list
64962089|NCT00148681|Doxorubicin|doxorubicin|mesh-list
64962090|NCT00148681|Trastuzumab|trastuzumab|mesh-list
64962091|NCT00148681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64962092|NCT00148681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962093|NCT00148681|Tubulin Modulators|tubulin modulators|mesh-ancestor
64962094|NCT00148681|Antimitotic Agents|antimitotic agents|mesh-ancestor
64962095|NCT00148681|Mitosis Modulators|mitosis modulators|mesh-ancestor
64962096|NCT00148681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962097|NCT00148681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64962098|NCT00148681|Immunologic Factors|immunologic factors|mesh-ancestor
64962099|NCT00148681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962100|NCT00148681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64962101|NCT00148681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64962102|NCT00148681|Alkylating Agents|alkylating agents|mesh-ancestor
64962103|NCT00148681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64962104|NCT00148681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64962105|NCT00148681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64962106|NCT00148681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64962107|NCT00148681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962108|NCT00148681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64962109|NCT00148720|Capecitabine|capecitabine|mesh-list
64962110|NCT00148720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64962111|NCT00148720|Antimetabolites|antimetabolites|mesh-ancestor
64962112|NCT00148720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962113|NCT00148720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962114|NCT00148837|Interferons|interferons|mesh-list
64962136|NCT00148876|Antimetabolites|antimetabolites|mesh-ancestor
64962137|NCT00148876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962138|NCT00148876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962139|NCT00148876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64962140|NCT00148915|Ibandronic Acid|ibandronic acid|mesh-list
64962141|NCT00148915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64962142|NCT00148915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962143|NCT00149110|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64962144|NCT00149110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64962145|NCT00149110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64653712|NCT02248571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64962146|NCT00149110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64962147|NCT00149110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962148|NCT00149110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64962149|NCT00149110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962150|NCT00149110|Analgesics|analgesics|mesh-ancestor
64962151|NCT00149110|Sensory System Agents|sensory system agents|mesh-ancestor
64962152|NCT00149110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962153|NCT00149110|Antidepressive Agents|antidepressive agents|mesh-ancestor
64962154|NCT00149110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64962155|NCT00149110|Dopamine Agents|dopamine agents|mesh-ancestor
64534983|NCT00457977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534984|NCT01473563|Pemetrexed|pemetrexed|mesh-list
64534985|NCT01473563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534986|NCT01473563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534987|NCT01473563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299583|NCT03099122|Autonomic Agents|autonomic agents|mesh-ancestor
64962156|NCT00149149|Polaprezinc|polaprezinc|mesh-list
64962157|NCT00149149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64962158|NCT00149149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64962159|NCT00149188|Lanreotide|lanreotide|mesh-list
64962160|NCT00149188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962161|NCT00048776|Cilostazol|cilostazol|mesh-list
64962162|NCT00048776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64962163|NCT00048776|Autonomic Agents|autonomic agents|mesh-ancestor
64962164|NCT00048776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962165|NCT00048776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962166|NCT00048776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64962167|NCT00048776|Respiratory System Agents|respiratory system agents|mesh-ancestor
64962168|NCT00048776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64962189|NCT00048854|Serotonin Agents|serotonin agents|mesh-ancestor
64962190|NCT00048854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962191|NCT00081978|Etravirine|etravirine|mesh-list
64962192|NCT00081978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64962193|NCT00081978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64962194|NCT00081978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962195|NCT00081978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962196|NCT00081978|Antiviral Agents|antiviral agents|mesh-ancestor
64962197|NCT00081978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64962198|NCT00149539|Buprenorphine|buprenorphine|mesh-list
64962199|NCT00149539|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64962200|NCT00149539|Naloxone|naloxone|mesh-list
64962201|NCT00149539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64962202|NCT00149539|Narcotics|narcotics|mesh-ancestor
64962203|NCT00149539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64962204|NCT00149539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962205|NCT00149539|Analgesics|analgesics|mesh-ancestor
64962206|NCT00149539|Sensory System Agents|sensory system agents|mesh-ancestor
64962207|NCT00149539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962208|NCT00149539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64962209|NCT00149578|Leucovorin|leucovorin|mesh-list
64962210|NCT00149578|Gemcitabine|gemcitabine|mesh-list
64962211|NCT00149578|Oxaliplatin|oxaliplatin|mesh-list
64962212|NCT00149578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64962213|NCT00149578|Antimetabolites|antimetabolites|mesh-ancestor
64962214|NCT00149578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962215|NCT00149578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962216|NCT00149578|Antiviral Agents|antiviral agents|mesh-ancestor
64962217|NCT00149578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64962218|NCT00149578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962219|NCT00149578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64977085|NCT00259792|Budesonide|budesonide|mesh-list
64962220|NCT00149578|Immunologic Factors|immunologic factors|mesh-ancestor
64962255|NCT00082095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962257|NCT00082095|Antimetabolites|antimetabolites|mesh-ancestor
64962258|NCT00149851|Tegaserod|tegaserod|mesh-list
64962259|NCT00149851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64962260|NCT00149851|Serotonin Agents|serotonin agents|mesh-ancestor
64962261|NCT00149851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64962286|NCT00049088|Tubulin Modulators|tubulin modulators|mesh-ancestor
64962287|NCT00049088|Antimitotic Agents|antimitotic agents|mesh-ancestor
64962288|NCT00049088|Mitosis Modulators|mitosis modulators|mesh-ancestor
64962289|NCT00049088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962290|NCT00149968|Mycophenolic Acid|mycophenolic acid|mesh-list
64962291|NCT00149968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64962292|NCT00149968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962293|NCT00149968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64962294|NCT00149968|Antitubercular Agents|antitubercular agents|mesh-ancestor
64962295|NCT00149968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64962296|NCT00149968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64962297|NCT00149968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64534988|NCT01473563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64534989|NCT01473563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64534990|NCT01795209|Ranibizumab|ranibizumab|mesh-list
64534991|NCT01795209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64534992|NCT01795209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64534993|NCT01795209|Growth Substances|growth substances|mesh-ancestor
64534994|NCT01795209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534995|NCT01795209|Growth Inhibitors|growth inhibitors|mesh-ancestor
64534996|NCT01795209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534997|NCT01484275|Siltuximab|siltuximab|mesh-list
64534998|NCT01484275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64534999|NCT01484197|Maleic acid|maleic acid|mesh-list
64535000|NCT01484197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535001|NCT01484197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535002|NCT01473407|Epoetin Alfa|epoetin alfa|mesh-list
64535003|NCT01473407|Hematinics|hematinics|mesh-ancestor
64535004|NCT04082897|Atezolizumab|atezolizumab|mesh-list
64535005|NCT04082897|Venetoclax|venetoclax|mesh-list
64535006|NCT04082897|Obinutuzumab|obinutuzumab|mesh-list
64535007|NCT04082897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299589|NCT02103361|Dermatologic Agents|dermatologic agents|mesh-ancestor
64962298|NCT00149968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962299|NCT04725448|Paclitaxel|paclitaxel|mesh-list
64962300|NCT04725448|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64962301|NCT04725448|Bevacizumab|bevacizumab|mesh-list
64962302|NCT04725448|Carboplatin|carboplatin|mesh-list
64962303|NCT04725448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64962304|NCT04725448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962305|NCT04725448|Tubulin Modulators|tubulin modulators|mesh-ancestor
64962306|NCT04725448|Antimitotic Agents|antimitotic agents|mesh-ancestor
64962307|NCT04725448|Mitosis Modulators|mitosis modulators|mesh-ancestor
64962308|NCT04725448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962309|NCT04725448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64962342|NCT00150007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962343|NCT00150007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962344|NCT00150046|Everolimus|everolimus|mesh-list
64962345|NCT00150046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962346|NCT00150046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64962347|NCT00150046|Immunologic Factors|immunologic factors|mesh-ancestor
64962348|NCT00150046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977138|NCT00260026|Docetaxel|docetaxel|mesh-list
64962349|NCT00150085|Cyclosporine|cyclosporine|mesh-list
64962350|NCT00150085|Cyclosporins|cyclosporins|mesh-list
64962351|NCT00150085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962352|NCT00150085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962369|NCT00082251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962370|NCT00082251|Vasodilator Agents|vasodilator agents|mesh-ancestor
64962371|NCT00082251|Vitamin B Complex|vitamin b complex|mesh-ancestor
64962372|NCT00082251|Vitamins|vitamins|mesh-ancestor
64962373|NCT00082251|Micronutrients|micronutrients|mesh-ancestor
64962374|NCT00082251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962375|NCT00049244|Capecitabine|capecitabine|mesh-list
64962376|NCT00049244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64962377|NCT00049244|Antimetabolites|antimetabolites|mesh-ancestor
64962378|NCT00049244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962379|NCT00049244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962380|NCT00150124|Methimazole|methimazole|mesh-list
64535008|NCT04082897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64535009|NCT01544179|Pemetrexed|pemetrexed|mesh-list
64535010|NCT01544179|Gefitinib|gefitinib|mesh-list
64535011|NCT01544179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962381|NCT00150124|Antithyroid Agents|antithyroid agents|mesh-ancestor
64962382|NCT00150124|Hormone Antagonists|hormone antagonists|mesh-ancestor
64962383|NCT00150124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64962384|NCT00150124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962385|NCT00049283|Docetaxel|docetaxel|mesh-list
64962386|NCT00049283|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64962387|NCT00049283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962388|NCT00049283|Tubulin Modulators|tubulin modulators|mesh-ancestor
64962389|NCT00049283|Antimitotic Agents|antimitotic agents|mesh-ancestor
64962390|NCT00049283|Mitosis Modulators|mitosis modulators|mesh-ancestor
64962391|NCT00049283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962392|NCT00049283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64962393|NCT00049283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962394|NCT00150241|Varenicline|varenicline|mesh-list
64962395|NCT00150241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64962396|NCT00150241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64962397|NCT00150241|Cholinergic Agents|cholinergic agents|mesh-ancestor
64962398|NCT00150241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64962399|NCT00150241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962400|NCT00150241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962401|NCT00150280|Ibuprofen|ibuprofen|mesh-list
64962402|NCT00150280|Celecoxib|celecoxib|mesh-list
64962403|NCT00150280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64962404|NCT00150280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64962405|NCT00150280|Analgesics|analgesics|mesh-ancestor
64962406|NCT00150280|Sensory System Agents|sensory system agents|mesh-ancestor
64962407|NCT00150280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962408|NCT00150280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962409|NCT00150280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64962410|NCT00150280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64962430|NCT00049361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962431|NCT00049361|Leprostatic Agents|leprostatic agents|mesh-ancestor
64962432|NCT00049361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64962433|NCT00049361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64962434|NCT00049361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64962435|NCT00049361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64962436|NCT00049361|Growth Substances|growth substances|mesh-ancestor
64962437|NCT00049361|Growth Inhibitors|growth inhibitors|mesh-ancestor
64962438|NCT00150436|Pregabalin|pregabalin|mesh-list
64962439|NCT00150436|Analgesics|analgesics|mesh-ancestor
64962440|NCT00150436|Sensory System Agents|sensory system agents|mesh-ancestor
64962441|NCT00150436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962442|NCT00150436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962443|NCT00150436|Anticonvulsants|anticonvulsants|mesh-ancestor
64962444|NCT00150436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64962445|NCT00150436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64962446|NCT00150436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962447|NCT00150436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64962448|NCT00150436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64962449|NCT00150436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64962450|NCT00150436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64962451|NCT00150436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64962452|NCT00150553|Carbamazepine|carbamazepine|mesh-list
64962453|NCT00150553|Anticonvulsants|anticonvulsants|mesh-ancestor
64962454|NCT00150553|Antimanic Agents|antimanic agents|mesh-ancestor
64962455|NCT00150553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64962456|NCT00150553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64962457|NCT00150553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962458|NCT00150553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64962459|NCT00150553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64962460|NCT00150553|Analgesics|analgesics|mesh-ancestor
64962461|NCT00150553|Sensory System Agents|sensory system agents|mesh-ancestor
64962462|NCT00150553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962463|NCT00150553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64962464|NCT00150553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64962495|NCT00150709|Levetiracetam|levetiracetam|mesh-list
64962496|NCT00150709|Anticonvulsants|anticonvulsants|mesh-ancestor
64535013|NCT01544179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535014|NCT01544179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64421937|NCT02552147|Nicotine|nicotine|mesh-list
64535015|NCT01544179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64535016|NCT01544179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64299615|NCT02100553|Itraconazole|itraconazole|mesh-list
64962497|NCT00150709|Nootropic Agents|nootropic agents|mesh-ancestor
64962498|NCT00150748|Levetiracetam|levetiracetam|mesh-list
64962499|NCT00150748|Anticonvulsants|anticonvulsants|mesh-ancestor
64962500|NCT00150748|Nootropic Agents|nootropic agents|mesh-ancestor
64962501|NCT00150787|Levetiracetam|levetiracetam|mesh-list
64962502|NCT00150787|Anticonvulsants|anticonvulsants|mesh-ancestor
64962503|NCT00150787|Nootropic Agents|nootropic agents|mesh-ancestor
64962504|NCT00150826|Quinapril|quinapril|mesh-list
64962505|NCT00150826|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64962535|NCT00049634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64962537|NCT00049634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962538|NCT00049634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962539|NCT00049634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64962540|NCT00049634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64962541|NCT00049634|Abortifacient Agents|abortifacient agents|mesh-ancestor
64962542|NCT00049634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64962543|NCT00049634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64962544|NCT00049634|Antimetabolites|antimetabolites|mesh-ancestor
64962545|NCT00049634|Dermatologic Agents|dermatologic agents|mesh-ancestor
64962546|NCT00049634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962547|NCT00049634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64962548|NCT00049634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64962549|NCT00049634|Antifungal Agents|antifungal agents|mesh-ancestor
64962550|NCT00049634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64962579|NCT00151138|Autonomic Agents|autonomic agents|mesh-ancestor
64962580|NCT00151138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962581|NCT00151138|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64962582|NCT00151138|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64962583|NCT00151138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64962584|NCT00151138|Adrenergic Agents|adrenergic agents|mesh-ancestor
64962585|NCT00151138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64962586|NCT00082485|Baclofen|baclofen|mesh-list
64962587|NCT00082485|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64962588|NCT00082485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962589|NCT00082485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64962590|NCT00082485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962591|NCT00082485|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64962592|NCT00082485|GABA Agonists|gaba agonists|mesh-ancestor
64962593|NCT00082485|GABA Agents|gaba agents|mesh-ancestor
64962594|NCT00082485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64962619|NCT00049751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64962620|NCT00049751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64962621|NCT00151294|Dexetimide|dexetimide|mesh-list
64962622|NCT00151294|Citalopram|citalopram|mesh-list
64962623|NCT00151294|Antidepressive Agents|antidepressive agents|mesh-list
64962624|NCT00151294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64962625|NCT00151294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64962626|NCT00151294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64962627|NCT00151294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962628|NCT00151294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64962629|NCT00151294|Serotonin Agents|serotonin agents|mesh-ancestor
64962630|NCT00151294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962631|NCT00151294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64962632|NCT00151294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64962633|NCT00151294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64962634|NCT00151294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64501300|NCT03385668|Pirfenidone|pirfenidone|mesh-list
64962635|NCT00151294|Parasympatholytics|parasympatholytics|mesh-ancestor
64962636|NCT00151294|Autonomic Agents|autonomic agents|mesh-ancestor
64535018|NCT01483651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64535019|NCT01483651|Glucagon|glucagon|mesh-list
64535020|NCT01483651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64535021|NCT01483651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535022|NCT01483651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64977198|NCT00261118|Rituximab|rituximab|mesh-list
64535023|NCT01483651|Hormones|hormones|mesh-ancestor
64653734|NCT03002675|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64535024|NCT01483651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64535026|NCT01464307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64535027|NCT01464307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64535028|NCT01464307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535029|NCT01464307|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64535030|NCT01464307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64535031|NCT01464307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535032|NCT01464307|Cholinergic Agents|cholinergic agents|mesh-ancestor
64962637|NCT00151294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962638|NCT00151294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64962639|NCT00151294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64962640|NCT00151294|Cholinergic Agents|cholinergic agents|mesh-ancestor
64962642|NCT00151450|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64962643|NCT00151450|Analgesics|analgesics|mesh-ancestor
64962644|NCT00151450|Sensory System Agents|sensory system agents|mesh-ancestor
64962645|NCT00151450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962655|NCT00151450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64962656|NCT00151450|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64962657|NCT00151450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64962658|NCT00151450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64962659|NCT00151450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64962660|NCT00151450|Antidepressive Agents|antidepressive agents|mesh-ancestor
64962661|NCT00151489|Pregabalin|pregabalin|mesh-list
64962662|NCT00151489|Analgesics|analgesics|mesh-ancestor
64962663|NCT00151489|Sensory System Agents|sensory system agents|mesh-ancestor
64962664|NCT00151489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962665|NCT00151489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962666|NCT00151489|Anticonvulsants|anticonvulsants|mesh-ancestor
64962667|NCT00151489|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64962668|NCT00151489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64962669|NCT00151489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962670|NCT00151489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64962671|NCT00151489|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64962672|NCT00151489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64962673|NCT00151489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64962674|NCT00151489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64962675|NCT00049790|Paclitaxel|paclitaxel|mesh-list
64962676|NCT00049790|Carboplatin|carboplatin|mesh-list
64962677|NCT00049790|Angiostatins|angiostatins|mesh-list
64962678|NCT00049790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64962679|NCT00049790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962680|NCT00049790|Tubulin Modulators|tubulin modulators|mesh-ancestor
64962681|NCT00049790|Antimitotic Agents|antimitotic agents|mesh-ancestor
64962682|NCT00049790|Mitosis Modulators|mitosis modulators|mesh-ancestor
64962683|NCT00049790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962684|NCT00049790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64962685|NCT00049790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64962686|NCT00049790|Growth Substances|growth substances|mesh-ancestor
64962687|NCT00049790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535033|NCT01464307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64535035|NCT01482169|Regadenoson|regadenoson|mesh-list
64535036|NCT01482169|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64535037|NCT01482169|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64535038|NCT01482169|Purinergic Agonists|purinergic agonists|mesh-ancestor
64535039|NCT01482169|Purinergic Agents|purinergic agents|mesh-ancestor
64535040|NCT01482169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64535041|NCT01482169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535042|NCT01482169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535043|NCT01482169|Analgesics|analgesics|mesh-ancestor
64535044|NCT01482169|Sensory System Agents|sensory system agents|mesh-ancestor
64535045|NCT01482169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64535046|NCT01482169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64535048|NCT01481779|Insulin Lispro|insulin lispro|mesh-list
64535049|NCT01481779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64535050|NCT01481779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535051|NCT01509547|Varenicline|varenicline|mesh-list
64535052|NCT01509547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64535053|NCT01509547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64535054|NCT01509547|Cholinergic Agents|cholinergic agents|mesh-ancestor
64535055|NCT01509547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64535056|NCT01509547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535057|NCT01509547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535058|NCT01509079|Vitamin D|vitamin d|mesh-list
64535059|NCT01509079|Ergocalciferols|ergocalciferols|mesh-list
64535060|NCT01509079|Cholecalciferol|cholecalciferol|mesh-list
64535061|NCT01509079|Vitamins|vitamins|mesh-list
64535062|NCT01509079|Micronutrients|micronutrients|mesh-ancestor
64962688|NCT00049790|Growth Inhibitors|growth inhibitors|mesh-ancestor
64962689|NCT00082524|Caspofungin|caspofungin|mesh-list
64962690|NCT00082524|Antifungal Agents|antifungal agents|mesh-ancestor
64962691|NCT00082524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64962692|NCT00082524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962693|NCT00082524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962694|NCT00406003|Paroxetine|paroxetine|mesh-list
64962695|NCT00406003|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64962696|NCT00406003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64962697|NCT00406003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64962698|NCT00406003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962699|NCT00406003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64962700|NCT00406003|Serotonin Agents|serotonin agents|mesh-ancestor
64962701|NCT00406003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962702|NCT00406003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64535063|NCT01509079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535064|NCT01509079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64535065|NCT01509079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64535067|NCT04650217|Carbidopa|carbidopa|mesh-list
64535068|NCT04650217|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64535069|NCT04650217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64535070|NCT04650217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64535071|NCT04650217|Dopamine Agents|dopamine agents|mesh-ancestor
64535072|NCT04650217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64535073|NCT04650217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535074|NCT04650217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535075|NCT04650217|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64535076|NCT04650217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535077|NCT04650217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64535078|NCT04650217|Immunologic Factors|immunologic factors|mesh-ancestor
64535079|NCT04650217|Dopamine Agonists|dopamine agonists|mesh-ancestor
64535080|NCT01462435|Celecoxib|celecoxib|mesh-list
64535081|NCT01462435|Diclofenac|diclofenac|mesh-list
64535082|NCT01462435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64535083|NCT01462435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64535084|NCT01462435|Analgesics|analgesics|mesh-ancestor
64535085|NCT01462435|Sensory System Agents|sensory system agents|mesh-ancestor
64535086|NCT01462435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64977260|NCT00261586|Acetaminophen|acetaminophen|mesh-list
64535087|NCT01462435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962703|NCT00406003|Antidepressive Agents|antidepressive agents|mesh-ancestor
64962704|NCT00406003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64962705|NCT00406003|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64962706|NCT00406003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64962730|NCT00406042|Protective Agents|protective agents|mesh-ancestor
64962732|NCT00082563|Chloroquine|chloroquine|mesh-list
64962733|NCT00082563|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64962734|NCT00082563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64962735|NCT00082563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64962736|NCT00082563|Amebicides|amebicides|mesh-ancestor
64962737|NCT00082563|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64962738|NCT00082563|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64962739|NCT00082563|Antimalarials|antimalarials|mesh-ancestor
64962740|NCT00082563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64962741|NCT00082563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64962742|NCT00082563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64962743|NCT00082563|Analgesics|analgesics|mesh-ancestor
64962744|NCT00082563|Sensory System Agents|sensory system agents|mesh-ancestor
64962745|NCT00082563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962746|NCT00082563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962747|NCT00082563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64962748|NCT00082563|Filaricides|filaricides|mesh-ancestor
64962749|NCT00082563|Antinematodal Agents|antinematodal agents|mesh-ancestor
64962750|NCT00082563|Anthelmintics|anthelmintics|mesh-ancestor
64962751|NCT00151528|Pregabalin|pregabalin|mesh-list
64962752|NCT00151528|Analgesics|analgesics|mesh-ancestor
64535088|NCT01462435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64535089|NCT01462435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64535090|NCT01462435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64535091|NCT01462435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64962753|NCT00151528|Sensory System Agents|sensory system agents|mesh-ancestor
64962754|NCT00151528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962755|NCT00151528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962756|NCT00151528|Anticonvulsants|anticonvulsants|mesh-ancestor
64962757|NCT00151528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64962758|NCT00151528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64962775|NCT00082602|Galantamine|galantamine|mesh-list
64962776|NCT00082602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64962777|NCT00082602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962778|NCT00082602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962779|NCT00082602|Cholinergic Agents|cholinergic agents|mesh-ancestor
64501441|NCT03376932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64962780|NCT00082602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64962781|NCT00082602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962782|NCT00082602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64962783|NCT00082602|Autonomic Agents|autonomic agents|mesh-ancestor
64962784|NCT00082602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962785|NCT00082602|Nootropic Agents|nootropic agents|mesh-ancestor
64962786|NCT00151567|Tamsulosin|tamsulosin|mesh-list
64962787|NCT00151567|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64962788|NCT00151567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64962789|NCT00151567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64962790|NCT00151567|Adrenergic Agents|adrenergic agents|mesh-ancestor
64962791|NCT00151567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64962792|NCT00151567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962793|NCT00151567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962794|NCT00151567|Urological Agents|urological agents|mesh-ancestor
64962795|NCT00397826|Simvastatin|simvastatin|mesh-list
64962796|NCT00397826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64962797|NCT00397826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64962798|NCT00397826|Antimetabolites|antimetabolites|mesh-ancestor
64962799|NCT00397826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962800|NCT00397826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64962801|NCT00397826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64962802|NCT00397826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962803|NCT00151684|Diazoxide|diazoxide|mesh-list
64962804|NCT00151684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64962805|NCT00151684|Vasodilator Agents|vasodilator agents|mesh-ancestor
64962806|NCT00151762|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
64962807|NCT00151762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64962808|NCT00151762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64962809|NCT00151762|Antimetabolites|antimetabolites|mesh-ancestor
64962810|NCT00151762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962811|NCT00151762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64962812|NCT00151801|Interferons|interferons|mesh-list
64962813|NCT00151801|Interferon-beta|interferon-beta|mesh-list
64962841|NCT00151957|Methylphenidate|methylphenidate|mesh-list
64962842|NCT00151957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64962843|NCT00151957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653756|NCT04374188|Ofloxacin|ofloxacin|mesh-list
64962844|NCT00151957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64962845|NCT00151957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64962846|NCT00151957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64962847|NCT00151957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962848|NCT00151957|Dopamine Agents|dopamine agents|mesh-ancestor
64962849|NCT00151957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64962850|NCT00049946|Risperidone|risperidone|mesh-list
64962851|NCT00049946|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64962852|NCT00049946|Serotonin Agents|serotonin agents|mesh-ancestor
64962853|NCT00049946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64962854|NCT00049946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962855|NCT00049946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962856|NCT00049946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64962857|NCT00049946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64962858|NCT00049946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64535093|NCT01462435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535095|NCT01472081|Ipilimumab|ipilimumab|mesh-list
64535096|NCT01472081|Sunitinib|sunitinib|mesh-list
64535097|NCT01472081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64535098|NCT01472081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535099|NCT01472081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64535100|NCT01472081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299696|NCT03295383|Rituximab|rituximab|mesh-list
64962859|NCT00049946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64962860|NCT00049946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64962861|NCT00049946|Dopamine Agents|dopamine agents|mesh-ancestor
64962862|NCT00152035|Amphetamine|amphetamine|mesh-list
64962863|NCT00152035|Dextroamphetamine|dextroamphetamine|mesh-list
64962883|NCT00082797|Levoleucovorin|levoleucovorin|mesh-list
64962884|NCT00082797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64962885|NCT00082797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962886|NCT00082797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64962887|NCT00082797|Abortifacient Agents|abortifacient agents|mesh-ancestor
64962888|NCT00082797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64962889|NCT00082797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64962890|NCT00082797|Antimetabolites|antimetabolites|mesh-ancestor
64962891|NCT00082797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962892|NCT00082797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962893|NCT00082797|Dermatologic Agents|dermatologic agents|mesh-ancestor
64962894|NCT00082797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962895|NCT00082797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64962896|NCT00082797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64962897|NCT00082797|Immunologic Factors|immunologic factors|mesh-ancestor
64962898|NCT00082797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64962899|NCT00082797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64962900|NCT00082797|Antidotes|antidotes|mesh-ancestor
64962901|NCT00082797|Protective Agents|protective agents|mesh-ancestor
64962902|NCT00082797|Vitamin B Complex|vitamin b complex|mesh-ancestor
64962903|NCT00082797|Vitamins|vitamins|mesh-ancestor
64962904|NCT00082797|Micronutrients|micronutrients|mesh-ancestor
64962905|NCT00152191|Cyclophosphamide|cyclophosphamide|mesh-list
64962906|NCT00152191|Fluorouracil|fluorouracil|mesh-list
64962907|NCT00152191|Methotrexate|methotrexate|mesh-list
64962908|NCT00152191|Tegafur|tegafur|mesh-list
64540280|NCT01429051|Fentanyl|fentanyl|mesh-list
64962909|NCT00152191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64962910|NCT00152191|Immunologic Factors|immunologic factors|mesh-ancestor
64962911|NCT00152191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962912|NCT00152191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64962913|NCT00152191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64962914|NCT00152191|Alkylating Agents|alkylating agents|mesh-ancestor
64962915|NCT00152191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962916|NCT00152191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962917|NCT00152191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64962918|NCT00152191|Antimetabolites|antimetabolites|mesh-ancestor
64962919|NCT00152191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64962920|NCT00152191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64962943|NCT00152308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64962945|NCT00152386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64962946|NCT00152386|Immunologic Factors|immunologic factors|mesh-ancestor
64962947|NCT00152386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962948|NCT00152386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64962949|NCT00082836|Rituximab|rituximab|mesh-list
64962950|NCT00082836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64962951|NCT00082836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962952|NCT00082836|Immunologic Factors|immunologic factors|mesh-ancestor
64962953|NCT00082836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962954|NCT00082836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64962955|NCT00152425|Certolizumab Pegol|certolizumab pegol|mesh-list
64962956|NCT00152425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64535101|NCT01472081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64535102|NCT01472081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64535103|NCT01472081|Growth Substances|growth substances|mesh-ancestor
64535104|NCT01472081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535105|NCT01472081|Growth Inhibitors|growth inhibitors|mesh-ancestor
64535106|NCT01472081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64535107|NCT01472081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535108|NCT01471691|Ranibizumab|ranibizumab|mesh-list
64535109|NCT01471691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64535110|NCT01471691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64535111|NCT01471691|Growth Substances|growth substances|mesh-ancestor
64535112|NCT01471691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299698|NCT03295383|Immunologic Factors|immunologic factors|mesh-ancestor
64299707|NCT02101255|Fluorides|fluorides|mesh-list
64962957|NCT00152425|Immunologic Factors|immunologic factors|mesh-ancestor
64962958|NCT00152425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962959|NCT00152425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64962960|NCT00152542|Nitric Oxide|nitric oxide|mesh-list
64962961|NCT00152542|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64962962|NCT00152542|Autonomic Agents|autonomic agents|mesh-ancestor
64962963|NCT00152542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962964|NCT00152542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962965|NCT00152542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64962966|NCT00152542|Respiratory System Agents|respiratory system agents|mesh-ancestor
64962967|NCT00152542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64962968|NCT00152542|Antioxidants|antioxidants|mesh-ancestor
64962969|NCT00152542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962970|NCT00152542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64962971|NCT00152542|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64962972|NCT00152542|Vasodilator Agents|vasodilator agents|mesh-ancestor
64962998|NCT00152581|Immunologic Factors|immunologic factors|mesh-ancestor
64962999|NCT00152581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963000|NCT00152620|Dexamethasone|dexamethasone|mesh-list
64963001|NCT00152620|Methylprednisolone|methylprednisolone|mesh-list
64963002|NCT00152620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64963003|NCT00152620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64963004|NCT00152620|Prednisolone|prednisolone|mesh-list
64963005|NCT00152620|Prednisolone acetate|prednisolone acetate|mesh-list
64963006|NCT00152620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64963007|NCT00152620|Prednisolone phosphate|prednisolone phosphate|mesh-list
64963008|NCT00152620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64963009|NCT00152620|Antiemetics|antiemetics|mesh-ancestor
64963010|NCT00152620|Autonomic Agents|autonomic agents|mesh-ancestor
64963011|NCT00152620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64963012|NCT00152620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963013|NCT00152620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64963014|NCT00152620|Glucocorticoids|glucocorticoids|mesh-ancestor
64963015|NCT00152620|Hormones|hormones|mesh-ancestor
64963016|NCT00152620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64963017|NCT00152620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64963018|NCT00152620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963019|NCT00152620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64963020|NCT00152620|Protective Agents|protective agents|mesh-ancestor
64963021|NCT00050141|Tipifarnib|tipifarnib|mesh-list
64963022|NCT00050141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963023|NCT04725214|Temozolomide|temozolomide|mesh-list
64963045|NCT00050180|Anesthetics|anesthetics|mesh-ancestor
64963046|NCT00050180|GABA Modulators|gaba modulators|mesh-ancestor
64963048|NCT00050180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64963049|NCT00050180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963050|NCT00050180|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64535113|NCT01471691|Growth Inhibitors|growth inhibitors|mesh-ancestor
64535114|NCT01471691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535116|NCT01471379|Levomilnacipran|levomilnacipran|mesh-list
64535117|NCT01471379|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64535118|NCT01471379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64535119|NCT01471379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64535120|NCT01471379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535121|NCT01471379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64977304|NCT00072059|Epoetin Alfa|epoetin alfa|mesh-list
64535122|NCT01471379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535123|NCT01471379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64535124|NCT01471379|Analgesics|analgesics|mesh-ancestor
64535125|NCT01471379|Sensory System Agents|sensory system agents|mesh-ancestor
64535126|NCT01471379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64535127|NCT01471379|Antidepressive Agents|antidepressive agents|mesh-ancestor
64535128|NCT01471379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64535129|NCT01470989|Triamcinolone|triamcinolone|mesh-list
64535130|NCT01470989|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64535131|NCT01470989|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64535132|NCT01470989|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64535133|NCT01470989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64535134|NCT01470989|Glucocorticoids|glucocorticoids|mesh-ancestor
64535135|NCT01470989|Hormones|hormones|mesh-ancestor
64535136|NCT01470989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64535137|NCT01470989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535138|NCT01470989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64535139|NCT01470989|Immunologic Factors|immunologic factors|mesh-ancestor
64299711|NCT05063318|Itraconazole|itraconazole|mesh-list
64963051|NCT00050180|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64963052|NCT00050180|Protease Inhibitors|protease inhibitors|mesh-ancestor
64963053|NCT00050180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963054|NCT00050180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64963055|NCT00050180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64963056|NCT00050180|Antiviral Agents|antiviral agents|mesh-ancestor
64963057|NCT00050180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64963058|NCT00050180|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64963059|NCT00050180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64963060|NCT00082914|Denileukin diftitox|denileukin diftitox|mesh-list
64963061|NCT00082914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963062|NCT00152815|Vitamin E|vitamin e|mesh-list
64963063|NCT00152815|Antioxidants|antioxidants|mesh-list
64963064|NCT00152815|Vitamins|vitamins|mesh-ancestor
64963065|NCT00152815|Micronutrients|micronutrients|mesh-ancestor
64963066|NCT00152815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535140|NCT01470989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535141|NCT01470989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535142|NCT01470599|Tofacitinib|tofacitinib|mesh-list
64535143|NCT01470599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64535144|NCT01470599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653772|NCT03401606|Dexmedetomidine|dexmedetomidine|mesh-list
64535145|NCT01470599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535146|NCT01469819|Lubiprostone|lubiprostone|mesh-list
64535147|NCT01469819|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64299739|NCT02106559|Trioxsalen|trioxsalen|mesh-list
64299740|NCT02106559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299743|NCT05047874|Methylprednisolone|methylprednisolone|mesh-list
64963067|NCT00152815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963068|NCT00152815|Protective Agents|protective agents|mesh-ancestor
64963069|NCT00043719|Vitamin D|vitamin d|mesh-list
64963070|NCT00043719|Nitroglycerin|nitroglycerin|mesh-list
64963071|NCT00043719|Calcium|calcium|mesh-list
64963072|NCT00043719|Vitamins|vitamins|mesh-ancestor
64963073|NCT00043719|Micronutrients|micronutrients|mesh-ancestor
64963074|NCT00043719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963075|NCT00043719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64963076|NCT00043719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64963077|NCT00043719|Vasodilator Agents|vasodilator agents|mesh-ancestor
64963089|NCT00152893|Niacin|niacin|mesh-list
64963090|NCT00152893|Trace Elements|trace elements|mesh-ancestor
64963091|NCT00152893|Micronutrients|micronutrients|mesh-ancestor
64963092|NCT00152893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963093|NCT00152893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64963094|NCT00152893|Antimetabolites|antimetabolites|mesh-ancestor
64963095|NCT00152893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963096|NCT00152893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64963097|NCT00152893|Vasodilator Agents|vasodilator agents|mesh-ancestor
64963098|NCT00152893|Vitamin B Complex|vitamin b complex|mesh-ancestor
64963099|NCT00152893|Vitamins|vitamins|mesh-ancestor
64963100|NCT00152932|Dorzolamide|dorzolamide|mesh-list
64963101|NCT00152932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64963102|NCT00152932|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64963103|NCT00152932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963104|NCT00152932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963105|NCT00083031|Cyclophosphamide|cyclophosphamide|mesh-list
64963106|NCT00083031|Bevacizumab|bevacizumab|mesh-list
64963107|NCT00083031|Methotrexate|methotrexate|mesh-list
64963108|NCT00083031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64963109|NCT00083031|Immunologic Factors|immunologic factors|mesh-ancestor
64963110|NCT00083031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963111|NCT00083031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64963112|NCT00083031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64963113|NCT00083031|Alkylating Agents|alkylating agents|mesh-ancestor
64963114|NCT00083031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963115|NCT00083031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963116|NCT00083031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64963117|NCT00083031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64963118|NCT00083031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64963119|NCT00083031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64963120|NCT00083031|Growth Substances|growth substances|mesh-ancestor
64963121|NCT00083031|Growth Inhibitors|growth inhibitors|mesh-ancestor
64963122|NCT00083031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64963123|NCT00083031|Abortifacient Agents|abortifacient agents|mesh-ancestor
64963124|NCT00083031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64963125|NCT00083031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64963126|NCT00083031|Antimetabolites|antimetabolites|mesh-ancestor
64963127|NCT00083031|Dermatologic Agents|dermatologic agents|mesh-ancestor
64963128|NCT00083031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963129|NCT00083031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64963130|NCT00083031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64535148|NCT01469819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64535149|NCT01469819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535150|NCT04618523|Artesunate|artesunate|mesh-list
64963131|NCT00050336|Lonafarnib|lonafarnib|mesh-list
64963132|NCT00050336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963133|NCT00050336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963134|NCT00043758|Tolvaptan|tolvaptan|mesh-list
64963149|NCT00153049|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64963150|NCT00153049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64963151|NCT00153049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963152|NCT00153049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64963153|NCT00153049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64963155|NCT00153088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64963156|NCT00153088|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64963157|NCT00153088|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64977358|NCT00261976|Infliximab|infliximab|mesh-list
64963158|NCT00153088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963159|NCT00083070|Temozolomide|temozolomide|mesh-list
64963160|NCT00083070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64963161|NCT00083070|Alkylating Agents|alkylating agents|mesh-ancestor
64963162|NCT00083070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963163|NCT00083070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963164|NCT00050414|Dexamethasone|dexamethasone|mesh-list
64963165|NCT00050414|Trabectedin|trabectedin|mesh-list
64963166|NCT00050414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64963167|NCT00050414|Antiemetics|antiemetics|mesh-ancestor
64963168|NCT00050414|Autonomic Agents|autonomic agents|mesh-ancestor
64963169|NCT00050414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64963170|NCT00050414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963171|NCT00050414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64963172|NCT00050414|Glucocorticoids|glucocorticoids|mesh-ancestor
64963173|NCT00050414|Hormones|hormones|mesh-ancestor
64963174|NCT00050414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64963175|NCT00050414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64963176|NCT00050414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963177|NCT00050414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64963178|NCT00050414|Alkylating Agents|alkylating agents|mesh-ancestor
64963179|NCT00050414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963180|NCT00153127|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64963181|NCT00153127|Laxatives|laxatives|mesh-ancestor
64963182|NCT00153127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64963183|NCT00083109|Suramin|suramin|mesh-list
64963184|NCT00083109|Fluorouracil|fluorouracil|mesh-list
64963185|NCT00083109|Antimetabolites|antimetabolites|mesh-ancestor
64963186|NCT00083109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963187|NCT00083109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64963188|NCT00083109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963189|NCT00083109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64963190|NCT00083109|Immunologic Factors|immunologic factors|mesh-ancestor
64963207|NCT00153244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64963208|NCT00153244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64963209|NCT00153244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64963211|NCT00153283|Analgesics|analgesics|mesh-ancestor
64540320|NCT03139422|Tranexamic Acid|tranexamic acid|mesh-list
64963212|NCT00153283|Sensory System Agents|sensory system agents|mesh-ancestor
64963213|NCT00153283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64963214|NCT00153283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963215|NCT00153283|Anticonvulsants|anticonvulsants|mesh-ancestor
64963216|NCT00153283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64963217|NCT00153283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64963218|NCT00153283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64963219|NCT00153283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64963220|NCT00153283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64963221|NCT00153283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64963222|NCT00153283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64963223|NCT00153283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963224|NCT00153283|Antimanic Agents|antimanic agents|mesh-ancestor
64963225|NCT00050531|Interferons|interferons|mesh-list
64963226|NCT00050531|Interferon-alpha|interferon-alpha|mesh-list
64535151|NCT04618523|Lumefantrine|lumefantrine|mesh-list
64535152|NCT04618523|Artemether|artemether|mesh-list
64535153|NCT04618523|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64535154|NCT04618523|Amodiaquine|amodiaquine|mesh-list
64535155|NCT04618523|Antimalarials|antimalarials|mesh-ancestor
64535156|NCT04618523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64535157|NCT04618523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64535158|NCT04618523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64535159|NCT04618523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535160|NCT04618523|Antiviral Agents|antiviral agents|mesh-ancestor
64299756|NCT05047874|Glucocorticoids|glucocorticoids|mesh-ancestor
64963227|NCT00050531|Interferon alpha-2|interferon alpha-2|mesh-list
64963228|NCT00050531|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64501890|NCT01593592|Omeprazole|omeprazole|mesh-list
64501910|NCT01593670|Decitabine|decitabine|mesh-list
64963229|NCT00050531|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
64963230|NCT00050531|Imatinib Mesylate|imatinib mesylate|mesh-list
64963231|NCT00050531|Molgramostim|molgramostim|mesh-list
64963232|NCT00050531|Sargramostim|sargramostim|mesh-list
64963233|NCT00050531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963234|NCT00050531|Antiviral Agents|antiviral agents|mesh-ancestor
64963235|NCT00050531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64963236|NCT00050531|Immunologic Factors|immunologic factors|mesh-ancestor
64963237|NCT00050531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963238|NCT00050531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64963239|NCT00050531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963240|NCT00050531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963241|NCT00083148|Capecitabine|capecitabine|mesh-list
64963242|NCT00083148|Irinotecan|irinotecan|mesh-list
64963243|NCT00083148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64963244|NCT00083148|Antimetabolites|antimetabolites|mesh-ancestor
64963245|NCT00083148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963246|NCT00083148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963247|NCT00083148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64963276|NCT00153634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64963277|NCT00153634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64963278|NCT00153634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64963279|NCT00153634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64963280|NCT00153634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963281|NCT00153634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963282|NCT00153634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963283|NCT00153634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64963284|NCT00153634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64963285|NCT00153634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64963287|NCT00050609|Vasodilator Agents|vasodilator agents|mesh-ancestor
64963288|NCT00050609|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64963289|NCT00050609|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64963290|NCT00050609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963291|NCT00050609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963292|NCT00050609|Urological Agents|urological agents|mesh-ancestor
64963293|NCT00153673|Celecoxib|celecoxib|mesh-list
64963294|NCT00153673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64963295|NCT00153673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64963296|NCT00153673|Analgesics|analgesics|mesh-ancestor
64963327|NCT00153907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64963328|NCT00153907|Tubulin Modulators|tubulin modulators|mesh-ancestor
64963329|NCT00153907|Antimitotic Agents|antimitotic agents|mesh-ancestor
64963330|NCT00153907|Mitosis Modulators|mitosis modulators|mesh-ancestor
64963331|NCT00050726|Interleukin-2|interleukin-2|mesh-list
64963332|NCT00050726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963333|NCT00050726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64963334|NCT00050726|Analgesics|analgesics|mesh-ancestor
64963335|NCT00050726|Sensory System Agents|sensory system agents|mesh-ancestor
64963336|NCT00050726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64963337|NCT00050726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963338|NCT00153946|Edaravone|edaravone|mesh-list
64535161|NCT04618523|Schistosomicides|schistosomicides|mesh-ancestor
64535162|NCT04618523|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64535163|NCT04618523|Anthelmintics|anthelmintics|mesh-ancestor
64535164|NCT01507831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64535165|NCT01507831|Immunologic Factors|immunologic factors|mesh-ancestor
64535166|NCT01507831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535167|NCT01479439|Losartan|losartan|mesh-list
64535168|NCT01479439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64535169|NCT01479439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64535170|NCT01479439|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64535171|NCT01479439|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64963339|NCT00153946|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64963340|NCT00153946|Antioxidants|antioxidants|mesh-ancestor
64963341|NCT00153946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963369|NCT00154180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963370|NCT00154180|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64963371|NCT00154180|Contraceptive Agents|contraceptive agents|mesh-ancestor
64963372|NCT00154180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64963373|NCT00154180|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64963374|NCT00154180|Progestins|progestins|mesh-ancestor
64963375|NCT00154219|Lumiracoxib|lumiracoxib|mesh-list
64963376|NCT00154219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64963377|NCT00154219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64963378|NCT00154219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963379|NCT00154219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502038|NCT05566834|Alkylating Agents|alkylating agents|mesh-ancestor
64963380|NCT00154219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64963381|NCT00154219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64963383|NCT00154219|Sensory System Agents|sensory system agents|mesh-ancestor
64963384|NCT00154219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64977443|NCT02966288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963385|NCT00154219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963386|NCT00154219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64963387|NCT00154219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64963388|NCT00043875|Lamotrigine|lamotrigine|mesh-list
64963414|NCT00154336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64963415|NCT00154336|Abortifacient Agents|abortifacient agents|mesh-ancestor
64963416|NCT00154336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64963417|NCT00154336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963418|NCT00154336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64963419|NCT00154336|Antimetabolites|antimetabolites|mesh-ancestor
64963420|NCT00154336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963421|NCT00154336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963422|NCT00154336|Dermatologic Agents|dermatologic agents|mesh-ancestor
64963423|NCT00154336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963424|NCT00154336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64963425|NCT00154336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64963426|NCT00154336|Immunologic Factors|immunologic factors|mesh-ancestor
64963427|NCT00154336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64963428|NCT00154336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64963429|NCT00154336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64963431|NCT00050804|Antidepressive Agents|antidepressive agents|mesh-ancestor
64963432|NCT00050804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64963433|NCT00050804|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64963452|NCT00154414|Liraglutide|liraglutide|mesh-list
64502125|NCT03372486|Naloxone|naloxone|mesh-list
64963453|NCT00154414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64963454|NCT00154414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963456|NCT00154414|Hormones|hormones|mesh-ancestor
64963457|NCT00154414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64963458|NCT04705987|Colchicine|colchicine|mesh-list
64963459|NCT04705987|Gout Suppressants|gout suppressants|mesh-ancestor
64963460|NCT04705987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64535172|NCT01479439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535173|NCT01478971|Epoetin Alfa|epoetin alfa|mesh-list
64535174|NCT01478971|Hematinics|hematinics|mesh-ancestor
64535175|NCT01507051|Vitamin K|vitamin k|mesh-list
64535176|NCT01507051|Vitamin K 1|vitamin k 1|mesh-list
64535177|NCT01507051|Warfarin|warfarin|mesh-list
64535178|NCT01507051|Rivaroxaban|rivaroxaban|mesh-list
64535179|NCT01507051|Vitamins|vitamins|mesh-ancestor
64535180|NCT01507051|Micronutrients|micronutrients|mesh-ancestor
64535181|NCT01507051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535182|NCT01507051|Anticoagulants|anticoagulants|mesh-ancestor
64535183|NCT01507051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64535184|NCT01507051|Antithrombins|antithrombins|mesh-ancestor
64535185|NCT01507051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64535186|NCT01507051|Protease Inhibitors|protease inhibitors|mesh-ancestor
64535187|NCT01507051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653811|NCT03401372|Immunologic Factors|immunologic factors|mesh-ancestor
64535188|NCT01507051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535189|NCT01507051|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64535190|NCT01507051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64535191|NCT01507051|Hemostatics|hemostatics|mesh-ancestor
64535192|NCT01507051|Coagulants|coagulants|mesh-ancestor
64535193|NCT04079257|Eculizumab|eculizumab|mesh-list
64535194|NCT04079257|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64535195|NCT04079257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64535196|NCT04079257|Immunologic Factors|immunologic factors|mesh-ancestor
64535197|NCT04079257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535198|NCT01478113|Amphetamine|amphetamine|mesh-list
64977463|NCT00262405|Analgesics|analgesics|mesh-ancestor
64963461|NCT04705987|Tubulin Modulators|tubulin modulators|mesh-ancestor
64963462|NCT04705987|Antimitotic Agents|antimitotic agents|mesh-ancestor
64963463|NCT04705987|Mitosis Modulators|mitosis modulators|mesh-ancestor
64963464|NCT04705987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963465|NCT04705987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963466|NCT04705909|Pitavastatin|pitavastatin|mesh-list
64963467|NCT04705909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
64963468|NCT04705909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64963469|NCT04705909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64963470|NCT04705909|Antimetabolites|antimetabolites|mesh-ancestor
64963471|NCT04705909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963472|NCT04705909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963473|NCT04705909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64963474|NCT00083304|Efaproxiral|efaproxiral|mesh-list
64963475|NCT00083304|Antisickling Agents|antisickling agents|mesh-ancestor
64963476|NCT00050843|Thalidomide|thalidomide|mesh-list
64963477|NCT00050843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64963478|NCT00050843|Immunologic Factors|immunologic factors|mesh-ancestor
64963479|NCT00050843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963480|NCT00050843|Leprostatic Agents|leprostatic agents|mesh-ancestor
64963481|NCT00050843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64963482|NCT00050843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64963483|NCT00050843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64963484|NCT00050843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64535199|NCT01478113|Adderall|adderall|mesh-list
64535200|NCT01478113|Dextroamphetamine|dextroamphetamine|mesh-list
64535201|NCT01478113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64535202|NCT01478113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535203|NCT01478113|Sympathomimetics|sympathomimetics|mesh-ancestor
64535204|NCT01478113|Autonomic Agents|autonomic agents|mesh-ancestor
64535205|NCT01478113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64535206|NCT01478113|Dopamine Agents|dopamine agents|mesh-ancestor
64535207|NCT01478113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64535208|NCT01478113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535209|NCT01478113|Adrenergic Agents|adrenergic agents|mesh-ancestor
64535210|NCT01478113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64535211|NCT01478113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64535212|NCT01478113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64535213|NCT01478113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64535214|NCT01506271|Imipenem|imipenem|mesh-list
64535215|NCT01506271|Relebactam|relebactam|mesh-list
64535216|NCT01506271|Cilastatin|cilastatin|mesh-list
64535217|NCT01506271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64535218|NCT01506271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64535219|NCT01506271|Protease Inhibitors|protease inhibitors|mesh-ancestor
64535220|NCT01506271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963485|NCT00050843|Growth Substances|growth substances|mesh-ancestor
64963486|NCT00050843|Growth Inhibitors|growth inhibitors|mesh-ancestor
64963487|NCT00050843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653820|NCT03401372|Antiemetics|antiemetics|mesh-ancestor
64963511|NCT00083343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963512|NCT00083343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963513|NCT00406471|Ranibizumab|ranibizumab|mesh-list
64963514|NCT00406471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64963515|NCT00406471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64963516|NCT00406471|Growth Substances|growth substances|mesh-ancestor
64963517|NCT00406471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963518|NCT00406471|Growth Inhibitors|growth inhibitors|mesh-ancestor
64963519|NCT00406471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963520|NCT00050921|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
64963521|NCT00050921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64963522|NCT00050921|Immunologic Factors|immunologic factors|mesh-ancestor
64977504|NCT00262795|Chlorambucil|chlorambucil|mesh-list
64963523|NCT00050921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963524|NCT00154687|Paclitaxel|paclitaxel|mesh-list
64963525|NCT00154687|Fluorouracil|fluorouracil|mesh-list
64502189|NCT03000634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64963526|NCT00154687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64963527|NCT00154687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963528|NCT00154687|Tubulin Modulators|tubulin modulators|mesh-ancestor
64963529|NCT00154687|Antimitotic Agents|antimitotic agents|mesh-ancestor
64963530|NCT00154687|Mitosis Modulators|mitosis modulators|mesh-ancestor
64963531|NCT00154687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963533|NCT00154687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64963534|NCT00154687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64963535|NCT00154687|Immunologic Factors|immunologic factors|mesh-ancestor
64963544|NCT00083460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64963545|NCT00083460|Glucocorticoids|glucocorticoids|mesh-ancestor
64963546|NCT00083460|Hormones|hormones|mesh-ancestor
64535221|NCT01506271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535222|NCT01506271|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64535223|NCT01506193|Vaccines|vaccines|mesh-list
64535224|NCT01506193|Immunologic Factors|immunologic factors|mesh-ancestor
64535225|NCT01506193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535226|NCT01505881|Warfarin|warfarin|mesh-list
64535227|NCT01505881|Dabigatran|dabigatran|mesh-list
64535228|NCT01505881|Anticoagulants|anticoagulants|mesh-ancestor
64535229|NCT01505881|Antithrombins|antithrombins|mesh-ancestor
64299820|NCT02104843|Antimetabolites|antimetabolites|mesh-ancestor
64963547|NCT00083460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64963548|NCT00083460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64963549|NCT00083460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963550|NCT00083460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64963551|NCT00083460|Immunologic Factors|immunologic factors|mesh-ancestor
64963552|NCT00083460|Leprostatic Agents|leprostatic agents|mesh-ancestor
64963553|NCT00083460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64963554|NCT00083460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64963555|NCT00083460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64963556|NCT00083460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64963557|NCT00083460|Growth Substances|growth substances|mesh-ancestor
64963558|NCT00083460|Growth Inhibitors|growth inhibitors|mesh-ancestor
64963559|NCT00154726|Paclitaxel|paclitaxel|mesh-list
64963560|NCT00154726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64963561|NCT00154726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963562|NCT00154726|Tubulin Modulators|tubulin modulators|mesh-ancestor
64963563|NCT00154726|Antimitotic Agents|antimitotic agents|mesh-ancestor
64963564|NCT00154726|Mitosis Modulators|mitosis modulators|mesh-ancestor
64963565|NCT00154726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963566|NCT00154804|Paclitaxel|paclitaxel|mesh-list
64963567|NCT00154804|Cisplatin|cisplatin|mesh-list
64963568|NCT00154804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64963569|NCT00154804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963570|NCT00154804|Tubulin Modulators|tubulin modulators|mesh-ancestor
64963571|NCT00154804|Antimitotic Agents|antimitotic agents|mesh-ancestor
64963572|NCT00154804|Mitosis Modulators|mitosis modulators|mesh-ancestor
64963573|NCT00154804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963574|NCT00154843|Lycopene|lycopene|mesh-list
64963575|NCT00154843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64963576|NCT00154843|Antioxidants|antioxidants|mesh-ancestor
64963577|NCT00154843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963578|NCT00154843|Protective Agents|protective agents|mesh-ancestor
64963579|NCT00154843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963580|NCT00154843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64963581|NCT00154843|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64963582|NCT00154843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963583|NCT00043953|Ritonavir|ritonavir|mesh-list
64963584|NCT00043953|Lopinavir|lopinavir|mesh-list
64963585|NCT00043953|Saquinavir|saquinavir|mesh-list
64963586|NCT00043953|Lamivudine|lamivudine|mesh-list
64963587|NCT00043953|Zidovudine|zidovudine|mesh-list
64963588|NCT00043953|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64963589|NCT00043953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64963590|NCT00043953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64963591|NCT00043953|Protease Inhibitors|protease inhibitors|mesh-ancestor
64963592|NCT00043953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963593|NCT00043953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963594|NCT00043953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64963595|NCT00043953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64963596|NCT00043953|Antiviral Agents|antiviral agents|mesh-ancestor
64963597|NCT00043953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64963598|NCT00043953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64502262|NCT04523844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963599|NCT00043953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64502336|NCT04398706|Immunologic Factors|immunologic factors|mesh-ancestor
64963600|NCT00043953|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64535230|NCT01505881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64535231|NCT01505881|Protease Inhibitors|protease inhibitors|mesh-ancestor
64535232|NCT01505881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535233|NCT01505881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535235|NCT01505647|Immunologic Factors|immunologic factors|mesh-ancestor
64535236|NCT01505647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535237|NCT01477333|Treprostinil|treprostinil|mesh-list
64535238|NCT01477333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64535239|NCT01505491|Adalimumab|adalimumab|mesh-list
64535240|NCT01505491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64535241|NCT01505491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64535242|NCT01504867|Aspirin|aspirin|mesh-list
64535243|NCT01504867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64535244|NCT01504867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64535245|NCT01504867|Analgesics|analgesics|mesh-ancestor
64535246|NCT01504867|Sensory System Agents|sensory system agents|mesh-ancestor
64535247|NCT01504867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64535248|NCT01504867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535249|NCT01504867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64535250|NCT01504867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64535251|NCT01504867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64535252|NCT01504867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64535253|NCT01504867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535254|NCT01504867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64963601|NCT00043953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64963630|NCT00155233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64963631|NCT00051116|Lenalidomide|lenalidomide|mesh-list
64963632|NCT00051116|Immunologic Factors|immunologic factors|mesh-ancestor
64963633|NCT00051116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963634|NCT00051116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64963635|NCT00051116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64963636|NCT00051116|Growth Substances|growth substances|mesh-ancestor
64963637|NCT00051116|Growth Inhibitors|growth inhibitors|mesh-ancestor
64963638|NCT00051116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963639|NCT00155272|Thalidomide|thalidomide|mesh-list
64963640|NCT00155272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64963641|NCT00155272|Immunologic Factors|immunologic factors|mesh-ancestor
64963642|NCT00155272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963643|NCT00155272|Leprostatic Agents|leprostatic agents|mesh-ancestor
64963644|NCT00155272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64963645|NCT00155272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64963646|NCT00155272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64963647|NCT00155272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64963648|NCT00155272|Growth Substances|growth substances|mesh-ancestor
64963649|NCT00155272|Growth Inhibitors|growth inhibitors|mesh-ancestor
64963650|NCT00155272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963651|NCT00155350|Pioglitazone|pioglitazone|mesh-list
64963652|NCT00155350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64425430|NCT01660763|Dsuvia|dsuvia|mesh-list
64963678|NCT00083538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64963679|NCT00083538|Alkylating Agents|alkylating agents|mesh-ancestor
64535255|NCT01504867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64535256|NCT01504867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535257|NCT01504867|Antipyretics|antipyretics|mesh-ancestor
64535258|NCT01476475|Insulin|insulin|mesh-list
64535259|NCT01476475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64535260|NCT01476475|Metformin|metformin|mesh-list
64535261|NCT01476475|Insulin Glargine|insulin glargine|mesh-list
64535262|NCT01476475|Lixisenatide|lixisenatide|mesh-list
64535263|NCT01476475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64535264|NCT01476475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535265|NCT01460719|Vaccines|vaccines|mesh-list
64535266|NCT01460719|Immunologic Factors|immunologic factors|mesh-ancestor
64535267|NCT01460719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535268|NCT00527943|Vorapaxar|vorapaxar|mesh-list
64535269|NCT00527943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64963680|NCT00083538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963681|NCT00083538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963682|NCT00083538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64963683|NCT00083538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64963684|NCT00083538|Antiemetics|antiemetics|mesh-ancestor
64963685|NCT00083538|Autonomic Agents|autonomic agents|mesh-ancestor
64963686|NCT00083538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64963687|NCT00083538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64963688|NCT00083538|Glucocorticoids|glucocorticoids|mesh-ancestor
64963689|NCT00083538|Hormones|hormones|mesh-ancestor
64963690|NCT00083538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64963691|NCT00083538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64963692|NCT00083538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64963693|NCT00083538|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64963694|NCT00083538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64963695|NCT00083538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963696|NCT00083538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64963697|NCT00083538|Leprostatic Agents|leprostatic agents|mesh-ancestor
64963698|NCT00083538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64963699|NCT00083538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64963700|NCT00083538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64963701|NCT00083538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64963702|NCT00083538|Growth Substances|growth substances|mesh-ancestor
64963703|NCT00083538|Growth Inhibitors|growth inhibitors|mesh-ancestor
64963704|NCT00083577|Thalidomide|thalidomide|mesh-list
64963732|NCT00399750|Growth Inhibitors|growth inhibitors|mesh-ancestor
64963733|NCT00044148|Ruboxistaurin|ruboxistaurin|mesh-list
64963734|NCT00044148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963735|NCT00044148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963736|NCT00156286|Imatinib Mesylate|imatinib mesylate|mesh-list
64963737|NCT00156286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963738|NCT00156286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64963739|NCT00156286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963740|NCT00156286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963741|NCT00156325|Citalopram|citalopram|mesh-list
64963742|NCT00156325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64963743|NCT00156325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64963744|NCT00156325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64963745|NCT00156325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653840|NCT02219321|Lidocaine|lidocaine|mesh-list
64963746|NCT00156325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64963747|NCT00156325|Serotonin Agents|serotonin agents|mesh-ancestor
64963748|NCT00156325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963749|NCT00156325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64963750|NCT00156325|Antidepressive Agents|antidepressive agents|mesh-ancestor
64963775|NCT00044187|Antidepressive Agents|antidepressive agents|mesh-ancestor
64963776|NCT00044187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64535271|NCT00448227|Antiviral Agents|antiviral agents|mesh-ancestor
64535272|NCT00448227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64535273|NCT00448227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64535274|NCT00448227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535275|NCT00448227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535276|NCT00529191|Atorvastatin|atorvastatin|mesh-list
64535277|NCT00529191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64535278|NCT00529191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64535279|NCT00529191|Antimetabolites|antimetabolites|mesh-ancestor
64535280|NCT00529191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535281|NCT00529191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64535282|NCT00529191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64535283|NCT00529191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535284|NCT00449007|Bupropion|bupropion|mesh-list
64535285|NCT00449007|Fluoxetine|fluoxetine|mesh-list
64535286|NCT00449007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64535287|NCT00449007|Antidepressive Agents|antidepressive agents|mesh-ancestor
64535288|NCT00449007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64963777|NCT00044187|Appetite Depressants|appetite depressants|mesh-ancestor
64963778|NCT00044187|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64963779|NCT00156520|Aminocaproic Acid|aminocaproic acid|mesh-list
64963780|NCT00156520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64963781|NCT00156520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64963782|NCT00156520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963783|NCT00156520|Hemostatics|hemostatics|mesh-ancestor
64963784|NCT00156520|Coagulants|coagulants|mesh-ancestor
64963785|NCT00083694|Thalidomide|thalidomide|mesh-list
64963786|NCT00083694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64963787|NCT00083694|Immunologic Factors|immunologic factors|mesh-ancestor
64963788|NCT00083694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963789|NCT00083694|Leprostatic Agents|leprostatic agents|mesh-ancestor
64963790|NCT00083694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64963791|NCT00083694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64963792|NCT00083694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64963793|NCT00083694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64963794|NCT00083694|Growth Substances|growth substances|mesh-ancestor
64963795|NCT00083694|Growth Inhibitors|growth inhibitors|mesh-ancestor
64963796|NCT00083694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963797|NCT00051389|Fosinopril|fosinopril|mesh-list
64963820|NCT00157066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64963821|NCT00157105|Factor VIII|factor viii|mesh-list
64963822|NCT00157105|Coagulants|coagulants|mesh-ancestor
64963823|NCT00083772|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64963824|NCT00083772|Natriuretic Agents|natriuretic agents|mesh-ancestor
64963825|NCT00083772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963827|NCT00157261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64963828|NCT00157261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64963829|NCT00157261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963830|NCT00157300|Epoetin Alfa|epoetin alfa|mesh-list
64963831|NCT00157300|Hematinics|hematinics|mesh-ancestor
64963832|NCT00157378|Haloperidol|haloperidol|mesh-list
64963833|NCT00157378|Risperidone|risperidone|mesh-list
64963834|NCT00157378|Haloperidol decanoate|haloperidol decanoate|mesh-list
64963835|NCT00157378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64963836|NCT00157378|Serotonin Agents|serotonin agents|mesh-ancestor
64535289|NCT00449007|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64535290|NCT00449007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64535291|NCT00449007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64535292|NCT00449007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535293|NCT00449007|Dopamine Agents|dopamine agents|mesh-ancestor
64535294|NCT00449007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64535295|NCT00449007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653858|NCT04955574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64535296|NCT00449007|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64535297|NCT00449007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64535298|NCT00449007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535299|NCT00449007|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64535300|NCT00449007|Serotonin Agents|serotonin agents|mesh-ancestor
64535302|NCT03331731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64535303|NCT03331731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535304|NCT00460551|Zalutumumab|zalutumumab|mesh-list
64535305|NCT00460551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64535306|NCT00460551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535307|NCT01468181|Dulaglutide|dulaglutide|mesh-list
64535308|NCT01468181|Biguanides|biguanides|mesh-list
64535309|NCT01468181|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
64535310|NCT01468181|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
64535311|NCT01468181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64535312|NCT01468181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535313|NCT01468181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535314|NCT01468181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535315|NCT01693562|Durvalumab|durvalumab|mesh-list
64535316|NCT01693562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64535317|NCT01693562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535318|NCT00461331|Insulin|insulin|mesh-list
64535319|NCT00461331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64535320|NCT00461331|Insulin Aspart|insulin aspart|mesh-list
64535321|NCT00461331|Insulin, Long-Acting|insulin, long-acting|mesh-list
64535323|NCT00461331|Insulin Lispro|insulin lispro|mesh-list
64535329|NCT00531453|Cyclophosphamide|cyclophosphamide|mesh-list
64535330|NCT00531453|Bortezomib|bortezomib|mesh-list
64535331|NCT00531453|BB 1101|bb 1101|mesh-list
64535332|NCT00531453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64535333|NCT00531453|Immunologic Factors|immunologic factors|mesh-ancestor
64535334|NCT00531453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535335|NCT00531453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64535336|NCT00531453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64535337|NCT00531453|Alkylating Agents|alkylating agents|mesh-ancestor
64535338|NCT00531453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535339|NCT00531453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535340|NCT00531453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64535341|NCT00531453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64535342|NCT00531453|Antiemetics|antiemetics|mesh-ancestor
64535343|NCT00531453|Autonomic Agents|autonomic agents|mesh-ancestor
64535344|NCT00531453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64535345|NCT00531453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64535346|NCT00531453|Glucocorticoids|glucocorticoids|mesh-ancestor
64535347|NCT00531453|Hormones|hormones|mesh-ancestor
64299934|NCT02105311|Travoprost|travoprost|mesh-list
64963837|NCT00157378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64963838|NCT00157378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963839|NCT00157378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963840|NCT00157378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64963841|NCT00157378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64963842|NCT00157378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64963843|NCT00157378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64963844|NCT00157378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64963845|NCT00157378|Dopamine Agents|dopamine agents|mesh-ancestor
64963846|NCT00157378|Antiemetics|antiemetics|mesh-ancestor
64963847|NCT00157378|Autonomic Agents|autonomic agents|mesh-ancestor
64963848|NCT00157378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64963849|NCT00157378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64963850|NCT00157378|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64963851|NCT00406861|Montelukast|montelukast|mesh-list
64963852|NCT00406861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64963853|NCT00406861|Respiratory System Agents|respiratory system agents|mesh-ancestor
64963885|NCT00406978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64963886|NCT00406978|Immunologic Factors|immunologic factors|mesh-ancestor
64963887|NCT00406978|Leprostatic Agents|leprostatic agents|mesh-ancestor
64963888|NCT00406978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64963889|NCT00406978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64963890|NCT00406978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64963891|NCT00406978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64963914|NCT00157729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963915|NCT00157729|Vitamin B Complex|vitamin b complex|mesh-ancestor
64963917|NCT00157729|Micronutrients|micronutrients|mesh-ancestor
64963918|NCT00157729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963919|NCT00051545|Seocalcitol|seocalcitol|mesh-list
64963920|NCT00051545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963921|NCT00051545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64963922|NCT00051545|Immunologic Factors|immunologic factors|mesh-ancestor
64963923|NCT00051545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963924|NCT00157885|Artesunate|artesunate|mesh-list
64535348|NCT00531453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64535349|NCT00531453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64535351|NCT00531453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535352|NCT00531453|Leprostatic Agents|leprostatic agents|mesh-ancestor
64535353|NCT00531453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64535354|NCT00531453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64535355|NCT00531453|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64535356|NCT00531453|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64535357|NCT00531453|Growth Substances|growth substances|mesh-ancestor
64535358|NCT00531453|Growth Inhibitors|growth inhibitors|mesh-ancestor
64535359|NCT00531843|PENTA|penta|mesh-list
64535360|NCT00531843|Fondaparinux|fondaparinux|mesh-list
64535361|NCT00531843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64535362|NCT00531843|Antithrombins|antithrombins|mesh-ancestor
64535363|NCT00531843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64535364|NCT00531843|Protease Inhibitors|protease inhibitors|mesh-ancestor
64535365|NCT00531843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535366|NCT00531843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535367|NCT00531843|Anticoagulants|anticoagulants|mesh-ancestor
64535368|NCT00531843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64535369|NCT00531843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64535370|NCT02073461|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64535371|NCT02073461|Dermatologic Agents|dermatologic agents|mesh-ancestor
64963925|NCT00157885|Amodiaquine|amodiaquine|mesh-list
64963926|NCT00157885|Antimalarials|antimalarials|mesh-ancestor
64963927|NCT00157885|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64963928|NCT00157885|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64963929|NCT00157885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64963930|NCT00157885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963931|NCT00157885|Antiviral Agents|antiviral agents|mesh-ancestor
64963932|NCT00157885|Schistosomicides|schistosomicides|mesh-ancestor
64963933|NCT00157885|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64963934|NCT00157885|Anthelmintics|anthelmintics|mesh-ancestor
64963935|NCT00158002|Topiramate|topiramate|mesh-list
64963936|NCT00158002|Anticonvulsants|anticonvulsants|mesh-ancestor
64963937|NCT00158002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64963938|NCT00158002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963939|NCT00158041|Amifostine|amifostine|mesh-list
64963940|NCT00158041|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64963941|NCT00158041|Protective Agents|protective agents|mesh-ancestor
64963942|NCT00158041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963943|NCT00051584|Gemcitabine|gemcitabine|mesh-list
64963944|NCT00051584|Doxorubicin|doxorubicin|mesh-list
64963945|NCT00051584|Immunoconjugates|immunoconjugates|mesh-list
64963946|NCT00051584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64963947|NCT00051584|Antimetabolites|antimetabolites|mesh-ancestor
64963948|NCT00051584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963949|NCT00051584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535373|NCT01590758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64535374|NCT01590758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64535375|NCT00534417|Capecitabine|capecitabine|mesh-list
64535376|NCT00534417|Fulvestrant|fulvestrant|mesh-list
64535377|NCT00534417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64535378|NCT00534417|Antimetabolites|antimetabolites|mesh-ancestor
64535379|NCT00534417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535380|NCT00534417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535381|NCT00534417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64535382|NCT00534417|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64535383|NCT00534417|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64535384|NCT00534417|Hormone Antagonists|hormone antagonists|mesh-ancestor
64535385|NCT00534417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64535386|NCT00534417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299978|NCT05039606|Nedaplatin|nedaplatin|mesh-list
64963950|NCT00051584|Antiviral Agents|antiviral agents|mesh-ancestor
64963975|NCT00158158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64963976|NCT00158158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963977|NCT00051623|Infliximab|infliximab|mesh-list
64963978|NCT00051623|Dermatologic Agents|dermatologic agents|mesh-ancestor
64963979|NCT00051623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64963980|NCT00051623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64963981|NCT00158236|Buprenorphine|buprenorphine|mesh-list
64963982|NCT00158236|Hydromorphone|hydromorphone|mesh-list
64963983|NCT00158236|Naloxone|naloxone|mesh-list
64963984|NCT00158236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64963985|NCT00158236|Narcotics|narcotics|mesh-ancestor
64963986|NCT00158236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64963987|NCT00158236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963988|NCT00158236|Analgesics|analgesics|mesh-ancestor
64963989|NCT00158236|Sensory System Agents|sensory system agents|mesh-ancestor
64963990|NCT00158236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64963991|NCT00158236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64963992|NCT00158275|Antidepressive Agents|antidepressive agents|mesh-list
64963993|NCT00158275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64963994|NCT00044421|Ruboxistaurin|ruboxistaurin|mesh-list
64963995|NCT00044421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963996|NCT00044421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963997|NCT00051701|Alemtuzumab|alemtuzumab|mesh-list
64963998|NCT00051701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64963999|NCT00051701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964000|NCT00158470|Lamivudine|lamivudine|mesh-list
64964001|NCT00158470|Efavirenz|efavirenz|mesh-list
64964022|NCT00158548|Chloroquine|chloroquine|mesh-list
64964024|NCT00158548|Amodiaquine|amodiaquine|mesh-list
64964025|NCT00158548|Antimalarials|antimalarials|mesh-ancestor
64977610|NCT00264082|Zoledronic Acid|zoledronic acid|mesh-list
64964026|NCT00158548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64964027|NCT00158548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64964028|NCT00158548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964029|NCT00158548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964030|NCT00158548|Antiviral Agents|antiviral agents|mesh-ancestor
64964031|NCT00158548|Schistosomicides|schistosomicides|mesh-ancestor
64964032|NCT00158548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64964033|NCT00158548|Anthelmintics|anthelmintics|mesh-ancestor
64964034|NCT00158548|Amebicides|amebicides|mesh-ancestor
64964035|NCT00158548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64964036|NCT00158587|Primaquine|primaquine|mesh-list
64964037|NCT00158587|Antimalarials|antimalarials|mesh-ancestor
64964038|NCT00158587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64964039|NCT00158587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64964040|NCT00158587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64535388|NCT01692626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64535389|NCT01692626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64535390|NCT01692626|Analgesics|analgesics|mesh-ancestor
64535391|NCT01692626|Sensory System Agents|sensory system agents|mesh-ancestor
64535392|NCT01692626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64535393|NCT01692626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535394|NCT01692626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64535395|NCT01692626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64535396|NCT01692626|Dermatologic Agents|dermatologic agents|mesh-ancestor
64535397|NCT01692626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64964041|NCT00158704|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64964042|NCT00158704|Antiviral Agents|antiviral agents|mesh-ancestor
64964043|NCT00158704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964044|NCT00158704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64964045|NCT00158704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64964046|NCT00158704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964047|NCT00158704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502707|NCT03556384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502708|NCT04520646|Empagliflozin|empagliflozin|mesh-list
64964048|NCT00158782|Lapatinib|lapatinib|mesh-list
64964049|NCT00158782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964050|NCT00158782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64964051|NCT00158782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964052|NCT00158782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964053|NCT00158821|Tenofovir|tenofovir|mesh-list
64964054|NCT00158821|Lamivudine|lamivudine|mesh-list
64964055|NCT00158821|Efavirenz|efavirenz|mesh-list
64964083|NCT05568147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964084|NCT05568147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64964085|NCT05568147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64964086|NCT05568147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964087|NCT05568147|Antipyretics|antipyretics|mesh-ancestor
64964088|NCT00051896|Vanoxerine|vanoxerine|mesh-list
64964089|NCT00051896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64964090|NCT00051896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64964091|NCT00051896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64964092|NCT00051896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964093|NCT00051896|Dopamine Agents|dopamine agents|mesh-ancestor
64964094|NCT00051896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64964095|NCT00051896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964096|NCT04724473|Tretinoin|tretinoin|mesh-list
64964097|NCT04724473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964098|NCT04724473|Keratolytic Agents|keratolytic agents|mesh-ancestor
64964099|NCT04724473|Dermatologic Agents|dermatologic agents|mesh-ancestor
64964100|NCT00159016|Imatinib Mesylate|imatinib mesylate|mesh-list
64964130|NCT00159133|GABA Agents|gaba agents|mesh-ancestor
64964131|NCT00159133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64964132|NCT00159133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964133|NCT00051974|Bortezomib|bortezomib|mesh-list
64964134|NCT00051974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964135|NCT00159211|Pioglitazone|pioglitazone|mesh-list
64964136|NCT00159211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64964137|NCT00159211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964138|NCT05567718|Anesthetics|anesthetics|mesh-list
64964139|NCT05567718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64964140|NCT05567718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964141|NCT00052013|Vatalanib|vatalanib|mesh-list
64964142|NCT00052013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64964143|NCT00052013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964173|NCT00159484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964174|NCT00159484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964175|NCT00159484|Tubulin Modulators|tubulin modulators|mesh-ancestor
64535399|NCT01692626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64535400|NCT01692626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535401|NCT01692626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535402|NCT00535587|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
64964176|NCT00159484|Antimitotic Agents|antimitotic agents|mesh-ancestor
64964177|NCT00159484|Mitosis Modulators|mitosis modulators|mesh-ancestor
64964179|NCT00052052|Interferon-gamma|interferon-gamma|mesh-list
64964180|NCT00052052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964181|NCT00052052|Antiviral Agents|antiviral agents|mesh-ancestor
64964182|NCT00052052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964184|NCT00044538|IDN 5109|idn 5109|mesh-list
64964185|NCT00044538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964186|NCT00159679|Pregabalin|pregabalin|mesh-list
64964187|NCT00159679|Analgesics|analgesics|mesh-ancestor
64964188|NCT00159679|Sensory System Agents|sensory system agents|mesh-ancestor
64964189|NCT00159679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64964213|NCT00159718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964214|NCT00159718|Vasodilator Agents|vasodilator agents|mesh-ancestor
64964215|NCT00159757|Ziprasidone|ziprasidone|mesh-list
64964216|NCT00159757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64964217|NCT00159757|Serotonin Agents|serotonin agents|mesh-ancestor
64964218|NCT00159757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64964219|NCT00159757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964220|NCT00159757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964221|NCT00159757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64964222|NCT00159757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64964223|NCT00159757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64964224|NCT00159757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64964225|NCT00159757|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64964226|NCT00159757|Dopamine Agents|dopamine agents|mesh-ancestor
64964227|NCT00159835|Atorvastatin|atorvastatin|mesh-list
64964228|NCT00159835|Simvastatin|simvastatin|mesh-list
64964229|NCT00159835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64964230|NCT00159835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64964231|NCT00159835|Antimetabolites|antimetabolites|mesh-ancestor
64964232|NCT00159835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964233|NCT00159835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64964234|NCT00159835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64964235|NCT00159835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964236|NCT00052169|Docetaxel|docetaxel|mesh-list
64964237|NCT00052169|Gefitinib|gefitinib|mesh-list
64964238|NCT00052169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964262|NCT00407017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964263|NCT00407017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964264|NCT00407017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964265|NCT00407017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964266|NCT00407017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64964267|NCT00407017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64977673|NCT00101829|Rituximab|rituximab|mesh-list
64964269|NCT00407017|Sensory System Agents|sensory system agents|mesh-ancestor
64964270|NCT00407017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64964271|NCT00407017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64964272|NCT00407017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64964273|NCT00407017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64964274|NCT00407017|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64964275|NCT00407017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64964276|NCT00160030|Cisplatin|cisplatin|mesh-list
64964277|NCT00160030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502944|NCT03354312|Mydriatics|mydriatics|mesh-ancestor
64964278|NCT00160069|Sagopilone|sagopilone|mesh-list
64964279|NCT00160069|Epothilones|epothilones|mesh-list
64964280|NCT00160069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964281|NCT00160069|Tubulin Modulators|tubulin modulators|mesh-ancestor
64964282|NCT00160069|Antimitotic Agents|antimitotic agents|mesh-ancestor
64964283|NCT00160069|Mitosis Modulators|mitosis modulators|mesh-ancestor
64964284|NCT00160069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964285|NCT00052286|Modafinil|modafinil|mesh-list
64964286|NCT00052286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64964287|NCT00052286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964288|NCT00052286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64535403|NCT00535587|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64535405|NCT00535587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535406|NCT00535587|Cholinergic Agents|cholinergic agents|mesh-ancestor
64535407|NCT00535587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64535408|NCT00535587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535409|NCT01475461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64535410|NCT01475461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64535411|NCT01475461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535412|NCT01475461|Incretins|incretins|mesh-ancestor
64535413|NCT01475461|Hormones|hormones|mesh-ancestor
64535414|NCT01475461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64535415|NCT01475461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64535416|NCT01475461|Protease Inhibitors|protease inhibitors|mesh-ancestor
64535417|NCT01475461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535418|NCT01475461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535419|NCT01589822|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64535420|NCT01589822|Hemostatics|hemostatics|mesh-ancestor
64535421|NCT01589822|Coagulants|coagulants|mesh-ancestor
64300015|NCT02460627|Lidocaine|lidocaine|mesh-list
64964289|NCT00052286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64964313|NCT00160264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64964314|NCT00160264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64964315|NCT00160264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64964316|NCT00160342|Methyltestosterone|methyltestosterone|mesh-list
64964317|NCT00160342|Estrogens|estrogens|mesh-list
64964318|NCT00160342|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
64964319|NCT00160342|Estrone|estrone|mesh-list
64964320|NCT00160342|Testosterone|testosterone|mesh-list
64964321|NCT00160342|Testosterone undecanoate|testosterone undecanoate|mesh-list
64964322|NCT00160342|Testosterone enanthate|testosterone enanthate|mesh-list
64964323|NCT00160342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64964324|NCT00160342|Hormones|hormones|mesh-ancestor
64964325|NCT00160342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64964326|NCT00160342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964327|NCT00160342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64964328|NCT00160342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964329|NCT00160342|Anabolic Agents|anabolic agents|mesh-ancestor
64964330|NCT00160342|Androgens|androgens|mesh-ancestor
64964331|NCT00052364|Oxaliplatin|oxaliplatin|mesh-list
64964332|NCT00052364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540380|NCT03141918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964333|NCT00052403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64964334|NCT00052403|Antibodies|antibodies|mesh-list
64964335|NCT00052403|Immunoglobulins|immunoglobulins|mesh-list
64964336|NCT00052403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64964337|NCT00052403|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
64964338|NCT00052403|Immunologic Factors|immunologic factors|mesh-list
64964339|NCT00052403|Mitogens|mitogens|mesh-list
64964340|NCT00052403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964341|NCT00052403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964364|NCT00160849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64964365|NCT00160849|Protease Inhibitors|protease inhibitors|mesh-ancestor
64964366|NCT00160849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964367|NCT00160849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535422|NCT01475071|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
64535423|NCT01475071|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64535424|NCT01475071|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64535425|NCT01475071|Dermatologic Agents|dermatologic agents|mesh-ancestor
64535426|NCT01474993|Sulforaphane|sulforaphane|mesh-list
64535427|NCT01474993|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64535428|NCT01474993|Protective Agents|protective agents|mesh-ancestor
64535429|NCT01474993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535430|NCT01474993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535431|NCT01691768|Tenofovir|tenofovir|mesh-list
64535432|NCT01691768|Antiviral Agents|antiviral agents|mesh-ancestor
64535433|NCT01691768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964368|NCT00160849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64964369|NCT00160849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64964370|NCT00160849|Antiviral Agents|antiviral agents|mesh-ancestor
64964371|NCT00160849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964372|NCT00160849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64964373|NCT00160849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64964374|NCT00160888|Nitroprusside|nitroprusside|mesh-list
64964375|NCT00160888|Acetylcholine|acetylcholine|mesh-list
64964376|NCT00160888|Bradykinin|bradykinin|mesh-list
64964377|NCT00160888|Kininogens|kininogens|mesh-list
64964378|NCT00160888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64964379|NCT00160888|Vasodilator Agents|vasodilator agents|mesh-ancestor
64964380|NCT00160888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64964381|NCT00160888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964382|NCT00160888|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64964383|NCT00160888|Cholinergic Agents|cholinergic agents|mesh-ancestor
64964384|NCT00160888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64964385|NCT00160888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964386|NCT00160888|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64964387|NCT00160888|Protease Inhibitors|protease inhibitors|mesh-ancestor
64964388|NCT00160888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964389|NCT00160927|Nitroprusside|nitroprusside|mesh-list
64964390|NCT00160927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64964391|NCT00160927|Vasodilator Agents|vasodilator agents|mesh-ancestor
64964392|NCT00160927|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64964416|NCT00052559|Fluorouracil|fluorouracil|mesh-list
64964417|NCT00052559|Antibodies|antibodies|mesh-list
64964418|NCT00052559|Immunoglobulins|immunoglobulins|mesh-list
64964419|NCT00052559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64964420|NCT00052559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964421|NCT00052559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64964422|NCT00052559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64964423|NCT00052559|Growth Substances|growth substances|mesh-ancestor
64964424|NCT00052559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964425|NCT00052559|Growth Inhibitors|growth inhibitors|mesh-ancestor
64964426|NCT00052559|Immunologic Factors|immunologic factors|mesh-ancestor
64964427|NCT00052559|Antimetabolites|antimetabolites|mesh-ancestor
64964428|NCT00052559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964429|NCT00052559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64964430|NCT00052559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64964431|NCT00161083|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64964432|NCT00161083|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64964433|NCT00161083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64964434|NCT00044577|Tenofovir|tenofovir|mesh-list
64964435|NCT00044577|Lamivudine|lamivudine|mesh-list
64964436|NCT00044577|Abacavir|abacavir|mesh-list
64964437|NCT00044577|Dideoxynucleosides|dideoxynucleosides|mesh-list
64964438|NCT00044577|Antiviral Agents|antiviral agents|mesh-ancestor
64964439|NCT00044577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964440|NCT00044577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64964441|NCT00044577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64964442|NCT00044577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964443|NCT00044577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535434|NCT01691768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64535435|NCT01691768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64535436|NCT01691768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535437|NCT01691768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535438|NCT01691768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64535439|NCT01691768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64535440|NCT01503229|Prednisone|prednisone|mesh-list
64964444|NCT00044577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64964474|NCT00161239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64964475|NCT00161239|Abortifacient Agents|abortifacient agents|mesh-ancestor
64964476|NCT00161239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64964477|NCT00161239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64964478|NCT00161239|Antimetabolites|antimetabolites|mesh-ancestor
64964479|NCT00161239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964480|NCT00161239|Dermatologic Agents|dermatologic agents|mesh-ancestor
64964481|NCT00161239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964482|NCT00161239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64964483|NCT00161239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64964484|NCT00161239|Immunologic Factors|immunologic factors|mesh-ancestor
64964485|NCT00161239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64964486|NCT00161239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64964487|NCT00161278|Paclitaxel|paclitaxel|mesh-list
64964488|NCT00161278|Carboplatin|carboplatin|mesh-list
64964489|NCT00161278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64964490|NCT00161278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964506|NCT00044616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64964507|NCT00044616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64964508|NCT00044616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964509|NCT00161356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64964510|NCT00161356|Antifungal Agents|antifungal agents|mesh-ancestor
64964511|NCT00161356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964512|NCT00161356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64964513|NCT00161356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64964514|NCT00052676|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
64964515|NCT00052676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64964516|NCT00052676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964518|NCT00161434|Antiviral Agents|antiviral agents|mesh-ancestor
64964519|NCT00161434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964520|NCT00044694|Exenatide|exenatide|mesh-list
64964521|NCT00044694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64964522|NCT00044694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964523|NCT00044694|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64964524|NCT00044694|Incretins|incretins|mesh-ancestor
64964525|NCT00044694|Hormones|hormones|mesh-ancestor
64964526|NCT00044694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64964527|NCT00052754|Gefitinib|gefitinib|mesh-list
64964528|NCT00052754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964529|NCT00052754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64964530|NCT00052754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964531|NCT00052754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964532|NCT00161590|Alemtuzumab|alemtuzumab|mesh-list
64964533|NCT00161590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64964534|NCT00161590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964535|NCT00161668|Gemtuzumab|gemtuzumab|mesh-list
64964536|NCT00161668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64964537|NCT00161668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964538|NCT00052832|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
64964539|NCT00052832|Vitamins|vitamins|mesh-ancestor
64964540|NCT00052832|Micronutrients|micronutrients|mesh-ancestor
64964541|NCT00052832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964542|NCT00052832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64964543|NCT00161707|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64964544|NCT00161707|Protein C Inhibitor|protein c inhibitor|mesh-list
64964545|NCT00161707|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64964582|NCT00162214|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64964583|NCT00162214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64535441|NCT01503229|Cortisone|cortisone|mesh-list
64535443|NCT01503229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64535444|NCT01503229|Glucocorticoids|glucocorticoids|mesh-ancestor
64535445|NCT01503229|Hormones|hormones|mesh-ancestor
64535446|NCT01503229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64535447|NCT01503229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535448|NCT01503229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64964584|NCT00162214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64964585|NCT00162214|Hormone Antagonists|hormone antagonists|mesh-ancestor
64964586|NCT00162214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64964601|NCT00405457|Immunologic Factors|immunologic factors|mesh-ancestor
64964602|NCT00405457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964603|NCT00405457|Antifungal Agents|antifungal agents|mesh-ancestor
64964604|NCT00405457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964605|NCT00405457|Dermatologic Agents|dermatologic agents|mesh-ancestor
64964606|NCT00405457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64964607|NCT00405457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64964608|NCT00053105|Cytarabine|cytarabine|mesh-list
64964609|NCT00053105|Methylprednisolone|methylprednisolone|mesh-list
64964610|NCT00053105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64964611|NCT00053105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64964612|NCT00053105|Prednisolone|prednisolone|mesh-list
64964613|NCT00053105|Prednisolone acetate|prednisolone acetate|mesh-list
64964614|NCT00053105|Pixantrone|pixantrone|mesh-list
64964615|NCT00053105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64964616|NCT00053105|Prednisolone phosphate|prednisolone phosphate|mesh-list
64964617|NCT00053105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964618|NCT00053105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64964619|NCT00053105|Antimetabolites|antimetabolites|mesh-ancestor
64964620|NCT00053105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964621|NCT00053105|Antiviral Agents|antiviral agents|mesh-ancestor
64964622|NCT00053105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964623|NCT00053105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64964624|NCT00053105|Immunologic Factors|immunologic factors|mesh-ancestor
64964625|NCT00053105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964626|NCT00053105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64964627|NCT00053105|Antiemetics|antiemetics|mesh-ancestor
64964628|NCT00053105|Autonomic Agents|autonomic agents|mesh-ancestor
64964629|NCT00053105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64964630|NCT00053105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64964631|NCT00053105|Glucocorticoids|glucocorticoids|mesh-ancestor
64964632|NCT00053105|Hormones|hormones|mesh-ancestor
64964633|NCT00053105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64964634|NCT00053105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64964635|NCT00053105|Protective Agents|protective agents|mesh-ancestor
64653912|NCT02461134|Ponesimod|ponesimod|mesh-list
64964637|NCT00053105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64964638|NCT00053105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64964639|NCT00053105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964640|NCT00162331|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
64964641|NCT00162331|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64964642|NCT00162331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964643|NCT00162409|Folic Acid|folic acid|mesh-list
64964644|NCT00162409|Hematinics|hematinics|mesh-ancestor
64964645|NCT00162409|Vitamin B Complex|vitamin b complex|mesh-ancestor
64964646|NCT00162409|Vitamins|vitamins|mesh-ancestor
64964647|NCT00162409|Micronutrients|micronutrients|mesh-ancestor
64964664|NCT00162487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64964665|NCT00162487|Autonomic Agents|autonomic agents|mesh-ancestor
64964666|NCT00162487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64964667|NCT00162487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964668|NCT00162487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64964669|NCT00162487|Respiratory System Agents|respiratory system agents|mesh-ancestor
64964670|NCT00162487|Tocolytic Agents|tocolytic agents|mesh-ancestor
64964671|NCT00162487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64964672|NCT00162487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64535449|NCT01503229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535450|NCT01503229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64977736|NCT00265291|Serotonin Agents|serotonin agents|mesh-ancestor
64535451|NCT01503229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535452|NCT01503229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535453|NCT01503229|Hormone Antagonists|hormone antagonists|mesh-ancestor
64300051|NCT02107807|Lactitol|lactitol|mesh-list
64964673|NCT00162487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64964674|NCT00162487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64964675|NCT00162487|Adrenergic Agents|adrenergic agents|mesh-ancestor
64964676|NCT00162487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64964677|NCT00162487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964678|NCT00162526|Tocopherols|tocopherols|mesh-list
64964679|NCT00162526|Vitamin E|vitamin e|mesh-list
64964680|NCT00162526|Tocotrienols|tocotrienols|mesh-list
64964681|NCT00162526|alpha-Tocopherol|alpha-tocopherol|mesh-list
64964682|NCT00162526|Antioxidants|antioxidants|mesh-ancestor
64964683|NCT00162526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964684|NCT00162526|Protective Agents|protective agents|mesh-ancestor
64964685|NCT00162526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964686|NCT00162526|Vitamins|vitamins|mesh-ancestor
64964687|NCT00162526|Micronutrients|micronutrients|mesh-ancestor
64964688|NCT00162565|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64964689|NCT00162565|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64964690|NCT00162565|Adrenergic Agents|adrenergic agents|mesh-ancestor
64964691|NCT00162565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64964692|NCT00162565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964693|NCT00162565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964694|NCT00162604|Cefuroxime|cefuroxime|mesh-list
64964695|NCT00162604|Cefuroxime axetil|cefuroxime axetil|mesh-list
64964696|NCT00162604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64964697|NCT00162604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964698|NCT00162643|Ritonavir|ritonavir|mesh-list
64964699|NCT00162643|Lopinavir|lopinavir|mesh-list
64964700|NCT00162643|Lamivudine|lamivudine|mesh-list
64964701|NCT00162643|Zidovudine|zidovudine|mesh-list
64964702|NCT00162643|Efavirenz|efavirenz|mesh-list
64964703|NCT00162643|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64964704|NCT00162643|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64964705|NCT00162643|Protease Inhibitors|protease inhibitors|mesh-ancestor
64964706|NCT00162643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964707|NCT00162643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964708|NCT00162643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64503389|NCT05098704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64964725|NCT00044772|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64964726|NCT00044772|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64964727|NCT00044772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64653918|NCT04373018|Chlorhexidine|chlorhexidine|mesh-list
64964728|NCT00044772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64964729|NCT00044772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964730|NCT00044772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64964731|NCT00044772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964732|NCT00044772|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64964733|NCT00044772|Antidepressive Agents|antidepressive agents|mesh-ancestor
64964734|NCT00044772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64964735|NCT00162721|Doxorubicin|doxorubicin|mesh-list
64964736|NCT00162721|Ifosfamide|ifosfamide|mesh-list
64964737|NCT00162721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964738|NCT00162721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64964739|NCT00162721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64964740|NCT00162721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64964741|NCT00162721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964742|NCT00162721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964743|NCT00162721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64964744|NCT00162721|Alkylating Agents|alkylating agents|mesh-ancestor
64964745|NCT00053222|Arsenic Trioxide|arsenic trioxide|mesh-list
64964746|NCT00053222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964747|NCT00162760|Thalidomide|thalidomide|mesh-list
64964748|NCT00162760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64964749|NCT00162760|Immunologic Factors|immunologic factors|mesh-ancestor
64964750|NCT00162760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535454|NCT01503229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64535455|NCT01460407|Clarithromycin|clarithromycin|mesh-list
64491558|NCT03089073|Hemostatics|hemostatics|mesh-ancestor
64535456|NCT01460407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64535457|NCT01460407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64535458|NCT01460407|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64535459|NCT01460407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535460|NCT01460407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964751|NCT00162760|Leprostatic Agents|leprostatic agents|mesh-ancestor
64964752|NCT00162760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64964753|NCT00162760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964754|NCT00162760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64964755|NCT00162760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64964756|NCT00162760|Growth Substances|growth substances|mesh-ancestor
64964757|NCT00162760|Growth Inhibitors|growth inhibitors|mesh-ancestor
64964758|NCT00162760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964760|NCT00162799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64964761|NCT00044811|Fexofenadine|fexofenadine|mesh-list
64964762|NCT00044811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64964786|NCT00162916|Antidepressive Agents|antidepressive agents|mesh-ancestor
64964787|NCT00162916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64964788|NCT00162955|Valsartan|valsartan|mesh-list
64964789|NCT00162955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64964790|NCT00162955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64964791|NCT00162955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64964792|NCT00162955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653924|NCT04373018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964793|NCT00163072|Megestrol Acetate|megestrol acetate|mesh-list
64964794|NCT00163072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64964795|NCT00163072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964796|NCT00163072|Appetite Stimulants|appetite stimulants|mesh-ancestor
64964797|NCT00163072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64964798|NCT00163072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964799|NCT00163111|Amphotericin B|amphotericin b|mesh-list
64503462|NCT04892706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64964800|NCT00163111|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64964801|NCT00163111|Fluconazole|fluconazole|mesh-list
64964802|NCT00163111|Amebicides|amebicides|mesh-ancestor
64964803|NCT00163111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64964804|NCT00163111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64964805|NCT00163111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964806|NCT00163111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64964807|NCT00163111|Antifungal Agents|antifungal agents|mesh-ancestor
64964808|NCT00163111|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64964809|NCT00163111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64964842|NCT00044889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64964843|NCT00044889|Antimetabolites|antimetabolites|mesh-ancestor
64964844|NCT00044889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964845|NCT00044889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964858|NCT00163423|Ciclesonide|ciclesonide|mesh-list
64964859|NCT00163423|Glucocorticoids|glucocorticoids|mesh-ancestor
64964860|NCT00163423|Hormones|hormones|mesh-ancestor
64964861|NCT00163423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64964862|NCT00163423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964863|NCT00163423|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64964864|NCT04731038|Paclitaxel|paclitaxel|mesh-list
64964865|NCT04731038|Carboplatin|carboplatin|mesh-list
64964866|NCT04731038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64964867|NCT04731038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964868|NCT04731038|Tubulin Modulators|tubulin modulators|mesh-ancestor
64964869|NCT04731038|Antimitotic Agents|antimitotic agents|mesh-ancestor
64503535|NCT01603420|Ascorbic Acid|ascorbic acid|mesh-list
64964870|NCT04731038|Mitosis Modulators|mitosis modulators|mesh-ancestor
64964871|NCT04731038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964873|NCT00163462|Glucocorticoids|glucocorticoids|mesh-ancestor
64964874|NCT00163462|Hormones|hormones|mesh-ancestor
64535461|NCT01460407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64535462|NCT01460407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64535464|NCT01502371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64535465|NCT01502371|Dermatologic Agents|dermatologic agents|mesh-ancestor
64535466|NCT01502371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64535467|NCT01588496|Evolocumab|evolocumab|mesh-list
64535468|NCT01588496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64535469|NCT01588496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64535470|NCT01588496|Antimetabolites|antimetabolites|mesh-ancestor
64535471|NCT01588496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535472|NCT01588496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64535473|NCT01502293|Interleukin-12|interleukin-12|mesh-list
64535474|NCT01502293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64535475|NCT01502293|Immunologic Factors|immunologic factors|mesh-ancestor
64535476|NCT01502293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535477|NCT01502293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64535478|NCT01502293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64535479|NCT01502293|Growth Substances|growth substances|mesh-ancestor
64535480|NCT01502293|Growth Inhibitors|growth inhibitors|mesh-ancestor
64535481|NCT01502293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535482|NCT01588184|Bevacizumab|bevacizumab|mesh-list
64535483|NCT01588184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64535484|NCT01588184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535485|NCT01588184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64535486|NCT01588184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64300064|NCT02113735|Hormones|hormones|mesh-ancestor
64964875|NCT00163462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64964876|NCT00163462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964877|NCT00163462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64964878|NCT00053300|Thalidomide|thalidomide|mesh-list
64964879|NCT00053300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64964880|NCT00053300|Immunologic Factors|immunologic factors|mesh-ancestor
64964881|NCT00053300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964882|NCT00053300|Leprostatic Agents|leprostatic agents|mesh-ancestor
64964883|NCT00053300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64964884|NCT00053300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964885|NCT00053300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64964886|NCT00053300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64964887|NCT00053300|Growth Substances|growth substances|mesh-ancestor
64964888|NCT00053300|Growth Inhibitors|growth inhibitors|mesh-ancestor
64964889|NCT00053300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964890|NCT00163501|Ciclesonide|ciclesonide|mesh-list
64964891|NCT00163501|Glucocorticoids|glucocorticoids|mesh-ancestor
64964892|NCT00163501|Hormones|hormones|mesh-ancestor
64964893|NCT00163501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64964894|NCT00163501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535487|NCT01588184|Growth Substances|growth substances|mesh-ancestor
64535488|NCT01588184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535489|NCT01588184|Growth Inhibitors|growth inhibitors|mesh-ancestor
64535490|NCT01564862|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64535491|NCT01564862|Vortioxetine|vortioxetine|mesh-list
64977815|NCT00415831|Levodopa|levodopa|mesh-list
64535492|NCT01564862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64535493|NCT01564862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64535494|NCT01564862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64535495|NCT01564862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535496|NCT01564862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64535497|NCT01564862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535498|NCT01564862|Analgesics|analgesics|mesh-ancestor
64535499|NCT01564862|Sensory System Agents|sensory system agents|mesh-ancestor
64535500|NCT01564862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64535501|NCT01564862|Antidepressive Agents|antidepressive agents|mesh-ancestor
64535502|NCT01564862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64535503|NCT01564862|Dopamine Agents|dopamine agents|mesh-ancestor
64300097|NCT03095222|Anesthetics|anesthetics|mesh-ancestor
64964895|NCT00163501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64964896|NCT00163540|Formaldehyde|formaldehyde|mesh-list
64964897|NCT00163540|Disinfectants|disinfectants|mesh-ancestor
64964898|NCT00163540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964900|NCT00053339|Trastuzumab|trastuzumab|mesh-list
64964901|NCT00053339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64964902|NCT00053339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964903|NCT00053339|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64964904|NCT00053339|Hormone Antagonists|hormone antagonists|mesh-ancestor
64964905|NCT00053339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64964906|NCT00053339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964907|NCT00053339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64964908|NCT00053339|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64964928|NCT05502900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64964929|NCT00163969|Ketamine|ketamine|mesh-list
64964930|NCT00163969|Analgesics|analgesics|mesh-ancestor
64964931|NCT00163969|Sensory System Agents|sensory system agents|mesh-ancestor
64964932|NCT00163969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64964933|NCT00163969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964934|NCT00163969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64964935|NCT00163969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64964936|NCT00163969|Anesthetics, General|anesthetics, general|mesh-ancestor
64964937|NCT00163969|Anesthetics|anesthetics|mesh-ancestor
64964938|NCT00163969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64964939|NCT00163969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64964940|NCT00163969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64964941|NCT00163969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64964942|NCT00163969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964943|NCT00164008|Zoledronic Acid|zoledronic acid|mesh-list
64503610|NCT01691560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64964944|NCT00164008|Pamidronate|pamidronate|mesh-list
64964945|NCT00164008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64964946|NCT00164008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964947|NCT00164047|Nitrous Oxide|nitrous oxide|mesh-list
64964948|NCT00164047|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64535504|NCT01564862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64535505|NCT01564862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64535506|NCT01564862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64535507|NCT01564862|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64535508|NCT01564862|Serotonin Agents|serotonin agents|mesh-ancestor
64535509|NCT01564862|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64535510|NCT01564862|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64535511|NCT01564862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64535512|NCT01564862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64535513|NCT04857164|Pembrolizumab|pembrolizumab|mesh-list
64535514|NCT04857164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64535515|NCT04857164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535516|NCT01467479|Interferons|interferons|mesh-list
64535517|NCT01467479|Ribavirin|ribavirin|mesh-list
64535518|NCT01467479|Interferon-alpha|interferon-alpha|mesh-list
64535519|NCT01467479|Interferon alpha-2|interferon alpha-2|mesh-list
64535520|NCT01467479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64535521|NCT01467479|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64535522|NCT01467479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535523|NCT01467479|Antiviral Agents|antiviral agents|mesh-ancestor
64535524|NCT01467479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64535525|NCT01467479|Antimetabolites|antimetabolites|mesh-ancestor
64535526|NCT01467479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535527|NCT01467479|Immunologic Factors|immunologic factors|mesh-ancestor
64714134|NCT00373789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491630|NCT03083613|Antimetabolites|antimetabolites|mesh-ancestor
64964949|NCT00164047|Anesthetics, General|anesthetics, general|mesh-ancestor
64964950|NCT00164047|Anesthetics|anesthetics|mesh-ancestor
64964951|NCT00164047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64964952|NCT00164047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964953|NCT00164047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64964954|NCT00164047|Analgesics|analgesics|mesh-ancestor
64964955|NCT00164047|Sensory System Agents|sensory system agents|mesh-ancestor
64964956|NCT00164047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64964957|NCT00164086|Atorvastatin|atorvastatin|mesh-list
64964958|NCT00164086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64964959|NCT00164086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64964960|NCT00164086|Antimetabolites|antimetabolites|mesh-ancestor
64964961|NCT00164086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964962|NCT00164086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64964989|NCT00164281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964990|NCT00164281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64964991|NCT00044928|Tazobactam|tazobactam|mesh-list
64964992|NCT00044928|Piperacillin|piperacillin|mesh-list
64964993|NCT00044928|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64964994|NCT00044928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64964995|NCT00044928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964996|NCT00044928|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64535528|NCT01467479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535529|NCT01466387|Vaccines|vaccines|mesh-list
64535530|NCT01466387|Immunologic Factors|immunologic factors|mesh-ancestor
64535531|NCT01466387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535532|NCT00535743|Bromides|bromides|mesh-list
64535533|NCT00535743|Rocuronium|rocuronium|mesh-list
64535534|NCT00535743|Anticonvulsants|anticonvulsants|mesh-ancestor
64535535|NCT00535743|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64300140|NCT02114359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64964997|NCT00044928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964998|NCT00044928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964999|NCT00164359|Artesunate|artesunate|mesh-list
64965000|NCT00164359|Amodiaquine|amodiaquine|mesh-list
64965001|NCT00164359|Dapsone|dapsone|mesh-list
64965002|NCT00164359|Chlorproguanil|chlorproguanil|mesh-list
64965003|NCT00164359|Antimalarials|antimalarials|mesh-ancestor
64965004|NCT00164359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64965005|NCT00164359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64965006|NCT00164359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64965007|NCT00164359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965008|NCT00164359|Antiviral Agents|antiviral agents|mesh-ancestor
64965009|NCT00164359|Schistosomicides|schistosomicides|mesh-ancestor
64965010|NCT00164359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64965011|NCT00164359|Anthelmintics|anthelmintics|mesh-ancestor
64965012|NCT00164359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64965033|NCT00164710|Dapsone|dapsone|mesh-list
64965034|NCT00164710|Chlorproguanil|chlorproguanil|mesh-list
64965035|NCT00164710|Antimalarials|antimalarials|mesh-ancestor
64965036|NCT00164710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64965037|NCT00164710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64965038|NCT00164710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64965039|NCT00164710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965040|NCT00164710|Antiviral Agents|antiviral agents|mesh-ancestor
64965041|NCT00164710|Schistosomicides|schistosomicides|mesh-ancestor
64965042|NCT00164710|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64965043|NCT00164710|Anthelmintics|anthelmintics|mesh-ancestor
64965044|NCT00164710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64965045|NCT00164710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965046|NCT00164710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965047|NCT00164710|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64965048|NCT00164710|Renal Agents|renal agents|mesh-ancestor
64965049|NCT00164710|Leprostatic Agents|leprostatic agents|mesh-ancestor
64965050|NCT00164710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64965051|NCT00045045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64965052|NCT00045045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64965053|NCT00045045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965054|NCT00164749|Curcumin|curcumin|mesh-list
64965055|NCT00164749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64965056|NCT00164749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64965057|NCT00164749|Analgesics|analgesics|mesh-ancestor
64965058|NCT00164749|Sensory System Agents|sensory system agents|mesh-ancestor
64965059|NCT00164749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64965060|NCT00164749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965061|NCT00164749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64965062|NCT00164749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64965063|NCT00164749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965064|NCT00164749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965065|NCT00164749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965066|NCT00164788|Esomeprazole|esomeprazole|mesh-list
64965067|NCT00164788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64965100|NCT00164866|Omeprazole|omeprazole|mesh-list
64965101|NCT00164866|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64965102|NCT00164866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64965103|NCT00164866|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64965104|NCT00164866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965105|NCT00164866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965131|NCT00165139|Tubulin Modulators|tubulin modulators|mesh-ancestor
64965132|NCT00165139|Antimitotic Agents|antimitotic agents|mesh-ancestor
64535536|NCT00535743|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64535537|NCT00535743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64535538|NCT00535743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64535539|NCT00535743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535540|NCT01564784|Cytarabine|cytarabine|mesh-list
64535541|NCT01564784|Fludarabine|fludarabine|mesh-list
64535542|NCT01564784|Mitoxantrone|mitoxantrone|mesh-list
64535543|NCT01564784|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
64535544|NCT01564784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535545|NCT01564784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64535546|NCT01564784|Antimetabolites|antimetabolites|mesh-ancestor
64535547|NCT01564784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535548|NCT01564784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64535549|NCT01564784|Immunologic Factors|immunologic factors|mesh-ancestor
64535550|NCT01564784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535551|NCT01564784|Antiviral Agents|antiviral agents|mesh-ancestor
64535552|NCT01564784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64535553|NCT01564784|Analgesics|analgesics|mesh-ancestor
64300153|NCT03093740|Sofosbuvir|sofosbuvir|mesh-list
64965158|NCT00165178|Vincristine|vincristine|mesh-list
64965159|NCT00165178|Asparaginase|asparaginase|mesh-list
64965160|NCT00165178|Dexrazoxane|dexrazoxane|mesh-list
64965194|NCT00165178|Micronutrients|micronutrients|mesh-ancestor
64965195|NCT00165178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64965196|NCT00165178|Tubulin Modulators|tubulin modulators|mesh-ancestor
64965197|NCT00165178|Antimitotic Agents|antimitotic agents|mesh-ancestor
64965198|NCT00165178|Mitosis Modulators|mitosis modulators|mesh-ancestor
64965199|NCT00165178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64965200|NCT00165217|Thalidomide|thalidomide|mesh-list
64965201|NCT00165217|Capecitabine|capecitabine|mesh-list
64965233|NCT00165334|Antimitotic Agents|antimitotic agents|mesh-ancestor
64965234|NCT00165334|Mitosis Modulators|mitosis modulators|mesh-ancestor
64540484|NCT00684723|L 647318|l 647318|mesh-list
64965235|NCT00165334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965237|NCT00165373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535554|NCT01564784|Sensory System Agents|sensory system agents|mesh-ancestor
64535555|NCT01564784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64535556|NCT01564784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64653979|NCT04347512|Azithromycin|azithromycin|mesh-list
64965239|NCT00165373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64965241|NCT00165373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965260|NCT00165451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64965261|NCT00165451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64965262|NCT00165451|Analgesics|analgesics|mesh-ancestor
64965263|NCT00165451|Sensory System Agents|sensory system agents|mesh-ancestor
64965264|NCT00165451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64965265|NCT00165451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64965266|NCT00165451|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64965267|NCT00165451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64965268|NCT00165451|Leprostatic Agents|leprostatic agents|mesh-ancestor
64965269|NCT00165451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64965270|NCT00165451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64965271|NCT00165451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64965272|NCT00165451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64965273|NCT00165451|Growth Substances|growth substances|mesh-ancestor
64965274|NCT00165451|Growth Inhibitors|growth inhibitors|mesh-ancestor
64965276|NCT00165490|Cetuximab|cetuximab|mesh-list
64965277|NCT00165490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965278|NCT00165490|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64965279|NCT00165490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64965280|NCT00165490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965281|NCT00165490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965282|NCT00165490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64965283|NCT00165568|Bevacizumab|bevacizumab|mesh-list
64965284|NCT00165568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64965285|NCT00165568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965286|NCT00165568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64965287|NCT00165568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64965288|NCT00165568|Growth Substances|growth substances|mesh-ancestor
64965289|NCT00165568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965290|NCT00165568|Growth Inhibitors|growth inhibitors|mesh-ancestor
64965291|NCT00165685|Sibutramine|sibutramine|mesh-list
64965292|NCT00165685|Antidepressive Agents|antidepressive agents|mesh-ancestor
64965293|NCT00165685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64965294|NCT00165685|Appetite Depressants|appetite depressants|mesh-ancestor
64965316|NCT00165880|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
64965317|NCT00165880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965318|NCT00165880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64965319|NCT00165880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965320|NCT00165880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965321|NCT00045318|Exatecan|exatecan|mesh-list
64965322|NCT00045318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64965323|NCT00045318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64965324|NCT00045318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965325|NCT00045318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965326|NCT00045318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965327|NCT00054002|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
64965329|NCT00054002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965330|NCT00054002|Dermatologic Agents|dermatologic agents|mesh-ancestor
64965331|NCT00054002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64965332|NCT00054041|Vaccines|vaccines|mesh-list
64965333|NCT00054041|Immunologic Factors|immunologic factors|mesh-ancestor
64965334|NCT00054041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965335|NCT00166153|Mycophenolic Acid|mycophenolic acid|mesh-list
64965336|NCT00166153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64965337|NCT00166153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965338|NCT00166153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64965339|NCT00166153|Antitubercular Agents|antitubercular agents|mesh-ancestor
64965340|NCT00166153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64965341|NCT00166153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64965342|NCT00166153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965343|NCT00166153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965344|NCT00054197|Gemcitabine|gemcitabine|mesh-list
64965345|NCT00054197|Paclitaxel|paclitaxel|mesh-list
64965346|NCT00054197|Vinorelbine|vinorelbine|mesh-list
64965347|NCT00054197|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
64965348|NCT00054197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64965349|NCT00054197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965350|NCT00054197|Tubulin Modulators|tubulin modulators|mesh-ancestor
64965381|NCT00166465|Oxaliplatin|oxaliplatin|mesh-list
64965382|NCT00166465|Antimetabolites|antimetabolites|mesh-ancestor
64965383|NCT00166465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965384|NCT00166465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64965385|NCT00166465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965386|NCT00166465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64965387|NCT00166465|Immunologic Factors|immunologic factors|mesh-ancestor
64535557|NCT01564784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64535558|NCT01564784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535559|NCT01564784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64535560|NCT01564784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64535561|NCT00536601|Cyclophosphamide|cyclophosphamide|mesh-list
64535562|NCT00536601|Melphalan|melphalan|mesh-list
64535563|NCT00536601|Busulfan|busulfan|mesh-list
64535564|NCT00536601|Thiotepa|thiotepa|mesh-list
64965388|NCT00166465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965389|NCT00166465|Antidotes|antidotes|mesh-ancestor
64965390|NCT00166465|Protective Agents|protective agents|mesh-ancestor
64965391|NCT00166465|Vitamin B Complex|vitamin b complex|mesh-ancestor
64965392|NCT00166465|Vitamins|vitamins|mesh-ancestor
64965393|NCT00166465|Micronutrients|micronutrients|mesh-ancestor
64965394|NCT00166621|Buspirone|buspirone|mesh-list
64965395|NCT00166621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64965424|NCT00054236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64965425|NCT00054236|Glucocorticoids|glucocorticoids|mesh-ancestor
64965426|NCT00054236|Hormones|hormones|mesh-ancestor
64965427|NCT00054236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64965428|NCT00054236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64965429|NCT00054236|Protective Agents|protective agents|mesh-ancestor
64965430|NCT00054392|Gemcitabine|gemcitabine|mesh-list
64965431|NCT00054392|Paclitaxel|paclitaxel|mesh-list
64965432|NCT00054392|Carboplatin|carboplatin|mesh-list
64965433|NCT00054392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64965434|NCT00054392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965435|NCT00054392|Tubulin Modulators|tubulin modulators|mesh-ancestor
64965436|NCT00054392|Antimitotic Agents|antimitotic agents|mesh-ancestor
64965437|NCT00054392|Mitosis Modulators|mitosis modulators|mesh-ancestor
64965438|NCT00054392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965439|NCT00054392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64965440|NCT00054392|Antimetabolites|antimetabolites|mesh-ancestor
64965466|NCT04723732|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64965467|NCT04723732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64965468|NCT04723732|Disinfectants|disinfectants|mesh-ancestor
64965469|NCT04723732|Dermatologic Agents|dermatologic agents|mesh-ancestor
64965470|NCT00054431|Imatinib Mesylate|imatinib mesylate|mesh-list
64965471|NCT00054431|Decitabine|decitabine|mesh-list
64965472|NCT00054431|Azacitidine|azacitidine|mesh-list
64965473|NCT00054431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504138|NCT01612546|Camptothecin|camptothecin|mesh-list
64965474|NCT00054431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64965475|NCT00054431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965476|NCT00054431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965477|NCT00054431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64965479|NCT00054470|Trastuzumab|trastuzumab|mesh-list
64965480|NCT00054470|Tipifarnib|tipifarnib|mesh-list
64965481|NCT00054470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64965482|NCT00054470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965483|NCT00054548|Paclitaxel|paclitaxel|mesh-list
64965484|NCT00054548|Oblimersen|oblimersen|mesh-list
64965485|NCT00054548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64653994|NCT04372316|Vitamin B 12|vitamin b 12|mesh-list
64965488|NCT00054548|Antimitotic Agents|antimitotic agents|mesh-ancestor
64965489|NCT00054548|Mitosis Modulators|mitosis modulators|mesh-ancestor
64965490|NCT00054548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965491|NCT00045513|Fludarabine|fludarabine|mesh-list
64965492|NCT00045513|Fludarabine phosphate|fludarabine phosphate|mesh-list
64965493|NCT00045513|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
64965521|NCT00054587|Cyclophosphamide|cyclophosphamide|mesh-list
64965522|NCT00054587|Docetaxel|docetaxel|mesh-list
64965523|NCT00054587|Fluorouracil|fluorouracil|mesh-list
64965524|NCT00054587|Trastuzumab|trastuzumab|mesh-list
64965525|NCT00054587|Epirubicin|epirubicin|mesh-list
64965526|NCT00054587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64965527|NCT00054587|Immunologic Factors|immunologic factors|mesh-ancestor
64965528|NCT00054587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965529|NCT00054587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64965530|NCT00054587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64535566|NCT00536601|Carboplatin|carboplatin|mesh-list
64535567|NCT00536601|Etoposide|etoposide|mesh-list
64535568|NCT00536601|Etoposide phosphate|etoposide phosphate|mesh-list
64714135|NCT00373789|Cholinergic Agents|cholinergic agents|mesh-ancestor
64535569|NCT00536601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64535570|NCT00536601|Immunologic Factors|immunologic factors|mesh-ancestor
64535571|NCT00536601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535572|NCT00536601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64535573|NCT00536601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64535574|NCT00536601|Alkylating Agents|alkylating agents|mesh-ancestor
64300206|NCT03090698|Viscosupplements|viscosupplements|mesh-ancestor
64965531|NCT00054587|Alkylating Agents|alkylating agents|mesh-ancestor
64965532|NCT00054587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965533|NCT00054587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965534|NCT00054587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64965535|NCT00054587|Tubulin Modulators|tubulin modulators|mesh-ancestor
64965536|NCT00054587|Antimitotic Agents|antimitotic agents|mesh-ancestor
64965537|NCT00054587|Mitosis Modulators|mitosis modulators|mesh-ancestor
64965538|NCT00054587|Antimetabolites|antimetabolites|mesh-ancestor
64965539|NCT00054587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64965540|NCT00054587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64965569|NCT00167674|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64965570|NCT00167674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64965571|NCT00054626|Gemcitabine|gemcitabine|mesh-list
64965572|NCT00054626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965573|NCT00054626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64965574|NCT00054626|Antimetabolites|antimetabolites|mesh-ancestor
64965575|NCT00054626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965576|NCT00054626|Antiviral Agents|antiviral agents|mesh-ancestor
64965577|NCT00054626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64965578|NCT00054626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965579|NCT00054626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64965580|NCT00054626|Immunologic Factors|immunologic factors|mesh-ancestor
64965581|NCT00054626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965582|NCT00167713|Ibuprofen|ibuprofen|mesh-list
64965583|NCT00167713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64977916|NCT00267319|Glatiramer Acetate|glatiramer acetate|mesh-list
64965584|NCT00167713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64965585|NCT00167713|Analgesics|analgesics|mesh-ancestor
64965586|NCT00167713|Sensory System Agents|sensory system agents|mesh-ancestor
64965614|NCT00167908|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64965615|NCT00167908|Protective Agents|protective agents|mesh-ancestor
64965616|NCT00167908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965617|NCT00167947|Cyclosporine|cyclosporine|mesh-list
64965618|NCT00167947|Sirolimus|sirolimus|mesh-list
64965619|NCT00167947|Cyclosporins|cyclosporins|mesh-list
64965620|NCT00167947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965621|NCT00167947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965622|NCT00167947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64965623|NCT00167947|Immunologic Factors|immunologic factors|mesh-ancestor
64965624|NCT00167947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965625|NCT00167947|Antifungal Agents|antifungal agents|mesh-ancestor
64965626|NCT00167947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64965627|NCT00167947|Dermatologic Agents|dermatologic agents|mesh-ancestor
64965628|NCT00167947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64965629|NCT00167947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64965630|NCT00167947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64965631|NCT00167947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64965651|NCT00407251|Epothilone B|epothilone b|mesh-list
64965652|NCT00407251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965653|NCT00407251|Tubulin Modulators|tubulin modulators|mesh-ancestor
64965654|NCT00407251|Antimitotic Agents|antimitotic agents|mesh-ancestor
64965655|NCT00407251|Mitosis Modulators|mitosis modulators|mesh-ancestor
64535575|NCT00536601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535576|NCT00536601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535577|NCT00536601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64535578|NCT00536601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64535579|NCT00536601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64535580|NCT00536601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64535581|NCT00536601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535582|NCT00536913|Budesonide|budesonide|mesh-list
64535583|NCT00536913|Formoterol Fumarate|formoterol fumarate|mesh-list
64535584|NCT00536913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64535585|NCT00536913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64300220|NCT02251171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64965656|NCT00407251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965657|NCT00045669|Imatinib Mesylate|imatinib mesylate|mesh-list
64965658|NCT00045669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965659|NCT00045669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64965660|NCT00045669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965661|NCT00045669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965662|NCT00407290|Neostigmine|neostigmine|mesh-list
64965663|NCT00407290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64965664|NCT00407290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965665|NCT00407290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965666|NCT00407290|Cholinergic Agents|cholinergic agents|mesh-ancestor
64965667|NCT00407290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64977932|NCT00267514|Sevelamer|sevelamer|mesh-list
64965668|NCT00407290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965669|NCT00407290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64965670|NCT00407290|Autonomic Agents|autonomic agents|mesh-ancestor
64965671|NCT00407290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64965672|NCT00407407|Carboplatin|carboplatin|mesh-list
64965673|NCT00407407|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64965674|NCT00407407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965675|NCT00407446|Sildenafil Citrate|sildenafil citrate|mesh-list
64965676|NCT00407446|Vasodilator Agents|vasodilator agents|mesh-ancestor
64965677|NCT00407446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64965678|NCT00407446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64965679|NCT00407446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965680|NCT00407446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965681|NCT00407446|Urological Agents|urological agents|mesh-ancestor
64965682|NCT00168415|Botulinum Toxins|botulinum toxins|mesh-list
64965683|NCT00168415|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64965684|NCT00168415|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64965685|NCT00168415|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64965686|NCT00168415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64965687|NCT00168415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965715|NCT00168532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965717|NCT00168532|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64965718|NCT00168532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64965719|NCT00168532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64965720|NCT00168610|Vitamin A|vitamin a|mesh-list
64965721|NCT00168610|Vitamins|vitamins|mesh-ancestor
64965722|NCT00168610|Micronutrients|micronutrients|mesh-ancestor
64965723|NCT00168610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965724|NCT04731948|Vitamins|vitamins|mesh-list
64965725|NCT04731948|Folic Acid|folic acid|mesh-list
64965726|NCT04731948|Hydroxocobalamin|hydroxocobalamin|mesh-list
64965727|NCT04731948|Vitamin B 12|vitamin b 12|mesh-list
64965728|NCT04731948|Vitamin B Complex|vitamin b complex|mesh-list
64965729|NCT04731948|Micronutrients|micronutrients|mesh-ancestor
64965730|NCT04731948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965731|NCT04731948|Hematinics|hematinics|mesh-ancestor
64965732|NCT00168649|Vitamin A|vitamin a|mesh-list
64965759|NCT00168883|Paclitaxel|paclitaxel|mesh-list
64535586|NCT00536913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64535587|NCT00536913|Autonomic Agents|autonomic agents|mesh-ancestor
64535588|NCT00536913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64535589|NCT00536913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535590|NCT00536913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64535591|NCT00536913|Respiratory System Agents|respiratory system agents|mesh-ancestor
64535592|NCT00536913|Glucocorticoids|glucocorticoids|mesh-ancestor
64535593|NCT00536913|Hormones|hormones|mesh-ancestor
64535594|NCT00536913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64535595|NCT00536913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64535596|NCT00536913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64535597|NCT00536913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64535598|NCT00536913|Adrenergic Agents|adrenergic agents|mesh-ancestor
64535599|NCT00536913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64535600|NCT00536913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965760|NCT00168883|Vinorelbine|vinorelbine|mesh-list
64965761|NCT00168883|Carboplatin|carboplatin|mesh-list
64965762|NCT00168883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64965763|NCT00168883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965764|NCT00168883|Tubulin Modulators|tubulin modulators|mesh-ancestor
64965765|NCT00168883|Antimitotic Agents|antimitotic agents|mesh-ancestor
64965766|NCT00168883|Mitosis Modulators|mitosis modulators|mesh-ancestor
64965767|NCT00168883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504434|NCT02508246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504444|NCT02499978|Darunavir|darunavir|mesh-list
64965768|NCT04731909|Cisplatin|cisplatin|mesh-list
64965769|NCT04731909|Carboplatin|carboplatin|mesh-list
64965770|NCT04731909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965771|NCT00168922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64965772|NCT00168922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64965773|NCT00168922|Alkylating Agents|alkylating agents|mesh-ancestor
64965774|NCT00168922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965775|NCT00168922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965777|NCT00054938|Ramipril|ramipril|mesh-list
64965778|NCT00054938|Pravastatin|pravastatin|mesh-list
64965779|NCT00054938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965780|NCT00054938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64965781|NCT00054938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64965782|NCT00054938|Analgesics|analgesics|mesh-ancestor
64965810|NCT00169000|Antimetabolites|antimetabolites|mesh-ancestor
64965811|NCT00045747|Fluorouracil|fluorouracil|mesh-list
64965812|NCT00045747|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
64965813|NCT00045747|Antimetabolites|antimetabolites|mesh-ancestor
64965814|NCT00045747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965815|NCT00045747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64965816|NCT00045747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965817|NCT00045747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64965818|NCT00045747|Immunologic Factors|immunologic factors|mesh-ancestor
64965819|NCT00045747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965820|NCT00045747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64965821|NCT00045747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965822|NCT00169039|Chlorpromazine|chlorpromazine|mesh-list
64965823|NCT00169039|Clozapine|clozapine|mesh-list
64965824|NCT00169039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64965825|NCT00169039|Serotonin Agents|serotonin agents|mesh-ancestor
64965826|NCT00169039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64965827|NCT00169039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535601|NCT00462423|Bevacizumab|bevacizumab|mesh-list
64535602|NCT00462423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64535612|NCT00462735|Hydroxyurea|hydroxyurea|mesh-list
64535613|NCT00462735|Antimetabolites|antimetabolites|mesh-ancestor
64535614|NCT00462735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535615|NCT00462735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64535616|NCT00462735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965852|NCT00054977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965853|NCT00054977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64965854|NCT00054977|Immunologic Factors|immunologic factors|mesh-ancestor
64965855|NCT00054977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965856|NCT00169156|Prednisone|prednisone|mesh-list
64965857|NCT00169156|Cyclophosphamide|cyclophosphamide|mesh-list
64965858|NCT00169156|Rituximab|rituximab|mesh-list
64965859|NCT00169156|Doxorubicin|doxorubicin|mesh-list
64965860|NCT00169156|Vincristine|vincristine|mesh-list
64965861|NCT00169156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64965862|NCT00169156|Immunologic Factors|immunologic factors|mesh-ancestor
64965863|NCT00169156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965864|NCT00169156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64965865|NCT00169156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64965866|NCT00169156|Alkylating Agents|alkylating agents|mesh-ancestor
64965867|NCT00169156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965868|NCT00169156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965869|NCT00169156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64965870|NCT00169156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64965871|NCT00169156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64540683|NCT00601965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64965872|NCT00169156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64965873|NCT00169156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64965874|NCT00169156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965875|NCT00169156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64965876|NCT00169156|Glucocorticoids|glucocorticoids|mesh-ancestor
64965877|NCT00169156|Hormones|hormones|mesh-ancestor
64965898|NCT00169195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64965899|NCT00169234|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64965900|NCT00169234|Immunologic Factors|immunologic factors|mesh-ancestor
64965901|NCT00169234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535617|NCT00462735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64535618|NCT00462735|Immunologic Factors|immunologic factors|mesh-ancestor
64535619|NCT00462735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535620|NCT00462735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64535621|NCT00462735|Antisickling Agents|antisickling agents|mesh-ancestor
64535622|NCT00462735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535623|NCT00462735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64535624|NCT01690988|Ketamine|ketamine|mesh-list
64535625|NCT01690988|Analgesics|analgesics|mesh-ancestor
64535626|NCT01690988|Sensory System Agents|sensory system agents|mesh-ancestor
64535627|NCT01690988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64535628|NCT01690988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535629|NCT01690988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64535630|NCT01690988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64535631|NCT01690988|Anesthetics, General|anesthetics, general|mesh-ancestor
64535633|NCT01690988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64535634|NCT01690988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64965902|NCT00169468|Rituximab|rituximab|mesh-list
64965903|NCT00169468|Bortezomib|bortezomib|mesh-list
64965904|NCT00169468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64965905|NCT00169468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965906|NCT00169468|Immunologic Factors|immunologic factors|mesh-ancestor
64965907|NCT00169468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965908|NCT00169468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64965909|NCT00169546|Fluticasone|fluticasone|mesh-list
64965911|NCT00169546|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64965912|NCT00169546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64965913|NCT00169546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64965914|NCT00169546|Autonomic Agents|autonomic agents|mesh-ancestor
64965915|NCT00169546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64965916|NCT00169546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965917|NCT00169546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64965918|NCT00169546|Respiratory System Agents|respiratory system agents|mesh-ancestor
64965919|NCT00169546|Dermatologic Agents|dermatologic agents|mesh-ancestor
64965920|NCT00169546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64965921|NCT00169546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64965922|NCT00169546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64965923|NCT00169546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64504586|NCT02234752|Memantine|memantine|mesh-list
64535635|NCT01690988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64535636|NCT01690988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64535637|NCT01690988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535638|NCT00463437|Vaccines|vaccines|mesh-list
64535639|NCT00463437|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64535640|NCT00463437|Immunologic Factors|immunologic factors|mesh-ancestor
64535641|NCT00463437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535642|NCT01466153|Rituximab|rituximab|mesh-list
64535643|NCT01466153|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64535644|NCT01466153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64535645|NCT01466153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535646|NCT01466153|Immunologic Factors|immunologic factors|mesh-ancestor
64535647|NCT01466153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535648|NCT01466153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64535649|NCT01466153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64535650|NCT01466153|Alkylating Agents|alkylating agents|mesh-ancestor
64504657|NCT02502708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64965924|NCT00169546|Adrenergic Agents|adrenergic agents|mesh-ancestor
64965925|NCT00169546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64965926|NCT00169546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965927|NCT00398372|Rituximab|rituximab|mesh-list
64965928|NCT00398372|Epratuzumab|epratuzumab|mesh-list
64965957|NCT00407641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64965958|NCT00407641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965959|NCT00407680|Valsartan|valsartan|mesh-list
64965960|NCT00407680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64965961|NCT00407680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64965962|NCT00407680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64965963|NCT00407680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965964|NCT00169819|Abciximab|abciximab|mesh-list
64965965|NCT00169819|Anticoagulants|anticoagulants|mesh-ancestor
64965966|NCT00169819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64965967|NCT00055133|Paclitaxel|paclitaxel|mesh-list
64965968|NCT00055133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64965969|NCT00055133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965970|NCT00055133|Tubulin Modulators|tubulin modulators|mesh-ancestor
64965971|NCT00055133|Antimitotic Agents|antimitotic agents|mesh-ancestor
64965972|NCT00055133|Mitosis Modulators|mitosis modulators|mesh-ancestor
64965973|NCT00055133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965974|NCT00170053|Sirolimus|sirolimus|mesh-list
64965975|NCT00170053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64966001|NCT00170209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64966003|NCT00170209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966004|NCT00170209|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64966005|NCT00170209|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64966006|NCT00170209|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64966007|NCT00170209|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64966008|NCT00170209|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64966009|NCT00170209|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64966010|NCT00170209|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64966011|NCT00170209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64966012|NCT00170209|Antimetabolites|antimetabolites|mesh-ancestor
64966013|NCT00170209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64535651|NCT01466153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535652|NCT00464685|Dexamethasone|dexamethasone|mesh-list
64535653|NCT00464685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64535654|NCT00464685|Antiemetics|antiemetics|mesh-ancestor
64535655|NCT00464685|Autonomic Agents|autonomic agents|mesh-ancestor
64535656|NCT00464685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64535657|NCT00464685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535658|NCT00464685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64535659|NCT00464685|Glucocorticoids|glucocorticoids|mesh-ancestor
64535661|NCT00464685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64535662|NCT00464685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64535663|NCT00464685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535664|NCT01465997|Lacosamide|lacosamide|mesh-list
64535665|NCT01465997|Carbamazepine|carbamazepine|mesh-list
64535666|NCT01465997|Anticonvulsants|anticonvulsants|mesh-ancestor
64535667|NCT01465997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64535668|NCT01465997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64535669|NCT01465997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64535670|NCT01465997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535671|NCT01465997|Antimanic Agents|antimanic agents|mesh-ancestor
64535672|NCT01465997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64535673|NCT01465997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64535674|NCT01465997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535675|NCT01465997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64535676|NCT01465997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64535677|NCT01465997|Analgesics|analgesics|mesh-ancestor
64535678|NCT01465997|Sensory System Agents|sensory system agents|mesh-ancestor
64535679|NCT01465997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64535680|NCT01465997|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64535681|NCT01465997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64535692|NCT00538863|Anesthetics, General|anesthetics, general|mesh-ancestor
64535693|NCT00538863|Anesthetics|anesthetics|mesh-ancestor
64535694|NCT04345341|Bupivacaine|bupivacaine|mesh-list
64535695|NCT04345341|Anesthetics, Local|anesthetics, local|mesh-ancestor
64535696|NCT04345341|Anesthetics|anesthetics|mesh-ancestor
64535697|NCT04345341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64535698|NCT04345341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535699|NCT04345341|Sensory System Agents|sensory system agents|mesh-ancestor
64535700|NCT04345341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64535701|NCT01465763|Tofacitinib|tofacitinib|mesh-list
64535702|NCT01465763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64535703|NCT01465763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535704|NCT01465763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535705|NCT00540579|Gemcitabine|gemcitabine|mesh-list
64535706|NCT00540579|Pomalidomide|pomalidomide|mesh-list
64535707|NCT00540579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64535708|NCT00540579|Antimetabolites|antimetabolites|mesh-ancestor
64535709|NCT00540579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535710|NCT00540579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535711|NCT00540579|Antiviral Agents|antiviral agents|mesh-ancestor
64535712|NCT00540579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64966014|NCT02964091|Sofosbuvir|sofosbuvir|mesh-list
64966015|NCT02964091|Ledipasvir|ledipasvir|mesh-list
64966016|NCT02964091|Antiviral Agents|antiviral agents|mesh-ancestor
64966017|NCT02964091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64966018|NCT00170404|Vitamins|vitamins|mesh-list
64966020|NCT00170404|Vitamin A|vitamin a|mesh-list
64966021|NCT00170404|Thiamine|thiamine|mesh-list
64966022|NCT00170404|Selenium|selenium|mesh-list
64966023|NCT00170404|Micronutrients|micronutrients|mesh-list
64966024|NCT00170404|Trace Elements|trace elements|mesh-list
64966025|NCT00170404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966026|NCT00170404|Hematinics|hematinics|mesh-ancestor
64966027|NCT00170404|Vitamin B Complex|vitamin b complex|mesh-ancestor
64966028|NCT00170404|Antioxidants|antioxidants|mesh-ancestor
64966060|NCT00170872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64966061|NCT00170872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966062|NCT00170872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540768|NCT00705003|Melatonin|melatonin|mesh-list
64966063|NCT00170872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64966064|NCT00170872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64966065|NCT00170872|Analgesics|analgesics|mesh-ancestor
64966066|NCT00170872|Sensory System Agents|sensory system agents|mesh-ancestor
64966067|NCT00170872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64966068|NCT00170872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966069|NCT00170872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64966070|NCT00170872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64966071|NCT00170989|Valsartan|valsartan|mesh-list
64966086|NCT00171028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966087|NCT00055484|Zonisamide|zonisamide|mesh-list
64966088|NCT00055484|Anticonvulsants|anticonvulsants|mesh-ancestor
64966089|NCT00055484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64966090|NCT00055484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64966091|NCT00055484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966092|NCT00055484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64535714|NCT00540579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64535715|NCT00540579|Immunologic Factors|immunologic factors|mesh-ancestor
64535716|NCT00540579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535717|NCT00540579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64535718|NCT00540579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64535719|NCT00540579|Growth Substances|growth substances|mesh-ancestor
64535720|NCT00540579|Growth Inhibitors|growth inhibitors|mesh-ancestor
64535721|NCT01690520|Cyclosporine|cyclosporine|mesh-list
64535722|NCT01690520|Mycophenolic Acid|mycophenolic acid|mesh-list
64535723|NCT01690520|Cyclophosphamide|cyclophosphamide|mesh-list
64535724|NCT01690520|Thiotepa|thiotepa|mesh-list
64535725|NCT01690520|Fludarabine|fludarabine|mesh-list
64535726|NCT01690520|Fludarabine phosphate|fludarabine phosphate|mesh-list
64535727|NCT01690520|Cyclosporins|cyclosporins|mesh-list
64535728|NCT01690520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64535729|NCT01690520|Immunologic Factors|immunologic factors|mesh-ancestor
64535730|NCT01690520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535731|NCT01690520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64300379|NCT03286803|Vaccines|vaccines|mesh-list
64966093|NCT00055484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966094|NCT00171067|Valsartan|valsartan|mesh-list
64966095|NCT00171067|Lisinopril|lisinopril|mesh-list
64966096|NCT00171067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64966097|NCT00171067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64966098|NCT00171067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64966099|NCT00171067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966100|NCT00171067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64966101|NCT00171067|Protease Inhibitors|protease inhibitors|mesh-ancestor
64966102|NCT00171067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540790|NCT03110640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540798|NCT00690495|Anesthetics|anesthetics|mesh-ancestor
64966103|NCT00171067|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64966104|NCT00171067|Protective Agents|protective agents|mesh-ancestor
64966105|NCT00171067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966106|NCT00171106|Valsartan|valsartan|mesh-list
64966107|NCT00171106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64966108|NCT00171106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64966109|NCT00171106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64966110|NCT00171106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966111|NCT00171145|Darifenacin|darifenacin|mesh-list
64966112|NCT00171145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64966113|NCT00171145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64966114|NCT00171145|Cholinergic Agents|cholinergic agents|mesh-ancestor
64966115|NCT00171145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64966116|NCT00171145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966117|NCT00171145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966118|NCT00171145|Urological Agents|urological agents|mesh-ancestor
64966119|NCT00171184|Darifenacin|darifenacin|mesh-list
64966120|NCT00171184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64966121|NCT00171184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64966122|NCT00171184|Cholinergic Agents|cholinergic agents|mesh-ancestor
64966123|NCT00171184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64966124|NCT00171184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966125|NCT00171184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966148|NCT00171457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64966149|NCT00171457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535732|NCT01690520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64535733|NCT01690520|Alkylating Agents|alkylating agents|mesh-ancestor
64535734|NCT01690520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535735|NCT01690520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535736|NCT01690520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64535737|NCT01690520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64535738|NCT01690520|Antimetabolites|antimetabolites|mesh-ancestor
64535739|NCT01690520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535740|NCT01690520|Antifungal Agents|antifungal agents|mesh-ancestor
64535741|NCT01690520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64535742|NCT01690520|Dermatologic Agents|dermatologic agents|mesh-ancestor
64535743|NCT01690520|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64535744|NCT01690520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64535745|NCT01690520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64540822|NCT04351230|Immunologic Factors|immunologic factors|mesh-ancestor
64535746|NCT01690520|Antitubercular Agents|antitubercular agents|mesh-ancestor
64535747|NCT01690520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64535749|NCT04081337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64535750|NCT04081337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535751|NCT04081337|Incretins|incretins|mesh-ancestor
64535752|NCT04081337|Hormones|hormones|mesh-ancestor
64535753|NCT04081337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64535754|NCT00541671|Promethazine|promethazine|mesh-list
64535755|NCT00541671|Antipruritics|antipruritics|mesh-ancestor
64535756|NCT00541671|Dermatologic Agents|dermatologic agents|mesh-ancestor
64535757|NCT00541671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64535758|NCT00541671|Histamine Antagonists|histamine antagonists|mesh-ancestor
64535759|NCT00541671|Histamine Agents|histamine agents|mesh-ancestor
64535760|NCT00541671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64535761|NCT00541671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535762|NCT00541671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535763|NCT00541671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64535764|NCT01563536|Ritonavir|ritonavir|mesh-list
64535765|NCT01563536|Ribavirin|ribavirin|mesh-list
64535766|NCT01563536|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64535771|NCT01563536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64535772|NCT01563536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64535773|NCT01563536|Antiviral Agents|antiviral agents|mesh-ancestor
64535774|NCT01563536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64535775|NCT01563536|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64535776|NCT01563536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64535777|NCT01563536|Antimetabolites|antimetabolites|mesh-ancestor
64535778|NCT01690052|Pilocarpine|pilocarpine|mesh-list
64535780|NCT01690052|Miotics|miotics|mesh-ancestor
64535781|NCT01690052|Autonomic Agents|autonomic agents|mesh-ancestor
64535782|NCT01690052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64966150|NCT00171457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966151|NCT00055562|Lenalidomide|lenalidomide|mesh-list
64966152|NCT00055562|Immunologic Factors|immunologic factors|mesh-ancestor
64966153|NCT00055562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966154|NCT00055562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64966155|NCT00055562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64966157|NCT00055562|Growth Inhibitors|growth inhibitors|mesh-ancestor
64966158|NCT00055562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966159|NCT04924374|Pembrolizumab|pembrolizumab|mesh-list
64966160|NCT04924374|Atezolizumab|atezolizumab|mesh-list
64966161|NCT04924374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64966162|NCT04924374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64966163|NCT04924374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966164|NCT04924374|Immunologic Factors|immunologic factors|mesh-ancestor
64966165|NCT04924374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966166|NCT00171496|Cyclosporine|cyclosporine|mesh-list
64966167|NCT00171496|Tacrolimus|tacrolimus|mesh-list
64966168|NCT00171496|Cyclosporins|cyclosporins|mesh-list
64966169|NCT00171496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64966170|NCT00171496|Immunologic Factors|immunologic factors|mesh-ancestor
64966171|NCT00171496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966172|NCT00171496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64966173|NCT00171496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966174|NCT00171496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966175|NCT00171496|Antifungal Agents|antifungal agents|mesh-ancestor
64966202|NCT00171613|Octreotide|octreotide|mesh-list
64966203|NCT00171613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64966204|NCT00171613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64540882|NCT00691665|Dermatologic Agents|dermatologic agents|mesh-ancestor
64966205|NCT00171613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966206|NCT04920981|Atezolizumab|atezolizumab|mesh-list
64966207|NCT04920981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966208|NCT00055640|Prednisone|prednisone|mesh-list
64966209|NCT00055640|Cyclophosphamide|cyclophosphamide|mesh-list
64966210|NCT00055640|Rituximab|rituximab|mesh-list
64966211|NCT00055640|Doxorubicin|doxorubicin|mesh-list
64966212|NCT00055640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64966213|NCT00055640|Vincristine|vincristine|mesh-list
64966214|NCT00055640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64966215|NCT00055640|Immunologic Factors|immunologic factors|mesh-ancestor
64966216|NCT00055640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966217|NCT00055640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64504882|NCT04930042|Dermatologic Agents|dermatologic agents|mesh-ancestor
64966218|NCT00055640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64966219|NCT00055640|Alkylating Agents|alkylating agents|mesh-ancestor
64966220|NCT00055640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966221|NCT00055640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966251|NCT00171691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64966252|NCT00171691|Analgesics|analgesics|mesh-ancestor
64966253|NCT00171691|Sensory System Agents|sensory system agents|mesh-ancestor
64966254|NCT00171691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64966255|NCT00171691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966256|NCT00171691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64535783|NCT01690052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535784|NCT01690052|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64535785|NCT01690052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64535786|NCT01690052|Cholinergic Agents|cholinergic agents|mesh-ancestor
64535787|NCT01690052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64535788|NCT01690052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535789|NCT01690052|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64535790|NCT01689974|Ipilimumab|ipilimumab|mesh-list
64535791|NCT01689974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64535792|NCT01689974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535793|NCT01689974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64535794|NCT01689974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535795|NCT04750083|Carboplatin|carboplatin|mesh-list
64535796|NCT04750083|Pembrolizumab|pembrolizumab|mesh-list
64535797|NCT04750083|Pemetrexed|pemetrexed|mesh-list
64535798|NCT04750083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535799|NCT04750083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64535800|NCT04750083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535801|NCT04750083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535802|NCT04750083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64535803|NCT04750083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64535804|NCT04409912|Sirolimus|sirolimus|mesh-list
64535805|NCT04409912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64535806|NCT04409912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64535807|NCT04409912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64535808|NCT04409912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535809|NCT04409912|Antifungal Agents|antifungal agents|mesh-ancestor
64535810|NCT04409912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64535811|NCT04409912|Immunologic Factors|immunologic factors|mesh-ancestor
64535812|NCT04409912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535818|NCT02954991|Nivolumab|nivolumab|mesh-list
64535825|NCT02954991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535826|NCT02892591|Oxycodone|oxycodone|mesh-list
64535901|NCT01458535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64535902|NCT01458535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64535903|NCT01458535|Antiviral Agents|antiviral agents|mesh-ancestor
64535904|NCT01458535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64535905|NCT01458535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64535906|NCT01458535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64535907|NCT01458535|Antimetabolites|antimetabolites|mesh-ancestor
64535908|NCT01464827|Ritonavir|ritonavir|mesh-list
64535909|NCT01464827|Ribavirin|ribavirin|mesh-list
64535910|NCT01464827|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64535911|NCT01464827|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64535912|NCT01464827|Protease Inhibitors|protease inhibitors|mesh-ancestor
64535913|NCT01464827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535914|NCT01464827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535915|NCT01464827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64535916|NCT01464827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64535917|NCT01464827|Antiviral Agents|antiviral agents|mesh-ancestor
64535918|NCT01464827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64535919|NCT01464827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64535920|NCT01464827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64535921|NCT01464827|Antimetabolites|antimetabolites|mesh-ancestor
64535922|NCT01463111|Lamotrigine|lamotrigine|mesh-list
64535923|NCT01463111|Valproic Acid|valproic acid|mesh-list
64535924|NCT01463111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64535925|NCT01463111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535926|NCT01463111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535927|NCT01463111|Antimanic Agents|antimanic agents|mesh-ancestor
64535928|NCT01463111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64535929|NCT01463111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64535930|NCT01463111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535931|NCT01463111|Anticonvulsants|anticonvulsants|mesh-ancestor
64535932|NCT01463111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64535933|NCT01463111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64535934|NCT01463111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64535935|NCT01463111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64535936|NCT01463111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64966257|NCT00171691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64966258|NCT00171691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64535937|NCT01463111|GABA Agents|gaba agents|mesh-ancestor
64535938|NCT01463111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64535939|NCT01463033|Levetiracetam|levetiracetam|mesh-list
64535940|NCT01463033|Anticonvulsants|anticonvulsants|mesh-ancestor
64535941|NCT01463033|Nootropic Agents|nootropic agents|mesh-ancestor
64535942|NCT01461551|Propofol|propofol|mesh-list
64535943|NCT01461551|Sevoflurane|sevoflurane|mesh-list
64535944|NCT01461551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64535945|NCT01461551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64535946|NCT01461551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535947|NCT01461551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64535948|NCT01461551|Anesthetics, General|anesthetics, general|mesh-ancestor
64535949|NCT01461551|Anesthetics|anesthetics|mesh-ancestor
64535950|NCT01461551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64535951|NCT01461551|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64535952|NCT01460381|Quinidine|quinidine|mesh-list
64535953|NCT01460381|Quinidine gluconate|quinidine gluconate|mesh-list
64535954|NCT01460381|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64535955|NCT01460381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64535956|NCT01460381|Adrenergic Agents|adrenergic agents|mesh-ancestor
64535957|NCT01460381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64535958|NCT01460381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535959|NCT01460381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535960|NCT01460381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64535962|NCT01460381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64535963|NCT01460381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64535964|NCT01460381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64300592|NCT03552601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64966259|NCT00171691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966260|NCT00171691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966262|NCT00171769|Anticoagulants|anticoagulants|mesh-ancestor
64966283|NCT00171847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64966284|NCT00171847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966285|NCT00055679|Cyclophosphamide|cyclophosphamide|mesh-list
64966286|NCT00055679|Fluorouracil|fluorouracil|mesh-list
64966287|NCT00055679|Epirubicin|epirubicin|mesh-list
64966288|NCT00055679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64966289|NCT00055679|Immunologic Factors|immunologic factors|mesh-ancestor
64966290|NCT00055679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966291|NCT00055679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64966292|NCT00055679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64966293|NCT00055679|Alkylating Agents|alkylating agents|mesh-ancestor
64966294|NCT00055679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966295|NCT00055679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966296|NCT00055679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64535965|NCT01460381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535966|NCT01460381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64535967|NCT01460381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64535968|NCT01460381|Cholinergic Agents|cholinergic agents|mesh-ancestor
64535969|NCT01460381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64535970|NCT01460381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64535971|NCT01460381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64535972|NCT01460381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64535973|NCT01460381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64535974|NCT00546897|Lenalidomide|lenalidomide|mesh-list
64535975|NCT00546897|Immunologic Factors|immunologic factors|mesh-ancestor
64535976|NCT00546897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64535977|NCT00546897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64535978|NCT00546897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64535979|NCT00546897|Growth Substances|growth substances|mesh-ancestor
64535980|NCT00546897|Growth Inhibitors|growth inhibitors|mesh-ancestor
64535981|NCT00546897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64535982|NCT03754725|Deferiprone|deferiprone|mesh-list
64535983|NCT03754725|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64300632|NCT03087890|Trimethoprim|trimethoprim|mesh-list
64966297|NCT00055679|Antimetabolites|antimetabolites|mesh-ancestor
64966298|NCT00055679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64966299|NCT00055679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64966300|NCT00055679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64966301|NCT00055679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64966302|NCT00055679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966303|NCT00171886|Octreotide|octreotide|mesh-list
64966304|NCT00171886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64966305|NCT00171886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64966306|NCT00171886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966307|NCT00171964|Zoledronic Acid|zoledronic acid|mesh-list
64966308|NCT00171964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64966309|NCT00171964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966310|NCT00172003|Zoledronic Acid|zoledronic acid|mesh-list
64966311|NCT00172003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64966312|NCT00172003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966313|NCT00055718|Silymarin|silymarin|mesh-list
64966314|NCT00055718|Antioxidants|antioxidants|mesh-ancestor
64966315|NCT00055718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966316|NCT00055718|Protective Agents|protective agents|mesh-ancestor
64654059|NCT03983993|Panitumumab|panitumumab|mesh-list
64966334|NCT00399867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966336|NCT00399867|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64966337|NCT00399867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966338|NCT00055835|Gemcitabine|gemcitabine|mesh-list
64966339|NCT00055835|Paclitaxel|paclitaxel|mesh-list
64966340|NCT00055835|Carboplatin|carboplatin|mesh-list
64966341|NCT00055835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64966342|NCT00055835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966343|NCT00055835|Tubulin Modulators|tubulin modulators|mesh-ancestor
64966344|NCT00055835|Antimitotic Agents|antimitotic agents|mesh-ancestor
64966345|NCT00055835|Mitosis Modulators|mitosis modulators|mesh-ancestor
64966346|NCT00055835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966347|NCT00055835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64966348|NCT00055835|Antimetabolites|antimetabolites|mesh-ancestor
64535984|NCT03754725|Chelating Agents|chelating agents|mesh-ancestor
64535985|NCT03754725|Sequestering Agents|sequestering agents|mesh-ancestor
64535986|NCT03754725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535987|NCT00474123|Simvastatin|simvastatin|mesh-list
64535988|NCT00474123|Ezetimibe|ezetimibe|mesh-list
64535989|NCT00474123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64535990|NCT00474123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64535991|NCT00474123|Antimetabolites|antimetabolites|mesh-ancestor
64535992|NCT00474123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64535993|NCT00474123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64535994|NCT00474123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64535995|NCT00474123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64535996|NCT00474201|Ritonavir|ritonavir|mesh-list
64535997|NCT00474201|Lopinavir|lopinavir|mesh-list
64535998|NCT00474201|Gemfibrozil|gemfibrozil|mesh-list
64535999|NCT00474201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64536000|NCT00474201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64536001|NCT00474201|Protease Inhibitors|protease inhibitors|mesh-ancestor
64536002|NCT00474201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536003|NCT00474201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536004|NCT00474201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64536005|NCT00474201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64536006|NCT00474201|Antiviral Agents|antiviral agents|mesh-ancestor
64536007|NCT00474201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64536008|NCT00474201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64536009|NCT00474201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64536010|NCT00474201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64536011|NCT00474201|Antimetabolites|antimetabolites|mesh-ancestor
64536030|NCT00549783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64536031|NCT00475215|Rocuronium|rocuronium|mesh-list
64536032|NCT00475215|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64536033|NCT00475215|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64536034|NCT00475215|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64536035|NCT00475215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64536036|NCT00475215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536037|NCT02733159|Pembrolizumab|pembrolizumab|mesh-list
64536038|NCT02733159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64536039|NCT02733159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536040|NCT00477087|Molgramostim|molgramostim|mesh-list
64536041|NCT00477087|Mitoxantrone|mitoxantrone|mesh-list
64536042|NCT00477087|Sargramostim|sargramostim|mesh-list
64536043|NCT00477087|Immunologic Factors|immunologic factors|mesh-ancestor
64536044|NCT00477087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536045|NCT00477087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536046|NCT00477087|Analgesics|analgesics|mesh-ancestor
64536047|NCT00477087|Sensory System Agents|sensory system agents|mesh-ancestor
64536048|NCT00477087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64536049|NCT00477087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64536050|NCT00477087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64536051|NCT00477087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300683|NCT04434404|Protective Agents|protective agents|mesh-ancestor
64966349|NCT00055835|Antiviral Agents|antiviral agents|mesh-ancestor
64966350|NCT00055835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64966351|NCT00055835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966352|NCT00055835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64966353|NCT00055835|Immunologic Factors|immunologic factors|mesh-ancestor
64966354|NCT00055835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966355|NCT00172354|Hydrocortisone|hydrocortisone|mesh-list
64966356|NCT00172354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64966357|NCT00055874|Interferons|interferons|mesh-list
64966358|NCT00055874|Cytarabine|cytarabine|mesh-list
64966359|NCT00055874|Interferon-alpha|interferon-alpha|mesh-list
64966360|NCT00055874|Imatinib Mesylate|imatinib mesylate|mesh-list
64966361|NCT00055874|Hydroxyurea|hydroxyurea|mesh-list
64966362|NCT00055874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966363|NCT00055874|Antiviral Agents|antiviral agents|mesh-ancestor
64966364|NCT00055874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64966365|NCT00055874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64966366|NCT00055874|Antimetabolites|antimetabolites|mesh-ancestor
64966367|NCT00055874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966368|NCT00055874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64966369|NCT00055874|Immunologic Factors|immunologic factors|mesh-ancestor
64966370|NCT00055874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966371|NCT00055874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64966372|NCT00055874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966373|NCT00055874|Antisickling Agents|antisickling agents|mesh-ancestor
64966374|NCT00055874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64966391|NCT04732845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966392|NCT04732845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966393|NCT04732845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64536052|NCT00477087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536053|NCT01473589|Vitamin D|vitamin d|mesh-list
64536054|NCT01473589|Teriparatide|teriparatide|mesh-list
64536055|NCT01473589|Calcium|calcium|mesh-list
64536056|NCT01473589|Vitamins|vitamins|mesh-ancestor
64536057|NCT01473589|Micronutrients|micronutrients|mesh-ancestor
64536058|NCT01473589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536059|NCT01473589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64536060|NCT01473589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64536061|NCT00478335|Calcitonin|calcitonin|mesh-list
64536062|NCT00478335|Salmon calcitonin|salmon calcitonin|mesh-list
64536063|NCT00478335|Indomethacin|indomethacin|mesh-list
64536064|NCT00478335|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64536065|NCT00478335|Amiloride|amiloride|mesh-list
64536066|NCT00478335|Sildenafil Citrate|sildenafil citrate|mesh-list
64300719|NCT03553537|Prednisone|prednisone|mesh-list
64966394|NCT00055913|Bevacizumab|bevacizumab|mesh-list
64966395|NCT00055913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64966396|NCT00055913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64966398|NCT00055913|Immunoglobulins|immunoglobulins|mesh-list
64966399|NCT00055913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64966400|NCT00055913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966401|NCT00055913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64966402|NCT00055913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64966403|NCT00055913|Growth Substances|growth substances|mesh-ancestor
64966404|NCT00055913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966405|NCT00055913|Growth Inhibitors|growth inhibitors|mesh-ancestor
64966406|NCT00055913|Immunologic Factors|immunologic factors|mesh-ancestor
64966407|NCT00055913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64966408|NCT00055913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966409|NCT00055913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966410|NCT00045864|Aldesleukin|aldesleukin|mesh-list
64966411|NCT00045864|Rituximab|rituximab|mesh-list
64966412|NCT00045864|Interleukin-2|interleukin-2|mesh-list
64966413|NCT00045864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64966414|NCT00045864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966415|NCT00045864|Immunologic Factors|immunologic factors|mesh-ancestor
64966416|NCT00045864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966418|NCT00045864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64966419|NCT00045864|Analgesics|analgesics|mesh-ancestor
64966420|NCT00045864|Sensory System Agents|sensory system agents|mesh-ancestor
64966421|NCT00045864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64966422|NCT00045864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64966423|NCT00045864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64966424|NCT00045864|Antiviral Agents|antiviral agents|mesh-ancestor
64966425|NCT00045864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64966426|NCT00055952|Exatecan|exatecan|mesh-list
64966427|NCT00055952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64966428|NCT00055952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64966429|NCT00055952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966430|NCT00055952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966431|NCT00055952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966432|NCT00055991|Bexarotene|bexarotene|mesh-list
64966433|NCT00055991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966459|NCT00056030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64966460|NCT00056030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966461|NCT00056030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64966462|NCT00056030|Immunologic Factors|immunologic factors|mesh-ancestor
64966463|NCT00056030|Antidotes|antidotes|mesh-ancestor
64966464|NCT00056030|Protective Agents|protective agents|mesh-ancestor
64966465|NCT00056030|Vitamin B Complex|vitamin b complex|mesh-ancestor
64966466|NCT00056030|Vitamins|vitamins|mesh-ancestor
64966467|NCT00056030|Micronutrients|micronutrients|mesh-ancestor
64536067|NCT00478335|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
64536068|NCT00478335|Katacalcin|katacalcin|mesh-list
64536069|NCT00478335|Vasodilator Agents|vasodilator agents|mesh-ancestor
64536070|NCT00478335|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64536071|NCT00478335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64536072|NCT00478335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536073|NCT00478335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536075|NCT00478335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64536076|NCT00478335|Diuretics|diuretics|mesh-ancestor
64536077|NCT00478335|Natriuretic Agents|natriuretic agents|mesh-ancestor
64536078|NCT00478335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536079|NCT00478335|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64536080|NCT00478335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64536081|NCT00478335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64536082|NCT00478335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64536083|NCT00478335|Analgesics|analgesics|mesh-ancestor
64536084|NCT00478335|Sensory System Agents|sensory system agents|mesh-ancestor
64536085|NCT00478335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64536086|NCT00478335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64536087|NCT00478335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64536088|NCT00478335|Gout Suppressants|gout suppressants|mesh-ancestor
64536089|NCT00478335|Tocolytic Agents|tocolytic agents|mesh-ancestor
64536090|NCT00478335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64536091|NCT00478335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64536092|NCT00478335|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
64536093|NCT00478335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64300721|NCT03553537|Doxorubicin|doxorubicin|mesh-list
64966468|NCT00056030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64966469|NCT00046020|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64966470|NCT00046020|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64966471|NCT00046020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64966472|NCT00046020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64966473|NCT00046020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966474|NCT00046020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64966475|NCT00046020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966476|NCT00046020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64966477|NCT00046020|Antidepressive Agents|antidepressive agents|mesh-ancestor
64966478|NCT00046020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64966480|NCT00173875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966481|NCT00173875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64966482|NCT00173875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966483|NCT00173875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966484|NCT04605081|Naltrexone|naltrexone|mesh-list
64536094|NCT00478335|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64536095|NCT00478335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64536096|NCT00478335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64536097|NCT00478335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64536098|NCT00478569|Hormones|hormones|mesh-list
64536099|NCT00478569|Parathyroid Hormone|parathyroid hormone|mesh-list
64536100|NCT00478569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64536101|NCT00478569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541049|NCT00695409|Antimetabolites|antimetabolites|mesh-ancestor
64536102|NCT00478569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64536103|NCT00479037|Strontium ranelate|strontium ranelate|mesh-list
64536104|NCT00479037|Hormones|hormones|mesh-list
64536105|NCT00479037|Parathyroid Hormone|parathyroid hormone|mesh-list
64536106|NCT00479037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64536107|NCT00479037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536108|NCT00479037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64536109|NCT00479037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64536110|NCT02985229|Misoprostol|misoprostol|mesh-list
64536111|NCT02985229|Mifepristone|mifepristone|mesh-list
64536112|NCT02985229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64536113|NCT02985229|Abortifacient Agents|abortifacient agents|mesh-ancestor
64536114|NCT02985229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64536115|NCT02985229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536116|NCT02985229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64536117|NCT02985229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64536118|NCT02985229|Oxytocics|oxytocics|mesh-ancestor
64536119|NCT02985229|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64536120|NCT02985229|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64536121|NCT02985229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64536137|NCT01472965|Heparin|heparin|mesh-list
64536138|NCT01472965|Calcium heparin|calcium heparin|mesh-list
64536139|NCT01472965|Anticoagulants|anticoagulants|mesh-ancestor
64536140|NCT01472965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64536141|NCT01472965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64536142|NCT01472965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536143|NCT01472965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64536144|NCT01472965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64536145|NCT01472965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64536146|NCT01472965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536148|NCT00480987|Oxaliplatin|oxaliplatin|mesh-list
64536149|NCT00480987|Fludarabine|fludarabine|mesh-list
64536150|NCT00480987|Fludarabine phosphate|fludarabine phosphate|mesh-list
64536151|NCT00480987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536152|NCT00480987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64536153|NCT00480987|Antimetabolites|antimetabolites|mesh-ancestor
64536154|NCT00480987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536155|NCT00480987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64536156|NCT00480987|Immunologic Factors|immunologic factors|mesh-ancestor
64536157|NCT00480987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536159|NCT00480987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64536160|NCT01457053|Torsemide|torsemide|mesh-list
64536161|NCT01457053|Furosemide|furosemide|mesh-list
64536162|NCT01457053|Bumetanide|bumetanide|mesh-list
64536186|NCT04082767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64536187|NCT04082767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64536188|NCT04082767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64536189|NCT04082767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64536190|NCT04082767|Anesthetics, General|anesthetics, general|mesh-ancestor
64536191|NCT04082767|Anesthetics|anesthetics|mesh-ancestor
64536192|NCT04082767|GABA Modulators|gaba modulators|mesh-ancestor
64536193|NCT04082767|GABA Agents|gaba agents|mesh-ancestor
64536194|NCT00481845|Anastrozole|anastrozole|mesh-list
64536195|NCT00481845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64536196|NCT00481845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536197|NCT00481845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64536198|NCT00481845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64536199|NCT00481845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536200|NCT00481845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536201|NCT00481845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64536202|NCT00481845|Hormone Antagonists|hormone antagonists|mesh-ancestor
64536203|NCT00481845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64541066|NCT05087706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536204|NCT00481845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536206|NCT01472185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64536207|NCT01472185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64536208|NCT01472185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536209|NCT00482625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64536210|NCT00482625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536211|NCT00482625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64536212|NCT00482625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536213|NCT00482625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536214|NCT00553839|Ketamine|ketamine|mesh-list
64536215|NCT00553839|Analgesics|analgesics|mesh-ancestor
64536216|NCT00553839|Sensory System Agents|sensory system agents|mesh-ancestor
64536217|NCT00553839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64966485|NCT04605081|Bupropion|bupropion|mesh-list
64536227|NCT00553839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536229|NCT00554463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536230|NCT00554463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64536231|NCT00554463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64536232|NCT00554463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64536233|NCT00554463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536234|NCT00554463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536235|NCT04082533|Hydrocortisone|hydrocortisone|mesh-list
64536236|NCT04082533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64536237|NCT00554853|Pioglitazone|pioglitazone|mesh-list
64536238|NCT00554853|Nitroglycerin|nitroglycerin|mesh-list
64536239|NCT00554853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64536240|NCT00554853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536241|NCT00554853|Vasodilator Agents|vasodilator agents|mesh-ancestor
64536242|NCT00556491|Minocycline|minocycline|mesh-list
64536243|NCT00556491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64536244|NCT00556491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64536245|NCT02685969|Flutemetamol|flutemetamol|mesh-list
64536246|NCT02685969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64300888|NCT02122939|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64966486|NCT04605081|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64966487|NCT04605081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64966488|NCT04605081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966489|NCT04605081|Sensory System Agents|sensory system agents|mesh-ancestor
64966515|NCT00174226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64505181|NCT01711918|Antiemetics|antiemetics|mesh-ancestor
64966516|NCT00174226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64966517|NCT00174226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966518|NCT00174226|Adrenergic Agents|adrenergic agents|mesh-ancestor
64966519|NCT00174226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64966520|NCT00174226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966521|NCT00174226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64966522|NCT00174226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64966523|NCT00174226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64966524|NCT00174226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64966525|NCT00174226|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64966526|NCT00174226|Serotonin Agents|serotonin agents|mesh-ancestor
64966527|NCT00174304|Amlodipine|amlodipine|mesh-list
64966528|NCT00174304|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
64966529|NCT00174304|Atorvastatin|atorvastatin|mesh-list
64966530|NCT00174304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64966531|NCT00174304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64966532|NCT00174304|Antimetabolites|antimetabolites|mesh-ancestor
64966546|NCT00174343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64966548|NCT00174343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966549|NCT00174343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64966550|NCT00174343|Hormone Antagonists|hormone antagonists|mesh-ancestor
64966551|NCT00174343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64966552|NCT00174343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966553|NCT00174499|Nicotine|nicotine|mesh-list
64966554|NCT00174499|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64966555|NCT00174499|Autonomic Agents|autonomic agents|mesh-ancestor
64536247|NCT02685969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536248|NCT00483561|Etoposide|etoposide|mesh-list
64536249|NCT00483561|Gefitinib|gefitinib|mesh-list
64536250|NCT00483561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64536251|NCT00483561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536252|NCT00483561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64536253|NCT00483561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64536254|NCT00483561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536255|NCT00483561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536256|NCT00483561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64536257|NCT00485433|Epinephrine|epinephrine|mesh-list
64536258|NCT00485433|Bupivacaine|bupivacaine|mesh-list
64536259|NCT00485433|Anesthetics, Local|anesthetics, local|mesh-ancestor
64536260|NCT00485433|Anesthetics|anesthetics|mesh-ancestor
64536261|NCT00485433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64536262|NCT00485433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536263|NCT00485433|Sensory System Agents|sensory system agents|mesh-ancestor
64536264|NCT00485433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64536265|NCT00485433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64536266|NCT00485433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64536267|NCT00485433|Adrenergic Agents|adrenergic agents|mesh-ancestor
64536268|NCT00485433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64536269|NCT00485433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536270|NCT00485433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64536271|NCT00485433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64536272|NCT00485433|Autonomic Agents|autonomic agents|mesh-ancestor
64536273|NCT00485433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64536274|NCT00485433|Respiratory System Agents|respiratory system agents|mesh-ancestor
64536275|NCT00485433|Mydriatics|mydriatics|mesh-ancestor
64536276|NCT00485433|Sympathomimetics|sympathomimetics|mesh-ancestor
64966556|NCT00174499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64966557|NCT00174499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966558|NCT00174499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64966559|NCT00174499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64966560|NCT00174499|Cholinergic Agents|cholinergic agents|mesh-ancestor
64966561|NCT00174499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64966562|NCT00174499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966563|NCT00174538|Codeine|codeine|mesh-list
64966564|NCT00174538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64966565|NCT00174538|Narcotics|narcotics|mesh-ancestor
64966566|NCT00174538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64966567|NCT00174538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966568|NCT00174538|Analgesics|analgesics|mesh-ancestor
64536277|NCT00485433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64536278|NCT02850081|Atorvastatin|atorvastatin|mesh-list
64536279|NCT02850081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
64536280|NCT02850081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64536281|NCT02850081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64536282|NCT02850081|Antimetabolites|antimetabolites|mesh-ancestor
64536283|NCT02850081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536284|NCT02850081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64536285|NCT02850081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966569|NCT00174538|Sensory System Agents|sensory system agents|mesh-ancestor
64966570|NCT00174538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64966571|NCT00174538|Antitussive Agents|antitussive agents|mesh-ancestor
64966572|NCT00174538|Respiratory System Agents|respiratory system agents|mesh-ancestor
64966573|NCT00174577|Risperidone|risperidone|mesh-list
64966574|NCT00174577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64966575|NCT00174577|Serotonin Agents|serotonin agents|mesh-ancestor
64966576|NCT00174577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64966577|NCT00174577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966578|NCT00174577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966579|NCT00174577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64966580|NCT00174577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64966581|NCT00174577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64966582|NCT00174577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64966583|NCT00174577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64966584|NCT00174577|Dopamine Agents|dopamine agents|mesh-ancestor
64966585|NCT00046137|Teriparatide|teriparatide|mesh-list
64966586|NCT00046137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64966587|NCT00046137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64966588|NCT00046137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966589|NCT00046137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64966617|NCT00174655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64966618|NCT00174655|Alkylating Agents|alkylating agents|mesh-ancestor
64966619|NCT00174655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966620|NCT00174655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966621|NCT00174655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64966622|NCT00174655|Tubulin Modulators|tubulin modulators|mesh-ancestor
64966623|NCT00174655|Antimitotic Agents|antimitotic agents|mesh-ancestor
64966624|NCT00174655|Mitosis Modulators|mitosis modulators|mesh-ancestor
64966625|NCT00174655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64966626|NCT00174655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64966627|NCT00174655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64966628|NCT00174655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966629|NCT00174694|Telithromycin|telithromycin|mesh-list
64966630|NCT00174694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64966631|NCT00174694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64966632|NCT00174733|Ciclesonide|ciclesonide|mesh-list
64966633|NCT00174733|Glucocorticoids|glucocorticoids|mesh-ancestor
64966634|NCT00174733|Hormones|hormones|mesh-ancestor
64966635|NCT00174733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64966636|NCT00174733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966637|NCT00174733|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64966638|NCT00056264|Infliximab|infliximab|mesh-list
64966639|NCT00056264|Dermatologic Agents|dermatologic agents|mesh-ancestor
64966661|NCT02963779|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64966662|NCT02963779|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64966663|NCT02963779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966664|NCT02963779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966665|NCT00046176|Lamivudine|lamivudine|mesh-list
64966666|NCT00046176|Abacavir|abacavir|mesh-list
64966667|NCT00046176|Dideoxynucleosides|dideoxynucleosides|mesh-list
64966668|NCT00046176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64966669|NCT00046176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64966670|NCT00046176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536287|NCT01456039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64536288|NCT01456039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536289|NCT01455415|Pregabalin|pregabalin|mesh-list
64536290|NCT01455415|Analgesics|analgesics|mesh-ancestor
64536291|NCT01455415|Sensory System Agents|sensory system agents|mesh-ancestor
64536292|NCT01455415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64536293|NCT01455415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536294|NCT01455415|Anticonvulsants|anticonvulsants|mesh-ancestor
64536295|NCT01455415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64536296|NCT01455415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64536297|NCT01455415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536298|NCT01455415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64536299|NCT01455415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64536300|NCT01455415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64536301|NCT01455415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64536302|NCT01455415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64536303|NCT01471171|Bromides|bromides|mesh-list
64536304|NCT01471171|Anticonvulsants|anticonvulsants|mesh-ancestor
64536306|NCT01471093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64536307|NCT01471093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64300953|NCT02121613|Saw palmetto extract|saw palmetto extract|mesh-list
64966671|NCT00046176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966672|NCT00046176|Antiviral Agents|antiviral agents|mesh-ancestor
64966675|NCT00046176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64966676|NCT00046176|Antimetabolites|antimetabolites|mesh-ancestor
64966677|NCT00174928|Lansoprazole|lansoprazole|mesh-list
64966678|NCT00174928|Dexlansoprazole|dexlansoprazole|mesh-list
64966679|NCT00174928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64966680|NCT00174928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64966681|NCT00174928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64966682|NCT00174928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966683|NCT00174928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966684|NCT00175045|Lansoprazole|lansoprazole|mesh-list
64966685|NCT00175045|Dexlansoprazole|dexlansoprazole|mesh-list
64966686|NCT00175045|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64966687|NCT00175045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64966688|NCT00175045|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64966689|NCT00175045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966690|NCT00175045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966691|NCT00056381|Anidulafungin|anidulafungin|mesh-list
64966692|NCT00056381|Antifungal Agents|antifungal agents|mesh-ancestor
64966693|NCT00056381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64966728|NCT00175396|Fertility Agents|fertility agents|mesh-ancestor
64966729|NCT00175396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64966730|NCT00175396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966731|NCT00175396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64966732|NCT00175396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966733|NCT00175396|Hormones|hormones|mesh-ancestor
64536308|NCT01471093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64536309|NCT01471093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64536310|NCT01471093|Antioxidants|antioxidants|mesh-ancestor
64536311|NCT01471093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536312|NCT01471093|Protective Agents|protective agents|mesh-ancestor
64536313|NCT01471093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536314|NCT01471093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536315|NCT01471015|Darbepoetin alfa|darbepoetin alfa|mesh-list
64536316|NCT01471015|Hematinics|hematinics|mesh-ancestor
64536317|NCT01470469|Guanfacine|guanfacine|mesh-list
64536318|NCT01470469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64536319|NCT01470469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64536320|NCT01470469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64536321|NCT01470469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64536322|NCT01470469|Adrenergic Agents|adrenergic agents|mesh-ancestor
64536323|NCT01470469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64536324|NCT01470469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300974|NCT02113267|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64300976|NCT03281187|Testosterone|testosterone|mesh-list
64966734|NCT00175396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64966735|NCT00175396|Antioxidants|antioxidants|mesh-ancestor
64966771|NCT00408031|Renal Agents|renal agents|mesh-ancestor
64966772|NCT00408031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64966773|NCT00408031|Antitubercular Agents|antitubercular agents|mesh-ancestor
64966774|NCT00408031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64966775|NCT00408031|Antimetabolites|antimetabolites|mesh-ancestor
64966776|NCT00408031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966793|NCT00056576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64966794|NCT00056576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966795|NCT00056576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64966796|NCT00056576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966798|NCT00175903|Levetiracetam|levetiracetam|mesh-list
64966799|NCT00175903|Valproic Acid|valproic acid|mesh-list
64966800|NCT00175903|Anticonvulsants|anticonvulsants|mesh-ancestor
64966801|NCT00175903|Nootropic Agents|nootropic agents|mesh-ancestor
64966802|NCT00175903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966803|NCT00175903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966804|NCT00175903|GABA Agents|gaba agents|mesh-ancestor
64654128|NCT03702725|Immunologic Factors|immunologic factors|mesh-ancestor
64966805|NCT00175903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64966806|NCT00175903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966808|NCT00175903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64966809|NCT00175903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64966810|NCT00175903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64966811|NCT00175903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64966812|NCT00175903|Analgesics|analgesics|mesh-ancestor
64966813|NCT00175903|Sensory System Agents|sensory system agents|mesh-ancestor
64966814|NCT00175903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64966815|NCT00175903|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64966816|NCT00175903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64966817|NCT00175903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64505482|NCT02492490|Basiliximab|basiliximab|mesh-list
64966818|NCT00175903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64966819|NCT00056654|Leuprolide|leuprolide|mesh-list
64536325|NCT01470469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536326|NCT01470001|Solifenacin Succinate|solifenacin succinate|mesh-list
64536327|NCT01470001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64536328|NCT01470001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64536329|NCT01470001|Cholinergic Agents|cholinergic agents|mesh-ancestor
64536330|NCT01470001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64536331|NCT01470001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536332|NCT01470001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536333|NCT01470001|Urological Agents|urological agents|mesh-ancestor
64536334|NCT01469377|Cariprazine|cariprazine|mesh-list
64536335|NCT01469377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64536336|NCT01469377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64536337|NCT01469377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64536338|NCT01469377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536339|NCT01469377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64536340|NCT01469221|Apaziquone|apaziquone|mesh-list
64536341|NCT01469221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536342|NCT01453855|Travoprost|travoprost|mesh-list
64536343|NCT01453855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64536344|NCT01453855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64536345|NCT01453855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64536346|NCT01469065|Nicotinic Acids|nicotinic acids|mesh-list
64536347|NCT01469065|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
64536348|NCT01469065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536349|NCT01469065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536350|NCT01469065|Vitamin B Complex|vitamin b complex|mesh-ancestor
64536351|NCT01469065|Vitamins|vitamins|mesh-ancestor
64536352|NCT01469065|Micronutrients|micronutrients|mesh-ancestor
64536353|NCT01469065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536354|NCT01586156|Carvedilol|carvedilol|mesh-list
64536355|NCT01586156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64536356|NCT01586156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64536357|NCT01586156|Adrenergic Agents|adrenergic agents|mesh-ancestor
64536358|NCT01586156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64536359|NCT01586156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300993|NCT03291249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64536360|NCT01586156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536361|NCT01586156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64536362|NCT01586156|Antioxidants|antioxidants|mesh-ancestor
64536363|NCT01586156|Protective Agents|protective agents|mesh-ancestor
64536364|NCT01586156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64536365|NCT01586156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64536366|NCT01586156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64536367|NCT01586156|Vasodilator Agents|vasodilator agents|mesh-ancestor
64536368|NCT01586156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64536369|NCT01586156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64536370|NCT01459913|Interferons|interferons|mesh-list
64536372|NCT01459913|Interferon-alpha|interferon-alpha|mesh-list
64536373|NCT01459913|Interferon alpha-2|interferon alpha-2|mesh-list
64536374|NCT01459913|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64536375|NCT01459913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536376|NCT01459913|Antiviral Agents|antiviral agents|mesh-ancestor
64536377|NCT01459913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64536378|NCT01459913|Antimetabolites|antimetabolites|mesh-ancestor
64301031|NCT02122003|Sorafenib|sorafenib|mesh-list
64966820|NCT00056654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64966821|NCT00056654|Fertility Agents|fertility agents|mesh-ancestor
64966822|NCT00056654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64966823|NCT00056654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966824|NCT00056654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64966825|NCT00056654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966826|NCT00175981|Sildenafil Citrate|sildenafil citrate|mesh-list
64966827|NCT00175981|Fluvoxamine|fluvoxamine|mesh-list
64966828|NCT00175981|Vasodilator Agents|vasodilator agents|mesh-ancestor
64966829|NCT00175981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64966830|NCT00175981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64966831|NCT00175981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966832|NCT00175981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966833|NCT00175981|Urological Agents|urological agents|mesh-ancestor
64966834|NCT00175981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64966864|NCT00176020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966865|NCT00176020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64966866|NCT00176020|Antimetabolites|antimetabolites|mesh-ancestor
64966867|NCT00176020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966868|NCT00176020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64966869|NCT00176020|Vasodilator Agents|vasodilator agents|mesh-ancestor
64966870|NCT00176059|Immunoglobulins|immunoglobulins|mesh-list
64966871|NCT00176059|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64966872|NCT00176059|Antibodies|antibodies|mesh-list
64966873|NCT00176059|gamma-Globulins|gamma-globulins|mesh-list
64966874|NCT00176059|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64966875|NCT00176059|Immunologic Factors|immunologic factors|mesh-ancestor
64966876|NCT00176059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966877|NCT00176098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64966878|NCT00176098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64966905|NCT00056693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64966906|NCT00056693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966907|NCT00056693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966908|NCT00176332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64966909|NCT00176332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64966910|NCT00176332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64536379|NCT01459913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536380|NCT01459913|Immunologic Factors|immunologic factors|mesh-ancestor
64536381|NCT01459913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536382|NCT01458587|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64536383|NCT01458587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64536384|NCT01458587|Dermatologic Agents|dermatologic agents|mesh-ancestor
64536385|NCT01458275|Ciclesonide|ciclesonide|mesh-list
64536386|NCT01458275|Glucocorticoids|glucocorticoids|mesh-ancestor
64536388|NCT01458275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64536389|NCT01458275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536390|NCT01458275|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64536391|NCT02334527|Palbociclib|palbociclib|mesh-list
64536392|NCT02334527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654147|NCT05208983|Vaccines|vaccines|mesh-list
64536393|NCT02334527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64536394|NCT02334527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536395|NCT02334527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536396|NCT01688726|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64536397|NCT01688726|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64966911|NCT00176332|Antimetabolites|antimetabolites|mesh-ancestor
64966912|NCT00176332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966913|NCT00176332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64966914|NCT00176332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64966915|NCT00176332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966916|NCT00176449|Bupropion|bupropion|mesh-list
64966917|NCT00176449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64966918|NCT00176449|Antidepressive Agents|antidepressive agents|mesh-ancestor
64966919|NCT00176449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64966920|NCT00176449|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64966921|NCT00176449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64966922|NCT00176449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64966923|NCT00176449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966924|NCT00176449|Dopamine Agents|dopamine agents|mesh-ancestor
64966938|NCT00398450|Antimetabolites|antimetabolites|mesh-ancestor
64966939|NCT00398450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966940|NCT00398450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966941|NCT00398450|Immunologic Factors|immunologic factors|mesh-ancestor
64966942|NCT00398450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966943|NCT00046293|Abciximab|abciximab|mesh-list
64966944|NCT00046293|Anticoagulants|anticoagulants|mesh-ancestor
64966945|NCT00046293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64966946|NCT00176527|Interferons|interferons|mesh-list
64966947|NCT00176527|Interferon-alpha|interferon-alpha|mesh-list
64966948|NCT00176527|Interferon alpha-2|interferon alpha-2|mesh-list
64966949|NCT00176527|Docetaxel|docetaxel|mesh-list
64966950|NCT00176527|Estramustine|estramustine|mesh-list
64966951|NCT00176527|Isotretinoin|isotretinoin|mesh-list
64966952|NCT00176527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966953|NCT00176527|Tubulin Modulators|tubulin modulators|mesh-ancestor
64966954|NCT00176527|Antimitotic Agents|antimitotic agents|mesh-ancestor
64966955|NCT00176527|Mitosis Modulators|mitosis modulators|mesh-ancestor
64966956|NCT00176527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966957|NCT00176527|Antiviral Agents|antiviral agents|mesh-ancestor
64966958|NCT00176527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64536398|NCT01457339|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64536399|NCT01457339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64536400|NCT01457339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536401|NCT01457339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64536402|NCT01457339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64536403|NCT01457339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64536404|NCT01457339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536405|NCT01457339|Dopamine Agents|dopamine agents|mesh-ancestor
64536406|NCT01457339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64966959|NCT00176527|Immunologic Factors|immunologic factors|mesh-ancestor
64966960|NCT00176527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966961|NCT00176527|Dermatologic Agents|dermatologic agents|mesh-ancestor
64966962|NCT00176527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64966963|NCT00176527|Alkylating Agents|alkylating agents|mesh-ancestor
64966964|NCT00176527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64966965|NCT00398489|Tamoxifen|tamoxifen|mesh-list
64505629|NCT03332316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64966967|NCT00398489|Docetaxel|docetaxel|mesh-list
64966968|NCT00398489|Trastuzumab|trastuzumab|mesh-list
64966969|NCT00398489|Epirubicin|epirubicin|mesh-list
64966970|NCT00398489|Anastrozole|anastrozole|mesh-list
64966971|NCT00398489|Goserelin|goserelin|mesh-list
64966972|NCT00398489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64966973|NCT00398489|Immunologic Factors|immunologic factors|mesh-ancestor
64966974|NCT00398489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966975|NCT00398489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64966976|NCT00398489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64966977|NCT00398489|Alkylating Agents|alkylating agents|mesh-ancestor
64966978|NCT00398489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966979|NCT00398489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966980|NCT00398489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64966981|NCT00398489|Tubulin Modulators|tubulin modulators|mesh-ancestor
64966982|NCT00398489|Antimitotic Agents|antimitotic agents|mesh-ancestor
64966983|NCT00398489|Mitosis Modulators|mitosis modulators|mesh-ancestor
64966984|NCT00398489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64966985|NCT00398489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64966986|NCT00398489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64966987|NCT00398489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64966988|NCT00398489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967009|NCT00176995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64967010|NCT00176995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64967011|NCT00176995|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64967012|NCT00176995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967013|NCT00176995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967014|NCT00423527|Levetiracetam|levetiracetam|mesh-list
64967015|NCT00423527|Anticonvulsants|anticonvulsants|mesh-ancestor
64967016|NCT00423527|Nootropic Agents|nootropic agents|mesh-ancestor
64967018|NCT00408148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64967019|NCT00408148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
64967020|NCT00408148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64967021|NCT00408148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64967022|NCT00408148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967023|NCT00408148|Hormones|hormones|mesh-ancestor
64967024|NCT00408148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64967025|NCT00408148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967026|NCT00397566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
64967027|NCT00397566|BMS-707035|bms-707035|mesh-list
64967028|NCT00397566|Integrase Inhibitors|integrase inhibitors|mesh-list
64967029|NCT00397566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967030|NCT00397566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967031|NCT00397566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64967032|NCT00397566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64967033|NCT00397566|Antiviral Agents|antiviral agents|mesh-ancestor
64536407|NCT01456169|Chlorthalidone|chlorthalidone|mesh-list
64536408|NCT01456169|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
64536409|NCT01456169|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64536410|NCT01456169|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64536411|NCT01456169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536412|NCT01456169|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64536413|NCT01456169|Diuretics|diuretics|mesh-ancestor
64536414|NCT01456169|Natriuretic Agents|natriuretic agents|mesh-ancestor
64536415|NCT01456169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536416|NCT01456169|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64536417|NCT01456169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64536419|NCT01453595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536420|NCT01585298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64536421|NCT01585298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64536422|NCT01585298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536423|NCT01585298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64536424|NCT01585298|Immunologic Factors|immunologic factors|mesh-ancestor
64536425|NCT01585298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536426|NCT04124198|Nimorazole|nimorazole|mesh-list
64536427|NCT04124198|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64536428|NCT04124198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64536429|NCT04124198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64536430|NCT04124198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64536431|NCT01453205|Rituximab|rituximab|mesh-list
64654171|NCT04371146|Reboxetine|reboxetine|mesh-list
64536433|NCT01453205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536434|NCT01453205|Immunologic Factors|immunologic factors|mesh-ancestor
64967034|NCT00397566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64967035|NCT00177424|Sertraline|sertraline|mesh-list
64967036|NCT00177424|Antidepressive Agents|antidepressive agents|mesh-ancestor
64967037|NCT00177424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64505705|NCT01730872|Autonomic Agents|autonomic agents|mesh-ancestor
64967038|NCT00177424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64505710|NCT02491086|Nicotine|nicotine|mesh-list
64967039|NCT00177424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64967070|NCT00177853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64967071|NCT00177853|Analgesics|analgesics|mesh-ancestor
64967072|NCT00177853|Sensory System Agents|sensory system agents|mesh-ancestor
64967073|NCT00177853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64967074|NCT00177853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967075|NCT00177853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64967076|NCT00177853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64967077|NCT00177853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64967078|NCT00177853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64536435|NCT01453205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536436|NCT01453205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64536438|NCT01453049|Rosiglitazone|rosiglitazone|mesh-list
64536439|NCT01453049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64536440|NCT01453049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64536441|NCT01453049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536442|NCT01453049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64536443|NCT01453049|Immunologic Factors|immunologic factors|mesh-ancestor
64536444|NCT01452347|Warfarin|warfarin|mesh-list
64536445|NCT01452347|Dabigatran|dabigatran|mesh-list
64536446|NCT01452347|Anticoagulants|anticoagulants|mesh-ancestor
64536447|NCT01452347|Antithrombins|antithrombins|mesh-ancestor
64536448|NCT01452347|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64536449|NCT01452347|Protease Inhibitors|protease inhibitors|mesh-ancestor
64536450|NCT01452347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536451|NCT01452347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536452|NCT01451723|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
64967080|NCT00178048|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64967081|NCT00178048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64967112|NCT00178828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967113|NCT00178828|Dopamine Agents|dopamine agents|mesh-ancestor
64967114|NCT00178828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64967115|NCT00178828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967116|NCT00178828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64967117|NCT00178828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64967118|NCT00178828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967119|NCT00178828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64967120|NCT00178828|Serotonin Agents|serotonin agents|mesh-ancestor
64967122|NCT00408187|Cyclosporins|cyclosporins|mesh-list
64967145|NCT00178945|Botulinum Toxins|botulinum toxins|mesh-list
64967146|NCT00178945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64967147|NCT00178945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64967148|NCT00178945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64967149|NCT00178945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64967150|NCT00178945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967151|NCT00178945|Cholinergic Agents|cholinergic agents|mesh-ancestor
64967152|NCT00178945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64967153|NCT00178945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967154|NCT00178945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64967155|NCT00178945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64967156|NCT00397722|Paroxetine|paroxetine|mesh-list
64967157|NCT00397722|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64967158|NCT00397722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64967159|NCT00397722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64967160|NCT00397722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967161|NCT00397722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64967162|NCT00397722|Serotonin Agents|serotonin agents|mesh-ancestor
64967163|NCT00397722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967164|NCT00397722|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64967165|NCT00397722|Antidepressive Agents|antidepressive agents|mesh-ancestor
64967166|NCT00397722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64967167|NCT00397722|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64967168|NCT00397722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64536453|NCT01451723|Antioxidants|antioxidants|mesh-ancestor
64536454|NCT01451723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536455|NCT01451723|Protective Agents|protective agents|mesh-ancestor
64536456|NCT01451723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536457|NCT01451723|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64536458|NCT01451723|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64536459|NCT01451723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536460|NCT01451723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64536461|NCT01451645|Colchicine|colchicine|mesh-list
64536462|NCT01451645|Allopurinol|allopurinol|mesh-list
64536463|NCT01451645|Gout Suppressants|gout suppressants|mesh-ancestor
64536464|NCT01451645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64536465|NCT01451645|Tubulin Modulators|tubulin modulators|mesh-ancestor
64536466|NCT01451645|Antimitotic Agents|antimitotic agents|mesh-ancestor
64536467|NCT01451645|Mitosis Modulators|mitosis modulators|mesh-ancestor
64536468|NCT01451645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536469|NCT01451645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536470|NCT01451645|Antimetabolites|antimetabolites|mesh-ancestor
64536471|NCT01451645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536472|NCT01451645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64536473|NCT01451645|Antioxidants|antioxidants|mesh-ancestor
64536474|NCT01451645|Protective Agents|protective agents|mesh-ancestor
64536475|NCT01451645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536476|NCT01450007|Dexamethasone|dexamethasone|mesh-list
64536477|NCT01450007|Dexamethasone acetate|dexamethasone acetate|mesh-list
64536478|NCT01450007|Ropivacaine|ropivacaine|mesh-list
64536479|NCT01450007|BB 1101|bb 1101|mesh-list
64536480|NCT01450007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64536481|NCT01450007|Antiemetics|antiemetics|mesh-ancestor
64536482|NCT01450007|Autonomic Agents|autonomic agents|mesh-ancestor
64536483|NCT01450007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301127|NCT02122393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967169|NCT00397722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967170|NCT00179023|Trimethaphan|trimethaphan|mesh-list
64967171|NCT00179023|Pseudoephedrine|pseudoephedrine|mesh-list
64967172|NCT00179023|Ephedrine|ephedrine|mesh-list
64967184|NCT00179023|Adrenergic Agents|adrenergic agents|mesh-ancestor
64967185|NCT00179023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64967186|NCT00179023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967187|NCT00179023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64967188|NCT00179023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64967189|NCT00179023|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
64967190|NCT00179023|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64967191|NCT00179023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64967192|NCT00179023|Cholinergic Agents|cholinergic agents|mesh-ancestor
64536484|NCT01450007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536485|NCT01450007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64536486|NCT01450007|Glucocorticoids|glucocorticoids|mesh-ancestor
64536487|NCT01450007|Hormones|hormones|mesh-ancestor
64541198|NCT02339415|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64536488|NCT01450007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64536489|NCT01450007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64536490|NCT01450007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536491|NCT01450007|Protease Inhibitors|protease inhibitors|mesh-ancestor
64536492|NCT01450007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536493|NCT01450007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536494|NCT01450007|Anesthetics, Local|anesthetics, local|mesh-ancestor
64536495|NCT01450007|Anesthetics|anesthetics|mesh-ancestor
64536496|NCT01450007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64536497|NCT01450007|Sensory System Agents|sensory system agents|mesh-ancestor
64536498|NCT01496365|Pregabalin|pregabalin|mesh-list
64536499|NCT01496365|Analgesics|analgesics|mesh-ancestor
64536500|NCT01496365|Sensory System Agents|sensory system agents|mesh-ancestor
64536501|NCT01496365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64536502|NCT01496365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536503|NCT01496365|Anticonvulsants|anticonvulsants|mesh-ancestor
64536504|NCT01496365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64536505|NCT01496365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64536506|NCT01496365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536507|NCT01496365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64536508|NCT01496365|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64536509|NCT01496365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64536510|NCT01496365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64536511|NCT01496365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64536512|NCT01468987|Insulin|insulin|mesh-list
64536513|NCT01468987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64536514|NCT01468987|Insulin Glargine|insulin glargine|mesh-list
64536515|NCT01468987|Insulin Lispro|insulin lispro|mesh-list
64536516|NCT01468987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64536517|NCT01468987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536518|NCT01687712|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64301158|NCT02788357|Adrenergic Agents|adrenergic agents|mesh-ancestor
64967193|NCT00179023|Vasodilator Agents|vasodilator agents|mesh-ancestor
64536520|NCT01687712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64536521|NCT01687712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536522|NCT01603628|Botulinum Toxins|botulinum toxins|mesh-list
64536523|NCT01603628|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64536524|NCT01603628|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64536525|NCT01603628|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64536526|NCT01603628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64536527|NCT01603628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536529|NCT01603628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64536530|NCT01603628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536531|NCT01603628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64536532|NCT01603628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64536533|NCT01453153|Gemcitabine|gemcitabine|mesh-list
64536534|NCT01453153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64536535|NCT01453153|Antimetabolites|antimetabolites|mesh-ancestor
64536536|NCT01453153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536537|NCT01453153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536538|NCT01453153|Antiviral Agents|antiviral agents|mesh-ancestor
64536539|NCT01453153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64536540|NCT01453153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536541|NCT01453153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64536542|NCT01453153|Immunologic Factors|immunologic factors|mesh-ancestor
64536543|NCT01453153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536544|NCT01584440|Quinidine|quinidine|mesh-list
64536545|NCT01584440|Dextromethorphan|dextromethorphan|mesh-list
64536546|NCT01584440|Antitussive Agents|antitussive agents|mesh-ancestor
64536547|NCT01584440|Respiratory System Agents|respiratory system agents|mesh-ancestor
64536548|NCT01584440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64536549|NCT01584440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64536550|NCT01584440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64536562|NCT01584440|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64536563|NCT01584440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64536564|NCT01584440|Cholinergic Agents|cholinergic agents|mesh-ancestor
64536565|NCT01584440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64536566|NCT01584440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64536567|NCT01584440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64536568|NCT01584440|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64536569|NCT01584440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64536570|NCT01687478|Olanzapine|olanzapine|mesh-list
64536571|NCT01687478|Fluoxetine|fluoxetine|mesh-list
64536572|NCT01687478|Antiemetics|antiemetics|mesh-ancestor
64536573|NCT01687478|Autonomic Agents|autonomic agents|mesh-ancestor
64536574|NCT01687478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64536575|NCT01687478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536576|NCT01687478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64536577|NCT01687478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64536578|NCT01687478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64536579|NCT01687478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64536580|NCT01687478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64536581|NCT01687478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64536582|NCT01687478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64536583|NCT01687478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64536584|NCT01687478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536585|NCT01687478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64967194|NCT00057005|Cyclophosphamide|cyclophosphamide|mesh-list
64967195|NCT00057005|Alemtuzumab|alemtuzumab|mesh-list
64967196|NCT00057005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64967197|NCT00057005|Immunologic Factors|immunologic factors|mesh-ancestor
64967198|NCT00057005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967199|NCT00057005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64967200|NCT00057005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64967201|NCT00057005|Alkylating Agents|alkylating agents|mesh-ancestor
64967202|NCT00057005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967203|NCT00057005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967204|NCT00057005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64967205|NCT00057005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64967206|NCT00179062|Olanzapine|olanzapine|mesh-list
64967207|NCT00179062|Risperidone|risperidone|mesh-list
64967208|NCT00179062|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64967209|NCT00179062|Serotonin Agents|serotonin agents|mesh-ancestor
64967210|NCT00179062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64967211|NCT00179062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967212|NCT00179062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967213|NCT00179062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64967214|NCT00179062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64967215|NCT00179062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64967216|NCT00179062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64967217|NCT00179062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64536586|NCT01687478|Serotonin Agents|serotonin agents|mesh-ancestor
64536587|NCT01687478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64536588|NCT01687478|Antidepressive Agents|antidepressive agents|mesh-ancestor
64536590|NCT01687478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64536591|NCT01687478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536592|NCT01468909|Paclitaxel|paclitaxel|mesh-list
64536593|NCT01468909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64536594|NCT01468909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64536595|NCT01468909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536596|NCT01468909|Tubulin Modulators|tubulin modulators|mesh-ancestor
64536597|NCT01468909|Antimitotic Agents|antimitotic agents|mesh-ancestor
64536598|NCT01468909|Mitosis Modulators|mitosis modulators|mesh-ancestor
64536599|NCT01468909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536600|NCT01687166|Acifluorfen|acifluorfen|mesh-list
64536601|NCT01687166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536602|NCT01687166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536603|NCT01561976|Metformin|metformin|mesh-list
64536604|NCT01561976|Glimepiride|glimepiride|mesh-list
64536605|NCT01561976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64536606|NCT01561976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536607|NCT01561976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64536608|NCT01561976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64536609|NCT01561976|Immunologic Factors|immunologic factors|mesh-ancestor
64536610|NCT01686932|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64536611|NCT01686932|Vildagliptin|vildagliptin|mesh-list
64536612|NCT01686932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64301264|NCT03280407|Levoleucovorin|levoleucovorin|mesh-list
64967218|NCT00179062|Dopamine Agents|dopamine agents|mesh-ancestor
64967219|NCT00179062|Antiemetics|antiemetics|mesh-ancestor
64967220|NCT00179062|Autonomic Agents|autonomic agents|mesh-ancestor
64967221|NCT00179062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64967223|NCT00179062|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64967224|NCT00179062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64967225|NCT00179062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64967226|NCT04723459|Ivermectin|ivermectin|mesh-list
64967227|NCT04723459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64967228|NCT04723459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64967229|NCT00179257|Sertraline|sertraline|mesh-list
64967230|NCT00179257|Antidepressive Agents|antidepressive agents|mesh-ancestor
64967231|NCT00179257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64967232|NCT00179257|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64967233|NCT00179257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64967234|NCT00179257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64967253|NCT00057122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64967254|NCT00057122|Leprostatic Agents|leprostatic agents|mesh-ancestor
64967255|NCT00057122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64536613|NCT01686932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536614|NCT01686932|Incretins|incretins|mesh-ancestor
64536615|NCT01686932|Hormones|hormones|mesh-ancestor
64536616|NCT01686932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64536617|NCT01686932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64536618|NCT01686932|Protease Inhibitors|protease inhibitors|mesh-ancestor
64536619|NCT01686932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967256|NCT00057122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506002|NCT01808339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64967257|NCT00057122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967258|NCT00057122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64967259|NCT00057122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64967260|NCT00057122|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64967261|NCT00057122|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64967262|NCT00057122|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64967263|NCT00057122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64967264|NCT00057122|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64967265|NCT00057122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64967266|NCT00057122|Antimetabolites|antimetabolites|mesh-ancestor
64967267|NCT00057122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64967268|NCT00179608|Lenalidomide|lenalidomide|mesh-list
64967269|NCT00179608|Immunologic Factors|immunologic factors|mesh-ancestor
64967270|NCT00179608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967271|NCT00179608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64967272|NCT00179608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64967273|NCT00179608|Growth Substances|growth substances|mesh-ancestor
64967274|NCT00179608|Growth Inhibitors|growth inhibitors|mesh-ancestor
64967275|NCT00179608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967276|NCT00179686|Lenalidomide|lenalidomide|mesh-list
64967277|NCT00179686|Immunologic Factors|immunologic factors|mesh-ancestor
64967278|NCT00179686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967279|NCT00179686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64967280|NCT00179686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64967281|NCT00179686|Growth Substances|growth substances|mesh-ancestor
64967282|NCT00179686|Growth Inhibitors|growth inhibitors|mesh-ancestor
64967283|NCT00179686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967284|NCT00179725|Doxorubicin|doxorubicin|mesh-list
64967285|NCT00179725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64967286|NCT00179725|Lenalidomide|lenalidomide|mesh-list
64967287|NCT00179725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64967288|NCT00179725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967289|NCT00179725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64967308|NCT00179881|Thalidomide|thalidomide|mesh-list
64967309|NCT00179881|Carboplatin|carboplatin|mesh-list
64967310|NCT00179881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967311|NCT00179881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64967312|NCT00179881|Immunologic Factors|immunologic factors|mesh-ancestor
64967313|NCT00179881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967314|NCT00179881|Leprostatic Agents|leprostatic agents|mesh-ancestor
64967315|NCT00179881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64967316|NCT00179881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64967317|NCT00179881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64967318|NCT00179881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64967319|NCT00179881|Growth Substances|growth substances|mesh-ancestor
64967320|NCT00179881|Growth Inhibitors|growth inhibitors|mesh-ancestor
64967321|NCT00179920|Carboplatin|carboplatin|mesh-list
64967322|NCT00179920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967323|NCT00180037|Ubiquinone|ubiquinone|mesh-list
64967324|NCT00180037|Coenzyme Q10|coenzyme q10|mesh-list
64967325|NCT00180037|Micronutrients|micronutrients|mesh-ancestor
64967326|NCT00180037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967327|NCT00180037|Vitamins|vitamins|mesh-ancestor
64967328|NCT00180076|Budesonide|budesonide|mesh-list
64967329|NCT00180076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64967330|NCT00180076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64506075|NCT02490774|Levonorgestrel|levonorgestrel|mesh-list
64967331|NCT00180076|Autonomic Agents|autonomic agents|mesh-ancestor
64967332|NCT00180076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64536620|NCT01686932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536621|NCT01468207|Adalimumab|adalimumab|mesh-list
64536622|NCT01468207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64536623|NCT01468207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64536624|NCT03026725|Calcium|calcium|mesh-list
64536625|NCT03026725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64536626|NCT03026725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536627|NCT01686152|Imiquimod|imiquimod|mesh-list
64536628|NCT01686152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64536629|NCT01686152|Immunologic Factors|immunologic factors|mesh-ancestor
64536630|NCT01686152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536631|NCT01686152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536632|NCT01686152|Interferon Inducers|interferon inducers|mesh-ancestor
64536633|NCT01561898|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64536634|NCT01561898|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64536635|NCT01561898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64536636|NCT01561898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64536637|NCT01561898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536638|NCT01561898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64536639|NCT01561898|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64967333|NCT00180076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967334|NCT00180076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64967335|NCT00180076|Respiratory System Agents|respiratory system agents|mesh-ancestor
64967336|NCT00180076|Glucocorticoids|glucocorticoids|mesh-ancestor
64967337|NCT00180076|Hormones|hormones|mesh-ancestor
64967338|NCT00180076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64967339|NCT00180115|Cytarabine|cytarabine|mesh-list
64967340|NCT00180115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64967341|NCT00180115|Antimetabolites|antimetabolites|mesh-ancestor
64967342|NCT00180115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967343|NCT00180115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967344|NCT00180115|Antiviral Agents|antiviral agents|mesh-ancestor
64967345|NCT00180115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64967346|NCT00180115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64967361|NCT00180310|Immunologic Factors|immunologic factors|mesh-ancestor
64967362|NCT00180310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967363|NCT00057278|Gabapentin|gabapentin|mesh-list
64967364|NCT00057278|Analgesics|analgesics|mesh-ancestor
64967365|NCT00057278|Sensory System Agents|sensory system agents|mesh-ancestor
64967366|NCT00057278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64967367|NCT00057278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967368|NCT00057278|Anticonvulsants|anticonvulsants|mesh-ancestor
64967369|NCT00057278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64967370|NCT00057278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64967371|NCT00057278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64967372|NCT00057278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64967373|NCT00057278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64967374|NCT00057278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64967375|NCT00057278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64967376|NCT00057278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967377|NCT00057278|Antimanic Agents|antimanic agents|mesh-ancestor
64967378|NCT04030026|Nalbuphine|nalbuphine|mesh-list
64967379|NCT04030026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64967380|NCT04030026|Narcotics|narcotics|mesh-ancestor
64536640|NCT01561898|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64536641|NCT01561898|Serotonin Agents|serotonin agents|mesh-ancestor
64536642|NCT01561898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64536643|NCT01561898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536644|NCT01561898|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64536645|NCT01561898|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64536646|NCT01561898|Dopamine Agents|dopamine agents|mesh-ancestor
64536647|NCT01452529|Hydrocodone|hydrocodone|mesh-list
64536648|NCT01452529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64536649|NCT01452529|Narcotics|narcotics|mesh-ancestor
64536650|NCT01452529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64536651|NCT01452529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536652|NCT01452529|Analgesics|analgesics|mesh-ancestor
64536653|NCT01452529|Sensory System Agents|sensory system agents|mesh-ancestor
64536654|NCT01452529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64536655|NCT01452529|Antitussive Agents|antitussive agents|mesh-ancestor
64536656|NCT01452529|Respiratory System Agents|respiratory system agents|mesh-ancestor
64536657|NCT01560416|Fulvestrant|fulvestrant|mesh-list
64536658|NCT01560416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64536659|NCT01560416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536660|NCT01560416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64536661|NCT01560416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64536662|NCT01560416|Hormone Antagonists|hormone antagonists|mesh-ancestor
64536663|NCT01560416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64536664|NCT01560416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967381|NCT04030026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64967382|NCT04030026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967383|NCT04030026|Analgesics|analgesics|mesh-ancestor
64967384|NCT04030026|Sensory System Agents|sensory system agents|mesh-ancestor
64967385|NCT04030026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64967386|NCT00180622|Nitric Oxide|nitric oxide|mesh-list
64967387|NCT00180622|Carbon Monoxide|carbon monoxide|mesh-list
64967388|NCT00180622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64967389|NCT00180622|Autonomic Agents|autonomic agents|mesh-ancestor
64967390|NCT00180622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64967391|NCT00180622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967392|NCT00180622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64967393|NCT00180622|Respiratory System Agents|respiratory system agents|mesh-ancestor
64967394|NCT00180622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64967395|NCT00180622|Antioxidants|antioxidants|mesh-ancestor
64967396|NCT00180622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967397|NCT00180622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64967398|NCT00180622|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64967399|NCT00180622|Vasodilator Agents|vasodilator agents|mesh-ancestor
64967400|NCT00180622|Gasotransmitters|gasotransmitters|mesh-ancestor
64967401|NCT00180622|Protective Agents|protective agents|mesh-ancestor
64967402|NCT00180622|Antimetabolites|antimetabolites|mesh-ancestor
64967403|NCT00180895|Rituximab|rituximab|mesh-list
64536665|NCT01685372|Vaccines|vaccines|mesh-list
64536666|NCT01685372|Immunologic Factors|immunologic factors|mesh-ancestor
64536667|NCT01685372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536668|NCT01685138|Ceritinib|ceritinib|mesh-list
64536669|NCT01685138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536670|NCT01685138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64536671|NCT01685138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536672|NCT01685138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536673|NCT01685060|Ceritinib|ceritinib|mesh-list
64536674|NCT01685060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536675|NCT01685060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64301346|NCT03269721|Gasotransmitters|gasotransmitters|mesh-ancestor
64967404|NCT00180895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64967405|NCT00180895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967406|NCT00180895|Immunologic Factors|immunologic factors|mesh-ancestor
64967407|NCT00180895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967421|NCT04729491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64967422|NCT04729491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967423|NCT04729491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967424|NCT04729491|Hormone Antagonists|hormone antagonists|mesh-ancestor
64967425|NCT04729491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64967426|NCT04729491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967427|NCT04729491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64967428|NCT00057356|Conivaptan|conivaptan|mesh-list
64967429|NCT00057356|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64967430|NCT00057356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967431|NCT00057356|Natriuretic Agents|natriuretic agents|mesh-ancestor
64967432|NCT00057356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967433|NCT00181012|Lidocaine|lidocaine|mesh-list
64967434|NCT00181012|Anesthetics, Local|anesthetics, local|mesh-ancestor
64967435|NCT00181012|Anesthetics|anesthetics|mesh-ancestor
64967436|NCT00181012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64967437|NCT00181012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967438|NCT00181012|Sensory System Agents|sensory system agents|mesh-ancestor
64967439|NCT00181012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64967440|NCT00181012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64967441|NCT00181012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64967442|NCT00181012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64967443|NCT00181012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64967444|NCT00181012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967445|NCT00181246|Fentanyl|fentanyl|mesh-list
64967446|NCT00181246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64967447|NCT00181246|Narcotics|narcotics|mesh-ancestor
64967448|NCT00181246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64967449|NCT00181246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967450|NCT00181246|Analgesics|analgesics|mesh-ancestor
64967451|NCT00181246|Sensory System Agents|sensory system agents|mesh-ancestor
64967452|NCT00181246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64967453|NCT00181246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64967454|NCT00181246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64967455|NCT00181246|Anesthetics, General|anesthetics, general|mesh-ancestor
64967456|NCT00181246|Anesthetics|anesthetics|mesh-ancestor
64967457|NCT00181558|Zoledronic Acid|zoledronic acid|mesh-list
64967458|NCT00181558|Atrasentan|atrasentan|mesh-list
64967459|NCT00181558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64967460|NCT00181558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967461|NCT00181558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967462|NCT00181558|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64967463|NCT00181558|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64654264|NCT03203525|Antimetabolites|antimetabolites|mesh-ancestor
64967464|NCT00181558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536676|NCT01685060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536677|NCT01685060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536678|NCT03887936|Testosterone|testosterone|mesh-list
64536679|NCT03887936|Androgens|androgens|mesh-ancestor
64536680|NCT03887936|Hormones|hormones|mesh-ancestor
64541278|NCT02864004|Apomorphine|apomorphine|mesh-list
64536681|NCT03887936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64536682|NCT03887936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536683|NCT01684202|Tolvaptan|tolvaptan|mesh-list
64536684|NCT01684202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64536685|NCT01684202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536686|NCT01684202|Natriuretic Agents|natriuretic agents|mesh-ancestor
64536687|NCT01684202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536688|NCT01559090|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64536689|NCT01559090|Immunologic Factors|immunologic factors|mesh-ancestor
64536690|NCT01559090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536691|NCT01683266|Insulin|insulin|mesh-list
64536692|NCT01683266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64536693|NCT01683266|Insulin Glargine|insulin glargine|mesh-list
64536694|NCT01683266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64536695|NCT01683266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536696|NCT01467661|Anagrelide|anagrelide|mesh-list
64536697|NCT01467661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64536698|NCT01467661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64967466|NCT00181597|Trilostane|trilostane|mesh-list
64967467|NCT00181597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64967484|NCT00181636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64967486|NCT00181675|Galantamine|galantamine|mesh-list
64967487|NCT00181675|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64967488|NCT00181675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967489|NCT00181675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967490|NCT00181675|Cholinergic Agents|cholinergic agents|mesh-ancestor
64967491|NCT00181675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64967492|NCT00181675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967493|NCT00181675|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64967494|NCT00181675|Autonomic Agents|autonomic agents|mesh-ancestor
64967495|NCT00181675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64967496|NCT00181675|Nootropic Agents|nootropic agents|mesh-ancestor
64967497|NCT00181870|Carbamazepine|carbamazepine|mesh-list
64967498|NCT00181870|Anticonvulsants|anticonvulsants|mesh-ancestor
64967499|NCT00181870|Antimanic Agents|antimanic agents|mesh-ancestor
64967500|NCT00181870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64967501|NCT00181870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64967502|NCT00181870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967503|NCT00181870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64967504|NCT00181870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64967505|NCT00181870|Analgesics|analgesics|mesh-ancestor
64967506|NCT00181870|Sensory System Agents|sensory system agents|mesh-ancestor
64967507|NCT00181870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64967508|NCT00181870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64967509|NCT00181870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64536699|NCT01467661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536700|NCT01467661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64536701|NCT01577186|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64536702|NCT01577186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64536703|NCT01577186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64536704|NCT01577186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64536705|NCT01577186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536706|NCT01577186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64536707|NCT01577186|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64536708|NCT01577186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64536709|NCT01577186|Serotonin Agents|serotonin agents|mesh-ancestor
64536711|NCT01577186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536712|NCT01577186|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64536713|NCT01577186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64536714|NCT01577186|Dopamine Agents|dopamine agents|mesh-ancestor
64536715|NCT01559012|Clonidine|clonidine|mesh-list
64536716|NCT01559012|Analgesics|analgesics|mesh-ancestor
64536717|NCT01559012|Sensory System Agents|sensory system agents|mesh-ancestor
64536718|NCT01559012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64536719|NCT01559012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536720|NCT01559012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64967510|NCT00181870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967511|NCT00181870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64967512|NCT00181870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64967513|NCT00181948|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64967514|NCT00181948|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64967515|NCT00181948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64967516|NCT00181948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64967517|NCT00181948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967518|NCT00181948|Adrenergic Agents|adrenergic agents|mesh-ancestor
64967519|NCT00181948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64967520|NCT00181948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967538|NCT00182143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64967539|NCT00182143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64967540|NCT00182143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967541|NCT00182221|Fibrin fragment D|fibrin fragment d|mesh-list
64967542|NCT00182221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64967543|NCT00182221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64967544|NCT00182221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967545|NCT00182221|Hemostatics|hemostatics|mesh-ancestor
64967546|NCT00182221|Coagulants|coagulants|mesh-ancestor
64967547|NCT00182260|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64967548|NCT00182260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967549|NCT00182260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967550|NCT00408538|UC-781|uc-781|mesh-list
64967552|NCT00408538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64967553|NCT00408538|Antiviral Agents|antiviral agents|mesh-ancestor
64967554|NCT00408655|Sirolimus|sirolimus|mesh-list
64536721|NCT01559012|Sympatholytics|sympatholytics|mesh-ancestor
64536722|NCT01559012|Autonomic Agents|autonomic agents|mesh-ancestor
64536723|NCT01559012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64536724|NCT01559012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64536725|NCT01559012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64536726|NCT01559012|Adrenergic Agents|adrenergic agents|mesh-ancestor
64536727|NCT01559012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64536728|NCT01559012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536729|NCT01451827|Tolvaptan|tolvaptan|mesh-list
64536730|NCT01451827|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64536731|NCT01451827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536732|NCT01451827|Natriuretic Agents|natriuretic agents|mesh-ancestor
64536733|NCT01451827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536734|NCT01557920|Propofol|propofol|mesh-list
64301403|NCT03265197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301404|NCT03078374|Warfarin|warfarin|mesh-list
64967555|NCT00408655|Paclitaxel|paclitaxel|mesh-list
64967556|NCT00408655|Carboplatin|carboplatin|mesh-list
64967557|NCT00408655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64967558|NCT00408655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967559|NCT00408655|Tubulin Modulators|tubulin modulators|mesh-ancestor
64967560|NCT00408655|Antimitotic Agents|antimitotic agents|mesh-ancestor
64967561|NCT00408655|Mitosis Modulators|mitosis modulators|mesh-ancestor
64967562|NCT00408655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967563|NCT00408655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64654281|NCT02249039|Sympatholytics|sympatholytics|mesh-ancestor
64967564|NCT00408655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64967565|NCT00408655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64967566|NCT00408655|Antifungal Agents|antifungal agents|mesh-ancestor
64967567|NCT00408655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64967568|NCT00408655|Immunologic Factors|immunologic factors|mesh-ancestor
64967569|NCT00408655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967570|NCT00182377|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
64967571|NCT00182377|Plasma Substitutes|plasma substitutes|mesh-ancestor
64967572|NCT00182377|Blood Substitutes|blood substitutes|mesh-ancestor
64967574|NCT00182455|Anticonvulsants|anticonvulsants|mesh-ancestor
64967575|NCT00182455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64967576|NCT00182455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967577|NCT00182494|Metformin|metformin|mesh-list
64967578|NCT00182494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64967579|NCT00182494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967580|NCT00182533|Sertraline|sertraline|mesh-list
64967581|NCT00182533|Antidepressive Agents|antidepressive agents|mesh-ancestor
64967591|NCT00182572|Buprenorphine|buprenorphine|mesh-list
64967592|NCT00182572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64967593|NCT00182572|Narcotics|narcotics|mesh-ancestor
64967594|NCT00182572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64967595|NCT00182572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967596|NCT00182572|Analgesics|analgesics|mesh-ancestor
64967597|NCT00182572|Sensory System Agents|sensory system agents|mesh-ancestor
64967598|NCT00182572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64967599|NCT00182572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64967600|NCT00182572|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64967601|NCT00182611|Tegafur|tegafur|mesh-list
64967602|NCT00182611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967603|NCT00182611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64967604|NCT00182611|Antimetabolites|antimetabolites|mesh-ancestor
64536735|NCT01557920|Sevoflurane|sevoflurane|mesh-list
64536736|NCT01557920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64536737|NCT01557920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64536738|NCT01557920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536739|NCT01557920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64536740|NCT01557920|Anesthetics, General|anesthetics, general|mesh-ancestor
64536741|NCT01557920|Anesthetics|anesthetics|mesh-ancestor
64536742|NCT01557920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64536743|NCT01557920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64536744|NCT01467583|PENTA|penta|mesh-list
64301418|NCT04940390|Dihydroergotamine|dihydroergotamine|mesh-list
64967605|NCT00182611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967606|NCT00182650|Aldesleukin|aldesleukin|mesh-list
64967607|NCT00182650|Rituximab|rituximab|mesh-list
64967608|NCT00182650|Fludarabine|fludarabine|mesh-list
64967609|NCT00182650|Fludarabine phosphate|fludarabine phosphate|mesh-list
64967610|NCT00182650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64967611|NCT00182650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967612|NCT00182650|Immunologic Factors|immunologic factors|mesh-ancestor
64967613|NCT00182650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967614|NCT00182650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64967615|NCT00182650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64967616|NCT00182650|Antimetabolites|antimetabolites|mesh-ancestor
64967617|NCT00182650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967618|NCT00182650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64967619|NCT00182650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64967620|NCT00182650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64967621|NCT00182650|Antiviral Agents|antiviral agents|mesh-ancestor
64967622|NCT00182650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64967623|NCT00182806|Gemcitabine|gemcitabine|mesh-list
64967624|NCT00182806|Irinotecan|irinotecan|mesh-list
64967625|NCT00182806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64967626|NCT00182806|Antimetabolites|antimetabolites|mesh-ancestor
64506302|NCT03957304|Analgesics|analgesics|mesh-ancestor
64967627|NCT00182806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967628|NCT00182806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967629|NCT00182806|Antiviral Agents|antiviral agents|mesh-ancestor
64967630|NCT00182806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64967631|NCT00182806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967632|NCT00182806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64967633|NCT00182806|Immunologic Factors|immunologic factors|mesh-ancestor
64967634|NCT00182806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967635|NCT00182806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64967636|NCT00182806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64967637|NCT00182845|Donepezil|donepezil|mesh-list
64967638|NCT00182845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64967639|NCT00182845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967640|NCT00182845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967641|NCT00182845|Cholinergic Agents|cholinergic agents|mesh-ancestor
64967642|NCT00182845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64967643|NCT00182845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967644|NCT00182845|Nootropic Agents|nootropic agents|mesh-ancestor
64967645|NCT00182884|Donepezil|donepezil|mesh-list
64967646|NCT00182884|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64967664|NCT00183040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64967665|NCT00183040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967666|NCT00183040|Androgens|androgens|mesh-ancestor
64967667|NCT00057395|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
64967668|NCT00057395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967669|NCT00183235|Aripiprazole|aripiprazole|mesh-list
64967670|NCT00183235|Antidepressive Agents|antidepressive agents|mesh-ancestor
64967671|NCT00183235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64967672|NCT00183235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64967673|NCT00183235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64967674|NCT00183235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64536745|NCT01467583|Fondaparinux|fondaparinux|mesh-list
64536746|NCT01467583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64536747|NCT01467583|Antithrombins|antithrombins|mesh-ancestor
64536748|NCT01467583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64536749|NCT01467583|Protease Inhibitors|protease inhibitors|mesh-ancestor
64536750|NCT01467583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536751|NCT01467583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536752|NCT01467583|Anticoagulants|anticoagulants|mesh-ancestor
64536753|NCT01467583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64536754|NCT01467583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64536755|NCT01576718|Fluticasone|fluticasone|mesh-list
64536756|NCT01576718|Xhance|xhance|mesh-list
64536757|NCT01576718|Albuterol|albuterol|mesh-list
64536758|NCT01576718|Adrenergic Agonists|adrenergic agonists|mesh-list
64536759|NCT01576718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64536760|NCT01576718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64536761|NCT01576718|Autonomic Agents|autonomic agents|mesh-ancestor
64536762|NCT01576718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64536763|NCT01576718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536764|NCT01576718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64536765|NCT01576718|Respiratory System Agents|respiratory system agents|mesh-ancestor
64536766|NCT01576718|Dermatologic Agents|dermatologic agents|mesh-ancestor
64536767|NCT01576718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64536768|NCT01576718|Tocolytic Agents|tocolytic agents|mesh-ancestor
64536769|NCT01576718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64536770|NCT01576718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64536771|NCT01576718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64536772|NCT01576718|Adrenergic Agents|adrenergic agents|mesh-ancestor
64536773|NCT01576718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64536774|NCT01576718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536775|NCT01493557|Pantoprazole|pantoprazole|mesh-list
64536776|NCT01493557|Dabigatran|dabigatran|mesh-list
64536777|NCT01493557|Antithrombins|antithrombins|mesh-ancestor
64536778|NCT01493557|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64536779|NCT01493557|Protease Inhibitors|protease inhibitors|mesh-ancestor
64967675|NCT00183235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967676|NCT00183235|Dopamine Agonists|dopamine agonists|mesh-ancestor
64967677|NCT00183235|Dopamine Agents|dopamine agents|mesh-ancestor
64967678|NCT00183235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64967679|NCT00183235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967680|NCT00183235|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64536780|NCT01493557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536781|NCT01493557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536782|NCT01493557|Anticoagulants|anticoagulants|mesh-ancestor
64536783|NCT01493557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64536784|NCT01493557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64536785|NCT01493557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64536786|NCT01451749|Donepezil|donepezil|mesh-list
64536787|NCT01451749|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64536788|NCT01451749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536789|NCT01451749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536790|NCT01451749|Cholinergic Agents|cholinergic agents|mesh-ancestor
64536791|NCT01451749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64536792|NCT01451749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536793|NCT01451749|Nootropic Agents|nootropic agents|mesh-ancestor
64536794|NCT01576484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64536795|NCT01576484|Immunologic Factors|immunologic factors|mesh-ancestor
64536796|NCT01576484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536797|NCT01467505|Interferons|interferons|mesh-list
64536798|NCT01467505|Ribavirin|ribavirin|mesh-list
64536799|NCT01467505|Interferon-alpha|interferon-alpha|mesh-list
64536800|NCT01467505|Interferon alpha-2|interferon alpha-2|mesh-list
64536801|NCT01467505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64967681|NCT00183235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64967682|NCT00183235|Serotonin Agents|serotonin agents|mesh-ancestor
64967683|NCT00183235|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64967684|NCT00183235|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64967685|NCT00183235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64967686|NCT00183235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64967687|NCT00057512|Masoprocol|masoprocol|mesh-list
64967688|NCT00057512|Antioxidants|antioxidants|mesh-ancestor
64967689|NCT00057512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967690|NCT00057512|Protective Agents|protective agents|mesh-ancestor
64967691|NCT00057512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967692|NCT00057512|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64967693|NCT00057512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967694|NCT00057512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64967695|NCT00057512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64967696|NCT00057512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64967697|NCT00057512|Analgesics|analgesics|mesh-ancestor
64967698|NCT00057512|Sensory System Agents|sensory system agents|mesh-ancestor
64967699|NCT00057512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64967700|NCT00057512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64506447|NCT01807624|Mydriatics|mydriatics|mesh-ancestor
64967701|NCT00057512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64967702|NCT00183742|Docetaxel|docetaxel|mesh-list
64967703|NCT00183742|Doxorubicin|doxorubicin|mesh-list
64967738|NCT00183820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64967740|NCT00183820|Tubulin Modulators|tubulin modulators|mesh-ancestor
64967741|NCT00183820|Antimitotic Agents|antimitotic agents|mesh-ancestor
64967742|NCT00183820|Mitosis Modulators|mitosis modulators|mesh-ancestor
64967743|NCT00183820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967744|NCT00183820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64967745|NCT00183820|Antimetabolites|antimetabolites|mesh-ancestor
64967746|NCT00183820|Antiviral Agents|antiviral agents|mesh-ancestor
64536802|NCT01467505|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64536803|NCT01467505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536804|NCT01467505|Antiviral Agents|antiviral agents|mesh-ancestor
64536805|NCT01467505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64536806|NCT01467505|Antimetabolites|antimetabolites|mesh-ancestor
64536807|NCT01467505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536808|NCT01467505|Immunologic Factors|immunologic factors|mesh-ancestor
64536809|NCT01467505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536810|NCT01449929|Ritonavir|ritonavir|mesh-list
64967760|NCT00183859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64967761|NCT00183859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64967762|NCT00183859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967763|NCT00183859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967764|NCT00183859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967766|NCT00183898|Oxaliplatin|oxaliplatin|mesh-list
64967767|NCT00183898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64967768|NCT00183898|Antimetabolites|antimetabolites|mesh-ancestor
64967769|NCT00183898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967770|NCT00183898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967771|NCT04730765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64967772|NCT04730765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64967773|NCT00183937|Docetaxel|docetaxel|mesh-list
64967774|NCT00183937|Bortezomib|bortezomib|mesh-list
64967775|NCT00183937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967776|NCT00183937|Tubulin Modulators|tubulin modulators|mesh-ancestor
64967777|NCT00183937|Antimitotic Agents|antimitotic agents|mesh-ancestor
64967778|NCT00183937|Mitosis Modulators|mitosis modulators|mesh-ancestor
64967779|NCT00183937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967781|NCT00408772|Capecitabine|capecitabine|mesh-list
64967782|NCT00408772|Oxaliplatin|oxaliplatin|mesh-list
64967783|NCT00408772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64967784|NCT00408772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967785|NCT00408772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64967786|NCT00408772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64967787|NCT00408772|Growth Substances|growth substances|mesh-ancestor
64541372|NCT05089344|Enclomiphene|enclomiphene|mesh-list
64967788|NCT00408772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967789|NCT00408772|Growth Inhibitors|growth inhibitors|mesh-ancestor
64967790|NCT00408772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64967791|NCT00408772|Antimetabolites|antimetabolites|mesh-ancestor
64967792|NCT00408772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967793|NCT00408850|Pioglitazone|pioglitazone|mesh-list
64967794|NCT00408850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64967795|NCT00408850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967796|NCT00183976|Rituximab|rituximab|mesh-list
64967797|NCT00183976|Doxorubicin|doxorubicin|mesh-list
64967798|NCT00183976|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64967799|NCT00183976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64967800|NCT00183976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967801|NCT00183976|Immunologic Factors|immunologic factors|mesh-ancestor
64967802|NCT00183976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967803|NCT00183976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64967804|NCT00183976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64967805|NCT00183976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64967806|NCT00183976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64967807|NCT00183976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967808|NCT00183976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967809|NCT00046683|Alemtuzumab|alemtuzumab|mesh-list
64967820|NCT00184015|Growth Inhibitors|growth inhibitors|mesh-ancestor
64967821|NCT00184171|Budesonide|budesonide|mesh-list
64967822|NCT00184171|Bismuth|bismuth|mesh-list
64967823|NCT00184171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64967824|NCT00184171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64967825|NCT00184171|Autonomic Agents|autonomic agents|mesh-ancestor
64967826|NCT00184171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64536811|NCT01449929|Darunavir|darunavir|mesh-list
64536812|NCT01449929|Dolutegravir|dolutegravir|mesh-list
64536813|NCT01449929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64536814|NCT01449929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64536815|NCT01449929|Protease Inhibitors|protease inhibitors|mesh-ancestor
64536816|NCT01449929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536817|NCT01449929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536818|NCT01449929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64536819|NCT01449929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64967827|NCT00184171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967828|NCT00184171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64967829|NCT00184171|Respiratory System Agents|respiratory system agents|mesh-ancestor
64967830|NCT00184171|Glucocorticoids|glucocorticoids|mesh-ancestor
64967832|NCT00184171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64967833|NCT00184171|Antacids|antacids|mesh-ancestor
64967834|NCT00184171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967835|NCT00184171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64967836|NCT00057707|Modafinil|modafinil|mesh-list
64967837|NCT00057707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64967838|NCT00057707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967839|NCT00057707|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64967840|NCT00057707|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64967841|NCT00057707|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64967842|NCT00057707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967843|NCT00184522|Esomeprazole|esomeprazole|mesh-list
64967844|NCT00184522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64967845|NCT00184522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64967846|NCT00184522|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64967847|NCT00184522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967848|NCT00184522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967849|NCT00184561|Insulin Aspart|insulin aspart|mesh-list
64967850|NCT00184561|Biphasic Insulins|biphasic insulins|mesh-list
64967851|NCT00184561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64506528|NCT02482272|Lamivudine|lamivudine|mesh-list
64967852|NCT00184561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967853|NCT00184639|Insulin Detemir|insulin detemir|mesh-list
64967854|NCT00184639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64967855|NCT00184639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967856|NCT00058097|Tipifarnib|tipifarnib|mesh-list
64967857|NCT00058097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967858|NCT03847311|Sulfasalazine|sulfasalazine|mesh-list
64967859|NCT03847311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64967860|NCT03847311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64967861|NCT03847311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64967862|NCT03847311|Analgesics|analgesics|mesh-ancestor
64967863|NCT03847311|Sensory System Agents|sensory system agents|mesh-ancestor
64967864|NCT03847311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64967865|NCT03847311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967866|NCT03847311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64967867|NCT03847311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64967868|NCT03847311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64967869|NCT00184795|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64967870|NCT00184795|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64967871|NCT00184795|Norethindrone|norethindrone|mesh-list
64967872|NCT00184795|Norethindrone Acetate|norethindrone acetate|mesh-list
64967873|NCT00184795|Estradiol|estradiol|mesh-list
64967893|NCT00046800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967894|NCT00058292|Cytarabine|cytarabine|mesh-list
64967895|NCT00058292|Rituximab|rituximab|mesh-list
64967896|NCT00058292|Etoposide|etoposide|mesh-list
64967897|NCT00058292|Etoposide phosphate|etoposide phosphate|mesh-list
64967898|NCT00058292|Melphalan|melphalan|mesh-list
64967899|NCT00058292|Carmustine|carmustine|mesh-list
64967900|NCT00058292|Lenograstim|lenograstim|mesh-list
64967901|NCT00058292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64967902|NCT00058292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967903|NCT00058292|Immunologic Factors|immunologic factors|mesh-ancestor
64536820|NCT01449929|Antiviral Agents|antiviral agents|mesh-ancestor
64536821|NCT01449929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64536822|NCT01449929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64654330|NCT03102125|Purinergic Agonists|purinergic agonists|mesh-ancestor
64536823|NCT01449929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64536825|NCT01449929|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64536826|NCT01451515|Cytarabine|cytarabine|mesh-list
64536827|NCT01451515|Dexamethasone|dexamethasone|mesh-list
64536828|NCT01451515|Prednisone|prednisone|mesh-list
64536829|NCT01451515|Prednisolone|prednisolone|mesh-list
64536830|NCT01451515|Hydrocortisone|hydrocortisone|mesh-list
64536831|NCT01451515|Cyclophosphamide|cyclophosphamide|mesh-list
64536832|NCT01451515|Doxorubicin|doxorubicin|mesh-list
64536833|NCT01451515|Methotrexate|methotrexate|mesh-list
64536834|NCT01451515|Etoposide|etoposide|mesh-list
64536835|NCT01451515|Vincristine|vincristine|mesh-list
64536836|NCT01451515|Daunorubicin|daunorubicin|mesh-list
64536837|NCT01451515|Asparaginase|asparaginase|mesh-list
64536838|NCT01451515|Mercaptopurine|mercaptopurine|mesh-list
64536839|NCT01451515|Clofarabine|clofarabine|mesh-list
64536840|NCT01451515|Pegaspargase|pegaspargase|mesh-list
64536841|NCT01451515|Thioguanine|thioguanine|mesh-list
64536842|NCT01451515|Antimetabolites|antimetabolites|mesh-list
64536843|NCT01451515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64536844|NCT01451515|Immunologic Factors|immunologic factors|mesh-ancestor
64536845|NCT01451515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536846|NCT01451515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64536847|NCT01451515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64536848|NCT01451515|Alkylating Agents|alkylating agents|mesh-ancestor
64536849|NCT01451515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536850|NCT01451515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536851|NCT01451515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64301501|NCT04459052|Acetylcysteine|acetylcysteine|mesh-list
64301505|NCT04459052|Expectorants|expectorants|mesh-ancestor
64967904|NCT00058292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967905|NCT00058292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64967906|NCT00058292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64967907|NCT00058292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64967908|NCT00058292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64967909|NCT00058292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967910|NCT00058292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967911|NCT00058292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64967912|NCT00058292|Antimetabolites|antimetabolites|mesh-ancestor
64967913|NCT00058292|Antiviral Agents|antiviral agents|mesh-ancestor
64967914|NCT00058292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64967915|NCT00058292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64536852|NCT01451515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64536853|NCT01451515|Antiemetics|antiemetics|mesh-ancestor
64536854|NCT01451515|Autonomic Agents|autonomic agents|mesh-ancestor
64536855|NCT01451515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64536856|NCT01451515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64536857|NCT01451515|Glucocorticoids|glucocorticoids|mesh-ancestor
64536858|NCT01451515|Hormones|hormones|mesh-ancestor
64536859|NCT01451515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64536860|NCT01451515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64536861|NCT01451515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64536862|NCT01451515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64536863|NCT01451515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64536864|NCT01451515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536865|NCT01451515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64536866|NCT01451515|Abortifacient Agents|abortifacient agents|mesh-ancestor
64536867|NCT01451515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64536868|NCT01451515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64536869|NCT01451515|Dermatologic Agents|dermatologic agents|mesh-ancestor
64536870|NCT01451515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64536871|NCT01451515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64536872|NCT01451515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64536874|NCT01451515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64536875|NCT01451515|Tubulin Modulators|tubulin modulators|mesh-ancestor
64536876|NCT01451515|Antimitotic Agents|antimitotic agents|mesh-ancestor
64536877|NCT01451515|Mitosis Modulators|mitosis modulators|mesh-ancestor
64536878|NCT01576406|Crizotinib|crizotinib|mesh-list
64967916|NCT00058292|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64967917|NCT00058292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64967918|NCT00058292|Alkylating Agents|alkylating agents|mesh-ancestor
64967919|NCT00058292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64967920|NCT03816774|Simethicone|simethicone|mesh-list
64967921|NCT03816774|Antifoaming Agents|antifoaming agents|mesh-ancestor
64967922|NCT03816774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967923|NCT03816774|Emollients|emollients|mesh-ancestor
64967924|NCT03816774|Dermatologic Agents|dermatologic agents|mesh-ancestor
64967925|NCT00184912|Caffeine|caffeine|mesh-list
64506598|NCT03314298|Methyltestosterone|methyltestosterone|mesh-list
64967926|NCT00184912|Annexin A5|annexin a5|mesh-list
64967927|NCT00184912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64967928|NCT00184912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967955|NCT00185068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64967956|NCT00185068|Diuretics|diuretics|mesh-ancestor
64967957|NCT00185068|Natriuretic Agents|natriuretic agents|mesh-ancestor
64967958|NCT00185068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967959|NCT00185068|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64967960|NCT00185068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64536879|NCT01576406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536880|NCT01576406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64536881|NCT01576406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536882|NCT01576406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536883|NCT01576172|Prednisone|prednisone|mesh-list
64536884|NCT01576172|Cortisone|cortisone|mesh-list
64301561|NCT04993040|Paclitaxel|paclitaxel|mesh-list
64967961|NCT00185068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967962|NCT00185068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64967963|NCT00185068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64967964|NCT00185107|Simvastatin|simvastatin|mesh-list
64967965|NCT00185107|Ezetimibe|ezetimibe|mesh-list
64967966|NCT00185107|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
64967967|NCT00185107|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64967968|NCT00185107|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64967969|NCT00185107|Antimetabolites|antimetabolites|mesh-ancestor
64967970|NCT00185107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967971|NCT00185107|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64967972|NCT00185107|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64967973|NCT00185107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967974|NCT00058448|Docetaxel|docetaxel|mesh-list
64967975|NCT00058448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967992|NCT00185185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64967993|NCT00185185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64967995|NCT00185185|Autonomic Agents|autonomic agents|mesh-ancestor
64967996|NCT00185185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64967997|NCT00185185|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64967998|NCT00185185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64967999|NCT00185185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64506672|NCT02481180|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
64968001|NCT00185185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64968002|NCT00185224|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
64968003|NCT00185224|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64968005|NCT00185224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64968006|NCT00185224|Contraceptive Agents|contraceptive agents|mesh-ancestor
64968007|NCT00185224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64968008|NCT00185224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968009|NCT00185224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64968010|NCT00185224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64968011|NCT00185224|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64968012|NCT00185224|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
64968013|NCT00185224|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64968014|NCT00185224|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64968015|NCT00185302|Entinostat|entinostat|mesh-list
64968016|NCT00185302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
64968017|NCT00185302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968018|NCT00185302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968019|NCT00185302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968020|NCT02969681|Ascorbic Acid|ascorbic acid|mesh-list
64968021|NCT02969681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968022|NCT02969681|Vitamins|vitamins|mesh-ancestor
64968023|NCT02969681|Micronutrients|micronutrients|mesh-ancestor
64968024|NCT02969681|Antioxidants|antioxidants|mesh-ancestor
64968025|NCT02969681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968026|NCT02969681|Protective Agents|protective agents|mesh-ancestor
64968027|NCT03784014|Durvalumab|durvalumab|mesh-list
64968028|NCT03784014|Olaparib|olaparib|mesh-list
64968029|NCT03784014|Lapatinib|lapatinib|mesh-list
64968030|NCT03784014|Palbociclib|palbociclib|mesh-list
64968031|NCT03784014|Trametinib|trametinib|mesh-list
64968032|NCT03784014|Dabrafenib|dabrafenib|mesh-list
64968056|NCT00058487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64968057|NCT00058487|Growth Substances|growth substances|mesh-ancestor
64968058|NCT00058487|Growth Inhibitors|growth inhibitors|mesh-ancestor
64968059|NCT00185419|Desogestrel|desogestrel|mesh-list
64536885|NCT01576172|Abiraterone Acetate|abiraterone acetate|mesh-list
64536886|NCT01576172|Veliparib|veliparib|mesh-list
64536887|NCT01576172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64536888|NCT01576172|Glucocorticoids|glucocorticoids|mesh-ancestor
64536889|NCT01576172|Hormones|hormones|mesh-ancestor
64536890|NCT01576172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64536891|NCT01576172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536892|NCT01576172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64301565|NCT04993040|Antimitotic Agents|antimitotic agents|mesh-ancestor
64301568|NCT05300035|Antibodies|antibodies|mesh-list
64968060|NCT00185419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64968061|NCT00185419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968062|NCT00185419|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64968063|NCT00185419|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64968064|NCT00185419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64968065|NCT00185419|Contraceptive Agents|contraceptive agents|mesh-ancestor
64968066|NCT00185419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64968067|NCT00185419|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64968068|NCT00185419|Progestins|progestins|mesh-ancestor
64968069|NCT00185419|Hormones|hormones|mesh-ancestor
64968070|NCT00185419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64968071|NCT00185575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64506745|NCT02480400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506752|NCT02480400|Autonomic Agents|autonomic agents|mesh-ancestor
64968072|NCT00185575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64968073|NCT00185575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64968074|NCT00185575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64968075|NCT00185575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968076|NCT00185575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64968077|NCT00185575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968078|NCT00185575|Analgesics|analgesics|mesh-ancestor
64968079|NCT00185575|Sensory System Agents|sensory system agents|mesh-ancestor
64968104|NCT03731832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64968106|NCT03731832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64968107|NCT03731832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64968108|NCT03731832|Growth Substances|growth substances|mesh-ancestor
64968109|NCT03731832|Growth Inhibitors|growth inhibitors|mesh-ancestor
64968110|NCT03731832|Protease Inhibitors|protease inhibitors|mesh-ancestor
64968111|NCT03731832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968112|NCT00185887|Terbutaline|terbutaline|mesh-list
64968113|NCT00185887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64968114|NCT00185887|Autonomic Agents|autonomic agents|mesh-ancestor
64968115|NCT00185887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64968116|NCT00185887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968117|NCT00185887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64968118|NCT00185887|Respiratory System Agents|respiratory system agents|mesh-ancestor
64968119|NCT00185887|Sympathomimetics|sympathomimetics|mesh-ancestor
64968120|NCT00185887|Tocolytic Agents|tocolytic agents|mesh-ancestor
64968121|NCT00185887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64968122|NCT00185887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64968123|NCT00185887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64968124|NCT00185887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64968125|NCT00185887|Adrenergic Agents|adrenergic agents|mesh-ancestor
64968126|NCT00185887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64968127|NCT00185887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968128|NCT00186082|Cefoxitin|cefoxitin|mesh-list
64968129|NCT00186082|Cefotetan|cefotetan|mesh-list
64968130|NCT00186082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64968154|NCT00186706|Antioxidants|antioxidants|mesh-ancestor
64968155|NCT00186706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968156|NCT00186706|Protective Agents|protective agents|mesh-ancestor
64968157|NCT00186706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968158|NCT00186706|Trace Elements|trace elements|mesh-ancestor
64536893|NCT01576172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536894|NCT01576172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64536895|NCT01576172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536896|NCT01576172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536897|NCT01576172|Hormone Antagonists|hormone antagonists|mesh-ancestor
64536898|NCT01576172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64536899|NCT01576172|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64536900|NCT01542788|Sofosbuvir|sofosbuvir|mesh-list
64536901|NCT01542788|Antiviral Agents|antiviral agents|mesh-ancestor
64536902|NCT01542788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64536904|NCT01541930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64536905|NCT01541930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64536906|NCT01541930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64536907|NCT01541930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64536908|NCT03028298|Sildenafil Citrate|sildenafil citrate|mesh-list
64536909|NCT03028298|Citric Acid|citric acid|mesh-list
64536910|NCT03028298|Sodium Citrate|sodium citrate|mesh-list
64536911|NCT03028298|Anticoagulants|anticoagulants|mesh-ancestor
64536912|NCT03028298|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64536913|NCT03028298|Chelating Agents|chelating agents|mesh-ancestor
64536914|NCT03028298|Sequestering Agents|sequestering agents|mesh-ancestor
64536915|NCT03028298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536916|NCT03028298|Vasodilator Agents|vasodilator agents|mesh-ancestor
64968159|NCT00186706|Micronutrients|micronutrients|mesh-ancestor
64968160|NCT00409201|Reboxetine|reboxetine|mesh-list
64968161|NCT00409201|Antidepressive Agents|antidepressive agents|mesh-ancestor
64968162|NCT00409201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64968163|NCT00409201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64968164|NCT00409201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64968165|NCT00409201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64968166|NCT00409201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968167|NCT00409201|Adrenergic Agents|adrenergic agents|mesh-ancestor
64968169|NCT00409201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968170|NCT00046878|Carmustine|carmustine|mesh-list
64968171|NCT00046878|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64968172|NCT00046878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64968173|NCT00046878|Alkylating Agents|alkylating agents|mesh-ancestor
64541558|NCT05738148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64968174|NCT00046878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968175|NCT00046878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968176|NCT00046878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968177|NCT00186745|Tinzaparin|tinzaparin|mesh-list
64968178|NCT00186745|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64968179|NCT00186745|Dalteparin|dalteparin|mesh-list
64968180|NCT00186745|Anticoagulants|anticoagulants|mesh-ancestor
64968181|NCT00186745|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64968182|NCT00186745|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64968183|NCT00186745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968184|NCT00186823|Antibodies|antibodies|mesh-list
64968193|NCT00186862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968195|NCT03551964|Cangrelor|cangrelor|mesh-list
64536917|NCT03028298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64536918|NCT03028298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64536919|NCT03028298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536920|NCT03028298|Urological Agents|urological agents|mesh-ancestor
64536921|NCT02986100|Rucaparib|rucaparib|mesh-list
64536922|NCT02986100|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64536923|NCT02986100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536924|NCT02986100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536925|NCT02986100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536926|NCT01540838|Acetaminophen|acetaminophen|mesh-list
64536927|NCT01540838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64536928|NCT01540838|Analgesics|analgesics|mesh-ancestor
64536929|NCT01540838|Sensory System Agents|sensory system agents|mesh-ancestor
64536930|NCT01540838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64536931|NCT01540838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536932|NCT01540838|Antipyretics|antipyretics|mesh-ancestor
64536933|NCT01451203|Methotrexate|methotrexate|mesh-list
64536934|NCT01451203|Certolizumab Pegol|certolizumab pegol|mesh-list
64536935|NCT01451203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64301597|NCT03550651|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64968196|NCT03551964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64968197|NCT03551964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64968198|NCT03551964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64968199|NCT03551964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64968200|NCT03551964|Purinergic Agents|purinergic agents|mesh-ancestor
64968201|NCT03551964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64968202|NCT03551964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968203|NCT03551964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968204|NCT00186940|Rasburicase|rasburicase|mesh-list
64968205|NCT00186940|Gout Suppressants|gout suppressants|mesh-ancestor
64968206|NCT00186940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64968207|NCT00186979|Cefixime|cefixime|mesh-list
64968208|NCT00186979|Cefpodoxime|cefpodoxime|mesh-list
64968209|NCT00186979|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
64968210|NCT00186979|Irinotecan|irinotecan|mesh-list
64968211|NCT00186979|Vincristine|vincristine|mesh-list
64968212|NCT00186979|Gefitinib|gefitinib|mesh-list
64968213|NCT00186979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64968214|NCT00186979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64968215|NCT00186979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968216|NCT00186979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968217|NCT00186979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968218|NCT00186979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64968219|NCT00186979|Tubulin Modulators|tubulin modulators|mesh-ancestor
64968220|NCT00186979|Antimitotic Agents|antimitotic agents|mesh-ancestor
64506893|NCT04858776|Hormones|hormones|mesh-ancestor
64968221|NCT00186979|Mitosis Modulators|mitosis modulators|mesh-ancestor
64968222|NCT00186979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64968223|NCT00186979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64968224|NCT00186979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64968225|NCT00187057|Cytarabine|cytarabine|mesh-list
64968226|NCT00187057|Dexamethasone|dexamethasone|mesh-list
64968227|NCT00187057|Prednisone|prednisone|mesh-list
64968228|NCT00187057|Cyclophosphamide|cyclophosphamide|mesh-list
64968229|NCT00187057|Doxorubicin|doxorubicin|mesh-list
64968230|NCT00187057|Methotrexate|methotrexate|mesh-list
64968231|NCT00187057|Etoposide|etoposide|mesh-list
64536936|NCT01451203|Abortifacient Agents|abortifacient agents|mesh-ancestor
64536937|NCT01451203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64536938|NCT01451203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536939|NCT01451203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64536940|NCT01451203|Antimetabolites|antimetabolites|mesh-ancestor
64536941|NCT01451203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536942|NCT01451203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536943|NCT01451203|Dermatologic Agents|dermatologic agents|mesh-ancestor
64536944|NCT01451203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536945|NCT01451203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64536946|NCT01451203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64536947|NCT01451203|Immunologic Factors|immunologic factors|mesh-ancestor
64536948|NCT01451203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64536949|NCT01451203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64536950|NCT01556438|Dexamethasone|dexamethasone|mesh-list
64536951|NCT01556438|Bortezomib|bortezomib|mesh-list
64536952|NCT01556438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64536953|NCT01556438|Antiemetics|antiemetics|mesh-ancestor
64536954|NCT01556438|Autonomic Agents|autonomic agents|mesh-ancestor
64536955|NCT01556438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64536956|NCT01556438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536957|NCT01556438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64536958|NCT01556438|Glucocorticoids|glucocorticoids|mesh-ancestor
64536959|NCT01556438|Hormones|hormones|mesh-ancestor
64536960|NCT01556438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64301618|NCT03551197|Glucocorticoids|glucocorticoids|mesh-ancestor
64968232|NCT00187057|Vincristine|vincristine|mesh-list
64968233|NCT00187057|Daunorubicin|daunorubicin|mesh-list
64968234|NCT00187057|Asparaginase|asparaginase|mesh-list
64968235|NCT00187057|Mercaptopurine|mercaptopurine|mesh-list
64968236|NCT00187057|Vinblastine|vinblastine|mesh-list
64968237|NCT00187057|Procarbazine|procarbazine|mesh-list
64968238|NCT00187057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64968239|NCT00187057|Immunologic Factors|immunologic factors|mesh-ancestor
64968240|NCT00187057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968241|NCT00187057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64968242|NCT00187057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64968243|NCT00187057|Alkylating Agents|alkylating agents|mesh-ancestor
64968244|NCT00187057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968245|NCT00187057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968246|NCT00187057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64968247|NCT00187057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64968248|NCT00187057|Antiemetics|antiemetics|mesh-ancestor
64968249|NCT00187057|Autonomic Agents|autonomic agents|mesh-ancestor
64968250|NCT00187057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64968251|NCT00187057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64968281|NCT00046917|Growth Inhibitors|growth inhibitors|mesh-ancestor
64536961|NCT01556438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64536962|NCT01556438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536964|NCT02073487|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64536965|NCT02073487|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64536966|NCT02073487|Trastuzumab|trastuzumab|mesh-list
64536967|NCT02073487|Lapatinib|lapatinib|mesh-list
64536968|NCT02073487|Pertuzumab|pertuzumab|mesh-list
64536969|NCT02073487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64541580|NCT02991495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536970|NCT02073487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536971|NCT02073487|Tubulin Modulators|tubulin modulators|mesh-ancestor
64536972|NCT02073487|Antimitotic Agents|antimitotic agents|mesh-ancestor
64536973|NCT02073487|Mitosis Modulators|mitosis modulators|mesh-ancestor
64536974|NCT02073487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536975|NCT02073487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64536976|NCT02073487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64536977|NCT02073487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536978|NCT01466491|Lidocaine|lidocaine|mesh-list
64536979|NCT01466491|Anesthetics, Local|anesthetics, local|mesh-ancestor
64536980|NCT01466491|Anesthetics|anesthetics|mesh-ancestor
64536981|NCT01466491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64536982|NCT01466491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536983|NCT01466491|Sensory System Agents|sensory system agents|mesh-ancestor
64536984|NCT01466491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64536985|NCT01466491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64536986|NCT01466491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64301647|NCT05075265|Methadone|methadone|mesh-list
64968282|NCT00046917|Growth Substances|growth substances|mesh-ancestor
64968283|NCT00046917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968284|NCT00046917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64968286|NCT00187174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968287|NCT00187174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64968288|NCT00187174|Immunologic Factors|immunologic factors|mesh-ancestor
64968289|NCT00187174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968290|NCT03538938|Nicotine|nicotine|mesh-list
64968291|NCT03538938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64968292|NCT03538938|Autonomic Agents|autonomic agents|mesh-ancestor
64968293|NCT03538938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64968294|NCT03538938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968295|NCT03538938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64506969|NCT02472054|Hormones|hormones|mesh-ancestor
64968296|NCT03538938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64968297|NCT03538938|Cholinergic Agents|cholinergic agents|mesh-ancestor
64968298|NCT03538938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64968321|NCT00187447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64968322|NCT00187447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64536987|NCT01466491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64536988|NCT01466491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64536989|NCT01466491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536990|NCT01466179|Blinatumomab|blinatumomab|mesh-list
64536991|NCT01466179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64536992|NCT01493089|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
64536993|NCT01493089|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64536994|NCT01493089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64536995|NCT01493089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64536996|NCT01450813|Bromides|bromides|mesh-list
64536997|NCT01450813|Rocuronium|rocuronium|mesh-list
64536998|NCT01450813|Anticonvulsants|anticonvulsants|mesh-ancestor
64536999|NCT01450813|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64537000|NCT01450813|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64301673|NCT02124655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64301674|NCT02124655|Disinfectants|disinfectants|mesh-ancestor
64968323|NCT00187447|Analgesics|analgesics|mesh-ancestor
64968324|NCT00187447|Sensory System Agents|sensory system agents|mesh-ancestor
64968325|NCT00187447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64968326|NCT00187447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968327|NCT00187447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64968328|NCT00187447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64968329|NCT00187447|Gout Suppressants|gout suppressants|mesh-ancestor
64968330|NCT00187447|Tocolytic Agents|tocolytic agents|mesh-ancestor
64968331|NCT00187447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64968332|NCT00187447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64968333|NCT00187447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541591|NCT00707655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541592|NCT04413396|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64541593|NCT04413396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541594|NCT04089150|Leucovorin|leucovorin|mesh-list
64541595|NCT04089150|Gemcitabine|gemcitabine|mesh-list
64968334|NCT00187447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968335|NCT02969564|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
64968336|NCT02969564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64968337|NCT02969564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968338|NCT00187525|Memantine|memantine|mesh-list
64968339|NCT00187525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64968340|NCT00187525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64968341|NCT00187525|Dopamine Agents|dopamine agents|mesh-ancestor
64968342|NCT00187525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64968343|NCT00187525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968344|NCT00187525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968345|NCT00187525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64968346|NCT00187525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64968347|NCT00187564|Thioctic Acid|thioctic acid|mesh-list
64968348|NCT00187564|Antioxidants|antioxidants|mesh-ancestor
64968349|NCT00187564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968350|NCT00187564|Protective Agents|protective agents|mesh-ancestor
64968351|NCT00187564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968362|NCT00046995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968364|NCT00046995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968365|NCT00046995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64968366|NCT00046995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64968367|NCT00046995|Immunologic Factors|immunologic factors|mesh-ancestor
64968368|NCT00046995|Antidotes|antidotes|mesh-ancestor
64968369|NCT00046995|Protective Agents|protective agents|mesh-ancestor
64968370|NCT00046995|Vitamin B Complex|vitamin b complex|mesh-ancestor
64968371|NCT00046995|Vitamins|vitamins|mesh-ancestor
64507042|NCT05607420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507052|NCT02471820|BB 1101|bb 1101|mesh-list
64537001|NCT01450813|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64537002|NCT01450813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64537003|NCT01450813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537004|NCT01539512|Rituximab|rituximab|mesh-list
64537005|NCT01539512|Idelalisib|idelalisib|mesh-list
64537006|NCT01539512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64537007|NCT01539512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537008|NCT01539512|Immunologic Factors|immunologic factors|mesh-ancestor
64537009|NCT01539512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537010|NCT01539512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64537011|NCT01539512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537012|NCT01539512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537013|NCT01449955|Sirolimus|sirolimus|mesh-list
64537014|NCT01449955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64537015|NCT01449955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64537016|NCT01449955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64537017|NCT01449955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537018|NCT01449955|Antifungal Agents|antifungal agents|mesh-ancestor
64537019|NCT01449955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64537020|NCT01449955|Immunologic Factors|immunologic factors|mesh-ancestor
64537021|NCT01449955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537022|NCT01574612|Acyclovir|acyclovir|mesh-list
64537023|NCT01574612|Hydrocortisone|hydrocortisone|mesh-list
64537024|NCT01574612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64537025|NCT01574612|Antiviral Agents|antiviral agents|mesh-ancestor
64537026|NCT01574612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64537027|NCT01573910|Moxifloxacin|moxifloxacin|mesh-list
64537028|NCT01573910|Ofloxacin|ofloxacin|mesh-list
64537029|NCT01573910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64537030|NCT01573910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64537031|NCT01573910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64537032|NCT01573910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64537033|NCT01573910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64537034|NCT01573910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64537035|NCT01573910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537036|NCT01573910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537041|NCT01573910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64537042|NCT01491919|Lisinopril|lisinopril|mesh-list
64537043|NCT01491919|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64537044|NCT01491919|Protease Inhibitors|protease inhibitors|mesh-ancestor
64537045|NCT01491919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537046|NCT01491919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537047|NCT01491919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64537048|NCT01491919|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64537049|NCT01491919|Protective Agents|protective agents|mesh-ancestor
64537050|NCT01491919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537051|NCT01573442|Testosterone|testosterone|mesh-list
64537052|NCT01573442|Androgens|androgens|mesh-ancestor
64484451|NCT01741532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301728|NCT02458755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968372|NCT00046995|Micronutrients|micronutrients|mesh-ancestor
64968373|NCT00058955|Sodium Oxybate|sodium oxybate|mesh-list
64968374|NCT00058955|Triazolam|triazolam|mesh-list
64968375|NCT00058955|Pentobarbital|pentobarbital|mesh-list
64968376|NCT00058955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64968377|NCT00058955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64968378|NCT00058955|Anesthetics, General|anesthetics, general|mesh-ancestor
64968379|NCT00058955|Anesthetics|anesthetics|mesh-ancestor
64968380|NCT00058955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64968381|NCT00058955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968382|NCT00058955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64968383|NCT00058955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64968384|NCT00058955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64968385|NCT00058955|GABA Modulators|gaba modulators|mesh-ancestor
64968386|NCT00058955|GABA Agents|gaba agents|mesh-ancestor
64968387|NCT00058955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654452|NCT02244710|Clopidogrel|clopidogrel|mesh-list
64968388|NCT00058955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968389|NCT00058955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64968390|NCT00187759|Cephalexin|cephalexin|mesh-list
64968391|NCT00187759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64968392|NCT00187759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64968393|NCT00187798|Metformin|metformin|mesh-list
64968394|NCT00187798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64968395|NCT00187798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968396|NCT00058994|Anecortave|anecortave|mesh-list
64968397|NCT00058994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64968398|NCT00058994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64968399|NCT00058994|Growth Substances|growth substances|mesh-ancestor
64968400|NCT00058994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968401|NCT00058994|Growth Inhibitors|growth inhibitors|mesh-ancestor
64968402|NCT00058994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968403|NCT00187915|Cyclosporine|cyclosporine|mesh-list
64968404|NCT00187915|Mycophenolic Acid|mycophenolic acid|mesh-list
64968405|NCT00187915|Tacrolimus|tacrolimus|mesh-list
64968406|NCT00187915|Cyclosporins|cyclosporins|mesh-list
64968407|NCT00187915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64968408|NCT00187915|Immunologic Factors|immunologic factors|mesh-ancestor
64968409|NCT00187915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968410|NCT00187915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64968411|NCT00187915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968412|NCT00187915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968413|NCT00187915|Antifungal Agents|antifungal agents|mesh-ancestor
64968414|NCT00187915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64968415|NCT00187915|Dermatologic Agents|dermatologic agents|mesh-ancestor
64968416|NCT00187915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64968417|NCT00187915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64968418|NCT00187915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968419|NCT00187915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64537054|NCT01573442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64537055|NCT01573442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537056|NCT02319369|Azacitidine|azacitidine|mesh-list
64537057|NCT02319369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64537058|NCT02319369|Antimetabolites|antimetabolites|mesh-ancestor
64537059|NCT02319369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537060|NCT02319369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537061|NCT02319369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537062|NCT01491841|Rituximab|rituximab|mesh-list
64537063|NCT01491841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64537064|NCT01491841|Pixantrone|pixantrone|mesh-list
64537065|NCT01491841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64537066|NCT01491841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537067|NCT01491841|Immunologic Factors|immunologic factors|mesh-ancestor
64301742|NCT02400580|Antipyretics|antipyretics|mesh-ancestor
64968435|NCT00188071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64968436|NCT00188071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64968437|NCT00188071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968438|NCT00188071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968439|NCT00188227|Midazolam|midazolam|mesh-list
64968440|NCT00188227|Pirinitramide|pirinitramide|mesh-list
64968441|NCT00188227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64968442|NCT00188227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64968443|NCT00188227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64968444|NCT00188227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968445|NCT00188227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64968446|NCT00188227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64968447|NCT00188227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64968448|NCT00188227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64968449|NCT00188227|Anesthetics, General|anesthetics, general|mesh-ancestor
64968450|NCT00188227|Anesthetics|anesthetics|mesh-ancestor
64968451|NCT00188227|GABA Modulators|gaba modulators|mesh-ancestor
64968452|NCT00188227|GABA Agents|gaba agents|mesh-ancestor
64968453|NCT00188227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64507188|NCT02989558|Ticagrelor|ticagrelor|mesh-list
64968454|NCT00188227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968455|NCT00188227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64968456|NCT00188227|Narcotics|narcotics|mesh-ancestor
64968457|NCT00188227|Analgesics|analgesics|mesh-ancestor
64968458|NCT00188227|Sensory System Agents|sensory system agents|mesh-ancestor
64968459|NCT00188227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64968460|NCT00188266|Fluorouracil|fluorouracil|mesh-list
64968461|NCT00188266|Cisplatin|cisplatin|mesh-list
64968462|NCT00188266|Antimetabolites|antimetabolites|mesh-ancestor
64968463|NCT00188266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968464|NCT00188266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64968465|NCT00188266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968466|NCT00188266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64968467|NCT00188266|Immunologic Factors|immunologic factors|mesh-ancestor
64968468|NCT00188266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968469|NCT00047073|Sirolimus|sirolimus|mesh-list
64968470|NCT00047073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64968471|NCT00047073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64968472|NCT00047073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64968473|NCT00047073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968474|NCT00047073|Antifungal Agents|antifungal agents|mesh-ancestor
64968475|NCT00047073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64968476|NCT00047073|Immunologic Factors|immunologic factors|mesh-ancestor
64968477|NCT00047073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537068|NCT01491841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537069|NCT01491841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64541620|NCT04089150|Vitamins|vitamins|mesh-ancestor
64537070|NCT01491841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64537071|NCT01491841|Alkylating Agents|alkylating agents|mesh-ancestor
64537072|NCT01491841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537073|NCT01491841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64537074|NCT01491841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64537075|NCT01491841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537077|NCT00297063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64537078|NCT00297063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537079|NCT01553318|Ketotifen|ketotifen|mesh-list
64537080|NCT01553318|Antipruritics|antipruritics|mesh-ancestor
64537081|NCT01553318|Dermatologic Agents|dermatologic agents|mesh-ancestor
64537082|NCT01553318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64301756|NCT03262857|Analgesics|analgesics|mesh-ancestor
64968478|NCT00188383|Amantadine|amantadine|mesh-list
64968479|NCT00188383|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64968514|NCT00409318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968515|NCT00409318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64968516|NCT00409318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64968517|NCT00409318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64968544|NCT00188773|Antiviral Agents|antiviral agents|mesh-ancestor
64968545|NCT00188773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64968546|NCT00188773|Expectorants|expectorants|mesh-ancestor
64968547|NCT00188773|Respiratory System Agents|respiratory system agents|mesh-ancestor
64968548|NCT00188773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64968549|NCT00188773|Antioxidants|antioxidants|mesh-ancestor
64968550|NCT00188773|Protective Agents|protective agents|mesh-ancestor
64968551|NCT00188773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968552|NCT00188773|Antidotes|antidotes|mesh-ancestor
64968553|NCT00188773|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64968554|NCT00188773|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64968555|NCT00188773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64968556|NCT00188812|Donepezil|donepezil|mesh-list
64968557|NCT00188812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64968558|NCT00188812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968559|NCT00188812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968560|NCT00188812|Cholinergic Agents|cholinergic agents|mesh-ancestor
64968590|NCT00188929|Deoxyglucose|deoxyglucose|mesh-list
64968591|NCT00188929|Antimetabolites|antimetabolites|mesh-ancestor
64968592|NCT00188929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968593|NCT00188929|Antiviral Agents|antiviral agents|mesh-ancestor
64968594|NCT00188929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64968595|NCT03428373|Rivaroxaban|rivaroxaban|mesh-list
64968596|NCT03428373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968597|NCT03428373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968598|NCT03428373|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64968599|NCT03428373|Antithrombins|antithrombins|mesh-ancestor
64968600|NCT03428373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64968602|NCT03428373|Anticoagulants|anticoagulants|mesh-ancestor
64968603|NCT00189007|Allopurinol|allopurinol|mesh-list
64968604|NCT00189007|Mannitol|mannitol|mesh-list
64968605|NCT00189007|Antimetabolites|antimetabolites|mesh-ancestor
64541628|NCT02076997|Methotrexate|methotrexate|mesh-list
64968606|NCT00189007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968633|NCT00189124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968634|NCT00189163|Pioglitazone|pioglitazone|mesh-list
64968635|NCT00189163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64968636|NCT00189163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968637|NCT00189358|Tamoxifen|tamoxifen|mesh-list
64537083|NCT01553318|Histamine Antagonists|histamine antagonists|mesh-ancestor
64537084|NCT01553318|Histamine Agents|histamine agents|mesh-ancestor
64537085|NCT01553318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64537086|NCT01553318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537087|NCT01553318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654517|NCT02245022|Efavirenz|efavirenz|mesh-list
64968639|NCT00189358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64968640|NCT00189358|Hormone Antagonists|hormone antagonists|mesh-ancestor
64968641|NCT00189358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64968642|NCT00189358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968643|NCT00189358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64968644|NCT00189358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968645|NCT00189358|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64968646|NCT00189358|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64968647|NCT00189358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64968648|NCT00189358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64968649|NCT00189358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968650|NCT00189358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968651|NCT00189397|Azathioprine|azathioprine|mesh-list
64968652|NCT00189397|Antimetabolites|antimetabolites|mesh-ancestor
64968653|NCT00189397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968654|NCT00189397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64968680|NCT00189709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64968681|NCT00189709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64968682|NCT00189709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64968683|NCT00189709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968684|NCT00189709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968685|NCT00189709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64968686|NCT00189709|Hormone Antagonists|hormone antagonists|mesh-ancestor
64968687|NCT00189709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64968688|NCT00189709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968689|NCT00189709|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64968690|NCT00189709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64968691|NCT04722796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64968693|NCT00189748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64968694|NCT00189748|Immunologic Factors|immunologic factors|mesh-ancestor
64968695|NCT00189748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968696|NCT00189748|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64968697|NCT00189748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968698|NCT00189748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968699|NCT00189787|Tacrolimus|tacrolimus|mesh-list
64968700|NCT00189787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64968701|NCT00189787|Immunologic Factors|immunologic factors|mesh-ancestor
64968731|NCT00190021|Nootropic Agents|nootropic agents|mesh-ancestor
64968732|NCT00190060|Testosterone|testosterone|mesh-list
64968733|NCT00190060|Androgens|androgens|mesh-ancestor
64968734|NCT00190060|Hormones|hormones|mesh-ancestor
64654534|NCT02245022|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64654535|NCT02224313|Estradiol|estradiol|mesh-list
64654536|NCT02224313|Progesterone|progesterone|mesh-list
64654537|NCT02224313|Estrogens|estrogens|mesh-ancestor
64654538|NCT02224313|Hormones|hormones|mesh-ancestor
64978080|NCT00268255|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64654539|NCT02224313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64654540|NCT02224313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654541|NCT02224313|Progestins|progestins|mesh-ancestor
64654542|NCT04362410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64654543|NCT04362410|Immunologic Factors|immunologic factors|mesh-ancestor
64654544|NCT04362410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968735|NCT00190060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64968736|NCT00190060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968737|NCT00047229|Doxorubicin|doxorubicin|mesh-list
64968738|NCT00047229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64968739|NCT00047229|Oblimersen|oblimersen|mesh-list
64968740|NCT00047229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64968741|NCT00047229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968742|NCT00047229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64968743|NCT00047229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64968744|NCT00047229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968745|NCT00047229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968746|NCT00190099|Dexamethasone|dexamethasone|mesh-list
64537090|NCT01572740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64537091|NCT01572740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537092|NCT01572740|Incretins|incretins|mesh-ancestor
64537094|NCT01572740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64537095|NCT01491607|Vaccines|vaccines|mesh-list
64537096|NCT01491607|Immunologic Factors|immunologic factors|mesh-ancestor
64537097|NCT01491607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537098|NCT02338713|Calcium Carbonate|calcium carbonate|mesh-list
64537099|NCT02338713|Antacids|antacids|mesh-ancestor
64537100|NCT02338713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537101|NCT02338713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64537102|NCT00557349|Omeprazole|omeprazole|mesh-list
64537103|NCT00557349|Famotidine|famotidine|mesh-list
64537104|NCT00557349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64301776|NCT02127697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64968763|NCT02963077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64968764|NCT00047268|Cytarabine|cytarabine|mesh-list
64968765|NCT00047268|Mercaptopurine|mercaptopurine|mesh-list
64968766|NCT00047268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64968767|NCT00047268|Antimetabolites|antimetabolites|mesh-ancestor
64968768|NCT00047268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968769|NCT00047268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968770|NCT00047268|Antiviral Agents|antiviral agents|mesh-ancestor
64968771|NCT00047268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64968772|NCT00047268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64968773|NCT00047268|Immunologic Factors|immunologic factors|mesh-ancestor
64968774|NCT00047268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968775|NCT00047268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64968776|NCT00047268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968777|NCT00190294|Misoprostol|misoprostol|mesh-list
64968778|NCT00190294|Mifepristone|mifepristone|mesh-list
64968779|NCT00190294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64968780|NCT00190294|Abortifacient Agents|abortifacient agents|mesh-ancestor
64968781|NCT00190294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64968782|NCT00190294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968783|NCT00190294|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64968784|NCT00190294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64968785|NCT00190294|Oxytocics|oxytocics|mesh-ancestor
64968786|NCT00190294|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64968787|NCT00190294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64968788|NCT00190294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64968789|NCT00190294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64968790|NCT00190294|Contraceptive Agents|contraceptive agents|mesh-ancestor
64968791|NCT00190294|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64968792|NCT00190294|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64541648|NCT05365165|Anesthetics|anesthetics|mesh-ancestor
64968793|NCT00190294|Hormone Antagonists|hormone antagonists|mesh-ancestor
64968794|NCT00190294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64968795|NCT00190294|Luteolytic Agents|luteolytic agents|mesh-ancestor
64654568|NCT02460198|Pembrolizumab|pembrolizumab|mesh-list
64654569|NCT02460198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64654570|NCT02460198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654571|NCT01633853|Vitamin D|vitamin d|mesh-list
64654572|NCT01633853|Ergocalciferols|ergocalciferols|mesh-list
64654573|NCT01633853|Cholecalciferol|cholecalciferol|mesh-list
64654574|NCT01633853|Vitamins|vitamins|mesh-list
64968797|NCT00190294|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64968798|NCT03238365|Nivolumab|nivolumab|mesh-list
64968799|NCT03238365|Tadalafil|tadalafil|mesh-list
64968800|NCT03238365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64968801|NCT03238365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968802|NCT03238365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64968824|NCT00190372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64968825|NCT00190372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968826|NCT00190411|Celiprolol|celiprolol|mesh-list
64537105|NCT00557349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64537106|NCT00557349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64537107|NCT00557349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537108|NCT00557349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537109|NCT00557349|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64537110|NCT00557349|Histamine Antagonists|histamine antagonists|mesh-ancestor
64537111|NCT00557349|Histamine Agents|histamine agents|mesh-ancestor
64537112|NCT00557349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64537113|NCT00557349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537114|NCT01553084|Nicotine|nicotine|mesh-list
64537115|NCT01553084|Varenicline|varenicline|mesh-list
64537116|NCT01553084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64537117|NCT01553084|Autonomic Agents|autonomic agents|mesh-ancestor
64537118|NCT01553084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301792|NCT02252341|Respiratory System Agents|respiratory system agents|mesh-ancestor
64968827|NCT00190411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64968828|NCT00190411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64968829|NCT00190411|Sympathomimetics|sympathomimetics|mesh-ancestor
64968830|NCT00190411|Autonomic Agents|autonomic agents|mesh-ancestor
64968831|NCT00190411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64968832|NCT00190411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968833|NCT00190411|Vasodilator Agents|vasodilator agents|mesh-ancestor
64968834|NCT00190411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64968835|NCT00190411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64968836|NCT00190411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64968837|NCT00190411|Adrenergic Agents|adrenergic agents|mesh-ancestor
64968838|NCT00190411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64968839|NCT00190411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968840|NCT00047307|Gemcitabine|gemcitabine|mesh-list
64968841|NCT00047307|Alvocidib|alvocidib|mesh-list
64968842|NCT00047307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64968843|NCT00047307|Antimetabolites|antimetabolites|mesh-ancestor
64968844|NCT00047307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968845|NCT00047307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968846|NCT00047307|Antiviral Agents|antiviral agents|mesh-ancestor
64968847|NCT00047307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64968848|NCT00047307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968849|NCT00047307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64968850|NCT00047307|Immunologic Factors|immunologic factors|mesh-ancestor
64968851|NCT00047307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968867|NCT00190567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968868|NCT00190567|Analgesics|analgesics|mesh-ancestor
64968869|NCT00190567|Sensory System Agents|sensory system agents|mesh-ancestor
64968870|NCT00190567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64968871|NCT00190567|Antidepressive Agents|antidepressive agents|mesh-ancestor
64968872|NCT00190567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64968873|NCT00190567|Dopamine Agents|dopamine agents|mesh-ancestor
64968875|NCT02969252|Rifamycin SV|rifamycin sv|mesh-list
64968876|NCT02969252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64968877|NCT02969252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64968878|NCT02969252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64968879|NCT00190606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64968880|NCT00190606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64968881|NCT00190606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64968882|NCT00190606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64968883|NCT00190606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537119|NCT01553084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537120|NCT01553084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64537121|NCT01553084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64537122|NCT01553084|Cholinergic Agents|cholinergic agents|mesh-ancestor
64537123|NCT01553084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64537124|NCT01553084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714137|NCT00373789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493222|NCT03867201|Erenumab|erenumab|mesh-list
64537125|NCT01552928|Moxifloxacin|moxifloxacin|mesh-list
64537126|NCT01552928|Anagrelide|anagrelide|mesh-list
64537127|NCT01552928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64537128|NCT01552928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64537129|NCT01552928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64537130|NCT01552928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64537131|NCT01552928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537132|NCT01552928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537133|NCT01552928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537134|NCT01552928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64537135|NCT01552928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64537136|NCT01552928|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64537137|NCT01448707|Ritonavir|ritonavir|mesh-list
64537138|NCT01448707|Darunavir|darunavir|mesh-list
64537139|NCT01448707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64537140|NCT01448707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64537141|NCT01448707|Protease Inhibitors|protease inhibitors|mesh-ancestor
64537142|NCT01448707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537143|NCT01448707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537144|NCT01448707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64968884|NCT00190606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64968885|NCT00190606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968886|NCT00190606|Analgesics|analgesics|mesh-ancestor
64968887|NCT00190606|Sensory System Agents|sensory system agents|mesh-ancestor
64968888|NCT00190606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64968889|NCT00190606|Antidepressive Agents|antidepressive agents|mesh-ancestor
64968890|NCT00190606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64968891|NCT00190606|Dopamine Agents|dopamine agents|mesh-ancestor
64968892|NCT00190645|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64968893|NCT00190645|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64968894|NCT00190645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64968895|NCT00190645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64968896|NCT00190645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968897|NCT00190645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64968898|NCT00190645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968899|NCT00190645|Analgesics|analgesics|mesh-ancestor
64968900|NCT00190645|Sensory System Agents|sensory system agents|mesh-ancestor
64537145|NCT01448707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64537146|NCT01448707|Antiviral Agents|antiviral agents|mesh-ancestor
64537147|NCT01448707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64537148|NCT01448707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64537149|NCT01448707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64537151|NCT01536704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64537152|NCT01536704|Autonomic Agents|autonomic agents|mesh-ancestor
64537153|NCT01536704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64537154|NCT01536704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301835|NCT01367119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64968901|NCT00190645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64968902|NCT00190645|Antidepressive Agents|antidepressive agents|mesh-ancestor
64968903|NCT00190645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64968904|NCT00190645|Dopamine Agents|dopamine agents|mesh-ancestor
64968905|NCT00190762|Pemetrexed|pemetrexed|mesh-list
64968919|NCT00047346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64968920|NCT00047346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968921|NCT00047346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968923|NCT00190840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968924|NCT00190840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968925|NCT00190840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968926|NCT00190840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64968927|NCT00190840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64968928|NCT00190879|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64968929|NCT00190879|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64968930|NCT00190879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64968931|NCT00190879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64968932|NCT00190879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968933|NCT00190879|Adrenergic Agents|adrenergic agents|mesh-ancestor
64968934|NCT00190879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64968935|NCT00190879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968936|NCT00190918|Pemetrexed|pemetrexed|mesh-list
64968937|NCT00190918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968938|NCT00190918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968939|NCT00190918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968940|NCT00190918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64968941|NCT00190918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64968942|NCT00190957|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64968943|NCT00190957|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64968944|NCT00190957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64968945|NCT00190957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64968946|NCT00190957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968947|NCT00190957|Adrenergic Agents|adrenergic agents|mesh-ancestor
64968948|NCT00190957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64968949|NCT00190957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968950|NCT00190996|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64968951|NCT00190996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64968952|NCT00190996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64968953|NCT00190996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64968954|NCT00190996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968955|NCT00190996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64968956|NCT00190996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968957|NCT00190996|Analgesics|analgesics|mesh-ancestor
64968958|NCT00190996|Sensory System Agents|sensory system agents|mesh-ancestor
64968959|NCT00190996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64968960|NCT00190996|Antidepressive Agents|antidepressive agents|mesh-ancestor
64968961|NCT00190996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64537155|NCT01536704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64537156|NCT01536704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64537157|NCT01536704|Cholinergic Agents|cholinergic agents|mesh-ancestor
64537158|NCT01536704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64537159|NCT01536704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537160|NCT04108676|Omeprazole|omeprazole|mesh-list
64537161|NCT04108676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64537162|NCT04108676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64537163|NCT04108676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64537164|NCT04108676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537165|NCT04108676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537166|NCT01552772|Aripiprazole|aripiprazole|mesh-list
64537167|NCT01552772|Antidepressive Agents|antidepressive agents|mesh-ancestor
64537168|NCT01552772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64537169|NCT01552772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64537170|NCT01552772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64537171|NCT01552772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64537172|NCT01552772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537173|NCT01552772|Dopamine Agonists|dopamine agonists|mesh-ancestor
64537174|NCT01552772|Dopamine Agents|dopamine agents|mesh-ancestor
64537175|NCT01552772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64537176|NCT01552772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537177|NCT01552772|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64537178|NCT01552772|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64968980|NCT02922894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968981|NCT02922894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64968983|NCT02922894|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64968984|NCT02922894|Antidepressive Agents|antidepressive agents|mesh-ancestor
64968985|NCT00191230|Gemcitabine|gemcitabine|mesh-list
64968986|NCT00191230|Carboplatin|carboplatin|mesh-list
64968987|NCT00191230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968988|NCT00191230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64968989|NCT00191230|Antimetabolites|antimetabolites|mesh-ancestor
64968990|NCT00191230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968991|NCT00191230|Antiviral Agents|antiviral agents|mesh-ancestor
64968992|NCT00191230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64968993|NCT00191230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968994|NCT00191230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64968995|NCT00191230|Immunologic Factors|immunologic factors|mesh-ancestor
64968996|NCT00191230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968997|NCT00191347|Gemcitabine|gemcitabine|mesh-list
64968998|NCT00191347|Pemetrexed|pemetrexed|mesh-list
64968999|NCT00191347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64969000|NCT00191347|Antimetabolites|antimetabolites|mesh-ancestor
64969001|NCT00191347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969002|NCT00191347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969003|NCT00191347|Antiviral Agents|antiviral agents|mesh-ancestor
64537179|NCT01552772|Serotonin Agents|serotonin agents|mesh-ancestor
64537180|NCT01552772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64537181|NCT01552772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64537182|NCT01552772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64537183|NCT01552772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64537184|NCT01552694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64537185|NCT01552694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64537186|NCT01552694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537187|NCT01552694|Incretins|incretins|mesh-ancestor
64537188|NCT01552694|Hormones|hormones|mesh-ancestor
64537189|NCT01552694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64537190|NCT01552694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64537191|NCT01552694|Protease Inhibitors|protease inhibitors|mesh-ancestor
64537192|NCT01552694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64301871|NCT02125201|Narcotics|narcotics|mesh-ancestor
64541706|NCT01270191|Exenatide|exenatide|mesh-list
64301872|NCT02125201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64969004|NCT00191347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969005|NCT00191347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969006|NCT00191347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64969007|NCT00191347|Immunologic Factors|immunologic factors|mesh-ancestor
64969008|NCT00191347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969009|NCT00191347|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64969010|NCT00191347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64969011|NCT00191425|Teriparatide|teriparatide|mesh-list
64969012|NCT00191425|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64969013|NCT00191425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64969014|NCT00191425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969015|NCT00191425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64969016|NCT00191425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64969017|NCT00191425|Hormone Antagonists|hormone antagonists|mesh-ancestor
64969034|NCT04723030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969035|NCT00191503|Gemcitabine|gemcitabine|mesh-list
64969036|NCT00191503|Pemetrexed|pemetrexed|mesh-list
64507787|NCT03686124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969037|NCT00191503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64969038|NCT00191503|Antimetabolites|antimetabolites|mesh-ancestor
64969039|NCT00191503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969040|NCT00191503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969041|NCT00191503|Antiviral Agents|antiviral agents|mesh-ancestor
64969042|NCT00191503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969043|NCT00191503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969045|NCT00191503|Immunologic Factors|immunologic factors|mesh-ancestor
64969046|NCT00191503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969047|NCT00191503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64969048|NCT00191503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64969049|NCT00191542|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64969050|NCT00191542|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64969051|NCT00191542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64969052|NCT00191542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64969053|NCT00191542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969054|NCT00191542|Adrenergic Agents|adrenergic agents|mesh-ancestor
64969055|NCT00191542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64969056|NCT00191542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969057|NCT00059735|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
64969058|NCT00059735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537193|NCT01552694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537194|NCT01464931|Denosumab|denosumab|mesh-list
64537195|NCT01464931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64537196|NCT01464931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537197|NCT01536392|Ondansetron|ondansetron|mesh-list
64714138|NCT00373789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64537198|NCT01536392|Granisetron|granisetron|mesh-list
64537199|NCT01536392|Antiemetics|antiemetics|mesh-ancestor
64537200|NCT01536392|Autonomic Agents|autonomic agents|mesh-ancestor
64537201|NCT01536392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64537202|NCT01536392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537203|NCT01536392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64537204|NCT01536392|Antipruritics|antipruritics|mesh-ancestor
64537205|NCT01536392|Dermatologic Agents|dermatologic agents|mesh-ancestor
64537206|NCT01536392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64537207|NCT01536392|Serotonin Agents|serotonin agents|mesh-ancestor
64537208|NCT01536392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64537209|NCT01536392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537210|NCT01536392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64537211|NCT01536392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64537212|NCT01536392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64537213|NCT01536392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64537214|NCT01536392|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64537215|NCT04767295|Paclitaxel|paclitaxel|mesh-list
64537216|NCT04767295|Carboplatin|carboplatin|mesh-list
64978120|NCT00073697|Serotonin Agents|serotonin agents|mesh-ancestor
64301888|NCT02125357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969059|NCT00059735|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64969060|NCT00059735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969061|NCT00059735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969062|NCT02628366|Dialysis Solutions|dialysis solutions|mesh-list
64969063|NCT02628366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64969064|NCT00191581|Insulin|insulin|mesh-list
64969065|NCT00191581|Insulin Lispro|insulin lispro|mesh-list
64969066|NCT00191581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64969067|NCT00191581|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
64969068|NCT00191581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64969069|NCT00191581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969070|NCT00191620|Gemcitabine|gemcitabine|mesh-list
64969071|NCT00191620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969072|NCT00191620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64969073|NCT00191620|Antimetabolites|antimetabolites|mesh-ancestor
64969095|NCT00191698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64969096|NCT00191698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969098|NCT02470299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64969099|NCT02470299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64969100|NCT02470299|Analgesics|analgesics|mesh-ancestor
64969101|NCT02470299|Sensory System Agents|sensory system agents|mesh-ancestor
64969102|NCT02470299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64537217|NCT04767295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64537218|NCT04767295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537219|NCT04767295|Tubulin Modulators|tubulin modulators|mesh-ancestor
64537220|NCT04767295|Antimitotic Agents|antimitotic agents|mesh-ancestor
64537221|NCT04767295|Mitosis Modulators|mitosis modulators|mesh-ancestor
64537222|NCT04767295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537223|NCT02118831|Bevacizumab|bevacizumab|mesh-list
64537224|NCT02118831|Ranibizumab|ranibizumab|mesh-list
64537225|NCT02118831|Aflibercept|aflibercept|mesh-list
64537226|NCT02118831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64969103|NCT02470299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969104|NCT02470299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64969105|NCT02470299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64507788|NCT03686124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64969106|NCT02470299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64969107|NCT02470299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969108|NCT02470299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969109|NCT00191737|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64969110|NCT00191737|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64969111|NCT00191737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64969112|NCT00191737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64969113|NCT00191737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969114|NCT00191737|Adrenergic Agents|adrenergic agents|mesh-ancestor
64969115|NCT00191737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64969116|NCT00191737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969117|NCT00191893|Teriparatide|teriparatide|mesh-list
64969118|NCT00191893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64969119|NCT00191893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969138|NCT00059813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969139|NCT00059813|Antiviral Agents|antiviral agents|mesh-ancestor
64969140|NCT00059813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969141|NCT00059813|Immunologic Factors|immunologic factors|mesh-ancestor
64969142|NCT00059813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969143|NCT00191971|Gemcitabine|gemcitabine|mesh-list
64969144|NCT00191971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64969145|NCT00191971|Antimetabolites|antimetabolites|mesh-ancestor
64969146|NCT00191971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969147|NCT00191971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969148|NCT00191971|Antiviral Agents|antiviral agents|mesh-ancestor
64969149|NCT00191971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969150|NCT00191971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969151|NCT00191971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64969152|NCT00191971|Immunologic Factors|immunologic factors|mesh-ancestor
64969153|NCT00191971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969154|NCT00047502|Imatinib Mesylate|imatinib mesylate|mesh-list
64969155|NCT00047502|Lonafarnib|lonafarnib|mesh-list
64969156|NCT00047502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969157|NCT00047502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64969158|NCT00047502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969159|NCT00047502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969160|NCT00192049|Gemcitabine|gemcitabine|mesh-list
64969161|NCT00192049|Mitomycins|mitomycins|mesh-list
64969162|NCT00192049|Mitomycin|mitomycin|mesh-list
64969163|NCT00192049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64969164|NCT00192049|Antimetabolites|antimetabolites|mesh-ancestor
64969165|NCT00192049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969166|NCT00192049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969167|NCT00192049|Antiviral Agents|antiviral agents|mesh-ancestor
64969168|NCT00192049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969169|NCT00192049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969170|NCT00192049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64969171|NCT00192049|Immunologic Factors|immunologic factors|mesh-ancestor
64969172|NCT00192049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537227|NCT02118831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537228|NCT02118831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64537229|NCT02118831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64537230|NCT02118831|Growth Substances|growth substances|mesh-ancestor
64537231|NCT02118831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537232|NCT02118831|Growth Inhibitors|growth inhibitors|mesh-ancestor
64537233|NCT01447927|Metformin|metformin|mesh-list
64537234|NCT01447927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64537235|NCT01447927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537236|NCT00490269|Dronabinol|dronabinol|mesh-list
64537237|NCT00490269|Hallucinogens|hallucinogens|mesh-ancestor
64537238|NCT00490269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537239|NCT00490269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64537240|NCT00490269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64537241|NCT00490269|Analgesics|analgesics|mesh-ancestor
64537242|NCT00490269|Sensory System Agents|sensory system agents|mesh-ancestor
64537243|NCT00490269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64537244|NCT00490269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64537245|NCT00490269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64537246|NCT00490269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64537247|NCT00490269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537248|NCT00490269|Hormones|hormones|mesh-ancestor
64537249|NCT00490269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64537250|NCT05621655|Vaccines|vaccines|mesh-list
64537251|NCT05621655|Immunologic Factors|immunologic factors|mesh-ancestor
64537252|NCT05621655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537253|NCT05621499|Lenvatinib|lenvatinib|mesh-list
64537254|NCT05621499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301924|NCT02128243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64969173|NCT00192049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64969174|NCT00192049|Alkylating Agents|alkylating agents|mesh-ancestor
64969196|NCT00047580|Tizanidine|tizanidine|mesh-list
64969197|NCT00047580|Analgesics|analgesics|mesh-ancestor
64969198|NCT00047580|Sensory System Agents|sensory system agents|mesh-ancestor
64969199|NCT00047580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64969200|NCT00047580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969201|NCT00047580|Anticonvulsants|anticonvulsants|mesh-ancestor
64969202|NCT00047580|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64969203|NCT00047580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64969204|NCT00047580|Parasympatholytics|parasympatholytics|mesh-ancestor
64969205|NCT00047580|Autonomic Agents|autonomic agents|mesh-ancestor
64969206|NCT00047580|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64969207|NCT00047580|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64969208|NCT00047580|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64969209|NCT00047580|Adrenergic Agents|adrenergic agents|mesh-ancestor
64537255|NCT05621499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64537256|NCT05621499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537257|NCT05621499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537258|NCT01490125|Glycopyrrolate|glycopyrrolate|mesh-list
64537259|NCT01490125|Albuterol|albuterol|mesh-list
64537260|NCT01490125|Tiotropium Bromide|tiotropium bromide|mesh-list
64969210|NCT00047580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64969211|NCT00047580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969212|NCT02968901|Tadalafil|tadalafil|mesh-list
64969213|NCT02968901|Macitentan|macitentan|mesh-list
64969214|NCT02968901|Vasodilator Agents|vasodilator agents|mesh-ancestor
64969215|NCT02968901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64969216|NCT02968901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64969217|NCT02968901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969218|NCT02968901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969219|NCT02968901|Urological Agents|urological agents|mesh-ancestor
64969220|NCT02968901|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64969221|NCT02968901|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64969222|NCT02968901|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64969223|NCT00192595|Tenofovir|tenofovir|mesh-list
64969224|NCT00192595|Lamivudine|lamivudine|mesh-list
64969225|NCT00192595|Zidovudine|zidovudine|mesh-list
64969226|NCT00192595|Efavirenz|efavirenz|mesh-list
64969227|NCT00192595|Antiviral Agents|antiviral agents|mesh-ancestor
64969251|NCT00192634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969253|NCT00192634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64507934|NCT05224336|Niacin|niacin|mesh-list
64508009|NCT02988700|Anesthetics|anesthetics|mesh-ancestor
64969254|NCT00192673|Asparaginase|asparaginase|mesh-list
64969255|NCT00192673|Pegaspargase|pegaspargase|mesh-list
64969256|NCT00192673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969257|NCT00192712|Gemcitabine|gemcitabine|mesh-list
64969258|NCT00192712|Irinotecan|irinotecan|mesh-list
64969259|NCT00192712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64969260|NCT00192712|Antimetabolites|antimetabolites|mesh-ancestor
64969261|NCT00192712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969262|NCT00192712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969263|NCT00192712|Antiviral Agents|antiviral agents|mesh-ancestor
64969265|NCT00192712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969266|NCT00192712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64969267|NCT00192712|Immunologic Factors|immunologic factors|mesh-ancestor
64969268|NCT00192712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969269|NCT00192712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64969270|NCT00192712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64969271|NCT00047658|Interferons|interferons|mesh-list
64969272|NCT00047658|Interferon-gamma|interferon-gamma|mesh-list
64969273|NCT00047658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969274|NCT00047658|Antiviral Agents|antiviral agents|mesh-ancestor
64969275|NCT00047658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969276|NCT00193024|Docetaxel|docetaxel|mesh-list
64969308|NCT00193141|Tubulin Modulators|tubulin modulators|mesh-ancestor
64969309|NCT00193141|Antimitotic Agents|antimitotic agents|mesh-ancestor
64969310|NCT00193141|Mitosis Modulators|mitosis modulators|mesh-ancestor
64969311|NCT00193141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969313|NCT00193141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64969314|NCT00193141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64969315|NCT00193141|Immunologic Factors|immunologic factors|mesh-ancestor
64969316|NCT00193141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969317|NCT00193297|Paclitaxel|paclitaxel|mesh-list
64969318|NCT00193297|Carboplatin|carboplatin|mesh-list
64969319|NCT00193297|Topotecan|topotecan|mesh-list
64969350|NCT00193570|Antimitotic Agents|antimitotic agents|mesh-ancestor
64969351|NCT00193570|Mitosis Modulators|mitosis modulators|mesh-ancestor
64969352|NCT00193570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969353|NCT00193570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64969354|NCT00193570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64969355|NCT00193570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969356|NCT00047736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64969357|NCT00047736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537261|NCT01490125|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64537262|NCT01490125|Autonomic Agents|autonomic agents|mesh-ancestor
64537263|NCT01490125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64537264|NCT01490125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537265|NCT01490125|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64537266|NCT01490125|Respiratory System Agents|respiratory system agents|mesh-ancestor
64537267|NCT01490125|Parasympatholytics|parasympatholytics|mesh-ancestor
64537268|NCT01490125|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64301964|NCT02132689|Heparin|heparin|mesh-list
64969358|NCT00047736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64969359|NCT00047736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969360|NCT00047736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969361|NCT00409591|Ritonavir|ritonavir|mesh-list
64969362|NCT00409591|Lopinavir|lopinavir|mesh-list
64969363|NCT00409591|Zidovudine|zidovudine|mesh-list
64969364|NCT00409591|Nevirapine|nevirapine|mesh-list
64969365|NCT00409591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64969366|NCT00409591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64969383|NCT00409630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64969384|NCT00409630|Autonomic Agents|autonomic agents|mesh-ancestor
64969385|NCT00409630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64969386|NCT00409630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969387|NCT00409630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64969388|NCT00409630|Respiratory System Agents|respiratory system agents|mesh-ancestor
64969389|NCT00409630|Dermatologic Agents|dermatologic agents|mesh-ancestor
64969390|NCT00409630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64969392|NCT00060125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969393|NCT00193648|Rosiglitazone|rosiglitazone|mesh-list
64969394|NCT00193648|Adalimumab|adalimumab|mesh-list
64969395|NCT00193648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64969396|NCT00193648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64969397|NCT00193648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64969398|NCT00193648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969399|NCT00193726|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64969400|NCT00193726|Estradiol|estradiol|mesh-list
64969401|NCT00193726|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64969402|NCT00193726|Estrogens|estrogens|mesh-ancestor
64969403|NCT00193726|Hormones|hormones|mesh-ancestor
64969404|NCT00193726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64969405|NCT00193726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508084|NCT03307590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64508159|NCT02468232|Enalapril|enalapril|mesh-list
64969406|NCT00193726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64969407|NCT00193726|Contraceptive Agents|contraceptive agents|mesh-ancestor
64969408|NCT00193726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64969409|NCT00193726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64541744|NCT00159432|Capecitabine|capecitabine|mesh-list
64969410|NCT00193726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64969411|NCT00193726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64969412|NCT00193882|Cisplatin|cisplatin|mesh-list
64969413|NCT00193882|Fluorouracil|fluorouracil|mesh-list
64969414|NCT00193882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969415|NCT00193882|Antimetabolites|antimetabolites|mesh-ancestor
64969416|NCT00193882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969417|NCT00193882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64969418|NCT00193882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64969419|NCT00193882|Immunologic Factors|immunologic factors|mesh-ancestor
64969420|NCT00193882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969421|NCT00060242|Fosbretabulin|fosbretabulin|mesh-list
64969422|NCT00060242|Combretastatin|combretastatin|mesh-list
64969445|NCT00193921|Mitosis Modulators|mitosis modulators|mesh-ancestor
64969446|NCT00194038|Aripiprazole|aripiprazole|mesh-list
64969447|NCT00194038|Antidepressive Agents|antidepressive agents|mesh-ancestor
64969448|NCT00194038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64969449|NCT00194038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64969450|NCT00194038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64969451|NCT00194038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64969452|NCT00194038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537269|NCT01490125|Cholinergic Agents|cholinergic agents|mesh-ancestor
64537270|NCT01490125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64537271|NCT01490125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537272|NCT01490125|Tocolytic Agents|tocolytic agents|mesh-ancestor
64537273|NCT01490125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64537274|NCT01490125|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64537275|NCT01490125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64537276|NCT01490125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64537277|NCT01490125|Adrenergic Agents|adrenergic agents|mesh-ancestor
64537278|NCT01490125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64537279|NCT01490125|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64537280|NCT00491751|Ascorbic Acid|ascorbic acid|mesh-list
64537281|NCT00491751|Atorvastatin|atorvastatin|mesh-list
64537282|NCT00491751|Vitamins|vitamins|mesh-ancestor
64537283|NCT00491751|Micronutrients|micronutrients|mesh-ancestor
64537284|NCT00491751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537285|NCT00491751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64537286|NCT00491751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64537287|NCT00491751|Antimetabolites|antimetabolites|mesh-ancestor
64301966|NCT02132689|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64969453|NCT00194038|Dopamine Agonists|dopamine agonists|mesh-ancestor
64969454|NCT00194038|Dopamine Agents|dopamine agents|mesh-ancestor
64969455|NCT00194038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64969456|NCT00194038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969457|NCT00194038|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64969458|NCT00194038|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64969459|NCT00194038|Serotonin Agents|serotonin agents|mesh-ancestor
64969460|NCT00194038|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64969461|NCT00194038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64969462|NCT00194038|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64969463|NCT00194038|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64969464|NCT00060359|Paclitaxel|paclitaxel|mesh-list
64969465|NCT00060359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64969466|NCT00060359|Carboplatin|carboplatin|mesh-list
64969467|NCT00060359|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
64969468|NCT00060359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64969469|NCT00060359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969470|NCT00060359|Tubulin Modulators|tubulin modulators|mesh-ancestor
64969472|NCT00060359|Mitosis Modulators|mitosis modulators|mesh-ancestor
64969473|NCT00060359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969474|NCT00194272|Methotrexate|methotrexate|mesh-list
64969504|NCT00060398|Autonomic Agents|autonomic agents|mesh-ancestor
64969505|NCT00060398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64969506|NCT00060398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969507|NCT00060398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64969508|NCT00060398|Glucocorticoids|glucocorticoids|mesh-ancestor
64969509|NCT00060398|Hormones|hormones|mesh-ancestor
64969510|NCT00060398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64969511|NCT00060398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64969512|NCT00060398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969513|NCT00060398|Hematinics|hematinics|mesh-ancestor
64969514|NCT00194623|Botulinum Toxins|botulinum toxins|mesh-list
64969515|NCT00194623|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64969516|NCT00194623|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64537288|NCT00491751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537289|NCT00491751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64537290|NCT00491751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64537291|NCT00491751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537292|NCT00491751|Antioxidants|antioxidants|mesh-ancestor
64537293|NCT00491751|Protective Agents|protective agents|mesh-ancestor
64537294|NCT01420549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64537295|NCT01420549|Simvastatin|simvastatin|mesh-list
64537296|NCT01420549|Ezetimibe|ezetimibe|mesh-list
64537297|NCT01420549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64537298|NCT01420549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64537299|NCT01420549|Antimetabolites|antimetabolites|mesh-ancestor
64537300|NCT01420549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537301|NCT01420549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64537302|NCT01420549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64537303|NCT01420549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537304|NCT01440595|Ribavirin|ribavirin|mesh-list
64537305|NCT01440595|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64537306|NCT01440595|Grazoprevir|grazoprevir|mesh-list
64537307|NCT01440595|Antimetabolites|antimetabolites|mesh-ancestor
64537308|NCT01440595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537309|NCT01440595|Antiviral Agents|antiviral agents|mesh-ancestor
64301985|NCT02457975|Aflibercept|aflibercept|mesh-list
64969517|NCT00194623|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64969518|NCT00194623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64969519|NCT00194623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969520|NCT00194623|Cholinergic Agents|cholinergic agents|mesh-ancestor
64969549|NCT00194935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969550|NCT00194974|Clonidine|clonidine|mesh-list
64969551|NCT00194974|Labetalol|labetalol|mesh-list
64508233|NCT03300960|Ganirelix|ganirelix|mesh-list
64508244|NCT02993146|Ropidoxuridine|ropidoxuridine|mesh-list
64969552|NCT00194974|Methyldopa|methyldopa|mesh-list
64969553|NCT00194974|Nifedipine|nifedipine|mesh-list
64969554|NCT00194974|Analgesics|analgesics|mesh-ancestor
64969555|NCT00194974|Sensory System Agents|sensory system agents|mesh-ancestor
64969556|NCT00194974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64969557|NCT00194974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969558|NCT00194974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64969559|NCT00194974|Sympatholytics|sympatholytics|mesh-ancestor
64969560|NCT00194974|Autonomic Agents|autonomic agents|mesh-ancestor
64969561|NCT00194974|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64969562|NCT00194974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64969563|NCT00194974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64969564|NCT00194974|Adrenergic Agents|adrenergic agents|mesh-ancestor
64969565|NCT00194974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64969586|NCT02963116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64969587|NCT02963116|Antimetabolites|antimetabolites|mesh-ancestor
64969588|NCT02963116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969589|NCT02963116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64969590|NCT02963116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64537311|NCT05560035|Lidocaine|lidocaine|mesh-list
64537312|NCT05560035|Anesthetics, Local|anesthetics, local|mesh-ancestor
64537313|NCT05560035|Anesthetics|anesthetics|mesh-ancestor
64537314|NCT05560035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64537315|NCT05560035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537316|NCT05560035|Sensory System Agents|sensory system agents|mesh-ancestor
64537317|NCT05560035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64537318|NCT05560035|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64537319|NCT05560035|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64537320|NCT05560035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64537321|NCT05560035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64537322|NCT05560035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537323|NCT00497055|Aripiprazole|aripiprazole|mesh-list
64537324|NCT00497055|Antidepressive Agents|antidepressive agents|mesh-ancestor
64537325|NCT00497055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64537326|NCT00497055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64537327|NCT00497055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64537328|NCT00497055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64537329|NCT00497055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537330|NCT00497055|Dopamine Agonists|dopamine agonists|mesh-ancestor
64969591|NCT02963116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969592|NCT00195286|Tazobactam|tazobactam|mesh-list
64969593|NCT00195286|Piperacillin|piperacillin|mesh-list
64969594|NCT00195286|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64969595|NCT00195286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64969596|NCT00195286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969597|NCT00195286|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64969598|NCT00195286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969599|NCT00195286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969600|NCT00084201|Amoxicillin|amoxicillin|mesh-list
64969601|NCT00084201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64969602|NCT00084201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969603|NCT00195364|Etanercept|etanercept|mesh-list
64969604|NCT00195364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64969605|NCT00195364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64969606|NCT00195364|Analgesics|analgesics|mesh-ancestor
64969607|NCT00195364|Sensory System Agents|sensory system agents|mesh-ancestor
64969608|NCT00195364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64969609|NCT00195364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969610|NCT00195364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64969611|NCT00195364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64969612|NCT00195364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64969613|NCT00195364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64969614|NCT00195364|Immunologic Factors|immunologic factors|mesh-ancestor
64969615|NCT00195481|Sirolimus|sirolimus|mesh-list
64969616|NCT00195481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64969617|NCT00195481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969639|NCT00084240|Chloroquine|chloroquine|mesh-list
64969640|NCT00084240|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64969641|NCT00084240|Pyrimethamine|pyrimethamine|mesh-list
64969642|NCT00084240|Sulfadoxine|sulfadoxine|mesh-list
64969643|NCT00084240|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64537332|NCT00497055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64537333|NCT00497055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537334|NCT00497055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64537335|NCT00497055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64537336|NCT00497055|Serotonin Agents|serotonin agents|mesh-ancestor
64537337|NCT00497055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64537338|NCT00497055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64537339|NCT00497055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64537340|NCT00497055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64537341|NCT00498615|Fasudil|fasudil|mesh-list
64537342|NCT00498615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64537343|NCT00498615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64537344|NCT00498615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537345|NCT00498615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64537346|NCT00498615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537347|NCT00498615|Vasodilator Agents|vasodilator agents|mesh-ancestor
64537348|NCT00498615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64969644|NCT00084240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64969645|NCT00084240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969647|NCT00084240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64969648|NCT00084240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64969649|NCT00084240|Antimalarials|antimalarials|mesh-ancestor
64969650|NCT00084240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64969651|NCT00084240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64969652|NCT00084240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64969653|NCT00084240|Analgesics|analgesics|mesh-ancestor
64969654|NCT00084240|Sensory System Agents|sensory system agents|mesh-ancestor
64969655|NCT00084240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64969656|NCT00084240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969657|NCT00084240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64969658|NCT00084240|Filaricides|filaricides|mesh-ancestor
64969659|NCT00084240|Antinematodal Agents|antinematodal agents|mesh-ancestor
64969660|NCT00084240|Anthelmintics|anthelmintics|mesh-ancestor
64969661|NCT00084240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64969662|NCT00084240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969663|NCT00084240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969664|NCT00084240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64969665|NCT00084240|Renal Agents|renal agents|mesh-ancestor
64969666|NCT00195598|Paroxetine|paroxetine|mesh-list
64969667|NCT00195598|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64969668|NCT00195598|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64969669|NCT00195598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64969691|NCT00195754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969692|NCT00195754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969694|NCT00195754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64969695|NCT00195754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969696|NCT00195754|Antimanic Agents|antimanic agents|mesh-ancestor
64969697|NCT00195754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64969698|NCT00195754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64969699|NCT00195754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64969700|NCT00195793|Atorvastatin|atorvastatin|mesh-list
64537350|NCT00498927|Temozolomide|temozolomide|mesh-list
64537351|NCT00498927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64537352|NCT00498927|Alkylating Agents|alkylating agents|mesh-ancestor
64537353|NCT00498927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537354|NCT00498927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537355|NCT05555901|Bevacizumab|bevacizumab|mesh-list
64537356|NCT05555901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64537357|NCT05555901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537358|NCT05555901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64537359|NCT05555901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64537360|NCT05555901|Growth Substances|growth substances|mesh-ancestor
64537361|NCT05555901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537362|NCT05555901|Growth Inhibitors|growth inhibitors|mesh-ancestor
64537363|NCT00499473|Sunitinib|sunitinib|mesh-list
64537364|NCT00499473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537365|NCT00499473|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64969701|NCT00195793|Ezetimibe|ezetimibe|mesh-list
64969702|NCT00195793|Fenofibrate|fenofibrate|mesh-list
64969703|NCT00195793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64969704|NCT00195793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64969705|NCT00195793|Antimetabolites|antimetabolites|mesh-ancestor
64969706|NCT00195793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969707|NCT00195793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64969708|NCT00195793|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64969709|NCT00195793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969710|NCT00195871|Cytarabine|cytarabine|mesh-list
64969711|NCT00195871|Prednisone|prednisone|mesh-list
64969712|NCT00195871|Cyclophosphamide|cyclophosphamide|mesh-list
64969713|NCT00195871|Methotrexate|methotrexate|mesh-list
64969714|NCT00195871|Etoposide|etoposide|mesh-list
64969715|NCT00195871|Vincristine|vincristine|mesh-list
64969716|NCT00195871|Daunorubicin|daunorubicin|mesh-list
64969717|NCT00195871|Asparaginase|asparaginase|mesh-list
64969718|NCT00195871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64969719|NCT00195871|Immunologic Factors|immunologic factors|mesh-ancestor
64969720|NCT00195871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969721|NCT00195871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64969722|NCT00195871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64969743|NCT00195871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64969744|NCT00195871|Tubulin Modulators|tubulin modulators|mesh-ancestor
64969745|NCT00195871|Antimitotic Agents|antimitotic agents|mesh-ancestor
64969746|NCT00195871|Mitosis Modulators|mitosis modulators|mesh-ancestor
64969747|NCT00195871|Antiviral Agents|antiviral agents|mesh-ancestor
64969748|NCT00195871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969749|NCT00195871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64969750|NCT00195910|Morphine|morphine|mesh-list
64969751|NCT00195910|Hydromorphone|hydromorphone|mesh-list
64969752|NCT00195910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64969753|NCT00195910|Narcotics|narcotics|mesh-ancestor
64969754|NCT00195910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64969755|NCT00195910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969756|NCT00195910|Analgesics|analgesics|mesh-ancestor
64969757|NCT00195910|Sensory System Agents|sensory system agents|mesh-ancestor
64969758|NCT00195910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64969759|NCT00195988|Mycophenolic Acid|mycophenolic acid|mesh-list
64969760|NCT00195988|Tacrolimus|tacrolimus|mesh-list
64969761|NCT00195988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64969762|NCT00195988|Immunologic Factors|immunologic factors|mesh-ancestor
64969763|NCT00195988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537366|NCT00499473|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64537367|NCT00499473|Growth Substances|growth substances|mesh-ancestor
64537368|NCT00499473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537369|NCT00499473|Growth Inhibitors|growth inhibitors|mesh-ancestor
64537370|NCT00499473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64537371|NCT00499473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537372|NCT00499473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537373|NCT00501891|Bevacizumab|bevacizumab|mesh-list
64537374|NCT00501891|Temozolomide|temozolomide|mesh-list
64537430|NCT05418777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537431|NCT05418777|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64537432|NCT05418777|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64537433|NCT05418777|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64537434|NCT05418777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64537436|NCT00505635|Interferon-alpha|interferon-alpha|mesh-list
64537437|NCT00505635|Interferon alpha-2|interferon alpha-2|mesh-list
64537438|NCT00505635|Thalidomide|thalidomide|mesh-list
64537439|NCT00505635|Cisplatin|cisplatin|mesh-list
64537440|NCT00505635|Temozolomide|temozolomide|mesh-list
64537441|NCT00505635|Interleukin-2|interleukin-2|mesh-list
64537442|NCT00505635|Vinblastine|vinblastine|mesh-list
64537443|NCT00505635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537444|NCT00505635|Antiviral Agents|antiviral agents|mesh-ancestor
64537445|NCT00505635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64537446|NCT00505635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64302137|NCT04991012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302138|NCT02252731|Warfarin|warfarin|mesh-list
64969764|NCT00195988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64969765|NCT00195988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969766|NCT00195988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969767|NCT00195988|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64969768|NCT00195988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969769|NCT00195988|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64969770|NCT00195988|Antitubercular Agents|antitubercular agents|mesh-ancestor
64969771|NCT00195988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64969772|NCT00195988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969773|NCT00060476|Rofecoxib|rofecoxib|mesh-list
64969774|NCT00060476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64969775|NCT00060476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64969805|NCT00196417|Heparin|heparin|mesh-list
64969806|NCT00196417|Certoparin|certoparin|mesh-list
64969807|NCT00196417|Anticoagulants|anticoagulants|mesh-ancestor
64969808|NCT00196417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64969809|NCT00196417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64969810|NCT00196417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969811|NCT00060554|Heparin|heparin|mesh-list
64541896|NCT05091138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64969813|NCT00060554|Fondaparinux|fondaparinux|mesh-list
64969814|NCT00060554|Anticoagulants|anticoagulants|mesh-ancestor
64969815|NCT00060554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64969816|NCT00060554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64969817|NCT00060554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969818|NCT00060554|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64969819|NCT00060554|Antithrombins|antithrombins|mesh-ancestor
64969841|NCT00048126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64969842|NCT00048126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64969843|NCT00048126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969844|NCT00196612|Emtricitabine|emtricitabine|mesh-list
64969845|NCT00196612|Efavirenz|efavirenz|mesh-list
64969846|NCT00196612|Didanosine|didanosine|mesh-list
64969847|NCT00196612|Antiviral Agents|antiviral agents|mesh-ancestor
64969848|NCT00196612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969849|NCT00196612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64969850|NCT00196612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64969851|NCT00196612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969852|NCT00196612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537447|NCT00505635|Alkylating Agents|alkylating agents|mesh-ancestor
64537448|NCT00505635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537449|NCT00505635|Immunologic Factors|immunologic factors|mesh-ancestor
64537450|NCT00505635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537451|NCT00505635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64537452|NCT00505635|Analgesics|analgesics|mesh-ancestor
64537453|NCT00505635|Sensory System Agents|sensory system agents|mesh-ancestor
64537454|NCT00505635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64537455|NCT00505635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64537456|NCT00505635|Leprostatic Agents|leprostatic agents|mesh-ancestor
64537457|NCT00505635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64537458|NCT00505635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64537459|NCT00505635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64537460|NCT00505635|Growth Substances|growth substances|mesh-ancestor
64537461|NCT00505635|Growth Inhibitors|growth inhibitors|mesh-ancestor
64537462|NCT00505635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64537463|NCT00505635|Tubulin Modulators|tubulin modulators|mesh-ancestor
64537464|NCT00505635|Antimitotic Agents|antimitotic agents|mesh-ancestor
64537465|NCT00505635|Mitosis Modulators|mitosis modulators|mesh-ancestor
64537466|NCT01842165|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64537467|NCT01842165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64537468|NCT01842165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537469|NCT04742751|Metformin|metformin|mesh-list
64537470|NCT04742751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64537471|NCT04742751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537472|NCT04479813|Moxonidine|moxonidine|mesh-list
64537473|NCT04479813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64537474|NCT04474899|Amlodipine|amlodipine|mesh-list
64537475|NCT04474899|Moxonidine|moxonidine|mesh-list
64537476|NCT04474899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64537477|NCT04474899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64537478|NCT04474899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64537479|NCT04474899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537480|NCT04474899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64537481|NCT04474899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969853|NCT00196612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64969854|NCT00196612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64537482|NCT04474899|Vasodilator Agents|vasodilator agents|mesh-ancestor
64537483|NCT00511173|Warfarin|warfarin|mesh-list
64537484|NCT00511173|Anticoagulants|anticoagulants|mesh-ancestor
64537485|NCT04037397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64537486|NCT00513435|Saracatinib|saracatinib|mesh-list
64537487|NCT00513435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537488|NCT00513435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537489|NCT00513435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537490|NCT00513747|Rituximab|rituximab|mesh-list
64537491|NCT00513747|Fludarabine|fludarabine|mesh-list
64537492|NCT00513747|Fludarabine phosphate|fludarabine phosphate|mesh-list
64537493|NCT00513747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64537494|NCT00513747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537495|NCT00513747|Immunologic Factors|immunologic factors|mesh-ancestor
64537496|NCT00513747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537497|NCT00513747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64537498|NCT00513747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64537499|NCT00513747|Antimetabolites|antimetabolites|mesh-ancestor
64537500|NCT00513747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537501|NCT00513747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64537502|NCT00514137|Sunitinib|sunitinib|mesh-list
64537503|NCT00514137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537504|NCT00514137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64537505|NCT00514137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64537506|NCT00514137|Growth Substances|growth substances|mesh-ancestor
64537507|NCT00514137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537508|NCT00514137|Growth Inhibitors|growth inhibitors|mesh-ancestor
64537509|NCT00514137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64537510|NCT00514137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537511|NCT00514137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537512|NCT00514215|Molgramostim|molgramostim|mesh-list
64537513|NCT00514215|Sargramostim|sargramostim|mesh-list
64537514|NCT00514215|Immunologic Factors|immunologic factors|mesh-ancestor
64969855|NCT00196612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64969856|NCT00196612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64969857|NCT00196612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64969858|NCT00196612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64969859|NCT00196612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64969860|NCT00196612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64969861|NCT00196612|Antimetabolites|antimetabolites|mesh-ancestor
64969862|NCT00196690|Donepezil|donepezil|mesh-list
64537515|NCT00514215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537516|NCT00514215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537517|NCT03912909|Empagliflozin|empagliflozin|mesh-list
64537518|NCT03912909|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64537519|NCT03912909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537520|NCT03912909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64537521|NCT03912909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537523|NCT02130063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64537524|NCT02130063|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
64537525|NCT02130063|Trace Elements|trace elements|mesh-ancestor
64537526|NCT02130063|Micronutrients|micronutrients|mesh-ancestor
64537527|NCT02130063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537528|NCT02130063|Hematinics|hematinics|mesh-ancestor
64537529|NCT00515697|Ramucirumab|ramucirumab|mesh-list
64537530|NCT00515697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537531|NCT00516165|Everolimus|everolimus|mesh-list
64537532|NCT00516165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537533|NCT00516165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64537534|NCT00516165|Immunologic Factors|immunologic factors|mesh-ancestor
64537535|NCT00516165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537536|NCT03631173|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64537537|NCT03631173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64537538|NCT04926285|Venetoclax|venetoclax|mesh-list
64537539|NCT04926285|Homoharringtonine|homoharringtonine|mesh-list
64537540|NCT04926285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537541|NCT04926285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64537542|NCT04926285|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64537543|NCT04926285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537544|NCT04926285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537545|NCT03419481|Pembrolizumab|pembrolizumab|mesh-list
64537546|NCT03419481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64537547|NCT03419481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537548|NCT02132169|Cetirizine|cetirizine|mesh-list
64537549|NCT02132169|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64302225|NCT03260829|Protective Agents|protective agents|mesh-ancestor
64969863|NCT00196690|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64969864|NCT00196690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969865|NCT00196690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969866|NCT00196690|Cholinergic Agents|cholinergic agents|mesh-ancestor
64537550|NCT02132169|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64537551|NCT02132169|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64537552|NCT02132169|Histamine Antagonists|histamine antagonists|mesh-ancestor
64537553|NCT02132169|Histamine Agents|histamine agents|mesh-ancestor
64537554|NCT02132169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64537555|NCT02132169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537556|NCT02132169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537557|NCT03174405|Avelumab|avelumab|mesh-list
64537558|NCT03174405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64537559|NCT03174405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537560|NCT00522795|Paclitaxel|paclitaxel|mesh-list
64537561|NCT00522795|Cisplatin|cisplatin|mesh-list
64537562|NCT00522795|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
64537563|NCT00522795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64537564|NCT00522795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537565|NCT00522795|Tubulin Modulators|tubulin modulators|mesh-ancestor
64537566|NCT00522795|Antimitotic Agents|antimitotic agents|mesh-ancestor
64537567|NCT00522795|Mitosis Modulators|mitosis modulators|mesh-ancestor
64537568|NCT00522795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969867|NCT00196690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64969868|NCT00196690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969869|NCT00196690|Nootropic Agents|nootropic agents|mesh-ancestor
64969870|NCT00196768|Arsenic Trioxide|arsenic trioxide|mesh-list
64969871|NCT00196768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969872|NCT00084396|Letrozole|letrozole|mesh-list
64969873|NCT00084396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969874|NCT00084396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64969914|NCT00048204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969915|NCT00048204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64969916|NCT00048204|Antidepressive Agents|antidepressive agents|mesh-ancestor
64969917|NCT00048204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64969918|NCT00048204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64969919|NCT00048204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64969920|NCT00048204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969921|NCT00048204|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64969922|NCT00197080|Ropinirole|ropinirole|mesh-list
64969923|NCT00197080|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64969924|NCT00197080|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64969925|NCT00197080|Dopamine Agonists|dopamine agonists|mesh-ancestor
64969926|NCT00197080|Dopamine Agents|dopamine agents|mesh-ancestor
64969927|NCT00197080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64969928|NCT00197080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969929|NCT00197080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969930|NCT00060671|Rituximab|rituximab|mesh-list
64969931|NCT00060671|Pixantrone|pixantrone|mesh-list
64508609|NCT02256696|Antimetabolites|antimetabolites|mesh-ancestor
64969932|NCT00060671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64969933|NCT00060671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969934|NCT00060671|Immunologic Factors|immunologic factors|mesh-ancestor
64541938|NCT05735184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64969935|NCT00060671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969936|NCT00060671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64969937|NCT00060671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64537570|NCT03121677|Rituximab|rituximab|mesh-list
64537571|NCT03121677|Nivolumab|nivolumab|mesh-list
64537572|NCT03121677|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64537573|NCT03121677|Poly ICLC|poly iclc|mesh-list
64537574|NCT03121677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64537575|NCT03121677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537576|NCT03121677|Immunologic Factors|immunologic factors|mesh-ancestor
64537577|NCT03121677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537578|NCT03121677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64537579|NCT03121677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64537580|NCT03121677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537581|NCT03121677|Interferon Inducers|interferon inducers|mesh-ancestor
64537582|NCT03121677|Laxatives|laxatives|mesh-ancestor
64537583|NCT03121677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64537584|NCT03121677|Antiviral Agents|antiviral agents|mesh-ancestor
64537585|NCT03121677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64537586|NCT02871687|Simvastatin|simvastatin|mesh-list
64537587|NCT02871687|Pravastatin|pravastatin|mesh-list
64537588|NCT02871687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64302281|NCT03377049|Diuretics|diuretics|mesh-ancestor
64969938|NCT00060671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64969939|NCT00060671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969940|NCT00060671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969941|NCT00197197|Aplaviroc|aplaviroc|mesh-list
64969942|NCT00197197|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64969943|NCT00197197|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64969944|NCT00197197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969945|NCT00197197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64969946|NCT00197197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64969947|NCT00197197|Antiviral Agents|antiviral agents|mesh-ancestor
64969948|NCT00197197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969949|NCT00409903|Eprosartan|eprosartan|mesh-list
64969950|NCT00409903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64969951|NCT00409903|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
64969952|NCT00409903|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64969953|NCT00409903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969954|NCT00084435|Docetaxel|docetaxel|mesh-list
64969955|NCT00084435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969956|NCT00084435|Tubulin Modulators|tubulin modulators|mesh-ancestor
64969957|NCT00084435|Antimitotic Agents|antimitotic agents|mesh-ancestor
64969958|NCT00084435|Mitosis Modulators|mitosis modulators|mesh-ancestor
64969959|NCT00084435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969960|NCT00197353|Bupivacaine|bupivacaine|mesh-list
64969961|NCT00197353|Anesthetics, Local|anesthetics, local|mesh-ancestor
64969962|NCT00197353|Anesthetics|anesthetics|mesh-ancestor
64969963|NCT00197353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64969964|NCT00197353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969965|NCT00197353|Sensory System Agents|sensory system agents|mesh-ancestor
64969966|NCT00197353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64969967|NCT02962999|Ketamine|ketamine|mesh-list
64969968|NCT02962999|Analgesics|analgesics|mesh-ancestor
64969969|NCT02962999|Sensory System Agents|sensory system agents|mesh-ancestor
64969970|NCT02962999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64969971|NCT02962999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969972|NCT02962999|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64537589|NCT02871687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64537590|NCT02871687|Antimetabolites|antimetabolites|mesh-ancestor
64537591|NCT02871687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537592|NCT02871687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64537593|NCT02871687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64537594|NCT02871687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537596|NCT00525057|Tinzaparin|tinzaparin|mesh-list
64537597|NCT00525057|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64537598|NCT00525057|Anticoagulants|anticoagulants|mesh-ancestor
64969973|NCT02962999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64969974|NCT02962999|Anesthetics, General|anesthetics, general|mesh-ancestor
64969975|NCT02962999|Anesthetics|anesthetics|mesh-ancestor
64969976|NCT02962999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64969977|NCT02962999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64969979|NCT02962999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64969980|NCT02962999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969981|NCT00084513|Trastuzumab|trastuzumab|mesh-list
64969982|NCT00084513|Imatinib Mesylate|imatinib mesylate|mesh-list
64969983|NCT00084513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64969984|NCT00084513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969985|NCT00084513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64969986|NCT00084513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969987|NCT00084513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969989|NCT00084591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64969990|NCT00084591|Antimetabolites|antimetabolites|mesh-ancestor
64969991|NCT00084591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969992|NCT00084591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969993|NCT00197548|Folic Acid|folic acid|mesh-list
64969994|NCT00197548|Vitamin B Complex|vitamin b complex|mesh-list
64969995|NCT00197548|Vitamins|vitamins|mesh-ancestor
64969996|NCT00197548|Micronutrients|micronutrients|mesh-ancestor
64969997|NCT00197548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969998|NCT00197548|Hematinics|hematinics|mesh-ancestor
64969999|NCT00197587|Nevirapine|nevirapine|mesh-list
64970000|NCT00197587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64970001|NCT00197587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64508679|NCT01770353|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64508695|NCT01769339|Miconazole|miconazole|mesh-list
64970002|NCT00197587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970003|NCT00197587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970004|NCT00197587|Antiviral Agents|antiviral agents|mesh-ancestor
64970005|NCT00197587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64970006|NCT00197587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64970007|NCT00197587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64970008|NCT00197587|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64970009|NCT00197587|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64970010|NCT00197743|Vitamin A|vitamin a|mesh-list
64970011|NCT00197743|Beta Carotene|beta carotene|mesh-list
64970012|NCT00197743|Carotenoids|carotenoids|mesh-list
64970013|NCT00197743|Vitamins|vitamins|mesh-ancestor
64970014|NCT00197743|Micronutrients|micronutrients|mesh-ancestor
64970015|NCT00197743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970016|NCT00197743|Antioxidants|antioxidants|mesh-ancestor
64970017|NCT00197743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970018|NCT00197743|Protective Agents|protective agents|mesh-ancestor
64970019|NCT00197743|Provitamins|provitamins|mesh-ancestor
64970020|NCT00084630|Imatinib Mesylate|imatinib mesylate|mesh-list
64970021|NCT00084630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970022|NCT00084630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64970023|NCT00084630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970024|NCT00084630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970025|NCT00197821|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64970026|NCT00197821|Immunologic Factors|immunologic factors|mesh-ancestor
64537599|NCT00525057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64537600|NCT00525057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64537601|NCT00525057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537602|NCT00525135|Valproic Acid|valproic acid|mesh-list
64537603|NCT00525135|Anticonvulsants|anticonvulsants|mesh-ancestor
64537604|NCT00525135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537605|NCT00525135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537606|NCT00525135|GABA Agents|gaba agents|mesh-ancestor
64537607|NCT00525135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64537608|NCT00525135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537609|NCT00525135|Antimanic Agents|antimanic agents|mesh-ancestor
64970027|NCT00197821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970028|NCT00084669|Zolpidem|zolpidem|mesh-list
64970029|NCT00084669|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64970030|NCT00084669|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64970031|NCT00084669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64970032|NCT00084669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64970033|NCT00084669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970034|NCT00084669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970035|NCT00084669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970036|NCT00084669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64970037|NCT00084669|Antidepressive Agents|antidepressive agents|mesh-ancestor
64970038|NCT00084669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64970039|NCT00084669|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64970040|NCT00084669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64970041|NCT00084669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64970042|NCT00084669|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64970043|NCT00084669|GABA Agonists|gaba agonists|mesh-ancestor
64970044|NCT00084669|GABA Agents|gaba agents|mesh-ancestor
64970045|NCT00060866|Propranolol|propranolol|mesh-list
64970046|NCT00060866|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64970047|NCT00060866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64970048|NCT00060866|Adrenergic Agents|adrenergic agents|mesh-ancestor
64970083|NCT00198055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64970084|NCT00198055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64970113|NCT00198250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64970114|NCT00198250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64970115|NCT00198250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970116|NCT00198250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970117|NCT00198250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970118|NCT00198250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64970119|NCT00198250|Antidepressive Agents|antidepressive agents|mesh-ancestor
64970120|NCT00198250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64970121|NCT00084708|Calcitriol|calcitriol|mesh-list
64970122|NCT00084708|Dexamethasone|dexamethasone|mesh-list
64970123|NCT00084708|Gefitinib|gefitinib|mesh-list
64970124|NCT00084708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64970125|NCT00084708|Antiemetics|antiemetics|mesh-ancestor
64970126|NCT00084708|Autonomic Agents|autonomic agents|mesh-ancestor
64970127|NCT00084708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64970128|NCT00084708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970140|NCT00084708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64970141|NCT00084708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64970143|NCT00084708|Micronutrients|micronutrients|mesh-ancestor
64970144|NCT00084708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64970145|NCT00198367|Cisplatin|cisplatin|mesh-list
64970146|NCT00198367|Carboplatin|carboplatin|mesh-list
64970147|NCT00198367|Vinorelbine|vinorelbine|mesh-list
64970148|NCT00198367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970149|NCT00198367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970150|NCT00198367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64537610|NCT00525135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64537611|NCT00525135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64537612|NCT00525135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64537613|NCT00525525|Bevacizumab|bevacizumab|mesh-list
64537614|NCT00525525|Temozolomide|temozolomide|mesh-list
64537615|NCT00525525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64537616|NCT00525525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64537617|NCT00525525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537618|NCT00525525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64537619|NCT00525525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64537620|NCT00525525|Growth Substances|growth substances|mesh-ancestor
64302323|NCT03251469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64970151|NCT00198367|Tubulin Modulators|tubulin modulators|mesh-ancestor
64970152|NCT00198367|Antimitotic Agents|antimitotic agents|mesh-ancestor
64970153|NCT00198367|Mitosis Modulators|mitosis modulators|mesh-ancestor
64970154|NCT00198445|Bromfenac|bromfenac|mesh-list
64970155|NCT00198445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64970156|NCT00198445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64970157|NCT00198445|Analgesics|analgesics|mesh-ancestor
64970158|NCT00198445|Sensory System Agents|sensory system agents|mesh-ancestor
64970159|NCT00198445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64970160|NCT00198445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970161|NCT00198445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64970162|NCT00198445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64970182|NCT00198523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64970183|NCT00198523|Prednisolone acetate|prednisolone acetate|mesh-list
64970184|NCT00198523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64970185|NCT00198523|Prednisolone phosphate|prednisolone phosphate|mesh-list
64970186|NCT00198523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64970187|NCT00198523|Glucocorticoids|glucocorticoids|mesh-ancestor
64970188|NCT00198523|Hormones|hormones|mesh-ancestor
64970189|NCT00198523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64970190|NCT00198523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970191|NCT00198523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64970192|NCT00198523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970193|NCT00198523|Antiemetics|antiemetics|mesh-ancestor
64970194|NCT00198523|Autonomic Agents|autonomic agents|mesh-ancestor
64970195|NCT00198523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64970196|NCT00198523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64970197|NCT00198523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64970198|NCT00198523|Protective Agents|protective agents|mesh-ancestor
64970199|NCT00198523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64970200|NCT00198523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64970201|NCT00198562|Losartan|losartan|mesh-list
64970202|NCT00198562|Amlodipine|amlodipine|mesh-list
64970203|NCT00198562|Antihypertensive Agents|antihypertensive agents|mesh-list
64970204|NCT00198562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64508905|NCT04551963|Hormone Antagonists|hormone antagonists|mesh-ancestor
64970205|NCT00198562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64970206|NCT00198562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970207|NCT00198562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64970208|NCT00198562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970209|NCT00198562|Vasodilator Agents|vasodilator agents|mesh-ancestor
64970210|NCT00198562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64970211|NCT00198562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64970212|NCT00198562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64970213|NCT00409942|Torsemide|torsemide|mesh-list
64970214|NCT00409942|Furosemide|furosemide|mesh-list
64970215|NCT00409942|Diuretics|diuretics|mesh-ancestor
64970216|NCT00409942|Natriuretic Agents|natriuretic agents|mesh-ancestor
64970217|NCT00409942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970218|NCT00409942|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64537621|NCT00525525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537622|NCT00525525|Growth Inhibitors|growth inhibitors|mesh-ancestor
64537623|NCT00525525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64537624|NCT00525525|Alkylating Agents|alkylating agents|mesh-ancestor
64537625|NCT00525525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537626|NCT00525525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64537627|NCT00525525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537628|NCT00525603|Cyclophosphamide|cyclophosphamide|mesh-list
64537629|NCT00525603|Rituximab|rituximab|mesh-list
64537630|NCT00525603|Fludarabine|fludarabine|mesh-list
64537631|NCT00525603|Fludarabine phosphate|fludarabine phosphate|mesh-list
64537632|NCT00525603|Alemtuzumab|alemtuzumab|mesh-list
64537633|NCT00525603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64537634|NCT00525603|Immunologic Factors|immunologic factors|mesh-ancestor
64302334|NCT02785939|Docetaxel|docetaxel|mesh-list
64970252|NCT00084825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970253|NCT00084825|Tubulin Modulators|tubulin modulators|mesh-ancestor
64970254|NCT00084825|Antimitotic Agents|antimitotic agents|mesh-ancestor
64970255|NCT00084825|Mitosis Modulators|mitosis modulators|mesh-ancestor
64970256|NCT00084825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970257|NCT00084825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64970258|NCT00084825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970259|NCT00048477|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
64970260|NCT00048477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970285|NCT00199186|Vincristine|vincristine|mesh-list
64970286|NCT00199186|Imatinib Mesylate|imatinib mesylate|mesh-list
64970287|NCT00199186|Idarubicin|idarubicin|mesh-list
64970288|NCT00199186|BB 1101|bb 1101|mesh-list
64970289|NCT00199186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64970290|NCT00199186|Immunologic Factors|immunologic factors|mesh-ancestor
64970291|NCT00199186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970292|NCT00199186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64970293|NCT00199186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64970294|NCT00199186|Alkylating Agents|alkylating agents|mesh-ancestor
64970295|NCT00199186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970296|NCT00199186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970297|NCT00199186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64970298|NCT00199186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64970299|NCT00199186|Antiemetics|antiemetics|mesh-ancestor
64970300|NCT00199186|Autonomic Agents|autonomic agents|mesh-ancestor
64542026|NCT01271439|Cetuximab|cetuximab|mesh-list
64970301|NCT00199186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64970302|NCT00199186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64970303|NCT00199186|Glucocorticoids|glucocorticoids|mesh-ancestor
64970304|NCT00199186|Hormones|hormones|mesh-ancestor
64970305|NCT00199186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64970306|NCT00199186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64970307|NCT00199186|Protease Inhibitors|protease inhibitors|mesh-ancestor
64970308|NCT00199186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970309|NCT00199186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64970310|NCT00199186|Abortifacient Agents|abortifacient agents|mesh-ancestor
64970311|NCT00199186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64970312|NCT00199186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64970313|NCT00199186|Antimetabolites|antimetabolites|mesh-ancestor
64970335|NCT00061022|Disufenton sodium|disufenton sodium|mesh-list
64970336|NCT00061022|Antioxidants|antioxidants|mesh-ancestor
64970337|NCT00061022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970338|NCT00061022|Protective Agents|protective agents|mesh-ancestor
64970339|NCT00061022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970340|NCT00199264|Albaconazole|albaconazole|mesh-list
64970341|NCT00199264|Antifungal Agents|antifungal agents|mesh-ancestor
64537635|NCT00525603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537637|NCT00525603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64537638|NCT00525603|Alkylating Agents|alkylating agents|mesh-ancestor
64537639|NCT00525603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537640|NCT00525603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537641|NCT00525603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64537642|NCT00525603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64537643|NCT00525603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64537644|NCT00525603|Antimetabolites|antimetabolites|mesh-ancestor
64537645|NCT00398307|Cisplatin|cisplatin|mesh-list
64537646|NCT00398307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64484452|NCT01727713|Aripiprazole|aripiprazole|mesh-list
64537647|NCT00564447|Azithromycin|azithromycin|mesh-list
64537648|NCT00564447|Moxifloxacin|moxifloxacin|mesh-list
64537649|NCT00564447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64537650|NCT00564447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64537651|NCT00564447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64537652|NCT00564447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64537653|NCT00564447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537654|NCT00564447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537655|NCT00564447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537656|NCT00564681|Botulinum Toxins|botulinum toxins|mesh-list
64302351|NCT03583229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64970342|NCT00199264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64970343|NCT00199342|Ecromeximab|ecromeximab|mesh-list
64970344|NCT00199342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64970345|NCT00199342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970346|NCT00199420|Istradefylline|istradefylline|mesh-list
64970347|NCT00199420|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
64970348|NCT00199420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64970349|NCT00199420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64970350|NCT00199420|Purinergic Agents|purinergic agents|mesh-ancestor
64970351|NCT00199420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970352|NCT00199420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970353|NCT00199420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970354|NCT00199576|Methylprednisolone|methylprednisolone|mesh-list
64970355|NCT00199576|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64970356|NCT00199576|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64970357|NCT00199576|Prednisolone|prednisolone|mesh-list
64509049|NCT02270632|Antimetabolites|antimetabolites|mesh-ancestor
64970358|NCT00199576|Prednisolone acetate|prednisolone acetate|mesh-list
64509126|NCT01932112|Adenosine|adenosine|mesh-list
64970359|NCT00199576|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64970360|NCT00199576|Prednisolone phosphate|prednisolone phosphate|mesh-list
64970361|NCT00199576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64970362|NCT00199576|Antiemetics|antiemetics|mesh-ancestor
64970363|NCT00199576|Autonomic Agents|autonomic agents|mesh-ancestor
64970399|NCT00084981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537657|NCT00564681|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64537658|NCT00564681|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64654701|NCT04358120|Protective Agents|protective agents|mesh-ancestor
64537659|NCT00564681|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64537660|NCT00564681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64537661|NCT00564681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537662|NCT00564681|Cholinergic Agents|cholinergic agents|mesh-ancestor
64537663|NCT00564681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64537664|NCT00564681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537665|NCT00564681|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64537666|NCT00564681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64537667|NCT00525837|Varenicline|varenicline|mesh-list
64537668|NCT00525837|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64537669|NCT00525837|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64537670|NCT00525837|Cholinergic Agents|cholinergic agents|mesh-ancestor
64537671|NCT00525837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64537672|NCT00525837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537673|NCT00525837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537674|NCT00527475|Ranibizumab|ranibizumab|mesh-list
64537675|NCT00527475|Verteporfin|verteporfin|mesh-list
64537676|NCT00527475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64537677|NCT00527475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64537678|NCT00527475|Growth Substances|growth substances|mesh-ancestor
64537679|NCT00527475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537680|NCT00527475|Growth Inhibitors|growth inhibitors|mesh-ancestor
64537681|NCT00527475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537682|NCT00527475|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64542050|NCT02992665|Ionophores|ionophores|mesh-list
64537683|NCT00527475|Dermatologic Agents|dermatologic agents|mesh-ancestor
64537684|NCT01798251|Capecitabine|capecitabine|mesh-list
64537685|NCT01798251|Oxaliplatin|oxaliplatin|mesh-list
64537686|NCT01798251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64537687|NCT01798251|Antimetabolites|antimetabolites|mesh-ancestor
64537688|NCT01798251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537689|NCT01798251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970400|NCT00084981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970401|NCT00084981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970402|NCT00084981|Anticonvulsants|anticonvulsants|mesh-ancestor
64970403|NCT00084981|GABA Agents|gaba agents|mesh-ancestor
64970404|NCT00084981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970429|NCT00410215|Cathartics|cathartics|mesh-ancestor
64970430|NCT00410215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64537690|NCT02121483|Empagliflozin|empagliflozin|mesh-list
64537691|NCT02121483|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64537692|NCT02121483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537693|NCT02121483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64537694|NCT02121483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537696|NCT01572038|Docetaxel|docetaxel|mesh-list
64537697|NCT01572038|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64537698|NCT01572038|Trastuzumab|trastuzumab|mesh-list
64537699|NCT01572038|Pertuzumab|pertuzumab|mesh-list
64537700|NCT01572038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64537701|NCT01572038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537702|NCT01572038|Tubulin Modulators|tubulin modulators|mesh-ancestor
64970431|NCT00410215|Laxatives|laxatives|mesh-ancestor
64970433|NCT00410254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64970434|NCT00410254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64509199|NCT04126083|Adrenergic Agents|adrenergic agents|mesh-ancestor
64970435|NCT00410254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64970436|NCT00410254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970437|NCT00410254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64970438|NCT00410254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64970439|NCT00410254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64970440|NCT00410254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64970441|NCT00410254|Anesthetics, General|anesthetics, general|mesh-ancestor
64970443|NCT00410254|GABA Modulators|gaba modulators|mesh-ancestor
64970444|NCT00410254|GABA Agents|gaba agents|mesh-ancestor
64970445|NCT00410254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970446|NCT00410254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970447|NCT00061178|Bevacizumab|bevacizumab|mesh-list
64654708|NCT00928694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64970449|NCT00061178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970450|NCT00061178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64970451|NCT00061178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64970452|NCT00061178|Growth Substances|growth substances|mesh-ancestor
64970453|NCT00061178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970454|NCT00061178|Growth Inhibitors|growth inhibitors|mesh-ancestor
64970455|NCT00200395|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64970469|NCT00200434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970471|NCT00200473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64970472|NCT00200473|Vasodilator Agents|vasodilator agents|mesh-ancestor
64970473|NCT00200473|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64970474|NCT00200473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64970475|NCT00200473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64970476|NCT00200473|Adrenergic Agents|adrenergic agents|mesh-ancestor
64970477|NCT00200473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970478|NCT00200473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970479|NCT00200473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970480|NCT02962804|Nivolumab|nivolumab|mesh-list
64970481|NCT02962804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64970482|NCT02962804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970483|NCT02962804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64970484|NCT02962804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970485|NCT00048555|Galiximab|galiximab|mesh-list
64970486|NCT00048555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64970487|NCT00048555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970488|NCT00200512|Apomorphine|apomorphine|mesh-list
64970489|NCT00200512|Emetics|emetics|mesh-ancestor
64970490|NCT00200512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970491|NCT00200512|Autonomic Agents|autonomic agents|mesh-ancestor
64970492|NCT00200512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64970493|NCT00200512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64537703|NCT01572038|Antimitotic Agents|antimitotic agents|mesh-ancestor
64537704|NCT01572038|Mitosis Modulators|mitosis modulators|mesh-ancestor
64537705|NCT01572038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537706|NCT01572038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64537707|NCT01448213|Fluorometholone|fluorometholone|mesh-list
64537708|NCT01448213|Prednisolone|prednisolone|mesh-list
64537709|NCT01448213|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64537710|NCT01448213|Methylprednisolone|methylprednisolone|mesh-list
64537712|NCT01448213|Prednisolone acetate|prednisolone acetate|mesh-list
64302421|NCT04986254|Meropenem|meropenem|mesh-list
64970494|NCT00200512|Dopamine Agonists|dopamine agonists|mesh-ancestor
64970495|NCT00200512|Dopamine Agents|dopamine agents|mesh-ancestor
64970496|NCT00200512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970497|NCT00200512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970498|NCT00200551|Cyclosporine|cyclosporine|mesh-list
64970499|NCT00200551|Mycophenolic Acid|mycophenolic acid|mesh-list
64970500|NCT00200551|Cyclosporins|cyclosporins|mesh-list
64970501|NCT00200551|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64970502|NCT00200551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970503|NCT00200551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970504|NCT00200551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64970505|NCT00200551|Immunologic Factors|immunologic factors|mesh-ancestor
64970506|NCT00200551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970507|NCT00200551|Antifungal Agents|antifungal agents|mesh-ancestor
64970508|NCT00200551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64970509|NCT00200551|Dermatologic Agents|dermatologic agents|mesh-ancestor
64970510|NCT00200551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64970511|NCT00200551|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64970512|NCT00200551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64970513|NCT00200551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970514|NCT00200551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64970569|NCT00201253|Dimercaprol|dimercaprol|mesh-list
64970570|NCT00201253|Chelating Agents|chelating agents|mesh-ancestor
64970571|NCT00201253|Sequestering Agents|sequestering agents|mesh-ancestor
64970572|NCT00201253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970573|NCT00201331|Leucovorin|leucovorin|mesh-list
64970574|NCT00201331|Antidotes|antidotes|mesh-ancestor
64970575|NCT00201331|Protective Agents|protective agents|mesh-ancestor
64970576|NCT00201331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970577|NCT00201331|Vitamin B Complex|vitamin b complex|mesh-ancestor
64970578|NCT00201331|Vitamins|vitamins|mesh-ancestor
64970579|NCT00201331|Micronutrients|micronutrients|mesh-ancestor
64970580|NCT00048672|Imatinib Mesylate|imatinib mesylate|mesh-list
64509276|NCT01902004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64970581|NCT00048672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970582|NCT00048672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64970583|NCT00048672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970584|NCT00048672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970586|NCT00201682|Rituximab|rituximab|mesh-list
64978220|NCT00102453|Vasodilator Agents|vasodilator agents|mesh-ancestor
64970587|NCT00201682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64970588|NCT00201682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970589|NCT00201682|Immunologic Factors|immunologic factors|mesh-ancestor
64970590|NCT00201682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970591|NCT00201682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64970592|NCT00201682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64970593|NCT00201682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64970594|NCT00201682|Analgesics|analgesics|mesh-ancestor
64970595|NCT00201682|Sensory System Agents|sensory system agents|mesh-ancestor
64970596|NCT00201682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64970597|NCT00201682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64970598|NCT00201682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64970599|NCT00201682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64970600|NCT00410371|Lamotrigine|lamotrigine|mesh-list
64970601|NCT00410371|Anticonvulsants|anticonvulsants|mesh-ancestor
64970602|NCT00410371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64537713|NCT01448213|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64537714|NCT01448213|Prednisolone phosphate|prednisolone phosphate|mesh-list
64537715|NCT01448213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64537716|NCT01448213|Glucocorticoids|glucocorticoids|mesh-ancestor
64537717|NCT01448213|Hormones|hormones|mesh-ancestor
64537718|NCT01448213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64537719|NCT01448213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537720|NCT01448213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64714139|NCT00373789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64537721|NCT01448213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537722|NCT01448213|Antiemetics|antiemetics|mesh-ancestor
64537723|NCT01448213|Autonomic Agents|autonomic agents|mesh-ancestor
64537724|NCT01448213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64537725|NCT01448213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64537726|NCT01448213|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64537727|NCT01448213|Protective Agents|protective agents|mesh-ancestor
64302431|NCT04986254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302432|NCT04986254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302433|NCT03257943|Ivermectin|ivermectin|mesh-list
64302434|NCT03257943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64302435|NCT03257943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64302436|NCT04996160|Dexamethasone|dexamethasone|mesh-list
64302437|NCT04996160|Dexamethasone acetate|dexamethasone acetate|mesh-list
64302438|NCT04996160|Doxorubicin|doxorubicin|mesh-list
64302439|NCT04996160|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64302440|NCT04996160|Bortezomib|bortezomib|mesh-list
64302441|NCT04996160|Palbociclib|palbociclib|mesh-list
64302442|NCT04996160|BB 1101|bb 1101|mesh-list
64302443|NCT04996160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64970603|NCT00410371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64970604|NCT00410371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970605|NCT00410371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64970630|NCT00061451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970631|NCT00061451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64970632|NCT00061451|Immunologic Factors|immunologic factors|mesh-ancestor
64970633|NCT00061451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970634|NCT00061451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64970635|NCT00061451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64970636|NCT00410527|Meropenem|meropenem|mesh-list
64970637|NCT00410527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64970638|NCT00410527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64970639|NCT00048750|Micafungin|micafungin|mesh-list
64970640|NCT00048750|Antifungal Agents|antifungal agents|mesh-ancestor
64970641|NCT00048750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64970642|NCT00221416|Aripiprazole|aripiprazole|mesh-list
64970643|NCT00221416|Antidepressive Agents|antidepressive agents|mesh-ancestor
64970644|NCT00221416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64537728|NCT01448213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64537729|NCT01448057|Acetaminophen|acetaminophen|mesh-list
64537730|NCT01448057|Dimethindene|dimethindene|mesh-list
64537731|NCT01448057|Phenylephrine|phenylephrine|mesh-list
64537732|NCT01448057|Oxymetazoline|oxymetazoline|mesh-list
64537733|NCT01448057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64537734|NCT01448057|Analgesics|analgesics|mesh-ancestor
64537735|NCT01448057|Sensory System Agents|sensory system agents|mesh-ancestor
64537736|NCT01448057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64537737|NCT01448057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537738|NCT01448057|Antipyretics|antipyretics|mesh-ancestor
64978236|NCT00268645|Insulin Glargine|insulin glargine|mesh-list
64537739|NCT01448057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537740|NCT01448057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64537741|NCT01448057|Mydriatics|mydriatics|mesh-ancestor
64537742|NCT01448057|Autonomic Agents|autonomic agents|mesh-ancestor
64537743|NCT01448057|Sympathomimetics|sympathomimetics|mesh-ancestor
64537744|NCT01448057|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64302450|NCT04996160|Hormones|hormones|mesh-ancestor
64970645|NCT00221416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64970646|NCT00221416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64970647|NCT00221416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64970648|NCT00221416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970649|NCT00221416|Dopamine Agonists|dopamine agonists|mesh-ancestor
64970650|NCT00221416|Dopamine Agents|dopamine agents|mesh-ancestor
64970651|NCT00221416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970652|NCT00221416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970653|NCT00221416|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64970654|NCT00221416|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64970655|NCT00221416|Serotonin Agents|serotonin agents|mesh-ancestor
64970656|NCT00221416|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64509349|NCT03004833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970682|NCT00221611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64970683|NCT00221611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64970684|NCT00221611|GABA Agonists|gaba agonists|mesh-ancestor
64970685|NCT00221611|GABA Agents|gaba agents|mesh-ancestor
64970686|NCT00221611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970687|NCT00221611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970689|NCT00221650|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64970690|NCT00221650|Antimetabolites|antimetabolites|mesh-ancestor
64970691|NCT00221650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970692|NCT00221650|Antiviral Agents|antiviral agents|mesh-ancestor
64970693|NCT00221650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64970694|NCT00221689|Baclofen|baclofen|mesh-list
64970695|NCT00221689|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64970696|NCT00221689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970697|NCT00221689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64970698|NCT00221689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64970699|NCT00221689|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64970700|NCT00221689|GABA Agonists|gaba agonists|mesh-ancestor
64970701|NCT00221689|GABA Agents|gaba agents|mesh-ancestor
64970702|NCT00221689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970703|NCT00221689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970704|NCT02968121|Brexpiprazole|brexpiprazole|mesh-list
64970705|NCT02968121|Serotonin Agents|serotonin agents|mesh-ancestor
64970706|NCT02968121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970726|NCT00048828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64970727|NCT00048828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64537745|NCT01448057|Nasal Decongestants|nasal decongestants|mesh-ancestor
64537746|NCT01448057|Respiratory System Agents|respiratory system agents|mesh-ancestor
64537747|NCT01448057|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64537748|NCT01448057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64537749|NCT01448057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64537750|NCT01448057|Adrenergic Agents|adrenergic agents|mesh-ancestor
64537751|NCT01448057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64537752|NCT01448057|Protective Agents|protective agents|mesh-ancestor
64537753|NCT01448057|Antipruritics|antipruritics|mesh-ancestor
64537754|NCT01448057|Dermatologic Agents|dermatologic agents|mesh-ancestor
64537755|NCT01448057|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64537756|NCT01448057|Histamine Antagonists|histamine antagonists|mesh-ancestor
64537757|NCT01448057|Histamine Agents|histamine agents|mesh-ancestor
64537758|NCT01448057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64537759|NCT05246631|Dexamethasone|dexamethasone|mesh-list
64537760|NCT05246631|Dexamethasone acetate|dexamethasone acetate|mesh-list
64537761|NCT05246631|Haloperidol|haloperidol|mesh-list
64537762|NCT05246631|Haloperidol decanoate|haloperidol decanoate|mesh-list
64537763|NCT05246631|BB 1101|bb 1101|mesh-list
64537764|NCT05246631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64537765|NCT05246631|Antiemetics|antiemetics|mesh-ancestor
64537766|NCT05246631|Autonomic Agents|autonomic agents|mesh-ancestor
64537767|NCT05246631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64537768|NCT05246631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537769|NCT05246631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64537770|NCT05246631|Glucocorticoids|glucocorticoids|mesh-ancestor
64537771|NCT05246631|Hormones|hormones|mesh-ancestor
64537772|NCT05246631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64537773|NCT05246631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64537774|NCT05246631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537775|NCT05246631|Protease Inhibitors|protease inhibitors|mesh-ancestor
64537776|NCT05246631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537777|NCT05246631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537778|NCT05246631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64970728|NCT00048828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64970729|NCT00048828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64509427|NCT02987920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64970730|NCT00048828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64970731|NCT00048828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970732|NCT00048828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970733|NCT00048828|Serotonin Agents|serotonin agents|mesh-ancestor
64537779|NCT05246631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64537780|NCT05246631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64537781|NCT05246631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64537782|NCT05246631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64537783|NCT05246631|Dopamine Agents|dopamine agents|mesh-ancestor
64537784|NCT05246631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64537785|NCT05246631|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64537786|NCT01447433|Calcium Carbonate|calcium carbonate|mesh-list
64537787|NCT01447433|Calcium|calcium|mesh-list
64537788|NCT01447433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64537789|NCT01447433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537790|NCT01447433|Antacids|antacids|mesh-ancestor
64537791|NCT01447433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537792|NCT01447433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64537793|NCT01798875|Metformin|metformin|mesh-list
64537794|NCT01798875|Contraceptive Agents|contraceptive agents|mesh-list
64537795|NCT01798875|Contraceptives, Oral|contraceptives, oral|mesh-list
64537796|NCT01798875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64537797|NCT01798875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537798|NCT01798875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64537799|NCT01798875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64537800|NCT05362851|Celecoxib|celecoxib|mesh-list
64537801|NCT05362851|Tramadol|tramadol|mesh-list
64537802|NCT05362851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64537803|NCT05362851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64537804|NCT05362851|Analgesics|analgesics|mesh-ancestor
64537805|NCT05362851|Sensory System Agents|sensory system agents|mesh-ancestor
64302497|NCT04989140|Dexamethasone|dexamethasone|mesh-list
64970734|NCT00048828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64970735|NCT00048828|GABA Antagonists|gaba antagonists|mesh-ancestor
64970736|NCT00048828|GABA Agents|gaba agents|mesh-ancestor
64970737|NCT00061529|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64970738|NCT00061529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64970739|NCT00061529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64970740|NCT00061529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64970741|NCT00061529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64970742|NCT00061529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64970743|NCT00061529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64970744|NCT00061529|Adrenergic Agents|adrenergic agents|mesh-ancestor
64970745|NCT00061529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970746|NCT00061529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970747|NCT00061529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970748|NCT00221845|Telmisartan|telmisartan|mesh-list
64970749|NCT00221845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64970750|NCT00221845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64970751|NCT00221845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64970752|NCT00221845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537806|NCT05362851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64537807|NCT05362851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537808|NCT05362851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64537809|NCT05362851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64537810|NCT05362851|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64537811|NCT05362851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64537812|NCT05362851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302524|NCT03246399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64970753|NCT00085761|Capsaicin|capsaicin|mesh-list
64970754|NCT00085761|Antipruritics|antipruritics|mesh-ancestor
64970755|NCT00085761|Dermatologic Agents|dermatologic agents|mesh-ancestor
64970756|NCT00085761|Sensory System Agents|sensory system agents|mesh-ancestor
64970757|NCT00085761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64970758|NCT00085761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970759|NCT00221962|Aripiprazole|aripiprazole|mesh-list
64970760|NCT00221962|Antidepressive Agents|antidepressive agents|mesh-ancestor
64970815|NCT00222469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64970816|NCT00222469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64970817|NCT00222469|Growth Substances|growth substances|mesh-ancestor
64970818|NCT00222469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970819|NCT00222469|Growth Inhibitors|growth inhibitors|mesh-ancestor
64970820|NCT00222469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64970822|NCT00222469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970823|NCT00222469|Antiviral Agents|antiviral agents|mesh-ancestor
64970824|NCT00222469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64970825|NCT00222469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970826|NCT00222469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64970827|NCT00222469|Immunologic Factors|immunologic factors|mesh-ancestor
64970829|NCT00222547|Albendazole|albendazole|mesh-list
64970830|NCT00222547|Vitamins|vitamins|mesh-ancestor
64970831|NCT00222547|Micronutrients|micronutrients|mesh-ancestor
64970832|NCT00222547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970833|NCT00222547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970834|NCT00222547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970835|NCT00222547|Anthelmintics|anthelmintics|mesh-ancestor
64970836|NCT00222547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64970858|NCT02968082|Cholinergic Agents|cholinergic agents|mesh-ancestor
64970859|NCT02968082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970860|NCT02968082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970861|NCT02968082|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64970862|NCT02968082|Parasympatholytics|parasympatholytics|mesh-ancestor
64970864|NCT00222820|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64970865|NCT00222820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64970866|NCT00222820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64970867|NCT00222820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970868|NCT00222820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970869|NCT00222820|Serotonin Agents|serotonin agents|mesh-ancestor
64970870|NCT00222820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970871|NCT00222820|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64970872|NCT00222820|Antidepressive Agents|antidepressive agents|mesh-ancestor
64970873|NCT00222820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64970874|NCT00085332|Docetaxel|docetaxel|mesh-list
64970875|NCT00085332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970876|NCT00085332|Tubulin Modulators|tubulin modulators|mesh-ancestor
64970877|NCT00085332|Antimitotic Agents|antimitotic agents|mesh-ancestor
64970878|NCT00085332|Mitosis Modulators|mitosis modulators|mesh-ancestor
64970879|NCT00085332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970880|NCT00222976|Naproxen|naproxen|mesh-list
64970881|NCT00222976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64970882|NCT00222976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64970883|NCT00222976|Analgesics|analgesics|mesh-ancestor
64970884|NCT00222976|Sensory System Agents|sensory system agents|mesh-ancestor
64970885|NCT00222976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64537813|NCT05362851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537814|NCT05362851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64537815|NCT05362851|Narcotics|narcotics|mesh-ancestor
64537816|NCT05362851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64537817|NCT04408235|Enoxaparin|enoxaparin|mesh-list
64537818|NCT04408235|Anticoagulants|anticoagulants|mesh-ancestor
64537819|NCT04408235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64537820|NCT04408235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64537821|NCT04408235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537822|NCT03517137|Cyclophosphamide|cyclophosphamide|mesh-list
64537823|NCT03517137|Dacarbazine|dacarbazine|mesh-list
64537824|NCT03517137|Etoposide|etoposide|mesh-list
64302531|NCT02134249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302533|NCT03245853|Riboflavin|riboflavin|mesh-list
64970886|NCT00222976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970887|NCT00222976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64970888|NCT00222976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64970889|NCT00222976|Gout Suppressants|gout suppressants|mesh-ancestor
64970915|NCT00223054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970916|NCT00223054|Antifungal Agents|antifungal agents|mesh-ancestor
64970917|NCT00223054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64970918|NCT00223054|Dermatologic Agents|dermatologic agents|mesh-ancestor
64970919|NCT00223054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64970920|NCT00223054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970921|NCT00223054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64970922|NCT00223054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64970923|NCT00223210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64970924|NCT00223210|Antidepressive Agents|antidepressive agents|mesh-ancestor
64970925|NCT00223210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64970926|NCT00223210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64970927|NCT00223210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64970928|NCT00223210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64970929|NCT00223210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970930|NCT00061802|Risperidone|risperidone|mesh-list
64970931|NCT00061802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64970932|NCT00061802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64970933|NCT00061802|Serotonin Agents|serotonin agents|mesh-ancestor
64970934|NCT00061802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970935|NCT00061802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970936|NCT00061802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970937|NCT00061802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64970938|NCT00061802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64970939|NCT00061802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64970955|NCT00223288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970957|NCT00223288|Serotonin Agents|serotonin agents|mesh-ancestor
64970958|NCT00223288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970959|NCT00223288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64970960|NCT00223288|Antidepressive Agents|antidepressive agents|mesh-ancestor
64970961|NCT00223288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64970962|NCT00085449|Cyclosporine|cyclosporine|mesh-list
64970963|NCT00085449|Mycophenolic Acid|mycophenolic acid|mesh-list
64970964|NCT00085449|Fludarabine|fludarabine|mesh-list
64970965|NCT00085449|Fludarabine phosphate|fludarabine phosphate|mesh-list
64970966|NCT00085449|Melphalan|melphalan|mesh-list
64970967|NCT00085449|Alemtuzumab|alemtuzumab|mesh-list
64970968|NCT00085449|Cyclosporins|cyclosporins|mesh-list
64970969|NCT00085449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970970|NCT00085449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64970971|NCT00085449|Antimetabolites|antimetabolites|mesh-ancestor
64970972|NCT00085449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970973|NCT00085449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64537825|NCT03517137|Doxorubicin|doxorubicin|mesh-list
64537826|NCT03517137|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64537827|NCT03517137|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64537828|NCT03517137|Vinblastine|vinblastine|mesh-list
64537829|NCT03517137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64537830|NCT03517137|Immunologic Factors|immunologic factors|mesh-ancestor
64537831|NCT03517137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537832|NCT03517137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64537833|NCT03517137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64537834|NCT03517137|Alkylating Agents|alkylating agents|mesh-ancestor
64537835|NCT03517137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537836|NCT03517137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537837|NCT03517137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64537838|NCT03517137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64537839|NCT03517137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64302543|NCT03574649|Cyclophosphamide|cyclophosphamide|mesh-list
64970974|NCT00085449|Immunologic Factors|immunologic factors|mesh-ancestor
64970975|NCT00085449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970976|NCT00085449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970977|NCT00085449|Antifungal Agents|antifungal agents|mesh-ancestor
64970978|NCT00085449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64970979|NCT00085449|Dermatologic Agents|dermatologic agents|mesh-ancestor
64970980|NCT00085449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64970981|NCT00085449|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64970982|NCT00085449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64970983|NCT00085449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64970984|NCT00085449|Antitubercular Agents|antitubercular agents|mesh-ancestor
64970985|NCT00085449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64970986|NCT00085449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64970987|NCT00085449|Alkylating Agents|alkylating agents|mesh-ancestor
64970988|NCT00085449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64970989|NCT00085449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64970990|NCT00223561|Methylphenidate|methylphenidate|mesh-list
64970991|NCT00223561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64970992|NCT00223561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970993|NCT00223561|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64970994|NCT00223561|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64970995|NCT00223561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64971026|NCT00223717|Analgesics|analgesics|mesh-ancestor
64971027|NCT00223717|Sensory System Agents|sensory system agents|mesh-ancestor
64971028|NCT00223717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64971029|NCT00223717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971030|NCT00223717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64971031|NCT00223717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64971032|NCT00223717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64971033|NCT00223717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64971034|NCT00223717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971035|NCT00223717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64971036|NCT00223717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64971037|NCT00223717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971038|NCT00223717|Antipyretics|antipyretics|mesh-ancestor
64971039|NCT00223717|Vasodilator Agents|vasodilator agents|mesh-ancestor
64971040|NCT00223717|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64971041|NCT00223717|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64971042|NCT00223717|Urological Agents|urological agents|mesh-ancestor
64971043|NCT00223717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64537840|NCT03517137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64537841|NCT03517137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537842|NCT03517137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64537843|NCT03517137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64537844|NCT03517137|Tubulin Modulators|tubulin modulators|mesh-ancestor
64537845|NCT03517137|Antimitotic Agents|antimitotic agents|mesh-ancestor
64537846|NCT03517137|Mitosis Modulators|mitosis modulators|mesh-ancestor
64654755|NCT04925076|Ethanol|ethanol|mesh-list
64537847|NCT01446809|Doxorubicin|doxorubicin|mesh-list
64537848|NCT01446809|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64537849|NCT01446809|Ifosfamide|ifosfamide|mesh-list
64537850|NCT01446809|Isophosphamide mustard|isophosphamide mustard|mesh-list
64537851|NCT01446809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64537852|NCT01446809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537853|NCT01446809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64537854|NCT01446809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64537855|NCT01446809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537856|NCT01446809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537857|NCT01446809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64537858|NCT01446809|Alkylating Agents|alkylating agents|mesh-ancestor
64484208|NCT01730053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537859|NCT03357159|Cyclophosphamide|cyclophosphamide|mesh-list
64537860|NCT03357159|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64537861|NCT03357159|Immunoglobulins|immunoglobulins|mesh-list
64537862|NCT03357159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64537863|NCT03357159|Antibodies|antibodies|mesh-list
64537864|NCT03357159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64537865|NCT03357159|Immunologic Factors|immunologic factors|mesh-ancestor
64537866|NCT03357159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537867|NCT03357159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64537868|NCT03357159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64537869|NCT03357159|Alkylating Agents|alkylating agents|mesh-ancestor
64537870|NCT03357159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537871|NCT03357159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971044|NCT00223717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64971045|NCT00223717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64971046|NCT00223717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64971072|NCT00223717|Hormone Antagonists|hormone antagonists|mesh-ancestor
64971073|NCT00223717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64971074|NCT00223717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64537872|NCT03357159|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64537874|NCT04387929|Immunologic Factors|immunologic factors|mesh-ancestor
64537875|NCT04387929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537876|NCT05361291|Dexamethasone|dexamethasone|mesh-list
64537877|NCT05361291|Lidocaine|lidocaine|mesh-list
64537878|NCT05361291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64971075|NCT00223717|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64971076|NCT00223717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64971077|NCT00223717|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64971078|NCT00223717|Hemostatics|hemostatics|mesh-ancestor
64971079|NCT00223717|Coagulants|coagulants|mesh-ancestor
64971080|NCT00223717|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64971081|NCT00223717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64971082|NCT00223717|Protease Inhibitors|protease inhibitors|mesh-ancestor
64971083|NCT00061919|Thalidomide|thalidomide|mesh-list
64971084|NCT00061919|Carboplatin|carboplatin|mesh-list
64971085|NCT00061919|Etoposide|etoposide|mesh-list
64971086|NCT00061919|Etoposide phosphate|etoposide phosphate|mesh-list
64971087|NCT00061919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971088|NCT00061919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64971089|NCT00061919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64971090|NCT00061919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64971091|NCT00061919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971092|NCT00061919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971109|NCT00224068|Hematinics|hematinics|mesh-ancestor
64971110|NCT00224146|Oxybutynin|oxybutynin|mesh-list
64971111|NCT00224146|Parasympatholytics|parasympatholytics|mesh-ancestor
64971112|NCT00224146|Autonomic Agents|autonomic agents|mesh-ancestor
64971113|NCT00224146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64971114|NCT00224146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971115|NCT00224146|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64971116|NCT00224146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64971117|NCT00224146|Cholinergic Agents|cholinergic agents|mesh-ancestor
64971118|NCT00224146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64971119|NCT00224146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971120|NCT00224146|Urological Agents|urological agents|mesh-ancestor
64971121|NCT00061997|Inositol|inositol|mesh-list
64971122|NCT00061997|Vitamin B Complex|vitamin b complex|mesh-ancestor
64971123|NCT00061997|Vitamins|vitamins|mesh-ancestor
64971124|NCT00061997|Micronutrients|micronutrients|mesh-ancestor
64971125|NCT00061997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971126|NCT00224185|Dimercaprol|dimercaprol|mesh-list
64971127|NCT00224185|Chelating Agents|chelating agents|mesh-ancestor
64971128|NCT00224185|Sequestering Agents|sequestering agents|mesh-ancestor
64971129|NCT00224185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971130|NCT00062036|Aldesleukin|aldesleukin|mesh-list
64971131|NCT00062036|Cyclophosphamide|cyclophosphamide|mesh-list
64971132|NCT00062036|Fludarabine|fludarabine|mesh-list
64971133|NCT00062036|Fludarabine phosphate|fludarabine phosphate|mesh-list
64971134|NCT00062036|Interleukin-2|interleukin-2|mesh-list
64971135|NCT00062036|Freund's Adjuvant|freund's adjuvant|mesh-list
64971136|NCT00062036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64971137|NCT00062036|Immunologic Factors|immunologic factors|mesh-ancestor
64971138|NCT00062036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971139|NCT00062036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64971140|NCT00062036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64971141|NCT00062036|Alkylating Agents|alkylating agents|mesh-ancestor
64971142|NCT00062036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971143|NCT00062036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971144|NCT00062036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64971145|NCT00062036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64971146|NCT00062036|Antimetabolites|antimetabolites|mesh-ancestor
64971147|NCT00062036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64971148|NCT00062036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64971149|NCT00062036|Analgesics|analgesics|mesh-ancestor
64971150|NCT00062036|Sensory System Agents|sensory system agents|mesh-ancestor
64971151|NCT00062036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64971152|NCT00062036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64971153|NCT00062036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64971154|NCT00062036|Antiviral Agents|antiviral agents|mesh-ancestor
64537880|NCT05361291|Autonomic Agents|autonomic agents|mesh-ancestor
64537881|NCT05361291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64537882|NCT05361291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537883|NCT05361291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64537884|NCT05361291|Glucocorticoids|glucocorticoids|mesh-ancestor
64537885|NCT05361291|Hormones|hormones|mesh-ancestor
64537886|NCT05361291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64537887|NCT05361291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64537888|NCT05361291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537889|NCT05361291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537890|NCT05361291|Anesthetics, Local|anesthetics, local|mesh-ancestor
64537891|NCT05361291|Anesthetics|anesthetics|mesh-ancestor
64971155|NCT00062036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64971179|NCT00224419|Cholinergic Agents|cholinergic agents|mesh-ancestor
64971180|NCT00224419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64971181|NCT00224419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971182|NCT00224458|Efavirenz|efavirenz|mesh-list
64971183|NCT00224458|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64971184|NCT00224458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64971185|NCT00224458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64971186|NCT00224458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971187|NCT00224458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971188|NCT00224458|Antiviral Agents|antiviral agents|mesh-ancestor
64971189|NCT00224458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64971190|NCT00224458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64971191|NCT00224458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64971192|NCT00224458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64971193|NCT00224458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64971194|NCT00224458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64971195|NCT00224458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64971196|NCT00224458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64971197|NCT00224458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64971198|NCT00062114|Rituximab|rituximab|mesh-list
64971199|NCT00062114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64971200|NCT00062114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971201|NCT00062114|Immunologic Factors|immunologic factors|mesh-ancestor
64971223|NCT00062231|Ciprofloxacin|ciprofloxacin|mesh-list
64971224|NCT00062231|Clavulanic Acid|clavulanic acid|mesh-list
64971225|NCT00062231|Clavulanic Acids|clavulanic acids|mesh-list
64971226|NCT00062231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64971227|NCT00062231|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64971228|NCT00062231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64971229|NCT00062231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64971230|NCT00062231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64971231|NCT00062231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64971232|NCT00062231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971233|NCT00062231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971234|NCT00062231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971235|NCT00062231|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64971236|NCT00062231|Contraceptive Agents|contraceptive agents|mesh-ancestor
64971237|NCT00062231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64971238|NCT00062231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971239|NCT00062231|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64971240|NCT00062231|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64971241|NCT00062231|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64971242|NCT00062231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64537892|NCT05361291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64537893|NCT05361291|Sensory System Agents|sensory system agents|mesh-ancestor
64537894|NCT05361291|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64537895|NCT05361291|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64537896|NCT05361291|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64537897|NCT05361291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64537899|NCT01445951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64537900|NCT01445951|Insulin Aspart|insulin aspart|mesh-list
64537901|NCT01445951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64537902|NCT01445951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537903|NCT03169101|Nicotine|nicotine|mesh-list
64537904|NCT03169101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64537905|NCT03169101|Autonomic Agents|autonomic agents|mesh-ancestor
64537906|NCT03169101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64537907|NCT03169101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537908|NCT03169101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64537909|NCT03169101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64971243|NCT00062231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64971244|NCT00062231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64971245|NCT00224692|Ketamine|ketamine|mesh-list
64971246|NCT00224692|Analgesics|analgesics|mesh-ancestor
64971247|NCT00224692|Sensory System Agents|sensory system agents|mesh-ancestor
64971248|NCT00224692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64971249|NCT00224692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971250|NCT00224692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64971251|NCT00224692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64971252|NCT00224692|Anesthetics, General|anesthetics, general|mesh-ancestor
64971253|NCT00224692|Anesthetics|anesthetics|mesh-ancestor
64971254|NCT00224692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64971255|NCT00224692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64971256|NCT00224692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64971275|NCT00224809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971276|NCT00224809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64971277|NCT00224809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64971278|NCT00224809|Antipyretics|antipyretics|mesh-ancestor
64971279|NCT00224809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64971280|NCT00224809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64971281|NCT00224809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64971282|NCT00224809|Purinergic Agents|purinergic agents|mesh-ancestor
64971283|NCT00224809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64971284|NCT00224809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64971285|NCT00224809|Hormone Antagonists|hormone antagonists|mesh-ancestor
64971286|NCT00224809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64971287|NCT00224809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64971289|NCT00224809|Natriuretic Agents|natriuretic agents|mesh-ancestor
64971290|NCT00224809|Protease Inhibitors|protease inhibitors|mesh-ancestor
64971291|NCT00062270|Gemcitabine|gemcitabine|mesh-list
64971292|NCT00062270|Docetaxel|docetaxel|mesh-list
64971293|NCT00062270|Gefitinib|gefitinib|mesh-list
64971294|NCT00062270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971295|NCT00062270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64971296|NCT00062270|Antimetabolites|antimetabolites|mesh-ancestor
64971297|NCT00062270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971298|NCT00062270|Antiviral Agents|antiviral agents|mesh-ancestor
64537910|NCT03169101|Cholinergic Agents|cholinergic agents|mesh-ancestor
64537911|NCT03169101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64537912|NCT03169101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537913|NCT03072771|Cytarabine|cytarabine|mesh-list
64537914|NCT03072771|Etoposide|etoposide|mesh-list
64537915|NCT03072771|Melphalan|melphalan|mesh-list
64537916|NCT03072771|Carmustine|carmustine|mesh-list
64537917|NCT03072771|Blinatumomab|blinatumomab|mesh-list
64537918|NCT03072771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64537919|NCT03072771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537920|NCT03072771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64537921|NCT03072771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64537922|NCT03072771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537923|NCT03072771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537924|NCT03072771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64537925|NCT03072771|Antimetabolites|antimetabolites|mesh-ancestor
64537926|NCT03072771|Antiviral Agents|antiviral agents|mesh-ancestor
64537927|NCT03072771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64537928|NCT03072771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64537929|NCT03072771|Immunologic Factors|immunologic factors|mesh-ancestor
64537930|NCT03072771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537931|NCT03072771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64537932|NCT03072771|Alkylating Agents|alkylating agents|mesh-ancestor
64302631|NCT02136589|Diclofenac|diclofenac|mesh-list
64971299|NCT00062270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64971300|NCT00062270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971301|NCT00062270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64971302|NCT00062270|Immunologic Factors|immunologic factors|mesh-ancestor
64971303|NCT00062270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971304|NCT00062270|Tubulin Modulators|tubulin modulators|mesh-ancestor
64971305|NCT00062270|Antimitotic Agents|antimitotic agents|mesh-ancestor
64971306|NCT00062270|Mitosis Modulators|mitosis modulators|mesh-ancestor
64971307|NCT00062270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64971308|NCT00413023|Casopitant|casopitant|mesh-list
64971309|NCT00413023|Antiemetics|antiemetics|mesh-ancestor
64971310|NCT00413023|Autonomic Agents|autonomic agents|mesh-ancestor
64971311|NCT00413023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64971312|NCT00413023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971330|NCT00413179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64971331|NCT00413179|Fertility Agents|fertility agents|mesh-ancestor
64971332|NCT00413179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64971333|NCT00413179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64971334|NCT00413179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64971335|NCT00413257|Nefopam|nefopam|mesh-list
64971336|NCT00413257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64971337|NCT00413257|Analgesics|analgesics|mesh-ancestor
64971338|NCT00413257|Sensory System Agents|sensory system agents|mesh-ancestor
64971339|NCT00413257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64971340|NCT00413257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971341|NCT00095316|Caspofungin|caspofungin|mesh-list
64971342|NCT00095316|Antifungal Agents|antifungal agents|mesh-ancestor
64971343|NCT00095316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64537933|NCT03072771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64537934|NCT05219877|Levofloxacin|levofloxacin|mesh-list
64537935|NCT05219877|Ofloxacin|ofloxacin|mesh-list
64537936|NCT05219877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64537937|NCT05219877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64537939|NCT05219877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64537940|NCT05219877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64537941|NCT05219877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64537942|NCT05219877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971344|NCT00095316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971345|NCT00095316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971346|NCT00225043|Phenylephrine|phenylephrine|mesh-list
64971347|NCT00225043|Epinephrine|epinephrine|mesh-list
64971348|NCT00225043|Oxymetazoline|oxymetazoline|mesh-list
64971349|NCT00225043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64971350|NCT00225043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64971351|NCT00225043|Adrenergic Agents|adrenergic agents|mesh-ancestor
64971352|NCT00225043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64971353|NCT00225043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971354|NCT00225043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971355|NCT00225043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64971356|NCT00225043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64971357|NCT00225043|Autonomic Agents|autonomic agents|mesh-ancestor
64971358|NCT00225043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64971359|NCT00225043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64971360|NCT00225043|Respiratory System Agents|respiratory system agents|mesh-ancestor
64971361|NCT00225043|Mydriatics|mydriatics|mesh-ancestor
64971362|NCT00225043|Sympathomimetics|sympathomimetics|mesh-ancestor
64971363|NCT00225043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64971364|NCT00225043|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64971365|NCT00225043|Nasal Decongestants|nasal decongestants|mesh-ancestor
64971366|NCT00225043|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64971367|NCT00225043|Protective Agents|protective agents|mesh-ancestor
64971368|NCT00095355|Valproic Acid|valproic acid|mesh-list
64971369|NCT00095355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64971370|NCT00095355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971396|NCT00062426|Calcium|calcium|mesh-list
64971397|NCT00062426|Levoleucovorin|levoleucovorin|mesh-list
64971398|NCT00062426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64971399|NCT00062426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971400|NCT00062426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64971401|NCT00062426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64971402|NCT00062426|Growth Substances|growth substances|mesh-ancestor
64971403|NCT00062426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971404|NCT00062426|Growth Inhibitors|growth inhibitors|mesh-ancestor
64971405|NCT00062426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64971406|NCT00062426|Antimetabolites|antimetabolites|mesh-ancestor
64971407|NCT00062426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971408|NCT00062426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64971409|NCT00062426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64971410|NCT00062426|Immunologic Factors|immunologic factors|mesh-ancestor
64971411|NCT00062426|Antidotes|antidotes|mesh-ancestor
64971412|NCT00062426|Protective Agents|protective agents|mesh-ancestor
64971413|NCT00062426|Vitamin B Complex|vitamin b complex|mesh-ancestor
64971415|NCT00062426|Micronutrients|micronutrients|mesh-ancestor
64971416|NCT00095433|Ranibizumab|ranibizumab|mesh-list
64971417|NCT00095433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64971418|NCT00095433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64971419|NCT00095433|Growth Substances|growth substances|mesh-ancestor
64971420|NCT00095433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971421|NCT00095433|Growth Inhibitors|growth inhibitors|mesh-ancestor
64971422|NCT00095433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971423|NCT00225355|Rosiglitazone|rosiglitazone|mesh-list
64971424|NCT00225355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64971449|NCT00225511|Levomilnacipran|levomilnacipran|mesh-list
64971450|NCT00225511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64971451|NCT00225511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64537943|NCT05219877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537944|NCT05219877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537945|NCT05219877|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64537946|NCT05219877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64537947|NCT05214339|Bevacizumab|bevacizumab|mesh-list
64537948|NCT05214339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64714140|NCT04736953|Sirolimus|sirolimus|mesh-list
64537949|NCT05214339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537950|NCT05214339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64302660|NCT02134717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64971452|NCT00225511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64971453|NCT00225511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971454|NCT00225511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64971455|NCT00225511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971456|NCT00225511|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64971457|NCT00225511|Antidepressive Agents|antidepressive agents|mesh-ancestor
64971458|NCT00225511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64971459|NCT00225511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64971460|NCT00225511|Analgesics|analgesics|mesh-ancestor
64971461|NCT00225511|Sensory System Agents|sensory system agents|mesh-ancestor
64971462|NCT00225511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64971463|NCT00095511|Aripiprazole|aripiprazole|mesh-list
64971464|NCT00095511|Antidepressive Agents|antidepressive agents|mesh-ancestor
64971465|NCT00095511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64971466|NCT00095511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64971467|NCT00095511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64971468|NCT00095511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64971469|NCT00095511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971470|NCT00095511|Dopamine Agonists|dopamine agonists|mesh-ancestor
64971471|NCT00095511|Dopamine Agents|dopamine agents|mesh-ancestor
64971487|NCT00225589|Antimetabolites|antimetabolites|mesh-ancestor
64971488|NCT00225589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971489|NCT00225589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64971490|NCT00225589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64971491|NCT00225589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971492|NCT02967887|Fluorouracil|fluorouracil|mesh-list
64971493|NCT02967887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971494|NCT02967887|Antimetabolites|antimetabolites|mesh-ancestor
64971495|NCT02967887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971496|NCT02967887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64971497|NCT02967887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64971498|NCT02967887|Immunologic Factors|immunologic factors|mesh-ancestor
64971499|NCT02967887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971500|NCT00225667|Irbesartan|irbesartan|mesh-list
64971501|NCT00225667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64971502|NCT00225667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64971503|NCT00225667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64971504|NCT00225667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971505|NCT00225706|Ibuprofen|ibuprofen|mesh-list
64971506|NCT00225706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64971507|NCT00225706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64971508|NCT00225706|Analgesics|analgesics|mesh-ancestor
64971509|NCT00225706|Sensory System Agents|sensory system agents|mesh-ancestor
64971510|NCT00225706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64971511|NCT00225706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971512|NCT00225706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64971513|NCT00225706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64971514|NCT00225706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64971515|NCT00225706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971516|NCT00225706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971517|NCT00095667|Lapatinib|lapatinib|mesh-list
64537951|NCT05214339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64537952|NCT05214339|Growth Substances|growth substances|mesh-ancestor
64537953|NCT05214339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537954|NCT05214339|Growth Inhibitors|growth inhibitors|mesh-ancestor
64537956|NCT01444781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64537957|NCT01444781|Immunologic Factors|immunologic factors|mesh-ancestor
64537958|NCT01444781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537959|NCT02471391|Venetoclax|venetoclax|mesh-list
64537960|NCT02471391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537961|NCT02431845|Fluoxetine|fluoxetine|mesh-list
64537962|NCT02431845|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64654791|NCT01640171|Analgesics|analgesics|mesh-ancestor
64537963|NCT02431845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64537964|NCT02431845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64537965|NCT02431845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537966|NCT02431845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64302671|NCT02136823|Memantine|memantine|mesh-list
64971518|NCT00095667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971519|NCT00095667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64971520|NCT00095667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971521|NCT00095667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971522|NCT00225862|Ropinirole|ropinirole|mesh-list
64971523|NCT00225862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64971524|NCT00225862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64971525|NCT00225862|Dopamine Agonists|dopamine agonists|mesh-ancestor
64971526|NCT00225862|Dopamine Agents|dopamine agents|mesh-ancestor
64971527|NCT00225862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64971552|NCT00095745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64971553|NCT00095745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64971554|NCT00095745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64971555|NCT00095745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64971556|NCT00095745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971557|NCT00095745|Dopamine Agonists|dopamine agonists|mesh-ancestor
64971558|NCT00095745|Dopamine Agents|dopamine agents|mesh-ancestor
64971559|NCT00095745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64971560|NCT00095745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971561|NCT00095745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64971562|NCT00095745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64971563|NCT00095745|Serotonin Agents|serotonin agents|mesh-ancestor
64971564|NCT00095745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64971565|NCT00095745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64971566|NCT00095745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64971567|NCT00095745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64971568|NCT00226096|Metoprolol|metoprolol|mesh-list
64971569|NCT00226096|Clonidine|clonidine|mesh-list
64971570|NCT00226096|Nitroprusside|nitroprusside|mesh-list
64971571|NCT00226096|Labetalol|labetalol|mesh-list
64971572|NCT00226096|Hydralazine|hydralazine|mesh-list
64971573|NCT00226096|Nicardipine|nicardipine|mesh-list
64971574|NCT00226096|Phentolamine|phentolamine|mesh-list
64971575|NCT00226096|Urapidil|urapidil|mesh-list
64971576|NCT00226096|Enalaprilat|enalaprilat|mesh-list
64971577|NCT00226096|Nitroglycerin|nitroglycerin|mesh-list
64971578|NCT00226096|Esmolol|esmolol|mesh-list
64971601|NCT00226096|Sympathomimetics|sympathomimetics|mesh-ancestor
64971602|NCT00226096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64971603|NCT00226096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64971604|NCT00226096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64542246|NCT00717405|Growth Substances|growth substances|mesh-ancestor
64971605|NCT00226096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64971606|NCT00226096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64537967|NCT02431845|Serotonin Agents|serotonin agents|mesh-ancestor
64537968|NCT02431845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537969|NCT02431845|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64537970|NCT02431845|Antidepressive Agents|antidepressive agents|mesh-ancestor
64537971|NCT02431845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64537972|NCT02431845|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64537973|NCT02431845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64302686|NCT02136823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64302688|NCT03250143|Cyclosporine|cyclosporine|mesh-list
64971607|NCT00226096|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64971608|NCT00226096|Serotonin Agents|serotonin agents|mesh-ancestor
64971609|NCT00226096|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64971610|NCT00226096|Protease Inhibitors|protease inhibitors|mesh-ancestor
64971611|NCT00226096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971612|NCT00226135|Lamotrigine|lamotrigine|mesh-list
64971613|NCT00226135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64971614|NCT00226135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971615|NCT00226135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64971616|NCT00226135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64971617|NCT00226135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971618|NCT00226135|Anticonvulsants|anticonvulsants|mesh-ancestor
64971619|NCT00226135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64971620|NCT00226135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64971621|NCT00226135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64971622|NCT00226135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64971623|NCT00226135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64971625|NCT00400374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64971626|NCT00400374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971627|NCT00400374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64971628|NCT00400374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971629|NCT00400374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971650|NCT00226408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64971651|NCT00226408|Immunologic Factors|immunologic factors|mesh-ancestor
64971652|NCT00226408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971653|NCT00226447|Interferons|interferons|mesh-list
64971655|NCT00226447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971656|NCT00226447|Antiviral Agents|antiviral agents|mesh-ancestor
64971657|NCT00226447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64971658|NCT00226447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64971659|NCT00226447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64971660|NCT00226447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971661|NCT00226447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971662|NCT00226447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64971663|NCT00226447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64971665|NCT00062660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64971666|NCT00062660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64971667|NCT00062660|Antiviral Agents|antiviral agents|mesh-ancestor
64971668|NCT00062660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64971669|NCT00413296|Levetiracetam|levetiracetam|mesh-list
64971670|NCT00413296|Anticonvulsants|anticonvulsants|mesh-ancestor
64971671|NCT00413296|Nootropic Agents|nootropic agents|mesh-ancestor
64971672|NCT00413452|Etanercept|etanercept|mesh-list
64971673|NCT00413452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64971674|NCT00413452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64971675|NCT00413452|Analgesics|analgesics|mesh-ancestor
64971676|NCT00413452|Sensory System Agents|sensory system agents|mesh-ancestor
64971677|NCT00413452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64971678|NCT00413452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971679|NCT00413452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64971680|NCT00413452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64971681|NCT00413452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64971682|NCT00413452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64537974|NCT02431845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537975|NCT05065671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64537977|NCT05065671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64542253|NCT01276977|Serotonin Agents|serotonin agents|mesh-ancestor
64537978|NCT05065671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64537979|NCT05065671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64537980|NCT05065671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64537981|NCT05065671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64537982|NCT05065671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64537983|NCT05065671|Analgesics|analgesics|mesh-ancestor
64537984|NCT05065671|Sensory System Agents|sensory system agents|mesh-ancestor
64537985|NCT05065671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64537986|NCT05065671|Antidepressive Agents|antidepressive agents|mesh-ancestor
64537987|NCT05065671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64537988|NCT05065671|Dopamine Agents|dopamine agents|mesh-ancestor
64537989|NCT05065671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64537990|NCT05065671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64537991|NCT05065671|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64537992|NCT05065671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64537993|NCT01443923|Interferons|interferons|mesh-list
64537994|NCT01443923|Ribavirin|ribavirin|mesh-list
64537995|NCT01443923|Interferon-alpha|interferon-alpha|mesh-list
64302694|NCT03250143|Immunologic Factors|immunologic factors|mesh-ancestor
64971683|NCT00413452|Immunologic Factors|immunologic factors|mesh-ancestor
64971684|NCT00095823|Aripiprazole|aripiprazole|mesh-list
64971685|NCT00095823|Antidepressive Agents|antidepressive agents|mesh-list
64971686|NCT00095823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64971707|NCT00226564|Analgesics|analgesics|mesh-ancestor
64654804|NCT04361474|Hormones|hormones|mesh-ancestor
64971708|NCT00226564|Sensory System Agents|sensory system agents|mesh-ancestor
64971709|NCT00226564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64971710|NCT00226564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64971711|NCT00226564|Anesthetics, General|anesthetics, general|mesh-ancestor
64971712|NCT00226564|Anesthetics|anesthetics|mesh-ancestor
64971713|NCT00062699|Calcitriol|calcitriol|mesh-list
64971714|NCT00062699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64971715|NCT00062699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971716|NCT00062699|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64971717|NCT00062699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64971718|NCT00062699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971719|NCT00062699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64971720|NCT00062699|Vitamins|vitamins|mesh-ancestor
64971721|NCT00062699|Micronutrients|micronutrients|mesh-ancestor
64971722|NCT00062699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64971723|NCT00226798|Capecitabine|capecitabine|mesh-list
64971724|NCT00226798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64971725|NCT00226798|Antimetabolites|antimetabolites|mesh-ancestor
64971726|NCT00226798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971727|NCT00226798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971728|NCT00399243|Sumatriptan|sumatriptan|mesh-list
64971729|NCT00399243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64971730|NCT00399243|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64537996|NCT01443923|Interferon alpha-2|interferon alpha-2|mesh-list
64537997|NCT01443923|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64537998|NCT01443923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64537999|NCT01443923|Antiviral Agents|antiviral agents|mesh-ancestor
64538000|NCT01443923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64538001|NCT01443923|Antimetabolites|antimetabolites|mesh-ancestor
64538002|NCT01443923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538003|NCT01443923|Immunologic Factors|immunologic factors|mesh-ancestor
64538004|NCT01443923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538005|NCT00569673|Docetaxel|docetaxel|mesh-list
64538006|NCT00569673|Trabectedin|trabectedin|mesh-list
64538007|NCT00569673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302717|NCT03073850|Antithrombins|antithrombins|mesh-ancestor
64971731|NCT00399243|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64971732|NCT00399243|Serotonin Agents|serotonin agents|mesh-ancestor
64971733|NCT00399243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64971734|NCT00399243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971754|NCT00226915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971756|NCT00095862|Interferon-alpha|interferon-alpha|mesh-list
64971757|NCT00095862|Cyclophosphamide|cyclophosphamide|mesh-list
64971758|NCT00095862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64971759|NCT00095862|Immunologic Factors|immunologic factors|mesh-ancestor
64971760|NCT00095862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971761|NCT00095862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64971762|NCT00095862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64971763|NCT00095862|Alkylating Agents|alkylating agents|mesh-ancestor
64971764|NCT00095862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971765|NCT00095862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971766|NCT00095862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64971767|NCT00095862|Antiviral Agents|antiviral agents|mesh-ancestor
64971768|NCT00095862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64971769|NCT00226954|Zoledronic Acid|zoledronic acid|mesh-list
64971770|NCT00226954|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64971771|NCT00226954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971772|NCT00227032|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64971773|NCT00227032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971774|NCT00227032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64971775|NCT00227032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971776|NCT00227032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971777|NCT00095901|Capecitabine|capecitabine|mesh-list
64971778|NCT00095901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64971779|NCT00095901|Antimetabolites|antimetabolites|mesh-ancestor
64971780|NCT00095901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971781|NCT00095901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971783|NCT00227110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64971784|NCT00227110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971785|NCT00062894|Tositumomab I-131|tositumomab i-131|mesh-list
64971786|NCT00062894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971787|NCT00227188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64971788|NCT00227188|Immunologic Factors|immunologic factors|mesh-ancestor
64971789|NCT00227188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971816|NCT00096096|Antitubercular Agents|antitubercular agents|mesh-ancestor
64971817|NCT00096096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64971818|NCT00096096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64971819|NCT04721899|Vitamin D|vitamin d|mesh-list
64971820|NCT04721899|Vitamins|vitamins|mesh-ancestor
64971821|NCT04721899|Micronutrients|micronutrients|mesh-ancestor
64971822|NCT04721899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971823|NCT04721899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64971824|NCT00062972|Donepezil|donepezil|mesh-list
64538008|NCT00569673|Tubulin Modulators|tubulin modulators|mesh-ancestor
64538009|NCT00569673|Antimitotic Agents|antimitotic agents|mesh-ancestor
64538010|NCT00569673|Mitosis Modulators|mitosis modulators|mesh-ancestor
64538011|NCT00569673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538012|NCT00569673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64538014|NCT01551212|Everolimus|everolimus|mesh-list
64538015|NCT01551212|Tacrolimus|tacrolimus|mesh-list
64538016|NCT01551212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64302729|NCT03070574|Mesalamine|mesalamine|mesh-list
64971825|NCT00062972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64971826|NCT00062972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971827|NCT00062972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971828|NCT00062972|Cholinergic Agents|cholinergic agents|mesh-ancestor
64971829|NCT00062972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64971830|NCT00062972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510558|NCT05826327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64510559|NCT05826327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510560|NCT05826327|Analgesics|analgesics|mesh-ancestor
64510561|NCT05826327|Sensory System Agents|sensory system agents|mesh-ancestor
64510562|NCT05826327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64510563|NCT05826327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64510564|NCT05826327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64971850|NCT00227695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64971851|NCT00227734|Capecitabine|capecitabine|mesh-list
64971852|NCT00227734|Oxaliplatin|oxaliplatin|mesh-list
64971853|NCT00227734|Cetuximab|cetuximab|mesh-list
64971854|NCT00227734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64971855|NCT00227734|Antimetabolites|antimetabolites|mesh-ancestor
64971856|NCT00227734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971857|NCT00227734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971858|NCT00227734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64971859|NCT00063011|Calcium|calcium|mesh-list
64971860|NCT00063011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64971861|NCT00063011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971862|NCT00227773|Octreotide|octreotide|mesh-list
64971863|NCT00227773|Hormones|hormones|mesh-list
64971864|NCT00227773|Somatostatin|somatostatin|mesh-list
64971865|NCT00227773|Mitogens|mitogens|mesh-list
64971866|NCT00227773|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64971867|NCT00227773|Vatalanib|vatalanib|mesh-list
64971868|NCT00227773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64971869|NCT00227773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971870|NCT00227773|Mitosis Modulators|mitosis modulators|mesh-ancestor
64971871|NCT00227773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971872|NCT00227773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64971873|NCT00227773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64971887|NCT00227812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64971888|NCT00227812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64971890|NCT00096291|Paclitaxel|paclitaxel|mesh-list
64971891|NCT00096291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64971892|NCT00096291|Doxorubicin|doxorubicin|mesh-list
64510632|NCT05825872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510634|NCT05825781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64510635|NCT05825781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64510636|NCT05825625|Atezolizumab|atezolizumab|mesh-list
64510637|NCT05825625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64510638|NCT05825599|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64510639|NCT05825599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64510640|NCT05825586|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64510641|NCT05825586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64510642|NCT05825573|Vitamin K|vitamin k|mesh-list
64510643|NCT05825573|Anticoagulants|anticoagulants|mesh-list
64510644|NCT05825573|Vitamins|vitamins|mesh-ancestor
64510645|NCT05825573|Micronutrients|micronutrients|mesh-ancestor
64510674|NCT05825417|Selexipag|selexipag|mesh-list
64971893|NCT00096291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64538017|NCT01551212|Immunologic Factors|immunologic factors|mesh-ancestor
64538018|NCT01551212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538019|NCT01551212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64538020|NCT01551212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538021|NCT01551212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538022|NCT01551212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538023|NCT00573261|Pregabalin|pregabalin|mesh-list
64538024|NCT00573261|Analgesics|analgesics|mesh-ancestor
64538025|NCT00573261|Sensory System Agents|sensory system agents|mesh-ancestor
64538026|NCT00573261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64538027|NCT00573261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538028|NCT00573261|Anticonvulsants|anticonvulsants|mesh-ancestor
64302736|NCT03070574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64302737|NCT03070574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64971894|NCT00096291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64971895|NCT00096291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971896|NCT00096291|Tubulin Modulators|tubulin modulators|mesh-ancestor
64971897|NCT00096291|Antimitotic Agents|antimitotic agents|mesh-ancestor
64971898|NCT00096291|Mitosis Modulators|mitosis modulators|mesh-ancestor
64971899|NCT00096291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971900|NCT00096291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64971901|NCT00096291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64971902|NCT00096291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64971903|NCT00096291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971904|NCT02967302|Triamcinolone|triamcinolone|mesh-list
64971905|NCT02967302|Morphine|morphine|mesh-list
64971906|NCT02967302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64971907|NCT02967302|Narcotics|narcotics|mesh-ancestor
64971908|NCT02967302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64971909|NCT02967302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971910|NCT02967302|Analgesics|analgesics|mesh-ancestor
64971911|NCT02967302|Sensory System Agents|sensory system agents|mesh-ancestor
64971912|NCT02967302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64971913|NCT02967302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64971914|NCT02967302|Glucocorticoids|glucocorticoids|mesh-ancestor
64971915|NCT02967302|Hormones|hormones|mesh-ancestor
64971916|NCT02967302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64971917|NCT00096330|Folic Acid|folic acid|mesh-list
64971918|NCT00096330|Hematinics|hematinics|mesh-ancestor
64971919|NCT00096330|Vitamin B Complex|vitamin b complex|mesh-ancestor
64971941|NCT00096369|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64542286|NCT01525082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64971942|NCT00096369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64971943|NCT00228007|Antidepressive Agents|antidepressive agents|mesh-list
64971944|NCT00228007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64971945|NCT00228046|Valproic Acid|valproic acid|mesh-list
64971946|NCT00228046|Methylphenidate|methylphenidate|mesh-list
64971947|NCT00228046|Amphetamine|amphetamine|mesh-list
64971948|NCT00228046|Dextroamphetamine|dextroamphetamine|mesh-list
64971949|NCT00228046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64971950|NCT00228046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971951|NCT00228046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64971952|NCT00228046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64971953|NCT00228046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64971954|NCT00228046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971955|NCT00228046|Dopamine Agents|dopamine agents|mesh-ancestor
64971956|NCT00228046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64971957|NCT00228046|Sympathomimetics|sympathomimetics|mesh-ancestor
64971958|NCT00228046|Autonomic Agents|autonomic agents|mesh-ancestor
64971959|NCT00228046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64971960|NCT00228046|Adrenergic Agents|adrenergic agents|mesh-ancestor
64971961|NCT00228046|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64538029|NCT00573261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64538030|NCT00573261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64538031|NCT00573261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538032|NCT00573261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64538033|NCT00573261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64538034|NCT00573261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64538035|NCT00573261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64538036|NCT00573261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64538037|NCT04315233|Belinostat|belinostat|mesh-list
64538038|NCT04315233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538039|NCT04315233|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64538040|NCT04315233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538041|NCT04315233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538042|NCT04268199|Bortezomib|bortezomib|mesh-list
64971962|NCT00228046|Anticonvulsants|anticonvulsants|mesh-ancestor
64971963|NCT00228046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971964|NCT00228046|GABA Agents|gaba agents|mesh-ancestor
64971965|NCT00228046|Antimanic Agents|antimanic agents|mesh-ancestor
64971966|NCT00228046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64542315|NCT03599791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64971967|NCT00228046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64971968|NCT00228046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64971969|NCT00063089|Immunoglobulins|immunoglobulins|mesh-list
64971970|NCT00063089|Antibodies|antibodies|mesh-list
64971971|NCT00063089|gamma-Globulins|gamma-globulins|mesh-list
64971986|NCT00228163|Immunologic Factors|immunologic factors|mesh-ancestor
64971987|NCT00063128|Insulin|insulin|mesh-list
64971988|NCT00063128|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64971989|NCT00063128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64971990|NCT00063128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971991|NCT00075465|Docetaxel|docetaxel|mesh-list
64971992|NCT00075465|Epirubicin|epirubicin|mesh-list
64971993|NCT00075465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971994|NCT00075465|Tubulin Modulators|tubulin modulators|mesh-ancestor
64971995|NCT00075465|Antimitotic Agents|antimitotic agents|mesh-ancestor
64971996|NCT00075465|Mitosis Modulators|mitosis modulators|mesh-ancestor
64971997|NCT00075465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971998|NCT00075465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64971999|NCT00075465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64972000|NCT00075465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64972001|NCT00075465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972002|NCT00228319|Vitamins|vitamins|mesh-list
64972003|NCT00228319|Ascorbic Acid|ascorbic acid|mesh-list
64972004|NCT00228319|Vitamin E|vitamin e|mesh-list
64972005|NCT00228319|Vitamin A|vitamin a|mesh-list
64972006|NCT00228319|Carboplatin|carboplatin|mesh-list
64972007|NCT00228319|Carotenoids|carotenoids|mesh-list
64972008|NCT00228319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972009|NCT00228319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972010|NCT00228319|Micronutrients|micronutrients|mesh-ancestor
64972011|NCT00228319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972012|NCT00228319|Antioxidants|antioxidants|mesh-ancestor
64972013|NCT00228319|Protective Agents|protective agents|mesh-ancestor
64972014|NCT00096525|Lenalidomide|lenalidomide|mesh-list
64972015|NCT00096525|Immunologic Factors|immunologic factors|mesh-ancestor
64972016|NCT00096525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972017|NCT00096525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64972018|NCT00096525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64972019|NCT00096525|Growth Substances|growth substances|mesh-ancestor
64972020|NCT00096525|Growth Inhibitors|growth inhibitors|mesh-ancestor
64972021|NCT00096525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972022|NCT00228358|Cyclophosphamide|cyclophosphamide|mesh-list
64972023|NCT00228358|Interleukin-2|interleukin-2|mesh-list
64538043|NCT04268199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538045|NCT04514211|Sevoflurane|sevoflurane|mesh-list
64538046|NCT04514211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64538047|NCT04514211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64538048|NCT04514211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538049|NCT04514211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64538050|NCT04514211|Anesthetics, General|anesthetics, general|mesh-ancestor
64538051|NCT04514211|Anesthetics|anesthetics|mesh-ancestor
64538052|NCT04514211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64538053|NCT04514211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64538054|NCT00574197|Mycophenolic Acid|mycophenolic acid|mesh-list
64538055|NCT00574197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64538056|NCT00574197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538057|NCT00574197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64538058|NCT00574197|Antitubercular Agents|antitubercular agents|mesh-ancestor
64538059|NCT00574197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64538060|NCT00574197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64538061|NCT00574197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538062|NCT00574197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538063|NCT00574587|Paclitaxel|paclitaxel|mesh-list
64538064|NCT00574587|Cyclophosphamide|cyclophosphamide|mesh-list
64542438|NCT00729807|Pentamidine|pentamidine|mesh-list
64972024|NCT00228358|Denileukin diftitox|denileukin diftitox|mesh-list
64972025|NCT00228358|Immunotoxins|immunotoxins|mesh-list
64972026|NCT00228358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64972027|NCT00228358|Immunologic Factors|immunologic factors|mesh-ancestor
64972028|NCT00228358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972029|NCT00228358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64972030|NCT00228358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64972031|NCT00228358|Alkylating Agents|alkylating agents|mesh-ancestor
64972032|NCT00228358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972033|NCT00228358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972034|NCT00228358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64972060|NCT00228475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972061|NCT00228475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64972062|NCT00228475|Respiratory System Agents|respiratory system agents|mesh-ancestor
64972063|NCT00228475|Glucocorticoids|glucocorticoids|mesh-ancestor
64972064|NCT00228475|Hormones|hormones|mesh-ancestor
64972065|NCT00228475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64972066|NCT00228514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64972067|NCT00228514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64972068|NCT00228514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64972069|NCT00228514|Antimetabolites|antimetabolites|mesh-ancestor
64972070|NCT00228514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972071|NCT00228514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64972072|NCT00228514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64972073|NCT00228514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972074|NCT00228592|Immunoglobulins|immunoglobulins|mesh-list
64972075|NCT00228592|Antibodies|antibodies|mesh-list
64972076|NCT00228592|gamma-Globulins|gamma-globulins|mesh-list
64978343|NCT00269035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64972077|NCT00228592|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64972078|NCT00228592|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64538065|NCT00574587|Doxorubicin|doxorubicin|mesh-list
64538066|NCT00574587|Trastuzumab|trastuzumab|mesh-list
64538067|NCT00574587|Vorinostat|vorinostat|mesh-list
64538068|NCT00574587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64538069|NCT00574587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538070|NCT00574587|Tubulin Modulators|tubulin modulators|mesh-ancestor
64538071|NCT00574587|Antimitotic Agents|antimitotic agents|mesh-ancestor
64538072|NCT00574587|Mitosis Modulators|mitosis modulators|mesh-ancestor
64538073|NCT00574587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538075|NCT00574587|Immunologic Factors|immunologic factors|mesh-ancestor
64538076|NCT00574587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538077|NCT00574587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64538078|NCT00574587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64538079|NCT00574587|Alkylating Agents|alkylating agents|mesh-ancestor
64538080|NCT00574587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64538081|NCT00574587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64538082|NCT00574587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64538083|NCT00574587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64538084|NCT00574587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538085|NCT00574587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64538086|NCT00574587|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64538087|NCT00603993|Adalimumab|adalimumab|mesh-list
64538088|NCT00603993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64538089|NCT00603993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64538090|NCT00575367|Azithromycin|azithromycin|mesh-list
64538091|NCT00575367|Moxifloxacin|moxifloxacin|mesh-list
64538092|NCT00575367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64538093|NCT00575367|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64972079|NCT00228592|Immunologic Factors|immunologic factors|mesh-ancestor
64972080|NCT00228592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972081|NCT00075621|Melphalan|melphalan|mesh-list
64972082|NCT00075621|Immunologic Factors|immunologic factors|mesh-ancestor
64972083|NCT00075621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510862|NCT05810233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510863|NCT05810233|Antioxidants|antioxidants|mesh-ancestor
64510864|NCT05810233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510865|NCT05810233|Protective Agents|protective agents|mesh-ancestor
64510866|NCT05801978|Vaccines|vaccines|mesh-list
64510867|NCT05801978|Immunologic Factors|immunologic factors|mesh-ancestor
64510868|NCT05801978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510869|NCT05800639|Anesthetics|anesthetics|mesh-list
64972113|NCT00229138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64972122|NCT00063323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64972123|NCT00063323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538094|NCT00575367|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64538095|NCT00575367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64538096|NCT00575367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64538097|NCT00575367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64538098|NCT00575367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64494177|NCT04447534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64538099|NCT00575367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538100|NCT00575367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538101|NCT00575367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538102|NCT00575367|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64538103|NCT00575367|Contraceptive Agents|contraceptive agents|mesh-ancestor
64302819|NCT02136979|Anesthetics, General|anesthetics, general|mesh-ancestor
64302820|NCT02136979|Anesthetics|anesthetics|mesh-ancestor
64302823|NCT04983836|Anesthetics|anesthetics|mesh-list
64972124|NCT00063323|Dopamine Agents|dopamine agents|mesh-ancestor
64972125|NCT00063323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64972126|NCT00063323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654849|NCT02487108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64972127|NCT00063323|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64972128|NCT00063323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64972129|NCT00063323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972158|NCT00229450|Hormones|hormones|mesh-ancestor
64972159|NCT00229450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64972160|NCT00229450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972161|NCT00229528|Paroxetine|paroxetine|mesh-list
64972162|NCT00229528|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64972163|NCT00229528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64972164|NCT00229528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64972165|NCT00229528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972166|NCT00229528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64510937|NCT05776108|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64510938|NCT05776108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64510939|NCT05776108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510940|NCT05776108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64510941|NCT05776108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64510942|NCT05776108|Antiviral Agents|antiviral agents|mesh-ancestor
64510943|NCT05776108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64972167|NCT00229528|Serotonin Agents|serotonin agents|mesh-ancestor
64972188|NCT00075699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972189|NCT00229567|Lidocaine|lidocaine|mesh-list
64972190|NCT00229567|Ketamine|ketamine|mesh-list
64972191|NCT00229567|Anesthetics, Local|anesthetics, local|mesh-ancestor
64972192|NCT00229567|Anesthetics|anesthetics|mesh-ancestor
64972193|NCT00229567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64972194|NCT00229567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972195|NCT00229567|Sensory System Agents|sensory system agents|mesh-ancestor
64972196|NCT00229567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64972197|NCT00229567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64972198|NCT00229567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64972199|NCT00229567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64972200|NCT00229567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64972201|NCT00229567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972202|NCT00229567|Analgesics|analgesics|mesh-ancestor
64972203|NCT00229567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64972204|NCT00229567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64972205|NCT00229567|Anesthetics, General|anesthetics, general|mesh-ancestor
64972206|NCT00229567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64972207|NCT00229567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64972208|NCT00229567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64538104|NCT00575367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64538105|NCT00575367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538106|NCT00575367|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64538107|NCT00575367|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64538108|NCT00575367|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64538110|NCT00604461|Carboplatin|carboplatin|mesh-list
64538111|NCT00604461|Pemetrexed|pemetrexed|mesh-list
64538112|NCT00604461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64538113|NCT00604461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538114|NCT00604461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64538115|NCT00604461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64538116|NCT00604461|Growth Substances|growth substances|mesh-ancestor
64538117|NCT00604461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538118|NCT00604461|Growth Inhibitors|growth inhibitors|mesh-ancestor
64538119|NCT00604461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538120|NCT00604461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538121|NCT00604461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64538122|NCT00604461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64972209|NCT00229645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64542667|NCT01408043|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64972210|NCT00229645|Antidepressive Agents|antidepressive agents|mesh-ancestor
64972211|NCT00229645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64972212|NCT00229645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64972213|NCT00229645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64972214|NCT00229645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64972215|NCT00229645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972217|NCT02967341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64972218|NCT02967341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64972219|NCT02967341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64972220|NCT02967341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64972247|NCT00413608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972248|NCT00413608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972249|NCT00229918|Triamcinolone|triamcinolone|mesh-list
64972250|NCT00229918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64972251|NCT00229918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64972252|NCT00229918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64972253|NCT00229918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64972254|NCT00229918|Glucocorticoids|glucocorticoids|mesh-ancestor
64972255|NCT00229918|Hormones|hormones|mesh-ancestor
64972256|NCT00229918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64972257|NCT00229918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972258|NCT00229918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64972259|NCT00229918|Immunologic Factors|immunologic factors|mesh-ancestor
64972260|NCT00229918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972261|NCT00229918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972262|NCT00096798|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
64972263|NCT00096798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64972300|NCT00230035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64972326|NCT00063401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64972328|NCT00063401|Tubulin Modulators|tubulin modulators|mesh-ancestor
64972329|NCT00063401|Antimitotic Agents|antimitotic agents|mesh-ancestor
64972330|NCT00063401|Mitosis Modulators|mitosis modulators|mesh-ancestor
64538123|NCT04417569|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64538124|NCT04417569|Estradiol|estradiol|mesh-list
64538125|NCT04417569|Progesterone|progesterone|mesh-list
64538126|NCT04417569|Hormones|hormones|mesh-ancestor
64538127|NCT04417569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64538128|NCT04417569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538129|NCT04417569|Estrogens|estrogens|mesh-ancestor
64538130|NCT04417569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64538131|NCT04417569|Progestins|progestins|mesh-ancestor
64538132|NCT01550744|Ustekinumab|ustekinumab|mesh-list
64538133|NCT01550744|Dermatologic Agents|dermatologic agents|mesh-ancestor
64538134|NCT00606489|Ibuprofen|ibuprofen|mesh-list
64538135|NCT00606489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64538136|NCT00606489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64538137|NCT00606489|Analgesics|analgesics|mesh-ancestor
64538138|NCT00606489|Sensory System Agents|sensory system agents|mesh-ancestor
64538139|NCT00606489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64538140|NCT00606489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538141|NCT00606489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64538142|NCT00606489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64538143|NCT00606489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64538144|NCT00606489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538145|NCT00606489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538146|NCT00578331|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64542757|NCT03598075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538147|NCT00578331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64538148|NCT00578331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64538149|NCT00578331|Analgesics|analgesics|mesh-ancestor
64538150|NCT00578331|Sensory System Agents|sensory system agents|mesh-ancestor
64538151|NCT00578331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64538152|NCT00578331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538153|NCT00578331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64538154|NCT00578331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64538155|NCT00578331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64538156|NCT00578331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64654884|NCT02486952|Tubulin Modulators|tubulin modulators|mesh-ancestor
64972331|NCT00063401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972332|NCT00063401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64972333|NCT00096837|Motexafin gadolinium|motexafin gadolinium|mesh-list
64972334|NCT00096837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972335|NCT00096837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64538157|NCT00578331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64538158|NCT00578331|Histamine Antagonists|histamine antagonists|mesh-ancestor
64538160|NCT00578331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64538161|NCT00578331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538162|NCT00607113|Bevacizumab|bevacizumab|mesh-list
64538163|NCT00607113|Everolimus|everolimus|mesh-list
64538164|NCT00607113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64538165|NCT00607113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538166|NCT00607113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64538167|NCT00607113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64538168|NCT00607113|Growth Substances|growth substances|mesh-ancestor
64538169|NCT00607113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538170|NCT00607113|Growth Inhibitors|growth inhibitors|mesh-ancestor
64714141|NCT04736953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64494315|NCT01163656|Cobalt|cobalt|mesh-list
64538171|NCT00607113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64538172|NCT00607113|Immunologic Factors|immunologic factors|mesh-ancestor
64538173|NCT01549964|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64538174|NCT01549964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64542816|NCT03592069|Amoxicillin|amoxicillin|mesh-list
64538175|NCT01549964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538176|NCT01549964|Incretins|incretins|mesh-ancestor
64538177|NCT01549964|Hormones|hormones|mesh-ancestor
64538178|NCT01549964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64972336|NCT00096837|Dermatologic Agents|dermatologic agents|mesh-ancestor
64972337|NCT00230464|Vildagliptin|vildagliptin|mesh-list
64972338|NCT00230464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64972339|NCT00230464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972340|NCT00230464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64972341|NCT00230464|Protease Inhibitors|protease inhibitors|mesh-ancestor
64972342|NCT00230464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972343|NCT00230464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511161|NCT05632627|Anticonvulsants|anticonvulsants|mesh-ancestor
64972344|NCT00096915|Darbepoetin alfa|darbepoetin alfa|mesh-list
64511168|NCT05586802|Anastrozole|anastrozole|mesh-list
64511169|NCT05586802|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64511170|NCT05586802|Testosterone|testosterone|mesh-list
64511171|NCT05586802|Androgens|androgens|mesh-ancestor
64511172|NCT05586802|Hormones|hormones|mesh-ancestor
64972357|NCT00424723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972358|NCT00424723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972359|NCT00424723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64972360|NCT00424723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64972361|NCT00230542|Carboplatin|carboplatin|mesh-list
64972362|NCT00230542|Pemetrexed|pemetrexed|mesh-list
64972363|NCT00230542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972364|NCT00230542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542844|NCT03591913|Oxytocics|oxytocics|mesh-ancestor
64972365|NCT00230542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972366|NCT00230542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64972367|NCT00230542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64972368|NCT00063479|Zoledronic Acid|zoledronic acid|mesh-list
64538179|NCT01549964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64538180|NCT01549964|Protease Inhibitors|protease inhibitors|mesh-ancestor
64538181|NCT01549964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538182|NCT01549964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538184|NCT00579111|Busulfan|busulfan|mesh-list
64538185|NCT00579111|Alemtuzumab|alemtuzumab|mesh-list
64538186|NCT00579111|Tacrolimus|tacrolimus|mesh-list
64538187|NCT00579111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538188|NCT00579111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538189|NCT00579111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64538190|NCT00579111|Immunologic Factors|immunologic factors|mesh-ancestor
64538191|NCT00579111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972369|NCT00063479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64972370|NCT00063479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972371|NCT00097032|Risperidone|risperidone|mesh-list
64972372|NCT00097032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64972373|NCT00097032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64972374|NCT00097032|Serotonin Agents|serotonin agents|mesh-ancestor
64972375|NCT00097032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64972376|NCT00097032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542884|NCT04438434|Immunologic Factors|immunologic factors|mesh-ancestor
64972377|NCT00097032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972378|NCT00097032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64972379|NCT00097032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64972380|NCT00097032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64972381|NCT00097032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64972382|NCT00097032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64972383|NCT00097032|Dopamine Agents|dopamine agents|mesh-ancestor
64972384|NCT00097032|Antidepressive Agents|antidepressive agents|mesh-ancestor
64972411|NCT00075738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64972412|NCT00075738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64972413|NCT00075738|Immunologic Factors|immunologic factors|mesh-ancestor
64972414|NCT00075738|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64972415|NCT00075738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64972416|NCT00075738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972417|NCT00075738|Antidotes|antidotes|mesh-ancestor
64972418|NCT00075738|Protective Agents|protective agents|mesh-ancestor
64972419|NCT00075738|Vitamin B Complex|vitamin b complex|mesh-ancestor
64972420|NCT00075738|Vitamins|vitamins|mesh-ancestor
64972421|NCT00075738|Micronutrients|micronutrients|mesh-ancestor
64972422|NCT00230698|Topiramate|topiramate|mesh-list
64972423|NCT00230698|Anticonvulsants|anticonvulsants|mesh-ancestor
64972424|NCT00230698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64972425|NCT00230698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972426|NCT00230776|Pregabalin|pregabalin|mesh-list
64972427|NCT00230776|Analgesics|analgesics|mesh-ancestor
64972428|NCT00230776|Sensory System Agents|sensory system agents|mesh-ancestor
64972429|NCT00230776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64972430|NCT00230776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972431|NCT00230776|Anticonvulsants|anticonvulsants|mesh-ancestor
64972432|NCT00230776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64972433|NCT00230776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64972457|NCT02967614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64542927|NCT03481842|Axitinib|axitinib|mesh-list
64972458|NCT02967614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972459|NCT02967614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972460|NCT02967614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64972461|NCT02967614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64972462|NCT02967614|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64972463|NCT02967614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64972464|NCT02967614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64972465|NCT02967614|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64538192|NCT00579111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64538193|NCT00579111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538194|NCT00579111|Alkylating Agents|alkylating agents|mesh-ancestor
64538195|NCT00579111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64538196|NCT00579111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64538197|NCT00579111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64538198|NCT04363437|Colchicine|colchicine|mesh-list
64538199|NCT04363437|Gout Suppressants|gout suppressants|mesh-ancestor
64538200|NCT04363437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64302900|NCT03248817|Anesthetics|anesthetics|mesh-ancestor
64972466|NCT02967614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972467|NCT00230815|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64972468|NCT00230815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64972469|NCT00230815|Hormones|hormones|mesh-ancestor
64972470|NCT00230815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64972473|NCT00097071|Insulin|insulin|mesh-list
64972474|NCT00097071|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64972475|NCT00097071|Insulin Aspart|insulin aspart|mesh-list
64972476|NCT00097071|Insulin Lispro|insulin lispro|mesh-list
64972477|NCT00097071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64972478|NCT00097071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972479|NCT02967380|Pentetic Acid|pentetic acid|mesh-list
64542951|NCT03982225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64972480|NCT02967380|Antidotes|antidotes|mesh-ancestor
64972481|NCT02967380|Protective Agents|protective agents|mesh-ancestor
64972482|NCT02967380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972483|NCT02967380|Chelating Agents|chelating agents|mesh-ancestor
64972484|NCT02967380|Sequestering Agents|sequestering agents|mesh-ancestor
64972514|NCT00231517|Analgesics|analgesics|mesh-ancestor
64972515|NCT00231517|Sensory System Agents|sensory system agents|mesh-ancestor
64972516|NCT00231517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64972517|NCT00075894|Alanosine|alanosine|mesh-list
64972518|NCT00075894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64972519|NCT00075894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972520|NCT00075894|Chelating Agents|chelating agents|mesh-ancestor
64972521|NCT00075894|Sequestering Agents|sequestering agents|mesh-ancestor
64972522|NCT00075894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972523|NCT00231556|Topiramate|topiramate|mesh-list
64511429|NCT05382338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64511430|NCT05382338|Alkylating Agents|alkylating agents|mesh-ancestor
64511431|NCT05382338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511432|NCT05382338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511433|NCT05382338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64511434|NCT05382338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64511435|NCT05382338|Tubulin Modulators|tubulin modulators|mesh-ancestor
64511436|NCT05382338|Antimitotic Agents|antimitotic agents|mesh-ancestor
64511437|NCT05382338|Mitosis Modulators|mitosis modulators|mesh-ancestor
64511438|NCT05382338|Protective Agents|protective agents|mesh-ancestor
64511440|NCT05382338|Antitubercular Agents|antitubercular agents|mesh-ancestor
64511441|NCT05382338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64511442|NCT05382338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64511443|NCT05382338|Chelating Agents|chelating agents|mesh-ancestor
64511444|NCT05382338|Sequestering Agents|sequestering agents|mesh-ancestor
64511445|NCT05375084|Nivolumab|nivolumab|mesh-list
64511446|NCT05375084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64511447|NCT05375084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511448|NCT05375084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64972535|NCT00231673|Topiramate|topiramate|mesh-list
64972536|NCT00231673|Anticonvulsants|anticonvulsants|mesh-ancestor
64972537|NCT00231673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64972538|NCT00231673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972540|NCT00097188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64972541|NCT00097188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972542|NCT00097188|Immunologic Factors|immunologic factors|mesh-ancestor
64538201|NCT04363437|Tubulin Modulators|tubulin modulators|mesh-ancestor
64654908|NCT01641653|Midazolam|midazolam|mesh-list
64538202|NCT04363437|Antimitotic Agents|antimitotic agents|mesh-ancestor
64538203|NCT04363437|Mitosis Modulators|mitosis modulators|mesh-ancestor
64538204|NCT04363437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538205|NCT04363437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538206|NCT01570244|Levonorgestrel|levonorgestrel|mesh-list
64538207|NCT01570244|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64538208|NCT01570244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64972543|NCT00097188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972544|NCT00097188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64972546|NCT00231829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64972547|NCT00231829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64972548|NCT00231829|Analgesics|analgesics|mesh-ancestor
64972549|NCT00231829|Sensory System Agents|sensory system agents|mesh-ancestor
64972550|NCT00231829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64972561|NCT00075933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64972563|NCT00075933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972564|NCT00075933|Antiviral Agents|antiviral agents|mesh-ancestor
64972565|NCT00063713|Bortezomib|bortezomib|mesh-list
64972566|NCT00063713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972567|NCT00232024|Tegaserod|tegaserod|mesh-list
64972568|NCT00232024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64972569|NCT00232024|Serotonin Agents|serotonin agents|mesh-ancestor
64972570|NCT00232024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64972571|NCT00232024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972572|NCT00232024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972573|NCT00232063|Cyclosporine|cyclosporine|mesh-list
64972574|NCT00232063|Cyclosporins|cyclosporins|mesh-list
64972575|NCT00232063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972576|NCT00232063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972577|NCT00232063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64972578|NCT00232063|Immunologic Factors|immunologic factors|mesh-ancestor
64972579|NCT00232063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972580|NCT00232063|Antifungal Agents|antifungal agents|mesh-ancestor
64972581|NCT00232063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64972582|NCT00232063|Dermatologic Agents|dermatologic agents|mesh-ancestor
64972583|NCT00232063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64972584|NCT00232063|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64972585|NCT00232102|Tegaserod|tegaserod|mesh-list
64978552|NCT00074399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64978553|NCT00074399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64978554|NCT00270283|Epoetin Alfa|epoetin alfa|mesh-list
64972586|NCT00232102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64972587|NCT00232102|Serotonin Agents|serotonin agents|mesh-ancestor
64972588|NCT00232102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64972589|NCT00232102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972590|NCT00232102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972591|NCT00097227|Paclitaxel|paclitaxel|mesh-list
64972592|NCT00097227|Carboplatin|carboplatin|mesh-list
64972593|NCT00097227|Cetuximab|cetuximab|mesh-list
64972594|NCT00097227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64972595|NCT00097227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972596|NCT00097227|Tubulin Modulators|tubulin modulators|mesh-ancestor
64972597|NCT00097227|Antimitotic Agents|antimitotic agents|mesh-ancestor
64972598|NCT00097227|Mitosis Modulators|mitosis modulators|mesh-ancestor
64972599|NCT00097227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972600|NCT00097227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64972601|NCT00232336|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64972602|NCT00232336|Antidepressive Agents|antidepressive agents|mesh-ancestor
64972603|NCT00232336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64511464|NCT05369832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972604|NCT00232336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64972605|NCT00232336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64511465|NCT05364424|Rituximab|rituximab|mesh-list
64511466|NCT05364424|Obinutuzumab|obinutuzumab|mesh-list
64511467|NCT05364424|Carboplatin|carboplatin|mesh-list
64511468|NCT05364424|Etoposide|etoposide|mesh-list
64511469|NCT05364424|Ifosfamide|ifosfamide|mesh-list
64511470|NCT05364424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64538209|NCT01570244|Contraceptive Agents|contraceptive agents|mesh-ancestor
64538210|NCT01570244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64538211|NCT01570244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543035|NCT02467452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64538212|NCT01570244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64538213|NCT01570244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64538214|NCT01570244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64538215|NCT01570244|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64538216|NCT01570244|Estrogens|estrogens|mesh-ancestor
64538217|NCT01570244|Hormones|hormones|mesh-ancestor
64538218|NCT01570244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64538219|NCT00579813|Pioglitazone|pioglitazone|mesh-list
64538220|NCT00579813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64538221|NCT00579813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538222|NCT01549886|Rituximab|rituximab|mesh-list
64538223|NCT01549886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64302918|NCT03248817|Protective Agents|protective agents|mesh-ancestor
64511471|NCT05364424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972606|NCT00232336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64972636|NCT00075972|Autonomic Agents|autonomic agents|mesh-ancestor
64972637|NCT00075972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64972638|NCT00075972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972639|NCT00075972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64972640|NCT00075972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64972641|NCT00075972|Cholinergic Agents|cholinergic agents|mesh-ancestor
64972642|NCT00075972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64972643|NCT00075972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972644|NCT00063869|Etanercept|etanercept|mesh-list
64972645|NCT00063869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64972646|NCT00063869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64972647|NCT00063869|Analgesics|analgesics|mesh-ancestor
64972648|NCT00063869|Sensory System Agents|sensory system agents|mesh-ancestor
64972649|NCT00063869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64972650|NCT00063869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972651|NCT00063869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64972667|NCT00232570|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64972668|NCT00232570|Antidepressive Agents|antidepressive agents|mesh-ancestor
64972669|NCT00232570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64972670|NCT00232570|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64972671|NCT00232570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64972672|NCT00232570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64972673|NCT00232570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972674|NCT00097266|Haloperidol|haloperidol|mesh-list
64972675|NCT00097266|Aripiprazole|aripiprazole|mesh-list
64972676|NCT00097266|Haloperidol decanoate|haloperidol decanoate|mesh-list
64972677|NCT00097266|Antidepressive Agents|antidepressive agents|mesh-ancestor
64972678|NCT00097266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64972679|NCT00097266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64972680|NCT00097266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64972681|NCT00097266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64511614|NCT05299125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64972682|NCT00097266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972683|NCT00097266|Dopamine Agonists|dopamine agonists|mesh-ancestor
64972684|NCT00097266|Dopamine Agents|dopamine agents|mesh-ancestor
64972685|NCT00097266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64972686|NCT00097266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972687|NCT00097266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64972688|NCT00097266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64538224|NCT01549886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538225|NCT01549886|Immunologic Factors|immunologic factors|mesh-ancestor
64538226|NCT01549886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538227|NCT01549886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64538228|NCT00610311|Aldesleukin|aldesleukin|mesh-list
64538229|NCT00610311|Cyclophosphamide|cyclophosphamide|mesh-list
64538230|NCT00610311|Fludarabine|fludarabine|mesh-list
64538231|NCT00610311|Fludarabine phosphate|fludarabine phosphate|mesh-list
64978592|NCT00270478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538232|NCT00610311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64538233|NCT00610311|Immunologic Factors|immunologic factors|mesh-ancestor
64538234|NCT00610311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538235|NCT00610311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64538236|NCT00610311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64538237|NCT00610311|Alkylating Agents|alkylating agents|mesh-ancestor
64538238|NCT00610311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538239|NCT00610311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538240|NCT00610311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64538241|NCT00610311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64538242|NCT00610311|Antimetabolites|antimetabolites|mesh-ancestor
64302935|NCT02832531|Aspirin|aspirin|mesh-list
64972689|NCT00097266|Serotonin Agents|serotonin agents|mesh-ancestor
64972690|NCT00097266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64972691|NCT00097266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64972692|NCT00097266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64972693|NCT00097266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64972694|NCT00097266|Antiemetics|antiemetics|mesh-ancestor
64972695|NCT00097266|Autonomic Agents|autonomic agents|mesh-ancestor
64972696|NCT00097266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64972697|NCT00097266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64972698|NCT00097266|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64972699|NCT00063947|Gemcitabine|gemcitabine|mesh-list
64972700|NCT00063947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64972701|NCT00063947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64972702|NCT00063947|Antimetabolites|antimetabolites|mesh-ancestor
64972703|NCT00063947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972704|NCT00063947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972705|NCT00063947|Antiviral Agents|antiviral agents|mesh-ancestor
64972706|NCT00063947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64972707|NCT00063947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972708|NCT00063947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64972709|NCT00063947|Immunologic Factors|immunologic factors|mesh-ancestor
64972710|NCT00063947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972732|NCT00232687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64972733|NCT00232687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972734|NCT00232687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64972735|NCT00232687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64511615|NCT05299125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64972736|NCT00232687|Serotonin Agents|serotonin agents|mesh-ancestor
64972737|NCT00232687|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64511621|NCT05285644|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64511622|NCT05285644|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64511623|NCT05277402|Pembrolizumab|pembrolizumab|mesh-list
64714142|NCT04736953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64494327|NCT01165840|Leprostatic Agents|leprostatic agents|mesh-ancestor
64538244|NCT00610311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64538245|NCT00610311|Antiviral Agents|antiviral agents|mesh-ancestor
64538246|NCT00610311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64538247|NCT04233567|Infigratinib|infigratinib|mesh-list
64538248|NCT04233567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538249|NCT00581061|Solifenacin Succinate|solifenacin succinate|mesh-list
64543287|NCT03832465|Ofloxacin|ofloxacin|mesh-list
64538250|NCT00581061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64538251|NCT00581061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64538252|NCT00581061|Cholinergic Agents|cholinergic agents|mesh-ancestor
64538253|NCT00581061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64538254|NCT00581061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538255|NCT00581061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538256|NCT00581061|Urological Agents|urological agents|mesh-ancestor
64538257|NCT01549652|Morphine|morphine|mesh-list
64538258|NCT01549652|Ondansetron|ondansetron|mesh-list
64538259|NCT01549652|Naloxone|naloxone|mesh-list
64538260|NCT01549652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64538261|NCT01549652|Narcotics|narcotics|mesh-ancestor
64538262|NCT01549652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64538263|NCT01549652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538264|NCT01549652|Analgesics|analgesics|mesh-ancestor
64538265|NCT01549652|Sensory System Agents|sensory system agents|mesh-ancestor
64538266|NCT01549652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64538267|NCT01549652|Antiemetics|antiemetics|mesh-ancestor
64538268|NCT01549652|Autonomic Agents|autonomic agents|mesh-ancestor
64538269|NCT01549652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64538270|NCT01549652|Antipruritics|antipruritics|mesh-ancestor
64538271|NCT01549652|Dermatologic Agents|dermatologic agents|mesh-ancestor
64538272|NCT01549652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64538273|NCT01549652|Serotonin Agents|serotonin agents|mesh-ancestor
64538274|NCT01549652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64978640|NCT04730375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64538276|NCT01549652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64538284|NCT01569464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64538285|NCT01569464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538286|NCT01569464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538287|NCT01534520|Lidocaine|lidocaine|mesh-list
64538288|NCT01534520|Anesthetics, Local|anesthetics, local|mesh-ancestor
64538289|NCT01534520|Anesthetics|anesthetics|mesh-ancestor
64538290|NCT01534520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64538291|NCT01534520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538292|NCT01534520|Sensory System Agents|sensory system agents|mesh-ancestor
64302996|NCT05635370|Vasodilator Agents|vasodilator agents|mesh-ancestor
64302997|NCT05635370|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64302998|NCT05635370|Antioxidants|antioxidants|mesh-ancestor
64511624|NCT05277402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64511625|NCT05277402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511638|NCT05245474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64511639|NCT05245474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511640|NCT05245474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511641|NCT05239741|Leucovorin|leucovorin|mesh-list
64511642|NCT05239741|Bevacizumab|bevacizumab|mesh-list
64511643|NCT05239741|Pembrolizumab|pembrolizumab|mesh-list
64511644|NCT05239741|Cetuximab|cetuximab|mesh-list
64511645|NCT05239741|Fluorouracil|fluorouracil|mesh-list
64511646|NCT05239741|Oxaliplatin|oxaliplatin|mesh-list
64511647|NCT05239741|Irinotecan|irinotecan|mesh-list
64511648|NCT05239741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64972738|NCT00232687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64972739|NCT00232687|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64972740|NCT00232687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64972741|NCT00232765|Sirolimus|sirolimus|mesh-list
64972742|NCT00232765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64972743|NCT00232765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64972744|NCT00232765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64972745|NCT00232765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972746|NCT00232765|Antifungal Agents|antifungal agents|mesh-ancestor
64972747|NCT00232765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64972777|NCT02958566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64972778|NCT02958566|Anesthetics, General|anesthetics, general|mesh-ancestor
64972779|NCT02958566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64972780|NCT02958566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64972781|NCT02958566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64972782|NCT02958566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64972783|NCT02958566|Narcotics|narcotics|mesh-ancestor
64972784|NCT02958566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64972785|NCT02958566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64972786|NCT02958566|Antipyretics|antipyretics|mesh-ancestor
64972787|NCT02958566|Anticonvulsants|anticonvulsants|mesh-ancestor
64972788|NCT02958566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64972789|NCT02958566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64972790|NCT02958566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64972791|NCT02958566|Antimanic Agents|antimanic agents|mesh-ancestor
64972792|NCT02958566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64543467|NCT01273233|Immunologic Factors|immunologic factors|mesh-ancestor
64543469|NCT01277211|NuvaRing|nuvaring|mesh-list
64972793|NCT02958566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64972794|NCT02958566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64972795|NCT02958566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64972796|NCT02958566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972797|NCT02958566|Antitussive Agents|antitussive agents|mesh-ancestor
64972808|NCT02958566|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
64972809|NCT02958566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64972810|NCT00097344|Toremifene|toremifene|mesh-list
64972811|NCT00097344|Letrozole|letrozole|mesh-list
64972812|NCT00097344|Hormones|hormones|mesh-list
64972813|NCT00097344|Atamestane|atamestane|mesh-list
64972814|NCT00097344|Estrogen Antagonists|estrogen antagonists|mesh-list
64972815|NCT00097344|Estrogens|estrogens|mesh-list
64972816|NCT00097344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
64538293|NCT01534520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64538294|NCT01534520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64538295|NCT01534520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64538296|NCT01534520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64538297|NCT01534520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64538298|NCT01534520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538299|NCT00611325|Bevacizumab|bevacizumab|mesh-list
64538300|NCT00611325|Bortezomib|bortezomib|mesh-list
64538301|NCT00611325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64538302|NCT00611325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538303|NCT00611325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64538304|NCT00611325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64538305|NCT00611325|Growth Substances|growth substances|mesh-ancestor
64543597|NCT01485614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64538306|NCT00611325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303007|NCT05635370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64972817|NCT00097344|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
64972818|NCT00097344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64972819|NCT00097344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972820|NCT00097344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972821|NCT00097344|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64972822|NCT00097344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64972823|NCT00097344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972824|NCT00097344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972825|NCT00097344|Hormone Antagonists|hormone antagonists|mesh-ancestor
64972826|NCT00097344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64972827|NCT00097344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64972828|NCT00097344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64972829|NCT00232882|Atenolol|atenolol|mesh-list
64972830|NCT00232882|Candesartan|candesartan|mesh-list
64972831|NCT00232882|Candesartan cilexetil|candesartan cilexetil|mesh-list
64972832|NCT00232882|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
64972833|NCT00232882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64972834|NCT00232882|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64972835|NCT00232882|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64972836|NCT00232882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972837|NCT00232882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64972838|NCT00232882|Sympatholytics|sympatholytics|mesh-ancestor
64972839|NCT00232882|Autonomic Agents|autonomic agents|mesh-ancestor
64972840|NCT00232882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64972841|NCT00232882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972842|NCT00232882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64972843|NCT00232882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64972844|NCT00232882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64972845|NCT00232882|Adrenergic Agents|adrenergic agents|mesh-ancestor
64972846|NCT00232882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64972847|NCT00232882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64972848|NCT00232882|Diuretics|diuretics|mesh-ancestor
64972849|NCT00232882|Natriuretic Agents|natriuretic agents|mesh-ancestor
64972876|NCT00233038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972877|NCT00097383|Epirubicin|epirubicin|mesh-list
64972878|NCT00097383|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64972879|NCT00097383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972880|NCT00097383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64972881|NCT00097383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64972882|NCT00097383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538307|NCT00611325|Growth Inhibitors|growth inhibitors|mesh-ancestor
64538309|NCT00611403|Lubricant Eye Drops|lubricant eye drops|mesh-list
64538311|NCT00611403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538312|NCT00611403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538313|NCT00611403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64538314|NCT00611403|Immunologic Factors|immunologic factors|mesh-ancestor
64538315|NCT00611403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538316|NCT00611403|Antifungal Agents|antifungal agents|mesh-ancestor
64538317|NCT00611403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64538318|NCT00611403|Dermatologic Agents|dermatologic agents|mesh-ancestor
64714143|NCT04736953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64538319|NCT00611403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64538320|NCT00611403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64538321|NCT00611403|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64538322|NCT00611403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64538324|NCT01534208|Clomiphene|clomiphene|mesh-list
64538325|NCT01534208|Zuclomiphene|zuclomiphene|mesh-list
64538326|NCT01534208|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64538327|NCT01534208|Hormone Antagonists|hormone antagonists|mesh-ancestor
64538328|NCT01534208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64538329|NCT01534208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538330|NCT01534208|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64538331|NCT01534208|Fertility Agents|fertility agents|mesh-ancestor
64538332|NCT01534208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64303023|NCT03576677|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64511841|NCT05015439|Anticonvulsants|anticonvulsants|mesh-ancestor
64511842|NCT05013502|Empagliflozin|empagliflozin|mesh-list
64972883|NCT00097383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972884|NCT00233155|Capsaicin|capsaicin|mesh-list
64972885|NCT00233155|Antipruritics|antipruritics|mesh-ancestor
64972886|NCT00233155|Dermatologic Agents|dermatologic agents|mesh-ancestor
64972887|NCT00233155|Sensory System Agents|sensory system agents|mesh-ancestor
64972888|NCT00233155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64972889|NCT00233155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972890|NCT00064142|Halofuginone|halofuginone|mesh-list
64972891|NCT00064142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543687|NCT04716114|Antiviral Agents|antiviral agents|mesh-ancestor
64972892|NCT00064142|Coccidiostats|coccidiostats|mesh-ancestor
64972893|NCT00064142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64972894|NCT00064142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64972895|NCT00064142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64972896|NCT00064142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64972925|NCT00064181|Vitamins|vitamins|mesh-ancestor
64972926|NCT00064181|Micronutrients|micronutrients|mesh-ancestor
64972927|NCT00064181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64972928|NCT00064181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64972929|NCT00064181|Analgesics|analgesics|mesh-ancestor
64972930|NCT00064181|Sensory System Agents|sensory system agents|mesh-ancestor
64538333|NCT01534208|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64538335|NCT01548638|Galantamine|galantamine|mesh-list
64538336|NCT01548638|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64538337|NCT01548638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538338|NCT01548638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538339|NCT01548638|Cholinergic Agents|cholinergic agents|mesh-ancestor
64538340|NCT01548638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64538341|NCT01548638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538342|NCT01548638|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64538343|NCT01548638|Autonomic Agents|autonomic agents|mesh-ancestor
64538344|NCT01548638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64538345|NCT01548638|Nootropic Agents|nootropic agents|mesh-ancestor
64538346|NCT00612339|Bevacizumab|bevacizumab|mesh-list
64538347|NCT00612339|Temozolomide|temozolomide|mesh-list
64538348|NCT00612339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64543765|NCT03023124|Trabectedin|trabectedin|mesh-list
64543766|NCT03023124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64303049|NCT03576599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972931|NCT00064181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64972932|NCT00064181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64972933|NCT00064181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64972934|NCT00064181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64972935|NCT00064181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64972936|NCT00233545|Miltefosine|miltefosine|mesh-list
64972937|NCT00233545|Antifungal Agents|antifungal agents|mesh-ancestor
64972938|NCT00233545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64972939|NCT00233545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972940|NCT00233545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64972941|NCT00233545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64972942|NCT00233584|Budesonide|budesonide|mesh-list
64972943|NCT00233584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64972944|NCT00233584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64972945|NCT00233584|Autonomic Agents|autonomic agents|mesh-ancestor
64972966|NCT00233623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972967|NCT00233623|Antidotes|antidotes|mesh-ancestor
64972968|NCT00233623|Protective Agents|protective agents|mesh-ancestor
64972969|NCT00233623|Vitamin B Complex|vitamin b complex|mesh-ancestor
64972971|NCT00233623|Micronutrients|micronutrients|mesh-ancestor
64972972|NCT00233623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64972974|NCT00233662|Dermatologic Agents|dermatologic agents|mesh-ancestor
64972975|NCT00233662|Immunologic Factors|immunologic factors|mesh-ancestor
64972976|NCT00233662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972977|NCT00064220|Soblidotin|soblidotin|mesh-list
64972978|NCT00064220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972979|NCT00233779|Sirolimus|sirolimus|mesh-list
64972980|NCT00233779|Heparin|heparin|mesh-list
64972981|NCT00233779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64972982|NCT00233779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64972983|NCT00233779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64972984|NCT00233779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972985|NCT00233779|Antifungal Agents|antifungal agents|mesh-ancestor
64972986|NCT00233779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64972987|NCT00233779|Immunologic Factors|immunologic factors|mesh-ancestor
64972988|NCT00233779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972989|NCT00233779|Anticoagulants|anticoagulants|mesh-ancestor
64972990|NCT00233779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64972991|NCT00233779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64511917|NCT04923893|Dexamethasone|dexamethasone|mesh-list
64538349|NCT00612339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538350|NCT00612339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64538351|NCT00612339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64538352|NCT00612339|Growth Substances|growth substances|mesh-ancestor
64538353|NCT00612339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538354|NCT00612339|Growth Inhibitors|growth inhibitors|mesh-ancestor
64538355|NCT00612339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64538356|NCT00612339|Alkylating Agents|alkylating agents|mesh-ancestor
64538357|NCT00612339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538359|NCT02740179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64538360|NCT02740179|Hormone Antagonists|hormone antagonists|mesh-ancestor
64538361|NCT02740179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64538362|NCT02740179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538363|NCT02740179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64538364|NCT02740179|Diuretics|diuretics|mesh-ancestor
64538365|NCT02740179|Natriuretic Agents|natriuretic agents|mesh-ancestor
64538366|NCT02740179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64538367|NCT01533428|Capsaicin|capsaicin|mesh-list
64538368|NCT01533428|Antipruritics|antipruritics|mesh-ancestor
64538369|NCT01533428|Dermatologic Agents|dermatologic agents|mesh-ancestor
64538370|NCT01533428|Sensory System Agents|sensory system agents|mesh-ancestor
64538371|NCT01533428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64511918|NCT04923893|Cyclophosphamide|cyclophosphamide|mesh-list
64511919|NCT04923893|Fludarabine|fludarabine|mesh-list
64511920|NCT04923893|Lenalidomide|lenalidomide|mesh-list
64511921|NCT04923893|Bortezomib|bortezomib|mesh-list
64511922|NCT04923893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64511923|NCT04923893|Immunologic Factors|immunologic factors|mesh-ancestor
64511924|NCT04923893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511925|NCT04923893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64973016|NCT00233896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973017|NCT00233896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64973018|NCT00233896|Respiratory System Agents|respiratory system agents|mesh-ancestor
64973019|NCT00233935|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
64973020|NCT00233935|Antioxidants|antioxidants|mesh-ancestor
64973022|NCT00233935|Protective Agents|protective agents|mesh-ancestor
64973023|NCT00233935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973024|NCT00233935|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64973025|NCT00233935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64973026|NCT00233935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973027|NCT00233935|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64973028|NCT00234091|Ritonavir|ritonavir|mesh-list
64973029|NCT00234091|Lopinavir|lopinavir|mesh-list
64973030|NCT00234091|Nelfinavir|nelfinavir|mesh-list
64973031|NCT00234091|Lamivudine|lamivudine|mesh-list
64973032|NCT00234091|Zidovudine|zidovudine|mesh-list
64973033|NCT00234091|Nevirapine|nevirapine|mesh-list
64973034|NCT00234091|Abacavir|abacavir|mesh-list
64973052|NCT00234091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64973053|NCT00234091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64973054|NCT00234091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64538372|NCT01533428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538373|NCT04066725|Aspirin|aspirin|mesh-list
64538374|NCT04066725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64538375|NCT04066725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64538376|NCT04066725|Analgesics|analgesics|mesh-ancestor
64538377|NCT04066725|Sensory System Agents|sensory system agents|mesh-ancestor
64538378|NCT04066725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64538379|NCT04066725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538380|NCT04066725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64538381|NCT04066725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64538382|NCT04066725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64538383|NCT04066725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64538384|NCT04066725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538385|NCT04066725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64538386|NCT04066725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64538387|NCT04066725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538388|NCT04066725|Antipyretics|antipyretics|mesh-ancestor
64543994|NCT04530630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64538389|NCT01517984|Mycophenolic Acid|mycophenolic acid|mesh-list
64538390|NCT01517984|Prednisone|prednisone|mesh-list
64538391|NCT01517984|Tacrolimus|tacrolimus|mesh-list
64538392|NCT01517984|Thymoglobulin|thymoglobulin|mesh-list
64538393|NCT01517984|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64538394|NCT01517984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64538395|NCT01517984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
64538396|NCT01517984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64538397|NCT01517984|Glucocorticoids|glucocorticoids|mesh-ancestor
64538398|NCT01517984|Hormones|hormones|mesh-ancestor
64538399|NCT01517984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64538400|NCT01517984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538401|NCT01517984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64538402|NCT01517984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538403|NCT01517984|Immunologic Factors|immunologic factors|mesh-ancestor
64973055|NCT04721704|Amoxicillin|amoxicillin|mesh-list
64973056|NCT04721704|Metronidazole|metronidazole|mesh-list
64973057|NCT04721704|Clarithromycin|clarithromycin|mesh-list
64973058|NCT04721704|Omeprazole|omeprazole|mesh-list
64973059|NCT04721704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64973060|NCT04721704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973061|NCT04721704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64973062|NCT04721704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64973063|NCT04721704|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64973064|NCT04721704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64538405|NCT01517984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538406|NCT01517984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64538407|NCT01517984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64538408|NCT01517984|Antitubercular Agents|antitubercular agents|mesh-ancestor
64538409|NCT01517984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64538410|NCT01517984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64538411|NCT00612573|Doxycycline|doxycycline|mesh-list
64538412|NCT00612573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64538413|NCT00612573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64538414|NCT00612573|Antimalarials|antimalarials|mesh-ancestor
64538415|NCT00612573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64538416|NCT00612573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64538417|NCT00614445|Pyridoxine|pyridoxine|mesh-list
64538418|NCT00614445|Vitamin B 6|vitamin b 6|mesh-list
64538419|NCT00614445|Doxylamine|doxylamine|mesh-list
64538420|NCT00614445|Doxylamine succinate|doxylamine succinate|mesh-list
64538421|NCT00614445|Vitamin B Complex|vitamin b complex|mesh-ancestor
64538422|NCT00614445|Vitamins|vitamins|mesh-ancestor
64538423|NCT00614445|Micronutrients|micronutrients|mesh-ancestor
64538424|NCT00614445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538425|NCT00614445|Antiemetics|antiemetics|mesh-ancestor
64538426|NCT00614445|Autonomic Agents|autonomic agents|mesh-ancestor
64538427|NCT00614445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64538428|NCT00614445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64538429|NCT00614445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64538430|NCT00614445|Histamine Antagonists|histamine antagonists|mesh-ancestor
64973065|NCT04721704|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64973066|NCT04721704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973067|NCT04721704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973068|NCT04721704|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64973069|NCT04721704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64973070|NCT04721704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64973072|NCT00076284|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64973073|NCT00076284|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64973074|NCT00076284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973075|NCT00076284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64973076|NCT00076284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64973077|NCT00076284|Antiviral Agents|antiviral agents|mesh-ancestor
64973078|NCT00076284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973079|NCT00234403|Fulvestrant|fulvestrant|mesh-list
64973080|NCT00234403|Gefitinib|gefitinib|mesh-list
64973081|NCT00234403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64973082|NCT00234403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973083|NCT00234403|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64973084|NCT00234403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64973085|NCT00234403|Hormone Antagonists|hormone antagonists|mesh-ancestor
64511990|NCT04898894|Methotrexate|methotrexate|mesh-list
64544110|NCT04149067|Hormones|hormones|mesh-ancestor
64511991|NCT04898894|Fludarabine phosphate|fludarabine phosphate|mesh-list
64538431|NCT00614445|Histamine Agents|histamine agents|mesh-ancestor
64538432|NCT00614445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64538433|NCT00614445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538434|NCT00583011|Anesthetics|anesthetics|mesh-list
64538435|NCT00583011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64538436|NCT00583011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538437|NCT01547390|Aspirin|aspirin|mesh-list
64538438|NCT01547390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64538439|NCT01547390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64538440|NCT01547390|Analgesics|analgesics|mesh-ancestor
64538441|NCT01547390|Sensory System Agents|sensory system agents|mesh-ancestor
64538442|NCT01547390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64538443|NCT01547390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538444|NCT01547390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64538445|NCT01547390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64538446|NCT01547390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64538447|NCT01547390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64538448|NCT01547390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511992|NCT04898894|Fludarabine|fludarabine|mesh-list
64511993|NCT04898894|Venetoclax|venetoclax|mesh-list
64511994|NCT04898894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64511995|NCT04898894|Abortifacient Agents|abortifacient agents|mesh-ancestor
64973109|NCT00234442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973111|NCT00076323|Antimalarials|antimalarials|mesh-ancestor
64973112|NCT00076323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64973113|NCT00076323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64973114|NCT00076323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973115|NCT00234598|Chlorhexidine|chlorhexidine|mesh-list
64973116|NCT00234598|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64973117|NCT00234598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64973118|NCT00234598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973119|NCT00234598|Disinfectants|disinfectants|mesh-ancestor
64973120|NCT00234598|Dermatologic Agents|dermatologic agents|mesh-ancestor
64973121|NCT00234637|Memantine|memantine|mesh-list
64973122|NCT00234637|Rivastigmine|rivastigmine|mesh-list
64973123|NCT00234637|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64973124|NCT00234637|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64973125|NCT00234637|Dopamine Agents|dopamine agents|mesh-ancestor
64973155|NCT00234871|Vasodilator Agents|vasodilator agents|mesh-ancestor
64973156|NCT00234871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64973157|NCT00234871|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64973158|NCT00234871|Protease Inhibitors|protease inhibitors|mesh-ancestor
64973159|NCT00234871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973161|NCT00234910|Lopinavir|lopinavir|mesh-list
64973162|NCT00234910|Tenofovir|tenofovir|mesh-list
64973163|NCT00234910|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64973164|NCT00234910|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64973165|NCT00234910|Protease Inhibitors|protease inhibitors|mesh-ancestor
64973166|NCT00234910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973167|NCT00234910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973168|NCT00234910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64973169|NCT00234910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64973170|NCT00234910|Antiviral Agents|antiviral agents|mesh-ancestor
64973186|NCT00400491|Ergocalciferols|ergocalciferols|mesh-list
64973187|NCT00400491|Cholecalciferol|cholecalciferol|mesh-list
64973188|NCT00400491|Vitamins|vitamins|mesh-list
64973189|NCT00400491|Micronutrients|micronutrients|mesh-ancestor
64538449|NCT01547390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64538450|NCT01547390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64538451|NCT01547390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538452|NCT01547390|Antipyretics|antipyretics|mesh-ancestor
64538453|NCT01546922|Hydrocortisone|hydrocortisone|mesh-list
64538454|NCT01546922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64538455|NCT00615927|Imatinib Mesylate|imatinib mesylate|mesh-list
64538456|NCT00615927|Hydroxyurea|hydroxyurea|mesh-list
64538457|NCT00615927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538458|NCT00615927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64538459|NCT00615927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538460|NCT00615927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538461|NCT00615927|Antisickling Agents|antisickling agents|mesh-ancestor
64538462|NCT00615927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64538463|NCT01532648|Budesonide|budesonide|mesh-list
64538464|NCT01532648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64538465|NCT01532648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64973190|NCT00400491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973191|NCT00400491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64973192|NCT00400491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64973193|NCT00235105|Adalimumab|adalimumab|mesh-list
64973194|NCT00235105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64973195|NCT00235105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64973196|NCT00235144|Sirolimus|sirolimus|mesh-list
64973197|NCT00235144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64973198|NCT00235144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973199|NCT00235144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64973200|NCT00235144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973201|NCT00235144|Antifungal Agents|antifungal agents|mesh-ancestor
64973202|NCT00235144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64973203|NCT00235144|Immunologic Factors|immunologic factors|mesh-ancestor
64973204|NCT00235144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973205|NCT00400530|Alendronate|alendronate|mesh-list
64973206|NCT00400530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973207|NCT00400530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64973208|NCT00064610|Bortezomib|bortezomib|mesh-list
64973209|NCT00064610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973210|NCT00235222|Stavudine|stavudine|mesh-list
64973211|NCT00235222|Antimetabolites|antimetabolites|mesh-ancestor
64973212|NCT00235222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973213|NCT00235222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64973214|NCT00235222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64973215|NCT00235222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973216|NCT00235222|Antiviral Agents|antiviral agents|mesh-ancestor
64973217|NCT00235222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973218|NCT00235222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64973219|NCT00235222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64973220|NCT00235261|Dexamethasone|dexamethasone|mesh-list
64973221|NCT00235261|Pregabalin|pregabalin|mesh-list
64973222|NCT00235261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64973223|NCT00235261|Antiemetics|antiemetics|mesh-ancestor
64973224|NCT00235261|Autonomic Agents|autonomic agents|mesh-ancestor
64973225|NCT00235261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64973226|NCT00235261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973227|NCT00235261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64973228|NCT00235261|Glucocorticoids|glucocorticoids|mesh-ancestor
64973229|NCT00235261|Hormones|hormones|mesh-ancestor
64973230|NCT00235261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64973231|NCT00235261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64538466|NCT01532648|Autonomic Agents|autonomic agents|mesh-ancestor
64544334|NCT04018872|Hormone Antagonists|hormone antagonists|mesh-ancestor
64538467|NCT01532648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64538468|NCT01532648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494550|NCT04246554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64538469|NCT01532648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64538470|NCT01532648|Respiratory System Agents|respiratory system agents|mesh-ancestor
64538471|NCT01532648|Glucocorticoids|glucocorticoids|mesh-ancestor
64538472|NCT01532648|Hormones|hormones|mesh-ancestor
64538473|NCT01532648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64538474|NCT00617097|Ketorolac|ketorolac|mesh-list
64538475|NCT00617097|Lidocaine|lidocaine|mesh-list
64538476|NCT00617097|Anesthetics, Local|anesthetics, local|mesh-ancestor
64538477|NCT00617097|Anesthetics|anesthetics|mesh-ancestor
64538478|NCT00617097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64538479|NCT00617097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538480|NCT00617097|Sensory System Agents|sensory system agents|mesh-ancestor
64538481|NCT00617097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64538482|NCT00617097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64544428|NCT02658084|Maytansine|maytansine|mesh-list
64538483|NCT00617097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64538484|NCT00617097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64538485|NCT00617097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64303184|NCT02523911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64512142|NCT04747314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64973243|NCT00235261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64973244|NCT00235300|Thymoglobulin|thymoglobulin|mesh-list
64973245|NCT00235300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64973246|NCT00235300|Basiliximab|basiliximab|mesh-list
64973247|NCT00235300|Immunologic Factors|immunologic factors|mesh-ancestor
64973248|NCT00235300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973249|NCT00235300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64973250|NCT00064649|Finasteride|finasteride|mesh-list
64973251|NCT00064649|Alfuzosin|alfuzosin|mesh-list
64973252|NCT00064649|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64973253|NCT00064649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64973254|NCT00064649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973255|NCT00064649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973256|NCT00064649|Hormone Antagonists|hormone antagonists|mesh-ancestor
64973257|NCT00064649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64973258|NCT00064649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973259|NCT00064649|Urological Agents|urological agents|mesh-ancestor
64973260|NCT00064649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64973261|NCT00064649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64973262|NCT00064649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64973263|NCT00064649|Adrenergic Agents|adrenergic agents|mesh-ancestor
64973264|NCT00064649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64973265|NCT00097734|Ertapenem|ertapenem|mesh-list
64973266|NCT00097734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64973267|NCT00097734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973268|NCT00064727|Rosiglitazone|rosiglitazone|mesh-list
64973269|NCT00064727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64973270|NCT00064727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973271|NCT00235651|Amphotericin B|amphotericin b|mesh-list
64538486|NCT00617097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538487|NCT00617097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64538488|NCT00617097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64538489|NCT00617097|Analgesics|analgesics|mesh-ancestor
64538490|NCT00617097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64538491|NCT00617097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64538492|NCT00617097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64538493|NCT00617097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538494|NCT01532414|Enclomiphene|enclomiphene|mesh-list
64538495|NCT01532414|Clomiphene|clomiphene|mesh-list
64538496|NCT01532414|Zuclomiphene|zuclomiphene|mesh-list
64538497|NCT01532414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64538498|NCT01532414|Hormone Antagonists|hormone antagonists|mesh-ancestor
64538499|NCT01532414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64654999|NCT01608659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64538501|NCT01532414|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64538502|NCT01532414|Fertility Agents|fertility agents|mesh-ancestor
64538503|NCT01532414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64538504|NCT01532414|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64538505|NCT01532414|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64538507|NCT01441973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538508|NCT02074709|Bupivacaine|bupivacaine|mesh-list
64538509|NCT02074709|Anesthetics, Local|anesthetics, local|mesh-ancestor
64538510|NCT02074709|Anesthetics|anesthetics|mesh-ancestor
64538511|NCT02074709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64538512|NCT02074709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538513|NCT02074709|Sensory System Agents|sensory system agents|mesh-ancestor
64538514|NCT02074709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64538515|NCT03571191|Denosumab|denosumab|mesh-list
64538516|NCT03571191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64538517|NCT03571191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538518|NCT01575899|Amoxicillin|amoxicillin|mesh-list
64538519|NCT01575899|Clarithromycin|clarithromycin|mesh-list
64538520|NCT01575899|Levofloxacin|levofloxacin|mesh-list
64973272|NCT00235651|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64973273|NCT00235651|Amebicides|amebicides|mesh-ancestor
64973274|NCT00235651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64973275|NCT00235651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64973276|NCT00235651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64538522|NCT01575899|Clavulanic Acid|clavulanic acid|mesh-list
64538523|NCT01575899|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64538524|NCT01575899|Rabeprazole|rabeprazole|mesh-list
64538525|NCT01575899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64538526|NCT01575899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64538527|NCT01575899|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64538528|NCT01575899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538529|NCT01575899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538530|NCT01575899|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64538531|NCT01575899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64538532|NCT01575899|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64538533|NCT01575899|Renal Agents|renal agents|mesh-ancestor
64538534|NCT01575899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64538535|NCT01575899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64973277|NCT00235651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64973278|NCT00235651|Antifungal Agents|antifungal agents|mesh-ancestor
64973279|NCT00097812|Zoledronic Acid|zoledronic acid|mesh-list
64973280|NCT00097812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64973281|NCT00097812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973282|NCT00064766|Doxycycline|doxycycline|mesh-list
64973283|NCT00064766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64973311|NCT00235963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64973312|NCT00235963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973314|NCT00236002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64973315|NCT00236002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973339|NCT00236392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64973340|NCT00236392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64973341|NCT00236392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64973342|NCT00236392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64714164|NCT02831569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64973343|NCT00236392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973344|NCT00236431|Galantamine|galantamine|mesh-list
64973345|NCT00236431|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64973346|NCT00236431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973347|NCT00236431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973348|NCT00236431|Cholinergic Agents|cholinergic agents|mesh-ancestor
64973349|NCT00236431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64973350|NCT00236431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973351|NCT00236431|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64973352|NCT00236431|Autonomic Agents|autonomic agents|mesh-ancestor
64973353|NCT00236431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64973354|NCT00236431|Nootropic Agents|nootropic agents|mesh-ancestor
64973355|NCT00097929|Vorinostat|vorinostat|mesh-list
64973356|NCT00097929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973357|NCT00097929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64973358|NCT00097929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973359|NCT00097929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973360|NCT00236470|Risperidone|risperidone|mesh-list
64973361|NCT00236470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64973362|NCT00236470|Serotonin Agents|serotonin agents|mesh-ancestor
64973363|NCT00236470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64973364|NCT00236470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973365|NCT00236470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973402|NCT00236587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64538536|NCT01575899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538537|NCT01575899|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64538538|NCT01575899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64538539|NCT01575899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64538540|NCT01575899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64714144|NCT04736953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538541|NCT01575899|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64538542|NCT01440881|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64538543|NCT01440881|Natriuretic Agents|natriuretic agents|mesh-ancestor
64538544|NCT01440881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538546|NCT00620061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64538547|NCT00620061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64538548|NCT00620061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538549|NCT04122443|Acetaminophen|acetaminophen|mesh-list
64538550|NCT04122443|Oxycodone|oxycodone|mesh-list
64538551|NCT04122443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64538552|NCT04122443|Analgesics|analgesics|mesh-ancestor
64538553|NCT04122443|Sensory System Agents|sensory system agents|mesh-ancestor
64538554|NCT04122443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64538555|NCT04122443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538556|NCT04122443|Antipyretics|antipyretics|mesh-ancestor
64538557|NCT04122443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64538558|NCT04122443|Narcotics|narcotics|mesh-ancestor
64538559|NCT04122443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64538560|NCT00587769|Bupropion|bupropion|mesh-list
64538561|NCT00587769|Varenicline|varenicline|mesh-list
64538562|NCT00587769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64538563|NCT00587769|Antidepressive Agents|antidepressive agents|mesh-ancestor
64538564|NCT00587769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64538565|NCT00587769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64538566|NCT00587769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64538567|NCT00587769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64538569|NCT00587769|Dopamine Agents|dopamine agents|mesh-ancestor
64538577|NCT00587769|Cholinergic Agents|cholinergic agents|mesh-ancestor
64538578|NCT00623181|Vaccines|vaccines|mesh-list
64538579|NCT00623181|Immunologic Factors|immunologic factors|mesh-ancestor
64538580|NCT00623181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538581|NCT03433833|Digoxin|digoxin|mesh-list
64655027|NCT02449902|Estrogens|estrogens|mesh-ancestor
64538582|NCT03433833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64538583|NCT03433833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64538584|NCT03433833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538585|NCT03433833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538586|NCT03433833|Protective Agents|protective agents|mesh-ancestor
64538587|NCT03433833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538588|NCT01574651|Glycopyrrolate|glycopyrrolate|mesh-list
64538589|NCT01574651|Formoterol Fumarate|formoterol fumarate|mesh-list
64538590|NCT01574651|Tiotropium Bromide|tiotropium bromide|mesh-list
64544920|NCT03583333|Linezolid|linezolid|mesh-list
64538591|NCT01574651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64538592|NCT01574651|Autonomic Agents|autonomic agents|mesh-ancestor
64538593|NCT01574651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64538594|NCT01574651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538595|NCT01574651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64303275|NCT02137213|Sensory System Agents|sensory system agents|mesh-ancestor
64303276|NCT02137213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64973403|NCT00236587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973404|NCT00236587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973431|NCT00236743|Anticonvulsants|anticonvulsants|mesh-ancestor
64973432|NCT00236743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64973433|NCT00236743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973434|NCT00236782|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64973435|NCT00236782|Norelgestromin|norelgestromin|mesh-list
64973437|NCT00236782|Estrogens|estrogens|mesh-ancestor
64973438|NCT00236782|Hormones|hormones|mesh-ancestor
64973439|NCT00236782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64973440|NCT00236782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973441|NCT00236782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64973442|NCT00236782|Contraceptive Agents|contraceptive agents|mesh-ancestor
64973443|NCT00236782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64544944|NCT01602510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64973444|NCT00236782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64973445|NCT00236782|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64973446|NCT00236782|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64973447|NCT00097968|Everolimus|everolimus|mesh-list
64973448|NCT00097968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512369|NCT04461639|Coagulants|coagulants|mesh-ancestor
64973449|NCT00097968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64973450|NCT00097968|Immunologic Factors|immunologic factors|mesh-ancestor
64973451|NCT00097968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973453|NCT00236821|Ofloxacin|ofloxacin|mesh-list
64973454|NCT00236821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64973455|NCT00236821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973456|NCT00236821|Renal Agents|renal agents|mesh-ancestor
64973457|NCT00236821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64973467|NCT00236860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64973468|NCT00236860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538596|NCT01574651|Respiratory System Agents|respiratory system agents|mesh-ancestor
64538597|NCT01574651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64538598|NCT01574651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64538599|NCT01574651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64538600|NCT01574651|Adrenergic Agents|adrenergic agents|mesh-ancestor
64538601|NCT01574651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64538602|NCT01574651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538603|NCT01574651|Parasympatholytics|parasympatholytics|mesh-ancestor
64538604|NCT01574651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64538605|NCT01574651|Cholinergic Agents|cholinergic agents|mesh-ancestor
64538606|NCT01574651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64538607|NCT01574651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64538608|NCT03179163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64538610|NCT03179163|Captopril|captopril|mesh-list
64538611|NCT03179163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64538612|NCT03179163|Diuretics|diuretics|mesh-ancestor
64538613|NCT03179163|Natriuretic Agents|natriuretic agents|mesh-ancestor
64538614|NCT03179163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538615|NCT03179163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64655032|NCT02449902|Contraceptive Agents|contraceptive agents|mesh-ancestor
64538616|NCT03179163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64538617|NCT03179163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538618|NCT03179163|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64538619|NCT03179163|Protease Inhibitors|protease inhibitors|mesh-ancestor
64538620|NCT03179163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538622|NCT01440803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64538623|NCT01440803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538624|NCT01440803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64538625|NCT05247177|Dexmedetomidine|dexmedetomidine|mesh-list
64538626|NCT05247177|Ketamine|ketamine|mesh-list
64538627|NCT05247177|Anesthetics|anesthetics|mesh-list
64973469|NCT00065117|Leucovorin|leucovorin|mesh-list
64973470|NCT00065117|Fluorouracil|fluorouracil|mesh-list
64973471|NCT00065117|Oxaliplatin|oxaliplatin|mesh-list
64973472|NCT00065117|Antimetabolites|antimetabolites|mesh-ancestor
64973473|NCT00065117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973474|NCT00065117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64973475|NCT00065117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973476|NCT00065117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64538629|NCT05247177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64538630|NCT05247177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538631|NCT05247177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64538632|NCT05247177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64538633|NCT05247177|Analgesics|analgesics|mesh-ancestor
64538634|NCT05247177|Sensory System Agents|sensory system agents|mesh-ancestor
64538635|NCT05247177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64538636|NCT05247177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64538637|NCT05247177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64538638|NCT05247177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64538639|NCT05247177|Adrenergic Agents|adrenergic agents|mesh-ancestor
64538640|NCT05247177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64538641|NCT05247177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538642|NCT05247177|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64538643|NCT05247177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64538644|NCT05247177|Anesthetics, General|anesthetics, general|mesh-ancestor
64538645|NCT05247177|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64538646|NCT05247177|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64538647|NCT05247177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64538648|NCT05247177|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64538649|NCT00624195|Etravirine|etravirine|mesh-list
64538650|NCT00624195|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64538651|NCT00624195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64538652|NCT00624195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64538653|NCT00624195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973477|NCT00065117|Immunologic Factors|immunologic factors|mesh-ancestor
64973478|NCT00065117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973479|NCT00065117|Antidotes|antidotes|mesh-ancestor
64973480|NCT00065117|Protective Agents|protective agents|mesh-ancestor
64973481|NCT00065117|Vitamin B Complex|vitamin b complex|mesh-ancestor
64973482|NCT00065117|Vitamins|vitamins|mesh-ancestor
64973483|NCT00065117|Micronutrients|micronutrients|mesh-ancestor
64973484|NCT00237016|Doxycycline|doxycycline|mesh-list
64973485|NCT00237016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64973486|NCT00237016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973487|NCT00237016|Antimalarials|antimalarials|mesh-ancestor
64973488|NCT00237016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64973489|NCT00237016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64973490|NCT00237133|Letrozole|letrozole|mesh-list
64973491|NCT00237133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973492|NCT00237133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64973493|NCT00237133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64973494|NCT00237133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973495|NCT00237133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973496|NCT00237133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64973497|NCT00237133|Hormone Antagonists|hormone antagonists|mesh-ancestor
64538654|NCT00624195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538655|NCT00624195|Antiviral Agents|antiviral agents|mesh-ancestor
64538656|NCT00624195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64538657|NCT01516970|Ritonavir|ritonavir|mesh-list
64538658|NCT01516970|Lopinavir|lopinavir|mesh-list
64538659|NCT01516970|Darunavir|darunavir|mesh-list
64538660|NCT01516970|Zidovudine|zidovudine|mesh-list
64538661|NCT01516970|Efavirenz|efavirenz|mesh-list
64538662|NCT01516970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64538663|NCT01516970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64538664|NCT01516970|Protease Inhibitors|protease inhibitors|mesh-ancestor
64538665|NCT01516970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538666|NCT01516970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538667|NCT01516970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64538668|NCT01516970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64538669|NCT01516970|Antiviral Agents|antiviral agents|mesh-ancestor
64538670|NCT01516970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64538671|NCT01516970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64538672|NCT01516970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64538673|NCT01516970|Antimetabolites|antimetabolites|mesh-ancestor
64538674|NCT01516970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64538675|NCT01516970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64538676|NCT01516970|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64538677|NCT01516970|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64538678|NCT01516970|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64538679|NCT01516970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64538680|NCT01516970|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64538681|NCT02140593|Rocuronium|rocuronium|mesh-list
64538682|NCT02140593|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64538683|NCT02140593|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64538684|NCT02140593|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64538685|NCT02140593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64538686|NCT02140593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538687|NCT01516892|Botulinum Toxins|botulinum toxins|mesh-list
64538688|NCT01516892|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64538689|NCT01516892|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64538691|NCT01516892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64538692|NCT01516892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538693|NCT01516892|Cholinergic Agents|cholinergic agents|mesh-ancestor
64538694|NCT01516892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64538695|NCT01516892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538696|NCT01516892|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64538697|NCT01516892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64538698|NCT00668811|Sunitinib|sunitinib|mesh-list
64538699|NCT00668811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538700|NCT00668811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64538701|NCT00668811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64538702|NCT00668811|Growth Substances|growth substances|mesh-ancestor
64538703|NCT00668811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538704|NCT00668811|Growth Inhibitors|growth inhibitors|mesh-ancestor
64545340|NCT03155893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545362|NCT05698771|Antimetabolites|antimetabolites|mesh-ancestor
64538705|NCT00668811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64538706|NCT00668811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538707|NCT00668811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538708|NCT02776605|Prednisone|prednisone|mesh-list
64303397|NCT05579119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64303398|NCT05579119|Protease Inhibitors|protease inhibitors|mesh-ancestor
64973498|NCT00237133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64973499|NCT00237133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973500|NCT00237172|Imatinib Mesylate|imatinib mesylate|mesh-list
64973501|NCT00237172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973502|NCT00237172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64973503|NCT00237172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973504|NCT00237172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545393|NCT03156829|Betamethasone|betamethasone|mesh-list
64973505|NCT00237211|Letrozole|letrozole|mesh-list
64973506|NCT00237211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973507|NCT00237211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64655045|NCT04942626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973508|NCT00237211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64973509|NCT00237211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973510|NCT00237211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973511|NCT00237211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64973512|NCT00237211|Hormone Antagonists|hormone antagonists|mesh-ancestor
64512456|NCT04364945|Dexmedetomidine|dexmedetomidine|mesh-list
64512457|NCT04364945|Remifentanil|remifentanil|mesh-list
64512458|NCT04364945|Sevoflurane|sevoflurane|mesh-list
64512459|NCT04364945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64512460|NCT04364945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64512461|NCT04364945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512462|NCT04364945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64512463|NCT04364945|Analgesics|analgesics|mesh-ancestor
64512464|NCT04364945|Sensory System Agents|sensory system agents|mesh-ancestor
64512465|NCT04364945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64973539|NCT00237367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64973540|NCT00237367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64973541|NCT00237367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973542|NCT00237367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973543|NCT00098046|Famciclovir|famciclovir|mesh-list
64973544|NCT00098046|Antiviral Agents|antiviral agents|mesh-ancestor
64538709|NCT02776605|Methotrexate|methotrexate|mesh-list
64538710|NCT02776605|Vincristine|vincristine|mesh-list
64538711|NCT02776605|Daunorubicin|daunorubicin|mesh-list
64538712|NCT02776605|Mercaptopurine|mercaptopurine|mesh-list
64538714|NCT02776605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64538715|NCT02776605|Glucocorticoids|glucocorticoids|mesh-ancestor
64538716|NCT02776605|Hormones|hormones|mesh-ancestor
64538717|NCT02776605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64538718|NCT02776605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538719|NCT02776605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64538720|NCT02776605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538721|NCT02776605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64538722|NCT02776605|Abortifacient Agents|abortifacient agents|mesh-ancestor
64545540|NCT04746937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64538723|NCT02776605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64538724|NCT02776605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64538725|NCT02776605|Antimetabolites|antimetabolites|mesh-ancestor
64538726|NCT02776605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538727|NCT02776605|Dermatologic Agents|dermatologic agents|mesh-ancestor
64538728|NCT02776605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538729|NCT02776605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64538730|NCT02776605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64538731|NCT02776605|Immunologic Factors|immunologic factors|mesh-ancestor
64538732|NCT02776605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64538733|NCT02776605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64538734|NCT02776605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64538735|NCT02776605|Tubulin Modulators|tubulin modulators|mesh-ancestor
64538736|NCT02776605|Antimitotic Agents|antimitotic agents|mesh-ancestor
64538737|NCT02776605|Mitosis Modulators|mitosis modulators|mesh-ancestor
64538738|NCT02776605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64538739|NCT02776605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64545585|NCT04497870|Peppermint oil|peppermint oil|mesh-list
64538740|NCT02776605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64538741|NCT02776605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64538742|NCT00627861|Metoprolol|metoprolol|mesh-list
64538743|NCT00627861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64538744|NCT00627861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64538747|NCT00627861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64538748|NCT00627861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538749|NCT00627861|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64538750|NCT00627861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64538751|NCT00627861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64538752|NCT00627861|Adrenergic Agents|adrenergic agents|mesh-ancestor
64538753|NCT00627861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64538754|NCT00627861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538756|NCT00669279|Carvedilol|carvedilol|mesh-list
64538757|NCT00669279|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64538758|NCT00669279|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64538759|NCT00669279|Adrenergic Agents|adrenergic agents|mesh-ancestor
64538760|NCT00669279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64655053|NCT02228681|Medroxyprogesterone|medroxyprogesterone|mesh-list
64538761|NCT00669279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538763|NCT00669279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64538764|NCT00669279|Antioxidants|antioxidants|mesh-ancestor
64538765|NCT00669279|Protective Agents|protective agents|mesh-ancestor
64538766|NCT00669279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64545643|NCT01631292|Vitamins|vitamins|mesh-list
64538767|NCT00669279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64538768|NCT00669279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64538769|NCT00669279|Vasodilator Agents|vasodilator agents|mesh-ancestor
64538770|NCT00669279|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64538771|NCT00669279|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64538772|NCT00669279|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64303457|NCT02138383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973545|NCT00098046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973546|NCT00098046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64973547|NCT00098046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973548|NCT00098046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973549|NCT00065273|Olanzapine|olanzapine|mesh-list
64973550|NCT00065273|Risperidone|risperidone|mesh-list
64973551|NCT00065273|Clozapine|clozapine|mesh-list
64973552|NCT00065273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64973553|NCT00065273|Serotonin Agents|serotonin agents|mesh-ancestor
64973554|NCT00065273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64973555|NCT00065273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973556|NCT00065273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973557|NCT00065273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64973558|NCT00065273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64973595|NCT00237523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973597|NCT00237523|Micronutrients|micronutrients|mesh-ancestor
64973598|NCT00237523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973599|NCT00098124|Milnacipran|milnacipran|mesh-list
64538773|NCT00669279|Sympatholytics|sympatholytics|mesh-ancestor
64538774|NCT00669279|Autonomic Agents|autonomic agents|mesh-ancestor
64538775|NCT00669279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64538776|NCT00669279|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64538777|NCT02394795|Calcium, Dietary|calcium, dietary|mesh-list
64538778|NCT02394795|Leucovorin|leucovorin|mesh-list
64538779|NCT02394795|Bevacizumab|bevacizumab|mesh-list
64538780|NCT02394795|Panitumumab|panitumumab|mesh-list
64538781|NCT02394795|Oxaliplatin|oxaliplatin|mesh-list
64538782|NCT02394795|Fluorouracil|fluorouracil|mesh-list
64538783|NCT02394795|Calcium|calcium|mesh-list
64538784|NCT02394795|Levoleucovorin|levoleucovorin|mesh-list
64538785|NCT02394795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64538786|NCT02394795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538787|NCT02394795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64538788|NCT02394795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64538789|NCT02394795|Growth Substances|growth substances|mesh-ancestor
64538790|NCT02394795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538791|NCT02394795|Growth Inhibitors|growth inhibitors|mesh-ancestor
64538792|NCT02394795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64538793|NCT02394795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64538794|NCT02394795|Antimetabolites|antimetabolites|mesh-ancestor
64538795|NCT02394795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538796|NCT02394795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64538797|NCT02394795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64538798|NCT02394795|Immunologic Factors|immunologic factors|mesh-ancestor
64538799|NCT02394795|Antidotes|antidotes|mesh-ancestor
64538800|NCT02394795|Protective Agents|protective agents|mesh-ancestor
64545738|NCT02570503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64545761|NCT02492269|Analgesics|analgesics|mesh-ancestor
64538801|NCT02394795|Vitamin B Complex|vitamin b complex|mesh-ancestor
64538802|NCT02394795|Vitamins|vitamins|mesh-ancestor
64538803|NCT02394795|Micronutrients|micronutrients|mesh-ancestor
64538804|NCT01546688|Zonisamide|zonisamide|mesh-list
64538805|NCT01546688|Anticonvulsants|anticonvulsants|mesh-ancestor
64538806|NCT01546688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64538807|NCT01546688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64538808|NCT01546688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303486|NCT02252419|Glucocorticoids|glucocorticoids|mesh-ancestor
64973600|NCT00098124|Levomilnacipran|levomilnacipran|mesh-list
64979026|NCT00274066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64973601|NCT00098124|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64538809|NCT01546688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64538810|NCT01546688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538811|NCT04409522|Melatonin|melatonin|mesh-list
64538812|NCT04409522|Antioxidants|antioxidants|mesh-ancestor
64538813|NCT04409522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538814|NCT04409522|Protective Agents|protective agents|mesh-ancestor
64538815|NCT04409522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538816|NCT04409522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64538817|NCT00672243|Sirolimus|sirolimus|mesh-list
64538818|NCT00672243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64538819|NCT00672243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538820|NCT00672243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64538821|NCT00672243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538822|NCT00672243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538823|NCT00672243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64538824|NCT00672243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64538825|NCT00672243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64538826|NCT00672243|Antifungal Agents|antifungal agents|mesh-ancestor
64538827|NCT00672243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64538828|NCT00672243|Immunologic Factors|immunologic factors|mesh-ancestor
64538829|NCT00672243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538830|NCT04105946|Dexmedetomidine|dexmedetomidine|mesh-list
64538831|NCT04105946|Remifentanil|remifentanil|mesh-list
64538832|NCT04105946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64538833|NCT04105946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64538834|NCT04105946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538835|NCT04105946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64538836|NCT04105946|Analgesics|analgesics|mesh-ancestor
64538837|NCT04105946|Sensory System Agents|sensory system agents|mesh-ancestor
64714145|NCT04736953|Antifungal Agents|antifungal agents|mesh-ancestor
64538841|NCT04105946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64538849|NCT01440569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64538850|NCT01440569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64538851|NCT01440569|Protease Inhibitors|protease inhibitors|mesh-ancestor
64538852|NCT01440569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538853|NCT01440569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538854|NCT01440569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64545948|NCT01427309|Vaccines|vaccines|mesh-list
64538855|NCT01440569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64538856|NCT01440569|Antiviral Agents|antiviral agents|mesh-ancestor
64538857|NCT01440569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64538858|NCT01440569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64538859|NCT01440569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64538860|NCT00629499|Paclitaxel|paclitaxel|mesh-list
64538861|NCT00629499|Cyclophosphamide|cyclophosphamide|mesh-list
64538862|NCT00629499|Trastuzumab|trastuzumab|mesh-list
64538863|NCT00629499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64538864|NCT00629499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538865|NCT00629499|Tubulin Modulators|tubulin modulators|mesh-ancestor
64538866|NCT00629499|Antimitotic Agents|antimitotic agents|mesh-ancestor
64538867|NCT00629499|Mitosis Modulators|mitosis modulators|mesh-ancestor
64538868|NCT00629499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538869|NCT00629499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64538870|NCT00629499|Immunologic Factors|immunologic factors|mesh-ancestor
64538871|NCT00629499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538872|NCT00629499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64538873|NCT00629499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64538874|NCT00629499|Alkylating Agents|alkylating agents|mesh-ancestor
64538875|NCT00629499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64538895|NCT01530464|Aminophylline|aminophylline|mesh-list
64538896|NCT01530464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64538897|NCT01530464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64538898|NCT01530464|Autonomic Agents|autonomic agents|mesh-ancestor
64655070|NCT02228681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64538899|NCT01530464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64538900|NCT01530464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538901|NCT01530464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64538902|NCT01530464|Respiratory System Agents|respiratory system agents|mesh-ancestor
64538903|NCT01530464|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64538904|NCT01530464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64538905|NCT01530464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538906|NCT01530464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538907|NCT01530464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64538908|NCT01530464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64538909|NCT01530464|Purinergic Agents|purinergic agents|mesh-ancestor
64538910|NCT01530464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64538911|NCT01530464|Protective Agents|protective agents|mesh-ancestor
64538913|NCT00633399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64303624|NCT03140423|Mupirocin|mupirocin|mesh-list
64973602|NCT00098124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64973603|NCT00098124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64546122|NCT03751423|Fentanyl|fentanyl|mesh-list
64973604|NCT00098124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973605|NCT00098124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64973606|NCT00098124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973607|NCT00098124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64973608|NCT00098124|Analgesics|analgesics|mesh-ancestor
64973638|NCT00398684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973640|NCT00398684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973641|NCT00398684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64973642|NCT00398684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64973643|NCT00398684|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64973644|NCT00398684|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64973645|NCT00076440|Leuprolide|leuprolide|mesh-list
64973646|NCT00076440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64973647|NCT00076440|Fertility Agents|fertility agents|mesh-ancestor
64973648|NCT00076440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64973649|NCT00076440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512600|NCT04195399|Imidazole|imidazole|mesh-list
64512601|NCT04195399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64512602|NCT04195399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973665|NCT00237874|Serotonin Agents|serotonin agents|mesh-ancestor
64973666|NCT00237874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64973667|NCT00237874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64973668|NCT00237874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64973669|NCT00237874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64973670|NCT00237913|Olanzapine|olanzapine|mesh-list
64973671|NCT00237913|Risperidone|risperidone|mesh-list
64973672|NCT00237913|Aripiprazole|aripiprazole|mesh-list
64973673|NCT00237913|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64973674|NCT00237913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64973675|NCT00237913|Serotonin Agents|serotonin agents|mesh-ancestor
64973676|NCT00237913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64973677|NCT00237913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538914|NCT00633399|Serotonin Agents|serotonin agents|mesh-ancestor
64538915|NCT00633399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64538916|NCT00633399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538917|NCT00633399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538918|NCT00633399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64538919|NCT00633399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64538920|NCT00633399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64546170|NCT03661411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64538921|NCT00633399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64538922|NCT00633399|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64538923|NCT00633399|Dopamine Agents|dopamine agents|mesh-ancestor
64538924|NCT01077843|Etoricoxib|etoricoxib|mesh-list
64655077|NCT00942578|Prednisone|prednisone|mesh-list
64538925|NCT01077843|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
64538926|NCT01077843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64303633|NCT02130817|Abatacept|abatacept|mesh-list
64303634|NCT02130817|Tacrolimus|tacrolimus|mesh-list
64303635|NCT02130817|Thymoglobulin|thymoglobulin|mesh-list
64973678|NCT00237913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973679|NCT00237913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64973680|NCT00237913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64973681|NCT00237913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64973682|NCT00237913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64973683|NCT00237913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64973684|NCT00237913|Dopamine Agents|dopamine agents|mesh-ancestor
64973685|NCT00237913|Antiemetics|antiemetics|mesh-ancestor
64973686|NCT00237913|Autonomic Agents|autonomic agents|mesh-ancestor
64973687|NCT00237913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64973688|NCT00237913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64973689|NCT00237913|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64973690|NCT00237913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64973691|NCT00237913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64973707|NCT04721119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64973708|NCT04721119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973709|NCT00238147|Carboplatin|carboplatin|mesh-list
64973710|NCT00238147|Docetaxel|docetaxel|mesh-list
64973711|NCT00238147|Capecitabine|capecitabine|mesh-list
64973712|NCT00238147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973713|NCT00238147|Tubulin Modulators|tubulin modulators|mesh-ancestor
64973714|NCT00238147|Antimitotic Agents|antimitotic agents|mesh-ancestor
64973715|NCT00238147|Mitosis Modulators|mitosis modulators|mesh-ancestor
64973716|NCT00238147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973717|NCT00238147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64973718|NCT00238147|Antimetabolites|antimetabolites|mesh-ancestor
64512675|NCT04097561|Immunologic Factors|immunologic factors|mesh-ancestor
64512676|NCT04097561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512677|NCT04085315|Osimertinib|osimertinib|mesh-list
64512682|NCT04083170|Vidarabine|vidarabine|mesh-list
64973719|NCT00065390|Pyrimethamine|pyrimethamine|mesh-list
64973720|NCT00065390|Antimalarials|antimalarials|mesh-ancestor
64973721|NCT00065390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64973722|NCT00065390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64973723|NCT00065390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973724|NCT00065390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64973725|NCT00065390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973726|NCT00065390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973728|NCT00238225|Ketoconazole|ketoconazole|mesh-list
64973729|NCT00238225|Dexamethasone|dexamethasone|mesh-list
64973730|NCT00238225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64973731|NCT00238225|Antiemetics|antiemetics|mesh-ancestor
64973732|NCT00238225|Autonomic Agents|autonomic agents|mesh-ancestor
64973733|NCT00238225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64538927|NCT01077843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64538928|NCT01077843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64538929|NCT01077843|Analgesics|analgesics|mesh-ancestor
64538930|NCT01077843|Sensory System Agents|sensory system agents|mesh-ancestor
64538931|NCT01077843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64538932|NCT01077843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538933|NCT01077843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64538934|NCT01077843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64538935|NCT01077843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538936|NCT01077843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538937|NCT00673959|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64538938|NCT00673959|Lubricant Eye Drops|lubricant eye drops|mesh-list
64538939|NCT00673959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64546273|NCT03825757|Antifungal Agents|antifungal agents|mesh-ancestor
64538940|NCT00635817|Leuprolide|leuprolide|mesh-list
64538941|NCT00635817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64538942|NCT00635817|Fertility Agents|fertility agents|mesh-ancestor
64538943|NCT00635817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64538944|NCT00635817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538945|NCT00635817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64538946|NCT00635817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538947|NCT01439945|Magnesium Oxide|magnesium oxide|mesh-list
64538950|NCT01439945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64538951|NCT00651963|Ezetimibe|ezetimibe|mesh-list
64538952|NCT00651963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64538953|NCT00651963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64538954|NCT00651963|Antimetabolites|antimetabolites|mesh-ancestor
64538955|NCT00651963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538956|NCT00651963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64538957|NCT00674115|Omeprazole|omeprazole|mesh-list
64538958|NCT00674115|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
64538959|NCT00674115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64538960|NCT00674115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64973734|NCT00238225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973735|NCT00238225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64973736|NCT00238225|Glucocorticoids|glucocorticoids|mesh-ancestor
64973737|NCT00238225|Hormones|hormones|mesh-ancestor
64538962|NCT00674115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538963|NCT00674115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538964|NCT02142153|Olorofim|olorofim|mesh-list
64538965|NCT02142153|Antifungal Agents|antifungal agents|mesh-ancestor
64538966|NCT02142153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64538967|NCT00674583|Vaccines|vaccines|mesh-list
64538968|NCT00674583|Immunologic Factors|immunologic factors|mesh-ancestor
64546338|NCT03807037|Tocotrienols|tocotrienols|mesh-list
64538969|NCT00674583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538970|NCT01420081|Gedatolisib|gedatolisib|mesh-list
64538971|NCT01420081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64538972|NCT01420081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538973|NCT01420081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538974|NCT01439867|Cinacalcet|cinacalcet|mesh-list
64538975|NCT01439867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64973738|NCT00238225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64973739|NCT00238225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64973740|NCT00238225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973741|NCT00238225|Antifungal Agents|antifungal agents|mesh-ancestor
64973742|NCT00238225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973743|NCT00238225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64973744|NCT00238225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64973745|NCT00238225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973746|NCT00238225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973767|NCT00065546|Lipotropic Agents|lipotropic agents|mesh-ancestor
64973768|NCT00065546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64546395|NCT03725059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973769|NCT00065546|Antimetabolites|antimetabolites|mesh-ancestor
64973770|NCT00065546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973771|NCT00065546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64973772|NCT00065546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64973773|NCT00065546|Nootropic Agents|nootropic agents|mesh-ancestor
64973775|NCT00098280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64973776|NCT00098280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64973777|NCT00098280|Immunologic Factors|immunologic factors|mesh-ancestor
64973778|NCT00098280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973779|NCT00238459|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64973780|NCT00238459|Vaccines|vaccines|mesh-list
64973781|NCT00238459|Immunologic Factors|immunologic factors|mesh-ancestor
64973782|NCT00238459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973783|NCT00238459|Antiviral Agents|antiviral agents|mesh-ancestor
64973784|NCT00238459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973785|NCT00238498|Vildagliptin|vildagliptin|mesh-list
64973786|NCT00238498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64973787|NCT00238498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973788|NCT00238498|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64973789|NCT00238498|Protease Inhibitors|protease inhibitors|mesh-ancestor
64973790|NCT00238498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973791|NCT00238498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973792|NCT00238537|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64973794|NCT00238537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64973795|NCT00238537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973796|NCT00098319|Folic Acid|folic acid|mesh-list
64973797|NCT00098319|Hematinics|hematinics|mesh-ancestor
64973798|NCT00098319|Vitamin B Complex|vitamin b complex|mesh-ancestor
64973799|NCT00098319|Vitamins|vitamins|mesh-ancestor
64973800|NCT00098319|Micronutrients|micronutrients|mesh-ancestor
64538976|NCT01439867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538977|NCT01439867|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64538978|NCT01439867|Hormone Antagonists|hormone antagonists|mesh-ancestor
64538979|NCT01439867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64538980|NCT00637923|Ribavirin|ribavirin|mesh-list
64538981|NCT00637923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64538982|NCT00637923|Nitazoxanide|nitazoxanide|mesh-list
64538983|NCT00637923|Antimetabolites|antimetabolites|mesh-ancestor
64538984|NCT00637923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714146|NCT04736953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64538986|NCT00637923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64538987|NCT00637923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64538988|NCT01439711|Letrozole|letrozole|mesh-list
64538989|NCT01439711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64538990|NCT01439711|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64538991|NCT01439711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64538992|NCT01439711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64538993|NCT01439711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64538994|NCT01439711|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64303697|NCT03548311|Micronutrients|micronutrients|mesh-ancestor
64973824|NCT00065624|Thioctic Acid|thioctic acid|mesh-list
64973825|NCT00065624|Antioxidants|antioxidants|mesh-ancestor
64973826|NCT00065624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973827|NCT00065624|Protective Agents|protective agents|mesh-ancestor
64973828|NCT00065624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973829|NCT00065624|Vitamin B Complex|vitamin b complex|mesh-ancestor
64973830|NCT00065624|Vitamins|vitamins|mesh-ancestor
64973831|NCT00065624|Micronutrients|micronutrients|mesh-ancestor
64973832|NCT00238966|Mycophenolic Acid|mycophenolic acid|mesh-list
64973833|NCT00238966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64973834|NCT00238966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973835|NCT00238966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64973836|NCT00238966|Antitubercular Agents|antitubercular agents|mesh-ancestor
64973837|NCT00238966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64973838|NCT00238966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973839|NCT00238966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973840|NCT00238966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973841|NCT00239044|Mycophenolic Acid|mycophenolic acid|mesh-list
64973842|NCT00239044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64973843|NCT00239044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973844|NCT00239044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64973845|NCT00239044|Antitubercular Agents|antitubercular agents|mesh-ancestor
64973846|NCT00239044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64973847|NCT00239044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973848|NCT00239044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973849|NCT00239044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973850|NCT00098358|Zileuton|zileuton|mesh-list
64973880|NCT00239161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64973881|NCT00239161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64973882|NCT00239161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973883|NCT00239161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655102|NCT02229461|Analgesics|analgesics|mesh-ancestor
64979142|NCT00274807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64538996|NCT01439711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64538997|NCT01439711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538999|NCT01439555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64539000|NCT01439555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64539001|NCT01439555|Antimetabolites|antimetabolites|mesh-ancestor
64539002|NCT01439555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539003|NCT01439555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64539004|NCT01439555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64539005|NCT01439555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539006|NCT00674739|Imiquimod|imiquimod|mesh-list
64539007|NCT00674739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64539008|NCT00674739|Immunologic Factors|immunologic factors|mesh-ancestor
64539009|NCT00674739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539010|NCT00674739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64539011|NCT00674739|Interferon Inducers|interferon inducers|mesh-ancestor
64539012|NCT00675909|Midazolam|midazolam|mesh-list
64539013|NCT00675909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64539014|NCT00675909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64539015|NCT00675909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64539016|NCT00675909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539017|NCT00675909|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64539018|NCT00675909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64539019|NCT00675909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64539020|NCT00675909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64539021|NCT00675909|Anesthetics, General|anesthetics, general|mesh-ancestor
64539022|NCT00675909|Anesthetics|anesthetics|mesh-ancestor
64539023|NCT00675909|GABA Modulators|gaba modulators|mesh-ancestor
64546512|NCT03630211|Immunologic Factors|immunologic factors|mesh-ancestor
64539024|NCT00675909|GABA Agents|gaba agents|mesh-ancestor
64539025|NCT00675909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64539026|NCT00675909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539027|NCT03027908|Fluorides|fluorides|mesh-list
64973884|NCT00239161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973885|NCT00239161|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64973886|NCT00239161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64973888|NCT00239200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973889|NCT00239200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64973890|NCT00239200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973891|NCT00239200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539028|NCT03027908|Cariostatic Agents|cariostatic agents|mesh-ancestor
64539029|NCT03027908|Protective Agents|protective agents|mesh-ancestor
64539030|NCT03027908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539031|NCT00638937|Saracatinib|saracatinib|mesh-list
64539032|NCT00638937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546552|NCT04412694|Hormones|hormones|mesh-ancestor
64539033|NCT00638937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539034|NCT00638937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539035|NCT01439009|Tolvaptan|tolvaptan|mesh-list
64539036|NCT01439009|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64539037|NCT01439009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539038|NCT01439009|Natriuretic Agents|natriuretic agents|mesh-ancestor
64539039|NCT01439009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539040|NCT00675987|Losartan|losartan|mesh-list
64539041|NCT00675987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64539042|NCT00675987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64539043|NCT00675987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64539044|NCT00675987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64539045|NCT00675987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539046|NCT00639717|Etanercept|etanercept|mesh-list
64539047|NCT00639717|Methoxsalen|methoxsalen|mesh-list
64539048|NCT00639717|Tacrolimus|tacrolimus|mesh-list
64539049|NCT00639717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64539050|NCT00639717|Immunologic Factors|immunologic factors|mesh-ancestor
64539052|NCT00639717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64539053|NCT00639717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539054|NCT00639717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539055|NCT00639717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64539056|NCT00639717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64539057|NCT00639717|Analgesics|analgesics|mesh-ancestor
64495159|NCT03460860|Vitamins|vitamins|mesh-ancestor
64539058|NCT00639717|Sensory System Agents|sensory system agents|mesh-ancestor
64539059|NCT00639717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64539060|NCT00639717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64973892|NCT02961829|Niacinamide|niacinamide|mesh-list
64539063|NCT00639717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64539064|NCT00639717|Dermatologic Agents|dermatologic agents|mesh-ancestor
64539065|NCT01571453|Vortioxetine|vortioxetine|mesh-list
64539066|NCT01571453|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64539067|NCT01571453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64539068|NCT01571453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64539069|NCT01571453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64539070|NCT01571453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539071|NCT01571453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64539072|NCT01571453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539073|NCT01571453|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64539074|NCT01571453|Antidepressive Agents|antidepressive agents|mesh-ancestor
64539075|NCT01571453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64539076|NCT01571453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64539077|NCT01571453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64539078|NCT01571453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64539079|NCT01571453|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64979226|NCT00277537|Mannitol|mannitol|mesh-list
64539080|NCT01571453|Serotonin Agents|serotonin agents|mesh-ancestor
64539081|NCT01571453|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64539082|NCT01571453|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64539083|NCT01571453|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64539084|NCT01571453|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64539085|NCT04120961|Hirudins|hirudins|mesh-list
64539086|NCT04120961|Bivalirudin|bivalirudin|mesh-list
64539087|NCT04120961|Antithrombins|antithrombins|mesh-ancestor
64539088|NCT04120961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64539089|NCT04120961|Protease Inhibitors|protease inhibitors|mesh-ancestor
64539090|NCT04120961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539091|NCT04120961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539092|NCT04120961|Anticoagulants|anticoagulants|mesh-ancestor
64539095|NCT04410263|Dimercaprol|dimercaprol|mesh-list
64539104|NCT01444651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539105|NCT01444651|Urological Agents|urological agents|mesh-ancestor
64539106|NCT01570751|Insulin|insulin|mesh-list
64539107|NCT01570751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64539108|NCT01570751|Insulin Glargine|insulin glargine|mesh-list
64539109|NCT01570751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64539110|NCT01570751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539111|NCT01419535|Mifepristone|mifepristone|mesh-list
64539112|NCT01419535|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64539113|NCT01419535|Abortifacient Agents|abortifacient agents|mesh-ancestor
64539114|NCT01419535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64539115|NCT01419535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539116|NCT01419535|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64539117|NCT01419535|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64539118|NCT01419535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64539119|NCT01419535|Contraceptive Agents|contraceptive agents|mesh-ancestor
64539120|NCT01419535|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64546700|NCT03699319|Leucovorin|leucovorin|mesh-list
64539121|NCT01419535|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64539123|NCT01419535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64539124|NCT01419535|Luteolytic Agents|luteolytic agents|mesh-ancestor
64714147|NCT04736953|Immunologic Factors|immunologic factors|mesh-ancestor
64539126|NCT01419535|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64539127|NCT01438151|Infliximab|infliximab|mesh-list
64539128|NCT01438151|Dermatologic Agents|dermatologic agents|mesh-ancestor
64539129|NCT01438151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64539130|NCT01438151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64539131|NCT02141451|Rituximab|rituximab|mesh-list
64539132|NCT02141451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64539133|NCT02141451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64539134|NCT02141451|Immunologic Factors|immunologic factors|mesh-ancestor
64973919|NCT00414349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64973920|NCT00414349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539135|NCT02141451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539136|NCT02141451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64539138|NCT01418365|Mesalamine|mesalamine|mesh-list
64539139|NCT01418365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64539140|NCT01418365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64539141|NCT01418365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64539142|NCT01418365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64539143|NCT01418365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64539144|NCT01418365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64539145|NCT01418365|Analgesics|analgesics|mesh-ancestor
64539146|NCT01418365|Sensory System Agents|sensory system agents|mesh-ancestor
64539147|NCT01418365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64539148|NCT01418365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539149|NCT01418365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64539150|NCT01418365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64539151|NCT02075125|Ticagrelor|ticagrelor|mesh-list
64539152|NCT02075125|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64539153|NCT02075125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64539154|NCT02075125|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64539155|NCT02075125|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64539156|NCT02075125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64539157|NCT02075125|Purinergic Agents|purinergic agents|mesh-ancestor
64539158|NCT02075125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64539159|NCT02075125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539160|NCT02075125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539161|NCT00678015|Masoprocol|masoprocol|mesh-list
64539162|NCT00678015|Antioxidants|antioxidants|mesh-ancestor
64539163|NCT00678015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539164|NCT00678015|Protective Agents|protective agents|mesh-ancestor
64539179|NCT01437995|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64539180|NCT01437995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64539181|NCT01437995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64539182|NCT01437995|Autonomic Agents|autonomic agents|mesh-ancestor
64539183|NCT01437995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64539184|NCT01437995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539185|NCT01437995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64539186|NCT01437995|Respiratory System Agents|respiratory system agents|mesh-ancestor
64539187|NCT01437995|Dermatologic Agents|dermatologic agents|mesh-ancestor
64303919|NCT03068234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64303920|NCT03068234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64973922|NCT00065741|Antioxidants|antioxidants|mesh-ancestor
64973923|NCT00065741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973924|NCT00065741|Protective Agents|protective agents|mesh-ancestor
64973925|NCT00065741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546795|NCT03600649|Cyclophosphamide|cyclophosphamide|mesh-list
64546796|NCT03600649|Topotecan|topotecan|mesh-list
64546797|NCT03600649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64546798|NCT03600649|Immunologic Factors|immunologic factors|mesh-ancestor
64546809|NCT00244881|Cediranib|cediranib|mesh-list
64546819|NCT00530517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64546820|NCT00530517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546821|NCT00530517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546822|NCT03767257|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
64546823|NCT03767257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64546824|NCT03767257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64546825|NCT03767257|Antimetabolites|antimetabolites|mesh-ancestor
64546826|NCT03767257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546827|NCT03767257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64546828|NCT03765541|Cytarabine|cytarabine|mesh-list
64546829|NCT03765541|Dexamethasone|dexamethasone|mesh-list
64973926|NCT00098397|Romidepsin|romidepsin|mesh-list
64973927|NCT00098397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64973928|NCT00098397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973929|NCT00239278|Prednisolone|prednisolone|mesh-list
64973930|NCT00239278|Budesonide|budesonide|mesh-list
64973931|NCT00239278|Formoterol Fumarate|formoterol fumarate|mesh-list
64512901|NCT03889756|Midazolam|midazolam|mesh-list
64512902|NCT03889756|Ketamine|ketamine|mesh-list
64512903|NCT03889756|Analgesics|analgesics|mesh-ancestor
64512904|NCT03889756|Sensory System Agents|sensory system agents|mesh-ancestor
64512905|NCT03889756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64512906|NCT03889756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512907|NCT03889756|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64512909|NCT03889756|Anesthetics, General|anesthetics, general|mesh-ancestor
64512910|NCT03889756|Anesthetics|anesthetics|mesh-ancestor
64512911|NCT03889756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64512918|NCT03889756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64973932|NCT00239278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64973933|NCT00239278|Glucocorticoids|glucocorticoids|mesh-ancestor
64973964|NCT00076635|Interferon-gamma|interferon-gamma|mesh-list
64973965|NCT00076635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973966|NCT00076635|Antiviral Agents|antiviral agents|mesh-ancestor
64973967|NCT00076635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973968|NCT00239434|Bromides|bromides|mesh-list
64973969|NCT00239434|Tiotropium Bromide|tiotropium bromide|mesh-list
64973970|NCT00239434|Ipratropium|ipratropium|mesh-list
64973971|NCT00239434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64973972|NCT00239434|Autonomic Agents|autonomic agents|mesh-ancestor
64973973|NCT00239434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64973974|NCT00239434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973975|NCT00239434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64973986|NCT00239473|Autonomic Agents|autonomic agents|mesh-ancestor
64973987|NCT00239473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64973988|NCT00239473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973989|NCT00239473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64973990|NCT00239473|Respiratory System Agents|respiratory system agents|mesh-ancestor
64973991|NCT00239473|Parasympatholytics|parasympatholytics|mesh-ancestor
64973992|NCT00239473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64973993|NCT00239473|Cholinergic Agents|cholinergic agents|mesh-ancestor
64973994|NCT00239473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64973995|NCT00239473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973996|NCT00239512|Ibuprofen|ibuprofen|mesh-list
64973997|NCT00239512|Indomethacin|indomethacin|mesh-list
64973998|NCT00239512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64512978|NCT03794349|Temozolomide|temozolomide|mesh-list
64512979|NCT03794349|Dinutuximab|dinutuximab|mesh-list
64512980|NCT03794349|Sargramostim|sargramostim|mesh-list
64512981|NCT03794349|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64512982|NCT03794349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64539188|NCT01437995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64539189|NCT01437995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64539190|NCT01437995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64539191|NCT01437995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64539192|NCT01437995|Adrenergic Agents|adrenergic agents|mesh-ancestor
64539193|NCT01437995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64539194|NCT01437995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539196|NCT01437995|Hormones|hormones|mesh-ancestor
64539197|NCT01437995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64539198|NCT01437995|Sympathomimetics|sympathomimetics|mesh-ancestor
64539199|NCT00641745|Risperidone|risperidone|mesh-list
64539200|NCT00641745|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64539201|NCT00641745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64539202|NCT00641745|Serotonin Agents|serotonin agents|mesh-ancestor
64303929|NCT05634824|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64303930|NCT05634824|Antibodies|antibodies|mesh-list
64512983|NCT03794349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64512984|NCT03794349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64512986|NCT03794349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973999|NCT00239512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64974000|NCT00239512|Analgesics|analgesics|mesh-ancestor
64974001|NCT00239512|Sensory System Agents|sensory system agents|mesh-ancestor
64974002|NCT00239512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64974003|NCT00239512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974004|NCT00239512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64974005|NCT00239512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64974006|NCT00239512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64974007|NCT00239512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974008|NCT00239512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974009|NCT00239512|Gout Suppressants|gout suppressants|mesh-ancestor
64974010|NCT00239512|Tocolytic Agents|tocolytic agents|mesh-ancestor
64974011|NCT00239512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64974013|NCT00076674|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64974014|NCT00076674|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64974015|NCT00076674|Dopamine Agents|dopamine agents|mesh-ancestor
64974016|NCT00076674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64974017|NCT00076674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974018|NCT00076674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974019|NCT00239551|Lansoprazole|lansoprazole|mesh-list
64974020|NCT00239551|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64974021|NCT00239551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64546949|NCT03672643|Crizotinib|crizotinib|mesh-list
64974022|NCT00239551|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64974023|NCT00239551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974024|NCT00239551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974025|NCT00239629|Teriparatide|teriparatide|mesh-list
64974026|NCT00239629|Strontium ranelate|strontium ranelate|mesh-list
64974027|NCT00239629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64974028|NCT00239629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974029|NCT00239629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64974030|NCT00098436|Temozolomide|temozolomide|mesh-list
64974031|NCT00098436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64974032|NCT00098436|Alkylating Agents|alkylating agents|mesh-ancestor
64974053|NCT00239785|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64974054|NCT00239785|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64974055|NCT00239785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539203|NCT00641745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64539204|NCT00641745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539205|NCT00641745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539206|NCT00641745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64539207|NCT00641745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64539208|NCT00641745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64539209|NCT00641745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64539210|NCT00641745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64539211|NCT00641745|Dopamine Agents|dopamine agents|mesh-ancestor
64539212|NCT00641745|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64974056|NCT00239785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64974057|NCT00239785|Immunologic Factors|immunologic factors|mesh-ancestor
64546960|NCT00350701|Hormones|hormones|mesh-ancestor
64974058|NCT00239785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974059|NCT00239863|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64974060|NCT00239863|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64974061|NCT00239863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974062|NCT00239863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64974063|NCT00239863|Immunologic Factors|immunologic factors|mesh-ancestor
64974064|NCT00239863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974065|NCT00239902|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64974066|NCT00239902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64513055|NCT03635996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64513056|NCT03635996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513059|NCT03613181|Paclitaxel|paclitaxel|mesh-list
64974067|NCT00239902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974068|NCT00239902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64974069|NCT00239902|Immunologic Factors|immunologic factors|mesh-ancestor
64974070|NCT00239902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974072|NCT00239980|Tinzaparin|tinzaparin|mesh-list
64974073|NCT00239980|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64974074|NCT00239980|Anticoagulants|anticoagulants|mesh-ancestor
64547005|NCT04187898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64974075|NCT00239980|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64974076|NCT00239980|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64974077|NCT00239980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974078|NCT00240019|Furosemide|furosemide|mesh-list
64974079|NCT00240019|Diuretics|diuretics|mesh-ancestor
64974080|NCT00240019|Natriuretic Agents|natriuretic agents|mesh-ancestor
64974099|NCT00240058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64974100|NCT00240058|Adrenergic Agents|adrenergic agents|mesh-ancestor
64974101|NCT00240058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64974102|NCT00240058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974103|NCT00240058|Protective Agents|protective agents|mesh-ancestor
64974104|NCT00240058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64974105|NCT00240058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64974106|NCT00240058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64974108|NCT00240058|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64974109|NCT00240058|Vasodilator Agents|vasodilator agents|mesh-ancestor
64974110|NCT00240058|Gasotransmitters|gasotransmitters|mesh-ancestor
64974111|NCT00098553|Everolimus|everolimus|mesh-list
64974112|NCT00098553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974113|NCT00098553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64974114|NCT00098553|Immunologic Factors|immunologic factors|mesh-ancestor
64974115|NCT00098553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974116|NCT00240214|Sirolimus|sirolimus|mesh-list
64974117|NCT00240214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64974118|NCT00240214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64974119|NCT00240214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64974120|NCT00240214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974121|NCT00240214|Antifungal Agents|antifungal agents|mesh-ancestor
64974122|NCT00240214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64974123|NCT00240214|Immunologic Factors|immunologic factors|mesh-ancestor
64539213|NCT00641745|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64539214|NCT00641745|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64539215|NCT00641745|Adrenergic Agents|adrenergic agents|mesh-ancestor
64539216|NCT00641745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64539217|NCT00641745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64539218|NCT01799109|Magnesium Sulfate|magnesium sulfate|mesh-list
64539219|NCT01799109|Albuterol|albuterol|mesh-list
64539220|NCT01799109|Analgesics|analgesics|mesh-ancestor
64303961|NCT03563963|Lidocaine|lidocaine|mesh-list
64974124|NCT00240214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974125|NCT00240253|Pramlintide|pramlintide|mesh-list
64974126|NCT00240253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64974127|NCT00240253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974128|NCT00065936|Naltrexone|naltrexone|mesh-list
64974129|NCT00065936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64974130|NCT00065936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64513132|NCT03468478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64974131|NCT00065936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513133|NCT03468478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64513134|NCT03468478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64513135|NCT03468478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513136|NCT03468478|Antifungal Agents|antifungal agents|mesh-ancestor
64974156|NCT00240448|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64974157|NCT00240448|Telmisartan|telmisartan|mesh-list
64974158|NCT00240448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64979290|NCT00108576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979291|NCT00108576|Antimanic Agents|antimanic agents|mesh-ancestor
64979292|NCT00108576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64979293|NCT00108576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64979294|NCT00108576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64979295|NCT00075491|Fenretinide|fenretinide|mesh-list
64979330|NCT00075647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64979331|NCT00075647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64979332|NCT00075647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64979333|NCT00075647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979334|NCT00075647|Antifungal Agents|antifungal agents|mesh-ancestor
64979335|NCT00075647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64979336|NCT00075647|Immunologic Factors|immunologic factors|mesh-ancestor
64979365|NCT00278278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64979366|NCT00278278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64979367|NCT00278278|Tubulin Modulators|tubulin modulators|mesh-ancestor
64979368|NCT00278278|Antimitotic Agents|antimitotic agents|mesh-ancestor
64979369|NCT00278278|Mitosis Modulators|mitosis modulators|mesh-ancestor
64979370|NCT00278278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64979371|NCT00278278|Alkylating Agents|alkylating agents|mesh-ancestor
64979372|NCT00108771|Fentanyl|fentanyl|mesh-list
64979373|NCT00108771|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64979374|NCT00108771|Narcotics|narcotics|mesh-ancestor
64547113|NCT00241839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547114|NCT00241839|Gout Suppressants|gout suppressants|mesh-ancestor
64547115|NCT00241839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64547117|NCT00241839|Antioxidants|antioxidants|mesh-ancestor
64974159|NCT00240448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64974160|NCT00240448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64974161|NCT00240448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974162|NCT00240448|Diuretics|diuretics|mesh-ancestor
64974163|NCT00240448|Natriuretic Agents|natriuretic agents|mesh-ancestor
64974164|NCT00240448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974165|NCT00240448|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64974166|NCT00240448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64974167|NCT00098631|Lapatinib|lapatinib|mesh-list
64974168|NCT00098631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974169|NCT00098631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64974170|NCT00098631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974194|NCT00240760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64974195|NCT00240760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64513209|NCT03067181|Tubulin Modulators|tubulin modulators|mesh-ancestor
64513210|NCT03067181|Antimitotic Agents|antimitotic agents|mesh-ancestor
64513211|NCT03067181|Mitosis Modulators|mitosis modulators|mesh-ancestor
64513212|NCT03054792|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
64513213|NCT03054792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64513214|NCT03054792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513224|NCT03032172|Risdiplam|risdiplam|mesh-list
64513225|NCT03032172|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64513226|NCT03032172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64513227|NCT03032172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974197|NCT00240760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64974198|NCT00240760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974199|NCT00240760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974200|NCT00240760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64974201|NCT00240760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64974202|NCT00066092|Lenograstim|lenograstim|mesh-list
64974203|NCT00066092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64974204|NCT00066092|Immunologic Factors|immunologic factors|mesh-ancestor
64974205|NCT00066092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974206|NCT04720807|Letrozole|letrozole|mesh-list
64974207|NCT04720807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547213|NCT02536794|Ipilimumab|ipilimumab|mesh-list
64974208|NCT04720807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64974209|NCT04720807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64974210|NCT04720807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974241|NCT00240955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539221|NCT01799109|Sensory System Agents|sensory system agents|mesh-ancestor
64539222|NCT01799109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64539223|NCT01799109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539224|NCT01799109|Anesthetics|anesthetics|mesh-ancestor
64539225|NCT01799109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64539226|NCT01799109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64539227|NCT01799109|Anticonvulsants|anticonvulsants|mesh-ancestor
64539228|NCT01799109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64539229|NCT01799109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64539230|NCT01799109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539231|NCT01799109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64539232|NCT01799109|Tocolytic Agents|tocolytic agents|mesh-ancestor
64539233|NCT01799109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64539234|NCT01799109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64539235|NCT01799109|Autonomic Agents|autonomic agents|mesh-ancestor
64539236|NCT01799109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64539237|NCT01799109|Respiratory System Agents|respiratory system agents|mesh-ancestor
64539238|NCT01799109|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64539239|NCT01799109|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64539240|NCT01799109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64539241|NCT01799109|Adrenergic Agents|adrenergic agents|mesh-ancestor
64539242|NCT01799109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64539243|NCT00588159|Diphenhydramine|diphenhydramine|mesh-list
64539244|NCT00588159|Promethazine|promethazine|mesh-list
64539245|NCT00588159|Gabapentin|gabapentin|mesh-list
64539270|NCT00588159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64539271|NCT00588159|Antipruritics|antipruritics|mesh-ancestor
64539272|NCT00588159|Dermatologic Agents|dermatologic agents|mesh-ancestor
64539273|NCT01439347|Vincristine|vincristine|mesh-list
64539274|NCT01439347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64539275|NCT01439347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64539276|NCT01439347|Tubulin Modulators|tubulin modulators|mesh-ancestor
64539277|NCT01439347|Antimitotic Agents|antimitotic agents|mesh-ancestor
64539278|NCT01439347|Mitosis Modulators|mitosis modulators|mesh-ancestor
64539279|NCT01439347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539280|NCT00680823|Ropivacaine|ropivacaine|mesh-list
64539281|NCT00680823|Anesthetics, Local|anesthetics, local|mesh-ancestor
64539282|NCT00680823|Anesthetics|anesthetics|mesh-ancestor
64539333|NCT00589563|Abortifacient Agents|abortifacient agents|mesh-ancestor
64539334|NCT00589563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64539335|NCT00589563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64539336|NCT00589563|Antimetabolites|antimetabolites|mesh-ancestor
64539337|NCT00589563|Dermatologic Agents|dermatologic agents|mesh-ancestor
64539338|NCT00589563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539339|NCT00589563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64539340|NCT00589563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64539341|NCT00589563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64539342|NCT00589563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64539343|NCT00589563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64539344|NCT00589563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64539345|NCT00589563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64539346|NCT00589563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64539396|NCT00654147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539397|NCT00654147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539398|NCT00654147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64539399|NCT00654147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64539400|NCT00654147|Antiviral Agents|antiviral agents|mesh-ancestor
64539401|NCT00654147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64539402|NCT00654147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64539403|NCT00654147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64539462|NCT00656487|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
64539463|NCT00656487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64539464|NCT00656487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64539465|NCT00656487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539467|NCT00656487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64539468|NCT00656487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539469|NCT01438411|Cholic Acids|cholic acids|mesh-list
64539530|NCT01442155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64539531|NCT01442155|Antimetabolites|antimetabolites|mesh-ancestor
64539532|NCT01442155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547393|NCT03506113|Antitubercular Agents|antitubercular agents|mesh-ancestor
64547394|NCT04412850|Magnesium Sulfate|magnesium sulfate|mesh-list
64547395|NCT04412850|Analgesics|analgesics|mesh-ancestor
64547396|NCT04412850|Sensory System Agents|sensory system agents|mesh-ancestor
64547397|NCT04412850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547398|NCT04412850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547399|NCT04412850|Anesthetics|anesthetics|mesh-ancestor
64547400|NCT04412850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64547401|NCT04412850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64547402|NCT04412850|Anticonvulsants|anticonvulsants|mesh-ancestor
64547403|NCT04412850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64547404|NCT04412850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64547405|NCT04412850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547406|NCT04412850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64539533|NCT01442155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64539534|NCT01416181|Natalizumab|natalizumab|mesh-list
64539535|NCT01416181|Immunologic Factors|immunologic factors|mesh-ancestor
64539536|NCT01416181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539537|NCT03026023|Ribavirin|ribavirin|mesh-list
64539538|NCT03026023|Grazoprevir|grazoprevir|mesh-list
64539539|NCT03026023|Antimetabolites|antimetabolites|mesh-ancestor
64539540|NCT03026023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539546|NCT01419665|Rituximab|rituximab|mesh-list
64539592|NCT04069273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64539593|NCT01436149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64539594|NCT01436149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64539595|NCT01436149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539596|NCT01436149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64539597|NCT01436149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64539598|NCT01436149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64539599|NCT01436149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539600|NCT01436149|Dopamine Agents|dopamine agents|mesh-ancestor
64539601|NCT01436149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64539602|NCT04063267|Nicotine|nicotine|mesh-list
64539603|NCT04063267|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64539604|NCT04063267|Autonomic Agents|autonomic agents|mesh-ancestor
64539605|NCT04063267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64539606|NCT04063267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539607|NCT04063267|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64539608|NCT04063267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64539609|NCT04063267|Cholinergic Agents|cholinergic agents|mesh-ancestor
64539610|NCT04063267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979405|NCT00278824|Analgesics|analgesics|mesh-ancestor
64539611|NCT04063267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539612|NCT01415401|Timolol|timolol|mesh-list
64539613|NCT01415401|Brinzolamide|brinzolamide|mesh-list
64539614|NCT01415401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539615|NCT01415401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539616|NCT01415401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64539617|NCT01415401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64539618|NCT01415401|Adrenergic Agents|adrenergic agents|mesh-ancestor
64539619|NCT01415401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64539620|NCT01415401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539621|NCT01415401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64539622|NCT01415401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64539623|NCT01415401|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64539624|NCT04049851|Ivermectin|ivermectin|mesh-list
64539625|NCT04049851|Moxidectin|moxidectin|mesh-list
64539632|NCT01414855|Doxorubicin|doxorubicin|mesh-list
64539633|NCT01414855|Vincristine|vincristine|mesh-list
64547457|NCT03809325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64539634|NCT01414855|Obinutuzumab|obinutuzumab|mesh-list
64655161|NCT02245490|Tamsulosin|tamsulosin|mesh-list
64539635|NCT01414855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64539637|NCT01414855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539638|NCT01414855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64539639|NCT01414855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64539640|NCT01414855|Alkylating Agents|alkylating agents|mesh-ancestor
64539641|NCT01414855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539642|NCT01414855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64539643|NCT01414855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64539644|NCT01414855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64539645|NCT01414855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64539646|NCT01414855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64974242|NCT00241072|Valsartan|valsartan|mesh-list
64974243|NCT00241072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64974244|NCT00241072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64974245|NCT00241072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64974246|NCT00241072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974247|NCT00241111|Zoledronic Acid|zoledronic acid|mesh-list
64974248|NCT00241111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64547513|NCT04762147|Fentanyl|fentanyl|mesh-list
64547545|NCT04183062|Docetaxel|docetaxel|mesh-list
64513282|NCT02811510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513283|NCT02811510|Hormones|hormones|mesh-ancestor
64513284|NCT02811510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64513285|NCT02786264|Dexmedetomidine|dexmedetomidine|mesh-list
64513286|NCT02786264|Propofol|propofol|mesh-list
64974252|NCT00241150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64974253|NCT00241150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64974254|NCT00241150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974255|NCT00076869|Amphotericin B|amphotericin b|mesh-list
64974256|NCT00076869|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64974257|NCT00076869|Caspofungin|caspofungin|mesh-list
64974258|NCT00076869|Amebicides|amebicides|mesh-ancestor
64974259|NCT00076869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64974260|NCT00076869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64974261|NCT00076869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64974262|NCT00076869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64974263|NCT00076869|Antifungal Agents|antifungal agents|mesh-ancestor
64974264|NCT00076869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974265|NCT00076869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974266|NCT00066248|Cyproheptadine|cyproheptadine|mesh-list
64974267|NCT00066248|Megestrol|megestrol|mesh-list
64974268|NCT00066248|Megestrol Acetate|megestrol acetate|mesh-list
64974269|NCT00066248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64974270|NCT00066248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64974271|NCT00066248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64974272|NCT00066248|Contraceptive Agents|contraceptive agents|mesh-ancestor
64974273|NCT00066248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64974274|NCT00066248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974275|NCT00066248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64974276|NCT00066248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64974277|NCT00066248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64974278|NCT00066248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974279|NCT00066248|Appetite Stimulants|appetite stimulants|mesh-ancestor
64974280|NCT00066248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64539647|NCT01414855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539648|NCT01414855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64539649|NCT01414855|Glucocorticoids|glucocorticoids|mesh-ancestor
64539650|NCT01414855|Hormones|hormones|mesh-ancestor
64714148|NCT04736953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539651|NCT01414855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64539652|NCT01414855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64539653|NCT01414855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64539654|NCT01414855|Tubulin Modulators|tubulin modulators|mesh-ancestor
64539655|NCT01414855|Antimitotic Agents|antimitotic agents|mesh-ancestor
64539656|NCT01414855|Mitosis Modulators|mitosis modulators|mesh-ancestor
64539657|NCT01414855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64539659|NCT02074735|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64539660|NCT02074735|Lipotropic Agents|lipotropic agents|mesh-ancestor
64539661|NCT02074735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64539662|NCT02074735|Antimetabolites|antimetabolites|mesh-ancestor
64547607|NCT01594398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64547616|NCT00782379|Busulfan|busulfan|mesh-list
64304402|NCT05619848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64304403|NCT05619848|Anticonvulsants|anticonvulsants|mesh-ancestor
64974281|NCT00066248|Antipruritics|antipruritics|mesh-ancestor
64974282|NCT00066248|Dermatologic Agents|dermatologic agents|mesh-ancestor
64974283|NCT00066248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64974284|NCT00066248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64974285|NCT00066248|Histamine Antagonists|histamine antagonists|mesh-ancestor
64974286|NCT00066248|Histamine Agents|histamine agents|mesh-ancestor
64974287|NCT00066248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64974288|NCT00066248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974308|NCT00241189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64974309|NCT00241189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64974310|NCT00241189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64974311|NCT00241189|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64974312|NCT00241189|Antifungal Agents|antifungal agents|mesh-ancestor
64974313|NCT00066326|Imatinib Mesylate|imatinib mesylate|mesh-list
64513356|NCT02612311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64513357|NCT02612311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513358|NCT02612311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64513359|NCT02612311|Alkylating Agents|alkylating agents|mesh-ancestor
64513360|NCT02612311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513361|NCT02511028|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64513363|NCT02511028|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64513366|NCT02477826|Paclitaxel|paclitaxel|mesh-list
64974314|NCT00066326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974315|NCT00066326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64974316|NCT00066326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979514|NCT00279565|Sensory System Agents|sensory system agents|mesh-ancestor
64979515|NCT00279565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64979516|NCT00279565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64979517|NCT00279565|Antitussive Agents|antitussive agents|mesh-ancestor
64979518|NCT00279565|Respiratory System Agents|respiratory system agents|mesh-ancestor
64979519|NCT00075998|Interferons|interferons|mesh-list
64979520|NCT00075998|Interferon-gamma|interferon-gamma|mesh-list
64979521|NCT00075998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979522|NCT00075998|Antiviral Agents|antiviral agents|mesh-ancestor
64979523|NCT00075998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64979524|NCT00109161|Antibodies|antibodies|mesh-list
64979525|NCT00109161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64979526|NCT00109161|Daclizumab|daclizumab|mesh-list
64979527|NCT00109161|Immunologic Factors|immunologic factors|mesh-ancestor
64547634|NCT00782379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64547635|NCT00782379|Antitubercular Agents|antitubercular agents|mesh-ancestor
64547636|NCT00782379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64547637|NCT00782379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64547638|NCT04572828|Naproxen|naproxen|mesh-list
64547639|NCT04572828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64547640|NCT04572828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64547641|NCT04572828|Analgesics|analgesics|mesh-ancestor
64547642|NCT04572828|Sensory System Agents|sensory system agents|mesh-ancestor
64547643|NCT04572828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547644|NCT04572828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547645|NCT04572828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64547646|NCT04572828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64547647|NCT04572828|Gout Suppressants|gout suppressants|mesh-ancestor
64547648|NCT04572828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64974317|NCT00066326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974318|NCT00241345|Valganciclovir|valganciclovir|mesh-list
64974319|NCT00241345|Ganciclovir|ganciclovir|mesh-list
64974320|NCT00241345|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64974321|NCT00241345|Antiviral Agents|antiviral agents|mesh-ancestor
64974322|NCT00241345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64974323|NCT00241345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64974324|NCT00241345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974325|NCT00241345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974326|NCT00241423|Exenatide|exenatide|mesh-list
64539663|NCT02074735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539664|NCT02074735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64539665|NCT02074735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64539666|NCT02074735|Nootropic Agents|nootropic agents|mesh-ancestor
64539667|NCT01527110|Zanamivir|zanamivir|mesh-list
64539668|NCT01527110|Antiviral Agents|antiviral agents|mesh-ancestor
64539669|NCT01527110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64539670|NCT01527110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539671|NCT01527110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539672|NCT01441063|Zidovudine|zidovudine|mesh-list
64539673|NCT01441063|Valganciclovir|valganciclovir|mesh-list
64539674|NCT01441063|Antimetabolites|antimetabolites|mesh-ancestor
64539675|NCT01441063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974327|NCT00241423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64974328|NCT00241423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974329|NCT00241423|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64974330|NCT00241423|Incretins|incretins|mesh-ancestor
64974331|NCT00241423|Hormones|hormones|mesh-ancestor
64974332|NCT00241423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64974333|NCT00241501|Esomeprazole|esomeprazole|mesh-list
64974334|NCT00241501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64974335|NCT00241501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64974354|NCT00066443|Antimitotic Agents|antimitotic agents|mesh-ancestor
64974355|NCT00066443|Mitosis Modulators|mitosis modulators|mesh-ancestor
64974356|NCT00066443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655171|NCT04355936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64974357|NCT00066443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64979530|NCT00279760|Abatacept|abatacept|mesh-list
64974358|NCT00066443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64974359|NCT00066443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64974360|NCT00066443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974361|NCT00098982|Leucovorin|leucovorin|mesh-list
64974362|NCT00098982|Fluorouracil|fluorouracil|mesh-list
64974363|NCT00098982|Oxaliplatin|oxaliplatin|mesh-list
64974364|NCT00098982|Bortezomib|bortezomib|mesh-list
64974365|NCT00098982|Calcium|calcium|mesh-list
64974366|NCT00098982|Levoleucovorin|levoleucovorin|mesh-list
64513437|NCT01948505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64974367|NCT00098982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64513438|NCT01948505|Analgesics|analgesics|mesh-ancestor
64513439|NCT01948505|Sensory System Agents|sensory system agents|mesh-ancestor
64513440|NCT01948505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64513441|NCT01948505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513442|NCT01948505|Antipyretics|antipyretics|mesh-ancestor
64513443|NCT01916005|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64513444|NCT01916005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64513445|NCT01916005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513446|NCT01909453|Vemurafenib|vemurafenib|mesh-list
64513447|NCT01909453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513448|NCT01909453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64513449|NCT01909453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64513450|NCT01909453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513451|NCT01861106|Mycophenolic Acid|mycophenolic acid|mesh-list
64513452|NCT01861106|Cyclophosphamide|cyclophosphamide|mesh-list
64513453|NCT01861106|Busulfan|busulfan|mesh-list
64513454|NCT01861106|Fludarabine|fludarabine|mesh-list
64513455|NCT01861106|Fludarabine phosphate|fludarabine phosphate|mesh-list
64513456|NCT01861106|Tacrolimus|tacrolimus|mesh-list
64513468|NCT01861106|Antimetabolites|antimetabolites|mesh-ancestor
64974368|NCT00098982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974369|NCT00098982|Antimetabolites|antimetabolites|mesh-ancestor
64974370|NCT00098982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974371|NCT00098982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64974372|NCT00098982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974388|NCT00241618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539676|NCT01441063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64539677|NCT01441063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64539678|NCT01441063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539679|NCT01441063|Antiviral Agents|antiviral agents|mesh-ancestor
64539680|NCT01441063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64539681|NCT01441063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64539682|NCT01441063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64539683|NCT01436071|Fluticasone|fluticasone|mesh-list
64539684|NCT01436071|Xhance|xhance|mesh-list
64539685|NCT01436071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64539686|NCT01436071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64539687|NCT01436071|Autonomic Agents|autonomic agents|mesh-ancestor
64539688|NCT01436071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64539689|NCT01436071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539690|NCT01436071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64539691|NCT01436071|Respiratory System Agents|respiratory system agents|mesh-ancestor
64539692|NCT01436071|Dermatologic Agents|dermatologic agents|mesh-ancestor
64539693|NCT01436071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64304435|NCT04157036|Prednisolone phosphate|prednisolone phosphate|mesh-list
64974390|NCT00241618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974391|NCT00066482|Cyclophosphamide|cyclophosphamide|mesh-list
64974392|NCT00066482|Cisplatin|cisplatin|mesh-list
64974393|NCT00066482|Etoposide|etoposide|mesh-list
64974394|NCT00066482|Bleomycin|bleomycin|mesh-list
64547683|NCT00761085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974395|NCT00066482|Lenograstim|lenograstim|mesh-list
64974396|NCT00066482|Mesna|mesna|mesh-list
64974397|NCT00066482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64974398|NCT00066482|Immunologic Factors|immunologic factors|mesh-ancestor
64974399|NCT00066482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974400|NCT00066482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64974401|NCT00066482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64974402|NCT00066482|Alkylating Agents|alkylating agents|mesh-ancestor
64974403|NCT00066482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974404|NCT00066482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974405|NCT00066482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64974406|NCT00066482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64974410|NCT00066482|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64974411|NCT00066482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64974412|NCT00066482|Protective Agents|protective agents|mesh-ancestor
64974413|NCT00099060|Lapatinib|lapatinib|mesh-list
64974414|NCT00099060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974415|NCT00099060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64974416|NCT00099060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974417|NCT00099060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974418|NCT00066599|Voriconazole|voriconazole|mesh-list
64974419|NCT00066599|Antifungal Agents|antifungal agents|mesh-ancestor
64974420|NCT00066599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64974421|NCT00066599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64974422|NCT00066599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64974423|NCT00066599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974424|NCT00066599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974425|NCT00066599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64974426|NCT00066599|Hormone Antagonists|hormone antagonists|mesh-ancestor
64539695|NCT01514864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64539696|NCT01514864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64539697|NCT01514864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539698|NCT01514864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539699|NCT01514240|Mesalamine|mesalamine|mesh-list
64539700|NCT01514240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64974427|NCT00066599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64974428|NCT00066599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974429|NCT00066599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64974430|NCT00242008|Rotigotine|rotigotine|mesh-list
64974431|NCT00242008|Dopamine Agonists|dopamine agonists|mesh-ancestor
64974432|NCT00242008|Dopamine Agents|dopamine agents|mesh-ancestor
64974433|NCT00242008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64974434|NCT00242008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974457|NCT00242203|Docetaxel|docetaxel|mesh-list
64974458|NCT00242203|Trastuzumab|trastuzumab|mesh-list
64974459|NCT00242203|Epirubicin|epirubicin|mesh-list
64974460|NCT00242203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974461|NCT00242203|Tubulin Modulators|tubulin modulators|mesh-ancestor
64974462|NCT00242203|Antimitotic Agents|antimitotic agents|mesh-ancestor
64974463|NCT00242203|Mitosis Modulators|mitosis modulators|mesh-ancestor
64974464|NCT00242203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974465|NCT00242203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64974466|NCT00242203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64974467|NCT00242203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64974468|NCT00242203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64974469|NCT00242203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974470|NCT00242203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64974471|NCT00242203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974472|NCT00077025|Gefitinib|gefitinib|mesh-list
64974473|NCT00077025|Anastrozole|anastrozole|mesh-list
64979661|NCT00280618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974474|NCT00077025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974475|NCT00077025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64974476|NCT00077025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974477|NCT00077025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974478|NCT00077025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64974479|NCT00077025|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64974480|NCT00077025|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64974481|NCT00077025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64974482|NCT00077025|Hormone Antagonists|hormone antagonists|mesh-ancestor
64974505|NCT00066716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64974506|NCT00066716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64974507|NCT00066716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64974508|NCT00066716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974509|NCT00077103|Doxorubicin|doxorubicin|mesh-list
64974510|NCT00077103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64974511|NCT00077103|Fosbretabulin|fosbretabulin|mesh-list
64974512|NCT00077103|Combretastatin|combretastatin|mesh-list
64974513|NCT00077103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979714|NCT04730297|Sensory System Agents|sensory system agents|mesh-ancestor
64974514|NCT00077103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64974515|NCT00077103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64974516|NCT00077103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64974517|NCT00077103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974518|NCT00077103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974519|NCT00077103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64974520|NCT00077103|Tubulin Modulators|tubulin modulators|mesh-ancestor
64539701|NCT01514240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64539702|NCT01514240|Analgesics|analgesics|mesh-ancestor
64539703|NCT01514240|Sensory System Agents|sensory system agents|mesh-ancestor
64539704|NCT01514240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64539705|NCT01514240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539706|NCT01514240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64539707|NCT01514240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64539708|NCT01435759|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64539709|NCT01435759|Antidepressive Agents|antidepressive agents|mesh-list
64539710|NCT01435759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64539711|NCT01435759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64539712|NCT01435759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304457|NCT03547375|Apatinib|apatinib|mesh-list
64304458|NCT03547375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974544|NCT00066794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64974545|NCT00066794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64974546|NCT00066794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64974547|NCT00066794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64974548|NCT00242554|Zoledronic Acid|zoledronic acid|mesh-list
64974549|NCT00242554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64974550|NCT00242554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974551|NCT00242593|Rosiglitazone|rosiglitazone|mesh-list
64979831|NCT00109941|Analgesics, Opioid|analgesics, opioid|mesh-list
64974552|NCT00242593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64974553|NCT00242593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974554|NCT00242749|Gefitinib|gefitinib|mesh-list
64974555|NCT00242749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974556|NCT00242749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64974557|NCT00242749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974558|NCT00242749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974559|NCT00242788|Capecitabine|capecitabine|mesh-list
64974560|NCT00242788|Gefitinib|gefitinib|mesh-list
64974561|NCT00242788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64974562|NCT00242788|Antimetabolites|antimetabolites|mesh-ancestor
64974563|NCT00242788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974564|NCT00242788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974565|NCT00242788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64974566|NCT00242788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974571|NCT00066872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974572|NCT00066872|Interferon Inducers|interferon inducers|mesh-ancestor
64974573|NCT00242944|Atorvastatin|atorvastatin|mesh-list
64974574|NCT00242944|Pitavastatin|pitavastatin|mesh-list
64974575|NCT00242944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64979877|NCT00076544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974576|NCT00242944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64974605|NCT00066989|Antibodies|antibodies|mesh-list
64974606|NCT00066989|gamma-Globulins|gamma-globulins|mesh-list
64974607|NCT00066989|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64974608|NCT00066989|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64974609|NCT00066989|Immunologic Factors|immunologic factors|mesh-ancestor
64979974|NCT00281983|Busulfan|busulfan|mesh-list
64974610|NCT00066989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974611|NCT00243178|Clopidogrel|clopidogrel|mesh-list
64974612|NCT00243178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64974613|NCT00243178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64974614|NCT00243178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64974615|NCT00243178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64974616|NCT00243178|Purinergic Agents|purinergic agents|mesh-ancestor
64974617|NCT00243178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64974618|NCT00243178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539713|NCT01435759|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64539714|NCT01435759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64539715|NCT01435759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64539716|NCT01435759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539717|NCT01435759|Dopamine Agents|dopamine agents|mesh-ancestor
64539718|NCT01435759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64539719|NCT04061239|Cytarabine|cytarabine|mesh-list
64539721|NCT04061239|Daunorubicin|daunorubicin|mesh-list
64304471|NCT01353911|Antimetabolites|antimetabolites|mesh-ancestor
64304472|NCT01353911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974619|NCT00243178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974644|NCT00243724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974645|NCT00243724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974646|NCT00243880|Lovastatin|lovastatin|mesh-list
64974647|NCT00243880|L 647318|l 647318|mesh-list
64974648|NCT00243880|Dihydromevinolin|dihydromevinolin|mesh-list
64974649|NCT00243880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64974650|NCT00243880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64974651|NCT00243880|Antimetabolites|antimetabolites|mesh-ancestor
64974652|NCT00243880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974653|NCT00243880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64974654|NCT00243880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64974655|NCT00243880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974656|NCT00244075|Hormones|hormones|mesh-list
64974657|NCT00244075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64974658|NCT00244075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974659|NCT00244153|Dexamethasone|dexamethasone|mesh-list
64974660|NCT00244153|Morphine|morphine|mesh-list
64974661|NCT00244153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64974662|NCT00244153|Antiemetics|antiemetics|mesh-ancestor
64974663|NCT00244153|Autonomic Agents|autonomic agents|mesh-ancestor
64974664|NCT00244153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64974665|NCT00244153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974666|NCT00244153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64974667|NCT00244153|Glucocorticoids|glucocorticoids|mesh-ancestor
64974668|NCT00244153|Hormones|hormones|mesh-ancestor
64974682|NCT02967029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974683|NCT02967029|Analgesics|analgesics|mesh-ancestor
64974684|NCT02967029|Sensory System Agents|sensory system agents|mesh-ancestor
64974685|NCT02967029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64974686|NCT02967029|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64974687|NCT02967029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64974688|NCT02967029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64974689|NCT02967029|Adrenergic Agents|adrenergic agents|mesh-ancestor
64974690|NCT02967029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64974691|NCT02967029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974693|NCT00244192|Dermatologic Agents|dermatologic agents|mesh-ancestor
64974694|NCT00244192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64974695|NCT00244192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64974696|NCT00077181|Cytarabine|cytarabine|mesh-list
64974697|NCT00077181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64974698|NCT00077181|Antimetabolites|antimetabolites|mesh-ancestor
64974699|NCT00077181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974700|NCT00077181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974701|NCT00077181|Antiviral Agents|antiviral agents|mesh-ancestor
64974702|NCT00077181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64547842|NCT04702464|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64974703|NCT00077181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64974704|NCT00077181|Immunologic Factors|immunologic factors|mesh-ancestor
64974705|NCT00077181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539722|NCT04061239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64539723|NCT04061239|Antimetabolites|antimetabolites|mesh-ancestor
64539724|NCT04061239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539725|NCT04061239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64539726|NCT04061239|Antiviral Agents|antiviral agents|mesh-ancestor
64539727|NCT04061239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64539728|NCT04061239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64539729|NCT04061239|Immunologic Factors|immunologic factors|mesh-ancestor
64539730|NCT04061239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539731|NCT04061239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539732|NCT04061239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64539733|NCT04061239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64539734|NCT04061239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64974706|NCT00244309|Tamsulosin|tamsulosin|mesh-list
64974707|NCT00244309|Dutasteride|dutasteride|mesh-list
64974708|NCT00244309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64974709|NCT00244309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64980084|NCT00282724|Androgen Antagonists|androgen antagonists|mesh-ancestor
64974710|NCT00244309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64974711|NCT00244309|Adrenergic Agents|adrenergic agents|mesh-ancestor
64974712|NCT00244309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64974713|NCT00244309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974714|NCT00244309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974715|NCT00244309|Urological Agents|urological agents|mesh-ancestor
64974716|NCT00244309|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64974717|NCT00244309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64974718|NCT00244309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974719|NCT00244309|Hormone Antagonists|hormone antagonists|mesh-ancestor
64974720|NCT00244309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64974721|NCT00244348|Fluorouracil|fluorouracil|mesh-list
64974722|NCT00244348|Oxaliplatin|oxaliplatin|mesh-list
64974723|NCT00244348|Antimetabolites|antimetabolites|mesh-ancestor
64974724|NCT00244348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974725|NCT00244348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64974726|NCT00244348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974748|NCT00244426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64974749|NCT00244426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64974750|NCT00244426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974751|NCT00244426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64974752|NCT00244426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64974753|NCT00244426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974754|NCT00244426|Antipyretics|antipyretics|mesh-ancestor
64974755|NCT00398957|Naltrexone|naltrexone|mesh-list
64974756|NCT00398957|Hydromorphone|hydromorphone|mesh-list
64974757|NCT00398957|Narcotic Antagonists|narcotic antagonists|mesh-list
64974758|NCT00398957|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64974759|NCT00398957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974760|NCT00398957|Sensory System Agents|sensory system agents|mesh-ancestor
64974761|NCT00398957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64974762|NCT00398957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64974763|NCT00398957|Narcotics|narcotics|mesh-ancestor
64974764|NCT00398957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64974765|NCT00398957|Analgesics|analgesics|mesh-ancestor
64974766|NCT00099450|INS 50589|ins 50589|mesh-list
64974767|NCT00099450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64974768|NCT00099450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64547957|NCT05011812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64974769|NCT00099450|Purinergic Agents|purinergic agents|mesh-ancestor
64974770|NCT00099450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64974771|NCT00099450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974772|NCT00099450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974773|NCT00244504|Moxonidine|moxonidine|mesh-list
64539735|NCT01393405|Methotrexate|methotrexate|mesh-list
64539736|NCT01393405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64547995|NCT01462370|Acetaminophen|acetaminophen|mesh-list
64539737|NCT01393405|Abortifacient Agents|abortifacient agents|mesh-ancestor
64539738|NCT01393405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64539739|NCT01393405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539740|NCT01393405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64539741|NCT01393405|Antimetabolites|antimetabolites|mesh-ancestor
64539742|NCT01393405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539743|NCT01393405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64539744|NCT01393405|Dermatologic Agents|dermatologic agents|mesh-ancestor
64539745|NCT01393405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539746|NCT01393405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64539747|NCT01393405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64539748|NCT01393405|Immunologic Factors|immunologic factors|mesh-ancestor
64539749|NCT01393405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64539750|NCT01393405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64539751|NCT01419197|Trastuzumab|trastuzumab|mesh-list
64539752|NCT01419197|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64539753|NCT01419197|Maytansine|maytansine|mesh-list
64304494|NCT05575297|Antitubercular Agents|antitubercular agents|mesh-ancestor
64304495|NCT05575297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64974774|NCT00244504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64974775|NCT00099489|Interferons|interferons|mesh-list
64974776|NCT00099489|Interferon-beta|interferon-beta|mesh-list
64974777|NCT00099489|Interferon beta-1a|interferon beta-1a|mesh-list
64974778|NCT00099489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974779|NCT00099489|Antiviral Agents|antiviral agents|mesh-ancestor
64974780|NCT00099489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64974781|NCT00099489|Immunologic Factors|immunologic factors|mesh-ancestor
64974782|NCT00099489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974813|NCT00067301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64974814|NCT00067301|Antidepressive Agents|antidepressive agents|mesh-ancestor
64974815|NCT00067301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64974817|NCT00244972|Tipifarnib|tipifarnib|mesh-list
64974818|NCT00244972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974819|NCT00244972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64974820|NCT00244972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64548051|NCT01479374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64548060|NCT00087529|Rituximab|rituximab|mesh-list
64974821|NCT00244972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974822|NCT00245089|Dactinomycin|dactinomycin|mesh-list
64974823|NCT00245089|Cyclophosphamide|cyclophosphamide|mesh-list
64974824|NCT00245089|Vincristine|vincristine|mesh-list
64974825|NCT00245089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64974848|NCT00245206|Olanzapine|olanzapine|mesh-list
64974849|NCT00245206|Risperidone|risperidone|mesh-list
64974850|NCT00245206|Aripiprazole|aripiprazole|mesh-list
64974851|NCT00245206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64974852|NCT00245206|Serotonin Agents|serotonin agents|mesh-ancestor
64974853|NCT00245206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64974854|NCT00245206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974855|NCT00245206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974856|NCT00245206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64974857|NCT00245206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64974858|NCT00245206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64974859|NCT00245206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64974860|NCT00245206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64539754|NCT01419197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64539755|NCT01419197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64539756|NCT01419197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64539757|NCT01419197|Tubulin Modulators|tubulin modulators|mesh-ancestor
64539758|NCT01419197|Antimitotic Agents|antimitotic agents|mesh-ancestor
64539759|NCT01419197|Mitosis Modulators|mitosis modulators|mesh-ancestor
64539760|NCT01419197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539762|NCT01414075|Trace Elements|trace elements|mesh-ancestor
64539763|NCT01414075|Micronutrients|micronutrients|mesh-ancestor
64539764|NCT01414075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539765|NCT01513460|Glycopyrrolate|glycopyrrolate|mesh-list
64539766|NCT01513460|Tiotropium Bromide|tiotropium bromide|mesh-list
64539767|NCT01513460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64539768|NCT01513460|Autonomic Agents|autonomic agents|mesh-ancestor
64539769|NCT01513460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64539770|NCT01513460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539771|NCT01513460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64539772|NCT01513460|Respiratory System Agents|respiratory system agents|mesh-ancestor
64539773|NCT01513460|Parasympatholytics|parasympatholytics|mesh-ancestor
64539774|NCT01513460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64548087|NCT05743101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64548090|NCT05743101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539775|NCT01513460|Cholinergic Agents|cholinergic agents|mesh-ancestor
64304513|NCT05400889|Tofacitinib|tofacitinib|mesh-list
64974861|NCT00245206|Dopamine Agents|dopamine agents|mesh-ancestor
64974864|NCT00245206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64974865|NCT00245206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64974866|NCT00245206|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64974867|NCT00245206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64974868|NCT00245206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64974869|NCT00245206|Antidepressive Agents|antidepressive agents|mesh-ancestor
64974870|NCT00245206|Dopamine Agonists|dopamine agonists|mesh-ancestor
64548119|NCT01500434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64548120|NCT00087139|Epothilones|epothilones|mesh-list
64548121|NCT00087139|Epothilone B|epothilone b|mesh-list
64548122|NCT00087139|Tubulin Modulators|tubulin modulators|mesh-ancestor
64548123|NCT00087139|Antimitotic Agents|antimitotic agents|mesh-ancestor
64548124|NCT00087139|Mitosis Modulators|mitosis modulators|mesh-ancestor
64548125|NCT00087139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548126|NCT00087139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548128|NCT00794547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64974871|NCT00245206|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64974872|NCT00245206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64974873|NCT00245206|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64974874|NCT00245206|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64974875|NCT00245245|Factor VIII|factor viii|mesh-list
64974902|NCT00245401|Immunologic Factors|immunologic factors|mesh-ancestor
64974903|NCT00245401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313050|NCT02433795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980214|NCT00110448|Aspirin|aspirin|mesh-list
64980244|NCT00077129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64980245|NCT00077129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980246|NCT00077129|Tubulin Modulators|tubulin modulators|mesh-ancestor
64980247|NCT00077129|Antimitotic Agents|antimitotic agents|mesh-ancestor
64980248|NCT00077129|Mitosis Modulators|mitosis modulators|mesh-ancestor
64980249|NCT00077129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980250|NCT00284323|Adenosine|adenosine|mesh-list
64980251|NCT00284323|Analgesics|analgesics|mesh-ancestor
64548153|NCT00768261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548154|NCT00768261|Nootropic Agents|nootropic agents|mesh-ancestor
64548155|NCT00768261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64548156|NCT00768261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64548157|NCT00768261|Dopamine Agents|dopamine agents|mesh-ancestor
64548158|NCT00768261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64974904|NCT00245440|Azithromycin|azithromycin|mesh-list
64974905|NCT00245440|Telithromycin|telithromycin|mesh-list
64974906|NCT00245440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64974907|NCT00245440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64548195|NCT03837015|Estradiol|estradiol|mesh-list
64974908|NCT00400608|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64974909|NCT00400608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64974910|NCT00400608|Autonomic Agents|autonomic agents|mesh-ancestor
64974911|NCT00400608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64974912|NCT00400608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974913|NCT00400608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64539776|NCT01513460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64539777|NCT01513460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548245|NCT00787761|Cyclophosphamide|cyclophosphamide|mesh-list
64539778|NCT01513460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64539779|NCT01513460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64539780|NCT01418339|Aripiprazole|aripiprazole|mesh-list
64539781|NCT01418339|Antidepressive Agents|antidepressive agents|mesh-ancestor
64539782|NCT01418339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64539783|NCT01418339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64539784|NCT01418339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64539785|NCT01418339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64539786|NCT01418339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539787|NCT01418339|Dopamine Agonists|dopamine agonists|mesh-ancestor
64539788|NCT01418339|Dopamine Agents|dopamine agents|mesh-ancestor
64548373|NCT01677949|Etoposide|etoposide|mesh-list
64539789|NCT01418339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64539790|NCT01418339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304537|NCT05395117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64974914|NCT00400608|Respiratory System Agents|respiratory system agents|mesh-ancestor
64974915|NCT00400608|Glucocorticoids|glucocorticoids|mesh-ancestor
64974916|NCT00400608|Hormones|hormones|mesh-ancestor
64974917|NCT00400608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64974918|NCT00400608|Sympathomimetics|sympathomimetics|mesh-ancestor
64974919|NCT00245596|Sildenafil Citrate|sildenafil citrate|mesh-list
64548519|NCT00081289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548520|NCT00081289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64548521|NCT00081289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64548522|NCT00081289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64548523|NCT00081289|Antidotes|antidotes|mesh-ancestor
64548526|NCT00081289|Vitamins|vitamins|mesh-ancestor
64974920|NCT00245596|Vasodilator Agents|vasodilator agents|mesh-ancestor
64974921|NCT00245596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64974922|NCT00245596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64655282|NCT01614509|Glucocorticoids|glucocorticoids|mesh-ancestor
64974924|NCT00245596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974925|NCT00245596|Urological Agents|urological agents|mesh-ancestor
64974942|NCT00067457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64974943|NCT00067457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64974945|NCT00067457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64974946|NCT00067457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974947|NCT00067457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974948|NCT00102843|Folic Acid|folic acid|mesh-list
64974949|NCT00102843|Betaine|betaine|mesh-list
64974950|NCT00102843|Hematinics|hematinics|mesh-ancestor
64974951|NCT00102843|Vitamin B Complex|vitamin b complex|mesh-ancestor
64974953|NCT00102843|Micronutrients|micronutrients|mesh-ancestor
64974954|NCT00102843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974955|NCT00102843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64974956|NCT00102843|Lipotropic Agents|lipotropic agents|mesh-ancestor
64974957|NCT00102843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64974958|NCT00102843|Antimetabolites|antimetabolites|mesh-ancestor
64548813|NCT01678963|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64974959|NCT00102843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974960|NCT00102843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64974961|NCT00245791|Levofloxacin|levofloxacin|mesh-list
64974962|NCT00245791|Ofloxacin|ofloxacin|mesh-list
64980814|NCT00287794|Diazepam|diazepam|mesh-list
64974963|NCT00245791|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64974964|NCT00245791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64974965|NCT00245791|Renal Agents|renal agents|mesh-ancestor
64980867|NCT00111540|Exenatide|exenatide|mesh-list
64974966|NCT00245791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64974967|NCT00245791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64974968|NCT00245791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64974969|NCT00245791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974970|NCT00245791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974971|NCT00245791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974972|NCT00245791|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64539791|NCT01418339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64539792|NCT01418339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64539793|NCT01418339|Serotonin Agents|serotonin agents|mesh-ancestor
64539794|NCT01418339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64539795|NCT01418339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64539796|NCT01418339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64539797|NCT01418339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64539798|NCT01417481|Glycine|glycine|mesh-list
64539799|NCT01417481|Glycine Agents|glycine agents|mesh-ancestor
64539800|NCT01417481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64539801|NCT01417481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539802|NCT01417481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539803|NCT01392469|Imatinib Mesylate|imatinib mesylate|mesh-list
64539804|NCT01392469|Bosentan|bosentan|mesh-list
64974975|NCT00400647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64974976|NCT00400647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974977|NCT00400647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64974978|NCT00400647|Antitubercular Agents|antitubercular agents|mesh-ancestor
64974979|NCT00400647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64548983|NCT05222529|Bromides|bromides|mesh-list
64974980|NCT00400647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64974981|NCT00400647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974982|NCT00400647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974984|NCT00245908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64974995|NCT00400725|Glucocorticoids|glucocorticoids|mesh-ancestor
64974996|NCT00400725|Hormones|hormones|mesh-ancestor
64981078|NCT00290602|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64974997|NCT00400725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64974998|NCT00400725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974999|NCT00246064|Infliximab|infliximab|mesh-list
64549144|NCT00801801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549145|NCT00801801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64549146|NCT00801801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549147|NCT01499576|Acetic Acid|acetic acid|mesh-list
64975000|NCT00246064|Dermatologic Agents|dermatologic agents|mesh-ancestor
64975001|NCT00246064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64975002|NCT00246064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64975003|NCT00246103|Cyclophosphamide|cyclophosphamide|mesh-list
64975004|NCT00246103|Fluorouracil|fluorouracil|mesh-list
64975005|NCT00246103|Epirubicin|epirubicin|mesh-list
64975006|NCT00246103|Valproic Acid|valproic acid|mesh-list
64975007|NCT00246103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64975008|NCT00246103|Immunologic Factors|immunologic factors|mesh-ancestor
64975009|NCT00246103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975010|NCT00246103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64975011|NCT00246103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64975012|NCT00246103|Alkylating Agents|alkylating agents|mesh-ancestor
64975013|NCT00246103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975014|NCT00246103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975015|NCT00246103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64975016|NCT00246103|Antimetabolites|antimetabolites|mesh-ancestor
64975017|NCT00246103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64975018|NCT00246103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64975019|NCT00246103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64975020|NCT00246103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64975021|NCT00246103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975022|NCT00246103|Anticonvulsants|anticonvulsants|mesh-ancestor
64975023|NCT00246103|GABA Agents|gaba agents|mesh-ancestor
64975024|NCT00246103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64975026|NCT00246103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64539805|NCT01392469|Sildenafil Citrate|sildenafil citrate|mesh-list
64539806|NCT01392469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64539807|NCT01392469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64539808|NCT01392469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539809|NCT01392469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539810|NCT01392469|Vasodilator Agents|vasodilator agents|mesh-ancestor
64539811|NCT01392469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64539812|NCT01392469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64539813|NCT01392469|Urological Agents|urological agents|mesh-ancestor
64539814|NCT01392469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64539815|NCT01392469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64539817|NCT01435577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64539818|NCT01435577|Narcotics|narcotics|mesh-ancestor
64539819|NCT01435577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64539820|NCT01435577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539822|NCT01435577|Sensory System Agents|sensory system agents|mesh-ancestor
64539823|NCT01435577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64539824|NCT01435577|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64549539|NCT04283604|Dopamine Agents|dopamine agents|mesh-ancestor
64549540|NCT04283604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64549541|NCT00810303|Efavirenz|efavirenz|mesh-list
64549542|NCT00810303|Ezetimibe|ezetimibe|mesh-list
64549543|NCT00810303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64549544|NCT00810303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64549545|NCT00810303|Antimetabolites|antimetabolites|mesh-ancestor
64981963|NCT00299884|Atorvastatin|atorvastatin|mesh-list
64539825|NCT01435577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64539826|NCT01435577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64304566|NCT05573581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64975027|NCT00246103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64975028|NCT00246103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64975029|NCT00246142|Botulinum Toxins|botulinum toxins|mesh-list
64975030|NCT00246142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64975031|NCT00246142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64975032|NCT00246142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64975033|NCT00246142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64975034|NCT00246142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975035|NCT00246142|Cholinergic Agents|cholinergic agents|mesh-ancestor
64975036|NCT00246142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64975037|NCT00246142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975038|NCT00246142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64975039|NCT00246142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64975040|NCT00067535|Cocaine|cocaine|mesh-list
64975041|NCT00067535|Anesthetics, Local|anesthetics, local|mesh-ancestor
64975042|NCT00067535|Anesthetics|anesthetics|mesh-ancestor
64975043|NCT00067535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64975044|NCT00067535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975045|NCT00067535|Sensory System Agents|sensory system agents|mesh-ancestor
64975046|NCT00067535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64975071|NCT00102882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64549629|NCT00775671|Adrenergic Agents|adrenergic agents|mesh-ancestor
64975072|NCT00102882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975074|NCT00102882|Hormones|hormones|mesh-ancestor
64549646|NCT01459796|Gout Suppressants|gout suppressants|mesh-ancestor
64975075|NCT00102882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64975076|NCT00102882|Sympathomimetics|sympathomimetics|mesh-ancestor
64539827|NCT01435577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539828|NCT01435577|Adrenergic Agents|adrenergic agents|mesh-ancestor
64539829|NCT01435577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64539830|NCT04039087|Sildenafil Citrate|sildenafil citrate|mesh-list
64539831|NCT04039087|Vasodilator Agents|vasodilator agents|mesh-ancestor
64982153|NCT00086541|Interferon alfacon-1|interferon alfacon-1|mesh-list
64982155|NCT00086541|Antiviral Agents|antiviral agents|mesh-ancestor
64982274|NCT00301483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64549693|NCT04989660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64549694|NCT02970318|Rituximab|rituximab|mesh-list
64539832|NCT04039087|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64539833|NCT04039087|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64539834|NCT04039087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539835|NCT04039087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539836|NCT04039087|Urological Agents|urological agents|mesh-ancestor
64539837|NCT01411891|Chlorhexidine|chlorhexidine|mesh-list
64549731|NCT04663347|Antiemetics|antiemetics|mesh-ancestor
64982516|NCT00202189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64539838|NCT01411891|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64539839|NCT01411891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64304590|NCT02253901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64975077|NCT00246220|Methylphenidate|methylphenidate|mesh-list
64975078|NCT00246220|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64975079|NCT00246220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975080|NCT00246220|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64975081|NCT00246220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64975082|NCT00246220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64982732|NCT00087165|Prednisone|prednisone|mesh-list
64975083|NCT00246220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975084|NCT00246220|Dopamine Agents|dopamine agents|mesh-ancestor
64975085|NCT00246220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64975086|NCT00424801|Nicorandil|nicorandil|mesh-list
64975087|NCT00424801|Valsartan|valsartan|mesh-list
64975088|NCT00424801|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64975089|NCT00424801|Doxazosin|doxazosin|mesh-list
64975090|NCT00424801|Lercanidipine|lercanidipine|mesh-list
64975091|NCT00424801|Pindolol|pindolol|mesh-list
64975092|NCT00424801|Moxonidine|moxonidine|mesh-list
64975093|NCT00424801|Amiloride|amiloride|mesh-list
64975094|NCT00424801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64549850|NCT04110444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64975095|NCT00424801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64975112|NCT00424801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64975113|NCT00424801|Vasodilator Agents|vasodilator agents|mesh-ancestor
64983061|NCT00303784|Goserelin|goserelin|mesh-list
64975114|NCT00424801|Vitamin B Complex|vitamin b complex|mesh-ancestor
64975116|NCT00424801|Micronutrients|micronutrients|mesh-ancestor
64975117|NCT00424801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64975118|NCT00424801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64975119|NCT00424801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64975120|NCT00424801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64975121|NCT00424801|Serotonin Agents|serotonin agents|mesh-ancestor
64975122|NCT00246298|Epoetin Alfa|epoetin alfa|mesh-list
64975123|NCT00246298|Hematinics|hematinics|mesh-ancestor
64975124|NCT00246415|Memantine|memantine|mesh-list
64975125|NCT00246415|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64983257|NCT00304993|Niacin|niacin|mesh-list
64975126|NCT00246415|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64975127|NCT00246415|Dopamine Agents|dopamine agents|mesh-ancestor
64975128|NCT00246415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64975129|NCT00246415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975130|NCT00246415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975131|NCT00246415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64975132|NCT00246415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64975133|NCT00246532|Morphine|morphine|mesh-list
64975134|NCT00246532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64975135|NCT00246532|Narcotics|narcotics|mesh-ancestor
64975136|NCT00246532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64975137|NCT00246532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975138|NCT00246532|Analgesics|analgesics|mesh-ancestor
64975139|NCT00246532|Sensory System Agents|sensory system agents|mesh-ancestor
64975140|NCT00246532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64539841|NCT01416389|Lenograstim|lenograstim|mesh-list
64539842|NCT01416389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64539843|NCT01416389|Immunologic Factors|immunologic factors|mesh-ancestor
64539844|NCT01416389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539845|NCT04497155|Norepinephrine|norepinephrine|mesh-list
64539846|NCT04497155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64550138|NCT03379051|Venetoclax|venetoclax|mesh-list
64550158|NCT03340909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64550159|NCT03340909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550160|NCT05686915|Cobalt|cobalt|mesh-list
64983739|NCT00308269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983754|NCT00308425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983755|NCT00308425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64983756|NCT00308425|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64539847|NCT04497155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64539848|NCT04497155|Adrenergic Agents|adrenergic agents|mesh-ancestor
64539849|NCT04497155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64539850|NCT04497155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539851|NCT04497155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539852|NCT04497155|Sympathomimetics|sympathomimetics|mesh-ancestor
64539853|NCT04497155|Autonomic Agents|autonomic agents|mesh-ancestor
64539854|NCT04497155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64304602|NCT02253901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64655358|NCT01704521|Ribavirin|ribavirin|mesh-list
64975142|NCT00246610|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64975143|NCT00246610|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64975144|NCT00246610|Protease Inhibitors|protease inhibitors|mesh-ancestor
64975145|NCT00246610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975146|NCT00246610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975175|NCT00247078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975176|NCT00247117|Metformin|metformin|mesh-list
64975177|NCT00247117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64975178|NCT00247117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975179|NCT00099606|Dasatinib|dasatinib|mesh-list
64975180|NCT00099606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975181|NCT00099606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64975182|NCT00099606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975183|NCT00099606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975184|NCT00247507|Acetylcysteine|acetylcysteine|mesh-list
64975185|NCT00247507|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64975186|NCT00247507|Antiviral Agents|antiviral agents|mesh-ancestor
64975187|NCT00247507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64975188|NCT00247507|Expectorants|expectorants|mesh-ancestor
64975189|NCT00247507|Respiratory System Agents|respiratory system agents|mesh-ancestor
64975190|NCT00247507|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64975191|NCT00247507|Antioxidants|antioxidants|mesh-ancestor
64984063|NCT00088686|Capsaicin|capsaicin|mesh-list
64975192|NCT00247507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975193|NCT00247507|Protective Agents|protective agents|mesh-ancestor
64975211|NCT00099645|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64975212|NCT00099645|Hormone Antagonists|hormone antagonists|mesh-ancestor
64975213|NCT00099645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64975214|NCT00099645|Luteolytic Agents|luteolytic agents|mesh-ancestor
64975215|NCT00099645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64975216|NCT00099645|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64975218|NCT00247663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975219|NCT00247663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64975220|NCT00247663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64975221|NCT00247663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975222|NCT00247663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975223|NCT00247663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64975224|NCT00247663|Hormone Antagonists|hormone antagonists|mesh-ancestor
64975225|NCT00247663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64539855|NCT04497155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64539856|NCT01544348|Omalizumab|omalizumab|mesh-list
64506560|NCT02479620|Hormones|hormones|mesh-ancestor
64539857|NCT01544348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64539858|NCT01544348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64550495|NCT00856791|ON 01910|on 01910|mesh-list
64539859|NCT01544348|Respiratory System Agents|respiratory system agents|mesh-ancestor
64539860|NCT01416155|Natalizumab|natalizumab|mesh-list
64539861|NCT01416155|Immunologic Factors|immunologic factors|mesh-ancestor
64539862|NCT01416155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304618|NCT04940546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64975226|NCT00247663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975227|NCT00247702|Warfarin|warfarin|mesh-list
64975228|NCT00247702|Anticoagulants|anticoagulants|mesh-ancestor
64975229|NCT01349660|Bevacizumab|bevacizumab|mesh-list
64975230|NCT01349660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64975231|NCT01349660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975232|NCT01349660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64975233|NCT01349660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64975234|NCT01349660|Growth Substances|growth substances|mesh-ancestor
64975235|NCT01349660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975236|NCT01349660|Growth Inhibitors|growth inhibitors|mesh-ancestor
64975237|NCT00247741|Lidocaine|lidocaine|mesh-list
64975238|NCT00247741|Carticaine|carticaine|mesh-list
64975239|NCT00247741|Anesthetics, Local|anesthetics, local|mesh-ancestor
64975240|NCT00247741|Anesthetics|anesthetics|mesh-ancestor
64975241|NCT00247741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64975242|NCT00247741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975243|NCT00247741|Sensory System Agents|sensory system agents|mesh-ancestor
64975244|NCT00247741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64975245|NCT00247741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64975246|NCT00247741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64975247|NCT00247741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64975248|NCT00247741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64975271|NCT00248092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64975272|NCT00248092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550684|NCT02155257|Anticonvulsants|anticonvulsants|mesh-ancestor
64975273|NCT00248092|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64975274|NCT00248092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64975275|NCT00248092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64985287|NCT00122226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64975276|NCT00248092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975278|NCT00248092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64975279|NCT00248131|Octreotide|octreotide|mesh-list
64975280|NCT00248131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64975281|NCT00248131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64975282|NCT00248131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975283|NCT00248209|Bupropion|bupropion|mesh-list
64975284|NCT00248209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64985484|NCT00323323|Prednisone|prednisone|mesh-list
64975285|NCT00248209|Antidepressive Agents|antidepressive agents|mesh-ancestor
64975286|NCT00248209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64655402|NCT04359212|Heparin|heparin|mesh-list
64975287|NCT00248209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64975288|NCT00248209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64975289|NCT00248209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64975290|NCT00248209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975292|NCT00248209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64975293|NCT00248209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975294|NCT00248209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64975295|NCT00248209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64975296|NCT00248209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975297|NCT00248248|Doxorubicin|doxorubicin|mesh-list
64975326|NCT00103233|Antimitotic Agents|antimitotic agents|mesh-ancestor
64975327|NCT00103233|Mitosis Modulators|mitosis modulators|mesh-ancestor
64975328|NCT00103233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975329|NCT00248716|Ferrous gluconate|ferrous gluconate|mesh-list
64975330|NCT00248716|Hematinics|hematinics|mesh-ancestor
64975331|NCT00067925|Calcium|calcium|mesh-list
64539863|NCT01415921|Bromides|bromides|mesh-list
64539864|NCT01415921|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
64539865|NCT01415921|Anticonvulsants|anticonvulsants|mesh-ancestor
64539866|NCT01415921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64985920|NCT00313690|Bortezomib|bortezomib|mesh-list
64539867|NCT01415921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539868|NCT01415921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539869|NCT01415921|Cholinergic Agents|cholinergic agents|mesh-ancestor
64539870|NCT01415921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64539871|NCT01415921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539872|NCT01415531|Nebivolol|nebivolol|mesh-list
64539873|NCT01415531|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64304625|NCT03547219|Citalopram|citalopram|mesh-list
64975332|NCT00067925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64550787|NCT05246371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64975333|NCT00067925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975334|NCT00103272|Bortezomib|bortezomib|mesh-list
64975335|NCT00103272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975336|NCT00248989|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64975337|NCT00248989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64975338|NCT00248989|Immunologic Factors|immunologic factors|mesh-ancestor
64975339|NCT00248989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975341|NCT00249106|Immunologic Factors|immunologic factors|mesh-ancestor
64975342|NCT00249106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975343|NCT00068042|Octreotide|octreotide|mesh-list
64975344|NCT00068042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64975362|NCT00099801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64975363|NCT00099801|Immunologic Factors|immunologic factors|mesh-ancestor
64975364|NCT00099801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975365|NCT00414739|Benzalkonium Compounds|benzalkonium compounds|mesh-list
64975366|NCT00414739|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64975367|NCT00414739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64975369|NCT00068081|Antipruritics|antipruritics|mesh-ancestor
64975370|NCT00068081|Dermatologic Agents|dermatologic agents|mesh-ancestor
64986852|NCT02960035|Etanercept|etanercept|mesh-list
64975371|NCT00068081|Sensory System Agents|sensory system agents|mesh-ancestor
64975372|NCT00068081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64975373|NCT00068081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975374|NCT00249223|Risperidone|risperidone|mesh-list
64975375|NCT00249223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64975376|NCT00249223|Serotonin Agents|serotonin agents|mesh-ancestor
64986933|NCT00420082|Histamine Agents|histamine agents|mesh-ancestor
64655549|NCT01622543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655550|NCT01622543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64655551|NCT01622543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64655552|NCT01622543|Immunologic Factors|immunologic factors|mesh-ancestor
64655553|NCT01622543|Antidotes|antidotes|mesh-ancestor
64655554|NCT01622543|Protective Agents|protective agents|mesh-ancestor
64655555|NCT01622543|Vitamin B Complex|vitamin b complex|mesh-ancestor
64655556|NCT01622543|Vitamins|vitamins|mesh-ancestor
64655557|NCT01622543|Micronutrients|micronutrients|mesh-ancestor
64655558|NCT03032042|Azithromycin|azithromycin|mesh-list
64655559|NCT03032042|Albendazole|albendazole|mesh-list
64655560|NCT03032042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64655561|NCT03032042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64655562|NCT03032042|Anthelmintics|anthelmintics|mesh-ancestor
64655563|NCT03032042|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64655564|NCT03032042|Anticestodal Agents|anticestodal agents|mesh-ancestor
64655565|NCT03032042|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64655566|NCT03032042|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64655567|NCT03032042|Tubulin Modulators|tubulin modulators|mesh-ancestor
64975377|NCT00249223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64550942|NCT00867789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975378|NCT00249223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975379|NCT00249223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975380|NCT00249223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64550943|NCT00867789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550944|NCT00867789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64987333|NCT00084227|Atovaquone|atovaquone|mesh-list
64975381|NCT00249223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64975382|NCT00249223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64975383|NCT00249223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64975384|NCT00249223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64975385|NCT00249223|Dopamine Agents|dopamine agents|mesh-ancestor
64975386|NCT00099840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64975387|NCT00099840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64975388|NCT02967224|Insulin|insulin|mesh-list
64975389|NCT02967224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64975390|NCT02967224|Insulin Glargine|insulin glargine|mesh-list
64975391|NCT02967224|Insulin Detemir|insulin detemir|mesh-list
64975392|NCT02967224|Insulin, Isophane|insulin, isophane|mesh-list
64975393|NCT02967224|Isophane Insulin, Human|isophane insulin, human|mesh-list
64975394|NCT02967224|Isophane insulin, beef|isophane insulin, beef|mesh-list
64975395|NCT02967224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64975396|NCT02967224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987443|NCT00324688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64975397|NCT00099918|Vildagliptin|vildagliptin|mesh-list
64975398|NCT00099918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64975399|NCT00099918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975400|NCT00099918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64975418|NCT00249691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975420|NCT00249730|Vasodilator Agents|vasodilator agents|mesh-ancestor
64539874|NCT01415531|Vasodilator Agents|vasodilator agents|mesh-ancestor
64539875|NCT01415531|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64539876|NCT01415531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64539877|NCT01415531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64539878|NCT01415531|Adrenergic Agents|adrenergic agents|mesh-ancestor
64539879|NCT01415531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64539880|NCT01415531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539881|NCT01415531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539882|NCT01544114|Naproxen|naproxen|mesh-list
64539883|NCT01544114|Esomeprazole|esomeprazole|mesh-list
64539884|NCT01544114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64539885|NCT01544114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64539886|NCT01544114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64539887|NCT01544114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539888|NCT01544114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539889|NCT01544114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64539890|NCT01544114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64987504|NCT00325000|Serotonin Agents|serotonin agents|mesh-ancestor
64987505|NCT00325000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987506|NCT00325000|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64539891|NCT01544114|Analgesics|analgesics|mesh-ancestor
64987507|NCT00325000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64987508|NCT00325000|Analgesics|analgesics|mesh-ancestor
64304633|NCT03547219|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64304634|NCT03547219|Antidepressive Agents|antidepressive agents|mesh-ancestor
64975421|NCT00249730|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64987509|NCT00325000|Sensory System Agents|sensory system agents|mesh-ancestor
64987510|NCT00325000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64987511|NCT00325000|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64975422|NCT00249730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64975423|NCT00249730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987513|NCT00318448|Zolpidem|zolpidem|mesh-list
64975424|NCT00249730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975425|NCT00249730|Urological Agents|urological agents|mesh-ancestor
64975426|NCT00249847|Paroxetine|paroxetine|mesh-list
64975427|NCT00249847|Estrogens|estrogens|mesh-list
64975428|NCT00249847|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64975429|NCT00249847|Hormones|hormones|mesh-ancestor
64975430|NCT00249847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64975431|NCT00249847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975432|NCT00249847|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64987551|NCT00084695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64987553|NCT00084695|Glucocorticoids|glucocorticoids|mesh-ancestor
64975433|NCT00249847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64975434|NCT00249847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64975436|NCT00249847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64975437|NCT00249847|Serotonin Agents|serotonin agents|mesh-ancestor
64975438|NCT00249847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64975439|NCT00249847|Antidepressive Agents|antidepressive agents|mesh-ancestor
64975440|NCT00249847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64987746|NCT00093600|Antiviral Agents|antiviral agents|mesh-ancestor
64975441|NCT00249847|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64975442|NCT00249847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64975443|NCT00249847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975445|NCT00249886|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64975446|NCT00249886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64975447|NCT00249886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64655688|NCT02238977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975448|NCT00249886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975449|NCT00249886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64975450|NCT00249886|Serotonin Agents|serotonin agents|mesh-ancestor
64539893|NCT01544114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64539894|NCT01544114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988066|NCT00085826|Analgesics|analgesics|mesh-ancestor
64539895|NCT01544114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64539896|NCT01544114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64551149|NCT02084797|Tolvaptan|tolvaptan|mesh-list
64539897|NCT01544114|Gout Suppressants|gout suppressants|mesh-ancestor
64539898|NCT01544114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64539900|NCT01410799|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
64539901|NCT01410799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64539902|NCT01410799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539903|NCT01432171|Lacosamide|lacosamide|mesh-list
64539904|NCT01432171|Anticonvulsants|anticonvulsants|mesh-ancestor
64988425|NCT00086606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64539905|NCT01432171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64539906|NCT01432171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64539907|NCT01432171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64975451|NCT00249886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975452|NCT00249886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64975453|NCT00249886|Antidepressive Agents|antidepressive agents|mesh-ancestor
64975482|NCT00068315|Fludarabine phosphate|fludarabine phosphate|mesh-list
64975483|NCT00068315|Bortezomib|bortezomib|mesh-list
64975484|NCT00068315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64975485|NCT00068315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975486|NCT00068315|Immunologic Factors|immunologic factors|mesh-ancestor
64975487|NCT00068315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975488|NCT00068315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64975489|NCT00068315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64975490|NCT00068315|Antimetabolites|antimetabolites|mesh-ancestor
64975491|NCT00068315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975492|NCT00068315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64975493|NCT00250081|Botulinum Toxins|botulinum toxins|mesh-list
64975494|NCT00250081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64975495|NCT00250081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64975496|NCT00250081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975497|NCT00250081|Cholinergic Agents|cholinergic agents|mesh-ancestor
64975498|NCT00250081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64975499|NCT00250081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975500|NCT00250120|Camptothecin|camptothecin|mesh-list
64975501|NCT00250120|Rubitecan|rubitecan|mesh-list
64975529|NCT00068432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988703|NCT05181007|Valproic Acid|valproic acid|mesh-list
64975530|NCT00068432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64975531|NCT00068432|Immunologic Factors|immunologic factors|mesh-ancestor
64988793|NCT00330655|Memantine|memantine|mesh-list
64975532|NCT00068432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975533|NCT00068432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64975534|NCT00068432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64975535|NCT00068432|Analgesics|analgesics|mesh-ancestor
64975537|NCT00068432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64975538|NCT00068432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64975539|NCT00068432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64551431|NCT02854488|Ipilimumab|ipilimumab|mesh-list
64539908|NCT01432171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539910|NCT04046263|Hematinics|hematinics|mesh-ancestor
64539911|NCT01414205|Obinutuzumab|obinutuzumab|mesh-list
64539912|NCT01414205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64539913|NCT01414205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989113|NCT00332020|Enoxaparin|enoxaparin|mesh-list
64539914|NCT01413503|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64539915|NCT01413503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64539916|NCT01413503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539917|NCT01413503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975540|NCT00068432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64975541|NCT00068432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64975542|NCT00250237|Haloperidol|haloperidol|mesh-list
64975543|NCT00250237|Haloperidol decanoate|haloperidol decanoate|mesh-list
64975544|NCT00250237|Antiemetics|antiemetics|mesh-ancestor
64975545|NCT00250237|Autonomic Agents|autonomic agents|mesh-ancestor
64975546|NCT00250237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64975572|NCT00250315|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64975573|NCT00250315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64975574|NCT00250315|Adrenergic Agents|adrenergic agents|mesh-ancestor
64975575|NCT00250315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64975576|NCT00250315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975577|NCT00250315|Protective Agents|protective agents|mesh-ancestor
64975579|NCT00068471|Antifungal Agents|antifungal agents|mesh-ancestor
64975580|NCT00068471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64975581|NCT00250354|Risperidone|risperidone|mesh-list
64975582|NCT00250354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64975583|NCT00250354|Serotonin Agents|serotonin agents|mesh-ancestor
64975584|NCT00250354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64975585|NCT00250354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975588|NCT00250354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64316705|NCT03334682|Antimalarials|antimalarials|mesh-ancestor
64551721|NCT02013336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64551722|NCT02013336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64551723|NCT02013336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551724|NCT04397653|Ezetimibe|ezetimibe|mesh-list
64551725|NCT04397653|Evolocumab|evolocumab|mesh-list
64975589|NCT00250354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64975590|NCT00250354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64975591|NCT00250354|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64975592|NCT00250354|Dopamine Agents|dopamine agents|mesh-ancestor
64975593|NCT00250393|Istradefylline|istradefylline|mesh-list
64975608|NCT02966717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975609|NCT02966717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64975610|NCT00099996|Ezetimibe|ezetimibe|mesh-list
64975611|NCT00099996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64975613|NCT00099996|Antimetabolites|antimetabolites|mesh-ancestor
64975614|NCT00099996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975615|NCT00099996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64975616|NCT00250744|Gabapentin|gabapentin|mesh-list
64975617|NCT00250744|Aprepitant|aprepitant|mesh-list
64975618|NCT00250744|Fosaprepitant|fosaprepitant|mesh-list
64975619|NCT00250744|Analgesics|analgesics|mesh-ancestor
64975620|NCT00250744|Sensory System Agents|sensory system agents|mesh-ancestor
64975621|NCT00250744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64975622|NCT00250744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975623|NCT00250744|Anticonvulsants|anticonvulsants|mesh-ancestor
64975624|NCT00250744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64975625|NCT00250744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64551927|NCT04032119|Sympathomimetics|sympathomimetics|mesh-ancestor
64551928|NCT04032119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64551929|NCT03211455|Lidocaine|lidocaine|mesh-list
64975626|NCT00250744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64975627|NCT00250744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64975628|NCT00250744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64975629|NCT00250744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64975630|NCT00250744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64975631|NCT00250744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975632|NCT00250744|Antimanic Agents|antimanic agents|mesh-ancestor
64975633|NCT00250744|Antiemetics|antiemetics|mesh-ancestor
64539918|NCT01413503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64539919|NCT01413191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64990293|NCT05372354|Dexamethasone|dexamethasone|mesh-list
64539920|NCT01413191|Immunologic Factors|immunologic factors|mesh-ancestor
64539921|NCT01413191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539922|NCT05021562|Niraparib|niraparib|mesh-list
64539923|NCT05021562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64990499|NCT05209295|Azacitidine|azacitidine|mesh-list
64990500|NCT05209295|Cc-486|cc-486|mesh-list
64990501|NCT05209295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64990502|NCT05209295|Antimetabolites|antimetabolites|mesh-ancestor
64551994|NCT05314569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64539924|NCT05021562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539925|NCT05021562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539926|NCT05021562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64539927|NCT01412957|Panitumumab|panitumumab|mesh-list
64539928|NCT01412957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64539929|NCT01412957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64539930|NCT04973826|Aztreonam|aztreonam|mesh-list
64539931|NCT04973826|Avibactam|avibactam|mesh-list
64304691|NCT04433156|Hormones|hormones|mesh-ancestor
64975634|NCT00250744|Autonomic Agents|autonomic agents|mesh-ancestor
64975635|NCT00250744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64975636|NCT00250744|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64975637|NCT00103623|Abarelix|abarelix|mesh-list
64975638|NCT00103623|Hormone Antagonists|hormone antagonists|mesh-ancestor
64975639|NCT00103623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64975640|NCT00103623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975641|NCT00250861|Aldesleukin|aldesleukin|mesh-list
64975642|NCT00250861|Rituximab|rituximab|mesh-list
64975643|NCT00250861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64975644|NCT00250861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975645|NCT00250861|Immunologic Factors|immunologic factors|mesh-ancestor
64975646|NCT00250861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991044|NCT04759586|Glucocorticoids|glucocorticoids|mesh-ancestor
64975647|NCT00250861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64975648|NCT00250861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64975649|NCT00250861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64655941|NCT03016832|Irbesartan|irbesartan|mesh-list
64975652|NCT00068549|Gemcitabine|gemcitabine|mesh-list
64975653|NCT00068549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975664|NCT04720183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64975665|NCT04720183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64552153|NCT01494506|Vitamin B Complex|vitamin b complex|mesh-ancestor
64975666|NCT04720183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64975667|NCT04720183|Analgesics|analgesics|mesh-ancestor
64975668|NCT04720183|Sensory System Agents|sensory system agents|mesh-ancestor
64975669|NCT04720183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64991319|NCT04537715|Rifampin|rifampin|mesh-list
64975670|NCT04720183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975671|NCT04720183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64975672|NCT04720183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64975673|NCT04720183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64991500|NCT04363801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64991501|NCT04363801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991502|NCT04363801|Antimetabolites|antimetabolites|mesh-ancestor
64991503|NCT04363801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991504|NCT04363801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64991505|NCT04363801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991507|NCT04363801|Immunologic Factors|immunologic factors|mesh-ancestor
64975674|NCT00250978|Bevacizumab|bevacizumab|mesh-list
64975675|NCT00250978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64975676|NCT00250978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975677|NCT00250978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64975678|NCT00250978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64975679|NCT00250978|Growth Substances|growth substances|mesh-ancestor
64975680|NCT00250978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975681|NCT00250978|Growth Inhibitors|growth inhibitors|mesh-ancestor
64975682|NCT00068666|Temozolomide|temozolomide|mesh-list
64975683|NCT00068666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64975684|NCT00068666|Alkylating Agents|alkylating agents|mesh-ancestor
64975685|NCT00068666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975686|NCT00068666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975687|NCT00103701|Dasatinib|dasatinib|mesh-list
64991820|NCT04164069|Dasatinib|dasatinib|mesh-list
64991821|NCT04164069|Endothelial Growth Factors|endothelial growth factors|mesh-list
64991822|NCT04164069|Antibodies|antibodies|mesh-list
64991823|NCT04164069|Immunoglobulins|immunoglobulins|mesh-list
64539932|NCT04973826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64539933|NCT04973826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64539935|NCT04973826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539936|NCT04973826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539937|NCT05387616|Obinutuzumab|obinutuzumab|mesh-list
64539938|NCT05387616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64539939|NCT05387616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64539940|NCT03025841|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64539941|NCT03025841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64539942|NCT03025841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64991939|NCT04088604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64539943|NCT01432457|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64539944|NCT01432457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64714149|NCT03062605|Povidone-Iodine|povidone-iodine|mesh-list
64539945|NCT01432457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64539946|NCT01432457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64539947|NCT01432457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539948|NCT01432457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64539949|NCT01432457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539950|NCT01432457|Antidepressive Agents|antidepressive agents|mesh-ancestor
64539951|NCT01432457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64539952|NCT05062278|Hydroxyurea|hydroxyurea|mesh-list
64539953|NCT05062278|Vinblastine|vinblastine|mesh-list
64539954|NCT05062278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64539955|NCT05062278|Antisickling Agents|antisickling agents|mesh-ancestor
64975688|NCT00103701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975689|NCT00103701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64975690|NCT00103701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975693|NCT00251017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64975694|NCT00251017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64975695|NCT00251056|Mannitol|mannitol|mesh-list
64975696|NCT00251056|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64975697|NCT00251056|Diuretics|diuretics|mesh-ancestor
64975698|NCT00251056|Natriuretic Agents|natriuretic agents|mesh-ancestor
64975699|NCT00251056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975700|NCT00251095|Paclitaxel|paclitaxel|mesh-list
64975701|NCT00251095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64992267|NCT03914300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64992268|NCT03914300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975702|NCT00251095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975703|NCT00251095|Tubulin Modulators|tubulin modulators|mesh-ancestor
64975704|NCT00251095|Antimitotic Agents|antimitotic agents|mesh-ancestor
64975705|NCT00251095|Mitosis Modulators|mitosis modulators|mesh-ancestor
64975706|NCT00251095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975707|NCT00100074|Lobeline|lobeline|mesh-list
64975708|NCT00100074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64539956|NCT05062278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64539957|NCT05062278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539958|NCT05062278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64992558|NCT03606967|Carboplatin|carboplatin|mesh-list
64992585|NCT03606967|Laxatives|laxatives|mesh-ancestor
64539959|NCT05062278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64539960|NCT05062278|Tubulin Modulators|tubulin modulators|mesh-ancestor
64552500|NCT01383707|Vitamins|vitamins|mesh-ancestor
64539961|NCT05062278|Antimitotic Agents|antimitotic agents|mesh-ancestor
64539962|NCT05062278|Mitosis Modulators|mitosis modulators|mesh-ancestor
64992711|NCT03462719|Venetoclax|venetoclax|mesh-list
64992786|NCT03269669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64992787|NCT03269669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64992801|NCT03269669|Growth Substances|growth substances|mesh-ancestor
64975710|NCT00100074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64975711|NCT00100074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975712|NCT00100074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64993022|NCT02968810|Simvastatin|simvastatin|mesh-list
64975713|NCT00100074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64975714|NCT00100074|Cholinergic Agents|cholinergic agents|mesh-ancestor
64975715|NCT00100074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64975716|NCT00100074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993121|NCT02830724|Alkylating Agents|alkylating agents|mesh-ancestor
64552615|NCT03216759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552616|NCT04023071|Cyclophosphamide|cyclophosphamide|mesh-list
64552617|NCT04023071|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64552618|NCT04023071|Rituximab|rituximab|mesh-list
64975730|NCT00068744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64975732|NCT00100113|Vanoxerine|vanoxerine|mesh-list
64975733|NCT00100113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64317686|NCT02171533|Verapamil|verapamil|mesh-list
64975734|NCT00100113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64975735|NCT00100113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64975736|NCT00100113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975738|NCT00100113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64993440|NCT02327078|Nivolumab|nivolumab|mesh-list
64975739|NCT00100113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975740|NCT00068783|Imatinib Mesylate|imatinib mesylate|mesh-list
64552702|NCT03304717|Tenofovir|tenofovir|mesh-list
64975741|NCT00068783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975742|NCT00068783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64975743|NCT00068783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993683|NCT01946477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64975744|NCT00068783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975745|NCT00251368|9-aminocamptothecin|9-aminocamptothecin|mesh-list
64975746|NCT00251368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975747|NCT00103779|Dacetuzumab|dacetuzumab|mesh-list
64975748|NCT00103779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64975749|NCT00103779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975750|NCT00251407|Docetaxel|docetaxel|mesh-list
64975751|NCT00251407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656171|NCT01685411|Antioxidants|antioxidants|mesh-ancestor
64975752|NCT00251407|Tubulin Modulators|tubulin modulators|mesh-ancestor
64975753|NCT00251407|Antimitotic Agents|antimitotic agents|mesh-ancestor
64993757|NCT00567580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64993758|NCT00567580|Fertility Agents|fertility agents|mesh-ancestor
64552740|NCT01494350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64552741|NCT01494350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64552742|NCT01494350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64552743|NCT01494350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552744|NCT01494350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552745|NCT01494350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64552746|NCT01494350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64552747|NCT02135484|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64552748|NCT02135484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552749|NCT03258385|Vitamin B 12|vitamin b 12|mesh-list
64552750|NCT03258385|Hydroxocobalamin|hydroxocobalamin|mesh-list
64552751|NCT03258385|Vitamins|vitamins|mesh-ancestor
64975754|NCT00251407|Mitosis Modulators|mitosis modulators|mesh-ancestor
64975755|NCT00251407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975756|NCT02966522|Thalidomide|thalidomide|mesh-list
64975757|NCT02966522|Dexamethasone|dexamethasone|mesh-list
64975758|NCT02966522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64975759|NCT02966522|Antiemetics|antiemetics|mesh-ancestor
64975760|NCT02966522|Autonomic Agents|autonomic agents|mesh-ancestor
64975761|NCT02966522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64975762|NCT02966522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975763|NCT02966522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64975764|NCT02966522|Glucocorticoids|glucocorticoids|mesh-ancestor
64552753|NCT03258385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552754|NCT03258385|Vitamin B Complex|vitamin b complex|mesh-ancestor
64552755|NCT03258385|Hematinics|hematinics|mesh-ancestor
64552756|NCT03024515|Analgesics, Opioid|analgesics, opioid|mesh-list
64552757|NCT03024515|Narcotics|narcotics|mesh-ancestor
64552758|NCT03024515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64552759|NCT03024515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552760|NCT03024515|Analgesics|analgesics|mesh-ancestor
64552761|NCT03024515|Sensory System Agents|sensory system agents|mesh-ancestor
64552762|NCT03024515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64552763|NCT01834911|Tetrabenazine|tetrabenazine|mesh-list
64552764|NCT01834911|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64552765|NCT01834911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64552766|NCT01834911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64552767|NCT01834911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552768|NCT01834911|Adrenergic Agents|adrenergic agents|mesh-ancestor
64552769|NCT01834911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64552770|NCT01834911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552771|NCT04287829|Pembrolizumab|pembrolizumab|mesh-list
64552772|NCT04287829|Lenvatinib|lenvatinib|mesh-list
64552773|NCT04287829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64975766|NCT02966522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64975767|NCT02966522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64975768|NCT02966522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975769|NCT02966522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64975770|NCT02966522|Immunologic Factors|immunologic factors|mesh-ancestor
64975771|NCT02966522|Leprostatic Agents|leprostatic agents|mesh-ancestor
64975772|NCT02966522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64975773|NCT02966522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64975774|NCT02966522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64975775|NCT02966522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64975776|NCT02966522|Growth Substances|growth substances|mesh-ancestor
64975777|NCT02966522|Growth Inhibitors|growth inhibitors|mesh-ancestor
64975799|NCT00068861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64975800|NCT00068861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552774|NCT04287829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552775|NCT04287829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64552776|NCT04287829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552777|NCT04287829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552779|NCT03083821|Antiviral Agents|antiviral agents|mesh-ancestor
64301391|NCT02457507|Hematinics|hematinics|mesh-ancestor
64975801|NCT00068861|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64539964|NCT02823990|Interleukin-2|interleukin-2|mesh-list
64539965|NCT02823990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539966|NCT02823990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64539967|NCT02823990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64539968|NCT02823990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64539969|NCT02823990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539970|NCT02823990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64539971|NCT02823990|Analgesics|analgesics|mesh-ancestor
64539972|NCT02823990|Sensory System Agents|sensory system agents|mesh-ancestor
64539973|NCT02823990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64539974|NCT02427126|Aspirin|aspirin|mesh-list
64539975|NCT02427126|Apixaban|apixaban|mesh-list
64552780|NCT03083821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64552781|NCT05367869|Methylene Blue|methylene blue|mesh-list
64552782|NCT05367869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552783|NCT05367869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552784|NCT01720095|Niacin|niacin|mesh-list
64552785|NCT01720095|Nicotinic Acids|nicotinic acids|mesh-list
64552786|NCT01720095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64552787|NCT01720095|Antimetabolites|antimetabolites|mesh-ancestor
64552788|NCT01720095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552789|NCT01720095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64552790|NCT01720095|Vasodilator Agents|vasodilator agents|mesh-ancestor
64552791|NCT01720095|Vitamin B Complex|vitamin b complex|mesh-ancestor
64552792|NCT01720095|Vitamins|vitamins|mesh-ancestor
64552793|NCT01720095|Micronutrients|micronutrients|mesh-ancestor
64552794|NCT01720095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552795|NCT05366777|Acetaminophen|acetaminophen|mesh-list
64552796|NCT05366777|Ibuprofen|ibuprofen|mesh-list
64552797|NCT05366777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64552798|NCT05366777|Analgesics|analgesics|mesh-ancestor
64552799|NCT05366777|Sensory System Agents|sensory system agents|mesh-ancestor
64552800|NCT05366777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317836|NCT05695664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552801|NCT05366777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552802|NCT05366777|Antipyretics|antipyretics|mesh-ancestor
64539976|NCT02427126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64539977|NCT02427126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64539978|NCT02427126|Analgesics|analgesics|mesh-ancestor
64539979|NCT02427126|Sensory System Agents|sensory system agents|mesh-ancestor
64539980|NCT02427126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64539981|NCT02427126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64539982|NCT02427126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64552817|NCT04021043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552818|NCT04021043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64552819|NCT04021043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552820|NCT03836157|Bevacizumab|bevacizumab|mesh-list
64552821|NCT03836157|Maytansine|maytansine|mesh-list
64552822|NCT03836157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64552823|NCT03836157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552824|NCT03836157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64552825|NCT03836157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64552826|NCT03836157|Growth Substances|growth substances|mesh-ancestor
64552827|NCT03836157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552828|NCT03836157|Growth Inhibitors|growth inhibitors|mesh-ancestor
64552829|NCT03836157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64552830|NCT03836157|Tubulin Modulators|tubulin modulators|mesh-ancestor
64552831|NCT03836157|Antimitotic Agents|antimitotic agents|mesh-ancestor
64552832|NCT03836157|Mitosis Modulators|mitosis modulators|mesh-ancestor
64552833|NCT03836157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552834|NCT03080545|Calcitriol|calcitriol|mesh-list
64552835|NCT03080545|Betamethasone|betamethasone|mesh-list
64317887|NCT02412033|Oxytocics|oxytocics|mesh-ancestor
64539983|NCT02427126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64539984|NCT02427126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64539985|NCT02427126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64539986|NCT02427126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64539987|NCT02427126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64539988|NCT02427126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64539989|NCT02427126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552836|NCT03080545|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64552838|NCT03080545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64552839|NCT03080545|Glucocorticoids|glucocorticoids|mesh-ancestor
64552840|NCT03080545|Hormones|hormones|mesh-ancestor
64552841|NCT03080545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64552842|NCT03080545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552843|NCT03080545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64552844|NCT03080545|Respiratory System Agents|respiratory system agents|mesh-ancestor
64552845|NCT03080545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64552846|NCT03080545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64552847|NCT03080545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64552848|NCT03080545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552849|NCT03080545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64552850|NCT03080545|Vitamins|vitamins|mesh-ancestor
64552851|NCT03080545|Micronutrients|micronutrients|mesh-ancestor
64552852|NCT03080545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64552853|NCT03080545|Dermatologic Agents|dermatologic agents|mesh-ancestor
64552854|NCT03101124|Tranexamic Acid|tranexamic acid|mesh-list
64552855|NCT03101124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64975802|NCT00068861|Hormone Antagonists|hormone antagonists|mesh-ancestor
64975803|NCT00068861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64975804|NCT00068861|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64975805|NCT00068861|Fertility Agents|fertility agents|mesh-ancestor
64975806|NCT00068861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64975807|NCT00068861|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64975808|NCT00068861|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64975809|NCT00251602|Propranolol|propranolol|mesh-list
64975810|NCT00251602|Atropine|atropine|mesh-list
64975811|NCT00251602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64975812|NCT00251602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64552856|NCT03101124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64552857|NCT03101124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552858|NCT03101124|Hemostatics|hemostatics|mesh-ancestor
64552859|NCT03101124|Coagulants|coagulants|mesh-ancestor
64552860|NCT02985203|Vinorelbine|vinorelbine|mesh-list
64552861|NCT02985203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64552862|NCT02985203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552863|NCT02985203|Tubulin Modulators|tubulin modulators|mesh-ancestor
64552864|NCT02985203|Antimitotic Agents|antimitotic agents|mesh-ancestor
64552865|NCT02985203|Mitosis Modulators|mitosis modulators|mesh-ancestor
64552866|NCT02985203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552867|NCT04283617|Insulin|insulin|mesh-list
64552868|NCT04283617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64552869|NCT04283617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552871|NCT05247619|Bevacizumab|bevacizumab|mesh-list
64552872|NCT05247619|Carboplatin|carboplatin|mesh-list
64552873|NCT05247619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64552874|NCT05247619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552875|NCT05247619|Tubulin Modulators|tubulin modulators|mesh-ancestor
64552876|NCT05247619|Antimitotic Agents|antimitotic agents|mesh-ancestor
64552877|NCT05247619|Mitosis Modulators|mitosis modulators|mesh-ancestor
64552878|NCT05247619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552879|NCT05247619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64552880|NCT05247619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64552881|NCT05247619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64552882|NCT05247619|Growth Substances|growth substances|mesh-ancestor
64552883|NCT05247619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552886|NCT04018937|Melphalan|melphalan|mesh-list
64975813|NCT00251602|Adrenergic Agents|adrenergic agents|mesh-ancestor
64975814|NCT00251602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64975815|NCT00251602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975816|NCT00251602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975817|NCT00251602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64975818|NCT00251602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64975819|NCT00251602|Vasodilator Agents|vasodilator agents|mesh-ancestor
64552891|NCT04018937|Immunologic Factors|immunologic factors|mesh-ancestor
64552892|NCT04018937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552893|NCT04018937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64552894|NCT04018937|Alkylating Agents|alkylating agents|mesh-ancestor
64552895|NCT04018937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64552896|NCT04018937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64552897|NCT00805584|Desloratadine|desloratadine|mesh-list
64552898|NCT00805584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64552899|NCT00805584|Cholinergic Agents|cholinergic agents|mesh-ancestor
64552900|NCT00805584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64552901|NCT00805584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552902|NCT00805584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552903|NCT00805584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64552904|NCT00805584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64552905|NCT00805584|Histamine Antagonists|histamine antagonists|mesh-ancestor
64552906|NCT00805584|Histamine Agents|histamine agents|mesh-ancestor
64975820|NCT00251602|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64552907|NCT01833351|Vitamins|vitamins|mesh-list
64539990|NCT02427126|Antipyretics|antipyretics|mesh-ancestor
64539991|NCT02427126|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64539992|NCT02427126|Antithrombins|antithrombins|mesh-ancestor
64539993|NCT02427126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64539994|NCT02427126|Protease Inhibitors|protease inhibitors|mesh-ancestor
64539995|NCT02427126|Anticoagulants|anticoagulants|mesh-ancestor
64539996|NCT04807920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64539997|NCT04807920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64539998|NCT04807920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64539999|NCT04807920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64540000|NCT04807920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540001|NCT04807920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64540002|NCT04807920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64540003|NCT04807920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552908|NCT01833351|Ascorbic Acid|ascorbic acid|mesh-list
64552909|NCT01833351|Micronutrients|micronutrients|mesh-ancestor
64552910|NCT01833351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552911|NCT01833351|Antioxidants|antioxidants|mesh-ancestor
64552912|NCT01833351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552913|NCT01833351|Protective Agents|protective agents|mesh-ancestor
64552914|NCT03187405|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64552915|NCT03187405|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64552916|NCT03187405|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64552917|NCT03187405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552918|NCT05066958|Antiviral Agents|antiviral agents|mesh-list
64552919|NCT05066958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64540004|NCT04807920|Cholinergic Agents|cholinergic agents|mesh-ancestor
64540005|NCT04807920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64540006|NCT00658515|Dalcetrapib|dalcetrapib|mesh-list
64540007|NCT00658515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64540008|NCT00658515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64975821|NCT00251602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64975822|NCT00251602|Autonomic Agents|autonomic agents|mesh-ancestor
64975823|NCT00251602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64975824|NCT00251602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64975825|NCT00251602|Respiratory System Agents|respiratory system agents|mesh-ancestor
64975826|NCT00251602|Mydriatics|mydriatics|mesh-ancestor
64975827|NCT00251602|Parasympatholytics|parasympatholytics|mesh-ancestor
64975828|NCT00251602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64552920|NCT03049189|Everolimus|everolimus|mesh-list
64552921|NCT03049189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64552922|NCT03049189|Edotreotide|edotreotide|mesh-list
64552923|NCT03049189|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
64552924|NCT03049189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552925|NCT03049189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64552926|NCT03049189|Immunologic Factors|immunologic factors|mesh-ancestor
64552927|NCT03049189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552928|NCT03049189|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64552929|NCT03049189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552930|NCT00218543|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64552931|NCT00218543|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64552932|NCT00218543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64552933|NCT00218543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64552934|NCT00218543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552936|NCT00218543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64552937|NCT00218543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552938|NCT00795522|Desloratadine|desloratadine|mesh-list
64552939|NCT00795522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64552940|NCT00795522|Cholinergic Agents|cholinergic agents|mesh-ancestor
64975829|NCT00251602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64975831|NCT02961166|Immunoglobulins|immunoglobulins|mesh-list
64975859|NCT00251797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64552941|NCT00795522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64975860|NCT00251797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64975861|NCT00251797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975862|NCT00251797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975863|NCT00251797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975864|NCT00251797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64975865|NCT00251797|Immunologic Factors|immunologic factors|mesh-ancestor
64552942|NCT00795522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552943|NCT00795522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552944|NCT00795522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64552945|NCT00795522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64552946|NCT00795522|Histamine Antagonists|histamine antagonists|mesh-ancestor
64552947|NCT00795522|Histamine Agents|histamine agents|mesh-ancestor
64552948|NCT00910845|Botulinum Toxins|botulinum toxins|mesh-list
64552949|NCT00910845|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64552950|NCT00910845|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64317999|NCT02401269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552951|NCT00910845|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64552952|NCT00910845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64552953|NCT00910845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552954|NCT00910845|Cholinergic Agents|cholinergic agents|mesh-ancestor
64552955|NCT00910845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64552956|NCT00910845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552957|NCT00910845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64552958|NCT00910845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64552959|NCT05243251|Olanzapine|olanzapine|mesh-list
64552960|NCT05243251|Antiemetics|antiemetics|mesh-ancestor
64552961|NCT05243251|Autonomic Agents|autonomic agents|mesh-ancestor
64552962|NCT05243251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64552963|NCT05243251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552964|NCT05243251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64552965|NCT05243251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64552966|NCT05243251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64552967|NCT05243251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64552968|NCT05243251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64552969|NCT05243251|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64552970|NCT05243251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64552971|NCT05243251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64552972|NCT05243251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552973|NCT05243251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64552974|NCT05243251|Serotonin Agents|serotonin agents|mesh-ancestor
64552979|NCT05242705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552981|NCT00216671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64552982|NCT00216671|Serotonin Agents|serotonin agents|mesh-ancestor
64552983|NCT00216671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64552984|NCT00216671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552985|NCT00216671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552986|NCT00216671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64552987|NCT00216671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64552988|NCT00216671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64552989|NCT00216671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64552990|NCT00216671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64552991|NCT00216671|Dopamine Agents|dopamine agents|mesh-ancestor
64552992|NCT05245669|Denosumab|denosumab|mesh-list
64552993|NCT05245669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64552994|NCT05245669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975866|NCT00251797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975867|NCT00251797|Leprostatic Agents|leprostatic agents|mesh-ancestor
64975868|NCT00251797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64975869|NCT00251797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64975870|NCT00251797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64975871|NCT00251797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64975872|NCT00251797|Growth Substances|growth substances|mesh-ancestor
64975873|NCT00251797|Growth Inhibitors|growth inhibitors|mesh-ancestor
64552999|NCT00783354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64553000|NCT00783354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553001|NCT00783354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553002|NCT00783354|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64553003|NCT00783354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64553004|NCT00783354|Histamine Antagonists|histamine antagonists|mesh-ancestor
64553005|NCT00783354|Histamine Agents|histamine agents|mesh-ancestor
64553006|NCT00783354|Antipruritics|antipruritics|mesh-ancestor
64553007|NCT00783354|Dermatologic Agents|dermatologic agents|mesh-ancestor
64553008|NCT00783354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64553009|NCT01833663|Solifenacin Succinate|solifenacin succinate|mesh-list
64553010|NCT01833663|Estrogens|estrogens|mesh-list
64553011|NCT01833663|Hormones|hormones|mesh-ancestor
64553012|NCT01833663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64553013|NCT01833663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553014|NCT01833663|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64553015|NCT01833663|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64553016|NCT01833663|Cholinergic Agents|cholinergic agents|mesh-ancestor
64318065|NCT03169335|Growth Substances|growth substances|mesh-ancestor
64318069|NCT03106623|Mirabegron|mirabegron|mesh-list
64553017|NCT01833663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64553018|NCT01833663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553019|NCT01833663|Urological Agents|urological agents|mesh-ancestor
64553020|NCT01720875|Dexamethasone|dexamethasone|mesh-list
64553021|NCT01720875|Bortezomib|bortezomib|mesh-list
64553022|NCT01720875|Vorinostat|vorinostat|mesh-list
64553023|NCT01720875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64553024|NCT01720875|Antiemetics|antiemetics|mesh-ancestor
64553025|NCT01720875|Autonomic Agents|autonomic agents|mesh-ancestor
64553026|NCT01720875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64553027|NCT01720875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975874|NCT00251914|Esomeprazole|esomeprazole|mesh-list
64975875|NCT00251914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64975876|NCT00251914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64975877|NCT00251914|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64975878|NCT00251914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975879|NCT00251914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975880|NCT00100269|Antioxidants|antioxidants|mesh-list
64975906|NCT00251992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64975907|NCT00251992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64553031|NCT01720875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64553032|NCT01720875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64553033|NCT01720875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553034|NCT01720875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64553035|NCT01720875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553036|NCT01720875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553038|NCT04277143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64553039|NCT04277143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64553040|NCT00750750|Mometasone Furoate|mometasone furoate|mesh-list
64553041|NCT00750750|Amoxicillin|amoxicillin|mesh-list
64553042|NCT00750750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64553043|NCT00750750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64553044|NCT00750750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64553045|NCT00750750|Dermatologic Agents|dermatologic agents|mesh-ancestor
64553046|NCT00750750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64553047|NCT05066802|Folfirinox|folfirinox|mesh-list
64553048|NCT05066802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553049|NCT04379739|Apatinib|apatinib|mesh-list
64318100|NCT00100789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64318114|NCT02410863|Trametinib|trametinib|mesh-list
64975908|NCT00251992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540009|NCT00658515|Antimetabolites|antimetabolites|mesh-ancestor
64540010|NCT00658515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540011|NCT00658515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64540012|NCT04797312|Sufentanil|sufentanil|mesh-list
64540013|NCT04797312|Remifentanil|remifentanil|mesh-list
64540014|NCT04797312|Analgesics, Opioid|analgesics, opioid|mesh-list
64540015|NCT04797312|Anesthetics|anesthetics|mesh-ancestor
64540016|NCT04797312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64540017|NCT04797312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540018|NCT04797312|Narcotics|narcotics|mesh-ancestor
64540019|NCT04797312|Analgesics|analgesics|mesh-ancestor
64540020|NCT04797312|Sensory System Agents|sensory system agents|mesh-ancestor
64540021|NCT04797312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64553050|NCT04379739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553051|NCT04379739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64553052|NCT04379739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553053|NCT04379739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553054|NCT05066568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64553055|NCT05066568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64553056|NCT05066568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553057|NCT05248633|Dexamethasone|dexamethasone|mesh-list
64553058|NCT05248633|Lenalidomide|lenalidomide|mesh-list
64553059|NCT05248633|Bortezomib|bortezomib|mesh-list
64553060|NCT05248633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64553061|NCT05248633|Antiemetics|antiemetics|mesh-ancestor
64553062|NCT05248633|Autonomic Agents|autonomic agents|mesh-ancestor
64553063|NCT05248633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64553064|NCT05248633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553065|NCT05248633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64553066|NCT05248633|Glucocorticoids|glucocorticoids|mesh-ancestor
64553067|NCT05248633|Hormones|hormones|mesh-ancestor
64553068|NCT05248633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64553069|NCT05248633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64553070|NCT05248633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553071|NCT05248633|Immunologic Factors|immunologic factors|mesh-ancestor
64553072|NCT05248633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64553073|NCT05248633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64553074|NCT05248633|Growth Substances|growth substances|mesh-ancestor
64553075|NCT05248633|Growth Inhibitors|growth inhibitors|mesh-ancestor
64553076|NCT00216203|Pemetrexed|pemetrexed|mesh-list
64540022|NCT04797312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64540023|NCT04797312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64540024|NCT04797312|Anesthetics, General|anesthetics, general|mesh-ancestor
64540025|NCT05080140|Ezetimibe|ezetimibe|mesh-list
64540026|NCT05080140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64540027|NCT05080140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64540028|NCT05080140|Antimetabolites|antimetabolites|mesh-ancestor
64540029|NCT05080140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540030|NCT05080140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64540031|NCT01390441|Acetaminophen|acetaminophen|mesh-list
64540032|NCT01390441|Loratadine|loratadine|mesh-list
64540033|NCT01390441|Methylprednisolone|methylprednisolone|mesh-list
64540034|NCT01390441|Rituximab|rituximab|mesh-list
64540035|NCT01390441|Methotrexate|methotrexate|mesh-list
64553077|NCT00216203|Cetuximab|cetuximab|mesh-list
64553078|NCT00216203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553079|NCT00216203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553080|NCT00216203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553081|NCT00216203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64553082|NCT00216203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64553083|NCT00216203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64553084|NCT01727271|Interferons|interferons|mesh-list
64553085|NCT01727271|Tenofovir|tenofovir|mesh-list
64553086|NCT01727271|Interferon-alpha|interferon-alpha|mesh-list
64553087|NCT01727271|Interferon alpha-2|interferon alpha-2|mesh-list
64553088|NCT01727271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64553089|NCT01727271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553090|NCT01727271|Antiviral Agents|antiviral agents|mesh-ancestor
64553091|NCT01727271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64553092|NCT01727271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64301405|NCT03078374|Anticoagulants|anticoagulants|mesh-ancestor
64301406|NCT04944836|Clomiphene|clomiphene|mesh-list
64301407|NCT04944836|Enclomiphene|enclomiphene|mesh-list
64301408|NCT04944836|Zuclomiphene|zuclomiphene|mesh-list
64301409|NCT04944836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64540036|NCT01390441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64540037|NCT01390441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540038|NCT01390441|Immunologic Factors|immunologic factors|mesh-ancestor
64540039|NCT01390441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540040|NCT01390441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64975909|NCT00251992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975911|NCT00103935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64975912|NCT00103935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975913|NCT00103935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64975914|NCT00103935|Incretins|incretins|mesh-ancestor
64975915|NCT00103935|Hormones|hormones|mesh-ancestor
64975916|NCT00103935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64975917|NCT00399152|Sunitinib|sunitinib|mesh-list
64975918|NCT00399152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975919|NCT00399152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64553093|NCT01727271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64553094|NCT01727271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553095|NCT01727271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553096|NCT01727271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64553097|NCT01727271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64553098|NCT01727271|Immunologic Factors|immunologic factors|mesh-ancestor
64553099|NCT01727271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553100|NCT00653796|Atorvastatin|atorvastatin|mesh-list
64553101|NCT00653796|Ezetimibe|ezetimibe|mesh-list
64553102|NCT00653796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64553103|NCT00653796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64553104|NCT00653796|Antimetabolites|antimetabolites|mesh-ancestor
64553105|NCT00653796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553106|NCT00653796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64553107|NCT00653796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64553108|NCT00653796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553109|NCT01833819|Lidocaine|lidocaine|mesh-list
64553110|NCT01833819|Dexmedetomidine|dexmedetomidine|mesh-list
64553111|NCT01833819|Remifentanil|remifentanil|mesh-list
64553112|NCT01833819|Anesthetics, Local|anesthetics, local|mesh-ancestor
64975920|NCT00399152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64975921|NCT00399152|Growth Substances|growth substances|mesh-ancestor
64975922|NCT00399152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540041|NCT01390441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64540042|NCT01390441|Abortifacient Agents|abortifacient agents|mesh-ancestor
64540043|NCT01390441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64540044|NCT01390441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64540045|NCT01390441|Antimetabolites|antimetabolites|mesh-ancestor
64540046|NCT01390441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540047|NCT01390441|Dermatologic Agents|dermatologic agents|mesh-ancestor
64304817|NCT03063242|Sargramostim|sargramostim|mesh-list
64975923|NCT00399152|Growth Inhibitors|growth inhibitors|mesh-ancestor
64553132|NCT01833819|Narcotics|narcotics|mesh-ancestor
64553133|NCT05244109|Antibodies|antibodies|mesh-list
64553134|NCT05244109|Immunoglobulins|immunoglobulins|mesh-list
64553135|NCT05244109|Immunologic Factors|immunologic factors|mesh-ancestor
64553136|NCT05244109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553137|NCT00651144|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64553138|NCT00651144|Ezetimibe|ezetimibe|mesh-list
64553139|NCT00651144|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64553140|NCT00651144|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64553141|NCT00651144|Antimetabolites|antimetabolites|mesh-ancestor
64553142|NCT00651144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553143|NCT00651144|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64553144|NCT00651144|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64553145|NCT00651144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553146|NCT01721031|Tramadol|tramadol|mesh-list
64553147|NCT01721031|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64553148|NCT01721031|Narcotics|narcotics|mesh-ancestor
64553149|NCT01721031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64553150|NCT01721031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553151|NCT01721031|Analgesics|analgesics|mesh-ancestor
64318209|NCT02400801|Estrogens|estrogens|mesh-ancestor
64301415|NCT04944836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64975924|NCT00399152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64553152|NCT01721031|Sensory System Agents|sensory system agents|mesh-ancestor
64975925|NCT00399152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975926|NCT00399152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975927|NCT00104013|Xaliproden|xaliproden|mesh-list
64975928|NCT00104013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64975929|NCT00104013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64975952|NCT00252343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64553153|NCT01721031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64553154|NCT03218683|Venetoclax|venetoclax|mesh-list
64553155|NCT03218683|AZD5991|azd5991|mesh-list
64553156|NCT03218683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553157|NCT03182491|Anaphylatoxins|anaphylatoxins|mesh-list
64553158|NCT03182491|Immunologic Factors|immunologic factors|mesh-ancestor
64553159|NCT03182491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553160|NCT04378647|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64553161|NCT04378647|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64553162|NCT04378647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64553163|NCT04378647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553164|NCT04378647|Immunologic Factors|immunologic factors|mesh-ancestor
64553165|NCT04378647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553166|NCT00370890|Gemcitabine|gemcitabine|mesh-list
64553167|NCT00370890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553168|NCT00370890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64553169|NCT00370890|Antimetabolites|antimetabolites|mesh-ancestor
64553170|NCT00370890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975953|NCT00252343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975954|NCT00252343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975955|NCT00252421|Nitroglycerin|nitroglycerin|mesh-list
64975956|NCT00252421|Vasodilator Agents|vasodilator agents|mesh-ancestor
64975957|NCT00252655|Sirolimus|sirolimus|mesh-list
64975958|NCT00252655|Tacrolimus|tacrolimus|mesh-list
64975959|NCT00252655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64975961|NCT00252655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975962|NCT00252655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64975963|NCT00252655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975964|NCT00252655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975965|NCT00252655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64975966|NCT00252655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64975967|NCT00252655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64975968|NCT00252655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553171|NCT00370890|Antiviral Agents|antiviral agents|mesh-ancestor
64553172|NCT00370890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64553173|NCT00370890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553174|NCT00370890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64553175|NCT00370890|Immunologic Factors|immunologic factors|mesh-ancestor
64553176|NCT00370890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553177|NCT02669953|Aflibercept|aflibercept|mesh-list
64553178|NCT02669953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64553179|NCT02669953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64553180|NCT02669953|Growth Substances|growth substances|mesh-ancestor
64553181|NCT02669953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553182|NCT02669953|Growth Inhibitors|growth inhibitors|mesh-ancestor
64553183|NCT02669953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553184|NCT03216967|Everolimus|everolimus|mesh-list
64318244|NCT02400021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318245|NCT05677490|Calcium, Dietary|calcium, dietary|mesh-list
64553185|NCT03216967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553186|NCT03216967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64553187|NCT03216967|Immunologic Factors|immunologic factors|mesh-ancestor
64553188|NCT03216967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553189|NCT01721655|Spironolactone|spironolactone|mesh-list
64553190|NCT01721655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64553191|NCT01721655|Hormone Antagonists|hormone antagonists|mesh-ancestor
64553192|NCT01721655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64553193|NCT01721655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553194|NCT01721655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64553195|NCT01721655|Diuretics|diuretics|mesh-ancestor
64553196|NCT01721655|Natriuretic Agents|natriuretic agents|mesh-ancestor
64553197|NCT00904995|Voriconazole|voriconazole|mesh-list
64553198|NCT00904995|Antifungal Agents|antifungal agents|mesh-ancestor
64553199|NCT00904995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64553200|NCT00904995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64975969|NCT00252655|Antifungal Agents|antifungal agents|mesh-ancestor
64975970|NCT00252811|Gefitinib|gefitinib|mesh-list
64975971|NCT00252811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975972|NCT00252811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64975973|NCT00252811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975974|NCT00252811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975975|NCT00069251|Bupropion|bupropion|mesh-list
64975976|NCT00069251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64553228|NCT01834209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64553229|NCT01834209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553230|NCT01834209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64553231|NCT01834209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553232|NCT01834209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553233|NCT01834209|Hormone Antagonists|hormone antagonists|mesh-ancestor
64553234|NCT01834209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64553235|NCT05241535|Moxifloxacin|moxifloxacin|mesh-list
64553236|NCT05241535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64553237|NCT05241535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64553238|NCT05241535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64553239|NCT05241535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64553240|NCT05241535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553241|NCT05241535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553242|NCT05241535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553243|NCT02488135|Hemostatics|hemostatics|mesh-list
64553244|NCT02488135|Coagulants|coagulants|mesh-ancestor
64553245|NCT01727973|Doxycycline|doxycycline|mesh-list
64318303|NCT05531942|Analgesics|analgesics|mesh-ancestor
64553246|NCT01727973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64553247|NCT01727973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64553248|NCT01727973|Antimalarials|antimalarials|mesh-ancestor
64553249|NCT01727973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64553250|NCT01727973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64553252|NCT03100734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64553253|NCT03100734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64553254|NCT03100734|Analgesics|analgesics|mesh-ancestor
64975977|NCT00069251|Antidepressive Agents|antidepressive agents|mesh-ancestor
64975978|NCT00069251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64975979|NCT00069251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64975980|NCT00069251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64975981|NCT00069251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64976007|NCT00253123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976009|NCT00253123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64976010|NCT00253123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64553277|NCT01728051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553278|NCT01728051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553279|NCT01728051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64553280|NCT01728051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64553281|NCT01728051|Immunologic Factors|immunologic factors|mesh-ancestor
64553282|NCT01728051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553283|NCT01722201|Risperidone|risperidone|mesh-list
64318346|NCT05696678|Morphine|morphine|mesh-list
64553284|NCT01722201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64553285|NCT01722201|Serotonin Agents|serotonin agents|mesh-ancestor
64553286|NCT01722201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64553287|NCT01722201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553288|NCT01722201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553289|NCT01722201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64553290|NCT01722201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64553291|NCT01722201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64553292|NCT01722201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64553293|NCT01722201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64553294|NCT01722201|Dopamine Agents|dopamine agents|mesh-ancestor
64553295|NCT01722513|Alprostadil|alprostadil|mesh-list
64553296|NCT01722513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64553297|NCT01722513|Vasodilator Agents|vasodilator agents|mesh-ancestor
64553298|NCT01722513|Urological Agents|urological agents|mesh-ancestor
64553300|NCT03179995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64553301|NCT03179995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64553302|NCT03179995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553303|NCT01728441|Paclitaxel|paclitaxel|mesh-list
64553304|NCT01728441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64318365|NCT05450822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976011|NCT00253123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64976012|NCT00253123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64976013|NCT00253123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64976014|NCT00253123|Dopamine Agents|dopamine agents|mesh-ancestor
64976015|NCT00253162|Risperidone|risperidone|mesh-list
64976016|NCT00253162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64976017|NCT00253162|Serotonin Agents|serotonin agents|mesh-ancestor
64976018|NCT00253162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64553305|NCT01728441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64553306|NCT01728441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553307|NCT01728441|Tubulin Modulators|tubulin modulators|mesh-ancestor
64553308|NCT01728441|Antimitotic Agents|antimitotic agents|mesh-ancestor
64553309|NCT01728441|Mitosis Modulators|mitosis modulators|mesh-ancestor
64553310|NCT01728441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553312|NCT03099408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64553313|NCT03099408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64553314|NCT03099408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64553315|NCT03099408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64553320|NCT04984200|Mydriatics|mydriatics|mesh-list
64553321|NCT04984200|Autonomic Agents|autonomic agents|mesh-ancestor
64553322|NCT04984200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64553323|NCT04984200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318384|NCT02166229|Valproic Acid|valproic acid|mesh-list
64318385|NCT02166229|Anticonvulsants|anticonvulsants|mesh-ancestor
64976019|NCT00253162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976020|NCT00253162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976021|NCT00253162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64656333|NCT05388500|Paclitaxel|paclitaxel|mesh-list
64976023|NCT00253162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64976025|NCT00253162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64976026|NCT00253162|Dopamine Agents|dopamine agents|mesh-ancestor
64553324|NCT00912873|Ropivacaine|ropivacaine|mesh-list
64553325|NCT00912873|Anesthetics, Local|anesthetics, local|mesh-ancestor
64553326|NCT00912873|Anesthetics|anesthetics|mesh-ancestor
64553327|NCT00912873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64553328|NCT00912873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553329|NCT00912873|Sensory System Agents|sensory system agents|mesh-ancestor
64553330|NCT00912873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64553331|NCT01494038|Isoniazid|isoniazid|mesh-list
64553332|NCT01494038|Antitubercular Agents|antitubercular agents|mesh-ancestor
64553333|NCT01494038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64553334|NCT01494038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64553335|NCT01494038|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64553336|NCT01494038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64553337|NCT01494038|Antimetabolites|antimetabolites|mesh-ancestor
64553338|NCT01494038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553339|NCT01494038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64553340|NCT05059782|Coal Tar|coal tar|mesh-list
64553341|NCT05059782|Keratolytic Agents|keratolytic agents|mesh-ancestor
64540048|NCT01390441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540049|NCT01390441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64553375|NCT04412304|Anticoagulants|anticoagulants|mesh-ancestor
64540050|NCT01390441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64540051|NCT01390441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64540052|NCT01390441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64540053|NCT01390441|Analgesics|analgesics|mesh-ancestor
64540054|NCT01390441|Sensory System Agents|sensory system agents|mesh-ancestor
64540055|NCT01390441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64540056|NCT01390441|Antipyretics|antipyretics|mesh-ancestor
64540057|NCT01390441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64540058|NCT01390441|Antiemetics|antiemetics|mesh-ancestor
64540059|NCT01390441|Autonomic Agents|autonomic agents|mesh-ancestor
64304820|NCT03897062|Suvorexant|suvorexant|mesh-list
64976027|NCT00253201|Galantamine|galantamine|mesh-list
64976028|NCT00253201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64976049|NCT00253318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64976050|NCT00253318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64553376|NCT04412304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64553377|NCT04412304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64553378|NCT04412304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553379|NCT05063838|Anesthetics|anesthetics|mesh-list
64553380|NCT05063838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64553381|NCT05063838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553382|NCT00915603|Paclitaxel|paclitaxel|mesh-list
64553383|NCT00915603|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64553384|NCT00915603|Bevacizumab|bevacizumab|mesh-list
64553385|NCT00915603|Everolimus|everolimus|mesh-list
64553386|NCT00915603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64553387|NCT00915603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553388|NCT00915603|Tubulin Modulators|tubulin modulators|mesh-ancestor
64553389|NCT00915603|Antimitotic Agents|antimitotic agents|mesh-ancestor
64553390|NCT00915603|Mitosis Modulators|mitosis modulators|mesh-ancestor
64509551|NCT01734785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64318452|NCT02172391|Parasympatholytics|parasympatholytics|mesh-ancestor
64553392|NCT00915603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64553393|NCT00915603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64553394|NCT00915603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64553395|NCT00915603|Growth Substances|growth substances|mesh-ancestor
64553396|NCT00915603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553397|NCT00915603|Growth Inhibitors|growth inhibitors|mesh-ancestor
64553398|NCT00915603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64553399|NCT00915603|Immunologic Factors|immunologic factors|mesh-ancestor
64553400|NCT01929265|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64553401|NCT01929265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64553402|NCT01929265|Alkylating Agents|alkylating agents|mesh-ancestor
64553403|NCT01929265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976051|NCT00253318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976052|NCT00253318|Tubulin Modulators|tubulin modulators|mesh-ancestor
64976053|NCT00253318|Antimitotic Agents|antimitotic agents|mesh-ancestor
64976054|NCT00253318|Mitosis Modulators|mitosis modulators|mesh-ancestor
64976055|NCT00253318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976056|NCT00253318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64976057|NCT00253318|Immunologic Factors|immunologic factors|mesh-ancestor
64976058|NCT00100464|Paroxetine|paroxetine|mesh-list
64976059|NCT00100464|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64553434|NCT02398825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553435|NCT02398825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64553436|NCT02398825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553437|NCT02398825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553438|NCT01723059|Amoxicillin|amoxicillin|mesh-list
64553439|NCT01723059|Metronidazole|metronidazole|mesh-list
64553440|NCT01723059|Clarithromycin|clarithromycin|mesh-list
64553441|NCT01723059|Omeprazole|omeprazole|mesh-list
64553442|NCT01723059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64553443|NCT01723059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64553444|NCT01723059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64553445|NCT01723059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64553446|NCT01723059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64553447|NCT01723059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64553448|NCT01723059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64553449|NCT01723059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553450|NCT01723059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553451|NCT01723059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64553452|NCT01723059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64553453|NCT01723059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64553454|NCT04379271|Calcium|calcium|mesh-list
64976060|NCT00100464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64976061|NCT00100464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64976062|NCT00100464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976063|NCT00100464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64976064|NCT00100464|Serotonin Agents|serotonin agents|mesh-ancestor
64976065|NCT00100464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976066|NCT00100464|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64976067|NCT00100464|Antidepressive Agents|antidepressive agents|mesh-ancestor
64976068|NCT00100464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64553455|NCT04379271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64553456|NCT04379271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553457|NCT01728909|Oxytocin|oxytocin|mesh-list
64553458|NCT01728909|Oxytocics|oxytocics|mesh-ancestor
64553459|NCT01728909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64553460|NCT01728909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553461|NCT01922713|Vitamin A|vitamin a|mesh-list
64553462|NCT01922713|Beta Carotene|beta carotene|mesh-list
64553463|NCT01922713|Retinol palmitate|retinol palmitate|mesh-list
64553464|NCT01922713|Vitamins|vitamins|mesh-ancestor
64945405|NCT05663580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64509625|NCT02954055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64553465|NCT01922713|Micronutrients|micronutrients|mesh-ancestor
64553466|NCT01922713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553467|NCT01922713|Antioxidants|antioxidants|mesh-ancestor
64553468|NCT01922713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553469|NCT01922713|Protective Agents|protective agents|mesh-ancestor
64553470|NCT01922713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64553471|NCT01922713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553472|NCT01922713|Provitamins|provitamins|mesh-ancestor
64553473|NCT05061732|Amoxicillin|amoxicillin|mesh-list
64553474|NCT05061732|Metronidazole|metronidazole|mesh-list
64976069|NCT00100464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64976070|NCT00100464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64976071|NCT00100464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976072|NCT00253396|Heparin|heparin|mesh-list
64976073|NCT00253396|Enoxaparin|enoxaparin|mesh-list
64553498|NCT05061732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64976074|NCT00253396|Calcium heparin|calcium heparin|mesh-list
64976075|NCT00253396|Anticoagulants|anticoagulants|mesh-ancestor
64976076|NCT00253396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64976077|NCT00253396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64976078|NCT00253396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976079|NCT00253474|Interferons|interferons|mesh-list
64976080|NCT00253474|Interferon-alpha|interferon-alpha|mesh-list
64976081|NCT00253474|Interferon alpha-2|interferon alpha-2|mesh-list
64976082|NCT00253474|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64976083|NCT00253474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976097|NCT00253552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64976098|NCT00253552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64553499|NCT05061732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64553500|NCT05061732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64553501|NCT05061732|Antacids|antacids|mesh-ancestor
64553502|NCT05061732|Diuretics|diuretics|mesh-ancestor
64318568|NCT00101101|Prednisone|prednisone|mesh-list
64553503|NCT05061732|Natriuretic Agents|natriuretic agents|mesh-ancestor
64553504|NCT05061732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553505|NCT05061732|Expectorants|expectorants|mesh-ancestor
64553506|NCT05061732|Respiratory System Agents|respiratory system agents|mesh-ancestor
64553507|NCT02391571|Naltrexone|naltrexone|mesh-list
64553508|NCT02391571|Oxycodone|oxycodone|mesh-list
64553509|NCT02391571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64553510|NCT02391571|Narcotics|narcotics|mesh-ancestor
64553511|NCT02391571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64553512|NCT02391571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553513|NCT02391571|Analgesics|analgesics|mesh-ancestor
64553514|NCT02391571|Sensory System Agents|sensory system agents|mesh-ancestor
64553515|NCT02391571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64553516|NCT02391571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64553517|NCT02391571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64553518|NCT01728987|Cholecalciferol|cholecalciferol|mesh-list
64553519|NCT01728987|Vitamin D|vitamin d|mesh-list
64553520|NCT01728987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64976099|NCT00253552|Alkylating Agents|alkylating agents|mesh-ancestor
64976100|NCT00253552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976101|NCT00253552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976102|NCT00253552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64976103|NCT00253552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64976104|NCT00253552|Abortifacient Agents|abortifacient agents|mesh-ancestor
64976105|NCT00253552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64976106|NCT00253552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64553521|NCT01728987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553523|NCT01728987|Micronutrients|micronutrients|mesh-ancestor
64553524|NCT01728987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64553525|NCT01834989|Mitogens|mitogens|mesh-list
64553526|NCT01834989|Mitosis Modulators|mitosis modulators|mesh-ancestor
64553527|NCT01834989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553528|NCT01835067|Ranibizumab|ranibizumab|mesh-list
64553529|NCT01835067|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64553530|NCT01835067|Plasminogen|plasminogen|mesh-list
64553531|NCT01835067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64553532|NCT01835067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64553533|NCT01835067|Growth Substances|growth substances|mesh-ancestor
64540060|NCT01390441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64540062|NCT01390441|Hormones|hormones|mesh-ancestor
64540063|NCT01390441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64540064|NCT01390441|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64540065|NCT01390441|Protective Agents|protective agents|mesh-ancestor
64540066|NCT01390441|Antipruritics|antipruritics|mesh-ancestor
64540067|NCT01390441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64540068|NCT01390441|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64540069|NCT01390441|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64304831|NCT05048264|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64553534|NCT01835067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553535|NCT01835067|Growth Inhibitors|growth inhibitors|mesh-ancestor
64553536|NCT01835067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553537|NCT01835067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64553538|NCT01835067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64553539|NCT01835067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553541|NCT03100422|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64945406|NCT05663580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553542|NCT03100422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553543|NCT03100422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553544|NCT03100422|Cholinergic Agents|cholinergic agents|mesh-ancestor
64553545|NCT03100422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64553546|NCT03100422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553548|NCT00639769|Irinotecan|irinotecan|mesh-list
64553549|NCT00639769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553550|NCT00639769|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64553551|NCT00639769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64553552|NCT00639769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553553|NCT00639769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553554|NCT02553642|Nivolumab|nivolumab|mesh-list
64318614|NCT02172781|Parasympatholytics|parasympatholytics|mesh-ancestor
64318635|NCT05142085|Dermatologic Agents|dermatologic agents|mesh-ancestor
64553555|NCT02553642|Ipilimumab|ipilimumab|mesh-list
64553556|NCT02553642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64976107|NCT00253552|Antimetabolites|antimetabolites|mesh-ancestor
64553557|NCT02553642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976108|NCT00253552|Dermatologic Agents|dermatologic agents|mesh-ancestor
64976109|NCT00253552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976110|NCT00253552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64976111|NCT00253552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64976112|NCT00253552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64976113|NCT00253552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64976114|NCT00253552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64976115|NCT00253552|Antifungal Agents|antifungal agents|mesh-ancestor
64976116|NCT00253552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64656492|NCT02249585|Iodine|iodine|mesh-list
64976119|NCT00253591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976120|NCT00253591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64976121|NCT00253591|Tubulin Modulators|tubulin modulators|mesh-ancestor
64976122|NCT00253591|Antimitotic Agents|antimitotic agents|mesh-ancestor
64976123|NCT00253591|Mitosis Modulators|mitosis modulators|mesh-ancestor
64976124|NCT00253591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976125|NCT04719481|Pravastatin|pravastatin|mesh-list
64553558|NCT02553642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64553559|NCT02553642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553560|NCT01723371|Carvedilol|carvedilol|mesh-list
64553561|NCT01723371|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64553562|NCT01723371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64553563|NCT01723371|Adrenergic Agents|adrenergic agents|mesh-ancestor
64553564|NCT01723371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64553565|NCT01723371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553566|NCT01723371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553567|NCT01723371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64553568|NCT01723371|Antioxidants|antioxidants|mesh-ancestor
64553569|NCT01723371|Protective Agents|protective agents|mesh-ancestor
64553570|NCT01723371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64553598|NCT01723527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64553599|NCT01723527|Antitussive Agents|antitussive agents|mesh-ancestor
64553600|NCT01723527|Respiratory System Agents|respiratory system agents|mesh-ancestor
64553601|NCT00639223|Pravastatin|pravastatin|mesh-list
64553602|NCT00639223|Red yeast rice|red yeast rice|mesh-list
64553603|NCT00639223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64553604|NCT00639223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64553605|NCT00639223|Antimetabolites|antimetabolites|mesh-ancestor
64553606|NCT00639223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553607|NCT00639223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64553609|NCT00639223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976126|NCT04719481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64553630|NCT05056896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64976127|NCT04719481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64976128|NCT04719481|Antimetabolites|antimetabolites|mesh-ancestor
64976129|NCT04719481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976130|NCT04719481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64976131|NCT04719481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64976132|NCT04719481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976133|NCT00253903|SR 46349B|sr 46349b|mesh-list
64976134|NCT00253903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64976135|NCT00253903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64553631|NCT05056896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64553632|NCT05056896|Analgesics|analgesics|mesh-ancestor
64553633|NCT05056896|Sensory System Agents|sensory system agents|mesh-ancestor
64318703|NCT04154150|Ketamine|ketamine|mesh-list
64553634|NCT05056896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64553635|NCT05056896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553636|NCT05056896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64553637|NCT05056896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64553638|NCT05056896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64553639|NCT05056896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64553640|NCT05056896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553641|NCT05056896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64553642|NCT05056896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64553643|NCT05056896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553644|NCT05056896|Antipyretics|antipyretics|mesh-ancestor
64553645|NCT05056896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64553646|NCT05056896|Antifungal Agents|antifungal agents|mesh-ancestor
64553647|NCT05056896|Keratolytic Agents|keratolytic agents|mesh-ancestor
64553648|NCT05056896|Dermatologic Agents|dermatologic agents|mesh-ancestor
64553649|NCT00638989|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64553650|NCT00638989|Immunologic Factors|immunologic factors|mesh-ancestor
64976136|NCT00253903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976137|NCT00253903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64976138|NCT00253903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64976139|NCT00253903|Serotonin Agents|serotonin agents|mesh-ancestor
64976140|NCT00253903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64976141|NCT00253903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976142|NCT00104130|Desoxyepothilone B|desoxyepothilone b|mesh-list
64976143|NCT00104130|Tubulin Modulators|tubulin modulators|mesh-ancestor
64976144|NCT00104130|Antimitotic Agents|antimitotic agents|mesh-ancestor
64553651|NCT00638989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553652|NCT01835691|Vitamin D|vitamin d|mesh-list
64553653|NCT01835691|Ergocalciferols|ergocalciferols|mesh-list
64553654|NCT01835691|Cholecalciferol|cholecalciferol|mesh-list
64553655|NCT01835691|Vitamins|vitamins|mesh-list
64553656|NCT01835691|Micronutrients|micronutrients|mesh-ancestor
64553657|NCT01835691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553658|NCT01835691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64553659|NCT01835691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64553660|NCT01729767|Acyclovir|acyclovir|mesh-list
64553661|NCT01729767|Antiviral Agents|antiviral agents|mesh-ancestor
64553662|NCT01729767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64553663|NCT00913263|Flutamide|flutamide|mesh-list
64553664|NCT00913263|Hydroxyflutamide|hydroxyflutamide|mesh-list
64553665|NCT00913263|Androgen Antagonists|androgen antagonists|mesh-ancestor
64553666|NCT00913263|Hormone Antagonists|hormone antagonists|mesh-ancestor
64976145|NCT00104130|Mitosis Modulators|mitosis modulators|mesh-ancestor
64976171|NCT00104169|Epoetin Alfa|epoetin alfa|mesh-list
64976172|NCT00104169|Hematinics|hematinics|mesh-ancestor
64976173|NCT00415090|Nevirapine|nevirapine|mesh-list
64976174|NCT00415090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64976175|NCT00415090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64976176|NCT00415090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976177|NCT00415090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976178|NCT00415090|Antiviral Agents|antiviral agents|mesh-ancestor
64976179|NCT00415090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64976180|NCT00415090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64540070|NCT01390441|Histamine Antagonists|histamine antagonists|mesh-ancestor
64540071|NCT01390441|Histamine Agents|histamine agents|mesh-ancestor
64540072|NCT01390441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64540073|NCT03142542|Udenafil|udenafil|mesh-list
64540074|NCT03142542|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64540075|NCT03142542|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64540076|NCT03142542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553667|NCT00913263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64553668|NCT00913263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553669|NCT00913263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64553670|NCT00913263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553672|NCT04377867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64553673|NCT04377867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553674|NCT04377867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553675|NCT04377867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64553676|NCT04377867|Immunologic Factors|immunologic factors|mesh-ancestor
64553677|NCT04377867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553678|NCT04377867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64553679|NCT00637273|Pioglitazone|pioglitazone|mesh-list
64553680|NCT00637273|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64553682|NCT00637273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64553684|NCT00637273|Incretins|incretins|mesh-ancestor
64304843|NCT05048264|Autonomic Agents|autonomic agents|mesh-ancestor
64304847|NCT05048264|Glucocorticoids|glucocorticoids|mesh-ancestor
64976181|NCT00415090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64976182|NCT00415090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64976183|NCT00415090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64976184|NCT00254176|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
64976185|NCT00254176|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64976186|NCT00254176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64976187|NCT00254254|Exenatide|exenatide|mesh-list
64553707|NCT03098160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64553708|NCT03098160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553709|NCT03098160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64553710|NCT03098160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553711|NCT01720563|Leucovorin|leucovorin|mesh-list
64318773|NCT02173717|Anticoagulants|anticoagulants|mesh-ancestor
64553712|NCT01720563|Tegafur|tegafur|mesh-list
64553713|NCT01720563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553714|NCT01720563|Antidotes|antidotes|mesh-ancestor
64553715|NCT01720563|Protective Agents|protective agents|mesh-ancestor
64553716|NCT01720563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553717|NCT01720563|Vitamin B Complex|vitamin b complex|mesh-ancestor
64553718|NCT01720563|Vitamins|vitamins|mesh-ancestor
64553719|NCT01720563|Micronutrients|micronutrients|mesh-ancestor
64553720|NCT01720563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64553721|NCT01720563|Antimetabolites|antimetabolites|mesh-ancestor
64553722|NCT01720563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553723|NCT01724385|Bevacizumab|bevacizumab|mesh-list
64553724|NCT01724385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64553725|NCT01724385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553726|NCT01724385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64553727|NCT01724385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64553728|NCT01724385|Growth Substances|growth substances|mesh-ancestor
64553729|NCT01724385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553730|NCT01724385|Growth Inhibitors|growth inhibitors|mesh-ancestor
64976188|NCT00254254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64976189|NCT00254254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976190|NCT00254254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64976191|NCT00254254|Incretins|incretins|mesh-ancestor
64976192|NCT00254254|Hormones|hormones|mesh-ancestor
64976193|NCT00254254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64976194|NCT00254371|Androgens|androgens|mesh-list
64976212|NCT00254800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64976213|NCT00254800|Levonorgestrel|levonorgestrel|mesh-list
64976214|NCT00254800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64553731|NCT04377789|Quercetin|quercetin|mesh-list
64553732|NCT04377789|Antioxidants|antioxidants|mesh-ancestor
64553733|NCT04377789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553734|NCT04377789|Protective Agents|protective agents|mesh-ancestor
64553735|NCT04377789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553736|NCT00988117|Rivastigmine|rivastigmine|mesh-list
64553737|NCT00988117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64553738|NCT00988117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318814|NCT04067648|Sensory System Agents|sensory system agents|mesh-ancestor
64318820|NCT02173795|Fenoterol|fenoterol|mesh-list
64301422|NCT04940390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64976215|NCT00254800|Estradiol|estradiol|mesh-list
64976216|NCT00254800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64976217|NCT00254800|Estrogens|estrogens|mesh-ancestor
64976218|NCT00254800|Hormones|hormones|mesh-ancestor
64976219|NCT00254800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64976220|NCT00254800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976221|NCT00254800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64976222|NCT00254800|Contraceptive Agents|contraceptive agents|mesh-ancestor
64976223|NCT00254800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64976224|NCT00254800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64976225|NCT00254800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64976226|NCT00254800|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64976228|NCT00254800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64976229|NCT00254800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64976231|NCT00104403|Dexamethasone|dexamethasone|mesh-list
64976232|NCT00104403|Dexamethasone acetate|dexamethasone acetate|mesh-list
64976233|NCT00104403|Ondansetron|ondansetron|mesh-list
64553739|NCT00988117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553740|NCT00988117|Cholinergic Agents|cholinergic agents|mesh-ancestor
64553741|NCT00988117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64553742|NCT00988117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553743|NCT00988117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64553744|NCT00988117|Protective Agents|protective agents|mesh-ancestor
64553745|NCT01728753|Favipiravir|favipiravir|mesh-list
64553746|NCT01728753|Antiviral Agents|antiviral agents|mesh-ancestor
64553747|NCT01728753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64553748|NCT01724619|Dihydrotestosterone|dihydrotestosterone|mesh-list
64553749|NCT01724619|Androgens|androgens|mesh-ancestor
64553750|NCT01724619|Hormones|hormones|mesh-ancestor
64553751|NCT01724619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64553752|NCT01724619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553753|NCT05045508|Varenicline|varenicline|mesh-list
64553754|NCT05045508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64553755|NCT05045508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64553756|NCT05045508|Cholinergic Agents|cholinergic agents|mesh-ancestor
64553757|NCT05045508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64553758|NCT05045508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553759|NCT05045508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553760|NCT00637195|Vaccines|vaccines|mesh-list
64553761|NCT00637195|Immunologic Factors|immunologic factors|mesh-ancestor
64976234|NCT00104403|Casopitant|casopitant|mesh-list
64976235|NCT00104403|BB 1101|bb 1101|mesh-list
64976236|NCT00104403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64976237|NCT00104403|Antiemetics|antiemetics|mesh-ancestor
64976238|NCT00104403|Autonomic Agents|autonomic agents|mesh-ancestor
64976239|NCT00104403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64976240|NCT00104403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976241|NCT00104403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64976242|NCT00104403|Glucocorticoids|glucocorticoids|mesh-ancestor
64976243|NCT00104403|Hormones|hormones|mesh-ancestor
64976244|NCT00104403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64976245|NCT00104403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64976246|NCT00104403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553859|NCT01041807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64553860|NCT01041807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64553861|NCT01041807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553862|NCT01041807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64553863|NCT01041807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553864|NCT01041807|Vasodilator Agents|vasodilator agents|mesh-ancestor
64318931|NCT04305002|Hormones|hormones|mesh-ancestor
64553865|NCT01041807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64553866|NCT01041807|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64553867|NCT01041807|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64553868|NCT01724931|Aminopterin|aminopterin|mesh-list
64553869|NCT01724931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64553870|NCT01724931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553871|NCT01724931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553872|NCT00635089|Reslizumab|reslizumab|mesh-list
64553873|NCT00635089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64553878|NCT01725087|Tapentadol|tapentadol|mesh-list
64976247|NCT00104403|Protease Inhibitors|protease inhibitors|mesh-ancestor
64976248|NCT00104403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976249|NCT00104403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976250|NCT00104403|Antipruritics|antipruritics|mesh-ancestor
64976251|NCT00104403|Dermatologic Agents|dermatologic agents|mesh-ancestor
64976252|NCT00104403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64976253|NCT00104403|Serotonin Agents|serotonin agents|mesh-ancestor
64976273|NCT00254878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64976274|NCT00254917|Vaccines|vaccines|mesh-list
64656658|NCT04005716|Cisplatin|cisplatin|mesh-list
64540077|NCT03142542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540079|NCT03025867|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64540080|NCT03025867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553905|NCT04151082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553906|NCT04151082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64553907|NCT04151082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553908|NCT04151082|Antiemetics|antiemetics|mesh-ancestor
64553909|NCT04151082|Autonomic Agents|autonomic agents|mesh-ancestor
64553910|NCT04151082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64553911|NCT04151082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64553912|NCT04151082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64553913|NCT04151082|Protective Agents|protective agents|mesh-ancestor
64553914|NCT00634543|Acetaminophen|acetaminophen|mesh-list
64553915|NCT00634543|Gabapentin|gabapentin|mesh-list
64553916|NCT00634543|Tramadol|tramadol|mesh-list
64510080|NCT04391361|Mydriatics|mydriatics|mesh-ancestor
64553917|NCT00634543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64553918|NCT00634543|Analgesics|analgesics|mesh-ancestor
64553919|NCT00634543|Sensory System Agents|sensory system agents|mesh-ancestor
64553920|NCT00634543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64553921|NCT00634543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553922|NCT00634543|Antipyretics|antipyretics|mesh-ancestor
64553923|NCT00634543|Anticonvulsants|anticonvulsants|mesh-ancestor
64553924|NCT00634543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64553925|NCT00634543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64553926|NCT00634543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64553927|NCT00634543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64540081|NCT03025867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540082|NCT03025867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540083|NCT01412879|Leucovorin|leucovorin|mesh-list
64540084|NCT01412879|Cytarabine|cytarabine|mesh-list
64540085|NCT01412879|Dexamethasone|dexamethasone|mesh-list
64540086|NCT01412879|Cyclophosphamide|cyclophosphamide|mesh-list
64540087|NCT01412879|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64540088|NCT01412879|Rituximab|rituximab|mesh-list
64540089|NCT01412879|Doxorubicin|doxorubicin|mesh-list
64540090|NCT01412879|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64553928|NCT00634543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64553929|NCT00634543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64553930|NCT00634543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64553931|NCT00634543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553932|NCT00634543|Antimanic Agents|antimanic agents|mesh-ancestor
64553933|NCT00634543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64553934|NCT00634543|Narcotics|narcotics|mesh-ancestor
64553935|NCT05054322|Fluticasone|fluticasone|mesh-list
64553936|NCT05054322|Xhance|xhance|mesh-list
64553937|NCT05054322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64553939|NCT05054322|Autonomic Agents|autonomic agents|mesh-ancestor
64553940|NCT05054322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64553941|NCT05054322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553942|NCT05054322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64553943|NCT05054322|Respiratory System Agents|respiratory system agents|mesh-ancestor
64553944|NCT05054322|Dermatologic Agents|dermatologic agents|mesh-ancestor
64553945|NCT05054322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64553946|NCT00985465|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64553947|NCT00985465|Immunologic Factors|immunologic factors|mesh-ancestor
64553948|NCT00985465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553949|NCT03097380|Tiotropium Bromide|tiotropium bromide|mesh-list
64553950|NCT03097380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64553951|NCT03097380|Autonomic Agents|autonomic agents|mesh-ancestor
64540091|NCT01412879|Methotrexate|methotrexate|mesh-list
64540092|NCT01412879|Vincristine|vincristine|mesh-list
64540094|NCT01412879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64304853|NCT05048264|Protective Agents|protective agents|mesh-ancestor
64976276|NCT00254917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976277|NCT00254956|Ciclesonide|ciclesonide|mesh-list
64976278|NCT00254956|Glucocorticoids|glucocorticoids|mesh-ancestor
64976279|NCT00254956|Hormones|hormones|mesh-ancestor
64976280|NCT00254956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64976281|NCT00254956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976282|NCT00254956|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64976283|NCT00255073|Baclofen|baclofen|mesh-list
64976284|NCT00255073|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64976285|NCT00255073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656698|NCT01027910|Doxorubicin|doxorubicin|mesh-list
64976286|NCT00255073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64976287|NCT00255073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64976288|NCT00255073|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64553970|NCT05053386|Idarubicin|idarubicin|mesh-list
64553971|NCT05053386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64553972|NCT05053386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553973|NCT05053386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64553974|NCT05053386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64553975|NCT05053386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553976|NCT05053386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553977|NCT01725243|Carbetocin|carbetocin|mesh-list
64553978|NCT01725243|Oxytocics|oxytocics|mesh-ancestor
64553979|NCT01725243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64553980|NCT01725243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553981|NCT01725477|Methylene Blue|methylene blue|mesh-list
64553982|NCT01725477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553983|NCT01725477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553984|NCT03096990|Apremilast|apremilast|mesh-list
64553985|NCT03096990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64553986|NCT03096990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64553987|NCT03096990|Analgesics|analgesics|mesh-ancestor
64553988|NCT03096990|Sensory System Agents|sensory system agents|mesh-ancestor
64553989|NCT03096990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64319071|NCT04526288|Cytarabine|cytarabine|mesh-list
64714189|NCT02988050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64553990|NCT03096990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553992|NCT03096990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64553993|NCT03096990|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64553997|NCT01725555|Podophyllotoxin|podophyllotoxin|mesh-list
64976289|NCT00255073|GABA Agonists|gaba agonists|mesh-ancestor
64976290|NCT00255073|GABA Agents|gaba agents|mesh-ancestor
64976291|NCT00255073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64976292|NCT00255073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976293|NCT00069875|Gemcitabine|gemcitabine|mesh-list
64976294|NCT00069875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976295|NCT00069875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64976296|NCT00069875|Antimetabolites|antimetabolites|mesh-ancestor
64976297|NCT00069875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976298|NCT00069875|Antiviral Agents|antiviral agents|mesh-ancestor
64656762|NCT03425006|Pembrolizumab|pembrolizumab|mesh-list
64976299|NCT00069875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64976300|NCT00069875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976301|NCT00069875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64553999|NCT01725555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554000|NCT01725555|Keratolytic Agents|keratolytic agents|mesh-ancestor
64554001|NCT01725555|Dermatologic Agents|dermatologic agents|mesh-ancestor
64554002|NCT01725555|Tubulin Modulators|tubulin modulators|mesh-ancestor
64319095|NCT00109967|Sirolimus|sirolimus|mesh-list
64554003|NCT01725555|Antimitotic Agents|antimitotic agents|mesh-ancestor
64554004|NCT01725555|Mitosis Modulators|mitosis modulators|mesh-ancestor
64554005|NCT01725555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554006|NCT01048671|Raltegravir Potassium|raltegravir potassium|mesh-list
64554007|NCT01048671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64554008|NCT01048671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64554009|NCT01048671|Antiviral Agents|antiviral agents|mesh-ancestor
64554010|NCT01048671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64554011|NCT01048671|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64554012|NCT01048671|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64554013|NCT01048671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554014|NCT01048671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554015|NCT03836781|Chlorhexidine|chlorhexidine|mesh-list
64554016|NCT03836781|Ketorolac|ketorolac|mesh-list
64554017|NCT03836781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64554018|NCT03836781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64554019|NCT03836781|Disinfectants|disinfectants|mesh-ancestor
64554020|NCT03836781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64554021|NCT03836781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64554022|NCT03836781|Analgesics|analgesics|mesh-ancestor
64554023|NCT03836781|Sensory System Agents|sensory system agents|mesh-ancestor
64554024|NCT03836781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64554025|NCT03836781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554026|NCT03836781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64554027|NCT03836781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64554028|NCT03836781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64554029|NCT03836781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554030|NCT03836781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554031|NCT01360866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64554032|NCT01360866|Citalopram|citalopram|mesh-list
64554033|NCT01360866|Fluoxetine|fluoxetine|mesh-list
64554034|NCT01360866|Paroxetine|paroxetine|mesh-list
64554035|NCT01360866|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64554036|NCT01360866|Sertraline|sertraline|mesh-list
64976302|NCT00069875|Immunologic Factors|immunologic factors|mesh-ancestor
64976303|NCT00069875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976305|NCT00255268|Bicalutamide|bicalutamide|mesh-list
64976306|NCT00255268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64976307|NCT00255268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976341|NCT00255463|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64976342|NCT00255463|Hormone Antagonists|hormone antagonists|mesh-ancestor
64976343|NCT00255463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64976344|NCT00255463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976345|NCT00255502|Metoprolol|metoprolol|mesh-list
64976346|NCT00255502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64976347|NCT00255502|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64540095|NCT01412879|Immunologic Factors|immunologic factors|mesh-ancestor
64540096|NCT01412879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540097|NCT01412879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64540098|NCT01412879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64656810|NCT01004354|Ergocalciferols|ergocalciferols|mesh-list
64554149|NCT00983515|Tubulin Modulators|tubulin modulators|mesh-ancestor
64554150|NCT00983515|Antimitotic Agents|antimitotic agents|mesh-ancestor
64554151|NCT00983515|Mitosis Modulators|mitosis modulators|mesh-ancestor
64554152|NCT00983515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554153|NCT05033574|Hormones|hormones|mesh-list
64554154|NCT05033574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64554155|NCT05033574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554156|NCT04471818|Ketamine|ketamine|mesh-list
64554157|NCT04471818|Analgesics|analgesics|mesh-ancestor
64554158|NCT04471818|Sensory System Agents|sensory system agents|mesh-ancestor
64554159|NCT04471818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64554160|NCT04471818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554161|NCT04471818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64554162|NCT04471818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64554163|NCT04471818|Anesthetics, General|anesthetics, general|mesh-ancestor
64554164|NCT04471818|Anesthetics|anesthetics|mesh-ancestor
64554165|NCT04471818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64319258|NCT02576678|Apremilast|apremilast|mesh-list
64554166|NCT04471818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64554167|NCT04471818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64554168|NCT04471818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64554169|NCT04471818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554170|NCT05050188|Lansoprazole|lansoprazole|mesh-list
64554171|NCT05050188|Dexlansoprazole|dexlansoprazole|mesh-list
64554172|NCT05050188|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64554175|NCT05050188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540100|NCT01412879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540101|NCT01412879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540102|NCT01412879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64554193|NCT00981799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64540103|NCT01412879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64304864|NCT05046314|Antimitotic Agents|antimitotic agents|mesh-ancestor
64976376|NCT00070148|Oxandrolone|oxandrolone|mesh-list
64976377|NCT00070148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64976378|NCT00070148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64976379|NCT00070148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64976380|NCT00070148|Contraceptive Agents|contraceptive agents|mesh-ancestor
64976381|NCT00070148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64976382|NCT00070148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976383|NCT00070148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64976384|NCT00070148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64976385|NCT00070148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64554194|NCT00981799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64554195|NCT00981799|Alkylating Agents|alkylating agents|mesh-ancestor
64554196|NCT00981799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554197|NCT00981799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554198|NCT00981799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64554199|NCT00981799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64554200|NCT00981799|Abortifacient Agents|abortifacient agents|mesh-ancestor
64554201|NCT00981799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64554202|NCT00981799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64554203|NCT00981799|Antimetabolites|antimetabolites|mesh-ancestor
64554204|NCT00981799|Dermatologic Agents|dermatologic agents|mesh-ancestor
64554205|NCT00981799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554206|NCT00981799|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64976386|NCT00070148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976387|NCT00070148|Appetite Stimulants|appetite stimulants|mesh-ancestor
64976388|NCT00070148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64976389|NCT00070148|Androgens|androgens|mesh-ancestor
64976408|NCT00100581|Protease Inhibitors|protease inhibitors|mesh-ancestor
64976409|NCT00100581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976410|NCT00100581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976412|NCT00100581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64976413|NCT00100581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64976414|NCT00100581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64976415|NCT00100581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64976416|NCT00100581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64976417|NCT00100581|Antimetabolites|antimetabolites|mesh-ancestor
64976418|NCT00100581|Immunologic Factors|immunologic factors|mesh-ancestor
64554207|NCT00981799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64554208|NCT00981799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64554209|NCT00981799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64554210|NCT00981799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64554211|NCT00981799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64554212|NCT05033106|Bevacizumab|bevacizumab|mesh-list
64554213|NCT05033106|Ranibizumab|ranibizumab|mesh-list
64554214|NCT05033106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64554215|NCT05033106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554216|NCT05033106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64554217|NCT05033106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64554218|NCT05033106|Growth Substances|growth substances|mesh-ancestor
64554219|NCT05033106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976419|NCT00100581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976420|NCT00100581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64976421|NCT00100581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64976422|NCT00100581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64976423|NCT00100581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64976424|NCT00100581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64976425|NCT00070187|Interferons|interferons|mesh-list
64976426|NCT00070187|Cytarabine|cytarabine|mesh-list
64976427|NCT00070187|Aldesleukin|aldesleukin|mesh-list
64976428|NCT00070187|Interferon-gamma|interferon-gamma|mesh-list
64976429|NCT00070187|Cyclosporine|cyclosporine|mesh-list
64976430|NCT00070187|Etoposide|etoposide|mesh-list
64976431|NCT00070187|Melphalan|melphalan|mesh-list
64554220|NCT05033106|Growth Inhibitors|growth inhibitors|mesh-ancestor
64554223|NCT03095040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554224|NCT03095040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64554225|NCT03095040|Immunologic Factors|immunologic factors|mesh-ancestor
64554226|NCT03095040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554227|NCT03095040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64554228|NCT03095040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736764|NCT05599919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64554229|NCT03095040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554231|NCT03099499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554232|NCT03096522|Phenytoin|phenytoin|mesh-list
64554233|NCT03096522|Anticonvulsants|anticonvulsants|mesh-ancestor
64554234|NCT03096522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64554235|NCT03096522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64554236|NCT03096522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64554237|NCT03096522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554238|NCT03096522|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64976432|NCT00070187|Interleukin-2|interleukin-2|mesh-list
64976433|NCT00070187|Carmustine|carmustine|mesh-list
64976434|NCT00070187|Cyclosporins|cyclosporins|mesh-list
64976435|NCT00070187|Lenograstim|lenograstim|mesh-list
64976436|NCT00070187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64976437|NCT00070187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976438|NCT00070187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64976439|NCT00070187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64976440|NCT00070187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976441|NCT00070187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976442|NCT00070187|Antiviral Agents|antiviral agents|mesh-ancestor
64976443|NCT00070187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64976444|NCT00070187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64976445|NCT00070187|Antimetabolites|antimetabolites|mesh-ancestor
64554239|NCT03096522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64976446|NCT00070187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64540104|NCT01412879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64540105|NCT01412879|Antiemetics|antiemetics|mesh-ancestor
64540106|NCT01412879|Autonomic Agents|autonomic agents|mesh-ancestor
64540107|NCT01412879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64540108|NCT01412879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64540109|NCT01412879|Glucocorticoids|glucocorticoids|mesh-ancestor
64540110|NCT01412879|Hormones|hormones|mesh-ancestor
64304875|NCT00100802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554240|NCT01045161|Bromides|bromides|mesh-list
64554241|NCT01045161|Anticonvulsants|anticonvulsants|mesh-ancestor
64554242|NCT05032248|Tacrolimus|tacrolimus|mesh-list
64554243|NCT05032248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64554244|NCT05032248|Immunologic Factors|immunologic factors|mesh-ancestor
64554245|NCT05032248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554246|NCT05032248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64554247|NCT05032248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554248|NCT05032248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554249|NCT00633217|Fluticasone|fluticasone|mesh-list
64319342|NCT05532020|Vasodilator Agents|vasodilator agents|mesh-ancestor
64554250|NCT00633217|Xhance|xhance|mesh-list
64554251|NCT00633217|Norflurane|norflurane|mesh-list
64554252|NCT00633217|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64554253|NCT00633217|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64554254|NCT00633217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64554255|NCT00633217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64554256|NCT00633217|Autonomic Agents|autonomic agents|mesh-ancestor
64554257|NCT00633217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64554258|NCT00633217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554259|NCT00633217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64554260|NCT00633217|Respiratory System Agents|respiratory system agents|mesh-ancestor
64554261|NCT00633217|Dermatologic Agents|dermatologic agents|mesh-ancestor
64554262|NCT00633217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64554263|NCT00633217|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64554264|NCT00633217|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64554265|NCT00633217|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64554266|NCT00633217|Adrenergic Agents|adrenergic agents|mesh-ancestor
64554267|NCT00633217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64554268|NCT00633217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554269|NCT00633217|Glucocorticoids|glucocorticoids|mesh-ancestor
64554270|NCT00633217|Hormones|hormones|mesh-ancestor
64319354|NCT02581982|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64976447|NCT00070187|Immunologic Factors|immunologic factors|mesh-ancestor
64976448|NCT00070187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976449|NCT00070187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64554271|NCT00633217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64976450|NCT00070187|Antifungal Agents|antifungal agents|mesh-ancestor
64976451|NCT00070187|Dermatologic Agents|dermatologic agents|mesh-ancestor
64976474|NCT00415285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976477|NCT00415285|Mitosis Modulators|mitosis modulators|mesh-ancestor
64976478|NCT00415285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976479|NCT00415285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64976480|NCT00415285|Antimetabolites|antimetabolites|mesh-ancestor
64976481|NCT00256009|Misoprostol|misoprostol|mesh-list
64554272|NCT00633217|Sympathomimetics|sympathomimetics|mesh-ancestor
64554273|NCT00633217|Anesthetics|anesthetics|mesh-ancestor
64554274|NCT00633217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64554275|NCT01673490|Tamsulosin|tamsulosin|mesh-list
64554276|NCT01673490|Dutasteride|dutasteride|mesh-list
64554277|NCT01673490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64554278|NCT01673490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64554279|NCT01673490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64554280|NCT01673490|Adrenergic Agents|adrenergic agents|mesh-ancestor
64554281|NCT01673490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64554282|NCT01673490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554283|NCT01673490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554284|NCT01673490|Urological Agents|urological agents|mesh-ancestor
64554285|NCT01673490|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64554286|NCT01673490|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64554287|NCT01673490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554288|NCT01673490|Hormone Antagonists|hormone antagonists|mesh-ancestor
64554289|NCT01673490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64554290|NCT00633061|Enoxaparin|enoxaparin|mesh-list
64554291|NCT00633061|Anticoagulants|anticoagulants|mesh-ancestor
64554292|NCT00633061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64554293|NCT00633061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64554294|NCT00633061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554295|NCT00632827|Leucovorin|leucovorin|mesh-list
64554296|NCT00632827|Gemcitabine|gemcitabine|mesh-list
64554297|NCT00632827|Cytarabine|cytarabine|mesh-list
64554298|NCT00632827|Cyclophosphamide|cyclophosphamide|mesh-list
64554299|NCT00632827|Carmustine|carmustine|mesh-list
64554300|NCT00632827|Doxorubicin|doxorubicin|mesh-list
64319400|NCT04099355|Hormones|hormones|mesh-ancestor
64976482|NCT00256009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64976483|NCT00256009|Abortifacient Agents|abortifacient agents|mesh-ancestor
64657092|NCT02416908|Cytarabine|cytarabine|mesh-list
64976484|NCT00256009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64976485|NCT00256009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976486|NCT00256009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64976487|NCT00256009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64976488|NCT00256009|Oxytocics|oxytocics|mesh-ancestor
64976489|NCT00100620|Zoledronic Acid|zoledronic acid|mesh-list
64976490|NCT00100620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64976491|NCT00100620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976492|NCT00070265|Capecitabine|capecitabine|mesh-list
64976493|NCT00070265|Oxaliplatin|oxaliplatin|mesh-list
64976494|NCT00070265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64976495|NCT00070265|Antimetabolites|antimetabolites|mesh-ancestor
64976496|NCT00070265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976497|NCT00070265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554313|NCT00632827|Alkylating Agents|alkylating agents|mesh-ancestor
64554314|NCT00632827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554315|NCT00632827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554316|NCT00632827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64554317|NCT00632827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64554318|NCT00632827|Antimetabolites|antimetabolites|mesh-ancestor
64554319|NCT00632827|Antiviral Agents|antiviral agents|mesh-ancestor
64554320|NCT00632827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64319419|NCT02176681|Protease Inhibitors|protease inhibitors|mesh-ancestor
64976498|NCT00104598|Bupropion|bupropion|mesh-list
64976499|NCT00104598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64976500|NCT00104598|Antidepressive Agents|antidepressive agents|mesh-ancestor
64976501|NCT00104598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64976502|NCT00104598|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64976503|NCT00104598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64976528|NCT00256321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64976529|NCT00256321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554323|NCT00632827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64554324|NCT00632827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64554325|NCT00632827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64554326|NCT00632827|Abortifacient Agents|abortifacient agents|mesh-ancestor
64554327|NCT00632827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64554328|NCT00632827|Dermatologic Agents|dermatologic agents|mesh-ancestor
64554329|NCT00632827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64554330|NCT00632827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64319426|NCT02179099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319427|NCT02179099|Cholinergic Agents|cholinergic agents|mesh-ancestor
64319428|NCT02179099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64319429|NCT02179099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319430|NCT02179099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64319431|NCT02179099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64319433|NCT02254577|Progestins|progestins|mesh-ancestor
64319434|NCT02254577|Hormones|hormones|mesh-ancestor
64319435|NCT02254577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64319436|NCT02254577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301428|NCT04940390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301429|NCT02788279|Atezolizumab|atezolizumab|mesh-list
64976531|NCT00070304|Vinorelbine|vinorelbine|mesh-list
64976532|NCT00070304|Lenograstim|lenograstim|mesh-list
64976533|NCT00070304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64976534|NCT00070304|Antimetabolites|antimetabolites|mesh-ancestor
64976535|NCT00070304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976536|NCT00070304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976537|NCT00070304|Antiviral Agents|antiviral agents|mesh-ancestor
64976538|NCT00070304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64976539|NCT00070304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976540|NCT00070304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64976541|NCT00070304|Immunologic Factors|immunologic factors|mesh-ancestor
64976542|NCT00070304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976543|NCT00070304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64976544|NCT00070304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64976545|NCT00070304|Tubulin Modulators|tubulin modulators|mesh-ancestor
64976546|NCT00070304|Antimitotic Agents|antimitotic agents|mesh-ancestor
64976547|NCT00070304|Mitosis Modulators|mitosis modulators|mesh-ancestor
64976548|NCT00100737|Rituximab|rituximab|mesh-list
64976549|NCT00100737|Interleukin-2|interleukin-2|mesh-list
64554331|NCT00632827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64554332|NCT00632827|Antidotes|antidotes|mesh-ancestor
64554333|NCT00632827|Protective Agents|protective agents|mesh-ancestor
64554334|NCT00632827|Vitamin B Complex|vitamin b complex|mesh-ancestor
64554335|NCT00632827|Vitamins|vitamins|mesh-ancestor
64554336|NCT00632827|Micronutrients|micronutrients|mesh-ancestor
64554337|NCT00632827|Tubulin Modulators|tubulin modulators|mesh-ancestor
64554338|NCT00632827|Antimitotic Agents|antimitotic agents|mesh-ancestor
64554339|NCT00632827|Mitosis Modulators|mitosis modulators|mesh-ancestor
64554340|NCT00632827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64554341|NCT00214019|Fluticasone|fluticasone|mesh-list
64554342|NCT00214019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64319437|NCT02176759|Citric Acid|citric acid|mesh-list
64319438|NCT02176759|Sodium Citrate|sodium citrate|mesh-list
64319439|NCT02176759|Anticoagulants|anticoagulants|mesh-ancestor
64319440|NCT02176759|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64319441|NCT02176759|Chelating Agents|chelating agents|mesh-ancestor
64319442|NCT02176759|Sequestering Agents|sequestering agents|mesh-ancestor
64319443|NCT02176759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319444|NCT02576990|Pembrolizumab|pembrolizumab|mesh-list
64554343|NCT00214019|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64554344|NCT00214019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64976550|NCT00100737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64976551|NCT00100737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976552|NCT00100737|Immunologic Factors|immunologic factors|mesh-ancestor
64976573|NCT00104715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64540111|NCT01412879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64540112|NCT01412879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64540113|NCT01412879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64540114|NCT01412879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64540115|NCT01412879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64540116|NCT01412879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554345|NCT00214019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64554346|NCT00214019|Autonomic Agents|autonomic agents|mesh-ancestor
64554347|NCT00214019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64554348|NCT00214019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554349|NCT00214019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64554350|NCT00214019|Respiratory System Agents|respiratory system agents|mesh-ancestor
64554351|NCT00214019|Dermatologic Agents|dermatologic agents|mesh-ancestor
64554352|NCT00214019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64554353|NCT00214019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64554354|NCT00214019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64554355|NCT00214019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64554356|NCT00214019|Adrenergic Agents|adrenergic agents|mesh-ancestor
64554357|NCT00214019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64554358|NCT00214019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319449|NCT03538171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554359|NCT00214019|Glucocorticoids|glucocorticoids|mesh-ancestor
64554360|NCT00214019|Hormones|hormones|mesh-ancestor
64554361|NCT00214019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64554362|NCT00214019|Sympathomimetics|sympathomimetics|mesh-ancestor
64554363|NCT03097848|Sorafenib|sorafenib|mesh-list
64554364|NCT03097848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64510532|NCT05826574|Rifampin|rifampin|mesh-list
64554365|NCT03097848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64554366|NCT03097848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554367|NCT03097848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554368|NCT05047848|Fulvestrant|fulvestrant|mesh-list
64554369|NCT05047848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64554370|NCT05047848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540117|NCT01412879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64540118|NCT01412879|Abortifacient Agents|abortifacient agents|mesh-ancestor
64540119|NCT01412879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64540120|NCT01412879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64540121|NCT01412879|Antimetabolites|antimetabolites|mesh-ancestor
64304882|NCT04703036|Acetylcysteine|acetylcysteine|mesh-list
64976574|NCT00104715|Hormone Antagonists|hormone antagonists|mesh-ancestor
64976575|NCT00104715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64554371|NCT05047848|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64554372|NCT05047848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64554373|NCT05047848|Hormone Antagonists|hormone antagonists|mesh-ancestor
64554374|NCT05047848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64554375|NCT05047848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554376|NCT00210119|Imatinib Mesylate|imatinib mesylate|mesh-list
64554377|NCT00210119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554378|NCT00210119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64319479|NCT02256319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64554379|NCT00210119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554380|NCT00210119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554381|NCT01044459|Bromides|bromides|mesh-list
64554382|NCT01044459|Anticonvulsants|anticonvulsants|mesh-ancestor
64554383|NCT01837329|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
64554384|NCT01837329|Chelating Agents|chelating agents|mesh-ancestor
64554385|NCT01837329|Sequestering Agents|sequestering agents|mesh-ancestor
64554386|NCT01837329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554387|NCT01837329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319490|NCT05450432|Ketamine|ketamine|mesh-list
64976576|NCT00104715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976577|NCT00256711|Vinorelbine|vinorelbine|mesh-list
64657333|NCT02413398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64976580|NCT00256711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976581|NCT00256711|Tubulin Modulators|tubulin modulators|mesh-ancestor
64976582|NCT00256711|Antimitotic Agents|antimitotic agents|mesh-ancestor
64976583|NCT00256711|Mitosis Modulators|mitosis modulators|mesh-ancestor
64976584|NCT00256711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976585|NCT00256711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64554389|NCT01837329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64554390|NCT01837329|Growth Substances|growth substances|mesh-ancestor
64554391|NCT01837329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554392|NCT01837329|Growth Inhibitors|growth inhibitors|mesh-ancestor
64554393|NCT01837329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554394|NCT03993353|Pembrolizumab|pembrolizumab|mesh-list
64554395|NCT03993353|Tadalafil|tadalafil|mesh-list
64554396|NCT03993353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64554397|NCT03993353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554398|NCT03993353|Vasodilator Agents|vasodilator agents|mesh-ancestor
64554399|NCT03993353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64319499|NCT05450432|Anesthetics|anesthetics|mesh-ancestor
64319506|NCT05450432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64301434|NCT03268863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64976586|NCT00256711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976587|NCT00070382|Epoetin Alfa|epoetin alfa|mesh-list
64976588|NCT00070382|Darbepoetin alfa|darbepoetin alfa|mesh-list
64976589|NCT00070382|Hematinics|hematinics|mesh-ancestor
64976590|NCT04709380|Sorafenib|sorafenib|mesh-list
64976591|NCT04709380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976592|NCT04709380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64976593|NCT04709380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976594|NCT04709380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976595|NCT00256828|Lamivudine|lamivudine|mesh-list
64976596|NCT00256828|Efavirenz|efavirenz|mesh-list
64976597|NCT00256828|Didanosine|didanosine|mesh-list
64554400|NCT03993353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64554401|NCT03993353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554402|NCT03993353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554403|NCT03993353|Urological Agents|urological agents|mesh-ancestor
64554405|NCT05040906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64554406|NCT05040906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554407|NCT05040906|Immunologic Factors|immunologic factors|mesh-ancestor
64554408|NCT05040906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554409|NCT05040906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64554410|NCT01044303|Mycophenolic Acid|mycophenolic acid|mesh-list
64554411|NCT01044303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64554412|NCT01044303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554413|NCT01044303|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64554414|NCT01044303|Antitubercular Agents|antitubercular agents|mesh-ancestor
64554415|NCT01044303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64554416|NCT01044303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64554417|NCT01044303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554418|NCT01044303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554419|NCT05040828|Montelukast|montelukast|mesh-list
64554420|NCT05040828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64319511|NCT02182063|Nintedanib|nintedanib|mesh-list
64554421|NCT05040828|Respiratory System Agents|respiratory system agents|mesh-ancestor
64554422|NCT05040828|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64554423|NCT05040828|Hormone Antagonists|hormone antagonists|mesh-ancestor
64554424|NCT05040828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64554425|NCT05040828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554426|NCT05040828|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64554427|NCT05040828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64554428|NCT05040828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976598|NCT00256828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64976599|NCT00256828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64976600|NCT00256828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976601|NCT00256828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976602|NCT00256828|Antiviral Agents|antiviral agents|mesh-ancestor
64976603|NCT00256828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64976605|NCT00256828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64976606|NCT00256828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64976627|NCT00100776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64976628|NCT00100776|Serotonin Agents|serotonin agents|mesh-ancestor
64976630|NCT04709185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64976631|NCT04709185|Antiemetics|antiemetics|mesh-ancestor
64976632|NCT04709185|Autonomic Agents|autonomic agents|mesh-ancestor
64976633|NCT04709185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64976634|NCT04709185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976635|NCT04709185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64976636|NCT04709185|Glucocorticoids|glucocorticoids|mesh-ancestor
64976637|NCT04709185|Hormones|hormones|mesh-ancestor
64976638|NCT04709185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64976639|NCT04709185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64554431|NCT00983437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554432|NCT00983437|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64554433|NCT00983437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64554434|NCT00983437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64714190|NCT02988050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64554435|NCT00983437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554436|NCT05031234|Morphine|morphine|mesh-list
64554437|NCT05031234|Anesthetics|anesthetics|mesh-list
64554438|NCT05031234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64976640|NCT04709185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976641|NCT00070538|Cytarabine|cytarabine|mesh-list
64976642|NCT00070538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64540122|NCT01412879|Dermatologic Agents|dermatologic agents|mesh-ancestor
64540123|NCT01412879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64540124|NCT01412879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64540125|NCT01412879|Antiviral Agents|antiviral agents|mesh-ancestor
64304894|NCT04703036|Antidotes|antidotes|mesh-ancestor
64976643|NCT00070538|Antimetabolites|antimetabolites|mesh-ancestor
64554439|NCT05031234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554441|NCT05031234|Narcotics|narcotics|mesh-ancestor
64554442|NCT05031234|Analgesics|analgesics|mesh-ancestor
64554443|NCT05031234|Sensory System Agents|sensory system agents|mesh-ancestor
64554444|NCT05031234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64554445|NCT03599609|Simvastatin|simvastatin|mesh-list
64554446|NCT03599609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64554447|NCT03599609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64554448|NCT03599609|Antimetabolites|antimetabolites|mesh-ancestor
64554449|NCT03599609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554450|NCT03599609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64554451|NCT03599609|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64554452|NCT03599609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554453|NCT05040594|Lidocaine|lidocaine|mesh-list
64319553|NCT02182453|Empagliflozin|empagliflozin|mesh-list
64976644|NCT00070538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976645|NCT00070538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976646|NCT00070538|Antiviral Agents|antiviral agents|mesh-ancestor
64976647|NCT00070538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64976648|NCT00070538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64976649|NCT00070538|Immunologic Factors|immunologic factors|mesh-ancestor
64976651|NCT00257023|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64976652|NCT00257023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64976653|NCT00257023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64976654|NCT00257023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64976655|NCT00257023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976656|NCT00257023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64976675|NCT00257062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554454|NCT05040594|Anesthetics, Local|anesthetics, local|mesh-ancestor
64554455|NCT05040594|Anesthetics|anesthetics|mesh-ancestor
64554456|NCT05040594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64554457|NCT05040594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554458|NCT05040594|Sensory System Agents|sensory system agents|mesh-ancestor
64554459|NCT05040594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64554460|NCT05040594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64554461|NCT05040594|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64554462|NCT05040594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64554463|NCT05040594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64554464|NCT05040594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554465|NCT01042977|Dapagliflozin|dapagliflozin|mesh-list
64554466|NCT01042977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64554467|NCT01042977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554468|NCT01042977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64554469|NCT01042977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554470|NCT03598673|Nebivolol|nebivolol|mesh-list
64554471|NCT03598673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64554472|NCT03598673|Vasodilator Agents|vasodilator agents|mesh-ancestor
64319567|NCT02182531|Nasal Decongestants|nasal decongestants|mesh-ancestor
64319568|NCT02182531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64976676|NCT00257062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64976677|NCT00257062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64976678|NCT00100854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64976679|NCT00100854|Fulvestrant|fulvestrant|mesh-list
64976680|NCT00100854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976681|NCT00100854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64976682|NCT00100854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976683|NCT00100854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976684|NCT00100854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64976685|NCT00100854|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64976686|NCT00100854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64976687|NCT00100854|Hormone Antagonists|hormone antagonists|mesh-ancestor
64554473|NCT03598673|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64554475|NCT03598673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64554476|NCT03598673|Adrenergic Agents|adrenergic agents|mesh-ancestor
64554477|NCT03598673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64554478|NCT03598673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554479|NCT03598673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554480|NCT05039580|Dexamethasone|dexamethasone|mesh-list
64554481|NCT05039580|Antibodies|antibodies|mesh-list
64554482|NCT05039580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64554483|NCT05039580|Immunologic Factors|immunologic factors|mesh-ancestor
64554484|NCT05039580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554485|NCT05039580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64554486|NCT05039580|Antiemetics|antiemetics|mesh-ancestor
64554487|NCT05039580|Autonomic Agents|autonomic agents|mesh-ancestor
64319588|NCT02177305|Autonomic Agents|autonomic agents|mesh-ancestor
64554488|NCT05039580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64554489|NCT05039580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64554490|NCT05039580|Glucocorticoids|glucocorticoids|mesh-ancestor
64554492|NCT05039580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64554493|NCT05039580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64554494|NCT05039580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554495|NCT05025228|Acetaminophen|acetaminophen|mesh-list
64976688|NCT00100854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64976689|NCT00100854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976690|NCT00257140|Levofloxacin|levofloxacin|mesh-list
64976691|NCT00257140|Ofloxacin|ofloxacin|mesh-list
64976692|NCT00257140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64976693|NCT00257140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64976694|NCT00257140|Renal Agents|renal agents|mesh-ancestor
64976695|NCT00257140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64976696|NCT00257140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64976697|NCT00257140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64554496|NCT05025228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64554497|NCT05025228|Analgesics|analgesics|mesh-ancestor
64554498|NCT05025228|Sensory System Agents|sensory system agents|mesh-ancestor
64554499|NCT05025228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64554500|NCT05025228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554501|NCT05025228|Antipyretics|antipyretics|mesh-ancestor
64554502|NCT05025072|Hydroxyurea|hydroxyurea|mesh-list
64554503|NCT05025072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554504|NCT05025072|Antisickling Agents|antisickling agents|mesh-ancestor
64554505|NCT05025072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554506|NCT05025072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319616|NCT02182765|Protease Inhibitors|protease inhibitors|mesh-ancestor
64976698|NCT00257140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976699|NCT00257140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976700|NCT00257140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976701|NCT00257140|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64976702|NCT00257140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64976703|NCT00257257|Rimonabant|rimonabant|mesh-list
64976704|NCT00257257|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64976705|NCT00257257|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
64976706|NCT00257257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64976707|NCT00257257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64657696|NCT02415855|Dabigatran|dabigatran|mesh-list
64976708|NCT00257257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554507|NCT05025072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64554508|NCT05024604|Progesterone|progesterone|mesh-list
64554509|NCT05024604|Progestins|progestins|mesh-ancestor
64554511|NCT05024604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64554512|NCT05024604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554513|NCT03597893|Oxytocin|oxytocin|mesh-list
64554514|NCT03597893|Oxytocics|oxytocics|mesh-ancestor
64319625|NCT02179645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64976732|NCT00257491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64976733|NCT00257491|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64976734|NCT00257491|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64976735|NCT00257491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976736|NCT00104793|Carboplatin|carboplatin|mesh-list
64976737|NCT00104793|Irinotecan|irinotecan|mesh-list
64976738|NCT00104793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976739|NCT00104793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64554515|NCT03597893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64554516|NCT03597893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554517|NCT01041573|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64554519|NCT01041573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554520|NCT05024448|Prednisone|prednisone|mesh-list
64976740|NCT00104793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64976741|NCT00104793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976742|NCT00104793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540126|NCT01412879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64540127|NCT01412879|Antidotes|antidotes|mesh-ancestor
64540128|NCT01412879|Protective Agents|protective agents|mesh-ancestor
64540129|NCT01412879|Vitamin B Complex|vitamin b complex|mesh-ancestor
64540130|NCT01412879|Vitamins|vitamins|mesh-ancestor
64540131|NCT01412879|Micronutrients|micronutrients|mesh-ancestor
64540132|NCT01412879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64540133|NCT01412879|Tubulin Modulators|tubulin modulators|mesh-ancestor
64540134|NCT01412879|Antimitotic Agents|antimitotic agents|mesh-ancestor
64554521|NCT05024448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64554522|NCT05024448|Glucocorticoids|glucocorticoids|mesh-ancestor
64554523|NCT05024448|Hormones|hormones|mesh-ancestor
64554524|NCT05024448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64554525|NCT05024448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554526|NCT05024448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64554527|NCT05024448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554528|NCT03596957|Tolvaptan|tolvaptan|mesh-list
64319641|NCT05529290|Ketoprofen|ketoprofen|mesh-list
64301449|NCT03078062|Autonomic Agents|autonomic agents|mesh-ancestor
64540135|NCT01412879|Mitosis Modulators|mitosis modulators|mesh-ancestor
64540136|NCT03143010|Dexmedetomidine|dexmedetomidine|mesh-list
64304899|NCT04661852|Mitogens|mitogens|mesh-list
64304900|NCT04661852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64976743|NCT00070655|Vitamin K|vitamin k|mesh-list
64976744|NCT00070655|Warfarin|warfarin|mesh-list
64976745|NCT00070655|Acenocoumarol|acenocoumarol|mesh-list
64976746|NCT00070655|Idraparinux|idraparinux|mesh-list
64976747|NCT00070655|Vitamins|vitamins|mesh-ancestor
64976748|NCT00070655|Micronutrients|micronutrients|mesh-ancestor
64657802|NCT01118624|Hematinics|hematinics|mesh-ancestor
64976749|NCT00070655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554529|NCT03596957|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64554530|NCT03596957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554532|NCT03596957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554533|NCT03408015|Lifitegrast|lifitegrast|mesh-list
64554534|NCT03408015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64554535|NCT03408015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64554536|NCT01041495|Cyclobenzaprine|cyclobenzaprine|mesh-list
64554537|NCT01041495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64554538|NCT01041495|Antidepressive Agents|antidepressive agents|mesh-ancestor
64554539|NCT01041495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64554540|NCT01041495|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64554541|NCT01041495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319647|NCT05529290|Antipyretics|antipyretics|mesh-ancestor
64554542|NCT01041495|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64554543|NCT01041495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64554544|NCT01041495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64554545|NCT01041495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64554546|NCT03407937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64554547|NCT03407937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64554548|NCT03407937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554549|NCT03596099|Acetic Acid|acetic acid|mesh-list
64554550|NCT03596099|Retinol acetate|retinol acetate|mesh-list
64554551|NCT03596099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64554552|NCT03596099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64976751|NCT00070655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64976752|NCT00070655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64976753|NCT00070655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976754|NCT00070655|Hemostatics|hemostatics|mesh-ancestor
64976755|NCT00070655|Coagulants|coagulants|mesh-ancestor
64976756|NCT00070655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64976757|NCT00070655|Antithrombins|antithrombins|mesh-ancestor
64976790|NCT00401115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64976791|NCT00401115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657865|NCT02180828|Fluconazole|fluconazole|mesh-list
64976793|NCT00401115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976794|NCT00401115|Antifungal Agents|antifungal agents|mesh-ancestor
64976795|NCT00401115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64554553|NCT03596099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64554554|NCT03596099|Immunologic Factors|immunologic factors|mesh-ancestor
64554555|NCT03596099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554556|NCT03596099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64554557|NCT03596099|Protective Agents|protective agents|mesh-ancestor
64554558|NCT03596099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554559|NCT01041417|Molgramostim|molgramostim|mesh-list
64554560|NCT01041417|Sargramostim|sargramostim|mesh-list
64554561|NCT01041417|Immunologic Factors|immunologic factors|mesh-ancestor
64554562|NCT01041417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554563|NCT01041417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554564|NCT03595397|Magnesium Sulfate|magnesium sulfate|mesh-list
64976796|NCT00401115|Immunologic Factors|immunologic factors|mesh-ancestor
64976797|NCT00401115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976799|NCT00257959|Sotalol|sotalol|mesh-list
64976827|NCT00070733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64976828|NCT00070733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976829|NCT00070733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64976830|NCT00070733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976831|NCT00070733|Anabolic Agents|anabolic agents|mesh-ancestor
64976832|NCT00258076|Contraceptive Agents|contraceptive agents|mesh-list
64554565|NCT03595397|Fentanyl|fentanyl|mesh-list
64554566|NCT03595397|Bupivacaine|bupivacaine|mesh-list
64554567|NCT03595397|Anesthetics, Local|anesthetics, local|mesh-ancestor
64554568|NCT03595397|Anesthetics|anesthetics|mesh-ancestor
64554569|NCT03595397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64554570|NCT03595397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554571|NCT03595397|Sensory System Agents|sensory system agents|mesh-ancestor
64554572|NCT03595397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64554573|NCT03595397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64554574|NCT03595397|Narcotics|narcotics|mesh-ancestor
64554575|NCT03595397|Analgesics|analgesics|mesh-ancestor
64554576|NCT03595397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64554577|NCT03595397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64301459|NCT02435992|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64554578|NCT03595397|Anesthetics, General|anesthetics, general|mesh-ancestor
64554579|NCT03595397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64554580|NCT03595397|Anticonvulsants|anticonvulsants|mesh-ancestor
64554581|NCT03595397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64319683|NCT02183077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64554583|NCT03595397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554584|NCT03595397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64554585|NCT03595397|Tocolytic Agents|tocolytic agents|mesh-ancestor
64554586|NCT03595397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64554587|NCT03595319|Sevoflurane|sevoflurane|mesh-list
64554588|NCT03595319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64554589|NCT03595319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64554590|NCT03595319|Anesthetics, General|anesthetics, general|mesh-ancestor
64554591|NCT03595319|Anesthetics|anesthetics|mesh-ancestor
64554592|NCT03595319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64554593|NCT03595319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554595|NCT01040871|Cyclophosphamide|cyclophosphamide|mesh-list
64554596|NCT01040871|Rituximab|rituximab|mesh-list
64554597|NCT01040871|Doxorubicin|doxorubicin|mesh-list
64554598|NCT01040871|Vincristine|vincristine|mesh-list
64554599|NCT01040871|Bortezomib|bortezomib|mesh-list
64554600|NCT01040871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64554601|NCT01040871|Immunologic Factors|immunologic factors|mesh-ancestor
64554602|NCT01040871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554603|NCT01040871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64554604|NCT01040871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64554605|NCT01040871|Alkylating Agents|alkylating agents|mesh-ancestor
64554606|NCT01040871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554607|NCT01040871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554608|NCT01040871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64554609|NCT01040871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64554610|NCT01040871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64554611|NCT01040871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64554612|NCT01040871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64554613|NCT01040871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554614|NCT01040871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64338823|NCT05350124|Vitamins|vitamins|mesh-list
64554615|NCT01040871|Glucocorticoids|glucocorticoids|mesh-ancestor
64554616|NCT01040871|Hormones|hormones|mesh-ancestor
64554617|NCT01040871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64554618|NCT01040871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64554619|NCT01040871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64554620|NCT01040871|Tubulin Modulators|tubulin modulators|mesh-ancestor
64554621|NCT01040871|Antimitotic Agents|antimitotic agents|mesh-ancestor
64554622|NCT01040871|Mitosis Modulators|mitosis modulators|mesh-ancestor
64554623|NCT01040169|Calcium Carbonate|calcium carbonate|mesh-list
64554624|NCT01040169|Calcium|calcium|mesh-list
64554625|NCT01040169|Fluorides|fluorides|mesh-list
64554626|NCT01040169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64554627|NCT01040169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976833|NCT00258076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64976834|NCT00258076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976835|NCT00258115|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
64976836|NCT00258115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64976837|NCT00258115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64976838|NCT00258115|Analgesics|analgesics|mesh-ancestor
64976839|NCT00258115|Sensory System Agents|sensory system agents|mesh-ancestor
64976840|NCT00258115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64976841|NCT00258115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976842|NCT00258115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64976843|NCT00258115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64976844|NCT00258193|Linaclotide|linaclotide|mesh-list
64976867|NCT00258232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976868|NCT00258232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64976869|NCT00258232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64554629|NCT01040169|Protective Agents|protective agents|mesh-ancestor
64554630|NCT01040169|Antacids|antacids|mesh-ancestor
64554631|NCT01040169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554632|NCT01040169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64554633|NCT01044381|Luliconazole|luliconazole|mesh-list
64554634|NCT01044381|Antifungal Agents|antifungal agents|mesh-ancestor
64554635|NCT01044381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64554636|NCT03594461|Aflibercept|aflibercept|mesh-list
64554637|NCT03594461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64554638|NCT03594461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64554639|NCT03594461|Growth Substances|growth substances|mesh-ancestor
64554640|NCT03594461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554641|NCT03594461|Growth Inhibitors|growth inhibitors|mesh-ancestor
64554642|NCT03594461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554643|NCT03407703|Grazoprevir|grazoprevir|mesh-list
64554644|NCT03407703|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
64554645|NCT03407703|Antiviral Agents|antiviral agents|mesh-ancestor
64554646|NCT03407703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64554647|NCT03594149|Levofloxacin|levofloxacin|mesh-list
64554648|NCT03594149|Ofloxacin|ofloxacin|mesh-list
64339007|NCT03520647|Cyclophosphamide|cyclophosphamide|mesh-list
64976870|NCT00258232|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64976871|NCT00258232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64976872|NCT00258271|Cytarabine|cytarabine|mesh-list
64976873|NCT00258271|Imatinib Mesylate|imatinib mesylate|mesh-list
64976874|NCT00258271|Cladribine|cladribine|mesh-list
64976875|NCT00258271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64540137|NCT03143010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64540138|NCT03143010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64540139|NCT03143010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540140|NCT03143010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64540142|NCT03143010|Sensory System Agents|sensory system agents|mesh-ancestor
64540143|NCT03143010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64540144|NCT03143010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64554649|NCT03594149|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64554650|NCT03594149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64554651|NCT03594149|Renal Agents|renal agents|mesh-ancestor
64554652|NCT03594149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64554653|NCT03594149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64554654|NCT03594149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64554655|NCT03594149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554656|NCT03594149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554657|NCT03594149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554658|NCT03594149|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64554659|NCT03594149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64554660|NCT00916539|Calpastatin|calpastatin|mesh-list
64510831|NCT05823363|Sensory System Agents|sensory system agents|mesh-ancestor
64554661|NCT00916539|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64554663|NCT00916539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554664|NCT00916539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554665|NCT03593447|Ribavirin|ribavirin|mesh-list
64554666|NCT03593447|Yimitasvir|yimitasvir|mesh-list
64554667|NCT03593447|Antimetabolites|antimetabolites|mesh-ancestor
64554668|NCT03593447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554669|NCT03593447|Antiviral Agents|antiviral agents|mesh-ancestor
64540145|NCT03143010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64540146|NCT03143010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64540147|NCT03143010|Adrenergic Agents|adrenergic agents|mesh-ancestor
64540148|NCT03143010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64540149|NCT03143010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304908|NCT04661852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64658049|NCT05307458|Buprenorphine|buprenorphine|mesh-list
64976877|NCT00258271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976879|NCT00258271|Antiviral Agents|antiviral agents|mesh-ancestor
64976880|NCT00258271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64976881|NCT00258271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64976882|NCT00258271|Immunologic Factors|immunologic factors|mesh-ancestor
64554670|NCT03593447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64554671|NCT03593291|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64554672|NCT03593291|Dalteparin|dalteparin|mesh-list
64554673|NCT03593291|Anticoagulants|anticoagulants|mesh-ancestor
64554674|NCT03593291|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64554675|NCT03593291|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64554676|NCT03593291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554677|NCT03593135|Metformin|metformin|mesh-list
64554678|NCT03593135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64554679|NCT03593135|Acetic Acid|acetic acid|mesh-list
64554680|NCT03593135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64554681|NCT03593135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554682|NCT03593135|Incretins|incretins|mesh-ancestor
64554683|NCT03593135|Hormones|hormones|mesh-ancestor
64554684|NCT03593135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64554685|NCT03593135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64554686|NCT03593135|Protease Inhibitors|protease inhibitors|mesh-ancestor
64554687|NCT03593135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554688|NCT03593135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554689|NCT03593135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64554690|NCT03593135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64554691|NCT03592901|Anesthetics|anesthetics|mesh-list
64319787|NCT02177539|Protective Agents|protective agents|mesh-ancestor
64976883|NCT00258271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976884|NCT00258271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64976885|NCT00258271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976887|NCT00258388|Docetaxel|docetaxel|mesh-list
64976888|NCT00258388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976889|NCT00258388|Tubulin Modulators|tubulin modulators|mesh-ancestor
64976890|NCT00258388|Antimitotic Agents|antimitotic agents|mesh-ancestor
64976891|NCT00258388|Mitosis Modulators|mitosis modulators|mesh-ancestor
64554692|NCT03592901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64554693|NCT03592901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554695|NCT03830385|Bleomycin|bleomycin|mesh-list
64554696|NCT03830385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554697|NCT03830385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64554698|NCT03592823|Hydroxychloroquine|hydroxychloroquine|mesh-list
64554699|NCT03592823|Antimalarials|antimalarials|mesh-ancestor
64554700|NCT03592823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64554701|NCT03592823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64554702|NCT03592823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64554703|NCT03592823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554704|NCT03592823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319809|NCT04141904|Tofacitinib|tofacitinib|mesh-list
64339257|NCT05297396|Analgesics|analgesics|mesh-ancestor
64976892|NCT00258388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976893|NCT00258388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64976894|NCT00258388|Glucocorticoids|glucocorticoids|mesh-ancestor
64976895|NCT00258388|Hormones|hormones|mesh-ancestor
64976896|NCT00258388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64976897|NCT00258388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976915|NCT00258622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64976916|NCT00258622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554705|NCT03592823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64554706|NCT03592667|Dapagliflozin|dapagliflozin|mesh-list
64554707|NCT03592667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64554708|NCT03592667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554709|NCT03592667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64554710|NCT03592667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554711|NCT03406689|Nepafenac|nepafenac|mesh-list
64554712|NCT03406689|Lubricant Eye Drops|lubricant eye drops|mesh-list
64554713|NCT03406689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64554714|NCT03406689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64554715|NCT03406689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64554716|NCT03406689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64554717|NCT03406689|Analgesics|analgesics|mesh-ancestor
64554718|NCT03406689|Sensory System Agents|sensory system agents|mesh-ancestor
64554719|NCT03406689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64554720|NCT03406689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554721|NCT03406689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64339343|NCT05079087|GABA Agents|gaba agents|mesh-ancestor
64976917|NCT00258622|Sensory System Agents|sensory system agents|mesh-ancestor
64976918|NCT00258622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64976919|NCT00258622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64976920|NCT00258622|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64976921|NCT00258622|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64976922|NCT00258622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64976923|NCT00258622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976925|NCT00423761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64976926|NCT00423761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64976927|NCT00423761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64976928|NCT00423761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976929|NCT00423761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64554722|NCT03406689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64554723|NCT03591575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64554725|NCT03591575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64554726|NCT03591575|Chelating Agents|chelating agents|mesh-ancestor
64554727|NCT03591575|Sequestering Agents|sequestering agents|mesh-ancestor
64554728|NCT03591575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976930|NCT00423761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64976931|NCT00423761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64976932|NCT00423761|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64976933|NCT00423761|Anesthetics, General|anesthetics, general|mesh-ancestor
64976934|NCT00423761|Anesthetics|anesthetics|mesh-ancestor
64976935|NCT00423761|GABA Modulators|gaba modulators|mesh-ancestor
64976936|NCT00423761|GABA Agents|gaba agents|mesh-ancestor
64976937|NCT00423761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64554729|NCT03406533|Fentanyl|fentanyl|mesh-list
64554730|NCT03406533|Midazolam|midazolam|mesh-list
64554731|NCT03406533|Dexmedetomidine|dexmedetomidine|mesh-list
64554732|NCT03406533|Remifentanil|remifentanil|mesh-list
64554733|NCT03406533|Propofol|propofol|mesh-list
64714191|NCT02988050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64554734|NCT03406533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64554735|NCT03406533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64554736|NCT03406533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554737|NCT03406533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64554738|NCT03406533|Anesthetics, General|anesthetics, general|mesh-ancestor
64554739|NCT03406533|Anesthetics|anesthetics|mesh-ancestor
64319845|NCT05527340|Antiemetics|antiemetics|mesh-ancestor
64319846|NCT05527340|Autonomic Agents|autonomic agents|mesh-ancestor
64540150|NCT03142776|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64540151|NCT03142776|Clarithromycin|clarithromycin|mesh-list
64540152|NCT03142776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64540153|NCT03142776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64540154|NCT03142776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540155|NCT03142776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540156|NCT03142776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64540157|NCT03142776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64540159|NCT01430611|Immunologic Factors|immunologic factors|mesh-ancestor
64540160|NCT01430611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540161|NCT03140826|Meropenem|meropenem|mesh-list
64540162|NCT03140826|Tazobactam|tazobactam|mesh-list
64540163|NCT03140826|Piperacillin|piperacillin|mesh-list
64554740|NCT03406533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64554741|NCT03406533|Analgesics|analgesics|mesh-ancestor
64554742|NCT03406533|Sensory System Agents|sensory system agents|mesh-ancestor
64554743|NCT03406533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64554744|NCT03406533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64554745|NCT03406533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64554746|NCT03406533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64540164|NCT03140826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64540165|NCT03140826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64540167|NCT03140826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64540169|NCT03140826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540170|NCT01389973|Ustekinumab|ustekinumab|mesh-list
64540171|NCT01389973|Dermatologic Agents|dermatologic agents|mesh-ancestor
64540172|NCT04529460|Antibodies|antibodies|mesh-list
64304928|NCT00002462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976938|NCT00423761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976939|NCT00104910|Cetuximab|cetuximab|mesh-list
64976940|NCT00104910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976941|NCT00104910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64976942|NCT00415324|Cisplatin|cisplatin|mesh-list
64976943|NCT00415324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554748|NCT03406533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64554749|NCT03406533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554750|NCT03406533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64554751|NCT03406533|Narcotics|narcotics|mesh-ancestor
64554752|NCT03406533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64554753|NCT03406533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64339899|NCT00889967|Ciprofloxacin|ciprofloxacin|mesh-list
64976944|NCT00258739|Gemcitabine|gemcitabine|mesh-list
64976945|NCT00258739|Carboplatin|carboplatin|mesh-list
64976946|NCT00258739|Docetaxel|docetaxel|mesh-list
64976947|NCT00258739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976948|NCT00258739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64976949|NCT00258739|Antimetabolites|antimetabolites|mesh-ancestor
64976950|NCT00258739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976951|NCT00258739|Antiviral Agents|antiviral agents|mesh-ancestor
64554757|NCT03406533|GABA Agents|gaba agents|mesh-ancestor
64554758|NCT03591341|Melatonin|melatonin|mesh-list
64554759|NCT03591341|Antioxidants|antioxidants|mesh-ancestor
64554760|NCT03591341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554761|NCT03591341|Protective Agents|protective agents|mesh-ancestor
64554762|NCT03591341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319871|NCT05522894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976952|NCT00258739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64976953|NCT00258739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976954|NCT00258739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64976974|NCT00101127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976975|NCT00101127|Tubulin Modulators|tubulin modulators|mesh-ancestor
64976976|NCT00101127|Antimitotic Agents|antimitotic agents|mesh-ancestor
64976977|NCT00101127|Mitosis Modulators|mitosis modulators|mesh-ancestor
64658191|NCT02486211|Amantadine|amantadine|mesh-list
64976979|NCT00259051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64554763|NCT03591341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64554764|NCT04377399|Vitamin D|vitamin d|mesh-list
64554765|NCT04377399|Vitamins|vitamins|mesh-ancestor
64554766|NCT04377399|Micronutrients|micronutrients|mesh-ancestor
64554767|NCT04377399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554768|NCT04377399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64554769|NCT03400995|Ziresovir|ziresovir|mesh-list
64976980|NCT00259051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64976981|NCT00259051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64976982|NCT00259051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976983|NCT00259051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540176|NCT04032067|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64540177|NCT04032067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64540179|NCT04032067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540180|NCT04032067|Hormone Antagonists|hormone antagonists|mesh-ancestor
64540181|NCT04032067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64554771|NCT03400995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64554772|NCT03590873|Vasopressins|vasopressins|mesh-list
64554773|NCT03590873|Arginine Vasopressin|arginine vasopressin|mesh-list
64554774|NCT03590873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554775|NCT03590873|Hemostatics|hemostatics|mesh-ancestor
64554776|NCT03590873|Coagulants|coagulants|mesh-ancestor
64554777|NCT03590873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64554778|NCT03590873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64554779|NCT03590873|Natriuretic Agents|natriuretic agents|mesh-ancestor
64554780|NCT02155335|Golimumab|golimumab|mesh-list
64554781|NCT02155335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64340232|NCT03132025|Capecitabine|capecitabine|mesh-list
64540182|NCT04032067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540183|NCT04032067|Urological Agents|urological agents|mesh-ancestor
64540184|NCT00659295|Insulin Detemir|insulin detemir|mesh-list
64976984|NCT00259129|Sorafenib|sorafenib|mesh-list
64976985|NCT00259129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976986|NCT00259129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64976987|NCT00259129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976988|NCT00259129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976989|NCT00259168|Nateglinide|nateglinide|mesh-list
64976990|NCT00259168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64976991|NCT00259168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976995|NCT00259363|Oxaliplatin|oxaliplatin|mesh-list
64554782|NCT02155335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64554783|NCT02155335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64554784|NCT02155335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64554785|NCT02155335|Immunologic Factors|immunologic factors|mesh-ancestor
64554786|NCT02155335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301469|NCT02457351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554787|NCT05024526|Edaravone|edaravone|mesh-list
64554788|NCT05024526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64554789|NCT05024526|Antioxidants|antioxidants|mesh-ancestor
64554790|NCT05024526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554791|NCT05024526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64554792|NCT05024526|Protective Agents|protective agents|mesh-ancestor
64554793|NCT05024526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554795|NCT03597035|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64554796|NCT03597035|Hormone Antagonists|hormone antagonists|mesh-ancestor
64976996|NCT00259363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976997|NCT00104988|Thalidomide|thalidomide|mesh-list
64976998|NCT00104988|Temozolomide|temozolomide|mesh-list
64976999|NCT00104988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64977000|NCT00104988|Alkylating Agents|alkylating agents|mesh-ancestor
64977001|NCT00104988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977002|NCT00104988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977003|NCT00104988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64977004|NCT00104988|Immunologic Factors|immunologic factors|mesh-ancestor
64658233|NCT02384850|Fluorouracil|fluorouracil|mesh-list
64977006|NCT00104988|Leprostatic Agents|leprostatic agents|mesh-ancestor
64977007|NCT00104988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64977008|NCT00104988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64977009|NCT00104988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64977010|NCT00104988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64736765|NCT05599919|Respiratory System Agents|respiratory system agents|mesh-ancestor
64554797|NCT03597035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64554798|NCT03597035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554799|NCT03597035|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64340560|NCT02276482|Vancomycin|vancomycin|mesh-list
64977040|NCT00071201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64554800|NCT03597035|Diuretics|diuretics|mesh-ancestor
64977041|NCT00071201|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64977042|NCT00071201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64977043|NCT00071201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977044|NCT00071201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977046|NCT00259636|Anticonvulsants|anticonvulsants|mesh-ancestor
64977047|NCT00259636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64977048|NCT00259636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64977049|NCT00259636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977050|NCT00259636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64977051|NCT00259636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977052|NCT00259675|Gemcitabine|gemcitabine|mesh-list
64977053|NCT00259675|Carboplatin|carboplatin|mesh-list
64977054|NCT00259675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977055|NCT00259675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64977080|NCT00259714|Dialysis Solutions|dialysis solutions|mesh-list
64977081|NCT00259714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64977082|NCT00071240|Hormones|hormones|mesh-list
64977083|NCT00071240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64554801|NCT03597035|Natriuretic Agents|natriuretic agents|mesh-ancestor
64554803|NCT03400683|Misoprostol|misoprostol|mesh-list
64554804|NCT03400683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554805|NCT03400683|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64554806|NCT03400683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64554807|NCT03400683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736766|NCT05599919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64554808|NCT03400683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554809|NCT03400683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64554810|NCT03400683|Hormone Antagonists|hormone antagonists|mesh-ancestor
64554811|NCT03400683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64554813|NCT03400683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64554814|NCT03400683|Abortifacient Agents|abortifacient agents|mesh-ancestor
64554815|NCT03400683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64554816|NCT03400683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64554817|NCT03400683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64554818|NCT03400683|Oxytocics|oxytocics|mesh-ancestor
64554819|NCT05037240|Quercetin|quercetin|mesh-list
64554820|NCT05037240|Antioxidants|antioxidants|mesh-ancestor
64554821|NCT05037240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554822|NCT05037240|Protective Agents|protective agents|mesh-ancestor
64554823|NCT05037240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554824|NCT05037006|Anesthetics|anesthetics|mesh-list
64554825|NCT05037006|Sevoflurane|sevoflurane|mesh-list
64554826|NCT05037006|Neostigmine|neostigmine|mesh-list
64736767|NCT05599919|Antioxidants|antioxidants|mesh-ancestor
64340736|NCT05134922|Gedatolisib|gedatolisib|mesh-list
64977084|NCT00071240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540185|NCT00659295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64540186|NCT00659295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540187|NCT01430455|Tranylcypromine|tranylcypromine|mesh-list
64540188|NCT01430455|Antidepressive Agents|antidepressive agents|mesh-ancestor
64540189|NCT01430455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64540190|NCT01430455|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64540191|NCT01430455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540253|NCT01429285|Sensory System Agents|sensory system agents|mesh-ancestor
64540254|NCT01429285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64540255|NCT00594945|Clonazepam|clonazepam|mesh-list
64540256|NCT00594945|Anticonvulsants|anticonvulsants|mesh-ancestor
64540257|NCT00594945|GABA Modulators|gaba modulators|mesh-ancestor
64540258|NCT00594945|GABA Agents|gaba agents|mesh-ancestor
64540259|NCT00594945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64977086|NCT00259792|Formoterol Fumarate|formoterol fumarate|mesh-list
64977087|NCT00259792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64554827|NCT05037006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64554828|NCT05037006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554829|NCT05037006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64554830|NCT05037006|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64554832|NCT05037006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64554833|NCT05037006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554834|NCT05037006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554835|NCT05037006|Cholinergic Agents|cholinergic agents|mesh-ancestor
64554836|NCT05037006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64554837|NCT05037006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64554838|NCT05037006|Autonomic Agents|autonomic agents|mesh-ancestor
64554839|NCT05037006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64554840|NCT03093090|Furosemide|furosemide|mesh-list
64554841|NCT03093090|Diuretics|diuretics|mesh-ancestor
64554842|NCT03093090|Natriuretic Agents|natriuretic agents|mesh-ancestor
64554843|NCT03093090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554844|NCT03093090|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64977088|NCT00259792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64977089|NCT00259792|Autonomic Agents|autonomic agents|mesh-ancestor
64977090|NCT00259792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64977091|NCT00259792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977092|NCT00259792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64977093|NCT00259792|Respiratory System Agents|respiratory system agents|mesh-ancestor
64977094|NCT00259792|Glucocorticoids|glucocorticoids|mesh-ancestor
64977095|NCT00259792|Hormones|hormones|mesh-ancestor
64977096|NCT00259792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64977097|NCT00259792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64977098|NCT00259792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64977099|NCT00259792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64977100|NCT00259792|Adrenergic Agents|adrenergic agents|mesh-ancestor
64977101|NCT00259792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64554845|NCT03093090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64554846|NCT03093090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554847|NCT03093168|Cyclophosphamide|cyclophosphamide|mesh-list
64554848|NCT03093168|Fludarabine|fludarabine|mesh-list
64554849|NCT03093168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64554850|NCT03093168|Immunologic Factors|immunologic factors|mesh-ancestor
64554851|NCT03093168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554852|NCT03093168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64554853|NCT03093168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64554854|NCT03093168|Alkylating Agents|alkylating agents|mesh-ancestor
64319963|NCT04295330|Anesthetics|anesthetics|mesh-ancestor
64977102|NCT00259792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977135|NCT00259987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64977137|NCT00259987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977139|NCT00260026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977140|NCT00260026|Tubulin Modulators|tubulin modulators|mesh-ancestor
64977141|NCT00260026|Antimitotic Agents|antimitotic agents|mesh-ancestor
64977142|NCT00260026|Mitosis Modulators|mitosis modulators|mesh-ancestor
64977143|NCT00260026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554855|NCT03093168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554856|NCT03093168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554857|NCT03093168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64554858|NCT04377321|Colchicine|colchicine|mesh-list
64554859|NCT04377321|Gout Suppressants|gout suppressants|mesh-ancestor
64554860|NCT04377321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64554861|NCT04377321|Tubulin Modulators|tubulin modulators|mesh-ancestor
64977144|NCT00260143|Methyltestosterone|methyltestosterone|mesh-list
64977145|NCT00260143|Testosterone|testosterone|mesh-list
64977155|NCT00260143|Anabolic Agents|anabolic agents|mesh-ancestor
64977156|NCT00260260|Oxycodone|oxycodone|mesh-list
64977157|NCT00260260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64977158|NCT00260260|Narcotics|narcotics|mesh-ancestor
64977159|NCT00260260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64977160|NCT00260260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977161|NCT00260260|Analgesics|analgesics|mesh-ancestor
64977162|NCT00260260|Sensory System Agents|sensory system agents|mesh-ancestor
64977163|NCT00260260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64977164|NCT00105300|Adalimumab|adalimumab|mesh-list
64977165|NCT00105300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64977166|NCT00105300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64554862|NCT04377321|Antimitotic Agents|antimitotic agents|mesh-ancestor
64554863|NCT04377321|Mitosis Modulators|mitosis modulators|mesh-ancestor
64554864|NCT04377321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554865|NCT04377321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554866|NCT05018364|Epoetin Alfa|epoetin alfa|mesh-list
64554867|NCT05018364|Hematinics|hematinics|mesh-ancestor
64554868|NCT03593213|Cariprazine|cariprazine|mesh-list
64341075|NCT05025800|Lenalidomide|lenalidomide|mesh-list
64977167|NCT00260416|Abciximab|abciximab|mesh-list
64977168|NCT00260416|Anticoagulants|anticoagulants|mesh-ancestor
64977169|NCT00260416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64977170|NCT00260611|Docetaxel|docetaxel|mesh-list
64977171|NCT00260611|Oxaliplatin|oxaliplatin|mesh-list
64658677|NCT01144442|Paclitaxel|paclitaxel|mesh-list
64977172|NCT00260611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977173|NCT00260611|Tubulin Modulators|tubulin modulators|mesh-ancestor
64977174|NCT00260611|Antimitotic Agents|antimitotic agents|mesh-ancestor
64977175|NCT00260611|Mitosis Modulators|mitosis modulators|mesh-ancestor
64977176|NCT00260611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977178|NCT00424086|Immunologic Factors|immunologic factors|mesh-ancestor
64977179|NCT00424086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977180|NCT00101205|Oxaliplatin|oxaliplatin|mesh-list
64977181|NCT00101205|Etoposide|etoposide|mesh-list
64977182|NCT00101205|Etoposide phosphate|etoposide phosphate|mesh-list
64977183|NCT00101205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977184|NCT00101205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64977185|NCT00101205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64977186|NCT00101205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64554870|NCT03593213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64554871|NCT03593213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64554872|NCT03593213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554873|NCT03593213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64554874|NCT05023824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
64554875|NCT05023824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64554876|NCT05023824|Adrenergic Agents|adrenergic agents|mesh-ancestor
64554877|NCT05023824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64554878|NCT05023824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319983|NCT05525156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64554879|NCT05023824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341328|NCT04462003|Enoxaparin|enoxaparin|mesh-list
64977187|NCT00101205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977188|NCT00101205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977189|NCT00261079|Fexofenadine|fexofenadine|mesh-list
64977190|NCT00261079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64540260|NCT00594945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540261|NCT00594945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540262|NCT00595101|Latanoprost|latanoprost|mesh-list
64540263|NCT00595101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64540264|NCT00595101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64540265|NCT00660075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64540266|NCT00660075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64554881|NCT03595163|Vitamin B Complex|vitamin b complex|mesh-list
64554882|NCT03595163|Propofol|propofol|mesh-list
64554883|NCT03595163|Sevoflurane|sevoflurane|mesh-list
64554884|NCT03595163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64554885|NCT03595163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64554886|NCT03595163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554887|NCT03595163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64554888|NCT03595163|Anesthetics, General|anesthetics, general|mesh-ancestor
64319996|NCT05512364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554889|NCT03595163|Anesthetics|anesthetics|mesh-ancestor
64554890|NCT03595163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64554891|NCT03595163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64554892|NCT03595163|Hematinics|hematinics|mesh-ancestor
64554893|NCT03595163|Vitamins|vitamins|mesh-ancestor
64554894|NCT03595163|Micronutrients|micronutrients|mesh-ancestor
64554895|NCT03404115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64554896|NCT03404115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64554897|NCT04199819|Entecavir|entecavir|mesh-list
64554898|NCT04199819|Antiviral Agents|antiviral agents|mesh-ancestor
64554899|NCT04199819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64554900|NCT00918723|Cyclophosphamide|cyclophosphamide|mesh-list
64540267|NCT00660075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540268|NCT00660075|Incretins|incretins|mesh-ancestor
64540269|NCT00660075|Hormones|hormones|mesh-ancestor
64305031|NCT03062462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977191|NCT00261079|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64977192|NCT00261079|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64977193|NCT00261079|Histamine Antagonists|histamine antagonists|mesh-ancestor
64977194|NCT00261079|Histamine Agents|histamine agents|mesh-ancestor
64977195|NCT00261079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64977196|NCT00261079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554901|NCT00918723|Rituximab|rituximab|mesh-list
64554902|NCT00918723|Fludarabine|fludarabine|mesh-list
64554903|NCT00918723|Fludarabine phosphate|fludarabine phosphate|mesh-list
64554904|NCT00918723|Vorinostat|vorinostat|mesh-list
64554905|NCT00918723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64554906|NCT00918723|Immunologic Factors|immunologic factors|mesh-ancestor
64554907|NCT00918723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554908|NCT00918723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64554909|NCT00918723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64554910|NCT00918723|Alkylating Agents|alkylating agents|mesh-ancestor
64554911|NCT00918723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554912|NCT00918723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554913|NCT00918723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64554914|NCT00918723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64554915|NCT00918723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64554916|NCT00918723|Antimetabolites|antimetabolites|mesh-ancestor
64554917|NCT00918723|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64554918|NCT00918723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554919|NCT04192331|Paclitaxel|paclitaxel|mesh-list
64554920|NCT04192331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64554921|NCT04192331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64320006|NCT04424641|Antibodies|antibodies|mesh-list
64554922|NCT04192331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554923|NCT04192331|Tubulin Modulators|tubulin modulators|mesh-ancestor
64554924|NCT04192331|Antimitotic Agents|antimitotic agents|mesh-ancestor
64554925|NCT04192331|Mitosis Modulators|mitosis modulators|mesh-ancestor
64554926|NCT04192331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554928|NCT00919035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64554929|NCT00919035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64554930|NCT00919035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64554931|NCT00919035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977197|NCT00261079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977199|NCT00261118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64977200|NCT00261118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977201|NCT00261118|Immunologic Factors|immunologic factors|mesh-ancestor
64977202|NCT00261118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977203|NCT00261118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64977204|NCT00071747|Lamotrigine|lamotrigine|mesh-list
64977205|NCT00071747|Anticonvulsants|anticonvulsants|mesh-ancestor
64977206|NCT00071747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64554933|NCT00919035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64554934|NCT00919035|Immunologic Factors|immunologic factors|mesh-ancestor
64554935|NCT00919035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554936|NCT03969953|Rivaroxaban|rivaroxaban|mesh-list
64554937|NCT03969953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64554938|NCT03969953|Antithrombins|antithrombins|mesh-ancestor
64554939|NCT03969953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64554940|NCT03969953|Protease Inhibitors|protease inhibitors|mesh-ancestor
64554941|NCT03969953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554942|NCT03969953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554943|NCT03969953|Anticoagulants|anticoagulants|mesh-ancestor
64554944|NCT04374981|Celecoxib|celecoxib|mesh-list
64554945|NCT04374981|Montelukast|montelukast|mesh-list
64977207|NCT00071747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64977208|NCT00071747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977209|NCT00071747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64977210|NCT00071747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977211|NCT00071747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64977238|NCT00261469|Anticonvulsants|anticonvulsants|mesh-ancestor
64658771|NCT02407704|GABA Agents|gaba agents|mesh-ancestor
64977239|NCT00261469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64554946|NCT04374981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64554947|NCT04374981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64554949|NCT04374981|Sensory System Agents|sensory system agents|mesh-ancestor
64554950|NCT04374981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301477|NCT02788513|Nootropic Agents|nootropic agents|mesh-ancestor
64301480|NCT03077828|Etoposide|etoposide|mesh-list
64554951|NCT04374981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554952|NCT04374981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64554953|NCT04374981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64554954|NCT04374981|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64554955|NCT04374981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64554956|NCT04374981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554957|NCT04374981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554958|NCT04374981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64554959|NCT04374981|Respiratory System Agents|respiratory system agents|mesh-ancestor
64554960|NCT04374981|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64977240|NCT00261469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977241|NCT00261508|Risperidone|risperidone|mesh-list
64977242|NCT00261508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64977243|NCT00261508|Serotonin Agents|serotonin agents|mesh-ancestor
64977244|NCT00261508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64977245|NCT00261508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977246|NCT00261508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977247|NCT00261508|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64977248|NCT00261508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64554983|NCT03405207|Vitamin D|vitamin d|mesh-list
64554984|NCT03405207|Cholecalciferol|cholecalciferol|mesh-list
64774736|NCT01721460|Analgesics|analgesics|mesh-ancestor
64774737|NCT01721460|Sensory System Agents|sensory system agents|mesh-ancestor
64774738|NCT01721460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774739|NCT01721460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64774740|NCT01721460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64774741|NCT01721460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64774742|NCT01721460|Adrenergic Agents|adrenergic agents|mesh-ancestor
64774743|NCT01721460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64774744|NCT01721460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774745|NCT01722318|Plecanatide|plecanatide|mesh-list
64774746|NCT01722318|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64774747|NCT01722318|Enzyme Activators|enzyme activators|mesh-ancestor
64774748|NCT01722318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774749|NCT01722318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64774750|NCT01723722|Methadone|methadone|mesh-list
64774751|NCT01723722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64774752|NCT01723722|Narcotics|narcotics|mesh-ancestor
64774753|NCT01723722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64774754|NCT01723722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774755|NCT01723722|Analgesics|analgesics|mesh-ancestor
64774756|NCT01723722|Sensory System Agents|sensory system agents|mesh-ancestor
64774757|NCT01723722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774758|NCT01723722|Antitussive Agents|antitussive agents|mesh-ancestor
64774759|NCT01723722|Respiratory System Agents|respiratory system agents|mesh-ancestor
64774760|NCT01728636|Tranexamic Acid|tranexamic acid|mesh-list
64977249|NCT00261508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64977250|NCT00261508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64977251|NCT00261508|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64977252|NCT00261508|Dopamine Agents|dopamine agents|mesh-ancestor
64977254|NCT00261547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64774761|NCT01728636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64977255|NCT00261547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977256|NCT00261547|Immunologic Factors|immunologic factors|mesh-ancestor
64977257|NCT00261547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977258|NCT00261547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64977259|NCT00261586|Aspirin|aspirin|mesh-list
64977261|NCT00261586|Ibuprofen|ibuprofen|mesh-list
64977262|NCT00261586|Celecoxib|celecoxib|mesh-list
64977263|NCT00261586|Naproxen|naproxen|mesh-list
64977264|NCT00261586|Rofecoxib|rofecoxib|mesh-list
64977292|NCT00261703|Tubulin Modulators|tubulin modulators|mesh-ancestor
64977293|NCT00261703|Antimitotic Agents|antimitotic agents|mesh-ancestor
64977294|NCT00261703|Mitosis Modulators|mitosis modulators|mesh-ancestor
64774762|NCT01728636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64323579|NCT00054158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64323580|NCT00054158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64323581|NCT00054158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64323582|NCT00054158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64323583|NCT00054158|Growth Substances|growth substances|mesh-ancestor
64323584|NCT00054158|Growth Inhibitors|growth inhibitors|mesh-ancestor
64323585|NCT01337167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64323586|NCT01337167|Immunologic Factors|immunologic factors|mesh-ancestor
64323587|NCT01337167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323588|NCT05496764|Dexamethasone|dexamethasone|mesh-list
64323589|NCT05496764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64323590|NCT05496764|Antiemetics|antiemetics|mesh-ancestor
64323591|NCT05496764|Autonomic Agents|autonomic agents|mesh-ancestor
64323592|NCT05496764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774763|NCT01728636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774792|NCT01729494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64774793|NCT01729494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774794|NCT01729494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64774795|NCT01729494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774796|NCT01729494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64774797|NCT01729494|Immunologic Factors|immunologic factors|mesh-ancestor
64774798|NCT01729494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64774799|NCT01729494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977295|NCT00261703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540270|NCT00660075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64540271|NCT00660075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64540272|NCT00660075|Protease Inhibitors|protease inhibitors|mesh-ancestor
64540273|NCT00660075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540274|NCT00660075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658934|NCT01151852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540276|NCT05174052|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64323597|NCT05496764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64774917|NCT00700596|Salvinorin A|salvinorin a|mesh-list
64540277|NCT05174052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540278|NCT05174052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64540279|NCT05174052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540281|NCT01429051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64540282|NCT01429051|Narcotics|narcotics|mesh-ancestor
64540283|NCT01429051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64540284|NCT01429051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540285|NCT01429051|Analgesics|analgesics|mesh-ancestor
64540286|NCT01429051|Sensory System Agents|sensory system agents|mesh-ancestor
64540287|NCT01429051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64540288|NCT01429051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64540289|NCT01429051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64540290|NCT01429051|Anesthetics, General|anesthetics, general|mesh-ancestor
64540291|NCT01429051|Anesthetics|anesthetics|mesh-ancestor
64540292|NCT03968562|Doxycycline|doxycycline|mesh-list
64540293|NCT03968562|Petrolatum|petrolatum|mesh-list
64540294|NCT03968562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64540295|NCT03968562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64540296|NCT03968562|Antimalarials|antimalarials|mesh-ancestor
64540297|NCT03968562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64774918|NCT00700596|Hallucinogens|hallucinogens|mesh-ancestor
64774919|NCT00700596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774920|NCT00700596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64774921|NCT01733472|Remifentanil|remifentanil|mesh-list
64774922|NCT01733472|Propofol|propofol|mesh-list
64774923|NCT01733472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64774924|NCT01733472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64774925|NCT01733472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774926|NCT01733472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64774927|NCT01733472|Anesthetics, General|anesthetics, general|mesh-ancestor
64774928|NCT01733472|Anesthetics|anesthetics|mesh-ancestor
64774929|NCT01733472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64774930|NCT01733472|Narcotics|narcotics|mesh-ancestor
64774931|NCT01733472|Analgesics|analgesics|mesh-ancestor
64774932|NCT01733472|Sensory System Agents|sensory system agents|mesh-ancestor
64774933|NCT01733472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774934|NCT01736358|Ketorolac|ketorolac|mesh-list
64774935|NCT01736358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64774936|NCT01736358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64774937|NCT01736358|Analgesics|analgesics|mesh-ancestor
64774938|NCT01736358|Sensory System Agents|sensory system agents|mesh-ancestor
64774939|NCT01736358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774946|NCT01740258|Bevacizumab|bevacizumab|mesh-list
64774949|NCT01740258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774950|NCT01740258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64774951|NCT01740258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64543626|NCT03022747|Antioxidants|antioxidants|mesh-ancestor
64774953|NCT01740258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774954|NCT01740258|Growth Inhibitors|growth inhibitors|mesh-ancestor
64774955|NCT01740258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64774956|NCT01740258|Alkylating Agents|alkylating agents|mesh-ancestor
64774957|NCT01740258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774958|NCT01740414|Ibudilast|ibudilast|mesh-list
64774959|NCT01740414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64774960|NCT01740414|Autonomic Agents|autonomic agents|mesh-ancestor
64774961|NCT01740414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774962|NCT01740414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774963|NCT01740414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64540298|NCT03968562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64540299|NCT03968562|Emollients|emollients|mesh-ancestor
64540300|NCT03968562|Dermatologic Agents|dermatologic agents|mesh-ancestor
64540301|NCT03425292|Bevacizumab|bevacizumab|mesh-list
64540302|NCT03425292|Nivolumab|nivolumab|mesh-list
64540303|NCT03425292|Ipilimumab|ipilimumab|mesh-list
64540304|NCT03425292|Temozolomide|temozolomide|mesh-list
64540305|NCT03425292|Lomustine|lomustine|mesh-list
64540306|NCT03425292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64774981|NCT01740726|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64774982|NCT01740726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64774983|NCT01740726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64774984|NCT01742208|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
64774985|NCT01742208|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64774986|NCT01742208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774987|NCT01742208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64774988|NCT01742208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774989|NCT01744704|Mitogens|mitogens|mesh-list
64774990|NCT01744704|Mitosis Modulators|mitosis modulators|mesh-ancestor
64386453|NCT01738139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64323618|NCT02744833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323619|NCT02234869|Interferons|interferons|mesh-list
64323620|NCT02234869|Interferon-beta|interferon-beta|mesh-list
64774991|NCT01744704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977296|NCT00261703|Antimetabolites|antimetabolites|mesh-ancestor
64977297|NCT00261703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64540307|NCT03425292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540308|NCT03425292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64540309|NCT03425292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64540310|NCT03425292|Growth Substances|growth substances|mesh-ancestor
64540311|NCT03425292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540312|NCT03425292|Growth Inhibitors|growth inhibitors|mesh-ancestor
64540313|NCT03425292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64775025|NCT01750398|Testosterone enanthate|testosterone enanthate|mesh-list
64386484|NCT01515527|Cytarabine|cytarabine|mesh-list
64386514|NCT01430351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64775026|NCT01750398|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64775029|NCT01750398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64775030|NCT01750398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775031|NCT01750398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64775032|NCT01750398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775033|NCT01750398|Anabolic Agents|anabolic agents|mesh-ancestor
64775034|NCT01750398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64775035|NCT01750398|Fertility Agents|fertility agents|mesh-ancestor
64775036|NCT01750398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64775037|NCT01752426|Deuterium Oxide|deuterium oxide|mesh-list
64775038|NCT01752426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775039|NCT01752426|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64775040|NCT01752426|Protective Agents|protective agents|mesh-ancestor
64775041|NCT01752426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775042|NCT01753362|Liraglutide|liraglutide|mesh-list
64775043|NCT01753362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64775044|NCT01753362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323622|NCT02234869|Interferon beta-1b|interferon beta-1b|mesh-list
64323623|NCT02234869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323624|NCT02234869|Antiviral Agents|antiviral agents|mesh-ancestor
64323625|NCT02234869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64323626|NCT02234869|Immunologic Factors|immunologic factors|mesh-ancestor
64323627|NCT02234869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323628|NCT02234869|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64540314|NCT03425292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305079|NCT05160805|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64977298|NCT00261703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64977299|NCT00261703|Immunologic Factors|immunologic factors|mesh-ancestor
64977300|NCT00261703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977301|NCT00261742|Penicillins|penicillins|mesh-list
64977302|NCT00261742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64977303|NCT00261742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64977305|NCT00072059|Hematinics|hematinics|mesh-ancestor
64775054|NCT01758432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775055|NCT01758432|Anticoagulants|anticoagulants|mesh-ancestor
64775056|NCT01758588|Interferons|interferons|mesh-list
64775057|NCT01758588|Interferon-alpha|interferon-alpha|mesh-list
64775058|NCT01758588|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64775059|NCT01758588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775060|NCT01758588|Antiviral Agents|antiviral agents|mesh-ancestor
64775061|NCT01758588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64775062|NCT01758588|Immunologic Factors|immunologic factors|mesh-ancestor
64775063|NCT01758588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775064|NCT01759602|Complement C1s|complement c1s|mesh-list
64386533|NCT05675033|Growth Inhibitors|growth inhibitors|mesh-ancestor
64323632|NCT05498714|Lactulose|lactulose|mesh-list
64323633|NCT05498714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64323634|NCT05490836|Interferon-alpha|interferon-alpha|mesh-list
64323635|NCT05490836|Interferon alpha-2|interferon alpha-2|mesh-list
64323636|NCT05490836|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
64323637|NCT05490836|Antiviral Agents|antiviral agents|mesh-ancestor
64775065|NCT01759602|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64775066|NCT01759602|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
64775067|NCT01759602|Immunologic Factors|immunologic factors|mesh-ancestor
64775068|NCT01759602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775069|NCT01759602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64977306|NCT00261820|Mycophenolic Acid|mycophenolic acid|mesh-list
64977307|NCT00261820|Sirolimus|sirolimus|mesh-list
64977308|NCT00261820|Methylprednisolone|methylprednisolone|mesh-list
64977309|NCT00261820|Prednisolone|prednisolone|mesh-list
64977310|NCT00261820|Tacrolimus|tacrolimus|mesh-list
64977311|NCT00261820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64977312|NCT00261820|Immunologic Factors|immunologic factors|mesh-ancestor
64977333|NCT00261820|Protective Agents|protective agents|mesh-ancestor
64977334|NCT00261820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64977335|NCT00072098|Interleukin-12|interleukin-12|mesh-list
64977336|NCT00072098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64977337|NCT00072098|Immunologic Factors|immunologic factors|mesh-ancestor
64977338|NCT00072098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977339|NCT00072098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64977340|NCT00072098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64977341|NCT00072098|Growth Substances|growth substances|mesh-ancestor
64977342|NCT00072098|Growth Inhibitors|growth inhibitors|mesh-ancestor
64977343|NCT00072098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977344|NCT00261937|Furosemide|furosemide|mesh-list
64977345|NCT00261937|Diuretics|diuretics|mesh-ancestor
64977346|NCT00261937|Natriuretic Agents|natriuretic agents|mesh-ancestor
64977347|NCT00261937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775154|NCT01773954|Growth Substances|growth substances|mesh-ancestor
64775155|NCT01773954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775156|NCT01773954|Growth Inhibitors|growth inhibitors|mesh-ancestor
64775245|NCT01790490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64775246|NCT01790490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64775247|NCT01790490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775248|NCT01790490|Anticonvulsants|anticonvulsants|mesh-ancestor
64775249|NCT01790490|Antiemetics|antiemetics|mesh-ancestor
64775250|NCT01790490|Autonomic Agents|autonomic agents|mesh-ancestor
64775251|NCT01790490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64543926|NCT04142749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64775252|NCT01790490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64775253|NCT01790490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64775254|NCT01790490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64775255|NCT01790490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64775256|NCT01790490|GABA Modulators|gaba modulators|mesh-ancestor
64775257|NCT01790490|GABA Agents|gaba agents|mesh-ancestor
64775259|NCT01791972|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64977348|NCT00261937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64977349|NCT00261937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64977350|NCT00261937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977351|NCT00105495|Deferiprone|deferiprone|mesh-list
64977352|NCT00105495|Deferoxamine|deferoxamine|mesh-list
64977353|NCT00105495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64977354|NCT00105495|Chelating Agents|chelating agents|mesh-ancestor
64977355|NCT00105495|Sequestering Agents|sequestering agents|mesh-ancestor
64977356|NCT00105495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977357|NCT00105495|Siderophores|siderophores|mesh-ancestor
64775313|NCT01809054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64775314|NCT01809054|Analgesics|analgesics|mesh-ancestor
64775315|NCT01809054|Sensory System Agents|sensory system agents|mesh-ancestor
64775316|NCT01809054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64386774|NCT04714372|Cyclophosphamide|cyclophosphamide|mesh-list
64977359|NCT00261976|Dermatologic Agents|dermatologic agents|mesh-ancestor
64977360|NCT00261976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64775457|NCT01833546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775458|NCT01834404|Topiramate|topiramate|mesh-list
64775459|NCT01834404|Phentermine|phentermine|mesh-list
64775460|NCT01834404|Anticonvulsants|anticonvulsants|mesh-ancestor
64775466|NCT01834404|Sympathomimetics|sympathomimetics|mesh-ancestor
64977361|NCT00261976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64977362|NCT00072137|Metronidazole|metronidazole|mesh-list
64977363|NCT00072137|Molgramostim|molgramostim|mesh-list
64977364|NCT00072137|Vaccines|vaccines|mesh-list
64977365|NCT00072137|Sargramostim|sargramostim|mesh-list
64977366|NCT00072137|Immunologic Factors|immunologic factors|mesh-ancestor
64977390|NCT00262132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64977391|NCT00262132|Antitubercular Agents|antitubercular agents|mesh-ancestor
64977392|NCT00262132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64977393|NCT00262132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64977394|NCT00262132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977395|NCT00262132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977396|NCT00262210|Prednisolone|prednisolone|mesh-list
64977397|NCT00262210|Cyclophosphamide|cyclophosphamide|mesh-list
64540315|NCT03425292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64540316|NCT03425292|Alkylating Agents|alkylating agents|mesh-ancestor
64540317|NCT00596271|Vaccines|vaccines|mesh-list
64540318|NCT00596271|Immunologic Factors|immunologic factors|mesh-ancestor
64540319|NCT00596271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540321|NCT03139422|Calcium Dobesilate|calcium dobesilate|mesh-list
64540322|NCT03139422|Calcium|calcium|mesh-list
64540323|NCT03139422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64540324|NCT03139422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775572|NCT01845792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64775573|NCT01845792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64775574|NCT01845792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775575|NCT01845792|Hormone Antagonists|hormone antagonists|mesh-ancestor
64775576|NCT01845792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64775577|NCT01845792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775578|NCT01845792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64775579|NCT01846728|Estrogens|estrogens|mesh-list
64775580|NCT01846728|Hormones|hormones|mesh-ancestor
64775581|NCT01846728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64775582|NCT01846728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775583|NCT01848054|Buprenorphine|buprenorphine|mesh-list
64775584|NCT01848054|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64775585|NCT01848054|Naloxone|naloxone|mesh-list
64775586|NCT01848054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64775587|NCT01848054|Narcotics|narcotics|mesh-ancestor
64775588|NCT01848054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64775589|NCT01848054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540325|NCT03139422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64540326|NCT03139422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64540327|NCT03139422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540328|NCT03139422|Hemostatics|hemostatics|mesh-ancestor
64540329|NCT03139422|Coagulants|coagulants|mesh-ancestor
64540330|NCT01428583|Naltrexone|naltrexone|mesh-list
64540331|NCT01428583|Oxycodone|oxycodone|mesh-list
64540332|NCT01428583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64540333|NCT01428583|Narcotics|narcotics|mesh-ancestor
64540334|NCT01428583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64540335|NCT01428583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540336|NCT01428583|Analgesics|analgesics|mesh-ancestor
64540337|NCT01428583|Sensory System Agents|sensory system agents|mesh-ancestor
64540338|NCT01428583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64540339|NCT01428583|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64540340|NCT01428583|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64540341|NCT00660543|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64323687|NCT03137407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64323689|NCT02588677|Anticonvulsants|anticonvulsants|mesh-ancestor
64323690|NCT02588677|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64775621|NCT01852344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775622|NCT01852344|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64775623|NCT01852344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64775624|NCT01852344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64775625|NCT01852344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775627|NCT01852344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64775628|NCT01856712|Naltrexone|naltrexone|mesh-list
64775629|NCT01856712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64775630|NCT01856712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64775631|NCT01856712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775632|NCT01856712|Sensory System Agents|sensory system agents|mesh-ancestor
64775633|NCT01856712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64775634|NCT01858428|Paclitaxel|paclitaxel|mesh-list
64775635|NCT01858428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64775636|NCT01858428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775637|NCT01858428|Tubulin Modulators|tubulin modulators|mesh-ancestor
64775638|NCT01858428|Antimitotic Agents|antimitotic agents|mesh-ancestor
64775639|NCT01858428|Mitosis Modulators|mitosis modulators|mesh-ancestor
64387113|NCT02379299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323691|NCT02588677|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64344100|NCT02505542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64540342|NCT00660543|Hematinics|hematinics|mesh-ancestor
64977398|NCT00262210|Etoposide|etoposide|mesh-list
64977399|NCT00262210|Epirubicin|epirubicin|mesh-list
64977400|NCT00262210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64977401|NCT00262210|Immunologic Factors|immunologic factors|mesh-ancestor
64977402|NCT00262210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977403|NCT00262210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64977404|NCT00262210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64977405|NCT00262210|Alkylating Agents|alkylating agents|mesh-ancestor
64977406|NCT00262210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977407|NCT00262210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977408|NCT00262210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64977409|NCT00262210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64977410|NCT00262210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64977411|NCT00262210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64775640|NCT01858428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775641|NCT01861002|Cytarabine|cytarabine|mesh-list
64775642|NCT01861002|Methotrexate|methotrexate|mesh-list
64775643|NCT01861002|Fludarabine phosphate|fludarabine phosphate|mesh-list
64775644|NCT01861002|Azacitidine|azacitidine|mesh-list
64775645|NCT01861002|Fludarabine|fludarabine|mesh-list
64775646|NCT01861002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64775647|NCT01861002|Abortifacient Agents|abortifacient agents|mesh-ancestor
64775648|NCT01861002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64775649|NCT01861002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977412|NCT00262210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977413|NCT00262210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64977415|NCT00262210|Hormones|hormones|mesh-ancestor
64977416|NCT00262210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64977417|NCT00262210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64977418|NCT00262210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64540343|NCT00660543|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64775681|NCT01876212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775682|NCT01876212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775683|NCT01876212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64775684|NCT01876212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64775685|NCT01876212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775686|NCT01876992|Metformin|metformin|mesh-list
64775687|NCT01876992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64775688|NCT01876992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775689|NCT01877538|Donepezil|donepezil|mesh-list
64775690|NCT01877538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64775691|NCT01877538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64775709|NCT01879332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64775710|NCT01879332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775712|NCT05328102|Immunologic Factors|immunologic factors|mesh-ancestor
64775720|NCT05327088|Nalbuphine|nalbuphine|mesh-list
64540344|NCT00660543|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64540345|NCT01428193|Flutamide|flutamide|mesh-list
64540346|NCT01428193|Estradiol|estradiol|mesh-list
64540347|NCT01428193|Progesterone|progesterone|mesh-list
64540348|NCT01428193|Estrogens|estrogens|mesh-ancestor
64540349|NCT01428193|Hormones|hormones|mesh-ancestor
64540350|NCT01428193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64540351|NCT01428193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540352|NCT01428193|Progestins|progestins|mesh-ancestor
64775745|NCT05228574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775746|NCT05228574|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
64775747|NCT05228574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64775748|NCT05228574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64775749|NCT05228574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775750|NCT05228574|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64540353|NCT01428193|Androgen Antagonists|androgen antagonists|mesh-ancestor
64540354|NCT01428193|Hormone Antagonists|hormone antagonists|mesh-ancestor
64540355|NCT01428193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64540356|NCT01428193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540357|NCT03864276|Propofol|propofol|mesh-list
64977419|NCT00262288|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64977444|NCT02966288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977445|NCT00262405|Prednisone|prednisone|mesh-list
64977446|NCT00262405|Zileuton|zileuton|mesh-list
64977447|NCT00262405|Azathioprine|azathioprine|mesh-list
64977448|NCT00262405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64977449|NCT00262405|Glucocorticoids|glucocorticoids|mesh-ancestor
64977450|NCT00262405|Hormones|hormones|mesh-ancestor
64775816|NCT05747352|Insulin|insulin|mesh-list
64993388|NCT02408861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993389|NCT02394834|Calcium, Dietary|calcium, dietary|mesh-list
64993390|NCT02394834|Leucovorin|leucovorin|mesh-list
64993414|NCT02394834|Vitamins|vitamins|mesh-ancestor
64993415|NCT02394834|Micronutrients|micronutrients|mesh-ancestor
64993416|NCT02392429|Cytarabine|cytarabine|mesh-list
64993417|NCT02392429|Alovudine|alovudine|mesh-list
64993418|NCT02392429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64993419|NCT02392429|Antimetabolites|antimetabolites|mesh-ancestor
64993420|NCT02392429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993421|NCT02392429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993422|NCT02392429|Antiviral Agents|antiviral agents|mesh-ancestor
64993423|NCT02392429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64993424|NCT02392429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64993425|NCT02392429|Immunologic Factors|immunologic factors|mesh-ancestor
64993426|NCT02392429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993427|NCT02381561|Ropidoxuridine|ropidoxuridine|mesh-list
64993428|NCT02381561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993429|NCT02381535|Cisplatin|cisplatin|mesh-list
64993430|NCT02381535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993431|NCT02339571|Nivolumab|nivolumab|mesh-list
64993432|NCT02339571|Ipilimumab|ipilimumab|mesh-list
64993433|NCT02339571|Sargramostim|sargramostim|mesh-list
64993434|NCT02339571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64993435|NCT02339571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993436|NCT02339571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64993437|NCT02339571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977451|NCT00262405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64775917|NCT05151588|Mitosis Modulators|mitosis modulators|mesh-ancestor
64977452|NCT00262405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977453|NCT00262405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64977454|NCT00262405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977455|NCT00262405|Antimetabolites|antimetabolites|mesh-ancestor
64977456|NCT00262405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977457|NCT00262405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64977458|NCT00262405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64977459|NCT00262405|Immunologic Factors|immunologic factors|mesh-ancestor
64977460|NCT00262405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64977461|NCT00262405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64977462|NCT00262405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64977464|NCT00262405|Sensory System Agents|sensory system agents|mesh-ancestor
64977465|NCT00262405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64977466|NCT00262405|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64977467|NCT00262405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977468|NCT00262405|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64977469|NCT00262405|Hormone Antagonists|hormone antagonists|mesh-ancestor
64977470|NCT00262483|Ribavirin|ribavirin|mesh-list
64977496|NCT00072215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977497|NCT00072215|Tubulin Modulators|tubulin modulators|mesh-ancestor
64775978|NCT04360044|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64775979|NCT04360044|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64775980|NCT04360044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64775981|NCT04360044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775982|NCT04360044|Hormones|hormones|mesh-ancestor
64977498|NCT00072215|Antimitotic Agents|antimitotic agents|mesh-ancestor
64977499|NCT00072215|Mitosis Modulators|mitosis modulators|mesh-ancestor
64977500|NCT00072215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659424|NCT01286402|Bupropion|bupropion|mesh-list
64659426|NCT01286402|Antidepressive Agents|antidepressive agents|mesh-ancestor
64977501|NCT00072215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64977502|NCT00072215|Alkylating Agents|alkylating agents|mesh-ancestor
64977505|NCT00262795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977506|NCT00262795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776179|NCT01907334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64776180|NCT01907334|Sympathomimetics|sympathomimetics|mesh-ancestor
64776181|NCT01907334|Miotics|miotics|mesh-ancestor
64977507|NCT00262795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64977508|NCT00262795|Alkylating Agents|alkylating agents|mesh-ancestor
64977509|NCT00072332|Cisplatin|cisplatin|mesh-list
64977510|NCT00072332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977511|NCT00263029|Capecitabine|capecitabine|mesh-list
64977512|NCT00263029|Oxaliplatin|oxaliplatin|mesh-list
64540358|NCT03864276|Desflurane|desflurane|mesh-list
64776257|NCT01929642|Sirolimus|sirolimus|mesh-list
64540359|NCT03864276|Anesthetics|anesthetics|mesh-ancestor
64659483|NCT03904251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776334|NCT01951950|Esmolol|esmolol|mesh-list
64540360|NCT03864276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64776407|NCT05739630|Cytarabine|cytarabine|mesh-list
64540361|NCT03864276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540362|NCT03864276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64540363|NCT03864276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64977513|NCT00263029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64977514|NCT00263029|Antimetabolites|antimetabolites|mesh-ancestor
64977515|NCT00263029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977516|NCT00263029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977517|NCT00263068|Rotigotine|rotigotine|mesh-list
64977518|NCT00263068|Dopamine Agonists|dopamine agonists|mesh-ancestor
64659544|NCT00365001|Abortifacient Agents|abortifacient agents|mesh-ancestor
64977534|NCT00101634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64977536|NCT00101634|Dopamine Agents|dopamine agents|mesh-ancestor
64977537|NCT00263185|Vitamin D|vitamin d|mesh-list
64977538|NCT00263185|Ergocalciferols|ergocalciferols|mesh-list
64977539|NCT00263185|Cholecalciferol|cholecalciferol|mesh-list
64977540|NCT00263185|Vitamins|vitamins|mesh-list
64977541|NCT00263185|Calcium Carbonate|calcium carbonate|mesh-list
64977542|NCT00263185|Micronutrients|micronutrients|mesh-ancestor
64977543|NCT00263185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977544|NCT00263185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64977545|NCT00263185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64776679|NCT04883346|Hormones|hormones|mesh-ancestor
64776680|NCT04883346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64776681|NCT04764942|Dexamethasone|dexamethasone|mesh-list
64776682|NCT04764942|Dexamethasone acetate|dexamethasone acetate|mesh-list
64776683|NCT04764942|Pomalidomide|pomalidomide|mesh-list
64776684|NCT04764942|Ichthammol|ichthammol|mesh-list
64776685|NCT04764942|BB 1101|bb 1101|mesh-list
64776686|NCT04764942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64776687|NCT04764942|Antiemetics|antiemetics|mesh-ancestor
64776688|NCT04764942|Autonomic Agents|autonomic agents|mesh-ancestor
64776689|NCT04764942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776690|NCT04764942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776691|NCT04764942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64776692|NCT04764942|Glucocorticoids|glucocorticoids|mesh-ancestor
64776693|NCT04764942|Hormones|hormones|mesh-ancestor
64776694|NCT04764942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64776695|NCT04764942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64776696|NCT04764942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776697|NCT04764942|Protease Inhibitors|protease inhibitors|mesh-ancestor
64776698|NCT04764942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776699|NCT04764942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776700|NCT04764942|Immunologic Factors|immunologic factors|mesh-ancestor
64776701|NCT04764942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64776702|NCT04764942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64776703|NCT04764942|Growth Substances|growth substances|mesh-ancestor
64776704|NCT04764942|Growth Inhibitors|growth inhibitors|mesh-ancestor
64776706|NCT04544436|Methylprednisolone|methylprednisolone|mesh-list
64977546|NCT00263185|Antacids|antacids|mesh-ancestor
64977547|NCT00263185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977548|NCT00263185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64977549|NCT00263263|Sirolimus|sirolimus|mesh-list
64977550|NCT00263263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64977551|NCT00263263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64977552|NCT00263263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64977553|NCT00263263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977554|NCT00263263|Antifungal Agents|antifungal agents|mesh-ancestor
64993438|NCT02339571|Immunologic Factors|immunologic factors|mesh-ancestor
64776720|NCT04544436|Protective Agents|protective agents|mesh-ancestor
64776721|NCT04544436|Immunologic Factors|immunologic factors|mesh-ancestor
64776722|NCT04544436|Histamine Agents|histamine agents|mesh-ancestor
64776723|NCT04544436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64776724|NCT04544436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776725|NCT04538742|Paclitaxel|paclitaxel|mesh-list
64776726|NCT04538742|Trastuzumab|trastuzumab|mesh-list
64776727|NCT04538742|Durvalumab|durvalumab|mesh-list
64776728|NCT04538742|Pertuzumab|pertuzumab|mesh-list
64977555|NCT00263263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64977556|NCT00263263|Immunologic Factors|immunologic factors|mesh-ancestor
64977557|NCT00263263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977559|NCT00101673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64977560|NCT00101673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977561|NCT00101673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64977562|NCT00101673|Protease Inhibitors|protease inhibitors|mesh-ancestor
64977563|NCT00101673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388267|NCT03159845|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64776771|NCT04158258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776772|NCT04158258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64776773|NCT04158258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64776774|NCT04158258|Growth Substances|growth substances|mesh-ancestor
64776775|NCT04158258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776776|NCT04158258|Growth Inhibitors|growth inhibitors|mesh-ancestor
64776777|NCT04158258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64776778|NCT04158258|Antimetabolites|antimetabolites|mesh-ancestor
64323831|NCT05485064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323832|NCT05485064|Analgesics|analgesics|mesh-ancestor
64323833|NCT05485064|Sensory System Agents|sensory system agents|mesh-ancestor
64323834|NCT05485064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64323835|NCT05485064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64323836|NCT05485064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64323837|NCT05485064|Anesthetics, General|anesthetics, general|mesh-ancestor
64323838|NCT05485064|Anesthetics|anesthetics|mesh-ancestor
64323839|NCT05626153|Anesthetics|anesthetics|mesh-list
64429991|NCT05023967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64776779|NCT04158258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776780|NCT03868956|Fibrin fragment D|fibrin fragment d|mesh-list
64776781|NCT03868956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64416664|NCT04845061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977564|NCT00101673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977565|NCT00263302|Dexamethasone|dexamethasone|mesh-list
64977566|NCT00263302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64977567|NCT00263302|Antiemetics|antiemetics|mesh-ancestor
64977568|NCT00263302|Autonomic Agents|autonomic agents|mesh-ancestor
64977569|NCT00263302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64977570|NCT00263302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977571|NCT00263302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64977572|NCT00263302|Glucocorticoids|glucocorticoids|mesh-ancestor
64977573|NCT00263302|Hormones|hormones|mesh-ancestor
64977574|NCT00263302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64977575|NCT00263302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64977576|NCT00263302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977592|NCT00101712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977594|NCT00072527|Irinotecan|irinotecan|mesh-list
64977595|NCT00072527|Etoposide|etoposide|mesh-list
64977596|NCT00072527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977597|NCT00072527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64977598|NCT00072527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64977599|NCT00072527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977600|NCT00072527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977601|NCT00072527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64977602|NCT00072527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64977603|NCT00101751|Insulin Aspart|insulin aspart|mesh-list
64776782|NCT03868956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64776783|NCT03868956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776784|NCT03868956|Hemostatics|hemostatics|mesh-ancestor
64776785|NCT03868956|Coagulants|coagulants|mesh-ancestor
64776786|NCT03847428|Bevacizumab|bevacizumab|mesh-list
64776787|NCT03847428|Durvalumab|durvalumab|mesh-list
64776788|NCT03847428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64323843|NCT02553343|Immunologic Factors|immunologic factors|mesh-ancestor
64323844|NCT02553343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323845|NCT02235415|Lacidipine|lacidipine|mesh-list
64323852|NCT03995017|Nivolumab|nivolumab|mesh-list
64977604|NCT00101751|Biphasic Insulins|biphasic insulins|mesh-list
64977605|NCT00101751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64977606|NCT00101751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977607|NCT00263965|Metformin|metformin|mesh-list
64977608|NCT00263965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64540364|NCT03864276|Anesthetics, General|anesthetics, general|mesh-ancestor
64540365|NCT03864276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64540367|NCT05083026|Antibodies, Blocking|antibodies, blocking|mesh-list
64540368|NCT05083026|Immunologic Factors|immunologic factors|mesh-ancestor
64540369|NCT05083026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540370|NCT03141918|Curcumin|curcumin|mesh-list
64540371|NCT03141918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64540372|NCT03141918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64540373|NCT03141918|Analgesics|analgesics|mesh-ancestor
64540374|NCT03141918|Sensory System Agents|sensory system agents|mesh-ancestor
64323869|NCT02233387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323870|NCT02233387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323871|NCT02521285|Aspirin|aspirin|mesh-list
64323872|NCT02521285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64323873|NCT02521285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64323874|NCT02521285|Analgesics|analgesics|mesh-ancestor
64323875|NCT02521285|Sensory System Agents|sensory system agents|mesh-ancestor
64323876|NCT02521285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64323877|NCT02521285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323878|NCT02521285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64323879|NCT02521285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64323880|NCT02521285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64323881|NCT02521285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64323882|NCT02521285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323883|NCT02521285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64323884|NCT02521285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64323885|NCT02521285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540375|NCT03141918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64540376|NCT03141918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540377|NCT03141918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64540378|NCT03141918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64540379|NCT03141918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977609|NCT00263965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977611|NCT00264082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64977612|NCT00264082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977613|NCT00072683|Tolvaptan|tolvaptan|mesh-list
64977614|NCT00072683|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64977615|NCT00072683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323893|NCT04227769|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64323894|NCT04227769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64323895|NCT02688387|Ambrisentan|ambrisentan|mesh-list
64323896|NCT02688387|Tadalafil|tadalafil|mesh-list
64323897|NCT02688387|Vasodilator Agents|vasodilator agents|mesh-ancestor
64323898|NCT02688387|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64323899|NCT02688387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64388303|NCT02350439|Adenosine|adenosine|mesh-list
64388304|NCT02350439|Analgesics|analgesics|mesh-ancestor
64388305|NCT02350439|Sensory System Agents|sensory system agents|mesh-ancestor
64388306|NCT02350439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64388311|NCT02350439|Purinergic Agonists|purinergic agonists|mesh-ancestor
64388312|NCT02350439|Purinergic Agents|purinergic agents|mesh-ancestor
64388313|NCT02350439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64776836|NCT03462342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977616|NCT00072683|Natriuretic Agents|natriuretic agents|mesh-ancestor
64977617|NCT00072683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977618|NCT00101790|Pamidronate|pamidronate|mesh-list
64977619|NCT00101790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64977620|NCT00101790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977621|NCT00264277|Vitamin K|vitamin k|mesh-list
64977622|NCT00264277|Anticoagulants|anticoagulants|mesh-list
64977623|NCT00264277|Vitamins|vitamins|mesh-ancestor
64977624|NCT00264277|Micronutrients|micronutrients|mesh-ancestor
64977625|NCT00264277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659910|NCT01715207|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64977626|NCT00264277|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64977627|NCT00264277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64977628|NCT00264277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977629|NCT00264277|Hemostatics|hemostatics|mesh-ancestor
64977630|NCT00264277|Coagulants|coagulants|mesh-ancestor
64977631|NCT00415753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64977632|NCT00415753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64977633|NCT04709029|Dexamethasone|dexamethasone|mesh-list
64977634|NCT04709029|Dexamethasone acetate|dexamethasone acetate|mesh-list
64977636|NCT04709029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64977637|NCT04709029|Antiemetics|antiemetics|mesh-ancestor
64977664|NCT00264355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977665|NCT00264355|Antifungal Agents|antifungal agents|mesh-ancestor
64977666|NCT00264355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64977667|NCT00264355|Dermatologic Agents|dermatologic agents|mesh-ancestor
64977668|NCT00264355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64977669|NCT00264355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64776837|NCT03366480|Paclitaxel|paclitaxel|mesh-list
64776838|NCT03366480|Carboplatin|carboplatin|mesh-list
64388314|NCT02350439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388315|NCT02350673|Atezolizumab|atezolizumab|mesh-list
64388316|NCT02350673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388317|NCT02350361|Endostatins|endostatins|mesh-list
64388318|NCT02350361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64388319|NCT02350361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64388320|NCT02350361|Growth Substances|growth substances|mesh-ancestor
64388321|NCT02350361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388322|NCT02350361|Growth Inhibitors|growth inhibitors|mesh-ancestor
64388323|NCT02350361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977670|NCT00264472|Eniluracil|eniluracil|mesh-list
64776870|NCT02723994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64977671|NCT00264472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659967|NCT01215344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64977672|NCT00264472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977674|NCT00101829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64977675|NCT00101829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977676|NCT00101829|Immunologic Factors|immunologic factors|mesh-ancestor
64977677|NCT00101829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977678|NCT00101829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64540381|NCT03141918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540383|NCT01427803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64540384|NCT01427803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64776871|NCT02723994|Alkylating Agents|alkylating agents|mesh-ancestor
64776872|NCT02723994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776873|NCT02723994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776874|NCT02723994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64776875|NCT02723994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64776876|NCT02723994|Antiemetics|antiemetics|mesh-ancestor
64776877|NCT02723994|Autonomic Agents|autonomic agents|mesh-ancestor
64776878|NCT02723994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776879|NCT02723994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64776880|NCT02723994|Glucocorticoids|glucocorticoids|mesh-ancestor
64540385|NCT01427803|Analgesics|analgesics|mesh-ancestor
64540386|NCT01427803|Sensory System Agents|sensory system agents|mesh-ancestor
64540387|NCT01427803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64540388|NCT01427803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540389|NCT01427803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64540390|NCT01427803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64540391|NCT01427803|Gout Suppressants|gout suppressants|mesh-ancestor
64540392|NCT01427803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64776919|NCT02216838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64776920|NCT02216838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64776921|NCT02216838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776922|NCT02216838|Cholinergic Agents|cholinergic agents|mesh-ancestor
64776923|NCT02216838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64776924|NCT02216838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776925|NCT02216838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64776926|NCT02216838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776927|NCT02065596|Fludarabine|fludarabine|mesh-list
64776928|NCT02065596|Fludarabine phosphate|fludarabine phosphate|mesh-list
64776929|NCT02065596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388390|NCT03154385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388391|NCT03154385|Immunologic Factors|immunologic factors|mesh-ancestor
64323905|NCT05489900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64323906|NCT05489900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64323907|NCT05489900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323908|NCT05489900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64323909|NCT05489900|Analgesics|analgesics|mesh-ancestor
64323910|NCT05489900|Sensory System Agents|sensory system agents|mesh-ancestor
64323911|NCT05489900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64323912|NCT05489900|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64323913|NCT05489900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64323914|NCT05489900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64540393|NCT01427803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540394|NCT01427803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540395|NCT03139500|Midazolam|midazolam|mesh-list
64540396|NCT03139500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64540397|NCT03139500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64540398|NCT03139500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64540399|NCT03139500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540401|NCT03139500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64540402|NCT03139500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64540403|NCT03139500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64540404|NCT03139500|Anesthetics, General|anesthetics, general|mesh-ancestor
64540405|NCT03139500|Anesthetics|anesthetics|mesh-ancestor
64540406|NCT03139500|GABA Modulators|gaba modulators|mesh-ancestor
64323921|NCT05542849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323922|NCT05542849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64323923|NCT05542849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323924|NCT05489666|Vitamin D|vitamin d|mesh-list
64323925|NCT05489666|Cholecalciferol|cholecalciferol|mesh-list
64323926|NCT05489666|Vitamins|vitamins|mesh-ancestor
64776952|NCT01976286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64776953|NCT01976286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64776954|NCT01976286|Analgesics|analgesics|mesh-ancestor
64776955|NCT01976286|Sensory System Agents|sensory system agents|mesh-ancestor
64776956|NCT01976286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776957|NCT01976286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776958|NCT01976286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64388429|NCT02349113|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64388430|NCT02349113|Hormones|hormones|mesh-ancestor
64388431|NCT02349113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64388432|NCT02349113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388433|NCT02349113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64388434|NCT02349113|Contraceptive Agents|contraceptive agents|mesh-ancestor
64388435|NCT02349113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64540407|NCT03139500|GABA Agents|gaba agents|mesh-ancestor
64540408|NCT03139500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64540409|NCT03139500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540410|NCT00661479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64323927|NCT05489666|Micronutrients|micronutrients|mesh-ancestor
64540411|NCT00661479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64540412|NCT00661479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64540413|NCT00661479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64540419|NCT04476966|Mirabegron|mirabegron|mesh-list
64540420|NCT04476966|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64540421|NCT04476966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64540422|NCT04476966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64305194|NCT02971891|Furosemide|furosemide|mesh-list
64323928|NCT05489666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776959|NCT01976286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64776960|NCT01976286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64776961|NCT01976286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776962|NCT01976286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776963|NCT01858740|Methotrexate|methotrexate|mesh-list
64776964|NCT01858740|Fludarabine phosphate|fludarabine phosphate|mesh-list
64776965|NCT01858740|Fludarabine|fludarabine|mesh-list
64776966|NCT01858740|Thiotepa|thiotepa|mesh-list
64776967|NCT01858740|Tacrolimus|tacrolimus|mesh-list
64776968|NCT01858740|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64323929|NCT05489666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64323930|NCT05489666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64323931|NCT05484284|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64977679|NCT00072839|Teduglutide|teduglutide|mesh-list
64977680|NCT00072839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64977681|NCT00072839|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64977682|NCT00072839|Protective Agents|protective agents|mesh-ancestor
64977683|NCT00072839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977684|NCT00264628|Casopitant|casopitant|mesh-list
64977685|NCT00264628|Antiemetics|antiemetics|mesh-ancestor
64977698|NCT00265018|Bleomycin|bleomycin|mesh-list
64977699|NCT00265018|Vinblastine|vinblastine|mesh-list
64977700|NCT00265018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64977701|NCT00265018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776977|NCT01858740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776978|NCT01858740|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64545658|NCT05222256|Simendan|simendan|mesh-list
64776979|NCT01858740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64776980|NCT01858740|Immunologic Factors|immunologic factors|mesh-ancestor
64776981|NCT01858740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64388444|NCT04183205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64388445|NCT04183205|Serotonin Agents|serotonin agents|mesh-ancestor
64388446|NCT04183205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388447|NCT04151849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64388448|NCT04151849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388449|NCT04151849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64388450|NCT04151849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388451|NCT02348177|Ritonavir|ritonavir|mesh-list
64388452|NCT02348177|Lopinavir|lopinavir|mesh-list
64388453|NCT02348177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64388454|NCT02348177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64388455|NCT02348177|Protease Inhibitors|protease inhibitors|mesh-ancestor
64388456|NCT02348177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776982|NCT01858740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64776983|NCT01858740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64776984|NCT01858740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64776985|NCT01858740|Alkylating Agents|alkylating agents|mesh-ancestor
64776986|NCT01858740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64776987|NCT01688076|Botulinum Toxins|botulinum toxins|mesh-list
64776988|NCT01688076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64776989|NCT01688076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64388457|NCT02348177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323932|NCT05484284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64323933|NCT05483894|Atorvastatin|atorvastatin|mesh-list
64323934|NCT05483894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64977702|NCT00265018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64977703|NCT00265018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64977704|NCT00265018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977705|NCT00265018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977706|NCT00265018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64977707|NCT00265018|Tubulin Modulators|tubulin modulators|mesh-ancestor
64977708|NCT00265018|Antimitotic Agents|antimitotic agents|mesh-ancestor
64977709|NCT00265018|Mitosis Modulators|mitosis modulators|mesh-ancestor
64977710|NCT00265135|Siltuximab|siltuximab|mesh-list
64977711|NCT00265135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64777001|NCT01239030|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64388464|NCT02348255|Bevacizumab|bevacizumab|mesh-list
64388465|NCT02348255|Carmustine|carmustine|mesh-list
64388466|NCT02348255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64388467|NCT02348255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388468|NCT02348255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64388469|NCT02348255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64388470|NCT02348255|Growth Substances|growth substances|mesh-ancestor
64777008|NCT01086540|Diphenhydramine|diphenhydramine|mesh-list
64777009|NCT01086540|Promethazine|promethazine|mesh-list
64777010|NCT01086540|Prednisone|prednisone|mesh-list
64777011|NCT01086540|Methylprednisolone|methylprednisolone|mesh-list
64388471|NCT02348255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388472|NCT02348255|Growth Inhibitors|growth inhibitors|mesh-ancestor
64388473|NCT02348255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64388474|NCT02348255|Alkylating Agents|alkylating agents|mesh-ancestor
64388475|NCT02348255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388476|NCT02348333|Dotinurad|dotinurad|mesh-list
64977712|NCT00106197|Bupropion|bupropion|mesh-list
64977713|NCT00106197|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64977714|NCT00106197|Antidepressive Agents|antidepressive agents|mesh-ancestor
64977715|NCT00106197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64977716|NCT00106197|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64977717|NCT00106197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64977718|NCT00106197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64977719|NCT00106197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323935|NCT05483894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64323936|NCT05483894|Antimetabolites|antimetabolites|mesh-ancestor
64323937|NCT05483894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323938|NCT05483894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64323939|NCT05483894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64323940|NCT05483894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323941|NCT01621243|Gemcitabine|gemcitabine|mesh-list
64323942|NCT01621243|Paclitaxel|paclitaxel|mesh-list
64323943|NCT01621243|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64323944|NCT01621243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64323945|NCT01621243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323946|NCT01621243|Tubulin Modulators|tubulin modulators|mesh-ancestor
64323949|NCT01621243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323951|NCT01621243|Antimetabolites|antimetabolites|mesh-ancestor
64777027|NCT01086540|Antipyretics|antipyretics|mesh-ancestor
64977720|NCT00106197|Dopamine Agents|dopamine agents|mesh-ancestor
64977721|NCT00106197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64977722|NCT00106197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977723|NCT00106197|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64977724|NCT00106197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64977725|NCT00106197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977726|NCT00265252|Alendronate|alendronate|mesh-list
64977727|NCT00265252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64977728|NCT00265252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977729|NCT00265291|Fluoxetine|fluoxetine|mesh-list
64977730|NCT00265291|Desipramine|desipramine|mesh-list
64977731|NCT00265291|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64977732|NCT00265291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64977733|NCT00265291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64993439|NCT02339571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777038|NCT01086540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64777039|NCT01086540|Histamine Antagonists|histamine antagonists|mesh-ancestor
64777041|NCT01086540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64777042|NCT01086540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777043|NCT01086540|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64777044|NCT01086540|Antipruritics|antipruritics|mesh-ancestor
64977734|NCT00265291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977735|NCT00265291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64977737|NCT00265291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977738|NCT00265291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64977739|NCT00265291|Antidepressive Agents|antidepressive agents|mesh-ancestor
64977740|NCT00265291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64977741|NCT00265291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64977742|NCT00265291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64977743|NCT00265291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977744|NCT00265291|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64977795|NCT00265993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977796|NCT00266149|Lamotrigine|lamotrigine|mesh-list
64977797|NCT00266149|Anticonvulsants|anticonvulsants|mesh-ancestor
64977798|NCT00266149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64977799|NCT00266149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64977800|NCT00266149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323987|NCT01610245|Antiviral Agents|antiviral agents|mesh-ancestor
64323988|NCT01610245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64777058|NCT01965366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777059|NCT01965366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777060|NCT01965366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64777061|NCT01965366|Glucocorticoids|glucocorticoids|mesh-ancestor
64777062|NCT01965366|Hormones|hormones|mesh-ancestor
64777063|NCT01965366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64777064|NCT01965366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64777065|NCT01965366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64777066|NCT01965756|Metformin|metformin|mesh-list
64777067|NCT01965756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64777068|NCT01965756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777069|NCT01967862|Listerine|listerine|mesh-list
64777070|NCT01967862|Fluorides|fluorides|mesh-list
64777071|NCT01967862|Sodium Fluoride|sodium fluoride|mesh-list
64777072|NCT01967862|Cariostatic Agents|cariostatic agents|mesh-ancestor
64777073|NCT01967862|Protective Agents|protective agents|mesh-ancestor
64388516|NCT04478513|Fluvoxamine|fluvoxamine|mesh-list
64323989|NCT01610245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323990|NCT01610245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323991|NCT01610245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64388528|NCT04478513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64388529|NCT04478513|Antidepressive Agents|antidepressive agents|mesh-ancestor
64388530|NCT04478513|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64388531|NCT04478513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64388532|NCT04478513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388533|NCT04478513|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64388534|NCT02342093|Drospirenone|drospirenone|mesh-list
64323992|NCT04138628|Atezolizumab|atezolizumab|mesh-list
64323993|NCT04138628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977801|NCT00266149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64977802|NCT00266149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977803|NCT00266149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64540423|NCT04476966|Adrenergic Agents|adrenergic agents|mesh-ancestor
64540424|NCT04476966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64777105|NCT01984398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64540425|NCT04476966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540426|NCT04476966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540427|NCT04476966|Urological Agents|urological agents|mesh-ancestor
64540428|NCT03821610|Cyclophosphamide|cyclophosphamide|mesh-list
64540430|NCT03821610|Fludarabine|fludarabine|mesh-list
64540431|NCT03821610|Alemtuzumab|alemtuzumab|mesh-list
64540432|NCT03821610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64777106|NCT01984398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64777107|NCT01987752|Timolol|timolol|mesh-list
64777108|NCT01987752|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64777109|NCT01987752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64777110|NCT01987752|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
64777111|NCT01987752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64777112|NCT01987752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777113|NCT01987752|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64777114|NCT01987752|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64777115|NCT01987752|Adrenergic Agents|adrenergic agents|mesh-ancestor
64777116|NCT01987752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64388556|NCT02341703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64388557|NCT02341703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64388558|NCT02341703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388559|NCT02341703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388560|NCT02341703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64388561|NCT02341703|Hormone Antagonists|hormone antagonists|mesh-ancestor
64388562|NCT02341703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64388563|NCT02341547|Epoetin Alfa|epoetin alfa|mesh-list
64388564|NCT02341547|Hematinics|hematinics|mesh-ancestor
64323998|NCT04138394|Antioxidants|antioxidants|mesh-ancestor
64323999|NCT04138394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540433|NCT03821610|Immunologic Factors|immunologic factors|mesh-ancestor
64540434|NCT03821610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540435|NCT03821610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64660373|NCT01243112|Mydriatics|mydriatics|mesh-ancestor
64540436|NCT03821610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64540437|NCT03821610|Alkylating Agents|alkylating agents|mesh-ancestor
64540438|NCT03821610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540439|NCT03821610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324000|NCT04138394|Protective Agents|protective agents|mesh-ancestor
64324002|NCT02741791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64324003|NCT02741791|Antidepressive Agents|antidepressive agents|mesh-ancestor
64324004|NCT02741791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64324005|NCT02741791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64324006|NCT02741791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64324007|NCT02741791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64324008|NCT02741791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324009|NCT02741791|Dopamine Agents|dopamine agents|mesh-ancestor
64324010|NCT02741791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64324011|NCT02741791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324012|NCT02741791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64777117|NCT01987752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777118|NCT01987752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64777119|NCT01987752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64777120|NCT01987752|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64777121|NCT01987752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64777122|NCT01987752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64777124|NCT01988922|Analgesics|analgesics|mesh-ancestor
64777125|NCT01988922|Sensory System Agents|sensory system agents|mesh-ancestor
64777126|NCT01988922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777127|NCT01988922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777128|NCT01988922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64777129|NCT01988922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64388572|NCT02346539|Nicotine|nicotine|mesh-list
64324014|NCT02741791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324015|NCT05436535|Triamcinolone|triamcinolone|mesh-list
64324016|NCT05436535|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64324017|NCT05436535|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64324018|NCT05436535|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64540440|NCT03821610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64977804|NCT00266149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64977805|NCT00266149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64977806|NCT00266149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64977807|NCT00266149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64977808|NCT00106314|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64977809|NCT00106314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64977810|NCT00106314|Immunologic Factors|immunologic factors|mesh-ancestor
64977811|NCT00106314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977812|NCT00415792|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64324021|NCT05436535|Hormones|hormones|mesh-ancestor
64324022|NCT05436535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64777138|NCT01994538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64777139|NCT01994538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64777140|NCT01994538|Adrenergic Agents|adrenergic agents|mesh-ancestor
64777141|NCT01994538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64777142|NCT01994538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388581|NCT02346539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388582|NCT05254223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64388584|NCT02340455|Analgesics|analgesics|mesh-ancestor
64388585|NCT02340455|Sensory System Agents|sensory system agents|mesh-ancestor
64324026|NCT05436535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324027|NCT05436535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777144|NCT01994538|Sympathomimetics|sympathomimetics|mesh-ancestor
64777145|NCT01994538|Autonomic Agents|autonomic agents|mesh-ancestor
64777146|NCT01994538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777147|NCT01994538|Nasal Decongestants|nasal decongestants|mesh-ancestor
64777148|NCT01994538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64777149|NCT01994538|Respiratory System Agents|respiratory system agents|mesh-ancestor
64777150|NCT01998438|Tranexamic Acid|tranexamic acid|mesh-list
64777151|NCT01998438|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64777152|NCT01998438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64777153|NCT01998438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388586|NCT02340455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64388587|NCT02340455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388588|NCT02340455|Anticonvulsants|anticonvulsants|mesh-ancestor
64777154|NCT01998438|Hemostatics|hemostatics|mesh-ancestor
64777155|NCT01998438|Coagulants|coagulants|mesh-ancestor
64777156|NCT01999530|Prazosin|prazosin|mesh-list
64777157|NCT01999530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64777158|NCT01999530|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64777159|NCT01999530|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64777160|NCT01999530|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64777161|NCT01999530|Adrenergic Agents|adrenergic agents|mesh-ancestor
64777162|NCT01999530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64777163|NCT01999530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777164|NCT01999530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977813|NCT00415792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64977814|NCT00415792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977816|NCT00415831|Carbidopa|carbidopa|mesh-list
64977817|NCT00415831|Entacapone|entacapone|mesh-list
64977818|NCT00415831|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64977819|NCT00415831|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64977820|NCT00415831|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64977821|NCT00415831|Dopamine Agents|dopamine agents|mesh-ancestor
64977822|NCT00415831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64977823|NCT00415831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977824|NCT00415831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977825|NCT00415831|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64388625|NCT02345993|Hormones|hormones|mesh-ancestor
64324037|NCT04275518|Immunologic Factors|immunologic factors|mesh-ancestor
64324038|NCT04275518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777193|NCT02004132|Androgens|androgens|mesh-ancestor
64777194|NCT02004132|Hormones|hormones|mesh-ancestor
64777195|NCT02004132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64777196|NCT02004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777197|NCT02004366|Insulin Glargine|insulin glargine|mesh-list
64777198|NCT02004366|Linagliptin|linagliptin|mesh-list
64777199|NCT02004366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64777200|NCT02004366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777201|NCT02004366|Incretins|incretins|mesh-ancestor
64545887|NCT02081443|Ticagrelor|ticagrelor|mesh-list
64777203|NCT02004366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64777204|NCT02004366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64777205|NCT02004366|Protease Inhibitors|protease inhibitors|mesh-ancestor
64388635|NCT02340611|Cediranib|cediranib|mesh-list
64324039|NCT04275518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324040|NCT02263495|Gemcitabine|gemcitabine|mesh-list
64324041|NCT02263495|Paclitaxel|paclitaxel|mesh-list
64324042|NCT02263495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64324043|NCT02263495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324044|NCT02263495|Tubulin Modulators|tubulin modulators|mesh-ancestor
64324045|NCT02263495|Antimitotic Agents|antimitotic agents|mesh-ancestor
64324046|NCT02263495|Mitosis Modulators|mitosis modulators|mesh-ancestor
64324047|NCT02263495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324048|NCT02263495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64324049|NCT02263495|Antimetabolites|antimetabolites|mesh-ancestor
64977826|NCT00415831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977827|NCT00415831|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64977828|NCT00415831|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64977829|NCT00415831|Immunologic Factors|immunologic factors|mesh-ancestor
64977830|NCT00415831|Dopamine Agonists|dopamine agonists|mesh-ancestor
64977831|NCT00102141|Drospirenone|drospirenone|mesh-list
64977832|NCT00102141|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64977833|NCT00102141|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64977834|NCT00102141|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64977835|NCT00102141|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
64977836|NCT00102141|Estradiol|estradiol|mesh-list
64977837|NCT00102141|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64977850|NCT00102141|Natriuretic Agents|natriuretic agents|mesh-ancestor
64977851|NCT00102141|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64324050|NCT02263495|Antiviral Agents|antiviral agents|mesh-ancestor
64324051|NCT02263495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324052|NCT02263495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324053|NCT02263495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64324054|NCT02263495|Immunologic Factors|immunologic factors|mesh-ancestor
64324055|NCT02263495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324056|NCT02687451|Oxymorphone|oxymorphone|mesh-list
64324057|NCT02687451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64324058|NCT02687451|Narcotics|narcotics|mesh-ancestor
64324059|NCT02687451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64324060|NCT02687451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324061|NCT02687451|Analgesics|analgesics|mesh-ancestor
64324062|NCT02687451|Sensory System Agents|sensory system agents|mesh-ancestor
64324063|NCT02687451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64324064|NCT02687451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64324066|NCT02557646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64324067|NCT02557646|Antimetabolites|antimetabolites|mesh-ancestor
64324068|NCT02557646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324069|NCT02557646|Antiviral Agents|antiviral agents|mesh-ancestor
64777206|NCT02004366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64777207|NCT02004366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777208|NCT02004990|Povidone-Iodine|povidone-iodine|mesh-list
64777209|NCT02004990|Povidone|povidone|mesh-list
64777210|NCT02004990|Plasma Substitutes|plasma substitutes|mesh-ancestor
64777211|NCT02004990|Blood Substitutes|blood substitutes|mesh-ancestor
64777222|NCT02011464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777223|NCT02011464|Sensory System Agents|sensory system agents|mesh-ancestor
64777224|NCT02011464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777226|NCT02020278|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64777227|NCT02020278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777228|NCT02020278|Natriuretic Agents|natriuretic agents|mesh-ancestor
64777229|NCT02020278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977852|NCT00102141|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64977853|NCT00266344|Gaboxadol|gaboxadol|mesh-list
64540441|NCT03821610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64540442|NCT00683163|Ibandronic Acid|ibandronic acid|mesh-list
64540443|NCT00683163|Parathyroid Hormone|parathyroid hormone|mesh-list
64540444|NCT00683163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64540445|NCT00683163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540446|NCT00683163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64540447|NCT03768414|Gemcitabine|gemcitabine|mesh-list
64540448|NCT03768414|Paclitaxel|paclitaxel|mesh-list
64540449|NCT03768414|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64540450|NCT03768414|Cisplatin|cisplatin|mesh-list
64540451|NCT03768414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64777233|NCT02024646|Immunologic Factors|immunologic factors|mesh-ancestor
64777234|NCT02024646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777235|NCT02024724|Dexamethasone|dexamethasone|mesh-list
64777236|NCT02024724|Triamcinolone|triamcinolone|mesh-list
64777237|NCT02024724|Bupivacaine|bupivacaine|mesh-list
64777238|NCT02024724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64777239|NCT02024724|Antiemetics|antiemetics|mesh-ancestor
64777240|NCT02024724|Autonomic Agents|autonomic agents|mesh-ancestor
64777241|NCT02024724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777242|NCT02024724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777243|NCT02024724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64777244|NCT02024724|Glucocorticoids|glucocorticoids|mesh-ancestor
64540452|NCT03768414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540453|NCT03768414|Tubulin Modulators|tubulin modulators|mesh-ancestor
64540454|NCT03768414|Antimitotic Agents|antimitotic agents|mesh-ancestor
64540455|NCT03768414|Mitosis Modulators|mitosis modulators|mesh-ancestor
64540456|NCT03768414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540457|NCT03768414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64540458|NCT03768414|Antimetabolites|antimetabolites|mesh-ancestor
64540459|NCT03768414|Antiviral Agents|antiviral agents|mesh-ancestor
64540460|NCT03768414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64540461|NCT03768414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540462|NCT03768414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64540463|NCT03768414|Immunologic Factors|immunologic factors|mesh-ancestor
64540464|NCT03768414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540465|NCT04044001|Isoniazid|isoniazid|mesh-list
64540466|NCT04044001|Pyrazinamide|pyrazinamide|mesh-list
64540467|NCT04044001|Ethambutol|ethambutol|mesh-list
64540468|NCT04044001|Dolutegravir|dolutegravir|mesh-list
64540469|NCT04044001|Antitubercular Agents|antitubercular agents|mesh-ancestor
64977854|NCT00266344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64977855|NCT00266344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977856|NCT00266344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977857|NCT00266344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777263|NCT02025426|Nasal Decongestants|nasal decongestants|mesh-ancestor
64777264|NCT02025426|Respiratory System Agents|respiratory system agents|mesh-ancestor
64777265|NCT02025426|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64388691|NCT02339207|Antiviral Agents|antiviral agents|mesh-ancestor
64388692|NCT02339207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64388693|NCT02344511|Vancomycin|vancomycin|mesh-list
64388694|NCT02344511|Cefazolin|cefazolin|mesh-list
64388695|NCT02344511|Dalbavancin|dalbavancin|mesh-list
64388696|NCT02344511|Oxacillin|oxacillin|mesh-list
64388697|NCT02344511|Nafcillin|nafcillin|mesh-list
64388700|NCT02344589|Lidocaine|lidocaine|mesh-list
64777298|NCT02030574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777299|NCT02030574|Antiviral Agents|antiviral agents|mesh-ancestor
64777300|NCT02030574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64777301|NCT02030574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64777302|NCT02030574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64777303|NCT02030574|Immunologic Factors|immunologic factors|mesh-ancestor
64777304|NCT02030574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777305|NCT02032212|Nicotine|nicotine|mesh-list
64388719|NCT02337881|Sildenafil Citrate|sildenafil citrate|mesh-list
64388720|NCT02337881|Vasodilator Agents|vasodilator agents|mesh-ancestor
64388721|NCT02337881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64324109|NCT01578655|Prednisone|prednisone|mesh-list
64324110|NCT01578655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64324113|NCT01578655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64324114|NCT01578655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324115|NCT01578655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64324119|NCT05361447|Diazepam|diazepam|mesh-list
64324120|NCT05361447|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64777306|NCT02032212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64777307|NCT02032212|Autonomic Agents|autonomic agents|mesh-ancestor
64777308|NCT02032212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777309|NCT02032212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777310|NCT02032212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64977858|NCT00266344|Analgesics|analgesics|mesh-ancestor
64977859|NCT00266344|Sensory System Agents|sensory system agents|mesh-ancestor
64977860|NCT00266344|Anticonvulsants|anticonvulsants|mesh-ancestor
64977861|NCT00266344|GABA Agonists|gaba agonists|mesh-ancestor
64977862|NCT00266344|GABA Agents|gaba agents|mesh-ancestor
64977863|NCT00266539|Fentanyl|fentanyl|mesh-list
64977864|NCT00266539|Morphine|morphine|mesh-list
64977865|NCT00266539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64977866|NCT00266539|Narcotics|narcotics|mesh-ancestor
64977867|NCT00266539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64777333|NCT02036424|Growth Inhibitors|growth inhibitors|mesh-ancestor
64777334|NCT02036424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64777335|NCT02036424|Antiemetics|antiemetics|mesh-ancestor
64777336|NCT02036424|Autonomic Agents|autonomic agents|mesh-ancestor
64777337|NCT02036424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64388769|NCT04850495|Mitosis Modulators|mitosis modulators|mesh-ancestor
64388770|NCT04850495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64388771|NCT02337023|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
64388772|NCT02337023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64388773|NCT02337023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388774|NCT04477811|Vitamins|vitamins|mesh-list
64388775|NCT04477811|Vitamin K|vitamin k|mesh-list
64977868|NCT00266539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977869|NCT00266539|Analgesics|analgesics|mesh-ancestor
64977870|NCT00266539|Sensory System Agents|sensory system agents|mesh-ancestor
64977871|NCT00266539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64977872|NCT00266539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64540470|NCT04044001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64540471|NCT04044001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64540472|NCT04044001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540473|NCT04044001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540474|NCT04044001|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64324125|NCT05361447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324126|NCT05361447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64324127|NCT05361447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64324128|NCT05361447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64324129|NCT05361447|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64324130|NCT05361447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64324131|NCT05361447|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64324132|NCT05361447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64660691|NCT01311674|Vaccines|vaccines|mesh-list
64540475|NCT04044001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64540476|NCT04044001|Antimetabolites|antimetabolites|mesh-ancestor
64540477|NCT04044001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64540478|NCT04044001|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64540479|NCT04044001|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64540480|NCT04044001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64540481|NCT04044001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64540482|NCT04044001|Antiviral Agents|antiviral agents|mesh-ancestor
64540485|NCT00684723|Dihydromevinolin|dihydromevinolin|mesh-list
64540486|NCT00684723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64540487|NCT00684723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64540488|NCT00684723|Antimetabolites|antimetabolites|mesh-ancestor
64993441|NCT02327078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64777397|NCT02057640|Panobinostat|panobinostat|mesh-list
64777398|NCT02057640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64777399|NCT02057640|Antiemetics|antiemetics|mesh-ancestor
64777400|NCT02057640|Autonomic Agents|autonomic agents|mesh-ancestor
64388831|NCT02820311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64388832|NCT02820311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64388833|NCT02820311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64388834|NCT02820311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388835|NCT02820311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388836|NCT02820311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388837|NCT02336633|Resveratrol|resveratrol|mesh-list
64388838|NCT02336633|Antioxidants|antioxidants|mesh-ancestor
64388839|NCT02336633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388840|NCT02336633|Protective Agents|protective agents|mesh-ancestor
64777407|NCT02057640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64777408|NCT02057640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64777409|NCT02057640|Protease Inhibitors|protease inhibitors|mesh-ancestor
64388850|NCT04624451|Dalbavancin|dalbavancin|mesh-list
64540489|NCT00684723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540490|NCT00684723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64540491|NCT00684723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64540492|NCT00684723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540493|NCT01405027|Interferons|interferons|mesh-list
64540494|NCT01405027|Ribavirin|ribavirin|mesh-list
64540495|NCT01405027|Interferon-alpha|interferon-alpha|mesh-list
64540496|NCT01405027|Interferon alpha-2|interferon alpha-2|mesh-list
64777419|NCT02059902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777420|NCT02059902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64388852|NCT04624451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64388853|NCT02642315|Gabapentin|gabapentin|mesh-list
64388854|NCT02642315|Analgesics|analgesics|mesh-ancestor
64388855|NCT02642315|Sensory System Agents|sensory system agents|mesh-ancestor
64388856|NCT02642315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64388857|NCT02642315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388858|NCT02642315|Anticonvulsants|anticonvulsants|mesh-ancestor
64388859|NCT02642315|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64388860|NCT02642315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64388861|NCT02642315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64324150|NCT01573351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324151|NCT01573351|Antiviral Agents|antiviral agents|mesh-ancestor
64388862|NCT02642315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64388863|NCT02642315|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64388864|NCT02642315|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64388865|NCT02642315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64388866|NCT02642315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388867|NCT02642315|Antimanic Agents|antimanic agents|mesh-ancestor
64388868|NCT02518139|Tiotropium Bromide|tiotropium bromide|mesh-list
64388869|NCT02518139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64324154|NCT01573351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324155|NCT01573351|Immunologic Factors|immunologic factors|mesh-ancestor
64324156|NCT01573351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324157|NCT01573351|Protease Inhibitors|protease inhibitors|mesh-ancestor
64777429|NCT02061384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64777430|NCT02061384|Keratolytic Agents|keratolytic agents|mesh-ancestor
64777431|NCT02061384|Dermatologic Agents|dermatologic agents|mesh-ancestor
64777432|NCT02061384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64777433|NCT02061384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540497|NCT01405027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64540498|NCT01405027|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64540499|NCT01405027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540500|NCT01405027|Antiviral Agents|antiviral agents|mesh-ancestor
64540501|NCT01405027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64540502|NCT01405027|Antimetabolites|antimetabolites|mesh-ancestor
64305243|NCT05030623|Urological Agents|urological agents|mesh-ancestor
64977873|NCT00266539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64977874|NCT00266539|Anesthetics, General|anesthetics, general|mesh-ancestor
64777434|NCT02061384|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64777435|NCT02061384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64777436|NCT02061384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388870|NCT02518139|Autonomic Agents|autonomic agents|mesh-ancestor
64388871|NCT02518139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64388872|NCT02518139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388873|NCT02518139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64388874|NCT02518139|Respiratory System Agents|respiratory system agents|mesh-ancestor
64388875|NCT02518139|Parasympatholytics|parasympatholytics|mesh-ancestor
64388876|NCT02518139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64388877|NCT02518139|Cholinergic Agents|cholinergic agents|mesh-ancestor
64388878|NCT02518139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64324158|NCT01573351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324159|NCT02685033|Dalbavancin|dalbavancin|mesh-list
64324160|NCT02685033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64324161|NCT02685033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324162|NCT05579223|Hydromorphone|hydromorphone|mesh-list
64324163|NCT05579223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64324164|NCT05579223|Narcotics|narcotics|mesh-ancestor
64777443|NCT02061774|Analgesics|analgesics|mesh-ancestor
64777444|NCT02061774|Sensory System Agents|sensory system agents|mesh-ancestor
64777445|NCT02061774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777446|NCT02061774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777447|NCT02061774|Antipyretics|antipyretics|mesh-ancestor
64777448|NCT02062710|Diphenhydramine|diphenhydramine|mesh-list
64777449|NCT02062710|Promethazine|promethazine|mesh-list
64388879|NCT02518139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388880|NCT02709889|Dexamethasone|dexamethasone|mesh-list
64388881|NCT02709889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64388882|NCT02709889|Antiemetics|antiemetics|mesh-ancestor
64388883|NCT02709889|Autonomic Agents|autonomic agents|mesh-ancestor
64388884|NCT02709889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64977875|NCT00266539|Anesthetics|anesthetics|mesh-ancestor
64977876|NCT00266578|Fluticasone|fluticasone|mesh-list
64977877|NCT00266578|Xhance|xhance|mesh-list
64977878|NCT00266578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64977879|NCT00266578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64977880|NCT00266578|Autonomic Agents|autonomic agents|mesh-ancestor
64977881|NCT00266578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64977882|NCT00266578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540503|NCT01405027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540504|NCT01405027|Immunologic Factors|immunologic factors|mesh-ancestor
64540505|NCT01405027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388887|NCT02709889|Glucocorticoids|glucocorticoids|mesh-ancestor
64388888|NCT02709889|Hormones|hormones|mesh-ancestor
64388889|NCT02709889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64324165|NCT05579223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64324166|NCT05579223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388893|NCT03189901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64540506|NCT00663039|Oxytocin|oxytocin|mesh-list
64540507|NCT00663039|Oxytocics|oxytocics|mesh-ancestor
64540508|NCT00663039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64540509|NCT00663039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540510|NCT04387539|Sofosbuvir|sofosbuvir|mesh-list
64540511|NCT04387539|Simeprevir|simeprevir|mesh-list
64540512|NCT04387539|Antiviral Agents|antiviral agents|mesh-ancestor
64540513|NCT04387539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64540514|NCT04387539|Protease Inhibitors|protease inhibitors|mesh-ancestor
64540515|NCT04387539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540516|NCT04387539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540517|NCT00664755|Nicotine|nicotine|mesh-list
64540518|NCT00664755|Varenicline|varenicline|mesh-list
64540519|NCT00664755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64540520|NCT00664755|Autonomic Agents|autonomic agents|mesh-ancestor
64540521|NCT00664755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64540522|NCT00664755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540523|NCT00664755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64540524|NCT00664755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64540525|NCT00664755|Cholinergic Agents|cholinergic agents|mesh-ancestor
64540526|NCT00664755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64540527|NCT00664755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540528|NCT01525628|Tolbutamide|tolbutamide|mesh-list
64540529|NCT01525628|Interferons|interferons|mesh-list
64540530|NCT01525628|Tenofovir|tenofovir|mesh-list
64540531|NCT01525628|Ribavirin|ribavirin|mesh-list
64540532|NCT01525628|Midazolam|midazolam|mesh-list
64777491|NCT02064582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64540533|NCT01525628|Caffeine|caffeine|mesh-list
64305277|NCT04251715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64977883|NCT00266578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64977884|NCT00266578|Respiratory System Agents|respiratory system agents|mesh-ancestor
64977885|NCT00266578|Dermatologic Agents|dermatologic agents|mesh-ancestor
64977886|NCT00266578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64977887|NCT00266617|Epoetin Alfa|epoetin alfa|mesh-list
64977888|NCT00266617|Hematinics|hematinics|mesh-ancestor
64977889|NCT00102219|Doxorubicin|doxorubicin|mesh-list
64977890|NCT00102219|Pemetrexed|pemetrexed|mesh-list
64977891|NCT00102219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64977892|NCT00102219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977893|NCT00102219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64977894|NCT00102219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64977895|NCT00102219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977896|NCT00102219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977897|NCT00102219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64540534|NCT01525628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540535|NCT01525628|Antiviral Agents|antiviral agents|mesh-ancestor
64540536|NCT01525628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64540537|NCT01525628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64540538|NCT01525628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64540539|NCT01525628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64540540|NCT01525628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484209|NCT01730053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64540541|NCT01525628|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64540542|NCT01525628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64540543|NCT01525628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64540544|NCT01525628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64540546|NCT01525628|Anesthetics|anesthetics|mesh-ancestor
64540547|NCT01525628|GABA Modulators|gaba modulators|mesh-ancestor
64540548|NCT01525628|GABA Agents|gaba agents|mesh-ancestor
64540549|NCT01525628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64540550|NCT01525628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540551|NCT01525628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64540552|NCT01525628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64540553|NCT01525628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540554|NCT01525628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64540555|NCT01525628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64540556|NCT01525628|Antimetabolites|antimetabolites|mesh-ancestor
64540557|NCT01525628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64540558|NCT01525628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64540559|NCT01525628|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64540560|NCT01525628|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64540561|NCT01525628|Purinergic Agents|purinergic agents|mesh-ancestor
64540562|NCT01525628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64540563|NCT00665457|Celecoxib|celecoxib|mesh-list
64540564|NCT00665457|Cyclophosphamide|cyclophosphamide|mesh-list
64540565|NCT00665457|Docetaxel|docetaxel|mesh-list
64977898|NCT00102219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64977899|NCT01349569|Lenalidomide|lenalidomide|mesh-list
64977900|NCT01349569|Vaccines|vaccines|mesh-list
64977901|NCT01349569|Immunologic Factors|immunologic factors|mesh-ancestor
64977917|NCT00267319|(T,G)-A-L|(t,g)-a-l|mesh-list
64977918|NCT00267319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64977919|NCT00267319|Immunologic Factors|immunologic factors|mesh-ancestor
64977920|NCT00267319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977921|NCT00267319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64977922|NCT00267319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64977923|NCT00073385|Docetaxel|docetaxel|mesh-list
64540566|NCT00665457|Doxorubicin|doxorubicin|mesh-list
64540567|NCT00665457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64540568|NCT00665457|Capecitabine|capecitabine|mesh-list
64540569|NCT00665457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64540570|NCT00665457|Immunologic Factors|immunologic factors|mesh-ancestor
64540571|NCT00665457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540572|NCT00665457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64540573|NCT00665457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64540574|NCT00665457|Alkylating Agents|alkylating agents|mesh-ancestor
64540575|NCT00665457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540576|NCT00665457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540577|NCT00665457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64540578|NCT00665457|Tubulin Modulators|tubulin modulators|mesh-ancestor
64540579|NCT00665457|Antimitotic Agents|antimitotic agents|mesh-ancestor
64540580|NCT00665457|Mitosis Modulators|mitosis modulators|mesh-ancestor
64540581|NCT00665457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64540582|NCT00665457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64540583|NCT00665457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64540584|NCT00665457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540585|NCT00665457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64540586|NCT00665457|Antimetabolites|antimetabolites|mesh-ancestor
64540587|NCT00665457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64540588|NCT00665457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64540589|NCT00665457|Analgesics|analgesics|mesh-ancestor
64540590|NCT00665457|Sensory System Agents|sensory system agents|mesh-ancestor
64540591|NCT00665457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64540592|NCT00665457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64540593|NCT00665457|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64540594|NCT00665457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64305367|NCT03063788|Copper|copper|mesh-list
64977924|NCT00073385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977925|NCT00073385|Tubulin Modulators|tubulin modulators|mesh-ancestor
64977926|NCT00073385|Antimitotic Agents|antimitotic agents|mesh-ancestor
64977927|NCT00073385|Mitosis Modulators|mitosis modulators|mesh-ancestor
64977928|NCT00073385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977930|NCT00102258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64977931|NCT00102258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977933|NCT00267514|Chelating Agents|chelating agents|mesh-ancestor
64977934|NCT00267514|Sequestering Agents|sequestering agents|mesh-ancestor
64977935|NCT00267514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977936|NCT00267553|Toremifene|toremifene|mesh-list
64977937|NCT00267553|Letrozole|letrozole|mesh-list
64540595|NCT02320695|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64540596|NCT02320695|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
64540598|NCT02320695|Neomycin|neomycin|mesh-list
64388973|NCT05233735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777542|NCT02148588|Lidocaine|lidocaine|mesh-list
64540599|NCT02320695|Polymyxin B|polymyxin b|mesh-list
64540600|NCT02320695|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64540601|NCT02320695|Ethanol|ethanol|mesh-list
64540602|NCT02320695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64540603|NCT02320695|Antitubercular Agents|antitubercular agents|mesh-ancestor
64540604|NCT02320695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64540605|NCT02320695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64540606|NCT02320695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660958|NCT01250990|Niacin|niacin|mesh-list
64540607|NCT02320695|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64540608|NCT02320695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540609|NCT02320695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540610|NCT01426009|Bromides|bromides|mesh-list
64540611|NCT01426009|Tiotropium Bromide|tiotropium bromide|mesh-list
64540612|NCT01426009|Ipratropium|ipratropium|mesh-list
64540613|NCT01426009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64540614|NCT01426009|Autonomic Agents|autonomic agents|mesh-ancestor
64540615|NCT01426009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64540616|NCT01426009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540617|NCT01426009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64540618|NCT01426009|Respiratory System Agents|respiratory system agents|mesh-ancestor
64540619|NCT01426009|Parasympatholytics|parasympatholytics|mesh-ancestor
64540620|NCT01426009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64540621|NCT01426009|Cholinergic Agents|cholinergic agents|mesh-ancestor
64540622|NCT01426009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64540623|NCT01426009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540624|NCT01426009|Anticonvulsants|anticonvulsants|mesh-ancestor
64540625|NCT01543958|Sevelamer|sevelamer|mesh-list
64540638|NCT01411085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64540639|NCT01411085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64540640|NCT01411085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64540641|NCT01411085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64540642|NCT01411085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64540643|NCT01411085|Dopamine Agents|dopamine agents|mesh-ancestor
64540644|NCT01411085|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64540645|NCT01411085|Antidepressive Agents|antidepressive agents|mesh-ancestor
64540646|NCT01411085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540647|NCT01411085|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64540648|NCT01411085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64540649|NCT01411085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64540650|NCT01411085|Adrenergic Agents|adrenergic agents|mesh-ancestor
64540651|NCT03473574|Gemcitabine|gemcitabine|mesh-list
64540652|NCT03473574|Durvalumab|durvalumab|mesh-list
64540653|NCT03473574|Tremelimumab|tremelimumab|mesh-list
64540654|NCT03473574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540655|NCT03473574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64540656|NCT03473574|Antimetabolites|antimetabolites|mesh-ancestor
64540657|NCT03473574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540658|NCT03473574|Antiviral Agents|antiviral agents|mesh-ancestor
64540659|NCT03473574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64540660|NCT03473574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540661|NCT03473574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64540662|NCT03473574|Immunologic Factors|immunologic factors|mesh-ancestor
64540663|NCT03473574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540664|NCT03473574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64540665|NCT01404949|Arsenic Trioxide|arsenic trioxide|mesh-list
64540666|NCT01404949|Tretinoin|tretinoin|mesh-list
64540667|NCT01404949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540668|NCT01404949|Keratolytic Agents|keratolytic agents|mesh-ancestor
64540669|NCT01404949|Dermatologic Agents|dermatologic agents|mesh-ancestor
64540670|NCT01431521|Pioglitazone|pioglitazone|mesh-list
64540671|NCT01431521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64540672|NCT01431521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540673|NCT00601965|Citalopram|citalopram|mesh-list
64301531|NCT04930900|Respiratory System Agents|respiratory system agents|mesh-ancestor
64301532|NCT04930900|Mydriatics|mydriatics|mesh-ancestor
64301533|NCT04930900|Sympathomimetics|sympathomimetics|mesh-ancestor
64354101|NCT03441529|Tazobactam|tazobactam|mesh-list
64977938|NCT00267553|Atamestane|atamestane|mesh-list
64977939|NCT00267553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977940|NCT00267553|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64977941|NCT00267553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64540674|NCT00601965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64540675|NCT00601965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64540676|NCT00601965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64540677|NCT00601965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540678|NCT00601965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64540680|NCT00601965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540681|NCT00601965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64540682|NCT00601965|Antidepressive Agents|antidepressive agents|mesh-ancestor
64540684|NCT04751994|Sorbitol|sorbitol|mesh-list
64540685|NCT04751994|Cathartics|cathartics|mesh-ancestor
64540686|NCT04751994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64540687|NCT00687453|Insulin Glargine|insulin glargine|mesh-list
64540688|NCT00687453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64540689|NCT00687453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540690|NCT00602043|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64540691|NCT00602043|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64540692|NCT00602043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540693|NCT04738422|Glycine|glycine|mesh-list
64540694|NCT04738422|Glycine Agents|glycine agents|mesh-ancestor
64540695|NCT04738422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64540696|NCT04738422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540697|NCT04738422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540698|NCT02998437|Amoxicillin|amoxicillin|mesh-list
64540699|NCT02998437|Clarithromycin|clarithromycin|mesh-list
64540700|NCT02998437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64540701|NCT02998437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64496823|NCT03009682|Olaparib|olaparib|mesh-list
64540702|NCT02998437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64540703|NCT02998437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540704|NCT02998437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540713|NCT01404325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540714|NCT01404325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64540715|NCT01404325|Immunologic Factors|immunologic factors|mesh-ancestor
64540716|NCT01404325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540718|NCT00602355|Antidepressive Agents|antidepressive agents|mesh-ancestor
64540719|NCT00602355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64540720|NCT00602355|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64540721|NCT00602355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64540722|NCT00602355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64540723|NCT00602355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540724|NCT00602355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64540725|NCT00602355|Serotonin Agents|serotonin agents|mesh-ancestor
64540726|NCT00602355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540727|NCT01425463|Glycine|glycine|mesh-list
64540728|NCT01425463|Glycine Agents|glycine agents|mesh-ancestor
64540729|NCT01425463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64540730|NCT01425463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540731|NCT01425463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540732|NCT02144259|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64540733|NCT02144259|Medroxyprogesterone|medroxyprogesterone|mesh-list
64540734|NCT02144259|Etonogestrel|etonogestrel|mesh-list
64540735|NCT02144259|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64301544|NCT02127151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301546|NCT03077516|Meloxicam|meloxicam|mesh-list
64301547|NCT03077516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64301548|NCT03077516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64301549|NCT03077516|Analgesics|analgesics|mesh-ancestor
64301550|NCT03077516|Sensory System Agents|sensory system agents|mesh-ancestor
64301557|NCT03077516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540736|NCT02144259|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64540737|NCT02144259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64540738|NCT02144259|Contraceptive Agents|contraceptive agents|mesh-ancestor
64540739|NCT02144259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64540740|NCT02144259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540741|NCT02144259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64540742|NCT02144259|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64540743|NCT02144259|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64540744|NCT02144259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64540745|NCT02144259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540746|NCT04655586|Heparin|heparin|mesh-list
64540751|NCT04655586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540752|NCT01388647|Carboplatin|carboplatin|mesh-list
64540753|NCT01388647|Trastuzumab|trastuzumab|mesh-list
64540754|NCT01388647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540755|NCT01388647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64540756|NCT03140982|Propofol|propofol|mesh-list
64540757|NCT03140982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64540758|NCT03140982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64540759|NCT03140982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540760|NCT03140982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64540761|NCT03140982|Anesthetics, General|anesthetics, general|mesh-ancestor
64540762|NCT03140982|Anesthetics|anesthetics|mesh-ancestor
64540763|NCT05392686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64540764|NCT05392686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64661165|NCT02620683|Lidocaine|lidocaine|mesh-list
64540765|NCT05392686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540766|NCT05392686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540767|NCT05392686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540769|NCT00705003|Buspirone|buspirone|mesh-list
64540770|NCT00705003|Antioxidants|antioxidants|mesh-ancestor
64540771|NCT00705003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540772|NCT00705003|Protective Agents|protective agents|mesh-ancestor
64540773|NCT00705003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714150|NCT03062605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64540774|NCT00705003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64540775|NCT00705003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64540776|NCT00705003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64540777|NCT00705003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64540778|NCT00705003|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64540779|NCT00705003|Serotonin Agents|serotonin agents|mesh-ancestor
64540780|NCT00705003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64540781|NCT03110640|Cyclophosphamide|cyclophosphamide|mesh-list
64540782|NCT03110640|Fludarabine|fludarabine|mesh-list
64540791|NCT03110640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64540793|NCT00690495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64540794|NCT00690495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64540795|NCT00690495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540796|NCT00690495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64540797|NCT00690495|Anesthetics, General|anesthetics, general|mesh-ancestor
64540799|NCT00691197|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64540800|NCT00691197|Glycerol|glycerol|mesh-list
64540801|NCT00691197|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64540802|NCT00691197|Protective Agents|protective agents|mesh-ancestor
64540803|NCT00691197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540804|NCT00691197|Laxatives|laxatives|mesh-ancestor
64540805|NCT00691197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64540806|NCT02997969|Vaccines|vaccines|mesh-list
64540807|NCT02997969|MF59 oil emulsion|mf59 oil emulsion|mesh-list
64540808|NCT02997969|Immunologic Factors|immunologic factors|mesh-ancestor
64540809|NCT02997969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540810|NCT02997969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64540811|NCT04351230|Trastuzumab|trastuzumab|mesh-list
64540812|NCT04351230|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64540813|NCT04351230|Maytansine|maytansine|mesh-list
64777546|NCT02148588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540814|NCT04351230|Immunoconjugates|immunoconjugates|mesh-list
64540815|NCT04351230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64540816|NCT04351230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540817|NCT04351230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64540818|NCT04351230|Tubulin Modulators|tubulin modulators|mesh-ancestor
64540819|NCT04351230|Antimitotic Agents|antimitotic agents|mesh-ancestor
64540820|NCT04351230|Mitosis Modulators|mitosis modulators|mesh-ancestor
64540821|NCT04351230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540836|NCT04028388|Docetaxel|docetaxel|mesh-list
64540837|NCT04028388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540838|NCT04028388|Tubulin Modulators|tubulin modulators|mesh-ancestor
64540839|NCT04028388|Antimitotic Agents|antimitotic agents|mesh-ancestor
64540840|NCT04028388|Mitosis Modulators|mitosis modulators|mesh-ancestor
64540841|NCT04028388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540842|NCT01402063|Temozolomide|temozolomide|mesh-list
64540843|NCT01402063|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
64540844|NCT01402063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64540845|NCT01402063|Alkylating Agents|alkylating agents|mesh-ancestor
64540846|NCT01402063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540847|NCT01402063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540848|NCT01796301|Teriparatide|teriparatide|mesh-list
64540849|NCT01796301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64540850|NCT01796301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540851|NCT01796301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64540853|NCT00868179|Antithrombins|antithrombins|mesh-ancestor
64540854|NCT00868179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64540855|NCT00868179|Protease Inhibitors|protease inhibitors|mesh-ancestor
64540856|NCT00868179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64540857|NCT00868179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540858|NCT00868179|Anticoagulants|anticoagulants|mesh-ancestor
64540859|NCT01204905|Raltegravir Potassium|raltegravir potassium|mesh-list
64540860|NCT01204905|Maraviroc|maraviroc|mesh-list
64540861|NCT01204905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64540862|NCT01204905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64540863|NCT01204905|Antiviral Agents|antiviral agents|mesh-ancestor
64540864|NCT01204905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64540865|NCT01204905|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64540866|NCT01204905|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64540878|NCT00691665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64540879|NCT00691665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540880|NCT00691665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64540881|NCT00691665|Respiratory System Agents|respiratory system agents|mesh-ancestor
64540883|NCT00691665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64540884|NCT00691665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64540885|NCT00691665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64540886|NCT00691665|Analgesics|analgesics|mesh-ancestor
64540887|NCT00691665|Sensory System Agents|sensory system agents|mesh-ancestor
64540888|NCT00691665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64540889|NCT00691665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64540890|NCT00691665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64540891|NCT00691665|Histamine Antagonists|histamine antagonists|mesh-ancestor
64540892|NCT00691665|Histamine Agents|histamine agents|mesh-ancestor
64540893|NCT00691665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64540894|NCT00691665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540895|NCT01388335|Warfarin|warfarin|mesh-list
64540896|NCT01388335|Anticoagulants|anticoagulants|mesh-ancestor
64540897|NCT00713583|Levodopa|levodopa|mesh-list
64540898|NCT00713583|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64540899|NCT00713583|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64388979|NCT02436499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64388980|NCT02436499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64388981|NCT02436499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388982|NCT02436499|Cholinergic Agents|cholinergic agents|mesh-ancestor
64388983|NCT02436499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64388984|NCT02436499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388985|NCT02436499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64540900|NCT00713583|Dopamine Agents|dopamine agents|mesh-ancestor
64540901|NCT00713583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64540902|NCT00713583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540903|NCT00713583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540904|NCT03359460|Lenalidomide|lenalidomide|mesh-list
64540905|NCT03359460|Immunologic Factors|immunologic factors|mesh-ancestor
64540906|NCT03359460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540907|NCT03359460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64540908|NCT03359460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64540909|NCT03359460|Growth Substances|growth substances|mesh-ancestor
64540910|NCT03359460|Growth Inhibitors|growth inhibitors|mesh-ancestor
64540911|NCT03359460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540912|NCT03025477|Paclitaxel|paclitaxel|mesh-list
64540913|NCT03025477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64540917|NCT03025477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64540918|NCT03025477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540919|NCT03025477|Tubulin Modulators|tubulin modulators|mesh-ancestor
64540920|NCT03025477|Antimitotic Agents|antimitotic agents|mesh-ancestor
64540921|NCT03025477|Mitosis Modulators|mitosis modulators|mesh-ancestor
64540922|NCT03025477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540923|NCT03025477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64540924|NCT03025477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64540925|NCT03025477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64540940|NCT00159744|Olanzapine|olanzapine|mesh-list
64540941|NCT00159744|Asenapine|asenapine|mesh-list
64540942|NCT00159744|Antiemetics|antiemetics|mesh-ancestor
64540943|NCT00159744|Autonomic Agents|autonomic agents|mesh-ancestor
64540944|NCT00159744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64540945|NCT00159744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540946|NCT00159744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64540947|NCT00159744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64540948|NCT00159744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64540949|NCT00159744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64540950|NCT00159744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64540951|NCT00159744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64540952|NCT00159744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64540953|NCT00159744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64540954|NCT00159744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540955|NCT00159744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64540956|NCT00159744|Serotonin Agents|serotonin agents|mesh-ancestor
64540957|NCT04041973|Lumefantrine|lumefantrine|mesh-list
64540958|NCT04041973|Artemether|artemether|mesh-list
64540959|NCT04041973|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64540960|NCT04041973|Antimalarials|antimalarials|mesh-ancestor
64540975|NCT00695097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540976|NCT00695097|Immunologic Factors|immunologic factors|mesh-ancestor
64540977|NCT00695097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540978|NCT00695097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64540979|NCT01795911|Interferons|interferons|mesh-list
64540980|NCT01795911|Ribavirin|ribavirin|mesh-list
64540981|NCT01795911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540982|NCT01795911|Antiviral Agents|antiviral agents|mesh-ancestor
64540983|NCT01795911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64540984|NCT01795911|Antimetabolites|antimetabolites|mesh-ancestor
64540985|NCT01795911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540986|NCT03137316|Hormones|hormones|mesh-list
64388986|NCT02436499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64540987|NCT03137316|Parathyroid Hormone|parathyroid hormone|mesh-list
64540988|NCT03137316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64540989|NCT03137316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64540990|NCT03137316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64540991|NCT03137082|Guanfacine|guanfacine|mesh-list
64540992|NCT03137082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64540993|NCT03137082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64540994|NCT03137082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64540995|NCT03137082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64540996|NCT03137082|Adrenergic Agents|adrenergic agents|mesh-ancestor
64540997|NCT03137082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64540998|NCT03137082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64540999|NCT03137082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541000|NCT03519906|Metoprolol|metoprolol|mesh-list
64541001|NCT03519906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64541002|NCT03519906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64541003|NCT03519906|Sympatholytics|sympatholytics|mesh-ancestor
64777568|NCT02154048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64777569|NCT02154048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64777570|NCT02154048|Anesthetics, Local|anesthetics, local|mesh-ancestor
64777571|NCT02154048|Anesthetics|anesthetics|mesh-ancestor
64777572|NCT02154048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64546252|NCT03660553|Insulin|insulin|mesh-list
64777573|NCT02154048|Sensory System Agents|sensory system agents|mesh-ancestor
64541004|NCT03519906|Autonomic Agents|autonomic agents|mesh-ancestor
64541005|NCT03519906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64541006|NCT03519906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541007|NCT03519906|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64541008|NCT03519906|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64305749|NCT02037503|Anesthetics|anesthetics|mesh-ancestor
64977942|NCT00267553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977943|NCT00267553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541009|NCT03519906|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64541010|NCT03519906|Adrenergic Agents|adrenergic agents|mesh-ancestor
64541011|NCT03519906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64541012|NCT03519906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541013|NCT05088174|Cyclosporine|cyclosporine|mesh-list
64541014|NCT05088174|Cyclosporins|cyclosporins|mesh-list
64541015|NCT05088174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541016|NCT05088174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541017|NCT05088174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64541018|NCT05088174|Immunologic Factors|immunologic factors|mesh-ancestor
64541019|NCT05088174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541020|NCT05088174|Antifungal Agents|antifungal agents|mesh-ancestor
64541021|NCT05088174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541022|NCT05088174|Dermatologic Agents|dermatologic agents|mesh-ancestor
64541023|NCT05088174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64541024|NCT05088174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64541025|NCT03041688|Decitabine|decitabine|mesh-list
64541026|NCT03041688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64541027|NCT03041688|Antimetabolites|antimetabolites|mesh-ancestor
64661649|NCT05190315|Antiemetics|antiemetics|mesh-ancestor
64541028|NCT03041688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541029|NCT03041688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541030|NCT03041688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541031|NCT00695409|Cytarabine|cytarabine|mesh-list
64541032|NCT00695409|Rituximab|rituximab|mesh-list
64541033|NCT00695409|Etoposide|etoposide|mesh-list
64541034|NCT00695409|Etoposide phosphate|etoposide phosphate|mesh-list
64541035|NCT00695409|Melphalan|melphalan|mesh-list
64541036|NCT00695409|Carmustine|carmustine|mesh-list
64541037|NCT00695409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64541038|NCT00695409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64541039|NCT00695409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541040|NCT00695409|Immunologic Factors|immunologic factors|mesh-ancestor
64541041|NCT00695409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541042|NCT00695409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64541043|NCT00695409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64661705|NCT02251379|Autonomic Agents|autonomic agents|mesh-ancestor
64541044|NCT00695409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64541048|NCT00695409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64541050|NCT00695409|Antiviral Agents|antiviral agents|mesh-ancestor
64541051|NCT00695409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541052|NCT00695409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64541053|NCT00695409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64541054|NCT00695409|Alkylating Agents|alkylating agents|mesh-ancestor
64541055|NCT00695409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64541057|NCT03469050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64541058|NCT03469050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541059|NCT03469050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64541060|NCT05087706|Bicalutamide|bicalutamide|mesh-list
64541061|NCT05087706|Leuprolide|leuprolide|mesh-list
64541062|NCT05087706|Androgen Antagonists|androgen antagonists|mesh-ancestor
64324179|NCT00258427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64324180|NCT00258427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64324181|NCT00258427|Alkylating Agents|alkylating agents|mesh-ancestor
64777597|NCT02159976|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64777598|NCT02159976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64777600|NCT02159976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64777601|NCT02159976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64777602|NCT02159976|Antacids|antacids|mesh-ancestor
64541063|NCT05087706|Hormone Antagonists|hormone antagonists|mesh-ancestor
64661762|NCT01779167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64661763|NCT01780337|Oxytocin|oxytocin|mesh-list
64541064|NCT05087706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64541065|NCT05087706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541067|NCT05087706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64541068|NCT05087706|Fertility Agents|fertility agents|mesh-ancestor
64541069|NCT05087706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64541070|NCT05087706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64541071|NCT02990403|Aspirin|aspirin|mesh-list
64541072|NCT02990403|Prednisone|prednisone|mesh-list
64541073|NCT02990403|Heparin|heparin|mesh-list
64541074|NCT02990403|Dydrogesterone|dydrogesterone|mesh-list
64541075|NCT02990403|Immunoglobulins|immunoglobulins|mesh-list
64661821|NCT01783847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64541076|NCT02990403|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64541077|NCT02990403|Antibodies|antibodies|mesh-list
64541078|NCT02990403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64541079|NCT02990403|Glucocorticoids|glucocorticoids|mesh-ancestor
64541080|NCT02990403|Hormones|hormones|mesh-ancestor
64661888|NCT02516813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64541081|NCT02990403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64541082|NCT02990403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541083|NCT02990403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64541084|NCT02990403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305820|NCT02426086|Niacinamide|niacinamide|mesh-list
64977944|NCT00267553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64541085|NCT02990403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64541086|NCT02990403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64541087|NCT02990403|Analgesics|analgesics|mesh-ancestor
64541088|NCT02990403|Sensory System Agents|sensory system agents|mesh-ancestor
64541089|NCT02990403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64541090|NCT02990403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64541091|NCT02990403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64541092|NCT02990403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64541093|NCT02990403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541094|NCT02990403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64541095|NCT02990403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64541096|NCT02990403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541097|NCT02990403|Antipyretics|antipyretics|mesh-ancestor
64541098|NCT02990403|Anticoagulants|anticoagulants|mesh-ancestor
64662097|NCT01372202|Paclitaxel|paclitaxel|mesh-list
64541099|NCT02990403|Immunologic Factors|immunologic factors|mesh-ancestor
64541100|NCT02990403|Progestins|progestins|mesh-ancestor
64541101|NCT00697203|Pravastatin|pravastatin|mesh-list
64541102|NCT00697203|Dalcetrapib|dalcetrapib|mesh-list
64541103|NCT00697203|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64541104|NCT00697203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64541105|NCT00697203|Antimetabolites|antimetabolites|mesh-ancestor
64541106|NCT00697203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541107|NCT00697203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64541108|NCT00697203|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64541109|NCT00697203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541110|NCT05086848|Leucovorin|leucovorin|mesh-list
64541111|NCT05086848|Fluorouracil|fluorouracil|mesh-list
64541112|NCT05086848|Irinotecan|irinotecan|mesh-list
64541113|NCT05086848|Antimetabolites|antimetabolites|mesh-ancestor
64541114|NCT05086848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541115|NCT05086848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64541116|NCT05086848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305857|NCT03524417|Immunoglobulins|immunoglobulins|mesh-list
64662231|NCT01332578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64977945|NCT00267553|Hormone Antagonists|hormone antagonists|mesh-ancestor
64977946|NCT00267553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64977947|NCT00267553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977948|NCT00267553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64977949|NCT00267553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64977950|NCT00267553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64977951|NCT00267553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64541117|NCT05086848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64541118|NCT05086848|Immunologic Factors|immunologic factors|mesh-ancestor
64541119|NCT05086848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541120|NCT05086848|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64541121|NCT05086848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64541122|NCT05086848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541123|NCT05086848|Antidotes|antidotes|mesh-ancestor
64541124|NCT05086848|Protective Agents|protective agents|mesh-ancestor
64541125|NCT05086848|Vitamin B Complex|vitamin b complex|mesh-ancestor
64541126|NCT05086848|Vitamins|vitamins|mesh-ancestor
64541127|NCT05086848|Micronutrients|micronutrients|mesh-ancestor
64541128|NCT00830895|Everolimus|everolimus|mesh-list
64541129|NCT00830895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541130|NCT00830895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64541131|NCT00830895|Immunologic Factors|immunologic factors|mesh-ancestor
64541132|NCT00830895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541133|NCT01158417|Resveratrol|resveratrol|mesh-list
64541134|NCT01158417|Antioxidants|antioxidants|mesh-ancestor
64777620|NCT02160990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64389044|NCT02709109|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64301610|NCT03551197|Formoterol Fumarate|formoterol fumarate|mesh-list
64301611|NCT03551197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64301612|NCT03551197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64301613|NCT03551197|Autonomic Agents|autonomic agents|mesh-ancestor
64301614|NCT03551197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301615|NCT03551197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301616|NCT03551197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64301617|NCT03551197|Respiratory System Agents|respiratory system agents|mesh-ancestor
64301620|NCT03551197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64541135|NCT01158417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541136|NCT01158417|Protective Agents|protective agents|mesh-ancestor
64541137|NCT01158417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541138|NCT01158417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541139|NCT01158417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64541140|NCT05086614|Thymalfasin|thymalfasin|mesh-list
64541171|NCT03113994|Antimetabolites|antimetabolites|mesh-ancestor
64541172|NCT03113994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541173|NCT03113994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64541174|NCT03113994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64541175|NCT03113994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541177|NCT03113994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64541178|NCT02003742|Tamsulosin|tamsulosin|mesh-list
64541179|NCT02003742|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64541180|NCT02003742|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64541181|NCT02003742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64541182|NCT02003742|Adrenergic Agents|adrenergic agents|mesh-ancestor
64541183|NCT02003742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64541184|NCT02003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541185|NCT02003742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541186|NCT02003742|Urological Agents|urological agents|mesh-ancestor
64541187|NCT03134118|Nivolumab|nivolumab|mesh-list
64541188|NCT03134118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64541189|NCT03134118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541190|NCT03134118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64541191|NCT03134118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541192|NCT05085912|Ethanol|ethanol|mesh-list
64541193|NCT05085912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64541194|NCT05085912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541195|NCT05085912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64541196|NCT05085912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541197|NCT02339415|Edoxaban|edoxaban|mesh-list
64541199|NCT02339415|Antithrombins|antithrombins|mesh-ancestor
64541200|NCT02339415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64541204|NCT02339415|Anticoagulants|anticoagulants|mesh-ancestor
64541211|NCT03110172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64541212|NCT03110172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541213|NCT03110172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64541214|NCT03110172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541215|NCT03110172|Analgesics|analgesics|mesh-ancestor
64389045|NCT02709109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64389046|NCT02709109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541216|NCT03110172|Sensory System Agents|sensory system agents|mesh-ancestor
64541217|NCT03110172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64541218|NCT03110172|Antidepressive Agents|antidepressive agents|mesh-ancestor
64541219|NCT03110172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64541220|NCT03110172|Dopamine Agents|dopamine agents|mesh-ancestor
64541221|NCT01400503|Siltuximab|siltuximab|mesh-list
64541222|NCT01400503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541223|NCT00706719|Enclomiphene|enclomiphene|mesh-list
64541224|NCT00706719|Clomiphene|clomiphene|mesh-list
64541225|NCT00706719|Zuclomiphene|zuclomiphene|mesh-list
64541226|NCT00706719|Testosterone|testosterone|mesh-list
64541227|NCT00706719|Androgens|androgens|mesh-ancestor
64541228|NCT00706719|Hormones|hormones|mesh-ancestor
64541229|NCT00706719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64484455|NCT01727713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64662523|NCT02194088|Autonomic Agents|autonomic agents|mesh-ancestor
64541230|NCT00706719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541231|NCT00706719|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64541232|NCT00706719|Hormone Antagonists|hormone antagonists|mesh-ancestor
64541233|NCT00706719|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64541234|NCT00706719|Fertility Agents|fertility agents|mesh-ancestor
64541235|NCT00706719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64541236|NCT00706719|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64541237|NCT00706719|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64541238|NCT05079672|Dexmedetomidine|dexmedetomidine|mesh-list
64541257|NCT04766827|Tubulin Modulators|tubulin modulators|mesh-ancestor
64541258|NCT04766827|Antimitotic Agents|antimitotic agents|mesh-ancestor
64541259|NCT04766827|Mitosis Modulators|mitosis modulators|mesh-ancestor
64777622|NCT02164422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64777623|NCT02164422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64777624|NCT02164422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64777625|NCT02164422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64777626|NCT02164422|Adrenergic Agents|adrenergic agents|mesh-ancestor
64777627|NCT02164422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64301643|NCT02435836|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64301644|NCT02435836|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64301645|NCT02127463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64301646|NCT02127463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64301648|NCT05075265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64301649|NCT05075265|Narcotics|narcotics|mesh-ancestor
64301650|NCT05075265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64301652|NCT05075265|Analgesics|analgesics|mesh-ancestor
64541260|NCT04766827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541261|NCT02960568|Primaquine|primaquine|mesh-list
64541262|NCT02960568|Antimalarials|antimalarials|mesh-ancestor
64541263|NCT02960568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64541264|NCT02960568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64541265|NCT02960568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541266|NCT02996409|Lidocaine|lidocaine|mesh-list
64541267|NCT02996409|Anesthetics, Local|anesthetics, local|mesh-ancestor
64541268|NCT02996409|Anesthetics|anesthetics|mesh-ancestor
64541269|NCT02996409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64541270|NCT02996409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541271|NCT02996409|Sensory System Agents|sensory system agents|mesh-ancestor
64541272|NCT02996409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64541273|NCT02996409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64662720|NCT01390064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64541274|NCT02996409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64541275|NCT02996409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64541276|NCT02996409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64541277|NCT02996409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541279|NCT02864004|Emetics|emetics|mesh-ancestor
64541280|NCT02864004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541281|NCT02864004|Autonomic Agents|autonomic agents|mesh-ancestor
64541282|NCT02864004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64541283|NCT02864004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64541284|NCT02864004|Dopamine Agonists|dopamine agonists|mesh-ancestor
64541285|NCT02864004|Dopamine Agents|dopamine agents|mesh-ancestor
64541286|NCT02864004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64541287|NCT02864004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541288|NCT01421719|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64662858|NCT01829399|Autonomic Agents|autonomic agents|mesh-ancestor
64541289|NCT01421719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64541290|NCT01421719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64541291|NCT01421719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541292|NCT01421719|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64541293|NCT01421719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64541294|NCT01421719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541295|NCT01421719|Cholinergic Agents|cholinergic agents|mesh-ancestor
64541296|NCT01421719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64541297|NCT02721654|Plasma-lyte 148|plasma-lyte 148|mesh-list
64541298|NCT02721654|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64541299|NCT02721654|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64541300|NCT01421641|Lidocaine|lidocaine|mesh-list
64541301|NCT01421641|Anesthetics, Local|anesthetics, local|mesh-ancestor
64714151|NCT03062605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541302|NCT01421641|Anesthetics|anesthetics|mesh-ancestor
64541303|NCT01421641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64541304|NCT01421641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541305|NCT01421641|Sensory System Agents|sensory system agents|mesh-ancestor
64541306|NCT01421641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64541307|NCT01421641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64541308|NCT01421641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64541309|NCT01421641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64541310|NCT01421641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64541311|NCT01421641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541312|NCT05068206|Bevacizumab|bevacizumab|mesh-list
64662995|NCT01480232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64541313|NCT05068206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64541314|NCT05068206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541315|NCT05068206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64541316|NCT05068206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64541317|NCT05068206|Growth Substances|growth substances|mesh-ancestor
64541318|NCT05068206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541319|NCT05068206|Growth Inhibitors|growth inhibitors|mesh-ancestor
64541320|NCT05063370|Simendan|simendan|mesh-list
64541321|NCT05063370|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64541322|NCT05063370|Vasodilator Agents|vasodilator agents|mesh-ancestor
64541323|NCT05063370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64541324|NCT05063370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64541325|NCT05063370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541327|NCT05063370|Protective Agents|protective agents|mesh-ancestor
64541328|NCT05063370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541329|NCT05090124|Adalimumab|adalimumab|mesh-list
64541330|NCT05090124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64541331|NCT05090124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64541332|NCT01421017|Cyclophosphamide|cyclophosphamide|mesh-list
64541333|NCT01421017|Imiquimod|imiquimod|mesh-list
64541334|NCT01421017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64541335|NCT01421017|Immunologic Factors|immunologic factors|mesh-ancestor
64541336|NCT01421017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541337|NCT01421017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64541338|NCT01421017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64541339|NCT01421017|Alkylating Agents|alkylating agents|mesh-ancestor
64541340|NCT01421017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541341|NCT01421017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541342|NCT01421017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64541343|NCT01421017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64541344|NCT01421017|Interferon Inducers|interferon inducers|mesh-ancestor
64541345|NCT05020392|Vidarabine|vidarabine|mesh-list
64541346|NCT05020392|Cyclophosphamide|cyclophosphamide|mesh-list
64541347|NCT05020392|Fludarabine|fludarabine|mesh-list
64541348|NCT05020392|Fludarabine phosphate|fludarabine phosphate|mesh-list
64541349|NCT05020392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64541350|NCT05020392|Immunologic Factors|immunologic factors|mesh-ancestor
64541351|NCT05020392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541352|NCT05020392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64663114|NCT03349281|Pegaspargase|pegaspargase|mesh-list
64541353|NCT05020392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64541354|NCT05020392|Alkylating Agents|alkylating agents|mesh-ancestor
64541355|NCT05020392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541356|NCT05020392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541357|NCT05020392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64541358|NCT05020392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64541359|NCT05020392|Antimetabolites|antimetabolites|mesh-ancestor
64541360|NCT05020392|Antiviral Agents|antiviral agents|mesh-ancestor
64541361|NCT05020392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541362|NCT04951050|Sirolimus|sirolimus|mesh-list
64977952|NCT00106548|Methotrexate|methotrexate|mesh-list
64977953|NCT00106548|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64977954|NCT00106548|Abortifacient Agents|abortifacient agents|mesh-ancestor
64977955|NCT00106548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64541363|NCT04951050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64541364|NCT04951050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541365|NCT04951050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64541366|NCT04951050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541367|NCT04951050|Antifungal Agents|antifungal agents|mesh-ancestor
64541368|NCT04951050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64541369|NCT04951050|Immunologic Factors|immunologic factors|mesh-ancestor
64541370|NCT04951050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541373|NCT05089344|Zuclomiphene|zuclomiphene|mesh-list
64541374|NCT05089344|Hormones|hormones|mesh-list
64541375|NCT05089344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64541376|NCT05089344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541377|NCT05089344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64541378|NCT05089344|Hormone Antagonists|hormone antagonists|mesh-ancestor
64541379|NCT05089344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64541381|NCT05089344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64541382|NCT05089344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64541383|NCT05089344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64541384|NCT01400113|Asenapine|asenapine|mesh-list
64541385|NCT01400113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64541386|NCT01400113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64541387|NCT01400113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64541388|NCT01400113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663224|NCT01843751|Analgesics|analgesics|mesh-ancestor
64541389|NCT01400113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64541390|NCT01399723|Amoxicillin|amoxicillin|mesh-list
64541391|NCT01399723|Penicillins|penicillins|mesh-list
64541392|NCT01399723|Penicillin G|penicillin g|mesh-list
64541393|NCT01399723|Penicillin G Benzathine|penicillin g benzathine|mesh-list
64389062|NCT03117595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64389063|NCT03117595|Narcotics|narcotics|mesh-ancestor
64389064|NCT03117595|Analgesics|analgesics|mesh-ancestor
64389065|NCT03117595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64777646|NCT02178696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777647|NCT02178696|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64777648|NCT02179788|Metformin|metformin|mesh-list
64541394|NCT01399723|Penicillin G Procaine|penicillin g procaine|mesh-list
64541411|NCT04726098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64541412|NCT04726098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541413|NCT04726098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64541414|NCT04726098|Glucocorticoids|glucocorticoids|mesh-ancestor
64541415|NCT04726098|Hormones|hormones|mesh-ancestor
64541416|NCT04726098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64541417|NCT04726098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64541418|NCT04726098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541419|NCT04726098|Protease Inhibitors|protease inhibitors|mesh-ancestor
64541420|NCT04726098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541421|NCT04726098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541422|NCT05088798|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
64541423|NCT05088798|Dopamine Agents|dopamine agents|mesh-ancestor
64541424|NCT05088798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64541425|NCT05088798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541426|NCT05088798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541427|NCT05088720|Misoprostol|misoprostol|mesh-list
64541428|NCT05088720|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64663283|NCT01848041|Mydriatics|mydriatics|mesh-ancestor
64541429|NCT05088720|Abortifacient Agents|abortifacient agents|mesh-ancestor
64541430|NCT05088720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64541431|NCT05088720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541432|NCT05088720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64541433|NCT05088720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64541434|NCT05088720|Oxytocics|oxytocics|mesh-ancestor
64541435|NCT01383499|Bromides|bromides|mesh-list
64541436|NCT01383499|Tiotropium Bromide|tiotropium bromide|mesh-list
64541437|NCT01383499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64541438|NCT01383499|Autonomic Agents|autonomic agents|mesh-ancestor
64541439|NCT01383499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64541440|NCT01383499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541441|NCT01383499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64541442|NCT01383499|Respiratory System Agents|respiratory system agents|mesh-ancestor
64306188|NCT02058485|Midazolam|midazolam|mesh-list
64541448|NCT01383499|Anticonvulsants|anticonvulsants|mesh-ancestor
64541449|NCT05084118|Landiolol|landiolol|mesh-list
64541450|NCT05084118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64541451|NCT05084118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64541452|NCT05084118|Adrenergic Agents|adrenergic agents|mesh-ancestor
64541453|NCT05084118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64541454|NCT05084118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541455|NCT05084118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541456|NCT05084118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64541457|NCT03025009|Insulin|insulin|mesh-list
64541458|NCT03025009|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64541459|NCT03025009|Insulin Glargine|insulin glargine|mesh-list
64541460|NCT03025009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64541461|NCT03025009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541462|NCT03135912|Terbinafine|terbinafine|mesh-list
64301721|NCT02458755|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64541463|NCT03135912|Antifungal Agents|antifungal agents|mesh-ancestor
64301722|NCT02458755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64301723|NCT02458755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64301727|NCT02458755|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64301729|NCT04462406|Pembrolizumab|pembrolizumab|mesh-list
64301730|NCT04462406|Nivolumab|nivolumab|mesh-list
64301731|NCT04462406|Ipilimumab|ipilimumab|mesh-list
64301732|NCT04462406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64301733|NCT04462406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541464|NCT03135912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541465|NCT03135912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541466|NCT03135912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541467|NCT01397461|Retapamulin|retapamulin|mesh-list
64541468|NCT01397461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64541469|NCT01397461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541470|NCT04505670|Donepezil|donepezil|mesh-list
64541471|NCT04505670|Zinc Oxide|zinc oxide|mesh-list
64541472|NCT04505670|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64541473|NCT04505670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541499|NCT02996019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541500|NCT02997501|Osimertinib|osimertinib|mesh-list
64541501|NCT02997501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541502|NCT02997501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64541503|NCT02997501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541504|NCT02997501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541505|NCT02998827|Thalidomide|thalidomide|mesh-list
64541506|NCT02998827|Azathioprine|azathioprine|mesh-list
64541507|NCT02998827|Infliximab|infliximab|mesh-list
64541508|NCT02998827|Dermatologic Agents|dermatologic agents|mesh-ancestor
64541509|NCT02998827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64541510|NCT02998827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64541511|NCT02998827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64541512|NCT02998827|Immunologic Factors|immunologic factors|mesh-ancestor
64541513|NCT02998827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541514|NCT02998827|Leprostatic Agents|leprostatic agents|mesh-ancestor
64541515|NCT02998827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64541516|NCT02998827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541517|NCT02998827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64541518|NCT02998827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64541519|NCT02998827|Growth Substances|growth substances|mesh-ancestor
64541520|NCT02998827|Growth Inhibitors|growth inhibitors|mesh-ancestor
64541553|NCT05738148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541554|NCT05738148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541555|NCT05738148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64541556|NCT05738148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64541557|NCT05738148|Autonomic Agents|autonomic agents|mesh-ancestor
64541559|NCT05738148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64541560|NCT05738148|Respiratory System Agents|respiratory system agents|mesh-ancestor
64541561|NCT05738148|Mydriatics|mydriatics|mesh-ancestor
64541562|NCT05738148|Sympathomimetics|sympathomimetics|mesh-ancestor
64541563|NCT05738148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64541564|NCT05738148|Hemostatics|hemostatics|mesh-ancestor
64541565|NCT05738148|Coagulants|coagulants|mesh-ancestor
64541566|NCT05738148|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64541567|NCT05738148|Natriuretic Agents|natriuretic agents|mesh-ancestor
64541568|NCT00704379|Sertraline|sertraline|mesh-list
64541569|NCT00704379|Antidepressive Agents|antidepressive agents|mesh-ancestor
64541570|NCT00704379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64541571|NCT00704379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64541572|NCT00704379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64541573|NCT00704379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64541574|NCT00704379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541575|NCT00704379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64541576|NCT00704379|Serotonin Agents|serotonin agents|mesh-ancestor
64541577|NCT00704379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541578|NCT02991495|Vaccines|vaccines|mesh-list
64541579|NCT02991495|Immunologic Factors|immunologic factors|mesh-ancestor
64541581|NCT04449042|Anesthetics|anesthetics|mesh-list
64541582|NCT04449042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64541583|NCT04449042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541584|NCT04341090|Apatinib|apatinib|mesh-list
64541585|NCT04341090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64306322|NCT02796677|Bromides|bromides|mesh-list
64777658|NCT02180100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777659|NCT02180100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64389095|NCT02331251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977956|NCT00106548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977957|NCT00106548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64977958|NCT00106548|Antimetabolites|antimetabolites|mesh-ancestor
64977959|NCT00106548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977996|NCT00267943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541586|NCT04341090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64541588|NCT04341090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541589|NCT00707655|Zalutumumab|zalutumumab|mesh-list
64541590|NCT00707655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64541596|NCT04089150|Paclitaxel|paclitaxel|mesh-list
64541597|NCT04089150|Fluorouracil|fluorouracil|mesh-list
64541598|NCT04089150|Capecitabine|capecitabine|mesh-list
64541599|NCT04089150|Oxaliplatin|oxaliplatin|mesh-list
64541600|NCT04089150|Irinotecan|irinotecan|mesh-list
64484456|NCT01727713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64541601|NCT04089150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64541602|NCT04089150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541603|NCT04089150|Tubulin Modulators|tubulin modulators|mesh-ancestor
64663850|NCT05439993|Paclitaxel|paclitaxel|mesh-list
64541604|NCT04089150|Antimitotic Agents|antimitotic agents|mesh-ancestor
64541605|NCT04089150|Mitosis Modulators|mitosis modulators|mesh-ancestor
64541606|NCT04089150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541607|NCT04089150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64541608|NCT04089150|Antimetabolites|antimetabolites|mesh-ancestor
64541609|NCT04089150|Antiviral Agents|antiviral agents|mesh-ancestor
64541610|NCT04089150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541611|NCT04089150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541612|NCT04089150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64541613|NCT04089150|Immunologic Factors|immunologic factors|mesh-ancestor
64977997|NCT00267943|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64977998|NCT00267943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64977999|NCT00267943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978000|NCT00267943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64978001|NCT00267943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64541614|NCT04089150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541615|NCT04089150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64541616|NCT04089150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64541617|NCT04089150|Antidotes|antidotes|mesh-ancestor
64541618|NCT04089150|Protective Agents|protective agents|mesh-ancestor
64541619|NCT04089150|Vitamin B Complex|vitamin b complex|mesh-ancestor
64541621|NCT04089150|Micronutrients|micronutrients|mesh-ancestor
64541622|NCT02076919|Acrizanib|acrizanib|mesh-list
64541623|NCT02076919|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64541624|NCT02076919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64541625|NCT02076919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64541626|NCT02076919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663961|NCT02676375|Dopamine Agents|dopamine agents|mesh-ancestor
64663962|NCT02676375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64541627|NCT02076919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541629|NCT02076997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64389102|NCT02331251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64301740|NCT02400580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301741|NCT02400580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301743|NCT03262857|Lidocaine|lidocaine|mesh-list
64301744|NCT03262857|Magnesium Sulfate|magnesium sulfate|mesh-list
64301745|NCT03262857|Anesthetics, Local|anesthetics, local|mesh-ancestor
64301746|NCT03262857|Anesthetics|anesthetics|mesh-ancestor
64301747|NCT03262857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64541630|NCT02076997|Abortifacient Agents|abortifacient agents|mesh-ancestor
64541631|NCT02076997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64541632|NCT02076997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541633|NCT02076997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64541634|NCT02076997|Antimetabolites|antimetabolites|mesh-ancestor
64541635|NCT02076997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541636|NCT02076997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541637|NCT02076997|Dermatologic Agents|dermatologic agents|mesh-ancestor
64541638|NCT02076997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541639|NCT02076997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64541640|NCT02076997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64541641|NCT02076997|Immunologic Factors|immunologic factors|mesh-ancestor
64306380|NCT02063789|Immunoglobulins|immunoglobulins|mesh-list
64978002|NCT04711265|Vaccines|vaccines|mesh-list
64978003|NCT04711265|Immunologic Factors|immunologic factors|mesh-ancestor
64978004|NCT04711265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978005|NCT00268138|Fluorides|fluorides|mesh-list
64978042|NCT00268216|Respiratory System Agents|respiratory system agents|mesh-ancestor
64978077|NCT00073658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64978078|NCT00073658|Antidepressive Agents|antidepressive agents|mesh-ancestor
64978079|NCT00268255|Gefitinib|gefitinib|mesh-list
64664026|NCT02677623|Mannitol|mannitol|mesh-list
64978102|NCT00268333|Antimetabolites|antimetabolites|mesh-ancestor
64978103|NCT00268333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978104|NCT00268333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64978105|NCT00268333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978106|NCT00268333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64978107|NCT00268333|Immunologic Factors|immunologic factors|mesh-ancestor
64978108|NCT00268333|Antidotes|antidotes|mesh-ancestor
64978109|NCT00268333|Protective Agents|protective agents|mesh-ancestor
64541642|NCT02076997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64541643|NCT02076997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64541644|NCT05365165|Sevoflurane|sevoflurane|mesh-list
64541645|NCT05365165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64541646|NCT05365165|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64541647|NCT05365165|Anesthetics, General|anesthetics, general|mesh-ancestor
64541649|NCT05365165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64541650|NCT05365165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541651|NCT03925350|Niraparib|niraparib|mesh-list
64541652|NCT03925350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64541653|NCT03925350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541654|NCT03925350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541655|NCT03925350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541656|NCT00707967|Vaccines|vaccines|mesh-list
64541657|NCT00707967|Immunologic Factors|immunologic factors|mesh-ancestor
64541658|NCT00707967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541659|NCT02994381|Ozanimod|ozanimod|mesh-list
64541660|NCT02994381|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64541661|NCT02994381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541662|NCT02994381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64541663|NCT02994381|Immunologic Factors|immunologic factors|mesh-ancestor
64777666|NCT02181426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64777667|NCT02181426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64777668|NCT02181426|Analgesics|analgesics|mesh-ancestor
64389103|NCT02331251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64389104|NCT02435797|Nicorandil|nicorandil|mesh-list
64389105|NCT02435797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64389106|NCT02435797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64389107|NCT02435797|Vasodilator Agents|vasodilator agents|mesh-ancestor
64389108|NCT02435797|Vitamin B Complex|vitamin b complex|mesh-ancestor
64389109|NCT02435797|Vitamins|vitamins|mesh-ancestor
64354682|NCT03428191|Narcotics|narcotics|mesh-ancestor
64541664|NCT02994381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541665|NCT00716079|Metoprolol|metoprolol|mesh-list
64541666|NCT00716079|Clonidine|clonidine|mesh-list
64541667|NCT00716079|Hydralazine|hydralazine|mesh-list
64541668|NCT00716079|Labetalol|labetalol|mesh-list
64541669|NCT00716079|Nicardipine|nicardipine|mesh-list
64541670|NCT00716079|Phentolamine|phentolamine|mesh-list
64541671|NCT00716079|Urapidil|urapidil|mesh-list
64541672|NCT00716079|Enalaprilat|enalaprilat|mesh-list
64664266|NCT00823563|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64541673|NCT00716079|Esmolol|esmolol|mesh-list
64541674|NCT00716079|Glycerol|glycerol|mesh-list
64541675|NCT00716079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64714152|NCT03050294|Desoximetasone|desoximetasone|mesh-list
64497786|NCT03421860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64541682|NCT00716079|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64541683|NCT00716079|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64541684|NCT00716079|Adrenergic Agents|adrenergic agents|mesh-ancestor
64541685|NCT00716079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64541686|NCT00716079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541687|NCT00716079|Analgesics|analgesics|mesh-ancestor
64541688|NCT00716079|Sensory System Agents|sensory system agents|mesh-ancestor
64541689|NCT00716079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64541690|NCT00716079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64541691|NCT00716079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64541692|NCT00716079|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64541693|NCT00716079|Protective Agents|protective agents|mesh-ancestor
64541694|NCT00716079|Vasodilator Agents|vasodilator agents|mesh-ancestor
64541695|NCT00716079|Sympathomimetics|sympathomimetics|mesh-ancestor
64541696|NCT00716079|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64541697|NCT00716079|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64541698|NCT00716079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64541699|NCT00716079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64541700|NCT00716079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64541701|NCT00716079|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64541702|NCT00716079|Serotonin Agents|serotonin agents|mesh-ancestor
64541703|NCT00716079|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64541704|NCT00716079|Protease Inhibitors|protease inhibitors|mesh-ancestor
64541705|NCT00716079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541707|NCT01270191|Isophane Insulin, Human|isophane insulin, human|mesh-list
64541708|NCT01270191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64306448|NCT02347072|Cholinergic Agents|cholinergic agents|mesh-ancestor
64978110|NCT00268333|Vitamin B Complex|vitamin b complex|mesh-ancestor
64978111|NCT00268333|Vitamins|vitamins|mesh-ancestor
64978112|NCT00268333|Micronutrients|micronutrients|mesh-ancestor
64978113|NCT00073697|Dexetimide|dexetimide|mesh-list
64978114|NCT00073697|Citalopram|citalopram|mesh-list
64978115|NCT00073697|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64978116|NCT00073697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64978117|NCT00073697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64389110|NCT02435797|Micronutrients|micronutrients|mesh-ancestor
64978118|NCT00073697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389111|NCT02435797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389112|NCT02330705|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64324185|NCT00258427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64978119|NCT00073697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64978121|NCT00073697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978122|NCT00073697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64664448|NCT01431014|Protease Inhibitors|protease inhibitors|mesh-ancestor
64978123|NCT00073697|Antidepressive Agents|antidepressive agents|mesh-ancestor
64978124|NCT00073697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64978125|NCT00073697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64978126|NCT00073697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64541709|NCT01270191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541711|NCT01270191|Incretins|incretins|mesh-ancestor
64541712|NCT01270191|Hormones|hormones|mesh-ancestor
64664515|NCT04732455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64541713|NCT01270191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64541714|NCT02999919|Bupivacaine|bupivacaine|mesh-list
64541715|NCT02999919|Anesthetics, Local|anesthetics, local|mesh-ancestor
64541716|NCT02999919|Anesthetics|anesthetics|mesh-ancestor
64541717|NCT02999919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64541718|NCT02999919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541719|NCT02999919|Sensory System Agents|sensory system agents|mesh-ancestor
64541720|NCT02999919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64541721|NCT04526652|Dexmedetomidine|dexmedetomidine|mesh-list
64541722|NCT04526652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64541723|NCT04526652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64541724|NCT04526652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541725|NCT04526652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64541726|NCT04526652|Analgesics|analgesics|mesh-ancestor
64541727|NCT04526652|Sensory System Agents|sensory system agents|mesh-ancestor
64541728|NCT04526652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64541729|NCT04526652|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64541730|NCT04526652|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64541731|NCT04526652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64541732|NCT04526652|Adrenergic Agents|adrenergic agents|mesh-ancestor
64541733|NCT04526652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64541734|NCT04526652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541735|NCT01381549|Imipenem|imipenem|mesh-list
64541736|NCT01381549|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
64541737|NCT01381549|Cilastatin|cilastatin|mesh-list
64541738|NCT01381549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64541739|NCT01381549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541740|NCT01381549|Protease Inhibitors|protease inhibitors|mesh-ancestor
64541741|NCT01381549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541742|NCT01381549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978127|NCT00073697|Parasympatholytics|parasympatholytics|mesh-ancestor
64978128|NCT00073697|Autonomic Agents|autonomic agents|mesh-ancestor
64978129|NCT00073697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64978130|NCT00073697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64541743|NCT00159432|Bevacizumab|bevacizumab|mesh-list
64664640|NCT04635189|Hormones|hormones|mesh-ancestor
64541745|NCT00159432|Oxaliplatin|oxaliplatin|mesh-list
64541746|NCT00159432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64541747|NCT00159432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64714153|NCT03050294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64541748|NCT00159432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64541749|NCT00159432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64484210|NCT01730053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64324189|NCT00258427|Autonomic Agents|autonomic agents|mesh-ancestor
64324190|NCT00258427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64324191|NCT00258427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64324192|NCT00258427|Glucocorticoids|glucocorticoids|mesh-ancestor
64777671|NCT02181426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777672|NCT02181426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64541750|NCT00159432|Growth Substances|growth substances|mesh-ancestor
64541751|NCT00159432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541752|NCT00159432|Growth Inhibitors|growth inhibitors|mesh-ancestor
64664700|NCT02688309|Glucocorticoids|glucocorticoids|mesh-ancestor
64541753|NCT00159432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64541754|NCT00159432|Antimetabolites|antimetabolites|mesh-ancestor
64541755|NCT00159432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541756|NCT02969850|Vitamin D|vitamin d|mesh-list
64541757|NCT02969850|Calcium|calcium|mesh-list
64541758|NCT02969850|Vitamins|vitamins|mesh-ancestor
64541759|NCT02969850|Micronutrients|micronutrients|mesh-ancestor
64541760|NCT02969850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541761|NCT02969850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64541762|NCT02969850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64541763|NCT02339766|Morphine|morphine|mesh-list
64541764|NCT02339766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64541765|NCT02339766|Narcotics|narcotics|mesh-ancestor
64541766|NCT02339766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64541767|NCT02339766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541768|NCT02339766|Analgesics|analgesics|mesh-ancestor
64541769|NCT02339766|Sensory System Agents|sensory system agents|mesh-ancestor
64541770|NCT02339766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64541771|NCT04287660|Clarithromycin|clarithromycin|mesh-list
64664758|NCT02421120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664759|NCT02421120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541772|NCT04287660|Dexamethasone|dexamethasone|mesh-list
64541773|NCT04287660|Lenalidomide|lenalidomide|mesh-list
64541774|NCT04287660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64541775|NCT04287660|Antiemetics|antiemetics|mesh-ancestor
64541781|NCT04287660|Hormones|hormones|mesh-ancestor
64541782|NCT04287660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64541783|NCT04287660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64541784|NCT04287660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541785|NCT04287660|Immunologic Factors|immunologic factors|mesh-ancestor
64541786|NCT04287660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64541787|NCT04287660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64777673|NCT02181426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64777674|NCT02181426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64777675|NCT02181426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64777676|NCT02181426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777678|NCT02192814|Anticonvulsants|anticonvulsants|mesh-ancestor
64777680|NCT02192814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64541788|NCT04287660|Growth Substances|growth substances|mesh-ancestor
64541789|NCT04287660|Growth Inhibitors|growth inhibitors|mesh-ancestor
64541790|NCT04287660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64541791|NCT04287660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541792|NCT04287660|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64541793|NCT04287660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541794|NCT04287660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541795|NCT04287660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64389132|NCT02335151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389133|NCT02709655|Vortioxetine|vortioxetine|mesh-list
64389134|NCT02709655|Fluoxetine|fluoxetine|mesh-list
64389135|NCT02709655|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64389136|NCT02709655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64389137|NCT02709655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64389138|NCT02709655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777704|NCT02201394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64777705|NCT02201394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777706|NCT02201394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64389139|NCT02709655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64389140|NCT02709655|Serotonin Agents|serotonin agents|mesh-ancestor
64389141|NCT02709655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389142|NCT02709655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64389143|NCT02709655|Antidepressive Agents|antidepressive agents|mesh-ancestor
64389144|NCT02709655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64389145|NCT02709655|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64389146|NCT02709655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64389147|NCT02709655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389148|NCT02709655|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64389149|NCT02709655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64389150|NCT02709655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64777716|NCT02203578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64777717|NCT02203578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64777719|NCT02206776|Ketamine|ketamine|mesh-list
64777720|NCT02206776|Analgesics|analgesics|mesh-ancestor
64777721|NCT02206776|Sensory System Agents|sensory system agents|mesh-ancestor
64777722|NCT02206776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777723|NCT02206776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777724|NCT02206776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64777725|NCT02206776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64777726|NCT02206776|Anesthetics, General|anesthetics, general|mesh-ancestor
64389172|NCT03187795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64389173|NCT03187795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389174|NCT03187795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389175|NCT03187795|Urological Agents|urological agents|mesh-ancestor
64777750|NCT02209272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64389184|NCT02435563|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64389185|NCT02435563|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64389186|NCT02435563|Protease Inhibitors|protease inhibitors|mesh-ancestor
64389187|NCT02435563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541796|NCT04287660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64541798|NCT01396057|Ranibizumab|ranibizumab|mesh-list
64541799|NCT01396057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64541800|NCT01396057|Antiemetics|antiemetics|mesh-ancestor
64541801|NCT01396057|Autonomic Agents|autonomic agents|mesh-ancestor
64541802|NCT01396057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64541803|NCT01396057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541804|NCT01396057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64541805|NCT01396057|Glucocorticoids|glucocorticoids|mesh-ancestor
64541806|NCT01396057|Hormones|hormones|mesh-ancestor
64541807|NCT01396057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64541808|NCT01396057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64541809|NCT01396057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541810|NCT01396057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64389188|NCT02435563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389189|NCT02435563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64389190|NCT02435563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64389191|NCT02435563|Antiviral Agents|antiviral agents|mesh-ancestor
64389192|NCT02435563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64389193|NCT02435563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64389194|NCT02435563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64301777|NCT02127697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301778|NCT02127697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64301779|NCT02127697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64301780|NCT02127697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64301781|NCT02127697|Cholinergic Agents|cholinergic agents|mesh-ancestor
64301783|NCT02127775|Gout Suppressants|gout suppressants|mesh-ancestor
64301784|NCT02127775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64301785|NCT02127775|Uricosuric Agents|uricosuric agents|mesh-ancestor
64301786|NCT02127775|Renal Agents|renal agents|mesh-ancestor
64301787|NCT02252341|Acetylcysteine|acetylcysteine|mesh-list
64301788|NCT02252341|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64301789|NCT02252341|Antiviral Agents|antiviral agents|mesh-ancestor
64301790|NCT02252341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64301791|NCT02252341|Expectorants|expectorants|mesh-ancestor
64541811|NCT01396057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64541812|NCT01396057|Growth Substances|growth substances|mesh-ancestor
64541813|NCT01396057|Growth Inhibitors|growth inhibitors|mesh-ancestor
64541814|NCT02419560|Venetoclax|venetoclax|mesh-list
64541815|NCT02419560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541816|NCT04011163|Morphine|morphine|mesh-list
64541817|NCT04011163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64541819|NCT04011163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64541820|NCT04011163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541821|NCT04011163|Analgesics|analgesics|mesh-ancestor
64714154|NCT03050294|Glucocorticoids|glucocorticoids|mesh-ancestor
64541822|NCT04011163|Sensory System Agents|sensory system agents|mesh-ancestor
64541823|NCT04011163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64541824|NCT00704847|Calcitonin|calcitonin|mesh-list
64541825|NCT00704847|Salmon calcitonin|salmon calcitonin|mesh-list
64541826|NCT00704847|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
64541828|NCT00704847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64541829|NCT00704847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541830|NCT00704847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64541831|NCT00704847|Vasodilator Agents|vasodilator agents|mesh-ancestor
64541832|NCT03393468|Dapivirine|dapivirine|mesh-list
64541833|NCT03393468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64541834|NCT03393468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64541835|NCT03393468|Antiviral Agents|antiviral agents|mesh-ancestor
64541836|NCT03393468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541837|NCT05091606|Anesthetics|anesthetics|mesh-list
64541838|NCT05091606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64541839|NCT05091606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664917|NCT04938765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64541872|NCT02993991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541873|NCT00158184|Oxycodone|oxycodone|mesh-list
64541874|NCT00158184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64541875|NCT00158184|Narcotics|narcotics|mesh-ancestor
64541876|NCT00158184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64541877|NCT00158184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541878|NCT00158184|Analgesics|analgesics|mesh-ancestor
64541879|NCT00158184|Sensory System Agents|sensory system agents|mesh-ancestor
64541880|NCT00158184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64541881|NCT02405520|Vaccines|vaccines|mesh-list
64541882|NCT02405520|Immunologic Factors|immunologic factors|mesh-ancestor
64541883|NCT02405520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541884|NCT02993835|Iron|iron|mesh-list
64541885|NCT02993835|Trace Elements|trace elements|mesh-ancestor
64541886|NCT02993835|Micronutrients|micronutrients|mesh-ancestor
64541887|NCT02993835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541888|NCT05091138|Buprenorphine|buprenorphine|mesh-list
64541889|NCT05091138|Bupivacaine|bupivacaine|mesh-list
64541890|NCT05091138|Anesthetics, Local|anesthetics, local|mesh-ancestor
64777757|NCT02214420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541891|NCT05091138|Anesthetics|anesthetics|mesh-ancestor
64541892|NCT05091138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64777759|NCT02214420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64777760|NCT02214420|Protease Inhibitors|protease inhibitors|mesh-ancestor
64777761|NCT02214420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64777762|NCT02215200|Lenograstim|lenograstim|mesh-list
64777763|NCT02215200|Thymoglobulin|thymoglobulin|mesh-list
64541893|NCT05091138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541894|NCT05091138|Sensory System Agents|sensory system agents|mesh-ancestor
64541895|NCT05091138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64541897|NCT05091138|Narcotics|narcotics|mesh-ancestor
64541898|NCT05091138|Analgesics|analgesics|mesh-ancestor
64541899|NCT05091138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64541900|NCT02999295|Nivolumab|nivolumab|mesh-list
64541901|NCT02999295|Ramucirumab|ramucirumab|mesh-list
64541902|NCT02999295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64541903|NCT02999295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541904|NCT02999295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64541905|NCT02999295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541906|NCT02998905|Aspirin|aspirin|mesh-list
64541907|NCT02998905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64978131|NCT00073697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64978132|NCT00073697|Cholinergic Agents|cholinergic agents|mesh-ancestor
64978133|NCT00268372|Docetaxel|docetaxel|mesh-list
64541908|NCT02998905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64541909|NCT02998905|Analgesics|analgesics|mesh-ancestor
64541910|NCT02998905|Sensory System Agents|sensory system agents|mesh-ancestor
64541911|NCT02998905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64541912|NCT02998905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541913|NCT02998905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64541914|NCT02998905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64541915|NCT02998905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64541916|NCT02998905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64541917|NCT02998905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541918|NCT02998905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64541919|NCT02998905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64541920|NCT02998905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541921|NCT02998905|Antipyretics|antipyretics|mesh-ancestor
64541922|NCT05735184|Cytarabine|cytarabine|mesh-list
64541923|NCT05735184|Azacitidine|azacitidine|mesh-list
64541924|NCT05735184|Daunorubicin|daunorubicin|mesh-list
64541925|NCT05735184|Venetoclax|venetoclax|mesh-list
64541926|NCT05735184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64541927|NCT05735184|Antimetabolites|antimetabolites|mesh-ancestor
64541928|NCT05735184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541929|NCT05735184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541930|NCT05735184|Antiviral Agents|antiviral agents|mesh-ancestor
64541931|NCT05735184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541932|NCT05735184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64541933|NCT05735184|Immunologic Factors|immunologic factors|mesh-ancestor
64541934|NCT05735184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541935|NCT05735184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541936|NCT05735184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64541937|NCT05735184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64541939|NCT02993367|3-n-butylphthalide|3-n-butylphthalide|mesh-list
64306682|NCT04964180|Analgesics|analgesics|mesh-ancestor
64978134|NCT00268372|Fluorouracil|fluorouracil|mesh-list
64978155|NCT00268411|Immunologic Factors|immunologic factors|mesh-ancestor
64978156|NCT00268411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978158|NCT00073736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64978159|NCT00073736|Antimetabolites|antimetabolites|mesh-ancestor
64665214|NCT03325959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64978160|NCT00073736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978161|NCT00073736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978162|NCT00073736|Antiviral Agents|antiviral agents|mesh-ancestor
64541940|NCT02993367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64541941|NCT02993367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64541942|NCT02993367|Protective Agents|protective agents|mesh-ancestor
64541943|NCT02993367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541944|NCT05094492|Fluorides|fluorides|mesh-list
64541945|NCT05094492|Fluorides, Topical|fluorides, topical|mesh-list
64541946|NCT05094492|Cariostatic Agents|cariostatic agents|mesh-ancestor
64541947|NCT05094492|Protective Agents|protective agents|mesh-ancestor
64541948|NCT05094492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541949|NCT01380691|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
64541950|NCT01380691|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64541951|NCT01380691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541952|NCT01380691|Disinfectants|disinfectants|mesh-ancestor
64541953|NCT05094414|Valacyclovir|valacyclovir|mesh-list
64541954|NCT05094414|Antiviral Agents|antiviral agents|mesh-ancestor
64541955|NCT05094414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541956|NCT02835222|Cytarabine|cytarabine|mesh-list
64541957|NCT02835222|Daunorubicin|daunorubicin|mesh-list
64541958|NCT02835222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64541959|NCT02835222|Antimetabolites|antimetabolites|mesh-ancestor
64541960|NCT02835222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541961|NCT02835222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541962|NCT02835222|Antiviral Agents|antiviral agents|mesh-ancestor
64541963|NCT02835222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541964|NCT02835222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64541965|NCT02835222|Immunologic Factors|immunologic factors|mesh-ancestor
64541966|NCT02835222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541967|NCT02835222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64541968|NCT02835222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64541969|NCT02835222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64714155|NCT03050294|Hormones|hormones|mesh-ancestor
64541970|NCT02835222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541971|NCT04386447|Oxytocin|oxytocin|mesh-list
64541972|NCT04386447|Oxytocics|oxytocics|mesh-ancestor
64389202|NCT04031729|Aspirin|aspirin|mesh-list
64541973|NCT04386447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64665350|NCT01439672|Insulin|insulin|mesh-list
64389205|NCT04031729|Analgesics|analgesics|mesh-ancestor
64541974|NCT04386447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541975|NCT02993133|Mycophenolic Acid|mycophenolic acid|mesh-list
64484211|NCT01730053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978163|NCT00073736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541976|NCT02993133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64541977|NCT02993133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64541978|NCT02993133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64541979|NCT02993133|Antitubercular Agents|antitubercular agents|mesh-ancestor
64541980|NCT02993133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64541981|NCT02993133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64541982|NCT02993133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64541983|NCT02993133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541984|NCT01380535|Methoxsalen|methoxsalen|mesh-list
64541985|NCT01380535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64541986|NCT01380535|Dermatologic Agents|dermatologic agents|mesh-ancestor
64541987|NCT00725361|Ambrisentan|ambrisentan|mesh-list
64541988|NCT00725361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64541989|NCT02816424|TEMPO|tempo|mesh-list
64541990|NCT02816424|Antioxidants|antioxidants|mesh-ancestor
64541991|NCT02816424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64541992|NCT02816424|Protective Agents|protective agents|mesh-ancestor
64541993|NCT02816424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541994|NCT01275885|Cholecalciferol|cholecalciferol|mesh-list
64541995|NCT01275885|Vitamin D|vitamin d|mesh-list
64541996|NCT01275885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64541997|NCT01275885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64541998|NCT01275885|Vitamins|vitamins|mesh-ancestor
64541999|NCT01275885|Micronutrients|micronutrients|mesh-ancestor
64542000|NCT01275885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64542001|NCT02794896|Fentanyl|fentanyl|mesh-list
64542002|NCT02794896|Propofol|propofol|mesh-list
64542003|NCT02794896|Sevoflurane|sevoflurane|mesh-list
64542004|NCT02794896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64542005|NCT02794896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64542006|NCT02794896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542007|NCT02794896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64542008|NCT02794896|Anesthetics, General|anesthetics, general|mesh-ancestor
64542009|NCT02794896|Anesthetics|anesthetics|mesh-ancestor
64542019|NCT01271283|Immunologic Factors|immunologic factors|mesh-ancestor
64542020|NCT01271283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542021|NCT01271283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64542022|NCT01271283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64542023|NCT01271283|Growth Substances|growth substances|mesh-ancestor
64542024|NCT01271283|Growth Inhibitors|growth inhibitors|mesh-ancestor
64542025|NCT01271283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542027|NCT01271439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64542028|NCT01271439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542029|NCT01271517|Insulin, Isophane|insulin, isophane|mesh-list
64542030|NCT01271517|Isophane Insulin, Human|isophane insulin, human|mesh-list
64542031|NCT01271517|Isophane insulin, beef|isophane insulin, beef|mesh-list
64542032|NCT01271517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64542033|NCT01271517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542034|NCT05090592|Atropine|atropine|mesh-list
64542035|NCT05090592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64542036|NCT05090592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64542037|NCT05090592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64542038|NCT05090592|Autonomic Agents|autonomic agents|mesh-ancestor
64542039|NCT05090592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64542040|NCT05090592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542041|NCT05090592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64542042|NCT05090592|Respiratory System Agents|respiratory system agents|mesh-ancestor
64542043|NCT05090592|Mydriatics|mydriatics|mesh-ancestor
64542044|NCT05090592|Parasympatholytics|parasympatholytics|mesh-ancestor
64542045|NCT05090592|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64665562|NCT02770365|Estradiol|estradiol|mesh-list
64542046|NCT05090592|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64542047|NCT05090592|Cholinergic Agents|cholinergic agents|mesh-ancestor
64542048|NCT05090592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64542049|NCT05090592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542051|NCT02992665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64542052|NCT02992665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542053|NCT05093478|Lidocaine|lidocaine|mesh-list
64484212|NCT01751113|Fluticasone|fluticasone|mesh-list
64542054|NCT05093478|Capsaicin|capsaicin|mesh-list
64542055|NCT05093478|Anesthetics, Local|anesthetics, local|mesh-ancestor
64542056|NCT05093478|Anesthetics|anesthetics|mesh-ancestor
64542057|NCT05093478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64542058|NCT05093478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542059|NCT05093478|Sensory System Agents|sensory system agents|mesh-ancestor
64542060|NCT05093478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64542061|NCT05093478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64306831|NCT02071043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64978164|NCT00073736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64978165|NCT00073736|Immunologic Factors|immunologic factors|mesh-ancestor
64978166|NCT00073736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978167|NCT00268489|Bevacizumab|bevacizumab|mesh-list
64978169|NCT00268489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64978170|NCT00268489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978171|NCT00268489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64978172|NCT00268489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64978173|NCT00268489|Growth Substances|growth substances|mesh-ancestor
64978174|NCT00268489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978175|NCT00268489|Growth Inhibitors|growth inhibitors|mesh-ancestor
64978176|NCT00268489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978177|NCT00268489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978178|NCT00268489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64978179|NCT00268489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64978180|NCT00268528|Methotrexate|methotrexate|mesh-list
64978181|NCT00268528|Mercaptopurine|mercaptopurine|mesh-list
64978182|NCT00268528|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64978183|NCT00268528|Abortifacient Agents|abortifacient agents|mesh-ancestor
64978184|NCT00268528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64978185|NCT00268528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978186|NCT00268528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64777797|NCT02223702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64777798|NCT02225106|Methylphenidate|methylphenidate|mesh-list
64389229|NCT02435095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64978206|NCT00073814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64978207|NCT00073814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64978208|NCT00073814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64978209|NCT00073814|Adrenergic Agents|adrenergic agents|mesh-ancestor
64978210|NCT00073814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64978211|NCT00073814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978212|NCT00102453|Pentoxifylline|pentoxifylline|mesh-list
64978213|NCT00102453|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64978214|NCT00102453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978215|NCT00102453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978216|NCT00102453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64978217|NCT00102453|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64978218|NCT00102453|Protective Agents|protective agents|mesh-ancestor
64978219|NCT00102453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978221|NCT00102453|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64978222|NCT00102453|Antioxidants|antioxidants|mesh-ancestor
64978223|NCT00268567|Prednisone|prednisone|mesh-list
64978224|NCT00268567|Leflunomide|leflunomide|mesh-list
64978225|NCT00268567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64978226|NCT00268567|Glucocorticoids|glucocorticoids|mesh-ancestor
64978227|NCT00268567|Hormones|hormones|mesh-ancestor
64978228|NCT00268567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64978229|NCT00268567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978230|NCT00268567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64978231|NCT00268567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978232|NCT00268567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978233|NCT00268567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978234|NCT00268567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64978235|NCT00268567|Immunologic Factors|immunologic factors|mesh-ancestor
64978237|NCT00268645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64665781|NCT04080843|Capecitabine|capecitabine|mesh-list
64542062|NCT05093478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64542063|NCT05093478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64542064|NCT05093478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64542065|NCT05093478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542066|NCT05093478|Antipruritics|antipruritics|mesh-ancestor
64542067|NCT05093478|Dermatologic Agents|dermatologic agents|mesh-ancestor
64389244|NCT03187093|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64542068|NCT00725751|Interferons|interferons|mesh-list
64542069|NCT00725751|Ribavirin|ribavirin|mesh-list
64542070|NCT00725751|Interferon-alpha|interferon-alpha|mesh-list
64542071|NCT00725751|Interferon alpha-2|interferon alpha-2|mesh-list
64542072|NCT00725751|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64542073|NCT00725751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542074|NCT00725751|Antiviral Agents|antiviral agents|mesh-ancestor
64542075|NCT00725751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64542076|NCT00725751|Antimetabolites|antimetabolites|mesh-ancestor
64542077|NCT00725751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542078|NCT00725751|Immunologic Factors|immunologic factors|mesh-ancestor
64542079|NCT00725751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542080|NCT05364385|Budesonide|budesonide|mesh-list
64542081|NCT05364385|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64542082|NCT05364385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64542083|NCT05364385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64542084|NCT05364385|Autonomic Agents|autonomic agents|mesh-ancestor
64542085|NCT05364385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64542086|NCT05364385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542087|NCT05364385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64542088|NCT05364385|Respiratory System Agents|respiratory system agents|mesh-ancestor
64542089|NCT05364385|Glucocorticoids|glucocorticoids|mesh-ancestor
64542090|NCT05364385|Hormones|hormones|mesh-ancestor
64666068|NCT05062317|Bevacizumab|bevacizumab|mesh-list
64666072|NCT05062317|Irinotecan|irinotecan|mesh-list
64542091|NCT05364385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64542092|NCT00726375|Etanercept|etanercept|mesh-list
64542093|NCT00726375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64306840|NCT02076893|Analgesics|analgesics|mesh-ancestor
64978238|NCT00268645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978239|NCT00268684|Temozolomide|temozolomide|mesh-list
64978240|NCT00268684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64978258|NCT00106821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64978259|NCT00106821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978261|NCT00073931|Tositumomab I-131|tositumomab i-131|mesh-list
64978262|NCT00073931|Sargramostim|sargramostim|mesh-list
64978263|NCT00073931|Immunologic Factors|immunologic factors|mesh-ancestor
64542094|NCT00726375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64542095|NCT00726375|Analgesics|analgesics|mesh-ancestor
64542096|NCT00726375|Sensory System Agents|sensory system agents|mesh-ancestor
64542097|NCT00726375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64542098|NCT00726375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542099|NCT00726375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64542100|NCT00726375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64542101|NCT00726375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64542102|NCT00726375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64542103|NCT00726375|Immunologic Factors|immunologic factors|mesh-ancestor
64542104|NCT02693184|Vitamin D|vitamin d|mesh-list
64542105|NCT02693184|Calcium|calcium|mesh-list
64542106|NCT02693184|Vitamins|vitamins|mesh-ancestor
64542107|NCT02693184|Micronutrients|micronutrients|mesh-ancestor
64542108|NCT02693184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542109|NCT02693184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64542110|NCT02693184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64542111|NCT05363059|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64542112|NCT05363059|Antihypertensive Agents|antihypertensive agents|mesh-list
64542113|NCT05363059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542114|NCT01394185|Dronabinol|dronabinol|mesh-list
64542115|NCT01394185|Hallucinogens|hallucinogens|mesh-ancestor
64542116|NCT01394185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542117|NCT01394185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64542118|NCT01394185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64542119|NCT01394185|Analgesics|analgesics|mesh-ancestor
64542120|NCT01394185|Sensory System Agents|sensory system agents|mesh-ancestor
64542121|NCT01394185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64542122|NCT01394185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64542123|NCT01394185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64542124|NCT01394185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64542125|NCT01394185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542126|NCT01394185|Hormones|hormones|mesh-ancestor
64542135|NCT05375916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64542136|NCT04361851|Pembrolizumab|pembrolizumab|mesh-list
64542137|NCT04361851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64542138|NCT04361851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542139|NCT04407715|Anesthetics|anesthetics|mesh-list
64542140|NCT04407715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64542141|NCT04407715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542142|NCT00727857|Metformin|metformin|mesh-list
64542143|NCT00727857|Pioglitazone|pioglitazone|mesh-list
64542144|NCT00727857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64542145|NCT00727857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542146|NCT05092152|Propofol|propofol|mesh-list
64542147|NCT05092152|Esketamine|esketamine|mesh-list
64542148|NCT05092152|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64542149|NCT05092152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64542150|NCT05092152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542151|NCT05092152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64542152|NCT05092152|Anesthetics, General|anesthetics, general|mesh-ancestor
64542153|NCT05092152|Anesthetics|anesthetics|mesh-ancestor
64542154|NCT05092152|Antidepressive Agents|antidepressive agents|mesh-ancestor
64542155|NCT05092152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64542156|NCT05081700|Ocrelizumab|ocrelizumab|mesh-list
64542157|NCT05081700|Immunologic Factors|immunologic factors|mesh-ancestor
64542158|NCT05081700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542159|NCT05001360|Nivolumab|nivolumab|mesh-list
64542160|NCT05001360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64542161|NCT05001360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64542162|NCT05001360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542163|NCT05001360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542164|NCT05022810|Acetaminophen|acetaminophen|mesh-list
64542165|NCT05022810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64542166|NCT05022810|Analgesics|analgesics|mesh-ancestor
64542167|NCT05022810|Sensory System Agents|sensory system agents|mesh-ancestor
64978264|NCT00073931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978265|NCT00073931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978266|NCT00268723|Albuterol|albuterol|mesh-list
64978267|NCT00268723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64978268|NCT00268723|Autonomic Agents|autonomic agents|mesh-ancestor
64978269|NCT00268723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64978270|NCT00268723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978271|NCT00268723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64978272|NCT00268723|Respiratory System Agents|respiratory system agents|mesh-ancestor
64978273|NCT00268723|Tocolytic Agents|tocolytic agents|mesh-ancestor
64542168|NCT05022810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64542169|NCT05022810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542170|NCT05022810|Antipyretics|antipyretics|mesh-ancestor
64542171|NCT01525550|Sunitinib|sunitinib|mesh-list
64542172|NCT01525550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542173|NCT01525550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64542174|NCT01525550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64542175|NCT01525550|Growth Substances|growth substances|mesh-ancestor
64542176|NCT01525550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542177|NCT01525550|Growth Inhibitors|growth inhibitors|mesh-ancestor
64542178|NCT01525550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64542179|NCT01525550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542180|NCT01525550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542181|NCT04730232|Paclitaxel|paclitaxel|mesh-list
64542182|NCT04730232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64542183|NCT04730232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542184|NCT04730232|Tubulin Modulators|tubulin modulators|mesh-ancestor
64542185|NCT04730232|Antimitotic Agents|antimitotic agents|mesh-ancestor
64542186|NCT04730232|Mitosis Modulators|mitosis modulators|mesh-ancestor
64542187|NCT04730232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542188|NCT04701918|Pembrolizumab|pembrolizumab|mesh-list
64542189|NCT04701918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64542190|NCT04701918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542191|NCT04540848|Bupivacaine|bupivacaine|mesh-list
64542192|NCT04540848|Anesthetics, Local|anesthetics, local|mesh-ancestor
64542193|NCT04540848|Anesthetics|anesthetics|mesh-ancestor
64542194|NCT04540848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64542195|NCT04540848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542196|NCT04540848|Sensory System Agents|sensory system agents|mesh-ancestor
64542211|NCT05366101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64542212|NCT05366101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64542213|NCT05366101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542215|NCT04993560|Immunologic Factors|immunologic factors|mesh-ancestor
64542216|NCT04993560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542217|NCT05365555|Anesthetics|anesthetics|mesh-list
64666500|NCT03581409|Aspirin|aspirin|mesh-list
64389266|NCT02039999|Sequestering Agents|sequestering agents|mesh-ancestor
64542218|NCT05365555|Ropivacaine|ropivacaine|mesh-list
64542219|NCT05365555|Anesthetics, Local|anesthetics, local|mesh-list
64542220|NCT05365555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64542221|NCT05365555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542222|NCT05365555|Sensory System Agents|sensory system agents|mesh-ancestor
64542223|NCT05365555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64542224|NCT01525238|Dapagliflozin|dapagliflozin|mesh-list
64542225|NCT01525238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64542226|NCT01525238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542227|NCT01525238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64542228|NCT01525238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542229|NCT05374356|Morphine|morphine|mesh-list
64542230|NCT05374356|Bupivacaine|bupivacaine|mesh-list
64542231|NCT05374356|Anesthetics, Local|anesthetics, local|mesh-ancestor
64542232|NCT05374356|Anesthetics|anesthetics|mesh-ancestor
64542233|NCT05374356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64542234|NCT05374356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542235|NCT05374356|Sensory System Agents|sensory system agents|mesh-ancestor
64542236|NCT05374356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64542237|NCT05374356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64542238|NCT05374356|Narcotics|narcotics|mesh-ancestor
64542239|NCT05374356|Analgesics|analgesics|mesh-ancestor
64542240|NCT00717405|Bevacizumab|bevacizumab|mesh-list
64542241|NCT00717405|Trastuzumab|trastuzumab|mesh-list
64666538|NCT03566667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64542242|NCT00717405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64542243|NCT00717405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978274|NCT00268723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64978275|NCT00268723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64978276|NCT00268723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64978277|NCT00268723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64978278|NCT00268723|Adrenergic Agents|adrenergic agents|mesh-ancestor
64978279|NCT00268723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64978280|NCT00268723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666606|NCT00373815|Everolimus|everolimus|mesh-list
64542244|NCT00717405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64542245|NCT00717405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64542247|NCT00717405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542248|NCT00717405|Growth Inhibitors|growth inhibitors|mesh-ancestor
64542249|NCT01276977|Zolmitriptan|zolmitriptan|mesh-list
64542250|NCT01276977|Eletriptan|eletriptan|mesh-list
64542251|NCT01276977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64542252|NCT01276977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64542254|NCT01276977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64542255|NCT01276977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389272|NCT02434861|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64389273|NCT02434861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389274|NCT02434861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389275|NCT02434861|Protective Agents|protective agents|mesh-ancestor
64324193|NCT00258427|Hormones|hormones|mesh-ancestor
64542256|NCT01276977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542257|NCT03832699|Dydrogesterone|dydrogesterone|mesh-list
64542258|NCT03832699|Progesterone|progesterone|mesh-list
64542259|NCT03832699|Progestins|progestins|mesh-ancestor
64542260|NCT03832699|Hormones|hormones|mesh-ancestor
64542261|NCT03832699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64542262|NCT03832699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542263|NCT03997903|Imatinib Mesylate|imatinib mesylate|mesh-list
64542264|NCT03997903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542265|NCT03997903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64542266|NCT03997903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542267|NCT03997903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542268|NCT01277289|Dexamethasone|dexamethasone|mesh-list
64978281|NCT00268840|Gemcitabine|gemcitabine|mesh-list
64978282|NCT00268840|Docetaxel|docetaxel|mesh-list
64978283|NCT00268840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64978284|NCT00268840|Antimetabolites|antimetabolites|mesh-ancestor
64978285|NCT00268840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978286|NCT00268840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978287|NCT00268840|Antiviral Agents|antiviral agents|mesh-ancestor
64978288|NCT00268840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64978289|NCT00268840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978290|NCT00268840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64978291|NCT00268840|Immunologic Factors|immunologic factors|mesh-ancestor
64978292|NCT00268840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978293|NCT00268840|Tubulin Modulators|tubulin modulators|mesh-ancestor
64978294|NCT00268840|Antimitotic Agents|antimitotic agents|mesh-ancestor
64978295|NCT00268840|Mitosis Modulators|mitosis modulators|mesh-ancestor
64978296|NCT00268879|Renzapride|renzapride|mesh-list
64978297|NCT00268879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64978310|NCT00268918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978311|NCT00268957|Sevelamer|sevelamer|mesh-list
64978312|NCT00268957|Chelating Agents|chelating agents|mesh-ancestor
64978313|NCT00268957|Sequestering Agents|sequestering agents|mesh-ancestor
64978314|NCT00268957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978315|NCT00073970|Celecoxib|celecoxib|mesh-list
64978316|NCT00073970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64978317|NCT00073970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64542269|NCT01277289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64542270|NCT01277289|Antiemetics|antiemetics|mesh-ancestor
64542271|NCT01277289|Autonomic Agents|autonomic agents|mesh-ancestor
64542272|NCT01277289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64945398|NCT05664789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498379|NCT01361620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542273|NCT01277289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542274|NCT01277289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64542275|NCT01277289|Glucocorticoids|glucocorticoids|mesh-ancestor
64542276|NCT01277289|Hormones|hormones|mesh-ancestor
64324202|NCT02233621|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64324203|NCT02233621|Estradiol|estradiol|mesh-list
64324204|NCT02233621|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64324205|NCT02233621|Estrogens|estrogens|mesh-ancestor
64777838|NCT02239380|GABA Modulators|gaba modulators|mesh-ancestor
64301925|NCT02128243|Immunologic Factors|immunologic factors|mesh-ancestor
64301926|NCT02128243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301927|NCT02128243|Antidotes|antidotes|mesh-ancestor
64301928|NCT02128243|Protective Agents|protective agents|mesh-ancestor
64301929|NCT02128243|Vitamin B Complex|vitamin b complex|mesh-ancestor
64301930|NCT02128243|Vitamins|vitamins|mesh-ancestor
64301931|NCT02128243|Micronutrients|micronutrients|mesh-ancestor
64542277|NCT01277289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64542278|NCT01277289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64542279|NCT01277289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542280|NCT01525082|Bevacizumab|bevacizumab|mesh-list
64542281|NCT01525082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64542282|NCT01525082|Capecitabine|capecitabine|mesh-list
64542283|NCT01525082|Temozolomide|temozolomide|mesh-list
64542284|NCT01525082|Antibodies|antibodies|mesh-list
64542285|NCT01525082|Immunoglobulins|immunoglobulins|mesh-list
64542287|NCT01525082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542288|NCT01525082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64542289|NCT01525082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64542290|NCT01525082|Growth Substances|growth substances|mesh-ancestor
64542291|NCT01525082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542292|NCT01525082|Growth Inhibitors|growth inhibitors|mesh-ancestor
64542293|NCT01525082|Immunologic Factors|immunologic factors|mesh-ancestor
64542294|NCT01525082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64542295|NCT01525082|Antimetabolites|antimetabolites|mesh-ancestor
64542296|NCT01525082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542297|NCT01525082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64542298|NCT01525082|Alkylating Agents|alkylating agents|mesh-ancestor
64542299|NCT03599791|Fluticasone|fluticasone|mesh-list
64542300|NCT03599791|Xhance|xhance|mesh-list
64542301|NCT03599791|Azelastine|azelastine|mesh-list
64542302|NCT03599791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64978318|NCT00073970|Analgesics|analgesics|mesh-ancestor
64978319|NCT00073970|Sensory System Agents|sensory system agents|mesh-ancestor
64978320|NCT00073970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64542303|NCT03599791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64542304|NCT03599791|Autonomic Agents|autonomic agents|mesh-ancestor
64542305|NCT03599791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64542306|NCT03599791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542307|NCT03599791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64542308|NCT03599791|Respiratory System Agents|respiratory system agents|mesh-ancestor
64777839|NCT02239380|GABA Agents|gaba agents|mesh-ancestor
64777840|NCT02239380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64542309|NCT03599791|Dermatologic Agents|dermatologic agents|mesh-ancestor
64542310|NCT03599791|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64542311|NCT03599791|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64542312|NCT03599791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542313|NCT03599791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542314|NCT03599791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64542316|NCT03599791|Histamine Antagonists|histamine antagonists|mesh-ancestor
64542317|NCT03599791|Histamine Agents|histamine agents|mesh-ancestor
64542318|NCT03599791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64542319|NCT01488578|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64542320|NCT01488578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64542321|NCT01488578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64542322|NCT01488578|Cholinergic Agents|cholinergic agents|mesh-ancestor
64542323|NCT01488578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64542324|NCT01488578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542325|NCT01488578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542326|NCT01488578|Urological Agents|urological agents|mesh-ancestor
64542327|NCT00720369|Ubiquinone|ubiquinone|mesh-list
64542328|NCT00720369|Coenzyme Q10|coenzyme q10|mesh-list
64542329|NCT00720369|Micronutrients|micronutrients|mesh-ancestor
64542330|NCT00720369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542331|NCT00720369|Vitamins|vitamins|mesh-ancestor
64542332|NCT01524770|Dulaglutide|dulaglutide|mesh-list
64542333|NCT01524770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64542334|NCT01524770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542345|NCT04088864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64542346|NCT02991339|Dexamethasone|dexamethasone|mesh-list
64945399|NCT05664789|Protective Agents|protective agents|mesh-ancestor
64542347|NCT02991339|Dexamethasone acetate|dexamethasone acetate|mesh-list
64542348|NCT02991339|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64542349|NCT02991339|BB 1101|bb 1101|mesh-list
64542350|NCT02991339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64542351|NCT02991339|Antiemetics|antiemetics|mesh-ancestor
64542352|NCT02991339|Autonomic Agents|autonomic agents|mesh-ancestor
64542353|NCT02991339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64542354|NCT02991339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542355|NCT02991339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64542356|NCT02991339|Glucocorticoids|glucocorticoids|mesh-ancestor
64542357|NCT02991339|Hormones|hormones|mesh-ancestor
64542358|NCT02991339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64542359|NCT02991339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64542360|NCT02991339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542361|NCT02991339|Protease Inhibitors|protease inhibitors|mesh-ancestor
64542362|NCT02991339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542363|NCT02991339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542364|NCT04018105|Metformin|metformin|mesh-list
64542365|NCT04018105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64542366|NCT04018105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542368|NCT05632549|Vitamin B Complex|vitamin b complex|mesh-ancestor
64542369|NCT05632549|Vitamins|vitamins|mesh-ancestor
64542370|NCT05632549|Micronutrients|micronutrients|mesh-ancestor
64542371|NCT05632549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542372|NCT00721617|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64542373|NCT00721617|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64542374|NCT00721617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64542375|NCT00721617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64542388|NCT01277835|Anesthetics|anesthetics|mesh-ancestor
64542389|NCT01277835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64542390|NCT01277835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542391|NCT01277835|Sensory System Agents|sensory system agents|mesh-ancestor
64542392|NCT01277835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64542393|NCT01277835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64542394|NCT01277835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64542395|NCT01277835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64542396|NCT01277835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64542397|NCT01277835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542398|NCT01431287|Tiotropium Bromide|tiotropium bromide|mesh-list
64542399|NCT01431287|Olodaterol|olodaterol|mesh-list
64542400|NCT01431287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64542401|NCT01431287|Autonomic Agents|autonomic agents|mesh-ancestor
64542402|NCT01431287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64542403|NCT01431287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542404|NCT01431287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64542405|NCT01431287|Respiratory System Agents|respiratory system agents|mesh-ancestor
64542406|NCT01431287|Parasympatholytics|parasympatholytics|mesh-ancestor
64542407|NCT01431287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64542408|NCT01431287|Cholinergic Agents|cholinergic agents|mesh-ancestor
64542409|NCT01431287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64542410|NCT01431287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542411|NCT05632159|Anesthetics|anesthetics|mesh-list
64542412|NCT05632159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64542413|NCT05632159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542414|NCT04017013|Lidocaine|lidocaine|mesh-list
64542415|NCT04017013|Anesthetics, Local|anesthetics, local|mesh-ancestor
64542416|NCT04017013|Anesthetics|anesthetics|mesh-ancestor
64542419|NCT04017013|Sensory System Agents|sensory system agents|mesh-ancestor
64542429|NCT01277913|Vitamins|vitamins|mesh-list
64542430|NCT01277913|Micronutrients|micronutrients|mesh-ancestor
64542431|NCT01277913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542432|NCT01277913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64542433|NCT01277913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64542434|NCT05631847|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64542435|NCT05631847|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64542436|NCT05631847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64542437|NCT05631847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542439|NCT00729807|Antifungal Agents|antifungal agents|mesh-ancestor
64542440|NCT00729807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64542441|NCT00729807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64542442|NCT00729807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64542443|NCT00729807|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64542444|NCT03590119|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64542445|NCT03590119|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64542446|NCT03590119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542447|NCT03992131|Rucaparib|rucaparib|mesh-list
64307223|NCT04947566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64978321|NCT00073970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978322|NCT00073970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64978323|NCT00073970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64978324|NCT00073970|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64978325|NCT00073970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64978326|NCT00073970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978327|NCT00073970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978328|NCT00102492|Casopitant|casopitant|mesh-list
64978329|NCT00102492|Antiemetics|antiemetics|mesh-ancestor
64978330|NCT00102492|Autonomic Agents|autonomic agents|mesh-ancestor
64978331|NCT00102492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64978332|NCT00102492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978333|NCT00102492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64978334|NCT00102492|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64978335|NCT00102492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64978336|NCT00102492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978337|NCT00269035|Risperidone|risperidone|mesh-list
64978338|NCT00269035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64978339|NCT00269035|Serotonin Agents|serotonin agents|mesh-ancestor
64978340|NCT00269035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64978341|NCT00269035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978342|NCT00269035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978344|NCT00269035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64978345|NCT00269035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64978346|NCT00269035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64978347|NCT00269035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64978348|NCT00269035|Dopamine Agents|dopamine agents|mesh-ancestor
64978349|NCT00074009|Bortezomib|bortezomib|mesh-list
64978350|NCT00074009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978351|NCT00269269|Antihypertensive Agents|antihypertensive agents|mesh-list
64978352|NCT00269386|Clarithromycin|clarithromycin|mesh-list
64978353|NCT00269386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64542448|NCT03992131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64542449|NCT03992131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542450|NCT03992131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542451|NCT03992131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542452|NCT03592693|Vitamins|vitamins|mesh-list
64542453|NCT03592693|Hydrocortisone|hydrocortisone|mesh-list
64542454|NCT03592693|Micronutrients|micronutrients|mesh-ancestor
64542455|NCT03592693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542456|NCT03592693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64542457|NCT00730353|Paclitaxel|paclitaxel|mesh-list
64542458|NCT00730353|Sunitinib|sunitinib|mesh-list
64542459|NCT00730353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64542460|NCT00730353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542461|NCT00730353|Tubulin Modulators|tubulin modulators|mesh-ancestor
64542462|NCT00730353|Antimitotic Agents|antimitotic agents|mesh-ancestor
64542463|NCT00730353|Mitosis Modulators|mitosis modulators|mesh-ancestor
64542464|NCT00730353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542465|NCT00730353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64307242|NCT03241875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64978354|NCT00269386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64978355|NCT00269386|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64978356|NCT00269386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978357|NCT00269386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389305|NCT03187015|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64978358|NCT00269386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64978372|NCT00269542|Micronutrients|micronutrients|mesh-ancestor
64978373|NCT00269542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978374|NCT00269542|Hematinics|hematinics|mesh-ancestor
64978375|NCT00269542|Vitamins|vitamins|mesh-ancestor
64978376|NCT00269620|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64978377|NCT00269620|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64978378|NCT00269620|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64978379|NCT00269620|Etonogestrel|etonogestrel|mesh-list
64978380|NCT00269620|NuvaRing|nuvaring|mesh-list
64978381|NCT00269620|Norelgestromin|norelgestromin|mesh-list
64978382|NCT00269620|Ortho Evra|ortho evra|mesh-list
64978383|NCT00269620|Contraceptive Agents|contraceptive agents|mesh-list
64978384|NCT00269620|Estradiol|estradiol|mesh-list
64978385|NCT00269620|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64978386|NCT00269620|Estrogens|estrogens|mesh-ancestor
64978387|NCT00269620|Hormones|hormones|mesh-ancestor
64978388|NCT00269620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64978389|NCT00269620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978390|NCT00269620|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64978391|NCT00269620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64978392|NCT00269620|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64978393|NCT00269620|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64978394|NCT00269620|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64978395|NCT00074204|Gemcitabine|gemcitabine|mesh-list
64978396|NCT00074204|Carboplatin|carboplatin|mesh-list
64978397|NCT00074204|Docetaxel|docetaxel|mesh-list
64978398|NCT00074204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978399|NCT00074204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64978400|NCT00074204|Antimetabolites|antimetabolites|mesh-ancestor
64978401|NCT00074204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978402|NCT00074204|Antiviral Agents|antiviral agents|mesh-ancestor
64978403|NCT00074204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64542466|NCT00730353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64542467|NCT00730353|Growth Substances|growth substances|mesh-ancestor
64542468|NCT00730353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542469|NCT00730353|Growth Inhibitors|growth inhibitors|mesh-ancestor
64542470|NCT00730353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64542471|NCT00730353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542472|NCT01272531|Valproic Acid|valproic acid|mesh-list
64542473|NCT01272531|Lithium Carbonate|lithium carbonate|mesh-list
64542474|NCT01272531|Anticonvulsants|anticonvulsants|mesh-ancestor
64542475|NCT01272531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542476|NCT01272531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542477|NCT01272531|GABA Agents|gaba agents|mesh-ancestor
64542478|NCT01272531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64542479|NCT01272531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542480|NCT01272531|Antimanic Agents|antimanic agents|mesh-ancestor
64542481|NCT01272531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64542482|NCT01272531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64542483|NCT01272531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64542484|NCT01272531|Antidepressive Agents|antidepressive agents|mesh-ancestor
64542485|NCT01272609|Timolol|timolol|mesh-list
64542486|NCT01272609|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64542487|NCT01272609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64542488|NCT01272609|Adrenergic Agents|adrenergic agents|mesh-ancestor
64542489|NCT01272609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64542490|NCT01272609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542491|NCT01272609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714156|NCT03050294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64542492|NCT01272609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64542493|NCT01272609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64542494|NCT03595189|Cilastatin|cilastatin|mesh-list
64978404|NCT00074204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978405|NCT00074204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64978406|NCT00074204|Immunologic Factors|immunologic factors|mesh-ancestor
64978407|NCT00074204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978408|NCT00074204|Tubulin Modulators|tubulin modulators|mesh-ancestor
64978409|NCT00074204|Antimitotic Agents|antimitotic agents|mesh-ancestor
64978410|NCT00074204|Mitosis Modulators|mitosis modulators|mesh-ancestor
64978411|NCT00416143|Prednisone|prednisone|mesh-list
64978412|NCT00416143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64978413|NCT00416143|Glucocorticoids|glucocorticoids|mesh-ancestor
64978414|NCT00416143|Hormones|hormones|mesh-ancestor
64978415|NCT00416143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64978416|NCT00416143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542495|NCT03595189|Protease Inhibitors|protease inhibitors|mesh-ancestor
64542496|NCT03595189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542497|NCT03595189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542498|NCT01410227|Factor VIII|factor viii|mesh-list
64542499|NCT01410227|Coagulants|coagulants|mesh-ancestor
64542500|NCT04007029|Cyclophosphamide|cyclophosphamide|mesh-list
64542501|NCT04007029|Fludarabine|fludarabine|mesh-list
64542502|NCT04007029|Fludarabine phosphate|fludarabine phosphate|mesh-list
64542503|NCT04007029|Immunoglobulins|immunoglobulins|mesh-list
64542504|NCT04007029|Immunoglobulin G|immunoglobulin g|mesh-list
64542505|NCT04007029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64542506|NCT04007029|Immunologic Factors|immunologic factors|mesh-ancestor
64542507|NCT04007029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542508|NCT04007029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64542509|NCT04007029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64542510|NCT04007029|Alkylating Agents|alkylating agents|mesh-ancestor
64542511|NCT04007029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542512|NCT04007029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542513|NCT04007029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64542514|NCT04007029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64542515|NCT04007029|Antimetabolites|antimetabolites|mesh-ancestor
64542517|NCT01274559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64542518|NCT01274559|Antimetabolites|antimetabolites|mesh-ancestor
64542519|NCT01274559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542520|NCT01274559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64542521|NCT01274559|Vasodilator Agents|vasodilator agents|mesh-ancestor
64542522|NCT01274559|Vitamin B Complex|vitamin b complex|mesh-ancestor
64542523|NCT01274559|Vitamins|vitamins|mesh-ancestor
64542524|NCT01274559|Micronutrients|micronutrients|mesh-ancestor
64542525|NCT01274559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542526|NCT01409993|Sildenafil Citrate|sildenafil citrate|mesh-list
64542527|NCT01409993|Vasodilator Agents|vasodilator agents|mesh-ancestor
64542528|NCT01409993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64978417|NCT00416143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64978418|NCT00416143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978419|NCT00416221|Antidepressive Agents|antidepressive agents|mesh-list
64978420|NCT00416221|Citalopram|citalopram|mesh-list
64978421|NCT00416221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64978422|NCT00416221|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64978423|NCT00416221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64978449|NCT00269776|Dopamine Agents|dopamine agents|mesh-ancestor
64978450|NCT00269776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64542529|NCT01409993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64542530|NCT01409993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542531|NCT01409993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542532|NCT01409993|Urological Agents|urological agents|mesh-ancestor
64542533|NCT01409915|Molgramostim|molgramostim|mesh-list
64542534|NCT01409915|Sargramostim|sargramostim|mesh-list
64667152|NCT05408585|Anesthetics|anesthetics|mesh-list
64542535|NCT01409915|Immunologic Factors|immunologic factors|mesh-ancestor
64542536|NCT01409915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542537|NCT01409915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542538|NCT01272921|Bupivacaine|bupivacaine|mesh-list
64542539|NCT01272921|Ropivacaine|ropivacaine|mesh-list
64542540|NCT01272921|Anesthetics, Local|anesthetics, local|mesh-ancestor
64542541|NCT01272921|Anesthetics|anesthetics|mesh-ancestor
64542542|NCT01272921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64542543|NCT01272921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542544|NCT01272921|Sensory System Agents|sensory system agents|mesh-ancestor
64542545|NCT01272921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64542547|NCT01409837|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64542548|NCT01409837|Protease Inhibitors|protease inhibitors|mesh-ancestor
64542549|NCT01409837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542550|NCT01409837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542551|NCT01409837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64542581|NCT01430585|Letrozole|letrozole|mesh-list
64542582|NCT01430585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542583|NCT01430585|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64542584|NCT01430585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64542585|NCT01430585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542586|NCT01430585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542587|NCT01430585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64542588|NCT01430585|Hormone Antagonists|hormone antagonists|mesh-ancestor
64542589|NCT01430585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64542590|NCT01430585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542591|NCT04005859|Lidocaine|lidocaine|mesh-list
64542592|NCT04005859|Anesthetics, Local|anesthetics, local|mesh-ancestor
64542593|NCT04005859|Anesthetics|anesthetics|mesh-ancestor
64542594|NCT04005859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64542595|NCT04005859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542596|NCT04005859|Sensory System Agents|sensory system agents|mesh-ancestor
64542597|NCT04005859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64542598|NCT04005859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64542599|NCT04005859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64542600|NCT04005859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64542601|NCT04005859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64542602|NCT04005859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542603|NCT05633719|Carboplatin|carboplatin|mesh-list
64542604|NCT05633719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542605|NCT01408901|Molgramostim|molgramostim|mesh-list
64542606|NCT01408901|Sargramostim|sargramostim|mesh-list
64542607|NCT01408901|Immunologic Factors|immunologic factors|mesh-ancestor
64542608|NCT01408901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542609|NCT01408901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542610|NCT02080195|Mycophenolic Acid|mycophenolic acid|mesh-list
64542611|NCT02080195|Cyclophosphamide|cyclophosphamide|mesh-list
64542612|NCT02080195|Fludarabine|fludarabine|mesh-list
64542613|NCT02080195|Tacrolimus|tacrolimus|mesh-list
64542614|NCT02080195|Thymoglobulin|thymoglobulin|mesh-list
64542615|NCT02080195|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64978451|NCT00269815|Methylphenidate|methylphenidate|mesh-list
64978452|NCT00269815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64978453|NCT00269815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978454|NCT00269815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64542616|NCT02080195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64542617|NCT02080195|Immunologic Factors|immunologic factors|mesh-ancestor
64542618|NCT02080195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542619|NCT02080195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64542620|NCT02080195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64542621|NCT02080195|Alkylating Agents|alkylating agents|mesh-ancestor
64542622|NCT02080195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542623|NCT02080195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542624|NCT02080195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64542625|NCT02080195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64542626|NCT02080195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542627|NCT02080195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64542628|NCT02080195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64542629|NCT02080195|Antitubercular Agents|antitubercular agents|mesh-ancestor
64542630|NCT02080195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64542631|NCT02080195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64542633|NCT04044131|Cathartics|cathartics|mesh-ancestor
64542634|NCT04044131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64542635|NCT01428713|Tranexamic Acid|tranexamic acid|mesh-list
64542636|NCT01428713|Contraceptive Agents|contraceptive agents|mesh-list
64542637|NCT01428713|Contraceptives, Oral|contraceptives, oral|mesh-list
64542638|NCT01428713|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64542639|NCT01428713|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64542640|NCT01428713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64542641|NCT01428713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542642|NCT01428713|Hemostatics|hemostatics|mesh-ancestor
64542663|NCT01408043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64542664|NCT01408043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64667205|NCT03019887|Dopamine Agents|dopamine agents|mesh-ancestor
64542665|NCT01408043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542666|NCT01408043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542668|NCT01408043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64542669|NCT01408043|Antiviral Agents|antiviral agents|mesh-ancestor
64542670|NCT01408043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64542671|NCT00219349|Citalopram|citalopram|mesh-list
64542672|NCT00219349|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64542673|NCT00219349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64542674|NCT00219349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64389333|NCT02022748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389334|NCT02333513|Vincristine|vincristine|mesh-list
64389335|NCT02333513|Lomustine|lomustine|mesh-list
64389336|NCT02333513|Procarbazine|procarbazine|mesh-list
64389337|NCT02333513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64389338|NCT02333513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64389339|NCT02333513|Tubulin Modulators|tubulin modulators|mesh-ancestor
64542675|NCT00219349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542676|NCT00219349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64542677|NCT00219349|Serotonin Agents|serotonin agents|mesh-ancestor
64542678|NCT00219349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542679|NCT00219349|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64542680|NCT00219349|Antidepressive Agents|antidepressive agents|mesh-ancestor
64542681|NCT00219349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64542682|NCT00218257|Progesterone|progesterone|mesh-list
64542683|NCT00218257|Progestins|progestins|mesh-ancestor
64542684|NCT00218257|Hormones|hormones|mesh-ancestor
64542685|NCT00218257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64542686|NCT00218257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542687|NCT01523366|Clopidogrel|clopidogrel|mesh-list
64542688|NCT01523366|Ticagrelor|ticagrelor|mesh-list
64542689|NCT01523366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64542690|NCT01523366|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64542691|NCT01523366|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64542692|NCT01523366|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64542693|NCT01523366|Purinergic Agents|purinergic agents|mesh-ancestor
64542694|NCT01523366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64993442|NCT02327078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302009|NCT04997564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64302010|NCT04997564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64302011|NCT04997564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64302012|NCT04997564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302013|NCT04997564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302014|NCT04997564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64302015|NCT04997564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64302016|NCT03842943|Pembrolizumab|pembrolizumab|mesh-list
64302017|NCT03842943|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
64302018|NCT03842943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64302019|NCT03842943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302020|NCT02126137|Ezetimibe|ezetimibe|mesh-list
64302021|NCT02126137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64302022|NCT02126137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64302024|NCT02126137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302025|NCT02126137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64302026|NCT02126293|Zinc|zinc|mesh-list
64302027|NCT02126293|Trace Elements|trace elements|mesh-ancestor
64302028|NCT02126293|Micronutrients|micronutrients|mesh-ancestor
64302029|NCT02126293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302030|NCT03261921|Dexamethasone|dexamethasone|mesh-list
64302031|NCT03261921|Dexmedetomidine|dexmedetomidine|mesh-list
64542695|NCT01523366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542701|NCT03024697|Sensory System Agents|sensory system agents|mesh-ancestor
64542702|NCT03024697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64542703|NCT01427933|Ramucirumab|ramucirumab|mesh-list
64542704|NCT01427933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542705|NCT00217087|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
64542706|NCT00217087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542707|NCT00217087|Dermatologic Agents|dermatologic agents|mesh-ancestor
64542708|NCT00217087|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64542709|NCT03780127|Fenfluramine|fenfluramine|mesh-list
64542710|NCT03780127|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64542711|NCT03780127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64542712|NCT03780127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64542713|NCT03780127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542714|NCT03780127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64542715|NCT03780127|Serotonin Agents|serotonin agents|mesh-ancestor
64542716|NCT03780127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542717|NCT01406873|Mexiletine|mexiletine|mesh-list
64542718|NCT01406873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64542719|NCT01406873|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64542720|NCT01406873|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64542721|NCT01406873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64542722|NCT01406873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542723|NCT01406795|Heparin|heparin|mesh-list
64542724|NCT01406795|Anticoagulants|anticoagulants|mesh-ancestor
64542725|NCT01406795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64484215|NCT01751113|Tiotropium Bromide|tiotropium bromide|mesh-list
64542726|NCT01406795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64542727|NCT01406795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542728|NCT01406015|Spironolactone|spironolactone|mesh-list
64542729|NCT01406015|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64542730|NCT01406015|Hormone Antagonists|hormone antagonists|mesh-ancestor
64542731|NCT01406015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64542732|NCT01406015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542733|NCT01406015|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64542734|NCT01406015|Diuretics|diuretics|mesh-ancestor
64978455|NCT00269815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64542735|NCT01406015|Natriuretic Agents|natriuretic agents|mesh-ancestor
64542736|NCT00215137|Citalopram|citalopram|mesh-list
64542737|NCT00215137|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64542738|NCT00215137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64542739|NCT00215137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64542740|NCT00215137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542741|NCT00215137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64542742|NCT00215137|Serotonin Agents|serotonin agents|mesh-ancestor
64542743|NCT00215137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302032|NCT03261921|Bupivacaine|bupivacaine|mesh-list
64302033|NCT03261921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64302034|NCT03261921|Antiemetics|antiemetics|mesh-ancestor
64302035|NCT03261921|Autonomic Agents|autonomic agents|mesh-ancestor
64302036|NCT03261921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302037|NCT03261921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302038|NCT03261921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64302039|NCT03261921|Glucocorticoids|glucocorticoids|mesh-ancestor
64302040|NCT03261921|Hormones|hormones|mesh-ancestor
64302041|NCT03261921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64542744|NCT00215137|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64542745|NCT00215137|Antidepressive Agents|antidepressive agents|mesh-ancestor
64542746|NCT00215137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64542747|NCT04406779|Hormones|hormones|mesh-list
64542748|NCT04406779|Autoantibodies|autoantibodies|mesh-list
64542749|NCT04406779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64542750|NCT04406779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542751|NCT04406779|Immunologic Factors|immunologic factors|mesh-ancestor
64542752|NCT00214201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
64542753|NCT00214201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542754|NCT00214201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777908|NCT02251938|Immunologic Factors|immunologic factors|mesh-ancestor
64389340|NCT02333513|Antimitotic Agents|antimitotic agents|mesh-ancestor
64389341|NCT02333513|Mitosis Modulators|mitosis modulators|mesh-ancestor
64389342|NCT02333513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389343|NCT02333513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64389344|NCT02333513|Alkylating Agents|alkylating agents|mesh-ancestor
64389345|NCT02434549|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64389346|NCT02434549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64302048|NCT03261921|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64302049|NCT03261921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64302050|NCT03261921|Analgesics|analgesics|mesh-ancestor
64302051|NCT03261921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64302053|NCT03261921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64302054|NCT03261921|Adrenergic Agents|adrenergic agents|mesh-ancestor
64302055|NCT03261921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64302056|NCT03261921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302057|NCT02635724|Peramivir|peramivir|mesh-list
64302058|NCT02635724|Antiviral Agents|antiviral agents|mesh-ancestor
64302059|NCT02635724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64416669|NCT01668667|Gabapentin|gabapentin|mesh-list
64542755|NCT03598075|Pramlintide|pramlintide|mesh-list
64542756|NCT03598075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64667260|NCT04667780|Colchicine|colchicine|mesh-list
64542758|NCT03984097|Dexamethasone|dexamethasone|mesh-list
64542759|NCT03984097|Lenalidomide|lenalidomide|mesh-list
64542760|NCT03984097|Bortezomib|bortezomib|mesh-list
64542761|NCT03984097|Pomalidomide|pomalidomide|mesh-list
64542762|NCT03984097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64542763|NCT03984097|Antiemetics|antiemetics|mesh-ancestor
64542764|NCT03984097|Autonomic Agents|autonomic agents|mesh-ancestor
64542765|NCT03984097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64542766|NCT03984097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542777|NCT03984097|Growth Inhibitors|growth inhibitors|mesh-ancestor
64542778|NCT03976063|Nifedipine|nifedipine|mesh-list
64542779|NCT03976063|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64542780|NCT03976063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64542781|NCT03976063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542782|NCT03976063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64542783|NCT03976063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542784|NCT03976063|Vasodilator Agents|vasodilator agents|mesh-ancestor
64542785|NCT03976063|Tocolytic Agents|tocolytic agents|mesh-ancestor
64542786|NCT03976063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64542787|NCT03597919|Vaccines|vaccines|mesh-list
64542788|NCT03597919|Immunologic Factors|immunologic factors|mesh-ancestor
64542789|NCT03597919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542790|NCT04001413|Durvalumab|durvalumab|mesh-list
64542791|NCT04001413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64542792|NCT04001413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542793|NCT01677858|Dexamethasone|dexamethasone|mesh-list
64542794|NCT01677858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64542795|NCT01677858|Antiemetics|antiemetics|mesh-ancestor
64542796|NCT01677858|Autonomic Agents|autonomic agents|mesh-ancestor
64542797|NCT01677858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64542798|NCT01677858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542799|NCT01677858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64542800|NCT01677858|Glucocorticoids|glucocorticoids|mesh-ancestor
64542801|NCT01677858|Hormones|hormones|mesh-ancestor
64542802|NCT01677858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64542803|NCT01677858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64542804|NCT01677858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542805|NCT03027284|Gemcitabine|gemcitabine|mesh-list
64542806|NCT03027284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542807|NCT03027284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64542808|NCT03027284|Antimetabolites|antimetabolites|mesh-ancestor
64542809|NCT03027284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307583|NCT04933292|Hormones|hormones|mesh-ancestor
64978456|NCT00269815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64978457|NCT00269815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978458|NCT00269815|Dopamine Agents|dopamine agents|mesh-ancestor
64978459|NCT00269815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64542810|NCT03027284|Antiviral Agents|antiviral agents|mesh-ancestor
64542811|NCT03027284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64542812|NCT03027284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993470|NCT02224781|Dabrafenib|dabrafenib|mesh-list
64389347|NCT02434549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64389348|NCT02434549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542813|NCT03027284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64542814|NCT03027284|Immunologic Factors|immunologic factors|mesh-ancestor
64667305|NCT03004196|Chlorhexidine|chlorhexidine|mesh-list
64542815|NCT03027284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542817|NCT03592069|Metronidazole|metronidazole|mesh-list
64542818|NCT03592069|Clarithromycin|clarithromycin|mesh-list
64542819|NCT03592069|Esomeprazole|esomeprazole|mesh-list
64542820|NCT03592069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64542821|NCT03592069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64542822|NCT03592069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64542823|NCT03592069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64542824|NCT03592069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64542825|NCT03592069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64542826|NCT03592069|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64542827|NCT03592069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542828|NCT03592069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542829|NCT03592069|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64542830|NCT03592069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64542831|NCT03592069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64542832|NCT03591991|Empagliflozin|empagliflozin|mesh-list
64542833|NCT03591991|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64542834|NCT03591991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542835|NCT03591991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64542836|NCT03591991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542837|NCT03591913|Misoprostol|misoprostol|mesh-list
64542838|NCT03591913|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64542839|NCT03591913|Abortifacient Agents|abortifacient agents|mesh-ancestor
64542840|NCT03591913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64542841|NCT03591913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978460|NCT00269854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64978461|NCT00269854|Infliximab|infliximab|mesh-list
64978462|NCT00269854|Antibodies|antibodies|mesh-list
64978463|NCT00269854|Immunoglobulins|immunoglobulins|mesh-list
64978464|NCT00269854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64978465|NCT00269854|Immunologic Factors|immunologic factors|mesh-ancestor
64978466|NCT00269854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978467|NCT00269854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64389356|NCT02328209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389357|NCT02328209|Growth Inhibitors|growth inhibitors|mesh-ancestor
64389358|NCT02328209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64389362|NCT02328443|Midazolam|midazolam|mesh-list
64978468|NCT00269854|Dermatologic Agents|dermatologic agents|mesh-ancestor
64978469|NCT00269854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64542842|NCT03591913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64667323|NCT05200442|Cetuximab|cetuximab|mesh-list
64542843|NCT03591913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64542845|NCT04510584|Bevacizumab|bevacizumab|mesh-list
64542846|NCT04510584|Atezolizumab|atezolizumab|mesh-list
64542847|NCT04510584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64542848|NCT04510584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542849|NCT04510584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64542850|NCT04510584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64542851|NCT04510584|Growth Substances|growth substances|mesh-ancestor
64542852|NCT04510584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542853|NCT04510584|Growth Inhibitors|growth inhibitors|mesh-ancestor
64542854|NCT04198129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64542855|NCT04198129|Amoxicillin|amoxicillin|mesh-list
64542856|NCT04198129|Clindamycin|clindamycin|mesh-list
64542857|NCT04198129|Clindamycin palmitate|clindamycin palmitate|mesh-list
64542858|NCT04198129|Clindamycin phosphate|clindamycin phosphate|mesh-list
64542859|NCT04198129|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64542861|NCT04198129|Sultamicillin|sultamicillin|mesh-list
64542862|NCT04198129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64542863|NCT04198129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64542864|NCT04198129|Antitubercular Agents|antitubercular agents|mesh-ancestor
64542865|NCT04198129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64542866|NCT04198129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542867|NCT04198129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542868|NCT04198129|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64542869|NCT03591757|Tolcapone|tolcapone|mesh-list
64542870|NCT03591757|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64542871|NCT03591757|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64542872|NCT03591757|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64542873|NCT03591757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307649|NCT05234619|Anesthetics, Local|anesthetics, local|mesh-ancestor
64978484|NCT00102609|Dexamethasone|dexamethasone|mesh-list
64978485|NCT00102609|Doxorubicin|doxorubicin|mesh-list
64978486|NCT00102609|Trabectedin|trabectedin|mesh-list
64978487|NCT00102609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64978488|NCT00102609|Antiemetics|antiemetics|mesh-ancestor
64978489|NCT00102609|Autonomic Agents|autonomic agents|mesh-ancestor
64978490|NCT00102609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64978491|NCT00102609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978492|NCT00102609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64542874|NCT03591757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542875|NCT04438434|Chlorhexidine|chlorhexidine|mesh-list
64542876|NCT04438434|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64542877|NCT04438434|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64542878|NCT04438434|Hyaluronic Acid|hyaluronic acid|mesh-list
64542879|NCT04438434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64542880|NCT04438434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64542881|NCT04438434|Disinfectants|disinfectants|mesh-ancestor
64542882|NCT04438434|Dermatologic Agents|dermatologic agents|mesh-ancestor
64542883|NCT04438434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64542885|NCT04438434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542886|NCT04438434|Viscosupplements|viscosupplements|mesh-ancestor
64542887|NCT04438434|Protective Agents|protective agents|mesh-ancestor
64542888|NCT03591679|Oxytocin|oxytocin|mesh-list
64542889|NCT03591679|Oxytocics|oxytocics|mesh-ancestor
64542890|NCT03591679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64993471|NCT02224781|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
64324212|NCT02233621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64542891|NCT03591679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542892|NCT04064814|Thioctic Acid|thioctic acid|mesh-list
64542893|NCT04064814|Flunarizine|flunarizine|mesh-list
64542894|NCT04064814|Antioxidants|antioxidants|mesh-ancestor
64542895|NCT04064814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542896|NCT04064814|Protective Agents|protective agents|mesh-ancestor
64542897|NCT04064814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542898|NCT04064814|Vitamin B Complex|vitamin b complex|mesh-ancestor
64542899|NCT04064814|Vitamins|vitamins|mesh-ancestor
64542900|NCT04064814|Micronutrients|micronutrients|mesh-ancestor
64542901|NCT04064814|Anticonvulsants|anticonvulsants|mesh-ancestor
64542902|NCT04064814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64542903|NCT04064814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64542904|NCT04064814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64542905|NCT04064814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64978493|NCT00102609|Glucocorticoids|glucocorticoids|mesh-ancestor
64978494|NCT00102609|Hormones|hormones|mesh-ancestor
64978495|NCT00102609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64978496|NCT00102609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64978497|NCT00102609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978498|NCT00102609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64978499|NCT00102609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64978500|NCT00102609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64978501|NCT00102609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978502|NCT00102609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978503|NCT00102609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64542906|NCT04064814|Histamine Antagonists|histamine antagonists|mesh-ancestor
64542907|NCT04064814|Histamine Agents|histamine agents|mesh-ancestor
64542908|NCT04064814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64542909|NCT04064814|Vasodilator Agents|vasodilator agents|mesh-ancestor
64542910|NCT04197817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64542911|NCT04197817|Antibodies|antibodies|mesh-list
64542912|NCT04197817|Immunoglobulins|immunoglobulins|mesh-list
64542913|NCT04197817|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64542914|NCT04197817|Immunologic Factors|immunologic factors|mesh-ancestor
64542915|NCT04197817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542916|NCT04197817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542917|NCT04585854|Caffeine|caffeine|mesh-list
64542918|NCT04585854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64542919|NCT04585854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542920|NCT04585854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64542921|NCT04585854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667380|NCT01880723|Albuterol|albuterol|mesh-list
64542922|NCT04585854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542923|NCT04585854|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64542924|NCT04585854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64542925|NCT04585854|Purinergic Agents|purinergic agents|mesh-ancestor
64542926|NCT04585854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64542928|NCT03481842|Afatinib|afatinib|mesh-list
64542929|NCT03481842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542930|NCT03481842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64542931|NCT03481842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542932|NCT03481842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542933|NCT04197739|Amikacin|amikacin|mesh-list
64542934|NCT04197739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64542935|NCT04197739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64978504|NCT00102609|Alkylating Agents|alkylating agents|mesh-ancestor
64978505|NCT00269932|Levofloxacin|levofloxacin|mesh-list
64978506|NCT00269932|Ofloxacin|ofloxacin|mesh-list
64978507|NCT00269932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64978508|NCT00269932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64978509|NCT00269932|Renal Agents|renal agents|mesh-ancestor
64978510|NCT00269932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64978511|NCT00269932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64978512|NCT00269932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64978513|NCT00269932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978514|NCT00269932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978515|NCT00269932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978516|NCT00269932|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64978517|NCT00269932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64542936|NCT03449706|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64542937|NCT03449706|Antiviral Agents|antiviral agents|mesh-ancestor
64542938|NCT03449706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64542939|NCT04197349|Sumatriptan|sumatriptan|mesh-list
64542940|NCT04197349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64302189|NCT02135965|Caffeine|caffeine|mesh-list
64542941|NCT04197349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64542942|NCT04197349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64542943|NCT04197349|Serotonin Agents|serotonin agents|mesh-ancestor
64542944|NCT04197349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64484216|NCT01751113|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64542945|NCT04197349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542946|NCT04197349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542947|NCT03982225|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
64542948|NCT03982225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64542949|NCT03982225|Antimetabolites|antimetabolites|mesh-ancestor
64667408|NCT01881113|Cetirizine|cetirizine|mesh-list
64542950|NCT03982225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542952|NCT03422094|Nivolumab|nivolumab|mesh-list
64542953|NCT03422094|Ipilimumab|ipilimumab|mesh-list
64542954|NCT03422094|Poly ICLC|poly iclc|mesh-list
64542955|NCT03422094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64542956|NCT03422094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542957|NCT03422094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64542958|NCT03422094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542959|NCT03422094|Interferon Inducers|interferon inducers|mesh-ancestor
64542960|NCT03422094|Immunologic Factors|immunologic factors|mesh-ancestor
64542961|NCT03422094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542962|NCT03973489|Methamphetamine|methamphetamine|mesh-list
64542963|NCT03973489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64542964|NCT03973489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542965|NCT03973489|Sympathomimetics|sympathomimetics|mesh-ancestor
64978518|NCT00269971|Epoetin Alfa|epoetin alfa|mesh-list
64978519|NCT00269971|Hematinics|hematinics|mesh-ancestor
64978520|NCT00270010|Epoetin Alfa|epoetin alfa|mesh-list
64978521|NCT00270010|Hematinics|hematinics|mesh-ancestor
64978522|NCT00270049|Epoetin Alfa|epoetin alfa|mesh-list
64978523|NCT00270049|Hematinics|hematinics|mesh-ancestor
64978524|NCT00107016|Letrozole|letrozole|mesh-list
64978525|NCT00107016|Everolimus|everolimus|mesh-list
64978526|NCT00107016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978527|NCT00107016|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64978528|NCT00107016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64978529|NCT00107016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542967|NCT03973489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64542968|NCT03973489|Dopamine Agents|dopamine agents|mesh-ancestor
64542969|NCT03973489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64542970|NCT03973489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542971|NCT03973489|Adrenergic Agents|adrenergic agents|mesh-ancestor
64542972|NCT03973489|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64542973|NCT03973489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64542974|NCT03973489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64389391|NCT02328443|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64429992|NCT05023967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302217|NCT02455401|Sensory System Agents|sensory system agents|mesh-ancestor
64302218|NCT02455401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302220|NCT03260829|Vitamins|vitamins|mesh-ancestor
64302221|NCT03260829|Micronutrients|micronutrients|mesh-ancestor
64302222|NCT03260829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302223|NCT03260829|Antioxidants|antioxidants|mesh-ancestor
64302226|NCT02134093|Midazolam|midazolam|mesh-list
64542975|NCT03973489|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64542976|NCT04356534|Antibodies|antibodies|mesh-list
64542977|NCT04356534|Immunologic Factors|immunologic factors|mesh-ancestor
64542978|NCT04356534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542979|NCT03591289|Bromides|bromides|mesh-list
64542980|NCT03591289|Rocuronium|rocuronium|mesh-list
64542981|NCT03591289|Anticonvulsants|anticonvulsants|mesh-ancestor
64542982|NCT03591289|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64542983|NCT03591289|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64667441|NCT03003728|Melphalan|melphalan|mesh-list
64542984|NCT03591289|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64542985|NCT03591289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64542986|NCT03591289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64542987|NCT05338866|Capecitabine|capecitabine|mesh-list
64542988|NCT05338866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64542989|NCT05338866|Antimetabolites|antimetabolites|mesh-ancestor
64307780|NCT04920500|Antimetabolites|antimetabolites|mesh-ancestor
64978530|NCT00107016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978531|NCT00107016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64978545|NCT00074399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64978546|NCT00074399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978547|NCT00074399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978548|NCT00074399|Antiviral Agents|antiviral agents|mesh-ancestor
64978549|NCT00074399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64978550|NCT00074399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64978551|NCT00074399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64667467|NCT03003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64978555|NCT00270283|Hematinics|hematinics|mesh-ancestor
64978556|NCT00270322|Fentanyl|fentanyl|mesh-list
64978557|NCT00270322|Morphine|morphine|mesh-list
64978558|NCT00270322|Bupivacaine|bupivacaine|mesh-list
64978559|NCT00270322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64978560|NCT00270322|Narcotics|narcotics|mesh-ancestor
64978561|NCT00270322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64978562|NCT00270322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978563|NCT00270322|Analgesics|analgesics|mesh-ancestor
64978564|NCT00270322|Sensory System Agents|sensory system agents|mesh-ancestor
64978565|NCT00270322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64978566|NCT00270322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64978567|NCT00270322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64542990|NCT05338866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64542991|NCT05338866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64542993|NCT02471118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64542994|NCT02471118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64542995|NCT04197115|Vitamins|vitamins|mesh-list
64542996|NCT04197115|Ascorbic Acid|ascorbic acid|mesh-list
64542997|NCT04197115|Vitamin B Complex|vitamin b complex|mesh-list
64542998|NCT04197115|Hydrocortisone|hydrocortisone|mesh-list
64542999|NCT04197115|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64543000|NCT04197115|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64543001|NCT04197115|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64389395|NCT02328443|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64543002|NCT04197115|Micronutrients|micronutrients|mesh-ancestor
64389396|NCT02328443|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64389397|NCT02039765|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64302266|NCT03074786|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64302267|NCT03074786|Dapivirine|dapivirine|mesh-list
64302268|NCT03074786|Antiviral Agents|antiviral agents|mesh-ancestor
64543003|NCT04197115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543004|NCT04197115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64543005|NCT04197115|Antioxidants|antioxidants|mesh-ancestor
64543006|NCT04197115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543007|NCT04197115|Protective Agents|protective agents|mesh-ancestor
64543008|NCT04126200|Dexamethasone|dexamethasone|mesh-list
64543009|NCT04126200|Lenalidomide|lenalidomide|mesh-list
64543010|NCT04126200|Pomalidomide|pomalidomide|mesh-list
64543011|NCT04126200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64543012|NCT04126200|Antiemetics|antiemetics|mesh-ancestor
64543013|NCT04126200|Autonomic Agents|autonomic agents|mesh-ancestor
64543014|NCT04126200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64543015|NCT04126200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543016|NCT04126200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64543017|NCT04126200|Glucocorticoids|glucocorticoids|mesh-ancestor
64543018|NCT04126200|Hormones|hormones|mesh-ancestor
64543019|NCT04126200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64543030|NCT02467452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64543031|NCT02467452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543032|NCT02467452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64543033|NCT02467452|Respiratory System Agents|respiratory system agents|mesh-ancestor
64543034|NCT02467452|Parasympatholytics|parasympatholytics|mesh-ancestor
64667530|NCT02223338|Ciprofloxacin|ciprofloxacin|mesh-list
64543036|NCT02467452|Cholinergic Agents|cholinergic agents|mesh-ancestor
64543037|NCT02467452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64543038|NCT02467452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543039|NCT03590587|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
64543040|NCT03590587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64543041|NCT03590587|Glucocorticoids|glucocorticoids|mesh-ancestor
64543043|NCT03590587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64543044|NCT03590587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543045|NCT03590431|Iodine|iodine|mesh-list
64543046|NCT03590431|Cadexomer iodine|cadexomer iodine|mesh-list
64543047|NCT03590431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64543048|NCT03590431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64543049|NCT03590431|Trace Elements|trace elements|mesh-ancestor
64543050|NCT03590431|Micronutrients|micronutrients|mesh-ancestor
64543051|NCT03590431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543052|NCT03980665|Arsenic Trioxide|arsenic trioxide|mesh-list
64543053|NCT03980665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543054|NCT03971461|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64543055|NCT03971461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64543056|NCT03971461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543057|NCT05102448|Methotrexate|methotrexate|mesh-list
64543058|NCT05102448|Tofacitinib|tofacitinib|mesh-list
64543059|NCT05102448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64543060|NCT05102448|Abortifacient Agents|abortifacient agents|mesh-ancestor
64543061|NCT05102448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64543062|NCT05102448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543063|NCT05102448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64978568|NCT00270322|Anesthetics, General|anesthetics, general|mesh-ancestor
64978569|NCT00270322|Anesthetics|anesthetics|mesh-ancestor
64978570|NCT00270322|Anesthetics, Local|anesthetics, local|mesh-ancestor
64978571|NCT00270361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64978572|NCT00270361|Natriuretic Agents|natriuretic agents|mesh-ancestor
64978573|NCT00270361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978574|NCT02966249|Levobupivacaine|levobupivacaine|mesh-list
64543064|NCT05102448|Antimetabolites|antimetabolites|mesh-ancestor
64543065|NCT05102448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543066|NCT05102448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543067|NCT05102448|Dermatologic Agents|dermatologic agents|mesh-ancestor
64543068|NCT05102448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543069|NCT05102448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64389398|NCT02039765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64389399|NCT02039765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64389400|NCT02039765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64543070|NCT05102448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64543071|NCT05102448|Immunologic Factors|immunologic factors|mesh-ancestor
64543072|NCT05102448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64543073|NCT05102448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64543074|NCT05102448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64543075|NCT03599323|Clotrimazole|clotrimazole|mesh-list
64543076|NCT03599323|Miconazole|miconazole|mesh-list
64543077|NCT03599323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64543078|NCT03599323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64543079|NCT03599323|Antifungal Agents|antifungal agents|mesh-ancestor
64543080|NCT03599323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64543081|NCT03599323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64543082|NCT03599323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543083|NCT03599323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543084|NCT03599323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64499219|NCT04593329|Dipyrone|dipyrone|mesh-list
64543085|NCT03599323|Hormone Antagonists|hormone antagonists|mesh-ancestor
64543086|NCT03599323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64543087|NCT03599323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543088|NCT03599323|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64543089|NCT03599323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64543090|NCT04195867|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64543091|NCT04195867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64543092|NCT04195867|Autonomic Agents|autonomic agents|mesh-ancestor
64543093|NCT04195867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64543094|NCT04195867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543102|NCT04195867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543104|NCT05102058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64543105|NCT05102058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64543106|NCT05102058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543107|NCT05102058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64543108|NCT05102058|Analgesics|analgesics|mesh-ancestor
64543109|NCT05102058|Sensory System Agents|sensory system agents|mesh-ancestor
64543110|NCT05102058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64543111|NCT05102058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64543112|NCT05102058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64543113|NCT05102058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64543114|NCT05102058|Adrenergic Agents|adrenergic agents|mesh-ancestor
64543115|NCT05102058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64543116|NCT05102058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543117|NCT03956797|Anesthetics|anesthetics|mesh-list
64543118|NCT03956797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64543119|NCT03956797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543120|NCT03598777|Botulinum Toxins|botulinum toxins|mesh-list
64543121|NCT03598777|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64543122|NCT03598777|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64543123|NCT03598777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64543124|NCT03598777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64543125|NCT03598777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543126|NCT03598777|Cholinergic Agents|cholinergic agents|mesh-ancestor
64543127|NCT03598777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64543128|NCT03598777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543129|NCT03598777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64543130|NCT03598777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64543131|NCT04195243|Dapagliflozin|dapagliflozin|mesh-list
64543132|NCT04195243|Empagliflozin|empagliflozin|mesh-list
64543133|NCT04195243|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64389404|NCT02039765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389405|NCT02039765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389406|NCT03191539|Apremilast|apremilast|mesh-list
64389407|NCT03191539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64389408|NCT03191539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64389409|NCT03191539|Analgesics|analgesics|mesh-ancestor
64389410|NCT03191539|Sensory System Agents|sensory system agents|mesh-ancestor
64302300|NCT02634788|Narcotics|narcotics|mesh-ancestor
64302301|NCT02634788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64302302|NCT02634788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302303|NCT02634788|Analgesics|analgesics|mesh-ancestor
64302304|NCT02634788|Sensory System Agents|sensory system agents|mesh-ancestor
64302305|NCT02634788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302306|NCT02634788|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64302307|NCT03260283|Fentanyl|fentanyl|mesh-list
64302308|NCT03260283|Meperidine|meperidine|mesh-list
64302309|NCT03260283|Ropivacaine|ropivacaine|mesh-list
64302310|NCT03260283|Anesthetics, Local|anesthetics, local|mesh-ancestor
64543137|NCT04195321|Phenylephrine|phenylephrine|mesh-list
64543140|NCT04195321|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64543141|NCT04195321|Mydriatics|mydriatics|mesh-ancestor
64543142|NCT04195321|Autonomic Agents|autonomic agents|mesh-ancestor
64543143|NCT04195321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64543144|NCT04195321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543145|NCT04195321|Sympathomimetics|sympathomimetics|mesh-ancestor
64543146|NCT04195321|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64543147|NCT04195321|Nasal Decongestants|nasal decongestants|mesh-ancestor
64543148|NCT04195321|Respiratory System Agents|respiratory system agents|mesh-ancestor
64543149|NCT04195321|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64543150|NCT04195321|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64543151|NCT04195321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64543152|NCT04195321|Adrenergic Agents|adrenergic agents|mesh-ancestor
64543153|NCT04195321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64543154|NCT04195321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714157|NCT03050294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543155|NCT04195321|Protective Agents|protective agents|mesh-ancestor
64543156|NCT03965845|Palbociclib|palbociclib|mesh-list
64543157|NCT03965845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543158|NCT03965845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64543159|NCT03965845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543160|NCT03965845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543162|NCT04766359|Cisplatin|cisplatin|mesh-list
64543163|NCT04766359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64543164|NCT04766359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64543165|NCT04766359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978575|NCT02966249|Anesthetics, Local|anesthetics, local|mesh-ancestor
64978576|NCT02966249|Anesthetics|anesthetics|mesh-ancestor
64978577|NCT02966249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64978578|NCT02966249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978579|NCT02966249|Sensory System Agents|sensory system agents|mesh-ancestor
64978580|NCT02966249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64978581|NCT00270400|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64978582|NCT00270400|Natriuretic Agents|natriuretic agents|mesh-ancestor
64978583|NCT00270400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978584|NCT00107094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64978585|NCT00107094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978586|NCT00270478|Hydroxyurea|hydroxyurea|mesh-list
64978587|NCT00270478|Epoetin Alfa|epoetin alfa|mesh-list
64978588|NCT00270478|Hematinics|hematinics|mesh-ancestor
64978589|NCT00270478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978590|NCT00270478|Antisickling Agents|antisickling agents|mesh-ancestor
64978591|NCT00270478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667610|NCT05672342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64667615|NCT05672342|Hormones|hormones|mesh-ancestor
64978593|NCT00270478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64978594|NCT00270517|Telithromycin|telithromycin|mesh-list
64978595|NCT00270517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64543166|NCT04766359|Tubulin Modulators|tubulin modulators|mesh-ancestor
64543167|NCT04766359|Antimitotic Agents|antimitotic agents|mesh-ancestor
64543168|NCT04766359|Mitosis Modulators|mitosis modulators|mesh-ancestor
64543169|NCT04766359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543171|NCT04020601|Anesthetics, Local|anesthetics, local|mesh-ancestor
64543172|NCT04020601|Anesthetics|anesthetics|mesh-ancestor
64543173|NCT04020601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64543174|NCT04020601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543175|NCT04020601|Sensory System Agents|sensory system agents|mesh-ancestor
64543176|NCT04020601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64543177|NCT03964051|Omalizumab|omalizumab|mesh-list
64543178|NCT03964051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64543179|NCT03964051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64543180|NCT03964051|Respiratory System Agents|respiratory system agents|mesh-ancestor
64543181|NCT04193137|Captopril|captopril|mesh-list
64543182|NCT04193137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64543183|NCT04193137|Protease Inhibitors|protease inhibitors|mesh-ancestor
64543184|NCT04193137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543185|NCT04193137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543186|NCT04193137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64543187|NCT05060484|Vaccines|vaccines|mesh-list
64543188|NCT05060484|Immunologic Factors|immunologic factors|mesh-ancestor
64543189|NCT05060484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543190|NCT04193059|Paclitaxel|paclitaxel|mesh-list
64543191|NCT04193059|Docetaxel|docetaxel|mesh-list
64543192|NCT04193059|Cyclophosphamide|cyclophosphamide|mesh-list
64543193|NCT04193059|Carboplatin|carboplatin|mesh-list
64543194|NCT04193059|Trastuzumab|trastuzumab|mesh-list
64543195|NCT04193059|Epirubicin|epirubicin|mesh-list
64543196|NCT04193059|Pertuzumab|pertuzumab|mesh-list
64543197|NCT04193059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64543198|NCT04193059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978615|NCT00074438|Abortifacient Agents|abortifacient agents|mesh-ancestor
64978616|NCT00074438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64978617|NCT00074438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64978618|NCT00074438|Antimetabolites|antimetabolites|mesh-ancestor
64978619|NCT00074438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978620|NCT00074438|Dermatologic Agents|dermatologic agents|mesh-ancestor
64978621|NCT00074438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978622|NCT00074438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64978623|NCT00074438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64978624|NCT00074438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64978626|NCT00270751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64978627|NCT00270751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64543199|NCT04193059|Tubulin Modulators|tubulin modulators|mesh-ancestor
64543200|NCT04193059|Antimitotic Agents|antimitotic agents|mesh-ancestor
64543201|NCT04193059|Mitosis Modulators|mitosis modulators|mesh-ancestor
64543202|NCT04193059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543203|NCT04193059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64543204|NCT04193059|Immunologic Factors|immunologic factors|mesh-ancestor
64543205|NCT04193059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543206|NCT04193059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64543207|NCT04193059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64543208|NCT04193059|Alkylating Agents|alkylating agents|mesh-ancestor
64543209|NCT04193059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64543210|NCT04193059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64543211|NCT04193059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64543212|NCT04193059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64543213|NCT04193059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64543214|NCT04193059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543215|NCT03962647|Letrozole|letrozole|mesh-list
64543216|NCT03962647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543217|NCT03962647|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64543218|NCT03962647|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64543219|NCT03962647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543220|NCT03962647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543221|NCT03962647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64543222|NCT03962647|Hormone Antagonists|hormone antagonists|mesh-ancestor
64543223|NCT03962647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64543224|NCT03962647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543225|NCT05286996|Anesthetics|anesthetics|mesh-list
64543226|NCT05286996|Anesthetics, Local|anesthetics, local|mesh-list
64777980|NCT02282514|Cyclophosphamide|cyclophosphamide|mesh-list
64543227|NCT05286996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64543228|NCT05286996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543229|NCT05286996|Sensory System Agents|sensory system agents|mesh-ancestor
64543231|NCT04028869|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
64543239|NCT02080273|Cariostatic Agents|cariostatic agents|mesh-ancestor
64543240|NCT02080273|Protective Agents|protective agents|mesh-ancestor
64543241|NCT02080273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543242|NCT02080273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64543243|NCT02080273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64543244|NCT04199143|Nitrous Oxide|nitrous oxide|mesh-list
64543245|NCT04199143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64543246|NCT04199143|Anesthetics, General|anesthetics, general|mesh-ancestor
64543247|NCT04199143|Anesthetics|anesthetics|mesh-ancestor
64543248|NCT04199143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64543249|NCT04199143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543250|NCT04199143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64543251|NCT04199143|Analgesics|analgesics|mesh-ancestor
64543252|NCT04199143|Sensory System Agents|sensory system agents|mesh-ancestor
64543253|NCT04199143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64543254|NCT04616274|Venetoclax|venetoclax|mesh-list
64543255|NCT04616274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543256|NCT04613622|Venetoclax|venetoclax|mesh-list
64543257|NCT04613622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543258|NCT04515186|Miltefosine|miltefosine|mesh-list
64543259|NCT04515186|Meglumine Antimoniate|meglumine antimoniate|mesh-list
64543260|NCT04515186|Antifungal Agents|antifungal agents|mesh-ancestor
64543261|NCT04515186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64543262|NCT04515186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543263|NCT04515186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64543264|NCT04515186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64543265|NCT04021225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64543266|NCT04021225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64543267|NCT05096676|Oxytocin|oxytocin|mesh-list
64543268|NCT05096676|Oxytocics|oxytocics|mesh-ancestor
64543269|NCT05096676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64543270|NCT05096676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543271|NCT03948763|Pembrolizumab|pembrolizumab|mesh-list
64543272|NCT03948763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64543273|NCT03948763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543274|NCT05096520|Lidocaine|lidocaine|mesh-list
64543275|NCT05096520|Anesthetics, Local|anesthetics, local|mesh-ancestor
64543276|NCT05096520|Anesthetics|anesthetics|mesh-ancestor
64308066|NCT05523401|Psilocybin|psilocybin|mesh-list
64978628|NCT00270829|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64543277|NCT05096520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64543278|NCT05096520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543280|NCT05096520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64543281|NCT05096520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64543282|NCT05096520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64543283|NCT05096520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64543284|NCT05096520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64667643|NCT00555035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543285|NCT05096520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543286|NCT03832465|Levofloxacin|levofloxacin|mesh-list
64543288|NCT03832465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64543289|NCT03832465|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64543290|NCT03832465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64543291|NCT03832465|Renal Agents|renal agents|mesh-ancestor
64543292|NCT03832465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64543293|NCT03832465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64543294|NCT03832465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64543295|NCT03832465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543296|NCT03832465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543297|NCT03832465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543298|NCT03832465|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64543299|NCT03832465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64543300|NCT04190173|Prucalopride|prucalopride|mesh-list
64543301|NCT04190173|Laxatives|laxatives|mesh-ancestor
64543302|NCT04190173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64543303|NCT04190173|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64978629|NCT00270829|Natriuretic Agents|natriuretic agents|mesh-ancestor
64978630|NCT00270829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978631|NCT04730375|Dexmedetomidine|dexmedetomidine|mesh-list
64978632|NCT04730375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64978633|NCT04730375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64978634|NCT04730375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978635|NCT04730375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64978636|NCT04730375|Analgesics|analgesics|mesh-ancestor
64978637|NCT04730375|Sensory System Agents|sensory system agents|mesh-ancestor
64978638|NCT04730375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64978639|NCT04730375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64978641|NCT04730375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64978642|NCT04730375|Adrenergic Agents|adrenergic agents|mesh-ancestor
64978643|NCT04730375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64978644|NCT04730375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543304|NCT04190173|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64543305|NCT04190173|Serotonin Agents|serotonin agents|mesh-ancestor
64543306|NCT04190173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64543307|NCT04190173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543308|NCT04190173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543309|NCT01272219|Liraglutide|liraglutide|mesh-list
64543310|NCT01272219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64543311|NCT01272219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543312|NCT01272219|Incretins|incretins|mesh-ancestor
64543313|NCT01272219|Hormones|hormones|mesh-ancestor
64543314|NCT01272219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64543315|NCT04198363|Amoxicillin|amoxicillin|mesh-list
64543316|NCT04198363|Clarithromycin|clarithromycin|mesh-list
64543317|NCT04198363|Potassium Citrate|potassium citrate|mesh-list
64543318|NCT04198363|Esomeprazole|esomeprazole|mesh-list
64543319|NCT04198363|Bismuth|bismuth|mesh-list
64543337|NCT04020133|Bupivacaine|bupivacaine|mesh-list
64543338|NCT04020133|Anesthetics, Local|anesthetics, local|mesh-ancestor
64543339|NCT04020133|Anesthetics|anesthetics|mesh-ancestor
64543340|NCT04020133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64543341|NCT04020133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543342|NCT04020133|Sensory System Agents|sensory system agents|mesh-ancestor
64543343|NCT04020133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64543344|NCT04020133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64778002|NCT02282514|Protective Agents|protective agents|mesh-ancestor
64778004|NCT02282904|Sirolimus|sirolimus|mesh-list
64543371|NCT04565574|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64543372|NCT04565574|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64543373|NCT04565574|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64543374|NCT04565574|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64543375|NCT04565574|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64543411|NCT04128774|Dexamethasone acetate|dexamethasone acetate|mesh-list
64543413|NCT04128774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64543414|NCT04128774|Antiemetics|antiemetics|mesh-ancestor
64543415|NCT04128774|Autonomic Agents|autonomic agents|mesh-ancestor
64543416|NCT04128774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64543417|NCT04128774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543418|NCT04128774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64543419|NCT04128774|Glucocorticoids|glucocorticoids|mesh-ancestor
64543420|NCT04128774|Hormones|hormones|mesh-ancestor
64543421|NCT04128774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64543422|NCT04128774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64543423|NCT04128774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543424|NCT04128774|Protease Inhibitors|protease inhibitors|mesh-ancestor
64543425|NCT04128774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543426|NCT04128774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543427|NCT00732225|Hyaluronic Acid|hyaluronic acid|mesh-list
64543428|NCT00732225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64543429|NCT00732225|Immunologic Factors|immunologic factors|mesh-ancestor
64543430|NCT00732225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543431|NCT00732225|Viscosupplements|viscosupplements|mesh-ancestor
64543432|NCT00732225|Protective Agents|protective agents|mesh-ancestor
64543433|NCT04194775|Lenvatinib|lenvatinib|mesh-list
64543434|NCT04194775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64714159|NCT02831569|Methocarbamol|methocarbamol|mesh-list
64543435|NCT04194775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64543436|NCT04194775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543437|NCT04194775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978645|NCT00270907|Gemcitabine|gemcitabine|mesh-list
64978646|NCT00270907|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
64978647|NCT00270907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64978648|NCT00270907|Antimetabolites|antimetabolites|mesh-ancestor
64978649|NCT00270907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978668|NCT00107523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64543439|NCT04026685|Oxymetazoline|oxymetazoline|mesh-list
64543440|NCT04026685|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64543441|NCT04026685|Mydriatics|mydriatics|mesh-ancestor
64302343|NCT03583229|Aspirin|aspirin|mesh-list
64543442|NCT04026685|Autonomic Agents|autonomic agents|mesh-ancestor
64543443|NCT04026685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64543444|NCT04026685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543445|NCT04026685|Sympathomimetics|sympathomimetics|mesh-ancestor
64543446|NCT04026685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64543447|NCT04026685|Nasal Decongestants|nasal decongestants|mesh-ancestor
64543448|NCT04026685|Respiratory System Agents|respiratory system agents|mesh-ancestor
64543449|NCT04026685|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64543450|NCT04026685|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64543451|NCT04026685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64543452|NCT04026685|Adrenergic Agents|adrenergic agents|mesh-ancestor
64543453|NCT04026685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64543454|NCT04026685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543455|NCT04026685|Protective Agents|protective agents|mesh-ancestor
64543456|NCT00751179|Bromides|bromides|mesh-list
64543457|NCT00751179|Rocuronium|rocuronium|mesh-list
64543458|NCT00751179|Succinylcholine|succinylcholine|mesh-list
64543459|NCT00751179|Anticonvulsants|anticonvulsants|mesh-ancestor
64543460|NCT00751179|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64543461|NCT00751179|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64543462|NCT00751179|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64543463|NCT00751179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64543464|NCT00751179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543465|NCT00751179|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
64543466|NCT01273233|Vaccines|vaccines|mesh-list
64543468|NCT01273233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543470|NCT01277211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64543471|NCT01277211|Contraceptive Agents|contraceptive agents|mesh-ancestor
64543472|NCT01277211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64978669|NCT00107523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64978670|NCT00107523|Immunologic Factors|immunologic factors|mesh-ancestor
64978671|NCT00107523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978672|NCT00107523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64978673|NCT00107523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64543473|NCT01277211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543475|NCT04022161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64543476|NCT04022161|Autonomic Agents|autonomic agents|mesh-ancestor
64543477|NCT04022161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64543478|NCT04022161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543479|NCT04022161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64543480|NCT04022161|Respiratory System Agents|respiratory system agents|mesh-ancestor
64543481|NCT04022161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64543482|NCT04022161|Antioxidants|antioxidants|mesh-ancestor
64543483|NCT04022161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543484|NCT04022161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64543485|NCT04022161|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64543486|NCT04022161|Vasodilator Agents|vasodilator agents|mesh-ancestor
64543487|NCT04022161|Gasotransmitters|gasotransmitters|mesh-ancestor
64543488|NCT04022161|Protective Agents|protective agents|mesh-ancestor
64543489|NCT01676220|Insulin|insulin|mesh-list
64543490|NCT01676220|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64543491|NCT01676220|Insulin Glargine|insulin glargine|mesh-list
64543492|NCT01676220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64543493|NCT01676220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543494|NCT03933631|Ofloxacin|ofloxacin|mesh-list
64543495|NCT03933631|Prednisolone|prednisolone|mesh-list
64543496|NCT03933631|Prednisolone acetate|prednisolone acetate|mesh-list
64543497|NCT03933631|Pilocarpine|pilocarpine|mesh-list
64543498|NCT03933631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64543499|NCT03933631|Glucocorticoids|glucocorticoids|mesh-ancestor
64543500|NCT03933631|Hormones|hormones|mesh-ancestor
64778025|NCT02283840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64778026|NCT02283840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778027|NCT02284386|Bupivacaine|bupivacaine|mesh-list
64543501|NCT03933631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64543502|NCT03933631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308248|NCT03221907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64978674|NCT00107523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64978675|NCT00107523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978676|NCT00107523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64978677|NCT00107523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64978678|NCT00107523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64978679|NCT00107523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64978680|NCT00416377|Prednisolone|prednisolone|mesh-list
64978681|NCT00416377|Doxorubicin|doxorubicin|mesh-list
64978682|NCT00416377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64978683|NCT00416377|Bleomycin|bleomycin|mesh-list
64978684|NCT00416377|Vincristine|vincristine|mesh-list
64978685|NCT00416377|Dacarbazine|dacarbazine|mesh-list
64978686|NCT00416377|Vinblastine|vinblastine|mesh-list
64667752|NCT03002636|Anesthetics|anesthetics|mesh-list
64978687|NCT00416377|Procarbazine|procarbazine|mesh-list
64978688|NCT00416377|Chlorambucil|chlorambucil|mesh-list
64543503|NCT03933631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64543504|NCT03933631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543505|NCT03933631|Autonomic Agents|autonomic agents|mesh-ancestor
64543506|NCT03933631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64389455|NCT02332811|Chelating Agents|chelating agents|mesh-ancestor
64389456|NCT02332811|Sequestering Agents|sequestering agents|mesh-ancestor
64389457|NCT02332811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389458|NCT02433457|Omeprazole|omeprazole|mesh-list
64389459|NCT02433457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64543507|NCT03933631|Miotics|miotics|mesh-ancestor
64543508|NCT03933631|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64543509|NCT03933631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64543510|NCT03933631|Cholinergic Agents|cholinergic agents|mesh-ancestor
64543511|NCT03933631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64543512|NCT03933631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543513|NCT03933631|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64543514|NCT03933631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64543515|NCT03933631|Renal Agents|renal agents|mesh-ancestor
64543516|NCT03933631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64543517|NCT03933631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64543518|NCT03933631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64543519|NCT03933631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543520|NCT03933631|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64543521|NCT03933631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64543522|NCT01275105|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64543523|NCT01275105|Phenylephrine|phenylephrine|mesh-list
64543524|NCT01275105|Oxymetazoline|oxymetazoline|mesh-list
64543525|NCT01275105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64543526|NCT01275105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64543527|NCT01275105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64543528|NCT01275105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64543529|NCT01275105|Adrenergic Agents|adrenergic agents|mesh-ancestor
64543530|NCT01275105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64543531|NCT01275105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543548|NCT01270347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64543549|NCT01270347|Renal Agents|renal agents|mesh-ancestor
64543550|NCT01270347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64543551|NCT01270347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64543552|NCT01270347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64543553|NCT01270347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543554|NCT01270347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543555|NCT01270347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543556|NCT01270347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64543557|NCT01270347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64543558|NCT03608436|Bromides|bromides|mesh-list
64543559|NCT03608436|Rocuronium|rocuronium|mesh-list
64543560|NCT03608436|Anticonvulsants|anticonvulsants|mesh-ancestor
64543561|NCT03608436|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64543562|NCT03608436|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64543563|NCT03608436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64543564|NCT03608436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64543565|NCT03608436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543566|NCT04025671|Naloxone|naloxone|mesh-list
64543567|NCT04025671|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64543568|NCT04025671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778046|NCT02284854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64778047|NCT02284854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64778048|NCT02284854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778049|NCT02284854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64778050|NCT02284854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64778051|NCT02284854|Analgesics|analgesics|mesh-ancestor
64778052|NCT02284854|Sensory System Agents|sensory system agents|mesh-ancestor
64778053|NCT02284854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64543569|NCT04025671|Sensory System Agents|sensory system agents|mesh-ancestor
64543570|NCT04025671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64543571|NCT03412188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64543572|NCT03412188|gamma-Globulins|gamma-globulins|mesh-list
64543573|NCT03412188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543574|NCT03412188|Immunologic Factors|immunologic factors|mesh-ancestor
64543575|NCT03412188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543576|NCT03412188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64543577|NCT03412188|Glucocorticoids|glucocorticoids|mesh-ancestor
64543593|NCT04022473|Immunologic Factors|immunologic factors|mesh-ancestor
64543594|NCT04022473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543595|NCT01485614|Metformin|metformin|mesh-list
64543596|NCT01485614|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64667774|NCT03002090|Iron|iron|mesh-list
64543598|NCT01485614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543599|NCT01485614|Incretins|incretins|mesh-ancestor
64543600|NCT01485614|Hormones|hormones|mesh-ancestor
64543601|NCT01485614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64543602|NCT01485614|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64543603|NCT01485614|Protease Inhibitors|protease inhibitors|mesh-ancestor
64543604|NCT01485614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543605|NCT01485614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543606|NCT00722553|Vitamins|vitamins|mesh-list
64543607|NCT00722553|Folic Acid|folic acid|mesh-list
64543608|NCT00722553|Vitamin B 12|vitamin b 12|mesh-list
64543609|NCT00722553|Vitamin B Complex|vitamin b complex|mesh-list
64543610|NCT00722553|10-deazaaminopterin|10-deazaaminopterin|mesh-list
64543611|NCT00722553|Aminopterin|aminopterin|mesh-list
64543612|NCT00722553|Micronutrients|micronutrients|mesh-ancestor
64543613|NCT00722553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543614|NCT00722553|Hematinics|hematinics|mesh-ancestor
64543615|NCT00722553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64543616|NCT00722553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543617|NCT00722553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543618|NCT00722553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543619|NCT03022747|Allopurinol|allopurinol|mesh-list
64543620|NCT03022747|Antimetabolites|antimetabolites|mesh-ancestor
64543621|NCT03022747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543622|NCT03022747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543623|NCT03022747|Gout Suppressants|gout suppressants|mesh-ancestor
64543635|NCT03928015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64543636|NCT03928015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64543637|NCT03928015|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64543638|NCT03928015|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64543639|NCT03928015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64543640|NCT03928015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543641|NCT03928015|Hormones|hormones|mesh-ancestor
64543642|NCT03928015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64543643|NCT00735969|Ribavirin|ribavirin|mesh-list
64543644|NCT00735969|Antimetabolites|antimetabolites|mesh-ancestor
64543645|NCT00735969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543646|NCT00735969|Antiviral Agents|antiviral agents|mesh-ancestor
64543647|NCT00735969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64543648|NCT03229512|Sildenafil Citrate|sildenafil citrate|mesh-list
64543649|NCT03229512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543650|NCT03229512|Vasodilator Agents|vasodilator agents|mesh-ancestor
64543651|NCT03229512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64543652|NCT03229512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64543653|NCT03229512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543654|NCT03229512|Urological Agents|urological agents|mesh-ancestor
64543655|NCT01279083|Timolol|timolol|mesh-list
64543656|NCT01279083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64543657|NCT01279083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543658|NCT01279083|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64543659|NCT01279083|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64543660|NCT01279083|Adrenergic Agents|adrenergic agents|mesh-ancestor
64543661|NCT01279083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64543662|NCT01279083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543663|NCT01279083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64543664|NCT01279083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64543665|NCT03022201|Domperidone|domperidone|mesh-list
64543666|NCT03022201|Antiemetics|antiemetics|mesh-ancestor
64543667|NCT03022201|Autonomic Agents|autonomic agents|mesh-ancestor
64978689|NCT00416377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64978690|NCT00416377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978691|NCT00416377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64978692|NCT00416377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64978693|NCT00416377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978694|NCT00416377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543668|NCT03022201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64543669|NCT03022201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543670|NCT03022201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64543671|NCT03022201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64543672|NCT03022201|Dopamine Agents|dopamine agents|mesh-ancestor
64543673|NCT03022201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64543674|NCT03022201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543676|NCT04716114|Fludarabine|fludarabine|mesh-list
64543677|NCT04716114|Azacitidine|azacitidine|mesh-list
64543678|NCT04716114|Homoharringtonine|homoharringtonine|mesh-list
64543679|NCT04716114|Aclarubicin|aclarubicin|mesh-list
64543680|NCT04716114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543681|NCT04716114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64543682|NCT04716114|Antimetabolites|antimetabolites|mesh-ancestor
64543683|NCT04716114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543684|NCT04716114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64543685|NCT04716114|Immunologic Factors|immunologic factors|mesh-ancestor
64543686|NCT04716114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543688|NCT04716114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64543689|NCT04716114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543690|NCT04716114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64543691|NCT04716114|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64543692|NCT04716114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64543693|NCT04716114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64543694|NCT04716114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64543695|NCT00752973|Malathion|malathion|mesh-list
64543696|NCT00752973|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64543697|NCT00752973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543713|NCT04025593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64543714|NCT04025593|Alkylating Agents|alkylating agents|mesh-ancestor
64543715|NCT04025593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543716|NCT04025593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543717|NCT04025593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64543718|NCT04025593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64543719|NCT04025593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64543720|NCT04025593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64543721|NCT04025593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64543722|NCT04025593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543723|NCT04025593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64543724|NCT04025593|Glucocorticoids|glucocorticoids|mesh-ancestor
64543725|NCT04025593|Hormones|hormones|mesh-ancestor
64543726|NCT04025593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64543727|NCT04025593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64543728|NCT04025593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64543729|NCT04025593|Tubulin Modulators|tubulin modulators|mesh-ancestor
64543730|NCT04025593|Antimitotic Agents|antimitotic agents|mesh-ancestor
64543731|NCT04025593|Mitosis Modulators|mitosis modulators|mesh-ancestor
64543732|NCT04025593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64543733|NCT04025593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64543734|NCT04025593|Growth Substances|growth substances|mesh-ancestor
64543735|NCT04025593|Growth Inhibitors|growth inhibitors|mesh-ancestor
64543736|NCT04025593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64543759|NCT02595060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543760|NCT01273779|Talactoferrin alfa|talactoferrin alfa|mesh-list
64543761|NCT01273779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543762|NCT03023124|Doxorubicin|doxorubicin|mesh-list
64543763|NCT03023124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64778074|NCT02285634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778076|NCT02285634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64302422|NCT04986254|Ceftriaxone|ceftriaxone|mesh-list
64302423|NCT04986254|Tazobactam|tazobactam|mesh-list
64302424|NCT04986254|Piperacillin|piperacillin|mesh-list
64302425|NCT04986254|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64302426|NCT04986254|Penicillin G|penicillin g|mesh-list
64302427|NCT04986254|Penicillin G Benzathine|penicillin g benzathine|mesh-list
64543764|NCT03023124|Dacarbazine|dacarbazine|mesh-list
64543767|NCT03023124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543768|NCT03023124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64543769|NCT03023124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64543770|NCT03023124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543771|NCT03023124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543772|NCT03023124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64543773|NCT03023124|Alkylating Agents|alkylating agents|mesh-ancestor
64543775|NCT03022123|Cyclophosphamide|cyclophosphamide|mesh-list
64543776|NCT03022123|Doxorubicin|doxorubicin|mesh-list
64543777|NCT03022123|Vincristine|vincristine|mesh-list
64543778|NCT03022123|Epirubicin|epirubicin|mesh-list
64543779|NCT03022123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64543780|NCT03022123|Immunologic Factors|immunologic factors|mesh-ancestor
64543781|NCT03022123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543782|NCT03022123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64543783|NCT03022123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64543784|NCT03022123|Alkylating Agents|alkylating agents|mesh-ancestor
64543785|NCT03022123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543786|NCT03022123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543787|NCT03022123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64543788|NCT03022123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64543789|NCT03022123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64543790|NCT03022123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64543791|NCT03022123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543792|NCT03022123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64543797|NCT03022123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64543798|NCT03022123|Tubulin Modulators|tubulin modulators|mesh-ancestor
64543799|NCT03022123|Antimitotic Agents|antimitotic agents|mesh-ancestor
64543800|NCT03022123|Mitosis Modulators|mitosis modulators|mesh-ancestor
64543801|NCT02700451|Acetaminophen|acetaminophen|mesh-list
64543802|NCT02700451|Ketorolac|ketorolac|mesh-list
64543803|NCT02700451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64543804|NCT02700451|Analgesics|analgesics|mesh-ancestor
64543805|NCT02700451|Sensory System Agents|sensory system agents|mesh-ancestor
64543806|NCT02700451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64714160|NCT02831569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64543807|NCT02700451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543808|NCT02700451|Antipyretics|antipyretics|mesh-ancestor
64543809|NCT02700451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64543810|NCT02700451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64543811|NCT02700451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64543812|NCT02700451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64543813|NCT02700451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543814|NCT02700451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543815|NCT00722865|Bevacizumab|bevacizumab|mesh-list
64667881|NCT05197751|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64543816|NCT00722865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64543817|NCT00722865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543818|NCT00722865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64543819|NCT00722865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64543847|NCT00723099|Cyclosporins|cyclosporins|mesh-list
64543848|NCT00723099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64543849|NCT00723099|Immunologic Factors|immunologic factors|mesh-ancestor
64543850|NCT00723099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543851|NCT00723099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64543852|NCT00723099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64543853|NCT00723099|Alkylating Agents|alkylating agents|mesh-ancestor
64543854|NCT00723099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543855|NCT00723099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543856|NCT00723099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64543857|NCT00723099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64543858|NCT00723099|Antimetabolites|antimetabolites|mesh-ancestor
64543859|NCT00723099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543860|NCT00723099|Antifungal Agents|antifungal agents|mesh-ancestor
64543861|NCT00723099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64543862|NCT00723099|Dermatologic Agents|dermatologic agents|mesh-ancestor
64543863|NCT00723099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64543864|NCT00723099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64543865|NCT00723099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64543866|NCT00723099|Antitubercular Agents|antitubercular agents|mesh-ancestor
64543867|NCT00723099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64543869|NCT01508936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64543898|NCT04323462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64543899|NCT04323462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543900|NCT00723177|Ibudilast|ibudilast|mesh-list
64543901|NCT00723177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64543902|NCT00723177|Autonomic Agents|autonomic agents|mesh-ancestor
64543903|NCT00723177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64667899|NCT03297710|Antimetabolites|antimetabolites|mesh-ancestor
64543904|NCT00723177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543905|NCT00723177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64543906|NCT00723177|Respiratory System Agents|respiratory system agents|mesh-ancestor
64543907|NCT00723177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64543908|NCT00723177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543909|NCT00723177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543910|NCT00723177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64543911|NCT00723177|Vasodilator Agents|vasodilator agents|mesh-ancestor
64543912|NCT04318392|Dimercaprol|dimercaprol|mesh-list
64543913|NCT04318392|Chelating Agents|chelating agents|mesh-ancestor
64543914|NCT04318392|Sequestering Agents|sequestering agents|mesh-ancestor
64543915|NCT04318392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543916|NCT04698434|Esketamine|esketamine|mesh-list
64543917|NCT04698434|Antidepressive Agents|antidepressive agents|mesh-ancestor
64543918|NCT04698434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64543919|NCT04142749|Oltipraz|oltipraz|mesh-list
64543920|NCT04142749|Antiviral Agents|antiviral agents|mesh-ancestor
64543921|NCT04142749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64543922|NCT04142749|Schistosomicides|schistosomicides|mesh-ancestor
64543923|NCT04142749|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64543924|NCT04142749|Anthelmintics|anthelmintics|mesh-ancestor
64543925|NCT04142749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64543927|NCT04142749|Protective Agents|protective agents|mesh-ancestor
64543928|NCT04142749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543929|NCT04142749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543932|NCT04142749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543942|NCT04024813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543943|NCT04024813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64543944|NCT01276041|Paclitaxel|paclitaxel|mesh-list
64543945|NCT01276041|Trastuzumab|trastuzumab|mesh-list
64543946|NCT01276041|Pertuzumab|pertuzumab|mesh-list
64543947|NCT01276041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64543948|NCT01276041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64543949|NCT01276041|Tubulin Modulators|tubulin modulators|mesh-ancestor
64543950|NCT01276041|Antimitotic Agents|antimitotic agents|mesh-ancestor
64543951|NCT01276041|Mitosis Modulators|mitosis modulators|mesh-ancestor
64543952|NCT01276041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543953|NCT01276041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64543954|NCT04150770|Infliximab|infliximab|mesh-list
64543955|NCT04150770|Dermatologic Agents|dermatologic agents|mesh-ancestor
64543956|NCT04150770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64543957|NCT04150770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64543958|NCT04026438|Potassium phosphate|potassium phosphate|mesh-list
64543959|NCT04026438|Cariostatic Agents|cariostatic agents|mesh-ancestor
64389519|NCT04682158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64543960|NCT04026438|Protective Agents|protective agents|mesh-ancestor
64543961|NCT04026438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543962|NCT01275339|Tadalafil|tadalafil|mesh-list
64714161|NCT02831569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64667944|NCT04826354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543995|NCT04530630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543996|NCT04530630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64543997|NCT04530630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64543998|NCT04530630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64543999|NCT04144153|Analgesics, Opioid|analgesics, opioid|mesh-list
64544000|NCT04144153|Anesthetics|anesthetics|mesh-list
64544001|NCT04144153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64544002|NCT04144153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544003|NCT04144153|Narcotics|narcotics|mesh-ancestor
64544004|NCT04144153|Analgesics|analgesics|mesh-ancestor
64544005|NCT04144153|Sensory System Agents|sensory system agents|mesh-ancestor
64544006|NCT04144153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64544007|NCT04094948|Clenbuterol|clenbuterol|mesh-list
64544008|NCT04094948|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64544009|NCT04094948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64544010|NCT04094948|Adrenergic Agents|adrenergic agents|mesh-ancestor
64544011|NCT04094948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64544012|NCT04094948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544013|NCT04094948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544014|NCT04094948|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64544015|NCT04094948|Autonomic Agents|autonomic agents|mesh-ancestor
64544016|NCT04094948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64544017|NCT04094948|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64544018|NCT04094948|Respiratory System Agents|respiratory system agents|mesh-ancestor
64544019|NCT04094948|Sympathomimetics|sympathomimetics|mesh-ancestor
64978695|NCT00416377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64978696|NCT00416377|Tubulin Modulators|tubulin modulators|mesh-ancestor
64978697|NCT00416377|Antimitotic Agents|antimitotic agents|mesh-ancestor
64978698|NCT00416377|Mitosis Modulators|mitosis modulators|mesh-ancestor
64978699|NCT00416377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64978700|NCT00416377|Glucocorticoids|glucocorticoids|mesh-ancestor
64978701|NCT00416377|Hormones|hormones|mesh-ancestor
64978702|NCT00416377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64978703|NCT00416377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978704|NCT00416377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64667974|NCT02249078|Quetmolimab|quetmolimab|mesh-list
64978705|NCT00416377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64978706|NCT00416377|Alkylating Agents|alkylating agents|mesh-ancestor
64978707|NCT02965859|Adefovir|adefovir|mesh-list
64978744|NCT00271453|Sensory System Agents|sensory system agents|mesh-ancestor
64978745|NCT00271453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64389525|NCT04682158|Vasodilator Agents|vasodilator agents|mesh-ancestor
64389531|NCT02075632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389533|NCT02430259|Rifapentine|rifapentine|mesh-list
64389534|NCT02430259|Antitubercular Agents|antitubercular agents|mesh-ancestor
64389535|NCT02430259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64324214|NCT02557100|Methotrexate|methotrexate|mesh-list
64324215|NCT02557100|Abatacept|abatacept|mesh-list
64324216|NCT02557100|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64978762|NCT00272077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978763|NCT00272116|Vitamins|vitamins|mesh-list
64978764|NCT00272116|Vitamin A|vitamin a|mesh-list
64978765|NCT00272116|Retinol palmitate|retinol palmitate|mesh-list
64978766|NCT00272116|Micronutrients|micronutrients|mesh-ancestor
64544020|NCT04023565|Perindopril|perindopril|mesh-list
64544021|NCT04023565|Moxonidine|moxonidine|mesh-list
64544022|NCT04023565|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64544023|NCT04023565|Protease Inhibitors|protease inhibitors|mesh-ancestor
64544024|NCT04023565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544025|NCT04023565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544026|NCT04023565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64544027|NCT01506908|Nicotine|nicotine|mesh-list
64544028|NCT01506908|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64544029|NCT01506908|Autonomic Agents|autonomic agents|mesh-ancestor
64544030|NCT01506908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64544031|NCT01506908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544032|NCT01506908|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64544033|NCT01506908|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64544034|NCT01506908|Cholinergic Agents|cholinergic agents|mesh-ancestor
64544035|NCT01506908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64714162|NCT02831569|Analgesics|analgesics|mesh-ancestor
64544036|NCT01506908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544037|NCT01519778|Tedizolid|tedizolid|mesh-list
64544038|NCT01519778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64544039|NCT01519778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544040|NCT04144933|Acetaminophen|acetaminophen|mesh-list
64544041|NCT04144933|Dexamethasone|dexamethasone|mesh-list
64544042|NCT04144933|Lidocaine|lidocaine|mesh-list
64544043|NCT04144933|Magnesium Sulfate|magnesium sulfate|mesh-list
64544044|NCT04144933|Sufentanil|sufentanil|mesh-list
64544045|NCT04144933|Dexmedetomidine|dexmedetomidine|mesh-list
64544046|NCT04144933|Ketamine|ketamine|mesh-list
64308817|NCT03209037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64978767|NCT00272116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978768|NCT00272116|Antioxidants|antioxidants|mesh-ancestor
64978769|NCT00272116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978770|NCT00272116|Protective Agents|protective agents|mesh-ancestor
64978771|NCT00272116|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64978772|NCT00272116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978773|NCT00272428|Ascorbic Acid|ascorbic acid|mesh-list
64978774|NCT00272428|Vitamin E|vitamin e|mesh-list
64978775|NCT00272428|Beta Carotene|beta carotene|mesh-list
64978776|NCT00272428|Selenium|selenium|mesh-list
64978777|NCT00272428|Carotenoids|carotenoids|mesh-list
64978778|NCT00272428|Vitamins|vitamins|mesh-ancestor
64978779|NCT00272428|Micronutrients|micronutrients|mesh-ancestor
64668031|NCT02219516|Verinurad|verinurad|mesh-list
64978780|NCT00272428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978781|NCT00272428|Antioxidants|antioxidants|mesh-ancestor
64993472|NCT02224781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64978782|NCT00272428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978783|NCT00272428|Protective Agents|protective agents|mesh-ancestor
64978784|NCT00272428|Trace Elements|trace elements|mesh-ancestor
64978785|NCT00272428|Provitamins|provitamins|mesh-ancestor
64978786|NCT00272467|Omeprazole|omeprazole|mesh-list
64978787|NCT00272467|Rebamipide|rebamipide|mesh-list
64978788|NCT00272467|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64544048|NCT04144933|Dsuvia|dsuvia|mesh-list
64544049|NCT04144933|Analgesics, Opioid|analgesics, opioid|mesh-list
64544050|NCT04144933|Ondansetron|ondansetron|mesh-list
64544051|NCT04144933|Sevoflurane|sevoflurane|mesh-list
64544052|NCT04144933|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64544053|NCT04144933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64544054|NCT04144933|Antiemetics|antiemetics|mesh-ancestor
64544055|NCT04144933|Autonomic Agents|autonomic agents|mesh-ancestor
64778104|NCT02288364|Anesthetics, Local|anesthetics, local|mesh-ancestor
64778105|NCT02288364|Anesthetics|anesthetics|mesh-ancestor
64778106|NCT02288364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64778107|NCT02288364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778108|NCT02288364|Sensory System Agents|sensory system agents|mesh-ancestor
64778109|NCT02288364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778110|NCT02288364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64389536|NCT02430259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64302515|NCT04989140|Growth Inhibitors|growth inhibitors|mesh-ancestor
64302516|NCT04989140|Protease Inhibitors|protease inhibitors|mesh-ancestor
64302517|NCT04989140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302518|NCT04989140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302519|NCT03246009|Lenograstim|lenograstim|mesh-list
64302520|NCT03246009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64302521|NCT03246009|Immunologic Factors|immunologic factors|mesh-ancestor
64302522|NCT03246009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302525|NCT02134249|Cabergoline|cabergoline|mesh-list
64302526|NCT02134249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64302527|NCT02134249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64302528|NCT02134249|Dopamine Agonists|dopamine agonists|mesh-ancestor
64302529|NCT02134249|Dopamine Agents|dopamine agents|mesh-ancestor
64302530|NCT02134249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64544056|NCT04144933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64544057|NCT04144933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544058|NCT04144933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64544059|NCT04144933|Glucocorticoids|glucocorticoids|mesh-ancestor
64544060|NCT04144933|Hormones|hormones|mesh-ancestor
64544061|NCT04144933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64544062|NCT04144933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64544063|NCT04144933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544064|NCT04144933|Anesthetics, Local|anesthetics, local|mesh-ancestor
64544065|NCT04144933|Anesthetics|anesthetics|mesh-ancestor
64544066|NCT04144933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64544067|NCT04144933|Sensory System Agents|sensory system agents|mesh-ancestor
64544068|NCT04144933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64544069|NCT04144933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64544070|NCT04144933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64544071|NCT04144933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64544072|NCT04144933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544073|NCT04144933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64544074|NCT04144933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64544075|NCT04144933|Analgesics|analgesics|mesh-ancestor
64544076|NCT04144933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64544077|NCT04144933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64544078|NCT04144933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64544079|NCT04144933|Adrenergic Agents|adrenergic agents|mesh-ancestor
64544089|NCT04144933|Anticonvulsants|anticonvulsants|mesh-ancestor
64544090|NCT04144933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64544091|NCT04144933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64544092|NCT04144933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64544093|NCT04144933|Antimanic Agents|antimanic agents|mesh-ancestor
64544094|NCT04144933|Narcotics|narcotics|mesh-ancestor
64544095|NCT04144933|Antipruritics|antipruritics|mesh-ancestor
64544096|NCT04144933|Dermatologic Agents|dermatologic agents|mesh-ancestor
64544097|NCT04144933|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64544098|NCT04144933|Serotonin Agents|serotonin agents|mesh-ancestor
64544099|NCT04144933|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64544100|NCT04144933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64544101|NCT04144933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64544102|NCT04144933|Tocolytic Agents|tocolytic agents|mesh-ancestor
64668036|NCT04976777|Antiemetics|antiemetics|mesh-ancestor
64544103|NCT04144933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64544104|NCT04144933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64544105|NCT04149067|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64544106|NCT04149067|Dapagliflozin|dapagliflozin|mesh-list
64544107|NCT04149067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64544108|NCT04149067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544109|NCT04149067|Incretins|incretins|mesh-ancestor
64544111|NCT04149067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64544112|NCT04149067|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64544113|NCT04149067|Protease Inhibitors|protease inhibitors|mesh-ancestor
64544114|NCT04149067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389537|NCT02430259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64544115|NCT04149067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544116|NCT04149067|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64544118|NCT04022941|Antifungal Agents|antifungal agents|mesh-ancestor
64544119|NCT04022941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544120|NCT05087862|Anesthetics|anesthetics|mesh-list
64544121|NCT05087862|Anesthetics, Local|anesthetics, local|mesh-list
64544135|NCT04143685|Oxytocics|oxytocics|mesh-ancestor
64544136|NCT04143685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64544137|NCT04143685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544138|NCT04143685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64544139|NCT04143685|Abortifacient Agents|abortifacient agents|mesh-ancestor
64544140|NCT04143685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64544141|NCT04143685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64544142|NCT04148599|Lidocaine|lidocaine|mesh-list
64544143|NCT04148599|Dexmedetomidine|dexmedetomidine|mesh-list
64544144|NCT04148599|Anesthetics, Local|anesthetics, local|mesh-ancestor
64544145|NCT04148599|Anesthetics|anesthetics|mesh-ancestor
64544146|NCT04148599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64544147|NCT04148599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544148|NCT04148599|Sensory System Agents|sensory system agents|mesh-ancestor
64544149|NCT04148599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64544150|NCT04148599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64544151|NCT04148599|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64544152|NCT04148599|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64544153|NCT04148599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64544154|NCT04148599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544156|NCT04148599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64544157|NCT04148599|Analgesics|analgesics|mesh-ancestor
64544158|NCT04148599|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64544159|NCT04148599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64544160|NCT04148599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64544161|NCT04148599|Adrenergic Agents|adrenergic agents|mesh-ancestor
64544162|NCT04148599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64544163|NCT05110482|Oxytocin|oxytocin|mesh-list
64544164|NCT05110482|Carbetocin|carbetocin|mesh-list
64544179|NCT04930458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544180|NCT04930458|Chelating Agents|chelating agents|mesh-ancestor
64544181|NCT04930458|Sequestering Agents|sequestering agents|mesh-ancestor
64544182|NCT04930458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544184|NCT04917588|Anesthetics, Local|anesthetics, local|mesh-ancestor
64544185|NCT04917588|Anesthetics|anesthetics|mesh-ancestor
64544186|NCT04917588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64544187|NCT04917588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544188|NCT04917588|Sensory System Agents|sensory system agents|mesh-ancestor
64544189|NCT04917588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64544190|NCT04917588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64544191|NCT04917588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64544192|NCT04917588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64544193|NCT04917588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64544194|NCT04917588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544195|NCT05101356|Antineoplastic Agents|antineoplastic agents|mesh-list
64544196|NCT05101356|Vaccines|vaccines|mesh-list
64544197|NCT05101356|Sargramostim|sargramostim|mesh-list
64544198|NCT05101356|Immunologic Factors|immunologic factors|mesh-ancestor
64544199|NCT05101356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544200|NCT04022317|Insulin|insulin|mesh-list
64544201|NCT04022317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64544202|NCT04022317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544203|NCT04022005|Gemcitabine|gemcitabine|mesh-list
64544204|NCT04022005|Rituximab|rituximab|mesh-list
64544205|NCT04022005|Oxaliplatin|oxaliplatin|mesh-list
64544206|NCT04022005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64544207|NCT04022005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544208|NCT04022005|Immunologic Factors|immunologic factors|mesh-ancestor
64544209|NCT04022005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544223|NCT05099250|Anesthetics, Local|anesthetics, local|mesh-ancestor
64544224|NCT05099250|Anesthetics|anesthetics|mesh-ancestor
64544225|NCT05099250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64544226|NCT05099250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484217|NCT01751113|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64544227|NCT05099250|Sensory System Agents|sensory system agents|mesh-ancestor
64544228|NCT05099250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64544229|NCT05099250|Analgesics|analgesics|mesh-ancestor
64544230|NCT05099250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64544231|NCT05099250|Anticonvulsants|anticonvulsants|mesh-ancestor
64544232|NCT05099250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64544233|NCT05099250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64544234|NCT05099250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544235|NCT05099250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64544236|NCT05099250|Tocolytic Agents|tocolytic agents|mesh-ancestor
64544237|NCT05099250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64544239|NCT04143451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64544240|NCT04143451|Immunologic Factors|immunologic factors|mesh-ancestor
64544241|NCT04143451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544242|NCT04143451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544243|NCT04143451|Interferon Inducers|interferon inducers|mesh-ancestor
64544244|NCT05105412|Gemcitabine|gemcitabine|mesh-list
64544245|NCT05105412|Lenalidomide|lenalidomide|mesh-list
64544246|NCT05105412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64544247|NCT05105412|Antimetabolites|antimetabolites|mesh-ancestor
64544248|NCT05105412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544249|NCT05105412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544250|NCT05105412|Antiviral Agents|antiviral agents|mesh-ancestor
64544251|NCT05105412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544252|NCT05105412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544253|NCT05105412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64544254|NCT05105412|Immunologic Factors|immunologic factors|mesh-ancestor
64544255|NCT05105412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544256|NCT05105412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64978789|NCT00272467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64978790|NCT00272467|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64978791|NCT00272467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978792|NCT00272467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544257|NCT05105412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64544258|NCT05105412|Growth Substances|growth substances|mesh-ancestor
64544259|NCT05105412|Growth Inhibitors|growth inhibitors|mesh-ancestor
64544260|NCT04766047|Dexmedetomidine|dexmedetomidine|mesh-list
64544261|NCT04766047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64544262|NCT04766047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64544263|NCT04766047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544264|NCT04766047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64544265|NCT04766047|Analgesics|analgesics|mesh-ancestor
64500341|NCT01873170|Hormones|hormones|mesh-ancestor
64544266|NCT04766047|Sensory System Agents|sensory system agents|mesh-ancestor
64544267|NCT04766047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64544268|NCT04766047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64544269|NCT04766047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64544270|NCT04766047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64544271|NCT04766047|Adrenergic Agents|adrenergic agents|mesh-ancestor
64544272|NCT04766047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64544273|NCT04766047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544274|NCT05105022|Propofol|propofol|mesh-list
64544275|NCT05105022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64544276|NCT05105022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64544277|NCT05105022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544278|NCT05105022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64544279|NCT05105022|Anesthetics, General|anesthetics, general|mesh-ancestor
64544280|NCT05105022|Anesthetics|anesthetics|mesh-ancestor
64544281|NCT02080819|Levodopa|levodopa|mesh-list
64544282|NCT02080819|Carbidopa|carbidopa|mesh-list
64544303|NCT04316364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64544304|NCT04316364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544305|NCT04316364|Tubulin Modulators|tubulin modulators|mesh-ancestor
64544306|NCT04316364|Antimitotic Agents|antimitotic agents|mesh-ancestor
64544307|NCT04316364|Mitosis Modulators|mitosis modulators|mesh-ancestor
64544308|NCT04316364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544309|NCT03916003|Primaquine|primaquine|mesh-list
64544310|NCT03916003|Antimalarials|antimalarials|mesh-ancestor
64544311|NCT03916003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64544312|NCT03916003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64544313|NCT03916003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544314|NCT04781478|Chlorhexidine|chlorhexidine|mesh-list
64544315|NCT04781478|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64544316|NCT04781478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544317|NCT04781478|Disinfectants|disinfectants|mesh-ancestor
64544318|NCT03937843|Carboplatin|carboplatin|mesh-list
64544319|NCT03937843|Etoposide|etoposide|mesh-list
64668098|NCT02143466|Immunologic Factors|immunologic factors|mesh-ancestor
64544320|NCT03937843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544321|NCT03937843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64544322|NCT03937843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64544323|NCT03937843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64544324|NCT03937843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544325|NCT03937843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544326|NCT04018872|Itraconazole|itraconazole|mesh-list
64544327|NCT04018872|Antifungal Agents|antifungal agents|mesh-ancestor
64544328|NCT04018872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544329|NCT04018872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64544330|NCT04018872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64544331|NCT04018872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544332|NCT04018872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544333|NCT04018872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64309107|NCT03195153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978793|NCT00272467|Antioxidants|antioxidants|mesh-ancestor
64978794|NCT00272467|Protective Agents|protective agents|mesh-ancestor
64978795|NCT00272467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978796|NCT00272584|Risperidone|risperidone|mesh-list
64978797|NCT00272584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64978798|NCT00272584|Serotonin Agents|serotonin agents|mesh-ancestor
64978799|NCT00272584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64978800|NCT00272584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544335|NCT04018872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64544336|NCT04018872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544337|NCT04018872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64544338|NCT03896737|Thalidomide|thalidomide|mesh-list
64714163|NCT02831569|Sensory System Agents|sensory system agents|mesh-ancestor
64544339|NCT03896737|Dexamethasone|dexamethasone|mesh-list
64544340|NCT03896737|Dexamethasone acetate|dexamethasone acetate|mesh-list
64544341|NCT03896737|Cyclophosphamide|cyclophosphamide|mesh-list
64544342|NCT03896737|Bortezomib|bortezomib|mesh-list
64544343|NCT03896737|Daratumumab|daratumumab|mesh-list
64544344|NCT03896737|BB 1101|bb 1101|mesh-list
64544345|NCT03896737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64544346|NCT03896737|Immunologic Factors|immunologic factors|mesh-ancestor
64544347|NCT03896737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544348|NCT03896737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64544349|NCT03896737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64544350|NCT03896737|Alkylating Agents|alkylating agents|mesh-ancestor
64544351|NCT03896737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544352|NCT03896737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544353|NCT03896737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64544354|NCT03896737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64544355|NCT03896737|Antiemetics|antiemetics|mesh-ancestor
64544356|NCT03896737|Autonomic Agents|autonomic agents|mesh-ancestor
64544357|NCT03896737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64544358|NCT03896737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64544359|NCT03896737|Glucocorticoids|glucocorticoids|mesh-ancestor
64544360|NCT03896737|Hormones|hormones|mesh-ancestor
64544383|NCT04685772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544384|NCT04685772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64544385|NCT04685772|Glucocorticoids|glucocorticoids|mesh-ancestor
64544386|NCT04685772|Hormones|hormones|mesh-ancestor
64544387|NCT04685772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64544388|NCT04685772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64544389|NCT04685772|Protective Agents|protective agents|mesh-ancestor
64544390|NCT04685772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64544391|NCT04685772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544392|NCT05076786|Carboplatin|carboplatin|mesh-list
64544393|NCT05076786|Etoposide|etoposide|mesh-list
64544394|NCT05076786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544395|NCT05076786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64544396|NCT05076786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64544397|NCT05076786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64544398|NCT05076786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544399|NCT05076786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544400|NCT03476317|Vancomycin|vancomycin|mesh-list
64544401|NCT03476317|Ciprofloxacin|ciprofloxacin|mesh-list
64544402|NCT03476317|Neomycin|neomycin|mesh-list
64544403|NCT03476317|Fluconazole|fluconazole|mesh-list
64544404|NCT03476317|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64544405|NCT03476317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64544406|NCT03476317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544407|NCT03476317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64544408|NCT03476317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64544409|NCT03476317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544410|NCT03476317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544429|NCT02658084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64544430|NCT02658084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544431|NCT02658084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64544432|NCT02658084|Tubulin Modulators|tubulin modulators|mesh-ancestor
64544433|NCT02658084|Antimitotic Agents|antimitotic agents|mesh-ancestor
64544434|NCT02658084|Mitosis Modulators|mitosis modulators|mesh-ancestor
64544435|NCT02658084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544436|NCT03588871|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64544437|NCT03588871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64544438|NCT03588871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544439|NCT03588715|Interferons|interferons|mesh-list
64544440|NCT03588715|Interferon-alpha|interferon-alpha|mesh-list
64544441|NCT03588715|Interferon alpha-2|interferon alpha-2|mesh-list
64324221|NCT02557100|Antimetabolites|antimetabolites|mesh-ancestor
64544442|NCT03588715|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64544443|NCT03588715|Antibodies, Blocking|antibodies, blocking|mesh-list
64544444|NCT03588715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544445|NCT03588715|Antiviral Agents|antiviral agents|mesh-ancestor
64544446|NCT03588715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544447|NCT03588715|Immunologic Factors|immunologic factors|mesh-ancestor
64544448|NCT03588715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544449|NCT04528758|Rhodamine 6G|rhodamine 6g|mesh-list
64544450|NCT04528758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544451|NCT04140409|Octreotide|octreotide|mesh-list
64544452|NCT04140409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64544453|NCT04140409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64544454|NCT04140409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544455|NCT04527432|Antibodies|antibodies|mesh-list
64544476|NCT03630055|Anticoagulants|anticoagulants|mesh-ancestor
64544477|NCT04642950|Sargramostim|sargramostim|mesh-list
64544478|NCT04642950|Immunologic Factors|immunologic factors|mesh-ancestor
64544479|NCT04642950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544480|NCT05110170|Goserelin|goserelin|mesh-list
64544481|NCT05110170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64544482|NCT05110170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544483|NCT04374240|Tretazicar|tretazicar|mesh-list
64544484|NCT04374240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544485|NCT05109390|Cyclosporine|cyclosporine|mesh-list
64544486|NCT05109390|Simethicone|simethicone|mesh-list
64544487|NCT05109390|Omeprazole|omeprazole|mesh-list
64544488|NCT05109390|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
64544489|NCT05109390|Calcium Carbonate|calcium carbonate|mesh-list
64544490|NCT05109390|Magnesium Hydroxide|magnesium hydroxide|mesh-list
64544491|NCT05109390|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
64544492|NCT05109390|Antacids|antacids|mesh-list
64544493|NCT05109390|Tacrolimus|tacrolimus|mesh-list
64544494|NCT05109390|Cyclosporins|cyclosporins|mesh-list
64544495|NCT05109390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778145|NCT02291016|Adrenergic Agents|adrenergic agents|mesh-ancestor
64544496|NCT05109390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64544497|NCT05109390|Immunologic Factors|immunologic factors|mesh-ancestor
64544498|NCT05109390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64778146|NCT02291016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64778147|NCT02291016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778149|NCT02296164|Alkylating Agents|alkylating agents|mesh-ancestor
64389585|NCT02326727|Anesthetics|anesthetics|mesh-ancestor
64389586|NCT02326727|Anesthetics, Local|anesthetics, local|mesh-ancestor
64389587|NCT02326727|Sensory System Agents|sensory system agents|mesh-ancestor
64389588|NCT02326727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302613|NCT02456025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302614|NCT02134483|Parathyroid Hormone|parathyroid hormone|mesh-list
64302615|NCT02134483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64302616|NCT02134483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302617|NCT03576911|Ubiquinone|ubiquinone|mesh-list
64302618|NCT03576911|Coenzyme Q10|coenzyme q10|mesh-list
64302619|NCT03576911|Micronutrients|micronutrients|mesh-ancestor
64302620|NCT03576911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544499|NCT05109390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544500|NCT05109390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544501|NCT05109390|Antifungal Agents|antifungal agents|mesh-ancestor
64544502|NCT05109390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544503|NCT05109390|Dermatologic Agents|dermatologic agents|mesh-ancestor
64544504|NCT05109390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64544505|NCT05109390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64668197|NCT01850108|Immunologic Factors|immunologic factors|mesh-ancestor
64544506|NCT05109390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64544507|NCT05109390|Antifoaming Agents|antifoaming agents|mesh-ancestor
64544508|NCT05109390|Emollients|emollients|mesh-ancestor
64544522|NCT05109312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64544523|NCT05109312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64544524|NCT05109312|Analgesics|analgesics|mesh-ancestor
64544525|NCT05109312|Antipyretics|antipyretics|mesh-ancestor
64544526|NCT05109312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64544527|NCT05109312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64544528|NCT05109312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64544529|NCT05109312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64544530|NCT05109312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544531|NCT05109312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544532|NCT03661632|Nivolumab|nivolumab|mesh-list
64544533|NCT03661632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64544534|NCT03661632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544535|NCT03661632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64544536|NCT03661632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544537|NCT04748250|Phytoestrogens|phytoestrogens|mesh-list
64544538|NCT04748250|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64544539|NCT04748250|Estrogens|estrogens|mesh-ancestor
64544540|NCT04748250|Hormones|hormones|mesh-ancestor
64544541|NCT04748250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64544542|NCT04748250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544543|NCT04726878|Acetaminophen|acetaminophen|mesh-list
64544544|NCT04726878|Oxycodone|oxycodone|mesh-list
64544545|NCT04726878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64544546|NCT04726878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544547|NCT04726878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64544548|NCT04726878|Analgesics|analgesics|mesh-ancestor
64978801|NCT00272584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978802|NCT00272584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64978803|NCT00272584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64978804|NCT00272584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64389589|NCT02326727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64389591|NCT02326727|Analgesics|analgesics|mesh-ancestor
64389592|NCT02326727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64389593|NCT02326727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64389594|NCT02326727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64389595|NCT02432911|Cytarabine|cytarabine|mesh-list
64389596|NCT02432911|Aclacinomycins|aclacinomycins|mesh-list
64978805|NCT00272584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64978806|NCT00272584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64978807|NCT00272584|Dopamine Agents|dopamine agents|mesh-ancestor
64978808|NCT00272701|Esomeprazole|esomeprazole|mesh-list
64978809|NCT00272701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64978827|NCT00416533|Prednisone|prednisone|mesh-list
64978828|NCT00416533|Docetaxel|docetaxel|mesh-list
64978829|NCT00416533|Doxorubicin|doxorubicin|mesh-list
64978830|NCT00416533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64978831|NCT00416533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978832|NCT00416533|Tubulin Modulators|tubulin modulators|mesh-ancestor
64978833|NCT00416533|Antimitotic Agents|antimitotic agents|mesh-ancestor
64978834|NCT00416533|Mitosis Modulators|mitosis modulators|mesh-ancestor
64978835|NCT00416533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978836|NCT00416533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64978837|NCT00416533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64544549|NCT04726878|Sensory System Agents|sensory system agents|mesh-ancestor
64544550|NCT04726878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64544551|NCT04726878|Antipyretics|antipyretics|mesh-ancestor
64544552|NCT04726878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64544553|NCT04726878|Narcotics|narcotics|mesh-ancestor
64544554|NCT04525638|Nivolumab|nivolumab|mesh-list
64544555|NCT04525638|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64544556|NCT04525638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64544557|NCT04525638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544558|NCT04525638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64544559|NCT04525638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544560|NCT04525638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64544561|NCT01482962|Gemcitabine|gemcitabine|mesh-list
64544562|NCT01482962|Romidepsin|romidepsin|mesh-list
64544563|NCT01482962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64544564|NCT01482962|Antimetabolites|antimetabolites|mesh-ancestor
64544565|NCT01482962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544566|NCT01482962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544567|NCT01482962|Antiviral Agents|antiviral agents|mesh-ancestor
64544568|NCT01482962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544569|NCT01482962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544570|NCT01482962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64544571|NCT01482962|Immunologic Factors|immunologic factors|mesh-ancestor
64544572|NCT01482962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544573|NCT01482962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64544574|NCT04701060|Apatinib|apatinib|mesh-list
64544575|NCT04701060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544597|NCT04339218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544598|NCT04339218|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64544599|NCT04339218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64544600|NCT03895801|Prednisone|prednisone|mesh-list
64544601|NCT03895801|Glucocorticoids|glucocorticoids|mesh-list
64544602|NCT03895801|Vilobelimab|vilobelimab|mesh-list
64544603|NCT03895801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64544604|NCT03895801|Hormones|hormones|mesh-ancestor
64544605|NCT03895801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64302650|NCT02129101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64302651|NCT02129101|Antimetabolites|antimetabolites|mesh-ancestor
64302652|NCT02129101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302653|NCT02129101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302654|NCT02129101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302655|NCT02134717|Maraviroc|maraviroc|mesh-list
64302656|NCT02134717|Dimercaprol|dimercaprol|mesh-list
64302657|NCT02134717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64302658|NCT02134717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64302659|NCT02134717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544606|NCT03895801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544607|NCT03895801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64544608|NCT03895801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544609|NCT03895801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64544610|NCT03895801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64544611|NCT03895801|Immunologic Factors|immunologic factors|mesh-ancestor
64544613|NCT03021421|Anesthetics, Local|anesthetics, local|mesh-ancestor
64544614|NCT03021421|Anesthetics|anesthetics|mesh-ancestor
64544615|NCT03021421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64544616|NCT03021421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544617|NCT03021421|Sensory System Agents|sensory system agents|mesh-ancestor
64544618|NCT03021421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64544619|NCT04521582|Amlodipine|amlodipine|mesh-list
64544647|NCT04720326|Immunologic Factors|immunologic factors|mesh-ancestor
64544648|NCT04720326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544649|NCT04720326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64544650|NCT04720326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544651|NCT04720326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544652|NCT03587779|Sevoflurane|sevoflurane|mesh-list
64544653|NCT03587779|Desflurane|desflurane|mesh-list
64544654|NCT03587779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64544655|NCT03587779|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64544656|NCT03587779|Anesthetics, General|anesthetics, general|mesh-ancestor
64544657|NCT03587779|Anesthetics|anesthetics|mesh-ancestor
64544658|NCT03587779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64544659|NCT03587779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544660|NCT04405921|Azithromycin|azithromycin|mesh-list
64544661|NCT04405921|Hydroxychloroquine|hydroxychloroquine|mesh-list
64544662|NCT04405921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64544663|NCT04405921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544664|NCT04405921|Antimalarials|antimalarials|mesh-ancestor
64544665|NCT04405921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64544666|NCT04405921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64544667|NCT04405921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544668|NCT04405921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544669|NCT04405921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64544670|NCT04516902|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
64544671|NCT04516902|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
64544672|NCT04516902|Hallucinogens|hallucinogens|mesh-ancestor
64544673|NCT04516902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544674|NCT04516902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64544675|NCT04516902|Serotonin Agents|serotonin agents|mesh-ancestor
64544676|NCT04516902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64544677|NCT04516902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544689|NCT03581149|Antioxidants|antioxidants|mesh-ancestor
64544690|NCT03581149|Protective Agents|protective agents|mesh-ancestor
64544691|NCT03581149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544692|NCT03581149|Vitamins|vitamins|mesh-ancestor
64544693|NCT03581149|Micronutrients|micronutrients|mesh-ancestor
64544694|NCT03581149|Cathartics|cathartics|mesh-ancestor
64544695|NCT03581149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64544696|NCT03919266|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64544697|NCT03919266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544698|NCT04765267|Vitamin D|vitamin d|mesh-list
64544699|NCT04765267|Cholecalciferol|cholecalciferol|mesh-list
64544700|NCT04765267|Zinc Sulfate|zinc sulfate|mesh-list
64544701|NCT04765267|Vitamins|vitamins|mesh-ancestor
64544702|NCT04765267|Micronutrients|micronutrients|mesh-ancestor
64544703|NCT04765267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544704|NCT04765267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64544705|NCT04765267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64544706|NCT04765267|Astringents|astringents|mesh-ancestor
64544707|NCT04765267|Dermatologic Agents|dermatologic agents|mesh-ancestor
64544708|NCT05583409|Osimertinib|osimertinib|mesh-list
64544709|NCT05583409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778150|NCT02296164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778151|NCT02296164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64778152|NCT02296164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778153|NCT02297100|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64356306|NCT03984045|Lidocaine|lidocaine|mesh-list
64544710|NCT05583409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64544711|NCT05583409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544712|NCT05583409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544713|NCT03020953|Estrogens|estrogens|mesh-list
64544714|NCT03020953|Hormones|hormones|mesh-ancestor
64544715|NCT03020953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64544716|NCT03020953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544717|NCT03625986|Nicotine|nicotine|mesh-list
64544718|NCT03625986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64544719|NCT03625986|Autonomic Agents|autonomic agents|mesh-ancestor
64544720|NCT03625986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64544721|NCT03625986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544722|NCT03625986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64544723|NCT03625986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64544724|NCT03625986|Cholinergic Agents|cholinergic agents|mesh-ancestor
64544725|NCT03625986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64978838|NCT00416533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64544726|NCT03625986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544728|NCT05583175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544729|NCT03891901|Isoniazid|isoniazid|mesh-list
64544730|NCT03891901|Rifabutin|rifabutin|mesh-list
64544731|NCT03891901|Imatinib Mesylate|imatinib mesylate|mesh-list
64544732|NCT03891901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544733|NCT03891901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64544734|NCT03891901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544735|NCT03891901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544736|NCT03891901|Antitubercular Agents|antitubercular agents|mesh-ancestor
64544737|NCT03891901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64544738|NCT03891901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544739|NCT03891901|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64544740|NCT03891901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64544741|NCT03891901|Antimetabolites|antimetabolites|mesh-ancestor
64544742|NCT03891901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64544743|NCT03891901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64544744|NCT03580681|Vitamin E|vitamin e|mesh-list
64544745|NCT03580681|Vitamins|vitamins|mesh-ancestor
64544746|NCT03580681|Micronutrients|micronutrients|mesh-ancestor
64544747|NCT03580681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544748|NCT03580681|Antioxidants|antioxidants|mesh-ancestor
64544749|NCT03580681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544750|NCT03580681|Protective Agents|protective agents|mesh-ancestor
64544751|NCT03452826|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64544752|NCT03452826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64544753|NCT03452826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544754|NCT03452826|Antitubercular Agents|antitubercular agents|mesh-ancestor
64544755|NCT05040126|Linezolid|linezolid|mesh-list
64544756|NCT05040126|Bedaquiline|bedaquiline|mesh-list
64544757|NCT05040126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64544758|NCT05040126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544759|NCT05040126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64544760|NCT05040126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544765|NCT03217201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544766|NCT03217201|Sympathomimetics|sympathomimetics|mesh-ancestor
64544767|NCT03217201|Autonomic Agents|autonomic agents|mesh-ancestor
64544768|NCT03217201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64544769|NCT03217201|Dopamine Agents|dopamine agents|mesh-ancestor
64544770|NCT03217201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64302667|NCT03245385|Halobetasol|halobetasol|mesh-list
64544771|NCT03217201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544772|NCT03217201|Adrenergic Agents|adrenergic agents|mesh-ancestor
64544773|NCT03217201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64544774|NCT03217201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64544775|NCT03217201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64544776|NCT03217201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64544777|NCT03069300|Acetylcysteine|acetylcysteine|mesh-list
64544778|NCT03069300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64544779|NCT03069300|Antiviral Agents|antiviral agents|mesh-ancestor
64389599|NCT02432911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389600|NCT02432911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64389601|NCT02432911|Antiviral Agents|antiviral agents|mesh-ancestor
64389602|NCT02432911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64389603|NCT02432911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64389604|NCT02432911|Immunologic Factors|immunologic factors|mesh-ancestor
64389605|NCT02432911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389606|NCT02432911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64389607|NCT02432911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64324229|NCT02557100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64302672|NCT02136823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64302673|NCT02136823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64302674|NCT02136823|Dopamine Agents|dopamine agents|mesh-ancestor
64302675|NCT02136823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64302676|NCT02136823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544780|NCT03069300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544781|NCT03069300|Expectorants|expectorants|mesh-ancestor
64544782|NCT03069300|Respiratory System Agents|respiratory system agents|mesh-ancestor
64544783|NCT03069300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64544784|NCT03069300|Antioxidants|antioxidants|mesh-ancestor
64544785|NCT03069300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544786|NCT03069300|Protective Agents|protective agents|mesh-ancestor
64544787|NCT03069300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544788|NCT03069300|Antidotes|antidotes|mesh-ancestor
64544789|NCT05582317|Simvastatin|simvastatin|mesh-list
64544790|NCT05582317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64544791|NCT05582317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64544792|NCT05582317|Antimetabolites|antimetabolites|mesh-ancestor
64544793|NCT05582317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544797|NCT03891355|Dexamethasone|dexamethasone|mesh-list
64544809|NCT03891355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544810|NCT03891355|Immunologic Factors|immunologic factors|mesh-ancestor
64544811|NCT03891355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64544812|NCT03891355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64544813|NCT03891355|Growth Substances|growth substances|mesh-ancestor
64544814|NCT03891355|Growth Inhibitors|growth inhibitors|mesh-ancestor
64544815|NCT05582083|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
64544816|NCT05582083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64544817|NCT05582083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544818|NCT05582083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544819|NCT03954132|Cholinergic Agents|cholinergic agents|mesh-list
64544820|NCT03954132|Muscarinic Antagonists|muscarinic antagonists|mesh-list
64544821|NCT03954132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64544822|NCT03954132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544823|NCT03954132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544824|NCT03954132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64544825|NCT03580291|Mycophenolic Acid|mycophenolic acid|mesh-list
64544826|NCT03580291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64544827|NCT03580291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544828|NCT03580291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64544829|NCT03580291|Antitubercular Agents|antitubercular agents|mesh-ancestor
64544830|NCT03580291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64544832|NCT03580291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544857|NCT04518306|Telmisartan|telmisartan|mesh-list
64544858|NCT04518306|Indapamide|indapamide|mesh-list
64544859|NCT04518306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64544860|NCT04518306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64544861|NCT04518306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64544862|NCT04518306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544863|NCT04518306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64544864|NCT04518306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544865|NCT04518306|Vasodilator Agents|vasodilator agents|mesh-ancestor
64544866|NCT04518306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64544867|NCT04518306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64544868|NCT04518306|Diuretics|diuretics|mesh-ancestor
64544869|NCT04518306|Natriuretic Agents|natriuretic agents|mesh-ancestor
64544870|NCT04518306|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64544871|NCT03580135|Propolis|propolis|mesh-list
64544872|NCT03580135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544873|NCT01890252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64544874|NCT03901573|Atezolizumab|atezolizumab|mesh-list
64544875|NCT03901573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544876|NCT03585829|Prednisolone|prednisolone|mesh-list
64324233|NCT02233777|Pregabalin|pregabalin|mesh-list
64544877|NCT03585829|Hydrocortisone|hydrocortisone|mesh-list
64544878|NCT03585829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64544879|NCT03585829|Glucocorticoids|glucocorticoids|mesh-ancestor
64544880|NCT03585829|Hormones|hormones|mesh-ancestor
64544881|NCT03585829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64544882|NCT03585829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544883|NCT03585829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64544884|NCT03585829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544885|NCT05701969|Melatonin|melatonin|mesh-list
64544886|NCT05701969|Antioxidants|antioxidants|mesh-ancestor
64544887|NCT05701969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544888|NCT05701969|Protective Agents|protective agents|mesh-ancestor
64544891|NCT03583255|Dexamethasone|dexamethasone|mesh-list
64544899|NCT03583255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544900|NCT03583255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64544901|NCT03583255|Glucocorticoids|glucocorticoids|mesh-ancestor
64544902|NCT03583255|Hormones|hormones|mesh-ancestor
64544903|NCT03583255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64544904|NCT03583255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64544906|NCT03583255|Protease Inhibitors|protease inhibitors|mesh-ancestor
64544907|NCT03583255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544908|NCT03583255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544909|NCT03583255|Dermatologic Agents|dermatologic agents|mesh-ancestor
64544910|NCT03585751|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64544911|NCT03585751|Simvastatin|simvastatin|mesh-list
64544912|NCT03585751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544913|NCT03585751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64544914|NCT03585751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64544915|NCT03585751|Antimetabolites|antimetabolites|mesh-ancestor
64544916|NCT03585751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544917|NCT03585751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64544918|NCT03585751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64544919|NCT03585751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544921|NCT03583333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64544922|NCT03583333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544923|NCT03583333|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64544924|NCT03583333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544925|NCT03583333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544926|NCT03585673|Docetaxel|docetaxel|mesh-list
64544927|NCT03585673|Oxaliplatin|oxaliplatin|mesh-list
64309725|NCT02444559|Clonidine|clonidine|mesh-list
64978839|NCT00416533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978840|NCT00416533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64978841|NCT00416533|Glucocorticoids|glucocorticoids|mesh-ancestor
64978842|NCT00416533|Hormones|hormones|mesh-ancestor
64978843|NCT00416533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64978844|NCT00416533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978845|NCT00416533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64978846|NCT00107796|Modafinil|modafinil|mesh-list
64978847|NCT00107796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64978848|NCT00107796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978849|NCT00107796|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64978850|NCT00107796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64978851|NCT00107796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64978852|NCT00107796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544928|NCT03585673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544929|NCT03585673|Tubulin Modulators|tubulin modulators|mesh-ancestor
64544930|NCT03585673|Antimitotic Agents|antimitotic agents|mesh-ancestor
64324238|NCT02233777|Anticonvulsants|anticonvulsants|mesh-ancestor
64324239|NCT02233777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64302687|NCT02136823|Vasodilator Agents|vasodilator agents|mesh-ancestor
64302689|NCT03250143|Azathioprine|azathioprine|mesh-list
64302690|NCT03250143|Cyclosporins|cyclosporins|mesh-list
64302691|NCT03250143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302692|NCT03250143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302693|NCT03250143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64544931|NCT03585673|Mitosis Modulators|mitosis modulators|mesh-ancestor
64544932|NCT03585673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544933|NCT01602510|Lamotrigine|lamotrigine|mesh-list
64544934|NCT01602510|Anticonvulsants|anticonvulsants|mesh-ancestor
64544935|NCT01602510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64544936|NCT01602510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64544937|NCT01602510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544938|NCT01602510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64544939|NCT01602510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544940|NCT01602510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64544941|NCT01602510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64544942|NCT01602510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64544943|NCT01602510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64544945|NCT03899467|Androgens|androgens|mesh-list
64544946|NCT03899467|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
64544947|NCT03899467|Hormones|hormones|mesh-ancestor
64544948|NCT03899467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64544949|NCT03899467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544979|NCT03158389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544980|NCT03158389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544981|NCT03158389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64544982|NCT03158389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64544983|NCT03158389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64544984|NCT03158389|Antifungal Agents|antifungal agents|mesh-ancestor
64544985|NCT03158389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64544986|NCT03158389|Immunologic Factors|immunologic factors|mesh-ancestor
64544987|NCT03158389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544989|NCT01236456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64544990|NCT01236456|Immunologic Factors|immunologic factors|mesh-ancestor
64544991|NCT01236456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64544992|NCT01236456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64544993|NCT01236456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64544994|NCT01236456|Alkylating Agents|alkylating agents|mesh-ancestor
64544995|NCT01236456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64544996|NCT01236456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64544997|NCT01236456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64544998|NCT05118048|Chrysarobin|chrysarobin|mesh-list
64544999|NCT05118048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64545000|NCT05118048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64545001|NCT05118048|Analgesics|analgesics|mesh-ancestor
64545002|NCT05118048|Sensory System Agents|sensory system agents|mesh-ancestor
64545003|NCT05118048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64545004|NCT05118048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545005|NCT05118048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64545006|NCT05118048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64545007|NCT04405375|Gemcitabine|gemcitabine|mesh-list
64545008|NCT04405375|Dexamethasone|dexamethasone|mesh-list
64545009|NCT04405375|Etoposide|etoposide|mesh-list
64545010|NCT04405375|Pegaspargase|pegaspargase|mesh-list
64545011|NCT04405375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64545012|NCT04405375|Antiemetics|antiemetics|mesh-ancestor
64545020|NCT04405375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64545021|NCT04405375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545022|NCT04405375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64545023|NCT04405375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64545024|NCT04405375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64545025|NCT04405375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545026|NCT04405375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545027|NCT04405375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64545028|NCT04405375|Antimetabolites|antimetabolites|mesh-ancestor
64545029|NCT04405375|Antiviral Agents|antiviral agents|mesh-ancestor
64545030|NCT04405375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64545031|NCT04405375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64545032|NCT04405375|Immunologic Factors|immunologic factors|mesh-ancestor
64545033|NCT03158857|Sofosbuvir|sofosbuvir|mesh-list
64545034|NCT03158857|Antiviral Agents|antiviral agents|mesh-ancestor
64778160|NCT02297100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778161|NCT02297100|Cholinergic Agents|cholinergic agents|mesh-ancestor
64545035|NCT03158857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64545036|NCT03029611|Paclitaxel|paclitaxel|mesh-list
64545037|NCT03029611|Carboplatin|carboplatin|mesh-list
64545038|NCT03029611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64545039|NCT03029611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64545040|NCT03029611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545041|NCT03029611|Tubulin Modulators|tubulin modulators|mesh-ancestor
64545042|NCT03029611|Antimitotic Agents|antimitotic agents|mesh-ancestor
64545043|NCT03029611|Mitosis Modulators|mitosis modulators|mesh-ancestor
64545044|NCT03029611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545045|NCT05701501|Pantothenic Acid|pantothenic acid|mesh-list
64545046|NCT05701501|Vitamins|vitamins|mesh-ancestor
64545067|NCT03159559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64545068|NCT03159559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64545069|NCT03159559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64545070|NCT03159559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64545071|NCT03159559|Purinergic Agents|purinergic agents|mesh-ancestor
64545072|NCT03159559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64545073|NCT03159559|Vasodilator Agents|vasodilator agents|mesh-ancestor
64545074|NCT03159559|Urological Agents|urological agents|mesh-ancestor
64545075|NCT03159403|Oritavancin|oritavancin|mesh-list
64778162|NCT02297100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64778163|NCT02299050|Bromocriptine|bromocriptine|mesh-list
64778164|NCT02299050|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64778165|NCT02299050|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64778166|NCT02299050|Hormone Antagonists|hormone antagonists|mesh-ancestor
64778167|NCT02299050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64778168|NCT02299050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778169|NCT02299050|Dopamine Agonists|dopamine agonists|mesh-ancestor
64778170|NCT02299050|Dopamine Agents|dopamine agents|mesh-ancestor
64778171|NCT02299050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64302695|NCT03250143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302696|NCT03250143|Antifungal Agents|antifungal agents|mesh-ancestor
64302697|NCT03250143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64302698|NCT03250143|Dermatologic Agents|dermatologic agents|mesh-ancestor
64302700|NCT03250143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64302701|NCT03250143|Antimetabolites|antimetabolites|mesh-ancestor
64302702|NCT03250143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64302703|NCT03250143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302704|NCT03073850|Anticoagulants|anticoagulants|mesh-list
64302705|NCT03073850|Edoxaban|edoxaban|mesh-list
64302706|NCT03073850|Clopidogrel|clopidogrel|mesh-list
64302707|NCT03073850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545076|NCT03159403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64545077|NCT03159403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64545078|NCT03583567|Chlorpheniramine|chlorpheniramine|mesh-list
64545079|NCT03583567|Ranitidine|ranitidine|mesh-list
64545080|NCT03583567|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
64545081|NCT03583567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64545082|NCT03583567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64545083|NCT03583567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64545084|NCT03583567|Histamine Antagonists|histamine antagonists|mesh-ancestor
64545085|NCT03583567|Histamine Agents|histamine agents|mesh-ancestor
64545086|NCT03583567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64545087|NCT03583567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545088|NCT03583567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545089|NCT03583567|Antipruritics|antipruritics|mesh-ancestor
64545090|NCT03583567|Dermatologic Agents|dermatologic agents|mesh-ancestor
64714165|NCT02831569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545091|NCT03583567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64545092|NCT03583567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64545093|NCT03583489|Ondansetron|ondansetron|mesh-list
64545094|NCT03583489|Antiemetics|antiemetics|mesh-ancestor
64545095|NCT03583489|Autonomic Agents|autonomic agents|mesh-ancestor
64545096|NCT03583489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64545097|NCT03583489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545110|NCT03158935|Aldesleukin|aldesleukin|mesh-list
64545111|NCT03158935|Cyclophosphamide|cyclophosphamide|mesh-list
64545112|NCT03158935|Pembrolizumab|pembrolizumab|mesh-list
64545113|NCT03158935|Fludarabine|fludarabine|mesh-list
64545114|NCT03158935|Interleukin-2|interleukin-2|mesh-list
64545115|NCT03158935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64545116|NCT03158935|Immunologic Factors|immunologic factors|mesh-ancestor
64545117|NCT03158935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545118|NCT03158935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64545119|NCT03158935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64545120|NCT03158935|Alkylating Agents|alkylating agents|mesh-ancestor
64545121|NCT03158935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545122|NCT03158935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545123|NCT03158935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64545124|NCT03158935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64545125|NCT03158935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64545126|NCT03158935|Analgesics|analgesics|mesh-ancestor
64545127|NCT03158935|Sensory System Agents|sensory system agents|mesh-ancestor
64545128|NCT03158935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64545129|NCT03158935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64545130|NCT03158935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64545131|NCT03158935|Antiviral Agents|antiviral agents|mesh-ancestor
64545132|NCT03158935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64545133|NCT04818372|Dexamethasone|dexamethasone|mesh-list
64545134|NCT04818372|Lenalidomide|lenalidomide|mesh-list
64545135|NCT04818372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64545136|NCT04818372|Antiemetics|antiemetics|mesh-ancestor
64545137|NCT04818372|Autonomic Agents|autonomic agents|mesh-ancestor
64545138|NCT04818372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64545139|NCT04818372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545140|NCT04818372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64545141|NCT04818372|Glucocorticoids|glucocorticoids|mesh-ancestor
64545142|NCT04818372|Hormones|hormones|mesh-ancestor
64545143|NCT04818372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64545144|NCT04818372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64545145|NCT04818372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545146|NCT04818372|Immunologic Factors|immunologic factors|mesh-ancestor
64545147|NCT04818372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64545148|NCT04818372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64545149|NCT04818372|Growth Substances|growth substances|mesh-ancestor
64545150|NCT04818372|Growth Inhibitors|growth inhibitors|mesh-ancestor
64545151|NCT05701189|Immunoglobulins|immunoglobulins|mesh-list
64545152|NCT05701189|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64545153|NCT05701189|Antibodies|antibodies|mesh-list
64545154|NCT05701189|gamma-Globulins|gamma-globulins|mesh-list
64545155|NCT05701189|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64545156|NCT05701189|Immunologic Factors|immunologic factors|mesh-ancestor
64545157|NCT05701189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545158|NCT01462578|Azacitidine|azacitidine|mesh-list
64545159|NCT01462578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64545160|NCT01462578|Antimetabolites|antimetabolites|mesh-ancestor
64545161|NCT01462578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545162|NCT01462578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545163|NCT01462578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545164|NCT03059173|Inositol|inositol|mesh-list
64545165|NCT03059173|Clomiphene|clomiphene|mesh-list
64545166|NCT03059173|Enclomiphene|enclomiphene|mesh-list
64545167|NCT03059173|Zuclomiphene|zuclomiphene|mesh-list
64545168|NCT03059173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64545170|NCT03059173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64545171|NCT03059173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545172|NCT03059173|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64545173|NCT03059173|Fertility Agents|fertility agents|mesh-ancestor
64545174|NCT03059173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64545175|NCT03059173|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64545176|NCT03059173|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64545177|NCT03059173|Vitamin B Complex|vitamin b complex|mesh-ancestor
64545178|NCT03059173|Vitamins|vitamins|mesh-ancestor
64545179|NCT03059173|Micronutrients|micronutrients|mesh-ancestor
64545192|NCT05122338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64545193|NCT05122338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545194|NCT05122338|Antidepressive Agents|antidepressive agents|mesh-ancestor
64545195|NCT05122338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64545196|NCT03157843|Heparin|heparin|mesh-list
64545197|NCT03157843|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64545198|NCT03157843|Tinzaparin|tinzaparin|mesh-list
64545199|NCT03157843|Dalteparin|dalteparin|mesh-list
64545200|NCT03157843|Anticoagulants|anticoagulants|mesh-ancestor
64545201|NCT03157843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64545202|NCT03157843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64545203|NCT03157843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545204|NCT03589027|Ritonavir|ritonavir|mesh-list
64545205|NCT03589027|Darunavir|darunavir|mesh-list
64545206|NCT03589027|Rilpivirine|rilpivirine|mesh-list
64545207|NCT03589027|Levonorgestrel|levonorgestrel|mesh-list
64545208|NCT03589027|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64545209|NCT03589027|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64545210|NCT03589027|Protease Inhibitors|protease inhibitors|mesh-ancestor
64545211|NCT03589027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545212|NCT03589027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545213|NCT03589027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64545214|NCT03589027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64545244|NCT03874494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64545245|NCT03874494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64545246|NCT03874494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64545247|NCT03156439|Huperzine A|huperzine a|mesh-list
64545248|NCT03156439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64545249|NCT03156439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545250|NCT03156439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545251|NCT03156439|Cholinergic Agents|cholinergic agents|mesh-ancestor
64545252|NCT03156439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64545253|NCT03156439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545254|NCT03156439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64545255|NCT03156439|Protective Agents|protective agents|mesh-ancestor
64545256|NCT04436328|Anti-Infective Agents|anti-infective agents|mesh-list
64545257|NCT04436328|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64545258|NCT03156361|Insulin|insulin|mesh-list
64545259|NCT03156361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64545260|NCT03156361|Insulin Lispro|insulin lispro|mesh-list
64545261|NCT03156361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64545262|NCT03156361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545263|NCT05002530|Vitamin D|vitamin d|mesh-list
64545264|NCT05002530|Ergocalciferols|ergocalciferols|mesh-list
64545265|NCT05002530|Cholecalciferol|cholecalciferol|mesh-list
64545266|NCT05002530|Vitamins|vitamins|mesh-list
64545267|NCT05002530|Tretinoin|tretinoin|mesh-list
64545268|NCT05002530|Isotretinoin|isotretinoin|mesh-list
64545269|NCT05002530|Micronutrients|micronutrients|mesh-ancestor
64545270|NCT05002530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545271|NCT05002530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64545272|NCT05002530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64545273|NCT05002530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545274|NCT05002530|Keratolytic Agents|keratolytic agents|mesh-ancestor
64545275|NCT05002530|Dermatologic Agents|dermatologic agents|mesh-ancestor
64545276|NCT03583021|Neostigmine|neostigmine|mesh-list
64978853|NCT00272896|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
64978854|NCT00272896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64978855|NCT00272896|Vasodilator Agents|vasodilator agents|mesh-ancestor
64978856|NCT00272896|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64978857|NCT00272896|Protective Agents|protective agents|mesh-ancestor
64978858|NCT00272896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978859|NCT00272935|Estrogens|estrogens|mesh-list
64978860|NCT00272935|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64978861|NCT00272935|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
64978862|NCT00272935|Hormones|hormones|mesh-ancestor
64545278|NCT03583021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545279|NCT03583021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545280|NCT03583021|Cholinergic Agents|cholinergic agents|mesh-ancestor
64545281|NCT03583021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64545282|NCT03583021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545283|NCT03583021|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64545284|NCT03583021|Autonomic Agents|autonomic agents|mesh-ancestor
64545285|NCT03583021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668497|NCT01691690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64668498|NCT01691690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64668499|NCT01691690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64668500|NCT01691690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64668501|NCT01691690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64668502|NCT01691690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64668503|NCT01691690|Anesthetics, General|anesthetics, general|mesh-ancestor
64668504|NCT01691690|Anesthetics|anesthetics|mesh-ancestor
64668505|NCT01691690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64300227|NCT02251171|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64300228|NCT02251171|Antitubercular Agents|antitubercular agents|mesh-ancestor
64545286|NCT04510194|Metformin|metformin|mesh-list
64545287|NCT04510194|Ivermectin|ivermectin|mesh-list
64545288|NCT04510194|Fluvoxamine|fluvoxamine|mesh-list
64545289|NCT04510194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64545290|NCT04510194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545291|NCT04510194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64545292|NCT04510194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64545293|NCT04510194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64545294|NCT04510194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64778186|NCT02304432|Renal Agents|renal agents|mesh-ancestor
64545295|NCT04510194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64545296|NCT04510194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64545297|NCT04510194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64545298|NCT04510194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64545299|NCT04510194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64545300|NCT04510194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545301|NCT04510194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64545302|NCT04510194|Serotonin Agents|serotonin agents|mesh-ancestor
64545303|NCT04510194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64545304|NCT04510194|Antidepressive Agents|antidepressive agents|mesh-ancestor
64545305|NCT04510194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64545306|NCT04510194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64545318|NCT03582319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64545319|NCT00307242|Adefovir|adefovir|mesh-list
64545320|NCT00307242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64545321|NCT00307242|Antiviral Agents|antiviral agents|mesh-ancestor
64545322|NCT00307242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64545323|NCT00307242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64545324|NCT00307242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64545325|NCT00307242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545326|NCT00307242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545327|NCT03155893|Moxifloxacin|moxifloxacin|mesh-list
64545328|NCT03155893|Adafosbuvir|adafosbuvir|mesh-list
64545329|NCT03155893|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64545330|NCT03155893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64545331|NCT03155893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64545332|NCT03155893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64545333|NCT03155893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64545334|NCT03155893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545335|NCT03155893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545336|NCT03155893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545337|NCT03155893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64545338|NCT03155893|Contraceptive Agents|contraceptive agents|mesh-ancestor
64545339|NCT03155893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64545360|NCT05698771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545361|NCT05698771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64545363|NCT05698771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545364|NCT05698771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64545365|NCT05698771|Vasodilator Agents|vasodilator agents|mesh-ancestor
64545366|NCT05698147|Rituximab|rituximab|mesh-list
64545367|NCT05698147|Methotrexate|methotrexate|mesh-list
64545368|NCT05698147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64545369|NCT05698147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545370|NCT05698147|Immunologic Factors|immunologic factors|mesh-ancestor
64545371|NCT05698147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545372|NCT05698147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64545373|NCT05698147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64545374|NCT05698147|Abortifacient Agents|abortifacient agents|mesh-ancestor
64545375|NCT05698147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64545376|NCT05698147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64545377|NCT05698147|Antimetabolites|antimetabolites|mesh-ancestor
64545378|NCT05698147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545379|NCT05698147|Dermatologic Agents|dermatologic agents|mesh-ancestor
64545380|NCT05698147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545381|NCT05698147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64714166|NCT02831569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64545382|NCT05698147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64545383|NCT05698147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64545384|NCT03156907|Buprenorphine|buprenorphine|mesh-list
64545385|NCT03156907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64310201|NCT04899674|Dopamine Agents|dopamine agents|mesh-ancestor
64978863|NCT00272935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64978892|NCT00107874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978894|NCT00107874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64978895|NCT00107874|Oxytocics|oxytocics|mesh-ancestor
64978896|NCT00074828|Enoxaparin|enoxaparin|mesh-list
64978897|NCT00074828|Anticoagulants|anticoagulants|mesh-ancestor
64978898|NCT00074828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64978899|NCT00074828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64978900|NCT00074828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978901|NCT00273247|Interferons|interferons|mesh-list
64978902|NCT00273247|Interferon-alpha|interferon-alpha|mesh-list
64978903|NCT00273247|Interferon alpha-2|interferon alpha-2|mesh-list
64978904|NCT00273247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978955|NCT00273559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978956|NCT00273559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64978957|NCT00273559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545386|NCT03156907|Narcotics|narcotics|mesh-ancestor
64545387|NCT03156907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64545388|NCT03156907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545389|NCT03156907|Analgesics|analgesics|mesh-ancestor
64545390|NCT03156907|Sensory System Agents|sensory system agents|mesh-ancestor
64545391|NCT03156907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64545392|NCT03156907|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64300242|NCT03293277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64300243|NCT03293277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64300244|NCT03293277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64300245|NCT03293277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64300246|NCT03293277|Adrenergic Agents|adrenergic agents|mesh-ancestor
64545394|NCT03156829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64545395|NCT03156829|Glucocorticoids|glucocorticoids|mesh-ancestor
64545396|NCT03156829|Hormones|hormones|mesh-ancestor
64545397|NCT03156829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64545398|NCT03156829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545399|NCT03156829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64545400|NCT03156829|Respiratory System Agents|respiratory system agents|mesh-ancestor
64545401|NCT04319328|Ciprofloxacin|ciprofloxacin|mesh-list
64545402|NCT04319328|Cefazolin|cefazolin|mesh-list
64545403|NCT04319328|Ceftazidime|ceftazidime|mesh-list
64545404|NCT04319328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64545405|NCT04319328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64545406|NCT04319328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64545407|NCT04319328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64545408|NCT04319328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545409|NCT04319328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545410|NCT04319328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545411|NCT04319328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64545412|NCT04319328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64545413|NCT05229510|Ribavirin|ribavirin|mesh-list
64545414|NCT05229510|Antimetabolites|antimetabolites|mesh-ancestor
64545415|NCT05229510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545416|NCT05229510|Antiviral Agents|antiviral agents|mesh-ancestor
64545417|NCT05229510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64545418|NCT05229276|Bone wax|bone wax|mesh-list
64545419|NCT05229276|Hemostatics|hemostatics|mesh-ancestor
64545420|NCT05229276|Coagulants|coagulants|mesh-ancestor
64545421|NCT03581773|Folic Acid|folic acid|mesh-list
64978958|NCT00273676|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64978959|NCT00273676|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64978960|NCT00273676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64978961|NCT00273676|Antitubercular Agents|antitubercular agents|mesh-ancestor
64545422|NCT03581773|Hematinics|hematinics|mesh-ancestor
64545423|NCT03581773|Vitamin B Complex|vitamin b complex|mesh-ancestor
64545424|NCT03581773|Vitamins|vitamins|mesh-ancestor
64389641|NCT03574571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64389642|NCT03574571|Tubulin Modulators|tubulin modulators|mesh-ancestor
64389643|NCT03574571|Antimitotic Agents|antimitotic agents|mesh-ancestor
64389644|NCT03574571|Mitosis Modulators|mitosis modulators|mesh-ancestor
64545425|NCT03581773|Micronutrients|micronutrients|mesh-ancestor
64545426|NCT03581773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545427|NCT04425174|Anesthetics|anesthetics|mesh-list
64545428|NCT04425174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64545429|NCT04425174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545430|NCT05119452|Adalimumab|adalimumab|mesh-list
64545431|NCT05119452|Etanercept|etanercept|mesh-list
64545432|NCT05119452|Golimumab|golimumab|mesh-list
64545433|NCT05119452|Infliximab|infliximab|mesh-list
64545434|NCT05119452|Certolizumab Pegol|certolizumab pegol|mesh-list
64545435|NCT05119452|Antirheumatic Agents|antirheumatic agents|mesh-list
64545436|NCT05119452|Tofacitinib|tofacitinib|mesh-list
64778203|NCT02314104|Anesthetics, Local|anesthetics, local|mesh-ancestor
64778204|NCT02314104|Anesthetics|anesthetics|mesh-ancestor
64302738|NCT03070574|Antitubercular Agents|antitubercular agents|mesh-ancestor
64302739|NCT03070574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64302740|NCT03070574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64302741|NCT03257241|Cytarabine|cytarabine|mesh-list
64302742|NCT03257241|Fludarabine|fludarabine|mesh-list
64302743|NCT03257241|Daunorubicin|daunorubicin|mesh-list
64302744|NCT03257241|Mitoxantrone|mitoxantrone|mesh-list
64302745|NCT03257241|Idarubicin|idarubicin|mesh-list
64302746|NCT03257241|Cladribine|cladribine|mesh-list
64302747|NCT03257241|Lenograstim|lenograstim|mesh-list
64302748|NCT03257241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302749|NCT03257241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64545437|NCT05119452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64545438|NCT05119452|Dermatologic Agents|dermatologic agents|mesh-ancestor
64545439|NCT05119452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64545440|NCT05119452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64545441|NCT05119452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64545442|NCT05119452|Analgesics|analgesics|mesh-ancestor
64545443|NCT05119452|Sensory System Agents|sensory system agents|mesh-ancestor
64545452|NCT02788591|Esomeprazole|esomeprazole|mesh-list
64300257|NCT02108743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64300258|NCT02108743|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64300259|NCT02108743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64300260|NCT02108743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64300261|NCT02108743|Adrenergic Agents|adrenergic agents|mesh-ancestor
64300262|NCT02108743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64435192|NCT02337491|Bevacizumab|bevacizumab|mesh-list
64545478|NCT03076164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545479|NCT03076164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545480|NCT01670773|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
64545481|NCT01670773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64545482|NCT01670773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64545483|NCT01670773|Analgesics|analgesics|mesh-ancestor
64545484|NCT01670773|Sensory System Agents|sensory system agents|mesh-ancestor
64545485|NCT01670773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64545486|NCT01670773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545487|NCT01670773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64545488|NCT01670773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64545489|NCT05228418|Naltrexone|naltrexone|mesh-list
64545490|NCT05228418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64545491|NCT05228418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64545492|NCT05228418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545493|NCT05228418|Sensory System Agents|sensory system agents|mesh-ancestor
64545494|NCT05228418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64545495|NCT01676233|Insulin|insulin|mesh-list
64545496|NCT01676233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64545497|NCT01676233|Insulin Glargine|insulin glargine|mesh-list
64545498|NCT01676233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64545499|NCT01676233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545500|NCT01670929|Progesterone|progesterone|mesh-list
64545501|NCT01670929|Progestins|progestins|mesh-ancestor
64545502|NCT01670929|Hormones|hormones|mesh-ancestor
64545503|NCT01670929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64545528|NCT05633563|Vasodilator Agents|vasodilator agents|mesh-ancestor
64545529|NCT04746937|Nitazoxanide|nitazoxanide|mesh-list
64545530|NCT04746937|Norfloxacin|norfloxacin|mesh-list
64545531|NCT04746937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64545532|NCT04746937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64545533|NCT04746937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64545534|NCT04746937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64545535|NCT04746937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64545536|NCT04746937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545537|NCT04746937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545538|NCT04746937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545539|NCT04746937|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64778207|NCT02314104|Sensory System Agents|sensory system agents|mesh-ancestor
64300263|NCT02108743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300265|NCT03292965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64300266|NCT03292965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300267|NCT03292965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300268|NCT03292965|Cholinergic Agents|cholinergic agents|mesh-ancestor
64300269|NCT03292965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64300270|NCT03292965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300271|NCT03292965|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64300272|NCT03292965|Autonomic Agents|autonomic agents|mesh-ancestor
64300273|NCT03292965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64300274|NCT05032118|Ketamine|ketamine|mesh-list
64300275|NCT05032118|Propofol|propofol|mesh-list
64300276|NCT05032118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64545541|NCT05220319|Methylprednisolone|methylprednisolone|mesh-list
64545542|NCT05220319|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64545543|NCT05220319|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64545544|NCT05220319|Prednisolone|prednisolone|mesh-list
64545545|NCT05220319|Prednisolone acetate|prednisolone acetate|mesh-list
64545546|NCT05220319|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64545547|NCT05220319|Prednisolone phosphate|prednisolone phosphate|mesh-list
64545548|NCT05220319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64545549|NCT05220319|Antiemetics|antiemetics|mesh-ancestor
64545550|NCT05220319|Autonomic Agents|autonomic agents|mesh-ancestor
64545551|NCT05220319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64545552|NCT05220319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545553|NCT05220319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64978962|NCT00273871|Cyclosporine|cyclosporine|mesh-list
64978963|NCT00273871|Tacrolimus|tacrolimus|mesh-list
64978964|NCT00273871|Cyclosporins|cyclosporins|mesh-list
64978965|NCT00273871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64978966|NCT00273871|Immunologic Factors|immunologic factors|mesh-ancestor
64978967|NCT00273871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978968|NCT00273871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64978969|NCT00273871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978970|NCT00273871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978971|NCT00273871|Antifungal Agents|antifungal agents|mesh-ancestor
64978972|NCT00273871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64978973|NCT00273871|Dermatologic Agents|dermatologic agents|mesh-ancestor
64978974|NCT00273871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64978975|NCT00273949|Lactulose|lactulose|mesh-list
64978976|NCT00273949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64978977|NCT00273988|Nevirapine|nevirapine|mesh-list
64978978|NCT00273988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64978979|NCT00273988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64978980|NCT00273988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978981|NCT00273988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978982|NCT00273988|Antiviral Agents|antiviral agents|mesh-ancestor
64545558|NCT05220319|Protective Agents|protective agents|mesh-ancestor
64545559|NCT05220319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64545560|NCT05220319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545567|NCT03155035|Albendazole|albendazole|mesh-list
64545568|NCT03155035|Calcium|calcium|mesh-list
64545569|NCT03155035|Vitamins|vitamins|mesh-ancestor
64545570|NCT03155035|Micronutrients|micronutrients|mesh-ancestor
64545571|NCT03155035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545572|NCT03155035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64545573|NCT03155035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64545574|NCT03155035|Anthelmintics|anthelmintics|mesh-ancestor
64545575|NCT03155035|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64545576|NCT03155035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64545577|NCT03155035|Anticestodal Agents|anticestodal agents|mesh-ancestor
64545578|NCT03155035|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64545579|NCT03155035|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64545580|NCT03155035|Tubulin Modulators|tubulin modulators|mesh-ancestor
64545581|NCT03155035|Antimitotic Agents|antimitotic agents|mesh-ancestor
64545582|NCT03155035|Mitosis Modulators|mitosis modulators|mesh-ancestor
64545583|NCT03155035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300287|NCT05032118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64300288|NCT05032118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64300289|NCT05032118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435265|NCT02362451|Immunologic Factors|immunologic factors|mesh-ancestor
64435266|NCT02362451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435269|NCT01765270|Hormones|hormones|mesh-ancestor
64545584|NCT03155035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310395|NCT03051698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64978983|NCT00273988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64978984|NCT00273988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64978985|NCT00273988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64978986|NCT00273988|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64978987|NCT00273988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64978988|NCT00274027|Bromides|bromides|mesh-list
64978989|NCT00274027|Tiotropium Bromide|tiotropium bromide|mesh-list
64978990|NCT00274027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64545586|NCT04497870|Menthol|menthol|mesh-list
64545587|NCT04497870|Antipruritics|antipruritics|mesh-ancestor
64545588|NCT04497870|Dermatologic Agents|dermatologic agents|mesh-ancestor
64545589|NCT04497870|Antiemetics|antiemetics|mesh-ancestor
64545590|NCT04497870|Autonomic Agents|autonomic agents|mesh-ancestor
64545591|NCT04497870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64545592|NCT04497870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545593|NCT04497870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64545594|NCT04497870|Parasympatholytics|parasympatholytics|mesh-ancestor
64545595|NCT03154723|Vitamin A|vitamin a|mesh-list
64545596|NCT03154723|Vitamins|vitamins|mesh-ancestor
64545597|NCT03154723|Micronutrients|micronutrients|mesh-ancestor
64545598|NCT03154723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545599|NCT04080908|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64545600|NCT04080908|Hematinics|hematinics|mesh-ancestor
64545601|NCT04080908|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64545602|NCT04080908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64545603|NCT02653482|Dapagliflozin|dapagliflozin|mesh-list
64545604|NCT02653482|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64545605|NCT02653482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545606|NCT02653482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64545607|NCT02653482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545608|NCT03154567|Yohimbine|yohimbine|mesh-list
64545609|NCT03154567|Mydriatics|mydriatics|mesh-ancestor
64545610|NCT03154567|Autonomic Agents|autonomic agents|mesh-ancestor
64545611|NCT03154567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64501683|NCT01585324|Ribavirin|ribavirin|mesh-list
64545635|NCT03154645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545636|NCT03154645|Anticonvulsants|anticonvulsants|mesh-ancestor
64545637|NCT03154645|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64545638|NCT03154645|Diuretics|diuretics|mesh-ancestor
64545639|NCT03154645|Natriuretic Agents|natriuretic agents|mesh-ancestor
64545640|NCT01631292|Vitamin D|vitamin d|mesh-list
64300290|NCT05024084|Anesthetics|anesthetics|mesh-list
64300291|NCT05024084|Sevoflurane|sevoflurane|mesh-list
64300292|NCT05024084|Desflurane|desflurane|mesh-list
64300293|NCT05024084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64300294|NCT05024084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300295|NCT05024084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64300296|NCT05024084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64300297|NCT05024084|Anesthetics, General|anesthetics, general|mesh-ancestor
64300298|NCT02109289|Etanercept|etanercept|mesh-list
64300299|NCT02109289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64300300|NCT02109289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64300301|NCT02109289|Analgesics|analgesics|mesh-ancestor
64300302|NCT02109289|Sensory System Agents|sensory system agents|mesh-ancestor
64300303|NCT02109289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64300304|NCT02109289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545641|NCT01631292|Ergocalciferols|ergocalciferols|mesh-list
64545642|NCT01631292|Cholecalciferol|cholecalciferol|mesh-list
64545644|NCT01631292|Micronutrients|micronutrients|mesh-ancestor
64545645|NCT01631292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545646|NCT01631292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64545647|NCT01631292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64545648|NCT01671709|Montelukast|montelukast|mesh-list
64545649|NCT01671709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64545650|NCT01671709|Respiratory System Agents|respiratory system agents|mesh-ancestor
64545651|NCT01671709|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64545652|NCT01671709|Hormone Antagonists|hormone antagonists|mesh-ancestor
64545653|NCT01671709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64545654|NCT01671709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545655|NCT01671709|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64545656|NCT01671709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64545657|NCT01671709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545659|NCT05222256|Epinephrine|epinephrine|mesh-list
64545660|NCT05222256|Racepinephrine|racepinephrine|mesh-list
64545661|NCT05222256|Epinephryl borate|epinephryl borate|mesh-list
64545662|NCT05222256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64545663|NCT05222256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64545664|NCT05222256|Adrenergic Agents|adrenergic agents|mesh-ancestor
64545665|NCT05222256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64545666|NCT05222256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545667|NCT05222256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545674|NCT05222256|Mydriatics|mydriatics|mesh-ancestor
64545676|NCT05222256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64545677|NCT05222256|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64545678|NCT05222256|Vasodilator Agents|vasodilator agents|mesh-ancestor
64545679|NCT05222256|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64545680|NCT05222256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64545681|NCT05222256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545682|NCT05222256|Protective Agents|protective agents|mesh-ancestor
64545684|NCT01671787|Antiviral Agents|antiviral agents|mesh-ancestor
64545685|NCT01671787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64545686|NCT01671787|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64714167|NCT02831569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64545687|NCT01671787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64545688|NCT01671787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545689|NCT01671787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545690|NCT01671787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64545691|NCT01671787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64545692|NCT01362348|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64545693|NCT01362348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64545694|NCT03154489|Acenocoumarol|acenocoumarol|mesh-list
64545695|NCT03154489|Anticoagulants|anticoagulants|mesh-ancestor
64545696|NCT00698022|Risperidone|risperidone|mesh-list
64545697|NCT00698022|Mifepristone|mifepristone|mesh-list
64545698|NCT00698022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64545699|NCT00698022|Serotonin Agents|serotonin agents|mesh-ancestor
64545700|NCT00698022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64545701|NCT00698022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545702|NCT00698022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545703|NCT00698022|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64545704|NCT00698022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64545705|NCT00698022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64545706|NCT00698022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64545707|NCT00698022|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64545708|NCT00698022|Dopamine Agents|dopamine agents|mesh-ancestor
64545709|NCT00698022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64545710|NCT00698022|Abortifacient Agents|abortifacient agents|mesh-ancestor
64545714|NCT00698022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64545715|NCT00698022|Contraceptive Agents|contraceptive agents|mesh-ancestor
64545716|NCT00698022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64545717|NCT00698022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64545718|NCT00698022|Hormone Antagonists|hormone antagonists|mesh-ancestor
64545719|NCT00698022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64545720|NCT00698022|Luteolytic Agents|luteolytic agents|mesh-ancestor
64545721|NCT00698022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64545722|NCT00698022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64545723|NCT02570503|Ketorolac|ketorolac|mesh-list
64545724|NCT02570503|Clonidine|clonidine|mesh-list
64545725|NCT02570503|Epinephrine|epinephrine|mesh-list
64545726|NCT02570503|Ropivacaine|ropivacaine|mesh-list
64778267|NCT02343276|Vasodilator Agents|vasodilator agents|mesh-ancestor
64778268|NCT02348658|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
64778269|NCT02348658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64778270|NCT02348658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64778271|NCT02348658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389704|NCT04996199|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64302865|NCT02634320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64302866|NCT02634320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64302868|NCT02435680|Carboplatin|carboplatin|mesh-list
64302879|NCT04988048|Vaccines|vaccines|mesh-list
64545727|NCT02570503|Anesthetics, Local|anesthetics, local|mesh-ancestor
64545728|NCT02570503|Anesthetics|anesthetics|mesh-ancestor
64545729|NCT02570503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64545730|NCT02570503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545731|NCT02570503|Sensory System Agents|sensory system agents|mesh-ancestor
64545732|NCT02570503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64545733|NCT02570503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64545734|NCT02570503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64545735|NCT02570503|Adrenergic Agents|adrenergic agents|mesh-ancestor
64545736|NCT02570503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64545737|NCT02570503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300308|NCT02109289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64300309|NCT02109289|Immunologic Factors|immunologic factors|mesh-ancestor
64300310|NCT03292731|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
64300311|NCT03292731|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
64300312|NCT03292731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64300313|NCT03292731|Hormone Antagonists|hormone antagonists|mesh-ancestor
64545739|NCT02570503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64545740|NCT02570503|Autonomic Agents|autonomic agents|mesh-ancestor
64545741|NCT02570503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64545759|NCT02492269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545760|NCT02492269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64501830|NCT05609253|Antifungal Agents|antifungal agents|mesh-ancestor
64545762|NCT02492269|Sensory System Agents|sensory system agents|mesh-ancestor
64545763|NCT02492269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64545764|NCT02492269|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64545765|NCT02492269|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64545766|NCT02492269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64545767|NCT02492269|Adrenergic Agents|adrenergic agents|mesh-ancestor
64545768|NCT02492269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64545769|NCT02492269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545770|NCT05561179|Hyaluronic Acid|hyaluronic acid|mesh-list
64545771|NCT05561179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64545772|NCT05561179|Immunologic Factors|immunologic factors|mesh-ancestor
64545773|NCT05561179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545774|NCT05561179|Viscosupplements|viscosupplements|mesh-ancestor
64545775|NCT05561179|Protective Agents|protective agents|mesh-ancestor
64545777|NCT02467153|Cholecalciferol|cholecalciferol|mesh-list
64545778|NCT02467153|Vitamins|vitamins|mesh-ancestor
64545779|NCT02467153|Micronutrients|micronutrients|mesh-ancestor
64545780|NCT02467153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545781|NCT02467153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64545782|NCT02467153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64978991|NCT00274027|Autonomic Agents|autonomic agents|mesh-ancestor
64978992|NCT00274027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64978993|NCT00274027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978994|NCT00274027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64979025|NCT00274066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64300351|NCT02251249|Sensory System Agents|sensory system agents|mesh-ancestor
64300352|NCT02251249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64389708|NCT04996199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64300353|NCT02251249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300354|NCT02251249|Antipyretics|antipyretics|mesh-ancestor
64300355|NCT05017766|Anti-Infective Agents|anti-infective agents|mesh-list
64300356|NCT05017766|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64300357|NCT03292263|Nivolumab|nivolumab|mesh-list
64300358|NCT03292263|Melphalan|melphalan|mesh-list
64300359|NCT03292263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64300360|NCT03292263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64300361|NCT03292263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64300362|NCT03292263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300363|NCT03292263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64300364|NCT03292263|Alkylating Agents|alkylating agents|mesh-ancestor
64300365|NCT03292263|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64300366|NCT03292263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64300367|NCT03292263|Immunologic Factors|immunologic factors|mesh-ancestor
64300368|NCT03292263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300369|NCT02115763|Caffeine|caffeine|mesh-list
64979027|NCT00274066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64979028|NCT00274066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64979029|NCT00274066|Adrenergic Agents|adrenergic agents|mesh-ancestor
64979030|NCT00274105|Telmisartan|telmisartan|mesh-list
64979031|NCT00274105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64979032|NCT00274105|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64979033|NCT00274105|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64979034|NCT00274105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979035|NCT00274144|Telmisartan|telmisartan|mesh-list
64979036|NCT00274144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64979037|NCT00274144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64979057|NCT00274339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979058|NCT00274339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979059|NCT00075179|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64979060|NCT00075179|Natriuretic Agents|natriuretic agents|mesh-ancestor
64979061|NCT00075179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979062|NCT00416650|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64545783|NCT04933903|Nivolumab|nivolumab|mesh-list
64545784|NCT04933903|Ipilimumab|ipilimumab|mesh-list
64545785|NCT04933903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64545786|NCT04933903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545787|NCT04933903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64545788|NCT04933903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545789|NCT03153163|Trastuzumab|trastuzumab|mesh-list
64545790|NCT03153163|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64545791|NCT03153163|Maytansine|maytansine|mesh-list
64545792|NCT03153163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64545793|NCT03153163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545794|NCT03153163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64389714|NCT02432833|Tacrolimus|tacrolimus|mesh-list
64545795|NCT03153163|Tubulin Modulators|tubulin modulators|mesh-ancestor
64545796|NCT03153163|Antimitotic Agents|antimitotic agents|mesh-ancestor
64545797|NCT03153163|Mitosis Modulators|mitosis modulators|mesh-ancestor
64545798|NCT03153163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545799|NCT03153085|Ipilimumab|ipilimumab|mesh-list
64545800|NCT03153085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64545801|NCT03153085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545802|NCT03153085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64545803|NCT03153085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545804|NCT03589339|Pembrolizumab|pembrolizumab|mesh-list
64545805|NCT03589339|Nivolumab|nivolumab|mesh-list
64545806|NCT03589339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64545807|NCT03589339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545808|NCT03589339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64545809|NCT03589339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545810|NCT05391061|Abrocitinib|abrocitinib|mesh-list
64545811|NCT05391061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64545825|NCT02626507|Fulvestrant|fulvestrant|mesh-list
64545826|NCT02626507|Goserelin|goserelin|mesh-list
64545827|NCT02626507|Palbociclib|palbociclib|mesh-list
64545828|NCT02626507|Gedatolisib|gedatolisib|mesh-list
64545829|NCT02626507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64545830|NCT02626507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545831|NCT02626507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64545832|NCT02626507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64545833|NCT02626507|Hormone Antagonists|hormone antagonists|mesh-ancestor
64714168|NCT02831569|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64545834|NCT02626507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64545835|NCT02626507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545836|NCT02626507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64545837|NCT02626507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545838|NCT02626507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545839|NCT03413995|Rucaparib|rucaparib|mesh-list
64545840|NCT03413995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64545841|NCT03413995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545842|NCT03413995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545843|NCT03413995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545844|NCT04508244|Propranolol|propranolol|mesh-list
64545845|NCT04508244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64545854|NCT03243175|Apixaban|apixaban|mesh-list
64545873|NCT03126331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64545874|NCT03126331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545875|NCT01674127|Methyldopa|methyldopa|mesh-list
64545876|NCT01674127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64545877|NCT01674127|Sympatholytics|sympatholytics|mesh-ancestor
64545878|NCT01674127|Autonomic Agents|autonomic agents|mesh-ancestor
64545879|NCT01674127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64545880|NCT01674127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545881|NCT01674127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64545882|NCT01674127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64545883|NCT01674127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64545884|NCT01674127|Adrenergic Agents|adrenergic agents|mesh-ancestor
64545885|NCT01674127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64545886|NCT01674127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545888|NCT02081443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64545889|NCT02081443|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64545890|NCT02081443|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64545891|NCT02081443|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64545892|NCT02081443|Purinergic Agents|purinergic agents|mesh-ancestor
64545893|NCT02081443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64545894|NCT02081443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545895|NCT02081443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545896|NCT01674205|Vaccines|vaccines|mesh-list
64545897|NCT01674205|Immunologic Factors|immunologic factors|mesh-ancestor
64545898|NCT01674205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545899|NCT02646475|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
64545900|NCT02646475|Angiotensin II|angiotensin ii|mesh-list
64545901|NCT02646475|Angiotensinogen|angiotensinogen|mesh-list
64545902|NCT02646475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64545903|NCT02646475|Vasodilator Agents|vasodilator agents|mesh-ancestor
64545904|NCT02646475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64545906|NCT02646475|Protease Inhibitors|protease inhibitors|mesh-ancestor
64545921|NCT01674517|Montelukast|montelukast|mesh-list
64545922|NCT01674517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64545923|NCT01674517|Respiratory System Agents|respiratory system agents|mesh-ancestor
64545924|NCT01674517|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64545925|NCT01674517|Hormone Antagonists|hormone antagonists|mesh-ancestor
64545926|NCT01674517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64545927|NCT01674517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545928|NCT01674517|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64545929|NCT01674517|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64545930|NCT01674517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545931|NCT01923649|Lanreotide|lanreotide|mesh-list
64545932|NCT01923649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545933|NCT01670071|Risperidone|risperidone|mesh-list
64300371|NCT02115763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300372|NCT02115763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64545934|NCT01670071|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64545935|NCT01670071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64545936|NCT01670071|Serotonin Agents|serotonin agents|mesh-ancestor
64545937|NCT01670071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64545938|NCT01670071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545939|NCT01670071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545940|NCT01670071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64545941|NCT01670071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64545942|NCT01670071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64545943|NCT01670071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64545944|NCT01670071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64545945|NCT01670071|Dopamine Agents|dopamine agents|mesh-ancestor
64545946|NCT01670071|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64545947|NCT01670071|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64545949|NCT01427309|Immunologic Factors|immunologic factors|mesh-ancestor
64545971|NCT03855007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64545973|NCT03855007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64545974|NCT03855007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64545975|NCT03855007|Antimetabolites|antimetabolites|mesh-ancestor
64545976|NCT03855007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545977|NCT03855007|Dermatologic Agents|dermatologic agents|mesh-ancestor
64545978|NCT03855007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64545979|NCT03855007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64545980|NCT03855007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64545981|NCT03855007|Immunologic Factors|immunologic factors|mesh-ancestor
64545982|NCT03855007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64545983|NCT03855007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64545984|NCT03855007|Antimalarials|antimalarials|mesh-ancestor
64545985|NCT03855007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64545986|NCT03855007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64545987|NCT03855007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64545988|NCT03852901|Empagliflozin|empagliflozin|mesh-list
64545989|NCT03852901|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64545990|NCT03852901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64545991|NCT03852901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64545992|NCT03852901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64545993|NCT01675999|Leucovorin|leucovorin|mesh-list
64545994|NCT01675999|Cetuximab|cetuximab|mesh-list
64545995|NCT01675999|Fluorouracil|fluorouracil|mesh-list
64545996|NCT01675999|Oxaliplatin|oxaliplatin|mesh-list
64545997|NCT01675999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64545998|NCT01675999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64545999|NCT01675999|Antimetabolites|antimetabolites|mesh-ancestor
64546000|NCT01675999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778303|NCT02355210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64546001|NCT01675999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64546002|NCT01675999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64546003|NCT01675999|Immunologic Factors|immunologic factors|mesh-ancestor
64979063|NCT00416650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979064|NCT00416650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64979065|NCT00416650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979066|NCT00416650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979067|NCT00274417|Dutasteride|dutasteride|mesh-list
64546004|NCT01675999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546006|NCT01675999|Protective Agents|protective agents|mesh-ancestor
64546007|NCT01675999|Vitamin B Complex|vitamin b complex|mesh-ancestor
64546008|NCT01675999|Vitamins|vitamins|mesh-ancestor
64546009|NCT01675999|Micronutrients|micronutrients|mesh-ancestor
64546010|NCT01425359|Ranolazine|ranolazine|mesh-list
64546011|NCT01425359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64546012|NCT01425359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64546013|NCT01425359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546014|NCT04404361|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
64546015|NCT04404361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64546016|NCT04404361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546017|NCT04404361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546018|NCT03875755|Inositol|inositol|mesh-list
64546019|NCT03875755|Vitamin B Complex|vitamin b complex|mesh-ancestor
64546020|NCT03875755|Vitamins|vitamins|mesh-ancestor
64546021|NCT03875755|Micronutrients|micronutrients|mesh-ancestor
64546022|NCT03875755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546023|NCT04404751|Folic Acid|folic acid|mesh-list
64546063|NCT03841357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546065|NCT04115748|Adalimumab|adalimumab|mesh-list
64546066|NCT04115748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64546067|NCT04115748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64546068|NCT03838159|Paclitaxel|paclitaxel|mesh-list
64546069|NCT03838159|Carboplatin|carboplatin|mesh-list
64546070|NCT03838159|Nivolumab|nivolumab|mesh-list
64546071|NCT03838159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64546072|NCT03838159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546073|NCT03838159|Tubulin Modulators|tubulin modulators|mesh-ancestor
64546074|NCT03838159|Antimitotic Agents|antimitotic agents|mesh-ancestor
64546075|NCT03838159|Mitosis Modulators|mitosis modulators|mesh-ancestor
64546076|NCT03838159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546077|NCT03838159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64546078|NCT03838159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64546079|NCT04747015|Oxytocin|oxytocin|mesh-list
64546080|NCT04747015|Oxytocics|oxytocics|mesh-ancestor
64546081|NCT04747015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64546082|NCT04747015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546083|NCT03754933|Fludarabine|fludarabine|mesh-list
64546084|NCT03754933|Fludarabine phosphate|fludarabine phosphate|mesh-list
64546085|NCT03754933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546086|NCT03754933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64546087|NCT03754933|Antimetabolites|antimetabolites|mesh-ancestor
64546088|NCT03754933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546113|NCT02082769|Antimetabolites|antimetabolites|mesh-ancestor
64300389|NCT05017454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300391|NCT05017454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64300392|NCT05017454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300393|NCT05017454|Antimanic Agents|antimanic agents|mesh-ancestor
64300394|NCT05017454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64300395|NCT05017454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64300396|NCT05017454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64300397|NCT03292185|Insulin|insulin|mesh-list
64300398|NCT03292185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64300399|NCT03292185|Liraglutide|liraglutide|mesh-list
64300400|NCT03292185|Insulin, Long-Acting|insulin, long-acting|mesh-list
64546114|NCT02082769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546115|NCT02082769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546116|NCT02082769|Gout Suppressants|gout suppressants|mesh-ancestor
64546117|NCT02082769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64546118|NCT02082769|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64546119|NCT02082769|Antioxidants|antioxidants|mesh-ancestor
64546120|NCT02082769|Protective Agents|protective agents|mesh-ancestor
64546121|NCT02082769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546123|NCT03751423|Ketamine|ketamine|mesh-list
64546124|NCT03751423|Morphine|morphine|mesh-list
64546125|NCT03751423|Analgesics|analgesics|mesh-ancestor
64546126|NCT03751423|Sensory System Agents|sensory system agents|mesh-ancestor
64546127|NCT03751423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64546128|NCT03751423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546129|NCT03751423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64546130|NCT03751423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64546131|NCT03751423|Anesthetics, General|anesthetics, general|mesh-ancestor
64546132|NCT03751423|Anesthetics|anesthetics|mesh-ancestor
64546133|NCT03751423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64546134|NCT03751423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64546135|NCT03751423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64546136|NCT03751423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64546137|NCT03751423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546138|NCT03751423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64546139|NCT03751423|Narcotics|narcotics|mesh-ancestor
64546140|NCT03751423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64546141|NCT03745729|Allopurinol|allopurinol|mesh-list
64546142|NCT03745729|Antimetabolites|antimetabolites|mesh-ancestor
64546143|NCT03745729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546159|NCT04904952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546160|NCT04904952|Protective Agents|protective agents|mesh-ancestor
64546161|NCT04904952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546162|NCT04904952|Antidotes|antidotes|mesh-ancestor
64546163|NCT03661411|Aspirin|aspirin|mesh-list
64546164|NCT03661411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64546165|NCT03661411|Clopidogrel|clopidogrel|mesh-list
64546166|NCT03661411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64546167|NCT03661411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64546168|NCT03661411|Analgesics|analgesics|mesh-ancestor
64546169|NCT03661411|Sensory System Agents|sensory system agents|mesh-ancestor
64300411|NCT04239339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300412|NCT04239339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64300413|NCT04239339|Serotonin Agents|serotonin agents|mesh-ancestor
64300414|NCT04239339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300415|NCT04239339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64300416|NCT04239339|Antidepressive Agents|antidepressive agents|mesh-ancestor
64300418|NCT02109679|Metformin|metformin|mesh-list
64300419|NCT02109679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64300420|NCT02109679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300421|NCT05023304|Prednisolone|prednisolone|mesh-list
64546171|NCT03661411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546172|NCT03661411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64546173|NCT03661411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64546174|NCT03661411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64546175|NCT03661411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64778323|NCT02359110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64546176|NCT03661411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546177|NCT03661411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64546178|NCT03661411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64546179|NCT03661411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546181|NCT03661411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64546182|NCT03661411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64546183|NCT03661411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64546184|NCT03661411|Purinergic Agents|purinergic agents|mesh-ancestor
64546185|NCT03661411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64546186|NCT03742297|Dexamethasone|dexamethasone|mesh-list
64546187|NCT03742297|Prednisone|prednisone|mesh-list
64546188|NCT03742297|Lenalidomide|lenalidomide|mesh-list
64546189|NCT03742297|Bortezomib|bortezomib|mesh-list
64546190|NCT03742297|Melphalan|melphalan|mesh-list
64546191|NCT03742297|Daratumumab|daratumumab|mesh-list
64546192|NCT03742297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64311026|NCT02086097|Ibuprofen|ibuprofen|mesh-list
64979068|NCT00274417|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64979069|NCT00274417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64979070|NCT00274417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979071|NCT00274417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546193|NCT03742297|Antiemetics|antiemetics|mesh-ancestor
64546194|NCT03742297|Autonomic Agents|autonomic agents|mesh-ancestor
64546195|NCT03742297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64546196|NCT03742297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546197|NCT03742297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64300441|NCT02109913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64300442|NCT02116231|Cisplatin|cisplatin|mesh-list
64546198|NCT03742297|Glucocorticoids|glucocorticoids|mesh-ancestor
64546199|NCT03742297|Hormones|hormones|mesh-ancestor
64546200|NCT03742297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64546201|NCT03742297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64546202|NCT03742297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546203|NCT03742297|Immunologic Factors|immunologic factors|mesh-ancestor
64546204|NCT03742297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64546205|NCT03742297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64546206|NCT03742297|Growth Substances|growth substances|mesh-ancestor
64546207|NCT03742297|Growth Inhibitors|growth inhibitors|mesh-ancestor
64546208|NCT03742297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64546209|NCT03742297|Alkylating Agents|alkylating agents|mesh-ancestor
64546210|NCT03742297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546211|NCT03742297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64546212|NCT03742297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64502279|NCT02998918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546213|NCT01677403|Tobramycin|tobramycin|mesh-list
64546214|NCT01677403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64546215|NCT01677403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64778336|NCT02369172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64546216|NCT03742141|Glycopyrrolate|glycopyrrolate|mesh-list
64546217|NCT03742141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64546218|NCT03742141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64546219|NCT03742141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64546220|NCT03742141|Cholinergic Agents|cholinergic agents|mesh-ancestor
64546221|NCT03742141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64546224|NCT03441750|Metformin|metformin|mesh-list
64546266|NCT04527744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546267|NCT04527744|Cholinergic Agents|cholinergic agents|mesh-ancestor
64546268|NCT04527744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979072|NCT00274417|Hormone Antagonists|hormone antagonists|mesh-ancestor
64979073|NCT00274417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64979074|NCT00274417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979076|NCT00274495|Ribavirin|ribavirin|mesh-list
64979077|NCT00274495|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64979078|NCT00274495|Antimetabolites|antimetabolites|mesh-ancestor
64546269|NCT03825757|Aspirin|aspirin|mesh-list
64546270|NCT03825757|Salicylic Acid|salicylic acid|mesh-list
64546271|NCT03825757|Salicylates|salicylates|mesh-list
64546272|NCT03825757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64546274|NCT03825757|Keratolytic Agents|keratolytic agents|mesh-ancestor
64546275|NCT03825757|Dermatologic Agents|dermatologic agents|mesh-ancestor
64546276|NCT03825757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64389780|NCT05076773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389781|NCT05076773|Analgesics|analgesics|mesh-ancestor
64389782|NCT05076773|Sensory System Agents|sensory system agents|mesh-ancestor
64429993|NCT05022329|Vaccines|vaccines|mesh-list
64778348|NCT02374398|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64778349|NCT02374398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64778350|NCT02374398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778352|NCT02374398|Coagulants|coagulants|mesh-ancestor
64778353|NCT02377752|Doxorubicin|doxorubicin|mesh-list
64778354|NCT02377752|Olaratumab|olaratumab|mesh-list
64778355|NCT02377752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64778356|NCT02377752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778357|NCT02377752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64778358|NCT02377752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64303070|NCT02239913|Anesthetics, Local|anesthetics, local|mesh-ancestor
64303071|NCT02239913|Anesthetics|anesthetics|mesh-ancestor
64303072|NCT02239913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64303088|NCT03576287|Apremilast|apremilast|mesh-list
64546277|NCT03825757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64546278|NCT03825757|Analgesics|analgesics|mesh-ancestor
64546279|NCT03825757|Sensory System Agents|sensory system agents|mesh-ancestor
64546280|NCT03825757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64546281|NCT03825757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546282|NCT03825757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64546283|NCT03825757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64546284|NCT03825757|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64546285|NCT03825757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546286|NCT03825757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714169|NCT02831569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64714170|NCT03065179|Nivolumab|nivolumab|mesh-list
64502365|NCT04526028|Fulvestrant|fulvestrant|mesh-list
64546287|NCT03825757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64546288|NCT03825757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64546289|NCT03825757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64546290|NCT03825757|Antipyretics|antipyretics|mesh-ancestor
64546291|NCT03657433|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64546292|NCT03657433|Hematinics|hematinics|mesh-ancestor
64546293|NCT03657433|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64546294|NCT03657433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64546295|NCT04827030|Ropivacaine|ropivacaine|mesh-list
64546296|NCT04827030|Anesthetics, Local|anesthetics, local|mesh-ancestor
64546297|NCT04827030|Anesthetics|anesthetics|mesh-ancestor
64546298|NCT04827030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64546300|NCT04827030|Sensory System Agents|sensory system agents|mesh-ancestor
64546309|NCT03651895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546310|NCT03818191|Acamprosate|acamprosate|mesh-list
64546311|NCT03818191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64546312|NCT02398656|Tenecteplase|tenecteplase|mesh-list
64546313|NCT02398656|Clopidogrel|clopidogrel|mesh-list
64546314|NCT02398656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64546315|NCT02398656|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64546316|NCT02398656|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64546317|NCT02398656|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64546318|NCT02398656|Purinergic Agents|purinergic agents|mesh-ancestor
64546319|NCT02398656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64546320|NCT02398656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546321|NCT02398656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546322|NCT02398656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64546323|NCT02398656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64546324|NCT03644485|Mycophenolic Acid|mycophenolic acid|mesh-list
64546325|NCT03644485|Tacrolimus|tacrolimus|mesh-list
64546326|NCT03644485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64546333|NCT03644485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546334|NCT03644485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64546335|NCT03644485|Antitubercular Agents|antitubercular agents|mesh-ancestor
64546336|NCT03644485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64546337|NCT03644485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64546339|NCT03807037|Vitamin E|vitamin e|mesh-list
64546340|NCT03807037|Tocopherols|tocopherols|mesh-list
64546341|NCT03807037|Tocovid|tocovid|mesh-list
64546342|NCT03807037|Antioxidants|antioxidants|mesh-ancestor
64546343|NCT03807037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546346|NCT03807037|Vitamins|vitamins|mesh-ancestor
64546368|NCT03805399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64546369|NCT03805399|Antimetabolites|antimetabolites|mesh-ancestor
64546370|NCT03805399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64546371|NCT03805399|Immunologic Factors|immunologic factors|mesh-ancestor
64546372|NCT03805399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546373|NCT03805399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546374|NCT03805399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64546375|NCT03805399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64546376|NCT03805399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64546377|NCT03805399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64546378|NCT03805399|Antifungal Agents|antifungal agents|mesh-ancestor
64546379|NCT03802591|Capecitabine|capecitabine|mesh-list
64546380|NCT03802591|Oxaliplatin|oxaliplatin|mesh-list
64546381|NCT03802591|Antibodies|antibodies|mesh-list
64546382|NCT03802591|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64546383|NCT03802591|Immunologic Factors|immunologic factors|mesh-ancestor
64546384|NCT03802591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546385|NCT03802591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64546386|NCT03802591|Antimetabolites|antimetabolites|mesh-ancestor
64546387|NCT03802591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546388|NCT03802591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546389|NCT03725059|Paclitaxel|paclitaxel|mesh-list
64303146|NCT03239457|Mitogens|mitogens|mesh-list
64546390|NCT03725059|Cyclophosphamide|cyclophosphamide|mesh-list
64546391|NCT03725059|Doxorubicin|doxorubicin|mesh-list
64546392|NCT03725059|Pembrolizumab|pembrolizumab|mesh-list
64546393|NCT03725059|Epirubicin|epirubicin|mesh-list
64546394|NCT03725059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64300593|NCT03552601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300594|NCT03552601|Adrenergic Agents|adrenergic agents|mesh-ancestor
64300595|NCT03552601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64300596|NCT03552601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64300597|NCT03552601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64300598|NCT03552601|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64300599|NCT05021588|Anticoagulants|anticoagulants|mesh-list
64546396|NCT03725059|Tubulin Modulators|tubulin modulators|mesh-ancestor
64979079|NCT00274495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979080|NCT00274495|Antiviral Agents|antiviral agents|mesh-ancestor
64979081|NCT00274495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64979082|NCT00274495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64979083|NCT00274495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979084|NCT00274534|Tiotropium Bromide|tiotropium bromide|mesh-list
64979085|NCT00274534|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64979086|NCT00274534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64979087|NCT00274534|Autonomic Agents|autonomic agents|mesh-ancestor
64979088|NCT00274534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64979089|NCT00274534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979110|NCT00274573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64979111|NCT00274573|Cholinergic Agents|cholinergic agents|mesh-ancestor
64979112|NCT00274573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979113|NCT00274573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979114|NCT00274573|Anticonvulsants|anticonvulsants|mesh-ancestor
64979115|NCT00274612|Telmisartan|telmisartan|mesh-list
64546397|NCT03725059|Antimitotic Agents|antimitotic agents|mesh-ancestor
64546398|NCT03725059|Mitosis Modulators|mitosis modulators|mesh-ancestor
64546399|NCT03725059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546400|NCT03725059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64546401|NCT03725059|Immunologic Factors|immunologic factors|mesh-ancestor
64546402|NCT03725059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546403|NCT03725059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64546404|NCT03725059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64546405|NCT03725059|Alkylating Agents|alkylating agents|mesh-ancestor
64546406|NCT03725059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64546407|NCT03725059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64546408|NCT03725059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64546409|NCT03725059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64546410|NCT03725059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546411|NCT03725059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64546412|NCT02652624|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64546413|NCT02652624|Antiviral Agents|antiviral agents|mesh-ancestor
64546414|NCT02652624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64546415|NCT02652624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64546416|NCT02652624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64389787|NCT02432677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64389788|NCT02432677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389789|NCT02432677|Analgesics|analgesics|mesh-ancestor
64546417|NCT03637075|Insulin|insulin|mesh-list
64546418|NCT03637075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64546419|NCT03637075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546420|NCT04403503|Thrombin|thrombin|mesh-list
64546421|NCT04403503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
64546422|NCT04403503|Hemostatics|hemostatics|mesh-ancestor
64546423|NCT04403503|Coagulants|coagulants|mesh-ancestor
64546424|NCT00249795|Irbesartan|irbesartan|mesh-list
64300633|NCT03087890|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64300634|NCT03087890|Sulfamethoxazole|sulfamethoxazole|mesh-list
64300635|NCT03087890|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64300636|NCT03087890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64300637|NCT03087890|Renal Agents|renal agents|mesh-ancestor
64300638|NCT03087890|Antimalarials|antimalarials|mesh-ancestor
64300639|NCT03087890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64546425|NCT00249795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64311237|NCT02089295|Narcotics|narcotics|mesh-ancestor
64979116|NCT00274612|Ramipril|ramipril|mesh-list
64979117|NCT00274612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64979118|NCT00274612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64979119|NCT00274612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64979120|NCT00274612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979121|NCT00274612|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64979122|NCT00274612|Protease Inhibitors|protease inhibitors|mesh-ancestor
64979123|NCT00274612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979124|NCT00075374|Docetaxel|docetaxel|mesh-list
64979125|NCT00075374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979126|NCT00075374|Tubulin Modulators|tubulin modulators|mesh-ancestor
64979127|NCT00075374|Antimitotic Agents|antimitotic agents|mesh-ancestor
64546426|NCT00249795|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64546427|NCT00249795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64546428|NCT00249795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546429|NCT04404127|Basiliximab|basiliximab|mesh-list
64546430|NCT04404127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64546431|NCT04404127|Immunologic Factors|immunologic factors|mesh-ancestor
64546432|NCT04404127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546433|NCT02651220|Adapalene|adapalene|mesh-list
64546434|NCT02651220|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
64546435|NCT02651220|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64546436|NCT02651220|Dermatologic Agents|dermatologic agents|mesh-ancestor
64546437|NCT02651220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64546438|NCT02651220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64546439|NCT02651220|Analgesics|analgesics|mesh-ancestor
64546440|NCT02651220|Sensory System Agents|sensory system agents|mesh-ancestor
64546441|NCT02651220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64546442|NCT02651220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324242|NCT02233777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64324243|NCT02233777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64546443|NCT02651220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64300640|NCT03087890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64300641|NCT03087890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64300642|NCT03087890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300643|NCT03087890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300644|NCT03087890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64300645|NCT03087890|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64300646|NCT03087890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64300647|NCT03087890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64300648|NCT02112019|Hydrocortisone|hydrocortisone|mesh-list
64435896|NCT01981473|Infliximab|infliximab|mesh-list
64546444|NCT02651220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64546445|NCT01279551|Lidocaine|lidocaine|mesh-list
64546446|NCT01279551|Nitroglycerin|nitroglycerin|mesh-list
64546447|NCT01279551|Anesthetics, Local|anesthetics, local|mesh-ancestor
64546448|NCT01279551|Anesthetics|anesthetics|mesh-ancestor
64546449|NCT01279551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64546450|NCT01279551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546451|NCT01279551|Sensory System Agents|sensory system agents|mesh-ancestor
64546452|NCT01279551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64546453|NCT01279551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64546454|NCT01279551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64546455|NCT01279551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64546456|NCT01279551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64546468|NCT00780403|Desloratadine|desloratadine|mesh-list
64546469|NCT00780403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64546470|NCT00780403|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64546471|NCT00780403|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64546472|NCT00780403|Histamine Antagonists|histamine antagonists|mesh-ancestor
64546473|NCT00780403|Histamine Agents|histamine agents|mesh-ancestor
64546474|NCT00780403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64778389|NCT02384070|Anticoagulants|anticoagulants|mesh-ancestor
64546475|NCT00780403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546476|NCT00780403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546477|NCT00780403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64546478|NCT00780403|Cholinergic Agents|cholinergic agents|mesh-ancestor
64546479|NCT04209504|Bupivacaine|bupivacaine|mesh-list
64546480|NCT04209504|Ropivacaine|ropivacaine|mesh-list
64546481|NCT04209504|Anesthetics, Local|anesthetics, local|mesh-ancestor
64546482|NCT04209504|Anesthetics|anesthetics|mesh-ancestor
64546483|NCT04209504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64546484|NCT04209504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546485|NCT04209504|Sensory System Agents|sensory system agents|mesh-ancestor
64546486|NCT04209504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64546487|NCT03704610|Infliximab|infliximab|mesh-list
64546488|NCT03704610|Dermatologic Agents|dermatologic agents|mesh-ancestor
64546489|NCT03704610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64546490|NCT03704610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64546491|NCT01979796|Nicotine|nicotine|mesh-list
64546492|NCT01979796|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64979128|NCT00075374|Mitosis Modulators|mitosis modulators|mesh-ancestor
64979129|NCT00075374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979130|NCT00274690|Casopitant|casopitant|mesh-list
64979131|NCT00274690|Antiemetics|antiemetics|mesh-ancestor
64979132|NCT00274690|Autonomic Agents|autonomic agents|mesh-ancestor
64979133|NCT00274690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64979134|NCT00274690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979135|NCT00274690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64979136|NCT00274690|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64979137|NCT00274690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979138|NCT00274690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979139|NCT00274807|Cytarabine|cytarabine|mesh-list
64979140|NCT00274807|Etoposide|etoposide|mesh-list
64979141|NCT00274807|Mitoxantrone|mitoxantrone|mesh-list
64979143|NCT00274807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979177|NCT00277264|Cholinergic Agents|cholinergic agents|mesh-ancestor
64979178|NCT00277264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979179|NCT00277264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979180|NCT00108420|Prazosin|prazosin|mesh-list
64979181|NCT00108420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64979182|NCT00108420|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64546493|NCT01979796|Autonomic Agents|autonomic agents|mesh-ancestor
64546494|NCT01979796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64546495|NCT01979796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546496|NCT01979796|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64546497|NCT01979796|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64546498|NCT01979796|Cholinergic Agents|cholinergic agents|mesh-ancestor
64546499|NCT01979796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64546500|NCT01979796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546501|NCT03630211|Cyclophosphamide|cyclophosphamide|mesh-list
64546502|NCT03630211|Thiotepa|thiotepa|mesh-list
64546503|NCT03630211|Rituximab|rituximab|mesh-list
64546504|NCT03630211|Alemtuzumab|alemtuzumab|mesh-list
64546505|NCT03630211|Thymoglobulin|thymoglobulin|mesh-list
64546506|NCT03630211|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64546507|NCT03630211|Immunoglobulins|immunoglobulins|mesh-list
64546508|NCT03630211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64546509|NCT03630211|gamma-Globulins|gamma-globulins|mesh-list
64546510|NCT03630211|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64300688|NCT02251483|Immunologic Factors|immunologic factors|mesh-ancestor
64300689|NCT02251483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300690|NCT02117869|Furocoumarins|furocoumarins|mesh-list
64300691|NCT02117869|Dermatologic Agents|dermatologic agents|mesh-ancestor
64300692|NCT02117869|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64300693|NCT02120599|Folic Acid|folic acid|mesh-list
64300694|NCT02120599|Hematinics|hematinics|mesh-ancestor
64300695|NCT02120599|Vitamin B Complex|vitamin b complex|mesh-ancestor
64300696|NCT02120599|Vitamins|vitamins|mesh-ancestor
64778430|NCT02401464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64778431|NCT02401464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64778432|NCT02401464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778434|NCT02401542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778435|NCT02401542|Tubulin Modulators|tubulin modulators|mesh-ancestor
64778436|NCT02401542|Antimitotic Agents|antimitotic agents|mesh-ancestor
64778437|NCT02401542|Mitosis Modulators|mitosis modulators|mesh-ancestor
64778438|NCT02401542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778439|NCT02411916|Misoprostol|misoprostol|mesh-list
64778440|NCT02411916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64389864|NCT05076461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64389865|NCT05076461|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64389866|NCT02428933|Bromocriptine|bromocriptine|mesh-list
64389867|NCT02428933|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64389868|NCT02428933|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64389869|NCT02428933|Hormone Antagonists|hormone antagonists|mesh-ancestor
64300697|NCT02120599|Micronutrients|micronutrients|mesh-ancestor
64300698|NCT02120599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300699|NCT02112097|Etanercept|etanercept|mesh-list
64300700|NCT02112097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64300701|NCT02112097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64300702|NCT02112097|Analgesics|analgesics|mesh-ancestor
64300703|NCT02112097|Sensory System Agents|sensory system agents|mesh-ancestor
64300704|NCT02112097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64300705|NCT02112097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300706|NCT02112097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64300707|NCT02112097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64300708|NCT02112097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64300709|NCT02112097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64300710|NCT02112097|Immunologic Factors|immunologic factors|mesh-ancestor
64546511|NCT03630211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64546513|NCT03630211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546514|NCT03630211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64546515|NCT03630211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64546516|NCT03630211|Alkylating Agents|alkylating agents|mesh-ancestor
64546517|NCT03630211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546518|NCT03630211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546519|NCT03630211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64546520|NCT03630211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64546521|NCT03628339|Tepotinib|tepotinib|mesh-list
64546522|NCT03628339|Midazolam|midazolam|mesh-list
64546523|NCT03628339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64546524|NCT03628339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64546525|NCT03628339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64778441|NCT02411916|Abortifacient Agents|abortifacient agents|mesh-ancestor
64778442|NCT02411916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64778443|NCT02411916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778444|NCT02411916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64778445|NCT02411916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64778446|NCT02411916|Oxytocics|oxytocics|mesh-ancestor
64546526|NCT03628339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546527|NCT03628339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64546528|NCT03628339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64979198|NCT00277498|Adrenergic Agents|adrenergic agents|mesh-ancestor
64979199|NCT00277498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64546529|NCT03628339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64546530|NCT03628339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64546531|NCT03628339|Anesthetics, General|anesthetics, general|mesh-ancestor
64546532|NCT03628339|Anesthetics|anesthetics|mesh-ancestor
64546533|NCT03628339|GABA Modulators|gaba modulators|mesh-ancestor
64546534|NCT03628339|GABA Agents|gaba agents|mesh-ancestor
64546535|NCT03628339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64546536|NCT03628339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546537|NCT03628339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546538|NCT03792763|Denosumab|denosumab|mesh-list
64778487|NCT05718492|Vitamins|vitamins|mesh-ancestor
64778488|NCT05718492|Micronutrients|micronutrients|mesh-ancestor
64778489|NCT05718024|Dexmedetomidine|dexmedetomidine|mesh-list
64778490|NCT05718024|Remifentanil|remifentanil|mesh-list
64778491|NCT05718024|Propofol|propofol|mesh-list
64778492|NCT05718024|Esketamine|esketamine|mesh-list
64778498|NCT05718024|Anesthetics|anesthetics|mesh-ancestor
64546539|NCT03792763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64546540|NCT03792763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64546541|NCT03792763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546542|NCT04412694|Dexamethasone|dexamethasone|mesh-list
64546543|NCT04412694|Dexamethasone acetate|dexamethasone acetate|mesh-list
64546544|NCT04412694|BB 1101|bb 1101|mesh-list
64546545|NCT04412694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64546546|NCT04412694|Antiemetics|antiemetics|mesh-ancestor
64546547|NCT04412694|Autonomic Agents|autonomic agents|mesh-ancestor
64300711|NCT02112175|Lenalidomide|lenalidomide|mesh-list
64300712|NCT02112175|Immunologic Factors|immunologic factors|mesh-ancestor
64300713|NCT02112175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300714|NCT02112175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64300715|NCT02112175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64300716|NCT02112175|Growth Substances|growth substances|mesh-ancestor
64300717|NCT02112175|Growth Inhibitors|growth inhibitors|mesh-ancestor
64300718|NCT02112175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64300720|NCT03553537|Cyclophosphamide|cyclophosphamide|mesh-list
64546548|NCT04412694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64546549|NCT04412694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546550|NCT04412694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64546551|NCT04412694|Glucocorticoids|glucocorticoids|mesh-ancestor
64546553|NCT04412694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64546578|NCT02083861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64546579|NCT02083861|Nasal Decongestants|nasal decongestants|mesh-ancestor
64546580|NCT02083861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64546581|NCT02083861|Respiratory System Agents|respiratory system agents|mesh-ancestor
64546582|NCT00246129|Alemtuzumab|alemtuzumab|mesh-list
64546583|NCT00246129|Daclizumab|daclizumab|mesh-list
64546584|NCT00246129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64546585|NCT00246129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778524|NCT05717790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778526|NCT05679258|Daratumumab|daratumumab|mesh-list
64546586|NCT00246129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64546587|NCT00246129|Immunologic Factors|immunologic factors|mesh-ancestor
64546588|NCT00246129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546589|NCT01274247|Benzocaine|benzocaine|mesh-list
64546590|NCT01274247|Anesthetics, Local|anesthetics, local|mesh-ancestor
64546591|NCT01274247|Anesthetics|anesthetics|mesh-ancestor
64546592|NCT01274247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64546593|NCT01274247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546594|NCT01274247|Sensory System Agents|sensory system agents|mesh-ancestor
64546595|NCT01274247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64546596|NCT03783715|Ketoprofen|ketoprofen|mesh-list
64546597|NCT03783715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64546598|NCT03783715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64546599|NCT03783715|Analgesics|analgesics|mesh-ancestor
64546600|NCT03783715|Sensory System Agents|sensory system agents|mesh-ancestor
64546601|NCT03783715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64546608|NCT01279629|Tazarotene|tazarotene|mesh-list
64546629|NCT01274403|Glucocorticoids|glucocorticoids|mesh-ancestor
64546630|NCT01274403|Hormones|hormones|mesh-ancestor
64546631|NCT01274403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64546632|NCT01274403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546633|NCT01274403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64546634|NCT01274403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546635|NCT01274403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64546636|NCT01274403|Alkylating Agents|alkylating agents|mesh-ancestor
64546637|NCT01274403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546638|NCT01274403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64546639|NCT01274403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64546640|NCT01274403|Immunologic Factors|immunologic factors|mesh-ancestor
64546641|NCT01274403|Leprostatic Agents|leprostatic agents|mesh-ancestor
64546642|NCT01274403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64546643|NCT01274403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64546644|NCT01274403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64546645|NCT01274403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64546646|NCT01274403|Growth Substances|growth substances|mesh-ancestor
64546647|NCT01274403|Growth Inhibitors|growth inhibitors|mesh-ancestor
64546648|NCT03700099|Docetaxel|docetaxel|mesh-list
64546649|NCT03700099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546650|NCT03700099|Tubulin Modulators|tubulin modulators|mesh-ancestor
64300722|NCT03553537|Vincristine|vincristine|mesh-list
64300723|NCT03553537|Decitabine|decitabine|mesh-list
64778563|NCT05317806|Metformin|metformin|mesh-list
64778564|NCT05317806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64778565|NCT05317806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778566|NCT05273346|Analgesics|analgesics|mesh-list
64778567|NCT05273346|Sensory System Agents|sensory system agents|mesh-ancestor
64303235|NCT02241161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303236|NCT02241161|Protective Agents|protective agents|mesh-ancestor
64303237|NCT02241161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303238|NCT02241161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64300724|NCT03553537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64300725|NCT03553537|Immunologic Factors|immunologic factors|mesh-ancestor
64300726|NCT03553537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546651|NCT03700099|Antimitotic Agents|antimitotic agents|mesh-ancestor
64546652|NCT03700099|Mitosis Modulators|mitosis modulators|mesh-ancestor
64546653|NCT03700099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546654|NCT01274481|Iloprost|iloprost|mesh-list
64546655|NCT01274481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64546656|NCT01274481|Vasodilator Agents|vasodilator agents|mesh-ancestor
64546657|NCT00245583|Topiramate|topiramate|mesh-list
64546658|NCT00245583|Anticonvulsants|anticonvulsants|mesh-ancestor
64546659|NCT00245583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64546660|NCT00245583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546661|NCT01379989|Carboplatin|carboplatin|mesh-list
64546662|NCT01379989|Doxorubicin|doxorubicin|mesh-list
64546663|NCT01379989|Trabectedin|trabectedin|mesh-list
64546664|NCT01379989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64311474|NCT02091401|Magnesium Sulfate|magnesium sulfate|mesh-list
64979200|NCT00277498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546665|NCT01379989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64546666|NCT01379989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64546667|NCT01379989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64546668|NCT01379989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546669|NCT01379989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546670|NCT01379989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64546671|NCT01379989|Alkylating Agents|alkylating agents|mesh-ancestor
64546672|NCT00754845|Letrozole|letrozole|mesh-list
64546673|NCT00754845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546674|NCT00754845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64546675|NCT00754845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64546676|NCT00754845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546677|NCT00754845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546678|NCT00754845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64546679|NCT00754845|Hormone Antagonists|hormone antagonists|mesh-ancestor
64546680|NCT00754845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64546681|NCT00754845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546682|NCT02652156|Bupivacaine|bupivacaine|mesh-list
64546683|NCT02652156|Ropivacaine|ropivacaine|mesh-list
64979201|NCT00277498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979202|NCT00277498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64979203|NCT00277498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64979204|NCT00277498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64979205|NCT00277498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64979206|NCT00108498|Mirtazapine|mirtazapine|mesh-list
64300727|NCT03553537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64300728|NCT03553537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64300729|NCT03553537|Alkylating Agents|alkylating agents|mesh-ancestor
64300730|NCT03553537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300731|NCT03553537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64300732|NCT03553537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64300733|NCT03553537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64300734|NCT03553537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64300735|NCT03553537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64300736|NCT03553537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979207|NCT00108498|Antidepressive Agents|antidepressive agents|mesh-ancestor
64979208|NCT00108498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64979209|NCT00108498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64979210|NCT00108498|Histamine Antagonists|histamine antagonists|mesh-ancestor
64979211|NCT00108498|Histamine Agents|histamine agents|mesh-ancestor
64979212|NCT00108498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979213|NCT00108498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979214|NCT00108498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979215|NCT00108498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64979216|NCT00108498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64979217|NCT00108498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64979218|NCT00108498|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64979219|NCT00108498|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64979220|NCT00108498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64979221|NCT00108498|Adrenergic Agents|adrenergic agents|mesh-ancestor
64979222|NCT00108498|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64979223|NCT00108498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64778714|NCT03191370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778715|NCT03191370|Sensory System Agents|sensory system agents|mesh-ancestor
64778716|NCT03191370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778717|NCT03179436|Pembrolizumab|pembrolizumab|mesh-list
64390128|NCT05387603|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
64390129|NCT05387603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64390130|NCT05387603|Antimetabolites|antimetabolites|mesh-ancestor
64390131|NCT05387603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390132|NCT05387603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390133|NCT05387603|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64390134|NCT03182413|Modafinil|modafinil|mesh-list
64390135|NCT03182413|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64390136|NCT03182413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390141|NCT03182257|ONO-7579|ono-7579|mesh-list
64778726|NCT02834052|Poly ICLC|poly iclc|mesh-list
64778727|NCT02834052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64778728|NCT02834052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778729|NCT02834052|Interferon Inducers|interferon inducers|mesh-ancestor
64778730|NCT02834052|Immunologic Factors|immunologic factors|mesh-ancestor
64778732|NCT02834052|Laxatives|laxatives|mesh-ancestor
64979224|NCT00108498|Serotonin Agents|serotonin agents|mesh-ancestor
64979225|NCT00108498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64979227|NCT00277537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64979228|NCT00277537|Diuretics|diuretics|mesh-ancestor
64979229|NCT00277537|Natriuretic Agents|natriuretic agents|mesh-ancestor
64979230|NCT00277537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979231|NCT00075452|Gemcitabine|gemcitabine|mesh-list
64979232|NCT00075452|Oxaliplatin|oxaliplatin|mesh-list
64979233|NCT00075452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64979234|NCT00075452|Antimetabolites|antimetabolites|mesh-ancestor
64546684|NCT02652156|Anesthetics, Local|anesthetics, local|mesh-ancestor
64546685|NCT02652156|Anesthetics|anesthetics|mesh-ancestor
64546686|NCT02652156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64546687|NCT02652156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546688|NCT02652156|Sensory System Agents|sensory system agents|mesh-ancestor
64546689|NCT02652156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64546690|NCT03699865|Nicotine|nicotine|mesh-list
64546691|NCT03699865|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64546692|NCT03699865|Autonomic Agents|autonomic agents|mesh-ancestor
64546693|NCT03699865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64546694|NCT03699865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546695|NCT03699865|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64546696|NCT03699865|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64300749|NCT04434170|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64300750|NCT04434170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64300751|NCT04434170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64300753|NCT04434170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300754|NCT03086174|Antibodies|antibodies|mesh-list
64300755|NCT03086174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64390158|NCT03117439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64390159|NCT03117439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64778744|NCT02828358|Methylprednisolone|methylprednisolone|mesh-list
64778745|NCT02828358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64300756|NCT03086174|Immunologic Factors|immunologic factors|mesh-ancestor
64300769|NCT05014490|Etoricoxib|etoricoxib|mesh-list
64546697|NCT03699865|Cholinergic Agents|cholinergic agents|mesh-ancestor
64546698|NCT03699865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64546699|NCT03699865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546701|NCT03699319|Folic Acid|folic acid|mesh-list
64546702|NCT03699319|Oxaliplatin|oxaliplatin|mesh-list
64546703|NCT03699319|Irinotecan|irinotecan|mesh-list
64546704|NCT03699319|Levoleucovorin|levoleucovorin|mesh-list
64546705|NCT03699319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546706|NCT03699319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390181|NCT02421289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64390182|NCT02421289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64546707|NCT03699319|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64546736|NCT02117076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546737|NCT02117076|Anticonvulsants|anticonvulsants|mesh-ancestor
64546738|NCT02117076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64546739|NCT02117076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64547540|NCT02963064|Antibodies|antibodies|mesh-list
64546740|NCT02117076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64546741|NCT02117076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64546742|NCT02117076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64546743|NCT02117076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64546744|NCT02117076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64546745|NCT02117076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546746|NCT02117076|Antimanic Agents|antimanic agents|mesh-ancestor
64546747|NCT01274793|Mosapride|mosapride|mesh-list
64546748|NCT01274793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546749|NCT01274793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64546750|NCT01274793|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64546751|NCT01274793|Serotonin Agents|serotonin agents|mesh-ancestor
64546752|NCT01274793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64546753|NCT01274793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546754|NCT00746889|Triamcinolone|triamcinolone|mesh-list
64546755|NCT00746889|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64546756|NCT00746889|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64546757|NCT00746889|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64546758|NCT00746889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64778923|NCT05721846|Nivolumab|nivolumab|mesh-list
64546759|NCT00746889|Glucocorticoids|glucocorticoids|mesh-ancestor
64546760|NCT00746889|Hormones|hormones|mesh-ancestor
64546761|NCT00746889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64546762|NCT00746889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546763|NCT00746889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64546764|NCT00746889|Immunologic Factors|immunologic factors|mesh-ancestor
64546765|NCT00746889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546766|NCT00746889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300775|NCT05014490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546767|NCT01675050|Cyproheptadine|cyproheptadine|mesh-list
64546768|NCT01675050|Antipruritics|antipruritics|mesh-ancestor
64546769|NCT01675050|Dermatologic Agents|dermatologic agents|mesh-ancestor
64546770|NCT01675050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64546771|NCT01675050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64546772|NCT01675050|Histamine Antagonists|histamine antagonists|mesh-ancestor
64546773|NCT01675050|Histamine Agents|histamine agents|mesh-ancestor
64546774|NCT01675050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64546775|NCT01675050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546776|NCT01675050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546777|NCT01675050|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64546778|NCT01675050|Serotonin Agents|serotonin agents|mesh-ancestor
64546779|NCT01675050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64546780|NCT00756093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64546781|NCT00756093|Lubricant Eye Drops|lubricant eye drops|mesh-list
64546782|NCT00756093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64546783|NCT00816582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64546784|NCT00816582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64546785|NCT00816582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546786|NCT03771313|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64546787|NCT03771313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64546788|NCT03771313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64546789|NCT03704688|Trametinib|trametinib|mesh-list
64546790|NCT03704688|Ponatinib|ponatinib|mesh-list
64546791|NCT03704688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546792|NCT03704688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64546793|NCT03704688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546794|NCT03704688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300847|NCT02112643|Protective Agents|protective agents|mesh-ancestor
64546830|NCT03765541|Azacitidine|azacitidine|mesh-list
64546831|NCT03765541|Amsacrine|amsacrine|mesh-list
64546832|NCT03765541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64546833|NCT03765541|Antiemetics|antiemetics|mesh-ancestor
64546834|NCT03765541|Autonomic Agents|autonomic agents|mesh-ancestor
64546835|NCT03765541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64390394|NCT04983095|Hormones|hormones|mesh-list
64546836|NCT03765541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546837|NCT03765541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64546838|NCT03765541|Glucocorticoids|glucocorticoids|mesh-ancestor
64546839|NCT03765541|Hormones|hormones|mesh-ancestor
64546840|NCT03765541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64546841|NCT03765541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64546842|NCT03765541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546843|NCT03765541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64546844|NCT03765541|Antimetabolites|antimetabolites|mesh-ancestor
64436192|NCT04561180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64436193|NCT04561180|Antiemetics|antiemetics|mesh-ancestor
64300910|NCT02251795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64300911|NCT02251795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64300912|NCT02251795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300913|NCT02251795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64300914|NCT02251795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64300915|NCT02251795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300916|NCT02251795|Antipyretics|antipyretics|mesh-ancestor
64300917|NCT02251795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64300918|NCT02251795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64300919|NCT02251795|Protease Inhibitors|protease inhibitors|mesh-ancestor
64300920|NCT02251795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64436194|NCT04561180|Autonomic Agents|autonomic agents|mesh-ancestor
64546845|NCT03765541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779034|NCT05713734|Hemostatics|hemostatics|mesh-ancestor
64546846|NCT03765541|Antiviral Agents|antiviral agents|mesh-ancestor
64546847|NCT03765541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64546848|NCT03765541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64546849|NCT03765541|Immunologic Factors|immunologic factors|mesh-ancestor
64546862|NCT05123976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64546863|NCT05123976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64546864|NCT05123976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546865|NCT05123976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64546866|NCT05123976|Serotonin Agents|serotonin agents|mesh-ancestor
64779072|NCT05665062|Immunologic Factors|immunologic factors|mesh-ancestor
64779073|NCT05665062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779074|NCT05665062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64779075|NCT05665062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64779077|NCT05665062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779078|NCT05665062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779079|NCT05665062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64779081|NCT05618808|Anticoagulants|anticoagulants|mesh-ancestor
64779082|NCT05618808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64779083|NCT05618808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64779084|NCT05618808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779092|NCT05600322|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64779093|NCT05600322|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64779094|NCT05600322|Dermatologic Agents|dermatologic agents|mesh-ancestor
64779095|NCT05579730|Ketotifen|ketotifen|mesh-list
64779096|NCT05579730|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64779097|NCT05579730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64779098|NCT05579730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64779099|NCT05579730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64546867|NCT00005803|Cytarabine|cytarabine|mesh-list
64546868|NCT00005803|Cyclosporine|cyclosporine|mesh-list
64546869|NCT00005803|Mycophenolic Acid|mycophenolic acid|mesh-list
64546870|NCT00005803|Cyclophosphamide|cyclophosphamide|mesh-list
64546871|NCT00005803|Melphalan|melphalan|mesh-list
64546872|NCT00005803|Mechlorethamine|mechlorethamine|mesh-list
64546873|NCT00005803|Carmustine|carmustine|mesh-list
64546874|NCT00005803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64546875|NCT00005803|Fludarabine|fludarabine|mesh-list
64546876|NCT00005803|Fludarabine phosphate|fludarabine phosphate|mesh-list
64546877|NCT00005803|Etoposide|etoposide|mesh-list
64546878|NCT00005803|Etoposide phosphate|etoposide phosphate|mesh-list
64546879|NCT00005803|Podophyllotoxin|podophyllotoxin|mesh-list
64546880|NCT00005803|Cyclosporins|cyclosporins|mesh-list
64546881|NCT00005803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64546882|NCT00005803|Immunologic Factors|immunologic factors|mesh-ancestor
64546883|NCT00005803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546884|NCT00005803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64546885|NCT00005803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64546886|NCT00005803|Alkylating Agents|alkylating agents|mesh-ancestor
64546887|NCT00005803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311718|NCT02250599|Tubulin Modulators|tubulin modulators|mesh-ancestor
64979235|NCT00075452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979236|NCT00075452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979237|NCT00075452|Antiviral Agents|antiviral agents|mesh-ancestor
64979238|NCT00075452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64979239|NCT00075452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979240|NCT00075452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64300921|NCT02251795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64300922|NCT02251795|Antiviral Agents|antiviral agents|mesh-ancestor
64300923|NCT02251795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64300924|NCT02251795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64300925|NCT02251795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64300926|NCT05013164|Leucovorin|leucovorin|mesh-list
64300927|NCT05013164|Folic Acid|folic acid|mesh-list
64300928|NCT05013164|Levoleucovorin|levoleucovorin|mesh-list
64300929|NCT05013164|Antidotes|antidotes|mesh-ancestor
64300930|NCT05013164|Protective Agents|protective agents|mesh-ancestor
64300931|NCT05013164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779144|NCT05549466|Apatinib|apatinib|mesh-list
64779145|NCT05549466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64779146|NCT05549466|Antimetabolites|antimetabolites|mesh-ancestor
64779147|NCT05549466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779148|NCT05549466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779149|NCT05549466|Antiviral Agents|antiviral agents|mesh-ancestor
64390537|NCT02425813|Respiratory System Agents|respiratory system agents|mesh-ancestor
64390538|NCT03106831|Norepinephrine|norepinephrine|mesh-list
64390539|NCT03106831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64300932|NCT05013164|Vitamin B Complex|vitamin b complex|mesh-ancestor
64979258|NCT00108537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64979259|NCT00108537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64979261|NCT00108537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64979262|NCT00108537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64979263|NCT00108537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979264|NCT00277654|Risperidone|risperidone|mesh-list
64979265|NCT00277654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64979266|NCT00277654|Serotonin Agents|serotonin agents|mesh-ancestor
64979267|NCT00277654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979268|NCT00277654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979269|NCT00277654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979270|NCT00277654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64979271|NCT00277654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64979272|NCT00277654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64979273|NCT00277654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64979274|NCT00277654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64311740|NCT03555929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64311741|NCT03555929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311742|NCT03555929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64311744|NCT03555929|Hormones|hormones|mesh-ancestor
64311745|NCT03555929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64311746|NCT03555929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64311747|NCT03555929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546888|NCT00005803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546889|NCT00005803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64546890|NCT00005803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64546891|NCT00005803|Antimetabolites|antimetabolites|mesh-ancestor
64546892|NCT00005803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64546893|NCT00005803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64546894|NCT00005803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64546895|NCT00005803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546896|NCT00005803|Antiviral Agents|antiviral agents|mesh-ancestor
64546897|NCT00005803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64546898|NCT00005803|Antifungal Agents|antifungal agents|mesh-ancestor
64546899|NCT00005803|Dermatologic Agents|dermatologic agents|mesh-ancestor
64546900|NCT00005803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64546935|NCT05126004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64546936|NCT05126004|Antimetabolites|antimetabolites|mesh-ancestor
64546937|NCT05126004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546938|NCT05126004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546939|NCT05126004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546940|NCT05126004|Antiviral Agents|antiviral agents|mesh-ancestor
64546941|NCT05126004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64546942|NCT05126004|Expectorants|expectorants|mesh-ancestor
64546943|NCT05126004|Respiratory System Agents|respiratory system agents|mesh-ancestor
64546944|NCT05126004|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64546945|NCT05126004|Antioxidants|antioxidants|mesh-ancestor
64546946|NCT05126004|Protective Agents|protective agents|mesh-ancestor
64546947|NCT05126004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546948|NCT05126004|Antidotes|antidotes|mesh-ancestor
64300950|NCT03091868|Dopamine Agents|dopamine agents|mesh-ancestor
64300951|NCT03091868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64546950|NCT03672643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546951|NCT03672643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64546952|NCT03672643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546953|NCT03672643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546954|NCT00350701|Methyltestosterone|methyltestosterone|mesh-list
64546955|NCT00350701|Testosterone|testosterone|mesh-list
64546956|NCT00350701|Testosterone undecanoate|testosterone undecanoate|mesh-list
64546957|NCT00350701|Testosterone enanthate|testosterone enanthate|mesh-list
64311784|NCT02097953|Rifampin|rifampin|mesh-list
64311785|NCT02097953|Daptomycin|daptomycin|mesh-list
64311786|NCT02097953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64779277|NCT05251038|Antimetabolites|antimetabolites|mesh-ancestor
64779278|NCT05251038|Antiviral Agents|antiviral agents|mesh-ancestor
64779279|NCT05251038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64779280|NCT05251038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779281|NCT05251038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64311787|NCT02097953|Antitubercular Agents|antitubercular agents|mesh-ancestor
64311788|NCT02097953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64311789|NCT02097953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64311790|NCT02097953|Leprostatic Agents|leprostatic agents|mesh-ancestor
64311791|NCT02097953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64311792|NCT02097953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311801|NCT02094287|Antipruritics|antipruritics|mesh-ancestor
64979275|NCT00277654|Dopamine Agents|dopamine agents|mesh-ancestor
64979276|NCT00277693|Spironolactone|spironolactone|mesh-list
64979277|NCT00277693|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64979278|NCT00277693|Hormone Antagonists|hormone antagonists|mesh-ancestor
64979279|NCT00277693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64979280|NCT00277693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979281|NCT00277693|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64979282|NCT00277693|Diuretics|diuretics|mesh-ancestor
64979283|NCT00277693|Natriuretic Agents|natriuretic agents|mesh-ancestor
64979284|NCT00108576|Valproic Acid|valproic acid|mesh-list
64546958|NCT00350701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64546959|NCT00350701|Androgens|androgens|mesh-ancestor
64300952|NCT03091868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300954|NCT02121613|Tamsulosin|tamsulosin|mesh-list
64300955|NCT02121613|Urological Agents|urological agents|mesh-ancestor
64300956|NCT02121613|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64300957|NCT02121613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64546961|NCT00350701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64546962|NCT00350701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546963|NCT00350701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64779302|NCT05206266|Protective Agents|protective agents|mesh-ancestor
64546964|NCT00350701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546965|NCT00350701|Anabolic Agents|anabolic agents|mesh-ancestor
64546966|NCT04277247|Botulinum Toxins|botulinum toxins|mesh-list
64546967|NCT04277247|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64546968|NCT04277247|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64546969|NCT04277247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64546970|NCT04277247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64546971|NCT04277247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546972|NCT04277247|Cholinergic Agents|cholinergic agents|mesh-ancestor
64546973|NCT04277247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64546974|NCT04277247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546975|NCT04277247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64546976|NCT04277247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64546977|NCT01505114|Tenofovir|tenofovir|mesh-list
64546978|NCT01505114|Emtricitabine|emtricitabine|mesh-list
64546979|NCT01505114|Maraviroc|maraviroc|mesh-list
64546980|NCT01505114|Antiviral Agents|antiviral agents|mesh-ancestor
64546981|NCT01505114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64546982|NCT01505114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64546983|NCT01505114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64546984|NCT01505114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546985|NCT01505114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546986|NCT01505114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64546987|NCT01505114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64546988|NCT01505114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64546989|NCT01505114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64546990|NCT01505114|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64546991|NCT04761757|Antidepressive Agents|antidepressive agents|mesh-list
64546992|NCT04761757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64546994|NCT03666559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64546995|NCT03666559|Antimetabolites|antimetabolites|mesh-ancestor
64546996|NCT03666559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64546997|NCT03666559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64546998|NCT03666559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64546999|NCT04187898|Cyclophosphamide|cyclophosphamide|mesh-list
64547000|NCT04187898|Docetaxel|docetaxel|mesh-list
64547001|NCT04187898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64547002|NCT04187898|Immunologic Factors|immunologic factors|mesh-ancestor
64547003|NCT04187898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547004|NCT04187898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64300958|NCT02121613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64436333|NCT02308163|Peficitinib|peficitinib|mesh-list
64547006|NCT04187898|Alkylating Agents|alkylating agents|mesh-ancestor
64547007|NCT04187898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547009|NCT04187898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64547010|NCT04187898|Tubulin Modulators|tubulin modulators|mesh-ancestor
64547011|NCT04187898|Antimitotic Agents|antimitotic agents|mesh-ancestor
64547012|NCT04187898|Mitosis Modulators|mitosis modulators|mesh-ancestor
64547013|NCT03663205|Cisplatin|cisplatin|mesh-list
64547014|NCT03663205|Carboplatin|carboplatin|mesh-list
64547015|NCT03663205|Pemetrexed|pemetrexed|mesh-list
64547016|NCT03663205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547017|NCT03663205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779361|NCT04924062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64779375|NCT04754334|Insulin|insulin|mesh-list
64547018|NCT03663205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547019|NCT03663205|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64547020|NCT03663205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64547021|NCT01275729|Furosemide|furosemide|mesh-list
64547022|NCT01275729|Diuretics|diuretics|mesh-ancestor
64547023|NCT01275729|Natriuretic Agents|natriuretic agents|mesh-ancestor
64547041|NCT01679899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547042|NCT01679899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547043|NCT01276821|Epinephrine|epinephrine|mesh-list
64547044|NCT01276821|Racepinephrine|racepinephrine|mesh-list
64547045|NCT01276821|Epinephryl borate|epinephryl borate|mesh-list
64547046|NCT01276821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64547047|NCT01276821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64547048|NCT01276821|Adrenergic Agents|adrenergic agents|mesh-ancestor
64547049|NCT01276821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64547050|NCT01276821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547051|NCT01276821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547052|NCT01276821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64547053|NCT01276821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64547054|NCT01276821|Autonomic Agents|autonomic agents|mesh-ancestor
64547055|NCT01276821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547056|NCT01276821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64547057|NCT01276821|Respiratory System Agents|respiratory system agents|mesh-ancestor
64547058|NCT01276821|Mydriatics|mydriatics|mesh-ancestor
64547059|NCT01276821|Sympathomimetics|sympathomimetics|mesh-ancestor
64547060|NCT01276821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64547061|NCT00245037|Cyclosporine|cyclosporine|mesh-list
64300959|NCT02121613|Adrenergic Agents|adrenergic agents|mesh-ancestor
64300960|NCT02121613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64300961|NCT02121613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300962|NCT02121613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300963|NCT03091712|Insulin|insulin|mesh-list
64300964|NCT03091712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64300965|NCT03091712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300966|NCT03552211|Biotin|biotin|mesh-list
64300967|NCT03552211|Vitamin B Complex|vitamin b complex|mesh-ancestor
64300968|NCT03552211|Vitamins|vitamins|mesh-ancestor
64300969|NCT03552211|Micronutrients|micronutrients|mesh-ancestor
64300970|NCT03552211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300971|NCT02113267|Mometasone Furoate|mometasone furoate|mesh-list
64300972|NCT02113267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64300973|NCT02113267|Dermatologic Agents|dermatologic agents|mesh-ancestor
64547062|NCT00245037|Mycophenolic Acid|mycophenolic acid|mesh-list
64547063|NCT00245037|Methotrexate|methotrexate|mesh-list
64547064|NCT00245037|Fludarabine phosphate|fludarabine phosphate|mesh-list
64547065|NCT00245037|Fludarabine|fludarabine|mesh-list
64547066|NCT00245037|Busulfan|busulfan|mesh-list
64547092|NCT00245037|Alkylating Agents|alkylating agents|mesh-ancestor
64547093|NCT00245037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64547094|NCT00245037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64547095|NCT00245037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64547096|NCT00245037|Anticonvulsants|anticonvulsants|mesh-ancestor
64547097|NCT00245037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64547098|NCT00245037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64547099|NCT00245037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64779529|NCT04320342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779530|NCT04320342|Anticonvulsants|anticonvulsants|mesh-ancestor
64779531|NCT04320342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64779532|NCT04320342|Glucocorticoids|glucocorticoids|mesh-ancestor
64779534|NCT04320342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64547100|NCT00245037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64547101|NCT00245037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64547102|NCT03532399|Bivalirudin|bivalirudin|mesh-list
64547103|NCT03532399|Antithrombins|antithrombins|mesh-ancestor
64547104|NCT03532399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64547105|NCT03532399|Protease Inhibitors|protease inhibitors|mesh-ancestor
64547106|NCT03532399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547107|NCT03532399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547108|NCT03532399|Anticoagulants|anticoagulants|mesh-ancestor
64547109|NCT00241839|Allopurinol|allopurinol|mesh-list
64547110|NCT00241839|Chlorthalidone|chlorthalidone|mesh-list
64547111|NCT00241839|Antimetabolites|antimetabolites|mesh-ancestor
64547112|NCT00241839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311943|NCT02106767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979285|NCT00108576|Anticonvulsants|anticonvulsants|mesh-ancestor
64979286|NCT00108576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979287|NCT00108576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979288|NCT00108576|GABA Agents|gaba agents|mesh-ancestor
64979289|NCT00108576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64436422|NCT01999179|Apixaban|apixaban|mesh-list
64436423|NCT01999179|Anticoagulants|anticoagulants|mesh-list
64436424|NCT01999179|Edoxaban|edoxaban|mesh-list
64547116|NCT00241839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64547118|NCT00241839|Protective Agents|protective agents|mesh-ancestor
64547119|NCT00241839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547120|NCT00241839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64547121|NCT00241839|Diuretics|diuretics|mesh-ancestor
64547122|NCT00241839|Natriuretic Agents|natriuretic agents|mesh-ancestor
64547123|NCT00241839|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64300975|NCT03281187|Methyltestosterone|methyltestosterone|mesh-list
64300977|NCT03281187|Testosterone undecanoate|testosterone undecanoate|mesh-list
64300978|NCT03281187|Testosterone enanthate|testosterone enanthate|mesh-list
64547124|NCT00241839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64547125|NCT05347381|Dexamethasone|dexamethasone|mesh-list
64547126|NCT05347381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64547127|NCT05347381|Antiemetics|antiemetics|mesh-ancestor
64547128|NCT05347381|Autonomic Agents|autonomic agents|mesh-ancestor
64547129|NCT05347381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547130|NCT05347381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547131|NCT05347381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64547132|NCT05347381|Glucocorticoids|glucocorticoids|mesh-ancestor
64503183|NCT03349866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547133|NCT05347381|Hormones|hormones|mesh-ancestor
64547134|NCT05347381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64547135|NCT05347381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64547136|NCT05347381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547137|NCT02651688|Enclomiphene|enclomiphene|mesh-list
64547138|NCT02651688|Clomiphene|clomiphene|mesh-list
64547139|NCT02651688|Zuclomiphene|zuclomiphene|mesh-list
64547140|NCT02651688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64779593|NCT03873402|Ipilimumab|ipilimumab|mesh-list
64547141|NCT02651688|Hormone Antagonists|hormone antagonists|mesh-ancestor
64547142|NCT02651688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64547143|NCT02651688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547145|NCT02651688|Fertility Agents|fertility agents|mesh-ancestor
64547154|NCT01276353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64547155|NCT01276353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547156|NCT01276353|Nootropic Agents|nootropic agents|mesh-ancestor
64547157|NCT03809013|Trastuzumab|trastuzumab|mesh-list
64547158|NCT03809013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64547159|NCT03809013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547161|NCT03807921|Warfarin|warfarin|mesh-list
64547162|NCT03807921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64547163|NCT03807921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64547164|NCT03807921|Analgesics|analgesics|mesh-ancestor
64547165|NCT03807921|Sensory System Agents|sensory system agents|mesh-ancestor
64547166|NCT03807921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64779624|NCT03778944|Dopamine Agents|dopamine agents|mesh-ancestor
64779680|NCT03436368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779681|NCT03393780|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64391062|NCT02702401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64391063|NCT02702401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64391064|NCT03116971|Etoposide|etoposide|mesh-list
64391065|NCT03116971|Peposertib|peposertib|mesh-list
64391066|NCT03116971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779682|NCT03393780|Hormones|hormones|mesh-ancestor
64779683|NCT03393780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64779684|NCT03393780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779685|NCT03367572|Dexamethasone|dexamethasone|mesh-list
64779686|NCT03367572|Dexamethasone acetate|dexamethasone acetate|mesh-list
64547167|NCT03807921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547168|NCT03807921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64547169|NCT03807921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64547170|NCT03807921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64547171|NCT03807921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64547172|NCT03807921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547173|NCT03807921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64547174|NCT03807921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64547175|NCT03807921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547176|NCT03807921|Antipyretics|antipyretics|mesh-ancestor
64547177|NCT03807921|Anticoagulants|anticoagulants|mesh-ancestor
64547178|NCT01675609|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64779709|NCT03367572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64547179|NCT01675609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64547180|NCT01675609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64547203|NCT00762177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64547204|NCT03458455|Pembrolizumab|pembrolizumab|mesh-list
64547205|NCT03458455|Nivolumab|nivolumab|mesh-list
64547206|NCT03458455|Ipilimumab|ipilimumab|mesh-list
64714172|NCT03065179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64547207|NCT03458455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64547208|NCT03458455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547209|NCT03458455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64547210|NCT03458455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547211|NCT02536794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64547212|NCT02536794|Durvalumab|durvalumab|mesh-list
64300979|NCT03281187|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64436485|NCT01759420|Antiemetics|antiemetics|mesh-ancestor
64547214|NCT02536794|Tremelimumab|tremelimumab|mesh-list
64547215|NCT02536794|Antibodies|antibodies|mesh-list
64547216|NCT02536794|Immunoglobulins|immunoglobulins|mesh-list
64547217|NCT02536794|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64547218|NCT02536794|Immunologic Factors|immunologic factors|mesh-ancestor
64547219|NCT02536794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547220|NCT02536794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64391139|NCT04643249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64391140|NCT04643249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64391141|NCT04643249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64779756|NCT03122262|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64779757|NCT03051282|Enalapril|enalapril|mesh-list
64779758|NCT03051282|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64779759|NCT03051282|Protease Inhibitors|protease inhibitors|mesh-ancestor
64779760|NCT03051282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779761|NCT03051282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779762|NCT03051282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64779763|NCT03042546|Calcium|calcium|mesh-list
64779764|NCT03042546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64547221|NCT02536794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64547222|NCT02536794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547223|NCT00777855|Rifampin|rifampin|mesh-list
64547224|NCT00777855|Warfarin|warfarin|mesh-list
64547225|NCT00777855|Anticoagulants|anticoagulants|mesh-ancestor
64547253|NCT05125380|Hemostatics|hemostatics|mesh-ancestor
64547254|NCT05125380|Coagulants|coagulants|mesh-ancestor
64547255|NCT00762645|Travoprost|travoprost|mesh-list
64547256|NCT00762645|Pilocarpine|pilocarpine|mesh-list
64547257|NCT00762645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64547258|NCT00762645|Miotics|miotics|mesh-ancestor
64547259|NCT00762645|Autonomic Agents|autonomic agents|mesh-ancestor
64547260|NCT00762645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547261|NCT00762645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547262|NCT00762645|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64547263|NCT00762645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64547264|NCT00762645|Cholinergic Agents|cholinergic agents|mesh-ancestor
64547265|NCT00762645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64547266|NCT00762645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547267|NCT02403193|Spartalizumab|spartalizumab|mesh-list
64547268|NCT02403193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64547269|NCT02403193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547270|NCT02403193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547271|NCT03807297|Dexmedetomidine|dexmedetomidine|mesh-list
64547272|NCT03807297|Nitrous Oxide|nitrous oxide|mesh-list
64547273|NCT03807297|Propofol|propofol|mesh-list
64547274|NCT03807297|Sevoflurane|sevoflurane|mesh-list
64547275|NCT03807297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64547276|NCT03807297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64547277|NCT03807297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547278|NCT03807297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64547279|NCT03807297|Anesthetics, General|anesthetics, general|mesh-ancestor
64547280|NCT03807297|Anesthetics|anesthetics|mesh-ancestor
64547281|NCT03807297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64300981|NCT03281187|Hormones|hormones|mesh-ancestor
64300982|NCT03281187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64300983|NCT03281187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300984|NCT03281187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64300985|NCT03281187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64300986|NCT03281187|Anabolic Agents|anabolic agents|mesh-ancestor
64300987|NCT05009342|Calpastatin|calpastatin|mesh-list
64300988|NCT05009342|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64300989|NCT05009342|Protease Inhibitors|protease inhibitors|mesh-ancestor
64300990|NCT05009342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300991|NCT05009342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300992|NCT03291249|Omeprazole|omeprazole|mesh-list
64547282|NCT03807297|Analgesics|analgesics|mesh-ancestor
64547283|NCT03807297|Sensory System Agents|sensory system agents|mesh-ancestor
64547284|NCT03807297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547285|NCT03807297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64547286|NCT03807297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64547293|NCT03573349|Ketamine|ketamine|mesh-list
64547295|NCT03573349|Sensory System Agents|sensory system agents|mesh-ancestor
64547296|NCT03573349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547297|NCT03573349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547298|NCT03573349|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64547299|NCT03573349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64547300|NCT03573349|Anesthetics, General|anesthetics, general|mesh-ancestor
64547301|NCT03573349|Anesthetics|anesthetics|mesh-ancestor
64547302|NCT03573349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64547303|NCT03573349|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64547304|NCT03573349|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64547305|NCT03573349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64993473|NCT02224781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779910|NCT02025036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779911|NCT02025036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779912|NCT01768338|Ofatumumab|ofatumumab|mesh-list
64779913|NCT01768338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779914|NCT01659606|Cyclosporine|cyclosporine|mesh-list
64779915|NCT01659606|Mycophenolic Acid|mycophenolic acid|mesh-list
64779916|NCT01659606|Fludarabine|fludarabine|mesh-list
64779917|NCT01659606|Alemtuzumab|alemtuzumab|mesh-list
64779918|NCT01659606|Tacrolimus|tacrolimus|mesh-list
64779919|NCT01659606|Cyclosporins|cyclosporins|mesh-list
64779920|NCT01659606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779921|NCT01659606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779933|NCT01659606|Antitubercular Agents|antitubercular agents|mesh-ancestor
64779934|NCT01659606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64779935|NCT01659606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64779936|NCT00819546|Everolimus|everolimus|mesh-list
64779937|NCT00819546|Midostaurin|midostaurin|mesh-list
64779938|NCT00819546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547306|NCT03573349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547307|NCT05387148|Cannabidiol|cannabidiol|mesh-list
64547308|NCT05387148|Anticonvulsants|anticonvulsants|mesh-ancestor
64547309|NCT03809637|Pemetrexed|pemetrexed|mesh-list
64547310|NCT03809637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547311|NCT03809637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547312|NCT03809637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547313|NCT03809637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64547314|NCT03809637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64547315|NCT03513445|Epinephrine|epinephrine|mesh-list
64547316|NCT03513445|Morphine|morphine|mesh-list
64547317|NCT03513445|Ropivacaine|ropivacaine|mesh-list
64547318|NCT03513445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64547346|NCT03802071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547347|NCT03802071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547348|NCT03802071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64547350|NCT03809793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64547351|NCT03809793|Antimetabolites|antimetabolites|mesh-ancestor
64547352|NCT03809793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547353|NCT03809793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64547355|NCT00758667|Protective Agents|protective agents|mesh-ancestor
64779968|NCT00596154|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64547356|NCT00758667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547357|NCT05041920|Omeprazole|omeprazole|mesh-list
64547358|NCT05041920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64547359|NCT05041920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64547360|NCT05041920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64547361|NCT05041920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547362|NCT05041920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547363|NCT03567577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64547364|NCT03508921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64547365|NCT03508921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64547366|NCT03508921|Trimethoprim|trimethoprim|mesh-list
64547367|NCT03508921|Sulfamethoxazole|sulfamethoxazole|mesh-list
64547368|NCT03508921|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64547369|NCT03508921|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64547370|NCT03508921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64547371|NCT03508921|Antitubercular Agents|antitubercular agents|mesh-ancestor
64547372|NCT03508921|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64547373|NCT03508921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547374|NCT03508921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547375|NCT03508921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64547376|NCT03508921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64547377|NCT03508921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547378|NCT03508921|Cholinergic Agents|cholinergic agents|mesh-ancestor
64547379|NCT03508921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979375|NCT00108771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64979376|NCT00108771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780014|NCT02421354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780015|NCT02421354|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64780016|NCT02421354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780017|NCT02422290|Ketamine|ketamine|mesh-list
64780018|NCT02422290|Analgesics|analgesics|mesh-ancestor
64979377|NCT00108771|Analgesics|analgesics|mesh-ancestor
64979378|NCT00108771|Sensory System Agents|sensory system agents|mesh-ancestor
64979379|NCT00108771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547381|NCT03508921|Renal Agents|renal agents|mesh-ancestor
64547382|NCT03508921|Antimalarials|antimalarials|mesh-ancestor
64547383|NCT03508921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64547384|NCT03508921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64547385|NCT03508921|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64547386|NCT03508921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547387|NCT03508921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64547388|NCT03508921|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64780035|NCT02430090|Narcotics|narcotics|mesh-ancestor
64547389|NCT03508921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64547390|NCT03506113|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64547391|NCT03506113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64547392|NCT03506113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64436642|NCT03565159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547407|NCT04412850|Tocolytic Agents|tocolytic agents|mesh-ancestor
64547408|NCT04412850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64547410|NCT00778167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64547423|NCT05008536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780100|NCT02462148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780101|NCT02462148|Anesthetics, Local|anesthetics, local|mesh-ancestor
64780102|NCT02462148|Anesthetics|anesthetics|mesh-ancestor
64780103|NCT02462148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64780104|NCT02462148|Sensory System Agents|sensory system agents|mesh-ancestor
64780105|NCT02462148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64780106|NCT02462148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64780107|NCT02462148|Adrenergic Agents|adrenergic agents|mesh-ancestor
64780108|NCT02462148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64780109|NCT02462148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64780110|NCT02462148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64780111|NCT02462148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64548758|NCT01678651|Hormones|hormones|mesh-ancestor
64780112|NCT02462148|Respiratory System Agents|respiratory system agents|mesh-ancestor
64391503|NCT04543643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64391504|NCT05377619|Buspirone|buspirone|mesh-list
64391505|NCT05377619|Prucalopride|prucalopride|mesh-list
64391506|NCT05377619|Laxatives|laxatives|mesh-ancestor
64391507|NCT05377619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64391508|NCT05377619|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64391509|NCT05377619|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64391510|NCT05377619|Serotonin Agents|serotonin agents|mesh-ancestor
64391511|NCT05377619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64391512|NCT05377619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547424|NCT05008536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547425|NCT05008536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64547426|NCT05008536|Immunologic Factors|immunologic factors|mesh-ancestor
64547427|NCT05008536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547428|NCT05008536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64547429|NCT05008536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64547430|NCT05008536|Alkylating Agents|alkylating agents|mesh-ancestor
64547431|NCT05008536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64547432|NCT04345419|Remdesivir|remdesivir|mesh-list
64547433|NCT04345419|Antimetabolites|antimetabolites|mesh-ancestor
64547434|NCT04345419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547435|NCT04345419|Antiviral Agents|antiviral agents|mesh-ancestor
64547436|NCT04345419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64547437|NCT01480076|4-Aminopyridine|4-aminopyridine|mesh-list
64547438|NCT01480076|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64547439|NCT01480076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64547440|NCT01480076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547441|NCT00759525|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
64547442|NCT00759525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64547443|NCT00759603|Rituximab|rituximab|mesh-list
64547444|NCT00759603|Lenalidomide|lenalidomide|mesh-list
64547445|NCT00759603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64312288|NCT03041948|Hormones|hormones|mesh-ancestor
64979380|NCT00108771|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64979381|NCT00108771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64979400|NCT00278824|Fentanyl|fentanyl|mesh-list
64979401|NCT00278824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64979402|NCT00278824|Narcotics|narcotics|mesh-ancestor
64300994|NCT03291249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64300995|NCT03291249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64300996|NCT03291249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780128|NCT02464176|BB 1101|bb 1101|mesh-list
64300997|NCT03291249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300998|NCT05013320|Glycopyrrolate|glycopyrrolate|mesh-list
64979403|NCT00278824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64979404|NCT00278824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979406|NCT00278824|Sensory System Agents|sensory system agents|mesh-ancestor
64979407|NCT00278824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64979408|NCT00278824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64979409|NCT00278824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64979410|NCT00278824|Anesthetics, General|anesthetics, general|mesh-ancestor
64979411|NCT00278824|Anesthetics|anesthetics|mesh-ancestor
64979412|NCT00278941|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64979413|NCT00278941|Antidepressive Agents|antidepressive agents|mesh-ancestor
64979414|NCT00278941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64979415|NCT00278941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64979416|NCT00278941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64979417|NCT00278941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64979418|NCT00278941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979419|NCT00279019|Tiotropium Bromide|tiotropium bromide|mesh-list
64979420|NCT00279019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64979421|NCT00279019|Autonomic Agents|autonomic agents|mesh-ancestor
64979422|NCT00279019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547446|NCT00759603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547447|NCT00759603|Immunologic Factors|immunologic factors|mesh-ancestor
64547448|NCT00759603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547449|NCT00759603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64547450|NCT00759603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64547451|NCT00759603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64547452|NCT00759603|Growth Substances|growth substances|mesh-ancestor
64547453|NCT00759603|Growth Inhibitors|growth inhibitors|mesh-ancestor
64547454|NCT03809325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64547455|NCT03809325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64547456|NCT03809325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64301000|NCT05013320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64301001|NCT05013320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64301002|NCT05013320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301003|NCT05013320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64301004|NCT05013320|Analgesics|analgesics|mesh-ancestor
64301005|NCT05013320|Sensory System Agents|sensory system agents|mesh-ancestor
64301006|NCT05013320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301007|NCT05013320|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64301008|NCT05013320|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64780155|NCT02464176|Mydriatics|mydriatics|mesh-ancestor
64301009|NCT05013320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64301010|NCT05013320|Adrenergic Agents|adrenergic agents|mesh-ancestor
64301011|NCT05013320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64301012|NCT05013320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301013|NCT05013320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64547458|NCT03809325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547459|NCT03809325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64547460|NCT03809325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64547461|NCT03809325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64547463|NCT03809325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64547464|NCT03809325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547465|NCT03809325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64547466|NCT03809325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64547467|NCT03809325|Dopamine Agents|dopamine agents|mesh-ancestor
64547468|NCT03510390|Metformin|metformin|mesh-list
64547469|NCT03510390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64547470|NCT03510390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547471|NCT03806673|Bupivacaine|bupivacaine|mesh-list
64547472|NCT03806673|Anesthetics, Local|anesthetics, local|mesh-ancestor
64547473|NCT03806673|Anesthetics|anesthetics|mesh-ancestor
64547474|NCT03806673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64547475|NCT03806673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547476|NCT03806673|Sensory System Agents|sensory system agents|mesh-ancestor
64547488|NCT03806595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547489|NCT03806595|Sensory System Agents|sensory system agents|mesh-ancestor
64547490|NCT03806595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547491|NCT03806595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64547492|NCT03806595|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64547493|NCT03806595|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64547494|NCT03806595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64547495|NCT03806595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547497|NCT03807999|Paclitaxel|paclitaxel|mesh-list
64547498|NCT03807999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64547499|NCT03807999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547500|NCT03807999|Tubulin Modulators|tubulin modulators|mesh-ancestor
64547501|NCT03807999|Antimitotic Agents|antimitotic agents|mesh-ancestor
64547502|NCT03807999|Mitosis Modulators|mitosis modulators|mesh-ancestor
64547503|NCT03807999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547504|NCT03807999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64547505|NCT03807999|Antimetabolites|antimetabolites|mesh-ancestor
64547506|NCT03807999|Antiviral Agents|antiviral agents|mesh-ancestor
64503560|NCT02064036|Fertility Agents|fertility agents|mesh-ancestor
64547507|NCT03807999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64548831|NCT05130684|Paclitaxel|paclitaxel|mesh-list
64547508|NCT03807999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547509|NCT03807999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64547510|NCT03807999|Immunologic Factors|immunologic factors|mesh-ancestor
64547511|NCT03807999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547512|NCT04762147|Acetaminophen|acetaminophen|mesh-list
64301014|NCT05013320|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64301015|NCT05013320|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64301016|NCT05013320|Cholinergic Agents|cholinergic agents|mesh-ancestor
64301018|NCT02437162|Ustekinumab|ustekinumab|mesh-list
64301019|NCT02437162|Dermatologic Agents|dermatologic agents|mesh-ancestor
64301020|NCT02437162|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64301021|NCT02437162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64301022|NCT02437162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64301023|NCT02437162|Immunologic Factors|immunologic factors|mesh-ancestor
64301024|NCT02437162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301025|NCT03291093|Flutemetamol|flutemetamol|mesh-list
64301026|NCT03291093|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64547514|NCT04762147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64547534|NCT04273737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547535|NCT04273737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547536|NCT04273737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64547538|NCT04273737|Sensory System Agents|sensory system agents|mesh-ancestor
64547539|NCT04273737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547541|NCT02963064|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64547542|NCT02963064|Immunologic Factors|immunologic factors|mesh-ancestor
64547543|NCT02963064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547544|NCT04183062|Gemcitabine|gemcitabine|mesh-list
64547546|NCT04183062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64547547|NCT04183062|Antimetabolites|antimetabolites|mesh-ancestor
64547548|NCT04183062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547549|NCT04183062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547550|NCT04183062|Antiviral Agents|antiviral agents|mesh-ancestor
64547551|NCT04183062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64547552|NCT04183062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547553|NCT04183062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64547554|NCT04183062|Immunologic Factors|immunologic factors|mesh-ancestor
64547555|NCT04183062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547556|NCT04183062|Tubulin Modulators|tubulin modulators|mesh-ancestor
64547557|NCT04183062|Antimitotic Agents|antimitotic agents|mesh-ancestor
64547558|NCT04183062|Mitosis Modulators|mitosis modulators|mesh-ancestor
64547559|NCT04325880|Tamsulosin|tamsulosin|mesh-list
64547560|NCT04325880|Solifenacin Succinate|solifenacin succinate|mesh-list
64547561|NCT04325880|Mirabegron|mirabegron|mesh-list
64547562|NCT04325880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64547563|NCT04325880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64547564|NCT04325880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64547565|NCT04325880|Adrenergic Agents|adrenergic agents|mesh-ancestor
64547566|NCT04325880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64547578|NCT04846218|Progestins|progestins|mesh-ancestor
64547579|NCT04846218|Hormones|hormones|mesh-ancestor
64547580|NCT04846218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64547581|NCT04846218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547582|NCT04846218|Luteolytic Agents|luteolytic agents|mesh-ancestor
64714173|NCT03065179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780270|NCT02500602|Doxazosin|doxazosin|mesh-list
64547583|NCT04846218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64547584|NCT04846218|Contraceptive Agents|contraceptive agents|mesh-ancestor
64301027|NCT03291093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301028|NCT02123563|Listerine|listerine|mesh-list
64301029|NCT02123563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64301032|NCT02122003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301033|NCT02122003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64301034|NCT02122003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64301035|NCT02122003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301036|NCT03079388|Azithromycin|azithromycin|mesh-list
64301037|NCT03079388|Pyrimethamine|pyrimethamine|mesh-list
64301038|NCT03079388|Sulfadoxine|sulfadoxine|mesh-list
64301039|NCT03079388|Albendazole|albendazole|mesh-list
64301040|NCT03079388|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64547585|NCT04846218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64547586|NCT04846218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64547587|NCT04846218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64547588|NCT04846218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547589|NCT02512692|Gemcitabine|gemcitabine|mesh-list
64547590|NCT02512692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312446|NCT03044912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64312447|NCT03044912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64312448|NCT03044912|Adrenergic Agents|adrenergic agents|mesh-ancestor
64312449|NCT03044912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64312450|NCT03044912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312451|NCT03044912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312452|NCT03044912|Urological Agents|urological agents|mesh-ancestor
64312453|NCT03041012|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64312454|NCT03041012|Romidepsin|romidepsin|mesh-list
64979423|NCT00279019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979424|NCT00279019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64979425|NCT00279019|Respiratory System Agents|respiratory system agents|mesh-ancestor
64979426|NCT00279019|Parasympatholytics|parasympatholytics|mesh-ancestor
64979427|NCT00279019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64979428|NCT00279019|Cholinergic Agents|cholinergic agents|mesh-ancestor
64780287|NCT02500836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64780288|NCT02500836|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64979429|NCT00279019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979430|NCT00279019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979431|NCT00108849|Estradiol|estradiol|mesh-list
64979432|NCT00108849|Estrogens|estrogens|mesh-ancestor
64979433|NCT00108849|Hormones|hormones|mesh-ancestor
64979434|NCT00108849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64979435|NCT00108849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979436|NCT00279253|Clonidine|clonidine|mesh-list
64979437|NCT00279253|Analgesics|analgesics|mesh-ancestor
64979438|NCT00279253|Sensory System Agents|sensory system agents|mesh-ancestor
64979449|NCT00279253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780317|NCT02515890|Analgesics|analgesics|mesh-ancestor
64780374|NCT02525718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64780375|NCT02525718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64780376|NCT02525718|Respiratory System Agents|respiratory system agents|mesh-ancestor
64780377|NCT02525718|Mydriatics|mydriatics|mesh-ancestor
64780378|NCT02525718|Sympathomimetics|sympathomimetics|mesh-ancestor
64780379|NCT02525718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64780380|NCT02527512|Povidone-Iodine|povidone-iodine|mesh-list
64780381|NCT02527512|Povidone|povidone|mesh-list
64780382|NCT02527512|Plasma Substitutes|plasma substitutes|mesh-ancestor
64979451|NCT00109044|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64979452|NCT00109044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64979453|NCT00109044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64979454|NCT00109044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979455|NCT00109044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979456|NCT00109044|Serotonin Agents|serotonin agents|mesh-ancestor
64547592|NCT02512692|Antimetabolites|antimetabolites|mesh-ancestor
64547593|NCT02512692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547594|NCT02512692|Antiviral Agents|antiviral agents|mesh-ancestor
64547595|NCT02512692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64547596|NCT02512692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547597|NCT02512692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64547598|NCT02512692|Immunologic Factors|immunologic factors|mesh-ancestor
64547599|NCT02512692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547600|NCT01594398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64547601|NCT01594398|Exemestane|exemestane|mesh-list
64547602|NCT01594398|Entinostat|entinostat|mesh-list
64547603|NCT01594398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780417|NCT02538042|Autonomic Agents|autonomic agents|mesh-ancestor
64324254|NCT01520545|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64324255|NCT01520545|GABA Agonists|gaba agonists|mesh-ancestor
64324256|NCT01520545|GABA Agents|gaba agents|mesh-ancestor
64324257|NCT01520545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64324258|NCT01520545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324259|NCT05488106|Riboflavin|riboflavin|mesh-list
64324260|NCT05488106|Vitamin B Complex|vitamin b complex|mesh-ancestor
64324261|NCT05488106|Vitamins|vitamins|mesh-ancestor
64324262|NCT05488106|Micronutrients|micronutrients|mesh-ancestor
64324263|NCT05488106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547604|NCT01594398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64547605|NCT01594398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547606|NCT01594398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301041|NCT03079388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64301042|NCT03079388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64301043|NCT03079388|Antimalarials|antimalarials|mesh-ancestor
64301044|NCT03079388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64301045|NCT03079388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64301046|NCT03079388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64301047|NCT03079388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64301048|NCT03079388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547608|NCT01594398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64547609|NCT01594398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64547610|NCT01594398|Hormone Antagonists|hormone antagonists|mesh-ancestor
64547611|NCT01594398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64547612|NCT01594398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547613|NCT01594398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64547614|NCT00782379|Mycophenolic Acid|mycophenolic acid|mesh-list
64547615|NCT00782379|Cyclophosphamide|cyclophosphamide|mesh-list
64547617|NCT00782379|Fludarabine|fludarabine|mesh-list
64547618|NCT00782379|Fludarabine phosphate|fludarabine phosphate|mesh-list
64547619|NCT00782379|Tacrolimus|tacrolimus|mesh-list
64979457|NCT00109044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979458|NCT00109044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64780511|NCT02560038|Paclitaxel|paclitaxel|mesh-list
64979459|NCT00109044|Antidepressive Agents|antidepressive agents|mesh-ancestor
64979460|NCT00109044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64979461|NCT00279448|Tamoxifen|tamoxifen|mesh-list
64979462|NCT00279448|Exemestane|exemestane|mesh-list
64979463|NCT00279448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64979464|NCT00279448|Hormone Antagonists|hormone antagonists|mesh-ancestor
64979465|NCT00279448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64979466|NCT00279448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979467|NCT00279448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64979468|NCT00279448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979469|NCT00279448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64979470|NCT00279448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64780649|NCT05248152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64780650|NCT05248152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780651|NCT05248152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780652|NCT05248152|Anticonvulsants|anticonvulsants|mesh-ancestor
64780653|NCT05248152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64780654|NCT05248152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64780655|NCT05248152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64780656|NCT05248152|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64780657|NCT05248152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64780658|NCT05248152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64780659|NCT05248152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64547620|NCT00782379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64547621|NCT00782379|Immunologic Factors|immunologic factors|mesh-ancestor
64547622|NCT00782379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547623|NCT00782379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64547624|NCT00782379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64547625|NCT00782379|Alkylating Agents|alkylating agents|mesh-ancestor
64547626|NCT00782379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547627|NCT00782379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547628|NCT00782379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64547629|NCT00782379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64547630|NCT00782379|Antimetabolites|antimetabolites|mesh-ancestor
64547631|NCT00782379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64549380|NCT04382781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549385|NCT04348032|Apatinib|apatinib|mesh-list
64547632|NCT00782379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547633|NCT00782379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64312503|NCT03189069|Dabigatran|dabigatran|mesh-list
64979471|NCT00279448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64979472|NCT00279448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64979473|NCT00279448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64979474|NCT00279448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979475|NCT00279448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979476|NCT00075959|Disufenton sodium|disufenton sodium|mesh-list
64979477|NCT00075959|Antioxidants|antioxidants|mesh-ancestor
64979478|NCT00075959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979479|NCT00075959|Protective Agents|protective agents|mesh-ancestor
64979480|NCT00075959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979481|NCT00279487|Gabapentin|gabapentin|mesh-list
64979482|NCT00279487|Analgesics|analgesics|mesh-ancestor
64979483|NCT00279487|Sensory System Agents|sensory system agents|mesh-ancestor
64979484|NCT00279487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64979485|NCT00279487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979486|NCT00279487|Anticonvulsants|anticonvulsants|mesh-ancestor
64979487|NCT00279487|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64979488|NCT00279487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64979489|NCT00279487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64979490|NCT00279487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64979491|NCT00279487|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64979492|NCT00279487|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64979493|NCT00279487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979494|NCT00279487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979495|NCT00279487|Antimanic Agents|antimanic agents|mesh-ancestor
64979496|NCT00279565|Interferons|interferons|mesh-list
64979498|NCT00279565|Interferon-alpha|interferon-alpha|mesh-list
64979499|NCT00279565|Interferon alpha-2|interferon alpha-2|mesh-list
64392204|NCT03968939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64392205|NCT03968939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64392206|NCT03968939|Anesthetics, Local|anesthetics, local|mesh-ancestor
64392207|NCT03968939|Anesthetics|anesthetics|mesh-ancestor
64392208|NCT03968939|Sensory System Agents|sensory system agents|mesh-ancestor
64392209|NCT03968939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392210|NCT03968939|Antiemetics|antiemetics|mesh-ancestor
64979500|NCT00279565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64979501|NCT00279565|Buprenorphine|buprenorphine|mesh-list
64979513|NCT00279565|Analgesics|analgesics|mesh-ancestor
64301049|NCT03079388|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64301050|NCT03079388|Renal Agents|renal agents|mesh-ancestor
64301051|NCT03079388|Anthelmintics|anthelmintics|mesh-ancestor
64301052|NCT03079388|Anticestodal Agents|anticestodal agents|mesh-ancestor
64301053|NCT03079388|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64301054|NCT03079388|Tubulin Modulators|tubulin modulators|mesh-ancestor
64301055|NCT03079388|Antimitotic Agents|antimitotic agents|mesh-ancestor
64301056|NCT03079388|Mitosis Modulators|mitosis modulators|mesh-ancestor
64301057|NCT03079388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301058|NCT03079544|Asparaginase|asparaginase|mesh-list
64301059|NCT03079544|Pegaspargase|pegaspargase|mesh-list
64301060|NCT03079544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780826|NCT02595684|Urological Agents|urological agents|mesh-ancestor
64780827|NCT02604810|Immunoglobulins|immunoglobulins|mesh-list
64780828|NCT02604810|Antibodies|antibodies|mesh-list
64780829|NCT02604810|gamma-Globulins|gamma-globulins|mesh-list
64301062|NCT03286101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64301063|NCT03286101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64301064|NCT02437084|Atorvastatin|atorvastatin|mesh-list
64301065|NCT02437084|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64301066|NCT02437084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64547649|NCT04572828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547650|NCT04572828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547651|NCT05134350|Omeprazole|omeprazole|mesh-list
64547652|NCT05134350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64547653|NCT05134350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64547654|NCT05134350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64547655|NCT05134350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64714174|NCT03065179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64301067|NCT02437084|Antimetabolites|antimetabolites|mesh-ancestor
64301068|NCT02437084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301069|NCT02437084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64547656|NCT05134350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547657|NCT05134194|Gemcitabine|gemcitabine|mesh-list
64979528|NCT00109161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979529|NCT00109161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64979531|NCT00279760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64979532|NCT00279760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979533|NCT00279760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979534|NCT00279760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64979535|NCT00279760|Immunologic Factors|immunologic factors|mesh-ancestor
64979536|NCT00279760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780870|NCT05731596|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64979537|NCT00279760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64979538|NCT00109200|Omalizumab|omalizumab|mesh-list
64979539|NCT00109200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64979540|NCT00109200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64979541|NCT00109200|Respiratory System Agents|respiratory system agents|mesh-ancestor
64979542|NCT00416728|Valsartan|valsartan|mesh-list
64979543|NCT00416728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64979544|NCT00416728|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64392306|NCT04658836|Hormones|hormones|mesh-ancestor
64979545|NCT00416728|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64979546|NCT00416728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979547|NCT00416767|Leucovorin|leucovorin|mesh-list
64979548|NCT00416767|Fluorouracil|fluorouracil|mesh-list
64979549|NCT00416767|Irinotecan|irinotecan|mesh-list
64979550|NCT00416767|Calcium|calcium|mesh-list
64979551|NCT00416767|Levoleucovorin|levoleucovorin|mesh-list
64547659|NCT05134194|Vinorelbine|vinorelbine|mesh-list
64547660|NCT05134194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64547661|NCT05134194|Antimetabolites|antimetabolites|mesh-ancestor
64547662|NCT05134194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547663|NCT05134194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547664|NCT05134194|Antiviral Agents|antiviral agents|mesh-ancestor
64547665|NCT05134194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64547666|NCT05134194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547667|NCT05134194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64547668|NCT05134194|Immunologic Factors|immunologic factors|mesh-ancestor
64547669|NCT05134194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437035|NCT05764733|Diphosphonates|diphosphonates|mesh-list
64547670|NCT05134194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64547671|NCT05134194|Tubulin Modulators|tubulin modulators|mesh-ancestor
64547672|NCT05134194|Antimitotic Agents|antimitotic agents|mesh-ancestor
64547673|NCT05134194|Mitosis Modulators|mitosis modulators|mesh-ancestor
64547675|NCT04435704|Oxytocics|oxytocics|mesh-ancestor
64547676|NCT04435704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64312537|NCT02304484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64979552|NCT00416767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64979553|NCT00416767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392341|NCT05097365|Vitamin B Complex|vitamin b complex|mesh-ancestor
64979554|NCT00416767|Antimetabolites|antimetabolites|mesh-ancestor
64979555|NCT00416767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979556|NCT00416767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64979557|NCT00416767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979558|NCT00416767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64979559|NCT00416767|Immunologic Factors|immunologic factors|mesh-ancestor
64979560|NCT00416767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64979572|NCT00076115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979573|NCT00076115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979574|NCT00076115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64979575|NCT00076115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64979576|NCT00076115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64979577|NCT00076115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64979578|NCT00076115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64979580|NCT00109239|Bevacizumab|bevacizumab|mesh-list
64979581|NCT00109239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64979582|NCT00109239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979583|NCT00109239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64979584|NCT00109239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64979585|NCT00109239|Growth Substances|growth substances|mesh-ancestor
64979586|NCT00109239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979587|NCT00109239|Growth Inhibitors|growth inhibitors|mesh-ancestor
64979588|NCT00280033|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64979589|NCT00280033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64979590|NCT00280033|Immunologic Factors|immunologic factors|mesh-ancestor
64979591|NCT00280033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979592|NCT00280033|Antacids|antacids|mesh-ancestor
64979593|NCT00280033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979594|NCT00280033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64979595|NCT00109278|Vaccines|vaccines|mesh-list
64979596|NCT00109278|Immunologic Factors|immunologic factors|mesh-ancestor
64979597|NCT00109278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979598|NCT00280267|Testosterone|testosterone|mesh-list
64979599|NCT00280267|Androgens|androgens|mesh-ancestor
64979600|NCT00280267|Hormones|hormones|mesh-ancestor
64547677|NCT04435704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547678|NCT00761085|Morphine|morphine|mesh-list
64547679|NCT00761085|Methadone|methadone|mesh-list
64547680|NCT00761085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64547681|NCT00761085|Narcotics|narcotics|mesh-ancestor
64547682|NCT00761085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64301070|NCT02437084|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64301071|NCT02437084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64301072|NCT05009498|Vitamin D|vitamin d|mesh-list
64301073|NCT05009498|Cholecalciferol|cholecalciferol|mesh-list
64301074|NCT05009498|Vitamins|vitamins|mesh-ancestor
64301075|NCT05009498|Micronutrients|micronutrients|mesh-ancestor
64301076|NCT05009498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301077|NCT05009498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64301078|NCT05009498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64301079|NCT02406586|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
64301080|NCT02406586|Carvedilol|carvedilol|mesh-list
64547684|NCT00761085|Analgesics|analgesics|mesh-ancestor
64547685|NCT00761085|Sensory System Agents|sensory system agents|mesh-ancestor
64547686|NCT00761085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547687|NCT00761085|Antitussive Agents|antitussive agents|mesh-ancestor
64547688|NCT00761085|Respiratory System Agents|respiratory system agents|mesh-ancestor
64547689|NCT02145039|Cyclophosphamide|cyclophosphamide|mesh-list
64547690|NCT02145039|Fludarabine|fludarabine|mesh-list
64547691|NCT02145039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64547692|NCT02145039|Immunologic Factors|immunologic factors|mesh-ancestor
64547693|NCT02145039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547694|NCT02145039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64547695|NCT02145039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64547696|NCT02145039|Alkylating Agents|alkylating agents|mesh-ancestor
64547697|NCT02145039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547698|NCT02145039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312574|NCT02708355|Esomeprazole|esomeprazole|mesh-list
64979601|NCT00280267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64979602|NCT00280267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979603|NCT00076232|Acyclovir|acyclovir|mesh-list
64979604|NCT00076232|Antiviral Agents|antiviral agents|mesh-ancestor
64979605|NCT00076232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64781234|NCT03529890|Nivolumab|nivolumab|mesh-list
64979606|NCT00280423|Casopitant|casopitant|mesh-list
64979607|NCT00280423|Antiemetics|antiemetics|mesh-ancestor
64979608|NCT00280423|Autonomic Agents|autonomic agents|mesh-ancestor
64979609|NCT00280423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64979610|NCT00280423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979611|NCT00280423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64979612|NCT00280423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64979613|NCT00280423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979614|NCT00280423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979615|NCT00109356|AQ4N|aq4n|mesh-list
64979616|NCT00109356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979617|NCT00280462|Nifedipine|nifedipine|mesh-list
64979618|NCT00280462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64979619|NCT00280462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64979620|NCT00280462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979621|NCT00280462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64979622|NCT00280462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392674|NCT02400151|Vitamin D|vitamin d|mesh-list
64979643|NCT00280540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64979644|NCT00280540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979645|NCT00280540|Diuretics|diuretics|mesh-ancestor
64979646|NCT00280540|Natriuretic Agents|natriuretic agents|mesh-ancestor
64979647|NCT00280540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979648|NCT00280540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64547699|NCT02145039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64547701|NCT03806049|Bevacizumab|bevacizumab|mesh-list
64547702|NCT03806049|Carboplatin|carboplatin|mesh-list
64547703|NCT03806049|Niraparib|niraparib|mesh-list
64547704|NCT03806049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64547705|NCT03806049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547706|NCT03806049|Tubulin Modulators|tubulin modulators|mesh-ancestor
64547707|NCT03806049|Antimitotic Agents|antimitotic agents|mesh-ancestor
64547708|NCT03806049|Mitosis Modulators|mitosis modulators|mesh-ancestor
64547709|NCT03806049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547710|NCT03806049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64312577|NCT02708355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64979649|NCT00280540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64979650|NCT00076349|Rituximab|rituximab|mesh-list
64979651|NCT00076349|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64979652|NCT00076349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64979653|NCT00076349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979654|NCT00076349|Immunologic Factors|immunologic factors|mesh-ancestor
64979655|NCT00076349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979656|NCT00076349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64979657|NCT00076349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64979658|NCT00076349|Alkylating Agents|alkylating agents|mesh-ancestor
64979659|NCT00076349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979660|NCT00280618|Oxaliplatin|oxaliplatin|mesh-list
64979662|NCT00416845|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64979663|NCT00416845|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64979664|NCT00416845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979665|NCT00416845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64979666|NCT00416845|Immunologic Factors|immunologic factors|mesh-ancestor
64979667|NCT00416845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979668|NCT00280696|Levetiracetam|levetiracetam|mesh-list
64979669|NCT00280696|Anticonvulsants|anticonvulsants|mesh-ancestor
64979670|NCT00280696|Nootropic Agents|nootropic agents|mesh-ancestor
64979671|NCT00076388|Docetaxel|docetaxel|mesh-list
64979672|NCT00076388|Gefitinib|gefitinib|mesh-list
64781289|NCT02369406|Antiviral Agents|antiviral agents|mesh-ancestor
64979673|NCT00076388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979674|NCT00076388|Tubulin Modulators|tubulin modulators|mesh-ancestor
64979675|NCT00076388|Antimitotic Agents|antimitotic agents|mesh-ancestor
64979676|NCT00076388|Mitosis Modulators|mitosis modulators|mesh-ancestor
64979696|NCT00109551|Astringents|astringents|mesh-ancestor
64979697|NCT00109551|Dermatologic Agents|dermatologic agents|mesh-ancestor
64979698|NCT00280930|Letrozole|letrozole|mesh-list
64979699|NCT00280930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979700|NCT00280930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64979701|NCT00280930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64979702|NCT00280930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993474|NCT02224781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64781304|NCT02652390|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64979703|NCT00280930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979704|NCT00280930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64979705|NCT00280930|Hormone Antagonists|hormone antagonists|mesh-ancestor
64979706|NCT00280930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64979707|NCT00280930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979708|NCT04730297|Acetaminophen|acetaminophen|mesh-list
64979709|NCT04730297|Ibuprofen|ibuprofen|mesh-list
64979710|NCT04730297|Codeine|codeine|mesh-list
64979711|NCT04730297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64979712|NCT04730297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64979713|NCT04730297|Analgesics|analgesics|mesh-ancestor
64301081|NCT02406586|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64301082|NCT02406586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64301083|NCT02406586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64301084|NCT02406586|Adrenergic Agents|adrenergic agents|mesh-ancestor
64301085|NCT02406586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64301086|NCT02406586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301087|NCT02406586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301088|NCT02406586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64301089|NCT02406586|Antioxidants|antioxidants|mesh-ancestor
64301090|NCT02406586|Protective Agents|protective agents|mesh-ancestor
64301091|NCT02406586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64301092|NCT02406586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64301093|NCT02406586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64979715|NCT04730297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64979716|NCT04730297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547711|NCT03806049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64547712|NCT03806049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64547713|NCT03806049|Growth Substances|growth substances|mesh-ancestor
64547714|NCT03806049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547715|NCT03806049|Growth Inhibitors|growth inhibitors|mesh-ancestor
64547716|NCT03806049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64547717|NCT03806049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547718|NCT00089479|Capecitabine|capecitabine|mesh-list
64547720|NCT00089479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64547721|NCT00089479|Antimetabolites|antimetabolites|mesh-ancestor
64547722|NCT00089479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547723|NCT00089479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547724|NCT00089479|Tubulin Modulators|tubulin modulators|mesh-ancestor
64547725|NCT00089479|Antimitotic Agents|antimitotic agents|mesh-ancestor
64547726|NCT00089479|Mitosis Modulators|mitosis modulators|mesh-ancestor
64547727|NCT01463306|Pregabalin|pregabalin|mesh-list
64547728|NCT01463306|Analgesics|analgesics|mesh-ancestor
64979717|NCT04730297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64979718|NCT04730297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64979719|NCT04730297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64979720|NCT04730297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979721|NCT04730297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979722|NCT04730297|Antipyretics|antipyretics|mesh-ancestor
64979723|NCT04730297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64979724|NCT04730297|Narcotics|narcotics|mesh-ancestor
64979725|NCT04730297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64979726|NCT04730297|Antitussive Agents|antitussive agents|mesh-ancestor
64979727|NCT04730297|Respiratory System Agents|respiratory system agents|mesh-ancestor
64979728|NCT00280969|Efavirenz|efavirenz|mesh-list
64979729|NCT00280969|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64979730|NCT00280969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64979731|NCT00280969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64979732|NCT00280969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979748|NCT00281008|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64979749|NCT00281008|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64979750|NCT00281008|Antimetabolites|antimetabolites|mesh-ancestor
64781465|NCT02673372|Ketamine|ketamine|mesh-list
64979751|NCT00281008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301094|NCT02406586|Vasodilator Agents|vasodilator agents|mesh-ancestor
64301095|NCT02406586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64301096|NCT02406586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64301097|NCT02406586|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64301098|NCT02406586|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64301099|NCT02406586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64301100|NCT02406586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64301101|NCT02406586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64301102|NCT02406586|Analgesics|analgesics|mesh-ancestor
64301103|NCT02406586|Sensory System Agents|sensory system agents|mesh-ancestor
64301104|NCT02406586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301105|NCT02406586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64301106|NCT02406586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64301107|NCT03091166|Dexmedetomidine|dexmedetomidine|mesh-list
64301108|NCT03091166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64979752|NCT00281008|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64979753|NCT00281125|Pemetrexed|pemetrexed|mesh-list
64979754|NCT00281125|Vatalanib|vatalanib|mesh-list
64979755|NCT00281125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979756|NCT00281125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979757|NCT00281125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979758|NCT00281125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64979759|NCT00281125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64979760|NCT00281125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64979761|NCT00109746|Chromium|chromium|mesh-list
64979762|NCT00109746|Picolinic acid|picolinic acid|mesh-list
64979763|NCT00109746|Trace Elements|trace elements|mesh-ancestor
64979764|NCT00109746|Micronutrients|micronutrients|mesh-ancestor
64979765|NCT00109746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979766|NCT00109746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64979767|NCT00109746|Chelating Agents|chelating agents|mesh-ancestor
64979768|NCT00109746|Sequestering Agents|sequestering agents|mesh-ancestor
64979769|NCT00109746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547729|NCT01463306|Sensory System Agents|sensory system agents|mesh-ancestor
64547730|NCT01463306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547731|NCT01463306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547732|NCT01463306|Anticonvulsants|anticonvulsants|mesh-ancestor
64547733|NCT01463306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64547734|NCT01463306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64392911|NCT02406781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547735|NCT01463306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547736|NCT01463306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64547737|NCT01463306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64547738|NCT01463306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64547739|NCT01463306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64547740|NCT01463306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64547741|NCT05055726|Benzydamine|benzydamine|mesh-list
64547742|NCT05055726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64547743|NCT00765375|Botulinum Toxins|botulinum toxins|mesh-list
64312607|NCT03043196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64312609|NCT03188835|Glycerol|glycerol|mesh-list
64979770|NCT00399269|Epoetin Alfa|epoetin alfa|mesh-list
64979771|NCT00399269|Hematinics|hematinics|mesh-ancestor
64979772|NCT00281281|Vancomycin|vancomycin|mesh-list
64979773|NCT00281281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64979774|NCT00281281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64979775|NCT00109785|Idoxuridine|idoxuridine|mesh-list
64979776|NCT00109785|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64979777|NCT00109785|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64979778|NCT00109785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979779|NCT00109785|Antiviral Agents|antiviral agents|mesh-ancestor
64979780|NCT00109785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64979781|NCT00109785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64979782|NCT00109785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979783|NCT00281476|Simvastatin|simvastatin|mesh-list
64979784|NCT00281476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64979785|NCT00281476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64979786|NCT00281476|Antimetabolites|antimetabolites|mesh-ancestor
64979787|NCT00281476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979788|NCT00281476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64979789|NCT00281476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64979815|NCT00109824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64979816|NCT00109824|Antimetabolites|antimetabolites|mesh-ancestor
64979817|NCT00109824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979818|NCT00109824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979819|NCT00109824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979820|NCT00109824|Anticonvulsants|anticonvulsants|mesh-ancestor
64979821|NCT00109824|GABA Agents|gaba agents|mesh-ancestor
64979822|NCT00109824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979823|NCT00109824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979824|NCT00109824|Antimanic Agents|antimanic agents|mesh-ancestor
64979825|NCT00109824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64979826|NCT00109824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64979827|NCT00109824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64979828|NCT00281515|Lonafarnib|lonafarnib|mesh-list
64979829|NCT00281515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979830|NCT00281515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979832|NCT00109941|Mitogens|mitogens|mesh-list
64547745|NCT00765375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64547746|NCT00765375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64547747|NCT00765375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64547748|NCT00765375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547749|NCT00765375|Cholinergic Agents|cholinergic agents|mesh-ancestor
64547750|NCT00765375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64547751|NCT00765375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547752|NCT00765375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64392980|NCT02658149|Analgesics|analgesics|mesh-ancestor
64547753|NCT00765375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547754|NCT03451591|Cilostazol|cilostazol|mesh-list
64547755|NCT03451591|Isosorbide|isosorbide|mesh-list
64547756|NCT03451591|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64547757|NCT03451591|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64547758|NCT03451591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64547759|NCT03451591|Autonomic Agents|autonomic agents|mesh-ancestor
64547760|NCT03451591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547761|NCT03451591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547762|NCT03451591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64547763|NCT03451591|Respiratory System Agents|respiratory system agents|mesh-ancestor
64979833|NCT00109941|Enkephalin, Methionine|enkephalin, methionine|mesh-list
64979834|NCT00109941|Narcotics|narcotics|mesh-ancestor
64979835|NCT00109941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64979836|NCT00109941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393024|NCT03172741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979837|NCT00109941|Analgesics|analgesics|mesh-ancestor
64979838|NCT00109941|Sensory System Agents|sensory system agents|mesh-ancestor
64979839|NCT00109941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64979840|NCT00109941|Mitosis Modulators|mitosis modulators|mesh-ancestor
64979841|NCT00109941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979868|NCT00281710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64979870|NCT00281710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64979871|NCT00281710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979872|NCT00076544|Ziconotide|ziconotide|mesh-list
64979873|NCT00076544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64979874|NCT00076544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64781642|NCT05443932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64781643|NCT05443308|Acetazolamide|acetazolamide|mesh-list
64781644|NCT05443308|Anticonvulsants|anticonvulsants|mesh-ancestor
64781645|NCT05443308|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64781646|NCT05443308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781647|NCT05443308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781648|NCT05443308|Diuretics|diuretics|mesh-ancestor
64781649|NCT05443308|Natriuretic Agents|natriuretic agents|mesh-ancestor
64781650|NCT05443308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781651|NCT05442996|Antibodies|antibodies|mesh-list
64781652|NCT05442996|Immunoglobulins|immunoglobulins|mesh-list
64781653|NCT05442996|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64781654|NCT05442996|Immunologic Factors|immunologic factors|mesh-ancestor
64781655|NCT05442996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781656|NCT05439564|Dexmedetomidine|dexmedetomidine|mesh-list
64781657|NCT05439564|Morphine|morphine|mesh-list
64550294|NCT00853671|Purinergic Agonists|purinergic agonists|mesh-ancestor
64781658|NCT05439564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64303945|NCT02359097|Hematinics|hematinics|mesh-ancestor
64303947|NCT02359097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64303954|NCT05284214|Sargramostim|sargramostim|mesh-list
64303955|NCT05284214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64979875|NCT00076544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979876|NCT00076544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64301109|NCT03091166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64301110|NCT03091166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301111|NCT03091166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64301112|NCT03091166|Analgesics|analgesics|mesh-ancestor
64301113|NCT03091166|Sensory System Agents|sensory system agents|mesh-ancestor
64301114|NCT03091166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301115|NCT03091166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64301116|NCT03091166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64301117|NCT03091166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64979878|NCT00076544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64979879|NCT00076544|Protective Agents|protective agents|mesh-ancestor
64979880|NCT00076544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64979881|NCT00076544|Analgesics|analgesics|mesh-ancestor
64979882|NCT00076544|Sensory System Agents|sensory system agents|mesh-ancestor
64979883|NCT00076544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64979884|NCT00281788|Paclitaxel|paclitaxel|mesh-list
64979885|NCT00281788|Carboplatin|carboplatin|mesh-list
64979886|NCT00281788|Capecitabine|capecitabine|mesh-list
64979905|NCT00281905|Immunologic Factors|immunologic factors|mesh-ancestor
64979906|NCT00281905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979907|NCT00281905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64979908|NCT00281905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64547764|NCT03451591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64547765|NCT03451591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64547766|NCT03451591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547767|NCT03451591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64547768|NCT03451591|Vasodilator Agents|vasodilator agents|mesh-ancestor
64547769|NCT03451591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64547770|NCT03451591|Protective Agents|protective agents|mesh-ancestor
64547771|NCT03451591|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64547772|NCT03451591|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64547773|NCT03451591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547774|NCT03451591|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64547775|NCT03451591|Diuretics|diuretics|mesh-ancestor
64547776|NCT03451591|Natriuretic Agents|natriuretic agents|mesh-ancestor
64979909|NCT00281905|Alkylating Agents|alkylating agents|mesh-ancestor
64979910|NCT00281905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979911|NCT00281905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979912|NCT00281905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64979913|NCT00281905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64979914|NCT00281905|Abortifacient Agents|abortifacient agents|mesh-ancestor
64979915|NCT00281905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64979916|NCT00281905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64979918|NCT00281905|Dermatologic Agents|dermatologic agents|mesh-ancestor
64979919|NCT00281905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979920|NCT00281905|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64979921|NCT00281905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64979922|NCT00281905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64979923|NCT00281905|Tubulin Modulators|tubulin modulators|mesh-ancestor
64979924|NCT00281905|Antimitotic Agents|antimitotic agents|mesh-ancestor
64979925|NCT00281905|Mitosis Modulators|mitosis modulators|mesh-ancestor
64979926|NCT00110058|Interferons|interferons|mesh-list
64979927|NCT00110058|Interferon-alpha|interferon-alpha|mesh-list
64979928|NCT00110058|Cyclosporine|cyclosporine|mesh-list
64979929|NCT00110058|Mycophenolic Acid|mycophenolic acid|mesh-list
64979930|NCT00110058|Fludarabine|fludarabine|mesh-list
64979931|NCT00110058|Fludarabine phosphate|fludarabine phosphate|mesh-list
64301118|NCT03091166|Adrenergic Agents|adrenergic agents|mesh-ancestor
64301119|NCT03091166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64301120|NCT03091166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301121|NCT02122393|Sertraline|sertraline|mesh-list
64301122|NCT02122393|Antidepressive Agents|antidepressive agents|mesh-ancestor
64301123|NCT02122393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64979932|NCT00110058|Imatinib Mesylate|imatinib mesylate|mesh-list
64979933|NCT00110058|Cyclosporins|cyclosporins|mesh-list
64979934|NCT00110058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979935|NCT00110058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64979936|NCT00110058|Antimetabolites|antimetabolites|mesh-ancestor
64979937|NCT00110058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979938|NCT00110058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64979939|NCT00110058|Immunologic Factors|immunologic factors|mesh-ancestor
64979940|NCT00110058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979941|NCT00110058|Antiviral Agents|antiviral agents|mesh-ancestor
64979942|NCT00110058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64979970|NCT00281944|Micronutrients|micronutrients|mesh-ancestor
64979971|NCT00281983|Cyclosporine|cyclosporine|mesh-list
64979972|NCT00281983|Mycophenolic Acid|mycophenolic acid|mesh-list
64979973|NCT00281983|Cyclophosphamide|cyclophosphamide|mesh-list
64979975|NCT00281983|Rituximab|rituximab|mesh-list
64979976|NCT00281983|Methotrexate|methotrexate|mesh-list
64979977|NCT00281983|Fludarabine|fludarabine|mesh-list
64979978|NCT00281983|Fludarabine phosphate|fludarabine phosphate|mesh-list
64979979|NCT00281983|Alemtuzumab|alemtuzumab|mesh-list
64979980|NCT00281983|Cyclosporins|cyclosporins|mesh-list
64979981|NCT00281983|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64979982|NCT00281983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64979983|NCT00281983|Immunologic Factors|immunologic factors|mesh-ancestor
64979984|NCT00281983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979985|NCT00281983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64979986|NCT00281983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64979987|NCT00281983|Alkylating Agents|alkylating agents|mesh-ancestor
64547777|NCT03451591|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64547779|NCT05744115|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64547780|NCT05744115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547781|NCT01677559|Paclitaxel|paclitaxel|mesh-list
64547782|NCT01677559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64547783|NCT01677559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547784|NCT01677559|Tubulin Modulators|tubulin modulators|mesh-ancestor
64547785|NCT01677559|Antimitotic Agents|antimitotic agents|mesh-ancestor
64547786|NCT01677559|Mitosis Modulators|mitosis modulators|mesh-ancestor
64547787|NCT01677559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547788|NCT05132712|Losartan|losartan|mesh-list
64547789|NCT05132712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64547790|NCT05132712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64547791|NCT05132712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64547792|NCT05132712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64547793|NCT05132712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547794|NCT02149173|Deoxyglucose|deoxyglucose|mesh-list
64547795|NCT02149173|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64547796|NCT02149173|Fluorides|fluorides|mesh-list
64547797|NCT02149173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64547798|NCT02149173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547799|NCT02149173|Cariostatic Agents|cariostatic agents|mesh-ancestor
64312657|NCT02429973|Antifungal Agents|antifungal agents|mesh-ancestor
64552679|NCT04007393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979988|NCT00281983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979989|NCT00281983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979990|NCT00281983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64979991|NCT00281983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64979992|NCT00281983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64980009|NCT00282061|Antioxidants|antioxidants|mesh-ancestor
64980010|NCT00282061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980011|NCT00282061|Protective Agents|protective agents|mesh-ancestor
64980012|NCT00282061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980013|NCT00282061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64980014|NCT00282100|Gefitinib|gefitinib|mesh-list
64980015|NCT00282100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980016|NCT00282100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64980017|NCT00282100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980018|NCT00282100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301124|NCT02122393|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64301125|NCT02122393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64980019|NCT00282139|Aripiprazole|aripiprazole|mesh-list
64980020|NCT00282139|Antidepressive Agents|antidepressive agents|mesh-ancestor
64980021|NCT00282139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64980022|NCT00282139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64980023|NCT00282139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64980024|NCT00282139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64980025|NCT00282139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547800|NCT02149173|Protective Agents|protective agents|mesh-ancestor
64547801|NCT02149173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547802|NCT02149173|Antimetabolites|antimetabolites|mesh-ancestor
64547803|NCT02149173|Antiviral Agents|antiviral agents|mesh-ancestor
64547804|NCT02149173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64547805|NCT04789434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64547806|NCT04789434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547807|NCT04789434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547808|NCT03805503|Chloroprocaine|chloroprocaine|mesh-list
64547809|NCT03805503|Procaine|procaine|mesh-list
64547810|NCT03805503|Anesthetics, Local|anesthetics, local|mesh-ancestor
64547811|NCT03805503|Anesthetics|anesthetics|mesh-ancestor
64547812|NCT03805503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64547813|NCT03805503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547814|NCT03805503|Sensory System Agents|sensory system agents|mesh-ancestor
64547815|NCT03805503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547816|NCT01504412|Pregabalin|pregabalin|mesh-list
64547817|NCT01504412|Analgesics|analgesics|mesh-ancestor
64547818|NCT01504412|Sensory System Agents|sensory system agents|mesh-ancestor
64547819|NCT01504412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64781682|NCT05423340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547820|NCT01504412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547821|NCT01504412|Anticonvulsants|anticonvulsants|mesh-ancestor
64547822|NCT01504412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64547823|NCT01504412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64547824|NCT01504412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547825|NCT01504412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64547826|NCT01504412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64547827|NCT01504412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64547828|NCT01504412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64547829|NCT01504412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64547830|NCT04702464|Fluconazole|fluconazole|mesh-list
64484218|NCT01751113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64547831|NCT04702464|Antifungal Agents|antifungal agents|mesh-ancestor
64547839|NCT04702464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64547840|NCT04702464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547841|NCT04702464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64547844|NCT00088465|Antiemetics|antiemetics|mesh-ancestor
64547845|NCT00088465|Autonomic Agents|autonomic agents|mesh-ancestor
64547846|NCT00088465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547847|NCT00088465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547848|NCT00088465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64547849|NCT00088465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64547850|NCT00088465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64547851|NCT00088465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64547852|NCT00088465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64547853|NCT00088465|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64547854|NCT00088465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64547855|NCT00088465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64547856|NCT00088465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312725|NCT02706951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980026|NCT00282139|Dopamine Agonists|dopamine agonists|mesh-ancestor
64393124|NCT02397499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64980027|NCT00282139|Dopamine Agents|dopamine agents|mesh-ancestor
64980028|NCT00282139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64980029|NCT00282139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980030|NCT00282139|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64980031|NCT00282139|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64980032|NCT00282139|Serotonin Agents|serotonin agents|mesh-ancestor
64980033|NCT00282139|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64980034|NCT00282139|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64980035|NCT00282139|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64980036|NCT00282139|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64980037|NCT00110253|Lidocaine|lidocaine|mesh-list
64980038|NCT00110253|Tetracaine|tetracaine|mesh-list
64980039|NCT00110253|Anesthetics, Local|anesthetics, local|mesh-ancestor
64980040|NCT00110253|Anesthetics|anesthetics|mesh-ancestor
64980041|NCT00110253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64980042|NCT00110253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980043|NCT00110253|Sensory System Agents|sensory system agents|mesh-ancestor
64980044|NCT00110253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64980045|NCT00110253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64980046|NCT00110253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64980047|NCT00110253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64980082|NCT00282607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980085|NCT00282724|Hormone Antagonists|hormone antagonists|mesh-ancestor
64980117|NCT00282997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64980118|NCT00283036|Irbesartan|irbesartan|mesh-list
64781718|NCT04978428|Anticonvulsants|anticonvulsants|mesh-ancestor
64781719|NCT04968054|Propofol|propofol|mesh-list
64781720|NCT04968054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64781721|NCT04968054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64781722|NCT04968054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781723|NCT04968054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64980119|NCT00283036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64980120|NCT00283036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64980121|NCT00283036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64980122|NCT00283036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980123|NCT00110370|Insulin Glargine|insulin glargine|mesh-list
64547858|NCT00088465|Serotonin Agents|serotonin agents|mesh-ancestor
64547859|NCT04405674|Paclitaxel|paclitaxel|mesh-list
64547860|NCT04405674|Bevacizumab|bevacizumab|mesh-list
64547861|NCT04405674|Carboplatin|carboplatin|mesh-list
64547862|NCT04405674|Pemetrexed|pemetrexed|mesh-list
64547863|NCT04405674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64547864|NCT04405674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547865|NCT04405674|Tubulin Modulators|tubulin modulators|mesh-ancestor
64547866|NCT04405674|Antimitotic Agents|antimitotic agents|mesh-ancestor
64547867|NCT04405674|Mitosis Modulators|mitosis modulators|mesh-ancestor
64547868|NCT04405674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547869|NCT04405674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64547870|NCT04405674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64547871|NCT04405674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64547872|NCT04405674|Growth Substances|growth substances|mesh-ancestor
64547873|NCT04405674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547874|NCT04405674|Growth Inhibitors|growth inhibitors|mesh-ancestor
64547875|NCT04405674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547876|NCT04405674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64547877|NCT04405674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64547878|NCT00088153|Progesterone|progesterone|mesh-list
64547879|NCT00088153|Estrogens|estrogens|mesh-list
64547880|NCT00088153|Progestins|progestins|mesh-ancestor
64547881|NCT00088153|Hormones|hormones|mesh-ancestor
64547882|NCT00088153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64547883|NCT00088153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547884|NCT02074358|Apixaban|apixaban|mesh-list
64547885|NCT02074358|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64547886|NCT02074358|Antithrombins|antithrombins|mesh-ancestor
64547887|NCT02074358|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64547888|NCT02074358|Protease Inhibitors|protease inhibitors|mesh-ancestor
64547889|NCT02074358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547890|NCT02074358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547891|NCT02074358|Anticoagulants|anticoagulants|mesh-ancestor
64547897|NCT05743725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64301128|NCT02122393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64301129|NCT02122393|Serotonin Agents|serotonin agents|mesh-ancestor
64301130|NCT02122393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301132|NCT03821883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64301133|NCT03821883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64301134|NCT03821883|Analgesics|analgesics|mesh-ancestor
64301135|NCT03821883|Sensory System Agents|sensory system agents|mesh-ancestor
64301136|NCT03821883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64437577|NCT05153226|Alkylating Agents|alkylating agents|mesh-ancestor
64547898|NCT05743725|Analgesics|analgesics|mesh-ancestor
64547899|NCT05743725|Sensory System Agents|sensory system agents|mesh-ancestor
64547900|NCT05743725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547901|NCT05743725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64547902|NCT05743725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64547903|NCT05743725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64547904|NCT05743725|Adrenergic Agents|adrenergic agents|mesh-ancestor
64547905|NCT05743725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64547906|NCT05743725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547907|NCT05743725|Anesthetics|anesthetics|mesh-ancestor
64547908|NCT05743725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64547909|NCT05743725|Anticonvulsants|anticonvulsants|mesh-ancestor
64547910|NCT05743725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64547911|NCT05743725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64547912|NCT05743725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64547913|NCT05743725|Tocolytic Agents|tocolytic agents|mesh-ancestor
64547914|NCT05743725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64547915|NCT05547321|Pembrolizumab|pembrolizumab|mesh-list
64547916|NCT05547321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64547917|NCT05547321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547918|NCT04912518|Dexmedetomidine|dexmedetomidine|mesh-list
64547919|NCT04912518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64547920|NCT04912518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64547921|NCT04912518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547922|NCT04912518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64547923|NCT04912518|Analgesics|analgesics|mesh-ancestor
64547924|NCT04912518|Sensory System Agents|sensory system agents|mesh-ancestor
64547925|NCT04912518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547927|NCT04912518|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64547941|NCT01502228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64547942|NCT01502228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64547943|NCT01502228|Growth Substances|growth substances|mesh-ancestor
64547944|NCT01502228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547945|NCT01502228|Growth Inhibitors|growth inhibitors|mesh-ancestor
64547946|NCT01502228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64547947|NCT01502228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547948|NCT01502228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547949|NCT05011812|Ritonavir|ritonavir|mesh-list
64547950|NCT05011812|Midazolam|midazolam|mesh-list
64547951|NCT05011812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64547952|NCT05011812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64547953|NCT05011812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64547954|NCT05011812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547955|NCT05011812|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64547956|NCT05011812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64301137|NCT03821883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301138|NCT03821883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64301139|NCT03821883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64301140|NCT03821883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64301141|NCT03821883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64301142|NCT03821883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301143|NCT03821883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64301144|NCT03821883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64301145|NCT03821883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64301146|NCT03821883|Antipyretics|antipyretics|mesh-ancestor
64301147|NCT03080480|Pioglitazone|pioglitazone|mesh-list
64301148|NCT03080480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64301150|NCT02126761|Vaccines|vaccines|mesh-list
64547958|NCT05011812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64547959|NCT05011812|Anesthetics, General|anesthetics, general|mesh-ancestor
64547960|NCT05011812|Anesthetics|anesthetics|mesh-ancestor
64547961|NCT05011812|GABA Modulators|gaba modulators|mesh-ancestor
64547962|NCT05011812|GABA Agents|gaba agents|mesh-ancestor
64547963|NCT05011812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64547964|NCT05011812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547965|NCT05011812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64547966|NCT05011812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64547967|NCT05011812|Protease Inhibitors|protease inhibitors|mesh-ancestor
64547968|NCT05011812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547969|NCT05011812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64547970|NCT05011812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64547971|NCT05011812|Antiviral Agents|antiviral agents|mesh-ancestor
64547972|NCT05011812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64547973|NCT05011812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64547974|NCT05011812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64547975|NCT05535231|Curcumin|curcumin|mesh-list
64547976|NCT05535231|Turmeric extract|turmeric extract|mesh-list
64547977|NCT05535231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64547978|NCT05535231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64547979|NCT05535231|Analgesics|analgesics|mesh-ancestor
64547980|NCT05535231|Sensory System Agents|sensory system agents|mesh-ancestor
64547981|NCT05535231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64547982|NCT05535231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547983|NCT05535231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64547984|NCT05535231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64547985|NCT05535231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64547986|NCT05535231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547987|NCT05535231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64547988|NCT05535231|Antioxidants|antioxidants|mesh-ancestor
64547989|NCT05535231|Protective Agents|protective agents|mesh-ancestor
64547990|NCT01502072|Ribavirin|ribavirin|mesh-list
64547991|NCT01502072|Antimetabolites|antimetabolites|mesh-ancestor
64781817|NCT02952534|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64781818|NCT02952534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781819|NCT02952534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781820|NCT02952534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781821|NCT01871766|Dactinomycin|dactinomycin|mesh-list
64781822|NCT01871766|Cyclophosphamide|cyclophosphamide|mesh-list
64781823|NCT01871766|Ifosfamide|ifosfamide|mesh-list
64781824|NCT01871766|Bevacizumab|bevacizumab|mesh-list
64781825|NCT01871766|Doxorubicin|doxorubicin|mesh-list
64393233|NCT02396329|Povidone-Iodine|povidone-iodine|mesh-list
64393234|NCT02396329|Povidone|povidone|mesh-list
64393235|NCT02396329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64393236|NCT02396329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64393243|NCT02395783|Melatonin|melatonin|mesh-list
64547992|NCT01502072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301152|NCT02126761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301153|NCT02788357|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64301154|NCT02788357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64301155|NCT02788357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64301156|NCT02788357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64301157|NCT02788357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301159|NCT02788357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64301160|NCT02788357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301161|NCT03280641|Warfarin|warfarin|mesh-list
64301162|NCT03280641|Dabigatran|dabigatran|mesh-list
64301163|NCT03280641|Anticoagulants|anticoagulants|mesh-ancestor
64301164|NCT03280641|Antithrombins|antithrombins|mesh-ancestor
64301165|NCT03280641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64301166|NCT03280641|Protease Inhibitors|protease inhibitors|mesh-ancestor
64301167|NCT03280641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64547993|NCT01502072|Antiviral Agents|antiviral agents|mesh-ancestor
64547994|NCT01502072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64547996|NCT01462370|Ibuprofen|ibuprofen|mesh-list
64547997|NCT01462370|Etoricoxib|etoricoxib|mesh-list
64547998|NCT01462370|Caffeine|caffeine|mesh-list
64547999|NCT01462370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64548000|NCT01462370|Analgesics|analgesics|mesh-ancestor
64548001|NCT01462370|Sensory System Agents|sensory system agents|mesh-ancestor
64548002|NCT01462370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64548003|NCT01462370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548004|NCT01462370|Antipyretics|antipyretics|mesh-ancestor
64548005|NCT01462370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64548006|NCT01462370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64980150|NCT00283309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980151|NCT00283309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980152|NCT00283309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64980153|NCT00283309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64980154|NCT00283309|Anticonvulsants|anticonvulsants|mesh-ancestor
64980155|NCT00283309|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64980156|NCT00283309|Protective Agents|protective agents|mesh-ancestor
64980157|NCT00417157|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64980158|NCT00417157|Ganirelix|ganirelix|mesh-list
64980159|NCT00417157|Hormone Antagonists|hormone antagonists|mesh-ancestor
64980160|NCT00417157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64980161|NCT00417157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393258|NCT04528667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64548007|NCT01462370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64548008|NCT01462370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64548009|NCT01462370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64548010|NCT01462370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548011|NCT01462370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64548012|NCT01462370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64548013|NCT01462370|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64548014|NCT01462370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64548015|NCT01462370|Purinergic Agents|purinergic agents|mesh-ancestor
64548016|NCT01462370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64548017|NCT01462370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64548018|NCT05743179|Zoledronic Acid|zoledronic acid|mesh-list
64548019|NCT05743179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64548020|NCT05743179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548021|NCT01479764|Glycopyrrolate|glycopyrrolate|mesh-list
64548022|NCT01479764|Neostigmine|neostigmine|mesh-list
64548023|NCT01479764|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64548024|NCT01479764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64548025|NCT01479764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548026|NCT01479764|Cholinergic Agents|cholinergic agents|mesh-ancestor
64548027|NCT01479764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64548028|NCT01479764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548029|NCT01479764|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64548030|NCT01479764|Autonomic Agents|autonomic agents|mesh-ancestor
64548031|NCT01479764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64548032|NCT01479764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64548033|NCT01479764|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64548034|NCT01479764|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64548035|NCT01479530|Rasagiline|rasagiline|mesh-list
64548036|NCT01479530|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64781852|NCT01871766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64548037|NCT01479530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64548038|NCT01479530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548039|NCT01479530|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64548040|NCT01479530|Protective Agents|protective agents|mesh-ancestor
64548044|NCT01479374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64548045|NCT01479374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64548046|NCT01479374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64548048|NCT01479374|Sensory System Agents|sensory system agents|mesh-ancestor
64548049|NCT01479374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64548050|NCT01479374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548052|NCT01479374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64548053|NCT01479374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64548054|NCT01479374|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64548055|NCT01479374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64548056|NCT01479374|Histamine Antagonists|histamine antagonists|mesh-ancestor
64548058|NCT01479374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64548059|NCT01479374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548061|NCT00087529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64548062|NCT00087529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548063|NCT00087529|Immunologic Factors|immunologic factors|mesh-ancestor
64548064|NCT00087529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548065|NCT00087529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64548066|NCT00794313|Topiramate|topiramate|mesh-list
64548067|NCT00794313|Amantadine|amantadine|mesh-list
64548068|NCT00794313|Anticonvulsants|anticonvulsants|mesh-ancestor
64548069|NCT00794313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64548070|NCT00794313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548071|NCT00794313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64548072|NCT00794313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64548073|NCT00794313|Antiviral Agents|antiviral agents|mesh-ancestor
64548074|NCT00794313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64548075|NCT00794313|Dopamine Agents|dopamine agents|mesh-ancestor
64548076|NCT00794313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64548077|NCT00794313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548085|NCT05743101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64548086|NCT05743101|Renal Agents|renal agents|mesh-ancestor
64301168|NCT03280641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301169|NCT03285165|Propofol|propofol|mesh-list
64301170|NCT03285165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64301171|NCT03285165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64301172|NCT03285165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301173|NCT03285165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64301174|NCT03285165|Anesthetics, General|anesthetics, general|mesh-ancestor
64301175|NCT03285165|Anesthetics|anesthetics|mesh-ancestor
64781879|NCT05450328|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64301176|NCT03285087|Dexmedetomidine|dexmedetomidine|mesh-list
64301177|NCT03285087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64301178|NCT03285087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64548088|NCT05743101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64548089|NCT05743101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64548091|NCT05743101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548092|NCT05743101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548093|NCT05743101|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64548094|NCT05743101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64548096|NCT01500434|Ticlopidine|ticlopidine|mesh-list
64548097|NCT01500434|Clopidogrel|clopidogrel|mesh-list
64548098|NCT01500434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64548099|NCT01500434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64548100|NCT01500434|Analgesics|analgesics|mesh-ancestor
64548101|NCT01500434|Sensory System Agents|sensory system agents|mesh-ancestor
64548102|NCT01500434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64548103|NCT01500434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548104|NCT01500434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64548105|NCT01500434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64548106|NCT01500434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64548107|NCT01500434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64548108|NCT01500434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548109|NCT01500434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64548110|NCT01500434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64548111|NCT01500434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64548112|NCT01500434|Antipyretics|antipyretics|mesh-ancestor
64548113|NCT01500434|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64548115|NCT01500434|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64548117|NCT01500434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64548118|NCT01500434|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64301179|NCT03285087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301180|NCT03285087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64301182|NCT03285087|Sensory System Agents|sensory system agents|mesh-ancestor
64393297|NCT04367909|Docetaxel|docetaxel|mesh-list
64393298|NCT04367909|Nimotuzumab|nimotuzumab|mesh-list
64301183|NCT03285087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301186|NCT03285087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64548129|NCT00794547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548130|NCT00794547|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64548131|NCT00794547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64548132|NCT00794547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548133|NCT00794547|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64548134|NCT00794547|Vitamins|vitamins|mesh-ancestor
64548135|NCT00794547|Micronutrients|micronutrients|mesh-ancestor
64548136|NCT00794547|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64548137|NCT03493165|Everolimus|everolimus|mesh-list
64548138|NCT03493165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548139|NCT03493165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64548140|NCT03493165|Immunologic Factors|immunologic factors|mesh-ancestor
64548141|NCT03493165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980162|NCT00417157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64980163|NCT00283465|Epoetin Alfa|epoetin alfa|mesh-list
64980164|NCT00283465|Hematinics|hematinics|mesh-ancestor
64980165|NCT00283543|Temozolomide|temozolomide|mesh-list
64980166|NCT00283543|Carmustine|carmustine|mesh-list
64980167|NCT00283543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64980168|NCT00283543|Alkylating Agents|alkylating agents|mesh-ancestor
64980198|NCT00283699|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64980199|NCT00283699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64980200|NCT00283699|Tubulin Modulators|tubulin modulators|mesh-ancestor
64980201|NCT00283699|Antimitotic Agents|antimitotic agents|mesh-ancestor
64980202|NCT00283699|Mitosis Modulators|mitosis modulators|mesh-ancestor
64980203|NCT00283699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980204|NCT00283699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980205|NCT00283777|Chromium|chromium|mesh-list
64980206|NCT00283777|Picolinic acid|picolinic acid|mesh-list
64980207|NCT00283777|Trace Elements|trace elements|mesh-ancestor
64980208|NCT00283777|Micronutrients|micronutrients|mesh-ancestor
64980209|NCT00283777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980210|NCT00283777|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64980211|NCT00283777|Chelating Agents|chelating agents|mesh-ancestor
64980212|NCT00283777|Sequestering Agents|sequestering agents|mesh-ancestor
64980213|NCT00283777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548142|NCT00786825|Somatostatin|somatostatin|mesh-list
64548143|NCT00786825|Hormones|hormones|mesh-ancestor
64548144|NCT00786825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64548145|NCT00786825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548146|NCT00768261|Memantine|memantine|mesh-list
64548147|NCT00768261|Donepezil|donepezil|mesh-list
64548148|NCT00768261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64548149|NCT00768261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64548150|NCT00768261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548151|NCT00768261|Cholinergic Agents|cholinergic agents|mesh-ancestor
64548152|NCT00768261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64548159|NCT00768261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64548160|NCT03804723|Prednisone|prednisone|mesh-list
64548161|NCT03804723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64548162|NCT03804723|Glucocorticoids|glucocorticoids|mesh-ancestor
64548163|NCT03804723|Hormones|hormones|mesh-ancestor
64548164|NCT03804723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64548165|NCT03804723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548166|NCT03804723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64548167|NCT03804723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548168|NCT00797277|Lorazepam|lorazepam|mesh-list
64548169|NCT00797277|Haloperidol|haloperidol|mesh-list
64548170|NCT00797277|Olanzapine|olanzapine|mesh-list
64548171|NCT00797277|Haloperidol decanoate|haloperidol decanoate|mesh-list
64548172|NCT00797277|Antiemetics|antiemetics|mesh-ancestor
64548173|NCT00797277|Autonomic Agents|autonomic agents|mesh-ancestor
64548174|NCT00797277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64980252|NCT00284323|Sensory System Agents|sensory system agents|mesh-ancestor
64393356|NCT03300479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64980253|NCT00284323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64548175|NCT00797277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548176|NCT00797277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64548177|NCT00797277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64548178|NCT00797277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64548179|NCT00797277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64548180|NCT00797277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64548181|NCT00797277|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64548182|NCT00797277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64548183|NCT00797277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64548184|NCT00797277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548185|NCT00797277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64548186|NCT00797277|Serotonin Agents|serotonin agents|mesh-ancestor
64548187|NCT00797277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64548188|NCT00797277|Dopamine Agents|dopamine agents|mesh-ancestor
64548189|NCT00797277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64548190|NCT00797277|Anticonvulsants|anticonvulsants|mesh-ancestor
64548191|NCT00797277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64548192|NCT00797277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64548193|NCT00797277|GABA Modulators|gaba modulators|mesh-ancestor
64548194|NCT00797277|GABA Agents|gaba agents|mesh-ancestor
64548196|NCT03837015|Estrogens|estrogens|mesh-ancestor
64548197|NCT03837015|Hormones|hormones|mesh-ancestor
64548198|NCT03837015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64548199|NCT03837015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548200|NCT05742789|Propofol|propofol|mesh-list
64548201|NCT05742789|Sevoflurane|sevoflurane|mesh-list
64548202|NCT05742789|Isoflurane|isoflurane|mesh-list
64548203|NCT05742789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64548204|NCT05742789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64548205|NCT05742789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781966|NCT04727424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64548206|NCT05742789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64548207|NCT05742789|Anesthetics, General|anesthetics, general|mesh-ancestor
64548208|NCT05742789|Anesthetics|anesthetics|mesh-ancestor
64548217|NCT01500278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548218|NCT01500278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64548219|NCT01500278|Antimetabolites|antimetabolites|mesh-ancestor
64548220|NCT01500278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548221|NCT01500278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548222|NCT01500278|Dermatologic Agents|dermatologic agents|mesh-ancestor
64548223|NCT01500278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64548224|NCT01500278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64548225|NCT01500278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64548226|NCT01500278|Immunologic Factors|immunologic factors|mesh-ancestor
64548227|NCT01500278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64548228|NCT01500278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64548229|NCT01500278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64548231|NCT00086281|Modafinil|modafinil|mesh-list
64548232|NCT00086281|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64548233|NCT00086281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548234|NCT00086281|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64548235|NCT00086281|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64548236|NCT00086281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64548237|NCT00086281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548238|NCT00086281|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64980266|NCT04718701|Antimitotic Agents|antimitotic agents|mesh-ancestor
64980267|NCT04718701|Mitosis Modulators|mitosis modulators|mesh-ancestor
64980268|NCT04718701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980270|NCT00077168|Anastrozole|anastrozole|mesh-list
64980271|NCT00077168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980272|NCT00077168|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64781996|NCT04519944|Antithrombins|antithrombins|mesh-ancestor
64980273|NCT00077168|Hormone Antagonists|hormone antagonists|mesh-ancestor
64980274|NCT00077168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64980275|NCT00077168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980276|NCT00077168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64980277|NCT00077168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980278|NCT00077168|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64980279|NCT00077168|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64980280|NCT00077168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64980281|NCT00077168|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64980282|NCT00077168|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64980283|NCT00077168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980284|NCT00110604|Folic Acid|folic acid|mesh-list
64980285|NCT00110604|Hematinics|hematinics|mesh-ancestor
64980286|NCT00110604|Vitamin B Complex|vitamin b complex|mesh-ancestor
64782033|NCT04176354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64980287|NCT00110604|Vitamins|vitamins|mesh-ancestor
64980288|NCT00110604|Micronutrients|micronutrients|mesh-ancestor
64980289|NCT00110604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980290|NCT00284752|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64980291|NCT00284752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980292|NCT00284791|Lamotrigine|lamotrigine|mesh-list
64980293|NCT00284791|Sertraline|sertraline|mesh-list
64980294|NCT00284791|Fluoxetine|fluoxetine|mesh-list
64548239|NCT00086281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64548240|NCT00086281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64548241|NCT00086281|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64548242|NCT00086281|GABA Agonists|gaba agonists|mesh-ancestor
64548244|NCT00086281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64548246|NCT00787761|Busulfan|busulfan|mesh-list
64548247|NCT00787761|Methotrexate|methotrexate|mesh-list
64548248|NCT00787761|Fludarabine|fludarabine|mesh-list
64548249|NCT00787761|Fludarabine phosphate|fludarabine phosphate|mesh-list
64548250|NCT00787761|Tacrolimus|tacrolimus|mesh-list
64548251|NCT00787761|Thymoglobulin|thymoglobulin|mesh-list
64548252|NCT00787761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64548253|NCT00787761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64548254|NCT00787761|Immunologic Factors|immunologic factors|mesh-ancestor
64548255|NCT00787761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548256|NCT00787761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64548257|NCT00787761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64548258|NCT00787761|Alkylating Agents|alkylating agents|mesh-ancestor
64548259|NCT00787761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548260|NCT00787761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548261|NCT00787761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64548262|NCT00787761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64548263|NCT00787761|Abortifacient Agents|abortifacient agents|mesh-ancestor
64548264|NCT00787761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64548265|NCT00787761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64548266|NCT00787761|Antimetabolites|antimetabolites|mesh-ancestor
64548267|NCT00787761|Dermatologic Agents|dermatologic agents|mesh-ancestor
64548268|NCT00787761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64548269|NCT00787761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64548270|NCT00787761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64548271|NCT00787761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64548272|NCT01478828|Lovastatin|lovastatin|mesh-list
64548273|NCT01478828|L 647318|l 647318|mesh-list
64548274|NCT01478828|Dihydromevinolin|dihydromevinolin|mesh-list
64548275|NCT01478828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64313184|NCT03181113|Antiviral Agents|antiviral agents|mesh-ancestor
64980295|NCT00284791|Antidepressive Agents|antidepressive agents|mesh-ancestor
64548276|NCT01478828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64548278|NCT01478828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548279|NCT01478828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64548280|NCT01478828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64548281|NCT01478828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64548282|NCT00085423|Aldesleukin|aldesleukin|mesh-list
64548283|NCT00085423|Cyclophosphamide|cyclophosphamide|mesh-list
64548284|NCT00085423|Fludarabine|fludarabine|mesh-list
64548285|NCT00085423|Fludarabine phosphate|fludarabine phosphate|mesh-list
64548286|NCT00085423|Interleukin-2|interleukin-2|mesh-list
64548287|NCT00085423|Molgramostim|molgramostim|mesh-list
64548288|NCT00085423|Sargramostim|sargramostim|mesh-list
64548289|NCT00085423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64548290|NCT00085423|Immunologic Factors|immunologic factors|mesh-ancestor
64548291|NCT00085423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548292|NCT00085423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64548293|NCT00085423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64548294|NCT00085423|Alkylating Agents|alkylating agents|mesh-ancestor
64548295|NCT00085423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548296|NCT00085423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548297|NCT00085423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64548298|NCT00085423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64548299|NCT00085423|Antimetabolites|antimetabolites|mesh-ancestor
64548300|NCT00085423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64548301|NCT00085423|Analgesics|analgesics|mesh-ancestor
64548302|NCT00085423|Sensory System Agents|sensory system agents|mesh-ancestor
64548303|NCT00085423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64548304|NCT00085423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64548306|NCT00085423|Antiviral Agents|antiviral agents|mesh-ancestor
64548307|NCT00085423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64548308|NCT04079192|Umirolimus|umirolimus|mesh-list
64548309|NCT04079192|Paclitaxel|paclitaxel|mesh-list
64782113|NCT03260712|Gemcitabine|gemcitabine|mesh-list
64548311|NCT04079192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548319|NCT04079192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548320|NCT03087877|Acetaminophen|acetaminophen|mesh-list
64548321|NCT03087877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64548322|NCT03087877|Analgesics|analgesics|mesh-ancestor
64548323|NCT03087877|Sensory System Agents|sensory system agents|mesh-ancestor
64548324|NCT03087877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64548325|NCT03087877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548326|NCT03087877|Antipyretics|antipyretics|mesh-ancestor
64548327|NCT05742477|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64548328|NCT05742477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64548329|NCT03447379|Aspirin|aspirin|mesh-list
64548330|NCT03447379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64548331|NCT03447379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64548332|NCT03447379|Analgesics|analgesics|mesh-ancestor
64548333|NCT03447379|Sensory System Agents|sensory system agents|mesh-ancestor
64548334|NCT03447379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64548335|NCT03447379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548336|NCT03447379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64548337|NCT03447379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64548338|NCT03447379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64548339|NCT03447379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64548340|NCT03447379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548341|NCT03447379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64980296|NCT00284791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64980297|NCT00284791|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64980298|NCT00284791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64980299|NCT00284791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64980300|NCT00284791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980301|NCT00284791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64980302|NCT00284791|Serotonin Agents|serotonin agents|mesh-ancestor
64980303|NCT00284791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980304|NCT00284791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64980305|NCT00284791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64980306|NCT00284791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64980307|NCT00284791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980308|NCT00284791|Anticonvulsants|anticonvulsants|mesh-ancestor
64980309|NCT00284791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64980310|NCT00284791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64980311|NCT00284791|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64980312|NCT00284791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64980313|NCT00284791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64980324|NCT00284947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64980325|NCT00284947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980327|NCT00284947|Autonomic Agents|autonomic agents|mesh-ancestor
64980328|NCT00284947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64980329|NCT00284947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64980330|NCT00284947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64980331|NCT00284947|Protective Agents|protective agents|mesh-ancestor
64980332|NCT00284947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64548342|NCT03447379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64548343|NCT03447379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64548344|NCT03447379|Antipyretics|antipyretics|mesh-ancestor
64548345|NCT03803553|Fluorouracil|fluorouracil|mesh-list
64548346|NCT03803553|Nivolumab|nivolumab|mesh-list
64548347|NCT03803553|Irinotecan|irinotecan|mesh-list
64548348|NCT03803553|Cetuximab|cetuximab|mesh-list
64548349|NCT03803553|Antimetabolites|antimetabolites|mesh-ancestor
64548350|NCT03803553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548351|NCT03803553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64548352|NCT03803553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548353|NCT03803553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64548354|NCT03803553|Immunologic Factors|immunologic factors|mesh-ancestor
64548355|NCT03803553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548356|NCT03803553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64548357|NCT03803553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64548358|NCT03803553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64301242|NCT05008250|Autonomic Agents|autonomic agents|mesh-ancestor
64548359|NCT03803553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64548372|NCT01677949|Cyclophosphamide|cyclophosphamide|mesh-list
64548374|NCT01677949|Clofarabine|clofarabine|mesh-list
64548375|NCT01677949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64548376|NCT01677949|Immunologic Factors|immunologic factors|mesh-ancestor
64548377|NCT01677949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548378|NCT01677949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64548379|NCT01677949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64548380|NCT01677949|Alkylating Agents|alkylating agents|mesh-ancestor
64548381|NCT01677949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548382|NCT01677949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548383|NCT01677949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64313291|NCT04841096|Protease Inhibitors|protease inhibitors|mesh-ancestor
64980333|NCT00284947|Immunologic Factors|immunologic factors|mesh-ancestor
64980334|NCT00110682|Imiquimod|imiquimod|mesh-list
64980335|NCT00110682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64980336|NCT00110682|Immunologic Factors|immunologic factors|mesh-ancestor
64980337|NCT00110682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980338|NCT00110682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980339|NCT00110682|Interferon Inducers|interferon inducers|mesh-ancestor
64980340|NCT00077246|Paclitaxel|paclitaxel|mesh-list
64980341|NCT00077246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64980342|NCT00077246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64980343|NCT00077246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980344|NCT00077246|Tubulin Modulators|tubulin modulators|mesh-ancestor
64980345|NCT00077246|Antimitotic Agents|antimitotic agents|mesh-ancestor
64980346|NCT00077246|Mitosis Modulators|mitosis modulators|mesh-ancestor
64548384|NCT01677949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64548385|NCT01677949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64548386|NCT01677949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64548387|NCT01677949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64548388|NCT01677949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64548389|NCT01677949|Antimetabolites|antimetabolites|mesh-ancestor
64548391|NCT03483883|Avelumab|avelumab|mesh-list
64548392|NCT03483883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64548393|NCT03483883|Antimetabolites|antimetabolites|mesh-ancestor
64548394|NCT03483883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548395|NCT03483883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548396|NCT03483883|Antiviral Agents|antiviral agents|mesh-ancestor
64548397|NCT03483883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64548398|NCT03483883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64548399|NCT03483883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64548400|NCT03483883|Immunologic Factors|immunologic factors|mesh-ancestor
64548401|NCT03483883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548402|NCT03483883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64548403|NCT03482167|Niacinamide|niacinamide|mesh-list
64548404|NCT03482167|Vitamin B Complex|vitamin b complex|mesh-ancestor
64548405|NCT03482167|Vitamins|vitamins|mesh-ancestor
64548406|NCT03482167|Micronutrients|micronutrients|mesh-ancestor
64548407|NCT03482167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548408|NCT00799227|Dexamethasone|dexamethasone|mesh-list
64548409|NCT00799227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64548410|NCT00799227|Antiemetics|antiemetics|mesh-ancestor
64548411|NCT00799227|Autonomic Agents|autonomic agents|mesh-ancestor
64782222|NCT05354466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548443|NCT00770133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548444|NCT00770133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64548445|NCT00770133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64548446|NCT00770133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64548447|NCT00770133|Adrenergic Agents|adrenergic agents|mesh-ancestor
64548448|NCT00770133|Nasal Decongestants|nasal decongestants|mesh-ancestor
64548449|NCT00770133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64548450|NCT00770133|Respiratory System Agents|respiratory system agents|mesh-ancestor
64548451|NCT00770757|Pomalidomide|pomalidomide|mesh-list
64548452|NCT00770757|Immunologic Factors|immunologic factors|mesh-ancestor
64548453|NCT00770757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548454|NCT00770757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64548455|NCT00770757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64548456|NCT00770757|Growth Substances|growth substances|mesh-ancestor
64548457|NCT00770757|Growth Inhibitors|growth inhibitors|mesh-ancestor
64548458|NCT00770757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548460|NCT01425281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548461|NCT01425281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64548462|NCT01425281|Immunologic Factors|immunologic factors|mesh-ancestor
64438356|NCT03987802|Insulin Aspart|insulin aspart|mesh-list
64548463|NCT01425281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548464|NCT04384653|Furosemide|furosemide|mesh-list
64548465|NCT04384653|Diuretics|diuretics|mesh-ancestor
64548466|NCT04384653|Natriuretic Agents|natriuretic agents|mesh-ancestor
64548467|NCT04384653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548468|NCT04384653|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64548469|NCT04384653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64548470|NCT04384653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548471|NCT04113720|Dexmedetomidine|dexmedetomidine|mesh-list
64548472|NCT04113720|Levobupivacaine|levobupivacaine|mesh-list
64548473|NCT04113720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64313385|NCT02426619|Fluorides|fluorides|mesh-list
64980347|NCT00077246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980348|NCT00110721|Fluorouracil|fluorouracil|mesh-list
64980349|NCT00110721|Antimetabolites|antimetabolites|mesh-ancestor
64980350|NCT00110721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980351|NCT00110721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64980352|NCT00110721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980353|NCT00110721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64980354|NCT00110721|Immunologic Factors|immunologic factors|mesh-ancestor
64980355|NCT00110721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980356|NCT00417235|Chlorhexidine|chlorhexidine|mesh-list
64980357|NCT00417235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64548474|NCT04113720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64548475|NCT04113720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548476|NCT04113720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64548477|NCT04113720|Analgesics|analgesics|mesh-ancestor
64548478|NCT04113720|Sensory System Agents|sensory system agents|mesh-ancestor
64548479|NCT04113720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64548480|NCT04113720|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64548481|NCT04113720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64548482|NCT04113720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64548483|NCT04113720|Adrenergic Agents|adrenergic agents|mesh-ancestor
64548484|NCT04113720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64548485|NCT04113720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548486|NCT04113720|Anesthetics, Local|anesthetics, local|mesh-ancestor
64548487|NCT04113720|Anesthetics|anesthetics|mesh-ancestor
64548488|NCT01402817|Sunitinib|sunitinib|mesh-list
64548489|NCT01402817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548490|NCT01402817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64548491|NCT01402817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64548492|NCT01402817|Growth Substances|growth substances|mesh-ancestor
64548493|NCT01402817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548494|NCT01402817|Growth Inhibitors|growth inhibitors|mesh-ancestor
64548495|NCT01402817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64548496|NCT01402817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64548497|NCT01402817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548498|NCT01425203|Ribavirin|ribavirin|mesh-list
64548499|NCT01425203|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64548500|NCT01425203|Antimetabolites|antimetabolites|mesh-ancestor
64548501|NCT01425203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548502|NCT01425203|Antiviral Agents|antiviral agents|mesh-ancestor
64324282|NCT05492318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64782290|NCT03341676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64782291|NCT03341676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64782292|NCT03341676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782293|NCT03341520|Obinutuzumab|obinutuzumab|mesh-list
64782294|NCT03341520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64782295|NCT03341520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782296|NCT03121716|Gemcitabine|gemcitabine|mesh-list
64782297|NCT03121716|Cisplatin|cisplatin|mesh-list
64548503|NCT01425203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64548504|NCT04215120|Epoetin Alfa|epoetin alfa|mesh-list
64548505|NCT04215120|Hematinics|hematinics|mesh-ancestor
64548506|NCT00081289|Leucovorin|leucovorin|mesh-list
64548507|NCT00081289|Folic Acid|folic acid|mesh-list
64548508|NCT00081289|Fluorouracil|fluorouracil|mesh-list
64980358|NCT00417235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64980359|NCT00417235|Disinfectants|disinfectants|mesh-ancestor
64980360|NCT00425035|Panitumumab|panitumumab|mesh-list
64980361|NCT00425035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64980362|NCT00425035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548509|NCT00081289|Capecitabine|capecitabine|mesh-list
64548510|NCT00081289|Oxaliplatin|oxaliplatin|mesh-list
64548511|NCT00081289|Irinotecan|irinotecan|mesh-list
64945400|NCT05664789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504619|NCT04498260|Hormones|hormones|mesh-ancestor
64548512|NCT00081289|Levoleucovorin|levoleucovorin|mesh-list
64548513|NCT00081289|Antimetabolites|antimetabolites|mesh-ancestor
64548514|NCT00081289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548515|NCT00081289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64548516|NCT00081289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548517|NCT00081289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64548518|NCT00081289|Immunologic Factors|immunologic factors|mesh-ancestor
64548524|NCT00081289|Protective Agents|protective agents|mesh-ancestor
64548525|NCT00081289|Vitamin B Complex|vitamin b complex|mesh-ancestor
64548527|NCT00081289|Micronutrients|micronutrients|mesh-ancestor
64548528|NCT00081289|Hematinics|hematinics|mesh-ancestor
64548529|NCT01478594|Bevacizumab|bevacizumab|mesh-list
64548530|NCT01478594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64548531|NCT01478594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548532|NCT01478594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64548533|NCT01478594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64548534|NCT01478594|Growth Substances|growth substances|mesh-ancestor
64548535|NCT01478594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548536|NCT01478594|Growth Inhibitors|growth inhibitors|mesh-ancestor
64548554|NCT03480061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64548555|NCT03480061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548556|NCT03480061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64548557|NCT03480061|Analgesics|analgesics|mesh-ancestor
64548558|NCT03480061|Sensory System Agents|sensory system agents|mesh-ancestor
64548559|NCT03480061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64548560|NCT03480061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64548561|NCT03480061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64548562|NCT03480061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64548563|NCT03480061|Adrenergic Agents|adrenergic agents|mesh-ancestor
64548564|NCT03480061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64548565|NCT03480061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548566|NCT03389022|Ketamine|ketamine|mesh-list
64548567|NCT03389022|Analgesics|analgesics|mesh-ancestor
64548568|NCT03389022|Sensory System Agents|sensory system agents|mesh-ancestor
64548569|NCT03389022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782299|NCT03121716|Antimetabolites|antimetabolites|mesh-ancestor
64548570|NCT03389022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548571|NCT03389022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64548572|NCT03389022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64980363|NCT00110760|Lidocaine|lidocaine|mesh-list
64980364|NCT00110760|Tetracaine|tetracaine|mesh-list
64980365|NCT00110760|Anesthetics, Local|anesthetics, local|mesh-ancestor
64980366|NCT00110760|Anesthetics|anesthetics|mesh-ancestor
64980367|NCT00110760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64980368|NCT00110760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980369|NCT00110760|Sensory System Agents|sensory system agents|mesh-ancestor
64980370|NCT00110760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64980371|NCT00110760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64980372|NCT00110760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64980373|NCT00110760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64980374|NCT00110760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64980375|NCT00110760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980376|NCT00285142|Rosiglitazone|rosiglitazone|mesh-list
64980377|NCT00285142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64980378|NCT00285142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980408|NCT00285376|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64980409|NCT00285376|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64980411|NCT00077363|Tipifarnib|tipifarnib|mesh-list
64980412|NCT00077363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64980413|NCT00077363|Antimetabolites|antimetabolites|mesh-ancestor
64980414|NCT00077363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301243|NCT05008250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64980415|NCT00077363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980416|NCT00285415|Carboplatin|carboplatin|mesh-list
64980417|NCT00285415|Docetaxel|docetaxel|mesh-list
64980418|NCT00285415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980419|NCT00285415|Tubulin Modulators|tubulin modulators|mesh-ancestor
64980420|NCT00285415|Antimitotic Agents|antimitotic agents|mesh-ancestor
64980431|NCT00285727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980433|NCT00077402|Fenretinide|fenretinide|mesh-list
64782314|NCT02714634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64782317|NCT02714634|Antimetabolites|antimetabolites|mesh-ancestor
64980434|NCT00077402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980435|NCT00077402|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64980436|NCT00077402|Protective Agents|protective agents|mesh-ancestor
64980437|NCT00077402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548573|NCT03389022|Anesthetics, General|anesthetics, general|mesh-ancestor
64548575|NCT03389022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64548576|NCT03389022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64548577|NCT03389022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64548578|NCT03389022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64548579|NCT03389022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548580|NCT00080899|Fenretinide|fenretinide|mesh-list
64548581|NCT00080899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548582|NCT00080899|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64548583|NCT00080899|Protective Agents|protective agents|mesh-ancestor
64548584|NCT00080899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945401|NCT05664789|Antidotes|antidotes|mesh-ancestor
64548585|NCT03627858|Beclomethasone|beclomethasone|mesh-list
64548586|NCT03627858|Glycopyrrolate|glycopyrrolate|mesh-list
64548587|NCT03627858|Formoterol Fumarate|formoterol fumarate|mesh-list
64548588|NCT03627858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64548589|NCT03627858|Autonomic Agents|autonomic agents|mesh-ancestor
64548590|NCT03627858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64548591|NCT03627858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548592|NCT03627858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64548593|NCT03627858|Respiratory System Agents|respiratory system agents|mesh-ancestor
64548594|NCT03627858|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64548595|NCT03627858|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64548596|NCT03627858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64548597|NCT03627858|Adrenergic Agents|adrenergic agents|mesh-ancestor
64548598|NCT03627858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64313502|NCT00709371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64313505|NCT00709371|Anticonvulsants|anticonvulsants|mesh-ancestor
64980438|NCT00285766|Selegiline|selegiline|mesh-list
64980439|NCT00285766|Antidepressive Agents|antidepressive agents|mesh-ancestor
64980440|NCT00285766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64980441|NCT00285766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64980442|NCT00285766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64980443|NCT00285766|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64980444|NCT00285766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980445|NCT00285766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980446|NCT00285766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64980447|NCT00285766|Protective Agents|protective agents|mesh-ancestor
64980448|NCT00285766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980449|NCT00285805|Rosiglitazone|rosiglitazone|mesh-list
64980450|NCT00285805|Amiloride|amiloride|mesh-list
64980451|NCT00285805|Furosemide|furosemide|mesh-list
64980452|NCT00285805|Diuretics|diuretics|mesh-ancestor
64548599|NCT03627858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548600|NCT03627858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64548601|NCT03627858|Glucocorticoids|glucocorticoids|mesh-ancestor
64548602|NCT03627858|Hormones|hormones|mesh-ancestor
64548603|NCT03627858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64548604|NCT03627858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64548605|NCT03627858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64548606|NCT03627858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64548607|NCT03627858|Cholinergic Agents|cholinergic agents|mesh-ancestor
64548608|NCT03086785|Apatinib|apatinib|mesh-list
64548609|NCT03086785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548610|NCT03086785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64548611|NCT03086785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782391|NCT02754570|Miotics|miotics|mesh-ancestor
64548612|NCT03086785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548613|NCT03259698|Tenofovir|tenofovir|mesh-list
64548614|NCT03259698|Emtricitabine|emtricitabine|mesh-list
64548615|NCT03259698|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64548616|NCT03259698|Antiviral Agents|antiviral agents|mesh-ancestor
64548617|NCT03259698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64548618|NCT03259698|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64548619|NCT03259698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64548620|NCT03259698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64548621|NCT03259698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548622|NCT03259698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64548623|NCT03259698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64548624|NCT00089635|Panitumumab|panitumumab|mesh-list
64548625|NCT00089635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64548626|NCT00089635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548627|NCT03445728|Nicorandil|nicorandil|mesh-list
64548628|NCT03445728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64548629|NCT03445728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64548630|NCT03445728|Vasodilator Agents|vasodilator agents|mesh-ancestor
64548631|NCT03445728|Vitamin B Complex|vitamin b complex|mesh-ancestor
64548632|NCT03445728|Vitamins|vitamins|mesh-ancestor
64548633|NCT03445728|Micronutrients|micronutrients|mesh-ancestor
64980454|NCT00285805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980455|NCT00285805|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64980456|NCT00285805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64548634|NCT03445728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548635|NCT02795520|OTS167|ots167|mesh-list
64548636|NCT02795520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64548637|NCT02795520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64548638|NCT02795520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548639|NCT03159000|Lidocaine|lidocaine|mesh-list
64548640|NCT03159000|Bupivacaine|bupivacaine|mesh-list
64548641|NCT03159000|Anesthetics, Local|anesthetics, local|mesh-ancestor
64548642|NCT03159000|Anesthetics|anesthetics|mesh-ancestor
64548643|NCT03159000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64548644|NCT03159000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548645|NCT03159000|Sensory System Agents|sensory system agents|mesh-ancestor
64548646|NCT03159000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64548647|NCT03159000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64548648|NCT03159000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64548649|NCT03159000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64548650|NCT03159000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64548651|NCT03159000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548652|NCT00086671|Antibodies|antibodies|mesh-list
64548653|NCT00086671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64548654|NCT00086671|Immunologic Factors|immunologic factors|mesh-ancestor
64548655|NCT00086671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548656|NCT02464878|Etanercept|etanercept|mesh-list
64548657|NCT02464878|Thymoglobulin|thymoglobulin|mesh-list
64548658|NCT02464878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64980457|NCT00285805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980458|NCT00285805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64980459|NCT00285805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
64980460|NCT00285805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64980461|NCT00285805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64980462|NCT00285805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64980463|NCT00285844|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
64980464|NCT00285844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64782444|NCT02767128|Sodium Citrate|sodium citrate|mesh-list
64782445|NCT02767128|Anticoagulants|anticoagulants|mesh-ancestor
64782446|NCT02767128|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64782447|NCT02767128|Chelating Agents|chelating agents|mesh-ancestor
64782448|NCT02767128|Sequestering Agents|sequestering agents|mesh-ancestor
64782449|NCT02767128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782450|NCT02769702|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64782451|NCT02769702|Hormones|hormones|mesh-ancestor
64782452|NCT02769702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64782453|NCT02769702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782454|NCT02770014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64782455|NCT02770014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782456|NCT02770014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64782457|NCT02770014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782458|NCT02770014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782459|NCT02771340|Immunoconjugates|immunoconjugates|mesh-list
64782460|NCT02771340|Immunologic Factors|immunologic factors|mesh-ancestor
64782461|NCT02771340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980465|NCT00285844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980466|NCT00077441|Bortezomib|bortezomib|mesh-list
64980467|NCT00077441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980468|NCT00285883|Saquinavir|saquinavir|mesh-list
64980469|NCT00285883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64980470|NCT00285883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64980471|NCT00285883|Protease Inhibitors|protease inhibitors|mesh-ancestor
64980472|NCT00285883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980473|NCT00285883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980474|NCT00285883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64980475|NCT00285883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64980476|NCT00285883|Antiviral Agents|antiviral agents|mesh-ancestor
64980477|NCT00285883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64782462|NCT02773758|Fluorides|fluorides|mesh-list
64782463|NCT02773758|Tin Fluorides|tin fluorides|mesh-list
64782464|NCT02773758|Fluorophosphate|fluorophosphate|mesh-list
64782465|NCT02773758|Cariostatic Agents|cariostatic agents|mesh-ancestor
64782466|NCT02773758|Protective Agents|protective agents|mesh-ancestor
64782467|NCT02773758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782468|NCT02774226|Vitamins|vitamins|mesh-list
64782469|NCT02774226|Vitamin E|vitamin e|mesh-list
64782470|NCT02774226|Thioctic Acid|thioctic acid|mesh-list
64782471|NCT02774226|Antioxidants|antioxidants|mesh-list
64782472|NCT02774226|Micronutrients|micronutrients|mesh-ancestor
64782473|NCT02774226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782474|NCT02774226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782475|NCT02774226|Protective Agents|protective agents|mesh-ancestor
64782476|NCT02774226|Vitamin B Complex|vitamin b complex|mesh-ancestor
64782477|NCT02775240|Maribavir|maribavir|mesh-list
64782478|NCT02775240|Digoxin|digoxin|mesh-list
64393882|NCT02403037|Hormones|hormones|mesh-ancestor
64980478|NCT00285883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64980479|NCT00285883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64980480|NCT00110877|Darunavir|darunavir|mesh-list
64548660|NCT02464878|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64548661|NCT02464878|Protein C Inhibitor|protein c inhibitor|mesh-list
64548662|NCT02464878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64548663|NCT02464878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64548664|NCT02464878|Analgesics|analgesics|mesh-ancestor
64548665|NCT02464878|Sensory System Agents|sensory system agents|mesh-ancestor
64548666|NCT02464878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64548667|NCT02464878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548668|NCT02464878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64548669|NCT02464878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64548670|NCT02464878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64548671|NCT02464878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64548672|NCT02464878|Immunologic Factors|immunologic factors|mesh-ancestor
64548673|NCT02464878|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64548674|NCT02464878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64548675|NCT02464878|Protease Inhibitors|protease inhibitors|mesh-ancestor
64548676|NCT02464878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64548677|NCT02464878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313599|NCT02105675|Docetaxel|docetaxel|mesh-list
64980481|NCT00110877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64980482|NCT00110877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64980483|NCT00110877|Protease Inhibitors|protease inhibitors|mesh-ancestor
64980507|NCT00110916|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64980508|NCT00110916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64980509|NCT00077558|Fludarabine|fludarabine|mesh-list
64980510|NCT00077558|Fludarabine phosphate|fludarabine phosphate|mesh-list
64980511|NCT00077558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980512|NCT00077558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64980513|NCT00077558|Antimetabolites|antimetabolites|mesh-ancestor
64980514|NCT00077558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980515|NCT00077558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64980516|NCT00077558|Immunologic Factors|immunologic factors|mesh-ancestor
64980517|NCT00077558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980518|NCT00286273|Heparin|heparin|mesh-list
64980519|NCT00286273|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64980520|NCT00286273|Tinzaparin|tinzaparin|mesh-list
64980521|NCT00286273|Dalteparin|dalteparin|mesh-list
64980522|NCT00286273|Nadroparin|nadroparin|mesh-list
64980523|NCT00286273|Citric Acid|citric acid|mesh-list
64980524|NCT00286273|Sodium Citrate|sodium citrate|mesh-list
64980525|NCT00286273|Anticoagulants|anticoagulants|mesh-ancestor
64980527|NCT00286273|Chelating Agents|chelating agents|mesh-ancestor
64980528|NCT00286273|Sequestering Agents|sequestering agents|mesh-ancestor
64980529|NCT00286273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980530|NCT00286273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64980531|NCT00286273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64980532|NCT00286312|Atorvastatin|atorvastatin|mesh-list
64980533|NCT00286312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64980534|NCT00286312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64980568|NCT00111072|Glucocorticoids|glucocorticoids|mesh-ancestor
64980569|NCT00111072|Hormones|hormones|mesh-ancestor
64980570|NCT00111072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64980571|NCT00111072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64980572|NCT00111072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548679|NCT02010606|Temozolomide|temozolomide|mesh-list
64548680|NCT02010606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64548681|NCT02010606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548682|NCT02010606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64548683|NCT02010606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64548684|NCT02010606|Growth Substances|growth substances|mesh-ancestor
64548685|NCT02010606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548686|NCT02010606|Growth Inhibitors|growth inhibitors|mesh-ancestor
64548687|NCT02010606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64548688|NCT02010606|Alkylating Agents|alkylating agents|mesh-ancestor
64548689|NCT02010606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548691|NCT00084253|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64548692|NCT00084253|Lamivudine|lamivudine|mesh-list
64548693|NCT00084253|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64548694|NCT00084253|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64548695|NCT00084253|Protease Inhibitors|protease inhibitors|mesh-ancestor
64548696|NCT00084253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64548697|NCT00084253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548698|NCT00084253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64548699|NCT00084253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64548700|NCT00084253|Antiviral Agents|antiviral agents|mesh-ancestor
64548701|NCT00084253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64548702|NCT00084253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64548703|NCT00084253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64548704|NCT00084253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64980573|NCT00286624|Cyclosporine|cyclosporine|mesh-list
64782531|NCT05348148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64980574|NCT00286624|Everolimus|everolimus|mesh-list
64980575|NCT00286624|Cyclosporins|cyclosporins|mesh-list
64980600|NCT00111111|Etanercept|etanercept|mesh-list
64980601|NCT00111111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64980602|NCT00111111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64980603|NCT00111111|Analgesics|analgesics|mesh-ancestor
64980604|NCT00111111|Sensory System Agents|sensory system agents|mesh-ancestor
64980605|NCT00111111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64980606|NCT00111111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980607|NCT00111111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64980608|NCT00111111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64980609|NCT00111111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64980610|NCT00111111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64980611|NCT00111111|Immunologic Factors|immunologic factors|mesh-ancestor
64980612|NCT00077714|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64980613|NCT00077714|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64980614|NCT00077714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64980615|NCT00077714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64782565|NCT05273814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782574|NCT04784208|Hormones|hormones|mesh-list
64980616|NCT00077714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980617|NCT00077714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64548705|NCT00084253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64548706|NCT02951364|Sofosbuvir|sofosbuvir|mesh-list
64548707|NCT02951364|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64548708|NCT02951364|Ledipasvir|ledipasvir|mesh-list
64548709|NCT02951364|Antiviral Agents|antiviral agents|mesh-ancestor
64548710|NCT02951364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64548711|NCT01678417|Rituximab|rituximab|mesh-list
64548712|NCT01678417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64548713|NCT01678417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548714|NCT01678417|Immunologic Factors|immunologic factors|mesh-ancestor
64548715|NCT01678417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548716|NCT01678417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64548717|NCT00083941|Interleukin-2|interleukin-2|mesh-list
64548718|NCT00083941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548719|NCT00083941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64548720|NCT00083941|Analgesics|analgesics|mesh-ancestor
64548721|NCT00083941|Sensory System Agents|sensory system agents|mesh-ancestor
64548722|NCT00083941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64548723|NCT00083941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548724|NCT02856438|Dexamethasone|dexamethasone|mesh-list
64548725|NCT02856438|Lenalidomide|lenalidomide|mesh-list
64548726|NCT02856438|Elotuzumab|elotuzumab|mesh-list
64548727|NCT02856438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64548728|NCT02856438|Antiemetics|antiemetics|mesh-ancestor
64548729|NCT02856438|Autonomic Agents|autonomic agents|mesh-ancestor
64548730|NCT02856438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64548731|NCT02856438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548732|NCT02856438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64548733|NCT02856438|Glucocorticoids|glucocorticoids|mesh-ancestor
64548734|NCT02856438|Hormones|hormones|mesh-ancestor
64548735|NCT02856438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64548736|NCT02856438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64548737|NCT02856438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548738|NCT02856438|Immunologic Factors|immunologic factors|mesh-ancestor
64548739|NCT02856438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64548747|NCT01678495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548748|NCT01678573|Abiraterone Acetate|abiraterone acetate|mesh-list
64548749|NCT01678573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548750|NCT01678573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64548751|NCT01678573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64548752|NCT01678573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548753|NCT01678573|Hormone Antagonists|hormone antagonists|mesh-ancestor
64548754|NCT01678573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64548755|NCT01678573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548756|NCT01678573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64548757|NCT01678651|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64548759|NCT01678651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64394048|NCT04255277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64548760|NCT01678651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548761|NCT03084523|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64548762|NCT03084523|Hematinics|hematinics|mesh-ancestor
64548763|NCT03084523|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64548764|NCT03084523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64548765|NCT04094090|Riboflavin|riboflavin|mesh-list
64548766|NCT04094090|Vitamin B Complex|vitamin b complex|mesh-ancestor
64548767|NCT04094090|Vitamins|vitamins|mesh-ancestor
64548768|NCT04094090|Micronutrients|micronutrients|mesh-ancestor
64548769|NCT04094090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548770|NCT04094090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64548771|NCT04094090|Dermatologic Agents|dermatologic agents|mesh-ancestor
64548772|NCT04670796|Trastuzumab|trastuzumab|mesh-list
64548773|NCT04670796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64548774|NCT04670796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548775|NCT02525796|Eplerenone|eplerenone|mesh-list
64548776|NCT02525796|Amiloride|amiloride|mesh-list
64548777|NCT02525796|Cinacalcet|cinacalcet|mesh-list
64313694|NCT04826822|Hormones|hormones|mesh-ancestor
64980618|NCT00077714|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64980619|NCT00077714|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64980620|NCT00077714|Serotonin Agents|serotonin agents|mesh-ancestor
64980621|NCT00077714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64980622|NCT00077714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980623|NCT00077714|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64980624|NCT00077714|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64980625|NCT00077714|Dopamine Agents|dopamine agents|mesh-ancestor
64548778|NCT02525796|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64548779|NCT02525796|Hormone Antagonists|hormone antagonists|mesh-ancestor
64548780|NCT02525796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64548781|NCT02525796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548782|NCT02525796|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64548783|NCT02525796|Diuretics|diuretics|mesh-ancestor
64548784|NCT02525796|Natriuretic Agents|natriuretic agents|mesh-ancestor
64548785|NCT02525796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64548786|NCT02525796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64548787|NCT02525796|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64548788|NCT02525796|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
64548789|NCT02525796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64548790|NCT02525796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64782659|NCT05101746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64782660|NCT05101746|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64782661|NCT05101746|Vasodilator Agents|vasodilator agents|mesh-ancestor
64782662|NCT05101746|Gasotransmitters|gasotransmitters|mesh-ancestor
64782663|NCT05101746|Protective Agents|protective agents|mesh-ancestor
64782664|NCT04763226|Furosemide|furosemide|mesh-list
64782665|NCT04763226|Diuretics|diuretics|mesh-ancestor
64782666|NCT04763226|Natriuretic Agents|natriuretic agents|mesh-ancestor
64548791|NCT02525796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548792|NCT02525796|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64313717|NCT02112305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64980658|NCT00111189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64980659|NCT00111189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980660|NCT00111189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64980661|NCT00111189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64980662|NCT00111189|Dopamine Agents|dopamine agents|mesh-ancestor
64980663|NCT00077792|Enoxaparin|enoxaparin|mesh-list
64980664|NCT00077792|Enoxaparin sodium|enoxaparin sodium|mesh-list
64980665|NCT00077792|Anticoagulants|anticoagulants|mesh-ancestor
64980666|NCT00077792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64980683|NCT00286936|GABA Agonists|gaba agonists|mesh-ancestor
64980684|NCT00286936|GABA Agents|gaba agents|mesh-ancestor
64980685|NCT00286936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64980686|NCT00286936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980687|NCT00111306|Epratuzumab|epratuzumab|mesh-list
64980688|NCT00111306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64980689|NCT00111306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980690|NCT00077870|Ocrelizumab|ocrelizumab|mesh-list
64980691|NCT00077870|Immunologic Factors|immunologic factors|mesh-ancestor
64980692|NCT00077870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980693|NCT00287170|Calcitriol|calcitriol|mesh-list
64980694|NCT00287170|Mercaptopurine|mercaptopurine|mesh-list
64980695|NCT00287170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64980696|NCT00287170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980697|NCT00287170|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64980698|NCT00287170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64301255|NCT03079076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980699|NCT00287170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980700|NCT00287170|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64980701|NCT00287170|Vitamins|vitamins|mesh-ancestor
64980702|NCT00287170|Micronutrients|micronutrients|mesh-ancestor
64980703|NCT00287170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64980704|NCT00287170|Antimetabolites|antimetabolites|mesh-ancestor
64980705|NCT00287170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64980706|NCT00287170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980707|NCT00287170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64980708|NCT00287170|Immunologic Factors|immunologic factors|mesh-ancestor
64980709|NCT00287170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64980710|NCT00287170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980711|NCT00287209|Amiodarone|amiodarone|mesh-list
64548793|NCT01019616|Paclitaxel|paclitaxel|mesh-list
64548794|NCT01019616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64548795|NCT01019616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548796|NCT01019616|Tubulin Modulators|tubulin modulators|mesh-ancestor
64548797|NCT01019616|Antimitotic Agents|antimitotic agents|mesh-ancestor
64548798|NCT01019616|Mitosis Modulators|mitosis modulators|mesh-ancestor
64548799|NCT01019616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548800|NCT03086395|Obinutuzumab|obinutuzumab|mesh-list
64548801|NCT03086395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64548802|NCT03086395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548803|NCT03083197|Azithromycin|azithromycin|mesh-list
64548804|NCT03083197|Doxycycline|doxycycline|mesh-list
64548805|NCT03083197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64548806|NCT03083197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324298|NCT01337635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324299|NCT01337635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64324300|NCT02264041|Itraconazole|itraconazole|mesh-list
64324301|NCT02264041|Antifungal Agents|antifungal agents|mesh-ancestor
64324302|NCT02264041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324303|NCT02264041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64782739|NCT04741620|Cinnamaldehyde|cinnamaldehyde|mesh-list
64548807|NCT03083197|Antimalarials|antimalarials|mesh-ancestor
64548808|NCT03083197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64548809|NCT03083197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64980712|NCT00287209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64980713|NCT00287209|Vasodilator Agents|vasodilator agents|mesh-ancestor
64980714|NCT00287209|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64980715|NCT00287209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64980716|NCT00287209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980717|NCT00287209|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64980718|NCT00287209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64980719|NCT00287209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64980720|NCT00287209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980721|NCT00287209|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64980722|NCT00287209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64980747|NCT00111345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64980748|NCT00111345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980749|NCT00111345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64980750|NCT00111345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64980751|NCT00111345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980752|NCT00111345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394189|NCT05744635|Tacrolimus|tacrolimus|mesh-list
64980753|NCT00111345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64980754|NCT00111345|Immunologic Factors|immunologic factors|mesh-ancestor
64980755|NCT00111345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980756|NCT00287326|Clonidine|clonidine|mesh-list
64980757|NCT00287326|Morphine|morphine|mesh-list
64980758|NCT00287326|Bupivacaine|bupivacaine|mesh-list
64980759|NCT00287326|Anesthetics, Local|anesthetics, local|mesh-ancestor
64980760|NCT00287326|Anesthetics|anesthetics|mesh-ancestor
64980761|NCT00287326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64394190|NCT05744635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64394191|NCT05744635|Immunologic Factors|immunologic factors|mesh-ancestor
64394192|NCT05744635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782799|NCT02791308|Analgesics|analgesics|mesh-ancestor
64782800|NCT02791308|Sensory System Agents|sensory system agents|mesh-ancestor
64782801|NCT02791308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782802|NCT02791308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782803|NCT02791308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64782804|NCT02791308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64782805|NCT02791308|Dermatologic Agents|dermatologic agents|mesh-ancestor
64782806|NCT02791308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64980762|NCT00287326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980763|NCT00287326|Sensory System Agents|sensory system agents|mesh-ancestor
64980764|NCT00287326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64980765|NCT00287326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64980766|NCT00287326|Narcotics|narcotics|mesh-ancestor
64980767|NCT00287326|Analgesics|analgesics|mesh-ancestor
64980768|NCT00287326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64980769|NCT00287326|Sympatholytics|sympatholytics|mesh-ancestor
64980770|NCT00287326|Autonomic Agents|autonomic agents|mesh-ancestor
64980771|NCT00287326|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64980772|NCT00287326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64980773|NCT00287326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64980776|NCT00287326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548810|NCT01678963|Squalamine|squalamine|mesh-list
64548811|NCT01678963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64548812|NCT01678963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64548814|NCT01678963|Protective Agents|protective agents|mesh-ancestor
64548815|NCT01678963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548816|NCT01678963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548817|NCT01678963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64548818|NCT01678963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64548819|NCT01678963|Growth Substances|growth substances|mesh-ancestor
64548820|NCT01678963|Growth Inhibitors|growth inhibitors|mesh-ancestor
64548821|NCT00790335|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64548822|NCT00790335|Plasminogen|plasminogen|mesh-list
64548823|NCT00790335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64548824|NCT00790335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64548825|NCT00790335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548826|NCT05136534|Anesthetics|anesthetics|mesh-list
64548827|NCT05136534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64548828|NCT05136534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548829|NCT05135442|Bortezomib|bortezomib|mesh-list
64548830|NCT05135442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548832|NCT05130684|Cisplatin|cisplatin|mesh-list
64324307|NCT02264041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64324309|NCT02264041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64324310|NCT02264041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782928|NCT02864706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64782929|NCT02865720|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64782930|NCT02865720|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64551536|NCT00882687|Lifitegrast|lifitegrast|mesh-list
64548833|NCT05130684|Nivolumab|nivolumab|mesh-list
64548834|NCT05130684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64548835|NCT05130684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313751|NCT02114645|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64980778|NCT00287443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64980779|NCT00287443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980780|NCT00077987|Sunitinib|sunitinib|mesh-list
64980781|NCT00077987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980782|NCT00077987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64980783|NCT00077987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64980784|NCT00077987|Growth Substances|growth substances|mesh-ancestor
64980785|NCT00077987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980786|NCT00077987|Growth Inhibitors|growth inhibitors|mesh-ancestor
64980787|NCT00077987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64980788|NCT00077987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980789|NCT00077987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980790|NCT00287521|Timolol|timolol|mesh-list
64980791|NCT00287521|Latanoprost|latanoprost|mesh-list
64980792|NCT00287521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980793|NCT00287521|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64980794|NCT00287521|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64980795|NCT00287521|Adrenergic Agents|adrenergic agents|mesh-ancestor
64980796|NCT00287521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64980797|NCT00287521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980798|NCT00287521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64548836|NCT05130684|Tubulin Modulators|tubulin modulators|mesh-ancestor
64548837|NCT05130684|Antimitotic Agents|antimitotic agents|mesh-ancestor
64394350|NCT01958476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64548838|NCT05130684|Mitosis Modulators|mitosis modulators|mesh-ancestor
64548839|NCT05130684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548840|NCT05130684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64548841|NCT05130684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64548842|NCT04402411|Analgesics, Opioid|analgesics, opioid|mesh-list
64548843|NCT04402411|Narcotics|narcotics|mesh-ancestor
64548844|NCT04402411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64548845|NCT04402411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548846|NCT04402411|Analgesics|analgesics|mesh-ancestor
64548847|NCT04402411|Sensory System Agents|sensory system agents|mesh-ancestor
64548848|NCT04402411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782995|NCT02902770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64782996|NCT02902770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782998|NCT02902770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64548849|NCT05265507|Glycopyrrolate|glycopyrrolate|mesh-list
64548850|NCT05265507|Ondansetron|ondansetron|mesh-list
64548851|NCT05265507|Antiemetics|antiemetics|mesh-ancestor
64980799|NCT00287521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64980800|NCT00287521|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64980801|NCT00287521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64980802|NCT00287560|Propofol|propofol|mesh-list
64980803|NCT00287560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64980804|NCT00287560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64980805|NCT00287560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980806|NCT00287560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64980807|NCT00287560|Anesthetics, General|anesthetics, general|mesh-ancestor
64980808|NCT00287560|Anesthetics|anesthetics|mesh-ancestor
64980809|NCT00111462|Darbepoetin alfa|darbepoetin alfa|mesh-list
64980810|NCT00111462|Hematinics|hematinics|mesh-ancestor
64980811|NCT00287677|Hormones|hormones|mesh-list
64301258|NCT03271749|Anesthetics|anesthetics|mesh-list
64980812|NCT00287677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64980813|NCT00287677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980815|NCT00287794|Melatonin|melatonin|mesh-list
64980816|NCT00287794|Antioxidants|antioxidants|mesh-ancestor
64980817|NCT00287794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980818|NCT00287794|Protective Agents|protective agents|mesh-ancestor
64980819|NCT00287794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980820|NCT00287794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64980821|NCT00287794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64980822|NCT00287794|Anticonvulsants|anticonvulsants|mesh-ancestor
64980823|NCT00287794|Antiemetics|antiemetics|mesh-ancestor
64980824|NCT00287794|Autonomic Agents|autonomic agents|mesh-ancestor
64980825|NCT00287794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64980826|NCT00287794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64980827|NCT00287794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64980828|NCT00287794|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64980829|NCT00287794|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64980830|NCT00287794|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64394497|NCT01362491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64783134|NCT02956044|Bexagliflozin|bexagliflozin|mesh-list
64980831|NCT00287794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64980832|NCT00287794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64980833|NCT00287794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64980834|NCT00287794|Anesthetics, General|anesthetics, general|mesh-ancestor
64980835|NCT00287794|Anesthetics|anesthetics|mesh-ancestor
64980836|NCT00287794|GABA Modulators|gaba modulators|mesh-ancestor
64980837|NCT00287794|GABA Agents|gaba agents|mesh-ancestor
64980838|NCT00287794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64980839|NCT00287911|Topotecan|topotecan|mesh-list
64980840|NCT00287911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980841|NCT00287911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64980842|NCT00287911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64548852|NCT05265507|Autonomic Agents|autonomic agents|mesh-ancestor
64548853|NCT05265507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64548854|NCT05265507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548855|NCT05265507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64548856|NCT05265507|Antipruritics|antipruritics|mesh-ancestor
64548857|NCT05265507|Dermatologic Agents|dermatologic agents|mesh-ancestor
64548858|NCT05265507|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64548859|NCT05265507|Serotonin Agents|serotonin agents|mesh-ancestor
64548860|NCT05265507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64548861|NCT05265507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783251|NCT03009396|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64548862|NCT05265507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64548863|NCT05265507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64548864|NCT05265507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64548865|NCT05265507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64548866|NCT05265507|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64548867|NCT05265507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64548868|NCT05265507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64548869|NCT05265507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64548870|NCT05265507|Cholinergic Agents|cholinergic agents|mesh-ancestor
64548871|NCT05135286|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64548872|NCT05135286|Carbachol|carbachol|mesh-list
64548873|NCT05135286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64548874|NCT05135286|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64548875|NCT05135286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64548876|NCT05135286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64548877|NCT05135286|Adrenergic Agents|adrenergic agents|mesh-ancestor
64548878|NCT05135286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64548879|NCT05135286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313794|NCT04823390|Fentanyl|fentanyl|mesh-list
64980843|NCT00287911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980844|NCT00287911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980845|NCT00287950|Cyclophosphamide|cyclophosphamide|mesh-list
64980860|NCT00287950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64980861|NCT00287950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980862|NCT00287950|Tubulin Modulators|tubulin modulators|mesh-ancestor
64980863|NCT00287950|Antimitotic Agents|antimitotic agents|mesh-ancestor
64980864|NCT00287950|Mitosis Modulators|mitosis modulators|mesh-ancestor
64980865|NCT00288028|Bortezomib|bortezomib|mesh-list
64980866|NCT00288028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301259|NCT03271749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64439058|NCT01358877|Docetaxel|docetaxel|mesh-list
64980868|NCT00111540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64980869|NCT00111540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980870|NCT00111540|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64980871|NCT00111540|Incretins|incretins|mesh-ancestor
64980872|NCT00111540|Hormones|hormones|mesh-ancestor
64980873|NCT00111540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64548880|NCT05135286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548881|NCT05135286|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64548883|NCT05135286|Autonomic Agents|autonomic agents|mesh-ancestor
64548884|NCT05135286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64548885|NCT05135286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64548886|NCT05135286|Cholinergic Agents|cholinergic agents|mesh-ancestor
64548887|NCT05135286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64548888|NCT05135286|Analgesics|analgesics|mesh-ancestor
64548889|NCT05135286|Sensory System Agents|sensory system agents|mesh-ancestor
64548890|NCT05135286|Protective Agents|protective agents|mesh-ancestor
64548891|NCT03089671|Vitamins|vitamins|mesh-list
64548892|NCT03089671|Riboflavin|riboflavin|mesh-list
64548893|NCT03089671|Vitamin B Complex|vitamin b complex|mesh-list
64548894|NCT03089671|Micronutrients|micronutrients|mesh-ancestor
64548895|NCT03089671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548896|NCT03089671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64548897|NCT03089671|Dermatologic Agents|dermatologic agents|mesh-ancestor
64548898|NCT05136924|Varenicline|varenicline|mesh-list
64548899|NCT05136924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64548900|NCT05136924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64548901|NCT05136924|Cholinergic Agents|cholinergic agents|mesh-ancestor
64394936|NCT04184453|Deferiprone|deferiprone|mesh-list
64783535|NCT05093790|Purinergic Agents|purinergic agents|mesh-ancestor
64783536|NCT05093790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64783537|NCT04933344|Daptomycin|daptomycin|mesh-list
64783538|NCT04933344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64783539|NCT04933344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64783540|NCT05406180|Vaccines|vaccines|mesh-list
64783541|NCT05406180|Immunologic Factors|immunologic factors|mesh-ancestor
64783542|NCT05406180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783543|NCT05405478|Omalizumab|omalizumab|mesh-list
64783544|NCT05405478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64783545|NCT05405478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64783546|NCT05405478|Respiratory System Agents|respiratory system agents|mesh-ancestor
64783547|NCT05262738|Misoprostol|misoprostol|mesh-list
64783548|NCT05262738|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64783549|NCT05262738|Abortifacient Agents|abortifacient agents|mesh-ancestor
64783550|NCT05262738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64783551|NCT05262738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783552|NCT05262738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64783553|NCT05262738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64783554|NCT05262738|Oxytocics|oxytocics|mesh-ancestor
64783555|NCT05011188|Antibodies|antibodies|mesh-list
64783556|NCT05011188|Immunoglobulins|immunoglobulins|mesh-list
64783557|NCT05011188|Immunoconjugates|immunoconjugates|mesh-list
64783558|NCT05011188|Immunologic Factors|immunologic factors|mesh-ancestor
64783559|NCT05011188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783560|NCT04890366|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64394959|NCT00719225|Abatacept|abatacept|mesh-list
64783561|NCT04890366|Dermatologic Agents|dermatologic agents|mesh-ancestor
64313822|NCT04826510|Lithium Carbonate|lithium carbonate|mesh-list
64313823|NCT04826510|Perospirone|perospirone|mesh-list
64980874|NCT00288184|Allopurinol|allopurinol|mesh-list
64980875|NCT00288184|Antimetabolites|antimetabolites|mesh-ancestor
64980876|NCT00288184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980877|NCT00288184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980878|NCT00288184|Gout Suppressants|gout suppressants|mesh-ancestor
64980879|NCT00288184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64980880|NCT00288184|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64783573|NCT04263792|Trimethoprim|trimethoprim|mesh-list
64783574|NCT04263792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64783575|NCT04263792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64783576|NCT04263792|Renal Agents|renal agents|mesh-ancestor
64783577|NCT04263792|Antimalarials|antimalarials|mesh-ancestor
64783586|NCT03872700|Fentanyl|fentanyl|mesh-list
64980881|NCT00288184|Antioxidants|antioxidants|mesh-ancestor
64980882|NCT00288184|Protective Agents|protective agents|mesh-ancestor
64980883|NCT00288184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980884|NCT00288223|Telithromycin|telithromycin|mesh-list
64980885|NCT00288223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64980886|NCT00288223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64980887|NCT00288262|Melatonin|melatonin|mesh-list
64980888|NCT00288262|Antioxidants|antioxidants|mesh-ancestor
64980889|NCT00288262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980890|NCT00288262|Protective Agents|protective agents|mesh-ancestor
64980891|NCT00288262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980892|NCT00288262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64980893|NCT00288379|Budesonide|budesonide|mesh-list
64980894|NCT00288379|Formoterol Fumarate|formoterol fumarate|mesh-list
64980895|NCT00288379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64980896|NCT00288379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64980897|NCT00288379|Autonomic Agents|autonomic agents|mesh-ancestor
64980898|NCT00288379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64980899|NCT00288379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980900|NCT00288379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64980901|NCT00288379|Respiratory System Agents|respiratory system agents|mesh-ancestor
64980902|NCT00288379|Glucocorticoids|glucocorticoids|mesh-ancestor
64980903|NCT00288379|Hormones|hormones|mesh-ancestor
64980904|NCT00288379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64548902|NCT05136924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64548903|NCT05136924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548904|NCT05136924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548905|NCT00791037|Cyclophosphamide|cyclophosphamide|mesh-list
64783613|NCT04589364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548906|NCT00791037|Sargramostim|sargramostim|mesh-list
64548907|NCT00791037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64548908|NCT00791037|Immunologic Factors|immunologic factors|mesh-ancestor
64548909|NCT00791037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548910|NCT00791037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64548911|NCT00791037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64548912|NCT00791037|Alkylating Agents|alkylating agents|mesh-ancestor
64301260|NCT03271749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301262|NCT03280407|Capecitabine|capecitabine|mesh-list
64548913|NCT00791037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548914|NCT00791037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548915|NCT00791037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64548916|NCT04403191|Ondansetron|ondansetron|mesh-list
64395138|NCT03163693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64395139|NCT03163693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64395140|NCT03163693|Adrenergic Agents|adrenergic agents|mesh-ancestor
64395141|NCT03163693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64395142|NCT03163693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395143|NCT05030545|Eplerenone|eplerenone|mesh-list
64395144|NCT05030545|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
64395145|NCT05030545|Mineralocorticoids|mineralocorticoids|mesh-list
64395146|NCT05030545|Hormone Antagonists|hormone antagonists|mesh-ancestor
64783735|NCT03218592|Dolutegravir|dolutegravir|mesh-list
64783736|NCT03218592|Antiviral Agents|antiviral agents|mesh-ancestor
64548917|NCT04403191|Antiemetics|antiemetics|mesh-ancestor
64548918|NCT04403191|Autonomic Agents|autonomic agents|mesh-ancestor
64548919|NCT04403191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64548920|NCT04403191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548922|NCT04403191|Antipruritics|antipruritics|mesh-ancestor
64548956|NCT05301660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548957|NCT01401959|Trastuzumab|trastuzumab|mesh-list
64548958|NCT01401959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64548959|NCT01401959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64548961|NCT04767035|Ketamine|ketamine|mesh-list
64505066|NCT02497716|Anticoagulants|anticoagulants|mesh-ancestor
64548962|NCT04767035|Analgesics|analgesics|mesh-ancestor
64548963|NCT04767035|Sensory System Agents|sensory system agents|mesh-ancestor
64783773|NCT03223272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64783774|NCT03223272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64783775|NCT03223272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783776|NCT03223272|Adrenergic Agents|adrenergic agents|mesh-ancestor
64783777|NCT03223272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64783778|NCT03239106|Apremilast|apremilast|mesh-list
64783779|NCT03239106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64395182|NCT03160807|Renal Agents|renal agents|mesh-ancestor
64548964|NCT04767035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64548965|NCT04767035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548966|NCT04767035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64548967|NCT04767035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64313898|NCT03553433|Apremilast|apremilast|mesh-list
64980905|NCT00288379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64980906|NCT00288379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64980917|NCT00078182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980919|NCT00078182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64980920|NCT00111618|Vadimezan|vadimezan|mesh-list
64980921|NCT00111618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980922|NCT00399425|Heparin|heparin|mesh-list
64980923|NCT00399425|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64980924|NCT00399425|Tinzaparin|tinzaparin|mesh-list
64980925|NCT00399425|Dalteparin|dalteparin|mesh-list
64980926|NCT00399425|Bemiparin|bemiparin|mesh-list
64980927|NCT00399425|Anticoagulants|anticoagulants|mesh-ancestor
64980928|NCT00399425|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64980929|NCT00399425|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64980930|NCT00399425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980931|NCT00288535|Sirolimus|sirolimus|mesh-list
64980932|NCT00288535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64980933|NCT00288535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64980934|NCT00288535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64783883|NCT03343080|Lidocaine|lidocaine|mesh-list
64783884|NCT03343080|Anesthetics, Local|anesthetics, local|mesh-ancestor
64783885|NCT03343080|Anesthetics|anesthetics|mesh-ancestor
64783886|NCT03343080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64783887|NCT03343080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395286|NCT04941937|Antiemetics|antiemetics|mesh-ancestor
64395287|NCT04941937|Autonomic Agents|autonomic agents|mesh-ancestor
64395288|NCT04941937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395289|NCT04941937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395290|NCT04941937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64395291|NCT04941937|Glucocorticoids|glucocorticoids|mesh-ancestor
64395292|NCT04941937|Hormones|hormones|mesh-ancestor
64395293|NCT04941937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64395294|NCT04941937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64395295|NCT04941937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395296|NCT04941937|Immunologic Factors|immunologic factors|mesh-ancestor
64783888|NCT03343080|Sensory System Agents|sensory system agents|mesh-ancestor
64783889|NCT03343080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783890|NCT03343080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64783891|NCT03343080|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64783892|NCT03343080|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64783893|NCT03343080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64783894|NCT03343080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783895|NCT03375294|Nitrous Oxide|nitrous oxide|mesh-list
64783896|NCT03375294|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64395297|NCT04941937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64395298|NCT04941937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64980935|NCT00288535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980936|NCT00288535|Antifungal Agents|antifungal agents|mesh-ancestor
64980937|NCT00288535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64980938|NCT00288535|Immunologic Factors|immunologic factors|mesh-ancestor
64980939|NCT00288535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980940|NCT00399464|Alfuzosin|alfuzosin|mesh-list
64980941|NCT00399464|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64980942|NCT00399464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64980943|NCT00399464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64980944|NCT00399464|Adrenergic Agents|adrenergic agents|mesh-ancestor
64980945|NCT00399464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64395313|NCT04935931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395314|NCT04935931|Sensory System Agents|sensory system agents|mesh-ancestor
64395315|NCT04935931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395316|NCT05124431|Everolimus|everolimus|mesh-list
64395317|NCT05124431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64783911|NCT03395808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64783912|NCT03395808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783913|NCT03395808|Analgesics|analgesics|mesh-ancestor
64783914|NCT03395808|Sensory System Agents|sensory system agents|mesh-ancestor
64783915|NCT03395808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783916|NCT03395886|Dexmedetomidine|dexmedetomidine|mesh-list
64783917|NCT03395886|Remifentanil|remifentanil|mesh-list
64783918|NCT03395886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64783919|NCT03395886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64783920|NCT03395886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783921|NCT03395886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64395318|NCT05124431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64395319|NCT05124431|Immunologic Factors|immunologic factors|mesh-ancestor
64395320|NCT05124431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395321|NCT04877275|Dexamethasone|dexamethasone|mesh-list
64395322|NCT04877275|Cyclophosphamide|cyclophosphamide|mesh-list
64304774|NCT00109837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64304775|NCT00109837|Antimetabolites|antimetabolites|mesh-ancestor
64304776|NCT00109837|Dermatologic Agents|dermatologic agents|mesh-ancestor
64304777|NCT00109837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64980946|NCT00399464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980947|NCT00399464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980948|NCT00399464|Urological Agents|urological agents|mesh-ancestor
64980949|NCT00288652|Reboxetine|reboxetine|mesh-list
64980950|NCT00288652|Antidepressive Agents|antidepressive agents|mesh-ancestor
64980951|NCT00288652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64980952|NCT00288652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64980953|NCT00288652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64980954|NCT00288652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64783927|NCT03395886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64783928|NCT03395886|Adrenergic Agents|adrenergic agents|mesh-ancestor
64783929|NCT03395886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64783930|NCT03395886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783931|NCT03395886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64783932|NCT03395886|Narcotics|narcotics|mesh-ancestor
64783933|NCT03426228|Progesterone|progesterone|mesh-list
64783934|NCT03426228|Estrogens|estrogens|mesh-list
64783935|NCT03426228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783936|NCT03426228|Hormones|hormones|mesh-ancestor
64783937|NCT03426228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64783938|NCT03426228|Progestins|progestins|mesh-ancestor
64783939|NCT03430050|Progesterone|progesterone|mesh-list
64783940|NCT03430050|Progestins|progestins|mesh-ancestor
64783941|NCT03430050|Hormones|hormones|mesh-ancestor
64783942|NCT03430050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64980955|NCT00288652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980956|NCT00288652|Adrenergic Agents|adrenergic agents|mesh-ancestor
64980957|NCT00288652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64980958|NCT00288652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980959|NCT00288730|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64980960|NCT00288730|Natriuretic Agents|natriuretic agents|mesh-ancestor
64980961|NCT00288730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980962|NCT00288769|Vitamin B 12|vitamin b 12|mesh-list
64548968|NCT04767035|Anesthetics, General|anesthetics, general|mesh-ancestor
64548969|NCT04767035|Anesthetics|anesthetics|mesh-ancestor
64783970|NCT03459612|Promethazine|promethazine|mesh-list
64783971|NCT03459612|Lasmiditan|lasmiditan|mesh-list
64783972|NCT03459612|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64783973|NCT03459612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64783974|NCT03459612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64783975|NCT03459612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783976|NCT03459612|Anesthetics, Local|anesthetics, local|mesh-ancestor
64783977|NCT03459612|Anesthetics|anesthetics|mesh-ancestor
64783978|NCT03459612|Sensory System Agents|sensory system agents|mesh-ancestor
64783979|NCT03459612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783980|NCT03459612|Antiemetics|antiemetics|mesh-ancestor
64783981|NCT03459612|Autonomic Agents|autonomic agents|mesh-ancestor
64783982|NCT03459612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64783983|NCT03459612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64783984|NCT03459612|Histamine Antagonists|histamine antagonists|mesh-ancestor
64783985|NCT03459612|Histamine Agents|histamine agents|mesh-ancestor
64783986|NCT03459612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64395359|NCT04955249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64395361|NCT05676463|Ascorbic Acid|ascorbic acid|mesh-list
64324363|NCT01515007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64548970|NCT04767035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64548971|NCT04767035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64548972|NCT04767035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64548973|NCT04767035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64548974|NCT04767035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548975|NCT04767035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64548976|NCT04767035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64548977|NCT04767035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64548978|NCT04767035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64548979|NCT04767035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64548980|NCT04767035|GABA Modulators|gaba modulators|mesh-ancestor
64548981|NCT04767035|GABA Agents|gaba agents|mesh-ancestor
64548982|NCT05222529|Glycopyrrolate|glycopyrrolate|mesh-list
64548984|NCT05222529|Anticonvulsants|anticonvulsants|mesh-ancestor
64548985|NCT05222529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64548986|NCT05222529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64548987|NCT05222529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64548988|NCT05222529|Cholinergic Agents|cholinergic agents|mesh-ancestor
64548989|NCT05222529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64548990|NCT05222529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548991|NCT05222529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64548992|NCT03081169|Heparin|heparin|mesh-list
64548993|NCT03081169|Enoxaparin|enoxaparin|mesh-list
64548994|NCT03081169|Enoxaparin sodium|enoxaparin sodium|mesh-list
64548995|NCT03081169|Anticoagulants|anticoagulants|mesh-ancestor
64980963|NCT00288769|Hydroxocobalamin|hydroxocobalamin|mesh-list
64980964|NCT00288769|Vitamins|vitamins|mesh-ancestor
64980965|NCT00288769|Micronutrients|micronutrients|mesh-ancestor
64980966|NCT00288769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980967|NCT00288769|Vitamin B Complex|vitamin b complex|mesh-ancestor
64980968|NCT00288769|Hematinics|hematinics|mesh-ancestor
64980969|NCT00111852|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
64980970|NCT00111852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64980985|NCT00111891|Vitamins|vitamins|mesh-ancestor
64980986|NCT00111891|Micronutrients|micronutrients|mesh-ancestor
64980987|NCT00111891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980988|NCT00289354|Chromium|chromium|mesh-list
64980990|NCT00289354|Picolinic acid|picolinic acid|mesh-list
64980991|NCT00289354|Trace Elements|trace elements|mesh-ancestor
64980992|NCT00289354|Micronutrients|micronutrients|mesh-ancestor
64980993|NCT00289354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980994|NCT00289354|Vitamin B Complex|vitamin b complex|mesh-ancestor
64980995|NCT00289354|Vitamins|vitamins|mesh-ancestor
64980996|NCT00289354|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64980997|NCT00289354|Chelating Agents|chelating agents|mesh-ancestor
64980998|NCT00289354|Sequestering Agents|sequestering agents|mesh-ancestor
64548996|NCT03081169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64548997|NCT03081169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64548998|NCT03081169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548999|NCT03803163|Treprostinil|treprostinil|mesh-list
64549000|NCT03803163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64549001|NCT05287308|Paclitaxel|paclitaxel|mesh-list
64301265|NCT03280407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64395406|NCT05136521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64301266|NCT03280407|Antimetabolites|antimetabolites|mesh-ancestor
64549002|NCT05287308|Docetaxel|docetaxel|mesh-list
64395407|NCT05136521|Serotonin Agents|serotonin agents|mesh-ancestor
64395419|NCT02388373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64395420|NCT02388373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64395421|NCT02388373|Autonomic Agents|autonomic agents|mesh-ancestor
64304802|NCT05229445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64304803|NCT05229445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304804|NCT01671332|Suramin|suramin|mesh-list
64304805|NCT01671332|Docetaxel|docetaxel|mesh-list
64304806|NCT01671332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304807|NCT01671332|Tubulin Modulators|tubulin modulators|mesh-ancestor
64304808|NCT01671332|Antimitotic Agents|antimitotic agents|mesh-ancestor
64304809|NCT01671332|Mitosis Modulators|mitosis modulators|mesh-ancestor
64304810|NCT01671332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304811|NCT01671332|Antinematodal Agents|antinematodal agents|mesh-ancestor
64304812|NCT01671332|Anthelmintics|anthelmintics|mesh-ancestor
64304813|NCT01671332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64304814|NCT01671332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64304815|NCT01671332|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64304816|NCT01671332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64304818|NCT03063242|Immunologic Factors|immunologic factors|mesh-ancestor
64304819|NCT03063242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549003|NCT05287308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64549004|NCT05287308|Cyclophosphamide|cyclophosphamide|mesh-list
64549005|NCT05287308|Doxorubicin|doxorubicin|mesh-list
64549006|NCT05287308|Epirubicin|epirubicin|mesh-list
64549007|NCT05287308|Pirarubicin|pirarubicin|mesh-list
64549008|NCT05287308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64549009|NCT05287308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549010|NCT05287308|Tubulin Modulators|tubulin modulators|mesh-ancestor
64549011|NCT05287308|Antimitotic Agents|antimitotic agents|mesh-ancestor
64549012|NCT05287308|Mitosis Modulators|mitosis modulators|mesh-ancestor
64549013|NCT05287308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549014|NCT05287308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64549015|NCT05287308|Immunologic Factors|immunologic factors|mesh-ancestor
64549016|NCT05287308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549017|NCT05287308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64549018|NCT05287308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64549019|NCT05287308|Alkylating Agents|alkylating agents|mesh-ancestor
64549020|NCT05287308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64549021|NCT05287308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64549024|NCT05287308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549044|NCT05346211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64549045|NCT05346211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549046|NCT05346211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549047|NCT05346211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549048|NCT05694897|Magnesium Sulfate|magnesium sulfate|mesh-list
64549049|NCT05694897|Bupivacaine|bupivacaine|mesh-list
64549050|NCT05694897|Anesthetics, Local|anesthetics, local|mesh-ancestor
64549051|NCT05694897|Anesthetics|anesthetics|mesh-ancestor
64549052|NCT05694897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64549053|NCT05694897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549054|NCT05694897|Sensory System Agents|sensory system agents|mesh-ancestor
64549055|NCT05694897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64549056|NCT05694897|Analgesics|analgesics|mesh-ancestor
64549057|NCT05694897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64549058|NCT05694897|Anticonvulsants|anticonvulsants|mesh-ancestor
64549059|NCT05694897|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64549060|NCT05694897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64549061|NCT05694897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549062|NCT05694897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64549063|NCT05694897|Tocolytic Agents|tocolytic agents|mesh-ancestor
64549064|NCT05694897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64549065|NCT01478048|Dexamethasone|dexamethasone|mesh-list
64549066|NCT01478048|Dexamethasone acetate|dexamethasone acetate|mesh-list
64549067|NCT01478048|Bortezomib|bortezomib|mesh-list
64549068|NCT01478048|Elotuzumab|elotuzumab|mesh-list
64549069|NCT01478048|BB 1101|bb 1101|mesh-list
64980999|NCT00289354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981000|NCT00289510|Vaccines|vaccines|mesh-list
64981001|NCT00289510|Immunologic Factors|immunologic factors|mesh-ancestor
64981002|NCT00289510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981003|NCT00289588|Mupirocin|mupirocin|mesh-list
64981004|NCT00289588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64981005|NCT00289588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64981006|NCT00289588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64981007|NCT00289588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981008|NCT00289588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981009|NCT00289627|Ipilimumab|ipilimumab|mesh-list
64981010|NCT00289627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64981011|NCT00289627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981012|NCT00289627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64981013|NCT00289627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981014|NCT00401661|Alfuzosin|alfuzosin|mesh-list
64981015|NCT00401661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64981016|NCT00401661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64981017|NCT00401661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64981018|NCT00401661|Adrenergic Agents|adrenergic agents|mesh-ancestor
64981019|NCT00401661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64549071|NCT01478048|Antiemetics|antiemetics|mesh-ancestor
64549072|NCT01478048|Autonomic Agents|autonomic agents|mesh-ancestor
64549073|NCT01478048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64549074|NCT01478048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549075|NCT01478048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64549076|NCT01478048|Glucocorticoids|glucocorticoids|mesh-ancestor
64439363|NCT01945281|Caspofungin|caspofungin|mesh-list
64549077|NCT01478048|Hormones|hormones|mesh-ancestor
64549078|NCT01478048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64549079|NCT01478048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64549080|NCT01478048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549081|NCT01478048|Protease Inhibitors|protease inhibitors|mesh-ancestor
64549082|NCT01478048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549083|NCT01478048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549084|NCT04585776|Insulin|insulin|mesh-list
64549085|NCT04585776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64549086|NCT04585776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549087|NCT01401647|Lidocaine|lidocaine|mesh-list
64981020|NCT00401661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981021|NCT00401661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981022|NCT00401661|Urological Agents|urological agents|mesh-ancestor
64981023|NCT00289861|Risperidone|risperidone|mesh-list
64981024|NCT00289861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64981025|NCT00289861|Serotonin Agents|serotonin agents|mesh-ancestor
64981026|NCT00289861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64981027|NCT00289861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981028|NCT00289861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981029|NCT00289861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64981030|NCT00289861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64981031|NCT00289861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64981046|NCT00112086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981047|NCT00112086|Tubulin Modulators|tubulin modulators|mesh-ancestor
64981048|NCT00112086|Antimitotic Agents|antimitotic agents|mesh-ancestor
64981049|NCT00112086|Mitosis Modulators|mitosis modulators|mesh-ancestor
64981050|NCT00112086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981052|NCT00290173|Sympathomimetics|sympathomimetics|mesh-ancestor
64395428|NCT02388373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64395429|NCT02388373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64395430|NCT02388373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64395431|NCT02388373|Adrenergic Agents|adrenergic agents|mesh-ancestor
64395432|NCT02388373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64395434|NCT01674647|Vitamin K|vitamin k|mesh-list
64981053|NCT00290173|Autonomic Agents|autonomic agents|mesh-ancestor
64981054|NCT00290173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64981055|NCT00290173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981056|NCT00290173|Tocolytic Agents|tocolytic agents|mesh-ancestor
64981057|NCT00290173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64981058|NCT00290173|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64981059|NCT00290173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64981060|NCT00290173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64981061|NCT00290173|Adrenergic Agents|adrenergic agents|mesh-ancestor
64981062|NCT00290173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64981063|NCT00290173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981064|NCT00290485|Imatinib Mesylate|imatinib mesylate|mesh-list
64981065|NCT00290485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981066|NCT00290485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64981067|NCT00290485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981068|NCT00290485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981069|NCT00112164|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
64981070|NCT00112164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64981071|NCT00078260|Pemetrexed|pemetrexed|mesh-list
64549088|NCT01401647|Amiodarone|amiodarone|mesh-list
64549089|NCT01401647|Anesthetics, Local|anesthetics, local|mesh-ancestor
64549090|NCT01401647|Anesthetics|anesthetics|mesh-ancestor
64549091|NCT01401647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64549092|NCT01401647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549093|NCT01401647|Sensory System Agents|sensory system agents|mesh-ancestor
64549094|NCT01401647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64549095|NCT01401647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64549096|NCT01401647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64549097|NCT01401647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64549098|NCT01401647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64549099|NCT01401647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314034|NCT04806230|Citalopram|citalopram|mesh-list
64314035|NCT04806230|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64981072|NCT00078260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981073|NCT00078260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981074|NCT00078260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981075|NCT00078260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64981076|NCT00078260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64981077|NCT00290602|Methylprednisolone|methylprednisolone|mesh-list
64981079|NCT00290602|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64981080|NCT00290602|Prednisolone|prednisolone|mesh-list
64981081|NCT00290602|Prednisolone acetate|prednisolone acetate|mesh-list
64981082|NCT00290602|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64981083|NCT00290602|Prednisolone phosphate|prednisolone phosphate|mesh-list
64981084|NCT00290602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64981085|NCT00290602|Antiemetics|antiemetics|mesh-ancestor
64981086|NCT00290602|Autonomic Agents|autonomic agents|mesh-ancestor
64981087|NCT00290602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64981088|NCT00290602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784078|NCT03557658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981089|NCT00290602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64981090|NCT00290602|Glucocorticoids|glucocorticoids|mesh-ancestor
64981091|NCT00290602|Hormones|hormones|mesh-ancestor
64981092|NCT00290602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64981118|NCT00290641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64981119|NCT00290641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64981120|NCT00290641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64981121|NCT00290641|Antitubercular Agents|antitubercular agents|mesh-ancestor
64981122|NCT00290641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64981124|NCT00290680|Bortezomib|bortezomib|mesh-list
64981125|NCT00290680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981126|NCT00290680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64981127|NCT00290680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64981128|NCT00290680|Analgesics|analgesics|mesh-ancestor
64981129|NCT00290680|Sensory System Agents|sensory system agents|mesh-ancestor
64981130|NCT00290680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64981131|NCT00290680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981132|NCT00290680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64981133|NCT00290680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64981134|NCT00290680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64981135|NCT00290680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64981136|NCT00290680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981137|NCT00290680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981138|NCT02960815|Imiquimod|imiquimod|mesh-list
64981139|NCT02960815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64981140|NCT02960815|Immunologic Factors|immunologic factors|mesh-ancestor
64981141|NCT02960815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981142|NCT02960815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549100|NCT01401647|Vasodilator Agents|vasodilator agents|mesh-ancestor
64549101|NCT01401647|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64549102|NCT01401647|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64549103|NCT01401647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64549104|NCT01401647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549105|NCT01401647|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64549106|NCT01401647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64549107|NCT01401647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64549108|NCT01423253|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64549109|NCT01423253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64549110|NCT01423253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64395453|NCT02669407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64395454|NCT02669407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395455|NCT02669407|Sensory System Agents|sensory system agents|mesh-ancestor
64395456|NCT02669407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395457|NCT02669407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64395458|NCT02669407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64395459|NCT02669407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64784100|NCT03593538|Metformin|metformin|mesh-list
64549111|NCT01423253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64549112|NCT01423253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549113|NCT01423253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64549114|NCT01423253|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64549115|NCT01423253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64549116|NCT01423253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64549117|NCT01423253|Adrenergic Agents|adrenergic agents|mesh-ancestor
64549118|NCT01423253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64549119|NCT01423253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314046|NCT04806230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64981167|NCT04729556|Antimetabolites|antimetabolites|mesh-ancestor
64981168|NCT04729556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981169|NCT04729556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64981170|NCT04729556|Chelating Agents|chelating agents|mesh-ancestor
64981171|NCT04729556|Sequestering Agents|sequestering agents|mesh-ancestor
64981173|NCT04729556|Coagulants|coagulants|mesh-ancestor
64981174|NCT00290914|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
64981175|NCT00290914|Antidepressive Agents|antidepressive agents|mesh-ancestor
64981176|NCT00290914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64981177|NCT00290914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64981178|NCT00290914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64981179|NCT00290914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64981180|NCT00290914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981181|NCT00290914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64981182|NCT00290914|Serotonin Agents|serotonin agents|mesh-ancestor
64981183|NCT00290914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981184|NCT00290914|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64981185|NCT00290914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64981186|NCT00290992|Rasburicase|rasburicase|mesh-list
64981187|NCT00290992|Gout Suppressants|gout suppressants|mesh-ancestor
64981188|NCT00290992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64981189|NCT00291109|Letrozole|letrozole|mesh-list
64981190|NCT00291109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981191|NCT00291109|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64981192|NCT00291109|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64981193|NCT00291109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981218|NCT00291148|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64549120|NCT01423253|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64549121|NCT01423253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64549122|NCT01423253|Serotonin Agents|serotonin agents|mesh-ancestor
64549123|NCT01423253|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64549124|NCT01423253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64549125|NCT01423253|Dopamine Agents|dopamine agents|mesh-ancestor
64549126|NCT03088891|Antioxidants|antioxidants|mesh-list
64549127|NCT03088891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549128|NCT03088891|Protective Agents|protective agents|mesh-ancestor
64549129|NCT03088891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549130|NCT01477892|Remifentanil|remifentanil|mesh-list
64549131|NCT01477892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64549132|NCT01477892|Narcotics|narcotics|mesh-ancestor
64395463|NCT04909853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64395464|NCT04909853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64395465|NCT04909853|Protease Inhibitors|protease inhibitors|mesh-ancestor
64395466|NCT04909853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64395467|NCT04909853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395468|NCT04909853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64304849|NCT05048264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64304850|NCT05048264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64549133|NCT01477892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64549134|NCT01477892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549135|NCT01477892|Analgesics|analgesics|mesh-ancestor
64549136|NCT01477892|Sensory System Agents|sensory system agents|mesh-ancestor
64549137|NCT01477892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64549139|NCT00801801|Sorafenib|sorafenib|mesh-list
64314069|NCT02603120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64981219|NCT00291148|Antidepressive Agents|antidepressive agents|mesh-ancestor
64981220|NCT00291148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64981221|NCT00291148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64981222|NCT00291148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981223|NCT00291382|Fluticasone|fluticasone|mesh-list
64981224|NCT00291382|Xhance|xhance|mesh-list
64981225|NCT00291382|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64981226|NCT00291382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64981227|NCT00291382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64981228|NCT00291382|Autonomic Agents|autonomic agents|mesh-ancestor
64981229|NCT00291382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64981230|NCT00291382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981231|NCT00291382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64981232|NCT00291382|Respiratory System Agents|respiratory system agents|mesh-ancestor
64981233|NCT00291382|Dermatologic Agents|dermatologic agents|mesh-ancestor
64981234|NCT00291382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64981235|NCT00291382|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64981236|NCT00291382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64981237|NCT00291382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64981304|NCT00112554|Antimetabolites|antimetabolites|mesh-ancestor
64981305|NCT00112554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981306|NCT00112554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981307|NCT00112554|Antiviral Agents|antiviral agents|mesh-ancestor
64981308|NCT00112554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64981309|NCT00112554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64981310|NCT00112554|Immunologic Factors|immunologic factors|mesh-ancestor
64981311|NCT00112554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981312|NCT04718311|Tacrolimus|tacrolimus|mesh-list
64981313|NCT04718311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64981314|NCT04718311|Immunologic Factors|immunologic factors|mesh-ancestor
64981315|NCT04718311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981316|NCT04718311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64981317|NCT04718311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549140|NCT00801801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549141|NCT00801801|Tubulin Modulators|tubulin modulators|mesh-ancestor
64549142|NCT00801801|Antimitotic Agents|antimitotic agents|mesh-ancestor
64549143|NCT00801801|Mitosis Modulators|mitosis modulators|mesh-ancestor
64549148|NCT01499576|Retinol acetate|retinol acetate|mesh-list
64549149|NCT01499576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64549150|NCT01499576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64549151|NCT01499576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64549152|NCT01499576|Immunologic Factors|immunologic factors|mesh-ancestor
64549153|NCT01499576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549154|NCT01499576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64304851|NCT05048264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304852|NCT05048264|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64304854|NCT05048264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64304855|NCT05048264|Immunologic Factors|immunologic factors|mesh-ancestor
64304856|NCT05048264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304857|NCT05048264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304858|NCT05048264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64304859|NCT05048264|Respiratory System Agents|respiratory system agents|mesh-ancestor
64304860|NCT05046314|Vincristine|vincristine|mesh-list
64304861|NCT05046314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64549155|NCT01499576|Protective Agents|protective agents|mesh-ancestor
64549156|NCT01499576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549157|NCT04546074|Pembrolizumab|pembrolizumab|mesh-list
64981318|NCT04718311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981319|NCT00078689|Daclizumab|daclizumab|mesh-list
64981320|NCT00078689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64981337|NCT00275275|Antioxidants|antioxidants|mesh-ancestor
64981338|NCT00275275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981339|NCT00275275|Protective Agents|protective agents|mesh-ancestor
64981340|NCT00275275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981341|NCT00275275|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64981342|NCT00275275|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64981343|NCT00275275|Dopamine Agonists|dopamine agonists|mesh-ancestor
64981344|NCT00275275|Dopamine Agents|dopamine agents|mesh-ancestor
64981345|NCT00275275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64981346|NCT00112710|Gemcitabine|gemcitabine|mesh-list
64981347|NCT00112710|Carboplatin|carboplatin|mesh-list
64981348|NCT00112710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981349|NCT00112710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64981350|NCT00112710|Antimetabolites|antimetabolites|mesh-ancestor
64981351|NCT00112710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981352|NCT00112710|Antiviral Agents|antiviral agents|mesh-ancestor
64981353|NCT00112710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64981354|NCT00112710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981355|NCT00112710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64981356|NCT00112710|Immunologic Factors|immunologic factors|mesh-ancestor
64981357|NCT00112710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981358|NCT00275236|Rotigotine|rotigotine|mesh-list
64981359|NCT00275236|Dopamine Agonists|dopamine agonists|mesh-ancestor
64981360|NCT00275236|Dopamine Agents|dopamine agents|mesh-ancestor
64981361|NCT00275236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64981362|NCT00275236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981363|NCT00275236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981364|NCT00275197|Sertraline|sertraline|mesh-list
64981365|NCT00275197|Antidepressive Agents|antidepressive agents|mesh-ancestor
64981366|NCT00275197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64981367|NCT00275197|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64981368|NCT00275197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64981369|NCT00275197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64981370|NCT00275197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981371|NCT00275197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64981372|NCT00275197|Serotonin Agents|serotonin agents|mesh-ancestor
64549158|NCT04546074|Imatinib Mesylate|imatinib mesylate|mesh-list
64549159|NCT04546074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64549160|NCT04546074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549161|NCT04546074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64549162|NCT04546074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549163|NCT04546074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549164|NCT00802113|Fludarabine|fludarabine|mesh-list
64549165|NCT00802113|Busulfan|busulfan|mesh-list
64324368|NCT01515007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324369|NCT01515007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324370|NCT01515007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64549166|NCT00802113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64549167|NCT00802113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549168|NCT00802113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549169|NCT00802113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64314107|NCT04803500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64314108|NCT04803500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64981373|NCT00275197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981374|NCT00275119|Gemcitabine|gemcitabine|mesh-list
64981375|NCT00275119|Fluorouracil|fluorouracil|mesh-list
64981376|NCT00275119|Oxaliplatin|oxaliplatin|mesh-list
64981377|NCT00275119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64981378|NCT00275119|Antimetabolites|antimetabolites|mesh-ancestor
64981379|NCT00275119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981380|NCT00275119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981399|NCT00078962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981401|NCT00078962|Antiviral Agents|antiviral agents|mesh-ancestor
64981402|NCT00078962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64981403|NCT00078962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981404|NCT00078962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64981405|NCT00078962|Immunologic Factors|immunologic factors|mesh-ancestor
64981406|NCT00078962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981407|NCT00275041|Irinotecan|irinotecan|mesh-list
64981408|NCT00275041|Cetuximab|cetuximab|mesh-list
64981409|NCT00275041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64981410|NCT00275041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64981411|NCT00275041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981412|NCT00275041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981413|NCT00275041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981414|NCT00275041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64981415|NCT00274963|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64981416|NCT00274963|Mitoxantrone|mitoxantrone|mesh-list
64981417|NCT00274963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64981418|NCT00274963|Alkylating Agents|alkylating agents|mesh-ancestor
64981419|NCT00274963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981420|NCT00274963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981421|NCT00274963|Analgesics|analgesics|mesh-ancestor
64981422|NCT00274963|Sensory System Agents|sensory system agents|mesh-ancestor
64981423|NCT00274963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64981424|NCT00274963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981425|NCT00274963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64981426|NCT00274963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64981427|NCT00274963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981428|NCT00102765|Fluticasone|fluticasone|mesh-list
64981429|NCT00102765|Xhance|xhance|mesh-list
64981430|NCT00102765|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64981431|NCT00102765|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64981432|NCT00102765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64981433|NCT00102765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64981434|NCT00102765|Autonomic Agents|autonomic agents|mesh-ancestor
64981435|NCT00102765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64549170|NCT00802113|Immunologic Factors|immunologic factors|mesh-ancestor
64549171|NCT00802113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549172|NCT00802113|Alkylating Agents|alkylating agents|mesh-ancestor
64549173|NCT00802113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64304874|NCT00100802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304876|NCT01355159|Folic Acid|folic acid|mesh-list
64304877|NCT01355159|Hematinics|hematinics|mesh-ancestor
64304878|NCT01355159|Vitamin B Complex|vitamin b complex|mesh-ancestor
64304879|NCT01355159|Vitamins|vitamins|mesh-ancestor
64304880|NCT01355159|Micronutrients|micronutrients|mesh-ancestor
64549174|NCT00802113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64549176|NCT03084601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64549177|NCT03084601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549178|NCT00791973|Fluticasone|fluticasone|mesh-list
64549179|NCT00791973|Xhance|xhance|mesh-list
64549180|NCT00791973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64549181|NCT00791973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64549182|NCT00791973|Autonomic Agents|autonomic agents|mesh-ancestor
64314119|NCT01331681|Growth Inhibitors|growth inhibitors|mesh-ancestor
64981458|NCT00079079|Antimetabolites|antimetabolites|mesh-ancestor
64981459|NCT00079079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981460|NCT00079079|Antiviral Agents|antiviral agents|mesh-ancestor
64981461|NCT00079079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64981462|NCT00079079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981463|NCT00079079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64981464|NCT00079079|Immunologic Factors|immunologic factors|mesh-ancestor
64981465|NCT00079079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981466|NCT00130351|Formoterol Fumarate|formoterol fumarate|mesh-list
64981467|NCT00130351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64981468|NCT00130351|Autonomic Agents|autonomic agents|mesh-ancestor
64981469|NCT00130351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64981470|NCT00130351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981471|NCT00130351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64981472|NCT00130351|Respiratory System Agents|respiratory system agents|mesh-ancestor
64981473|NCT00130351|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64981474|NCT00130351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64981475|NCT00130351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64981476|NCT00130351|Adrenergic Agents|adrenergic agents|mesh-ancestor
64981477|NCT00130351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64981478|NCT00130351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981479|NCT00130312|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
64981480|NCT00130312|Anticoagulants|anticoagulants|mesh-ancestor
64981481|NCT00130312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64981482|NCT00130312|Antimetabolites|antimetabolites|mesh-ancestor
64981483|NCT00130312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981484|NCT00130312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64981485|NCT00130312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64981486|NCT00130312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64981512|NCT00119301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64981513|NCT00119301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64981514|NCT00119301|Antidotes|antidotes|mesh-ancestor
64981515|NCT00119301|Protective Agents|protective agents|mesh-ancestor
64981516|NCT00119301|Vitamin B Complex|vitamin b complex|mesh-ancestor
64981517|NCT00119301|Vitamins|vitamins|mesh-ancestor
64981518|NCT00119301|Micronutrients|micronutrients|mesh-ancestor
64981519|NCT00119301|Antifungal Agents|antifungal agents|mesh-ancestor
64981520|NCT00119301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64981521|NCT00079118|Docetaxel|docetaxel|mesh-list
64981522|NCT00079118|Irinotecan|irinotecan|mesh-list
64981523|NCT00079118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981524|NCT00079118|Tubulin Modulators|tubulin modulators|mesh-ancestor
64981525|NCT00079118|Antimitotic Agents|antimitotic agents|mesh-ancestor
64981526|NCT00079118|Mitosis Modulators|mitosis modulators|mesh-ancestor
64981527|NCT00079118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395477|NCT04637555|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64784111|NCT03610464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784112|NCT03610464|Adrenergic Agents|adrenergic agents|mesh-ancestor
64981528|NCT00079118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64981529|NCT00079118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64981530|NCT00079118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549183|NCT00791973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64549184|NCT00791973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549185|NCT00791973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64549186|NCT00791973|Respiratory System Agents|respiratory system agents|mesh-ancestor
64549187|NCT00791973|Dermatologic Agents|dermatologic agents|mesh-ancestor
64549188|NCT00791973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64549189|NCT00773955|Acetic Acid|acetic acid|mesh-list
64549190|NCT00773955|Retinol acetate|retinol acetate|mesh-list
64549191|NCT00773955|Gossypol acetic acid|gossypol acetic acid|mesh-list
64549192|NCT00773955|Gossypol|gossypol|mesh-list
64549193|NCT00773955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64549194|NCT00773955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64549195|NCT00773955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64549196|NCT00773955|Immunologic Factors|immunologic factors|mesh-ancestor
64549197|NCT00773955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549198|NCT00773955|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64549199|NCT00773955|Protective Agents|protective agents|mesh-ancestor
64549200|NCT00773955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549201|NCT00773955|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64549202|NCT00773955|Contraceptive Agents|contraceptive agents|mesh-ancestor
64549203|NCT00773955|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64549204|NCT00773955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64549205|NCT00773955|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64981531|NCT00130195|Cytarabine|cytarabine|mesh-list
64981532|NCT00130195|Dexamethasone|dexamethasone|mesh-list
64981533|NCT00130195|Prednisolone|prednisolone|mesh-list
64981534|NCT00130195|Cyclophosphamide|cyclophosphamide|mesh-list
64981535|NCT00130195|Methotrexate|methotrexate|mesh-list
64981536|NCT00130195|Vincristine|vincristine|mesh-list
64981537|NCT00130195|Imatinib Mesylate|imatinib mesylate|mesh-list
64981538|NCT00130195|Daunorubicin|daunorubicin|mesh-list
64981539|NCT00130195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64981540|NCT00130195|Immunologic Factors|immunologic factors|mesh-ancestor
64981541|NCT00130195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981558|NCT00130195|Abortifacient Agents|abortifacient agents|mesh-ancestor
64981559|NCT00130195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64981560|NCT00130195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64981561|NCT00130195|Antimetabolites|antimetabolites|mesh-ancestor
64301267|NCT03280407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301268|NCT03280407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784115|NCT03610464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64784116|NCT03610464|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64784117|NCT03615534|Niacin|niacin|mesh-list
64784118|NCT03615534|Fenofibrate|fenofibrate|mesh-list
64784119|NCT03615534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64784120|NCT03615534|Antimetabolites|antimetabolites|mesh-ancestor
64439753|NCT02000089|Hormones|hormones|mesh-ancestor
64981562|NCT00130195|Dermatologic Agents|dermatologic agents|mesh-ancestor
64981563|NCT00130195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981564|NCT00130195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64981565|NCT00130195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64981566|NCT00130195|Antiviral Agents|antiviral agents|mesh-ancestor
64981567|NCT00130195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64981568|NCT00130195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64981569|NCT00130195|Tubulin Modulators|tubulin modulators|mesh-ancestor
64981570|NCT00130195|Antimitotic Agents|antimitotic agents|mesh-ancestor
64324375|NCT02262169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64324376|NCT02262169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304895|NCT04703036|Glycine Agents|glycine agents|mesh-ancestor
64304896|NCT04703036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64304897|NCT04661852|Cyclophosphamide|cyclophosphamide|mesh-list
64304898|NCT04661852|Topotecan|topotecan|mesh-list
64369220|NCT03318419|Immunologic Factors|immunologic factors|mesh-ancestor
64981571|NCT00130195|Mitosis Modulators|mitosis modulators|mesh-ancestor
64981572|NCT00130195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64981573|NCT00130195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64981574|NCT00130195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64981575|NCT00130195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64981576|NCT00394303|Insulin|insulin|mesh-list
64549206|NCT00773955|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
64549207|NCT00773955|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
64549208|NCT01421459|Insulin Glargine|insulin glargine|mesh-list
64549209|NCT01421459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64549210|NCT01421459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549211|NCT01498952|Sorafenib|sorafenib|mesh-list
64549212|NCT01498952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549213|NCT01498952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64549214|NCT01498952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549215|NCT01498952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549216|NCT04499196|Glucocorticoids|glucocorticoids|mesh-list
64549217|NCT04499196|Hormones|hormones|mesh-ancestor
64549218|NCT04499196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64549219|NCT04499196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549220|NCT04608266|Camostat|camostat|mesh-list
64549221|NCT04608266|Protease Inhibitors|protease inhibitors|mesh-ancestor
64549222|NCT04608266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549223|NCT04608266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549224|NCT04608266|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64549225|NCT04608266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64549226|NCT00774267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64549227|NCT00774267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64549228|NCT00774267|Hormone Antagonists|hormone antagonists|mesh-ancestor
64549229|NCT00774267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64549230|NCT00774267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549231|NCT00774267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64549232|NCT00774267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64549233|NCT00774267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64549234|NCT04460352|Leucovorin|leucovorin|mesh-list
64549235|NCT04460352|Paclitaxel|paclitaxel|mesh-list
64549236|NCT04460352|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64549247|NCT04460352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549248|NCT04460352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64549249|NCT04460352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549250|NCT04460352|Antimetabolites|antimetabolites|mesh-ancestor
64549251|NCT04460352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64549252|NCT04460352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64549253|NCT04460352|Immunologic Factors|immunologic factors|mesh-ancestor
64549254|NCT04460352|Antidotes|antidotes|mesh-ancestor
64549255|NCT04460352|Protective Agents|protective agents|mesh-ancestor
64549256|NCT04460352|Vitamin B Complex|vitamin b complex|mesh-ancestor
64549257|NCT04460352|Vitamins|vitamins|mesh-ancestor
64549258|NCT04460352|Micronutrients|micronutrients|mesh-ancestor
64549260|NCT03083353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64549261|NCT03083353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64549262|NCT03083353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64324377|NCT02262169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549263|NCT03083353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301270|NCT03280407|Protective Agents|protective agents|mesh-ancestor
64301271|NCT03280407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301272|NCT03280407|Vitamin B Complex|vitamin b complex|mesh-ancestor
64301273|NCT03280407|Vitamins|vitamins|mesh-ancestor
64301274|NCT03280407|Micronutrients|micronutrients|mesh-ancestor
64549264|NCT03083353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64549265|NCT03083353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549266|NCT03083353|Vasodilator Agents|vasodilator agents|mesh-ancestor
64549267|NCT01421303|Etanercept|etanercept|mesh-list
64549268|NCT01421303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64549269|NCT01421303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64549270|NCT01421303|Analgesics|analgesics|mesh-ancestor
64549271|NCT01421303|Sensory System Agents|sensory system agents|mesh-ancestor
64549272|NCT01421303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64549273|NCT01421303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549274|NCT01421303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64549275|NCT01421303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64549276|NCT01421303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64549277|NCT01421303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64549278|NCT01421303|Immunologic Factors|immunologic factors|mesh-ancestor
64549279|NCT03703375|Gemcitabine|gemcitabine|mesh-list
64549280|NCT03703375|Azacitidine|azacitidine|mesh-list
64549281|NCT03703375|Romidepsin|romidepsin|mesh-list
64549282|NCT03703375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64981577|NCT00394303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64981578|NCT00394303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981579|NCT00119340|Cyclosporine|cyclosporine|mesh-list
64549283|NCT03703375|Antimetabolites|antimetabolites|mesh-ancestor
64549284|NCT03703375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549285|NCT03703375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549286|NCT03703375|Antiviral Agents|antiviral agents|mesh-ancestor
64549287|NCT03703375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64549288|NCT03703375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981580|NCT00119340|Mycophenolic Acid|mycophenolic acid|mesh-list
64981581|NCT00119340|Fludarabine|fludarabine|mesh-list
64981582|NCT00119340|Fludarabine phosphate|fludarabine phosphate|mesh-list
64981583|NCT00119340|Cyclosporins|cyclosporins|mesh-list
64981584|NCT00119340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981585|NCT00119340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64981586|NCT00119340|Antimetabolites|antimetabolites|mesh-ancestor
64981587|NCT00119340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981588|NCT00119340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64784124|NCT03615534|Vitamin B Complex|vitamin b complex|mesh-ancestor
64784125|NCT03615534|Vitamins|vitamins|mesh-ancestor
64784126|NCT03615534|Micronutrients|micronutrients|mesh-ancestor
64784127|NCT03615534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784128|NCT03630198|Lidocaine|lidocaine|mesh-list
64784129|NCT03630198|Anesthetics, Local|anesthetics, local|mesh-ancestor
64784130|NCT03630198|Anesthetics|anesthetics|mesh-ancestor
64395485|NCT02388061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395486|NCT04556357|Phenylephrine|phenylephrine|mesh-list
64395487|NCT04556357|Oxymetazoline|oxymetazoline|mesh-list
64395488|NCT04556357|Norepinephrine|norepinephrine|mesh-list
64395489|NCT04556357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64395490|NCT04556357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64395491|NCT04556357|Mydriatics|mydriatics|mesh-ancestor
64395492|NCT04556357|Autonomic Agents|autonomic agents|mesh-ancestor
64324394|NCT05491694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64981589|NCT00119340|Immunologic Factors|immunologic factors|mesh-ancestor
64981590|NCT00119340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981591|NCT00119340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981592|NCT00119340|Antifungal Agents|antifungal agents|mesh-ancestor
64981593|NCT00119340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64981594|NCT00119340|Dermatologic Agents|dermatologic agents|mesh-ancestor
64981595|NCT00119340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64981596|NCT00119340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64981597|NCT00119340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64981608|NCT00130156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64981609|NCT00130156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981610|NCT00130156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981611|NCT00130117|Contraceptive Agents|contraceptive agents|mesh-list
64981612|NCT00130117|Contraceptives, Oral|contraceptives, oral|mesh-list
64981613|NCT00130117|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64981614|NCT00130117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64981615|NCT00130117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324398|NCT05491694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324399|NCT05105035|Meropenem|meropenem|mesh-list
64324400|NCT05105035|Ceftazidime|ceftazidime|mesh-list
64324401|NCT05105035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64324402|NCT05105035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324403|NCT01501513|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64324404|NCT01501513|Laxatives|laxatives|mesh-ancestor
64324405|NCT01501513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64324406|NCT05480072|Palmidrol|palmidrol|mesh-list
64324407|NCT05480072|Analgesics|analgesics|mesh-ancestor
64784141|NCT03638622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64784142|NCT03638622|Dermatologic Agents|dermatologic agents|mesh-ancestor
64784143|NCT03655080|Paclitaxel|paclitaxel|mesh-list
64784144|NCT03655080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64784145|NCT03655080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64304915|NCT00002462|Cobalt|cobalt|mesh-list
64981616|NCT00130117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64981617|NCT00079157|Sargramostim|sargramostim|mesh-list
64981618|NCT00079157|Freund's Adjuvant|freund's adjuvant|mesh-list
64981619|NCT00079157|Immunologic Factors|immunologic factors|mesh-ancestor
64981620|NCT00079157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981621|NCT00079157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64981622|NCT00130000|Eculizumab|eculizumab|mesh-list
64981623|NCT00130000|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64981624|NCT00130000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64981625|NCT00130000|Immunologic Factors|immunologic factors|mesh-ancestor
64981626|NCT00130000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981627|NCT00079235|Sirolimus|sirolimus|mesh-list
64981628|NCT00079235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64981629|NCT00079235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64981630|NCT00079235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64981631|NCT00079235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981632|NCT00079235|Antifungal Agents|antifungal agents|mesh-ancestor
64301277|NCT03078842|Micronutrients|micronutrients|mesh-ancestor
64301279|NCT05007860|Vaccines|vaccines|mesh-list
64981633|NCT00079235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64981634|NCT00079235|Immunologic Factors|immunologic factors|mesh-ancestor
64981635|NCT00079235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981636|NCT00129844|Motexafin gadolinium|motexafin gadolinium|mesh-list
64981637|NCT00129844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981638|NCT00129844|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64981639|NCT00129844|Dermatologic Agents|dermatologic agents|mesh-ancestor
64981640|NCT00129805|Aspirin|aspirin|mesh-list
64981641|NCT00129805|Sarpogrelate|sarpogrelate|mesh-list
64981642|NCT00129805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64981643|NCT00129805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64981644|NCT00129805|Analgesics|analgesics|mesh-ancestor
64981645|NCT00129805|Sensory System Agents|sensory system agents|mesh-ancestor
64981646|NCT00129805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64981647|NCT00129805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981648|NCT00129805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64981649|NCT00129805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64981650|NCT00129805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64981651|NCT00129805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64549290|NCT03703375|Immunologic Factors|immunologic factors|mesh-ancestor
64549291|NCT03703375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549292|NCT03703375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64549293|NCT05303688|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
64549294|NCT05303688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64549295|NCT05303688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64549296|NCT05303688|Analgesics|analgesics|mesh-ancestor
64395512|NCT04553939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64395513|NCT04553939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64549297|NCT05303688|Sensory System Agents|sensory system agents|mesh-ancestor
64549298|NCT05303688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64549299|NCT05303688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549300|NCT05303688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64549301|NCT05303688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64549302|NCT04383717|Azithromycin|azithromycin|mesh-list
64549303|NCT04383717|Hydroxychloroquine|hydroxychloroquine|mesh-list
64549304|NCT04383717|Levamisole|levamisole|mesh-list
64549305|NCT04383717|Inosine Pranobex|inosine pranobex|mesh-list
64549306|NCT04383717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64549307|NCT04383717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64549308|NCT04383717|Antimalarials|antimalarials|mesh-ancestor
64549309|NCT04383717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64549310|NCT04383717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64549311|NCT04383717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549312|NCT04383717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549313|NCT04383717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64549314|NCT04383717|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64549315|NCT04383717|Immunologic Factors|immunologic factors|mesh-ancestor
64314242|NCT05617430|Vitamins|vitamins|mesh-ancestor
64314243|NCT05617430|Micronutrients|micronutrients|mesh-ancestor
64981652|NCT00129805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981653|NCT00129805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64981654|NCT00129805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64981655|NCT00129805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981656|NCT00129805|Antipyretics|antipyretics|mesh-ancestor
64981657|NCT00129805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64981658|NCT00129805|Serotonin Agents|serotonin agents|mesh-ancestor
64981659|NCT00129805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64981660|NCT00129727|Paclitaxel|paclitaxel|mesh-list
64981661|NCT00129727|Bevacizumab|bevacizumab|mesh-list
64981662|NCT00129727|Carboplatin|carboplatin|mesh-list
64981679|NCT00079313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981681|NCT00129688|Cloxacillin|cloxacillin|mesh-list
64981682|NCT00129688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64981683|NCT00129688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64981684|NCT00079352|Gemcitabine|gemcitabine|mesh-list
64981685|NCT00079352|Irinotecan|irinotecan|mesh-list
64784155|NCT03674970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981686|NCT00079352|Alvocidib|alvocidib|mesh-list
64549316|NCT04383717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784157|NCT03674970|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64784158|NCT03674970|Cholinergic Agents|cholinergic agents|mesh-ancestor
64784159|NCT03674970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64784160|NCT03674970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784161|NCT03704376|Clonidine|clonidine|mesh-list
64784162|NCT03704376|Ropivacaine|ropivacaine|mesh-list
64784163|NCT03704376|Anesthetics, Local|anesthetics, local|mesh-ancestor
64784164|NCT03704376|Anesthetics|anesthetics|mesh-ancestor
64549317|NCT04383717|Antinematodal Agents|antinematodal agents|mesh-ancestor
64549318|NCT04383717|Anthelmintics|anthelmintics|mesh-ancestor
64549319|NCT04383717|Antiviral Agents|antiviral agents|mesh-ancestor
64549320|NCT01400243|Nicotine|nicotine|mesh-list
64549321|NCT01400243|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64549322|NCT01400243|Autonomic Agents|autonomic agents|mesh-ancestor
64549323|NCT01400243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64549324|NCT01400243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549325|NCT01400243|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64549326|NCT01400243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64549327|NCT01400243|Cholinergic Agents|cholinergic agents|mesh-ancestor
64549328|NCT01400243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64549329|NCT01400243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549330|NCT05685277|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64549331|NCT05685277|Ramipril|ramipril|mesh-list
64549332|NCT05685277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64549333|NCT05685277|Diuretics|diuretics|mesh-ancestor
64549334|NCT05685277|Natriuretic Agents|natriuretic agents|mesh-ancestor
64549336|NCT05685277|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64549337|NCT05685277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64549338|NCT05685277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549339|NCT05685277|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64549341|NCT05685277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549342|NCT00809055|Caffeine|caffeine|mesh-list
64549343|NCT00809055|Caffeine citrate|caffeine citrate|mesh-list
64549344|NCT00809055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314272|NCT02251769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64981687|NCT00079352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64981688|NCT00079352|Antimetabolites|antimetabolites|mesh-ancestor
64981689|NCT00079352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981690|NCT00079352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981691|NCT00079352|Antiviral Agents|antiviral agents|mesh-ancestor
64981692|NCT00079352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64981693|NCT00079352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981694|NCT00079352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64981695|NCT00079352|Immunologic Factors|immunologic factors|mesh-ancestor
64981696|NCT00079352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429995|NCT05022329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981697|NCT00079352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64324412|NCT05480072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64324413|NCT05480072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64324414|NCT05480072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64324415|NCT05480072|Antiviral Agents|antiviral agents|mesh-ancestor
64324416|NCT05480072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324417|NCT05480072|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64324418|NCT05480072|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64324419|NCT05480072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64324420|NCT05480072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324421|NCT05480072|Hormones|hormones|mesh-ancestor
64324422|NCT05480072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64324423|NCT01499563|Risperidone|risperidone|mesh-list
64324427|NCT01499563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324428|NCT01499563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304956|NCT01995578|Azacitidine|azacitidine|mesh-list
64304957|NCT01995578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64981698|NCT00079352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64981699|NCT00079352|Growth Inhibitors|growth inhibitors|mesh-ancestor
64981700|NCT00079352|Growth Substances|growth substances|mesh-ancestor
64981701|NCT00079352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64981702|NCT00119496|Rosiglitazone|rosiglitazone|mesh-list
64981703|NCT00119496|Beclomethasone|beclomethasone|mesh-list
64981704|NCT00119496|Theophylline|theophylline|mesh-list
64549345|NCT00809055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64549346|NCT00809055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549347|NCT00809055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64549348|NCT00809055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549349|NCT00809055|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64549350|NCT00809055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64549351|NCT00809055|Purinergic Agents|purinergic agents|mesh-ancestor
64549352|NCT00809055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64549353|NCT01421225|Insulin|insulin|mesh-list
64549354|NCT01421225|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64549355|NCT01421225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64549390|NCT05007873|Decitabine|decitabine|mesh-list
64549391|NCT05007873|Dasatinib|dasatinib|mesh-list
64549392|NCT05007873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64549393|NCT05007873|Antimetabolites|antimetabolites|mesh-ancestor
64549395|NCT05007873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549436|NCT03082573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64549437|NCT03082573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945403|NCT05663580|Cabotegravir|cabotegravir|mesh-list
64549471|NCT04301310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549472|NCT04301310|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64549473|NCT04301310|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64549474|NCT04301310|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64549475|NCT04301310|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64549476|NCT04301310|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64549477|NCT04301310|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64549478|NCT03026894|Salicylic Acid|salicylic acid|mesh-list
64549479|NCT03026894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64549480|NCT03026894|Antifungal Agents|antifungal agents|mesh-ancestor
64549481|NCT03026894|Keratolytic Agents|keratolytic agents|mesh-ancestor
64549482|NCT03026894|Dermatologic Agents|dermatologic agents|mesh-ancestor
64549484|NCT00804609|Morphine|morphine|mesh-list
64301282|NCT03270033|Dexamethasone|dexamethasone|mesh-list
64301284|NCT03270033|Dexmedetomidine|dexmedetomidine|mesh-list
64549485|NCT00804609|Anesthetics|anesthetics|mesh-list
64549486|NCT00804609|Anesthetics, Local|anesthetics, local|mesh-ancestor
64549487|NCT00804609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64549488|NCT00804609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549489|NCT00804609|Sensory System Agents|sensory system agents|mesh-ancestor
64549490|NCT00804609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64549491|NCT00804609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64549492|NCT00804609|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64549493|NCT00804609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64549494|NCT00804609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64784173|NCT03704376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64784174|NCT03704376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64784175|NCT03704376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64784176|NCT03704376|Adrenergic Agents|adrenergic agents|mesh-ancestor
64784177|NCT03704376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64304959|NCT01995578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549495|NCT00804609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549496|NCT00804609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64549497|NCT00804609|Narcotics|narcotics|mesh-ancestor
64549498|NCT00804609|Analgesics|analgesics|mesh-ancestor
64549499|NCT03082183|Rifampin|rifampin|mesh-list
64981705|NCT00119496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981706|NCT00119496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981707|NCT00119496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64981708|NCT00119496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981709|NCT00119496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64981710|NCT00119496|Glucocorticoids|glucocorticoids|mesh-ancestor
64981711|NCT00119496|Hormones|hormones|mesh-ancestor
64549500|NCT03082183|BI 425809|bi 425809|mesh-list
64549501|NCT03082183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64549502|NCT03082183|Antitubercular Agents|antitubercular agents|mesh-ancestor
64549503|NCT03082183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64549504|NCT03082183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64549506|NCT03082183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64549507|NCT03082183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549508|NCT03082183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549509|NCT03082183|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64549510|NCT03082183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64549511|NCT03082183|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64549512|NCT03082183|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64549513|NCT03082183|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64314395|NCT02788175|Vedolizumab|vedolizumab|mesh-list
64981712|NCT00119496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64981713|NCT00119496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64981714|NCT00119496|Respiratory System Agents|respiratory system agents|mesh-ancestor
64981715|NCT00119496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64981716|NCT00119496|Autonomic Agents|autonomic agents|mesh-ancestor
64981717|NCT00119496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64981718|NCT00119496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64981719|NCT00119496|Vasodilator Agents|vasodilator agents|mesh-ancestor
64981736|NCT00298324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64981737|NCT00298324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981738|NCT00298324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64981739|NCT00298324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981740|NCT00298324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981741|NCT00298324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981742|NCT00298324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64981743|NCT00298324|Immunologic Factors|immunologic factors|mesh-ancestor
64981744|NCT00298324|Antifungal Agents|antifungal agents|mesh-ancestor
64981745|NCT00298324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64981746|NCT00298324|Dermatologic Agents|dermatologic agents|mesh-ancestor
64981747|NCT00298324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64981748|NCT00298324|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64981749|NCT00298324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64981750|NCT00298324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64981751|NCT00298324|Antitubercular Agents|antitubercular agents|mesh-ancestor
64981752|NCT00298324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64981754|NCT00079430|Bevacizumab|bevacizumab|mesh-list
64981755|NCT00079430|Carboplatin|carboplatin|mesh-list
64981756|NCT00079430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64981757|NCT00079430|Antibodies|antibodies|mesh-list
64981758|NCT00079430|Immunoglobulins|immunoglobulins|mesh-list
64981759|NCT00079430|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64981760|NCT00079430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64981761|NCT00079430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981762|NCT00079430|Tubulin Modulators|tubulin modulators|mesh-ancestor
64981763|NCT00079430|Antimitotic Agents|antimitotic agents|mesh-ancestor
64981764|NCT00079430|Mitosis Modulators|mitosis modulators|mesh-ancestor
64981765|NCT00079430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981766|NCT00079430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64981767|NCT00079430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64981768|NCT00079430|Growth Substances|growth substances|mesh-ancestor
64981769|NCT00079430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981770|NCT00079430|Growth Inhibitors|growth inhibitors|mesh-ancestor
64981771|NCT00079430|Immunologic Factors|immunologic factors|mesh-ancestor
64549514|NCT03082183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64549515|NCT03082183|Nootropic Agents|nootropic agents|mesh-ancestor
64549516|NCT05665387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64549517|NCT05665387|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64549518|NCT03361735|Leuprolide|leuprolide|mesh-list
64549519|NCT03361735|Goserelin|goserelin|mesh-list
64549520|NCT03361735|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64549521|NCT03361735|Hormones|hormones|mesh-list
64549522|NCT03361735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64395542|NCT04359329|Estradiol|estradiol|mesh-list
64395543|NCT04359329|Estrogens|estrogens|mesh-ancestor
64395544|NCT04359329|Hormones|hormones|mesh-ancestor
64395545|NCT04359329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64549523|NCT03361735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549524|NCT03361735|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64549525|NCT03361735|Fertility Agents|fertility agents|mesh-ancestor
64549526|NCT03361735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64549527|NCT03361735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64549528|NCT03361735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549529|NCT00804999|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64549530|NCT00804999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64549531|NCT00804999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64549532|NCT04283604|Methylphenidate|methylphenidate|mesh-list
64549533|NCT04283604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64314410|NCT02787083|Urological Agents|urological agents|mesh-ancestor
64981772|NCT00298597|Epoetin Alfa|epoetin alfa|mesh-list
64981773|NCT00298597|Hematinics|hematinics|mesh-ancestor
64981774|NCT00298636|Adenosine|adenosine|mesh-list
64981775|NCT00298636|Analgesics|analgesics|mesh-ancestor
64981776|NCT00298636|Sensory System Agents|sensory system agents|mesh-ancestor
64981777|NCT00298636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64981778|NCT00298636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981779|NCT00298636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64981780|NCT00298636|Vasodilator Agents|vasodilator agents|mesh-ancestor
64981801|NCT00079469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64981802|NCT00079469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64981803|NCT00079469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64981804|NCT00079469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64981805|NCT00079469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981806|NCT00079469|Dopamine Agents|dopamine agents|mesh-ancestor
64981807|NCT00079469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64981808|NCT00079469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981809|NCT00079469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64981810|NCT00079469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64981811|NCT00079469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981812|NCT00298675|Irinotecan|irinotecan|mesh-list
64981813|NCT00298675|Iniparib|iniparib|mesh-list
64981814|NCT00298675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64981815|NCT00298675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64981816|NCT00298675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981817|NCT00298675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981818|NCT00298675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981819|NCT00298675|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64981820|NCT00298714|Losartan|losartan|mesh-list
64981821|NCT00298714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64981822|NCT00298714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64981823|NCT00298714|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64784207|NCT04138758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64549534|NCT04283604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549535|NCT04283604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64301291|NCT03270033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301292|NCT03270033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64439994|NCT01545271|Xenon|xenon|mesh-list
64549536|NCT04283604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64549537|NCT04283604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64314427|NCT02125565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64981824|NCT00298714|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64981825|NCT00298714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981826|NCT00079508|Bivalirudin|bivalirudin|mesh-list
64981827|NCT00079508|Antithrombins|antithrombins|mesh-ancestor
64981828|NCT00079508|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64981829|NCT00079508|Protease Inhibitors|protease inhibitors|mesh-ancestor
64981830|NCT00079508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981831|NCT00079508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981832|NCT00079508|Anticoagulants|anticoagulants|mesh-ancestor
64981864|NCT00299065|Analgesics|analgesics|mesh-ancestor
64981865|NCT00299065|Sensory System Agents|sensory system agents|mesh-ancestor
64981866|NCT00299065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64981867|NCT00299065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981868|NCT00299065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64981869|NCT00299065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64981870|NCT00299065|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64981871|NCT00299065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981872|NCT00299065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981873|NCT00299065|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64981874|NCT00299065|Hormone Antagonists|hormone antagonists|mesh-ancestor
64981875|NCT00299065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64981876|NCT00079586|Heparin|heparin|mesh-list
64981902|NCT00299377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64981903|NCT00299455|Amoxicillin|amoxicillin|mesh-list
64981904|NCT00299455|Clavulanic Acid|clavulanic acid|mesh-list
64981905|NCT00299455|Clavulanic Acids|clavulanic acids|mesh-list
64784208|NCT04138758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784209|NCT04138758|Anticonvulsants|anticonvulsants|mesh-ancestor
64784210|NCT04323852|Vitamin D|vitamin d|mesh-list
64784211|NCT04323852|Vitamins|vitamins|mesh-ancestor
64784212|NCT04323852|Micronutrients|micronutrients|mesh-ancestor
64784213|NCT04323852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784214|NCT04323852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64784215|NCT04420572|Betamethasone|betamethasone|mesh-list
64784216|NCT04420572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64784217|NCT04420572|Glucocorticoids|glucocorticoids|mesh-ancestor
64784218|NCT04420572|Hormones|hormones|mesh-ancestor
64784219|NCT04420572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64784220|NCT04420572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395563|NCT04203875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64395564|NCT04203875|Immunologic Factors|immunologic factors|mesh-ancestor
64395565|NCT04203875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395567|NCT04491383|Tocovid|tocovid|mesh-list
64981906|NCT00299455|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64981907|NCT00299455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64981908|NCT00299455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64981909|NCT00299455|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64981910|NCT00299455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981911|NCT00299455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981912|NCT00086268|Zoledronic Acid|zoledronic acid|mesh-list
64981913|NCT00086268|Carboplatin|carboplatin|mesh-list
64981914|NCT00086268|Docetaxel|docetaxel|mesh-list
64981915|NCT00086268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981916|NCT00086268|Tubulin Modulators|tubulin modulators|mesh-ancestor
64981917|NCT00086268|Antimitotic Agents|antimitotic agents|mesh-ancestor
64981918|NCT00086268|Mitosis Modulators|mitosis modulators|mesh-ancestor
64981919|NCT00086268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981920|NCT00086268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64981921|NCT00086268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981922|NCT00299572|Alendronate|alendronate|mesh-list
64981923|NCT00299572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64981924|NCT00299572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981925|NCT00299611|Levetiracetam|levetiracetam|mesh-list
64981926|NCT00299611|Sertraline|sertraline|mesh-list
64981927|NCT00299611|Antidepressive Agents|antidepressive agents|mesh-ancestor
64981928|NCT00299611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64981945|NCT00299650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64981946|NCT00299650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64981947|NCT00299650|Cholinergic Agents|cholinergic agents|mesh-ancestor
64981948|NCT00299650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64981949|NCT00299650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981950|NCT04727853|Irinotecan|irinotecan|mesh-list
64981951|NCT04727853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64981952|NCT04727853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64981953|NCT04727853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324429|NCT01499563|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64324430|NCT01499563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64324431|NCT01499563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64324432|NCT01499563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64324433|NCT01499563|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64324434|NCT01499563|Dopamine Agents|dopamine agents|mesh-ancestor
64324435|NCT03922880|Nivolumab|nivolumab|mesh-list
64784231|NCT04511520|Vasodilator Agents|vasodilator agents|mesh-ancestor
64784232|NCT04463004|Mavrilimumab|mavrilimumab|mesh-list
64395574|NCT04576325|Voriconazole|voriconazole|mesh-list
64981954|NCT04727853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981955|NCT04727853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981956|NCT00299845|Lansoprazole|lansoprazole|mesh-list
64981957|NCT00299845|Dexlansoprazole|dexlansoprazole|mesh-list
64549538|NCT04283604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549546|NCT00810303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549547|NCT00810303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64549548|NCT00810303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64314431|NCT02125643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64314432|NCT02125643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981958|NCT00299845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64981959|NCT00299845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64981960|NCT00299845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64981961|NCT00299845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981962|NCT00299845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981964|NCT00299884|Ezetimibe|ezetimibe|mesh-list
64981965|NCT00299884|Fenofibrate|fenofibrate|mesh-list
64981966|NCT00299884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64981967|NCT00299884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64981968|NCT00299884|Antimetabolites|antimetabolites|mesh-ancestor
64981969|NCT00299884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981970|NCT00299884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64981971|NCT00299884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64981972|NCT00299884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981973|NCT00119652|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64981974|NCT00119652|Paroxetine|paroxetine|mesh-list
64981975|NCT00119652|Antidepressive Agents|antidepressive agents|mesh-ancestor
64981976|NCT00119652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64981977|NCT00119652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64981978|NCT00119652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64981979|NCT00119652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64981980|NCT00119652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981981|NCT00119652|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64981982|NCT00119652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64981983|NCT00119652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64981995|NCT00299923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981996|NCT00299923|Antiviral Agents|antiviral agents|mesh-ancestor
64981997|NCT00299923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64981998|NCT00299923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64981999|NCT00299923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64982000|NCT00299923|Dopamine Agents|dopamine agents|mesh-ancestor
64982001|NCT00299923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64982002|NCT00299923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982003|NCT00299923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64395577|NCT04576325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64982005|NCT00299923|Sensory System Agents|sensory system agents|mesh-ancestor
64982006|NCT00299923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64982007|NCT00299962|Interferons|interferons|mesh-list
64982008|NCT00299962|Interferon-beta|interferon-beta|mesh-list
64982009|NCT00299962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982010|NCT00299962|Antiviral Agents|antiviral agents|mesh-ancestor
64982011|NCT00299962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64982012|NCT00299962|Immunologic Factors|immunologic factors|mesh-ancestor
64982013|NCT00299962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982014|NCT00418171|Olanzapine|olanzapine|mesh-list
64982015|NCT00418171|Ziprasidone|ziprasidone|mesh-list
64982016|NCT00418171|Antiemetics|antiemetics|mesh-ancestor
64549549|NCT00810303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64549550|NCT00810303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549551|NCT00810303|Antiviral Agents|antiviral agents|mesh-ancestor
64549552|NCT00810303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64549553|NCT00810303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64549554|NCT00810303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64549555|NCT00810303|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64549556|NCT00810303|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64549557|NCT00810303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64784245|NCT04335552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64784246|NCT04284930|Bupivacaine|bupivacaine|mesh-list
64784247|NCT04284930|Anesthetics, Local|anesthetics, local|mesh-ancestor
64784248|NCT04284930|Anesthetics|anesthetics|mesh-ancestor
64784249|NCT04284930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64784250|NCT04284930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784251|NCT04284930|Sensory System Agents|sensory system agents|mesh-ancestor
64395584|NCT04576325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395585|NCT04576325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64395587|NCT04564625|Vitamins|vitamins|mesh-ancestor
64395588|NCT04564625|Micronutrients|micronutrients|mesh-ancestor
64395589|NCT04564625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395590|NCT04564625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64395591|NCT04520711|Pembrolizumab|pembrolizumab|mesh-list
64549558|NCT00810303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64549559|NCT04401085|Antibodies|antibodies|mesh-list
64549560|NCT04401085|Immunologic Factors|immunologic factors|mesh-ancestor
64549561|NCT04401085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549562|NCT05645107|Immunoglobulins|immunoglobulins|mesh-list
64549563|NCT05645107|gamma-Globulins|gamma-globulins|mesh-list
64549564|NCT05645107|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64549565|NCT05645107|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64549566|NCT05645107|Immunologic Factors|immunologic factors|mesh-ancestor
64549567|NCT05645107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549568|NCT04227756|Psilocybin|psilocybin|mesh-list
64549569|NCT04227756|Mescaline|mescaline|mesh-list
64549570|NCT04227756|Hallucinogens|hallucinogens|mesh-ancestor
64549571|NCT04227756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982017|NCT00418171|Autonomic Agents|autonomic agents|mesh-ancestor
64982018|NCT00418171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64982019|NCT00418171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982020|NCT00418171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64982021|NCT00418171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64982022|NCT00418171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64982023|NCT00418171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64982024|NCT00418171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64982025|NCT00418171|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64982026|NCT00418171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64982027|NCT00418171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64982028|NCT00418171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982029|NCT00418171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64982030|NCT00418171|Serotonin Agents|serotonin agents|mesh-ancestor
64982031|NCT00418171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64982032|NCT00418171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64982033|NCT00418171|Dopamine Agents|dopamine agents|mesh-ancestor
64982034|NCT00119691|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64982035|NCT00119691|Natriuretic Agents|natriuretic agents|mesh-ancestor
64982036|NCT00119691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982037|NCT00300040|Chrysarobin|chrysarobin|mesh-list
64982038|NCT00300040|HBOC 201|hboc 201|mesh-list
64982039|NCT00300040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64982040|NCT00300040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64982041|NCT00300040|Analgesics|analgesics|mesh-ancestor
64982042|NCT00300040|Sensory System Agents|sensory system agents|mesh-ancestor
64549572|NCT04227756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64395620|NCT04592159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395622|NCT05137145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64395623|NCT05137145|Enzyme Activators|enzyme activators|mesh-ancestor
64395624|NCT05137145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395625|NCT05137145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64395626|NCT04419389|Rituximab|rituximab|mesh-list
64549573|NCT04227756|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64549574|NCT04227756|Serotonin Agents|serotonin agents|mesh-ancestor
64549575|NCT04227756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64549576|NCT04227756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549577|NCT01460342|Tadalafil|tadalafil|mesh-list
64549578|NCT01460342|Vasodilator Agents|vasodilator agents|mesh-ancestor
64549579|NCT01460342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64549580|NCT01460342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64549581|NCT01460342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549582|NCT01460342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549583|NCT01460342|Urological Agents|urological agents|mesh-ancestor
64549584|NCT05044962|Rilpivirine|rilpivirine|mesh-list
64549585|NCT05044962|Cabotegravir|cabotegravir|mesh-list
64549586|NCT05044962|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64549587|NCT05044962|Levonorgestrel|levonorgestrel|mesh-list
64549588|NCT05044962|Medroxyprogesterone|medroxyprogesterone|mesh-list
64549589|NCT05044962|Etonogestrel|etonogestrel|mesh-list
64549590|NCT05044962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64549591|NCT05044962|Contraceptive Agents|contraceptive agents|mesh-ancestor
64549592|NCT05044962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64549593|NCT05044962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784292|NCT04112160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64784293|NCT04112160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64784294|NCT04112160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64784295|NCT04112160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784296|NCT04112160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784297|NCT04102956|Kallikreins|kallikreins|mesh-list
64784298|NCT04102956|Coagulants|coagulants|mesh-ancestor
64784299|NCT04102956|Fertility Agents, Male|fertility agents, male|mesh-ancestor
64395627|NCT04419389|Venetoclax|venetoclax|mesh-list
64395628|NCT04419389|Acalabrutinib|acalabrutinib|mesh-list
64395629|NCT04419389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64549594|NCT05044962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64549622|NCT00775671|Sympatholytics|sympatholytics|mesh-ancestor
64549623|NCT00775671|Autonomic Agents|autonomic agents|mesh-ancestor
64549624|NCT00775671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64549625|NCT00775671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549626|NCT00775671|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64549627|NCT00775671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64549628|NCT00775671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64549630|NCT00775671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64549631|NCT00775671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549632|NCT00775671|Vasodilator Agents|vasodilator agents|mesh-ancestor
64982043|NCT00300040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64982044|NCT00300040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982045|NCT00300040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64982058|NCT00300118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64982059|NCT00300118|Autonomic Agents|autonomic agents|mesh-ancestor
64982060|NCT00300118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64982061|NCT00300118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982062|NCT00300118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64982063|NCT00300118|Respiratory System Agents|respiratory system agents|mesh-ancestor
64982064|NCT00300118|Glucocorticoids|glucocorticoids|mesh-ancestor
64982066|NCT00300118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64982067|NCT00300118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64982068|NCT00300118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64982069|NCT00300118|Analgesics|analgesics|mesh-ancestor
64982070|NCT00300118|Sensory System Agents|sensory system agents|mesh-ancestor
64982071|NCT00300118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64982073|NCT00119730|Fludarabine|fludarabine|mesh-list
64784343|NCT03933774|Keratolytic Agents|keratolytic agents|mesh-ancestor
64395660|NCT05303597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64395661|NCT05303597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395662|NCT04892459|Vaccines|vaccines|mesh-list
64395663|NCT04892459|Immunologic Factors|immunologic factors|mesh-ancestor
64395664|NCT04892459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395665|NCT04881539|Cannabidiol|cannabidiol|mesh-list
64395666|NCT04881539|Anticonvulsants|anticonvulsants|mesh-ancestor
64395667|NCT05303285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64395668|NCT05303285|Immunologic Factors|immunologic factors|mesh-ancestor
64395669|NCT05303285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395670|NCT04280939|Anesthetics|anesthetics|mesh-list
64324438|NCT03922880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324439|NCT03922880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64395686|NCT04489589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64395687|NCT04489589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64395688|NCT04489589|Adrenergic Agents|adrenergic agents|mesh-ancestor
64395689|NCT04489589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64395690|NCT04489589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395691|NCT04328441|BCG Vaccine|bcg vaccine|mesh-list
64395692|NCT04328441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64305150|NCT03742921|Romidepsin|romidepsin|mesh-list
64982074|NCT00119730|Mitoxantrone|mitoxantrone|mesh-list
64982075|NCT00119730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64982076|NCT00119730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982077|NCT00119730|Immunologic Factors|immunologic factors|mesh-ancestor
64982078|NCT00119730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982079|NCT00119730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64982080|NCT00119730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982081|NCT00119730|Analgesics|analgesics|mesh-ancestor
64982082|NCT00119730|Sensory System Agents|sensory system agents|mesh-ancestor
64982083|NCT00119730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64982084|NCT00119730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64982085|NCT00119730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64982086|NCT00119730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982087|NCT00300196|Ancrod|ancrod|mesh-list
64982088|NCT00300196|Anticoagulants|anticoagulants|mesh-ancestor
64982089|NCT00300196|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64982090|NCT00300196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64982091|NCT00300196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982092|NCT00119769|Hormones|hormones|mesh-list
64982093|NCT00119769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64982094|NCT00119769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982095|NCT00300313|Citalopram|citalopram|mesh-list
64982096|NCT00300313|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64982097|NCT00300313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64982098|NCT00300313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64982099|NCT00300313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549640|NCT03800745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64549642|NCT01459796|Allopurinol|allopurinol|mesh-list
64549643|NCT01459796|Antimetabolites|antimetabolites|mesh-ancestor
64549644|NCT01459796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549645|NCT01459796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549647|NCT01459796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64549648|NCT01459796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64549649|NCT01459796|Antioxidants|antioxidants|mesh-ancestor
64784382|NCT03849690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64549650|NCT01459796|Protective Agents|protective agents|mesh-ancestor
64549651|NCT01459796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314531|NCT05272865|Sensory System Agents|sensory system agents|mesh-ancestor
64982100|NCT00300313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64982101|NCT00300313|Serotonin Agents|serotonin agents|mesh-ancestor
64982102|NCT00300313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982103|NCT00300313|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64982104|NCT00300313|Antidepressive Agents|antidepressive agents|mesh-ancestor
64982105|NCT00300313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64982106|NCT00399659|Tegaserod|tegaserod|mesh-list
64982107|NCT00399659|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64982119|NCT00300508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64982121|NCT00300508|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64982122|NCT00300508|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64982123|NCT00300508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982124|NCT00300508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982125|NCT00300508|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64982126|NCT00300508|Hormone Antagonists|hormone antagonists|mesh-ancestor
64982127|NCT00300508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64982128|NCT00300508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982129|NCT00086463|Iloprost|iloprost|mesh-list
64982130|NCT00086463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64982131|NCT00086463|Vasodilator Agents|vasodilator agents|mesh-ancestor
64982132|NCT00079976|Tigecycline|tigecycline|mesh-list
64982133|NCT00079976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64549652|NCT01459796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64549653|NCT05043714|Nivolumab|nivolumab|mesh-list
64549654|NCT05043714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64549655|NCT05043714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549656|NCT05043714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64549657|NCT05043714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549658|NCT04721691|Cannabidiol|cannabidiol|mesh-list
64549659|NCT04721691|Anticonvulsants|anticonvulsants|mesh-ancestor
64549660|NCT04760821|Trimetazidine|trimetazidine|mesh-list
64549661|NCT04760821|Vasodilator Agents|vasodilator agents|mesh-ancestor
64549662|NCT04382079|Propolis|propolis|mesh-list
64549663|NCT04382079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64549671|NCT05688007|Hormones|hormones|mesh-list
64549672|NCT05688007|Parathyroid Hormone|parathyroid hormone|mesh-list
64549673|NCT05688007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64549674|NCT05688007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549675|NCT05688007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64549676|NCT01459718|Deferasirox|deferasirox|mesh-list
64549677|NCT01459718|Deferoxamine|deferoxamine|mesh-list
64549678|NCT01459718|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64549679|NCT01459718|Chelating Agents|chelating agents|mesh-ancestor
64549680|NCT01459718|Sequestering Agents|sequestering agents|mesh-ancestor
64549681|NCT01459718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395696|NCT04314713|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64395697|NCT04314713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64395698|NCT04314713|Antiemetics|antiemetics|mesh-ancestor
64395699|NCT04314713|Autonomic Agents|autonomic agents|mesh-ancestor
64314558|NCT04809818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64982134|NCT00079976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64982135|NCT00079976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64982136|NCT00079976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982137|NCT00079976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982138|NCT00300586|Gemcitabine|gemcitabine|mesh-list
64982139|NCT00300586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64982140|NCT00300586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64982141|NCT00300586|Antimetabolites|antimetabolites|mesh-ancestor
64982142|NCT00300586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982143|NCT00300586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982144|NCT00300586|Antiviral Agents|antiviral agents|mesh-ancestor
64982145|NCT00300586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64982146|NCT00300586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982147|NCT00300586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64982148|NCT00300586|Immunologic Factors|immunologic factors|mesh-ancestor
64982149|NCT00300586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982150|NCT00300586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64982151|NCT00086541|Interferons|interferons|mesh-list
64982152|NCT00086541|Ribavirin|ribavirin|mesh-list
64982154|NCT00086541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982156|NCT00086541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64982157|NCT00086541|Antimetabolites|antimetabolites|mesh-ancestor
64982158|NCT00086541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982159|NCT00300664|Hormones|hormones|mesh-list
64549682|NCT01459718|Siderophores|siderophores|mesh-ancestor
64549683|NCT04918407|Empagliflozin|empagliflozin|mesh-list
64549684|NCT04918407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64549685|NCT04918407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549686|NCT04918407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64549687|NCT04918407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549688|NCT04989660|Phenol|phenol|mesh-list
64549689|NCT04989660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64549690|NCT04989660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64549691|NCT04989660|Disinfectants|disinfectants|mesh-ancestor
64784398|NCT03812328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64784399|NCT03812328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64784400|NCT03812328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784401|NCT03805386|Analgesics, Opioid|analgesics, opioid|mesh-list
64784402|NCT03805386|Narcotics|narcotics|mesh-ancestor
64784403|NCT03805386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64784404|NCT03805386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784405|NCT03805386|Analgesics|analgesics|mesh-ancestor
64784406|NCT03805386|Sensory System Agents|sensory system agents|mesh-ancestor
64395706|NCT04314713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64549692|NCT04989660|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64314580|NCT02126267|Azithromycin|azithromycin|mesh-list
64314581|NCT02126267|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64982160|NCT00300664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64982161|NCT00300664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982162|NCT04718038|Cetuximab|cetuximab|mesh-list
64982163|NCT04718038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64982164|NCT04718038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982165|NCT00080054|Motexafin gadolinium|motexafin gadolinium|mesh-list
64982166|NCT00080054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982167|NCT00080054|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64982168|NCT00080054|Dermatologic Agents|dermatologic agents|mesh-ancestor
64982169|NCT04718233|Sildenafil Citrate|sildenafil citrate|mesh-list
64982170|NCT04718233|Vasodilator Agents|vasodilator agents|mesh-ancestor
64982228|NCT00301210|Tramadol|tramadol|mesh-list
64982229|NCT00301210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64982230|NCT00301210|Narcotics|narcotics|mesh-ancestor
64982231|NCT00301210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64982232|NCT00301210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982233|NCT00301210|Analgesics|analgesics|mesh-ancestor
64982234|NCT00301210|Sensory System Agents|sensory system agents|mesh-ancestor
64982235|NCT00301210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64982236|NCT00080327|Aripiprazole|aripiprazole|mesh-list
64982237|NCT00080327|Antidepressive Agents|antidepressive agents|mesh-ancestor
64982238|NCT00080327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64982239|NCT00080327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64982240|NCT00080327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64982241|NCT00080327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64982242|NCT00080327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982243|NCT00080327|Dopamine Agonists|dopamine agonists|mesh-ancestor
64982244|NCT00080327|Dopamine Agents|dopamine agents|mesh-ancestor
64982245|NCT00080327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64982246|NCT00080327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982247|NCT00080327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64982248|NCT00080327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64982249|NCT00080327|Serotonin Agents|serotonin agents|mesh-ancestor
64982250|NCT00080327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64982251|NCT00080327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64982252|NCT00080327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64982253|NCT00080327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64982254|NCT00301405|Thalidomide|thalidomide|mesh-list
64982255|NCT00301405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64982256|NCT00301405|Immunologic Factors|immunologic factors|mesh-ancestor
64982268|NCT00301483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64982269|NCT00301483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64982270|NCT00301483|Analgesics|analgesics|mesh-ancestor
64982271|NCT00301483|Sensory System Agents|sensory system agents|mesh-ancestor
64982272|NCT00301483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64982273|NCT00301483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549695|NCT02970318|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64549696|NCT02970318|Acalabrutinib|acalabrutinib|mesh-list
64549697|NCT02970318|Idelalisib|idelalisib|mesh-list
64549698|NCT02970318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64549699|NCT02970318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549700|NCT02970318|Immunologic Factors|immunologic factors|mesh-ancestor
64549701|NCT02970318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549702|NCT02970318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64549703|NCT02970318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64549704|NCT02970318|Alkylating Agents|alkylating agents|mesh-ancestor
64982275|NCT00301483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64982276|NCT00301483|Blood Substitutes|blood substitutes|mesh-ancestor
64982277|NCT00301522|Paclitaxel|paclitaxel|mesh-list
64982278|NCT00301522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64982279|NCT00301522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982280|NCT00301522|Tubulin Modulators|tubulin modulators|mesh-ancestor
64982281|NCT00301522|Antimitotic Agents|antimitotic agents|mesh-ancestor
64982282|NCT00301522|Mitosis Modulators|mitosis modulators|mesh-ancestor
64982283|NCT00301522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982284|NCT00080405|Bortezomib|bortezomib|mesh-list
64982285|NCT00080405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982286|NCT00292123|Methadone|methadone|mesh-list
64982287|NCT00292123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64982288|NCT00292123|Narcotics|narcotics|mesh-ancestor
64982289|NCT00292123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64982290|NCT00292123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982291|NCT00292123|Analgesics|analgesics|mesh-ancestor
64982292|NCT00292123|Sensory System Agents|sensory system agents|mesh-ancestor
64982293|NCT00292123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64982294|NCT00292123|Antitussive Agents|antitussive agents|mesh-ancestor
64982295|NCT00292123|Respiratory System Agents|respiratory system agents|mesh-ancestor
64982296|NCT00080444|Dexamethasone|dexamethasone|mesh-list
64982297|NCT00080444|Dexamethasone acetate|dexamethasone acetate|mesh-list
64982298|NCT00080444|Ondansetron|ondansetron|mesh-list
64982299|NCT00080444|Aprepitant|aprepitant|mesh-list
64982300|NCT00080444|Fosaprepitant|fosaprepitant|mesh-list
64982301|NCT00080444|BB 1101|bb 1101|mesh-list
64982302|NCT00080444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64982303|NCT00080444|Antiemetics|antiemetics|mesh-ancestor
64982304|NCT00080444|Autonomic Agents|autonomic agents|mesh-ancestor
64982305|NCT00080444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64982306|NCT00080444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982307|NCT00080444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64982308|NCT00080444|Glucocorticoids|glucocorticoids|mesh-ancestor
64982309|NCT00080444|Hormones|hormones|mesh-ancestor
64982310|NCT00080444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64982311|NCT00080444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64982312|NCT00080444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982313|NCT00080444|Protease Inhibitors|protease inhibitors|mesh-ancestor
64982314|NCT00080444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982315|NCT00080444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982316|NCT00080444|Antipruritics|antipruritics|mesh-ancestor
64982317|NCT00080444|Dermatologic Agents|dermatologic agents|mesh-ancestor
64982318|NCT00080444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64982319|NCT00080444|Serotonin Agents|serotonin agents|mesh-ancestor
64395738|NCT03790397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64395739|NCT03790397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395740|NCT03718559|Edoxaban|edoxaban|mesh-list
64395741|NCT03718559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64395742|NCT03718559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64395743|NCT03718559|Antithrombins|antithrombins|mesh-ancestor
64784433|NCT03730116|Protease Inhibitors|protease inhibitors|mesh-ancestor
64395744|NCT03718559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64395745|NCT03718559|Protease Inhibitors|protease inhibitors|mesh-ancestor
64395746|NCT03718559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64395748|NCT03718559|Anticoagulants|anticoagulants|mesh-ancestor
64982320|NCT00080444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64982321|NCT00080444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64982322|NCT00080444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64982323|NCT00080444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64982347|NCT00292201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64982349|NCT00292279|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64982350|NCT00292279|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64549705|NCT02970318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549706|NCT02970318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549708|NCT04663347|Cytarabine|cytarabine|mesh-list
64549709|NCT04663347|Dexamethasone|dexamethasone|mesh-list
64549710|NCT04663347|Prednisone|prednisone|mesh-list
64549711|NCT04663347|Cyclophosphamide|cyclophosphamide|mesh-list
64549712|NCT04663347|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64549713|NCT04663347|Rituximab|rituximab|mesh-list
64314604|NCT05615636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982351|NCT00292279|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64982352|NCT00292279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64982353|NCT00080522|Ritonavir|ritonavir|mesh-list
64982354|NCT00080522|Lopinavir|lopinavir|mesh-list
64982355|NCT00080522|Lamivudine|lamivudine|mesh-list
64982356|NCT00080522|Zidovudine|zidovudine|mesh-list
64982357|NCT00080522|Didanosine|didanosine|mesh-list
64982358|NCT00080522|Stavudine|stavudine|mesh-list
64982359|NCT00080522|Efavirenz|efavirenz|mesh-list
64982360|NCT00080522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64982361|NCT00080522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64982362|NCT00080522|Protease Inhibitors|protease inhibitors|mesh-ancestor
64982363|NCT00080522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982364|NCT00080522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982365|NCT00080522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64982366|NCT00080522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64982367|NCT00080522|Antiviral Agents|antiviral agents|mesh-ancestor
64982368|NCT00080522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64982369|NCT00080522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64982370|NCT00080522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64982371|NCT00080522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64982372|NCT00080522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64982382|NCT00086775|Fludarabine phosphate|fludarabine phosphate|mesh-list
64982383|NCT00086775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64982384|NCT00086775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395772|NCT01228331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784478|NCT02985840|Dermatologic Agents|dermatologic agents|mesh-ancestor
64784479|NCT02985840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64395781|NCT01228331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64305291|NCT04251715|Antimetabolites|antimetabolites|mesh-ancestor
64305292|NCT04251715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64982385|NCT00086775|Immunologic Factors|immunologic factors|mesh-ancestor
64982386|NCT00086775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982387|NCT00086775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64982388|NCT00086775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64982390|NCT00086775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982391|NCT00086775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64982392|NCT00086892|Carboplatin|carboplatin|mesh-list
64982393|NCT00086892|Cetuximab|cetuximab|mesh-list
64982394|NCT00086892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982395|NCT00086892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64982396|NCT00292708|Cefmetazole|cefmetazole|mesh-list
64982397|NCT00292708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64982398|NCT00292708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64982399|NCT00086931|Capecitabine|capecitabine|mesh-list
64982400|NCT00086931|Oxaliplatin|oxaliplatin|mesh-list
64982401|NCT00086931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64982402|NCT00086931|Antimetabolites|antimetabolites|mesh-ancestor
64982403|NCT00086931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982404|NCT00086931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982405|NCT00292747|Ibuprofen|ibuprofen|mesh-list
64982406|NCT00292747|Drotaverin|drotaverin|mesh-list
64982407|NCT00292747|Papaverine|papaverine|mesh-list
64982408|NCT00292747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64982409|NCT00292747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64982410|NCT00292747|Analgesics|analgesics|mesh-ancestor
64982411|NCT00292747|Sensory System Agents|sensory system agents|mesh-ancestor
64982412|NCT00292747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64982413|NCT00292747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982414|NCT00292747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64982415|NCT00292747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64982416|NCT00292747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64549715|NCT04663347|Doxorubicin|doxorubicin|mesh-list
64549716|NCT04663347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64549717|NCT04663347|Oxaliplatin|oxaliplatin|mesh-list
64549718|NCT04663347|Vincristine|vincristine|mesh-list
64549719|NCT04663347|Lenalidomide|lenalidomide|mesh-list
64549720|NCT04663347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64549721|NCT04663347|Immunologic Factors|immunologic factors|mesh-ancestor
64395782|NCT01228331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64395783|NCT01228331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64395784|NCT01228331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64305333|NCT04079621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64305334|NCT04079621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64305335|NCT04940299|Nivolumab|nivolumab|mesh-list
64305336|NCT04940299|Ipilimumab|ipilimumab|mesh-list
64549722|NCT04663347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549723|NCT04663347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64549724|NCT04663347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64549725|NCT04663347|Alkylating Agents|alkylating agents|mesh-ancestor
64549726|NCT04663347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549727|NCT04663347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549728|NCT04663347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64549729|NCT04663347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64549730|NCT04663347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64549732|NCT04663347|Autonomic Agents|autonomic agents|mesh-ancestor
64314613|NCT02126579|Poly ICLC|poly iclc|mesh-list
64324440|NCT03922880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324442|NCT02264119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64324443|NCT02264119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64395790|NCT01228331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64395791|NCT01228331|Antimetabolites|antimetabolites|mesh-ancestor
64395792|NCT01228331|Dermatologic Agents|dermatologic agents|mesh-ancestor
64784506|NCT02966184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64784507|NCT02966184|Respiratory System Agents|respiratory system agents|mesh-ancestor
64395801|NCT01228331|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64395802|NCT01228331|Protective Agents|protective agents|mesh-ancestor
64395803|NCT01171937|Risperidone|risperidone|mesh-list
64395804|NCT01171937|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64395805|NCT01171937|Serotonin Agents|serotonin agents|mesh-ancestor
64395806|NCT01171937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64395807|NCT01171937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395808|NCT01171937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395809|NCT01171937|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64395810|NCT01171937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64305370|NCT03063788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305371|NCT02821715|Flecainide|flecainide|mesh-list
64305372|NCT02821715|Modafinil|modafinil|mesh-list
64305373|NCT02821715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64305374|NCT02821715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305375|NCT02821715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64305376|NCT02821715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64305377|NCT02821715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64305378|NCT02821715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305379|NCT02821715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64370384|NCT02481791|Propofol|propofol|mesh-list
64982417|NCT00292747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982418|NCT00292747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982419|NCT00292747|Parasympatholytics|parasympatholytics|mesh-ancestor
64982420|NCT00292747|Autonomic Agents|autonomic agents|mesh-ancestor
64982421|NCT00292747|Vasodilator Agents|vasodilator agents|mesh-ancestor
64982422|NCT00292747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64982423|NCT00292747|Urological Agents|urological agents|mesh-ancestor
64982424|NCT00120003|Candesartan|candesartan|mesh-list
64982425|NCT00120003|Candesartan cilexetil|candesartan cilexetil|mesh-list
64982426|NCT00120003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64982427|NCT00120003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64982428|NCT00120003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64982429|NCT00120003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982430|NCT00201721|Cyclophosphamide|cyclophosphamide|mesh-list
64982431|NCT00201721|Rituximab|rituximab|mesh-list
64982432|NCT00201721|Pentostatin|pentostatin|mesh-list
64982433|NCT00201721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64982434|NCT00201721|Immunologic Factors|immunologic factors|mesh-ancestor
64982435|NCT00201721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982436|NCT00201721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64982458|NCT00086970|Ifosfamide|ifosfamide|mesh-list
64982459|NCT00086970|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64982460|NCT00086970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64982461|NCT00086970|Alkylating Agents|alkylating agents|mesh-ancestor
64982462|NCT00086970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982463|NCT00086970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982464|NCT00086970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982465|NCT00201955|Rebamipide|rebamipide|mesh-list
64982466|NCT00201955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64982467|NCT00201955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64982468|NCT00201955|Antioxidants|antioxidants|mesh-ancestor
64982469|NCT00201955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982470|NCT00201955|Protective Agents|protective agents|mesh-ancestor
64982471|NCT00201955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982472|NCT00201955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982473|NCT00080795|Gemcitabine|gemcitabine|mesh-list
64982474|NCT00080795|Doxorubicin|doxorubicin|mesh-list
64549734|NCT04663347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64549735|NCT04663347|Glucocorticoids|glucocorticoids|mesh-ancestor
64549736|NCT04663347|Hormones|hormones|mesh-ancestor
64549737|NCT04663347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64549738|NCT04663347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64549739|NCT04663347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64549740|NCT04663347|Antimetabolites|antimetabolites|mesh-ancestor
64549741|NCT04663347|Antiviral Agents|antiviral agents|mesh-ancestor
64314630|NCT04808648|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64982475|NCT00080795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64982476|NCT00080795|Ifosfamide|ifosfamide|mesh-list
64982477|NCT00080795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982478|NCT00080795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64982479|NCT00080795|Antimetabolites|antimetabolites|mesh-ancestor
64982480|NCT00080795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982481|NCT00080795|Antiviral Agents|antiviral agents|mesh-ancestor
64982482|NCT00080795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64982483|NCT00080795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982484|NCT00080795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64982485|NCT00080795|Immunologic Factors|immunologic factors|mesh-ancestor
64395811|NCT01171937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64395812|NCT01171937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64982486|NCT00080795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982487|NCT00080795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64982488|NCT00080795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64982489|NCT00080795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64982506|NCT00120120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982507|NCT00120120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64982508|NCT00120120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64982509|NCT00120120|Growth Substances|growth substances|mesh-ancestor
64982510|NCT00120120|Growth Inhibitors|growth inhibitors|mesh-ancestor
64982511|NCT00120120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982512|NCT00202189|Budesonide|budesonide|mesh-list
64982513|NCT00202189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64982514|NCT00202189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64982515|NCT00202189|Autonomic Agents|autonomic agents|mesh-ancestor
64440454|NCT02275481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64982517|NCT00202189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982518|NCT00202189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64982519|NCT00202189|Respiratory System Agents|respiratory system agents|mesh-ancestor
64982520|NCT00202189|Glucocorticoids|glucocorticoids|mesh-ancestor
64982521|NCT00202189|Hormones|hormones|mesh-ancestor
64982522|NCT00202189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64982523|NCT00202228|Riboflavin|riboflavin|mesh-list
64982524|NCT00202228|Thiamine|thiamine|mesh-list
64982525|NCT00202228|Vitamin B Complex|vitamin b complex|mesh-ancestor
64982526|NCT00202228|Vitamins|vitamins|mesh-ancestor
64982527|NCT00202228|Micronutrients|micronutrients|mesh-ancestor
64982528|NCT00202228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982529|NCT00202228|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64982530|NCT00202228|Dermatologic Agents|dermatologic agents|mesh-ancestor
64982531|NCT00087009|Rituximab|rituximab|mesh-list
64982532|NCT00087009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64982533|NCT00087009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982534|NCT00087009|Immunologic Factors|immunologic factors|mesh-ancestor
64982535|NCT00087009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982536|NCT00087009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64982537|NCT00306319|Moxifloxacin|moxifloxacin|mesh-list
64982538|NCT00306319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64982539|NCT00306319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64982540|NCT00306319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64982541|NCT00306319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64982542|NCT00306319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982543|NCT00306319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549742|NCT04663347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64549743|NCT04663347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549744|NCT04663347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64549745|NCT04663347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64549746|NCT04663347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64549747|NCT04663347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64549748|NCT04663347|Tubulin Modulators|tubulin modulators|mesh-ancestor
64549749|NCT04663347|Antimitotic Agents|antimitotic agents|mesh-ancestor
64549750|NCT04663347|Mitosis Modulators|mitosis modulators|mesh-ancestor
64549751|NCT04663347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64549752|NCT04663347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64549753|NCT04663347|Growth Substances|growth substances|mesh-ancestor
64549754|NCT04663347|Growth Inhibitors|growth inhibitors|mesh-ancestor
64784534|NCT02587650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549756|NCT04384731|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
64549757|NCT04384731|Respiratory System Agents|respiratory system agents|mesh-ancestor
64549759|NCT05042466|Hallucinogens|hallucinogens|mesh-ancestor
64549760|NCT05042466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549761|NCT05042466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64549762|NCT05615467|Metformin|metformin|mesh-list
64549763|NCT05615467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64549764|NCT05615467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549765|NCT03800433|Pentoxifylline|pentoxifylline|mesh-list
64549766|NCT03800433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64549767|NCT03800433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549768|NCT03800433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549769|NCT03800433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64549770|NCT03800433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64982544|NCT00306319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982545|NCT00306358|Vitamin B 12|vitamin b 12|mesh-list
64982547|NCT00306358|Vitamins|vitamins|mesh-ancestor
64982548|NCT00306358|Micronutrients|micronutrients|mesh-ancestor
64982565|NCT00418600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982566|NCT00418600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64982567|NCT00418600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64982569|NCT00087048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64982570|NCT00087048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64982571|NCT00087048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982572|NCT00087048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982573|NCT00087048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982574|NCT00080951|Leucovorin|leucovorin|mesh-list
64982575|NCT00080951|Fluorouracil|fluorouracil|mesh-list
64982576|NCT00080951|Oxaliplatin|oxaliplatin|mesh-list
64982577|NCT00080951|Irinotecan|irinotecan|mesh-list
64982578|NCT00080951|Calcium|calcium|mesh-list
64982579|NCT00080951|Levoleucovorin|levoleucovorin|mesh-list
64549771|NCT03800433|Protective Agents|protective agents|mesh-ancestor
64549772|NCT03800433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549773|NCT03800433|Vasodilator Agents|vasodilator agents|mesh-ancestor
64549774|NCT03800433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64549775|NCT03800433|Antioxidants|antioxidants|mesh-ancestor
64549776|NCT03395899|Bevacizumab|bevacizumab|mesh-list
64549777|NCT03395899|Atezolizumab|atezolizumab|mesh-list
64549778|NCT03395899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64549779|NCT03395899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549780|NCT03395899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64549781|NCT03395899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64549782|NCT03395899|Growth Substances|growth substances|mesh-ancestor
64549783|NCT03395899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549784|NCT03395899|Growth Inhibitors|growth inhibitors|mesh-ancestor
64982580|NCT00080951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64982581|NCT00080951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982582|NCT00080951|Antimetabolites|antimetabolites|mesh-ancestor
64982583|NCT00080951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982584|NCT00080951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64982585|NCT00080951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982586|NCT00080951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64982587|NCT00080951|Immunologic Factors|immunologic factors|mesh-ancestor
64982588|NCT00080951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64982589|NCT00080951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64982590|NCT00080951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982591|NCT00080951|Antidotes|antidotes|mesh-ancestor
64982592|NCT00080951|Protective Agents|protective agents|mesh-ancestor
64982593|NCT00080951|Vitamin B Complex|vitamin b complex|mesh-ancestor
64982594|NCT00080951|Vitamins|vitamins|mesh-ancestor
64982595|NCT00080951|Micronutrients|micronutrients|mesh-ancestor
64982596|NCT00301600|Mycophenolic Acid|mycophenolic acid|mesh-list
64982597|NCT00301600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64982598|NCT00301600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982599|NCT00301600|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64982600|NCT00301600|Antitubercular Agents|antitubercular agents|mesh-ancestor
64982601|NCT00301600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64982602|NCT00301600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64982603|NCT00301600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982604|NCT00301600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982605|NCT00301639|Methylphenidate|methylphenidate|mesh-list
64982606|NCT00301639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64982607|NCT00301639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982608|NCT00301639|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64982637|NCT00080990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64982638|NCT00080990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982639|NCT00080990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64982641|NCT00080990|Antidotes|antidotes|mesh-ancestor
64982642|NCT00080990|Protective Agents|protective agents|mesh-ancestor
64982643|NCT00080990|Vitamin B Complex|vitamin b complex|mesh-ancestor
64982644|NCT00080990|Vitamins|vitamins|mesh-ancestor
64982645|NCT00080990|Micronutrients|micronutrients|mesh-ancestor
64982646|NCT00080990|Growth Inhibitors|growth inhibitors|mesh-ancestor
64982647|NCT00080990|Growth Substances|growth substances|mesh-ancestor
64982648|NCT00080990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64982649|NCT00080990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982650|NCT00301912|Methotrexate|methotrexate|mesh-list
64982651|NCT00301912|Fludarabine phosphate|fludarabine phosphate|mesh-list
64982652|NCT00301912|Fludarabine|fludarabine|mesh-list
64982653|NCT00301912|Busulfan|busulfan|mesh-list
64982654|NCT00301912|Tacrolimus|tacrolimus|mesh-list
64982655|NCT00301912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64982656|NCT00301912|Abortifacient Agents|abortifacient agents|mesh-ancestor
64549786|NCT02900976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64549788|NCT02900976|Immunoglobulins|immunoglobulins|mesh-list
64549789|NCT02900976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64549790|NCT02900976|Immunologic Factors|immunologic factors|mesh-ancestor
64549791|NCT02900976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549792|NCT02900976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549793|NCT02900976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64549794|NCT05602597|Itraconazole|itraconazole|mesh-list
64549795|NCT05602597|Fluconazole|fluconazole|mesh-list
64549796|NCT05602597|Rifampin|rifampin|mesh-list
64549797|NCT05602597|Rabeprazole|rabeprazole|mesh-list
64549798|NCT05602597|Antifungal Agents|antifungal agents|mesh-ancestor
64549799|NCT05602597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64549800|NCT05602597|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64549801|NCT05602597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64549802|NCT05602597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549803|NCT05602597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549804|NCT05602597|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64549805|NCT05602597|Hormone Antagonists|hormone antagonists|mesh-ancestor
64549806|NCT05602597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64549807|NCT05602597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549808|NCT05602597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64549809|NCT05602597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64549810|NCT05602597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64314681|NCT02252627|Mydriatics|mydriatics|mesh-ancestor
64982689|NCT00301951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982690|NCT00301951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64982691|NCT00301951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64982692|NCT00301951|Antitubercular Agents|antitubercular agents|mesh-ancestor
64982693|NCT00301951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64982694|NCT00301951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64982695|NCT00301951|Alkylating Agents|alkylating agents|mesh-ancestor
64982696|NCT00301951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64982697|NCT00301951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64982733|NCT00087165|Docetaxel|docetaxel|mesh-list
64982734|NCT00087165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982735|NCT00087165|Tubulin Modulators|tubulin modulators|mesh-ancestor
64982736|NCT00087165|Antimitotic Agents|antimitotic agents|mesh-ancestor
64982764|NCT00302419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64982765|NCT00302419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64982766|NCT00302419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982768|NCT00302497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64982769|NCT00302497|Immunologic Factors|immunologic factors|mesh-ancestor
64982770|NCT00302497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982771|NCT00081107|Epothilones|epothilones|mesh-list
64549812|NCT05602597|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64549813|NCT05602597|Antitubercular Agents|antitubercular agents|mesh-ancestor
64484458|NCT01727713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549814|NCT05602597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64549815|NCT05602597|Leprostatic Agents|leprostatic agents|mesh-ancestor
64549816|NCT05602597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64549817|NCT05602597|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64549818|NCT05602597|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64549819|NCT05602597|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64549820|NCT05602597|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64549821|NCT05602597|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64549822|NCT05602597|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64549823|NCT05602597|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64982772|NCT00081107|Desoxyepothilone B|desoxyepothilone b|mesh-list
64982773|NCT00081107|Tubulin Modulators|tubulin modulators|mesh-ancestor
64982774|NCT00081107|Antimitotic Agents|antimitotic agents|mesh-ancestor
64982775|NCT00081107|Mitosis Modulators|mitosis modulators|mesh-ancestor
64982776|NCT00081107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982777|NCT00081107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982778|NCT00302536|Tacrolimus|tacrolimus|mesh-list
64982779|NCT00302536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64982780|NCT00302536|Immunologic Factors|immunologic factors|mesh-ancestor
64982815|NCT00081302|Tubulin Modulators|tubulin modulators|mesh-ancestor
64982816|NCT00081302|Antimitotic Agents|antimitotic agents|mesh-ancestor
64982817|NCT00081302|Mitosis Modulators|mitosis modulators|mesh-ancestor
64982818|NCT00081302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982819|NCT00081302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64982820|NCT00302653|Rasburicase|rasburicase|mesh-list
64982840|NCT00087282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982841|NCT00087282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982842|NCT00087282|Growth Inhibitors|growth inhibitors|mesh-ancestor
64982843|NCT00087282|Growth Substances|growth substances|mesh-ancestor
64982844|NCT00087282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982845|NCT00087282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64982846|NCT00418366|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64982847|NCT00418366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64982848|NCT00418366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982849|NCT00418366|Incretins|incretins|mesh-ancestor
64982850|NCT00418366|Hormones|hormones|mesh-ancestor
64982851|NCT00418366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64982852|NCT00418366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64784550|NCT02434146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64784551|NCT02434146|Mydriatics|mydriatics|mesh-ancestor
64784552|NCT02434146|Autonomic Agents|autonomic agents|mesh-ancestor
64784553|NCT02434146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64784554|NCT02434146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784555|NCT02434146|Sympathomimetics|sympathomimetics|mesh-ancestor
64784556|NCT02434146|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64784557|NCT02434146|Nasal Decongestants|nasal decongestants|mesh-ancestor
64784558|NCT02434146|Respiratory System Agents|respiratory system agents|mesh-ancestor
64305689|NCT02427646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64305690|NCT02427646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305691|NCT02427646|Cholinergic Agents|cholinergic agents|mesh-ancestor
64305692|NCT02427646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64305694|NCT02048969|Antidotes|antidotes|mesh-ancestor
64982853|NCT00418366|Protease Inhibitors|protease inhibitors|mesh-ancestor
64982854|NCT00418366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982855|NCT00418366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982856|NCT00120315|Esomeprazole|esomeprazole|mesh-list
64982857|NCT00120315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64982858|NCT00120315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64982859|NCT00120315|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64982860|NCT00120315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982861|NCT00120315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982862|NCT00081380|Valproic Acid|valproic acid|mesh-list
64982863|NCT00081380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64982864|NCT00081380|Antipsychotic Agents|antipsychotic agents|mesh-list
64982865|NCT00081380|Antidepressive Agents|antidepressive agents|mesh-ancestor
64982866|NCT00081380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64549824|NCT05602597|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64549825|NCT04608201|Nicotine|nicotine|mesh-list
64549826|NCT04608201|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64549827|NCT04608201|Autonomic Agents|autonomic agents|mesh-ancestor
64549828|NCT04608201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64549829|NCT04608201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549830|NCT04608201|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64549831|NCT04608201|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64549832|NCT04608201|Cholinergic Agents|cholinergic agents|mesh-ancestor
64549833|NCT04608201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64549834|NCT04608201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549835|NCT03323437|Risperidone|risperidone|mesh-list
64314729|NCT03550781|Glucocorticoids|glucocorticoids|mesh-ancestor
64982867|NCT00081380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64982868|NCT00081380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64982869|NCT00081380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982870|NCT00081380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982871|NCT00081380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982872|NCT00081380|Antimanic Agents|antimanic agents|mesh-ancestor
64982873|NCT00081380|Anticonvulsants|anticonvulsants|mesh-ancestor
64982874|NCT00081380|GABA Agents|gaba agents|mesh-ancestor
64982886|NCT00302692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64982887|NCT00302692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982888|NCT00302692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64982889|NCT00302692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64982890|NCT00302692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64982891|NCT00302692|Adrenergic Agents|adrenergic agents|mesh-ancestor
64982892|NCT00302692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64982893|NCT00302692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982894|NCT00302770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64982895|NCT00302770|Antidepressive Agents|antidepressive agents|mesh-ancestor
64982896|NCT00302770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64982897|NCT00302770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64982898|NCT00302770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64982899|NCT00302770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64982900|NCT00302770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395838|NCT03199547|Azithromycin|azithromycin|mesh-list
64395839|NCT03199547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64395840|NCT03199547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64395841|NCT03189641|Cilostazol|cilostazol|mesh-list
64395842|NCT03189641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64395843|NCT03189641|Autonomic Agents|autonomic agents|mesh-ancestor
64324444|NCT02264119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64305751|NCT02037503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64305752|NCT02037503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64305753|NCT02037503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64305754|NCT02037503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305755|NCT02049671|Hormones|hormones|mesh-list
64982901|NCT00081536|Capecitabine|capecitabine|mesh-list
64982902|NCT00081536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64982903|NCT00081536|Antimetabolites|antimetabolites|mesh-ancestor
64982904|NCT00081536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982905|NCT00081536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982907|NCT00303004|Sildenafil Citrate|sildenafil citrate|mesh-list
64982908|NCT00303004|Vasodilator Agents|vasodilator agents|mesh-ancestor
64982909|NCT00303004|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64982910|NCT00303004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64982911|NCT00303004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982912|NCT00303004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982913|NCT00303004|Urological Agents|urological agents|mesh-ancestor
64982914|NCT00303004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64982915|NCT00303004|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64982916|NCT00081575|Levofloxacin|levofloxacin|mesh-list
64982917|NCT00081575|Ofloxacin|ofloxacin|mesh-list
64982918|NCT00081575|Tigecycline|tigecycline|mesh-list
64982919|NCT00081575|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64982920|NCT00081575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64982921|NCT00081575|Renal Agents|renal agents|mesh-ancestor
64982922|NCT00081575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64982923|NCT00081575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64982924|NCT00081575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64982925|NCT00081575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549836|NCT03323437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64549837|NCT03323437|Serotonin Agents|serotonin agents|mesh-ancestor
64549838|NCT03323437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64549839|NCT03323437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549840|NCT03323437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549841|NCT03323437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64549842|NCT03323437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64549843|NCT03323437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64549844|NCT03323437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64549845|NCT03323437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64549846|NCT03323437|Dopamine Agents|dopamine agents|mesh-ancestor
64549847|NCT04110444|Sildenafil Citrate|sildenafil citrate|mesh-list
64549848|NCT04110444|Vasodilator Agents|vasodilator agents|mesh-ancestor
64314734|NCT02260661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64982926|NCT00081575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982927|NCT00081575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982928|NCT00081575|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64982929|NCT00081575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64982930|NCT00081575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64982931|NCT00087399|Gabapentin|gabapentin|mesh-list
64982932|NCT00087399|Antidepressive Agents|antidepressive agents|mesh-list
64982933|NCT00087399|Analgesics|analgesics|mesh-ancestor
64982934|NCT00087399|Sensory System Agents|sensory system agents|mesh-ancestor
64982935|NCT00087399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64982936|NCT00087399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982937|NCT00087399|Anticonvulsants|anticonvulsants|mesh-ancestor
64982961|NCT00303277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64982962|NCT00303277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64982963|NCT00303277|Antimetabolites|antimetabolites|mesh-ancestor
64982964|NCT00303277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982965|NCT00303277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64982966|NCT00303277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64982967|NCT00303277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982968|NCT00303394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64982969|NCT00303394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64982970|NCT00303433|Memantine|memantine|mesh-list
64982971|NCT00303433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64982972|NCT00303433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64982973|NCT00303433|Dopamine Agents|dopamine agents|mesh-ancestor
64982974|NCT00303433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64982975|NCT00303433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324445|NCT02264119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324446|NCT02264119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324447|NCT02262481|Dydrogesterone|dydrogesterone|mesh-list
64324448|NCT02262481|Progestins|progestins|mesh-ancestor
64982976|NCT00303433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982977|NCT00303433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64982978|NCT00303433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64982979|NCT00303550|Linezolid|linezolid|mesh-list
64982980|NCT00303550|Iclaprim|iclaprim|mesh-list
64982981|NCT00303550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64982982|NCT00303550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64982983|NCT00303550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64982984|NCT00303550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982985|NCT00303550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983014|NCT00081848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64983015|NCT00081848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64983016|NCT00081848|Analgesics|analgesics|mesh-ancestor
64983017|NCT00081848|Sensory System Agents|sensory system agents|mesh-ancestor
64983018|NCT00081848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64983019|NCT00081848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549849|NCT04110444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64301293|NCT03270033|Glucocorticoids|glucocorticoids|mesh-ancestor
64301294|NCT03270033|Hormones|hormones|mesh-ancestor
64549851|NCT04110444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549852|NCT04110444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549853|NCT04110444|Urological Agents|urological agents|mesh-ancestor
64549854|NCT04520217|Imipramine|imipramine|mesh-list
64549855|NCT04520217|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64549856|NCT04520217|Antidepressive Agents|antidepressive agents|mesh-ancestor
64549857|NCT04520217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64549858|NCT04520217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64549859|NCT04520217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64549860|NCT04520217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64549861|NCT04520217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549863|NCT04520217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64549864|NCT04520217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549865|NCT04951986|Levofloxacin|levofloxacin|mesh-list
64549866|NCT04951986|Ofloxacin|ofloxacin|mesh-list
64549867|NCT04951986|Rifampin|rifampin|mesh-list
64549868|NCT04951986|Isoniazid|isoniazid|mesh-list
64549869|NCT04951986|Pyrazinamide|pyrazinamide|mesh-list
64549870|NCT04951986|Ethambutol|ethambutol|mesh-list
64549871|NCT04951986|Prednisone|prednisone|mesh-list
64549872|NCT04951986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64549873|NCT04951986|Glucocorticoids|glucocorticoids|mesh-ancestor
64549874|NCT04951986|Hormones|hormones|mesh-ancestor
64549875|NCT04951986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64549876|NCT04951986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314747|NCT02136329|Urological Agents|urological agents|mesh-ancestor
64983020|NCT00081848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64983021|NCT00081848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64784560|NCT02434146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64784561|NCT02434146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64784562|NCT02434146|Adrenergic Agents|adrenergic agents|mesh-ancestor
64784563|NCT02434146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64784564|NCT02434146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784565|NCT02434146|Protective Agents|protective agents|mesh-ancestor
64784566|NCT02382588|Ganciclovir|ganciclovir|mesh-list
64784567|NCT02382588|Antiviral Agents|antiviral agents|mesh-ancestor
64784568|NCT02382588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64305873|NCT02052323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64305874|NCT02052323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983022|NCT00081848|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64983023|NCT00081848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64983024|NCT00081848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983025|NCT00081848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983026|NCT00081848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983027|NCT00081848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64983028|NCT00081848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64983029|NCT00081848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64983030|NCT00120432|Phenylephrine|phenylephrine|mesh-list
64983031|NCT00120432|Oxymetazoline|oxymetazoline|mesh-list
64983032|NCT00120432|Tropicamide|tropicamide|mesh-list
64983033|NCT00120432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64983034|NCT00120432|Mydriatics|mydriatics|mesh-ancestor
64983051|NCT00120432|Cholinergic Agents|cholinergic agents|mesh-ancestor
64983052|NCT00303745|Capecitabine|capecitabine|mesh-list
64983053|NCT00303745|Irinotecan|irinotecan|mesh-list
64549877|NCT04951986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64549878|NCT04951986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549879|NCT04951986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64549880|NCT04951986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64549881|NCT04951986|Renal Agents|renal agents|mesh-ancestor
64549882|NCT04951986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64549883|NCT04951986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64549884|NCT04951986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64549885|NCT04951986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945404|NCT05663580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64549886|NCT04951986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549887|NCT04951986|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64549888|NCT04951986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64549889|NCT04951986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64549890|NCT04951986|Antitubercular Agents|antitubercular agents|mesh-ancestor
64549891|NCT04951986|Leprostatic Agents|leprostatic agents|mesh-ancestor
64549892|NCT04951986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64549893|NCT04951986|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64549894|NCT04951986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64549895|NCT04951986|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64983054|NCT00303745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64983055|NCT00303745|Antimetabolites|antimetabolites|mesh-ancestor
64983056|NCT00303745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983057|NCT00303745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301296|NCT03270033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64983058|NCT00303745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64983059|NCT00303745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64983060|NCT00303745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983062|NCT00303784|Estradiol|estradiol|mesh-list
64983063|NCT00303784|Estrogens|estrogens|mesh-ancestor
64983064|NCT00303784|Hormones|hormones|mesh-ancestor
64983065|NCT00303784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64983066|NCT00303784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983067|NCT00303784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64983068|NCT00303784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983069|NCT00081887|Clofarabine|clofarabine|mesh-list
64983070|NCT00081887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64983071|NCT00081887|Antimetabolites|antimetabolites|mesh-ancestor
64983072|NCT00081887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983073|NCT00081887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983074|NCT00303940|Carboplatin|carboplatin|mesh-list
64983075|NCT00303940|Temozolomide|temozolomide|mesh-list
64983076|NCT00303940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983077|NCT00303940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64983078|NCT00303940|Alkylating Agents|alkylating agents|mesh-ancestor
64983079|NCT00303940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305948|NCT02055131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64305949|NCT02055131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305950|NCT02055131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64983080|NCT00304018|Prednisone|prednisone|mesh-list
64983081|NCT00304018|Fludarabine|fludarabine|mesh-list
64983082|NCT00304018|Fludarabine phosphate|fludarabine phosphate|mesh-list
64983083|NCT00304018|Etoposide|etoposide|mesh-list
64549896|NCT04951986|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64549897|NCT04951986|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64549898|NCT04951986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64549899|NCT04951986|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64549900|NCT04951986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64549901|NCT04951986|Antimetabolites|antimetabolites|mesh-ancestor
64549902|NCT04951986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64549904|NCT04278859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64549905|NCT04278859|Immunologic Factors|immunologic factors|mesh-ancestor
64549906|NCT04278859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549907|NCT04484337|Cabotegravir|cabotegravir|mesh-list
64549908|NCT04484337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64549909|NCT04484337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64549910|NCT04484337|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64549911|NCT04484337|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64549912|NCT04484337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549913|NCT04484337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549914|NCT04484337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64549915|NCT04484337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64549916|NCT04484337|Antiviral Agents|antiviral agents|mesh-ancestor
64549917|NCT04484337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64549918|NCT04484337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64549919|NCT04484337|Analgesics|analgesics|mesh-ancestor
64549920|NCT04484337|Sensory System Agents|sensory system agents|mesh-ancestor
64549921|NCT04484337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64549922|NCT04484337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549923|NCT04484337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64549924|NCT01474538|Insulin|insulin|mesh-list
64549925|NCT01474538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64549926|NCT01474538|Insulin Aspart|insulin aspart|mesh-list
64314798|NCT03549689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64983084|NCT00304018|Busulfan|busulfan|mesh-list
64983085|NCT00304018|Tacrolimus|tacrolimus|mesh-list
64983086|NCT00304018|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64983087|NCT00304018|Sargramostim|sargramostim|mesh-list
64983088|NCT00304018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64983089|NCT00304018|Glucocorticoids|glucocorticoids|mesh-ancestor
64983090|NCT00304018|Hormones|hormones|mesh-ancestor
64983091|NCT00304018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64983107|NCT00304018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64983108|NCT00081926|Imatinib Mesylate|imatinib mesylate|mesh-list
64983109|NCT00081926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549927|NCT01474538|Insulin Lispro|insulin lispro|mesh-list
64549928|NCT01474538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64549929|NCT01474538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549930|NCT04278703|Oxycodone|oxycodone|mesh-list
64549931|NCT04278703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64549932|NCT04278703|Narcotics|narcotics|mesh-ancestor
64306042|NCT02801669|Anticoagulants|anticoagulants|mesh-ancestor
64306043|NCT02804399|Rifampin|rifampin|mesh-list
64306044|NCT02804399|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64306045|NCT02804399|Antitubercular Agents|antitubercular agents|mesh-ancestor
64306046|NCT02804399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64306047|NCT02804399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64306048|NCT02804399|Leprostatic Agents|leprostatic agents|mesh-ancestor
64306049|NCT02804399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64306050|NCT02804399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306051|NCT02804399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306052|NCT02804399|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64306058|NCT05614037|Felodipine|felodipine|mesh-list
64549933|NCT04278703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64549934|NCT04278703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549935|NCT04278703|Analgesics|analgesics|mesh-ancestor
64549936|NCT04278703|Sensory System Agents|sensory system agents|mesh-ancestor
64549937|NCT04278703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64549938|NCT02647788|Acetaminophen|acetaminophen|mesh-list
64549939|NCT02647788|Ibuprofen|ibuprofen|mesh-list
64549940|NCT02647788|Codeine|codeine|mesh-list
64549941|NCT02647788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64549942|NCT02647788|Analgesics|analgesics|mesh-ancestor
64549943|NCT02647788|Sensory System Agents|sensory system agents|mesh-ancestor
64549944|NCT02647788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64983110|NCT00081926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64983111|NCT00081926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983112|NCT00081926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983113|NCT00304135|Gemcitabine|gemcitabine|mesh-list
64983114|NCT00304135|Oxaliplatin|oxaliplatin|mesh-list
64983115|NCT00304135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983116|NCT00304135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64983117|NCT00304135|Antimetabolites|antimetabolites|mesh-ancestor
64983118|NCT00304135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983119|NCT00304135|Antiviral Agents|antiviral agents|mesh-ancestor
64983120|NCT00304135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983121|NCT00304135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983122|NCT00304135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64983123|NCT00304135|Immunologic Factors|immunologic factors|mesh-ancestor
64983124|NCT00304135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983125|NCT00304213|Testosterone|testosterone|mesh-list
64983126|NCT00304213|Androgens|androgens|mesh-ancestor
64983127|NCT00304213|Hormones|hormones|mesh-ancestor
64983128|NCT00304213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64983129|NCT00304213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983130|NCT00304252|Interferons|interferons|mesh-list
64983131|NCT00304252|Interferon-beta|interferon-beta|mesh-list
64983132|NCT00304252|Interferon beta-1a|interferon beta-1a|mesh-list
64983133|NCT00304252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983134|NCT00304252|Antiviral Agents|antiviral agents|mesh-ancestor
64983135|NCT00304252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983136|NCT00304252|Immunologic Factors|immunologic factors|mesh-ancestor
64983137|NCT00304252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983138|NCT00304252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64983139|NCT00120471|Tenofovir|tenofovir|mesh-list
64983140|NCT00120471|Antiviral Agents|antiviral agents|mesh-ancestor
64983141|NCT00120471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983142|NCT00120471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64983143|NCT00120471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64983144|NCT00120471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983145|NCT00120471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983146|NCT00120471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64983147|NCT00120471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64983148|NCT00082043|Dutasteride|dutasteride|mesh-list
64306091|NCT02059031|Cabotegravir|cabotegravir|mesh-list
64306092|NCT02059031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64306093|NCT02059031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64306094|NCT02059031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306095|NCT02059031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306096|NCT02059031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64306097|NCT02059031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64306098|NCT02059031|Antiviral Agents|antiviral agents|mesh-ancestor
64306099|NCT02059031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64306100|NCT01333865|Memantine|memantine|mesh-list
64306101|NCT01333865|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64306103|NCT01333865|Dopamine Agents|dopamine agents|mesh-ancestor
64549945|NCT02647788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549946|NCT02647788|Antipyretics|antipyretics|mesh-ancestor
64549947|NCT02647788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64549948|NCT02647788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64549949|NCT02647788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64549950|NCT02647788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64549951|NCT02647788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549952|NCT02647788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549953|NCT02647788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64549954|NCT02647788|Narcotics|narcotics|mesh-ancestor
64549955|NCT02647788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64983170|NCT00304369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64983171|NCT00082082|Thymalfasin|thymalfasin|mesh-list
64983172|NCT00082082|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64983173|NCT00082082|Immunologic Factors|immunologic factors|mesh-ancestor
64983174|NCT00082082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983175|NCT00304447|Gemtuzumab|gemtuzumab|mesh-list
64983176|NCT00304447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64983177|NCT00304447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983178|NCT00087711|Gemcitabine|gemcitabine|mesh-list
64983179|NCT00087711|Pemetrexed|pemetrexed|mesh-list
64983180|NCT00087711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983181|NCT00087711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64983182|NCT00087711|Antimetabolites|antimetabolites|mesh-ancestor
64983183|NCT00087711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983184|NCT00087711|Antiviral Agents|antiviral agents|mesh-ancestor
64983185|NCT00087711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983186|NCT00087711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983187|NCT00087711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64983188|NCT00087711|Immunologic Factors|immunologic factors|mesh-ancestor
64983189|NCT00087711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983190|NCT00087711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64983191|NCT00087711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64983192|NCT00304642|Dapivirine|dapivirine|mesh-list
64983193|NCT00304642|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64983194|NCT00304642|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64983195|NCT00304642|Antiviral Agents|antiviral agents|mesh-ancestor
64983196|NCT00304642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983197|NCT00304681|Methylphenidate|methylphenidate|mesh-list
64983198|NCT00304681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64983199|NCT00304681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983200|NCT00304681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64983214|NCT00082199|Antidepressive Agents|antidepressive agents|mesh-ancestor
64983215|NCT00082199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64983216|NCT00082199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64983217|NCT00082199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64983218|NCT00082199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64983219|NCT00082199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983220|NCT00082199|Dopamine Agonists|dopamine agonists|mesh-ancestor
64983221|NCT00082199|Dopamine Agents|dopamine agents|mesh-ancestor
64983222|NCT00082199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64306143|NCT05636501|Prednisolone|prednisolone|mesh-list
64306144|NCT05636501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64306145|NCT05636501|Glucocorticoids|glucocorticoids|mesh-ancestor
64306146|NCT05636501|Hormones|hormones|mesh-ancestor
64306147|NCT05636501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64306148|NCT05636501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306149|NCT05636501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64306150|NCT05636501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64306151|NCT02058173|Chloroquine|chloroquine|mesh-list
64306152|NCT02058173|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64983223|NCT00082199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983224|NCT00082199|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64983225|NCT00082199|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64983226|NCT00082199|Serotonin Agents|serotonin agents|mesh-ancestor
64983227|NCT00082199|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64983228|NCT00082199|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64983229|NCT00082199|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64983230|NCT00082199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64983231|NCT00120510|Lamivudine|lamivudine|mesh-list
64983232|NCT00120510|Zidovudine|zidovudine|mesh-list
64983233|NCT00120510|Efavirenz|efavirenz|mesh-list
64983234|NCT00120510|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64549956|NCT02647788|Antitussive Agents|antitussive agents|mesh-ancestor
64549957|NCT02647788|Respiratory System Agents|respiratory system agents|mesh-ancestor
64549958|NCT03319537|Pemetrexed|pemetrexed|mesh-list
64549959|NCT03319537|Pevonedistat|pevonedistat|mesh-list
64549960|NCT03319537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549961|NCT03319537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549962|NCT03319537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549963|NCT03319537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64549964|NCT03319537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64549965|NCT04382859|Bupivacaine|bupivacaine|mesh-list
64549966|NCT04382859|Anesthetics, Local|anesthetics, local|mesh-ancestor
64549967|NCT04382859|Anesthetics|anesthetics|mesh-ancestor
64549968|NCT04382859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64549969|NCT04382859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549970|NCT04382859|Sensory System Agents|sensory system agents|mesh-ancestor
64549971|NCT04382859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64549972|NCT03318133|Anesthetics|anesthetics|mesh-list
64549973|NCT03318133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64549974|NCT03318133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549975|NCT04134663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64549976|NCT04134663|Oxytocin|oxytocin|mesh-list
64549977|NCT04134663|Oxytocics|oxytocics|mesh-ancestor
64549978|NCT04134663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64983235|NCT00120510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64983236|NCT00120510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64983237|NCT00120510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983238|NCT00120510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983239|NCT00120510|Antiviral Agents|antiviral agents|mesh-ancestor
64983240|NCT00120510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983241|NCT00120510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64983242|NCT00120510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64983243|NCT00120510|Antimetabolites|antimetabolites|mesh-ancestor
64983244|NCT00120510|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64983245|NCT00120510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64983246|NCT00120510|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64983247|NCT00120510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64983248|NCT00120510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64983249|NCT00120510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64983250|NCT00087750|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64983251|NCT00087750|Antidepressive Agents|antidepressive agents|mesh-ancestor
64983252|NCT00087750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64983253|NCT00087750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64983254|NCT00087750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64983255|NCT00087750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64983256|NCT00087750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983258|NCT00304993|Rosiglitazone|rosiglitazone|mesh-list
64983259|NCT00304993|Fenofibrate|fenofibrate|mesh-list
64983260|NCT00304993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64983293|NCT00082316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64549979|NCT04134663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549981|NCT05431764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64549982|NCT05431764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549983|NCT05431764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549984|NCT05431764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64549985|NCT05431764|Antimetabolites|antimetabolites|mesh-ancestor
64549986|NCT05431764|Antiviral Agents|antiviral agents|mesh-ancestor
64549987|NCT05431764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64549988|NCT05431764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549989|NCT05431764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64549990|NCT05431764|Immunologic Factors|immunologic factors|mesh-ancestor
64549991|NCT05431764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549992|NCT04311411|Liraglutide|liraglutide|mesh-list
64549993|NCT04311411|Tirzepatide|tirzepatide|mesh-list
64549994|NCT04311411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64549995|NCT04311411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549996|NCT04311411|Incretins|incretins|mesh-ancestor
64549997|NCT04311411|Hormones|hormones|mesh-ancestor
64549998|NCT04311411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64549999|NCT03382561|Cisplatin|cisplatin|mesh-list
64983294|NCT00082316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983295|NCT00305383|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64983296|NCT00305383|Taribavirin|taribavirin|mesh-list
64983297|NCT00305383|Antiviral Agents|antiviral agents|mesh-ancestor
64983298|NCT00305383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983299|NCT00305422|Risperidone|risperidone|mesh-list
64983300|NCT00305422|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64983301|NCT00305422|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64983302|NCT00305422|Serotonin Agents|serotonin agents|mesh-ancestor
64983303|NCT00305422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64983320|NCT00082394|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64983321|NCT00082394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64983322|NCT00082394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64983323|NCT00082394|Protease Inhibitors|protease inhibitors|mesh-ancestor
64983324|NCT00082394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983325|NCT00082394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983326|NCT00082394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64983327|NCT00082394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64983328|NCT00082394|Antiviral Agents|antiviral agents|mesh-ancestor
64983329|NCT00082394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983330|NCT00082394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64983331|NCT00082394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64983332|NCT00305500|Citalopram|citalopram|mesh-list
64983333|NCT00305500|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64983334|NCT00305500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64983335|NCT00305500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64983336|NCT00305500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983337|NCT00305500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64983338|NCT00305500|Serotonin Agents|serotonin agents|mesh-ancestor
64983339|NCT00305500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550001|NCT03382561|Nivolumab|nivolumab|mesh-list
64550002|NCT03382561|Etoposide|etoposide|mesh-list
64550003|NCT03382561|Etoposide phosphate|etoposide phosphate|mesh-list
64550004|NCT03382561|Podophyllotoxin|podophyllotoxin|mesh-list
64550005|NCT03382561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550006|NCT03382561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64550007|NCT03382561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64550008|NCT03382561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550009|NCT03382561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64550010|NCT03382561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64550011|NCT03382561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64550012|NCT03382561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64550013|NCT03382561|Keratolytic Agents|keratolytic agents|mesh-ancestor
64550014|NCT03382561|Dermatologic Agents|dermatologic agents|mesh-ancestor
64550015|NCT03382561|Tubulin Modulators|tubulin modulators|mesh-ancestor
64550016|NCT03382561|Antimitotic Agents|antimitotic agents|mesh-ancestor
64550017|NCT03382561|Mitosis Modulators|mitosis modulators|mesh-ancestor
64550018|NCT00843531|Everolimus|everolimus|mesh-list
64550019|NCT00843531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64550020|NCT00843531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550021|NCT00843531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64550022|NCT00843531|Immunologic Factors|immunologic factors|mesh-ancestor
64550023|NCT00843531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550024|NCT00843531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64550025|NCT00843531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64550026|NCT00843531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550027|NCT00812877|Calcium|calcium|mesh-list
64736758|NCT00616343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983340|NCT00305500|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64983341|NCT00305500|Antidepressive Agents|antidepressive agents|mesh-ancestor
64983342|NCT00305500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64983343|NCT00305539|Adalimumab|adalimumab|mesh-list
64983344|NCT00305539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64983345|NCT00305539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64983346|NCT00305617|Antineoplastic Agents|antineoplastic agents|mesh-list
64983347|NCT00305734|Gemcitabine|gemcitabine|mesh-list
64983348|NCT00305734|Bortezomib|bortezomib|mesh-list
64983349|NCT00305734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64983350|NCT00305734|Antimetabolites|antimetabolites|mesh-ancestor
64983351|NCT00305734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983352|NCT00305734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983353|NCT00305734|Antiviral Agents|antiviral agents|mesh-ancestor
64983354|NCT00305734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983355|NCT00305734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983356|NCT00305734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64550028|NCT00812877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64550029|NCT00812877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550031|NCT00813111|Bupivacaine|bupivacaine|mesh-list
64550032|NCT00813111|Anesthetics, Local|anesthetics, local|mesh-ancestor
64550033|NCT00813111|Anesthetics|anesthetics|mesh-ancestor
64550034|NCT00813111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64550035|NCT00813111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550036|NCT00813111|Sensory System Agents|sensory system agents|mesh-ancestor
64550037|NCT00813111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550038|NCT00813111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64550039|NCT00813111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64550040|NCT00813111|Adrenergic Agents|adrenergic agents|mesh-ancestor
64550041|NCT00813111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64550042|NCT00813111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550043|NCT00813111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64550044|NCT00813111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64550045|NCT00813111|Autonomic Agents|autonomic agents|mesh-ancestor
64550046|NCT00813111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64550047|NCT00813111|Respiratory System Agents|respiratory system agents|mesh-ancestor
64550048|NCT00813111|Mydriatics|mydriatics|mesh-ancestor
64550049|NCT00813111|Sympathomimetics|sympathomimetics|mesh-ancestor
64550050|NCT00813111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64550051|NCT00845481|Calcitriol|calcitriol|mesh-list
64550052|NCT00845481|Betamethasone|betamethasone|mesh-list
64314933|NCT02137265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64983357|NCT00305734|Immunologic Factors|immunologic factors|mesh-ancestor
64983358|NCT00305734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983359|NCT00082472|Docetaxel|docetaxel|mesh-list
64983360|NCT00082472|Doxorubicin|doxorubicin|mesh-list
64983361|NCT00082472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64983380|NCT00305812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983381|NCT00305812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64983382|NCT00305812|Glucocorticoids|glucocorticoids|mesh-ancestor
64983383|NCT00305812|Hormones|hormones|mesh-ancestor
64983384|NCT00305812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64983385|NCT00305812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64983386|NCT00305812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983387|NCT00305812|Immunologic Factors|immunologic factors|mesh-ancestor
64983388|NCT00305812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64983389|NCT00305812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64983390|NCT00305812|Growth Substances|growth substances|mesh-ancestor
64983391|NCT00305812|Growth Inhibitors|growth inhibitors|mesh-ancestor
64983392|NCT00305812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64983393|NCT00305812|Alkylating Agents|alkylating agents|mesh-ancestor
64983394|NCT00305812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983395|NCT00305812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64983396|NCT00305812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64983397|NCT00082511|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64550053|NCT00845481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64550054|NCT00845481|Glucocorticoids|glucocorticoids|mesh-ancestor
64550056|NCT00845481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64550057|NCT00845481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550058|NCT00845481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64550059|NCT00845481|Respiratory System Agents|respiratory system agents|mesh-ancestor
64550060|NCT00845481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64550061|NCT00845481|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64550062|NCT00845481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64550063|NCT00845481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550064|NCT00845481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64550065|NCT00845481|Vitamins|vitamins|mesh-ancestor
64550066|NCT00845481|Micronutrients|micronutrients|mesh-ancestor
64550067|NCT00845481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64550068|NCT03641001|Micronutrients|micronutrients|mesh-list
64550069|NCT03641001|Trace Elements|trace elements|mesh-list
64550070|NCT03641001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550071|NCT01421069|Etanercept|etanercept|mesh-list
64550072|NCT01421069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64550073|NCT01421069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64550074|NCT01421069|Analgesics|analgesics|mesh-ancestor
64550075|NCT01421069|Sensory System Agents|sensory system agents|mesh-ancestor
64550076|NCT01421069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550077|NCT01421069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550078|NCT01421069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64983398|NCT00082511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64324457|NCT01252693|Goserelin|goserelin|mesh-list
64983399|NCT00082511|Immunologic Factors|immunologic factors|mesh-ancestor
64983400|NCT00082511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983401|NCT00306046|Diphosphonates|diphosphonates|mesh-list
64983402|NCT00306046|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64983403|NCT00306046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983404|NCT00306124|Levodopa|levodopa|mesh-list
64983405|NCT00306124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64983406|NCT00306124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64983407|NCT00306124|Dopamine Agents|dopamine agents|mesh-ancestor
64983408|NCT00306124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64983409|NCT00306124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983410|NCT00306124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983411|NCT00082589|Eplerenone|eplerenone|mesh-list
64983412|NCT00082589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64983413|NCT00082589|Hormone Antagonists|hormone antagonists|mesh-ancestor
64983414|NCT00082589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64983415|NCT00082589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983416|NCT00082589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64983417|NCT00082589|Diuretics|diuretics|mesh-ancestor
64550080|NCT01421069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64550081|NCT01421069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64550082|NCT01421069|Immunologic Factors|immunologic factors|mesh-ancestor
64550083|NCT04276233|Albuterol|albuterol|mesh-list
64550084|NCT04276233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64550085|NCT04276233|Autonomic Agents|autonomic agents|mesh-ancestor
64550086|NCT04276233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550087|NCT04276233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550088|NCT04276233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64550089|NCT04276233|Respiratory System Agents|respiratory system agents|mesh-ancestor
64550090|NCT04276233|Tocolytic Agents|tocolytic agents|mesh-ancestor
64550091|NCT04276233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64550092|NCT04276233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64550093|NCT04276233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64550094|NCT04276233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64550095|NCT04276233|Adrenergic Agents|adrenergic agents|mesh-ancestor
64550096|NCT04276233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64550097|NCT04276233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983418|NCT00082589|Natriuretic Agents|natriuretic agents|mesh-ancestor
64983434|NCT00306475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983435|NCT00306475|Antimanic Agents|antimanic agents|mesh-ancestor
64983436|NCT00306475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64983437|NCT00306475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64983438|NCT00306475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64983439|NCT00082667|Gefitinib|gefitinib|mesh-list
64983440|NCT00082667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983441|NCT00082667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64983442|NCT00082667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983443|NCT00082667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983444|NCT00306748|Linaclotide|linaclotide|mesh-list
64983445|NCT00306748|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64983446|NCT00306748|Enzyme Activators|enzyme activators|mesh-ancestor
64983447|NCT00306748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983448|NCT00306748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64983450|NCT00082784|Alvocidib|alvocidib|mesh-list
64983451|NCT00082784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983452|NCT00082784|Growth Inhibitors|growth inhibitors|mesh-ancestor
64983453|NCT00082784|Growth Substances|growth substances|mesh-ancestor
64983454|NCT00082784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324462|NCT03980509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64784642|NCT01980342|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64784643|NCT01980342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64784644|NCT01980342|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64983455|NCT00082784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64983456|NCT00082784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983457|NCT00082784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983458|NCT00306826|Pioglitazone|pioglitazone|mesh-list
64983459|NCT00306826|Simvastatin|simvastatin|mesh-list
64983460|NCT00306826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64983461|NCT00306826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64983462|NCT00306826|Antimetabolites|antimetabolites|mesh-ancestor
64983463|NCT00306826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983464|NCT00306826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64983465|NCT00306826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64550098|NCT04681430|Gabexate|gabexate|mesh-list
64550099|NCT04681430|Camostat|camostat|mesh-list
64550100|NCT04681430|Protease Inhibitors|protease inhibitors|mesh-ancestor
64550101|NCT04681430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64550102|NCT04681430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550103|NCT04681430|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64550104|NCT04681430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64550105|NCT04681430|Anticoagulants|anticoagulants|mesh-ancestor
64550106|NCT03309475|Psychotropic Drugs|psychotropic drugs|mesh-list
64550107|NCT00814671|Rifampin|rifampin|mesh-list
64550108|NCT00814671|Rifapentine|rifapentine|mesh-list
64315004|NCT02130869|Mechlorethamine|mechlorethamine|mesh-list
64983466|NCT00306826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983467|NCT00306826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64983468|NCT00306826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983469|NCT00082823|Aflibercept|aflibercept|mesh-list
64983470|NCT00082823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64983471|NCT00082823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64983472|NCT00082823|Growth Substances|growth substances|mesh-ancestor
64983473|NCT00082823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983474|NCT00082823|Growth Inhibitors|growth inhibitors|mesh-ancestor
64983475|NCT00082823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983476|NCT00087945|Lamivudine|lamivudine|mesh-list
64983477|NCT00087945|Zidovudine|zidovudine|mesh-list
64983486|NCT00087945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64983487|NCT00087945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64983488|NCT00087945|Antimetabolites|antimetabolites|mesh-ancestor
64983489|NCT00082862|Gemcitabine|gemcitabine|mesh-list
64983490|NCT00082862|Interferons|interferons|mesh-list
64983491|NCT00082862|Interferon-alpha|interferon-alpha|mesh-list
64983492|NCT00082862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983493|NCT00082862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64983494|NCT00082862|Antimetabolites|antimetabolites|mesh-ancestor
64983495|NCT00082862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983496|NCT00082862|Antiviral Agents|antiviral agents|mesh-ancestor
64983497|NCT00082862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983498|NCT00082862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983499|NCT00082862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64983500|NCT00082862|Immunologic Factors|immunologic factors|mesh-ancestor
64983501|NCT00082862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983502|NCT00307099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64983503|NCT00307099|Meropenem|meropenem|mesh-list
64983504|NCT00307099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983505|NCT00082940|Denileukin diftitox|denileukin diftitox|mesh-list
64983506|NCT00082940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983507|NCT00307138|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
64983508|NCT00307138|Plasma Substitutes|plasma substitutes|mesh-ancestor
64983509|NCT00307138|Blood Substitutes|blood substitutes|mesh-ancestor
64784648|NCT01881984|Glycerol|glycerol|mesh-list
64784649|NCT01881984|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64784650|NCT01881984|Protective Agents|protective agents|mesh-ancestor
64784651|NCT01881984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784652|NCT01878786|Mycophenolic Acid|mycophenolic acid|mesh-list
64983510|NCT00307177|Vaccines|vaccines|mesh-list
64983511|NCT00307177|Immunologic Factors|immunologic factors|mesh-ancestor
64983512|NCT00307177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983513|NCT00120705|Darbepoetin alfa|darbepoetin alfa|mesh-list
64983514|NCT00120705|Hematinics|hematinics|mesh-ancestor
64983516|NCT00307255|Paclitaxel|paclitaxel|mesh-list
64983517|NCT00307255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64983518|NCT00307255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64983519|NCT00307255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983520|NCT00307255|Tubulin Modulators|tubulin modulators|mesh-ancestor
64983521|NCT00307255|Antimitotic Agents|antimitotic agents|mesh-ancestor
64983522|NCT00307255|Mitosis Modulators|mitosis modulators|mesh-ancestor
64983523|NCT00307255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983524|NCT00307255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64983525|NCT00307255|Antimetabolites|antimetabolites|mesh-ancestor
64983526|NCT00307255|Antiviral Agents|antiviral agents|mesh-ancestor
64983527|NCT00307255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983528|NCT00307255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983529|NCT00307255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64983530|NCT00307255|Immunologic Factors|immunologic factors|mesh-ancestor
64550109|NCT00814671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64550110|NCT00814671|Antitubercular Agents|antitubercular agents|mesh-ancestor
64550111|NCT00814671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64550112|NCT00814671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64550113|NCT00814671|Leprostatic Agents|leprostatic agents|mesh-ancestor
64550114|NCT00814671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64550115|NCT00814671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64550116|NCT00814671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550117|NCT00814671|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64550118|NCT00814671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64550119|NCT00814671|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64550120|NCT00814671|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64550121|NCT00814671|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64550122|NCT00814671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64550124|NCT05686993|Cinnarizine|cinnarizine|mesh-list
64550125|NCT05686993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64550126|NCT05686993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64550127|NCT05686993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550128|NCT05686993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64550129|NCT05686993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550130|NCT05686993|Vasodilator Agents|vasodilator agents|mesh-ancestor
64550131|NCT05686993|Tocolytic Agents|tocolytic agents|mesh-ancestor
64550132|NCT05686993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64550133|NCT05686993|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64306658|NCT04976816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306659|NCT04976816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64306660|NCT04976816|Respiratory System Agents|respiratory system agents|mesh-ancestor
64306661|NCT03061838|Rituximab|rituximab|mesh-list
64306662|NCT03061838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64306663|NCT03061838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64306664|NCT03061838|Immunologic Factors|immunologic factors|mesh-ancestor
64306665|NCT03061838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306666|NCT03061838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64306667|NCT04964180|Indomethacin|indomethacin|mesh-list
64306668|NCT04964180|Lidocaine|lidocaine|mesh-list
64306669|NCT04964180|Anesthetics, Local|anesthetics, local|mesh-ancestor
64306670|NCT04964180|Anesthetics|anesthetics|mesh-ancestor
64306671|NCT04964180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64550134|NCT05686993|Histamine Antagonists|histamine antagonists|mesh-ancestor
64315014|NCT02130869|Antiviral Agents|antiviral agents|mesh-ancestor
64983531|NCT00307255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983532|NCT00307411|Hormones|hormones|mesh-list
64983533|NCT00307411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64983534|NCT00307411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983535|NCT00307450|Levetiracetam|levetiracetam|mesh-list
64983536|NCT00307450|Anticonvulsants|anticonvulsants|mesh-ancestor
64983537|NCT00307450|Nootropic Agents|nootropic agents|mesh-ancestor
64983538|NCT00307528|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64983539|NCT00307528|Immunologic Factors|immunologic factors|mesh-ancestor
64983540|NCT00307528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983541|NCT00120744|Ondansetron|ondansetron|mesh-list
64983542|NCT00120744|Antiemetics|antiemetics|mesh-ancestor
64983543|NCT00120744|Autonomic Agents|autonomic agents|mesh-ancestor
64983544|NCT00120744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64983545|NCT00120744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983546|NCT00120744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64983570|NCT00307606|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64983572|NCT00307606|Prednisolone acetate|prednisolone acetate|mesh-list
64550136|NCT05686993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64550137|NCT03379051|Lenalidomide|lenalidomide|mesh-list
64550139|NCT03379051|Immunologic Factors|immunologic factors|mesh-ancestor
64550140|NCT03379051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550141|NCT03379051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64550142|NCT03379051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64324464|NCT03980509|Sensory System Agents|sensory system agents|mesh-ancestor
64324465|NCT03980509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64324466|NCT03980509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324467|NCT03980509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64324468|NCT03980509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64324469|NCT03980509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550143|NCT03379051|Growth Substances|growth substances|mesh-ancestor
64550144|NCT03379051|Growth Inhibitors|growth inhibitors|mesh-ancestor
64550145|NCT03379051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550146|NCT01473836|Metronidazole|metronidazole|mesh-list
64550147|NCT01473836|Ceftriaxone|ceftriaxone|mesh-list
64550148|NCT01473836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64550149|NCT01473836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64550150|NCT01473836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64550151|NCT01473836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64550152|NCT03340909|Prednisolone|prednisolone|mesh-list
64550153|NCT03340909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64550154|NCT03340909|Glucocorticoids|glucocorticoids|mesh-ancestor
64550155|NCT03340909|Hormones|hormones|mesh-ancestor
64983573|NCT00307606|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64983574|NCT00307606|Prednisolone phosphate|prednisolone phosphate|mesh-list
64983575|NCT00307606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64983576|NCT00307606|Antiemetics|antiemetics|mesh-ancestor
64983577|NCT00307606|Autonomic Agents|autonomic agents|mesh-ancestor
64983578|NCT00307606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64983579|NCT00307606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983580|NCT00307606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64983581|NCT00307606|Glucocorticoids|glucocorticoids|mesh-ancestor
64983582|NCT00307606|Hormones|hormones|mesh-ancestor
64983583|NCT00307606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64983584|NCT00307606|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64983585|NCT00307606|Protective Agents|protective agents|mesh-ancestor
64983586|NCT00307606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64983587|NCT00307606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983588|NCT00083096|Temozolomide|temozolomide|mesh-list
64983589|NCT00083096|Lonafarnib|lonafarnib|mesh-list
64983590|NCT00083096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64983591|NCT00083096|Alkylating Agents|alkylating agents|mesh-ancestor
64983592|NCT00083096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983593|NCT00083096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983594|NCT00083096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983596|NCT00307645|Prednisone|prednisone|mesh-list
64983597|NCT00307645|Methylprednisolone|methylprednisolone|mesh-list
64983598|NCT00307645|Cyclophosphamide|cyclophosphamide|mesh-list
64983627|NCT00307645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64983629|NCT00120783|Indinavir|indinavir|mesh-list
64983630|NCT00120783|Lamivudine|lamivudine|mesh-list
64983631|NCT00120783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64983632|NCT00120783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64983633|NCT00120783|Protease Inhibitors|protease inhibitors|mesh-ancestor
64983634|NCT00120783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983635|NCT00120783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983636|NCT00120783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64983637|NCT00120783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64550156|NCT03340909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64550157|NCT03340909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550161|NCT05686915|Chromium|chromium|mesh-list
64550162|NCT05686915|Trace Elements|trace elements|mesh-ancestor
64550163|NCT05686915|Micronutrients|micronutrients|mesh-ancestor
64550164|NCT05686915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550165|NCT03674151|Povidone|povidone|mesh-list
64550166|NCT03674151|Plasma Substitutes|plasma substitutes|mesh-ancestor
64550167|NCT03674151|Blood Substitutes|blood substitutes|mesh-ancestor
64550168|NCT03643965|Budesonide|budesonide|mesh-list
64550169|NCT03643965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64550170|NCT03643965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64550171|NCT03643965|Autonomic Agents|autonomic agents|mesh-ancestor
64550172|NCT03643965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550173|NCT03643965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550174|NCT03643965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64550175|NCT03643965|Respiratory System Agents|respiratory system agents|mesh-ancestor
64550176|NCT03643965|Glucocorticoids|glucocorticoids|mesh-ancestor
64550177|NCT03643965|Hormones|hormones|mesh-ancestor
64550178|NCT03643965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64550179|NCT02979522|Doxorubicin|doxorubicin|mesh-list
64983638|NCT00120783|Antiviral Agents|antiviral agents|mesh-ancestor
64983639|NCT00120783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983640|NCT00120783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64983641|NCT00120783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64983642|NCT00120783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64983643|NCT00120783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64983676|NCT00083213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64983677|NCT00083213|Growth Substances|growth substances|mesh-ancestor
64983678|NCT00083213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983679|NCT00083213|Growth Inhibitors|growth inhibitors|mesh-ancestor
64983680|NCT00083213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983681|NCT00307996|Ubiquinone|ubiquinone|mesh-list
64983682|NCT00307996|Coenzyme Q10|coenzyme q10|mesh-list
64983683|NCT00307996|Micronutrients|micronutrients|mesh-ancestor
64983684|NCT00307996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983685|NCT00307996|Vitamins|vitamins|mesh-ancestor
64983686|NCT00083252|Cisplatin|cisplatin|mesh-list
64983687|NCT00083252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983688|NCT00418639|Nitazoxanide|nitazoxanide|mesh-list
64983689|NCT00418639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64983690|NCT00418639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983691|NCT00418678|Nabilone|nabilone|mesh-list
64983720|NCT00308191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983721|NCT00308191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64395963|NCT03748433|Insulin|insulin|mesh-list
64395964|NCT03748433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64324480|NCT01486849|Protective Agents|protective agents|mesh-ancestor
64324481|NCT01484119|Cetirizine|cetirizine|mesh-list
64324482|NCT01484119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64324483|NCT01484119|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64395979|NCT00540995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395987|NCT03103451|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64395996|NCT05103215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395998|NCT05103215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64395999|NCT05103215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64396000|NCT05103215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64983722|NCT00308191|Respiratory System Agents|respiratory system agents|mesh-ancestor
64983723|NCT00308191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64550180|NCT02979522|Dacarbazine|dacarbazine|mesh-list
64550181|NCT02979522|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64550182|NCT02979522|Vinblastine|vinblastine|mesh-list
64550183|NCT02979522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64506262|NCT05093140|Glucocorticoids|glucocorticoids|mesh-ancestor
64550184|NCT02979522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550185|NCT02979522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64550186|NCT02979522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64550187|NCT02979522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64550188|NCT02979522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550189|NCT02979522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64550190|NCT02979522|Alkylating Agents|alkylating agents|mesh-ancestor
64550191|NCT02979522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64983724|NCT00308191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64983726|NCT00308191|Adrenergic Agents|adrenergic agents|mesh-ancestor
64983727|NCT00308191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64983728|NCT00308191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983729|NCT00308191|Parasympatholytics|parasympatholytics|mesh-ancestor
64983730|NCT00308191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64983731|NCT00308191|Cholinergic Agents|cholinergic agents|mesh-ancestor
64983732|NCT00308191|Anticonvulsants|anticonvulsants|mesh-ancestor
64983733|NCT00308269|Folic Acid|folic acid|mesh-list
64983734|NCT00308269|Vinca Alkaloids|vinca alkaloids|mesh-list
64983735|NCT00308269|Hematinics|hematinics|mesh-ancestor
64983736|NCT00308269|Vitamin B Complex|vitamin b complex|mesh-ancestor
64983737|NCT00308269|Vitamins|vitamins|mesh-ancestor
64983738|NCT00308269|Micronutrients|micronutrients|mesh-ancestor
64983757|NCT00308425|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64983759|NCT00308503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64983760|NCT00308503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64983761|NCT00308503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983762|NCT00308503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64983763|NCT00308503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64983764|NCT00308503|Serotonin Agents|serotonin agents|mesh-ancestor
64983765|NCT00308503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64983766|NCT00308503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324485|NCT01484119|Histamine Antagonists|histamine antagonists|mesh-ancestor
64324486|NCT01484119|Histamine Agents|histamine agents|mesh-ancestor
64324487|NCT01484119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64324488|NCT01484119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324497|NCT01482403|Antimetabolites|antimetabolites|mesh-ancestor
64324498|NCT01482403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324499|NCT01481077|Latanoprost|latanoprost|mesh-list
64324500|NCT01481077|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64784748|NCT01608906|Calcium heparin|calcium heparin|mesh-list
64784749|NCT01608906|Anticoagulants|anticoagulants|mesh-ancestor
64784750|NCT01608906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64396011|NCT04771637|Dexmedetomidine|dexmedetomidine|mesh-list
64983767|NCT00308542|Dexamethasone|dexamethasone|mesh-list
64983768|NCT00308542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64983769|NCT00308542|Antiemetics|antiemetics|mesh-ancestor
64983770|NCT00308542|Autonomic Agents|autonomic agents|mesh-ancestor
64983771|NCT00308542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64983772|NCT00308542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983773|NCT00308542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64983774|NCT00308542|Glucocorticoids|glucocorticoids|mesh-ancestor
64983775|NCT00308542|Hormones|hormones|mesh-ancestor
64983776|NCT00308542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64983777|NCT00308542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64983778|NCT00308542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983779|NCT00308776|Cholecystokinin|cholecystokinin|mesh-list
64983780|NCT00308776|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64983781|NCT00308776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64983782|NCT00083408|Pamidronate|pamidronate|mesh-list
64983783|NCT00083408|Thalidomide|thalidomide|mesh-list
64983784|NCT00083408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64983785|NCT00083408|Immunologic Factors|immunologic factors|mesh-ancestor
64983786|NCT00083408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983787|NCT00083408|Leprostatic Agents|leprostatic agents|mesh-ancestor
64550192|NCT02979522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64550193|NCT02979522|Tubulin Modulators|tubulin modulators|mesh-ancestor
64550194|NCT02979522|Antimitotic Agents|antimitotic agents|mesh-ancestor
64550195|NCT02979522|Mitosis Modulators|mitosis modulators|mesh-ancestor
64550196|NCT01420679|10-deazaaminopterin|10-deazaaminopterin|mesh-list
64550197|NCT01420679|Aminopterin|aminopterin|mesh-list
64550198|NCT01420679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64550199|NCT01420679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64550200|NCT01420679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550201|NCT01420679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550202|NCT00851409|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64550203|NCT00851409|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64550204|NCT00851409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64550205|NCT00851409|Immunologic Factors|immunologic factors|mesh-ancestor
64550206|NCT00851409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550207|NCT04401007|Lidocaine|lidocaine|mesh-list
64550208|NCT04401007|Anesthetics, Local|anesthetics, local|mesh-ancestor
64550209|NCT04401007|Anesthetics|anesthetics|mesh-ancestor
64550210|NCT04401007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64550211|NCT04401007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983788|NCT00083408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64983789|NCT00083408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983790|NCT00083408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64983791|NCT00083408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64983792|NCT00083408|Growth Substances|growth substances|mesh-ancestor
64983793|NCT00083408|Growth Inhibitors|growth inhibitors|mesh-ancestor
64983794|NCT00083408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983795|NCT00083408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64983796|NCT00308971|Vitamin E|vitamin e|mesh-list
64983797|NCT00308971|Tocopherols|tocopherols|mesh-list
64983798|NCT00308971|Tocotrienols|tocotrienols|mesh-list
64983799|NCT00308971|alpha-Tocopherol|alpha-tocopherol|mesh-list
64983800|NCT00308971|Thioctic Acid|thioctic acid|mesh-list
64983821|NCT00309088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983822|NCT00309088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64983823|NCT00309088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983824|NCT00309088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983825|NCT00083486|Epoetin Alfa|epoetin alfa|mesh-list
64983826|NCT00083486|Hematinics|hematinics|mesh-ancestor
64983827|NCT00120978|Fluticasone|fluticasone|mesh-list
64983828|NCT00120978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64983829|NCT00120978|Autonomic Agents|autonomic agents|mesh-ancestor
64983830|NCT00120978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64983831|NCT00120978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983832|NCT00120978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64983833|NCT00120978|Respiratory System Agents|respiratory system agents|mesh-ancestor
64983834|NCT00120978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64983835|NCT00120978|Dermatologic Agents|dermatologic agents|mesh-ancestor
64983836|NCT00120978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64983837|NCT00309205|Dapivirine|dapivirine|mesh-list
64983838|NCT00309205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64983839|NCT00309205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64983840|NCT00309205|Antiviral Agents|antiviral agents|mesh-ancestor
64983841|NCT00309205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983842|NCT00309283|Somatostatin|somatostatin|mesh-list
64983843|NCT00309283|Hormones|hormones|mesh-ancestor
64550212|NCT04401007|Sensory System Agents|sensory system agents|mesh-ancestor
64550213|NCT04401007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550214|NCT04401007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64550215|NCT04401007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64550216|NCT04401007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64550217|NCT04401007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64550218|NCT04401007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550219|NCT01496846|Lidocaine|lidocaine|mesh-list
64550220|NCT01496846|Carticaine|carticaine|mesh-list
64550221|NCT01496846|Anesthetics, Local|anesthetics, local|mesh-ancestor
64550222|NCT01496846|Anesthetics|anesthetics|mesh-ancestor
64550223|NCT01496846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64550224|NCT01496846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550225|NCT01496846|Sensory System Agents|sensory system agents|mesh-ancestor
64550226|NCT01496846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550227|NCT01496846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64550228|NCT01496846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64550229|NCT01496846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64550230|NCT01496846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64550231|NCT01496846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550232|NCT00964002|Efavirenz|efavirenz|mesh-list
64550233|NCT00964002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64550234|NCT00964002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64550235|NCT00964002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64550236|NCT00964002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550237|NCT00964002|Antiviral Agents|antiviral agents|mesh-ancestor
64550238|NCT00964002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64550239|NCT00964002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64550240|NCT00964002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64550241|NCT00964002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64550242|NCT00964002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64983844|NCT00309283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64983845|NCT00309283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983846|NCT00083525|Capecitabine|capecitabine|mesh-list
64983847|NCT00083525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64983848|NCT00083525|Antimetabolites|antimetabolites|mesh-ancestor
64550243|NCT00964002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64550244|NCT00964002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64550246|NCT00818337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64550247|NCT00818337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64550248|NCT00818337|Analgesics|analgesics|mesh-ancestor
64550249|NCT00818337|Sensory System Agents|sensory system agents|mesh-ancestor
64550250|NCT00818337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550251|NCT00818337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550252|NCT00818337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64714175|NCT03065179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484459|NCT01727713|Dopamine Agonists|dopamine agonists|mesh-ancestor
64550253|NCT00818337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64550254|NCT00818337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64550255|NCT00818337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64550256|NCT00818337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550257|NCT00818337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64550258|NCT00818337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64550259|NCT00818337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64550260|NCT00818337|Antipyretics|antipyretics|mesh-ancestor
64550261|NCT02710851|Vaccines|vaccines|mesh-list
64550262|NCT02710851|Immunologic Factors|immunologic factors|mesh-ancestor
64550263|NCT02710851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550264|NCT02577120|Decanoic acid|decanoic acid|mesh-list
64550265|NCT02577120|Petrolatum|petrolatum|mesh-list
64550266|NCT02577120|Emollients|emollients|mesh-ancestor
64550267|NCT02577120|Dermatologic Agents|dermatologic agents|mesh-ancestor
64550268|NCT02577120|Antifungal Agents|antifungal agents|mesh-ancestor
64550269|NCT02577120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64550270|NCT01399697|Methotrexate|methotrexate|mesh-list
64550271|NCT01399697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64550284|NCT01399697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64550285|NCT01399697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64550286|NCT00853671|Adenosine|adenosine|mesh-list
64550287|NCT00853671|Analgesics|analgesics|mesh-ancestor
64550288|NCT00853671|Sensory System Agents|sensory system agents|mesh-ancestor
64550289|NCT00853671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550290|NCT00853671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550291|NCT00853671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64550292|NCT00853671|Vasodilator Agents|vasodilator agents|mesh-ancestor
64315210|NCT03511118|Fluvoxamine|fluvoxamine|mesh-list
64983849|NCT00083525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983850|NCT00083525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983851|NCT00309322|Phentolamine|phentolamine|mesh-list
64983852|NCT00309322|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64983853|NCT00309322|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64983854|NCT00309322|Adrenergic Agents|adrenergic agents|mesh-ancestor
64983855|NCT00309322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64983856|NCT00309322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983857|NCT00309322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983858|NCT00309322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64983865|NCT04727502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983866|NCT04727502|Analgesics|analgesics|mesh-ancestor
64983867|NCT04727502|Sensory System Agents|sensory system agents|mesh-ancestor
64983868|NCT04727502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64983869|NCT04727502|Antidepressive Agents|antidepressive agents|mesh-ancestor
64983870|NCT04727502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64983871|NCT04727502|Dopamine Agents|dopamine agents|mesh-ancestor
64983872|NCT00309361|Phentolamine|phentolamine|mesh-list
64983873|NCT00309361|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64983874|NCT00309361|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64983875|NCT00309361|Adrenergic Agents|adrenergic agents|mesh-ancestor
64983876|NCT00309361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64983877|NCT00309361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983878|NCT00309361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983879|NCT00309361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64983880|NCT00088491|Olanzapine|olanzapine|mesh-list
64983881|NCT00088491|Antiemetics|antiemetics|mesh-ancestor
64983882|NCT00088491|Autonomic Agents|autonomic agents|mesh-ancestor
64983883|NCT00088491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64983884|NCT00088491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550293|NCT00853671|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64441742|NCT02260154|Mebeverine|mebeverine|mesh-list
64550295|NCT00853671|Purinergic Agents|purinergic agents|mesh-ancestor
64550296|NCT00853671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64550297|NCT00853671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550298|NCT00818805|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64550299|NCT00818805|Tranilast|tranilast|mesh-list
64550300|NCT00818805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64550301|NCT00818805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64550302|NCT00818805|Analgesics|analgesics|mesh-ancestor
64550303|NCT00818805|Sensory System Agents|sensory system agents|mesh-ancestor
64550304|NCT00818805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64983885|NCT00088491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64983886|NCT00088491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64983887|NCT00088491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64983888|NCT00088491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64784781|NCT01483872|Anticoagulants|anticoagulants|mesh-list
64396031|NCT04701593|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64983889|NCT00088491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64983890|NCT00088491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64983891|NCT00088491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64983892|NCT00088491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64983893|NCT00088491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983894|NCT00088491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64983895|NCT00088491|Serotonin Agents|serotonin agents|mesh-ancestor
64983896|NCT00309478|Tamoxifen|tamoxifen|mesh-list
64983897|NCT00309478|Cyclophosphamide|cyclophosphamide|mesh-list
64983898|NCT00309478|Fluorouracil|fluorouracil|mesh-list
64983899|NCT00309478|Methotrexate|methotrexate|mesh-list
64983900|NCT00309478|Goserelin|goserelin|mesh-list
64983901|NCT00309478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64983902|NCT00309478|Immunologic Factors|immunologic factors|mesh-ancestor
64983903|NCT00309478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983904|NCT00309478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64983905|NCT00309478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64983906|NCT00309478|Alkylating Agents|alkylating agents|mesh-ancestor
64983907|NCT00309478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983908|NCT00309478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983909|NCT00309478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64983910|NCT00309478|Antimetabolites|antimetabolites|mesh-ancestor
64983911|NCT00309478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64983912|NCT00309478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64983913|NCT00309478|Abortifacient Agents|abortifacient agents|mesh-ancestor
64983914|NCT00309478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64983915|NCT00309478|Dermatologic Agents|dermatologic agents|mesh-ancestor
64983916|NCT00309478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983917|NCT00309478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64983918|NCT00309478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64983919|NCT00309478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64983920|NCT00309478|Hormone Antagonists|hormone antagonists|mesh-ancestor
64983921|NCT00309478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64983922|NCT00309478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64983923|NCT00309478|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64983949|NCT00121017|Antiviral Agents|antiviral agents|mesh-ancestor
64983950|NCT00121017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983951|NCT00121017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64983952|NCT00121017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64983953|NCT00121017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64983954|NCT00121017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64983955|NCT00121017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64550305|NCT00818805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550306|NCT00818805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64550307|NCT00818805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64550308|NCT00818805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64550309|NCT00818805|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64550310|NCT00818805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64550311|NCT00818805|Histamine Antagonists|histamine antagonists|mesh-ancestor
64307070|NCT03061136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307071|NCT04952792|Apixaban|apixaban|mesh-list
64307072|NCT04952792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64307073|NCT04952792|Antithrombins|antithrombins|mesh-ancestor
64307074|NCT04952792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64307075|NCT04952792|Protease Inhibitors|protease inhibitors|mesh-ancestor
64307076|NCT04952792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307077|NCT04952792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550312|NCT00818805|Histamine Agents|histamine agents|mesh-ancestor
64550313|NCT00818805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64714176|NCT02988050|Lidocaine|lidocaine|mesh-list
64550314|NCT00818805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550315|NCT00818805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64550316|NCT00818805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64550317|NCT00818805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64550318|NCT00818805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64550319|NCT00854061|Prednisone|prednisone|mesh-list
64550320|NCT00854061|Prednisolone acetate|prednisolone acetate|mesh-list
64983956|NCT00121017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64983957|NCT00121017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64983958|NCT00121017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64983959|NCT00121017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64983960|NCT00309556|Docetaxel|docetaxel|mesh-list
64983961|NCT00309556|Capecitabine|capecitabine|mesh-list
64983962|NCT00309556|Trastuzumab|trastuzumab|mesh-list
64983963|NCT00309556|Epirubicin|epirubicin|mesh-list
64983964|NCT00309556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983965|NCT00309556|Tubulin Modulators|tubulin modulators|mesh-ancestor
64983966|NCT00309556|Antimitotic Agents|antimitotic agents|mesh-ancestor
64983967|NCT00309556|Mitosis Modulators|mitosis modulators|mesh-ancestor
64983968|NCT00309556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983969|NCT00309556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64983970|NCT00309556|Antimetabolites|antimetabolites|mesh-ancestor
64983971|NCT00309556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64983972|NCT00309556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64983991|NCT00399737|Protease Inhibitors|protease inhibitors|mesh-ancestor
64983992|NCT00399737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983993|NCT00399737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983994|NCT00309634|Vaccines|vaccines|mesh-list
64983995|NCT00309634|Immunologic Factors|immunologic factors|mesh-ancestor
64983996|NCT00309634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983997|NCT00309673|Lidocaine|lidocaine|mesh-list
64983998|NCT00309673|Prilocaine|prilocaine|mesh-list
64983999|NCT00309673|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64984000|NCT00309673|Anesthetics, Local|anesthetics, local|mesh-ancestor
64984001|NCT00309673|Anesthetics|anesthetics|mesh-ancestor
64984002|NCT00309673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64984003|NCT00309673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984004|NCT00309673|Sensory System Agents|sensory system agents|mesh-ancestor
64984005|NCT00309673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64984006|NCT00309673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64984007|NCT00309673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64984008|NCT00309673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64984009|NCT00309673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64550321|NCT00854061|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64550322|NCT00854061|Methylprednisolone|methylprednisolone|mesh-list
64550323|NCT00854061|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64550324|NCT00854061|Prednisolone|prednisolone|mesh-list
64550325|NCT00854061|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64550326|NCT00854061|Prednisolone phosphate|prednisolone phosphate|mesh-list
64550327|NCT00854061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64550328|NCT00854061|Glucocorticoids|glucocorticoids|mesh-ancestor
64396042|NCT04701593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396043|NCT05243693|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64396044|NCT05243693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64396045|NCT05243693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396046|NCT04552847|Octreotide|octreotide|mesh-list
64396047|NCT04552847|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
64307123|NCT04959578|Darbepoetin alfa|darbepoetin alfa|mesh-list
64307124|NCT04959578|Hematinics|hematinics|mesh-ancestor
64307125|NCT04959500|Temozolomide|temozolomide|mesh-list
64307137|NCT04950530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64550329|NCT00854061|Hormones|hormones|mesh-ancestor
64550330|NCT00854061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64550331|NCT00854061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550332|NCT00854061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64550333|NCT00854061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550334|NCT00854061|Antiemetics|antiemetics|mesh-ancestor
64550335|NCT00854061|Autonomic Agents|autonomic agents|mesh-ancestor
64550336|NCT00854061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550337|NCT00854061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64550338|NCT00854061|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64550339|NCT00854061|Protective Agents|protective agents|mesh-ancestor
64315263|NCT03511118|Dopamine Agents|dopamine agents|mesh-ancestor
64984010|NCT00309673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984011|NCT00309673|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64984012|NCT00309712|Simvastatin|simvastatin|mesh-list
64984013|NCT00309712|Fenofibrate|fenofibrate|mesh-list
64984014|NCT00309712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64984015|NCT00309712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64984016|NCT00309712|Antimetabolites|antimetabolites|mesh-ancestor
64984017|NCT00309712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984018|NCT00309712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64984019|NCT00309712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64984020|NCT00309712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984021|NCT00121056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64984022|NCT00121056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64984023|NCT00309790|Sildenafil Citrate|sildenafil citrate|mesh-list
64984024|NCT00309790|Vasodilator Agents|vasodilator agents|mesh-ancestor
64984025|NCT00309790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64396048|NCT04552847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64396049|NCT04552847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64984026|NCT00309790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64984027|NCT00309790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984062|NCT00310141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984064|NCT00088686|Antipruritics|antipruritics|mesh-ancestor
64984065|NCT00088686|Dermatologic Agents|dermatologic agents|mesh-ancestor
64984066|NCT00088686|Sensory System Agents|sensory system agents|mesh-ancestor
64984067|NCT00088686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64984068|NCT00088686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984069|NCT00083681|Thalidomide|thalidomide|mesh-list
64984096|NCT00083681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64984097|NCT00083681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64984098|NCT00083681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64984099|NCT00083681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64984100|NCT00083681|Growth Substances|growth substances|mesh-ancestor
64984101|NCT00083681|Growth Inhibitors|growth inhibitors|mesh-ancestor
64984103|NCT00121095|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
64984104|NCT00121095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550340|NCT01473602|Vitamin D|vitamin d|mesh-list
64550341|NCT01473602|Teriparatide|teriparatide|mesh-list
64550342|NCT01473602|Calcium|calcium|mesh-list
64550343|NCT01473602|Vitamins|vitamins|mesh-ancestor
64550344|NCT01473602|Micronutrients|micronutrients|mesh-ancestor
64550345|NCT01473602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550346|NCT01473602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64550347|NCT01473602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64550348|NCT03336073|Dexamethasone|dexamethasone|mesh-list
64550349|NCT03336073|Cyclophosphamide|cyclophosphamide|mesh-list
64550350|NCT03336073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64550351|NCT03336073|Immunologic Factors|immunologic factors|mesh-ancestor
64550352|NCT03336073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550353|NCT03336073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64550354|NCT03336073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64550355|NCT03336073|Alkylating Agents|alkylating agents|mesh-ancestor
64315282|NCT03511118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64984105|NCT00121095|Tubulin Modulators|tubulin modulators|mesh-ancestor
64984106|NCT00121095|Antimitotic Agents|antimitotic agents|mesh-ancestor
64984107|NCT00121095|Mitosis Modulators|mitosis modulators|mesh-ancestor
64984108|NCT00121095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984109|NCT00121095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64984110|NCT00121095|Analgesics|analgesics|mesh-ancestor
64984111|NCT00121095|Sensory System Agents|sensory system agents|mesh-ancestor
64984112|NCT00121095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64984113|NCT00121095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984114|NCT00310297|Insulin glulisine|insulin glulisine|mesh-list
64984115|NCT00310297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64984132|NCT00310336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64984133|NCT00310336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64984134|NCT05568602|Dexamethasone|dexamethasone|mesh-list
64984135|NCT05568602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64984136|NCT05568602|Antiemetics|antiemetics|mesh-ancestor
64984137|NCT05568602|Autonomic Agents|autonomic agents|mesh-ancestor
64984138|NCT05568602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64984139|NCT05568602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984140|NCT05568602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64984141|NCT05568602|Glucocorticoids|glucocorticoids|mesh-ancestor
64984142|NCT05568602|Hormones|hormones|mesh-ancestor
64984143|NCT05568602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64984144|NCT05568602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64984145|NCT05568602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984146|NCT00310531|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64984147|NCT00310531|Estradiol|estradiol|mesh-list
64984148|NCT00310531|Estrogens|estrogens|mesh-ancestor
64984149|NCT00310531|Hormones|hormones|mesh-ancestor
64984150|NCT00310531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64984151|NCT00310531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984152|NCT00310531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64984153|NCT00310531|Hormone Antagonists|hormone antagonists|mesh-ancestor
64984154|NCT00310531|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64984155|NCT00310531|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64984156|NCT00310531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64984157|NCT00310765|Pregabalin|pregabalin|mesh-list
64984158|NCT00310765|Gabapentin|gabapentin|mesh-list
64984159|NCT00310765|Analgesics|analgesics|mesh-ancestor
64984160|NCT00310765|Sensory System Agents|sensory system agents|mesh-ancestor
64984161|NCT00310765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550356|NCT03336073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550357|NCT03336073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550358|NCT03336073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64550359|NCT03336073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64550360|NCT03336073|Antiemetics|antiemetics|mesh-ancestor
64550361|NCT03336073|Autonomic Agents|autonomic agents|mesh-ancestor
64550362|NCT03336073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550363|NCT03336073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64550364|NCT03336073|Glucocorticoids|glucocorticoids|mesh-ancestor
64550365|NCT03336073|Hormones|hormones|mesh-ancestor
64550366|NCT03336073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64550367|NCT03336073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64550368|NCT05334433|Anesthetics|anesthetics|mesh-list
64550369|NCT05334433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64550370|NCT05334433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550372|NCT01496612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64550373|NCT01496612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64550374|NCT01496612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64550375|NCT01496612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550376|NCT01496612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64550377|NCT01496612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64550378|NCT01496612|Serotonin Agents|serotonin agents|mesh-ancestor
64550379|NCT01496612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64550380|NCT01496612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550381|NCT00790218|Adenosine|adenosine|mesh-list
64550382|NCT00790218|Analgesics|analgesics|mesh-ancestor
64550383|NCT00790218|Sensory System Agents|sensory system agents|mesh-ancestor
64550384|NCT00790218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550385|NCT00790218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315297|NCT03511118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64984162|NCT00310765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984163|NCT00310765|Anticonvulsants|anticonvulsants|mesh-ancestor
64984164|NCT00310765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64984165|NCT00310765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64984166|NCT00310765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984167|NCT00310765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64984168|NCT00310765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64984169|NCT00310765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64984170|NCT00310765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64984171|NCT00310765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64984172|NCT00310765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64550386|NCT00790218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64550387|NCT00790218|Vasodilator Agents|vasodilator agents|mesh-ancestor
64550388|NCT00790218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64550389|NCT00790218|Purinergic Agonists|purinergic agonists|mesh-ancestor
64550390|NCT00790218|Purinergic Agents|purinergic agents|mesh-ancestor
64550391|NCT00790218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64550392|NCT00790218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550394|NCT03300427|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64550395|NCT03300427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64550396|NCT03300427|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64550397|NCT03300427|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64984173|NCT00310765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64984174|NCT00310765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64984175|NCT00310765|Antimanic Agents|antimanic agents|mesh-ancestor
64984176|NCT00310843|Nevirapine|nevirapine|mesh-list
64984177|NCT00310843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64442083|NCT04834310|Clindamycin|clindamycin|mesh-list
64984203|NCT00121329|Anesthetics, Local|anesthetics, local|mesh-ancestor
64984205|NCT00121329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64984206|NCT00121329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984207|NCT00121329|Sensory System Agents|sensory system agents|mesh-ancestor
64984208|NCT00121329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64984209|NCT00121329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64984210|NCT00121329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64984211|NCT00121329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64984212|NCT00121329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64984213|NCT00121329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984214|NCT00311038|Landiolol|landiolol|mesh-list
64984215|NCT00311038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64984216|NCT00311038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64984217|NCT00311038|Adrenergic Agents|adrenergic agents|mesh-ancestor
64984218|NCT00311038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64984219|NCT00311038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984220|NCT00311038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984221|NCT00311038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64984222|NCT00311077|Insulin glulisine|insulin glulisine|mesh-list
64984223|NCT00311077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64984234|NCT00088959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984235|NCT00088959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64984236|NCT00088959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984237|NCT00088959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984238|NCT00088959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64984239|NCT00088959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64984240|NCT00088959|Analgesics|analgesics|mesh-ancestor
64984241|NCT00088959|Sensory System Agents|sensory system agents|mesh-ancestor
64984242|NCT00088959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64984243|NCT00088959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984244|NCT00088959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64984245|NCT00088959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64984246|NCT00088959|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64984247|NCT00088959|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64984248|NCT05568017|Edotreotide|edotreotide|mesh-list
64984249|NCT05568017|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64984250|NCT05568017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984251|NCT00311389|Timolol|timolol|mesh-list
64984252|NCT00311389|Travoprost|travoprost|mesh-list
64984253|NCT00311389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64984254|NCT00311389|Latanoprost|latanoprost|mesh-list
64550398|NCT03300427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550399|NCT00818961|Cyclophosphamide|cyclophosphamide|mesh-list
64550400|NCT00818961|Busulfan|busulfan|mesh-list
64550401|NCT00818961|Rituximab|rituximab|mesh-list
64550402|NCT00818961|Methotrexate|methotrexate|mesh-list
64550403|NCT00818961|Fludarabine|fludarabine|mesh-list
64550404|NCT00818961|Fludarabine phosphate|fludarabine phosphate|mesh-list
64550405|NCT00818961|Alemtuzumab|alemtuzumab|mesh-list
64550406|NCT00818961|Tacrolimus|tacrolimus|mesh-list
64550407|NCT00818961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64550408|NCT00818961|Immunologic Factors|immunologic factors|mesh-ancestor
64550409|NCT00818961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550410|NCT00818961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64550411|NCT00818961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64550412|NCT00818961|Alkylating Agents|alkylating agents|mesh-ancestor
64550413|NCT00818961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550414|NCT00818961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550415|NCT00818961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64550416|NCT00818961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64550417|NCT00818961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64550418|NCT00818961|Abortifacient Agents|abortifacient agents|mesh-ancestor
64550419|NCT00818961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64550420|NCT00818961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64984255|NCT00311389|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64984256|NCT00311389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984257|NCT00311389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64984258|NCT00311389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64984259|NCT00311389|Adrenergic Agents|adrenergic agents|mesh-ancestor
64984260|NCT00311389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64984261|NCT00311389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984262|NCT00311389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64984263|NCT00311389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64984265|NCT00088998|Docetaxel|docetaxel|mesh-list
64984266|NCT00088998|Capecitabine|capecitabine|mesh-list
64984267|NCT00088998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64984268|NCT00088998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984269|NCT00088998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64984270|NCT00088998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64984271|NCT00088998|Growth Substances|growth substances|mesh-ancestor
64984272|NCT00088998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984273|NCT00088998|Growth Inhibitors|growth inhibitors|mesh-ancestor
64984274|NCT00088998|Tubulin Modulators|tubulin modulators|mesh-ancestor
64984275|NCT00088998|Antimitotic Agents|antimitotic agents|mesh-ancestor
64984276|NCT00088998|Mitosis Modulators|mitosis modulators|mesh-ancestor
64984277|NCT00088998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984278|NCT00088998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64984279|NCT00088998|Antimetabolites|antimetabolites|mesh-ancestor
64984280|NCT00311467|Interferons|interferons|mesh-list
64984281|NCT00311467|Capecitabine|capecitabine|mesh-list
64984282|NCT00311467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64984283|NCT00311467|Antimetabolites|antimetabolites|mesh-ancestor
64550421|NCT00818961|Antimetabolites|antimetabolites|mesh-ancestor
64550422|NCT00818961|Dermatologic Agents|dermatologic agents|mesh-ancestor
64550423|NCT00818961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64550424|NCT00818961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64550425|NCT00818961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64550426|NCT00818961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64550427|NCT05431218|Cholecalciferol|cholecalciferol|mesh-list
64550428|NCT05431218|Vitamin D|vitamin d|mesh-list
64550429|NCT05431218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64550430|NCT05431218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550431|NCT05431218|Vitamins|vitamins|mesh-ancestor
64550432|NCT05431218|Micronutrients|micronutrients|mesh-ancestor
64550433|NCT05431218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64550434|NCT05431062|Bupivacaine|bupivacaine|mesh-list
64550435|NCT05431062|Anesthetics, Local|anesthetics, local|mesh-ancestor
64550436|NCT05431062|Anesthetics|anesthetics|mesh-ancestor
64784860|NCT01169610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64550437|NCT05431062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64550438|NCT05431062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550439|NCT05431062|Sensory System Agents|sensory system agents|mesh-ancestor
64550440|NCT05431062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550442|NCT00819507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64550443|NCT00819507|Glucocorticoids|glucocorticoids|mesh-ancestor
64550444|NCT00819507|Hormones|hormones|mesh-ancestor
64550445|NCT00819507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64550446|NCT00819507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550447|NCT00819507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64550448|NCT03696121|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64550449|NCT03696121|Hemostatics|hemostatics|mesh-ancestor
64550450|NCT03696121|Coagulants|coagulants|mesh-ancestor
64550451|NCT03696121|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64550452|NCT03696121|Natriuretic Agents|natriuretic agents|mesh-ancestor
64315396|NCT04791332|Aticaprant|aticaprant|mesh-list
64984284|NCT00311467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984285|NCT00311467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984286|NCT00311467|Antiviral Agents|antiviral agents|mesh-ancestor
64984287|NCT00311467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64984288|NCT00311545|Siltuximab|siltuximab|mesh-list
64984289|NCT00311545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984308|NCT00089037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64984309|NCT00089037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64984310|NCT00089037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64984311|NCT00089037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64984312|NCT00089037|Antifungal Agents|antifungal agents|mesh-ancestor
64984313|NCT00311740|Valsartan|valsartan|mesh-list
64550453|NCT03696121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550454|NCT01995669|Lenalidomide|lenalidomide|mesh-list
64550455|NCT01995669|Obinutuzumab|obinutuzumab|mesh-list
64442229|NCT02164513|Fluticasone|fluticasone|mesh-list
64550456|NCT01995669|Immunologic Factors|immunologic factors|mesh-ancestor
64550457|NCT01995669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550458|NCT01995669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64550459|NCT01995669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64550460|NCT01995669|Growth Substances|growth substances|mesh-ancestor
64550461|NCT01995669|Growth Inhibitors|growth inhibitors|mesh-ancestor
64550462|NCT01995669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550463|NCT01995669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64550464|NCT03298945|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64550465|NCT03298945|Laxatives|laxatives|mesh-ancestor
64550466|NCT03298945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64550467|NCT01457924|Ofatumumab|ofatumumab|mesh-list
64550468|NCT01457924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64550469|NCT01457924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550470|NCT01457924|Immunologic Factors|immunologic factors|mesh-ancestor
64550471|NCT01457924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550472|NCT05237115|Amoxicillin|amoxicillin|mesh-list
64550473|NCT05237115|Clarithromycin|clarithromycin|mesh-list
64550474|NCT05237115|Esomeprazole|esomeprazole|mesh-list
64315398|NCT04791332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984314|NCT00311740|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64984315|NCT00311740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64984316|NCT00311740|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64984317|NCT00311740|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64984318|NCT00311740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984319|NCT00311740|Diuretics|diuretics|mesh-ancestor
64984320|NCT00311740|Natriuretic Agents|natriuretic agents|mesh-ancestor
64984321|NCT00311740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984322|NCT00311740|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64984323|NCT00311740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64984324|NCT00311818|Insulin Glargine|insulin glargine|mesh-list
64984325|NCT00311818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64984326|NCT00311818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984327|NCT00121407|Verteporfin|verteporfin|mesh-list
64984328|NCT00121407|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64984329|NCT00121407|Dermatologic Agents|dermatologic agents|mesh-ancestor
64984330|NCT00311857|Cetuximab|cetuximab|mesh-list
64984331|NCT00311857|Temozolomide|temozolomide|mesh-list
64984332|NCT00311857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64984333|NCT00311857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984334|NCT00311857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64984335|NCT00311857|Alkylating Agents|alkylating agents|mesh-ancestor
64984336|NCT00311857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984337|NCT00311896|Bemiparin|bemiparin|mesh-list
64984338|NCT00311896|Anticoagulants|anticoagulants|mesh-ancestor
64984339|NCT00121446|Enoxaparin|enoxaparin|mesh-list
64984340|NCT00121446|Tenecteplase|tenecteplase|mesh-list
64984341|NCT00121446|Clopidogrel|clopidogrel|mesh-list
64984342|NCT00121446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64550475|NCT05237115|Bismuth|bismuth|mesh-list
64550476|NCT05237115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64550477|NCT05237115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64550478|NCT05237115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64550479|NCT05237115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64550480|NCT05237115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64550481|NCT05237115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64550482|NCT05237115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550483|NCT05237115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64550484|NCT05237115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64550485|NCT05237115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64550486|NCT05237115|Antacids|antacids|mesh-ancestor
64550487|NCT04040621|Ceftazidime|ceftazidime|mesh-list
64550488|NCT04040621|Avibactam|avibactam|mesh-list
64550489|NCT04040621|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
64550490|NCT04040621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64315419|NCT02531906|Methadone|methadone|mesh-list
64315420|NCT02531906|Gabapentin|gabapentin|mesh-list
64984343|NCT00121446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64984344|NCT00121446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64984345|NCT00121446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64984365|NCT00121524|Adrenergic Agents|adrenergic agents|mesh-ancestor
64984366|NCT00121524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64984367|NCT00121524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984368|NCT00121524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984369|NCT00121524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64984370|NCT00121524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64984371|NCT00121524|Autonomic Agents|autonomic agents|mesh-ancestor
64984372|NCT00121524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64984373|NCT00121524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64984374|NCT00121524|Respiratory System Agents|respiratory system agents|mesh-ancestor
64984375|NCT00121524|Mydriatics|mydriatics|mesh-ancestor
64984376|NCT00121524|Sympathomimetics|sympathomimetics|mesh-ancestor
64984377|NCT00121524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64984378|NCT00121524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64984379|NCT00121524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64984380|NCT00121524|Parasympatholytics|parasympatholytics|mesh-ancestor
64984381|NCT00121524|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64984382|NCT00121524|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64984383|NCT00121524|Cholinergic Agents|cholinergic agents|mesh-ancestor
64984384|NCT00121524|Vasodilator Agents|vasodilator agents|mesh-ancestor
64984385|NCT00121524|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64984386|NCT00121524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64984387|NCT00121524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64984388|NCT00121524|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64984389|NCT00121524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64984390|NCT00121524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984391|NCT00121524|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64984392|NCT00121524|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64984393|NCT00121524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64984394|NCT00312130|Vildagliptin|vildagliptin|mesh-list
64984395|NCT00312130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64984396|NCT00312130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984397|NCT00312130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64984398|NCT00312130|Protease Inhibitors|protease inhibitors|mesh-ancestor
64550491|NCT04040621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64550492|NCT04040621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64550493|NCT04040621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64550494|NCT04040621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550496|NCT00856791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550497|NCT00856791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64550498|NCT00856791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64550499|NCT00856791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550500|NCT05236569|Tranexamic Acid|tranexamic acid|mesh-list
64550501|NCT05236569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64550502|NCT05236569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64550503|NCT05236569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550504|NCT05236569|Hemostatics|hemostatics|mesh-ancestor
64550505|NCT05236569|Coagulants|coagulants|mesh-ancestor
64550506|NCT05090371|Ofatumumab|ofatumumab|mesh-list
64550507|NCT05090371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315436|NCT02531906|Antimanic Agents|antimanic agents|mesh-ancestor
64984399|NCT00312130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984400|NCT00312130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984401|NCT00089115|Rituximab|rituximab|mesh-list
64984421|NCT05567471|Immunologic Factors|immunologic factors|mesh-ancestor
64984422|NCT05567471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984423|NCT00089154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64984424|NCT00089154|Antibodies|antibodies|mesh-list
64984425|NCT00089154|Immunoglobulins|immunoglobulins|mesh-list
64984426|NCT00089154|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64984427|NCT00089154|Immunologic Factors|immunologic factors|mesh-ancestor
64984428|NCT00089154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984429|NCT00089154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984430|NCT00312481|Ascorbic Acid|ascorbic acid|mesh-list
64984431|NCT00312481|Picosulfate sodium|picosulfate sodium|mesh-list
64984432|NCT00312481|Magnesium citrate|magnesium citrate|mesh-list
64984433|NCT00312481|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64984434|NCT00312481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984435|NCT00312481|Antioxidants|antioxidants|mesh-ancestor
64984436|NCT00312481|Protective Agents|protective agents|mesh-ancestor
64984437|NCT00312481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984438|NCT00312481|Vitamins|vitamins|mesh-ancestor
64984439|NCT00312481|Micronutrients|micronutrients|mesh-ancestor
64984440|NCT00312481|Cathartics|cathartics|mesh-ancestor
64984441|NCT00312481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64984442|NCT00312481|Laxatives|laxatives|mesh-ancestor
64984443|NCT00312520|Methylprednisolone|methylprednisolone|mesh-list
64984444|NCT00312520|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64984445|NCT00312520|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64984446|NCT00312520|Prednisolone|prednisolone|mesh-list
64984447|NCT00312520|Prednisolone acetate|prednisolone acetate|mesh-list
64984448|NCT00312520|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64984449|NCT00312520|Prednisolone phosphate|prednisolone phosphate|mesh-list
64984450|NCT00312520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64984451|NCT00312520|Antiemetics|antiemetics|mesh-ancestor
64984452|NCT00312520|Autonomic Agents|autonomic agents|mesh-ancestor
64984453|NCT00312520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64984454|NCT00312520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984455|NCT00312520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64984456|NCT00312520|Glucocorticoids|glucocorticoids|mesh-ancestor
64984457|NCT00312520|Hormones|hormones|mesh-ancestor
64550509|NCT00857727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64550510|NCT00857727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64550511|NCT00857727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550512|NCT00857727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64550513|NCT00857727|Analgesics|analgesics|mesh-ancestor
64550514|NCT00857727|Sensory System Agents|sensory system agents|mesh-ancestor
64550515|NCT00857727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550516|NCT00857727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64550517|NCT00857727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64550518|NCT00857727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64550519|NCT00857727|Adrenergic Agents|adrenergic agents|mesh-ancestor
64550520|NCT00857727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64550521|NCT00857727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550522|NCT00857961|Testosterone|testosterone|mesh-list
64315454|NCT02227940|Cisplatin|cisplatin|mesh-list
64315455|NCT02227940|Ceritinib|ceritinib|mesh-list
64315463|NCT02227940|Antimetabolites|antimetabolites|mesh-ancestor
64984490|NCT00121563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64984491|NCT00121563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64984493|NCT00121563|Sensory System Agents|sensory system agents|mesh-ancestor
64984494|NCT00121563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64984495|NCT00121563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984496|NCT00121563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64984525|NCT00121563|Anesthetics|anesthetics|mesh-ancestor
64984526|NCT00121563|GABA Modulators|gaba modulators|mesh-ancestor
64984527|NCT00121563|GABA Agents|gaba agents|mesh-ancestor
64984528|NCT00121563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64984529|NCT00293332|Bevacizumab|bevacizumab|mesh-list
64984530|NCT00293332|Carboplatin|carboplatin|mesh-list
64984531|NCT00293332|Docetaxel|docetaxel|mesh-list
64984532|NCT00293332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64984533|NCT00293332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984534|NCT00293332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64984535|NCT00293332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64984536|NCT00293332|Growth Substances|growth substances|mesh-ancestor
64984537|NCT00293332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984538|NCT00293332|Growth Inhibitors|growth inhibitors|mesh-ancestor
64984539|NCT00293332|Tubulin Modulators|tubulin modulators|mesh-ancestor
64984540|NCT00293332|Antimitotic Agents|antimitotic agents|mesh-ancestor
64984541|NCT00293332|Mitosis Modulators|mitosis modulators|mesh-ancestor
64984542|NCT00293332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984543|NCT00293371|Prednisone|prednisone|mesh-list
64984544|NCT00293371|Docetaxel|docetaxel|mesh-list
64984629|NCT00423969|Cholinergic Agents|cholinergic agents|mesh-ancestor
64984630|NCT00423969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64984631|NCT00423969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984632|NCT00423969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64984633|NCT00423969|Nootropic Agents|nootropic agents|mesh-ancestor
64984634|NCT00293839|Oxybutynin|oxybutynin|mesh-list
64984635|NCT00293839|Parasympatholytics|parasympatholytics|mesh-ancestor
64984636|NCT00293839|Autonomic Agents|autonomic agents|mesh-ancestor
64984637|NCT00293839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64984638|NCT00293839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984639|NCT00293839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64984640|NCT00293839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64984641|NCT00293839|Cholinergic Agents|cholinergic agents|mesh-ancestor
64550523|NCT00857961|Androgens|androgens|mesh-ancestor
64550524|NCT00857961|Hormones|hormones|mesh-ancestor
64550525|NCT00857961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64550526|NCT00857961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550527|NCT03839433|Ciclesonide|ciclesonide|mesh-list
64550528|NCT03839433|Glucocorticoids|glucocorticoids|mesh-ancestor
64550529|NCT03839433|Hormones|hormones|mesh-ancestor
64550530|NCT03839433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64550531|NCT03839433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550532|NCT03839433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64550533|NCT05033041|Metoclopramide|metoclopramide|mesh-list
64550534|NCT05033041|Antiemetics|antiemetics|mesh-ancestor
64550535|NCT05033041|Autonomic Agents|autonomic agents|mesh-ancestor
64550536|NCT05033041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550537|NCT05033041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784956|NCT00832572|Ranolazine|ranolazine|mesh-list
64550538|NCT05033041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64315470|NCT02227940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64984642|NCT00293839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64984643|NCT00293839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984644|NCT00293839|Urological Agents|urological agents|mesh-ancestor
64984645|NCT00293917|Tacrolimus|tacrolimus|mesh-list
64984646|NCT00293917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64984661|NCT05567081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64984662|NCT05567081|Immunologic Factors|immunologic factors|mesh-ancestor
64984663|NCT05567081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984664|NCT05567081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984666|NCT04710927|Cariostatic Agents|cariostatic agents|mesh-ancestor
64984667|NCT04710927|Protective Agents|protective agents|mesh-ancestor
64984668|NCT04710927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984669|NCT00294112|Remestemcel-l|remestemcel-l|mesh-list
64984670|NCT00294112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64984671|NCT00294112|Antiviral Agents|antiviral agents|mesh-ancestor
64984672|NCT00294112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64984673|NCT00417898|Aspirin|aspirin|mesh-list
64984674|NCT00417898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64984675|NCT00417898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64984676|NCT00417898|Analgesics|analgesics|mesh-ancestor
64984677|NCT00417898|Sensory System Agents|sensory system agents|mesh-ancestor
64984678|NCT00417898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64984679|NCT00417898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984680|NCT00417898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64984681|NCT00417898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64984682|NCT00417898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64984683|NCT00417898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64984684|NCT00417898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396197|NCT02668393|Mitosis Modulators|mitosis modulators|mesh-ancestor
64396198|NCT02668393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324508|NCT02268487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64324509|NCT02268487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64324510|NCT02268487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984685|NCT00417898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64984686|NCT00417898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64984687|NCT00417898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984688|NCT00417898|Antipyretics|antipyretics|mesh-ancestor
64984689|NCT00294190|Topotecan|topotecan|mesh-list
64984690|NCT00294190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64984691|NCT00294190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64984692|NCT00294190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984693|NCT00294190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984694|NCT00294190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984695|NCT02960503|Azithromycin|azithromycin|mesh-list
64550539|NCT05033041|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64550540|NCT05033041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64550541|NCT05033041|Dopamine Agents|dopamine agents|mesh-ancestor
64550542|NCT05033041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64550543|NCT05033041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550545|NCT05029063|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64550546|NCT05029063|Antithrombins|antithrombins|mesh-ancestor
64550547|NCT05029063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64550548|NCT05029063|Protease Inhibitors|protease inhibitors|mesh-ancestor
64550549|NCT05029063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64550550|NCT05029063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550551|NCT05029063|Anticoagulants|anticoagulants|mesh-ancestor
64550552|NCT00823797|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64550553|NCT00823797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64550554|NCT00823797|Alkylating Agents|alkylating agents|mesh-ancestor
64550555|NCT00823797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550556|NCT00823797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550557|NCT00824733|Trastuzumab|trastuzumab|mesh-list
64550558|NCT00824733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64550559|NCT00824733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550560|NCT02150499|Albuterol|albuterol|mesh-list
64550561|NCT02150499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64550562|NCT02150499|Autonomic Agents|autonomic agents|mesh-ancestor
64550563|NCT02150499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315486|NCT05578001|Pilocarpine|pilocarpine|mesh-list
64984696|NCT02960503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64984697|NCT02960503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64984698|NCT04706091|Suvorexant|suvorexant|mesh-list
64984699|NCT04706091|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64984700|NCT04706091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64984701|NCT04706091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64984702|NCT04706091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784989|NCT00738972|Antimetabolites|antimetabolites|mesh-ancestor
64984703|NCT04706091|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64984704|NCT04706091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64984723|NCT00294463|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64984724|NCT00294463|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64984725|NCT00294463|Medroxyprogesterone|medroxyprogesterone|mesh-list
64984726|NCT00294463|Estradiol|estradiol|mesh-list
64984727|NCT00294463|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64984728|NCT00294463|Progesterone|progesterone|mesh-list
64984729|NCT00294463|Estrogens|estrogens|mesh-ancestor
64984730|NCT00294463|Hormones|hormones|mesh-ancestor
64984731|NCT00294463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64984732|NCT00294463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984733|NCT00294463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64984734|NCT00294463|Contraceptive Agents|contraceptive agents|mesh-ancestor
64550564|NCT02150499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550565|NCT02150499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64550566|NCT02150499|Respiratory System Agents|respiratory system agents|mesh-ancestor
64550567|NCT02150499|Tocolytic Agents|tocolytic agents|mesh-ancestor
64550568|NCT02150499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64550569|NCT02150499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64550570|NCT02150499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64550571|NCT02150499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64550572|NCT02150499|Adrenergic Agents|adrenergic agents|mesh-ancestor
64550573|NCT02150499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64550574|NCT02150499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550575|NCT03287947|Nintedanib|nintedanib|mesh-list
64550576|NCT03287947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315512|NCT04790708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64984735|NCT00294463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64984736|NCT00294463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64984737|NCT00294463|Progestins|progestins|mesh-ancestor
64984738|NCT00294463|Androgen Antagonists|androgen antagonists|mesh-ancestor
64984739|NCT00294463|Hormone Antagonists|hormone antagonists|mesh-ancestor
64984740|NCT00294463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64984741|NCT00294463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64984742|NCT00294463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984743|NCT00294463|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64984744|NCT00294463|Anabolic Agents|anabolic agents|mesh-ancestor
64984745|NCT00294463|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64984746|NCT00294463|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64984747|NCT00294463|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64984748|NCT00294463|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64984749|NCT00294502|Minocycline|minocycline|mesh-list
64984750|NCT00294502|Gentamicins|gentamicins|mesh-list
64984751|NCT00294502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984752|NCT00294502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64984753|NCT00294502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64984754|NCT00294502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64984755|NCT00294502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984756|NCT00089349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64984757|NCT00089349|Alemtuzumab|alemtuzumab|mesh-list
64984758|NCT00089349|Methotrexate|methotrexate|mesh-list
64984759|NCT00089349|Mercaptopurine|mercaptopurine|mesh-list
64984760|NCT00089349|Antibodies|antibodies|mesh-list
64984761|NCT00089349|Immunoglobulins|immunoglobulins|mesh-list
64984762|NCT00089349|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64984763|NCT00089349|Immunologic Factors|immunologic factors|mesh-ancestor
64984764|NCT00089349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984790|NCT00294736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984792|NCT00294775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64984793|NCT00294775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64984794|NCT00294775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64984795|NCT00294775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984796|NCT00121680|Lenvatinib|lenvatinib|mesh-list
64984797|NCT00121680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984798|NCT00121680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64984799|NCT00121680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984800|NCT00121680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984801|NCT00294853|Calcium|calcium|mesh-list
64984802|NCT00294853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64984803|NCT00294853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984804|NCT00294892|Nevirapine|nevirapine|mesh-list
64984805|NCT00294892|Carbamazepine|carbamazepine|mesh-list
64550577|NCT03287947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64550578|NCT03287947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64550579|NCT03287947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550580|NCT05685667|Hyaluronic Acid|hyaluronic acid|mesh-list
64550581|NCT05685667|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64550582|NCT05685667|Immunologic Factors|immunologic factors|mesh-ancestor
64550583|NCT05685667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550584|NCT05685667|Viscosupplements|viscosupplements|mesh-ancestor
64550585|NCT05685667|Protective Agents|protective agents|mesh-ancestor
64550586|NCT00859131|Thymoglobulin|thymoglobulin|mesh-list
64550587|NCT00859131|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64550588|NCT00859131|Daclizumab|daclizumab|mesh-list
64550589|NCT00859131|Immunologic Factors|immunologic factors|mesh-ancestor
64550590|NCT00859131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550591|NCT00859131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64550592|NCT00859833|Adenosine|adenosine|mesh-list
64550593|NCT00859833|Regadenoson|regadenoson|mesh-list
64550594|NCT00859833|Analgesics|analgesics|mesh-ancestor
64550595|NCT00859833|Sensory System Agents|sensory system agents|mesh-ancestor
64550596|NCT00859833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550597|NCT00859833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550598|NCT00859833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64550599|NCT00859833|Vasodilator Agents|vasodilator agents|mesh-ancestor
64550600|NCT00859833|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64550601|NCT00859833|Purinergic Agonists|purinergic agonists|mesh-ancestor
64550602|NCT00859833|Purinergic Agents|purinergic agents|mesh-ancestor
64315533|NCT02135393|Folic Acid|folic acid|mesh-list
64984806|NCT00294892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64984807|NCT00294892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64984808|NCT00294892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984845|NCT00294931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984877|NCT00089622|Serotonin Agents|serotonin agents|mesh-ancestor
64984878|NCT00089622|Dopamine Agonists|dopamine agonists|mesh-ancestor
64984879|NCT00295555|Doxazosin|doxazosin|mesh-list
64984880|NCT00295555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64984881|NCT00295555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64984882|NCT00295555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64984883|NCT00295555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64984884|NCT00295555|Adrenergic Agents|adrenergic agents|mesh-ancestor
64984885|NCT00295555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64984897|NCT00121875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984899|NCT00295672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64984900|NCT00295672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984901|NCT00295672|Tubulin Modulators|tubulin modulators|mesh-ancestor
64984902|NCT00295672|Antimitotic Agents|antimitotic agents|mesh-ancestor
64984903|NCT00295672|Mitosis Modulators|mitosis modulators|mesh-ancestor
64442554|NCT01601132|Autonomic Agents|autonomic agents|mesh-ancestor
64984904|NCT00295672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550603|NCT00859833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64550604|NCT00859833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550605|NCT00859833|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64550606|NCT02154477|Insulin|insulin|mesh-list
64550607|NCT02154477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64550608|NCT02154477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550609|NCT00860379|Selenium|selenium|mesh-list
64550610|NCT00860379|Antioxidants|antioxidants|mesh-ancestor
64550611|NCT00860379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550612|NCT00860379|Protective Agents|protective agents|mesh-ancestor
64550613|NCT00860379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550614|NCT00860379|Trace Elements|trace elements|mesh-ancestor
64550615|NCT00860379|Micronutrients|micronutrients|mesh-ancestor
64550616|NCT00860457|Rituximab|rituximab|mesh-list
64550617|NCT00860457|Fludarabine|fludarabine|mesh-list
64550618|NCT00860457|Lenalidomide|lenalidomide|mesh-list
64984905|NCT00295789|Paclitaxel|paclitaxel|mesh-list
64984906|NCT00295789|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64984907|NCT00295789|Carboplatin|carboplatin|mesh-list
64984908|NCT00295789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64984909|NCT00295789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984910|NCT00295789|Tubulin Modulators|tubulin modulators|mesh-ancestor
64984911|NCT00295789|Antimitotic Agents|antimitotic agents|mesh-ancestor
64984912|NCT00295789|Mitosis Modulators|mitosis modulators|mesh-ancestor
64984913|NCT00295789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984914|NCT00089700|Ibalizumab|ibalizumab|mesh-list
64984915|NCT00089700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64984916|NCT00089700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64984917|NCT00089700|Antiviral Agents|antiviral agents|mesh-ancestor
64984918|NCT00089700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64984919|NCT04718584|Antibodies|antibodies|mesh-list
64984920|NCT04718584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64984921|NCT04718584|Immunologic Factors|immunologic factors|mesh-ancestor
64984922|NCT04718584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984923|NCT00417937|Azelaic acid|azelaic acid|mesh-list
64984924|NCT00417937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396249|NCT02382679|Micronutrients|micronutrients|mesh-ancestor
64396250|NCT02382679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396251|NCT00916747|Zoledronic Acid|zoledronic acid|mesh-list
64396253|NCT00916747|Lonafarnib|lonafarnib|mesh-list
64396254|NCT00916747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64984925|NCT00417937|Dermatologic Agents|dermatologic agents|mesh-ancestor
64984926|NCT00418054|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64984927|NCT00418054|Interferon-alpha|interferon-alpha|mesh-list
64984928|NCT00418054|Nitazoxanide|nitazoxanide|mesh-list
64984929|NCT00418054|Antiviral Agents|antiviral agents|mesh-ancestor
64984930|NCT00418054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64984931|NCT00418054|Immunologic Factors|immunologic factors|mesh-ancestor
64984932|NCT00418054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984933|NCT00418054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64984934|NCT00295945|Fentanyl|fentanyl|mesh-list
64984935|NCT00295945|Hydromorphone|hydromorphone|mesh-list
64984936|NCT00295945|Ropivacaine|ropivacaine|mesh-list
64984937|NCT00295945|Anesthetics, Local|anesthetics, local|mesh-ancestor
64984938|NCT00295945|Anesthetics|anesthetics|mesh-ancestor
64984939|NCT00295945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64984940|NCT00295945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984941|NCT00295945|Sensory System Agents|sensory system agents|mesh-ancestor
64984942|NCT00295945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64984943|NCT00295945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64984944|NCT00295945|Narcotics|narcotics|mesh-ancestor
64984945|NCT00295945|Analgesics|analgesics|mesh-ancestor
64984946|NCT00295945|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64984947|NCT00295945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64984948|NCT00295945|Anesthetics, General|anesthetics, general|mesh-ancestor
64984962|NCT00295984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64984963|NCT00295984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550619|NCT00860457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64550620|NCT00860457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550621|NCT00860457|Immunologic Factors|immunologic factors|mesh-ancestor
64550622|NCT00860457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550623|NCT00860457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64550624|NCT00860457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64550625|NCT00860457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64550626|NCT00860457|Growth Substances|growth substances|mesh-ancestor
64550627|NCT00860457|Growth Inhibitors|growth inhibitors|mesh-ancestor
64550629|NCT00827073|Tetracaine|tetracaine|mesh-list
64550630|NCT00827073|Anesthetics, Local|anesthetics, local|mesh-ancestor
64550631|NCT00827073|Anesthetics|anesthetics|mesh-ancestor
64550632|NCT00827073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64550633|NCT00827073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550634|NCT00827073|Sensory System Agents|sensory system agents|mesh-ancestor
64550635|NCT00827073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550636|NCT00827073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64550637|NCT00827073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64550638|NCT00827073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64984964|NCT00296023|Methotrexate|methotrexate|mesh-list
64984965|NCT00296023|Fludarabine phosphate|fludarabine phosphate|mesh-list
64984966|NCT00296023|Fludarabine|fludarabine|mesh-list
64984967|NCT00296023|Busulfan|busulfan|mesh-list
64984968|NCT00296023|Tacrolimus|tacrolimus|mesh-list
64984969|NCT00296023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64984970|NCT00296023|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64984971|NCT00296023|Abortifacient Agents|abortifacient agents|mesh-ancestor
64984972|NCT00296023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64984973|NCT00296023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984974|NCT00296023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64984975|NCT00296023|Antimetabolites|antimetabolites|mesh-ancestor
64984976|NCT00296023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984977|NCT00296023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984978|NCT00296023|Dermatologic Agents|dermatologic agents|mesh-ancestor
64984979|NCT00296023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785021|NCT00676026|Zolpidem|zolpidem|mesh-list
64785022|NCT00676026|Fluoxetine|fluoxetine|mesh-list
64984980|NCT00296023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64984981|NCT00296023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64984982|NCT00296023|Immunologic Factors|immunologic factors|mesh-ancestor
64984983|NCT00296023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64984984|NCT00296023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64984985|NCT00296023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64984986|NCT00296023|Alkylating Agents|alkylating agents|mesh-ancestor
64984987|NCT00296023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64984988|NCT00296023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64984989|NCT00121953|Rosiglitazone|rosiglitazone|mesh-list
64984990|NCT00121953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64984991|NCT00121953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984992|NCT00296062|Bevacizumab|bevacizumab|mesh-list
64984993|NCT00296062|Capecitabine|capecitabine|mesh-list
64984994|NCT00296062|Oxaliplatin|oxaliplatin|mesh-list
64984995|NCT00296062|Irinotecan|irinotecan|mesh-list
64984996|NCT00296062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64984997|NCT00296062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984998|NCT00296062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64550639|NCT00827073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64550640|NCT00827073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550642|NCT00860847|Coenzyme Q10|coenzyme q10|mesh-list
64550643|NCT00860847|Micronutrients|micronutrients|mesh-ancestor
64550644|NCT00860847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550645|NCT00860847|Vitamins|vitamins|mesh-ancestor
64550646|NCT04347733|Triamcinolone|triamcinolone|mesh-list
64550647|NCT04347733|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64550648|NCT04347733|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64550649|NCT04347733|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64550650|NCT04347733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64550651|NCT04347733|Glucocorticoids|glucocorticoids|mesh-ancestor
64550652|NCT04347733|Hormones|hormones|mesh-ancestor
64550653|NCT04347733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64550654|NCT04347733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550655|NCT04347733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64550656|NCT04347733|Immunologic Factors|immunologic factors|mesh-ancestor
64550657|NCT04347733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64550658|NCT04347733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550659|NCT02155101|Ritonavir|ritonavir|mesh-list
64550660|NCT02155101|Lopinavir|lopinavir|mesh-list
64550661|NCT02155101|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64984999|NCT00296062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64985000|NCT00296062|Growth Substances|growth substances|mesh-ancestor
64985001|NCT00296062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985002|NCT00296062|Growth Inhibitors|growth inhibitors|mesh-ancestor
64985003|NCT00296062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64985004|NCT00296062|Antimetabolites|antimetabolites|mesh-ancestor
64985005|NCT00296062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985006|NCT00296062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64985007|NCT00296062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64442726|NCT03740204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985008|NCT00296062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985009|NCT00296179|Zolpidem|zolpidem|mesh-list
64985010|NCT00296179|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64985011|NCT00296179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64985031|NCT00089856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64985032|NCT00089856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985033|NCT00089856|Tubulin Modulators|tubulin modulators|mesh-ancestor
64985034|NCT00089856|Antimitotic Agents|antimitotic agents|mesh-ancestor
64985035|NCT00089856|Mitosis Modulators|mitosis modulators|mesh-ancestor
64985036|NCT00089856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985037|NCT00296257|Rimacalib|rimacalib|mesh-list
64985038|NCT00296257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64985039|NCT00296257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985040|NCT00296257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985041|NCT00296530|Fluticasone|fluticasone|mesh-list
64985042|NCT00296530|Xhance|xhance|mesh-list
64985043|NCT00296530|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64985044|NCT00296530|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64985045|NCT00296530|Montelukast|montelukast|mesh-list
64985046|NCT00296530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64550662|NCT02155101|Darunavir|darunavir|mesh-list
64550663|NCT02155101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64550664|NCT02155101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64550665|NCT02155101|Protease Inhibitors|protease inhibitors|mesh-ancestor
64550666|NCT02155101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64550667|NCT02155101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550668|NCT02155101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64550669|NCT02155101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64550670|NCT02155101|Antiviral Agents|antiviral agents|mesh-ancestor
64550671|NCT02155101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64550672|NCT02155101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64550673|NCT02155101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64550674|NCT03245437|Oxytocin|oxytocin|mesh-list
64550675|NCT03245437|Oxytocics|oxytocics|mesh-ancestor
64550676|NCT03245437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64550677|NCT03245437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550678|NCT02155257|Gabapentin|gabapentin|mesh-list
64550679|NCT02155257|Modafinil|modafinil|mesh-list
64550680|NCT02155257|Analgesics|analgesics|mesh-ancestor
64315608|NCT05614622|Cyclopentolate|cyclopentolate|mesh-list
64985047|NCT00296530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64985048|NCT00296530|Autonomic Agents|autonomic agents|mesh-ancestor
64985049|NCT00296530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64985050|NCT00296530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985051|NCT00296530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64985052|NCT00296530|Respiratory System Agents|respiratory system agents|mesh-ancestor
64985053|NCT00296530|Dermatologic Agents|dermatologic agents|mesh-ancestor
64985054|NCT00296530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64985055|NCT00296530|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64985056|NCT00296530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64985057|NCT00296530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64985058|NCT00296530|Adrenergic Agents|adrenergic agents|mesh-ancestor
64985059|NCT00296530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64985060|NCT00296530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985061|NCT00296530|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64985062|NCT00296530|Hormone Antagonists|hormone antagonists|mesh-ancestor
64985063|NCT00296530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64985064|NCT00296530|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64985100|NCT00296608|Protective Agents|protective agents|mesh-ancestor
64985101|NCT00296608|Vitamin B Complex|vitamin b complex|mesh-ancestor
64985103|NCT00296608|Micronutrients|micronutrients|mesh-ancestor
64985104|NCT00296686|Tranylcypromine|tranylcypromine|mesh-list
64985105|NCT00296686|Dextroamphetamine|dextroamphetamine|mesh-list
64985106|NCT00296686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64985138|NCT00090090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64985139|NCT00090090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985140|NCT00296959|Topiramate|topiramate|mesh-list
64985141|NCT00296959|Anticonvulsants|anticonvulsants|mesh-ancestor
64985142|NCT00296959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64985143|NCT00296959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985144|NCT00297076|Aplaviroc|aplaviroc|mesh-list
64985145|NCT00297076|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64985146|NCT00297076|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64985164|NCT00297388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64985165|NCT00297388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64985166|NCT00297388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64550681|NCT02155257|Sensory System Agents|sensory system agents|mesh-ancestor
64550682|NCT02155257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550683|NCT02155257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315630|NCT02140073|Antiemetics|antiemetics|mesh-ancestor
64985167|NCT00297388|Dopamine Agents|dopamine agents|mesh-ancestor
64985169|NCT00297466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64985170|NCT00297466|Autonomic Agents|autonomic agents|mesh-ancestor
64985171|NCT00297466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64985172|NCT00297466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985173|NCT00297466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64985174|NCT00297466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64985175|NCT00297466|Cholinergic Agents|cholinergic agents|mesh-ancestor
64985176|NCT00297466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64985177|NCT00297466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985178|NCT00297505|Citalopram|citalopram|mesh-list
64985179|NCT00297505|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64985180|NCT00297505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64985181|NCT00297505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64985182|NCT00297505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985183|NCT00297505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64985184|NCT00297505|Serotonin Agents|serotonin agents|mesh-ancestor
64985185|NCT00297505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985186|NCT00297505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64985187|NCT00297505|Antidepressive Agents|antidepressive agents|mesh-ancestor
64985188|NCT00297505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64985189|NCT00297544|Sildenafil Citrate|sildenafil citrate|mesh-list
64985190|NCT00297544|Vasodilator Agents|vasodilator agents|mesh-ancestor
64985191|NCT00297544|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64985192|NCT00297544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64985193|NCT00297544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985194|NCT00297544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985195|NCT00297544|Urological Agents|urological agents|mesh-ancestor
64985196|NCT00297583|Insulin glulisine|insulin glulisine|mesh-list
64985197|NCT00297583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64985198|NCT00297583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985199|NCT00297661|Sirolimus|sirolimus|mesh-list
64985200|NCT00297661|Paclitaxel|paclitaxel|mesh-list
64985201|NCT00297661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64985202|NCT00297661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985235|NCT00297739|Serotonin Agents|serotonin agents|mesh-ancestor
64985236|NCT00297739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64985237|NCT00297739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985238|NCT00297739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985239|NCT00297739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64985240|NCT00297739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64985241|NCT00297739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64985242|NCT00297739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64985243|NCT00297739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64985244|NCT00297739|Dopamine Agents|dopamine agents|mesh-ancestor
64985245|NCT00090246|Ondansetron|ondansetron|mesh-list
64985246|NCT00090246|Aprepitant|aprepitant|mesh-list
64985247|NCT00090246|Antiemetics|antiemetics|mesh-ancestor
64985271|NCT00090324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64985272|NCT00090324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64985273|NCT00090324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985275|NCT05319353|Antiviral Agents|antiviral agents|mesh-ancestor
64985276|NCT05319353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64985277|NCT00122226|Ritonavir|ritonavir|mesh-list
64985278|NCT00122226|Lopinavir|lopinavir|mesh-list
64985279|NCT00122226|Lamivudine|lamivudine|mesh-list
64985280|NCT00122226|Zidovudine|zidovudine|mesh-list
64985281|NCT00122226|Nevirapine|nevirapine|mesh-list
64985282|NCT00122226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64985283|NCT00122226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64985284|NCT00122226|Protease Inhibitors|protease inhibitors|mesh-ancestor
64985285|NCT00122226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985286|NCT00122226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442909|NCT02158975|Ixazomib|ixazomib|mesh-list
64550685|NCT02155257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64550686|NCT02155257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64550687|NCT02155257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64550688|NCT02155257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64550689|NCT02155257|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64550690|NCT02155257|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64550691|NCT02155257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64550692|NCT02155257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550693|NCT02155257|Antimanic Agents|antimanic agents|mesh-ancestor
64550694|NCT02155257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64550695|NCT02155257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64550696|NCT02155257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64550697|NCT02155257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64550698|NCT03243019|Sirolimus|sirolimus|mesh-list
64550699|NCT03243019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64315634|NCT02140073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64985288|NCT00122226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64985289|NCT00122226|Antiviral Agents|antiviral agents|mesh-ancestor
64985290|NCT00122226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64985291|NCT00122226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64985292|NCT00122226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64985293|NCT00122226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64985294|NCT00122226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64985295|NCT00122226|Antimetabolites|antimetabolites|mesh-ancestor
64985296|NCT00122226|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64985297|NCT00122226|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64985298|NCT05200559|Pembrolizumab|pembrolizumab|mesh-list
64985323|NCT00298168|Antiviral Agents|antiviral agents|mesh-ancestor
64985324|NCT00298168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64985325|NCT00298168|Interferon Inducers|interferon inducers|mesh-ancestor
64985326|NCT00298168|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64985327|NCT00298168|Protective Agents|protective agents|mesh-ancestor
64985329|NCT00122304|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64985330|NCT00122304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64985331|NCT00122304|Immunologic Factors|immunologic factors|mesh-ancestor
64985332|NCT00122304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985333|NCT00322543|Pimecrolimus|pimecrolimus|mesh-list
64985334|NCT00322543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64985335|NCT00322543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64985336|NCT00322543|Analgesics|analgesics|mesh-ancestor
64985337|NCT00322543|Sensory System Agents|sensory system agents|mesh-ancestor
64985338|NCT00322543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64985339|NCT00322543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985340|NCT00322543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64985341|NCT00322543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64985342|NCT00322543|Dermatologic Agents|dermatologic agents|mesh-ancestor
64985343|NCT00322543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64985344|NCT00322543|Immunologic Factors|immunologic factors|mesh-ancestor
64985345|NCT00322543|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64985346|NCT00322543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985359|NCT00313963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985361|NCT00313963|Tocolytic Agents|tocolytic agents|mesh-ancestor
64985362|NCT00313963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64985363|NCT00122343|Sirolimus|sirolimus|mesh-list
64785100|NCT00577356|Docetaxel|docetaxel|mesh-list
64985364|NCT00122343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64985365|NCT00122343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64550700|NCT03243019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64550701|NCT03243019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64550702|NCT03243019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550703|NCT03243019|Antifungal Agents|antifungal agents|mesh-ancestor
64550704|NCT03243019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64550705|NCT03243019|Immunologic Factors|immunologic factors|mesh-ancestor
64550706|NCT03243019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550707|NCT04382625|Hydroxychloroquine|hydroxychloroquine|mesh-list
64985366|NCT00122343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64985367|NCT00122343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985368|NCT00122343|Antifungal Agents|antifungal agents|mesh-ancestor
64985369|NCT00122343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64442949|NCT04802408|Listerine|listerine|mesh-list
64985370|NCT00122343|Immunologic Factors|immunologic factors|mesh-ancestor
64985371|NCT00122343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985372|NCT00314080|Antitoxins|antitoxins|mesh-list
64985373|NCT00314080|Botulinum Antitoxin|botulinum antitoxin|mesh-list
64985374|NCT00314080|Immunologic Factors|immunologic factors|mesh-ancestor
64985375|NCT00314080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985376|NCT00314158|Timolol|timolol|mesh-list
64985377|NCT00314158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64985378|NCT00314158|Brinzolamide|brinzolamide|mesh-list
64985379|NCT00314158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64985380|NCT00314158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64985381|NCT00314158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64985382|NCT00314158|Adrenergic Agents|adrenergic agents|mesh-ancestor
64985383|NCT00314158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64985384|NCT00314158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985385|NCT00314158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985386|NCT00314158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64985387|NCT00314158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64985388|NCT00314158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64985389|NCT00314158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985390|NCT00090480|Vaccines|vaccines|mesh-list
64985391|NCT00090480|Immunologic Factors|immunologic factors|mesh-ancestor
64985392|NCT00090480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985393|NCT00322660|Epinephrine|epinephrine|mesh-list
64985394|NCT00322660|Racepinephrine|racepinephrine|mesh-list
64985395|NCT00322660|Epinephryl borate|epinephryl borate|mesh-list
64985396|NCT00322660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64985397|NCT00322660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64985398|NCT00322660|Adrenergic Agents|adrenergic agents|mesh-ancestor
64985399|NCT00322660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64985400|NCT00322660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985401|NCT00322660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985402|NCT00322660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64985403|NCT00322660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64985404|NCT00322660|Autonomic Agents|autonomic agents|mesh-ancestor
64985405|NCT00322660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64985431|NCT00323011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64985432|NCT00323011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64985433|NCT00323011|Growth Substances|growth substances|mesh-ancestor
64985434|NCT00323011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985435|NCT00323011|Growth Inhibitors|growth inhibitors|mesh-ancestor
64985436|NCT00323011|Antimetabolites|antimetabolites|mesh-ancestor
64985437|NCT00323011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985438|NCT00323011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64985439|NCT00323011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64985440|NCT00323011|Immunologic Factors|immunologic factors|mesh-ancestor
64985441|NCT00323011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64985442|NCT00323011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64985443|NCT00323011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985444|NCT00323011|Antidotes|antidotes|mesh-ancestor
64985445|NCT00323011|Protective Agents|protective agents|mesh-ancestor
64985446|NCT00323011|Vitamin B Complex|vitamin b complex|mesh-ancestor
64985447|NCT00323011|Vitamins|vitamins|mesh-ancestor
64985448|NCT00323011|Micronutrients|micronutrients|mesh-ancestor
64550708|NCT04382625|Antimalarials|antimalarials|mesh-ancestor
64550709|NCT04382625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64550710|NCT04382625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64550711|NCT04382625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64985449|NCT00323011|Hematinics|hematinics|mesh-ancestor
64985450|NCT00323011|Anticoagulants|anticoagulants|mesh-ancestor
64985451|NCT00323011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64985452|NCT00323011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64985453|NCT00323206|Interleukin-12|interleukin-12|mesh-list
64985454|NCT00323206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64985455|NCT00323206|Immunologic Factors|immunologic factors|mesh-ancestor
64985456|NCT00323206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985457|NCT00323206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64985458|NCT00323206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64985460|NCT00323206|Growth Inhibitors|growth inhibitors|mesh-ancestor
64985479|NCT04717531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64985480|NCT04717531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64985481|NCT04717531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64985482|NCT04717531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64985483|NCT04717531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985485|NCT00323323|Cyclophosphamide|cyclophosphamide|mesh-list
64985486|NCT00323323|Doxorubicin|doxorubicin|mesh-list
64985487|NCT00323323|Vincristine|vincristine|mesh-list
64985488|NCT00323323|Alemtuzumab|alemtuzumab|mesh-list
64985489|NCT00323323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64985490|NCT00323323|Immunologic Factors|immunologic factors|mesh-ancestor
64985491|NCT00323323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985492|NCT00323323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64985493|NCT00323323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64985494|NCT00323323|Alkylating Agents|alkylating agents|mesh-ancestor
64985495|NCT00323323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985496|NCT00323323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985497|NCT00323323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64785128|NCT05164614|Teriparatide|teriparatide|mesh-list
64985498|NCT00323323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64985499|NCT00323323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64985500|NCT00323323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64985501|NCT00323323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985502|NCT00323323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64985503|NCT00323323|Glucocorticoids|glucocorticoids|mesh-ancestor
64985504|NCT00323323|Hormones|hormones|mesh-ancestor
64985505|NCT00323323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64985506|NCT00323323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64985507|NCT00323323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64985508|NCT00323323|Tubulin Modulators|tubulin modulators|mesh-ancestor
64985509|NCT00323323|Antimitotic Agents|antimitotic agents|mesh-ancestor
64985510|NCT00323323|Mitosis Modulators|mitosis modulators|mesh-ancestor
64985511|NCT00323323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64985512|NCT00122499|Tadalafil|tadalafil|mesh-list
64985513|NCT00122499|Vasodilator Agents|vasodilator agents|mesh-ancestor
64985514|NCT00122499|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64985515|NCT00122499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64985516|NCT00122499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985517|NCT00122499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985536|NCT00312598|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64985537|NCT00312754|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64985538|NCT00312754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64985539|NCT00312754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64985540|NCT00312754|Protease Inhibitors|protease inhibitors|mesh-ancestor
64985541|NCT00312754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985542|NCT00312754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985543|NCT00312754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64985544|NCT00312754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64985545|NCT00312754|Antiviral Agents|antiviral agents|mesh-ancestor
64985546|NCT00312754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64985547|NCT00312871|Epoetin Alfa|epoetin alfa|mesh-list
64985548|NCT00312871|Hematinics|hematinics|mesh-ancestor
64985549|NCT00090675|Gefitinib|gefitinib|mesh-list
64985550|NCT00090675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985551|NCT00090675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64550712|NCT04382625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64550713|NCT04382625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550714|NCT04382625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64550715|NCT01673646|Pasireotide|pasireotide|mesh-list
64550716|NCT01673646|Hormones|hormones|mesh-ancestor
64550717|NCT01673646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64550718|NCT01673646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550719|NCT05296837|Doxycycline|doxycycline|mesh-list
64985552|NCT00090675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985553|NCT00090675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785153|NCT04954638|Eusol|eusol|mesh-list
64985554|NCT00312988|Gemcitabine|gemcitabine|mesh-list
64985555|NCT00312988|Topotecan|topotecan|mesh-list
64985556|NCT00312988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64985557|NCT00312988|Antimetabolites|antimetabolites|mesh-ancestor
64985558|NCT00312988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985559|NCT00312988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985560|NCT00312988|Antiviral Agents|antiviral agents|mesh-ancestor
64985561|NCT00312988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64443084|NCT04786964|Hematinics|hematinics|mesh-ancestor
64985562|NCT00312988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985563|NCT00312988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64985564|NCT00312988|Immunologic Factors|immunologic factors|mesh-ancestor
64985565|NCT00312988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985566|NCT00312988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64985567|NCT00312988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64985568|NCT00122538|Lamivudine|lamivudine|mesh-list
64985569|NCT00122538|Efavirenz|efavirenz|mesh-list
64985570|NCT00122538|Didanosine|didanosine|mesh-list
64985571|NCT00122538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64985572|NCT00122538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64985573|NCT00122538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985604|NCT00122577|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64985606|NCT00122577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985607|NCT00122577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985608|NCT00122577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64985609|NCT00122577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64985610|NCT00122577|Antiviral Agents|antiviral agents|mesh-ancestor
64985611|NCT00122577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64985612|NCT00122577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64985613|NCT00122577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64985614|NCT00122577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64985638|NCT00425074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64985639|NCT00425074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64985640|NCT00425074|Antipyretics|antipyretics|mesh-ancestor
64985641|NCT00425152|Leucovorin|leucovorin|mesh-list
64985642|NCT00425152|Levamisole|levamisole|mesh-list
64985643|NCT00425152|Fluorouracil|fluorouracil|mesh-list
64985644|NCT00425152|Calcium|calcium|mesh-list
64985645|NCT00425152|Levoleucovorin|levoleucovorin|mesh-list
64985646|NCT00425152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64985647|NCT00425152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985648|NCT00425152|Antimetabolites|antimetabolites|mesh-ancestor
64985649|NCT00425152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985650|NCT00425152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64985651|NCT00425152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985652|NCT00425152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64985653|NCT00425152|Immunologic Factors|immunologic factors|mesh-ancestor
64985654|NCT00425152|Antidotes|antidotes|mesh-ancestor
64985655|NCT00425152|Protective Agents|protective agents|mesh-ancestor
64985656|NCT00425152|Vitamin B Complex|vitamin b complex|mesh-ancestor
64985657|NCT00425152|Vitamins|vitamins|mesh-ancestor
64985658|NCT00425152|Micronutrients|micronutrients|mesh-ancestor
64985659|NCT00425152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64985660|NCT00425152|Antinematodal Agents|antinematodal agents|mesh-ancestor
64985661|NCT00425152|Anthelmintics|anthelmintics|mesh-ancestor
64985662|NCT00425152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64985663|NCT00425152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64550720|NCT05296837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64550721|NCT05296837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64550722|NCT05296837|Antimalarials|antimalarials|mesh-ancestor
64550723|NCT05296837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64550724|NCT05296837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64550725|NCT02647944|Liraglutide|liraglutide|mesh-list
64550726|NCT02647944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64550727|NCT02647944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550728|NCT02647944|Incretins|incretins|mesh-ancestor
64550729|NCT02647944|Hormones|hormones|mesh-ancestor
64550730|NCT02647944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64550731|NCT00862563|Topiramate|topiramate|mesh-list
64550732|NCT00862563|Zonisamide|zonisamide|mesh-list
64396380|NCT02380417|Anesthetics, Local|anesthetics, local|mesh-ancestor
64396381|NCT02380417|Anesthetics|anesthetics|mesh-ancestor
64396382|NCT02380417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64396386|NCT02390089|Capsaicin|capsaicin|mesh-list
64550733|NCT00862563|Levetiracetam|levetiracetam|mesh-list
64550734|NCT00862563|Anticonvulsants|anticonvulsants|mesh-ancestor
64550735|NCT00862563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64550736|NCT00862563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550737|NCT00862563|Nootropic Agents|nootropic agents|mesh-ancestor
64550738|NCT00862563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64550739|NCT00862563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64985664|NCT00425152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64985665|NCT00314314|Insulin|insulin|mesh-list
64985666|NCT00314314|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64985667|NCT00314314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985668|NCT00122616|Ribavirin|ribavirin|mesh-list
64985669|NCT00122616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64985696|NCT00314509|Ciclesonide|ciclesonide|mesh-list
64985697|NCT00314509|Formoterol Fumarate|formoterol fumarate|mesh-list
64985698|NCT00314509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64985699|NCT00314509|Autonomic Agents|autonomic agents|mesh-ancestor
64985700|NCT00314509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64985701|NCT00314509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985702|NCT00314509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64985703|NCT00314509|Respiratory System Agents|respiratory system agents|mesh-ancestor
64985704|NCT00314509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64985705|NCT00314509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64985706|NCT00314509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64985707|NCT00314509|Adrenergic Agents|adrenergic agents|mesh-ancestor
64985708|NCT00314509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64985709|NCT00314509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985710|NCT00314509|Glucocorticoids|glucocorticoids|mesh-ancestor
64985711|NCT00314509|Hormones|hormones|mesh-ancestor
64550740|NCT00862563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550741|NCT00862563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64550743|NCT04399525|Loratadine|loratadine|mesh-list
64550744|NCT04399525|Levocetirizine|levocetirizine|mesh-list
64550745|NCT04399525|Desloratadine|desloratadine|mesh-list
64550746|NCT04399525|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64552680|NCT04007393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64785183|NCT03472872|Ketorolac|ketorolac|mesh-list
64785184|NCT03472872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64785185|NCT03472872|Analgesics|analgesics|mesh-ancestor
64985712|NCT00314509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64985713|NCT00314509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64985714|NCT00314548|Epoprostenol|epoprostenol|mesh-list
64985715|NCT00314548|Alprostadil|alprostadil|mesh-list
64985739|NCT00314665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64985740|NCT00314665|Immunologic Factors|immunologic factors|mesh-ancestor
64985741|NCT00314665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985742|NCT00314665|Leprostatic Agents|leprostatic agents|mesh-ancestor
64985743|NCT00314665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64985744|NCT00314665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64985745|NCT00314665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64985746|NCT00314665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64985747|NCT00314665|Growth Substances|growth substances|mesh-ancestor
64985748|NCT00314665|Growth Inhibitors|growth inhibitors|mesh-ancestor
64985749|NCT00314665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985750|NCT00314704|Dopamine|dopamine|mesh-list
64985751|NCT00314704|Norepinephrine|norepinephrine|mesh-list
64985752|NCT00314704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64985753|NCT00314704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64985754|NCT00314704|Adrenergic Agents|adrenergic agents|mesh-ancestor
64985755|NCT00314704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64985756|NCT00314704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985757|NCT00314704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985758|NCT00314704|Sympathomimetics|sympathomimetics|mesh-ancestor
64985759|NCT00314704|Autonomic Agents|autonomic agents|mesh-ancestor
64985760|NCT00314704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64985761|NCT00314704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64985762|NCT00314704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64985763|NCT00314704|Dopamine Agents|dopamine agents|mesh-ancestor
64985764|NCT00314704|Protective Agents|protective agents|mesh-ancestor
64985765|NCT00090909|Gemcitabine|gemcitabine|mesh-list
64985766|NCT00090909|Dexamethasone|dexamethasone|mesh-list
64985793|NCT04943627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985794|NCT04943627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985796|NCT04943627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64985797|NCT04943627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985798|NCT04943627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64985799|NCT04943627|Immunologic Factors|immunologic factors|mesh-ancestor
64985800|NCT04943627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985801|NCT04943627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64985802|NCT04943627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64985803|NCT04943627|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64785192|NCT03472872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64396407|NCT01975246|Natriuretic Agents|natriuretic agents|mesh-ancestor
64985804|NCT04943627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64985805|NCT04943627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64985806|NCT04943627|Tubulin Modulators|tubulin modulators|mesh-ancestor
64985807|NCT04943627|Antimitotic Agents|antimitotic agents|mesh-ancestor
64985808|NCT04943627|Mitosis Modulators|mitosis modulators|mesh-ancestor
64985809|NCT00314743|Dexamethasone|dexamethasone|mesh-list
64985810|NCT00314743|Ondansetron|ondansetron|mesh-list
64985811|NCT00314743|Aprepitant|aprepitant|mesh-list
64985812|NCT00314743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64985813|NCT00314743|Antiemetics|antiemetics|mesh-ancestor
64985814|NCT00314743|Autonomic Agents|autonomic agents|mesh-ancestor
64985815|NCT00314743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64985816|NCT00314743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985841|NCT00122655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
64985842|NCT00122655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
64985843|NCT00122655|Protease Inhibitors|protease inhibitors|mesh-list
64985844|NCT00122655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64985845|NCT00122655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985846|NCT00122655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985847|NCT00122655|Antiviral Agents|antiviral agents|mesh-ancestor
64550747|NCT04399525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64550748|NCT04399525|Histamine Antagonists|histamine antagonists|mesh-ancestor
64550749|NCT04399525|Histamine Agents|histamine agents|mesh-ancestor
64550750|NCT04399525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64550751|NCT04399525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550752|NCT04399525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985848|NCT00122655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64985849|NCT00122655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64985850|NCT00122655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64985851|NCT00122655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64985853|NCT00314821|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64985854|NCT00314821|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64985855|NCT00314821|Dopamine Agonists|dopamine agonists|mesh-ancestor
64985856|NCT00314821|Dopamine Agents|dopamine agents|mesh-ancestor
64985857|NCT00314821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64985858|NCT00314821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985859|NCT00314821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985860|NCT00314860|Ropinirole|ropinirole|mesh-list
64985861|NCT00314860|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64985862|NCT00314860|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64985879|NCT00091104|Freund's Adjuvant|freund's adjuvant|mesh-list
64985880|NCT00091104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64985881|NCT00091104|Immunologic Factors|immunologic factors|mesh-ancestor
64985882|NCT00091104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985883|NCT00091104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64985884|NCT00091104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64985885|NCT00091104|Alkylating Agents|alkylating agents|mesh-ancestor
64985886|NCT00091104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985887|NCT00091104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985888|NCT00091104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64985889|NCT00091104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64985890|NCT00091104|Antimetabolites|antimetabolites|mesh-ancestor
64985891|NCT00091104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64985892|NCT00091104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64985893|NCT00091104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64985894|NCT00091104|Antiviral Agents|antiviral agents|mesh-ancestor
64985895|NCT00091104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64985896|NCT00122694|Carbon Monoxide|carbon monoxide|mesh-list
64985897|NCT00122694|Antimetabolites|antimetabolites|mesh-ancestor
64985898|NCT00122694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985899|NCT00122694|Gasotransmitters|gasotransmitters|mesh-ancestor
64985900|NCT00122694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64985901|NCT00122694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985902|NCT00313456|Satraplatin|satraplatin|mesh-list
64985903|NCT00313456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985904|NCT00313534|Masoprocol|masoprocol|mesh-list
64985905|NCT00313534|Antioxidants|antioxidants|mesh-ancestor
64985906|NCT00313534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985907|NCT00313534|Protective Agents|protective agents|mesh-ancestor
64443265|NCT02187055|Antimetabolites|antimetabolites|mesh-ancestor
64985908|NCT00313534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985909|NCT00313534|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64985910|NCT00313534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985911|NCT00313534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64985912|NCT00313534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64985913|NCT00313534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64985914|NCT00313534|Analgesics|analgesics|mesh-ancestor
64985915|NCT00313534|Sensory System Agents|sensory system agents|mesh-ancestor
64985916|NCT00313534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64985917|NCT00313534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64985918|NCT00313534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64985921|NCT00313690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985922|NCT00313690|Tubulin Modulators|tubulin modulators|mesh-ancestor
64985956|NCT00122733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64985957|NCT00122733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985958|NCT00122733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64985959|NCT00122733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64550753|NCT04399525|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64550754|NCT04399525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64550755|NCT04399525|Cholinergic Agents|cholinergic agents|mesh-ancestor
64550756|NCT04399525|Antipruritics|antipruritics|mesh-ancestor
64550757|NCT04399525|Dermatologic Agents|dermatologic agents|mesh-ancestor
64550758|NCT04278937|Azithromycin|azithromycin|mesh-list
64550759|NCT04278937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64714178|NCT02988050|Dexmedetomidine|dexmedetomidine|mesh-list
64550760|NCT04278937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64550761|NCT04278469|Antineoplastic Agents|antineoplastic agents|mesh-list
64550763|NCT04278547|Antiviral Agents|antiviral agents|mesh-ancestor
64985960|NCT00122733|Dopamine Agents|dopamine agents|mesh-ancestor
64985961|NCT00122733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64985962|NCT00122733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985963|NCT04432012|Dexamethasone|dexamethasone|mesh-list
64985991|NCT00122811|Perindopril|perindopril|mesh-list
64985992|NCT00122811|Indapamide|indapamide|mesh-list
64985993|NCT00122811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64985994|NCT00122811|Protease Inhibitors|protease inhibitors|mesh-ancestor
64985995|NCT00122811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985996|NCT00122811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985997|NCT00122811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64985998|NCT00122811|Diuretics|diuretics|mesh-ancestor
64985999|NCT00122811|Natriuretic Agents|natriuretic agents|mesh-ancestor
64986000|NCT00122811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986001|NCT00122811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64986002|NCT00122811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64986003|NCT04551170|Theophylline|theophylline|mesh-list
64986004|NCT04551170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64986005|NCT04551170|Autonomic Agents|autonomic agents|mesh-ancestor
64986006|NCT04551170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64986007|NCT04551170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986008|NCT04551170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64986009|NCT04551170|Respiratory System Agents|respiratory system agents|mesh-ancestor
64986010|NCT04551170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64986011|NCT04551170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986012|NCT04551170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986040|NCT04542278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986041|NCT03975439|Chrysarobin|chrysarobin|mesh-list
64986042|NCT03975439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64308993|NCT02150317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64308994|NCT02150317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308995|NCT02150317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64308997|NCT02310568|GABA Modulators|gaba modulators|mesh-ancestor
64986043|NCT03975439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64986044|NCT03975439|Analgesics|analgesics|mesh-ancestor
64986045|NCT03975439|Sensory System Agents|sensory system agents|mesh-ancestor
64986046|NCT03975439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64986047|NCT03975439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986048|NCT03975439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64986049|NCT03975439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64986050|NCT00091377|Paclitaxel|paclitaxel|mesh-list
64986051|NCT00091377|Cisplatin|cisplatin|mesh-list
64986052|NCT00091377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64986053|NCT00091377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986054|NCT00091377|Tubulin Modulators|tubulin modulators|mesh-ancestor
64986055|NCT00091377|Antimitotic Agents|antimitotic agents|mesh-ancestor
64986056|NCT00091377|Mitosis Modulators|mitosis modulators|mesh-ancestor
64986094|NCT03878524|Sunitinib|sunitinib|mesh-list
64443322|NCT02246582|Insulin|insulin|mesh-list
64986095|NCT03878524|Daunorubicin|daunorubicin|mesh-list
64986096|NCT03878524|Venetoclax|venetoclax|mesh-list
64986097|NCT03878524|Dasatinib|dasatinib|mesh-list
64986098|NCT03878524|Lenvatinib|lenvatinib|mesh-list
64986099|NCT03878524|Olaparib|olaparib|mesh-list
64986100|NCT03878524|Palbociclib|palbociclib|mesh-list
64986101|NCT03878524|Pertuzumab|pertuzumab|mesh-list
64986102|NCT03878524|Vorinostat|vorinostat|mesh-list
64986103|NCT03878524|Trametinib|trametinib|mesh-list
64986132|NCT03878524|Growth Substances|growth substances|mesh-ancestor
64986133|NCT03878524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986134|NCT03878524|Growth Inhibitors|growth inhibitors|mesh-ancestor
64550765|NCT05430438|Dialysis Solutions|dialysis solutions|mesh-list
64550766|NCT05430438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64550767|NCT05261269|Niraparib|niraparib|mesh-list
64550768|NCT05261269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64550769|NCT05261269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64550770|NCT05261269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550771|NCT05261269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550772|NCT00863109|Ribavirin|ribavirin|mesh-list
64986135|NCT03878524|Micronutrients|micronutrients|mesh-ancestor
64986136|NCT03878524|Immunologic Factors|immunologic factors|mesh-ancestor
64986137|NCT03878524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64986138|NCT03878524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64986139|NCT03878524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64986140|NCT03878524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986141|NCT03878524|Antimetabolites|antimetabolites|mesh-ancestor
64986142|NCT03878524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64986143|NCT03878524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64986144|NCT03878524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64986146|NCT03878524|Protective Agents|protective agents|mesh-ancestor
64986147|NCT03878524|Vitamin B Complex|vitamin b complex|mesh-ancestor
64986148|NCT03878524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64986149|NCT03878524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64986150|NCT03878524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64986170|NCT03878524|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64986171|NCT03878524|Androgen Antagonists|androgen antagonists|mesh-ancestor
64986172|NCT03878524|Hormone Antagonists|hormone antagonists|mesh-ancestor
64986173|NCT03878524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64986174|NCT03878524|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64986175|NCT00122889|Allicin|allicin|mesh-list
64986176|NCT00122889|Allyl sulfide|allyl sulfide|mesh-list
64986177|NCT00122889|Antioxidants|antioxidants|mesh-ancestor
64986178|NCT00122889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986179|NCT00122889|Protective Agents|protective agents|mesh-ancestor
64986180|NCT00122889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986181|NCT00122889|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64309067|NCT02447835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309068|NCT02447835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64309069|NCT02447835|Serotonin Agents|serotonin agents|mesh-ancestor
64309071|NCT02447679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64309072|NCT02447679|Antimetabolites|antimetabolites|mesh-ancestor
64309073|NCT02447679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309075|NCT03203967|Morphine|morphine|mesh-list
64986182|NCT00122889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986183|NCT00122889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64986184|NCT00122889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986185|NCT00122889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64986186|NCT00122889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64986187|NCT00122889|Antimetabolites|antimetabolites|mesh-ancestor
64986188|NCT00122889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64986189|NCT00122889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64986190|NCT00122889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64986191|NCT04729868|Dexmedetomidine|dexmedetomidine|mesh-list
64986192|NCT04729868|Bupivacaine|bupivacaine|mesh-list
64986193|NCT04729868|Levobupivacaine|levobupivacaine|mesh-list
64986194|NCT04729868|Anesthetics, Local|anesthetics, local|mesh-ancestor
64986195|NCT04729868|Anesthetics|anesthetics|mesh-ancestor
64986196|NCT04729868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64986197|NCT04729868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986198|NCT04729868|Sensory System Agents|sensory system agents|mesh-ancestor
64986199|NCT04729868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64986200|NCT04729868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64986201|NCT04729868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64986202|NCT04729868|Analgesics|analgesics|mesh-ancestor
64986203|NCT04729868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64986204|NCT04729868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64986233|NCT03690544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64986234|NCT03690544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986235|NCT03690544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64986236|NCT03690544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64443371|NCT02186821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64986237|NCT03690544|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64550773|NCT00863109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64550774|NCT00863109|Antimetabolites|antimetabolites|mesh-ancestor
64550775|NCT00863109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550776|NCT00863109|Antiviral Agents|antiviral agents|mesh-ancestor
64550777|NCT00863109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64550778|NCT03238807|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64550779|NCT03238807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64315731|NCT05035862|Albuterol|albuterol|mesh-list
64986238|NCT03690544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64986239|NCT03690544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986240|NCT03690544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986241|NCT00314977|Cyclophosphamide|cyclophosphamide|mesh-list
64986242|NCT00314977|Docetaxel|docetaxel|mesh-list
64986243|NCT00314977|Doxorubicin|doxorubicin|mesh-list
64986244|NCT00314977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64986245|NCT00314977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64986246|NCT00314977|Immunologic Factors|immunologic factors|mesh-ancestor
64986247|NCT00314977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986248|NCT00314977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64986249|NCT00314977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64986280|NCT00419068|Micronutrients|micronutrients|mesh-ancestor
64986281|NCT00419068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64986282|NCT00419146|Vitamins|vitamins|mesh-list
64986283|NCT00419146|Vitamin E|vitamin e|mesh-list
64986284|NCT00419146|Tocopherols|tocopherols|mesh-list
64986285|NCT00419146|Tocotrienols|tocotrienols|mesh-list
64986286|NCT00419146|alpha-Tocopherol|alpha-tocopherol|mesh-list
64986287|NCT00419146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
64986288|NCT00419146|Micronutrients|micronutrients|mesh-ancestor
64986289|NCT00419146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986290|NCT00419146|Antioxidants|antioxidants|mesh-ancestor
64986291|NCT00419146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986313|NCT00091611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64986314|NCT00091611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64986315|NCT00091611|Alkylating Agents|alkylating agents|mesh-ancestor
64986316|NCT00091611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324513|NCT02268487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324514|NCT02265289|Clopidogrel|clopidogrel|mesh-list
64324515|NCT02265289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64324516|NCT02265289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64986317|NCT00091611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986318|NCT00091611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64986319|NCT00091611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64986320|NCT00091611|Analgesics|analgesics|mesh-ancestor
64986321|NCT00091611|Sensory System Agents|sensory system agents|mesh-ancestor
64986322|NCT00091611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64986323|NCT00123201|Dronabinol|dronabinol|mesh-list
64986324|NCT00123201|Hallucinogens|hallucinogens|mesh-ancestor
64986325|NCT00123201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986326|NCT00123201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64986327|NCT00123201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64986328|NCT00123201|Analgesics|analgesics|mesh-ancestor
64986329|NCT00123201|Sensory System Agents|sensory system agents|mesh-ancestor
64986330|NCT00123201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64986331|NCT00123201|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64986332|NCT00123201|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64986333|NCT00123201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64986334|NCT00123201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986335|NCT00123201|Hormones|hormones|mesh-ancestor
64986336|NCT00123201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64986337|NCT03031483|Clarithromycin|clarithromycin|mesh-list
64986338|NCT03031483|Lenalidomide|lenalidomide|mesh-list
64986339|NCT03031483|Immunologic Factors|immunologic factors|mesh-ancestor
64986340|NCT03031483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986341|NCT03031483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64986342|NCT03031483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64986343|NCT03031483|Growth Substances|growth substances|mesh-ancestor
64986344|NCT03031483|Growth Inhibitors|growth inhibitors|mesh-ancestor
64986345|NCT03031483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550780|NCT03238807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550781|NCT05246371|Dexmedetomidine|dexmedetomidine|mesh-list
64550782|NCT05246371|Propofol|propofol|mesh-list
64550783|NCT05246371|Desflurane|desflurane|mesh-list
64550784|NCT05246371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64443457|NCT01907217|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64550785|NCT05246371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64550786|NCT05246371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550788|NCT05246371|Anesthetics, General|anesthetics, general|mesh-ancestor
64550789|NCT05246371|Anesthetics|anesthetics|mesh-ancestor
64550790|NCT05246371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64550791|NCT05246371|Analgesics|analgesics|mesh-ancestor
64550792|NCT05246371|Sensory System Agents|sensory system agents|mesh-ancestor
64550793|NCT05246371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550794|NCT05246371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64550795|NCT05246371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64315738|NCT05035862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315739|NCT05035862|Antiviral Agents|antiviral agents|mesh-ancestor
64986377|NCT01808599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64986378|NCT01808599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986379|NCT01808599|Immunologic Factors|immunologic factors|mesh-ancestor
64986380|NCT01808599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986381|NCT01808599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64986382|NCT01808599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64986383|NCT01808599|Alkylating Agents|alkylating agents|mesh-ancestor
64552681|NCT04007393|Appetite Depressants|appetite depressants|mesh-ancestor
64324519|NCT02265289|Purinergic Agents|purinergic agents|mesh-ancestor
64396439|NCT02389231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396440|NCT02389231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64396442|NCT02389231|Sensory System Agents|sensory system agents|mesh-ancestor
64396443|NCT02389231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64309256|NCT03197571|Cyclophosphamide|cyclophosphamide|mesh-list
64309257|NCT03197571|Bevacizumab|bevacizumab|mesh-list
64309258|NCT03197571|Fluorouracil|fluorouracil|mesh-list
64309259|NCT03197571|Capecitabine|capecitabine|mesh-list
64309260|NCT03197571|Fulvestrant|fulvestrant|mesh-list
64986384|NCT01808599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986411|NCT00123279|Plasminogen|plasminogen|mesh-list
64986412|NCT00123279|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64986413|NCT00123279|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64986414|NCT00123279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986415|NCT00091806|Panitumumab|panitumumab|mesh-list
64986416|NCT00091806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64986417|NCT00091806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986418|NCT00123318|Cisplatin|cisplatin|mesh-list
64986419|NCT00123318|Fluorouracil|fluorouracil|mesh-list
64986420|NCT00123318|Epirubicin|epirubicin|mesh-list
64986421|NCT00123318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986422|NCT00123318|Antimetabolites|antimetabolites|mesh-ancestor
64986423|NCT00123318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986424|NCT00123318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64986425|NCT00123318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64986426|NCT00123318|Immunologic Factors|immunologic factors|mesh-ancestor
64986427|NCT00123318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986428|NCT00123318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64986429|NCT00123318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64986430|NCT00123318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64986490|NCT00092001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986491|NCT00092001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64986492|NCT00092001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64986493|NCT00092001|Growth Substances|growth substances|mesh-ancestor
64986494|NCT00092001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986495|NCT00092001|Growth Inhibitors|growth inhibitors|mesh-ancestor
64986496|NCT00092001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64986497|NCT00092001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64550796|NCT05246371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64550797|NCT05246371|Adrenergic Agents|adrenergic agents|mesh-ancestor
64550798|NCT05246371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64550799|NCT05246371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550800|NCT05246371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64396450|NCT02383771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64396451|NCT02383771|Analgesics|analgesics|mesh-ancestor
64396452|NCT02383771|Sensory System Agents|sensory system agents|mesh-ancestor
64396453|NCT02383771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785239|NCT00548886|Epinephrine|epinephrine|mesh-list
64785240|NCT00548886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64550801|NCT00863265|Ezetimibe|ezetimibe|mesh-list
64550802|NCT00863265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64550803|NCT00863265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64550804|NCT00863265|Antimetabolites|antimetabolites|mesh-ancestor
64550805|NCT00863265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315753|NCT05035862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315754|NCT03549221|Ketorolac|ketorolac|mesh-list
64986498|NCT00092001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986499|NCT03883919|Vitamin D|vitamin d|mesh-list
64986500|NCT03883919|Leucovorin|leucovorin|mesh-list
64986501|NCT03883919|Fluorouracil|fluorouracil|mesh-list
64986502|NCT03883919|Irinotecan|irinotecan|mesh-list
64986503|NCT03883919|Vitamins|vitamins|mesh-ancestor
64986504|NCT03883919|Micronutrients|micronutrients|mesh-ancestor
64986505|NCT03883919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986506|NCT03883919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64986507|NCT03883919|Antimetabolites|antimetabolites|mesh-ancestor
64986508|NCT03883919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986509|NCT03883919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64986510|NCT03883919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986511|NCT03883919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64986512|NCT03883919|Immunologic Factors|immunologic factors|mesh-ancestor
64986513|NCT03883919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64986514|NCT03883919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64986515|NCT03883919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986516|NCT03883919|Antidotes|antidotes|mesh-ancestor
64986554|NCT00315211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986555|NCT00315211|Tubulin Modulators|tubulin modulators|mesh-ancestor
64986556|NCT00315211|Antimitotic Agents|antimitotic agents|mesh-ancestor
64986557|NCT00315211|Mitosis Modulators|mitosis modulators|mesh-ancestor
64986586|NCT00092196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64396474|NCT02378623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396475|NCT02378623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396476|NCT02378623|Anticoagulants|anticoagulants|mesh-ancestor
64396477|NCT02372149|Immunoglobulins|immunoglobulins|mesh-list
64396478|NCT02372149|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64396480|NCT02372149|gamma-Globulins|gamma-globulins|mesh-list
64396481|NCT02372149|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64396482|NCT02372149|Immunologic Factors|immunologic factors|mesh-ancestor
64309413|NCT02446431|GABA Agents|gaba agents|mesh-ancestor
64986587|NCT00092196|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64986588|NCT00092196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64986589|NCT00092196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986590|NCT00315601|Azithromycin|azithromycin|mesh-list
64986591|NCT00315601|Telithromycin|telithromycin|mesh-list
64986592|NCT00315601|Dimercaprol|dimercaprol|mesh-list
64986593|NCT00315601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64986594|NCT00315601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64986595|NCT00315601|Chelating Agents|chelating agents|mesh-ancestor
64986596|NCT00315601|Sequestering Agents|sequestering agents|mesh-ancestor
64986597|NCT00315601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986598|NCT00315679|Pentoxifylline|pentoxifylline|mesh-list
64986599|NCT00315679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64986600|NCT00315679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986601|NCT00315679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986602|NCT00315679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64986626|NCT00315874|Sensory System Agents|sensory system agents|mesh-ancestor
64986627|NCT00315874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64986628|NCT00315874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64986630|NCT00315913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64986631|NCT00315913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64986632|NCT00315913|Adrenergic Agents|adrenergic agents|mesh-ancestor
64986633|NCT00315913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64550806|NCT00863265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64550807|NCT00831675|Vaccines|vaccines|mesh-list
64550808|NCT00831675|Immunologic Factors|immunologic factors|mesh-ancestor
64550809|NCT00831675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550810|NCT01397825|Rituximab|rituximab|mesh-list
64550811|NCT01397825|Vincristine|vincristine|mesh-list
64550812|NCT01397825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64986634|NCT00315913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986635|NCT00315913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986636|NCT00315913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64986637|NCT00315913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64986638|NCT00315913|Vasodilator Agents|vasodilator agents|mesh-ancestor
64986639|NCT00092313|Acetaminophen|acetaminophen|mesh-list
64986640|NCT00092313|Rofecoxib|rofecoxib|mesh-list
64986641|NCT00092313|Oxycodone|oxycodone|mesh-list
64986642|NCT00092313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64986643|NCT00092313|Analgesics|analgesics|mesh-ancestor
64986644|NCT00092313|Sensory System Agents|sensory system agents|mesh-ancestor
64986645|NCT00092313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64986646|NCT00092313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986647|NCT00092313|Antipyretics|antipyretics|mesh-ancestor
64986648|NCT00092313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64986649|NCT00092313|Narcotics|narcotics|mesh-ancestor
64986650|NCT00092313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64986651|NCT00092313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64986652|NCT00092313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64986653|NCT00092313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986654|NCT00092313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986655|NCT00092313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64986675|NCT00123552|Schistosomicides|schistosomicides|mesh-ancestor
64986676|NCT00123552|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64986677|NCT00123552|Anthelmintics|anthelmintics|mesh-ancestor
64986678|NCT00123552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64986679|NCT00123552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986680|NCT00123552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552682|NCT04007393|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64396483|NCT02372149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396484|NCT02661061|Midazolam|midazolam|mesh-list
64396485|NCT02661061|Ketamine|ketamine|mesh-list
64396486|NCT02661061|Analgesics|analgesics|mesh-ancestor
64986681|NCT00123552|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64986682|NCT00123552|Renal Agents|renal agents|mesh-ancestor
64986683|NCT03352427|Everolimus|everolimus|mesh-list
64986684|NCT03352427|Dasatinib|dasatinib|mesh-list
64986685|NCT03352427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986686|NCT03352427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64986687|NCT03352427|Immunologic Factors|immunologic factors|mesh-ancestor
64986688|NCT03352427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986689|NCT03352427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64986690|NCT03352427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986691|NCT03352427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986692|NCT00316420|Gemcitabine|gemcitabine|mesh-list
64986693|NCT00316420|Capecitabine|capecitabine|mesh-list
64986694|NCT00316420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64986695|NCT00316420|Antimetabolites|antimetabolites|mesh-ancestor
64986696|NCT00316420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986697|NCT00316420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986698|NCT00316420|Antiviral Agents|antiviral agents|mesh-ancestor
64986699|NCT00316420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64986700|NCT00316420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986701|NCT00316420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64986702|NCT00316420|Immunologic Factors|immunologic factors|mesh-ancestor
64986703|NCT00316420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986704|NCT00092352|Celecoxib|celecoxib|mesh-list
64986705|NCT00092352|Rofecoxib|rofecoxib|mesh-list
64986706|NCT00092352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64986707|NCT00092352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64986708|NCT00092352|Analgesics|analgesics|mesh-ancestor
64986709|NCT00092352|Sensory System Agents|sensory system agents|mesh-ancestor
64986710|NCT00092352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64986711|NCT00092352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986712|NCT00092352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64986713|NCT00092352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64986714|NCT00092352|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64550813|NCT01397825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550814|NCT01397825|Immunologic Factors|immunologic factors|mesh-ancestor
64550815|NCT01397825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550816|NCT01397825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64550817|NCT01397825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64550818|NCT01397825|Tubulin Modulators|tubulin modulators|mesh-ancestor
64550819|NCT01397825|Antimitotic Agents|antimitotic agents|mesh-ancestor
64315771|NCT03549221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64315774|NCT03549221|Analgesics|analgesics|mesh-ancestor
64986715|NCT00092352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64986732|NCT00316810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64986733|NCT00316810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986734|NCT00316810|Immunologic Factors|immunologic factors|mesh-ancestor
64986735|NCT00316810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986736|NCT00316810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64986737|NCT00092391|Vaccines|vaccines|mesh-list
64986738|NCT00092391|Immunologic Factors|immunologic factors|mesh-ancestor
64986739|NCT00092391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986740|NCT00316849|Sirolimus|sirolimus|mesh-list
64986741|NCT00316849|Temozolomide|temozolomide|mesh-list
64986742|NCT00316849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64986743|NCT00316849|Alkylating Agents|alkylating agents|mesh-ancestor
64986744|NCT00316849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986745|NCT00316849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986746|NCT00316849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64986747|NCT00316849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64986748|NCT00316849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64986749|NCT00316849|Antifungal Agents|antifungal agents|mesh-ancestor
64986750|NCT00316849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64396491|NCT02661061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64396492|NCT02661061|Anesthetics, General|anesthetics, general|mesh-ancestor
64396493|NCT02661061|Anesthetics|anesthetics|mesh-ancestor
64396494|NCT02661061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64396495|NCT02661061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64986751|NCT00316849|Immunologic Factors|immunologic factors|mesh-ancestor
64986752|NCT00316849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986753|NCT03272477|Tamoxifen|tamoxifen|mesh-list
64986754|NCT03272477|Paclitaxel|paclitaxel|mesh-list
64986755|NCT03272477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64986756|NCT03272477|Cyclophosphamide|cyclophosphamide|mesh-list
64986757|NCT03272477|Trastuzumab|trastuzumab|mesh-list
64986758|NCT03272477|Letrozole|letrozole|mesh-list
64986759|NCT03272477|Epirubicin|epirubicin|mesh-list
64986760|NCT03272477|Anastrozole|anastrozole|mesh-list
64986761|NCT03272477|Pertuzumab|pertuzumab|mesh-list
64986762|NCT03272477|Exemestane|exemestane|mesh-list
64986763|NCT03272477|Goserelin|goserelin|mesh-list
64986764|NCT03272477|Leuprolide|leuprolide|mesh-list
64986765|NCT03272477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64986766|NCT03272477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986767|NCT03272477|Tubulin Modulators|tubulin modulators|mesh-ancestor
64986768|NCT03272477|Antimitotic Agents|antimitotic agents|mesh-ancestor
64986769|NCT03272477|Mitosis Modulators|mitosis modulators|mesh-ancestor
64986770|NCT03272477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986771|NCT03272477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64986772|NCT03272477|Immunologic Factors|immunologic factors|mesh-ancestor
64986773|NCT03272477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986774|NCT03272477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64986775|NCT03272477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64986794|NCT03272477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64986796|NCT02959957|Cefoxitin|cefoxitin|mesh-list
64986797|NCT02959957|Temocillin|temocillin|mesh-list
64986798|NCT02959957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64986799|NCT02959957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64986800|NCT00316927|Aspirin|aspirin|mesh-list
64986801|NCT00316927|Dexamethasone|dexamethasone|mesh-list
64986802|NCT00316927|Fosfestrol|fosfestrol|mesh-list
64986803|NCT00316927|Diethylstilbestrol|diethylstilbestrol|mesh-list
64986804|NCT00316927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64986805|NCT00316927|Antiemetics|antiemetics|mesh-ancestor
64986806|NCT00316927|Autonomic Agents|autonomic agents|mesh-ancestor
64986807|NCT00316927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64986808|NCT00316927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550820|NCT01397825|Mitosis Modulators|mitosis modulators|mesh-ancestor
64550821|NCT01397825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550823|NCT05373186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64550824|NCT05373186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550825|NCT05353764|Ropivacaine|ropivacaine|mesh-list
64550826|NCT05353764|Anesthetics, Local|anesthetics, local|mesh-ancestor
64550827|NCT05353764|Anesthetics|anesthetics|mesh-ancestor
64550828|NCT05353764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64550829|NCT05353764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550830|NCT05353764|Sensory System Agents|sensory system agents|mesh-ancestor
64550831|NCT05353764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550832|NCT00831987|Vaccines|vaccines|mesh-list
64550833|NCT00831987|Immunologic Factors|immunologic factors|mesh-ancestor
64550834|NCT00831987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550835|NCT05239884|Nicotine|nicotine|mesh-list
64506933|NCT01746238|Bevacizumab|bevacizumab|mesh-list
64550836|NCT05239884|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64550837|NCT05239884|Autonomic Agents|autonomic agents|mesh-ancestor
64986809|NCT00316927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64986810|NCT00316927|Glucocorticoids|glucocorticoids|mesh-ancestor
64986811|NCT00316927|Hormones|hormones|mesh-ancestor
64986812|NCT00316927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64986813|NCT00316927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64986814|NCT00316927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986815|NCT00316927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64986816|NCT00316927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64396497|NCT02661061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64785278|NCT00503880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64785279|NCT00503880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64309611|NCT03192579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64309612|NCT03192579|Antimetabolites|antimetabolites|mesh-ancestor
64309628|NCT02444169|Viscosupplements|viscosupplements|mesh-ancestor
64309629|NCT02444169|Protective Agents|protective agents|mesh-ancestor
64986817|NCT00316927|Analgesics|analgesics|mesh-ancestor
64986818|NCT00316927|Sensory System Agents|sensory system agents|mesh-ancestor
64986819|NCT00316927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64986820|NCT00316927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64986821|NCT00316927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64986822|NCT00316927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986823|NCT00316927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64986824|NCT00316927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64986825|NCT00316927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986827|NCT00316927|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64986828|NCT00316927|Estrogens|estrogens|mesh-ancestor
64986829|NCT00123669|Progesterone|progesterone|mesh-list
64986830|NCT00123669|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
64986831|NCT00123669|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
64986845|NCT00317200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986846|NCT00317200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64986847|NCT00317200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64986848|NCT00317200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64986849|NCT00317200|Growth Substances|growth substances|mesh-ancestor
64986850|NCT00317200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986851|NCT00317200|Growth Inhibitors|growth inhibitors|mesh-ancestor
64986853|NCT02960035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64986854|NCT02960035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64986855|NCT02960035|Analgesics|analgesics|mesh-ancestor
64986856|NCT02960035|Sensory System Agents|sensory system agents|mesh-ancestor
64986857|NCT02960035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785280|NCT00503880|Immunologic Factors|immunologic factors|mesh-ancestor
64785281|NCT00503880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785282|NCT00475332|Tositumomab I-131|tositumomab i-131|mesh-list
64785283|NCT00475332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64785284|NCT00470574|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
64785285|NCT00470574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64785286|NCT00470574|Immunologic Factors|immunologic factors|mesh-ancestor
64785287|NCT00470574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785288|NCT00442260|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64396498|NCT02661061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396499|NCT02661061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64396500|NCT02661061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64396505|NCT02661061|GABA Agents|gaba agents|mesh-ancestor
64986858|NCT02960035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550838|NCT05239884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550839|NCT05239884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550840|NCT05239884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64550841|NCT05239884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64550842|NCT05239884|Cholinergic Agents|cholinergic agents|mesh-ancestor
64550843|NCT05239884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64550844|NCT05239884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550845|NCT03836352|Cyclophosphamide|cyclophosphamide|mesh-list
64550846|NCT03836352|Pembrolizumab|pembrolizumab|mesh-list
64550847|NCT03836352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64315797|NCT05614544|Anesthetics, General|anesthetics, general|mesh-ancestor
64986859|NCT02960035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64986860|NCT02960035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64986861|NCT02960035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64986862|NCT02960035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64986863|NCT02960035|Immunologic Factors|immunologic factors|mesh-ancestor
64986864|NCT00317434|Lapatinib|lapatinib|mesh-list
64986865|NCT00317434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986866|NCT00317434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64986867|NCT00317434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986868|NCT00317434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986869|NCT00328120|Fulvestrant|fulvestrant|mesh-list
64986870|NCT00328120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64986871|NCT00328120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986872|NCT00328120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64986873|NCT00328120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64986874|NCT00328120|Hormone Antagonists|hormone antagonists|mesh-ancestor
64986875|NCT00328120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64986876|NCT00328120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986877|NCT00328393|Pioglitazone|pioglitazone|mesh-list
64986878|NCT00328393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64986879|NCT00328393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986880|NCT00328432|Celecoxib|celecoxib|mesh-list
64986881|NCT00328432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64986882|NCT00328432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64986883|NCT00328432|Analgesics|analgesics|mesh-ancestor
64986884|NCT00328432|Sensory System Agents|sensory system agents|mesh-ancestor
64986885|NCT00328432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64986886|NCT00328432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986887|NCT00328432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64986888|NCT00328432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64986889|NCT00328432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64986890|NCT00328432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64986892|NCT00328432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986921|NCT00328822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986923|NCT00420043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986924|NCT00420043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64986925|NCT00420043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986926|NCT00420043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986927|NCT00420082|Cetirizine|cetirizine|mesh-list
64986928|NCT00420082|Fexofenadine|fexofenadine|mesh-list
64986929|NCT00420082|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64785294|NCT00145704|Diphosphonates|diphosphonates|mesh-list
64785296|NCT00145704|Micronutrients|micronutrients|mesh-ancestor
64785297|NCT00145704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785298|NCT00145704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64396509|NCT02376985|Immunologic Factors|immunologic factors|mesh-ancestor
64309750|NCT03190239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64309752|NCT02439411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986930|NCT00420082|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64986931|NCT00420082|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64986932|NCT00420082|Histamine Antagonists|histamine antagonists|mesh-ancestor
64986934|NCT00420082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64986935|NCT00420082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986936|NCT00420082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986937|NCT01821833|Paclitaxel|paclitaxel|mesh-list
64550848|NCT03836352|Immunologic Factors|immunologic factors|mesh-ancestor
64550849|NCT03836352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550850|NCT03836352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64550851|NCT03836352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64550852|NCT03836352|Alkylating Agents|alkylating agents|mesh-ancestor
64550853|NCT03836352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550854|NCT03836352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550855|NCT03836352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64550856|NCT03836352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64550857|NCT01397201|Fluticasone|fluticasone|mesh-list
64550859|NCT01397201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64550860|NCT01397201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64550861|NCT01397201|Autonomic Agents|autonomic agents|mesh-ancestor
64550862|NCT01397201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550863|NCT01397201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550864|NCT01397201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64550865|NCT01397201|Respiratory System Agents|respiratory system agents|mesh-ancestor
64550866|NCT01397201|Dermatologic Agents|dermatologic agents|mesh-ancestor
64550867|NCT01397201|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64550868|NCT04845919|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64550869|NCT04845919|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64550870|NCT04845919|Dermatologic Agents|dermatologic agents|mesh-ancestor
64550871|NCT00834171|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64550872|NCT00834171|Tobramycin|tobramycin|mesh-list
64550873|NCT00834171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64550874|NCT00834171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64550875|NCT00834171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64550876|NCT02985437|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64986969|NCT00328939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64986971|NCT00328939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986972|NCT00328978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64986973|NCT00328978|Antidepressive Agents|antidepressive agents|mesh-ancestor
64986974|NCT00328978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64986975|NCT00328978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64986976|NCT00328978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64986977|NCT00328978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64986978|NCT00328978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986979|NCT00329095|Bimatoprost|bimatoprost|mesh-list
64986980|NCT00329095|Travoprost|travoprost|mesh-list
64986981|NCT00329095|Antihypertensive Agents|antihypertensive agents|mesh-list
64987004|NCT00329173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64987005|NCT00329173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987006|NCT00123825|Gemcitabine|gemcitabine|mesh-list
64987007|NCT00123825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987008|NCT00123825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64987009|NCT00123825|Antimetabolites|antimetabolites|mesh-ancestor
64550877|NCT02985437|Respiratory System Agents|respiratory system agents|mesh-ancestor
64550878|NCT05205577|Iodine|iodine|mesh-list
64550879|NCT05205577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64550880|NCT05205577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64550881|NCT05205577|Trace Elements|trace elements|mesh-ancestor
64550882|NCT05205577|Micronutrients|micronutrients|mesh-ancestor
64550883|NCT05205577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396510|NCT02376985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396511|NCT02371993|Choline|choline|mesh-list
64396512|NCT02371993|Lipotropic Agents|lipotropic agents|mesh-ancestor
64396513|NCT02371993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64396514|NCT02371993|Antimetabolites|antimetabolites|mesh-ancestor
64396515|NCT02371993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396516|NCT02371993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64550884|NCT00835185|Leucovorin|leucovorin|mesh-list
64987010|NCT00123825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987011|NCT00123825|Antiviral Agents|antiviral agents|mesh-ancestor
64987012|NCT00123825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64987013|NCT00123825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987014|NCT00123825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64987015|NCT00123825|Immunologic Factors|immunologic factors|mesh-ancestor
64987016|NCT00123825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987017|NCT00329329|Capecitabine|capecitabine|mesh-list
64987018|NCT00329329|Satraplatin|satraplatin|mesh-list
64987019|NCT00329329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64987020|NCT00329329|Antimetabolites|antimetabolites|mesh-ancestor
64987021|NCT00329329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987022|NCT00329329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987023|NCT00329368|Folic Acid|folic acid|mesh-list
64987024|NCT00329368|Vitamin B Complex|vitamin b complex|mesh-list
64987025|NCT00329368|Interferons|interferons|mesh-list
64987026|NCT00329368|Interferon-alpha|interferon-alpha|mesh-list
64987027|NCT00329368|Interleukin-2|interleukin-2|mesh-list
64987028|NCT00329368|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
64987029|NCT00329368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987030|NCT00329368|Antiviral Agents|antiviral agents|mesh-ancestor
64987031|NCT00329368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64987032|NCT00329368|Immunologic Factors|immunologic factors|mesh-ancestor
64987033|NCT00329368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987034|NCT00329368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64987035|NCT00329368|Analgesics|analgesics|mesh-ancestor
64987036|NCT00329368|Sensory System Agents|sensory system agents|mesh-ancestor
64987054|NCT00329446|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64987055|NCT00329446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64324525|NCT02265445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324526|NCT04476121|Aspirin|aspirin|mesh-list
64324527|NCT04476121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64324528|NCT04476121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64785299|NCT00145704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64785300|NCT00145704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64785301|NCT00145704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64785302|NCT00145704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785303|NCT00108342|Nicotine|nicotine|mesh-list
64785304|NCT00108342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64785305|NCT00108342|Autonomic Agents|autonomic agents|mesh-ancestor
64785306|NCT00108342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785307|NCT00108342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785308|NCT00108342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64785309|NCT00108342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64785310|NCT00108342|Cholinergic Agents|cholinergic agents|mesh-ancestor
64987056|NCT00329446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64987057|NCT00092937|Busulfan|busulfan|mesh-list
64987058|NCT00092937|Alkylating Agents|alkylating agents|mesh-ancestor
64987059|NCT00092937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987060|NCT00092937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64987061|NCT00092937|Immunologic Factors|immunologic factors|mesh-ancestor
64987062|NCT00092937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987063|NCT00092937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64987064|NCT00092937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987065|NCT00092937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64987066|NCT00420277|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
64987067|NCT00420277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64987068|NCT00420277|Plasma Substitutes|plasma substitutes|mesh-ancestor
64987069|NCT00420277|Blood Substitutes|blood substitutes|mesh-ancestor
64987070|NCT04716751|Paclitaxel|paclitaxel|mesh-list
64987071|NCT04716751|Carboplatin|carboplatin|mesh-list
64987072|NCT04716751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64987073|NCT04716751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987074|NCT04716751|Tubulin Modulators|tubulin modulators|mesh-ancestor
64987075|NCT04716751|Antimitotic Agents|antimitotic agents|mesh-ancestor
64987076|NCT04716751|Mitosis Modulators|mitosis modulators|mesh-ancestor
64987077|NCT04716751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987078|NCT00123903|Metoprolol|metoprolol|mesh-list
64987079|NCT00123903|Carvedilol|carvedilol|mesh-list
64987080|NCT00123903|Lisinopril|lisinopril|mesh-list
64550886|NCT00835185|Oxaliplatin|oxaliplatin|mesh-list
64550887|NCT00835185|Necitumumab|necitumumab|mesh-list
64550888|NCT00835185|Levoleucovorin|levoleucovorin|mesh-list
64550889|NCT00835185|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64550890|NCT00835185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550891|NCT00835185|Antidotes|antidotes|mesh-ancestor
64550892|NCT00835185|Protective Agents|protective agents|mesh-ancestor
64550893|NCT00835185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550894|NCT00835185|Vitamin B Complex|vitamin b complex|mesh-ancestor
64550895|NCT00835185|Vitamins|vitamins|mesh-ancestor
64550896|NCT00835185|Micronutrients|micronutrients|mesh-ancestor
64550897|NCT00835185|Hematinics|hematinics|mesh-ancestor
64550898|NCT00835185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64550899|NCT00835185|Immunologic Factors|immunologic factors|mesh-ancestor
64550900|NCT00864123|Cycloserine|cycloserine|mesh-list
64550901|NCT00864123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64550902|NCT00864123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64550903|NCT00864123|Renal Agents|renal agents|mesh-ancestor
64550904|NCT00864123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64550905|NCT00864123|Antitubercular Agents|antitubercular agents|mesh-ancestor
64550906|NCT00864123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64550907|NCT00864123|Antimetabolites|antimetabolites|mesh-ancestor
64550908|NCT00864123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714179|NCT02988050|Remifentanil|remifentanil|mesh-list
64484460|NCT01727713|Dopamine Agents|dopamine agents|mesh-ancestor
64550909|NCT03858465|Phenylephrine|phenylephrine|mesh-list
64550910|NCT03858465|Oxymetazoline|oxymetazoline|mesh-list
64550911|NCT03858465|Ephedrine|ephedrine|mesh-list
64550912|NCT03858465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64550913|NCT03858465|Mydriatics|mydriatics|mesh-ancestor
64301312|NCT04959812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64550914|NCT03858465|Autonomic Agents|autonomic agents|mesh-ancestor
64315849|NCT05612984|Analgesics|analgesics|mesh-ancestor
64987081|NCT00123903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64987082|NCT00123903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64987083|NCT00123903|Sympatholytics|sympatholytics|mesh-ancestor
64987084|NCT00123903|Autonomic Agents|autonomic agents|mesh-ancestor
64987085|NCT00123903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64987086|NCT00123903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987087|NCT00123903|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64396527|NCT02371603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64396528|NCT02371603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396529|NCT02371603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64396530|NCT02371603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309963|NCT03369717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64309964|NCT03054662|Hemostatics|hemostatics|mesh-list
64987088|NCT00123903|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64987089|NCT00123903|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64987090|NCT00123903|Adrenergic Agents|adrenergic agents|mesh-ancestor
64987091|NCT00123903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64987092|NCT00123903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987093|NCT00123903|Antioxidants|antioxidants|mesh-ancestor
64987110|NCT00329680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64550915|NCT03858465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550916|NCT03858465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550917|NCT03858465|Sympathomimetics|sympathomimetics|mesh-ancestor
64550918|NCT03858465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64550919|NCT03858465|Nasal Decongestants|nasal decongestants|mesh-ancestor
64550920|NCT03858465|Respiratory System Agents|respiratory system agents|mesh-ancestor
64550921|NCT03858465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64550922|NCT03858465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64550923|NCT03858465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64550924|NCT03858465|Adrenergic Agents|adrenergic agents|mesh-ancestor
64550925|NCT03858465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64550926|NCT03858465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550927|NCT03858465|Protective Agents|protective agents|mesh-ancestor
64550928|NCT03858465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64550929|NCT05155579|Vaccines|vaccines|mesh-list
64550930|NCT05155579|Immunologic Factors|immunologic factors|mesh-ancestor
64550931|NCT05155579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550932|NCT00867789|Trimethoprim|trimethoprim|mesh-list
64550933|NCT00867789|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64550934|NCT00867789|Sulfamethoxazole|sulfamethoxazole|mesh-list
64315879|NCT05424263|Antacids|antacids|mesh-ancestor
64552683|NCT04007393|Sympathomimetics|sympathomimetics|mesh-ancestor
64785325|NCT00090870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64785326|NCT00090870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64785327|NCT00090870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64785328|NCT00090870|Growth Substances|growth substances|mesh-ancestor
64785329|NCT00090870|Growth Inhibitors|growth inhibitors|mesh-ancestor
64785331|NCT00074724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64785332|NCT00074724|Sympathomimetics|sympathomimetics|mesh-ancestor
64785333|NCT00074724|Autonomic Agents|autonomic agents|mesh-ancestor
64785334|NCT00074724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785335|NCT00074724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396542|NCT04230109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64987111|NCT00329680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64987112|NCT00329680|Analgesics|analgesics|mesh-ancestor
64987113|NCT00329680|Sensory System Agents|sensory system agents|mesh-ancestor
64987114|NCT00329680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64987115|NCT00329680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64987116|NCT00329680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64987117|NCT00329680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64987118|NCT00329680|Antimetabolites|antimetabolites|mesh-ancestor
64987119|NCT00329680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64987120|NCT00329680|Dermatologic Agents|dermatologic agents|mesh-ancestor
64987121|NCT00329758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64987122|NCT00329758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64987123|NCT00329758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64987124|NCT00329758|Antimetabolites|antimetabolites|mesh-ancestor
64987125|NCT00329758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987126|NCT00329758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64987127|NCT00329758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64987128|NCT00329758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987129|NCT00329914|Progesterone|progesterone|mesh-list
64987130|NCT00329914|Progestins|progestins|mesh-ancestor
64987132|NCT00329914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64987133|NCT00329914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987134|NCT00092976|Factor VIII|factor viii|mesh-list
64987135|NCT00092976|Coagulants|coagulants|mesh-ancestor
64987136|NCT00083876|Thalidomide|thalidomide|mesh-list
64987137|NCT00083876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64987138|NCT00083876|Immunologic Factors|immunologic factors|mesh-ancestor
64987139|NCT00083876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987140|NCT00083876|Leprostatic Agents|leprostatic agents|mesh-ancestor
64987141|NCT00083876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64550935|NCT00867789|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64446566|NCT01529632|Glycopyrrolate|glycopyrrolate|mesh-list
64550936|NCT00867789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64550937|NCT00867789|Renal Agents|renal agents|mesh-ancestor
64550938|NCT00867789|Antimalarials|antimalarials|mesh-ancestor
64315902|NCT05398757|Analgesics|analgesics|mesh-ancestor
64987142|NCT00083876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64987143|NCT00083876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64987144|NCT00083876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64987145|NCT00083876|Growth Substances|growth substances|mesh-ancestor
64987146|NCT00083876|Growth Inhibitors|growth inhibitors|mesh-ancestor
64987147|NCT00083876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987148|NCT00330148|Eflornithine|eflornithine|mesh-list
64987173|NCT00330304|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64987174|NCT00330304|Antitubercular Agents|antitubercular agents|mesh-ancestor
64987175|NCT00330304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64987176|NCT00330304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64987177|NCT00330304|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64987178|NCT00330304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64987179|NCT00330304|Antimetabolites|antimetabolites|mesh-ancestor
64987180|NCT00330304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987181|NCT00330304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64987182|NCT00330304|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64987183|NCT00330304|Renal Agents|renal agents|mesh-ancestor
64987184|NCT00330304|Antimalarials|antimalarials|mesh-ancestor
64987185|NCT00330304|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64987186|NCT00330304|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64987187|NCT00330499|Cisplatin|cisplatin|mesh-list
64987188|NCT00330499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987189|NCT00083954|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64987190|NCT00083954|Antidepressive Agents|antidepressive agents|mesh-ancestor
64987191|NCT00083954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64987192|NCT00083954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64987193|NCT00083954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64987194|NCT00083954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64987195|NCT00083954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987196|NCT00330577|Timolol|timolol|mesh-list
64987197|NCT00330577|Latanoprost|latanoprost|mesh-list
64987198|NCT00330577|Lubricant Eye Drops|lubricant eye drops|mesh-list
64987199|NCT00330577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987200|NCT00330577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64987201|NCT00330577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64987202|NCT00330577|Adrenergic Agents|adrenergic agents|mesh-ancestor
64987221|NCT00083993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64987222|NCT00083993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64987223|NCT00083993|Antifungal Agents|antifungal agents|mesh-ancestor
64987224|NCT00083993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64987225|NCT00083993|Immunologic Factors|immunologic factors|mesh-ancestor
64987226|NCT00323791|Gemcitabine|gemcitabine|mesh-list
64987227|NCT00323791|Imatinib Mesylate|imatinib mesylate|mesh-list
64987228|NCT00323791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64987229|NCT00323791|Antimetabolites|antimetabolites|mesh-ancestor
64987230|NCT00323791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987231|NCT00323791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987232|NCT00323791|Antiviral Agents|antiviral agents|mesh-ancestor
64987233|NCT00323791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64987234|NCT00323791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987235|NCT00323791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64987236|NCT00323791|Immunologic Factors|immunologic factors|mesh-ancestor
64987237|NCT00323791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987238|NCT00323791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64987239|NCT00323830|Capecitabine|capecitabine|mesh-list
64987240|NCT00323830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987241|NCT00323830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64987242|NCT00323830|Antimetabolites|antimetabolites|mesh-ancestor
64987243|NCT00323830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987244|NCT00317512|Chrysarobin|chrysarobin|mesh-list
64987245|NCT00317512|HBOC 201|hboc 201|mesh-list
64987246|NCT00317512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64987247|NCT00317512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64987248|NCT00317512|Analgesics|analgesics|mesh-ancestor
64550939|NCT00867789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64550940|NCT00867789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64550941|NCT00867789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64310198|NCT04899674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64310199|NCT04899674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64310200|NCT04899674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310202|NCT04899674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64310203|NCT04899674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310204|NCT04899674|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64310207|NCT04907708|Metformin|metformin|mesh-list
64550945|NCT00867789|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64550946|NCT00867789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64550947|NCT00867789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64987249|NCT00317512|Sensory System Agents|sensory system agents|mesh-ancestor
64987250|NCT00317512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64987251|NCT00317512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987252|NCT00317512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64987253|NCT00317512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64987254|NCT00317512|Blood Substitutes|blood substitutes|mesh-ancestor
64987255|NCT00124059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64987256|NCT00124059|Antidepressive Agents|antidepressive agents|mesh-ancestor
64987257|NCT00124059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64987285|NCT00317629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987286|NCT00317629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64987287|NCT00317629|Respiratory System Agents|respiratory system agents|mesh-ancestor
64987288|NCT00317629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64987289|NCT00317629|Antioxidants|antioxidants|mesh-ancestor
64987290|NCT00317629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987291|NCT00317629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64987292|NCT00317629|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64987293|NCT00317629|Vasodilator Agents|vasodilator agents|mesh-ancestor
64987294|NCT00317629|Gasotransmitters|gasotransmitters|mesh-ancestor
64987295|NCT00317629|Protective Agents|protective agents|mesh-ancestor
64987296|NCT00317629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64987297|NCT00317629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64987298|NCT00317629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64987299|NCT00093249|Clevidipine|clevidipine|mesh-list
64987300|NCT00093249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64987301|NCT00093249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64987319|NCT00324298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64987320|NCT00324298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64987321|NCT00324298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987322|NCT00324298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987323|NCT00324298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64987325|NCT00124137|Natriuretic Agents|natriuretic agents|mesh-ancestor
64987326|NCT00124137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987328|NCT00324376|Chelating Agents|chelating agents|mesh-ancestor
64987329|NCT00324376|Sequestering Agents|sequestering agents|mesh-ancestor
64987330|NCT00324376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987331|NCT00084227|Azithromycin|azithromycin|mesh-list
64987332|NCT00084227|Chloroquine|chloroquine|mesh-list
64987334|NCT00084227|Proguanil|proguanil|mesh-list
64987335|NCT00084227|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
64987336|NCT00084227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64987337|NCT00084227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64987338|NCT00084227|Amebicides|amebicides|mesh-ancestor
64987339|NCT00084227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64987340|NCT00084227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64987341|NCT00084227|Antimalarials|antimalarials|mesh-ancestor
64987342|NCT00084227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64987343|NCT00084227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987344|NCT00084227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987345|NCT00084227|Antimetabolites|antimetabolites|mesh-ancestor
64550948|NCT01396421|Brexpiprazole|brexpiprazole|mesh-list
64550949|NCT01396421|Serotonin Agents|serotonin agents|mesh-ancestor
64550950|NCT01396421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64550951|NCT01396421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324530|NCT04476121|Sensory System Agents|sensory system agents|mesh-ancestor
64396551|NCT02378389|Tubulin Modulators|tubulin modulators|mesh-ancestor
64396552|NCT02378389|Antimitotic Agents|antimitotic agents|mesh-ancestor
64550952|NCT01396421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550953|NCT01396421|Dopamine Agonists|dopamine agonists|mesh-ancestor
64550955|NCT04797013|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64550956|NCT04797013|Plasminogen|plasminogen|mesh-list
64550957|NCT04797013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64550958|NCT04797013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64550959|NCT04797013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550960|NCT00838695|Phenylephrine|phenylephrine|mesh-list
64315912|NCT04787276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64987347|NCT00317746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64987348|NCT00317746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64987349|NCT00317746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64987350|NCT00317746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987351|NCT00317746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64987352|NCT00317746|Serotonin Agents|serotonin agents|mesh-ancestor
64987353|NCT00317746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987354|NCT00317746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64987355|NCT00317746|Antidepressive Agents|antidepressive agents|mesh-ancestor
64987356|NCT00317746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64987357|NCT00317785|Cyclosporine|cyclosporine|mesh-list
64987388|NCT00317785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64987389|NCT00093288|Bupropion|bupropion|mesh-list
64987390|NCT00093288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64987391|NCT00093288|Antidepressive Agents|antidepressive agents|mesh-ancestor
64987392|NCT00093288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64987393|NCT00093288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64987394|NCT00093288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64987395|NCT00093288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64987396|NCT00093288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987397|NCT00093288|Dopamine Agents|dopamine agents|mesh-ancestor
64987398|NCT00093288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64987399|NCT00093288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987400|NCT00093288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64987401|NCT00093288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64987420|NCT00084461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64987421|NCT00084461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987422|NCT00324610|Capecitabine|capecitabine|mesh-list
64987423|NCT00324610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64987424|NCT00324610|Antimetabolites|antimetabolites|mesh-ancestor
64987425|NCT00324610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550961|NCT00838695|Oxymetazoline|oxymetazoline|mesh-list
64550962|NCT00838695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64550963|NCT00838695|Mydriatics|mydriatics|mesh-ancestor
64550964|NCT00838695|Autonomic Agents|autonomic agents|mesh-ancestor
64550965|NCT00838695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64550966|NCT00838695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550967|NCT00838695|Sympathomimetics|sympathomimetics|mesh-ancestor
64550968|NCT00838695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64550969|NCT00838695|Nasal Decongestants|nasal decongestants|mesh-ancestor
64550970|NCT00838695|Respiratory System Agents|respiratory system agents|mesh-ancestor
64550971|NCT00838695|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64987426|NCT00324610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987428|NCT00093366|Arsenic Trioxide|arsenic trioxide|mesh-list
64987429|NCT00093366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64987430|NCT00093366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64987431|NCT00093366|Analgesics|analgesics|mesh-ancestor
64987432|NCT00093366|Sensory System Agents|sensory system agents|mesh-ancestor
64987433|NCT00093366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64987434|NCT00093366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987435|NCT00093366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64987436|NCT00093366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64987437|NCT00093366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64987438|NCT00093366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64987439|NCT00093366|Immunologic Factors|immunologic factors|mesh-ancestor
64987440|NCT00093366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987441|NCT00324688|Tenofovir|tenofovir|mesh-list
64987442|NCT00324688|Antiviral Agents|antiviral agents|mesh-ancestor
64451442|NCT04170465|Doxorubicin|doxorubicin|mesh-list
64987444|NCT00324688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64987445|NCT00324688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64987446|NCT00324688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987447|NCT00324688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987448|NCT00324688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64987449|NCT00324688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64987450|NCT00324727|Melphalan|melphalan|mesh-list
64987451|NCT00324727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64987452|NCT00324727|Alkylating Agents|alkylating agents|mesh-ancestor
64987453|NCT00324727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987454|NCT00324727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987455|NCT00324727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64987456|NCT00324727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64396572|NCT02376049|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64324531|NCT04476121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64324532|NCT04476121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324533|NCT04476121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64324534|NCT04476121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64324535|NCT04476121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64324536|NCT04476121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64987457|NCT00324727|Immunologic Factors|immunologic factors|mesh-ancestor
64987458|NCT00324727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987459|NCT00324766|Simendan|simendan|mesh-list
64987460|NCT00324766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64987480|NCT00084578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987481|NCT00084578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987482|NCT00084578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64987483|NCT00318175|Bosentan|bosentan|mesh-list
64987484|NCT00318175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64987485|NCT00318175|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64987486|NCT00318175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987487|NCT00093444|Doxorubicin|doxorubicin|mesh-list
64987488|NCT00093444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64987489|NCT00093444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64987490|NCT00093444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987491|NCT00093444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64987492|NCT00093444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64987493|NCT00093444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987494|NCT00093444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987495|NCT00325000|Amitriptyline|amitriptyline|mesh-list
64987496|NCT00325000|Sertraline|sertraline|mesh-list
64987497|NCT00325000|Antidepressive Agents|antidepressive agents|mesh-ancestor
64550972|NCT00838695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64550973|NCT00838695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64550974|NCT00838695|Adrenergic Agents|adrenergic agents|mesh-ancestor
64550975|NCT00838695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64714180|NCT02988050|Bupivacaine|bupivacaine|mesh-list
64714181|NCT02988050|Propofol|propofol|mesh-list
64507095|NCT01783912|Nicotine|nicotine|mesh-list
64550976|NCT00838695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550977|NCT00838695|Protective Agents|protective agents|mesh-ancestor
64550978|NCT04775173|Sirolimus|sirolimus|mesh-list
64550979|NCT04775173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64550980|NCT04775173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64550981|NCT04775173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64550982|NCT04775173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550983|NCT04775173|Antifungal Agents|antifungal agents|mesh-ancestor
64550984|NCT04775173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64550985|NCT04775173|Immunologic Factors|immunologic factors|mesh-ancestor
64550986|NCT04775173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64550987|NCT01396265|Rifampin|rifampin|mesh-list
64550988|NCT01396265|Afatinib|afatinib|mesh-list
64550989|NCT01396265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64550990|NCT01396265|Antitubercular Agents|antitubercular agents|mesh-ancestor
64550991|NCT01396265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64315945|NCT05279183|Erythritol|erythritol|mesh-list
64987498|NCT00325000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64987499|NCT00325000|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64987500|NCT00325000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64987501|NCT00325000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64987502|NCT00325000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987503|NCT00325000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64452998|NCT02005471|Venetoclax|venetoclax|mesh-list
64987512|NCT00325000|Adrenergic Agents|adrenergic agents|mesh-ancestor
64987536|NCT00084695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64987537|NCT00084695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64987538|NCT00084695|Immunologic Factors|immunologic factors|mesh-ancestor
64987539|NCT00084695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987540|NCT00084695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64987541|NCT00084695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64987542|NCT00084695|Alkylating Agents|alkylating agents|mesh-ancestor
64987543|NCT00084695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987544|NCT00084695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987545|NCT00084695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64987546|NCT00084695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64987547|NCT00084695|Antimetabolites|antimetabolites|mesh-ancestor
64550992|NCT01396265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64550993|NCT01396265|Leprostatic Agents|leprostatic agents|mesh-ancestor
64550994|NCT01396265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64550995|NCT01396265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64550996|NCT01396265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64550997|NCT01396265|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64550998|NCT01396265|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64315966|NCT04429022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64315967|NCT04429022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987548|NCT00084695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64987549|NCT00084695|Antiemetics|antiemetics|mesh-ancestor
64987550|NCT00084695|Autonomic Agents|autonomic agents|mesh-ancestor
64453148|NCT02066129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64987552|NCT00084695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64987555|NCT00084695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64987556|NCT00084695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64987557|NCT00084695|Protective Agents|protective agents|mesh-ancestor
64987558|NCT00325351|Carboplatin|carboplatin|mesh-list
64987559|NCT00325351|Sagopilone|sagopilone|mesh-list
64987560|NCT00325351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987561|NCT00093483|Cytarabine|cytarabine|mesh-list
64987562|NCT00093483|Idarubicin|idarubicin|mesh-list
64987563|NCT00093483|Arsenic Trioxide|arsenic trioxide|mesh-list
64987564|NCT00093483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64987565|NCT00093483|Antimetabolites|antimetabolites|mesh-ancestor
64987584|NCT00084734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64987585|NCT00084734|Antimetabolites|antimetabolites|mesh-ancestor
64987586|NCT00325390|Clopidogrel|clopidogrel|mesh-list
64987587|NCT00325390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64987588|NCT00325390|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64987589|NCT00325390|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64987590|NCT00325390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64987591|NCT00325390|Purinergic Agents|purinergic agents|mesh-ancestor
64987592|NCT00325390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64987593|NCT00325390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987594|NCT00325390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987595|NCT00325429|Vildagliptin|vildagliptin|mesh-list
64987596|NCT00325429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64987597|NCT00325429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987598|NCT00325429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64987599|NCT00325429|Protease Inhibitors|protease inhibitors|mesh-ancestor
64987600|NCT00325429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987601|NCT00325429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987602|NCT00093522|Fludarabine|fludarabine|mesh-list
64987603|NCT00093522|Fludarabine phosphate|fludarabine phosphate|mesh-list
64987604|NCT00093522|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
64987605|NCT00093522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64785370|NCT02595996|Vasodilator Agents|vasodilator agents|mesh-ancestor
64310559|NCT02145559|Sirolimus|sirolimus|mesh-list
64310560|NCT02145559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64310561|NCT02145559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310562|NCT02145559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64310563|NCT02145559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64310564|NCT02145559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64310565|NCT02145559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987606|NCT00093522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64987607|NCT00093522|Antimetabolites|antimetabolites|mesh-ancestor
64987608|NCT00093522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987609|NCT00093522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64987610|NCT00093522|Immunologic Factors|immunologic factors|mesh-ancestor
64987611|NCT00093522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987612|NCT00093522|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64987613|NCT00084773|Fluorouracil|fluorouracil|mesh-list
64987614|NCT00084773|Cetuximab|cetuximab|mesh-list
64987615|NCT00084773|Antimetabolites|antimetabolites|mesh-ancestor
64987616|NCT00084773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987617|NCT00084773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64987618|NCT00084773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64550999|NCT01396265|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64551000|NCT01396265|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64551001|NCT01396265|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64551002|NCT01396265|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64551003|NCT01396265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551004|NCT01396265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64551005|NCT04760431|Paclitaxel|paclitaxel|mesh-list
64551006|NCT04760431|Docetaxel|docetaxel|mesh-list
64551007|NCT04760431|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64551008|NCT04760431|Trastuzumab|trastuzumab|mesh-list
64551009|NCT04760431|Pertuzumab|pertuzumab|mesh-list
64551011|NCT04760431|Tucatinib|tucatinib|mesh-list
64551012|NCT04760431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64551013|NCT04760431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551014|NCT04760431|Tubulin Modulators|tubulin modulators|mesh-ancestor
64551015|NCT04760431|Antimitotic Agents|antimitotic agents|mesh-ancestor
64551016|NCT04760431|Mitosis Modulators|mitosis modulators|mesh-ancestor
64551017|NCT04760431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551018|NCT04760431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64551019|NCT04760431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64551020|NCT04760431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551021|NCT00839319|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64551022|NCT00839319|Testosterone|testosterone|mesh-list
64551023|NCT00839319|Acyline|acyline|mesh-list
64551024|NCT00839319|Androgens|androgens|mesh-ancestor
64551025|NCT00839319|Hormones|hormones|mesh-ancestor
64551026|NCT00839319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64551029|NCT00839319|Hormone Antagonists|hormone antagonists|mesh-ancestor
64551040|NCT00868959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64551041|NCT00868959|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64551042|NCT00868959|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64551043|NCT00868959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64551044|NCT00868959|Adrenergic Agents|adrenergic agents|mesh-ancestor
64551045|NCT00868959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64714182|NCT02988050|Anesthetics, Local|anesthetics, local|mesh-ancestor
64736760|NCT05599919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64316017|NCT05557604|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64316018|NCT05557604|Luteolytic Agents|luteolytic agents|mesh-ancestor
64987619|NCT00084773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64987620|NCT00084773|Immunologic Factors|immunologic factors|mesh-ancestor
64987651|NCT00318760|Autonomic Agents|autonomic agents|mesh-ancestor
64987652|NCT00318760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64987653|NCT00318760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64987654|NCT00318760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64987655|NCT00318760|Adrenergic Agents|adrenergic agents|mesh-ancestor
64987656|NCT00318760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64987657|NCT00318760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987658|NCT00093561|Lycopene|lycopene|mesh-list
64987659|NCT00093561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64987660|NCT00093561|Antioxidants|antioxidants|mesh-ancestor
64987661|NCT00093561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987662|NCT00093561|Protective Agents|protective agents|mesh-ancestor
64552684|NCT04007393|Autonomic Agents|autonomic agents|mesh-ancestor
64987663|NCT00093561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987664|NCT00093561|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64987690|NCT00085124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64987691|NCT00085124|Immunologic Factors|immunologic factors|mesh-ancestor
64987692|NCT00085124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987693|NCT00085124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64987694|NCT00085124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64987695|NCT00085124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64987696|NCT00085124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987697|NCT00402441|Risedronic Acid|risedronic acid|mesh-list
64987698|NCT00402441|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64987699|NCT00402441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64987700|NCT00402441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987701|NCT00402441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64987702|NCT00402441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987703|NCT00402441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64987704|NCT00325858|Tramadol|tramadol|mesh-list
64987705|NCT00325858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64987706|NCT00325858|Narcotics|narcotics|mesh-ancestor
64987707|NCT00325858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64987708|NCT00325858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987710|NCT00325858|Sensory System Agents|sensory system agents|mesh-ancestor
64987711|NCT00325858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64987712|NCT00318955|Dexmedetomidine|dexmedetomidine|mesh-list
64987713|NCT00318955|Propofol|propofol|mesh-list
64987741|NCT00093600|Midostaurin|midostaurin|mesh-list
64987742|NCT00093600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64987743|NCT00093600|Antimetabolites|antimetabolites|mesh-ancestor
64987744|NCT00093600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987745|NCT00093600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987747|NCT00093600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64987748|NCT00093600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64987749|NCT00093600|Immunologic Factors|immunologic factors|mesh-ancestor
64987750|NCT00093600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987751|NCT00093600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64987752|NCT00093600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64987753|NCT00093600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64551046|NCT00868959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551047|NCT00868959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64551048|NCT00868959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64551049|NCT00868959|Serotonin Agents|serotonin agents|mesh-ancestor
64987754|NCT00093600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987755|NCT00093600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64987756|NCT00319033|Bosentan|bosentan|mesh-list
64987757|NCT00319033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64987758|NCT00319033|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64987775|NCT00085163|Vitamin B Complex|vitamin b complex|mesh-ancestor
64987776|NCT00085163|Vitamins|vitamins|mesh-ancestor
64987777|NCT00085163|Micronutrients|micronutrients|mesh-ancestor
64987778|NCT00085163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64987779|NCT00085163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64987780|NCT00085163|Analgesics|analgesics|mesh-ancestor
64987781|NCT00085163|Sensory System Agents|sensory system agents|mesh-ancestor
64987782|NCT00085163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64987783|NCT00085163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64987784|NCT00085163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64987785|NCT00085163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64785381|NCT00000132|Betaxolol|betaxolol|mesh-list
64785382|NCT00000132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64785383|NCT00000132|Sympatholytics|sympatholytics|mesh-ancestor
64396582|NCT02376049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396583|NCT02376049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64396584|NCT02376049|Respiratory System Agents|respiratory system agents|mesh-ancestor
64396586|NCT02376049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64987786|NCT00085163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64987787|NCT00085163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987789|NCT00319072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64987790|NCT00319072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987791|NCT00093639|Everolimus|everolimus|mesh-list
64987792|NCT00093639|Imatinib Mesylate|imatinib mesylate|mesh-list
64987793|NCT00093639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987794|NCT00093639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64987795|NCT00093639|Immunologic Factors|immunologic factors|mesh-ancestor
64987796|NCT00093639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987797|NCT00093639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64987798|NCT00093639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987799|NCT00093639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987800|NCT00319150|Epoetin Alfa|epoetin alfa|mesh-list
64987801|NCT00319150|Hematinics|hematinics|mesh-ancestor
64987802|NCT00326053|Budesonide|budesonide|mesh-list
64987803|NCT00326053|Formoterol Fumarate|formoterol fumarate|mesh-list
64987804|NCT00326053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64987805|NCT00326053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64987806|NCT00326053|Autonomic Agents|autonomic agents|mesh-ancestor
64987807|NCT00326053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64987808|NCT00326053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987809|NCT00326053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64987810|NCT00326053|Respiratory System Agents|respiratory system agents|mesh-ancestor
64987811|NCT00326053|Glucocorticoids|glucocorticoids|mesh-ancestor
64987812|NCT00326053|Hormones|hormones|mesh-ancestor
64987813|NCT00326053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64987814|NCT00326053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64987815|NCT00326053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64987816|NCT00326053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64987817|NCT00326053|Adrenergic Agents|adrenergic agents|mesh-ancestor
64987818|NCT00326053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64987829|NCT00400088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987830|NCT00400088|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64987831|NCT00400088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64987832|NCT00400088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64987833|NCT00400088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64987835|NCT00400088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64987836|NCT00400088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64987837|NCT00400088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64987838|NCT00326092|Timolol|timolol|mesh-list
64987839|NCT00326092|Brinzolamide|brinzolamide|mesh-list
64987840|NCT00326092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64987841|NCT00326092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64987842|NCT00326092|Adrenergic Agents|adrenergic agents|mesh-ancestor
64987843|NCT00326092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64551050|NCT00868959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64551051|NCT00868959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64551052|NCT00868959|Dopamine Agents|dopamine agents|mesh-ancestor
64551053|NCT02647866|KHK4083|khk4083|mesh-list
64551054|NCT02647866|Dermatologic Agents|dermatologic agents|mesh-ancestor
64551055|NCT02246127|Everolimus|everolimus|mesh-list
64551056|NCT02246127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551057|NCT02246127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64551058|NCT02246127|Immunologic Factors|immunologic factors|mesh-ancestor
64551059|NCT02246127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551060|NCT04277923|SMOFlipid|smoflipid|mesh-list
64551061|NCT04277923|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64551062|NCT04277923|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64551063|NCT04277923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64551064|NCT05233722|Sirolimus|sirolimus|mesh-list
64316029|NCT05557136|Anesthetics|anesthetics|mesh-ancestor
64310837|NCT02154217|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64310838|NCT02154217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64310839|NCT02147041|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
64310840|NCT02147041|Antioxidants|antioxidants|mesh-ancestor
64310842|NCT02147041|Protective Agents|protective agents|mesh-ancestor
64987844|NCT00326092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987845|NCT00326092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987846|NCT00326092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64987847|NCT00326092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64987848|NCT00326092|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64987849|NCT00326092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987850|NCT00326131|Taxane|taxane|mesh-list
64987851|NCT00326131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987852|NCT00319189|Nateglinide|nateglinide|mesh-list
64987853|NCT00319189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64987854|NCT00319189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987855|NCT00319267|Bosentan|bosentan|mesh-list
64987856|NCT00319267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64987857|NCT00319267|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64987858|NCT00319267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987859|NCT00085280|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64987860|NCT00085280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987861|NCT00085280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64987862|NCT00085280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987863|NCT00085280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987864|NCT00326248|Casopitant|casopitant|mesh-list
64987865|NCT00326248|Antiemetics|antiemetics|mesh-ancestor
64987866|NCT00326248|Autonomic Agents|autonomic agents|mesh-ancestor
64987867|NCT00326248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64987868|NCT00326248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987869|NCT00326248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64987870|NCT00326248|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64987871|NCT00326248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64987872|NCT00326248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987873|NCT00319306|Budesonide|budesonide|mesh-list
64987874|NCT00319306|Formoterol Fumarate|formoterol fumarate|mesh-list
64987875|NCT00319306|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64987876|NCT00319306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64987877|NCT00319306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64987878|NCT00319306|Autonomic Agents|autonomic agents|mesh-ancestor
64987879|NCT00319306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64987912|NCT00093678|Celecoxib|celecoxib|mesh-list
64987913|NCT00093678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64987914|NCT00093678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64987915|NCT00093678|Analgesics|analgesics|mesh-ancestor
64987916|NCT00093678|Sensory System Agents|sensory system agents|mesh-ancestor
64987917|NCT00093678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64987918|NCT00093678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551065|NCT05233722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551066|NCT05233722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64551067|NCT05233722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64551068|NCT05233722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64551069|NCT05233722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551070|NCT05233722|Antifungal Agents|antifungal agents|mesh-ancestor
64551071|NCT05233722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64551072|NCT05233722|Immunologic Factors|immunologic factors|mesh-ancestor
64324539|NCT04476121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64324540|NCT04476121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324541|NCT04476121|Antipyretics|antipyretics|mesh-ancestor
64324542|NCT01234519|Doxorubicin|doxorubicin|mesh-list
64324543|NCT01234519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64310964|NCT02157649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64551074|NCT00870363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
64551075|NCT00870363|Raltegravir Potassium|raltegravir potassium|mesh-list
64551076|NCT00870363|Maraviroc|maraviroc|mesh-list
64551077|NCT00870363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64551078|NCT00870363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551079|NCT00870363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551080|NCT00870363|Antiviral Agents|antiviral agents|mesh-ancestor
64551081|NCT00870363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64551082|NCT00870363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64551083|NCT00870363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64551084|NCT00870363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64551085|NCT00870363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64551086|NCT00870363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64987919|NCT00093678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64987920|NCT00093678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64987921|NCT00093678|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64987927|NCT00319345|Diuretics|diuretics|mesh-ancestor
64987928|NCT00319345|Natriuretic Agents|natriuretic agents|mesh-ancestor
64987929|NCT00319345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987931|NCT00419536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987932|NCT00419536|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64987933|NCT00419536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987934|NCT00419536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987935|NCT00326404|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64987936|NCT00326404|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64987937|NCT00326404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64987938|NCT00326404|Desogestrel|desogestrel|mesh-list
64987939|NCT00326404|Estradiol|estradiol|mesh-list
64987940|NCT00326404|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64987941|NCT00326404|Estrogens|estrogens|mesh-ancestor
64987942|NCT00326404|Hormones|hormones|mesh-ancestor
64987943|NCT00326404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64987944|NCT00326404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987945|NCT00326404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64987946|NCT00326404|Contraceptive Agents|contraceptive agents|mesh-ancestor
64987947|NCT00326404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64987948|NCT00326404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64987949|NCT00326404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64987950|NCT00326404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64987951|NCT00326404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64551087|NCT00870363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64551088|NCT00870363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64551089|NCT00870363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64551090|NCT00870363|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64551091|NCT00870363|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64551092|NCT00870363|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64785390|NCT00000132|Adrenergic Agents|adrenergic agents|mesh-ancestor
64785391|NCT00000132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64785392|NCT00000132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785393|NCT00000138|Acyclovir|acyclovir|mesh-list
64785394|NCT00000138|Prednisolone|prednisolone|mesh-list
64785396|NCT00000138|Methylprednisolone|methylprednisolone|mesh-list
64551093|NCT00870363|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64551094|NCT00870363|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64551095|NCT03104634|Bromides|bromides|mesh-list
64551096|NCT03104634|Formoterol Fumarate|formoterol fumarate|mesh-list
64551097|NCT03104634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64551098|NCT03104634|Autonomic Agents|autonomic agents|mesh-ancestor
64551099|NCT03104634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64551100|NCT03104634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551101|NCT03104634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64551102|NCT03104634|Respiratory System Agents|respiratory system agents|mesh-ancestor
64551103|NCT03104634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64551104|NCT03104634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64551105|NCT03104634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64987952|NCT00326404|Progestins|progestins|mesh-ancestor
64987953|NCT00093834|Cyclophosphamide|cyclophosphamide|mesh-list
64987954|NCT00093834|Doxorubicin|doxorubicin|mesh-list
64987955|NCT00093834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64987956|NCT00093834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64987957|NCT00093834|Immunologic Factors|immunologic factors|mesh-ancestor
64987958|NCT00093834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987959|NCT00093834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64987960|NCT00093834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64987961|NCT00093834|Alkylating Agents|alkylating agents|mesh-ancestor
64987962|NCT00093834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785402|NCT00000138|Glucocorticoids|glucocorticoids|mesh-ancestor
64785404|NCT00000138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64785405|NCT00000138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785406|NCT00000138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64785407|NCT00000138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64785408|NCT00000138|Antiemetics|antiemetics|mesh-ancestor
64785409|NCT00000138|Autonomic Agents|autonomic agents|mesh-ancestor
64396604|NCT02376205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64396605|NCT02370433|Glycopyrrolate|glycopyrrolate|mesh-list
64396606|NCT02370433|Neostigmine|neostigmine|mesh-list
64396607|NCT02370433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64396608|NCT02370433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396609|NCT02370433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396610|NCT02370433|Cholinergic Agents|cholinergic agents|mesh-ancestor
64396611|NCT02370433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64396612|NCT02370433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396613|NCT02370433|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64396614|NCT02370433|Autonomic Agents|autonomic agents|mesh-ancestor
64301317|NCT04959812|Sensory System Agents|sensory system agents|mesh-ancestor
64301318|NCT04959812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301319|NCT04959812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64987963|NCT00093834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987964|NCT00093834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64987965|NCT00093834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64987966|NCT00093834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64987967|NCT00093834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64987968|NCT00093834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987969|NCT00085475|Imatinib Mesylate|imatinib mesylate|mesh-list
64987970|NCT00085475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987971|NCT00085475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64987972|NCT00085475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987973|NCT00085475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785421|NCT00000174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64785422|NCT00000174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785423|NCT00000174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64785424|NCT00000174|Protective Agents|protective agents|mesh-ancestor
64785425|NCT00000192|Lamotrigine|lamotrigine|mesh-list
64785426|NCT00000192|Anticonvulsants|anticonvulsants|mesh-ancestor
64785427|NCT00000192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64785428|NCT00000192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64785429|NCT00000192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785430|NCT00000192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64785431|NCT00000192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396617|NCT02370433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64396618|NCT02370433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64396619|NCT01957150|Fluticasone|fluticasone|mesh-list
64396620|NCT01957150|Xhance|xhance|mesh-list
64396621|NCT01957150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64396623|NCT01957150|Autonomic Agents|autonomic agents|mesh-ancestor
64785433|NCT00000192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64987974|NCT00319618|Docetaxel|docetaxel|mesh-list
64987975|NCT00319618|Gefitinib|gefitinib|mesh-list
64987976|NCT00319618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987977|NCT00319618|Tubulin Modulators|tubulin modulators|mesh-ancestor
64987978|NCT00319618|Antimitotic Agents|antimitotic agents|mesh-ancestor
64987979|NCT00319618|Mitosis Modulators|mitosis modulators|mesh-ancestor
64987980|NCT00319618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987981|NCT00319618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64987982|NCT00319618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987983|NCT00124332|Rimonabant|rimonabant|mesh-list
64987984|NCT00124332|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64987985|NCT00124332|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
64987986|NCT00124332|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64987987|NCT00124332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64551106|NCT03104634|Adrenergic Agents|adrenergic agents|mesh-ancestor
64551107|NCT03104634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64551108|NCT03104634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551109|NCT03104634|Anticonvulsants|anticonvulsants|mesh-ancestor
64551111|NCT00871689|Cyclophosphamide|cyclophosphamide|mesh-list
64551112|NCT00871689|Fludarabine|fludarabine|mesh-list
64551113|NCT00871689|Fludarabine phosphate|fludarabine phosphate|mesh-list
64551114|NCT00871689|Interleukin-2|interleukin-2|mesh-list
64551115|NCT00871689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64551116|NCT00871689|Immunologic Factors|immunologic factors|mesh-ancestor
64551117|NCT00871689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551118|NCT00871689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64551119|NCT00871689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64551120|NCT00871689|Alkylating Agents|alkylating agents|mesh-ancestor
64551121|NCT00871689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551122|NCT00871689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551123|NCT00871689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64316085|NCT05549336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64987988|NCT00124332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987989|NCT00124332|Hormones|hormones|mesh-ancestor
64987990|NCT00124332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64988025|NCT00326833|Hematinics|hematinics|mesh-ancestor
64988026|NCT00085748|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64988027|NCT00085748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64988028|NCT00085748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64988029|NCT00085748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64988042|NCT04717102|Anesthetics, General|anesthetics, general|mesh-ancestor
64396645|NCT01946152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64396646|NCT01946152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396647|NCT01946152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64396648|NCT01946152|Glucocorticoids|glucocorticoids|mesh-ancestor
64396649|NCT01946152|Hormones|hormones|mesh-ancestor
64396650|NCT01946152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64396651|NCT01946152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64396652|NCT01946152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396653|NCT01946152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64396654|NCT01946152|Immunologic Factors|immunologic factors|mesh-ancestor
64988044|NCT04717102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64988045|NCT04717102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988046|NCT00320047|Baclofen|baclofen|mesh-list
64988047|NCT00320047|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64988048|NCT00320047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988049|NCT00320047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64988050|NCT00320047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64988051|NCT00320047|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64988052|NCT00320047|GABA Agonists|gaba agonists|mesh-ancestor
64988053|NCT00320047|GABA Agents|gaba agents|mesh-ancestor
64988054|NCT00320047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64988055|NCT00320047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988056|NCT00085826|Sulindac sulfone|sulindac sulfone|mesh-list
64988057|NCT00085826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988058|NCT00085826|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64988059|NCT00085826|Protective Agents|protective agents|mesh-ancestor
64988060|NCT00085826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988061|NCT00085826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64988062|NCT00085826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64301320|NCT04959812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64988063|NCT00085826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396667|NCT01971346|Sensory System Agents|sensory system agents|mesh-ancestor
64396668|NCT01971346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64396669|NCT01971346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396670|NCT01971346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64396671|NCT01971346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64396672|NCT01971346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64396673|NCT01971346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64396674|NCT01971346|Immunologic Factors|immunologic factors|mesh-ancestor
64396675|NCT01945216|Alogliptin|alogliptin|mesh-list
64396676|NCT01945216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64324547|NCT01234519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324548|NCT01234519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324549|NCT01474135|Travoprost|travoprost|mesh-list
64324550|NCT01474135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64785477|NCT00000228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64988064|NCT00085826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64988065|NCT00085826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64988067|NCT00085826|Sensory System Agents|sensory system agents|mesh-ancestor
64988068|NCT00085826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64551124|NCT00871689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64551126|NCT00871689|Antiviral Agents|antiviral agents|mesh-ancestor
64551127|NCT00871689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64551128|NCT00871689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64551129|NCT00871689|Analgesics|analgesics|mesh-ancestor
64551130|NCT00871689|Sensory System Agents|sensory system agents|mesh-ancestor
64551131|NCT00871689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64551132|NCT00871689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64551133|NCT00871689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64551134|NCT04174170|Sertraline|sertraline|mesh-list
64551135|NCT04174170|Brexpiprazole|brexpiprazole|mesh-list
64551136|NCT04174170|Antidepressive Agents|antidepressive agents|mesh-ancestor
64551137|NCT04174170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64551138|NCT04174170|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64551139|NCT04174170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64316105|NCT01666730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64988069|NCT00085826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64988070|NCT00085826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64988071|NCT00320125|Calcium|calcium|mesh-list
64988072|NCT00320125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64988073|NCT00320125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988074|NCT00093873|Motesanib diphosphate|motesanib diphosphate|mesh-list
64988075|NCT00093873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64988077|NCT00093873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988078|NCT00320320|Irinotecan|irinotecan|mesh-list
64988079|NCT00320320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64988080|NCT00320320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64988081|NCT00320320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988082|NCT00320320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988083|NCT00320320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988084|NCT00327106|Tranexamic Acid|tranexamic acid|mesh-list
64988085|NCT00327106|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64988086|NCT00327106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64988087|NCT00327106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988088|NCT00327106|Hemostatics|hemostatics|mesh-ancestor
64988112|NCT00327145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64988113|NCT00327145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64988114|NCT00327145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64988115|NCT00327145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64988116|NCT00327145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988117|NCT00327145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64988118|NCT00327145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988119|NCT00327145|Vasodilator Agents|vasodilator agents|mesh-ancestor
64988120|NCT00327145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64988121|NCT00327145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64988122|NCT00327145|Diuretics|diuretics|mesh-ancestor
64988123|NCT00327145|Natriuretic Agents|natriuretic agents|mesh-ancestor
64988124|NCT00327145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64988125|NCT00085943|Ritonavir|ritonavir|mesh-list
64988126|NCT00085943|Fosamprenavir|fosamprenavir|mesh-list
64988127|NCT00085943|Lamivudine|lamivudine|mesh-list
64988128|NCT00085943|Abacavir|abacavir|mesh-list
64988129|NCT00085943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64988130|NCT00085943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64551140|NCT04174170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64551141|NCT04174170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551142|NCT04174170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64551144|NCT04174170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551145|NCT04174170|Dopamine Agonists|dopamine agonists|mesh-ancestor
64551146|NCT04174170|Dopamine Agents|dopamine agents|mesh-ancestor
64551147|NCT02084797|Vasopressins|vasopressins|mesh-list
64551148|NCT02084797|Arginine Vasopressin|arginine vasopressin|mesh-list
64301321|NCT04959812|Anesthetics, General|anesthetics, general|mesh-ancestor
64316121|NCT04434560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316122|NCT04434560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64988131|NCT00085943|Protease Inhibitors|protease inhibitors|mesh-ancestor
64988132|NCT00085943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988133|NCT00085943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988134|NCT00085943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64988135|NCT00085943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64988136|NCT00085943|Antiviral Agents|antiviral agents|mesh-ancestor
64988137|NCT00085943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64988138|NCT00085943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64396702|NCT05070221|Immunologic Factors|immunologic factors|mesh-ancestor
64396703|NCT05070221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988139|NCT00085943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64988140|NCT00085943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64988170|NCT00327379|Hemostatics|hemostatics|mesh-ancestor
64988171|NCT00327379|Coagulants|coagulants|mesh-ancestor
64988172|NCT00327379|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64988173|NCT00327379|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64988174|NCT00327379|Protease Inhibitors|protease inhibitors|mesh-ancestor
64988175|NCT00327379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988176|NCT00327379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988177|NCT00327418|Atorvastatin|atorvastatin|mesh-list
64988178|NCT00327418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64988179|NCT00327418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64988180|NCT00327418|Antimetabolites|antimetabolites|mesh-ancestor
64988181|NCT00327418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988182|NCT00327418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64988183|NCT00327418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64988184|NCT00327418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988185|NCT00094029|Sunitinib|sunitinib|mesh-list
64988186|NCT00094029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988206|NCT00320632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64988207|NCT00320632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64988208|NCT00320632|Adrenergic Agents|adrenergic agents|mesh-ancestor
64988209|NCT00320632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64988210|NCT00320632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988212|NCT00320827|Immunologic Factors|immunologic factors|mesh-ancestor
64988213|NCT00320827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988214|NCT00320983|Topotecan|topotecan|mesh-list
64988215|NCT00320983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988216|NCT00320983|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64988217|NCT00320983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64988218|NCT00320983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988219|NCT00320983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988220|NCT00086177|Progesterone|progesterone|mesh-list
64988221|NCT00086177|Progestins|progestins|mesh-ancestor
64311299|NCT02087579|Aripiprazole|aripiprazole|mesh-list
64311300|NCT02087579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64311313|NCT02087579|Antiemetics|antiemetics|mesh-ancestor
64311314|NCT02087579|Autonomic Agents|autonomic agents|mesh-ancestor
64311315|NCT02087579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64311316|NCT02087579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64311317|NCT02087579|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64311318|NCT02087579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64311319|NCT02087579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64311320|NCT02087579|Antidepressive Agents|antidepressive agents|mesh-ancestor
64311321|NCT02087579|Dopamine Agonists|dopamine agonists|mesh-ancestor
64311322|NCT02087579|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64311323|NCT02087579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64311324|NCT02087579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64311325|NCT02087579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64311326|NCT02339584|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64311327|NCT02339584|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64988222|NCT00086177|Hormones|hormones|mesh-ancestor
64988223|NCT00086177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64988224|NCT00086177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988226|NCT05458765|Emtricitabine|emtricitabine|mesh-list
64988227|NCT05458765|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64988228|NCT05458765|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64988229|NCT05458765|Antiviral Agents|antiviral agents|mesh-ancestor
64551150|NCT02084797|Hemostatics|hemostatics|mesh-ancestor
64551151|NCT02084797|Coagulants|coagulants|mesh-ancestor
64551152|NCT02084797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64551153|NCT02084797|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64551154|NCT02084797|Natriuretic Agents|natriuretic agents|mesh-ancestor
64551155|NCT02084797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551156|NCT02084797|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64551157|NCT02084797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551158|NCT00873327|Tazobactam|tazobactam|mesh-list
64551159|NCT00873327|Piperacillin|piperacillin|mesh-list
64551160|NCT00873327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64551161|NCT00873327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64551162|NCT00873327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64551163|NCT00873327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64551164|NCT00873327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551165|NCT00873327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316130|NCT00103285|Leucovorin|leucovorin|mesh-list
64988230|NCT05458765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64988231|NCT05458765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64988232|NCT05458765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64988233|NCT05458765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988234|NCT05458765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988235|NCT05458765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64988236|NCT05458765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64988237|NCT00094146|Octreotide|octreotide|mesh-list
64988238|NCT00094146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64988239|NCT00094146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64988255|NCT00321178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988257|NCT00321178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64988258|NCT00124527|Capecitabine|capecitabine|mesh-list
64988259|NCT00124527|Irofulven|irofulven|mesh-list
64988260|NCT00124527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64988261|NCT00124527|Antimetabolites|antimetabolites|mesh-ancestor
64988262|NCT00124527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988263|NCT00124527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988264|NCT00124527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64988265|NCT00124527|Alkylating Agents|alkylating agents|mesh-ancestor
64988266|NCT00086294|Levodopa|levodopa|mesh-list
64988267|NCT00086294|Pimavanserin|pimavanserin|mesh-list
64988268|NCT00086294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64988269|NCT00086294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64988270|NCT00086294|Dopamine Agents|dopamine agents|mesh-ancestor
64988271|NCT00086294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64988272|NCT00086294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988273|NCT00086294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988274|NCT00086294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64988275|NCT00086294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64396715|NCT04404439|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64396716|NCT04404439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64396717|NCT04404439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64396719|NCT04404439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64988276|NCT00086294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64988277|NCT00086294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64988278|NCT00086294|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64988279|NCT00086294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64988280|NCT00086294|Serotonin Agents|serotonin agents|mesh-ancestor
64988281|NCT05458492|Sirolimus|sirolimus|mesh-list
64988282|NCT05458492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64988283|NCT05458492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64988284|NCT05458492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64551166|NCT04816890|Insulin Lispro|insulin lispro|mesh-list
64551167|NCT04816890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64551169|NCT01392677|Dapagliflozin|dapagliflozin|mesh-list
64551235|NCT03995004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64551236|NCT03995004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551237|NCT03995004|Antioxidants|antioxidants|mesh-ancestor
64551238|NCT03995004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551239|NCT03995004|Protective Agents|protective agents|mesh-ancestor
64551240|NCT03995004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64551241|NCT03995004|Cathartics|cathartics|mesh-ancestor
64551243|NCT03216525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64551244|NCT03249181|Dolutegravir|dolutegravir|mesh-list
64551245|NCT03249181|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64551246|NCT03249181|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64551247|NCT03249181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551248|NCT03249181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551249|NCT03249181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64551250|NCT03249181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64551251|NCT03249181|Antiviral Agents|antiviral agents|mesh-ancestor
64551252|NCT03249181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64551253|NCT03216447|Tacrolimus|tacrolimus|mesh-list
64316229|NCT02160223|Neostigmine|neostigmine|mesh-list
64988285|NCT05458492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988286|NCT05458492|Antifungal Agents|antifungal agents|mesh-ancestor
64988287|NCT05458492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64988288|NCT05458492|Immunologic Factors|immunologic factors|mesh-ancestor
64988289|NCT05458492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988290|NCT00086333|Docetaxel|docetaxel|mesh-list
64988291|NCT00086333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988292|NCT00086333|Tubulin Modulators|tubulin modulators|mesh-ancestor
64988293|NCT00086333|Antimitotic Agents|antimitotic agents|mesh-ancestor
64988294|NCT00086333|Mitosis Modulators|mitosis modulators|mesh-ancestor
64988295|NCT00086333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988319|NCT05458180|Tubulin Modulators|tubulin modulators|mesh-ancestor
64988320|NCT05458180|Antimitotic Agents|antimitotic agents|mesh-ancestor
64988321|NCT05458180|Mitosis Modulators|mitosis modulators|mesh-ancestor
64988322|NCT05458180|Analgesics|analgesics|mesh-ancestor
64988323|NCT05458180|Sensory System Agents|sensory system agents|mesh-ancestor
64988324|NCT05458180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64988325|NCT00419653|Haloperidol|haloperidol|mesh-list
64988326|NCT00419653|Olanzapine|olanzapine|mesh-list
64988327|NCT00419653|Haloperidol decanoate|haloperidol decanoate|mesh-list
64988328|NCT00419653|Amisulpride|amisulpride|mesh-list
64988329|NCT00419653|Antiemetics|antiemetics|mesh-ancestor
64988330|NCT00419653|Autonomic Agents|autonomic agents|mesh-ancestor
64988331|NCT00419653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64988332|NCT00419653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988333|NCT00419653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64988334|NCT00419653|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64988335|NCT00419653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64988336|NCT00419653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64988337|NCT00419653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64988338|NCT00419653|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64988339|NCT00419653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64311426|NCT04884802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64988340|NCT00419653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64988341|NCT00419653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988342|NCT00419653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64988343|NCT00419653|Serotonin Agents|serotonin agents|mesh-ancestor
64551254|NCT03216447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64551255|NCT03216447|Immunologic Factors|immunologic factors|mesh-ancestor
64551256|NCT03216447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551257|NCT03216447|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64551258|NCT03216447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551259|NCT03216447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551260|NCT04669938|Immunologic Factors|immunologic factors|mesh-list
64551261|NCT04669938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551262|NCT03957876|Cytarabine|cytarabine|mesh-list
64551263|NCT03957876|Daunorubicin|daunorubicin|mesh-list
64316244|NCT05256797|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64316245|NCT05256797|Antithrombins|antithrombins|mesh-ancestor
64988344|NCT00419653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64988345|NCT00419653|Dopamine Agents|dopamine agents|mesh-ancestor
64988346|NCT00419653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64988347|NCT00419653|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64988380|NCT00321490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64988381|NCT00321490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64988382|NCT00321490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64988383|NCT00321490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64988384|NCT00321490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988385|NCT00321490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64988386|NCT00321490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64988387|NCT00321490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64785522|NCT00000270|Sensory System Agents|sensory system agents|mesh-ancestor
64785523|NCT00000270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785524|NCT00000270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64785525|NCT00000270|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64785526|NCT00000270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64785527|NCT00000270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64311516|NCT02090153|Leucovorin|leucovorin|mesh-list
64311517|NCT02090153|Tegafur|tegafur|mesh-list
64311518|NCT02090153|Antidotes|antidotes|mesh-ancestor
64988401|NCT05457829|Irinotecan|irinotecan|mesh-list
64988402|NCT05457829|Vincristine|vincristine|mesh-list
64988403|NCT05457829|Temozolomide|temozolomide|mesh-list
64988404|NCT05457829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64988405|NCT05457829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988406|NCT05457829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64988407|NCT05457829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64988408|NCT05457829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988409|NCT05457829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988410|NCT05457829|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64988411|NCT05457829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64988412|NCT05457829|Tubulin Modulators|tubulin modulators|mesh-ancestor
64988413|NCT05457829|Antimitotic Agents|antimitotic agents|mesh-ancestor
64988414|NCT05457829|Mitosis Modulators|mitosis modulators|mesh-ancestor
64988415|NCT05457829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64988416|NCT05457829|Alkylating Agents|alkylating agents|mesh-ancestor
64988417|NCT05457751|Rocuronium|rocuronium|mesh-list
64988418|NCT05457751|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64988419|NCT05457751|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64988420|NCT05457751|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64988421|NCT05457751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64988422|NCT05457751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988423|NCT00086606|Omalizumab|omalizumab|mesh-list
64988424|NCT00086606|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64988426|NCT00086606|Respiratory System Agents|respiratory system agents|mesh-ancestor
64988427|NCT00124566|Prednisone|prednisone|mesh-list
64988428|NCT00124566|Capecitabine|capecitabine|mesh-list
64988429|NCT00124566|Mitoxantrone|mitoxantrone|mesh-list
64988430|NCT00124566|Irofulven|irofulven|mesh-list
64988431|NCT00124566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64988432|NCT00124566|Glucocorticoids|glucocorticoids|mesh-ancestor
64988433|NCT00124566|Hormones|hormones|mesh-ancestor
64988434|NCT00124566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64988435|NCT00124566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988436|NCT00124566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64988437|NCT00124566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988438|NCT00124566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64988439|NCT00124566|Antimetabolites|antimetabolites|mesh-ancestor
64551264|NCT03957876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64551265|NCT03957876|Antimetabolites|antimetabolites|mesh-ancestor
64551266|NCT03957876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714183|NCT02988050|Anesthetics|anesthetics|mesh-ancestor
64551267|NCT03957876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551269|NCT03957876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64551270|NCT03957876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64551271|NCT03957876|Immunologic Factors|immunologic factors|mesh-ancestor
64551272|NCT03957876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551273|NCT03957876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64551274|NCT03957876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64551275|NCT03957876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64551276|NCT03957876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551277|NCT03837925|Atorvastatin|atorvastatin|mesh-list
64551278|NCT03837925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64551279|NCT03837925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64551280|NCT03837925|Antimetabolites|antimetabolites|mesh-ancestor
64551281|NCT03837925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551282|NCT03837925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64551283|NCT03837925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64551284|NCT03837925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551285|NCT04398589|Dexmedetomidine|dexmedetomidine|mesh-list
64551286|NCT04398589|Ropivacaine|ropivacaine|mesh-list
64551287|NCT04398589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64551288|NCT04398589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64316254|NCT02160301|Oxycodone|oxycodone|mesh-list
64316255|NCT02160301|Gabapentin|gabapentin|mesh-list
64316263|NCT02160301|Hormones|hormones|mesh-ancestor
64988440|NCT00124566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988441|NCT00124566|Analgesics|analgesics|mesh-ancestor
64988442|NCT00124566|Sensory System Agents|sensory system agents|mesh-ancestor
64988443|NCT00124566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64988444|NCT00124566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64988445|NCT00124566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64988446|NCT00124566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988447|NCT00124566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64988448|NCT00124566|Alkylating Agents|alkylating agents|mesh-ancestor
64988477|NCT00321802|Antimetabolites|antimetabolites|mesh-ancestor
64988478|NCT00321802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988479|NCT00321802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64988480|NCT00321802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64988481|NCT00321802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988482|NCT00124605|Pamidronate|pamidronate|mesh-list
64988483|NCT00124605|Arsenic Trioxide|arsenic trioxide|mesh-list
64988484|NCT00124605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551289|NCT04398589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551290|NCT04398589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64551291|NCT04398589|Analgesics|analgesics|mesh-ancestor
64551292|NCT04398589|Sensory System Agents|sensory system agents|mesh-ancestor
64551293|NCT04398589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64551294|NCT04398589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64551295|NCT04398589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64551296|NCT04398589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64551297|NCT04398589|Adrenergic Agents|adrenergic agents|mesh-ancestor
64551298|NCT04398589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64551299|NCT04398589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551300|NCT04398589|Anesthetics, Local|anesthetics, local|mesh-ancestor
64551301|NCT04398589|Anesthetics|anesthetics|mesh-ancestor
64551302|NCT03892044|Nivolumab|nivolumab|mesh-list
64551303|NCT03892044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64551304|NCT03892044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551305|NCT03892044|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64551306|NCT03892044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316281|NCT02160301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64988485|NCT00124605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64988486|NCT00124605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988487|NCT05457361|Azacitidine|azacitidine|mesh-list
64988488|NCT05457361|Homoharringtonine|homoharringtonine|mesh-list
64988489|NCT05457361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64988490|NCT05457361|Antimetabolites|antimetabolites|mesh-ancestor
64988491|NCT05457361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988492|NCT05457361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988493|NCT05457361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988510|NCT00086801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988511|NCT00086801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64988512|NCT00086801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64988513|NCT00086801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64988514|NCT00086801|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64988515|NCT00086801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64988516|NCT00086801|Tubulin Modulators|tubulin modulators|mesh-ancestor
64988517|NCT00086801|Antimitotic Agents|antimitotic agents|mesh-ancestor
64988518|NCT00086801|Mitosis Modulators|mitosis modulators|mesh-ancestor
64988519|NCT05456113|Cannabidiol|cannabidiol|mesh-list
64988520|NCT05456113|Anticonvulsants|anticonvulsants|mesh-ancestor
64988522|NCT00124644|Etoposide|etoposide|mesh-list
64988523|NCT00124644|Daunorubicin|daunorubicin|mesh-list
64988524|NCT00124644|Tipifarnib|tipifarnib|mesh-list
64988525|NCT00124644|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64988526|NCT00124644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64988527|NCT00124644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396725|NCT04404439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64396726|NCT04404439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396727|NCT04404439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64396728|NCT04404439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64324552|NCT02268565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64324553|NCT02268565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64311674|NCT02097329|Antioxidants|antioxidants|mesh-ancestor
64988528|NCT00124644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64988529|NCT00124644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64988530|NCT00124644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551308|NCT00874887|Gatifloxacin|gatifloxacin|mesh-list
64551309|NCT00874887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64551310|NCT00874887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64551311|NCT00874887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64551312|NCT00874887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64551313|NCT00874887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64551314|NCT00874887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64551315|NCT00874887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551316|NCT00874887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551317|NCT00874887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551318|NCT03882060|Epoetin Alfa|epoetin alfa|mesh-list
64551319|NCT03882060|Hematinics|hematinics|mesh-ancestor
64551320|NCT01376505|Vaccines|vaccines|mesh-list
64551321|NCT01376505|Immunologic Factors|immunologic factors|mesh-ancestor
64551322|NCT01376505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551323|NCT00875277|Betamethasone|betamethasone|mesh-list
64551324|NCT00875277|Betamethasone Valerate|betamethasone valerate|mesh-list
64988531|NCT00124644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64988532|NCT00124644|Antimetabolites|antimetabolites|mesh-ancestor
64988533|NCT00124644|Antiviral Agents|antiviral agents|mesh-ancestor
64988534|NCT00124644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64988535|NCT00124644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64988536|NCT00124644|Immunologic Factors|immunologic factors|mesh-ancestor
64988537|NCT00124644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988538|NCT00124644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64988539|NCT00086840|Sirolimus|sirolimus|mesh-list
64988540|NCT00086840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64988541|NCT00086840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64988542|NCT00086840|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64988543|NCT00086840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988544|NCT00086840|Antifungal Agents|antifungal agents|mesh-ancestor
64988545|NCT00086840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64988546|NCT00086840|Immunologic Factors|immunologic factors|mesh-ancestor
64988547|NCT00086840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988548|NCT00124683|Bupropion|bupropion|mesh-list
64551325|NCT00875277|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64551326|NCT00875277|Betamethasone benzoate|betamethasone benzoate|mesh-list
64551327|NCT00875277|Calcipotriene|calcipotriene|mesh-list
64551328|NCT00875277|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64551329|NCT00875277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64551331|NCT00875277|Hormones|hormones|mesh-ancestor
64551332|NCT00875277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64551333|NCT00875277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551334|NCT00875277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64551335|NCT00875277|Respiratory System Agents|respiratory system agents|mesh-ancestor
64551336|NCT00875277|Dermatologic Agents|dermatologic agents|mesh-ancestor
64551337|NCT04634539|Gemcitabine|gemcitabine|mesh-list
64551338|NCT04634539|Paclitaxel|paclitaxel|mesh-list
64551339|NCT04634539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64551340|NCT04634539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551341|NCT04634539|Tubulin Modulators|tubulin modulators|mesh-ancestor
64551342|NCT04634539|Antimitotic Agents|antimitotic agents|mesh-ancestor
64551343|NCT04634539|Mitosis Modulators|mitosis modulators|mesh-ancestor
64551344|NCT04634539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311807|NCT02094287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311808|NCT02094287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311809|NCT02094287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64311810|NCT02100293|Magnesium Sulfate|magnesium sulfate|mesh-list
64311811|NCT02100293|Analgesics|analgesics|mesh-ancestor
64311812|NCT02100293|Sensory System Agents|sensory system agents|mesh-ancestor
64311815|NCT02100293|Anesthetics|anesthetics|mesh-ancestor
64551345|NCT04634539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64551346|NCT04634539|Antimetabolites|antimetabolites|mesh-ancestor
64551347|NCT04634539|Antiviral Agents|antiviral agents|mesh-ancestor
64551348|NCT04634539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64551349|NCT04634539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988549|NCT00124683|Nicotine|nicotine|mesh-list
64988550|NCT00124683|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64988551|NCT00124683|Autonomic Agents|autonomic agents|mesh-ancestor
64988552|NCT00124683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64988553|NCT00124683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988554|NCT00124683|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64988573|NCT00086879|Carmustine|carmustine|mesh-list
64988574|NCT00086879|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64988575|NCT00086879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64988576|NCT00086879|Alkylating Agents|alkylating agents|mesh-ancestor
64988577|NCT00086879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988578|NCT00086879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988579|NCT00086879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64988580|NCT00086879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988581|NCT00124722|Bromides|bromides|mesh-list
64988582|NCT00124722|Rocuronium|rocuronium|mesh-list
64988583|NCT00124722|Anticonvulsants|anticonvulsants|mesh-ancestor
64988584|NCT00124722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64988585|NCT00124722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64988586|NCT00124722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64988587|NCT00124722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64988588|NCT00124722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988589|NCT00322036|Flurbiprofen|flurbiprofen|mesh-list
64988590|NCT00322036|Analgesics|analgesics|mesh-ancestor
64988591|NCT00322036|Sensory System Agents|sensory system agents|mesh-ancestor
64988592|NCT00322036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316358|NCT05125055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64551350|NCT04634539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64551351|NCT04634539|Immunologic Factors|immunologic factors|mesh-ancestor
64551352|NCT04634539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551354|NCT03750786|Antidotes|antidotes|mesh-ancestor
64551355|NCT03750786|Protective Agents|protective agents|mesh-ancestor
64551356|NCT03750786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551357|NCT03750786|Vitamin B Complex|vitamin b complex|mesh-ancestor
64551358|NCT03750786|Vitamins|vitamins|mesh-ancestor
64551359|NCT03750786|Micronutrients|micronutrients|mesh-ancestor
64551360|NCT04457245|Fluorides|fluorides|mesh-list
64301322|NCT04959812|Anesthetics|anesthetics|mesh-ancestor
64988593|NCT00322036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988594|NCT00322036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64988595|NCT00322036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64988596|NCT00322036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64988597|NCT00322036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64988598|NCT00322036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64988599|NCT00322036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988600|NCT00322036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988602|NCT00094614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64988603|NCT00094614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64311862|NCT02100761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988604|NCT00094614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64988605|NCT00094614|Autonomic Agents|autonomic agents|mesh-ancestor
64988606|NCT00094614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64988607|NCT00094614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988608|NCT00094614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64988630|NCT00322114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64988631|NCT00322114|Antioxidants|antioxidants|mesh-ancestor
64988632|NCT00322114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988633|NCT00322114|Protective Agents|protective agents|mesh-ancestor
64988634|NCT00322114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988635|NCT00322114|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64988636|NCT00322114|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64988637|NCT00322114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988638|NCT00087074|Sirolimus|sirolimus|mesh-list
64988639|NCT00087074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64988640|NCT00087074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64988641|NCT00087074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64988642|NCT00087074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988643|NCT00087074|Antifungal Agents|antifungal agents|mesh-ancestor
64988644|NCT00087074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64988645|NCT00087074|Immunologic Factors|immunologic factors|mesh-ancestor
64988646|NCT00087074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988647|NCT00332176|Ribavirin|ribavirin|mesh-list
64988648|NCT00332176|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64988649|NCT00332176|Antimetabolites|antimetabolites|mesh-ancestor
64988650|NCT00332176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988651|NCT00332176|Antiviral Agents|antiviral agents|mesh-ancestor
64988652|NCT00332176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64988653|NCT00087113|Pemetrexed|pemetrexed|mesh-list
64988654|NCT00087113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988655|NCT00087113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988656|NCT00087113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988657|NCT00087113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64785530|NCT00000270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64785531|NCT00000276|Bupropion|bupropion|mesh-list
64785532|NCT00000276|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64785533|NCT00000276|Antidepressive Agents|antidepressive agents|mesh-ancestor
64988658|NCT00087113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64988659|NCT00332254|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64988660|NCT00332254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64988661|NCT00332293|Moxifloxacin|moxifloxacin|mesh-list
64988662|NCT00332293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64988688|NCT00094692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64988689|NCT00094692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64988690|NCT00094692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64551362|NCT04457245|Protective Agents|protective agents|mesh-ancestor
64551363|NCT04457245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551364|NCT03828799|Folfirinox|folfirinox|mesh-list
64551365|NCT03828799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551366|NCT03710460|Metformin|metformin|mesh-list
64551367|NCT03710460|Dapagliflozin|dapagliflozin|mesh-list
64551368|NCT03710460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64551369|NCT03710460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551370|NCT03710460|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64551371|NCT03710460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551372|NCT01395017|Dasatinib|dasatinib|mesh-list
64551373|NCT01395017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551374|NCT01395017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64551375|NCT01395017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551376|NCT01395017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551377|NCT03299088|Pembrolizumab|pembrolizumab|mesh-list
64551378|NCT03299088|Trametinib|trametinib|mesh-list
64551379|NCT03299088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64551380|NCT03299088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64484219|NCT01751113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64484220|NCT01751113|Autonomic Agents|autonomic agents|mesh-ancestor
64736761|NCT05599919|Autonomic Agents|autonomic agents|mesh-ancestor
64988691|NCT00094692|Autonomic Agents|autonomic agents|mesh-ancestor
64988692|NCT00094692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64988693|NCT00094692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988694|NCT00094692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64988695|NCT00094692|Respiratory System Agents|respiratory system agents|mesh-ancestor
64988697|NCT00094692|Parasympatholytics|parasympatholytics|mesh-ancestor
64988698|NCT00094692|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64988699|NCT00094692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64988700|NCT00094692|Cholinergic Agents|cholinergic agents|mesh-ancestor
64988701|NCT00094692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64988702|NCT00094692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988704|NCT05181007|Anticonvulsants|anticonvulsants|mesh-ancestor
64988705|NCT05181007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988706|NCT05181007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988707|NCT05181007|GABA Agents|gaba agents|mesh-ancestor
64988708|NCT05181007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64988709|NCT05181007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988730|NCT05126836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64988731|NCT05126836|Respiratory System Agents|respiratory system agents|mesh-ancestor
64988732|NCT05126836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64988733|NCT05126836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64988734|NCT05126836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988735|NCT05126836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64785538|NCT00000276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785539|NCT00000276|Dopamine Agents|dopamine agents|mesh-ancestor
64785540|NCT00000276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64988736|NCT05126836|Vasodilator Agents|vasodilator agents|mesh-ancestor
64988737|NCT05126836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64988738|NCT05126836|Protective Agents|protective agents|mesh-ancestor
64988739|NCT05126836|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64484221|NCT01751113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64551381|NCT03299088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64551383|NCT03299088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551384|NCT03235986|Poractant alfa|poractant alfa|mesh-list
64551385|NCT03235986|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
64551386|NCT03235986|Respiratory System Agents|respiratory system agents|mesh-ancestor
64551387|NCT03657342|Cyclosporine|cyclosporine|mesh-list
64551388|NCT03657342|Cyclosporins|cyclosporins|mesh-list
64551389|NCT03657342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551390|NCT03657342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551391|NCT03657342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64551392|NCT03657342|Immunologic Factors|immunologic factors|mesh-ancestor
64551393|NCT03657342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316390|NCT05699876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64988740|NCT05126836|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64988742|NCT00087347|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64988743|NCT00087347|Hematinics|hematinics|mesh-ancestor
64988744|NCT00087347|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64988745|NCT00087347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64988746|NCT04960930|Minocycline|minocycline|mesh-list
64988747|NCT04960930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64988748|NCT04960930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64988750|NCT00419692|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64988751|NCT00419692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64988752|NCT00419692|Dopamine Agonists|dopamine agonists|mesh-ancestor
64988753|NCT00419692|Dopamine Agents|dopamine agents|mesh-ancestor
64988754|NCT00419692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64988755|NCT00419692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988756|NCT00419692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988757|NCT00419731|Naltrexone|naltrexone|mesh-list
64988758|NCT00419731|Bupropion|bupropion|mesh-list
64988759|NCT00419731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64988760|NCT00419731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64988761|NCT00419731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988762|NCT00419731|Sensory System Agents|sensory system agents|mesh-ancestor
64988763|NCT00419731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64988783|NCT00094848|Mapatumumab|mapatumumab|mesh-list
64988784|NCT00094848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988785|NCT00087425|Rituximab|rituximab|mesh-list
64988786|NCT00087425|Bryostatin 1|bryostatin 1|mesh-list
64988787|NCT00087425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64988788|NCT00087425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988789|NCT00087425|Immunologic Factors|immunologic factors|mesh-ancestor
64988790|NCT00087425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988791|NCT00087425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64988792|NCT00087425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64988794|NCT00330655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64988795|NCT00330655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64988796|NCT00330655|Dopamine Agents|dopamine agents|mesh-ancestor
64988797|NCT00330655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64988798|NCT00330655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988799|NCT00330655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988800|NCT00330655|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64988801|NCT00330655|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64988802|NCT00330772|Aspirin|aspirin|mesh-list
64988803|NCT00330772|Clopidogrel|clopidogrel|mesh-list
64551394|NCT03657342|Antifungal Agents|antifungal agents|mesh-ancestor
64551395|NCT03657342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64551396|NCT03657342|Dermatologic Agents|dermatologic agents|mesh-ancestor
64551397|NCT03657342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64551398|NCT03657342|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64551399|NCT03600090|Paclitaxel|paclitaxel|mesh-list
64551400|NCT03600090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64551401|NCT03600090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551402|NCT03600090|Tubulin Modulators|tubulin modulators|mesh-ancestor
64551403|NCT03600090|Antimitotic Agents|antimitotic agents|mesh-ancestor
64551404|NCT03600090|Mitosis Modulators|mitosis modulators|mesh-ancestor
64551405|NCT03600090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551407|NCT02912988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316403|NCT05610878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64988804|NCT00330772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64988805|NCT00330772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64988806|NCT00330772|Analgesics|analgesics|mesh-ancestor
64988807|NCT00330772|Sensory System Agents|sensory system agents|mesh-ancestor
64988808|NCT00330772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64988809|NCT00330772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988810|NCT00330772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64988811|NCT00330772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64988812|NCT00330772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64988813|NCT00330772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64988814|NCT00330772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988815|NCT00330772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64988816|NCT00330772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64988850|NCT00331045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64988851|NCT00331084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64988852|NCT00331084|Moxifloxacin|moxifloxacin|mesh-list
64988853|NCT00331084|Dexamethasone|dexamethasone|mesh-list
64785549|NCT00000294|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64785550|NCT00000294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64554134|NCT00983515|Ritonavir|ritonavir|mesh-list
64785551|NCT00000294|Adrenergic Agents|adrenergic agents|mesh-ancestor
64785552|NCT00000294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64785553|NCT00000294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785554|NCT00000294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988854|NCT00331084|Dexamethasone acetate|dexamethasone acetate|mesh-list
64988855|NCT00331084|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64988856|NCT00331084|BB 1101|bb 1101|mesh-list
64988857|NCT00331084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64988858|NCT00331084|Antiemetics|antiemetics|mesh-ancestor
64988859|NCT00331084|Autonomic Agents|autonomic agents|mesh-ancestor
64988860|NCT00331084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64988878|NCT00331084|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64988879|NCT00331084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64988880|NCT00420355|Ritonavir|ritonavir|mesh-list
64988881|NCT00420355|Lopinavir|lopinavir|mesh-list
64988882|NCT00420355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64988883|NCT00420355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64988884|NCT00420355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64988885|NCT00420355|Protease Inhibitors|protease inhibitors|mesh-ancestor
64988886|NCT00420355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988887|NCT00420355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988888|NCT00420355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64988889|NCT00420355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64988890|NCT00420355|Antiviral Agents|antiviral agents|mesh-ancestor
64988891|NCT00420355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64988892|NCT00420355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64988893|NCT00420355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64988894|NCT00331123|Testosterone|testosterone|mesh-list
64988895|NCT00331123|Androgens|androgens|mesh-ancestor
64988897|NCT00331123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64988898|NCT00331123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988899|NCT00087542|Pimavanserin|pimavanserin|mesh-list
64988900|NCT00087542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64551408|NCT02912988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64551409|NCT02912988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64551410|NCT02912988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551411|NCT02912988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551412|NCT02912988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64551413|NCT02912988|Hormone Antagonists|hormone antagonists|mesh-ancestor
64551414|NCT02912988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64551415|NCT02912988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551416|NCT03103074|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
64551417|NCT03103074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64551418|NCT03103074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64551419|NCT03103074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64316417|NCT02706405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64988901|NCT00087542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64988902|NCT00087542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64988903|NCT00087542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64988904|NCT00087542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64988905|NCT00087542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988906|NCT00087542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64312242|NCT04864496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64312243|NCT04864496|Expectorants|expectorants|mesh-ancestor
64312244|NCT04864496|Respiratory System Agents|respiratory system agents|mesh-ancestor
64312245|NCT04864496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64312246|NCT04864496|Antioxidants|antioxidants|mesh-ancestor
64312247|NCT04864496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312249|NCT04864496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312250|NCT04864496|Antidotes|antidotes|mesh-ancestor
64312252|NCT02250833|Telmisartan|telmisartan|mesh-list
64988907|NCT00087542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64988908|NCT00087542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64988909|NCT00087542|Serotonin Agents|serotonin agents|mesh-ancestor
64988910|NCT00087542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64988911|NCT00087542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988912|NCT00331240|Timolol|timolol|mesh-list
64988913|NCT00331240|Travoprost|travoprost|mesh-list
64988914|NCT00331240|Lubricant Eye Drops|lubricant eye drops|mesh-list
64988915|NCT00331240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64988916|NCT00331240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64988942|NCT00087581|Antifungal Agents|antifungal agents|mesh-ancestor
64988943|NCT00087581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64988944|NCT00087581|Dermatologic Agents|dermatologic agents|mesh-ancestor
64988945|NCT00087581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64988946|NCT00087581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64988947|NCT00087581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988948|NCT00087581|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64988949|NCT00087581|Antitubercular Agents|antitubercular agents|mesh-ancestor
64988950|NCT00087581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64988952|NCT00094965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988953|NCT00331435|Verteporfin|verteporfin|mesh-list
64988954|NCT00331435|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64988955|NCT00331435|Dermatologic Agents|dermatologic agents|mesh-ancestor
64988956|NCT00331513|Vorinostat|vorinostat|mesh-list
64988957|NCT00331513|Idarubicin|idarubicin|mesh-list
64988958|NCT00331513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988959|NCT00331513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64988960|NCT00331513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988961|NCT00331513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988962|NCT00331513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64988963|NCT00331513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64988980|NCT00124995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64988981|NCT00124995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64988982|NCT00124995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64988983|NCT00124995|Adrenergic Agents|adrenergic agents|mesh-ancestor
64988984|NCT00124995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64988985|NCT00124995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988987|NCT00331708|Pyrimethamine|pyrimethamine|mesh-list
64785564|NCT00000306|Dextroamphetamine|dextroamphetamine|mesh-list
64785573|NCT00000318|Buprenorphine|buprenorphine|mesh-list
64551420|NCT03103074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551421|NCT03103074|Cholinergic Agents|cholinergic agents|mesh-ancestor
64551422|NCT03103074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64551423|NCT03103074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551424|NCT00876915|Dalteparin|dalteparin|mesh-list
64551425|NCT00876915|Tinzaparin|tinzaparin|mesh-list
64551426|NCT00876915|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64551427|NCT00876915|Anticoagulants|anticoagulants|mesh-ancestor
64551428|NCT00876915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64551429|NCT00876915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64551430|NCT00876915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551432|NCT02854488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64551433|NCT02854488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551434|NCT02854488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64551435|NCT02854488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551436|NCT02804022|Morphine|morphine|mesh-list
64551437|NCT02804022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64551438|NCT02804022|Narcotics|narcotics|mesh-ancestor
64551439|NCT02804022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64551440|NCT02804022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551441|NCT02804022|Analgesics|analgesics|mesh-ancestor
64551442|NCT02804022|Sensory System Agents|sensory system agents|mesh-ancestor
64988988|NCT00331708|Sulfadoxine|sulfadoxine|mesh-list
64988989|NCT00331708|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64988990|NCT00331708|Antimalarials|antimalarials|mesh-ancestor
64988991|NCT00331708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64988992|NCT00331708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64988993|NCT00331708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64988994|NCT00331708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988995|NCT00331708|Antiviral Agents|antiviral agents|mesh-ancestor
64988996|NCT00331708|Schistosomicides|schistosomicides|mesh-ancestor
64988997|NCT00331708|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64988998|NCT00331708|Anthelmintics|anthelmintics|mesh-ancestor
64988999|NCT00331708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64989000|NCT00331708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64989001|NCT00331708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989002|NCT00331708|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64989003|NCT00331708|Renal Agents|renal agents|mesh-ancestor
64989004|NCT00331747|Glatiramer Acetate|glatiramer acetate|mesh-list
64989005|NCT00331747|(T,G)-A-L|(t,g)-a-l|mesh-list
64989006|NCT00331747|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64989007|NCT00331747|Immunologic Factors|immunologic factors|mesh-ancestor
64989008|NCT00331747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989009|NCT00331747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64989010|NCT00331747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64989011|NCT00087659|Zoledronic Acid|zoledronic acid|mesh-list
64989012|NCT00087659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64989013|NCT00087659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989014|NCT00331786|Aspirin|aspirin|mesh-list
64989015|NCT00331786|Nitroaspirin|nitroaspirin|mesh-list
64989016|NCT00331786|Nitric Oxide|nitric oxide|mesh-list
64551443|NCT02804022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64551444|NCT00876993|Bevacizumab|bevacizumab|mesh-list
64551445|NCT00876993|Irinotecan|irinotecan|mesh-list
64551446|NCT00876993|Temozolomide|temozolomide|mesh-list
64551447|NCT00876993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64551448|NCT00876993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551449|NCT00876993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64551450|NCT00876993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64551451|NCT00876993|Growth Substances|growth substances|mesh-ancestor
64551452|NCT00876993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551453|NCT00876993|Growth Inhibitors|growth inhibitors|mesh-ancestor
64551454|NCT00876993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64551455|NCT00876993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64551456|NCT00876993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551457|NCT00876993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551458|NCT00876993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64551459|NCT00876993|Alkylating Agents|alkylating agents|mesh-ancestor
64551460|NCT00896181|Carboplatin|carboplatin|mesh-list
64551461|NCT00896181|Docetaxel|docetaxel|mesh-list
64551462|NCT00896181|Fluorouracil|fluorouracil|mesh-list
64551463|NCT00896181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989017|NCT00331786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64989018|NCT00331786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64989019|NCT00331786|Analgesics|analgesics|mesh-ancestor
64989020|NCT00331786|Sensory System Agents|sensory system agents|mesh-ancestor
64989021|NCT00331786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64989022|NCT00331786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989023|NCT00331786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64989024|NCT00331786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64989042|NCT00331786|Protective Agents|protective agents|mesh-ancestor
64301337|NCT04463030|Ascorbic Acid|ascorbic acid|mesh-list
64989043|NCT00331786|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64989044|NCT00331786|Protease Inhibitors|protease inhibitors|mesh-ancestor
64989045|NCT00331825|Olanzapine|olanzapine|mesh-list
64989046|NCT00331825|Risperidone|risperidone|mesh-list
64989047|NCT00331825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64989048|NCT00331825|Serotonin Agents|serotonin agents|mesh-ancestor
64989049|NCT00331825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64989050|NCT00331825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989051|NCT00331825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989052|NCT00331825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64989053|NCT00331825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64989054|NCT00331825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64989055|NCT00331825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64989056|NCT00331825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64989057|NCT00331825|Dopamine Agents|dopamine agents|mesh-ancestor
64989058|NCT00331825|Antiemetics|antiemetics|mesh-ancestor
64989059|NCT00331825|Autonomic Agents|autonomic agents|mesh-ancestor
64989060|NCT00331825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64989061|NCT00331825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64989062|NCT00331825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64989063|NCT00331825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64989064|NCT00331825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64989065|NCT00420472|Mycophenolic Acid|mycophenolic acid|mesh-list
64989066|NCT00420472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64551464|NCT00896181|Tubulin Modulators|tubulin modulators|mesh-ancestor
64551465|NCT00896181|Antimitotic Agents|antimitotic agents|mesh-ancestor
64551466|NCT00896181|Mitosis Modulators|mitosis modulators|mesh-ancestor
64551467|NCT00896181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551468|NCT00896181|Antimetabolites|antimetabolites|mesh-ancestor
64551469|NCT00896181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64551470|NCT00896181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64551471|NCT00896181|Immunologic Factors|immunologic factors|mesh-ancestor
64551472|NCT00896181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551473|NCT02647320|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64551474|NCT02647320|Firuglipel|firuglipel|mesh-list
64507597|NCT01375608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551475|NCT02647320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64551476|NCT02647320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551477|NCT02647320|Incretins|incretins|mesh-ancestor
64551478|NCT02647320|Hormones|hormones|mesh-ancestor
64551479|NCT02647320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64551480|NCT02647320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64551481|NCT02647320|Protease Inhibitors|protease inhibitors|mesh-ancestor
64316473|NCT01569659|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64989067|NCT00420472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989068|NCT00420472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64989069|NCT00420472|Antitubercular Agents|antitubercular agents|mesh-ancestor
64989070|NCT00420472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64989071|NCT00420472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64989072|NCT00420472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64989073|NCT00420472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989074|NCT00087737|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64989075|NCT00087737|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64989076|NCT00087737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64785605|NCT00000342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785606|NCT00000342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64396772|NCT02369965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989077|NCT00087737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64989078|NCT00087737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989079|NCT00087737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64989099|NCT00126633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989100|NCT00126633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64989101|NCT00126633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64989102|NCT00126633|Growth Substances|growth substances|mesh-ancestor
64989103|NCT00126633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989104|NCT00126633|Growth Inhibitors|growth inhibitors|mesh-ancestor
64989105|NCT00126633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64989106|NCT00126633|Antimetabolites|antimetabolites|mesh-ancestor
64989107|NCT00126633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989108|NCT00126633|Antiviral Agents|antiviral agents|mesh-ancestor
64989109|NCT00126633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64989110|NCT00126633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64989111|NCT00126633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64989112|NCT00126633|Immunologic Factors|immunologic factors|mesh-ancestor
64989114|NCT00332020|Rivaroxaban|rivaroxaban|mesh-list
64989115|NCT00332020|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64989116|NCT00332020|Antithrombins|antithrombins|mesh-ancestor
64551482|NCT02647320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551483|NCT02647320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551484|NCT03457896|Trastuzumab|trastuzumab|mesh-list
64551485|NCT03457896|Cetuximab|cetuximab|mesh-list
64551486|NCT03457896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64551487|NCT03457896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551488|NCT04380597|Betamethasone|betamethasone|mesh-list
64551489|NCT04380597|Betamethasone Valerate|betamethasone valerate|mesh-list
64551490|NCT04380597|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64551491|NCT04380597|Betamethasone benzoate|betamethasone benzoate|mesh-list
64551492|NCT04380597|Calcipotriene|calcipotriene|mesh-list
64551493|NCT04380597|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64312510|NCT03189069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312511|NCT03189069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312512|NCT03040934|Sirolimus|sirolimus|mesh-list
64312513|NCT03040934|Everolimus|everolimus|mesh-list
64312514|NCT03040934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312515|NCT03040934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64312516|NCT03040934|Immunologic Factors|immunologic factors|mesh-ancestor
64312517|NCT03040934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312518|NCT03040934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64312519|NCT03040934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64312520|NCT03040934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64312521|NCT03040934|Antifungal Agents|antifungal agents|mesh-ancestor
64312522|NCT04861142|Denosumab|denosumab|mesh-list
64312523|NCT04861142|Alendronate|alendronate|mesh-list
64551494|NCT04380597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64551495|NCT04380597|Glucocorticoids|glucocorticoids|mesh-ancestor
64551496|NCT04380597|Hormones|hormones|mesh-ancestor
64551497|NCT04380597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64551498|NCT04380597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551499|NCT04380597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64551500|NCT04380597|Respiratory System Agents|respiratory system agents|mesh-ancestor
64551501|NCT04380597|Dermatologic Agents|dermatologic agents|mesh-ancestor
64551502|NCT03214731|Artesunate|artesunate|mesh-list
64551503|NCT03214731|Antimalarials|antimalarials|mesh-ancestor
64551504|NCT03214731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64551505|NCT03214731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64551506|NCT03214731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64551507|NCT03214731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551508|NCT03214731|Antiviral Agents|antiviral agents|mesh-ancestor
64551509|NCT03214731|Schistosomicides|schistosomicides|mesh-ancestor
64551510|NCT03214731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64316490|NCT02253953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64989117|NCT00332020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64989118|NCT00332020|Protease Inhibitors|protease inhibitors|mesh-ancestor
64989119|NCT00332020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64989120|NCT00332020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989121|NCT00332020|Anticoagulants|anticoagulants|mesh-ancestor
64989122|NCT00332020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64989123|NCT00332020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64989124|NCT02965274|Fluoxetine|fluoxetine|mesh-list
64989125|NCT02965274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64989126|NCT02965274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64989127|NCT02965274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64989128|NCT02965274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989129|NCT02965274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64989130|NCT02965274|Serotonin Agents|serotonin agents|mesh-ancestor
64551511|NCT03214731|Anthelmintics|anthelmintics|mesh-ancestor
64551512|NCT04424862|Cyclosporine|cyclosporine|mesh-list
64551513|NCT04424862|Mycophenolic Acid|mycophenolic acid|mesh-list
64551514|NCT04424862|Prednisone|prednisone|mesh-list
64551515|NCT04424862|Cyclosporins|cyclosporins|mesh-list
64551516|NCT04424862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64551517|NCT04424862|Glucocorticoids|glucocorticoids|mesh-ancestor
64551518|NCT04424862|Hormones|hormones|mesh-ancestor
64551519|NCT04424862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64551520|NCT04424862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551521|NCT04424862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64551522|NCT04424862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551523|NCT04424862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551524|NCT04424862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551525|NCT04424862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64551526|NCT04424862|Immunologic Factors|immunologic factors|mesh-ancestor
64396786|NCT02640755|Antimitotic Agents|antimitotic agents|mesh-ancestor
64396787|NCT02640755|Mitosis Modulators|mitosis modulators|mesh-ancestor
64396788|NCT02640755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785617|NCT00000348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785619|NCT00000354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64785620|NCT00000354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64312544|NCT02434029|Autonomic Agents|autonomic agents|mesh-ancestor
64312545|NCT02434029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312546|NCT02434029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312550|NCT02434029|Hormones|hormones|mesh-ancestor
64551527|NCT04424862|Antifungal Agents|antifungal agents|mesh-ancestor
64551528|NCT04424862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64551529|NCT04424862|Dermatologic Agents|dermatologic agents|mesh-ancestor
64551530|NCT04424862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64551531|NCT04424862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64551532|NCT04424862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64551533|NCT04424862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64551534|NCT04424862|Antitubercular Agents|antitubercular agents|mesh-ancestor
64316520|NCT03107169|Vancomycin|vancomycin|mesh-list
64989131|NCT02965274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989132|NCT02965274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64989144|NCT00332059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989145|NCT00332059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989147|NCT00332059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64989148|NCT00332137|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64989149|NCT00332137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64989150|NCT00332137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64989151|NCT00332137|Cholinergic Agents|cholinergic agents|mesh-ancestor
64989152|NCT00332137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64989153|NCT00332137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989154|NCT00332137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989155|NCT00332137|Urological Agents|urological agents|mesh-ancestor
64989156|NCT00126789|Fentanyl|fentanyl|mesh-list
64989157|NCT00126789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64989158|NCT00126789|Narcotics|narcotics|mesh-ancestor
64989159|NCT00126789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64989160|NCT00126789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989161|NCT00126789|Analgesics|analgesics|mesh-ancestor
64989162|NCT00126789|Sensory System Agents|sensory system agents|mesh-ancestor
64989163|NCT00126789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64989164|NCT00126789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64989165|NCT00126789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64551535|NCT04424862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64551538|NCT00882687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64551539|NCT04313166|Copper|copper|mesh-list
64551540|NCT04313166|Trace Elements|trace elements|mesh-ancestor
64551541|NCT04313166|Micronutrients|micronutrients|mesh-ancestor
64551542|NCT04313166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551543|NCT00883233|Adapalene|adapalene|mesh-list
64551544|NCT00883233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64551545|NCT00883233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64551546|NCT00883233|Analgesics|analgesics|mesh-ancestor
64714184|NCT02988050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64551547|NCT00883233|Sensory System Agents|sensory system agents|mesh-ancestor
64551548|NCT00883233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64551549|NCT00883233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507672|NCT05542264|Olanzapine|olanzapine|mesh-list
64316545|NCT02422563|Antimitotic Agents|antimitotic agents|mesh-ancestor
64316550|NCT03185403|Sufentanil|sufentanil|mesh-list
64989166|NCT00126789|Anesthetics, General|anesthetics, general|mesh-ancestor
64989167|NCT00126789|Anesthetics|anesthetics|mesh-ancestor
64989168|NCT05831969|Lenalidomide|lenalidomide|mesh-list
64989169|NCT05831969|Immunologic Factors|immunologic factors|mesh-ancestor
64989170|NCT05831969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785621|NCT00000354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989171|NCT05831969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64989172|NCT05831969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64989173|NCT05831969|Growth Substances|growth substances|mesh-ancestor
64989174|NCT05831969|Growth Inhibitors|growth inhibitors|mesh-ancestor
64989175|NCT05831969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989176|NCT05831774|Vancomycin|vancomycin|mesh-list
64989177|NCT05831774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64989178|NCT05831774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64989179|NCT05831761|Lidocaine|lidocaine|mesh-list
64989180|NCT05831761|Analgesics|analgesics|mesh-list
64989181|NCT05831761|Anesthetics, Local|anesthetics, local|mesh-ancestor
64989182|NCT05831761|Anesthetics|anesthetics|mesh-ancestor
64989183|NCT05831761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64989184|NCT05831761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989185|NCT05831761|Sensory System Agents|sensory system agents|mesh-ancestor
64989186|NCT05831761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64989187|NCT05831761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64989188|NCT05831761|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64989189|NCT05831761|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64989190|NCT05831761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64989191|NCT05831761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989192|NCT05831683|Anesthetics|anesthetics|mesh-list
64989193|NCT05831683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64989194|NCT05831683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989211|NCT05831566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64989212|NCT05831566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989213|NCT05831462|Ticagrelor|ticagrelor|mesh-list
64989214|NCT05831462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64989215|NCT05831462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64989216|NCT05831462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64989217|NCT05831462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64989218|NCT05831462|Purinergic Agents|purinergic agents|mesh-ancestor
64989219|NCT05831462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64551550|NCT00883233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64551551|NCT00883233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64551552|NCT00883233|Dermatologic Agents|dermatologic agents|mesh-ancestor
64551553|NCT01394939|Irinotecan|irinotecan|mesh-list
64551554|NCT01394939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64551555|NCT01394939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64396789|NCT02640755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64396790|NCT02640755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64396791|NCT02640755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64396792|NCT02640755|Hormone Antagonists|hormone antagonists|mesh-ancestor
64396793|NCT02640755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64396794|NCT02640755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312589|NCT02337478|Antimitotic Agents|antimitotic agents|mesh-ancestor
64312590|NCT02337478|Mitosis Modulators|mitosis modulators|mesh-ancestor
64312592|NCT02434653|Chrysarobin|chrysarobin|mesh-list
64551556|NCT01394939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551557|NCT01394939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551558|NCT01394939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551559|NCT01394627|Eplerenone|eplerenone|mesh-list
64551560|NCT01394627|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64551561|NCT01394627|Hormone Antagonists|hormone antagonists|mesh-ancestor
64316562|NCT03185403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64989220|NCT05831462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989221|NCT05831462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989222|NCT05831449|Ropivacaine|ropivacaine|mesh-list
64989223|NCT05831449|Anesthetics, Local|anesthetics, local|mesh-list
64989224|NCT05831449|Anesthetics|anesthetics|mesh-list
64989225|NCT05831449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64989226|NCT05831449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989227|NCT05831449|Sensory System Agents|sensory system agents|mesh-ancestor
64989228|NCT05831449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64989233|NCT05831345|Sufentanil|sufentanil|mesh-list
64989234|NCT05831345|Dsuvia|dsuvia|mesh-list
64989235|NCT05831345|Methadone|methadone|mesh-list
64989236|NCT05831345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64989237|NCT05831345|Narcotics|narcotics|mesh-ancestor
64989238|NCT05831345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64989239|NCT05831345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989240|NCT05831345|Analgesics|analgesics|mesh-ancestor
64989241|NCT05831345|Sensory System Agents|sensory system agents|mesh-ancestor
64989242|NCT05831345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64989243|NCT05831345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64989244|NCT05831345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64989245|NCT05831345|Anesthetics, General|anesthetics, general|mesh-ancestor
64989246|NCT05831345|Anesthetics|anesthetics|mesh-ancestor
64989247|NCT05831345|Antitussive Agents|antitussive agents|mesh-ancestor
64989248|NCT05831345|Respiratory System Agents|respiratory system agents|mesh-ancestor
64989249|NCT05831267|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64989250|NCT05831267|Hemostatics|hemostatics|mesh-ancestor
64989251|NCT05831267|Coagulants|coagulants|mesh-ancestor
64989252|NCT05831176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64989253|NCT05831176|Immunologic Factors|immunologic factors|mesh-ancestor
64989275|NCT05830799|Caffeine|caffeine|mesh-list
64989276|NCT05830799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64989277|NCT05830799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64324561|NCT02268565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64324562|NCT02268565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324563|NCT02268565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64324564|NCT02268565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64324565|NCT02268565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324566|NCT02268565|Antipyretics|antipyretics|mesh-ancestor
64324567|NCT05479448|Prednisone|prednisone|mesh-list
64324568|NCT05479448|Hormones|hormones|mesh-list
64324569|NCT05479448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64324570|NCT05479448|Glucocorticoids|glucocorticoids|mesh-ancestor
64312608|NCT03043196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312610|NCT03188835|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64312614|NCT04847024|Parecoxib|parecoxib|mesh-list
64989278|NCT05830799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64989279|NCT05830799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989280|NCT05830799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64989281|NCT05830799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64989282|NCT05830799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64989283|NCT05830799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64989284|NCT05830799|Anesthetics, General|anesthetics, general|mesh-ancestor
64989285|NCT05830799|Anesthetics|anesthetics|mesh-ancestor
64989286|NCT05830799|GABA Modulators|gaba modulators|mesh-ancestor
64989287|NCT05830799|GABA Agents|gaba agents|mesh-ancestor
64989288|NCT05830799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64989289|NCT05830799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989290|NCT05830799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64989291|NCT05830799|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64989292|NCT05830799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64989293|NCT05830799|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64551562|NCT01394627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64551563|NCT01394627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301342|NCT04463030|Protective Agents|protective agents|mesh-ancestor
64551564|NCT01394627|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64551565|NCT01394627|Diuretics|diuretics|mesh-ancestor
64551566|NCT01394627|Natriuretic Agents|natriuretic agents|mesh-ancestor
64551567|NCT01394627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64551569|NCT02288377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551570|NCT04133532|Metoprolol|metoprolol|mesh-list
64551571|NCT04133532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64551572|NCT04133532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64551573|NCT04133532|Sympatholytics|sympatholytics|mesh-ancestor
64551574|NCT04133532|Autonomic Agents|autonomic agents|mesh-ancestor
64551575|NCT04133532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64551576|NCT04133532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551577|NCT04133532|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64551578|NCT04133532|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64551579|NCT04133532|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64551580|NCT04133532|Adrenergic Agents|adrenergic agents|mesh-ancestor
64551581|NCT04133532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64551582|NCT04133532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551583|NCT01391663|Alogliptin|alogliptin|mesh-list
64551584|NCT01391663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64551585|NCT01391663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551586|NCT01391663|Incretins|incretins|mesh-ancestor
64551587|NCT01391663|Hormones|hormones|mesh-ancestor
64785640|NCT00000372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785642|NCT00000372|Serotonin Agents|serotonin agents|mesh-ancestor
64785643|NCT00000372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64396807|NCT02375503|Vitamins|vitamins|mesh-ancestor
64551588|NCT01391663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64551589|NCT01391663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64551590|NCT01391663|Protease Inhibitors|protease inhibitors|mesh-ancestor
64551591|NCT01391663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551592|NCT01391663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551593|NCT03176173|Immunologic Factors|immunologic factors|mesh-list
64316579|NCT03635021|Growth Substances|growth substances|mesh-ancestor
64989294|NCT05830799|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64989295|NCT05830799|Purinergic Agents|purinergic agents|mesh-ancestor
64989296|NCT05830799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989297|NCT05830799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64989298|NCT05830799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64989299|NCT05830747|Prednisone|prednisone|mesh-list
64551595|NCT02220985|Mycophenolic Acid|mycophenolic acid|mesh-list
64551596|NCT02220985|Cyclophosphamide|cyclophosphamide|mesh-list
64551597|NCT02220985|Thiotepa|thiotepa|mesh-list
64551598|NCT02220985|Methotrexate|methotrexate|mesh-list
64551599|NCT02220985|Fludarabine|fludarabine|mesh-list
64551600|NCT02220985|Fludarabine phosphate|fludarabine phosphate|mesh-list
64551601|NCT02220985|Tacrolimus|tacrolimus|mesh-list
64551602|NCT02220985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64551603|NCT02220985|Immunologic Factors|immunologic factors|mesh-ancestor
64551604|NCT02220985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551605|NCT02220985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64551606|NCT02220985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64551607|NCT02220985|Alkylating Agents|alkylating agents|mesh-ancestor
64551608|NCT02220985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551609|NCT02220985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551610|NCT02220985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64551611|NCT02220985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64551612|NCT02220985|Abortifacient Agents|abortifacient agents|mesh-ancestor
64551613|NCT02220985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64551614|NCT02220985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64316612|NCT05699720|Anesthetics|anesthetics|mesh-ancestor
64989300|NCT05830747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64989301|NCT05830747|Glucocorticoids|glucocorticoids|mesh-ancestor
64989302|NCT05830747|Hormones|hormones|mesh-ancestor
64989303|NCT05830747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64989304|NCT05830747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989305|NCT05830747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64989306|NCT05830747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989307|NCT05830630|Bupivacaine|bupivacaine|mesh-list
64989308|NCT05830630|Methylene Blue|methylene blue|mesh-list
64989309|NCT05830630|Anesthetics, Local|anesthetics, local|mesh-ancestor
64989310|NCT05830630|Anesthetics|anesthetics|mesh-ancestor
64989311|NCT05830630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64989341|NCT05830136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64989342|NCT05830071|Moxifloxacin|moxifloxacin|mesh-list
64989343|NCT05830071|Beclomethasone|beclomethasone|mesh-list
64989344|NCT05830071|Glycopyrrolate|glycopyrrolate|mesh-list
64989345|NCT05830071|Bromides|bromides|mesh-list
64396808|NCT02375503|Micronutrients|micronutrients|mesh-ancestor
64396809|NCT02375503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396812|NCT00867191|Desloratadine|desloratadine|mesh-list
64989346|NCT05830071|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64989347|NCT05830071|Formoterol Fumarate|formoterol fumarate|mesh-list
64989348|NCT05830071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64989349|NCT05830071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64989350|NCT05830071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64989351|NCT05830071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64989352|NCT05830071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64989353|NCT05830071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989354|NCT05830071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989355|NCT05830071|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64989356|NCT05830071|Contraceptive Agents|contraceptive agents|mesh-ancestor
64989357|NCT05830071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64714185|NCT02988050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551622|NCT02220985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64551623|NCT02220985|Antitubercular Agents|antitubercular agents|mesh-ancestor
64551624|NCT02220985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64551625|NCT02220985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64551626|NCT05072106|Bosentan|bosentan|mesh-list
64551627|NCT05072106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64551628|NCT05072106|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64551629|NCT05072106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551630|NCT03838497|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64551631|NCT03838497|Immunologic Factors|immunologic factors|mesh-ancestor
64551632|NCT03838497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551633|NCT03367533|Ketamine|ketamine|mesh-list
64551634|NCT03367533|Analgesics|analgesics|mesh-ancestor
64551635|NCT03367533|Sensory System Agents|sensory system agents|mesh-ancestor
64551636|NCT03367533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64551637|NCT03367533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551638|NCT03367533|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64989358|NCT05830071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989359|NCT05830071|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64989360|NCT05830071|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64989361|NCT05830071|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64312658|NCT04860284|Hydroxychloroquine|hydroxychloroquine|mesh-list
64312659|NCT04860284|Antimalarials|antimalarials|mesh-ancestor
64312660|NCT04860284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64312661|NCT04860284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64312662|NCT04860284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64312663|NCT04860284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312664|NCT04860284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312665|NCT04860284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64312666|NCT04846634|Gemcitabine|gemcitabine|mesh-list
64312667|NCT04846634|Paclitaxel|paclitaxel|mesh-list
64312668|NCT04846634|Docetaxel|docetaxel|mesh-list
64989362|NCT05830071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64989363|NCT05830071|Autonomic Agents|autonomic agents|mesh-ancestor
64989388|NCT05829655|Suvorexant|suvorexant|mesh-list
64989389|NCT05829655|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64989390|NCT05829655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64989391|NCT05829655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64989392|NCT05829655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989393|NCT05829655|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64989394|NCT05829655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64989395|NCT05829655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989396|NCT05828758|Amoxicillin|amoxicillin|mesh-list
64989397|NCT05828758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64551639|NCT03367533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64551640|NCT03367533|Anesthetics, General|anesthetics, general|mesh-ancestor
64551642|NCT03367533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64551643|NCT03367533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64551644|NCT03367533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64551645|NCT03367533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64551646|NCT03367533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551647|NCT03358875|Docetaxel|docetaxel|mesh-list
64551648|NCT03358875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551649|NCT03358875|Tubulin Modulators|tubulin modulators|mesh-ancestor
64551650|NCT03358875|Antimitotic Agents|antimitotic agents|mesh-ancestor
64551651|NCT03358875|Mitosis Modulators|mitosis modulators|mesh-ancestor
64551652|NCT03358875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551653|NCT05071482|Imatinib Mesylate|imatinib mesylate|mesh-list
64551654|NCT05071482|HH-GV-678|hh-gv-678|mesh-list
64551655|NCT05071482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551656|NCT05071482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64551657|NCT05071482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551658|NCT05071482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551659|NCT03213249|Gentamicins|gentamicins|mesh-list
64551660|NCT03213249|Cefazolin|cefazolin|mesh-list
64551661|NCT03213249|Bacitracin|bacitracin|mesh-list
64989398|NCT05828758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64989399|NCT05828459|Paclitaxel|paclitaxel|mesh-list
64989400|NCT05828459|Bevacizumab|bevacizumab|mesh-list
64989401|NCT05828459|Lenalidomide|lenalidomide|mesh-list
64989402|NCT05828459|Pomalidomide|pomalidomide|mesh-list
64312695|NCT02433717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64312696|NCT02433717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64312697|NCT02433717|Serotonin Agents|serotonin agents|mesh-ancestor
64312698|NCT02433717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64312699|NCT02433717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312700|NCT02433717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64312701|NCT02433717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64312703|NCT02429817|Edetic Acid|edetic acid|mesh-list
64312704|NCT02429817|Pentetic Acid|pentetic acid|mesh-list
64312705|NCT02429817|Antidotes|antidotes|mesh-ancestor
64312706|NCT02429817|Protective Agents|protective agents|mesh-ancestor
64312707|NCT02429817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312708|NCT02429817|Chelating Agents|chelating agents|mesh-ancestor
64312709|NCT02429817|Sequestering Agents|sequestering agents|mesh-ancestor
64312711|NCT02429817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64989403|NCT05828459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64989404|NCT05828459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989405|NCT05828459|Tubulin Modulators|tubulin modulators|mesh-ancestor
64989406|NCT05828459|Antimitotic Agents|antimitotic agents|mesh-ancestor
64989407|NCT05828459|Mitosis Modulators|mitosis modulators|mesh-ancestor
64989408|NCT05828459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989409|NCT05828459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64989410|NCT05828459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64989411|NCT05828459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64989412|NCT05828459|Growth Substances|growth substances|mesh-ancestor
64989413|NCT05828459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989414|NCT05828459|Growth Inhibitors|growth inhibitors|mesh-ancestor
64989415|NCT05828459|Immunologic Factors|immunologic factors|mesh-ancestor
64989416|NCT05828303|Metformin|metformin|mesh-list
64989417|NCT05828303|Digoxin|digoxin|mesh-list
64989418|NCT05828303|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64989419|NCT05828303|Calcium|calcium|mesh-list
64989448|NCT05820997|Anesthetics, Local|anesthetics, local|mesh-ancestor
64989449|NCT05820997|Anesthetics|anesthetics|mesh-ancestor
64989450|NCT05820997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64989451|NCT05820997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989452|NCT05820997|Sensory System Agents|sensory system agents|mesh-ancestor
64989453|NCT05820997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64989454|NCT05814523|Ganaxolone|ganaxolone|mesh-list
64316683|NCT02761915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64989456|NCT05814523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64989457|NCT05814523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989458|NCT05814523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989459|NCT05814523|GABA Modulators|gaba modulators|mesh-ancestor
64989460|NCT05814523|GABA Agents|gaba agents|mesh-ancestor
64989461|NCT05807126|Olaparib|olaparib|mesh-list
64989462|NCT05807126|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64989463|NCT05807126|Magrolimab|magrolimab|mesh-list
64989464|NCT05807126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64989465|NCT05807126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989466|NCT05807126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989467|NCT05807126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64989468|NCT05803382|Capecitabine|capecitabine|mesh-list
64989469|NCT05803382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64989470|NCT05803382|Antimetabolites|antimetabolites|mesh-ancestor
64989471|NCT05803382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989510|NCT05790252|Sensory System Agents|sensory system agents|mesh-ancestor
64396824|NCT00834119|Dermatologic Agents|dermatologic agents|mesh-ancestor
64396828|NCT02299141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64396829|NCT02299141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396830|NCT02299141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396832|NCT02643251|Analgesics|analgesics|mesh-ancestor
64396833|NCT02643251|Sensory System Agents|sensory system agents|mesh-ancestor
64396834|NCT02643251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312745|NCT04851392|Hallucinogens|hallucinogens|mesh-ancestor
64312746|NCT04851392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312747|NCT04851392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64312748|NCT04851392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64989511|NCT05790252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64989512|NCT05790252|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64989513|NCT05784844|Meropenem|meropenem|mesh-list
64989514|NCT05784844|Micafungin|micafungin|mesh-list
64989515|NCT05784844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64989516|NCT05784844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64989517|NCT05784844|Antifungal Agents|antifungal agents|mesh-ancestor
64989562|NCT05774951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64989563|NCT05774951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989564|NCT05774951|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64989565|NCT05774951|Hormone Antagonists|hormone antagonists|mesh-ancestor
64989566|NCT05774951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64989567|NCT05774951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989568|NCT05774951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64989569|NCT05774951|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64989570|NCT05774951|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64989571|NCT05774951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64989572|NCT05773274|Everolimus|everolimus|mesh-list
64989600|NCT05773053|Cholinergic Agents|cholinergic agents|mesh-ancestor
64989601|NCT05773053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64989603|NCT05746559|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64989604|NCT05746559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64989605|NCT05746559|Immunologic Factors|immunologic factors|mesh-ancestor
64551671|NCT03317067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551672|NCT03317067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64551673|NCT03317067|Analgesics|analgesics|mesh-ancestor
64551674|NCT03317067|Sensory System Agents|sensory system agents|mesh-ancestor
64551675|NCT03317067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64551676|NCT03317067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64551677|NCT03317067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64551678|NCT03317067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64551679|NCT03317067|Adrenergic Agents|adrenergic agents|mesh-ancestor
64551680|NCT03317067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64551681|NCT03317067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551682|NCT04440007|Abivertinib|abivertinib|mesh-list
64551683|NCT04440007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64989606|NCT05746559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989607|NCT05744648|Titanium dioxide|titanium dioxide|mesh-list
64989608|NCT05744648|Sunscreening Agents|sunscreening agents|mesh-ancestor
64989609|NCT05744648|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64989610|NCT05744648|Protective Agents|protective agents|mesh-ancestor
64989611|NCT05744648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989612|NCT05744648|Dermatologic Agents|dermatologic agents|mesh-ancestor
64989613|NCT05744648|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64989614|NCT05743270|Paclitaxel|paclitaxel|mesh-list
64989615|NCT05743270|Carboplatin|carboplatin|mesh-list
64989633|NCT05735353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989635|NCT05735353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64989636|NCT05735353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64989637|NCT05735353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64989638|NCT05735353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64989639|NCT05733611|Bevacizumab|bevacizumab|mesh-list
64989640|NCT05733611|Atezolizumab|atezolizumab|mesh-list
64989641|NCT05733611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64989642|NCT05733611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989643|NCT05733611|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64989644|NCT05733611|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64989645|NCT05733611|Growth Substances|growth substances|mesh-ancestor
64989646|NCT05733611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989647|NCT05733611|Growth Inhibitors|growth inhibitors|mesh-ancestor
64324571|NCT05479448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64989648|NCT05733598|Bevacizumab|bevacizumab|mesh-list
64989649|NCT05733598|Atezolizumab|atezolizumab|mesh-list
64989650|NCT05733598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64989651|NCT05733598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989652|NCT05733598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64989653|NCT05733598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64989654|NCT05733598|Growth Substances|growth substances|mesh-ancestor
64989655|NCT05733598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989656|NCT05733598|Growth Inhibitors|growth inhibitors|mesh-ancestor
64989657|NCT05715281|Atezolizumab|atezolizumab|mesh-list
64989658|NCT05715281|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64989659|NCT05715281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989660|NCT05715281|Immunologic Factors|immunologic factors|mesh-ancestor
64989661|NCT05715281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989712|NCT05691517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989714|NCT05691517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64989715|NCT05687123|Sunitinib|sunitinib|mesh-list
64989716|NCT05687123|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64989717|NCT05687123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989718|NCT05687123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64989719|NCT05687123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64989720|NCT05687123|Growth Substances|growth substances|mesh-ancestor
64989721|NCT05687123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551684|NCT04440007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551685|NCT04440007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64551687|NCT00888459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64551688|NCT00888459|Autonomic Agents|autonomic agents|mesh-ancestor
64551689|NCT00888459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64551690|NCT00888459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551691|NCT00888459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64551692|NCT00888459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64551693|NCT00888459|Cholinergic Agents|cholinergic agents|mesh-ancestor
64507824|NCT00559936|Growth Substances|growth substances|mesh-ancestor
64551694|NCT00888459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64551695|NCT00888459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989722|NCT05687123|Growth Inhibitors|growth inhibitors|mesh-ancestor
64989723|NCT05687123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64989724|NCT05687123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64989725|NCT05687123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989726|NCT05687123|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64989740|NCT05685602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64989741|NCT05685602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64989742|NCT05685602|Immunologic Factors|immunologic factors|mesh-ancestor
64989743|NCT05685602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989744|NCT05680818|Vitamin D|vitamin d|mesh-list
64989745|NCT05680818|Calcitriol|calcitriol|mesh-list
64989746|NCT05680818|Alfacalcidol|alfacalcidol|mesh-list
64989747|NCT05680818|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
64989748|NCT05680818|26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3|26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin d3|mesh-list
64989749|NCT05680818|Calcium|calcium|mesh-list
64989750|NCT05680818|Vitamins|vitamins|mesh-ancestor
64989751|NCT05680818|Micronutrients|micronutrients|mesh-ancestor
64989752|NCT05680818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989753|NCT05680818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64989754|NCT05680818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64989755|NCT05680818|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64989756|NCT05680818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64989757|NCT05680818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989758|NCT05680818|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64989759|NCT05680818|Dermatologic Agents|dermatologic agents|mesh-ancestor
64989760|NCT05675410|Deoxyglucose|deoxyglucose|mesh-list
64989761|NCT05675410|Prednisone|prednisone|mesh-list
64989762|NCT05675410|Prednisolone|prednisolone|mesh-list
64989763|NCT05675410|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64989764|NCT05675410|Methylprednisolone|methylprednisolone|mesh-list
64989765|NCT05675410|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64989766|NCT05675410|Prednisolone acetate|prednisolone acetate|mesh-list
64989767|NCT05675410|Hydrocortisone|hydrocortisone|mesh-list
64989768|NCT05675410|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64989769|NCT05675410|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64989770|NCT05675410|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64989771|NCT05675410|Cortisone|cortisone|mesh-list
64989772|NCT05675410|Cyclophosphamide|cyclophosphamide|mesh-list
64989773|NCT05675410|Dacarbazine|dacarbazine|mesh-list
64989774|NCT05675410|Doxorubicin|doxorubicin|mesh-list
64989775|NCT05675410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64989776|NCT05675410|Nivolumab|nivolumab|mesh-list
64989777|NCT05675410|Etoposide|etoposide|mesh-list
64989778|NCT05675410|Etoposide phosphate|etoposide phosphate|mesh-list
64989779|NCT05675410|Vincristine|vincristine|mesh-list
64989780|NCT05675410|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64989781|NCT05675410|Bleomycin|bleomycin|mesh-list
64989782|NCT05675410|Vinblastine|vinblastine|mesh-list
64989783|NCT05675410|Podophyllotoxin|podophyllotoxin|mesh-list
64551696|NCT05312541|Bupivacaine|bupivacaine|mesh-list
64551697|NCT05312541|Anesthetics, Local|anesthetics, local|mesh-list
64551698|NCT05312541|Anesthetics|anesthetics|mesh-list
64551699|NCT05312541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64551700|NCT05312541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551701|NCT05312541|Sensory System Agents|sensory system agents|mesh-ancestor
64551702|NCT05312541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64551703|NCT04398823|Polidocanol|polidocanol|mesh-list
64551704|NCT04398823|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64551705|NCT04398823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64551706|NCT04410913|Psilocybin|psilocybin|mesh-list
64551707|NCT04410913|Hallucinogens|hallucinogens|mesh-ancestor
64551708|NCT04410913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551709|NCT04410913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64551710|NCT02013336|Cyclophosphamide|cyclophosphamide|mesh-list
64551711|NCT02013336|Irinotecan|irinotecan|mesh-list
64551712|NCT02013336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64551713|NCT02013336|Immunologic Factors|immunologic factors|mesh-ancestor
64551714|NCT02013336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551715|NCT02013336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64551716|NCT02013336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64551717|NCT02013336|Alkylating Agents|alkylating agents|mesh-ancestor
64551718|NCT02013336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551719|NCT02013336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551720|NCT02013336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64316718|NCT02161159|Botulinum Toxins|botulinum toxins|mesh-list
64989784|NCT05675410|Procarbazine|procarbazine|mesh-list
64989785|NCT05675410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64989786|NCT05675410|Antibodies|antibodies|mesh-list
64989787|NCT05675410|Immunoglobulins|immunoglobulins|mesh-list
64989788|NCT05675410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64989789|NCT05675410|Immunoconjugates|immunoconjugates|mesh-list
64989790|NCT05675410|Imidazole|imidazole|mesh-list
64989791|NCT05675410|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64989792|NCT05675410|Prednisolone phosphate|prednisolone phosphate|mesh-list
64989819|NCT05675410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64989820|NCT05675410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64989821|NCT05675410|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64989822|NCT05675410|Protective Agents|protective agents|mesh-ancestor
64989823|NCT05675410|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64989824|NCT05675410|Keratolytic Agents|keratolytic agents|mesh-ancestor
64551726|NCT04397653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64551727|NCT04397653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64551728|NCT04397653|Antimetabolites|antimetabolites|mesh-ancestor
64551729|NCT04397653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551730|NCT04397653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64551731|NCT03212781|Ferrous fumarate|ferrous fumarate|mesh-list
64551732|NCT03212781|Dextrans|dextrans|mesh-list
64551733|NCT03212781|Iron-Dextran Complex|iron-dextran complex|mesh-list
64551734|NCT03212781|Anticoagulants|anticoagulants|mesh-ancestor
64551735|NCT03212781|Plasma Substitutes|plasma substitutes|mesh-ancestor
64551736|NCT03212781|Blood Substitutes|blood substitutes|mesh-ancestor
64551737|NCT03212781|Trace Elements|trace elements|mesh-ancestor
64551738|NCT03212781|Micronutrients|micronutrients|mesh-ancestor
64551739|NCT03212781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551740|NCT03212781|Hematinics|hematinics|mesh-ancestor
64551741|NCT03212937|Carboplatin|carboplatin|mesh-list
64551742|NCT03212937|Etoposide|etoposide|mesh-list
64551743|NCT03212937|Ifosfamide|ifosfamide|mesh-list
64551744|NCT03212937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551745|NCT03212937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64551746|NCT03212937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64551747|NCT03212937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64551748|NCT03212937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551749|NCT03212937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551750|NCT03212937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64551751|NCT03212937|Alkylating Agents|alkylating agents|mesh-ancestor
64316748|NCT05546060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64989825|NCT05675410|Dermatologic Agents|dermatologic agents|mesh-ancestor
64989826|NCT05675410|Antimetabolites|antimetabolites|mesh-ancestor
64989827|NCT05675410|Antiviral Agents|antiviral agents|mesh-ancestor
64989828|NCT05675410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64785712|NCT00000510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64785713|NCT00000510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64989829|NCT05670379|Exenatide|exenatide|mesh-list
64989830|NCT05670379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64989831|NCT05670379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989832|NCT05670379|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64989833|NCT05670379|Incretins|incretins|mesh-ancestor
64989834|NCT05670379|Hormones|hormones|mesh-ancestor
64989835|NCT05670379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64989836|NCT05665270|Prednisolone|prednisolone|mesh-list
64989837|NCT05665270|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64989838|NCT05665270|Methylprednisolone|methylprednisolone|mesh-list
64989839|NCT05665270|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64989863|NCT05653973|Acetylcholine|acetylcholine|mesh-list
64989864|NCT05653973|Vasodilator Agents|vasodilator agents|mesh-ancestor
64989865|NCT05653973|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64989866|NCT05653973|Cholinergic Agents|cholinergic agents|mesh-ancestor
64989867|NCT05653973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64989868|NCT05653973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989869|NCT05653973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551752|NCT04397497|Mavrilimumab|mavrilimumab|mesh-list
64551753|NCT04397497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64551754|NCT04412538|Vaccines|vaccines|mesh-list
64551755|NCT04412538|Immunologic Factors|immunologic factors|mesh-ancestor
64551756|NCT04412538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551757|NCT04397341|Docetaxel|docetaxel|mesh-list
64551758|NCT04397341|Fluorouracil|fluorouracil|mesh-list
64551759|NCT04397341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551760|NCT04397341|Tubulin Modulators|tubulin modulators|mesh-ancestor
64551761|NCT04397341|Antimitotic Agents|antimitotic agents|mesh-ancestor
64551762|NCT04397341|Mitosis Modulators|mitosis modulators|mesh-ancestor
64551763|NCT04397341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551764|NCT04397341|Antimetabolites|antimetabolites|mesh-ancestor
64551765|NCT04397341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64714186|NCT02988050|Sensory System Agents|sensory system agents|mesh-ancestor
64551766|NCT04397341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64551767|NCT04397341|Immunologic Factors|immunologic factors|mesh-ancestor
64551768|NCT04397341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551769|NCT03940326|Levetiracetam|levetiracetam|mesh-list
64551770|NCT03940326|Valproic Acid|valproic acid|mesh-list
64989882|NCT05649748|Treprostinil|treprostinil|mesh-list
64989883|NCT05649748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64989884|NCT05646719|Phentolamine|phentolamine|mesh-list
64989885|NCT05646719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64989886|NCT05646719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64989887|NCT05646719|Pilocarpine|pilocarpine|mesh-list
64396901|NCT00794495|Histamine Agents|histamine agents|mesh-ancestor
64396902|NCT00794495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64313051|NCT03038516|Cholecalciferol|cholecalciferol|mesh-list
64313052|NCT03038516|Vitamin D|vitamin d|mesh-list
64313053|NCT03038516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64313054|NCT03038516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313055|NCT03038516|Vitamins|vitamins|mesh-ancestor
64313056|NCT03038516|Micronutrients|micronutrients|mesh-ancestor
64313057|NCT03038516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64313058|NCT02424435|Methylprednisolone|methylprednisolone|mesh-list
64313059|NCT02424435|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64313060|NCT02424435|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64313061|NCT02424435|Prednisolone|prednisolone|mesh-list
64313062|NCT02424435|Prednisolone acetate|prednisolone acetate|mesh-list
64313063|NCT02424435|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64313064|NCT02424435|Prednisolone phosphate|prednisolone phosphate|mesh-list
64989888|NCT05646719|Miotics|miotics|mesh-ancestor
64989889|NCT05646719|Autonomic Agents|autonomic agents|mesh-ancestor
64989890|NCT05646719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64989913|NCT05627271|Ofatumumab|ofatumumab|mesh-list
64989914|NCT05627271|Ocrelizumab|ocrelizumab|mesh-list
64989915|NCT05627271|Natalizumab|natalizumab|mesh-list
64989916|NCT05627271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989917|NCT05627271|Immunologic Factors|immunologic factors|mesh-ancestor
64989918|NCT05627271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989924|NCT05618301|Natalizumab|natalizumab|mesh-list
64989925|NCT05618301|Immunologic Factors|immunologic factors|mesh-ancestor
64989926|NCT05618301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989927|NCT05603754|Lorecivivint|lorecivivint|mesh-list
64989928|NCT05603754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64989935|NCT05600894|Decitabine|decitabine|mesh-list
64989937|NCT05600894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64989938|NCT05600894|Antimetabolites|antimetabolites|mesh-ancestor
64989939|NCT05600894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989940|NCT05600894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989941|NCT05600894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64989946|NCT05581589|Camptothecin|camptothecin|mesh-list
64990015|NCT05568888|Hemostatics|hemostatics|mesh-ancestor
64990016|NCT05568888|Coagulants|coagulants|mesh-ancestor
64990017|NCT05564377|Leucovorin|leucovorin|mesh-list
64990018|NCT05564377|Paclitaxel|paclitaxel|mesh-list
64551771|NCT03940326|Anticonvulsants|anticonvulsants|mesh-ancestor
64551772|NCT03940326|Nootropic Agents|nootropic agents|mesh-ancestor
64551773|NCT03940326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551774|NCT03940326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551775|NCT03940326|GABA Agents|gaba agents|mesh-ancestor
64551776|NCT03940326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64551777|NCT03940326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551778|NCT03940326|Antimanic Agents|antimanic agents|mesh-ancestor
64551779|NCT03940326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64551780|NCT03940326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64551781|NCT03940326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64551782|NCT04347889|Hydroxychloroquine|hydroxychloroquine|mesh-list
64551783|NCT04347889|Antimalarials|antimalarials|mesh-ancestor
64551784|NCT04347889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64551785|NCT04347889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64551786|NCT04347889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64551787|NCT04347889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551788|NCT04347889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551789|NCT04347889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64551790|NCT01473524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
64551791|NCT01473524|Cathartics|cathartics|mesh-ancestor
64551792|NCT01473524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64551793|NCT01390649|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64551794|NCT01390649|Immunologic Factors|immunologic factors|mesh-ancestor
64551795|NCT01390649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551796|NCT03696355|GDC-0084|gdc-0084|mesh-list
64551797|NCT03696355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396908|NCT04157075|Anesthetics, Local|anesthetics, local|mesh-ancestor
64396909|NCT04157075|Anesthetics|anesthetics|mesh-ancestor
64396910|NCT04157075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64396911|NCT04157075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396916|NCT00763529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64396917|NCT00763529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64551798|NCT03696355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551799|NCT03882996|Atorvastatin|atorvastatin|mesh-list
64551800|NCT03882996|Ezetimibe|ezetimibe|mesh-list
64551801|NCT03882996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64316802|NCT03540979|Hormones|hormones|mesh-ancestor
64990019|NCT05564377|Fluorouracil|fluorouracil|mesh-list
64990020|NCT05564377|Oxaliplatin|oxaliplatin|mesh-list
64990021|NCT05564377|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64990022|NCT05564377|Olaparib|olaparib|mesh-list
64990023|NCT05564377|Fulvestrant|fulvestrant|mesh-list
64990024|NCT05564377|Palbociclib|palbociclib|mesh-list
64990025|NCT05564377|Panitumumab|panitumumab|mesh-list
64990026|NCT05564377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64990027|NCT05564377|Antibodies|antibodies|mesh-list
64990028|NCT05564377|Immunoglobulins|immunoglobulins|mesh-list
64990029|NCT05564377|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64990030|NCT05564377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64990031|NCT05564377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990032|NCT05564377|Tubulin Modulators|tubulin modulators|mesh-ancestor
64551802|NCT03882996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64551804|NCT03882996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551805|NCT03882996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64551806|NCT03882996|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64551807|NCT03882996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551808|NCT04383691|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64551809|NCT04383691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64551810|NCT04383691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64551811|NCT04383691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64551812|NCT04383691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551813|NCT04383691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64551814|NCT04383691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64551815|NCT04383691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64785765|NCT00000654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785767|NCT00000660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64785768|NCT00000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64785769|NCT00000660|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64785770|NCT00000660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64785771|NCT00000660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313145|NCT03181815|Aclarubicin|aclarubicin|mesh-list
64313146|NCT03181815|Aclacinomycins|aclacinomycins|mesh-list
64313147|NCT03181815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64313148|NCT03181815|Antimetabolites|antimetabolites|mesh-ancestor
64313149|NCT03181815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313150|NCT03181815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313151|NCT03181815|Antiviral Agents|antiviral agents|mesh-ancestor
64313152|NCT03181815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64313160|NCT03181815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64313161|NCT03038048|Ranibizumab|ranibizumab|mesh-list
64313162|NCT03038048|Aflibercept|aflibercept|mesh-list
64313163|NCT03038048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64313164|NCT03038048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64551816|NCT04383691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64551817|NCT04383691|Adrenergic Agents|adrenergic agents|mesh-ancestor
64551818|NCT04383691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64551819|NCT04383691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551820|NCT04383691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64551821|NCT04383691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64551822|NCT04383691|Serotonin Agents|serotonin agents|mesh-ancestor
64551823|NCT04383691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64551824|NCT04383691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64551825|NCT04383691|Dopamine Agents|dopamine agents|mesh-ancestor
64551826|NCT05070468|Dexamethasone|dexamethasone|mesh-list
64551827|NCT05070468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64551829|NCT05070468|Autonomic Agents|autonomic agents|mesh-ancestor
64551830|NCT05070468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64551831|NCT05070468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551845|NCT02641080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64551846|NCT02641080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64551847|NCT02641080|Analgesics|analgesics|mesh-ancestor
64551848|NCT02641080|Sensory System Agents|sensory system agents|mesh-ancestor
64551849|NCT02641080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64551850|NCT02641080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551851|NCT02641080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64551852|NCT02641080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64551853|NCT02641080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64551854|NCT02641080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64551855|NCT02641080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551856|NCT02641080|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64551857|NCT02641080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64551858|NCT02641080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551859|NCT02641080|Antipyretics|antipyretics|mesh-ancestor
64551860|NCT03101280|Atezolizumab|atezolizumab|mesh-list
64551861|NCT03101280|Rucaparib|rucaparib|mesh-list
64551862|NCT03101280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551863|NCT03101280|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64551864|NCT03101280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64301345|NCT03269721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551865|NCT03101280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551866|NCT03672487|Benzonidazole|benzonidazole|mesh-list
64551867|NCT03672487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64551868|NCT03672487|Immunologic Factors|immunologic factors|mesh-ancestor
64551869|NCT03672487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551870|NCT03672487|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64551871|NCT03672487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64551872|NCT03672487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64990033|NCT05564377|Antimitotic Agents|antimitotic agents|mesh-ancestor
64990034|NCT05564377|Mitosis Modulators|mitosis modulators|mesh-ancestor
64990035|NCT05564377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990036|NCT05564377|Immunologic Factors|immunologic factors|mesh-ancestor
64990068|NCT05554380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64990069|NCT05554380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64990070|NCT05554380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990071|NCT05554380|Tubulin Modulators|tubulin modulators|mesh-ancestor
64990072|NCT05554380|Antimitotic Agents|antimitotic agents|mesh-ancestor
64990073|NCT05554380|Mitosis Modulators|mitosis modulators|mesh-ancestor
64990074|NCT05554380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990076|NCT05554354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64990077|NCT05554354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990078|NCT05554354|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64990079|NCT05554354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64551873|NCT03672487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64551874|NCT04015739|Bevacizumab|bevacizumab|mesh-list
64551876|NCT04015739|Olaparib|olaparib|mesh-list
64551877|NCT04015739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64551878|NCT04015739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551879|NCT04015739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64551880|NCT04015739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64551881|NCT04015739|Growth Substances|growth substances|mesh-ancestor
64551882|NCT04015739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551883|NCT04015739|Growth Inhibitors|growth inhibitors|mesh-ancestor
64551884|NCT04015739|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64551885|NCT04015739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64551886|NCT04015739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551887|NCT03867318|Atorvastatin|atorvastatin|mesh-list
64551888|NCT03867318|Ezetimibe|ezetimibe|mesh-list
64551889|NCT03867318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64551890|NCT03867318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64551891|NCT03867318|Antimetabolites|antimetabolites|mesh-ancestor
64551892|NCT03867318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551893|NCT03867318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64551894|NCT03867318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64551895|NCT03867318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990080|NCT05554354|Hormone Antagonists|hormone antagonists|mesh-ancestor
64990081|NCT05554354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64990096|NCT05552976|Hormones|hormones|mesh-ancestor
64990097|NCT05552976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64990098|NCT05552976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64990099|NCT05552976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990100|NCT05548296|Gemcitabine|gemcitabine|mesh-list
64990101|NCT05548296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64990102|NCT05548296|Antimetabolites|antimetabolites|mesh-ancestor
64396937|NCT03105193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64396938|NCT03105193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396939|NCT03105193|Sensory System Agents|sensory system agents|mesh-ancestor
64396940|NCT03105193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64396941|NCT03105193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64990103|NCT05548296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990104|NCT05548296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990105|NCT05548296|Antiviral Agents|antiviral agents|mesh-ancestor
64990106|NCT05548296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64990107|NCT05548296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990108|NCT05548296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64990109|NCT05548296|Immunologic Factors|immunologic factors|mesh-ancestor
64990110|NCT05548296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990111|NCT05546359|Dexamethasone|dexamethasone|mesh-list
64990112|NCT05546359|Amisulpride|amisulpride|mesh-list
64990113|NCT05546359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64990114|NCT05546359|Antiemetics|antiemetics|mesh-ancestor
64990115|NCT05546359|Autonomic Agents|autonomic agents|mesh-ancestor
64301352|NCT05010434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64301353|NCT05010434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64990116|NCT05546359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64990117|NCT05546359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990118|NCT05546359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64990119|NCT05546359|Glucocorticoids|glucocorticoids|mesh-ancestor
64990120|NCT05546359|Hormones|hormones|mesh-ancestor
64551897|NCT01876771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551898|NCT01876771|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64551899|NCT05360615|Empagliflozin|empagliflozin|mesh-list
64551900|NCT05360615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64551901|NCT05360615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551902|NCT05360615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64551903|NCT05360615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551904|NCT04381377|Bromides|bromides|mesh-list
64551905|NCT04381377|Anticonvulsants|anticonvulsants|mesh-ancestor
64551906|NCT01457846|Paclitaxel|paclitaxel|mesh-list
64551907|NCT01457846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64551908|NCT01457846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551909|NCT01457846|Tubulin Modulators|tubulin modulators|mesh-ancestor
64551910|NCT01457846|Antimitotic Agents|antimitotic agents|mesh-ancestor
64551911|NCT01457846|Mitosis Modulators|mitosis modulators|mesh-ancestor
64551912|NCT01457846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551913|NCT04032119|Epinephrine|epinephrine|mesh-list
64316928|NCT02410005|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64990121|NCT05546359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64990122|NCT05546359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64990123|NCT05546359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990124|NCT05546359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64990125|NCT05546359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64990126|NCT05546359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64990127|NCT05546359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64990128|NCT05546359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64785788|NCT00000714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785789|NCT00000714|Antidotes|antidotes|mesh-ancestor
64785790|NCT00000714|Protective Agents|protective agents|mesh-ancestor
64785791|NCT00000714|Vitamin B Complex|vitamin b complex|mesh-ancestor
64396951|NCT05066633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313297|NCT02426697|Fentanyl|fentanyl|mesh-list
64990129|NCT05546359|Dopamine Agents|dopamine agents|mesh-ancestor
64990130|NCT05546359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64990131|NCT05546359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990132|NCT05546359|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64990133|NCT05546359|Antidepressive Agents|antidepressive agents|mesh-ancestor
64990134|NCT05539365|Pembrolizumab|pembrolizumab|mesh-list
64990135|NCT05539365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64990136|NCT05539365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990137|NCT05538897|Megestrol|megestrol|mesh-list
64990138|NCT05538897|Megestrol Acetate|megestrol acetate|mesh-list
64990139|NCT05538897|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64990140|NCT05538897|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64990141|NCT05538897|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64990142|NCT05538897|Contraceptive Agents|contraceptive agents|mesh-ancestor
64990143|NCT05538897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64990177|NCT05478837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64990178|NCT05478837|Immunologic Factors|immunologic factors|mesh-ancestor
64990179|NCT05478837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990180|NCT05478837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64990181|NCT05478837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64990194|NCT05440708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64990195|NCT05440708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990196|NCT05440708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64990197|NCT05440708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64990198|NCT05440708|Growth Substances|growth substances|mesh-ancestor
64714187|NCT02988050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64551914|NCT04032119|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64551915|NCT04032119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64551916|NCT04032119|Adrenergic Agents|adrenergic agents|mesh-ancestor
64551917|NCT04032119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64551918|NCT04032119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551919|NCT04032119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551920|NCT04032119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64551921|NCT04032119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64551922|NCT04032119|Autonomic Agents|autonomic agents|mesh-ancestor
64551923|NCT04032119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64551924|NCT04032119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64551925|NCT04032119|Respiratory System Agents|respiratory system agents|mesh-ancestor
64551926|NCT04032119|Mydriatics|mydriatics|mesh-ancestor
64551930|NCT03211455|Anesthetics, Local|anesthetics, local|mesh-ancestor
64551931|NCT03211455|Anesthetics|anesthetics|mesh-ancestor
64551932|NCT03211455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64551933|NCT03211455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551934|NCT03211455|Sensory System Agents|sensory system agents|mesh-ancestor
64551935|NCT03211455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64551936|NCT03211455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64396957|NCT05066633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64551937|NCT03211455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64551938|NCT03211455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64316942|NCT03174561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64990199|NCT05440708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990200|NCT05440708|Growth Inhibitors|growth inhibitors|mesh-ancestor
64990201|NCT05432804|Temozolomide|temozolomide|mesh-list
64990202|NCT05432804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64990203|NCT05432804|Alkylating Agents|alkylating agents|mesh-ancestor
64990204|NCT05432804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990205|NCT05432804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990206|NCT05422794|Paclitaxel|paclitaxel|mesh-list
64990207|NCT05422794|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64990208|NCT05422794|Pembrolizumab|pembrolizumab|mesh-list
64990209|NCT05422794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64990210|NCT05422794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990211|NCT05422794|Tubulin Modulators|tubulin modulators|mesh-ancestor
64990212|NCT05422794|Antimitotic Agents|antimitotic agents|mesh-ancestor
64990213|NCT05422794|Mitosis Modulators|mitosis modulators|mesh-ancestor
64990214|NCT05422794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990215|NCT05422794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64990216|NCT05421858|Fluconazole|fluconazole|mesh-list
64990217|NCT05421858|Caspofungin|caspofungin|mesh-list
64551939|NCT03211455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64551940|NCT03211455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551941|NCT04375033|Buprenorphine|buprenorphine|mesh-list
64551942|NCT04375033|Naloxone|naloxone|mesh-list
64551943|NCT04375033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64551944|NCT04375033|Narcotics|narcotics|mesh-ancestor
64551945|NCT04375033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64551946|NCT04375033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551947|NCT04375033|Analgesics|analgesics|mesh-ancestor
64551948|NCT04375033|Sensory System Agents|sensory system agents|mesh-ancestor
64551949|NCT04375033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64551950|NCT04375033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64551951|NCT03172819|Pembrolizumab|pembrolizumab|mesh-list
64551952|NCT03172819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64551953|NCT03172819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551954|NCT01389323|Interferons|interferons|mesh-list
64551955|NCT01389323|Ribavirin|ribavirin|mesh-list
64551956|NCT01389323|Interferon-alpha|interferon-alpha|mesh-list
64551957|NCT01389323|Interferon alpha-2|interferon alpha-2|mesh-list
64551958|NCT01389323|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64990218|NCT05421858|Antifungal Agents|antifungal agents|mesh-ancestor
64990219|NCT05421858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64990220|NCT05421858|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64990221|NCT05421858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64990222|NCT05421858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990223|NCT05421858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990224|NCT05421858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64990225|NCT05421858|Hormone Antagonists|hormone antagonists|mesh-ancestor
64990226|NCT05421858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64990227|NCT05421858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785801|NCT00000714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785802|NCT00000732|Zidovudine|zidovudine|mesh-list
64785803|NCT00000732|Trimethoprim|trimethoprim|mesh-list
64990228|NCT05421858|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64990229|NCT05421858|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64990230|NCT05413330|Triamcinolone|triamcinolone|mesh-list
64990231|NCT05413330|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64990232|NCT05413330|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64990233|NCT05413330|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64990234|NCT05413330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64990235|NCT05413330|Glucocorticoids|glucocorticoids|mesh-ancestor
64990236|NCT05413330|Hormones|hormones|mesh-ancestor
64383213|NCT03175679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64990237|NCT05413330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64990238|NCT05413330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990239|NCT05413330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64990240|NCT05413330|Immunologic Factors|immunologic factors|mesh-ancestor
64990290|NCT05384119|Hormone Antagonists|hormone antagonists|mesh-ancestor
64990291|NCT05384119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64990292|NCT05384119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990294|NCT05372354|Trametinib|trametinib|mesh-list
64990295|NCT05372354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64990296|NCT05372354|Antiemetics|antiemetics|mesh-ancestor
64990297|NCT05372354|Autonomic Agents|autonomic agents|mesh-ancestor
64990298|NCT05372354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64551964|NCT01389323|Immunologic Factors|immunologic factors|mesh-ancestor
64551965|NCT01389323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551966|NCT05310591|Nivolumab|nivolumab|mesh-list
64316989|NCT02162407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990299|NCT05372354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990300|NCT05372354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64990301|NCT05372354|Glucocorticoids|glucocorticoids|mesh-ancestor
64990302|NCT05372354|Hormones|hormones|mesh-ancestor
64990303|NCT05372354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64990304|NCT05372354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64990340|NCT05350202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64324581|NCT02264587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64313484|NCT02251145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64313485|NCT02251145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64313486|NCT02251145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64313487|NCT04792424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64313488|NCT04792424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64990341|NCT05350202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990342|NCT05350202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64990343|NCT05350202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990349|NCT05322954|Psilocybin|psilocybin|mesh-list
64990350|NCT05322954|Hallucinogens|hallucinogens|mesh-ancestor
64990369|NCT05286801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64990370|NCT05272384|Nivolumab|nivolumab|mesh-list
64990371|NCT05272384|Decitabine|decitabine|mesh-list
64990372|NCT05272384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64990373|NCT05272384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990374|NCT05272384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64990375|NCT05272384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990376|NCT05272384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64990377|NCT05272384|Antimetabolites|antimetabolites|mesh-ancestor
64990378|NCT05272384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990379|NCT05271630|Proteasome Inhibitors|proteasome inhibitors|mesh-list
64990380|NCT05271630|Protease Inhibitors|protease inhibitors|mesh-ancestor
64990381|NCT05271630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990382|NCT05271630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990383|NCT05263388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64990384|NCT05263388|Hormones|hormones|mesh-ancestor
64990385|NCT05263388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64990386|NCT05263388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551967|NCT05310591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64551968|NCT05310591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64551969|NCT05310591|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64551970|NCT05310591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64551971|NCT05314569|Fentanyl|fentanyl|mesh-list
64551972|NCT05314569|Midazolam|midazolam|mesh-list
64551973|NCT05314569|Dexmedetomidine|dexmedetomidine|mesh-list
64551974|NCT05314569|Ketamine|ketamine|mesh-list
64551975|NCT05314569|Isoflurane|isoflurane|mesh-list
64551976|NCT05314569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64551977|NCT05314569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64551978|NCT05314569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64551979|NCT05314569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64508169|NCT02246920|Xhance|xhance|mesh-list
64990387|NCT05256225|Paclitaxel|paclitaxel|mesh-list
64990388|NCT05256225|Carboplatin|carboplatin|mesh-list
64990389|NCT05256225|Trastuzumab|trastuzumab|mesh-list
64990390|NCT05256225|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64990391|NCT05256225|Pertuzumab|pertuzumab|mesh-list
64990392|NCT05256225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64990393|NCT05256225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990394|NCT05256225|Tubulin Modulators|tubulin modulators|mesh-ancestor
64990395|NCT05256225|Antimitotic Agents|antimitotic agents|mesh-ancestor
64990396|NCT05256225|Mitosis Modulators|mitosis modulators|mesh-ancestor
64990397|NCT05256225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785812|NCT00000732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64785813|NCT00000732|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64313520|NCT02426463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313521|NCT02426229|Dabigatran|dabigatran|mesh-list
64313522|NCT02426229|Antithrombins|antithrombins|mesh-ancestor
64313523|NCT02426229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64313524|NCT02426229|Protease Inhibitors|protease inhibitors|mesh-ancestor
64990398|NCT05256225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64990399|NCT05254639|Donepezil|donepezil|mesh-list
64990400|NCT05254639|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64990401|NCT05254639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990402|NCT05254639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990403|NCT05254639|Cholinergic Agents|cholinergic agents|mesh-ancestor
64990404|NCT05254639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64990405|NCT05254639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990406|NCT05254639|Nootropic Agents|nootropic agents|mesh-ancestor
64990407|NCT05243940|Lidocaine|lidocaine|mesh-list
64990408|NCT05243940|Dexmedetomidine|dexmedetomidine|mesh-list
64990409|NCT05243940|Ketamine|ketamine|mesh-list
64990410|NCT05243940|Remifentanil|remifentanil|mesh-list
64990411|NCT05243940|Anesthetics, Local|anesthetics, local|mesh-ancestor
64990412|NCT05243940|Anesthetics|anesthetics|mesh-ancestor
64990413|NCT05243940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64990426|NCT05243940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64990428|NCT05243940|Adrenergic Agents|adrenergic agents|mesh-ancestor
64990429|NCT05243940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64990430|NCT05243940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64990431|NCT05243940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64990432|NCT05243940|Anesthetics, General|anesthetics, general|mesh-ancestor
64990433|NCT05243940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64990434|NCT05243940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64990435|NCT05243940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64990436|NCT05243940|Narcotics|narcotics|mesh-ancestor
64990437|NCT05232071|Empagliflozin|empagliflozin|mesh-list
64990438|NCT05232071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64785814|NCT00000732|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64785815|NCT00000732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64785816|NCT00000732|Renal Agents|renal agents|mesh-ancestor
64785817|NCT00000732|Antimalarials|antimalarials|mesh-ancestor
64785818|NCT00000732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64785819|NCT00000732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64785820|NCT00000732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64785821|NCT00000732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64785822|NCT00000732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64785823|NCT00000732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64785824|NCT00000732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64785825|NCT00000738|Zidovudine|zidovudine|mesh-list
64785826|NCT00000738|Nimodipine|nimodipine|mesh-list
64785827|NCT00000738|Antimetabolites|antimetabolites|mesh-ancestor
64785828|NCT00000738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785829|NCT00000738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64785830|NCT00000738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64313570|NCT04836806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64313571|NCT04836806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990439|NCT05232071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990440|NCT05232071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64990441|NCT05232071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990442|NCT05231122|Bevacizumab|bevacizumab|mesh-list
64990443|NCT05231122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64990444|NCT05231122|Pembrolizumab|pembrolizumab|mesh-list
64990445|NCT05231122|Endothelial Growth Factors|endothelial growth factors|mesh-list
64990446|NCT05231122|Antibodies|antibodies|mesh-list
64990447|NCT05231122|Immunoglobulins|immunoglobulins|mesh-list
64990448|NCT05231122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64551993|NCT05314569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64990449|NCT05231122|Immunoglobulin G|immunoglobulin g|mesh-list
64990450|NCT05231122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990451|NCT05231122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64990452|NCT05231122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64990453|NCT05231122|Growth Substances|growth substances|mesh-ancestor
64990454|NCT05231122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990455|NCT05231122|Growth Inhibitors|growth inhibitors|mesh-ancestor
64785831|NCT00000738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785832|NCT00000738|Antiviral Agents|antiviral agents|mesh-ancestor
64785833|NCT00000738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64785834|NCT00000738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64785835|NCT00000738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64785836|NCT00000738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64785837|NCT00000738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64785838|NCT00000738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64313596|NCT02430909|Immunologic Factors|immunologic factors|mesh-ancestor
64313597|NCT02430909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313598|NCT02430909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64313600|NCT02105675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313601|NCT02105675|Tubulin Modulators|tubulin modulators|mesh-ancestor
64313602|NCT02105675|Antimitotic Agents|antimitotic agents|mesh-ancestor
64313603|NCT02105675|Mitosis Modulators|mitosis modulators|mesh-ancestor
64313604|NCT02105675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313605|NCT02336230|Remestemcel-l|remestemcel-l|mesh-list
64990456|NCT05231122|Immunologic Factors|immunologic factors|mesh-ancestor
64990457|NCT05220046|Psilocybin|psilocybin|mesh-list
64990458|NCT05220046|Hallucinogens|hallucinogens|mesh-ancestor
64990459|NCT05220046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990460|NCT05220046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64990461|NCT05216250|Botulinum Toxins|botulinum toxins|mesh-list
64990462|NCT05216250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64990463|NCT05216250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64990464|NCT05216250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64990465|NCT05216250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64990466|NCT05216250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990467|NCT05216250|Cholinergic Agents|cholinergic agents|mesh-ancestor
64990468|NCT05216250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64990469|NCT05216250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990496|NCT05209347|Carbon Fiber|carbon fiber|mesh-list
64990497|NCT05209347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64990498|NCT05209347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64551995|NCT05314569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64551996|NCT05314569|Narcotics|narcotics|mesh-ancestor
64551997|NCT05314569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64551998|NCT05314569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64551999|NCT05314569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64552000|NCT05314569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64552001|NCT05314569|GABA Modulators|gaba modulators|mesh-ancestor
64552002|NCT05314569|GABA Agents|gaba agents|mesh-ancestor
64552003|NCT05314569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64552004|NCT01494818|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64552005|NCT01494818|Contact Lens Solutions|contact lens solutions|mesh-list
64552006|NCT01494818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64552007|NCT01494818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64552008|NCT01494818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64552009|NCT01494818|Disinfectants|disinfectants|mesh-ancestor
64552010|NCT03167905|Fentanyl|fentanyl|mesh-list
64552011|NCT03167905|Meperidine|meperidine|mesh-list
64552012|NCT03167905|Remifentanil|remifentanil|mesh-list
64990503|NCT05209295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785839|NCT00000738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64785840|NCT00000738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313616|NCT04824404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64313617|NCT04824404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313618|NCT04824404|Analgesics|analgesics|mesh-ancestor
64313619|NCT04824404|Sensory System Agents|sensory system agents|mesh-ancestor
64313620|NCT04824404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313621|NCT04824404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64313622|NCT02109341|Paclitaxel|paclitaxel|mesh-list
64990504|NCT05209295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990505|NCT05209295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990506|NCT05208047|Sunitinib|sunitinib|mesh-list
64990507|NCT05208047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990508|NCT05208047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64990509|NCT05208047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64990510|NCT05208047|Growth Substances|growth substances|mesh-ancestor
64990511|NCT05208047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990512|NCT05208047|Growth Inhibitors|growth inhibitors|mesh-ancestor
64990513|NCT05208047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64990514|NCT05208047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990515|NCT05208047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990516|NCT05198830|Cisplatin|cisplatin|mesh-list
64990517|NCT05198830|Pemetrexed|pemetrexed|mesh-list
64990518|NCT05198830|Durvalumab|durvalumab|mesh-list
64990519|NCT05198830|Immunoglobulins|immunoglobulins|mesh-list
64990520|NCT05198830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64990521|NCT05198830|Immunoglobulin G|immunoglobulin g|mesh-list
64990522|NCT05198830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990523|NCT05198830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990524|NCT05198830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990525|NCT05198830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64990526|NCT05198830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64990527|NCT05198830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64990528|NCT05198830|Immunologic Factors|immunologic factors|mesh-ancestor
64990529|NCT05198830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990530|NCT05198544|Hyaluronic Acid|hyaluronic acid|mesh-list
64990531|NCT05198544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64990532|NCT05198544|Immunologic Factors|immunologic factors|mesh-ancestor
64990533|NCT05198544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990534|NCT05198544|Viscosupplements|viscosupplements|mesh-ancestor
64990535|NCT05198544|Protective Agents|protective agents|mesh-ancestor
64990595|NCT05130463|Incretins|incretins|mesh-ancestor
64990596|NCT05130463|Hormones|hormones|mesh-ancestor
64990597|NCT05130463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64990598|NCT05130463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64990599|NCT05130463|Protease Inhibitors|protease inhibitors|mesh-ancestor
64990600|NCT05130463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990601|NCT05126719|Docetaxel|docetaxel|mesh-list
64990602|NCT05126719|Capecitabine|capecitabine|mesh-list
64990609|NCT05126719|Antimetabolites|antimetabolites|mesh-ancestor
64990610|NCT05119140|Hydroxychloroquine|hydroxychloroquine|mesh-list
64990611|NCT05119140|Mesalamine|mesalamine|mesh-list
64990612|NCT05119140|Antimalarials|antimalarials|mesh-ancestor
64990613|NCT05119140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64990614|NCT05119140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64990615|NCT05119140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64990616|NCT05119140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990617|NCT05119140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990618|NCT05119140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64990619|NCT05119140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64990636|NCT05111574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990637|NCT05107050|Anti-Infective Agents|anti-infective agents|mesh-list
64990638|NCT05107050|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64990640|NCT05097261|Analgesics|analgesics|mesh-ancestor
64990641|NCT05097261|Sensory System Agents|sensory system agents|mesh-ancestor
64990642|NCT05097261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64990643|NCT05097261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324585|NCT02264587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324586|NCT02264587|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64324588|NCT05475080|Anticoagulants|anticoagulants|mesh-list
64324590|NCT02264665|Everolimus|everolimus|mesh-list
64324591|NCT02264665|Sunitinib|sunitinib|mesh-list
64324592|NCT02264665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324593|NCT02264665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64313647|NCT04367168|Colchicine|colchicine|mesh-list
64990644|NCT05097261|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64990645|NCT05097261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64990646|NCT05097261|Anesthetics, General|anesthetics, general|mesh-ancestor
64990647|NCT05097261|Anesthetics|anesthetics|mesh-ancestor
64990648|NCT05097261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64990649|NCT05097261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64990650|NCT05097261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64990651|NCT05097261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64990652|NCT05097261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990659|NCT05067933|Vaccines|vaccines|mesh-list
64990660|NCT05067933|Immunologic Factors|immunologic factors|mesh-ancestor
64990661|NCT05067933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552021|NCT03167905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64552022|NCT03167905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64552023|NCT03167905|Narcotics|narcotics|mesh-ancestor
64552024|NCT03167905|Analgesics|analgesics|mesh-ancestor
64552025|NCT03167905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64552026|NCT03167905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64552027|NCT03167905|Anesthetics, General|anesthetics, general|mesh-ancestor
64552028|NCT03167905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64552029|NCT03167905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64552030|NCT03167905|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64552031|NCT04030169|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
64552032|NCT04030169|Hallucinogens|hallucinogens|mesh-ancestor
64785841|NCT00000738|Vasodilator Agents|vasodilator agents|mesh-ancestor
64785842|NCT00000750|Zidovudine|zidovudine|mesh-list
64785843|NCT00000750|Antimetabolites|antimetabolites|mesh-ancestor
64785844|NCT00000750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785845|NCT00000750|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64785846|NCT00000750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64785847|NCT00000750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785848|NCT00000750|Antiviral Agents|antiviral agents|mesh-ancestor
64785849|NCT00000750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64785850|NCT00000750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64785851|NCT00000750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64785852|NCT00000804|Indinavir|indinavir|mesh-list
64313710|NCT02112305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313711|NCT02112305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313712|NCT02112305|Anesthetics|anesthetics|mesh-ancestor
64313713|NCT02112305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64313714|NCT02112305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64313715|NCT02112305|Anticonvulsants|anticonvulsants|mesh-ancestor
64313716|NCT02112305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64313718|NCT02112305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313719|NCT02112305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64313720|NCT02112305|Tocolytic Agents|tocolytic agents|mesh-ancestor
64313722|NCT02114099|Atorvastatin|atorvastatin|mesh-list
64552033|NCT04030169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552034|NCT04030169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64552035|NCT04030169|Serotonin Agents|serotonin agents|mesh-ancestor
64552036|NCT04030169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64552037|NCT04030169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552038|NCT04030169|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64552039|NCT04030169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64552040|NCT04030169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64552041|NCT04030169|Adrenergic Agents|adrenergic agents|mesh-ancestor
64990690|NCT05019716|Etoposide phosphate|etoposide phosphate|mesh-list
64990691|NCT05019716|Podophyllotoxin|podophyllotoxin|mesh-list
64990692|NCT05019716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990693|NCT05019716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64990694|NCT05019716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64990695|NCT05019716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64990696|NCT05019716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990697|NCT05019716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990698|NCT05019716|Keratolytic Agents|keratolytic agents|mesh-ancestor
64990699|NCT05019716|Dermatologic Agents|dermatologic agents|mesh-ancestor
64990700|NCT05019716|Tubulin Modulators|tubulin modulators|mesh-ancestor
64990701|NCT05019716|Antimitotic Agents|antimitotic agents|mesh-ancestor
64990702|NCT05019716|Mitosis Modulators|mitosis modulators|mesh-ancestor
64990703|NCT05001880|Bevacizumab|bevacizumab|mesh-list
64990704|NCT05001880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64990705|NCT05001880|Carboplatin|carboplatin|mesh-list
64990706|NCT05001880|Pemetrexed|pemetrexed|mesh-list
64990707|NCT05001880|Atezolizumab|atezolizumab|mesh-list
64990708|NCT05001880|Endothelial Growth Factors|endothelial growth factors|mesh-list
64990709|NCT05001880|Antibodies|antibodies|mesh-list
64990710|NCT05001880|Immunoglobulins|immunoglobulins|mesh-list
64990711|NCT05001880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64990712|NCT05001880|Immunoglobulin G|immunoglobulin g|mesh-list
64990713|NCT05001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990714|NCT05001880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64990715|NCT05001880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64990716|NCT05001880|Growth Substances|growth substances|mesh-ancestor
64552043|NCT02638389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64552044|NCT02638389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64552045|NCT02638389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64552046|NCT02638389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552047|NCT02638389|Antifungal Agents|antifungal agents|mesh-ancestor
64552048|NCT02638389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64785853|NCT00000804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64785854|NCT00000804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64313734|NCT02251223|Protease Inhibitors|protease inhibitors|mesh-ancestor
64313735|NCT02251223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313736|NCT02251223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313737|NCT02251223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64313738|NCT02251223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64313739|NCT02251223|Antiviral Agents|antiviral agents|mesh-ancestor
64313740|NCT02251223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64313741|NCT02251223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64313742|NCT02251223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64313743|NCT02114333|Vaccines|vaccines|mesh-list
64313749|NCT02114645|Leuprolide|leuprolide|mesh-list
64552049|NCT02638389|Immunologic Factors|immunologic factors|mesh-ancestor
64552050|NCT02638389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552051|NCT01494584|Ezogabine|ezogabine|mesh-list
64552052|NCT01494584|Anticonvulsants|anticonvulsants|mesh-ancestor
64714188|NCT02988050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64552053|NCT01494584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64552054|NCT01494584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552055|NCT03211143|Esomeprazole|esomeprazole|mesh-list
64552056|NCT03211143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64552057|NCT03211143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64552058|NCT03211143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64552059|NCT03211143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736762|NCT05599919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317091|NCT05544656|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64990717|NCT05001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990718|NCT05001880|Growth Inhibitors|growth inhibitors|mesh-ancestor
64990719|NCT05001880|Immunologic Factors|immunologic factors|mesh-ancestor
64990720|NCT05001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990721|NCT05001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990722|NCT05001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64990723|NCT05001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64990724|NCT04989283|Paclitaxel|paclitaxel|mesh-list
64990725|NCT04989283|Etoposide|etoposide|mesh-list
64990726|NCT04989283|Podophyllotoxin|podophyllotoxin|mesh-list
64990727|NCT04989283|Cisplatin|cisplatin|mesh-list
64990728|NCT04989283|Carboplatin|carboplatin|mesh-list
64990729|NCT04989283|Pemetrexed|pemetrexed|mesh-list
64990730|NCT04989283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64990731|NCT04989283|Etoposide phosphate|etoposide phosphate|mesh-list
64990732|NCT04989283|Atezolizumab|atezolizumab|mesh-list
64990733|NCT04989283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64990734|NCT04989283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64990735|NCT04989283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990736|NCT04989283|Tubulin Modulators|tubulin modulators|mesh-ancestor
64990737|NCT04989283|Antimitotic Agents|antimitotic agents|mesh-ancestor
64990738|NCT04989283|Mitosis Modulators|mitosis modulators|mesh-ancestor
64990739|NCT04989283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990740|NCT04989283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64324595|NCT02264665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324596|NCT02264665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64324597|NCT02264665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64324598|NCT02264665|Growth Substances|growth substances|mesh-ancestor
64324599|NCT02264665|Growth Inhibitors|growth inhibitors|mesh-ancestor
64990741|NCT04989283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64990742|NCT04989283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990743|NCT04989283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64990778|NCT04941287|Immunoglobulin G|immunoglobulin g|mesh-list
64990779|NCT04941287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990780|NCT04941287|Immunologic Factors|immunologic factors|mesh-ancestor
64990781|NCT04941287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990783|NCT04929041|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64990784|NCT04929041|Carboplatin|carboplatin|mesh-list
64990785|NCT04929041|Pembrolizumab|pembrolizumab|mesh-list
64552060|NCT03211143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552061|NCT01388543|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64552062|NCT01388543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64552063|NCT01388543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64552064|NCT01388543|Protease Inhibitors|protease inhibitors|mesh-ancestor
64552065|NCT01388543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990786|NCT04929041|Nivolumab|nivolumab|mesh-list
64990807|NCT04929028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64990808|NCT04929028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990809|NCT04929028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64990810|NCT04929028|Immunologic Factors|immunologic factors|mesh-ancestor
64990811|NCT04929028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990812|NCT04929028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64990813|NCT04929028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64990814|NCT04929028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64990815|NCT04929028|Alkylating Agents|alkylating agents|mesh-ancestor
64990816|NCT04929028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64990817|NCT04929028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990818|NCT04925752|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64990819|NCT04925752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64990820|NCT04925752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64990821|NCT04925752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990822|NCT04925752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990823|NCT04925752|Antiviral Agents|antiviral agents|mesh-ancestor
64990824|NCT04925752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64990825|NCT04925752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64990826|NCT04925752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64990827|NCT04921358|Docetaxel|docetaxel|mesh-list
64990828|NCT04921358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990829|NCT04921358|Tubulin Modulators|tubulin modulators|mesh-ancestor
64990830|NCT04921358|Antimitotic Agents|antimitotic agents|mesh-ancestor
64990831|NCT04921358|Mitosis Modulators|mitosis modulators|mesh-ancestor
64990832|NCT04921358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990868|NCT04904588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990870|NCT04904588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64990871|NCT04904588|Alkylating Agents|alkylating agents|mesh-ancestor
64990872|NCT04904588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990873|NCT04904588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313778|NCT02603432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313779|NCT04826900|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64313780|NCT04826900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64313781|NCT04826900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313782|NCT04826900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313783|NCT04826900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64313784|NCT04826900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64313785|NCT04826900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313786|NCT04826900|Cholinergic Agents|cholinergic agents|mesh-ancestor
64313787|NCT04826900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64990874|NCT04904588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64990875|NCT04904588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64990876|NCT04904588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990877|NCT04904588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64990878|NCT04904588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64990879|NCT04904588|Antitubercular Agents|antitubercular agents|mesh-ancestor
64990880|NCT04904588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64990881|NCT04904588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64990882|NCT04903197|Lenalidomide|lenalidomide|mesh-list
64990883|NCT04903197|Immunologic Factors|immunologic factors|mesh-ancestor
64990884|NCT04903197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990885|NCT04903197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64990886|NCT04903197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64990887|NCT04903197|Growth Substances|growth substances|mesh-ancestor
64990930|NCT04856189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64990931|NCT04856189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990932|NCT04847557|Tirzepatide|tirzepatide|mesh-list
64990933|NCT04847557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64990934|NCT04847557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990935|NCT04847557|Incretins|incretins|mesh-ancestor
64990948|NCT04847453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64990949|NCT04847453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990950|NCT04847453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64990951|NCT04847453|Glucocorticoids|glucocorticoids|mesh-ancestor
64990952|NCT04847453|Hormones|hormones|mesh-ancestor
64990953|NCT04847453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64990954|NCT04847453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64552066|NCT01388543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552067|NCT01388543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64552068|NCT01388543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64552069|NCT01388543|Antiviral Agents|antiviral agents|mesh-ancestor
64552070|NCT01388543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64552071|NCT03518203|Eculizumab|eculizumab|mesh-list
64552072|NCT03518203|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64552073|NCT03518203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64552074|NCT03518203|Immunologic Factors|immunologic factors|mesh-ancestor
64552075|NCT03518203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552076|NCT00882895|Mycophenolic Acid|mycophenolic acid|mesh-list
64552077|NCT00882895|Methylprednisolone|methylprednisolone|mesh-list
64317119|NCT04425590|Antipyretics|antipyretics|mesh-ancestor
64313792|NCT04361162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64313793|NCT04361162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313795|NCT04823390|Midazolam|midazolam|mesh-list
64313796|NCT04823390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64313797|NCT04823390|Narcotics|narcotics|mesh-ancestor
64313798|NCT04823390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64313799|NCT04823390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313800|NCT04823390|Analgesics|analgesics|mesh-ancestor
64990955|NCT04847453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990956|NCT04847453|Protease Inhibitors|protease inhibitors|mesh-ancestor
64990957|NCT04847453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990958|NCT04847453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990959|NCT04847453|Dermatologic Agents|dermatologic agents|mesh-ancestor
64990960|NCT04847453|Glycine Agents|glycine agents|mesh-ancestor
64990961|NCT04847453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64990962|NCT04840199|Letermovir|letermovir|mesh-list
64990963|NCT04840199|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64990964|NCT04840199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990965|NCT04840199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990966|NCT04840199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990967|NCT04840199|Antiviral Agents|antiviral agents|mesh-ancestor
64990968|NCT04840199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64990969|NCT04838769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
64990970|NCT04838769|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
64990971|NCT04838769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64990972|NCT04838769|Adrenergic Agents|adrenergic agents|mesh-ancestor
64990973|NCT04838769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64990974|NCT04838769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990975|NCT04838769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990976|NCT04838769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64990977|NCT04838769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990978|NCT04838769|Hormone Antagonists|hormone antagonists|mesh-ancestor
64990979|NCT04838769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64990980|NCT04821622|Talazoparib|talazoparib|mesh-list
64990981|NCT04821622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64990982|NCT04821622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990983|NCT04821622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990984|NCT04821622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990985|NCT04800393|Propofol|propofol|mesh-list
64990986|NCT04800393|Sevoflurane|sevoflurane|mesh-list
64990987|NCT04800393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64785856|NCT00000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785858|NCT00000804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64990988|NCT04800393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64990989|NCT04800393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990990|NCT04800393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64990991|NCT04800393|Anesthetics, General|anesthetics, general|mesh-ancestor
64990992|NCT04800393|Anesthetics|anesthetics|mesh-ancestor
64990993|NCT04800393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64990994|NCT04800393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64990995|NCT04768881|Pembrolizumab|pembrolizumab|mesh-list
64990996|NCT04768881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64990997|NCT04768881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990998|NCT04768296|Topotecan|topotecan|mesh-list
64990999|NCT04768296|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64991000|NCT04768296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64991020|NCT04759586|Etoposide|etoposide|mesh-list
64991021|NCT04759586|Vincristine|vincristine|mesh-list
64991022|NCT04759586|Etoposide phosphate|etoposide phosphate|mesh-list
64552078|NCT00882895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64552079|NCT00882895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64552080|NCT00882895|Prednisolone|prednisolone|mesh-list
64552081|NCT00882895|Prednisolone acetate|prednisolone acetate|mesh-list
64552082|NCT00882895|Tacrolimus|tacrolimus|mesh-list
64552083|NCT00882895|Thymoglobulin|thymoglobulin|mesh-list
64552084|NCT00882895|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64552085|NCT00882895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64552086|NCT00882895|Prednisolone phosphate|prednisolone phosphate|mesh-list
64552087|NCT00882895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64552088|NCT00882895|Immunologic Factors|immunologic factors|mesh-ancestor
64552089|NCT00882895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552090|NCT00882895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64552091|NCT00882895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552092|NCT00882895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317129|NCT00707889|Oxaliplatin|oxaliplatin|mesh-list
64991023|NCT04759586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64991024|NCT04759586|Antibodies|antibodies|mesh-list
64991025|NCT04759586|Immunoglobulins|immunoglobulins|mesh-list
64991026|NCT04759586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64991027|NCT04759586|Lenograstim|lenograstim|mesh-list
64991028|NCT04759586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64991029|NCT04759586|Prednisolone phosphate|prednisolone phosphate|mesh-list
64785862|NCT00000810|Zidovudine|zidovudine|mesh-list
64785863|NCT00000810|Didanosine|didanosine|mesh-list
64785864|NCT00000810|Delavirdine|delavirdine|mesh-list
64785865|NCT00000810|Antimetabolites|antimetabolites|mesh-ancestor
64785866|NCT00000810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785867|NCT00000810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64785868|NCT00000810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64785869|NCT00000810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785870|NCT00000810|Antiviral Agents|antiviral agents|mesh-ancestor
64785871|NCT00000810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64785874|NCT00000834|Lamivudine|lamivudine|mesh-list
64991030|NCT04759586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64991031|NCT04759586|Immunologic Factors|immunologic factors|mesh-ancestor
64991032|NCT04759586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991033|NCT04759586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64991034|NCT04759586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64991035|NCT04759586|Alkylating Agents|alkylating agents|mesh-ancestor
64991036|NCT04759586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991037|NCT04759586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991038|NCT04759586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64991039|NCT04759586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64991040|NCT04759586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64991041|NCT04759586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64991042|NCT04759586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991043|NCT04759586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64991045|NCT04759586|Hormones|hormones|mesh-ancestor
64991046|NCT04759586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64991047|NCT04759586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64991048|NCT04759586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64991049|NCT04759586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64991050|NCT04759586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64991051|NCT04759586|Tubulin Modulators|tubulin modulators|mesh-ancestor
64991052|NCT04759586|Antimitotic Agents|antimitotic agents|mesh-ancestor
64991053|NCT04759586|Mitosis Modulators|mitosis modulators|mesh-ancestor
64991054|NCT04759586|Antiemetics|antiemetics|mesh-ancestor
64991055|NCT04759586|Autonomic Agents|autonomic agents|mesh-ancestor
64991056|NCT04759586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64991057|NCT04759586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64991058|NCT04759586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64991071|NCT04751383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64991072|NCT04751370|Nivolumab|nivolumab|mesh-list
64991073|NCT04751370|Ipilimumab|ipilimumab|mesh-list
64991074|NCT04751370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64991075|NCT04751370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64785883|NCT00000834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785884|NCT00000834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313910|NCT03553433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313911|NCT02604212|Tenofovir|tenofovir|mesh-list
64313912|NCT02604212|Entecavir|entecavir|mesh-list
64313913|NCT02604212|Histamine Antagonists|histamine antagonists|mesh-list
64313914|NCT02604212|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
64313915|NCT02604212|Antiviral Agents|antiviral agents|mesh-ancestor
64313916|NCT02604212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64313917|NCT02604212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64313926|NCT02115659|Triptolide|triptolide|mesh-list
64991076|NCT04751370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64552093|NCT00882895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64552094|NCT00882895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552095|NCT00882895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64552096|NCT00882895|Antitubercular Agents|antitubercular agents|mesh-ancestor
64552097|NCT00882895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64552098|NCT00882895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64552099|NCT00882895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64552101|NCT00882895|Autonomic Agents|autonomic agents|mesh-ancestor
64552102|NCT00882895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64552103|NCT00882895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64552104|NCT00882895|Glucocorticoids|glucocorticoids|mesh-ancestor
64552105|NCT00882895|Hormones|hormones|mesh-ancestor
64552106|NCT00882895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64552107|NCT00882895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64552108|NCT00882895|Protective Agents|protective agents|mesh-ancestor
64552109|NCT00882895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64552110|NCT05367245|Butyric Acid|butyric acid|mesh-list
64552111|NCT05367245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552112|NCT05367245|Histamine Antagonists|histamine antagonists|mesh-ancestor
64552113|NCT05367245|Histamine Agents|histamine agents|mesh-ancestor
64552114|NCT05367245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64317143|NCT00707889|Antidotes|antidotes|mesh-ancestor
64991077|NCT04751370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991078|NCT04750954|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64991079|NCT04750954|Peposertib|peposertib|mesh-list
64991080|NCT04750954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991081|NCT04750954|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64991082|NCT04750954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64991083|NCT04750954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991084|NCT04739800|Paclitaxel|paclitaxel|mesh-list
64991085|NCT04739800|Doxorubicin|doxorubicin|mesh-list
64991086|NCT04739800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64991087|NCT04739800|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64991088|NCT04739800|Durvalumab|durvalumab|mesh-list
64991089|NCT04739800|Topotecan|topotecan|mesh-list
64991090|NCT04739800|Olaparib|olaparib|mesh-list
64991091|NCT04739800|Cediranib|cediranib|mesh-list
64991092|NCT04739800|Maleic acid|maleic acid|mesh-list
64991093|NCT04739800|Immunoglobulins|immunoglobulins|mesh-list
64991094|NCT04739800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64991095|NCT04739800|Immunoglobulin G|immunoglobulin g|mesh-list
64991096|NCT04739800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64991097|NCT04739800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991098|NCT04739800|Tubulin Modulators|tubulin modulators|mesh-ancestor
64991099|NCT04739800|Antimitotic Agents|antimitotic agents|mesh-ancestor
64991100|NCT04739800|Mitosis Modulators|mitosis modulators|mesh-ancestor
64991101|NCT04739800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785885|NCT00000834|Dermatologic Agents|dermatologic agents|mesh-ancestor
64785886|NCT00000834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785887|NCT00000834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64785893|NCT00000834|Antiviral Agents|antiviral agents|mesh-ancestor
64991102|NCT04739800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64991103|NCT04739800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64991104|NCT04739800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64991105|NCT04739800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991106|NCT04739800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64552115|NCT05367245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552119|NCT00900237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64552120|NCT00900237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64552121|NCT00900237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64552122|NCT00900237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552123|NCT00900237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64552124|NCT00900237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64552125|NCT00893997|Vaccines|vaccines|mesh-list
64552126|NCT00893997|Immunologic Factors|immunologic factors|mesh-ancestor
64552127|NCT00893997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552128|NCT00512317|Ganaxolone|ganaxolone|mesh-list
64552129|NCT00512317|Neurosteroids|neurosteroids|mesh-ancestor
64552130|NCT00512317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64552131|NCT00512317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552132|NCT00512317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552133|NCT00512317|GABA Modulators|gaba modulators|mesh-ancestor
64552134|NCT00512317|GABA Agents|gaba agents|mesh-ancestor
64552135|NCT04337827|Rituximab|rituximab|mesh-list
64552136|NCT04337827|Acalabrutinib|acalabrutinib|mesh-list
64552137|NCT04337827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64317168|NCT02419443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991107|NCT04739800|Immunologic Factors|immunologic factors|mesh-ancestor
64991108|NCT04739800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991109|NCT04739800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64991110|NCT04739800|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64991111|NCT04739800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64991112|NCT04736173|Paclitaxel|paclitaxel|mesh-list
64991113|NCT04736173|Carboplatin|carboplatin|mesh-list
64991114|NCT04736173|Pembrolizumab|pembrolizumab|mesh-list
64991115|NCT04736173|Pemetrexed|pemetrexed|mesh-list
64991116|NCT04736173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64991117|NCT04736173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991118|NCT04736173|Tubulin Modulators|tubulin modulators|mesh-ancestor
64991119|NCT04736173|Antimitotic Agents|antimitotic agents|mesh-ancestor
64991120|NCT04736173|Mitosis Modulators|mitosis modulators|mesh-ancestor
64991121|NCT04736173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991122|NCT04736173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64991149|NCT04718220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324602|NCT02264665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324603|NCT02683941|Lanreotide|lanreotide|mesh-list
64314016|NCT03552575|Valsartan|valsartan|mesh-list
64314017|NCT03552575|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64314018|NCT03552575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64314019|NCT03552575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64314020|NCT03552575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64991153|NCT04704661|Trastuzumab|trastuzumab|mesh-list
64991154|NCT04704661|Camptothecin|camptothecin|mesh-list
64991155|NCT04704661|Immunoconjugates|immunoconjugates|mesh-list
64991156|NCT04704661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64991157|NCT04704661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991158|NCT04704661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64991159|NCT04704661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64991160|NCT04704661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64991161|NCT04704661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991162|NCT04704661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991241|NCT04609046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64324604|NCT02683941|Somatostatin|somatostatin|mesh-list
64324605|NCT02683941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324606|NCT02683941|Hormones|hormones|mesh-ancestor
64429996|NCT05056883|Ivermectin|ivermectin|mesh-list
64785897|NCT00000864|Zidovudine|zidovudine|mesh-list
64785898|NCT00000864|Abacavir|abacavir|mesh-list
64785899|NCT00000864|Antimetabolites|antimetabolites|mesh-ancestor
64785900|NCT00000864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785901|NCT00000864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64785902|NCT00000864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64785903|NCT00000864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785904|NCT00000864|Antiviral Agents|antiviral agents|mesh-ancestor
64785905|NCT00000864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64785906|NCT00000864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64397051|NCT02374645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314037|NCT04806230|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64314038|NCT04806230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64314039|NCT04806230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64314040|NCT04806230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314041|NCT04806230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64314042|NCT04806230|Serotonin Agents|serotonin agents|mesh-ancestor
64314043|NCT04806230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314044|NCT04806230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64314045|NCT04806230|Antidepressive Agents|antidepressive agents|mesh-ancestor
64991243|NCT04609046|Methotrexate|methotrexate|mesh-list
64991244|NCT04609046|Lenalidomide|lenalidomide|mesh-list
64991245|NCT04609046|Antibodies|antibodies|mesh-list
64991246|NCT04609046|Immunoglobulins|immunoglobulins|mesh-list
64991247|NCT04609046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64991248|NCT04609046|Immunologic Factors|immunologic factors|mesh-ancestor
64991249|NCT04609046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991250|NCT04609046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991251|NCT04609046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64991252|NCT04609046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64991253|NCT04609046|Abortifacient Agents|abortifacient agents|mesh-ancestor
64991254|NCT04609046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64991255|NCT04609046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64991256|NCT04609046|Antimetabolites|antimetabolites|mesh-ancestor
64552152|NCT01494506|Protective Agents|protective agents|mesh-ancestor
64552154|NCT01494506|Vitamins|vitamins|mesh-ancestor
64552155|NCT01494506|Micronutrients|micronutrients|mesh-ancestor
64552156|NCT03024905|Misoprostol|misoprostol|mesh-list
64552157|NCT03024905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64552158|NCT03024905|Abortifacient Agents|abortifacient agents|mesh-ancestor
64552159|NCT03024905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64552160|NCT03024905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552161|NCT03024905|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64314047|NCT04806230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64314048|NCT04806230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64314049|NCT04806230|Histamine Antagonists|histamine antagonists|mesh-ancestor
64314050|NCT04806230|Histamine Agents|histamine agents|mesh-ancestor
64314051|NCT04806230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64314052|NCT04806230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64314053|NCT04806230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64314054|NCT04806230|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64314055|NCT04806230|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64314056|NCT04806230|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64314057|NCT04806230|Adrenergic Agents|adrenergic agents|mesh-ancestor
64314058|NCT04806230|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64314059|NCT04806230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64314060|NCT04806230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64314061|NCT02603120|Tenofovir|tenofovir|mesh-list
64314062|NCT02603120|Emtricitabine|emtricitabine|mesh-list
64314063|NCT02603120|Lamivudine|lamivudine|mesh-list
64314064|NCT02603120|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64314065|NCT02603120|Triumeq|triumeq|mesh-list
64314066|NCT02603120|Antiviral Agents|antiviral agents|mesh-ancestor
64314067|NCT02603120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64314068|NCT02603120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64552162|NCT03024905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64552163|NCT03024905|Oxytocics|oxytocics|mesh-ancestor
64552164|NCT02643420|Cyclophosphamide|cyclophosphamide|mesh-list
64552165|NCT02643420|Docetaxel|docetaxel|mesh-list
64552166|NCT02643420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64552167|NCT02643420|Immunologic Factors|immunologic factors|mesh-ancestor
64552168|NCT02643420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552169|NCT02643420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64552170|NCT02643420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64552171|NCT02643420|Alkylating Agents|alkylating agents|mesh-ancestor
64552172|NCT02643420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552173|NCT02643420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552174|NCT02643420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64552175|NCT02643420|Tubulin Modulators|tubulin modulators|mesh-ancestor
64552176|NCT02643420|Antimitotic Agents|antimitotic agents|mesh-ancestor
64317205|NCT02414919|Levonorgestrel|levonorgestrel|mesh-list
64317206|NCT02414919|Etonogestrel|etonogestrel|mesh-list
64991257|NCT04609046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991258|NCT04609046|Dermatologic Agents|dermatologic agents|mesh-ancestor
64991259|NCT04609046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991260|NCT04609046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64991261|NCT04609046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64991262|NCT04609046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64991263|NCT04609046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64991264|NCT04609046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64991265|NCT04609046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64991266|NCT04609046|Growth Substances|growth substances|mesh-ancestor
64991267|NCT04609046|Growth Inhibitors|growth inhibitors|mesh-ancestor
64991285|NCT04572295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64991286|NCT04572295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991287|NCT04572295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64991288|NCT04572295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64991289|NCT04572295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991290|NCT04572295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991291|NCT04557956|Trametinib|trametinib|mesh-list
64991292|NCT04557956|Dabrafenib|dabrafenib|mesh-list
64991293|NCT04557956|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
64991294|NCT04557956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552178|NCT01830465|Rituximab|rituximab|mesh-list
64552179|NCT01830465|Bortezomib|bortezomib|mesh-list
64552180|NCT01830465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64552181|NCT01830465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324607|NCT02683941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64324608|NCT02683941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324610|NCT05232123|Anticonvulsants|anticonvulsants|mesh-ancestor
64324611|NCT01225393|Adalimumab|adalimumab|mesh-list
64324612|NCT01225393|Methotrexate|methotrexate|mesh-list
64324613|NCT01225393|Leflunomide|leflunomide|mesh-list
64314070|NCT02603120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314074|NCT04815200|Copper|copper|mesh-list
64552182|NCT01830465|Immunologic Factors|immunologic factors|mesh-ancestor
64552183|NCT01830465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552184|NCT01830465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64552185|NCT03485911|Berotralstat|berotralstat|mesh-list
64317231|NCT05089565|Antibodies|antibodies|mesh-list
64317232|NCT05089565|Immunoglobulin G|immunoglobulin g|mesh-list
64991295|NCT04557956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64991296|NCT04557956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991297|NCT04557956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991298|NCT04557956|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64991299|NCT04557956|Protective Agents|protective agents|mesh-ancestor
64991300|NCT04557956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991301|NCT04557956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64991302|NCT04557956|Antioxidants|antioxidants|mesh-ancestor
64991310|NCT04541017|Mogamulizumab|mogamulizumab|mesh-list
64991311|NCT04541017|Magrolimab|magrolimab|mesh-list
64991312|NCT04541017|Immunoglobulins|immunoglobulins|mesh-list
64991313|NCT04541017|Immunoglobulin G|immunoglobulin g|mesh-list
64991314|NCT04541017|Immunologic Factors|immunologic factors|mesh-ancestor
64991315|NCT04541017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991316|NCT04541017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991317|NCT04541017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64991318|NCT04537715|Itraconazole|itraconazole|mesh-list
64991320|NCT04537715|Antifungal Agents|antifungal agents|mesh-ancestor
64991321|NCT04537715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64991322|NCT04537715|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64991323|NCT04537715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64991324|NCT04537715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991325|NCT04537715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991326|NCT04537715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64991327|NCT04537715|Hormone Antagonists|hormone antagonists|mesh-ancestor
64991328|NCT04537715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64991329|NCT04537715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991330|NCT04537715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64991331|NCT04537715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64991332|NCT04537715|Antitubercular Agents|antitubercular agents|mesh-ancestor
64991333|NCT04537715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64991334|NCT04537715|Leprostatic Agents|leprostatic agents|mesh-ancestor
64991335|NCT04537715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64991347|NCT04521868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64991348|NCT04521868|Protective Agents|protective agents|mesh-ancestor
64991349|NCT04521868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991350|NCT04521868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991351|NCT04514497|Irinotecan|irinotecan|mesh-list
64991352|NCT04514497|Topotecan|topotecan|mesh-list
64991353|NCT04514497|Camptothecin|camptothecin|mesh-list
64991354|NCT04514497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64991355|NCT04514497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64314089|NCT04813952|Sevoflurane|sevoflurane|mesh-list
64314090|NCT04813952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64314091|NCT04813952|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64314092|NCT04813952|Anesthetics, General|anesthetics, general|mesh-ancestor
64314093|NCT04813952|Anesthetics|anesthetics|mesh-ancestor
64314094|NCT04813952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64314095|NCT04813952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314096|NCT04813874|Nitrous Oxide|nitrous oxide|mesh-list
64991356|NCT04514497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991357|NCT04514497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991358|NCT04514497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991359|NCT04514497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64991360|NCT04514484|Nivolumab|nivolumab|mesh-list
64991361|NCT04514484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64991362|NCT04514484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991363|NCT04514484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64991364|NCT04514484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552186|NCT03485911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552187|NCT03485911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552188|NCT00894465|Midazolam|midazolam|mesh-list
64552189|NCT00894465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64552190|NCT00894465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64552191|NCT00894465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64552192|NCT00894465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552193|NCT00894465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64552194|NCT00894465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64552195|NCT00894465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64552196|NCT00894465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64552197|NCT00894465|Anesthetics, General|anesthetics, general|mesh-ancestor
64552198|NCT00894465|Anesthetics|anesthetics|mesh-ancestor
64552199|NCT00894465|GABA Modulators|gaba modulators|mesh-ancestor
64552200|NCT00894465|GABA Agents|gaba agents|mesh-ancestor
64552201|NCT00894465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64991365|NCT04481204|Leucovorin|leucovorin|mesh-list
64991366|NCT04481204|Gemcitabine|gemcitabine|mesh-list
64991367|NCT04481204|Paclitaxel|paclitaxel|mesh-list
64991368|NCT04481204|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64991369|NCT04481204|Cisplatin|cisplatin|mesh-list
64991370|NCT04481204|Fluorouracil|fluorouracil|mesh-list
64991371|NCT04481204|Oxaliplatin|oxaliplatin|mesh-list
64991372|NCT04481204|Irinotecan|irinotecan|mesh-list
64991373|NCT04481204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64991374|NCT04481204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991375|NCT04481204|Tubulin Modulators|tubulin modulators|mesh-ancestor
64991376|NCT04481204|Antimitotic Agents|antimitotic agents|mesh-ancestor
64991377|NCT04481204|Mitosis Modulators|mitosis modulators|mesh-ancestor
64991378|NCT04481204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991379|NCT04481204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64991380|NCT04481204|Antimetabolites|antimetabolites|mesh-ancestor
64991381|NCT04481204|Antiviral Agents|antiviral agents|mesh-ancestor
64991382|NCT04481204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64991383|NCT04481204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991384|NCT04481204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64991385|NCT04481204|Immunologic Factors|immunologic factors|mesh-ancestor
64991386|NCT04481204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991387|NCT04481204|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64991388|NCT04481204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64991389|NCT04481204|Antidotes|antidotes|mesh-ancestor
64785907|NCT00000864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64785908|NCT00000876|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
64785909|NCT00000876|Immunologic Factors|immunologic factors|mesh-ancestor
64785910|NCT00000876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785911|NCT00000894|Ganciclovir|ganciclovir|mesh-list
64314109|NCT04803500|Antimetabolites|antimetabolites|mesh-ancestor
64314110|NCT04803500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314111|NCT04803500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64314113|NCT04803500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991390|NCT04481204|Protective Agents|protective agents|mesh-ancestor
64991391|NCT04481204|Vitamin B Complex|vitamin b complex|mesh-ancestor
64991392|NCT04481204|Vitamins|vitamins|mesh-ancestor
64991393|NCT04481204|Micronutrients|micronutrients|mesh-ancestor
64991417|NCT04442022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64991419|NCT04442022|Glucocorticoids|glucocorticoids|mesh-ancestor
64991420|NCT04442022|Hormones|hormones|mesh-ancestor
64991421|NCT04442022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64991422|NCT04442022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64991423|NCT04442022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64991424|NCT04442022|Antimetabolites|antimetabolites|mesh-ancestor
64991425|NCT04442022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991426|NCT04442022|Antiviral Agents|antiviral agents|mesh-ancestor
64991427|NCT04442022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64991428|NCT04442022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991429|NCT04442022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64991430|NCT04440735|Atezolizumab|atezolizumab|mesh-list
64991431|NCT04440735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991432|NCT04419493|Heparin|heparin|mesh-list
64991433|NCT04419493|Calcium heparin|calcium heparin|mesh-list
64991434|NCT04419493|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64552202|NCT00894465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552203|NCT01456130|Alogliptin|alogliptin|mesh-list
64552204|NCT01456130|Insulin, Short-Acting|insulin, short-acting|mesh-list
64552205|NCT01456130|Secretagogues|secretagogues|mesh-list
64552206|NCT01456130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64552207|NCT01456130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552208|NCT01456130|Incretins|incretins|mesh-ancestor
64552209|NCT01456130|Hormones|hormones|mesh-ancestor
64552210|NCT01456130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64552211|NCT01456130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64991435|NCT04419493|Anticoagulants|anticoagulants|mesh-ancestor
64991436|NCT04419493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64991437|NCT04419493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64991438|NCT04419493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991439|NCT04402788|Atezolizumab|atezolizumab|mesh-list
64991440|NCT04402788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64991441|NCT04402788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991442|NCT04402788|Immunologic Factors|immunologic factors|mesh-ancestor
64991443|NCT04402788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991444|NCT04401748|Azacitidine|azacitidine|mesh-list
64991445|NCT04401748|Venetoclax|venetoclax|mesh-list
64991446|NCT04401748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64991447|NCT04401748|Antimetabolites|antimetabolites|mesh-ancestor
64991448|NCT04401748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991449|NCT04401748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991450|NCT04401748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991451|NCT04395183|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
64785912|NCT00000894|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64785913|NCT00000894|Cidofovir|cidofovir|mesh-list
64785914|NCT00000894|Probenecid|probenecid|mesh-list
64785915|NCT00000894|Antiviral Agents|antiviral agents|mesh-ancestor
64785916|NCT00000894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64785917|NCT00000894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64785918|NCT00000894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314122|NCT02120339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64314123|NCT02120339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64991452|NCT04395183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64991453|NCT04395183|Antidepressive Agents|antidepressive agents|mesh-ancestor
64991454|NCT04395183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64991455|NCT04394975|Sunitinib|sunitinib|mesh-list
64991456|NCT04394975|Axitinib|axitinib|mesh-list
64991457|NCT04394975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991458|NCT04394975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64991459|NCT04394975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64991460|NCT04394975|Growth Substances|growth substances|mesh-ancestor
64991461|NCT04394975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991462|NCT04394975|Growth Inhibitors|growth inhibitors|mesh-ancestor
64991463|NCT04394975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64991477|NCT04381910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991478|NCT04381910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991479|NCT04381910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991495|NCT04363801|Fluorouracil|fluorouracil|mesh-list
64991496|NCT04363801|Capecitabine|capecitabine|mesh-list
64991497|NCT04363801|Oxaliplatin|oxaliplatin|mesh-list
64991498|NCT04363801|Calcium|calcium|mesh-list
64991499|NCT04363801|Levoleucovorin|levoleucovorin|mesh-list
64991506|NCT04363801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64991508|NCT04363801|Antidotes|antidotes|mesh-ancestor
64991509|NCT04363801|Protective Agents|protective agents|mesh-ancestor
64991510|NCT04363801|Vitamin B Complex|vitamin b complex|mesh-ancestor
64991511|NCT04363801|Vitamins|vitamins|mesh-ancestor
64991512|NCT04363801|Micronutrients|micronutrients|mesh-ancestor
64991513|NCT04345913|Halichondrin B|halichondrin b|mesh-list
64991514|NCT04345913|Tubulin Modulators|tubulin modulators|mesh-ancestor
64991515|NCT04345913|Antimitotic Agents|antimitotic agents|mesh-ancestor
64314133|NCT02120339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64314134|NCT02120339|Vasodilator Agents|vasodilator agents|mesh-ancestor
64314135|NCT02120339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64314136|NCT02120339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64314138|NCT02123381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64314139|NCT02123381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314140|NCT02123615|Immunoglobulins|immunoglobulins|mesh-list
64314141|NCT02123615|Antibodies|antibodies|mesh-list
64314142|NCT02123615|gamma-Globulins|gamma-globulins|mesh-list
64314143|NCT02123615|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64314144|NCT02123615|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64314145|NCT02123615|Immunoglobulin G|immunoglobulin g|mesh-list
64314146|NCT02123615|Immunologic Factors|immunologic factors|mesh-ancestor
64314147|NCT02123615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314148|NCT02120651|Hemostatics|hemostatics|mesh-list
64314149|NCT02120651|Coagulants|coagulants|mesh-ancestor
64314150|NCT02117219|Azacitidine|azacitidine|mesh-list
64314151|NCT02117219|Durvalumab|durvalumab|mesh-list
64314152|NCT02117219|Tremelimumab|tremelimumab|mesh-list
64314153|NCT02117219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64314154|NCT02117219|Antimetabolites|antimetabolites|mesh-ancestor
64991516|NCT04345913|Mitosis Modulators|mitosis modulators|mesh-ancestor
64552212|NCT01456130|Protease Inhibitors|protease inhibitors|mesh-ancestor
64552213|NCT01456130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552214|NCT01456130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552215|NCT03479671|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64552216|NCT03479671|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64552217|NCT03479671|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64552218|NCT03479671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64552219|NCT03219645|Aspirin|aspirin|mesh-list
64552220|NCT03219645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64552221|NCT03219645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64552222|NCT03219645|Analgesics|analgesics|mesh-ancestor
64552223|NCT03219645|Sensory System Agents|sensory system agents|mesh-ancestor
64991517|NCT04345913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991518|NCT04345913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991520|NCT04340843|Azacitidine|azacitidine|mesh-list
64991521|NCT04340843|Belinostat|belinostat|mesh-list
64991522|NCT04340843|Guadecitabine|guadecitabine|mesh-list
64991523|NCT04340843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64991524|NCT04340843|Antimetabolites|antimetabolites|mesh-ancestor
64991525|NCT04340843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991590|NCT04302870|Antiviral Agents|antiviral agents|mesh-ancestor
64991591|NCT04302870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64991592|NCT04302870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64991594|NCT04302870|Sensory System Agents|sensory system agents|mesh-ancestor
64991595|NCT04302870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64991596|NCT04302870|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64991597|NCT04302870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64991598|NCT04302870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64991599|NCT04302870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64991600|NCT04302870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64991601|NCT04302870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64991602|NCT04302870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64991603|NCT04302870|Serotonin Agents|serotonin agents|mesh-ancestor
64991604|NCT04302870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64991605|NCT04302870|Antidepressive Agents|antidepressive agents|mesh-ancestor
64991607|NCT04294628|Camptothecin|camptothecin|mesh-list
64991608|NCT04294628|Immunoconjugates|immunoconjugates|mesh-list
64991609|NCT04294628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64991610|NCT04294628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991611|NCT04294628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64991612|NCT04294628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64991613|NCT04294628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64991614|NCT04294628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991615|NCT04294628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991616|NCT04294628|Immunologic Factors|immunologic factors|mesh-ancestor
64991617|NCT04294628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991618|NCT04284774|Tipifarnib|tipifarnib|mesh-list
64991619|NCT04284774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991620|NCT04269902|Venetoclax|venetoclax|mesh-list
64991621|NCT04269902|Obinutuzumab|obinutuzumab|mesh-list
64991622|NCT04269902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991623|NCT04269902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64991659|NCT04231214|Parasympatholytics|parasympatholytics|mesh-ancestor
64991660|NCT04231214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64991661|NCT04231214|Cholinergic Agents|cholinergic agents|mesh-ancestor
64991662|NCT04231214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64991663|NCT04231214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991665|NCT04229095|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64991666|NCT04229095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64552224|NCT03219645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64552225|NCT03219645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324615|NCT01225393|Abortifacient Agents|abortifacient agents|mesh-ancestor
64314161|NCT02117453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64552226|NCT03219645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64552227|NCT03219645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64552228|NCT03219645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64552229|NCT03219645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64552230|NCT03219645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552231|NCT03219645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64552232|NCT03219645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64552233|NCT03219645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552234|NCT03219645|Antipyretics|antipyretics|mesh-ancestor
64552235|NCT04435314|Nitazoxanide|nitazoxanide|mesh-list
64552236|NCT04435314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64552237|NCT04435314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64552238|NCT03102450|Benzalkonium Compounds|benzalkonium compounds|mesh-list
64552239|NCT03102450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64552240|NCT03102450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64552241|NCT01387607|Pregabalin|pregabalin|mesh-list
64552242|NCT01387607|Analgesics|analgesics|mesh-ancestor
64552243|NCT01387607|Sensory System Agents|sensory system agents|mesh-ancestor
64552244|NCT01387607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64552245|NCT01387607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552246|NCT01387607|Anticonvulsants|anticonvulsants|mesh-ancestor
64991667|NCT04229095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64991668|NCT04229095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991669|NCT04229095|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64991670|NCT04229095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64991671|NCT04229095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991672|NCT04223856|Gemcitabine|gemcitabine|mesh-list
64991673|NCT04223856|Carboplatin|carboplatin|mesh-list
64991674|NCT04223856|Pembrolizumab|pembrolizumab|mesh-list
64991675|NCT04223856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991676|NCT04223856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64991677|NCT04223856|Antimetabolites|antimetabolites|mesh-ancestor
64991678|NCT04223856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991679|NCT04223856|Antiviral Agents|antiviral agents|mesh-ancestor
64991680|NCT04223856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64991681|NCT04223856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991682|NCT04223856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64991683|NCT04223856|Immunologic Factors|immunologic factors|mesh-ancestor
64991684|NCT04223856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991685|NCT04223856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64991686|NCT04216316|Gemcitabine|gemcitabine|mesh-list
64991687|NCT04216316|Carboplatin|carboplatin|mesh-list
64991688|NCT04216316|Pembrolizumab|pembrolizumab|mesh-list
64991689|NCT04216316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324616|NCT01225393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64324617|NCT01225393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324619|NCT01225393|Antimetabolites|antimetabolites|mesh-ancestor
64991690|NCT04216316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64991691|NCT04216316|Antimetabolites|antimetabolites|mesh-ancestor
64991692|NCT04216316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991693|NCT04216316|Antiviral Agents|antiviral agents|mesh-ancestor
64991694|NCT04216316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64552247|NCT01387607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64552248|NCT01387607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64552249|NCT01387607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552250|NCT01387607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64552252|NCT01387607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64552253|NCT01387607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64552254|NCT01387607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64552255|NCT05069454|Vaccines|vaccines|mesh-list
64552256|NCT05069454|Immunologic Factors|immunologic factors|mesh-ancestor
64552257|NCT05069454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552258|NCT05069688|Rifampin|rifampin|mesh-list
64552259|NCT05069688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64552260|NCT05069688|Antitubercular Agents|antitubercular agents|mesh-ancestor
64552261|NCT05069688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64552262|NCT05069688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64552263|NCT05069688|Leprostatic Agents|leprostatic agents|mesh-ancestor
64552264|NCT05069688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64552265|NCT05069688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552266|NCT05069688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552267|NCT05069688|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64785928|NCT00000912|Nelfinavir|nelfinavir|mesh-list
64785929|NCT00000912|Indinavir|indinavir|mesh-list
64785930|NCT00000912|Saquinavir|saquinavir|mesh-list
64785931|NCT00000912|Amprenavir|amprenavir|mesh-list
64314244|NCT02251691|Tacrolimus|tacrolimus|mesh-list
64314245|NCT02251691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64314246|NCT02251691|Immunologic Factors|immunologic factors|mesh-ancestor
64314247|NCT02251691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314251|NCT02595398|Triamcinolone|triamcinolone|mesh-list
64552268|NCT05069688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64552269|NCT05069688|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64552270|NCT05069688|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64552271|NCT05069688|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64552272|NCT05069688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64552274|NCT01830777|Etoposide|etoposide|mesh-list
64552275|NCT01830777|Mitoxantrone|mitoxantrone|mesh-list
64552276|NCT01830777|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64552277|NCT01830777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64552278|NCT01830777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991695|NCT04216316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991696|NCT04216316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64991697|NCT04216316|Immunologic Factors|immunologic factors|mesh-ancestor
64991728|NCT04214249|Cytarabine|cytarabine|mesh-list
64991729|NCT04214249|Pembrolizumab|pembrolizumab|mesh-list
64991730|NCT04214249|Daunorubicin|daunorubicin|mesh-list
64991731|NCT04214249|Idarubicin|idarubicin|mesh-list
64991732|NCT04214249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64552279|NCT01830777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64552280|NCT01830777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64552281|NCT01830777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552282|NCT01830777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552283|NCT01830777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64552284|NCT01830777|Antimetabolites|antimetabolites|mesh-ancestor
64552285|NCT01830777|Antiviral Agents|antiviral agents|mesh-ancestor
64552286|NCT01830777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64552287|NCT01830777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64552288|NCT01830777|Immunologic Factors|immunologic factors|mesh-ancestor
64552289|NCT01830777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552290|NCT01830777|Analgesics|analgesics|mesh-ancestor
64552291|NCT01830777|Sensory System Agents|sensory system agents|mesh-ancestor
64552292|NCT01830777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317316|NCT05540834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64991733|NCT04214249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991734|NCT04214249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64991735|NCT04214249|Antimetabolites|antimetabolites|mesh-ancestor
64991736|NCT04214249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991737|NCT04214249|Antiviral Agents|antiviral agents|mesh-ancestor
64991738|NCT04214249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64991739|NCT04214249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64991740|NCT04214249|Immunologic Factors|immunologic factors|mesh-ancestor
64991764|NCT04190433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314271|NCT02251769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314273|NCT02251769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64314274|NCT02251769|Antiviral Agents|antiviral agents|mesh-ancestor
64314275|NCT02251769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64314276|NCT02251769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64314277|NCT02251769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64314278|NCT02251769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64314279|NCT02251769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64314280|NCT02118311|Cyclophosphamide|cyclophosphamide|mesh-list
64314281|NCT02118311|Fludarabine|fludarabine|mesh-list
64314282|NCT02118311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64991765|NCT04190433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64991767|NCT04190433|Protective Agents|protective agents|mesh-ancestor
64991768|NCT04190433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64991769|NCT04190433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64991770|NCT04190433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64991771|NCT04190433|Vasodilator Agents|vasodilator agents|mesh-ancestor
64991772|NCT04190433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64991773|NCT04190433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64991774|NCT04190433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64991775|NCT04190433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64991776|NCT04190433|Antimetabolites|antimetabolites|mesh-ancestor
64991777|NCT04190433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64991778|NCT04190433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64991779|NCT04190433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991780|NCT04190433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64991781|NCT04190433|Protease Inhibitors|protease inhibitors|mesh-ancestor
64991782|NCT04190433|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64991817|NCT04164069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64991819|NCT04164069|Oxaliplatin|oxaliplatin|mesh-list
64991824|NCT04164069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64991825|NCT04164069|Immunoglobulin G|immunoglobulin g|mesh-list
64991826|NCT04164069|Calcium|calcium|mesh-list
64991827|NCT04164069|Levoleucovorin|levoleucovorin|mesh-list
64991828|NCT04164069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991829|NCT04164069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64991830|NCT04164069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64991831|NCT04164069|Growth Substances|growth substances|mesh-ancestor
64991832|NCT04164069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991833|NCT04164069|Growth Inhibitors|growth inhibitors|mesh-ancestor
64991834|NCT04164069|Immunologic Factors|immunologic factors|mesh-ancestor
64552293|NCT01830777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64552294|NCT04479306|Osimertinib|osimertinib|mesh-list
64552295|NCT04479306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552296|NCT04479306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64324629|NCT01225393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64324630|NCT02264743|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64324631|NCT02264743|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64324632|NCT02264743|Estradiol|estradiol|mesh-list
64324633|NCT02264743|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64324634|NCT02264743|Estrogens|estrogens|mesh-ancestor
64324635|NCT02264743|Hormones|hormones|mesh-ancestor
64324636|NCT02264743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64785932|NCT00000912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64785933|NCT00000912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64785934|NCT00000912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785935|NCT00000912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785936|NCT00000912|Antiviral Agents|antiviral agents|mesh-ancestor
64785937|NCT00000912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64785938|NCT00000912|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64552297|NCT04479306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552298|NCT04479306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552299|NCT03215277|Certolizumab Pegol|certolizumab pegol|mesh-list
64552300|NCT03215277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64552301|NCT03215277|Immunologic Factors|immunologic factors|mesh-ancestor
64552302|NCT03215277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552303|NCT03215277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64552304|NCT04025489|Vitamin D|vitamin d|mesh-list
64552305|NCT04025489|Vitamins|vitamins|mesh-ancestor
64552306|NCT04025489|Micronutrients|micronutrients|mesh-ancestor
64552307|NCT04025489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552308|NCT04025489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64552309|NCT03218631|Oxandrolone|oxandrolone|mesh-list
64317333|NCT02407899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64991835|NCT04164069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64991836|NCT04164069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64991837|NCT04164069|Antimetabolites|antimetabolites|mesh-ancestor
64991838|NCT04164069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991839|NCT04164069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64991840|NCT04164069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64991841|NCT04164069|Antidotes|antidotes|mesh-ancestor
64991842|NCT04164069|Protective Agents|protective agents|mesh-ancestor
64991843|NCT04164069|Vitamin B Complex|vitamin b complex|mesh-ancestor
64991844|NCT04164069|Vitamins|vitamins|mesh-ancestor
64991845|NCT04164069|Micronutrients|micronutrients|mesh-ancestor
64991846|NCT04164069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64991893|NCT04092283|Pemetrexed|pemetrexed|mesh-list
64991894|NCT04092283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64991895|NCT04092283|Etoposide phosphate|etoposide phosphate|mesh-list
64991896|NCT04092283|Durvalumab|durvalumab|mesh-list
64991898|NCT04092283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64991899|NCT04092283|Immunoglobulin G|immunoglobulin g|mesh-list
64991900|NCT04092283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64991901|NCT04092283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991902|NCT04092283|Tubulin Modulators|tubulin modulators|mesh-ancestor
64991903|NCT04092283|Antimitotic Agents|antimitotic agents|mesh-ancestor
64991904|NCT04092283|Mitosis Modulators|mitosis modulators|mesh-ancestor
64991928|NCT04090398|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64991929|NCT04090398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64991930|NCT04090398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991931|NCT04090398|Tubulin Modulators|tubulin modulators|mesh-ancestor
64991932|NCT04090398|Antimitotic Agents|antimitotic agents|mesh-ancestor
64991933|NCT04090398|Mitosis Modulators|mitosis modulators|mesh-ancestor
64991934|NCT04090398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991936|NCT04088604|Irinotecan|irinotecan|mesh-list
64991937|NCT04088604|Antimetabolites|antimetabolites|mesh-ancestor
64301355|NCT05010434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991938|NCT04088604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991940|NCT04088604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991941|NCT04088604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64991942|NCT04088604|Immunologic Factors|immunologic factors|mesh-ancestor
64785939|NCT00000912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64397082|NCT02374567|Lamotrigine|lamotrigine|mesh-list
64314393|NCT04816838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314394|NCT04816838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314396|NCT02788175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64314397|NCT03551171|Niraparib|niraparib|mesh-list
64314398|NCT03551171|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64552310|NCT03218631|Androgens|androgens|mesh-ancestor
64552311|NCT03218631|Hormones|hormones|mesh-ancestor
64552312|NCT03218631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64552313|NCT03218631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552314|NCT03218631|Anabolic Agents|anabolic agents|mesh-ancestor
64552315|NCT03451045|Dronabinol|dronabinol|mesh-list
64552316|NCT03451045|Lenabasum|lenabasum|mesh-list
64552317|NCT03451045|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64552318|NCT03451045|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64552319|NCT03451045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64552320|NCT03451045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552321|NCT03451045|Hormones|hormones|mesh-ancestor
64552322|NCT03451045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64552323|NCT03451045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552324|NCT03451045|Hallucinogens|hallucinogens|mesh-ancestor
64552325|NCT03451045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64552326|NCT03451045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64552327|NCT03451045|Analgesics|analgesics|mesh-ancestor
64552328|NCT03451045|Sensory System Agents|sensory system agents|mesh-ancestor
64552329|NCT03451045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64552330|NCT01831011|Aspirin|aspirin|mesh-list
64552331|NCT01831011|Cinepazide|cinepazide|mesh-list
64552332|NCT01831011|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
64552333|NCT01831011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64991943|NCT04088604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991944|NCT04088604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64991945|NCT04088604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64991946|NCT04088604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991947|NCT04078152|Durvalumab|durvalumab|mesh-list
64991948|NCT04078152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64314408|NCT02787083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314409|NCT02787083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314411|NCT02122211|Betaine|betaine|mesh-list
64314412|NCT02122211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64314413|NCT02122211|Lipotropic Agents|lipotropic agents|mesh-ancestor
64314414|NCT02122211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64314415|NCT02122211|Antimetabolites|antimetabolites|mesh-ancestor
64314416|NCT02122211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314417|NCT02122211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64314418|NCT02125565|Lidocaine|lidocaine|mesh-list
64314419|NCT02125565|Anesthetics, Local|anesthetics, local|mesh-ancestor
64314420|NCT02125565|Anesthetics|anesthetics|mesh-ancestor
64314421|NCT02125565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64314422|NCT02125565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314423|NCT02125565|Sensory System Agents|sensory system agents|mesh-ancestor
64314424|NCT02125565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64314425|NCT02125565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64314426|NCT02125565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64991949|NCT04078152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991950|NCT04071223|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64991951|NCT04071223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991952|NCT04068194|Avelumab|avelumab|mesh-list
64991953|NCT04068194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64991954|NCT04068194|Peposertib|peposertib|mesh-list
64991984|NCT04006288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64991985|NCT04006288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64991986|NCT04006288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64991987|NCT04006288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64991988|NCT04006288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991989|NCT04006288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64991990|NCT04006288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64991991|NCT04006288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991992|NCT04006288|Antipyretics|antipyretics|mesh-ancestor
64991993|NCT04006288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64991994|NCT04006288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64991995|NCT04006288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64991996|NCT04006288|Purinergic Agents|purinergic agents|mesh-ancestor
64991997|NCT04006288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64552334|NCT01831011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64552336|NCT01831011|Sensory System Agents|sensory system agents|mesh-ancestor
64552337|NCT01831011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64552338|NCT01831011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552339|NCT01831011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64552340|NCT01831011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64552341|NCT01831011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64552342|NCT01831011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64552343|NCT01831011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552344|NCT01831011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64552345|NCT01831011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64552346|NCT01831011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552348|NCT01831011|Vasodilator Agents|vasodilator agents|mesh-ancestor
64552349|NCT01831011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64552350|NCT01831011|Immunologic Factors|immunologic factors|mesh-ancestor
64552351|NCT03218709|Vitamins|vitamins|mesh-list
64552352|NCT03218709|Micronutrients|micronutrients|mesh-ancestor
64552353|NCT03218709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552354|NCT03218553|Dexamethasone|dexamethasone|mesh-list
64552355|NCT03218553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64552356|NCT03218553|Antiemetics|antiemetics|mesh-ancestor
64552357|NCT03218553|Autonomic Agents|autonomic agents|mesh-ancestor
64552358|NCT03218553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64552359|NCT03218553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552360|NCT03218553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64991998|NCT04006288|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64991999|NCT04006288|Antithrombins|antithrombins|mesh-ancestor
64992000|NCT04006288|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64992024|NCT03984448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992025|NCT03984448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992026|NCT03984448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64992027|NCT03984448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64992028|NCT03984448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64992029|NCT03984448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64992030|NCT03984448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992031|NCT03984448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64992032|NCT03984448|Glucocorticoids|glucocorticoids|mesh-ancestor
64992034|NCT03984448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64992035|NCT03984448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64992036|NCT03984448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64992037|NCT03984448|Tubulin Modulators|tubulin modulators|mesh-ancestor
64992038|NCT03984448|Antimitotic Agents|antimitotic agents|mesh-ancestor
64314428|NCT02125565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64314429|NCT02125565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374664|NCT00700817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992039|NCT03984448|Mitosis Modulators|mitosis modulators|mesh-ancestor
64992040|NCT03984448|Keratolytic Agents|keratolytic agents|mesh-ancestor
64552361|NCT03218553|Glucocorticoids|glucocorticoids|mesh-ancestor
64552362|NCT03218553|Hormones|hormones|mesh-ancestor
64552363|NCT03218553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64552364|NCT03218553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64552365|NCT03218553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552366|NCT03430843|Paclitaxel|paclitaxel|mesh-list
64552367|NCT03430843|Docetaxel|docetaxel|mesh-list
64552368|NCT03430843|Irinotecan|irinotecan|mesh-list
64552369|NCT03430843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64552370|NCT03430843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552371|NCT03430843|Tubulin Modulators|tubulin modulators|mesh-ancestor
64552372|NCT03430843|Antimitotic Agents|antimitotic agents|mesh-ancestor
64552373|NCT03430843|Mitosis Modulators|mitosis modulators|mesh-ancestor
64552374|NCT03430843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552375|NCT03430843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64552376|NCT03430843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64552377|NCT03430843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552378|NCT01386125|Mometasone Furoate|mometasone furoate|mesh-list
64552379|NCT01386125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64552380|NCT01386125|Dermatologic Agents|dermatologic agents|mesh-ancestor
64552381|NCT01386125|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64552382|NCT01831323|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64317401|NCT04320290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64992041|NCT03984448|Dermatologic Agents|dermatologic agents|mesh-ancestor
64992042|NCT03979131|Avelumab|avelumab|mesh-list
64992043|NCT03979131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64992044|NCT03979131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992045|NCT03970096|Cyclosporine|cyclosporine|mesh-list
64992046|NCT03970096|Sirolimus|sirolimus|mesh-list
64992047|NCT03970096|Cyclophosphamide|cyclophosphamide|mesh-list
64992048|NCT03970096|Busulfan|busulfan|mesh-list
64992049|NCT03970096|Thiotepa|thiotepa|mesh-list
64992050|NCT03970096|Methotrexate|methotrexate|mesh-list
64992051|NCT03970096|Fludarabine|fludarabine|mesh-list
64992052|NCT03970096|Tacrolimus|tacrolimus|mesh-list
64992053|NCT03970096|Cyclosporins|cyclosporins|mesh-list
64992054|NCT03970096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64992055|NCT03970096|Immunologic Factors|immunologic factors|mesh-ancestor
64992056|NCT03970096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992057|NCT03970096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64992058|NCT03970096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64992072|NCT03970096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64992073|NCT03970096|Antifungal Agents|antifungal agents|mesh-ancestor
64992074|NCT03970096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64992075|NCT03970096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64992076|NCT03970096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64992077|NCT03958045|Nivolumab|nivolumab|mesh-list
64324637|NCT02264743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324638|NCT02264743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64324639|NCT02264743|Contraceptive Agents|contraceptive agents|mesh-ancestor
64324640|NCT02264743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64324641|NCT02264743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64324642|NCT01220947|Ritonavir|ritonavir|mesh-list
64785941|NCT00000912|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64992078|NCT03958045|Rucaparib|rucaparib|mesh-list
64992079|NCT03958045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64992080|NCT03958045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992081|NCT03958045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64992082|NCT03958045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992083|NCT03958045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64992084|NCT03958045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552383|NCT01831323|Rifaximin|rifaximin|mesh-list
64552384|NCT01831323|Mesalamine|mesalamine|mesh-list
64552385|NCT01831323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64552386|NCT01831323|Psyllium|psyllium|mesh-list
64552387|NCT01831323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64552388|NCT01831323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64552389|NCT01831323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64552390|NCT01831323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64552391|NCT01831323|Analgesics|analgesics|mesh-ancestor
64552392|NCT01831323|Sensory System Agents|sensory system agents|mesh-ancestor
64552393|NCT01831323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64552394|NCT01831323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552395|NCT01831323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64552396|NCT01831323|Cathartics|cathartics|mesh-ancestor
64552397|NCT03221400|Leucovorin|leucovorin|mesh-list
64552398|NCT03221400|Folic Acid|folic acid|mesh-list
64552399|NCT03221400|Fluorouracil|fluorouracil|mesh-list
64552400|NCT03221400|Niraparib|niraparib|mesh-list
64552401|NCT03221400|Levoleucovorin|levoleucovorin|mesh-list
64552402|NCT03221400|Antimetabolites|antimetabolites|mesh-ancestor
64552403|NCT03221400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552404|NCT03221400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64552405|NCT03221400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64785947|NCT00000912|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64785948|NCT00000912|Protease Inhibitors|protease inhibitors|mesh-ancestor
64785949|NCT00000912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64785950|NCT00000912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64785951|NCT00000912|Antitubercular Agents|antitubercular agents|mesh-ancestor
64324643|NCT01220947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64324644|NCT01220947|Lactams|lactams|mesh-list
64324645|NCT01220947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64324646|NCT01220947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64324647|NCT01220947|Protease Inhibitors|protease inhibitors|mesh-ancestor
64314442|NCT05319587|Cytarabine|cytarabine|mesh-list
64552406|NCT03221400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64552407|NCT03221400|Immunologic Factors|immunologic factors|mesh-ancestor
64552408|NCT03221400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552409|NCT03221400|Antidotes|antidotes|mesh-ancestor
64552410|NCT03221400|Protective Agents|protective agents|mesh-ancestor
64552411|NCT03221400|Vitamin B Complex|vitamin b complex|mesh-ancestor
64317424|NCT02407821|Citalopram|citalopram|mesh-list
64992085|NCT03956680|Nivolumab|nivolumab|mesh-list
64992086|NCT03956680|Ipilimumab|ipilimumab|mesh-list
64992087|NCT03956680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64992088|NCT03956680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992089|NCT03956680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64992090|NCT03956680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992091|NCT03953898|Olaparib|olaparib|mesh-list
64992092|NCT03953898|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64992093|NCT03953898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992094|NCT03953898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992095|NCT03953898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992096|NCT03952585|Cisplatin|cisplatin|mesh-list
64992097|NCT03952585|Nivolumab|nivolumab|mesh-list
64992098|NCT03952585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992099|NCT03952585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64992100|NCT03952585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64992101|NCT03952585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992102|NCT03952273|Sirolimus|sirolimus|mesh-list
64552413|NCT03221400|Micronutrients|micronutrients|mesh-ancestor
64552414|NCT03221400|Hematinics|hematinics|mesh-ancestor
64552415|NCT03221400|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64552416|NCT03221400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552417|NCT01384877|Lidocaine|lidocaine|mesh-list
64552418|NCT01384877|Anesthetics, Local|anesthetics, local|mesh-ancestor
64552419|NCT01384877|Anesthetics|anesthetics|mesh-ancestor
64552420|NCT01384877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64552421|NCT01384877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552422|NCT01384877|Sensory System Agents|sensory system agents|mesh-ancestor
64552423|NCT01384877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64552424|NCT01384877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64314466|NCT02127593|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64314467|NCT02127593|Estradiol|estradiol|mesh-list
64314468|NCT02127593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64314469|NCT02127593|Estrogens|estrogens|mesh-ancestor
64314470|NCT02127593|Hormones|hormones|mesh-ancestor
64314471|NCT02127593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64314474|NCT02127593|Contraceptive Agents|contraceptive agents|mesh-ancestor
64552425|NCT01384877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64552426|NCT01384877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64552427|NCT01384877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64552428|NCT01384877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552429|NCT00114517|Hormones|hormones|mesh-list
64317453|NCT02417337|Antipyretics|antipyretics|mesh-ancestor
64992103|NCT03952273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64992104|NCT03952273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64992105|NCT03952273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64992106|NCT03952273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992107|NCT03952273|Antifungal Agents|antifungal agents|mesh-ancestor
64992108|NCT03952273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64992109|NCT03952273|Immunologic Factors|immunologic factors|mesh-ancestor
64992110|NCT03952273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992111|NCT03947827|Minocycline|minocycline|mesh-list
64992112|NCT03947827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64992113|NCT03947827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64992114|NCT03941860|Lenalidomide|lenalidomide|mesh-list
64992115|NCT03941860|Ixazomib|ixazomib|mesh-list
64992116|NCT03941860|Glycine|glycine|mesh-list
64992117|NCT03941860|Immunologic Factors|immunologic factors|mesh-ancestor
64992118|NCT03941860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992119|NCT03941860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64992132|NCT03927989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64992133|NCT03927989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992134|NCT03927989|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64992135|NCT03927989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64992136|NCT03927989|Cholinergic Agents|cholinergic agents|mesh-ancestor
64992137|NCT03927989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64992138|NCT03927989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992140|NCT03923725|Lumefantrine|lumefantrine|mesh-list
64992141|NCT03923725|Artemether|artemether|mesh-list
64992142|NCT03923725|Piperaquine|piperaquine|mesh-list
64992143|NCT03923725|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64992144|NCT03923725|Amodiaquine|amodiaquine|mesh-list
64992145|NCT03923725|Mefloquine|mefloquine|mesh-list
64992146|NCT03923725|Antimalarials|antimalarials|mesh-ancestor
64992147|NCT03923725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64992148|NCT03923725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64992149|NCT03923725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64314532|NCT05272865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64314533|NCT05272865|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64314534|NCT05272865|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64314535|NCT05272865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64314536|NCT05272865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314537|NCT05272865|Hormones|hormones|mesh-ancestor
64314538|NCT05272865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64314539|NCT02787863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64992150|NCT03923725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992151|NCT03923725|Antiviral Agents|antiviral agents|mesh-ancestor
64992152|NCT03923725|Schistosomicides|schistosomicides|mesh-ancestor
64992153|NCT03923725|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64992154|NCT03923725|Anthelmintics|anthelmintics|mesh-ancestor
64552430|NCT00114517|Estradiol|estradiol|mesh-list
64552431|NCT00114517|Estrogens|estrogens|mesh-list
64552432|NCT00114517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64552433|NCT00114517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552434|NCT01831479|Olmesartan|olmesartan|mesh-list
64552435|NCT01831479|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64552436|NCT01831479|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64552437|NCT01831479|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64552438|NCT01831479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64552439|NCT01831479|Antimetabolites|antimetabolites|mesh-ancestor
64552440|NCT01831479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552441|NCT01831479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64552442|NCT01831479|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64552443|NCT01831479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552444|NCT01831479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64552445|NCT01831479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64552446|NCT01831479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64552447|NCT03099720|Ropivacaine|ropivacaine|mesh-list
64552448|NCT03099720|Anesthetics, Local|anesthetics, local|mesh-ancestor
64552449|NCT03099720|Anesthetics|anesthetics|mesh-ancestor
64317469|NCT02162797|Zinc|zinc|mesh-list
64992155|NCT03919071|Trametinib|trametinib|mesh-list
64992156|NCT03919071|Dabrafenib|dabrafenib|mesh-list
64992157|NCT03919071|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
64992158|NCT03919071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992159|NCT03919071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64992160|NCT03919071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314556|NCT04809818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314557|NCT04809818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64314559|NCT04809818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314560|NCT04809818|Antipyretics|antipyretics|mesh-ancestor
64314561|NCT04809818|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64314562|NCT04809818|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64314563|NCT04809818|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64314564|NCT04809818|Purinergic Agents|purinergic agents|mesh-ancestor
64314565|NCT04809818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64314566|NCT04809818|Antithrombins|antithrombins|mesh-ancestor
64314567|NCT04809818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64314568|NCT04809818|Protease Inhibitors|protease inhibitors|mesh-ancestor
64314569|NCT04809818|Anticoagulants|anticoagulants|mesh-ancestor
64992161|NCT03919071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992162|NCT03919071|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64992163|NCT03919071|Protective Agents|protective agents|mesh-ancestor
64992164|NCT03919071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992165|NCT03919071|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64992166|NCT03919071|Antioxidants|antioxidants|mesh-ancestor
64992167|NCT03914625|Calcium, Dietary|calcium, dietary|mesh-list
64992168|NCT03914625|Leucovorin|leucovorin|mesh-list
64992169|NCT03914625|Folic Acid|folic acid|mesh-list
64992170|NCT03914625|Cytarabine|cytarabine|mesh-list
64992171|NCT03914625|Dexamethasone|dexamethasone|mesh-list
64992172|NCT03914625|Dexamethasone acetate|dexamethasone acetate|mesh-list
64992173|NCT03914625|Prednisone|prednisone|mesh-list
64992174|NCT03914625|Prednisolone|prednisolone|mesh-list
64785952|NCT00000912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64785953|NCT00000918|Ritonavir|ritonavir|mesh-list
64785954|NCT00000918|Indinavir|indinavir|mesh-list
64785955|NCT00000918|Saquinavir|saquinavir|mesh-list
64785956|NCT00000918|Amprenavir|amprenavir|mesh-list
64785957|NCT00000918|Lamivudine|lamivudine|mesh-list
64785958|NCT00000918|Zidovudine|zidovudine|mesh-list
64785959|NCT00000918|Didanosine|didanosine|mesh-list
64785960|NCT00000918|Stavudine|stavudine|mesh-list
64397110|NCT02374567|Zolpidem|zolpidem|mesh-list
64314592|NCT02128061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64314593|NCT02128061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64314594|NCT02128061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64314595|NCT02128061|Growth Substances|growth substances|mesh-ancestor
64314596|NCT02128061|Growth Inhibitors|growth inhibitors|mesh-ancestor
64314597|NCT05615636|Lenalidomide|lenalidomide|mesh-list
64314598|NCT05615636|Immunologic Factors|immunologic factors|mesh-ancestor
64314599|NCT05615636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314600|NCT05615636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64314601|NCT05615636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64314602|NCT05615636|Growth Substances|growth substances|mesh-ancestor
64314603|NCT05615636|Growth Inhibitors|growth inhibitors|mesh-ancestor
64992175|NCT03914625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64992176|NCT03914625|Methylprednisolone|methylprednisolone|mesh-list
64992177|NCT03914625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64992178|NCT03914625|Prednisolone acetate|prednisolone acetate|mesh-list
64992179|NCT03914625|Hydrocortisone|hydrocortisone|mesh-list
64992180|NCT03914625|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64992181|NCT03914625|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64324649|NCT01220947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324651|NCT01220947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64324652|NCT01220947|Antiviral Agents|antiviral agents|mesh-ancestor
64324653|NCT01220947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324654|NCT01220947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64324655|NCT01220947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64324656|NCT01220947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64324657|NCT03953833|Antibodies|antibodies|mesh-list
64324658|NCT03953833|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64324659|NCT03953833|Immunologic Factors|immunologic factors|mesh-ancestor
64324660|NCT03953833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324661|NCT01393639|Prednisone|prednisone|mesh-list
64324662|NCT01393639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64324663|NCT01393639|Glucocorticoids|glucocorticoids|mesh-ancestor
64324664|NCT01393639|Hormones|hormones|mesh-ancestor
64324665|NCT01393639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64314605|NCT02596958|Bevacizumab|bevacizumab|mesh-list
64314606|NCT02596958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64314607|NCT02596958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314608|NCT02596958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64314609|NCT02596958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64314610|NCT02596958|Growth Substances|growth substances|mesh-ancestor
64314611|NCT02596958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374778|NCT04947345|Propofol|propofol|mesh-list
64992182|NCT03914625|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64992183|NCT03914625|Cortisone|cortisone|mesh-list
64992184|NCT03914625|Cyclophosphamide|cyclophosphamide|mesh-list
64992185|NCT03914625|Doxorubicin|doxorubicin|mesh-list
64992219|NCT03914625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64992221|NCT03914625|Hormones|hormones|mesh-ancestor
64992222|NCT03914625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64992223|NCT03914625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64552450|NCT03099720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64552451|NCT03099720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552452|NCT03099720|Sensory System Agents|sensory system agents|mesh-ancestor
64552453|NCT03099720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64552454|NCT03025295|Dexmedetomidine|dexmedetomidine|mesh-list
64552455|NCT03025295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64552456|NCT03025295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64552457|NCT03025295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552458|NCT03025295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64552459|NCT03025295|Analgesics|analgesics|mesh-ancestor
64552460|NCT03025295|Sensory System Agents|sensory system agents|mesh-ancestor
64552461|NCT03025295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64992224|NCT03914625|Protease Inhibitors|protease inhibitors|mesh-ancestor
64992225|NCT03914625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992226|NCT03914625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64992227|NCT03914625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64992228|NCT03914625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64992229|NCT03914625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64992230|NCT03914625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64992256|NCT03914612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64992257|NCT03914612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992258|NCT03914612|Tubulin Modulators|tubulin modulators|mesh-ancestor
64992259|NCT03914612|Antimitotic Agents|antimitotic agents|mesh-ancestor
64992260|NCT03914612|Mitosis Modulators|mitosis modulators|mesh-ancestor
64992261|NCT03914612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992262|NCT03914612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64992263|NCT03914300|Nivolumab|nivolumab|mesh-list
64992264|NCT03914300|Ipilimumab|ipilimumab|mesh-list
64992265|NCT03914300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64992266|NCT03914300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301378|NCT02457520|Dermatologic Agents|dermatologic agents|mesh-ancestor
64992269|NCT03907488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64992270|NCT03907488|Nivolumab|nivolumab|mesh-list
64992271|NCT03907488|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64992272|NCT03907488|Doxorubicin|doxorubicin|mesh-list
64992273|NCT03907488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64992274|NCT03907488|Dacarbazine|dacarbazine|mesh-list
64992275|NCT03907488|Vinblastine|vinblastine|mesh-list
64992276|NCT03907488|Antibodies|antibodies|mesh-list
64992277|NCT03907488|Immunoglobulins|immunoglobulins|mesh-list
64992278|NCT03907488|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64992279|NCT03907488|Lenograstim|lenograstim|mesh-list
64992280|NCT03907488|Immunoconjugates|immunoconjugates|mesh-list
64992281|NCT03907488|Imidazole|imidazole|mesh-list
64992282|NCT03907488|Immunologic Factors|immunologic factors|mesh-ancestor
64314612|NCT02596958|Growth Inhibitors|growth inhibitors|mesh-ancestor
64374793|NCT04947189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64992312|NCT03878095|Olaparib|olaparib|mesh-list
64992313|NCT03878095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64992314|NCT03878095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992315|NCT03878095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992316|NCT03878095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992317|NCT03871257|Carboplatin|carboplatin|mesh-list
64992318|NCT03871257|Vincristine|vincristine|mesh-list
64992319|NCT03871257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992320|NCT03871257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64992321|NCT03871257|Tubulin Modulators|tubulin modulators|mesh-ancestor
64992322|NCT03871257|Antimitotic Agents|antimitotic agents|mesh-ancestor
64992323|NCT03871257|Mitosis Modulators|mitosis modulators|mesh-ancestor
64992324|NCT03871257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992398|NCT03803787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64992399|NCT03803787|Respiratory System Agents|respiratory system agents|mesh-ancestor
64992400|NCT03803787|Glucocorticoids|glucocorticoids|mesh-ancestor
64992401|NCT03803787|Hormones|hormones|mesh-ancestor
64992402|NCT03803787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64992418|NCT03775265|Gemcitabine|gemcitabine|mesh-list
64992419|NCT03775265|Cisplatin|cisplatin|mesh-list
64992420|NCT03775265|Fluorouracil|fluorouracil|mesh-list
64992421|NCT03775265|Atezolizumab|atezolizumab|mesh-list
64992422|NCT03775265|Mitomycins|mitomycins|mesh-list
64992456|NCT03742414|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64992486|NCT03698019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64992487|NCT03698019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992504|NCT03654716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64992505|NCT03654716|Antimetabolites|antimetabolites|mesh-ancestor
64992506|NCT03654716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992507|NCT03654716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992508|NCT03654716|Antiviral Agents|antiviral agents|mesh-ancestor
64992509|NCT03654716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324666|NCT01393639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785961|NCT00000918|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64785963|NCT00000918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64785964|NCT00000918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64785965|NCT00000918|Protease Inhibitors|protease inhibitors|mesh-ancestor
64785966|NCT00000918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314614|NCT02126579|Interferon Inducers|interferon inducers|mesh-ancestor
64314615|NCT02126579|Immunologic Factors|immunologic factors|mesh-ancestor
64314616|NCT02126579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314617|NCT04808648|Itraconazole|itraconazole|mesh-list
64314618|NCT04808648|Rifampin|rifampin|mesh-list
64314619|NCT04808648|Antifungal Agents|antifungal agents|mesh-ancestor
64314620|NCT04808648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64314621|NCT04808648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64314622|NCT04808648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64314623|NCT04808648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314624|NCT04808648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314626|NCT04808648|Hormone Antagonists|hormone antagonists|mesh-ancestor
64992510|NCT03654716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64992511|NCT03654716|Immunologic Factors|immunologic factors|mesh-ancestor
64992512|NCT03654716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992513|NCT03643822|Dexamethasone|dexamethasone|mesh-list
64992514|NCT03643822|Dexamethasone acetate|dexamethasone acetate|mesh-list
64992545|NCT03641313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992547|NCT03620981|Brexpiprazole|brexpiprazole|mesh-list
64992548|NCT03620981|Serotonin Agents|serotonin agents|mesh-ancestor
64992549|NCT03620981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64992550|NCT03620981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992551|NCT03620981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552472|NCT01471574|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64552473|NCT01471574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552474|NCT01471574|Antiviral Agents|antiviral agents|mesh-ancestor
64552475|NCT01471574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64552476|NCT01471574|Antimetabolites|antimetabolites|mesh-ancestor
64552477|NCT01471574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552478|NCT01471574|Immunologic Factors|immunologic factors|mesh-ancestor
64552479|NCT01471574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552480|NCT01383707|Leucovorin|leucovorin|mesh-list
64552481|NCT01383707|Bevacizumab|bevacizumab|mesh-list
64552482|NCT01383707|Fluorouracil|fluorouracil|mesh-list
64992552|NCT03620981|Dopamine Agonists|dopamine agonists|mesh-ancestor
64992553|NCT03620981|Dopamine Agents|dopamine agents|mesh-ancestor
64992554|NCT03606967|Gemcitabine|gemcitabine|mesh-list
64992555|NCT03606967|Poly I-C|poly i-c|mesh-list
64992556|NCT03606967|Paclitaxel|paclitaxel|mesh-list
64992557|NCT03606967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64992583|NCT03606967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64992584|NCT03606967|Interferon Inducers|interferon inducers|mesh-ancestor
64992586|NCT03606967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64992587|NCT03604991|Paclitaxel|paclitaxel|mesh-list
64992588|NCT03604991|Carboplatin|carboplatin|mesh-list
64992589|NCT03604991|Nivolumab|nivolumab|mesh-list
64992590|NCT03604991|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64992591|NCT03604991|Ipilimumab|ipilimumab|mesh-list
64992592|NCT03604991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64992593|NCT03604991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992594|NCT03604991|Tubulin Modulators|tubulin modulators|mesh-ancestor
64992595|NCT03604991|Antimitotic Agents|antimitotic agents|mesh-ancestor
64992596|NCT03604991|Mitosis Modulators|mitosis modulators|mesh-ancestor
64992597|NCT03604991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992598|NCT03604991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64992599|NCT03604991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64785967|NCT00000918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785968|NCT00000918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64785969|NCT00000918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64785970|NCT00000918|Antiviral Agents|antiviral agents|mesh-ancestor
64785971|NCT00000918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64785972|NCT00000918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64785973|NCT00000918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64324670|NCT01379209|Sirolimus|sirolimus|mesh-list
64324671|NCT01379209|Methotrexate|methotrexate|mesh-list
64324672|NCT01379209|KRN 7000|krn 7000|mesh-list
64314631|NCT04808648|Antitubercular Agents|antitubercular agents|mesh-ancestor
64314632|NCT04808648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64314633|NCT04808648|Leprostatic Agents|leprostatic agents|mesh-ancestor
64314634|NCT04808648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64314635|NCT04808648|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64992600|NCT03604978|Nivolumab|nivolumab|mesh-list
64992601|NCT03604978|Ipilimumab|ipilimumab|mesh-list
64992602|NCT03604978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64992603|NCT03604978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992604|NCT03604978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64992605|NCT03604978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992606|NCT03603964|Guadecitabine|guadecitabine|mesh-list
64992607|NCT03603964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992608|NCT03600701|Atezolizumab|atezolizumab|mesh-list
64992609|NCT03600701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64992610|NCT03600701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992611|NCT03600701|Immunologic Factors|immunologic factors|mesh-ancestor
64992634|NCT03575000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64992635|NCT03575000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64992636|NCT03575000|Hormone Antagonists|hormone antagonists|mesh-ancestor
64992637|NCT03575000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64992638|NCT03575000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992639|NCT03575000|Dopamine Agonists|dopamine agonists|mesh-ancestor
64992640|NCT03575000|Dopamine Agents|dopamine agents|mesh-ancestor
64992641|NCT03575000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64992642|NCT03575000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992643|NCT03539744|Dexamethasone|dexamethasone|mesh-list
64992644|NCT03539744|Venetoclax|venetoclax|mesh-list
64992645|NCT03539744|Pomalidomide|pomalidomide|mesh-list
64992646|NCT03539744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64992647|NCT03539744|Antiemetics|antiemetics|mesh-ancestor
64992648|NCT03539744|Autonomic Agents|autonomic agents|mesh-ancestor
64992649|NCT03539744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64992650|NCT03539744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992651|NCT03539744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64314637|NCT04808648|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64314638|NCT04808648|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64314639|NCT04808648|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64314640|NCT04808648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64314641|NCT02126657|Glycolic acid|glycolic acid|mesh-list
64314642|NCT02126657|Keratolytic Agents|keratolytic agents|mesh-ancestor
64314643|NCT02126657|Dermatologic Agents|dermatologic agents|mesh-ancestor
64314644|NCT02128451|Fentanyl|fentanyl|mesh-list
64314645|NCT02128451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64314646|NCT02128451|Narcotics|narcotics|mesh-ancestor
64314647|NCT02128451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64314648|NCT02128451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314649|NCT02128451|Analgesics|analgesics|mesh-ancestor
64314650|NCT02128451|Sensory System Agents|sensory system agents|mesh-ancestor
64314651|NCT02128451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64314652|NCT02128451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64314653|NCT02128451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64314654|NCT02128451|Anesthetics, General|anesthetics, general|mesh-ancestor
64992652|NCT03539744|Glucocorticoids|glucocorticoids|mesh-ancestor
64992653|NCT03539744|Hormones|hormones|mesh-ancestor
64552483|NCT01383707|Oxaliplatin|oxaliplatin|mesh-list
64552484|NCT01383707|Levoleucovorin|levoleucovorin|mesh-list
64552485|NCT01383707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64552486|NCT01383707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552487|NCT01383707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64552488|NCT01383707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64552489|NCT01383707|Growth Substances|growth substances|mesh-ancestor
64552490|NCT01383707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552491|NCT01383707|Growth Inhibitors|growth inhibitors|mesh-ancestor
64552492|NCT01383707|Antimetabolites|antimetabolites|mesh-ancestor
64552493|NCT01383707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552494|NCT01383707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64552495|NCT01383707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64552496|NCT01383707|Immunologic Factors|immunologic factors|mesh-ancestor
64552497|NCT01383707|Antidotes|antidotes|mesh-ancestor
64552498|NCT01383707|Protective Agents|protective agents|mesh-ancestor
64552499|NCT01383707|Vitamin B Complex|vitamin b complex|mesh-ancestor
64992654|NCT03539744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64992655|NCT03539744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64992656|NCT03539744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992657|NCT03539744|Immunologic Factors|immunologic factors|mesh-ancestor
64992658|NCT03539744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64992659|NCT03539744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64992660|NCT03539744|Growth Substances|growth substances|mesh-ancestor
64992661|NCT03539744|Growth Inhibitors|growth inhibitors|mesh-ancestor
64992662|NCT03513952|Atezolizumab|atezolizumab|mesh-list
64992663|NCT03513952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64992673|NCT03498261|Gabapentin|gabapentin|mesh-list
64992674|NCT03498261|Analgesics|analgesics|mesh-ancestor
64992675|NCT03498261|Sensory System Agents|sensory system agents|mesh-ancestor
64992676|NCT03498261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64992677|NCT03498261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992678|NCT03498261|Anticonvulsants|anticonvulsants|mesh-ancestor
64992679|NCT03498261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64992680|NCT03498261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64992681|NCT03498261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64992682|NCT03498261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64992683|NCT03498261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64992684|NCT03498261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64992685|NCT03498261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64992686|NCT03498261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992687|NCT03498261|Antimanic Agents|antimanic agents|mesh-ancestor
64992688|NCT03495921|Irinotecan|irinotecan|mesh-list
64992689|NCT03495921|Camptothecin|camptothecin|mesh-list
64785974|NCT00000918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64992690|NCT03495921|Temozolomide|temozolomide|mesh-list
64992691|NCT03495921|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64992692|NCT03495921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64992693|NCT03495921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992694|NCT03495921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992695|NCT03495921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992696|NCT03495921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64992697|NCT03495921|Alkylating Agents|alkylating agents|mesh-ancestor
64992698|NCT03495921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64992699|NCT03475186|Ramipril|ramipril|mesh-list
64992700|NCT03475186|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64992701|NCT03475186|Protease Inhibitors|protease inhibitors|mesh-ancestor
64552501|NCT01383707|Micronutrients|micronutrients|mesh-ancestor
64552502|NCT01839357|Rivaroxaban|rivaroxaban|mesh-list
64552503|NCT01839357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64552504|NCT01839357|Antithrombins|antithrombins|mesh-ancestor
64552505|NCT01839357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64552506|NCT01839357|Protease Inhibitors|protease inhibitors|mesh-ancestor
64552507|NCT01839357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552508|NCT01839357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552509|NCT01839357|Anticoagulants|anticoagulants|mesh-ancestor
64552510|NCT03306901|Fluorouracil|fluorouracil|mesh-list
64552511|NCT03306901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552512|NCT03306901|Antimetabolites|antimetabolites|mesh-ancestor
64552513|NCT03306901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552514|NCT03306901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64552515|NCT03306901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64552516|NCT03306901|Immunologic Factors|immunologic factors|mesh-ancestor
64552517|NCT03306901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552518|NCT01455428|Pregabalin|pregabalin|mesh-list
64552519|NCT01455428|Analgesics|analgesics|mesh-ancestor
64552520|NCT01455428|Sensory System Agents|sensory system agents|mesh-ancestor
64552521|NCT01455428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64552522|NCT01455428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552523|NCT01455428|Anticonvulsants|anticonvulsants|mesh-ancestor
64785986|NCT00000924|Nelfinavir|nelfinavir|mesh-list
64785987|NCT00000924|Nevirapine|nevirapine|mesh-list
64785988|NCT00000924|Didanosine|didanosine|mesh-list
64314682|NCT02252627|Autonomic Agents|autonomic agents|mesh-ancestor
64314683|NCT02252627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64314685|NCT02252627|Sympathomimetics|sympathomimetics|mesh-ancestor
64552524|NCT01455428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64992702|NCT03475186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992703|NCT03475186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992704|NCT03475186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64992705|NCT03464097|Ozanimod|ozanimod|mesh-list
64992706|NCT03464097|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64992707|NCT03464097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992708|NCT03464097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64992709|NCT03464097|Immunologic Factors|immunologic factors|mesh-ancestor
64992710|NCT03464097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992712|NCT03462719|Obinutuzumab|obinutuzumab|mesh-list
64992713|NCT03462719|Chlorambucil|chlorambucil|mesh-list
64992714|NCT03462719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992715|NCT03462719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64992716|NCT03462719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64992717|NCT03462719|Alkylating Agents|alkylating agents|mesh-ancestor
64992718|NCT03462719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992719|NCT03456700|Sirolimus|sirolimus|mesh-list
64992720|NCT03456700|Auranofin|auranofin|mesh-list
64992721|NCT03456700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64992722|NCT03456700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64992723|NCT03456700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64992724|NCT03456700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992725|NCT03456700|Antifungal Agents|antifungal agents|mesh-ancestor
64992726|NCT03456700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64992727|NCT03456700|Immunologic Factors|immunologic factors|mesh-ancestor
64552525|NCT01455428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64552526|NCT01455428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552527|NCT01455428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64552528|NCT01455428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64552529|NCT01455428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64552530|NCT01455428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64552531|NCT01455428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64552532|NCT01831947|Ranibizumab|ranibizumab|mesh-list
64552533|NCT01831947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64552534|NCT01831947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64552535|NCT01831947|Growth Substances|growth substances|mesh-ancestor
64317570|NCT05697614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317578|NCT02171221|DFP-11207|dfp-11207|mesh-list
64992745|NCT03321643|Antibodies|antibodies|mesh-list
64992746|NCT03321643|Immunoglobulins|immunoglobulins|mesh-list
64992747|NCT03321643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64992748|NCT03321643|Immunologic Factors|immunologic factors|mesh-ancestor
64992749|NCT03321643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992750|NCT03321643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992751|NCT03321643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64992752|NCT03321643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64314715|NCT03550859|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64314716|NCT03550859|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64314717|NCT03550781|Prednisone|prednisone|mesh-list
64314718|NCT03550781|Cyclophosphamide|cyclophosphamide|mesh-list
64314719|NCT03550781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64314720|NCT03550781|Immunologic Factors|immunologic factors|mesh-ancestor
64314721|NCT03550781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314722|NCT03550781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64992753|NCT03321643|Antimetabolites|antimetabolites|mesh-ancestor
64992754|NCT03321643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992755|NCT03321643|Antiviral Agents|antiviral agents|mesh-ancestor
64992756|NCT03321643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64992757|NCT03321643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992758|NCT03321643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64992759|NCT03278925|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
64992760|NCT03278925|Antioxidants|antioxidants|mesh-ancestor
64992761|NCT03278925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992762|NCT03278925|Protective Agents|protective agents|mesh-ancestor
64992763|NCT03278925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992764|NCT03278925|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64992765|NCT03278925|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64992766|NCT03278925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992767|NCT03278925|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64992768|NCT03269669|Prednisone|prednisone|mesh-list
64992769|NCT03269669|Cortisone|cortisone|mesh-list
64992770|NCT03269669|Cyclophosphamide|cyclophosphamide|mesh-list
64992771|NCT03269669|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64992772|NCT03269669|Doxorubicin|doxorubicin|mesh-list
64992773|NCT03269669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64992774|NCT03269669|Vincristine|vincristine|mesh-list
64992775|NCT03269669|Lenalidomide|lenalidomide|mesh-list
64992776|NCT03269669|Obinutuzumab|obinutuzumab|mesh-list
64992777|NCT03269669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64992778|NCT03269669|Immunologic Factors|immunologic factors|mesh-ancestor
64992779|NCT03269669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992780|NCT03269669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64992781|NCT03269669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64992782|NCT03269669|Alkylating Agents|alkylating agents|mesh-ancestor
64992783|NCT03269669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992784|NCT03269669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992785|NCT03269669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64992802|NCT03269669|Growth Inhibitors|growth inhibitors|mesh-ancestor
64992803|NCT03269669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64992804|NCT03258567|Nivolumab|nivolumab|mesh-list
64552536|NCT01831947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552537|NCT01831947|Growth Inhibitors|growth inhibitors|mesh-ancestor
64552538|NCT01831947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552539|NCT01383161|Curcumin|curcumin|mesh-list
64552540|NCT01383161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64552541|NCT01383161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64552542|NCT01383161|Analgesics|analgesics|mesh-ancestor
64552543|NCT01383161|Sensory System Agents|sensory system agents|mesh-ancestor
64552544|NCT01383161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64552545|NCT01383161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552546|NCT01383161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64552547|NCT01383161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64552548|NCT01383161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552549|NCT01383161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552550|NCT01383161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552551|NCT00894699|Sufentanil|sufentanil|mesh-list
64552552|NCT00894699|Triazolam|triazolam|mesh-list
64552553|NCT00894699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64552554|NCT00894699|Narcotics|narcotics|mesh-ancestor
64552555|NCT00894699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64324673|NCT01379209|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
64324674|NCT01379209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64324675|NCT01379209|Abortifacient Agents|abortifacient agents|mesh-ancestor
64324676|NCT01379209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64552556|NCT00894699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552557|NCT00894699|Analgesics|analgesics|mesh-ancestor
64552558|NCT00894699|Sensory System Agents|sensory system agents|mesh-ancestor
64992805|NCT03258567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64992806|NCT03258567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992807|NCT03258567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64992808|NCT03258567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992809|NCT03258554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64992811|NCT03258554|Durvalumab|durvalumab|mesh-list
64992812|NCT03258554|Antibodies|antibodies|mesh-list
64992813|NCT03258554|Immunoglobulins|immunoglobulins|mesh-list
64992814|NCT03258554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64992815|NCT03258554|Immunoglobulin G|immunoglobulin g|mesh-list
64992816|NCT03258554|Immunologic Factors|immunologic factors|mesh-ancestor
64992817|NCT03258554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992818|NCT03258554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992819|NCT03244384|Pembrolizumab|pembrolizumab|mesh-list
64992820|NCT03244384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64992821|NCT03244384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992822|NCT03213652|Ensartinib|ensartinib|mesh-list
64992823|NCT03213652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992824|NCT03213652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64992825|NCT03213652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992826|NCT03213652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992827|NCT03212274|Olaparib|olaparib|mesh-list
64992828|NCT03212274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64992829|NCT03212274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992830|NCT03212274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992831|NCT03212274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992832|NCT03199885|Paclitaxel|paclitaxel|mesh-list
64992833|NCT03199885|Docetaxel|docetaxel|mesh-list
64992834|NCT03199885|Trastuzumab|trastuzumab|mesh-list
64552560|NCT00894699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64552561|NCT00894699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64552562|NCT00894699|Anesthetics, General|anesthetics, general|mesh-ancestor
64552563|NCT00894699|Anesthetics|anesthetics|mesh-ancestor
64552564|NCT00894699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64552565|NCT00894699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64324677|NCT01379209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314746|NCT02136329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314748|NCT02129231|Magnesium Oxide|magnesium oxide|mesh-list
64314749|NCT02129231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64314750|NCT02129231|Simvastatin|simvastatin|mesh-list
64314751|NCT02129231|Ezetimibe|ezetimibe|mesh-list
64314752|NCT02129231|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
64314753|NCT02129231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64552566|NCT00894699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64552567|NCT00894699|GABA Modulators|gaba modulators|mesh-ancestor
64552568|NCT00894699|GABA Agents|gaba agents|mesh-ancestor
64552569|NCT00894699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64552570|NCT00894699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552571|NCT03087019|Pembrolizumab|pembrolizumab|mesh-list
64552572|NCT03087019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64992835|NCT03199885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64992836|NCT03199885|Atezolizumab|atezolizumab|mesh-list
64992837|NCT03199885|Pertuzumab|pertuzumab|mesh-list
64992838|NCT03199885|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
64992839|NCT03199885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64992840|NCT03199885|Antibodies|antibodies|mesh-list
64992841|NCT03199885|Immunoglobulins|immunoglobulins|mesh-list
64992842|NCT03199885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64992843|NCT03199885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64992844|NCT03199885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992845|NCT03199885|Tubulin Modulators|tubulin modulators|mesh-ancestor
64992846|NCT03199885|Antimitotic Agents|antimitotic agents|mesh-ancestor
64992847|NCT03199885|Mitosis Modulators|mitosis modulators|mesh-ancestor
64992848|NCT03199885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992881|NCT03178149|Immunologic Factors|immunologic factors|mesh-ancestor
64992882|NCT03178149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992883|NCT03178149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64992884|NCT03178149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992885|NCT03178149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992886|NCT03155620|Olaparib|olaparib|mesh-list
64992887|NCT03155620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64992888|NCT03155620|Palbociclib|palbociclib|mesh-list
64992889|NCT03155620|Vemurafenib|vemurafenib|mesh-list
64992890|NCT03155620|Tipifarnib|tipifarnib|mesh-list
64992891|NCT03155620|Ensartinib|ensartinib|mesh-list
64992892|NCT03155620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992893|NCT03155620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992894|NCT03155620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992919|NCT03114072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64992920|NCT03114072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992921|NCT03114072|Sympathomimetics|sympathomimetics|mesh-ancestor
64992922|NCT03114072|Autonomic Agents|autonomic agents|mesh-ancestor
64992923|NCT03114072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64992924|NCT03114072|Dopamine Agents|dopamine agents|mesh-ancestor
64992925|NCT03114072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64314775|NCT02136641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64314776|NCT02136641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64314777|NCT02136641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314778|NCT02136641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64314779|NCT02136641|Narcotics|narcotics|mesh-ancestor
64314780|NCT02136641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64314781|NCT02136641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64992926|NCT03114072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992927|NCT03114072|Adrenergic Agents|adrenergic agents|mesh-ancestor
64992928|NCT03114072|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64992929|NCT03114072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64992930|NCT03114072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64992931|NCT03114072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64992932|NCT03063619|Tamoxifen|tamoxifen|mesh-list
64992933|NCT03063619|Afimoxifene|afimoxifene|mesh-list
64992934|NCT03063619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64992935|NCT03063619|Hormone Antagonists|hormone antagonists|mesh-ancestor
64992936|NCT03063619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64552573|NCT03087019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552574|NCT01382225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64552575|NCT01382225|Hyaluronic Acid|hyaluronic acid|mesh-list
64552576|NCT01382225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64552577|NCT01382225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64552578|NCT01382225|Immunologic Factors|immunologic factors|mesh-ancestor
64552579|NCT01382225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552580|NCT01382225|Viscosupplements|viscosupplements|mesh-ancestor
64552581|NCT01382225|Protective Agents|protective agents|mesh-ancestor
64552582|NCT01381679|Ezetimibe|ezetimibe|mesh-list
64552583|NCT01381679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64552584|NCT01381679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64552585|NCT01381679|Antimetabolites|antimetabolites|mesh-ancestor
64552586|NCT01381679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552587|NCT01381679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64552588|NCT01832415|Bevacizumab|bevacizumab|mesh-list
64317615|NCT03171987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64992937|NCT03063619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992938|NCT03063619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64992939|NCT03063619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992940|NCT03063619|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64992941|NCT03063619|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64992942|NCT03063619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64992943|NCT03030378|Pembrolizumab|pembrolizumab|mesh-list
64992944|NCT03030378|Interleukin-12|interleukin-12|mesh-list
64992945|NCT03030378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64992946|NCT03030378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992967|NCT03002103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64992968|NCT03002103|Immunologic Factors|immunologic factors|mesh-ancestor
64992969|NCT03002103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993019|NCT02975882|Immunologic Factors|immunologic factors|mesh-ancestor
64993020|NCT02975882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993021|NCT02975882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64993023|NCT02968810|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64785989|NCT00000924|Stavudine|stavudine|mesh-list
64785990|NCT00000924|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64785991|NCT00000924|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64785992|NCT00000924|Protease Inhibitors|protease inhibitors|mesh-ancestor
64785993|NCT00000924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314806|NCT02129621|Diuretics|diuretics|mesh-ancestor
64993024|NCT02968810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64993025|NCT02968810|Antimetabolites|antimetabolites|mesh-ancestor
64993026|NCT02968810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993027|NCT02968810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64993028|NCT02968810|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64993029|NCT02968810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993030|NCT02935205|Indomethacin|indomethacin|mesh-list
64993031|NCT02935205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64993032|NCT02935205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64993033|NCT02935205|Analgesics|analgesics|mesh-ancestor
64993034|NCT02935205|Sensory System Agents|sensory system agents|mesh-ancestor
64993035|NCT02935205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64993036|NCT02935205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993037|NCT02935205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64993038|NCT02935205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64993039|NCT02935205|Gout Suppressants|gout suppressants|mesh-ancestor
64993040|NCT02935205|Tocolytic Agents|tocolytic agents|mesh-ancestor
64993041|NCT02935205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64993042|NCT02935205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64993043|NCT02935205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993044|NCT02935205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552589|NCT01832415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64552590|NCT01832415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552591|NCT01832415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64552592|NCT01832415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64552593|NCT01832415|Growth Substances|growth substances|mesh-ancestor
64552594|NCT01832415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552595|NCT01832415|Growth Inhibitors|growth inhibitors|mesh-ancestor
64552596|NCT01455194|Ciclesonide|ciclesonide|mesh-list
64552597|NCT01455194|Glucocorticoids|glucocorticoids|mesh-ancestor
64552598|NCT01455194|Hormones|hormones|mesh-ancestor
64552599|NCT01455194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64317631|NCT03172065|Analgesics|analgesics|mesh-ancestor
64993045|NCT02923778|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
64993046|NCT02923778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64993069|NCT02912559|Vitamins|vitamins|mesh-ancestor
64993070|NCT02912559|Micronutrients|micronutrients|mesh-ancestor
64993071|NCT02912559|Hematinics|hematinics|mesh-ancestor
64993072|NCT02898207|Olaparib|olaparib|mesh-list
64993073|NCT02898207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64993074|NCT02898207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993075|NCT02898207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993076|NCT02898207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993077|NCT02862275|Atezolizumab|atezolizumab|mesh-list
64993078|NCT02862275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64993079|NCT02862275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993080|NCT02862275|Immunologic Factors|immunologic factors|mesh-ancestor
64993081|NCT02862275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993082|NCT02849496|Atezolizumab|atezolizumab|mesh-list
64993083|NCT02849496|Olaparib|olaparib|mesh-list
64993084|NCT02849496|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64993085|NCT02849496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64993086|NCT02849496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993087|NCT02849496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993088|NCT02849496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785995|NCT00000924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64785996|NCT00000924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64314848|NCT02132897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64314849|NCT02132897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64314850|NCT02132897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993089|NCT02849496|Immunologic Factors|immunologic factors|mesh-ancestor
64993090|NCT02849496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993091|NCT02839707|Bevacizumab|bevacizumab|mesh-list
64993092|NCT02839707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64993093|NCT02839707|Doxorubicin|doxorubicin|mesh-list
64993094|NCT02839707|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64993095|NCT02839707|Atezolizumab|atezolizumab|mesh-list
64993096|NCT02839707|Endothelial Growth Factors|endothelial growth factors|mesh-list
64993097|NCT02839707|Antibodies|antibodies|mesh-list
64993098|NCT02839707|Immunoglobulins|immunoglobulins|mesh-list
64993099|NCT02839707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64993100|NCT02839707|Immunoglobulin G|immunoglobulin g|mesh-list
64993101|NCT02839707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993122|NCT02830724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993123|NCT02830724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993124|NCT02830724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64993126|NCT02830724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64993127|NCT02830724|Antiviral Agents|antiviral agents|mesh-ancestor
64993128|NCT02830724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64993129|NCT02807805|Niclosamide|niclosamide|mesh-list
64993130|NCT02807805|Prednisone|prednisone|mesh-list
64993131|NCT02807805|Cortisone|cortisone|mesh-list
64993132|NCT02807805|Abiraterone Acetate|abiraterone acetate|mesh-list
64993133|NCT02807805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64993134|NCT02807805|Glucocorticoids|glucocorticoids|mesh-ancestor
64993135|NCT02807805|Hormones|hormones|mesh-ancestor
64993136|NCT02807805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64552600|NCT01455194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552602|NCT03216759|Dexmedetomidine|dexmedetomidine|mesh-list
64552603|NCT03216759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64552604|NCT03216759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64552605|NCT03216759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552606|NCT03216759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64552607|NCT03216759|Analgesics|analgesics|mesh-ancestor
64552608|NCT03216759|Sensory System Agents|sensory system agents|mesh-ancestor
64552609|NCT03216759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64552610|NCT03216759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64552611|NCT03216759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64552612|NCT03216759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64552613|NCT03216759|Adrenergic Agents|adrenergic agents|mesh-ancestor
64552614|NCT03216759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64317642|NCT02171299|Anesthetics|anesthetics|mesh-list
64317644|NCT02171299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314859|NCT02132897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64314860|NCT02132897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64314861|NCT02133053|Beclomethasone|beclomethasone|mesh-list
64314862|NCT02133053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64314863|NCT02133053|Glucocorticoids|glucocorticoids|mesh-ancestor
64314864|NCT02133053|Hormones|hormones|mesh-ancestor
64314865|NCT02133053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64314866|NCT02133053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314867|NCT02133053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64993137|NCT02807805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993138|NCT02807805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64993139|NCT02807805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993140|NCT02807805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64993141|NCT02807805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993142|NCT02807805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993143|NCT02807805|Hormone Antagonists|hormone antagonists|mesh-ancestor
64993144|NCT02807805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64993145|NCT02807805|Anticestodal Agents|anticestodal agents|mesh-ancestor
64993146|NCT02807805|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64993147|NCT02807805|Anthelmintics|anthelmintics|mesh-ancestor
64993148|NCT02807805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64993149|NCT02807805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64993150|NCT02807805|Antinematodal Agents|antinematodal agents|mesh-ancestor
64993151|NCT02775851|Pembrolizumab|pembrolizumab|mesh-list
64993152|NCT02775851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64993153|NCT02775851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993154|NCT02737046|Interferons|interferons|mesh-list
64993190|NCT02682485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64993191|NCT02682485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64993192|NCT02682485|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64993193|NCT02649790|Dexamethasone|dexamethasone|mesh-list
64993194|NCT02649790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64993195|NCT02649790|Antiemetics|antiemetics|mesh-ancestor
64993227|NCT02595931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64993228|NCT02595931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993229|NCT02595931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993230|NCT02595931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993231|NCT02595931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64993232|NCT02595879|Deoxyglucose|deoxyglucose|mesh-list
64993233|NCT02595879|Cisplatin|cisplatin|mesh-list
64993234|NCT02595879|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64993235|NCT02595879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993236|NCT02595879|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64993237|NCT02595879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993238|NCT02595879|Antimetabolites|antimetabolites|mesh-ancestor
64314882|NCT02130167|Parasympatholytics|parasympatholytics|mesh-ancestor
64314883|NCT02130167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64314884|NCT02130167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64314885|NCT02130167|Cholinergic Agents|cholinergic agents|mesh-ancestor
64314886|NCT02130167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64314887|NCT02130167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314888|NCT02130323|Imiquimod|imiquimod|mesh-list
64314889|NCT02130323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64314890|NCT02130323|Immunologic Factors|immunologic factors|mesh-ancestor
64314891|NCT02130323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314892|NCT02130323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314893|NCT02130323|Interferon Inducers|interferon inducers|mesh-ancestor
64314894|NCT03549611|Acetaminophen|acetaminophen|mesh-list
64314895|NCT03549611|Celecoxib|celecoxib|mesh-list
64314896|NCT03549611|Oxycodone|oxycodone|mesh-list
64314897|NCT03549611|Gabapentin|gabapentin|mesh-list
64314898|NCT03549611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64314899|NCT03549611|Analgesics|analgesics|mesh-ancestor
64993272|NCT02521493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993273|NCT02521493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64552619|NCT04023071|Fludarabine|fludarabine|mesh-list
64552620|NCT04023071|Obinutuzumab|obinutuzumab|mesh-list
64552621|NCT04023071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64552622|NCT04023071|Immunologic Factors|immunologic factors|mesh-ancestor
64552623|NCT04023071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552624|NCT04023071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64552625|NCT04023071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64552626|NCT04023071|Alkylating Agents|alkylating agents|mesh-ancestor
64552627|NCT04023071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552628|NCT04023071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552629|NCT04023071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64552630|NCT04023071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64552631|NCT03799445|Nivolumab|nivolumab|mesh-list
64552632|NCT03799445|Ipilimumab|ipilimumab|mesh-list
64552633|NCT03799445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64552634|NCT03799445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552635|NCT03799445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64552636|NCT03799445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552637|NCT04009109|Dexamethasone|dexamethasone|mesh-list
64317660|NCT03171831|Alkylating Agents|alkylating agents|mesh-ancestor
64993274|NCT02521493|Antimetabolites|antimetabolites|mesh-ancestor
64993275|NCT02521493|Antiviral Agents|antiviral agents|mesh-ancestor
64993276|NCT02521493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64993277|NCT02521493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64993278|NCT02521493|Immunologic Factors|immunologic factors|mesh-ancestor
64993279|NCT02521493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993280|NCT02521493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64993281|NCT02521493|Analgesics|analgesics|mesh-ancestor
64993282|NCT02521493|Sensory System Agents|sensory system agents|mesh-ancestor
64993305|NCT02502266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64993306|NCT02502266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64993307|NCT02502266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64993308|NCT02502266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993309|NCT02502266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64993310|NCT02502266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64993311|NCT02498613|Misonidazole|misonidazole|mesh-list
64993312|NCT02498613|Olaparib|olaparib|mesh-list
64993313|NCT02498613|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64993314|NCT02498613|Cediranib|cediranib|mesh-list
64314904|NCT03549611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64314905|NCT03549611|Narcotics|narcotics|mesh-ancestor
64314906|NCT03549611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64314907|NCT03549611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64314908|NCT03549611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64314909|NCT03549611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64314910|NCT03549611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64314911|NCT03549611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64314912|NCT03549611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314913|NCT03549611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993315|NCT02498613|Maleic acid|maleic acid|mesh-list
64993316|NCT02498613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993317|NCT02498613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993318|NCT02498613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993319|NCT02498613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64993320|NCT02498613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64993321|NCT02498613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64552638|NCT04009109|Lenalidomide|lenalidomide|mesh-list
64552639|NCT04009109|Daratumumab|daratumumab|mesh-list
64552640|NCT04009109|Ixazomib|ixazomib|mesh-list
64552641|NCT04009109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64552642|NCT04009109|Antiemetics|antiemetics|mesh-ancestor
64552643|NCT04009109|Autonomic Agents|autonomic agents|mesh-ancestor
64552644|NCT04009109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64552645|NCT04009109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552646|NCT04009109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64552647|NCT04009109|Glucocorticoids|glucocorticoids|mesh-ancestor
64552648|NCT04009109|Hormones|hormones|mesh-ancestor
64552649|NCT04009109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64552650|NCT04009109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64552651|NCT04009109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552652|NCT04009109|Immunologic Factors|immunologic factors|mesh-ancestor
64552653|NCT04009109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64552654|NCT04009109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64552655|NCT04009109|Growth Substances|growth substances|mesh-ancestor
64552656|NCT04009109|Growth Inhibitors|growth inhibitors|mesh-ancestor
64552657|NCT04009109|Protease Inhibitors|protease inhibitors|mesh-ancestor
64552658|NCT04009109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552659|NCT04009109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552660|NCT01832571|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64552661|NCT01832571|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64993322|NCT02498613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64993334|NCT02496208|Ipilimumab|ipilimumab|mesh-list
64324678|NCT01379209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64397169|NCT02374567|Maprotiline|maprotiline|mesh-list
64785997|NCT00000924|Antiviral Agents|antiviral agents|mesh-ancestor
64785998|NCT00000924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64314945|NCT02592434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314946|NCT02130713|Fluoroquinolones|fluoroquinolones|mesh-list
64314947|NCT02130713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64314948|NCT02130713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64314949|NCT02130713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64314950|NCT02130713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314951|NCT02130713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314952|NCT02137421|Resveratrol|resveratrol|mesh-list
64314953|NCT02137421|Antioxidants|antioxidants|mesh-ancestor
64993335|NCT02496208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64993336|NCT02496208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993337|NCT02496208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64993368|NCT02465060|Immunologic Factors|immunologic factors|mesh-ancestor
64993369|NCT02465060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993370|NCT02465060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993371|NCT02465060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64993372|NCT02465060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993373|NCT02465060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64993374|NCT02465060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64993375|NCT02465060|Growth Substances|growth substances|mesh-ancestor
64993376|NCT02465060|Growth Inhibitors|growth inhibitors|mesh-ancestor
64993377|NCT02465060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64993378|NCT02465060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993379|NCT02465060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64993380|NCT02465060|Tubulin Modulators|tubulin modulators|mesh-ancestor
64993381|NCT02465060|Antimitotic Agents|antimitotic agents|mesh-ancestor
64993382|NCT02465060|Mitosis Modulators|mitosis modulators|mesh-ancestor
64993384|NCT02408861|Ipilimumab|ipilimumab|mesh-list
64993385|NCT02408861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64993386|NCT02408861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552662|NCT01832571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64552663|NCT01832571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552664|NCT01832571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552665|NCT01832571|Antiviral Agents|antiviral agents|mesh-ancestor
64552666|NCT01832571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64785999|NCT00000924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64786000|NCT00000924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64786001|NCT00000924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786002|NCT00000924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786003|NCT00000924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64786004|NCT00000924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64786005|NCT00000924|Antimetabolites|antimetabolites|mesh-ancestor
64314977|NCT02137733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64314978|NCT02137733|Vasodilator Agents|vasodilator agents|mesh-ancestor
64314979|NCT02137733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64509236|NCT03672292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64509237|NCT03672292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509238|NCT03672292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64509239|NCT01937260|Brodalumab|brodalumab|mesh-list
64509240|NCT01937260|Dermatologic Agents|dermatologic agents|mesh-ancestor
64509241|NCT03829371|Dexamethasone|dexamethasone|mesh-list
64509242|NCT03829371|Prednisone|prednisone|mesh-list
64509243|NCT03829371|Lenalidomide|lenalidomide|mesh-list
64509244|NCT03829371|Melphalan|melphalan|mesh-list
64509246|NCT03829371|Daratumumab|daratumumab|mesh-list
64509247|NCT03829371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64509248|NCT03829371|Antiemetics|antiemetics|mesh-ancestor
64509250|NCT03829371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509265|NCT03829371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509266|NCT03829371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64509267|NCT03829371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64509268|NCT03827889|Fluorides|fluorides|mesh-list
64509269|NCT03827889|Fluorides, Topical|fluorides, topical|mesh-list
64509270|NCT03827889|Cariostatic Agents|cariostatic agents|mesh-ancestor
64509271|NCT03827889|Protective Agents|protective agents|mesh-ancestor
64509272|NCT03827889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509273|NCT01902004|Memantine|memantine|mesh-list
64509274|NCT01902004|Citalopram|citalopram|mesh-list
64509275|NCT01902004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64509277|NCT01902004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64509278|NCT01902004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509279|NCT01902004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64509280|NCT01902004|Serotonin Agents|serotonin agents|mesh-ancestor
64509281|NCT01902004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509282|NCT01902004|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64509283|NCT01902004|Antidepressive Agents|antidepressive agents|mesh-ancestor
64509284|NCT01902004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64509285|NCT01902004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64509286|NCT01902004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64509287|NCT01902004|Dopamine Agents|dopamine agents|mesh-ancestor
64509288|NCT01902004|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64509289|NCT01902004|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64509290|NCT01938040|Ibuprofen|ibuprofen|mesh-list
64509291|NCT01938040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64509292|NCT01938040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64509293|NCT01938040|Analgesics|analgesics|mesh-ancestor
64509294|NCT01938040|Sensory System Agents|sensory system agents|mesh-ancestor
64509295|NCT01938040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509296|NCT01938040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509297|NCT01938040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64509298|NCT01938040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64726898|NCT00002581|Methotrexate|methotrexate|mesh-list
64726899|NCT00002581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64726900|NCT00002581|Immunologic Factors|immunologic factors|mesh-ancestor
64509299|NCT01938040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64494243|NCT02930044|Insulin|insulin|mesh-list
64955500|NCT00203281|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64315005|NCT02130869|Sargramostim|sargramostim|mesh-list
64315006|NCT02130869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315007|NCT02130869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64315008|NCT02130869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64315009|NCT02130869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64315010|NCT02130869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64315011|NCT02130869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315012|NCT02130869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64315013|NCT02130869|Antimetabolites|antimetabolites|mesh-ancestor
64375095|NCT03238703|Tamoxifen|tamoxifen|mesh-list
64955501|NCT00203281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64509300|NCT01938040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509301|NCT01938040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509302|NCT03829839|Lorazepam|lorazepam|mesh-list
64509303|NCT03829839|Oxytocin|oxytocin|mesh-list
64509304|NCT03829839|Oxytocics|oxytocics|mesh-ancestor
64509305|NCT03829839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64509306|NCT03829839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509307|NCT03829839|Anticonvulsants|anticonvulsants|mesh-ancestor
64509308|NCT03829839|Antiemetics|antiemetics|mesh-ancestor
64509309|NCT03829839|Autonomic Agents|autonomic agents|mesh-ancestor
64509313|NCT03829839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64509314|NCT03829839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64509315|NCT03829839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64509316|NCT03829839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64509317|NCT03829839|GABA Modulators|gaba modulators|mesh-ancestor
64509318|NCT03829839|GABA Agents|gaba agents|mesh-ancestor
64509319|NCT03829839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64509320|NCT03829839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509321|NCT01938664|Candesartan|candesartan|mesh-list
64509322|NCT01938664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64509323|NCT01938664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64509324|NCT01938664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64509325|NCT01938664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509326|NCT03829917|Paromomycin|paromomycin|mesh-list
64509327|NCT03829917|Miltefosine|miltefosine|mesh-list
64509328|NCT03829917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64509329|NCT03829917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64509330|NCT03829917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64509331|NCT03829917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64509332|NCT03829917|Antifungal Agents|antifungal agents|mesh-ancestor
64509333|NCT03829917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509335|NCT02284126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64509336|NCT02284126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64509337|NCT03004833|Nivolumab|nivolumab|mesh-list
64509338|NCT03004833|Doxorubicin|doxorubicin|mesh-list
64509339|NCT03004833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64509340|NCT03004833|Dacarbazine|dacarbazine|mesh-list
64315015|NCT02130869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64315016|NCT02130869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64315017|NCT02130869|Immunologic Factors|immunologic factors|mesh-ancestor
64315018|NCT02130869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315019|NCT02130869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64315020|NCT02130869|Alkylating Agents|alkylating agents|mesh-ancestor
64315021|NCT02130869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64315022|NCT02130869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64315023|NCT02130869|Analgesics|analgesics|mesh-ancestor
64315024|NCT02130869|Sensory System Agents|sensory system agents|mesh-ancestor
64315025|NCT02130869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509341|NCT03004833|Vinblastine|vinblastine|mesh-list
64509342|NCT03004833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64509343|NCT03004833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509344|NCT03004833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64509345|NCT03004833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509346|NCT03004833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64509347|NCT03004833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64509348|NCT03004833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64509350|NCT03004833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64509351|NCT03004833|Alkylating Agents|alkylating agents|mesh-ancestor
64509352|NCT03004833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64509353|NCT03004833|Tubulin Modulators|tubulin modulators|mesh-ancestor
64509354|NCT03004833|Antimitotic Agents|antimitotic agents|mesh-ancestor
64509355|NCT03004833|Mitosis Modulators|mitosis modulators|mesh-ancestor
64509356|NCT01736579|Immunoglobulins|immunoglobulins|mesh-list
64509357|NCT01736579|Antibodies|antibodies|mesh-list
64509358|NCT01736579|gamma-Globulins|gamma-globulins|mesh-list
64509359|NCT01736579|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64509360|NCT01736579|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64509361|NCT01736579|Immunologic Factors|immunologic factors|mesh-ancestor
64509362|NCT01736579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509363|NCT03004287|Thalidomide|thalidomide|mesh-list
64509364|NCT03004287|Dexamethasone|dexamethasone|mesh-list
64509365|NCT03004287|Cyclophosphamide|cyclophosphamide|mesh-list
64509366|NCT03004287|Melphalan|melphalan|mesh-list
64509367|NCT03004287|Doxorubicin|doxorubicin|mesh-list
64509368|NCT03004287|Etoposide|etoposide|mesh-list
64509369|NCT03004287|Lenalidomide|lenalidomide|mesh-list
64509370|NCT03004287|Bortezomib|bortezomib|mesh-list
64726901|NCT00002581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726902|NCT00002581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64726903|NCT00002581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64726904|NCT00002581|Alkylating Agents|alkylating agents|mesh-ancestor
64726905|NCT00002581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726906|NCT00002581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726907|NCT00002581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64726908|NCT00002581|Antimetabolites|antimetabolites|mesh-ancestor
64786006|NCT00000936|Cyclosporine|cyclosporine|mesh-list
64786007|NCT00000936|Cyclosporins|cyclosporins|mesh-list
64786008|NCT00000936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786009|NCT00000936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786010|NCT00000936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64786011|NCT00000936|Immunologic Factors|immunologic factors|mesh-ancestor
64315041|NCT02133989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315042|NCT02133989|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64315043|NCT02133989|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64315044|NCT02133989|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64315045|NCT02133989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64315046|NCT02133989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64315059|NCT02138045|Liraglutide|liraglutide|mesh-list
64315060|NCT02138045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64315061|NCT02138045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509371|NCT03004287|Daratumumab|daratumumab|mesh-list
64509372|NCT03004287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64509373|NCT03004287|Immunologic Factors|immunologic factors|mesh-ancestor
64509374|NCT03004287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509375|NCT03004287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64509376|NCT03004287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64955502|NCT00203281|Immunologic Factors|immunologic factors|mesh-ancestor
64509377|NCT03004287|Alkylating Agents|alkylating agents|mesh-ancestor
64509378|NCT03004287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509379|NCT03004287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509380|NCT03004287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64509381|NCT03004287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64509382|NCT03004287|Antiemetics|antiemetics|mesh-ancestor
64509389|NCT03004287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64509390|NCT03004287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64509391|NCT03004287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64509392|NCT03004287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64509393|NCT03004287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509394|NCT03004287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64509395|NCT03004287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64509396|NCT03004287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64509397|NCT03004287|Growth Substances|growth substances|mesh-ancestor
64509400|NCT03004287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64509401|NCT03004287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64509402|NCT04124913|Progesterone|progesterone|mesh-list
64509403|NCT04124913|Dydrogesterone|dydrogesterone|mesh-list
64509404|NCT04124913|Progestins|progestins|mesh-ancestor
64509405|NCT04124913|Hormones|hormones|mesh-ancestor
64509406|NCT04124913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64509407|NCT04124913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509408|NCT02962401|Obinutuzumab|obinutuzumab|mesh-list
64509409|NCT02962401|Idelalisib|idelalisib|mesh-list
64509410|NCT02962401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64509411|NCT02962401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509412|NCT02962401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509413|NCT02962401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509414|NCT03828279|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64552667|NCT01832571|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64509415|NCT03828279|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64509416|NCT03828279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64509417|NCT03828279|Immunologic Factors|immunologic factors|mesh-ancestor
64509418|NCT03828279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509419|NCT02987920|Acetaminophen|acetaminophen|mesh-list
64509420|NCT02987920|Celecoxib|celecoxib|mesh-list
64509421|NCT02987920|Ketorolac|ketorolac|mesh-list
64509422|NCT02987920|Oxycodone|oxycodone|mesh-list
64509423|NCT02987920|Gabapentin|gabapentin|mesh-list
64509424|NCT02987920|Hydromorphone|hydromorphone|mesh-list
64509425|NCT02987920|Dextromethorphan|dextromethorphan|mesh-list
64509426|NCT02987920|Pantoprazole|pantoprazole|mesh-list
64509428|NCT02987920|Analgesics|analgesics|mesh-ancestor
64509429|NCT02987920|Sensory System Agents|sensory system agents|mesh-ancestor
64509430|NCT02987920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509431|NCT02987920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509432|NCT02987920|Antipyretics|antipyretics|mesh-ancestor
64509433|NCT02987920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64509434|NCT02987920|Narcotics|narcotics|mesh-ancestor
64509435|NCT02987920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64726909|NCT00002581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64726910|NCT00002581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64726911|NCT00002581|Abortifacient Agents|abortifacient agents|mesh-ancestor
64726912|NCT00002581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64509436|NCT02987920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64509437|NCT02987920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64509438|NCT02987920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64509439|NCT02987920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64509440|NCT02987920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64509441|NCT02987920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509442|NCT02987920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509443|NCT02987920|Anticonvulsants|anticonvulsants|mesh-ancestor
64509444|NCT02987920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64509445|NCT02987920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64509446|NCT02987920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64509447|NCT02987920|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64509448|NCT02987920|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64509449|NCT02987920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64955503|NCT00203281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955504|NCT00203281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64509450|NCT02987920|Antimanic Agents|antimanic agents|mesh-ancestor
64509451|NCT02987920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64509469|NCT02970981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509471|NCT03374800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64509472|NCT03374800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64509473|NCT03374800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64422174|NCT02710097|Ethanol|ethanol|mesh-list
64509474|NCT03374800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509475|NCT03374800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509477|NCT02983773|Hallucinogens|hallucinogens|mesh-ancestor
64786023|NCT00000942|Antiviral Agents|antiviral agents|mesh-ancestor
64324679|NCT01379209|Antimetabolites|antimetabolites|mesh-ancestor
64324680|NCT01379209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324681|NCT01379209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324682|NCT01379209|Dermatologic Agents|dermatologic agents|mesh-ancestor
64324683|NCT01379209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64315102|NCT03962114|Niacin|niacin|mesh-list
64509478|NCT02983773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509479|NCT02983773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64509480|NCT02983773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64509481|NCT02983773|Analgesics|analgesics|mesh-ancestor
64509482|NCT02983773|Sensory System Agents|sensory system agents|mesh-ancestor
64509483|NCT02983773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509484|NCT02983773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64509485|NCT02983773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64509486|NCT02983773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64509487|NCT02983773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509488|NCT02983773|Hormones|hormones|mesh-ancestor
64509489|NCT02983773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64509490|NCT01941628|Rocuronium|rocuronium|mesh-list
64509491|NCT01941628|Succinylcholine|succinylcholine|mesh-list
64509492|NCT01941628|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64509493|NCT01941628|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64509494|NCT01941628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64509495|NCT01941628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509496|NCT01941628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509497|NCT01941628|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
64509498|NCT02987218|Propofol|propofol|mesh-list
64509499|NCT02987218|Desflurane|desflurane|mesh-list
64509500|NCT02987218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64509501|NCT02987218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64509503|NCT02987218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64509504|NCT02987218|Anesthetics, General|anesthetics, general|mesh-ancestor
64509505|NCT02987218|Anesthetics|anesthetics|mesh-ancestor
64509506|NCT02987218|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64509507|NCT01762943|Leuprolide|leuprolide|mesh-list
64509508|NCT01762943|Estradiol|estradiol|mesh-list
64509509|NCT01762943|Progesterone|progesterone|mesh-list
64509510|NCT01762943|Estrogens|estrogens|mesh-ancestor
64315113|NCT04346186|Immunoglobulin G|immunoglobulin g|mesh-list
64315114|NCT04346186|Immunoglobulin M|immunoglobulin m|mesh-list
64315115|NCT04346186|Immunologic Factors|immunologic factors|mesh-ancestor
64315116|NCT04346186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315118|NCT05472896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64315119|NCT05472896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315120|NCT05472896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64315121|NCT05472896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64315122|NCT05472896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64315123|NCT05472896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315124|NCT02138357|Buprenorphine|buprenorphine|mesh-list
64315125|NCT02138357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64315126|NCT02138357|Narcotics|narcotics|mesh-ancestor
64315127|NCT02138357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64315128|NCT02138357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509511|NCT01762943|Hormones|hormones|mesh-ancestor
64509512|NCT01762943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64509525|NCT04392063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64509526|NCT01903798|Mycophenolic Acid|mycophenolic acid|mesh-list
64509528|NCT01903798|Rilonacept|rilonacept|mesh-list
64955505|NCT00203281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955506|NCT00203281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726913|NCT00002581|Dermatologic Agents|dermatologic agents|mesh-ancestor
64726914|NCT00002581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726915|NCT00002581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64726916|NCT00002581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64955507|NCT00203281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64509529|NCT01903798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64509530|NCT01903798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509531|NCT01903798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64509532|NCT01903798|Antitubercular Agents|antitubercular agents|mesh-ancestor
64509533|NCT01903798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64509534|NCT01903798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64509535|NCT01903798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509536|NCT01903798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509537|NCT01903798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64509538|NCT01903798|Glucocorticoids|glucocorticoids|mesh-ancestor
64509539|NCT01903798|Hormones|hormones|mesh-ancestor
64509540|NCT01903798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64509541|NCT01903798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509542|NCT01903798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64509543|NCT01945138|Insulin|insulin|mesh-list
64509544|NCT01945138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64509546|NCT01945138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509547|NCT01734785|Empagliflozin|empagliflozin|mesh-list
64509548|NCT01734785|Linagliptin|linagliptin|mesh-list
64509549|NCT01734785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64509550|NCT01734785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509552|NCT01734785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509553|NCT01734785|Incretins|incretins|mesh-ancestor
64509554|NCT01734785|Hormones|hormones|mesh-ancestor
64509555|NCT01734785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64509556|NCT01734785|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64509557|NCT01734785|Protease Inhibitors|protease inhibitors|mesh-ancestor
64509558|NCT01734785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509559|NCT03821415|Estradiol|estradiol|mesh-list
64509560|NCT03821415|Estrogens|estrogens|mesh-ancestor
64509561|NCT03821415|Hormones|hormones|mesh-ancestor
64509562|NCT03821415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64509563|NCT03821415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509564|NCT01734395|Galantamine|galantamine|mesh-list
64509565|NCT01734395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64509566|NCT01734395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509567|NCT01734395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509568|NCT01734395|Cholinergic Agents|cholinergic agents|mesh-ancestor
64509569|NCT01734395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64509570|NCT01734395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509571|NCT01734395|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64509577|NCT02918721|Anesthetics, Local|anesthetics, local|mesh-ancestor
64509579|NCT02918721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64509580|NCT02918721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509581|NCT02918721|Sensory System Agents|sensory system agents|mesh-ancestor
64509582|NCT02918721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509583|NCT02918721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64786024|NCT00000942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64315141|NCT03596918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64315142|NCT03535298|Interferons|interferons|mesh-list
64509584|NCT02918721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64509585|NCT02918721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64509586|NCT02918721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64509587|NCT02918721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509588|NCT02918721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64509589|NCT02918721|Immunologic Factors|immunologic factors|mesh-ancestor
64509590|NCT02918721|Viscosupplements|viscosupplements|mesh-ancestor
64509591|NCT02918721|Protective Agents|protective agents|mesh-ancestor
64509592|NCT01945294|Interferons|interferons|mesh-list
64509593|NCT01945294|Ribavirin|ribavirin|mesh-list
64509594|NCT01945294|Interferon-alpha|interferon-alpha|mesh-list
64509595|NCT01945294|Interferon alpha-2|interferon alpha-2|mesh-list
64509596|NCT01945294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64509597|NCT01945294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509598|NCT01945294|Antiviral Agents|antiviral agents|mesh-ancestor
64509599|NCT01945294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726917|NCT00002581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64726918|NCT00002581|Hormone Antagonists|hormone antagonists|mesh-ancestor
64726919|NCT00002581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64726920|NCT00002581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64726921|NCT00002581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64726922|NCT00002581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64509600|NCT01945294|Antimetabolites|antimetabolites|mesh-ancestor
64509601|NCT01945294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509602|NCT01945294|Immunologic Factors|immunologic factors|mesh-ancestor
64509603|NCT01945294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509604|NCT04392297|Antibodies|antibodies|mesh-list
64509605|NCT04392297|Immunoglobulin G|immunoglobulin g|mesh-list
64509606|NCT04392297|Immunologic Factors|immunologic factors|mesh-ancestor
64509607|NCT04392297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509608|NCT01947946|Benralizumab|benralizumab|mesh-list
64509609|NCT01947946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64422187|NCT02547935|Incretins|incretins|mesh-ancestor
64509610|NCT01947946|Respiratory System Agents|respiratory system agents|mesh-ancestor
64509611|NCT02954055|Paclitaxel|paclitaxel|mesh-list
64509612|NCT02954055|Vinorelbine|vinorelbine|mesh-list
64509613|NCT02954055|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64509614|NCT02954055|Cyclophosphamide|cyclophosphamide|mesh-list
64509615|NCT02954055|Capecitabine|capecitabine|mesh-list
64509616|NCT02954055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64509617|NCT02954055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509618|NCT02954055|Tubulin Modulators|tubulin modulators|mesh-ancestor
64509619|NCT02954055|Antimitotic Agents|antimitotic agents|mesh-ancestor
64509620|NCT02954055|Mitosis Modulators|mitosis modulators|mesh-ancestor
64509621|NCT02954055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509622|NCT02954055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64509623|NCT02954055|Immunologic Factors|immunologic factors|mesh-ancestor
64509624|NCT02954055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509626|NCT02954055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64509627|NCT02954055|Alkylating Agents|alkylating agents|mesh-ancestor
64509628|NCT02954055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64509629|NCT02954055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64509630|NCT02954055|Antimetabolites|antimetabolites|mesh-ancestor
64509631|NCT03313180|Nintedanib|nintedanib|mesh-list
64509632|NCT03313180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509633|NCT03313180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64509634|NCT03313180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509635|NCT03313180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509636|NCT03275506|Bevacizumab|bevacizumab|mesh-list
64509637|NCT03275506|Pembrolizumab|pembrolizumab|mesh-list
64509638|NCT03275506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64509639|NCT03275506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509640|NCT03275506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64509641|NCT03275506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64509642|NCT03275506|Growth Substances|growth substances|mesh-ancestor
64509643|NCT03275506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509644|NCT03275506|Growth Inhibitors|growth inhibitors|mesh-ancestor
64509645|NCT03820245|Lycopene|lycopene|mesh-list
64509660|NCT03826485|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64509662|NCT03826485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64509663|NCT03826485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509664|NCT03823989|Mitomycins|mitomycins|mesh-list
64509665|NCT03823989|Mitomycin|mitomycin|mesh-list
64509666|NCT03823989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64509667|NCT03823989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509668|NCT03823989|Alkylating Agents|alkylating agents|mesh-ancestor
64509669|NCT03823989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509670|NCT03823989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64509671|NCT03823989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509672|NCT03826875|Fluoxetine|fluoxetine|mesh-list
64509673|NCT03826875|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64509674|NCT03826875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64726923|NCT00002581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64726924|NCT00003182|Gemcitabine|gemcitabine|mesh-list
64726925|NCT00003182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726926|NCT00003182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64509675|NCT03826875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64509676|NCT03826875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509677|NCT03826875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64786034|NCT00000948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786035|NCT00000954|Didanosine|didanosine|mesh-list
64315246|NCT03511118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64315247|NCT03511118|Antimanic Agents|antimanic agents|mesh-ancestor
64315248|NCT03511118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64315249|NCT03511118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64315250|NCT03511118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64315251|NCT03511118|Serotonin Agents|serotonin agents|mesh-ancestor
64315252|NCT03511118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64955509|NCT00203281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64509678|NCT03826875|Serotonin Agents|serotonin agents|mesh-ancestor
64509679|NCT03826875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509680|NCT03826875|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64509681|NCT03826875|Antidepressive Agents|antidepressive agents|mesh-ancestor
64509682|NCT03826875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64509683|NCT03826875|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64422193|NCT04258111|Antibodies|antibodies|mesh-list
64509684|NCT03826875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64509685|NCT03826875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509686|NCT01951066|Dexamethasone|dexamethasone|mesh-list
64509687|NCT01951066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64509688|NCT01951066|Antiemetics|antiemetics|mesh-ancestor
64509689|NCT01951066|Autonomic Agents|autonomic agents|mesh-ancestor
64509690|NCT01951066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509691|NCT01951066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509692|NCT01951066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64509693|NCT01951066|Glucocorticoids|glucocorticoids|mesh-ancestor
64509694|NCT01951066|Hormones|hormones|mesh-ancestor
64509695|NCT01951066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64509696|NCT01951066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64509697|NCT01951066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509698|NCT02916771|Dexamethasone|dexamethasone|mesh-list
64509699|NCT02916771|Lenalidomide|lenalidomide|mesh-list
64509700|NCT02916771|Ixazomib|ixazomib|mesh-list
64509701|NCT02916771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64509702|NCT02916771|Antiemetics|antiemetics|mesh-ancestor
64509703|NCT02916771|Autonomic Agents|autonomic agents|mesh-ancestor
64509704|NCT02916771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509712|NCT02916771|Immunologic Factors|immunologic factors|mesh-ancestor
64509713|NCT02916771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64509714|NCT02916771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64509715|NCT02916771|Growth Substances|growth substances|mesh-ancestor
64509716|NCT02916771|Growth Inhibitors|growth inhibitors|mesh-ancestor
64509717|NCT02916771|Protease Inhibitors|protease inhibitors|mesh-ancestor
64509718|NCT02916771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509719|NCT02916771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509720|NCT05735626|Capsaicin|capsaicin|mesh-list
64509721|NCT05735626|Piperine|piperine|mesh-list
64509722|NCT05735626|Antipruritics|antipruritics|mesh-ancestor
64509723|NCT05735626|Dermatologic Agents|dermatologic agents|mesh-ancestor
64509724|NCT05735626|Sensory System Agents|sensory system agents|mesh-ancestor
64509725|NCT05735626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509726|NCT05735626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509727|NCT05735626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64509729|NCT05735626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509730|NCT01951768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64509731|NCT01951768|Gentamicins|gentamicins|mesh-list
64315264|NCT03511118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64315265|NCT03511118|Diuretics|diuretics|mesh-ancestor
64315266|NCT03511118|Natriuretic Agents|natriuretic agents|mesh-ancestor
64315267|NCT03511118|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64315268|NCT03511118|Antimalarials|antimalarials|mesh-ancestor
64315269|NCT03511118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64315270|NCT03511118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64315271|NCT03511118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64509732|NCT01951768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64509733|NCT01951768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64509734|NCT01951768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955510|NCT00203281|Antitubercular Agents|antitubercular agents|mesh-ancestor
64955511|NCT00203281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64955512|NCT00203281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64955513|NCT00203320|Etanercept|etanercept|mesh-list
64955514|NCT00203320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64955515|NCT00203320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64955516|NCT00203320|Analgesics|analgesics|mesh-ancestor
64955517|NCT00203320|Sensory System Agents|sensory system agents|mesh-ancestor
64955518|NCT00203320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64955519|NCT00203320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955520|NCT00203320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64955521|NCT00203320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64955522|NCT00203320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64955523|NCT00203320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64726927|NCT00003182|Antimetabolites|antimetabolites|mesh-ancestor
64726928|NCT00003182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726929|NCT00003182|Antiviral Agents|antiviral agents|mesh-ancestor
64726930|NCT00003182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726931|NCT00003182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726932|NCT00003182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64726933|NCT00003182|Immunologic Factors|immunologic factors|mesh-ancestor
64334414|NCT02292121|Natriuretic Agents|natriuretic agents|mesh-ancestor
64955524|NCT00203320|Immunologic Factors|immunologic factors|mesh-ancestor
64955525|NCT00038792|Mitogens|mitogens|mesh-list
64509735|NCT01951768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509736|NCT05735470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64955526|NCT00038792|Mitosis Modulators|mitosis modulators|mesh-ancestor
64955527|NCT00038792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509737|NCT05735470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64509738|NCT03825861|Folfirinox|folfirinox|mesh-list
64509739|NCT03825861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509740|NCT01760447|Metformin|metformin|mesh-list
64509741|NCT01760447|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64509742|NCT01760447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64509743|NCT01760447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509744|NCT01760447|Incretins|incretins|mesh-ancestor
64509745|NCT01760447|Hormones|hormones|mesh-ancestor
64509746|NCT01760447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64509747|NCT01760447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64509748|NCT01760447|Protease Inhibitors|protease inhibitors|mesh-ancestor
64509749|NCT01760447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509750|NCT01760447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509751|NCT01915108|Remifentanil|remifentanil|mesh-list
64509752|NCT01915108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64509753|NCT01915108|Narcotics|narcotics|mesh-ancestor
64509754|NCT01915108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64315283|NCT03511118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64315284|NCT03511118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64315285|NCT03511118|Vasodilator Agents|vasodilator agents|mesh-ancestor
64315286|NCT03511118|Tocolytic Agents|tocolytic agents|mesh-ancestor
64315287|NCT03511118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64315288|NCT03511118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64315289|NCT03511118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64315291|NCT03511118|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64509765|NCT03825471|Sensory System Agents|sensory system agents|mesh-ancestor
64509766|NCT03825471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509767|NCT01917136|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64509768|NCT01917136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64509769|NCT01917136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509770|NCT01450215|Lenalidomide|lenalidomide|mesh-list
64509771|NCT01450215|Immunologic Factors|immunologic factors|mesh-ancestor
64509772|NCT01450215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509773|NCT01450215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64509774|NCT01450215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64509775|NCT01450215|Growth Substances|growth substances|mesh-ancestor
64509776|NCT01450215|Growth Inhibitors|growth inhibitors|mesh-ancestor
64509777|NCT01450215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509778|NCT02915523|Avelumab|avelumab|mesh-list
64509779|NCT02915523|Entinostat|entinostat|mesh-list
64509780|NCT02915523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64509781|NCT02915523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509782|NCT02915523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64509783|NCT02915523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509784|NCT02915523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509785|NCT01917214|Sunitinib|sunitinib|mesh-list
64509786|NCT01917214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509787|NCT01917214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64509788|NCT01917214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64509789|NCT01917214|Growth Substances|growth substances|mesh-ancestor
64509790|NCT01917214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509791|NCT01917214|Growth Inhibitors|growth inhibitors|mesh-ancestor
64509792|NCT01917214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64509793|NCT01917214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509794|NCT01917214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509795|NCT01955434|Cyclophosphamide|cyclophosphamide|mesh-list
64509796|NCT01955434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64509797|NCT01955434|Immunologic Factors|immunologic factors|mesh-ancestor
64509798|NCT01955434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726934|NCT00003182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726935|NCT00002587|Paclitaxel|paclitaxel|mesh-list
64726936|NCT00002587|Topotecan|topotecan|mesh-list
64334422|NCT02223611|Tubulin Modulators|tubulin modulators|mesh-ancestor
64509799|NCT01955434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64324684|NCT01379209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64315300|NCT03511118|Adrenergic Agents|adrenergic agents|mesh-ancestor
64315301|NCT03511118|Sympathomimetics|sympathomimetics|mesh-ancestor
64315302|NCT03511118|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64315303|NCT03511118|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64315305|NCT02134457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64315306|NCT02134457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64315307|NCT02134457|Growth Substances|growth substances|mesh-ancestor
64315308|NCT02134457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315309|NCT02134457|Growth Inhibitors|growth inhibitors|mesh-ancestor
64509800|NCT01955434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64509801|NCT01955434|Alkylating Agents|alkylating agents|mesh-ancestor
64509802|NCT01955434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509803|NCT01955434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509804|NCT01955434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64509805|NCT01732913|Rituximab|rituximab|mesh-list
64509806|NCT01732913|Idelalisib|idelalisib|mesh-list
64509807|NCT01732913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64509808|NCT01732913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509809|NCT01732913|Immunologic Factors|immunologic factors|mesh-ancestor
64955528|NCT00203359|Etanercept|etanercept|mesh-list
64422214|NCT05476991|Antipyretics|antipyretics|mesh-ancestor
64509810|NCT01732913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509811|NCT01732913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64509812|NCT01732913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509813|NCT01732913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509814|NCT03824925|Zinc|zinc|mesh-list
64509815|NCT03824925|Zinc Sulfate|zinc sulfate|mesh-list
64509816|NCT03824925|Trace Elements|trace elements|mesh-ancestor
64509817|NCT03824925|Micronutrients|micronutrients|mesh-ancestor
64509818|NCT03824925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509819|NCT03824925|Astringents|astringents|mesh-ancestor
64509822|NCT03825081|Pilocarpine|pilocarpine|mesh-list
64509823|NCT03825081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64509824|NCT03825081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64509825|NCT03825081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64509826|NCT03825081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64509827|NCT03825081|Adrenergic Agents|adrenergic agents|mesh-ancestor
64509828|NCT03825081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64509829|NCT03825081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509830|NCT03825081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509831|NCT03825081|Miotics|miotics|mesh-ancestor
64509832|NCT03825081|Autonomic Agents|autonomic agents|mesh-ancestor
64509833|NCT03825081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64324685|NCT01379209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64324686|NCT01379209|Immunologic Factors|immunologic factors|mesh-ancestor
64324687|NCT01379209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64324688|NCT01379209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64324689|NCT01379209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64786036|NCT00000954|Zalcitabine|zalcitabine|mesh-list
64786037|NCT00000954|Doxorubicin|doxorubicin|mesh-list
64315339|NCT02253095|Micronutrients|micronutrients|mesh-list
64315340|NCT02253095|Trace Elements|trace elements|mesh-list
64315341|NCT02253095|Albendazole|albendazole|mesh-list
64315342|NCT02253095|Anthelmintics|anthelmintics|mesh-ancestor
64315343|NCT02253095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64315344|NCT02253095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64509834|NCT03825081|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64509835|NCT03825081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64509836|NCT03825081|Cholinergic Agents|cholinergic agents|mesh-ancestor
64509837|NCT02912715|Paclitaxel|paclitaxel|mesh-list
64509838|NCT02912715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64509839|NCT02912715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509840|NCT02912715|Tubulin Modulators|tubulin modulators|mesh-ancestor
64509841|NCT02912715|Antimitotic Agents|antimitotic agents|mesh-ancestor
64509842|NCT02912715|Mitosis Modulators|mitosis modulators|mesh-ancestor
64509843|NCT02912715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509844|NCT01920802|Olanzapine|olanzapine|mesh-list
64509845|NCT01920802|Iloperidone|iloperidone|mesh-list
64509846|NCT01920802|Antiemetics|antiemetics|mesh-ancestor
64509847|NCT01920802|Autonomic Agents|autonomic agents|mesh-ancestor
64509848|NCT01920802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509849|NCT01920802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509850|NCT01920802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64509851|NCT01920802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64509852|NCT01920802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64509853|NCT01920802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64509854|NCT01920802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64509855|NCT01920802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64509856|NCT01920802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64509857|NCT01920802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64509858|NCT01920802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509859|NCT01920802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64509860|NCT01920802|Serotonin Agents|serotonin agents|mesh-ancestor
64509862|NCT01451229|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64509863|NCT01451229|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64509864|NCT01451229|Adrenergic Agents|adrenergic agents|mesh-ancestor
64509865|NCT01451229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64509866|NCT01451229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786038|NCT00000954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64786039|NCT00000954|Bleomycin|bleomycin|mesh-list
64786040|NCT00000954|Vincristine|vincristine|mesh-list
64786041|NCT00000954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64786042|NCT00000954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64786043|NCT00000954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64509867|NCT01451229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509868|NCT01451229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64726937|NCT00002587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64726938|NCT00002587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726939|NCT00002587|Tubulin Modulators|tubulin modulators|mesh-ancestor
64726940|NCT00002587|Antimitotic Agents|antimitotic agents|mesh-ancestor
64726941|NCT00002587|Mitosis Modulators|mitosis modulators|mesh-ancestor
64726942|NCT00002587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726943|NCT00002587|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64726944|NCT00002587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64726945|NCT00002587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64726946|NCT00002876|Etoposide|etoposide|mesh-list
64726947|NCT00002876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726948|NCT00002876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64726949|NCT00002876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64726950|NCT00002876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64726951|NCT00002876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509869|NCT01451229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64509870|NCT01451229|Analgesics|analgesics|mesh-ancestor
64509871|NCT01451229|Sensory System Agents|sensory system agents|mesh-ancestor
64509872|NCT01451229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509873|NCT01451229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64955529|NCT00203359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64955530|NCT00203359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64955531|NCT00203359|Analgesics|analgesics|mesh-ancestor
64315399|NCT04791332|Sensory System Agents|sensory system agents|mesh-ancestor
64315400|NCT04791332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315401|NCT05461820|Methimazole|methimazole|mesh-list
64315402|NCT05461820|Antithyroid Agents|antithyroid agents|mesh-ancestor
64315403|NCT05461820|Hormone Antagonists|hormone antagonists|mesh-ancestor
64315404|NCT05461820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64315405|NCT05461820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315406|NCT04791020|Lidocaine|lidocaine|mesh-list
64315407|NCT04791020|Anesthetics, Local|anesthetics, local|mesh-ancestor
64315408|NCT04791020|Anesthetics|anesthetics|mesh-ancestor
64315409|NCT04791020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64315410|NCT04791020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315411|NCT04791020|Sensory System Agents|sensory system agents|mesh-ancestor
64315412|NCT04791020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315413|NCT04791020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64315414|NCT04791020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64315415|NCT04791020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64315416|NCT04791020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64315417|NCT04791020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315418|NCT02531906|Oxycodone|oxycodone|mesh-list
64955532|NCT00203359|Sensory System Agents|sensory system agents|mesh-ancestor
64955533|NCT00203359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64955534|NCT00203359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955535|NCT00203359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64955536|NCT00203359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64955537|NCT00203359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64955538|NCT00203359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64509874|NCT01451229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64509875|NCT01451229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64509876|NCT01451229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64509877|NCT01451229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64509880|NCT03054519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64509881|NCT03054519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509882|NCT01921894|Vitamin D|vitamin d|mesh-list
64509883|NCT01921894|Cholecalciferol|cholecalciferol|mesh-list
64509884|NCT01921894|Vitamins|vitamins|mesh-ancestor
64509885|NCT01921894|Micronutrients|micronutrients|mesh-ancestor
64509894|NCT03824379|Magnesium citrate|magnesium citrate|mesh-list
64509895|NCT03824379|Cathartics|cathartics|mesh-ancestor
64509896|NCT03824379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64509897|NCT03824379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509898|NCT01957930|Insulin|insulin|mesh-list
64509899|NCT01957930|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64509900|NCT01957930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64509901|NCT01957930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509902|NCT01732757|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64509903|NCT01732757|Dextrans|dextrans|mesh-list
64509904|NCT01732757|Alcaftadine|alcaftadine|mesh-list
64509905|NCT01732757|Anticoagulants|anticoagulants|mesh-ancestor
64509906|NCT01732757|Plasma Substitutes|plasma substitutes|mesh-ancestor
64509907|NCT01732757|Blood Substitutes|blood substitutes|mesh-ancestor
64509908|NCT01732757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64509909|NCT01732757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64509910|NCT01732757|Analgesics|analgesics|mesh-ancestor
64509911|NCT01732757|Sensory System Agents|sensory system agents|mesh-ancestor
64509912|NCT01732757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509913|NCT01732757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509914|NCT01732757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64324690|NCT01379209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64315421|NCT02531906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64315422|NCT02531906|Narcotics|narcotics|mesh-ancestor
64315423|NCT02531906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64315424|NCT02531906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315425|NCT02531906|Analgesics|analgesics|mesh-ancestor
64315426|NCT02531906|Sensory System Agents|sensory system agents|mesh-ancestor
64315427|NCT02531906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315428|NCT02531906|Anticonvulsants|anticonvulsants|mesh-ancestor
64315429|NCT02531906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64726952|NCT00002876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726953|NCT00002593|Leucovorin|leucovorin|mesh-list
64726954|NCT00002593|Levamisole|levamisole|mesh-list
64726955|NCT00002593|Fluorouracil|fluorouracil|mesh-list
64726956|NCT00002593|Calcium|calcium|mesh-list
64726957|NCT00002593|Levoleucovorin|levoleucovorin|mesh-list
64726958|NCT00002593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64726959|NCT00002593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726960|NCT00002593|Antimetabolites|antimetabolites|mesh-ancestor
64726961|NCT00002593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334440|NCT02351973|Amiloride|amiloride|mesh-list
64509915|NCT01732757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64509916|NCT01732757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64509917|NCT01732757|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64509918|NCT01732757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64509919|NCT01732757|Histamine Antagonists|histamine antagonists|mesh-ancestor
64509920|NCT01732757|Histamine Agents|histamine agents|mesh-ancestor
64509921|NCT01732757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64509922|NCT01732757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509923|NCT01758731|Cetuximab|cetuximab|mesh-list
64509924|NCT01758731|Olaparib|olaparib|mesh-list
64422220|NCT05476991|Gout Suppressants|gout suppressants|mesh-ancestor
64509925|NCT01758731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64509926|NCT01758731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509927|NCT01758731|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64509928|NCT01758731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509929|NCT01758731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509931|NCT01452477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64509932|NCT01452477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64509933|NCT01452477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64509934|NCT01452477|Analgesics|analgesics|mesh-ancestor
64509935|NCT01452477|Sensory System Agents|sensory system agents|mesh-ancestor
64509936|NCT01452477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509937|NCT01452477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509938|NCT01452477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64509939|NCT01452477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64509940|NCT01452477|Anticoagulants|anticoagulants|mesh-ancestor
64509941|NCT01452477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64509942|NCT01452477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509943|NCT01452477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64509944|NCT01452477|Immunologic Factors|immunologic factors|mesh-ancestor
64509945|NCT01452633|Bupivacaine|bupivacaine|mesh-list
64509946|NCT01452633|Anesthetics, Local|anesthetics, local|mesh-ancestor
64324691|NCT01379209|Antitubercular Agents|antitubercular agents|mesh-ancestor
64324692|NCT01379209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64324693|NCT01379209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324694|NCT01379209|Antifungal Agents|antifungal agents|mesh-ancestor
64786047|NCT00000954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64786048|NCT00000954|Tubulin Modulators|tubulin modulators|mesh-ancestor
64315451|NCT02227940|Gemcitabine|gemcitabine|mesh-list
64509947|NCT01452633|Anesthetics|anesthetics|mesh-ancestor
64509948|NCT01452633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64509949|NCT01452633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955539|NCT00203359|Immunologic Factors|immunologic factors|mesh-ancestor
64509950|NCT01452633|Sensory System Agents|sensory system agents|mesh-ancestor
64509951|NCT01452633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509952|NCT01606319|Acetaminophen|acetaminophen|mesh-list
64509967|NCT01452711|Dexlansoprazole|dexlansoprazole|mesh-list
64509968|NCT01452711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64509969|NCT01452711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64509970|NCT01452711|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64509971|NCT01452711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509972|NCT01452711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509973|NCT02630121|Phenylephrine|phenylephrine|mesh-list
64509974|NCT02630121|Oxymetazoline|oxymetazoline|mesh-list
64509975|NCT02630121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64509976|NCT02630121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64509977|NCT02630121|Adrenergic Agents|adrenergic agents|mesh-ancestor
64509978|NCT02630121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64509979|NCT02630121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509980|NCT02630121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509981|NCT02630121|Sympathomimetics|sympathomimetics|mesh-ancestor
64509982|NCT02630121|Autonomic Agents|autonomic agents|mesh-ancestor
64509983|NCT02630121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509984|NCT02630121|Nasal Decongestants|nasal decongestants|mesh-ancestor
64509985|NCT02630121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64509986|NCT02630121|Respiratory System Agents|respiratory system agents|mesh-ancestor
64509987|NCT02630121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64509989|NCT02630121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64509990|NCT02630121|Protective Agents|protective agents|mesh-ancestor
64509991|NCT02956785|Dinoprostone|dinoprostone|mesh-list
64509992|NCT02956785|Oxytocics|oxytocics|mesh-ancestor
64509993|NCT02956785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64509994|NCT02956785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509995|NCT01452867|Chlorhexidine|chlorhexidine|mesh-list
64509996|NCT01452867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64509997|NCT01452867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64509998|NCT01452867|Disinfectants|disinfectants|mesh-ancestor
64509999|NCT02910531|Thioctic Acid|thioctic acid|mesh-list
64510000|NCT02910531|Antioxidants|antioxidants|mesh-ancestor
64510001|NCT02910531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510002|NCT02910531|Protective Agents|protective agents|mesh-ancestor
64510003|NCT02910531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510004|NCT02910531|Vitamin B Complex|vitamin b complex|mesh-ancestor
64510005|NCT02910531|Vitamins|vitamins|mesh-ancestor
64510006|NCT02910531|Micronutrients|micronutrients|mesh-ancestor
64955547|NCT00410644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64955548|NCT00038831|Fludarabine|fludarabine|mesh-list
64786049|NCT00000954|Antimitotic Agents|antimitotic agents|mesh-ancestor
64786050|NCT00000954|Mitosis Modulators|mitosis modulators|mesh-ancestor
64786051|NCT00000954|Antimetabolites|antimetabolites|mesh-ancestor
64786052|NCT00000954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786053|NCT00000954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64315471|NCT02072486|Sorafenib|sorafenib|mesh-list
64315472|NCT02072486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955549|NCT00038831|Fludarabine phosphate|fludarabine phosphate|mesh-list
64955551|NCT00038831|Gemtuzumab|gemtuzumab|mesh-list
64955552|NCT00038831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64510011|NCT02947581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64510012|NCT02947581|Anticestodal Agents|anticestodal agents|mesh-ancestor
64510013|NCT02947581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64955553|NCT00038831|Thymoglobulin|thymoglobulin|mesh-list
64955554|NCT00038831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64510014|NCT02947581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64510015|NCT02947581|Tubulin Modulators|tubulin modulators|mesh-ancestor
64510016|NCT02947581|Antimitotic Agents|antimitotic agents|mesh-ancestor
64510017|NCT02947581|Mitosis Modulators|mitosis modulators|mesh-ancestor
64510018|NCT02947581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510019|NCT02947581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64510028|NCT05606757|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64510029|NCT05606757|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64510030|NCT05606757|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64510031|NCT05606757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64510032|NCT05606757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510033|NCT05606757|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64510034|NCT05606757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64510035|NCT05606757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510036|NCT05606757|Cholinergic Agents|cholinergic agents|mesh-ancestor
64510037|NCT05606757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64510038|NCT01453881|Beclomethasone|beclomethasone|mesh-list
64726970|NCT00002593|Micronutrients|micronutrients|mesh-ancestor
64726971|NCT00002593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64726972|NCT00002593|Antinematodal Agents|antinematodal agents|mesh-ancestor
64726973|NCT00002593|Anthelmintics|anthelmintics|mesh-ancestor
64726974|NCT00002593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64510039|NCT01453881|Formoterol Fumarate|formoterol fumarate|mesh-list
64510040|NCT01453881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64510041|NCT01453881|Autonomic Agents|autonomic agents|mesh-ancestor
64510042|NCT01453881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64510043|NCT01453881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510044|NCT01453881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64510045|NCT01453881|Respiratory System Agents|respiratory system agents|mesh-ancestor
64510046|NCT01453881|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64315487|NCT05578001|Miotics|miotics|mesh-ancestor
64315488|NCT05578001|Autonomic Agents|autonomic agents|mesh-ancestor
64315489|NCT05578001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315490|NCT05578001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315491|NCT05578001|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64315492|NCT05578001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64315493|NCT05578001|Cholinergic Agents|cholinergic agents|mesh-ancestor
64315494|NCT05578001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64315495|NCT05578001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315496|NCT05577923|Trastuzumab|trastuzumab|mesh-list
64315497|NCT05577923|Fulvestrant|fulvestrant|mesh-list
64510047|NCT01453881|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64510048|NCT01453881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64510049|NCT01453881|Adrenergic Agents|adrenergic agents|mesh-ancestor
64510050|NCT01453881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64510051|NCT01453881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510052|NCT01453881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64510053|NCT01453881|Glucocorticoids|glucocorticoids|mesh-ancestor
64510055|NCT01453881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64510056|NCT04391361|Atropine|atropine|mesh-list
64510057|NCT04391361|Scopolamine|scopolamine|mesh-list
64510058|NCT04391361|Dexmedetomidine|dexmedetomidine|mesh-list
64510059|NCT04391361|Edaravone|edaravone|mesh-list
64510060|NCT04391361|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64510061|NCT04391361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64510062|NCT04391361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64510063|NCT04391361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510072|NCT04391361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64510073|NCT04391361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510074|NCT04391361|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64510075|NCT04391361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64510076|NCT04391361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64510077|NCT04391361|Autonomic Agents|autonomic agents|mesh-ancestor
64510078|NCT04391361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64510079|NCT04391361|Respiratory System Agents|respiratory system agents|mesh-ancestor
64510081|NCT04391361|Parasympatholytics|parasympatholytics|mesh-ancestor
64510082|NCT04391361|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64510083|NCT04391361|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64510084|NCT04391361|Cholinergic Agents|cholinergic agents|mesh-ancestor
64510085|NCT04391361|Antiemetics|antiemetics|mesh-ancestor
64510086|NCT04391361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64510087|NCT04391361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64955555|NCT00038831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64510088|NCT04391361|Antioxidants|antioxidants|mesh-ancestor
64955556|NCT00038831|Antimetabolites|antimetabolites|mesh-ancestor
64510089|NCT04391361|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64510090|NCT04391361|Protective Agents|protective agents|mesh-ancestor
64510091|NCT03035331|Pembrolizumab|pembrolizumab|mesh-list
64510092|NCT03035331|Vaccines|vaccines|mesh-list
64510093|NCT03035331|Immunologic Factors|immunologic factors|mesh-ancestor
64510094|NCT03035331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510095|NCT03035331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64510096|NCT03035331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64510097|NCT04273191|Brexanolone|brexanolone|mesh-list
64510098|NCT04273191|Neurosteroids|neurosteroids|mesh-ancestor
64510099|NCT04273191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64315513|NCT04790708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315514|NCT05615012|Metformin|metformin|mesh-list
64315515|NCT05615012|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64315516|NCT05615012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64315517|NCT05615012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315518|NCT05615012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64315519|NCT05615012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64315520|NCT05615012|Antimetabolites|antimetabolites|mesh-ancestor
64315521|NCT05615012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315522|NCT05615012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64315523|NCT05615012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64315524|NCT05615012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64315525|NCT05614934|Clarithromycin|clarithromycin|mesh-list
64375448|NCT04918719|Antioxidants|antioxidants|mesh-ancestor
64510100|NCT04273191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510101|NCT04273191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510102|NCT04273191|GABA Modulators|gaba modulators|mesh-ancestor
64510103|NCT04273191|GABA Agents|gaba agents|mesh-ancestor
64510104|NCT04391985|Sofosbuvir|sofosbuvir|mesh-list
64510105|NCT04391985|Antiviral Agents|antiviral agents|mesh-ancestor
64510106|NCT04391985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64510107|NCT01455597|Estradiol|estradiol|mesh-list
64510108|NCT01455597|Estrogens|estrogens|mesh-ancestor
64510109|NCT01455597|Hormones|hormones|mesh-ancestor
64510110|NCT01455597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64510111|NCT01455597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726975|NCT00002593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64726976|NCT00002593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64726977|NCT00003194|Cyclophosphamide|cyclophosphamide|mesh-list
64726978|NCT00003194|Thiotepa|thiotepa|mesh-list
64726979|NCT00003194|Carboplatin|carboplatin|mesh-list
64726980|NCT00003194|Etoposide|etoposide|mesh-list
64726981|NCT00003194|Topotecan|topotecan|mesh-list
64726982|NCT00003194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64726983|NCT00003194|Immunologic Factors|immunologic factors|mesh-ancestor
64334457|NCT03520543|Clonidine|clonidine|mesh-list
64510112|NCT01453101|Fludarabine|fludarabine|mesh-list
64510113|NCT01453101|Fludarabine phosphate|fludarabine phosphate|mesh-list
64510114|NCT01453101|Bortezomib|bortezomib|mesh-list
64510115|NCT01453101|Melphalan|melphalan|mesh-list
64510116|NCT01453101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324701|NCT01204099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324702|NCT01204099|Tubulin Modulators|tubulin modulators|mesh-ancestor
64786054|NCT00000954|Antiviral Agents|antiviral agents|mesh-ancestor
64786055|NCT00000954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786056|NCT00000954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786057|NCT00000954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786059|NCT00000960|Antimetabolites|antimetabolites|mesh-ancestor
64786060|NCT00000960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786061|NCT00000960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786062|NCT00000960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786063|NCT00000960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786064|NCT00000960|Antiviral Agents|antiviral agents|mesh-ancestor
64786065|NCT00000960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786066|NCT00000960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786067|NCT00000960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64315526|NCT05614934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64315527|NCT05614934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64315528|NCT05614934|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64315529|NCT05614934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64315530|NCT05614934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315531|NCT05614934|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64510117|NCT01453101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64510118|NCT01453101|Antimetabolites|antimetabolites|mesh-ancestor
64510119|NCT01453101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510120|NCT01453101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64510121|NCT01453101|Immunologic Factors|immunologic factors|mesh-ancestor
64510122|NCT01453101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510123|NCT01453101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64510124|NCT01453101|Alkylating Agents|alkylating agents|mesh-ancestor
64510125|NCT01453101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64510126|NCT02085447|Haloperidol|haloperidol|mesh-list
64510127|NCT02085447|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64510128|NCT02085447|Haloperidol decanoate|haloperidol decanoate|mesh-list
64510129|NCT02085447|Antipsychotic Agents|antipsychotic agents|mesh-list
64510130|NCT02085447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64510134|NCT02085447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64510135|NCT02085447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64510137|NCT02085447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64510138|NCT02085447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510139|NCT02085447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64510140|NCT02085447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64510141|NCT02085447|Dopamine Agents|dopamine agents|mesh-ancestor
64510142|NCT02085447|Antiemetics|antiemetics|mesh-ancestor
64510143|NCT02085447|Autonomic Agents|autonomic agents|mesh-ancestor
64510144|NCT02085447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64510145|NCT02085447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64510146|NCT02085447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64510148|NCT04847193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64510149|NCT04847193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64510150|NCT04847193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64510151|NCT04847193|Growth Substances|growth substances|mesh-ancestor
64510152|NCT04847193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510153|NCT04847193|Growth Inhibitors|growth inhibitors|mesh-ancestor
64510154|NCT04848519|Pembrolizumab|pembrolizumab|mesh-list
64510155|NCT04848519|Propranolol|propranolol|mesh-list
64510156|NCT04848519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64510157|NCT04848519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64510158|NCT04848519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64510159|NCT04848519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64510160|NCT04848519|Adrenergic Agents|adrenergic agents|mesh-ancestor
64786069|NCT00000990|Antimetabolites|antimetabolites|mesh-ancestor
64786070|NCT00000990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786071|NCT00000990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786072|NCT00000990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786073|NCT00000990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786074|NCT00000990|Antiviral Agents|antiviral agents|mesh-ancestor
64786075|NCT00000990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786076|NCT00000990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786077|NCT00000990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64315552|NCT02139761|Dopamine Agents|dopamine agents|mesh-ancestor
64510161|NCT04848519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64510162|NCT04848519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510163|NCT04848519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510164|NCT04848519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64510165|NCT04848519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64510166|NCT04848519|Vasodilator Agents|vasodilator agents|mesh-ancestor
64510167|NCT04273035|Midazolam|midazolam|mesh-list
64510168|NCT04273035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64510169|NCT04273035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64510170|NCT04273035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64510171|NCT04273035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510172|NCT04273035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64510173|NCT04273035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64510174|NCT04273035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64726984|NCT00003194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64726985|NCT00003194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64726986|NCT00003194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64726987|NCT00003194|Alkylating Agents|alkylating agents|mesh-ancestor
64726988|NCT00003194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64726989|NCT00003194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726990|NCT00003194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64726991|NCT00003194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64726992|NCT00003194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64726993|NCT00003194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64726994|NCT00003194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64510175|NCT04273035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64510176|NCT04273035|Anesthetics, General|anesthetics, general|mesh-ancestor
64510177|NCT04273035|Anesthetics|anesthetics|mesh-ancestor
64510178|NCT04273035|GABA Modulators|gaba modulators|mesh-ancestor
64510179|NCT04273035|GABA Agents|gaba agents|mesh-ancestor
64510180|NCT04273035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64510181|NCT04273035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510182|NCT02836899|Nitric Oxide|nitric oxide|mesh-list
64510183|NCT02836899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64510184|NCT02836899|Autonomic Agents|autonomic agents|mesh-ancestor
64510185|NCT02836899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64510186|NCT02836899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510187|NCT02836899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64510188|NCT02836899|Respiratory System Agents|respiratory system agents|mesh-ancestor
64510189|NCT02836899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64510190|NCT02836899|Antioxidants|antioxidants|mesh-ancestor
64510191|NCT02836899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510192|NCT02836899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64510193|NCT02836899|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64315567|NCT05474924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64315568|NCT05474924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315569|NCT05474924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64315570|NCT05474924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315571|NCT05474924|Autonomic Agents|autonomic agents|mesh-ancestor
64315572|NCT05474924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315573|NCT05474924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64315574|NCT05474924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64510194|NCT02836899|Vasodilator Agents|vasodilator agents|mesh-ancestor
64510195|NCT02836899|Gasotransmitters|gasotransmitters|mesh-ancestor
64510196|NCT02836899|Protective Agents|protective agents|mesh-ancestor
64510197|NCT02902029|Atezolizumab|atezolizumab|mesh-list
64510198|NCT02902029|Vemurafenib|vemurafenib|mesh-list
64510199|NCT02902029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64510200|NCT02902029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64510201|NCT02902029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64510205|NCT02933697|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64510206|NCT02933697|Antithrombins|antithrombins|mesh-ancestor
64510207|NCT02933697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64510208|NCT02933697|Protease Inhibitors|protease inhibitors|mesh-ancestor
64510209|NCT02933697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64510210|NCT02933697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510211|NCT02933697|Anticoagulants|anticoagulants|mesh-ancestor
64510212|NCT03859869|Pancrelipase|pancrelipase|mesh-list
64510214|NCT03859869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64510215|NCT01455129|Tiotropium Bromide|tiotropium bromide|mesh-list
64510216|NCT01455129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64510217|NCT01455129|Autonomic Agents|autonomic agents|mesh-ancestor
64510218|NCT01455129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64510219|NCT01455129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510220|NCT01455129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64510221|NCT01455129|Respiratory System Agents|respiratory system agents|mesh-ancestor
64510222|NCT01455129|Parasympatholytics|parasympatholytics|mesh-ancestor
64510223|NCT01455129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64510224|NCT01455129|Cholinergic Agents|cholinergic agents|mesh-ancestor
64510225|NCT01455129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64510226|NCT01455129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510227|NCT02784171|Pembrolizumab|pembrolizumab|mesh-list
64510228|NCT02784171|Pemetrexed|pemetrexed|mesh-list
64510229|NCT02784171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64726995|NCT00003194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64726996|NCT00002882|Interferons|interferons|mesh-list
64726997|NCT00002882|Interferon-alpha|interferon-alpha|mesh-list
64726998|NCT00002882|Interferon alpha-2|interferon alpha-2|mesh-list
64726999|NCT00002882|Aldesleukin|aldesleukin|mesh-list
64727000|NCT00002882|Cisplatin|cisplatin|mesh-list
64727001|NCT00002882|Interleukin-2|interleukin-2|mesh-list
64727002|NCT00002882|Dacarbazine|dacarbazine|mesh-list
64727003|NCT00002882|Vinblastine|vinblastine|mesh-list
64786079|NCT00000996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64786080|NCT00000996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64315586|NCT02135627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315587|NCT02135627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64315588|NCT02135627|Respiratory System Agents|respiratory system agents|mesh-ancestor
64315589|NCT02135627|Mydriatics|mydriatics|mesh-ancestor
64315590|NCT02135627|Sympathomimetics|sympathomimetics|mesh-ancestor
64315591|NCT02135627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64315592|NCT05613140|Valsartan|valsartan|mesh-list
64315598|NCT05613062|Oren gedoku to|oren gedoku to|mesh-list
64727004|NCT00002882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64510230|NCT02784171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64510231|NCT02784171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64510232|NCT02784171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510233|NCT02784171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64510234|NCT02784171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64510235|NCT01455441|Liraglutide|liraglutide|mesh-list
64510236|NCT01455441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64510237|NCT01455441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955557|NCT00038831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510238|NCT01455441|Incretins|incretins|mesh-ancestor
64510239|NCT01455441|Hormones|hormones|mesh-ancestor
64510240|NCT01455441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64510242|NCT01455831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64510243|NCT01455831|Dalteparin|dalteparin|mesh-list
64510244|NCT01455831|Anticoagulants|anticoagulants|mesh-ancestor
64510245|NCT01455831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64510246|NCT01455831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64510247|NCT01455831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510248|NCT04840641|Efavirenz|efavirenz|mesh-list
64510249|NCT04840641|Floxacillin|floxacillin|mesh-list
64510250|NCT04840641|Losartan|losartan|mesh-list
64510251|NCT04840641|Metoprolol|metoprolol|mesh-list
64510252|NCT04840641|Midazolam|midazolam|mesh-list
64510253|NCT04840641|Caffeine|caffeine|mesh-list
64510254|NCT04840641|Omeprazole|omeprazole|mesh-list
64510255|NCT04840641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64510256|NCT04840641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64510257|NCT04840641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64510258|NCT04840641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510259|NCT04840641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64510260|NCT04840641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64510261|NCT04840641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64510262|NCT04840641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64510263|NCT04840641|Anesthetics, General|anesthetics, general|mesh-ancestor
64510265|NCT04840641|GABA Modulators|gaba modulators|mesh-ancestor
64510266|NCT04840641|GABA Agents|gaba agents|mesh-ancestor
64510267|NCT04840641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64552668|NCT01832571|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786081|NCT00000996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64786082|NCT00000996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64786083|NCT00000996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64786084|NCT00000996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786085|NCT00000996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786086|NCT00001044|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64786090|NCT00001044|Antacids|antacids|mesh-ancestor
64510268|NCT04840641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510269|NCT04840641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64510270|NCT04840641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64510271|NCT04840641|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64510272|NCT04840641|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64510273|NCT04840641|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64510274|NCT04840641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64510275|NCT04840641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64510276|NCT04840641|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64510279|NCT04840641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64510280|NCT04840641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64510281|NCT04840641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64510282|NCT04840641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64510283|NCT04840641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64510284|NCT04840641|Antiviral Agents|antiviral agents|mesh-ancestor
64510285|NCT04840641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64510286|NCT04840641|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64510287|NCT04840641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64510288|NCT04840641|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64510289|NCT04840641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64727005|NCT00002882|Antiviral Agents|antiviral agents|mesh-ancestor
64727006|NCT00002882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64727007|NCT00002882|Immunologic Factors|immunologic factors|mesh-ancestor
64727008|NCT00002882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727009|NCT00002882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64727010|NCT00002882|Analgesics|analgesics|mesh-ancestor
64727011|NCT00002882|Sensory System Agents|sensory system agents|mesh-ancestor
64727012|NCT00002882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64727013|NCT00002882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64727014|NCT00002882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64727015|NCT00002882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64727016|NCT00002882|Alkylating Agents|alkylating agents|mesh-ancestor
64727017|NCT00002882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727018|NCT00002882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64510290|NCT04840641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64510291|NCT04840641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64510292|NCT04840641|Sympatholytics|sympatholytics|mesh-ancestor
64510293|NCT04840641|Autonomic Agents|autonomic agents|mesh-ancestor
64510294|NCT04840641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64510295|NCT04840641|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64510296|NCT04840641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64510297|NCT04840641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64510298|NCT04840641|Adrenergic Agents|adrenergic agents|mesh-ancestor
64510299|NCT04840641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64510300|NCT01455909|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64510301|NCT01455909|Exenatide|exenatide|mesh-list
64510302|NCT01455909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64510303|NCT01455909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510304|NCT01455909|Incretins|incretins|mesh-ancestor
64510305|NCT01455909|Hormones|hormones|mesh-ancestor
64510306|NCT01455909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64510307|NCT01455909|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64510308|NCT01455909|Protease Inhibitors|protease inhibitors|mesh-ancestor
64510309|NCT01455909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64510310|NCT01455909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510311|NCT01455909|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64510312|NCT04844619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64315632|NCT02140073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315633|NCT02140073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315635|NCT02140073|Dopamine Agents|dopamine agents|mesh-ancestor
64375559|NCT02157298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375560|NCT02157298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64375586|NCT04903275|Fluorides|fluorides|mesh-list
64510313|NCT04844619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64510315|NCT02555787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64510316|NCT02555787|Immunologic Factors|immunologic factors|mesh-ancestor
64510317|NCT02555787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510318|NCT02555787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64510319|NCT02555787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422263|NCT02301975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64510320|NCT02555787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510322|NCT01730729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64510323|NCT01730729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64510324|NCT01730729|Dopamine Agonists|dopamine agonists|mesh-ancestor
64510325|NCT01730729|Dopamine Agents|dopamine agents|mesh-ancestor
64510326|NCT01730729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64510327|NCT01730729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510328|NCT01730729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510329|NCT01756157|Complement C1s|complement c1s|mesh-list
64510330|NCT01756157|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64510331|NCT01756157|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
64510332|NCT01756157|Immunologic Factors|immunologic factors|mesh-ancestor
64510333|NCT01756157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510334|NCT01756157|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64727019|NCT00002882|Tubulin Modulators|tubulin modulators|mesh-ancestor
64727020|NCT00002882|Antimitotic Agents|antimitotic agents|mesh-ancestor
64727021|NCT00002882|Mitosis Modulators|mitosis modulators|mesh-ancestor
64727022|NCT00002888|Paclitaxel|paclitaxel|mesh-list
64727023|NCT00002888|Fluorouracil|fluorouracil|mesh-list
64727024|NCT00002888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64727025|NCT00002888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64510335|NCT01756157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64510336|NCT04846491|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64510337|NCT04846491|Interferon-alpha|interferon-alpha|mesh-list
64510338|NCT04846491|Antiviral Agents|antiviral agents|mesh-ancestor
64510339|NCT04846491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64510340|NCT04846491|Immunologic Factors|immunologic factors|mesh-ancestor
64510341|NCT04846491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510342|NCT01756079|Ribavirin|ribavirin|mesh-list
64510343|NCT01756079|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64510344|NCT01756079|Antimetabolites|antimetabolites|mesh-ancestor
64510345|NCT01756079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510346|NCT01756079|Antiviral Agents|antiviral agents|mesh-ancestor
64510347|NCT01756079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64510348|NCT04272645|Atezolizumab|atezolizumab|mesh-list
64510370|NCT01456689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510371|NCT01456689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64510372|NCT01456689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64315636|NCT02140073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64315637|NCT05474690|Cyclophosphamide|cyclophosphamide|mesh-list
64315638|NCT05474690|Carboplatin|carboplatin|mesh-list
64315639|NCT05474690|Docetaxel|docetaxel|mesh-list
64315640|NCT05474690|Trastuzumab|trastuzumab|mesh-list
64315641|NCT05474690|Epirubicin|epirubicin|mesh-list
64315642|NCT05474690|Pertuzumab|pertuzumab|mesh-list
64315643|NCT05474690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64315644|NCT05474690|Immunologic Factors|immunologic factors|mesh-ancestor
64315645|NCT05474690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510373|NCT01456689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64510374|NCT01456689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64510375|NCT01456689|Anesthetics, General|anesthetics, general|mesh-ancestor
64510376|NCT01456689|Anesthetics|anesthetics|mesh-ancestor
64510377|NCT01456689|GABA Modulators|gaba modulators|mesh-ancestor
64510378|NCT01456689|GABA Agents|gaba agents|mesh-ancestor
64510379|NCT01456689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64510380|NCT01456689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510381|NCT05827211|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64510382|NCT05827211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64510383|NCT05827211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64510384|NCT05827211|Antitubercular Agents|antitubercular agents|mesh-ancestor
64510385|NCT05827159|Naltrexone|naltrexone|mesh-list
64510386|NCT05827159|Gabapentin|gabapentin|mesh-list
64510387|NCT05827159|Analgesics|analgesics|mesh-ancestor
64510388|NCT05827159|Sensory System Agents|sensory system agents|mesh-ancestor
64955558|NCT00038831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64510389|NCT05827159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64510390|NCT05827159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510391|NCT05827159|Anticonvulsants|anticonvulsants|mesh-ancestor
64510392|NCT05827159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64510393|NCT05827159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64510394|NCT05827159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64510395|NCT05827159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64510396|NCT05827159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64510397|NCT05827159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64510398|NCT05827159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64510399|NCT05827159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510400|NCT05827159|Antimanic Agents|antimanic agents|mesh-ancestor
64510401|NCT05827159|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64510444|NCT05827042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510445|NCT05827016|Lenalidomide|lenalidomide|mesh-list
64510446|NCT05827016|Immunologic Factors|immunologic factors|mesh-ancestor
64510447|NCT05827016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510448|NCT05827016|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64510449|NCT05827016|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64510450|NCT05827016|Growth Substances|growth substances|mesh-ancestor
64510451|NCT05827016|Growth Inhibitors|growth inhibitors|mesh-ancestor
64510452|NCT05827016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64510453|NCT05826990|Cefepime|cefepime|mesh-list
64510454|NCT05826990|Enmetazobactam|enmetazobactam|mesh-list
64510455|NCT05826990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64510456|NCT05826990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64510457|NCT05826990|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64510458|NCT05826990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64510459|NCT05826990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727026|NCT00002888|Tubulin Modulators|tubulin modulators|mesh-ancestor
64727027|NCT00002888|Antimitotic Agents|antimitotic agents|mesh-ancestor
64727028|NCT00002888|Mitosis Modulators|mitosis modulators|mesh-ancestor
64727029|NCT00002888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727030|NCT00002888|Antimetabolites|antimetabolites|mesh-ancestor
64334508|NCT00503035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64510460|NCT05826964|Tamoxifen|tamoxifen|mesh-list
64510461|NCT05826964|Sirolimus|sirolimus|mesh-list
64510462|NCT05826964|Capecitabine|capecitabine|mesh-list
64510463|NCT05826964|Everolimus|everolimus|mesh-list
64955559|NCT00038831|Immunologic Factors|immunologic factors|mesh-ancestor
64955560|NCT00038831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510464|NCT05826964|Letrozole|letrozole|mesh-list
64510466|NCT05826964|Fulvestrant|fulvestrant|mesh-list
64510467|NCT05826964|Palbociclib|palbociclib|mesh-list
64510468|NCT05826964|Anastrozole|anastrozole|mesh-list
64324703|NCT01204099|Antimitotic Agents|antimitotic agents|mesh-ancestor
64324704|NCT01204099|Mitosis Modulators|mitosis modulators|mesh-ancestor
64315657|NCT05474690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64315658|NCT05474690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64315659|NCT05474690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64315660|NCT05575973|Rituximab|rituximab|mesh-list
64375603|NCT02121262|Antiemetics|antiemetics|mesh-ancestor
64510469|NCT05826964|Exemestane|exemestane|mesh-list
64510470|NCT05826964|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64510471|NCT05826964|Elafin|elafin|mesh-list
64510472|NCT05826964|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-list
64510473|NCT05826964|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
64510474|NCT05826964|Estrogens|estrogens|mesh-list
64510475|NCT05826964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64510476|NCT05826964|Antimetabolites|antimetabolites|mesh-ancestor
64510491|NCT05826964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64510492|NCT05826964|Tubulin Modulators|tubulin modulators|mesh-ancestor
64510493|NCT05826964|Antimitotic Agents|antimitotic agents|mesh-ancestor
64510494|NCT05826964|Mitosis Modulators|mitosis modulators|mesh-ancestor
64510495|NCT05826964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64510496|NCT05826964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64510497|NCT05826964|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64510498|NCT05826964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64510499|NCT05826964|Hormones|hormones|mesh-ancestor
64510500|NCT05826964|Protease Inhibitors|protease inhibitors|mesh-ancestor
64510501|NCT05826912|Minocycline|minocycline|mesh-list
64510502|NCT05826912|Candesartan|candesartan|mesh-list
64510503|NCT05826912|Candesartan cilexetil|candesartan cilexetil|mesh-list
64510504|NCT05826912|Atorvastatin|atorvastatin|mesh-list
64510505|NCT05826912|Calcium|calcium|mesh-list
64510506|NCT05826912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64510507|NCT05826912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510508|NCT05826912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64510509|NCT05826912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64510510|NCT05826912|Antimetabolites|antimetabolites|mesh-ancestor
64510511|NCT05826912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510512|NCT05826912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64510513|NCT05826912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64510514|NCT05826912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64510515|NCT05826912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64510516|NCT05826912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64510517|NCT05826912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64510518|NCT05826912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64510519|NCT05826912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64510520|NCT05826873|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64510521|NCT05826873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64510522|NCT05826821|Pirfenidone|pirfenidone|mesh-list
64510523|NCT05826821|Analgesics|analgesics|mesh-ancestor
64510524|NCT05826821|Sensory System Agents|sensory system agents|mesh-ancestor
64510525|NCT05826821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64510526|NCT05826821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510527|NCT05826821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64510528|NCT05826821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64510529|NCT05826821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64510530|NCT05826821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64510531|NCT05826821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955561|NCT00038831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64955562|NCT00038831|Alkylating Agents|alkylating agents|mesh-ancestor
64955563|NCT00038831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64510537|NCT05826574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324705|NCT01204099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324706|NCT02853500|Doxorubicin|doxorubicin|mesh-list
64315661|NCT05575973|Lenalidomide|lenalidomide|mesh-list
64315662|NCT05575973|Mitoxantrone|mitoxantrone|mesh-list
64315663|NCT05575973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64315664|NCT05575973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315665|NCT05575973|Immunologic Factors|immunologic factors|mesh-ancestor
64315666|NCT05575973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315667|NCT05575973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64315668|NCT05575973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64727031|NCT00002888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64727032|NCT00002888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727033|NCT00002888|Immunologic Factors|immunologic factors|mesh-ancestor
64727034|NCT00002888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510538|NCT05826574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510539|NCT05826574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64510540|NCT05826574|Antitubercular Agents|antitubercular agents|mesh-ancestor
64510541|NCT05826574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64510542|NCT05826574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64510543|NCT05826574|Leprostatic Agents|leprostatic agents|mesh-ancestor
64510544|NCT05826574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64510545|NCT05826574|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64510546|NCT05826574|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64510547|NCT05826574|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64510548|NCT05826574|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64510549|NCT05826574|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64510550|NCT05826574|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64510551|NCT05826444|Calcium|calcium|mesh-list
64510552|NCT05826444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64510553|NCT05826444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510554|NCT05826327|Sufentanil|sufentanil|mesh-list
64510555|NCT05826327|Esketamine|esketamine|mesh-list
64510556|NCT05826327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64510557|NCT05826327|Narcotics|narcotics|mesh-ancestor
64510574|NCT05826249|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64510575|NCT05826249|Protease Inhibitors|protease inhibitors|mesh-ancestor
64510576|NCT05826249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64510577|NCT05826249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510578|NCT05826249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64510579|NCT05826249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64510580|NCT05826249|Antiviral Agents|antiviral agents|mesh-ancestor
64510581|NCT05826249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64510582|NCT05826249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64510583|NCT05826249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64510599|NCT05826015|Paclitaxel|paclitaxel|mesh-list
64510600|NCT05826015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64510601|NCT05826015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64510602|NCT05826015|Tubulin Modulators|tubulin modulators|mesh-ancestor
64510603|NCT05826015|Antimitotic Agents|antimitotic agents|mesh-ancestor
64510604|NCT05826015|Mitosis Modulators|mitosis modulators|mesh-ancestor
64510605|NCT05826015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510606|NCT05825963|Psyllium|psyllium|mesh-list
64510607|NCT05825963|Cathartics|cathartics|mesh-ancestor
64510608|NCT05825963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64510609|NCT05825924|Nicotine|nicotine|mesh-list
64510610|NCT05825924|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64510611|NCT05825924|Autonomic Agents|autonomic agents|mesh-ancestor
64510612|NCT05825924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64786091|NCT00001044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786093|NCT00001062|Ganciclovir|ganciclovir|mesh-list
64786094|NCT00001062|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64786095|NCT00001062|Antiviral Agents|antiviral agents|mesh-ancestor
64786096|NCT00001062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786097|NCT00001062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786098|NCT00001062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786099|NCT00001062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786100|NCT00001068|Lamivudine|lamivudine|mesh-list
64786101|NCT00001068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64375644|NCT04902027|Mitoxantrone|mitoxantrone|mesh-list
64510613|NCT05825924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510614|NCT05825924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64510615|NCT05825924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64510616|NCT05825924|Cholinergic Agents|cholinergic agents|mesh-ancestor
64510617|NCT05825924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64510618|NCT05825924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510619|NCT05825872|Lidocaine|lidocaine|mesh-list
64510620|NCT05825872|Bupivacaine|bupivacaine|mesh-list
64510621|NCT05825872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64510622|NCT05825872|Anesthetics, Local|anesthetics, local|mesh-ancestor
64510623|NCT05825872|Anesthetics|anesthetics|mesh-ancestor
64510624|NCT05825872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64510625|NCT05825872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510626|NCT05825872|Sensory System Agents|sensory system agents|mesh-ancestor
64510627|NCT05825872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64510628|NCT05825872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64510629|NCT05825872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64510630|NCT05825872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64510631|NCT05825872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64955567|NCT00071955|Antibodies|antibodies|mesh-list
64510668|NCT05825430|Anesthetics, General|anesthetics, general|mesh-list
64510669|NCT05825430|Anesthetics, Local|anesthetics, local|mesh-ancestor
64727037|NCT00002599|Interferon-alpha|interferon-alpha|mesh-list
64727038|NCT00002599|Prednisone|prednisone|mesh-list
64727039|NCT00002599|Methylprednisolone|methylprednisolone|mesh-list
64727040|NCT00002599|Cyclophosphamide|cyclophosphamide|mesh-list
64727041|NCT00002599|Melphalan|melphalan|mesh-list
64727042|NCT00002599|Carmustine|carmustine|mesh-list
64727043|NCT00002599|Doxorubicin|doxorubicin|mesh-list
64727044|NCT00002599|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64510670|NCT05825430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64510671|NCT05825430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510672|NCT05825430|Sensory System Agents|sensory system agents|mesh-ancestor
64510673|NCT05825430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64510675|NCT05825417|Riociguat|riociguat|mesh-list
64315669|NCT05575973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64315670|NCT05575973|Growth Substances|growth substances|mesh-ancestor
64315671|NCT05575973|Growth Inhibitors|growth inhibitors|mesh-ancestor
64315672|NCT05575973|Analgesics|analgesics|mesh-ancestor
64315673|NCT05575973|Sensory System Agents|sensory system agents|mesh-ancestor
64315674|NCT05575973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315675|NCT05575973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64315676|NCT05575973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64315677|NCT05575973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64315678|NCT05575973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315679|NCT03547895|Vitamin K|vitamin k|mesh-list
64315680|NCT03547895|Vitamin K 1|vitamin k 1|mesh-list
64315681|NCT03547895|Ribavirin|ribavirin|mesh-list
64510676|NCT05825417|Enzyme Activators|enzyme activators|mesh-ancestor
64510677|NCT05825417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510678|NCT05825417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64510679|NCT05825391|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64510680|NCT05825378|Dexamethasone|dexamethasone|mesh-list
64510681|NCT05825378|Ropivacaine|ropivacaine|mesh-list
64510682|NCT05825378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64510683|NCT05825378|Antiemetics|antiemetics|mesh-ancestor
64510684|NCT05825378|Autonomic Agents|autonomic agents|mesh-ancestor
64510685|NCT05825378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64510686|NCT05825378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510687|NCT05825378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64510688|NCT05825378|Glucocorticoids|glucocorticoids|mesh-ancestor
64510689|NCT05825378|Hormones|hormones|mesh-ancestor
64510690|NCT05825378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64510691|NCT05825378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64510692|NCT05825378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64510693|NCT05825378|Anesthetics, Local|anesthetics, local|mesh-ancestor
64510694|NCT05825378|Anesthetics|anesthetics|mesh-ancestor
64510695|NCT05825378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64510696|NCT05825378|Sensory System Agents|sensory system agents|mesh-ancestor
64510697|NCT05825352|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64510698|NCT05825352|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64510699|NCT05825235|Pramipexole|pramipexole|mesh-list
64510700|NCT05825235|Antioxidants|antioxidants|mesh-ancestor
64510701|NCT05825235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510702|NCT05825235|Protective Agents|protective agents|mesh-ancestor
64510703|NCT05825235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510704|NCT05825235|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64510705|NCT05825235|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64510706|NCT05825235|Dopamine Agonists|dopamine agonists|mesh-ancestor
64510707|NCT05825235|Dopamine Agents|dopamine agents|mesh-ancestor
64510708|NCT05825235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64510709|NCT05825092|Methyltestosterone|methyltestosterone|mesh-list
64510710|NCT05825092|Testosterone|testosterone|mesh-list
64510711|NCT05825092|Testosterone undecanoate|testosterone undecanoate|mesh-list
64510712|NCT05825092|Testosterone enanthate|testosterone enanthate|mesh-list
64510713|NCT05825092|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64510714|NCT05825092|Androgens|androgens|mesh-ancestor
64510715|NCT05825092|Hormones|hormones|mesh-ancestor
64510716|NCT05825092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64422307|NCT02300103|Velpatasvir|velpatasvir|mesh-list
64510718|NCT05825092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64510719|NCT05825092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64510720|NCT05825092|Anabolic Agents|anabolic agents|mesh-ancestor
64510721|NCT05825066|Gemcitabine|gemcitabine|mesh-list
64510722|NCT05825066|Paclitaxel|paclitaxel|mesh-list
64510723|NCT05825066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64510724|NCT05825066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64510740|NCT05824897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510741|NCT05824897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64510742|NCT05824871|Bedaquiline|bedaquiline|mesh-list
64510743|NCT05824871|Antitubercular Agents|antitubercular agents|mesh-ancestor
64955569|NCT00071955|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
64510744|NCT05824871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64727046|NCT00002599|Sargramostim|sargramostim|mesh-list
64727047|NCT00002599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64315703|NCT03547895|Hemostatics|hemostatics|mesh-ancestor
64315704|NCT03547895|Coagulants|coagulants|mesh-ancestor
64315705|NCT03547895|Antioxidants|antioxidants|mesh-ancestor
64315706|NCT03547895|Protective Agents|protective agents|mesh-ancestor
64315707|NCT01359254|Fludarabine|fludarabine|mesh-list
64315708|NCT01359254|Fludarabine phosphate|fludarabine phosphate|mesh-list
64315709|NCT01359254|Melphalan|melphalan|mesh-list
64315710|NCT01359254|Busulfan|busulfan|mesh-list
64315711|NCT01359254|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64375703|NCT04900311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727048|NCT00002599|Immunologic Factors|immunologic factors|mesh-ancestor
64727049|NCT00002599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727050|NCT00002599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64727051|NCT00002599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64727052|NCT00002599|Alkylating Agents|alkylating agents|mesh-ancestor
64727053|NCT00002599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727054|NCT00002599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727055|NCT00002599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64510745|NCT05824871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64510746|NCT05824832|Dexamethasone|dexamethasone|mesh-list
64510747|NCT05824832|Dexamethasone acetate|dexamethasone acetate|mesh-list
64510748|NCT05824832|Clonidine|clonidine|mesh-list
64510749|NCT05824832|Buprenorphine|buprenorphine|mesh-list
64510750|NCT05824832|BB 1101|bb 1101|mesh-list
64510751|NCT05824832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64510752|NCT05824832|Antiemetics|antiemetics|mesh-ancestor
64510753|NCT05824832|Autonomic Agents|autonomic agents|mesh-ancestor
64510754|NCT05824832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64510755|NCT05824832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510756|NCT05824832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64510757|NCT05824832|Glucocorticoids|glucocorticoids|mesh-ancestor
64510758|NCT05824832|Hormones|hormones|mesh-ancestor
64510759|NCT05824832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64510760|NCT05824832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64510761|NCT05824832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64510762|NCT05824832|Protease Inhibitors|protease inhibitors|mesh-ancestor
64510763|NCT05824832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64510764|NCT05824832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510765|NCT05824832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64510766|NCT05824832|Narcotics|narcotics|mesh-ancestor
64510767|NCT05824832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64510768|NCT05824832|Analgesics|analgesics|mesh-ancestor
64510769|NCT05824832|Sensory System Agents|sensory system agents|mesh-ancestor
64510770|NCT05824832|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64510771|NCT05824832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64510772|NCT05824832|Sympatholytics|sympatholytics|mesh-ancestor
64510773|NCT05824832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64510774|NCT05824832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64510775|NCT05824832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64510776|NCT05824832|Adrenergic Agents|adrenergic agents|mesh-ancestor
64510777|NCT05824832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64510778|NCT05824806|Hyaluronic Acid|hyaluronic acid|mesh-list
64510779|NCT05824806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64510780|NCT05824806|Immunologic Factors|immunologic factors|mesh-ancestor
64510781|NCT05824806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510782|NCT05824806|Viscosupplements|viscosupplements|mesh-ancestor
64510783|NCT05824806|Protective Agents|protective agents|mesh-ancestor
64510788|NCT05824767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64510790|NCT05824767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64510791|NCT05824767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510792|NCT05824728|Levetiracetam|levetiracetam|mesh-list
64510793|NCT05824728|Anticonvulsants|anticonvulsants|mesh-ancestor
64510794|NCT05824728|Nootropic Agents|nootropic agents|mesh-ancestor
64510795|NCT05823896|Ritonavir|ritonavir|mesh-list
64510796|NCT05823896|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64510797|NCT05823896|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64510798|NCT05823896|Protease Inhibitors|protease inhibitors|mesh-ancestor
64510799|NCT05823896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64510800|NCT05823896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510801|NCT05823896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64315712|NCT01359254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315713|NCT01359254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64315714|NCT01359254|Antimetabolites|antimetabolites|mesh-ancestor
64315715|NCT01359254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315716|NCT01359254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64315718|NCT01359254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510802|NCT05823896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64510803|NCT05823896|Antiviral Agents|antiviral agents|mesh-ancestor
64727056|NCT00002599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64727057|NCT00002599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64727058|NCT00002599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64727059|NCT00002599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727060|NCT00002599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64727061|NCT00002599|Glucocorticoids|glucocorticoids|mesh-ancestor
64727062|NCT00002599|Hormones|hormones|mesh-ancestor
64727063|NCT00002599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64727064|NCT00002599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64727065|NCT00002599|Antiviral Agents|antiviral agents|mesh-ancestor
64727066|NCT00002599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64727067|NCT00002599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64727068|NCT00002599|Tubulin Modulators|tubulin modulators|mesh-ancestor
64727069|NCT00002599|Antimitotic Agents|antimitotic agents|mesh-ancestor
64727070|NCT00002599|Mitosis Modulators|mitosis modulators|mesh-ancestor
64727071|NCT00002599|Antiemetics|antiemetics|mesh-ancestor
64727072|NCT00002599|Autonomic Agents|autonomic agents|mesh-ancestor
64727073|NCT00002599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64727074|NCT00002599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64510804|NCT05823896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64510805|NCT05823896|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64510806|NCT05823896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64510807|NCT05823844|Suvorexant|suvorexant|mesh-list
64510808|NCT05823844|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64510809|NCT05823844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64510810|NCT05823844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64510811|NCT05823844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510812|NCT05823844|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64510813|NCT05823844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64510814|NCT05823844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955570|NCT00071955|Immunologic Factors|immunologic factors|mesh-ancestor
64510815|NCT05823753|Cannabidiol|cannabidiol|mesh-list
64510816|NCT05823753|Anticonvulsants|anticonvulsants|mesh-ancestor
64510817|NCT05823662|Silodosin|silodosin|mesh-list
64510823|NCT05823662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510824|NCT05823662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510825|NCT05823662|Urological Agents|urological agents|mesh-ancestor
64510827|NCT05823363|Anesthetics, Local|anesthetics, local|mesh-ancestor
64510828|NCT05823363|Anesthetics|anesthetics|mesh-ancestor
64510829|NCT05823363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64510830|NCT05823363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510832|NCT05823363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64510839|NCT05822076|Ropivacaine|ropivacaine|mesh-list
64510840|NCT05822076|Anesthetics, Local|anesthetics, local|mesh-ancestor
64510841|NCT05822076|Anesthetics|anesthetics|mesh-ancestor
64510842|NCT05822076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64510843|NCT05822076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510844|NCT05822076|Sensory System Agents|sensory system agents|mesh-ancestor
64510845|NCT05822076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64510846|NCT05821543|Metformin|metformin|mesh-list
64510847|NCT05821543|Sibutramine|sibutramine|mesh-list
64510848|NCT05821543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64510849|NCT05821543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510850|NCT05821543|Antidepressive Agents|antidepressive agents|mesh-ancestor
64786105|NCT00001068|Antiviral Agents|antiviral agents|mesh-ancestor
64510851|NCT05821543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64510852|NCT05821543|Appetite Depressants|appetite depressants|mesh-ancestor
64727075|NCT00002599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64727076|NCT00002599|Protective Agents|protective agents|mesh-ancestor
64727078|NCT00002599|Micronutrients|micronutrients|mesh-ancestor
64727079|NCT00003440|Paclitaxel|paclitaxel|mesh-list
64727081|NCT00003440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64727082|NCT00003440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64510854|NCT05811949|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64510855|NCT05811949|Dermatologic Agents|dermatologic agents|mesh-ancestor
64510856|NCT05811949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64510857|NCT05811949|Immunologic Factors|immunologic factors|mesh-ancestor
64510858|NCT05811949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510859|NCT05810233|Ascorbic Acid|ascorbic acid|mesh-list
64510860|NCT05810233|Vitamins|vitamins|mesh-ancestor
64510870|NCT05800639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64510871|NCT05800639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510891|NCT05791565|Norflurane|norflurane|mesh-list
64510892|NCT05791565|Albuterol|albuterol|mesh-list
64510893|NCT05791565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64510894|NCT05791565|Autonomic Agents|autonomic agents|mesh-ancestor
64510895|NCT05791565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64510896|NCT05791565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510897|NCT05791565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64510902|NCT05791565|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64510903|NCT05791565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64510904|NCT05791565|Adrenergic Agents|adrenergic agents|mesh-ancestor
64510905|NCT05791565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64510906|NCT05791565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510907|NCT05791565|Anesthetics|anesthetics|mesh-ancestor
64510908|NCT05791565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64510909|NCT05781217|Goserelin|goserelin|mesh-list
64510910|NCT05781217|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64510911|NCT05781217|Leuprolide|leuprolide|mesh-list
64510912|NCT05781217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64510913|NCT05781217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64510914|NCT05781217|Luteolytic Agents|luteolytic agents|mesh-ancestor
64510915|NCT05781217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64510916|NCT05781217|Contraceptive Agents|contraceptive agents|mesh-ancestor
64510917|NCT05781217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64510918|NCT05781217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955571|NCT00071955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510919|NCT05781217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64510963|NCT05752461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510964|NCT05750992|Fentanyl|fentanyl|mesh-list
64510965|NCT05750992|Meperidine|meperidine|mesh-list
64510966|NCT05750992|Bupivacaine|bupivacaine|mesh-list
64510967|NCT05750992|Anesthetics, Local|anesthetics, local|mesh-ancestor
64510968|NCT05750992|Anesthetics|anesthetics|mesh-ancestor
64510969|NCT05750992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64510970|NCT05750992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510971|NCT05750992|Sensory System Agents|sensory system agents|mesh-ancestor
64510972|NCT05750992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64510973|NCT05750992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64510974|NCT05750992|Narcotics|narcotics|mesh-ancestor
64510975|NCT05750992|Analgesics|analgesics|mesh-ancestor
64510976|NCT05750992|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64510977|NCT05750992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64510978|NCT05750992|Anesthetics, General|anesthetics, general|mesh-ancestor
64510979|NCT05733546|Psilocybin|psilocybin|mesh-list
64510980|NCT05733546|Hallucinogens|hallucinogens|mesh-ancestor
64510981|NCT05733546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510982|NCT05733546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64510983|NCT05724550|Neostigmine|neostigmine|mesh-list
64510984|NCT05724550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64510985|NCT05724550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422323|NCT02366091|Antimetabolites|antimetabolites|mesh-ancestor
64510986|NCT05724550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727083|NCT00003440|Tubulin Modulators|tubulin modulators|mesh-ancestor
64727084|NCT00003440|Antimitotic Agents|antimitotic agents|mesh-ancestor
64727085|NCT00003440|Mitosis Modulators|mitosis modulators|mesh-ancestor
64727086|NCT00003440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727087|NCT00003440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64727088|NCT00003200|Docetaxel|docetaxel|mesh-list
64510987|NCT05724550|Cholinergic Agents|cholinergic agents|mesh-ancestor
64510988|NCT05724550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64510989|NCT05724550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510990|NCT05724550|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64510991|NCT05724550|Autonomic Agents|autonomic agents|mesh-ancestor
64510992|NCT05724550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64511015|NCT05711940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511016|NCT05711940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64511034|NCT05676112|Pirfenidone|pirfenidone|mesh-list
64511035|NCT05676112|Nintedanib|nintedanib|mesh-list
64511036|NCT05676112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511037|NCT05676112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64511038|NCT05676112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64511039|NCT05676112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511040|NCT05676112|Analgesics|analgesics|mesh-ancestor
64511041|NCT05676112|Sensory System Agents|sensory system agents|mesh-ancestor
64955573|NCT00203554|Vasodilator Agents|vasodilator agents|mesh-ancestor
64511042|NCT05676112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64511043|NCT05676112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511044|NCT05676112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64511045|NCT05676112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64511046|NCT05676112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64511047|NCT05676112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64511073|NCT05665088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511075|NCT05664737|Hematinics|hematinics|mesh-ancestor
64511076|NCT05662319|Antithrombins|antithrombins|mesh-list
64511077|NCT05662319|Antithrombin III|antithrombin iii|mesh-list
64511078|NCT05662319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64511079|NCT05662319|Protease Inhibitors|protease inhibitors|mesh-ancestor
64511080|NCT05662319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64511081|NCT05662319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511082|NCT05662319|Anticoagulants|anticoagulants|mesh-ancestor
64511099|NCT05659329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64511100|NCT05659329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64511101|NCT05659329|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64511102|NCT05659329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64511103|NCT05659329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511104|NCT05653258|Dasatinib|dasatinib|mesh-list
64511105|NCT05653258|Quercetin|quercetin|mesh-list
64511106|NCT05653258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511107|NCT05653258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64511108|NCT05653258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64511109|NCT05653258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786119|NCT00001080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324707|NCT02853500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64315740|NCT05035862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64315741|NCT05035862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64315742|NCT05035862|Autonomic Agents|autonomic agents|mesh-ancestor
64315746|NCT05035862|Tocolytic Agents|tocolytic agents|mesh-ancestor
64511110|NCT05653258|Antioxidants|antioxidants|mesh-ancestor
64511111|NCT05653258|Protective Agents|protective agents|mesh-ancestor
64511112|NCT05653258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511125|NCT05647551|Lidocaine|lidocaine|mesh-list
64511126|NCT05647551|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64511127|NCT05647551|Anesthetics, Local|anesthetics, local|mesh-ancestor
64511128|NCT05647551|Anesthetics|anesthetics|mesh-ancestor
64511129|NCT05647551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64511130|NCT05647551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511131|NCT05647551|Sensory System Agents|sensory system agents|mesh-ancestor
64511132|NCT05647551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64511133|NCT05647551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64511134|NCT05647551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64511135|NCT05647551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64511136|NCT05647551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64422352|NCT02546765|Propofol|propofol|mesh-list
64727089|NCT00003200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727090|NCT00003200|Tubulin Modulators|tubulin modulators|mesh-ancestor
64727091|NCT00003200|Antimitotic Agents|antimitotic agents|mesh-ancestor
64727092|NCT00003200|Mitosis Modulators|mitosis modulators|mesh-ancestor
64727093|NCT00003200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727094|NCT00003206|Paclitaxel|paclitaxel|mesh-list
64727095|NCT00003206|Carboplatin|carboplatin|mesh-list
64727096|NCT00003206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64511137|NCT05647551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955574|NCT00203554|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64955575|NCT00203554|Protective Agents|protective agents|mesh-ancestor
64511260|NCT05555732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64511261|NCT05555732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64511274|NCT05545735|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64511275|NCT05545735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64511285|NCT05504291|Carboplatin|carboplatin|mesh-list
64511286|NCT05504291|Etoposide|etoposide|mesh-list
64511287|NCT05504291|Vincristine|vincristine|mesh-list
64511288|NCT05504291|Etoposide phosphate|etoposide phosphate|mesh-list
64511289|NCT05504291|Melphalan|melphalan|mesh-list
64511290|NCT05504291|Mechlorethamine|mechlorethamine|mesh-list
64511291|NCT05504291|Podophyllotoxin|podophyllotoxin|mesh-list
64511292|NCT05504291|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64511293|NCT05504291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511294|NCT05504291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511295|NCT05504291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64511296|NCT05504291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64511297|NCT05504291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64511298|NCT05504291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64511299|NCT05504291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511300|NCT05504291|Tubulin Modulators|tubulin modulators|mesh-ancestor
64511301|NCT05504291|Antimitotic Agents|antimitotic agents|mesh-ancestor
64511302|NCT05504291|Mitosis Modulators|mitosis modulators|mesh-ancestor
64511303|NCT05504291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64511304|NCT05504291|Alkylating Agents|alkylating agents|mesh-ancestor
64511305|NCT05504291|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64511306|NCT05504291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64511307|NCT05504291|Immunologic Factors|immunologic factors|mesh-ancestor
64511308|NCT05504291|Keratolytic Agents|keratolytic agents|mesh-ancestor
64511309|NCT05504291|Dermatologic Agents|dermatologic agents|mesh-ancestor
64511310|NCT05496036|Pembrolizumab|pembrolizumab|mesh-list
64511311|NCT05496036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64324708|NCT02853500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315755|NCT03549221|Epinephrine|epinephrine|mesh-list
64315756|NCT03549221|Levobupivacaine|levobupivacaine|mesh-list
64315757|NCT03549221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64315758|NCT03549221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64315759|NCT03549221|Adrenergic Agents|adrenergic agents|mesh-ancestor
64315760|NCT03549221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64511316|NCT05487859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511317|NCT05487859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64511318|NCT05487859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511319|NCT05479812|Pembrolizumab|pembrolizumab|mesh-list
64511320|NCT05479812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64511321|NCT05479812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511322|NCT05457556|Mycophenolic Acid|mycophenolic acid|mesh-list
64511323|NCT05457556|Cyclophosphamide|cyclophosphamide|mesh-list
64511324|NCT05457556|Melphalan|melphalan|mesh-list
64511325|NCT05457556|Busulfan|busulfan|mesh-list
64511326|NCT05457556|Mechlorethamine|mechlorethamine|mesh-list
64511327|NCT05457556|Thiotepa|thiotepa|mesh-list
64511328|NCT05457556|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64511329|NCT05457556|Rituximab|rituximab|mesh-list
64511330|NCT05457556|Methotrexate|methotrexate|mesh-list
64511331|NCT05457556|Fludarabine|fludarabine|mesh-list
64511332|NCT05457556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64511333|NCT05457556|Tacrolimus|tacrolimus|mesh-list
64511334|NCT05457556|Thymoglobulin|thymoglobulin|mesh-list
64511335|NCT05457556|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64511336|NCT05457556|Antibodies|antibodies|mesh-list
64511337|NCT05457556|Immunoglobulins|immunoglobulins|mesh-list
64511338|NCT05457556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64511339|NCT05457556|gamma-Globulins|gamma-globulins|mesh-list
64511340|NCT05457556|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64511341|NCT05457556|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64511342|NCT05457556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64511343|NCT05457556|Immunologic Factors|immunologic factors|mesh-ancestor
64422357|NCT02546765|Anesthetics, General|anesthetics, general|mesh-ancestor
64727098|NCT00003206|Tubulin Modulators|tubulin modulators|mesh-ancestor
64727099|NCT00003206|Antimitotic Agents|antimitotic agents|mesh-ancestor
64727100|NCT00003206|Mitosis Modulators|mitosis modulators|mesh-ancestor
64727101|NCT00003206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727103|NCT00003446|Trimetrexate|trimetrexate|mesh-list
64334574|NCT02295475|Warfarin|warfarin|mesh-list
64511344|NCT05457556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511345|NCT05457556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64511346|NCT05457556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64511347|NCT05457556|Alkylating Agents|alkylating agents|mesh-ancestor
64511357|NCT05457556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64511358|NCT05457556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64511359|NCT05457556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64511360|NCT05457556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64511361|NCT05457556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64955578|NCT00203632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64511362|NCT05457556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64511363|NCT05457556|Antitubercular Agents|antitubercular agents|mesh-ancestor
64511364|NCT05457556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64511365|NCT05457556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64511366|NCT05451849|Cyclophosphamide|cyclophosphamide|mesh-list
64511367|NCT05451849|Fludarabine|fludarabine|mesh-list
64511368|NCT05451849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64511369|NCT05451849|Immunologic Factors|immunologic factors|mesh-ancestor
64511370|NCT05451849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511371|NCT05451849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64511372|NCT05451849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64511373|NCT05451849|Alkylating Agents|alkylating agents|mesh-ancestor
64511374|NCT05451849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511375|NCT05451849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511376|NCT05451849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64511377|NCT05413304|Temozolomide|temozolomide|mesh-list
64511378|NCT05413304|Dialysis Solutions|dialysis solutions|mesh-list
64315764|NCT03549221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64315765|NCT03549221|Autonomic Agents|autonomic agents|mesh-ancestor
64315766|NCT03549221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315767|NCT03549221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64315768|NCT03549221|Respiratory System Agents|respiratory system agents|mesh-ancestor
64315769|NCT03549221|Mydriatics|mydriatics|mesh-ancestor
64315770|NCT03549221|Sympathomimetics|sympathomimetics|mesh-ancestor
64511379|NCT05413304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64511380|NCT05413304|Alkylating Agents|alkylating agents|mesh-ancestor
64511381|NCT05413304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511382|NCT05413304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511383|NCT05413304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64511449|NCT05375084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511459|NCT05369832|Ozanimod|ozanimod|mesh-list
64511460|NCT05369832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64511461|NCT05369832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511462|NCT05369832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64511463|NCT05369832|Immunologic Factors|immunologic factors|mesh-ancestor
64511472|NCT05364424|Immunologic Factors|immunologic factors|mesh-ancestor
64511473|NCT05364424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511474|NCT05364424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64511475|NCT05364424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64511476|NCT05364424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64511477|NCT05364424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64511478|NCT05364424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422369|NCT02546765|Antipyretics|antipyretics|mesh-ancestor
64511479|NCT05364424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511480|NCT05364424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64511481|NCT05364424|Alkylating Agents|alkylating agents|mesh-ancestor
64511505|NCT05346354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64511506|NCT05346354|Immunologic Factors|immunologic factors|mesh-ancestor
64511507|NCT05346354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511508|NCT05331664|Moxifloxacin|moxifloxacin|mesh-list
64511510|NCT05331664|Trimethoprim|trimethoprim|mesh-list
64511511|NCT05331664|Prednisolone|prednisolone|mesh-list
64511512|NCT05331664|Prednisolone acetate|prednisolone acetate|mesh-list
64511513|NCT05331664|Triamcinolone|triamcinolone|mesh-list
64511514|NCT05331664|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64727104|NCT00003446|Fluorouracil|fluorouracil|mesh-list
64727105|NCT00003446|Calcium|calcium|mesh-list
64727106|NCT00003446|Levoleucovorin|levoleucovorin|mesh-list
64727107|NCT00003446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64727108|NCT00003446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727109|NCT00003446|Antimetabolites|antimetabolites|mesh-ancestor
64334583|NCT02227901|Temozolomide|temozolomide|mesh-list
64511515|NCT05331664|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64511516|NCT05331664|Atropine|atropine|mesh-list
64511517|NCT05331664|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64511518|NCT05331664|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64511519|NCT05331664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64511520|NCT05331664|Glucocorticoids|glucocorticoids|mesh-ancestor
64511521|NCT05331664|Hormones|hormones|mesh-ancestor
64511522|NCT05331664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64511523|NCT05331664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511524|NCT05331664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64511525|NCT05331664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511526|NCT05331664|Autonomic Agents|autonomic agents|mesh-ancestor
64511527|NCT05331664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64511528|NCT05331664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64511529|NCT05331664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64315772|NCT03549221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64315773|NCT03549221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64315775|NCT03549221|Sensory System Agents|sensory system agents|mesh-ancestor
64315776|NCT03549221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64315777|NCT03549221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64511530|NCT05331664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64511531|NCT05331664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64511532|NCT05331664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64511533|NCT05331664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511534|NCT05331664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64511535|NCT05331664|Contraceptive Agents|contraceptive agents|mesh-ancestor
64511536|NCT05331664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64511537|NCT05331664|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64511538|NCT05331664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64511539|NCT05331664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64511540|NCT05331664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64511541|NCT05331664|Immunologic Factors|immunologic factors|mesh-ancestor
64511542|NCT05331664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64511543|NCT05331664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64511544|NCT05331664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64511545|NCT05331664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64511550|NCT05331664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64511551|NCT05331664|Cholinergic Agents|cholinergic agents|mesh-ancestor
64511552|NCT05331664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64511553|NCT05331664|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64511554|NCT05331664|Renal Agents|renal agents|mesh-ancestor
64511555|NCT05331664|Antimalarials|antimalarials|mesh-ancestor
64511556|NCT05331664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64786121|NCT00001080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786122|NCT00001104|Zidovudine|zidovudine|mesh-list
64786123|NCT00001104|Antimetabolites|antimetabolites|mesh-ancestor
64786124|NCT00001104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786125|NCT00001104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786126|NCT00001104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786127|NCT00001104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786129|NCT00001104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786130|NCT00001104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786131|NCT00001104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786132|NCT00001110|Dimercaprol|dimercaprol|mesh-list
64786133|NCT00001110|Chelating Agents|chelating agents|mesh-ancestor
64315778|NCT03549221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64315779|NCT03549221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64315780|NCT03549221|Anesthetics, Local|anesthetics, local|mesh-ancestor
64315781|NCT03549221|Anesthetics|anesthetics|mesh-ancestor
64315782|NCT03549221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64315783|NCT05013632|Antiviral Agents|antiviral agents|mesh-list
64315784|NCT05013632|Remdesivir|remdesivir|mesh-list
64315785|NCT05013632|Antibodies|antibodies|mesh-list
64315792|NCT05614544|Propofol|propofol|mesh-list
64511557|NCT05331664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64511558|NCT05331664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64511559|NCT05331664|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64511560|NCT05331664|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64511561|NCT05331664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64511562|NCT05325632|Paclitaxel|paclitaxel|mesh-list
64511563|NCT05325632|Trastuzumab|trastuzumab|mesh-list
64511564|NCT05325632|Pertuzumab|pertuzumab|mesh-list
64511565|NCT05325632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64511566|NCT05325632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511567|NCT05325632|Tubulin Modulators|tubulin modulators|mesh-ancestor
64511568|NCT05325632|Antimitotic Agents|antimitotic agents|mesh-ancestor
64511569|NCT05325632|Mitosis Modulators|mitosis modulators|mesh-ancestor
64422382|NCT03555851|Alkylating Agents|alkylating agents|mesh-ancestor
64511570|NCT05325632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511571|NCT05325632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64511572|NCT05320068|Vancomycin|vancomycin|mesh-list
64511573|NCT05320068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64511574|NCT05320068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64511575|NCT05317416|Lenalidomide|lenalidomide|mesh-list
64511576|NCT05317416|Immunologic Factors|immunologic factors|mesh-ancestor
64511577|NCT05317416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511578|NCT05317416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64511579|NCT05317416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64511580|NCT05317416|Growth Substances|growth substances|mesh-ancestor
64727110|NCT00003446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727111|NCT00003446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64727112|NCT00003446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727113|NCT00003446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727114|NCT00003446|Immunologic Factors|immunologic factors|mesh-ancestor
64727115|NCT00003446|Antidotes|antidotes|mesh-ancestor
64727116|NCT00003446|Protective Agents|protective agents|mesh-ancestor
64511581|NCT05317416|Growth Inhibitors|growth inhibitors|mesh-ancestor
64511582|NCT05317416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511583|NCT05304585|Dactinomycin|dactinomycin|mesh-list
64511584|NCT05304585|Cactinomycin|cactinomycin|mesh-list
64511585|NCT05304585|Cyclophosphamide|cyclophosphamide|mesh-list
64511586|NCT05304585|Vincristine|vincristine|mesh-list
64324709|NCT02853500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64324710|NCT02853500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64324711|NCT02853500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324712|NCT02853500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315798|NCT05614544|Anesthetics|anesthetics|mesh-ancestor
64315799|NCT05185505|Bevacizumab|bevacizumab|mesh-list
64315800|NCT05185505|Atezolizumab|atezolizumab|mesh-list
64315801|NCT05185505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64375950|NCT02616783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64511587|NCT05304585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64511588|NCT05304585|Immunologic Factors|immunologic factors|mesh-ancestor
64955579|NCT00203632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511589|NCT05304585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511590|NCT05304585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64511591|NCT05304585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64511592|NCT05304585|Alkylating Agents|alkylating agents|mesh-ancestor
64511593|NCT05304585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511594|NCT05304585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511595|NCT05304585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64511596|NCT05304585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64511597|NCT05304585|Tubulin Modulators|tubulin modulators|mesh-ancestor
64511598|NCT05304585|Antimitotic Agents|antimitotic agents|mesh-ancestor
64511599|NCT05304585|Mitosis Modulators|mitosis modulators|mesh-ancestor
64511600|NCT05304585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64511601|NCT05304585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64511602|NCT05304585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64511603|NCT05304585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64511604|NCT05304585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64511605|NCT05304585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64511606|NCT05299125|Pemetrexed|pemetrexed|mesh-list
64511607|NCT05299125|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
64511608|NCT05299125|Lazertinib|lazertinib|mesh-list
64511609|NCT05299125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511610|NCT05299125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64511611|NCT05299125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511612|NCT05299125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64511613|NCT05299125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64511649|NCT05239741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511650|NCT05239741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64511651|NCT05239741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64511667|NCT05239741|Micronutrients|micronutrients|mesh-ancestor
64511668|NCT05223647|Carboplatin|carboplatin|mesh-list
64511669|NCT05223647|Etoposide|etoposide|mesh-list
64511670|NCT05223647|Durvalumab|durvalumab|mesh-list
64511671|NCT05223647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511672|NCT05223647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64511673|NCT05223647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64511674|NCT05223647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64511675|NCT05223647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64511676|NCT05223647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511677|NCT05223647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64511678|NCT05204160|Pembrolizumab|pembrolizumab|mesh-list
64511679|NCT05204160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64511680|NCT05204160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511681|NCT05202262|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64511682|NCT05202262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64511683|NCT05202262|Respiratory System Agents|respiratory system agents|mesh-ancestor
64511684|NCT05176951|Treprostinil|treprostinil|mesh-list
64511685|NCT05176951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64511686|NCT05171062|Pembrolizumab|pembrolizumab|mesh-list
64786134|NCT00001110|Sequestering Agents|sequestering agents|mesh-ancestor
64786135|NCT00001110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786136|NCT00001122|Efavirenz|efavirenz|mesh-list
64786137|NCT00001122|Didanosine|didanosine|mesh-list
64786138|NCT00001122|Stavudine|stavudine|mesh-list
64786139|NCT00001122|Nelfinavir|nelfinavir|mesh-list
64511687|NCT05171062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64511688|NCT05171062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511696|NCT05161637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64727117|NCT00003446|Vitamin B Complex|vitamin b complex|mesh-ancestor
64727119|NCT00003446|Micronutrients|micronutrients|mesh-ancestor
64727120|NCT00003446|Antifungal Agents|antifungal agents|mesh-ancestor
64727121|NCT00003446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64494314|NCT02182492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955580|NCT00071994|Gefitinib|gefitinib|mesh-list
64955581|NCT00071994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955582|NCT00071994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64955583|NCT00071994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955584|NCT00071994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511702|NCT05155254|Pembrolizumab|pembrolizumab|mesh-list
64511703|NCT05155254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64511704|NCT05155254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511705|NCT05151744|Ranibizumab|ranibizumab|mesh-list
64511706|NCT05151744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64511707|NCT05151744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64511708|NCT05151744|Growth Substances|growth substances|mesh-ancestor
64511709|NCT05151744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511710|NCT05151744|Growth Inhibitors|growth inhibitors|mesh-ancestor
64511711|NCT05151744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511712|NCT05151731|Ranibizumab|ranibizumab|mesh-list
64511732|NCT05136677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511733|NCT05136677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64511734|NCT05136677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64511735|NCT05136677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64511736|NCT05089734|Docetaxel|docetaxel|mesh-list
64511737|NCT05089734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511738|NCT05089734|Tubulin Modulators|tubulin modulators|mesh-ancestor
64511739|NCT05089734|Antimitotic Agents|antimitotic agents|mesh-ancestor
64511740|NCT05089734|Mitosis Modulators|mitosis modulators|mesh-ancestor
64511741|NCT05089734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511742|NCT05080322|Fluticasone|fluticasone|mesh-list
64511744|NCT05080322|Azelastine|azelastine|mesh-list
64511745|NCT05080322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64511746|NCT05080322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64511747|NCT05080322|Autonomic Agents|autonomic agents|mesh-ancestor
64786144|NCT00001122|Antiviral Agents|antiviral agents|mesh-ancestor
64786145|NCT00001122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786146|NCT00001122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64786147|NCT00001122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64397299|NCT05063513|Antitubercular Agents|antitubercular agents|mesh-ancestor
64315810|NCT01667432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64315811|NCT05575271|Norepinephrine|norepinephrine|mesh-list
64315812|NCT05575271|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64315813|NCT05575271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64315814|NCT05575271|Adrenergic Agents|adrenergic agents|mesh-ancestor
64315815|NCT05575271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64315818|NCT05575271|Sympathomimetics|sympathomimetics|mesh-ancestor
64511748|NCT05080322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64511749|NCT05080322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511750|NCT05080322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64511751|NCT05080322|Respiratory System Agents|respiratory system agents|mesh-ancestor
64511752|NCT05080322|Dermatologic Agents|dermatologic agents|mesh-ancestor
64511753|NCT05080322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64511754|NCT05080322|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64511755|NCT05080322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64511756|NCT05080322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511757|NCT05080322|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64511758|NCT05080322|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64511759|NCT05080322|Histamine Antagonists|histamine antagonists|mesh-ancestor
64511760|NCT05080322|Histamine Agents|histamine agents|mesh-ancestor
64511761|NCT05080322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64511762|NCT05079230|Azacitidine|azacitidine|mesh-list
64511763|NCT05079230|Venetoclax|venetoclax|mesh-list
64511764|NCT05079230|Magrolimab|magrolimab|mesh-list
64511765|NCT05079230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64511766|NCT05079230|Antimetabolites|antimetabolites|mesh-ancestor
64511767|NCT05079230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511768|NCT05079230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511769|NCT05079230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64511770|NCT05079230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64511771|NCT05071313|Vaccines|vaccines|mesh-list
64511772|NCT05071313|Immunologic Factors|immunologic factors|mesh-ancestor
64511773|NCT05071313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511774|NCT05069597|Pancrelipase|pancrelipase|mesh-list
64511775|NCT05069597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64511776|NCT05065424|Atropine|atropine|mesh-list
64511777|NCT05065424|Fentanyl|fentanyl|mesh-list
64511778|NCT05065424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64511779|NCT05065424|Narcotics|narcotics|mesh-ancestor
64511780|NCT05065424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64511781|NCT05065424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511782|NCT05065424|Analgesics|analgesics|mesh-ancestor
64727122|NCT00003446|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64727124|NCT00003938|Amphotericin B|amphotericin b|mesh-list
64727125|NCT00003938|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64727126|NCT00003938|Amebicides|amebicides|mesh-ancestor
64727127|NCT00003938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64727128|NCT00003938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64511783|NCT05065424|Sensory System Agents|sensory system agents|mesh-ancestor
64511796|NCT05065424|Parasympatholytics|parasympatholytics|mesh-ancestor
64511797|NCT05065424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64511798|NCT05065424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64511799|NCT05065424|Cholinergic Agents|cholinergic agents|mesh-ancestor
64511800|NCT05065424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64511801|NCT05061550|Paclitaxel|paclitaxel|mesh-list
64511802|NCT05061550|Cisplatin|cisplatin|mesh-list
64511803|NCT05061550|Carboplatin|carboplatin|mesh-list
64511804|NCT05061550|Pemetrexed|pemetrexed|mesh-list
64511805|NCT05061550|Durvalumab|durvalumab|mesh-list
64315848|NCT05612984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64315850|NCT05612984|Sensory System Agents|sensory system agents|mesh-ancestor
64315851|NCT05612984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315852|NCT05612984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64315853|NCT05612984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64315854|NCT05612984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64376060|NCT04882683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64511806|NCT05061550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64511807|NCT05061550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511808|NCT05061550|Tubulin Modulators|tubulin modulators|mesh-ancestor
64511809|NCT05061550|Antimitotic Agents|antimitotic agents|mesh-ancestor
64511810|NCT05061550|Mitosis Modulators|mitosis modulators|mesh-ancestor
64511811|NCT05061550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511812|NCT05061550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64511813|NCT05061550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64511814|NCT05061550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64511815|NCT05061550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64511828|NCT05041257|Maytansine|maytansine|mesh-list
64511829|NCT05041257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64511830|NCT05041257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511831|NCT05041257|Tubulin Modulators|tubulin modulators|mesh-ancestor
64511832|NCT05041257|Antimitotic Agents|antimitotic agents|mesh-ancestor
64511833|NCT05041257|Mitosis Modulators|mitosis modulators|mesh-ancestor
64511834|NCT05041257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511835|NCT05037929|Astegolimab|astegolimab|mesh-list
64511836|NCT05037929|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64511837|NCT05037929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64511838|NCT05037929|Antiviral Agents|antiviral agents|mesh-ancestor
64511839|NCT05037929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64511840|NCT05015439|Cannabidiol|cannabidiol|mesh-list
64511847|NCT05007821|Linezolid|linezolid|mesh-list
64511848|NCT05007821|Bedaquiline|bedaquiline|mesh-list
64511849|NCT05007821|Diarylquinolines|diarylquinolines|mesh-list
64511850|NCT05007821|Clofazimine|clofazimine|mesh-list
64511851|NCT05007821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64511852|NCT05007821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64511853|NCT05007821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64955586|NCT00203788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64511864|NCT04994132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64511865|NCT04994132|Immunologic Factors|immunologic factors|mesh-ancestor
64511866|NCT04994132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511867|NCT04994132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64511868|NCT04994132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64511869|NCT04994132|Alkylating Agents|alkylating agents|mesh-ancestor
64511870|NCT04994132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511871|NCT04994132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511872|NCT04994132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64511873|NCT04994132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64786149|NCT00001122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64315855|NCT05612984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64315856|NCT05612984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315857|NCT05612984|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64315858|NCT05612984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64315859|NCT05612984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64315860|NCT05612984|Antipyretics|antipyretics|mesh-ancestor
64315861|NCT05612984|Hematinics|hematinics|mesh-ancestor
64315862|NCT05612984|Vitamin B Complex|vitamin b complex|mesh-ancestor
64315863|NCT05612984|Vitamins|vitamins|mesh-ancestor
64315864|NCT04787510|Heparin|heparin|mesh-list
64315865|NCT04787510|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64315866|NCT04787510|Tinzaparin|tinzaparin|mesh-list
64315867|NCT04787510|Dalteparin|dalteparin|mesh-list
64315868|NCT04787510|Anticoagulants|anticoagulants|mesh-ancestor
64511874|NCT04994132|Tubulin Modulators|tubulin modulators|mesh-ancestor
64511875|NCT04994132|Antimitotic Agents|antimitotic agents|mesh-ancestor
64511876|NCT04994132|Mitosis Modulators|mitosis modulators|mesh-ancestor
64511877|NCT04994132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64511878|NCT04994132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64511879|NCT04994132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64511880|NCT04994132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64511881|NCT04994132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64511882|NCT04994132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64727130|NCT00003938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64727131|NCT00003938|Antifungal Agents|antifungal agents|mesh-ancestor
64727132|NCT00003212|Doxorubicin|doxorubicin|mesh-list
64727133|NCT00003212|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64727134|NCT00003212|Ifosfamide|ifosfamide|mesh-list
64727135|NCT00003212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64727136|NCT00003212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727137|NCT00003212|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64727138|NCT00003212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64511883|NCT04989803|Cyclophosphamide|cyclophosphamide|mesh-list
64511884|NCT04989803|Fludarabine|fludarabine|mesh-list
64511885|NCT04989803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64511886|NCT04989803|Immunologic Factors|immunologic factors|mesh-ancestor
64511887|NCT04989803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511888|NCT04989803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64511889|NCT04989803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64511890|NCT04989803|Alkylating Agents|alkylating agents|mesh-ancestor
64511891|NCT04989803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511892|NCT04989803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511893|NCT04989803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64511894|NCT04987996|Pembrolizumab|pembrolizumab|mesh-list
64511895|NCT04987996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64511896|NCT04987996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511898|NCT04939597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64511899|NCT04939597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64511900|NCT04939597|Dopamine Agents|dopamine agents|mesh-ancestor
64511901|NCT04939597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64511902|NCT04939597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511903|NCT04939597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511904|NCT04939597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64511905|NCT04939597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64511912|NCT04924322|Enoxaparin|enoxaparin|mesh-list
64511913|NCT04924322|Anticoagulants|anticoagulants|mesh-ancestor
64511914|NCT04924322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64511915|NCT04924322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64511926|NCT04923893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64511927|NCT04923893|Alkylating Agents|alkylating agents|mesh-ancestor
64511928|NCT04923893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511929|NCT04923893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511930|NCT04923893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64511931|NCT04923893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64511960|NCT04911166|Interleukin-12|interleukin-12|mesh-list
64511961|NCT04911166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511962|NCT04911166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64511963|NCT04911166|Immunologic Factors|immunologic factors|mesh-ancestor
64511964|NCT04911166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511965|NCT04911166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64511966|NCT04911166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64511967|NCT04911166|Growth Substances|growth substances|mesh-ancestor
64511968|NCT04911166|Growth Inhibitors|growth inhibitors|mesh-ancestor
64511969|NCT04903353|Risperidone|risperidone|mesh-list
64511970|NCT04903353|Aripiprazole|aripiprazole|mesh-list
64511971|NCT04903353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64511972|NCT04903353|Serotonin Agents|serotonin agents|mesh-ancestor
64511973|NCT04903353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64511974|NCT04903353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511975|NCT04903353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511976|NCT04903353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64511977|NCT04903353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64511978|NCT04903353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64422412|NCT02364999|Bevacizumab|bevacizumab|mesh-list
64511981|NCT04903353|Dopamine Agents|dopamine agents|mesh-ancestor
64511982|NCT04903353|Antidepressive Agents|antidepressive agents|mesh-ancestor
64727139|NCT00003212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727140|NCT00003212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727141|NCT00003212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64727142|NCT00003212|Alkylating Agents|alkylating agents|mesh-ancestor
64727143|NCT00002611|Dactinomycin|dactinomycin|mesh-list
64727144|NCT00002611|Cyclophosphamide|cyclophosphamide|mesh-list
64511983|NCT04903353|Dopamine Agonists|dopamine agonists|mesh-ancestor
64511984|NCT04903353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64512006|NCT04898894|Immunologic Factors|immunologic factors|mesh-ancestor
64512007|NCT04898894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64512008|NCT04898894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64512009|NCT04898894|Antiviral Agents|antiviral agents|mesh-ancestor
64512010|NCT04898894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64512011|NCT04898894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64512012|NCT04895436|Venetoclax|venetoclax|mesh-list
64512013|NCT04895436|Obinutuzumab|obinutuzumab|mesh-list
64512014|NCT04895436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512015|NCT04895436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64512033|NCT04856904|Trifarotene|trifarotene|mesh-list
64512034|NCT04856904|Dermatologic Agents|dermatologic agents|mesh-ancestor
64512035|NCT04831047|Phenylephrine|phenylephrine|mesh-list
64512036|NCT04831047|Oxymetazoline|oxymetazoline|mesh-list
64512037|NCT04831047|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64512038|NCT04831047|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64512039|NCT04831047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64512040|NCT04831047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64512041|NCT04831047|Adrenergic Agents|adrenergic agents|mesh-ancestor
64512042|NCT04831047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64512043|NCT04831047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512044|NCT04831047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512046|NCT04831047|Autonomic Agents|autonomic agents|mesh-ancestor
64512047|NCT04831047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64512048|NCT04831047|Nasal Decongestants|nasal decongestants|mesh-ancestor
64512049|NCT04831047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64512050|NCT04831047|Respiratory System Agents|respiratory system agents|mesh-ancestor
64512051|NCT04831047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64512052|NCT04831047|Mydriatics|mydriatics|mesh-ancestor
64512053|NCT04831047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64512054|NCT04831047|Protective Agents|protective agents|mesh-ancestor
64512104|NCT04764162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64512105|NCT04764162|Antimetabolites|antimetabolites|mesh-ancestor
64512106|NCT04764162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786165|NCT00001128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786166|NCT00001128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64324713|NCT01188187|Dexamethasone|dexamethasone|mesh-list
64324714|NCT01188187|Prednisone|prednisone|mesh-list
64324715|NCT01188187|Docetaxel|docetaxel|mesh-list
64324716|NCT01188187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64315903|NCT05398757|Sensory System Agents|sensory system agents|mesh-ancestor
64315907|NCT05398757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64512107|NCT04764162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64512108|NCT04764162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64512109|NCT04764162|Nootropic Agents|nootropic agents|mesh-ancestor
64512110|NCT04747314|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64512111|NCT04747314|Aripiprazole|aripiprazole|mesh-list
64512112|NCT04747314|Mirtazapine|mirtazapine|mesh-list
64512113|NCT04747314|Citalopram|citalopram|mesh-list
64512114|NCT04747314|Bupropion|bupropion|mesh-list
64512115|NCT04747314|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64512116|NCT04747314|Sertraline|sertraline|mesh-list
64512117|NCT04747314|Antidepressive Agents|antidepressive agents|mesh-list
64512118|NCT04747314|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64512119|NCT04747314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64512120|NCT04747314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64512121|NCT04747314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512122|NCT04747314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64512123|NCT04747314|Serotonin Agents|serotonin agents|mesh-ancestor
64512124|NCT04747314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512125|NCT04747314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64512126|NCT04747314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64512127|NCT04747314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64512128|NCT04747314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64512130|NCT04747314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64512131|NCT04747314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64512132|NCT04747314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727145|NCT00002611|Doxorubicin|doxorubicin|mesh-list
64727146|NCT00002611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64727147|NCT00002611|Etoposide|etoposide|mesh-list
64727148|NCT00002611|Vincristine|vincristine|mesh-list
64727149|NCT00002611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727150|NCT00002611|Immunologic Factors|immunologic factors|mesh-ancestor
64334615|NCT03159741|Incretins|incretins|mesh-ancestor
64512133|NCT04747314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64512134|NCT04747314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64512135|NCT04747314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64955590|NCT00203788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512136|NCT04747314|Dopamine Agonists|dopamine agonists|mesh-ancestor
64512137|NCT04747314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64512138|NCT04747314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64512152|NCT04747314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64512153|NCT04747314|Adrenergic Agents|adrenergic agents|mesh-ancestor
64512154|NCT04747314|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64512155|NCT04731363|Erythritol|erythritol|mesh-list
64512156|NCT04731363|Vasodilator Agents|vasodilator agents|mesh-ancestor
64786168|NCT00001128|Growth Substances|growth substances|mesh-ancestor
64786169|NCT00001128|Growth Inhibitors|growth inhibitors|mesh-ancestor
64786170|NCT00001128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64786171|NCT00001128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64786172|NCT00001128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64315913|NCT04787276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64315914|NCT01564979|Botulinum Toxins|botulinum toxins|mesh-list
64315915|NCT01564979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64512157|NCT04712643|Atezolizumab|atezolizumab|mesh-list
64512158|NCT04712643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512164|NCT04700514|Dexmedetomidine|dexmedetomidine|mesh-list
64512165|NCT04700514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64512166|NCT04700514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64512167|NCT04700514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512168|NCT04700514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64512169|NCT04700514|Analgesics|analgesics|mesh-ancestor
64512170|NCT04700514|Sensory System Agents|sensory system agents|mesh-ancestor
64512171|NCT04700514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64512172|NCT04700514|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64512173|NCT04700514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64512174|NCT04700514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64512175|NCT04700514|Adrenergic Agents|adrenergic agents|mesh-ancestor
64512176|NCT04700514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64512177|NCT04700514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512178|NCT04684368|Carboplatin|carboplatin|mesh-list
64512179|NCT04684368|Etoposide|etoposide|mesh-list
64512180|NCT04684368|Etoposide phosphate|etoposide phosphate|mesh-list
64512181|NCT04684368|Ifosfamide|ifosfamide|mesh-list
64512182|NCT04684368|Isophosphamide mustard|isophosphamide mustard|mesh-list
64512183|NCT04684368|Thiotepa|thiotepa|mesh-list
64512184|NCT04684368|Podophyllotoxin|podophyllotoxin|mesh-list
64512185|NCT04684368|Lenograstim|lenograstim|mesh-list
64512186|NCT04684368|Mesna|mesna|mesh-list
64512187|NCT04684368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512188|NCT04684368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64512189|NCT04684368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64512190|NCT04684368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64512191|NCT04684368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64512192|NCT04684368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512193|NCT04684368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64512194|NCT04684368|Immunologic Factors|immunologic factors|mesh-ancestor
64512195|NCT04684368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512196|NCT04684368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64512197|NCT04684368|Alkylating Agents|alkylating agents|mesh-ancestor
64786174|NCT00001296|Interferon-gamma|interferon-gamma|mesh-list
64786175|NCT00001296|Melphalan|melphalan|mesh-list
64786176|NCT00001296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64786177|NCT00001296|Antiviral Agents|antiviral agents|mesh-ancestor
64315916|NCT01564979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64315917|NCT01564979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64315918|NCT01564979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64315919|NCT01564979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315920|NCT01564979|Cholinergic Agents|cholinergic agents|mesh-ancestor
64512198|NCT04684368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64512199|NCT04684368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64512200|NCT04684368|Protective Agents|protective agents|mesh-ancestor
64512201|NCT04684368|Keratolytic Agents|keratolytic agents|mesh-ancestor
64512202|NCT04684368|Dermatologic Agents|dermatologic agents|mesh-ancestor
64512203|NCT04684368|Tubulin Modulators|tubulin modulators|mesh-ancestor
64512204|NCT04684368|Antimitotic Agents|antimitotic agents|mesh-ancestor
64512205|NCT04684368|Mitosis Modulators|mitosis modulators|mesh-ancestor
64512206|NCT04677569|Azithromycin|azithromycin|mesh-list
64512207|NCT04677569|Amikacin|amikacin|mesh-list
64512208|NCT04677569|Ethambutol|ethambutol|mesh-list
64512210|NCT04677569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64512211|NCT04677569|Antitubercular Agents|antitubercular agents|mesh-ancestor
64512212|NCT04669145|Ropivacaine|ropivacaine|mesh-list
64512213|NCT04669145|Anesthetics, Local|anesthetics, local|mesh-ancestor
64512214|NCT04669145|Anesthetics|anesthetics|mesh-ancestor
64727151|NCT00002611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727152|NCT00002611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64727153|NCT00002611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64727154|NCT00002611|Alkylating Agents|alkylating agents|mesh-ancestor
64334621|NCT02292277|Purinergic Agents|purinergic agents|mesh-ancestor
64512215|NCT04669145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64512216|NCT04669145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512229|NCT04650074|Sensory System Agents|sensory system agents|mesh-ancestor
64512230|NCT04650074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64512231|NCT04650074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64512232|NCT04650074|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64512233|NCT04650074|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64512234|NCT04650074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64512235|NCT04650074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512236|NCT04650074|Analgesics|analgesics|mesh-ancestor
64512237|NCT04650074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64512238|NCT04650074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64512239|NCT04650074|Anesthetics, General|anesthetics, general|mesh-ancestor
64512240|NCT04650074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64512241|NCT04650074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64512242|NCT04650074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64512243|NCT04620304|UB-421|ub-421|mesh-list
64512244|NCT04620304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64512245|NCT04620304|Antiviral Agents|antiviral agents|mesh-ancestor
64512246|NCT04620304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64512247|NCT04600336|Oxybutynin|oxybutynin|mesh-list
64512248|NCT04600336|Parasympatholytics|parasympatholytics|mesh-ancestor
64512249|NCT04600336|Autonomic Agents|autonomic agents|mesh-ancestor
64512250|NCT04600336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64512251|NCT04600336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512252|NCT04600336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64512253|NCT04600336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64512254|NCT04600336|Cholinergic Agents|cholinergic agents|mesh-ancestor
64512255|NCT04600336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64512256|NCT04600336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512257|NCT04600336|Urological Agents|urological agents|mesh-ancestor
64512258|NCT04579380|Trastuzumab|trastuzumab|mesh-list
64512259|NCT04579380|Fulvestrant|fulvestrant|mesh-list
64512260|NCT04579380|Tucatinib|tucatinib|mesh-list
64315940|NCT03547505|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
64315941|NCT03547505|Vasodilator Agents|vasodilator agents|mesh-ancestor
64315942|NCT03547505|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64315943|NCT03547505|Protective Agents|protective agents|mesh-ancestor
64315944|NCT03547505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315946|NCT05279183|Vasodilator Agents|vasodilator agents|mesh-ancestor
64315947|NCT05184842|Decitabine|decitabine|mesh-list
64315948|NCT05184842|Venetoclax|venetoclax|mesh-list
64512261|NCT04579380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64512262|NCT04579380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512263|NCT04579380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64512264|NCT04579380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64512265|NCT04579380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64512266|NCT04579380|Hormone Antagonists|hormone antagonists|mesh-ancestor
64512267|NCT04579380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64512268|NCT04579380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512269|NCT04579380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64512270|NCT04579380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64512271|NCT04579380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512272|NCT04578886|Guanfacine|guanfacine|mesh-list
64512273|NCT04578886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64512274|NCT04578886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64512275|NCT04578886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64512276|NCT04578886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64512277|NCT04578886|Adrenergic Agents|adrenergic agents|mesh-ancestor
64512278|NCT04578886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64512279|NCT04578886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512280|NCT04578886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512281|NCT04550585|Insulin|insulin|mesh-list
64512282|NCT04550585|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64512283|NCT04550585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64512284|NCT04550585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512292|NCT04545515|Ivacaftor|ivacaftor|mesh-list
64512293|NCT04545515|Elexacaftor|elexacaftor|mesh-list
64512294|NCT04545515|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64512304|NCT04519619|Growth Inhibitors|growth inhibitors|mesh-ancestor
64512305|NCT04519619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727155|NCT00002611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727156|NCT00002611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727157|NCT00002611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64727158|NCT00002611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64727159|NCT00002611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64727160|NCT00002611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64324717|NCT01188187|Antiemetics|antiemetics|mesh-ancestor
64324718|NCT01188187|Autonomic Agents|autonomic agents|mesh-ancestor
64324719|NCT01188187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315949|NCT05184842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64315950|NCT05184842|Antimetabolites|antimetabolites|mesh-ancestor
64315951|NCT05184842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315952|NCT05184842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315953|NCT05184842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64315954|NCT04462952|Adavosertib|adavosertib|mesh-list
64315955|NCT04462952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64315956|NCT04462952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315957|NCT04429022|Acetaminophen|acetaminophen|mesh-list
64315958|NCT04429022|Celecoxib|celecoxib|mesh-list
64315959|NCT04429022|Ketorolac|ketorolac|mesh-list
64727161|NCT00002611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64512306|NCT04513925|Atezolizumab|atezolizumab|mesh-list
64955594|NCT00203788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64512307|NCT04513925|Durvalumab|durvalumab|mesh-list
64512308|NCT04513925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512309|NCT04513925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64512310|NCT04512235|Dexamethasone|dexamethasone|mesh-list
64512311|NCT04512235|Cyclophosphamide|cyclophosphamide|mesh-list
64512312|NCT04512235|Bortezomib|bortezomib|mesh-list
64512313|NCT04512235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64512314|NCT04512235|Immunologic Factors|immunologic factors|mesh-ancestor
64512315|NCT04512235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512316|NCT04512235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64512317|NCT04512235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64512318|NCT04512235|Alkylating Agents|alkylating agents|mesh-ancestor
64512319|NCT04512235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512320|NCT04512235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512321|NCT04512235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64512322|NCT04512235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64512323|NCT04512235|Antiemetics|antiemetics|mesh-ancestor
64512324|NCT04512235|Autonomic Agents|autonomic agents|mesh-ancestor
64512325|NCT04512235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64512326|NCT04512235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64512327|NCT04512235|Glucocorticoids|glucocorticoids|mesh-ancestor
64512328|NCT04512235|Hormones|hormones|mesh-ancestor
64512329|NCT04512235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64512330|NCT04512235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64512331|NCT04512066|Risperidone|risperidone|mesh-list
64512332|NCT04512066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64512333|NCT04512066|Serotonin Agents|serotonin agents|mesh-ancestor
64512334|NCT04512066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64512335|NCT04512066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512336|NCT04512066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512337|NCT04512066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64512338|NCT04512066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64512339|NCT04512066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64512340|NCT04512066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64512341|NCT04512066|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64512342|NCT04512066|Dopamine Agents|dopamine agents|mesh-ancestor
64512343|NCT04504825|Dexamethasone|dexamethasone|mesh-list
64512344|NCT04504825|Cyclophosphamide|cyclophosphamide|mesh-list
64324720|NCT01188187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324721|NCT01188187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64786178|NCT00001296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786179|NCT00001296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64786180|NCT00001296|Alkylating Agents|alkylating agents|mesh-ancestor
64786181|NCT00001296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397342|NCT02367937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64512346|NCT04504825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64512347|NCT04504825|Immunologic Factors|immunologic factors|mesh-ancestor
64512348|NCT04504825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512349|NCT04504825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64512350|NCT04504825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64512351|NCT04504825|Alkylating Agents|alkylating agents|mesh-ancestor
64512352|NCT04504825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512353|NCT04504825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512354|NCT04504825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64512355|NCT04504825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64512356|NCT04504825|Antiemetics|antiemetics|mesh-ancestor
64512357|NCT04504825|Autonomic Agents|autonomic agents|mesh-ancestor
64512358|NCT04504825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64512359|NCT04504825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64727162|NCT00002611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64727164|NCT00002611|Antimitotic Agents|antimitotic agents|mesh-ancestor
64727165|NCT00002611|Mitosis Modulators|mitosis modulators|mesh-ancestor
64727166|NCT00002611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64727167|NCT00002611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64727168|NCT00002611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64334632|NCT02228135|Glucocorticoids|glucocorticoids|mesh-ancestor
64512381|NCT04449549|Paclitaxel|paclitaxel|mesh-list
64512382|NCT04449549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64512383|NCT04449549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512384|NCT04449549|Tubulin Modulators|tubulin modulators|mesh-ancestor
64955595|NCT00203788|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64512397|NCT04447027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512399|NCT04447027|Glucocorticoids|glucocorticoids|mesh-ancestor
64512400|NCT04447027|Hormones|hormones|mesh-ancestor
64512401|NCT04447027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64512402|NCT04447027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64512403|NCT04447027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512404|NCT04447027|Immunologic Factors|immunologic factors|mesh-ancestor
64512405|NCT04447027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64315974|NCT04429022|Narcotics|narcotics|mesh-ancestor
64315975|NCT04429022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64315976|NCT04429022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64315977|NCT04429022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64315978|NCT04429022|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64315979|NCT04429022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64315980|NCT04429022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64315981|NCT04429022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315982|NCT04429022|Anticonvulsants|anticonvulsants|mesh-ancestor
64315983|NCT04429022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64315984|NCT04429022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64512406|NCT04447027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64512407|NCT04447027|Growth Substances|growth substances|mesh-ancestor
64512408|NCT04447027|Growth Inhibitors|growth inhibitors|mesh-ancestor
64512409|NCT04447027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64512410|NCT04447027|Antimetabolites|antimetabolites|mesh-ancestor
64512411|NCT04447027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512412|NCT04447027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64512413|NCT04447027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64512426|NCT04421092|Lidocaine|lidocaine|mesh-list
64512427|NCT04421092|Anesthetics, Local|anesthetics, local|mesh-ancestor
64512428|NCT04421092|Anesthetics|anesthetics|mesh-ancestor
64512429|NCT04421092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64512430|NCT04421092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512431|NCT04421092|Sensory System Agents|sensory system agents|mesh-ancestor
64512432|NCT04421092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64512433|NCT04421092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64512434|NCT04421092|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64512435|NCT04421092|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64512436|NCT04421092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64512437|NCT04421092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512438|NCT04406727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64512439|NCT04406727|UB-421|ub-421|mesh-list
64512440|NCT04406727|Antiviral Agents|antiviral agents|mesh-ancestor
64512441|NCT04406727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64512468|NCT04364945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64512469|NCT04364945|Adrenergic Agents|adrenergic agents|mesh-ancestor
64512470|NCT04364945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64512471|NCT04364945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512487|NCT04322318|Doxorubicin|doxorubicin|mesh-list
64512488|NCT04322318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64512489|NCT04322318|Irinotecan|irinotecan|mesh-list
64512490|NCT04322318|Etoposide|etoposide|mesh-list
64512491|NCT04322318|Vincristine|vincristine|mesh-list
64955596|NCT00203788|Dopamine Agents|dopamine agents|mesh-ancestor
64512547|NCT04256941|Anastrozole|anastrozole|mesh-list
64512548|NCT04256941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512549|NCT04256941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64512550|NCT04256941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64512551|NCT04256941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64512552|NCT04256941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512553|NCT04256941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64512554|NCT04256941|Hormone Antagonists|hormone antagonists|mesh-ancestor
64512555|NCT04256941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64512556|NCT04256941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727169|NCT00002611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64727170|NCT00003944|Paclitaxel|paclitaxel|mesh-list
64727171|NCT00003944|Cyclophosphamide|cyclophosphamide|mesh-list
64727172|NCT00003944|Carboplatin|carboplatin|mesh-list
64727173|NCT00003944|Topotecan|topotecan|mesh-list
64727174|NCT00003944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64727175|NCT00003944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334644|NCT02295709|Dexamethasone|dexamethasone|mesh-list
64512557|NCT04256941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64316024|NCT05557604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64316025|NCT05557604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316027|NCT05557136|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64316028|NCT05557136|Anesthetics, General|anesthetics, general|mesh-ancestor
64376447|NCT03235037|Dopamine Agents|dopamine agents|mesh-ancestor
64512558|NCT04256941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64512559|NCT04256941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64512560|NCT04235608|Propofol|propofol|mesh-list
64512561|NCT04235608|Sevoflurane|sevoflurane|mesh-list
64512562|NCT04235608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64512563|NCT04235608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64512564|NCT04235608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512565|NCT04235608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64955597|NCT00072033|Docetaxel|docetaxel|mesh-list
64512566|NCT04235608|Anesthetics, General|anesthetics, general|mesh-ancestor
64512567|NCT04235608|Anesthetics|anesthetics|mesh-ancestor
64512635|NCT04161027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512636|NCT04161027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64512637|NCT04161027|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64512638|NCT04161027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64512639|NCT04161027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64512640|NCT04161027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64512647|NCT04126135|Nicotine|nicotine|mesh-list
64512648|NCT04126135|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64512649|NCT04126135|Autonomic Agents|autonomic agents|mesh-ancestor
64512650|NCT04126135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64955598|NCT00072033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512651|NCT04126135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512652|NCT04126135|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64512653|NCT04126135|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64955599|NCT00072033|Tubulin Modulators|tubulin modulators|mesh-ancestor
64955600|NCT00072033|Antimitotic Agents|antimitotic agents|mesh-ancestor
64512654|NCT04126135|Cholinergic Agents|cholinergic agents|mesh-ancestor
64512655|NCT04126135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64512656|NCT04126135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512678|NCT04085315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512679|NCT04085315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64512680|NCT04085315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64512681|NCT04085315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512683|NCT04083170|Cyclophosphamide|cyclophosphamide|mesh-list
64512684|NCT04083170|Thiotepa|thiotepa|mesh-list
64512685|NCT04083170|Fludarabine|fludarabine|mesh-list
64512686|NCT04083170|Fludarabine phosphate|fludarabine phosphate|mesh-list
64512687|NCT04083170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64512688|NCT04083170|Immunologic Factors|immunologic factors|mesh-ancestor
64512714|NCT04025554|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64512715|NCT04025554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64512716|NCT04022239|Mycophenolic Acid|mycophenolic acid|mesh-list
64512717|NCT04022239|Cyclophosphamide|cyclophosphamide|mesh-list
64512718|NCT04022239|Melphalan|melphalan|mesh-list
64512719|NCT04022239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64512720|NCT04022239|Mechlorethamine|mechlorethamine|mesh-list
64512721|NCT04022239|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64512722|NCT04022239|Rituximab|rituximab|mesh-list
64512723|NCT04022239|Fludarabine|fludarabine|mesh-list
64727176|NCT00003944|Tubulin Modulators|tubulin modulators|mesh-ancestor
64727177|NCT00003944|Antimitotic Agents|antimitotic agents|mesh-ancestor
64727178|NCT00003944|Mitosis Modulators|mitosis modulators|mesh-ancestor
64324723|NCT01188187|Hormones|hormones|mesh-ancestor
64324724|NCT01188187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64324725|NCT01188187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64324726|NCT01188187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316030|NCT05557136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64316031|NCT05557136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334647|NCT02295709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64512724|NCT04022239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64512726|NCT04022239|Antibodies|antibodies|mesh-list
64512727|NCT04022239|Immunoglobulins|immunoglobulins|mesh-list
64512728|NCT04022239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64512729|NCT04022239|Lenograstim|lenograstim|mesh-list
64512730|NCT04022239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64512731|NCT04022239|Immunologic Factors|immunologic factors|mesh-ancestor
64512732|NCT04022239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512733|NCT04022239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64512734|NCT04022239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64512735|NCT04022239|Alkylating Agents|alkylating agents|mesh-ancestor
64512736|NCT04022239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512737|NCT04022239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512738|NCT04022239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64512739|NCT04022239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64512740|NCT04022239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64512741|NCT04022239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64512742|NCT04022239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64512743|NCT04022239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64512744|NCT04022239|Antitubercular Agents|antitubercular agents|mesh-ancestor
64512745|NCT04022239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64512746|NCT04022239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64512748|NCT04019964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64512749|NCT04019964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512750|NCT04019964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64512751|NCT04019964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512752|NCT04011345|Folic Acid|folic acid|mesh-list
64512765|NCT04001829|Mitosis Modulators|mitosis modulators|mesh-ancestor
64512766|NCT04001829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512767|NCT03990571|Avelumab|avelumab|mesh-list
64512768|NCT03990571|Axitinib|axitinib|mesh-list
64422473|NCT05450965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64422474|NCT05450965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422475|NCT05450965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512769|NCT03990571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64512770|NCT03990571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64512771|NCT03990571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512772|NCT03990571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64512773|NCT03990571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324727|NCT01188187|Tubulin Modulators|tubulin modulators|mesh-ancestor
64324728|NCT01188187|Antimitotic Agents|antimitotic agents|mesh-ancestor
64324729|NCT01188187|Mitosis Modulators|mitosis modulators|mesh-ancestor
64316043|NCT05556122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64316044|NCT05556122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64316045|NCT05556122|Respiratory System Agents|respiratory system agents|mesh-ancestor
64512774|NCT03990571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512775|NCT03990571|Immunologic Factors|immunologic factors|mesh-ancestor
64512776|NCT03990571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512777|NCT03959085|Calcium, Dietary|calcium, dietary|mesh-list
64512778|NCT03959085|Leucovorin|leucovorin|mesh-list
64512779|NCT03959085|Folic Acid|folic acid|mesh-list
64512780|NCT03959085|Cytarabine|cytarabine|mesh-list
64512781|NCT03959085|Dexamethasone|dexamethasone|mesh-list
64512782|NCT03959085|Dexamethasone acetate|dexamethasone acetate|mesh-list
64512783|NCT03959085|Prednisolone|prednisolone|mesh-list
64512784|NCT03959085|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64512785|NCT03959085|Methylprednisolone|methylprednisolone|mesh-list
64512786|NCT03959085|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64512787|NCT03959085|Prednisolone acetate|prednisolone acetate|mesh-list
64512788|NCT03959085|Hydrocortisone|hydrocortisone|mesh-list
64512789|NCT03959085|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64512790|NCT03959085|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64512791|NCT03959085|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64512792|NCT03959085|Cyclophosphamide|cyclophosphamide|mesh-list
64512793|NCT03959085|Doxorubicin|doxorubicin|mesh-list
64512794|NCT03959085|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64512795|NCT03959085|Methotrexate|methotrexate|mesh-list
64512796|NCT03959085|Vincristine|vincristine|mesh-list
64512797|NCT03959085|Daunorubicin|daunorubicin|mesh-list
64512798|NCT03959085|Asparaginase|asparaginase|mesh-list
64512799|NCT03959085|Mercaptopurine|mercaptopurine|mesh-list
64512800|NCT03959085|Pegaspargase|pegaspargase|mesh-list
64512801|NCT03959085|Thioguanine|thioguanine|mesh-list
64512802|NCT03959085|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
64512803|NCT03959085|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64512804|NCT03959085|Prednisolone phosphate|prednisolone phosphate|mesh-list
64512805|NCT03959085|BB 1101|bb 1101|mesh-list
64512806|NCT03959085|Calcium|calcium|mesh-list
64512807|NCT03959085|2-Aminopurine|2-aminopurine|mesh-list
64512808|NCT03959085|Levoleucovorin|levoleucovorin|mesh-list
64727179|NCT00003944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727180|NCT00003944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64786182|NCT00001296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64786183|NCT00001296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64786184|NCT00001296|Immunologic Factors|immunologic factors|mesh-ancestor
64786185|NCT00001296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786186|NCT00001422|Fludarabine|fludarabine|mesh-list
64786187|NCT00001422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64786188|NCT00001428|Fluorouracil|fluorouracil|mesh-list
64786189|NCT00001428|Antimetabolites|antimetabolites|mesh-ancestor
64786190|NCT00001428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727181|NCT00003944|Immunologic Factors|immunologic factors|mesh-ancestor
64727182|NCT00003944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727183|NCT00003944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64727184|NCT00003944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64727185|NCT00003944|Alkylating Agents|alkylating agents|mesh-ancestor
64727186|NCT00003944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64727187|NCT00003944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64727188|NCT00003944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64727189|NCT00003944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727191|NCT00003950|Irinotecan|irinotecan|mesh-list
64727192|NCT00003950|Cyclosporins|cyclosporins|mesh-list
64727193|NCT00003950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64727194|NCT00003950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64727195|NCT00003950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64512809|NCT03959085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64512810|NCT03959085|Immunologic Factors|immunologic factors|mesh-ancestor
64512811|NCT03959085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512812|NCT03959085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64512813|NCT03959085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64512814|NCT03959085|Alkylating Agents|alkylating agents|mesh-ancestor
64512815|NCT03959085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512816|NCT03959085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512817|NCT03959085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64512818|NCT03959085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64512819|NCT03959085|Antiemetics|antiemetics|mesh-ancestor
64512820|NCT03959085|Autonomic Agents|autonomic agents|mesh-ancestor
64512829|NCT03959085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64512830|NCT03959085|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64512831|NCT03959085|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64512845|NCT03959085|Protective Agents|protective agents|mesh-ancestor
64603610|NCT02379195|Analgesics|analgesics|mesh-ancestor
64512846|NCT03959085|Vitamin B Complex|vitamin b complex|mesh-ancestor
64512848|NCT03959085|Micronutrients|micronutrients|mesh-ancestor
64512849|NCT03959085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64512850|NCT03959085|Tubulin Modulators|tubulin modulators|mesh-ancestor
64316086|NCT05549336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316087|NCT05549336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316088|NCT04759274|Diuretics|diuretics|mesh-list
64316089|NCT04759274|Natriuretic Agents|natriuretic agents|mesh-ancestor
64316090|NCT04759274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316091|NCT05549024|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64316092|NCT05549024|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64316093|NCT05549024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316094|NCT01666730|Leucovorin|leucovorin|mesh-list
64316095|NCT01666730|Metformin|metformin|mesh-list
64316096|NCT01666730|Fluorouracil|fluorouracil|mesh-list
64316097|NCT01666730|Oxaliplatin|oxaliplatin|mesh-list
64316098|NCT01666730|Calcium|calcium|mesh-list
64316099|NCT01666730|Levoleucovorin|levoleucovorin|mesh-list
64316100|NCT01666730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64316101|NCT01666730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316102|NCT01666730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64316103|NCT01666730|Antimetabolites|antimetabolites|mesh-ancestor
64376538|NCT02452307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512851|NCT03959085|Antimitotic Agents|antimitotic agents|mesh-ancestor
64512852|NCT03959085|Mitosis Modulators|mitosis modulators|mesh-ancestor
64512853|NCT03959085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64512854|NCT03959085|Hematinics|hematinics|mesh-ancestor
64512855|NCT03959085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64512871|NCT03937830|Bevacizumab|bevacizumab|mesh-list
64512873|NCT03937830|Doxorubicin|doxorubicin|mesh-list
64512874|NCT03937830|Tremelimumab|tremelimumab|mesh-list
64512875|NCT03937830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64512876|NCT03937830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512877|NCT03937830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64512878|NCT03937830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64512879|NCT03937830|Growth Substances|growth substances|mesh-ancestor
64512880|NCT03937830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512881|NCT03937830|Growth Inhibitors|growth inhibitors|mesh-ancestor
64512882|NCT03937830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64512883|NCT03937830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64512884|NCT03937830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64512885|NCT03937830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64512886|NCT03937830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512887|NCT03936777|Fenfluramine|fenfluramine|mesh-list
64512888|NCT03936777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64727196|NCT00003950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727197|NCT00003950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727198|NCT00003950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727199|NCT00003950|Immunologic Factors|immunologic factors|mesh-ancestor
64727200|NCT00003950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512889|NCT03936777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64512890|NCT03936777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64512891|NCT03936777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512892|NCT03936777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64512893|NCT03936777|Serotonin Agents|serotonin agents|mesh-ancestor
64512894|NCT03936777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512895|NCT03927521|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64512896|NCT03927521|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64512897|NCT03927521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512912|NCT03889756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64512913|NCT03889756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64512914|NCT03889756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64512915|NCT03889756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955602|NCT00072033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316104|NCT01666730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316106|NCT01666730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316107|NCT01666730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64316108|NCT01666730|Immunologic Factors|immunologic factors|mesh-ancestor
64316109|NCT01666730|Antidotes|antidotes|mesh-ancestor
64316110|NCT01666730|Protective Agents|protective agents|mesh-ancestor
64316111|NCT01666730|Vitamin B Complex|vitamin b complex|mesh-ancestor
64316112|NCT01666730|Vitamins|vitamins|mesh-ancestor
64316113|NCT01666730|Micronutrients|micronutrients|mesh-ancestor
64316114|NCT05554094|Psilocybin|psilocybin|mesh-list
64316115|NCT05554094|Hallucinogens|hallucinogens|mesh-ancestor
64316116|NCT05554094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316117|NCT05554094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64316118|NCT04434560|Nivolumab|nivolumab|mesh-list
64316119|NCT04434560|Ipilimumab|ipilimumab|mesh-list
64376587|NCT03226145|Scopolamine|scopolamine|mesh-list
64512929|NCT03887780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512931|NCT03882580|Antineoplastic Agents|antineoplastic agents|mesh-list
64512932|NCT03881696|Omalizumab|omalizumab|mesh-list
64512933|NCT03881696|Immunologic Factors|immunologic factors|mesh-list
64512934|NCT03881696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64512935|NCT03881696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512936|NCT03881696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64512937|NCT03881696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64512938|NCT03881696|Respiratory System Agents|respiratory system agents|mesh-ancestor
64512939|NCT03864406|Darunavir|darunavir|mesh-list
64512940|NCT03864406|Cobicistat|cobicistat|mesh-list
64512941|NCT03864406|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
64512945|NCT03864406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64512946|NCT03864406|Protease Inhibitors|protease inhibitors|mesh-ancestor
64512947|NCT03864406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422497|NCT02293863|Oseltamivir|oseltamivir|mesh-list
64422498|NCT02293863|Antiviral Agents|antiviral agents|mesh-ancestor
64422499|NCT02293863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64422500|NCT02293863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422501|NCT02293863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422502|NCT02293395|Aspirin|aspirin|mesh-list
64512948|NCT03864406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512949|NCT03864406|Anticoagulants|anticoagulants|mesh-ancestor
64512950|NCT03864406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64512951|NCT03864406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64512952|NCT03864406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64512953|NCT03864406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64512954|NCT03864406|Antiviral Agents|antiviral agents|mesh-ancestor
64512955|NCT03864406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64512956|NCT03864406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64512957|NCT03864406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64512962|NCT03845114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64512963|NCT03845114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64512964|NCT03845114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512975|NCT03794349|Eflornithine|eflornithine|mesh-list
64512976|NCT03794349|Irinotecan|irinotecan|mesh-list
64512977|NCT03794349|Camptothecin|camptothecin|mesh-list
64512985|NCT03794349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512987|NCT03794349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64512988|NCT03794349|Alkylating Agents|alkylating agents|mesh-ancestor
64512989|NCT03794349|Immunologic Factors|immunologic factors|mesh-ancestor
64512990|NCT03794349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512991|NCT03794349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64512992|NCT03794349|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64512993|NCT03794349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64512994|NCT03794349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64512995|NCT03794349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64512996|NCT03794349|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64955604|NCT00203905|Fluorouracil|fluorouracil|mesh-list
64955605|NCT00203905|Hydroxyurea|hydroxyurea|mesh-list
64513019|NCT03778502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64513020|NCT03778502|Protease Inhibitors|protease inhibitors|mesh-ancestor
64513021|NCT03778502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64513022|NCT03778502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727201|NCT00003950|Antifungal Agents|antifungal agents|mesh-ancestor
64727202|NCT00003950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64727203|NCT00003950|Dermatologic Agents|dermatologic agents|mesh-ancestor
64727204|NCT00003950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64727205|NCT00003950|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64513024|NCT03775200|Hallucinogens|hallucinogens|mesh-ancestor
64324730|NCT01188187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324732|NCT05478356|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64316123|NCT04434560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316124|NCT05700656|Capecitabine|capecitabine|mesh-list
64316125|NCT05700656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64513025|NCT03775200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513026|NCT03775200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64513027|NCT03761095|Dacarbazine|dacarbazine|mesh-list
64513028|NCT03761095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64513029|NCT03761095|Alkylating Agents|alkylating agents|mesh-ancestor
64513030|NCT03761095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513031|NCT03761095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513040|NCT03698669|Analgesics, Opioid|analgesics, opioid|mesh-list
64513041|NCT03698669|Narcotics|narcotics|mesh-ancestor
64513042|NCT03698669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64513043|NCT03698669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513044|NCT03698669|Analgesics|analgesics|mesh-ancestor
64513045|NCT03698669|Sensory System Agents|sensory system agents|mesh-ancestor
64513046|NCT03698669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64513050|NCT03689855|Atezolizumab|atezolizumab|mesh-list
64513051|NCT03689855|Ramucirumab|ramucirumab|mesh-list
64513052|NCT03689855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513053|NCT03635996|Etripamil|etripamil|mesh-list
64513054|NCT03635996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64513057|NCT03635996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64513058|NCT03635996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513060|NCT03613181|Capecitabine|capecitabine|mesh-list
64513061|NCT03613181|Methotrexate|methotrexate|mesh-list
64513062|NCT03613181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64513063|NCT03613181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513064|NCT03613181|Tubulin Modulators|tubulin modulators|mesh-ancestor
64513065|NCT03613181|Antimitotic Agents|antimitotic agents|mesh-ancestor
64513066|NCT03613181|Mitosis Modulators|mitosis modulators|mesh-ancestor
64513067|NCT03613181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513068|NCT03613181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64513069|NCT03613181|Antimetabolites|antimetabolites|mesh-ancestor
64513070|NCT03613181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64513083|NCT03533582|Carboplatin|carboplatin|mesh-list
64513084|NCT03533582|Doxorubicin|doxorubicin|mesh-list
64513085|NCT03533582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64513086|NCT03533582|Fluorouracil|fluorouracil|mesh-list
64513087|NCT03533582|Oxaliplatin|oxaliplatin|mesh-list
64513088|NCT03533582|Irinotecan|irinotecan|mesh-list
64513089|NCT03533582|Etoposide|etoposide|mesh-list
64324733|NCT05478356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64324734|NCT05478356|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64786194|NCT00001428|Immunologic Factors|immunologic factors|mesh-ancestor
64786195|NCT00001428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786196|NCT00001440|Interleukin-2|interleukin-2|mesh-list
64786197|NCT00001440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513090|NCT03533582|Vincristine|vincristine|mesh-list
64513091|NCT03533582|Etoposide phosphate|etoposide phosphate|mesh-list
64513092|NCT03533582|Sorafenib|sorafenib|mesh-list
64513093|NCT03533582|Daunorubicin|daunorubicin|mesh-list
64513094|NCT03533582|Podophyllotoxin|podophyllotoxin|mesh-list
64513095|NCT03533582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513096|NCT03533582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64513097|NCT03533582|Antimetabolites|antimetabolites|mesh-ancestor
64955606|NCT00203905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64513098|NCT03533582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513099|NCT03533582|Antiviral Agents|antiviral agents|mesh-ancestor
64513100|NCT03533582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64513101|NCT03533582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64513102|NCT03533582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64513103|NCT03533582|Immunologic Factors|immunologic factors|mesh-ancestor
64513104|NCT03533582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513105|NCT03533582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64513106|NCT03533582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64513107|NCT03533582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64513108|NCT03533582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64513109|NCT03533582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64513110|NCT03533582|Tubulin Modulators|tubulin modulators|mesh-ancestor
64513111|NCT03533582|Antimitotic Agents|antimitotic agents|mesh-ancestor
64727207|NCT00003464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64727208|NCT00003464|Alkylating Agents|alkylating agents|mesh-ancestor
64727209|NCT00003464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727210|NCT00003464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727211|NCT00003230|Paclitaxel|paclitaxel|mesh-list
64727212|NCT00003230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64727213|NCT00003230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513112|NCT03533582|Mitosis Modulators|mitosis modulators|mesh-ancestor
64513113|NCT03533582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64513114|NCT03533582|Keratolytic Agents|keratolytic agents|mesh-ancestor
64513115|NCT03533582|Dermatologic Agents|dermatologic agents|mesh-ancestor
64513122|NCT03468478|Mycophenolic Acid|mycophenolic acid|mesh-list
64513123|NCT03468478|Sirolimus|sirolimus|mesh-list
64513124|NCT03468478|Everolimus|everolimus|mesh-list
64513125|NCT03468478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513126|NCT03468478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64513127|NCT03468478|Immunologic Factors|immunologic factors|mesh-ancestor
64513128|NCT03468478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513129|NCT03468478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64513130|NCT03468478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64513131|NCT03468478|Antitubercular Agents|antitubercular agents|mesh-ancestor
64513142|NCT03436745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64316151|NCT00103285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64316152|NCT00103285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64316224|NCT03541603|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64316225|NCT03541603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316226|NCT03541603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316227|NCT03541603|Protective Agents|protective agents|mesh-ancestor
64316228|NCT03541603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316230|NCT02160223|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64316239|NCT04802837|Vancomycin|vancomycin|mesh-list
64513143|NCT03436745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64513144|NCT03436745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513145|NCT03436745|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64513146|NCT03436745|GABA Agonists|gaba agonists|mesh-ancestor
64513147|NCT03436745|GABA Agents|gaba agents|mesh-ancestor
64513148|NCT03436745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64513173|NCT03164447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64513174|NCT03164447|Antiviral Agents|antiviral agents|mesh-ancestor
64513175|NCT03164447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64513194|NCT03067181|Cisplatin|cisplatin|mesh-list
64513195|NCT03067181|Carboplatin|carboplatin|mesh-list
64513196|NCT03067181|Etoposide|etoposide|mesh-list
64513197|NCT03067181|Etoposide phosphate|etoposide phosphate|mesh-list
64513198|NCT03067181|Bleomycin|bleomycin|mesh-list
64513199|NCT03067181|Podophyllotoxin|podophyllotoxin|mesh-list
64513200|NCT03067181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513201|NCT03067181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64422509|NCT02293395|Sensory System Agents|sensory system agents|mesh-ancestor
64513202|NCT03067181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64513203|NCT03067181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64513204|NCT03067181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64513205|NCT03067181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513206|NCT03067181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64513207|NCT03067181|Keratolytic Agents|keratolytic agents|mesh-ancestor
64513208|NCT03067181|Dermatologic Agents|dermatologic agents|mesh-ancestor
64513229|NCT02985957|Nivolumab|nivolumab|mesh-list
64513230|NCT02985957|Ipilimumab|ipilimumab|mesh-list
64513231|NCT02985957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64513232|NCT02985957|Glucocorticoids|glucocorticoids|mesh-ancestor
64513233|NCT02985957|Hormones|hormones|mesh-ancestor
64513234|NCT02985957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64513235|NCT02985957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513236|NCT02985957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64513237|NCT02985957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513238|NCT02985957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64513239|NCT02985957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64513240|NCT02985957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513246|NCT02875262|Deferoxamine|deferoxamine|mesh-list
64513247|NCT02875262|Siderophores|siderophores|mesh-ancestor
64513248|NCT02875262|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64513249|NCT02875262|Chelating Agents|chelating agents|mesh-ancestor
64513250|NCT02875262|Sequestering Agents|sequestering agents|mesh-ancestor
64513251|NCT02875262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513326|NCT02778971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513333|NCT02724579|Lomustine|lomustine|mesh-list
64513334|NCT02724579|Cisplatin|cisplatin|mesh-list
64513335|NCT02724579|Vincristine|vincristine|mesh-list
64513336|NCT02724579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727214|NCT00003230|Tubulin Modulators|tubulin modulators|mesh-ancestor
64727215|NCT00003230|Antimitotic Agents|antimitotic agents|mesh-ancestor
64727216|NCT00003230|Mitosis Modulators|mitosis modulators|mesh-ancestor
64727217|NCT00003230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727218|NCT00003956|Leucovorin|leucovorin|mesh-list
64727219|NCT00003956|Fluorouracil|fluorouracil|mesh-list
64727220|NCT00003956|Calcium|calcium|mesh-list
64727221|NCT00003956|Levoleucovorin|levoleucovorin|mesh-list
64727222|NCT00003956|Lonafarnib|lonafarnib|mesh-list
64727223|NCT00003956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64727224|NCT00003956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334687|NCT04464967|Trastuzumab|trastuzumab|mesh-list
64316246|NCT05256797|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64316247|NCT05256797|Protease Inhibitors|protease inhibitors|mesh-ancestor
64316248|NCT05256797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316249|NCT05256797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316250|NCT05256797|Anticoagulants|anticoagulants|mesh-ancestor
64316251|NCT02160301|Acetaminophen|acetaminophen|mesh-list
64316252|NCT02160301|Dexamethasone|dexamethasone|mesh-list
64316253|NCT02160301|Celecoxib|celecoxib|mesh-list
64513337|NCT02724579|Immunologic Factors|immunologic factors|mesh-ancestor
64513338|NCT02724579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513339|NCT02724579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64513340|NCT02724579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64513341|NCT02724579|Alkylating Agents|alkylating agents|mesh-ancestor
64513342|NCT02724579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513343|NCT02724579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513344|NCT02724579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64513345|NCT02724579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64513346|NCT02724579|Tubulin Modulators|tubulin modulators|mesh-ancestor
64513347|NCT02724579|Antimitotic Agents|antimitotic agents|mesh-ancestor
64513348|NCT02724579|Mitosis Modulators|mitosis modulators|mesh-ancestor
64513349|NCT02639273|Nalmefene|nalmefene|mesh-list
64513350|NCT02639273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64513351|NCT02639273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513352|NCT02639273|Sensory System Agents|sensory system agents|mesh-ancestor
64513353|NCT02639273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64513354|NCT02612311|Obinutuzumab|obinutuzumab|mesh-list
64513355|NCT02612311|Chlorambucil|chlorambucil|mesh-list
64513364|NCT02511028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64513365|NCT02477826|Gemcitabine|gemcitabine|mesh-list
64513367|NCT02477826|Carboplatin|carboplatin|mesh-list
64513368|NCT02477826|Nivolumab|nivolumab|mesh-list
64513369|NCT02477826|Pemetrexed|pemetrexed|mesh-list
64513370|NCT02477826|Ipilimumab|ipilimumab|mesh-list
64513371|NCT02477826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64513372|NCT02477826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513373|NCT02477826|Tubulin Modulators|tubulin modulators|mesh-ancestor
64422514|NCT02293395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64422515|NCT02293395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64316256|NCT02160301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64316257|NCT02160301|Antiemetics|antiemetics|mesh-ancestor
64316258|NCT02160301|Autonomic Agents|autonomic agents|mesh-ancestor
64316259|NCT02160301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316260|NCT02160301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316261|NCT02160301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64316262|NCT02160301|Glucocorticoids|glucocorticoids|mesh-ancestor
64316264|NCT02160301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64316265|NCT02160301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64316266|NCT02160301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316267|NCT02160301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64316268|NCT02160301|Analgesics|analgesics|mesh-ancestor
64316269|NCT02160301|Sensory System Agents|sensory system agents|mesh-ancestor
64316270|NCT02160301|Antipyretics|antipyretics|mesh-ancestor
64316271|NCT02160301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64316272|NCT02160301|Narcotics|narcotics|mesh-ancestor
64316273|NCT02160301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64316274|NCT02160301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64316275|NCT02160301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64316276|NCT02160301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64316277|NCT02160301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64316280|NCT02160301|Anticonvulsants|anticonvulsants|mesh-ancestor
64513377|NCT02477826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64513379|NCT02477826|Antiviral Agents|antiviral agents|mesh-ancestor
64513380|NCT02477826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64513381|NCT02477826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64513382|NCT02477826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64513383|NCT02477826|Immunologic Factors|immunologic factors|mesh-ancestor
64513384|NCT02477826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513385|NCT02477826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64513386|NCT02477826|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64513387|NCT02477826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64513388|NCT02477826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64513389|NCT02444546|Sargramostim|sargramostim|mesh-list
64513390|NCT02444546|Immunologic Factors|immunologic factors|mesh-ancestor
64513391|NCT02444546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513400|NCT02176967|Cyclophosphamide|cyclophosphamide|mesh-list
64513401|NCT02176967|Carboplatin|carboplatin|mesh-list
64513402|NCT02176967|Doxorubicin|doxorubicin|mesh-list
64513403|NCT02176967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64513404|NCT02176967|Etoposide|etoposide|mesh-list
64513405|NCT02176967|Etoposide phosphate|etoposide phosphate|mesh-list
64513406|NCT02176967|Podophyllotoxin|podophyllotoxin|mesh-list
64513407|NCT02176967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64513408|NCT02176967|Immunologic Factors|immunologic factors|mesh-ancestor
64513409|NCT02176967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513410|NCT02176967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64727226|NCT00003956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727227|NCT00003956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64727228|NCT00003956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727229|NCT00003956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727230|NCT00003956|Immunologic Factors|immunologic factors|mesh-ancestor
64727231|NCT00003956|Antidotes|antidotes|mesh-ancestor
64727232|NCT00003956|Protective Agents|protective agents|mesh-ancestor
64727233|NCT00003956|Vitamin B Complex|vitamin b complex|mesh-ancestor
64727234|NCT00003956|Vitamins|vitamins|mesh-ancestor
64727235|NCT00003956|Micronutrients|micronutrients|mesh-ancestor
64334697|NCT03146871|Decitabine|decitabine|mesh-list
64513411|NCT02176967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64513412|NCT02176967|Alkylating Agents|alkylating agents|mesh-ancestor
64513413|NCT02176967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513414|NCT02176967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64786205|NCT00001446|Immunologic Factors|immunologic factors|mesh-ancestor
64786206|NCT00001446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786207|NCT00001446|Leprostatic Agents|leprostatic agents|mesh-ancestor
64786208|NCT00001446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64786209|NCT00001446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64513415|NCT02176967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64513416|NCT02176967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64513417|NCT02176967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64513418|NCT02176967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64513419|NCT02176967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64513420|NCT02176967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64513421|NCT02176967|Keratolytic Agents|keratolytic agents|mesh-ancestor
64513422|NCT02176967|Dermatologic Agents|dermatologic agents|mesh-ancestor
64513423|NCT02176967|Tubulin Modulators|tubulin modulators|mesh-ancestor
64513424|NCT02176967|Antimitotic Agents|antimitotic agents|mesh-ancestor
64513425|NCT02176967|Mitosis Modulators|mitosis modulators|mesh-ancestor
64513457|NCT01861106|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64513458|NCT01861106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64955607|NCT00203905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513459|NCT01861106|Immunologic Factors|immunologic factors|mesh-ancestor
64513460|NCT01861106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955608|NCT00203905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64513461|NCT01861106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64513462|NCT01861106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64513463|NCT01861106|Alkylating Agents|alkylating agents|mesh-ancestor
64513464|NCT01861106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513465|NCT01861106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513466|NCT01861106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64513467|NCT01861106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64513469|NCT01861106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64513470|NCT01861106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64513471|NCT01861106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64513472|NCT01861106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64513473|NCT01861106|Antitubercular Agents|antitubercular agents|mesh-ancestor
64513474|NCT01861106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64513475|NCT01861106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64513476|NCT01842386|Rituximab|rituximab|mesh-list
64513477|NCT01842386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64513478|NCT01842386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513479|NCT01842386|Immunologic Factors|immunologic factors|mesh-ancestor
64513480|NCT01842386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786213|NCT00001446|Growth Inhibitors|growth inhibitors|mesh-ancestor
64324738|NCT05478356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64324739|NCT05478356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316327|NCT05174585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64513481|NCT01842386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64513482|NCT01712620|Spironolactone|spironolactone|mesh-list
64513524|NCT01160926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64513525|NCT01160926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64513526|NCT01160926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513527|NCT01126957|Fentanyl|fentanyl|mesh-list
64513528|NCT01126957|Ketamine|ketamine|mesh-list
64513529|NCT01126957|Propofol|propofol|mesh-list
64513530|NCT01126957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64513531|NCT01126957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64513532|NCT01126957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727236|NCT00003956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727237|NCT00002623|Carboplatin|carboplatin|mesh-list
64727238|NCT00002623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727239|NCT00003962|Aldesleukin|aldesleukin|mesh-list
64727240|NCT00003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727241|NCT00003962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64727242|NCT00003962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64727243|NCT00003962|Antiviral Agents|antiviral agents|mesh-ancestor
64727244|NCT00003962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64727245|NCT00003236|ISIS 5132|isis 5132|mesh-list
64727246|NCT00003236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727247|NCT00003236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727248|NCT00003236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727249|NCT00003968|Bryostatin 1|bryostatin 1|mesh-list
64727250|NCT00003968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64727251|NCT00003968|Immunologic Factors|immunologic factors|mesh-ancestor
64513533|NCT01126957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64513534|NCT01126957|Anesthetics, General|anesthetics, general|mesh-ancestor
64513535|NCT01126957|Anesthetics|anesthetics|mesh-ancestor
64513536|NCT01126957|Analgesics|analgesics|mesh-ancestor
64513537|NCT01126957|Sensory System Agents|sensory system agents|mesh-ancestor
64513538|NCT01126957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64513539|NCT01126957|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64513540|NCT01126957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64513541|NCT01126957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64513542|NCT01126957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64513543|NCT01126957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513544|NCT01126957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64513545|NCT01126957|Narcotics|narcotics|mesh-ancestor
64513546|NCT01126957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64513547|NCT01125228|Interferons|interferons|mesh-list
64513548|NCT01125228|Interferon-alpha|interferon-alpha|mesh-list
64513549|NCT01125228|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
64513550|NCT01125228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324740|NCT05478356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64324741|NCT05478356|Respiratory System Agents|respiratory system agents|mesh-ancestor
64324743|NCT05478356|Parasympatholytics|parasympatholytics|mesh-ancestor
64324744|NCT05478356|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64316359|NCT05125055|Immunologic Factors|immunologic factors|mesh-ancestor
64316360|NCT05125055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316361|NCT04355858|Paclitaxel|paclitaxel|mesh-list
64316362|NCT04355858|Capecitabine|capecitabine|mesh-list
64316363|NCT04355858|Everolimus|everolimus|mesh-list
64316364|NCT04355858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64316365|NCT04355858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316366|NCT04355858|Tubulin Modulators|tubulin modulators|mesh-ancestor
64316367|NCT04355858|Antimitotic Agents|antimitotic agents|mesh-ancestor
64376774|NCT03045471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64513551|NCT01125228|Antiviral Agents|antiviral agents|mesh-ancestor
64513552|NCT01125228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64513553|NCT01125228|Immunologic Factors|immunologic factors|mesh-ancestor
64513554|NCT01125228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513555|NCT00977977|Cyclosporine|cyclosporine|mesh-list
64513556|NCT00977977|Rituximab|rituximab|mesh-list
64513557|NCT00977977|Cyclosporins|cyclosporins|mesh-list
64513558|NCT00977977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64513559|NCT00977977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513560|NCT00977977|Immunologic Factors|immunologic factors|mesh-ancestor
64513561|NCT00977977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955609|NCT00203905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64513562|NCT00977977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64955610|NCT00203905|Growth Substances|growth substances|mesh-ancestor
64513563|NCT00977977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64513564|NCT00977977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513565|NCT00977977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64513566|NCT00977977|Antifungal Agents|antifungal agents|mesh-ancestor
64513567|NCT00977977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64513568|NCT00977977|Dermatologic Agents|dermatologic agents|mesh-ancestor
64513569|NCT00977977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64513570|NCT00858273|Insulin|insulin|mesh-list
64513571|NCT00858273|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64513572|NCT00858273|Antioxidants|antioxidants|mesh-list
64727784|NCT00003578|Antimitotic Agents|antimitotic agents|mesh-ancestor
64727785|NCT00003578|Mitosis Modulators|mitosis modulators|mesh-ancestor
64727787|NCT00003584|Estramustine|estramustine|mesh-list
64727788|NCT00003584|Vinorelbine|vinorelbine|mesh-list
64727789|NCT00003584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64727790|NCT00003584|Glucocorticoids|glucocorticoids|mesh-ancestor
64727791|NCT00003584|Hormones|hormones|mesh-ancestor
64727792|NCT00003584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64727793|NCT00003584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727794|NCT00003584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64727795|NCT00003584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727796|NCT00003584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64727797|NCT00003584|Tubulin Modulators|tubulin modulators|mesh-ancestor
64727798|NCT00003584|Antimitotic Agents|antimitotic agents|mesh-ancestor
64727799|NCT00003584|Mitosis Modulators|mitosis modulators|mesh-ancestor
64727800|NCT00003584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727801|NCT00003584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64727802|NCT00003584|Alkylating Agents|alkylating agents|mesh-ancestor
64316368|NCT04355858|Mitosis Modulators|mitosis modulators|mesh-ancestor
64316369|NCT04355858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316370|NCT04355858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64316371|NCT04355858|Antimetabolites|antimetabolites|mesh-ancestor
64316372|NCT04355858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64316373|NCT04355858|Immunologic Factors|immunologic factors|mesh-ancestor
64316374|NCT04355858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316375|NCT05610956|Empagliflozin|empagliflozin|mesh-list
64316376|NCT05610956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64727803|NCT00002701|Cytarabine|cytarabine|mesh-list
64727804|NCT00002701|Cyclophosphamide|cyclophosphamide|mesh-list
64727805|NCT00002701|Busulfan|busulfan|mesh-list
64727806|NCT00002701|Methotrexate|methotrexate|mesh-list
64727807|NCT00002701|Etoposide|etoposide|mesh-list
64727819|NCT00002701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727820|NCT00002701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727821|NCT00002701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64727822|NCT00002701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64727823|NCT00002701|Abortifacient Agents|abortifacient agents|mesh-ancestor
64727824|NCT00002701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64727825|NCT00002701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64727826|NCT00002701|Antimetabolites|antimetabolites|mesh-ancestor
64727827|NCT00002701|Dermatologic Agents|dermatologic agents|mesh-ancestor
64727828|NCT00002701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727829|NCT00002701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64727830|NCT00002701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64727831|NCT00002701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64727832|NCT00002701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64727833|NCT00002701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64727834|NCT00002701|Antiviral Agents|antiviral agents|mesh-ancestor
64727835|NCT00002701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64727836|NCT00002701|Analgesics|analgesics|mesh-ancestor
64727837|NCT00002701|Sensory System Agents|sensory system agents|mesh-ancestor
64727838|NCT00002701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64727839|NCT00002701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64727840|NCT00002701|Keratolytic Agents|keratolytic agents|mesh-ancestor
64727841|NCT00004070|Interleukin-12|interleukin-12|mesh-list
64727974|NCT00003332|Antimetabolites|antimetabolites|mesh-ancestor
64727975|NCT00003332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727976|NCT00003332|Antiviral Agents|antiviral agents|mesh-ancestor
64727977|NCT00003332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64727978|NCT00003332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64727979|NCT00003332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64727980|NCT00003332|Immunologic Factors|immunologic factors|mesh-ancestor
64727981|NCT00003332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727982|NCT00003614|Paclitaxel|paclitaxel|mesh-list
64727983|NCT00003614|Estramustine|estramustine|mesh-list
64727984|NCT00003614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64727985|NCT00003614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64727989|NCT00003614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64727991|NCT00003614|Alkylating Agents|alkylating agents|mesh-ancestor
64727992|NCT00003614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64727993|NCT00004094|Paclitaxel|paclitaxel|mesh-list
64727994|NCT00004094|Carboplatin|carboplatin|mesh-list
64727995|NCT00004094|Fluorouracil|fluorouracil|mesh-list
64727996|NCT00004094|Hydroxyurea|hydroxyurea|mesh-list
64727997|NCT00004094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64316392|NCT05699876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64316393|NCT05699876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64316394|NCT05699876|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64316395|NCT05699876|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64316396|NCT05699876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64316397|NCT05699876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316398|NCT05699876|Antimanic Agents|antimanic agents|mesh-ancestor
64316399|NCT05699876|Antioxidants|antioxidants|mesh-ancestor
64316400|NCT05699876|Protective Agents|protective agents|mesh-ancestor
64316401|NCT05610878|Curcumin|curcumin|mesh-list
64316402|NCT05610878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64376830|NCT04873011|Quinine|quinine|mesh-list
64728014|NCT00004100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64728015|NCT00004100|Antimetabolites|antimetabolites|mesh-ancestor
64728016|NCT00004100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728017|NCT00004100|Antiviral Agents|antiviral agents|mesh-ancestor
64728018|NCT00004100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64728019|NCT00004100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728020|NCT00004100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728021|NCT00004100|Immunologic Factors|immunologic factors|mesh-ancestor
64728022|NCT00004100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728030|NCT00002737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728031|NCT00002737|Antiviral Agents|antiviral agents|mesh-ancestor
64728032|NCT00002737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64728033|NCT00002737|Immunologic Factors|immunologic factors|mesh-ancestor
64728034|NCT00002737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728035|NCT00002737|Dermatologic Agents|dermatologic agents|mesh-ancestor
64728036|NCT00003338|Epratuzumab|epratuzumab|mesh-list
64728037|NCT00003338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64728038|NCT00003338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728040|NCT00003620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728041|NCT00003620|Growth Inhibitors|growth inhibitors|mesh-ancestor
64728042|NCT00003620|Growth Substances|growth substances|mesh-ancestor
64728043|NCT00003620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728044|NCT00003620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64728045|NCT00003620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728046|NCT00003620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728047|NCT00003344|Irinotecan|irinotecan|mesh-list
64728048|NCT00003344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64728049|NCT00003344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64728050|NCT00003344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728051|NCT00003344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728052|NCT00003344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728053|NCT00003626|Dolastatin 10|dolastatin 10|mesh-list
64728054|NCT00003626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335458|NCT03766295|Antimetabolites|antimetabolites|mesh-ancestor
64728145|NCT00003356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64728173|NCT00004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728232|NCT00003650|Mitosis Modulators|mitosis modulators|mesh-ancestor
64728233|NCT00003650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64728234|NCT00003650|Protective Agents|protective agents|mesh-ancestor
64728235|NCT00003650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64728236|NCT00003650|Analgesics|analgesics|mesh-ancestor
64728237|NCT00003650|Sensory System Agents|sensory system agents|mesh-ancestor
64728238|NCT00002755|Tamoxifen|tamoxifen|mesh-list
64728239|NCT00002755|Cobalt|cobalt|mesh-list
64728240|NCT00002755|Cyclophosphamide|cyclophosphamide|mesh-list
64728241|NCT00002755|Thiotepa|thiotepa|mesh-list
64728242|NCT00002755|Doxorubicin|doxorubicin|mesh-list
64728243|NCT00002755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64728244|NCT00002755|Fluorouracil|fluorouracil|mesh-list
64728245|NCT00002755|Methotrexate|methotrexate|mesh-list
64467503|NCT04783636|Leuprolide|leuprolide|mesh-list
64728246|NCT00002755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728247|NCT00002755|Immunologic Factors|immunologic factors|mesh-ancestor
64786214|NCT00001446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64786215|NCT00001572|Saponin QA-21V1|saponin qa-21v1|mesh-list
64786219|NCT00001626|Cyclosporine|cyclosporine|mesh-list
64728248|NCT00002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728249|NCT00002755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64728250|NCT00002755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64728251|NCT00002755|Alkylating Agents|alkylating agents|mesh-ancestor
64728252|NCT00002755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728253|NCT00002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728254|NCT00002755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64728255|NCT00002755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64728256|NCT00002755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64728257|NCT00002755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64728258|NCT00002755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728259|NCT00002755|Antimetabolites|antimetabolites|mesh-ancestor
64955828|NCT00039455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64728260|NCT00002755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64728261|NCT00002755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64728262|NCT00002755|Abortifacient Agents|abortifacient agents|mesh-ancestor
64728263|NCT00002755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64728264|NCT00002755|Dermatologic Agents|dermatologic agents|mesh-ancestor
64728265|NCT00002755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64336931|NCT02314351|Autonomic Agents|autonomic agents|mesh-ancestor
64728290|NCT00002761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728291|NCT00002761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728292|NCT00002761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64728293|NCT00002761|Antiviral Agents|antiviral agents|mesh-ancestor
64728294|NCT00002761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64728295|NCT00002761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64728296|NCT00002761|Antimetabolites|antimetabolites|mesh-ancestor
64728297|NCT00002761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728298|NCT00002761|Antifungal Agents|antifungal agents|mesh-ancestor
64728299|NCT00002761|Dermatologic Agents|dermatologic agents|mesh-ancestor
64728300|NCT00002761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64728301|NCT00002761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64728302|NCT00002761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64728365|NCT00002773|Alkylating Agents|alkylating agents|mesh-ancestor
64728366|NCT00002773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728367|NCT00002773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728368|NCT00002773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64786223|NCT00001626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64786224|NCT00001626|Immunologic Factors|immunologic factors|mesh-ancestor
64786225|NCT00001626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324745|NCT05478356|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64324746|NCT05478356|Cholinergic Agents|cholinergic agents|mesh-ancestor
64324747|NCT05478356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64324748|NCT05478356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316418|NCT02706405|Immunoglobulin G|immunoglobulin g|mesh-list
64316419|NCT02706405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64316420|NCT02706405|Immunologic Factors|immunologic factors|mesh-ancestor
64316421|NCT02706405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316422|NCT02706405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64316423|NCT02706405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64316424|NCT02706405|Alkylating Agents|alkylating agents|mesh-ancestor
64316429|NCT02254031|Maytansine|maytansine|mesh-list
64728369|NCT00002773|Antiviral Agents|antiviral agents|mesh-ancestor
64728370|NCT00002773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64728371|NCT00004160|Gemcitabine|gemcitabine|mesh-list
64728382|NCT00004160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64728383|NCT00004160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728502|NCT00002785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64728503|NCT00002785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64728504|NCT00002785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64728505|NCT00002785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64728506|NCT00002785|Antiviral Agents|antiviral agents|mesh-ancestor
64728507|NCT00002785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64728508|NCT00002785|Antidotes|antidotes|mesh-ancestor
64728509|NCT00002785|Protective Agents|protective agents|mesh-ancestor
64728510|NCT00002785|Vitamin B Complex|vitamin b complex|mesh-ancestor
64728511|NCT00002785|Vitamins|vitamins|mesh-ancestor
64728512|NCT00002785|Micronutrients|micronutrients|mesh-ancestor
64728513|NCT00002785|Tubulin Modulators|tubulin modulators|mesh-ancestor
64728514|NCT00002785|Antimitotic Agents|antimitotic agents|mesh-ancestor
64728515|NCT00002785|Mitosis Modulators|mitosis modulators|mesh-ancestor
64728516|NCT00002785|Antifungal Agents|antifungal agents|mesh-ancestor
64728517|NCT00002785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64728518|NCT00002785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64728519|NCT00002785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64728520|NCT00002785|Trace Elements|trace elements|mesh-ancestor
64728521|NCT00004184|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64728522|NCT00004184|Antibodies|antibodies|mesh-list
64728523|NCT00004184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64728524|NCT00004184|Sargramostim|sargramostim|mesh-list
64728525|NCT00004184|Aluminum sulfate|aluminum sulfate|mesh-list
64728526|NCT00004184|Immunologic Factors|immunologic factors|mesh-ancestor
64728527|NCT00004184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64728528|NCT00004184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64728529|NCT00004184|Antacids|antacids|mesh-ancestor
64728530|NCT00004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728531|NCT00004184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64728532|NCT00003386|Paclitaxel|paclitaxel|mesh-list
64728533|NCT00003386|Cyclophosphamide|cyclophosphamide|mesh-list
64728534|NCT00003386|Carboplatin|carboplatin|mesh-list
64728535|NCT00003386|Vaccines|vaccines|mesh-list
64728536|NCT00003386|BCG Vaccine|bcg vaccine|mesh-list
64316431|NCT02254031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64316432|NCT02254031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316433|NCT02254031|Tubulin Modulators|tubulin modulators|mesh-ancestor
64316434|NCT02254031|Antimitotic Agents|antimitotic agents|mesh-ancestor
64316435|NCT02254031|Mitosis Modulators|mitosis modulators|mesh-ancestor
64316436|NCT02254031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316437|NCT02254031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64316438|NCT04174352|Tamoxifen|tamoxifen|mesh-list
64316439|NCT04174352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64316440|NCT04174352|Hormone Antagonists|hormone antagonists|mesh-ancestor
64316441|NCT04174352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64316448|NCT03545711|Irinotecan|irinotecan|mesh-list
64728537|NCT00003386|Immunologic Factors|immunologic factors|mesh-ancestor
64728559|NCT00384566|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64728560|NCT00384566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64728561|NCT00384566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64728562|NCT00384566|Adrenergic Agents|adrenergic agents|mesh-ancestor
64728670|NCT05495035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728671|NCT00004856|Trastuzumab|trastuzumab|mesh-list
64728672|NCT00004856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64728673|NCT00004856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728674|NCT00003698|Fosbretabulin|fosbretabulin|mesh-list
64728675|NCT00003698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64728676|NCT00003698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728677|NCT00004862|Cytarabine|cytarabine|mesh-list
64728678|NCT00004862|Fludarabine|fludarabine|mesh-list
64728679|NCT00004862|Fludarabine phosphate|fludarabine phosphate|mesh-list
64728681|NCT00004862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728682|NCT00004862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64728683|NCT00004862|Antimetabolites|antimetabolites|mesh-ancestor
64728684|NCT00004862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64728685|NCT00004862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64728686|NCT00004862|Immunologic Factors|immunologic factors|mesh-ancestor
64728687|NCT00004862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336088|NCT02335281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64728834|NCT00003728|Cyclophosphamide|cyclophosphamide|mesh-list
64728835|NCT00003728|Doxorubicin|doxorubicin|mesh-list
64612932|NCT04364321|Anesthetics|anesthetics|mesh-ancestor
64728979|NCT00004904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64728980|NCT00004904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64728981|NCT00004904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64728982|NCT00004904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64728983|NCT00004904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64728984|NCT00004904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728985|NCT00004904|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64316454|NCT03546959|Botulinum Toxins|botulinum toxins|mesh-list
64316455|NCT03546959|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64316456|NCT03546959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64316457|NCT03546959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316458|NCT03546959|Cholinergic Agents|cholinergic agents|mesh-ancestor
64316459|NCT03546959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64316460|NCT03546959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316461|NCT01569659|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64316462|NCT01569659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64316463|NCT01569659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64316464|NCT01569659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64316465|NCT01569659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316466|NCT01569659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64316467|NCT01569659|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64316468|NCT01569659|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64728986|NCT00004904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64729015|NCT00003758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729016|NCT00003758|Antiviral Agents|antiviral agents|mesh-ancestor
64729018|NCT00003758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64729019|NCT00003758|Immunologic Factors|immunologic factors|mesh-ancestor
64729020|NCT00003758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729021|NCT00003758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64729022|NCT00003758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64729023|NCT00003758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64729024|NCT00003758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729025|NCT00004310|Clomipramine|clomipramine|mesh-list
64729026|NCT00004310|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64729027|NCT00004310|Antidepressive Agents|antidepressive agents|mesh-ancestor
64729028|NCT00004310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64729029|NCT00004310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64729030|NCT00004310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64955871|NCT00205738|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64955872|NCT00205738|Serotonin Agents|serotonin agents|mesh-ancestor
64955873|NCT00205738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64955874|NCT00205738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955875|NCT00205738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955876|NCT00205738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64955877|NCT00205738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64955878|NCT00205738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64955879|NCT00205738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64729031|NCT00004310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64729032|NCT00004310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729033|NCT00004310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64729034|NCT00004310|Serotonin Agents|serotonin agents|mesh-ancestor
64729035|NCT00004310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729037|NCT00004922|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64729038|NCT00004922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64729039|NCT00004922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786226|NCT00001626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64786227|NCT00001626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64786228|NCT00001626|Alkylating Agents|alkylating agents|mesh-ancestor
64786229|NCT00001626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786230|NCT00001626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64786231|NCT00001626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64786232|NCT00001626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316477|NCT01569659|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64316478|NCT01569659|Dopamine Agents|dopamine agents|mesh-ancestor
64316479|NCT02253953|Ritonavir|ritonavir|mesh-list
64316480|NCT02253953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64316481|NCT02253953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64316482|NCT02253953|Protease Inhibitors|protease inhibitors|mesh-ancestor
64316493|NCT02422953|Micronutrients|micronutrients|mesh-list
64729040|NCT00004922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729041|NCT00004922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729042|NCT00004316|Capsaicin|capsaicin|mesh-list
64729043|NCT00004316|Antipruritics|antipruritics|mesh-ancestor
64729044|NCT00004316|Dermatologic Agents|dermatologic agents|mesh-ancestor
64729045|NCT00004316|Sensory System Agents|sensory system agents|mesh-ancestor
64729046|NCT00004316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64729047|NCT00004316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729048|NCT00003764|Cyclophosphamide|cyclophosphamide|mesh-list
64729049|NCT00003764|Fludarabine|fludarabine|mesh-list
64729050|NCT00003764|Fludarabine phosphate|fludarabine phosphate|mesh-list
64729051|NCT00003764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64729052|NCT00003764|Immunologic Factors|immunologic factors|mesh-ancestor
64729053|NCT00003764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729054|NCT00003764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64729055|NCT00003764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64729056|NCT00003764|Alkylating Agents|alkylating agents|mesh-ancestor
64729057|NCT00003764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729058|NCT00003764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729059|NCT00003764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64729060|NCT00003764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64729061|NCT00003764|Antimetabolites|antimetabolites|mesh-ancestor
64729062|NCT00004928|Zoledronic Acid|zoledronic acid|mesh-list
64955880|NCT00205738|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64955881|NCT00205738|Dopamine Agents|dopamine agents|mesh-ancestor
64955882|NCT00205738|Antiemetics|antiemetics|mesh-ancestor
64955883|NCT00205738|Autonomic Agents|autonomic agents|mesh-ancestor
64955884|NCT00205738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64955885|NCT00205738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64729083|NCT00004934|Carboplatin|carboplatin|mesh-list
64729084|NCT00004934|Epirubicin|epirubicin|mesh-list
64729085|NCT00004934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64729086|NCT00004934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64468335|NCT01472835|Fentanyl|fentanyl|mesh-list
64468408|NCT01526733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64729087|NCT00004934|Tubulin Modulators|tubulin modulators|mesh-ancestor
64729088|NCT00004934|Antimitotic Agents|antimitotic agents|mesh-ancestor
64729089|NCT00004934|Mitosis Modulators|mitosis modulators|mesh-ancestor
64729090|NCT00004934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729091|NCT00004934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64729092|NCT00004934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64729093|NCT00004934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64729094|NCT00004934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729095|NCT00003776|Leucovorin|leucovorin|mesh-list
64729096|NCT00003776|Trimetrexate|trimetrexate|mesh-list
64729097|NCT00003776|Doxorubicin|doxorubicin|mesh-list
64729098|NCT00003776|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64316498|NCT04053140|Penicillin G Benzathine|penicillin g benzathine|mesh-list
64316499|NCT04053140|Penicillin G Procaine|penicillin g procaine|mesh-list
64316500|NCT04053140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64316501|NCT04053140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64316502|NCT03733535|Benralizumab|benralizumab|mesh-list
64316503|NCT03733535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64316504|NCT03733535|Respiratory System Agents|respiratory system agents|mesh-ancestor
64316505|NCT03713879|Indomethacin|indomethacin|mesh-list
64316506|NCT03713879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64316507|NCT03713879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64316508|NCT03713879|Analgesics|analgesics|mesh-ancestor
64316509|NCT03713879|Sensory System Agents|sensory system agents|mesh-ancestor
64729109|NCT00003776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64729110|NCT00003776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729111|NCT00003776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64729126|NCT00003776|Micronutrients|micronutrients|mesh-ancestor
64729127|NCT00003776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64729128|NCT00003776|Alkylating Agents|alkylating agents|mesh-ancestor
64729129|NCT00003776|Antifungal Agents|antifungal agents|mesh-ancestor
64729130|NCT00003776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64729131|NCT00003788|Carmustine|carmustine|mesh-list
64729132|NCT00003788|Lomustine|lomustine|mesh-list
64729133|NCT00003788|Procarbazine|procarbazine|mesh-list
64729134|NCT00003788|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
64729135|NCT00003788|Trioxsalen|trioxsalen|mesh-list
64729136|NCT00003788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64729137|NCT00003788|Alkylating Agents|alkylating agents|mesh-ancestor
64729138|NCT00003788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729139|NCT00003788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729140|NCT00003788|Dermatologic Agents|dermatologic agents|mesh-ancestor
64729141|NCT00003788|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64729142|NCT00004340|Calcitriol|calcitriol|mesh-list
64729143|NCT00004340|Hormones|hormones|mesh-list
64729144|NCT00004340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64729145|NCT00004340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729146|NCT00004340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64729147|NCT00004340|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64729148|NCT00004340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64729149|NCT00004340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729150|NCT00004340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64729151|NCT00004340|Vitamins|vitamins|mesh-ancestor
64729152|NCT00004340|Micronutrients|micronutrients|mesh-ancestor
64729153|NCT00004340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64729154|NCT00004346|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
64729155|NCT00004346|Lovastatin|lovastatin|mesh-list
64729156|NCT00004346|L 647318|l 647318|mesh-list
64729157|NCT00004346|Dihydromevinolin|dihydromevinolin|mesh-list
64729158|NCT00004346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64336515|NCT02311231|Heparin|heparin|mesh-list
64729160|NCT00004346|Antimetabolites|antimetabolites|mesh-ancestor
64729161|NCT00004346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729162|NCT00004346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64729163|NCT00004346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64729164|NCT00004346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729166|NCT00004346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64729167|NCT00384800|Thalidomide|thalidomide|mesh-list
64336543|NCT03105375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955886|NCT00205738|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64729180|NCT00384800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64336551|NCT02304445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64729218|NCT00004364|Natriuretic Agents|natriuretic agents|mesh-ancestor
64316546|NCT02422563|Mitosis Modulators|mitosis modulators|mesh-ancestor
64316547|NCT02422563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316548|NCT02422563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64316549|NCT02422563|Alkylating Agents|alkylating agents|mesh-ancestor
64316551|NCT03185403|Ropivacaine|ropivacaine|mesh-list
64316552|NCT03185403|Anesthetics, Local|anesthetics, local|mesh-ancestor
64316553|NCT03185403|Anesthetics|anesthetics|mesh-ancestor
64316554|NCT03185403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64316555|NCT03185403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316556|NCT03185403|Sensory System Agents|sensory system agents|mesh-ancestor
64729219|NCT00004364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729220|NCT00005000|Lamivudine|lamivudine|mesh-list
64729221|NCT00005000|Zidovudine|zidovudine|mesh-list
64729222|NCT00005000|Efavirenz|efavirenz|mesh-list
64729223|NCT00005000|Stavudine|stavudine|mesh-list
64729224|NCT00005000|Didanosine|didanosine|mesh-list
64729225|NCT00005000|Nelfinavir|nelfinavir|mesh-list
64729226|NCT00005000|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
64729227|NCT00005000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64729228|NCT00005000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64729229|NCT00005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729230|NCT00005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729231|NCT00005000|Antiviral Agents|antiviral agents|mesh-ancestor
64729232|NCT00005000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64729233|NCT00005000|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64729234|NCT00005000|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64729235|NCT00005000|Antimetabolites|antimetabolites|mesh-ancestor
64729236|NCT00005000|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64729237|NCT00005000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64729238|NCT00005000|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64729239|NCT00005000|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64729240|NCT00005000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64729241|NCT00005000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64729242|NCT00005000|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64729243|NCT00005000|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64729244|NCT00005000|Protease Inhibitors|protease inhibitors|mesh-ancestor
64729245|NCT00005000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64729246|NCT00005000|Immunologic Factors|immunologic factors|mesh-ancestor
64955889|NCT00205816|Tigecycline|tigecycline|mesh-list
64955890|NCT00205816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64955897|NCT00072540|Mitogens|mitogens|mesh-list
64729327|NCT00005024|Cyclophosphamide|cyclophosphamide|mesh-list
64729376|NCT00004424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729377|NCT00004430|Prednisolone|prednisolone|mesh-list
64729378|NCT00004430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64729379|NCT00004430|Glucocorticoids|glucocorticoids|mesh-ancestor
64729380|NCT00004430|Hormones|hormones|mesh-ancestor
64729381|NCT00004430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64729382|NCT00004430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729383|NCT00004430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64729384|NCT00004430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729385|NCT00003842|Interleukin-4|interleukin-4|mesh-list
64729386|NCT00003842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64729387|NCT00003842|Immunologic Factors|immunologic factors|mesh-ancestor
64729388|NCT00003842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729389|NCT00003842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729390|NCT00003842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64729391|NCT00005036|Leucovorin|leucovorin|mesh-list
64729392|NCT00005036|Fluorouracil|fluorouracil|mesh-list
64729393|NCT00005036|Oxaliplatin|oxaliplatin|mesh-list
64729394|NCT00005036|Irinotecan|irinotecan|mesh-list
64729395|NCT00005036|Calcium|calcium|mesh-list
64729396|NCT00005036|Levoleucovorin|levoleucovorin|mesh-list
64729397|NCT00005036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64729398|NCT00005036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729399|NCT00005036|Antimetabolites|antimetabolites|mesh-ancestor
64316563|NCT03185403|Anesthetics, General|anesthetics, general|mesh-ancestor
64316564|NCT04329806|Amlodipine|amlodipine|mesh-list
64316565|NCT04329806|Moxonidine|moxonidine|mesh-list
64316566|NCT04329806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64316567|NCT04329806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64316568|NCT04329806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64316569|NCT04329806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316570|NCT04329806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64729400|NCT00005036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729401|NCT00005036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64729402|NCT00005036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729403|NCT00005036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64729404|NCT00005036|Immunologic Factors|immunologic factors|mesh-ancestor
64729405|NCT00005036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64729406|NCT00005036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64729407|NCT00005036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729408|NCT00005036|Antidotes|antidotes|mesh-ancestor
64729418|NCT00004436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64729419|NCT00004436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729420|NCT00004436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64729421|NCT00004436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729422|NCT00004436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64729423|NCT00004436|Fertility Agents|fertility agents|mesh-ancestor
64729424|NCT00004436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64729425|NCT00005042|Semaxinib|semaxinib|mesh-list
64729426|NCT00005042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64337764|NCT01590719|Hematinics|hematinics|mesh-ancestor
64729436|NCT00004442|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
64729437|NCT00004442|Cholic Acids|cholic acids|mesh-list
64729438|NCT00004442|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64336797|NCT01767675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955898|NCT00072540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64955899|NCT00072540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64955900|NCT00072540|Analgesics|analgesics|mesh-ancestor
64955901|NCT00072540|Sensory System Agents|sensory system agents|mesh-ancestor
64955902|NCT00072540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64729439|NCT00004442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64729441|NCT05444569|Liraglutide|liraglutide|mesh-list
64729442|NCT05444569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64729443|NCT05444569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729444|NCT05444569|Incretins|incretins|mesh-ancestor
64729445|NCT05444569|Hormones|hormones|mesh-ancestor
64729446|NCT05444569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64729447|NCT00004448|Prednisone|prednisone|mesh-list
64729448|NCT00004448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64729449|NCT00004448|Glucocorticoids|glucocorticoids|mesh-ancestor
64729450|NCT00004448|Hormones|hormones|mesh-ancestor
64316575|NCT03635021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64316576|NCT03635021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316577|NCT03635021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64316578|NCT03635021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64316580|NCT03635021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316581|NCT03635021|Growth Inhibitors|growth inhibitors|mesh-ancestor
64316582|NCT02422485|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
64316583|NCT02422485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64316584|NCT02422485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64316585|NCT02422485|Analgesics|analgesics|mesh-ancestor
64729451|NCT00004448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64729452|NCT00004448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729453|NCT00004448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64729454|NCT00004448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729455|NCT00003860|Carboplatin|carboplatin|mesh-list
64729456|NCT00003860|Etoposide|etoposide|mesh-list
64729457|NCT00003860|Ifosfamide|ifosfamide|mesh-list
64729458|NCT00003860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729459|NCT00003860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64729460|NCT00003860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64729461|NCT00003860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64729462|NCT00003860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729463|NCT00003860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64468730|NCT00194896|Glyburide|glyburide|mesh-list
64729464|NCT00003860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64729465|NCT00003860|Alkylating Agents|alkylating agents|mesh-ancestor
64729466|NCT00005048|Paclitaxel|paclitaxel|mesh-list
64729498|NCT04742101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729499|NCT04742101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729500|NCT04742101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64729501|NCT00004478|Droxidopa|droxidopa|mesh-list
64729502|NCT00004478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64729510|NCT00005060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729511|NCT00005060|Tubulin Modulators|tubulin modulators|mesh-ancestor
64729512|NCT00005060|Antimitotic Agents|antimitotic agents|mesh-ancestor
64729513|NCT00005060|Mitosis Modulators|mitosis modulators|mesh-ancestor
64729514|NCT00005060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729515|NCT00003884|Zoledronic Acid|zoledronic acid|mesh-list
64729547|NCT00004496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729548|NCT00004496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64729549|NCT00004496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729550|NCT00003902|Capecitabine|capecitabine|mesh-list
64729551|NCT00003902|Vinorelbine|vinorelbine|mesh-list
64729552|NCT00003902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64729553|NCT00003902|Antimetabolites|antimetabolites|mesh-ancestor
64729554|NCT00003902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729555|NCT00003902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729556|NCT00003902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64786233|NCT00001626|Antifungal Agents|antifungal agents|mesh-ancestor
64786234|NCT00001626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786235|NCT00001626|Dermatologic Agents|dermatologic agents|mesh-ancestor
64786236|NCT00001626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64786237|NCT00001680|Thalidomide|thalidomide|mesh-list
64786238|NCT00001680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64786239|NCT00001680|Immunologic Factors|immunologic factors|mesh-ancestor
64786240|NCT00001680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786241|NCT00001680|Leprostatic Agents|leprostatic agents|mesh-ancestor
64786242|NCT00001680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64786243|NCT00001680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786244|NCT00001680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64786245|NCT00001680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64786246|NCT00001680|Growth Substances|growth substances|mesh-ancestor
64786247|NCT00001680|Growth Inhibitors|growth inhibitors|mesh-ancestor
64316616|NCT05699720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64316617|NCT05699720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64729557|NCT00003902|Tubulin Modulators|tubulin modulators|mesh-ancestor
64729558|NCT00003902|Antimitotic Agents|antimitotic agents|mesh-ancestor
64729559|NCT00003902|Mitosis Modulators|mitosis modulators|mesh-ancestor
64729560|NCT04700527|Butyric Acid|butyric acid|mesh-list
64729561|NCT04700527|Histamine Antagonists|histamine antagonists|mesh-ancestor
64729562|NCT04700527|Histamine Agents|histamine agents|mesh-ancestor
64729563|NCT04700527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64729564|NCT04700527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729565|NCT04700527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64729566|NCT00003908|Carboplatin|carboplatin|mesh-list
64729567|NCT00003908|Docetaxel|docetaxel|mesh-list
64729568|NCT00003908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729569|NCT00003908|Tubulin Modulators|tubulin modulators|mesh-ancestor
64729570|NCT00003908|Antimitotic Agents|antimitotic agents|mesh-ancestor
64729571|NCT00003908|Mitosis Modulators|mitosis modulators|mesh-ancestor
64729572|NCT00003908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729573|NCT00382837|Epratuzumab|epratuzumab|mesh-list
64729574|NCT00382837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64336925|NCT02314351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64955903|NCT00072540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955904|NCT00072540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64955905|NCT00072540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64324755|NCT01175785|Mycophenolic Acid|mycophenolic acid|mesh-list
64324756|NCT01175785|Cyclophosphamide|cyclophosphamide|mesh-list
64324758|NCT01175785|Fludarabine phosphate|fludarabine phosphate|mesh-list
64324759|NCT01175785|Cyclosporins|cyclosporins|mesh-list
64324760|NCT01175785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64324761|NCT01175785|Immunologic Factors|immunologic factors|mesh-ancestor
64324762|NCT01175785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324763|NCT01175785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64316657|NCT03660488|Penicillins|penicillins|mesh-list
64316658|NCT03660488|Cefixime|cefixime|mesh-list
64316659|NCT03660488|Penicillin G|penicillin g|mesh-list
64316660|NCT03660488|Penicillin G Benzathine|penicillin g benzathine|mesh-list
64316661|NCT03660488|Penicillin G Procaine|penicillin g procaine|mesh-list
64316662|NCT03660488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64316663|NCT03660488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64316664|NCT02422017|Timolol|timolol|mesh-list
64316665|NCT02422017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64316666|NCT02422017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64316667|NCT02422017|Adrenergic Agents|adrenergic agents|mesh-ancestor
64316668|NCT02422017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64316669|NCT02422017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316670|NCT02422017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316671|NCT02422017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64316674|NCT02761915|Fludarabine|fludarabine|mesh-list
64955906|NCT00072540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64955907|NCT00072540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64955908|NCT00072540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955909|NCT00072540|Mitosis Modulators|mitosis modulators|mesh-ancestor
64729575|NCT00382837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729576|NCT00003914|Dolastatin 10|dolastatin 10|mesh-list
64729577|NCT00003914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729578|NCT00003914|Tubulin Modulators|tubulin modulators|mesh-ancestor
64729579|NCT00003914|Antimitotic Agents|antimitotic agents|mesh-ancestor
64729580|NCT00003914|Mitosis Modulators|mitosis modulators|mesh-ancestor
64337775|NCT01534403|Epratuzumab|epratuzumab|mesh-list
64729636|NCT00003926|Immunologic Factors|immunologic factors|mesh-ancestor
64955910|NCT00206050|Esomeprazole|esomeprazole|mesh-list
64786248|NCT00001680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64786250|NCT00001698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64786251|NCT00001698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64786252|NCT00001698|Analgesics|analgesics|mesh-ancestor
64786253|NCT00001698|Sensory System Agents|sensory system agents|mesh-ancestor
64786256|NCT00001698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64955911|NCT00206050|Pantoprazole|pantoprazole|mesh-list
64337823|NCT01516073|Dermatologic Agents|dermatologic agents|mesh-ancestor
64614333|NCT05394493|Axitinib|axitinib|mesh-list
64729694|NCT00005096|Tubulin Modulators|tubulin modulators|mesh-ancestor
64729695|NCT00005096|Antimitotic Agents|antimitotic agents|mesh-ancestor
64729857|NCT00004748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64729858|NCT00004748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64729859|NCT00004748|Immunologic Factors|immunologic factors|mesh-ancestor
64729860|NCT00004748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64729861|NCT00004748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64729862|NCT00004748|Gout Suppressants|gout suppressants|mesh-ancestor
64729863|NCT00004748|Tubulin Modulators|tubulin modulators|mesh-ancestor
64729864|NCT00004748|Antimitotic Agents|antimitotic agents|mesh-ancestor
64736773|NCT05599919|Protective Agents|protective agents|mesh-ancestor
64730014|NCT00005612|Paclitaxel|paclitaxel|mesh-list
64730015|NCT00005612|Etoposide|etoposide|mesh-list
64730016|NCT00005612|Cyclophosphamide|cyclophosphamide|mesh-list
64730017|NCT00005612|Carboplatin|carboplatin|mesh-list
64730018|NCT00005612|Topotecan|topotecan|mesh-list
64730019|NCT00005612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64730020|NCT00005612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955941|NCT00206167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64955942|NCT00206167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64955943|NCT00206167|Autonomic Agents|autonomic agents|mesh-ancestor
64730022|NCT00005612|Antimitotic Agents|antimitotic agents|mesh-ancestor
64730023|NCT00005612|Mitosis Modulators|mitosis modulators|mesh-ancestor
64730024|NCT00005612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730025|NCT00005612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64730026|NCT00005612|Immunologic Factors|immunologic factors|mesh-ancestor
64730090|NCT00005648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730091|NCT00005648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730092|NCT00005648|Antiviral Agents|antiviral agents|mesh-ancestor
64730153|NCT04456699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730154|NCT04456699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64730155|NCT04456699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64730159|NCT04456699|Vitamin B Complex|vitamin b complex|mesh-ancestor
64316692|NCT02160925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316693|NCT05551208|Bevacizumab|bevacizumab|mesh-list
64316694|NCT05551208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64316695|NCT05551208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316696|NCT05551208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64316697|NCT05551208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64316698|NCT05551208|Growth Substances|growth substances|mesh-ancestor
64316699|NCT05551208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316700|NCT05551208|Growth Inhibitors|growth inhibitors|mesh-ancestor
64316701|NCT03334682|Doxycycline|doxycycline|mesh-list
64316702|NCT03334682|Spironolactone|spironolactone|mesh-list
64316703|NCT03334682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64316704|NCT03334682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64730160|NCT04456699|Vitamins|vitamins|mesh-ancestor
64730161|NCT04456699|Micronutrients|micronutrients|mesh-ancestor
64730162|NCT04456699|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64730163|NCT04456699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730164|NCT00385658|Simvastatin|simvastatin|mesh-list
64730165|NCT00385658|Ezetimibe|ezetimibe|mesh-list
64730166|NCT00385658|Fenofibrate|fenofibrate|mesh-list
64730167|NCT00385658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64730168|NCT00385658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64730169|NCT00385658|Antimetabolites|antimetabolites|mesh-ancestor
64730170|NCT00385658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730171|NCT00385658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64337512|NCT03492385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64730172|NCT00385658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64730173|NCT00385658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730175|NCT00005762|Nelfinavir|nelfinavir|mesh-list
64730176|NCT00005762|Indinavir|indinavir|mesh-list
64730177|NCT00005762|Saquinavir|saquinavir|mesh-list
64730178|NCT00005762|Amprenavir|amprenavir|mesh-list
64730179|NCT00005762|Efavirenz|efavirenz|mesh-list
64730180|NCT00005762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64730181|NCT00005762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64730182|NCT00005762|Protease Inhibitors|protease inhibitors|mesh-ancestor
64730183|NCT00005762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730184|NCT00005762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730185|NCT00005762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64730186|NCT00005762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64730187|NCT00005762|Antiviral Agents|antiviral agents|mesh-ancestor
64730188|NCT00005762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64730189|NCT00005762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64730190|NCT00005762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64730191|NCT00005762|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64730192|NCT00005762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64730193|NCT00005762|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64730344|NCT04379635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730345|NCT04379635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730346|NCT04379635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64730347|NCT04379635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64338105|NCT05260541|Sensory System Agents|sensory system agents|mesh-ancestor
64730415|NCT02278172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64730443|NCT04563962|Sympathomimetics|sympathomimetics|mesh-ancestor
64730444|NCT04563962|Autonomic Agents|autonomic agents|mesh-ancestor
64730445|NCT04563962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64730446|NCT04563962|Dopamine Agents|dopamine agents|mesh-ancestor
64730447|NCT04563962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64730448|NCT04563962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730449|NCT04563962|Adrenergic Agents|adrenergic agents|mesh-ancestor
64324764|NCT01175785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64324765|NCT01175785|Alkylating Agents|alkylating agents|mesh-ancestor
64324769|NCT01175785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64324770|NCT01175785|Antimetabolites|antimetabolites|mesh-ancestor
64324771|NCT01175785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324772|NCT01175785|Antifungal Agents|antifungal agents|mesh-ancestor
64324773|NCT01175785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64316706|NCT03334682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64316707|NCT03334682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64316708|NCT03334682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64316709|NCT03334682|Hormone Antagonists|hormone antagonists|mesh-ancestor
64316710|NCT03334682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64730450|NCT04563962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64730505|NCT04561856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64730506|NCT04561856|Antiemetics|antiemetics|mesh-ancestor
64730507|NCT04561856|Autonomic Agents|autonomic agents|mesh-ancestor
64730508|NCT04561856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64730509|NCT04561856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730510|NCT04561856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64730511|NCT04561856|Glucocorticoids|glucocorticoids|mesh-ancestor
64730512|NCT04561856|Hormones|hormones|mesh-ancestor
64730513|NCT04561856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64730514|NCT04561856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64730515|NCT04561856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730516|NCT04561856|Protease Inhibitors|protease inhibitors|mesh-ancestor
64730517|NCT04561856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337848|NCT02264171|Tamsulosin|tamsulosin|mesh-list
64730518|NCT04561856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730519|NCT04909801|Adalimumab|adalimumab|mesh-list
64730520|NCT04909801|Methotrexate|methotrexate|mesh-list
64730521|NCT04909801|Abatacept|abatacept|mesh-list
64730522|NCT04909801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64730523|NCT04909801|Abortifacient Agents|abortifacient agents|mesh-ancestor
64730524|NCT04909801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64730525|NCT04909801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730526|NCT04909801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64730527|NCT04909801|Antimetabolites|antimetabolites|mesh-ancestor
64730528|NCT04909801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730529|NCT04909801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730530|NCT04909801|Dermatologic Agents|dermatologic agents|mesh-ancestor
64730531|NCT04909801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730532|NCT04909801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64730533|NCT04909801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64730534|NCT04909801|Immunologic Factors|immunologic factors|mesh-ancestor
64730535|NCT04909801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64730536|NCT04909801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64730537|NCT04909801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64730642|NCT03905941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730643|NCT03905941|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64730645|NCT03900715|Hematinics|hematinics|mesh-ancestor
64730646|NCT03818581|Suvorexant|suvorexant|mesh-list
64730647|NCT03818581|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64730648|NCT03818581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64730649|NCT03818581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64730650|NCT03818581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730651|NCT03818581|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64730667|NCT00002905|Alkylating Agents|alkylating agents|mesh-ancestor
64730668|NCT00002905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786260|NCT00001698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786261|NCT00001716|Nitric Oxide|nitric oxide|mesh-list
64786262|NCT00001716|Nitroglycerin|nitroglycerin|mesh-list
64786263|NCT00001716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64730670|NCT00002905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64730671|NCT00002905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64730672|NCT00002905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64730673|NCT00002905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64730686|NCT00002911|Marimastat|marimastat|mesh-list
64730687|NCT00002911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730688|NCT00002911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730689|NCT00002917|Paclitaxel|paclitaxel|mesh-list
64955969|NCT00039611|Immunologic Factors|immunologic factors|mesh-ancestor
64955970|NCT00039611|Antidotes|antidotes|mesh-ancestor
64955971|NCT00039611|Protective Agents|protective agents|mesh-ancestor
64730694|NCT00002917|Mitosis Modulators|mitosis modulators|mesh-ancestor
64730695|NCT00002917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730696|NCT00383695|Capecitabine|capecitabine|mesh-list
64730697|NCT00383695|Oxaliplatin|oxaliplatin|mesh-list
64730698|NCT00383695|Cetuximab|cetuximab|mesh-list
64730699|NCT00383695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64730700|NCT00383695|Antimetabolites|antimetabolites|mesh-ancestor
64730701|NCT00383695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730702|NCT00383695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338033|NCT01360853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64730726|NCT02636569|Analgesics|analgesics|mesh-ancestor
64730727|NCT02636569|Sensory System Agents|sensory system agents|mesh-ancestor
64730728|NCT02636569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64730729|NCT02636569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730730|NCT02636569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64730731|NCT02636569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64730732|NCT02636569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64730733|NCT02636569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316719|NCT02161159|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64316720|NCT02161159|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64316721|NCT02161159|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64316722|NCT02161159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64316723|NCT02161159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316724|NCT02161159|Cholinergic Agents|cholinergic agents|mesh-ancestor
64316725|NCT02161159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64316726|NCT02161159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316727|NCT02161159|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64316728|NCT02161159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316729|NCT02161237|Tacrolimus|tacrolimus|mesh-list
64316730|NCT02161237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64316731|NCT02161237|Immunologic Factors|immunologic factors|mesh-ancestor
64316732|NCT02161237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316733|NCT02161237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64316734|NCT02161237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730734|NCT02636569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730735|NCT02461927|Midazolam|midazolam|mesh-list
64730736|NCT02461927|Naltrexone|naltrexone|mesh-list
64730737|NCT02461927|Ketamine|ketamine|mesh-list
64730738|NCT02461927|Analgesics|analgesics|mesh-ancestor
64730739|NCT02461927|Sensory System Agents|sensory system agents|mesh-ancestor
64469983|NCT05605470|Immunologic Factors|immunologic factors|mesh-ancestor
64469984|NCT05605470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64469985|NCT05604222|Mirabegron|mirabegron|mesh-list
64469994|NCT05603910|Pembrolizumab|pembrolizumab|mesh-list
64730740|NCT02461927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64730756|NCT02461927|GABA Modulators|gaba modulators|mesh-ancestor
64730757|NCT02461927|GABA Agents|gaba agents|mesh-ancestor
64730758|NCT02461927|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64730759|NCT02461927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64730760|NCT00002935|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
64730762|NCT00002935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730763|NCT00002935|Dermatologic Agents|dermatologic agents|mesh-ancestor
64730764|NCT00002935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64730765|NCT00002941|Cyclophosphamide|cyclophosphamide|mesh-list
64730766|NCT00002941|Carmustine|carmustine|mesh-list
64730767|NCT00002941|Etoposide|etoposide|mesh-list
64730768|NCT00002941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64730789|NCT00002953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730790|NCT00002953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64730791|NCT00002953|Immunologic Factors|immunologic factors|mesh-ancestor
64730792|NCT00002953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64730793|NCT00002953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64730794|NCT00002953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64730795|NCT00002953|Alkylating Agents|alkylating agents|mesh-ancestor
64730796|NCT00002953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64730797|NCT00002953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64730798|NCT00002953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64730799|NCT00002953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64730800|NCT00002953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64730801|NCT03693781|Colchicine|colchicine|mesh-list
64730802|NCT03693781|Gout Suppressants|gout suppressants|mesh-ancestor
64730803|NCT03693781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64730804|NCT03693781|Tubulin Modulators|tubulin modulators|mesh-ancestor
64730805|NCT03693781|Antimitotic Agents|antimitotic agents|mesh-ancestor
64730806|NCT03693781|Mitosis Modulators|mitosis modulators|mesh-ancestor
64730807|NCT03693781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64730808|NCT03693781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730809|NCT02283853|Interferons|interferons|mesh-list
64730810|NCT02283853|Interferon-beta|interferon-beta|mesh-list
64730811|NCT02283853|Interferon beta-1a|interferon beta-1a|mesh-list
64730812|NCT02283853|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64730813|NCT02283853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64730814|NCT02283853|Antiviral Agents|antiviral agents|mesh-ancestor
64730815|NCT02283853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786278|NCT00001812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64316749|NCT05546060|Glucocorticoids|glucocorticoids|mesh-ancestor
64316750|NCT05546060|Hormones|hormones|mesh-ancestor
64316751|NCT05546060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64316752|NCT05546060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64316753|NCT05546060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316761|NCT02416869|BB 1101|bb 1101|mesh-list
64730816|NCT02283853|Dermatologic Agents|dermatologic agents|mesh-ancestor
64730817|NCT02283853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64730828|NCT03668041|Anticonvulsants|anticonvulsants|mesh-ancestor
64730829|NCT03668041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64730830|NCT03668041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64730831|NCT03668041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64730832|NCT03668041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64730833|NCT03668041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64730834|NCT03668041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64730835|NCT03668041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64731017|NCT00003421|Vinblastine|vinblastine|mesh-list
64731112|NCT00003013|Antimetabolites|antimetabolites|mesh-ancestor
64731113|NCT00003013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64731114|NCT00003013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64731115|NCT00003013|Abortifacient Agents|abortifacient agents|mesh-ancestor
64731116|NCT00003013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64731117|NCT00003013|Dermatologic Agents|dermatologic agents|mesh-ancestor
64731118|NCT00003013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64731119|NCT00003013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64470373|NCT05383170|Pembrolizumab|pembrolizumab|mesh-list
64731121|NCT00003013|Hormone Antagonists|hormone antagonists|mesh-ancestor
64731122|NCT00003013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64731123|NCT00003013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64731124|NCT00003013|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64731125|NCT00003013|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64786279|NCT00001812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786280|NCT00001812|Antifungal Agents|antifungal agents|mesh-ancestor
64786281|NCT00001812|Ionophores|ionophores|mesh-ancestor
64786282|NCT00001812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64786283|NCT00001812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786284|NCT00001842|Dexamethasone|dexamethasone|mesh-list
64786285|NCT00001842|Lenograstim|lenograstim|mesh-list
64786286|NCT00001842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64786287|NCT00001842|Antiemetics|antiemetics|mesh-ancestor
64786288|NCT00001842|Autonomic Agents|autonomic agents|mesh-ancestor
64786289|NCT00001842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64786291|NCT00001842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64731126|NCT00003013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64731128|NCT00003445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731159|NCT00003019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64731160|NCT00003019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731274|NCT00002803|Immunologic Factors|immunologic factors|mesh-ancestor
64731275|NCT00002803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731276|NCT00002803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64731277|NCT00002803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64731278|NCT00002803|Alkylating Agents|alkylating agents|mesh-ancestor
64736775|NCT01645709|Verapamil|verapamil|mesh-list
64731298|NCT00383929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64731299|NCT00383929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731300|NCT00383929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64731301|NCT00383929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64731302|NCT00003541|Prednisone|prednisone|mesh-list
64731303|NCT00003541|Cyclophosphamide|cyclophosphamide|mesh-list
64731304|NCT00003541|Ifosfamide|ifosfamide|mesh-list
64731305|NCT00003541|Carboplatin|carboplatin|mesh-list
64731306|NCT00003541|Doxorubicin|doxorubicin|mesh-list
64731307|NCT00003541|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64956043|NCT00411229|Oxaliplatin|oxaliplatin|mesh-list
64956044|NCT00411229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64956045|NCT00411229|Antimetabolites|antimetabolites|mesh-ancestor
64731309|NCT00003541|Vincristine|vincristine|mesh-list
64731310|NCT00003541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64731311|NCT00003541|Immunologic Factors|immunologic factors|mesh-ancestor
64414980|NCT04885777|Anesthetics|anesthetics|mesh-ancestor
64731404|NCT00003049|Calcium|calcium|mesh-list
64731405|NCT00003049|Levoleucovorin|levoleucovorin|mesh-list
64731406|NCT00003049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64731407|NCT00003049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731408|NCT00003049|Antimetabolites|antimetabolites|mesh-ancestor
64731409|NCT00003049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731410|NCT00003049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64731411|NCT00003049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956084|NCT00068484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731543|NCT00003589|Paclitaxel|paclitaxel|mesh-list
64731544|NCT00003589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64731545|NCT00003589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316811|NCT02159131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316812|NCT02159131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64316813|NCT02159131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64316814|NCT02159131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64316815|NCT02159131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64316816|NCT02159131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64316817|NCT02159131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316818|NCT02159131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316819|NCT02159131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64316820|NCT02159131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64316821|NCT02159131|Antiviral Agents|antiviral agents|mesh-ancestor
64316822|NCT02159131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64316823|NCT05550506|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64316836|NCT03174795|Meropenem|meropenem|mesh-list
64731729|NCT00002887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731730|NCT00002887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731731|NCT00002887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731732|NCT00002887|Tubulin Modulators|tubulin modulators|mesh-ancestor
64731733|NCT00002887|Antimitotic Agents|antimitotic agents|mesh-ancestor
64731734|NCT00002887|Mitosis Modulators|mitosis modulators|mesh-ancestor
64731735|NCT00002887|Antisickling Agents|antisickling agents|mesh-ancestor
64731736|NCT00002887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64731737|NCT00003937|Cisplatin|cisplatin|mesh-list
64731738|NCT00003937|Doxorubicin|doxorubicin|mesh-list
64731739|NCT00003937|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64731740|NCT00003937|Methotrexate|methotrexate|mesh-list
64731741|NCT00003937|Etoposide|etoposide|mesh-list
64731742|NCT00003937|Ifosfamide|ifosfamide|mesh-list
64731773|NCT00003625|Cyclosporins|cyclosporins|mesh-list
64731774|NCT00003625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64731775|NCT00003625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731776|NCT00003625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64731777|NCT00003625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64731778|NCT00003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64731779|NCT00003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731780|NCT00003625|Tubulin Modulators|tubulin modulators|mesh-ancestor
64731781|NCT00003625|Antimitotic Agents|antimitotic agents|mesh-ancestor
64731782|NCT00003625|Mitosis Modulators|mitosis modulators|mesh-ancestor
64731783|NCT00003625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64731784|NCT00003625|Immunologic Factors|immunologic factors|mesh-ancestor
64731785|NCT00003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731786|NCT00003625|Antifungal Agents|antifungal agents|mesh-ancestor
64731787|NCT00003625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64731788|NCT00003625|Dermatologic Agents|dermatologic agents|mesh-ancestor
64731789|NCT00003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64731790|NCT00003625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64731791|NCT00003637|Fluorouracil|fluorouracil|mesh-list
64731792|NCT00003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731793|NCT00003637|Antimetabolites|antimetabolites|mesh-ancestor
64731794|NCT00003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731795|NCT00003637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64731796|NCT00003637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64731797|NCT00003637|Immunologic Factors|immunologic factors|mesh-ancestor
64731798|NCT00003637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731799|NCT00003943|Paclitaxel|paclitaxel|mesh-list
64731800|NCT00003943|Cyclophosphamide|cyclophosphamide|mesh-list
64731801|NCT00003943|Carboplatin|carboplatin|mesh-list
64731802|NCT00003943|Topotecan|topotecan|mesh-list
64731803|NCT00003943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64731804|NCT00003943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731805|NCT00003943|Tubulin Modulators|tubulin modulators|mesh-ancestor
64786294|NCT00001842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64786295|NCT00001842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64786296|NCT00001842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64731806|NCT00003943|Antimitotic Agents|antimitotic agents|mesh-ancestor
64731807|NCT00003943|Mitosis Modulators|mitosis modulators|mesh-ancestor
64320164|NCT02184091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64320166|NCT02184091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64731986|NCT00003985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64731987|NCT00003985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320187|NCT02184247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64320188|NCT04292756|Triamcinolone|triamcinolone|mesh-list
64415154|NCT04878835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64732128|NCT00004039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64732129|NCT00004039|Vincristine|vincristine|mesh-list
64732130|NCT00004039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732131|NCT00004039|Immunologic Factors|immunologic factors|mesh-ancestor
64732132|NCT00004039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732133|NCT00004039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64732134|NCT00004039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64732135|NCT00004039|Alkylating Agents|alkylating agents|mesh-ancestor
64732136|NCT00004039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732138|NCT00004039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64732139|NCT00004039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64732140|NCT00004039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64732141|NCT00004039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64320221|NCT02184559|Anesthetics, Local|anesthetics, local|mesh-ancestor
64320222|NCT02184559|Anesthetics|anesthetics|mesh-ancestor
64320223|NCT02184559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64786303|NCT00001848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786304|NCT00001848|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64786305|NCT00001848|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64786306|NCT00001848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64786307|NCT00001854|Ribavirin|ribavirin|mesh-list
64786308|NCT00001854|Antimetabolites|antimetabolites|mesh-ancestor
64786309|NCT00001854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786310|NCT00001854|Antiviral Agents|antiviral agents|mesh-ancestor
64732200|NCT00004051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64732201|NCT00004051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732202|NCT00004051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732203|NCT00004051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732204|NCT00003727|Gemcitabine|gemcitabine|mesh-list
64732205|NCT00003727|Interferons|interferons|mesh-list
64732206|NCT00003727|Interferon-alpha|interferon-alpha|mesh-list
64732207|NCT00003727|Cyclophosphamide|cyclophosphamide|mesh-list
64732208|NCT00003727|Melphalan|melphalan|mesh-list
64732209|NCT00003727|Carmustine|carmustine|mesh-list
64732210|NCT00003727|Etoposide|etoposide|mesh-list
64732211|NCT00003727|Sargramostim|sargramostim|mesh-list
64786313|NCT00001860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64786314|NCT00001860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64786315|NCT00001860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64786317|NCT00001890|Hormones|hormones|mesh-ancestor
64786318|NCT00001890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64786319|NCT00001890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786320|NCT00001944|Vinorelbine|vinorelbine|mesh-list
64786321|NCT00001944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64786322|NCT00001944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316931|NCT02410005|Vitamins|vitamins|mesh-ancestor
64316932|NCT02410005|Micronutrients|micronutrients|mesh-ancestor
64316933|NCT02410005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64316934|NCT05543330|Cisplatin|cisplatin|mesh-list
64316935|NCT05543330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316936|NCT03174561|Choline|choline|mesh-list
64316937|NCT03174561|Silymarin|silymarin|mesh-list
64316938|NCT03174561|Lipotropic Agents|lipotropic agents|mesh-ancestor
64316939|NCT03174561|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64316940|NCT03174561|Antimetabolites|antimetabolites|mesh-ancestor
64316941|NCT03174561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383691|NCT03171623|Enzyme Activators|enzyme activators|mesh-ancestor
64383692|NCT03171623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383693|NCT03171389|Ponatinib|ponatinib|mesh-list
64383694|NCT03171389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383722|NCT05502705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383724|NCT04591431|Trastuzumab|trastuzumab|mesh-list
64383725|NCT04591431|Ipilimumab|ipilimumab|mesh-list
64383726|NCT04591431|Pertuzumab|pertuzumab|mesh-list
64383727|NCT04591431|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64383728|NCT04591431|Everolimus|everolimus|mesh-list
64383729|NCT04591431|Atezolizumab|atezolizumab|mesh-list
64383730|NCT04591431|Lapatinib|lapatinib|mesh-list
64383731|NCT04591431|Palbociclib|palbociclib|mesh-list
64732212|NCT00003727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732214|NCT00003727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732215|NCT00003727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64732216|NCT00003727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64732217|NCT00003727|Alkylating Agents|alkylating agents|mesh-ancestor
64732218|NCT00003727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732219|NCT00003727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732220|NCT00003727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64320277|NCT04870424|Mitosis Modulators|mitosis modulators|mesh-ancestor
64320278|NCT04870424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320279|NCT04870424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320280|NCT03536845|Vitamin D|vitamin d|mesh-list
64320281|NCT03536845|Cholecalciferol|cholecalciferol|mesh-list
64320282|NCT03536845|Vitamins|vitamins|mesh-ancestor
64732250|NCT00004063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732251|NCT00004063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64732252|NCT00004063|Antimetabolites|antimetabolites|mesh-ancestor
64732253|NCT00004063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320283|NCT03536845|Micronutrients|micronutrients|mesh-ancestor
64320284|NCT03536845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320285|NCT03536845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64732255|NCT00004063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64732256|NCT00004063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732267|NCT00003733|Mitosis Modulators|mitosis modulators|mesh-ancestor
64732268|NCT00003733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732269|NCT00003733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64732270|NCT00003733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64732271|NCT00003733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732273|NCT00003739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64732274|NCT00003739|Immunologic Factors|immunologic factors|mesh-ancestor
64732275|NCT00003739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732276|NCT00003745|Topotecan|topotecan|mesh-list
64732277|NCT00003745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64316943|NCT03174561|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64316944|NCT03174561|Nootropic Agents|nootropic agents|mesh-ancestor
64316945|NCT03174561|Antioxidants|antioxidants|mesh-ancestor
64316946|NCT03174561|Protective Agents|protective agents|mesh-ancestor
64316947|NCT03174561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316948|NCT05545592|Estrogens|estrogens|mesh-list
64316949|NCT05545592|Hormones|hormones|mesh-ancestor
64316950|NCT05545592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64316951|NCT05545592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316952|NCT05545436|Capecitabine|capecitabine|mesh-list
64316953|NCT05545436|Oxaliplatin|oxaliplatin|mesh-list
64316954|NCT05545436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64316955|NCT05545436|Antimetabolites|antimetabolites|mesh-ancestor
64316957|NCT05545436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732278|NCT00003745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64732279|NCT00003745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732280|NCT00003745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732281|NCT00003745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732282|NCT00003163|Cyclophosphamide|cyclophosphamide|mesh-list
64732284|NCT00003163|Sargramostim|sargramostim|mesh-list
64732285|NCT00003163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732286|NCT00003163|Immunologic Factors|immunologic factors|mesh-ancestor
64732287|NCT00003163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732288|NCT00003163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64732289|NCT00003163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64732290|NCT00003163|Alkylating Agents|alkylating agents|mesh-ancestor
64732291|NCT00003163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732292|NCT00003163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732293|NCT00003163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64732294|NCT00004081|Docetaxel|docetaxel|mesh-list
64732295|NCT00004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732296|NCT00004081|Tubulin Modulators|tubulin modulators|mesh-ancestor
64732297|NCT00004081|Antimitotic Agents|antimitotic agents|mesh-ancestor
64732298|NCT00004081|Mitosis Modulators|mitosis modulators|mesh-ancestor
64732299|NCT00004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732300|NCT00003751|Penicillamine|penicillamine|mesh-list
64732301|NCT00003751|Antidotes|antidotes|mesh-ancestor
64732302|NCT00003751|Protective Agents|protective agents|mesh-ancestor
64316970|NCT00664040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64316971|NCT00664040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64316972|NCT00664040|Analgesics|analgesics|mesh-ancestor
64316973|NCT00664040|Sensory System Agents|sensory system agents|mesh-ancestor
64316974|NCT00664040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316975|NCT00664040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316976|NCT00664040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64316977|NCT00664040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64316978|NCT00664040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64316979|NCT00664040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64316980|NCT00664040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316983|NCT00664040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732303|NCT00003751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732304|NCT00003751|Chelating Agents|chelating agents|mesh-ancestor
64732305|NCT00003751|Sequestering Agents|sequestering agents|mesh-ancestor
64732306|NCT00003751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732307|NCT00003751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64415182|NCT04872283|Antipyretics|antipyretics|mesh-ancestor
64320300|NCT05514080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320301|NCT02185963|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64320302|NCT02185963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64320303|NCT02185963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64320304|NCT02185963|Antimetabolites|antimetabolites|mesh-ancestor
64320305|NCT02185963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320306|NCT02185963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64320307|NCT02185963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64320308|NCT02185963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320309|NCT05513924|Fluorouracil|fluorouracil|mesh-list
64320310|NCT05513924|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64320311|NCT05513924|Latanoprost|latanoprost|mesh-list
64320312|NCT05513924|Antimetabolites|antimetabolites|mesh-ancestor
64320313|NCT05513924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320314|NCT05513924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64320315|NCT05513924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732324|NCT00003175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64732325|NCT00003175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732378|NCT00004105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64732380|NCT00003187|Cyclosporine|cyclosporine|mesh-list
64732381|NCT00003187|Methylprednisolone|methylprednisolone|mesh-list
64732382|NCT00003187|Cyclophosphamide|cyclophosphamide|mesh-list
64732383|NCT00003187|Methotrexate|methotrexate|mesh-list
64732384|NCT00003187|Cyclosporins|cyclosporins|mesh-list
64732385|NCT00003187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732386|NCT00003187|Immunologic Factors|immunologic factors|mesh-ancestor
64732387|NCT00003187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732403|NCT00003187|Antiviral Agents|antiviral agents|mesh-ancestor
64732404|NCT00003187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324792|NCT01445899|Ranibizumab|ranibizumab|mesh-list
64324793|NCT01445899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64324794|NCT01445899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64324795|NCT01445899|Growth Substances|growth substances|mesh-ancestor
64324796|NCT01445899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324797|NCT01445899|Growth Inhibitors|growth inhibitors|mesh-ancestor
64324798|NCT01445899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732405|NCT00003187|Antifungal Agents|antifungal agents|mesh-ancestor
64732406|NCT00003187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64732407|NCT00003187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64732408|NCT00003187|Antiemetics|antiemetics|mesh-ancestor
64732409|NCT00003187|Autonomic Agents|autonomic agents|mesh-ancestor
64471751|NCT04165317|BCG Vaccine|bcg vaccine|mesh-list
64732410|NCT00003187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64732411|NCT00003187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64732412|NCT00003187|Glucocorticoids|glucocorticoids|mesh-ancestor
64732413|NCT00003187|Hormones|hormones|mesh-ancestor
64732414|NCT00003187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64732416|NCT00003187|Protective Agents|protective agents|mesh-ancestor
64732417|NCT00003769|Perillyl alcohol|perillyl alcohol|mesh-list
64732418|NCT00003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732419|NCT00003769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736778|NCT01645709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64320339|NCT02573012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64320340|NCT02573012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320341|NCT02573012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64732420|NCT00003769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732421|NCT00003775|Leflunomide|leflunomide|mesh-list
64732422|NCT00003775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732423|NCT00003775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732424|NCT00003775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732425|NCT00003775|Immunologic Factors|immunologic factors|mesh-ancestor
64732426|NCT00003775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64732427|NCT00004123|Doxorubicin|doxorubicin|mesh-list
64732428|NCT00004123|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64732429|NCT00004123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64732430|NCT00004123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732431|NCT00004123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64732432|NCT00004123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64732433|NCT00004123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732434|NCT00004123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732435|NCT00003781|Docetaxel|docetaxel|mesh-list
64732436|NCT00003781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732437|NCT00003781|Tubulin Modulators|tubulin modulators|mesh-ancestor
64732517|NCT00003211|Mitosis Modulators|mitosis modulators|mesh-ancestor
64732518|NCT00003211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64732519|NCT00003211|Protective Agents|protective agents|mesh-ancestor
64732520|NCT00003805|Vancomycin|vancomycin|mesh-list
64732521|NCT00003805|Tazobactam|tazobactam|mesh-list
64732522|NCT00003805|Piperacillin|piperacillin|mesh-list
64732523|NCT00003805|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64732524|NCT00003805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64732525|NCT00003805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786323|NCT00001944|Tubulin Modulators|tubulin modulators|mesh-ancestor
64786324|NCT00001944|Antimitotic Agents|antimitotic agents|mesh-ancestor
64786327|NCT00001968|Ritonavir|ritonavir|mesh-list
64732526|NCT00003805|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64732527|NCT00003805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732528|NCT00003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732529|NCT00004159|Gemcitabine|gemcitabine|mesh-list
64732530|NCT00004159|Paclitaxel|paclitaxel|mesh-list
64732531|NCT00004159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64732532|NCT00004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64732533|NCT00004159|Tubulin Modulators|tubulin modulators|mesh-ancestor
64732534|NCT00004159|Antimitotic Agents|antimitotic agents|mesh-ancestor
64423630|NCT05209711|Lidocaine|lidocaine|mesh-list
64732616|NCT00003217|Vincristine|vincristine|mesh-list
64320383|NCT05519072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64320384|NCT05519072|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64320386|NCT05519072|Antimalarials|antimalarials|mesh-ancestor
64732642|NCT00003217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64732643|NCT00003217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64732644|NCT00003217|Antimetabolites|antimetabolites|mesh-ancestor
64732645|NCT00003217|Dermatologic Agents|dermatologic agents|mesh-ancestor
64732646|NCT00003217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64732685|NCT00003835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64732686|NCT00003835|Immunologic Factors|immunologic factors|mesh-ancestor
64732687|NCT00003835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64732688|NCT00003835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64320557|NCT05509946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64320558|NCT05509946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64320559|NCT05509946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64320560|NCT05509946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64320561|NCT05509946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64733072|NCT00003313|Carboplatin|carboplatin|mesh-list
64733073|NCT00003313|Amifostine|amifostine|mesh-list
64320725|NCT04535089|Sensory System Agents|sensory system agents|mesh-ancestor
64320755|NCT02188537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64320756|NCT02188537|Protease Inhibitors|protease inhibitors|mesh-ancestor
64320757|NCT02188537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320812|NCT02562716|Gemcitabine|gemcitabine|mesh-list
64320813|NCT02562716|Paclitaxel|paclitaxel|mesh-list
64320814|NCT02562716|Camptothecin|camptothecin|mesh-list
64320815|NCT02562716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64320816|NCT02562716|Fluorouracil|fluorouracil|mesh-list
64320817|NCT02562716|Oxaliplatin|oxaliplatin|mesh-list
64320818|NCT02562716|Irinotecan|irinotecan|mesh-list
64320819|NCT02562716|Pancrelipase|pancrelipase|mesh-list
64320914|NCT04291508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64733609|NCT00005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733610|NCT00005113|Cyclosporine|cyclosporine|mesh-list
64733611|NCT00005113|Sirolimus|sirolimus|mesh-list
64786334|NCT00001968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786335|NCT00001968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786336|NCT00001968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786337|NCT00001968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786338|NCT00001968|Antiviral Agents|antiviral agents|mesh-ancestor
64786339|NCT00001968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64317037|NCT03178539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317038|NCT03178539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317039|NCT03178539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64317040|NCT03178539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64317041|NCT03178539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64317042|NCT03178539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377665|NCT04843449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64377666|NCT03037593|Vitamin D|vitamin d|mesh-list
64377702|NCT04854759|Amantadine|amantadine|mesh-list
64733613|NCT00005113|Cyclosporins|cyclosporins|mesh-list
64733614|NCT00005113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64733615|NCT00005113|Immunologic Factors|immunologic factors|mesh-ancestor
64733616|NCT00005113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733617|NCT00005113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64733618|NCT00005113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320918|NCT04291508|Antipyretics|antipyretics|mesh-ancestor
64320919|NCT02933671|Ropivacaine|ropivacaine|mesh-list
64320920|NCT02933671|Anesthetics, Local|anesthetics, local|mesh-ancestor
64320921|NCT02933671|Anesthetics|anesthetics|mesh-ancestor
64320922|NCT02933671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64733626|NCT00005113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733628|NCT00004573|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64733629|NCT00004573|Antiviral Agents|antiviral agents|mesh-ancestor
64733630|NCT00004573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64733631|NCT00004573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64733632|NCT00004573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320923|NCT02933671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304154|NCT04882358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64304155|NCT04882358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304156|NCT04882358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64304157|NCT04882358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304159|NCT04926844|Levetiracetam|levetiracetam|mesh-list
64304160|NCT04926844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64304161|NCT04926844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64304162|NCT04926844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64304163|NCT04926844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304164|NCT04926844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64304165|NCT04926844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64304166|NCT04926844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64304167|NCT04926844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64304168|NCT04926844|Anesthetics, General|anesthetics, general|mesh-ancestor
64304169|NCT04926844|Anesthetics|anesthetics|mesh-ancestor
64304170|NCT04926844|GABA Modulators|gaba modulators|mesh-ancestor
64304171|NCT04926844|GABA Agents|gaba agents|mesh-ancestor
64304172|NCT04926844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64304173|NCT04926844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304174|NCT04926844|Anticonvulsants|anticonvulsants|mesh-ancestor
64304175|NCT04926844|Nootropic Agents|nootropic agents|mesh-ancestor
64304211|NCT05458856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64304212|NCT05458856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304213|NCT05458856|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64304214|NCT05458856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64317043|NCT03178539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317044|NCT03174483|Fluticasone|fluticasone|mesh-list
64317045|NCT03174483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64317046|NCT03174483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64317047|NCT03174483|Autonomic Agents|autonomic agents|mesh-ancestor
64317048|NCT03174483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317049|NCT03174483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317050|NCT03174483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64304215|NCT05458856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304216|NCT02630966|Vedolizumab|vedolizumab|mesh-list
64304217|NCT02630966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64304218|NCT05724212|Interferons|interferons|mesh-list
64304219|NCT05724212|Interferon-gamma|interferon-gamma|mesh-list
64304220|NCT05724212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304221|NCT05724212|Antiviral Agents|antiviral agents|mesh-ancestor
64304222|NCT05724212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64304223|NCT05723588|Nicotine|nicotine|mesh-list
64304224|NCT05723588|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64304225|NCT05723588|Autonomic Agents|autonomic agents|mesh-ancestor
64304226|NCT05723588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64304227|NCT05723588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304228|NCT05723588|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64304229|NCT05723588|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64304230|NCT05723588|Cholinergic Agents|cholinergic agents|mesh-ancestor
64304249|NCT05376878|Camptothecin|camptothecin|mesh-list
64304250|NCT05376878|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
64304251|NCT05376878|Antibodies|antibodies|mesh-list
64304252|NCT05376878|Immunoglobulins|immunoglobulins|mesh-list
64304253|NCT05376878|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64304254|NCT05376878|Immunoconjugates|immunoconjugates|mesh-list
64304255|NCT05376878|Immunologic Factors|immunologic factors|mesh-ancestor
64304256|NCT05376878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304257|NCT05376878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304258|NCT05376878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304259|NCT05376878|Trace Elements|trace elements|mesh-ancestor
64304260|NCT05376878|Micronutrients|micronutrients|mesh-ancestor
64304261|NCT05376878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64304262|NCT05376878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64304263|NCT05376878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64304264|NCT05376878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304265|NCT05362760|Fulvestrant|fulvestrant|mesh-list
64304266|NCT05362760|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64473271|NCT00121186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64473272|NCT00121186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64473273|NCT00121186|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64473274|NCT00121186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64473275|NCT00121186|Alkylating Agents|alkylating agents|mesh-ancestor
64473276|NCT00121186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64473277|NCT00121810|Mycophenolic Acid|mycophenolic acid|mesh-list
64473278|NCT00121810|Sirolimus|sirolimus|mesh-list
64473279|NCT00121810|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
64473280|NCT00121810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64473281|NCT00121810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597614|NCT01279213|Dopamine Agents|dopamine agents|mesh-ancestor
64304267|NCT05362760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64304268|NCT05362760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304269|NCT05362760|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64304281|NCT02430532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304283|NCT05357612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64304284|NCT05357612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64786340|NCT00001968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64786341|NCT00001968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64786342|NCT00001968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786343|NCT00001968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64304285|NCT05357612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64304286|NCT05357612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64304287|NCT05357612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64304288|NCT05357612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304289|NCT05357612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64304290|NCT05357612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64304291|NCT05357612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64304292|NCT05357612|Serotonin Agents|serotonin agents|mesh-ancestor
64304293|NCT05357612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64304294|NCT05357612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304295|NCT02394340|Luliconazole|luliconazole|mesh-list
64304296|NCT02394340|Omeprazole|omeprazole|mesh-list
64304297|NCT02394340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64304298|NCT02394340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64304976|NCT03595592|Tubulin Modulators|tubulin modulators|mesh-ancestor
64304977|NCT03595592|Antimitotic Agents|antimitotic agents|mesh-ancestor
64304978|NCT03595592|Mitosis Modulators|mitosis modulators|mesh-ancestor
64304979|NCT03595592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304980|NCT03595592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64304981|NCT03595592|Immunologic Factors|immunologic factors|mesh-ancestor
64304982|NCT03595592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304983|NCT03595592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64304984|NCT03595592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64304985|NCT03595592|Alkylating Agents|alkylating agents|mesh-ancestor
64304986|NCT03595592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64304987|NCT03595592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64304988|NCT03595592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64304989|NCT03595592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64304990|NCT03595592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786344|NCT00001968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64305025|NCT03062462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64586291|NCT00322439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305567|NCT02036879|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
64305568|NCT02036879|Estradiol|estradiol|mesh-list
64305569|NCT02036879|Estrogens|estrogens|mesh-ancestor
64305570|NCT02036879|Hormones|hormones|mesh-ancestor
64305571|NCT02036879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64305572|NCT02036879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305573|NCT02036879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65495205|NCT00911820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495206|NCT00911820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65495207|NCT00911820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65495208|NCT00911820|Growth Substances|growth substances|mesh-ancestor
65495209|NCT00911820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495210|NCT00911820|Growth Inhibitors|growth inhibitors|mesh-ancestor
64415600|NCT04864717|Doxycycline|doxycycline|mesh-list
65495212|NCT00911820|Antimitotic Agents|antimitotic agents|mesh-ancestor
65495213|NCT00911820|Mitosis Modulators|mitosis modulators|mesh-ancestor
65495214|NCT00911820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495215|NCT00911820|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64473282|NCT00121810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64305737|NCT02037737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64305738|NCT02037737|Immunologic Factors|immunologic factors|mesh-ancestor
64305739|NCT02037737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305740|NCT02037737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64305741|NCT02037503|Ketamine|ketamine|mesh-list
64305742|NCT02037503|Analgesics|analgesics|mesh-ancestor
64305814|NCT02051387|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64305815|NCT02051387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64305816|NCT02051387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64305817|NCT02051387|Antidepressive Agents|antidepressive agents|mesh-ancestor
64305914|NCT02383966|Antimetabolites|antimetabolites|mesh-ancestor
64305915|NCT02383966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305916|NCT02383966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64305917|NCT02383966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64305918|NCT02383966|Immunologic Factors|immunologic factors|mesh-ancestor
64305919|NCT02383966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305920|NCT02383966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64305921|NCT02054663|Clopidogrel|clopidogrel|mesh-list
64305922|NCT02054663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64305923|NCT02054663|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64305924|NCT02054663|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64305925|NCT02054663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64305926|NCT02054663|Purinergic Agents|purinergic agents|mesh-ancestor
64305927|NCT02054663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64305928|NCT02054663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305929|NCT02054663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305930|NCT02054975|Vitamin D|vitamin d|mesh-list
64305931|NCT02054975|Ergocalciferols|ergocalciferols|mesh-list
64305932|NCT02054975|Cholecalciferol|cholecalciferol|mesh-list
64305933|NCT02054975|Vitamins|vitamins|mesh-list
64305934|NCT02054975|Micronutrients|micronutrients|mesh-ancestor
64305935|NCT02054975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305936|NCT02054975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64586293|NCT00322439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64306028|NCT02388724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64306029|NCT02388724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64306030|NCT02388724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306066|NCT05614037|Vasodilator Agents|vasodilator agents|mesh-ancestor
64306104|NCT01333865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64306105|NCT01333865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306171|NCT02060201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64306172|NCT02060201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306267|NCT02046590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64306309|NCT02422186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64306310|NCT02422186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64306441|NCT02347072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64306442|NCT02347072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64306443|NCT02347072|Adrenergic Agents|adrenergic agents|mesh-ancestor
64306444|NCT02347072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64306445|NCT02347072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306446|NCT02347072|Parasympatholytics|parasympatholytics|mesh-ancestor
64306447|NCT02347072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65495216|NCT00911820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65495217|NCT00911820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473284|NCT00121810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64473285|NCT00121810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64306793|NCT03061916|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64306903|NCT04975022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306904|NCT03061604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64306905|NCT03061604|Ceftriaxone|ceftriaxone|mesh-list
64306907|NCT03061604|Hemostatics|hemostatics|mesh-list
64306908|NCT03061604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64306909|NCT03061604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64306910|NCT03061604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64306911|NCT03061604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64306912|NCT03061604|Coagulants|coagulants|mesh-ancestor
64306913|NCT04974944|Paclitaxel|paclitaxel|mesh-list
64786397|NCT00002040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306977|NCT04970342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64306978|NCT04970342|GABA Modulators|gaba modulators|mesh-ancestor
64306979|NCT04970342|GABA Agents|gaba agents|mesh-ancestor
64306980|NCT02077751|Biotin|biotin|mesh-list
64306981|NCT02077751|Vitamin B Complex|vitamin b complex|mesh-ancestor
64306982|NCT02077751|Vitamins|vitamins|mesh-ancestor
64306983|NCT02077751|Micronutrients|micronutrients|mesh-ancestor
64306984|NCT02077751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306985|NCT04961684|Amorolfine|amorolfine|mesh-list
64306986|NCT04961684|Antifungal Agents|antifungal agents|mesh-ancestor
64306987|NCT04961684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64306988|NCT03061058|Docetaxel|docetaxel|mesh-list
64307214|NCT03254511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64307215|NCT03254511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64307216|NCT03254511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307217|NCT04947566|Ibuprofen|ibuprofen|mesh-list
64307218|NCT04947566|Naproxen|naproxen|mesh-list
64307219|NCT04947566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64307366|NCT01369433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64307367|NCT01369433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64307368|NCT01369433|Antifungal Agents|antifungal agents|mesh-ancestor
64307369|NCT01369433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64307370|NCT01369433|Immunologic Factors|immunologic factors|mesh-ancestor
64307371|NCT01369433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307372|NCT04946162|Tadalafil|tadalafil|mesh-list
64307373|NCT04946162|Vasodilator Agents|vasodilator agents|mesh-ancestor
64307374|NCT04946162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64307375|NCT04946162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64307376|NCT04946162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307440|NCT02420847|Glycine Agents|glycine agents|mesh-ancestor
64307441|NCT02420847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64307442|NCT03253887|Ethanol|ethanol|mesh-list
64307443|NCT03253887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64307444|NCT03253887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64307445|NCT03253887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64307446|NCT03253887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307447|NCT02453607|Infliximab|infliximab|mesh-list
64307448|NCT02453607|Dermatologic Agents|dermatologic agents|mesh-ancestor
64307449|NCT02453607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64307450|NCT02453607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64307451|NCT02453529|Nafithromycin|nafithromycin|mesh-list
64307452|NCT02453529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64307453|NCT02453529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64307454|NCT02453529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64307455|NCT02453529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307456|NCT02453529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307457|NCT03241017|Durvalumab|durvalumab|mesh-list
64307458|NCT03241017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64307459|NCT03241017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307460|NCT03237741|Rabeprazole|rabeprazole|mesh-list
64307919|NCT02085005|Aflibercept|aflibercept|mesh-list
64307920|NCT02085005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64307921|NCT02085005|Antimetabolites|antimetabolites|mesh-ancestor
64307922|NCT02085005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307923|NCT02085005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415604|NCT04864717|Antimalarials|antimalarials|mesh-ancestor
64307924|NCT02085005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64307925|NCT02085005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64307926|NCT02085005|Growth Substances|growth substances|mesh-ancestor
64307961|NCT03056846|Renal Agents|renal agents|mesh-ancestor
64307962|NCT03056846|Antimalarials|antimalarials|mesh-ancestor
64307963|NCT03056846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64307964|NCT03056846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65495218|NCT05348122|Dulaglutide|dulaglutide|mesh-list
65495219|NCT05348122|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
64473286|NCT00121810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64473287|NCT00121810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307965|NCT03227679|Bupropion|bupropion|mesh-list
64307966|NCT03227679|Nicotine|nicotine|mesh-list
64307967|NCT03227679|Varenicline|varenicline|mesh-list
64308056|NCT02085317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308058|NCT03234153|Tremelimumab|tremelimumab|mesh-list
64308059|NCT03234153|Immunologic Factors|immunologic factors|mesh-list
64308060|NCT03234153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64308310|NCT00105157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64308311|NCT00105157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64308312|NCT00105157|Antiviral Agents|antiviral agents|mesh-ancestor
64308313|NCT00105157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64308314|NCT00105157|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64308315|NCT00105157|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64308316|NCT00105157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586294|NCT00322439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64308479|NCT02143531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64308480|NCT02143531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64308541|NCT02451033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308542|NCT04485429|Methylprednisolone|methylprednisolone|mesh-list
64308578|NCT02140801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308580|NCT02148601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64308581|NCT02148601|Vancomycin|vancomycin|mesh-list
64308582|NCT02148601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64308583|NCT02141035|Acetylcarnitine|acetylcarnitine|mesh-list
64786551|NCT00002148|Protective Agents|protective agents|mesh-ancestor
64308584|NCT02141035|Vitamin B Complex|vitamin b complex|mesh-ancestor
64308610|NCT02141113|Adrenergic Agents|adrenergic agents|mesh-ancestor
64308611|NCT02141113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64308612|NCT02141113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308662|NCT02148913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64308663|NCT02148913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64308664|NCT02148913|Immunologic Factors|immunologic factors|mesh-ancestor
64308665|NCT02148913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308666|NCT03208101|Vaccines|vaccines|mesh-list
64308667|NCT03208101|Immunologic Factors|immunologic factors|mesh-ancestor
64308668|NCT03208101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308669|NCT02149225|Poly I-C|poly i-c|mesh-list
64308670|NCT02149225|Molgramostim|molgramostim|mesh-list
64308671|NCT02149225|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64308672|NCT02149225|Vaccines|vaccines|mesh-list
64308673|NCT02149225|Sargramostim|sargramostim|mesh-list
64308674|NCT02149225|Poly ICLC|poly iclc|mesh-list
64308675|NCT02149225|Immunologic Factors|immunologic factors|mesh-ancestor
64308676|NCT02149225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308677|NCT02149225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308678|NCT02149225|Interferon Inducers|interferon inducers|mesh-ancestor
64308679|NCT02149225|Laxatives|laxatives|mesh-ancestor
64308680|NCT02149225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64308681|NCT02149225|Antiviral Agents|antiviral agents|mesh-ancestor
64308682|NCT02149225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64308771|NCT03207165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308772|NCT03207165|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64308773|NCT03207165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64308774|NCT03207165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64308775|NCT03207165|Adrenergic Agents|adrenergic agents|mesh-ancestor
64308776|NCT03207165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64308777|NCT03207165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309019|NCT04484493|Mometasone Furoate|mometasone furoate|mesh-list
64309020|NCT04484493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64309021|NCT04484493|Dermatologic Agents|dermatologic agents|mesh-ancestor
64309085|NCT03204045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64309086|NCT03204045|Narcotics|narcotics|mesh-ancestor
64309087|NCT03204045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64309088|NCT03204045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309089|NCT03204045|Analgesics|analgesics|mesh-ancestor
64309090|NCT03204045|Sensory System Agents|sensory system agents|mesh-ancestor
64309091|NCT03204045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64309092|NCT03204045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64309093|NCT03204045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64309094|NCT03204045|Anesthetics, General|anesthetics, general|mesh-ancestor
64309096|NCT03199521|Thrombin|thrombin|mesh-list
64309097|NCT03199521|Hemostatics|hemostatics|mesh-ancestor
64309098|NCT03199521|Coagulants|coagulants|mesh-ancestor
65495220|NCT05348122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65495221|NCT05348122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473288|NCT00121810|Antifungal Agents|antifungal agents|mesh-ancestor
64309099|NCT03195153|Allopurinol|allopurinol|mesh-list
64309100|NCT03195153|Atorvastatin|atorvastatin|mesh-list
64309101|NCT03195153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64309102|NCT03195153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64309103|NCT03195153|Antimetabolites|antimetabolites|mesh-ancestor
64309104|NCT03195153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309105|NCT03195153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64309106|NCT03195153|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64309225|NCT03197961|Emtricitabine|emtricitabine|mesh-list
64309226|NCT03197961|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64309227|NCT03197961|Medroxyprogesterone|medroxyprogesterone|mesh-list
64309228|NCT03197961|Antiviral Agents|antiviral agents|mesh-ancestor
64309229|NCT03197961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64309230|NCT03197961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64309231|NCT03197961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64309232|NCT03197961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309233|NCT03197961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309234|NCT03197961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64309235|NCT03197961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64309263|NCT03197571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309264|NCT03197571|Tubulin Modulators|tubulin modulators|mesh-ancestor
64309265|NCT03197571|Antimitotic Agents|antimitotic agents|mesh-ancestor
64309266|NCT03197571|Mitosis Modulators|mitosis modulators|mesh-ancestor
64309389|NCT02446431|Sirolimus|sirolimus|mesh-list
64309390|NCT02446431|Cyclophosphamide|cyclophosphamide|mesh-list
64309446|NCT04484259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64309447|NCT04484259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64309448|NCT04484259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64309449|NCT04484259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64552669|NCT03216915|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64309450|NCT04484259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309451|NCT04484259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64309452|NCT04484259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64309453|NCT04484259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309454|NCT04484259|Antipyretics|antipyretics|mesh-ancestor
64309622|NCT03192657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309623|NCT03192657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309624|NCT02444169|Hyaluronic Acid|hyaluronic acid|mesh-list
64309625|NCT02444169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64309626|NCT02444169|Immunologic Factors|immunologic factors|mesh-ancestor
64309713|NCT02439489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309715|NCT02444481|Neomycin|neomycin|mesh-list
64309716|NCT02444481|Nystatin|nystatin|mesh-list
64309717|NCT02444481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64309718|NCT02444481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64309772|NCT02443311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64309773|NCT02443311|Analgesics|analgesics|mesh-ancestor
64309774|NCT02443311|Sensory System Agents|sensory system agents|mesh-ancestor
64309775|NCT02443311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64309776|NCT02443311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64309777|NCT02443311|Dermatologic Agents|dermatologic agents|mesh-ancestor
64309838|NCT02622074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309839|NCT02622074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64309840|NCT02438709|Etoricoxib|etoricoxib|mesh-list
64309841|NCT02438709|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
64309868|NCT05438758|Antidepressive Agents|antidepressive agents|mesh-ancestor
64309869|NCT05438758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64309870|NCT02442921|Colchicine|colchicine|mesh-list
64309871|NCT02442921|Gout Suppressants|gout suppressants|mesh-ancestor
64309872|NCT02442921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64309873|NCT02442921|Tubulin Modulators|tubulin modulators|mesh-ancestor
64309874|NCT02442921|Antimitotic Agents|antimitotic agents|mesh-ancestor
64309875|NCT02442921|Mitosis Modulators|mitosis modulators|mesh-ancestor
64309876|NCT02442921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309877|NCT02442921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309878|NCT02438865|Epirubicin|epirubicin|mesh-list
64309879|NCT02438865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64309880|NCT02438865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309881|NCT02438865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64310008|NCT02441673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64310009|NCT02441673|Narcotics|narcotics|mesh-ancestor
65495222|NCT05348122|Immunologic Factors|immunologic factors|mesh-ancestor
65495223|NCT05125276|Aspirin|aspirin|mesh-list
64310010|NCT02441673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64310011|NCT02441673|Analgesics|analgesics|mesh-ancestor
64310012|NCT02441673|Sensory System Agents|sensory system agents|mesh-ancestor
64310013|NCT02441673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64310014|NCT02441673|Antiemetics|antiemetics|mesh-ancestor
64786812|NCT00002322|Atevirdine|atevirdine|mesh-list
64310015|NCT02441673|Autonomic Agents|autonomic agents|mesh-ancestor
64310016|NCT02441673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64310039|NCT04910126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310040|NCT04922450|Paclitaxel|paclitaxel|mesh-list
64310041|NCT04922450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64310042|NCT04922450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64310043|NCT04922450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310044|NCT04922450|Tubulin Modulators|tubulin modulators|mesh-ancestor
64310045|NCT04922450|Antimitotic Agents|antimitotic agents|mesh-ancestor
64310046|NCT04922450|Mitosis Modulators|mitosis modulators|mesh-ancestor
64310047|NCT04922450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310048|NCT04903808|Allyl sulfide|allyl sulfide|mesh-list
64310049|NCT04903808|Antioxidants|antioxidants|mesh-ancestor
64310050|NCT04903808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310051|NCT04903808|Protective Agents|protective agents|mesh-ancestor
64310052|NCT04903808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310053|NCT04903808|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64310054|NCT04903808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310171|NCT04900766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64310172|NCT04900766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310173|NCT04900766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310174|NCT04900766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64310175|NCT04900766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64310176|NCT04900766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310177|NCT04900766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310178|NCT04908566|Folfirinox|folfirinox|mesh-list
64310179|NCT04908566|Antibodies|antibodies|mesh-list
64310180|NCT04908566|Immunoglobulins|immunoglobulins|mesh-list
64310181|NCT04908566|Immunologic Factors|immunologic factors|mesh-ancestor
64310182|NCT04908566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310183|NCT04908566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310184|NCT04892654|Dolutegravir|dolutegravir|mesh-list
64310185|NCT04892654|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64310186|NCT04892654|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64310187|NCT04892654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310188|NCT04892654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310189|NCT04892654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64310190|NCT04892654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64310307|NCT04906772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64310308|NCT04906772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64310309|NCT04906772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64310310|NCT04906772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64310311|NCT04906772|Adrenergic Agents|adrenergic agents|mesh-ancestor
64310312|NCT04906772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64786873|NCT00002364|Abacavir|abacavir|mesh-list
64310313|NCT04906772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310314|NCT04906772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64310315|NCT04906772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64310343|NCT04898270|Antipsychotic Agents|antipsychotic agents|mesh-list
64310344|NCT04898270|Flupenthixol|flupenthixol|mesh-list
64310455|NCT05028608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64310456|NCT05028608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64310457|NCT05028608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310458|NCT05028608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64310459|NCT05028608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64310460|NCT05028608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64310461|NCT05028608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64310462|NCT05028608|Anesthetics, General|anesthetics, general|mesh-ancestor
64310464|NCT05028608|GABA Modulators|gaba modulators|mesh-ancestor
64310465|NCT05028608|GABA Agents|gaba agents|mesh-ancestor
64310466|NCT05028608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64310467|NCT05028608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310468|NCT05028608|Anticonvulsants|anticonvulsants|mesh-ancestor
64310469|NCT05028608|Antimanic Agents|antimanic agents|mesh-ancestor
64310470|NCT05028608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64310471|NCT05028608|Analgesics|analgesics|mesh-ancestor
64310472|NCT05028608|Sensory System Agents|sensory system agents|mesh-ancestor
64310474|NCT05028608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64310475|NCT05028608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64310510|NCT01596062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64310663|NCT00806390|Sympatholytics|sympatholytics|mesh-ancestor
64310664|NCT00806390|Autonomic Agents|autonomic agents|mesh-ancestor
64310665|NCT00806390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64310666|NCT00806390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310667|NCT00806390|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64310669|NCT00806390|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64310670|NCT00806390|Adrenergic Agents|adrenergic agents|mesh-ancestor
64310671|NCT00806390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64310672|NCT00806390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310673|NCT00566618|Zoledronic Acid|zoledronic acid|mesh-list
64310674|NCT00566618|Dasatinib|dasatinib|mesh-list
64310675|NCT00566618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310700|NCT02152969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310762|NCT03542851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310764|NCT03542851|GABA Agents|gaba agents|mesh-ancestor
64310765|NCT03542851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64310766|NCT03542851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310767|NCT02769247|Naproxen|naproxen|mesh-list
64310768|NCT02769247|Lidocaine|lidocaine|mesh-list
64310769|NCT02769247|Anesthetics, Local|anesthetics, local|mesh-ancestor
64310798|NCT02153437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64310800|NCT02146651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64310801|NCT02146651|Insulin Lispro|insulin lispro|mesh-list
64310802|NCT02146651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64310803|NCT02146651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310804|NCT03542149|Tocopherols|tocopherols|mesh-list
64310805|NCT03542149|Vitamin E|vitamin e|mesh-list
64310806|NCT03542149|Tocotrienols|tocotrienols|mesh-list
64310807|NCT03542149|alpha-Tocopherol|alpha-tocopherol|mesh-list
64310808|NCT03542149|Piperaquine|piperaquine|mesh-list
64310898|NCT02159599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64310899|NCT02159599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64310900|NCT02159599|Antiviral Agents|antiviral agents|mesh-ancestor
64310901|NCT02159599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64310902|NCT02159599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64310903|NCT02159599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64310904|NCT02159599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64310905|NCT02159599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64310950|NCT02157649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64310951|NCT02157649|Antitussive Agents|antitussive agents|mesh-ancestor
64310952|NCT02157649|Respiratory System Agents|respiratory system agents|mesh-ancestor
64310953|NCT02157649|Expectorants|expectorants|mesh-ancestor
64310954|NCT02157649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64310955|NCT02157649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64310956|NCT02157649|Adrenergic Agents|adrenergic agents|mesh-ancestor
64310957|NCT02157649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64310988|NCT04878770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310990|NCT04878770|Immunologic Factors|immunologic factors|mesh-ancestor
64310991|NCT04878770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310992|NCT04878770|Antifungal Agents|antifungal agents|mesh-ancestor
64310993|NCT04878770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64310994|NCT04878770|Dermatologic Agents|dermatologic agents|mesh-ancestor
64310995|NCT04878770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64310996|NCT04878770|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64310997|NCT02086019|Ramipril|ramipril|mesh-list
64310998|NCT02086019|Bisoprolol|bisoprolol|mesh-list
64310999|NCT02086019|Heparin|heparin|mesh-list
64311000|NCT02086019|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64311001|NCT02086019|Tinzaparin|tinzaparin|mesh-list
64311002|NCT02086019|Dalteparin|dalteparin|mesh-list
64311003|NCT02086019|Clopidogrel|clopidogrel|mesh-list
64311004|NCT02086019|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64311070|NCT04870502|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64311071|NCT04870502|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64311072|NCT02088671|Propofol|propofol|mesh-list
64311073|NCT02088671|Desflurane|desflurane|mesh-list
64311074|NCT02088671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64311075|NCT02088671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64311076|NCT02088671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311077|NCT02088671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64311078|NCT02088671|Anesthetics, General|anesthetics, general|mesh-ancestor
64473289|NCT00121810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64311079|NCT02088671|Anesthetics|anesthetics|mesh-ancestor
64311080|NCT02088671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64311081|NCT04870190|Osimertinib|osimertinib|mesh-list
64311082|NCT04870190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64311083|NCT04870190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64311306|NCT02087579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311307|NCT02087579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64311308|NCT02087579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64311309|NCT02087579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64311310|NCT02087579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64311311|NCT02087579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64311312|NCT02087579|Dopamine Agents|dopamine agents|mesh-ancestor
64311396|NCT03046238|Analgesics|analgesics|mesh-ancestor
64311397|NCT03046238|Sensory System Agents|sensory system agents|mesh-ancestor
64311453|NCT03045770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311454|NCT03045770|Antimetabolites|antimetabolites|mesh-ancestor
64311455|NCT03045770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64311456|NCT03045770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64311457|NCT03045770|Immunologic Factors|immunologic factors|mesh-ancestor
64311458|NCT03045770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64311459|NCT03045770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64311460|NCT03045770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311461|NCT03045770|Antidotes|antidotes|mesh-ancestor
64311462|NCT03045770|Protective Agents|protective agents|mesh-ancestor
64311463|NCT03045770|Vitamin B Complex|vitamin b complex|mesh-ancestor
64311464|NCT03045770|Vitamins|vitamins|mesh-ancestor
64311465|NCT03045770|Micronutrients|micronutrients|mesh-ancestor
64311466|NCT02260505|Imatinib Mesylate|imatinib mesylate|mesh-list
64311467|NCT02260505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64311468|NCT02260505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64311669|NCT02097329|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64311703|NCT02097407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64311704|NCT02097407|Analgesics|analgesics|mesh-ancestor
64311705|NCT02097407|Sensory System Agents|sensory system agents|mesh-ancestor
64311706|NCT02097407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64311707|NCT02097407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64311708|NCT02097407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64311709|NCT02097407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64311710|NCT02097407|Adrenergic Agents|adrenergic agents|mesh-ancestor
64311711|NCT02097407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64311712|NCT02097407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311713|NCT02250599|Paclitaxel|paclitaxel|mesh-list
64311714|NCT02250599|Bevacizumab|bevacizumab|mesh-list
64311888|NCT02098499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64311915|NCT02101151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64311917|NCT02101229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64311918|NCT02101229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64311919|NCT02101229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311920|NCT02102555|Acetaminophen|acetaminophen|mesh-list
64311921|NCT02102555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64311922|NCT02102555|Analgesics|analgesics|mesh-ancestor
64311923|NCT02102555|Sensory System Agents|sensory system agents|mesh-ancestor
64311924|NCT02102555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64311925|NCT02102555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311926|NCT02102555|Antipyretics|antipyretics|mesh-ancestor
64311927|NCT02102633|Dabigatran|dabigatran|mesh-list
64311928|NCT02102633|Antithrombins|antithrombins|mesh-ancestor
64311929|NCT02102633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64311930|NCT02102633|Protease Inhibitors|protease inhibitors|mesh-ancestor
64312042|NCT02102321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64312043|NCT02102321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64312044|NCT02102321|Anticestodal Agents|anticestodal agents|mesh-ancestor
64312045|NCT02102321|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64787126|NCT00002490|BCG Vaccine|bcg vaccine|mesh-list
64312046|NCT02102321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64312047|NCT02102321|Tubulin Modulators|tubulin modulators|mesh-ancestor
64312048|NCT02102321|Antimitotic Agents|antimitotic agents|mesh-ancestor
64312049|NCT02102321|Mitosis Modulators|mitosis modulators|mesh-ancestor
64312050|NCT02102321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495224|NCT05125276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64312051|NCT02102321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312052|NCT02103569|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64312386|NCT01453179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64312387|NCT01453179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312388|NCT01453179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312389|NCT01453179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64312390|NCT01453179|Immunologic Factors|immunologic factors|mesh-ancestor
64312391|NCT01453179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312392|NCT01453179|Interferon Inducers|interferon inducers|mesh-ancestor
64312394|NCT03192033|Coagulants|coagulants|mesh-ancestor
64312395|NCT03188445|Ascorbic Acid|ascorbic acid|mesh-list
64312396|NCT03188445|Ferrous fumarate|ferrous fumarate|mesh-list
64312398|NCT03188445|Antioxidants|antioxidants|mesh-ancestor
64312399|NCT03188445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312434|NCT03188289|Protective Agents|protective agents|mesh-ancestor
64313012|NCT02432781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64313013|NCT02432781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313014|NCT01667900|Dulaglutide|dulaglutide|mesh-list
64313015|NCT01667900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64313016|NCT01667900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313017|NCT04843280|Coal Tar|coal tar|mesh-list
64313018|NCT04843280|Keratolytic Agents|keratolytic agents|mesh-ancestor
64313019|NCT04843280|Dermatologic Agents|dermatologic agents|mesh-ancestor
64313020|NCT04833296|Ropivacaine|ropivacaine|mesh-list
64313359|NCT03183375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313360|NCT03183375|Antisickling Agents|antisickling agents|mesh-ancestor
64313361|NCT03183375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313362|NCT03183375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787205|NCT00002514|Abortifacient Agents|abortifacient agents|mesh-ancestor
64313363|NCT03183375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64313365|NCT03183297|Naproxen|naproxen|mesh-list
64313366|NCT03183297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64313677|NCT02114021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64313678|NCT02114021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313679|NCT02114021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64313681|NCT02114021|Hormones|hormones|mesh-ancestor
64313682|NCT02114021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64313683|NCT02114021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64313863|NCT02115035|Vemurafenib|vemurafenib|mesh-list
64313864|NCT02115035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313967|NCT02123069|Adrenergic Agents|adrenergic agents|mesh-ancestor
64313968|NCT02123069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64313969|NCT02123069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313970|NCT02123069|Protective Agents|protective agents|mesh-ancestor
64313971|NCT02123069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64313972|NCT02123069|Vasodilator Agents|vasodilator agents|mesh-ancestor
64314318|NCT04801940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314320|NCT04801940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64314321|NCT04801940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314322|NCT04801940|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64314323|NCT04801940|Antithrombins|antithrombins|mesh-ancestor
64314324|NCT04801940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64314325|NCT04801940|Protease Inhibitors|protease inhibitors|mesh-ancestor
64314326|NCT04801940|Anticoagulants|anticoagulants|mesh-ancestor
64314327|NCT02251847|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64314328|NCT02251847|Ezetimibe|ezetimibe|mesh-list
64314329|NCT02251847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64314330|NCT02251847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64314331|NCT02251847|Antimetabolites|antimetabolites|mesh-ancestor
64314332|NCT02251847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314333|NCT02251847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64314334|NCT02251847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64314335|NCT02251847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314336|NCT02127047|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64314337|NCT02127047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64314496|NCT02127749|Metronidazole|metronidazole|mesh-list
64314498|NCT02127749|Ciprofloxacin|ciprofloxacin|mesh-list
64314499|NCT02127749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64314500|NCT02127749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64314501|NCT02127749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64314502|NCT02127749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64314503|NCT02127749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64314504|NCT02127749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64314505|NCT02127749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314506|NCT02127749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314507|NCT02127749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495225|NCT05125276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65495226|NCT05125276|Analgesics|analgesics|mesh-ancestor
64314508|NCT02127749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64314509|NCT02127749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64314510|NCT04797338|Nafarelin|nafarelin|mesh-list
64315202|NCT03511118|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64315203|NCT03511118|Labetalol|labetalol|mesh-list
64315204|NCT03511118|Nifedipine|nifedipine|mesh-list
64315205|NCT03511118|Furosemide|furosemide|mesh-list
64315206|NCT03511118|Sumatriptan|sumatriptan|mesh-list
64315207|NCT03511118|Oxycodone|oxycodone|mesh-list
64315208|NCT03511118|Gabapentin|gabapentin|mesh-list
64315209|NCT03511118|Ondansetron|ondansetron|mesh-list
64316003|NCT05700812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316004|NCT05700812|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64316005|NCT05700812|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64316007|NCT02589626|Empagliflozin|empagliflozin|mesh-list
64316008|NCT02589626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64316009|NCT02589626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316010|NCT02589626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64316011|NCT02589626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316012|NCT04976036|Nintedanib|nintedanib|mesh-list
64316013|NCT04976036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316014|NCT04976036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64316015|NCT04976036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316016|NCT04976036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316153|NCT00103285|Alkylating Agents|alkylating agents|mesh-ancestor
64316154|NCT00103285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316155|NCT00103285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316156|NCT00103285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64316157|NCT00103285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64316158|NCT00103285|Antiemetics|antiemetics|mesh-ancestor
64316159|NCT00103285|Autonomic Agents|autonomic agents|mesh-ancestor
64316160|NCT00103285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316161|NCT00103285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64316162|NCT00103285|Glucocorticoids|glucocorticoids|mesh-ancestor
64316163|NCT00103285|Hormones|hormones|mesh-ancestor
64316164|NCT00103285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64316165|NCT00103285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64316166|NCT00103285|Protease Inhibitors|protease inhibitors|mesh-ancestor
64316167|NCT00103285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316168|NCT00103285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64316169|NCT00103285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64316170|NCT00103285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64316171|NCT00103285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64316172|NCT00103285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64316173|NCT00103285|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64316174|NCT00103285|Abortifacient Agents|abortifacient agents|mesh-ancestor
64316175|NCT00103285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64316176|NCT00103285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64316177|NCT00103285|Antimetabolites|antimetabolites|mesh-ancestor
64316178|NCT00103285|Dermatologic Agents|dermatologic agents|mesh-ancestor
64316179|NCT00103285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64316198|NCT03541915|Anesthetics|anesthetics|mesh-ancestor
64316199|NCT03541915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64316200|NCT03541915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64316201|NCT03541915|Anticonvulsants|anticonvulsants|mesh-ancestor
64316202|NCT03541915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64316203|NCT03541915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64316204|NCT03541915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316205|NCT03541915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64316206|NCT03541915|Tocolytic Agents|tocolytic agents|mesh-ancestor
64316207|NCT03541915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64316208|NCT03541837|Ropivacaine|ropivacaine|mesh-list
64316209|NCT03541837|Anesthetics, Local|anesthetics, local|mesh-ancestor
64316210|NCT03541837|Anesthetics|anesthetics|mesh-ancestor
64316211|NCT03541837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64316212|NCT03541837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317378|NCT03265574|Enalapril|enalapril|mesh-list
64316213|NCT03541837|Sensory System Agents|sensory system agents|mesh-ancestor
64316214|NCT03541837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316215|NCT02158117|Naloxone|naloxone|mesh-list
64316216|NCT02158117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64316217|NCT02158117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316218|NCT02158117|Sensory System Agents|sensory system agents|mesh-ancestor
64316219|NCT02158117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316220|NCT03541603|Simendan|simendan|mesh-list
64316221|NCT03541603|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64316222|NCT03541603|Vasodilator Agents|vasodilator agents|mesh-ancestor
64316223|NCT03541603|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64316856|NCT02410083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64316857|NCT02410083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64316858|NCT02410083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316859|NCT02410083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64316860|NCT02410083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64316861|NCT02410083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316862|NCT02410083|Antipyretics|antipyretics|mesh-ancestor
64316863|NCT02410083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64316864|NCT02410083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64316865|NCT02410083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64316866|NCT02410083|Purinergic Agents|purinergic agents|mesh-ancestor
64316867|NCT02410083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64316868|NCT02416245|Micronutrients|micronutrients|mesh-list
64319189|NCT00108953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64787675|NCT00002676|Micronutrients|micronutrients|mesh-ancestor
64319191|NCT00108953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64319192|NCT00108953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64319193|NCT00108953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386658|NCT02389751|Antimitotic Agents|antimitotic agents|mesh-ancestor
64386659|NCT02389751|Mitosis Modulators|mitosis modulators|mesh-ancestor
64386660|NCT02389751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386661|NCT02390063|Cyclophosphamide|cyclophosphamide|mesh-list
64386662|NCT02390063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64386663|NCT02390063|Immunologic Factors|immunologic factors|mesh-ancestor
64386664|NCT02390063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386695|NCT02663453|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64386696|NCT02663453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64386697|NCT04439825|Botulinum Toxins|botulinum toxins|mesh-list
64386698|NCT04439825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64386699|NCT04439825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64386700|NCT04439825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386701|NCT04439825|Cholinergic Agents|cholinergic agents|mesh-ancestor
64386702|NCT04439825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64386844|NCT02382263|Gemcitabine|gemcitabine|mesh-list
64386845|NCT02382263|Paclitaxel|paclitaxel|mesh-list
64386846|NCT02382263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64386847|NCT02382263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64386848|NCT02382263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386849|NCT02382263|Tubulin Modulators|tubulin modulators|mesh-ancestor
64386850|NCT02382263|Antimitotic Agents|antimitotic agents|mesh-ancestor
64386851|NCT02382263|Mitosis Modulators|mitosis modulators|mesh-ancestor
64386852|NCT02382263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386853|NCT02382263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64386854|NCT02382263|Antimetabolites|antimetabolites|mesh-ancestor
64386855|NCT02382263|Antiviral Agents|antiviral agents|mesh-ancestor
64387191|NCT02378129|Sympathomimetics|sympathomimetics|mesh-ancestor
64387192|NCT02378129|Autonomic Agents|autonomic agents|mesh-ancestor
64387193|NCT02378129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387194|NCT02378129|Dopamine Agents|dopamine agents|mesh-ancestor
64387195|NCT02378129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64387196|NCT02378129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387197|NCT02378129|Adrenergic Agents|adrenergic agents|mesh-ancestor
64387198|NCT02378129|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64387199|NCT02378129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64387200|NCT02378129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64387201|NCT02378129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64387203|NCT02376335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64387204|NCT02376335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387291|NCT02372357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64387292|NCT02372357|Hormone Antagonists|hormone antagonists|mesh-ancestor
64387293|NCT02372357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64387294|NCT02372357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387295|NCT03672773|Temozolomide|temozolomide|mesh-list
64387296|NCT03672773|Talazoparib|talazoparib|mesh-list
64387297|NCT03672773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64387298|NCT03672773|Alkylating Agents|alkylating agents|mesh-ancestor
64387299|NCT03672773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788149|NCT05296278|Lenvatinib|lenvatinib|mesh-list
64387300|NCT03672773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387301|NCT03672773|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64387524|NCT05653817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64387525|NCT05653817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387526|NCT05653817|Tubulin Modulators|tubulin modulators|mesh-ancestor
64387527|NCT05653817|Antimitotic Agents|antimitotic agents|mesh-ancestor
64387851|NCT03112889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64387852|NCT03112889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64387853|NCT03112889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64387854|NCT03112577|Fluticasone|fluticasone|mesh-list
64387856|NCT03112577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64387857|NCT03112577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64387858|NCT03112577|Autonomic Agents|autonomic agents|mesh-ancestor
64387859|NCT03112577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387860|NCT03112577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387861|NCT03112577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64387862|NCT03112577|Respiratory System Agents|respiratory system agents|mesh-ancestor
64387899|NCT02358707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64387900|NCT02358707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387927|NCT02358161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387928|NCT02358161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64387930|NCT02358161|Antiviral Agents|antiviral agents|mesh-ancestor
64387931|NCT02358161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64387932|NCT02358161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387933|NCT02358161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64387989|NCT03160001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64387990|NCT03160001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64387991|NCT03160001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64388025|NCT02357303|Simethicone|simethicone|mesh-list
64388026|NCT02357303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64388027|NCT02357303|Antiviral Agents|antiviral agents|mesh-ancestor
64388028|NCT02357303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64388029|NCT02357303|Expectorants|expectorants|mesh-ancestor
64388030|NCT02357303|Respiratory System Agents|respiratory system agents|mesh-ancestor
64388031|NCT02357303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64388032|NCT02357303|Antioxidants|antioxidants|mesh-ancestor
64388069|NCT02356913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64388070|NCT02356913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388071|NCT02352545|Montelukast|montelukast|mesh-list
64388135|NCT02352155|Epinephrine|epinephrine|mesh-list
64388136|NCT02352155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64388137|NCT02352155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64388138|NCT02352155|Adrenergic Agents|adrenergic agents|mesh-ancestor
64390213|NCT03141125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64390214|NCT03141125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64390215|NCT03141125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64390216|NCT03141125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390219|NCT02426983|Respiratory System Agents|respiratory system agents|mesh-ancestor
64390220|NCT02426983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64390597|NCT02018458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64390599|NCT02018458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64390830|NCT03178123|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64390831|NCT03178123|Immunologic Factors|immunologic factors|mesh-ancestor
64390832|NCT03178123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390833|NCT03178123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390834|NCT03178123|Antiviral Agents|antiviral agents|mesh-ancestor
64390835|NCT03178123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64390836|NCT03820817|Rifaximin|rifaximin|mesh-list
64390837|NCT03820817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64390838|NCT03820817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64390839|NCT03820817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64390840|NCT05106517|Zoledronic Acid|zoledronic acid|mesh-list
64391284|NCT03179839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64391285|NCT03179839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64391286|NCT03179839|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64391287|NCT03179839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64391288|NCT03179839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391289|NCT03179839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64391290|NCT05736887|Acetylcysteine|acetylcysteine|mesh-list
65495227|NCT05125276|Sensory System Agents|sensory system agents|mesh-ancestor
64473292|NCT00053014|Cyclosporine|cyclosporine|mesh-list
64473293|NCT00053014|Mycophenolic Acid|mycophenolic acid|mesh-list
64392453|NCT04088123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64392454|NCT04088123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64392455|NCT04088123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64392456|NCT04088123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64392457|NCT04088123|Purinergic Agents|purinergic agents|mesh-ancestor
64392458|NCT04088123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64392459|NCT04088123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392766|NCT05108051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64392767|NCT05108051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392768|NCT03765359|Metformin|metformin|mesh-list
64392769|NCT03765359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64392770|NCT03765359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392771|NCT04351295|Chloroquine|chloroquine|mesh-list
64392772|NCT04351295|Favipiravir|favipiravir|mesh-list
64392773|NCT04351295|Amebicides|amebicides|mesh-ancestor
64392774|NCT04351295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64392966|NCT04524611|Ustekinumab|ustekinumab|mesh-list
64392967|NCT04524611|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64392968|NCT04524611|Dermatologic Agents|dermatologic agents|mesh-ancestor
64392969|NCT04524611|Immunologic Factors|immunologic factors|mesh-ancestor
64392970|NCT04524611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392971|NCT02658149|Ketorolac|ketorolac|mesh-list
64393587|NCT04518293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393588|NCT04518293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64393590|NCT04518293|Vasodilator Agents|vasodilator agents|mesh-ancestor
64393591|NCT04518293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64393592|NCT04518293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64393593|NCT04518293|Diuretics|diuretics|mesh-ancestor
64393594|NCT04518293|Natriuretic Agents|natriuretic agents|mesh-ancestor
64393595|NCT04518293|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64394286|NCT02392039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394287|NCT03106363|Ethanol|ethanol|mesh-list
64394288|NCT03106363|Dronabinol|dronabinol|mesh-list
64395239|NCT05131295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64395240|NCT05131295|Immunologic Factors|immunologic factors|mesh-ancestor
64395241|NCT05131295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395243|NCT05131295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64396348|NCT03105661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396349|NCT03105661|Vasodilator Agents|vasodilator agents|mesh-ancestor
64397572|NCT03097211|Benserazide|benserazide|mesh-list
64397573|NCT03097211|Resveratrol|resveratrol|mesh-list
64397574|NCT03097211|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
64397575|NCT03097211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64397576|NCT03097211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64397577|NCT03097211|Dopamine Agents|dopamine agents|mesh-ancestor
64397578|NCT03097211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64397581|NCT03097211|Antioxidants|antioxidants|mesh-ancestor
64397620|NCT01951378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64397621|NCT01951378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397622|NCT03359863|Pirfenidone|pirfenidone|mesh-list
64397623|NCT03359863|Analgesics|analgesics|mesh-ancestor
64397624|NCT03359863|Sensory System Agents|sensory system agents|mesh-ancestor
64397625|NCT03359863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64397626|NCT03359863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397627|NCT03359863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64397628|NCT03359863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64397629|NCT03359863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64397630|NCT03359863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64397631|NCT03359863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64397632|NCT05043233|Methimazole|methimazole|mesh-list
64397633|NCT05043233|Antithyroid Agents|antithyroid agents|mesh-ancestor
64397634|NCT05043233|Hormone Antagonists|hormone antagonists|mesh-ancestor
64397635|NCT05043233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64397636|NCT05043233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397637|NCT03258853|Pancrelipase|pancrelipase|mesh-list
64397638|NCT03258853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64397641|NCT05054465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495228|NCT05125276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64397642|NCT03860233|Oxytocin|oxytocin|mesh-list
64397643|NCT03860233|Oxytocics|oxytocics|mesh-ancestor
64397644|NCT03860233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64397645|NCT03860233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397646|NCT04154189|Etoposide|etoposide|mesh-list
64397647|NCT04154189|Ifosfamide|ifosfamide|mesh-list
64397648|NCT04154189|Lenvatinib|lenvatinib|mesh-list
64397649|NCT04154189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64397666|NCT01361009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64397667|NCT01361009|Dopamine Agonists|dopamine agonists|mesh-ancestor
64397668|NCT01361009|Dopamine Agents|dopamine agents|mesh-ancestor
64397669|NCT01361009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64788485|NCT01821690|Serotonin Agents|serotonin agents|mesh-ancestor
64397701|NCT02366299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64397703|NCT02366299|Adrenergic Agents|adrenergic agents|mesh-ancestor
64397704|NCT02366299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64397705|NCT02366299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397706|NCT05041985|Diazepam|diazepam|mesh-list
64397715|NCT05041985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64397717|NCT05041985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64397718|NCT05041985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64397719|NCT05041985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64397720|NCT05041985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64397721|NCT05041985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64397794|NCT02362711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64397795|NCT02362711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64397796|NCT02362711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64397799|NCT02362711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64397800|NCT01944046|Oxytocin|oxytocin|mesh-list
64397801|NCT01944046|Oxytocics|oxytocics|mesh-ancestor
64397802|NCT01944046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64397803|NCT01944046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397804|NCT00773695|Paclitaxel|paclitaxel|mesh-list
64397805|NCT00773695|Docetaxel|docetaxel|mesh-list
64397806|NCT00773695|Cyclophosphamide|cyclophosphamide|mesh-list
64397807|NCT00773695|Bevacizumab|bevacizumab|mesh-list
64397808|NCT00773695|Fluorouracil|fluorouracil|mesh-list
64397809|NCT00773695|Epirubicin|epirubicin|mesh-list
64397810|NCT00773695|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64397811|NCT00773695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64397812|NCT00773695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64397813|NCT00773695|Tubulin Modulators|tubulin modulators|mesh-ancestor
64397814|NCT00773695|Antimitotic Agents|antimitotic agents|mesh-ancestor
64397815|NCT00773695|Mitosis Modulators|mitosis modulators|mesh-ancestor
64397816|NCT00773695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397817|NCT00773695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64397818|NCT00773695|Immunologic Factors|immunologic factors|mesh-ancestor
64397819|NCT00773695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397820|NCT00773695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64397821|NCT00773695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64397859|NCT04410887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397861|NCT02358499|Posaconazole|posaconazole|mesh-list
64397862|NCT02358499|Antifungal Agents|antifungal agents|mesh-ancestor
64397863|NCT02358499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64397864|NCT02358499|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64397865|NCT02358499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64397866|NCT02358499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64788544|NCT00577200|GABA Modulators|gaba modulators|mesh-ancestor
64397867|NCT02358499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64397868|NCT02358499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64397869|NCT02358499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397870|NCT02358499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397871|NCT02358499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64397872|NCT02358499|Hormone Antagonists|hormone antagonists|mesh-ancestor
64397873|NCT02358499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64397874|NCT02358499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397875|NCT02358265|Cyproheptadine|cyproheptadine|mesh-list
64397908|NCT01968694|Histamine Antagonists|histamine antagonists|mesh-ancestor
64397909|NCT01968694|Histamine Agents|histamine agents|mesh-ancestor
64397910|NCT01968694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64397911|NCT01968694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64397912|NCT01968694|Antipruritics|antipruritics|mesh-ancestor
64397913|NCT01968694|Dermatologic Agents|dermatologic agents|mesh-ancestor
64397914|NCT04639414|Empagliflozin|empagliflozin|mesh-list
64397915|NCT04639414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64473296|NCT00053014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473297|NCT00053014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473298|NCT00053014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64473299|NCT00053014|Immunologic Factors|immunologic factors|mesh-ancestor
64473300|NCT00053014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64473301|NCT00053014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397916|NCT04639414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397917|NCT04639414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64397918|NCT04639414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397919|NCT05038007|Bupivacaine|bupivacaine|mesh-list
64397920|NCT05038007|Anesthetics, Local|anesthetics, local|mesh-ancestor
64397921|NCT05038007|Anesthetics|anesthetics|mesh-ancestor
64397922|NCT05038007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64397923|NCT05038007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397924|NCT05038007|Sensory System Agents|sensory system agents|mesh-ancestor
64397956|NCT05049473|Cyclophosphamide|cyclophosphamide|mesh-list
64397957|NCT05049473|Rituximab|rituximab|mesh-list
64397958|NCT05049473|Doxorubicin|doxorubicin|mesh-list
64397959|NCT05049473|Methotrexate|methotrexate|mesh-list
64397960|NCT05049473|Etoposide|etoposide|mesh-list
64397961|NCT05049473|Vincristine|vincristine|mesh-list
64397962|NCT05049473|Vindesine|vindesine|mesh-list
64397963|NCT05049473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64397964|NCT05049473|Immunologic Factors|immunologic factors|mesh-ancestor
64397965|NCT05049473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397966|NCT05049473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64397967|NCT05049473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64397968|NCT05049473|Alkylating Agents|alkylating agents|mesh-ancestor
64397986|NCT05049473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64397988|NCT05049473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64398013|NCT02357797|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64398014|NCT02357797|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64398015|NCT02357797|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64398016|NCT02357797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64398017|NCT02361931|Epoetin Alfa|epoetin alfa|mesh-list
64398018|NCT02361931|Hematinics|hematinics|mesh-ancestor
64398019|NCT05037695|Empagliflozin|empagliflozin|mesh-list
64398020|NCT05037695|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64398029|NCT02357563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398030|NCT02357563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64398032|NCT02357563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64398033|NCT02357563|Contraceptive Agents|contraceptive agents|mesh-ancestor
64398034|NCT02357563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64398036|NCT02640053|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64398037|NCT02640053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64398038|NCT02640053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398039|NCT02640053|Tubulin Modulators|tubulin modulators|mesh-ancestor
64398040|NCT02640053|Antimitotic Agents|antimitotic agents|mesh-ancestor
64398041|NCT02640053|Mitosis Modulators|mitosis modulators|mesh-ancestor
64398042|NCT02640053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398043|NCT03160261|Exenatide|exenatide|mesh-list
64398079|NCT02361619|GABA Modulators|gaba modulators|mesh-ancestor
64398080|NCT02361619|GABA Agents|gaba agents|mesh-ancestor
64398081|NCT02361619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64398082|NCT02361619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398083|NCT02361619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64398084|NCT02361619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64398085|NCT02361619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64398086|NCT02361619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398087|NCT02361619|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64398130|NCT01950364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398131|NCT01950364|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64398132|NCT01950364|Antitubercular Agents|antitubercular agents|mesh-ancestor
64398133|NCT01950364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64398134|NCT01950364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65495229|NCT05125276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495230|NCT05125276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65495231|NCT05125276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65495232|NCT05125276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65495233|NCT05125276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65495234|NCT05125276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495235|NCT05125276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64398135|NCT01950364|Leprostatic Agents|leprostatic agents|mesh-ancestor
64398136|NCT01950364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64398178|NCT00014443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398179|NCT00014443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64398180|NCT00014443|Immunologic Factors|immunologic factors|mesh-ancestor
64398181|NCT00014443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398182|NCT00014443|Leprostatic Agents|leprostatic agents|mesh-ancestor
64398183|NCT00014443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64398184|NCT00014443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64398185|NCT00014443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64398186|NCT00014443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64398187|NCT00014443|Growth Substances|growth substances|mesh-ancestor
64398214|NCT03160651|Methylprednisolone|methylprednisolone|mesh-list
64398215|NCT03160651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64398216|NCT03160651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64398217|NCT03160651|Prednisolone|prednisolone|mesh-list
64398218|NCT03160651|Prednisolone acetate|prednisolone acetate|mesh-list
64398219|NCT03160651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64398220|NCT03160651|Prednisolone phosphate|prednisolone phosphate|mesh-list
64398237|NCT05034965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398238|NCT05034965|Viscosupplements|viscosupplements|mesh-ancestor
64398239|NCT05034965|Protective Agents|protective agents|mesh-ancestor
64398240|NCT03160339|Vaccines|vaccines|mesh-list
64398241|NCT03160339|Immunologic Factors|immunologic factors|mesh-ancestor
64398242|NCT03160339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398243|NCT05034887|Trastuzumab|trastuzumab|mesh-list
64398244|NCT05034887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64398245|NCT05034887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398246|NCT02039011|Tiotropium Bromide|tiotropium bromide|mesh-list
64398247|NCT02039011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64398248|NCT02039011|Autonomic Agents|autonomic agents|mesh-ancestor
64398249|NCT02039011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64398295|NCT03093467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398296|NCT03149653|SMOFlipid|smoflipid|mesh-list
64398323|NCT01968070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398324|NCT01968070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64398326|NCT01968070|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64398327|NCT01968070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64398328|NCT01968070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398329|NCT01968070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398330|NCT01949662|Lorazepam|lorazepam|mesh-list
64398331|NCT01949662|Haloperidol|haloperidol|mesh-list
64398332|NCT01949662|Haloperidol decanoate|haloperidol decanoate|mesh-list
64398333|NCT01949662|Antiemetics|antiemetics|mesh-ancestor
64398334|NCT01949662|Autonomic Agents|autonomic agents|mesh-ancestor
64398336|NCT01949662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398337|NCT01949662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64398338|NCT01949662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64398339|NCT01949662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64398340|NCT01949662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64398341|NCT01949662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64398342|NCT01949662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64398387|NCT02350387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64398388|NCT02350387|Adrenergic Agents|adrenergic agents|mesh-ancestor
64398389|NCT02350387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64398390|NCT02350387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398391|NCT02350387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398392|NCT02350387|Sympathomimetics|sympathomimetics|mesh-ancestor
64398393|NCT02350387|Autonomic Agents|autonomic agents|mesh-ancestor
64398394|NCT02350387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64398395|NCT02350387|Nasal Decongestants|nasal decongestants|mesh-ancestor
64398396|NCT02350387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64398397|NCT02350387|Respiratory System Agents|respiratory system agents|mesh-ancestor
64398398|NCT02350543|Aspirin|aspirin|mesh-list
64398399|NCT02350543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64398400|NCT02350543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64398401|NCT02350543|Analgesics|analgesics|mesh-ancestor
64398402|NCT02350543|Sensory System Agents|sensory system agents|mesh-ancestor
64398409|NCT02350543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398410|NCT02350543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65495236|NCT05125276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64473303|NCT00053014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64473304|NCT00053014|Dermatologic Agents|dermatologic agents|mesh-ancestor
64398411|NCT02350543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64398412|NCT02350543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398440|NCT05023577|Diuretics|diuretics|mesh-ancestor
64398441|NCT05023577|Natriuretic Agents|natriuretic agents|mesh-ancestor
64398442|NCT05023577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398443|NCT05023577|Expectorants|expectorants|mesh-ancestor
64398444|NCT05023577|Respiratory System Agents|respiratory system agents|mesh-ancestor
64398445|NCT03149419|Paroxetine|paroxetine|mesh-list
64398446|NCT03149419|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64398447|NCT03149419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64398448|NCT03149419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64398449|NCT03149419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398450|NCT03149419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64398451|NCT03149419|Serotonin Agents|serotonin agents|mesh-ancestor
64398452|NCT03149419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398453|NCT03149419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64398454|NCT03149419|Antidepressive Agents|antidepressive agents|mesh-ancestor
64398455|NCT03149419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64398456|NCT03149419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64398457|NCT03149419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64398458|NCT03149419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398459|NCT03092765|Quetmolimab|quetmolimab|mesh-list
64398460|NCT03092765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64398461|NCT01939366|Pregabalin|pregabalin|mesh-list
64398462|NCT01939366|Analgesics|analgesics|mesh-ancestor
64398503|NCT04434365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64398504|NCT05031923|Anti-Infective Agents|anti-infective agents|mesh-list
64398505|NCT05031923|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64398506|NCT03149575|Carboplatin|carboplatin|mesh-list
64398507|NCT03149575|Temozolomide|temozolomide|mesh-list
64398508|NCT03149575|Lomustine|lomustine|mesh-list
64398509|NCT03149575|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
64398510|NCT03149575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398511|NCT03149575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64398512|NCT03149575|Alkylating Agents|alkylating agents|mesh-ancestor
64398513|NCT03149575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398543|NCT05031143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64398545|NCT05031143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64398546|NCT05031143|Immunologic Factors|immunologic factors|mesh-ancestor
64398547|NCT05031143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398548|NCT05031143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398549|NCT01916980|Desloratadine|desloratadine|mesh-list
64398550|NCT01916980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64633297|NCT00003892|ISIS 5132|isis 5132|mesh-list
64398551|NCT01916980|Cholinergic Agents|cholinergic agents|mesh-ancestor
64398552|NCT01916980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64398553|NCT01916980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398554|NCT01916980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398555|NCT01916980|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64398556|NCT01916980|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64398557|NCT01916980|Histamine Antagonists|histamine antagonists|mesh-ancestor
64398558|NCT01916980|Histamine Agents|histamine agents|mesh-ancestor
64398559|NCT02348281|Bicalutamide|bicalutamide|mesh-list
64398560|NCT02348281|Androgen Antagonists|androgen antagonists|mesh-ancestor
64398561|NCT02348281|Hormone Antagonists|hormone antagonists|mesh-ancestor
64789143|NCT00003204|Glucocorticoids|glucocorticoids|mesh-ancestor
64398562|NCT02348281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64789144|NCT00003204|Hormones|hormones|mesh-ancestor
64398641|NCT03094481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64398704|NCT03148717|Abortifacient Agents|abortifacient agents|mesh-ancestor
64398705|NCT03148717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64398706|NCT03148717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398707|NCT03148717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64398708|NCT03148717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64398709|NCT03148717|Oxytocics|oxytocics|mesh-ancestor
64398710|NCT02349607|Ibuprofen|ibuprofen|mesh-list
64398711|NCT02349607|Pregabalin|pregabalin|mesh-list
64398712|NCT02349607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64398713|NCT02349607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64398714|NCT02349607|Analgesics|analgesics|mesh-ancestor
64398715|NCT02349607|Sensory System Agents|sensory system agents|mesh-ancestor
64398716|NCT02349607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65495237|NCT05125276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495238|NCT05125276|Antipyretics|antipyretics|mesh-ancestor
65495239|NCT05054842|Metformin|metformin|mesh-list
64398717|NCT02349607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398718|NCT02349607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64398719|NCT02349607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64398720|NCT02349607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64398721|NCT02349607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398722|NCT02349607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398723|NCT02349607|Anticonvulsants|anticonvulsants|mesh-ancestor
64398724|NCT02349607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64398725|NCT02349607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64398726|NCT02349607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64398760|NCT02353507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64398762|NCT03148561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64398763|NCT03148561|Abortifacient Agents|abortifacient agents|mesh-ancestor
64398764|NCT03148561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64398765|NCT03148561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398766|NCT03148561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64398767|NCT03148561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64398768|NCT03148561|Oxytocics|oxytocics|mesh-ancestor
64398769|NCT02353429|Toremifene|toremifene|mesh-list
64398770|NCT02353429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64789200|NCT00003252|Protective Agents|protective agents|mesh-ancestor
64789205|NCT00003264|Antimetabolites|antimetabolites|mesh-ancestor
64398771|NCT02353429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398772|NCT02353429|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64398773|NCT02353429|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64398774|NCT02353429|Hormone Antagonists|hormone antagonists|mesh-ancestor
64398775|NCT02353429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64398992|NCT03090035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64398993|NCT03090035|Antimetabolites|antimetabolites|mesh-ancestor
64398994|NCT03090035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398995|NCT05008367|Dexamethasone|dexamethasone|mesh-list
64398996|NCT05008367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64398997|NCT05008367|Antiemetics|antiemetics|mesh-ancestor
64398998|NCT05008367|Autonomic Agents|autonomic agents|mesh-ancestor
64398999|NCT05008367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399000|NCT05008367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399001|NCT05008367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64399002|NCT05008367|Glucocorticoids|glucocorticoids|mesh-ancestor
64399003|NCT05008367|Hormones|hormones|mesh-ancestor
64399004|NCT05008367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64399005|NCT05008367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64399012|NCT02346331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64399013|NCT02346331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64399014|NCT02342509|Sevoflurane|sevoflurane|mesh-list
64399015|NCT02342509|Desflurane|desflurane|mesh-list
64399048|NCT05007587|Fluorouracil|fluorouracil|mesh-list
64399049|NCT05007587|Raltitrexed|raltitrexed|mesh-list
64399050|NCT05007587|Oxaliplatin|oxaliplatin|mesh-list
64399051|NCT05007587|Lenvatinib|lenvatinib|mesh-list
64399052|NCT05007587|Antimetabolites|antimetabolites|mesh-ancestor
64399053|NCT05007587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399054|NCT05007587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64399055|NCT05007587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399126|NCT02341963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64399127|NCT02341963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399129|NCT05014685|Metronidazole|metronidazole|mesh-list
64399130|NCT05014685|Potassium Citrate|potassium citrate|mesh-list
64399131|NCT05014685|Rabeprazole|rabeprazole|mesh-list
64399132|NCT05014685|Bismuth|bismuth|mesh-list
64399178|NCT04762459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64399180|NCT03078569|Androgens|androgens|mesh-ancestor
64399181|NCT03078569|Hormones|hormones|mesh-ancestor
64399182|NCT03078569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64399183|NCT03078569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399184|NCT02345863|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64789271|NCT00003336|Hormones|hormones|mesh-ancestor
64399185|NCT02345863|Obinutuzumab|obinutuzumab|mesh-list
64399186|NCT02345863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64399220|NCT02341573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399222|NCT05005715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64399223|NCT05005715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64399224|NCT05005715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495240|NCT05054842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64399226|NCT05005715|Analgesics|analgesics|mesh-ancestor
64399227|NCT05005715|Sensory System Agents|sensory system agents|mesh-ancestor
64399228|NCT05005715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399229|NCT05005715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64399230|NCT05005715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64399232|NCT05005715|Adrenergic Agents|adrenergic agents|mesh-ancestor
64399233|NCT05005715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64399257|NCT02336659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399259|NCT02336659|Hormones|hormones|mesh-ancestor
64399260|NCT02336659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64399261|NCT02336659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64399262|NCT02336659|Protease Inhibitors|protease inhibitors|mesh-ancestor
64399263|NCT02336659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399264|NCT02336659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399265|NCT03081923|Durvalumab|durvalumab|mesh-list
64399266|NCT03081923|Tremelimumab|tremelimumab|mesh-list
64399267|NCT03081923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64399268|NCT03081923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399269|NCT02341105|Amiodarone|amiodarone|mesh-list
64399270|NCT02341105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64399278|NCT02341105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399279|NCT02341105|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64399280|NCT02341105|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64399281|NCT02341105|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64399282|NCT03078101|Empagliflozin|empagliflozin|mesh-list
64399283|NCT03078101|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64399284|NCT03078101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399285|NCT03078101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64399286|NCT03078101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399287|NCT02345239|Pantoprazole|pantoprazole|mesh-list
64399288|NCT02345239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64399319|NCT05254405|Neurosteroids|neurosteroids|mesh-ancestor
64399320|NCT05254405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64399321|NCT05254405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399322|NCT05254405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399323|NCT05254405|GABA Modulators|gaba modulators|mesh-ancestor
64399324|NCT05254405|GABA Agents|gaba agents|mesh-ancestor
64399325|NCT04509973|Dexamethasone|dexamethasone|mesh-list
64399326|NCT04509973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64399327|NCT04509973|Antiemetics|antiemetics|mesh-ancestor
64399328|NCT04509973|Autonomic Agents|autonomic agents|mesh-ancestor
64399329|NCT04509973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399330|NCT04509973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399443|NCT05178823|Dental Disinfectants|dental disinfectants|mesh-ancestor
64399444|NCT03105583|Vitamins|vitamins|mesh-list
64399445|NCT03105583|Micronutrients|micronutrients|mesh-ancestor
64399446|NCT03105583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399447|NCT03105115|Fentanyl|fentanyl|mesh-list
64399448|NCT03105115|Bupivacaine|bupivacaine|mesh-list
64399449|NCT03105115|Anesthetics, Local|anesthetics, local|mesh-ancestor
64399450|NCT03105115|Anesthetics|anesthetics|mesh-ancestor
64399451|NCT03105115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64399452|NCT03105115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399453|NCT03105115|Sensory System Agents|sensory system agents|mesh-ancestor
64399454|NCT03105115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399455|NCT03105115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64399456|NCT03105115|Narcotics|narcotics|mesh-ancestor
64399457|NCT03105115|Analgesics|analgesics|mesh-ancestor
64399458|NCT03105115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64399459|NCT03105115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64399518|NCT02334475|Prednisolone|prednisolone|mesh-list
64399519|NCT02334475|Prednisolone acetate|prednisolone acetate|mesh-list
64399520|NCT02334475|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64399521|NCT02334475|Prednisolone phosphate|prednisolone phosphate|mesh-list
64399522|NCT02334475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64399523|NCT02334475|Antiemetics|antiemetics|mesh-ancestor
64399524|NCT02334475|Autonomic Agents|autonomic agents|mesh-ancestor
64399525|NCT02334475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399526|NCT02334475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399527|NCT02334475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64399528|NCT02334475|Glucocorticoids|glucocorticoids|mesh-ancestor
64399529|NCT02334475|Hormones|hormones|mesh-ancestor
64399535|NCT02334631|Simethicone|simethicone|mesh-list
64399536|NCT02334631|Antifoaming Agents|antifoaming agents|mesh-ancestor
64586295|NCT00322439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64399568|NCT02332057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399570|NCT02332057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64399571|NCT02332057|Analgesics|analgesics|mesh-ancestor
64399572|NCT02332057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64399573|NCT02332057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64399574|NCT02332057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64399575|NCT02332057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399576|NCT02331745|Lenograstim|lenograstim|mesh-list
64399577|NCT02331745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64399578|NCT02331745|Immunologic Factors|immunologic factors|mesh-ancestor
64399579|NCT02331745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399580|NCT02638259|GP2015|gp2015|mesh-list
64399686|NCT04463615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399687|NCT05003765|Magnesium Sulfate|magnesium sulfate|mesh-list
64399689|NCT05003765|Bupivacaine|bupivacaine|mesh-list
64399690|NCT05003765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64399691|NCT05003765|Anesthetics, Local|anesthetics, local|mesh-ancestor
64399692|NCT05003765|Anesthetics|anesthetics|mesh-ancestor
64399693|NCT05003765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64399694|NCT05003765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399695|NCT05003765|Sensory System Agents|sensory system agents|mesh-ancestor
64399696|NCT05003765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399697|NCT05003765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64399698|NCT05003765|Narcotics|narcotics|mesh-ancestor
64399699|NCT05003765|Analgesics|analgesics|mesh-ancestor
64399700|NCT05003765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64399701|NCT05003765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64399702|NCT05003765|Anticonvulsants|anticonvulsants|mesh-ancestor
64399703|NCT05003765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64399704|NCT05003765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64399735|NCT02331511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64399737|NCT02331511|Sensory System Agents|sensory system agents|mesh-ancestor
64399738|NCT02331511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399739|NCT02331511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399740|NCT02331511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64399741|NCT02331511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64399742|NCT02331511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64399743|NCT02331511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64399744|NCT02331511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399745|NCT02331511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64399746|NCT02331511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64399747|NCT02331511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399748|NCT02331511|Antipyretics|antipyretics|mesh-ancestor
64399749|NCT02331511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64399750|NCT02331511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64399751|NCT02331511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64399752|NCT02331511|Purinergic Agents|purinergic agents|mesh-ancestor
64399753|NCT02331511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64399754|NCT02326441|KX2-361|kx2-361|mesh-list
64399755|NCT02326441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64399793|NCT03111511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64399842|NCT02332603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64399843|NCT02332603|Antiemetics|antiemetics|mesh-ancestor
64399844|NCT02332603|Autonomic Agents|autonomic agents|mesh-ancestor
64399845|NCT02332603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399846|NCT02332603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399847|NCT02332603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64399848|NCT02332603|Glucocorticoids|glucocorticoids|mesh-ancestor
64399849|NCT02332603|Hormones|hormones|mesh-ancestor
64399850|NCT02332603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64399851|NCT02332603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64399852|NCT02332603|Protective Agents|protective agents|mesh-ancestor
64399853|NCT02332603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64399854|NCT02332603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399865|NCT05077813|Tretinoin|tretinoin|mesh-list
64399866|NCT05077813|Alitretinoin|alitretinoin|mesh-list
64399867|NCT05077813|Isotretinoin|isotretinoin|mesh-list
64399868|NCT05077813|Micronutrients|micronutrients|mesh-ancestor
64399869|NCT05077813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399904|NCT05075863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64399906|NCT05075863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399937|NCT03142165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64399938|NCT03142165|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64399939|NCT03142165|Histamine Antagonists|histamine antagonists|mesh-ancestor
64399940|NCT03142165|Histamine Agents|histamine agents|mesh-ancestor
64399941|NCT03142165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64399942|NCT03142165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399943|NCT03142165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64399944|NCT03142165|Antipruritics|antipruritics|mesh-ancestor
64399945|NCT03142165|Dermatologic Agents|dermatologic agents|mesh-ancestor
64399946|NCT03142165|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64399947|NCT03142165|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64399948|NCT02330029|Pinaverium|pinaverium|mesh-list
64399949|NCT02330029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64399950|NCT02330029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64399972|NCT02329561|Narcotics|narcotics|mesh-ancestor
64399973|NCT02329561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64399974|NCT02329561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399975|NCT02329561|Analgesics|analgesics|mesh-ancestor
64399976|NCT02329561|Sensory System Agents|sensory system agents|mesh-ancestor
64399977|NCT02329561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399978|NCT03143491|Paclitaxel|paclitaxel|mesh-list
64399979|NCT03143491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64399980|NCT03143491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399981|NCT03143491|Tubulin Modulators|tubulin modulators|mesh-ancestor
64399982|NCT03143491|Antimitotic Agents|antimitotic agents|mesh-ancestor
64399983|NCT03143491|Mitosis Modulators|mitosis modulators|mesh-ancestor
64399984|NCT03143491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399985|NCT05002673|Anesthetics|anesthetics|mesh-list
64399986|NCT05002673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64399987|NCT05002673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399988|NCT03076151|Tacrolimus|tacrolimus|mesh-list
64399989|NCT03076151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64399990|NCT03076151|Immunologic Factors|immunologic factors|mesh-ancestor
64399991|NCT03076151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399992|NCT03076151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64399993|NCT03076151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400001|NCT05002517|Prednisolone phosphate|prednisolone phosphate|mesh-list
64400034|NCT02329405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400035|NCT02329405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400036|NCT02329405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64400037|NCT02329405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64400038|NCT02329405|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64400039|NCT02329405|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64400040|NCT02329405|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64400071|NCT04498741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64400072|NCT04498741|Antimetabolites|antimetabolites|mesh-ancestor
64400073|NCT04498741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64400074|NCT04498741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64400075|NCT04498741|Antithrombins|antithrombins|mesh-ancestor
64400076|NCT04498741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64400077|NCT04498741|Protease Inhibitors|protease inhibitors|mesh-ancestor
64400078|NCT04498741|Anticoagulants|anticoagulants|mesh-ancestor
64400080|NCT03551743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64400081|NCT03551743|Antithrombins|antithrombins|mesh-ancestor
64400082|NCT03551743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64400083|NCT03551743|Protease Inhibitors|protease inhibitors|mesh-ancestor
64400084|NCT03551743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400085|NCT03551743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400086|NCT03551743|Anticoagulants|anticoagulants|mesh-ancestor
64400088|NCT04654429|Antiemetics|antiemetics|mesh-ancestor
64400089|NCT04654429|Autonomic Agents|autonomic agents|mesh-ancestor
64400090|NCT04654429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400091|NCT04654429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400092|NCT04654429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64400094|NCT04654429|Dermatologic Agents|dermatologic agents|mesh-ancestor
64400095|NCT04654429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64400096|NCT04654429|Serotonin Agents|serotonin agents|mesh-ancestor
64400097|NCT04654429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64400124|NCT02328469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64400125|NCT02328469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64400126|NCT02328469|Antiviral Agents|antiviral agents|mesh-ancestor
64400127|NCT04998071|Bupivacaine|bupivacaine|mesh-list
64400128|NCT04998071|Anesthetics, Local|anesthetics, local|mesh-ancestor
64400129|NCT04998071|Anesthetics|anesthetics|mesh-ancestor
64400130|NCT04998071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64400131|NCT04998071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400133|NCT04998071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400134|NCT03734263|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64400135|NCT03734263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400136|NCT03073343|Betaine|betaine|mesh-list
64400147|NCT03073265|Protease Inhibitors|protease inhibitors|mesh-ancestor
64400148|NCT03073265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400149|NCT03073265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400150|NCT03073265|Anticoagulants|anticoagulants|mesh-ancestor
64400151|NCT04433741|Oxytocin|oxytocin|mesh-list
64400152|NCT04433741|Oxytocics|oxytocics|mesh-ancestor
64400153|NCT04433741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64400154|NCT04433741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400155|NCT04997837|Capecitabine|capecitabine|mesh-list
64400190|NCT04997291|Protective Agents|protective agents|mesh-ancestor
64400191|NCT04997291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400192|NCT04997291|Antimitotic Agents|antimitotic agents|mesh-ancestor
64400216|NCT02328079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64400217|NCT04992533|Oxymetazoline|oxymetazoline|mesh-list
64400218|NCT04992533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64400219|NCT04992533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64400220|NCT04992533|Adrenergic Agents|adrenergic agents|mesh-ancestor
64400221|NCT04992533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64400222|NCT04992533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400223|NCT04992533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400224|NCT04992533|Sympathomimetics|sympathomimetics|mesh-ancestor
64400225|NCT04992533|Autonomic Agents|autonomic agents|mesh-ancestor
64400226|NCT04992533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400227|NCT04992533|Nasal Decongestants|nasal decongestants|mesh-ancestor
64400228|NCT04992533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64400229|NCT04992533|Respiratory System Agents|respiratory system agents|mesh-ancestor
64400231|NCT02578069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64400232|NCT02578069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64400233|NCT02578069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64400234|NCT02578069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400235|NCT02578069|Antifungal Agents|antifungal agents|mesh-ancestor
64400236|NCT02578069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64400237|NCT02578069|Immunologic Factors|immunologic factors|mesh-ancestor
64400238|NCT02578069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400239|NCT03074825|Chiauranib|chiauranib|mesh-list
64400240|NCT03074825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400241|NCT03074825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64400242|NCT03074825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400243|NCT03074825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400244|NCT03072485|Metformin|metformin|mesh-list
64400245|NCT03072485|Sirolimus|sirolimus|mesh-list
64400246|NCT03072485|Diclofenac|diclofenac|mesh-list
64400247|NCT03072485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64400248|NCT03072485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400249|NCT03072485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64400250|NCT03072485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64400251|NCT03072485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64400252|NCT03072485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400253|NCT03072485|Antifungal Agents|antifungal agents|mesh-ancestor
64400254|NCT03072485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64400255|NCT03072485|Immunologic Factors|immunologic factors|mesh-ancestor
64400256|NCT03072485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64400257|NCT03072485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64400258|NCT03072485|Analgesics|analgesics|mesh-ancestor
64400259|NCT03072485|Sensory System Agents|sensory system agents|mesh-ancestor
64400260|NCT03072485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400261|NCT03072485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64400262|NCT03072485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64400263|NCT03072485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64400264|NCT03072485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400265|NCT03072485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400266|NCT05080543|Terlipressin|terlipressin|mesh-list
64400314|NCT02327689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64400315|NCT02327689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400316|NCT02327689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400317|NCT02327689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64400318|NCT02327689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64400319|NCT02327923|Ketorolac|ketorolac|mesh-list
64400320|NCT02327923|Lidocaine|lidocaine|mesh-list
64790524|NCT00004404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400321|NCT02327923|Atropine|atropine|mesh-list
64400322|NCT02327923|Ephedrine|ephedrine|mesh-list
64400323|NCT02327923|Fentanyl|fentanyl|mesh-list
64400324|NCT02327923|Glycopyrrolate|glycopyrrolate|mesh-list
64400325|NCT02327923|Morphine|morphine|mesh-list
64400326|NCT02327923|Tramadol|tramadol|mesh-list
64400327|NCT02327923|Ondansetron|ondansetron|mesh-list
64400328|NCT02327923|Bupivacaine|bupivacaine|mesh-list
64400329|NCT02327923|Propofol|propofol|mesh-list
64400364|NCT02327923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64400365|NCT02327923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64400367|NCT02327923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64400368|NCT02327923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400369|NCT02327923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64400370|NCT02327923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64400371|NCT02327923|Respiratory System Agents|respiratory system agents|mesh-ancestor
64400372|NCT02327923|Mydriatics|mydriatics|mesh-ancestor
64400373|NCT02327923|Parasympatholytics|parasympatholytics|mesh-ancestor
64400374|NCT02327923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64400375|NCT02327923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64400376|NCT02327923|Cholinergic Agents|cholinergic agents|mesh-ancestor
64400377|NCT02327923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64400378|NCT02327923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64400379|NCT02327923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64400380|NCT02327923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64400381|NCT02327923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64400382|NCT02327923|Adrenergic Agents|adrenergic agents|mesh-ancestor
64400383|NCT02327923|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64400384|NCT02327923|Sympathomimetics|sympathomimetics|mesh-ancestor
64400385|NCT02327923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64400386|NCT02327923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64400387|NCT02327923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64400388|NCT02327923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64400389|NCT02327923|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64400391|NCT04991207|Zamicastat|zamicastat|mesh-list
64400407|NCT02327299|Cholinergic Agents|cholinergic agents|mesh-ancestor
64400408|NCT02327299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64400409|NCT02327299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317804|NCT05698394|Esketamine|esketamine|mesh-list
64400410|NCT02327299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400411|NCT02327299|Urological Agents|urological agents|mesh-ancestor
64400412|NCT03494569|Fludarabine|fludarabine|mesh-list
64400413|NCT03494569|Melphalan|melphalan|mesh-list
64400414|NCT03494569|Mechlorethamine|mechlorethamine|mesh-list
64400435|NCT03071549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400436|NCT03071549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64400437|NCT03071549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64400438|NCT03071549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64400439|NCT03071549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400440|NCT03071549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400441|NCT03144817|Dialysis Solutions|dialysis solutions|mesh-list
64400442|NCT03144817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64400443|NCT04994951|Triamcinolone|triamcinolone|mesh-list
64400444|NCT04994951|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64400445|NCT04994951|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64400446|NCT04994951|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64400447|NCT04994951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64400448|NCT04994951|Glucocorticoids|glucocorticoids|mesh-ancestor
65495241|NCT05054842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400468|NCT03071705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400469|NCT03071705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64400470|NCT03071705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495242|NCT05038618|Somatomedin B|somatomedin b|mesh-list
64400472|NCT03351439|Celecoxib|celecoxib|mesh-list
64400473|NCT03351439|Naproxen|naproxen|mesh-list
64400474|NCT03351439|Gabapentin|gabapentin|mesh-list
64400475|NCT03351439|Zopiclone|zopiclone|mesh-list
64400476|NCT03351439|Analgesics|analgesics|mesh-ancestor
64400477|NCT03351439|Sensory System Agents|sensory system agents|mesh-ancestor
64400478|NCT03351439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400479|NCT03351439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400480|NCT03351439|Anticonvulsants|anticonvulsants|mesh-ancestor
64400481|NCT03351439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64400482|NCT03351439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64400483|NCT03351439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64400484|NCT03351439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64400485|NCT03351439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64586296|NCT00322439|Immunologic Factors|immunologic factors|mesh-ancestor
64400523|NCT03139591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64400524|NCT03139591|Antiemetics|antiemetics|mesh-ancestor
64400525|NCT03139591|Autonomic Agents|autonomic agents|mesh-ancestor
64400526|NCT03139591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400527|NCT03139591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400528|NCT03139591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64400529|NCT03139591|Glucocorticoids|glucocorticoids|mesh-ancestor
64400530|NCT03139591|Hormones|hormones|mesh-ancestor
64790570|NCT00004440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64552685|NCT04007393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400531|NCT03139591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64400532|NCT03139591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64400533|NCT03139591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400534|NCT03139591|Anesthetics, Local|anesthetics, local|mesh-ancestor
64400535|NCT03139591|Anesthetics|anesthetics|mesh-ancestor
64400536|NCT03139591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64400537|NCT03139591|Sensory System Agents|sensory system agents|mesh-ancestor
64400538|NCT03139591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64400539|NCT03139591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64400540|NCT03139591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64400541|NCT03139591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64400542|NCT03139591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400543|NCT04412291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64400544|NCT04412291|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64400545|NCT04412291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64400546|NCT04412291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64400547|NCT03139513|Vemurafenib|vemurafenib|mesh-list
64400548|NCT03139513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400549|NCT03139513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64400550|NCT03139513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400551|NCT03139513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400552|NCT04986995|Opicapone|opicapone|mesh-list
64400613|NCT03140449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400614|NCT03140449|Antifungal Agents|antifungal agents|mesh-ancestor
64400615|NCT03140449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64400616|NCT03140449|Immunologic Factors|immunologic factors|mesh-ancestor
64400617|NCT03140449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400618|NCT03140449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64400619|NCT03140449|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64400620|NCT03140449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64400621|NCT03140449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400622|NCT03140449|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64400623|NCT03140449|Vitamins|vitamins|mesh-ancestor
64400624|NCT03140449|Micronutrients|micronutrients|mesh-ancestor
64400643|NCT04985435|Immunologic Factors|immunologic factors|mesh-ancestor
64790633|NCT00004488|Vitamins|vitamins|mesh-ancestor
64400645|NCT05084365|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64400646|NCT05084365|Protective Agents|protective agents|mesh-ancestor
64400647|NCT05084365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400648|NCT05084365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400649|NCT03070613|Lectins|lectins|mesh-list
64400650|NCT03070613|Agglutinins|agglutinins|mesh-ancestor
64400651|NCT03070613|Immunologic Factors|immunologic factors|mesh-ancestor
64400652|NCT03070613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400653|NCT03070613|Coagulants|coagulants|mesh-ancestor
64400654|NCT03441139|Analgesics|analgesics|mesh-list
64400655|NCT03441139|Sensory System Agents|sensory system agents|mesh-ancestor
64400656|NCT03441139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400675|NCT04753957|Progestins|progestins|mesh-ancestor
64400676|NCT04753957|Hormones|hormones|mesh-ancestor
64400677|NCT04753957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64599387|NCT03650114|Ofatumumab|ofatumumab|mesh-list
64400678|NCT04753957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400679|NCT03070379|Lidocaine|lidocaine|mesh-list
64400680|NCT03070379|Anesthetics, Local|anesthetics, local|mesh-ancestor
64400681|NCT03070379|Anesthetics|anesthetics|mesh-ancestor
64400682|NCT03070379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64400683|NCT03070379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400702|NCT04985201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64400703|NCT04985201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400704|NCT04985201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400705|NCT04985201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400706|NCT04985201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64400707|NCT04985201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64400709|NCT04985201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64400710|NCT04985201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64400711|NCT02031601|Carboplatin|carboplatin|mesh-list
64400712|NCT02031601|Docetaxel|docetaxel|mesh-list
64400713|NCT02031601|Pemetrexed|pemetrexed|mesh-list
64400714|NCT02031601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64400715|NCT02031601|Gefitinib|gefitinib|mesh-list
64400716|NCT02031601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400717|NCT02031601|Tubulin Modulators|tubulin modulators|mesh-ancestor
64400718|NCT02031601|Antimitotic Agents|antimitotic agents|mesh-ancestor
64400719|NCT02031601|Mitosis Modulators|mitosis modulators|mesh-ancestor
64400720|NCT02031601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400721|NCT02031601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400722|NCT02031601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64400723|NCT02031601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64400724|NCT02031601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64400725|NCT04984577|Edaravone|edaravone|mesh-list
64400726|NCT04984577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64400727|NCT04984577|Antioxidants|antioxidants|mesh-ancestor
64552686|NCT04007393|Adrenergic Agents|adrenergic agents|mesh-ancestor
64400728|NCT04984577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400729|NCT04984577|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64400730|NCT04984577|Protective Agents|protective agents|mesh-ancestor
64400731|NCT04984577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400755|NCT05088343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64400757|NCT03068429|Sertraline|sertraline|mesh-list
64400758|NCT03068429|Antidepressive Agents|antidepressive agents|mesh-ancestor
64400759|NCT03068429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64400760|NCT03068429|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64400761|NCT03068429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64400762|NCT03068429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64400763|NCT03068429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400764|NCT03068429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64400765|NCT03068429|Serotonin Agents|serotonin agents|mesh-ancestor
64400766|NCT03068429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400767|NCT03068351|Daratumumab|daratumumab|mesh-list
64400768|NCT03068351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400769|NCT03140293|Lidocaine|lidocaine|mesh-list
64400770|NCT03140293|Ethyl Chloride|ethyl chloride|mesh-list
64400771|NCT03140293|Anesthetics, Local|anesthetics, local|mesh-ancestor
64400772|NCT03140293|Anesthetics|anesthetics|mesh-ancestor
64400773|NCT03140293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64400774|NCT03140293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400775|NCT03140293|Sensory System Agents|sensory system agents|mesh-ancestor
64400776|NCT03140293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400777|NCT03140293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64400778|NCT03140293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64400779|NCT03140293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64400780|NCT03140293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64400781|NCT03140293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400782|NCT04982861|Cefixime|cefixime|mesh-list
64400783|NCT04982861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64400784|NCT04982861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64400785|NCT04572217|Topiramate|topiramate|mesh-list
64400786|NCT04572217|Phentermine|phentermine|mesh-list
64400787|NCT04572217|Anticonvulsants|anticonvulsants|mesh-ancestor
64400788|NCT04572217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64400789|NCT04572217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400790|NCT04572217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64400819|NCT04452461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64400820|NCT04452461|Antimetabolites|antimetabolites|mesh-ancestor
65495243|NCT05038618|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64400821|NCT04452461|Antiviral Agents|antiviral agents|mesh-ancestor
64400822|NCT04452461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64400823|NCT04452461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400824|NCT04452461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64400825|NCT04452461|Immunologic Factors|immunologic factors|mesh-ancestor
64400826|NCT04452461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400828|NCT04452461|Protective Agents|protective agents|mesh-ancestor
64400829|NCT04452461|Vitamin B Complex|vitamin b complex|mesh-ancestor
64400830|NCT04452461|Vitamins|vitamins|mesh-ancestor
64400831|NCT04452461|Micronutrients|micronutrients|mesh-ancestor
64400832|NCT03137017|Acetaminophen|acetaminophen|mesh-list
64400833|NCT03137017|Hydrocodone|hydrocodone|mesh-list
64400834|NCT03137017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64400835|NCT03137017|Analgesics|analgesics|mesh-ancestor
64400836|NCT03137017|Sensory System Agents|sensory system agents|mesh-ancestor
64400837|NCT03137017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400838|NCT03137017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400839|NCT03137017|Antipyretics|antipyretics|mesh-ancestor
64400840|NCT03137017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64400841|NCT03137017|Narcotics|narcotics|mesh-ancestor
64400842|NCT03137017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64400843|NCT03137017|Antitussive Agents|antitussive agents|mesh-ancestor
64400844|NCT03137017|Respiratory System Agents|respiratory system agents|mesh-ancestor
64400845|NCT03019003|Durvalumab|durvalumab|mesh-list
64400846|NCT03019003|Decitabine|decitabine|mesh-list
64400847|NCT03019003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64400848|NCT03019003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400849|NCT03019003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64400850|NCT03019003|Antimetabolites|antimetabolites|mesh-ancestor
64400889|NCT05214911|Cholinergic Agents|cholinergic agents|mesh-ancestor
64400890|NCT05214911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64400891|NCT05214911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400892|NCT05214911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64400893|NCT05214911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64400894|NCT05214911|Histamine Antagonists|histamine antagonists|mesh-ancestor
64400895|NCT05214911|Histamine Agents|histamine agents|mesh-ancestor
64400896|NCT05214911|Antipruritics|antipruritics|mesh-ancestor
64400897|NCT05214911|Dermatologic Agents|dermatologic agents|mesh-ancestor
64400898|NCT05214911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64400925|NCT04035187|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64400926|NCT04035187|Hormone Antagonists|hormone antagonists|mesh-ancestor
64400927|NCT04035187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64400928|NCT04035187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400929|NCT04035187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64400930|NCT00157963|Losartan|losartan|mesh-list
64400931|NCT00157963|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64400932|NCT00157963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64400933|NCT00157963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64400934|NCT00157963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64400935|NCT00157963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64400936|NCT00157963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400937|NCT00157963|Diuretics|diuretics|mesh-ancestor
64400938|NCT00157963|Natriuretic Agents|natriuretic agents|mesh-ancestor
64400939|NCT00157963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400940|NCT00157963|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64400941|NCT00157963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64400942|NCT05087797|Nicorandil|nicorandil|mesh-list
64400943|NCT05087797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64400944|NCT05087797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64400990|NCT05634473|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64400991|NCT05634473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64400992|NCT05634473|Cholinergic Agents|cholinergic agents|mesh-ancestor
64401008|NCT04858711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401009|NCT04858711|Sensory System Agents|sensory system agents|mesh-ancestor
64401010|NCT04858711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64791553|NCT00359658|Hormones|hormones|mesh-ancestor
64401011|NCT04858711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64401024|NCT04858711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64401025|NCT04858711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64401026|NCT04858711|Anesthetics, General|anesthetics, general|mesh-ancestor
64401027|NCT04858711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64401028|NCT04858711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65495244|NCT05038618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65066969|NCT00418704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066970|NCT00418704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65066971|NCT00418704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066973|NCT00313950|Immunologic Factors|immunologic factors|mesh-ancestor
65066974|NCT00313950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066975|NCT00273299|Valsartan|valsartan|mesh-list
65066976|NCT00273299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65066977|NCT00273299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65066978|NCT00273299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65066979|NCT00273299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65066980|NCT00273299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066981|NCT00273299|Diuretics|diuretics|mesh-ancestor
65066982|NCT00273299|Natriuretic Agents|natriuretic agents|mesh-ancestor
65066983|NCT00273299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066984|NCT00273299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65066985|NCT00273299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65066986|NCT00418782|Naproxen|naproxen|mesh-list
65066987|NCT00418782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65066988|NCT00418782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65066989|NCT00418782|Analgesics|analgesics|mesh-ancestor
65066990|NCT00418782|Sensory System Agents|sensory system agents|mesh-ancestor
65066991|NCT00418782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65066992|NCT00418782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65066993|NCT00418782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65066994|NCT00418782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65066995|NCT00418782|Gout Suppressants|gout suppressants|mesh-ancestor
65066996|NCT00418782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65066997|NCT00418782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65066998|NCT00418782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65066999|NCT00273338|Calcitriol|calcitriol|mesh-list
65067000|NCT00273338|Docetaxel|docetaxel|mesh-list
65067001|NCT00273338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067002|NCT00273338|Tubulin Modulators|tubulin modulators|mesh-ancestor
65067003|NCT00273338|Antimitotic Agents|antimitotic agents|mesh-ancestor
64791557|NCT00359814|Cyclosporine|cyclosporine|mesh-list
65067004|NCT00273338|Mitosis Modulators|mitosis modulators|mesh-ancestor
65067005|NCT00273338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067006|NCT00273338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65067007|NCT00273338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067008|NCT00273338|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65067009|NCT00273338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65067010|NCT00273338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65067012|NCT00273338|Micronutrients|micronutrients|mesh-ancestor
65067013|NCT00273338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65067014|NCT00273377|Dexamethasone|dexamethasone|mesh-list
65067015|NCT00273377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65067016|NCT00273377|Antiemetics|antiemetics|mesh-ancestor
65067017|NCT00273377|Autonomic Agents|autonomic agents|mesh-ancestor
65067018|NCT00273377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65067019|NCT00273377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067020|NCT00273377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65067021|NCT00273377|Glucocorticoids|glucocorticoids|mesh-ancestor
65067022|NCT00273377|Hormones|hormones|mesh-ancestor
65067023|NCT00273377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65067024|NCT00273377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65067025|NCT00273377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067026|NCT00273416|Sildenafil Citrate|sildenafil citrate|mesh-list
65067027|NCT00273416|Vasodilator Agents|vasodilator agents|mesh-ancestor
65067028|NCT00273416|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65067029|NCT00273416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65067030|NCT00273416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067031|NCT00273416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067032|NCT00273416|Urological Agents|urological agents|mesh-ancestor
65067033|NCT00314184|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65067034|NCT00314184|Antidepressive Agents|antidepressive agents|mesh-ancestor
65067035|NCT00314184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65067036|NCT00314184|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65067037|NCT00314184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65067038|NCT00314184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65067039|NCT00314184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067040|NCT00273455|Timolol|timolol|mesh-list
65067041|NCT00273455|Bimatoprost|bimatoprost|mesh-list
65067042|NCT00273455|Dorzolamide|dorzolamide|mesh-list
65495245|NCT05038618|Protease Inhibitors|protease inhibitors|mesh-ancestor
65495246|NCT05038618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067043|NCT00273455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067044|NCT00273455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067045|NCT00273455|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65067046|NCT00273455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65067047|NCT00273455|Adrenergic Agents|adrenergic agents|mesh-ancestor
65067048|NCT00273455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65067049|NCT00273455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067050|NCT00273455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65067051|NCT00273455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65067052|NCT00273455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65067053|NCT00273533|Ramipril|ramipril|mesh-list
65067054|NCT00273533|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65067055|NCT00273533|Protease Inhibitors|protease inhibitors|mesh-ancestor
65067056|NCT00273533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067057|NCT00273533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067058|NCT00273533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65067059|NCT00273611|Vitamin D|vitamin d|mesh-list
65067060|NCT00273611|Vitamins|vitamins|mesh-ancestor
65067061|NCT00273611|Micronutrients|micronutrients|mesh-ancestor
65067062|NCT00273611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067063|NCT00273611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65067064|NCT00273689|Albuterol|albuterol|mesh-list
65067065|NCT00273689|Montelukast|montelukast|mesh-list
65067066|NCT00273689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65067067|NCT00273689|Respiratory System Agents|respiratory system agents|mesh-ancestor
65067068|NCT00273689|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65067069|NCT00273689|Hormone Antagonists|hormone antagonists|mesh-ancestor
65067070|NCT00273689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65067071|NCT00273689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067072|NCT00273689|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64791582|NCT00360438|Rasburicase|rasburicase|mesh-list
65067073|NCT00273689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65067074|NCT00273689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067075|NCT00273689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65067076|NCT00273689|Autonomic Agents|autonomic agents|mesh-ancestor
65067077|NCT00273689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65067078|NCT00273689|Tocolytic Agents|tocolytic agents|mesh-ancestor
65067079|NCT00273689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65067080|NCT00273689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65067081|NCT00273689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65067082|NCT00273689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65067083|NCT00273689|Adrenergic Agents|adrenergic agents|mesh-ancestor
65067084|NCT00273689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65067085|NCT00308334|Domperidone|domperidone|mesh-list
65067086|NCT00308334|Antiemetics|antiemetics|mesh-ancestor
65067087|NCT00308334|Autonomic Agents|autonomic agents|mesh-ancestor
65067088|NCT00308334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65067089|NCT00308334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067090|NCT00308334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65067091|NCT00308334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65067092|NCT00308334|Dopamine Agents|dopamine agents|mesh-ancestor
65067093|NCT00308334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65067094|NCT00308334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067095|NCT00273767|Epoetin Alfa|epoetin alfa|mesh-list
65067096|NCT00273767|Hematinics|hematinics|mesh-ancestor
65067098|NCT00314379|Vitamins|vitamins|mesh-ancestor
65067099|NCT00314379|Micronutrients|micronutrients|mesh-ancestor
65067100|NCT00314379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067101|NCT00314379|Antioxidants|antioxidants|mesh-ancestor
65067102|NCT00314379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067103|NCT00314379|Protective Agents|protective agents|mesh-ancestor
65067104|NCT00273884|Cytarabine|cytarabine|mesh-list
65067105|NCT00273884|Amonafide|amonafide|mesh-list
65067106|NCT00273884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65067107|NCT00273884|Antimetabolites|antimetabolites|mesh-ancestor
65067108|NCT00273884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067109|NCT00273884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067110|NCT00273884|Antiviral Agents|antiviral agents|mesh-ancestor
65495247|NCT05038618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495248|NCT01244880|Ketamine|ketamine|mesh-list
65495249|NCT01244880|Analgesics|analgesics|mesh-ancestor
65495250|NCT01244880|Sensory System Agents|sensory system agents|mesh-ancestor
65495251|NCT01244880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65495252|NCT01244880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067111|NCT00273884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65067112|NCT00273884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65067113|NCT00273884|Immunologic Factors|immunologic factors|mesh-ancestor
65067114|NCT00273884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067115|NCT00273884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067116|NCT00308373|Metformin|metformin|mesh-list
65067117|NCT00308373|Pioglitazone|pioglitazone|mesh-list
65067118|NCT00308373|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
65067119|NCT00308373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65067120|NCT00308373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067121|NCT00273962|Albuterol|albuterol|mesh-list
65067122|NCT00273962|Ipratropium|ipratropium|mesh-list
65067123|NCT00273962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65067124|NCT00273962|Autonomic Agents|autonomic agents|mesh-ancestor
65067125|NCT00273962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65067126|NCT00273962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067127|NCT00273962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65067128|NCT00273962|Respiratory System Agents|respiratory system agents|mesh-ancestor
65067129|NCT00273962|Tocolytic Agents|tocolytic agents|mesh-ancestor
65067130|NCT00273962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65067131|NCT00273962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65067132|NCT00273962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65067133|NCT00273962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65067134|NCT00273962|Adrenergic Agents|adrenergic agents|mesh-ancestor
65067135|NCT00273962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65067136|NCT00273962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067137|NCT00273962|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65067138|NCT00273962|Cholinergic Agents|cholinergic agents|mesh-ancestor
65067139|NCT00274001|Nevirapine|nevirapine|mesh-list
65067140|NCT00274001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65067141|NCT00274001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65067142|NCT00274001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067143|NCT00274001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067144|NCT00274001|Antiviral Agents|antiviral agents|mesh-ancestor
65067145|NCT00274001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65067146|NCT00274001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65067147|NCT00274001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65067148|NCT00274001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65067149|NCT00274001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65067150|NCT00274040|Tiotropium Bromide|tiotropium bromide|mesh-list
65067151|NCT00274040|Ipratropium|ipratropium|mesh-list
65067152|NCT00274040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65067153|NCT00274040|Autonomic Agents|autonomic agents|mesh-ancestor
65067154|NCT00274040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65067155|NCT00274040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067156|NCT00274040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65067157|NCT00274040|Respiratory System Agents|respiratory system agents|mesh-ancestor
65067158|NCT00274040|Parasympatholytics|parasympatholytics|mesh-ancestor
65067159|NCT00274040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65067160|NCT00274040|Cholinergic Agents|cholinergic agents|mesh-ancestor
65067161|NCT00274040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65067162|NCT00274040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067163|NCT00314457|Bupivacaine|bupivacaine|mesh-list
65067164|NCT00314457|Anesthetics, Local|anesthetics, local|mesh-ancestor
65067165|NCT00314457|Anesthetics|anesthetics|mesh-ancestor
65067166|NCT00314457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65067167|NCT00314457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067168|NCT00314457|Sensory System Agents|sensory system agents|mesh-ancestor
65067169|NCT00314457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65067170|NCT00308451|Chromium|chromium|mesh-list
65067172|NCT00308451|Picolinic acid|picolinic acid|mesh-list
65067173|NCT00308451|Trace Elements|trace elements|mesh-ancestor
65067174|NCT00308451|Micronutrients|micronutrients|mesh-ancestor
65067175|NCT00308451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067176|NCT00308451|Vitamin B Complex|vitamin b complex|mesh-ancestor
65067177|NCT00308451|Vitamins|vitamins|mesh-ancestor
65067178|NCT00308451|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65067179|NCT00308451|Chelating Agents|chelating agents|mesh-ancestor
65067180|NCT00308451|Sequestering Agents|sequestering agents|mesh-ancestor
65067181|NCT00308451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067182|NCT00274079|Tiotropium Bromide|tiotropium bromide|mesh-list
65067183|NCT00274079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65067184|NCT00274079|Autonomic Agents|autonomic agents|mesh-ancestor
65067185|NCT00274079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65067186|NCT00274079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067187|NCT00274079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65067188|NCT00274079|Respiratory System Agents|respiratory system agents|mesh-ancestor
65067189|NCT00274079|Parasympatholytics|parasympatholytics|mesh-ancestor
65067190|NCT00274079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65067191|NCT00274079|Cholinergic Agents|cholinergic agents|mesh-ancestor
65067192|NCT00274079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65067193|NCT00274079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067195|NCT00274118|Enalapril|enalapril|mesh-list
65067196|NCT00274118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65067197|NCT00274118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65067198|NCT00274118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65067199|NCT00274118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067200|NCT00274118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65067201|NCT00274118|Protease Inhibitors|protease inhibitors|mesh-ancestor
65067202|NCT00274118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067203|NCT00308490|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65067204|NCT00308490|Hematinics|hematinics|mesh-ancestor
65067205|NCT00416585|Isotretinoin|isotretinoin|mesh-list
65067206|NCT00416585|Dermatologic Agents|dermatologic agents|mesh-ancestor
65067207|NCT00308529|Bevacizumab|bevacizumab|mesh-list
65067208|NCT00308529|Carboplatin|carboplatin|mesh-list
65067209|NCT00308529|Irinotecan|irinotecan|mesh-list
65067210|NCT00308529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65067211|NCT00308529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067212|NCT00308529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65067213|NCT00308529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65067214|NCT00308529|Growth Substances|growth substances|mesh-ancestor
65067215|NCT00308529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067216|NCT00308529|Growth Inhibitors|growth inhibitors|mesh-ancestor
65067217|NCT00308529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65067218|NCT00308529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65067219|NCT00308529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067220|NCT00308529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067221|NCT00274235|Pyrimethamine|pyrimethamine|mesh-list
65067222|NCT00274235|Sulfadoxine|sulfadoxine|mesh-list
65067223|NCT00274235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65067224|NCT00274235|Mefloquine|mefloquine|mesh-list
65067225|NCT00274235|Antimalarials|antimalarials|mesh-ancestor
65067226|NCT00274235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65067227|NCT00274235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65067228|NCT00274235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65067229|NCT00274235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65067230|NCT00274235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067231|NCT00274235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067232|NCT00274235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65067233|NCT00274235|Renal Agents|renal agents|mesh-ancestor
65067234|NCT00274274|Insulin|insulin|mesh-list
65067235|NCT00274274|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65067236|NCT00274274|Insulin Aspart|insulin aspart|mesh-list
65067237|NCT00274274|Insulin Detemir|insulin detemir|mesh-list
65067238|NCT00274274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65067239|NCT00274274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067240|NCT00308607|Interferons|interferons|mesh-list
64791839|NCT00367068|GABA Agents|gaba agents|mesh-ancestor
65067241|NCT00308607|Interferon-alpha|interferon-alpha|mesh-list
65067242|NCT00308607|Interferon alpha-2|interferon alpha-2|mesh-list
65067243|NCT00308607|Bevacizumab|bevacizumab|mesh-list
65067244|NCT00308607|Dacarbazine|dacarbazine|mesh-list
65067245|NCT00308607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65067246|NCT00308607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067247|NCT00308607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65067248|NCT00308607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65067249|NCT00308607|Growth Substances|growth substances|mesh-ancestor
65067250|NCT00308607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067251|NCT00308607|Growth Inhibitors|growth inhibitors|mesh-ancestor
65067252|NCT00308607|Antiviral Agents|antiviral agents|mesh-ancestor
65067253|NCT00308607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65067254|NCT00308607|Immunologic Factors|immunologic factors|mesh-ancestor
65067255|NCT00308607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65067256|NCT00308607|Alkylating Agents|alkylating agents|mesh-ancestor
65067257|NCT00308607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067258|NCT00314613|Risperidone|risperidone|mesh-list
65067259|NCT00314613|Antipsychotic Agents|antipsychotic agents|mesh-list
65067260|NCT00314613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65067261|NCT00314613|Serotonin Agents|serotonin agents|mesh-ancestor
65067262|NCT00314613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65067263|NCT00314613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067264|NCT00314613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067265|NCT00314613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65067266|NCT00314613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65067267|NCT00314613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65067268|NCT00314613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65067269|NCT00314613|Dopamine Agents|dopamine agents|mesh-ancestor
65067270|NCT00274352|Adalimumab|adalimumab|mesh-list
65067271|NCT00274352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65067272|NCT00274352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65067273|NCT00314652|Buprenorphine|buprenorphine|mesh-list
65067274|NCT00314652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65067275|NCT00314652|Narcotics|narcotics|mesh-ancestor
65067276|NCT00314652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65067277|NCT00314652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067278|NCT00314652|Analgesics|analgesics|mesh-ancestor
65067279|NCT00314652|Sensory System Agents|sensory system agents|mesh-ancestor
65067280|NCT00314652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65067281|NCT00314652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65067282|NCT00274391|Amiloride|amiloride|mesh-list
65067283|NCT00274391|Diuretics|diuretics|mesh-ancestor
65067284|NCT00274391|Natriuretic Agents|natriuretic agents|mesh-ancestor
65067285|NCT00274391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067286|NCT00274391|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65067287|NCT00274391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65067288|NCT00274391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65067289|NCT00274391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067290|NCT00274391|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65067291|NCT00274391|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65067292|NCT00274430|Dexamethasone|dexamethasone|mesh-list
65067293|NCT00274430|Tadalafil|tadalafil|mesh-list
65067294|NCT00274430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65067295|NCT00274430|Antiemetics|antiemetics|mesh-ancestor
65067296|NCT00274430|Autonomic Agents|autonomic agents|mesh-ancestor
65067297|NCT00274430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65067298|NCT00274430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067299|NCT00274430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65067300|NCT00274430|Glucocorticoids|glucocorticoids|mesh-ancestor
65067301|NCT00274430|Hormones|hormones|mesh-ancestor
65067302|NCT00274430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65067303|NCT00274430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65067304|NCT00274430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067305|NCT00274430|Vasodilator Agents|vasodilator agents|mesh-ancestor
65067306|NCT00274430|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65067307|NCT00274430|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65067308|NCT00274430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067309|NCT00274430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067310|NCT00274430|Urological Agents|urological agents|mesh-ancestor
65067311|NCT00274508|Bromides|bromides|mesh-list
65067312|NCT00274508|Tiotropium Bromide|tiotropium bromide|mesh-list
65067313|NCT00274508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65067314|NCT00274508|Autonomic Agents|autonomic agents|mesh-ancestor
65067315|NCT00274508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65067316|NCT00274508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067317|NCT00274508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65067318|NCT00274508|Respiratory System Agents|respiratory system agents|mesh-ancestor
65067319|NCT00274508|Parasympatholytics|parasympatholytics|mesh-ancestor
65067320|NCT00274508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65067321|NCT00274508|Cholinergic Agents|cholinergic agents|mesh-ancestor
65067322|NCT00274508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65067323|NCT00274508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067324|NCT00274508|Anticonvulsants|anticonvulsants|mesh-ancestor
65067325|NCT00274547|Tiotropium Bromide|tiotropium bromide|mesh-list
65067326|NCT00274547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65067327|NCT00274547|Autonomic Agents|autonomic agents|mesh-ancestor
65067328|NCT00274547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65067329|NCT00274547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067330|NCT00274547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65067331|NCT00274547|Respiratory System Agents|respiratory system agents|mesh-ancestor
65495253|NCT01244880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65495254|NCT01244880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65495255|NCT01244880|Anesthetics, General|anesthetics, general|mesh-ancestor
65495256|NCT01244880|Anesthetics|anesthetics|mesh-ancestor
65495257|NCT01244880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65495258|NCT01244880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65067332|NCT00274547|Parasympatholytics|parasympatholytics|mesh-ancestor
65067333|NCT00274547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65067334|NCT00274547|Cholinergic Agents|cholinergic agents|mesh-ancestor
65067335|NCT00274547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65067336|NCT00274547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067338|NCT00308763|Nicotine|nicotine|mesh-list
65067339|NCT00308763|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65067340|NCT00308763|Autonomic Agents|autonomic agents|mesh-ancestor
65067341|NCT00308763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65067342|NCT00308763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067343|NCT00308763|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65067344|NCT00308763|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65067345|NCT00308763|Cholinergic Agents|cholinergic agents|mesh-ancestor
65067346|NCT00308763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65067347|NCT00308763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067348|NCT00308763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65067349|NCT00308763|Antidepressive Agents|antidepressive agents|mesh-ancestor
65067350|NCT00308763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65067351|NCT00308763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65067352|NCT00308763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65067353|NCT00308763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65067354|NCT00308763|Dopamine Agents|dopamine agents|mesh-ancestor
65067355|NCT00308763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65067356|NCT00308763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65067357|NCT00308763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067358|NCT00274586|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
65067359|NCT00274586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65067360|NCT00274820|Ascorbic Acid|ascorbic acid|mesh-list
65067361|NCT00274820|Thalidomide|thalidomide|mesh-list
65067362|NCT00274820|Dexamethasone|dexamethasone|mesh-list
65067363|NCT00274820|Arsenic Trioxide|arsenic trioxide|mesh-list
65067364|NCT00274820|Vitamins|vitamins|mesh-ancestor
65067365|NCT00274820|Micronutrients|micronutrients|mesh-ancestor
65067366|NCT00274820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067367|NCT00274820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65067368|NCT00274820|Antiemetics|antiemetics|mesh-ancestor
65067369|NCT00274820|Autonomic Agents|autonomic agents|mesh-ancestor
65067370|NCT00274820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65067371|NCT00274820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65067372|NCT00274820|Glucocorticoids|glucocorticoids|mesh-ancestor
65067373|NCT00274820|Hormones|hormones|mesh-ancestor
65067374|NCT00274820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65067375|NCT00274820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64792291|NCT00378456|Selenium|selenium|mesh-list
65067376|NCT00274820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067377|NCT00274820|Antioxidants|antioxidants|mesh-ancestor
65067378|NCT00274820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067379|NCT00274820|Protective Agents|protective agents|mesh-ancestor
65067380|NCT00274820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65067381|NCT00274820|Immunologic Factors|immunologic factors|mesh-ancestor
65067382|NCT00274820|Leprostatic Agents|leprostatic agents|mesh-ancestor
65067383|NCT00274820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65067384|NCT00274820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65067385|NCT00274820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65067386|NCT00274820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65067387|NCT00274820|Growth Substances|growth substances|mesh-ancestor
65067388|NCT00274820|Growth Inhibitors|growth inhibitors|mesh-ancestor
65067389|NCT00308841|Lidocaine|lidocaine|mesh-list
65067390|NCT00308841|Anesthetics, Local|anesthetics, local|mesh-ancestor
65067391|NCT00308841|Anesthetics|anesthetics|mesh-ancestor
65067392|NCT00308841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65067393|NCT00308841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067394|NCT00308841|Sensory System Agents|sensory system agents|mesh-ancestor
65067395|NCT00308841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65067396|NCT00308841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65067397|NCT00308841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65067398|NCT00308841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65067399|NCT00308841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65067400|NCT00308841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067401|NCT00274859|Gemcitabine|gemcitabine|mesh-list
65067402|NCT00274859|Oxaliplatin|oxaliplatin|mesh-list
65067403|NCT00274859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65067404|NCT00274859|Antimetabolites|antimetabolites|mesh-ancestor
65067405|NCT00274859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067406|NCT00274859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067407|NCT00274859|Antiviral Agents|antiviral agents|mesh-ancestor
65067408|NCT00274859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65067409|NCT00274859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067410|NCT00274859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65067411|NCT00274859|Immunologic Factors|immunologic factors|mesh-ancestor
65067412|NCT00274859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067413|NCT00274898|Celecoxib|celecoxib|mesh-list
65067414|NCT00274898|Docetaxel|docetaxel|mesh-list
65067415|NCT00274898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067416|NCT00274898|Tubulin Modulators|tubulin modulators|mesh-ancestor
65067417|NCT00274898|Antimitotic Agents|antimitotic agents|mesh-ancestor
65067418|NCT00274898|Mitosis Modulators|mitosis modulators|mesh-ancestor
65067419|NCT00274898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067420|NCT00274898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65067421|NCT00274898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65067422|NCT00274898|Analgesics|analgesics|mesh-ancestor
65067423|NCT00274898|Sensory System Agents|sensory system agents|mesh-ancestor
65067424|NCT00274898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65067425|NCT00274898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067426|NCT00274898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65067427|NCT00274898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65067428|NCT00274898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65067429|NCT00274898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65067430|NCT00274898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067431|NCT00308880|Tranexamic Acid|tranexamic acid|mesh-list
65067432|NCT00308880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65067433|NCT00308880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65067434|NCT00308880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067436|NCT00308880|Coagulants|coagulants|mesh-ancestor
65067437|NCT00277199|Abatacept|abatacept|mesh-list
65067438|NCT00277199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65067439|NCT00277199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067440|NCT00277199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067441|NCT00277199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65067442|NCT00277199|Immunologic Factors|immunologic factors|mesh-ancestor
65067443|NCT00277199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067444|NCT00277199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65067445|NCT00277472|Valsartan|valsartan|mesh-list
65067446|NCT00277472|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65067447|NCT00277472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65067448|NCT00277472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65067449|NCT00277472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65067450|NCT00277472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067452|NCT00277472|Natriuretic Agents|natriuretic agents|mesh-ancestor
65067453|NCT00277472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067454|NCT00277472|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65067455|NCT00277472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65067456|NCT00277511|Levofloxacin|levofloxacin|mesh-list
65067457|NCT00277511|Ofloxacin|ofloxacin|mesh-list
65067458|NCT00277511|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65067459|NCT00277511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65067460|NCT00277511|Renal Agents|renal agents|mesh-ancestor
65067461|NCT00277511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65067462|NCT00277511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65067463|NCT00277511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65067464|NCT00277511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067465|NCT00277511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067466|NCT00277511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067467|NCT00277511|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65067468|NCT00277511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65067469|NCT00315003|Azithromycin|azithromycin|mesh-list
65067470|NCT00315003|Telithromycin|telithromycin|mesh-list
65067471|NCT00315003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65067472|NCT00315003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65067473|NCT00277550|Tegaserod|tegaserod|mesh-list
65067474|NCT00277550|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65067475|NCT00277550|Serotonin Agents|serotonin agents|mesh-ancestor
65067476|NCT00277550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65067477|NCT00277550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067478|NCT00277550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067479|NCT00277589|Iodine|iodine|mesh-list
65067481|NCT00277589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65067482|NCT00277589|Trace Elements|trace elements|mesh-ancestor
65067483|NCT00277589|Micronutrients|micronutrients|mesh-ancestor
65067484|NCT00277589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067485|NCT00315042|Penicillins|penicillins|mesh-list
65067486|NCT00315042|Telithromycin|telithromycin|mesh-list
65067487|NCT00315042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65067488|NCT00315042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65067489|NCT00277667|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65067490|NCT00277667|Antidepressive Agents|antidepressive agents|mesh-ancestor
65067491|NCT00277667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65067492|NCT00277667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65067493|NCT00277667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65067494|NCT00277667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65067495|NCT00277667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067496|NCT00315081|Bromocriptine|bromocriptine|mesh-list
65067497|NCT00315081|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65067498|NCT00315081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65067499|NCT00315081|Hormone Antagonists|hormone antagonists|mesh-ancestor
65067500|NCT00315081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65067501|NCT00315081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067502|NCT00315081|Dopamine Agonists|dopamine agonists|mesh-ancestor
65067503|NCT00315081|Dopamine Agents|dopamine agents|mesh-ancestor
65067504|NCT00315081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65067505|NCT00315081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067506|NCT00277706|Vitamin D|vitamin d|mesh-list
65067507|NCT00277706|Calcium|calcium|mesh-list
65067508|NCT00277706|Vitamins|vitamins|mesh-ancestor
65067509|NCT00277706|Micronutrients|micronutrients|mesh-ancestor
65067510|NCT00277706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067511|NCT00277706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65067512|NCT00277706|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65067513|NCT00277862|Ribavirin|ribavirin|mesh-list
65067514|NCT00277862|Interferon-alpha|interferon-alpha|mesh-list
65067515|NCT00277862|Interferon alpha-2|interferon alpha-2|mesh-list
65067516|NCT00277862|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65067517|NCT00277862|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65067518|NCT00277862|Antimetabolites|antimetabolites|mesh-ancestor
65067519|NCT00277862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067520|NCT00277862|Antiviral Agents|antiviral agents|mesh-ancestor
65067521|NCT00277862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65067522|NCT00277862|Immunologic Factors|immunologic factors|mesh-ancestor
65067523|NCT00277862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067525|NCT00309270|Alemtuzumab|alemtuzumab|mesh-list
65067526|NCT00309270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65067527|NCT00309270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067528|NCT00315276|Modafinil|modafinil|mesh-list
65067529|NCT00315276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65067530|NCT00315276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067531|NCT00315276|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65067532|NCT00315276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65067533|NCT00315276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65067534|NCT00315276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067535|NCT00309309|Rosiglitazone|rosiglitazone|mesh-list
65067536|NCT00309309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65067537|NCT00309309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067538|NCT00278174|Interferons|interferons|mesh-list
65067539|NCT00278174|Interferon-alpha|interferon-alpha|mesh-list
65067540|NCT00278174|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
65067541|NCT00278174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067542|NCT00278174|Antiviral Agents|antiviral agents|mesh-ancestor
65067543|NCT00278174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65067544|NCT00278174|Immunologic Factors|immunologic factors|mesh-ancestor
65067545|NCT00278174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067546|NCT00278213|Cyclophosphamide|cyclophosphamide|mesh-list
65067547|NCT00278213|Fludarabine|fludarabine|mesh-list
65067548|NCT00278213|Fludarabine phosphate|fludarabine phosphate|mesh-list
65067549|NCT00278213|Mitoxantrone|mitoxantrone|mesh-list
65067550|NCT00278213|Alemtuzumab|alemtuzumab|mesh-list
65067551|NCT00278213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65067552|NCT00278213|Immunologic Factors|immunologic factors|mesh-ancestor
65067553|NCT00278213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067554|NCT00278213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65067555|NCT00278213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65067556|NCT00278213|Alkylating Agents|alkylating agents|mesh-ancestor
65495259|NCT01244880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65067557|NCT00278213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067558|NCT00278213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067559|NCT00278213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65067560|NCT00278213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65067561|NCT00278213|Antimetabolites|antimetabolites|mesh-ancestor
65067562|NCT00278213|Analgesics|analgesics|mesh-ancestor
65067563|NCT00278213|Sensory System Agents|sensory system agents|mesh-ancestor
65067564|NCT00278213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65067565|NCT00278213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65067566|NCT00278213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65067567|NCT00278213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067568|NCT00278213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65067569|NCT00278252|Etoposide|etoposide|mesh-list
65067570|NCT00278252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65067571|NCT00278252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067572|NCT00278252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65067573|NCT00278252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65067574|NCT00278252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067575|NCT00278252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067576|NCT00315432|Interferons|interferons|mesh-list
65067577|NCT00315432|Ribavirin|ribavirin|mesh-list
65067578|NCT00315432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067579|NCT00315432|Antiviral Agents|antiviral agents|mesh-ancestor
65067580|NCT00315432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65067581|NCT00315432|Antimetabolites|antimetabolites|mesh-ancestor
65067582|NCT00315432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067583|NCT00278330|Vorinostat|vorinostat|mesh-list
65067584|NCT00278330|Alvocidib|alvocidib|mesh-list
65067585|NCT00278330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067586|NCT00278330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65067587|NCT00278330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067588|NCT00278330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067589|NCT00278330|Growth Inhibitors|growth inhibitors|mesh-ancestor
65067590|NCT00278330|Growth Substances|growth substances|mesh-ancestor
65067591|NCT00278330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067592|NCT00278330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65067593|NCT00315510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65067594|NCT00315510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64552870|NCT05247619|Paclitaxel|paclitaxel|mesh-list
65067595|NCT00315510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65067596|NCT00315510|Antimetabolites|antimetabolites|mesh-ancestor
65067597|NCT00315510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067598|NCT00315510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65067599|NCT00315510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65067600|NCT00315510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067601|NCT00278369|Aldesleukin|aldesleukin|mesh-list
65067602|NCT00278369|Interleukin-2|interleukin-2|mesh-list
65067603|NCT00278369|Denileukin diftitox|denileukin diftitox|mesh-list
65067604|NCT00278369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067605|NCT00278369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65067606|NCT00278369|Analgesics|analgesics|mesh-ancestor
65067607|NCT00278369|Sensory System Agents|sensory system agents|mesh-ancestor
65067608|NCT00278369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65067609|NCT00278369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067610|NCT00278369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65067611|NCT00278369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65067612|NCT00278369|Antiviral Agents|antiviral agents|mesh-ancestor
65067613|NCT00278369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65067614|NCT00315549|Penicillins|penicillins|mesh-list
65067615|NCT00315549|Telithromycin|telithromycin|mesh-list
65067616|NCT00315549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65067617|NCT00315549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65067618|NCT00278408|Prednisone|prednisone|mesh-list
65067619|NCT00278408|Cyclophosphamide|cyclophosphamide|mesh-list
65067620|NCT00278408|Rituximab|rituximab|mesh-list
65067621|NCT00278408|Doxorubicin|doxorubicin|mesh-list
65067622|NCT00278408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65067623|NCT00278408|Vincristine|vincristine|mesh-list
65067624|NCT00278408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65067625|NCT00278408|Immunologic Factors|immunologic factors|mesh-ancestor
65067626|NCT00278408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067627|NCT00278408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65067628|NCT00278408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65067629|NCT00278408|Alkylating Agents|alkylating agents|mesh-ancestor
65067630|NCT00278408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067631|NCT00278408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067632|NCT00278408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65067633|NCT00278408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65067634|NCT00278408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65067635|NCT00278408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65067636|NCT00278408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65067637|NCT00278408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067638|NCT00278408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65067639|NCT00278408|Glucocorticoids|glucocorticoids|mesh-ancestor
65067640|NCT00278408|Hormones|hormones|mesh-ancestor
65067641|NCT00278408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65067642|NCT00278408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65067643|NCT00278408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65067644|NCT00278408|Tubulin Modulators|tubulin modulators|mesh-ancestor
65067645|NCT00278408|Antimitotic Agents|antimitotic agents|mesh-ancestor
65067646|NCT00278408|Mitosis Modulators|mitosis modulators|mesh-ancestor
65067647|NCT00315666|Memantine|memantine|mesh-list
65067648|NCT00315666|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65067649|NCT00315666|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65067650|NCT00315666|Dopamine Agents|dopamine agents|mesh-ancestor
65067651|NCT00315666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65067652|NCT00315666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067653|NCT00315666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067654|NCT00315666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65067655|NCT00315666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65067656|NCT00315744|Fluticasone|fluticasone|mesh-list
65067657|NCT00315744|Xhance|xhance|mesh-list
65067658|NCT00315744|Albuterol|albuterol|mesh-list
65067659|NCT00315744|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65067660|NCT00315744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65067661|NCT00315744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65067662|NCT00315744|Autonomic Agents|autonomic agents|mesh-ancestor
65067663|NCT00315744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65067664|NCT00315744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067665|NCT00315744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65067666|NCT00315744|Respiratory System Agents|respiratory system agents|mesh-ancestor
65067667|NCT00315744|Dermatologic Agents|dermatologic agents|mesh-ancestor
65067668|NCT00315744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65067669|NCT00315744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65067670|NCT00315744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65067671|NCT00315744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65067672|NCT00315744|Adrenergic Agents|adrenergic agents|mesh-ancestor
65067673|NCT00315744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65067674|NCT00315744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067675|NCT00315744|Tocolytic Agents|tocolytic agents|mesh-ancestor
65067676|NCT00315744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65067677|NCT00309543|Leucovorin|leucovorin|mesh-list
65067678|NCT00309543|Fluorouracil|fluorouracil|mesh-list
65067679|NCT00309543|Antimetabolites|antimetabolites|mesh-ancestor
65067680|NCT00309543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067681|NCT00309543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65067682|NCT00309543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067683|NCT00309543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65067684|NCT00309543|Immunologic Factors|immunologic factors|mesh-ancestor
65067685|NCT00309543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067686|NCT00309543|Antidotes|antidotes|mesh-ancestor
65067687|NCT00309543|Protective Agents|protective agents|mesh-ancestor
65067688|NCT00309543|Vitamin B Complex|vitamin b complex|mesh-ancestor
65067689|NCT00309543|Vitamins|vitamins|mesh-ancestor
65067690|NCT00309543|Micronutrients|micronutrients|mesh-ancestor
65067691|NCT00309621|Alitretinoin|alitretinoin|mesh-list
65067692|NCT00309621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067693|NCT00309621|Dermatologic Agents|dermatologic agents|mesh-ancestor
65067694|NCT00315861|Pemetrexed|pemetrexed|mesh-list
65067695|NCT00315861|Topotecan|topotecan|mesh-list
65067696|NCT00315861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067697|NCT00315861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067698|NCT00315861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067699|NCT00315861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65067700|NCT00315861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65067701|NCT00315861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65067702|NCT00315861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65067703|NCT00309660|Rosiglitazone|rosiglitazone|mesh-list
65067704|NCT00309660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65067705|NCT00309660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495260|NCT01244880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65067706|NCT00315900|Valproic Acid|valproic acid|mesh-list
65067707|NCT00315900|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65067708|NCT00315900|Antidepressive Agents|antidepressive agents|mesh-ancestor
65067709|NCT00315900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65067710|NCT00315900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65067711|NCT00315900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65067712|NCT00315900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65067713|NCT00315900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067714|NCT00315900|Anticonvulsants|anticonvulsants|mesh-ancestor
65067715|NCT00315900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067716|NCT00315900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067717|NCT00315900|GABA Agents|gaba agents|mesh-ancestor
65067718|NCT00315900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65067719|NCT00315900|Antimanic Agents|antimanic agents|mesh-ancestor
65067720|NCT00279110|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65067721|NCT00279110|Antiviral Agents|antiviral agents|mesh-ancestor
65067722|NCT00279110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65067723|NCT00309699|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65067724|NCT00309699|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65067725|NCT00309699|Antidepressive Agents|antidepressive agents|mesh-ancestor
65067726|NCT00309699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65067727|NCT00309699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65067728|NCT00309699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65067729|NCT00309699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65067730|NCT00309699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067731|NCT00309699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65067732|NCT00309699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65067733|NCT00309699|Serotonin Agents|serotonin agents|mesh-ancestor
65067734|NCT00309699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65067735|NCT00309699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067736|NCT00309699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65067737|NCT00309699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65067738|NCT00309699|Dopamine Agents|dopamine agents|mesh-ancestor
65067739|NCT00309816|Sildenafil Citrate|sildenafil citrate|mesh-list
65067740|NCT00309816|Vasodilator Agents|vasodilator agents|mesh-ancestor
65067741|NCT00309816|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65067742|NCT00309816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65067743|NCT00309816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067744|NCT00309816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067745|NCT00309816|Urological Agents|urological agents|mesh-ancestor
65067746|NCT00279266|Thiamine|thiamine|mesh-list
65067747|NCT00279266|Vitamin B Complex|vitamin b complex|mesh-ancestor
65067748|NCT00279266|Vitamins|vitamins|mesh-ancestor
65067749|NCT00279266|Micronutrients|micronutrients|mesh-ancestor
65067750|NCT00279266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067752|NCT00316095|Simvastatin|simvastatin|mesh-list
65067753|NCT00316095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65067754|NCT00316095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65067755|NCT00316095|Antimetabolites|antimetabolites|mesh-ancestor
65067756|NCT00316095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067757|NCT00316095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65067758|NCT00316095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65067759|NCT00316095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067760|NCT00316095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65067761|NCT00316095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65067762|NCT00316095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65067763|NCT00279344|Fentanyl|fentanyl|mesh-list
65067764|NCT00279344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65067765|NCT00279344|Narcotics|narcotics|mesh-ancestor
65067766|NCT00279344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65067767|NCT00279344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067768|NCT00279344|Analgesics|analgesics|mesh-ancestor
65067769|NCT00279344|Sensory System Agents|sensory system agents|mesh-ancestor
65067770|NCT00279344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65067771|NCT00279344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65067772|NCT00279344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65067773|NCT00279344|Anesthetics, General|anesthetics, general|mesh-ancestor
65067774|NCT00279344|Anesthetics|anesthetics|mesh-ancestor
65067775|NCT00418860|Aspirin|aspirin|mesh-list
65067776|NCT00418860|Clopidogrel|clopidogrel|mesh-list
65067777|NCT00418860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65067778|NCT00418860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65067779|NCT00418860|Analgesics|analgesics|mesh-ancestor
65067780|NCT00418860|Sensory System Agents|sensory system agents|mesh-ancestor
65067781|NCT00418860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65067782|NCT00418860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067783|NCT00418860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65067784|NCT00418860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65067785|NCT00418860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65067786|NCT00418860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65067787|NCT00418860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067788|NCT00418860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65067789|NCT00418860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64793646|NCT03218514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65067790|NCT00418860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067792|NCT00418860|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65067793|NCT00418860|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65067794|NCT00418860|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65067795|NCT00418860|Purinergic Agents|purinergic agents|mesh-ancestor
65067796|NCT00418860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65067797|NCT00316212|INS 50589|ins 50589|mesh-list
65067798|NCT00316212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65067799|NCT00316212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65067800|NCT00316212|Purinergic Agents|purinergic agents|mesh-ancestor
65067801|NCT00316212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65067802|NCT00316212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067803|NCT00316212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067804|NCT00309855|Anastrozole|anastrozole|mesh-list
65067805|NCT00309855|Testosterone|testosterone|mesh-list
65067806|NCT00309855|Dutasteride|dutasteride|mesh-list
65067807|NCT00309855|Androgens|androgens|mesh-ancestor
65067808|NCT00309855|Hormones|hormones|mesh-ancestor
65067809|NCT00309855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65067810|NCT00309855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067811|NCT00309855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65067812|NCT00309855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067813|NCT00309855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65067814|NCT00309855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65067815|NCT00309855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067816|NCT00309855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067817|NCT00309855|Hormone Antagonists|hormone antagonists|mesh-ancestor
65067818|NCT00309855|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65067819|NCT00309855|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65067820|NCT00279383|Thrombin|thrombin|mesh-list
65067821|NCT00279383|Hemostatics|hemostatics|mesh-ancestor
65067822|NCT00279383|Coagulants|coagulants|mesh-ancestor
65067823|NCT00279422|Visilizumab|visilizumab|mesh-list
64509245|NCT03829371|Bortezomib|bortezomib|mesh-list
65067824|NCT00279422|Immunologic Factors|immunologic factors|mesh-ancestor
65067825|NCT00279422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067826|NCT00309894|Ketoconazole|ketoconazole|mesh-list
65067827|NCT00309894|Hydrocortisone|hydrocortisone|mesh-list
65067828|NCT00309894|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
65067829|NCT00309894|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65067830|NCT00309894|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65067831|NCT00309894|Sargramostim|sargramostim|mesh-list
65067832|NCT00309894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65067833|NCT00309894|Immunologic Factors|immunologic factors|mesh-ancestor
65067834|NCT00309894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067835|NCT00309894|Antifungal Agents|antifungal agents|mesh-ancestor
65067836|NCT00309894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65067837|NCT00309894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65067838|NCT00309894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65067839|NCT00309894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067840|NCT00309894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067841|NCT00309894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65067842|NCT00309894|Hormone Antagonists|hormone antagonists|mesh-ancestor
65067843|NCT00309894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65067844|NCT00309894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65067845|NCT00279461|Vitamin D|vitamin d|mesh-list
65067846|NCT00279461|Ergocalciferols|ergocalciferols|mesh-list
65067847|NCT00279461|Cholecalciferol|cholecalciferol|mesh-list
65067848|NCT00279461|Vitamins|vitamins|mesh-list
65067849|NCT00279461|Micronutrients|micronutrients|mesh-ancestor
65067850|NCT00279461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067851|NCT00279461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65067852|NCT00279461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65067853|NCT00316329|Artesunate|artesunate|mesh-list
65067854|NCT00316329|Amodiaquine|amodiaquine|mesh-list
65067855|NCT00316329|Antimalarials|antimalarials|mesh-ancestor
65067856|NCT00316329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65067858|NCT00316329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65067859|NCT00316329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067860|NCT00316329|Antiviral Agents|antiviral agents|mesh-ancestor
65067861|NCT00316329|Schistosomicides|schistosomicides|mesh-ancestor
65067862|NCT00316329|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65067863|NCT00316329|Anthelmintics|anthelmintics|mesh-ancestor
65067864|NCT00279539|Mitogens|mitogens|mesh-list
65067865|NCT00279539|Endothelial Growth Factors|endothelial growth factors|mesh-list
65067866|NCT00279539|Mitosis Modulators|mitosis modulators|mesh-ancestor
65067867|NCT00279539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067868|NCT00279539|Growth Substances|growth substances|mesh-ancestor
65067869|NCT00279539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067870|NCT00279578|Tranexamic Acid|tranexamic acid|mesh-list
65067871|NCT00279578|Factor VIII|factor viii|mesh-list
65067872|NCT00279578|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65067873|NCT00279578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65067874|NCT00279578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067875|NCT00279578|Hemostatics|hemostatics|mesh-ancestor
65067876|NCT00279578|Coagulants|coagulants|mesh-ancestor
65067877|NCT00279617|Levetiracetam|levetiracetam|mesh-list
65067878|NCT00279617|Anticonvulsants|anticonvulsants|mesh-ancestor
65067879|NCT00279617|Nootropic Agents|nootropic agents|mesh-ancestor
65067880|NCT00310011|Gemcitabine|gemcitabine|mesh-list
65067881|NCT00310011|Paclitaxel|paclitaxel|mesh-list
65067882|NCT00310011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65067883|NCT00310011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067884|NCT00310011|Tubulin Modulators|tubulin modulators|mesh-ancestor
65067885|NCT00310011|Antimitotic Agents|antimitotic agents|mesh-ancestor
65067886|NCT00310011|Mitosis Modulators|mitosis modulators|mesh-ancestor
65067887|NCT00310011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067888|NCT00310011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65067889|NCT00310011|Antimetabolites|antimetabolites|mesh-ancestor
65067890|NCT00310011|Antiviral Agents|antiviral agents|mesh-ancestor
65067891|NCT00310011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65067892|NCT00310011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067893|NCT00310011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65067894|NCT00310011|Immunologic Factors|immunologic factors|mesh-ancestor
65067895|NCT00310011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067896|NCT00316407|Paclitaxel|paclitaxel|mesh-list
65067897|NCT00316407|Carboplatin|carboplatin|mesh-list
65067898|NCT00316407|Lapatinib|lapatinib|mesh-list
64794353|NCT01724658|Methyltestosterone|methyltestosterone|mesh-list
65067899|NCT00316407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65067900|NCT00316407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067902|NCT00316407|Antimitotic Agents|antimitotic agents|mesh-ancestor
65067903|NCT00316407|Mitosis Modulators|mitosis modulators|mesh-ancestor
65067904|NCT00316407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067905|NCT00316407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65067906|NCT00316407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067907|NCT00310089|Cyclophosphamide|cyclophosphamide|mesh-list
65067908|NCT00310089|Docetaxel|docetaxel|mesh-list
65067909|NCT00310089|Doxorubicin|doxorubicin|mesh-list
65067910|NCT00310089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65067911|NCT00310089|Cediranib|cediranib|mesh-list
65067912|NCT00310089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65067913|NCT00310089|Immunologic Factors|immunologic factors|mesh-ancestor
65067914|NCT00310089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067915|NCT00310089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65067916|NCT00310089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65067917|NCT00310089|Alkylating Agents|alkylating agents|mesh-ancestor
65067918|NCT00310089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067919|NCT00310089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067920|NCT00310089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65067921|NCT00310089|Tubulin Modulators|tubulin modulators|mesh-ancestor
65067922|NCT00310089|Antimitotic Agents|antimitotic agents|mesh-ancestor
65067923|NCT00310089|Mitosis Modulators|mitosis modulators|mesh-ancestor
65067924|NCT00310089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65067925|NCT00310089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65067926|NCT00310089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65067927|NCT00310089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067928|NCT00310089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65067929|NCT00279734|Abatacept|abatacept|mesh-list
65067930|NCT00279734|Vaccines|vaccines|mesh-list
65067931|NCT00279734|Immunologic Factors|immunologic factors|mesh-ancestor
65067932|NCT00279734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067933|NCT00279734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64600421|NCT00637832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65067934|NCT00279734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067936|NCT00279734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65067937|NCT00279734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65067938|NCT00310128|Cytarabine|cytarabine|mesh-list
65067939|NCT00310128|Methylprednisolone|methylprednisolone|mesh-list
65067940|NCT00310128|Rituximab|rituximab|mesh-list
65067941|NCT00310128|Etoposide|etoposide|mesh-list
65067942|NCT00310128|Antibodies|antibodies|mesh-list
65067943|NCT00310128|Immunoglobulins|immunoglobulins|mesh-list
65067944|NCT00310128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65067945|NCT00310128|Immunologic Factors|immunologic factors|mesh-ancestor
65067946|NCT00310128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067947|NCT00310128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65067948|NCT00310128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067949|NCT00310128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65067950|NCT00310128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65067951|NCT00310128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65067952|NCT00310128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65067953|NCT00310128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65067954|NCT00310128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067955|NCT00310128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65067956|NCT00310128|Antimetabolites|antimetabolites|mesh-ancestor
65067957|NCT00310128|Antiviral Agents|antiviral agents|mesh-ancestor
65067958|NCT00310128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65067959|NCT00310128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65067960|NCT00310128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65067961|NCT00310128|Antiemetics|antiemetics|mesh-ancestor
65067962|NCT00310128|Autonomic Agents|autonomic agents|mesh-ancestor
65067963|NCT00310128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65067964|NCT00310128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65067965|NCT00310128|Glucocorticoids|glucocorticoids|mesh-ancestor
65067967|NCT00310128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65067968|NCT00310128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65067969|NCT00310128|Protective Agents|protective agents|mesh-ancestor
65067970|NCT00316563|Dronabinol|dronabinol|mesh-list
65067971|NCT00316563|Hallucinogens|hallucinogens|mesh-ancestor
65067972|NCT00316563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067973|NCT00316563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65067974|NCT00316563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65067975|NCT00316563|Analgesics|analgesics|mesh-ancestor
65067976|NCT00316563|Sensory System Agents|sensory system agents|mesh-ancestor
65067978|NCT00316563|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65067979|NCT00316563|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65067980|NCT00316563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65067981|NCT00316563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65067982|NCT00316563|Hormones|hormones|mesh-ancestor
65067983|NCT00316563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65067984|NCT00416819|Leucovorin|leucovorin|mesh-list
65067985|NCT00416819|Cytarabine|cytarabine|mesh-list
65067986|NCT00416819|Rituximab|rituximab|mesh-list
65067987|NCT00416819|Methotrexate|methotrexate|mesh-list
65067988|NCT00416819|Etoposide|etoposide|mesh-list
65067989|NCT00416819|Temozolomide|temozolomide|mesh-list
65067990|NCT00416819|Etoposide phosphate|etoposide phosphate|mesh-list
65067991|NCT00416819|Levoleucovorin|levoleucovorin|mesh-list
65067992|NCT00416819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65067993|NCT00416819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65067994|NCT00416819|Immunologic Factors|immunologic factors|mesh-ancestor
65067995|NCT00416819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65067996|NCT00416819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65067997|NCT00416819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65067998|NCT00416819|Abortifacient Agents|abortifacient agents|mesh-ancestor
65067999|NCT00416819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65068000|NCT00416819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65068001|NCT00416819|Antimetabolites|antimetabolites|mesh-ancestor
65068002|NCT00416819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068003|NCT00416819|Dermatologic Agents|dermatologic agents|mesh-ancestor
65068004|NCT00416819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068005|NCT00416819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65068006|NCT00416819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65068007|NCT00416819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65068008|NCT00416819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65068009|NCT00416819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65068010|NCT00416819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64318438|NCT05613842|Copper|copper|mesh-list
65068011|NCT00416819|Antiviral Agents|antiviral agents|mesh-ancestor
65068012|NCT00416819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65068013|NCT00416819|Antidotes|antidotes|mesh-ancestor
65068014|NCT00416819|Protective Agents|protective agents|mesh-ancestor
65068015|NCT00416819|Vitamin B Complex|vitamin b complex|mesh-ancestor
65068016|NCT00416819|Vitamins|vitamins|mesh-ancestor
65068017|NCT00416819|Micronutrients|micronutrients|mesh-ancestor
65068018|NCT00416819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65068019|NCT00416819|Alkylating Agents|alkylating agents|mesh-ancestor
65068020|NCT00310206|Vaccines|vaccines|mesh-list
65068021|NCT00310206|Immunologic Factors|immunologic factors|mesh-ancestor
65068022|NCT00310206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068024|NCT00280007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65068025|NCT00280007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068026|NCT00280007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65068027|NCT00280007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65068028|NCT00280007|Growth Substances|growth substances|mesh-ancestor
65068029|NCT00280007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068030|NCT00280007|Growth Inhibitors|growth inhibitors|mesh-ancestor
65068031|NCT00316680|Vaccines|vaccines|mesh-list
65068032|NCT00316680|Immunologic Factors|immunologic factors|mesh-ancestor
65068033|NCT00316680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068034|NCT00280046|Insulin Aspart|insulin aspart|mesh-list
65068035|NCT00280046|Biphasic Insulins|biphasic insulins|mesh-list
65068036|NCT00280046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64563604|NCT01924273|Talaporfin|talaporfin|mesh-list
65068037|NCT00280046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068038|NCT00310323|Dextromethorphan|dextromethorphan|mesh-list
65068039|NCT00310323|Caffeine|caffeine|mesh-list
65068040|NCT00310323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65068041|NCT00310323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068042|NCT00310323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65068043|NCT00310323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068044|NCT00310323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068045|NCT00310323|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65068046|NCT00310323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65068047|NCT00310323|Purinergic Agents|purinergic agents|mesh-ancestor
65068048|NCT00310323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65068049|NCT00310323|Antitussive Agents|antitussive agents|mesh-ancestor
65068050|NCT00310323|Respiratory System Agents|respiratory system agents|mesh-ancestor
64509476|NCT02983773|Dronabinol|dronabinol|mesh-list
65068051|NCT00310323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65068052|NCT00310323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65068053|NCT00280280|Baclofen|baclofen|mesh-list
65068054|NCT00280280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65068055|NCT00280280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068056|NCT00280280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65068057|NCT00280280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65068058|NCT00280280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65068059|NCT00280280|GABA Agonists|gaba agonists|mesh-ancestor
65068060|NCT00280280|GABA Agents|gaba agents|mesh-ancestor
65068061|NCT00280280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65068062|NCT00280280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068063|NCT00316758|Metformin|metformin|mesh-list
65068064|NCT00316758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65068065|NCT00316758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068066|NCT00280358|Fluticasone|fluticasone|mesh-list
65068067|NCT00280358|Xhance|xhance|mesh-list
65068068|NCT00280358|Formoterol Fumarate|formoterol fumarate|mesh-list
65068069|NCT00280358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64795298|NCT03834012|Beclomethasone|beclomethasone|mesh-list
65068070|NCT00280358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65068071|NCT00280358|Autonomic Agents|autonomic agents|mesh-ancestor
65068072|NCT00280358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65068073|NCT00280358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068074|NCT00280358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65068075|NCT00280358|Respiratory System Agents|respiratory system agents|mesh-ancestor
65068076|NCT00280358|Dermatologic Agents|dermatologic agents|mesh-ancestor
65068077|NCT00280358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65068078|NCT00280358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65068079|NCT00280358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65068080|NCT00280358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65068081|NCT00280358|Adrenergic Agents|adrenergic agents|mesh-ancestor
65068082|NCT00280358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65068083|NCT00280358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068084|NCT00310518|Beta-lapachone|beta-lapachone|mesh-list
64401029|NCT04858711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65068085|NCT00310518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65068086|NCT00310518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65068087|NCT00310518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65068088|NCT00310518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068089|NCT00310518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068090|NCT00310518|Antiviral Agents|antiviral agents|mesh-ancestor
65068091|NCT00280436|Casopitant|casopitant|mesh-list
65068092|NCT00280436|Antiemetics|antiemetics|mesh-ancestor
65068093|NCT00280436|Autonomic Agents|autonomic agents|mesh-ancestor
65068094|NCT00280436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65068095|NCT00280436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068096|NCT00280436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65068097|NCT00280436|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65068098|NCT00280436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65068099|NCT00280436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068100|NCT00280514|Moxifloxacin|moxifloxacin|mesh-list
65068101|NCT00280514|Cefpirome|cefpirome|mesh-list
65068102|NCT00280514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65068103|NCT00280514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65068104|NCT00280514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65068105|NCT00280514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65068106|NCT00280514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068107|NCT00280514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068108|NCT00280514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068109|NCT00280553|Bupivacaine|bupivacaine|mesh-list
65068110|NCT00280553|Anesthetics, Local|anesthetics, local|mesh-ancestor
65068111|NCT00280553|Anesthetics|anesthetics|mesh-ancestor
65068112|NCT00280553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65068113|NCT00280553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068114|NCT00280553|Sensory System Agents|sensory system agents|mesh-ancestor
65068115|NCT00280553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65068116|NCT00316875|Doxorubicin|doxorubicin|mesh-list
65068117|NCT00316875|Lapatinib|lapatinib|mesh-list
65068118|NCT00316875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65068119|NCT00316875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068120|NCT00316875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65068121|NCT00316875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65068122|NCT00316875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068123|NCT00316875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068124|NCT00316875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65068125|NCT00316953|Dasatinib|dasatinib|mesh-list
65068126|NCT00316953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068127|NCT00316953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65068128|NCT00316953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068129|NCT00316953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068130|NCT00419172|Rifampin|rifampin|mesh-list
65068131|NCT00419172|Deferasirox|deferasirox|mesh-list
65068132|NCT00419172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65068133|NCT00419172|Antitubercular Agents|antitubercular agents|mesh-ancestor
65068134|NCT00419172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65068135|NCT00419172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65068136|NCT00419172|Leprostatic Agents|leprostatic agents|mesh-ancestor
65068137|NCT00419172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65068138|NCT00419172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795709|NCT05678348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65068139|NCT00419172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068140|NCT00419172|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65068141|NCT00419172|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65068142|NCT00419172|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65068143|NCT00419172|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65068144|NCT00419172|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65068145|NCT00419172|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65068146|NCT00419172|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65068147|NCT00419172|Chelating Agents|chelating agents|mesh-ancestor
65068148|NCT00419172|Sequestering Agents|sequestering agents|mesh-ancestor
65068149|NCT00280787|Paclitaxel|paclitaxel|mesh-list
65068150|NCT00280787|Carboplatin|carboplatin|mesh-list
65068151|NCT00280787|Irinotecan|irinotecan|mesh-list
65068152|NCT00280787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65068153|NCT00280787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068154|NCT00280787|Tubulin Modulators|tubulin modulators|mesh-ancestor
65068155|NCT00280787|Antimitotic Agents|antimitotic agents|mesh-ancestor
65068156|NCT00280787|Mitosis Modulators|mitosis modulators|mesh-ancestor
65068157|NCT00280787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068158|NCT00280787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65068160|NCT00280787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068161|NCT00310596|Moxifloxacin|moxifloxacin|mesh-list
65068162|NCT00310596|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65068163|NCT00310596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65068164|NCT00310596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65068165|NCT00310596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65068166|NCT00310596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65068168|NCT00310596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068169|NCT00310596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64795815|NCT05602636|Anesthetics, Local|anesthetics, local|mesh-ancestor
65068170|NCT00310596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65068171|NCT00310596|Contraceptive Agents|contraceptive agents|mesh-ancestor
65068172|NCT00310596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65068173|NCT00310596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068174|NCT00310596|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65068175|NCT00310596|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65068176|NCT00310596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65068177|NCT00280865|Pioglitazone|pioglitazone|mesh-list
65068178|NCT00280865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65068179|NCT00280865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068180|NCT00317031|Naltrexone|naltrexone|mesh-list
65068181|NCT00317031|Acamprosate|acamprosate|mesh-list
65068182|NCT00317031|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65068183|NCT00317031|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65068184|NCT00317031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068185|NCT00317031|Sensory System Agents|sensory system agents|mesh-ancestor
65068186|NCT00317031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65068187|NCT00317070|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
65068188|NCT00317070|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65068189|NCT00317070|Protective Agents|protective agents|mesh-ancestor
65068190|NCT00317070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068191|NCT00317070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65068192|NCT00317070|Antioxidants|antioxidants|mesh-ancestor
65068193|NCT00317070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068194|NCT00281255|Allopurinol|allopurinol|mesh-list
65068195|NCT00281255|Dobutamine|dobutamine|mesh-list
65068196|NCT00281255|Antimetabolites|antimetabolites|mesh-ancestor
65068197|NCT00281255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068198|NCT00281255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068199|NCT00281255|Gout Suppressants|gout suppressants|mesh-ancestor
65068200|NCT00281255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65068201|NCT00281255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65068202|NCT00281255|Antioxidants|antioxidants|mesh-ancestor
65068203|NCT00281255|Protective Agents|protective agents|mesh-ancestor
65068204|NCT00281255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068205|NCT00281255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65068206|NCT00281255|Sympathomimetics|sympathomimetics|mesh-ancestor
65068207|NCT00281255|Autonomic Agents|autonomic agents|mesh-ancestor
65068208|NCT00281255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65068209|NCT00281255|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65068210|NCT00281255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65068211|NCT00281255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65068212|NCT00281255|Adrenergic Agents|adrenergic agents|mesh-ancestor
65068213|NCT00281255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65068214|NCT00317187|Vaccines|vaccines|mesh-list
65068215|NCT00317187|Immunologic Factors|immunologic factors|mesh-ancestor
65068216|NCT00317187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068217|NCT00310908|Tramadol|tramadol|mesh-list
65068218|NCT00310908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65068219|NCT00310908|Narcotics|narcotics|mesh-ancestor
65068220|NCT00310908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65068221|NCT00310908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068222|NCT00310908|Analgesics|analgesics|mesh-ancestor
65068223|NCT00310908|Sensory System Agents|sensory system agents|mesh-ancestor
65068224|NCT00310908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65068225|NCT00281489|Anesthetics|anesthetics|mesh-list
65068226|NCT00281489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65068227|NCT00281489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068228|NCT00317343|Anticoagulants|anticoagulants|mesh-list
65068229|NCT00317343|Bivalirudin|bivalirudin|mesh-list
65068230|NCT00317343|Thrombin|thrombin|mesh-list
65068231|NCT00317343|Hemostatics|hemostatics|mesh-ancestor
65068232|NCT00317343|Coagulants|coagulants|mesh-ancestor
65068233|NCT00317343|Antithrombins|antithrombins|mesh-ancestor
65068234|NCT00317343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65495261|NCT01244880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068235|NCT00317343|Protease Inhibitors|protease inhibitors|mesh-ancestor
65068236|NCT00317343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068237|NCT00317343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068238|NCT00416858|Fluorouracil|fluorouracil|mesh-list
65068239|NCT00416858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068241|NCT00416858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068242|NCT00416858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65068243|NCT00416858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65068244|NCT00416858|Immunologic Factors|immunologic factors|mesh-ancestor
65068245|NCT00416858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068246|NCT00416897|Dexamethasone|dexamethasone|mesh-list
65068247|NCT00416897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65068248|NCT00416897|Antiemetics|antiemetics|mesh-ancestor
65068249|NCT00416897|Autonomic Agents|autonomic agents|mesh-ancestor
65068250|NCT00416897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65068251|NCT00416897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495262|NCT01244958|Rituximab|rituximab|mesh-list
65495263|NCT01244958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65495264|NCT01244958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495265|NCT01244958|Immunologic Factors|immunologic factors|mesh-ancestor
64796459|NCT04469959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65495266|NCT01244958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495267|NCT01244958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65495268|NCT00246324|Interferons|interferons|mesh-list
65495269|NCT00246324|Interferon-beta|interferon-beta|mesh-list
65495270|NCT00246324|Interferon beta-1a|interferon beta-1a|mesh-list
65495271|NCT00246324|Doxycycline|doxycycline|mesh-list
65495272|NCT00246324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495273|NCT00246324|Antiviral Agents|antiviral agents|mesh-ancestor
65495274|NCT00246324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65495275|NCT00246324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65495276|NCT00246324|Antimalarials|antimalarials|mesh-ancestor
65495277|NCT00246324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65495278|NCT00246324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65495279|NCT00246324|Immunologic Factors|immunologic factors|mesh-ancestor
65495280|NCT00246324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495281|NCT00246324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65495282|NCT01237782|Propolis|propolis|mesh-list
65495283|NCT01237782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65495284|NCT01237782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65495285|NCT01245660|Lapatinib|lapatinib|mesh-list
65495286|NCT01245660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495287|NCT01245660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65495288|NCT01245660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495289|NCT01245660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495290|NCT03686904|Benzalkonium Compounds|benzalkonium compounds|mesh-list
65495291|NCT03686904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65495292|NCT03686904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65495293|NCT03913806|Bevacizumab|bevacizumab|mesh-list
65495294|NCT03913806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65495295|NCT03913806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495296|NCT03913806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65495297|NCT03913806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65495298|NCT03913806|Growth Substances|growth substances|mesh-ancestor
65495299|NCT03913806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495300|NCT03913806|Growth Inhibitors|growth inhibitors|mesh-ancestor
65495301|NCT01250808|Dexamethasone|dexamethasone|mesh-list
65495302|NCT01250808|Bortezomib|bortezomib|mesh-list
65495303|NCT01250808|Melphalan|melphalan|mesh-list
65495304|NCT01250808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65495305|NCT01250808|Antiemetics|antiemetics|mesh-ancestor
65495306|NCT01250808|Autonomic Agents|autonomic agents|mesh-ancestor
65495307|NCT01250808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65495308|NCT01250808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495309|NCT01250808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65495310|NCT01250808|Glucocorticoids|glucocorticoids|mesh-ancestor
65495311|NCT01250808|Hormones|hormones|mesh-ancestor
65495312|NCT01250808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65495313|NCT01250808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65495314|NCT01250808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495315|NCT01250808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65495316|NCT01250808|Alkylating Agents|alkylating agents|mesh-ancestor
64473333|NCT00221338|Gabapentin|gabapentin|mesh-list
65495317|NCT01250808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495318|NCT01250808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65495319|NCT01250808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65495320|NCT01250808|Immunologic Factors|immunologic factors|mesh-ancestor
65495321|NCT01146678|Insulin Glargine|insulin glargine|mesh-list
65495322|NCT01146678|Lixisenatide|lixisenatide|mesh-list
65495323|NCT01146678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65495324|NCT01146678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495325|NCT05429866|Nivolumab|nivolumab|mesh-list
65495326|NCT05429866|Durvalumab|durvalumab|mesh-list
65495327|NCT05429866|Avelumab|avelumab|mesh-list
65495328|NCT05429866|Cemiplimab|cemiplimab|mesh-list
65495329|NCT05429866|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
65495330|NCT05429866|Atezolizumab|atezolizumab|mesh-list
65495331|NCT05429866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65495332|NCT05429866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495333|NCT05429866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495334|NCT04778982|Fulvestrant|fulvestrant|mesh-list
65495335|NCT04778982|Palbociclib|palbociclib|mesh-list
65495336|NCT04778982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65495337|NCT04778982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495338|NCT04778982|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65495339|NCT04778982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65495340|NCT04778982|Hormone Antagonists|hormone antagonists|mesh-ancestor
65495341|NCT04778982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65495342|NCT04778982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495343|NCT04778982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65495344|NCT04778982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796936|NCT02932826|Insulin|insulin|mesh-list
65495345|NCT04778982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495346|NCT01250886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65495347|NCT03632590|Magnesium Sulfate|magnesium sulfate|mesh-list
65495348|NCT03632590|Magnesium citrate|magnesium citrate|mesh-list
65495349|NCT03632590|Magnesium Oxide|magnesium oxide|mesh-list
65495350|NCT03632590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495351|NCT03632590|Analgesics|analgesics|mesh-ancestor
65495352|NCT03632590|Sensory System Agents|sensory system agents|mesh-ancestor
65495353|NCT03632590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65495354|NCT03632590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495355|NCT03632590|Anesthetics|anesthetics|mesh-ancestor
65495356|NCT03632590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65495357|NCT03632590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65495358|NCT03632590|Anticonvulsants|anticonvulsants|mesh-ancestor
65495359|NCT03632590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65495360|NCT03632590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65495361|NCT03632590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65495362|NCT03632590|Tocolytic Agents|tocolytic agents|mesh-ancestor
65495363|NCT03632590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65495364|NCT03632590|Cathartics|cathartics|mesh-ancestor
65495365|NCT03632590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65495366|NCT03632590|Antacids|antacids|mesh-ancestor
65495367|NCT05376670|Gentamicins|gentamicins|mesh-list
65495368|NCT05376670|Tobramycin|tobramycin|mesh-list
65495369|NCT05376670|Amikacin|amikacin|mesh-list
65495370|NCT05376670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65495371|NCT05376670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65495372|NCT05376670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65495373|NCT05376670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495374|NCT05376670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796938|NCT02932826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796939|NCT02860000|Fulvestrant|fulvestrant|mesh-list
65495375|NCT01242774|Panobinostat|panobinostat|mesh-list
65495376|NCT01242774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495377|NCT01242774|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65495378|NCT01242774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495379|NCT01242774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495380|NCT01243086|Dexamethasone|dexamethasone|mesh-list
65495381|NCT01243086|Ranibizumab|ranibizumab|mesh-list
65495382|NCT01243086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65495383|NCT01243086|Antiemetics|antiemetics|mesh-ancestor
65495384|NCT01243086|Autonomic Agents|autonomic agents|mesh-ancestor
65495385|NCT01243086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65495386|NCT01243086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495387|NCT01243086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65495388|NCT01243086|Glucocorticoids|glucocorticoids|mesh-ancestor
65495389|NCT01243086|Hormones|hormones|mesh-ancestor
65495390|NCT01243086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65495391|NCT01243086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65495392|NCT01243086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495393|NCT01243086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65495394|NCT01243086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65495395|NCT01243086|Growth Substances|growth substances|mesh-ancestor
65495396|NCT01243086|Growth Inhibitors|growth inhibitors|mesh-ancestor
65495397|NCT03908814|Antibodies|antibodies|mesh-list
65495398|NCT03908814|Immunologic Factors|immunologic factors|mesh-ancestor
65495399|NCT03908814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495400|NCT01253382|Ecallantide|ecallantide|mesh-list
65495401|NCT01253382|Analgesics|analgesics|mesh-ancestor
65495402|NCT01253382|Sensory System Agents|sensory system agents|mesh-ancestor
65495403|NCT01253382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65495404|NCT01253382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495405|NCT01253382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65495406|NCT01253382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65495407|NCT01253382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65495408|NCT01253382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65495409|NCT01148160|Voriconazole|voriconazole|mesh-list
65495410|NCT01148160|Antifungal Agents|antifungal agents|mesh-ancestor
65495411|NCT01148160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65495412|NCT01148160|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65495413|NCT01148160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65495414|NCT01148160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495415|NCT01148160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495416|NCT01148160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65495417|NCT01148160|Hormone Antagonists|hormone antagonists|mesh-ancestor
65495418|NCT01148160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65495419|NCT01148160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495420|NCT01148160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65495421|NCT01147692|Simvastatin|simvastatin|mesh-list
65495422|NCT01147692|rGLP-1 protein|rglp-1 protein|mesh-list
65495423|NCT01147692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65495424|NCT01147692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65495425|NCT01147692|Antimetabolites|antimetabolites|mesh-ancestor
65495426|NCT01147692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495427|NCT01147692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65495428|NCT01147692|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65495429|NCT01147692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495430|NCT01147692|Incretins|incretins|mesh-ancestor
65495431|NCT01147692|Hormones|hormones|mesh-ancestor
65495432|NCT01147692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65495433|NCT01147692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495434|NCT03913182|Apatinib|apatinib|mesh-list
65495435|NCT03913182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495436|NCT03913182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65495437|NCT03913182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495438|NCT03913182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495439|NCT02780310|Lenvatinib|lenvatinib|mesh-list
65495440|NCT02780310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495441|NCT02780310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65495442|NCT02780310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495443|NCT02780310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495444|NCT02713386|Paclitaxel|paclitaxel|mesh-list
65495445|NCT02713386|Carboplatin|carboplatin|mesh-list
65495446|NCT02713386|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65495447|NCT02713386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65495448|NCT02713386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495449|NCT02713386|Tubulin Modulators|tubulin modulators|mesh-ancestor
65495450|NCT02713386|Antimitotic Agents|antimitotic agents|mesh-ancestor
65495451|NCT02713386|Mitosis Modulators|mitosis modulators|mesh-ancestor
65495452|NCT02713386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495453|NCT02671890|Gemcitabine|gemcitabine|mesh-list
65495454|NCT02671890|Disulfiram|disulfiram|mesh-list
65495455|NCT02671890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65495456|NCT02671890|Antimetabolites|antimetabolites|mesh-ancestor
65495457|NCT02671890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495458|NCT02671890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495459|NCT02671890|Antiviral Agents|antiviral agents|mesh-ancestor
65495460|NCT02671890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65495461|NCT02671890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495462|NCT02671890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65495463|NCT02671890|Immunologic Factors|immunologic factors|mesh-ancestor
65495464|NCT02671890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495465|NCT02671890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65495466|NCT02671890|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65495467|NCT02344680|Anti-HIV Agents|anti-hiv agents|mesh-list
64473459|NCT01469013|Methotrexate|methotrexate|mesh-list
65495468|NCT02344680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65495469|NCT02344680|Antiviral Agents|antiviral agents|mesh-ancestor
65495470|NCT02344680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65495471|NCT02287428|Pembrolizumab|pembrolizumab|mesh-list
65495472|NCT02287428|Temozolomide|temozolomide|mesh-list
65495473|NCT02287428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65495474|NCT02287428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495475|NCT02287428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65495476|NCT02287428|Alkylating Agents|alkylating agents|mesh-ancestor
65495477|NCT02287428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495479|NCT01967238|Immunologic Factors|immunologic factors|mesh-ancestor
65495480|NCT01967238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495481|NCT05616000|Folic Acid|folic acid|mesh-list
65495482|NCT05616000|Acetylcarnitine|acetylcarnitine|mesh-list
65495483|NCT05616000|Hematinics|hematinics|mesh-ancestor
65495484|NCT05616000|Vitamin B Complex|vitamin b complex|mesh-ancestor
65495485|NCT05616000|Vitamins|vitamins|mesh-ancestor
65495486|NCT05616000|Micronutrients|micronutrients|mesh-ancestor
65495487|NCT05616000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495488|NCT05616000|Nootropic Agents|nootropic agents|mesh-ancestor
65495489|NCT00999804|Trastuzumab|trastuzumab|mesh-list
65495490|NCT00999804|Letrozole|letrozole|mesh-list
65495491|NCT00999804|Lapatinib|lapatinib|mesh-list
65495492|NCT00999804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65495493|NCT00999804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495494|NCT00999804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65495495|NCT00999804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65495496|NCT00999804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495497|NCT00999804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495498|NCT00999804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65495499|NCT00999804|Hormone Antagonists|hormone antagonists|mesh-ancestor
65495500|NCT00999804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65495501|NCT00999804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495502|NCT00999804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65495503|NCT03912402|Paclitaxel|paclitaxel|mesh-list
65495504|NCT03912402|Bevacizumab|bevacizumab|mesh-list
65495505|NCT03912402|Carboplatin|carboplatin|mesh-list
65495506|NCT03912402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65495507|NCT03912402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495508|NCT03912402|Tubulin Modulators|tubulin modulators|mesh-ancestor
65495509|NCT03912402|Antimitotic Agents|antimitotic agents|mesh-ancestor
65495510|NCT03912402|Mitosis Modulators|mitosis modulators|mesh-ancestor
65495511|NCT03912402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495512|NCT03912402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65495513|NCT03912402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65495514|NCT03912402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65495515|NCT03912402|Growth Substances|growth substances|mesh-ancestor
65495516|NCT03912402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495517|NCT03912402|Growth Inhibitors|growth inhibitors|mesh-ancestor
65495518|NCT01147770|Progesterone|progesterone|mesh-list
65495519|NCT01147770|Progestins|progestins|mesh-ancestor
65495520|NCT01147770|Hormones|hormones|mesh-ancestor
65495521|NCT01147770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65495522|NCT01147770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495523|NCT01148316|Fluoxetine|fluoxetine|mesh-list
65495524|NCT01148316|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65495525|NCT01148316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65495526|NCT01148316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65495527|NCT01148316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797090|NCT02579161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495528|NCT01148316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65495529|NCT01148316|Serotonin Agents|serotonin agents|mesh-ancestor
65495530|NCT01148316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495531|NCT01148316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65495532|NCT01148316|Antidepressive Agents|antidepressive agents|mesh-ancestor
65495533|NCT01148316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65495534|NCT01148316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65495535|NCT01148316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65495536|NCT01148316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495537|NCT01249638|Bevacizumab|bevacizumab|mesh-list
65495538|NCT01249638|Capecitabine|capecitabine|mesh-list
65495539|NCT01249638|Irinotecan|irinotecan|mesh-list
65495540|NCT01249638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65495541|NCT01249638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64473525|NCT01609478|Mometasone Furoate|mometasone furoate|mesh-list
65495542|NCT01249638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65495543|NCT01249638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65495544|NCT01249638|Growth Substances|growth substances|mesh-ancestor
65495545|NCT01249638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495546|NCT01249638|Growth Inhibitors|growth inhibitors|mesh-ancestor
65495547|NCT01249638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65495548|NCT01249638|Antimetabolites|antimetabolites|mesh-ancestor
65495549|NCT01249638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495550|NCT01249638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65495551|NCT01249638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65495552|NCT01249638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495553|NCT03907098|Endostar protein|endostar protein|mesh-list
65495554|NCT03907098|Endostatins|endostatins|mesh-list
65495555|NCT03907098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65495556|NCT03907098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65495557|NCT03907098|Growth Substances|growth substances|mesh-ancestor
65495558|NCT03907098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495559|NCT03907098|Growth Inhibitors|growth inhibitors|mesh-ancestor
65495560|NCT03907098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495561|NCT01251822|Prucalopride|prucalopride|mesh-list
65495562|NCT01251822|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65495563|NCT01251822|Laxatives|laxatives|mesh-ancestor
65495564|NCT01251822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65495565|NCT01251822|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65495566|NCT01251822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65495567|NCT01251822|Serotonin Agents|serotonin agents|mesh-ancestor
65495568|NCT01251822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65495569|NCT01251822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495570|NCT01251822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495571|NCT01253694|Ranibizumab|ranibizumab|mesh-list
65495572|NCT01253694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65495573|NCT01253694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65495574|NCT01253694|Growth Substances|growth substances|mesh-ancestor
65495575|NCT01253694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495576|NCT01253694|Growth Inhibitors|growth inhibitors|mesh-ancestor
65495577|NCT01253694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495578|NCT01148004|Ritonavir|ritonavir|mesh-list
65495579|NCT01148004|Lopinavir|lopinavir|mesh-list
65495580|NCT01148004|Fenofibrate|fenofibrate|mesh-list
65495581|NCT01148004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65495582|NCT01148004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65495583|NCT01148004|Protease Inhibitors|protease inhibitors|mesh-ancestor
65495584|NCT01148004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495585|NCT01148004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495586|NCT01148004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65495587|NCT01148004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65495588|NCT01148004|Antiviral Agents|antiviral agents|mesh-ancestor
65495589|NCT01148004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65495590|NCT01148004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65495591|NCT01148004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65495592|NCT01148004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65495593|NCT01148004|Antimetabolites|antimetabolites|mesh-ancestor
65495594|NCT01148004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65495595|NCT01252056|Cilostazol|cilostazol|mesh-list
65495596|NCT01252056|Probucol|probucol|mesh-list
65495597|NCT01252056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65495598|NCT01252056|Autonomic Agents|autonomic agents|mesh-ancestor
65495599|NCT01252056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65495600|NCT01252056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495601|NCT01252056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65495602|NCT01252056|Respiratory System Agents|respiratory system agents|mesh-ancestor
65495603|NCT01252056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65495604|NCT01252056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65495605|NCT01252056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495606|NCT01252056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65495607|NCT01252056|Vasodilator Agents|vasodilator agents|mesh-ancestor
65495608|NCT01252056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65495609|NCT01252056|Protective Agents|protective agents|mesh-ancestor
65495610|NCT01252056|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65495611|NCT01252056|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65495612|NCT01252056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495613|NCT01252056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65495614|NCT01252056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65495615|NCT01252056|Antimetabolites|antimetabolites|mesh-ancestor
65068252|NCT00416897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65068253|NCT00416897|Glucocorticoids|glucocorticoids|mesh-ancestor
65068254|NCT00416897|Hormones|hormones|mesh-ancestor
65495616|NCT01252056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65495617|NCT01252056|Antioxidants|antioxidants|mesh-ancestor
65495618|NCT02528448|Plasma-lyte 148|plasma-lyte 148|mesh-list
65495619|NCT02528448|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65495620|NCT02528448|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65495621|NCT01148472|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65495622|NCT01148472|Citalopram|citalopram|mesh-list
65495623|NCT01148472|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65495624|NCT01148472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65495625|NCT01148472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65495626|NCT01148472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495627|NCT01148472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65495628|NCT01148472|Serotonin Agents|serotonin agents|mesh-ancestor
65495629|NCT01148472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495630|NCT01148472|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65495631|NCT01148472|Antidepressive Agents|antidepressive agents|mesh-ancestor
65495632|NCT01148472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65495633|NCT01148472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65495634|NCT01148472|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65495635|NCT01148472|Analgesics|analgesics|mesh-ancestor
65495636|NCT01148472|Sensory System Agents|sensory system agents|mesh-ancestor
65495637|NCT01148472|Dopamine Agents|dopamine agents|mesh-ancestor
65495638|NCT01147146|Fentanyl|fentanyl|mesh-list
65495639|NCT01147146|Midazolam|midazolam|mesh-list
65495640|NCT01147146|Bupivacaine|bupivacaine|mesh-list
65495641|NCT01147146|Propofol|propofol|mesh-list
65495642|NCT01147146|Atracurium|atracurium|mesh-list
65495643|NCT01147146|Anesthetics, Local|anesthetics, local|mesh-ancestor
65495644|NCT01147146|Anesthetics|anesthetics|mesh-ancestor
65495645|NCT01147146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65495646|NCT01147146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495647|NCT01147146|Sensory System Agents|sensory system agents|mesh-ancestor
65495648|NCT01147146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65495649|NCT01147146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65495650|NCT01147146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65495651|NCT01147146|Anesthetics, General|anesthetics, general|mesh-ancestor
65495652|NCT01147146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65495653|NCT01147146|Narcotics|narcotics|mesh-ancestor
65495654|NCT01147146|Analgesics|analgesics|mesh-ancestor
65495655|NCT01147146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65495656|NCT01147146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65495657|NCT01147146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65495658|NCT01147146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65495659|NCT01147146|GABA Modulators|gaba modulators|mesh-ancestor
65495660|NCT01147146|GABA Agents|gaba agents|mesh-ancestor
65495661|NCT01147146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65495662|NCT01147146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495663|NCT01147146|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65495664|NCT01147146|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65495665|NCT01147146|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65495666|NCT01147146|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65495667|NCT01147146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65495668|NCT01147146|Cholinergic Agents|cholinergic agents|mesh-ancestor
65495669|NCT01250340|Aspirin|aspirin|mesh-list
65495670|NCT01250340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65495671|NCT01250340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65495672|NCT01250340|Analgesics|analgesics|mesh-ancestor
65495673|NCT01250340|Sensory System Agents|sensory system agents|mesh-ancestor
65495674|NCT01250340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65495675|NCT01250340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495676|NCT01250340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65495677|NCT01250340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65495678|NCT01250340|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65495679|NCT01250340|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65495680|NCT01250340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495681|NCT01250340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65495682|NCT01250340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65495683|NCT01250340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495684|NCT01250340|Antipyretics|antipyretics|mesh-ancestor
65495685|NCT03915132|Nimotuzumab|nimotuzumab|mesh-list
64473678|NCT01788566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495686|NCT03915132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65495687|NCT03915132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495688|NCT01250652|Cetirizine|cetirizine|mesh-list
65068255|NCT00416897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65495689|NCT01250652|Hydroxyzine|hydroxyzine|mesh-list
65495690|NCT01250652|Levocetirizine|levocetirizine|mesh-list
65495691|NCT01250652|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65495692|NCT01250652|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65495693|NCT01250652|Histamine Antagonists|histamine antagonists|mesh-ancestor
65495694|NCT01250652|Histamine Agents|histamine agents|mesh-ancestor
65495695|NCT01250652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65495696|NCT01250652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495697|NCT01250652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495698|NCT01250652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65495699|NCT01250652|Antipruritics|antipruritics|mesh-ancestor
65495700|NCT01250652|Dermatologic Agents|dermatologic agents|mesh-ancestor
65495701|NCT01253928|Pioglitazone|pioglitazone|mesh-list
65495702|NCT01253928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65495703|NCT01253928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495704|NCT01252524|Calcium polycarbophil|calcium polycarbophil|mesh-list
65495705|NCT01252524|Psyllium|psyllium|mesh-list
65495706|NCT01252524|Calcium|calcium|mesh-list
65495707|NCT01252524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65495708|NCT01252524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495709|NCT01252524|Antidiarrheals|antidiarrheals|mesh-ancestor
65495710|NCT01252524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65495711|NCT01252524|Cathartics|cathartics|mesh-ancestor
65495712|NCT03914352|Antibodies|antibodies|mesh-list
65495713|NCT03914352|Immunologic Factors|immunologic factors|mesh-ancestor
65495714|NCT03914352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495715|NCT01254006|Thiamine|thiamine|mesh-list
65495716|NCT01254006|Vitamins|vitamins|mesh-ancestor
65495717|NCT01254006|Micronutrients|micronutrients|mesh-ancestor
65495718|NCT01254006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495719|NCT01254006|Vitamin B Complex|vitamin b complex|mesh-ancestor
65495720|NCT03914118|Modafinil|modafinil|mesh-list
65495721|NCT03914118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65495722|NCT03914118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495723|NCT03914118|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65495724|NCT03914118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65495725|NCT03914118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65495726|NCT03914118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495727|NCT02528136|Oxytocin|oxytocin|mesh-list
65495728|NCT02528136|Carbetocin|carbetocin|mesh-list
65495729|NCT02528136|Oxytocics|oxytocics|mesh-ancestor
65495730|NCT02528136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65495731|NCT02528136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495732|NCT01252680|Vaccines|vaccines|mesh-list
65495733|NCT01252680|Immunologic Factors|immunologic factors|mesh-ancestor
65495734|NCT01252680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495735|NCT01252758|Albuterol|albuterol|mesh-list
65495736|NCT01252758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65495737|NCT01252758|Autonomic Agents|autonomic agents|mesh-ancestor
65495738|NCT01252758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65495739|NCT01252758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495740|NCT01252758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65495741|NCT01252758|Respiratory System Agents|respiratory system agents|mesh-ancestor
65495742|NCT01252758|Tocolytic Agents|tocolytic agents|mesh-ancestor
65495743|NCT01252758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65495744|NCT01252758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65495745|NCT01252758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65495746|NCT01252758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65495747|NCT01252758|Adrenergic Agents|adrenergic agents|mesh-ancestor
65495748|NCT01252758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65495749|NCT01252758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495750|NCT03913884|Mitogens|mitogens|mesh-list
65495751|NCT03913884|Mitosis Modulators|mitosis modulators|mesh-ancestor
65495752|NCT03913884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495753|NCT01147224|Ciclesonide|ciclesonide|mesh-list
65495754|NCT01147224|Glucocorticoids|glucocorticoids|mesh-ancestor
65495755|NCT01147224|Hormones|hormones|mesh-ancestor
65495756|NCT01147224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65495757|NCT01147224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495758|NCT01147224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65495759|NCT03913650|Bupivacaine|bupivacaine|mesh-list
65495760|NCT03913650|Anesthetics, Local|anesthetics, local|mesh-ancestor
65495761|NCT03913650|Anesthetics|anesthetics|mesh-ancestor
65495762|NCT03913650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64473755|NCT01898728|Trace Elements|trace elements|mesh-ancestor
65068256|NCT00416897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65068257|NCT00416897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495763|NCT03913650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495764|NCT03913650|Sensory System Agents|sensory system agents|mesh-ancestor
65495765|NCT03913650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65495766|NCT02874742|Dexamethasone|dexamethasone|mesh-list
65495767|NCT02874742|Lenalidomide|lenalidomide|mesh-list
65495768|NCT02874742|Bortezomib|bortezomib|mesh-list
65495769|NCT02874742|Daratumumab|daratumumab|mesh-list
65495770|NCT02874742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65495771|NCT02874742|Antiemetics|antiemetics|mesh-ancestor
65495772|NCT02874742|Autonomic Agents|autonomic agents|mesh-ancestor
65495773|NCT02874742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65495774|NCT02874742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495775|NCT02874742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65495776|NCT02874742|Glucocorticoids|glucocorticoids|mesh-ancestor
65495777|NCT02874742|Hormones|hormones|mesh-ancestor
65495778|NCT02874742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65495779|NCT02874742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65495780|NCT02874742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495781|NCT02874742|Immunologic Factors|immunologic factors|mesh-ancestor
65495782|NCT02874742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65495783|NCT02874742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65495784|NCT02874742|Growth Substances|growth substances|mesh-ancestor
65495785|NCT02874742|Growth Inhibitors|growth inhibitors|mesh-ancestor
65495786|NCT01149174|Mitomycins|mitomycins|mesh-list
65495787|NCT01149174|Mitomycin|mitomycin|mesh-list
65495788|NCT01149174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65495789|NCT01149174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495790|NCT01149174|Alkylating Agents|alkylating agents|mesh-ancestor
65495791|NCT01149174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495792|NCT01149174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65495793|NCT01149174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495794|NCT04353778|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
65495795|NCT04353778|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65495796|NCT04353778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495797|NCT04353778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495798|NCT04353778|Cholinergic Agents|cholinergic agents|mesh-ancestor
65495799|NCT04353778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65495800|NCT04353778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495801|NCT01148628|Everolimus|everolimus|mesh-list
65495802|NCT01148628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495803|NCT01148628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65495804|NCT01148628|Immunologic Factors|immunologic factors|mesh-ancestor
65495805|NCT01148628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495806|NCT01254708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65495807|NCT01254708|Antifungal Agents|antifungal agents|mesh-ancestor
65495808|NCT01254708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65495809|NCT01254708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65495810|NCT01254708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65495811|NCT03909594|Ketamine|ketamine|mesh-list
65495812|NCT03909594|Bupivacaine|bupivacaine|mesh-list
65495813|NCT03909594|Anesthetics, Local|anesthetics, local|mesh-ancestor
65495814|NCT03909594|Anesthetics|anesthetics|mesh-ancestor
65495815|NCT03909594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65495816|NCT03909594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495817|NCT03909594|Sensory System Agents|sensory system agents|mesh-ancestor
65495818|NCT03909594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65495819|NCT03909594|Analgesics|analgesics|mesh-ancestor
65495820|NCT03909594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65495821|NCT03909594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65495822|NCT03909594|Anesthetics, General|anesthetics, general|mesh-ancestor
65495823|NCT03909594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65495824|NCT03909594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65495825|NCT03909594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65495826|NCT03909594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495827|NCT04492072|Misoprostol|misoprostol|mesh-list
65495828|NCT04492072|Oxytocin|oxytocin|mesh-list
65495829|NCT04492072|Oxytocics|oxytocics|mesh-ancestor
65495830|NCT04492072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65495831|NCT04492072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495832|NCT04492072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65068258|NCT00417014|Prednisolone|prednisolone|mesh-list
65495833|NCT04492072|Abortifacient Agents|abortifacient agents|mesh-ancestor
64797699|NCT01386567|Androgens|androgens|mesh-ancestor
65495834|NCT04492072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65495835|NCT04492072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65495837|NCT04181008|Diuretics|diuretics|mesh-ancestor
65495838|NCT04181008|Natriuretic Agents|natriuretic agents|mesh-ancestor
65495839|NCT04181008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495840|NCT04181008|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65495841|NCT04181008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65495842|NCT04181008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65495843|NCT04181008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495844|NCT04181008|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65495845|NCT04181008|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65495846|NCT04421248|Methylphenidate|methylphenidate|mesh-list
65495847|NCT04421248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65495848|NCT04421248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495849|NCT04421248|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65495850|NCT04421248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65495851|NCT04421248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65495852|NCT04421248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495853|NCT04421248|Dopamine Agents|dopamine agents|mesh-ancestor
65495854|NCT04421248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65495855|NCT04160494|Atezolizumab|atezolizumab|mesh-list
65495856|NCT04160494|Immunoconjugates|immunoconjugates|mesh-list
65495857|NCT04160494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495858|NCT04160494|Immunologic Factors|immunologic factors|mesh-ancestor
65495859|NCT04160494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495860|NCT03629340|Metformin|metformin|mesh-list
65495861|NCT03629340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65495862|NCT03629340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495863|NCT03904836|Tobramycin|tobramycin|mesh-list
65495864|NCT03904836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65495865|NCT03904836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65495866|NCT03908580|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65495867|NCT03908580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65495868|NCT03908580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65495869|NCT03908580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495870|NCT03908580|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65495871|NCT03908580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65495872|NCT03908580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495873|NCT03908580|Cholinergic Agents|cholinergic agents|mesh-ancestor
65495874|NCT03908580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65495875|NCT03904680|Vitamin D|vitamin d|mesh-list
65495876|NCT03904680|Methotrexate|methotrexate|mesh-list
65495877|NCT03904680|Vitamins|vitamins|mesh-ancestor
65495878|NCT03904680|Micronutrients|micronutrients|mesh-ancestor
65495879|NCT03904680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495880|NCT03904680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65495881|NCT03904680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65495882|NCT03904680|Abortifacient Agents|abortifacient agents|mesh-ancestor
65495883|NCT03904680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65495884|NCT03904680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65495885|NCT03904680|Antimetabolites|antimetabolites|mesh-ancestor
65495886|NCT03904680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495887|NCT03904680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495888|NCT03904680|Dermatologic Agents|dermatologic agents|mesh-ancestor
65495889|NCT03904680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495890|NCT03904680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65495891|NCT03904680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65495892|NCT03904680|Immunologic Factors|immunologic factors|mesh-ancestor
65495893|NCT03904680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65495894|NCT03904680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65495895|NCT01150266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65495896|NCT01150266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65495897|NCT01150266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65495898|NCT01150266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495899|NCT04415944|Carboplatin|carboplatin|mesh-list
65495900|NCT04415944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495901|NCT01256268|Paclitaxel|paclitaxel|mesh-list
65495902|NCT01256268|Carboplatin|carboplatin|mesh-list
65495903|NCT01256268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65495904|NCT01256268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495905|NCT01256268|Tubulin Modulators|tubulin modulators|mesh-ancestor
65068259|NCT00417014|Vinblastine|vinblastine|mesh-list
65068260|NCT00417014|Procarbazine|procarbazine|mesh-list
65495906|NCT01256268|Antimitotic Agents|antimitotic agents|mesh-ancestor
65068261|NCT00417014|Chlorambucil|chlorambucil|mesh-list
65068262|NCT00417014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65495908|NCT01256268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495909|NCT03902106|Albuterol|albuterol|mesh-list
65495910|NCT03902106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65495911|NCT03902106|Autonomic Agents|autonomic agents|mesh-ancestor
65495912|NCT03902106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65495913|NCT03902106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495914|NCT03902106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65495915|NCT03902106|Respiratory System Agents|respiratory system agents|mesh-ancestor
65495916|NCT03902106|Tocolytic Agents|tocolytic agents|mesh-ancestor
65495917|NCT03902106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65495918|NCT03902106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65495919|NCT03902106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65495920|NCT03902106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65495921|NCT03902106|Adrenergic Agents|adrenergic agents|mesh-ancestor
65495922|NCT03902106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65495923|NCT03902106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495924|NCT03902340|Analgesics|analgesics|mesh-list
65495925|NCT03902340|Sensory System Agents|sensory system agents|mesh-ancestor
65495926|NCT03902340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65495927|NCT03902340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495928|NCT05285566|Lidocaine|lidocaine|mesh-list
65495929|NCT05285566|Bupivacaine|bupivacaine|mesh-list
65495930|NCT05285566|Anesthetics, Local|anesthetics, local|mesh-ancestor
65495931|NCT05285566|Anesthetics|anesthetics|mesh-ancestor
65495932|NCT05285566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65495933|NCT05285566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495934|NCT05285566|Sensory System Agents|sensory system agents|mesh-ancestor
65495935|NCT05285566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65495936|NCT05285566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65495937|NCT05285566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65495938|NCT05285566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65495939|NCT05285566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65495940|NCT05285566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495941|NCT01149330|Adapalene|adapalene|mesh-list
65495942|NCT01149330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65495943|NCT01149330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65495944|NCT01149330|Analgesics|analgesics|mesh-ancestor
65495945|NCT01149330|Sensory System Agents|sensory system agents|mesh-ancestor
65495946|NCT01149330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65495947|NCT01149330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495948|NCT01149330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65495949|NCT01149330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65495950|NCT01149330|Dermatologic Agents|dermatologic agents|mesh-ancestor
65495951|NCT03984214|Dronabinol|dronabinol|mesh-list
65495952|NCT03984214|Hallucinogens|hallucinogens|mesh-ancestor
65495953|NCT03984214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495954|NCT03984214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65495955|NCT03984214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65495956|NCT03984214|Analgesics|analgesics|mesh-ancestor
65495957|NCT03984214|Sensory System Agents|sensory system agents|mesh-ancestor
65495958|NCT03984214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65495960|NCT03984214|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65495961|NCT03984214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65495962|NCT03984214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495964|NCT03984214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65495965|NCT01150344|Artemether|artemether|mesh-list
65495966|NCT01150344|Atovaquone|atovaquone|mesh-list
65495967|NCT01150344|Proguanil|proguanil|mesh-list
65495968|NCT01150344|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
65495969|NCT01150344|Antimalarials|antimalarials|mesh-ancestor
65495970|NCT01150344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65495971|NCT01150344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65495972|NCT01150344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65495973|NCT01150344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65495974|NCT01150344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495975|NCT01150344|Antimetabolites|antimetabolites|mesh-ancestor
65495976|NCT05125224|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65495977|NCT05125224|Calcium Channel Blockers|calcium channel blockers|mesh-list
65495978|NCT05125224|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
65495979|NCT05125224|Calcium|calcium|mesh-list
65495980|NCT05125224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65495981|NCT05125224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495982|NCT05125224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65495983|NCT05125224|Diuretics|diuretics|mesh-ancestor
65495984|NCT05125224|Natriuretic Agents|natriuretic agents|mesh-ancestor
65495985|NCT05125224|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65495986|NCT05125224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65495987|NCT05125224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65495988|NCT01256580|Dexamethasone|dexamethasone|mesh-list
65495989|NCT01256580|Bevacizumab|bevacizumab|mesh-list
65495990|NCT01256580|Verteporfin|verteporfin|mesh-list
65495991|NCT01256580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65495992|NCT01256580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65495993|NCT01256580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65495994|NCT01256580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65495995|NCT01256580|Growth Substances|growth substances|mesh-ancestor
65495996|NCT01256580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65495997|NCT01256580|Growth Inhibitors|growth inhibitors|mesh-ancestor
65495998|NCT01256580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65495999|NCT01256580|Antiemetics|antiemetics|mesh-ancestor
65496000|NCT01256580|Autonomic Agents|autonomic agents|mesh-ancestor
65496001|NCT01256580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496002|NCT01256580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65496003|NCT01256580|Glucocorticoids|glucocorticoids|mesh-ancestor
65496004|NCT01256580|Hormones|hormones|mesh-ancestor
65496005|NCT01256580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65496006|NCT01256580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65496007|NCT01256580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65496008|NCT01256580|Dermatologic Agents|dermatologic agents|mesh-ancestor
65496009|NCT03901716|Fentanyl|fentanyl|mesh-list
65496010|NCT03901716|Midazolam|midazolam|mesh-list
65496011|NCT03901716|Sufentanil|sufentanil|mesh-list
65496012|NCT03901716|Remifentanil|remifentanil|mesh-list
65496013|NCT03901716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65496014|NCT03901716|Narcotics|narcotics|mesh-ancestor
65496015|NCT03901716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65496016|NCT03901716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496017|NCT03901716|Analgesics|analgesics|mesh-ancestor
65496018|NCT03901716|Sensory System Agents|sensory system agents|mesh-ancestor
65496019|NCT03901716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496020|NCT03901716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65496021|NCT03901716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65496022|NCT03901716|Anesthetics, General|anesthetics, general|mesh-ancestor
65496023|NCT03901716|Anesthetics|anesthetics|mesh-ancestor
65496024|NCT03901716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65496025|NCT03901716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65496026|NCT03901716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65496027|NCT03901716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65496028|NCT03901716|GABA Modulators|gaba modulators|mesh-ancestor
65496029|NCT03901716|GABA Agents|gaba agents|mesh-ancestor
65496030|NCT03901716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65496031|NCT03901716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496032|NCT04113538|Aflibercept|aflibercept|mesh-list
65496033|NCT04113538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65496035|NCT04113538|Growth Substances|growth substances|mesh-ancestor
65496036|NCT04113538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496037|NCT04113538|Growth Inhibitors|growth inhibitors|mesh-ancestor
65496038|NCT04113538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496039|NCT03904368|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65496040|NCT03904368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65496041|NCT03904368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496042|NCT03922750|Insulin|insulin|mesh-list
65496043|NCT03922750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65496044|NCT03922750|Insulin Glargine|insulin glargine|mesh-list
65496045|NCT03922750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65496046|NCT03922750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496047|NCT03898128|Immunotoxins|immunotoxins|mesh-list
65496048|NCT03898128|Immunologic Factors|immunologic factors|mesh-ancestor
65496049|NCT03898128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496050|NCT01149408|Decitabine|decitabine|mesh-list
65068263|NCT00417014|Glucocorticoids|glucocorticoids|mesh-ancestor
65496051|NCT01149408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65068264|NCT00417014|Hormones|hormones|mesh-ancestor
65496052|NCT01149408|Antimetabolites|antimetabolites|mesh-ancestor
64474049|NCT00287872|Thalidomide|thalidomide|mesh-list
65496053|NCT01149408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64474119|NCT00291694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496055|NCT01149408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496056|NCT03631966|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65496057|NCT03631966|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65496058|NCT03631966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64552687|NCT04007393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65496059|NCT03631966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496060|NCT03631966|Cholinergic Agents|cholinergic agents|mesh-ancestor
65496061|NCT03631966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65496062|NCT03631966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496063|NCT01149018|Dronabinol|dronabinol|mesh-list
65496064|NCT01149018|Hallucinogens|hallucinogens|mesh-ancestor
65496065|NCT01149018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496066|NCT01149018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65496067|NCT01149018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65496068|NCT01149018|Analgesics|analgesics|mesh-ancestor
65496069|NCT01149018|Sensory System Agents|sensory system agents|mesh-ancestor
65496070|NCT01149018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496071|NCT01149018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65496072|NCT01149018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65496073|NCT01149018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65496074|NCT01149018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496075|NCT01149018|Hormones|hormones|mesh-ancestor
65496076|NCT01149018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65496077|NCT03904056|Ranibizumab|ranibizumab|mesh-list
65496078|NCT03904056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65496079|NCT03904056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65496080|NCT03904056|Growth Substances|growth substances|mesh-ancestor
65496081|NCT03904056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496082|NCT03904056|Growth Inhibitors|growth inhibitors|mesh-ancestor
65496083|NCT03904056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496084|NCT03897660|Vitamins|vitamins|mesh-list
65496085|NCT03897660|Vitamin K|vitamin k|mesh-list
65496086|NCT03897660|Vitamin K 2|vitamin k 2|mesh-list
65496087|NCT03897660|Micronutrients|micronutrients|mesh-ancestor
64798617|NCT01392014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65496088|NCT03897660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496089|NCT03897660|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65496090|NCT03897660|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65496091|NCT03897660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496092|NCT03897660|Hemostatics|hemostatics|mesh-ancestor
65496093|NCT03897660|Coagulants|coagulants|mesh-ancestor
65496094|NCT03901170|Letrozole|letrozole|mesh-list
65496095|NCT03901170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496096|NCT03901170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65496097|NCT03901170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65496098|NCT03901170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496099|NCT03901170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496100|NCT03901170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65496101|NCT03901170|Hormone Antagonists|hormone antagonists|mesh-ancestor
64415732|NCT05002127|Mitosis Modulators|mitosis modulators|mesh-ancestor
65496102|NCT03901170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65496103|NCT03901170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496104|NCT03900858|Isoniazid|isoniazid|mesh-list
65496105|NCT03900858|Rifapentine|rifapentine|mesh-list
65496106|NCT03900858|Rifampin|rifampin|mesh-list
65496107|NCT03900858|Antitubercular Agents|antitubercular agents|mesh-ancestor
65496108|NCT03900858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65496109|NCT03900858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65496110|NCT03900858|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65496111|NCT03900858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65496112|NCT03900858|Antimetabolites|antimetabolites|mesh-ancestor
65496113|NCT03900858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496114|NCT03900858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65496115|NCT03900858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65496116|NCT03900858|Leprostatic Agents|leprostatic agents|mesh-ancestor
65496117|NCT03900858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65496118|NCT03900858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496119|NCT03900858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65496120|NCT03900858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65496121|NCT03900858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65496122|NCT03900858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65496123|NCT03900858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65496124|NCT03900858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65496125|NCT01149564|Ibuprofen|ibuprofen|mesh-list
65068265|NCT00417014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64474194|NCT01791400|Serotonin Agents|serotonin agents|mesh-ancestor
65496126|NCT01149564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65496127|NCT01149564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65496128|NCT01149564|Analgesics|analgesics|mesh-ancestor
65496129|NCT01149564|Sensory System Agents|sensory system agents|mesh-ancestor
65496130|NCT01149564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496131|NCT01149564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496132|NCT01149564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65496133|NCT01149564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65496134|NCT01149564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65496135|NCT01149564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496136|NCT01149564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496137|NCT02527746|Cyclophosphamide|cyclophosphamide|mesh-list
65496138|NCT02527746|Epirubicin|epirubicin|mesh-list
65496139|NCT02527746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65496140|NCT02527746|Immunologic Factors|immunologic factors|mesh-ancestor
65496141|NCT02527746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496142|NCT02527746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65496143|NCT02527746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65496144|NCT02527746|Alkylating Agents|alkylating agents|mesh-ancestor
65496145|NCT02527746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496146|NCT02527746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496147|NCT02527746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65496148|NCT02527746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65496149|NCT02527746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65496150|NCT02527746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65496151|NCT02527746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496152|NCT01586286|Nifedipine|nifedipine|mesh-list
65496153|NCT01586286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65496154|NCT01586286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65496155|NCT01586286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496156|NCT01586286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65496157|NCT01586286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496158|NCT01586286|Vasodilator Agents|vasodilator agents|mesh-ancestor
65496159|NCT01586286|Tocolytic Agents|tocolytic agents|mesh-ancestor
65496160|NCT01586286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65496161|NCT01257048|Budesonide|budesonide|mesh-list
65496162|NCT01257048|Formoterol Fumarate|formoterol fumarate|mesh-list
65496163|NCT01257048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65496164|NCT01257048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65496165|NCT01257048|Autonomic Agents|autonomic agents|mesh-ancestor
65496166|NCT01257048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496167|NCT01257048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496168|NCT01257048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65496169|NCT01257048|Respiratory System Agents|respiratory system agents|mesh-ancestor
65496170|NCT01257048|Glucocorticoids|glucocorticoids|mesh-ancestor
65496172|NCT01257048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65496173|NCT01257048|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65496174|NCT01257048|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65496175|NCT01257048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65496176|NCT01257048|Adrenergic Agents|adrenergic agents|mesh-ancestor
65496177|NCT01257048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65496178|NCT01257048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496179|NCT01258296|Fentanyl|fentanyl|mesh-list
65496180|NCT01258296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65496181|NCT01258296|Narcotics|narcotics|mesh-ancestor
65496182|NCT01258296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65496183|NCT01258296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496184|NCT01258296|Analgesics|analgesics|mesh-ancestor
65496185|NCT01258296|Sensory System Agents|sensory system agents|mesh-ancestor
65496186|NCT01258296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496187|NCT01258296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65496188|NCT01258296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65496189|NCT01258296|Anesthetics, General|anesthetics, general|mesh-ancestor
65496190|NCT01258296|Anesthetics|anesthetics|mesh-ancestor
65496191|NCT01257126|Diclofenac|diclofenac|mesh-list
65496192|NCT01257126|Nimesulide|nimesulide|mesh-list
65496193|NCT01257126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65496194|NCT01257126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65496195|NCT01257126|Analgesics|analgesics|mesh-ancestor
65496196|NCT01257126|Sensory System Agents|sensory system agents|mesh-ancestor
65496197|NCT01257126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496198|NCT01257126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496199|NCT01257126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65496200|NCT01257126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65496201|NCT01257126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65496202|NCT01257126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496203|NCT01257126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496204|NCT02527824|Oxaliplatin|oxaliplatin|mesh-list
65496205|NCT02527824|Irinotecan|irinotecan|mesh-list
65496206|NCT02527824|Tegafur|tegafur|mesh-list
65496207|NCT02527824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496208|NCT02527824|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65496209|NCT02527824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65496210|NCT02527824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496211|NCT02527824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496212|NCT02527824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65496213|NCT02527824|Antimetabolites|antimetabolites|mesh-ancestor
65496214|NCT01586208|Phenytoin|phenytoin|mesh-list
65496215|NCT01586208|Valproic Acid|valproic acid|mesh-list
65496216|NCT01586208|Anticonvulsants|anticonvulsants|mesh-ancestor
65496217|NCT01586208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496218|NCT01586208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496219|NCT01586208|GABA Agents|gaba agents|mesh-ancestor
65496220|NCT01586208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65496221|NCT01586208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496222|NCT01586208|Antimanic Agents|antimanic agents|mesh-ancestor
65496223|NCT01586208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65496224|NCT01586208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65496225|NCT01586208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65496226|NCT01586208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65496227|NCT01586208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65496228|NCT01586208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65496229|NCT01586208|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65496230|NCT01586208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65496231|NCT03893526|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65496232|NCT03893526|Valsartan|valsartan|mesh-list
65496233|NCT03893526|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65496234|NCT03893526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65496235|NCT03893526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496236|NCT03893526|Incretins|incretins|mesh-ancestor
65496237|NCT03893526|Hormones|hormones|mesh-ancestor
65496238|NCT03893526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65496239|NCT03893526|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65496240|NCT03893526|Protease Inhibitors|protease inhibitors|mesh-ancestor
65496241|NCT03893526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496242|NCT03893526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496243|NCT03893526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65496244|NCT03893526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65496245|NCT03893526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65496246|NCT01149798|Cisplatin|cisplatin|mesh-list
65496247|NCT01149798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65496248|NCT01149798|Paclitaxel|paclitaxel|mesh-list
65496249|NCT01149798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496250|NCT01149798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65496251|NCT01149798|Tubulin Modulators|tubulin modulators|mesh-ancestor
65496252|NCT01149798|Antimitotic Agents|antimitotic agents|mesh-ancestor
65496253|NCT01149798|Mitosis Modulators|mitosis modulators|mesh-ancestor
65496254|NCT01149798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496255|NCT01257360|Panitumumab|panitumumab|mesh-list
65496256|NCT01257360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65496257|NCT01257360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496258|NCT01257516|Pregabalin|pregabalin|mesh-list
65496259|NCT01257516|Analgesics|analgesics|mesh-ancestor
65496260|NCT01257516|Sensory System Agents|sensory system agents|mesh-ancestor
65496261|NCT01257516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496262|NCT01257516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496263|NCT01257516|Anticonvulsants|anticonvulsants|mesh-ancestor
65496264|NCT01257516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65496265|NCT01257516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65068266|NCT00417014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068267|NCT00417014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65068268|NCT00417014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068269|NCT00417014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65068270|NCT00417014|Tubulin Modulators|tubulin modulators|mesh-ancestor
64474277|NCT00302848|Progestins|progestins|mesh-list
65496266|NCT01257516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496267|NCT01257516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65496268|NCT01257516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65496269|NCT01257516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65496270|NCT01257516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65496271|NCT01257516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65496272|NCT01257594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65496273|NCT01257594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496274|NCT01257594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65496275|NCT01257594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496276|NCT01257594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496278|NCT01149954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65496279|NCT01149954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65496280|NCT01149954|Analgesics|analgesics|mesh-ancestor
65496281|NCT01149954|Sensory System Agents|sensory system agents|mesh-ancestor
65496282|NCT01149954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496283|NCT01149954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496284|NCT01149954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65496285|NCT01149954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65496286|NCT01149954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65496287|NCT01149954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496288|NCT01149954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496289|NCT03899610|Durvalumab|durvalumab|mesh-list
65496290|NCT03899610|Tremelimumab|tremelimumab|mesh-list
65496291|NCT03899610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65496292|NCT03899610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496293|NCT02527668|Vitamin D|vitamin d|mesh-list
65496294|NCT02527668|Cholecalciferol|cholecalciferol|mesh-list
65496295|NCT02527668|Calcifediol|calcifediol|mesh-list
65496296|NCT02527668|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65496297|NCT02527668|Vitamins|vitamins|mesh-ancestor
65496298|NCT02527668|Micronutrients|micronutrients|mesh-ancestor
65496299|NCT02527668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496300|NCT02527668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65496301|NCT02527668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65496302|NCT03896646|Iminodiacetic acid|iminodiacetic acid|mesh-list
65496303|NCT03896646|Chelating Agents|chelating agents|mesh-ancestor
65496304|NCT03896646|Sequestering Agents|sequestering agents|mesh-ancestor
65496305|NCT03896646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496306|NCT03896256|Ketamine|ketamine|mesh-list
65496307|NCT03896256|Analgesics|analgesics|mesh-ancestor
65496308|NCT03896256|Sensory System Agents|sensory system agents|mesh-ancestor
65496309|NCT03896256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496310|NCT03896256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496311|NCT03896256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65496312|NCT03896256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65496313|NCT03896256|Anesthetics, General|anesthetics, general|mesh-ancestor
65496314|NCT03896256|Anesthetics|anesthetics|mesh-ancestor
65496315|NCT03896256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65496316|NCT03896256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65496317|NCT03896256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65496318|NCT03896256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65496319|NCT03896256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496320|NCT03893136|Leflunomide|leflunomide|mesh-list
65496321|NCT03893136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496322|NCT03893136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496323|NCT03893136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65496324|NCT03893136|Immunologic Factors|immunologic factors|mesh-ancestor
65496325|NCT03893136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496326|NCT01258530|Oseltamivir|oseltamivir|mesh-list
65496327|NCT01258530|Antiviral Agents|antiviral agents|mesh-ancestor
65496328|NCT01258530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65496329|NCT01258530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496330|NCT01258530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496331|NCT01255410|Vaccines|vaccines|mesh-list
65496332|NCT01255410|Immunologic Factors|immunologic factors|mesh-ancestor
65496333|NCT01255410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496334|NCT01150110|Salicylic Acid|salicylic acid|mesh-list
65496335|NCT01150110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65496336|NCT01150110|Antifungal Agents|antifungal agents|mesh-ancestor
65496337|NCT01150110|Keratolytic Agents|keratolytic agents|mesh-ancestor
65496338|NCT01150110|Dermatologic Agents|dermatologic agents|mesh-ancestor
65068271|NCT00417014|Antimitotic Agents|antimitotic agents|mesh-ancestor
65068272|NCT00417014|Mitosis Modulators|mitosis modulators|mesh-ancestor
65496339|NCT01257672|Ondansetron|ondansetron|mesh-list
65496340|NCT01257672|Domperidone|domperidone|mesh-list
65496341|NCT01257672|Antiemetics|antiemetics|mesh-ancestor
65496342|NCT01257672|Autonomic Agents|autonomic agents|mesh-ancestor
65496343|NCT01257672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64799177|NCT01394887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496344|NCT01257672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496345|NCT01257672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65496346|NCT01257672|Antipruritics|antipruritics|mesh-ancestor
65496347|NCT01257672|Dermatologic Agents|dermatologic agents|mesh-ancestor
65496348|NCT01257672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65496349|NCT01257672|Serotonin Agents|serotonin agents|mesh-ancestor
65496350|NCT01257672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65496351|NCT01257672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496352|NCT01257672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65496353|NCT01257672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65496354|NCT01257672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65496355|NCT01257672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65496356|NCT01257672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65496357|NCT01257672|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65496358|NCT01257672|Dopamine Agents|dopamine agents|mesh-ancestor
65496359|NCT01258686|Silymarin|silymarin|mesh-list
65496360|NCT01258686|Antioxidants|antioxidants|mesh-ancestor
65496361|NCT01258686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496362|NCT01258686|Protective Agents|protective agents|mesh-ancestor
65496363|NCT01258686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496364|NCT01258764|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65496365|NCT01258764|Lisinopril|lisinopril|mesh-list
65496366|NCT01258764|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65496367|NCT01258764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65496368|NCT01258764|Diuretics|diuretics|mesh-ancestor
65496369|NCT01258764|Natriuretic Agents|natriuretic agents|mesh-ancestor
65496370|NCT01258764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496371|NCT01258764|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65496372|NCT01258764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65496373|NCT01258764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496374|NCT01258764|Protease Inhibitors|protease inhibitors|mesh-ancestor
65496375|NCT01258764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496376|NCT01258764|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65496377|NCT01258764|Protective Agents|protective agents|mesh-ancestor
65496378|NCT03895788|Niraparib|niraparib|mesh-list
65496379|NCT03895788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65496380|NCT03895788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496381|NCT03895788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496382|NCT03895788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496383|NCT01257828|Riluzole|riluzole|mesh-list
65496384|NCT01257828|Anticonvulsants|anticonvulsants|mesh-ancestor
65496385|NCT01257828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65496386|NCT01257828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65496387|NCT01257828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65496388|NCT01257828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496389|NCT01257828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496390|NCT01257828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65496391|NCT01257828|Protective Agents|protective agents|mesh-ancestor
65496392|NCT03899142|Immunoglobulins|immunoglobulins|mesh-list
65496393|NCT03899142|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65496394|NCT03899142|Antibodies|antibodies|mesh-list
65496395|NCT03899142|Immunologic Factors|immunologic factors|mesh-ancestor
65496396|NCT03899142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496397|NCT03892902|Zopiclone|zopiclone|mesh-list
65496398|NCT03892902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65496399|NCT03892902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65496400|NCT03892902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496401|NCT03892668|Tranexamic Acid|tranexamic acid|mesh-list
65496402|NCT03892668|Oxytocin|oxytocin|mesh-list
65496403|NCT03892668|Oxytocics|oxytocics|mesh-ancestor
65496404|NCT03892668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65496405|NCT03892668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496406|NCT03892668|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65496407|NCT03892668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65496408|NCT03892668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496409|NCT03892668|Hemostatics|hemostatics|mesh-ancestor
65496410|NCT03892668|Coagulants|coagulants|mesh-ancestor
65496411|NCT01258920|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65496412|NCT01258920|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65496413|NCT01258920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65496414|NCT01258920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65496415|NCT01258920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496416|NCT01258920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65496417|NCT01258920|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65496418|NCT01258920|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65496419|NCT01258920|Serotonin Agents|serotonin agents|mesh-ancestor
65496420|NCT01258920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65496421|NCT01258920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496422|NCT01258920|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65496423|NCT01258920|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65496424|NCT01258920|Dopamine Agents|dopamine agents|mesh-ancestor
65496425|NCT03898752|Coenzyme Q10|coenzyme q10|mesh-list
65496427|NCT03898752|Micronutrients|micronutrients|mesh-ancestor
65496428|NCT03898752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496429|NCT01255644|Valganciclovir|valganciclovir|mesh-list
65496430|NCT01255644|Antiviral Agents|antiviral agents|mesh-ancestor
65496431|NCT01255644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65496432|NCT01255800|Cetuximab|cetuximab|mesh-list
65496433|NCT01255800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65496434|NCT01255800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496435|NCT01257906|Tretinoin|tretinoin|mesh-list
65496436|NCT01257906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496437|NCT01257906|Keratolytic Agents|keratolytic agents|mesh-ancestor
65496438|NCT01257906|Dermatologic Agents|dermatologic agents|mesh-ancestor
65496439|NCT03892512|Dexmedetomidine|dexmedetomidine|mesh-list
65496440|NCT03892512|Esmolol|esmolol|mesh-list
65496441|NCT03892512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65496442|NCT03892512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65496443|NCT03892512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496444|NCT03892512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65496445|NCT03892512|Analgesics|analgesics|mesh-ancestor
65496446|NCT03892512|Sensory System Agents|sensory system agents|mesh-ancestor
65496447|NCT03892512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496448|NCT03892512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65496449|NCT03892512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65496450|NCT03892512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65496451|NCT03892512|Adrenergic Agents|adrenergic agents|mesh-ancestor
65496452|NCT03892512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65496453|NCT03892512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496454|NCT03892512|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65496456|NCT03892512|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65496457|NCT01255878|Gabapentin|gabapentin|mesh-list
65496458|NCT01255878|Analgesics|analgesics|mesh-ancestor
65496459|NCT01255878|Sensory System Agents|sensory system agents|mesh-ancestor
65496460|NCT01255878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496461|NCT01255878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496462|NCT01255878|Anticonvulsants|anticonvulsants|mesh-ancestor
65496463|NCT01255878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65496464|NCT01255878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65496465|NCT01255878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65496466|NCT01255878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65496467|NCT01255878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65496468|NCT01255878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65496469|NCT01255878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65496470|NCT01255878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496471|NCT01255878|Antimanic Agents|antimanic agents|mesh-ancestor
65496472|NCT01255956|Sirolimus|sirolimus|mesh-list
65496473|NCT01255956|Paclitaxel|paclitaxel|mesh-list
65496474|NCT01255956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64799547|NCT01397006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65496475|NCT01255956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496476|NCT01255956|Tubulin Modulators|tubulin modulators|mesh-ancestor
65496477|NCT01255956|Antimitotic Agents|antimitotic agents|mesh-ancestor
65496478|NCT01255956|Mitosis Modulators|mitosis modulators|mesh-ancestor
65496479|NCT01255956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496480|NCT01255956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65496481|NCT01255956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65496482|NCT01255956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65496483|NCT01255956|Antifungal Agents|antifungal agents|mesh-ancestor
65496484|NCT01255956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65496485|NCT01255956|Immunologic Factors|immunologic factors|mesh-ancestor
65496486|NCT01255956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496487|NCT03892434|Dexamethasone|dexamethasone|mesh-list
64474489|NCT01755416|Hormones|hormones|mesh-ancestor
64474564|NCT00336700|Antimetabolites|antimetabolites|mesh-ancestor
65496488|NCT03892434|Dexamethasone acetate|dexamethasone acetate|mesh-list
65496489|NCT03892434|Bevacizumab|bevacizumab|mesh-list
65496490|NCT03892434|BB 1101|bb 1101|mesh-list
65496491|NCT03892434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65496492|NCT03892434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496493|NCT03892434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65496494|NCT03892434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65496495|NCT03892434|Growth Substances|growth substances|mesh-ancestor
65496496|NCT03892434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496497|NCT03892434|Growth Inhibitors|growth inhibitors|mesh-ancestor
65496498|NCT03892434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65496499|NCT03892434|Antiemetics|antiemetics|mesh-ancestor
65496500|NCT03892434|Autonomic Agents|autonomic agents|mesh-ancestor
65496501|NCT03892434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496502|NCT03892434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65496503|NCT03892434|Glucocorticoids|glucocorticoids|mesh-ancestor
65496504|NCT03892434|Hormones|hormones|mesh-ancestor
65496505|NCT03892434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65496506|NCT03892434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65496507|NCT03892434|Protease Inhibitors|protease inhibitors|mesh-ancestor
65496508|NCT03892434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496509|NCT03892434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496510|NCT03889626|Capecitabine|capecitabine|mesh-list
65496511|NCT03889626|Apatinib|apatinib|mesh-list
65496512|NCT03889626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64799615|NCT05268718|Voriconazole|voriconazole|mesh-list
65496513|NCT03889626|Antimetabolites|antimetabolites|mesh-ancestor
65496514|NCT03889626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496515|NCT03889626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496516|NCT03889626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65496517|NCT03889626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496518|NCT03892122|Dexmedetomidine|dexmedetomidine|mesh-list
65496519|NCT03892122|Propofol|propofol|mesh-list
65496520|NCT03892122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65496521|NCT03892122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65496522|NCT03892122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496523|NCT03892122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65496524|NCT03892122|Anesthetics, General|anesthetics, general|mesh-ancestor
65496526|NCT03892122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65496527|NCT03892122|Analgesics|analgesics|mesh-ancestor
65496528|NCT03892122|Sensory System Agents|sensory system agents|mesh-ancestor
65496529|NCT03892122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496530|NCT03892122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65496531|NCT03892122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65496532|NCT03892122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65496533|NCT03892122|Adrenergic Agents|adrenergic agents|mesh-ancestor
65496534|NCT03892122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65496535|NCT03892122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496536|NCT01589562|Megestrol|megestrol|mesh-list
65496537|NCT01589562|Megestrol Acetate|megestrol acetate|mesh-list
65496538|NCT01589562|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65496539|NCT01589562|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65496540|NCT01589562|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65496541|NCT01589562|Contraceptive Agents|contraceptive agents|mesh-ancestor
65496542|NCT01589562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65496543|NCT01589562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496544|NCT01589562|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65496545|NCT01589562|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65496546|NCT01589562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65496547|NCT01589562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496548|NCT01589562|Appetite Stimulants|appetite stimulants|mesh-ancestor
65496549|NCT01589562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65496550|NCT01152372|Insulin|insulin|mesh-list
65496551|NCT01152372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64799695|NCT04604353|Calcium|calcium|mesh-list
65496552|NCT01152372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496553|NCT01589640|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65496554|NCT01589640|Lubricant Eye Drops|lubricant eye drops|mesh-list
65496555|NCT01589640|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65496556|NCT01259934|Interferons|interferons|mesh-list
65496557|NCT01259934|Interferon-alpha|interferon-alpha|mesh-list
65496558|NCT01259934|Interferon alpha-2|interferon alpha-2|mesh-list
65496559|NCT01259934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496560|NCT01259934|Antiviral Agents|antiviral agents|mesh-ancestor
65496561|NCT01259934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65496562|NCT01259934|Immunologic Factors|immunologic factors|mesh-ancestor
65496563|NCT01259934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496565|NCT01153386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65496566|NCT01260012|Praziquantel|praziquantel|mesh-list
65496567|NCT01260012|Antioxidants|antioxidants|mesh-list
65496568|NCT01260012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496569|NCT01260012|Protective Agents|protective agents|mesh-ancestor
65496570|NCT01260012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496571|NCT01260012|Anthelmintics|anthelmintics|mesh-ancestor
65496572|NCT01260012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65496573|NCT01260012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65496574|NCT03888924|Vaccines|vaccines|mesh-list
65496575|NCT03888924|BCG Vaccine|bcg vaccine|mesh-list
65496576|NCT03888924|Immunologic Factors|immunologic factors|mesh-ancestor
65496577|NCT03888924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496578|NCT03888924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65496579|NCT01151592|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
65496580|NCT01151592|Hematinics|hematinics|mesh-ancestor
65496581|NCT01151670|Pioglitazone|pioglitazone|mesh-list
65496582|NCT01151670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65496583|NCT01151670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496584|NCT03888846|Colchicine|colchicine|mesh-list
65496585|NCT03888846|Pentoxifylline|pentoxifylline|mesh-list
65496586|NCT03888846|Gout Suppressants|gout suppressants|mesh-ancestor
65496587|NCT03888846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65496588|NCT03888846|Tubulin Modulators|tubulin modulators|mesh-ancestor
65496589|NCT03888846|Antimitotic Agents|antimitotic agents|mesh-ancestor
65496590|NCT03888846|Mitosis Modulators|mitosis modulators|mesh-ancestor
65496591|NCT03888846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496592|NCT03888846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496593|NCT03888846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65496594|NCT03888846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496595|NCT03888846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65496596|NCT03888846|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65496597|NCT03888846|Protective Agents|protective agents|mesh-ancestor
65496598|NCT03888846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496599|NCT03888846|Vasodilator Agents|vasodilator agents|mesh-ancestor
65496600|NCT03888846|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65496601|NCT03888846|Antioxidants|antioxidants|mesh-ancestor
65496602|NCT03891420|Galidesivir|galidesivir|mesh-list
65496603|NCT03891420|Antiviral Agents|antiviral agents|mesh-ancestor
65496604|NCT03891420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65496605|NCT01153542|Ivacaftor|ivacaftor|mesh-list
65496606|NCT01153542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65496607|NCT01153542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65496608|NCT01153542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496609|NCT01152606|Trastuzumab|trastuzumab|mesh-list
65496610|NCT01152606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65496611|NCT01152606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496612|NCT01153854|Racecadotril|racecadotril|mesh-list
65496613|NCT01153854|Antidiarrheals|antidiarrheals|mesh-ancestor
65496614|NCT01153854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65496615|NCT01153854|Protease Inhibitors|protease inhibitors|mesh-ancestor
65496616|NCT01153854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496617|NCT01153854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496618|NCT01260246|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65496619|NCT01260246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65496620|NCT01260246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496621|NCT01260246|Incretins|incretins|mesh-ancestor
65496622|NCT01260246|Hormones|hormones|mesh-ancestor
65496623|NCT01260246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65496624|NCT01260246|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65496625|NCT01260246|Protease Inhibitors|protease inhibitors|mesh-ancestor
65496626|NCT01260246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496627|NCT01260246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496628|NCT03888534|Ixazomib|ixazomib|mesh-list
65496629|NCT03888534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496630|NCT03888534|Protease Inhibitors|protease inhibitors|mesh-ancestor
65496631|NCT03888534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496632|NCT03888534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496633|NCT03885804|Dexmedetomidine|dexmedetomidine|mesh-list
65496634|NCT03885804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65496635|NCT03885804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65496636|NCT03885804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068273|NCT00417014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496637|NCT03885804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65496638|NCT03885804|Analgesics|analgesics|mesh-ancestor
65496639|NCT03885804|Sensory System Agents|sensory system agents|mesh-ancestor
65496640|NCT03885804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496641|NCT03885804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65496642|NCT03885804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65496643|NCT03885804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65496644|NCT03885804|Adrenergic Agents|adrenergic agents|mesh-ancestor
65496645|NCT03885804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65496646|NCT03885804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496647|NCT03885258|Melatonin|melatonin|mesh-list
65496648|NCT03885258|Antioxidants|antioxidants|mesh-ancestor
65496649|NCT03885258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496650|NCT03885258|Protective Agents|protective agents|mesh-ancestor
65496651|NCT03885258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496652|NCT03885258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65496653|NCT01262196|Chrysarobin|chrysarobin|mesh-list
65496654|NCT01262196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65496655|NCT01262196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65496656|NCT01262196|Analgesics|analgesics|mesh-ancestor
65496657|NCT01262196|Sensory System Agents|sensory system agents|mesh-ancestor
65496658|NCT01262196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496659|NCT01262196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496660|NCT01262196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65496661|NCT01262196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65496662|NCT03885180|Warfarin|warfarin|mesh-list
65496663|NCT03885180|Anticoagulants|anticoagulants|mesh-ancestor
65496664|NCT03888144|Ketorolac|ketorolac|mesh-list
65496665|NCT03888144|Oxycodone|oxycodone|mesh-list
65496666|NCT03888144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65496667|NCT03888144|Narcotics|narcotics|mesh-ancestor
65496668|NCT03888144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65496669|NCT03888144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496670|NCT03888144|Analgesics|analgesics|mesh-ancestor
65496671|NCT03888144|Sensory System Agents|sensory system agents|mesh-ancestor
65496672|NCT03888144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496673|NCT03888144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65496674|NCT03888144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65496675|NCT03888144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65496676|NCT03888144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65496677|NCT03888144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65496678|NCT03888144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496679|NCT03888144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496680|NCT03890406|Rocuronium|rocuronium|mesh-list
65496681|NCT03890406|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65496682|NCT03890406|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65496683|NCT03890406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65496684|NCT03890406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496685|NCT03890406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496686|NCT01154400|Caseins|caseins|mesh-list
65496687|NCT01154400|Chelating Agents|chelating agents|mesh-ancestor
65496688|NCT01154400|Sequestering Agents|sequestering agents|mesh-ancestor
65496689|NCT01154400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496690|NCT01152840|Everolimus|everolimus|mesh-list
65496691|NCT01152840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496692|NCT01152840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65496693|NCT01152840|Immunologic Factors|immunologic factors|mesh-ancestor
65496694|NCT01152840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496695|NCT01262274|Anastrozole|anastrozole|mesh-list
65496696|NCT01262274|Tegafur|tegafur|mesh-list
65496697|NCT01262274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65496698|NCT01262274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496699|NCT01262274|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65496700|NCT01262274|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65496701|NCT01262274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496702|NCT01262274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496703|NCT01262274|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65496704|NCT01262274|Hormone Antagonists|hormone antagonists|mesh-ancestor
65496705|NCT01262274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65496706|NCT01262274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496707|NCT01262274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65496708|NCT01262274|Antimetabolites|antimetabolites|mesh-ancestor
65496709|NCT01260558|Sirolimus|sirolimus|mesh-list
64553547|NCT00639769|Cisplatin|cisplatin|mesh-list
65496710|NCT01260558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65496711|NCT01260558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65496712|NCT01260558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65496713|NCT01260558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496714|NCT01260558|Antifungal Agents|antifungal agents|mesh-ancestor
65496715|NCT01260558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65496716|NCT01260558|Immunologic Factors|immunologic factors|mesh-ancestor
65496717|NCT01260558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496718|NCT01260714|Etoposide|etoposide|mesh-list
65496719|NCT01260714|Podophyllotoxin|podophyllotoxin|mesh-list
65496720|NCT01260714|Mitoxantrone|mitoxantrone|mesh-list
65496721|NCT01260714|Azacitidine|azacitidine|mesh-list
65496722|NCT01260714|Etoposide phosphate|etoposide phosphate|mesh-list
65496723|NCT01260714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65496724|NCT01260714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496725|NCT01260714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65496726|NCT01260714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65496727|NCT01260714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496728|NCT01260714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496729|NCT01260714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65496730|NCT01260714|Antimetabolites|antimetabolites|mesh-ancestor
65496731|NCT01260714|Analgesics|analgesics|mesh-ancestor
65496732|NCT01260714|Sensory System Agents|sensory system agents|mesh-ancestor
65496733|NCT01260714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496734|NCT01260714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496735|NCT01260714|Keratolytic Agents|keratolytic agents|mesh-ancestor
65496736|NCT01260714|Dermatologic Agents|dermatologic agents|mesh-ancestor
65496737|NCT01260714|Tubulin Modulators|tubulin modulators|mesh-ancestor
65496738|NCT01260714|Antimitotic Agents|antimitotic agents|mesh-ancestor
65496740|NCT03890094|Sufentanil|sufentanil|mesh-list
65496741|NCT03890094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65496742|NCT03890094|Narcotics|narcotics|mesh-ancestor
65496743|NCT03890094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65496744|NCT03890094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496745|NCT03890094|Analgesics|analgesics|mesh-ancestor
65496746|NCT03890094|Sensory System Agents|sensory system agents|mesh-ancestor
65496747|NCT03890094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496748|NCT03890094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65496749|NCT03890094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65496750|NCT03890094|Anesthetics, General|anesthetics, general|mesh-ancestor
65496751|NCT03890094|Anesthetics|anesthetics|mesh-ancestor
65496752|NCT03887754|Risperidone|risperidone|mesh-list
65496753|NCT03887754|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65496754|NCT03887754|Serotonin Agents|serotonin agents|mesh-ancestor
65496755|NCT03887754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65496756|NCT03887754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496757|NCT03887754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496758|NCT03887754|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65496759|NCT03887754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65496760|NCT03887754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65496761|NCT03887754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65496762|NCT03887754|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65496763|NCT03887754|Dopamine Agents|dopamine agents|mesh-ancestor
65496764|NCT03889470|Nitroglycerin|nitroglycerin|mesh-list
65496765|NCT03889470|Vasodilator Agents|vasodilator agents|mesh-ancestor
65496766|NCT01262586|Glimepiride|glimepiride|mesh-list
65496767|NCT01262586|Vildagliptin|vildagliptin|mesh-list
65496768|NCT01262586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65496769|NCT01262586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65496770|NCT01262586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496771|NCT01262586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65496772|NCT01262586|Immunologic Factors|immunologic factors|mesh-ancestor
65496773|NCT01262586|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65496774|NCT01262586|Protease Inhibitors|protease inhibitors|mesh-ancestor
65496775|NCT01262586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496776|NCT01262586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496777|NCT01157052|Capecitabine|capecitabine|mesh-list
65496778|NCT01157052|Oxaliplatin|oxaliplatin|mesh-list
65496779|NCT01157052|Calcium|calcium|mesh-list
65496780|NCT01157052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65496781|NCT01157052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496782|NCT01157052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65496783|NCT01157052|Antimetabolites|antimetabolites|mesh-ancestor
64474778|NCT01465347|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65496784|NCT01157052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496785|NCT01157052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496786|NCT03887130|Gemcitabine|gemcitabine|mesh-list
65068274|NCT00417014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65068275|NCT00417014|Alkylating Agents|alkylating agents|mesh-ancestor
65496787|NCT03887130|Paclitaxel|paclitaxel|mesh-list
65496788|NCT03887130|Vinorelbine|vinorelbine|mesh-list
65496789|NCT03887130|Docetaxel|docetaxel|mesh-list
65496790|NCT03887130|Capecitabine|capecitabine|mesh-list
65496791|NCT03887130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65496792|NCT03887130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496793|NCT03887130|Tubulin Modulators|tubulin modulators|mesh-ancestor
65496794|NCT03887130|Antimitotic Agents|antimitotic agents|mesh-ancestor
65496795|NCT03887130|Mitosis Modulators|mitosis modulators|mesh-ancestor
65496796|NCT03887130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496797|NCT03887130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65496798|NCT03887130|Antimetabolites|antimetabolites|mesh-ancestor
65496799|NCT03887130|Antiviral Agents|antiviral agents|mesh-ancestor
65496800|NCT03887130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65496801|NCT03887130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496802|NCT03887130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65496803|NCT03887130|Immunologic Factors|immunologic factors|mesh-ancestor
65496804|NCT03887130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496805|NCT01155960|Anastrozole|anastrozole|mesh-list
65496806|NCT01155960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65496807|NCT01155960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496808|NCT01155960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65496809|NCT01155960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65496810|NCT01155960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496811|NCT01155960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496812|NCT01155960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65496813|NCT01155960|Hormone Antagonists|hormone antagonists|mesh-ancestor
65496814|NCT01155960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65496815|NCT01155960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496816|NCT03883776|Octreotide|octreotide|mesh-list
65496817|NCT03883776|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
65496818|NCT03883776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65496819|NCT03883776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65496820|NCT03883776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496821|NCT03883776|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65496822|NCT03883776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496823|NCT03886896|Lidocaine|lidocaine|mesh-list
65496824|NCT03886896|Anesthetics, Local|anesthetics, local|mesh-ancestor
65496825|NCT03886896|Anesthetics|anesthetics|mesh-ancestor
65496826|NCT03886896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65496827|NCT03886896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496828|NCT03886896|Sensory System Agents|sensory system agents|mesh-ancestor
65496829|NCT03886896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496830|NCT03886896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65496831|NCT03886896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65496832|NCT03886896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65496833|NCT03886896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65496834|NCT03886896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496835|NCT03881904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65496836|NCT03881904|Gestodene|gestodene|mesh-list
65496837|NCT03881904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65496838|NCT03881904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65496839|NCT03881904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65496840|NCT03881904|Contraceptive Agents|contraceptive agents|mesh-ancestor
65496841|NCT03881904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65496842|NCT03881904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496843|NCT03881904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65496844|NCT03881904|Estrogens|estrogens|mesh-ancestor
65496845|NCT03881904|Hormones|hormones|mesh-ancestor
65496846|NCT03881904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65496847|NCT03881904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65496848|NCT03881904|Progestins|progestins|mesh-ancestor
65496849|NCT01262742|Carbetocin|carbetocin|mesh-list
65496850|NCT01262742|Oxytocin|oxytocin|mesh-list
65496851|NCT01262742|Oxytocics|oxytocics|mesh-ancestor
65496852|NCT01262742|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65496853|NCT01262742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496854|NCT01261416|Levetiracetam|levetiracetam|mesh-list
65068276|NCT00317421|Sildenafil Citrate|sildenafil citrate|mesh-list
65068277|NCT00317421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068278|NCT00317421|Vasodilator Agents|vasodilator agents|mesh-ancestor
65068279|NCT00317421|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64474859|NCT01461057|Pertuzumab|pertuzumab|mesh-list
65496855|NCT01261416|Anticonvulsants|anticonvulsants|mesh-ancestor
65496856|NCT01261416|Nootropic Agents|nootropic agents|mesh-ancestor
65496857|NCT03617172|Misoprostol|misoprostol|mesh-list
65496858|NCT03617172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65496859|NCT03617172|Abortifacient Agents|abortifacient agents|mesh-ancestor
65496860|NCT03617172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65496861|NCT03617172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496862|NCT03617172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65496863|NCT03617172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65496864|NCT03617172|Oxytocics|oxytocics|mesh-ancestor
65496865|NCT01154790|Naproxen|naproxen|mesh-list
65496866|NCT01154790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65496867|NCT01154790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65496868|NCT01154790|Analgesics|analgesics|mesh-ancestor
65496869|NCT01154790|Sensory System Agents|sensory system agents|mesh-ancestor
65496870|NCT01154790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496871|NCT01154790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496872|NCT01154790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65496873|NCT01154790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65496874|NCT01154790|Gout Suppressants|gout suppressants|mesh-ancestor
65496875|NCT01154790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65496876|NCT01154790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64637032|NCT01899248|Desflurane|desflurane|mesh-list
65496877|NCT01154790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496878|NCT03883698|Sofosbuvir|sofosbuvir|mesh-list
65496879|NCT03883698|Antiviral Agents|antiviral agents|mesh-ancestor
65496880|NCT03883698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65496881|NCT01263210|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65496882|NCT01263210|Immunologic Factors|immunologic factors|mesh-ancestor
65496883|NCT01263210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496884|NCT01263288|Cholecalciferol|cholecalciferol|mesh-list
65496885|NCT01263288|Vitamin D|vitamin d|mesh-list
65496886|NCT01263288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65496887|NCT01263288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496888|NCT01263288|Vitamins|vitamins|mesh-ancestor
65496889|NCT01263288|Micronutrients|micronutrients|mesh-ancestor
65496890|NCT01263288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65496891|NCT01263834|Bevacizumab|bevacizumab|mesh-list
65496892|NCT01263834|Mitomycins|mitomycins|mesh-list
65496893|NCT01263834|Mitomycin|mitomycin|mesh-list
65496894|NCT01263834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65496895|NCT01263834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496896|NCT01263834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65496897|NCT01263834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65496898|NCT01263834|Growth Substances|growth substances|mesh-ancestor
65496899|NCT01263834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496900|NCT01263834|Growth Inhibitors|growth inhibitors|mesh-ancestor
65496901|NCT01263834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65496902|NCT01263834|Alkylating Agents|alkylating agents|mesh-ancestor
65496903|NCT01263834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496904|NCT01263834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65496905|NCT01263834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496906|NCT01263366|Norepinephrine|norepinephrine|mesh-list
65496907|NCT01263366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65496908|NCT01263366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65496909|NCT01263366|Adrenergic Agents|adrenergic agents|mesh-ancestor
65496910|NCT01263366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65496911|NCT01263366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496912|NCT01263366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496913|NCT01263366|Sympathomimetics|sympathomimetics|mesh-ancestor
65496914|NCT01263366|Autonomic Agents|autonomic agents|mesh-ancestor
65496915|NCT01263366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496916|NCT01263366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65496917|NCT01155102|Anastrozole|anastrozole|mesh-list
65496918|NCT01155102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65496919|NCT01155102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496920|NCT01155102|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65496921|NCT01155102|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65496922|NCT01155102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496923|NCT01155102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496924|NCT01155102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65496925|NCT01155102|Hormone Antagonists|hormone antagonists|mesh-ancestor
65068280|NCT00317421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64474919|NCT00318136|Bevacizumab|bevacizumab|mesh-list
65496926|NCT01155102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65496927|NCT01155102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068281|NCT00317421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496928|NCT01156350|Fludarabine|fludarabine|mesh-list
65496929|NCT01156350|Busulfan|busulfan|mesh-list
65496930|NCT01156350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800366|NCT05045313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65496931|NCT01156350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496932|NCT01156350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65496933|NCT01156350|Immunologic Factors|immunologic factors|mesh-ancestor
65496934|NCT01156350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496935|NCT01156350|Alkylating Agents|alkylating agents|mesh-ancestor
65496936|NCT01156350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65496937|NCT01156350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65496938|NCT03886662|LB100|lb100|mesh-list
65496939|NCT03886662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496940|NCT03886662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65496941|NCT03886662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496942|NCT01155258|Sirolimus|sirolimus|mesh-list
65496943|NCT01155258|Vinorelbine|vinorelbine|mesh-list
65496944|NCT01155258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65496945|NCT01155258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65496946|NCT01155258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65496947|NCT01155258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496948|NCT01155258|Antifungal Agents|antifungal agents|mesh-ancestor
65496949|NCT01155258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65496950|NCT01155258|Immunologic Factors|immunologic factors|mesh-ancestor
65496951|NCT01155258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496952|NCT01155258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65496953|NCT01155258|Tubulin Modulators|tubulin modulators|mesh-ancestor
65496954|NCT01155258|Antimitotic Agents|antimitotic agents|mesh-ancestor
65496955|NCT01155258|Mitosis Modulators|mitosis modulators|mesh-ancestor
65496956|NCT01155258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496957|NCT01156584|Flucytosine|flucytosine|mesh-list
65496958|NCT01156584|Antifungal Agents|antifungal agents|mesh-ancestor
65496959|NCT01156584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65496960|NCT01156584|Antimetabolites|antimetabolites|mesh-ancestor
65496961|NCT01156584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496962|NCT03879174|Tamoxifen|tamoxifen|mesh-list
65496963|NCT03879174|Pembrolizumab|pembrolizumab|mesh-list
65496964|NCT03879174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65496965|NCT03879174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65496966|NCT03879174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65496967|NCT03879174|Hormone Antagonists|hormone antagonists|mesh-ancestor
65496968|NCT03879174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65496969|NCT03879174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496970|NCT03879174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65496971|NCT03879174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65496972|NCT03879174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65496973|NCT03879174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64800507|NCT04530006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800510|NCT04530006|Analgesics|analgesics|mesh-ancestor
65496974|NCT01159548|Promethazine|promethazine|mesh-list
65496975|NCT01159548|Diphenhydramine|diphenhydramine|mesh-list
65496976|NCT01159548|Antipruritics|antipruritics|mesh-ancestor
65496977|NCT01159548|Dermatologic Agents|dermatologic agents|mesh-ancestor
65496978|NCT01159548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65496979|NCT01159548|Histamine Antagonists|histamine antagonists|mesh-ancestor
65496980|NCT01159548|Histamine Agents|histamine agents|mesh-ancestor
65496981|NCT01159548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65496982|NCT01159548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65496983|NCT01159548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65496984|NCT01159548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65496985|NCT01159548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65496986|NCT01159548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65496987|NCT01159548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65496988|NCT01159548|Anesthetics, Local|anesthetics, local|mesh-ancestor
65496989|NCT01159548|Anesthetics|anesthetics|mesh-ancestor
65496990|NCT01159548|Sensory System Agents|sensory system agents|mesh-ancestor
65496991|NCT01159548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65496992|NCT01159548|Antiemetics|antiemetics|mesh-ancestor
65496993|NCT01159548|Autonomic Agents|autonomic agents|mesh-ancestor
65496994|NCT01159548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65496995|NCT01156740|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65496996|NCT01156740|Amoxicillin|amoxicillin|mesh-list
65496997|NCT01156740|Penicillins|penicillins|mesh-list
65496998|NCT01156740|beta-Lactams|beta-lactams|mesh-list
65496999|NCT01156740|Penicillin G|penicillin g|mesh-list
65497000|NCT01156740|Penicillin G Benzathine|penicillin g benzathine|mesh-list
65497001|NCT01156740|Penicillin G Procaine|penicillin g procaine|mesh-list
65497002|NCT01156740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65497004|NCT03880968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65497005|NCT03880968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65497006|NCT03880968|Analgesics|analgesics|mesh-ancestor
65497007|NCT03880968|Sensory System Agents|sensory system agents|mesh-ancestor
65497008|NCT03880968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65497009|NCT03880968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497010|NCT03880968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65497011|NCT03880968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65497012|NCT03880968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65497013|NCT03880968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65497014|NCT03880968|Immunologic Factors|immunologic factors|mesh-ancestor
65497015|NCT03880734|Cholecalciferol|cholecalciferol|mesh-list
65497016|NCT03880734|Vitamin D|vitamin d|mesh-list
65497017|NCT03880734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65497018|NCT03880734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497019|NCT03880734|Vitamins|vitamins|mesh-ancestor
65497020|NCT03880734|Micronutrients|micronutrients|mesh-ancestor
65497021|NCT03880734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65497022|NCT01157754|Levonorgestrel|levonorgestrel|mesh-list
65497023|NCT01157754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65497024|NCT01157754|Contraceptive Agents|contraceptive agents|mesh-ancestor
65497025|NCT01157754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65497026|NCT01157754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497027|NCT01157754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65497028|NCT01157754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65497029|NCT01157754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65497030|NCT01265940|Vinblastine|vinblastine|mesh-list
65497031|NCT01265940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65497032|NCT01265940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497033|NCT01265940|Tubulin Modulators|tubulin modulators|mesh-ancestor
65497034|NCT01265940|Antimitotic Agents|antimitotic agents|mesh-ancestor
65497035|NCT01265940|Mitosis Modulators|mitosis modulators|mesh-ancestor
65497036|NCT01265940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497037|NCT01264302|Finasteride|finasteride|mesh-list
65497038|NCT01264302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65497039|NCT01264302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65497040|NCT01264302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497041|NCT01264302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497042|NCT01264302|Hormone Antagonists|hormone antagonists|mesh-ancestor
65497043|NCT01264302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65497044|NCT01264302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497045|NCT01264302|Urological Agents|urological agents|mesh-ancestor
65497046|NCT03760146|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65497047|NCT03760146|Immunologic Factors|immunologic factors|mesh-ancestor
65497048|NCT03760146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800705|NCT03845270|Docetaxel|docetaxel|mesh-list
65497049|NCT01161654|Naratriptan|naratriptan|mesh-list
65497050|NCT01161654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65497051|NCT01161654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65497052|NCT01161654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65497053|NCT01161654|Serotonin Agents|serotonin agents|mesh-ancestor
65497054|NCT01161654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65497055|NCT01161654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497056|NCT01161654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497057|NCT01266174|Eltoprazine|eltoprazine|mesh-list
65497058|NCT01266174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65497059|NCT01266174|Serotonin Agents|serotonin agents|mesh-ancestor
65497060|NCT01266174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65497061|NCT01266174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497062|NCT01266174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497063|NCT01266252|Dexmedetomidine|dexmedetomidine|mesh-list
65497064|NCT01266252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65497065|NCT01266252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65497066|NCT01266252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497067|NCT01266252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65497068|NCT01266252|Analgesics|analgesics|mesh-ancestor
65497069|NCT01266252|Sensory System Agents|sensory system agents|mesh-ancestor
65497070|NCT01266252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65497071|NCT01266252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65068282|NCT00317421|Urological Agents|urological agents|mesh-ancestor
65068283|NCT00417053|Cyclophosphamide|cyclophosphamide|mesh-list
65068285|NCT00417053|Busulfan|busulfan|mesh-list
65068286|NCT00417053|Carboplatin|carboplatin|mesh-list
65068287|NCT00417053|Doxorubicin|doxorubicin|mesh-list
65068288|NCT00417053|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65497072|NCT01266252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65497073|NCT01266252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65497074|NCT01266252|Adrenergic Agents|adrenergic agents|mesh-ancestor
65497075|NCT01266252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65497076|NCT01266252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497077|NCT01266486|Metformin|metformin|mesh-list
65497078|NCT01266486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65497079|NCT01266486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497080|NCT01161888|Imiquimod|imiquimod|mesh-list
65497081|NCT01161888|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65497082|NCT01161888|Immunologic Factors|immunologic factors|mesh-ancestor
65497083|NCT01161888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497084|NCT01161888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497085|NCT01161888|Interferon Inducers|interferon inducers|mesh-ancestor
65497086|NCT03759366|Eculizumab|eculizumab|mesh-list
64415782|NCT05518799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65497087|NCT03759366|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65497088|NCT03759366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65497089|NCT03759366|Immunologic Factors|immunologic factors|mesh-ancestor
65497090|NCT03759366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497092|NCT03760068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65497093|NCT03760068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497094|NCT03759600|Niraparib|niraparib|mesh-list
65497095|NCT03759600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65497096|NCT03759600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497097|NCT03759600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497098|NCT03759600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497099|NCT01161966|Zonisamide|zonisamide|mesh-list
65497100|NCT01161966|Anticonvulsants|anticonvulsants|mesh-ancestor
65497101|NCT01161966|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65497102|NCT01161966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65497103|NCT01161966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497104|NCT01161966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65497105|NCT01161966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497106|NCT01158144|Paclitaxel|paclitaxel|mesh-list
65497107|NCT01158144|Carboplatin|carboplatin|mesh-list
65497108|NCT01158144|Endostar protein|endostar protein|mesh-list
65497109|NCT01158144|Endostatins|endostatins|mesh-list
65497110|NCT01158144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65497111|NCT01158144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497112|NCT01158144|Tubulin Modulators|tubulin modulators|mesh-ancestor
65497113|NCT01158144|Antimitotic Agents|antimitotic agents|mesh-ancestor
65497114|NCT01158144|Mitosis Modulators|mitosis modulators|mesh-ancestor
65497115|NCT01158144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497116|NCT01158144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65497117|NCT01158144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65497118|NCT01158144|Growth Substances|growth substances|mesh-ancestor
65497119|NCT01158144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800803|NCT03659799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497120|NCT01158144|Growth Inhibitors|growth inhibitors|mesh-ancestor
65497121|NCT01264536|Lactoferrin|lactoferrin|mesh-list
65497122|NCT01264536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65497123|NCT01160172|Vaccines|vaccines|mesh-list
65497124|NCT01160172|Immunologic Factors|immunologic factors|mesh-ancestor
65497125|NCT01160172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497126|NCT03878784|Sumatriptan|sumatriptan|mesh-list
65497127|NCT03878784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65497128|NCT03878784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65497129|NCT03878784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65497130|NCT03878784|Serotonin Agents|serotonin agents|mesh-ancestor
65497131|NCT03878784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65497132|NCT03878784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497133|NCT03878784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497134|NCT01266720|Gemcitabine|gemcitabine|mesh-list
65497135|NCT01266720|Immunologic Factors|immunologic factors|mesh-ancestor
65497136|NCT01266720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497137|NCT01266720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65497138|NCT01266720|Antimetabolites|antimetabolites|mesh-ancestor
65497139|NCT01266720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497140|NCT01266720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497141|NCT01266720|Antiviral Agents|antiviral agents|mesh-ancestor
65497142|NCT01266720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65497143|NCT01266720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497144|NCT01266720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65497145|NCT01589952|Interferons|interferons|mesh-list
65497146|NCT01589952|Entecavir|entecavir|mesh-list
65497147|NCT01589952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497148|NCT01589952|Antiviral Agents|antiviral agents|mesh-ancestor
65497149|NCT01589952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65497150|NCT03876444|Methylprednisolone|methylprednisolone|mesh-list
65497151|NCT03876444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65497152|NCT03876444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65497153|NCT03876444|Prednisolone|prednisolone|mesh-list
65497154|NCT03876444|Prednisolone acetate|prednisolone acetate|mesh-list
65497155|NCT03876444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65497156|NCT03876444|Prednisolone phosphate|prednisolone phosphate|mesh-list
65497157|NCT03876444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65497158|NCT03876444|Antiemetics|antiemetics|mesh-ancestor
65497159|NCT03876444|Autonomic Agents|autonomic agents|mesh-ancestor
65497160|NCT03876444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65497161|NCT03876444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497162|NCT03876444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65497163|NCT03876444|Glucocorticoids|glucocorticoids|mesh-ancestor
65497164|NCT03876444|Hormones|hormones|mesh-ancestor
65497165|NCT03876444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65497166|NCT03876444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65497167|NCT03876444|Protective Agents|protective agents|mesh-ancestor
65497168|NCT03876444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65497169|NCT03876444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497170|NCT01264692|Amlodipine|amlodipine|mesh-list
65497171|NCT01264692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65497172|NCT01264692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65497173|NCT01264692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64801081|NCT03011775|Ramipril|ramipril|mesh-list
65497174|NCT01264692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497175|NCT01264692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65497176|NCT01264692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497177|NCT01264692|Vasodilator Agents|vasodilator agents|mesh-ancestor
65497178|NCT01160328|Leuprolide|leuprolide|mesh-list
65497179|NCT01160328|Testosterone|testosterone|mesh-list
65497180|NCT01160328|Androgens|androgens|mesh-ancestor
65497181|NCT01160328|Hormones|hormones|mesh-ancestor
65497182|NCT01160328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65497183|NCT01160328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497184|NCT01160328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65497185|NCT01160328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497186|NCT01160328|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65497187|NCT01160328|Fertility Agents|fertility agents|mesh-ancestor
65497188|NCT01160328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65497189|NCT05068440|Zanubrutinib|zanubrutinib|mesh-list
65497190|NCT05068440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497191|NCT05068440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65497192|NCT05068440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497193|NCT05068440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497194|NCT01162746|Dexamethasone|dexamethasone|mesh-list
65497195|NCT01162746|Ranibizumab|ranibizumab|mesh-list
65497196|NCT01162746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65497197|NCT01162746|Antiemetics|antiemetics|mesh-ancestor
65497198|NCT01162746|Autonomic Agents|autonomic agents|mesh-ancestor
65497199|NCT01162746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65497200|NCT01162746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497201|NCT01162746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65497202|NCT01162746|Glucocorticoids|glucocorticoids|mesh-ancestor
65497203|NCT01162746|Hormones|hormones|mesh-ancestor
65497204|NCT01162746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65497205|NCT01162746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65497206|NCT01162746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497207|NCT01162746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65497208|NCT01162746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65497209|NCT01162746|Growth Substances|growth substances|mesh-ancestor
65497210|NCT01162746|Growth Inhibitors|growth inhibitors|mesh-ancestor
65497211|NCT01268202|Pravastatin|pravastatin|mesh-list
65497212|NCT01268202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65497213|NCT01268202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65497214|NCT01268202|Antimetabolites|antimetabolites|mesh-ancestor
65497215|NCT01268202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497216|NCT01268202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65068289|NCT00417053|Etoposide|etoposide|mesh-list
65497217|NCT01268202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65497218|NCT01268202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068290|NCT00417053|Vincristine|vincristine|mesh-list
65068291|NCT00417053|Etoposide phosphate|etoposide phosphate|mesh-list
65497220|NCT01162824|Acetylcholine|acetylcholine|mesh-list
65497221|NCT01162824|Analgesics|analgesics|mesh-ancestor
65497222|NCT01162824|Sensory System Agents|sensory system agents|mesh-ancestor
65497223|NCT01162824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65497224|NCT01162824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497225|NCT01162824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65497226|NCT01162824|Vasodilator Agents|vasodilator agents|mesh-ancestor
65497227|NCT01162824|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65497228|NCT01162824|Purinergic Agonists|purinergic agonists|mesh-ancestor
65497229|NCT01162824|Purinergic Agents|purinergic agents|mesh-ancestor
65497230|NCT01162824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64801143|NCT02924064|Metformin|metformin|mesh-list
65497231|NCT01162824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497233|NCT01162824|Cholinergic Agents|cholinergic agents|mesh-ancestor
65497234|NCT01265004|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65497235|NCT01265004|Hemostatics|hemostatics|mesh-ancestor
65497236|NCT01265004|Coagulants|coagulants|mesh-ancestor
65497237|NCT01162902|Candesartan|candesartan|mesh-list
65497238|NCT01162902|Bisoprolol|bisoprolol|mesh-list
65497239|NCT01162902|Diltiazem|diltiazem|mesh-list
65497240|NCT01162902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65497241|NCT01162902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65497242|NCT01162902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65497243|NCT01162902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497244|NCT01162902|Sympatholytics|sympatholytics|mesh-ancestor
65497245|NCT01162902|Autonomic Agents|autonomic agents|mesh-ancestor
65497246|NCT01162902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65497247|NCT01162902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497248|NCT01162902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65497249|NCT01162902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65497250|NCT01162902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65497251|NCT01162902|Adrenergic Agents|adrenergic agents|mesh-ancestor
65497252|NCT01162902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65497253|NCT01162902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65497254|NCT01162902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65497255|NCT01162902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65497256|NCT01162902|Vasodilator Agents|vasodilator agents|mesh-ancestor
65497257|NCT03877536|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65497258|NCT03877536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65497259|NCT03877536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65497260|NCT03877536|Antiviral Agents|antiviral agents|mesh-ancestor
65497261|NCT03877536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65497262|NCT02526888|Diltiazem|diltiazem|mesh-list
65497263|NCT02526888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65497264|NCT02526888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65497265|NCT02526888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65497266|NCT02526888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497267|NCT02526888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65497268|NCT02526888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497269|NCT02526888|Vasodilator Agents|vasodilator agents|mesh-ancestor
65497270|NCT01158612|Hormones|hormones|mesh-list
65497271|NCT01158612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65497272|NCT01158612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497273|NCT03877692|Labetalol|labetalol|mesh-list
65497274|NCT03877692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65497275|NCT03877692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65497276|NCT03877692|Adrenergic Agents|adrenergic agents|mesh-ancestor
65497277|NCT03877692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65497278|NCT03877692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497279|NCT03877692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497280|NCT03877692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65497281|NCT03877692|Sympathomimetics|sympathomimetics|mesh-ancestor
65497282|NCT03877692|Autonomic Agents|autonomic agents|mesh-ancestor
65497283|NCT03877692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65497284|NCT03877692|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65497285|NCT03877692|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65497286|NCT01158846|Bivalirudin|bivalirudin|mesh-list
65497287|NCT01158846|Abciximab|abciximab|mesh-list
65497288|NCT01158846|Clopidogrel|clopidogrel|mesh-list
65497289|NCT01158846|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65068292|NCT00417053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65068293|NCT00417053|Immunologic Factors|immunologic factors|mesh-ancestor
65497290|NCT01158846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65497291|NCT01158846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65497292|NCT01158846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65497293|NCT01158846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65497294|NCT01158846|Purinergic Agents|purinergic agents|mesh-ancestor
65497295|NCT01158846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65497296|NCT01158846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497297|NCT01158846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497298|NCT01158846|Antithrombins|antithrombins|mesh-ancestor
65497299|NCT01158846|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65497301|NCT01158846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497302|NCT01158846|Anticoagulants|anticoagulants|mesh-ancestor
65497304|NCT01268670|Oxycodone|oxycodone|mesh-list
65497305|NCT01268670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65497306|NCT01268670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65497307|NCT01268670|Analgesics|analgesics|mesh-ancestor
65497308|NCT01268670|Sensory System Agents|sensory system agents|mesh-ancestor
65497309|NCT01268670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65497310|NCT01268670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497311|NCT01268670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65497312|NCT01268670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65497313|NCT01268670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65497314|NCT01268670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497315|NCT01268670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497316|NCT01268670|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65497317|NCT01268670|Narcotics|narcotics|mesh-ancestor
64801269|NCT02666794|Dsuvia|dsuvia|mesh-list
65497318|NCT01268670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65497319|NCT01160718|Fulvestrant|fulvestrant|mesh-list
65497320|NCT01160718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65497321|NCT01160718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497322|NCT01160718|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65497323|NCT01160718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65497324|NCT01160718|Hormone Antagonists|hormone antagonists|mesh-ancestor
65497325|NCT01160718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64801540|NCT01982448|Mitosis Modulators|mitosis modulators|mesh-ancestor
64801542|NCT01951469|Pemetrexed|pemetrexed|mesh-list
65497326|NCT01160718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497327|NCT01159080|Mycophenolic Acid|mycophenolic acid|mesh-list
65497328|NCT01159080|Tacrolimus|tacrolimus|mesh-list
65497329|NCT01159080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65497330|NCT01159080|Immunologic Factors|immunologic factors|mesh-ancestor
65497331|NCT01159080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497332|NCT01159080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65497333|NCT01159080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497334|NCT01159080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497335|NCT01159080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65497336|NCT01159080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497337|NCT01159080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65497338|NCT01159080|Antitubercular Agents|antitubercular agents|mesh-ancestor
65497339|NCT01159080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65497340|NCT01159080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65497341|NCT01160952|Itraconazole|itraconazole|mesh-list
65497342|NCT01160952|Antifungal Agents|antifungal agents|mesh-ancestor
65497343|NCT01160952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65497344|NCT01160952|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65497345|NCT01160952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65497346|NCT01160952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497347|NCT01160952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497348|NCT01160952|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65497349|NCT01160952|Hormone Antagonists|hormone antagonists|mesh-ancestor
65497350|NCT01160952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65497351|NCT01160952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497352|NCT01160952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65497353|NCT01159158|Nateglinide|nateglinide|mesh-list
65497354|NCT01159158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65497355|NCT01159158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497356|NCT01161108|Melatonin|melatonin|mesh-list
65497357|NCT01161108|Antioxidants|antioxidants|mesh-ancestor
65497358|NCT01161108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497359|NCT01161108|Protective Agents|protective agents|mesh-ancestor
65497360|NCT01161108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068294|NCT00417053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497361|NCT01161108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65497362|NCT01161186|Gemcitabine|gemcitabine|mesh-list
65497363|NCT01161186|Paclitaxel|paclitaxel|mesh-list
65497364|NCT01161186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65497365|NCT01161186|Capecitabine|capecitabine|mesh-list
65497366|NCT01161186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65497367|NCT01161186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497368|NCT01161186|Tubulin Modulators|tubulin modulators|mesh-ancestor
65497369|NCT01161186|Antimitotic Agents|antimitotic agents|mesh-ancestor
65497370|NCT01161186|Mitosis Modulators|mitosis modulators|mesh-ancestor
64637538|NCT01043393|Hormones|hormones|mesh-ancestor
65497371|NCT01161186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497372|NCT01161186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65497374|NCT01161186|Antiviral Agents|antiviral agents|mesh-ancestor
65497375|NCT01161186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65497376|NCT01161186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497377|NCT01161186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65497378|NCT01161186|Immunologic Factors|immunologic factors|mesh-ancestor
65497379|NCT01161186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497380|NCT01159236|Paclitaxel|paclitaxel|mesh-list
65497381|NCT01159236|Cyclophosphamide|cyclophosphamide|mesh-list
65497382|NCT01159236|Bevacizumab|bevacizumab|mesh-list
65497383|NCT01159236|Doxorubicin|doxorubicin|mesh-list
65497384|NCT01159236|Fluorouracil|fluorouracil|mesh-list
65497385|NCT01159236|Epirubicin|epirubicin|mesh-list
65497386|NCT01159236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65497387|NCT01159236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497388|NCT01159236|Tubulin Modulators|tubulin modulators|mesh-ancestor
65497389|NCT01159236|Antimitotic Agents|antimitotic agents|mesh-ancestor
65497390|NCT01159236|Mitosis Modulators|mitosis modulators|mesh-ancestor
65497391|NCT01159236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497392|NCT01159236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65497393|NCT01159236|Immunologic Factors|immunologic factors|mesh-ancestor
65497394|NCT01159236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497395|NCT01159236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65497396|NCT01159236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65497397|NCT01159236|Alkylating Agents|alkylating agents|mesh-ancestor
65497398|NCT01159236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65497399|NCT01159236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65497400|NCT01159236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65497401|NCT01159236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65497402|NCT01159236|Growth Substances|growth substances|mesh-ancestor
65497403|NCT01159236|Growth Inhibitors|growth inhibitors|mesh-ancestor
65497404|NCT01159236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65497405|NCT01159236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65497406|NCT01159236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65497407|NCT01159236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497408|NCT01159236|Antimetabolites|antimetabolites|mesh-ancestor
65497409|NCT01159236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65497410|NCT01267344|Gemcitabine|gemcitabine|mesh-list
65497411|NCT01267344|Oxaliplatin|oxaliplatin|mesh-list
65497412|NCT01267344|Cetuximab|cetuximab|mesh-list
65497413|NCT01267344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65497414|NCT01267344|Antimetabolites|antimetabolites|mesh-ancestor
65497415|NCT01267344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497416|NCT01267344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497417|NCT01267344|Antiviral Agents|antiviral agents|mesh-ancestor
65497418|NCT01267344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65497419|NCT01267344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497420|NCT01267344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65497421|NCT01267344|Immunologic Factors|immunologic factors|mesh-ancestor
65497422|NCT01267344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497423|NCT01267344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65497424|NCT03879564|Ketamine|ketamine|mesh-list
65497425|NCT03879564|Analgesics|analgesics|mesh-ancestor
65497426|NCT03879564|Sensory System Agents|sensory system agents|mesh-ancestor
65497427|NCT03879564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65497428|NCT03879564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497429|NCT03879564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65497430|NCT03879564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65497431|NCT03879564|Anesthetics, General|anesthetics, general|mesh-ancestor
65497432|NCT03879564|Anesthetics|anesthetics|mesh-ancestor
65497433|NCT03879564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65497434|NCT03879564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65497435|NCT03879564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65497436|NCT03879564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65497437|NCT03879564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497439|NCT01581840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65497440|NCT01581840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497441|NCT03879486|Povidone-Iodine|povidone-iodine|mesh-list
65497442|NCT03879486|Formaldehyde|formaldehyde|mesh-list
65497443|NCT03879486|Povidone|povidone|mesh-list
65497444|NCT03879486|Plasma Substitutes|plasma substitutes|mesh-ancestor
65497445|NCT03879486|Blood Substitutes|blood substitutes|mesh-ancestor
65497446|NCT03879486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65497447|NCT03879486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65497448|NCT03879486|Disinfectants|disinfectants|mesh-ancestor
65497449|NCT01269294|Moxifloxacin|moxifloxacin|mesh-list
65497450|NCT01269294|Simeprevir|simeprevir|mesh-list
65497451|NCT01269294|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65497452|NCT01269294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65497453|NCT01269294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65497454|NCT01269294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65497455|NCT01269294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65497456|NCT01269294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497457|NCT01269294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497458|NCT01269294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497459|NCT01269294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65497460|NCT01269294|Contraceptive Agents|contraceptive agents|mesh-ancestor
65497461|NCT01269294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65497462|NCT01269294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497463|NCT01269294|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65497464|NCT01269294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65497465|NCT01269294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65497466|NCT01269294|Antiviral Agents|antiviral agents|mesh-ancestor
65497467|NCT01269294|Protease Inhibitors|protease inhibitors|mesh-ancestor
65497468|NCT01163994|Doxycycline|doxycycline|mesh-list
65497469|NCT01163994|Ceftriaxone|ceftriaxone|mesh-list
65497470|NCT01163994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65497471|NCT01163994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65497472|NCT01163994|Antimalarials|antimalarials|mesh-ancestor
65497473|NCT01163994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65497474|NCT01163994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65497475|NCT01267734|Everolimus|everolimus|mesh-list
65497476|NCT01267734|Clopidogrel|clopidogrel|mesh-list
65497477|NCT01267734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497478|NCT01267734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65497479|NCT01267734|Immunologic Factors|immunologic factors|mesh-ancestor
65497480|NCT01267734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497481|NCT01267734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65497482|NCT01267734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65497483|NCT01267734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65497484|NCT01267734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65497485|NCT01267734|Purinergic Agents|purinergic agents|mesh-ancestor
65497486|NCT01267734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65497487|NCT01267734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497488|NCT01164306|Nicotine|nicotine|mesh-list
65497489|NCT01164306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65497490|NCT01164306|Autonomic Agents|autonomic agents|mesh-ancestor
65497491|NCT01164306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65497492|NCT01164306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497493|NCT01164306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65497494|NCT01164306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65497495|NCT01164306|Cholinergic Agents|cholinergic agents|mesh-ancestor
65497496|NCT01164306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65497497|NCT01164306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497498|NCT01269450|Progesterone|progesterone|mesh-list
65497499|NCT01269450|Progestins|progestins|mesh-ancestor
65497500|NCT01269450|Hormones|hormones|mesh-ancestor
65497501|NCT01269450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65497502|NCT01269450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497503|NCT01269528|Nitric Oxide|nitric oxide|mesh-list
65497504|NCT01269528|Methacholine Chloride|methacholine chloride|mesh-list
65497505|NCT01269528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65497506|NCT01269528|Autonomic Agents|autonomic agents|mesh-ancestor
65497507|NCT01269528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65497508|NCT01269528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802204|NCT01400633|Antimetabolites|antimetabolites|mesh-ancestor
65497509|NCT01269528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64475516|NCT03127774|Antidotes|antidotes|mesh-ancestor
65068295|NCT00417053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65497510|NCT01269528|Respiratory System Agents|respiratory system agents|mesh-ancestor
65497511|NCT01269528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65497513|NCT01269528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497514|NCT01269528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65497515|NCT01269528|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65497516|NCT01269528|Vasodilator Agents|vasodilator agents|mesh-ancestor
65497517|NCT01269528|Gasotransmitters|gasotransmitters|mesh-ancestor
65497519|NCT01269528|Miotics|miotics|mesh-ancestor
65497520|NCT01269528|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65497521|NCT01269528|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
65497522|NCT01269528|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65497523|NCT01269528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65497524|NCT01269528|Cholinergic Agents|cholinergic agents|mesh-ancestor
65497525|NCT01268904|Valproic Acid|valproic acid|mesh-list
65497526|NCT01268904|Anticonvulsants|anticonvulsants|mesh-ancestor
65497527|NCT01268904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497528|NCT01268904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497529|NCT01268904|GABA Agents|gaba agents|mesh-ancestor
65497530|NCT01268904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65497531|NCT01268904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497532|NCT01268904|Antimanic Agents|antimanic agents|mesh-ancestor
65497533|NCT01268904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65497534|NCT01268904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65497535|NCT01268904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65497536|NCT01269606|Insulin|insulin|mesh-list
65497537|NCT01269606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65497538|NCT01269606|Insulin Aspart|insulin aspart|mesh-list
65497539|NCT01269606|Insulin, Long-Acting|insulin, long-acting|mesh-list
65497540|NCT01269606|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65497541|NCT01269606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65497542|NCT01269606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497543|NCT03872232|Telmisartan|telmisartan|mesh-list
65497544|NCT03872232|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65497545|NCT03872232|Ezetimibe|ezetimibe|mesh-list
65497546|NCT03872232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65497547|NCT03872232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65497548|NCT03872232|Antimetabolites|antimetabolites|mesh-ancestor
65497549|NCT03872232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497550|NCT03872232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65497551|NCT03872232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65497552|NCT03872232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497553|NCT03872232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65497554|NCT03872232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65497555|NCT03872232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65497556|NCT01280214|Triamcinolone|triamcinolone|mesh-list
65497557|NCT01280214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65497558|NCT01280214|Glucocorticoids|glucocorticoids|mesh-ancestor
65497559|NCT01280214|Hormones|hormones|mesh-ancestor
65497560|NCT01280214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65497561|NCT01280214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497562|NCT01165008|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
65497563|NCT01165008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65497564|NCT01164540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65497565|NCT01164540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65497566|NCT01164540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65497567|NCT01164540|Antimetabolites|antimetabolites|mesh-ancestor
65497568|NCT01164540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497569|NCT01164540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65497570|NCT01164540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65497571|NCT01164540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497572|NCT01269684|Everolimus|everolimus|mesh-list
65497573|NCT01269684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497574|NCT01269684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65497575|NCT01269684|Immunologic Factors|immunologic factors|mesh-ancestor
65497576|NCT01269684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497577|NCT01165164|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65497578|NCT01165164|Lubricant Eye Drops|lubricant eye drops|mesh-list
65497579|NCT01165164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65497580|NCT01280526|Romidepsin|romidepsin|mesh-list
65497581|NCT01280526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65497582|NCT01280526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497583|NCT01164774|Ramipril|ramipril|mesh-list
65068296|NCT00417053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65497584|NCT01164774|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65497585|NCT01164774|Protease Inhibitors|protease inhibitors|mesh-ancestor
65497586|NCT01164774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497587|NCT01164774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497588|NCT01164774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65497590|NCT01269138|Hemostatics|hemostatics|mesh-ancestor
65497591|NCT01269138|Coagulants|coagulants|mesh-ancestor
65497592|NCT02526810|Insulin|insulin|mesh-list
65497593|NCT02526810|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65497594|NCT02526810|Insulin Glargine|insulin glargine|mesh-list
65497595|NCT02526810|Insulin Lispro|insulin lispro|mesh-list
65497596|NCT02526810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65497597|NCT02526810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497599|NCT01280682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65497600|NCT01280682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497601|NCT01280682|Immunologic Factors|immunologic factors|mesh-ancestor
65497602|NCT01280682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497603|NCT01280682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65497604|NCT01269216|Leucovorin|leucovorin|mesh-list
65497605|NCT01269216|Irinotecan|irinotecan|mesh-list
65497606|NCT01269216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65497607|NCT01269216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65497608|NCT01269216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497609|NCT01269216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497610|NCT01269216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497611|NCT01269216|Antidotes|antidotes|mesh-ancestor
65497612|NCT01269216|Protective Agents|protective agents|mesh-ancestor
65497613|NCT01269216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497614|NCT01269216|Vitamin B Complex|vitamin b complex|mesh-ancestor
65497615|NCT01269216|Vitamins|vitamins|mesh-ancestor
65497616|NCT01269216|Micronutrients|micronutrients|mesh-ancestor
65497617|NCT03874806|Ropivacaine|ropivacaine|mesh-list
65497618|NCT03874806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65497619|NCT03874806|Anesthetics, Local|anesthetics, local|mesh-ancestor
65497620|NCT03874806|Anesthetics|anesthetics|mesh-ancestor
64802389|NCT01401933|Rifampin|rifampin|mesh-list
65497621|NCT03874806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65497622|NCT03874806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497623|NCT03874806|Sensory System Agents|sensory system agents|mesh-ancestor
65497624|NCT03874806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65497625|NCT01165476|Treprostinil|treprostinil|mesh-list
65497626|NCT01165476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65497627|NCT01169922|Ethanol|ethanol|mesh-list
65497628|NCT01169922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65497629|NCT01169922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65497630|NCT01169922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65497631|NCT01169922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497632|NCT01283100|Dolutegravir|dolutegravir|mesh-list
65497633|NCT01283100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65497634|NCT01283100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65497635|NCT01283100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497636|NCT01283100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497637|NCT01283100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65497638|NCT01283100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65497639|NCT01283100|Antiviral Agents|antiviral agents|mesh-ancestor
65497640|NCT01283100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65497641|NCT01269996|Metformin|metformin|mesh-list
65497642|NCT01269996|Gliclazide|gliclazide|mesh-list
65497643|NCT01269996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65497644|NCT01269996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497645|NCT01283178|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65497646|NCT01283178|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65497647|NCT01283178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497648|NCT01281150|Paclitaxel|paclitaxel|mesh-list
65497649|NCT01281150|Carboplatin|carboplatin|mesh-list
65497650|NCT01281150|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65497651|NCT01281150|Veliparib|veliparib|mesh-list
65497652|NCT01281150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65497653|NCT01281150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497654|NCT01281150|Tubulin Modulators|tubulin modulators|mesh-ancestor
65497655|NCT01281150|Antimitotic Agents|antimitotic agents|mesh-ancestor
65497656|NCT01281150|Mitosis Modulators|mitosis modulators|mesh-ancestor
65497657|NCT01281150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497658|NCT01281150|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65497659|NCT01281150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068297|NCT00417053|Alkylating Agents|alkylating agents|mesh-ancestor
64475735|NCT00428584|Interferons|interferons|mesh-list
65497660|NCT03871218|Hyaluronic Acid|hyaluronic acid|mesh-list
65497661|NCT03871218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65497662|NCT03871218|Immunologic Factors|immunologic factors|mesh-ancestor
65497663|NCT03871218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497664|NCT03871218|Viscosupplements|viscosupplements|mesh-ancestor
65497665|NCT03871218|Protective Agents|protective agents|mesh-ancestor
65497666|NCT01281228|Exenatide|exenatide|mesh-list
65497667|NCT01281228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65497668|NCT01281228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497669|NCT01281228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65497670|NCT01281228|Incretins|incretins|mesh-ancestor
65497671|NCT01281228|Hormones|hormones|mesh-ancestor
65497672|NCT01281228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65497673|NCT01283256|Zonisamide|zonisamide|mesh-list
65497674|NCT01283256|Anticonvulsants|anticonvulsants|mesh-ancestor
65497675|NCT01283256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65497676|NCT01283256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65497677|NCT01283256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497678|NCT01283256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65497679|NCT01283256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497680|NCT01270776|Chlorhexidine|chlorhexidine|mesh-list
65497681|NCT01270776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
65497682|NCT01270776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65497683|NCT01270776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65497684|NCT01270776|Disinfectants|disinfectants|mesh-ancestor
65497685|NCT01270776|Dermatologic Agents|dermatologic agents|mesh-ancestor
65497686|NCT03874260|Fenofibrate|fenofibrate|mesh-list
65497687|NCT03874260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65497688|NCT03874260|Antimetabolites|antimetabolites|mesh-ancestor
65497689|NCT03874260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497690|NCT03874260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65497691|NCT01281540|Cisapride|cisapride|mesh-list
65497692|NCT01281540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65497693|NCT01281540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65497694|NCT01281540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65497695|NCT01281540|Serotonin Agents|serotonin agents|mesh-ancestor
64802474|NCT01402245|Vaccines|vaccines|mesh-list
65497696|NCT01281540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65497697|NCT01281540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497698|NCT01281540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497699|NCT03874026|Cetuximab|cetuximab|mesh-list
65497700|NCT03874026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65497701|NCT03874026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497702|NCT01283412|Dexmedetomidine|dexmedetomidine|mesh-list
65497703|NCT01283412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65497704|NCT01283412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65497705|NCT01283412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497706|NCT01283412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65497707|NCT01283412|Analgesics|analgesics|mesh-ancestor
65497708|NCT01283412|Sensory System Agents|sensory system agents|mesh-ancestor
65497709|NCT01283412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65497710|NCT01283412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65497711|NCT01283412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65497712|NCT01283412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65497713|NCT01283412|Adrenergic Agents|adrenergic agents|mesh-ancestor
65497714|NCT01283412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65497715|NCT01283412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497716|NCT01271478|Telmisartan|telmisartan|mesh-list
65497717|NCT01271478|Captopril|captopril|mesh-list
65497718|NCT01271478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65497719|NCT01271478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65497720|NCT01271478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65497721|NCT01271478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497722|NCT01271478|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65497723|NCT01271478|Protease Inhibitors|protease inhibitors|mesh-ancestor
65497724|NCT01271478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497725|NCT03871062|Anesthetics|anesthetics|mesh-list
65497726|NCT03871062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65497727|NCT03871062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497728|NCT01281696|Bevacizumab|bevacizumab|mesh-list
65497729|NCT01281696|Methotrexate|methotrexate|mesh-list
65497730|NCT01281696|Etoposide|etoposide|mesh-list
65497731|NCT01281696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65497732|NCT01281696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068298|NCT00417053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497733|NCT01281696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65497734|NCT01281696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65497736|NCT01281696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802510|NCT01402479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497738|NCT01281696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65497739|NCT01281696|Abortifacient Agents|abortifacient agents|mesh-ancestor
65497740|NCT01281696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65497741|NCT01281696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65497742|NCT01281696|Antimetabolites|antimetabolites|mesh-ancestor
65497743|NCT01281696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497744|NCT01281696|Dermatologic Agents|dermatologic agents|mesh-ancestor
65497745|NCT01281696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497746|NCT01281696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65497747|NCT01281696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65497748|NCT01281696|Immunologic Factors|immunologic factors|mesh-ancestor
65497749|NCT01281696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65497750|NCT01281696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65497751|NCT01281696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65497752|NCT01281696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65497753|NCT01281696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65497754|NCT05835726|Daratumumab|daratumumab|mesh-list
65497755|NCT05835726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497756|NCT05835713|Propofol|propofol|mesh-list
65497757|NCT05835713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65497758|NCT05835713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65497759|NCT05835713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497760|NCT05835713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65497761|NCT05835713|Anesthetics, General|anesthetics, general|mesh-ancestor
65497762|NCT05835713|Anesthetics|anesthetics|mesh-ancestor
65497763|NCT05835479|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65497764|NCT05835479|Rezafungin|rezafungin|mesh-list
65497765|NCT05835479|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65497766|NCT05835479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65497767|NCT05835479|Renal Agents|renal agents|mesh-ancestor
65497768|NCT05835479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65497769|NCT05835479|Antimalarials|antimalarials|mesh-ancestor
65497770|NCT05835479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65497771|NCT05835479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65497772|NCT05835479|Antifungal Agents|antifungal agents|mesh-ancestor
65497773|NCT05835284|Silicon|silicon|mesh-list
65497774|NCT05835284|Trace Elements|trace elements|mesh-ancestor
65497775|NCT05835284|Micronutrients|micronutrients|mesh-ancestor
65497776|NCT05835284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497777|NCT05835258|Melatonin|melatonin|mesh-list
65497778|NCT05835258|Capsaicin|capsaicin|mesh-list
65497779|NCT05835258|Antioxidants|antioxidants|mesh-ancestor
65497780|NCT05835258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497781|NCT05835258|Protective Agents|protective agents|mesh-ancestor
65497782|NCT05835258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497783|NCT05835258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65497784|NCT05835258|Antipruritics|antipruritics|mesh-ancestor
65497785|NCT05835258|Dermatologic Agents|dermatologic agents|mesh-ancestor
65497786|NCT05835258|Sensory System Agents|sensory system agents|mesh-ancestor
65497787|NCT05835258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65497788|NCT05835245|Lenvatinib|lenvatinib|mesh-list
65497789|NCT05835245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497790|NCT05835245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65497791|NCT05835245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497792|NCT05835245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497793|NCT05835089|Estradiol|estradiol|mesh-list
65497794|NCT05835089|Testosterone|testosterone|mesh-list
65497795|NCT05835089|Estrogens|estrogens|mesh-ancestor
65497796|NCT05835089|Hormones|hormones|mesh-ancestor
65497797|NCT05835089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65497798|NCT05835089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497799|NCT05835089|Androgens|androgens|mesh-ancestor
65497800|NCT05835011|Decitabine|decitabine|mesh-list
65497801|NCT05835011|Magrolimab|magrolimab|mesh-list
65497802|NCT05835011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65497803|NCT05835011|Antimetabolites|antimetabolites|mesh-ancestor
65497804|NCT05835011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068299|NCT00417053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068300|NCT00417053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65497805|NCT05835011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497806|NCT05835011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497807|NCT05835011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65497808|NCT05834868|Insulin Lispro|insulin lispro|mesh-list
65497809|NCT05834868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64637981|NCT00185900|Anesthetics|anesthetics|mesh-ancestor
65497810|NCT05834868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497811|NCT05834855|Rituximab|rituximab|mesh-list
65497812|NCT05834855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65497813|NCT05834855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497814|NCT05834855|Immunologic Factors|immunologic factors|mesh-ancestor
65497815|NCT05834855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497816|NCT05834855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65497817|NCT05834777|Icatibant|icatibant|mesh-list
65497818|NCT05834777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65497819|NCT05834777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65497820|NCT05834777|Analgesics|analgesics|mesh-ancestor
65497821|NCT05834777|Sensory System Agents|sensory system agents|mesh-ancestor
65497822|NCT05834777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65497823|NCT05834777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497824|NCT05834777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65497825|NCT05834777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65497826|NCT05834777|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
65497827|NCT05834777|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
65497828|NCT05834777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497829|NCT05834777|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65497830|NCT05834777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65497831|NCT05834777|Immunologic Factors|immunologic factors|mesh-ancestor
65497832|NCT05834764|Maleic acid|maleic acid|mesh-list
65497833|NCT05834764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497834|NCT05834764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497835|NCT05834738|Atrasentan|atrasentan|mesh-list
65497836|NCT05834738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497837|NCT05834738|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65497838|NCT05834738|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65497839|NCT05834738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497840|NCT05834647|Lidocaine|lidocaine|mesh-list
65497841|NCT05834647|Prilocaine|prilocaine|mesh-list
65497842|NCT05834647|Anesthetics, Local|anesthetics, local|mesh-ancestor
65497843|NCT05834647|Anesthetics|anesthetics|mesh-ancestor
65497844|NCT05834647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65497845|NCT05834647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497846|NCT05834647|Sensory System Agents|sensory system agents|mesh-ancestor
65497847|NCT05834647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65497848|NCT05834647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65497849|NCT05834647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65497850|NCT05834647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65497851|NCT05834647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65497852|NCT05834647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497853|NCT05834582|Paclitaxel|paclitaxel|mesh-list
65497854|NCT05834582|Cyclophosphamide|cyclophosphamide|mesh-list
65497855|NCT05834582|Epirubicin|epirubicin|mesh-list
65497856|NCT05834582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65497857|NCT05834582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497858|NCT05834582|Tubulin Modulators|tubulin modulators|mesh-ancestor
65497859|NCT05834582|Antimitotic Agents|antimitotic agents|mesh-ancestor
65497860|NCT05834582|Mitosis Modulators|mitosis modulators|mesh-ancestor
65497861|NCT05834582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497862|NCT05834582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65497863|NCT05834582|Immunologic Factors|immunologic factors|mesh-ancestor
65497864|NCT05834582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497865|NCT05834582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65497866|NCT05834582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65497867|NCT05834582|Alkylating Agents|alkylating agents|mesh-ancestor
65497868|NCT05834582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65497869|NCT05834582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65497870|NCT05834582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65497871|NCT05834582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65497872|NCT05834582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497873|NCT05834569|Acetaminophen|acetaminophen|mesh-list
65497874|NCT05834569|Ibuprofen|ibuprofen|mesh-list
65497875|NCT05834569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65497876|NCT05834569|Analgesics|analgesics|mesh-ancestor
65068301|NCT00417053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65068302|NCT00417053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65497877|NCT05834569|Sensory System Agents|sensory system agents|mesh-ancestor
65497878|NCT05834569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65497879|NCT05834569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497880|NCT05834569|Antipyretics|antipyretics|mesh-ancestor
65497881|NCT05834569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65497882|NCT05834569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65497883|NCT05834569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65497884|NCT05834569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65497885|NCT05834569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497886|NCT05834569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497887|NCT05834543|Paclitaxel|paclitaxel|mesh-list
65497888|NCT05834543|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65497889|NCT05834543|Cisplatin|cisplatin|mesh-list
65497890|NCT05834543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65497891|NCT05834543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497892|NCT05834543|Tubulin Modulators|tubulin modulators|mesh-ancestor
65497893|NCT05834543|Antimitotic Agents|antimitotic agents|mesh-ancestor
65497894|NCT05834543|Mitosis Modulators|mitosis modulators|mesh-ancestor
65497895|NCT05834543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497896|NCT05834517|Hyaluronic Acid|hyaluronic acid|mesh-list
65497897|NCT05834517|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65497898|NCT05834517|Immunologic Factors|immunologic factors|mesh-ancestor
65497899|NCT05834517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497900|NCT05834517|Viscosupplements|viscosupplements|mesh-ancestor
65497901|NCT05834517|Protective Agents|protective agents|mesh-ancestor
65497902|NCT05834478|Fallypride|fallypride|mesh-list
65497903|NCT05834478|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65497904|NCT05834478|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65497905|NCT05834478|Dopamine Agents|dopamine agents|mesh-ancestor
65497906|NCT05834478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65497907|NCT05834478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497908|NCT05834478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497909|NCT05834361|Carboprost|carboprost|mesh-list
65497910|NCT05834361|Carboprost tromethamine|carboprost tromethamine|mesh-list
65497911|NCT05834361|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65497912|NCT05834361|Abortifacient Agents|abortifacient agents|mesh-ancestor
65497913|NCT05834361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65497914|NCT05834361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497915|NCT05834361|Oxytocics|oxytocics|mesh-ancestor
65497916|NCT05834348|Docetaxel|docetaxel|mesh-list
65497917|NCT05834348|Bevacizumab|bevacizumab|mesh-list
65497918|NCT05834348|Carboplatin|carboplatin|mesh-list
65497919|NCT05834348|Pembrolizumab|pembrolizumab|mesh-list
65497920|NCT05834348|Nivolumab|nivolumab|mesh-list
65497921|NCT05834348|Atezolizumab|atezolizumab|mesh-list
65497922|NCT05834348|Gefitinib|gefitinib|mesh-list
65497923|NCT05834348|Osimertinib|osimertinib|mesh-list
65497924|NCT05834348|Afatinib|afatinib|mesh-list
65497925|NCT05834348|Crizotinib|crizotinib|mesh-list
65497926|NCT05834348|Ceritinib|ceritinib|mesh-list
65497927|NCT05834348|Entrectinib|entrectinib|mesh-list
65497928|NCT05834348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497929|NCT05834348|Tubulin Modulators|tubulin modulators|mesh-ancestor
65497930|NCT05834348|Antimitotic Agents|antimitotic agents|mesh-ancestor
65497931|NCT05834348|Mitosis Modulators|mitosis modulators|mesh-ancestor
65497932|NCT05834348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497933|NCT05834348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65497934|NCT05834348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65497935|NCT05834348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65497936|NCT05834348|Growth Substances|growth substances|mesh-ancestor
65497937|NCT05834348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497938|NCT05834348|Growth Inhibitors|growth inhibitors|mesh-ancestor
65497939|NCT05834348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65497940|NCT05834348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65497941|NCT05834348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497942|NCT05834270|Tamsulosin|tamsulosin|mesh-list
65497943|NCT05834270|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65497944|NCT05834270|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65497945|NCT05834270|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65497946|NCT05834270|Adrenergic Agents|adrenergic agents|mesh-ancestor
65497947|NCT05834270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65497948|NCT05834270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068303|NCT00417053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65068304|NCT00417053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497949|NCT05834270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497950|NCT05834270|Urological Agents|urological agents|mesh-ancestor
64475953|NCT00462280|Lovastatin|lovastatin|mesh-list
65068305|NCT00417053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65497951|NCT05834244|Azacitidine|azacitidine|mesh-list
65497953|NCT05834244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65497955|NCT05834244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497956|NCT05834244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65497957|NCT05834244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497958|NCT05834231|Memantine|memantine|mesh-list
65497959|NCT05834231|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65497960|NCT05834231|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65497961|NCT05834231|Dopamine Agents|dopamine agents|mesh-ancestor
65497962|NCT05834231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65497963|NCT05834231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497964|NCT05834231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497965|NCT05834231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65497966|NCT05834231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65497967|NCT05834049|Midazolam|midazolam|mesh-list
65497968|NCT05834049|Anesthetics|anesthetics|mesh-ancestor
65497969|NCT05834049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65497970|NCT05834049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497971|NCT05834049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65497972|NCT05834049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65497973|NCT05834049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65497974|NCT05834049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65497975|NCT05834049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65497976|NCT05834049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65497977|NCT05834049|Anesthetics, General|anesthetics, general|mesh-ancestor
65497978|NCT05834049|GABA Modulators|gaba modulators|mesh-ancestor
65497979|NCT05834049|GABA Agents|gaba agents|mesh-ancestor
65497980|NCT05834049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65497981|NCT05834049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497982|NCT05834036|Amoxicillin|amoxicillin|mesh-list
65497983|NCT05834036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65497984|NCT05834036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65497985|NCT05833958|Metformin|metformin|mesh-list
65497986|NCT05833958|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65497987|NCT05833958|Dapagliflozin|dapagliflozin|mesh-list
65497988|NCT05833958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65497989|NCT05833958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65497990|NCT05833958|Incretins|incretins|mesh-ancestor
65497991|NCT05833958|Hormones|hormones|mesh-ancestor
65497992|NCT05833958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65497993|NCT05833958|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65497994|NCT05833958|Protease Inhibitors|protease inhibitors|mesh-ancestor
65497995|NCT05833958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65497996|NCT05833958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65497997|NCT05833958|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65497998|NCT05833776|Fentanyl|fentanyl|mesh-list
65497999|NCT05833776|Bupivacaine|bupivacaine|mesh-list
65498000|NCT05833776|Anesthetics, Local|anesthetics, local|mesh-ancestor
65498001|NCT05833776|Anesthetics|anesthetics|mesh-ancestor
65498002|NCT05833776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65498003|NCT05833776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498004|NCT05833776|Sensory System Agents|sensory system agents|mesh-ancestor
65498005|NCT05833776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65498006|NCT05833776|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65498007|NCT05833776|Narcotics|narcotics|mesh-ancestor
65498008|NCT05833776|Analgesics|analgesics|mesh-ancestor
65498009|NCT05833776|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65498010|NCT05833776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65498011|NCT05833776|Anesthetics, General|anesthetics, general|mesh-ancestor
65498012|NCT05832047|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65498013|NCT05830162|Amoxicillin|amoxicillin|mesh-list
65498014|NCT05830162|Clavulanic Acids|clavulanic acids|mesh-list
65498015|NCT05830162|Clavulanic Acid|clavulanic acid|mesh-list
65498016|NCT05830162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65498017|NCT05830162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65498018|NCT05830162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498019|NCT05830162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498020|NCT05830162|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65498021|NCT05829707|Diclofenac|diclofenac|mesh-list
65498022|NCT05829707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
65498023|NCT05829707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65498024|NCT05829707|Anesthetics|anesthetics|mesh-list
65498025|NCT05829707|Levobupivacaine|levobupivacaine|mesh-list
65068306|NCT00417053|Tubulin Modulators|tubulin modulators|mesh-ancestor
65068307|NCT00417053|Antimitotic Agents|antimitotic agents|mesh-ancestor
65498026|NCT05829707|Anesthetics, Local|anesthetics, local|mesh-list
65498027|NCT05829707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65498028|NCT05829707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498029|NCT05829707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65498030|NCT05829707|Analgesics|analgesics|mesh-ancestor
65498031|NCT05829707|Sensory System Agents|sensory system agents|mesh-ancestor
65498032|NCT05829707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65498033|NCT05829707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65498034|NCT05829707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65498035|NCT05829707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498036|NCT05829707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498038|NCT05829356|Immunologic Factors|immunologic factors|mesh-ancestor
65498039|NCT05829356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498040|NCT05823948|Insulin|insulin|mesh-list
65498041|NCT05823948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65498042|NCT05823948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498043|NCT05821556|Gemcitabine|gemcitabine|mesh-list
65498044|NCT05821556|Paclitaxel|paclitaxel|mesh-list
65498045|NCT05821556|Capecitabine|capecitabine|mesh-list
65498046|NCT05821556|Valproic Acid|valproic acid|mesh-list
65498047|NCT05821556|Simvastatin|simvastatin|mesh-list
65498048|NCT05821556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65498049|NCT05821556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498050|NCT05821556|Tubulin Modulators|tubulin modulators|mesh-ancestor
65498051|NCT05821556|Antimitotic Agents|antimitotic agents|mesh-ancestor
65498052|NCT05821556|Mitosis Modulators|mitosis modulators|mesh-ancestor
65498053|NCT05821556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498054|NCT05821556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65498055|NCT05821556|Antimetabolites|antimetabolites|mesh-ancestor
65498056|NCT05821556|Antiviral Agents|antiviral agents|mesh-ancestor
65498057|NCT05821556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65498058|NCT05821556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498059|NCT05821556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65498060|NCT05821556|Immunologic Factors|immunologic factors|mesh-ancestor
65498061|NCT05821556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498062|NCT05821556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65498063|NCT05821556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65498064|NCT05821556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65498065|NCT05821556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65498066|NCT05821556|Anticonvulsants|anticonvulsants|mesh-ancestor
65498067|NCT05821556|GABA Agents|gaba agents|mesh-ancestor
65498068|NCT05821556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65498069|NCT05821556|Antimanic Agents|antimanic agents|mesh-ancestor
65498070|NCT05821556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65498071|NCT05821556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65498072|NCT05821556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65498073|NCT05819918|Calcifediol|calcifediol|mesh-list
65498074|NCT05819918|Vitamins|vitamins|mesh-ancestor
65498075|NCT05819918|Micronutrients|micronutrients|mesh-ancestor
65498076|NCT05819918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498077|NCT05819918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65498078|NCT05810883|Insulin|insulin|mesh-list
65498079|NCT05810883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64803162|NCT01405482|Cholinergic Agents|cholinergic agents|mesh-ancestor
65498080|NCT05810883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498081|NCT05807074|Tranexamic Acid|tranexamic acid|mesh-list
65498082|NCT05807074|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65498083|NCT05807074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65498084|NCT05807074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498085|NCT05807074|Hemostatics|hemostatics|mesh-ancestor
65498086|NCT05807074|Coagulants|coagulants|mesh-ancestor
65498087|NCT05804162|Moxifloxacin|moxifloxacin|mesh-list
65498088|NCT05804162|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65498089|NCT05804162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65498090|NCT05804162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65498091|NCT05804162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65498092|NCT05804162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65498093|NCT05804162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498094|NCT05804162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498095|NCT05804162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498096|NCT05804162|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65498097|NCT05804162|Contraceptive Agents|contraceptive agents|mesh-ancestor
64476104|NCT00444028|Dopamine Agents|dopamine agents|mesh-ancestor
65498098|NCT05804162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65068308|NCT00417053|Mitosis Modulators|mitosis modulators|mesh-ancestor
65498099|NCT05804162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498100|NCT05804162|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65498101|NCT05804162|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65498102|NCT05804162|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65498103|NCT05797246|Bevacizumab|bevacizumab|mesh-list
65498104|NCT05797246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65498105|NCT05797246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498106|NCT05797246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65498107|NCT05797246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65498108|NCT05797246|Growth Substances|growth substances|mesh-ancestor
65498109|NCT05797246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498110|NCT05797246|Growth Inhibitors|growth inhibitors|mesh-ancestor
65498111|NCT05797233|Cyclophosphamide|cyclophosphamide|mesh-list
65498112|NCT05797233|Fludarabine|fludarabine|mesh-list
65498113|NCT05797233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65498114|NCT05797233|Immunologic Factors|immunologic factors|mesh-ancestor
65498115|NCT05797233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498116|NCT05797233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65498117|NCT05797233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65498118|NCT05797233|Alkylating Agents|alkylating agents|mesh-ancestor
65498119|NCT05797233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498120|NCT05797233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498121|NCT05797233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65498122|NCT05789303|Dexamethasone|dexamethasone|mesh-list
65498123|NCT05789303|Pomalidomide|pomalidomide|mesh-list
65498124|NCT05789303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65498125|NCT05789303|Antiemetics|antiemetics|mesh-ancestor
65498126|NCT05789303|Autonomic Agents|autonomic agents|mesh-ancestor
65498127|NCT05789303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65498128|NCT05789303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498129|NCT05789303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65498130|NCT05789303|Glucocorticoids|glucocorticoids|mesh-ancestor
65498131|NCT05789303|Hormones|hormones|mesh-ancestor
65498132|NCT05789303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65498133|NCT05789303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65498134|NCT05789303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498135|NCT05789303|Immunologic Factors|immunologic factors|mesh-ancestor
65498136|NCT05789303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65498137|NCT05789303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65498138|NCT05789303|Growth Substances|growth substances|mesh-ancestor
65498139|NCT05789303|Growth Inhibitors|growth inhibitors|mesh-ancestor
65498140|NCT05784363|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65498141|NCT05784363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65498142|NCT05784363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65498143|NCT05784363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498144|NCT05784363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65498145|NCT05784363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65498146|NCT05784363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498147|NCT05784363|Cholinergic Agents|cholinergic agents|mesh-ancestor
65498148|NCT05784363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65498149|NCT05777603|Vancomycin|vancomycin|mesh-list
65498150|NCT05777603|Aztreonam|aztreonam|mesh-list
65498151|NCT05777603|Pembrolizumab|pembrolizumab|mesh-list
65498152|NCT05777603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65498153|NCT05777603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498154|NCT05777603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65498155|NCT05777603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65498156|NCT05775380|Pioglitazone|pioglitazone|mesh-list
65498157|NCT05775380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65498158|NCT05775380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498159|NCT05772273|Azacitidine|azacitidine|mesh-list
65498160|NCT05772273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65498161|NCT05772273|Antimetabolites|antimetabolites|mesh-ancestor
65498162|NCT05772273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498163|NCT05772273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498164|NCT05772273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498165|NCT05765851|Trastuzumab|trastuzumab|mesh-list
65498166|NCT05765851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65498167|NCT05765851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498168|NCT05753098|Sildenafil Citrate|sildenafil citrate|mesh-list
65498169|NCT05753098|Clomiphene|clomiphene|mesh-list
65498170|NCT05753098|Enclomiphene|enclomiphene|mesh-list
65068309|NCT00281567|Tiotropium Bromide|tiotropium bromide|mesh-list
65498171|NCT05753098|Zuclomiphene|zuclomiphene|mesh-list
65498172|NCT05753098|Estrogens|estrogens|mesh-list
65498173|NCT05753098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498174|NCT05753098|Vasodilator Agents|vasodilator agents|mesh-ancestor
65498175|NCT05753098|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65498176|NCT05753098|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65498177|NCT05753098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498178|NCT05753098|Urological Agents|urological agents|mesh-ancestor
65498179|NCT05753098|Hormones|hormones|mesh-ancestor
65498180|NCT05753098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65498181|NCT05753098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498182|NCT05753098|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65498183|NCT05753098|Hormone Antagonists|hormone antagonists|mesh-ancestor
65498184|NCT05753098|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65498185|NCT05753098|Fertility Agents|fertility agents|mesh-ancestor
65498186|NCT05753098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65498187|NCT05753098|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65498188|NCT05753098|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65498189|NCT05726292|Androgens|androgens|mesh-list
65498190|NCT05726292|Hormones|hormones|mesh-ancestor
65498191|NCT05726292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65498192|NCT05726292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498193|NCT05723562|Dostarlimab-gxly|dostarlimab-gxly|mesh-list
65498194|NCT05723562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498195|NCT05713799|Thioctic Acid|thioctic acid|mesh-list
65498196|NCT05713799|Mirabegron|mirabegron|mesh-list
65498197|NCT05713799|Antioxidants|antioxidants|mesh-ancestor
65498198|NCT05713799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498199|NCT05713799|Protective Agents|protective agents|mesh-ancestor
65498200|NCT05713799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498201|NCT05713799|Vitamin B Complex|vitamin b complex|mesh-ancestor
65498202|NCT05713799|Vitamins|vitamins|mesh-ancestor
65498203|NCT05713799|Micronutrients|micronutrients|mesh-ancestor
65498204|NCT05713799|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65498205|NCT05713799|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65498206|NCT05713799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65498207|NCT05713799|Adrenergic Agents|adrenergic agents|mesh-ancestor
65498208|NCT05713799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65498209|NCT05713799|Urological Agents|urological agents|mesh-ancestor
65498210|NCT05699811|Paclitaxel|paclitaxel|mesh-list
65498211|NCT05699811|Cyclophosphamide|cyclophosphamide|mesh-list
65498212|NCT05699811|Antibodies|antibodies|mesh-list
65498213|NCT05699811|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65498214|NCT05699811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65498215|NCT05699811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498216|NCT05699811|Tubulin Modulators|tubulin modulators|mesh-ancestor
65498217|NCT05699811|Antimitotic Agents|antimitotic agents|mesh-ancestor
65498218|NCT05699811|Mitosis Modulators|mitosis modulators|mesh-ancestor
65498219|NCT05699811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498220|NCT05699811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65498221|NCT05699811|Immunologic Factors|immunologic factors|mesh-ancestor
65498222|NCT05699811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498223|NCT05699811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65498224|NCT05699811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65498225|NCT05699811|Alkylating Agents|alkylating agents|mesh-ancestor
65498226|NCT05699811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65498227|NCT05696080|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65498228|NCT05696080|Immunologic Factors|immunologic factors|mesh-ancestor
65498229|NCT05696080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498230|NCT05694013|Atezolizumab|atezolizumab|mesh-list
64803419|NCT01407016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65498231|NCT05694013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498232|NCT05692908|Immunoconjugates|immunoconjugates|mesh-list
65498233|NCT05692908|Immunologic Factors|immunologic factors|mesh-ancestor
65498234|NCT05692908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498235|NCT05692843|Cyclosporine|cyclosporine|mesh-list
65498236|NCT05692843|Cyclosporins|cyclosporins|mesh-list
65498237|NCT05692843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498238|NCT05692843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498239|NCT05692843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65498240|NCT05692843|Immunologic Factors|immunologic factors|mesh-ancestor
65498241|NCT05692843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498242|NCT05692843|Antifungal Agents|antifungal agents|mesh-ancestor
65498243|NCT05692843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65498244|NCT05692843|Dermatologic Agents|dermatologic agents|mesh-ancestor
64476249|NCT00389818|Doxorubicin|doxorubicin|mesh-list
65498245|NCT05692843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65498246|NCT05692843|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65498247|NCT05687266|Paclitaxel|paclitaxel|mesh-list
65068310|NCT00281567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65498248|NCT05687266|Carboplatin|carboplatin|mesh-list
65498249|NCT05687266|Pembrolizumab|pembrolizumab|mesh-list
65498250|NCT05687266|Pemetrexed|pemetrexed|mesh-list
65498251|NCT05687266|Durvalumab|durvalumab|mesh-list
65498252|NCT05687266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65498253|NCT05687266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498254|NCT05687266|Tubulin Modulators|tubulin modulators|mesh-ancestor
65498255|NCT05687266|Antimitotic Agents|antimitotic agents|mesh-ancestor
65498256|NCT05687266|Mitosis Modulators|mitosis modulators|mesh-ancestor
65498257|NCT05687266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498258|NCT05687266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65498259|NCT05687266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498260|NCT05687266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65498261|NCT05687266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65498262|NCT05662865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
65498263|NCT05662865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498264|NCT05662865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65498265|NCT05662865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498266|NCT05660616|Gemcitabine|gemcitabine|mesh-list
65498267|NCT05660616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65498268|NCT05660616|Antimetabolites|antimetabolites|mesh-ancestor
65498269|NCT05660616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498270|NCT05660616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498271|NCT05660616|Antiviral Agents|antiviral agents|mesh-ancestor
65498272|NCT05660616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65498273|NCT05660616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498274|NCT05660616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65498275|NCT05660616|Immunologic Factors|immunologic factors|mesh-ancestor
65498276|NCT05660616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498277|NCT05659810|Gabapentin|gabapentin|mesh-list
65498278|NCT05659810|Analgesics|analgesics|mesh-ancestor
65498279|NCT05659810|Sensory System Agents|sensory system agents|mesh-ancestor
65498280|NCT05659810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65498281|NCT05659810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498282|NCT05659810|Anticonvulsants|anticonvulsants|mesh-ancestor
65498283|NCT05659810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65498284|NCT05659810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65498285|NCT05659810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65498286|NCT05659810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65498287|NCT05659810|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65498288|NCT05659810|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65498289|NCT05659810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65498290|NCT05659810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498291|NCT05659810|Antimanic Agents|antimanic agents|mesh-ancestor
65498292|NCT05658497|Interferons|interferons|mesh-list
65498293|NCT05658497|Interferon-beta|interferon-beta|mesh-list
65498294|NCT05658497|Interferon beta-1a|interferon beta-1a|mesh-list
65498295|NCT05658497|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65498296|NCT05658497|Natalizumab|natalizumab|mesh-list
65498297|NCT05658497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498298|NCT05658497|Antiviral Agents|antiviral agents|mesh-ancestor
65498299|NCT05658497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65498300|NCT05658497|Immunologic Factors|immunologic factors|mesh-ancestor
65498301|NCT05658497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498302|NCT05658497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65498303|NCT05658497|Dermatologic Agents|dermatologic agents|mesh-ancestor
65498304|NCT05658497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65498305|NCT05652478|Tenofovir|tenofovir|mesh-list
65498306|NCT05652478|Dolutegravir|dolutegravir|mesh-list
65498307|NCT05652478|Antiviral Agents|antiviral agents|mesh-ancestor
65498308|NCT05652478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65498309|NCT05652478|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65498310|NCT05652478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65498311|NCT05652478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498312|NCT05652478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498313|NCT05652478|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65498314|NCT05652478|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65498315|NCT05652478|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65498316|NCT05652478|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65498318|NCT05651711|Dermatologic Agents|dermatologic agents|mesh-ancestor
65068311|NCT00281567|Autonomic Agents|autonomic agents|mesh-ancestor
65068312|NCT00281567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65498319|NCT05650879|Trastuzumab|trastuzumab|mesh-list
65498320|NCT05650879|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65498322|NCT05650879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65498323|NCT05650879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498324|NCT05650879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65498325|NCT05650879|Tubulin Modulators|tubulin modulators|mesh-ancestor
65498326|NCT05650879|Antimitotic Agents|antimitotic agents|mesh-ancestor
65498327|NCT05650879|Mitosis Modulators|mitosis modulators|mesh-ancestor
65498328|NCT05650879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498329|NCT05645757|Ertapenem|ertapenem|mesh-list
65498330|NCT05645757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65498331|NCT05645757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65498332|NCT05642195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
65498333|NCT05642195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65498334|NCT05642195|Immunologic Factors|immunologic factors|mesh-ancestor
65498335|NCT05642195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498336|NCT05630781|Suvorexant|suvorexant|mesh-list
65498337|NCT05630781|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65498338|NCT05630781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65498339|NCT05630781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65498340|NCT05630781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498341|NCT05630781|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
65498342|NCT05630781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65498343|NCT05630781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498344|NCT05625347|Aspirin|aspirin|mesh-list
65498345|NCT05625347|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65498346|NCT05625347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65498347|NCT05625347|Analgesics|analgesics|mesh-ancestor
65498348|NCT05625347|Sensory System Agents|sensory system agents|mesh-ancestor
65498349|NCT05625347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65498350|NCT05625347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498351|NCT05625347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65498352|NCT05625347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65498353|NCT05625347|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65498354|NCT05625347|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65498355|NCT05625347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498356|NCT05625347|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65498357|NCT05625347|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65498358|NCT05625347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498359|NCT05625347|Antipyretics|antipyretics|mesh-ancestor
65498360|NCT05624554|Cyclophosphamide|cyclophosphamide|mesh-list
65498361|NCT05624554|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65498362|NCT05624554|Rituximab|rituximab|mesh-list
65498363|NCT05624554|Fludarabine|fludarabine|mesh-list
65498364|NCT05624554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65498365|NCT05624554|Immunologic Factors|immunologic factors|mesh-ancestor
65498366|NCT05624554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498367|NCT05624554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65498368|NCT05624554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65498369|NCT05624554|Alkylating Agents|alkylating agents|mesh-ancestor
65498370|NCT05624554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498371|NCT05624554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498372|NCT05624554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65498373|NCT05624554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65498374|NCT05619913|Pembrolizumab|pembrolizumab|mesh-list
65498375|NCT05619913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65498376|NCT05619913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498377|NCT05616013|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65498378|NCT05616013|Antibodies, Blocking|antibodies, blocking|mesh-list
65498379|NCT05616013|Immunologic Factors|immunologic factors|mesh-ancestor
65498380|NCT05616013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498381|NCT05602194|Asparaginase|asparaginase|mesh-list
65498382|NCT05602194|Pegaspargase|pegaspargase|mesh-list
65498383|NCT05602194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498384|NCT05601882|Upadacitinib|upadacitinib|mesh-list
65498385|NCT05601882|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64803818|NCT01409603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65498386|NCT05601882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64803899|NCT01410201|BB 1101|bb 1101|mesh-list
65498387|NCT05601882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498388|NCT05601882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498389|NCT05601882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65498390|NCT05601336|Metformin|metformin|mesh-list
65498391|NCT05601336|Dapagliflozin|dapagliflozin|mesh-list
65498392|NCT05601336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65498393|NCT05601336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068313|NCT00281567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068314|NCT00281567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65068315|NCT00281567|Respiratory System Agents|respiratory system agents|mesh-ancestor
65498394|NCT05601336|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65498395|NCT05601336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498397|NCT05594680|Cilostazol|cilostazol|mesh-list
65498398|NCT05594680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65498399|NCT05594680|Abortifacient Agents|abortifacient agents|mesh-ancestor
65498400|NCT05594680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65498401|NCT05594680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498402|NCT05594680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65498403|NCT05594680|Antimetabolites|antimetabolites|mesh-ancestor
65498404|NCT05594680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498405|NCT05594680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498406|NCT05594680|Dermatologic Agents|dermatologic agents|mesh-ancestor
65498407|NCT05594680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498408|NCT05594680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65498409|NCT05594680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65498410|NCT05594680|Immunologic Factors|immunologic factors|mesh-ancestor
65498411|NCT05594680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65498412|NCT05594680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65498413|NCT05594680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65498414|NCT05594680|Autonomic Agents|autonomic agents|mesh-ancestor
65498415|NCT05594680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65498416|NCT05594680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65498417|NCT05594680|Respiratory System Agents|respiratory system agents|mesh-ancestor
65498418|NCT05594680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65498419|NCT05594680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65498420|NCT05594680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65498421|NCT05594680|Vasodilator Agents|vasodilator agents|mesh-ancestor
65498422|NCT05594680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65498423|NCT05594680|Protective Agents|protective agents|mesh-ancestor
65498424|NCT05594680|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65498425|NCT05594680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65498426|NCT05594563|Eflornithine|eflornithine|mesh-list
65498427|NCT05594563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498428|NCT05594563|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65498429|NCT05594563|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65498430|NCT05594563|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65498431|NCT05594563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65498432|NCT05594563|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
65498433|NCT05594563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498434|NCT05594563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498435|NCT05592379|Psilocybin|psilocybin|mesh-list
65498436|NCT05592379|Hallucinogens|hallucinogens|mesh-ancestor
65498437|NCT05592379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498438|NCT05592379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65498439|NCT05590728|Apramycin|apramycin|mesh-list
65498440|NCT05590728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65498441|NCT05590728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65498442|NCT05585151|Evolocumab|evolocumab|mesh-list
65498443|NCT05585151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65498444|NCT05585151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65498445|NCT05585151|Antimetabolites|antimetabolites|mesh-ancestor
65498446|NCT05585151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498447|NCT05585151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65498448|NCT05582694|UB-421|ub-421|mesh-list
65498449|NCT05582694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65498450|NCT05582694|Antiviral Agents|antiviral agents|mesh-ancestor
65498451|NCT05582694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65498452|NCT05578976|Prednisone|prednisone|mesh-list
65498453|NCT05578976|Cyclophosphamide|cyclophosphamide|mesh-list
65498455|NCT05578976|Doxorubicin|doxorubicin|mesh-list
65498456|NCT05578976|Vincristine|vincristine|mesh-list
65498457|NCT05578976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65498458|NCT05578976|Immunologic Factors|immunologic factors|mesh-ancestor
65498459|NCT05578976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498460|NCT05578976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65498461|NCT05578976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65498462|NCT05578976|Alkylating Agents|alkylating agents|mesh-ancestor
65498463|NCT05578976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498464|NCT05578976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498465|NCT05578976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65498466|NCT05578976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65498467|NCT05578976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65068316|NCT00281567|Parasympatholytics|parasympatholytics|mesh-ancestor
65498468|NCT05578976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65498469|NCT05578976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65498470|NCT05578976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498471|NCT05578976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65498473|NCT05578976|Hormones|hormones|mesh-ancestor
65498474|NCT05578976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65498475|NCT05578976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65498476|NCT05578976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65498477|NCT05578976|Tubulin Modulators|tubulin modulators|mesh-ancestor
65498478|NCT05578976|Antimitotic Agents|antimitotic agents|mesh-ancestor
65498479|NCT05578976|Mitosis Modulators|mitosis modulators|mesh-ancestor
65498480|NCT05569044|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65498481|NCT05567029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65498482|NCT05567029|Immunologic Factors|immunologic factors|mesh-ancestor
65498483|NCT05567029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498484|NCT05557695|Acalabrutinib|acalabrutinib|mesh-list
65498485|NCT05557695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498486|NCT05557643|Psilocybin|psilocybin|mesh-list
65498487|NCT05557643|Hallucinogens|hallucinogens|mesh-ancestor
65498488|NCT05557643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498489|NCT05557643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65498490|NCT05556512|Tirzepatide|tirzepatide|mesh-list
65498491|NCT05556512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65498492|NCT05556512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498493|NCT05556512|Incretins|incretins|mesh-ancestor
65498494|NCT05556512|Hormones|hormones|mesh-ancestor
65498495|NCT05556512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65498496|NCT05538910|Nicotine|nicotine|mesh-list
65498497|NCT05538910|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65498498|NCT05538910|Autonomic Agents|autonomic agents|mesh-ancestor
65498499|NCT05538910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65498500|NCT05538910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498501|NCT05538910|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65498502|NCT05538910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65498503|NCT05538910|Cholinergic Agents|cholinergic agents|mesh-ancestor
65498504|NCT05538910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65498505|NCT05538910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498506|NCT05533775|Rituximab|rituximab|mesh-list
65498507|NCT05533775|Obinutuzumab|obinutuzumab|mesh-list
65498508|NCT05533775|Carboplatin|carboplatin|mesh-list
65498509|NCT05533775|Etoposide|etoposide|mesh-list
65498510|NCT05533775|Ifosfamide|ifosfamide|mesh-list
65498511|NCT05533775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65498512|NCT05533775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498513|NCT05533775|Immunologic Factors|immunologic factors|mesh-ancestor
65498514|NCT05533775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498515|NCT05533775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65498516|NCT05533775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65498517|NCT05533775|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65498518|NCT05533775|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65498519|NCT05533775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498520|NCT05533775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498521|NCT05533775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65498522|NCT05533775|Alkylating Agents|alkylating agents|mesh-ancestor
65498523|NCT05526443|Antineoplastic Agents|antineoplastic agents|mesh-list
65498524|NCT05510063|Adalimumab|adalimumab|mesh-list
65498525|NCT05510063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65498526|NCT05510063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65498527|NCT05488457|Oxytocin|oxytocin|mesh-list
65498528|NCT05488457|Oxytocics|oxytocics|mesh-ancestor
65498529|NCT05488457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65498530|NCT05488457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498532|NCT05470283|Fludarabine|fludarabine|mesh-list
65498533|NCT05470283|Fludarabine phosphate|fludarabine phosphate|mesh-list
65498534|NCT05470283|Furosemide|furosemide|mesh-list
65498535|NCT05470283|Acetazolamide|acetazolamide|mesh-list
65498536|NCT05470283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65498537|NCT05470283|Immunologic Factors|immunologic factors|mesh-ancestor
65498538|NCT05470283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498539|NCT05470283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64476549|NCT00529126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65498540|NCT05470283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65498541|NCT05470283|Alkylating Agents|alkylating agents|mesh-ancestor
65068317|NCT00281567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65068318|NCT00281567|Cholinergic Agents|cholinergic agents|mesh-ancestor
65498542|NCT05470283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498543|NCT05470283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498544|NCT05470283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65498545|NCT05470283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65498546|NCT05470283|Antimetabolites|antimetabolites|mesh-ancestor
64804021|NCT01411176|Menthol|menthol|mesh-list
65498547|NCT05470283|Diuretics|diuretics|mesh-ancestor
65498548|NCT05470283|Natriuretic Agents|natriuretic agents|mesh-ancestor
65498549|NCT05470283|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65498550|NCT05470283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65498551|NCT05470283|Anticonvulsants|anticonvulsants|mesh-ancestor
65498552|NCT05470283|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65498553|NCT05470283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498554|NCT05469737|Azacitidine|azacitidine|mesh-list
65498555|NCT05469737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65498556|NCT05469737|Antimetabolites|antimetabolites|mesh-ancestor
65498557|NCT05469737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498558|NCT05469737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498559|NCT05469737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498560|NCT05422534|Ubiquinone|ubiquinone|mesh-list
65498561|NCT05422534|Micronutrients|micronutrients|mesh-ancestor
65498562|NCT05422534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498563|NCT05411081|Atezolizumab|atezolizumab|mesh-list
65498564|NCT05411081|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65498565|NCT05411081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498566|NCT05411081|Immunologic Factors|immunologic factors|mesh-ancestor
65498567|NCT05411081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498568|NCT05404945|Doxorubicin|doxorubicin|mesh-list
65498569|NCT05404945|Pembrolizumab|pembrolizumab|mesh-list
65498570|NCT05404945|Dacarbazine|dacarbazine|mesh-list
65498571|NCT05404945|Brentuximab Vedotin|brentuximab vedotin|mesh-list
65498572|NCT05404945|Vinblastine|vinblastine|mesh-list
65498573|NCT05404945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65498574|NCT05404945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498575|NCT05404945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65498576|NCT05404945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65498577|NCT05404945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498578|NCT05404945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498579|NCT05404945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65498580|NCT05404945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65498581|NCT05404945|Alkylating Agents|alkylating agents|mesh-ancestor
65498582|NCT05404945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65498583|NCT05404945|Tubulin Modulators|tubulin modulators|mesh-ancestor
65498584|NCT05404945|Antimitotic Agents|antimitotic agents|mesh-ancestor
65498585|NCT05404945|Mitosis Modulators|mitosis modulators|mesh-ancestor
65498586|NCT05389423|Prednisone|prednisone|mesh-list
65498587|NCT05389423|Cyclophosphamide|cyclophosphamide|mesh-list
65498588|NCT05389423|Rituximab|rituximab|mesh-list
65498589|NCT05389423|Doxorubicin|doxorubicin|mesh-list
65498590|NCT05389423|Etoposide|etoposide|mesh-list
65498591|NCT05389423|Vincristine|vincristine|mesh-list
65498592|NCT05389423|Pomalidomide|pomalidomide|mesh-list
65498593|NCT05389423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65498594|NCT05389423|Immunologic Factors|immunologic factors|mesh-ancestor
65498595|NCT05389423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498596|NCT05389423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65498597|NCT05389423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65498598|NCT05389423|Alkylating Agents|alkylating agents|mesh-ancestor
65498599|NCT05389423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498600|NCT05389423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498601|NCT05389423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65498602|NCT05389423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65498603|NCT05389423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65498604|NCT05389423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65498605|NCT05389423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65498606|NCT05389423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498607|NCT05389423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65498608|NCT05389423|Glucocorticoids|glucocorticoids|mesh-ancestor
65498609|NCT05389423|Hormones|hormones|mesh-ancestor
65498610|NCT05389423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65498611|NCT05389423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65498612|NCT05389423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65498613|NCT05389423|Tubulin Modulators|tubulin modulators|mesh-ancestor
65498614|NCT05389423|Antimitotic Agents|antimitotic agents|mesh-ancestor
65498615|NCT05389423|Mitosis Modulators|mitosis modulators|mesh-ancestor
65498616|NCT05389423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65498617|NCT05389423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65498618|NCT05389423|Growth Substances|growth substances|mesh-ancestor
65498619|NCT05389423|Growth Inhibitors|growth inhibitors|mesh-ancestor
65498620|NCT05365451|Metformin|metformin|mesh-list
65498621|NCT05365451|Probenecid|probenecid|mesh-list
65498622|NCT05365451|Furosemide|furosemide|mesh-list
65498623|NCT05365451|Cimetidine|cimetidine|mesh-list
65498624|NCT05365451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65498625|NCT05365451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498626|NCT05365451|Diuretics|diuretics|mesh-ancestor
65498627|NCT05365451|Natriuretic Agents|natriuretic agents|mesh-ancestor
65498628|NCT05365451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65498629|NCT05365451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65498630|NCT05365451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498631|NCT05365451|Uricosuric Agents|uricosuric agents|mesh-ancestor
65498632|NCT05365451|Gout Suppressants|gout suppressants|mesh-ancestor
65498633|NCT05365451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65498634|NCT05365451|Renal Agents|renal agents|mesh-ancestor
65498635|NCT05365451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65498636|NCT05365451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65498637|NCT05365451|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65498638|NCT05365451|Histamine Antagonists|histamine antagonists|mesh-ancestor
65498639|NCT05365451|Histamine Agents|histamine agents|mesh-ancestor
65498640|NCT05365451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65498641|NCT05365451|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65498642|NCT05365451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65498643|NCT05365451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498644|NCT05350774|Immunoglobulins|immunoglobulins|mesh-list
65498645|NCT05350774|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65498646|NCT05350774|Antibodies|antibodies|mesh-list
65498647|NCT05350774|gamma-Globulins|gamma-globulins|mesh-list
65498648|NCT05350774|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65498649|NCT05350774|Immunologic Factors|immunologic factors|mesh-ancestor
65498650|NCT05350774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498651|NCT05333458|Atezolizumab|atezolizumab|mesh-list
65498652|NCT05333458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65498653|NCT05333458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498654|NCT05333458|Immunologic Factors|immunologic factors|mesh-ancestor
65498655|NCT05333458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498656|NCT05325593|Dexamethasone|dexamethasone|mesh-list
65498657|NCT05325593|Dexamethasone acetate|dexamethasone acetate|mesh-list
65498658|NCT05325593|BB 1101|bb 1101|mesh-list
65498659|NCT05325593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65498660|NCT05325593|Antiemetics|antiemetics|mesh-ancestor
65498661|NCT05325593|Autonomic Agents|autonomic agents|mesh-ancestor
65498662|NCT05325593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65498663|NCT05325593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498664|NCT05325593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65498665|NCT05325593|Glucocorticoids|glucocorticoids|mesh-ancestor
65498666|NCT05325593|Hormones|hormones|mesh-ancestor
65498667|NCT05325593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65498668|NCT05325593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65498669|NCT05325593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498670|NCT05325593|Protease Inhibitors|protease inhibitors|mesh-ancestor
65498671|NCT05325593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498672|NCT05325593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498673|NCT05322967|Antihypertensive Agents|antihypertensive agents|mesh-list
65498674|NCT05321121|Dexmedetomidine|dexmedetomidine|mesh-list
65498675|NCT05321121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65498676|NCT05321121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65498677|NCT05321121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498678|NCT05321121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65498679|NCT05321121|Analgesics|analgesics|mesh-ancestor
65498680|NCT05321121|Sensory System Agents|sensory system agents|mesh-ancestor
65498681|NCT05321121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65498682|NCT05321121|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65498683|NCT05321121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65498684|NCT05321121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65498685|NCT05321121|Adrenergic Agents|adrenergic agents|mesh-ancestor
65068320|NCT00281567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068321|NCT00317499|Etanercept|etanercept|mesh-list
65068322|NCT00317499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65498686|NCT05321121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65068323|NCT00317499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65498687|NCT05321121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498688|NCT05315713|Atezolizumab|atezolizumab|mesh-list
65498689|NCT05315713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498690|NCT05310734|Benzyl Alcohol|benzyl alcohol|mesh-list
65498691|NCT05310734|Anesthetics, Local|anesthetics, local|mesh-ancestor
65498692|NCT05310734|Anesthetics|anesthetics|mesh-ancestor
65498693|NCT05310734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65498694|NCT05310734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498695|NCT05310734|Sensory System Agents|sensory system agents|mesh-ancestor
65498696|NCT05310734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65498697|NCT05286827|Olaparib|olaparib|mesh-list
65498698|NCT05286827|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65498699|NCT05286827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498700|NCT05286827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498701|NCT05286827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498702|NCT05284747|Evolocumab|evolocumab|mesh-list
65498703|NCT05284747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65498704|NCT05284747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65498705|NCT05284747|Antimetabolites|antimetabolites|mesh-ancestor
65498706|NCT05284747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498707|NCT05284747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65498708|NCT05284552|Tinzaparin|tinzaparin|mesh-list
65498709|NCT05284552|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65498710|NCT05284552|Dalteparin|dalteparin|mesh-list
65498711|NCT05284552|Anticoagulants|anticoagulants|mesh-ancestor
65498712|NCT05284552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65498713|NCT05284552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65498714|NCT05284552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498715|NCT05281614|Etanercept|etanercept|mesh-list
65498716|NCT05281614|Vedolizumab|vedolizumab|mesh-list
65498717|NCT05281614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65498718|NCT05281614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65498719|NCT05281614|Analgesics|analgesics|mesh-ancestor
65498720|NCT05281614|Sensory System Agents|sensory system agents|mesh-ancestor
65498721|NCT05281614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65498722|NCT05281614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498723|NCT05281614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65498724|NCT05281614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65498725|NCT05281614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65498726|NCT05281614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65498727|NCT05281614|Immunologic Factors|immunologic factors|mesh-ancestor
65498728|NCT05267613|Esomeprazole|esomeprazole|mesh-list
65498729|NCT05267613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65498730|NCT05267613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65498731|NCT05267613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65498732|NCT05267613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498733|NCT05267613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498734|NCT05267470|Paclitaxel|paclitaxel|mesh-list
65498735|NCT05267470|Docetaxel|docetaxel|mesh-list
65498736|NCT05267470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65498737|NCT05267470|Carboplatin|carboplatin|mesh-list
65498738|NCT05267470|Pembrolizumab|pembrolizumab|mesh-list
65498739|NCT05267470|Bemarituzumab|bemarituzumab|mesh-list
65498740|NCT05267470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65498741|NCT05267470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498742|NCT05267470|Tubulin Modulators|tubulin modulators|mesh-ancestor
65498743|NCT05267470|Antimitotic Agents|antimitotic agents|mesh-ancestor
65498744|NCT05267470|Mitosis Modulators|mitosis modulators|mesh-ancestor
65498745|NCT05267470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498746|NCT05267470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65498747|NCT05228288|Pyrithione zinc|pyrithione zinc|mesh-list
65498748|NCT05228288|Keratolytic Agents|keratolytic agents|mesh-ancestor
65498749|NCT05228288|Dermatologic Agents|dermatologic agents|mesh-ancestor
65498750|NCT05215574|Pembrolizumab|pembrolizumab|mesh-list
65498751|NCT05215574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65498752|NCT05215574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498753|NCT05215418|Topiramate|topiramate|mesh-list
65498754|NCT05215418|Phentermine|phentermine|mesh-list
65498755|NCT05215418|Anticonvulsants|anticonvulsants|mesh-ancestor
65498756|NCT05215418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65498757|NCT05215418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498758|NCT05215418|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65498759|NCT05215418|Appetite Depressants|appetite depressants|mesh-ancestor
65498760|NCT05215418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65498761|NCT05215418|Sympathomimetics|sympathomimetics|mesh-ancestor
65498762|NCT05215418|Autonomic Agents|autonomic agents|mesh-ancestor
65498763|NCT05215418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65498764|NCT05215418|Adrenergic Agents|adrenergic agents|mesh-ancestor
65498765|NCT05215418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65498766|NCT05215418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498767|NCT05211323|Gemcitabine|gemcitabine|mesh-list
65498768|NCT05211323|Bevacizumab|bevacizumab|mesh-list
65498769|NCT05211323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65498770|NCT05211323|Cisplatin|cisplatin|mesh-list
65498771|NCT05211323|Atezolizumab|atezolizumab|mesh-list
65498772|NCT05211323|Endothelial Growth Factors|endothelial growth factors|mesh-list
65498773|NCT05211323|Antibodies|antibodies|mesh-list
65498774|NCT05211323|Immunoglobulins|immunoglobulins|mesh-list
65498775|NCT05211323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65498776|NCT05211323|Immunoglobulin G|immunoglobulin g|mesh-list
65498777|NCT05211323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498778|NCT05211323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65498779|NCT05211323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65498780|NCT05211323|Growth Substances|growth substances|mesh-ancestor
65498781|NCT05211323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498782|NCT05211323|Growth Inhibitors|growth inhibitors|mesh-ancestor
65498783|NCT05211323|Immunologic Factors|immunologic factors|mesh-ancestor
65498784|NCT05211323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65498785|NCT05211323|Antimetabolites|antimetabolites|mesh-ancestor
65498786|NCT05211323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498787|NCT05211323|Antiviral Agents|antiviral agents|mesh-ancestor
65498788|NCT05211323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65498789|NCT05211323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498790|NCT05211323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65498791|NCT05203510|Treprostinil|treprostinil|mesh-list
65498792|NCT05203510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65498793|NCT05186974|Carboplatin|carboplatin|mesh-list
65498794|NCT05186974|Pembrolizumab|pembrolizumab|mesh-list
65498795|NCT05186974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498796|NCT05186974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65498797|NCT05185089|Maleic acid|maleic acid|mesh-list
65498798|NCT05185089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498799|NCT05185089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498800|NCT05172908|Dexamethasone|dexamethasone|mesh-list
65498801|NCT05172908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65498802|NCT05172908|Antiemetics|antiemetics|mesh-ancestor
65498803|NCT05172908|Autonomic Agents|autonomic agents|mesh-ancestor
65498804|NCT05172908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65498805|NCT05172908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498806|NCT05172908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65498807|NCT05172908|Glucocorticoids|glucocorticoids|mesh-ancestor
65498808|NCT05172908|Hormones|hormones|mesh-ancestor
65498809|NCT05172908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65498810|NCT05172908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65498811|NCT05172908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498812|NCT05144009|Rituximab|rituximab|mesh-list
65498813|NCT05144009|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
65498814|NCT05144009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65498815|NCT05144009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498816|NCT05144009|Immunologic Factors|immunologic factors|mesh-ancestor
65498817|NCT05144009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498818|NCT05144009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65498819|NCT05141721|Leucovorin|leucovorin|mesh-list
65498820|NCT05141721|Bevacizumab|bevacizumab|mesh-list
65498821|NCT05141721|Ipilimumab|ipilimumab|mesh-list
65498822|NCT05141721|Atezolizumab|atezolizumab|mesh-list
65498823|NCT05141721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65498824|NCT05141721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498825|NCT05141721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65498826|NCT05141721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65498827|NCT05141721|Growth Substances|growth substances|mesh-ancestor
65498828|NCT05141721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498829|NCT05141721|Growth Inhibitors|growth inhibitors|mesh-ancestor
65498830|NCT05141721|Antidotes|antidotes|mesh-ancestor
65498831|NCT05141721|Protective Agents|protective agents|mesh-ancestor
65498832|NCT05141721|Vitamin B Complex|vitamin b complex|mesh-ancestor
65498833|NCT05141721|Vitamins|vitamins|mesh-ancestor
65498834|NCT05141721|Micronutrients|micronutrients|mesh-ancestor
65498835|NCT05141721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65068324|NCT00317499|Analgesics|analgesics|mesh-ancestor
65498836|NCT05141721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476834|NCT00498550|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65498837|NCT05136196|Nivolumab|nivolumab|mesh-list
65498838|NCT05136196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65498839|NCT05136196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498840|NCT05136196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65498841|NCT05136196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498842|NCT05108428|Capecitabine|capecitabine|mesh-list
65498843|NCT05108428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65498844|NCT05108428|Antimetabolites|antimetabolites|mesh-ancestor
65498845|NCT05108428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498846|NCT05108428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498847|NCT05101551|Gemcitabine|gemcitabine|mesh-list
65498848|NCT05101551|Topotecan|topotecan|mesh-list
65498849|NCT05101551|Talazoparib|talazoparib|mesh-list
64804364|NCT01414231|Cytarabine|cytarabine|mesh-list
65498850|NCT05101551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65498851|NCT05101551|Antimetabolites|antimetabolites|mesh-ancestor
65498852|NCT05101551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498853|NCT05101551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498854|NCT05101551|Antiviral Agents|antiviral agents|mesh-ancestor
65498855|NCT05101551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65498856|NCT05101551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498857|NCT05101551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65498858|NCT05101551|Immunologic Factors|immunologic factors|mesh-ancestor
65498859|NCT05101551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498860|NCT05101551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65498861|NCT05101551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65498862|NCT05101551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65498863|NCT05092958|Avelumab|avelumab|mesh-list
65498864|NCT05092958|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65498865|NCT05092958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65498866|NCT05092958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498867|NCT05092958|Immunologic Factors|immunologic factors|mesh-ancestor
65498868|NCT05092958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498869|NCT05091567|Carboplatin|carboplatin|mesh-list
65498870|NCT05091567|Etoposide|etoposide|mesh-list
65498871|NCT05091567|Atezolizumab|atezolizumab|mesh-list
65498872|NCT05091567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498873|NCT05091567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65498874|NCT05091567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65498875|NCT05091567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65498876|NCT05091567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498877|NCT05091567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498878|NCT05077904|Alprazolam|alprazolam|mesh-list
65498879|NCT05077904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65498880|NCT05077904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65498881|NCT05077904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498882|NCT05077904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65498883|NCT05077904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65498884|NCT05077904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65498885|NCT05077904|GABA Modulators|gaba modulators|mesh-ancestor
65498886|NCT05077904|GABA Agents|gaba agents|mesh-ancestor
65498887|NCT05077904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65498888|NCT05077904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498889|NCT05076617|Alprazolam|alprazolam|mesh-list
65498890|NCT05076617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65498891|NCT05076617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65498892|NCT05076617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498893|NCT05076617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65498894|NCT05076617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65498895|NCT05076617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65498896|NCT05076617|GABA Modulators|gaba modulators|mesh-ancestor
65498897|NCT05076617|GABA Agents|gaba agents|mesh-ancestor
65498898|NCT05076617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65498899|NCT05076617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498900|NCT05058651|Cisplatin|cisplatin|mesh-list
65498901|NCT05058651|Carboplatin|carboplatin|mesh-list
65498902|NCT05058651|Etoposide|etoposide|mesh-list
65498903|NCT05058651|Etoposide phosphate|etoposide phosphate|mesh-list
65498904|NCT05058651|Atezolizumab|atezolizumab|mesh-list
65498905|NCT05058651|Podophyllotoxin|podophyllotoxin|mesh-list
65498906|NCT05058651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65498907|NCT05058651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498908|NCT05058651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65498909|NCT05058651|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65498910|NCT05058651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65498911|NCT05058651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64476909|NCT00500656|Analgesics|analgesics|mesh-ancestor
65498912|NCT05058651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498913|NCT05058651|Immunologic Factors|immunologic factors|mesh-ancestor
65068325|NCT00317499|Sensory System Agents|sensory system agents|mesh-ancestor
65498914|NCT05058651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498915|NCT05058651|Keratolytic Agents|keratolytic agents|mesh-ancestor
65498916|NCT05058651|Dermatologic Agents|dermatologic agents|mesh-ancestor
65498917|NCT05058651|Tubulin Modulators|tubulin modulators|mesh-ancestor
65498918|NCT05058651|Antimitotic Agents|antimitotic agents|mesh-ancestor
65498919|NCT05058651|Mitosis Modulators|mitosis modulators|mesh-ancestor
65498920|NCT05053737|Atezolizumab|atezolizumab|mesh-list
65498921|NCT05053737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498922|NCT05052801|Bemarituzumab|bemarituzumab|mesh-list
65498923|NCT05052801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65498924|NCT05052801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498925|NCT05041153|Pembrolizumab|pembrolizumab|mesh-list
65498926|NCT05041153|Lenvatinib|lenvatinib|mesh-list
65498927|NCT05041153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65498928|NCT05041153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498929|NCT05041153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65498930|NCT05041153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498931|NCT05041153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498932|NCT05019703|Atezolizumab|atezolizumab|mesh-list
65498933|NCT05019703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65498934|NCT05019703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498935|NCT05019703|Immunologic Factors|immunologic factors|mesh-ancestor
65498936|NCT05019703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498937|NCT05017571|Colchicine|colchicine|mesh-list
65498938|NCT05017571|Gout Suppressants|gout suppressants|mesh-ancestor
65498939|NCT05017571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65498940|NCT05017571|Tubulin Modulators|tubulin modulators|mesh-ancestor
65498941|NCT05017571|Antimitotic Agents|antimitotic agents|mesh-ancestor
65498942|NCT05017571|Mitosis Modulators|mitosis modulators|mesh-ancestor
65498943|NCT05017571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498944|NCT05017571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498945|NCT04994808|Fludarabine|fludarabine|mesh-list
65498946|NCT04994808|Clofarabine|clofarabine|mesh-list
65498947|NCT04994808|Treosulfan|treosulfan|mesh-list
65498948|NCT04994808|Busulfan|busulfan|mesh-list
65498949|NCT04994808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498950|NCT04994808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65498951|NCT04994808|Antimetabolites|antimetabolites|mesh-ancestor
65498952|NCT04994808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498953|NCT04994808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65498954|NCT04994808|Immunologic Factors|immunologic factors|mesh-ancestor
65498955|NCT04994808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498956|NCT04994808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65498957|NCT04994808|Alkylating Agents|alkylating agents|mesh-ancestor
65498958|NCT04994808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65498959|NCT04977024|Vaccines|vaccines|mesh-list
65498960|NCT04977024|Immunologic Factors|immunologic factors|mesh-ancestor
65498961|NCT04977024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498962|NCT04960709|Durvalumab|durvalumab|mesh-list
65498963|NCT04960709|Tremelimumab|tremelimumab|mesh-list
65498964|NCT04960709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65498965|NCT04960709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498966|NCT04955938|Ivosidenib|ivosidenib|mesh-list
65498967|NCT04955938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498968|NCT04955938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498969|NCT04955938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498971|NCT04938830|Antiviral Agents|antiviral agents|mesh-ancestor
65498972|NCT04938830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65498973|NCT04928846|Docetaxel|docetaxel|mesh-list
65498974|NCT04928846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498975|NCT04928846|Tubulin Modulators|tubulin modulators|mesh-ancestor
65498976|NCT04928846|Antimitotic Agents|antimitotic agents|mesh-ancestor
65498977|NCT04928846|Mitosis Modulators|mitosis modulators|mesh-ancestor
65498978|NCT04928846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498979|NCT04915183|Atorvastatin|atorvastatin|mesh-list
65498980|NCT04915183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65498981|NCT04915183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65498982|NCT04915183|Antimetabolites|antimetabolites|mesh-ancestor
65498983|NCT04915183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65498984|NCT04915183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65498985|NCT04915183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65498986|NCT04915183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65498987|NCT04907851|Denosumab|denosumab|mesh-list
65498988|NCT04907851|Pembrolizumab|pembrolizumab|mesh-list
65498989|NCT04907851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65498990|NCT04907851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498991|NCT04907851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65498992|NCT04907851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65498993|NCT04905693|Treprostinil|treprostinil|mesh-list
65498994|NCT04905693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65498995|NCT04895722|Pembrolizumab|pembrolizumab|mesh-list
65498996|NCT04895722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65498997|NCT04895722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65498998|NCT04890093|Vincristine|vincristine|mesh-list
65498999|NCT04890093|Temozolomide|temozolomide|mesh-list
65499000|NCT04890093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65499001|NCT04890093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499002|NCT04890093|Tubulin Modulators|tubulin modulators|mesh-ancestor
65499003|NCT04890093|Antimitotic Agents|antimitotic agents|mesh-ancestor
65499004|NCT04890093|Mitosis Modulators|mitosis modulators|mesh-ancestor
65499005|NCT04890093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499006|NCT04890093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65499007|NCT04890093|Alkylating Agents|alkylating agents|mesh-ancestor
65499008|NCT04879589|Abiraterone Acetate|abiraterone acetate|mesh-list
65499009|NCT04879589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499010|NCT04879589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65499011|NCT04879589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499012|NCT04879589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499013|NCT04879589|Hormone Antagonists|hormone antagonists|mesh-ancestor
65499014|NCT04879589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65499015|NCT04879589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499016|NCT04879589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65499018|NCT04872608|Palbociclib|palbociclib|mesh-list
65499019|NCT04872608|Onapristone|onapristone|mesh-list
65499020|NCT04872608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499021|NCT04872608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65499022|NCT04872608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65499023|NCT04872608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499024|NCT04872608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499025|NCT04872608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65499026|NCT04872608|Hormone Antagonists|hormone antagonists|mesh-ancestor
65499027|NCT04872608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65499028|NCT04872608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499029|NCT04872608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65499030|NCT04872608|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65499031|NCT04872608|Fertility Agents|fertility agents|mesh-ancestor
65499032|NCT04872608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65499033|NCT04869501|Atezolizumab|atezolizumab|mesh-list
65499034|NCT04869501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499035|NCT04831398|Melatonin|melatonin|mesh-list
65499036|NCT04831398|Antioxidants|antioxidants|mesh-ancestor
65499037|NCT04831398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499038|NCT04831398|Protective Agents|protective agents|mesh-ancestor
65499039|NCT04831398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499040|NCT04831398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65499041|NCT04826484|Bupivacaine|bupivacaine|mesh-list
65499042|NCT04826484|Anesthetics, Local|anesthetics, local|mesh-ancestor
65499043|NCT04826484|Anesthetics|anesthetics|mesh-ancestor
65499044|NCT04826484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65499045|NCT04826484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499046|NCT04826484|Sensory System Agents|sensory system agents|mesh-ancestor
65499047|NCT04826484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65499048|NCT04818216|Niacinamide|niacinamide|mesh-list
65499049|NCT04818216|Niacin|niacin|mesh-list
65499050|NCT04818216|Nicotinic Acids|nicotinic acids|mesh-list
65499051|NCT04818216|Vitamin B Complex|vitamin b complex|mesh-ancestor
65499052|NCT04818216|Vitamins|vitamins|mesh-ancestor
65499053|NCT04818216|Micronutrients|micronutrients|mesh-ancestor
65499054|NCT04818216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499055|NCT04818216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65499056|NCT04818216|Antimetabolites|antimetabolites|mesh-ancestor
65499057|NCT04818216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499058|NCT04818216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65499059|NCT04818216|Vasodilator Agents|vasodilator agents|mesh-ancestor
65499060|NCT04804553|Apremilast|apremilast|mesh-list
65499061|NCT04804553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65499062|NCT04804553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65068326|NCT00317499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65499063|NCT04804553|Analgesics|analgesics|mesh-ancestor
65499064|NCT04804553|Sensory System Agents|sensory system agents|mesh-ancestor
65499065|NCT04804553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65499066|NCT04804553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499067|NCT04804553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65499068|NCT04804553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65499069|NCT04804553|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65499070|NCT04804553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65499071|NCT04804553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499072|NCT04804553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499073|NCT04801849|Vitamin E|vitamin e|mesh-list
65499074|NCT04801849|Tocopherols|tocopherols|mesh-list
65499075|NCT04801849|alpha-Tocopherol|alpha-tocopherol|mesh-list
65499076|NCT04801849|Vitamins|vitamins|mesh-ancestor
65499077|NCT04801849|Micronutrients|micronutrients|mesh-ancestor
65499078|NCT04801849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499079|NCT04801849|Antioxidants|antioxidants|mesh-ancestor
65499080|NCT04801849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499081|NCT04801849|Protective Agents|protective agents|mesh-ancestor
65499082|NCT04793958|Cetuximab|cetuximab|mesh-list
65499083|NCT04793958|Adagrasib|adagrasib|mesh-list
65499084|NCT04793958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499085|NCT04793958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499086|NCT04775953|Vancomycin|vancomycin|mesh-list
65499087|NCT04775953|Cefazolin|cefazolin|mesh-list
65499088|NCT04775953|Daptomycin|daptomycin|mesh-list
65499089|NCT04775953|Dalbavancin|dalbavancin|mesh-list
65499090|NCT04775953|Oxacillin|oxacillin|mesh-list
65499091|NCT04775953|Nafcillin|nafcillin|mesh-list
65499092|NCT04775953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65499093|NCT04775953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65499094|NCT04775082|Liraglutide|liraglutide|mesh-list
65499095|NCT04775082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65499096|NCT04775082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499097|NCT04775082|Incretins|incretins|mesh-ancestor
65499098|NCT04775082|Hormones|hormones|mesh-ancestor
65499099|NCT04775082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65499100|NCT04770896|Sorafenib|sorafenib|mesh-list
65499101|NCT04770896|Atezolizumab|atezolizumab|mesh-list
65499102|NCT04770896|Lenvatinib|lenvatinib|mesh-list
65499103|NCT04770896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499104|NCT04770896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65499105|NCT04770896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499106|NCT04770896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499107|NCT04739813|Prednisone|prednisone|mesh-list
65499108|NCT04739813|Lenalidomide|lenalidomide|mesh-list
65499109|NCT04739813|Venetoclax|venetoclax|mesh-list
65499110|NCT04739813|Obinutuzumab|obinutuzumab|mesh-list
65499111|NCT04739813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65499112|NCT04739813|Glucocorticoids|glucocorticoids|mesh-ancestor
65499113|NCT04739813|Hormones|hormones|mesh-ancestor
65499114|NCT04739813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65499115|NCT04739813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499116|NCT04739813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65499117|NCT04739813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499118|NCT04739813|Immunologic Factors|immunologic factors|mesh-ancestor
65499119|NCT04739813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65499120|NCT04739813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65499121|NCT04739813|Growth Substances|growth substances|mesh-ancestor
65499122|NCT04739813|Growth Inhibitors|growth inhibitors|mesh-ancestor
65499123|NCT04739813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499124|NCT04714359|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65499125|NCT04714359|Hallucinogens|hallucinogens|mesh-ancestor
65499126|NCT04714359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499127|NCT04714359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65499128|NCT04714359|Serotonin Agents|serotonin agents|mesh-ancestor
65499129|NCT04714359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65499130|NCT04714359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499131|NCT04714359|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65499132|NCT04714359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64477128|NCT01428063|Ribavirin|ribavirin|mesh-list
65499133|NCT04714359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65499134|NCT04714359|Adrenergic Agents|adrenergic agents|mesh-ancestor
65499135|NCT04711252|Palbociclib|palbociclib|mesh-list
65499136|NCT04711252|Anastrozole|anastrozole|mesh-list
65499137|NCT04711252|Hormones|hormones|mesh-list
65499138|NCT04711252|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65499139|NCT04711252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65499140|NCT04711252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499141|NCT04711252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499142|NCT04711252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65499143|NCT04711252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499144|NCT04711252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499145|NCT04711252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65499146|NCT04711252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65499147|NCT04711252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65499148|NCT04711252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65499149|NCT04711252|Hormone Antagonists|hormone antagonists|mesh-ancestor
65499151|NCT04708782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65499152|NCT04697628|Gemcitabine|gemcitabine|mesh-list
65499153|NCT04697628|Irinotecan|irinotecan|mesh-list
65499154|NCT04697628|Pemetrexed|pemetrexed|mesh-list
65499155|NCT04697628|Topotecan|topotecan|mesh-list
65499156|NCT04697628|Vinorelbine|vinorelbine|mesh-list
65499157|NCT04697628|Tisotumab vedotin|tisotumab vedotin|mesh-list
65499158|NCT04697628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65499159|NCT04697628|Antimetabolites|antimetabolites|mesh-ancestor
65499160|NCT04697628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499161|NCT04697628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499162|NCT04697628|Antiviral Agents|antiviral agents|mesh-ancestor
65499163|NCT04697628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65499164|NCT04697628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499165|NCT04697628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65499166|NCT04697628|Immunologic Factors|immunologic factors|mesh-ancestor
65499167|NCT04697628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499168|NCT04697628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65499169|NCT04697628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65499170|NCT04697628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65499171|NCT04697628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65499172|NCT04697628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65499173|NCT04697628|Tubulin Modulators|tubulin modulators|mesh-ancestor
65499174|NCT04697628|Antimitotic Agents|antimitotic agents|mesh-ancestor
65499175|NCT04697628|Mitosis Modulators|mitosis modulators|mesh-ancestor
65499176|NCT04697628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499177|NCT04639466|Vaccines|vaccines|mesh-list
65499178|NCT04639466|Immunologic Factors|immunologic factors|mesh-ancestor
65499179|NCT04639466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499180|NCT04635839|Heparin|heparin|mesh-list
65499181|NCT04635839|Calcium heparin|calcium heparin|mesh-list
65499182|NCT04635839|Anticoagulants|anticoagulants|mesh-ancestor
65499183|NCT04635839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65499184|NCT04635839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65499185|NCT04635839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499186|NCT04628767|Gemcitabine|gemcitabine|mesh-list
65499187|NCT04628767|Cisplatin|cisplatin|mesh-list
65499188|NCT04628767|Doxorubicin|doxorubicin|mesh-list
65499189|NCT04628767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65499190|NCT04628767|Methotrexate|methotrexate|mesh-list
65499191|NCT04628767|Durvalumab|durvalumab|mesh-list
65499192|NCT04628767|Vinblastine|vinblastine|mesh-list
65499193|NCT04628767|Lenograstim|lenograstim|mesh-list
65499194|NCT04628767|Immunoglobulins|immunoglobulins|mesh-list
65499195|NCT04628767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65499196|NCT04628767|Immunoglobulin G|immunoglobulin g|mesh-list
65499197|NCT04628767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499198|NCT04628767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65499199|NCT04628767|Antimetabolites|antimetabolites|mesh-ancestor
64804898|NCT01417572|Sensory System Agents|sensory system agents|mesh-ancestor
64804899|NCT01417572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64804905|NCT01417689|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65499200|NCT04628767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499201|NCT04628767|Antiviral Agents|antiviral agents|mesh-ancestor
65499202|NCT04628767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65499203|NCT04628767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499204|NCT04628767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65499205|NCT04628767|Immunologic Factors|immunologic factors|mesh-ancestor
65499206|NCT04628767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499207|NCT04628767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65499208|NCT04628767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65499209|NCT04628767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65499210|NCT04628767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65499211|NCT04628767|Abortifacient Agents|abortifacient agents|mesh-ancestor
65499212|NCT04628767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65068327|NCT00317499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068328|NCT00317499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65499213|NCT04628767|Dermatologic Agents|dermatologic agents|mesh-ancestor
65499214|NCT04628767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65068329|NCT00317499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65499215|NCT04628767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65499216|NCT04628767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65499217|NCT04628767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65499218|NCT04628767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499219|NCT04628767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65499220|NCT04628767|Tubulin Modulators|tubulin modulators|mesh-ancestor
65499221|NCT04628767|Antimitotic Agents|antimitotic agents|mesh-ancestor
65499222|NCT04628767|Mitosis Modulators|mitosis modulators|mesh-ancestor
65499223|NCT04626635|Cemiplimab|cemiplimab|mesh-list
64804977|NCT01418118|Vasodilator Agents|vasodilator agents|mesh-ancestor
64804978|NCT01418118|Dopamine Agonists|dopamine agonists|mesh-ancestor
65499224|NCT04626635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499225|NCT04626635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499226|NCT04610671|Nivolumab|nivolumab|mesh-list
65499227|NCT04610671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499228|NCT04610671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499229|NCT04610671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65499230|NCT04610671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499231|NCT04607421|Leucovorin|leucovorin|mesh-list
65499232|NCT04607421|Bevacizumab|bevacizumab|mesh-list
65499233|NCT04607421|Cetuximab|cetuximab|mesh-list
65499234|NCT04607421|Fluorouracil|fluorouracil|mesh-list
65499235|NCT04607421|Capecitabine|capecitabine|mesh-list
65499236|NCT04607421|Oxaliplatin|oxaliplatin|mesh-list
65499237|NCT04607421|Irinotecan|irinotecan|mesh-list
65499238|NCT04607421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499239|NCT04607421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499240|NCT04607421|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65499241|NCT04607421|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65499242|NCT04607421|Growth Substances|growth substances|mesh-ancestor
65499243|NCT04607421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499244|NCT04607421|Growth Inhibitors|growth inhibitors|mesh-ancestor
65499245|NCT04607421|Antimetabolites|antimetabolites|mesh-ancestor
65499246|NCT04607421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499247|NCT04607421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65499248|NCT04607421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65499249|NCT04607421|Immunologic Factors|immunologic factors|mesh-ancestor
65499250|NCT04607421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65499251|NCT04607421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65499252|NCT04607421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499253|NCT04607421|Antidotes|antidotes|mesh-ancestor
65499254|NCT04607421|Protective Agents|protective agents|mesh-ancestor
65499255|NCT04607421|Vitamin B Complex|vitamin b complex|mesh-ancestor
65499256|NCT04607421|Vitamins|vitamins|mesh-ancestor
65499257|NCT04607421|Micronutrients|micronutrients|mesh-ancestor
65499258|NCT04591275|Denosumab|denosumab|mesh-list
65499259|NCT04591275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65499260|NCT04591275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499261|NCT04586023|Teriflunomide|teriflunomide|mesh-list
65499262|NCT04586023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65499263|NCT04586023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65499264|NCT04586023|Analgesics|analgesics|mesh-ancestor
65499265|NCT04586023|Sensory System Agents|sensory system agents|mesh-ancestor
65499266|NCT04586023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65499267|NCT04586023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499268|NCT04586023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65499269|NCT04586023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65499270|NCT04586023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65499271|NCT04586023|Immunologic Factors|immunologic factors|mesh-ancestor
65499272|NCT04560179|Tobramycin|tobramycin|mesh-list
65499273|NCT04560179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65499274|NCT04560179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65499275|NCT04560179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65499276|NCT04548752|Pembrolizumab|pembrolizumab|mesh-list
65499277|NCT04548752|Olaparib|olaparib|mesh-list
65499278|NCT04548752|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65499279|NCT04548752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499280|NCT04548752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499281|NCT04548752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499282|NCT04548752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499283|NCT04543591|Ravulizumab|ravulizumab|mesh-list
65499284|NCT04543591|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65499285|NCT04543591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65499286|NCT04543591|Immunologic Factors|immunologic factors|mesh-ancestor
64805369|NCT01420575|Serotonin Agents|serotonin agents|mesh-ancestor
64805370|NCT01420666|Acetaminophen|acetaminophen|mesh-list
64805371|NCT01420666|Ibuprofen|ibuprofen|mesh-list
65068330|NCT00317499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65499287|NCT04543591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499288|NCT04536337|Entecavir|entecavir|mesh-list
65499289|NCT04536337|Antiviral Agents|antiviral agents|mesh-ancestor
65068331|NCT00317499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65499290|NCT04536337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65499292|NCT04525014|Temozolomide|temozolomide|mesh-list
65499293|NCT04525014|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65499294|NCT04525014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65499295|NCT04525014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499296|NCT04525014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499297|NCT04525014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499298|NCT04525014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65499299|NCT04525014|Alkylating Agents|alkylating agents|mesh-ancestor
65499300|NCT04521231|Blinatumomab|blinatumomab|mesh-list
65499301|NCT04521231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499302|NCT04515836|Olaparib|olaparib|mesh-list
65499303|NCT04515836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65499304|NCT04515836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499305|NCT04515836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499306|NCT04515836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499307|NCT04512365|Dronabinol|dronabinol|mesh-list
65499308|NCT04512365|Hallucinogens|hallucinogens|mesh-ancestor
65499309|NCT04512365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499310|NCT04512365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65499311|NCT04512365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65499312|NCT04512365|Analgesics|analgesics|mesh-ancestor
65499313|NCT04512365|Sensory System Agents|sensory system agents|mesh-ancestor
65499314|NCT04512365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65499315|NCT04512365|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65499316|NCT04512365|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65499317|NCT04512365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65499318|NCT04512365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499319|NCT04512365|Hormones|hormones|mesh-ancestor
65499320|NCT04512365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65499321|NCT04499248|Bimatoprost|bimatoprost|mesh-list
65499322|NCT04499248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65499323|NCT04495621|Cetuximab|cetuximab|mesh-list
65499324|NCT04495621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499325|NCT04495621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499326|NCT04493060|Niraparib|niraparib|mesh-list
65499327|NCT04493060|Immunoglobulins|immunoglobulins|mesh-list
65499328|NCT04493060|Immunoglobulin G|immunoglobulin g|mesh-list
65499329|NCT04493060|Immunologic Factors|immunologic factors|mesh-ancestor
65499330|NCT04493060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499331|NCT04493060|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65499332|NCT04493060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499333|NCT04493060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499334|NCT04493060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499335|NCT04464798|Rituximab|rituximab|mesh-list
65499336|NCT04464798|Obinutuzumab|obinutuzumab|mesh-list
65499337|NCT04464798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499338|NCT04464798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499340|NCT04464798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499341|NCT04464798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65499342|NCT04454684|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65499343|NCT04454684|Hallucinogens|hallucinogens|mesh-ancestor
65499344|NCT04454684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499345|NCT04454684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65499346|NCT04454684|Serotonin Agents|serotonin agents|mesh-ancestor
65499347|NCT04454684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65499348|NCT04454684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499349|NCT04454684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65499350|NCT04454684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64805764|NCT01422954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65499351|NCT04454684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65499352|NCT04454684|Adrenergic Agents|adrenergic agents|mesh-ancestor
65499353|NCT04441034|Anticonvulsants|anticonvulsants|mesh-list
65499354|NCT04441034|Convulsants|convulsants|mesh-list
65499355|NCT04441034|Antidepressive Agents|antidepressive agents|mesh-list
65499356|NCT04441034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65499357|NCT04441034|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65499358|NCT04441034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499359|NCT04438824|Palbociclib|palbociclib|mesh-list
65499360|NCT04438824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499361|NCT04438824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65068332|NCT00317499|Immunologic Factors|immunologic factors|mesh-ancestor
64805861|NCT01423500|Fludarabine|fludarabine|mesh-list
64805862|NCT01423500|Etoposide|etoposide|mesh-list
64805863|NCT01423500|Etoposide phosphate|etoposide phosphate|mesh-list
64805864|NCT01423500|Thiotepa|thiotepa|mesh-list
64805865|NCT01423500|Treosulfan|treosulfan|mesh-list
64805866|NCT01423500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64805867|NCT01423500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805868|NCT01423500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64805869|NCT01423500|Immunologic Factors|immunologic factors|mesh-ancestor
64805870|NCT01423500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324801|NCT03649724|Fertility Agents|fertility agents|mesh-ancestor
64324802|NCT03649724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64324803|NCT03649724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068333|NCT00281606|Ritonavir|ritonavir|mesh-list
65499362|NCT04438824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499363|NCT04438824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499364|NCT04421963|Olaparib|olaparib|mesh-list
65499365|NCT04421963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65499366|NCT04421963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499367|NCT04421963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499368|NCT04421963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499369|NCT04408638|Gemcitabine|gemcitabine|mesh-list
65499370|NCT04408638|Oxaliplatin|oxaliplatin|mesh-list
65499371|NCT04408638|Obinutuzumab|obinutuzumab|mesh-list
65499372|NCT04408638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65499373|NCT04408638|Antimetabolites|antimetabolites|mesh-ancestor
65499374|NCT04408638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499375|NCT04408638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499376|NCT04408638|Antiviral Agents|antiviral agents|mesh-ancestor
65499377|NCT04408638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65499378|NCT04408638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499379|NCT04408638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65499380|NCT04408638|Immunologic Factors|immunologic factors|mesh-ancestor
65499381|NCT04408638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499382|NCT04408638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499383|NCT04394624|Pembrolizumab|pembrolizumab|mesh-list
65499384|NCT04394624|Ramucirumab|ramucirumab|mesh-list
65499385|NCT04394624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499386|NCT04394624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499387|NCT04391049|Paclitaxel|paclitaxel|mesh-list
65499388|NCT04391049|Carboplatin|carboplatin|mesh-list
65499389|NCT04391049|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65499390|NCT04391049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65499391|NCT04391049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499392|NCT04391049|Tubulin Modulators|tubulin modulators|mesh-ancestor
65499393|NCT04391049|Antimitotic Agents|antimitotic agents|mesh-ancestor
65499394|NCT04391049|Mitosis Modulators|mitosis modulators|mesh-ancestor
65499395|NCT04391049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499396|NCT04381650|Pembrolizumab|pembrolizumab|mesh-list
65499397|NCT04381650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499398|NCT04381650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499399|NCT04370795|Sirolimus|sirolimus|mesh-list
65499400|NCT04370795|Busulfan|busulfan|mesh-list
64805962|NCT01424111|Citalopram|citalopram|mesh-list
65499401|NCT04370795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65499402|NCT04370795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65499403|NCT04370795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65499404|NCT04370795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499405|NCT04370795|Antifungal Agents|antifungal agents|mesh-ancestor
65499406|NCT04370795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65499407|NCT04370795|Immunologic Factors|immunologic factors|mesh-ancestor
65499408|NCT04370795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499409|NCT04370795|Alkylating Agents|alkylating agents|mesh-ancestor
65499410|NCT04370795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499411|NCT04370795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65499412|NCT04370795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65499413|NCT04361708|Leucovorin|leucovorin|mesh-list
65499414|NCT04361708|Docetaxel|docetaxel|mesh-list
65499415|NCT04361708|Fluorouracil|fluorouracil|mesh-list
65499416|NCT04361708|Oxaliplatin|oxaliplatin|mesh-list
65499417|NCT04361708|Irinotecan|irinotecan|mesh-list
65499418|NCT04361708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499419|NCT04361708|Tubulin Modulators|tubulin modulators|mesh-ancestor
65499420|NCT04361708|Antimitotic Agents|antimitotic agents|mesh-ancestor
65499421|NCT04361708|Mitosis Modulators|mitosis modulators|mesh-ancestor
65499422|NCT04361708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499423|NCT04361708|Antimetabolites|antimetabolites|mesh-ancestor
65499424|NCT04361708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65499425|NCT04361708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65499426|NCT04361708|Immunologic Factors|immunologic factors|mesh-ancestor
65499427|NCT04361708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499428|NCT04361708|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65499429|NCT04361708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65499430|NCT04361708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499431|NCT04361708|Antidotes|antidotes|mesh-ancestor
64806275|NCT01425580|Metformin|metformin|mesh-list
65499432|NCT04361708|Protective Agents|protective agents|mesh-ancestor
65499433|NCT04361708|Vitamin B Complex|vitamin b complex|mesh-ancestor
65499434|NCT04361708|Vitamins|vitamins|mesh-ancestor
65499435|NCT04361708|Micronutrients|micronutrients|mesh-ancestor
65499436|NCT04348006|Dexamethasone|dexamethasone|mesh-list
65499437|NCT04348006|Cyclophosphamide|cyclophosphamide|mesh-list
65499438|NCT04348006|Lenalidomide|lenalidomide|mesh-list
65499439|NCT04348006|Bortezomib|bortezomib|mesh-list
65499440|NCT04348006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65499441|NCT04348006|Immunologic Factors|immunologic factors|mesh-ancestor
65499442|NCT04348006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499443|NCT04348006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65499444|NCT04348006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65499445|NCT04348006|Alkylating Agents|alkylating agents|mesh-ancestor
65499446|NCT04348006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499447|NCT04348006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499448|NCT04348006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65499449|NCT04348006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65499450|NCT04348006|Antiemetics|antiemetics|mesh-ancestor
65499451|NCT04348006|Autonomic Agents|autonomic agents|mesh-ancestor
65499452|NCT04348006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65499453|NCT04348006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65499454|NCT04348006|Glucocorticoids|glucocorticoids|mesh-ancestor
65499455|NCT04348006|Hormones|hormones|mesh-ancestor
65499456|NCT04348006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65499457|NCT04348006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65499458|NCT04348006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65499459|NCT04348006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65499460|NCT04348006|Growth Substances|growth substances|mesh-ancestor
65499461|NCT04348006|Growth Inhibitors|growth inhibitors|mesh-ancestor
65499462|NCT04339751|Vorinostat|vorinostat|mesh-list
65499463|NCT04339751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499464|NCT04339751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65499465|NCT04339751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499466|NCT04339751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499467|NCT04339738|Paclitaxel|paclitaxel|mesh-list
65499468|NCT04339738|Nivolumab|nivolumab|mesh-list
65499469|NCT04339738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65499470|NCT04339738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65499471|NCT04339738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499472|NCT04339738|Tubulin Modulators|tubulin modulators|mesh-ancestor
65499473|NCT04339738|Antimitotic Agents|antimitotic agents|mesh-ancestor
65499474|NCT04339738|Mitosis Modulators|mitosis modulators|mesh-ancestor
65499475|NCT04339738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499476|NCT04339738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499477|NCT04339738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65499478|NCT04313972|Naltrexone|naltrexone|mesh-list
65499479|NCT04313972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65499480|NCT04313972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65499481|NCT04313972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499482|NCT04313972|Sensory System Agents|sensory system agents|mesh-ancestor
65499483|NCT04313972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65499484|NCT04310020|Atezolizumab|atezolizumab|mesh-list
65499485|NCT04310020|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65499486|NCT04310020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499487|NCT04310020|Immunologic Factors|immunologic factors|mesh-ancestor
65499488|NCT04310020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499489|NCT04304625|Tranexamic Acid|tranexamic acid|mesh-list
65499490|NCT04304625|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65499491|NCT04304625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65499492|NCT04304625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499493|NCT04304625|Hemostatics|hemostatics|mesh-ancestor
65499494|NCT04304625|Coagulants|coagulants|mesh-ancestor
65499495|NCT04295863|Pembrolizumab|pembrolizumab|mesh-list
65499496|NCT04295863|Nivolumab|nivolumab|mesh-list
65499497|NCT04295863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499498|NCT04295863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499499|NCT04295863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65499500|NCT04295863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499501|NCT04294160|Trametinib|trametinib|mesh-list
65499502|NCT04294160|Dabrafenib|dabrafenib|mesh-list
65499503|NCT04294160|Spartalizumab|spartalizumab|mesh-list
65499504|NCT04294160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499505|NCT04294160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65499506|NCT04294160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499507|NCT04294160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499508|NCT04294160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65499509|NCT04273945|Macitentan|macitentan|mesh-list
64806443|NCT05385094|Cystatins|cystatins|mesh-list
65499510|NCT04273945|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
65068334|NCT00281606|Lopinavir|lopinavir|mesh-list
65499511|NCT04273945|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65068335|NCT00281606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65068336|NCT00281606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65499512|NCT04273945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499513|NCT04273945|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65499514|NCT04267848|Gemcitabine|gemcitabine|mesh-list
65499515|NCT04267848|Paclitaxel|paclitaxel|mesh-list
65499516|NCT04267848|Cisplatin|cisplatin|mesh-list
65499517|NCT04267848|Carboplatin|carboplatin|mesh-list
65499518|NCT04267848|Pembrolizumab|pembrolizumab|mesh-list
65499519|NCT04267848|Pemetrexed|pemetrexed|mesh-list
65499520|NCT04267848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65499521|NCT04267848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65499522|NCT04267848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499523|NCT04267848|Tubulin Modulators|tubulin modulators|mesh-ancestor
65499524|NCT04267848|Antimitotic Agents|antimitotic agents|mesh-ancestor
65499525|NCT04267848|Mitosis Modulators|mitosis modulators|mesh-ancestor
65499526|NCT04267848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499527|NCT04267848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65499528|NCT04267848|Antimetabolites|antimetabolites|mesh-ancestor
65499529|NCT04267848|Antiviral Agents|antiviral agents|mesh-ancestor
65499530|NCT04267848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65499531|NCT04267848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499532|NCT04267848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65499533|NCT04267848|Immunologic Factors|immunologic factors|mesh-ancestor
65499534|NCT04267848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499535|NCT04267848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499536|NCT04267848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65499537|NCT04267848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65499538|NCT04231526|Pembrolizumab|pembrolizumab|mesh-list
65499539|NCT04231526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499540|NCT04231526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499541|NCT04214262|Atezolizumab|atezolizumab|mesh-list
65499542|NCT04214262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65499543|NCT04214262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499544|NCT04214262|Immunologic Factors|immunologic factors|mesh-ancestor
65499545|NCT04214262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499546|NCT04201873|Poly I-C|poly i-c|mesh-list
65499547|NCT04201873|Pembrolizumab|pembrolizumab|mesh-list
65499548|NCT04201873|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
65499549|NCT04201873|Vaccines|vaccines|mesh-list
65499550|NCT04201873|Poly ICLC|poly iclc|mesh-list
65499551|NCT04201873|Immunologic Factors|immunologic factors|mesh-ancestor
65499552|NCT04201873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499553|NCT04201873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499554|NCT04201873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499555|NCT04201873|Interferon Inducers|interferon inducers|mesh-ancestor
65499557|NCT04201873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65499558|NCT04201873|Antiviral Agents|antiviral agents|mesh-ancestor
65499559|NCT04201873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65499560|NCT04195555|Ivosidenib|ivosidenib|mesh-list
65499561|NCT04195555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499562|NCT04195555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499563|NCT04195555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499564|NCT04185883|Docetaxel|docetaxel|mesh-list
65499565|NCT04185883|Bevacizumab|bevacizumab|mesh-list
65499566|NCT04185883|Carboplatin|carboplatin|mesh-list
65499567|NCT04185883|Pembrolizumab|pembrolizumab|mesh-list
65499568|NCT04185883|Pemetrexed|pemetrexed|mesh-list
65499569|NCT04185883|Everolimus|everolimus|mesh-list
65499570|NCT04185883|Atezolizumab|atezolizumab|mesh-list
65499571|NCT04185883|Palbociclib|palbociclib|mesh-list
65499572|NCT04185883|Panitumumab|panitumumab|mesh-list
65499573|NCT04185883|Trametinib|trametinib|mesh-list
65499574|NCT04185883|Afatinib|afatinib|mesh-list
65499575|NCT04185883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499576|NCT04185883|Tubulin Modulators|tubulin modulators|mesh-ancestor
65499577|NCT04185883|Antimitotic Agents|antimitotic agents|mesh-ancestor
65499578|NCT04185883|Mitosis Modulators|mitosis modulators|mesh-ancestor
65499579|NCT04185883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499580|NCT04185883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499581|NCT04185883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65499582|NCT04185883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65499583|NCT04185883|Growth Substances|growth substances|mesh-ancestor
65499584|NCT04185883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499585|NCT04185883|Growth Inhibitors|growth inhibitors|mesh-ancestor
65499586|NCT04185883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499587|NCT04185883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65499588|NCT04185883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65499589|NCT04185883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65499590|NCT04185883|Immunologic Factors|immunologic factors|mesh-ancestor
65499591|NCT04185883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65499592|NCT04181060|Bevacizumab|bevacizumab|mesh-list
65499593|NCT04181060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65499594|NCT04181060|Osimertinib|osimertinib|mesh-list
65499595|NCT04181060|Endothelial Growth Factors|endothelial growth factors|mesh-list
65499596|NCT04181060|Antibodies|antibodies|mesh-list
65499597|NCT04181060|Immunoglobulins|immunoglobulins|mesh-list
65499598|NCT04181060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65499599|NCT04181060|Immunoglobulin G|immunoglobulin g|mesh-list
65499600|NCT04181060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499601|NCT04181060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65499602|NCT04181060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65499603|NCT04181060|Growth Substances|growth substances|mesh-ancestor
65499604|NCT04181060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499605|NCT04181060|Growth Inhibitors|growth inhibitors|mesh-ancestor
65499606|NCT04181060|Immunologic Factors|immunologic factors|mesh-ancestor
65499607|NCT04181060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499608|NCT04181060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65499609|NCT04181060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499610|NCT04161885|Azacitidine|azacitidine|mesh-list
65499611|NCT04161885|Venetoclax|venetoclax|mesh-list
65499612|NCT04161885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65499613|NCT04161885|Antimetabolites|antimetabolites|mesh-ancestor
65499614|NCT04161885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499615|NCT04161885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499616|NCT04161885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499617|NCT04107077|Mitomycins|mitomycins|mesh-list
65499618|NCT04107077|Mitomycin|mitomycin|mesh-list
65499619|NCT04107077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499620|NCT04107077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65499621|NCT04107077|Alkylating Agents|alkylating agents|mesh-ancestor
65499622|NCT04107077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499623|NCT04107077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65499624|NCT04107077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499625|NCT04102436|Aldesleukin|aldesleukin|mesh-list
65499626|NCT04102436|Cyclophosphamide|cyclophosphamide|mesh-list
65499627|NCT04102436|Fludarabine|fludarabine|mesh-list
65499628|NCT04102436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65499629|NCT04102436|Immunologic Factors|immunologic factors|mesh-ancestor
65499630|NCT04102436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499631|NCT04102436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65499632|NCT04102436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65499633|NCT04102436|Alkylating Agents|alkylating agents|mesh-ancestor
65499634|NCT04102436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499635|NCT04102436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499636|NCT04102436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65499637|NCT04102436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65499638|NCT04102436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65499639|NCT04102436|Antiviral Agents|antiviral agents|mesh-ancestor
65499640|NCT04102436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65499641|NCT04092270|Doxorubicin|doxorubicin|mesh-list
65499642|NCT04092270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65499643|NCT04092270|Peposertib|peposertib|mesh-list
65499644|NCT04092270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65499645|NCT04092270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499646|NCT04092270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65499647|NCT04092270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65499648|NCT04092270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499649|NCT04092270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499650|NCT04092270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65499651|NCT04089904|Pembrolizumab|pembrolizumab|mesh-list
64806771|NCT03811262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64806772|NCT03811262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806773|NCT03811262|Sensory System Agents|sensory system agents|mesh-ancestor
64806774|NCT03811262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806775|NCT03771612|Naproxen|naproxen|mesh-list
64806776|NCT03771612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64806778|NCT03771612|Analgesics|analgesics|mesh-ancestor
64806779|NCT03771612|Sensory System Agents|sensory system agents|mesh-ancestor
65499652|NCT04089904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499653|NCT04089904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499654|NCT04077437|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65499655|NCT04077437|Hallucinogens|hallucinogens|mesh-ancestor
65499656|NCT04077437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499657|NCT04077437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65499658|NCT04077437|Serotonin Agents|serotonin agents|mesh-ancestor
65499659|NCT04077437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65499660|NCT04077437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499661|NCT04077437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65499662|NCT04077437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65499663|NCT04077437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65068337|NCT00281606|Protease Inhibitors|protease inhibitors|mesh-ancestor
65068338|NCT00281606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499664|NCT04077437|Adrenergic Agents|adrenergic agents|mesh-ancestor
65499665|NCT04054752|Vaccines|vaccines|mesh-list
65499666|NCT04054752|Immunologic Factors|immunologic factors|mesh-ancestor
65499667|NCT04054752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499668|NCT03930953|Rituximab|rituximab|mesh-list
65499669|NCT03930953|Obinutuzumab|obinutuzumab|mesh-list
65499670|NCT03930953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499671|NCT03930953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499672|NCT03930953|Immunologic Factors|immunologic factors|mesh-ancestor
65499673|NCT03930953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499674|NCT03930953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65499675|NCT03873883|Pembrolizumab|pembrolizumab|mesh-list
65499676|NCT03873883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499677|NCT03873883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499678|NCT03850574|Venetoclax|venetoclax|mesh-list
65499679|NCT03850574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499680|NCT03831932|Osimertinib|osimertinib|mesh-list
65499681|NCT03831932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499682|NCT03831932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65499683|NCT03831932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499684|NCT03831932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499685|NCT03811015|Cisplatin|cisplatin|mesh-list
65499686|NCT03811015|Nivolumab|nivolumab|mesh-list
65499687|NCT03811015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499688|NCT03811015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499689|NCT03811015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65499690|NCT03811015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499691|NCT03785678|Tenecteplase|tenecteplase|mesh-list
65499692|NCT03785678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65499693|NCT03785678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65499694|NCT03785678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499695|NCT03783403|Rituximab|rituximab|mesh-list
65499696|NCT03783403|Cetuximab|cetuximab|mesh-list
65499697|NCT03783403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499698|NCT03783403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499699|NCT03783403|Immunologic Factors|immunologic factors|mesh-ancestor
65499700|NCT03783403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499701|NCT03783403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65499702|NCT03757689|Pembrolizumab|pembrolizumab|mesh-list
65499703|NCT03757689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499704|NCT03757689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499705|NCT03733067|Abatacept|abatacept|mesh-list
65499706|NCT03733067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65499707|NCT03733067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499708|NCT03733067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499709|NCT03733067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65499710|NCT03733067|Immunologic Factors|immunologic factors|mesh-ancestor
65499711|NCT03733067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499712|NCT03733067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65499713|NCT03729804|Dexamethasone|dexamethasone|mesh-list
65499714|NCT03729804|Lenalidomide|lenalidomide|mesh-list
65499715|NCT03729804|Bortezomib|bortezomib|mesh-list
65499716|NCT03729804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65499717|NCT03729804|Antiemetics|antiemetics|mesh-ancestor
65499718|NCT03729804|Autonomic Agents|autonomic agents|mesh-ancestor
65499719|NCT03729804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65499720|NCT03729804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499721|NCT03729804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65499722|NCT03729804|Glucocorticoids|glucocorticoids|mesh-ancestor
65499723|NCT03729804|Hormones|hormones|mesh-ancestor
65499724|NCT03729804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65499725|NCT03729804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65499726|NCT03729804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499727|NCT03729804|Immunologic Factors|immunologic factors|mesh-ancestor
65499728|NCT03729804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65499729|NCT03729804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65499730|NCT03729804|Growth Substances|growth substances|mesh-ancestor
65499731|NCT03729804|Growth Inhibitors|growth inhibitors|mesh-ancestor
65499732|NCT03697564|Gemcitabine|gemcitabine|mesh-list
65499733|NCT03697564|Nivolumab|nivolumab|mesh-list
65499734|NCT03697564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65499735|NCT03697564|Antimetabolites|antimetabolites|mesh-ancestor
65499736|NCT03697564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499737|NCT03697564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499738|NCT03697564|Antiviral Agents|antiviral agents|mesh-ancestor
65499739|NCT03697564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65068339|NCT00281606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499740|NCT03697564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499741|NCT03697564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65499742|NCT03697564|Immunologic Factors|immunologic factors|mesh-ancestor
65499743|NCT03697564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499744|NCT03697564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499745|NCT03697564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65499746|NCT03678753|Cenobamate|cenobamate|mesh-list
65499747|NCT03678753|Anticonvulsants|anticonvulsants|mesh-ancestor
65499748|NCT03660826|Durvalumab|durvalumab|mesh-list
65499749|NCT03660826|Olaparib|olaparib|mesh-list
65499750|NCT03660826|Cediranib|cediranib|mesh-list
65499751|NCT03660826|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65499752|NCT03660826|Immunoglobulins|immunoglobulins|mesh-list
65499753|NCT03660826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65499754|NCT03660826|Immunoglobulin G|immunoglobulin g|mesh-list
65499755|NCT03660826|Maleic acid|maleic acid|mesh-list
65499756|NCT03660826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499757|NCT03660826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499758|NCT03660826|Immunologic Factors|immunologic factors|mesh-ancestor
65499759|NCT03660826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499760|NCT03660826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499761|NCT03660826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499762|NCT03660826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65499763|NCT03645928|Pembrolizumab|pembrolizumab|mesh-list
65499764|NCT03645928|Nivolumab|nivolumab|mesh-list
65499765|NCT03645928|Ipilimumab|ipilimumab|mesh-list
65499766|NCT03645928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499767|NCT03645928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499768|NCT03645928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65499769|NCT03645928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499770|NCT03630081|Ciprofloxacin|ciprofloxacin|mesh-list
65499771|NCT03630081|Meropenem|meropenem|mesh-list
65499772|NCT03630081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65499773|NCT03630081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65499774|NCT03630081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65499775|NCT03630081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65499776|NCT03630081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499777|NCT03630081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499778|NCT03630081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499779|NCT03630081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65499780|NCT03630081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65499781|NCT03595683|Pembrolizumab|pembrolizumab|mesh-list
65499782|NCT03595683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499783|NCT03595683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499784|NCT03573401|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65499785|NCT03573401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65499786|NCT03573401|Dermatologic Agents|dermatologic agents|mesh-ancestor
65499787|NCT03571321|Cytarabine|cytarabine|mesh-list
65499788|NCT03571321|Dexamethasone|dexamethasone|mesh-list
65499789|NCT03571321|Cyclophosphamide|cyclophosphamide|mesh-list
65499790|NCT03571321|Rituximab|rituximab|mesh-list
65499791|NCT03571321|Doxorubicin|doxorubicin|mesh-list
65499792|NCT03571321|Methotrexate|methotrexate|mesh-list
65499793|NCT03571321|Vincristine|vincristine|mesh-list
65499794|NCT03571321|Mercaptopurine|mercaptopurine|mesh-list
65499795|NCT03571321|Pegaspargase|pegaspargase|mesh-list
65499796|NCT03571321|Thioguanine|thioguanine|mesh-list
65499797|NCT03571321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65499798|NCT03571321|Immunologic Factors|immunologic factors|mesh-ancestor
65499799|NCT03571321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499800|NCT03571321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65499801|NCT03571321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65499802|NCT03571321|Alkylating Agents|alkylating agents|mesh-ancestor
65499803|NCT03571321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499804|NCT03571321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499805|NCT03571321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65499806|NCT03571321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499807|NCT03571321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65499808|NCT03571321|Antiemetics|antiemetics|mesh-ancestor
65499809|NCT03571321|Autonomic Agents|autonomic agents|mesh-ancestor
65499810|NCT03571321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65499811|NCT03571321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65499812|NCT03571321|Glucocorticoids|glucocorticoids|mesh-ancestor
65068340|NCT00281606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65499813|NCT03571321|Hormones|hormones|mesh-ancestor
65499814|NCT03571321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65068341|NCT00281606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65499815|NCT03571321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65499816|NCT03571321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65499817|NCT03571321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65499818|NCT03571321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65499819|NCT03571321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499820|NCT03571321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65499821|NCT03571321|Abortifacient Agents|abortifacient agents|mesh-ancestor
65499822|NCT03571321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65499823|NCT03571321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65499824|NCT03571321|Antimetabolites|antimetabolites|mesh-ancestor
65499825|NCT03571321|Dermatologic Agents|dermatologic agents|mesh-ancestor
65499826|NCT03571321|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65499827|NCT03571321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65499828|NCT03571321|Antiviral Agents|antiviral agents|mesh-ancestor
65499829|NCT03571321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64807580|NCT01429025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64807581|NCT01429025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807582|NCT01429025|Immunologic Factors|immunologic factors|mesh-ancestor
64807583|NCT01429025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499830|NCT03571321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65499831|NCT03571321|Tubulin Modulators|tubulin modulators|mesh-ancestor
65499832|NCT03571321|Antimitotic Agents|antimitotic agents|mesh-ancestor
65499833|NCT03571321|Mitosis Modulators|mitosis modulators|mesh-ancestor
65499834|NCT03565445|Pembrolizumab|pembrolizumab|mesh-list
65499835|NCT03565445|Nivolumab|nivolumab|mesh-list
65499836|NCT03565445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499837|NCT03565445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499838|NCT03565445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65499839|NCT03565445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499840|NCT03516812|Methyltestosterone|methyltestosterone|mesh-list
65499841|NCT03516812|Olaparib|olaparib|mesh-list
65499842|NCT03516812|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
65499843|NCT03516812|Testosterone|testosterone|mesh-list
65499844|NCT03516812|Testosterone undecanoate|testosterone undecanoate|mesh-list
65499845|NCT03516812|Testosterone enanthate|testosterone enanthate|mesh-list
65499846|NCT03516812|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65499847|NCT03516812|Androgens|androgens|mesh-ancestor
65499849|NCT03516812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65499850|NCT03516812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499851|NCT03516812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65499852|NCT03516812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499853|NCT03516812|Anabolic Agents|anabolic agents|mesh-ancestor
65499854|NCT03516812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499855|NCT03516812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499856|NCT03500445|Dexamethasone|dexamethasone|mesh-list
65499857|NCT03500445|Lenalidomide|lenalidomide|mesh-list
65499858|NCT03500445|Daratumumab|daratumumab|mesh-list
65499859|NCT03500445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65499860|NCT03500445|Antiemetics|antiemetics|mesh-ancestor
65499861|NCT03500445|Autonomic Agents|autonomic agents|mesh-ancestor
65499862|NCT03500445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65499863|NCT03500445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499864|NCT03500445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65499865|NCT03500445|Glucocorticoids|glucocorticoids|mesh-ancestor
65499866|NCT03500445|Hormones|hormones|mesh-ancestor
65499867|NCT03500445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65499868|NCT03500445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65499869|NCT03500445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499870|NCT03500445|Immunologic Factors|immunologic factors|mesh-ancestor
65499871|NCT03500445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65499872|NCT03500445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64807657|NCT01429545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64807658|NCT01429545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499873|NCT03500445|Growth Substances|growth substances|mesh-ancestor
65499874|NCT03500445|Growth Inhibitors|growth inhibitors|mesh-ancestor
65499875|NCT03494530|Edoxaban|edoxaban|mesh-list
65499876|NCT03494530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65499877|NCT03494530|Antithrombins|antithrombins|mesh-ancestor
65499878|NCT03494530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65499879|NCT03494530|Protease Inhibitors|protease inhibitors|mesh-ancestor
65499880|NCT03494530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499881|NCT03494530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499882|NCT03494530|Anticoagulants|anticoagulants|mesh-ancestor
65499883|NCT03485287|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65499884|NCT03485287|Hallucinogens|hallucinogens|mesh-ancestor
65499885|NCT03485287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499886|NCT03485287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65499887|NCT03485287|Serotonin Agents|serotonin agents|mesh-ancestor
65499888|NCT03485287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65499889|NCT03485287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499890|NCT03485287|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65499891|NCT03485287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65499892|NCT03485287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65499894|NCT03466736|Flutemetamol|flutemetamol|mesh-list
65499895|NCT03466736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65499896|NCT03466736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499897|NCT03423264|Gabapentin|gabapentin|mesh-list
65499898|NCT03423264|Analgesics|analgesics|mesh-ancestor
65499899|NCT03423264|Sensory System Agents|sensory system agents|mesh-ancestor
65499900|NCT03423264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65499901|NCT03423264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499902|NCT03423264|Anticonvulsants|anticonvulsants|mesh-ancestor
65499903|NCT03423264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65499904|NCT03423264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65499905|NCT03423264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65499906|NCT03423264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65499907|NCT03423264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65499908|NCT03423264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65499909|NCT03423264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65499910|NCT03423264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499911|NCT03423264|Antimanic Agents|antimanic agents|mesh-ancestor
65499912|NCT03400332|Nivolumab|nivolumab|mesh-list
65499913|NCT03400332|Ipilimumab|ipilimumab|mesh-list
65499914|NCT03400332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499915|NCT03400332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499916|NCT03400332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65499917|NCT03400332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499918|NCT03366844|Pembrolizumab|pembrolizumab|mesh-list
65499919|NCT03366844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499920|NCT03366844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499921|NCT03282123|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65499923|NCT03282123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499924|NCT03282123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65499925|NCT03282123|Serotonin Agents|serotonin agents|mesh-ancestor
65499926|NCT03282123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65499927|NCT03282123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499928|NCT03282123|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65499929|NCT03282123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65499930|NCT03282123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65499931|NCT03282123|Adrenergic Agents|adrenergic agents|mesh-ancestor
65499932|NCT03225547|Pembrolizumab|pembrolizumab|mesh-list
65499933|NCT03225547|Mifepristone|mifepristone|mesh-list
65499934|NCT03225547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499935|NCT03225547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807876|NCT01431053|Exemestane|exemestane|mesh-list
65499936|NCT03225547|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65499937|NCT03225547|Abortifacient Agents|abortifacient agents|mesh-ancestor
65499938|NCT03225547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65499939|NCT03225547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499940|NCT03225547|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65499941|NCT03225547|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65499942|NCT03225547|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65499943|NCT03225547|Contraceptive Agents|contraceptive agents|mesh-ancestor
65499944|NCT03225547|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65499945|NCT03225547|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65499946|NCT03225547|Hormone Antagonists|hormone antagonists|mesh-ancestor
65499947|NCT03225547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65499948|NCT03225547|Luteolytic Agents|luteolytic agents|mesh-ancestor
65499949|NCT03225547|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65499950|NCT03225547|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65499951|NCT03191149|Osimertinib|osimertinib|mesh-list
65499952|NCT03191149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499953|NCT03191149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65499954|NCT03191149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499955|NCT03191149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499956|NCT03181763|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65499957|NCT03181763|Hallucinogens|hallucinogens|mesh-ancestor
65068342|NCT00281606|Antiviral Agents|antiviral agents|mesh-ancestor
65068343|NCT00281606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65499958|NCT03181763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499959|NCT03181763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65499960|NCT03181763|Serotonin Agents|serotonin agents|mesh-ancestor
65499961|NCT03181763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65499962|NCT03181763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499963|NCT03181763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65499964|NCT03181763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65499965|NCT03181763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65499966|NCT03181763|Adrenergic Agents|adrenergic agents|mesh-ancestor
65499967|NCT03178552|Gemcitabine|gemcitabine|mesh-list
65499968|NCT03178552|Bevacizumab|bevacizumab|mesh-list
65499969|NCT03178552|Carboplatin|carboplatin|mesh-list
65499970|NCT03178552|Docetaxel|docetaxel|mesh-list
65499971|NCT03178552|Pemetrexed|pemetrexed|mesh-list
65499972|NCT03178552|Atezolizumab|atezolizumab|mesh-list
65499973|NCT03178552|Vemurafenib|vemurafenib|mesh-list
65499974|NCT03178552|Entrectinib|entrectinib|mesh-list
65499975|NCT03178552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65499976|NCT03178552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65499977|NCT03178552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65499978|NCT03178552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65499979|NCT03178552|Growth Substances|growth substances|mesh-ancestor
65499980|NCT03178552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65499981|NCT03178552|Growth Inhibitors|growth inhibitors|mesh-ancestor
65499982|NCT03178552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65499983|NCT03178552|Antimetabolites|antimetabolites|mesh-ancestor
65499984|NCT03178552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65499985|NCT03178552|Antiviral Agents|antiviral agents|mesh-ancestor
65499986|NCT03178552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65499987|NCT03178552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65499988|NCT03178552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65499990|NCT03178552|Tubulin Modulators|tubulin modulators|mesh-ancestor
65499991|NCT03178552|Antimitotic Agents|antimitotic agents|mesh-ancestor
65499992|NCT03178552|Mitosis Modulators|mitosis modulators|mesh-ancestor
65499993|NCT03178552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65499994|NCT03178552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65499995|NCT03178552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65499996|NCT03107182|Diphenhydramine|diphenhydramine|mesh-list
65499997|NCT03107182|Promethazine|promethazine|mesh-list
65499998|NCT03107182|Dexamethasone|dexamethasone|mesh-list
65499999|NCT03107182|Paclitaxel|paclitaxel|mesh-list
65500000|NCT03107182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65500001|NCT03107182|Carboplatin|carboplatin|mesh-list
65500002|NCT03107182|Nivolumab|nivolumab|mesh-list
65500003|NCT03107182|Hydroxyurea|hydroxyurea|mesh-list
65500004|NCT03107182|Famotidine|famotidine|mesh-list
65500005|NCT03107182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64808172|NCT01432028|Progestins|progestins|mesh-ancestor
65500006|NCT03107182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500007|NCT03107182|Tubulin Modulators|tubulin modulators|mesh-ancestor
65500008|NCT03107182|Antimitotic Agents|antimitotic agents|mesh-ancestor
65500009|NCT03107182|Mitosis Modulators|mitosis modulators|mesh-ancestor
65500010|NCT03107182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500011|NCT03107182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65500012|NCT03107182|Antiemetics|antiemetics|mesh-ancestor
65500013|NCT03107182|Autonomic Agents|autonomic agents|mesh-ancestor
65500014|NCT03107182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65500015|NCT03107182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500016|NCT03107182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65500017|NCT03107182|Glucocorticoids|glucocorticoids|mesh-ancestor
65500018|NCT03107182|Hormones|hormones|mesh-ancestor
65500019|NCT03107182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65500020|NCT03107182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65500021|NCT03107182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65500022|NCT03107182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65500023|NCT03107182|Antisickling Agents|antisickling agents|mesh-ancestor
65500024|NCT03107182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500025|NCT03107182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65500026|NCT03107182|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65500027|NCT03107182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65500028|NCT03107182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65500029|NCT03107182|Anesthetics, Local|anesthetics, local|mesh-ancestor
65500030|NCT03107182|Anesthetics|anesthetics|mesh-ancestor
65500031|NCT03107182|Sensory System Agents|sensory system agents|mesh-ancestor
65500032|NCT03107182|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65500033|NCT03107182|Histamine Antagonists|histamine antagonists|mesh-ancestor
65500034|NCT03107182|Histamine Agents|histamine agents|mesh-ancestor
65068344|NCT00281606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65500035|NCT03107182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65500036|NCT03107182|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65500037|NCT03107182|Antipruritics|antipruritics|mesh-ancestor
65500038|NCT03107182|Dermatologic Agents|dermatologic agents|mesh-ancestor
65500039|NCT03107182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65500040|NCT03107182|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65500041|NCT03037385|Pralsetinib|pralsetinib|mesh-list
65500042|NCT03037385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500043|NCT02997228|Leucovorin|leucovorin|mesh-list
65500044|NCT02997228|Bevacizumab|bevacizumab|mesh-list
65500045|NCT02997228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65500046|NCT02997228|Fluorouracil|fluorouracil|mesh-list
65500047|NCT02997228|Oxaliplatin|oxaliplatin|mesh-list
65500048|NCT02997228|Atezolizumab|atezolizumab|mesh-list
65500049|NCT02997228|Endothelial Growth Factors|endothelial growth factors|mesh-list
65500050|NCT02997228|Antibodies|antibodies|mesh-list
65500051|NCT02997228|Immunoglobulins|immunoglobulins|mesh-list
65500052|NCT02997228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65500053|NCT02997228|Immunoglobulin G|immunoglobulin g|mesh-list
65500054|NCT02997228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500055|NCT02997228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65500056|NCT02997228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65500057|NCT02997228|Growth Substances|growth substances|mesh-ancestor
65500058|NCT02997228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500059|NCT02997228|Growth Inhibitors|growth inhibitors|mesh-ancestor
65500060|NCT02997228|Immunologic Factors|immunologic factors|mesh-ancestor
65500061|NCT02997228|Antimetabolites|antimetabolites|mesh-ancestor
65500062|NCT02997228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500063|NCT02997228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65500064|NCT02997228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65500065|NCT02997228|Antidotes|antidotes|mesh-ancestor
65500066|NCT02997228|Protective Agents|protective agents|mesh-ancestor
65500067|NCT02997228|Vitamin B Complex|vitamin b complex|mesh-ancestor
65500068|NCT02997228|Vitamins|vitamins|mesh-ancestor
65500069|NCT02997228|Micronutrients|micronutrients|mesh-ancestor
65500070|NCT02990533|Methyltestosterone|methyltestosterone|mesh-list
65500071|NCT02990533|Testosterone|testosterone|mesh-list
65500072|NCT02990533|Testosterone undecanoate|testosterone undecanoate|mesh-list
65500073|NCT02990533|Testosterone enanthate|testosterone enanthate|mesh-list
65500074|NCT02990533|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65500075|NCT02990533|Androgens|androgens|mesh-ancestor
65500076|NCT02990533|Hormones|hormones|mesh-ancestor
65500077|NCT02990533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65500078|NCT02990533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500079|NCT02990533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65500080|NCT02990533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500081|NCT02990533|Anabolic Agents|anabolic agents|mesh-ancestor
65500082|NCT02974725|Trametinib|trametinib|mesh-list
65500083|NCT02974725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500084|NCT02974725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65500085|NCT02974725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500086|NCT02974725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500087|NCT02969837|Dexamethasone|dexamethasone|mesh-list
65500088|NCT02969837|Lenalidomide|lenalidomide|mesh-list
65500089|NCT02969837|Elotuzumab|elotuzumab|mesh-list
65500090|NCT02969837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65500091|NCT02969837|Antiemetics|antiemetics|mesh-ancestor
65500092|NCT02969837|Autonomic Agents|autonomic agents|mesh-ancestor
65500093|NCT02969837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65500094|NCT02969837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500095|NCT02969837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65500096|NCT02969837|Glucocorticoids|glucocorticoids|mesh-ancestor
65500097|NCT02969837|Hormones|hormones|mesh-ancestor
65500098|NCT02969837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65500099|NCT02969837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65500100|NCT02969837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500101|NCT02969837|Immunologic Factors|immunologic factors|mesh-ancestor
65500102|NCT02969837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65500103|NCT02969837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65500104|NCT02969837|Growth Substances|growth substances|mesh-ancestor
65500105|NCT02969837|Growth Inhibitors|growth inhibitors|mesh-ancestor
65500106|NCT02954874|Pembrolizumab|pembrolizumab|mesh-list
65500107|NCT02954874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65500108|NCT02954874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500109|NCT02944071|Paclitaxel|paclitaxel|mesh-list
65500110|NCT02944071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65500111|NCT02944071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500112|NCT02944071|Tubulin Modulators|tubulin modulators|mesh-ancestor
65500113|NCT02944071|Antimitotic Agents|antimitotic agents|mesh-ancestor
65500114|NCT02944071|Mitosis Modulators|mitosis modulators|mesh-ancestor
65500115|NCT02944071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500116|NCT02913313|Nivolumab|nivolumab|mesh-list
65500117|NCT02913313|Ipilimumab|ipilimumab|mesh-list
65500118|NCT02913313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65500119|NCT02913313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500120|NCT02913313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65500121|NCT02913313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500122|NCT02776917|Paclitaxel|paclitaxel|mesh-list
65500123|NCT02776917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65500124|NCT02776917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500125|NCT02776917|Tubulin Modulators|tubulin modulators|mesh-ancestor
65500126|NCT02776917|Antimitotic Agents|antimitotic agents|mesh-ancestor
65500127|NCT02776917|Mitosis Modulators|mitosis modulators|mesh-ancestor
65500128|NCT02776917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500129|NCT02751255|Tretinoin|tretinoin|mesh-list
65500130|NCT02751255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500131|NCT02751255|Keratolytic Agents|keratolytic agents|mesh-ancestor
65500132|NCT02751255|Dermatologic Agents|dermatologic agents|mesh-ancestor
65500133|NCT02707666|Pembrolizumab|pembrolizumab|mesh-list
65500134|NCT02707666|Pemetrexed|pemetrexed|mesh-list
65500135|NCT02707666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500136|NCT02707666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65500137|NCT02707666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500138|NCT02707666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500139|NCT02707666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65500140|NCT02707666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65500142|NCT02668770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65500143|NCT02668770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500144|NCT02668770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65500145|NCT02668770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500146|NCT02659293|Dexamethasone|dexamethasone|mesh-list
65500147|NCT02659293|Lenalidomide|lenalidomide|mesh-list
65500148|NCT02659293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65500149|NCT02659293|Antiemetics|antiemetics|mesh-ancestor
65500150|NCT02659293|Autonomic Agents|autonomic agents|mesh-ancestor
65500151|NCT02659293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65500152|NCT02659293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500153|NCT02659293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65500154|NCT02659293|Glucocorticoids|glucocorticoids|mesh-ancestor
65500155|NCT02659293|Hormones|hormones|mesh-ancestor
65500156|NCT02659293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65500157|NCT02659293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65500158|NCT02659293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500159|NCT02659293|Immunologic Factors|immunologic factors|mesh-ancestor
65500160|NCT02659293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65500161|NCT02659293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65500162|NCT02659293|Growth Substances|growth substances|mesh-ancestor
65500163|NCT02659293|Growth Inhibitors|growth inhibitors|mesh-ancestor
65500164|NCT02656511|Tenofovir|tenofovir|mesh-list
65500165|NCT02656511|Emtricitabine|emtricitabine|mesh-list
65500166|NCT02656511|Dolutegravir|dolutegravir|mesh-list
65500167|NCT02656511|Antiviral Agents|antiviral agents|mesh-ancestor
65500168|NCT02656511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65500169|NCT02656511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65500170|NCT02656511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65500171|NCT02656511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500172|NCT02656511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500173|NCT02656511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65500174|NCT02656511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65500175|NCT02656511|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65500176|NCT02656511|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65500177|NCT02618577|Edoxaban|edoxaban|mesh-list
65500178|NCT02618577|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65500179|NCT02618577|Antithrombins|antithrombins|mesh-ancestor
65500180|NCT02618577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65500181|NCT02618577|Protease Inhibitors|protease inhibitors|mesh-ancestor
65500182|NCT02618577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500183|NCT02618577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500184|NCT02618577|Anticoagulants|anticoagulants|mesh-ancestor
65500185|NCT02613169|Isoniazid|isoniazid|mesh-list
65500186|NCT02613169|Antitubercular Agents|antitubercular agents|mesh-ancestor
64478168|NCT01877083|Lenvatinib|lenvatinib|mesh-list
65500188|NCT02613169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65500189|NCT02613169|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65500190|NCT02613169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65500191|NCT02613169|Antimetabolites|antimetabolites|mesh-ancestor
65500192|NCT02613169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500193|NCT02613169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65500194|NCT02572323|Tesamorelin|tesamorelin|mesh-list
65500195|NCT02572323|Growth Substances|growth substances|mesh-ancestor
65500196|NCT02572323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500197|NCT02525757|Paclitaxel|paclitaxel|mesh-list
65500198|NCT02525757|Carboplatin|carboplatin|mesh-list
65500199|NCT02525757|Atezolizumab|atezolizumab|mesh-list
65500200|NCT02525757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65500201|NCT02525757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500202|NCT02525757|Tubulin Modulators|tubulin modulators|mesh-ancestor
65500203|NCT02525757|Antimitotic Agents|antimitotic agents|mesh-ancestor
65500204|NCT02525757|Mitosis Modulators|mitosis modulators|mesh-ancestor
65500205|NCT02525757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500206|NCT02513186|Dexamethasone|dexamethasone|mesh-list
64809075|NCT01437800|Metformin|metformin|mesh-list
65500207|NCT02513186|Cyclophosphamide|cyclophosphamide|mesh-list
65500208|NCT02513186|Lenalidomide|lenalidomide|mesh-list
65500209|NCT02513186|Bortezomib|bortezomib|mesh-list
65500210|NCT02513186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65500211|NCT02513186|Immunologic Factors|immunologic factors|mesh-ancestor
64640405|NCT05361642|Analgesics|analgesics|mesh-ancestor
65500212|NCT02513186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500213|NCT02513186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65500214|NCT02513186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65500215|NCT02513186|Alkylating Agents|alkylating agents|mesh-ancestor
65500216|NCT02513186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500217|NCT02513186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500218|NCT02513186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65500219|NCT02513186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65500220|NCT02513186|Antiemetics|antiemetics|mesh-ancestor
65500221|NCT02513186|Autonomic Agents|autonomic agents|mesh-ancestor
64809104|NCT01437982|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64809105|NCT01437982|Prednisolone|prednisolone|mesh-list
64809106|NCT01437982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64809114|NCT01437982|Hormones|hormones|mesh-ancestor
65500222|NCT02513186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65500223|NCT02513186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65500224|NCT02513186|Glucocorticoids|glucocorticoids|mesh-ancestor
65500225|NCT02513186|Hormones|hormones|mesh-ancestor
65500226|NCT02513186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65500227|NCT02513186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65500228|NCT02513186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65500229|NCT02513186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65500230|NCT02513186|Growth Substances|growth substances|mesh-ancestor
65500231|NCT02513186|Growth Inhibitors|growth inhibitors|mesh-ancestor
65500232|NCT02441491|Cyclophosphamide|cyclophosphamide|mesh-list
65500233|NCT02441491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65500234|NCT02441491|Immunologic Factors|immunologic factors|mesh-ancestor
65500235|NCT02441491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500236|NCT02441491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65500237|NCT02441491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65500238|NCT02441491|Alkylating Agents|alkylating agents|mesh-ancestor
65500239|NCT02441491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500240|NCT02441491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500241|NCT02441491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65500242|NCT02431988|Cyclophosphamide|cyclophosphamide|mesh-list
65500243|NCT02431988|Fludarabine|fludarabine|mesh-list
65500244|NCT02431988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65500245|NCT02431988|Immunologic Factors|immunologic factors|mesh-ancestor
65500246|NCT02431988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500247|NCT02431988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65500248|NCT02431988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65500249|NCT02431988|Alkylating Agents|alkylating agents|mesh-ancestor
65500250|NCT02431988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500251|NCT02431988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500252|NCT02431988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65500253|NCT02427568|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65500254|NCT02427568|Hallucinogens|hallucinogens|mesh-ancestor
65500255|NCT02427568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500256|NCT02427568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65500257|NCT02427568|Serotonin Agents|serotonin agents|mesh-ancestor
65068345|NCT00281606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65500258|NCT02427568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65068346|NCT00317538|Etanercept|etanercept|mesh-list
65500259|NCT02427568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500260|NCT02427568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65500261|NCT02427568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65500262|NCT02427568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65500264|NCT02399371|Pembrolizumab|pembrolizumab|mesh-list
65500265|NCT02399371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65500266|NCT02399371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500267|NCT02389517|Dexamethasone|dexamethasone|mesh-list
65500268|NCT02389517|Lenalidomide|lenalidomide|mesh-list
65500269|NCT02389517|Ixazomib|ixazomib|mesh-list
65500270|NCT02389517|Glycine|glycine|mesh-list
65500271|NCT02389517|Proteasome Inhibitors|proteasome inhibitors|mesh-list
65500272|NCT02389517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65500273|NCT02389517|Antiemetics|antiemetics|mesh-ancestor
65500274|NCT02389517|Autonomic Agents|autonomic agents|mesh-ancestor
65500275|NCT02389517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65500276|NCT02389517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500277|NCT02389517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65500278|NCT02389517|Glucocorticoids|glucocorticoids|mesh-ancestor
65500279|NCT02389517|Hormones|hormones|mesh-ancestor
65500280|NCT02389517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65500281|NCT02389517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65500282|NCT02389517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500283|NCT02389517|Immunologic Factors|immunologic factors|mesh-ancestor
65500284|NCT02389517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65500285|NCT02389517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65500286|NCT02389517|Growth Substances|growth substances|mesh-ancestor
65500287|NCT02389517|Growth Inhibitors|growth inhibitors|mesh-ancestor
65500288|NCT02389517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500289|NCT02389517|Protease Inhibitors|protease inhibitors|mesh-ancestor
64809335|NCT05060731|Iron|iron|mesh-list
65500290|NCT02389517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500291|NCT02389517|Glycine Agents|glycine agents|mesh-ancestor
65500292|NCT02389517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65500293|NCT02366819|Leucovorin|leucovorin|mesh-list
65500294|NCT02366819|Fluorouracil|fluorouracil|mesh-list
65500295|NCT02366819|Oxaliplatin|oxaliplatin|mesh-list
65500296|NCT02366819|Irinotecan|irinotecan|mesh-list
65500297|NCT02366819|Calcium|calcium|mesh-list
65500298|NCT02366819|Levoleucovorin|levoleucovorin|mesh-list
65500299|NCT02366819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65500300|NCT02366819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500301|NCT02366819|Antimetabolites|antimetabolites|mesh-ancestor
65500302|NCT02366819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500303|NCT02366819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65500304|NCT02366819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500305|NCT02366819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65500306|NCT02366819|Immunologic Factors|immunologic factors|mesh-ancestor
65500307|NCT02366819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65500308|NCT02366819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65500309|NCT02366819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500310|NCT02366819|Antidotes|antidotes|mesh-ancestor
65500311|NCT02366819|Protective Agents|protective agents|mesh-ancestor
65500312|NCT02366819|Vitamin B Complex|vitamin b complex|mesh-ancestor
65500313|NCT02366819|Vitamins|vitamins|mesh-ancestor
65500314|NCT02366819|Micronutrients|micronutrients|mesh-ancestor
65500315|NCT02352948|Gemcitabine|gemcitabine|mesh-list
65500316|NCT02352948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65500317|NCT02352948|Durvalumab|durvalumab|mesh-list
65500318|NCT02352948|Vinorelbine|vinorelbine|mesh-list
65500319|NCT02352948|Tremelimumab|tremelimumab|mesh-list
65500320|NCT02352948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65500321|NCT02352948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65500322|NCT02352948|Antimetabolites|antimetabolites|mesh-ancestor
65500323|NCT02352948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500324|NCT02352948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500325|NCT02352948|Antiviral Agents|antiviral agents|mesh-ancestor
65500326|NCT02352948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65500327|NCT02352948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500328|NCT02352948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64809464|NCT04787848|Bromides|bromides|mesh-list
65500329|NCT02352948|Immunologic Factors|immunologic factors|mesh-ancestor
65500330|NCT02352948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068347|NCT00317538|Infliximab|infliximab|mesh-list
65068348|NCT00317538|Dermatologic Agents|dermatologic agents|mesh-ancestor
65500331|NCT02352948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65068349|NCT00317538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65500332|NCT02352948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65068350|NCT00317538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65500333|NCT02352948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65500334|NCT02352948|Tubulin Modulators|tubulin modulators|mesh-ancestor
65500335|NCT02352948|Antimitotic Agents|antimitotic agents|mesh-ancestor
65500336|NCT02352948|Mitosis Modulators|mitosis modulators|mesh-ancestor
65500337|NCT02333162|Mycophenolic Acid|mycophenolic acid|mesh-list
65500338|NCT02333162|Fludarabine|fludarabine|mesh-list
65500339|NCT02333162|Fludarabine phosphate|fludarabine phosphate|mesh-list
65500340|NCT02333162|Melphalan|melphalan|mesh-list
65500341|NCT02333162|Tacrolimus|tacrolimus|mesh-list
65500342|NCT02333162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500343|NCT02333162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65500344|NCT02333162|Antimetabolites|antimetabolites|mesh-ancestor
65500345|NCT02333162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500346|NCT02333162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65500347|NCT02333162|Immunologic Factors|immunologic factors|mesh-ancestor
65500348|NCT02333162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500349|NCT02333162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65500350|NCT02333162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809543|NCT04588688|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64809544|NCT04588688|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64809545|NCT04588688|Contraceptive Agents|contraceptive agents|mesh-ancestor
64809546|NCT04588688|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65500351|NCT02333162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65500352|NCT02333162|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65500353|NCT02333162|Antitubercular Agents|antitubercular agents|mesh-ancestor
65500354|NCT02333162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65500355|NCT02333162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65500356|NCT02333162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65500357|NCT02333162|Alkylating Agents|alkylating agents|mesh-ancestor
65500358|NCT02333162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65500359|NCT02281838|Enalapril|enalapril|mesh-list
65500360|NCT02281838|Hydralazine|hydralazine|mesh-list
65500361|NCT02281838|Labetalol|labetalol|mesh-list
65500362|NCT02281838|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65500363|NCT02281838|Protease Inhibitors|protease inhibitors|mesh-ancestor
65500364|NCT02281838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500365|NCT02281838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500366|NCT02281838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65500367|NCT02281838|Vasodilator Agents|vasodilator agents|mesh-ancestor
65500368|NCT02281838|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65500369|NCT02281838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65500370|NCT02281838|Adrenergic Agents|adrenergic agents|mesh-ancestor
65500371|NCT02281838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65500372|NCT02281838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500373|NCT02281838|Sympathomimetics|sympathomimetics|mesh-ancestor
65500374|NCT02281838|Autonomic Agents|autonomic agents|mesh-ancestor
65500375|NCT02281838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65500376|NCT02281838|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65500377|NCT02281838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65500378|NCT02213913|Prednisone|prednisone|mesh-list
65500379|NCT02213913|Cyclophosphamide|cyclophosphamide|mesh-list
65500380|NCT02213913|Rituximab|rituximab|mesh-list
65500381|NCT02213913|Doxorubicin|doxorubicin|mesh-list
65500382|NCT02213913|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65500383|NCT02213913|Etoposide|etoposide|mesh-list
65500384|NCT02213913|Vincristine|vincristine|mesh-list
65500385|NCT02213913|Lenalidomide|lenalidomide|mesh-list
65500386|NCT02213913|Etoposide phosphate|etoposide phosphate|mesh-list
65500387|NCT02213913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64809672|NCT03860077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64809673|NCT03860077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809674|NCT03860077|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64809675|NCT03860077|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64809676|NCT03860077|Cholinergic Agents|cholinergic agents|mesh-ancestor
64809677|NCT03860077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64809679|NCT03697512|Rituximab|rituximab|mesh-list
65500388|NCT02213913|Immunologic Factors|immunologic factors|mesh-ancestor
65500389|NCT02213913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500390|NCT02213913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65500391|NCT02213913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65500392|NCT02213913|Alkylating Agents|alkylating agents|mesh-ancestor
65500393|NCT02213913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500394|NCT02213913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500395|NCT02213913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65500396|NCT02213913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65500397|NCT02213913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65500398|NCT02213913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65500399|NCT02213913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65500400|NCT02213913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500401|NCT02213913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65500402|NCT02213913|Glucocorticoids|glucocorticoids|mesh-ancestor
65500403|NCT02213913|Hormones|hormones|mesh-ancestor
65068351|NCT00317538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65500404|NCT02213913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65500405|NCT02213913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65500406|NCT02213913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65500407|NCT02213913|Tubulin Modulators|tubulin modulators|mesh-ancestor
65500408|NCT02213913|Antimitotic Agents|antimitotic agents|mesh-ancestor
65500409|NCT02213913|Mitosis Modulators|mitosis modulators|mesh-ancestor
65500410|NCT02213913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65500411|NCT02213913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65500412|NCT02213913|Growth Substances|growth substances|mesh-ancestor
65500413|NCT02213913|Growth Inhibitors|growth inhibitors|mesh-ancestor
65500414|NCT02194738|Gemcitabine|gemcitabine|mesh-list
65500415|NCT02194738|Paclitaxel|paclitaxel|mesh-list
65500416|NCT02194738|Cisplatin|cisplatin|mesh-list
65500417|NCT02194738|Carboplatin|carboplatin|mesh-list
65500418|NCT02194738|Pembrolizumab|pembrolizumab|mesh-list
65500419|NCT02194738|Nivolumab|nivolumab|mesh-list
65500420|NCT02194738|Pemetrexed|pemetrexed|mesh-list
65500421|NCT02194738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65500422|NCT02194738|Crizotinib|crizotinib|mesh-list
65500423|NCT02194738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65500424|NCT02194738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500425|NCT02194738|Tubulin Modulators|tubulin modulators|mesh-ancestor
65500426|NCT02194738|Antimitotic Agents|antimitotic agents|mesh-ancestor
65500427|NCT02194738|Mitosis Modulators|mitosis modulators|mesh-ancestor
65500428|NCT02194738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809792|NCT03200015|Metformin|metformin|mesh-list
65500429|NCT02194738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65500430|NCT02194738|Antimetabolites|antimetabolites|mesh-ancestor
65500431|NCT02194738|Antiviral Agents|antiviral agents|mesh-ancestor
65500432|NCT02194738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65500433|NCT02194738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500434|NCT02194738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65500435|NCT02194738|Immunologic Factors|immunologic factors|mesh-ancestor
65500436|NCT02194738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500437|NCT02194738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65500438|NCT02194738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65500439|NCT02194738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65500440|NCT02194738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65500441|NCT02194738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65500442|NCT02122172|Afatinib|afatinib|mesh-list
65500443|NCT02122172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500444|NCT02122172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65500445|NCT02122172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500446|NCT02122172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500447|NCT02008396|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65500448|NCT02008396|Hallucinogens|hallucinogens|mesh-ancestor
65500449|NCT02008396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500450|NCT02008396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65500451|NCT02008396|Serotonin Agents|serotonin agents|mesh-ancestor
65500452|NCT02008396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65500453|NCT02008396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500454|NCT02008396|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65500455|NCT02008396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65500456|NCT02008396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65500457|NCT02008396|Adrenergic Agents|adrenergic agents|mesh-ancestor
65500458|NCT01968109|Nivolumab|nivolumab|mesh-list
65500459|NCT01968109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65500460|NCT01968109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500461|NCT01968109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65500462|NCT01968109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500463|NCT01958593|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65500464|NCT01958593|Hallucinogens|hallucinogens|mesh-ancestor
65500465|NCT01958593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500466|NCT01958593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65500467|NCT01958593|Serotonin Agents|serotonin agents|mesh-ancestor
65500468|NCT01958593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65500469|NCT01958593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500470|NCT01958593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65500471|NCT01958593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65500472|NCT01958593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65500473|NCT01958593|Adrenergic Agents|adrenergic agents|mesh-ancestor
65500474|NCT01847326|Paclitaxel|paclitaxel|mesh-list
65500475|NCT01847326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65500476|NCT01847326|Carboplatin|carboplatin|mesh-list
65500477|NCT01847326|Fluorouracil|fluorouracil|mesh-list
65500478|NCT01847326|Hydroxyurea|hydroxyurea|mesh-list
65068352|NCT00317538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65500479|NCT01847326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65068353|NCT00317538|Analgesics|analgesics|mesh-ancestor
64478466|NCT01856257|Abatacept|abatacept|mesh-list
65500480|NCT01847326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500481|NCT01847326|Tubulin Modulators|tubulin modulators|mesh-ancestor
65500482|NCT01847326|Antimitotic Agents|antimitotic agents|mesh-ancestor
65500483|NCT01847326|Mitosis Modulators|mitosis modulators|mesh-ancestor
65500484|NCT01847326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500485|NCT01847326|Antimetabolites|antimetabolites|mesh-ancestor
65500486|NCT01847326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65500487|NCT01847326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65500488|NCT01847326|Immunologic Factors|immunologic factors|mesh-ancestor
65500489|NCT01847326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500490|NCT01847326|Antisickling Agents|antisickling agents|mesh-ancestor
65500491|NCT01847326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500492|NCT01847326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65500493|NCT01793610|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65500494|NCT01793610|Hallucinogens|hallucinogens|mesh-ancestor
65500495|NCT01793610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500496|NCT01793610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65500497|NCT01793610|Serotonin Agents|serotonin agents|mesh-ancestor
65500498|NCT01793610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65500499|NCT01793610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500500|NCT01793610|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65500501|NCT01793610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65500502|NCT01793610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65500503|NCT01793610|Adrenergic Agents|adrenergic agents|mesh-ancestor
65500504|NCT01665794|Dexamethasone|dexamethasone|mesh-list
65500505|NCT01665794|Daratumumab|daratumumab|mesh-list
65500506|NCT01665794|Pomalidomide|pomalidomide|mesh-list
65500507|NCT01665794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65500508|NCT01665794|Antiemetics|antiemetics|mesh-ancestor
65500509|NCT01665794|Autonomic Agents|autonomic agents|mesh-ancestor
65500510|NCT01665794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65500511|NCT01665794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500512|NCT01665794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65500513|NCT01665794|Glucocorticoids|glucocorticoids|mesh-ancestor
65500515|NCT01665794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65500516|NCT01665794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65500517|NCT01665794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500518|NCT01665794|Immunologic Factors|immunologic factors|mesh-ancestor
65500519|NCT01665794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65500520|NCT01665794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65500521|NCT01665794|Growth Substances|growth substances|mesh-ancestor
65500522|NCT01665794|Growth Inhibitors|growth inhibitors|mesh-ancestor
65500523|NCT01592370|Dexamethasone|dexamethasone|mesh-list
65500524|NCT01592370|Nivolumab|nivolumab|mesh-list
65500525|NCT01592370|Ipilimumab|ipilimumab|mesh-list
65500526|NCT01592370|Daratumumab|daratumumab|mesh-list
65500527|NCT01592370|Pomalidomide|pomalidomide|mesh-list
65500528|NCT01592370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65500529|NCT01592370|Antiemetics|antiemetics|mesh-ancestor
65500530|NCT01592370|Autonomic Agents|autonomic agents|mesh-ancestor
65500531|NCT01592370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65500532|NCT01592370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500533|NCT01592370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65500534|NCT01592370|Glucocorticoids|glucocorticoids|mesh-ancestor
65500535|NCT01592370|Hormones|hormones|mesh-ancestor
64810411|NCT01441297|Nintedanib|nintedanib|mesh-list
65500536|NCT01592370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65500537|NCT01592370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65500538|NCT01592370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500539|NCT01592370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65500540|NCT01592370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65500541|NCT01592370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500542|NCT01592370|Immunologic Factors|immunologic factors|mesh-ancestor
65500543|NCT01592370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65500544|NCT01592370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65500545|NCT01592370|Growth Substances|growth substances|mesh-ancestor
65500546|NCT01592370|Growth Inhibitors|growth inhibitors|mesh-ancestor
65500547|NCT01526096|Plerixafor|plerixafor|mesh-list
65500548|NCT01526096|Melphalan|melphalan|mesh-list
65500549|NCT01526096|Basiliximab|basiliximab|mesh-list
65500550|NCT01526096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65500551|NCT01526096|Alkylating Agents|alkylating agents|mesh-ancestor
64478538|NCT03593811|Antipruritics|antipruritics|mesh-ancestor
65500552|NCT01526096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500553|NCT01526096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500554|NCT01526096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65500555|NCT01526096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65500556|NCT01526096|Immunologic Factors|immunologic factors|mesh-ancestor
65500557|NCT01526096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500558|NCT01526096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65500559|NCT01526096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65500560|NCT01526096|Antiviral Agents|antiviral agents|mesh-ancestor
65500561|NCT01526096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65500562|NCT01404754|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
65500563|NCT01404754|Hallucinogens|hallucinogens|mesh-ancestor
65500564|NCT01404754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500565|NCT01404754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65500566|NCT01404754|Serotonin Agents|serotonin agents|mesh-ancestor
65500567|NCT01404754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65500568|NCT01404754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500569|NCT01404754|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65500570|NCT01404754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65500571|NCT01404754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65500572|NCT01404754|Adrenergic Agents|adrenergic agents|mesh-ancestor
65500573|NCT01369212|Tenofovir|tenofovir|mesh-list
65500574|NCT01369212|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65500575|NCT01369212|Antiviral Agents|antiviral agents|mesh-ancestor
65500576|NCT01369212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65500577|NCT01369212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65500578|NCT01369212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65500579|NCT01369212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500580|NCT01369212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500581|NCT01369212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65500582|NCT01369212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65500583|NCT01351103|Spartalizumab|spartalizumab|mesh-list
65500584|NCT01351103|LGK974|lgk974|mesh-list
65500585|NCT01351103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65500586|NCT01351103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500587|NCT01351103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500588|NCT01351103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500589|NCT00800215|Lacosamide|lacosamide|mesh-list
65500590|NCT00800215|Anticonvulsants|anticonvulsants|mesh-ancestor
65500591|NCT00800215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65500592|NCT00800215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65500593|NCT00800215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65500594|NCT00800215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500595|NCT00669734|Metronidazole|metronidazole|mesh-list
65500596|NCT00669734|Tricyclodecane-9-yl-xanthogenate|tricyclodecane-9-yl-xanthogenate|mesh-list
65500597|NCT00669734|Vaccines|vaccines|mesh-list
65500598|NCT00669734|Sargramostim|sargramostim|mesh-list
65500599|NCT00669734|Immunologic Factors|immunologic factors|mesh-ancestor
65500600|NCT00669734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500601|NCT00669734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500602|NCT00669734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65500603|NCT00669734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65500604|NCT00669734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65500605|NCT00669734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65500606|NCT00669734|Antioxidants|antioxidants|mesh-ancestor
65500607|NCT00669734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500608|NCT00669734|Protective Agents|protective agents|mesh-ancestor
65500609|NCT00669734|Antiviral Agents|antiviral agents|mesh-ancestor
65500610|NCT00669734|Growth Inhibitors|growth inhibitors|mesh-ancestor
65500611|NCT00669734|Growth Substances|growth substances|mesh-ancestor
65500612|NCT00669734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65500613|NCT00669734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500614|NCT00353938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
64810752|NCT01443065|Leucovorin|leucovorin|mesh-list
65500615|NCT00353938|Hallucinogens|hallucinogens|mesh-ancestor
65500616|NCT00353938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500617|NCT00353938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65500618|NCT00353938|Serotonin Agents|serotonin agents|mesh-ancestor
65500619|NCT00353938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65500620|NCT00353938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500621|NCT00353938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65500622|NCT00353938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65500623|NCT00353938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65500624|NCT00353938|Adrenergic Agents|adrenergic agents|mesh-ancestor
65500625|NCT00337649|Trastuzumab|trastuzumab|mesh-list
65500626|NCT00337649|Epothilones|epothilones|mesh-list
65068354|NCT00317538|Sensory System Agents|sensory system agents|mesh-ancestor
64478611|NCT03592485|Narcotics|narcotics|mesh-ancestor
65500627|NCT00337649|Desoxyepothilone B|desoxyepothilone b|mesh-list
65500628|NCT00337649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65500629|NCT00337649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500630|NCT00337649|Tubulin Modulators|tubulin modulators|mesh-ancestor
65500631|NCT00337649|Antimitotic Agents|antimitotic agents|mesh-ancestor
65500632|NCT00337649|Mitosis Modulators|mitosis modulators|mesh-ancestor
65500633|NCT00337649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500634|NCT00071084|Zanolimumab|zanolimumab|mesh-list
65500635|NCT00071084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65500636|NCT00071084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65500637|NCT00071084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500638|NCT00071084|Immunologic Factors|immunologic factors|mesh-ancestor
65500639|NCT00071084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500641|NCT00042406|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65500642|NCT00042406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65500643|NCT00042406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65500644|NCT00042406|Immunologic Factors|immunologic factors|mesh-ancestor
65500645|NCT00042406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65500646|NCT00025935|Lithium Carbonate|lithium carbonate|mesh-list
65500647|NCT00025935|Antidepressive Agents|antidepressive agents|mesh-ancestor
65500648|NCT00025935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65500649|NCT00025935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65500650|NCT00025935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65500651|NCT00025935|Antimanic Agents|antimanic agents|mesh-ancestor
65500652|NCT00025935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65500653|NCT00025935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65500654|NCT00025935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068355|NCT00317538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64478687|NCT03987711|Warfarin|warfarin|mesh-list
65068356|NCT00317538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068357|NCT00317538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64478833|NCT04191135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65068359|NCT00317538|Immunologic Factors|immunologic factors|mesh-ancestor
65068360|NCT00281645|Analgesics|analgesics|mesh-list
65068361|NCT00281645|Sensory System Agents|sensory system agents|mesh-ancestor
64478980|NCT04190745|Tubulin Modulators|tubulin modulators|mesh-ancestor
65068362|NCT00281645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64479053|NCT04021173|Fibrinolysin|fibrinolysin|mesh-list
64479125|NCT01613599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64479200|NCT04145583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65068363|NCT00281645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068364|NCT00317577|Timolol|timolol|mesh-list
65068365|NCT00317577|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65068366|NCT00317577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65068367|NCT00317577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64479348|NCT00527644|Hormones|hormones|mesh-ancestor
65068368|NCT00317577|Adrenergic Agents|adrenergic agents|mesh-ancestor
65068369|NCT00317577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64479511|NCT05072236|Lidocaine|lidocaine|mesh-list
65068370|NCT00317577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068371|NCT00317577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068372|NCT00317577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64479786|NCT01868893|Chlorambucil|chlorambucil|mesh-list
65068373|NCT00317577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65068374|NCT00317577|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65068375|NCT00317577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65068376|NCT00317577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65068377|NCT00317655|Ibuprofen|ibuprofen|mesh-list
65068378|NCT00317655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65068379|NCT00317655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65068380|NCT00317655|Analgesics|analgesics|mesh-ancestor
65068381|NCT00317655|Sensory System Agents|sensory system agents|mesh-ancestor
65068382|NCT00317655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65068383|NCT00317655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811149|NCT01445522|Veliparib|veliparib|mesh-list
65068384|NCT00317655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65068385|NCT00317655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65068386|NCT00317655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65068387|NCT00317655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068388|NCT00317655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068390|NCT00281996|Imatinib Mesylate|imatinib mesylate|mesh-list
64480155|NCT01802437|Serotonin Agents|serotonin agents|mesh-ancestor
65068391|NCT00281996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64480224|NCT01571128|Emtricitabine|emtricitabine|mesh-list
65068392|NCT00281996|Antimetabolites|antimetabolites|mesh-ancestor
64480288|NCT00756418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65068393|NCT00281996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068394|NCT00281996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068395|NCT00281996|Antiviral Agents|antiviral agents|mesh-ancestor
65068396|NCT00281996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65068397|NCT00281996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068398|NCT00281996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65068399|NCT00281996|Immunologic Factors|immunologic factors|mesh-ancestor
65068400|NCT00281996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068401|NCT00281996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65068402|NCT00311259|Melatonin|melatonin|mesh-list
65068403|NCT00311259|Antioxidants|antioxidants|mesh-ancestor
65068404|NCT00311259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068405|NCT00311259|Protective Agents|protective agents|mesh-ancestor
64480501|NCT00670774|Eculizumab|eculizumab|mesh-list
64480572|NCT00627406|Fertility Agents|fertility agents|mesh-ancestor
65068406|NCT00311259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068407|NCT00311259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65068409|NCT00317733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65068410|NCT00317733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65068411|NCT00317733|Analgesics|analgesics|mesh-ancestor
65068412|NCT00317733|Sensory System Agents|sensory system agents|mesh-ancestor
65068413|NCT00317733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64480941|NCT01840579|Pembrolizumab|pembrolizumab|mesh-list
65068414|NCT00317733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068415|NCT00317733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65068416|NCT00317733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65068417|NCT00317733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65068418|NCT00317733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068419|NCT00317733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068420|NCT00311337|Bortezomib|bortezomib|mesh-list
65068421|NCT00311337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068422|NCT00317811|Ascorbic Acid|ascorbic acid|mesh-list
65068423|NCT00317811|Bortezomib|bortezomib|mesh-list
65068424|NCT00317811|Melphalan|melphalan|mesh-list
65068425|NCT00317811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509861|NCT01451229|Higenamine|higenamine|mesh-list
64481378|NCT02990884|Anesthetics|anesthetics|mesh-ancestor
65068426|NCT00317811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65068428|NCT00317811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068429|NCT00317811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65068430|NCT00317811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65068431|NCT00317811|Immunologic Factors|immunologic factors|mesh-ancestor
65068432|NCT00317811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068433|NCT00317811|Antioxidants|antioxidants|mesh-ancestor
65068434|NCT00317811|Protective Agents|protective agents|mesh-ancestor
65068435|NCT00317811|Vitamins|vitamins|mesh-ancestor
65068436|NCT00317811|Micronutrients|micronutrients|mesh-ancestor
65068437|NCT00282386|Rofecoxib|rofecoxib|mesh-list
65068438|NCT00282386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068439|NCT00282386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068440|NCT00282386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64481671|NCT00719134|Rizatriptan|rizatriptan|mesh-list
65068441|NCT00282386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65068442|NCT00282386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65068443|NCT00282386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068444|NCT00282386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65068445|NCT00282386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65068446|NCT00282386|Analgesics|analgesics|mesh-ancestor
65068447|NCT00282386|Sensory System Agents|sensory system agents|mesh-ancestor
65068448|NCT00282386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65068450|NCT00317850|Gabapentin|gabapentin|mesh-list
64811436|NCT01447173|Vitamin D|vitamin d|mesh-list
65068451|NCT00317850|Analgesics|analgesics|mesh-ancestor
65068452|NCT00317850|Sensory System Agents|sensory system agents|mesh-ancestor
64811509|NCT01447797|Irbesartan|irbesartan|mesh-list
65068453|NCT00317850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65068454|NCT00317850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068455|NCT00317850|Anticonvulsants|anticonvulsants|mesh-ancestor
65068456|NCT00317850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64482109|NCT03904329|Anticoagulants|anticoagulants|mesh-list
65068457|NCT00317850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65068458|NCT00317850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65068459|NCT00317850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65068460|NCT00317850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65068461|NCT00317850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65068462|NCT00317850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64482316|NCT03588351|Chlorhexidine|chlorhexidine|mesh-list
64482390|NCT01797445|Antiviral Agents|antiviral agents|mesh-ancestor
65068463|NCT00317850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068464|NCT00317850|Antimanic Agents|antimanic agents|mesh-ancestor
65068465|NCT00282503|Methylprednisolone|methylprednisolone|mesh-list
65068466|NCT00282503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64640997|NCT00407966|Cytarabine|cytarabine|mesh-list
65068467|NCT00282503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65068468|NCT00282503|Prednisolone|prednisolone|mesh-list
65068469|NCT00282503|Prednisolone acetate|prednisolone acetate|mesh-list
65068470|NCT00282503|Methoxsalen|methoxsalen|mesh-list
65068471|NCT00282503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65068472|NCT00282503|Prednisolone phosphate|prednisolone phosphate|mesh-list
65068473|NCT00282503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65068474|NCT00282503|Antiemetics|antiemetics|mesh-ancestor
65068475|NCT00282503|Autonomic Agents|autonomic agents|mesh-ancestor
65068476|NCT00282503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65068477|NCT00282503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068478|NCT00282503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65068479|NCT00282503|Glucocorticoids|glucocorticoids|mesh-ancestor
65068480|NCT00282503|Hormones|hormones|mesh-ancestor
65068481|NCT00282503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65068482|NCT00282503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65068483|NCT00282503|Protective Agents|protective agents|mesh-ancestor
65068484|NCT00282503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65068485|NCT00282503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068486|NCT00282503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65068487|NCT00282503|Dermatologic Agents|dermatologic agents|mesh-ancestor
64811686|NCT01448772|Sensory System Agents|sensory system agents|mesh-ancestor
65068488|NCT00317928|Metformin|metformin|mesh-list
65068489|NCT00317928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65068490|NCT00317928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068491|NCT00282698|Insulin|insulin|mesh-list
65068492|NCT00282698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65068493|NCT00282698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068494|NCT00317967|Atorvastatin|atorvastatin|mesh-list
65068495|NCT00317967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65068496|NCT00317967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65068497|NCT00317967|Antimetabolites|antimetabolites|mesh-ancestor
65068498|NCT00317967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068499|NCT00317967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64811727|NCT01449110|Antioxidants|antioxidants|mesh-ancestor
64811728|NCT01449110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811729|NCT01449110|Protective Agents|protective agents|mesh-ancestor
64811730|NCT01449110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811731|NCT01449110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811732|NCT01449110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64811733|NCT01449123|Mannitol|mannitol|mesh-list
64811734|NCT01449123|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64811735|NCT01449123|Diuretics|diuretics|mesh-ancestor
64811736|NCT01449123|Natriuretic Agents|natriuretic agents|mesh-ancestor
64509930|NCT01452477|Tanshinone|tanshinone|mesh-list
65068500|NCT00317967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65068501|NCT00317967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068502|NCT00318084|Esomeprazole|esomeprazole|mesh-list
65068503|NCT00318084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65068504|NCT00318084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65068505|NCT00318084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65068506|NCT00318084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068507|NCT00318084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068508|NCT00282932|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65068509|NCT00282932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64811791|NCT01449344|Hormones|hormones|mesh-ancestor
65068510|NCT00282932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64811792|NCT01449344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64811793|NCT01449344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64811794|NCT01449344|Protease Inhibitors|protease inhibitors|mesh-ancestor
64811795|NCT01449344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811796|NCT01449344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811797|NCT01449344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64811798|NCT01449344|Antimetabolites|antimetabolites|mesh-ancestor
64811799|NCT01449344|Antiviral Agents|antiviral agents|mesh-ancestor
64811800|NCT01449344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64811801|NCT01449344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64811802|NCT01449357|Zalutumumab|zalutumumab|mesh-list
64811803|NCT01449357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64811804|NCT01449357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068511|NCT00282932|Cholinergic Agents|cholinergic agents|mesh-ancestor
65068512|NCT00282932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65068513|NCT00282932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068514|NCT00282932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068515|NCT00282932|Urological Agents|urological agents|mesh-ancestor
65068516|NCT00318162|Naltrexone|naltrexone|mesh-list
65068517|NCT00318162|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65068518|NCT00318162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65068519|NCT00318162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068520|NCT00318162|Sensory System Agents|sensory system agents|mesh-ancestor
65068521|NCT00318162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65068522|NCT00283088|Plasminogen|plasminogen|mesh-list
65068523|NCT00283088|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65068524|NCT00283088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64811838|NCT01449552|Hemostatics|hemostatics|mesh-ancestor
64811839|NCT01449552|Coagulants|coagulants|mesh-ancestor
64811840|NCT01449565|Naltrexone|naltrexone|mesh-list
64811841|NCT01449565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64811842|NCT01449565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64811843|NCT01449565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811844|NCT01449565|Sensory System Agents|sensory system agents|mesh-ancestor
64811845|NCT01449565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64811846|NCT01449578|Pramipexole|pramipexole|mesh-list
64811847|NCT01449578|Antioxidants|antioxidants|mesh-ancestor
64811848|NCT01449578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811849|NCT01449578|Protective Agents|protective agents|mesh-ancestor
64811850|NCT01449578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811851|NCT01449578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65068525|NCT00283088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65068526|NCT00283088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068527|NCT00318201|Erythromycin|erythromycin|mesh-list
65068528|NCT00318201|Erythromycin Estolate|erythromycin estolate|mesh-list
65068529|NCT00318201|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65068530|NCT00318201|Erythromycin stearate|erythromycin stearate|mesh-list
65068531|NCT00318201|Diltiazem|diltiazem|mesh-list
65068532|NCT00318201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65068533|NCT00318201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65068534|NCT00318201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65068535|NCT00318201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068536|NCT00318201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65068537|NCT00318201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068538|NCT00318201|Vasodilator Agents|vasodilator agents|mesh-ancestor
65068539|NCT00318201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65068540|NCT00318201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65068541|NCT00318201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65068542|NCT00318201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65068543|NCT00318201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068544|NCT00311688|Interleukin-2|interleukin-2|mesh-list
65068545|NCT00311688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068546|NCT00311688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65068547|NCT00311688|Analgesics|analgesics|mesh-ancestor
65068548|NCT00311688|Sensory System Agents|sensory system agents|mesh-ancestor
65068549|NCT00311688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65068550|NCT00311688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068551|NCT00283478|Gemcitabine|gemcitabine|mesh-list
65068552|NCT00283478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65068553|NCT00283478|Antimetabolites|antimetabolites|mesh-ancestor
64482496|NCT02947503|Metformin|metformin|mesh-list
64812290|NCT01461174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64812291|NCT01461174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64812356|NCT01462422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812357|NCT01462422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64812359|NCT01462422|Oxytocics|oxytocics|mesh-ancestor
65068554|NCT00283478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068555|NCT00283478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068556|NCT00283478|Antiviral Agents|antiviral agents|mesh-ancestor
65068557|NCT00283478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65068558|NCT00283478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068559|NCT00283478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65068560|NCT00283478|Immunologic Factors|immunologic factors|mesh-ancestor
65068561|NCT00283478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068562|NCT00318318|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65068563|NCT00318318|Estrogens|estrogens|mesh-ancestor
65068564|NCT00318318|Hormones|hormones|mesh-ancestor
65068565|NCT00318318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65068566|NCT00318318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068567|NCT00283517|Antipsychotic Agents|antipsychotic agents|mesh-list
64812550|NCT01464099|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65068568|NCT00283517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65068569|NCT00283517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65068570|NCT00283517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068571|NCT00283517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65068572|NCT00311883|Hydroxychloroquine|hydroxychloroquine|mesh-list
65068573|NCT00311883|Antimalarials|antimalarials|mesh-ancestor
65068574|NCT00311883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65068575|NCT00311883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64812931|NCT01468272|Hormones|hormones|mesh-ancestor
65068576|NCT00311883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65068577|NCT00311883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068578|NCT00311883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068579|NCT00311883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65068580|NCT00283556|Irinotecan|irinotecan|mesh-list
65068581|NCT00283556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65068582|NCT00283556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65068583|NCT00283556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068584|NCT00283556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068585|NCT00283556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068586|NCT00283634|Bortezomib|bortezomib|mesh-list
65068587|NCT00283634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65068588|NCT00283634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068589|NCT00283634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65068590|NCT00283634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068591|NCT00283634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068592|NCT00318513|Bevacizumab|bevacizumab|mesh-list
64813119|NCT01469572|Pasireotide|pasireotide|mesh-list
64813120|NCT01469572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813121|NCT01469572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64813122|NCT01469572|Immunologic Factors|immunologic factors|mesh-ancestor
64813123|NCT01469572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813124|NCT01469572|Hormones|hormones|mesh-ancestor
64813125|NCT01469572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64813126|NCT01469598|Gemcitabine|gemcitabine|mesh-list
64813127|NCT01469598|Docetaxel|docetaxel|mesh-list
64813128|NCT01469598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64813129|NCT01469598|Antimetabolites|antimetabolites|mesh-ancestor
64813130|NCT01469598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813131|NCT01469598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813132|NCT01469598|Antiviral Agents|antiviral agents|mesh-ancestor
64813133|NCT01469598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64813134|NCT01469598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813135|NCT01469598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64813136|NCT01469598|Immunologic Factors|immunologic factors|mesh-ancestor
64813137|NCT01469598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813138|NCT01469598|Tubulin Modulators|tubulin modulators|mesh-ancestor
65068593|NCT00318513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65068594|NCT00318513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068595|NCT00318513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65068596|NCT00318513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65068597|NCT00318513|Growth Substances|growth substances|mesh-ancestor
65068598|NCT00318513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068599|NCT00318513|Growth Inhibitors|growth inhibitors|mesh-ancestor
65068600|NCT00318552|Meropenem|meropenem|mesh-list
65068601|NCT00318552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65068602|NCT00318552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65068603|NCT00283751|Insulin|insulin|mesh-list
65068604|NCT00283751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65068605|NCT00283751|Insulin Glargine|insulin glargine|mesh-list
65068606|NCT00283751|Insulin Detemir|insulin detemir|mesh-list
65068607|NCT00283751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65068608|NCT00283751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068609|NCT00318630|Rosiglitazone|rosiglitazone|mesh-list
65068610|NCT00318630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65068611|NCT00318630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068613|NCT00283790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65068614|NCT00283790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65068615|NCT00283790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65068616|NCT00283790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068617|NCT00283790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65068618|NCT00283790|GABA Agonists|gaba agonists|mesh-ancestor
65068619|NCT00283790|GABA Agents|gaba agents|mesh-ancestor
65068620|NCT00283790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64813379|NCT01471158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65068621|NCT00283790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068622|NCT00318669|Paroxetine|paroxetine|mesh-list
65068623|NCT00318669|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65068624|NCT00318669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65068625|NCT00318669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65068626|NCT00318669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068627|NCT00318669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65068628|NCT00318669|Serotonin Agents|serotonin agents|mesh-ancestor
65068629|NCT00318669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068630|NCT00318669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65068631|NCT00318669|Antidepressive Agents|antidepressive agents|mesh-ancestor
65068632|NCT00318669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65068633|NCT00318669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65068634|NCT00318669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65068635|NCT00318669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068636|NCT00283829|Docetaxel|docetaxel|mesh-list
65068637|NCT00283829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068638|NCT00283829|Tubulin Modulators|tubulin modulators|mesh-ancestor
65068639|NCT00283829|Antimitotic Agents|antimitotic agents|mesh-ancestor
64813730|NCT01473303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65068640|NCT00283829|Mitosis Modulators|mitosis modulators|mesh-ancestor
65068641|NCT00283829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068642|NCT00311961|Prednisolone|prednisolone|mesh-list
65068643|NCT00311961|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65068644|NCT00311961|Methylprednisolone|methylprednisolone|mesh-list
65068645|NCT00311961|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65068646|NCT00311961|Prednisolone acetate|prednisolone acetate|mesh-list
65068647|NCT00311961|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65068648|NCT00311961|Prednisolone phosphate|prednisolone phosphate|mesh-list
65068649|NCT00311961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65068650|NCT00311961|Glucocorticoids|glucocorticoids|mesh-ancestor
65068652|NCT00311961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65068653|NCT00311961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068654|NCT00311961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65068655|NCT00311961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068656|NCT00311961|Antiemetics|antiemetics|mesh-ancestor
65068657|NCT00311961|Autonomic Agents|autonomic agents|mesh-ancestor
65068658|NCT00311961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65068659|NCT00311961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65068660|NCT00311961|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65068661|NCT00311961|Protective Agents|protective agents|mesh-ancestor
65068662|NCT00283946|Zolpidem|zolpidem|mesh-list
65068663|NCT00283946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65068664|NCT00283946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64814005|NCT01475890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65068665|NCT00283946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65068666|NCT00283946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068667|NCT00283946|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65068668|NCT00283946|GABA Agonists|gaba agonists|mesh-ancestor
65068669|NCT00283946|GABA Agents|gaba agents|mesh-ancestor
65068670|NCT00283946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65068671|NCT00283946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068672|NCT00312000|Capecitabine|capecitabine|mesh-list
65068673|NCT00312000|Irinotecan|irinotecan|mesh-list
65068674|NCT00312000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65068675|NCT00312000|Antimetabolites|antimetabolites|mesh-ancestor
65068676|NCT00312000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068677|NCT00312000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068678|NCT00312000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65068679|NCT00312000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65068680|NCT00312000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068681|NCT00283985|Dexamethasone|dexamethasone|mesh-list
65068682|NCT00283985|Methotrexate|methotrexate|mesh-list
65068683|NCT00283985|Asparaginase|asparaginase|mesh-list
65068684|NCT00283985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64814190|NCT01477034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64814191|NCT01477060|Metformin|metformin|mesh-list
65068685|NCT00283985|Antiemetics|antiemetics|mesh-ancestor
65068686|NCT00283985|Autonomic Agents|autonomic agents|mesh-ancestor
65068687|NCT00283985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65068688|NCT00283985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068689|NCT00283985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65068690|NCT00283985|Glucocorticoids|glucocorticoids|mesh-ancestor
65068691|NCT00283985|Hormones|hormones|mesh-ancestor
65068692|NCT00283985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65068693|NCT00283985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65068694|NCT00283985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068695|NCT00283985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65068696|NCT00283985|Abortifacient Agents|abortifacient agents|mesh-ancestor
65068697|NCT00283985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65068698|NCT00283985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65068699|NCT00283985|Antimetabolites|antimetabolites|mesh-ancestor
65068700|NCT00283985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068701|NCT00283985|Dermatologic Agents|dermatologic agents|mesh-ancestor
65068702|NCT00283985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068703|NCT00283985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65068704|NCT00283985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65068705|NCT00283985|Immunologic Factors|immunologic factors|mesh-ancestor
64814425|NCT01478230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64814482|NCT01478503|Mirabegron|mirabegron|mesh-list
65068706|NCT00283985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65068707|NCT00283985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65068708|NCT00419250|Lenalidomide|lenalidomide|mesh-list
65068709|NCT00419250|Immunologic Factors|immunologic factors|mesh-ancestor
65068710|NCT00419250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068711|NCT00419250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65068712|NCT00419250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65068713|NCT00419250|Growth Substances|growth substances|mesh-ancestor
65068714|NCT00419250|Growth Inhibitors|growth inhibitors|mesh-ancestor
65068715|NCT00419250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068716|NCT00284024|Domperidone|domperidone|mesh-list
65068717|NCT00284024|Antiemetics|antiemetics|mesh-ancestor
65068718|NCT00284024|Autonomic Agents|autonomic agents|mesh-ancestor
65068719|NCT00284024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65068720|NCT00284024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068721|NCT00284024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64553991|NCT03096990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65068722|NCT00284024|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65068723|NCT00284024|Dopamine Agents|dopamine agents|mesh-ancestor
65068724|NCT00284024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65068725|NCT00284024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068726|NCT00312039|Lamivudine|lamivudine|mesh-list
65068727|NCT00312039|Dexelvucitabine|dexelvucitabine|mesh-list
65068728|NCT00312039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65068729|NCT00312039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65068730|NCT00312039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068731|NCT00312039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068732|NCT00312039|Antiviral Agents|antiviral agents|mesh-ancestor
65068733|NCT00312039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65068734|NCT00312039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65068735|NCT00312039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65068736|NCT00284258|Irinotecan|irinotecan|mesh-list
64814680|NCT01479751|Magnesium Sulfate|magnesium sulfate|mesh-list
65068737|NCT00284258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65068738|NCT00284258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65068739|NCT00284258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068740|NCT00284258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068741|NCT00284258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068742|NCT00318786|Insulin Aspart|insulin aspart|mesh-list
65068743|NCT00318786|Biphasic Insulins|biphasic insulins|mesh-list
65068744|NCT00318786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65068745|NCT00318786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068746|NCT00284336|Cyclophosphamide|cyclophosphamide|mesh-list
65068747|NCT00284336|Doxorubicin|doxorubicin|mesh-list
65068748|NCT00284336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65068749|NCT00284336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65068750|NCT00284336|Immunologic Factors|immunologic factors|mesh-ancestor
65068751|NCT00284336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068752|NCT00284336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64814800|NCT01480492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64814801|NCT01480492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64814802|NCT01480492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814803|NCT01480492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814804|NCT01480531|Clevidipine|clevidipine|mesh-list
64814806|NCT01480531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65068753|NCT00284336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65068754|NCT00284336|Alkylating Agents|alkylating agents|mesh-ancestor
65068755|NCT00284336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068756|NCT00284336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068757|NCT00284336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65068758|NCT00284336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65068759|NCT00284336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65068760|NCT00284336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65068761|NCT00284336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068762|NCT00312156|Insulin|insulin|mesh-list
65068763|NCT00312156|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65068764|NCT00312156|Insulin Aspart|insulin aspart|mesh-list
65068765|NCT00312156|Insulin Detemir|insulin detemir|mesh-list
65068766|NCT00312156|Isophane Insulin, Human|isophane insulin, human|mesh-list
65068767|NCT00312156|Insulin, Isophane|insulin, isophane|mesh-list
65068768|NCT00312156|Isophane insulin, beef|isophane insulin, beef|mesh-list
65068769|NCT00312156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65068770|NCT00312156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068771|NCT00318825|Nitrous Oxide|nitrous oxide|mesh-list
65068772|NCT00318825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65068773|NCT00318825|Anesthetics, General|anesthetics, general|mesh-ancestor
65068774|NCT00318825|Anesthetics|anesthetics|mesh-ancestor
65068775|NCT00318825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65068776|NCT00318825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068777|NCT00318825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65068778|NCT00318825|Analgesics|analgesics|mesh-ancestor
65068779|NCT00318825|Sensory System Agents|sensory system agents|mesh-ancestor
65068780|NCT00318825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65068781|NCT00284531|Daclizumab|daclizumab|mesh-list
65068782|NCT00284531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65068783|NCT00284531|Immunologic Factors|immunologic factors|mesh-ancestor
65068784|NCT00284531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068785|NCT00312273|Aminophylline|aminophylline|mesh-list
65068786|NCT00312273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65068787|NCT00312273|Autonomic Agents|autonomic agents|mesh-ancestor
65068788|NCT00312273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65068789|NCT00312273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068790|NCT00312273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64815198|NCT01482897|Methylprednisolone|methylprednisolone|mesh-list
65068791|NCT00312273|Respiratory System Agents|respiratory system agents|mesh-ancestor
65068792|NCT00312273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65068793|NCT00312273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65068794|NCT00312273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068795|NCT00312273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068796|NCT00312273|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65068797|NCT00312273|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65068798|NCT00312273|Purinergic Agents|purinergic agents|mesh-ancestor
65068799|NCT00312273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65068800|NCT00312273|Protective Agents|protective agents|mesh-ancestor
65068801|NCT00318903|Docetaxel|docetaxel|mesh-list
64815449|NCT01485198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64815450|NCT01485198|Analgesics|analgesics|mesh-ancestor
64815451|NCT01485198|Sensory System Agents|sensory system agents|mesh-ancestor
64815485|NCT01485367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815486|NCT01485367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64815488|NCT01485367|Dermatologic Agents|dermatologic agents|mesh-ancestor
64815489|NCT01485406|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64815490|NCT01485406|Immunologic Factors|immunologic factors|mesh-ancestor
64815491|NCT01485406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815492|NCT01485445|Fluticasone|fluticasone|mesh-list
64815493|NCT01485445|Xhance|xhance|mesh-list
65068802|NCT00318903|Irinotecan|irinotecan|mesh-list
65068803|NCT00318903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068804|NCT00318903|Tubulin Modulators|tubulin modulators|mesh-ancestor
65068805|NCT00318903|Antimitotic Agents|antimitotic agents|mesh-ancestor
65068806|NCT00318903|Mitosis Modulators|mitosis modulators|mesh-ancestor
65068807|NCT00318903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068808|NCT00318903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65068809|NCT00318903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65068810|NCT00318903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068811|NCT00284687|Artesunate|artesunate|mesh-list
65068812|NCT00284687|Antimalarials|antimalarials|mesh-ancestor
65068813|NCT00284687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65068814|NCT00284687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65068815|NCT00284687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65068816|NCT00284687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068817|NCT00284687|Antiviral Agents|antiviral agents|mesh-ancestor
65068818|NCT00284687|Schistosomicides|schistosomicides|mesh-ancestor
65068819|NCT00284687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65068820|NCT00284687|Anthelmintics|anthelmintics|mesh-ancestor
64815538|NCT01485692|Anesthetics, General|anesthetics, general|mesh-ancestor
65068821|NCT00284765|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
65068822|NCT00284765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64815539|NCT01485692|Anesthetics|anesthetics|mesh-ancestor
65068823|NCT00284765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65068824|NCT00284765|Analgesics|analgesics|mesh-ancestor
65068825|NCT00284765|Sensory System Agents|sensory system agents|mesh-ancestor
65068826|NCT00284765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65068827|NCT00284765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068828|NCT00284765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65068829|NCT00284765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65068830|NCT00318981|Methylphenidate|methylphenidate|mesh-list
65068831|NCT00318981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65068832|NCT00318981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815734|NCT01486485|Protease Inhibitors|protease inhibitors|mesh-ancestor
64815735|NCT01486485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815736|NCT01486485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068833|NCT00318981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65068834|NCT00318981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65068835|NCT00318981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65068836|NCT00318981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068837|NCT00318981|Dopamine Agents|dopamine agents|mesh-ancestor
65068838|NCT00318981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65068839|NCT00284921|Mycophenolic Acid|mycophenolic acid|mesh-list
65068840|NCT00284921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65068841|NCT00284921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068842|NCT00284921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65068843|NCT00284921|Antitubercular Agents|antitubercular agents|mesh-ancestor
65068844|NCT00284921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65068845|NCT00284921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65068846|NCT00284921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068847|NCT00284921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068848|NCT00319059|Annexin A5|annexin a5|mesh-list
65068849|NCT00319059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068850|NCT00319059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068851|NCT00312507|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65068852|NCT00312507|Respiratory System Agents|respiratory system agents|mesh-ancestor
65068853|NCT00312546|Enfuvirtide|enfuvirtide|mesh-list
65068854|NCT00312546|Valproic Acid|valproic acid|mesh-list
65068855|NCT00312546|Anticonvulsants|anticonvulsants|mesh-ancestor
65068856|NCT00312546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068857|NCT00312546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068858|NCT00312546|GABA Agents|gaba agents|mesh-ancestor
65068859|NCT00312546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65068860|NCT00312546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068861|NCT00312546|Antimanic Agents|antimanic agents|mesh-ancestor
65068862|NCT00312546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64816001|NCT01488253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64816010|NCT01488266|Milnacipran|milnacipran|mesh-list
65068863|NCT00312546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65068864|NCT00312546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65068865|NCT00312546|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65068866|NCT00312546|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65068867|NCT00312546|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65068868|NCT00312546|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65068869|NCT00312546|Antiviral Agents|antiviral agents|mesh-ancestor
65068870|NCT00312546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65068871|NCT00425009|Metformin|metformin|mesh-list
65068872|NCT00425009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65068873|NCT00425009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068874|NCT04718402|Mitoxantrone|mitoxantrone|mesh-list
65068875|NCT04718402|Analgesics|analgesics|mesh-ancestor
65068876|NCT04718402|Sensory System Agents|sensory system agents|mesh-ancestor
65068877|NCT04718402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65068878|NCT04718402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068879|NCT04718402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068880|NCT04718402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65068881|NCT04718402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65068882|NCT04718402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068883|NCT04718402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068884|NCT00319215|Zopiclone|zopiclone|mesh-list
65068885|NCT00319215|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64816298|NCT01489644|Metformin|metformin|mesh-list
65068886|NCT00319215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65068887|NCT00319215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068888|NCT00285155|Bupropion|bupropion|mesh-list
65068889|NCT00285155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65068890|NCT00285155|Antidepressive Agents|antidepressive agents|mesh-ancestor
65068891|NCT00285155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65068892|NCT00285155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65068893|NCT00285155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64415858|NCT04862845|Dopamine Agents|dopamine agents|mesh-ancestor
65068895|NCT00285155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068896|NCT00285155|Dopamine Agents|dopamine agents|mesh-ancestor
64816676|NCT01491191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65068897|NCT00285155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64816678|NCT01491191|Hormones|hormones|mesh-ancestor
65068898|NCT00285155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068899|NCT00285155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65068900|NCT00285155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65068901|NCT00285155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068902|NCT00319293|Metformin|metformin|mesh-list
65068903|NCT00319293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65068904|NCT00319293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068905|NCT00319332|Tositumomab I-131|tositumomab i-131|mesh-list
65068906|NCT00319332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068907|NCT00285350|Mycophenolic Acid|mycophenolic acid|mesh-list
65068908|NCT00285350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65068909|NCT00285350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068910|NCT00285350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65068911|NCT00285350|Antitubercular Agents|antitubercular agents|mesh-ancestor
65068912|NCT00285350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65068913|NCT00285350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65068914|NCT00285350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068915|NCT00285350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817209|NCT01494857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64817260|NCT01495156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64817270|NCT01495195|Selegiline|selegiline|mesh-list
65068916|NCT00285389|Dexamethasone|dexamethasone|mesh-list
65068917|NCT00285389|Cyclophosphamide|cyclophosphamide|mesh-list
65068918|NCT00285389|Melphalan|melphalan|mesh-list
65068919|NCT00285389|Chlorambucil|chlorambucil|mesh-list
65068920|NCT00285389|Rituximab|rituximab|mesh-list
65068921|NCT00285389|Vincristine|vincristine|mesh-list
65068922|NCT00285389|Doxorubicin|doxorubicin|mesh-list
65068923|NCT00285389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65068924|NCT00285389|Immunologic Factors|immunologic factors|mesh-ancestor
65068925|NCT00285389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586073|NCT03438487|Vaccines|vaccines|mesh-list
64817493|NCT01496443|Glimepiride|glimepiride|mesh-list
64817494|NCT01496443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64817495|NCT01496443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64817496|NCT01496443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068926|NCT00285389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65068927|NCT00285389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65068928|NCT00285389|Alkylating Agents|alkylating agents|mesh-ancestor
65068929|NCT00285389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068930|NCT00285389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068931|NCT00285389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65068932|NCT00285389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65068933|NCT00285389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65068934|NCT00285389|Antiemetics|antiemetics|mesh-ancestor
65068935|NCT00285389|Autonomic Agents|autonomic agents|mesh-ancestor
65068936|NCT00285389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65068937|NCT00285389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65068938|NCT00285389|Glucocorticoids|glucocorticoids|mesh-ancestor
65068939|NCT00285389|Hormones|hormones|mesh-ancestor
65068940|NCT00285389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64818007|NCT01499641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65068941|NCT00285389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65068942|NCT00285389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65068943|NCT00285389|Tubulin Modulators|tubulin modulators|mesh-ancestor
65068944|NCT00285389|Antimitotic Agents|antimitotic agents|mesh-ancestor
65068945|NCT00285389|Mitosis Modulators|mitosis modulators|mesh-ancestor
65068946|NCT00285389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65068947|NCT00285389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65068948|NCT00285389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65068949|NCT00285389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068951|NCT00285428|Antibodies|antibodies|mesh-list
65068952|NCT00285428|Immunologic Factors|immunologic factors|mesh-ancestor
65068953|NCT00285428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068954|NCT00285428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068955|NCT00312819|Disulfiram|disulfiram|mesh-list
65068956|NCT00312819|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65068957|NCT00312819|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65068958|NCT00312819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65068959|NCT00312819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068960|NCT00319488|Budesonide|budesonide|mesh-list
65068961|NCT00319488|Albuterol|albuterol|mesh-list
64818623|NCT01502020|Imiquimod|imiquimod|mesh-list
65068962|NCT00319488|Montelukast|montelukast|mesh-list
65068963|NCT00319488|Leukotriene Antagonists|leukotriene antagonists|mesh-list
65068964|NCT00319488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65068965|NCT00319488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65068966|NCT00319488|Autonomic Agents|autonomic agents|mesh-ancestor
65068967|NCT00319488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65068968|NCT00319488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65068969|NCT00319488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64818882|NCT01503450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65068970|NCT00319488|Respiratory System Agents|respiratory system agents|mesh-ancestor
65068972|NCT00319488|Hormones|hormones|mesh-ancestor
65068973|NCT00319488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65068974|NCT00319488|Hormone Antagonists|hormone antagonists|mesh-ancestor
65068975|NCT00319488|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65068976|NCT00319488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65068977|NCT00319488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65068978|NCT00319488|Tocolytic Agents|tocolytic agents|mesh-ancestor
65068979|NCT00319488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65068980|NCT00319488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65068981|NCT00319488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65068982|NCT00319488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65068983|NCT00319488|Adrenergic Agents|adrenergic agents|mesh-ancestor
65068984|NCT00319488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65068985|NCT00285623|Thrombin|thrombin|mesh-list
65068986|NCT00285623|Hemostatics|hemostatics|mesh-ancestor
65068987|NCT00285623|Coagulants|coagulants|mesh-ancestor
65068988|NCT00285662|Artesunate|artesunate|mesh-list
65068989|NCT00285662|Pyrimethamine|pyrimethamine|mesh-list
65068990|NCT00285662|Sulfadoxine|sulfadoxine|mesh-list
65068991|NCT00285662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65068992|NCT00285662|Amodiaquine|amodiaquine|mesh-list
64819743|NCT01507285|Liraglutide|liraglutide|mesh-list
65068993|NCT00285662|Antimalarials|antimalarials|mesh-ancestor
64819787|NCT01507428|Paclitaxel|paclitaxel|mesh-list
65068994|NCT00285662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65068995|NCT00285662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65068996|NCT00285662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65068997|NCT00285662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65068998|NCT00285662|Antiviral Agents|antiviral agents|mesh-ancestor
65068999|NCT00285662|Schistosomicides|schistosomicides|mesh-ancestor
65069000|NCT00285662|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65069001|NCT00285662|Anthelmintics|anthelmintics|mesh-ancestor
65069002|NCT00285662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64820102|NCT01508858|Liraglutide|liraglutide|mesh-list
65069003|NCT00285662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069004|NCT00285662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069005|NCT00285662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65069006|NCT00285662|Renal Agents|renal agents|mesh-ancestor
65069007|NCT00319566|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65069008|NCT00319566|Medroxyprogesterone|medroxyprogesterone|mesh-list
65069009|NCT00319566|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65069010|NCT00319566|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65069011|NCT00319566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65069012|NCT00319566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64820411|NCT01510860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65069013|NCT00319566|Contraceptive Agents|contraceptive agents|mesh-ancestor
65069014|NCT00319566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65069015|NCT00319566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069016|NCT00319566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65069017|NCT00319566|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65069018|NCT00319566|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65069019|NCT00319566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64820596|NCT01511562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069020|NCT00319566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069021|NCT00319566|Estrogens|estrogens|mesh-ancestor
65069022|NCT00319566|Hormones|hormones|mesh-ancestor
65069023|NCT00319566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65069024|NCT00319605|Levetiracetam|levetiracetam|mesh-list
65069025|NCT00319605|Anticonvulsants|anticonvulsants|mesh-ancestor
65069026|NCT00319605|Nootropic Agents|nootropic agents|mesh-ancestor
65069027|NCT00313053|Vincristine|vincristine|mesh-list
65069028|NCT00313053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65069029|NCT00313053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069030|NCT00313053|Tubulin Modulators|tubulin modulators|mesh-ancestor
65069031|NCT00313053|Antimitotic Agents|antimitotic agents|mesh-ancestor
65069032|NCT00313053|Mitosis Modulators|mitosis modulators|mesh-ancestor
65069033|NCT00313053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069034|NCT00285896|Glucagon|glucagon|mesh-list
65069035|NCT00285896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
65069036|NCT00285896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65069037|NCT00285896|Hormones|hormones|mesh-ancestor
65069038|NCT00285896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65069039|NCT00285896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069040|NCT00285896|Incretins|incretins|mesh-ancestor
65069041|NCT00319683|Eniluracil|eniluracil|mesh-list
65069043|NCT00319683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069044|NCT00286052|Naloxone|naloxone|mesh-list
65069045|NCT00286052|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65069046|NCT00286052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069047|NCT00286052|Sensory System Agents|sensory system agents|mesh-ancestor
65069048|NCT00286052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65069049|NCT00319761|Calcitriol|calcitriol|mesh-list
65069050|NCT00319761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65069051|NCT00319761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069052|NCT00319761|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65069053|NCT00319761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65069054|NCT00319761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069055|NCT00319761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65069056|NCT00319761|Vitamins|vitamins|mesh-ancestor
65069057|NCT00319761|Micronutrients|micronutrients|mesh-ancestor
65069058|NCT00319761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65069059|NCT00286130|Leucovorin|leucovorin|mesh-list
65069060|NCT00286130|Oxaliplatin|oxaliplatin|mesh-list
65069061|NCT00286130|Irinotecan|irinotecan|mesh-list
65069062|NCT00286130|Cetuximab|cetuximab|mesh-list
65069063|NCT00286130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069064|NCT00286130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65069065|NCT00286130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65069066|NCT00286130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069067|NCT00286130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821340|NCT01515553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821341|NCT01515553|Incretins|incretins|mesh-ancestor
64821342|NCT01515553|Hormones|hormones|mesh-ancestor
64821351|NCT01515592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64821352|NCT01515592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821353|NCT01515592|Incretins|incretins|mesh-ancestor
64821355|NCT01515592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65069068|NCT00286130|Antidotes|antidotes|mesh-ancestor
65069069|NCT00286130|Protective Agents|protective agents|mesh-ancestor
65069070|NCT00286130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069071|NCT00286130|Vitamin B Complex|vitamin b complex|mesh-ancestor
65069072|NCT00286130|Vitamins|vitamins|mesh-ancestor
65069073|NCT00286130|Micronutrients|micronutrients|mesh-ancestor
65069074|NCT00286130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65069075|NCT00286208|Misoprostol|misoprostol|mesh-list
65069076|NCT00286208|Mifepristone|mifepristone|mesh-list
65069077|NCT00286208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65069078|NCT00286208|Abortifacient Agents|abortifacient agents|mesh-ancestor
65069079|NCT00286208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64821426|NCT01515839|Thioctic Acid|thioctic acid|mesh-list
64821427|NCT01515839|Acetylcarnitine|acetylcarnitine|mesh-list
64821428|NCT01515839|Acetylcysteine|acetylcysteine|mesh-list
64821429|NCT01515839|Vinpocetine|vinpocetine|mesh-list
64821430|NCT01515839|Huperzine A|huperzine a|mesh-list
64821431|NCT01515839|Antioxidants|antioxidants|mesh-ancestor
64821432|NCT01515839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821436|NCT01515839|Vitamins|vitamins|mesh-ancestor
65069080|NCT00286208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069081|NCT00286208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65069082|NCT00286208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65069083|NCT00286208|Oxytocics|oxytocics|mesh-ancestor
65069084|NCT00286208|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65069085|NCT00286208|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65069086|NCT00286208|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65069087|NCT00286208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65069088|NCT00286208|Contraceptive Agents|contraceptive agents|mesh-ancestor
65069089|NCT00286208|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65069090|NCT00286208|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65069091|NCT00286208|Hormone Antagonists|hormone antagonists|mesh-ancestor
65069092|NCT00286208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65069093|NCT00286208|Luteolytic Agents|luteolytic agents|mesh-ancestor
65069094|NCT00286208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65069095|NCT00286208|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65069096|NCT00319800|Irinotecan|irinotecan|mesh-list
65069097|NCT00319800|Gefitinib|gefitinib|mesh-list
65069098|NCT00319800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65069099|NCT00319800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65069100|NCT00319800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069101|NCT00319800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822059|NCT01519154|Ketamine|ketamine|mesh-list
65069102|NCT00319800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069103|NCT00319800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65069104|NCT00313131|Metronidazole|metronidazole|mesh-list
65069105|NCT00313131|Fluconazole|fluconazole|mesh-list
65069106|NCT00313131|Clotrimazole|clotrimazole|mesh-list
65069107|NCT00313131|Miconazole|miconazole|mesh-list
65069108|NCT00313131|Tinidazole|tinidazole|mesh-list
65069109|NCT00313131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65069110|NCT00313131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65069111|NCT00313131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65069112|NCT00313131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65069113|NCT00313131|Antifungal Agents|antifungal agents|mesh-ancestor
65069114|NCT00313131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65069115|NCT00313131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65069116|NCT00313131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069117|NCT00313131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069118|NCT00313131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65069119|NCT00313131|Hormone Antagonists|hormone antagonists|mesh-ancestor
64822408|NCT01521455|Sympathomimetics|sympathomimetics|mesh-ancestor
65069120|NCT00313131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65069121|NCT00313131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069122|NCT00313131|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65069123|NCT00313131|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64822602|NCT01522820|Sirolimus|sirolimus|mesh-list
65069124|NCT00313131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65069125|NCT00313131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65069126|NCT00313131|Alkylating Agents|alkylating agents|mesh-ancestor
65069127|NCT00313131|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
65069129|NCT00319878|Sirolimus|sirolimus|mesh-list
65069130|NCT00319878|Cyclosporins|cyclosporins|mesh-list
65069131|NCT00319878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069132|NCT00319878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069133|NCT00319878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65069134|NCT00319878|Immunologic Factors|immunologic factors|mesh-ancestor
65069135|NCT00319878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822850|NCT01523574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65069136|NCT00319878|Antifungal Agents|antifungal agents|mesh-ancestor
65069137|NCT00319878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65069138|NCT00319878|Dermatologic Agents|dermatologic agents|mesh-ancestor
65069139|NCT00319878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65069140|NCT00319878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65069141|NCT00319878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65069142|NCT00319878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65069143|NCT00319878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069144|NCT00286364|Androgens|androgens|mesh-list
65069145|NCT00286364|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65069146|NCT00286364|Hormones|hormones|mesh-ancestor
65069147|NCT00286364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64823326|NCT01526317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823327|NCT01526317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65069148|NCT00286364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069149|NCT00286364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65069150|NCT00286364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069151|NCT00286364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069152|NCT00286364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65069153|NCT00286364|Hormone Antagonists|hormone antagonists|mesh-ancestor
65069154|NCT00319917|Tacrolimus|tacrolimus|mesh-list
65069155|NCT00319917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65069156|NCT00319917|Immunologic Factors|immunologic factors|mesh-ancestor
65069157|NCT00319917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069158|NCT00319917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65069159|NCT00319917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069160|NCT00319917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069161|NCT00286403|Fenoldopam|fenoldopam|mesh-list
64823532|NCT01527097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64823533|NCT01527097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65069162|NCT00286403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823539|NCT01527279|Antazoline|antazoline|mesh-list
65069163|NCT00286403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65069164|NCT00286403|Vasodilator Agents|vasodilator agents|mesh-ancestor
65069165|NCT00286403|Dopamine Agonists|dopamine agonists|mesh-ancestor
65069166|NCT00286403|Dopamine Agents|dopamine agents|mesh-ancestor
65069167|NCT00286403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65069168|NCT00286403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069169|NCT00313287|Clevudine|clevudine|mesh-list
64823921|NCT01529177|Metformin|metformin|mesh-list
65069170|NCT00313287|Antiviral Agents|antiviral agents|mesh-ancestor
65069171|NCT00313287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65069172|NCT00286481|Simvastatin|simvastatin|mesh-list
65069173|NCT00286481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65069174|NCT00286481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65069175|NCT00286481|Antimetabolites|antimetabolites|mesh-ancestor
65069176|NCT00286481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069177|NCT00286481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64824151|NCT01530217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069178|NCT00286481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65069179|NCT00286481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069180|NCT00320034|Albuterol|albuterol|mesh-list
64482551|NCT03580395|Tubulin Modulators|tubulin modulators|mesh-ancestor
65069181|NCT00320034|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65069182|NCT00320034|Autonomic Agents|autonomic agents|mesh-ancestor
65069183|NCT00320034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65069184|NCT00320034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824550|NCT01532544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65069185|NCT00320034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65069186|NCT00320034|Respiratory System Agents|respiratory system agents|mesh-ancestor
65069188|NCT00320034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65069189|NCT00320034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65069190|NCT00320034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65069191|NCT00320034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65069192|NCT00320034|Adrenergic Agents|adrenergic agents|mesh-ancestor
65069193|NCT00320034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65069194|NCT00320034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069195|NCT00320073|Pemetrexed|pemetrexed|mesh-list
65069196|NCT00320073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65069197|NCT00320073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069198|NCT00320073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069199|NCT00320073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069200|NCT00320073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65069201|NCT00320073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64825001|NCT01535079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64825003|NCT01535079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65069202|NCT00320073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65069203|NCT00286871|Tacrolimus|tacrolimus|mesh-list
65069204|NCT00286871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65069205|NCT00286871|Immunologic Factors|immunologic factors|mesh-ancestor
65069206|NCT00286871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069207|NCT00286871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65069208|NCT00286871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069209|NCT00286871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069210|NCT00417326|Sivelestat|sivelestat|mesh-list
65069211|NCT00417326|Glycine|glycine|mesh-list
65069212|NCT00417326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65069213|NCT00417326|Protease Inhibitors|protease inhibitors|mesh-ancestor
65069214|NCT00417326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825396|NCT01537471|Meclizine|meclizine|mesh-list
65069215|NCT00417326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069216|NCT00417326|Glycine Agents|glycine agents|mesh-ancestor
65069217|NCT00417326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65069218|NCT00417326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069219|NCT00320229|Abciximab|abciximab|mesh-list
65069220|NCT00320229|Anticoagulants|anticoagulants|mesh-ancestor
64825611|NCT01538641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65069221|NCT00320229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65069222|NCT00320268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65069223|NCT00320268|Antidepressive Agents|antidepressive agents|mesh-ancestor
65069224|NCT00320268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65069225|NCT00320268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65069226|NCT00320268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65069227|NCT00320268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64825851|NCT01539655|Ranitidine|ranitidine|mesh-list
65069228|NCT00320268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069229|NCT00417404|Vitamins|vitamins|mesh-list
65069230|NCT00417404|Vitamin A|vitamin a|mesh-list
65069231|NCT00417404|Retinol palmitate|retinol palmitate|mesh-list
65069232|NCT00417404|Micronutrients|micronutrients|mesh-ancestor
65069233|NCT00417404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069234|NCT00417404|Antioxidants|antioxidants|mesh-ancestor
65069235|NCT00417404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826216|NCT01541475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65069236|NCT00417404|Protective Agents|protective agents|mesh-ancestor
65069237|NCT00417404|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65069238|NCT00417404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069239|NCT00417443|Clonidine|clonidine|mesh-list
65069240|NCT00417443|Analgesics|analgesics|mesh-ancestor
65069241|NCT00417443|Sensory System Agents|sensory system agents|mesh-ancestor
65069242|NCT00417443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65069243|NCT00417443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069244|NCT00417443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65069245|NCT00417443|Sympatholytics|sympatholytics|mesh-ancestor
65069246|NCT00417443|Autonomic Agents|autonomic agents|mesh-ancestor
65069247|NCT00417443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65069248|NCT00417443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65069249|NCT00417443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65069250|NCT00417443|Adrenergic Agents|adrenergic agents|mesh-ancestor
65069251|NCT00417443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65069252|NCT00417443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069253|NCT00313482|Prednisone|prednisone|mesh-list
65069254|NCT00313482|Docetaxel|docetaxel|mesh-list
65069255|NCT00313482|Sargramostim|sargramostim|mesh-list
65069256|NCT00313482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069257|NCT00313482|Tubulin Modulators|tubulin modulators|mesh-ancestor
65069258|NCT00313482|Antimitotic Agents|antimitotic agents|mesh-ancestor
65069259|NCT00313482|Mitosis Modulators|mitosis modulators|mesh-ancestor
65069260|NCT00313482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069261|NCT00313482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65069262|NCT00313482|Glucocorticoids|glucocorticoids|mesh-ancestor
65069263|NCT00313482|Hormones|hormones|mesh-ancestor
64827111|NCT01547455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65069264|NCT00313482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65069265|NCT00313482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069266|NCT00313482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65069267|NCT00313482|Immunologic Factors|immunologic factors|mesh-ancestor
65069268|NCT00286988|Topiramate|topiramate|mesh-list
65069269|NCT00286988|Anticonvulsants|anticonvulsants|mesh-ancestor
65069270|NCT00286988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65069271|NCT00286988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069272|NCT00320307|Abacavir|abacavir|mesh-list
64827442|NCT01549574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069273|NCT00320307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65069274|NCT00320307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65069275|NCT00320307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069276|NCT00320307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069277|NCT00320307|Antiviral Agents|antiviral agents|mesh-ancestor
65069278|NCT00320307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65069279|NCT00320307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65069280|NCT00320307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65069281|NCT00287027|Antipsychotic Agents|antipsychotic agents|mesh-list
65069282|NCT00287027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069283|NCT00287027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65069284|NCT00287027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65069285|NCT00287027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65069286|NCT02960906|Nivolumab|nivolumab|mesh-list
65069287|NCT02960906|Ipilimumab|ipilimumab|mesh-list
65069288|NCT02960906|Sunitinib|sunitinib|mesh-list
65069289|NCT02960906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64827667|NCT01551290|Infliximab|infliximab|mesh-list
65069290|NCT02960906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069291|NCT02960906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65069292|NCT02960906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069293|NCT02960906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65069294|NCT02960906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65069295|NCT02960906|Growth Substances|growth substances|mesh-ancestor
65069296|NCT02960906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069297|NCT02960906|Growth Inhibitors|growth inhibitors|mesh-ancestor
65069298|NCT02960906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65069299|NCT02960906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069300|NCT00287066|Insulin|insulin|mesh-list
64827775|NCT01551719|Penicillins|penicillins|mesh-list
64827838|NCT01552122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069301|NCT00287066|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64827911|NCT01552850|Oxycodone|oxycodone|mesh-list
65069302|NCT00287066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65069303|NCT00287066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069304|NCT00313521|Thiotepa|thiotepa|mesh-list
65069305|NCT00313521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65069306|NCT00313521|Alkylating Agents|alkylating agents|mesh-ancestor
65069307|NCT00313521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069308|NCT00313521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069309|NCT00313521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65069310|NCT00313521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65069311|NCT00313521|Immunologic Factors|immunologic factors|mesh-ancestor
65069312|NCT00313521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069313|NCT00287105|Imatinib Mesylate|imatinib mesylate|mesh-list
65069314|NCT00287105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828046|NCT01554059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64828047|NCT01554059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828136|NCT01554930|Mannitol|mannitol|mesh-list
65069315|NCT00287105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65069317|NCT00287105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069318|NCT00287261|Zoledronic Acid|zoledronic acid|mesh-list
65069319|NCT00287261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65069320|NCT00287261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069322|NCT00313599|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65069323|NCT00313599|Lapatinib|lapatinib|mesh-list
65069324|NCT00313599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65069325|NCT00313599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069326|NCT00313599|Tubulin Modulators|tubulin modulators|mesh-ancestor
65069327|NCT00313599|Antimitotic Agents|antimitotic agents|mesh-ancestor
65069328|NCT00313599|Mitosis Modulators|mitosis modulators|mesh-ancestor
65069329|NCT00313599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069330|NCT00313599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65069331|NCT00313599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069332|NCT00287300|Azithromycin|azithromycin|mesh-list
65069333|NCT00287300|Artesunate|artesunate|mesh-list
65069334|NCT00287300|Pyrimethamine|pyrimethamine|mesh-list
65069335|NCT00287300|Sulfadoxine|sulfadoxine|mesh-list
65069336|NCT00287300|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64828790|NCT01559285|Ropivacaine|ropivacaine|mesh-list
65069337|NCT00287300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65069338|NCT00287300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65069339|NCT00287300|Antimalarials|antimalarials|mesh-ancestor
65069340|NCT00287300|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65069341|NCT00287300|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65069342|NCT00287300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069343|NCT00287300|Antiviral Agents|antiviral agents|mesh-ancestor
65069344|NCT00287300|Schistosomicides|schistosomicides|mesh-ancestor
64828914|NCT05570409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828916|NCT05570409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65069345|NCT00287300|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65069346|NCT00287300|Anthelmintics|anthelmintics|mesh-ancestor
65069347|NCT00287300|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65069348|NCT00287300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069349|NCT00287300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069350|NCT00287300|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65069351|NCT00287300|Renal Agents|renal agents|mesh-ancestor
65069352|NCT00287378|Omalizumab|omalizumab|mesh-list
65069353|NCT00287378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65069354|NCT00287378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65069355|NCT00287378|Respiratory System Agents|respiratory system agents|mesh-ancestor
65069356|NCT00320580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65069357|NCT00320580|Norelgestromin|norelgestromin|mesh-list
65069358|NCT00320580|Estradiol|estradiol|mesh-list
65069359|NCT00320580|Estrogens|estrogens|mesh-ancestor
65069360|NCT00320580|Hormones|hormones|mesh-ancestor
65069361|NCT00320580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65069362|NCT00320580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069363|NCT00320580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65069364|NCT00320580|Contraceptive Agents|contraceptive agents|mesh-ancestor
65069365|NCT00320580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65069366|NCT00320580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65069367|NCT00320580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65069368|NCT00320580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65069369|NCT00320619|Aminocaproic Acid|aminocaproic acid|mesh-list
65069370|NCT00320619|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65069371|NCT00320619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64829923|NCT01570790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069372|NCT00320619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069373|NCT00320619|Hemostatics|hemostatics|mesh-ancestor
65069374|NCT00320619|Coagulants|coagulants|mesh-ancestor
65069375|NCT00287456|Insulin|insulin|mesh-list
65069376|NCT00287456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65069377|NCT00287456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65069378|NCT00287456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069379|NCT00313833|Buprenorphine|buprenorphine|mesh-list
65069380|NCT00313833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65069381|NCT00313833|Narcotics|narcotics|mesh-ancestor
65069382|NCT00313833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65069383|NCT00313833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069384|NCT00313833|Analgesics|analgesics|mesh-ancestor
65069385|NCT00313833|Sensory System Agents|sensory system agents|mesh-ancestor
65069386|NCT00313833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65069387|NCT00313833|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65069388|NCT00287495|Sorafenib|sorafenib|mesh-list
65069389|NCT00287495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069390|NCT00287495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65069391|NCT00287495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069392|NCT00287495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069393|NCT00320658|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65069394|NCT00320658|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65069395|NCT00320658|Immunologic Factors|immunologic factors|mesh-ancestor
65069396|NCT00320658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069397|NCT00320658|Antacids|antacids|mesh-ancestor
65069398|NCT00320658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069399|NCT00320658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65069400|NCT00287534|Tamoxifen|tamoxifen|mesh-list
65069401|NCT00287534|Anastrozole|anastrozole|mesh-list
65069402|NCT00287534|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65069403|NCT00287534|Hormone Antagonists|hormone antagonists|mesh-ancestor
64601837|NCT01975935|Amlexanox|amlexanox|mesh-list
65069404|NCT00287534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65069405|NCT00287534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069406|NCT00287534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65069408|NCT00287534|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65069409|NCT00287534|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65069410|NCT00287534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65069411|NCT00287534|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65069412|NCT00287534|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65069413|NCT00287534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069414|NCT00287534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069415|NCT00320697|Bupropion|bupropion|mesh-list
65069416|NCT00320697|Nicotine|nicotine|mesh-list
65069417|NCT00320697|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65069418|NCT00320697|Autonomic Agents|autonomic agents|mesh-ancestor
65069419|NCT00320697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65069420|NCT00320697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830767|NCT01576627|Zinc Oxide|zinc oxide|mesh-list
64830768|NCT01576627|Trace Elements|trace elements|mesh-ancestor
64830769|NCT01576627|Micronutrients|micronutrients|mesh-ancestor
65069421|NCT00320697|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65069422|NCT00320697|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65069423|NCT00320697|Cholinergic Agents|cholinergic agents|mesh-ancestor
65069424|NCT00320697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65069425|NCT00320697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069426|NCT00320697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65069427|NCT00320697|Antidepressive Agents|antidepressive agents|mesh-ancestor
65069428|NCT00320697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65069429|NCT00320697|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65069430|NCT00320697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65069431|NCT00320697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65069432|NCT00320697|Dopamine Agents|dopamine agents|mesh-ancestor
65069433|NCT00320697|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65069434|NCT00320697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65069435|NCT00320697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069436|NCT00287651|Insulin|insulin|mesh-list
65069437|NCT00287651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65069438|NCT00287651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65069439|NCT00287651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069440|NCT00322296|Bexarotene|bexarotene|mesh-list
65069441|NCT00322296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069442|NCT00320736|Galantamine|galantamine|mesh-list
65069443|NCT00320736|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65069444|NCT00320736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069445|NCT00320736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069446|NCT00320736|Cholinergic Agents|cholinergic agents|mesh-ancestor
65069447|NCT00320736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65069448|NCT00320736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069449|NCT00320736|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65069450|NCT00320736|Autonomic Agents|autonomic agents|mesh-ancestor
65069451|NCT00320736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65069452|NCT00320736|Nootropic Agents|nootropic agents|mesh-ancestor
65069453|NCT00287768|Docetaxel|docetaxel|mesh-list
65069454|NCT00287768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069455|NCT00287768|Tubulin Modulators|tubulin modulators|mesh-ancestor
65069456|NCT00287768|Antimitotic Agents|antimitotic agents|mesh-ancestor
65069457|NCT00287768|Mitosis Modulators|mitosis modulators|mesh-ancestor
64831181|NCT01578629|Vitamin E|vitamin e|mesh-list
64831182|NCT01578629|Tocopherols|tocopherols|mesh-list
65069458|NCT00287768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069459|NCT00320775|Aflibercept|aflibercept|mesh-list
65069460|NCT00320775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65069461|NCT00320775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65069462|NCT00320775|Growth Substances|growth substances|mesh-ancestor
65069463|NCT00320775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069464|NCT00320775|Growth Inhibitors|growth inhibitors|mesh-ancestor
65069465|NCT00320775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069466|NCT00320814|Aflibercept|aflibercept|mesh-list
65069467|NCT00320814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65069468|NCT00320814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65069469|NCT00320814|Growth Substances|growth substances|mesh-ancestor
65069470|NCT00320814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069471|NCT00320814|Growth Inhibitors|growth inhibitors|mesh-ancestor
65069472|NCT00320814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069473|NCT00287846|Imatinib Mesylate|imatinib mesylate|mesh-list
65069474|NCT00287846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069475|NCT00287846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65069476|NCT00287846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831361|NCT01579539|Antiemetics|antiemetics|mesh-ancestor
65069477|NCT00287846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069478|NCT00322413|Epoetin Alfa|epoetin alfa|mesh-list
65069479|NCT00322413|Hematinics|hematinics|mesh-ancestor
65069480|NCT00320853|Vitamin D|vitamin d|mesh-list
65069481|NCT00320853|Vitamins|vitamins|mesh-ancestor
65069482|NCT00320853|Micronutrients|micronutrients|mesh-ancestor
65069483|NCT00320853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069484|NCT00320853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65069485|NCT00287885|Docetaxel|docetaxel|mesh-list
65069486|NCT00287885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069487|NCT00287885|Tubulin Modulators|tubulin modulators|mesh-ancestor
65069488|NCT00287885|Antimitotic Agents|antimitotic agents|mesh-ancestor
65069489|NCT00287885|Mitosis Modulators|mitosis modulators|mesh-ancestor
65069490|NCT00287885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069491|NCT00287924|Methotrexate|methotrexate|mesh-list
65069492|NCT00287924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65069493|NCT00287924|Abortifacient Agents|abortifacient agents|mesh-ancestor
65069494|NCT00287924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65069495|NCT00287924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831529|NCT01583972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069496|NCT00287924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65069497|NCT00287924|Antimetabolites|antimetabolites|mesh-ancestor
65069498|NCT00287924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069499|NCT00287924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069500|NCT00287924|Dermatologic Agents|dermatologic agents|mesh-ancestor
65069501|NCT00287924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069502|NCT00287924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65069503|NCT00287924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65069504|NCT00287924|Immunologic Factors|immunologic factors|mesh-ancestor
65069505|NCT00287924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65069506|NCT00287924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65069507|NCT00287963|Topotecan|topotecan|mesh-list
65069508|NCT00287963|Vinorelbine|vinorelbine|mesh-list
65069509|NCT00287963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65069510|NCT00287963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65069511|NCT00287963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069512|NCT00287963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069513|NCT00287963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069514|NCT00287963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65069515|NCT00287963|Tubulin Modulators|tubulin modulators|mesh-ancestor
65069516|NCT00287963|Antimitotic Agents|antimitotic agents|mesh-ancestor
65069517|NCT00287963|Mitosis Modulators|mitosis modulators|mesh-ancestor
65069518|NCT00320892|Atropine|atropine|mesh-list
65069519|NCT00320892|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65069520|NCT00320892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65069521|NCT00320892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65069522|NCT00320892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65069523|NCT00320892|Autonomic Agents|autonomic agents|mesh-ancestor
65069524|NCT00320892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65069525|NCT00320892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069526|NCT00320892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64831668|NCT01590199|Pasireotide|pasireotide|mesh-list
64831669|NCT01590199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069527|NCT00320892|Respiratory System Agents|respiratory system agents|mesh-ancestor
65069528|NCT00320892|Mydriatics|mydriatics|mesh-ancestor
65069529|NCT00320892|Parasympatholytics|parasympatholytics|mesh-ancestor
65069530|NCT00320892|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65069531|NCT00320892|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65069532|NCT00320892|Cholinergic Agents|cholinergic agents|mesh-ancestor
65069533|NCT00320892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65069534|NCT00320892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069535|NCT00320892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65069536|NCT00288002|Cyclophosphamide|cyclophosphamide|mesh-list
65069537|NCT00288002|Docetaxel|docetaxel|mesh-list
65069538|NCT00288002|Capecitabine|capecitabine|mesh-list
65069539|NCT00288002|Trastuzumab|trastuzumab|mesh-list
65069540|NCT00288002|Epirubicin|epirubicin|mesh-list
65069541|NCT00288002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65069542|NCT00288002|Immunologic Factors|immunologic factors|mesh-ancestor
65069543|NCT00288002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069544|NCT00288002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65069545|NCT00288002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65069546|NCT00288002|Alkylating Agents|alkylating agents|mesh-ancestor
65069547|NCT00288002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069548|NCT00288002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069549|NCT00288002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64482573|NCT01770145|Emetics|emetics|mesh-ancestor
64554812|NCT03400683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069551|NCT00288002|Antimitotic Agents|antimitotic agents|mesh-ancestor
65069552|NCT00288002|Mitosis Modulators|mitosis modulators|mesh-ancestor
65069553|NCT00288002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65069554|NCT00288002|Antimetabolites|antimetabolites|mesh-ancestor
65069555|NCT00288002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65069556|NCT00288002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65069557|NCT00288002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65069558|NCT00288002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65069559|NCT00288002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069560|NCT00322569|Pimecrolimus|pimecrolimus|mesh-list
65069561|NCT00322569|Paclitaxel|paclitaxel|mesh-list
65069562|NCT00322569|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65069563|NCT00322569|Tacrolimus|tacrolimus|mesh-list
65069564|NCT00322569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65069565|NCT00322569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069566|NCT00322569|Tubulin Modulators|tubulin modulators|mesh-ancestor
65069567|NCT00322569|Antimitotic Agents|antimitotic agents|mesh-ancestor
65069568|NCT00322569|Mitosis Modulators|mitosis modulators|mesh-ancestor
65069569|NCT00322569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069570|NCT00322569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65069571|NCT00322569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65069572|NCT00322569|Analgesics|analgesics|mesh-ancestor
65069573|NCT00322569|Sensory System Agents|sensory system agents|mesh-ancestor
65069574|NCT00322569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65069575|NCT00322569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069576|NCT00322569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65069577|NCT00322569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65069578|NCT00322569|Dermatologic Agents|dermatologic agents|mesh-ancestor
65069579|NCT00322569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65069580|NCT00322569|Immunologic Factors|immunologic factors|mesh-ancestor
65069581|NCT00322569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65069582|NCT00322569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069583|NCT00288041|Paclitaxel|paclitaxel|mesh-list
65069584|NCT00288041|Carboplatin|carboplatin|mesh-list
65069585|NCT00288041|Bortezomib|bortezomib|mesh-list
65069586|NCT00288041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65069587|NCT00288041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069588|NCT00288041|Tubulin Modulators|tubulin modulators|mesh-ancestor
65069589|NCT00288041|Antimitotic Agents|antimitotic agents|mesh-ancestor
65069590|NCT00288041|Mitosis Modulators|mitosis modulators|mesh-ancestor
65069591|NCT00288041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069592|NCT00320970|Candesartan|candesartan|mesh-list
65069593|NCT00320970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65069594|NCT00320970|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64832028|NCT01592279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64832166|NCT01593306|Paclitaxel|paclitaxel|mesh-list
65069595|NCT00320970|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65069596|NCT00320970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069597|NCT00288158|Allopurinol|allopurinol|mesh-list
65069598|NCT00288158|Probenecid|probenecid|mesh-list
65069599|NCT00288158|Antimetabolites|antimetabolites|mesh-ancestor
65069600|NCT00288158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069601|NCT00288158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069602|NCT00288158|Gout Suppressants|gout suppressants|mesh-ancestor
65069603|NCT00288158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65069604|NCT00288158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65069605|NCT00288158|Antioxidants|antioxidants|mesh-ancestor
65069606|NCT00288158|Protective Agents|protective agents|mesh-ancestor
65069607|NCT00288158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069608|NCT00288158|Uricosuric Agents|uricosuric agents|mesh-ancestor
65069610|NCT04717752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65069611|NCT04717752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65069612|NCT04717752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069613|NCT00288197|Voriconazole|voriconazole|mesh-list
65069614|NCT00288197|Antifungal Agents|antifungal agents|mesh-ancestor
65069615|NCT00288197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65069616|NCT00288197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65069617|NCT00288197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65069618|NCT00288197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069619|NCT00288197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069620|NCT00288197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65069621|NCT00288197|Hormone Antagonists|hormone antagonists|mesh-ancestor
65069622|NCT00288197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65069623|NCT00288197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832181|NCT01593332|Rituximab|rituximab|mesh-list
64832182|NCT01593332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64832183|NCT01593332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64832212|NCT01593410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64832213|NCT01593410|Glucocorticoids|glucocorticoids|mesh-ancestor
64832215|NCT01593410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64832218|NCT01593410|Immunologic Factors|immunologic factors|mesh-ancestor
65069624|NCT00288197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65069626|NCT00288236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65069627|NCT00288236|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65069628|NCT00288236|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65069629|NCT00288236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65069630|NCT00288236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069631|NCT00288236|Hormones|hormones|mesh-ancestor
65069632|NCT00288236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65069633|NCT00288236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069634|NCT00321126|Zinc|zinc|mesh-list
65069635|NCT00321126|Trace Elements|trace elements|mesh-ancestor
65069636|NCT00321126|Micronutrients|micronutrients|mesh-ancestor
65069637|NCT00321126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069638|NCT00288353|Aripiprazole|aripiprazole|mesh-list
65069639|NCT00288353|Ziprasidone|ziprasidone|mesh-list
65069640|NCT00288353|Antidepressive Agents|antidepressive agents|mesh-ancestor
65069641|NCT00288353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65069642|NCT00288353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65069643|NCT00288353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65069644|NCT00288353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65069645|NCT00288353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069646|NCT00288353|Dopamine Agonists|dopamine agonists|mesh-ancestor
65069647|NCT00288353|Dopamine Agents|dopamine agents|mesh-ancestor
65069648|NCT00288353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65069649|NCT00288353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069650|NCT00288353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65069651|NCT00288353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65069652|NCT00288353|Serotonin Agents|serotonin agents|mesh-ancestor
65069653|NCT00288353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65069654|NCT00288353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65069655|NCT00288353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65069656|NCT00288353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65069657|NCT00288431|Sirolimus|sirolimus|mesh-list
65069658|NCT00288431|Doxorubicin|doxorubicin|mesh-list
65069659|NCT00288431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65069660|NCT00288431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069661|NCT00288431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65069662|NCT00288431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65069663|NCT00288431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069664|NCT00288431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069665|NCT00288431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65069666|NCT00288431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65069667|NCT00288431|Antifungal Agents|antifungal agents|mesh-ancestor
65069668|NCT00288431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65069669|NCT00288431|Immunologic Factors|immunologic factors|mesh-ancestor
65069670|NCT00288431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069671|NCT00321165|Taurolidine|taurolidine|mesh-list
65069672|NCT00321165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65069673|NCT00321165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65069674|NCT00321165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069675|NCT00322803|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|mesh-list
65069676|NCT00322803|Anticonvulsants|anticonvulsants|mesh-ancestor
65069677|NCT00322803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65069678|NCT00322803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65069679|NCT00322803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65069680|NCT00322803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069681|NCT00322803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65069682|NCT00322803|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65069683|NCT00322803|GABA Agonists|gaba agonists|mesh-ancestor
65069684|NCT00322803|GABA Agents|gaba agents|mesh-ancestor
65069685|NCT00322803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65069686|NCT00322803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069687|NCT00322920|Topotecan|topotecan|mesh-list
65069688|NCT00322920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069689|NCT00322920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65069690|NCT00322920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65069691|NCT00322920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069692|NCT00322920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069693|NCT00321009|Enoxaparin|enoxaparin|mesh-list
65069694|NCT00321009|Anticoagulants|anticoagulants|mesh-ancestor
65069695|NCT00321009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65069696|NCT00321009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65069697|NCT00321009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069698|NCT00417677|Sirolimus|sirolimus|mesh-list
65069699|NCT00417677|Sunitinib|sunitinib|mesh-list
65069700|NCT00417677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64832277|NCT01593826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64832278|NCT01593826|Autonomic Agents|autonomic agents|mesh-ancestor
64832279|NCT01593826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65069701|NCT00417677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65069702|NCT00417677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65069703|NCT00417677|Growth Substances|growth substances|mesh-ancestor
65069704|NCT00417677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069705|NCT00417677|Growth Inhibitors|growth inhibitors|mesh-ancestor
65069706|NCT00417677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65069707|NCT00417677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069708|NCT00417677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069709|NCT00417677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65069710|NCT00417677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65069711|NCT00417677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65069712|NCT00417677|Antifungal Agents|antifungal agents|mesh-ancestor
65069713|NCT00417677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65069714|NCT00417677|Immunologic Factors|immunologic factors|mesh-ancestor
65069715|NCT00417716|Bevacizumab|bevacizumab|mesh-list
65069716|NCT00417716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65069717|NCT00417716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069718|NCT00417716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65069719|NCT00417716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65069720|NCT00417716|Growth Substances|growth substances|mesh-ancestor
65069721|NCT00417716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069722|NCT00417716|Growth Inhibitors|growth inhibitors|mesh-ancestor
65069723|NCT00288470|Hylan|hylan|mesh-list
64832415|NCT01594489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65069724|NCT00288470|Viscosupplements|viscosupplements|mesh-ancestor
65069725|NCT00288470|Protective Agents|protective agents|mesh-ancestor
65069726|NCT00288470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069727|NCT00321360|Propofol|propofol|mesh-list
65069728|NCT00321360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65069729|NCT00321360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65069730|NCT00321360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069731|NCT00321360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65069732|NCT00321360|Anesthetics, General|anesthetics, general|mesh-ancestor
65069733|NCT00321360|Anesthetics|anesthetics|mesh-ancestor
65069734|NCT00288548|Metoprolol|metoprolol|mesh-list
65069735|NCT00288548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65069736|NCT00288548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65069737|NCT00288548|Sympatholytics|sympatholytics|mesh-ancestor
65069738|NCT00288548|Autonomic Agents|autonomic agents|mesh-ancestor
65069739|NCT00288548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65069740|NCT00288548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069741|NCT00288548|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65069742|NCT00288548|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65069743|NCT00288548|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65069744|NCT00288548|Adrenergic Agents|adrenergic agents|mesh-ancestor
65069745|NCT00288548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65069746|NCT00288548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069747|NCT00321477|Casopitant|casopitant|mesh-list
65069748|NCT00321477|Antiemetics|antiemetics|mesh-ancestor
65069749|NCT00321477|Autonomic Agents|autonomic agents|mesh-ancestor
65069750|NCT00321477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65069751|NCT00321477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069752|NCT00321477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65069753|NCT00321477|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65069754|NCT00321477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65069755|NCT00321477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069756|NCT00321516|Aripiprazole|aripiprazole|mesh-list
65069757|NCT00321516|Antidepressive Agents|antidepressive agents|mesh-ancestor
65069758|NCT00321516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65069759|NCT00321516|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65069760|NCT00321516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65069761|NCT00321516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65069762|NCT00321516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069763|NCT00321516|Dopamine Agonists|dopamine agonists|mesh-ancestor
65069764|NCT00321516|Dopamine Agents|dopamine agents|mesh-ancestor
65069765|NCT00321516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64832846|NCT01596673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64832847|NCT01596673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832848|NCT01596673|Analgesics|analgesics|mesh-ancestor
64832849|NCT01596673|Sensory System Agents|sensory system agents|mesh-ancestor
64832850|NCT01596673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832851|NCT01596673|Antitussive Agents|antitussive agents|mesh-ancestor
64832852|NCT01596673|Respiratory System Agents|respiratory system agents|mesh-ancestor
64832853|NCT01596686|Picosulfate sodium|picosulfate sodium|mesh-list
64832854|NCT01596686|Cathartics|cathartics|mesh-ancestor
64832855|NCT01596686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64832856|NCT01596738|Tranexamic Acid|tranexamic acid|mesh-list
64832857|NCT01596738|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64832858|NCT01596738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64832859|NCT01596738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832860|NCT01596738|Hemostatics|hemostatics|mesh-ancestor
64832861|NCT01596738|Coagulants|coagulants|mesh-ancestor
64832862|NCT01596764|Sulfasalazine|sulfasalazine|mesh-list
64832863|NCT01596764|Naloxone|naloxone|mesh-list
64832864|NCT01596764|Methylnaltrexone|methylnaltrexone|mesh-list
64832865|NCT01596764|Loperamide|loperamide|mesh-list
64832866|NCT01596764|Antidiarrheals|antidiarrheals|mesh-list
64832867|NCT01596764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64832868|NCT01596764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832869|NCT01596764|Sensory System Agents|sensory system agents|mesh-ancestor
64832870|NCT01596764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832871|NCT01596764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64832872|NCT01596764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64832874|NCT01596764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65069766|NCT00321516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482577|NCT01770145|Antiemetics|antiemetics|mesh-ancestor
65069767|NCT00321516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65069768|NCT00321516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65069769|NCT00321516|Serotonin Agents|serotonin agents|mesh-ancestor
65069770|NCT00321516|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65069771|NCT00321516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65069772|NCT00321516|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65069773|NCT00321516|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65069774|NCT00288743|Insulin|insulin|mesh-list
65069775|NCT00288743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65069776|NCT00288743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069777|NCT00321633|Carboplatin|carboplatin|mesh-list
65069778|NCT00321633|Docetaxel|docetaxel|mesh-list
65069779|NCT00321633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069780|NCT00321633|Tubulin Modulators|tubulin modulators|mesh-ancestor
65069781|NCT00321633|Antimitotic Agents|antimitotic agents|mesh-ancestor
65069782|NCT00321633|Mitosis Modulators|mitosis modulators|mesh-ancestor
65069783|NCT00321633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069784|NCT00288782|Mirtazapine|mirtazapine|mesh-list
65069785|NCT00288782|Antidepressive Agents|antidepressive agents|mesh-ancestor
65069786|NCT00288782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65069787|NCT00288782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65069788|NCT00288782|Histamine Antagonists|histamine antagonists|mesh-ancestor
65069789|NCT00288782|Histamine Agents|histamine agents|mesh-ancestor
65069790|NCT00288782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65069791|NCT00288782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069792|NCT00288782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069793|NCT00288782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65069794|NCT00288782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65069795|NCT00288782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65069796|NCT00288782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65069797|NCT00288782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64832887|NCT01596777|Analgesics|analgesics|mesh-ancestor
65069798|NCT00288782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65069799|NCT00288782|Adrenergic Agents|adrenergic agents|mesh-ancestor
65069800|NCT00288782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65069801|NCT00288782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65069802|NCT00288782|Serotonin Agents|serotonin agents|mesh-ancestor
65069803|NCT00288782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65069804|NCT01059825|Metformin|metformin|mesh-list
65069805|NCT01059825|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65069806|NCT01059825|Ertugliflozin|ertugliflozin|mesh-list
65069807|NCT01059825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65069808|NCT01059825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069809|NCT01059825|Incretins|incretins|mesh-ancestor
65069810|NCT01059825|Hormones|hormones|mesh-ancestor
65069811|NCT01059825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65069812|NCT01059825|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65069813|NCT01059825|Protease Inhibitors|protease inhibitors|mesh-ancestor
65069814|NCT01059825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069815|NCT01059825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069816|NCT01059825|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65069817|NCT00321750|Pimecrolimus|pimecrolimus|mesh-list
65069818|NCT00321750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65069819|NCT00321750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65069820|NCT00321750|Analgesics|analgesics|mesh-ancestor
65069821|NCT00321750|Sensory System Agents|sensory system agents|mesh-ancestor
65069822|NCT00321750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642381|NCT05150496|Vaccines|vaccines|mesh-list
65069823|NCT00321750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069824|NCT00321750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65069825|NCT00321750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65069826|NCT00321750|Dermatologic Agents|dermatologic agents|mesh-ancestor
65069827|NCT00321750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65069828|NCT00321750|Immunologic Factors|immunologic factors|mesh-ancestor
65069829|NCT00321750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65069830|NCT00321750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832936|NCT01596907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832937|NCT01596907|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64832938|NCT01596907|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64832939|NCT01596907|Purinergic Agents|purinergic agents|mesh-ancestor
64832940|NCT01596907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64832941|NCT01596907|Sympathomimetics|sympathomimetics|mesh-ancestor
64832942|NCT01596907|Autonomic Agents|autonomic agents|mesh-ancestor
64324833|NCT02551874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324834|NCT03646604|Upadacitinib|upadacitinib|mesh-list
64324835|NCT03646604|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64324836|NCT03646604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64324837|NCT03646604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069831|NCT00321750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069832|NCT00321945|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65069833|NCT00321945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65069834|NCT00321945|Protease Inhibitors|protease inhibitors|mesh-ancestor
65069835|NCT00321945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069836|NCT00321945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069837|NCT00323076|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
65069838|NCT00323076|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65069839|NCT00323076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069840|NCT00323154|Nalbuphine|nalbuphine|mesh-list
65069841|NCT00323154|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65069842|NCT00323154|Narcotics|narcotics|mesh-ancestor
65069843|NCT00323154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65069844|NCT00323154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832959|NCT01596998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832960|NCT01596998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64832961|NCT01596998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64832962|NCT01596998|Autonomic Agents|autonomic agents|mesh-ancestor
64832963|NCT01596998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832964|NCT01596998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64832965|NCT01596998|Respiratory System Agents|respiratory system agents|mesh-ancestor
64832966|NCT01596998|Mydriatics|mydriatics|mesh-ancestor
64832967|NCT01596998|Sympathomimetics|sympathomimetics|mesh-ancestor
64444165|NCT02236520|Chlorthalidone|chlorthalidone|mesh-list
64832969|NCT01596998|Anesthetics, Local|anesthetics, local|mesh-ancestor
64832970|NCT01596998|Anesthetics|anesthetics|mesh-ancestor
64832971|NCT01596998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64832972|NCT01596998|Sensory System Agents|sensory system agents|mesh-ancestor
64832973|NCT01597011|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64832974|NCT01597011|Hemostatics|hemostatics|mesh-ancestor
64832975|NCT01597011|Coagulants|coagulants|mesh-ancestor
64832976|NCT01597167|Magnesium Sulfate|magnesium sulfate|mesh-list
64832977|NCT01597167|Analgesics|analgesics|mesh-ancestor
64832978|NCT01597167|Sensory System Agents|sensory system agents|mesh-ancestor
64832979|NCT01597167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832980|NCT01597167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832981|NCT01597167|Anesthetics|anesthetics|mesh-ancestor
64832982|NCT01597167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64832983|NCT01597167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65069845|NCT00323154|Analgesics|analgesics|mesh-ancestor
65069846|NCT00323154|Sensory System Agents|sensory system agents|mesh-ancestor
65069847|NCT00323154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65069848|NCT00289250|Artesunate|artesunate|mesh-list
65069849|NCT00289250|Pyrimethamine|pyrimethamine|mesh-list
65069850|NCT00289250|Sulfadoxine|sulfadoxine|mesh-list
65069851|NCT00289250|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65069852|NCT00289250|Antimalarials|antimalarials|mesh-ancestor
65069853|NCT00289250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65069854|NCT00289250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65069855|NCT00289250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65069856|NCT00289250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069857|NCT00289250|Antiviral Agents|antiviral agents|mesh-ancestor
65069858|NCT00289250|Schistosomicides|schistosomicides|mesh-ancestor
65069859|NCT00289250|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65069860|NCT00289250|Anthelmintics|anthelmintics|mesh-ancestor
65069861|NCT00289250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65069862|NCT00289250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069863|NCT00289250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324839|NCT03646604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64324840|NCT01354717|Fluorouracil|fluorouracil|mesh-list
64324841|NCT01354717|Antimetabolites|antimetabolites|mesh-ancestor
64832988|NCT01597167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64832989|NCT01597167|Tocolytic Agents|tocolytic agents|mesh-ancestor
64832990|NCT01597167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64832991|NCT01597206|Cobalt|cobalt|mesh-list
64832992|NCT01597206|Trace Elements|trace elements|mesh-ancestor
64832993|NCT01597206|Micronutrients|micronutrients|mesh-ancestor
64832994|NCT01597206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832995|NCT01597232|Chrysarobin|chrysarobin|mesh-list
64832996|NCT01597232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64832997|NCT01597232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64832998|NCT01597232|Analgesics|analgesics|mesh-ancestor
64389797|NCT03442673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64389798|NCT03442673|Antiviral Agents|antiviral agents|mesh-ancestor
64389799|NCT03442673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64389800|NCT03442673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389801|NCT03442673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64389802|NCT03442673|Immunologic Factors|immunologic factors|mesh-ancestor
64389803|NCT03442673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389804|NCT03442673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64389805|NCT03442673|Tubulin Modulators|tubulin modulators|mesh-ancestor
64389806|NCT03442673|Antimitotic Agents|antimitotic agents|mesh-ancestor
64389807|NCT03442673|Mitosis Modulators|mitosis modulators|mesh-ancestor
65069864|NCT00289250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65069865|NCT00289250|Renal Agents|renal agents|mesh-ancestor
65069866|NCT00323505|Interferons|interferons|mesh-list
65069867|NCT00323505|Interferon-alpha|interferon-alpha|mesh-list
65069868|NCT00323505|Interferon alpha-2|interferon alpha-2|mesh-list
65069869|NCT00323505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069870|NCT00323505|Antiviral Agents|antiviral agents|mesh-ancestor
65069871|NCT00323505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65069872|NCT00323505|Immunologic Factors|immunologic factors|mesh-ancestor
65069873|NCT00323505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069874|NCT00289406|Amlodipine|amlodipine|mesh-list
65069875|NCT00289406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65069876|NCT00289406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65069877|NCT00289406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65069878|NCT00289406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069879|NCT00289406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65069880|NCT00289406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069881|NCT00289406|Vasodilator Agents|vasodilator agents|mesh-ancestor
65069882|NCT00323544|Tenofovir|tenofovir|mesh-list
65069883|NCT00323544|Lamivudine|lamivudine|mesh-list
65069884|NCT00323544|Zidovudine|zidovudine|mesh-list
65069885|NCT00323544|Emtricitabine|emtricitabine|mesh-list
65069886|NCT00323544|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
65069887|NCT00323544|Antiviral Agents|antiviral agents|mesh-ancestor
65069888|NCT00323544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65069889|NCT00323544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65069890|NCT00323544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65069891|NCT00323544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832999|NCT01597232|Sensory System Agents|sensory system agents|mesh-ancestor
64833000|NCT01597232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64833001|NCT01597232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833002|NCT01597232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64833003|NCT01597232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64833004|NCT01597297|4-Aminopyridine|4-aminopyridine|mesh-list
64444191|NCT01922271|Albuterol|albuterol|mesh-list
64444192|NCT01922271|Tiotropium Bromide|tiotropium bromide|mesh-list
64389879|NCT02428777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64389880|NCT02428777|Analgesics|analgesics|mesh-ancestor
64389881|NCT02428777|Sensory System Agents|sensory system agents|mesh-ancestor
64389882|NCT02428777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64389883|NCT02428777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389884|NCT02428777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65069892|NCT00323544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069893|NCT00323544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65069894|NCT00323544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65069895|NCT00323544|Antimetabolites|antimetabolites|mesh-ancestor
65069896|NCT00289445|Leucovorin|leucovorin|mesh-list
65069897|NCT00289445|Folic Acid|folic acid|mesh-list
65069899|NCT00289445|Mitomycin|mitomycin|mesh-list
65069900|NCT00289445|Levoleucovorin|levoleucovorin|mesh-list
65069901|NCT00289445|Antidotes|antidotes|mesh-ancestor
65069902|NCT00289445|Protective Agents|protective agents|mesh-ancestor
65069903|NCT00289445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069904|NCT00289445|Vitamin B Complex|vitamin b complex|mesh-ancestor
65069905|NCT00289445|Vitamins|vitamins|mesh-ancestor
65069906|NCT00289445|Micronutrients|micronutrients|mesh-ancestor
65069907|NCT00289445|Hematinics|hematinics|mesh-ancestor
65069908|NCT00289445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65069909|NCT00289445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069910|NCT00289445|Alkylating Agents|alkylating agents|mesh-ancestor
65069911|NCT00289445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069912|NCT00289445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65069913|NCT00289445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069914|NCT00323583|Leucovorin|leucovorin|mesh-list
65069915|NCT00323583|Paclitaxel|paclitaxel|mesh-list
65069916|NCT00323583|Fluorouracil|fluorouracil|mesh-list
65069917|NCT00323583|Oxaliplatin|oxaliplatin|mesh-list
65069918|NCT00323583|Calcium|calcium|mesh-list
65069919|NCT00323583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65069920|NCT00323583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069921|NCT00323583|Tubulin Modulators|tubulin modulators|mesh-ancestor
64833005|NCT01597297|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64833006|NCT01597297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64833007|NCT01597297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833008|NCT01597310|Pramipexole|pramipexole|mesh-list
64833009|NCT01597310|Warfarin|warfarin|mesh-list
64833010|NCT01597310|Anticoagulants|anticoagulants|mesh-ancestor
64833011|NCT01597310|Antioxidants|antioxidants|mesh-ancestor
65069922|NCT00323583|Antimitotic Agents|antimitotic agents|mesh-ancestor
65069923|NCT00323583|Mitosis Modulators|mitosis modulators|mesh-ancestor
65069924|NCT00323583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069925|NCT00323583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65069926|NCT00323583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069927|NCT00323583|Antimetabolites|antimetabolites|mesh-ancestor
65069928|NCT00323583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65069929|NCT00323583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65069930|NCT00323583|Immunologic Factors|immunologic factors|mesh-ancestor
65069931|NCT00323583|Antidotes|antidotes|mesh-ancestor
65069932|NCT00323583|Protective Agents|protective agents|mesh-ancestor
65069933|NCT00323583|Vitamin B Complex|vitamin b complex|mesh-ancestor
65069934|NCT00323583|Vitamins|vitamins|mesh-ancestor
65069935|NCT00323583|Micronutrients|micronutrients|mesh-ancestor
65069936|NCT00289601|Eptifibatide|eptifibatide|mesh-list
65069937|NCT00289601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65069938|NCT00323778|Hyaluronic Acid|hyaluronic acid|mesh-list
65069939|NCT00323778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65069940|NCT00323778|Immunologic Factors|immunologic factors|mesh-ancestor
65069941|NCT00323778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069942|NCT00323778|Viscosupplements|viscosupplements|mesh-ancestor
65069943|NCT00323778|Protective Agents|protective agents|mesh-ancestor
65069944|NCT00323817|Z 338|z 338|mesh-list
65069945|NCT00323817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65069946|NCT00323817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069947|NCT00323817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069948|NCT00323817|Cholinergic Agents|cholinergic agents|mesh-ancestor
65069949|NCT00323817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65069950|NCT00323817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069951|NCT00323817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65069952|NCT00289835|Paclitaxel|paclitaxel|mesh-list
65069953|NCT00289835|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65069954|NCT00289835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65069955|NCT00289835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069956|NCT00289835|Tubulin Modulators|tubulin modulators|mesh-ancestor
65069957|NCT00289835|Antimitotic Agents|antimitotic agents|mesh-ancestor
65069958|NCT00289835|Mitosis Modulators|mitosis modulators|mesh-ancestor
65069959|NCT00289835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069960|NCT00323934|Mocetinostat|mocetinostat|mesh-list
65069961|NCT00323934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64389959|NCT03143465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389960|NCT03143465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389961|NCT03143465|Urological Agents|urological agents|mesh-ancestor
64389962|NCT03143465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64389963|NCT03143465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389964|NCT03143465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64389965|NCT05034809|Melatonin|melatonin|mesh-list
64389966|NCT05034809|Antioxidants|antioxidants|mesh-ancestor
64389967|NCT05034809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389968|NCT05034809|Protective Agents|protective agents|mesh-ancestor
64389969|NCT05034809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389970|NCT05034809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64389971|NCT02428543|Cytarabine|cytarabine|mesh-list
64389972|NCT02428543|Ponatinib|ponatinib|mesh-list
64389973|NCT02428543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64389974|NCT02428543|Antimetabolites|antimetabolites|mesh-ancestor
65069962|NCT00323934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069963|NCT00323934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069964|NCT00290030|Alfuzosin|alfuzosin|mesh-list
65069965|NCT00290030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65069966|NCT00290030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65069967|NCT00290030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65069968|NCT00290030|Adrenergic Agents|adrenergic agents|mesh-ancestor
65069969|NCT00290030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65069970|NCT00290030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069971|NCT00290030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069972|NCT00290030|Urological Agents|urological agents|mesh-ancestor
65069973|NCT00303264|Esomeprazole|esomeprazole|mesh-list
65069974|NCT00303264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65069975|NCT00303264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65069976|NCT00303264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65069977|NCT00303264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069978|NCT00303264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069979|NCT00290069|Sirolimus|sirolimus|mesh-list
65069980|NCT00290069|Tacrolimus|tacrolimus|mesh-list
65069981|NCT00290069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65069982|NCT00290069|Immunologic Factors|immunologic factors|mesh-ancestor
65069983|NCT00290069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069984|NCT00290069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65069985|NCT00290069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65069986|NCT00290069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65069987|NCT00290069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65069988|NCT00290069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65069989|NCT00290069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65069990|NCT00290069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65069991|NCT00290069|Antifungal Agents|antifungal agents|mesh-ancestor
65069992|NCT04718259|Midazolam|midazolam|mesh-list
65069993|NCT04718259|Bupivacaine|bupivacaine|mesh-list
65069994|NCT04718259|Anesthetics, Local|anesthetics, local|mesh-ancestor
65069995|NCT04718259|Anesthetics|anesthetics|mesh-ancestor
65069996|NCT04718259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65069997|NCT04718259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65069998|NCT04718259|Sensory System Agents|sensory system agents|mesh-ancestor
65069999|NCT04718259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65070000|NCT04718259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65070001|NCT04718259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64511439|NCT05382338|Antioxidants|antioxidants|mesh-ancestor
64324846|NCT01354717|Immunologic Factors|immunologic factors|mesh-ancestor
64324847|NCT01354717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324848|NCT01072981|Gemcitabine|gemcitabine|mesh-list
64324849|NCT01072981|Fluorouracil|fluorouracil|mesh-list
64833027|NCT01597427|Sensory System Agents|sensory system agents|mesh-ancestor
64833028|NCT01597427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65070002|NCT04718259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65070003|NCT04718259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65070004|NCT04718259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65070005|NCT04718259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65070006|NCT04718259|Anesthetics, General|anesthetics, general|mesh-ancestor
65070007|NCT04718259|GABA Modulators|gaba modulators|mesh-ancestor
65070008|NCT04718259|GABA Agents|gaba agents|mesh-ancestor
65070009|NCT04718259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65070010|NCT04718259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070011|NCT00290108|Propofol|propofol|mesh-list
65070012|NCT00290108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65070013|NCT00290108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65070014|NCT00290108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070015|NCT00290108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65070016|NCT00290108|Anesthetics, General|anesthetics, general|mesh-ancestor
65070017|NCT00290108|Anesthetics|anesthetics|mesh-ancestor
65070018|NCT00323973|Bisoprolol|bisoprolol|mesh-list
65070019|NCT00323973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65070020|NCT00323973|Sympatholytics|sympatholytics|mesh-ancestor
65070021|NCT00323973|Autonomic Agents|autonomic agents|mesh-ancestor
65070022|NCT00323973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65070023|NCT00323973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070024|NCT00323973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65070025|NCT00323973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65070026|NCT00323973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65070027|NCT00323973|Adrenergic Agents|adrenergic agents|mesh-ancestor
65070028|NCT00323973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65070029|NCT00323973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070030|NCT00324012|Docetaxel|docetaxel|mesh-list
65070031|NCT00324012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070032|NCT00324012|Tubulin Modulators|tubulin modulators|mesh-ancestor
65070033|NCT00324012|Antimitotic Agents|antimitotic agents|mesh-ancestor
65070034|NCT00324012|Mitosis Modulators|mitosis modulators|mesh-ancestor
65070035|NCT00324012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070036|NCT00290264|Budesonide|budesonide|mesh-list
64833033|NCT01597427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64833034|NCT01597427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64833035|NCT01597427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64833036|NCT01597427|Adrenergic Agents|adrenergic agents|mesh-ancestor
64833037|NCT01597427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64833038|NCT01597427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833039|NCT01597518|Riluzole|riluzole|mesh-list
64833040|NCT01597518|Anticonvulsants|anticonvulsants|mesh-ancestor
64833041|NCT01597518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64833042|NCT01597518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64833043|NCT01597518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64833044|NCT01597518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444243|NCT01641809|Tenofovir|tenofovir|mesh-list
65070037|NCT00290264|Formoterol Fumarate|formoterol fumarate|mesh-list
65070038|NCT00290264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65070039|NCT00290264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65070040|NCT00290264|Autonomic Agents|autonomic agents|mesh-ancestor
65070041|NCT00290264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65070042|NCT00290264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070043|NCT00290264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65070044|NCT00290264|Respiratory System Agents|respiratory system agents|mesh-ancestor
65070046|NCT00290264|Hormones|hormones|mesh-ancestor
65070047|NCT00290264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65070048|NCT00290264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65070049|NCT00290264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65070050|NCT00290264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65070051|NCT00290264|Adrenergic Agents|adrenergic agents|mesh-ancestor
65070052|NCT00290264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65070053|NCT00290264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070054|NCT00324051|Olanzapine|olanzapine|mesh-list
65070055|NCT00324051|Antiemetics|antiemetics|mesh-ancestor
65070056|NCT00324051|Autonomic Agents|autonomic agents|mesh-ancestor
65070057|NCT00324051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65070058|NCT00324051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070059|NCT00324051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65070060|NCT00324051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65070061|NCT00324051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65070062|NCT00324051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65070063|NCT00324051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65070064|NCT00324051|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65070065|NCT00324051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65070066|NCT00324051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65070067|NCT00324051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070068|NCT00324051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65070069|NCT00324051|Serotonin Agents|serotonin agents|mesh-ancestor
65070070|NCT00303381|Interferons|interferons|mesh-list
65070071|NCT00303381|Interferon-beta|interferon-beta|mesh-list
65070072|NCT00303381|Interferon beta-1a|interferon beta-1a|mesh-list
65070073|NCT00303381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070074|NCT00303381|Antiviral Agents|antiviral agents|mesh-ancestor
65070075|NCT00303381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65070076|NCT00303381|Immunologic Factors|immunologic factors|mesh-ancestor
65070077|NCT00303381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070078|NCT00303381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65070079|NCT00290420|Chloroquine|chloroquine|mesh-list
65070080|NCT00290420|Amebicides|amebicides|mesh-ancestor
64833047|NCT01597518|Protective Agents|protective agents|mesh-ancestor
64833048|NCT01597531|Liraglutide|liraglutide|mesh-list
64833049|NCT01597531|Orlistat|orlistat|mesh-list
64833050|NCT01597531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64833051|NCT01597531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833052|NCT01597531|Incretins|incretins|mesh-ancestor
64833053|NCT01597531|Hormones|hormones|mesh-ancestor
64833054|NCT01597531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64390270|NCT03139487|Apixaban|apixaban|mesh-list
65070081|NCT00290420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65070082|NCT00290420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65070083|NCT00290420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65070084|NCT00290420|Antimalarials|antimalarials|mesh-ancestor
65070085|NCT00290420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65070086|NCT00303420|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65070087|NCT00303420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65070088|NCT00303420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65070089|NCT00303420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070090|NCT00324129|Mocetinostat|mocetinostat|mesh-list
65070091|NCT00324129|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65070092|NCT00324129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070093|NCT00324129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070094|NCT00303537|Metformin|metformin|mesh-list
65070095|NCT00303537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65070096|NCT00303537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070097|NCT00290849|Bivalirudin|bivalirudin|mesh-list
65070098|NCT00290849|Antithrombins|antithrombins|mesh-ancestor
65070099|NCT00290849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65070100|NCT00290849|Protease Inhibitors|protease inhibitors|mesh-ancestor
65070101|NCT00290849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070102|NCT00290849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070103|NCT00290849|Anticoagulants|anticoagulants|mesh-ancestor
65070104|NCT00290927|Insulin glulisine|insulin glulisine|mesh-list
65070105|NCT00290927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64324850|NCT01072981|Pancrelipase|pancrelipase|mesh-list
64324851|NCT01072981|Immunologic Factors|immunologic factors|mesh-list
64324852|NCT01072981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64324853|NCT01072981|Antimetabolites|antimetabolites|mesh-ancestor
64390424|NCT05083013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64390426|NCT05083013|Sensory System Agents|sensory system agents|mesh-ancestor
64390427|NCT05083013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64390428|NCT05083013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390429|NCT05083013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64390430|NCT05083013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64390431|NCT05073653|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64390432|NCT05073653|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64390433|NCT05073653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390434|NCT03223883|Curcumin|curcumin|mesh-list
64390435|NCT03223883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64390436|NCT03223883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64390437|NCT03223883|Analgesics|analgesics|mesh-ancestor
64390452|NCT02420899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64390454|NCT05048069|Rebamipide|rebamipide|mesh-list
64390455|NCT05048069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64390456|NCT05048069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64390457|NCT05048069|Antioxidants|antioxidants|mesh-ancestor
64390459|NCT05048069|Protective Agents|protective agents|mesh-ancestor
65070106|NCT00290927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070108|NCT00303576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65070109|NCT00303576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65070110|NCT00303576|Antiviral Agents|antiviral agents|mesh-ancestor
65070111|NCT00303576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65070112|NCT00291005|Docetaxel|docetaxel|mesh-list
65070113|NCT00291005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070114|NCT00291005|Tubulin Modulators|tubulin modulators|mesh-ancestor
65070115|NCT00291005|Antimitotic Agents|antimitotic agents|mesh-ancestor
65070116|NCT00291005|Mitosis Modulators|mitosis modulators|mesh-ancestor
65070117|NCT00291005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070118|NCT00303615|Anastrozole|anastrozole|mesh-list
65070119|NCT00303615|Fluoxymesterone|fluoxymesterone|mesh-list
65070120|NCT00303615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65070121|NCT00303615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070122|NCT00303615|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65070123|NCT00303615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65070124|NCT00303615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070125|NCT00303615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070126|NCT00303615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65070127|NCT00303615|Hormone Antagonists|hormone antagonists|mesh-ancestor
65070128|NCT00303615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65070129|NCT00303615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070130|NCT00303615|Anabolic Agents|anabolic agents|mesh-ancestor
65070131|NCT00303615|Hormones|hormones|mesh-ancestor
65070132|NCT00324324|Moxifloxacin|moxifloxacin|mesh-list
65070133|NCT00324324|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65070134|NCT00324324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65070135|NCT00324324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65070136|NCT00324324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65070137|NCT00324324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65070138|NCT00324324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444266|NCT01632566|Celecoxib|celecoxib|mesh-list
64833055|NCT01597531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833056|NCT01597531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833057|NCT01597531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64833058|NCT01597531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64833059|NCT01597609|Sibutramine|sibutramine|mesh-list
64833060|NCT01597609|Antidepressive Agents|antidepressive agents|mesh-ancestor
64833061|NCT01597609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64833062|NCT01597609|Appetite Depressants|appetite depressants|mesh-ancestor
64390486|NCT04065113|Ethanol|ethanol|mesh-list
64390487|NCT04065113|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64390488|NCT04065113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64390501|NCT03116659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64390502|NCT03116659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64390503|NCT03116659|Antimalarials|antimalarials|mesh-ancestor
64390504|NCT03116659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64390505|NCT03116659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64390506|NCT03116659|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64390507|NCT03116659|Immunologic Factors|immunologic factors|mesh-ancestor
64390508|NCT03116659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070139|NCT00324324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070140|NCT00324324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070141|NCT00324324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65070142|NCT00324324|Contraceptive Agents|contraceptive agents|mesh-ancestor
65070143|NCT00324324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65070144|NCT00324324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070145|NCT00324324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65070146|NCT00324324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65070147|NCT00324324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65070148|NCT00291122|Celecoxib|celecoxib|mesh-list
65070149|NCT00291122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65070150|NCT00291122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64555421|NCT04373967|Incretins|incretins|mesh-ancestor
65070151|NCT00291122|Analgesics|analgesics|mesh-ancestor
65070152|NCT00291122|Sensory System Agents|sensory system agents|mesh-ancestor
65070153|NCT00291122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64833063|NCT01597609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64833064|NCT01597648|Maraviroc|maraviroc|mesh-list
64833065|NCT01597648|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64833066|NCT01597648|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64833067|NCT01597648|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64833068|NCT01597648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833069|NCT01597648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64833070|NCT01597648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64324854|NCT01072981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324855|NCT01072981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324856|NCT01072981|Antiviral Agents|antiviral agents|mesh-ancestor
64324857|NCT01072981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324858|NCT01072981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324859|NCT01072981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64833072|NCT01597648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64833073|NCT01597648|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64390560|NCT03138785|Hormone Antagonists|hormone antagonists|mesh-ancestor
64390561|NCT03138785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64390562|NCT03138785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390563|NCT03138785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64390564|NCT03138785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65070154|NCT00291122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070155|NCT00291122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65070156|NCT00291122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65070157|NCT00291122|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65070158|NCT00291122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65070159|NCT00291122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070160|NCT00291122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070161|NCT00324363|Exenatide|exenatide|mesh-list
65070162|NCT00324363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65070163|NCT00324363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070164|NCT00324363|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65070165|NCT00324363|Incretins|incretins|mesh-ancestor
65070166|NCT00324363|Hormones|hormones|mesh-ancestor
65070167|NCT00324363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65070168|NCT00303732|Everolimus|everolimus|mesh-list
65070169|NCT00303732|Vatalanib|vatalanib|mesh-list
65070170|NCT00303732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070171|NCT00303732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65070172|NCT00303732|Immunologic Factors|immunologic factors|mesh-ancestor
65070173|NCT00303732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070174|NCT00303732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65070175|NCT00303732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070176|NCT00303732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070177|NCT00303771|Leucovorin|leucovorin|mesh-list
65070178|NCT00303771|Fluorouracil|fluorouracil|mesh-list
65070179|NCT00303771|Irinotecan|irinotecan|mesh-list
65070180|NCT00303771|Calcium|calcium|mesh-list
65070181|NCT00303771|Levoleucovorin|levoleucovorin|mesh-list
65070182|NCT00303771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64833074|NCT01597648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64833075|NCT01597648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64833076|NCT01597648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833077|NCT01597661|Bupropion|bupropion|mesh-list
64833078|NCT01597661|Antidepressive Agents|antidepressive agents|mesh-list
64833079|NCT01597661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64833080|NCT01597661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64833081|NCT01597661|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64833082|NCT01597661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64833083|NCT01597661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64833084|NCT01597661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444278|NCT01632566|Analgesics|analgesics|mesh-ancestor
64390566|NCT03138785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64390567|NCT03138785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64390568|NCT03138785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64390569|NCT03138785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390570|NCT03138785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64390572|NCT03106597|Manidipine|manidipine|mesh-list
64390573|NCT03106597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65070183|NCT00303771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070184|NCT00303771|Antimetabolites|antimetabolites|mesh-ancestor
65070185|NCT00303771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070186|NCT00303771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65070187|NCT00303771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070188|NCT00303771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65070189|NCT00303771|Immunologic Factors|immunologic factors|mesh-ancestor
65070190|NCT00303771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65070191|NCT00303771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65070192|NCT00303771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070193|NCT00303771|Antidotes|antidotes|mesh-ancestor
65070194|NCT00303771|Protective Agents|protective agents|mesh-ancestor
65070195|NCT00303771|Vitamin B Complex|vitamin b complex|mesh-ancestor
65070196|NCT00303771|Vitamins|vitamins|mesh-ancestor
65070197|NCT00303771|Micronutrients|micronutrients|mesh-ancestor
65070198|NCT00303810|Cyclophosphamide|cyclophosphamide|mesh-list
65070199|NCT00303810|Thiotepa|thiotepa|mesh-list
65070200|NCT00303810|Lomustine|lomustine|mesh-list
65070201|NCT00303810|Carboplatin|carboplatin|mesh-list
65070202|NCT00303810|Methotrexate|methotrexate|mesh-list
65070203|NCT00303810|Etoposide|etoposide|mesh-list
65070204|NCT00303810|Vincristine|vincristine|mesh-list
65070205|NCT00303810|Etoposide phosphate|etoposide phosphate|mesh-list
65070206|NCT00303810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65070207|NCT00303810|Immunologic Factors|immunologic factors|mesh-ancestor
65070208|NCT00303810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070209|NCT00303810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65070210|NCT00303810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65070211|NCT00303810|Alkylating Agents|alkylating agents|mesh-ancestor
65070212|NCT00303810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070213|NCT00303810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070214|NCT00303810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65070215|NCT00303810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65070216|NCT00303810|Abortifacient Agents|abortifacient agents|mesh-ancestor
65070217|NCT00303810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65070218|NCT00303810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65070219|NCT00303810|Antimetabolites|antimetabolites|mesh-ancestor
65070220|NCT00303810|Dermatologic Agents|dermatologic agents|mesh-ancestor
65070221|NCT00303810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070222|NCT00303810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65070223|NCT00303810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64324860|NCT01072981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324861|NCT01072981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64833085|NCT01597661|Dopamine Agents|dopamine agents|mesh-ancestor
64833086|NCT01597661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64833087|NCT01597661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833088|NCT01597661|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64833089|NCT01597661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64833090|NCT01597661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833091|NCT01597700|Ezetimibe|ezetimibe|mesh-list
64833092|NCT01597700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64833093|NCT01597700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64833094|NCT01597700|Antimetabolites|antimetabolites|mesh-ancestor
64833095|NCT01597700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444285|NCT01632566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65070224|NCT00303810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65070225|NCT00303810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65070226|NCT00303810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65070227|NCT00303810|Tubulin Modulators|tubulin modulators|mesh-ancestor
65070228|NCT00303810|Antimitotic Agents|antimitotic agents|mesh-ancestor
65070229|NCT00303810|Mitosis Modulators|mitosis modulators|mesh-ancestor
65070231|NCT00324480|Alvocidib|alvocidib|mesh-list
65070232|NCT00324480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070233|NCT00324480|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65070234|NCT00324480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070235|NCT00324480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070236|NCT00324480|Growth Inhibitors|growth inhibitors|mesh-ancestor
65070237|NCT00324480|Growth Substances|growth substances|mesh-ancestor
65070238|NCT00324480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070239|NCT00324480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65070240|NCT00303888|Docetaxel|docetaxel|mesh-list
65070241|NCT00303888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070242|NCT00303888|Tubulin Modulators|tubulin modulators|mesh-ancestor
65070243|NCT00303888|Antimitotic Agents|antimitotic agents|mesh-ancestor
65070244|NCT00303888|Mitosis Modulators|mitosis modulators|mesh-ancestor
65070245|NCT00303888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070246|NCT00291707|Pemetrexed|pemetrexed|mesh-list
65070247|NCT00291707|Cetuximab|cetuximab|mesh-list
65070248|NCT00291707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324864|NCT03347708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64324865|NCT03347708|Immunologic Factors|immunologic factors|mesh-ancestor
64390729|NCT03138239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64390730|NCT03138239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390732|NCT02416063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64390733|NCT02416063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64390734|NCT02416063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390735|NCT02416063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65070249|NCT00291707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070250|NCT00291707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070251|NCT00291707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65070252|NCT00291707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65070253|NCT00291707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65070254|NCT00324519|Misoprostol|misoprostol|mesh-list
65070255|NCT00324519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65070256|NCT00324519|Abortifacient Agents|abortifacient agents|mesh-ancestor
65070257|NCT00324519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65070258|NCT00324519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070259|NCT00324519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65070260|NCT00324519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65070261|NCT00324519|Oxytocics|oxytocics|mesh-ancestor
65070262|NCT00291746|Esomeprazole|esomeprazole|mesh-list
65070263|NCT00291746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65070264|NCT00291746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65070265|NCT00291746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65070266|NCT00291746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070267|NCT00291746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070268|NCT00303927|Capecitabine|capecitabine|mesh-list
65070269|NCT00303927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65070270|NCT00303927|Antimetabolites|antimetabolites|mesh-ancestor
65070271|NCT00303927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070272|NCT00303927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070273|NCT00419484|Pioglitazone|pioglitazone|mesh-list
65070274|NCT00419484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65070275|NCT00419484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070276|NCT00291785|Leucovorin|leucovorin|mesh-list
65070277|NCT00291785|Folic Acid|folic acid|mesh-list
65070278|NCT00291785|Fluorouracil|fluorouracil|mesh-list
65070279|NCT00291785|Levoleucovorin|levoleucovorin|mesh-list
65070280|NCT00291785|Antimetabolites|antimetabolites|mesh-ancestor
65070281|NCT00291785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070282|NCT00291785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65070283|NCT00291785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070284|NCT00291785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65070285|NCT00291785|Immunologic Factors|immunologic factors|mesh-ancestor
65070286|NCT00291785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070287|NCT00291785|Antidotes|antidotes|mesh-ancestor
64833096|NCT01597700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64833097|NCT01597713|Insulin Glargine|insulin glargine|mesh-list
64833098|NCT01597713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64833099|NCT01597713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833101|NCT01597726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64833102|NCT01597726|Abortifacient Agents|abortifacient agents|mesh-ancestor
64833103|NCT01597726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64833104|NCT01597726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833105|NCT01597726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65070288|NCT00291785|Protective Agents|protective agents|mesh-ancestor
65070289|NCT00291785|Vitamin B Complex|vitamin b complex|mesh-ancestor
65070290|NCT00291785|Vitamins|vitamins|mesh-ancestor
65070291|NCT00291785|Micronutrients|micronutrients|mesh-ancestor
65070292|NCT00291785|Hematinics|hematinics|mesh-ancestor
65070293|NCT00324558|Bemiparin|bemiparin|mesh-list
65070294|NCT00324558|Anticoagulants|anticoagulants|mesh-ancestor
65070295|NCT00291863|Simvastatin|simvastatin|mesh-list
65070296|NCT00291863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65070297|NCT00291863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65070298|NCT00291863|Antimetabolites|antimetabolites|mesh-ancestor
65070299|NCT00291863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070300|NCT00291863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65070301|NCT00291863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65070302|NCT00291863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070303|NCT00304200|Temozolomide|temozolomide|mesh-list
65070304|NCT00304200|Sunitinib|sunitinib|mesh-list
65070305|NCT00304200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65070306|NCT00304200|Alkylating Agents|alkylating agents|mesh-ancestor
65070307|NCT00304200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070308|NCT00304200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070309|NCT00304200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65070310|NCT00304200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65070311|NCT00304200|Growth Substances|growth substances|mesh-ancestor
65070312|NCT00304200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070313|NCT00304200|Growth Inhibitors|growth inhibitors|mesh-ancestor
65070314|NCT00304200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65070315|NCT00304200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070316|NCT00304239|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65070317|NCT00304239|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65070318|NCT00304239|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64324867|NCT03347708|Viscosupplements|viscosupplements|mesh-ancestor
64324868|NCT03347708|Protective Agents|protective agents|mesh-ancestor
64324869|NCT01159249|Vildagliptin|vildagliptin|mesh-list
64324870|NCT01159249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64324871|NCT01159249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324872|NCT01159249|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64833112|NCT01597765|alpha-Tocopherol|alpha-tocopherol|mesh-list
64833113|NCT01597765|Acetylcysteine|acetylcysteine|mesh-list
64833114|NCT01597765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64833115|NCT01597765|Deferiprone|deferiprone|mesh-list
64390824|NCT03180229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390825|NCT05091619|Vaccines|vaccines|mesh-list
64390826|NCT05091619|Immunologic Factors|immunologic factors|mesh-ancestor
65070319|NCT00304239|Dermatologic Agents|dermatologic agents|mesh-ancestor
65070320|NCT00291980|Vaccines|vaccines|mesh-list
65070321|NCT00291980|Immunologic Factors|immunologic factors|mesh-ancestor
65070322|NCT00291980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070323|NCT00324597|Gemcitabine|gemcitabine|mesh-list
65070324|NCT00324597|Motesanib diphosphate|motesanib diphosphate|mesh-list
65070325|NCT00324597|Imetelstat|imetelstat|mesh-list
65070326|NCT00324597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65070327|NCT00324597|Antimetabolites|antimetabolites|mesh-ancestor
65070328|NCT00324597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070329|NCT00324597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070330|NCT00324597|Antiviral Agents|antiviral agents|mesh-ancestor
65070331|NCT00324597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65070332|NCT00324597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070333|NCT00324597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65070334|NCT00324597|Immunologic Factors|immunologic factors|mesh-ancestor
65070335|NCT00324597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070336|NCT00324597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65070337|NCT00324714|Risedronic Acid|risedronic acid|mesh-list
65070338|NCT00324714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65070339|NCT00324714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65070340|NCT00324714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070341|NCT00324714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65070342|NCT00324714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070343|NCT00324714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65070344|NCT00304317|Celecoxib|celecoxib|mesh-list
65070345|NCT00304317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64833116|NCT01597765|Micronutrients|micronutrients|mesh-ancestor
64833117|NCT01597765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833118|NCT01597765|Antiviral Agents|antiviral agents|mesh-ancestor
64833119|NCT01597765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64833120|NCT01597765|Expectorants|expectorants|mesh-ancestor
64833121|NCT01597765|Respiratory System Agents|respiratory system agents|mesh-ancestor
64833122|NCT01597765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64833123|NCT01597765|Antioxidants|antioxidants|mesh-ancestor
64833124|NCT01597765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833125|NCT01597765|Protective Agents|protective agents|mesh-ancestor
64833126|NCT01597765|Antidotes|antidotes|mesh-ancestor
64833127|NCT01597765|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64833128|NCT01597765|Chelating Agents|chelating agents|mesh-ancestor
64833129|NCT01597765|Sequestering Agents|sequestering agents|mesh-ancestor
64833130|NCT01597817|Chitosan|chitosan|mesh-list
64833131|NCT01597817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64833132|NCT01597817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64833133|NCT01597817|Antimetabolites|antimetabolites|mesh-ancestor
64833134|NCT01597817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833135|NCT01597817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64833136|NCT01597817|Chelating Agents|chelating agents|mesh-ancestor
64833137|NCT01597817|Sequestering Agents|sequestering agents|mesh-ancestor
64833138|NCT01597817|Hemostatics|hemostatics|mesh-ancestor
65070346|NCT00304317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65070347|NCT00304317|Analgesics|analgesics|mesh-ancestor
65070348|NCT00304317|Sensory System Agents|sensory system agents|mesh-ancestor
65070349|NCT00304317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65070350|NCT00304317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070351|NCT00304317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65070352|NCT00304317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65070353|NCT00304317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65070354|NCT00304317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65070355|NCT00304317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070356|NCT00304317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070357|NCT00324792|Insulin|insulin|mesh-list
65070358|NCT00324792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65070359|NCT00324792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070360|NCT00292214|Acetaminophen|acetaminophen|mesh-list
65070361|NCT00292214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65070362|NCT00292214|Analgesics|analgesics|mesh-ancestor
65070363|NCT00292214|Sensory System Agents|sensory system agents|mesh-ancestor
65070364|NCT00292214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65070365|NCT00292214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070366|NCT00292214|Antipyretics|antipyretics|mesh-ancestor
65070367|NCT00324831|Prednisone|prednisone|mesh-list
65070368|NCT00324831|Cyclophosphamide|cyclophosphamide|mesh-list
65070369|NCT00324831|Rituximab|rituximab|mesh-list
65070370|NCT00324831|Doxorubicin|doxorubicin|mesh-list
65070371|NCT00324831|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65070372|NCT00324831|Vincristine|vincristine|mesh-list
64833141|NCT01597895|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64833142|NCT01597895|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64601727|NCT03801733|Sulfasalazine|sulfasalazine|mesh-list
64833143|NCT01597895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833145|NCT01597895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64833146|NCT01597895|Antiviral Agents|antiviral agents|mesh-ancestor
65070373|NCT00324831|Vaccines|vaccines|mesh-list
65070374|NCT00324831|Antibodies|antibodies|mesh-list
65070375|NCT00324831|Immunoglobulins|immunoglobulins|mesh-list
65070376|NCT00324831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65070377|NCT00324831|Sargramostim|sargramostim|mesh-list
65070378|NCT00324831|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
64555652|NCT03401541|Vitamins|vitamins|mesh-ancestor
65070379|NCT00324831|Immunologic Factors|immunologic factors|mesh-ancestor
65070380|NCT00324831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070381|NCT00324831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65070382|NCT00324831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65070383|NCT00324831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65070384|NCT00324831|Alkylating Agents|alkylating agents|mesh-ancestor
65070385|NCT00324831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070386|NCT00324831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070387|NCT00324831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65070388|NCT00324831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65070389|NCT00324831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65070390|NCT00324831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65070391|NCT00324831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65070392|NCT00324831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070393|NCT00324831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64324876|NCT01156753|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
64833163|NCT01597986|Isavuconazole|isavuconazole|mesh-list
64833164|NCT01597986|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64833165|NCT01597986|Norethindrone|norethindrone|mesh-list
64833166|NCT01597986|Norethindrone Acetate|norethindrone acetate|mesh-list
64833167|NCT01597986|Norinyl|norinyl|mesh-list
64833168|NCT01597986|Contraceptive Agents|contraceptive agents|mesh-list
64833169|NCT01597986|Contraceptives, Oral|contraceptives, oral|mesh-list
64833170|NCT01597986|Estradiol|estradiol|mesh-list
64833171|NCT01597986|Estrogens|estrogens|mesh-ancestor
64833172|NCT01597986|Hormones|hormones|mesh-ancestor
64833173|NCT01597986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64833174|NCT01597986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833175|NCT01597986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64833176|NCT01597986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64391034|NCT03135977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64391035|NCT03135977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64391036|NCT03135977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391037|NCT03135977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391038|NCT03135977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64391039|NCT01966120|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64391040|NCT01966120|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64391048|NCT04850651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391049|NCT04850651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64391050|NCT04850651|Hormone Antagonists|hormone antagonists|mesh-ancestor
65070396|NCT00324831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65070397|NCT00324831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65070398|NCT00324831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65070399|NCT00324831|Tubulin Modulators|tubulin modulators|mesh-ancestor
65070400|NCT00324831|Antimitotic Agents|antimitotic agents|mesh-ancestor
65070401|NCT00324831|Mitosis Modulators|mitosis modulators|mesh-ancestor
65070402|NCT00292253|Interferon beta-1a|interferon beta-1a|mesh-list
65070403|NCT00292253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65070404|NCT00292253|Immunologic Factors|immunologic factors|mesh-ancestor
65070405|NCT00292253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070406|NCT00292253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070407|NCT00292253|Antiviral Agents|antiviral agents|mesh-ancestor
65070408|NCT00292253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65070409|NCT00304434|Oseltamivir|oseltamivir|mesh-list
65070410|NCT00304434|Probenecid|probenecid|mesh-list
65070411|NCT00304434|Antiviral Agents|antiviral agents|mesh-ancestor
65070412|NCT00304434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65070413|NCT00304434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070414|NCT00304434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070415|NCT00304434|Uricosuric Agents|uricosuric agents|mesh-ancestor
65070416|NCT00304434|Gout Suppressants|gout suppressants|mesh-ancestor
65070417|NCT00304434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65070418|NCT00304434|Renal Agents|renal agents|mesh-ancestor
65070419|NCT00292409|Aripiprazole|aripiprazole|mesh-list
64324877|NCT01156753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64324878|NCT01156753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324879|NCT01345045|Pregabalin|pregabalin|mesh-list
64324880|NCT01345045|Analgesics|analgesics|mesh-ancestor
64324881|NCT01345045|Sensory System Agents|sensory system agents|mesh-ancestor
64391075|NCT02414581|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64391076|NCT02414581|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64391077|NCT02414581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64391078|NCT02414581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64391079|NCT02414581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391080|NCT02414581|Disinfectants|disinfectants|mesh-ancestor
64391081|NCT02414581|Dermatologic Agents|dermatologic agents|mesh-ancestor
64391084|NCT02419105|Testosterone|testosterone|mesh-list
64391085|NCT02419105|Vitamins|vitamins|mesh-ancestor
64391086|NCT02419105|Micronutrients|micronutrients|mesh-ancestor
64391087|NCT02419105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391088|NCT02419105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65070420|NCT00292409|Antidepressive Agents|antidepressive agents|mesh-ancestor
65070421|NCT00292409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65070422|NCT00292409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65070423|NCT00292409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65070424|NCT00292409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65070425|NCT00292409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070426|NCT00292409|Dopamine Agonists|dopamine agonists|mesh-ancestor
65070427|NCT00292409|Dopamine Agents|dopamine agents|mesh-ancestor
65070428|NCT00292409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65070429|NCT00292409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070430|NCT00292409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65070431|NCT00292409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65070432|NCT00292409|Serotonin Agents|serotonin agents|mesh-ancestor
65070433|NCT00292409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65070434|NCT00292409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65070435|NCT00292409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65070436|NCT00292409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65070437|NCT00304473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65070438|NCT00304473|Antidepressive Agents|antidepressive agents|mesh-ancestor
65070439|NCT00304473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65070440|NCT00304473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65070441|NCT00304473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65070442|NCT00304473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65070443|NCT00304473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070444|NCT00292448|Tiotropium Bromide|tiotropium bromide|mesh-list
64324882|NCT01345045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65070445|NCT00292448|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65070446|NCT00292448|Autonomic Agents|autonomic agents|mesh-ancestor
65070447|NCT00292448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65070448|NCT00292448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070449|NCT00292448|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65070450|NCT00292448|Respiratory System Agents|respiratory system agents|mesh-ancestor
65070451|NCT00292448|Parasympatholytics|parasympatholytics|mesh-ancestor
65070452|NCT00292448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65070453|NCT00292448|Cholinergic Agents|cholinergic agents|mesh-ancestor
65070454|NCT00292448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65070455|NCT00292448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070456|NCT00324948|Alprostadil|alprostadil|mesh-list
65070457|NCT00324948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65070458|NCT00324948|Vasodilator Agents|vasodilator agents|mesh-ancestor
65070459|NCT00324948|Urological Agents|urological agents|mesh-ancestor
65070461|NCT00304551|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65070462|NCT00304551|Interferon-alpha|interferon-alpha|mesh-list
65070463|NCT00304551|Antimetabolites|antimetabolites|mesh-ancestor
65070464|NCT00304551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070465|NCT00304551|Antiviral Agents|antiviral agents|mesh-ancestor
65070466|NCT00304551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65070467|NCT00304551|Immunologic Factors|immunologic factors|mesh-ancestor
65070468|NCT00304551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070469|NCT00325026|Misoprostol|misoprostol|mesh-list
64324894|NCT01344187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64324895|NCT01344187|Vitamin B Complex|vitamin b complex|mesh-ancestor
64324896|NCT01344187|Vitamins|vitamins|mesh-ancestor
64324897|NCT01344187|Micronutrients|micronutrients|mesh-ancestor
64324898|NCT01344187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324899|NCT01344187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64324900|NCT01344187|Dermatologic Agents|dermatologic agents|mesh-ancestor
64429998|NCT05056883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324904|NCT01338883|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64324905|NCT01338883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64324907|NCT01338883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324908|NCT01338883|Antiviral Agents|antiviral agents|mesh-ancestor
64833194|NCT01598012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833195|NCT01598051|Rivaroxaban|rivaroxaban|mesh-list
64833196|NCT01598051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64833197|NCT01598051|Antithrombins|antithrombins|mesh-ancestor
65070470|NCT00325026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65070471|NCT00325026|Abortifacient Agents|abortifacient agents|mesh-ancestor
65070472|NCT00325026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65070473|NCT00325026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070474|NCT00325026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65070475|NCT00325026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65070476|NCT00325026|Oxytocics|oxytocics|mesh-ancestor
65070477|NCT00325104|Calcium|calcium|mesh-list
65070478|NCT00325104|Parathyroid Hormone|parathyroid hormone|mesh-list
65070479|NCT00325104|Hormones|hormones|mesh-list
65070480|NCT00325104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65070481|NCT00325104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070482|NCT00325104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65070483|NCT00292526|Enalapril|enalapril|mesh-list
65070484|NCT00292526|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65070485|NCT00292526|Protease Inhibitors|protease inhibitors|mesh-ancestor
65070486|NCT00292526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070487|NCT00292526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070488|NCT00292526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65070489|NCT00418509|Mometasone Furoate|mometasone furoate|mesh-list
65070490|NCT00418509|Formoterol Fumarate|formoterol fumarate|mesh-list
65070491|NCT00418509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65070492|NCT00418509|Autonomic Agents|autonomic agents|mesh-ancestor
64833211|NCT01598259|Melatonin|melatonin|mesh-list
64833212|NCT01598259|Antioxidants|antioxidants|mesh-ancestor
64833213|NCT01598259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833214|NCT01598259|Protective Agents|protective agents|mesh-ancestor
64833215|NCT01598259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444392|NCT05544071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64324909|NCT01338883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324910|NCT01338883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64324911|NCT01338883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64324912|NCT01338883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64324913|NCT01338883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64833216|NCT01598259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64833217|NCT01598337|Aspirin|aspirin|mesh-list
64833218|NCT01598337|Tirofiban|tirofiban|mesh-list
64833219|NCT01598337|Clopidogrel|clopidogrel|mesh-list
64833220|NCT01598337|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64833221|NCT01598337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64833222|NCT01598337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64833223|NCT01598337|Analgesics|analgesics|mesh-ancestor
64833224|NCT01598337|Sensory System Agents|sensory system agents|mesh-ancestor
64833225|NCT01598337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64833226|NCT01598337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070493|NCT00418509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65070494|NCT00418509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070495|NCT00418509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65070496|NCT00418509|Respiratory System Agents|respiratory system agents|mesh-ancestor
65070497|NCT00418509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65070498|NCT00418509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65070499|NCT00418509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65070500|NCT00418509|Adrenergic Agents|adrenergic agents|mesh-ancestor
65070501|NCT00418509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65070502|NCT00418509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070503|NCT00418509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65070504|NCT00418509|Dermatologic Agents|dermatologic agents|mesh-ancestor
65070505|NCT00418509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65070506|NCT00292721|Celecoxib|celecoxib|mesh-list
65070507|NCT00292721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65070508|NCT00292721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64833231|NCT01598337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833232|NCT01598337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64833233|NCT01598337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64833234|NCT01598337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833235|NCT01598337|Antipyretics|antipyretics|mesh-ancestor
64833236|NCT01598337|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64833237|NCT01598337|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64833238|NCT01598337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64833239|NCT01598337|Purinergic Agents|purinergic agents|mesh-ancestor
64833240|NCT01598337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64833241|NCT01598363|Digoxin|digoxin|mesh-list
64833242|NCT01598363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64833243|NCT01598363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64833244|NCT01598363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64833245|NCT01598363|Antimetabolites|antimetabolites|mesh-ancestor
64833246|NCT01598363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833247|NCT01598363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64833248|NCT01598363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64833249|NCT01598363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833250|NCT01598363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64833251|NCT01598363|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65070509|NCT00292721|Analgesics|analgesics|mesh-ancestor
65070510|NCT00292721|Sensory System Agents|sensory system agents|mesh-ancestor
65070511|NCT00292721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65070512|NCT00292721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070513|NCT00292721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65070514|NCT00292721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65070515|NCT00292721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65070516|NCT00292721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65070517|NCT00292721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070518|NCT00292721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070519|NCT00292760|Alemtuzumab|alemtuzumab|mesh-list
65070520|NCT00292760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65070521|NCT00292760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070522|NCT00325182|Levetiracetam|levetiracetam|mesh-list
65070523|NCT00325182|Anticonvulsants|anticonvulsants|mesh-ancestor
65070524|NCT00325182|Nootropic Agents|nootropic agents|mesh-ancestor
65070525|NCT00292799|Metformin|metformin|mesh-list
65070526|NCT00292799|Orlistat|orlistat|mesh-list
65070527|NCT00292799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65070528|NCT00292799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511988|NCT04898894|Cytarabine|cytarabine|mesh-list
65070529|NCT00292799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070530|NCT00292799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070531|NCT00292799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65070532|NCT00292799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65070533|NCT00304629|Galantamine|galantamine|mesh-list
65070534|NCT00304629|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65070535|NCT00304629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070536|NCT00304629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070537|NCT00304629|Cholinergic Agents|cholinergic agents|mesh-ancestor
64324914|NCT01338883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64324915|NCT01338883|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64324916|NCT01338883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64324917|NCT01338883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64833265|NCT01598480|Anti-Infective Agents|anti-infective agents|mesh-list
64833266|NCT01598480|Silver Sulfadiazine|silver sulfadiazine|mesh-list
64833267|NCT01598480|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64833268|NCT01598480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64833269|NCT01598493|Anti-Infective Agents|anti-infective agents|mesh-list
64833270|NCT01598493|Silver Sulfadiazine|silver sulfadiazine|mesh-list
64833271|NCT01598493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64833272|NCT01598493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64833273|NCT01598558|Rituximab|rituximab|mesh-list
64833274|NCT01598558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64833275|NCT01598558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833276|NCT01598558|Immunologic Factors|immunologic factors|mesh-ancestor
65070538|NCT00304629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65070539|NCT00304629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070540|NCT00304629|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65070542|NCT00304629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65070543|NCT00304629|Nootropic Agents|nootropic agents|mesh-ancestor
65070544|NCT00292838|Fluticasone|fluticasone|mesh-list
65070545|NCT00292838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65070546|NCT00292838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65070547|NCT00292838|Autonomic Agents|autonomic agents|mesh-ancestor
65070548|NCT00292838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65070549|NCT00292838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070550|NCT00292838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65070551|NCT00292838|Respiratory System Agents|respiratory system agents|mesh-ancestor
65070552|NCT00292838|Dermatologic Agents|dermatologic agents|mesh-ancestor
65070553|NCT00292838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65070555|NCT00304668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65070556|NCT00304668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65070557|NCT00304668|Antiviral Agents|antiviral agents|mesh-ancestor
65070558|NCT00304668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65070559|NCT00292955|Cetuximab|cetuximab|mesh-list
65070560|NCT00292955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65070561|NCT00292955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070563|NCT00293072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65070564|NCT00293072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070565|NCT00293072|Immunologic Factors|immunologic factors|mesh-ancestor
65070566|NCT00293072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070567|NCT00293072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65070568|NCT00293111|Etodolac|etodolac|mesh-list
65070569|NCT00293111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65070570|NCT00293111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65070571|NCT00293111|Analgesics|analgesics|mesh-ancestor
65070572|NCT00293111|Sensory System Agents|sensory system agents|mesh-ancestor
65070573|NCT00293111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65070574|NCT00293111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070575|NCT00293111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65070576|NCT00293111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65070577|NCT00293111|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65070578|NCT00293111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65070579|NCT00293111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070580|NCT00293111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070581|NCT00304785|Latanoprost|latanoprost|mesh-list
65070582|NCT00304785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65070583|NCT00304785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65070584|NCT00293150|Eplerenone|eplerenone|mesh-list
65070585|NCT00293150|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65070586|NCT00293150|Hormone Antagonists|hormone antagonists|mesh-ancestor
65070587|NCT00293150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65070588|NCT00293150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070589|NCT00293150|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65070590|NCT00293150|Diuretics|diuretics|mesh-ancestor
65070591|NCT00293150|Natriuretic Agents|natriuretic agents|mesh-ancestor
65070592|NCT00293150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65070593|NCT00293228|Isoniazid|isoniazid|mesh-list
65070594|NCT00293228|Antitubercular Agents|antitubercular agents|mesh-ancestor
65070595|NCT00293228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65070596|NCT00293228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65070597|NCT00293228|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65070598|NCT00293228|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65070599|NCT00293228|Antimetabolites|antimetabolites|mesh-ancestor
65070600|NCT00293228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070601|NCT00293228|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64512045|NCT04831047|Sympathomimetics|sympathomimetics|mesh-ancestor
64555889|NCT05006898|Miotics|miotics|mesh-ancestor
64324918|NCT01338883|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64324920|NCT05625919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64833277|NCT01598558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833278|NCT01598558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64833279|NCT01598584|Gemcitabine|gemcitabine|mesh-list
64833280|NCT01598584|Mirtazapine|mirtazapine|mesh-list
64833281|NCT01598584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64833282|NCT01598584|Antimetabolites|antimetabolites|mesh-ancestor
64833283|NCT01598584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833284|NCT01598584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833285|NCT01598584|Antiviral Agents|antiviral agents|mesh-ancestor
64833286|NCT01598584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64833287|NCT01598584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833288|NCT01598584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64833289|NCT01598584|Immunologic Factors|immunologic factors|mesh-ancestor
64833290|NCT01598584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833292|NCT01598584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65070602|NCT00293345|Gemcitabine|gemcitabine|mesh-list
65070603|NCT00293345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65070604|NCT00293345|Antimetabolites|antimetabolites|mesh-ancestor
65070605|NCT00293345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070606|NCT00293345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070607|NCT00293345|Antiviral Agents|antiviral agents|mesh-ancestor
65070608|NCT00293345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65070609|NCT00293345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070610|NCT00293345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65070611|NCT00293345|Immunologic Factors|immunologic factors|mesh-ancestor
65070612|NCT00293345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070613|NCT00293501|Tinzaparin|tinzaparin|mesh-list
65070614|NCT00293501|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65070615|NCT00293501|Dalteparin|dalteparin|mesh-list
65070616|NCT00293501|Anticoagulants|anticoagulants|mesh-ancestor
65070617|NCT00293501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65070618|NCT00293501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65070619|NCT00293501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070620|NCT00325455|Anacetrapib|anacetrapib|mesh-list
65070621|NCT00325455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65070622|NCT00325455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65070623|NCT00325455|Antimetabolites|antimetabolites|mesh-ancestor
65070624|NCT00325455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070625|NCT00325455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65070626|NCT00293657|Lornoxicam|lornoxicam|mesh-list
65070627|NCT00293657|Piroxicam|piroxicam|mesh-list
65070628|NCT00293657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65070629|NCT00293657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65070630|NCT00293657|Analgesics|analgesics|mesh-ancestor
65070631|NCT00293657|Sensory System Agents|sensory system agents|mesh-ancestor
64833302|NCT01598584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64833303|NCT01598584|Adrenergic Agents|adrenergic agents|mesh-ancestor
64833304|NCT01598584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64833305|NCT01598584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64833306|NCT01598584|Serotonin Agents|serotonin agents|mesh-ancestor
64833307|NCT01598584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64833308|NCT01598623|Oxytocin|oxytocin|mesh-list
64833309|NCT01598623|Oxytocics|oxytocics|mesh-ancestor
64833310|NCT01598623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64833311|NCT01598623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833312|NCT01598649|Mannitol|mannitol|mesh-list
64833313|NCT01598649|Caseins|caseins|mesh-list
64833314|NCT01598649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65070632|NCT00293657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65070633|NCT00293657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070635|NCT00293657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65070636|NCT00293657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65070637|NCT00293657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070638|NCT00293657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070639|NCT00293696|Goserelin|goserelin|mesh-list
65070640|NCT00293696|Bicalutamide|bicalutamide|mesh-list
65070641|NCT00293696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65070642|NCT00293696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070643|NCT00293696|Androgen Antagonists|androgen antagonists|mesh-ancestor
65070644|NCT00293696|Hormone Antagonists|hormone antagonists|mesh-ancestor
65070645|NCT00293696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65070646|NCT00293696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070647|NCT00293735|Labetalol|labetalol|mesh-list
65070648|NCT00293735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65070649|NCT00293735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65070650|NCT00293735|Adrenergic Agents|adrenergic agents|mesh-ancestor
65070651|NCT00293735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65070652|NCT00293735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070653|NCT00293735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070654|NCT00293735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65070655|NCT00293735|Sympathomimetics|sympathomimetics|mesh-ancestor
65070656|NCT00293735|Autonomic Agents|autonomic agents|mesh-ancestor
65070657|NCT00293735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64833324|NCT01598675|Sympathomimetics|sympathomimetics|mesh-ancestor
64833325|NCT01598675|Autonomic Agents|autonomic agents|mesh-ancestor
64833326|NCT01598675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64833327|NCT01598675|Dopamine Agents|dopamine agents|mesh-ancestor
64833328|NCT01598675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64833329|NCT01598675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833330|NCT01598675|Adrenergic Agents|adrenergic agents|mesh-ancestor
64833331|NCT01598675|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64833332|NCT01598675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64833333|NCT01598675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64391489|NCT04543643|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64391490|NCT04543643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64391491|NCT04543643|Adrenergic Agents|adrenergic agents|mesh-ancestor
64391492|NCT04543643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64391494|NCT04543643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391514|NCT05377619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64391515|NCT05377619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64391516|NCT05377619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64391517|NCT05377619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64391518|NCT03199157|Fentanyl|fentanyl|mesh-list
64391519|NCT03199157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64391520|NCT03199157|Narcotics|narcotics|mesh-ancestor
64391521|NCT03199157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65070658|NCT00293735|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65070659|NCT00293735|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65070661|NCT00304980|Artemether|artemether|mesh-list
65070662|NCT00304980|Pyrimethamine|pyrimethamine|mesh-list
65070663|NCT00304980|Sulfadoxine|sulfadoxine|mesh-list
65070664|NCT00304980|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65070665|NCT00304980|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65070666|NCT00304980|Antimalarials|antimalarials|mesh-ancestor
65070667|NCT00304980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65070668|NCT00304980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65070669|NCT00304980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65070670|NCT00304980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65070671|NCT00304980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070672|NCT00304980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070673|NCT00304980|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65070674|NCT00304980|Renal Agents|renal agents|mesh-ancestor
65070675|NCT00293891|Tacrolimus|tacrolimus|mesh-list
65070676|NCT00293891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65070677|NCT00293891|Immunologic Factors|immunologic factors|mesh-ancestor
65070678|NCT00293891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070679|NCT00293891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65070680|NCT00293891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070681|NCT00293891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070682|NCT00293930|Tacrolimus|tacrolimus|mesh-list
65070683|NCT00293930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65070684|NCT00293930|Immunologic Factors|immunologic factors|mesh-ancestor
65070685|NCT00293930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070686|NCT00293930|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65070687|NCT00293930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070688|NCT00293930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070689|NCT00305019|Clevudine|clevudine|mesh-list
65070690|NCT00305019|Antiviral Agents|antiviral agents|mesh-ancestor
65070691|NCT00305019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65070692|NCT00293969|Morphine|morphine|mesh-list
65070693|NCT00293969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65070694|NCT00293969|Narcotics|narcotics|mesh-ancestor
65070695|NCT00293969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65070696|NCT00293969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070697|NCT00293969|Analgesics|analgesics|mesh-ancestor
65070698|NCT00293969|Sensory System Agents|sensory system agents|mesh-ancestor
65070699|NCT00293969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65070700|NCT00294008|Risperidone|risperidone|mesh-list
65070701|NCT00294008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65070702|NCT00294008|Serotonin Agents|serotonin agents|mesh-ancestor
65070703|NCT00294008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64415947|NCT04894643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070704|NCT00294008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070705|NCT00294008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070707|NCT00294008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64833334|NCT01598675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64833335|NCT01598883|Heparin|heparin|mesh-list
64833336|NCT01598883|Calcium heparin|calcium heparin|mesh-list
64833337|NCT01598883|Antithrombins|antithrombins|mesh-list
64833338|NCT01598883|Anticoagulants|anticoagulants|mesh-ancestor
64833339|NCT01598883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65070708|NCT00294008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65070709|NCT00294008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65070710|NCT00294008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65070711|NCT00294008|Dopamine Agents|dopamine agents|mesh-ancestor
65070712|NCT00294086|Valsartan|valsartan|mesh-list
65070713|NCT00294086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65070714|NCT00294086|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65070715|NCT00294086|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65070716|NCT00294086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070717|NCT00325689|Risperidone|risperidone|mesh-list
65070718|NCT00325689|Aripiprazole|aripiprazole|mesh-list
65070719|NCT00325689|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65070720|NCT00325689|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65070721|NCT00325689|Serotonin Agents|serotonin agents|mesh-ancestor
65070722|NCT00325689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65070723|NCT00325689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070724|NCT00325689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070725|NCT00325689|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65070726|NCT00325689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64482668|NCT03584529|Vitamins|vitamins|mesh-ancestor
65070727|NCT00325689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65070728|NCT00325689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65070729|NCT00325689|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65070730|NCT00325689|Dopamine Agents|dopamine agents|mesh-ancestor
65070731|NCT00325689|Antidepressive Agents|antidepressive agents|mesh-ancestor
65070732|NCT00325689|Dopamine Agonists|dopamine agonists|mesh-ancestor
65070733|NCT00325689|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65070734|NCT00325689|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65070735|NCT00325689|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65070736|NCT00325689|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65070738|NCT00294164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65070739|NCT00294164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070740|NCT00417794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65070741|NCT00417794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65070742|NCT00417794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65070743|NCT00417794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65070744|NCT00417794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070745|NCT00417794|Adrenergic Agents|adrenergic agents|mesh-ancestor
65070746|NCT00417794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65070747|NCT00417794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070748|NCT00417833|Bevacizumab|bevacizumab|mesh-list
65070749|NCT00417833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65070750|NCT00417833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070751|NCT00417833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65070752|NCT00417833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65070753|NCT00417833|Growth Substances|growth substances|mesh-ancestor
65070754|NCT00417833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070755|NCT00417833|Growth Inhibitors|growth inhibitors|mesh-ancestor
65070756|NCT00417872|Metronidazole|metronidazole|mesh-list
65070757|NCT00417872|Nitazoxanide|nitazoxanide|mesh-list
65070758|NCT00417872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65070759|NCT00417872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65070760|NCT00417872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65070761|NCT00417872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65070762|NCT00294203|Epoetin Alfa|epoetin alfa|mesh-list
65070763|NCT00294203|Hematinics|hematinics|mesh-ancestor
65070764|NCT00305292|Modafinil|modafinil|mesh-list
65070765|NCT00305292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65070766|NCT00305292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070767|NCT00305292|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65070768|NCT00305292|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65070769|NCT00305292|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65070770|NCT00305292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070771|NCT00305331|Domperidone|domperidone|mesh-list
65070772|NCT00305331|Antiemetics|antiemetics|mesh-ancestor
65070773|NCT00305331|Autonomic Agents|autonomic agents|mesh-ancestor
65070774|NCT00305331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65070775|NCT00305331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070776|NCT00305331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65070777|NCT00305331|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65070778|NCT00305331|Dopamine Agents|dopamine agents|mesh-ancestor
65070779|NCT00305331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65070780|NCT00305331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070781|NCT00325767|Albuterol|albuterol|mesh-list
65070782|NCT00325767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65070783|NCT00325767|Autonomic Agents|autonomic agents|mesh-ancestor
65070784|NCT00325767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65070785|NCT00325767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070786|NCT00325767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65070787|NCT00325767|Respiratory System Agents|respiratory system agents|mesh-ancestor
65070788|NCT00325767|Tocolytic Agents|tocolytic agents|mesh-ancestor
65070789|NCT00325767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65070790|NCT00325767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65070791|NCT00325767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65070792|NCT00325767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65070793|NCT00325767|Adrenergic Agents|adrenergic agents|mesh-ancestor
65070794|NCT00325767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65070795|NCT00325767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070796|NCT00294359|Bevacizumab|bevacizumab|mesh-list
65070797|NCT00294359|Capecitabine|capecitabine|mesh-list
65070798|NCT00294359|Mitomycins|mitomycins|mesh-list
65070799|NCT00294359|Mitomycin|mitomycin|mesh-list
65070800|NCT00294359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65070801|NCT00294359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070802|NCT00294359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65070803|NCT00294359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65070804|NCT00294359|Growth Substances|growth substances|mesh-ancestor
65070805|NCT00294359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070806|NCT00294359|Growth Inhibitors|growth inhibitors|mesh-ancestor
65070807|NCT00294359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65070808|NCT00294359|Antimetabolites|antimetabolites|mesh-ancestor
64391824|NCT01668719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64391825|NCT01668719|Immunologic Factors|immunologic factors|mesh-ancestor
64391826|NCT01668719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64391827|NCT01668719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64391828|NCT01668719|Growth Substances|growth substances|mesh-ancestor
64391829|NCT01668719|Growth Inhibitors|growth inhibitors|mesh-ancestor
64391830|NCT01668719|Protease Inhibitors|protease inhibitors|mesh-ancestor
64391831|NCT01668719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391857|NCT04254731|Narcotics|narcotics|mesh-ancestor
64391858|NCT04254731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64391859|NCT04254731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391860|NCT04254731|Analgesics|analgesics|mesh-ancestor
64391861|NCT04254731|Sensory System Agents|sensory system agents|mesh-ancestor
65070809|NCT00294359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070810|NCT00294359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65070811|NCT00294359|Alkylating Agents|alkylating agents|mesh-ancestor
65070812|NCT00294359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65070813|NCT00294359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070814|NCT00294437|Zoledronic Acid|zoledronic acid|mesh-list
65070815|NCT00294437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65070816|NCT00294437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070817|NCT00305370|Aripiprazole|aripiprazole|mesh-list
65070818|NCT00305370|Antidepressive Agents|antidepressive agents|mesh-ancestor
65070819|NCT00305370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65070820|NCT00305370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65070821|NCT00305370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65070822|NCT00305370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65070823|NCT00305370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070824|NCT00305370|Dopamine Agonists|dopamine agonists|mesh-ancestor
65070825|NCT00305370|Dopamine Agents|dopamine agents|mesh-ancestor
65070826|NCT00305370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65070827|NCT00305370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070828|NCT00305370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65070829|NCT00305370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65070830|NCT00305370|Serotonin Agents|serotonin agents|mesh-ancestor
65070831|NCT00305370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65070832|NCT00305370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65070833|NCT00305370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65070834|NCT00305370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65070835|NCT00325806|Ramipril|ramipril|mesh-list
65070836|NCT00325806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65070837|NCT00325806|Protease Inhibitors|protease inhibitors|mesh-ancestor
65070838|NCT00325806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070839|NCT00325806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070840|NCT00325806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65070841|NCT00305409|Sulfalene|sulfalene|mesh-list
65070842|NCT00305409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65070843|NCT00305409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65070844|NCT00305409|Renal Agents|renal agents|mesh-ancestor
65070845|NCT00305409|Antimalarials|antimalarials|mesh-ancestor
65070846|NCT00305409|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65070847|NCT00305409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65070849|NCT00294593|Folic Acid|folic acid|mesh-list
65070850|NCT00294593|Levoleucovorin|levoleucovorin|mesh-list
65070851|NCT00294593|Antidotes|antidotes|mesh-ancestor
65070852|NCT00294593|Protective Agents|protective agents|mesh-ancestor
65070853|NCT00294593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070854|NCT00294593|Vitamin B Complex|vitamin b complex|mesh-ancestor
65070855|NCT00294593|Vitamins|vitamins|mesh-ancestor
65070856|NCT00294593|Micronutrients|micronutrients|mesh-ancestor
65070857|NCT00294593|Hematinics|hematinics|mesh-ancestor
65070858|NCT00325845|Hylan|hylan|mesh-list
65070859|NCT00325845|Viscosupplements|viscosupplements|mesh-ancestor
65070860|NCT00325845|Protective Agents|protective agents|mesh-ancestor
64324923|NCT05625919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070861|NCT00325845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070862|NCT00294749|Ciprofloxacin|ciprofloxacin|mesh-list
65070863|NCT00294749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65070864|NCT00294749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65070865|NCT00294749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65070866|NCT00294749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65070867|NCT00294749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070868|NCT00294749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070869|NCT00294749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070870|NCT00294749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65070871|NCT00294749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65070872|NCT00325962|Verapamil|verapamil|mesh-list
65070873|NCT00325962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65070874|NCT00325962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65070875|NCT00325962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65070876|NCT00325962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070877|NCT00325962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65070878|NCT00325962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070879|NCT00325962|Vasodilator Agents|vasodilator agents|mesh-ancestor
65070880|NCT00305487|Ciclesonide|ciclesonide|mesh-list
65070881|NCT00305487|Glucocorticoids|glucocorticoids|mesh-ancestor
65070882|NCT00305487|Hormones|hormones|mesh-ancestor
65070883|NCT00305487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65070884|NCT00305487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070885|NCT00305487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65070886|NCT00294944|Idazoxan|idazoxan|mesh-list
65070887|NCT00294944|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65070888|NCT00294944|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65070889|NCT00294944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65070890|NCT00294944|Adrenergic Agents|adrenergic agents|mesh-ancestor
65070891|NCT00294944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65070892|NCT00294944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324931|NCT02682927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65070893|NCT00294944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070894|NCT00326157|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65070895|NCT00326157|Antifungal Agents|antifungal agents|mesh-ancestor
65070896|NCT00326157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65070897|NCT00326157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65070898|NCT00326157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65070899|NCT00295100|Tamoxifen|tamoxifen|mesh-list
65070900|NCT00295100|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65070901|NCT00295100|Hormone Antagonists|hormone antagonists|mesh-ancestor
64482719|NCT01609231|Irinotecan|irinotecan|mesh-list
65070902|NCT00295100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65070903|NCT00295100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070904|NCT00295100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65070905|NCT00295100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070906|NCT00295100|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65070907|NCT00295100|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65070908|NCT00295100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65070909|NCT00326235|Buspirone|buspirone|mesh-list
65070910|NCT00326235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65070911|NCT00326235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65070912|NCT00326235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65070913|NCT00326235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070914|NCT00326235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65070915|NCT00326235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65070916|NCT00326235|Serotonin Agents|serotonin agents|mesh-ancestor
65070917|NCT00326235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65070918|NCT00326235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070919|NCT00295178|Vancomycin|vancomycin|mesh-list
65070921|NCT00295178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65070922|NCT00295178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65070923|NCT00305838|Tamoxifen|tamoxifen|mesh-list
65070924|NCT00305838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65070925|NCT00305838|Hormone Antagonists|hormone antagonists|mesh-ancestor
65070926|NCT00305838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65070927|NCT00305838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070928|NCT00305838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65070929|NCT00305838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65070930|NCT00305838|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65070931|NCT00305838|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65070932|NCT00305838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65070933|NCT00295373|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65070934|NCT00295373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64324941|NCT02266537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64324942|NCT02266537|Adrenergic Agents|adrenergic agents|mesh-ancestor
64324943|NCT02266537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64324944|NCT02266537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324945|NCT02266537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392162|NCT01987102|Calcium|calcium|mesh-list
65070935|NCT00295373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65070936|NCT00295373|Antimetabolites|antimetabolites|mesh-ancestor
65070937|NCT00295373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070938|NCT00295373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65070939|NCT00295373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65070940|NCT00295373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070941|NCT00295412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65070942|NCT00295412|Antidepressive Agents|antidepressive agents|mesh-ancestor
65070943|NCT00295412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65070944|NCT00295412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65070945|NCT00295412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65070946|NCT00295412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65070947|NCT00295412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070948|NCT00326352|Remifentanil|remifentanil|mesh-list
65070949|NCT00326352|Propofol|propofol|mesh-list
65070950|NCT00326352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65070951|NCT00326352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65070952|NCT00326352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070953|NCT00326352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65070954|NCT00326352|Anesthetics, General|anesthetics, general|mesh-ancestor
65070955|NCT00326352|Anesthetics|anesthetics|mesh-ancestor
65070956|NCT00326352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65070957|NCT00326352|Narcotics|narcotics|mesh-ancestor
65070958|NCT00326352|Analgesics|analgesics|mesh-ancestor
65070959|NCT00326352|Sensory System Agents|sensory system agents|mesh-ancestor
65070960|NCT00326352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65070961|NCT00419601|Fentanyl|fentanyl|mesh-list
65070962|NCT00419601|Remifentanil|remifentanil|mesh-list
65070963|NCT00419601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65070964|NCT00419601|Narcotics|narcotics|mesh-ancestor
65070965|NCT00419601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65070966|NCT00419601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070967|NCT00419601|Analgesics|analgesics|mesh-ancestor
65070968|NCT00419601|Sensory System Agents|sensory system agents|mesh-ancestor
65070969|NCT00419601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65070970|NCT00419601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65070971|NCT00419601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65070972|NCT00419601|Anesthetics, General|anesthetics, general|mesh-ancestor
65070973|NCT00419601|Anesthetics|anesthetics|mesh-ancestor
65070974|NCT00306033|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65070975|NCT00306033|gamma-Globulins|gamma-globulins|mesh-list
65070976|NCT00306033|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65070977|NCT00306033|Immunoglobulins|immunoglobulins|mesh-list
65070978|NCT00306033|Immunologic Factors|immunologic factors|mesh-ancestor
65070979|NCT00306033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070980|NCT00295607|Antibodies|antibodies|mesh-list
65070981|NCT00295607|Tacrolimus|tacrolimus|mesh-list
65070982|NCT00295607|Immunologic Factors|immunologic factors|mesh-ancestor
65070983|NCT00295607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070984|NCT00295607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65070985|NCT00295607|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65070986|NCT00295607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65070987|NCT00295607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070988|NCT00326391|Methylphenidate|methylphenidate|mesh-list
65070989|NCT00326391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65070990|NCT00326391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65070991|NCT00326391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65070992|NCT00326391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65070993|NCT00326391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65070994|NCT00326391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070995|NCT00326391|Dopamine Agents|dopamine agents|mesh-ancestor
65070996|NCT00326391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65070997|NCT00295685|Antacids|antacids|mesh-list
65070998|NCT00295685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65070999|NCT00295685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65071000|NCT00306150|Aprotinin|aprotinin|mesh-list
65071001|NCT00306150|Hemostatics|hemostatics|mesh-ancestor
65071002|NCT00306150|Coagulants|coagulants|mesh-ancestor
65071003|NCT00306150|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65071004|NCT00306150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65071005|NCT00306150|Protease Inhibitors|protease inhibitors|mesh-ancestor
65071006|NCT00306150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071007|NCT00306150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071008|NCT00417911|Bortezomib|bortezomib|mesh-list
65071009|NCT00417911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071010|NCT00326469|Lanreotide|lanreotide|mesh-list
65071011|NCT00326469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071012|NCT00417950|Acarbose|acarbose|mesh-list
65071013|NCT00417950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65071014|NCT00417950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071015|NCT00417950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071016|NCT00417950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65071017|NCT00417950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071018|NCT00306267|Epoetin Alfa|epoetin alfa|mesh-list
65071019|NCT00306267|Hematinics|hematinics|mesh-ancestor
65071020|NCT00326508|Daclizumab|daclizumab|mesh-list
65071021|NCT00326508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65071022|NCT00326508|Immunologic Factors|immunologic factors|mesh-ancestor
65071023|NCT00326508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071024|NCT00326586|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
65071025|NCT00326586|Androgen Antagonists|androgen antagonists|mesh-ancestor
65071026|NCT00326586|Hormone Antagonists|hormone antagonists|mesh-ancestor
65071027|NCT00326586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65071028|NCT00326586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071029|NCT00295841|Cytarabine|cytarabine|mesh-list
65071030|NCT00295841|Clofarabine|clofarabine|mesh-list
65071031|NCT00295841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65071032|NCT00295841|Antimetabolites|antimetabolites|mesh-ancestor
65071033|NCT00295841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071034|NCT00295841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071035|NCT00295841|Antiviral Agents|antiviral agents|mesh-ancestor
65071036|NCT00295841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071037|NCT00295841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65071038|NCT00295841|Immunologic Factors|immunologic factors|mesh-ancestor
65071039|NCT00295841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071040|NCT00326664|Cediranib|cediranib|mesh-list
65071041|NCT00326664|Maleic acid|maleic acid|mesh-list
65071042|NCT00326664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071043|NCT00326664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071044|NCT00326664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071045|NCT00326664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65071046|NCT00295919|Ketoconazole|ketoconazole|mesh-list
65071047|NCT00295919|Fenretinide|fenretinide|mesh-list
64392503|NCT02409199|Docetaxel|docetaxel|mesh-list
65071048|NCT00295919|Antifungal Agents|antifungal agents|mesh-ancestor
65071049|NCT00295919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071050|NCT00295919|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65071051|NCT00295919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65071052|NCT00295919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071053|NCT00295919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071054|NCT00295919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65071055|NCT00295919|Hormone Antagonists|hormone antagonists|mesh-ancestor
65071056|NCT00295919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65071057|NCT00295919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071058|NCT00295919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65071059|NCT00295919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071060|NCT00295919|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65071061|NCT00295919|Protective Agents|protective agents|mesh-ancestor
65071063|NCT00295958|Immunotoxins|immunotoxins|mesh-list
65071064|NCT00295958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65071065|NCT00295958|Immunologic Factors|immunologic factors|mesh-ancestor
65071066|NCT00295958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071067|NCT00295997|Mycophenolic Acid|mycophenolic acid|mesh-list
65071068|NCT00295997|Cyclophosphamide|cyclophosphamide|mesh-list
65071069|NCT00295997|Busulfan|busulfan|mesh-list
65071070|NCT00295997|Methotrexate|methotrexate|mesh-list
65071071|NCT00295997|Fludarabine|fludarabine|mesh-list
65071072|NCT00295997|Fludarabine phosphate|fludarabine phosphate|mesh-list
65071073|NCT00295997|Tacrolimus|tacrolimus|mesh-list
65071074|NCT00295997|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65071075|NCT00295997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65071076|NCT00295997|Immunologic Factors|immunologic factors|mesh-ancestor
65071077|NCT00295997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071078|NCT00295997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65071079|NCT00295997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65071080|NCT00295997|Alkylating Agents|alkylating agents|mesh-ancestor
65071081|NCT00295997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071082|NCT00295997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071083|NCT00295997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65071084|NCT00295997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65071085|NCT00295997|Abortifacient Agents|abortifacient agents|mesh-ancestor
65071086|NCT00295997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65071087|NCT00295997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65071088|NCT00295997|Antimetabolites|antimetabolites|mesh-ancestor
65071089|NCT00295997|Dermatologic Agents|dermatologic agents|mesh-ancestor
64833353|NCT01599000|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64833354|NCT01599000|Antimalarials|antimalarials|mesh-ancestor
65071090|NCT00295997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071091|NCT00295997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65071092|NCT00295997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65071093|NCT00295997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65071094|NCT00295997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65071095|NCT00295997|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65071096|NCT00295997|Antitubercular Agents|antitubercular agents|mesh-ancestor
65071097|NCT00295997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65071098|NCT00295997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071099|NCT00418067|Sirolimus|sirolimus|mesh-list
65071100|NCT00418067|Paclitaxel|paclitaxel|mesh-list
65071101|NCT00418067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65071102|NCT00418067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071103|NCT00418067|Tubulin Modulators|tubulin modulators|mesh-ancestor
65071104|NCT00418067|Antimitotic Agents|antimitotic agents|mesh-ancestor
65071105|NCT00418067|Mitosis Modulators|mitosis modulators|mesh-ancestor
65071106|NCT00418067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071107|NCT00418067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65071108|NCT00418067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071109|NCT00418067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65071110|NCT00418067|Antifungal Agents|antifungal agents|mesh-ancestor
65071111|NCT00418067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65071112|NCT00418067|Immunologic Factors|immunologic factors|mesh-ancestor
65071113|NCT00418067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071114|NCT00296309|Tacrolimus|tacrolimus|mesh-list
65071115|NCT00296309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65071116|NCT00296309|Immunologic Factors|immunologic factors|mesh-ancestor
65071117|NCT00296309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071118|NCT00296309|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65071119|NCT00296309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071120|NCT00296309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071121|NCT00296348|Mycophenolic Acid|mycophenolic acid|mesh-list
65071122|NCT00296348|Tacrolimus|tacrolimus|mesh-list
65071123|NCT00296348|Daclizumab|daclizumab|mesh-list
65071124|NCT00296348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64556395|NCT04148963|Loxapine|loxapine|mesh-list
65071125|NCT00296348|Immunologic Factors|immunologic factors|mesh-ancestor
65071126|NCT00296348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071127|NCT00296348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65071128|NCT00296348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071129|NCT00296348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071130|NCT00296348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65071131|NCT00296348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071132|NCT00296348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65071133|NCT00296348|Antitubercular Agents|antitubercular agents|mesh-ancestor
65071134|NCT00296348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65071135|NCT00296348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071136|NCT00296387|Atorvastatin|atorvastatin|mesh-list
65071137|NCT00296387|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65071138|NCT00296387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65071139|NCT00296387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65071140|NCT00296387|Antimetabolites|antimetabolites|mesh-ancestor
65071141|NCT00296387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071142|NCT00296387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65071143|NCT00296387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65071144|NCT00296387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071145|NCT00326820|Zoledronic Acid|zoledronic acid|mesh-list
65071146|NCT00326820|Ibandronic Acid|ibandronic acid|mesh-list
65071147|NCT00326820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65071148|NCT00326820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071149|NCT00296465|Citric Acid|citric acid|mesh-list
65071150|NCT00296465|Sodium Citrate|sodium citrate|mesh-list
65071151|NCT00296465|Clomiphene|clomiphene|mesh-list
65071152|NCT00296465|Enclomiphene|enclomiphene|mesh-list
64392731|NCT05100329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64392736|NCT04530539|Melatonin|melatonin|mesh-list
65071153|NCT00296465|Zuclomiphene|zuclomiphene|mesh-list
65071154|NCT00296465|Hormones|hormones|mesh-list
65071155|NCT00296465|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
65071156|NCT00296465|Anticoagulants|anticoagulants|mesh-ancestor
65071157|NCT00296465|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65071158|NCT00296465|Chelating Agents|chelating agents|mesh-ancestor
65071159|NCT00296465|Sequestering Agents|sequestering agents|mesh-ancestor
65071160|NCT00296465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071161|NCT00296465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65071162|NCT00296465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071163|NCT00296465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65071164|NCT00296465|Hormone Antagonists|hormone antagonists|mesh-ancestor
65071165|NCT00296465|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65071166|NCT00296465|Fertility Agents|fertility agents|mesh-ancestor
65071167|NCT00296465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65071168|NCT00296465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65071169|NCT00296465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65071170|NCT00326859|Remifentanil|remifentanil|mesh-list
65071171|NCT00326859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65071172|NCT00326859|Narcotics|narcotics|mesh-ancestor
65071173|NCT00326859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65071174|NCT00326859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071175|NCT00326859|Analgesics|analgesics|mesh-ancestor
65071176|NCT00326859|Sensory System Agents|sensory system agents|mesh-ancestor
65071177|NCT00326859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65071178|NCT00296699|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65071179|NCT00296699|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65071180|NCT00296699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65071181|NCT00296699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65071182|NCT00296699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071183|NCT00296699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65071184|NCT00296699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071185|NCT00296699|Analgesics|analgesics|mesh-ancestor
65071186|NCT00296699|Sensory System Agents|sensory system agents|mesh-ancestor
65071187|NCT00296699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64324948|NCT02269735|Insulin|insulin|mesh-list
64324949|NCT02269735|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64324950|NCT02269735|Insulin Aspart|insulin aspart|mesh-list
64392897|NCT05106179|Autonomic Agents|autonomic agents|mesh-ancestor
64392898|NCT05106179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392899|NCT05106179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64392901|NCT04670471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64392902|NCT04670471|Narcotics|narcotics|mesh-ancestor
65071188|NCT00296699|Antidepressive Agents|antidepressive agents|mesh-ancestor
65071189|NCT00296699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65071190|NCT00296699|Dopamine Agents|dopamine agents|mesh-ancestor
65071191|NCT04717089|Anesthetics|anesthetics|mesh-list
65071192|NCT04717089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65071193|NCT04717089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071194|NCT00296777|Citalopram|citalopram|mesh-list
65071195|NCT00296777|Bupropion|bupropion|mesh-list
65071196|NCT00296777|Imipramine|imipramine|mesh-list
65071197|NCT00296777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65071198|NCT00296777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65071199|NCT00296777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65071200|NCT00296777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071201|NCT00296777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65071202|NCT00296777|Serotonin Agents|serotonin agents|mesh-ancestor
65071203|NCT00296777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071204|NCT00296777|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65071205|NCT00296777|Antidepressive Agents|antidepressive agents|mesh-ancestor
65071206|NCT00296777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65071207|NCT00296777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65071208|NCT00296777|Dopamine Agents|dopamine agents|mesh-ancestor
64415960|NCT05506865|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65071209|NCT00296777|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65071210|NCT00296777|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65071211|NCT00296777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071212|NCT00296777|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65071213|NCT00296777|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65071214|NCT00296777|Adrenergic Agents|adrenergic agents|mesh-ancestor
65071215|NCT00296894|Adalimumab|adalimumab|mesh-list
65071216|NCT00296894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65071217|NCT00296894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65071218|NCT00296933|Citalopram|citalopram|mesh-list
65071219|NCT00296933|Bupropion|bupropion|mesh-list
65071220|NCT00296933|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65071221|NCT00296933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65071222|NCT00296933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65071223|NCT00296933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071224|NCT00296933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65071225|NCT00296933|Serotonin Agents|serotonin agents|mesh-ancestor
65071226|NCT00296933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071227|NCT00296933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65071228|NCT00296933|Antidepressive Agents|antidepressive agents|mesh-ancestor
65071229|NCT00296933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64324951|NCT02269735|MK-2640|mk-2640|mesh-list
64324952|NCT02269735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65071230|NCT00296933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65071231|NCT00296933|Dopamine Agents|dopamine agents|mesh-ancestor
65071232|NCT00296933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65071233|NCT00296933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65071234|NCT00296933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071235|NCT00296972|Interferons|interferons|mesh-list
65071236|NCT00296972|Ribavirin|ribavirin|mesh-list
65071237|NCT00296972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071238|NCT00296972|Antiviral Agents|antiviral agents|mesh-ancestor
65071239|NCT00296972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071240|NCT00296972|Antimetabolites|antimetabolites|mesh-ancestor
65071241|NCT00296972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071242|NCT00297011|Valacyclovir|valacyclovir|mesh-list
65071243|NCT00297011|Clobetasol|clobetasol|mesh-list
65071244|NCT00297011|Antiviral Agents|antiviral agents|mesh-ancestor
65071245|NCT00297011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071246|NCT00297011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65071247|NCT00297011|Glucocorticoids|glucocorticoids|mesh-ancestor
65071248|NCT00297011|Hormones|hormones|mesh-ancestor
65071249|NCT00297011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65071250|NCT00297011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071251|NCT00327093|Bevacizumab|bevacizumab|mesh-list
65071252|NCT00327093|Cetuximab|cetuximab|mesh-list
65071253|NCT00327093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65071254|NCT00327093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071255|NCT00327093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65071256|NCT00327093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65071257|NCT00327093|Growth Substances|growth substances|mesh-ancestor
65071258|NCT00327093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071259|NCT00327093|Growth Inhibitors|growth inhibitors|mesh-ancestor
65071260|NCT00297050|Peramivir|peramivir|mesh-list
65071261|NCT00297050|Antiviral Agents|antiviral agents|mesh-ancestor
65071262|NCT00297050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071263|NCT00297050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071264|NCT00297050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071265|NCT00297128|Capecitabine|capecitabine|mesh-list
65071266|NCT00297128|Cetuximab|cetuximab|mesh-list
65071267|NCT00297128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65071268|NCT00297128|Antimetabolites|antimetabolites|mesh-ancestor
65071269|NCT00297128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071270|NCT00297128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071271|NCT00297128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65071272|NCT00327132|Amoxicillin|amoxicillin|mesh-list
65071273|NCT00327132|Clarithromycin|clarithromycin|mesh-list
65071275|NCT00327132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65071276|NCT00327132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071277|NCT00327132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65071278|NCT00327132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65071279|NCT00327132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65071280|NCT00327132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071281|NCT00327132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071282|NCT00327132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64393145|NCT05110469|Analgesics|analgesics|mesh-ancestor
64393146|NCT05110469|Sensory System Agents|sensory system agents|mesh-ancestor
64393147|NCT05110469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393148|NCT05110469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393149|NCT05110469|Anesthetics|anesthetics|mesh-ancestor
64393150|NCT05110469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64393151|NCT05110469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64393152|NCT05110469|Anticonvulsants|anticonvulsants|mesh-ancestor
64393153|NCT05110469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64393154|NCT05110469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64393157|NCT05110469|Tocolytic Agents|tocolytic agents|mesh-ancestor
65071283|NCT00327132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65071284|NCT00327132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65071285|NCT00297206|Valacyclovir|valacyclovir|mesh-list
65071286|NCT00297206|Antiviral Agents|antiviral agents|mesh-ancestor
65071287|NCT00297206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071288|NCT04485195|Procainamide|procainamide|mesh-list
65071289|NCT04485195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65071290|NCT04485195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65071291|NCT04485195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65071292|NCT04485195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65071293|NCT04485195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071294|NCT04478019|Povidone-Iodine|povidone-iodine|mesh-list
65071295|NCT04478019|Povidone|povidone|mesh-list
65071296|NCT04478019|Plasma Substitutes|plasma substitutes|mesh-ancestor
65071297|NCT04478019|Blood Substitutes|blood substitutes|mesh-ancestor
65071298|NCT04478019|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65071299|NCT04478019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071300|NCT00297284|Modafinil|modafinil|mesh-list
65071301|NCT00297284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65071302|NCT00297284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071303|NCT00297284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65071304|NCT00297284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65071305|NCT00297284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65071306|NCT00297284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071307|NCT04392531|Cyclosporine|cyclosporine|mesh-list
65071308|NCT04392531|Cyclosporins|cyclosporins|mesh-list
65071309|NCT04392531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071310|NCT04392531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071311|NCT04392531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65071312|NCT04392531|Immunologic Factors|immunologic factors|mesh-ancestor
65071313|NCT04392531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071314|NCT04392531|Antifungal Agents|antifungal agents|mesh-ancestor
65071315|NCT04392531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071316|NCT04392531|Dermatologic Agents|dermatologic agents|mesh-ancestor
64833358|NCT01599013|Gemcitabine|gemcitabine|mesh-list
64833359|NCT01599013|Carboplatin|carboplatin|mesh-list
65071317|NCT04392531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65071318|NCT04392531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65071319|NCT00297323|Topiramate|topiramate|mesh-list
65071320|NCT00297323|Anticonvulsants|anticonvulsants|mesh-ancestor
65071321|NCT00297323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65071322|NCT00297323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071323|NCT00327288|Docetaxel|docetaxel|mesh-list
65071324|NCT00327288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071325|NCT00327288|Tubulin Modulators|tubulin modulators|mesh-ancestor
65071326|NCT00327288|Antimitotic Agents|antimitotic agents|mesh-ancestor
65071327|NCT00327288|Mitosis Modulators|mitosis modulators|mesh-ancestor
65071328|NCT00327288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071329|NCT00327327|Gemcitabine|gemcitabine|mesh-list
65071330|NCT00327327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65071331|NCT00327327|Antimetabolites|antimetabolites|mesh-ancestor
65071332|NCT00327327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071333|NCT00327327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071334|NCT00327327|Antiviral Agents|antiviral agents|mesh-ancestor
65071335|NCT00327327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071336|NCT00327327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071337|NCT00327327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65071338|NCT00327327|Immunologic Factors|immunologic factors|mesh-ancestor
65071339|NCT00327327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071340|NCT00297362|Galantamine|galantamine|mesh-list
65071341|NCT00297362|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65071342|NCT00297362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071343|NCT00297362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071344|NCT00297362|Cholinergic Agents|cholinergic agents|mesh-ancestor
65071345|NCT00297362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65071346|NCT00297362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071347|NCT00297362|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64833368|NCT01599013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64601897|NCT00809809|Zinc|zinc|mesh-list
64833369|NCT01599013|Immunologic Factors|immunologic factors|mesh-ancestor
64833370|NCT01599013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833371|NCT01599013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65071348|NCT00297362|Autonomic Agents|autonomic agents|mesh-ancestor
65071349|NCT00297362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65071350|NCT00297362|Nootropic Agents|nootropic agents|mesh-ancestor
65071351|NCT04231773|Nitric Oxide|nitric oxide|mesh-list
64415966|NCT05506319|Norepinephrine|norepinephrine|mesh-list
65071353|NCT04231773|Autonomic Agents|autonomic agents|mesh-ancestor
65071354|NCT04231773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65071355|NCT04231773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071356|NCT04231773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65071357|NCT04231773|Respiratory System Agents|respiratory system agents|mesh-ancestor
65071358|NCT04231773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65071359|NCT04231773|Antioxidants|antioxidants|mesh-ancestor
65071360|NCT04231773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071361|NCT04231773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65071362|NCT04231773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65071363|NCT04231773|Vasodilator Agents|vasodilator agents|mesh-ancestor
65071364|NCT04231773|Gasotransmitters|gasotransmitters|mesh-ancestor
65071365|NCT04231773|Protective Agents|protective agents|mesh-ancestor
65071366|NCT00297674|Clarithromycin|clarithromycin|mesh-list
65071367|NCT00297674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65071368|NCT00297674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071369|NCT00297674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65071370|NCT00297674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071371|NCT00297674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071372|NCT00297674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65071373|NCT00297674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65071374|NCT00297752|Silver Sulfadiazine|silver sulfadiazine|mesh-list
65071375|NCT00297752|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65071376|NCT00297752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64393396|NCT04765787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64393398|NCT04765787|Parasympatholytics|parasympatholytics|mesh-ancestor
64393399|NCT04765787|Autonomic Agents|autonomic agents|mesh-ancestor
64393400|NCT04765787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64393401|NCT04765787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64393402|NCT04765787|Cholinergic Agents|cholinergic agents|mesh-ancestor
64393403|NCT04765787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64393404|NCT04765787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393405|NCT04765787|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
64393406|NCT04765787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64393407|NCT04765787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393408|NCT02944799|Vitamin D|vitamin d|mesh-list
64393409|NCT02944799|Alendronate|alendronate|mesh-list
64393410|NCT02944799|Calcium|calcium|mesh-list
64393411|NCT02944799|Vitamins|vitamins|mesh-ancestor
64393412|NCT02944799|Micronutrients|micronutrients|mesh-ancestor
64393413|NCT02944799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393433|NCT04305899|Dermatologic Agents|dermatologic agents|mesh-ancestor
64393434|NCT04305899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64393435|NCT04305899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071377|NCT00297947|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65071378|NCT00297947|Antidepressive Agents|antidepressive agents|mesh-ancestor
65071379|NCT00297947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65071380|NCT00297947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65071381|NCT00297947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65071382|NCT00297947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65071383|NCT00297947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071384|NCT04718714|Midazolam|midazolam|mesh-list
65071385|NCT04718714|Dexmedetomidine|dexmedetomidine|mesh-list
65071386|NCT04718714|Propofol|propofol|mesh-list
65071387|NCT04718714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65071388|NCT04718714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65071389|NCT04718714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071390|NCT04718714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65071391|NCT04718714|Anesthetics, General|anesthetics, general|mesh-ancestor
65071392|NCT04718714|Anesthetics|anesthetics|mesh-ancestor
65071393|NCT04718714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65071394|NCT04718714|Analgesics|analgesics|mesh-ancestor
65071395|NCT04718714|Sensory System Agents|sensory system agents|mesh-ancestor
65071396|NCT04718714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65071397|NCT04718714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65071398|NCT04718714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65071399|NCT04718714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65071400|NCT04718714|Adrenergic Agents|adrenergic agents|mesh-ancestor
65071401|NCT04718714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65071402|NCT04718714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071403|NCT04718714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65071404|NCT04718714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65071405|NCT04718714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65071406|NCT04718714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65071407|NCT04718714|GABA Modulators|gaba modulators|mesh-ancestor
65071408|NCT04718714|GABA Agents|gaba agents|mesh-ancestor
65071409|NCT00298025|Cetrorelix|cetrorelix|mesh-list
65071410|NCT00298025|Menotropins|menotropins|mesh-list
64393464|NCT03169985|Ezetimibe|ezetimibe|mesh-list
64393465|NCT03169985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64393466|NCT03169985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64393467|NCT03169985|Antimetabolites|antimetabolites|mesh-ancestor
64393482|NCT01986010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393483|NCT01986010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64393484|NCT02700841|Melphalan|melphalan|mesh-list
64393485|NCT02700841|Mechlorethamine|mechlorethamine|mesh-list
65071411|NCT00298025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65071412|NCT00298025|Hormones|hormones|mesh-list
65071413|NCT00298025|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65071414|NCT00298025|Ganirelix|ganirelix|mesh-list
65071415|NCT00298025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65071416|NCT00298025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071417|NCT00298025|Hormone Antagonists|hormone antagonists|mesh-ancestor
65071418|NCT00298025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65071419|NCT00298025|Fertility Agents|fertility agents|mesh-ancestor
65071420|NCT00298025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65071421|NCT00298181|polysaccharide-K|polysaccharide-k|mesh-list
65071422|NCT00298181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65071423|NCT00298181|Immunologic Factors|immunologic factors|mesh-ancestor
65071424|NCT00298181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071425|NCT00298181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65071426|NCT00298181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071427|NCT00298181|Antiviral Agents|antiviral agents|mesh-ancestor
65071428|NCT00298181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071429|NCT00298181|Interferon Inducers|interferon inducers|mesh-ancestor
65071430|NCT00298181|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65071431|NCT00298181|Protective Agents|protective agents|mesh-ancestor
65071432|NCT05458089|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65071433|NCT05458089|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65071434|NCT05458089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071435|NCT03754140|Polidocanol|polidocanol|mesh-list
65071436|NCT03754140|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65071437|NCT03754140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65071438|NCT00298415|Gemcitabine|gemcitabine|mesh-list
65071439|NCT00298415|Paclitaxel|paclitaxel|mesh-list
65071440|NCT00298415|Vinorelbine|vinorelbine|mesh-list
65071441|NCT00298415|Carboplatin|carboplatin|mesh-list
65071442|NCT00298415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65071443|NCT00298415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65071444|NCT00298415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071445|NCT00298415|Tubulin Modulators|tubulin modulators|mesh-ancestor
65071446|NCT00298415|Antimitotic Agents|antimitotic agents|mesh-ancestor
65071447|NCT00298415|Mitosis Modulators|mitosis modulators|mesh-ancestor
65071448|NCT00298415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071449|NCT00298415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65071450|NCT00298415|Antimetabolites|antimetabolites|mesh-ancestor
64324957|NCT01038739|Mesalamine|mesalamine|mesh-list
64833375|NCT01599078|Paclitaxel|paclitaxel|mesh-list
64833376|NCT01599078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64833377|NCT01599078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071451|NCT00298415|Antiviral Agents|antiviral agents|mesh-ancestor
65071452|NCT00298415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071453|NCT00298415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071454|NCT00298415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65071455|NCT00298415|Immunologic Factors|immunologic factors|mesh-ancestor
65071456|NCT00298415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071457|NCT00298415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65071458|NCT00298454|Furosemide|furosemide|mesh-list
65071459|NCT00298454|Diuretics|diuretics|mesh-ancestor
65071460|NCT00298454|Natriuretic Agents|natriuretic agents|mesh-ancestor
64482757|NCT01984229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071461|NCT00298454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071462|NCT00298454|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65071463|NCT00298454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65071464|NCT00298454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071465|NCT00298571|Epinephrine|epinephrine|mesh-list
65071466|NCT00298571|Bupivacaine|bupivacaine|mesh-list
65071467|NCT00298571|Anesthetics, Local|anesthetics, local|mesh-ancestor
65071468|NCT00298571|Anesthetics|anesthetics|mesh-ancestor
65071469|NCT00298571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65071470|NCT00298571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071471|NCT00298571|Sensory System Agents|sensory system agents|mesh-ancestor
65071472|NCT00298571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65071473|NCT00298571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65071474|NCT00298571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65071475|NCT00298571|Adrenergic Agents|adrenergic agents|mesh-ancestor
65071476|NCT00298571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65071477|NCT00298571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071478|NCT00298571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65071479|NCT00298571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65071480|NCT00298571|Autonomic Agents|autonomic agents|mesh-ancestor
65071481|NCT00298571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65071482|NCT00298571|Respiratory System Agents|respiratory system agents|mesh-ancestor
65071483|NCT00298571|Mydriatics|mydriatics|mesh-ancestor
65071484|NCT00298571|Sympathomimetics|sympathomimetics|mesh-ancestor
65071485|NCT00298571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65071486|NCT00298688|Gefitinib|gefitinib|mesh-list
65071487|NCT00298688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071488|NCT00298688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65071489|NCT00298688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071490|NCT00298688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071491|NCT05457894|Vaccines|vaccines|mesh-list
65071492|NCT05457894|Immunologic Factors|immunologic factors|mesh-ancestor
65071493|NCT05457894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071495|NCT00298883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65071496|NCT00298883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071497|NCT00298883|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65071498|NCT00298883|Antitubercular Agents|antitubercular agents|mesh-ancestor
65071499|NCT00298883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65071500|NCT00298883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071501|NCT00298883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071502|NCT00298883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071503|NCT00298922|Azithromycin|azithromycin|mesh-list
65071504|NCT00298922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65071505|NCT00298922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071506|NCT00299039|Acetaminophen|acetaminophen|mesh-list
65071507|NCT00299039|Ibuprofen|ibuprofen|mesh-list
65071508|NCT00299039|Codeine|codeine|mesh-list
65071509|NCT00299039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65071510|NCT00299039|Analgesics|analgesics|mesh-ancestor
65071511|NCT00299039|Sensory System Agents|sensory system agents|mesh-ancestor
65071512|NCT00299039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65071513|NCT00299039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071514|NCT00299039|Antipyretics|antipyretics|mesh-ancestor
65071515|NCT00299039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65071516|NCT00299039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65071517|NCT00299039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65071518|NCT00299039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65071519|NCT00299039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071520|NCT00299039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071521|NCT00299039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65071522|NCT00299039|Narcotics|narcotics|mesh-ancestor
65071523|NCT00299039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65071524|NCT00299039|Antitussive Agents|antitussive agents|mesh-ancestor
65071525|NCT00299039|Respiratory System Agents|respiratory system agents|mesh-ancestor
65071526|NCT00299234|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65071527|NCT00299234|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65071528|NCT00299234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65071529|NCT00299234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65071530|NCT00299234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071531|NCT00299234|Adrenergic Agents|adrenergic agents|mesh-ancestor
65071532|NCT00299234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65071533|NCT00299234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071534|NCT00299351|Romidepsin|romidepsin|mesh-list
65071535|NCT00299351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65071536|NCT00299351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071537|NCT00299390|Sagopilone|sagopilone|mesh-list
64833398|NCT01599312|Trace Elements|trace elements|mesh-ancestor
64324958|NCT01038739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64324959|NCT01038739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64393769|NCT05120687|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64393770|NCT05120687|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64393771|NCT05120687|Abortifacient Agents|abortifacient agents|mesh-ancestor
64393772|NCT05120687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65071538|NCT00299390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071539|NCT02808585|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
65071540|NCT02808585|Vasodilator Agents|vasodilator agents|mesh-ancestor
65071541|NCT00299819|Sifalimumab|sifalimumab|mesh-list
65071542|NCT00299819|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65071543|NCT00299819|Immunologic Factors|immunologic factors|mesh-ancestor
65071544|NCT00299819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071545|NCT00299858|Theophylline|theophylline|mesh-list
65071546|NCT00299858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65071547|NCT00299858|Autonomic Agents|autonomic agents|mesh-ancestor
65071548|NCT00299858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65071549|NCT00299858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071550|NCT00299858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65071551|NCT00299858|Respiratory System Agents|respiratory system agents|mesh-ancestor
65071552|NCT00299858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65071553|NCT00299858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071554|NCT00299858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071555|NCT00299858|Vasodilator Agents|vasodilator agents|mesh-ancestor
65071556|NCT00299858|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65071557|NCT00299858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65071558|NCT00299858|Purinergic Agents|purinergic agents|mesh-ancestor
65071559|NCT00299858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65071560|NCT05455944|Pregabalin|pregabalin|mesh-list
65071561|NCT05455944|Analgesics|analgesics|mesh-ancestor
64415987|NCT05505539|Immunologic Factors|immunologic factors|mesh-ancestor
65071562|NCT05455944|Sensory System Agents|sensory system agents|mesh-ancestor
65071563|NCT05455944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65071564|NCT05455944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071565|NCT05455944|Anticonvulsants|anticonvulsants|mesh-ancestor
65071566|NCT05455944|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65071567|NCT05455944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65071568|NCT05455944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071569|NCT05455944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65071570|NCT05455944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65071571|NCT05455944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64556848|NCT04144439|Histamine Antagonists|histamine antagonists|mesh-ancestor
65071572|NCT05455944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65071573|NCT05455944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65071574|NCT00299936|Ribavirin|ribavirin|mesh-list
65071575|NCT00299936|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65071576|NCT00299936|Antimetabolites|antimetabolites|mesh-ancestor
65071577|NCT00299936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071578|NCT00299936|Antiviral Agents|antiviral agents|mesh-ancestor
65071579|NCT00299936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071580|NCT00300014|Triamcinolone|triamcinolone|mesh-list
65071581|NCT00300014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65071582|NCT00300014|Glucocorticoids|glucocorticoids|mesh-ancestor
65071583|NCT00300014|Hormones|hormones|mesh-ancestor
65071584|NCT00300014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65071585|NCT00300014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071586|NCT02329080|Cytarabine|cytarabine|mesh-list
65071587|NCT02329080|Rituximab|rituximab|mesh-list
65071588|NCT02329080|Methotrexate|methotrexate|mesh-list
65071589|NCT02329080|Etoposide|etoposide|mesh-list
65071590|NCT02329080|Ifosfamide|ifosfamide|mesh-list
65071591|NCT02329080|Thiotepa|thiotepa|mesh-list
65071592|NCT02329080|Carmustine|carmustine|mesh-list
65071593|NCT02329080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65071594|NCT02329080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071595|NCT02329080|Immunologic Factors|immunologic factors|mesh-ancestor
65071596|NCT02329080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071597|NCT02329080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65071598|NCT02329080|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65071599|NCT02329080|Abortifacient Agents|abortifacient agents|mesh-ancestor
65071600|NCT02329080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65071601|NCT02329080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65071602|NCT02329080|Antimetabolites|antimetabolites|mesh-ancestor
65071603|NCT02329080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071604|NCT02329080|Dermatologic Agents|dermatologic agents|mesh-ancestor
65071605|NCT02329080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071606|NCT02329080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65071607|NCT02329080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65071608|NCT02329080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65071609|NCT02329080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65071610|NCT02329080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65071611|NCT02329080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65071612|NCT02329080|Antiviral Agents|antiviral agents|mesh-ancestor
65071613|NCT02329080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071614|NCT02329080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65071615|NCT02329080|Alkylating Agents|alkylating agents|mesh-ancestor
65071616|NCT02329080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65071617|NCT00300131|Everolimus|everolimus|mesh-list
65071618|NCT00300131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071619|NCT00300131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65071620|NCT00300131|Immunologic Factors|immunologic factors|mesh-ancestor
65071621|NCT00300131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071622|NCT01820910|Doxycycline|doxycycline|mesh-list
65071623|NCT01820910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65071624|NCT01820910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071625|NCT01820910|Antimalarials|antimalarials|mesh-ancestor
65071626|NCT01820910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65071627|NCT01820910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65071628|NCT01785459|Prochlorperazine|prochlorperazine|mesh-list
65071629|NCT01785459|Bupivacaine|bupivacaine|mesh-list
65071630|NCT01785459|Anesthetics, Local|anesthetics, local|mesh-ancestor
65071631|NCT01785459|Anesthetics|anesthetics|mesh-ancestor
65071632|NCT01785459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65071633|NCT01785459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071634|NCT01785459|Sensory System Agents|sensory system agents|mesh-ancestor
65071635|NCT01785459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65071636|NCT01785459|Antiemetics|antiemetics|mesh-ancestor
65071637|NCT01785459|Autonomic Agents|autonomic agents|mesh-ancestor
65071638|NCT01785459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65071639|NCT01785459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65071640|NCT01785459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65071641|NCT01785459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65071642|NCT01785459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65071643|NCT01785459|Dopamine Agents|dopamine agents|mesh-ancestor
65071644|NCT01785459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65071645|NCT01785459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071646|NCT04716894|Itraconazole|itraconazole|mesh-list
65071647|NCT04716894|Antifungal Agents|antifungal agents|mesh-ancestor
65071648|NCT04716894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64556932|NCT04355247|Hormones|hormones|mesh-ancestor
65071649|NCT04716894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65071650|NCT04716894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65071651|NCT04716894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071652|NCT04716894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071653|NCT04716894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65071654|NCT04716894|Hormone Antagonists|hormone antagonists|mesh-ancestor
65071655|NCT04716894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65071656|NCT04716894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071657|NCT04716894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65071658|NCT00300287|Vildagliptin|vildagliptin|mesh-list
65071659|NCT00300287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64393920|NCT01980940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64393921|NCT01980940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393922|NCT01980940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393923|NCT01980940|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64393924|NCT01980940|Protective Agents|protective agents|mesh-ancestor
65071660|NCT00300287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071661|NCT00300287|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65071662|NCT00300287|Protease Inhibitors|protease inhibitors|mesh-ancestor
65071663|NCT00300287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071664|NCT00300287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071665|NCT00300404|Leucovorin|leucovorin|mesh-list
65071666|NCT00300404|Folic Acid|folic acid|mesh-list
65071667|NCT00300404|Pyrimethamine|pyrimethamine|mesh-list
65071668|NCT00300404|Levoleucovorin|levoleucovorin|mesh-list
65071669|NCT00300404|Antidotes|antidotes|mesh-ancestor
65071670|NCT00300404|Protective Agents|protective agents|mesh-ancestor
65071671|NCT00300404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071672|NCT00300404|Vitamin B Complex|vitamin b complex|mesh-ancestor
65071673|NCT00300404|Vitamins|vitamins|mesh-ancestor
65071674|NCT00300404|Micronutrients|micronutrients|mesh-ancestor
65071675|NCT00300404|Hematinics|hematinics|mesh-ancestor
65071676|NCT00300404|Antimalarials|antimalarials|mesh-ancestor
65071677|NCT00300404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65071678|NCT00300404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65071679|NCT00300404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071680|NCT00300404|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65071681|NCT00300404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071682|NCT00300404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071683|NCT01539447|Naproxen|naproxen|mesh-list
65071684|NCT01539447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65071685|NCT01539447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65071686|NCT01539447|Analgesics|analgesics|mesh-ancestor
65071687|NCT01539447|Sensory System Agents|sensory system agents|mesh-ancestor
65071688|NCT01539447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65071689|NCT01539447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071690|NCT01539447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65071691|NCT01539447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65071692|NCT01539447|Gout Suppressants|gout suppressants|mesh-ancestor
65071693|NCT01539447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65071694|NCT01539447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071695|NCT01539447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071696|NCT00300443|Bimatoprost|bimatoprost|mesh-list
65071697|NCT00300443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65071698|NCT00300560|Colistin|colistin|mesh-list
65071699|NCT00300560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65071700|NCT00300560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071701|NCT00327522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65071702|NCT00327522|Immunologic Factors|immunologic factors|mesh-ancestor
65071703|NCT00327522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071704|NCT00300716|Memantine|memantine|mesh-list
65071705|NCT00300716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65071706|NCT00300716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65071707|NCT00300716|Dopamine Agents|dopamine agents|mesh-ancestor
65071708|NCT00300716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64415989|NCT05505461|Antibodies|antibodies|mesh-list
65071709|NCT00300716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071710|NCT00300716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833399|NCT01599312|Micronutrients|micronutrients|mesh-ancestor
64394002|NCT02092571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64394003|NCT02092571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394005|NCT02402725|Dexamethasone acetate|dexamethasone acetate|mesh-list
64394006|NCT02402725|BB 1101|bb 1101|mesh-list
64394007|NCT02402725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64394008|NCT02402725|Antiemetics|antiemetics|mesh-ancestor
64394009|NCT02402725|Autonomic Agents|autonomic agents|mesh-ancestor
64394012|NCT02402725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65071711|NCT00300716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65071712|NCT00300716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65071714|NCT00300794|Analgesics|analgesics|mesh-ancestor
65071715|NCT00300794|Sensory System Agents|sensory system agents|mesh-ancestor
65071716|NCT00300794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65071717|NCT00300794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071718|NCT00300794|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65071719|NCT00300794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65071720|NCT00300794|Anesthetics, General|anesthetics, general|mesh-ancestor
65071721|NCT00300794|Anesthetics|anesthetics|mesh-ancestor
65071722|NCT00300794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65071723|NCT00300794|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64557002|NCT04989270|Anesthetics|anesthetics|mesh-list
65071724|NCT00300794|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65071725|NCT00300794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65071726|NCT00300794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071727|NCT05373303|Epoetin Alfa|epoetin alfa|mesh-list
65071728|NCT05373303|Hematinics|hematinics|mesh-ancestor
65071729|NCT00300833|Tirofiban|tirofiban|mesh-list
65071730|NCT00300833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65071731|NCT00300833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65071732|NCT00300833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071733|NCT00300833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65071734|NCT00300911|Rosiglitazone|rosiglitazone|mesh-list
65071735|NCT00300911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65071736|NCT00300911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071737|NCT00327678|Rituximab|rituximab|mesh-list
65071738|NCT00327678|Imatinib Mesylate|imatinib mesylate|mesh-list
65071739|NCT00327678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65071740|NCT00327678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071741|NCT00327678|Immunologic Factors|immunologic factors|mesh-ancestor
65071742|NCT00327678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071743|NCT00327678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65071744|NCT00327678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65071745|NCT00327678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071746|NCT00327678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071747|NCT00300950|Gemcitabine|gemcitabine|mesh-list
65071748|NCT00300950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65071749|NCT00300950|Antimetabolites|antimetabolites|mesh-ancestor
65071750|NCT00300950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071751|NCT00300950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071752|NCT00300950|Antiviral Agents|antiviral agents|mesh-ancestor
65071753|NCT00300950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071754|NCT00300950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071755|NCT00300950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65071756|NCT00300950|Immunologic Factors|immunologic factors|mesh-ancestor
65071757|NCT00300950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071758|NCT00327756|Ubiquinone|ubiquinone|mesh-list
65071759|NCT00327756|Coenzyme Q10|coenzyme q10|mesh-list
65071760|NCT00327756|Micronutrients|micronutrients|mesh-ancestor
65071761|NCT00327756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071762|NCT00327756|Vitamins|vitamins|mesh-ancestor
65071763|NCT00301106|Interleukin-12|interleukin-12|mesh-list
65071764|NCT00301106|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65071765|NCT00301106|Immunologic Factors|immunologic factors|mesh-ancestor
65071766|NCT00301106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071767|NCT00301106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65071768|NCT00301106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65071769|NCT00301106|Growth Substances|growth substances|mesh-ancestor
65071770|NCT00301106|Growth Inhibitors|growth inhibitors|mesh-ancestor
65071771|NCT00301106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394092|NCT05117957|Sorafenib|sorafenib|mesh-list
65071772|NCT00301145|Varenicline|varenicline|mesh-list
65071773|NCT00301145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65071774|NCT00301145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65071775|NCT00301145|Cholinergic Agents|cholinergic agents|mesh-ancestor
65071776|NCT00301145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65071777|NCT00301145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071778|NCT00301145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071779|NCT00301223|Pregabalin|pregabalin|mesh-list
65071780|NCT00301223|Analgesics|analgesics|mesh-ancestor
65071781|NCT00301223|Sensory System Agents|sensory system agents|mesh-ancestor
64415990|NCT05505461|Immunologic Factors|immunologic factors|mesh-ancestor
65071782|NCT00301223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65071783|NCT00301223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071784|NCT00301223|Anticonvulsants|anticonvulsants|mesh-ancestor
65071785|NCT00301223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65071786|NCT00301223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65071787|NCT00301223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071788|NCT00301223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65071789|NCT00301223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65071790|NCT00301223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65071791|NCT00301223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65071792|NCT00301223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65071793|NCT00301301|Gemcitabine|gemcitabine|mesh-list
65071794|NCT00301301|Rituximab|rituximab|mesh-list
65071795|NCT00301301|Cisplatin|cisplatin|mesh-list
65071796|NCT00301301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65071797|NCT00301301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557072|NCT04661007|Lenalidomide|lenalidomide|mesh-list
65071798|NCT00301301|Immunologic Factors|immunologic factors|mesh-ancestor
65071799|NCT00301301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071800|NCT00301301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65071801|NCT00301301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65071802|NCT00301301|Antimetabolites|antimetabolites|mesh-ancestor
65071803|NCT00301301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071804|NCT00301301|Antiviral Agents|antiviral agents|mesh-ancestor
65071805|NCT00301301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071806|NCT00301301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071807|NCT00301301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65071808|NCT00301535|Chrysarobin|chrysarobin|mesh-list
65071809|NCT00301535|HBOC 201|hboc 201|mesh-list
65071810|NCT00301535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65071811|NCT00301535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65071812|NCT00301535|Analgesics|analgesics|mesh-ancestor
65071813|NCT00301535|Sensory System Agents|sensory system agents|mesh-ancestor
64394207|NCT02003638|Niacin|niacin|mesh-list
65071814|NCT00301535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65071815|NCT00301535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071816|NCT00301535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65071817|NCT00301535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65071818|NCT00301535|Blood Substitutes|blood substitutes|mesh-ancestor
65071819|NCT00301574|Galantamine|galantamine|mesh-list
65071820|NCT00301574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65071821|NCT00301574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071822|NCT00301574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071823|NCT00301574|Cholinergic Agents|cholinergic agents|mesh-ancestor
65071824|NCT00301574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65071825|NCT00301574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071826|NCT00301574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65071827|NCT00301574|Autonomic Agents|autonomic agents|mesh-ancestor
65071828|NCT00301574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65071829|NCT00301574|Nootropic Agents|nootropic agents|mesh-ancestor
65071830|NCT00327834|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65071831|NCT00327834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65071832|NCT00327834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65071833|NCT00327834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65071834|NCT00327834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071835|NCT00327834|Adrenergic Agents|adrenergic agents|mesh-ancestor
65071836|NCT00327834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65071837|NCT00327834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071838|NCT00301613|Mycophenolic Acid|mycophenolic acid|mesh-list
65071839|NCT00301613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65071840|NCT00301613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071841|NCT00301613|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65071842|NCT00301613|Antitubercular Agents|antitubercular agents|mesh-ancestor
65071843|NCT00301613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65071844|NCT00301613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071845|NCT00301613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071846|NCT00301613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071847|NCT00301652|Mycophenolic Acid|mycophenolic acid|mesh-list
65071848|NCT00301652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65071849|NCT00301652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071850|NCT00301652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65071851|NCT00301652|Antitubercular Agents|antitubercular agents|mesh-ancestor
65071852|NCT00301652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65071853|NCT00301652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071854|NCT00301652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071855|NCT00301652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071856|NCT00301730|Aldesleukin|aldesleukin|mesh-list
65071857|NCT00301730|Paclitaxel|paclitaxel|mesh-list
65071858|NCT00301730|Trastuzumab|trastuzumab|mesh-list
65071859|NCT00301730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65071860|NCT00301730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833409|NCT01599364|Lamivudine|lamivudine|mesh-list
64833410|NCT01599364|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64833411|NCT01599364|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64833412|NCT01599364|Protease Inhibitors|protease inhibitors|mesh-ancestor
64833413|NCT01599364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071861|NCT00301730|Tubulin Modulators|tubulin modulators|mesh-ancestor
65071862|NCT00301730|Antimitotic Agents|antimitotic agents|mesh-ancestor
65071863|NCT00301730|Mitosis Modulators|mitosis modulators|mesh-ancestor
65071864|NCT00301730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071865|NCT00301730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65071866|NCT00301730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65071867|NCT00301730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65071868|NCT00301730|Antiviral Agents|antiviral agents|mesh-ancestor
65071869|NCT00301730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65071870|NCT00301847|Sorafenib|sorafenib|mesh-list
65071871|NCT00301847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071872|NCT00301847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65071873|NCT00301847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071874|NCT00301847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071875|NCT00327990|Alendronate|alendronate|mesh-list
65071876|NCT00327990|Ibandronic Acid|ibandronic acid|mesh-list
65071877|NCT00327990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65071878|NCT00327990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071879|NCT00301886|Zoledronic Acid|zoledronic acid|mesh-list
65071880|NCT00301886|Ibandronic Acid|ibandronic acid|mesh-list
65071881|NCT00301886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65071882|NCT00301886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071883|NCT05238831|Paclitaxel|paclitaxel|mesh-list
65071884|NCT05238831|Vinorelbine|vinorelbine|mesh-list
65071885|NCT05238831|Maytansine|maytansine|mesh-list
65071886|NCT05238831|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
65071887|NCT05238831|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65071888|NCT05238831|Bevacizumab|bevacizumab|mesh-list
65071889|NCT05238831|Carboplatin|carboplatin|mesh-list
65071890|NCT05238831|Capecitabine|capecitabine|mesh-list
65071891|NCT05238831|Trastuzumab|trastuzumab|mesh-list
65071892|NCT05238831|Irinotecan|irinotecan|mesh-list
65071893|NCT05238831|Atezolizumab|atezolizumab|mesh-list
65071894|NCT05238831|Letrozole|letrozole|mesh-list
65071895|NCT05238831|Olaparib|olaparib|mesh-list
65071896|NCT05238831|Fulvestrant|fulvestrant|mesh-list
65071897|NCT05238831|Palbociclib|palbociclib|mesh-list
65071898|NCT05238831|Anastrozole|anastrozole|mesh-list
65071899|NCT05238831|Pertuzumab|pertuzumab|mesh-list
65071900|NCT05238831|Niraparib|niraparib|mesh-list
65071901|NCT05238831|Vemurafenib|vemurafenib|mesh-list
65071902|NCT05238831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65071903|NCT05238831|Endothelial Growth Factors|endothelial growth factors|mesh-list
65071904|NCT05238831|Antibodies|antibodies|mesh-list
65071905|NCT05238831|Immunoglobulins|immunoglobulins|mesh-list
65071906|NCT05238831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65071907|NCT05238831|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65071908|NCT05238831|Immunoglobulin G|immunoglobulin g|mesh-list
65071909|NCT05238831|Immunoconjugates|immunoconjugates|mesh-list
65071910|NCT05238831|Entrectinib|entrectinib|mesh-list
65071911|NCT05238831|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
65071912|NCT05238831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65071913|NCT05238831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394262|NCT05117021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394263|NCT05117021|Sensory System Agents|sensory system agents|mesh-ancestor
64394264|NCT05117021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64394265|NCT02392663|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64394266|NCT02392117|Insulin|insulin|mesh-list
64394267|NCT02392117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64394268|NCT02392117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394269|NCT02812433|Sildenafil Citrate|sildenafil citrate|mesh-list
64394270|NCT02812433|Vasodilator Agents|vasodilator agents|mesh-ancestor
64394271|NCT02812433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64394307|NCT03106519|Anesthetics|anesthetics|mesh-ancestor
64394308|NCT03106519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65071914|NCT05238831|Tubulin Modulators|tubulin modulators|mesh-ancestor
65071915|NCT05238831|Antimitotic Agents|antimitotic agents|mesh-ancestor
65071916|NCT05238831|Mitosis Modulators|mitosis modulators|mesh-ancestor
65071917|NCT05238831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071918|NCT05238831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65071919|NCT05238831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65071920|NCT05238831|Growth Substances|growth substances|mesh-ancestor
65071921|NCT05238831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071922|NCT05238831|Growth Inhibitors|growth inhibitors|mesh-ancestor
65071923|NCT05238831|Immunologic Factors|immunologic factors|mesh-ancestor
65071924|NCT05238831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65071925|NCT05238831|Antimetabolites|antimetabolites|mesh-ancestor
65071926|NCT05238831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65071927|NCT05238831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65071928|NCT05238831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071929|NCT05238831|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65071930|NCT05238831|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65071931|NCT05238831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65071932|NCT05238831|Hormone Antagonists|hormone antagonists|mesh-ancestor
65071933|NCT05238831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65071934|NCT05238831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65071935|NCT05238831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65071936|NCT05238831|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65071937|NCT05238831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65071938|NCT00301925|Cyclophosphamide|cyclophosphamide|mesh-list
65071939|NCT00301925|Fluorouracil|fluorouracil|mesh-list
65071940|NCT00301925|Capecitabine|capecitabine|mesh-list
65071941|NCT00301925|Methotrexate|methotrexate|mesh-list
65071942|NCT00301925|Epirubicin|epirubicin|mesh-list
65071943|NCT00301925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65071944|NCT00301925|Immunologic Factors|immunologic factors|mesh-ancestor
65071945|NCT00301925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071946|NCT00301925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65071947|NCT00301925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65071948|NCT00301925|Alkylating Agents|alkylating agents|mesh-ancestor
65071949|NCT00301925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071950|NCT00301925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071951|NCT00301925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65071952|NCT00301925|Antimetabolites|antimetabolites|mesh-ancestor
65071953|NCT00301925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65071954|NCT00301925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65071955|NCT00301925|Abortifacient Agents|abortifacient agents|mesh-ancestor
65071956|NCT00301925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65071957|NCT00301925|Dermatologic Agents|dermatologic agents|mesh-ancestor
65071958|NCT00301925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65071959|NCT00301925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65071960|NCT00301925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65071961|NCT00301925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65071962|NCT00301925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65071963|NCT00301925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65071965|NCT00328029|Alkylating Agents|alkylating agents|mesh-ancestor
65071966|NCT00328029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071967|NCT00328029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65071968|NCT00328029|Immunologic Factors|immunologic factors|mesh-ancestor
65071969|NCT00328029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071970|NCT00328029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65071971|NCT00328029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65071972|NCT00328029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65071973|NCT00302354|Methylphenidate|methylphenidate|mesh-list
65071974|NCT00302354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65071975|NCT00302354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071976|NCT00302354|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65071977|NCT00302354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65071978|NCT00302354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65071979|NCT00302354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071980|NCT00302354|Dopamine Agents|dopamine agents|mesh-ancestor
65071981|NCT00302354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65071982|NCT00302393|Methylphenidate|methylphenidate|mesh-list
65071983|NCT00302393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65071984|NCT00302393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071985|NCT00302393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65071986|NCT00302393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65071987|NCT00302393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65071988|NCT00302393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65071989|NCT00302393|Dopamine Agents|dopamine agents|mesh-ancestor
65071990|NCT00302393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65071991|NCT00328107|Hemagglutinins|hemagglutinins|mesh-list
65071992|NCT00328107|Agglutinins|agglutinins|mesh-ancestor
65071993|NCT00328107|Immunologic Factors|immunologic factors|mesh-ancestor
65071994|NCT00328107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65071995|NCT00302432|Menthol|menthol|mesh-list
65071996|NCT00302432|Antipruritics|antipruritics|mesh-ancestor
65071997|NCT00302432|Dermatologic Agents|dermatologic agents|mesh-ancestor
65071998|NCT00419913|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65071999|NCT00419913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65072000|NCT00419913|Immunologic Factors|immunologic factors|mesh-ancestor
65072001|NCT00419913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072002|NCT00302549|Tacrolimus|tacrolimus|mesh-list
65072003|NCT00302549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65072005|NCT00302549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072006|NCT00302549|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65072007|NCT00302549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072008|NCT00302549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072009|NCT00419991|Tigecycline|tigecycline|mesh-list
65072010|NCT00419991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65072011|NCT00419991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65072012|NCT00419991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65072013|NCT00419991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072014|NCT00419991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072015|NCT00302627|Calcium, Dietary|calcium, dietary|mesh-list
65072016|NCT00302627|Vitamin D|vitamin d|mesh-list
65072017|NCT00302627|Ergocalciferols|ergocalciferols|mesh-list
65072018|NCT00302627|Cholecalciferol|cholecalciferol|mesh-list
65072019|NCT00302627|Pamidronate|pamidronate|mesh-list
65072020|NCT00302627|Vitamins|vitamins|mesh-list
65072021|NCT00302627|Calcium Carbonate|calcium carbonate|mesh-list
64394437|NCT04585061|Lidocaine|lidocaine|mesh-list
64394438|NCT04585061|Anesthetics, Local|anesthetics, local|mesh-ancestor
64394448|NCT04585061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394471|NCT03874091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394472|NCT03874091|Sensory System Agents|sensory system agents|mesh-ancestor
64394473|NCT03874091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64394474|NCT03874091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65072022|NCT00302627|Calcium|calcium|mesh-list
65072023|NCT00302627|Micronutrients|micronutrients|mesh-ancestor
65072024|NCT00302627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072025|NCT00302627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65072026|NCT00302627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65072027|NCT00302627|Antacids|antacids|mesh-ancestor
65072028|NCT00302627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072029|NCT00302627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65072030|NCT00302666|Dienogest|dienogest|mesh-list
65072031|NCT00302666|Nandrolone|nandrolone|mesh-list
65072032|NCT00302666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65072033|NCT00302666|Contraceptive Agents|contraceptive agents|mesh-ancestor
65072034|NCT00302666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65072035|NCT00302666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072036|NCT00302666|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65072037|NCT00302666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65072038|NCT00302666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65072039|NCT00302666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65072040|NCT00302666|Hormone Antagonists|hormone antagonists|mesh-ancestor
65072041|NCT00302666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65072042|NCT00302666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65072043|NCT00302666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072044|NCT00302666|Androgens|androgens|mesh-ancestor
65072045|NCT00302666|Hormones|hormones|mesh-ancestor
65072046|NCT00302666|Anabolic Agents|anabolic agents|mesh-ancestor
65072047|NCT00328302|Candesartan|candesartan|mesh-list
65072048|NCT00328302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65072049|NCT00328302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65072050|NCT00328302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65072051|NCT00328302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072052|NCT00328380|Rifaximin|rifaximin|mesh-list
65072053|NCT00328380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65072054|NCT00328380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65072055|NCT00328380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65072056|NCT00418496|Aldesleukin|aldesleukin|mesh-list
65072057|NCT00418496|Sorafenib|sorafenib|mesh-list
65072058|NCT00418496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072059|NCT00418496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65072060|NCT00418496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072061|NCT00418496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072062|NCT00418496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65072063|NCT00418496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65072064|NCT00418496|Antiviral Agents|antiviral agents|mesh-ancestor
65072065|NCT00418496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65072066|NCT00302705|Valsartan|valsartan|mesh-list
65072067|NCT00302705|Enalapril|enalapril|mesh-list
65072068|NCT00302705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65072069|NCT00302705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65072070|NCT00302705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65072071|NCT00302705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072072|NCT00302705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65072073|NCT00302705|Protease Inhibitors|protease inhibitors|mesh-ancestor
65072074|NCT00302705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072075|NCT00302822|Tenofovir|tenofovir|mesh-list
65072076|NCT00302822|Emtricitabine|emtricitabine|mesh-list
65072077|NCT00302822|Efavirenz|efavirenz|mesh-list
65072078|NCT00302822|Lopinavir|lopinavir|mesh-list
65072079|NCT00302822|Enfuvirtide|enfuvirtide|mesh-list
65072080|NCT00302822|Antiviral Agents|antiviral agents|mesh-ancestor
65072081|NCT00302822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65072082|NCT00302822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65072083|NCT00302822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65072084|NCT00302822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394504|NCT03560297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65072085|NCT00302822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072086|NCT00302822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65072087|NCT00302822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65072088|NCT00302822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65072089|NCT00302822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65072090|NCT00302822|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65072091|NCT00302822|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65072092|NCT00302822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65072093|NCT00302822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65072094|NCT00302822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65072095|NCT00302822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65072096|NCT00302822|Protease Inhibitors|protease inhibitors|mesh-ancestor
65072097|NCT00302822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65072098|NCT00302822|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65072099|NCT00302822|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65072101|NCT00328458|Epothilone B|epothilone b|mesh-list
65072102|NCT00328458|Tubulin Modulators|tubulin modulators|mesh-ancestor
65072103|NCT00328458|Antimitotic Agents|antimitotic agents|mesh-ancestor
65072104|NCT00328458|Mitosis Modulators|mitosis modulators|mesh-ancestor
65072105|NCT00328458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072106|NCT00328458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072107|NCT05008224|Prednisone|prednisone|mesh-list
65072108|NCT05008224|Cyclophosphamide|cyclophosphamide|mesh-list
65072109|NCT05008224|Dacarbazine|dacarbazine|mesh-list
65072110|NCT05008224|Doxorubicin|doxorubicin|mesh-list
65072111|NCT05008224|Pembrolizumab|pembrolizumab|mesh-list
65072112|NCT05008224|Etoposide|etoposide|mesh-list
65072113|NCT05008224|Etoposide phosphate|etoposide phosphate|mesh-list
65072114|NCT05008224|Vincristine|vincristine|mesh-list
65072115|NCT05008224|Bleomycin|bleomycin|mesh-list
65072116|NCT05008224|Vinblastine|vinblastine|mesh-list
65072117|NCT05008224|Procarbazine|procarbazine|mesh-list
65072118|NCT05008224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65072119|NCT05008224|Immunologic Factors|immunologic factors|mesh-ancestor
65072120|NCT05008224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072121|NCT05008224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65072122|NCT05008224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65072123|NCT05008224|Alkylating Agents|alkylating agents|mesh-ancestor
65072124|NCT05008224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072125|NCT05008224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072126|NCT05008224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65072127|NCT05008224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65072128|NCT05008224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65072129|NCT05008224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65072130|NCT05008224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072131|NCT05008224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65072132|NCT05008224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65072133|NCT05008224|Glucocorticoids|glucocorticoids|mesh-ancestor
65072134|NCT05008224|Hormones|hormones|mesh-ancestor
65072135|NCT05008224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65072136|NCT05008224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65072137|NCT05008224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65072138|NCT05008224|Tubulin Modulators|tubulin modulators|mesh-ancestor
65072139|NCT05008224|Antimitotic Agents|antimitotic agents|mesh-ancestor
65072140|NCT05008224|Mitosis Modulators|mitosis modulators|mesh-ancestor
65072141|NCT00303017|Naproxen|naproxen|mesh-list
65072142|NCT00303017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65072143|NCT00303017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65072144|NCT00303017|Analgesics|analgesics|mesh-ancestor
65072145|NCT00303017|Sensory System Agents|sensory system agents|mesh-ancestor
64394606|NCT05403125|Cariostatic Agents|cariostatic agents|mesh-ancestor
64394607|NCT05403125|Protective Agents|protective agents|mesh-ancestor
64394608|NCT05403125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394609|NCT05403125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64394610|NCT05403125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65072146|NCT00303017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65072147|NCT00303017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072148|NCT00303017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65072149|NCT00303017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65072150|NCT00303017|Gout Suppressants|gout suppressants|mesh-ancestor
65072151|NCT00303017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65072152|NCT00303017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072153|NCT00303017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072154|NCT00303056|Icatibant|icatibant|mesh-list
65072155|NCT00303056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65072156|NCT00303056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65072157|NCT00303056|Analgesics|analgesics|mesh-ancestor
65072158|NCT00303056|Sensory System Agents|sensory system agents|mesh-ancestor
65072159|NCT00303056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65072160|NCT00303056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072161|NCT00303056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65072162|NCT00303056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65072163|NCT00303056|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
65072164|NCT00303056|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
65072165|NCT00303056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072166|NCT00303056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65072167|NCT00303056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65072168|NCT00303056|Immunologic Factors|immunologic factors|mesh-ancestor
65072169|NCT00328497|Bevacizumab|bevacizumab|mesh-list
65072170|NCT00328497|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
65072171|NCT00328497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65072172|NCT00328497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072173|NCT00328497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65072174|NCT00328497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65072175|NCT00328497|Growth Substances|growth substances|mesh-ancestor
65072176|NCT00328497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072177|NCT00328497|Growth Inhibitors|growth inhibitors|mesh-ancestor
65072178|NCT00328497|Tubulin Modulators|tubulin modulators|mesh-ancestor
65072179|NCT00328497|Antimitotic Agents|antimitotic agents|mesh-ancestor
65072180|NCT00328497|Mitosis Modulators|mitosis modulators|mesh-ancestor
65072181|NCT00328497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072183|NCT04998669|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
65072184|NCT04998669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65072185|NCT04998669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072186|NCT04998669|Immunologic Factors|immunologic factors|mesh-ancestor
65072187|NCT04998669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072188|NCT04998669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65072189|NCT00303290|Interferons|interferons|mesh-list
65072190|NCT00303290|Cytarabine|cytarabine|mesh-list
65072191|NCT00303290|Interferon-alpha|interferon-alpha|mesh-list
65072192|NCT00303290|Interferon alpha-2|interferon alpha-2|mesh-list
65072193|NCT00303290|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65072194|NCT00303290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072195|NCT00303290|Antiviral Agents|antiviral agents|mesh-ancestor
65072196|NCT00303290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65072197|NCT00303290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65072198|NCT00303290|Antimetabolites|antimetabolites|mesh-ancestor
65072199|NCT00303290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072200|NCT00303290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65072201|NCT00303290|Immunologic Factors|immunologic factors|mesh-ancestor
65072202|NCT00303290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072203|NCT00328692|Rolofylline|rolofylline|mesh-list
65072204|NCT00328692|Diuretics|diuretics|mesh-ancestor
65072205|NCT00328692|Natriuretic Agents|natriuretic agents|mesh-ancestor
64833423|NCT01599377|Tofacitinib|tofacitinib|mesh-list
65072206|NCT00328692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072207|NCT04982796|Psilocybin|psilocybin|mesh-list
65072208|NCT04982796|Hallucinogens|hallucinogens|mesh-ancestor
65072209|NCT04982796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072210|NCT04982796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65072211|NCT00419718|Insulin|insulin|mesh-list
65072212|NCT00419718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65072213|NCT00419718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65072214|NCT00419718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072215|NCT00303407|Nadroparin|nadroparin|mesh-list
65072216|NCT00303407|Anticoagulants|anticoagulants|mesh-ancestor
65072217|NCT00303407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65072218|NCT00303407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65072219|NCT00303407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072220|NCT00303524|Goserelin|goserelin|mesh-list
65072221|NCT00303524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65072222|NCT00303524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072223|NCT00419796|Lumiracoxib|lumiracoxib|mesh-list
65072224|NCT00419796|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65072225|NCT00419796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65072226|NCT00419796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072227|NCT00419796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072228|NCT00419796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65072229|NCT00419796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65072230|NCT00419796|Analgesics|analgesics|mesh-ancestor
65072231|NCT00419796|Sensory System Agents|sensory system agents|mesh-ancestor
65072232|NCT00419796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65072233|NCT00419796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072234|NCT00419796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65072235|NCT00419796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65072236|NCT00419835|Losartan|losartan|mesh-list
65072237|NCT00419835|Enalapril|enalapril|mesh-list
65072238|NCT00419835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65072239|NCT00419835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65072240|NCT00419835|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65072241|NCT00419835|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65072242|NCT00419835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072243|NCT00419835|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65072244|NCT00419835|Protease Inhibitors|protease inhibitors|mesh-ancestor
65072245|NCT00419835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072246|NCT00328809|Spironolactone|spironolactone|mesh-list
65072247|NCT00328809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65072248|NCT00328809|Hormone Antagonists|hormone antagonists|mesh-ancestor
65072249|NCT00328809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65072250|NCT00328809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072251|NCT00328809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65072252|NCT00328809|Diuretics|diuretics|mesh-ancestor
65072253|NCT00328809|Natriuretic Agents|natriuretic agents|mesh-ancestor
65072254|NCT00420030|Abciximab|abciximab|mesh-list
65072255|NCT00420030|Anticoagulants|anticoagulants|mesh-ancestor
65072256|NCT00420030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65072257|NCT00303758|Leucovorin|leucovorin|mesh-list
65072258|NCT00303758|Gemcitabine|gemcitabine|mesh-list
65072259|NCT00303758|Fluorouracil|fluorouracil|mesh-list
65072260|NCT00303758|Calcium|calcium|mesh-list
65072261|NCT00303758|Levoleucovorin|levoleucovorin|mesh-list
65072262|NCT00303758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072263|NCT00303758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65072264|NCT00303758|Antimetabolites|antimetabolites|mesh-ancestor
65072265|NCT00303758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072266|NCT00303758|Antiviral Agents|antiviral agents|mesh-ancestor
65072267|NCT00303758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65072268|NCT00303758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072269|NCT00303758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65072270|NCT00303758|Immunologic Factors|immunologic factors|mesh-ancestor
65072271|NCT00303758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072272|NCT00303758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65072273|NCT00303758|Antidotes|antidotes|mesh-ancestor
65072274|NCT00303758|Protective Agents|protective agents|mesh-ancestor
65072275|NCT00303758|Vitamin B Complex|vitamin b complex|mesh-ancestor
65072276|NCT00303758|Vitamins|vitamins|mesh-ancestor
65072277|NCT00303758|Micronutrients|micronutrients|mesh-ancestor
65072278|NCT00303797|Bortezomib|bortezomib|mesh-list
65072279|NCT00303797|Sorafenib|sorafenib|mesh-list
65072280|NCT00303797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072281|NCT00303797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65072282|NCT00303797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072283|NCT00303797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072284|NCT00303836|Aldesleukin|aldesleukin|mesh-list
65072285|NCT00303836|Cyclophosphamide|cyclophosphamide|mesh-list
65072286|NCT00303836|Fludarabine|fludarabine|mesh-list
65072287|NCT00303836|Fludarabine phosphate|fludarabine phosphate|mesh-list
65072288|NCT00303836|Interleukin-2|interleukin-2|mesh-list
65072289|NCT00303836|Freund's Adjuvant|freund's adjuvant|mesh-list
65072290|NCT00303836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65072291|NCT00303836|Immunologic Factors|immunologic factors|mesh-ancestor
65072292|NCT00303836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072293|NCT00303836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65072294|NCT00303836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65072295|NCT00303836|Alkylating Agents|alkylating agents|mesh-ancestor
65072296|NCT00303836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072297|NCT00303836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072298|NCT00303836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65072299|NCT00303836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65072300|NCT00303836|Antimetabolites|antimetabolites|mesh-ancestor
65072301|NCT00303836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65072302|NCT00303836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65072303|NCT00303836|Analgesics|analgesics|mesh-ancestor
65072304|NCT00303836|Sensory System Agents|sensory system agents|mesh-ancestor
65072305|NCT00303836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65072306|NCT00303836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65072307|NCT00303836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65072308|NCT00303836|Antiviral Agents|antiviral agents|mesh-ancestor
65072309|NCT00303836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65072310|NCT00303992|Trastuzumab|trastuzumab|mesh-list
65072311|NCT00303992|Irinotecan|irinotecan|mesh-list
65072312|NCT00303992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65072313|NCT00303992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072314|NCT00303992|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65072315|NCT00303992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65072316|NCT00303992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072317|NCT00303992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072318|NCT00304226|Amlodipine|amlodipine|mesh-list
65072319|NCT00304226|Valsartan|valsartan|mesh-list
65072320|NCT00304226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65072321|NCT00304226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65072322|NCT00304226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64833438|NCT05691010|Tubulin Modulators|tubulin modulators|mesh-ancestor
64833439|NCT05691010|Antimitotic Agents|antimitotic agents|mesh-ancestor
64833440|NCT05691010|Mitosis Modulators|mitosis modulators|mesh-ancestor
64833441|NCT05691010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072323|NCT00304226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714363|NCT03108482|Analgesics|analgesics|mesh-ancestor
65072324|NCT00304226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65072325|NCT00304226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072326|NCT00304226|Vasodilator Agents|vasodilator agents|mesh-ancestor
65072327|NCT00304226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65072328|NCT00304226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65072330|NCT00332319|Antiemetics|antiemetics|mesh-ancestor
65072331|NCT00332319|Autonomic Agents|autonomic agents|mesh-ancestor
65072332|NCT00332319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65072333|NCT00332319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072334|NCT00332319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65072335|NCT00332319|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65072336|NCT00332319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65072337|NCT00332319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072338|NCT00304382|Vaccines|vaccines|mesh-list
65072339|NCT00304382|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65072340|NCT00304382|Immunologic Factors|immunologic factors|mesh-ancestor
65072341|NCT00304382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072342|NCT00304421|Rabeprazole|rabeprazole|mesh-list
65072343|NCT00304421|Pantoprazole|pantoprazole|mesh-list
65072344|NCT00304421|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65072345|NCT00304421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65072346|NCT00304421|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65072347|NCT00304421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072348|NCT00304421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072349|NCT00332397|Sirolimus|sirolimus|mesh-list
65072350|NCT00332397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65072351|NCT00332397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65072352|NCT00332397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65072353|NCT00332397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072354|NCT00332397|Antifungal Agents|antifungal agents|mesh-ancestor
65072355|NCT00332397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65072356|NCT00332397|Immunologic Factors|immunologic factors|mesh-ancestor
65072357|NCT00332397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444639|NCT04615949|Cannabidiol|cannabidiol|mesh-list
64833449|NCT05690802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64833450|NCT05690802|Serotonin Agents|serotonin agents|mesh-ancestor
64394947|NCT05127707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64394948|NCT05205109|Pembrolizumab|pembrolizumab|mesh-list
64394949|NCT05205109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64394950|NCT05205109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394951|NCT02207465|Paclitaxel|paclitaxel|mesh-list
64394952|NCT02207465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65072358|NCT00304460|Aldesleukin|aldesleukin|mesh-list
65072359|NCT00304460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072360|NCT00304460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65072361|NCT00304460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65072362|NCT00304460|Antiviral Agents|antiviral agents|mesh-ancestor
65072363|NCT00304460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65072364|NCT00304499|Oxybutynin|oxybutynin|mesh-list
65072365|NCT00304499|Parasympatholytics|parasympatholytics|mesh-ancestor
65072366|NCT00304499|Autonomic Agents|autonomic agents|mesh-ancestor
65072367|NCT00304499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65072368|NCT00304499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072369|NCT00304499|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65072370|NCT00304499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65072371|NCT00304499|Cholinergic Agents|cholinergic agents|mesh-ancestor
65072372|NCT00304499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65072373|NCT00304499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072374|NCT00304499|Urological Agents|urological agents|mesh-ancestor
65072375|NCT00304538|Glucagon|glucagon|mesh-list
65072376|NCT00304538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65072377|NCT00304538|Hormones|hormones|mesh-ancestor
65072378|NCT00304538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65072379|NCT00304538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072380|NCT00420498|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65072381|NCT00420498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65072382|NCT00420498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65072383|NCT00420498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65072384|NCT00420498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072385|NCT00420498|Adrenergic Agents|adrenergic agents|mesh-ancestor
65072386|NCT00420498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65072387|NCT00420498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072388|NCT00328965|Lacidipine|lacidipine|mesh-list
65072389|NCT00328965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65072390|NCT00328965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65072391|NCT00328965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65072392|NCT00328965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072393|NCT00328965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65072394|NCT00328965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072395|NCT00304616|Olanzapine|olanzapine|mesh-list
65072396|NCT00304616|Risperidone|risperidone|mesh-list
65072397|NCT00304616|Aripiprazole|aripiprazole|mesh-list
65072398|NCT00304616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65072399|NCT00304616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65072400|NCT00304616|Serotonin Agents|serotonin agents|mesh-ancestor
65072402|NCT00304616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072403|NCT00304616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072404|NCT00304616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65072405|NCT00304616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65072406|NCT00304616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65072407|NCT00304616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65072408|NCT00304616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65072409|NCT00304616|Dopamine Agents|dopamine agents|mesh-ancestor
65072410|NCT00304616|Antiemetics|antiemetics|mesh-ancestor
65072411|NCT00304616|Autonomic Agents|autonomic agents|mesh-ancestor
65072412|NCT00304616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65072413|NCT00304616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65072414|NCT00304616|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65072415|NCT00304616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65072416|NCT00304616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65072417|NCT00304616|Antidepressive Agents|antidepressive agents|mesh-ancestor
65072418|NCT00304616|Dopamine Agonists|dopamine agonists|mesh-ancestor
65072419|NCT00304616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65072420|NCT00304616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65072421|NCT00304616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65072422|NCT00304616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65072423|NCT00332436|Timolol|timolol|mesh-list
65072424|NCT00332436|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65072425|NCT00332436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64395024|NCT05279963|Adrenergic Agents|adrenergic agents|mesh-ancestor
64395025|NCT05279963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64395026|NCT05126693|Botulinum Toxins|botulinum toxins|mesh-list
64395027|NCT05126693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64395028|NCT05126693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64395029|NCT05126693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395030|NCT05126693|Cholinergic Agents|cholinergic agents|mesh-ancestor
64395031|NCT05126693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64395040|NCT05133635|Prednisolone acetate|prednisolone acetate|mesh-list
64395041|NCT05133635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64395042|NCT05133635|Prednisolone phosphate|prednisolone phosphate|mesh-list
64395043|NCT05133635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64395044|NCT05133635|Antiemetics|antiemetics|mesh-ancestor
64395045|NCT05133635|Autonomic Agents|autonomic agents|mesh-ancestor
64395046|NCT05133635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65072426|NCT00332436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65072427|NCT00332436|Adrenergic Agents|adrenergic agents|mesh-ancestor
65072428|NCT00332436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65072429|NCT00332436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072430|NCT00332436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072431|NCT00332436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65072432|NCT00332436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65072433|NCT00332436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65072434|NCT00332436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65072435|NCT00332436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65072436|NCT00304655|Aripiprazole|aripiprazole|mesh-list
65072437|NCT00304655|Antidepressive Agents|antidepressive agents|mesh-ancestor
65072438|NCT00304655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65072439|NCT00304655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65072440|NCT00304655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65072441|NCT00304655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65072442|NCT00304655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072443|NCT00304655|Dopamine Agonists|dopamine agonists|mesh-ancestor
65072444|NCT00304655|Dopamine Agents|dopamine agents|mesh-ancestor
65072445|NCT00304655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64416003|NCT05514119|Fenofibrate|fenofibrate|mesh-list
65072446|NCT00304655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072447|NCT00304655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65072448|NCT00304655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65072449|NCT00304655|Serotonin Agents|serotonin agents|mesh-ancestor
65072450|NCT00304655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65072451|NCT00304655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65072452|NCT00304655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65072453|NCT00304655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65072454|NCT00332553|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
65072455|NCT00332553|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65072456|NCT00332553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65072457|NCT00332553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65072458|NCT00332553|Medroxyprogesterone|medroxyprogesterone|mesh-list
65072459|NCT00332553|Estradiol|estradiol|mesh-list
65072460|NCT00332553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65072461|NCT00332553|Estrogens|estrogens|mesh-list
65072462|NCT00332553|Hormones|hormones|mesh-ancestor
65072463|NCT00332553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65072464|NCT00332553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072465|NCT00332553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65072466|NCT00332553|Contraceptive Agents|contraceptive agents|mesh-ancestor
65072467|NCT00332553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65072468|NCT00332553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65072469|NCT00332553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65072470|NCT00332553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65072471|NCT00332553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65072472|NCT00332553|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65072473|NCT00332553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65072474|NCT00332553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072475|NCT00332553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65072476|NCT00332553|Hormone Antagonists|hormone antagonists|mesh-ancestor
65072477|NCT00332553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65072478|NCT00332553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65072479|NCT00332553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65072480|NCT00332631|Acetylcysteine|acetylcysteine|mesh-list
65072481|NCT00332631|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65072482|NCT00332631|Antiviral Agents|antiviral agents|mesh-ancestor
65072483|NCT00332631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65072484|NCT00332631|Expectorants|expectorants|mesh-ancestor
65072485|NCT00332631|Respiratory System Agents|respiratory system agents|mesh-ancestor
64429999|NCT05055323|Pyrvinium|pyrvinium|mesh-list
65072486|NCT00332631|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65072487|NCT00332631|Antioxidants|antioxidants|mesh-ancestor
65072488|NCT00332631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072489|NCT00332631|Protective Agents|protective agents|mesh-ancestor
65072490|NCT00332631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072491|NCT00332631|Antidotes|antidotes|mesh-ancestor
65072492|NCT00304772|Fluconazole|fluconazole|mesh-list
65072493|NCT00304772|Micafungin|micafungin|mesh-list
65072494|NCT00304772|Antifungal Agents|antifungal agents|mesh-ancestor
65072495|NCT00304772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65072496|NCT00304772|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65072497|NCT00304772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65072498|NCT00304772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072499|NCT00304772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072500|NCT00304772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65072501|NCT00304772|Hormone Antagonists|hormone antagonists|mesh-ancestor
65072502|NCT00304772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65072503|NCT00304772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072504|NCT00304772|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65072505|NCT00304772|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65072506|NCT00304811|Vancomycin|vancomycin|mesh-list
65072507|NCT00304811|Rifampin|rifampin|mesh-list
65072508|NCT00304811|Gentamicins|gentamicins|mesh-list
65072509|NCT00304811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65072510|NCT00304811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65072511|NCT00304811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65072512|NCT00304811|Antitubercular Agents|antitubercular agents|mesh-ancestor
65072513|NCT00304811|Leprostatic Agents|leprostatic agents|mesh-ancestor
65072514|NCT00304811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65072515|NCT00304811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072516|NCT00304811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072517|NCT00304811|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65072518|NCT00304811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65072519|NCT00304811|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65072520|NCT00304811|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65072521|NCT00304811|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65072522|NCT00304811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65072523|NCT00304811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65072524|NCT00332787|Fluoxetine|fluoxetine|mesh-list
65072525|NCT00332787|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64395204|NCT03160729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64395205|NCT03160729|Glucocorticoids|glucocorticoids|mesh-ancestor
64395206|NCT03160729|Hormones|hormones|mesh-ancestor
64395207|NCT03160729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64395208|NCT03160729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64395209|NCT03160729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395210|NCT04439929|Adalimumab|adalimumab|mesh-list
64395211|NCT04439929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64395212|NCT04439929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64395213|NCT05131841|Vinorelbine|vinorelbine|mesh-list
65072526|NCT00332787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65072527|NCT00332787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65072528|NCT00332787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072529|NCT00332787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65072530|NCT00332787|Serotonin Agents|serotonin agents|mesh-ancestor
65072531|NCT00332787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072532|NCT00332787|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65072533|NCT00332787|Antidepressive Agents|antidepressive agents|mesh-ancestor
65072534|NCT00332787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65072535|NCT00332787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65072536|NCT00332787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65072537|NCT00332787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072538|NCT00304850|Ketamine|ketamine|mesh-list
65072539|NCT00304850|Analgesics|analgesics|mesh-ancestor
65072540|NCT00304850|Sensory System Agents|sensory system agents|mesh-ancestor
65072541|NCT00304850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65072542|NCT00304850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072543|NCT00304850|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64714587|NCT05404334|Androgens|androgens|mesh-list
65072544|NCT00304850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65072545|NCT00304850|Anesthetics, General|anesthetics, general|mesh-ancestor
65072547|NCT00304850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65072548|NCT00304850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65072549|NCT00304850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65072550|NCT00304850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65072551|NCT00304850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072552|NCT00329316|Progesterone|progesterone|mesh-list
65072553|NCT00329316|Progestins|progestins|mesh-ancestor
65072554|NCT00329316|Hormones|hormones|mesh-ancestor
65072555|NCT00329316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65072556|NCT00329316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072557|NCT00332826|Insulin|insulin|mesh-list
65072558|NCT00332826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65072559|NCT00332826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072560|NCT00305201|Pravastatin|pravastatin|mesh-list
65072561|NCT00305201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65072562|NCT00305201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64833463|NCT05690321|Antitussive Agents|antitussive agents|mesh-ancestor
64833464|NCT05690321|Respiratory System Agents|respiratory system agents|mesh-ancestor
64833465|NCT05690282|Acetaminophen|acetaminophen|mesh-list
64833466|NCT05690282|Ibuprofen|ibuprofen|mesh-list
64833467|NCT05690282|Gabapentin|gabapentin|mesh-list
64833468|NCT05690282|Bupivacaine|bupivacaine|mesh-list
64833469|NCT05690282|Anesthetics, Local|anesthetics, local|mesh-ancestor
64833470|NCT05690282|Anesthetics|anesthetics|mesh-ancestor
64833471|NCT05690282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64833476|NCT05690282|Analgesics|analgesics|mesh-ancestor
65072563|NCT00305201|Antimetabolites|antimetabolites|mesh-ancestor
65072564|NCT00305201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072565|NCT00305201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65072566|NCT00305201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65072567|NCT00305201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072568|NCT00329355|Naproxen|naproxen|mesh-list
65072569|NCT00329355|Sumatriptan|sumatriptan|mesh-list
65072570|NCT00329355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65072571|NCT00329355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65072572|NCT00329355|Analgesics|analgesics|mesh-ancestor
65072573|NCT00329355|Sensory System Agents|sensory system agents|mesh-ancestor
65072574|NCT00329355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65072575|NCT00329355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072576|NCT00329355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65072577|NCT00329355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65072578|NCT00329355|Gout Suppressants|gout suppressants|mesh-ancestor
65072579|NCT00329355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65072580|NCT00329355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072581|NCT00329355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072582|NCT00329355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65072583|NCT00329355|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65072584|NCT00329355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65072585|NCT00329355|Serotonin Agents|serotonin agents|mesh-ancestor
65072586|NCT00329355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65072587|NCT00332904|Propranolol|propranolol|mesh-list
65072588|NCT00332904|Spironolactone|spironolactone|mesh-list
65072589|NCT00332904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65072590|NCT00332904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65072591|NCT00332904|Adrenergic Agents|adrenergic agents|mesh-ancestor
65072592|NCT00332904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65072593|NCT00332904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072594|NCT00332904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072595|NCT00332904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65072596|NCT00332904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65072597|NCT00332904|Vasodilator Agents|vasodilator agents|mesh-ancestor
65072598|NCT00332904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65072599|NCT00332904|Hormone Antagonists|hormone antagonists|mesh-ancestor
65072600|NCT00332904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65072601|NCT00332904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65072602|NCT00332904|Diuretics|diuretics|mesh-ancestor
65072603|NCT00332904|Natriuretic Agents|natriuretic agents|mesh-ancestor
65072604|NCT00329394|Ketamine|ketamine|mesh-list
65072605|NCT00329394|Analgesics|analgesics|mesh-ancestor
65072606|NCT00329394|Sensory System Agents|sensory system agents|mesh-ancestor
65072607|NCT00329394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65072608|NCT00329394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072609|NCT00329394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65072610|NCT00329394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65072611|NCT00329394|Anesthetics, General|anesthetics, general|mesh-ancestor
65072612|NCT00329394|Anesthetics|anesthetics|mesh-ancestor
65072613|NCT00329394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65072614|NCT00329394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65072615|NCT00329394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64714661|NCT03082196|Fluorides, Topical|fluorides, topical|mesh-list
65072616|NCT00329394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65072617|NCT00329394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072619|NCT00305396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65072620|NCT00305396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65072621|NCT00305396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65072622|NCT00305396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072623|NCT00305396|Antifungal Agents|antifungal agents|mesh-ancestor
65072624|NCT00305396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64833477|NCT05690282|Antipyretics|antipyretics|mesh-ancestor
65072625|NCT00305396|Immunologic Factors|immunologic factors|mesh-ancestor
65072626|NCT00305396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072627|NCT00329472|Gemcitabine|gemcitabine|mesh-list
65072628|NCT00329472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072629|NCT00329472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65072630|NCT00329472|Antimetabolites|antimetabolites|mesh-ancestor
65072631|NCT00329472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072632|NCT00329472|Antiviral Agents|antiviral agents|mesh-ancestor
65072633|NCT00329472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65072634|NCT00329472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072635|NCT00329472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65072636|NCT00329472|Immunologic Factors|immunologic factors|mesh-ancestor
65072637|NCT00329472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072638|NCT00305474|Risperidone|risperidone|mesh-list
65072639|NCT00305474|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65072640|NCT00305474|Serotonin Agents|serotonin agents|mesh-ancestor
65072641|NCT00305474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65072642|NCT00305474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072643|NCT00305474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072644|NCT00305474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65072645|NCT00305474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65072646|NCT00305474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65072647|NCT00305474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65072648|NCT00305474|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65072649|NCT00305474|Dopamine Agents|dopamine agents|mesh-ancestor
65072650|NCT00329511|Clonidine|clonidine|mesh-list
65072651|NCT00329511|Methyldopa|methyldopa|mesh-list
65072652|NCT00329511|Analgesics|analgesics|mesh-ancestor
65072653|NCT00329511|Sensory System Agents|sensory system agents|mesh-ancestor
65072654|NCT00329511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65072655|NCT00329511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072656|NCT00329511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65072657|NCT00329511|Sympatholytics|sympatholytics|mesh-ancestor
65072658|NCT00329511|Autonomic Agents|autonomic agents|mesh-ancestor
65072659|NCT00329511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65072660|NCT00329511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65072661|NCT00329511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65072662|NCT00329511|Adrenergic Agents|adrenergic agents|mesh-ancestor
65072663|NCT00329511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65072664|NCT00329511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072665|NCT00305513|Caffeine|caffeine|mesh-list
65072666|NCT00305513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65072667|NCT00305513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072668|NCT00305513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65072669|NCT00305513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072670|NCT00305513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072671|NCT00305513|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65072672|NCT00305513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65072673|NCT00305513|Purinergic Agents|purinergic agents|mesh-ancestor
65072674|NCT00305513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65072675|NCT00333021|PENTA|penta|mesh-list
65072676|NCT00333021|Fondaparinux|fondaparinux|mesh-list
65072677|NCT00333021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65072678|NCT00333021|Antithrombins|antithrombins|mesh-ancestor
65072679|NCT00333021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65072680|NCT00333021|Protease Inhibitors|protease inhibitors|mesh-ancestor
65072681|NCT00333021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833484|NCT05690282|Anticonvulsants|anticonvulsants|mesh-ancestor
65072682|NCT00333021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072683|NCT00333021|Anticoagulants|anticoagulants|mesh-ancestor
65072685|NCT00333021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65072686|NCT00305552|Thalidomide|thalidomide|mesh-list
65072687|NCT00305552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65072688|NCT00305552|Immunologic Factors|immunologic factors|mesh-ancestor
65072689|NCT00305552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072690|NCT00305552|Leprostatic Agents|leprostatic agents|mesh-ancestor
65072691|NCT00305552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65072692|NCT00305552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65072693|NCT00305552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65072694|NCT00305552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65072695|NCT00305552|Growth Substances|growth substances|mesh-ancestor
65072696|NCT00305552|Growth Inhibitors|growth inhibitors|mesh-ancestor
65072697|NCT00305552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072698|NCT00329589|Bortezomib|bortezomib|mesh-list
65072699|NCT00329589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072700|NCT00305591|N-Methylaspartate|n-methylaspartate|mesh-list
65072701|NCT00305591|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
65072702|NCT00305591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65072703|NCT00305591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65072704|NCT00305591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072705|NCT00305591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072706|NCT00333060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65072707|NCT00333060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65072708|NCT00305630|Triamcinolone|triamcinolone|mesh-list
65072709|NCT00305630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65072710|NCT00305630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65072711|NCT00305630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65072712|NCT00305630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65072713|NCT00305630|Glucocorticoids|glucocorticoids|mesh-ancestor
65072714|NCT00305630|Hormones|hormones|mesh-ancestor
65072715|NCT00305630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65072716|NCT00305630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072717|NCT00305630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65072718|NCT00305630|Immunologic Factors|immunologic factors|mesh-ancestor
65072719|NCT00305630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072720|NCT00305630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072721|NCT00329628|Enoxaparin|enoxaparin|mesh-list
65072722|NCT00329628|Rivaroxaban|rivaroxaban|mesh-list
65072723|NCT00329628|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65072724|NCT00329628|Antithrombins|antithrombins|mesh-ancestor
65072725|NCT00329628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65072726|NCT00329628|Protease Inhibitors|protease inhibitors|mesh-ancestor
65072727|NCT00329628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072728|NCT00329628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072729|NCT00329628|Anticoagulants|anticoagulants|mesh-ancestor
65072730|NCT00329628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65072731|NCT00329628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65072732|NCT00305669|Sargramostim|sargramostim|mesh-list
65072733|NCT00305669|Immunologic Factors|immunologic factors|mesh-ancestor
65072734|NCT00305669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072735|NCT00305708|Fludarabine|fludarabine|mesh-list
65072736|NCT00305708|Fludarabine phosphate|fludarabine phosphate|mesh-list
65072737|NCT00305708|Busulfan|busulfan|mesh-list
65072738|NCT00305708|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65072739|NCT00305708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072740|NCT00305708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65072741|NCT00305708|Antimetabolites|antimetabolites|mesh-ancestor
65072742|NCT00305708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072743|NCT00305708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65072744|NCT00305708|Immunologic Factors|immunologic factors|mesh-ancestor
65072745|NCT00305708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072746|NCT00305708|Alkylating Agents|alkylating agents|mesh-ancestor
65072747|NCT00305708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65072748|NCT00305708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65072749|NCT00305747|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
65072750|NCT00305747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65072751|NCT00305747|Protective Agents|protective agents|mesh-ancestor
65072752|NCT00305747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072753|NCT00305747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072754|NCT00333255|Nepafenac|nepafenac|mesh-list
65072755|NCT00333255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65072756|NCT00333255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65072757|NCT00333255|Analgesics|analgesics|mesh-ancestor
65072758|NCT00333255|Sensory System Agents|sensory system agents|mesh-ancestor
65072759|NCT00333255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65072760|NCT00333255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072761|NCT00333255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65072762|NCT00333255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65072763|NCT00305786|Gemcitabine|gemcitabine|mesh-list
65072764|NCT00305786|Oxaliplatin|oxaliplatin|mesh-list
65072765|NCT00305786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65072766|NCT00305786|Antimetabolites|antimetabolites|mesh-ancestor
65072767|NCT00305786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072768|NCT00305786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072769|NCT00305786|Antiviral Agents|antiviral agents|mesh-ancestor
65072770|NCT00305786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65072771|NCT00305786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072772|NCT00305786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65072773|NCT00305786|Immunologic Factors|immunologic factors|mesh-ancestor
65072774|NCT00305786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072775|NCT00305825|Bevacizumab|bevacizumab|mesh-list
65072776|NCT00305825|Letrozole|letrozole|mesh-list
65072777|NCT00305825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65072778|NCT00305825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072779|NCT00305825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65072780|NCT00305825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65072781|NCT00305825|Growth Substances|growth substances|mesh-ancestor
65072782|NCT00305825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072783|NCT00305825|Growth Inhibitors|growth inhibitors|mesh-ancestor
65072784|NCT00305825|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65072785|NCT00305825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65072786|NCT00305825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072787|NCT00305825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072788|NCT00305825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65072789|NCT00305825|Hormone Antagonists|hormone antagonists|mesh-ancestor
65072790|NCT00305825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65072791|NCT00333294|Vinorelbine|vinorelbine|mesh-list
65072792|NCT00333294|Gefitinib|gefitinib|mesh-list
65072793|NCT00333294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072794|NCT00333294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65072795|NCT00333294|Tubulin Modulators|tubulin modulators|mesh-ancestor
65072796|NCT00333294|Antimitotic Agents|antimitotic agents|mesh-ancestor
65072797|NCT00333294|Mitosis Modulators|mitosis modulators|mesh-ancestor
65072798|NCT00333294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072799|NCT00333294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65072800|NCT00333294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072801|NCT00305903|Memantine|memantine|mesh-list
65072802|NCT00305903|Rivastigmine|rivastigmine|mesh-list
65072803|NCT00305903|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65072804|NCT00305903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65072805|NCT00305903|Dopamine Agents|dopamine agents|mesh-ancestor
65072806|NCT00305903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65072807|NCT00305903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072808|NCT00305903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072809|NCT00305903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65072810|NCT00305903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65072811|NCT00305903|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65072812|NCT00305903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072813|NCT00305903|Cholinergic Agents|cholinergic agents|mesh-ancestor
65072814|NCT00305903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65072815|NCT00305903|Protective Agents|protective agents|mesh-ancestor
65072816|NCT00329823|Etanercept|etanercept|mesh-list
65072817|NCT00329823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65072818|NCT00329823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65072819|NCT00329823|Analgesics|analgesics|mesh-ancestor
65072820|NCT00329823|Sensory System Agents|sensory system agents|mesh-ancestor
65072821|NCT00329823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65072822|NCT00329823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072823|NCT00329823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65072824|NCT00329823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64833506|NCT05689983|Formoterol Fumarate|formoterol fumarate|mesh-list
65072825|NCT00329823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65072826|NCT00329823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65072827|NCT00329823|Immunologic Factors|immunologic factors|mesh-ancestor
65072829|NCT00306020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65072830|NCT00306020|Narcotics|narcotics|mesh-ancestor
65072831|NCT00306020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65072832|NCT00306020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072833|NCT00306020|Analgesics|analgesics|mesh-ancestor
65072834|NCT00306020|Sensory System Agents|sensory system agents|mesh-ancestor
65072835|NCT00306020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65072836|NCT00306137|Aprotinin|aprotinin|mesh-list
65072837|NCT00306137|Hemostatics|hemostatics|mesh-ancestor
65072838|NCT00306137|Coagulants|coagulants|mesh-ancestor
65072839|NCT00306137|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65072840|NCT00306137|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65072841|NCT00306137|Protease Inhibitors|protease inhibitors|mesh-ancestor
65072842|NCT00306137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072843|NCT00306137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072845|NCT00329940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072846|NCT00329940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65072847|NCT00329940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65072848|NCT00329940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072849|NCT00329940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072850|NCT00329940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65072851|NCT00329940|Hormone Antagonists|hormone antagonists|mesh-ancestor
65072852|NCT00329940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65072853|NCT00329940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072854|NCT00306176|Rosiglitazone|rosiglitazone|mesh-list
65072855|NCT00306176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65072856|NCT00306176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072857|NCT00333372|Z 338|z 338|mesh-list
65072858|NCT00333372|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65072859|NCT00333372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072860|NCT00333372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072861|NCT00333372|Cholinergic Agents|cholinergic agents|mesh-ancestor
65072862|NCT00333372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65072863|NCT00333372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072864|NCT00333372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65072865|NCT00330018|Acyclovir|acyclovir|mesh-list
65072866|NCT00330018|Valganciclovir|valganciclovir|mesh-list
65072867|NCT00330018|Antiviral Agents|antiviral agents|mesh-ancestor
65072868|NCT00330018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65072869|NCT00333450|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65072870|NCT00333450|Immunologic Factors|immunologic factors|mesh-ancestor
65072871|NCT00333450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072872|NCT00306254|Enoxaparin|enoxaparin|mesh-list
65072873|NCT00306254|N-(4-chlorophenyl)-N-(2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|n-(4-chlorophenyl)-n-(2-fluoro-4-(2-oxopyridin-1(2h)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|mesh-list
65072874|NCT00306254|Anticoagulants|anticoagulants|mesh-ancestor
65072875|NCT00306254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65072876|NCT00306254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65072877|NCT00306254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072878|NCT00306254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65072879|NCT00306254|Antithrombins|antithrombins|mesh-ancestor
65072880|NCT00306254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65072881|NCT00306254|Protease Inhibitors|protease inhibitors|mesh-ancestor
65072882|NCT00306254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072883|NCT00333489|Valsartan|valsartan|mesh-list
65072884|NCT00333489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65072885|NCT00333489|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65072886|NCT00333489|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65072887|NCT00333489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072888|NCT00330135|Hyaluronic Acid|hyaluronic acid|mesh-list
65072889|NCT00330135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64833515|NCT05689983|Hormones|hormones|mesh-ancestor
64324995|NCT02540954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324996|NCT02540954|Growth Inhibitors|growth inhibitors|mesh-ancestor
65072890|NCT00330135|Immunologic Factors|immunologic factors|mesh-ancestor
65072891|NCT00330135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072892|NCT00330135|Viscosupplements|viscosupplements|mesh-ancestor
65072893|NCT00330135|Protective Agents|protective agents|mesh-ancestor
65072894|NCT03275558|Sunitinib|sunitinib|mesh-list
65072895|NCT03275558|Axitinib|axitinib|mesh-list
65072896|NCT03275558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072897|NCT03275558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65072898|NCT03275558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65072899|NCT03275558|Growth Substances|growth substances|mesh-ancestor
65072900|NCT03275558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072901|NCT03275558|Growth Inhibitors|growth inhibitors|mesh-ancestor
65072902|NCT03275558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65072903|NCT03275558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072904|NCT03275558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072905|NCT03275519|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65072906|NCT03275519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65072907|NCT03275519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65072908|NCT03275519|Antitubercular Agents|antitubercular agents|mesh-ancestor
65072909|NCT00333567|Lumiracoxib|lumiracoxib|mesh-list
65072910|NCT00333567|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65072911|NCT00333567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65072912|NCT00333567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072913|NCT00333567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64714965|NCT00422708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65072914|NCT00333567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65072915|NCT00333567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65072916|NCT00333567|Analgesics|analgesics|mesh-ancestor
65072917|NCT00333567|Sensory System Agents|sensory system agents|mesh-ancestor
65072918|NCT00333567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65072919|NCT00333567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072920|NCT00333567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65072921|NCT00333567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65072922|NCT00330252|Rituximab|rituximab|mesh-list
65072923|NCT00330252|Alemtuzumab|alemtuzumab|mesh-list
65072924|NCT00330252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65072925|NCT00330252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072926|NCT00330252|Immunologic Factors|immunologic factors|mesh-ancestor
65072927|NCT00330252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072928|NCT00330252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65072929|NCT00333645|Caspofungin|caspofungin|mesh-list
65072930|NCT00333645|Antifungal Agents|antifungal agents|mesh-ancestor
65072931|NCT00333645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65072932|NCT00333645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072933|NCT00333645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072934|NCT00451100|Glycopyrrolate|glycopyrrolate|mesh-list
65072935|NCT00451100|Neostigmine|neostigmine|mesh-list
65072936|NCT00451100|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65072937|NCT00451100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072938|NCT00451100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072939|NCT00451100|Cholinergic Agents|cholinergic agents|mesh-ancestor
65072940|NCT00451100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65072941|NCT00451100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072942|NCT00451100|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65072943|NCT00451100|Autonomic Agents|autonomic agents|mesh-ancestor
64395478|NCT04637555|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64395479|NCT04637555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395480|NCT02388061|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64395481|NCT02388061|Plasminogen|plasminogen|mesh-list
64395482|NCT02388061|Tenecteplase|tenecteplase|mesh-list
64395483|NCT02388061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64395484|NCT02388061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65072944|NCT00451100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65072945|NCT00451100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65072946|NCT00451100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65072947|NCT00451100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65072948|NCT00420537|Cyclosporine|cyclosporine|mesh-list
65072949|NCT00420537|Mycophenolic Acid|mycophenolic acid|mesh-list
65072950|NCT00420537|Everolimus|everolimus|mesh-list
65072951|NCT00420537|Cyclosporins|cyclosporins|mesh-list
65072952|NCT00420537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072953|NCT00420537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072954|NCT00420537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65072955|NCT00420537|Immunologic Factors|immunologic factors|mesh-ancestor
65072956|NCT00420537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072957|NCT00420537|Antifungal Agents|antifungal agents|mesh-ancestor
65072958|NCT00420537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65072959|NCT00420537|Dermatologic Agents|dermatologic agents|mesh-ancestor
65072960|NCT00420537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65072961|NCT00420537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65072962|NCT00420537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65072963|NCT00420537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65072964|NCT00420537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65072965|NCT00420537|Antitubercular Agents|antitubercular agents|mesh-ancestor
65072966|NCT00420537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65072967|NCT00451139|Lumefantrine|lumefantrine|mesh-list
65072969|NCT00451139|Quinine|quinine|mesh-list
65072970|NCT00451139|Atovaquone|atovaquone|mesh-list
65072971|NCT00451139|Proguanil|proguanil|mesh-list
65072972|NCT00451139|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65072973|NCT00451139|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
65072974|NCT00451139|Antimalarials|antimalarials|mesh-ancestor
65072975|NCT00451139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65072976|NCT00451139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65072977|NCT00451139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65072978|NCT00451139|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65072979|NCT00451139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072980|NCT00451139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65072981|NCT00451139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65072982|NCT00451139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65072983|NCT00451139|Analgesics|analgesics|mesh-ancestor
65072984|NCT00451139|Sensory System Agents|sensory system agents|mesh-ancestor
65072985|NCT00451139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65072986|NCT00451139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65072987|NCT00451139|Antimetabolites|antimetabolites|mesh-ancestor
65072988|NCT00330486|Acamprosate|acamprosate|mesh-list
65072989|NCT00330486|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65072992|NCT00451373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65072993|NCT00451373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65072994|NCT00333723|Rosiglitazone|rosiglitazone|mesh-list
65072995|NCT00333723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65072996|NCT00333723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65072997|NCT00451412|Heparin|heparin|mesh-list
65072998|NCT00451412|Calcium heparin|calcium heparin|mesh-list
65072999|NCT00451412|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65073000|NCT00451412|Tinzaparin|tinzaparin|mesh-list
65073001|NCT00451412|Dalteparin|dalteparin|mesh-list
65073002|NCT00451412|Certoparin|certoparin|mesh-list
65073003|NCT00451412|Anticoagulants|anticoagulants|mesh-ancestor
65073004|NCT00451412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65073005|NCT00451412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65073006|NCT00451412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073007|NCT00451490|S 20098|s 20098|mesh-list
65073008|NCT00451490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65073009|NCT00451490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65073010|NCT00451490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073011|NCT00330525|Sibutramine|sibutramine|mesh-list
64833516|NCT05689983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64833517|NCT05689983|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64395493|NCT04556357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395494|NCT04556357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073012|NCT00330525|Antidepressive Agents|antidepressive agents|mesh-ancestor
65073013|NCT00330525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65073014|NCT00330525|Appetite Depressants|appetite depressants|mesh-ancestor
65073015|NCT00330525|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65073016|NCT00333918|Bromfenac|bromfenac|mesh-list
65073017|NCT00333918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65073018|NCT00333918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65073019|NCT00333918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65073020|NCT00333918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65073021|NCT00333918|Analgesics|analgesics|mesh-ancestor
65073022|NCT00333918|Sensory System Agents|sensory system agents|mesh-ancestor
65073023|NCT00333918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65073024|NCT00333918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073025|NCT00333918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65073026|NCT00333918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65073027|NCT00451568|Metformin|metformin|mesh-list
65073028|NCT00451568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65073029|NCT00451568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073030|NCT00451646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65073031|NCT00451646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65073032|NCT00451646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65073034|NCT00451724|Ketamine|ketamine|mesh-list
65073035|NCT00451724|Analgesics|analgesics|mesh-ancestor
65073036|NCT00451724|Sensory System Agents|sensory system agents|mesh-ancestor
65073037|NCT00451724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65073038|NCT00451724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073039|NCT00451724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65073040|NCT00451724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65073041|NCT00451724|Anesthetics, General|anesthetics, general|mesh-ancestor
65073042|NCT00451724|Anesthetics|anesthetics|mesh-ancestor
65073043|NCT00451724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65073044|NCT00451724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65073045|NCT00451724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65073046|NCT00451724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64833518|NCT05689983|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65073047|NCT00451724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605506|NCT02641522|Siltuximab|siltuximab|mesh-list
65073048|NCT00451763|Bevacizumab|bevacizumab|mesh-list
65073049|NCT00451763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65073050|NCT00451763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073051|NCT00451763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65073052|NCT00451763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65073053|NCT00451763|Growth Substances|growth substances|mesh-ancestor
65073054|NCT00451763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073055|NCT00451763|Growth Inhibitors|growth inhibitors|mesh-ancestor
65073056|NCT00330798|Ketorolac|ketorolac|mesh-list
65073057|NCT00330798|Nepafenac|nepafenac|mesh-list
65073058|NCT00330798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65073059|NCT00330798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65073060|NCT00330798|Analgesics|analgesics|mesh-ancestor
65073061|NCT00330798|Sensory System Agents|sensory system agents|mesh-ancestor
65073062|NCT00330798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65073063|NCT00330798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073064|NCT00330798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65073065|NCT00330798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64715114|NCT02969317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65073066|NCT00330798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65073067|NCT00330798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073068|NCT00330798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073070|NCT00451880|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65073071|NCT00451880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65073072|NCT00451880|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65073073|NCT00451880|Histamine Antagonists|histamine antagonists|mesh-ancestor
65073074|NCT00451880|Histamine Agents|histamine agents|mesh-ancestor
65073075|NCT00451880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65073076|NCT00451880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073077|NCT00451880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073078|NCT00451997|Cytarabine|cytarabine|mesh-list
65073079|NCT00451997|Imatinib Mesylate|imatinib mesylate|mesh-list
65073080|NCT00451997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65073081|NCT00451997|Antimetabolites|antimetabolites|mesh-ancestor
65073082|NCT00451997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073083|NCT00451997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073084|NCT00451997|Antiviral Agents|antiviral agents|mesh-ancestor
65073085|NCT00451997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65073086|NCT00451997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65073087|NCT00451997|Immunologic Factors|immunologic factors|mesh-ancestor
65073088|NCT00451997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073089|NCT00451997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65073090|NCT00451997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073091|NCT00330993|Misoprostol|misoprostol|mesh-list
65073092|NCT00330993|Mifepristone|mifepristone|mesh-list
65073093|NCT00330993|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65073094|NCT00330993|Abortifacient Agents|abortifacient agents|mesh-ancestor
65073095|NCT00330993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65073096|NCT00330993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073097|NCT00330993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65073098|NCT00330993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65073099|NCT00330993|Oxytocics|oxytocics|mesh-ancestor
65073100|NCT00330993|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65073101|NCT00330993|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65073102|NCT00330993|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65073103|NCT00330993|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64833576|NCT05689242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073104|NCT00330993|Contraceptive Agents|contraceptive agents|mesh-ancestor
65073105|NCT00330993|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65073106|NCT00330993|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65073107|NCT00330993|Hormone Antagonists|hormone antagonists|mesh-ancestor
65073108|NCT00330993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65073109|NCT00330993|Luteolytic Agents|luteolytic agents|mesh-ancestor
65073110|NCT00330993|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65073111|NCT00330993|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65073112|NCT00452075|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65073113|NCT00452075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073114|NCT00452075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65073115|NCT00452075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073116|NCT00452075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073117|NCT00331071|Contraceptive Agents|contraceptive agents|mesh-list
65073118|NCT00331071|Ortho Evra|ortho evra|mesh-list
65073119|NCT00331071|Contraceptives, Oral|contraceptives, oral|mesh-list
65073120|NCT00331071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65073121|NCT00331071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073122|NCT00331071|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65073123|NCT00331071|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65073124|NCT00333996|Dexamethasone|dexamethasone|mesh-list
65073125|NCT00333996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65073126|NCT00333996|Antiemetics|antiemetics|mesh-ancestor
65073127|NCT00333996|Autonomic Agents|autonomic agents|mesh-ancestor
65073128|NCT00333996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65073129|NCT00333996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073130|NCT00333996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65073131|NCT00333996|Glucocorticoids|glucocorticoids|mesh-ancestor
65073132|NCT00333996|Hormones|hormones|mesh-ancestor
65073133|NCT00333996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65073134|NCT00333996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65073135|NCT00333996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073136|NCT00452192|Telmisartan|telmisartan|mesh-list
65073137|NCT00452192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65073138|NCT00452192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65073139|NCT00452192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65073140|NCT00452192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073141|NCT00334035|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65073142|NCT00334035|Antidepressive Agents|antidepressive agents|mesh-ancestor
65073143|NCT00334035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65073144|NCT00334035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65073145|NCT00334035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65073146|NCT00334035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65073147|NCT00334035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073148|NCT00334152|Casopitant|casopitant|mesh-list
65073149|NCT00334152|Antiemetics|antiemetics|mesh-ancestor
65073150|NCT00334152|Autonomic Agents|autonomic agents|mesh-ancestor
65073151|NCT00334152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65073152|NCT00334152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073153|NCT00334152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65073154|NCT00334152|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65073155|NCT00334152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65073156|NCT00334152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073157|NCT04698512|Sirolimus|sirolimus|mesh-list
65073158|NCT04698512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65073159|NCT04698512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65073160|NCT04698512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65073161|NCT04698512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073162|NCT04698512|Antifungal Agents|antifungal agents|mesh-ancestor
65073163|NCT04698512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65073164|NCT04698512|Immunologic Factors|immunologic factors|mesh-ancestor
65073165|NCT04698512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073166|NCT00334308|Caseins|caseins|mesh-list
64833592|NCT05646563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65073167|NCT00334308|Chelating Agents|chelating agents|mesh-ancestor
65073168|NCT00334308|Sequestering Agents|sequestering agents|mesh-ancestor
65073169|NCT00334308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073170|NCT00334347|Valproic Acid|valproic acid|mesh-list
65073171|NCT00334347|Anticonvulsants|anticonvulsants|mesh-ancestor
65073172|NCT00334347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073173|NCT00334347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073174|NCT00334347|GABA Agents|gaba agents|mesh-ancestor
65073175|NCT00334347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65073176|NCT00334347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073177|NCT00334347|Antimanic Agents|antimanic agents|mesh-ancestor
65073178|NCT00334347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65073179|NCT00334347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65073180|NCT00334347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65073181|NCT00334386|Torsemide|torsemide|mesh-list
65073182|NCT00334386|Diuretics|diuretics|mesh-list
65073183|NCT00334386|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
65073184|NCT00334386|Natriuretic Agents|natriuretic agents|mesh-ancestor
65073185|NCT00334386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073186|NCT00334386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65073187|NCT00334386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073188|NCT00334386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65073189|NCT00452231|Cycloserine|cycloserine|mesh-list
65073190|NCT00452231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65073191|NCT00452231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65073192|NCT00452231|Renal Agents|renal agents|mesh-ancestor
65073193|NCT00452231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65073194|NCT00452231|Antitubercular Agents|antitubercular agents|mesh-ancestor
65073195|NCT00452231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65073196|NCT00452231|Antimetabolites|antimetabolites|mesh-ancestor
65073197|NCT00452231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073198|NCT00334425|Menotropins|menotropins|mesh-list
65073199|NCT00334425|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65073200|NCT00334425|Fertility Agents|fertility agents|mesh-ancestor
65073201|NCT00334425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65073202|NCT00334425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073203|NCT03275207|Dexmedetomidine|dexmedetomidine|mesh-list
65073204|NCT03275207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65073205|NCT03275207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65073206|NCT03275207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073207|NCT03275207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65073208|NCT03275207|Analgesics|analgesics|mesh-ancestor
65073209|NCT03275207|Sensory System Agents|sensory system agents|mesh-ancestor
65073210|NCT03275207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65073211|NCT03275207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64715262|NCT05113004|Mycophenolic Acid|mycophenolic acid|mesh-list
65073212|NCT03275207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65073213|NCT03275207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65073214|NCT03275207|Adrenergic Agents|adrenergic agents|mesh-ancestor
65073215|NCT03275207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65073216|NCT03275207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073218|NCT00334464|Anticoagulants|anticoagulants|mesh-ancestor
65073219|NCT03275012|Morphine|morphine|mesh-list
65073220|NCT03275012|Gabapentin|gabapentin|mesh-list
65073221|NCT03275012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65073222|NCT03275012|Narcotics|narcotics|mesh-ancestor
65073223|NCT03275012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65073224|NCT03275012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073225|NCT03275012|Analgesics|analgesics|mesh-ancestor
65073226|NCT03275012|Sensory System Agents|sensory system agents|mesh-ancestor
65073227|NCT03275012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65073228|NCT03275012|Anticonvulsants|anticonvulsants|mesh-ancestor
65073229|NCT03275012|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65073230|NCT03275012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65073231|NCT03275012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64833593|NCT05646563|Immunologic Factors|immunologic factors|mesh-ancestor
65073232|NCT03275012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65073233|NCT03275012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65073234|NCT03275012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65073235|NCT03275012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073236|NCT03275012|Antimanic Agents|antimanic agents|mesh-ancestor
65073237|NCT00334503|Miglitol|miglitol|mesh-list
65073238|NCT00334503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073239|NCT00334503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073240|NCT00334503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65073241|NCT00334503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073242|NCT00334503|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65073243|NCT00334581|Irbesartan|irbesartan|mesh-list
65073244|NCT00334581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65073245|NCT00334581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65073246|NCT00334581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65073247|NCT00334581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073249|NCT00452270|Nasal Decongestants|nasal decongestants|mesh-ancestor
65073250|NCT00452270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65073251|NCT00452270|Respiratory System Agents|respiratory system agents|mesh-ancestor
65073252|NCT00452582|Sildenafil Citrate|sildenafil citrate|mesh-list
65073253|NCT00452582|Vasodilator Agents|vasodilator agents|mesh-ancestor
65073254|NCT00452582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65073255|NCT00452582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65073256|NCT00452582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073257|NCT00452582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073258|NCT00452582|Urological Agents|urological agents|mesh-ancestor
65073259|NCT00334698|Cetirizine|cetirizine|mesh-list
65073260|NCT00334698|Pseudoephedrine|pseudoephedrine|mesh-list
65073261|NCT00334698|Ephedrine|ephedrine|mesh-list
65073262|NCT00334698|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65073263|NCT00334698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65073264|NCT00334698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65073265|NCT00334698|Histamine Antagonists|histamine antagonists|mesh-ancestor
65073266|NCT00334698|Histamine Agents|histamine agents|mesh-ancestor
65073267|NCT00334698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65073268|NCT00334698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073269|NCT00334698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073270|NCT00334698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65073271|NCT00334698|Autonomic Agents|autonomic agents|mesh-ancestor
65073272|NCT00334698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65073273|NCT00334698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65073274|NCT00334698|Respiratory System Agents|respiratory system agents|mesh-ancestor
65073275|NCT00334698|Nasal Decongestants|nasal decongestants|mesh-ancestor
65073276|NCT00334698|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65073277|NCT00334698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65073278|NCT00334698|Sympathomimetics|sympathomimetics|mesh-ancestor
65073279|NCT00334698|Adrenergic Agents|adrenergic agents|mesh-ancestor
65073280|NCT00452660|Deferasirox|deferasirox|mesh-list
65073281|NCT00452660|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65073282|NCT00452660|Chelating Agents|chelating agents|mesh-ancestor
65073283|NCT00452660|Sequestering Agents|sequestering agents|mesh-ancestor
64833602|NCT05610072|Acetylcysteine|acetylcysteine|mesh-list
64833613|NCT05610072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073284|NCT00452660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073285|NCT00334854|Doxorubicin|doxorubicin|mesh-list
65073286|NCT00334854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65073287|NCT00334854|Ifosfamide|ifosfamide|mesh-list
65073288|NCT00334854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65073289|NCT00334854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073290|NCT00334854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65073291|NCT00334854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65073292|NCT00334854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073293|NCT00334854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073294|NCT00334854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65073295|NCT00334854|Alkylating Agents|alkylating agents|mesh-ancestor
65073296|NCT00334932|Doxorubicin|doxorubicin|mesh-list
65073297|NCT00334932|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65073298|NCT00334932|Bortezomib|bortezomib|mesh-list
65073299|NCT00334932|Melphalan|melphalan|mesh-list
65073300|NCT00334932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65073301|NCT00334932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073302|NCT00334932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65073303|NCT00334932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65073304|NCT00334932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073305|NCT00334932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073306|NCT00334932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65073307|NCT00334932|Alkylating Agents|alkylating agents|mesh-ancestor
65073308|NCT00334932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65073309|NCT00334932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65073310|NCT00334932|Immunologic Factors|immunologic factors|mesh-ancestor
65073311|NCT00334932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073312|NCT00335010|Nitroglycerin|nitroglycerin|mesh-list
65073313|NCT00335010|Vasodilator Agents|vasodilator agents|mesh-ancestor
65073314|NCT00452855|Remifentanil|remifentanil|mesh-list
65073315|NCT00452855|Sevoflurane|sevoflurane|mesh-list
65073316|NCT00452855|Anesthetics|anesthetics|mesh-ancestor
65073317|NCT00452855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65073318|NCT00452855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073319|NCT00452855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65073320|NCT00452855|Narcotics|narcotics|mesh-ancestor
65073322|NCT00452855|Sensory System Agents|sensory system agents|mesh-ancestor
65073323|NCT00452855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65073324|NCT00452855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65073325|NCT00452855|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65073326|NCT00452855|Anesthetics, General|anesthetics, general|mesh-ancestor
65073327|NCT00335088|Iodine|iodine|mesh-list
65073328|NCT00335088|Moxifloxacin|moxifloxacin|mesh-list
65073329|NCT00335088|Povidone-Iodine|povidone-iodine|mesh-list
65073330|NCT00335088|Povidone|povidone|mesh-list
65073331|NCT00335088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65073332|NCT00335088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65073333|NCT00335088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65073334|NCT00335088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65073335|NCT00335088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073336|NCT00335088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073337|NCT00335088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073338|NCT00335088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073339|NCT00335088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65073340|NCT00335088|Trace Elements|trace elements|mesh-ancestor
65073341|NCT00335088|Micronutrients|micronutrients|mesh-ancestor
65073342|NCT00335088|Plasma Substitutes|plasma substitutes|mesh-ancestor
65073343|NCT00335088|Blood Substitutes|blood substitutes|mesh-ancestor
65073344|NCT00452894|Varenicline|varenicline|mesh-list
65073345|NCT00452894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65073346|NCT00452894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65073347|NCT00452894|Cholinergic Agents|cholinergic agents|mesh-ancestor
65073348|NCT00452894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65073349|NCT00452894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073350|NCT00452894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325003|NCT05265975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325004|NCT05265975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64325005|NCT05265975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65073351|NCT00335166|Pramipexole|pramipexole|mesh-list
65073352|NCT00335166|Antioxidants|antioxidants|mesh-ancestor
65073353|NCT00335166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073354|NCT00335166|Protective Agents|protective agents|mesh-ancestor
65073355|NCT00335166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073356|NCT00335166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65073357|NCT00335166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65073358|NCT00335166|Dopamine Agonists|dopamine agonists|mesh-ancestor
65073359|NCT00335166|Dopamine Agents|dopamine agents|mesh-ancestor
65073360|NCT00335166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65073361|NCT00452972|Anesthetics|anesthetics|mesh-list
65073362|NCT00452972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65073363|NCT00452972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073364|NCT00335205|Ropinirole|ropinirole|mesh-list
65073365|NCT00335205|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65073366|NCT00335205|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65073367|NCT00335205|Dopamine Agonists|dopamine agonists|mesh-ancestor
65073368|NCT00335205|Dopamine Agents|dopamine agents|mesh-ancestor
65073369|NCT00335205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65073370|NCT00335205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073371|NCT00335205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073372|NCT00453050|Imiquimod|imiquimod|mesh-list
65073373|NCT00453050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65073374|NCT00453050|Immunologic Factors|immunologic factors|mesh-ancestor
65073375|NCT00453050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073376|NCT00453050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073377|NCT00453050|Interferon Inducers|interferon inducers|mesh-ancestor
65073378|NCT00335400|Anesthetics|anesthetics|mesh-list
65073379|NCT00335400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65073380|NCT00335400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073381|NCT00420615|Epothilone B|epothilone b|mesh-list
65073382|NCT00420615|Epothilones|epothilones|mesh-list
65073383|NCT00420615|Omeprazole|omeprazole|mesh-list
65073384|NCT00420615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65073385|NCT00420615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65073386|NCT00420615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65073387|NCT00420615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073388|NCT00420615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073389|NCT00420615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073390|NCT00420615|Tubulin Modulators|tubulin modulators|mesh-ancestor
65073391|NCT00420615|Antimitotic Agents|antimitotic agents|mesh-ancestor
65073392|NCT00420615|Mitosis Modulators|mitosis modulators|mesh-ancestor
65073393|NCT00453167|Gemcitabine|gemcitabine|mesh-list
65073394|NCT00453167|Paclitaxel|paclitaxel|mesh-list
65073395|NCT00453167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65073396|NCT00453167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073397|NCT00453167|Tubulin Modulators|tubulin modulators|mesh-ancestor
65073398|NCT00453167|Antimitotic Agents|antimitotic agents|mesh-ancestor
65073399|NCT00453167|Mitosis Modulators|mitosis modulators|mesh-ancestor
65073400|NCT00453167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073401|NCT00453167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65073402|NCT00453167|Antimetabolites|antimetabolites|mesh-ancestor
64833618|NCT05610072|Analgesics|analgesics|mesh-ancestor
64833619|NCT05610072|Sensory System Agents|sensory system agents|mesh-ancestor
64833620|NCT05610072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64833622|NCT05553808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833623|NCT05553808|Tubulin Modulators|tubulin modulators|mesh-ancestor
64833624|NCT05553808|Antimitotic Agents|antimitotic agents|mesh-ancestor
64833625|NCT05553808|Mitosis Modulators|mitosis modulators|mesh-ancestor
65073403|NCT00453167|Antiviral Agents|antiviral agents|mesh-ancestor
65073404|NCT00453167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65073405|NCT00453167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073406|NCT00453167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65073407|NCT00453167|Immunologic Factors|immunologic factors|mesh-ancestor
65073408|NCT00453167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073409|NCT00420654|Hormones|hormones|mesh-list
65073410|NCT00420654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65073411|NCT00420654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073412|NCT00420693|Sevoflurane|sevoflurane|mesh-list
65073413|NCT00420693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65073414|NCT00420693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65073415|NCT00420693|Anesthetics, General|anesthetics, general|mesh-ancestor
65073416|NCT00420693|Anesthetics|anesthetics|mesh-ancestor
65073417|NCT00420693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65073418|NCT00420693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073419|NCT03274895|Biguanides|biguanides|mesh-list
65073420|NCT03274895|Polihexanide|polihexanide|mesh-list
65073421|NCT03274895|Dibrompropamidine|dibrompropamidine|mesh-list
65073422|NCT03274895|Propamidine|propamidine|mesh-list
65073423|NCT03274895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65073424|NCT03274895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073425|NCT03274895|Disinfectants|disinfectants|mesh-ancestor
65073426|NCT03274895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65073427|NCT03274895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65073428|NCT03274895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65073429|NCT03274895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65073430|NCT00453323|Paclitaxel|paclitaxel|mesh-list
65073431|NCT00453323|Capecitabine|capecitabine|mesh-list
65073432|NCT00453323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65073433|NCT00453323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073434|NCT00453323|Tubulin Modulators|tubulin modulators|mesh-ancestor
65073435|NCT00453323|Antimitotic Agents|antimitotic agents|mesh-ancestor
65073436|NCT00453323|Mitosis Modulators|mitosis modulators|mesh-ancestor
65073437|NCT00453323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073438|NCT00453323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65073439|NCT00453323|Antimetabolites|antimetabolites|mesh-ancestor
65073440|NCT00335439|Ketorolac|ketorolac|mesh-list
65073441|NCT00335439|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65073442|NCT00335439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65073443|NCT00335439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65073444|NCT00335439|Analgesics|analgesics|mesh-ancestor
65073445|NCT00335439|Sensory System Agents|sensory system agents|mesh-ancestor
65073446|NCT00335439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65073447|NCT00335439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073448|NCT00335439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65073449|NCT00335439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65073450|NCT00335439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65073451|NCT00335439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073452|NCT00335439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073453|NCT00453401|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
65073454|NCT00453401|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
65073455|NCT00453401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073456|NCT00453401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073457|NCT00335673|Irbesartan|irbesartan|mesh-list
65073458|NCT00335673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65073459|NCT00335673|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65073460|NCT00335673|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65073461|NCT00335673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073462|NCT00453635|Carboplatin|carboplatin|mesh-list
65073463|NCT00453635|Docetaxel|docetaxel|mesh-list
65073464|NCT00453635|Trastuzumab|trastuzumab|mesh-list
65073465|NCT00453635|Vinorelbine|vinorelbine|mesh-list
65073466|NCT00453635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073467|NCT00453635|Tubulin Modulators|tubulin modulators|mesh-ancestor
65073468|NCT00453635|Antimitotic Agents|antimitotic agents|mesh-ancestor
65073469|NCT00453635|Mitosis Modulators|mitosis modulators|mesh-ancestor
65073470|NCT00453635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073471|NCT00453635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65073472|NCT00453635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65073473|NCT00335907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65073474|NCT00335985|Immunoglobulins|immunoglobulins|mesh-list
65073475|NCT00335985|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65073476|NCT00335985|gamma-Globulins|gamma-globulins|mesh-list
65073477|NCT00335985|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65073478|NCT00335985|Immunologic Factors|immunologic factors|mesh-ancestor
65073479|NCT00335985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073480|NCT00336141|Vorinostat|vorinostat|mesh-list
65073481|NCT00336141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073482|NCT00336141|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65073483|NCT00336141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073484|NCT00336141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073485|NCT00336219|Pantoprazole|pantoprazole|mesh-list
65073486|NCT00336219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65073487|NCT00336219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65073488|NCT00336219|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65073489|NCT00336219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073490|NCT00336219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073491|NCT00453908|Alfuzosin|alfuzosin|mesh-list
65073492|NCT00453908|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65073493|NCT00453908|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65073494|NCT00453908|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65073495|NCT00453908|Adrenergic Agents|adrenergic agents|mesh-ancestor
65073496|NCT00453908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65073497|NCT00453908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073498|NCT00453908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073499|NCT00453908|Urological Agents|urological agents|mesh-ancestor
65073500|NCT00336336|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65073501|NCT00336336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65073502|NCT00336336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65073503|NCT00336336|Antimetabolites|antimetabolites|mesh-ancestor
65073504|NCT00336336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073505|NCT00336336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65073506|NCT00336336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65073507|NCT00336336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073508|NCT00336375|Lumefantrine|lumefantrine|mesh-list
65073509|NCT00336375|Artemether|artemether|mesh-list
65073510|NCT00336375|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65073511|NCT00336375|Antimalarials|antimalarials|mesh-ancestor
65073512|NCT00336375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65073513|NCT00336375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65073514|NCT00336375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65073515|NCT00336414|Prednisone|prednisone|mesh-list
65073516|NCT00336414|Cyclophosphamide|cyclophosphamide|mesh-list
65073517|NCT00336414|Azathioprine|azathioprine|mesh-list
65073518|NCT00336414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65073519|NCT00336414|Immunologic Factors|immunologic factors|mesh-ancestor
65073520|NCT00336414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073521|NCT00336414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65073522|NCT00336414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65073523|NCT00336414|Alkylating Agents|alkylating agents|mesh-ancestor
65073524|NCT00336414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073525|NCT00336414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073526|NCT00336414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65073527|NCT00336414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65073528|NCT00336414|Glucocorticoids|glucocorticoids|mesh-ancestor
65073529|NCT00336414|Hormones|hormones|mesh-ancestor
65073530|NCT00336414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65073531|NCT00336414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65073532|NCT00336414|Antimetabolites|antimetabolites|mesh-ancestor
65073533|NCT00336414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65073534|NCT00336453|Hemagglutinins|hemagglutinins|mesh-list
65073535|NCT00336453|Agglutinins|agglutinins|mesh-ancestor
65073536|NCT00336453|Immunologic Factors|immunologic factors|mesh-ancestor
65073537|NCT00336453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073538|NCT00336531|Itraconazole|itraconazole|mesh-list
65073539|NCT00336531|Antifungal Agents|antifungal agents|mesh-ancestor
65073540|NCT00336531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65073541|NCT00336531|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65073542|NCT00336531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65073543|NCT00336531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073544|NCT00336531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073545|NCT00336531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65073546|NCT00336531|Hormone Antagonists|hormone antagonists|mesh-ancestor
65073547|NCT00336531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65073548|NCT00336531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073549|NCT00336531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65073551|NCT00322062|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65073552|NCT00322062|Antioxidants|antioxidants|mesh-ancestor
65073553|NCT00322062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073554|NCT00322062|Protective Agents|protective agents|mesh-ancestor
65073555|NCT00322062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073556|NCT00322062|Vitamins|vitamins|mesh-ancestor
65073557|NCT00322062|Micronutrients|micronutrients|mesh-ancestor
65073558|NCT00322062|Laxatives|laxatives|mesh-ancestor
65073559|NCT00322062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65073560|NCT00336648|Gemcitabine|gemcitabine|mesh-list
65073561|NCT00336648|Bevacizumab|bevacizumab|mesh-list
65073562|NCT00336648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65073563|NCT00336648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073564|NCT00336648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65073565|NCT00336648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65073566|NCT00336648|Growth Substances|growth substances|mesh-ancestor
65073567|NCT00336648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073568|NCT00336648|Growth Inhibitors|growth inhibitors|mesh-ancestor
65073569|NCT00336648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65073570|NCT00336648|Antimetabolites|antimetabolites|mesh-ancestor
65073571|NCT00336648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073572|NCT00336648|Antiviral Agents|antiviral agents|mesh-ancestor
65073573|NCT00336648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65073574|NCT00336648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073575|NCT00336648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65073576|NCT00336648|Immunologic Factors|immunologic factors|mesh-ancestor
64833637|NCT05540184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833638|NCT05540184|Vasodilator Agents|vasodilator agents|mesh-ancestor
64833639|NCT05493761|Denosumab|denosumab|mesh-list
64833640|NCT05493761|Alendronate|alendronate|mesh-list
64833641|NCT05493761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64833642|NCT05493761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395951|NCT02102477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395952|NCT03103685|Clopidogrel|clopidogrel|mesh-list
64395954|NCT03103685|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65073577|NCT03274817|Citalopram|citalopram|mesh-list
65073578|NCT03274817|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65073579|NCT03274817|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65073580|NCT03274817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65073581|NCT03274817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65073582|NCT03274817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073583|NCT03274817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65073584|NCT03274817|Serotonin Agents|serotonin agents|mesh-ancestor
65073585|NCT03274817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073586|NCT03274817|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64715643|NCT00716755|Dopamine Agents|dopamine agents|mesh-ancestor
65073587|NCT03274817|Antidepressive Agents|antidepressive agents|mesh-ancestor
65073588|NCT03274817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65073589|NCT03274817|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65073590|NCT00230204|Antibodies|antibodies|mesh-list
65073591|NCT00230204|Immunologic Factors|immunologic factors|mesh-ancestor
65073592|NCT00230204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073593|NCT00230321|Darbepoetin alfa|darbepoetin alfa|mesh-list
65073594|NCT00230321|Hematinics|hematinics|mesh-ancestor
65073595|NCT00230399|Celecoxib|celecoxib|mesh-list
65073596|NCT00230399|Capecitabine|capecitabine|mesh-list
65073597|NCT00230399|Irinotecan|irinotecan|mesh-list
65073598|NCT00230399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65073599|NCT00230399|Antimetabolites|antimetabolites|mesh-ancestor
65073600|NCT00230399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073601|NCT00230399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073602|NCT00230399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65073603|NCT00230399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65073604|NCT00230399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073605|NCT00230399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65073606|NCT00230399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65073607|NCT00230399|Analgesics|analgesics|mesh-ancestor
65073608|NCT00230399|Sensory System Agents|sensory system agents|mesh-ancestor
65073609|NCT00230399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65073610|NCT00230399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073611|NCT00230399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65073612|NCT00230399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65073613|NCT00230399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65073614|NCT00230399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65073616|NCT00336765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073617|NCT00336765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65073618|NCT00336765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073619|NCT00336765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073620|NCT00230477|Lamivudine|lamivudine|mesh-list
65073621|NCT00230477|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65073622|NCT00230477|Adefovir|adefovir|mesh-list
65073623|NCT00230477|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65073624|NCT00230477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65073625|NCT00230477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073626|NCT00230477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073627|NCT00230477|Antiviral Agents|antiviral agents|mesh-ancestor
65073628|NCT00230477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65073629|NCT00230477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65073630|NCT00230477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65073631|NCT00230516|Lansoprazole|lansoprazole|mesh-list
65073632|NCT00230516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65073633|NCT00230516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65073634|NCT00230516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65073635|NCT00230516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073636|NCT00230516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073637|NCT00336882|Midazolam|midazolam|mesh-list
65073638|NCT00336882|Propofol|propofol|mesh-list
64396041|NCT04701593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073639|NCT00336882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65073640|NCT00336882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65073641|NCT00336882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073642|NCT00336882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65073643|NCT00336882|Anesthetics, General|anesthetics, general|mesh-ancestor
65073644|NCT00336882|Anesthetics|anesthetics|mesh-ancestor
65073645|NCT00336882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65073646|NCT00336882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65073647|NCT00336882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65073648|NCT00336882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65073649|NCT00336882|GABA Modulators|gaba modulators|mesh-ancestor
65073650|NCT00336882|GABA Agents|gaba agents|mesh-ancestor
65073651|NCT00336882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65073652|NCT00336882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073653|NCT00336921|Alfuzosin|alfuzosin|mesh-list
65073654|NCT00336921|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65073655|NCT00336921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65073656|NCT00336921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65073657|NCT00336921|Adrenergic Agents|adrenergic agents|mesh-ancestor
65073658|NCT00336921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65073659|NCT00336921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073660|NCT00336921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073661|NCT00336921|Urological Agents|urological agents|mesh-ancestor
65073662|NCT00336960|Celecoxib|celecoxib|mesh-list
65073663|NCT00336960|Fluorouracil|fluorouracil|mesh-list
65073664|NCT00336960|Antimetabolites|antimetabolites|mesh-ancestor
65073665|NCT00336960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073666|NCT00336960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65073667|NCT00336960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073668|NCT00336960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65073669|NCT00336960|Immunologic Factors|immunologic factors|mesh-ancestor
65073670|NCT00336960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073671|NCT00336960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65073672|NCT00336960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65073673|NCT00336960|Analgesics|analgesics|mesh-ancestor
65073674|NCT00336960|Sensory System Agents|sensory system agents|mesh-ancestor
65073675|NCT00336960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65073676|NCT00336960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65073677|NCT00336960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65073678|NCT00336960|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65073679|NCT00336960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65073680|NCT00336960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073681|NCT00306410|Cholecalciferol|cholecalciferol|mesh-list
65073682|NCT00306410|Vitamin D|vitamin d|mesh-list
65073683|NCT00306410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65073684|NCT00306410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073685|NCT00306410|Vitamins|vitamins|mesh-ancestor
65073686|NCT00306410|Micronutrients|micronutrients|mesh-ancestor
65073687|NCT00306410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65073688|NCT00340080|Abacavir|abacavir|mesh-list
65073689|NCT00340080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64833643|NCT05473195|Isoniazid|isoniazid|mesh-list
64833644|NCT05473195|Ethionamide|ethionamide|mesh-list
64833645|NCT05473195|Antitubercular Agents|antitubercular agents|mesh-ancestor
64833646|NCT05473195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64396082|NCT01641107|Ponatinib|ponatinib|mesh-list
65073690|NCT00340080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65073691|NCT00340080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073692|NCT00340080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073693|NCT00340080|Antiviral Agents|antiviral agents|mesh-ancestor
65073694|NCT00340080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65073695|NCT00340080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65073696|NCT00340080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65073698|NCT00418535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073699|NCT02960711|Metformin|metformin|mesh-list
65073700|NCT02960711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65073701|NCT02960711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073702|NCT00337155|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65073703|NCT00337155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073704|NCT00340314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
65073705|NCT00306644|Rosiglitazone|rosiglitazone|mesh-list
65073706|NCT00306644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65073707|NCT00306644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073708|NCT00306683|Diazoxide|diazoxide|mesh-list
65073709|NCT00306683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65073710|NCT00306683|Vasodilator Agents|vasodilator agents|mesh-ancestor
65073711|NCT00306722|Fospropofol|fospropofol|mesh-list
65073712|NCT00306722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65073713|NCT00306722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65073714|NCT00306722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073715|NCT00337389|Leucovorin|leucovorin|mesh-list
65073716|NCT00337389|Bevacizumab|bevacizumab|mesh-list
65073717|NCT00337389|Fluorouracil|fluorouracil|mesh-list
65073718|NCT00337389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65073719|NCT00337389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073720|NCT00337389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65073721|NCT00337389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65073722|NCT00337389|Growth Substances|growth substances|mesh-ancestor
65073723|NCT00337389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073724|NCT00337389|Growth Inhibitors|growth inhibitors|mesh-ancestor
65073725|NCT00337389|Antimetabolites|antimetabolites|mesh-ancestor
65073726|NCT00337389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073727|NCT00337389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65073728|NCT00337389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65073729|NCT00337389|Immunologic Factors|immunologic factors|mesh-ancestor
65073730|NCT00337389|Antidotes|antidotes|mesh-ancestor
65073731|NCT00337389|Protective Agents|protective agents|mesh-ancestor
65073732|NCT00337389|Vitamin B Complex|vitamin b complex|mesh-ancestor
65073733|NCT00337389|Vitamins|vitamins|mesh-ancestor
65073734|NCT00337389|Micronutrients|micronutrients|mesh-ancestor
65073735|NCT00306800|Aminolevulinic Acid|aminolevulinic acid|mesh-list
65073736|NCT00306800|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65073737|NCT00306800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65073738|NCT00306800|Dermatologic Agents|dermatologic agents|mesh-ancestor
64715798|NCT03185065|Analgesics|analgesics|mesh-ancestor
65073739|NCT00306878|Abatacept|abatacept|mesh-list
65073740|NCT00306878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65073741|NCT00306878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073742|NCT00306878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073743|NCT00306878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65073744|NCT00306878|Immunologic Factors|immunologic factors|mesh-ancestor
65073745|NCT00306878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073746|NCT00306878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65073747|NCT00337506|Dexamethasone|dexamethasone|mesh-list
65073748|NCT00337506|Bortezomib|bortezomib|mesh-list
65073749|NCT00337506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65073750|NCT00337506|Antiemetics|antiemetics|mesh-ancestor
65073751|NCT00337506|Autonomic Agents|autonomic agents|mesh-ancestor
65073752|NCT00337506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65073753|NCT00337506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073754|NCT00337506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65073755|NCT00337506|Glucocorticoids|glucocorticoids|mesh-ancestor
65073756|NCT00337506|Hormones|hormones|mesh-ancestor
64482840|NCT04385836|Protease Inhibitors|protease inhibitors|mesh-ancestor
64416081|NCT05504213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073757|NCT00337506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65073758|NCT00337506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65073759|NCT00337506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073761|NCT00337545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073762|NCT00337545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65073763|NCT00337545|Immunologic Factors|immunologic factors|mesh-ancestor
65073764|NCT00337545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073765|NCT00307307|Niacin|niacin|mesh-list
65073766|NCT00307307|Simvastatin|simvastatin|mesh-list
65073767|NCT00307307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65073768|NCT00307307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65073769|NCT00307307|Antimetabolites|antimetabolites|mesh-ancestor
65073770|NCT00307307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073771|NCT00307307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65073772|NCT00307307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65073773|NCT00307307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073774|NCT00307307|Vasodilator Agents|vasodilator agents|mesh-ancestor
65073775|NCT00307307|Vitamin B Complex|vitamin b complex|mesh-ancestor
65073776|NCT00307307|Vitamins|vitamins|mesh-ancestor
65073777|NCT00307307|Micronutrients|micronutrients|mesh-ancestor
65073778|NCT00307307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073779|NCT00337623|Prednisolone|prednisolone|mesh-list
65073780|NCT00337623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65073781|NCT00337623|Glucocorticoids|glucocorticoids|mesh-ancestor
65073782|NCT00337623|Hormones|hormones|mesh-ancestor
65073783|NCT00337623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65073784|NCT00337623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073785|NCT00337623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65073786|NCT00337623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073787|NCT00337701|Enfuvirtide|enfuvirtide|mesh-list
65073788|NCT00337701|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65073789|NCT00337701|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65073790|NCT00337701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073791|NCT00337701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64833664|NCT05419505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833665|NCT05419505|Hemostatics|hemostatics|mesh-ancestor
64833666|NCT05419505|Coagulants|coagulants|mesh-ancestor
64833667|NCT05414240|Ibudilast|ibudilast|mesh-list
64833668|NCT05414240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64833669|NCT05414240|Autonomic Agents|autonomic agents|mesh-ancestor
64833670|NCT05414240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64833671|NCT05414240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833672|NCT05414240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64833673|NCT05414240|Respiratory System Agents|respiratory system agents|mesh-ancestor
64396169|NCT03882905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396171|NCT02669017|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
65073792|NCT00337701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65073793|NCT00337701|Antiviral Agents|antiviral agents|mesh-ancestor
65073794|NCT00337701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65073795|NCT00307463|Antihypertensive Agents|antihypertensive agents|mesh-list
65073796|NCT00337740|Propranolol|propranolol|mesh-list
65073797|NCT00337740|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65073798|NCT00337740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65073799|NCT00337740|Adrenergic Agents|adrenergic agents|mesh-ancestor
65073800|NCT00337740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65073801|NCT00337740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073802|NCT00337740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073803|NCT00337740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65073804|NCT00337740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65073805|NCT00337740|Vasodilator Agents|vasodilator agents|mesh-ancestor
65073806|NCT00307502|Ritonavir|ritonavir|mesh-list
65073807|NCT00307502|Lopinavir|lopinavir|mesh-list
65073808|NCT00307502|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65073809|NCT00307502|Darunavir|darunavir|mesh-list
65073810|NCT00307502|Nelfinavir|nelfinavir|mesh-list
65073811|NCT00307502|Indinavir|indinavir|mesh-list
65073812|NCT00307502|Saquinavir|saquinavir|mesh-list
65073813|NCT00307502|Amprenavir|amprenavir|mesh-list
64715868|NCT02185014|Adalimumab|adalimumab|mesh-list
65073814|NCT00307502|Fosamprenavir|fosamprenavir|mesh-list
65073815|NCT00307502|Nevirapine|nevirapine|mesh-list
65073816|NCT00307502|Tipranavir|tipranavir|mesh-list
65073818|NCT00307502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65073819|NCT00307502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65073820|NCT00307502|Protease Inhibitors|protease inhibitors|mesh-ancestor
65073821|NCT00307502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073822|NCT00307502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073823|NCT00307502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65073824|NCT00307502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65073825|NCT00307502|Antiviral Agents|antiviral agents|mesh-ancestor
65073826|NCT00307502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65073827|NCT00307502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65073828|NCT00307502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65073829|NCT00307502|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64416085|NCT02564471|Doxycycline|doxycycline|mesh-list
64833675|NCT05414240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073830|NCT00307502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65073831|NCT00307502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65073832|NCT00307502|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65073833|NCT00307502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65073834|NCT00307502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65073835|NCT00307502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65073836|NCT00307502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65073837|NCT00307502|Antitubercular Agents|antitubercular agents|mesh-ancestor
65073838|NCT00307502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65073839|NCT00307580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
65073840|NCT00307580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65073841|NCT00307580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65073842|NCT00307580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073843|NCT00307619|Topiramate|topiramate|mesh-list
65073844|NCT00307619|Anticonvulsants|anticonvulsants|mesh-ancestor
65073845|NCT00307619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65073846|NCT00307619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073847|NCT00307658|Immunoglobulins|immunoglobulins|mesh-list
65073848|NCT00307658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65073849|NCT00307658|Antibodies|antibodies|mesh-list
65073850|NCT00307658|Immunoglobulin G|immunoglobulin g|mesh-list
65073851|NCT00307658|gamma-Globulins|gamma-globulins|mesh-list
65073852|NCT00307658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65073853|NCT00307658|Immunologic Factors|immunologic factors|mesh-ancestor
65073854|NCT00307658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073855|NCT00307775|Estradiol|estradiol|mesh-list
65073856|NCT00307775|Estrogens|estrogens|mesh-ancestor
65073857|NCT00307775|Hormones|hormones|mesh-ancestor
65073858|NCT00307775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65073859|NCT00307775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073860|NCT00307814|Epoetin Alfa|epoetin alfa|mesh-list
65073861|NCT00307814|Hematinics|hematinics|mesh-ancestor
65073862|NCT00341055|Epoetin Alfa|epoetin alfa|mesh-list
65073863|NCT00341055|Hematinics|hematinics|mesh-ancestor
65073864|NCT00338052|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65073865|NCT00338052|Norethindrone|norethindrone|mesh-list
65073866|NCT00338052|Norethindrone Acetate|norethindrone acetate|mesh-list
65073867|NCT00338052|Estradiol|estradiol|mesh-list
65073868|NCT00338052|Estrogens|estrogens|mesh-ancestor
65073869|NCT00338052|Hormones|hormones|mesh-ancestor
65073870|NCT00338052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65073871|NCT00338052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073872|NCT00338052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65073873|NCT00338052|Contraceptive Agents|contraceptive agents|mesh-ancestor
65073874|NCT00338052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65073875|NCT00338052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65073876|NCT00338052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65073877|NCT00338052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65073878|NCT00338052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65073879|NCT00338091|Losartan|losartan|mesh-list
65073880|NCT00338091|Benazepril|benazepril|mesh-list
65073881|NCT00338091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65073882|NCT00338091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65073883|NCT00338091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65073884|NCT00338091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65073885|NCT00338091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073886|NCT00338091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65073887|NCT00338091|Protease Inhibitors|protease inhibitors|mesh-ancestor
65073888|NCT00338091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073889|NCT00308048|Interferons|interferons|mesh-list
65073890|NCT00308048|Ribavirin|ribavirin|mesh-list
64715939|NCT02158806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073892|NCT00308048|Interferon alpha-2|interferon alpha-2|mesh-list
65073893|NCT00308048|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65073894|NCT00308048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073895|NCT00308048|Antiviral Agents|antiviral agents|mesh-ancestor
65073896|NCT00308048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65073897|NCT00308048|Antimetabolites|antimetabolites|mesh-ancestor
65073898|NCT00308048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073899|NCT00308048|Immunologic Factors|immunologic factors|mesh-ancestor
65073900|NCT00308048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073901|NCT00338130|Temozolomide|temozolomide|mesh-list
64416086|NCT02564471|Chloroquine|chloroquine|mesh-list
65073902|NCT00338130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65073903|NCT00338130|Alkylating Agents|alkylating agents|mesh-ancestor
65073904|NCT00338130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073905|NCT00338130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64482853|NCT01274260|Antiemetics|antiemetics|mesh-ancestor
65073906|NCT00308126|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65073907|NCT00308126|Plasma Substitutes|plasma substitutes|mesh-ancestor
65073908|NCT00308126|Blood Substitutes|blood substitutes|mesh-ancestor
65073910|NCT00308165|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65073911|NCT00308165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65073912|NCT00308165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073913|NCT00308165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073914|NCT00308165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073915|NCT04715568|Losartan|losartan|mesh-list
65073916|NCT04715568|Antihypertensive Agents|antihypertensive agents|mesh-list
65073917|NCT04715568|Angiotensin II|angiotensin ii|mesh-list
65073918|NCT04715568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65073919|NCT04715568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65073920|NCT04715568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65073921|NCT04715568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073922|NCT04715568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65073923|NCT00418730|Proteasome Inhibitors|proteasome inhibitors|mesh-list
65073924|NCT00418730|Protease Inhibitors|protease inhibitors|mesh-ancestor
65073925|NCT00418730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073926|NCT00418730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073927|NCT00425334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64833703|NCT05344911|Narcotics|narcotics|mesh-ancestor
64833704|NCT05344911|Analgesics|analgesics|mesh-ancestor
64833705|NCT05344911|Sensory System Agents|sensory system agents|mesh-ancestor
65073928|NCT00338247|Capecitabine|capecitabine|mesh-list
65073929|NCT00338247|Lapatinib|lapatinib|mesh-list
65073930|NCT00338247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65073931|NCT00338247|Antimetabolites|antimetabolites|mesh-ancestor
65073932|NCT00338247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073933|NCT00338247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073934|NCT00338247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65073935|NCT00338247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073936|NCT00308321|Prednisolone|prednisolone|mesh-list
65073937|NCT00308321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65073938|NCT00308321|Methylprednisolone|methylprednisolone|mesh-list
65073939|NCT00308321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65073940|NCT00308321|Prednisolone acetate|prednisolone acetate|mesh-list
65073941|NCT00308321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65073942|NCT00308321|Prednisolone phosphate|prednisolone phosphate|mesh-list
65073943|NCT00308321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65073944|NCT00308321|Glucocorticoids|glucocorticoids|mesh-ancestor
65073945|NCT00308321|Hormones|hormones|mesh-ancestor
65073946|NCT00308321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65073947|NCT00308321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073948|NCT00308321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65073949|NCT00308321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073950|NCT00308321|Antiemetics|antiemetics|mesh-ancestor
65073951|NCT00308321|Autonomic Agents|autonomic agents|mesh-ancestor
65073952|NCT00308321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65073953|NCT00308321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65073954|NCT00308321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65073955|NCT00308321|Protective Agents|protective agents|mesh-ancestor
65073956|NCT00308360|Valproic Acid|valproic acid|mesh-list
65073957|NCT00308360|Risperidone|risperidone|mesh-list
65073958|NCT00308360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65073959|NCT00308360|Serotonin Agents|serotonin agents|mesh-ancestor
65073960|NCT00308360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65073961|NCT00308360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073962|NCT00308360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073963|NCT00308360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65073964|NCT00308360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65073965|NCT00308360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65073966|NCT00308360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65073967|NCT00308360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65073968|NCT00308360|Dopamine Agents|dopamine agents|mesh-ancestor
65073969|NCT00308360|Anticonvulsants|anticonvulsants|mesh-ancestor
65073970|NCT00308360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65073972|NCT00308360|Antimanic Agents|antimanic agents|mesh-ancestor
65073973|NCT00341250|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65073974|NCT00341250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65073975|NCT00341250|Immunologic Factors|immunologic factors|mesh-ancestor
65073976|NCT00341250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073978|NCT00341250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65073979|NCT00341250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65073980|NCT00308438|Teduglutide|teduglutide|mesh-list
65073981|NCT00308438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65073982|NCT00308438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65073983|NCT00308438|Protective Agents|protective agents|mesh-ancestor
65073984|NCT00308438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073985|NCT00308477|Dexamethasone|dexamethasone|mesh-list
65073986|NCT00308477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65073987|NCT00308477|Antiemetics|antiemetics|mesh-ancestor
65073988|NCT00308477|Autonomic Agents|autonomic agents|mesh-ancestor
65073989|NCT00308477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65073990|NCT00308477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65073991|NCT00308477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65073992|NCT00308477|Glucocorticoids|glucocorticoids|mesh-ancestor
65073993|NCT00308477|Hormones|hormones|mesh-ancestor
65073994|NCT00308477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65073995|NCT00308477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65073996|NCT00308477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65073997|NCT00308594|Dexamethasone|dexamethasone|mesh-list
65073998|NCT00308594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65073999|NCT00308594|Antiemetics|antiemetics|mesh-ancestor
65074000|NCT00308594|Autonomic Agents|autonomic agents|mesh-ancestor
65074001|NCT00308594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65074002|NCT00308594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074003|NCT00308594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65074004|NCT00308594|Glucocorticoids|glucocorticoids|mesh-ancestor
65074005|NCT00308594|Hormones|hormones|mesh-ancestor
65074006|NCT00308594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65074007|NCT00308594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65074008|NCT00308594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074009|NCT00308945|Travoprost|travoprost|mesh-list
65074010|NCT00308945|Latanoprost|latanoprost|mesh-list
65074011|NCT00308945|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65074012|NCT00308945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65074013|NCT00308945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65074014|NCT00338481|Morphine|morphine|mesh-list
65074015|NCT00338481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65074016|NCT00338481|Narcotics|narcotics|mesh-ancestor
65074017|NCT00338481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65074018|NCT00338481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074019|NCT00338481|Analgesics|analgesics|mesh-ancestor
65074020|NCT00338481|Sensory System Agents|sensory system agents|mesh-ancestor
65074021|NCT00338481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65074022|NCT00309101|Tacrolimus|tacrolimus|mesh-list
65074023|NCT00309101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65074024|NCT00309101|Immunologic Factors|immunologic factors|mesh-ancestor
65074025|NCT00309101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074026|NCT00309101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65074027|NCT00309101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074028|NCT00309101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074029|NCT00309218|Methylprednisolone|methylprednisolone|mesh-list
65074030|NCT00309218|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65074031|NCT00309218|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65074032|NCT00309218|Prednisolone|prednisolone|mesh-list
65074033|NCT00309218|Prednisolone acetate|prednisolone acetate|mesh-list
65074034|NCT00309218|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65074036|NCT00309218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65074037|NCT00309218|Antiemetics|antiemetics|mesh-ancestor
64716101|NCT03312517|Suvorexant|suvorexant|mesh-list
65074038|NCT00309218|Autonomic Agents|autonomic agents|mesh-ancestor
65074039|NCT00309218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65074040|NCT00309218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074041|NCT00309218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65074043|NCT00309218|Hormones|hormones|mesh-ancestor
65074044|NCT00309218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65074045|NCT00309218|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65074046|NCT00309218|Protective Agents|protective agents|mesh-ancestor
65074047|NCT00309218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65074048|NCT00309218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074049|NCT00309335|Phentolamine|phentolamine|mesh-list
65074050|NCT00309335|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65074051|NCT00309335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65074052|NCT00309335|Adrenergic Agents|adrenergic agents|mesh-ancestor
65074053|NCT00309335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65074054|NCT00309335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074055|NCT00309335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074056|NCT00309335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65074058|NCT00309374|Simvastatin|simvastatin|mesh-list
65074059|NCT00309374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65074060|NCT00309374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65074061|NCT00309374|Antimetabolites|antimetabolites|mesh-ancestor
64833722|NCT05281328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074062|NCT00309374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833723|NCT05267626|Aldesleukin|aldesleukin|mesh-list
64833724|NCT05267626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325006|NCT05265975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64325007|NCT05265975|Growth Substances|growth substances|mesh-ancestor
65074063|NCT00309374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65074064|NCT00309374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65074065|NCT00309374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074066|NCT00309413|Cannabidiol|cannabidiol|mesh-list
65074067|NCT00309413|Anticonvulsants|anticonvulsants|mesh-ancestor
65074068|NCT00309491|Tamoxifen|tamoxifen|mesh-list
65074069|NCT00309491|Aminoglutethimide|aminoglutethimide|mesh-list
65074070|NCT00309491|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65074071|NCT00309491|Hormone Antagonists|hormone antagonists|mesh-ancestor
65074072|NCT00309491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65074073|NCT00309491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074074|NCT00309491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65074075|NCT00309491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074076|NCT00309491|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65074077|NCT00309491|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65074078|NCT00309491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65074079|NCT00309491|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65074080|NCT00309491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65074081|NCT00309491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074082|NCT00309491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074083|NCT02960048|Salicylic Acid|salicylic acid|mesh-list
65074084|NCT02960048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65074085|NCT02960048|Antifungal Agents|antifungal agents|mesh-ancestor
65074086|NCT02960048|Keratolytic Agents|keratolytic agents|mesh-ancestor
65074087|NCT02960048|Dermatologic Agents|dermatologic agents|mesh-ancestor
65074088|NCT00309530|Interferons|interferons|mesh-list
65074089|NCT00309530|Fluorouracil|fluorouracil|mesh-list
65074090|NCT00309530|Antimetabolites|antimetabolites|mesh-ancestor
65074091|NCT00309530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074092|NCT00309530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65074093|NCT00309530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074094|NCT00309530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65074095|NCT00309530|Immunologic Factors|immunologic factors|mesh-ancestor
65074096|NCT00309530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074097|NCT00309530|Antiviral Agents|antiviral agents|mesh-ancestor
65074098|NCT00309530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65074099|NCT00309569|Cyclophosphamide|cyclophosphamide|mesh-list
65074100|NCT00309569|Fluorouracil|fluorouracil|mesh-list
65074101|NCT00309569|Methotrexate|methotrexate|mesh-list
65074102|NCT00309569|Epirubicin|epirubicin|mesh-list
65074103|NCT00309569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65074104|NCT00309569|Immunologic Factors|immunologic factors|mesh-ancestor
65074105|NCT00309569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074106|NCT00309569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65074107|NCT00309569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65074108|NCT00309569|Alkylating Agents|alkylating agents|mesh-ancestor
65074109|NCT00309569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074110|NCT00309569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074111|NCT00309569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65074112|NCT00309569|Antimetabolites|antimetabolites|mesh-ancestor
65074113|NCT00309569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65074114|NCT00309569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65074115|NCT00309569|Abortifacient Agents|abortifacient agents|mesh-ancestor
65074116|NCT00309569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65074117|NCT00309569|Dermatologic Agents|dermatologic agents|mesh-ancestor
65074118|NCT00309569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074119|NCT00309569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65074120|NCT00309569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65074121|NCT00309569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65074122|NCT00309569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65074123|NCT00309569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65074124|NCT00309686|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65074125|NCT00309686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65074126|NCT00309686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65074127|NCT00309686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65074128|NCT00309686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074129|NCT00309686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65074130|NCT00309686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65074131|NCT00309686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65074132|NCT00309686|Serotonin Agents|serotonin agents|mesh-ancestor
65074133|NCT00309686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65074134|NCT00309686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074135|NCT00309686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65074136|NCT00309686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65074137|NCT00309686|Dopamine Agents|dopamine agents|mesh-ancestor
65074138|NCT00309725|Galantamine|galantamine|mesh-list
65074139|NCT00309725|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65074140|NCT00309725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074141|NCT00309725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074142|NCT00309725|Cholinergic Agents|cholinergic agents|mesh-ancestor
65074143|NCT00309725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65074144|NCT00309725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074145|NCT00309725|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65074146|NCT00309725|Autonomic Agents|autonomic agents|mesh-ancestor
65074147|NCT00309725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65074148|NCT00309725|Nootropic Agents|nootropic agents|mesh-ancestor
65074150|NCT00338754|Antibodies|antibodies|mesh-list
65074151|NCT00338754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65074152|NCT00338754|Immunologic Factors|immunologic factors|mesh-ancestor
65074153|NCT00338754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074154|NCT00338754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65074155|NCT00338754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65074156|NCT00338793|Prednisolone|prednisolone|mesh-list
65074157|NCT00338793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65074158|NCT00338793|Glucocorticoids|glucocorticoids|mesh-ancestor
65074159|NCT00338793|Hormones|hormones|mesh-ancestor
65074160|NCT00338793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65074161|NCT00338793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074162|NCT00338793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65074163|NCT00338793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074164|NCT00418847|Miglustat|miglustat|mesh-list
65074165|NCT00418847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074166|NCT00418847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074167|NCT00418847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65074168|NCT00418847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65074169|NCT00418847|Antiviral Agents|antiviral agents|mesh-ancestor
65074170|NCT00418847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65074171|NCT00418847|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65074172|NCT00418847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65074173|NCT00418847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074174|NCT00309881|Prednisone|prednisone|mesh-list
65074175|NCT00309881|Cyclophosphamide|cyclophosphamide|mesh-list
65074176|NCT00309881|Rituximab|rituximab|mesh-list
65074177|NCT00309881|Doxorubicin|doxorubicin|mesh-list
65074178|NCT00309881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65074179|NCT00309881|Vincristine|vincristine|mesh-list
65074180|NCT00309881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65074181|NCT00309881|Immunologic Factors|immunologic factors|mesh-ancestor
64416133|NCT02568683|Tubulin Modulators|tubulin modulators|mesh-ancestor
64396531|NCT02371603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64396532|NCT02371603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64396533|NCT02371603|Renal Agents|renal agents|mesh-ancestor
64396548|NCT04149145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396549|NCT02378389|Docetaxel|docetaxel|mesh-list
64396550|NCT02378389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074182|NCT00309881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074183|NCT00309881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65074184|NCT00309881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65074185|NCT00309881|Alkylating Agents|alkylating agents|mesh-ancestor
65074186|NCT00309881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074187|NCT00309881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074188|NCT00309881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65074189|NCT00309881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65074190|NCT00309881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65074191|NCT00309881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65074192|NCT00309881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65074193|NCT00309881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074194|NCT00309881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65074195|NCT00309881|Glucocorticoids|glucocorticoids|mesh-ancestor
65074197|NCT00309881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65074198|NCT00309881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65074199|NCT00309881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65074200|NCT00309881|Tubulin Modulators|tubulin modulators|mesh-ancestor
65074201|NCT00309881|Antimitotic Agents|antimitotic agents|mesh-ancestor
65074202|NCT00309881|Mitosis Modulators|mitosis modulators|mesh-ancestor
65074203|NCT00309920|Cyclophosphamide|cyclophosphamide|mesh-list
65074204|NCT00309920|Docetaxel|docetaxel|mesh-list
65074205|NCT00309920|Doxorubicin|doxorubicin|mesh-list
65074206|NCT00309920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65074207|NCT00309920|Fluorouracil|fluorouracil|mesh-list
65074208|NCT00309920|Epirubicin|epirubicin|mesh-list
65074209|NCT00309920|Darbepoetin alfa|darbepoetin alfa|mesh-list
65074210|NCT00309920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65074211|NCT00309920|Immunologic Factors|immunologic factors|mesh-ancestor
65074212|NCT00309920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074213|NCT00309920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65074214|NCT00309920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65074215|NCT00309920|Alkylating Agents|alkylating agents|mesh-ancestor
65074216|NCT00309920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074217|NCT00309920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074218|NCT00309920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65074219|NCT00309920|Tubulin Modulators|tubulin modulators|mesh-ancestor
65074220|NCT00309920|Antimitotic Agents|antimitotic agents|mesh-ancestor
65074221|NCT00309920|Mitosis Modulators|mitosis modulators|mesh-ancestor
65074222|NCT00309920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65074223|NCT00309920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65074224|NCT00309920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65074225|NCT00309920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074226|NCT00309920|Antimetabolites|antimetabolites|mesh-ancestor
65074227|NCT00309920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65074228|NCT00309920|Hematinics|hematinics|mesh-ancestor
65074229|NCT00309998|Bevacizumab|bevacizumab|mesh-list
65074230|NCT00309998|Vinorelbine|vinorelbine|mesh-list
65074231|NCT00309998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65074232|NCT00309998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074233|NCT00309998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65074234|NCT00309998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65074235|NCT00309998|Growth Substances|growth substances|mesh-ancestor
65074236|NCT00309998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074237|NCT00309998|Growth Inhibitors|growth inhibitors|mesh-ancestor
65074238|NCT00309998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65074239|NCT00309998|Tubulin Modulators|tubulin modulators|mesh-ancestor
65074240|NCT00309998|Antimitotic Agents|antimitotic agents|mesh-ancestor
65074241|NCT00309998|Mitosis Modulators|mitosis modulators|mesh-ancestor
65074242|NCT00309998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074243|NCT04715217|Cyclophosphamide|cyclophosphamide|mesh-list
65074244|NCT04715217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64396573|NCT02376049|Betamethasone benzoate|betamethasone benzoate|mesh-list
65074245|NCT04715217|Immunologic Factors|immunologic factors|mesh-ancestor
65074246|NCT04715217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074247|NCT04715217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65074248|NCT04715217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65074249|NCT04715217|Alkylating Agents|alkylating agents|mesh-ancestor
65074250|NCT04715217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074251|NCT04715217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074252|NCT04715217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65074253|NCT00310154|Docetaxel|docetaxel|mesh-list
65074254|NCT00310154|Gefitinib|gefitinib|mesh-list
64646829|NCT01210079|Gabapentin|gabapentin|mesh-list
65074255|NCT00310154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074256|NCT00310154|Tubulin Modulators|tubulin modulators|mesh-ancestor
65074257|NCT00310154|Antimitotic Agents|antimitotic agents|mesh-ancestor
65074258|NCT00310154|Mitosis Modulators|mitosis modulators|mesh-ancestor
65074259|NCT00310154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074260|NCT00310154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65074261|NCT00310154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074262|NCT00338910|Metronidazole|metronidazole|mesh-list
65074263|NCT00338910|Budesonide|budesonide|mesh-list
65074264|NCT00338910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65074266|NCT00338910|Autonomic Agents|autonomic agents|mesh-ancestor
65074267|NCT00338910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65074268|NCT00338910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074269|NCT00338910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65074270|NCT00338910|Respiratory System Agents|respiratory system agents|mesh-ancestor
65074271|NCT00338910|Glucocorticoids|glucocorticoids|mesh-ancestor
65074272|NCT00338910|Hormones|hormones|mesh-ancestor
65074273|NCT00338910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65074274|NCT00338910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65074275|NCT00338910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65074276|NCT00338910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65074277|NCT00338910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65074279|NCT00310232|Hematinics|hematinics|mesh-ancestor
65074280|NCT00310349|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65074281|NCT00310349|Immunologic Factors|immunologic factors|mesh-ancestor
65074282|NCT00310349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074283|NCT00310505|Amphotericin B|amphotericin b|mesh-list
65074284|NCT00310505|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65074285|NCT00310505|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
65074286|NCT00310505|Deoxycholic Acid|deoxycholic acid|mesh-list
65074287|NCT00310505|Amebicides|amebicides|mesh-ancestor
65074288|NCT00310505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65074289|NCT00310505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65074290|NCT00310505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65074291|NCT00310505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65074292|NCT00310505|Antifungal Agents|antifungal agents|mesh-ancestor
65074293|NCT00310505|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65074294|NCT00310505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65074295|NCT00339066|Sertraline|sertraline|mesh-list
65074296|NCT00339066|Antidepressive Agents|antidepressive agents|mesh-ancestor
65074297|NCT00339066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65074298|NCT00339066|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65074299|NCT00339066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65074300|NCT00339066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65074301|NCT00339066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074302|NCT00339066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65074303|NCT00339066|Serotonin Agents|serotonin agents|mesh-ancestor
64833725|NCT05267626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64833726|NCT05267626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65074304|NCT00339066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074305|NCT00310583|Pregabalin|pregabalin|mesh-list
65074306|NCT00310583|Analgesics|analgesics|mesh-ancestor
65074307|NCT00310583|Sensory System Agents|sensory system agents|mesh-ancestor
65074308|NCT00310583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65074309|NCT00310583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074310|NCT00310583|Anticonvulsants|anticonvulsants|mesh-ancestor
65074311|NCT00310583|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65074312|NCT00310583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65074313|NCT00310583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074314|NCT00310583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65074315|NCT00310583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65074316|NCT00310583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65074317|NCT00310583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65074318|NCT00310583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65074319|NCT00421044|Epothilone B|epothilone b|mesh-list
65074320|NCT00421044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074321|NCT00421044|Tubulin Modulators|tubulin modulators|mesh-ancestor
65074322|NCT00421044|Antimitotic Agents|antimitotic agents|mesh-ancestor
65074323|NCT00421044|Mitosis Modulators|mitosis modulators|mesh-ancestor
65074324|NCT00421044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074325|NCT00425217|Rituximab|rituximab|mesh-list
65074326|NCT00425217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65074327|NCT00425217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074328|NCT00425217|Immunologic Factors|immunologic factors|mesh-ancestor
65074329|NCT00425217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074330|NCT00425217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65074332|NCT00310778|Valsartan|valsartan|mesh-list
65074333|NCT00310778|Candesartan|candesartan|mesh-list
65074334|NCT00310778|Ramipril|ramipril|mesh-list
65074335|NCT00310778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65074336|NCT00310778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65074337|NCT00310778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65074338|NCT00310778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074339|NCT00310778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65074340|NCT00310778|Protease Inhibitors|protease inhibitors|mesh-ancestor
65074341|NCT00310778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074342|NCT00310778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65074343|NCT00310778|Sympatholytics|sympatholytics|mesh-ancestor
65074344|NCT00310778|Autonomic Agents|autonomic agents|mesh-ancestor
65074345|NCT00310778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65074346|NCT00310778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074347|NCT00310778|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65074348|NCT00310778|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65074349|NCT00310778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65074350|NCT00310778|Adrenergic Agents|adrenergic agents|mesh-ancestor
65074351|NCT00310778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65074352|NCT00421083|Tadalafil|tadalafil|mesh-list
65074353|NCT00421083|Vasodilator Agents|vasodilator agents|mesh-ancestor
65074354|NCT00421083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65074355|NCT00421083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65074356|NCT00421083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074357|NCT00421083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074358|NCT00421083|Urological Agents|urological agents|mesh-ancestor
65074359|NCT00310895|Imetelstat|imetelstat|mesh-list
65074360|NCT00310895|Motesanib diphosphate|motesanib diphosphate|mesh-list
65074361|NCT00310895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074362|NCT00310895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074363|NCT00310895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65074364|NCT00310934|Buprenorphine|buprenorphine|mesh-list
65074365|NCT00310934|Methadone|methadone|mesh-list
65074366|NCT00310934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65074367|NCT00310934|Narcotics|narcotics|mesh-ancestor
65074368|NCT00310934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64833734|NCT05251376|Morphine|morphine|mesh-list
64833735|NCT05251376|Methadone|methadone|mesh-list
65074369|NCT00310934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074370|NCT00310934|Analgesics|analgesics|mesh-ancestor
65074371|NCT00310934|Sensory System Agents|sensory system agents|mesh-ancestor
65074372|NCT00310934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65074373|NCT00310934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65074374|NCT00310934|Antitussive Agents|antitussive agents|mesh-ancestor
65074375|NCT00310934|Respiratory System Agents|respiratory system agents|mesh-ancestor
65074376|NCT00421122|Budesonide|budesonide|mesh-list
65074377|NCT00421122|Terbutaline|terbutaline|mesh-list
65074378|NCT00421122|Formoterol Fumarate|formoterol fumarate|mesh-list
65074379|NCT00421122|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
65074380|NCT00421122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65074381|NCT00421122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65074382|NCT00421122|Autonomic Agents|autonomic agents|mesh-ancestor
65074383|NCT00421122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65074384|NCT00421122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074385|NCT00421122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65074386|NCT00421122|Respiratory System Agents|respiratory system agents|mesh-ancestor
65074387|NCT00421122|Glucocorticoids|glucocorticoids|mesh-ancestor
65074388|NCT00421122|Hormones|hormones|mesh-ancestor
65074389|NCT00421122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65074390|NCT00421122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65074391|NCT00421122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65074392|NCT00421122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65074393|NCT00421122|Adrenergic Agents|adrenergic agents|mesh-ancestor
65074394|NCT00421122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65074395|NCT00421122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074396|NCT00421122|Sympathomimetics|sympathomimetics|mesh-ancestor
65074397|NCT00421122|Tocolytic Agents|tocolytic agents|mesh-ancestor
65074398|NCT00421122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65074399|NCT00311051|Ramatroban|ramatroban|mesh-list
65074400|NCT00311051|Montelukast|montelukast|mesh-list
65074401|NCT00311051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65074402|NCT00311051|Respiratory System Agents|respiratory system agents|mesh-ancestor
65074403|NCT00311051|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65074404|NCT00311051|Hormone Antagonists|hormone antagonists|mesh-ancestor
65074405|NCT00311051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65074406|NCT00311051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074407|NCT00311051|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65074408|NCT00311051|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65074409|NCT00311051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074410|NCT00311051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64396622|NCT01957150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64396624|NCT01957150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64396625|NCT01957150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396626|NCT01957150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64396627|NCT01957150|Respiratory System Agents|respiratory system agents|mesh-ancestor
64396628|NCT01957150|Dermatologic Agents|dermatologic agents|mesh-ancestor
64396629|NCT01957150|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64396630|NCT01995526|Insulin|insulin|mesh-list
64396631|NCT01995526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64396632|NCT01995526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396633|NCT01973218|Vaccines|vaccines|mesh-list
64396634|NCT01973218|Immunologic Factors|immunologic factors|mesh-ancestor
64396635|NCT01973218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396636|NCT01946152|Dexamethasone|dexamethasone|mesh-list
64396637|NCT01946152|Dexamethasone acetate|dexamethasone acetate|mesh-list
65074411|NCT00311129|Rituximab|rituximab|mesh-list
65074412|NCT00311129|Fludarabine|fludarabine|mesh-list
65074413|NCT00311129|Fludarabine phosphate|fludarabine phosphate|mesh-list
65074414|NCT00311129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65074415|NCT00311129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074416|NCT00311129|Immunologic Factors|immunologic factors|mesh-ancestor
65074417|NCT00311129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074418|NCT00311129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65074419|NCT00311129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65074420|NCT00311129|Antimetabolites|antimetabolites|mesh-ancestor
65074421|NCT00311129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074422|NCT00311129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65074423|NCT00311285|Hydrocortisone|hydrocortisone|mesh-list
65074424|NCT00311285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65074425|NCT00342381|Amifampridine|amifampridine|mesh-list
65074426|NCT00342381|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65074427|NCT00342381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65074428|NCT00342381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074429|NCT00342381|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65074430|NCT00342381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65074431|NCT00342381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074432|NCT00311558|Interferons|interferons|mesh-list
65074433|NCT00311558|Interferon-alpha|interferon-alpha|mesh-list
65074434|NCT00311558|Interferon alpha-2|interferon alpha-2|mesh-list
65074435|NCT00311558|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
65074436|NCT00311558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074437|NCT00311558|Antiviral Agents|antiviral agents|mesh-ancestor
65074438|NCT00311558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65074439|NCT00311558|Immunologic Factors|immunologic factors|mesh-ancestor
65074440|NCT00311558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074441|NCT00311558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65074442|NCT00311558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65074443|NCT00311558|Schistosomicides|schistosomicides|mesh-ancestor
65074444|NCT00311558|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65074445|NCT00311558|Anthelmintics|anthelmintics|mesh-ancestor
65074446|NCT00418925|Dronabinol|dronabinol|mesh-list
65074447|NCT00418925|Hallucinogens|hallucinogens|mesh-ancestor
65074448|NCT00418925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074449|NCT00418925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65074450|NCT00418925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65074451|NCT00418925|Analgesics|analgesics|mesh-ancestor
65074452|NCT00418925|Sensory System Agents|sensory system agents|mesh-ancestor
65074453|NCT00418925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65074454|NCT00418925|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65074455|NCT00418925|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65074456|NCT00418925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65074457|NCT00418925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074458|NCT00418925|Hormones|hormones|mesh-ancestor
65074459|NCT00418925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65074460|NCT00339417|Ivermectin|ivermectin|mesh-list
65074461|NCT00339417|Albendazole|albendazole|mesh-list
65074462|NCT00339417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65074463|NCT00339417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65074464|NCT00339417|Anthelmintics|anthelmintics|mesh-ancestor
65074465|NCT00339417|Anticestodal Agents|anticestodal agents|mesh-ancestor
65074466|NCT00339417|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65074467|NCT00339417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65074468|NCT00339417|Tubulin Modulators|tubulin modulators|mesh-ancestor
65074469|NCT00339417|Antimitotic Agents|antimitotic agents|mesh-ancestor
65074470|NCT00339417|Mitosis Modulators|mitosis modulators|mesh-ancestor
65074471|NCT00339417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074472|NCT00339417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074473|NCT00311636|Paclitaxel|paclitaxel|mesh-list
65074474|NCT00311636|Docetaxel|docetaxel|mesh-list
64325020|NCT02151305|Remifentanil|remifentanil|mesh-list
64325021|NCT02151305|Propofol|propofol|mesh-list
64325022|NCT02151305|Sevoflurane|sevoflurane|mesh-list
64325023|NCT02151305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65074475|NCT00311636|Cyclophosphamide|cyclophosphamide|mesh-list
65074476|NCT00311636|Doxorubicin|doxorubicin|mesh-list
65074477|NCT00311636|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65074478|NCT00311636|Fluorouracil|fluorouracil|mesh-list
65074479|NCT00311636|Methotrexate|methotrexate|mesh-list
65074480|NCT00311636|Epirubicin|epirubicin|mesh-list
65074481|NCT00311636|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65074482|NCT00311636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65074483|NCT00311636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074484|NCT00311636|Tubulin Modulators|tubulin modulators|mesh-ancestor
65074485|NCT00311636|Antimitotic Agents|antimitotic agents|mesh-ancestor
65074486|NCT00311636|Mitosis Modulators|mitosis modulators|mesh-ancestor
65074487|NCT00311636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074488|NCT00311636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65074489|NCT00311636|Immunologic Factors|immunologic factors|mesh-ancestor
65074490|NCT00311636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074491|NCT00311636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65074492|NCT00311636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65074493|NCT00311636|Alkylating Agents|alkylating agents|mesh-ancestor
65074494|NCT00311636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65074495|NCT00311636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65074496|NCT00311636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65074497|NCT00311636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65074498|NCT00311636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074500|NCT00311636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65074501|NCT00311636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65074502|NCT00311636|Abortifacient Agents|abortifacient agents|mesh-ancestor
65074503|NCT00311636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65074504|NCT00311636|Dermatologic Agents|dermatologic agents|mesh-ancestor
65074505|NCT00311636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65074506|NCT00311636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65074507|NCT00311636|Luteolytic Agents|luteolytic agents|mesh-ancestor
65074508|NCT00311636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65074509|NCT00311636|Contraceptive Agents|contraceptive agents|mesh-ancestor
65074510|NCT00311636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65074511|NCT00311636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65074512|NCT00311753|Heparin|heparin|mesh-list
65074513|NCT00311753|Certoparin|certoparin|mesh-list
65074514|NCT00311753|Anticoagulants|anticoagulants|mesh-ancestor
65074515|NCT00311753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65074516|NCT00311753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65074517|NCT00311753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074518|NCT00311870|Lisinopril|lisinopril|mesh-list
65074519|NCT00311870|Nisoldipine|nisoldipine|mesh-list
65074520|NCT00311870|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65074521|NCT00311870|Protease Inhibitors|protease inhibitors|mesh-ancestor
65074522|NCT00311870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074523|NCT00311870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074524|NCT00311870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65074525|NCT00311870|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65074526|NCT00311870|Protective Agents|protective agents|mesh-ancestor
65074527|NCT00311870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074528|NCT00311870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65074529|NCT00311870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65074530|NCT00311870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65074531|NCT00311870|Vasodilator Agents|vasodilator agents|mesh-ancestor
65074532|NCT00311987|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
65074533|NCT00311987|Hormones|hormones|mesh-ancestor
65074534|NCT00311987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65074535|NCT00311987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074536|NCT00342849|Succimer|succimer|mesh-list
65074537|NCT00342849|Antidotes|antidotes|mesh-ancestor
64325031|NCT02151305|Analgesics|analgesics|mesh-ancestor
64325032|NCT02151305|Sensory System Agents|sensory system agents|mesh-ancestor
64325033|NCT02151305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64325035|NCT02151305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65074538|NCT00342849|Protective Agents|protective agents|mesh-ancestor
65074539|NCT00342849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074540|NCT00342849|Chelating Agents|chelating agents|mesh-ancestor
65074541|NCT00342849|Sequestering Agents|sequestering agents|mesh-ancestor
65074542|NCT00342849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074543|NCT00312104|Insulin|insulin|mesh-list
65074544|NCT00312104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65074545|NCT00312104|Insulin Glargine|insulin glargine|mesh-list
65074546|NCT00312104|Insulin Aspart|insulin aspart|mesh-list
65074547|NCT00312104|Insulin Detemir|insulin detemir|mesh-list
65074548|NCT00312104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65074549|NCT00312104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074550|NCT00312143|Mycophenolic Acid|mycophenolic acid|mesh-list
65074551|NCT00312143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65074552|NCT00312143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074553|NCT00312143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65074554|NCT00312143|Antitubercular Agents|antitubercular agents|mesh-ancestor
65074555|NCT00312143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65074556|NCT00312143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65074557|NCT00312143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074558|NCT00312143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074560|NCT00343005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65074561|NCT00343005|Immunologic Factors|immunologic factors|mesh-ancestor
65074562|NCT00343005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716617|NCT03537404|Ritonavir|ritonavir|mesh-list
65074563|NCT00343005|Antacids|antacids|mesh-ancestor
65074564|NCT00343005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074565|NCT00343005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65074566|NCT00312182|Nelfinavir|nelfinavir|mesh-list
65074567|NCT00312182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65074568|NCT00312182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65074569|NCT00312182|Protease Inhibitors|protease inhibitors|mesh-ancestor
65074570|NCT00312182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074571|NCT00312182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074572|NCT00312182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65074573|NCT00312182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65074574|NCT00312182|Antiviral Agents|antiviral agents|mesh-ancestor
65074575|NCT00312182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65074576|NCT00312260|Gabapentin|gabapentin|mesh-list
65074577|NCT00312260|Amitriptyline|amitriptyline|mesh-list
65074578|NCT00312260|Analgesics|analgesics|mesh-ancestor
65074579|NCT00312260|Sensory System Agents|sensory system agents|mesh-ancestor
65074580|NCT00312260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65074581|NCT00312260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074582|NCT00312260|Anticonvulsants|anticonvulsants|mesh-ancestor
65074583|NCT00312260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65074584|NCT00312260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65074585|NCT00312260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65074586|NCT00312260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65074587|NCT00312260|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65074588|NCT00312260|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65074589|NCT00312260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65074590|NCT00312260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833736|NCT05251376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64396737|NCT01953328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64396738|NCT01953328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64396739|NCT01953328|Antimetabolites|antimetabolites|mesh-ancestor
64396740|NCT01953328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396741|NCT01953328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64396743|NCT01953328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074591|NCT00312260|Antimanic Agents|antimanic agents|mesh-ancestor
65074592|NCT00312260|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65074593|NCT00312260|Antidepressive Agents|antidepressive agents|mesh-ancestor
65074594|NCT00312260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65074595|NCT00312260|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65074596|NCT00312260|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65074597|NCT00312260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65074598|NCT00312260|Adrenergic Agents|adrenergic agents|mesh-ancestor
65074599|NCT00312299|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
65074600|NCT00312299|Vasodilator Agents|vasodilator agents|mesh-ancestor
65074601|NCT00312299|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65074602|NCT00312299|Protective Agents|protective agents|mesh-ancestor
65074603|NCT00312299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074604|NCT00312416|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65074605|NCT00312416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65074606|NCT00312416|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65074607|NCT00312416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65074608|NCT00312416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65074609|NCT00312416|Adrenergic Agents|adrenergic agents|mesh-ancestor
65074610|NCT00312416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65074611|NCT00312416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074612|NCT00312416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074613|NCT00339768|Amoxicillin|amoxicillin|mesh-list
65074614|NCT00339768|Omeprazole|omeprazole|mesh-list
65074615|NCT00339768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65074616|NCT00339768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65074617|NCT00339768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65074618|NCT00339768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65074619|NCT00339768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65074620|NCT00339768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074621|NCT00339768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074622|NCT00343161|Esomeprazole|esomeprazole|mesh-list
65074623|NCT00343161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65074625|NCT00343161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65074626|NCT00343161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65074627|NCT00343161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65074628|NCT00343161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074629|NCT00343161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074630|NCT00343161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65074631|NCT00343161|Immunologic Factors|immunologic factors|mesh-ancestor
65074632|NCT00343161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074633|NCT00343161|Antacids|antacids|mesh-ancestor
65074635|NCT00312533|Viscosupplements|viscosupplements|mesh-ancestor
65074636|NCT00312533|Protective Agents|protective agents|mesh-ancestor
65074637|NCT00312533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074638|NCT00312650|Gemcitabine|gemcitabine|mesh-list
65074639|NCT00312650|Doxorubicin|doxorubicin|mesh-list
65074640|NCT00312650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65074641|NCT00312650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65074642|NCT00312650|Antimetabolites|antimetabolites|mesh-ancestor
65074643|NCT00312650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074644|NCT00312650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074645|NCT00312650|Antiviral Agents|antiviral agents|mesh-ancestor
65074646|NCT00312650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65074647|NCT00312650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074648|NCT00312650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65074649|NCT00312650|Immunologic Factors|immunologic factors|mesh-ancestor
65074650|NCT00312650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074651|NCT00312650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65074652|NCT00312650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65074653|NCT00312650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65074654|NCT00343200|Sildenafil Citrate|sildenafil citrate|mesh-list
65074655|NCT00343200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074656|NCT00343200|Vasodilator Agents|vasodilator agents|mesh-ancestor
65074657|NCT00343200|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65074658|NCT00343200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65074659|NCT00343200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074660|NCT00343200|Urological Agents|urological agents|mesh-ancestor
65074661|NCT00312806|Pantoprazole|pantoprazole|mesh-list
65074662|NCT00312806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65074663|NCT00312806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65074664|NCT00312806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65074665|NCT00312806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074666|NCT00312806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074667|NCT00347685|Tramadol|tramadol|mesh-list
65074668|NCT00347685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65074669|NCT00347685|Narcotics|narcotics|mesh-ancestor
65074670|NCT00347685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65074671|NCT00347685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074672|NCT00347685|Analgesics|analgesics|mesh-ancestor
65074673|NCT00347685|Sensory System Agents|sensory system agents|mesh-ancestor
65074674|NCT00347685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65074675|NCT00343239|Docetaxel|docetaxel|mesh-list
65074676|NCT00343239|Fluorouracil|fluorouracil|mesh-list
65074677|NCT00343239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074678|NCT00343239|Tubulin Modulators|tubulin modulators|mesh-ancestor
65074679|NCT00343239|Antimitotic Agents|antimitotic agents|mesh-ancestor
65074680|NCT00343239|Mitosis Modulators|mitosis modulators|mesh-ancestor
65074681|NCT00343239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074682|NCT00343239|Antimetabolites|antimetabolites|mesh-ancestor
65074683|NCT00343239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65074684|NCT00343239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65074685|NCT00343239|Immunologic Factors|immunologic factors|mesh-ancestor
65074686|NCT00343239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074687|NCT00313001|Insulin Aspart|insulin aspart|mesh-list
65074688|NCT00313001|Exenatide|exenatide|mesh-list
65074689|NCT00313001|Biphasic Insulins|biphasic insulins|mesh-list
65074690|NCT00313001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65074691|NCT00313001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074692|NCT00313001|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65074693|NCT00313001|Incretins|incretins|mesh-ancestor
65074694|NCT00313001|Hormones|hormones|mesh-ancestor
65074695|NCT00313001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65074696|NCT00343278|Valacyclovir|valacyclovir|mesh-list
65074697|NCT00343278|Antiviral Agents|antiviral agents|mesh-ancestor
65074700|NCT00343317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65074701|NCT00343317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65074702|NCT00313079|Vincristine|vincristine|mesh-list
65074703|NCT00313079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65074704|NCT00313079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074705|NCT00313079|Tubulin Modulators|tubulin modulators|mesh-ancestor
65074706|NCT00313079|Antimitotic Agents|antimitotic agents|mesh-ancestor
65074707|NCT00313079|Mitosis Modulators|mitosis modulators|mesh-ancestor
65074708|NCT00313079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074709|NCT00347724|Tramadol|tramadol|mesh-list
65074710|NCT00347724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65074711|NCT00347724|Narcotics|narcotics|mesh-ancestor
65074712|NCT00347724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65074713|NCT00347724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074714|NCT00347724|Analgesics|analgesics|mesh-ancestor
65074715|NCT00347724|Sensory System Agents|sensory system agents|mesh-ancestor
65074716|NCT00347724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65074717|NCT00313157|Metoprolol|metoprolol|mesh-list
65074718|NCT00313157|Verapamil|verapamil|mesh-list
65074719|NCT00313157|Carvedilol|carvedilol|mesh-list
65074720|NCT00313157|Diltiazem|diltiazem|mesh-list
65074721|NCT00313157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65074722|NCT00313157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65074723|NCT00313157|Sympatholytics|sympatholytics|mesh-ancestor
65074724|NCT00313157|Autonomic Agents|autonomic agents|mesh-ancestor
65074725|NCT00313157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65074726|NCT00313157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074727|NCT00313157|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65074728|NCT00313157|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65074729|NCT00313157|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65074730|NCT00313157|Adrenergic Agents|adrenergic agents|mesh-ancestor
65074731|NCT00313157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65074732|NCT00313157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074733|NCT00313157|Antioxidants|antioxidants|mesh-ancestor
65074734|NCT00313157|Protective Agents|protective agents|mesh-ancestor
65074735|NCT00313157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65074736|NCT00313157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65074737|NCT00313157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65074738|NCT00313157|Vasodilator Agents|vasodilator agents|mesh-ancestor
65074739|NCT00313157|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65074740|NCT00313157|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65074741|NCT00347763|Permethrin|permethrin|mesh-list
65074742|NCT00347763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074743|NCT00347763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074744|NCT00313235|Cyclophosphamide|cyclophosphamide|mesh-list
65074745|NCT00313235|Vaccines|vaccines|mesh-list
65074746|NCT00313235|Immunologic Factors|immunologic factors|mesh-ancestor
65074747|NCT00313235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074748|NCT00313235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65074749|NCT00313235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65074750|NCT00313235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65074751|NCT00313235|Alkylating Agents|alkylating agents|mesh-ancestor
65074752|NCT00313235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074753|NCT00313235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074754|NCT00313235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65074755|NCT00347802|Bimatoprost|bimatoprost|mesh-list
65074756|NCT00347802|Travoprost|travoprost|mesh-list
65074757|NCT00347802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65074758|NCT00313274|Clevudine|clevudine|mesh-list
65074759|NCT00313274|Antiviral Agents|antiviral agents|mesh-ancestor
65074760|NCT00313274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65074761|NCT00419042|Gemcitabine|gemcitabine|mesh-list
65074762|NCT00419042|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65074763|NCT00419042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65074764|NCT00419042|Antimetabolites|antimetabolites|mesh-ancestor
65074765|NCT00419042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074766|NCT00419042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074767|NCT00419042|Antiviral Agents|antiviral agents|mesh-ancestor
65074768|NCT00419042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64833765|NCT05189483|Antimitotic Agents|antimitotic agents|mesh-ancestor
64833766|NCT05189483|Mitosis Modulators|mitosis modulators|mesh-ancestor
64396795|NCT04400539|Nivolumab|nivolumab|mesh-list
64396796|NCT04400539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64396797|NCT04400539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396798|NCT04400539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65074769|NCT00419042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074770|NCT00419042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65074771|NCT00419042|Immunologic Factors|immunologic factors|mesh-ancestor
64416146|NCT05510141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65074773|NCT00419042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65074774|NCT00347841|Bimatoprost|bimatoprost|mesh-list
65074775|NCT00347841|Latanoprost|latanoprost|mesh-list
65074776|NCT00347841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65074777|NCT00347841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65074778|NCT00347841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65074779|NCT00425126|Epoetin Alfa|epoetin alfa|mesh-list
65074780|NCT00425126|Hematinics|hematinics|mesh-ancestor
65074781|NCT00343629|Sulindac|sulindac|mesh-list
65074782|NCT00343629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65074783|NCT00343629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65074784|NCT00343629|Analgesics|analgesics|mesh-ancestor
65074785|NCT00343629|Sensory System Agents|sensory system agents|mesh-ancestor
65074786|NCT00343629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65074787|NCT00343629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64716845|NCT04338074|Tranexamic Acid|tranexamic acid|mesh-list
64716846|NCT04338074|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64716847|NCT04338074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64716849|NCT04338074|Hemostatics|hemostatics|mesh-ancestor
65074788|NCT00343629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65074790|NCT00343629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074791|NCT00343629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65074792|NCT00343629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64482869|NCT03154983|Tubulin Modulators|tubulin modulators|mesh-ancestor
65074793|NCT00343629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074795|NCT00343668|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65074796|NCT00343668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65074797|NCT00343668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074798|NCT00343668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074799|NCT00343668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074800|NCT00343707|Paroxetine|paroxetine|mesh-list
65074801|NCT00343707|Vestipitant|vestipitant|mesh-list
65074802|NCT00343707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65074803|NCT00343707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65074804|NCT00343707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65074805|NCT00343707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074806|NCT00343707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65074807|NCT00343707|Serotonin Agents|serotonin agents|mesh-ancestor
65074808|NCT00343707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074809|NCT00343707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65074810|NCT00343707|Antidepressive Agents|antidepressive agents|mesh-ancestor
65074811|NCT00343707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65074812|NCT00343707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65074813|NCT00343707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65074814|NCT00343707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074815|NCT00343707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65074816|NCT00313391|Risperidone|risperidone|mesh-list
65074817|NCT00313391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65074818|NCT00313391|Serotonin Agents|serotonin agents|mesh-ancestor
65074819|NCT00313391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65074820|NCT00313391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074821|NCT00313391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074822|NCT00313391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65074823|NCT00313391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65074824|NCT00313391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65074825|NCT00313391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65074826|NCT00313391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64833767|NCT05189483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833768|NCT05188820|Cortisone|cortisone|mesh-list
64833769|NCT05188820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64833770|NCT05177055|Methamphetamine|methamphetamine|mesh-list
65074827|NCT00313391|Dopamine Agents|dopamine agents|mesh-ancestor
65074828|NCT00348153|Adalimumab|adalimumab|mesh-list
65074829|NCT00348153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65074830|NCT00348153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65074831|NCT00313508|Vidarabine|vidarabine|mesh-list
65074832|NCT00313508|Fludarabine|fludarabine|mesh-list
65074833|NCT00313508|Fludarabine phosphate|fludarabine phosphate|mesh-list
65074834|NCT00313508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074835|NCT00313508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65074836|NCT00313508|Antimetabolites|antimetabolites|mesh-ancestor
65074837|NCT00313508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074838|NCT00313508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65074839|NCT00313508|Immunologic Factors|immunologic factors|mesh-ancestor
65074840|NCT00313508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074841|NCT00313508|Antiviral Agents|antiviral agents|mesh-ancestor
65074842|NCT00313508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65074843|NCT00313547|Amlodipine|amlodipine|mesh-list
65074844|NCT00313547|Quinapril|quinapril|mesh-list
65074845|NCT00313547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65074846|NCT00313547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65074847|NCT00313547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65074848|NCT00313547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074849|NCT00313547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65074850|NCT00313547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074851|NCT00313547|Vasodilator Agents|vasodilator agents|mesh-ancestor
65074852|NCT00313547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65074853|NCT00313547|Protease Inhibitors|protease inhibitors|mesh-ancestor
65074854|NCT00313547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074855|NCT00348192|Donepezil|donepezil|mesh-list
65074856|NCT00348192|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65074857|NCT00348192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074858|NCT00348192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074859|NCT00348192|Cholinergic Agents|cholinergic agents|mesh-ancestor
65074860|NCT00348192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65074861|NCT00348192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074862|NCT00348192|Nootropic Agents|nootropic agents|mesh-ancestor
65074863|NCT00313625|Methotrexate|methotrexate|mesh-list
65074864|NCT00313625|Melphalan|melphalan|mesh-list
65074865|NCT00313625|Busulfan|busulfan|mesh-list
65074866|NCT00313625|Tacrolimus|tacrolimus|mesh-list
65074867|NCT00313625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65074868|NCT00313625|Abortifacient Agents|abortifacient agents|mesh-ancestor
65074869|NCT00313625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65074870|NCT00313625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074871|NCT00313625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65074872|NCT00313625|Antimetabolites|antimetabolites|mesh-ancestor
65074873|NCT00313625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074874|NCT00313625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833776|NCT05177055|Dopamine Agents|dopamine agents|mesh-ancestor
64833777|NCT05177055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65074875|NCT00313625|Dermatologic Agents|dermatologic agents|mesh-ancestor
64833779|NCT05177055|Adrenergic Agents|adrenergic agents|mesh-ancestor
65074876|NCT00313625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074877|NCT00313625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65074878|NCT00313625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65074879|NCT00313625|Immunologic Factors|immunologic factors|mesh-ancestor
65074880|NCT00313625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65074881|NCT00313625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65074882|NCT00313625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65074883|NCT00313625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65074884|NCT00313625|Alkylating Agents|alkylating agents|mesh-ancestor
65074885|NCT00313625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65074886|NCT00343980|Insulin|insulin|mesh-list
65074887|NCT00343980|Glimepiride|glimepiride|mesh-list
65074888|NCT00343980|Rosiglitazone|rosiglitazone|mesh-list
65074889|NCT00343980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65074890|NCT00343980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65074891|NCT00343980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074892|NCT00343980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65074893|NCT00343980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65074894|NCT00343980|Immunologic Factors|immunologic factors|mesh-ancestor
65074895|NCT00313742|Insulin|insulin|mesh-list
65074896|NCT00313742|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65074897|NCT00313742|Insulin Glargine|insulin glargine|mesh-list
65074898|NCT00313742|Insulin Detemir|insulin detemir|mesh-list
65074899|NCT00313742|Isophane Insulin, Human|isophane insulin, human|mesh-list
65074900|NCT00313742|Insulin, Isophane|insulin, isophane|mesh-list
65074901|NCT00313742|Isophane insulin, beef|isophane insulin, beef|mesh-list
65074902|NCT00313742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65074903|NCT00313742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074904|NCT00313859|Simvastatin|simvastatin|mesh-list
65074905|NCT00313859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65074906|NCT00313859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65074907|NCT00313859|Antimetabolites|antimetabolites|mesh-ancestor
65074908|NCT00313859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074909|NCT00313859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65074910|NCT00313859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65074911|NCT00313859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074912|NCT00348231|Insulin|insulin|mesh-list
65074913|NCT00348231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65074914|NCT00348231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074915|NCT00313898|Sildenafil Citrate|sildenafil citrate|mesh-list
65074916|NCT00313898|Vasodilator Agents|vasodilator agents|mesh-ancestor
65074917|NCT00313898|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65074918|NCT00313898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65074919|NCT00313898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074920|NCT00313898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074921|NCT00313898|Urological Agents|urological agents|mesh-ancestor
65074922|NCT00344058|Magnesium Sulfate|magnesium sulfate|mesh-list
65074923|NCT00344058|Analgesics|analgesics|mesh-ancestor
65074924|NCT00344058|Sensory System Agents|sensory system agents|mesh-ancestor
65074925|NCT00344058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65074926|NCT00344058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074927|NCT00344058|Anesthetics|anesthetics|mesh-ancestor
65074928|NCT00344058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65074929|NCT00344058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65074930|NCT00344058|Anticonvulsants|anticonvulsants|mesh-ancestor
65074931|NCT00344058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65074932|NCT00344058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65074933|NCT00344058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074934|NCT00344058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65074935|NCT00344058|Tocolytic Agents|tocolytic agents|mesh-ancestor
65074936|NCT00344058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65074937|NCT00313937|Insulin Glargine|insulin glargine|mesh-list
65074938|NCT00313937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65074939|NCT00313937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396981|NCT02368795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396982|NCT02368795|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65074940|NCT00313976|Interferons|interferons|mesh-list
65074941|NCT00313976|Interferon-beta|interferon-beta|mesh-list
65074942|NCT00313976|Interferon beta-1b|interferon beta-1b|mesh-list
65074943|NCT00313976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074944|NCT00313976|Antiviral Agents|antiviral agents|mesh-ancestor
65074945|NCT00313976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65074946|NCT00313976|Immunologic Factors|immunologic factors|mesh-ancestor
65074947|NCT00313976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074948|NCT00313976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65074950|NCT00348387|Immunologic Factors|immunologic factors|mesh-ancestor
65074951|NCT00348387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074952|NCT00314171|Timolol|timolol|mesh-list
65074953|NCT00314171|Dorzolamide|dorzolamide|mesh-list
65074954|NCT00314171|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65074955|NCT00314171|Brinzolamide|brinzolamide|mesh-list
65074956|NCT00314171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65074957|NCT00314171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65074958|NCT00314171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65074959|NCT00314171|Adrenergic Agents|adrenergic agents|mesh-ancestor
65074960|NCT00314171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65074961|NCT00314171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074962|NCT00314171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074963|NCT00314171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65074964|NCT00314171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65074965|NCT00314171|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65074966|NCT00314171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074967|NCT00348426|Antitoxins|antitoxins|mesh-list
65074968|NCT00348426|Botulinum Antitoxin|botulinum antitoxin|mesh-list
65074969|NCT00348426|Immunologic Factors|immunologic factors|mesh-ancestor
65074970|NCT00348426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074971|NCT00314210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65074972|NCT00314210|Antidepressive Agents|antidepressive agents|mesh-ancestor
65074973|NCT00314210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65074974|NCT00314210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65074975|NCT00314210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65074976|NCT00314210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65074977|NCT00314210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074978|NCT00344253|Interferons|interferons|mesh-list
65074979|NCT00344253|Interferon-beta|interferon-beta|mesh-list
65074980|NCT00344253|Methotrexate|methotrexate|mesh-list
65074981|NCT00344253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65074982|NCT00344253|Abortifacient Agents|abortifacient agents|mesh-ancestor
65074983|NCT00344253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65074984|NCT00344253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65074985|NCT00344253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65074986|NCT00344253|Antimetabolites|antimetabolites|mesh-ancestor
65074987|NCT00344253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65074988|NCT00344253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65074989|NCT00344253|Dermatologic Agents|dermatologic agents|mesh-ancestor
65074990|NCT00344253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65074991|NCT00344253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65074992|NCT00344253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65074993|NCT00344253|Immunologic Factors|immunologic factors|mesh-ancestor
65074994|NCT00344253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65074995|NCT00344253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65074996|NCT00344253|Antiviral Agents|antiviral agents|mesh-ancestor
65074997|NCT00344253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65074998|NCT00314405|Methylene Blue|methylene blue|mesh-list
65074999|NCT00314405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075000|NCT00314405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075001|NCT04715295|Azithromycin|azithromycin|mesh-list
65075002|NCT04715295|Doxycycline|doxycycline|mesh-list
65075003|NCT04715295|Hydroxychloroquine|hydroxychloroquine|mesh-list
65075004|NCT04715295|Rivaroxaban|rivaroxaban|mesh-list
65075005|NCT04715295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65075006|NCT04715295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65075007|NCT04715295|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65075008|NCT04715295|Antithrombins|antithrombins|mesh-ancestor
65075009|NCT04715295|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65075010|NCT04715295|Protease Inhibitors|protease inhibitors|mesh-ancestor
65075011|NCT04715295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075012|NCT04715295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717075|NCT03711578|Tenalisib|tenalisib|mesh-list
65075013|NCT04715295|Anticoagulants|anticoagulants|mesh-ancestor
65075014|NCT04715295|Antimalarials|antimalarials|mesh-ancestor
65075015|NCT04715295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65075016|NCT04715295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65075017|NCT04715295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65075018|NCT00348504|Simendan|simendan|mesh-list
65075019|NCT00348504|Dobutamine|dobutamine|mesh-list
64325037|NCT03164421|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65075020|NCT00348504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65075021|NCT00348504|Vasodilator Agents|vasodilator agents|mesh-ancestor
65075022|NCT00348504|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65075023|NCT00348504|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65075024|NCT00348504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075025|NCT00348504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075026|NCT00348504|Protective Agents|protective agents|mesh-ancestor
65075027|NCT00348504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075028|NCT00348504|Sympathomimetics|sympathomimetics|mesh-ancestor
65075029|NCT00348504|Autonomic Agents|autonomic agents|mesh-ancestor
65075030|NCT00348504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65075031|NCT00348504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65075032|NCT00348504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65075033|NCT00348504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65075034|NCT00348504|Adrenergic Agents|adrenergic agents|mesh-ancestor
65075035|NCT00348504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65075036|NCT00314561|Pioglitazone|pioglitazone|mesh-list
65075037|NCT00314561|Rosiglitazone|rosiglitazone|mesh-list
65075038|NCT00314561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65075039|NCT00314561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075040|NCT00344409|Darbepoetin alfa|darbepoetin alfa|mesh-list
65075041|NCT00344409|Hematinics|hematinics|mesh-ancestor
65075042|NCT00348582|Ketorolac|ketorolac|mesh-list
65075043|NCT00348582|Nepafenac|nepafenac|mesh-list
65075044|NCT00348582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65075045|NCT00348582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65075046|NCT00348582|Analgesics|analgesics|mesh-ancestor
65075047|NCT00348582|Sensory System Agents|sensory system agents|mesh-ancestor
65075048|NCT00348582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65075049|NCT00348582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075050|NCT00348582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65075051|NCT00348582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65075052|NCT00348582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65075053|NCT00348582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075054|NCT00348582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075055|NCT00314639|Modafinil|modafinil|mesh-list
65075056|NCT00314639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65075057|NCT00314639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075058|NCT00314639|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65075059|NCT00314639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65075060|NCT00314639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65075061|NCT00314639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075062|NCT00314678|Paclitaxel|paclitaxel|mesh-list
65075063|NCT00314678|Topotecan|topotecan|mesh-list
65075064|NCT00314678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65075065|NCT00314678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075066|NCT00314678|Tubulin Modulators|tubulin modulators|mesh-ancestor
65075067|NCT00314678|Antimitotic Agents|antimitotic agents|mesh-ancestor
65075068|NCT00314678|Mitosis Modulators|mitosis modulators|mesh-ancestor
65075069|NCT00314678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075070|NCT00314678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65075071|NCT00314678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65075072|NCT00314678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075073|NCT00344526|Dexamethasone|dexamethasone|mesh-list
65075074|NCT00344526|Melphalan|melphalan|mesh-list
64325038|NCT03164421|Antiviral Agents|antiviral agents|mesh-ancestor
64833793|NCT05156281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65075075|NCT00344526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65075076|NCT00344526|Antiemetics|antiemetics|mesh-ancestor
65075077|NCT00344526|Autonomic Agents|autonomic agents|mesh-ancestor
65075078|NCT00344526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65075079|NCT00344526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075080|NCT00344526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65075081|NCT00344526|Glucocorticoids|glucocorticoids|mesh-ancestor
65075082|NCT00344526|Hormones|hormones|mesh-ancestor
65075083|NCT00344526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65075084|NCT00344526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65075085|NCT00344526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075086|NCT00344526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65075087|NCT00344526|Alkylating Agents|alkylating agents|mesh-ancestor
65075088|NCT00344526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075089|NCT00344526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65075090|NCT00344526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65075091|NCT00344526|Immunologic Factors|immunologic factors|mesh-ancestor
65075092|NCT00314756|Imiquimod|imiquimod|mesh-list
65075093|NCT00314756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65075094|NCT00314756|Immunologic Factors|immunologic factors|mesh-ancestor
65075095|NCT00314756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075096|NCT00314756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075097|NCT00314756|Interferon Inducers|interferon inducers|mesh-ancestor
65075098|NCT00344565|Modafinil|modafinil|mesh-list
65075099|NCT00344565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65075100|NCT00344565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075101|NCT00344565|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65075102|NCT00344565|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65075103|NCT00344565|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65075104|NCT00344565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075105|NCT00314873|Imatinib Mesylate|imatinib mesylate|mesh-list
65075106|NCT00314873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075107|NCT00314873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65075108|NCT00314873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075109|NCT00314873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075110|NCT00348738|Epoetin Alfa|epoetin alfa|mesh-list
65075111|NCT00348738|Hematinics|hematinics|mesh-ancestor
65075112|NCT00314912|Tramiprosate|tramiprosate|mesh-list
65075113|NCT00314912|Anticonvulsants|anticonvulsants|mesh-ancestor
65075114|NCT00314912|GABA Agonists|gaba agonists|mesh-ancestor
65075115|NCT00314912|GABA Agents|gaba agents|mesh-ancestor
65075116|NCT00314912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65075117|NCT00314912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075118|NCT00314912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075119|NCT00314990|Folic Acid|folic acid|mesh-list
65075120|NCT00314990|Pyridoxine|pyridoxine|mesh-list
65075121|NCT00314990|Vitamin B 12|vitamin b 12|mesh-list
65075122|NCT00314990|Hydroxocobalamin|hydroxocobalamin|mesh-list
65075123|NCT00314990|Hematinics|hematinics|mesh-ancestor
65075124|NCT00314990|Vitamin B Complex|vitamin b complex|mesh-ancestor
65075125|NCT00314990|Vitamins|vitamins|mesh-ancestor
65075126|NCT00314990|Micronutrients|micronutrients|mesh-ancestor
65075127|NCT00314990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075128|NCT02960126|Aspirin|aspirin|mesh-list
65075129|NCT02960126|Clopidogrel|clopidogrel|mesh-list
65075130|NCT02960126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65075131|NCT02960126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65075132|NCT02960126|Analgesics|analgesics|mesh-ancestor
64833794|NCT05156281|Immunologic Factors|immunologic factors|mesh-ancestor
65075133|NCT02960126|Sensory System Agents|sensory system agents|mesh-ancestor
64833795|NCT05149313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64833796|NCT05149313|Immunologic Factors|immunologic factors|mesh-ancestor
64833797|NCT05149313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833798|NCT05121974|Azithromycin|azithromycin|mesh-list
65075134|NCT02960126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65075135|NCT02960126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075136|NCT02960126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65075137|NCT02960126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65075138|NCT02960126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65075139|NCT02960126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65075140|NCT02960126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075141|NCT02960126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65075142|NCT02960126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65075143|NCT02960126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075145|NCT02960126|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65075146|NCT02960126|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65075147|NCT02960126|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65075148|NCT02960126|Purinergic Agents|purinergic agents|mesh-ancestor
65075149|NCT02960126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65075150|NCT00315185|Cetuximab|cetuximab|mesh-list
65075151|NCT00315185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65075152|NCT00315185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075153|NCT00344760|Tenofovir|tenofovir|mesh-list
65075154|NCT00344760|Lamivudine|lamivudine|mesh-list
65075155|NCT00344760|Efavirenz|efavirenz|mesh-list
65075156|NCT00344760|Enfuvirtide|enfuvirtide|mesh-list
65075157|NCT00344760|Antiviral Agents|antiviral agents|mesh-ancestor
65075158|NCT00344760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65075159|NCT00344760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64482879|NCT01983683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65075160|NCT00344760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65075161|NCT00344760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075162|NCT00344760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64717222|NCT03862040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65075163|NCT00344760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65075164|NCT00344760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65075165|NCT00344760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65075166|NCT00344760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65075167|NCT00344760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65075168|NCT00344760|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65075169|NCT00344760|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65075170|NCT00344760|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65075171|NCT00344760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65075172|NCT00344760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65075174|NCT00348894|Antidepressive Agents|antidepressive agents|mesh-ancestor
65075175|NCT00348894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65075176|NCT00348894|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65075177|NCT00348894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65075178|NCT00348894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65075179|NCT00348894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075180|NCT00348894|Adrenergic Agents|adrenergic agents|mesh-ancestor
65075181|NCT00348894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65075182|NCT00348894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075183|NCT00315536|Glycopyrrolate|glycopyrrolate|mesh-list
65075184|NCT00315536|Remifentanil|remifentanil|mesh-list
65075185|NCT00315536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65075186|NCT00315536|Narcotics|narcotics|mesh-ancestor
65075187|NCT00315536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65075188|NCT00315536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075189|NCT00315536|Analgesics|analgesics|mesh-ancestor
65075190|NCT00315536|Sensory System Agents|sensory system agents|mesh-ancestor
65075191|NCT00315536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65075192|NCT00315536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65075193|NCT00315536|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65075194|NCT00315536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65075195|NCT00315536|Cholinergic Agents|cholinergic agents|mesh-ancestor
65075196|NCT00315536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65075197|NCT00315536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075198|NCT00348972|Insulin Glargine|insulin glargine|mesh-list
65075199|NCT00348972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65075200|NCT00348972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075201|NCT00349089|Pemetrexed|pemetrexed|mesh-list
65075202|NCT00349089|Vinorelbine|vinorelbine|mesh-list
65075203|NCT00349089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075204|NCT00349089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075205|NCT00349089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075206|NCT00349089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65075207|NCT00349089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65075208|NCT00349089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65075209|NCT00349089|Tubulin Modulators|tubulin modulators|mesh-ancestor
65075210|NCT00349089|Antimitotic Agents|antimitotic agents|mesh-ancestor
65075211|NCT00349089|Mitosis Modulators|mitosis modulators|mesh-ancestor
65075212|NCT00349128|Metformin|metformin|mesh-list
65075213|NCT00349128|Fenofibrate|fenofibrate|mesh-list
65075214|NCT00349128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65075215|NCT00349128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075216|NCT00349128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65075217|NCT00349128|Antimetabolites|antimetabolites|mesh-ancestor
65075218|NCT00349128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075219|NCT00349128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65075220|NCT00315848|Buprenorphine|buprenorphine|mesh-list
65075221|NCT00315848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65075222|NCT00315848|Narcotics|narcotics|mesh-ancestor
65075223|NCT00315848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65075224|NCT00315848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075225|NCT00315848|Analgesics|analgesics|mesh-ancestor
65075226|NCT00315848|Sensory System Agents|sensory system agents|mesh-ancestor
65075227|NCT00315848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65075228|NCT00315848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65075229|NCT00349206|Sirolimus|sirolimus|mesh-list
65075230|NCT00349206|Sorafenib|sorafenib|mesh-list
65075231|NCT00349206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075232|NCT00349206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65075233|NCT00349206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075234|NCT00349206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075235|NCT00349206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65075236|NCT00349206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65075237|NCT00349206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65075238|NCT00349206|Antifungal Agents|antifungal agents|mesh-ancestor
65075239|NCT00349206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65075240|NCT00349206|Immunologic Factors|immunologic factors|mesh-ancestor
65075241|NCT00349206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075242|NCT00315887|Buprenorphine|buprenorphine|mesh-list
65075243|NCT00315887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65075244|NCT00315887|Narcotics|narcotics|mesh-ancestor
65075245|NCT00315887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65075246|NCT00315887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075247|NCT00315887|Analgesics|analgesics|mesh-ancestor
65075248|NCT00315887|Sensory System Agents|sensory system agents|mesh-ancestor
65075249|NCT00315887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65075250|NCT00315887|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65075251|NCT00421395|Epratuzumab|epratuzumab|mesh-list
65075252|NCT00421395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65075253|NCT00421395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075254|NCT00315926|Melatonin|melatonin|mesh-list
65075255|NCT00315926|Antioxidants|antioxidants|mesh-ancestor
65075256|NCT00315926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075257|NCT00315926|Protective Agents|protective agents|mesh-ancestor
65075258|NCT00315926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075259|NCT00315926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65075260|NCT00421434|Ribavirin|ribavirin|mesh-list
65075261|NCT00421434|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65075262|NCT00421434|Interferon-alpha|interferon-alpha|mesh-list
65075263|NCT00421434|Nitazoxanide|nitazoxanide|mesh-list
65075264|NCT00421434|Antimetabolites|antimetabolites|mesh-ancestor
65075265|NCT00421434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075266|NCT00421434|Antiviral Agents|antiviral agents|mesh-ancestor
65075267|NCT00421434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65075268|NCT00421434|Immunologic Factors|immunologic factors|mesh-ancestor
65075269|NCT00421434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075270|NCT00421434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65075271|NCT00315965|Nitric Oxide|nitric oxide|mesh-list
65075272|NCT00315965|Carbon Monoxide|carbon monoxide|mesh-list
65075273|NCT00315965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65075274|NCT00315965|Autonomic Agents|autonomic agents|mesh-ancestor
65075275|NCT00315965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65075276|NCT00315965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075277|NCT00315965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65075278|NCT00315965|Respiratory System Agents|respiratory system agents|mesh-ancestor
65075279|NCT00315965|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65075280|NCT00315965|Antioxidants|antioxidants|mesh-ancestor
65075281|NCT00315965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075282|NCT00315965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65075283|NCT00315965|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65075284|NCT00315965|Vasodilator Agents|vasodilator agents|mesh-ancestor
65075286|NCT00315965|Protective Agents|protective agents|mesh-ancestor
65075287|NCT00315965|Antimetabolites|antimetabolites|mesh-ancestor
65075288|NCT00349245|Dexmedetomidine|dexmedetomidine|mesh-list
65075289|NCT00349245|Remifentanil|remifentanil|mesh-list
65075290|NCT00349245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65075291|NCT00349245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65075292|NCT00349245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075293|NCT00349245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65075294|NCT00349245|Analgesics|analgesics|mesh-ancestor
65075295|NCT00349245|Sensory System Agents|sensory system agents|mesh-ancestor
65075296|NCT00349245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65075297|NCT00349245|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65075298|NCT00349245|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65075299|NCT00349245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65075300|NCT00349245|Adrenergic Agents|adrenergic agents|mesh-ancestor
65075301|NCT00349245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65075302|NCT00349245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075303|NCT00349245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65075304|NCT00349245|Narcotics|narcotics|mesh-ancestor
65075305|NCT00349284|Ezetimibe|ezetimibe|mesh-list
65075306|NCT00349284|Fenofibrate|fenofibrate|mesh-list
65075307|NCT00349284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65075308|NCT00349284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65075309|NCT00349284|Antimetabolites|antimetabolites|mesh-ancestor
65075310|NCT00349284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075311|NCT00349284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65075312|NCT00316160|Bupropion|bupropion|mesh-list
65075313|NCT00316160|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65075314|NCT00316160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65075315|NCT00316160|Antidepressive Agents|antidepressive agents|mesh-ancestor
65075316|NCT00316160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65075317|NCT00316160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65075318|NCT00316160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65075319|NCT00316160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65075320|NCT00316160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075322|NCT00316160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65075323|NCT00316160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075324|NCT00316160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65075325|NCT00316160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65075326|NCT00316160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397074|NCT02374489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64397075|NCT02374489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64397076|NCT02374489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075327|NCT00316160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65075328|NCT00349362|Testosterone|testosterone|mesh-list
65075329|NCT00349362|Androgens|androgens|mesh-ancestor
65075330|NCT00349362|Hormones|hormones|mesh-ancestor
65075331|NCT00349362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65075332|NCT00349362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075333|NCT00316238|Olanzapine|olanzapine|mesh-list
65075334|NCT00316238|Antiemetics|antiemetics|mesh-ancestor
65075335|NCT00316238|Autonomic Agents|autonomic agents|mesh-ancestor
65075336|NCT00316238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65075337|NCT00316238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075338|NCT00316238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65075339|NCT00316238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65075340|NCT00316238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65075341|NCT00316238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65075342|NCT00316238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65075343|NCT00316238|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65075344|NCT00316238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65075345|NCT00316238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65075346|NCT00316238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075347|NCT00316238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65075348|NCT00316238|Serotonin Agents|serotonin agents|mesh-ancestor
65075349|NCT00349401|Ketorolac|ketorolac|mesh-list
65075350|NCT00349401|Morphine|morphine|mesh-list
65075351|NCT00349401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65075352|NCT00349401|Narcotics|narcotics|mesh-ancestor
65075353|NCT00349401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65075354|NCT00349401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075355|NCT00349401|Analgesics|analgesics|mesh-ancestor
65075356|NCT00349401|Sensory System Agents|sensory system agents|mesh-ancestor
65075357|NCT00349401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65075358|NCT00349401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65075359|NCT00349401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65075360|NCT00349401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65075361|NCT00349401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65075362|NCT00349401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65075363|NCT00349401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075364|NCT00349401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075365|NCT00349440|Cyclosporine|cyclosporine|mesh-list
65075366|NCT00349440|Cyclosporins|cyclosporins|mesh-list
65075367|NCT00349440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075368|NCT00349440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075369|NCT00349440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65075370|NCT00349440|Immunologic Factors|immunologic factors|mesh-ancestor
65075371|NCT00349440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075372|NCT00349440|Antifungal Agents|antifungal agents|mesh-ancestor
65075373|NCT00349440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65075374|NCT00349440|Dermatologic Agents|dermatologic agents|mesh-ancestor
65075375|NCT00349440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65075376|NCT00349440|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65075377|NCT00316433|Oxaliplatin|oxaliplatin|mesh-list
65075378|NCT00316433|Irinotecan|irinotecan|mesh-list
65075379|NCT00316433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075380|NCT00316433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65075381|NCT00316433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64833809|NCT05106192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65075382|NCT00316433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075383|NCT00316433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075384|NCT00349518|Dasatinib|dasatinib|mesh-list
65075385|NCT00349518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075386|NCT00349518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65075387|NCT00349518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075388|NCT00349518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075389|NCT00316472|Niacinamide|niacinamide|mesh-list
65075390|NCT00316472|Niacin|niacin|mesh-list
65075391|NCT00316472|Nicotinic Acids|nicotinic acids|mesh-list
65075392|NCT00316472|Vitamin B Complex|vitamin b complex|mesh-ancestor
65075393|NCT00316472|Vitamins|vitamins|mesh-ancestor
65075394|NCT00316472|Micronutrients|micronutrients|mesh-ancestor
65075395|NCT00316472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075396|NCT00316472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65075397|NCT00316472|Antimetabolites|antimetabolites|mesh-ancestor
65075398|NCT00316472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075399|NCT00316472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65075400|NCT00316472|Vasodilator Agents|vasodilator agents|mesh-ancestor
65075401|NCT00349557|Bevacizumab|bevacizumab|mesh-list
65075402|NCT00349557|Goserelin|goserelin|mesh-list
65075403|NCT00349557|Bicalutamide|bicalutamide|mesh-list
65075404|NCT00349557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65075405|NCT00349557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075406|NCT00349557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65075407|NCT00349557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65075408|NCT00349557|Growth Substances|growth substances|mesh-ancestor
65075409|NCT00349557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075410|NCT00349557|Growth Inhibitors|growth inhibitors|mesh-ancestor
65075411|NCT00349557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65075412|NCT00349557|Androgen Antagonists|androgen antagonists|mesh-ancestor
65075413|NCT00349557|Hormone Antagonists|hormone antagonists|mesh-ancestor
65075414|NCT00349557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65075415|NCT00349596|Decitabine|decitabine|mesh-list
64833810|NCT05106192|Glucocorticoids|glucocorticoids|mesh-ancestor
65075416|NCT00349596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65075417|NCT00349596|Antimetabolites|antimetabolites|mesh-ancestor
65075418|NCT00349596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075419|NCT00349596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075420|NCT00349596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075421|NCT00349635|Metformin|metformin|mesh-list
65075422|NCT00349635|Fenofibrate|fenofibrate|mesh-list
65075423|NCT00349635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65075424|NCT00349635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075425|NCT00349635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65075426|NCT00349635|Antimetabolites|antimetabolites|mesh-ancestor
65075427|NCT00349635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075428|NCT00349635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65075429|NCT00316745|Leucovorin|leucovorin|mesh-list
65075430|NCT00316745|Fluorouracil|fluorouracil|mesh-list
65075431|NCT00316745|Oxaliplatin|oxaliplatin|mesh-list
65075432|NCT00316745|Irinotecan|irinotecan|mesh-list
65075433|NCT00316745|Antimetabolites|antimetabolites|mesh-ancestor
65075434|NCT00316745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075435|NCT00316745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65075436|NCT00316745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075437|NCT00316745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65075438|NCT00316745|Immunologic Factors|immunologic factors|mesh-ancestor
65075439|NCT00316745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075440|NCT00316745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65075441|NCT00316745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65075442|NCT00316745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075443|NCT00316745|Antidotes|antidotes|mesh-ancestor
65075444|NCT00316745|Protective Agents|protective agents|mesh-ancestor
64833812|NCT05106192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64833813|NCT05106192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075445|NCT00316745|Vitamin B Complex|vitamin b complex|mesh-ancestor
65075446|NCT00316745|Vitamins|vitamins|mesh-ancestor
65075447|NCT00316745|Micronutrients|micronutrients|mesh-ancestor
65075448|NCT00349674|Methotrexate|methotrexate|mesh-list
65075449|NCT00349674|Azathioprine|azathioprine|mesh-list
65075450|NCT00349674|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65075451|NCT00349674|Abortifacient Agents|abortifacient agents|mesh-ancestor
65075452|NCT00349674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64482885|NCT03154515|Antiviral Agents|antiviral agents|mesh-ancestor
65075453|NCT00349674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075454|NCT00349674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65075455|NCT00349674|Antimetabolites|antimetabolites|mesh-ancestor
65075456|NCT00349674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075457|NCT00349674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075458|NCT00349674|Dermatologic Agents|dermatologic agents|mesh-ancestor
65075459|NCT00349674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075460|NCT00349674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65075461|NCT00349674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65075462|NCT00349674|Immunologic Factors|immunologic factors|mesh-ancestor
65075463|NCT00349674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65075464|NCT00349674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65075465|NCT00344916|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
65075466|NCT00344916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075467|NCT00344916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075469|NCT00344955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65075470|NCT00344955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65075471|NCT00344955|Antimetabolites|antimetabolites|mesh-ancestor
65075472|NCT00344955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075473|NCT00344955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65075474|NCT00344955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65075475|NCT00344955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075476|NCT00316901|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65075477|NCT00316901|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65075478|NCT00316901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075479|NCT00316940|Bortezomib|bortezomib|mesh-list
65075480|NCT00316940|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
65075481|NCT00316940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075482|NCT00316940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65075483|NCT00316940|Analgesics|analgesics|mesh-ancestor
65075484|NCT00316940|Sensory System Agents|sensory system agents|mesh-ancestor
65075485|NCT00316940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65075486|NCT00316940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075487|NCT00344994|Pramipexole|pramipexole|mesh-list
65075488|NCT00344994|Antioxidants|antioxidants|mesh-ancestor
65075489|NCT00344994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075490|NCT00344994|Protective Agents|protective agents|mesh-ancestor
65075491|NCT00344994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075492|NCT00344994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65075493|NCT00344994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65075494|NCT00344994|Dopamine Agonists|dopamine agonists|mesh-ancestor
65075495|NCT00344994|Dopamine Agents|dopamine agents|mesh-ancestor
65075496|NCT00344994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65075497|NCT00349791|Testosterone|testosterone|mesh-list
65075498|NCT00349791|Androgens|androgens|mesh-ancestor
65075499|NCT00349791|Hormones|hormones|mesh-ancestor
65075500|NCT00349791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65075501|NCT00349791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075503|NCT00317096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65075504|NCT00317096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075505|NCT00317096|Immunologic Factors|immunologic factors|mesh-ancestor
65075506|NCT00317096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075507|NCT00317096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65075508|NCT00317135|Vaccines|vaccines|mesh-list
65075509|NCT00317135|Immunologic Factors|immunologic factors|mesh-ancestor
65075510|NCT00317135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075511|NCT00349986|Insulin Glargine|insulin glargine|mesh-list
65075512|NCT00349986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65075513|NCT00349986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075514|NCT00345150|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
65075515|NCT00345150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075516|NCT00345150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075517|NCT00317252|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65075518|NCT00317252|Protease Inhibitors|protease inhibitors|mesh-ancestor
65075519|NCT00317252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075520|NCT00317252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075521|NCT00317330|Rifampin|rifampin|mesh-list
65075522|NCT00317330|Isoniazid|isoniazid|mesh-list
65075523|NCT00317330|Pyrazinamide|pyrazinamide|mesh-list
65075524|NCT00317330|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65075525|NCT00317330|Antitubercular Agents|antitubercular agents|mesh-ancestor
65075526|NCT00317330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65075527|NCT00317330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65075528|NCT00317330|Leprostatic Agents|leprostatic agents|mesh-ancestor
65075529|NCT00317330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65075530|NCT00317330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075531|NCT00317330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075532|NCT00317330|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65075533|NCT00317330|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65075534|NCT00317330|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65075535|NCT00317330|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65075536|NCT00317330|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65075537|NCT00317330|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65075538|NCT00317330|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65075539|NCT00317330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65075540|NCT00317330|Antimetabolites|antimetabolites|mesh-ancestor
65075541|NCT00317330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65075544|NCT00317408|Cyclosporine|cyclosporine|mesh-list
65075545|NCT00317408|Dexamethasone|dexamethasone|mesh-list
65075546|NCT00317408|Prednisolone|prednisolone|mesh-list
65075547|NCT00317408|Carboplatin|carboplatin|mesh-list
65075548|NCT00317408|Methotrexate|methotrexate|mesh-list
65075549|NCT00317408|Etoposide|etoposide|mesh-list
65075550|NCT00317408|Melphalan|melphalan|mesh-list
65075551|NCT00317408|Busulfan|busulfan|mesh-list
65075552|NCT00317408|Ifosfamide|ifosfamide|mesh-list
65075553|NCT00317408|Mitoxantrone|mitoxantrone|mesh-list
65075554|NCT00317408|Idarubicin|idarubicin|mesh-list
65075555|NCT00317408|Thiotepa|thiotepa|mesh-list
65075556|NCT00317408|Carmustine|carmustine|mesh-list
65075557|NCT00317408|Vinblastine|vinblastine|mesh-list
65075558|NCT00317408|Lomustine|lomustine|mesh-list
65075559|NCT00317408|Etoposide phosphate|etoposide phosphate|mesh-list
65075560|NCT00317408|Vindesine|vindesine|mesh-list
65075561|NCT00317408|Cyclosporins|cyclosporins|mesh-list
65075562|NCT00317408|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65075563|NCT00317408|Levoleucovorin|levoleucovorin|mesh-list
65075564|NCT00317408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65075565|NCT00317408|Antiemetics|antiemetics|mesh-ancestor
65075566|NCT00317408|Autonomic Agents|autonomic agents|mesh-ancestor
65075567|NCT00317408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65075568|NCT00317408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075569|NCT00317408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65075570|NCT00317408|Glucocorticoids|glucocorticoids|mesh-ancestor
65075571|NCT00317408|Hormones|hormones|mesh-ancestor
65075572|NCT00317408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65075573|NCT00317408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65075574|NCT00317408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075575|NCT00317408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65075576|NCT00317408|Abortifacient Agents|abortifacient agents|mesh-ancestor
65075577|NCT00317408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65075578|NCT00317408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65075579|NCT00317408|Antimetabolites|antimetabolites|mesh-ancestor
65075580|NCT00317408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075581|NCT00317408|Dermatologic Agents|dermatologic agents|mesh-ancestor
65075582|NCT00317408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075583|NCT00317408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65075584|NCT00317408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65075585|NCT00317408|Immunologic Factors|immunologic factors|mesh-ancestor
65075586|NCT00317408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65075587|NCT00317408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65075588|NCT00317408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65075589|NCT00317408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65075590|NCT00317408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65075591|NCT00317408|Antiviral Agents|antiviral agents|mesh-ancestor
65075592|NCT00317408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65075593|NCT00317408|Antidotes|antidotes|mesh-ancestor
65075594|NCT00317408|Protective Agents|protective agents|mesh-ancestor
65075595|NCT00317408|Vitamin B Complex|vitamin b complex|mesh-ancestor
65075596|NCT00317408|Vitamins|vitamins|mesh-ancestor
65075597|NCT00317408|Micronutrients|micronutrients|mesh-ancestor
65075598|NCT00317408|Antifungal Agents|antifungal agents|mesh-ancestor
65075599|NCT00317408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65075600|NCT00317408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65075601|NCT00317408|Alkylating Agents|alkylating agents|mesh-ancestor
65075602|NCT00317408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65075603|NCT00317408|Analgesics|analgesics|mesh-ancestor
65075604|NCT00317408|Sensory System Agents|sensory system agents|mesh-ancestor
65075605|NCT00317408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65075606|NCT00317408|Tubulin Modulators|tubulin modulators|mesh-ancestor
65075607|NCT00317408|Antimitotic Agents|antimitotic agents|mesh-ancestor
65075608|NCT00317408|Mitosis Modulators|mitosis modulators|mesh-ancestor
65075609|NCT00317447|Prednisone|prednisone|mesh-list
65075610|NCT00317447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65075611|NCT00317447|Glucocorticoids|glucocorticoids|mesh-ancestor
65075612|NCT00317447|Hormones|hormones|mesh-ancestor
65075613|NCT00317447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65075614|NCT00317447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075615|NCT00317447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65075616|NCT00317447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075617|NCT02959554|Nivolumab|nivolumab|mesh-list
65075618|NCT02959554|Sunitinib|sunitinib|mesh-list
65075619|NCT02959554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65075620|NCT02959554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075621|NCT02959554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65075622|NCT02959554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075623|NCT02959554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65075624|NCT02959554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65075625|NCT02959554|Growth Substances|growth substances|mesh-ancestor
65075626|NCT02959554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075627|NCT02959554|Growth Inhibitors|growth inhibitors|mesh-ancestor
65075628|NCT02959554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65075629|NCT02959554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075630|NCT00345306|Progesterone|progesterone|mesh-list
65075631|NCT00345306|Progestins|progestins|mesh-ancestor
65075632|NCT00345306|Hormones|hormones|mesh-ancestor
65075633|NCT00345306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65075634|NCT00345306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075635|NCT00317681|Tacrolimus|tacrolimus|mesh-list
65075636|NCT00317681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65075637|NCT00317681|Immunologic Factors|immunologic factors|mesh-ancestor
65075638|NCT00317681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075639|NCT00317681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65075640|NCT00317681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075641|NCT00317681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075642|NCT00350181|Mycophenolic Acid|mycophenolic acid|mesh-list
65075643|NCT00350181|Sirolimus|sirolimus|mesh-list
65075644|NCT00350181|Cyclophosphamide|cyclophosphamide|mesh-list
65075645|NCT00350181|Busulfan|busulfan|mesh-list
65075646|NCT00350181|Carmustine|carmustine|mesh-list
65075647|NCT00350181|Etoposide|etoposide|mesh-list
65075648|NCT00350181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64325045|NCT03164421|Protective Agents|protective agents|mesh-ancestor
64325046|NCT03164421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325047|NCT03164421|Antidotes|antidotes|mesh-ancestor
64325048|NCT05476952|Rocuronium|rocuronium|mesh-list
64325049|NCT05476952|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64325050|NCT05476952|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65075649|NCT00350181|Immunologic Factors|immunologic factors|mesh-ancestor
65075650|NCT00350181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075651|NCT00350181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65075652|NCT00350181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65075653|NCT00350181|Alkylating Agents|alkylating agents|mesh-ancestor
65075654|NCT00350181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075655|NCT00350181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075656|NCT00350181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65075657|NCT00350181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65075658|NCT00350181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65075659|NCT00350181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65075660|NCT00350181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075661|NCT00350181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65075662|NCT00350181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65075663|NCT00350181|Antitubercular Agents|antitubercular agents|mesh-ancestor
65075664|NCT00350181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65075665|NCT00350181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65075666|NCT00350181|Antifungal Agents|antifungal agents|mesh-ancestor
65075667|NCT00317759|Fludarabine|fludarabine|mesh-list
65075668|NCT00317759|Fludarabine phosphate|fludarabine phosphate|mesh-list
65075669|NCT00317759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075670|NCT00317759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65075671|NCT00317759|Antimetabolites|antimetabolites|mesh-ancestor
65075672|NCT00317759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075673|NCT00317759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65075674|NCT00317759|Immunologic Factors|immunologic factors|mesh-ancestor
65075675|NCT00317759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075676|NCT00317798|Sirolimus|sirolimus|mesh-list
65075677|NCT00317798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65075678|NCT00317798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65075679|NCT00317798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65075680|NCT00317798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65075681|NCT00317798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075682|NCT00317798|Antifungal Agents|antifungal agents|mesh-ancestor
65075683|NCT00317798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65075684|NCT00317798|Immunologic Factors|immunologic factors|mesh-ancestor
65075685|NCT00317798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075687|NCT00345501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65075688|NCT00345501|Vasodilator Agents|vasodilator agents|mesh-ancestor
65075689|NCT00345657|Niacin|niacin|mesh-list
65075690|NCT00345657|Lovastatin|lovastatin|mesh-list
65075691|NCT00345657|L 647318|l 647318|mesh-list
64717780|NCT03723980|Propolis|propolis|mesh-list
65075692|NCT00345657|Dihydromevinolin|dihydromevinolin|mesh-list
65075693|NCT00345657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65075694|NCT00345657|Antimetabolites|antimetabolites|mesh-ancestor
65075695|NCT00345657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075696|NCT00345657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65075697|NCT00345657|Vasodilator Agents|vasodilator agents|mesh-ancestor
65075698|NCT00345657|Vitamin B Complex|vitamin b complex|mesh-ancestor
65075699|NCT00345657|Vitamins|vitamins|mesh-ancestor
65075700|NCT00345657|Micronutrients|micronutrients|mesh-ancestor
64325052|NCT05476952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64325053|NCT05476952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325054|NCT05228613|Vaccines|vaccines|mesh-list
64325055|NCT05228613|Immunologic Factors|immunologic factors|mesh-ancestor
64325056|NCT05228613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325057|NCT02658812|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
65075701|NCT00345657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075702|NCT00345657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65075703|NCT00345657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65075704|NCT00345657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075705|NCT00317876|Cyclosporine|cyclosporine|mesh-list
65075706|NCT00317876|Cyclophosphamide|cyclophosphamide|mesh-list
65075707|NCT00317876|Methotrexate|methotrexate|mesh-list
65075708|NCT00317876|Cyclosporins|cyclosporins|mesh-list
65075709|NCT00317876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65075710|NCT00317876|Immunologic Factors|immunologic factors|mesh-ancestor
65075711|NCT00317876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075712|NCT00317876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65075713|NCT00317876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65075714|NCT00317876|Alkylating Agents|alkylating agents|mesh-ancestor
65075715|NCT00317876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075716|NCT00317876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075717|NCT00317876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65075718|NCT00317876|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65075719|NCT00317876|Abortifacient Agents|abortifacient agents|mesh-ancestor
65075720|NCT00317876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65075721|NCT00317876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65075722|NCT00317876|Antimetabolites|antimetabolites|mesh-ancestor
65075723|NCT00317876|Dermatologic Agents|dermatologic agents|mesh-ancestor
65075724|NCT00317876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075725|NCT00317876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65075726|NCT00317876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65075727|NCT00317876|Antifungal Agents|antifungal agents|mesh-ancestor
65075728|NCT00317876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65075729|NCT00317876|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65075730|NCT04714827|Cyclophosphamide|cyclophosphamide|mesh-list
65075731|NCT04714827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65075732|NCT04714827|Immunologic Factors|immunologic factors|mesh-ancestor
65075733|NCT04714827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075734|NCT04714827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65075735|NCT04714827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65075736|NCT04714827|Alkylating Agents|alkylating agents|mesh-ancestor
65075737|NCT04714827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075738|NCT04714827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075739|NCT04714827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65075740|NCT00317915|Irbesartan|irbesartan|mesh-list
65075741|NCT00317915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65075742|NCT00317915|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65075743|NCT00317915|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65075744|NCT00317915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075745|NCT00317954|Spironolactone|spironolactone|mesh-list
65075746|NCT00317954|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65075747|NCT00317954|Hormone Antagonists|hormone antagonists|mesh-ancestor
65075748|NCT00317954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64482891|NCT03158025|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65075749|NCT00317954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075750|NCT00317954|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65075751|NCT00317954|Diuretics|diuretics|mesh-ancestor
65075752|NCT00317954|Natriuretic Agents|natriuretic agents|mesh-ancestor
65075753|NCT00317993|Simvastatin|simvastatin|mesh-list
65075754|NCT00317993|Ezetimibe|ezetimibe|mesh-list
65075755|NCT00317993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65075756|NCT00317993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65075757|NCT00317993|Antimetabolites|antimetabolites|mesh-ancestor
65075758|NCT00317993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075759|NCT00317993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65075760|NCT00317993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65075761|NCT00317993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833819|NCT05106192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65075762|NCT00350415|Mesalamine|mesalamine|mesh-list
65075763|NCT00350415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65075764|NCT00350415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65075765|NCT00350415|Analgesics|analgesics|mesh-ancestor
65075766|NCT00350415|Sensory System Agents|sensory system agents|mesh-ancestor
65075767|NCT00350415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65075768|NCT00350415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075769|NCT00350415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65075770|NCT00350415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65075771|NCT00345696|Bevacizumab|bevacizumab|mesh-list
65075772|NCT00345696|Capecitabine|capecitabine|mesh-list
65075773|NCT00345696|Oxaliplatin|oxaliplatin|mesh-list
65075774|NCT00345696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65075775|NCT00345696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075776|NCT00345696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65075777|NCT00345696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65075778|NCT00345696|Growth Substances|growth substances|mesh-ancestor
65075779|NCT00345696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075780|NCT00345696|Growth Inhibitors|growth inhibitors|mesh-ancestor
65075781|NCT00345696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65075782|NCT00345696|Antimetabolites|antimetabolites|mesh-ancestor
65075783|NCT00345696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075784|NCT00350454|Sirolimus|sirolimus|mesh-list
65075785|NCT00350454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65075786|NCT00350454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65075787|NCT00350454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65075788|NCT00350454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075789|NCT00350454|Antifungal Agents|antifungal agents|mesh-ancestor
65075790|NCT00350454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65075791|NCT00350454|Immunologic Factors|immunologic factors|mesh-ancestor
65075792|NCT00350454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075793|NCT00345735|Fentanyl|fentanyl|mesh-list
65075794|NCT00345735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65075795|NCT00345735|Narcotics|narcotics|mesh-ancestor
65075796|NCT00345735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65075797|NCT00345735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075798|NCT00345735|Analgesics|analgesics|mesh-ancestor
65075799|NCT00345735|Sensory System Agents|sensory system agents|mesh-ancestor
65075800|NCT00345735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65075801|NCT00345735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65075802|NCT00345735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65075803|NCT00345735|Anesthetics, General|anesthetics, general|mesh-ancestor
65075804|NCT00345735|Anesthetics|anesthetics|mesh-ancestor
65075805|NCT02959749|Bevacizumab|bevacizumab|mesh-list
65075806|NCT02959749|Docetaxel|docetaxel|mesh-list
65075807|NCT02959749|Osimertinib|osimertinib|mesh-list
65075808|NCT02959749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65075809|NCT02959749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075810|NCT02959749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65075811|NCT02959749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65075812|NCT02959749|Growth Substances|growth substances|mesh-ancestor
65075813|NCT02959749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075814|NCT02959749|Growth Inhibitors|growth inhibitors|mesh-ancestor
65075815|NCT02959749|Tubulin Modulators|tubulin modulators|mesh-ancestor
65075816|NCT02959749|Antimitotic Agents|antimitotic agents|mesh-ancestor
65075817|NCT02959749|Mitosis Modulators|mitosis modulators|mesh-ancestor
65075818|NCT02959749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075819|NCT02959749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65075820|NCT02959749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075822|NCT00318383|Immunologic Factors|immunologic factors|mesh-ancestor
65075823|NCT00318383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075824|NCT00318422|Liraglutide|liraglutide|mesh-list
65075825|NCT00318422|Glimepiride|glimepiride|mesh-list
65075826|NCT00318422|Rosiglitazone|rosiglitazone|mesh-list
65075827|NCT00318422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65075828|NCT00318422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075829|NCT00318422|Incretins|incretins|mesh-ancestor
65075830|NCT00318422|Hormones|hormones|mesh-ancestor
65075831|NCT00318422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65075832|NCT00318422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65075833|NCT00318422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65075834|NCT00318422|Immunologic Factors|immunologic factors|mesh-ancestor
65075835|NCT00318539|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65075836|NCT00318539|Antidepressive Agents|antidepressive agents|mesh-ancestor
65075837|NCT00318539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65075838|NCT00318539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65075839|NCT00318539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65075840|NCT00318539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65075841|NCT00318539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075842|NCT00346047|Buprenorphine|buprenorphine|mesh-list
65075843|NCT00346047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65075845|NCT00346047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65075846|NCT00346047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075847|NCT00346047|Analgesics|analgesics|mesh-ancestor
65075848|NCT00346047|Sensory System Agents|sensory system agents|mesh-ancestor
65075849|NCT00346047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65075850|NCT00346047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65075851|NCT00421200|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65075852|NCT00421200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65075853|NCT00421200|Plasma Substitutes|plasma substitutes|mesh-ancestor
65075854|NCT00421200|Blood Substitutes|blood substitutes|mesh-ancestor
65075855|NCT00318773|Sertraline|sertraline|mesh-list
65075856|NCT00318773|Antidepressive Agents|antidepressive agents|mesh-ancestor
65075857|NCT00318773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65075858|NCT00318773|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65075859|NCT00318773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65075860|NCT00318773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65075861|NCT00318773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075862|NCT00318773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65075863|NCT00318773|Serotonin Agents|serotonin agents|mesh-ancestor
65075864|NCT00318773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075865|NCT00318890|Docetaxel|docetaxel|mesh-list
65075866|NCT00318890|Amifostine|amifostine|mesh-list
65075867|NCT00318890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075868|NCT00318890|Tubulin Modulators|tubulin modulators|mesh-ancestor
65075869|NCT00318890|Antimitotic Agents|antimitotic agents|mesh-ancestor
65075870|NCT00318890|Mitosis Modulators|mitosis modulators|mesh-ancestor
65075871|NCT00318890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075872|NCT00318890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65075873|NCT00318890|Protective Agents|protective agents|mesh-ancestor
65075874|NCT00318890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075875|NCT00318968|Esomeprazole|esomeprazole|mesh-list
65075876|NCT00318968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65075877|NCT00318968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65075878|NCT00318968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65075879|NCT00318968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075880|NCT00318968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075881|NCT00319007|Sulindac|sulindac|mesh-list
65075882|NCT00319007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65075883|NCT00319007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65075884|NCT00319007|Analgesics|analgesics|mesh-ancestor
65075885|NCT00319007|Sensory System Agents|sensory system agents|mesh-ancestor
65075886|NCT00319007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65075887|NCT00319007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075888|NCT00319007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65075889|NCT00319007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64482903|NCT01998893|Immunologic Factors|immunologic factors|mesh-ancestor
65075890|NCT00319007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075891|NCT00319007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65075892|NCT00319007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075893|NCT00319007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075894|NCT00350961|Gemcitabine|gemcitabine|mesh-list
65075895|NCT00350961|Capecitabine|capecitabine|mesh-list
65075896|NCT00350961|Oxaliplatin|oxaliplatin|mesh-list
65075897|NCT00350961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65075898|NCT00350961|Antimetabolites|antimetabolites|mesh-ancestor
65075899|NCT00350961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075900|NCT00350961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075901|NCT00350961|Antiviral Agents|antiviral agents|mesh-ancestor
65075902|NCT00350961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64833839|NCT04969250|Vaccines|vaccines|mesh-list
65075903|NCT00350961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075904|NCT00350961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65075905|NCT00350961|Immunologic Factors|immunologic factors|mesh-ancestor
65075906|NCT00350961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075907|NCT00346242|Zoledronic Acid|zoledronic acid|mesh-list
65075908|NCT00346242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65075909|NCT00346242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075910|NCT00421473|Atovaquone|atovaquone|mesh-list
65075911|NCT00421473|Proguanil|proguanil|mesh-list
65075912|NCT00421473|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
65075913|NCT00421473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65075914|NCT00421473|Antimalarials|antimalarials|mesh-ancestor
65075915|NCT00421473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65075916|NCT00421473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65075917|NCT00421473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075918|NCT00421473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075919|NCT00421473|Antimetabolites|antimetabolites|mesh-ancestor
65075920|NCT00319163|Levonorgestrel|levonorgestrel|mesh-list
65075921|NCT00319163|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65075922|NCT00319163|Estradiol|estradiol|mesh-list
65075923|NCT00319163|Estrogens|estrogens|mesh-ancestor
65075924|NCT00319163|Hormones|hormones|mesh-ancestor
65075925|NCT00319163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65075926|NCT00319163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075927|NCT00319163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65075928|NCT00319163|Contraceptive Agents|contraceptive agents|mesh-ancestor
65075929|NCT00319163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65075930|NCT00319163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65075931|NCT00319163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65075932|NCT00319163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65075933|NCT00319163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65075934|NCT00319202|Candesartan|candesartan|mesh-list
65075935|NCT00319202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65075936|NCT00319202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65075937|NCT00319202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65075938|NCT00319202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075939|NCT00421512|Bevacizumab|bevacizumab|mesh-list
65075940|NCT00421512|Sunitinib|sunitinib|mesh-list
65075941|NCT00421512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65075942|NCT00421512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075943|NCT00421512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65075944|NCT00421512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65075945|NCT00421512|Growth Substances|growth substances|mesh-ancestor
65075946|NCT00421512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075947|NCT00421512|Growth Inhibitors|growth inhibitors|mesh-ancestor
65075948|NCT00421512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65075949|NCT00421512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075950|NCT00421512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075951|NCT00319319|Mecamylamine|mecamylamine|mesh-list
65075952|NCT00319319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65075953|NCT00319319|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
65075954|NCT00319319|Autonomic Agents|autonomic agents|mesh-ancestor
65075955|NCT00319319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65075956|NCT00319319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075957|NCT00319319|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
65075958|NCT00319319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65075959|NCT00319319|Cholinergic Agents|cholinergic agents|mesh-ancestor
65075960|NCT00319319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65075961|NCT00319319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075962|NCT00346359|Methotrexate|methotrexate|mesh-list
65075963|NCT00346359|Fludarabine phosphate|fludarabine phosphate|mesh-list
65075964|NCT00346359|Fludarabine|fludarabine|mesh-list
65075965|NCT00346359|Busulfan|busulfan|mesh-list
65075966|NCT00346359|Tacrolimus|tacrolimus|mesh-list
65075967|NCT00346359|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65075968|NCT00346359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64833840|NCT04969250|Immunologic Factors|immunologic factors|mesh-ancestor
64833841|NCT04969250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325071|NCT02628704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325072|NCT02152475|Curcumin|curcumin|mesh-list
65075969|NCT00346359|Abortifacient Agents|abortifacient agents|mesh-ancestor
65075970|NCT00346359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65075971|NCT00346359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075972|NCT00346359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65075973|NCT00346359|Antimetabolites|antimetabolites|mesh-ancestor
65075974|NCT00346359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075975|NCT00346359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075976|NCT00346359|Dermatologic Agents|dermatologic agents|mesh-ancestor
65075977|NCT00346359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65075978|NCT00346359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65075979|NCT00346359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65075980|NCT00346359|Immunologic Factors|immunologic factors|mesh-ancestor
65075981|NCT00346359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65075982|NCT00346359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65075983|NCT00346359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65075984|NCT00346359|Alkylating Agents|alkylating agents|mesh-ancestor
65075985|NCT00346359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65075986|NCT00346359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65075987|NCT00319358|Antioxidants|antioxidants|mesh-list
65075988|NCT00319358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075989|NCT00319358|Protective Agents|protective agents|mesh-ancestor
65075990|NCT00319358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65075991|NCT00319514|Docetaxel|docetaxel|mesh-list
65075992|NCT00319514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65075993|NCT00319514|Tubulin Modulators|tubulin modulators|mesh-ancestor
65075994|NCT00319514|Antimitotic Agents|antimitotic agents|mesh-ancestor
65075995|NCT00319514|Mitosis Modulators|mitosis modulators|mesh-ancestor
65075996|NCT00319514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65075997|NCT00319670|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65075998|NCT00319670|Laxatives|laxatives|mesh-ancestor
65075999|NCT00319670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65076000|NCT00351195|Capecitabine|capecitabine|mesh-list
65076001|NCT00351195|Oxaliplatin|oxaliplatin|mesh-list
65076002|NCT00351195|Etoposide|etoposide|mesh-list
65076003|NCT00351195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65076004|NCT00351195|Antimetabolites|antimetabolites|mesh-ancestor
65076005|NCT00351195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076006|NCT00351195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076007|NCT00351195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65076008|NCT00351195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65076009|NCT00351195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65076010|NCT00351195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076011|NCT00319709|Amibegron|amibegron|mesh-list
65076012|NCT00319709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64648579|NCT03834506|Docetaxel|docetaxel|mesh-list
65076013|NCT00319709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65076014|NCT00319709|Adrenergic Agents|adrenergic agents|mesh-ancestor
65076015|NCT00319709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65076016|NCT00319709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64482922|NCT03154281|Everolimus|everolimus|mesh-list
65076017|NCT00319709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076018|NCT00319787|Gefitinib|gefitinib|mesh-list
65076019|NCT00319787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076020|NCT00319787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65076021|NCT00319787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076022|NCT00319787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076023|NCT00319865|Thalidomide|thalidomide|mesh-list
65076024|NCT00319865|Dexamethasone|dexamethasone|mesh-list
65076025|NCT00319865|Doxorubicin|doxorubicin|mesh-list
65076026|NCT00319865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65076027|NCT00319865|Bortezomib|bortezomib|mesh-list
65076028|NCT00319865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65076029|NCT00319865|Antiemetics|antiemetics|mesh-ancestor
65076030|NCT00319865|Autonomic Agents|autonomic agents|mesh-ancestor
65076031|NCT00319865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65076032|NCT00319865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076033|NCT00319865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65076034|NCT00319865|Glucocorticoids|glucocorticoids|mesh-ancestor
65076035|NCT00319865|Hormones|hormones|mesh-ancestor
65076036|NCT00319865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65076037|NCT00319865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65076038|NCT00319865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325074|NCT02152475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65076039|NCT00319865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65076040|NCT00319865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65076041|NCT00319865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65076042|NCT00319865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076043|NCT00319865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076044|NCT00319865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65076045|NCT00319865|Immunologic Factors|immunologic factors|mesh-ancestor
65076046|NCT00319865|Leprostatic Agents|leprostatic agents|mesh-ancestor
65076047|NCT00319865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65076048|NCT00319865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65076049|NCT00319865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65076050|NCT00319865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65076051|NCT00319865|Growth Substances|growth substances|mesh-ancestor
65076052|NCT00319865|Growth Inhibitors|growth inhibitors|mesh-ancestor
65076053|NCT00320021|Pyridoxamine|pyridoxamine|mesh-list
65076054|NCT00320021|Vitamin B Complex|vitamin b complex|mesh-ancestor
65076055|NCT00320021|Vitamins|vitamins|mesh-ancestor
65076056|NCT00320021|Micronutrients|micronutrients|mesh-ancestor
65076057|NCT00320021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076058|NCT00320060|Pyridoxamine|pyridoxamine|mesh-list
65076059|NCT00320060|Vitamin B Complex|vitamin b complex|mesh-ancestor
64325076|NCT02152475|Sensory System Agents|sensory system agents|mesh-ancestor
65076060|NCT00320060|Vitamins|vitamins|mesh-ancestor
65076061|NCT00320060|Micronutrients|micronutrients|mesh-ancestor
65076062|NCT00320060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076063|NCT00320099|Insulin|insulin|mesh-list
65076064|NCT00320099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65076065|NCT00320099|Hydrocortisone|hydrocortisone|mesh-list
65076066|NCT00320099|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64718126|NCT04327843|Haloperidol|haloperidol|mesh-list
65076067|NCT00320099|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
65076068|NCT00320099|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
65076069|NCT00320099|Fludrocortisone|fludrocortisone|mesh-list
65076070|NCT00320099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65076071|NCT00320099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076072|NCT00320099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65076073|NCT00320294|Irinotecan|irinotecan|mesh-list
65076074|NCT00320294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076075|NCT00320294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65076076|NCT00320294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65076077|NCT00320294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076078|NCT00320294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076079|NCT00346749|Fluticasone|fluticasone|mesh-list
65076081|NCT00346749|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65076082|NCT00346749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65076083|NCT00346749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65076084|NCT00346749|Autonomic Agents|autonomic agents|mesh-ancestor
65076085|NCT00346749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65076086|NCT00346749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076087|NCT00346749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65076088|NCT00346749|Respiratory System Agents|respiratory system agents|mesh-ancestor
65076089|NCT00346749|Dermatologic Agents|dermatologic agents|mesh-ancestor
65076090|NCT00346749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65076091|NCT00346749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65076092|NCT00346749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65076093|NCT00346749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65076094|NCT00346749|Adrenergic Agents|adrenergic agents|mesh-ancestor
65076095|NCT00346749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65076096|NCT00346749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076098|NCT00351507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65076099|NCT00351507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076100|NCT00351507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65076101|NCT00351507|Protease Inhibitors|protease inhibitors|mesh-ancestor
65076102|NCT00351507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64325077|NCT02152475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64325078|NCT02152475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325079|NCT02152475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65076103|NCT00351507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076104|NCT00320567|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65076105|NCT00320567|Norgestimate|norgestimate|mesh-list
65076106|NCT00320567|Estradiol|estradiol|mesh-list
65076107|NCT00320567|Estrogens|estrogens|mesh-ancestor
65076108|NCT00320567|Hormones|hormones|mesh-ancestor
65076109|NCT00320567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65076110|NCT00320567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076111|NCT00320567|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65076112|NCT00320567|Contraceptive Agents|contraceptive agents|mesh-ancestor
65076113|NCT00320567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65076114|NCT00320567|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65076115|NCT00320567|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65076116|NCT00320567|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65076117|NCT00320567|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65076118|NCT00346827|Apomorphine|apomorphine|mesh-list
65076119|NCT00346827|Emetics|emetics|mesh-ancestor
65076120|NCT00346827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076121|NCT00346827|Autonomic Agents|autonomic agents|mesh-ancestor
65076122|NCT00346827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65076123|NCT00346827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65076124|NCT00346827|Dopamine Agonists|dopamine agonists|mesh-ancestor
65076125|NCT00346827|Dopamine Agents|dopamine agents|mesh-ancestor
65076126|NCT00346827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65076127|NCT00346827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076128|NCT00346866|Anecortave|anecortave|mesh-list
65076129|NCT00346866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65076130|NCT00346866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65076131|NCT00346866|Growth Substances|growth substances|mesh-ancestor
65076132|NCT00346866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076133|NCT00346866|Growth Inhibitors|growth inhibitors|mesh-ancestor
65076134|NCT00346866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076135|NCT00320723|Bupropion|bupropion|mesh-list
65076136|NCT00320723|Nicotine|nicotine|mesh-list
65076137|NCT00320723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65076138|NCT00320723|Autonomic Agents|autonomic agents|mesh-ancestor
65076139|NCT00320723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65076140|NCT00320723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076141|NCT00320723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64718201|NCT03608839|Glucocorticoids|glucocorticoids|mesh-ancestor
65076142|NCT00320723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65076143|NCT00320723|Cholinergic Agents|cholinergic agents|mesh-ancestor
65076144|NCT00320723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65076145|NCT00320723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076146|NCT00320723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65076147|NCT00320723|Antidepressive Agents|antidepressive agents|mesh-ancestor
65076148|NCT00320723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65076149|NCT00320723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65076150|NCT00320723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65076151|NCT00320723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65076152|NCT00320723|Dopamine Agents|dopamine agents|mesh-ancestor
65076153|NCT00320723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65076154|NCT00320723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65076155|NCT00320723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076156|NCT00351546|Vildagliptin|vildagliptin|mesh-list
65076157|NCT00351546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64833843|NCT04965077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64833844|NCT04965077|Immunologic Factors|immunologic factors|mesh-ancestor
64833845|NCT04965077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833846|NCT04950426|Propranolol|propranolol|mesh-list
65076158|NCT00351546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076159|NCT00351546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65076160|NCT00351546|Protease Inhibitors|protease inhibitors|mesh-ancestor
65076161|NCT00351546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076162|NCT00351546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076164|NCT00351585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65076165|NCT00351585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076166|NCT00351585|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65076167|NCT00351585|Protease Inhibitors|protease inhibitors|mesh-ancestor
65076168|NCT00351585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076169|NCT00351585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076170|NCT00320879|Irbesartan|irbesartan|mesh-list
65076171|NCT00320879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65076172|NCT00320879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65076173|NCT00320879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65076174|NCT00320879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076175|NCT00347100|Metformin|metformin|mesh-list
65076176|NCT00347100|Insulin Glargine|insulin glargine|mesh-list
65076177|NCT00347100|Glyburide|glyburide|mesh-list
65076178|NCT00347100|Glipizide|glipizide|mesh-list
65076179|NCT00347100|Gliclazide|gliclazide|mesh-list
65076180|NCT00347100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65076181|NCT00347100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076182|NCT00347139|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65076183|NCT00347139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65076184|NCT00347139|Autonomic Agents|autonomic agents|mesh-ancestor
65076185|NCT00347139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65076186|NCT00347139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076187|NCT00347139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65076188|NCT00347139|Respiratory System Agents|respiratory system agents|mesh-ancestor
65076189|NCT00347139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65076190|NCT00347139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65076191|NCT00347139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65076192|NCT00347139|Adrenergic Agents|adrenergic agents|mesh-ancestor
65076193|NCT00347139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65076194|NCT00347139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076195|NCT00321074|Tacrolimus|tacrolimus|mesh-list
65076196|NCT00321074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65076197|NCT00321074|Immunologic Factors|immunologic factors|mesh-ancestor
65076198|NCT00321074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076199|NCT00321074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65076200|NCT00321074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076201|NCT00321074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076202|NCT00321113|Mycophenolic Acid|mycophenolic acid|mesh-list
65076203|NCT00321113|Tacrolimus|tacrolimus|mesh-list
65076204|NCT00321113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65076205|NCT00321113|Immunologic Factors|immunologic factors|mesh-ancestor
65076206|NCT00321113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076207|NCT00321113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65076208|NCT00321113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076209|NCT00321113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076210|NCT00321113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65076211|NCT00321113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076212|NCT00321113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65076213|NCT00321113|Antitubercular Agents|antitubercular agents|mesh-ancestor
65076214|NCT00321113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65076215|NCT00321113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65076216|NCT00347256|Cisplatin|cisplatin|mesh-list
65076217|NCT00347256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076219|NCT00347295|Brotizolam|brotizolam|mesh-list
65076220|NCT00347295|Anticonvulsants|anticonvulsants|mesh-ancestor
65076221|NCT00347295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65076222|NCT00347295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65076223|NCT00347295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65076224|NCT00347295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076225|NCT00347295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65076226|NCT00347295|GABA Modulators|gaba modulators|mesh-ancestor
65076227|NCT00347295|GABA Agents|gaba agents|mesh-ancestor
65076228|NCT00347295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65076229|NCT00347295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076230|NCT00347295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65076231|NCT00321191|Nitrous Oxide|nitrous oxide|mesh-list
65076232|NCT00321191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65076233|NCT00321191|Anesthetics, General|anesthetics, general|mesh-ancestor
65076234|NCT00321191|Anesthetics|anesthetics|mesh-ancestor
65076235|NCT00321191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65076236|NCT00321191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076237|NCT00321191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65076239|NCT00321191|Sensory System Agents|sensory system agents|mesh-ancestor
65076240|NCT00321191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65076241|NCT00321230|Ascorbic Acid|ascorbic acid|mesh-list
65076242|NCT00321230|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65076243|NCT00321230|Antioxidants|antioxidants|mesh-ancestor
65076244|NCT00321230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076245|NCT00321230|Protective Agents|protective agents|mesh-ancestor
65076246|NCT00321230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076247|NCT00321230|Vitamins|vitamins|mesh-ancestor
65076248|NCT00321230|Micronutrients|micronutrients|mesh-ancestor
65076249|NCT00321230|Laxatives|laxatives|mesh-ancestor
65076250|NCT00321230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65076251|NCT00351663|Enoxaparin|enoxaparin|mesh-list
65076252|NCT00351663|Anticoagulants|anticoagulants|mesh-ancestor
65076253|NCT00351663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65076254|NCT00351663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65076255|NCT00351663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076256|NCT00321347|Lidocaine|lidocaine|mesh-list
65076257|NCT00321347|Anesthetics, Local|anesthetics, local|mesh-ancestor
65076258|NCT00321347|Anesthetics|anesthetics|mesh-ancestor
65076259|NCT00321347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65076260|NCT00321347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076261|NCT00321347|Sensory System Agents|sensory system agents|mesh-ancestor
65076262|NCT00321347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65076263|NCT00321347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65076264|NCT00321347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65076265|NCT00321347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65076266|NCT00321347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65076267|NCT00321347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076268|NCT00351702|Isoniazid|isoniazid|mesh-list
65076269|NCT00351702|Ethambutol|ethambutol|mesh-list
65076270|NCT00351702|Antitubercular Agents|antitubercular agents|mesh-ancestor
65076271|NCT00351702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65076272|NCT00351702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65076273|NCT00351702|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65076274|NCT00351702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65076275|NCT00351702|Antimetabolites|antimetabolites|mesh-ancestor
65076276|NCT00351702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076277|NCT00351702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65076278|NCT00351975|Azacitidine|azacitidine|mesh-list
65076279|NCT00351975|Belinostat|belinostat|mesh-list
65076280|NCT00351975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65076281|NCT00351975|Antimetabolites|antimetabolites|mesh-ancestor
65076282|NCT00351975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076283|NCT00351975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076284|NCT00351975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076285|NCT00351975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65076286|NCT00321581|Cediranib|cediranib|mesh-list
65076287|NCT00321581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076288|NCT00321581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65076289|NCT00321581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076290|NCT00321581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076291|NCT00352092|Mycophenolic Acid|mycophenolic acid|mesh-list
65076294|NCT00352092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65076295|NCT00352092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076296|NCT00352092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65076297|NCT00352092|Antitubercular Agents|antitubercular agents|mesh-ancestor
65076298|NCT00352092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65076299|NCT00352092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65076300|NCT00352092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076301|NCT00352092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076302|NCT00352092|Antifungal Agents|antifungal agents|mesh-ancestor
65076303|NCT00352092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65076304|NCT00352092|Immunologic Factors|immunologic factors|mesh-ancestor
65076305|NCT00352092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076306|NCT00322127|Plerixafor|plerixafor|mesh-list
65076307|NCT00322127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65076308|NCT00322127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65076309|NCT00322127|Antiviral Agents|antiviral agents|mesh-ancestor
65076310|NCT00322127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65076311|NCT00352170|Calcium, Dietary|calcium, dietary|mesh-list
65076312|NCT00352170|Vitamin D|vitamin d|mesh-list
65076313|NCT00352170|Cholecalciferol|cholecalciferol|mesh-list
65076314|NCT00352170|Calcium|calcium|mesh-list
65076315|NCT00352170|Vitamins|vitamins|mesh-ancestor
65076316|NCT00352170|Micronutrients|micronutrients|mesh-ancestor
65076317|NCT00352170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076318|NCT00352170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65076319|NCT00352170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65076320|NCT00322166|Calcium|calcium|mesh-list
65076321|NCT00322166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65076322|NCT00322166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076323|NCT02959580|Hydrocortisone|hydrocortisone|mesh-list
65076324|NCT02959580|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
65076325|NCT02959580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65076326|NCT02959580|Dermatologic Agents|dermatologic agents|mesh-ancestor
65076327|NCT00352287|Pioglitazone|pioglitazone|mesh-list
65076328|NCT00352287|Hormones|hormones|mesh-list
65076329|NCT00352287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65076330|NCT00352287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076331|NCT00352287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65076332|NCT00352443|Everolimus|everolimus|mesh-list
65076333|NCT00352443|Lapatinib|lapatinib|mesh-list
65076334|NCT00352443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076335|NCT00352443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65076336|NCT00352443|Immunologic Factors|immunologic factors|mesh-ancestor
65076337|NCT00352443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076338|NCT00352443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65076339|NCT00352443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076340|NCT00352443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076341|NCT00352482|Sildenafil Citrate|sildenafil citrate|mesh-list
65076342|NCT00352482|Vasodilator Agents|vasodilator agents|mesh-ancestor
65076343|NCT00352482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65076344|NCT00352482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65076345|NCT00352482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076346|NCT00352482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076347|NCT00352482|Urological Agents|urological agents|mesh-ancestor
65076348|NCT00322400|Paclitaxel|paclitaxel|mesh-list
65076349|NCT00322400|Docetaxel|docetaxel|mesh-list
65076350|NCT00322400|Motesanib diphosphate|motesanib diphosphate|mesh-list
65076351|NCT00322400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65076352|NCT00322400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076353|NCT00322400|Tubulin Modulators|tubulin modulators|mesh-ancestor
65076354|NCT00322400|Antimitotic Agents|antimitotic agents|mesh-ancestor
65076355|NCT00322400|Mitosis Modulators|mitosis modulators|mesh-ancestor
65076356|NCT00322400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076357|NCT00322400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65076358|NCT00322400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076359|NCT00352521|Bevacizumab|bevacizumab|mesh-list
64833863|NCT04896320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833864|NCT04873557|Copper|copper|mesh-list
65076360|NCT00352521|Irinotecan|irinotecan|mesh-list
64833865|NCT04873557|Trace Elements|trace elements|mesh-ancestor
64833866|NCT04873557|Micronutrients|micronutrients|mesh-ancestor
64833867|NCT04873557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833868|NCT04856566|Ethanol|ethanol|mesh-list
65076361|NCT00352521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65076362|NCT00352521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076363|NCT00352521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65076364|NCT00352521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65076366|NCT00352521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076367|NCT00352521|Growth Inhibitors|growth inhibitors|mesh-ancestor
64718425|NCT00726830|Morphine|morphine|mesh-list
65076368|NCT00352521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65076369|NCT00352521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65076370|NCT00352521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076371|NCT00352521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076372|NCT00352599|Lovastatin|lovastatin|mesh-list
65076373|NCT00352599|L 647318|l 647318|mesh-list
65076374|NCT00352599|Dihydromevinolin|dihydromevinolin|mesh-list
65076375|NCT00352599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65076376|NCT00352599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65076377|NCT00352599|Antimetabolites|antimetabolites|mesh-ancestor
65076378|NCT00352599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076379|NCT00352599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65076380|NCT00352599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65076382|NCT00322595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65076383|NCT00322595|Paroxetine|paroxetine|mesh-list
65076384|NCT00322595|Antidepressive Agents|antidepressive agents|mesh-ancestor
65076385|NCT00322595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65076386|NCT00322595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65076387|NCT00322595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65076388|NCT00322595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65076389|NCT00322595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076390|NCT00322595|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65076391|NCT00322595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65076392|NCT00322595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65076393|NCT00322595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076394|NCT00322595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65076395|NCT00322595|Serotonin Agents|serotonin agents|mesh-ancestor
65076396|NCT00322595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65076397|NCT00322595|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65076398|NCT00322595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65076399|NCT00322595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076400|NCT00352677|Bafetinib|bafetinib|mesh-list
65076401|NCT00352677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65076402|NCT00352677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076403|NCT00352677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076404|NCT00331149|Ropinirole|ropinirole|mesh-list
65076405|NCT00331149|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65076406|NCT00331149|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65076407|NCT00331149|Dopamine Agonists|dopamine agonists|mesh-ancestor
65076408|NCT00331149|Dopamine Agents|dopamine agents|mesh-ancestor
65076409|NCT00331149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65076410|NCT00331149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076411|NCT00331149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076412|NCT00331188|Vapreotide|vapreotide|mesh-list
65076413|NCT00331188|Analgesics|analgesics|mesh-ancestor
64833869|NCT04856566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64833870|NCT04856566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64833871|NCT04856566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64833872|NCT04856566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397317|NCT04632433|Cemiplimab|cemiplimab|mesh-list
65076414|NCT00331188|Sensory System Agents|sensory system agents|mesh-ancestor
65076415|NCT00331188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65076416|NCT00331188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076417|NCT00331188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076418|NCT00352833|Catumaxomab|catumaxomab|mesh-list
65076419|NCT00352833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65076420|NCT00331305|Sertraline|sertraline|mesh-list
65076421|NCT00331305|Antidepressive Agents|antidepressive agents|mesh-ancestor
65076422|NCT00331305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65076423|NCT00331305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65076424|NCT00331305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65076425|NCT00331305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65076426|NCT00331305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076427|NCT00331305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65076428|NCT00331305|Serotonin Agents|serotonin agents|mesh-ancestor
65076429|NCT00331305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076430|NCT00322751|Topotecan|topotecan|mesh-list
65076431|NCT00322751|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65076432|NCT00322751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65076433|NCT00322751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076434|NCT00322751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076435|NCT00322751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076436|NCT00352950|Panitumumab|panitumumab|mesh-list
65076437|NCT00352950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65076438|NCT00352950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076439|NCT00322907|Mefloquine|mefloquine|mesh-list
65076440|NCT00322907|Quinine|quinine|mesh-list
65076441|NCT00322907|Antimalarials|antimalarials|mesh-ancestor
65076442|NCT00322907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65076443|NCT00322907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65076444|NCT00322907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65076445|NCT00322907|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65076446|NCT00322907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076447|NCT00322907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65076448|NCT00322907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65076449|NCT00322907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65076450|NCT00322907|Analgesics|analgesics|mesh-ancestor
65076451|NCT00322907|Sensory System Agents|sensory system agents|mesh-ancestor
65076452|NCT00331500|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
65076453|NCT00331500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65076454|NCT00331500|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65076455|NCT00331500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65076456|NCT00331500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65076457|NCT00331500|Analgesics|analgesics|mesh-ancestor
65076458|NCT00331500|Sensory System Agents|sensory system agents|mesh-ancestor
65076459|NCT00331500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65076460|NCT00331500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076461|NCT00331500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65076462|NCT00331500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65076463|NCT00331500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65076464|NCT00331500|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65076465|NCT00331500|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65076466|NCT00331500|Histamine Antagonists|histamine antagonists|mesh-ancestor
65076467|NCT00331500|Histamine Agents|histamine agents|mesh-ancestor
65076468|NCT00331500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65076469|NCT00331500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076470|NCT00322985|Lenalidomide|lenalidomide|mesh-list
65076471|NCT00322985|Immunologic Factors|immunologic factors|mesh-ancestor
65076472|NCT00322985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076473|NCT00322985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65076474|NCT00322985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65076475|NCT00322985|Growth Substances|growth substances|mesh-ancestor
65076476|NCT00322985|Growth Inhibitors|growth inhibitors|mesh-ancestor
65076477|NCT00322985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076478|NCT00353028|Fluvoxamine|fluvoxamine|mesh-list
64833873|NCT04812457|Povidone-Iodine|povidone-iodine|mesh-list
64833874|NCT04812457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65076479|NCT00353028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076480|NCT00353028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076481|NCT00353028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65076482|NCT00353028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65076483|NCT00353028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65076484|NCT00353028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076485|NCT00353028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65076486|NCT00353028|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65076487|NCT00353028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65076488|NCT00353028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65076489|NCT00353028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65076490|NCT00353028|Serotonin Agents|serotonin agents|mesh-ancestor
65076491|NCT00353028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65076492|NCT00353028|Antidepressive Agents|antidepressive agents|mesh-ancestor
65076493|NCT00353028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65076494|NCT00353028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65076495|NCT00353028|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65076496|NCT00353067|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|mesh-list
65076497|NCT00353067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65076498|NCT00353067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65076499|NCT00353067|Analgesics|analgesics|mesh-ancestor
65076500|NCT00353067|Sensory System Agents|sensory system agents|mesh-ancestor
65076501|NCT00353067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65076502|NCT00353067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076503|NCT00353067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65076504|NCT00353067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65076505|NCT00353067|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
65076506|NCT00353067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076507|NCT00353067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076508|NCT00323219|Moxifloxacin|moxifloxacin|mesh-list
65076509|NCT00323219|Cefazolin|cefazolin|mesh-list
65076510|NCT00323219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65076511|NCT00323219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65076512|NCT00323219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65076513|NCT00323219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65076514|NCT00323219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076515|NCT00323219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076516|NCT00323219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076519|NCT00323375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65076520|NCT00323375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65076521|NCT00323375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65076522|NCT00323375|Antimalarials|antimalarials|mesh-ancestor
65076523|NCT00323375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65076524|NCT00331695|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
65076525|NCT00331695|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
65076526|NCT00331695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65076527|NCT00331695|Hormone Antagonists|hormone antagonists|mesh-ancestor
65076528|NCT00331695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65076529|NCT00331695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076530|NCT00331695|Progestins|progestins|mesh-ancestor
65076531|NCT00331695|Hormones|hormones|mesh-ancestor
65076532|NCT00353145|Gemcitabine|gemcitabine|mesh-list
65076533|NCT00353145|Oxaliplatin|oxaliplatin|mesh-list
65076534|NCT00353145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65076535|NCT00353145|Antimetabolites|antimetabolites|mesh-ancestor
65076536|NCT00353145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076537|NCT00353145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076538|NCT00353145|Antiviral Agents|antiviral agents|mesh-ancestor
65076539|NCT00353145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65076540|NCT00353145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076541|NCT00353145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65076542|NCT00353145|Immunologic Factors|immunologic factors|mesh-ancestor
65076543|NCT00353145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076544|NCT00323648|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65076545|NCT00323648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65076546|NCT00353184|Montelukast|montelukast|mesh-list
65076547|NCT00353184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65076548|NCT00353184|Respiratory System Agents|respiratory system agents|mesh-ancestor
65076549|NCT00353184|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65076550|NCT00353184|Hormone Antagonists|hormone antagonists|mesh-ancestor
65076551|NCT00353184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65076552|NCT00353184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076553|NCT00353184|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65076554|NCT00353184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65076555|NCT00353184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076556|NCT00323687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65076557|NCT00323687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65076558|NCT00323687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65076559|NCT00323687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076560|NCT00323687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076561|NCT00323687|Antiviral Agents|antiviral agents|mesh-ancestor
65076562|NCT00323687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65076563|NCT00323687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65076564|NCT00323687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65076565|NCT00323804|Ribavirin|ribavirin|mesh-list
65076566|NCT00323804|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65076567|NCT00323804|Antimetabolites|antimetabolites|mesh-ancestor
65076568|NCT00323804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076569|NCT00323804|Antiviral Agents|antiviral agents|mesh-ancestor
65076570|NCT00323804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65076571|NCT00353340|Acetylcysteine|acetylcysteine|mesh-list
65076572|NCT00353340|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65076573|NCT00353340|Antiviral Agents|antiviral agents|mesh-ancestor
65076574|NCT00353340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65076575|NCT00353340|Expectorants|expectorants|mesh-ancestor
65076576|NCT00353340|Respiratory System Agents|respiratory system agents|mesh-ancestor
65076577|NCT00353340|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65076578|NCT00353340|Antioxidants|antioxidants|mesh-ancestor
65076579|NCT00353340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076580|NCT00353340|Protective Agents|protective agents|mesh-ancestor
65076581|NCT00353340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076583|NCT00323843|Isoproterenol|isoproterenol|mesh-list
65076584|NCT00323843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65076585|NCT00323843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65076586|NCT00323843|Adrenergic Agents|adrenergic agents|mesh-ancestor
65076587|NCT00323843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65076588|NCT00323843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076589|NCT00323843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076591|NCT00323843|Autonomic Agents|autonomic agents|mesh-ancestor
65076592|NCT00323843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65076593|NCT00323843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65076594|NCT00323843|Respiratory System Agents|respiratory system agents|mesh-ancestor
65076595|NCT00323843|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65076596|NCT00323843|Sympathomimetics|sympathomimetics|mesh-ancestor
65076597|NCT00323843|Protective Agents|protective agents|mesh-ancestor
65076598|NCT00323921|Dermatologic Agents|dermatologic agents|mesh-list
65076600|NCT00331851|Insulin Glargine|insulin glargine|mesh-list
65076601|NCT00331851|Liraglutide|liraglutide|mesh-list
65076602|NCT00331851|Glimepiride|glimepiride|mesh-list
65076603|NCT00331851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65076604|NCT00331851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076605|NCT00331851|Incretins|incretins|mesh-ancestor
65076606|NCT00331851|Hormones|hormones|mesh-ancestor
65076607|NCT00331851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65076608|NCT00331851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65076609|NCT00331851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65076610|NCT00331851|Immunologic Factors|immunologic factors|mesh-ancestor
65076611|NCT00331890|Choline|choline|mesh-list
65076612|NCT00331890|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
65076613|NCT00331890|Lipotropic Agents|lipotropic agents|mesh-ancestor
65076614|NCT00331890|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64325084|NCT02152553|Hydrocortisone|hydrocortisone|mesh-list
64325085|NCT02152553|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64325086|NCT02152553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64325087|NCT03161457|Rituximab|rituximab|mesh-list
64325088|NCT03161457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65076615|NCT00331890|Antimetabolites|antimetabolites|mesh-ancestor
65076616|NCT00331890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076617|NCT00331890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65076618|NCT00331890|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65076619|NCT00331890|Nootropic Agents|nootropic agents|mesh-ancestor
65076620|NCT01059773|Methotrexate|methotrexate|mesh-list
65076621|NCT01059773|Ustekinumab|ustekinumab|mesh-list
65076622|NCT01059773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65076623|NCT01059773|Abortifacient Agents|abortifacient agents|mesh-ancestor
65076624|NCT01059773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65076625|NCT01059773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076626|NCT01059773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65076627|NCT01059773|Antimetabolites|antimetabolites|mesh-ancestor
65076628|NCT01059773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076629|NCT01059773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076630|NCT01059773|Dermatologic Agents|dermatologic agents|mesh-ancestor
65076631|NCT01059773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076632|NCT01059773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65076633|NCT01059773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65076634|NCT01059773|Immunologic Factors|immunologic factors|mesh-ancestor
65076635|NCT01059773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65076636|NCT01059773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65076637|NCT00353379|Guanfacine|guanfacine|mesh-list
65076638|NCT00353379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65076639|NCT00353379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65076640|NCT00353379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65076641|NCT00353379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65076642|NCT00353379|Adrenergic Agents|adrenergic agents|mesh-ancestor
65076643|NCT00353379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65076644|NCT00353379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076645|NCT00353379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076646|NCT00324077|Imatinib Mesylate|imatinib mesylate|mesh-list
65076647|NCT00324077|Dasatinib|dasatinib|mesh-list
65076648|NCT00324077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076649|NCT00324077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65076650|NCT00324077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076651|NCT00324077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076652|NCT00324194|Mocetinostat|mocetinostat|mesh-list
65076653|NCT00324194|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65076654|NCT00324194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076655|NCT00324194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076656|NCT00324389|Interferons|interferons|mesh-list
65076657|NCT00324389|Interferon-alpha|interferon-alpha|mesh-list
65076658|NCT00324389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076659|NCT00324389|Antiviral Agents|antiviral agents|mesh-ancestor
65076660|NCT00324389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65076661|NCT00324389|Immunologic Factors|immunologic factors|mesh-ancestor
64458098|NCT03595930|Fluticasone|fluticasone|mesh-list
65076662|NCT00324389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076663|NCT00353691|Metformin|metformin|mesh-list
65076664|NCT00353691|Glimepiride|glimepiride|mesh-list
65076665|NCT00353691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65076666|NCT00353691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076667|NCT00353691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65076668|NCT00353691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65076669|NCT00353691|Immunologic Factors|immunologic factors|mesh-ancestor
65076670|NCT00332046|Casopitant|casopitant|mesh-list
65076671|NCT00332046|Antiemetics|antiemetics|mesh-ancestor
65076672|NCT00332046|Autonomic Agents|autonomic agents|mesh-ancestor
64482937|NCT05701059|Cimetidine|cimetidine|mesh-list
65076673|NCT00332046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65076674|NCT00332046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076675|NCT00332046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65076676|NCT00332046|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65076677|NCT00332046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65076678|NCT00332046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076679|NCT00324467|Acetaminophen|acetaminophen|mesh-list
65076680|NCT00324467|Diphenhydramine|diphenhydramine|mesh-list
65076681|NCT00324467|Promethazine|promethazine|mesh-list
65076682|NCT00324467|Dexamethasone|dexamethasone|mesh-list
65076683|NCT00324467|Dexamethasone acetate|dexamethasone acetate|mesh-list
65076684|NCT00324467|Prednisone|prednisone|mesh-list
65076685|NCT00324467|Cyclophosphamide|cyclophosphamide|mesh-list
65076686|NCT00324467|Ifosfamide|ifosfamide|mesh-list
65076687|NCT00324467|Rituximab|rituximab|mesh-list
65076688|NCT00324467|Carboplatin|carboplatin|mesh-list
65076689|NCT00324467|Doxorubicin|doxorubicin|mesh-list
65076690|NCT00324467|Etoposide|etoposide|mesh-list
65076691|NCT00324467|Vincristine|vincristine|mesh-list
65076692|NCT00324467|Ondansetron|ondansetron|mesh-list
65076693|NCT00324467|BB 1101|bb 1101|mesh-list
65076694|NCT00324467|Mesna|mesna|mesh-list
65076695|NCT00324467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65076696|NCT00324467|Immunologic Factors|immunologic factors|mesh-ancestor
65076697|NCT00324467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076698|NCT00324467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65076699|NCT00324467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65076700|NCT00324467|Alkylating Agents|alkylating agents|mesh-ancestor
65076701|NCT00324467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076702|NCT00324467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076703|NCT00324467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65076704|NCT00324467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65076705|NCT00324467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65076706|NCT00324467|Antiemetics|antiemetics|mesh-ancestor
65076707|NCT00324467|Autonomic Agents|autonomic agents|mesh-ancestor
65076708|NCT00324467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65076709|NCT00324467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65076710|NCT00324467|Glucocorticoids|glucocorticoids|mesh-ancestor
65076711|NCT00324467|Hormones|hormones|mesh-ancestor
65076712|NCT00324467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65076713|NCT00324467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65076714|NCT00324467|Protease Inhibitors|protease inhibitors|mesh-ancestor
65076715|NCT00324467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076716|NCT00324467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65076717|NCT00324467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65076718|NCT00324467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65076719|NCT00324467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65076720|NCT00324467|Tubulin Modulators|tubulin modulators|mesh-ancestor
65076721|NCT00324467|Antimitotic Agents|antimitotic agents|mesh-ancestor
65076722|NCT00324467|Mitosis Modulators|mitosis modulators|mesh-ancestor
65076723|NCT00324467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65076724|NCT00324467|Analgesics|analgesics|mesh-ancestor
65076725|NCT00324467|Sensory System Agents|sensory system agents|mesh-ancestor
65076726|NCT00324467|Antipyretics|antipyretics|mesh-ancestor
64833881|NCT04808505|Antiviral Agents|antiviral agents|mesh-ancestor
65076727|NCT00324467|Antipruritics|antipruritics|mesh-ancestor
65076728|NCT00324467|Dermatologic Agents|dermatologic agents|mesh-ancestor
65076729|NCT00324467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65076730|NCT00324467|Serotonin Agents|serotonin agents|mesh-ancestor
65076731|NCT00324467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65076732|NCT00324467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65076733|NCT00324467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65076734|NCT00324467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65076735|NCT00324467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65076736|NCT00324467|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65076737|NCT00324467|Protective Agents|protective agents|mesh-ancestor
65076738|NCT00324467|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65076739|NCT00324467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65076740|NCT00324467|Anesthetics, Local|anesthetics, local|mesh-ancestor
65076741|NCT00324467|Anesthetics|anesthetics|mesh-ancestor
65076742|NCT00324467|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65076743|NCT00324467|Histamine Antagonists|histamine antagonists|mesh-ancestor
65076744|NCT00324467|Histamine Agents|histamine agents|mesh-ancestor
65076745|NCT00324467|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65076746|NCT00332085|Chromium|chromium|mesh-list
65076747|NCT00332085|Picolinic acid|picolinic acid|mesh-list
65076748|NCT00332085|Trace Elements|trace elements|mesh-ancestor
65076749|NCT00332085|Micronutrients|micronutrients|mesh-ancestor
65076750|NCT00332085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076751|NCT00332085|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65076752|NCT00332085|Chelating Agents|chelating agents|mesh-ancestor
65076753|NCT00332085|Sequestering Agents|sequestering agents|mesh-ancestor
65076754|NCT00332085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076755|NCT00324506|Mycophenolic Acid|mycophenolic acid|mesh-list
65076756|NCT00324506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65076757|NCT00324506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076758|NCT00324506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65076759|NCT00324506|Antitubercular Agents|antitubercular agents|mesh-ancestor
65076760|NCT00324506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65076761|NCT00324506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65076762|NCT00324506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076763|NCT00324506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076764|NCT00332124|Choline|choline|mesh-list
65076765|NCT00332124|Lipotropic Agents|lipotropic agents|mesh-ancestor
65076766|NCT00332124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65076767|NCT00332124|Antimetabolites|antimetabolites|mesh-ancestor
65076768|NCT00332124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076769|NCT00332124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65076770|NCT00332124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65076771|NCT00332124|Nootropic Agents|nootropic agents|mesh-ancestor
65076772|NCT04714554|Erythromycin|erythromycin|mesh-list
65076773|NCT04714554|Erythromycin Estolate|erythromycin estolate|mesh-list
65076774|NCT04714554|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
65076775|NCT04714554|Erythromycin stearate|erythromycin stearate|mesh-list
65076776|NCT04714554|Relugolix|relugolix|mesh-list
65076777|NCT04714554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65076778|NCT04714554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65076779|NCT04714554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65076780|NCT04714554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65076781|NCT04714554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076782|NCT04714554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076783|NCT04714554|Androgen Antagonists|androgen antagonists|mesh-ancestor
65076784|NCT04714554|Hormone Antagonists|hormone antagonists|mesh-ancestor
65076785|NCT04714554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65076786|NCT04714554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076787|NCT00419471|Citalopram|citalopram|mesh-list
65076788|NCT00419471|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65076789|NCT00419471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65076790|NCT00419471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65076791|NCT00419471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076792|NCT00419471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65076793|NCT00419471|Serotonin Agents|serotonin agents|mesh-ancestor
65076794|NCT00419471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076795|NCT00419471|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65076796|NCT00419471|Antidepressive Agents|antidepressive agents|mesh-ancestor
65076797|NCT00419471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65076798|NCT00426348|Valsartan|valsartan|mesh-list
65076799|NCT00426348|Probucol|probucol|mesh-list
65076800|NCT00426348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65076801|NCT00426348|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64833882|NCT04808505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65076802|NCT00426348|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65076803|NCT00426348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076804|NCT00426348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65076805|NCT00426348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65076806|NCT00426348|Antimetabolites|antimetabolites|mesh-ancestor
64416221|NCT04338529|Vitamins|vitamins|mesh-ancestor
65076807|NCT00426348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65076808|NCT00426348|Antioxidants|antioxidants|mesh-ancestor
65076809|NCT00426348|Protective Agents|protective agents|mesh-ancestor
65076810|NCT00426348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076811|NCT00353808|Reboxetine|reboxetine|mesh-list
65076812|NCT00353808|Antidepressive Agents|antidepressive agents|mesh-ancestor
65076813|NCT00353808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65076814|NCT00353808|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65076815|NCT00353808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65076816|NCT00353808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65076817|NCT00353808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076818|NCT00353808|Adrenergic Agents|adrenergic agents|mesh-ancestor
65076819|NCT00353808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65076820|NCT00353808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076822|NCT00324623|Fludarabine|fludarabine|mesh-list
64833885|NCT04808505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076823|NCT00324623|Fludarabine phosphate|fludarabine phosphate|mesh-list
65076824|NCT00324623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65076825|NCT00324623|Immunologic Factors|immunologic factors|mesh-ancestor
65076826|NCT00324623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076827|NCT00324623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65076828|NCT00324623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65076829|NCT00324623|Alkylating Agents|alkylating agents|mesh-ancestor
65076830|NCT00324623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076831|NCT00324623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076832|NCT00324623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65076833|NCT00324623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65076834|NCT00324623|Antimetabolites|antimetabolites|mesh-ancestor
65076835|NCT00324779|Rituximab|rituximab|mesh-list
65076836|NCT00324779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65076837|NCT00324779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076838|NCT00324779|Immunologic Factors|immunologic factors|mesh-ancestor
65076839|NCT00324779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076840|NCT00324779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65076841|NCT00324818|Azithromycin|azithromycin|mesh-list
65076842|NCT00324818|Metronidazole|metronidazole|mesh-list
65076843|NCT00324818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65076844|NCT00324818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65076845|NCT00324818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65076846|NCT00324818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65076847|NCT00324974|Lansoprazole|lansoprazole|mesh-list
65076848|NCT00324974|Dexlansoprazole|dexlansoprazole|mesh-list
65076849|NCT00324974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65076850|NCT00324974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65076851|NCT00324974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65076852|NCT00324974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076853|NCT00324974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076854|NCT00325169|Tiotropium Bromide|tiotropium bromide|mesh-list
65076855|NCT00325169|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65076856|NCT00325169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65076857|NCT00325169|Autonomic Agents|autonomic agents|mesh-ancestor
65076858|NCT00325169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65076859|NCT00325169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076860|NCT00325169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65076861|NCT00325169|Respiratory System Agents|respiratory system agents|mesh-ancestor
65076862|NCT00325169|Parasympatholytics|parasympatholytics|mesh-ancestor
65076863|NCT00325169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64833887|NCT04789616|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64833888|NCT04789616|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64833889|NCT04789616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833890|NCT04789616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65076864|NCT00325169|Cholinergic Agents|cholinergic agents|mesh-ancestor
65076865|NCT00325169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65076866|NCT00325169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076867|NCT00325169|Glucocorticoids|glucocorticoids|mesh-ancestor
65076868|NCT00325169|Hormones|hormones|mesh-ancestor
65076869|NCT00325169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65076870|NCT00325169|Sympathomimetics|sympathomimetics|mesh-ancestor
65076871|NCT00426543|Rituximab|rituximab|mesh-list
65076872|NCT00426543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65076873|NCT00426543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076874|NCT00426543|Immunologic Factors|immunologic factors|mesh-ancestor
65076875|NCT00426543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076876|NCT00426543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65076877|NCT00325286|Carbamazepine|carbamazepine|mesh-list
65076878|NCT00325286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65076879|NCT00325286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076880|NCT00325286|Antimanic Agents|antimanic agents|mesh-ancestor
65076881|NCT00325286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65076882|NCT00325286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65076883|NCT00325286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076884|NCT00325286|Anticonvulsants|anticonvulsants|mesh-ancestor
65076885|NCT00325286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65076886|NCT00325286|Analgesics|analgesics|mesh-ancestor
65076887|NCT00325286|Sensory System Agents|sensory system agents|mesh-ancestor
65076888|NCT00325286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65076889|NCT00325286|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65076890|NCT00325286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65076891|NCT00325286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65076892|NCT00325286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65076893|NCT00325325|Everolimus|everolimus|mesh-list
65076894|NCT00325325|Tacrolimus|tacrolimus|mesh-list
65076895|NCT00325325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65076896|NCT00325325|Immunologic Factors|immunologic factors|mesh-ancestor
65076897|NCT00325325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076898|NCT00325325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65076899|NCT00325325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076900|NCT00325325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076901|NCT00325325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076902|NCT04705428|Fluorides|fluorides|mesh-list
65076903|NCT04705428|Cariostatic Agents|cariostatic agents|mesh-ancestor
65076904|NCT04705428|Protective Agents|protective agents|mesh-ancestor
65076905|NCT04705428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076906|NCT00354081|Vitamins|vitamins|mesh-list
65076907|NCT00354081|Folic Acid|folic acid|mesh-list
65076908|NCT00354081|Hydroxocobalamin|hydroxocobalamin|mesh-list
65076909|NCT00354081|Vitamin B 12|vitamin b 12|mesh-list
65076910|NCT00354081|Pyridoxine|pyridoxine|mesh-list
65076911|NCT00354081|Pyridoxal|pyridoxal|mesh-list
65076912|NCT00354081|Vitamin B 6|vitamin b 6|mesh-list
65076913|NCT00354081|Vitamin B Complex|vitamin b complex|mesh-list
65076914|NCT00354081|Micronutrients|micronutrients|mesh-ancestor
65076915|NCT00354081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076916|NCT00354081|Hematinics|hematinics|mesh-ancestor
65076917|NCT00325637|Losartan|losartan|mesh-list
65076918|NCT00325637|Cilnidipine|cilnidipine|mesh-list
65076919|NCT00325637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65076920|NCT00325637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65076921|NCT00325637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65076922|NCT00325637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65076923|NCT00325637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076924|NCT00325637|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65076925|NCT00325637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65076926|NCT00325637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65076927|NCT00325637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076928|NCT04714593|Cyclophosphamide|cyclophosphamide|mesh-list
65076929|NCT04714593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65076930|NCT04714593|Immunologic Factors|immunologic factors|mesh-ancestor
65076931|NCT04714593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076932|NCT04714593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65076933|NCT04714593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65076934|NCT04714593|Alkylating Agents|alkylating agents|mesh-ancestor
65076935|NCT04714593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076936|NCT04714593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076937|NCT04714593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65076938|NCT00426582|Epothilone B|epothilone b|mesh-list
65076939|NCT00426582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076940|NCT00426582|Tubulin Modulators|tubulin modulators|mesh-ancestor
65076941|NCT00426582|Antimitotic Agents|antimitotic agents|mesh-ancestor
65076942|NCT00426582|Mitosis Modulators|mitosis modulators|mesh-ancestor
65076943|NCT00426582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076944|NCT00354198|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65076945|NCT00354198|Pentoxifylline|pentoxifylline|mesh-list
65076946|NCT00354198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65076947|NCT00354198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076948|NCT00354198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076949|NCT00354198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65076950|NCT00354198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65076951|NCT00354198|Protective Agents|protective agents|mesh-ancestor
65076952|NCT00354198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076953|NCT00354198|Vasodilator Agents|vasodilator agents|mesh-ancestor
65076954|NCT00354198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65076955|NCT00354198|Antioxidants|antioxidants|mesh-ancestor
65076956|NCT00354198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65076957|NCT00354198|Glucocorticoids|glucocorticoids|mesh-ancestor
65076958|NCT00354198|Hormones|hormones|mesh-ancestor
65076959|NCT00354198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65076960|NCT00354198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65076961|NCT00354198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65076962|NCT00354198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65076963|NCT00325676|Pantoprazole|pantoprazole|mesh-list
65076964|NCT00325676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65076965|NCT00325676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65076966|NCT00325676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65076967|NCT00325676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076968|NCT00325676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076970|NCT00325715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65076971|NCT00325715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65076972|NCT00325715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65076973|NCT00325715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076974|NCT00325715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076975|NCT00354237|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65076976|NCT00354237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076978|NCT00325793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65076979|NCT00325793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65076980|NCT00325793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65076981|NCT00325793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076982|NCT00325793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65076983|NCT00325793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076984|NCT00325793|Vasodilator Agents|vasodilator agents|mesh-ancestor
65076985|NCT00426621|Diclofenac|diclofenac|mesh-list
65076986|NCT00426621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65076987|NCT00426621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65076988|NCT00426621|Analgesics|analgesics|mesh-ancestor
65076989|NCT00426621|Sensory System Agents|sensory system agents|mesh-ancestor
65076990|NCT00426621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65076991|NCT00426621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65076992|NCT00426621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65076993|NCT00426621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65076994|NCT00426621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65076995|NCT00426621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65076996|NCT00426621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65076997|NCT04714242|Ranibizumab|ranibizumab|mesh-list
65076998|NCT04714242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65076999|NCT04714242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65077000|NCT04714242|Growth Substances|growth substances|mesh-ancestor
65077001|NCT04714242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077002|NCT04714242|Growth Inhibitors|growth inhibitors|mesh-ancestor
65077003|NCT04714242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077004|NCT00354276|Cytarabine|cytarabine|mesh-list
65077005|NCT00354276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65077006|NCT00354276|Antimetabolites|antimetabolites|mesh-ancestor
65077007|NCT00354276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077008|NCT00354276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077009|NCT00354276|Antiviral Agents|antiviral agents|mesh-ancestor
65077010|NCT00354276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65077011|NCT00354276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65077012|NCT00354276|Immunologic Factors|immunologic factors|mesh-ancestor
65077013|NCT00354276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077014|NCT00325910|Metformin|metformin|mesh-list
65077015|NCT00325910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65077016|NCT00325910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077017|NCT00325949|Acetaminophen|acetaminophen|mesh-list
65077018|NCT00325949|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65077019|NCT00325949|Hydrocodone|hydrocodone|mesh-list
65077020|NCT00325949|Oxycodone|oxycodone|mesh-list
65077021|NCT00325949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65077022|NCT00325949|Analgesics|analgesics|mesh-ancestor
65077023|NCT00325949|Sensory System Agents|sensory system agents|mesh-ancestor
65077024|NCT00325949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65077025|NCT00325949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077026|NCT00325949|Antipyretics|antipyretics|mesh-ancestor
65077027|NCT00325949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65077028|NCT00325949|Narcotics|narcotics|mesh-ancestor
65077029|NCT00325949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65077030|NCT00325949|Antitussive Agents|antitussive agents|mesh-ancestor
65077031|NCT00325949|Respiratory System Agents|respiratory system agents|mesh-ancestor
65077032|NCT00325949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65077033|NCT00325949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65077034|NCT00325949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65077035|NCT00326027|Pantoprazole|pantoprazole|mesh-list
65077036|NCT00326027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65077037|NCT00326027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65077038|NCT00326027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65077039|NCT00326027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077040|NCT00326027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077041|NCT01059318|Everolimus|everolimus|mesh-list
65077042|NCT01059318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077043|NCT01059318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65077044|NCT01059318|Immunologic Factors|immunologic factors|mesh-ancestor
65077045|NCT01059318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077046|NCT04714515|Hydroxychloroquine|hydroxychloroquine|mesh-list
65077047|NCT04714515|Ivermectin|ivermectin|mesh-list
65077048|NCT04714515|Montelukast|montelukast|mesh-list
65077049|NCT04714515|Antimalarials|antimalarials|mesh-ancestor
65077050|NCT04714515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65077051|NCT04714515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65077052|NCT04714515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65077053|NCT04714515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077054|NCT04714515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077055|NCT04714515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65077056|NCT04714515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65077057|NCT04714515|Respiratory System Agents|respiratory system agents|mesh-ancestor
65077058|NCT04714515|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65077059|NCT04714515|Hormone Antagonists|hormone antagonists|mesh-ancestor
65077060|NCT04714515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65077061|NCT04714515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077062|NCT04714515|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65077063|NCT04714515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65077064|NCT00326105|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65077065|NCT00326105|Antidepressive Agents|antidepressive agents|mesh-ancestor
65077066|NCT00326105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65077067|NCT00326105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65077068|NCT00326105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65077069|NCT00326105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65077070|NCT00326105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077071|NCT00354354|Ipratropium|ipratropium|mesh-list
65077072|NCT00354354|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65077073|NCT00354354|Autonomic Agents|autonomic agents|mesh-ancestor
65077074|NCT00354354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65077075|NCT00354354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077076|NCT00354354|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65077077|NCT00354354|Respiratory System Agents|respiratory system agents|mesh-ancestor
65077078|NCT00354354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65077079|NCT00354354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077080|NCT00354354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65077081|NCT00354354|Cholinergic Agents|cholinergic agents|mesh-ancestor
65077082|NCT00326144|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65077083|NCT00326144|Antidepressive Agents|antidepressive agents|mesh-ancestor
65077084|NCT00326144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65077085|NCT00326144|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65077086|NCT00326144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65077087|NCT00326144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65077088|NCT00326144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077089|NCT01058655|Everolimus|everolimus|mesh-list
65077090|NCT01058655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077091|NCT01058655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65077092|NCT01058655|Immunologic Factors|immunologic factors|mesh-ancestor
65077093|NCT01058655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077094|NCT00326300|Methylphenidate|methylphenidate|mesh-list
65077095|NCT00326300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65077096|NCT00326300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077097|NCT00326300|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65077098|NCT00326300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65077099|NCT00326300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65077100|NCT00326300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077101|NCT00326300|Dopamine Agents|dopamine agents|mesh-ancestor
65077102|NCT00326300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65077103|NCT00426777|Risedronic Acid|risedronic acid|mesh-list
65077104|NCT00426777|Etidronic Acid|etidronic acid|mesh-list
65077105|NCT00426777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65077106|NCT00426777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65077107|NCT00426777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077108|NCT00426777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65077109|NCT00426777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077110|NCT00426777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65077111|NCT00419549|Valdecoxib|valdecoxib|mesh-list
65077112|NCT00419549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65077113|NCT00419549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65077114|NCT00419549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077115|NCT00419549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077116|NCT00419549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65077117|NCT00419549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64325089|NCT03161457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325090|NCT03161457|Immunologic Factors|immunologic factors|mesh-ancestor
64325091|NCT03161457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325094|NCT02576912|Hallucinogens|hallucinogens|mesh-ancestor
64325095|NCT02576912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325096|NCT02576912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65077118|NCT00419549|Analgesics|analgesics|mesh-ancestor
65077119|NCT00419549|Sensory System Agents|sensory system agents|mesh-ancestor
65077120|NCT00419549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65077121|NCT00419549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077122|NCT00419549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65077123|NCT00419549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65077124|NCT00354393|Methotrexate|methotrexate|mesh-list
65077125|NCT00354393|Vinorelbine|vinorelbine|mesh-list
65077126|NCT00354393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077127|NCT00354393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65077128|NCT00354393|Abortifacient Agents|abortifacient agents|mesh-ancestor
65077129|NCT00354393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65077130|NCT00354393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077131|NCT00354393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65077132|NCT00354393|Antimetabolites|antimetabolites|mesh-ancestor
65077133|NCT00354393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077134|NCT00354393|Dermatologic Agents|dermatologic agents|mesh-ancestor
65077135|NCT00354393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077136|NCT00354393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65077137|NCT00354393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65077138|NCT00354393|Immunologic Factors|immunologic factors|mesh-ancestor
65077139|NCT00354393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65077140|NCT00354393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65077141|NCT00354393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65077142|NCT00354393|Tubulin Modulators|tubulin modulators|mesh-ancestor
65077143|NCT00354393|Antimitotic Agents|antimitotic agents|mesh-ancestor
65077144|NCT00354393|Mitosis Modulators|mitosis modulators|mesh-ancestor
65077145|NCT00326378|Docetaxel|docetaxel|mesh-list
65077146|NCT00326378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077147|NCT00326378|Tubulin Modulators|tubulin modulators|mesh-ancestor
65077148|NCT00326378|Antimitotic Agents|antimitotic agents|mesh-ancestor
65077149|NCT00326378|Mitosis Modulators|mitosis modulators|mesh-ancestor
65077150|NCT00326378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077151|NCT00326768|Telmisartan|telmisartan|mesh-list
65077152|NCT00326768|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65077153|NCT00326768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65077154|NCT00326768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65077155|NCT00326768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65077156|NCT00326768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077157|NCT00326768|Diuretics|diuretics|mesh-ancestor
65077158|NCT00326768|Natriuretic Agents|natriuretic agents|mesh-ancestor
65077159|NCT00326768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077160|NCT00326768|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65077161|NCT00326768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65077162|NCT00326807|Naltrexone|naltrexone|mesh-list
65077163|NCT00326807|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65077164|NCT00326807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65077165|NCT00326807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077166|NCT00326807|Sensory System Agents|sensory system agents|mesh-ancestor
65077167|NCT00326807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65077168|NCT00354549|Gemcitabine|gemcitabine|mesh-list
65077169|NCT00354549|Bevacizumab|bevacizumab|mesh-list
65077170|NCT00354549|Carboplatin|carboplatin|mesh-list
65077171|NCT00354549|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65077172|NCT00354549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65077173|NCT00354549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077174|NCT00354549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65077175|NCT00354549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65077176|NCT00354549|Growth Substances|growth substances|mesh-ancestor
65077177|NCT00354549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077178|NCT00354549|Growth Inhibitors|growth inhibitors|mesh-ancestor
65077179|NCT00354549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65077180|NCT00354549|Antimetabolites|antimetabolites|mesh-ancestor
64397470|NCT05059145|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65077181|NCT00354549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077182|NCT00354549|Antiviral Agents|antiviral agents|mesh-ancestor
65077183|NCT00354549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65077184|NCT00354549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077185|NCT00354549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65077186|NCT00354549|Immunologic Factors|immunologic factors|mesh-ancestor
65077187|NCT00354549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65077188|NCT01057251|Nebivolol|nebivolol|mesh-list
65077189|NCT01057251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65077190|NCT01057251|Vasodilator Agents|vasodilator agents|mesh-ancestor
65077191|NCT01057251|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65077192|NCT01057251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65077193|NCT01057251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65077194|NCT01057251|Adrenergic Agents|adrenergic agents|mesh-ancestor
65077195|NCT01057251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65077196|NCT01057251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077197|NCT01057251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077198|NCT04708353|Pregabalin|pregabalin|mesh-list
65077199|NCT04708353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077200|NCT04708353|Analgesics|analgesics|mesh-ancestor
65077201|NCT04708353|Sensory System Agents|sensory system agents|mesh-ancestor
65077202|NCT04708353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65077203|NCT04708353|Anticonvulsants|anticonvulsants|mesh-ancestor
65077204|NCT04708353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65077205|NCT04708353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65077206|NCT04708353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077207|NCT04708353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65077208|NCT04708353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65077209|NCT04708353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65077210|NCT04708353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65077211|NCT04708353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65077212|NCT00425646|Bevacizumab|bevacizumab|mesh-list
65077213|NCT00425646|Imatinib Mesylate|imatinib mesylate|mesh-list
65077214|NCT00425646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65077215|NCT00425646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077216|NCT00425646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65077217|NCT00425646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65077218|NCT00425646|Growth Substances|growth substances|mesh-ancestor
65077219|NCT00425646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077220|NCT00425646|Growth Inhibitors|growth inhibitors|mesh-ancestor
65077221|NCT00425646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65077222|NCT00425646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077223|NCT00425646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077224|NCT00327080|Acetylcholine|acetylcholine|mesh-list
65077225|NCT00327080|Vasodilator Agents|vasodilator agents|mesh-ancestor
65077226|NCT00327080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65077227|NCT00327080|Cholinergic Agents|cholinergic agents|mesh-ancestor
65077228|NCT00327080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65077229|NCT00327080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077230|NCT00327080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077231|NCT00327119|Panitumumab|panitumumab|mesh-list
65077232|NCT00327119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65077233|NCT00327119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077234|NCT00426933|Vancomycin|vancomycin|mesh-list
65077235|NCT00426933|Daptomycin|daptomycin|mesh-list
65077236|NCT00426933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65077237|NCT00426933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65077238|NCT00327197|Prednisolone|prednisolone|mesh-list
65077239|NCT00327197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65077240|NCT00327197|Glucocorticoids|glucocorticoids|mesh-ancestor
65077241|NCT00327197|Hormones|hormones|mesh-ancestor
65077242|NCT00327197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65077243|NCT00327197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077244|NCT00327197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65077245|NCT00327197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077246|NCT00425724|Cyclosporine|cyclosporine|mesh-list
64833891|NCT04789616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64833892|NCT04789616|Antiviral Agents|antiviral agents|mesh-ancestor
64833893|NCT04789616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64833895|NCT04785300|Dasatinib|dasatinib|mesh-list
65077247|NCT00425724|Prednisone|prednisone|mesh-list
65077248|NCT00425724|Methylprednisolone|methylprednisolone|mesh-list
65077249|NCT00425724|Cyclosporins|cyclosporins|mesh-list
65077250|NCT00425724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65077251|NCT00425724|Glucocorticoids|glucocorticoids|mesh-ancestor
65077252|NCT00425724|Hormones|hormones|mesh-ancestor
65077253|NCT00425724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65077254|NCT00425724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077255|NCT00425724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65077256|NCT00425724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077257|NCT00425724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077258|NCT00425724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077260|NCT00425724|Immunologic Factors|immunologic factors|mesh-ancestor
65077261|NCT00425724|Antifungal Agents|antifungal agents|mesh-ancestor
65077262|NCT00425724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65077263|NCT00425724|Dermatologic Agents|dermatologic agents|mesh-ancestor
65077264|NCT00425724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65077265|NCT00425724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65077266|NCT00425724|Antiemetics|antiemetics|mesh-ancestor
65077267|NCT00425724|Autonomic Agents|autonomic agents|mesh-ancestor
65077268|NCT00425724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65077269|NCT00425724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65077270|NCT00425724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65077271|NCT00425724|Protective Agents|protective agents|mesh-ancestor
65077272|NCT00426972|Estradiol|estradiol|mesh-list
65077273|NCT00426972|Estrogens|estrogens|mesh-ancestor
65077274|NCT00426972|Hormones|hormones|mesh-ancestor
65077275|NCT00426972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65077276|NCT00426972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077277|NCT00327353|Formoterol Fumarate|formoterol fumarate|mesh-list
65077278|NCT00327353|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65077279|NCT00327353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65077280|NCT00327353|Autonomic Agents|autonomic agents|mesh-ancestor
65077281|NCT00327353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65077282|NCT00327353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077283|NCT00327353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65077284|NCT00327353|Respiratory System Agents|respiratory system agents|mesh-ancestor
65077285|NCT00327353|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65077286|NCT00327353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65077287|NCT00327353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65077288|NCT00327353|Adrenergic Agents|adrenergic agents|mesh-ancestor
65077289|NCT00327353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65077290|NCT00327353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077291|NCT00425841|Gemcitabine|gemcitabine|mesh-list
65077292|NCT00425841|Oxaliplatin|oxaliplatin|mesh-list
65077293|NCT00425841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65077294|NCT00425841|Antimetabolites|antimetabolites|mesh-ancestor
65077295|NCT00425841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077296|NCT00425841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077297|NCT00425841|Antiviral Agents|antiviral agents|mesh-ancestor
65077298|NCT00425841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65077299|NCT00425841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077300|NCT00425841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65077301|NCT00425841|Immunologic Factors|immunologic factors|mesh-ancestor
64833896|NCT04785300|Quercetin|quercetin|mesh-list
64833897|NCT04785300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077302|NCT00425841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077303|NCT00427089|Ascorbic Acid|ascorbic acid|mesh-list
65077304|NCT00427089|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65077305|NCT00427089|Antioxidants|antioxidants|mesh-ancestor
65077306|NCT00427089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077307|NCT00427089|Protective Agents|protective agents|mesh-ancestor
65077308|NCT00427089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077309|NCT00427089|Vitamins|vitamins|mesh-ancestor
65077310|NCT00427089|Micronutrients|micronutrients|mesh-ancestor
65077311|NCT00427089|Laxatives|laxatives|mesh-ancestor
65077312|NCT00427089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65077314|NCT00427128|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65077315|NCT00427128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65077316|NCT00427128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65077317|NCT00427128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077318|NCT00427128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65077319|NCT00427128|Serotonin Agents|serotonin agents|mesh-ancestor
65077320|NCT00427128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077321|NCT00427128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65077322|NCT00427128|Antidepressive Agents|antidepressive agents|mesh-ancestor
65077323|NCT00427128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65077324|NCT00427128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65077325|NCT00427128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65077326|NCT00427128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077327|NCT00427167|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65077328|NCT00427167|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65077329|NCT00427167|Immunologic Factors|immunologic factors|mesh-ancestor
65077330|NCT00427167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077331|NCT00427167|Antacids|antacids|mesh-ancestor
65077332|NCT00427167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077333|NCT00427167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65077334|NCT00427206|Acetaminophen|acetaminophen|mesh-list
65077335|NCT00427206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65077336|NCT00427206|Analgesics|analgesics|mesh-ancestor
65077337|NCT00427206|Sensory System Agents|sensory system agents|mesh-ancestor
65077338|NCT00427206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65077339|NCT00427206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077340|NCT00427206|Antipyretics|antipyretics|mesh-ancestor
65077341|NCT00425997|Amlodipine|amlodipine|mesh-list
65077342|NCT00425997|Valsartan|valsartan|mesh-list
65077343|NCT00425997|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65077344|NCT00425997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65077345|NCT00425997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65077346|NCT00425997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65077347|NCT00425997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077348|NCT00425997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65077349|NCT00425997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077350|NCT00425997|Vasodilator Agents|vasodilator agents|mesh-ancestor
65077351|NCT00425997|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65077352|NCT00425997|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65077353|NCT00425997|Diuretics|diuretics|mesh-ancestor
65077354|NCT00425997|Natriuretic Agents|natriuretic agents|mesh-ancestor
65077355|NCT00425997|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65077356|NCT00427245|Cyclophosphamide|cyclophosphamide|mesh-list
65077357|NCT00427245|Goserelin|goserelin|mesh-list
65077358|NCT00427245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65077359|NCT00427245|Immunologic Factors|immunologic factors|mesh-ancestor
65077360|NCT00427245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077361|NCT00427245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65077362|NCT00427245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65077363|NCT00427245|Alkylating Agents|alkylating agents|mesh-ancestor
65077364|NCT00427245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077365|NCT00427245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077366|NCT00427245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64833916|NCT04753216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833917|NCT04753216|Growth Inhibitors|growth inhibitors|mesh-ancestor
64833918|NCT04753216|Immunologic Factors|immunologic factors|mesh-ancestor
64833919|NCT04753216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65077367|NCT00427245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65077368|NCT05458076|Ritonavir|ritonavir|mesh-list
65077369|NCT05458076|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65077370|NCT05458076|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65077371|NCT05458076|Protease Inhibitors|protease inhibitors|mesh-ancestor
65077372|NCT05458076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077373|NCT05458076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077374|NCT05458076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65077375|NCT05458076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65077376|NCT05458076|Antiviral Agents|antiviral agents|mesh-ancestor
65077377|NCT05458076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65077378|NCT05458076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65077379|NCT05458076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65077380|NCT00427362|Adalimumab|adalimumab|mesh-list
65077381|NCT00427362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65077382|NCT00427362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65077383|NCT00426192|Mannitol|mannitol|mesh-list
65077384|NCT00426192|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65077385|NCT00426192|Diuretics|diuretics|mesh-ancestor
64649961|NCT00857714|Lapatinib|lapatinib|mesh-list
65077386|NCT00426192|Natriuretic Agents|natriuretic agents|mesh-ancestor
65077387|NCT00426192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077388|NCT05457530|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
65077389|NCT05457530|Antiviral Agents|antiviral agents|mesh-ancestor
65077390|NCT05457530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65077391|NCT05457530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65077392|NCT05457530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65077393|NCT05457530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077394|NCT05457530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077395|NCT05457530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65077396|NCT05457530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65077397|NCT00432393|Levodopa|levodopa|mesh-list
65077398|NCT00432393|Carbidopa|carbidopa|mesh-list
65077399|NCT00432393|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65077400|NCT00432393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65077401|NCT00432393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65077402|NCT00432393|Dopamine Agents|dopamine agents|mesh-ancestor
65077403|NCT00432393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65077404|NCT00432393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077405|NCT00432393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077406|NCT00432393|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65077407|NCT00432393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077408|NCT00432393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65077409|NCT00432393|Immunologic Factors|immunologic factors|mesh-ancestor
65077410|NCT00432393|Dopamine Agonists|dopamine agonists|mesh-ancestor
65077412|NCT05453045|Anthelmintics|anthelmintics|mesh-ancestor
65077413|NCT05453045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65077414|NCT05453045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65077415|NCT05453045|Anticestodal Agents|anticestodal agents|mesh-ancestor
65077416|NCT05453045|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65077417|NCT05453045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65077418|NCT05453045|Tubulin Modulators|tubulin modulators|mesh-ancestor
65077419|NCT05453045|Antimitotic Agents|antimitotic agents|mesh-ancestor
65077420|NCT05453045|Mitosis Modulators|mitosis modulators|mesh-ancestor
65077421|NCT05453045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077422|NCT05453045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077423|NCT00432432|Infliximab|infliximab|mesh-list
65077424|NCT00432432|Dermatologic Agents|dermatologic agents|mesh-ancestor
65077425|NCT00432432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65077426|NCT00432432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65077427|NCT02957448|Rifampin|rifampin|mesh-list
64833921|NCT04753216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833922|NCT04753216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833923|NCT04742634|Decitabine|decitabine|mesh-list
64397776|NCT02365675|Dermatologic Agents|dermatologic agents|mesh-ancestor
65077428|NCT02957448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65077429|NCT02957448|Antitubercular Agents|antitubercular agents|mesh-ancestor
65077430|NCT02957448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65077431|NCT02957448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65077432|NCT02957448|Leprostatic Agents|leprostatic agents|mesh-ancestor
65077433|NCT02957448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65077434|NCT02957448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077435|NCT02957448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077436|NCT02957448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65077437|NCT02957448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65077438|NCT02957448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65077439|NCT02957448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65077440|NCT02957448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65077441|NCT02957448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65077442|NCT05371964|Imetelstat|imetelstat|mesh-list
65077443|NCT05371964|Motesanib diphosphate|motesanib diphosphate|mesh-list
65077444|NCT05371964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077445|NCT05371964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077446|NCT05371964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65077447|NCT00427596|Solabegron|solabegron|mesh-list
65077448|NCT00427596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65077449|NCT00427596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65077450|NCT00427596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65077451|NCT00427596|Adrenergic Agents|adrenergic agents|mesh-ancestor
65077452|NCT00427596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65077453|NCT00427596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077454|NCT00427596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077455|NCT00432510|Complement C1s|complement c1s|mesh-list
65077456|NCT00432510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
65077457|NCT00432510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
65077459|NCT00432510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077460|NCT00432510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65077461|NCT00432510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65077462|NCT05354258|Pyrimethamine|pyrimethamine|mesh-list
65077463|NCT05354258|Sulfadoxine|sulfadoxine|mesh-list
65077464|NCT05354258|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65077465|NCT05354258|Amodiaquine|amodiaquine|mesh-list
65077466|NCT05354258|Albendazole|albendazole|mesh-list
65077467|NCT05354258|Praziquantel|praziquantel|mesh-list
65077468|NCT05354258|Antimalarials|antimalarials|mesh-ancestor
65077469|NCT05354258|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65077470|NCT05354258|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65077471|NCT05354258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65077472|NCT05354258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65077473|NCT05354258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077474|NCT05354258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077475|NCT05354258|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65077476|NCT05354258|Renal Agents|renal agents|mesh-ancestor
65077477|NCT05354258|Anthelmintics|anthelmintics|mesh-ancestor
65077478|NCT05354258|Anticestodal Agents|anticestodal agents|mesh-ancestor
65077479|NCT05354258|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65077480|NCT05354258|Tubulin Modulators|tubulin modulators|mesh-ancestor
65077481|NCT05354258|Antimitotic Agents|antimitotic agents|mesh-ancestor
65077482|NCT05354258|Mitosis Modulators|mitosis modulators|mesh-ancestor
65077483|NCT05354258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077484|NCT05338580|Pembrolizumab|pembrolizumab|mesh-list
65077485|NCT05338580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65077486|NCT05338580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077487|NCT05296070|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
65077488|NCT05296070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65077489|NCT05296070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077490|NCT02273466|Desipramine|desipramine|mesh-list
65077491|NCT02273466|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65077492|NCT02273466|Antidepressive Agents|antidepressive agents|mesh-ancestor
65077493|NCT02273466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65077494|NCT02273466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077495|NCT02273466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077496|NCT02273466|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65077497|NCT02273466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65077498|NCT02273466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65077499|NCT02273466|Adrenergic Agents|adrenergic agents|mesh-ancestor
65077500|NCT02273466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65077501|NCT02273466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077502|NCT00427713|Capecitabine|capecitabine|mesh-list
65077503|NCT00427713|Oxaliplatin|oxaliplatin|mesh-list
65077504|NCT00427713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65077505|NCT00427713|Antimetabolites|antimetabolites|mesh-ancestor
65077506|NCT00427713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077507|NCT00427713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077508|NCT02273505|Aspirin|aspirin|mesh-list
65077509|NCT02273505|Salicylic Acid|salicylic acid|mesh-list
65077510|NCT02273505|Salicylates|salicylates|mesh-list
65077511|NCT02273505|Dipyridamole|dipyridamole|mesh-list
65077512|NCT02273505|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
65077513|NCT02273505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65077514|NCT02273505|Antifungal Agents|antifungal agents|mesh-ancestor
65077515|NCT02273505|Keratolytic Agents|keratolytic agents|mesh-ancestor
65077516|NCT02273505|Dermatologic Agents|dermatologic agents|mesh-ancestor
65077517|NCT02273505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65077518|NCT02273505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65077519|NCT02273505|Analgesics|analgesics|mesh-ancestor
65077520|NCT02273505|Sensory System Agents|sensory system agents|mesh-ancestor
65077521|NCT02273505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65077522|NCT02273505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077523|NCT02273505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65077524|NCT02273505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65077525|NCT02273505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65077526|NCT02273505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077527|NCT02273505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077528|NCT02273505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65077529|NCT02273505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65077530|NCT02273505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64650123|NCT01492673|Topotecan|topotecan|mesh-list
65077531|NCT02273505|Antipyretics|antipyretics|mesh-ancestor
65077532|NCT02273505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65077533|NCT02273505|Vasodilator Agents|vasodilator agents|mesh-ancestor
65077534|NCT05210621|Ocrelizumab|ocrelizumab|mesh-list
65077535|NCT05210621|Immunologic Factors|immunologic factors|mesh-ancestor
65077536|NCT05210621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077537|NCT05198960|Aspirin|aspirin|mesh-list
65077538|NCT05198960|Anticoagulants|anticoagulants|mesh-list
65077539|NCT05198960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65077540|NCT05198960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65077541|NCT05198960|Analgesics|analgesics|mesh-ancestor
65077542|NCT05198960|Sensory System Agents|sensory system agents|mesh-ancestor
65077543|NCT05198960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65077544|NCT05198960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077545|NCT05198960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65077546|NCT05198960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65077547|NCT05198960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65077548|NCT05198960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64482954|NCT05701059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65077549|NCT05198960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077550|NCT05198960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65077551|NCT05198960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65077552|NCT05198960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077553|NCT05198960|Antipyretics|antipyretics|mesh-ancestor
65077554|NCT00432549|Topiramate|topiramate|mesh-list
65077555|NCT00432549|Almotriptan|almotriptan|mesh-list
65077556|NCT00432549|Anticonvulsants|anticonvulsants|mesh-ancestor
65077557|NCT00432549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65077558|NCT00432549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077559|NCT00432549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65077561|NCT00432549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65077562|NCT00432549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077563|NCT00427947|Ropivacaine|ropivacaine|mesh-list
65077564|NCT00427947|Anesthetics, Local|anesthetics, local|mesh-ancestor
65077565|NCT00427947|Anesthetics|anesthetics|mesh-ancestor
65077566|NCT00427947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65077567|NCT00427947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077568|NCT00427947|Sensory System Agents|sensory system agents|mesh-ancestor
65077569|NCT00427947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65077570|NCT00432588|Misoprostol|misoprostol|mesh-list
65077571|NCT00432588|Dinoprostone|dinoprostone|mesh-list
65077572|NCT00432588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65077573|NCT00432588|Abortifacient Agents|abortifacient agents|mesh-ancestor
65077574|NCT00432588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65077575|NCT00432588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077576|NCT00432588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65077577|NCT00432588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65077578|NCT00432588|Oxytocics|oxytocics|mesh-ancestor
65077579|NCT00428025|Diclofenac|diclofenac|mesh-list
65077580|NCT00428025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65077581|NCT00428025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65077582|NCT00428025|Analgesics|analgesics|mesh-ancestor
65077583|NCT00428025|Sensory System Agents|sensory system agents|mesh-ancestor
65077584|NCT00428025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65077585|NCT00428025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077586|NCT00428025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65077587|NCT00428025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65077588|NCT00428025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65077589|NCT00428025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077590|NCT00428025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077591|NCT00428064|Cyclosporine|cyclosporine|mesh-list
65077592|NCT00428064|Sirolimus|sirolimus|mesh-list
65077593|NCT00428064|Cyclosporins|cyclosporins|mesh-list
65077594|NCT00428064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077595|NCT00428064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077596|NCT00428064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65077597|NCT00428064|Immunologic Factors|immunologic factors|mesh-ancestor
65077598|NCT00428064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077599|NCT00428064|Antifungal Agents|antifungal agents|mesh-ancestor
65077600|NCT00428064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65077601|NCT00428064|Dermatologic Agents|dermatologic agents|mesh-ancestor
65077602|NCT00428064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65077603|NCT00428064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65077604|NCT00428064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65077605|NCT00428064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65077606|NCT00428064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077607|NCT00432627|Deferasirox|deferasirox|mesh-list
65077608|NCT00432627|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65077609|NCT00432627|Chelating Agents|chelating agents|mesh-ancestor
65077610|NCT00432627|Sequestering Agents|sequestering agents|mesh-ancestor
65077611|NCT00432627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077612|NCT00419783|Moxifloxacin|moxifloxacin|mesh-list
65077613|NCT00419783|Ketoconazole|ketoconazole|mesh-list
65077614|NCT00419783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65077615|NCT00419783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65077616|NCT00419783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65077617|NCT00419783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65077618|NCT00419783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077619|NCT00419783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077620|NCT00419783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077621|NCT00419783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077622|NCT00419783|Antifungal Agents|antifungal agents|mesh-ancestor
65077623|NCT00419783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65077624|NCT00419783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65077625|NCT00419783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65077626|NCT00419783|Hormone Antagonists|hormone antagonists|mesh-ancestor
65077627|NCT00419783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65077628|NCT00419783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65077629|NCT04942340|Dexmedetomidine|dexmedetomidine|mesh-list
65077630|NCT04942340|Caffeine|caffeine|mesh-list
65077631|NCT04942340|Atipamezole|atipamezole|mesh-list
65077632|NCT04942340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65077633|NCT04942340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65077634|NCT04942340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077635|NCT04942340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65077636|NCT04942340|Analgesics|analgesics|mesh-ancestor
65077637|NCT04942340|Sensory System Agents|sensory system agents|mesh-ancestor
65077638|NCT04942340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65077639|NCT04942340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65077640|NCT04942340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65077641|NCT04942340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65077642|NCT04942340|Adrenergic Agents|adrenergic agents|mesh-ancestor
65077643|NCT04942340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65077644|NCT04942340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077645|NCT04942340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65077646|NCT04942340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65077647|NCT04942340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077648|NCT04942340|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65077649|NCT04942340|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65077650|NCT04942340|Purinergic Agents|purinergic agents|mesh-ancestor
65077651|NCT04942340|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65077652|NCT04942340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65077653|NCT04942340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65077654|NCT00428142|Prednisone|prednisone|mesh-list
65077655|NCT00428142|Cyclophosphamide|cyclophosphamide|mesh-list
65077656|NCT00428142|Rituximab|rituximab|mesh-list
65077657|NCT00428142|Vincristine|vincristine|mesh-list
65077658|NCT00428142|Bortezomib|bortezomib|mesh-list
65077659|NCT00428142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65077660|NCT00428142|Immunologic Factors|immunologic factors|mesh-ancestor
65077661|NCT00428142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077662|NCT00428142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65077663|NCT00428142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65077664|NCT00428142|Alkylating Agents|alkylating agents|mesh-ancestor
65077665|NCT00428142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077666|NCT00428142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077667|NCT00428142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65077668|NCT00428142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65077669|NCT00428142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65077670|NCT00428142|Glucocorticoids|glucocorticoids|mesh-ancestor
65077671|NCT00428142|Hormones|hormones|mesh-ancestor
65077672|NCT00428142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65077673|NCT00428142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65077674|NCT00428142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65077675|NCT00428142|Tubulin Modulators|tubulin modulators|mesh-ancestor
65077676|NCT00428142|Antimitotic Agents|antimitotic agents|mesh-ancestor
64325099|NCT02576912|Sensory System Agents|sensory system agents|mesh-ancestor
64325103|NCT02576912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65077677|NCT00428142|Mitosis Modulators|mitosis modulators|mesh-ancestor
65077678|NCT00428181|Ethanol|ethanol|mesh-list
65077679|NCT00428181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65077680|NCT00428181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65077681|NCT00428181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65077682|NCT00428181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077683|NCT04803422|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65077684|NCT04803422|Amoxicillin|amoxicillin|mesh-list
65077685|NCT04803422|Metronidazole|metronidazole|mesh-list
65077686|NCT04803422|Tazobactam|tazobactam|mesh-list
65077687|NCT04803422|Piperacillin|piperacillin|mesh-list
65077688|NCT04803422|Clavulanic Acids|clavulanic acids|mesh-list
65077689|NCT04803422|Clavulanic Acid|clavulanic acid|mesh-list
65077690|NCT04803422|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65077691|NCT04803422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65077692|NCT04803422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65077693|NCT04803422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65077694|NCT04803422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65077695|NCT04803422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077696|NCT04803422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077697|NCT00432861|Pancrelipase|pancrelipase|mesh-list
65077698|NCT00432861|Pancreatin|pancreatin|mesh-list
65077699|NCT00432861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65077700|NCT04575233|Ropivacaine|ropivacaine|mesh-list
65077701|NCT04575233|Anesthetics, Local|anesthetics, local|mesh-ancestor
65077702|NCT04575233|Anesthetics|anesthetics|mesh-ancestor
65077703|NCT04575233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65077704|NCT04575233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077705|NCT04575233|Sensory System Agents|sensory system agents|mesh-ancestor
65077706|NCT04575233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65077707|NCT04507412|Dexamethasone|dexamethasone|mesh-list
64719784|NCT00000254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077708|NCT04507412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65077709|NCT04507412|Antiemetics|antiemetics|mesh-ancestor
65077710|NCT04507412|Autonomic Agents|autonomic agents|mesh-ancestor
65077711|NCT04507412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65077712|NCT04507412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077713|NCT04507412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65077714|NCT04507412|Glucocorticoids|glucocorticoids|mesh-ancestor
65077715|NCT04507412|Hormones|hormones|mesh-ancestor
65077716|NCT04507412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65077717|NCT04507412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65077718|NCT04507412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077719|NCT00428454|Sirolimus|sirolimus|mesh-list
65077720|NCT00428454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65077721|NCT00428454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65077722|NCT00428454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65077723|NCT00428454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077724|NCT00428454|Antifungal Agents|antifungal agents|mesh-ancestor
65077725|NCT00428454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65077726|NCT00428454|Immunologic Factors|immunologic factors|mesh-ancestor
65077727|NCT00428454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077728|NCT00432978|Bosentan|bosentan|mesh-list
65077729|NCT00432978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65077730|NCT00432978|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65077731|NCT00432978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077732|NCT01051791|Everolimus|everolimus|mesh-list
65077733|NCT01051791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077734|NCT01051791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65077735|NCT01051791|Immunologic Factors|immunologic factors|mesh-ancestor
65077736|NCT01051791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077737|NCT01056510|Rituximab|rituximab|mesh-list
65077738|NCT01056510|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64833941|NCT04714619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833942|NCT04714619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64833947|NCT04690855|Atezolizumab|atezolizumab|mesh-list
65077739|NCT01056510|Chlorambucil|chlorambucil|mesh-list
65077740|NCT01056510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65077741|NCT01056510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077742|NCT01056510|Immunologic Factors|immunologic factors|mesh-ancestor
65077743|NCT01056510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077744|NCT01056510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65077745|NCT01056510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65077746|NCT01056510|Alkylating Agents|alkylating agents|mesh-ancestor
65077747|NCT01056510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077748|NCT04326257|Nivolumab|nivolumab|mesh-list
65077749|NCT04326257|Ipilimumab|ipilimumab|mesh-list
65077750|NCT04326257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65077751|NCT04326257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077752|NCT04326257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65077753|NCT04326257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077754|NCT01056276|Dexamethasone|dexamethasone|mesh-list
65077755|NCT01056276|Bortezomib|bortezomib|mesh-list
65077756|NCT01056276|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
65077757|NCT01056276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65077758|NCT01056276|Antiemetics|antiemetics|mesh-ancestor
65077759|NCT01056276|Autonomic Agents|autonomic agents|mesh-ancestor
65077760|NCT01056276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65077761|NCT01056276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077762|NCT01056276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65077763|NCT01056276|Glucocorticoids|glucocorticoids|mesh-ancestor
65077764|NCT01056276|Hormones|hormones|mesh-ancestor
65077765|NCT01056276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65077766|NCT01056276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65077767|NCT01056276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077768|NCT01056276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65077769|NCT01056276|Alkylating Agents|alkylating agents|mesh-ancestor
65077770|NCT01056276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077772|NCT01055886|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65077773|NCT01055886|Autonomic Agents|autonomic agents|mesh-ancestor
65077774|NCT01055886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65077775|NCT01055886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077776|NCT01055886|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65077777|NCT01055886|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65077778|NCT01055886|Cholinergic Agents|cholinergic agents|mesh-ancestor
65077779|NCT01055886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65077780|NCT01055886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64719862|NCT00001028|Dapsone|dapsone|mesh-list
65077781|NCT00433095|Trastuzumab|trastuzumab|mesh-list
65077782|NCT00433095|Vinorelbine|vinorelbine|mesh-list
65077783|NCT00433095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65077784|NCT00433095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077785|NCT00433095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65077786|NCT00433095|Tubulin Modulators|tubulin modulators|mesh-ancestor
65077787|NCT00433095|Antimitotic Agents|antimitotic agents|mesh-ancestor
65077788|NCT00433095|Mitosis Modulators|mitosis modulators|mesh-ancestor
64833948|NCT04690855|Talazoparib|talazoparib|mesh-list
64833949|NCT04690855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833950|NCT04690855|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64833951|NCT04690855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833952|NCT04690855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833953|NCT04689945|Morphine|morphine|mesh-list
64833954|NCT04689945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64833955|NCT04689945|Narcotics|narcotics|mesh-ancestor
65077789|NCT00433095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077790|NCT01055613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65077791|NCT01055457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65077792|NCT00428649|Selenium|selenium|mesh-list
65077793|NCT00428649|Antioxidants|antioxidants|mesh-ancestor
65077794|NCT00428649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077795|NCT00428649|Protective Agents|protective agents|mesh-ancestor
65077796|NCT00428649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077797|NCT00428649|Trace Elements|trace elements|mesh-ancestor
65077798|NCT00428649|Micronutrients|micronutrients|mesh-ancestor
65077799|NCT03852992|Minoxidil|minoxidil|mesh-list
65077800|NCT03852992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65077801|NCT03852992|Vasodilator Agents|vasodilator agents|mesh-ancestor
65077802|NCT00433173|Anastrozole|anastrozole|mesh-list
65077803|NCT00433173|Goserelin|goserelin|mesh-list
65077804|NCT00433173|Testosterone|testosterone|mesh-list
65077805|NCT00433173|Androgens|androgens|mesh-ancestor
65077806|NCT00433173|Hormones|hormones|mesh-ancestor
65077807|NCT00433173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65077808|NCT00433173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077809|NCT00433173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65077810|NCT00433173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077811|NCT00433173|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65077812|NCT00433173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65077813|NCT00433173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077814|NCT00433173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077815|NCT00433173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65077816|NCT00433173|Hormone Antagonists|hormone antagonists|mesh-ancestor
65077817|NCT01055028|Paclitaxel|paclitaxel|mesh-list
65077818|NCT01055028|Bevacizumab|bevacizumab|mesh-list
65077819|NCT01055028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65077820|NCT01055028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077821|NCT01055028|Tubulin Modulators|tubulin modulators|mesh-ancestor
65077822|NCT01055028|Antimitotic Agents|antimitotic agents|mesh-ancestor
65077823|NCT01055028|Mitosis Modulators|mitosis modulators|mesh-ancestor
65077824|NCT01055028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077825|NCT01055028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65077826|NCT01055028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65077827|NCT01055028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65077828|NCT01055028|Growth Substances|growth substances|mesh-ancestor
65077829|NCT01055028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077830|NCT01055028|Growth Inhibitors|growth inhibitors|mesh-ancestor
65077831|NCT00428727|Nitric Oxide|nitric oxide|mesh-list
65077832|NCT00428727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65077833|NCT00428727|Autonomic Agents|autonomic agents|mesh-ancestor
65077834|NCT00428727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65077835|NCT00428727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64482963|NCT03013491|Ipilimumab|ipilimumab|mesh-list
65077836|NCT00428727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65077837|NCT00428727|Respiratory System Agents|respiratory system agents|mesh-ancestor
65077838|NCT00428727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65077839|NCT00428727|Antioxidants|antioxidants|mesh-ancestor
65077840|NCT00428727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077841|NCT00428727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65077842|NCT00428727|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65077843|NCT00428727|Vasodilator Agents|vasodilator agents|mesh-ancestor
65077844|NCT00428727|Gasotransmitters|gasotransmitters|mesh-ancestor
65077845|NCT00428727|Protective Agents|protective agents|mesh-ancestor
65077846|NCT03474029|Rifampin|rifampin|mesh-list
65077847|NCT03474029|Rifapentine|rifapentine|mesh-list
65077848|NCT03474029|Isoniazid|isoniazid|mesh-list
65077849|NCT03474029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65077850|NCT03474029|Antitubercular Agents|antitubercular agents|mesh-ancestor
65077851|NCT03474029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65077852|NCT03474029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65077853|NCT03474029|Leprostatic Agents|leprostatic agents|mesh-ancestor
65077854|NCT03474029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65077855|NCT03474029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64719935|NCT00000290|Cocaine|cocaine|mesh-list
65077856|NCT03474029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077857|NCT03474029|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65077858|NCT03474029|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65077859|NCT03474029|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65077860|NCT03474029|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65077861|NCT03474029|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65077862|NCT03474029|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65077863|NCT03474029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65077864|NCT03474029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65077865|NCT03474029|Antimetabolites|antimetabolites|mesh-ancestor
65077866|NCT03474029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65077867|NCT00433368|N-Methylaspartate|n-methylaspartate|mesh-list
65077868|NCT00433368|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
65077869|NCT00433368|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65077870|NCT00433368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65077871|NCT00433368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077872|NCT00433368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077873|NCT00428766|Farletuzumab|farletuzumab|mesh-list
65077874|NCT00428766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077875|NCT04716569|Ivermectin|ivermectin|mesh-list
65077876|NCT04716569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65077877|NCT04716569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65077878|NCT04703127|Lidocaine|lidocaine|mesh-list
65077879|NCT04703127|Tadalafil|tadalafil|mesh-list
65077880|NCT04703127|Anesthetics, Local|anesthetics, local|mesh-ancestor
65077881|NCT04703127|Anesthetics|anesthetics|mesh-ancestor
65077882|NCT04703127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65077883|NCT04703127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077884|NCT04703127|Sensory System Agents|sensory system agents|mesh-ancestor
65077885|NCT04703127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65077886|NCT04703127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65077887|NCT04703127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65077889|NCT04703127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65077890|NCT04703127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077891|NCT04703127|Vasodilator Agents|vasodilator agents|mesh-ancestor
65077892|NCT04703127|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65077893|NCT04703127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65077894|NCT04703127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65077895|NCT04703127|Urological Agents|urological agents|mesh-ancestor
65077896|NCT00428883|Acetylcysteine|acetylcysteine|mesh-list
65077897|NCT00428883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65077898|NCT00428883|Antiviral Agents|antiviral agents|mesh-ancestor
65077899|NCT00428883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65077900|NCT00428883|Expectorants|expectorants|mesh-ancestor
65077901|NCT00428883|Respiratory System Agents|respiratory system agents|mesh-ancestor
65077902|NCT00428883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65077903|NCT00428883|Antioxidants|antioxidants|mesh-ancestor
65077904|NCT00428883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077905|NCT00428883|Protective Agents|protective agents|mesh-ancestor
65077906|NCT00428883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833956|NCT04689945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64833957|NCT04689945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833959|NCT04689945|Sensory System Agents|sensory system agents|mesh-ancestor
64833960|NCT04689945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65077907|NCT00428883|Antidotes|antidotes|mesh-ancestor
65077908|NCT04702971|Flunarizine|flunarizine|mesh-list
65077909|NCT04702971|Anticonvulsants|anticonvulsants|mesh-ancestor
65077910|NCT04702971|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65077911|NCT04702971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65077912|NCT04702971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077913|NCT04702971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65077914|NCT04702971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077915|NCT04702971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65077916|NCT04702971|Histamine Antagonists|histamine antagonists|mesh-ancestor
65077917|NCT04702971|Histamine Agents|histamine agents|mesh-ancestor
65077918|NCT04702971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65077919|NCT04702971|Vasodilator Agents|vasodilator agents|mesh-ancestor
65077920|NCT00433407|Trastuzumab|trastuzumab|mesh-list
65077921|NCT00433407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65077922|NCT00433407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077923|NCT00433485|Sirolimus|sirolimus|mesh-list
65077924|NCT00433485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65077925|NCT00433485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65077926|NCT00433485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65077927|NCT00433485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077928|NCT00433485|Antifungal Agents|antifungal agents|mesh-ancestor
65077929|NCT00433485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65077930|NCT00433485|Immunologic Factors|immunologic factors|mesh-ancestor
65077931|NCT00433485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077932|NCT02676791|Povidone-Iodine|povidone-iodine|mesh-list
65077933|NCT02676791|Povidone|povidone|mesh-list
65077934|NCT02676791|Plasma Substitutes|plasma substitutes|mesh-ancestor
65077935|NCT02676791|Blood Substitutes|blood substitutes|mesh-ancestor
65077936|NCT02676791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65077937|NCT02676791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65077938|NCT02244125|Dexamethasone|dexamethasone|mesh-list
65077939|NCT02244125|Cyclophosphamide|cyclophosphamide|mesh-list
65077940|NCT02244125|Pomalidomide|pomalidomide|mesh-list
65077941|NCT02244125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65077942|NCT02244125|Immunologic Factors|immunologic factors|mesh-ancestor
65077943|NCT02244125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077944|NCT02244125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65077945|NCT02244125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65077946|NCT02244125|Alkylating Agents|alkylating agents|mesh-ancestor
65077947|NCT02244125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077948|NCT02244125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65077949|NCT02244125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65077950|NCT02244125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65077951|NCT02244125|Antiemetics|antiemetics|mesh-ancestor
65077952|NCT02244125|Autonomic Agents|autonomic agents|mesh-ancestor
65077953|NCT02244125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65077954|NCT02244125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65077955|NCT02244125|Glucocorticoids|glucocorticoids|mesh-ancestor
65077956|NCT02244125|Hormones|hormones|mesh-ancestor
65077957|NCT02244125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65077958|NCT02244125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65077959|NCT02244125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64833961|NCT04682483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64833962|NCT04643574|Cyclophosphamide|cyclophosphamide|mesh-list
64833963|NCT04643574|Fludarabine|fludarabine|mesh-list
64833964|NCT04643574|Interleukin-2|interleukin-2|mesh-list
64833965|NCT04643574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64833966|NCT04643574|Immunologic Factors|immunologic factors|mesh-ancestor
64833967|NCT04643574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833968|NCT04643574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64833969|NCT04643574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64833970|NCT04643574|Alkylating Agents|alkylating agents|mesh-ancestor
65077961|NCT02244125|Growth Substances|growth substances|mesh-ancestor
65077962|NCT02244125|Growth Inhibitors|growth inhibitors|mesh-ancestor
65077963|NCT01600079|Vaccines|vaccines|mesh-list
65077964|NCT01600079|Immunologic Factors|immunologic factors|mesh-ancestor
65077965|NCT01600079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077966|NCT01370486|Melatonin|melatonin|mesh-list
65077967|NCT01370486|Antioxidants|antioxidants|mesh-ancestor
65077968|NCT01370486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077969|NCT01370486|Protective Agents|protective agents|mesh-ancestor
65077970|NCT01370486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077971|NCT01370486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65077972|NCT00327587|Amlodipine|amlodipine|mesh-list
65077973|NCT00327587|Valsartan|valsartan|mesh-list
65077974|NCT00327587|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65077975|NCT00327587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65077976|NCT00327587|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65077977|NCT00327587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65077978|NCT00327587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65077979|NCT00327587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65077980|NCT00327587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077982|NCT00327587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65077983|NCT00327587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65077984|NCT00327587|Diuretics|diuretics|mesh-ancestor
65077985|NCT00327587|Natriuretic Agents|natriuretic agents|mesh-ancestor
65077986|NCT00327587|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65077987|NCT00327665|Vaccines|vaccines|mesh-list
65077988|NCT00327665|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65077989|NCT00327665|Immunologic Factors|immunologic factors|mesh-ancestor
65077990|NCT00327665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65077991|NCT00433641|Sibutramine|sibutramine|mesh-list
65077992|NCT00433641|Antidepressive Agents|antidepressive agents|mesh-ancestor
65077993|NCT00433641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65077994|NCT00433641|Appetite Depressants|appetite depressants|mesh-ancestor
65077995|NCT00433641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65077996|NCT00429234|Gemcitabine|gemcitabine|mesh-list
65077997|NCT00429234|Dasatinib|dasatinib|mesh-list
65077998|NCT00429234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65077999|NCT00429234|Antimetabolites|antimetabolites|mesh-ancestor
65078000|NCT00429234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078001|NCT00429234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078002|NCT00429234|Antiviral Agents|antiviral agents|mesh-ancestor
65078003|NCT00429234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65078004|NCT00429234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078005|NCT00429234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65078006|NCT00429234|Immunologic Factors|immunologic factors|mesh-ancestor
65078007|NCT00429234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078008|NCT00429234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65078009|NCT00433719|Efavirenz|efavirenz|mesh-list
65078010|NCT00433719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
65078011|NCT00433719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65078012|NCT00433719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65078013|NCT00433719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078014|NCT00433719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078015|NCT00433719|Antiviral Agents|antiviral agents|mesh-ancestor
64325104|NCT02576912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325105|NCT02576912|Hormones|hormones|mesh-ancestor
64325106|NCT02576912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64325107|NCT02159573|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64325108|NCT02159573|Natalizumab|natalizumab|mesh-list
64325109|NCT02159573|Immunologic Factors|immunologic factors|mesh-ancestor
65078016|NCT00433719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65078017|NCT00433719|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65078018|NCT00433719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65078019|NCT00433719|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65078020|NCT00433719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65078021|NCT00433719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65078022|NCT00433719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65078023|NCT00433719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65078024|NCT00433719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65078025|NCT04704297|Acetaminophen|acetaminophen|mesh-list
65078026|NCT04704297|Ibuprofen|ibuprofen|mesh-list
65078027|NCT04704297|Ketorolac|ketorolac|mesh-list
65078028|NCT04704297|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65078029|NCT04704297|Amitriptyline|amitriptyline|mesh-list
65078030|NCT04704297|Bupivacaine|bupivacaine|mesh-list
65078031|NCT04704297|Cyclobenzaprine|cyclobenzaprine|mesh-list
65078032|NCT04704297|Anesthetics, Local|anesthetics, local|mesh-ancestor
65078033|NCT04704297|Anesthetics|anesthetics|mesh-ancestor
65078034|NCT04704297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65078035|NCT04704297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078036|NCT04704297|Sensory System Agents|sensory system agents|mesh-ancestor
65078037|NCT04704297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65078038|NCT04704297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65078040|NCT04704297|Antipyretics|antipyretics|mesh-ancestor
65078041|NCT04704297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65078042|NCT04704297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65078043|NCT04704297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65078044|NCT04704297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65078045|NCT04704297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078046|NCT04704297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078047|NCT04704297|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65078048|NCT04704297|Antidepressive Agents|antidepressive agents|mesh-ancestor
65078049|NCT04704297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65078050|NCT04704297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65078051|NCT04704297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65078052|NCT04704297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65078053|NCT04704297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65078054|NCT04704297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65078055|NCT04704297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65078056|NCT04704297|Adrenergic Agents|adrenergic agents|mesh-ancestor
65078057|NCT04704297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65078058|NCT00328211|Bile Acids and Salts|bile acids and salts|mesh-list
65078059|NCT00328211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65078060|NCT00328367|Aripiprazole|aripiprazole|mesh-list
65078061|NCT00328367|Antidepressive Agents|antidepressive agents|mesh-ancestor
65078062|NCT00328367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65078063|NCT00328367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65078064|NCT00328367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65078065|NCT00328367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65078066|NCT00328367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078067|NCT00328367|Dopamine Agonists|dopamine agonists|mesh-ancestor
65078068|NCT00328367|Dopamine Agents|dopamine agents|mesh-ancestor
65078069|NCT00328367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65078070|NCT00328367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078071|NCT00328367|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65078072|NCT00328367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65078073|NCT00328367|Serotonin Agents|serotonin agents|mesh-ancestor
65078074|NCT00328367|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65078075|NCT00328367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65078076|NCT00328367|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65078077|NCT00328367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65078078|NCT04703088|Ondansetron|ondansetron|mesh-list
64833972|NCT04643574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833973|NCT04643574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65078079|NCT04703088|Antiemetics|antiemetics|mesh-ancestor
65078080|NCT04703088|Autonomic Agents|autonomic agents|mesh-ancestor
65078081|NCT04703088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65078082|NCT04703088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078083|NCT04703088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65078084|NCT04703088|Antipruritics|antipruritics|mesh-ancestor
65078085|NCT04703088|Dermatologic Agents|dermatologic agents|mesh-ancestor
65078086|NCT04703088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65078087|NCT04703088|Serotonin Agents|serotonin agents|mesh-ancestor
65078088|NCT04703088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65078089|NCT04703088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078090|NCT04703088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65078091|NCT04703088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65078092|NCT04703088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65078093|NCT04703088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65078094|NCT04703088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65078095|NCT00328718|Fluticasone|fluticasone|mesh-list
65078096|NCT00328718|Xhance|xhance|mesh-list
65078097|NCT00328718|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65078098|NCT00328718|Montelukast|montelukast|mesh-list
65078099|NCT00328718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65078100|NCT00328718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65078101|NCT00328718|Autonomic Agents|autonomic agents|mesh-ancestor
65078102|NCT00328718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65078103|NCT00328718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078104|NCT00328718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65078105|NCT00328718|Respiratory System Agents|respiratory system agents|mesh-ancestor
65078106|NCT00328718|Dermatologic Agents|dermatologic agents|mesh-ancestor
65078107|NCT00328718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65078108|NCT00328718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65078109|NCT00328718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65078110|NCT00328718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65078111|NCT00328718|Adrenergic Agents|adrenergic agents|mesh-ancestor
65078112|NCT00328718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65078113|NCT00328718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078114|NCT00328718|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65078115|NCT00328718|Hormone Antagonists|hormone antagonists|mesh-ancestor
65078116|NCT00328718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65078117|NCT00328718|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65078118|NCT00328718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65078119|NCT00328796|Lidocaine|lidocaine|mesh-list
65078120|NCT00328796|Anesthetics, Local|anesthetics, local|mesh-ancestor
65078121|NCT00328796|Anesthetics|anesthetics|mesh-ancestor
65078122|NCT00328796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65078123|NCT00328796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078124|NCT00328796|Sensory System Agents|sensory system agents|mesh-ancestor
65078125|NCT00328796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65078126|NCT00328796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65078127|NCT00328796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65078128|NCT00328796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65078129|NCT00328796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65078130|NCT00328796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078131|NCT00429468|Acetaminophen|acetaminophen|mesh-list
65078132|NCT00429468|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
65078133|NCT00429468|Hydrocodone|hydrocodone|mesh-list
65078134|NCT00429468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65078135|NCT00429468|Analgesics|analgesics|mesh-ancestor
65078136|NCT00429468|Sensory System Agents|sensory system agents|mesh-ancestor
65078137|NCT00429468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65078138|NCT00429468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078139|NCT00429468|Antipyretics|antipyretics|mesh-ancestor
65078140|NCT00429468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65078141|NCT00429468|Narcotics|narcotics|mesh-ancestor
65078142|NCT00429468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65078143|NCT00429468|Antitussive Agents|antitussive agents|mesh-ancestor
65078144|NCT00429468|Respiratory System Agents|respiratory system agents|mesh-ancestor
65078145|NCT00429468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65078146|NCT00429468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65078147|NCT00429468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65078148|NCT04702698|Peposertib|peposertib|mesh-list
65078149|NCT04702698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65078150|NCT04702698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078151|NCT04702698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078152|NCT00328874|Ubiquinone|ubiquinone|mesh-list
65078153|NCT00328874|Coenzyme Q10|coenzyme q10|mesh-list
65078154|NCT00328874|Micronutrients|micronutrients|mesh-ancestor
65078155|NCT00328874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078157|NCT00328913|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
65078158|NCT00328913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65078159|NCT00328913|Antidepressive Agents|antidepressive agents|mesh-ancestor
65078160|NCT00328913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65078161|NCT00433953|Mycophenolic Acid|mycophenolic acid|mesh-list
65078162|NCT00433953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65078163|NCT00433953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078164|NCT00433953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65078165|NCT00433953|Antitubercular Agents|antitubercular agents|mesh-ancestor
65078166|NCT00433953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65078167|NCT00433953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65078168|NCT00433953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078169|NCT00433953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078170|NCT02957643|Iron|iron|mesh-list
65078171|NCT02957643|Trace Elements|trace elements|mesh-ancestor
65078172|NCT02957643|Micronutrients|micronutrients|mesh-ancestor
65078173|NCT02957643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078174|NCT02957604|Evolocumab|evolocumab|mesh-list
65078175|NCT02957604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65078176|NCT02957604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65078177|NCT02957604|Antimetabolites|antimetabolites|mesh-ancestor
65078178|NCT02957604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078179|NCT02957604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65078180|NCT00329069|Atorvastatin|atorvastatin|mesh-list
65078181|NCT00329069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65078182|NCT00329069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65078183|NCT00329069|Antimetabolites|antimetabolites|mesh-ancestor
65078184|NCT00329069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078185|NCT00329069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65078186|NCT00329069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65078187|NCT00329069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078188|NCT00429624|Acetaminophen|acetaminophen|mesh-list
65078189|NCT00429624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65078190|NCT00429624|Analgesics|analgesics|mesh-ancestor
65078191|NCT00429624|Sensory System Agents|sensory system agents|mesh-ancestor
65078192|NCT00429624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65078193|NCT00429624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078194|NCT00429624|Antipyretics|antipyretics|mesh-ancestor
65078195|NCT00329147|Paroxetine|paroxetine|mesh-list
65078196|NCT00329147|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65078197|NCT00329147|Desipramine|desipramine|mesh-list
65078198|NCT00329147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65078199|NCT00329147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65078200|NCT00329147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65078201|NCT00329147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078202|NCT00329147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65078203|NCT00329147|Serotonin Agents|serotonin agents|mesh-ancestor
65078204|NCT00329147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078205|NCT00329147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65078206|NCT00329147|Antidepressive Agents|antidepressive agents|mesh-ancestor
65078207|NCT00329147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65078208|NCT00329147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65078209|NCT00329147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65078210|NCT00329147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078211|NCT00329147|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65078212|NCT00329147|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64833976|NCT04643574|Sensory System Agents|sensory system agents|mesh-ancestor
64833977|NCT04643574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64833978|NCT04583501|Omalizumab|omalizumab|mesh-list
64602488|NCT01985685|Vitamins|vitamins|mesh-ancestor
64445160|NCT02222714|Protein C|protein c|mesh-list
65078213|NCT00329147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65078214|NCT00329147|Adrenergic Agents|adrenergic agents|mesh-ancestor
65078215|NCT00329186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65078216|NCT00329186|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65078217|NCT00329186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65078218|NCT00329186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65078219|NCT00329186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65078220|NCT00329186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078221|NCT00329186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65078222|NCT00329186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078223|NCT00329186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65078224|NCT00329186|Antidepressive Agents|antidepressive agents|mesh-ancestor
65078225|NCT00329186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65078226|NCT00434031|Cyclophosphamide|cyclophosphamide|mesh-list
65078228|NCT00434031|Doxorubicin|doxorubicin|mesh-list
65078229|NCT00434031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65078230|NCT00434031|Trastuzumab|trastuzumab|mesh-list
65078231|NCT00434031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65078232|NCT00434031|Immunologic Factors|immunologic factors|mesh-ancestor
65078233|NCT00434031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078234|NCT00434031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65078235|NCT00434031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65078236|NCT00434031|Alkylating Agents|alkylating agents|mesh-ancestor
65078237|NCT00434031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078238|NCT00434031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078239|NCT00434031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65078240|NCT00434031|Tubulin Modulators|tubulin modulators|mesh-ancestor
65078241|NCT00434031|Antimitotic Agents|antimitotic agents|mesh-ancestor
65078242|NCT00434031|Mitosis Modulators|mitosis modulators|mesh-ancestor
65078243|NCT00434031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65078244|NCT00434031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65078245|NCT00434031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65078246|NCT00434031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078247|NCT00434031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65078248|NCT00329225|Rosiglitazone|rosiglitazone|mesh-list
65078249|NCT00329225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65078250|NCT00329225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078251|NCT01050543|Neostigmine|neostigmine|mesh-list
65078252|NCT01050543|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65078253|NCT01050543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078254|NCT01050543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078255|NCT01050543|Cholinergic Agents|cholinergic agents|mesh-ancestor
65078256|NCT01050543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65078257|NCT01050543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078258|NCT01050543|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65078259|NCT01050543|Autonomic Agents|autonomic agents|mesh-ancestor
65078260|NCT01050543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65078261|NCT00329264|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65078262|NCT00329264|Antidepressive Agents|antidepressive agents|mesh-ancestor
65078263|NCT00329264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65078264|NCT00329264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65078265|NCT00329264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65078266|NCT00329264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65078267|NCT00329264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078269|NCT00329381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65078270|NCT00329381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65078271|NCT00329381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65078272|NCT00329381|Respiratory System Agents|respiratory system agents|mesh-ancestor
65078273|NCT00329381|Immunologic Factors|immunologic factors|mesh-ancestor
65078274|NCT00329381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078275|NCT00429780|Aluminum sulfate|aluminum sulfate|mesh-list
65078276|NCT00429780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65078277|NCT00429780|Immunologic Factors|immunologic factors|mesh-ancestor
64403407|NCT04952129|Trace Elements|trace elements|mesh-ancestor
65078278|NCT00429780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078279|NCT00329459|Naproxen|naproxen|mesh-list
65078280|NCT00329459|Sumatriptan|sumatriptan|mesh-list
65078281|NCT00329459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65078282|NCT00329459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65078283|NCT00329459|Analgesics|analgesics|mesh-ancestor
65078284|NCT00329459|Sensory System Agents|sensory system agents|mesh-ancestor
65078285|NCT00329459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65078286|NCT00329459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078287|NCT00329459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65078288|NCT00329459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65078289|NCT00329459|Gout Suppressants|gout suppressants|mesh-ancestor
65078290|NCT00329459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65078291|NCT00329459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078292|NCT00329459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078293|NCT00329459|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65078294|NCT00329459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65078295|NCT00329459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65078296|NCT00329459|Serotonin Agents|serotonin agents|mesh-ancestor
65078297|NCT00329459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65078298|NCT00329498|Ascorbic Acid|ascorbic acid|mesh-list
65078299|NCT00329498|Antioxidants|antioxidants|mesh-ancestor
65078300|NCT00329498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720387|NCT00000458|Sertraline|sertraline|mesh-list
65078301|NCT00329498|Protective Agents|protective agents|mesh-ancestor
65078302|NCT00329498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078303|NCT00329498|Vitamins|vitamins|mesh-ancestor
65078304|NCT00329498|Micronutrients|micronutrients|mesh-ancestor
65078305|NCT00329537|Sargramostim|sargramostim|mesh-list
65078306|NCT00329537|Immunologic Factors|immunologic factors|mesh-ancestor
65078307|NCT00329537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078308|NCT00429897|Bendroflumethiazide|bendroflumethiazide|mesh-list
65078309|NCT00429897|Amiloride|amiloride|mesh-list
65078310|NCT00429897|Spironolactone|spironolactone|mesh-list
65078311|NCT00429897|Furosemide|furosemide|mesh-list
65078312|NCT00429897|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65078313|NCT00429897|Hormone Antagonists|hormone antagonists|mesh-ancestor
65078314|NCT00429897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65078315|NCT00429897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078316|NCT00429897|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65078317|NCT00429897|Diuretics|diuretics|mesh-ancestor
65078318|NCT00429897|Natriuretic Agents|natriuretic agents|mesh-ancestor
65078319|NCT00429897|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
65078320|NCT00429897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65078321|NCT00429897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65078322|NCT00429897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078323|NCT00429897|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
65078324|NCT00429897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
65078325|NCT00429897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65078326|NCT00429897|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65078327|NCT00429936|Fenretinide|fenretinide|mesh-list
65078328|NCT00429936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078329|NCT00429936|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65078330|NCT00429936|Protective Agents|protective agents|mesh-ancestor
65078331|NCT00429936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078332|NCT00429975|Levofloxacin|levofloxacin|mesh-list
65078333|NCT00429975|Ofloxacin|ofloxacin|mesh-list
65078334|NCT00429975|Ceftriaxone|ceftriaxone|mesh-list
65078335|NCT00429975|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65078336|NCT00429975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65078337|NCT00429975|Renal Agents|renal agents|mesh-ancestor
65078338|NCT00429975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65078339|NCT00429975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65078340|NCT00429975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65078341|NCT00429975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078342|NCT00429975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078343|NCT00429975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078344|NCT00429975|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65078345|NCT00429975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65078346|NCT00329615|Isophane Insulin, Human|isophane insulin, human|mesh-list
65078347|NCT00329615|Insulin, Isophane|insulin, isophane|mesh-list
65078348|NCT00329615|Isophane insulin, beef|isophane insulin, beef|mesh-list
65078349|NCT00329615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65078350|NCT00329615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078351|NCT04716686|Niraparib|niraparib|mesh-list
65078352|NCT04716686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65078353|NCT04716686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078354|NCT04716686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078355|NCT04716686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078356|NCT01056393|Ibalizumab|ibalizumab|mesh-list
65078357|NCT01056393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65078358|NCT01056393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65078359|NCT01056393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65078360|NCT01056393|Antiviral Agents|antiviral agents|mesh-ancestor
65078361|NCT01056393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65078362|NCT01056393|Immunologic Factors|immunologic factors|mesh-ancestor
65078363|NCT01056393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078364|NCT01055106|Metronidazole|metronidazole|mesh-list
65078365|NCT01055106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65078366|NCT01055106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65078367|NCT01055106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65078368|NCT01055106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65078369|NCT00329693|Quinagolide|quinagolide|mesh-list
65078370|NCT00329693|Dopamine Agonists|dopamine agonists|mesh-ancestor
65078371|NCT00329693|Dopamine Agents|dopamine agents|mesh-ancestor
65078372|NCT00329693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65078373|NCT00329693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078374|NCT00329693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64720460|NCT00381134|Hormone Antagonists|hormone antagonists|mesh-ancestor
65078375|NCT00329810|Aripiprazole|aripiprazole|mesh-list
65078376|NCT00329810|Antidepressive Agents|antidepressive agents|mesh-ancestor
65078377|NCT00329810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65078378|NCT00329810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65078379|NCT00329810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65078380|NCT00329810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65078381|NCT00329810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078382|NCT00329810|Dopamine Agonists|dopamine agonists|mesh-ancestor
65078383|NCT00329810|Dopamine Agents|dopamine agents|mesh-ancestor
65078384|NCT00329810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65078385|NCT00329810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078386|NCT00329810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65078387|NCT00329810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65078388|NCT00329810|Serotonin Agents|serotonin agents|mesh-ancestor
65078389|NCT00329810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65078390|NCT00329810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65078391|NCT00329810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65078392|NCT00329810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65078393|NCT00430170|Dipyridamole|dipyridamole|mesh-list
65078394|NCT00430170|Caffeine|caffeine|mesh-list
65078395|NCT00430170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65078396|NCT00430170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078397|NCT00430170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65078398|NCT00430170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078399|NCT00430170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078400|NCT00430170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65078401|NCT00430170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65078402|NCT00430170|Purinergic Agents|purinergic agents|mesh-ancestor
65078403|NCT00430170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65078404|NCT00430170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65078405|NCT00430170|Vasodilator Agents|vasodilator agents|mesh-ancestor
65078406|NCT00330044|Carboplatin|carboplatin|mesh-list
65078407|NCT00330044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078408|NCT00430365|Lenalidomide|lenalidomide|mesh-list
65078409|NCT00430365|Immunologic Factors|immunologic factors|mesh-ancestor
64482981|NCT03157401|Hemostatics|hemostatics|mesh-ancestor
65078410|NCT00430365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078411|NCT00430365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65078412|NCT00430365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65078413|NCT00430365|Growth Substances|growth substances|mesh-ancestor
65078414|NCT00430365|Growth Inhibitors|growth inhibitors|mesh-ancestor
65078415|NCT00430365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078417|NCT00330239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65078418|NCT00330239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65078419|NCT00330239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65078420|NCT00330239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078421|NCT00330239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65078422|NCT00330239|Serotonin Agents|serotonin agents|mesh-ancestor
65078423|NCT00330239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078424|NCT00330239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65078425|NCT00330239|Antidepressive Agents|antidepressive agents|mesh-ancestor
65078426|NCT00330239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65078427|NCT00330239|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65078428|NCT00330239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65078429|NCT00330239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078430|NCT01051557|Sirolimus|sirolimus|mesh-list
65078431|NCT01051557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65078432|NCT01051557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65078433|NCT01051557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65078434|NCT01051557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078435|NCT01051557|Antifungal Agents|antifungal agents|mesh-ancestor
65078436|NCT01051557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65078437|NCT01051557|Immunologic Factors|immunologic factors|mesh-ancestor
65078438|NCT01051557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078439|NCT00330278|Cefazolin|cefazolin|mesh-list
65078440|NCT00330278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65078441|NCT00330278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65078442|NCT00330317|Letrozole|letrozole|mesh-list
65078443|NCT00330317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078444|NCT00330317|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65078445|NCT00330317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65078446|NCT00330317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078447|NCT00330317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078448|NCT00330317|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65078449|NCT00330317|Hormone Antagonists|hormone antagonists|mesh-ancestor
65078450|NCT00330317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65078451|NCT00330317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078452|NCT00430443|Annamycin|annamycin|mesh-list
65078453|NCT00430443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65078454|NCT00430443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078455|NCT00330395|Caspofungin|caspofungin|mesh-list
65078456|NCT00330395|Antifungal Agents|antifungal agents|mesh-ancestor
65078457|NCT00330395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65078458|NCT00330395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078459|NCT00330395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078460|NCT00434382|Fentanyl|fentanyl|mesh-list
65078461|NCT00434382|Sufentanil|sufentanil|mesh-list
65078462|NCT00434382|Remifentanil|remifentanil|mesh-list
65078463|NCT00434382|Alfentanil|alfentanil|mesh-list
65078464|NCT00434382|Propofol|propofol|mesh-list
65078465|NCT00434382|Sevoflurane|sevoflurane|mesh-list
65078466|NCT00434382|Desflurane|desflurane|mesh-list
65078467|NCT00434382|Isoflurane|isoflurane|mesh-list
65078468|NCT00434382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65078469|NCT00434382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65078470|NCT00434382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078471|NCT00434382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65078472|NCT00434382|Anesthetics, General|anesthetics, general|mesh-ancestor
65078473|NCT00434382|Anesthetics|anesthetics|mesh-ancestor
65078474|NCT00434382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65078475|NCT00434382|Narcotics|narcotics|mesh-ancestor
64325111|NCT02159573|Dermatologic Agents|dermatologic agents|mesh-ancestor
64325112|NCT02159573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64325113|NCT02152709|Vaccines|vaccines|mesh-list
64325114|NCT02152709|Immunologic Factors|immunologic factors|mesh-ancestor
65078476|NCT00434382|Analgesics|analgesics|mesh-ancestor
65078477|NCT00434382|Sensory System Agents|sensory system agents|mesh-ancestor
65078478|NCT00434382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65078479|NCT00434382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65078480|NCT00434382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65078481|NCT00434382|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65078482|NCT00330707|Interferons|interferons|mesh-list
65078483|NCT00330707|Interferon-alpha|interferon-alpha|mesh-list
65078484|NCT00330707|BCG Vaccine|bcg vaccine|mesh-list
65078485|NCT00330707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078486|NCT00330707|Antiviral Agents|antiviral agents|mesh-ancestor
65078487|NCT00330707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65078488|NCT00330707|Immunologic Factors|immunologic factors|mesh-ancestor
65078489|NCT00330707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078490|NCT00330707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65078491|NCT00330746|Gemcitabine|gemcitabine|mesh-list
65078492|NCT00330746|Cetuximab|cetuximab|mesh-list
65078493|NCT00330746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65078494|NCT00330746|Antimetabolites|antimetabolites|mesh-ancestor
65078495|NCT00330746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078496|NCT00330746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078497|NCT00330746|Antiviral Agents|antiviral agents|mesh-ancestor
65078498|NCT00330746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65078499|NCT00330746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078500|NCT00330746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65078501|NCT00330746|Immunologic Factors|immunologic factors|mesh-ancestor
65078502|NCT00330746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078503|NCT00330746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65078504|NCT01053741|Plasma-lyte 148|plasma-lyte 148|mesh-list
65078505|NCT01053741|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65078506|NCT01053741|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65078507|NCT00330785|Amlodipine|amlodipine|mesh-list
65078508|NCT00330785|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
65078509|NCT00330785|Atorvastatin|atorvastatin|mesh-list
65078510|NCT00330785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65078511|NCT00330785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65078512|NCT00330785|Antimetabolites|antimetabolites|mesh-ancestor
65078513|NCT00330785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078514|NCT00330785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65078515|NCT00330785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65078516|NCT00330785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078517|NCT00330785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65078518|NCT00330785|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65078519|NCT00330785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65078520|NCT00330785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65078521|NCT00330785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078522|NCT00330785|Vasodilator Agents|vasodilator agents|mesh-ancestor
65078523|NCT00330824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65078524|NCT00330824|Moxifloxacin|moxifloxacin|mesh-list
65078525|NCT00330824|Dexamethasone|dexamethasone|mesh-list
65078526|NCT00330824|Dexamethasone acetate|dexamethasone acetate|mesh-list
65078527|NCT00330824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65078528|NCT00330824|BB 1101|bb 1101|mesh-list
65078529|NCT00330824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65078530|NCT00330824|Antiemetics|antiemetics|mesh-ancestor
64325117|NCT03164109|Avasopasem manganese|avasopasem manganese|mesh-list
64325118|NCT03164109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64325119|NCT03164109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64325120|NCT03164109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64430000|NCT05055323|Anthelmintics|anthelmintics|mesh-ancestor
64833979|NCT04583501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64833980|NCT04583501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64833981|NCT04583501|Respiratory System Agents|respiratory system agents|mesh-ancestor
64833982|NCT04563494|Dexamethasone|dexamethasone|mesh-list
64833983|NCT04563494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65078531|NCT00330824|Autonomic Agents|autonomic agents|mesh-ancestor
65078532|NCT00330824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65078533|NCT00330824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078534|NCT00330824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65078535|NCT00330824|Glucocorticoids|glucocorticoids|mesh-ancestor
65078536|NCT00330824|Hormones|hormones|mesh-ancestor
65078537|NCT00330824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65078538|NCT00330824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65078539|NCT00330824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078540|NCT00330824|Protease Inhibitors|protease inhibitors|mesh-ancestor
65078541|NCT00330824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416285|NCT03041935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078542|NCT00330824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078543|NCT00330824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65078544|NCT00330824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65078545|NCT00330824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65078546|NCT00330824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65078547|NCT00330824|Contraceptive Agents|contraceptive agents|mesh-ancestor
65078548|NCT00330824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65078549|NCT00330824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65078550|NCT00330824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65078551|NCT00330824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65078552|NCT00330902|Artesunate|artesunate|mesh-list
65078553|NCT00330902|Pyrimethamine|pyrimethamine|mesh-list
65078554|NCT00330902|Primaquine|primaquine|mesh-list
65078555|NCT00330902|Sulfadoxine|sulfadoxine|mesh-list
65078556|NCT00330902|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65078557|NCT00330902|Antimalarials|antimalarials|mesh-ancestor
65078558|NCT00330902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65078559|NCT00330902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65078560|NCT00330902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65078561|NCT00330902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078562|NCT00330902|Antiviral Agents|antiviral agents|mesh-ancestor
65078563|NCT00330902|Schistosomicides|schistosomicides|mesh-ancestor
65078564|NCT00330902|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65078565|NCT00330902|Anthelmintics|anthelmintics|mesh-ancestor
65078566|NCT00330902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65078567|NCT00330902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078568|NCT00330902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078569|NCT00330902|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65078570|NCT00330902|Renal Agents|renal agents|mesh-ancestor
65078571|NCT04703868|Rabeprazole|rabeprazole|mesh-list
65078572|NCT04703868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65078573|NCT04703868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65078574|NCT04703868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65078575|NCT04703868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078576|NCT04703868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078577|NCT00430794|Spironolactone|spironolactone|mesh-list
65078578|NCT00430794|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65078579|NCT00430794|Hormone Antagonists|hormone antagonists|mesh-ancestor
65078580|NCT00430794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65078581|NCT00430794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078582|NCT00430794|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65078583|NCT00430794|Diuretics|diuretics|mesh-ancestor
65078584|NCT00430794|Natriuretic Agents|natriuretic agents|mesh-ancestor
65078585|NCT00330980|Simvastatin|simvastatin|mesh-list
65078586|NCT00330980|Pravastatin|pravastatin|mesh-list
64833984|NCT04563494|Antiemetics|antiemetics|mesh-ancestor
64833985|NCT04563494|Autonomic Agents|autonomic agents|mesh-ancestor
64833986|NCT04563494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64833987|NCT04563494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833988|NCT04563494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64405561|NCT04888715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078587|NCT00330980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65078588|NCT00330980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65078589|NCT00330980|Antimetabolites|antimetabolites|mesh-ancestor
65078590|NCT00330980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078591|NCT00330980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65078592|NCT00330980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65078593|NCT00330980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078594|NCT00430833|Candesartan|candesartan|mesh-list
65078595|NCT00430833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65078596|NCT00430833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65078597|NCT00430833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65078598|NCT00430833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078599|NCT00331058|Prednisolone|prednisolone|mesh-list
65078600|NCT00331058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65078601|NCT00331058|Glucocorticoids|glucocorticoids|mesh-ancestor
65078602|NCT00331058|Hormones|hormones|mesh-ancestor
65078603|NCT00331058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65078604|NCT00331058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078605|NCT00331058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65078606|NCT00331058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078607|NCT00331097|Cyclophosphamide|cyclophosphamide|mesh-list
65078608|NCT00331097|Docetaxel|docetaxel|mesh-list
65078609|NCT00331097|Fluorouracil|fluorouracil|mesh-list
65078610|NCT00331097|Methotrexate|methotrexate|mesh-list
65078611|NCT00331097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65078612|NCT00331097|Immunologic Factors|immunologic factors|mesh-ancestor
65078613|NCT00331097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078614|NCT00331097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65078615|NCT00331097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65078616|NCT00331097|Alkylating Agents|alkylating agents|mesh-ancestor
65078617|NCT00331097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078618|NCT00331097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078619|NCT00331097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65078620|NCT00331097|Tubulin Modulators|tubulin modulators|mesh-ancestor
65078621|NCT00331097|Antimitotic Agents|antimitotic agents|mesh-ancestor
65078622|NCT00331097|Mitosis Modulators|mitosis modulators|mesh-ancestor
65078623|NCT00331097|Antimetabolites|antimetabolites|mesh-ancestor
65078624|NCT00331097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65078625|NCT00331097|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65078626|NCT00331097|Abortifacient Agents|abortifacient agents|mesh-ancestor
65078627|NCT00331097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65078628|NCT00331097|Dermatologic Agents|dermatologic agents|mesh-ancestor
65078629|NCT00331097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078630|NCT00331097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65078631|NCT00331097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65078632|NCT00331214|Testosterone|testosterone|mesh-list
65078633|NCT00331214|Androgens|androgens|mesh-ancestor
65078634|NCT00331214|Hormones|hormones|mesh-ancestor
65078635|NCT00331214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65078636|NCT00331214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078637|NCT00434772|Glucagon|glucagon|mesh-list
65078638|NCT00434772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65078639|NCT00434772|Hormones|hormones|mesh-ancestor
65078640|NCT00434772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65078641|NCT00434772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078642|NCT00431028|Ciprofloxacin|ciprofloxacin|mesh-list
65078643|NCT00431028|Triamcinolone|triamcinolone|mesh-list
65078644|NCT00431028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65078645|NCT00431028|Glucocorticoids|glucocorticoids|mesh-ancestor
65078646|NCT00431028|Hormones|hormones|mesh-ancestor
65078647|NCT00431028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65078648|NCT00431028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078649|NCT00431028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078650|NCT00431028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078651|NCT00431028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65078652|NCT00431028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65078653|NCT00431028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65078654|NCT00431028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65078655|NCT00431028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078656|NCT00431028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65078657|NCT00431028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65078658|NCT00431106|Gemcitabine|gemcitabine|mesh-list
65078659|NCT00431106|Capecitabine|capecitabine|mesh-list
65078660|NCT00431106|Vinorelbine|vinorelbine|mesh-list
65078661|NCT00431106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65078662|NCT00431106|Antimetabolites|antimetabolites|mesh-ancestor
65078663|NCT00431106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078664|NCT00431106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078665|NCT00431106|Antiviral Agents|antiviral agents|mesh-ancestor
65078666|NCT00431106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65078667|NCT00431106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078668|NCT00431106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65078669|NCT00431106|Immunologic Factors|immunologic factors|mesh-ancestor
65078670|NCT00431106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078671|NCT00431106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65078672|NCT00431106|Tubulin Modulators|tubulin modulators|mesh-ancestor
65078673|NCT00431106|Antimitotic Agents|antimitotic agents|mesh-ancestor
65078674|NCT00431106|Mitosis Modulators|mitosis modulators|mesh-ancestor
64720772|NCT00000638|Vitamins|vitamins|mesh-ancestor
65078676|NCT00431145|Niacinamide|niacinamide|mesh-list
65078677|NCT00431145|Nicotinic Acids|nicotinic acids|mesh-list
65078678|NCT00431145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65078679|NCT00431145|Antimetabolites|antimetabolites|mesh-ancestor
65078680|NCT00431145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078681|NCT00431145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65078682|NCT00431145|Vasodilator Agents|vasodilator agents|mesh-ancestor
65078683|NCT00431145|Vitamin B Complex|vitamin b complex|mesh-ancestor
65078684|NCT00431145|Vitamins|vitamins|mesh-ancestor
65078685|NCT00431145|Micronutrients|micronutrients|mesh-ancestor
65078686|NCT00431145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078687|NCT00331487|Pioglitazone|pioglitazone|mesh-list
65078688|NCT00331487|Rosiglitazone|rosiglitazone|mesh-list
65078689|NCT00331487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65078690|NCT00331487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078691|NCT00331526|Aldesleukin|aldesleukin|mesh-list
65078692|NCT00331526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078693|NCT00331526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65078694|NCT00331526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65078695|NCT00331526|Antiviral Agents|antiviral agents|mesh-ancestor
65078696|NCT00331526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65078697|NCT00431262|Disulfiram|disulfiram|mesh-list
65078698|NCT00431262|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65078699|NCT00431262|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65078700|NCT00431262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078701|NCT00431262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078702|NCT00331604|Insulin|insulin|mesh-list
65078703|NCT00331604|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65078704|NCT00331604|Insulin Aspart|insulin aspart|mesh-list
65078705|NCT00331604|Insulin, Long-Acting|insulin, long-acting|mesh-list
65078706|NCT00331604|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65078707|NCT00331604|Insulin Detemir|insulin detemir|mesh-list
65078708|NCT00331604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65078709|NCT00331604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078710|NCT00331643|Epothilones|epothilones|mesh-list
65078711|NCT00331643|Epothilone B|epothilone b|mesh-list
65078712|NCT00331643|Tubulin Modulators|tubulin modulators|mesh-ancestor
65078713|NCT00331643|Antimitotic Agents|antimitotic agents|mesh-ancestor
65078714|NCT00331643|Mitosis Modulators|mitosis modulators|mesh-ancestor
65078715|NCT00331643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078716|NCT00331643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078717|NCT00431340|Belinostat|belinostat|mesh-list
65078718|NCT00431340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078719|NCT00431340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65078720|NCT00431340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078721|NCT00431340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078722|NCT00431379|Tenecteplase|tenecteplase|mesh-list
65078723|NCT00431379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65078724|NCT00431379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65078725|NCT00431379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078726|NCT00331838|Enoxaparin|enoxaparin|mesh-list
65078727|NCT00331838|Semuloparin|semuloparin|mesh-list
65078728|NCT00331838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65078729|NCT00331838|Enoxaparin sodium|enoxaparin sodium|mesh-list
65078730|NCT00331838|Anticoagulants|anticoagulants|mesh-ancestor
65078731|NCT00331838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65078732|NCT00331838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65078733|NCT00331838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078734|NCT00431418|Sildenafil Citrate|sildenafil citrate|mesh-list
65078735|NCT00431418|Vasodilator Agents|vasodilator agents|mesh-ancestor
65078736|NCT00431418|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65078737|NCT00431418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65078738|NCT00431418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078739|NCT00431418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078740|NCT00431418|Urological Agents|urological agents|mesh-ancestor
65078741|NCT00331955|Doxorubicin|doxorubicin|mesh-list
65078742|NCT00331955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65078743|NCT00331955|Vorinostat|vorinostat|mesh-list
65078744|NCT00331955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65078745|NCT00331955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078746|NCT00331955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65078747|NCT00331955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65078748|NCT00331955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078749|NCT00331955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64720848|NCT00000680|Zidovudine|zidovudine|mesh-list
65078750|NCT00331955|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65078751|NCT03277482|Durvalumab|durvalumab|mesh-list
65078752|NCT03277482|Tremelimumab|tremelimumab|mesh-list
65078753|NCT03277482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65078754|NCT03277482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078755|NCT00331994|Metronidazole|metronidazole|mesh-list
65078756|NCT00331994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64416292|NCT03041935|Narcotics|narcotics|mesh-ancestor
65078757|NCT00331994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65078758|NCT00331994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65078759|NCT00331994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65078760|NCT00332033|Pirfenidone|pirfenidone|mesh-list
65078761|NCT00332033|Analgesics|analgesics|mesh-ancestor
65078762|NCT00332033|Sensory System Agents|sensory system agents|mesh-ancestor
65078763|NCT00332033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65078764|NCT00332033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078765|NCT00332033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65078766|NCT00332033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65078767|NCT00332033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65078768|NCT00332033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65078769|NCT00332033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078770|NCT00435279|Eszopiclone|eszopiclone|mesh-list
65078771|NCT00435279|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65078772|NCT00435279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65078773|NCT00435279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65078774|NCT00435279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65078775|NCT00435279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078776|NCT00435279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65078777|NCT00435279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078778|NCT00435279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65078779|NCT00435279|Antidepressive Agents|antidepressive agents|mesh-ancestor
65078780|NCT00435279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65078781|NCT00435279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65078782|NCT00435279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65078783|NCT00332072|Timolol|timolol|mesh-list
65078784|NCT00332072|Bimatoprost|bimatoprost|mesh-list
65078785|NCT00332072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65078786|NCT00332072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65078787|NCT00332072|Adrenergic Agents|adrenergic agents|mesh-ancestor
65078788|NCT00332072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65078789|NCT00332072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078790|NCT00332072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078791|NCT00332072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65078792|NCT00332072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65078793|NCT00431613|Gemcitabine|gemcitabine|mesh-list
65078794|NCT00431613|Carboplatin|carboplatin|mesh-list
65078795|NCT00431613|Docetaxel|docetaxel|mesh-list
65078796|NCT00431613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078797|NCT00431613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65078798|NCT00431613|Antimetabolites|antimetabolites|mesh-ancestor
65078799|NCT00431613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078800|NCT00431613|Antiviral Agents|antiviral agents|mesh-ancestor
65078801|NCT00431613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65078802|NCT00431613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078803|NCT00431613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65078804|NCT00431613|Immunologic Factors|immunologic factors|mesh-ancestor
65078805|NCT00431613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078806|NCT00431613|Tubulin Modulators|tubulin modulators|mesh-ancestor
65078807|NCT00431613|Antimitotic Agents|antimitotic agents|mesh-ancestor
65078808|NCT00431613|Mitosis Modulators|mitosis modulators|mesh-ancestor
65078809|NCT00332228|Naltrexone|naltrexone|mesh-list
65078810|NCT00332228|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65078811|NCT00332228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65078812|NCT00332228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078813|NCT00332228|Sensory System Agents|sensory system agents|mesh-ancestor
65078814|NCT00332228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65078815|NCT00431691|Nitroglycerin|nitroglycerin|mesh-list
65078816|NCT00431691|Vasodilator Agents|vasodilator agents|mesh-ancestor
65078817|NCT00332306|Lamivudine|lamivudine|mesh-list
65078818|NCT00332306|Efavirenz|efavirenz|mesh-list
65078819|NCT00332306|Nevirapine|nevirapine|mesh-list
65078820|NCT00332306|Didanosine|didanosine|mesh-list
65078821|NCT00332306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65078822|NCT00332306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65078823|NCT00332306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64720912|NCT00002198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65078824|NCT00332306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078825|NCT00332306|Antiviral Agents|antiviral agents|mesh-ancestor
65078826|NCT00332306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65078828|NCT00332306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65078829|NCT00332306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65078830|NCT00332306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65078831|NCT00332306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65078832|NCT00332306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65078833|NCT00332306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65078834|NCT00332306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65078835|NCT00332306|Antimetabolites|antimetabolites|mesh-ancestor
65078837|NCT00332345|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65078838|NCT00332345|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65078839|NCT00332345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65078840|NCT00332345|Adrenergic Agents|adrenergic agents|mesh-ancestor
65078841|NCT00332345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65078842|NCT00332345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078843|NCT00332345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078844|NCT00332345|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65078845|NCT00332345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65078846|NCT00332345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65078847|NCT00332345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65078848|NCT00332345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65078849|NCT00332384|Timolol|timolol|mesh-list
65078850|NCT00332384|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64482990|NCT03156855|Antacids|antacids|mesh-ancestor
65078851|NCT00332384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65078852|NCT00332384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65078853|NCT00332384|Adrenergic Agents|adrenergic agents|mesh-ancestor
64325121|NCT03164109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64325122|NCT03164109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64325123|NCT03164109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078854|NCT00332384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65078855|NCT00332384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078856|NCT00332384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078857|NCT00332384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65078858|NCT00332384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65078859|NCT00332384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65078860|NCT00332384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65078861|NCT00332384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65078862|NCT00435435|Disulfiram|disulfiram|mesh-list
65078863|NCT00435435|Acamprosate|acamprosate|mesh-list
65078864|NCT00435435|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65078865|NCT00435435|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
65078866|NCT00435435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078867|NCT00435435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078868|NCT00332540|Timolol|timolol|mesh-list
65078869|NCT00332540|Bimatoprost|bimatoprost|mesh-list
65078870|NCT00332540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65078871|NCT00332540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65078872|NCT00332540|Adrenergic Agents|adrenergic agents|mesh-ancestor
65078873|NCT00332540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65078874|NCT00332540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078875|NCT00332540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078876|NCT00332540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65078877|NCT00332540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65078878|NCT00332618|Glycerol|glycerol|mesh-list
65078879|NCT00332618|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65078880|NCT00332618|Protective Agents|protective agents|mesh-ancestor
65078881|NCT00332618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078882|NCT00332735|Bupivacaine|bupivacaine|mesh-list
65078883|NCT00332735|Carticaine|carticaine|mesh-list
65078884|NCT00332735|Anesthetics, Local|anesthetics, local|mesh-ancestor
65078885|NCT00332735|Anesthetics|anesthetics|mesh-ancestor
65078886|NCT00332735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65078887|NCT00332735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078888|NCT00332735|Sensory System Agents|sensory system agents|mesh-ancestor
65078889|NCT00332735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65078890|NCT00332774|Ketorolac|ketorolac|mesh-list
65078891|NCT00332774|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
65078892|NCT00332774|Nepafenac|nepafenac|mesh-list
65078893|NCT00332774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65078894|NCT00332774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64416309|NCT03041935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65078895|NCT00332774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65078897|NCT00332774|Analgesics|analgesics|mesh-ancestor
65078898|NCT00332774|Sensory System Agents|sensory system agents|mesh-ancestor
65078899|NCT00332774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65078900|NCT00332774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078901|NCT00332774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65078902|NCT00332774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65078903|NCT00332774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65078904|NCT00332774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078905|NCT00332774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078907|NCT00431769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833989|NCT04563494|Glucocorticoids|glucocorticoids|mesh-ancestor
64833990|NCT04563494|Hormones|hormones|mesh-ancestor
64833991|NCT04563494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64833992|NCT04563494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64833993|NCT04563494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833994|NCT04552288|Benralizumab|benralizumab|mesh-list
64833995|NCT04552288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64833996|NCT04552288|Respiratory System Agents|respiratory system agents|mesh-ancestor
64833997|NCT04541173|Bevacizumab|bevacizumab|mesh-list
65078908|NCT00332852|Letrozole|letrozole|mesh-list
65078909|NCT00332852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078910|NCT00332852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65078911|NCT00332852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65078912|NCT00332852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078913|NCT00332852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078914|NCT00332852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65078915|NCT00332852|Hormone Antagonists|hormone antagonists|mesh-ancestor
65078916|NCT00332852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65078917|NCT00332852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078918|NCT00332891|Amibegron|amibegron|mesh-list
65078919|NCT00332891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65078920|NCT00332891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65078921|NCT00332891|Adrenergic Agents|adrenergic agents|mesh-ancestor
65078922|NCT00332891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65078923|NCT00332891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078924|NCT00332891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078925|NCT00332930|Interferons|interferons|mesh-list
65078926|NCT00332930|Interferon-gamma|interferon-gamma|mesh-list
65078927|NCT00332930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078928|NCT00332930|Antiviral Agents|antiviral agents|mesh-ancestor
65078929|NCT00332930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65078930|NCT00332969|Octreotide|octreotide|mesh-list
65078931|NCT00332969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65078932|NCT00332969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65078933|NCT00332969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078934|NCT00333008|Prednisone|prednisone|mesh-list
65078935|NCT00333008|Cyclophosphamide|cyclophosphamide|mesh-list
65078936|NCT00333008|Rituximab|rituximab|mesh-list
65078937|NCT00333008|Vincristine|vincristine|mesh-list
65078938|NCT00333008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65078939|NCT00333008|Immunologic Factors|immunologic factors|mesh-ancestor
65078940|NCT00333008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078941|NCT00333008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65078942|NCT00333008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65078943|NCT00333008|Alkylating Agents|alkylating agents|mesh-ancestor
65078944|NCT00333008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078945|NCT00333008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078946|NCT00333008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65078947|NCT00333008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65078948|NCT00333008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65078949|NCT00333008|Glucocorticoids|glucocorticoids|mesh-ancestor
65078950|NCT00333008|Hormones|hormones|mesh-ancestor
65078951|NCT00333008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65078952|NCT00333008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65078953|NCT00333008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65078954|NCT00333008|Tubulin Modulators|tubulin modulators|mesh-ancestor
65078955|NCT00333008|Antimitotic Agents|antimitotic agents|mesh-ancestor
65078956|NCT00333008|Mitosis Modulators|mitosis modulators|mesh-ancestor
65078957|NCT00435747|Parecoxib|parecoxib|mesh-list
65078958|NCT00435747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65078959|NCT00435747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65078960|NCT00435747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078961|NCT00435747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078962|NCT00435747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65078963|NCT00435747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65078964|NCT00435747|Analgesics|analgesics|mesh-ancestor
65078965|NCT00435747|Sensory System Agents|sensory system agents|mesh-ancestor
64833998|NCT04541173|Atezolizumab|atezolizumab|mesh-list
64833999|NCT04541173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64834000|NCT04541173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834001|NCT04541173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64834002|NCT04541173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64834003|NCT04541173|Growth Substances|growth substances|mesh-ancestor
64834004|NCT04541173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078966|NCT00435747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65078967|NCT00435747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078968|NCT00435747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65078969|NCT00435747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65078970|NCT00333047|Letrozole|letrozole|mesh-list
65078971|NCT00333047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078972|NCT00333047|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65078973|NCT00333047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65078974|NCT00333047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078975|NCT00333047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078976|NCT00333047|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65078977|NCT00333047|Hormone Antagonists|hormone antagonists|mesh-ancestor
65078978|NCT00333047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65078979|NCT00333047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078980|NCT00333086|Letrozole|letrozole|mesh-list
65078981|NCT00333086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65078982|NCT00333086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65078983|NCT00333086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65078984|NCT00333086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65078985|NCT00333086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65078986|NCT00333086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65078987|NCT00333086|Hormone Antagonists|hormone antagonists|mesh-ancestor
65078988|NCT00333086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65078989|NCT00333086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65078990|NCT00333125|Timolol|timolol|mesh-list
65078991|NCT00333125|Travoprost|travoprost|mesh-list
65078992|NCT00333125|Dorzolamide|dorzolamide|mesh-list
65078993|NCT00333125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65078994|NCT00333125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65078995|NCT00333125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65078996|NCT00333125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65078997|NCT00333125|Adrenergic Agents|adrenergic agents|mesh-ancestor
65078998|NCT00333125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65078999|NCT00333125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079000|NCT00333125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079001|NCT00333125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65079002|NCT00333125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65079003|NCT00333125|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65079004|NCT00333125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079005|NCT00333164|Cilostazol|cilostazol|mesh-list
65079006|NCT00333164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65079007|NCT00333164|Autonomic Agents|autonomic agents|mesh-ancestor
65079008|NCT00333164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65079009|NCT00333164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079010|NCT00333164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65079011|NCT00333164|Respiratory System Agents|respiratory system agents|mesh-ancestor
65079012|NCT00333164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65079013|NCT00333164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65079014|NCT00333164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079015|NCT00333164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65079016|NCT00333164|Vasodilator Agents|vasodilator agents|mesh-ancestor
65079017|NCT00333164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65079018|NCT00333164|Protective Agents|protective agents|mesh-ancestor
65079019|NCT00333164|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65079020|NCT00333164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65079021|NCT00333164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079022|NCT01052493|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
65079023|NCT01052493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65079024|NCT01052493|Hormones|hormones|mesh-ancestor
65079025|NCT01052493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65079026|NCT01052493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079027|NCT00333242|Dextromethorphan|dextromethorphan|mesh-list
65079028|NCT00333242|Antitussive Agents|antitussive agents|mesh-ancestor
65079029|NCT00333242|Respiratory System Agents|respiratory system agents|mesh-ancestor
65079030|NCT00333242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65079031|NCT00333242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65079032|NCT00333242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65079033|NCT00333242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079034|NCT00333242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079036|NCT00333281|Vasodilator Agents|vasodilator agents|mesh-ancestor
65079037|NCT00333281|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65079038|NCT00333281|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65079039|NCT00333281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079040|NCT00333281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079041|NCT00333281|Urological Agents|urological agents|mesh-ancestor
65079042|NCT00333398|Vaccines|vaccines|mesh-list
65079043|NCT00333398|Immunologic Factors|immunologic factors|mesh-ancestor
65079044|NCT00333398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079045|NCT00333476|Squalamine|squalamine|mesh-list
65079046|NCT00333476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65079047|NCT00333476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65079048|NCT00333476|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65079049|NCT00333476|Protective Agents|protective agents|mesh-ancestor
65079050|NCT00333476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079051|NCT00333476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079052|NCT00333476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65079053|NCT00333476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65079054|NCT00333476|Growth Substances|growth substances|mesh-ancestor
65079055|NCT00333476|Growth Inhibitors|growth inhibitors|mesh-ancestor
65079056|NCT00435981|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65079057|NCT00435981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65079058|NCT00435981|Immunologic Factors|immunologic factors|mesh-ancestor
65079059|NCT00435981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079061|NCT00435981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079062|NCT00435981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65079063|NCT00432081|Indomethacin|indomethacin|mesh-list
65079064|NCT00432081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65079065|NCT00432081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65079066|NCT00432081|Analgesics|analgesics|mesh-ancestor
65079067|NCT00432081|Sensory System Agents|sensory system agents|mesh-ancestor
65079068|NCT00432081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65079069|NCT00432081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079070|NCT00432081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65079071|NCT00432081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65079072|NCT00432081|Gout Suppressants|gout suppressants|mesh-ancestor
65079073|NCT00432081|Tocolytic Agents|tocolytic agents|mesh-ancestor
65079074|NCT00432081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65079075|NCT00432081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65079076|NCT00432081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079077|NCT00432081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079078|NCT00333632|Fentanyl|fentanyl|mesh-list
65079079|NCT00333632|Midazolam|midazolam|mesh-list
65079080|NCT00333632|Dexmedetomidine|dexmedetomidine|mesh-list
65079081|NCT00333632|Propofol|propofol|mesh-list
65079082|NCT00333632|Isoflurane|isoflurane|mesh-list
65079083|NCT00333632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65079084|NCT00333632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65079085|NCT00333632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079086|NCT00333632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65079087|NCT00333632|Anesthetics, General|anesthetics, general|mesh-ancestor
65079088|NCT00333632|Anesthetics|anesthetics|mesh-ancestor
65079089|NCT00333632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65079090|NCT00333632|Analgesics|analgesics|mesh-ancestor
65079091|NCT00333632|Sensory System Agents|sensory system agents|mesh-ancestor
65079092|NCT00333632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65079093|NCT00333632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65079094|NCT00333632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65079095|NCT00333632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65079096|NCT00333632|Adrenergic Agents|adrenergic agents|mesh-ancestor
65079097|NCT00333632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65079098|NCT00333632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079099|NCT00333632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65079100|NCT00333632|Narcotics|narcotics|mesh-ancestor
65079101|NCT00333632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65079102|NCT00333632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65079103|NCT00333632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65079104|NCT00333632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65079105|NCT00333632|GABA Modulators|gaba modulators|mesh-ancestor
65079106|NCT00333632|GABA Agents|gaba agents|mesh-ancestor
65079107|NCT00333632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65079108|NCT00436059|Bortezomib|bortezomib|mesh-list
65079109|NCT00436059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079110|NCT00420524|Epothilone B|epothilone b|mesh-list
65079111|NCT00420524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079112|NCT00420524|Tubulin Modulators|tubulin modulators|mesh-ancestor
65079113|NCT00420524|Antimitotic Agents|antimitotic agents|mesh-ancestor
65079114|NCT00420524|Mitosis Modulators|mitosis modulators|mesh-ancestor
65079115|NCT00420524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079116|NCT00432120|Clopidogrel|clopidogrel|mesh-list
65079117|NCT00432120|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65079118|NCT00432120|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65079119|NCT00432120|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65079120|NCT00432120|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65079121|NCT00432120|Purinergic Agents|purinergic agents|mesh-ancestor
65079122|NCT00432120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65079123|NCT00432120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079124|NCT00432120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079125|NCT00432198|Zolpidem|zolpidem|mesh-list
65079126|NCT00432198|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65079127|NCT00432198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65079128|NCT00432198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65079129|NCT00432198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079130|NCT00432198|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65079131|NCT00432198|GABA Agonists|gaba agonists|mesh-ancestor
65079132|NCT00432198|GABA Agents|gaba agents|mesh-ancestor
65079133|NCT00432198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65079134|NCT00432198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079135|NCT00420563|Cyclophosphamide|cyclophosphamide|mesh-list
65079136|NCT00420563|Megestrol|megestrol|mesh-list
65079137|NCT00420563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65079138|NCT00420563|Immunologic Factors|immunologic factors|mesh-ancestor
65079139|NCT00420563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079140|NCT00420563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65079141|NCT00420563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65079142|NCT00420563|Alkylating Agents|alkylating agents|mesh-ancestor
65079143|NCT00420563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079144|NCT00420563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079145|NCT00420563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65079146|NCT00420563|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64834007|NCT04530747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64834008|NCT04530747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408926|NCT05006911|Nasal Decongestants|nasal decongestants|mesh-ancestor
64408927|NCT05006911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64408928|NCT05006911|Respiratory System Agents|respiratory system agents|mesh-ancestor
64408929|NCT05006911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64408930|NCT05006911|Mydriatics|mydriatics|mesh-ancestor
64408985|NCT02637895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65079147|NCT00420563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65079148|NCT00420563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65079149|NCT00420563|Contraceptive Agents|contraceptive agents|mesh-ancestor
65079150|NCT00420563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65079151|NCT00420563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65079152|NCT00420563|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65079153|NCT00420563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65079154|NCT00432315|Docetaxel|docetaxel|mesh-list
65079155|NCT00432315|Cisplatin|cisplatin|mesh-list
65079156|NCT00432315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079157|NCT00432315|Tubulin Modulators|tubulin modulators|mesh-ancestor
65079158|NCT00432315|Antimitotic Agents|antimitotic agents|mesh-ancestor
65079159|NCT00432315|Mitosis Modulators|mitosis modulators|mesh-ancestor
65079160|NCT00432315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079161|NCT00333671|Glycerol|glycerol|mesh-list
65079162|NCT00333671|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65079163|NCT00333671|Protective Agents|protective agents|mesh-ancestor
65079164|NCT00333671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079165|NCT00432354|Atorvastatin|atorvastatin|mesh-list
65079166|NCT00432354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65079167|NCT00432354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65079168|NCT00432354|Antimetabolites|antimetabolites|mesh-ancestor
65079169|NCT00432354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079170|NCT00432354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65079171|NCT00432354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65079172|NCT00432354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079173|NCT00333944|Pralidoxime|pralidoxime|mesh-list
65079174|NCT00333944|Antidotes|antidotes|mesh-ancestor
65079175|NCT00333944|Protective Agents|protective agents|mesh-ancestor
65079176|NCT00333944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079177|NCT00333944|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
65079178|NCT00333944|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
65079179|NCT00333944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079180|NCT00333944|Cholinergic Agents|cholinergic agents|mesh-ancestor
65079181|NCT00333944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65079182|NCT00334022|Enfuvirtide|enfuvirtide|mesh-list
65079183|NCT00334022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65079184|NCT00334022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65079185|NCT00334022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079186|NCT00334022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65079187|NCT00334022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65079188|NCT00334022|Antiviral Agents|antiviral agents|mesh-ancestor
65079189|NCT00334022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65079190|NCT04701528|Tacrolimus|tacrolimus|mesh-list
65079191|NCT04701528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65079192|NCT04701528|Immunologic Factors|immunologic factors|mesh-ancestor
65079193|NCT04701528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079194|NCT04701528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65079195|NCT04701528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079196|NCT04701528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079197|NCT00334139|Zoledronic Acid|zoledronic acid|mesh-list
65079198|NCT00334139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65079199|NCT00334139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079200|NCT03279978|Midazolam|midazolam|mesh-list
65079201|NCT03279978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65079202|NCT03279978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65079203|NCT03279978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65079204|NCT03279978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079205|NCT03279978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65079206|NCT03279978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65079207|NCT03279978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65079208|NCT03279978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65079209|NCT03279978|Anesthetics, General|anesthetics, general|mesh-ancestor
65079210|NCT03279978|Anesthetics|anesthetics|mesh-ancestor
65079211|NCT03279978|GABA Modulators|gaba modulators|mesh-ancestor
65079212|NCT03279978|GABA Agents|gaba agents|mesh-ancestor
65079213|NCT03279978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65079214|NCT03279978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079215|NCT00438048|Pilocarpine|pilocarpine|mesh-list
65079216|NCT00438048|Miotics|miotics|mesh-ancestor
65079217|NCT00438048|Autonomic Agents|autonomic agents|mesh-ancestor
65079218|NCT00438048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65079219|NCT00438048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079220|NCT00438048|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65079221|NCT00438048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65079222|NCT00438048|Cholinergic Agents|cholinergic agents|mesh-ancestor
65079223|NCT00438048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65079224|NCT00438048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079225|NCT00334256|Tenofovir|tenofovir|mesh-list
65079226|NCT00334256|Emtricitabine|emtricitabine|mesh-list
65079227|NCT00334256|Antiviral Agents|antiviral agents|mesh-ancestor
65079228|NCT00334256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65079229|NCT00334256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65079230|NCT00334256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65079231|NCT00334256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079232|NCT00334256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079233|NCT00334256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65079234|NCT00334256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65079235|NCT00438087|Methylprednisolone|methylprednisolone|mesh-list
65079236|NCT00438087|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65079237|NCT00438087|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65079238|NCT00438087|Prednisolone|prednisolone|mesh-list
65079239|NCT00438087|Prednisolone acetate|prednisolone acetate|mesh-list
65079240|NCT00438087|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65079241|NCT00438087|Prednisolone phosphate|prednisolone phosphate|mesh-list
65079242|NCT00438087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65079243|NCT00438087|Antiemetics|antiemetics|mesh-ancestor
65079244|NCT00438087|Autonomic Agents|autonomic agents|mesh-ancestor
65079245|NCT00438087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65079246|NCT00438087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079247|NCT00438087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65079248|NCT00438087|Glucocorticoids|glucocorticoids|mesh-ancestor
65079250|NCT00438087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65079251|NCT00438087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65079252|NCT00438087|Protective Agents|protective agents|mesh-ancestor
65079253|NCT00438087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65079254|NCT00438087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079255|NCT00334412|Caspofungin|caspofungin|mesh-list
65079256|NCT00334412|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65079257|NCT00334412|Antifungal Agents|antifungal agents|mesh-ancestor
65079258|NCT00334412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65079259|NCT00334412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079260|NCT00334412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079261|NCT00334412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65079262|NCT00334412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65079263|NCT00334490|Sildenafil Citrate|sildenafil citrate|mesh-list
65079264|NCT00334490|Vasodilator Agents|vasodilator agents|mesh-ancestor
65079265|NCT00334490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65079266|NCT00334490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65079267|NCT00334490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079268|NCT00334490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079269|NCT00334490|Urological Agents|urological agents|mesh-ancestor
65079270|NCT00334529|Oseltamivir|oseltamivir|mesh-list
65079271|NCT00334529|Antiviral Agents|antiviral agents|mesh-ancestor
65079272|NCT00334529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65079273|NCT00334529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834018|NCT04464174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834019|NCT04464174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64834020|NCT04464174|Immunologic Factors|immunologic factors|mesh-ancestor
64834021|NCT04464174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079274|NCT00334529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079275|NCT00334568|Rosiglitazone|rosiglitazone|mesh-list
65079276|NCT00334568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65079277|NCT00334568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079278|NCT02273544|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
65079279|NCT02273544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65079280|NCT00436293|Docetaxel|docetaxel|mesh-list
65079281|NCT00436293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079282|NCT00436293|Tubulin Modulators|tubulin modulators|mesh-ancestor
65079283|NCT00436293|Antimitotic Agents|antimitotic agents|mesh-ancestor
65079284|NCT00436293|Mitosis Modulators|mitosis modulators|mesh-ancestor
65079285|NCT00436293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079286|NCT00334646|Cyclophosphamide|cyclophosphamide|mesh-list
65079287|NCT00334646|Casopitant|casopitant|mesh-list
65079288|NCT00334646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65079289|NCT00334646|Immunologic Factors|immunologic factors|mesh-ancestor
65079290|NCT00334646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079291|NCT00334646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65079292|NCT00334646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65079293|NCT00334646|Alkylating Agents|alkylating agents|mesh-ancestor
65079294|NCT00334646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079295|NCT00334646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079296|NCT00334646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65079297|NCT00334646|Antiemetics|antiemetics|mesh-ancestor
65079298|NCT00334646|Autonomic Agents|autonomic agents|mesh-ancestor
65079299|NCT00334646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65079300|NCT00334646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65079301|NCT00334646|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65079302|NCT00334646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65079303|NCT04701606|Artesunate|artesunate|mesh-list
65079304|NCT04701606|Pyronaridine|pyronaridine|mesh-list
65079305|NCT04701606|Antimalarials|antimalarials|mesh-ancestor
65079306|NCT04701606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65079307|NCT04701606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65079308|NCT04701606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65079309|NCT04701606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079310|NCT04701606|Antiviral Agents|antiviral agents|mesh-ancestor
65079311|NCT04701606|Schistosomicides|schistosomicides|mesh-ancestor
65079312|NCT04701606|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65079313|NCT04701606|Anthelmintics|anthelmintics|mesh-ancestor
65079314|NCT00334685|Pregabalin|pregabalin|mesh-list
65079315|NCT00334685|Reboxetine|reboxetine|mesh-list
65079316|NCT00334685|Analgesics|analgesics|mesh-ancestor
65079318|NCT00334685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65079319|NCT00334685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079320|NCT00334685|Anticonvulsants|anticonvulsants|mesh-ancestor
65079321|NCT00334685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65079322|NCT00334685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65079323|NCT00334685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079324|NCT00334685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65079325|NCT00334685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65079326|NCT00334685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65079327|NCT00334685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65079328|NCT00334685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65079329|NCT00334685|Antidepressive Agents|antidepressive agents|mesh-ancestor
65079330|NCT00334685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65079331|NCT00334685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65079332|NCT00334685|Adrenergic Agents|adrenergic agents|mesh-ancestor
65079333|NCT00334685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65079334|NCT00436371|Amisulpride|amisulpride|mesh-list
65079335|NCT00436371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65079336|NCT00436371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64325124|NCT03164109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325125|NCT03164109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325126|NCT03164109|Antioxidants|antioxidants|mesh-ancestor
64325127|NCT03164109|Protective Agents|protective agents|mesh-ancestor
65079337|NCT00436371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65079338|NCT00436371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079339|NCT00436371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65079340|NCT00436371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65079341|NCT00436371|Dopamine Agents|dopamine agents|mesh-ancestor
65079342|NCT00436371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65079343|NCT00436371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079344|NCT00436371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65079345|NCT00436371|Antidepressive Agents|antidepressive agents|mesh-ancestor
65079346|NCT00334763|Paclitaxel|paclitaxel|mesh-list
65079347|NCT00334763|Bevacizumab|bevacizumab|mesh-list
65079348|NCT00334763|Carboplatin|carboplatin|mesh-list
65079349|NCT00334763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65079350|NCT00334763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079351|NCT00334763|Tubulin Modulators|tubulin modulators|mesh-ancestor
65079352|NCT00334763|Antimitotic Agents|antimitotic agents|mesh-ancestor
65079353|NCT00334763|Mitosis Modulators|mitosis modulators|mesh-ancestor
65079354|NCT00334763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079355|NCT00334763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65079356|NCT00334763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65079357|NCT00334763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65079358|NCT00334763|Growth Substances|growth substances|mesh-ancestor
65079359|NCT00334763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079360|NCT00334763|Growth Inhibitors|growth inhibitors|mesh-ancestor
64483001|NCT03153657|Piroxicam|piroxicam|mesh-list
65079361|NCT00436722|Immunoglobulins|immunoglobulins|mesh-list
65079362|NCT00436722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65079363|NCT00436722|Immunologic Factors|immunologic factors|mesh-ancestor
65079364|NCT00436722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079365|NCT00436722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65079366|NCT00334880|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65079367|NCT00334880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65079368|NCT00334880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079369|NCT00334880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65079370|NCT00334880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65079371|NCT00334880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65079372|NCT00334880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079373|NCT00334880|Dopamine Agents|dopamine agents|mesh-ancestor
65079374|NCT00334880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65079375|NCT00436761|Cyclosporine|cyclosporine|mesh-list
65079376|NCT00436761|Methylprednisolone|methylprednisolone|mesh-list
65079377|NCT00436761|Melphalan|melphalan|mesh-list
65079378|NCT00436761|Busulfan|busulfan|mesh-list
65079379|NCT00436761|Cyclosporins|cyclosporins|mesh-list
65079380|NCT00436761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65079381|NCT00436761|Sargramostim|sargramostim|mesh-list
65079382|NCT00436761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079383|NCT00436761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079384|NCT00436761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65079385|NCT00436761|Immunologic Factors|immunologic factors|mesh-ancestor
65079386|NCT00436761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079387|NCT00436761|Antifungal Agents|antifungal agents|mesh-ancestor
65079388|NCT00436761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65079389|NCT00436761|Dermatologic Agents|dermatologic agents|mesh-ancestor
65079390|NCT00436761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65079391|NCT00436761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65079392|NCT00436761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65079393|NCT00436761|Antiemetics|antiemetics|mesh-ancestor
65079394|NCT00436761|Autonomic Agents|autonomic agents|mesh-ancestor
65079395|NCT00436761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65079396|NCT00436761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65079397|NCT00436761|Glucocorticoids|glucocorticoids|mesh-ancestor
65079398|NCT00436761|Hormones|hormones|mesh-ancestor
65079399|NCT00436761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65079400|NCT00436761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65079401|NCT00436761|Protective Agents|protective agents|mesh-ancestor
65079402|NCT00436761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079403|NCT00436761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64410241|NCT04340141|Leucovorin|leucovorin|mesh-list
65079404|NCT00436761|Alkylating Agents|alkylating agents|mesh-ancestor
65079405|NCT00436761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65079406|NCT00334919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
65079407|NCT00436800|Gemcitabine|gemcitabine|mesh-list
65079408|NCT00436800|Oxaliplatin|oxaliplatin|mesh-list
65079409|NCT00436800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65079410|NCT00436800|Antimetabolites|antimetabolites|mesh-ancestor
65079411|NCT00436800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079412|NCT00436800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079413|NCT00436800|Antiviral Agents|antiviral agents|mesh-ancestor
65079414|NCT00436800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65079415|NCT00436800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079416|NCT00436800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65079417|NCT00436800|Immunologic Factors|immunologic factors|mesh-ancestor
65079418|NCT00436800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079419|NCT00436839|Prednisone|prednisone|mesh-list
65079420|NCT00436839|Docetaxel|docetaxel|mesh-list
64721516|NCT00002420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65079421|NCT00436839|Mitoxantrone|mitoxantrone|mesh-list
65079422|NCT00436839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079423|NCT00436839|Tubulin Modulators|tubulin modulators|mesh-ancestor
65079425|NCT00436839|Mitosis Modulators|mitosis modulators|mesh-ancestor
65079426|NCT00436839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079427|NCT00436839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65079428|NCT00436839|Glucocorticoids|glucocorticoids|mesh-ancestor
65079429|NCT00436839|Hormones|hormones|mesh-ancestor
65079430|NCT00436839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65079431|NCT00436839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079432|NCT00436839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65079433|NCT00436839|Analgesics|analgesics|mesh-ancestor
65079434|NCT00436839|Sensory System Agents|sensory system agents|mesh-ancestor
65079435|NCT00436839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65079436|NCT00436839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65079437|NCT00436839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65079438|NCT00436839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079439|NCT00335075|Temozolomide|temozolomide|mesh-list
65079440|NCT00335075|Semustine|semustine|mesh-list
65079441|NCT00335075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65079442|NCT00335075|Alkylating Agents|alkylating agents|mesh-ancestor
65079443|NCT00335075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079444|NCT00335075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079445|NCT00436995|Darbepoetin alfa|darbepoetin alfa|mesh-list
65079446|NCT00436995|Hematinics|hematinics|mesh-ancestor
65079447|NCT00335114|Cyclosporine|cyclosporine|mesh-list
65079448|NCT00335114|Cyclosporins|cyclosporins|mesh-list
65079449|NCT00335114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079450|NCT00335114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079451|NCT00335114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65079452|NCT00335114|Immunologic Factors|immunologic factors|mesh-ancestor
65079453|NCT00335114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079454|NCT00335114|Antifungal Agents|antifungal agents|mesh-ancestor
65079455|NCT00335114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65079456|NCT00335114|Dermatologic Agents|dermatologic agents|mesh-ancestor
65079457|NCT00335114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65079458|NCT00335114|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65079459|NCT04716179|Hormones|hormones|mesh-list
65079460|NCT04716179|Testosterone|testosterone|mesh-list
64652091|NCT03217292|Tramadol|tramadol|mesh-list
64834026|NCT04463498|Autonomic Agents|autonomic agents|mesh-ancestor
64834027|NCT04463498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64834028|NCT04463498|Dopamine Agents|dopamine agents|mesh-ancestor
64834029|NCT04463498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64834030|NCT04463498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834031|NCT04463498|Adrenergic Agents|adrenergic agents|mesh-ancestor
64834032|NCT04463498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64834034|NCT04463498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65079461|NCT04716179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65079462|NCT04716179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079463|NCT04716179|Androgens|androgens|mesh-ancestor
65079464|NCT00437229|Dexamethasone|dexamethasone|mesh-list
65079465|NCT00437229|Dexamethasone acetate|dexamethasone acetate|mesh-list
65079466|NCT00437229|Ondansetron|ondansetron|mesh-list
65079467|NCT00437229|Casopitant|casopitant|mesh-list
65079468|NCT00437229|BB 1101|bb 1101|mesh-list
65079469|NCT00437229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65079470|NCT00437229|Antiemetics|antiemetics|mesh-ancestor
65079471|NCT00437229|Autonomic Agents|autonomic agents|mesh-ancestor
65079472|NCT00437229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65079473|NCT00437229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079474|NCT00437229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65079475|NCT00437229|Glucocorticoids|glucocorticoids|mesh-ancestor
65079476|NCT00437229|Hormones|hormones|mesh-ancestor
65079477|NCT00437229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65079478|NCT00437229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65079479|NCT00437229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079480|NCT00437229|Protease Inhibitors|protease inhibitors|mesh-ancestor
65079481|NCT00437229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079482|NCT00437229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079483|NCT00437229|Antipruritics|antipruritics|mesh-ancestor
65079484|NCT00437229|Dermatologic Agents|dermatologic agents|mesh-ancestor
65079485|NCT00437229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65079486|NCT00437229|Serotonin Agents|serotonin agents|mesh-ancestor
65079487|NCT00437229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65079488|NCT00437229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65079489|NCT00437229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65079490|NCT00437229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65079491|NCT00437229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65079492|NCT00437229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65079493|NCT00437229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65079494|NCT00335192|Tenofovir|tenofovir|mesh-list
65079495|NCT00335192|Lamivudine|lamivudine|mesh-list
65079496|NCT00335192|Abacavir|abacavir|mesh-list
65079497|NCT00335192|Antiviral Agents|antiviral agents|mesh-ancestor
65079498|NCT00335192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65079499|NCT00335192|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65079500|NCT00335192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65079501|NCT00335192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079502|NCT00335192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079503|NCT00335192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65079504|NCT00335192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65079505|NCT00437307|Topotecan|topotecan|mesh-list
65079506|NCT00437307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65079507|NCT00437307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65079508|NCT00437307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079509|NCT00437307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079510|NCT00437307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079511|NCT00335231|Gatifloxacin|gatifloxacin|mesh-list
65079512|NCT00335231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65079513|NCT00335231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65079514|NCT00335231|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65079515|NCT00335231|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65079516|NCT00335231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65079517|NCT00335231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65079518|NCT00335231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079519|NCT00335231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834036|NCT04456296|Methyltestosterone|methyltestosterone|mesh-list
64834037|NCT04456296|Testosterone|testosterone|mesh-list
64834038|NCT04456296|Testosterone undecanoate|testosterone undecanoate|mesh-list
64834039|NCT04456296|Testosterone enanthate|testosterone enanthate|mesh-list
64834040|NCT04456296|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64834041|NCT04456296|Androgens|androgens|mesh-ancestor
65079520|NCT00335231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079522|NCT00335270|Amprenavir|amprenavir|mesh-list
65079523|NCT00335270|Fosamprenavir|fosamprenavir|mesh-list
65079524|NCT00335270|Lamivudine|lamivudine|mesh-list
65079525|NCT00335270|Abacavir|abacavir|mesh-list
65079526|NCT00335270|Calcium|calcium|mesh-list
65079527|NCT00335270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65079528|NCT00335270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079529|NCT00335270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65079530|NCT00335270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65079531|NCT00335270|Protease Inhibitors|protease inhibitors|mesh-ancestor
65079532|NCT00335270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079533|NCT00335270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079534|NCT00335270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65079535|NCT00335270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65079536|NCT00335270|Antiviral Agents|antiviral agents|mesh-ancestor
65079537|NCT00335270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65079538|NCT00335270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65079539|NCT00335270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65079540|NCT00335270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65079541|NCT00335270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65079542|NCT00335270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65079543|NCT00335270|Antitubercular Agents|antitubercular agents|mesh-ancestor
65079544|NCT00335270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65079545|NCT00437385|Lithium Carbonate|lithium carbonate|mesh-list
65079546|NCT00437385|Antidepressive Agents|antidepressive agents|mesh-ancestor
65079547|NCT00437385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65079548|NCT00437385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079549|NCT00437385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079550|NCT00437385|Antimanic Agents|antimanic agents|mesh-ancestor
65079551|NCT00437385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65079552|NCT00437385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65079553|NCT00437385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079554|NCT00335309|Amoxicillin|amoxicillin|mesh-list
65079555|NCT00335309|Clavulanic Acid|clavulanic acid|mesh-list
65079556|NCT00335309|Clavulanic Acids|clavulanic acids|mesh-list
65079557|NCT00335309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65079558|NCT00335309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65079559|NCT00335309|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65079560|NCT00335309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079561|NCT00335309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079562|NCT00335348|Dexamethasone|dexamethasone|mesh-list
65079563|NCT00335348|Bortezomib|bortezomib|mesh-list
65079564|NCT00335348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65079565|NCT00335348|Antiemetics|antiemetics|mesh-ancestor
65079566|NCT00335348|Autonomic Agents|autonomic agents|mesh-ancestor
65079567|NCT00335348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65079568|NCT00335348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079569|NCT00335348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65079570|NCT00335348|Glucocorticoids|glucocorticoids|mesh-ancestor
65079571|NCT00335348|Hormones|hormones|mesh-ancestor
65079572|NCT00335348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65079573|NCT00335348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65079574|NCT00335348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079575|NCT00437463|Ramipril|ramipril|mesh-list
65079576|NCT00437463|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65079577|NCT00437463|Protease Inhibitors|protease inhibitors|mesh-ancestor
65079578|NCT00437463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079579|NCT00437463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079580|NCT00437463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65079581|NCT00437502|Vaccines|vaccines|mesh-list
65079582|NCT00437502|Immunologic Factors|immunologic factors|mesh-ancestor
65079583|NCT00437502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079584|NCT00420797|Phenylephrine|phenylephrine|mesh-list
65079585|NCT00420797|Oxymetazoline|oxymetazoline|mesh-list
65079586|NCT00420797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65079587|NCT00420797|Mydriatics|mydriatics|mesh-ancestor
65079588|NCT00420797|Autonomic Agents|autonomic agents|mesh-ancestor
65079589|NCT00420797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65079590|NCT00420797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079591|NCT00420797|Sympathomimetics|sympathomimetics|mesh-ancestor
65079592|NCT00420797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65079593|NCT00420797|Nasal Decongestants|nasal decongestants|mesh-ancestor
65079594|NCT00420797|Respiratory System Agents|respiratory system agents|mesh-ancestor
65079595|NCT00420797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65079596|NCT00420797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65079597|NCT00420797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65079598|NCT00420797|Adrenergic Agents|adrenergic agents|mesh-ancestor
65079599|NCT00420797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65079600|NCT00420797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079601|NCT00420797|Protective Agents|protective agents|mesh-ancestor
65079602|NCT00437619|Calcipotriene|calcipotriene|mesh-list
65079603|NCT00437619|Dermatologic Agents|dermatologic agents|mesh-ancestor
65079604|NCT00420836|Tobramycin|tobramycin|mesh-list
65079605|NCT00420836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65079606|NCT00420836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65079607|NCT00437697|Dalteparin|dalteparin|mesh-list
65079608|NCT00437697|Tinzaparin|tinzaparin|mesh-list
65079609|NCT00437697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65079610|NCT00437697|Anticoagulants|anticoagulants|mesh-ancestor
65079611|NCT00437697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65079612|NCT00437697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65079613|NCT00437697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079614|NCT00335465|Insulin Glargine|insulin glargine|mesh-list
65079615|NCT00335465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65079616|NCT00335465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079617|NCT00335543|Gemcitabine|gemcitabine|mesh-list
65079618|NCT00335543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079619|NCT00335543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65079620|NCT00335543|Antimetabolites|antimetabolites|mesh-ancestor
65079621|NCT00335543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079622|NCT00335543|Antiviral Agents|antiviral agents|mesh-ancestor
65079623|NCT00335543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65079624|NCT00335543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079625|NCT00335543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65079626|NCT00335543|Immunologic Factors|immunologic factors|mesh-ancestor
65079627|NCT00335543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079628|NCT00437814|Ketamine|ketamine|mesh-list
65079629|NCT00437814|Analgesics|analgesics|mesh-ancestor
65079630|NCT00437814|Sensory System Agents|sensory system agents|mesh-ancestor
65079631|NCT00437814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65079632|NCT00437814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079633|NCT00437814|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65079634|NCT00437814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65079635|NCT00437814|Anesthetics, General|anesthetics, general|mesh-ancestor
65079636|NCT00437814|Anesthetics|anesthetics|mesh-ancestor
65079637|NCT00437814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65079638|NCT00437814|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65079639|NCT00437814|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65079640|NCT00437814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65079641|NCT00437814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079642|NCT00335582|Clonidine|clonidine|mesh-list
65079643|NCT00335582|Analgesics|analgesics|mesh-ancestor
65079644|NCT00335582|Sensory System Agents|sensory system agents|mesh-ancestor
65079645|NCT00335582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65079646|NCT00335582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079647|NCT00335582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65079648|NCT00335582|Sympatholytics|sympatholytics|mesh-ancestor
65079649|NCT00335582|Autonomic Agents|autonomic agents|mesh-ancestor
65079650|NCT00335582|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65079651|NCT00335582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65079652|NCT00335582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65079653|NCT00335582|Adrenergic Agents|adrenergic agents|mesh-ancestor
65079654|NCT00335582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65079655|NCT00335582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079656|NCT00437853|Anastrozole|anastrozole|mesh-list
65079657|NCT00437853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65079658|NCT00437853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079659|NCT00437853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65079660|NCT00437853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65079661|NCT00437853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079662|NCT00437853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079663|NCT00437853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65079664|NCT00437853|Hormone Antagonists|hormone antagonists|mesh-ancestor
65079665|NCT00437853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65079666|NCT00437853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079667|NCT00335621|Tiotropium Bromide|tiotropium bromide|mesh-list
65079668|NCT00335621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65079669|NCT00335621|Autonomic Agents|autonomic agents|mesh-ancestor
65079670|NCT00335621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65079671|NCT00335621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079672|NCT00335621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65079673|NCT00335621|Respiratory System Agents|respiratory system agents|mesh-ancestor
65079674|NCT00335621|Parasympatholytics|parasympatholytics|mesh-ancestor
65079675|NCT00335621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65079676|NCT00335621|Cholinergic Agents|cholinergic agents|mesh-ancestor
65079677|NCT00335621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65079678|NCT00335621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079679|NCT00437892|Atorvastatin|atorvastatin|mesh-list
65079680|NCT00437892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65079681|NCT00437892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65079682|NCT00437892|Antimetabolites|antimetabolites|mesh-ancestor
65079683|NCT00437892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079684|NCT00437892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65079685|NCT00437892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65079686|NCT00437892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079687|NCT00437970|Metformin|metformin|mesh-list
65079688|NCT00437970|Pioglitazone|pioglitazone|mesh-list
65079689|NCT00437970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65079690|NCT00437970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079691|NCT00335699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65079692|NCT00335699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65079693|NCT00335699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65079694|NCT00335699|Antimetabolites|antimetabolites|mesh-ancestor
65079695|NCT00335699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079696|NCT00335699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65079697|NCT00335699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65079698|NCT00335699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079699|NCT03277170|Montelukast|montelukast|mesh-list
65079700|NCT03277170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65079701|NCT03277170|Respiratory System Agents|respiratory system agents|mesh-ancestor
65079702|NCT03277170|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65079703|NCT03277170|Hormone Antagonists|hormone antagonists|mesh-ancestor
65079704|NCT03277170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65079705|NCT03277170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079706|NCT03277170|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65079707|NCT03277170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65079708|NCT03277170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079709|NCT00335933|Gabapentin|gabapentin|mesh-list
65079710|NCT00335933|Analgesics|analgesics|mesh-ancestor
65079711|NCT00335933|Sensory System Agents|sensory system agents|mesh-ancestor
65079712|NCT00335933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65079713|NCT00335933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079714|NCT00335933|Anticonvulsants|anticonvulsants|mesh-ancestor
65079715|NCT00335933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64834048|NCT04408118|Paclitaxel|paclitaxel|mesh-list
64834049|NCT04408118|Atezolizumab|atezolizumab|mesh-list
64834050|NCT04408118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64411886|NCT04981093|Dexamethasone|dexamethasone|mesh-list
65079716|NCT00335933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65079717|NCT00335933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65079718|NCT00335933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65079719|NCT00335933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65079720|NCT00335933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65079721|NCT00335933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64721833|NCT02360059|Metformin|metformin|mesh-list
65079722|NCT00335933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079723|NCT00335933|Antimanic Agents|antimanic agents|mesh-ancestor
65079724|NCT00336167|Bezafibrate|bezafibrate|mesh-list
65079725|NCT00336167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65079726|NCT00336167|Antimetabolites|antimetabolites|mesh-ancestor
65079727|NCT00336167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079728|NCT00336167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65079729|NCT00336206|Alemtuzumab|alemtuzumab|mesh-list
65079730|NCT00336206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65079731|NCT00336206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079732|NCT00336245|Copper|copper|mesh-list
65079733|NCT00336245|Contraceptive Agents|contraceptive agents|mesh-list
65079734|NCT00336245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65079735|NCT00336245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079736|NCT00336245|Trace Elements|trace elements|mesh-ancestor
65079737|NCT00336245|Micronutrients|micronutrients|mesh-ancestor
65079738|NCT00336362|Hydroxyurea|hydroxyurea|mesh-list
65079739|NCT00336362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079740|NCT00336362|Antisickling Agents|antisickling agents|mesh-ancestor
65079741|NCT00336362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079742|NCT00336362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079743|NCT00336362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65079744|NCT00336401|Propofol|propofol|mesh-list
65079745|NCT00336401|Sevoflurane|sevoflurane|mesh-list
65079746|NCT00336401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65079747|NCT00336401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65079748|NCT00336401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079749|NCT00336401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65079750|NCT00336401|Anesthetics, General|anesthetics, general|mesh-ancestor
65079751|NCT00336401|Anesthetics|anesthetics|mesh-ancestor
65079752|NCT00336401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65079753|NCT00336401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65079754|NCT00336518|Ribavirin|ribavirin|mesh-list
65079755|NCT00336518|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65079756|NCT00336518|Antimetabolites|antimetabolites|mesh-ancestor
65079757|NCT00336518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079758|NCT00336518|Antiviral Agents|antiviral agents|mesh-ancestor
65079759|NCT00336518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65079760|NCT03277872|Pyrithione zinc|pyrithione zinc|mesh-list
65079761|NCT03277872|Keratolytic Agents|keratolytic agents|mesh-ancestor
65079762|NCT03277872|Dermatologic Agents|dermatologic agents|mesh-ancestor
65079763|NCT00347490|Enoxaparin|enoxaparin|mesh-list
64834051|NCT04408118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834052|NCT04408118|Tubulin Modulators|tubulin modulators|mesh-ancestor
64834053|NCT04408118|Antimitotic Agents|antimitotic agents|mesh-ancestor
64834054|NCT04408118|Mitosis Modulators|mitosis modulators|mesh-ancestor
64834055|NCT04408118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834056|NCT04403321|Tacrolimus|tacrolimus|mesh-list
64834057|NCT04403321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64834058|NCT04403321|Immunologic Factors|immunologic factors|mesh-ancestor
64834059|NCT04403321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834060|NCT04403321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64834061|NCT04403321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445237|NCT05651789|Antioxidants|antioxidants|mesh-ancestor
65079764|NCT00347490|Anticoagulants|anticoagulants|mesh-ancestor
65079765|NCT00347490|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65079766|NCT00347490|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65079767|NCT00347490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079768|NCT00336674|Insulin|insulin|mesh-list
65079769|NCT00336674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65079770|NCT00336674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079771|NCT00444522|Alprazolam|alprazolam|mesh-list
65079772|NCT00444522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65079773|NCT00444522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65079774|NCT00444522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079775|NCT00444522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65079776|NCT00444522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65079777|NCT00444522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65079778|NCT00444522|GABA Modulators|gaba modulators|mesh-ancestor
65079779|NCT00444522|GABA Agents|gaba agents|mesh-ancestor
65079780|NCT00444522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65079781|NCT00444522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079782|NCT00336791|Paclitaxel|paclitaxel|mesh-list
65079783|NCT00336791|Cyclophosphamide|cyclophosphamide|mesh-list
65079784|NCT00336791|Doxorubicin|doxorubicin|mesh-list
65079785|NCT00336791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65079786|NCT00336791|Fluorouracil|fluorouracil|mesh-list
65079787|NCT00336791|Epirubicin|epirubicin|mesh-list
65079788|NCT00336791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65079789|NCT00336791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079790|NCT00336791|Tubulin Modulators|tubulin modulators|mesh-ancestor
65079791|NCT00336791|Antimitotic Agents|antimitotic agents|mesh-ancestor
65079792|NCT00336791|Mitosis Modulators|mitosis modulators|mesh-ancestor
65079793|NCT00336791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079794|NCT00336791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65079795|NCT00336791|Immunologic Factors|immunologic factors|mesh-ancestor
65079796|NCT00336791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079797|NCT00336791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65079798|NCT00336791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65079800|NCT00336791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65079801|NCT00336791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65079802|NCT00336791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65079803|NCT00336791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65079804|NCT00336791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079805|NCT00336791|Antimetabolites|antimetabolites|mesh-ancestor
65079806|NCT00336791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65079807|NCT00444561|Pramlintide|pramlintide|mesh-list
65079808|NCT00444561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65079809|NCT00444561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079810|NCT00444639|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65079811|NCT00444639|Luteolytic Agents|luteolytic agents|mesh-ancestor
65079812|NCT00444639|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65079813|NCT00444639|Contraceptive Agents|contraceptive agents|mesh-ancestor
65079814|NCT00444639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65079815|NCT00444639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079816|NCT00444639|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65079817|NCT00444639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65079818|NCT00444639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079819|NCT00336947|Tegafur|tegafur|mesh-list
65079820|NCT00336947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65079821|NCT00336947|Antimetabolites|antimetabolites|mesh-ancestor
65079822|NCT00336947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079823|NCT00336947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079825|NCT00444717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65079826|NCT00444717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65079827|NCT00444717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65079828|NCT00444717|Antimetabolites|antimetabolites|mesh-ancestor
65079829|NCT00444717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325128|NCT02152787|Propofol|propofol|mesh-list
64325129|NCT02152787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64412737|NCT05678933|Glucocorticoids|glucocorticoids|mesh-ancestor
65079830|NCT00444717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079831|NCT00444717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65079832|NCT00347646|Fibrinolysin|fibrinolysin|mesh-list
65079833|NCT00347646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65079834|NCT00347646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65079835|NCT00347646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079836|NCT00421317|Imatinib Mesylate|imatinib mesylate|mesh-list
65079837|NCT00421317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079838|NCT00421317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65079839|NCT00421317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079840|NCT00421317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079841|NCT00337259|Gemcitabine|gemcitabine|mesh-list
65079842|NCT00337259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65079843|NCT00337259|Antimetabolites|antimetabolites|mesh-ancestor
65079844|NCT00337259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079845|NCT00337259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079846|NCT00337259|Antiviral Agents|antiviral agents|mesh-ancestor
65079847|NCT00337259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65079848|NCT00337259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079849|NCT00337259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65079850|NCT00337259|Immunologic Factors|immunologic factors|mesh-ancestor
65079851|NCT00337259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079852|NCT04699734|Lidocaine|lidocaine|mesh-list
65079853|NCT04699734|Anesthetics, Local|anesthetics, local|mesh-ancestor
65079854|NCT04699734|Anesthetics|anesthetics|mesh-ancestor
65079855|NCT04699734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65079856|NCT04699734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079857|NCT04699734|Sensory System Agents|sensory system agents|mesh-ancestor
65079858|NCT04699734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65079859|NCT04699734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65079860|NCT04699734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65079861|NCT04699734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65079862|NCT04699734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65079863|NCT04699734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079864|NCT00337298|Amlodipine|amlodipine|mesh-list
65079865|NCT00337298|Lisinopril|lisinopril|mesh-list
65079866|NCT00337298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65079867|NCT00337298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65079868|NCT00337298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65079869|NCT00337298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079870|NCT00337298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65079872|NCT00337298|Vasodilator Agents|vasodilator agents|mesh-ancestor
65079873|NCT00337298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65079874|NCT00337298|Protease Inhibitors|protease inhibitors|mesh-ancestor
65079875|NCT00337298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079876|NCT00337298|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65079877|NCT00337298|Protective Agents|protective agents|mesh-ancestor
65079878|NCT00337376|Sirolimus|sirolimus|mesh-list
65079879|NCT00337376|Paclitaxel|paclitaxel|mesh-list
65079880|NCT00337376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65079881|NCT00337376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65079882|NCT00337376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834062|NCT04403321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834064|NCT04332744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64834065|NCT04332744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079883|NCT00337376|Tubulin Modulators|tubulin modulators|mesh-ancestor
65079884|NCT00337376|Antimitotic Agents|antimitotic agents|mesh-ancestor
65079885|NCT00337376|Mitosis Modulators|mitosis modulators|mesh-ancestor
65079886|NCT00337376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079887|NCT00337376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65079888|NCT00337376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65079889|NCT00337376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65079890|NCT00337376|Antifungal Agents|antifungal agents|mesh-ancestor
65079891|NCT00337376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65079892|NCT00337376|Immunologic Factors|immunologic factors|mesh-ancestor
65079893|NCT00337376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079894|NCT00337493|Cyclosporine|cyclosporine|mesh-list
65079895|NCT00337493|Mycophenolic Acid|mycophenolic acid|mesh-list
65079896|NCT00337493|Tacrolimus|tacrolimus|mesh-list
65079897|NCT00337493|Cyclosporins|cyclosporins|mesh-list
65079898|NCT00337493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65079899|NCT00337493|Immunologic Factors|immunologic factors|mesh-ancestor
65079900|NCT00337493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079901|NCT00337493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65079902|NCT00337493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079903|NCT00337493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079904|NCT00337493|Antifungal Agents|antifungal agents|mesh-ancestor
65079905|NCT00337493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65079906|NCT00337493|Dermatologic Agents|dermatologic agents|mesh-ancestor
65079907|NCT00337493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65079908|NCT00337493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65079909|NCT00337493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079910|NCT00337493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65079911|NCT00337493|Antitubercular Agents|antitubercular agents|mesh-ancestor
65079912|NCT00337493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65079913|NCT00444756|Lidocaine|lidocaine|mesh-list
65079914|NCT00444756|Anesthetics, Local|anesthetics, local|mesh-ancestor
65079915|NCT00444756|Anesthetics|anesthetics|mesh-ancestor
65079916|NCT00444756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65079917|NCT00444756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079918|NCT00444756|Sensory System Agents|sensory system agents|mesh-ancestor
65079919|NCT00444756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65079920|NCT00444756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65079921|NCT00444756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65079922|NCT00444756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65079923|NCT00444756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65079924|NCT00444756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079934|NCT00444834|Carvedilol|carvedilol|mesh-list
65079935|NCT00444834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65079936|NCT00444834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65079937|NCT00444834|Adrenergic Agents|adrenergic agents|mesh-ancestor
65079938|NCT00444834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65079939|NCT00444834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079940|NCT00444834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079941|NCT00444834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64834066|NCT04332744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834067|NCT04332744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834068|NCT04265755|Erenumab|erenumab|mesh-list
64834069|NCT04265755|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64834070|NCT04265755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834071|NCT04265755|Analgesics|analgesics|mesh-ancestor
64834072|NCT04265755|Sensory System Agents|sensory system agents|mesh-ancestor
64834073|NCT04265755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64834074|NCT04265755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834075|NCT04246372|Tofacitinib|tofacitinib|mesh-list
64834076|NCT04246372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65079943|NCT00444834|Protective Agents|protective agents|mesh-ancestor
65079944|NCT00444834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65079945|NCT00444834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65079946|NCT00444834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65079947|NCT00444834|Vasodilator Agents|vasodilator agents|mesh-ancestor
65079948|NCT00444834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65079949|NCT00444834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65079950|NCT00337766|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
65079951|NCT00337766|Hemostatics|hemostatics|mesh-ancestor
65079952|NCT00337766|Coagulants|coagulants|mesh-ancestor
65079953|NCT00337766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65079954|NCT00337766|Natriuretic Agents|natriuretic agents|mesh-ancestor
65079955|NCT00337766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079956|NCT00444873|Lanreotide|lanreotide|mesh-list
65079957|NCT00444873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079958|NCT00337805|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65079959|NCT00337805|Plasma Substitutes|plasma substitutes|mesh-ancestor
65079960|NCT00337805|Blood Substitutes|blood substitutes|mesh-ancestor
65079961|NCT00337883|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65079962|NCT00337883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65079963|NCT00337883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65079964|NCT00337883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079965|NCT00337883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079966|NCT00451113|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65079967|NCT00451113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65079968|NCT00451113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65079969|NCT00451113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079970|NCT00451113|Incretins|incretins|mesh-ancestor
65079971|NCT00451113|Hormones|hormones|mesh-ancestor
65079972|NCT00451113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65079973|NCT00451113|Protease Inhibitors|protease inhibitors|mesh-ancestor
65079974|NCT00451113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079975|NCT00451113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079976|NCT00337922|Lamivudine|lamivudine|mesh-list
65079977|NCT00337922|Abacavir|abacavir|mesh-list
65079978|NCT00337922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65079979|NCT00337922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65079980|NCT00337922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65079981|NCT00337922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65079982|NCT00337922|Antiviral Agents|antiviral agents|mesh-ancestor
65079983|NCT00337922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65079984|NCT00337922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65079985|NCT00337922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65079986|NCT00451230|Hydrocortisone|hydrocortisone|mesh-list
65079987|NCT00451230|Cocaine|cocaine|mesh-list
65079988|NCT00451230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65079989|NCT00451230|Anesthetics, Local|anesthetics, local|mesh-ancestor
65079990|NCT00451230|Anesthetics|anesthetics|mesh-ancestor
65079991|NCT00451230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65079992|NCT00451230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65079993|NCT00451230|Sensory System Agents|sensory system agents|mesh-ancestor
65079994|NCT00451230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65079995|NCT00451230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65079996|NCT00451230|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65079997|NCT00451230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65079998|NCT00451230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65079999|NCT00451230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080000|NCT00451230|Dopamine Agents|dopamine agents|mesh-ancestor
65080001|NCT00451230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65080002|NCT00338000|Epoetin Alfa|epoetin alfa|mesh-list
65080003|NCT00338000|Hematinics|hematinics|mesh-ancestor
65080004|NCT00338117|Galantamine|galantamine|mesh-list
65080005|NCT00338117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65080006|NCT00338117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080007|NCT00338117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080008|NCT00338117|Cholinergic Agents|cholinergic agents|mesh-ancestor
65080009|NCT00338117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65080010|NCT00338117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080011|NCT00338117|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65080012|NCT00338117|Autonomic Agents|autonomic agents|mesh-ancestor
65080013|NCT00338117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65080014|NCT00338117|Nootropic Agents|nootropic agents|mesh-ancestor
65080015|NCT00338195|Caffeine|caffeine|mesh-list
65080016|NCT00338195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65080017|NCT00338195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080018|NCT00338195|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65080019|NCT00338195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080020|NCT00338195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080021|NCT00338195|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65080022|NCT00338195|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65080023|NCT00338195|Purinergic Agents|purinergic agents|mesh-ancestor
65080024|NCT00338195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65080026|NCT00338273|Antidepressive Agents|antidepressive agents|mesh-ancestor
64834077|NCT04246372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834078|NCT04246372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834079|NCT04229771|Proxymetacaine|proxymetacaine|mesh-list
64834080|NCT04229771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64834081|NCT04229771|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64834082|NCT04229771|Anesthetics, Local|anesthetics, local|mesh-ancestor
64834083|NCT04229771|Anesthetics|anesthetics|mesh-ancestor
64834084|NCT04229771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64834085|NCT04229771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834086|NCT04229771|Sensory System Agents|sensory system agents|mesh-ancestor
64834087|NCT04229771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64834088|NCT04217278|Cytarabine|cytarabine|mesh-list
64325130|NCT02152787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64325131|NCT02152787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325132|NCT02152787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64325133|NCT02152787|Anesthetics, General|anesthetics, general|mesh-ancestor
64325134|NCT02152787|Anesthetics|anesthetics|mesh-ancestor
64325135|NCT00154375|Imatinib Mesylate|imatinib mesylate|mesh-list
64414217|NCT02457195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080027|NCT00338273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65080028|NCT00338273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65080029|NCT00338273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65080030|NCT00338273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65080031|NCT00338273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080032|NCT00338273|Dopamine Agonists|dopamine agonists|mesh-ancestor
65080033|NCT00338273|Dopamine Agents|dopamine agents|mesh-ancestor
65080034|NCT00338273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65080035|NCT00338273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080036|NCT00338273|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65080037|NCT00338273|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65080038|NCT00338273|Serotonin Agents|serotonin agents|mesh-ancestor
65080039|NCT00338273|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65080040|NCT00338273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64416379|NCT04859569|Denosumab|denosumab|mesh-list
65080041|NCT00338273|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65080042|NCT00338273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65080043|NCT00338312|Testosterone|testosterone|mesh-list
65080044|NCT00338312|Androgens|androgens|mesh-ancestor
65080045|NCT00338312|Hormones|hormones|mesh-ancestor
65080046|NCT00338312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65080047|NCT00338312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080048|NCT00451386|Ceftriaxone|ceftriaxone|mesh-list
65080049|NCT00451386|Ertapenem|ertapenem|mesh-list
65080050|NCT00451386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65080051|NCT00451386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65080052|NCT00338390|Lamivudine|lamivudine|mesh-list
65080053|NCT00338390|Abacavir|abacavir|mesh-list
65080054|NCT00338390|Dideoxynucleosides|dideoxynucleosides|mesh-list
65080055|NCT00338390|Didanosine|didanosine|mesh-list
65080056|NCT00338390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65080057|NCT00338390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65080058|NCT00338390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080059|NCT00338390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080060|NCT00338390|Antiviral Agents|antiviral agents|mesh-ancestor
65080061|NCT00338390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65080062|NCT00338390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65080063|NCT00338390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65080064|NCT00338390|Antimetabolites|antimetabolites|mesh-ancestor
65080065|NCT00338468|Epoetin Alfa|epoetin alfa|mesh-list
65080066|NCT00338468|Hematinics|hematinics|mesh-ancestor
65080067|NCT00338507|Erdosteine|erdosteine|mesh-list
65080068|NCT00338507|Expectorants|expectorants|mesh-ancestor
65080069|NCT00338507|Respiratory System Agents|respiratory system agents|mesh-ancestor
65080070|NCT00445185|Vaccines|vaccines|mesh-list
65080071|NCT00445185|Immunologic Factors|immunologic factors|mesh-ancestor
65080072|NCT00445185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080073|NCT00338546|Cocaine|cocaine|mesh-list
65080074|NCT00338546|Dexmedetomidine|dexmedetomidine|mesh-list
65080075|NCT00338546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65080076|NCT00338546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65080077|NCT00338546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080078|NCT00338546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65080079|NCT00338546|Analgesics|analgesics|mesh-ancestor
65080080|NCT00338546|Sensory System Agents|sensory system agents|mesh-ancestor
65080081|NCT00338546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65080082|NCT00338546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65080083|NCT00338546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65080084|NCT00338546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65080085|NCT00338546|Adrenergic Agents|adrenergic agents|mesh-ancestor
65080086|NCT00338546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65080087|NCT00338546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080088|NCT00338546|Anesthetics, Local|anesthetics, local|mesh-ancestor
65080089|NCT00338546|Anesthetics|anesthetics|mesh-ancestor
65080090|NCT00338546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65080091|NCT00338546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65080092|NCT00338546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65080093|NCT00338546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65080094|NCT00338546|Dopamine Agents|dopamine agents|mesh-ancestor
65080096|NCT00338624|Parasympatholytics|parasympatholytics|mesh-ancestor
65080097|NCT00338624|Autonomic Agents|autonomic agents|mesh-ancestor
65080098|NCT00338624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65080099|NCT00338624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080100|NCT00338624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65080101|NCT00338624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65080102|NCT00338624|Cholinergic Agents|cholinergic agents|mesh-ancestor
65080103|NCT00338624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65080104|NCT00338624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080105|NCT00338624|Urological Agents|urological agents|mesh-ancestor
65080106|NCT00338780|Lamivudine|lamivudine|mesh-list
65080107|NCT00338780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65080108|NCT00338780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65080109|NCT00338780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080110|NCT00338780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080111|NCT00338780|Antiviral Agents|antiviral agents|mesh-ancestor
65080112|NCT00338780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65080113|NCT00338780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65080114|NCT00338780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65080115|NCT00451620|Glyburide|glyburide|mesh-list
65080116|NCT00451620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65080117|NCT00451620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080118|NCT00445497|Amoxicillin|amoxicillin|mesh-list
65080119|NCT00445497|Ciprofloxacin|ciprofloxacin|mesh-list
65080120|NCT00445497|Clavulanic Acid|clavulanic acid|mesh-list
65080121|NCT00445497|Clavulanic Acids|clavulanic acids|mesh-list
65080122|NCT00445497|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65080123|NCT00445497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65080124|NCT00445497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65080125|NCT00445497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65080126|NCT00445497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65080127|NCT00445497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080128|NCT00445497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080129|NCT00445497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834089|NCT04217278|Fludarabine|fludarabine|mesh-list
64834090|NCT04217278|Busulfan|busulfan|mesh-list
64834091|NCT04217278|Thiotepa|thiotepa|mesh-list
64834092|NCT04217278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834093|NCT04217278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64834094|NCT04217278|Antimetabolites|antimetabolites|mesh-ancestor
64834095|NCT04217278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834096|NCT04217278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64834097|NCT04217278|Immunologic Factors|immunologic factors|mesh-ancestor
64834098|NCT04217278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834099|NCT04217278|Antiviral Agents|antiviral agents|mesh-ancestor
64834100|NCT04217278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64834101|NCT04217278|Alkylating Agents|alkylating agents|mesh-ancestor
64834102|NCT04217278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65080130|NCT00445497|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65080131|NCT00445497|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65080132|NCT00445497|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65080133|NCT00451776|Propofol|propofol|mesh-list
65080134|NCT00451776|Etomidate|etomidate|mesh-list
65080135|NCT00451776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65080136|NCT00451776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65080137|NCT00451776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080138|NCT00451776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65080139|NCT00451776|Anesthetics, General|anesthetics, general|mesh-ancestor
65080140|NCT00451776|Anesthetics|anesthetics|mesh-ancestor
65080141|NCT00338936|Valsartan|valsartan|mesh-list
65080142|NCT00338936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65080143|NCT00338936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65080144|NCT00338936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65080145|NCT00338936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65080146|NCT00338936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080147|NCT00338936|Diuretics|diuretics|mesh-ancestor
65080148|NCT00338936|Natriuretic Agents|natriuretic agents|mesh-ancestor
65080149|NCT00338936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080150|NCT00338936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65080151|NCT00338936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65080152|NCT00445575|Risedronic Acid|risedronic acid|mesh-list
65080153|NCT00445575|Etidronic Acid|etidronic acid|mesh-list
65080154|NCT00445575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65080155|NCT00445575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65080156|NCT00445575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080157|NCT00445575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65080158|NCT00445575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080159|NCT00445575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64483025|NCT01275274|Dermatologic Agents|dermatologic agents|mesh-ancestor
64483026|NCT01997333|Capecitabine|capecitabine|mesh-list
65080160|NCT00451815|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
65080161|NCT00451815|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
65080162|NCT00451815|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65080163|NCT00451815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65080164|NCT00451815|Purinergic Agents|purinergic agents|mesh-ancestor
65080165|NCT00451815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65080166|NCT00451815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080167|NCT00451815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080168|NCT00339014|Zonisamide|zonisamide|mesh-list
65080169|NCT00339014|Bupropion|bupropion|mesh-list
65080170|NCT00339014|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65080171|NCT00339014|Antidepressive Agents|antidepressive agents|mesh-ancestor
65080172|NCT00339014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65080173|NCT00339014|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65080174|NCT00339014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65080175|NCT00339014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65080176|NCT00339014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080177|NCT00339014|Dopamine Agents|dopamine agents|mesh-ancestor
65080178|NCT00339014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65080179|NCT00339014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080180|NCT00339014|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65080181|NCT00339014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65080182|NCT00339014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080183|NCT00339014|Anticonvulsants|anticonvulsants|mesh-ancestor
65080184|NCT00339014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65080185|NCT00339014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65080186|NCT00420953|Amiodarone|amiodarone|mesh-list
65080187|NCT00420953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65080188|NCT00420953|Vasodilator Agents|vasodilator agents|mesh-ancestor
65080189|NCT00420953|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
65080190|NCT00420953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65080191|NCT00420953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080192|NCT00420953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65080193|NCT00420953|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65080194|NCT00420953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65080195|NCT00420953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080196|NCT00420953|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65080197|NCT00420953|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65080198|NCT00420953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65080199|NCT03275415|Budesonide|budesonide|mesh-list
65080200|NCT03275415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65080201|NCT03275415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65080202|NCT03275415|Autonomic Agents|autonomic agents|mesh-ancestor
65080203|NCT03275415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65080204|NCT03275415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080205|NCT03275415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65080206|NCT03275415|Respiratory System Agents|respiratory system agents|mesh-ancestor
65080207|NCT03275415|Glucocorticoids|glucocorticoids|mesh-ancestor
65080208|NCT03275415|Hormones|hormones|mesh-ancestor
65080209|NCT03275415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65080210|NCT00425204|Panitumumab|panitumumab|mesh-list
65080211|NCT00425204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65080212|NCT00425204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080213|NCT00425243|Zolpidem|zolpidem|mesh-list
65080214|NCT00425243|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65080215|NCT00425243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65080216|NCT00425243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65080217|NCT00425243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080218|NCT00425243|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65080219|NCT00425243|GABA Agonists|gaba agonists|mesh-ancestor
65080220|NCT00425243|GABA Agents|gaba agents|mesh-ancestor
65080221|NCT00425243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64325136|NCT00154375|Hydroxyurea|hydroxyurea|mesh-list
64325137|NCT00154375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325138|NCT00154375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64325139|NCT00154375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64325140|NCT00154375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325141|NCT00154375|Antisickling Agents|antisickling agents|mesh-ancestor
64325142|NCT00154375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64325143|NCT02765399|Liraglutide|liraglutide|mesh-list
64834103|NCT04217278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64834104|NCT04182334|TEMPO|tempo|mesh-list
64834105|NCT04182334|Antioxidants|antioxidants|mesh-ancestor
64834106|NCT04182334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834107|NCT04182334|Protective Agents|protective agents|mesh-ancestor
64834108|NCT04182334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834109|NCT04123444|Iloprost|iloprost|mesh-list
64834110|NCT04123444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64834111|NCT04123444|Vasodilator Agents|vasodilator agents|mesh-ancestor
65080222|NCT00425243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080223|NCT00339131|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
65080224|NCT00339131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080225|NCT00339131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080226|NCT00339131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080227|NCT00339131|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64612705|NCT02978547|Metformin|metformin|mesh-list
65080228|NCT00451971|Leflunomide|leflunomide|mesh-list
65080229|NCT00451971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080230|NCT00451971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080231|NCT00451971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65080232|NCT00451971|Immunologic Factors|immunologic factors|mesh-ancestor
65080233|NCT00451971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080234|NCT00452166|Rosiglitazone|rosiglitazone|mesh-list
65080235|NCT00452166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65080236|NCT00452166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080237|NCT00446004|Imatinib Mesylate|imatinib mesylate|mesh-list
65080238|NCT00446004|Omeprazole|omeprazole|mesh-list
65080239|NCT00446004|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
65080240|NCT00446004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080241|NCT00446004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65080242|NCT00446004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080243|NCT00446004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080244|NCT00446004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65080245|NCT00446004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65080246|NCT00446043|Adapalene|adapalene|mesh-list
65080247|NCT00446043|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
65080248|NCT00446043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
65080249|NCT00446043|Dermatologic Agents|dermatologic agents|mesh-ancestor
65080250|NCT00446043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65080251|NCT00446043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65080252|NCT00446043|Analgesics|analgesics|mesh-ancestor
65080253|NCT00446043|Sensory System Agents|sensory system agents|mesh-ancestor
65080254|NCT00446043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65080255|NCT00446043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080256|NCT00446043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65080257|NCT00446043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65080258|NCT00446082|Pasireotide|pasireotide|mesh-list
65080259|NCT00446082|Hormones|hormones|mesh-ancestor
64834112|NCT04098250|Erenumab|erenumab|mesh-list
64834113|NCT04098250|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64834114|NCT04098250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834115|NCT04098250|Analgesics|analgesics|mesh-ancestor
64834116|NCT04098250|Sensory System Agents|sensory system agents|mesh-ancestor
64834117|NCT04098250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64834118|NCT04098250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834119|NCT04002115|Mycophenolic Acid|mycophenolic acid|mesh-list
65080260|NCT00446082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65080261|NCT00446082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080262|NCT03275376|Atorvastatin|atorvastatin|mesh-list
65080263|NCT03275376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65080264|NCT03275376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65080265|NCT03275376|Antimetabolites|antimetabolites|mesh-ancestor
65080266|NCT03275376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080267|NCT03275376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65080268|NCT03275376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65080269|NCT03275376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080270|NCT00340184|Paclitaxel|paclitaxel|mesh-list
65080271|NCT00340184|Carboplatin|carboplatin|mesh-list
65080272|NCT00340184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65080273|NCT00340184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080274|NCT00340184|Tubulin Modulators|tubulin modulators|mesh-ancestor
65080275|NCT00340184|Antimitotic Agents|antimitotic agents|mesh-ancestor
65080276|NCT00340184|Mitosis Modulators|mitosis modulators|mesh-ancestor
65080277|NCT00340184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080278|NCT00446316|Imatinib Mesylate|imatinib mesylate|mesh-list
65080279|NCT00446316|Antacids|antacids|mesh-list
65080280|NCT00446316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080281|NCT00446316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65080282|NCT00446316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080283|NCT00446316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080284|NCT00446316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65080285|NCT00446433|Lenalidomide|lenalidomide|mesh-list
65080286|NCT00446433|Immunologic Factors|immunologic factors|mesh-ancestor
65080287|NCT00446433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080288|NCT00446433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65080289|NCT00446433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65080290|NCT00446433|Growth Substances|growth substances|mesh-ancestor
65080291|NCT00446433|Growth Inhibitors|growth inhibitors|mesh-ancestor
65080292|NCT00446433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080293|NCT00340574|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65080294|NCT00340574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65080295|NCT00340574|Immunologic Factors|immunologic factors|mesh-ancestor
65080296|NCT00340574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080297|NCT00340574|Antacids|antacids|mesh-ancestor
64325145|NCT02765399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325146|NCT02765399|Incretins|incretins|mesh-ancestor
64325147|NCT02765399|Hormones|hormones|mesh-ancestor
64325148|NCT02765399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65080298|NCT00340574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080299|NCT00340574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65080300|NCT00340613|Insulin Glargine|insulin glargine|mesh-list
65080301|NCT00340613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65080302|NCT00340613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080304|NCT00340691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65080305|NCT00340691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65080306|NCT00340691|Antimalarials|antimalarials|mesh-ancestor
65080307|NCT00340691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65080308|NCT00340691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65080309|NCT00452244|Gefitinib|gefitinib|mesh-list
65080310|NCT00452244|Simvastatin|simvastatin|mesh-list
65080311|NCT00452244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65080312|NCT00452244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65080313|NCT00452244|Antimetabolites|antimetabolites|mesh-ancestor
65080314|NCT00452244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080315|NCT00452244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65080316|NCT00452244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65080317|NCT00452244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080318|NCT00452244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080319|NCT00452244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65080320|NCT00446472|Becaplermin|becaplermin|mesh-list
65080321|NCT00446472|Anticoagulants|anticoagulants|mesh-ancestor
65080322|NCT00446472|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
65080323|NCT00446472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65080324|NCT00446472|Growth Substances|growth substances|mesh-ancestor
65080325|NCT00446472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080326|NCT00446589|Teriparatide|teriparatide|mesh-list
65080327|NCT00446589|Ibandronic Acid|ibandronic acid|mesh-list
65080328|NCT00446589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65080329|NCT00446589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080330|NCT00446589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65080331|NCT00452322|Methyltestosterone|methyltestosterone|mesh-list
65080332|NCT00452322|Testosterone|testosterone|mesh-list
65080333|NCT00452322|Testosterone undecanoate|testosterone undecanoate|mesh-list
65080334|NCT00452322|Testosterone enanthate|testosterone enanthate|mesh-list
65080335|NCT00452322|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65080336|NCT00452322|Androgens|androgens|mesh-ancestor
65080337|NCT00452322|Hormones|hormones|mesh-ancestor
65080338|NCT00452322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65080339|NCT00452322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080340|NCT00452322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65080341|NCT00452322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080342|NCT00452322|Anabolic Agents|anabolic agents|mesh-ancestor
64834141|NCT04002115|Antitubercular Agents|antitubercular agents|mesh-ancestor
64834142|NCT04002115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64416008|NCT05514041|Varenicline|varenicline|mesh-list
65080343|NCT00452556|Docetaxel|docetaxel|mesh-list
65080344|NCT00452556|Leuprolide|leuprolide|mesh-list
65080345|NCT00452556|Androgens|androgens|mesh-list
65080346|NCT00452556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080347|NCT00452556|Tubulin Modulators|tubulin modulators|mesh-ancestor
65080348|NCT00452556|Antimitotic Agents|antimitotic agents|mesh-ancestor
65080349|NCT00452556|Mitosis Modulators|mitosis modulators|mesh-ancestor
65080350|NCT00452556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080351|NCT00452556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65080352|NCT00452556|Fertility Agents|fertility agents|mesh-ancestor
65080353|NCT00452556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65080354|NCT00452556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080355|NCT00452556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65080356|NCT00452556|Hormones|hormones|mesh-ancestor
65080357|NCT00452556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65080358|NCT00446667|Mannitol|mannitol|mesh-list
65080359|NCT00446667|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65080360|NCT00446667|Diuretics|diuretics|mesh-ancestor
65080361|NCT00446667|Natriuretic Agents|natriuretic agents|mesh-ancestor
65080362|NCT00446667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080363|NCT03277755|Adafosbuvir|adafosbuvir|mesh-list
65080364|NCT03277755|Antiviral Agents|antiviral agents|mesh-ancestor
65080365|NCT03277755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65080366|NCT00452595|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65080367|NCT00452595|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65080368|NCT00452595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65080369|NCT00452595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65080370|NCT00452595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080371|NCT00452595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65080372|NCT00452595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080373|NCT00452595|Antidepressive Agents|antidepressive agents|mesh-ancestor
65080374|NCT00452595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65080375|NCT00341432|Nicotine|nicotine|mesh-list
65080376|NCT00341432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65080378|NCT00341432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65080379|NCT00341432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080380|NCT00341432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65080381|NCT00341432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65080382|NCT00341432|Cholinergic Agents|cholinergic agents|mesh-ancestor
65080383|NCT00341432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65080384|NCT00341432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080385|NCT00452634|Irinotecan|irinotecan|mesh-list
65080386|NCT00452634|Simvastatin|simvastatin|mesh-list
65080387|NCT00452634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080388|NCT00452634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65080389|NCT00452634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65080390|NCT00452634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080391|NCT00452634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080392|NCT00452634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65080393|NCT00452634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65080394|NCT00452634|Antimetabolites|antimetabolites|mesh-ancestor
65080395|NCT00452634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65080396|NCT00452634|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65080397|NCT03277599|Tramadol|tramadol|mesh-list
65080398|NCT03277599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65080399|NCT03277599|Narcotics|narcotics|mesh-ancestor
65080400|NCT03277599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65080401|NCT03277599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080402|NCT03277599|Analgesics|analgesics|mesh-ancestor
65080403|NCT03277599|Sensory System Agents|sensory system agents|mesh-ancestor
65080404|NCT03277599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64834143|NCT04002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64834144|NCT04002115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64834145|NCT03987503|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64834146|NCT03987503|Antiviral Agents|antiviral agents|mesh-ancestor
65080405|NCT00452829|Folic Acid|folic acid|mesh-list
65080406|NCT00452829|Vitamin B Complex|vitamin b complex|mesh-list
65080407|NCT00452829|Inositol|inositol|mesh-list
65080408|NCT00452829|Hematinics|hematinics|mesh-ancestor
65080409|NCT00452829|Vitamins|vitamins|mesh-ancestor
65080410|NCT00452829|Micronutrients|micronutrients|mesh-ancestor
65080411|NCT00452829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080412|NCT00452907|Artesunate|artesunate|mesh-list
65080413|NCT00452907|Lumefantrine|lumefantrine|mesh-list
65080414|NCT00452907|Pyrimethamine|pyrimethamine|mesh-list
65080415|NCT00452907|Sulfadoxine|sulfadoxine|mesh-list
65080416|NCT00452907|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65080417|NCT00452907|Antimalarials|antimalarials|mesh-ancestor
65080418|NCT00452907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65080419|NCT00452907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65080420|NCT00452907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65080421|NCT00452907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080422|NCT00452907|Antiviral Agents|antiviral agents|mesh-ancestor
65080423|NCT00452907|Schistosomicides|schistosomicides|mesh-ancestor
65080424|NCT00452907|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65080425|NCT00452907|Anthelmintics|anthelmintics|mesh-ancestor
65080426|NCT00452907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65080427|NCT00452907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080428|NCT00452907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080429|NCT00452907|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65080430|NCT00452907|Renal Agents|renal agents|mesh-ancestor
65080431|NCT00446784|Methotrexate|methotrexate|mesh-list
65080432|NCT00446784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65080433|NCT00446784|Abortifacient Agents|abortifacient agents|mesh-ancestor
65080434|NCT00446784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65080435|NCT00446784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080436|NCT00446784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65080437|NCT00446784|Antimetabolites|antimetabolites|mesh-ancestor
65080438|NCT00446784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080439|NCT00446784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080440|NCT00446784|Dermatologic Agents|dermatologic agents|mesh-ancestor
65080441|NCT00446784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080442|NCT00446784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65080443|NCT00446784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65080444|NCT00446784|Immunologic Factors|immunologic factors|mesh-ancestor
65080445|NCT00446784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65080446|NCT00446784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65080447|NCT00452985|Carboplatin|carboplatin|mesh-list
65080448|NCT00452985|Docetaxel|docetaxel|mesh-list
65080449|NCT00452985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080450|NCT00452985|Tubulin Modulators|tubulin modulators|mesh-ancestor
65080451|NCT00452985|Antimitotic Agents|antimitotic agents|mesh-ancestor
65080452|NCT00452985|Mitosis Modulators|mitosis modulators|mesh-ancestor
65080453|NCT00452985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080454|NCT03277209|Plerixafor|plerixafor|mesh-list
65080455|NCT03277209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65080456|NCT03277209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65080457|NCT03277209|Antiviral Agents|antiviral agents|mesh-ancestor
65080458|NCT03277209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65080459|NCT00453141|Betamethasone|betamethasone|mesh-list
65080460|NCT00453141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65080461|NCT00453141|Glucocorticoids|glucocorticoids|mesh-ancestor
65080462|NCT00453141|Hormones|hormones|mesh-ancestor
65080463|NCT00453141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65080464|NCT00453141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080465|NCT00453141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65080466|NCT00453141|Respiratory System Agents|respiratory system agents|mesh-ancestor
65080467|NCT00421109|Levocetirizine|levocetirizine|mesh-list
65080468|NCT00421109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64722567|NCT00002738|Leucovorin|leucovorin|mesh-list
64325161|NCT01037179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64325162|NCT01037179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64325163|NCT01037179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64416364|NCT04429633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64416365|NCT04429633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416366|NCT03042091|Metronidazole|metronidazole|mesh-list
65080469|NCT00421109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65080470|NCT00421109|Histamine Antagonists|histamine antagonists|mesh-ancestor
65080471|NCT00421109|Histamine Agents|histamine agents|mesh-ancestor
65080472|NCT00421109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65080473|NCT00421109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080474|NCT00421109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080475|NCT02273583|Cyclophosphamide|cyclophosphamide|mesh-list
65080476|NCT02273583|Methotrexate|methotrexate|mesh-list
65080477|NCT02273583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65080478|NCT02273583|Immunologic Factors|immunologic factors|mesh-ancestor
65080479|NCT02273583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080480|NCT02273583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65080481|NCT02273583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65080482|NCT02273583|Alkylating Agents|alkylating agents|mesh-ancestor
65080483|NCT02273583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080484|NCT02273583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080485|NCT02273583|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65080486|NCT02273583|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65080487|NCT02273583|Abortifacient Agents|abortifacient agents|mesh-ancestor
65080488|NCT02273583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65080489|NCT02273583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65080490|NCT02273583|Antimetabolites|antimetabolites|mesh-ancestor
65080491|NCT02273583|Dermatologic Agents|dermatologic agents|mesh-ancestor
65080492|NCT02273583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080493|NCT02273583|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65080494|NCT02273583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65080495|NCT00446862|Losartan|losartan|mesh-list
65080496|NCT00446862|Enalapril|enalapril|mesh-list
65080497|NCT00446862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
65080498|NCT00446862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65080499|NCT00446862|Enzyme Inhibitors|enzyme inhibitors|mesh-list
65080500|NCT00446862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65080501|NCT00446862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65080502|NCT00446862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65080503|NCT00446862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080504|NCT00446862|Protease Inhibitors|protease inhibitors|mesh-ancestor
65080505|NCT00446901|Selenium|selenium|mesh-list
65080506|NCT00446901|Antioxidants|antioxidants|mesh-ancestor
65080507|NCT00446901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080508|NCT00446901|Protective Agents|protective agents|mesh-ancestor
65080509|NCT00446901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080510|NCT00446901|Trace Elements|trace elements|mesh-ancestor
65080511|NCT00446901|Micronutrients|micronutrients|mesh-ancestor
65080512|NCT00453375|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
65080513|NCT00453375|Antioxidants|antioxidants|mesh-ancestor
65080514|NCT00453375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080515|NCT00453375|Protective Agents|protective agents|mesh-ancestor
65080516|NCT00453375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080517|NCT00446940|Atorvastatin|atorvastatin|mesh-list
65080518|NCT00446940|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65080519|NCT00446940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65080520|NCT00446940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65080521|NCT00446940|Antimetabolites|antimetabolites|mesh-ancestor
65080522|NCT00446940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080523|NCT00446940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65080524|NCT00446940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65080525|NCT00446940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080526|NCT00453414|Iloprost|iloprost|mesh-list
64325164|NCT01037179|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64325165|NCT01037179|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64325166|NCT01037179|Histamine Antagonists|histamine antagonists|mesh-ancestor
65080527|NCT00453414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65080528|NCT00453414|Vasodilator Agents|vasodilator agents|mesh-ancestor
65080529|NCT00446979|UC-781|uc-781|mesh-list
65080530|NCT00446979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65080531|NCT00446979|Antiviral Agents|antiviral agents|mesh-ancestor
65080532|NCT00446979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65080533|NCT00453453|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65080534|NCT00453453|Natriuretic Agents|natriuretic agents|mesh-ancestor
65080535|NCT00453453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080536|NCT00447018|Mannitol|mannitol|mesh-list
65080537|NCT00447018|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65080538|NCT00447018|Diuretics|diuretics|mesh-ancestor
65080539|NCT00447018|Natriuretic Agents|natriuretic agents|mesh-ancestor
65080540|NCT00447018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080541|NCT00343070|Citalopram|citalopram|mesh-list
65080542|NCT00343070|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65080543|NCT00343070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64834152|NCT03978598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834153|NCT03978598|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64834154|NCT03967197|Lidocaine|lidocaine|mesh-list
64834155|NCT03967197|Anesthetics, Local|anesthetics, local|mesh-ancestor
64834156|NCT03967197|Anesthetics|anesthetics|mesh-ancestor
64834157|NCT03967197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64834158|NCT03967197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834159|NCT03967197|Sensory System Agents|sensory system agents|mesh-ancestor
64834160|NCT03967197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64834161|NCT03967197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64834162|NCT03967197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64445333|NCT03966053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64325168|NCT01037179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64325169|NCT01037179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325171|NCT02269969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64325172|NCT02269969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64325173|NCT03555578|Leuprolide|leuprolide|mesh-list
65080544|NCT00343070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65080545|NCT00343070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080546|NCT00343070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65080547|NCT00343070|Serotonin Agents|serotonin agents|mesh-ancestor
65080548|NCT00343070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080549|NCT00343070|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65080550|NCT00343070|Antidepressive Agents|antidepressive agents|mesh-ancestor
65080551|NCT00343070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65080552|NCT00453492|Risedronic Acid|risedronic acid|mesh-list
65080553|NCT00453492|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65080554|NCT00453492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65080555|NCT00453492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080556|NCT00453492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65080557|NCT00453492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834163|NCT03967197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64834164|NCT03967197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64834165|NCT03967197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834166|NCT03935646|Adderall|adderall|mesh-list
64834167|NCT03935646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64834168|NCT03935646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834169|NCT03926026|Fluticasone|fluticasone|mesh-list
64834170|NCT03926026|Xhance|xhance|mesh-list
64834171|NCT03926026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64834172|NCT03926026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64834173|NCT03926026|Autonomic Agents|autonomic agents|mesh-ancestor
64834174|NCT03926026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64834175|NCT03926026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834176|NCT03926026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64834177|NCT03926026|Respiratory System Agents|respiratory system agents|mesh-ancestor
64834178|NCT03926026|Dermatologic Agents|dermatologic agents|mesh-ancestor
64834179|NCT03926026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64834180|NCT03875573|Durvalumab|durvalumab|mesh-list
64834181|NCT03875573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64834182|NCT03875573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834183|NCT03871153|Paclitaxel|paclitaxel|mesh-list
64834184|NCT03871153|Carboplatin|carboplatin|mesh-list
64834185|NCT03871153|Durvalumab|durvalumab|mesh-list
64834186|NCT03871153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64834187|NCT03871153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834188|NCT03871153|Tubulin Modulators|tubulin modulators|mesh-ancestor
64834189|NCT03871153|Antimitotic Agents|antimitotic agents|mesh-ancestor
64834190|NCT03871153|Mitosis Modulators|mitosis modulators|mesh-ancestor
64423632|NCT05209711|Anesthetics|anesthetics|mesh-ancestor
65080558|NCT00453492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65080560|NCT00343187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65080561|NCT00343187|Antimalarials|antimalarials|mesh-ancestor
65080562|NCT00343187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65080563|NCT00343187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65080564|NCT00343187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65080565|NCT00343187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080566|NCT00343187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080567|NCT00343187|Leprostatic Agents|leprostatic agents|mesh-ancestor
65080568|NCT00343187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65080569|NCT00343226|Basiliximab|basiliximab|mesh-list
65080570|NCT00343226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65080571|NCT00343226|Immunologic Factors|immunologic factors|mesh-ancestor
65080572|NCT00343226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080573|NCT00343265|Progesterone|progesterone|mesh-list
65080574|NCT00343265|Progestins|progestins|mesh-ancestor
65080575|NCT00343265|Hormones|hormones|mesh-ancestor
65080576|NCT00343265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65080577|NCT00343265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080578|NCT00453609|Naltrexone|naltrexone|mesh-list
65080579|NCT00453609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65080580|NCT00453609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65080581|NCT00453609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080582|NCT00453609|Sensory System Agents|sensory system agents|mesh-ancestor
65080583|NCT00453609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65080584|NCT00447213|Insulin|insulin|mesh-list
65080585|NCT00447213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65080586|NCT00447213|Insulin Glargine|insulin glargine|mesh-list
65080587|NCT00447213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65080588|NCT00447213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080589|NCT00453648|Vitamin A|vitamin a|mesh-list
65080590|NCT00453648|Retinol palmitate|retinol palmitate|mesh-list
65080591|NCT00453648|Antioxidants|antioxidants|mesh-ancestor
65080592|NCT00453648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080593|NCT00453648|Protective Agents|protective agents|mesh-ancestor
65080594|NCT00453648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080595|NCT00453648|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65080596|NCT00453648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080597|NCT00453648|Vitamins|vitamins|mesh-ancestor
65080598|NCT00453648|Micronutrients|micronutrients|mesh-ancestor
65080599|NCT00343421|Vaccines|vaccines|mesh-list
65080600|NCT00343421|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65080601|NCT00343421|Immunologic Factors|immunologic factors|mesh-ancestor
65080602|NCT00343421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080603|NCT00343499|Valsartan|valsartan|mesh-list
65080604|NCT00343499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65080605|NCT00343499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65080606|NCT00343499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65080607|NCT00343499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080608|NCT04715360|Favipiravir|favipiravir|mesh-list
65080609|NCT04715360|Antiviral Agents|antiviral agents|mesh-ancestor
65080610|NCT04715360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65080611|NCT00447369|Pregabalin|pregabalin|mesh-list
65080612|NCT00447369|Valproic Acid|valproic acid|mesh-list
65080613|NCT00447369|Analgesics|analgesics|mesh-ancestor
65080614|NCT00447369|Sensory System Agents|sensory system agents|mesh-ancestor
65080615|NCT00447369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65080616|NCT00447369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080617|NCT00447369|Anticonvulsants|anticonvulsants|mesh-ancestor
65080618|NCT00447369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65080619|NCT00447369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65080620|NCT00447369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080621|NCT00447369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64834194|NCT03547999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65080622|NCT00447369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65080623|NCT00447369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65080624|NCT00447369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65080625|NCT00447369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65080626|NCT00447369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080627|NCT00447369|GABA Agents|gaba agents|mesh-ancestor
65080628|NCT00447369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65080629|NCT00447369|Antimanic Agents|antimanic agents|mesh-ancestor
65080630|NCT00343655|Atorvastatin|atorvastatin|mesh-list
65080631|NCT00343655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65080632|NCT00343655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65080633|NCT00343655|Antimetabolites|antimetabolites|mesh-ancestor
65080634|NCT00343655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080635|NCT00343655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65080636|NCT00343655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65080637|NCT00343655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080638|NCT00453765|Montelukast|montelukast|mesh-list
65080639|NCT00453765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65080640|NCT00453765|Respiratory System Agents|respiratory system agents|mesh-ancestor
65080641|NCT00453765|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65080642|NCT00453765|Hormone Antagonists|hormone antagonists|mesh-ancestor
65080643|NCT00453765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65080644|NCT00453765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080645|NCT00453765|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65080646|NCT00453765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65080647|NCT00453765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080648|NCT00343733|Fentanyl|fentanyl|mesh-list
65080649|NCT00343733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65080650|NCT00343733|Narcotics|narcotics|mesh-ancestor
65080651|NCT00343733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65080652|NCT00343733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080653|NCT00343733|Analgesics|analgesics|mesh-ancestor
65080654|NCT00343733|Sensory System Agents|sensory system agents|mesh-ancestor
65080655|NCT00343733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65080656|NCT00343733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65080657|NCT00343733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65080658|NCT00343733|Anesthetics, General|anesthetics, general|mesh-ancestor
65080659|NCT00343733|Anesthetics|anesthetics|mesh-ancestor
65080660|NCT00343811|Modafinil|modafinil|mesh-list
65080661|NCT00343811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65080662|NCT00343811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080663|NCT00343811|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64834195|NCT03547999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834196|NCT03547999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64834197|NCT03547999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834199|NCT03536728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834200|NCT03536728|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64834201|NCT03536728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64602713|NCT05217355|Cholinergic Agents|cholinergic agents|mesh-ancestor
64834202|NCT03536728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64834203|NCT03536728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64834204|NCT03536728|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64834205|NCT03536728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445372|NCT03943901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64325175|NCT03555578|Fertility Agents|fertility agents|mesh-ancestor
64325176|NCT03555578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65080664|NCT00343811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65080665|NCT00343811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65080666|NCT00343811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080667|NCT00453804|Naltrexone|naltrexone|mesh-list
65080668|NCT00453804|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65080669|NCT00453804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65080670|NCT00453804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080671|NCT00453804|Sensory System Agents|sensory system agents|mesh-ancestor
65080672|NCT00453804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65080673|NCT00343850|Mesalamine|mesalamine|mesh-list
65080674|NCT00343850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65080675|NCT00343850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65080676|NCT00343850|Analgesics|analgesics|mesh-ancestor
65080677|NCT00343850|Sensory System Agents|sensory system agents|mesh-ancestor
65080678|NCT00343850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65080679|NCT00343850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080680|NCT00343850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65080681|NCT00343850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65080682|NCT00344006|Artesunate|artesunate|mesh-list
65080683|NCT00344006|Lumefantrine|lumefantrine|mesh-list
65080684|NCT00344006|Artemether|artemether|mesh-list
65080685|NCT00344006|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65080686|NCT00344006|Dapsone|dapsone|mesh-list
65080687|NCT00344006|Chlorproguanil|chlorproguanil|mesh-list
65080688|NCT00344006|Proguanil|proguanil|mesh-list
65080689|NCT00344006|Antimalarials|antimalarials|mesh-ancestor
65080690|NCT00344006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65080691|NCT00344006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65080692|NCT00344006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64722797|NCT01702909|Interleukin-2|interleukin-2|mesh-list
65080693|NCT00344006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080695|NCT00344006|Schistosomicides|schistosomicides|mesh-ancestor
65080696|NCT00344006|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65080697|NCT00344006|Anthelmintics|anthelmintics|mesh-ancestor
65080698|NCT00344006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65080699|NCT00344006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080700|NCT00344006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080701|NCT00344006|Leprostatic Agents|leprostatic agents|mesh-ancestor
65080702|NCT00344006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65080703|NCT00344006|Antimetabolites|antimetabolites|mesh-ancestor
65080704|NCT02273661|Amphotericin B|amphotericin b|mesh-list
65080705|NCT02273661|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64834207|NCT03517423|Brivaracetam|brivaracetam|mesh-list
64834208|NCT03517423|Anticonvulsants|anticonvulsants|mesh-ancestor
64834209|NCT03470675|Ketamine|ketamine|mesh-list
64834210|NCT03470675|Morphine|morphine|mesh-list
64834211|NCT03470675|Analgesics|analgesics|mesh-ancestor
64834212|NCT03470675|Sensory System Agents|sensory system agents|mesh-ancestor
64834213|NCT03470675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64834214|NCT03470675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834215|NCT03470675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64834216|NCT03470675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64834217|NCT03470675|Anesthetics, General|anesthetics, general|mesh-ancestor
64423770|NCT05154487|Hormone Antagonists|hormone antagonists|mesh-ancestor
65080706|NCT02273661|Amebicides|amebicides|mesh-ancestor
65080707|NCT02273661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65080708|NCT02273661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65080709|NCT02273661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65080710|NCT02273661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65080711|NCT02273661|Antifungal Agents|antifungal agents|mesh-ancestor
65080712|NCT00344123|Ritonavir|ritonavir|mesh-list
65080713|NCT00344123|Tipranavir|tipranavir|mesh-list
65080714|NCT00344123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65080715|NCT00344123|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65080716|NCT00344123|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65080717|NCT00344123|Protease Inhibitors|protease inhibitors|mesh-ancestor
65080718|NCT00344123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080719|NCT00344123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080720|NCT00344123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65080721|NCT00344123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65080722|NCT00344123|Antiviral Agents|antiviral agents|mesh-ancestor
65080723|NCT00344123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65080724|NCT00344123|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65080725|NCT00344123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65080726|NCT00344123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65080727|NCT00344123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65080728|NCT00344123|Antimetabolites|antimetabolites|mesh-ancestor
65080729|NCT00344123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65080730|NCT00344123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65080731|NCT00344201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65080732|NCT00344201|Hemostatics|hemostatics|mesh-ancestor
65080733|NCT00344201|Coagulants|coagulants|mesh-ancestor
65080734|NCT00453960|Norethindrone|norethindrone|mesh-list
65080735|NCT00453960|Norethindrone Acetate|norethindrone acetate|mesh-list
65080736|NCT00453960|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65080737|NCT00453960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65080738|NCT00453960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65080739|NCT00453960|Contraceptive Agents|contraceptive agents|mesh-ancestor
65080740|NCT00453960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65080741|NCT00453960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080742|NCT00453960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65080743|NCT00453960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65080744|NCT00447681|Fezakinumab|fezakinumab|mesh-list
65080745|NCT00447681|Dermatologic Agents|dermatologic agents|mesh-ancestor
65080746|NCT00447759|Ibuprofen|ibuprofen|mesh-list
65080747|NCT00447759|Celecoxib|celecoxib|mesh-list
65080748|NCT00447759|Diclofenac|diclofenac|mesh-list
65080749|NCT00447759|Naproxen|naproxen|mesh-list
65080750|NCT00447759|Meloxicam|meloxicam|mesh-list
64423816|NCT05107999|Doxepin|doxepin|mesh-list
65080751|NCT00447759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65080752|NCT00447759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65080753|NCT00447759|Analgesics|analgesics|mesh-ancestor
65080754|NCT00447759|Sensory System Agents|sensory system agents|mesh-ancestor
65080755|NCT00447759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65080756|NCT00447759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080757|NCT00447759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65080758|NCT00447759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65080759|NCT00447759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65080760|NCT00447759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080761|NCT00447759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080762|NCT00447759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65080763|NCT00447759|Gout Suppressants|gout suppressants|mesh-ancestor
65080764|NCT00344513|Carvedilol|carvedilol|mesh-list
65080765|NCT00344513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65080766|NCT00344513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65080767|NCT00344513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65080768|NCT00344513|Adrenergic Agents|adrenergic agents|mesh-ancestor
64722885|NCT01122511|Hormones|hormones|mesh-ancestor
65080769|NCT00344513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65080770|NCT00344513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080771|NCT00344513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080772|NCT00344513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65080773|NCT00344513|Antioxidants|antioxidants|mesh-ancestor
65080774|NCT00344513|Protective Agents|protective agents|mesh-ancestor
65080775|NCT00344513|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65080776|NCT00344513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65080777|NCT00344513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65080778|NCT00344513|Vasodilator Agents|vasodilator agents|mesh-ancestor
65080779|NCT00344513|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65080780|NCT00344513|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65080781|NCT00344513|Protease Inhibitors|protease inhibitors|mesh-ancestor
65080782|NCT00344513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080783|NCT00344552|Paclitaxel|paclitaxel|mesh-list
65080784|NCT00344552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65080785|NCT00344552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080786|NCT00344552|Tubulin Modulators|tubulin modulators|mesh-ancestor
65080787|NCT00344552|Antimitotic Agents|antimitotic agents|mesh-ancestor
65080788|NCT00344552|Mitosis Modulators|mitosis modulators|mesh-ancestor
65080789|NCT00344552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080790|NCT00447915|Vitamin D|vitamin d|mesh-list
65080791|NCT00447915|Cholecalciferol|cholecalciferol|mesh-list
65080792|NCT00447915|Ibandronic Acid|ibandronic acid|mesh-list
65080793|NCT00447915|Calcium|calcium|mesh-list
65080794|NCT00447915|Vitamins|vitamins|mesh-ancestor
65080795|NCT00447915|Micronutrients|micronutrients|mesh-ancestor
65080796|NCT00447915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080797|NCT00447915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64325178|NCT03555578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64325180|NCT03232424|Temozolomide|temozolomide|mesh-list
64325181|NCT03232424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64834219|NCT03470675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64834220|NCT03470675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64834221|NCT03470675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64834222|NCT03470675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64834223|NCT03470675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834224|NCT03470675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64834225|NCT03470675|Narcotics|narcotics|mesh-ancestor
65080798|NCT00447915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65080799|NCT00344669|Albendazole|albendazole|mesh-list
65080800|NCT00344669|Anthelmintics|anthelmintics|mesh-ancestor
65080801|NCT00344669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65080802|NCT00344669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65080803|NCT00344669|Anticestodal Agents|anticestodal agents|mesh-ancestor
65080804|NCT00344669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65080805|NCT00344669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65080806|NCT00344669|Tubulin Modulators|tubulin modulators|mesh-ancestor
65080807|NCT00344669|Antimitotic Agents|antimitotic agents|mesh-ancestor
65080808|NCT00344669|Mitosis Modulators|mitosis modulators|mesh-ancestor
65080809|NCT00344669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080810|NCT00344669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080811|NCT04715165|Dexmedetomidine|dexmedetomidine|mesh-list
65080812|NCT04715165|Bupivacaine|bupivacaine|mesh-list
65080813|NCT04715165|Anesthetics, Local|anesthetics, local|mesh-ancestor
65080814|NCT04715165|Anesthetics|anesthetics|mesh-ancestor
65080815|NCT04715165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64834226|NCT03462251|Paclitaxel|paclitaxel|mesh-list
64834227|NCT03462251|Bevacizumab|bevacizumab|mesh-list
64834228|NCT03462251|Capecitabine|capecitabine|mesh-list
64834229|NCT03462251|Fulvestrant|fulvestrant|mesh-list
64834230|NCT03462251|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64445408|NCT03877289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64423899|NCT05175781|Analgesics|analgesics|mesh-ancestor
64294845|NCT03108963|Metformin|metformin|mesh-list
65080816|NCT04715165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080817|NCT04715165|Sensory System Agents|sensory system agents|mesh-ancestor
65080818|NCT04715165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65080819|NCT04715165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65080820|NCT04715165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65080821|NCT04715165|Analgesics|analgesics|mesh-ancestor
65080822|NCT04715165|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65080823|NCT04715165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65080824|NCT04715165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65080825|NCT04715165|Adrenergic Agents|adrenergic agents|mesh-ancestor
65080826|NCT04715165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65080827|NCT04715165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080828|NCT00454233|Metformin|metformin|mesh-list
65080829|NCT00454233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65080830|NCT00454233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080831|NCT00454272|Vancomycin|vancomycin|mesh-list
65080832|NCT00454272|Teicoplanin|teicoplanin|mesh-list
65080833|NCT00454272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65080834|NCT00454272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65080835|NCT00344825|Fludarabine|fludarabine|mesh-list
65080836|NCT00344825|Fludarabine phosphate|fludarabine phosphate|mesh-list
65080837|NCT00344825|Alemtuzumab|alemtuzumab|mesh-list
65080838|NCT00344825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834231|NCT03462251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65080839|NCT00344825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65080840|NCT00344825|Antimetabolites|antimetabolites|mesh-ancestor
65080841|NCT00344825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080842|NCT00344825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65080843|NCT00344825|Immunologic Factors|immunologic factors|mesh-ancestor
65080844|NCT00344825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080845|NCT00344825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65080847|NCT00448110|Ketorolac|ketorolac|mesh-list
65080848|NCT00448110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65080849|NCT00448110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65080850|NCT00448110|Analgesics|analgesics|mesh-ancestor
65080851|NCT00448110|Sensory System Agents|sensory system agents|mesh-ancestor
65080852|NCT00448110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65080853|NCT00448110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080854|NCT00448110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65080855|NCT00448110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65080856|NCT00448110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65080857|NCT00448110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080858|NCT00448110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080859|NCT00448149|Everolimus|everolimus|mesh-list
65080860|NCT00448149|Sorafenib|sorafenib|mesh-list
65080861|NCT00448149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080862|NCT00448149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65080863|NCT00448149|Immunologic Factors|immunologic factors|mesh-ancestor
65080864|NCT00448149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080865|NCT00448149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65080866|NCT00448149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080867|NCT00448149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080868|NCT00344942|Triamcinolone|triamcinolone|mesh-list
64834232|NCT03462251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834233|NCT03462251|Tubulin Modulators|tubulin modulators|mesh-ancestor
64834234|NCT03462251|Antimitotic Agents|antimitotic agents|mesh-ancestor
64834235|NCT03462251|Mitosis Modulators|mitosis modulators|mesh-ancestor
64834236|NCT03462251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834237|NCT03462251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64834238|NCT03462251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64834239|NCT03462251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65080869|NCT00344942|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65080870|NCT00344942|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65080871|NCT00344942|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65080872|NCT00344942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65080873|NCT00344942|Glucocorticoids|glucocorticoids|mesh-ancestor
65080874|NCT00344942|Hormones|hormones|mesh-ancestor
65080875|NCT00344942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65080876|NCT00344942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080877|NCT00344942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65080878|NCT00344942|Immunologic Factors|immunologic factors|mesh-ancestor
65080879|NCT00344942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080880|NCT00344942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080881|NCT00454350|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
65080882|NCT00454350|Vitamins|vitamins|mesh-ancestor
65080883|NCT00454350|Micronutrients|micronutrients|mesh-ancestor
65080884|NCT00454350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080885|NCT00454350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65080886|NCT00454389|Ranibizumab|ranibizumab|mesh-list
65080887|NCT00454389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65080888|NCT00454389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65080889|NCT00454389|Growth Substances|growth substances|mesh-ancestor
65080890|NCT00454389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080891|NCT00454389|Growth Inhibitors|growth inhibitors|mesh-ancestor
65080892|NCT00454389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080893|NCT00344981|Tenofovir|tenofovir|mesh-list
65080894|NCT00344981|Hydroxyurea|hydroxyurea|mesh-list
65080895|NCT00344981|Antiviral Agents|antiviral agents|mesh-ancestor
65080896|NCT00344981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65080897|NCT00344981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65080898|NCT00344981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65080899|NCT00344981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080900|NCT00344981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080901|NCT00344981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65080902|NCT00344981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65080903|NCT00344981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080904|NCT00344981|Antisickling Agents|antisickling agents|mesh-ancestor
65080905|NCT00448266|Cyclophosphamide|cyclophosphamide|mesh-list
65080906|NCT00448266|Thiotepa|thiotepa|mesh-list
65080907|NCT00448266|Carboplatin|carboplatin|mesh-list
65080908|NCT00448266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65080909|NCT00448266|Immunologic Factors|immunologic factors|mesh-ancestor
65080910|NCT00448266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080911|NCT00448266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65080912|NCT00448266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65080913|NCT00448266|Alkylating Agents|alkylating agents|mesh-ancestor
65080914|NCT00448266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080915|NCT00448266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080916|NCT00448266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65080917|NCT00454545|Atorvastatin|atorvastatin|mesh-list
65080918|NCT00454545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64723027|NCT04706377|Vitamin B 12|vitamin b 12|mesh-list
65080919|NCT00454545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64325182|NCT03232424|Alkylating Agents|alkylating agents|mesh-ancestor
64325183|NCT03232424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325184|NCT03232424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423954|NCT05086627|Capecitabine|capecitabine|mesh-list
65080921|NCT00454545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080922|NCT00454545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65080923|NCT00454545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65080924|NCT00454545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080925|NCT00345059|Gemcitabine|gemcitabine|mesh-list
65080926|NCT00345059|Capecitabine|capecitabine|mesh-list
65080927|NCT00345059|Docetaxel|docetaxel|mesh-list
65080928|NCT00345059|Vinorelbine|vinorelbine|mesh-list
65080929|NCT00345059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65080930|NCT00345059|Antimetabolites|antimetabolites|mesh-ancestor
65080931|NCT00345059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080932|NCT00345059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080933|NCT00345059|Antiviral Agents|antiviral agents|mesh-ancestor
65080934|NCT00345059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65080935|NCT00345059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080936|NCT00345059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65080937|NCT00345059|Immunologic Factors|immunologic factors|mesh-ancestor
65080938|NCT00345059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080939|NCT00345059|Tubulin Modulators|tubulin modulators|mesh-ancestor
65080940|NCT00345059|Antimitotic Agents|antimitotic agents|mesh-ancestor
65080941|NCT00345059|Mitosis Modulators|mitosis modulators|mesh-ancestor
65080942|NCT00345059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65080943|NCT00345098|Amibegron|amibegron|mesh-list
65080944|NCT00345098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65080945|NCT00345098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65080946|NCT00345098|Adrenergic Agents|adrenergic agents|mesh-ancestor
64834243|NCT03462251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64834244|NCT03462251|Antimetabolites|antimetabolites|mesh-ancestor
64834245|NCT03462251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64834246|NCT03462251|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64834247|NCT03462251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64834248|NCT03462251|Hormone Antagonists|hormone antagonists|mesh-ancestor
64834249|NCT03462251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64834250|NCT03462251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64834251|NCT03462251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834252|NCT03418038|Vitamins|vitamins|mesh-list
64834253|NCT03418038|Ascorbic Acid|ascorbic acid|mesh-list
64834254|NCT03418038|Gemcitabine|gemcitabine|mesh-list
64424005|NCT05050981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64424006|NCT05123131|Dexamethasone|dexamethasone|mesh-list
64424007|NCT05123131|Lenalidomide|lenalidomide|mesh-list
64424008|NCT05123131|Bortezomib|bortezomib|mesh-list
64424009|NCT05123131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65080947|NCT00345098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65080948|NCT00345098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080949|NCT00345098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080950|NCT00448305|Paclitaxel|paclitaxel|mesh-list
65080951|NCT00448305|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65080952|NCT00448305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65080953|NCT00448305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080954|NCT00448305|Tubulin Modulators|tubulin modulators|mesh-ancestor
65080955|NCT00448305|Antimitotic Agents|antimitotic agents|mesh-ancestor
65080956|NCT00448305|Mitosis Modulators|mitosis modulators|mesh-ancestor
65080957|NCT00448305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080958|NCT00345137|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
65080959|NCT00345137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080960|NCT00345137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080961|NCT00448383|Adalimumab|adalimumab|mesh-list
65080962|NCT00448383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65080963|NCT00448383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65080965|NCT00448461|Bivalirudin|bivalirudin|mesh-list
65080966|NCT00448461|Anticoagulants|anticoagulants|mesh-ancestor
65080967|NCT00448461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65080968|NCT00448461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64325188|NCT02484404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64325189|NCT02484404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325190|NCT02484404|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64834256|NCT03418038|Dexamethasone|dexamethasone|mesh-list
64834257|NCT03418038|Dexamethasone acetate|dexamethasone acetate|mesh-list
64834258|NCT03418038|Rituximab|rituximab|mesh-list
64834259|NCT03418038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64834260|NCT03418038|Cisplatin|cisplatin|mesh-list
64834261|NCT03418038|Carboplatin|carboplatin|mesh-list
64834262|NCT03418038|Oxaliplatin|oxaliplatin|mesh-list
64834263|NCT03418038|Etoposide|etoposide|mesh-list
64834264|NCT03418038|Etoposide phosphate|etoposide phosphate|mesh-list
64834265|NCT03418038|Ifosfamide|ifosfamide|mesh-list
64424038|NCT05039281|Atezolizumab|atezolizumab|mesh-list
64424039|NCT05039281|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64424040|NCT05039281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65080969|NCT00448461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080970|NCT00448461|Antithrombins|antithrombins|mesh-ancestor
65080971|NCT00448461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65080972|NCT00448461|Protease Inhibitors|protease inhibitors|mesh-ancestor
65080973|NCT00448461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65080974|NCT00454662|Amlodipine|amlodipine|mesh-list
65080975|NCT00454662|Olmesartan|olmesartan|mesh-list
65080976|NCT00454662|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65080977|NCT00454662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65080978|NCT00454662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65080979|NCT00454662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65080980|NCT00454662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080981|NCT00454662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65080982|NCT00454662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080983|NCT00454662|Vasodilator Agents|vasodilator agents|mesh-ancestor
65080984|NCT00454662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65080985|NCT00454662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65080986|NCT00345644|Risedronic Acid|risedronic acid|mesh-list
65080987|NCT00345644|Etidronic Acid|etidronic acid|mesh-list
65080988|NCT00345644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65080989|NCT00345644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65080990|NCT00345644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65080991|NCT00345644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65080992|NCT00345644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080993|NCT00345644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65080994|NCT00454701|Alefacept|alefacept|mesh-list
65080995|NCT00454701|Dermatologic Agents|dermatologic agents|mesh-ancestor
65080996|NCT00454701|Immunologic Factors|immunologic factors|mesh-ancestor
65080997|NCT00454701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65080998|NCT00345761|Bevacizumab|bevacizumab|mesh-list
65080999|NCT00345761|Capecitabine|capecitabine|mesh-list
65081000|NCT00345761|Oxaliplatin|oxaliplatin|mesh-list
65081001|NCT00345761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65081002|NCT00345761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081003|NCT00345761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65081004|NCT00345761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65081005|NCT00345761|Growth Substances|growth substances|mesh-ancestor
64834266|NCT03418038|Isophosphamide mustard|isophosphamide mustard|mesh-list
64834267|NCT03418038|Podophyllotoxin|podophyllotoxin|mesh-list
64834268|NCT03418038|Antibodies|antibodies|mesh-list
64834269|NCT03418038|Immunoglobulins|immunoglobulins|mesh-list
64834270|NCT03418038|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64834271|NCT03418038|BB 1101|bb 1101|mesh-list
64834272|NCT03418038|Micronutrients|micronutrients|mesh-ancestor
64834273|NCT03418038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834274|NCT03418038|Immunologic Factors|immunologic factors|mesh-ancestor
64834275|NCT03418038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834276|NCT03418038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64602786|NCT02812615|Antinematodal Agents|antinematodal agents|mesh-ancestor
64834277|NCT03418038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64834278|NCT03418038|Antiemetics|antiemetics|mesh-ancestor
64834279|NCT03418038|Autonomic Agents|autonomic agents|mesh-ancestor
64834280|NCT03418038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64834281|NCT03418038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64834282|NCT03418038|Glucocorticoids|glucocorticoids|mesh-ancestor
64834283|NCT03418038|Hormones|hormones|mesh-ancestor
65081006|NCT00345761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081007|NCT00345761|Growth Inhibitors|growth inhibitors|mesh-ancestor
65081008|NCT00345761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65081009|NCT00345761|Antimetabolites|antimetabolites|mesh-ancestor
65081010|NCT00345761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081011|NCT00345800|Sodium Oxybate|sodium oxybate|mesh-list
65081012|NCT00345800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65081013|NCT00345800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65081014|NCT00345800|Anesthetics, General|anesthetics, general|mesh-ancestor
65081015|NCT00345800|Anesthetics|anesthetics|mesh-ancestor
65081016|NCT00345800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65081017|NCT00345800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081018|NCT00454740|Solifenacin Succinate|solifenacin succinate|mesh-list
65081019|NCT00454740|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65081020|NCT00454740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65081021|NCT00454740|Cholinergic Agents|cholinergic agents|mesh-ancestor
65081022|NCT00454740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65081023|NCT00454740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081024|NCT00454740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081025|NCT00454740|Urological Agents|urological agents|mesh-ancestor
65081026|NCT03276858|Midazolam|midazolam|mesh-list
65081027|NCT03276858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65081028|NCT03276858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65081029|NCT03276858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65081030|NCT03276858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65081031|NCT03276858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081032|NCT03276858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65081033|NCT03276858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65081034|NCT03276858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65081035|NCT03276858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65081036|NCT03276858|Anesthetics, General|anesthetics, general|mesh-ancestor
65081037|NCT03276858|Anesthetics|anesthetics|mesh-ancestor
65081038|NCT03276858|GABA Modulators|gaba modulators|mesh-ancestor
65081039|NCT03276858|GABA Agents|gaba agents|mesh-ancestor
65081040|NCT03276858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65081041|NCT03276858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081042|NCT00421187|Amphotericin B|amphotericin b|mesh-list
65081043|NCT00421187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65081044|NCT00421187|Amebicides|amebicides|mesh-ancestor
65081045|NCT00421187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65081046|NCT00421187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65081047|NCT00421187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65081048|NCT00421187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65081049|NCT00421187|Antifungal Agents|antifungal agents|mesh-ancestor
65081050|NCT00454896|Solifenacin Succinate|solifenacin succinate|mesh-list
65081051|NCT00454896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65081052|NCT00454896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64445468|NCT01634555|Antidotes|antidotes|mesh-ancestor
64834285|NCT03418038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64834286|NCT03418038|Protease Inhibitors|protease inhibitors|mesh-ancestor
64834287|NCT03418038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834288|NCT03418038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834289|NCT03418038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65081053|NCT00454896|Cholinergic Agents|cholinergic agents|mesh-ancestor
65081054|NCT00454896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65081055|NCT00454896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081056|NCT00454896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081057|NCT00454896|Urological Agents|urological agents|mesh-ancestor
65081058|NCT00346190|Alendronate|alendronate|mesh-list
65081059|NCT00346190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65081060|NCT00346190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081061|NCT00346229|Doxorubicin|doxorubicin|mesh-list
65081062|NCT00346229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65081063|NCT00346229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65081064|NCT00346229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081065|NCT00346229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65081066|NCT00346229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65081067|NCT00346229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081068|NCT00346229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081069|NCT00346385|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
65081070|NCT00346385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65081071|NCT00346385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081072|NCT00346385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65081073|NCT00448578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65081074|NCT00448578|Antidepressive Agents|antidepressive agents|mesh-ancestor
65081075|NCT00448578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65081076|NCT00448578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65081077|NCT00448578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65081078|NCT00448578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65081079|NCT00448578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081080|NCT00346463|Allopurinol|allopurinol|mesh-list
65081081|NCT00346463|Antimetabolites|antimetabolites|mesh-ancestor
65081082|NCT00346463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081083|NCT00346463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64325192|NCT02484404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325193|NCT02484404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64325194|NCT03163407|Norepinephrine|norepinephrine|mesh-list
64325195|NCT03163407|Ephedrine|ephedrine|mesh-list
64325196|NCT03163407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64325197|NCT03163407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64325198|NCT03163407|Adrenergic Agents|adrenergic agents|mesh-ancestor
64325199|NCT03163407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64325200|NCT03163407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430001|NCT05055323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64834306|NCT03409718|Cimetidine|cimetidine|mesh-list
64834307|NCT03409718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64834308|NCT03409718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64834309|NCT03409718|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64834318|NCT03404778|Cimetidine|cimetidine|mesh-list
65081084|NCT00346463|Gout Suppressants|gout suppressants|mesh-ancestor
65081085|NCT00346463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65081086|NCT00346463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65081087|NCT00346463|Antioxidants|antioxidants|mesh-ancestor
65081088|NCT00346463|Protective Agents|protective agents|mesh-ancestor
65081089|NCT00346463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081090|NCT00455091|Lamivudine|lamivudine|mesh-list
65081091|NCT00455091|Adefovir|adefovir|mesh-list
65081092|NCT00455091|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65081093|NCT00455091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65081094|NCT00455091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65081095|NCT00455091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081096|NCT00455091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081097|NCT00455091|Antiviral Agents|antiviral agents|mesh-ancestor
65081098|NCT00455091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65081099|NCT00455091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65081100|NCT00455091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65081101|NCT00346502|Betulinic acid|betulinic acid|mesh-list
65081102|NCT00346502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65081103|NCT00346502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65081104|NCT00346502|Analgesics|analgesics|mesh-ancestor
65081105|NCT00346502|Sensory System Agents|sensory system agents|mesh-ancestor
65081106|NCT00346502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65081107|NCT00346502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081108|NCT00346502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65081109|NCT00346502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65081110|NCT00346502|Antimalarials|antimalarials|mesh-ancestor
65081111|NCT00346502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65081112|NCT00346502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64834323|NCT03404778|Histamine Agents|histamine agents|mesh-ancestor
64834324|NCT03404778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64834325|NCT03404778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834326|NCT03404778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834327|NCT03404778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64834328|NCT03404778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64834329|NCT03404778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834330|NCT03392246|Osimertinib|osimertinib|mesh-list
64834331|NCT03392246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834332|NCT03392246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64834333|NCT03392246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834334|NCT03392246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445515|NCT03800693|Leucovorin|leucovorin|mesh-list
65081113|NCT00346502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65081114|NCT00346502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65081115|NCT00346502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081116|NCT00346502|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
65081117|NCT00346502|Hormone Antagonists|hormone antagonists|mesh-ancestor
65081118|NCT00346502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65081119|NCT00346502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65081120|NCT00346502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65081121|NCT00346502|Antiviral Agents|antiviral agents|mesh-ancestor
65081122|NCT00346580|Nelfinavir|nelfinavir|mesh-list
65081123|NCT00346580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65081124|NCT00346580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65081125|NCT00346580|Protease Inhibitors|protease inhibitors|mesh-ancestor
65081126|NCT00346580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081127|NCT00346580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081128|NCT00346580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65081129|NCT00346580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65081130|NCT00346580|Antiviral Agents|antiviral agents|mesh-ancestor
65081131|NCT00346580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65081132|NCT00346619|Nelfinavir|nelfinavir|mesh-list
65081133|NCT00346619|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65081134|NCT00346619|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65081135|NCT00346619|Protease Inhibitors|protease inhibitors|mesh-ancestor
65081136|NCT00346619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081137|NCT00346619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081138|NCT00346619|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65081139|NCT00346619|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65081140|NCT00346619|Antiviral Agents|antiviral agents|mesh-ancestor
65081141|NCT00346619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65081142|NCT02273700|Rivaroxaban|rivaroxaban|mesh-list
64834354|NCT03294954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64834355|NCT03294954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64834356|NCT03294954|Alkylating Agents|alkylating agents|mesh-ancestor
64834357|NCT03294954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834358|NCT03294954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834359|NCT03294954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64834361|NCT03274414|Etoposide|etoposide|mesh-list
64445540|NCT01582282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64834362|NCT03274414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834363|NCT03274414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64834364|NCT03274414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64834365|NCT03274414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64834366|NCT03274414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834367|NCT03274414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834369|NCT03272685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64834370|NCT03272685|Autonomic Agents|autonomic agents|mesh-ancestor
64834371|NCT03272685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64834372|NCT03272685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325210|NCT00154297|Everolimus|everolimus|mesh-list
64325211|NCT00154297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424214|NCT02291289|Fluorouracil|fluorouracil|mesh-list
65081143|NCT02273700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65081144|NCT02273700|Antithrombins|antithrombins|mesh-ancestor
65081145|NCT02273700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65081146|NCT02273700|Protease Inhibitors|protease inhibitors|mesh-ancestor
65081147|NCT02273700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081148|NCT02273700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081149|NCT02273700|Anticoagulants|anticoagulants|mesh-ancestor
65081150|NCT02959658|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65081151|NCT02959658|Dermatologic Agents|dermatologic agents|mesh-ancestor
65081152|NCT02959658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65081153|NCT02959658|Immunologic Factors|immunologic factors|mesh-ancestor
65081154|NCT02959658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081155|NCT04698213|Avelumab|avelumab|mesh-list
65081156|NCT04698213|Axitinib|axitinib|mesh-list
65081157|NCT04698213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65081158|NCT04698213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081159|NCT04698213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65081160|NCT04698213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081161|NCT04698213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081162|NCT02273817|Ciclesonide|ciclesonide|mesh-list
65081163|NCT02273817|Glucocorticoids|glucocorticoids|mesh-ancestor
65081164|NCT02273817|Hormones|hormones|mesh-ancestor
65081165|NCT02273817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65081166|NCT02273817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081167|NCT02273817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65081168|NCT00346853|Fomepizole|fomepizole|mesh-list
65081169|NCT00346853|Antidotes|antidotes|mesh-ancestor
65081170|NCT00346853|Protective Agents|protective agents|mesh-ancestor
65081171|NCT00346853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081172|NCT00346853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081173|NCT00346853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081174|NCT00448734|Docetaxel|docetaxel|mesh-list
65081175|NCT00448734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081176|NCT00448734|Tubulin Modulators|tubulin modulators|mesh-ancestor
65081177|NCT00448734|Antimitotic Agents|antimitotic agents|mesh-ancestor
65081178|NCT00448734|Mitosis Modulators|mitosis modulators|mesh-ancestor
65081179|NCT00448734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081180|NCT00346970|Niacin|niacin|mesh-list
65081181|NCT00346970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64325212|NCT00154297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64325213|NCT00154297|Immunologic Factors|immunologic factors|mesh-ancestor
64325214|NCT00154297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325215|NCT02270281|Dexmedetomidine|dexmedetomidine|mesh-list
64325216|NCT02270281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64325217|NCT02270281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65081182|NCT00346970|Antimetabolites|antimetabolites|mesh-ancestor
65081183|NCT00346970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081184|NCT00346970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65081185|NCT00346970|Vasodilator Agents|vasodilator agents|mesh-ancestor
65081186|NCT00346970|Vitamin B Complex|vitamin b complex|mesh-ancestor
65081187|NCT00346970|Vitamins|vitamins|mesh-ancestor
65081188|NCT00346970|Micronutrients|micronutrients|mesh-ancestor
65081189|NCT00346970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081190|NCT00455130|Mannitol|mannitol|mesh-list
65081191|NCT00455130|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65081192|NCT00455130|Diuretics|diuretics|mesh-ancestor
65081193|NCT00455130|Natriuretic Agents|natriuretic agents|mesh-ancestor
65081194|NCT00455130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081195|NCT00347048|Tacrolimus|tacrolimus|mesh-list
65081196|NCT00347048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65081197|NCT00347048|Immunologic Factors|immunologic factors|mesh-ancestor
65081198|NCT00347048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081199|NCT00347048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65081200|NCT00347048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081201|NCT00347048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081202|NCT00347087|Irbesartan|irbesartan|mesh-list
65081203|NCT00347087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65081204|NCT00347087|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65081205|NCT00347087|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65081206|NCT00347087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081207|NCT00347165|Bevacizumab|bevacizumab|mesh-list
65081208|NCT00347165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65081210|NCT00347165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65081211|NCT00347165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65081212|NCT00347165|Growth Substances|growth substances|mesh-ancestor
65081213|NCT00347165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081214|NCT00347165|Growth Inhibitors|growth inhibitors|mesh-ancestor
65081215|NCT00347204|Ketorolac|ketorolac|mesh-list
65081216|NCT00347204|Nepafenac|nepafenac|mesh-list
64834373|NCT03272685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64834374|NCT03272685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64834375|NCT03272685|Cholinergic Agents|cholinergic agents|mesh-ancestor
64834376|NCT03272685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64834377|NCT03272685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834378|NCT03272334|Pembrolizumab|pembrolizumab|mesh-list
64834379|NCT03272334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64834380|NCT03272334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834381|NCT03258281|Evolocumab|evolocumab|mesh-list
64834382|NCT03258281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64834383|NCT03258281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64834384|NCT03258281|Antimetabolites|antimetabolites|mesh-ancestor
64834385|NCT03258281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834386|NCT03258281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64834387|NCT05705492|Olanzapine|olanzapine|mesh-list
65081217|NCT00347204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65081218|NCT00347204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65081220|NCT00347204|Sensory System Agents|sensory system agents|mesh-ancestor
65081221|NCT00347204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65081222|NCT00347204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081223|NCT00347204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65081224|NCT00347204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65081225|NCT00347204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65081226|NCT00347204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081227|NCT00347204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081228|NCT00455286|Methylprednisolone|methylprednisolone|mesh-list
65081229|NCT00455286|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65081230|NCT00455286|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65081231|NCT00455286|Prednisolone|prednisolone|mesh-list
65081232|NCT00455286|Prednisolone acetate|prednisolone acetate|mesh-list
65081233|NCT00455286|Methotrexate|methotrexate|mesh-list
65081234|NCT00455286|Temozolomide|temozolomide|mesh-list
65081235|NCT00455286|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65081236|NCT00455286|Prednisolone phosphate|prednisolone phosphate|mesh-list
65081237|NCT00455286|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65081238|NCT00455286|Abortifacient Agents|abortifacient agents|mesh-ancestor
65081239|NCT00455286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65081240|NCT00455286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081241|NCT00455286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65081242|NCT00455286|Antimetabolites|antimetabolites|mesh-ancestor
65081243|NCT00455286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081244|NCT00455286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081245|NCT00455286|Dermatologic Agents|dermatologic agents|mesh-ancestor
65081246|NCT00455286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081247|NCT00455286|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65081248|NCT00455286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64325218|NCT02270281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325219|NCT02270281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64325220|NCT02270281|Analgesics|analgesics|mesh-ancestor
64325221|NCT02270281|Sensory System Agents|sensory system agents|mesh-ancestor
64325222|NCT02270281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65081249|NCT00455286|Immunologic Factors|immunologic factors|mesh-ancestor
65081250|NCT00455286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65081251|NCT00455286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65081252|NCT00455286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65081253|NCT00455286|Alkylating Agents|alkylating agents|mesh-ancestor
65081254|NCT00455286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65081255|NCT00455286|Antiemetics|antiemetics|mesh-ancestor
65081256|NCT00455286|Autonomic Agents|autonomic agents|mesh-ancestor
65081257|NCT00455286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65081258|NCT00455286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65081259|NCT00455286|Glucocorticoids|glucocorticoids|mesh-ancestor
65081260|NCT00455286|Hormones|hormones|mesh-ancestor
65081261|NCT00455286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65081262|NCT00455286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65081263|NCT00455286|Protective Agents|protective agents|mesh-ancestor
65081264|NCT00455286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65081265|NCT00455364|Voriconazole|voriconazole|mesh-list
65081266|NCT00455364|Antifungal Agents|antifungal agents|mesh-ancestor
65081267|NCT00455364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65081268|NCT00455364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65081269|NCT00455364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65081270|NCT00455364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081271|NCT00455364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081272|NCT00455364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65081273|NCT00455364|Hormone Antagonists|hormone antagonists|mesh-ancestor
65081274|NCT00455364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65081275|NCT00455364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081276|NCT00455364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65081277|NCT00347399|Bevacizumab|bevacizumab|mesh-list
65081278|NCT00347399|Verteporfin|verteporfin|mesh-list
65081279|NCT00347399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65081280|NCT00347399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416413|NCT03041779|Antipyretics|antipyretics|mesh-ancestor
65081281|NCT00347399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65081282|NCT00347399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65081283|NCT00347399|Growth Substances|growth substances|mesh-ancestor
65081284|NCT00347399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081285|NCT00347399|Growth Inhibitors|growth inhibitors|mesh-ancestor
65081286|NCT00347399|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65081287|NCT00347399|Dermatologic Agents|dermatologic agents|mesh-ancestor
65081288|NCT00455442|Mifepristone|mifepristone|mesh-list
65081289|NCT00455442|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
65081290|NCT00455442|Abortifacient Agents|abortifacient agents|mesh-ancestor
65081291|NCT00455442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65081292|NCT00455442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081293|NCT00455442|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65081294|NCT00455442|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65081295|NCT00455442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65081296|NCT00455442|Contraceptive Agents|contraceptive agents|mesh-ancestor
64325229|NCT01033123|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64325231|NCT01033123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834424|NCT05704959|Povidone-Iodine|povidone-iodine|mesh-list
64834426|NCT05704959|Plasma Substitutes|plasma substitutes|mesh-ancestor
64424407|NCT05010421|Glucocorticoids|glucocorticoids|mesh-ancestor
65081297|NCT00455442|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
65081298|NCT00455442|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
65081299|NCT00455442|Hormone Antagonists|hormone antagonists|mesh-ancestor
65081300|NCT00455442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65081301|NCT00455442|Luteolytic Agents|luteolytic agents|mesh-ancestor
65081302|NCT00455442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65081303|NCT00455442|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
65081304|NCT00347555|Aluminum phosphate|aluminum phosphate|mesh-list
65081305|NCT00347555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65081306|NCT00347555|Immunologic Factors|immunologic factors|mesh-ancestor
65081307|NCT00347555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081308|NCT00347555|Antacids|antacids|mesh-ancestor
65081309|NCT00347555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081310|NCT00347555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65081311|NCT00455637|Botulinum Toxins|botulinum toxins|mesh-list
65081312|NCT00455637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65081313|NCT00455637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65081314|NCT00455637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65081315|NCT00455637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65081316|NCT00455637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081317|NCT00455637|Cholinergic Agents|cholinergic agents|mesh-ancestor
65081318|NCT00455637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65081319|NCT00455637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081320|NCT00455637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65081321|NCT00455637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65081322|NCT00347750|Lopinavir|lopinavir|mesh-list
65081323|NCT00347750|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65081324|NCT00347750|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65081325|NCT00347750|Protease Inhibitors|protease inhibitors|mesh-ancestor
65081326|NCT00347750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081327|NCT00347750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081328|NCT00347750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65081329|NCT00347750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65081330|NCT00347750|Antiviral Agents|antiviral agents|mesh-ancestor
65081331|NCT00347750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65081332|NCT00347750|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65081333|NCT00347750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65081334|NCT00347828|Moxifloxacin|moxifloxacin|mesh-list
65081335|NCT00347828|Gatifloxacin|gatifloxacin|mesh-list
65081336|NCT00347828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65081337|NCT00347828|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65081338|NCT00347828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65081339|NCT00347828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65081340|NCT00347828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65081341|NCT00347828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65081342|NCT00347828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081343|NCT00347828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081344|NCT00347828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081345|NCT00347867|Sildenafil Citrate|sildenafil citrate|mesh-list
65081346|NCT00347867|Vasodilator Agents|vasodilator agents|mesh-ancestor
65081347|NCT00347867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64834427|NCT05704959|Blood Substitutes|blood substitutes|mesh-ancestor
64834428|NCT05704959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64834429|NCT05704959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64834431|NCT05704894|Hematinics|hematinics|mesh-ancestor
64834432|NCT05704816|Anesthetics|anesthetics|mesh-list
64834433|NCT05704816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64834434|NCT05704816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834435|NCT05704634|Cemiplimab|cemiplimab|mesh-list
64834436|NCT05704634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64834437|NCT05704634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081348|NCT00347867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65081349|NCT00347867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081350|NCT00347867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081351|NCT00347867|Urological Agents|urological agents|mesh-ancestor
65081352|NCT00449202|Oleoyl-estrone|oleoyl-estrone|mesh-list
65081353|NCT00449202|Estrone|estrone|mesh-list
65081354|NCT00449202|Estrogens|estrogens|mesh-ancestor
65081355|NCT00449202|Hormones|hormones|mesh-ancestor
65081356|NCT00449202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65081357|NCT00449202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64723477|NCT00279409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64723478|NCT00279409|Serotonin Agents|serotonin agents|mesh-ancestor
64723479|NCT00279409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64723480|NCT00279409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64723481|NCT00279409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64723482|NCT00279409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64723483|NCT05007392|Febuxostat|febuxostat|mesh-list
65081358|NCT00449202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65081359|NCT00455715|Sildenafil Citrate|sildenafil citrate|mesh-list
65081360|NCT00455715|Vasodilator Agents|vasodilator agents|mesh-ancestor
65081361|NCT00455715|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65081362|NCT00455715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65081363|NCT00455715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081364|NCT00455715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081365|NCT00455715|Urological Agents|urological agents|mesh-ancestor
65081366|NCT00455754|Esomeprazole|esomeprazole|mesh-list
64325232|NCT01033123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325233|NCT01033123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325234|NCT03163173|Avasopasem manganese|avasopasem manganese|mesh-list
64325235|NCT03163173|Antioxidants|antioxidants|mesh-ancestor
64325236|NCT03163173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325237|NCT03163173|Protective Agents|protective agents|mesh-ancestor
64325238|NCT03163173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325239|NCT01323205|Antipsychotic Agents|antipsychotic agents|mesh-list
64325240|NCT01323205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64325241|NCT01323205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64834440|NCT05704595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834441|NCT05704400|Rituximab|rituximab|mesh-list
64834442|NCT05704400|Daratumumab|daratumumab|mesh-list
64834443|NCT05704400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64834444|NCT05704400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834445|NCT05704400|Immunologic Factors|immunologic factors|mesh-ancestor
64834446|NCT05704400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834447|NCT05704400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64834448|NCT05704374|Pregabalin|pregabalin|mesh-list
64834449|NCT05704374|Analgesics|analgesics|mesh-ancestor
65081367|NCT00455754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65081368|NCT00455754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65081369|NCT00455754|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65081370|NCT00455754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081371|NCT00455754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081372|NCT00347984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65081373|NCT00347984|Lubricant Eye Drops|lubricant eye drops|mesh-list
65081374|NCT00347984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65081376|NCT00348023|Bimatoprost|bimatoprost|mesh-list
65081377|NCT00348023|Travoprost|travoprost|mesh-list
65081378|NCT00348023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65081379|NCT00348023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65081380|NCT00348023|Adrenergic Agents|adrenergic agents|mesh-ancestor
65081381|NCT00348023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65081382|NCT00348023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081383|NCT00348023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081384|NCT00348023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65081385|NCT00348023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65081386|NCT00348062|Bimatoprost|bimatoprost|mesh-list
65081387|NCT00348062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65081388|NCT00348101|Enoximone|enoximone|mesh-list
65081389|NCT00348101|Esmolol|esmolol|mesh-list
65081390|NCT00348101|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65081391|NCT00348101|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65081392|NCT00348101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65081393|NCT00348101|Adrenergic Agents|adrenergic agents|mesh-ancestor
65081394|NCT00348101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65081395|NCT00348101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081396|NCT00348101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081397|NCT00348101|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65081398|NCT00348101|Vasodilator Agents|vasodilator agents|mesh-ancestor
65081399|NCT00348101|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65081400|NCT00348101|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65081401|NCT00348101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081402|NCT00348101|Protective Agents|protective agents|mesh-ancestor
64325242|NCT01323205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081403|NCT00455832|Ribavirin|ribavirin|mesh-list
65081404|NCT00455832|Antimetabolites|antimetabolites|mesh-ancestor
65081405|NCT00455832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081406|NCT00455832|Antiviral Agents|antiviral agents|mesh-ancestor
65081407|NCT00455832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65081408|NCT00455871|Ranibizumab|ranibizumab|mesh-list
65081409|NCT00455871|Verteporfin|verteporfin|mesh-list
65081410|NCT00455871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65081411|NCT00455871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65081412|NCT00455871|Growth Substances|growth substances|mesh-ancestor
65081413|NCT00455871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416420|NCT02612779|Dexamethasone|dexamethasone|mesh-list
65081414|NCT00455871|Growth Inhibitors|growth inhibitors|mesh-ancestor
65081415|NCT00455871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081416|NCT00455871|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65081417|NCT00455871|Dermatologic Agents|dermatologic agents|mesh-ancestor
65081419|NCT00449280|Sorafenib|sorafenib|mesh-list
65081420|NCT00449280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081421|NCT00449280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65081422|NCT00449280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081423|NCT00449280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081424|NCT00449280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65081425|NCT00449280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65081426|NCT00449280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65081427|NCT00449280|Antifungal Agents|antifungal agents|mesh-ancestor
65081428|NCT00449280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65081429|NCT00449280|Immunologic Factors|immunologic factors|mesh-ancestor
65081430|NCT00449280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081431|NCT00455910|Thalidomide|thalidomide|mesh-list
65081432|NCT00455910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64723554|NCT05048719|Dulaglutide|dulaglutide|mesh-list
65081433|NCT00455910|Immunologic Factors|immunologic factors|mesh-ancestor
65081434|NCT00455910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834450|NCT05704374|Sensory System Agents|sensory system agents|mesh-ancestor
64834451|NCT05704374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64834452|NCT05704374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834453|NCT05704374|Anticonvulsants|anticonvulsants|mesh-ancestor
64834454|NCT05704374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64834455|NCT05704374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64834456|NCT05704374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834457|NCT05704374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64834458|NCT05704374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64424601|NCT02483611|Lidocaine|lidocaine|mesh-list
65081435|NCT00455910|Leprostatic Agents|leprostatic agents|mesh-ancestor
65081436|NCT00455910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65081437|NCT00455910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65081438|NCT00455910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65081439|NCT00455910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65081440|NCT00455910|Growth Substances|growth substances|mesh-ancestor
65081441|NCT00455910|Growth Inhibitors|growth inhibitors|mesh-ancestor
65081442|NCT00455910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081443|NCT00348296|Immunoglobulins|immunoglobulins|mesh-list
65081444|NCT00348296|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65081445|NCT00348296|Antibodies|antibodies|mesh-list
65081446|NCT00348296|gamma-Globulins|gamma-globulins|mesh-list
65081447|NCT00348296|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65081448|NCT00348296|Immunologic Factors|immunologic factors|mesh-ancestor
65081449|NCT00348296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081450|NCT00449319|Daunorubicin|daunorubicin|mesh-list
65081451|NCT00449319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65081452|NCT00449319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081453|NCT00449319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65081454|NCT00449319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65081455|NCT00449319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081456|NCT00449319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081457|NCT00348335|Cyclosporine|cyclosporine|mesh-list
65081458|NCT00348335|Cyclosporins|cyclosporins|mesh-list
65081459|NCT00348335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081460|NCT00348335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081461|NCT00348335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65081462|NCT00348335|Immunologic Factors|immunologic factors|mesh-ancestor
65081463|NCT00348335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081464|NCT00348335|Antifungal Agents|antifungal agents|mesh-ancestor
65081465|NCT00348335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65081466|NCT00348335|Dermatologic Agents|dermatologic agents|mesh-ancestor
65081467|NCT00348335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65081468|NCT00348335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65081469|NCT00348413|Methylprednisolone|methylprednisolone|mesh-list
65081470|NCT00348413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65081471|NCT00348413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65081472|NCT00348413|Prednisolone|prednisolone|mesh-list
65081473|NCT00348413|Prednisolone acetate|prednisolone acetate|mesh-list
65081474|NCT00348413|Methotrexate|methotrexate|mesh-list
65081475|NCT00348413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65081476|NCT00348413|Prednisolone phosphate|prednisolone phosphate|mesh-list
65081477|NCT00348413|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65081478|NCT00348413|Abortifacient Agents|abortifacient agents|mesh-ancestor
65081479|NCT00348413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65081480|NCT00348413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424638|NCT02495857|Viscosupplements|viscosupplements|mesh-list
64424639|NCT02495857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64424640|NCT02495857|Immunologic Factors|immunologic factors|mesh-ancestor
64424641|NCT02495857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424642|NCT02495857|Protective Agents|protective agents|mesh-ancestor
64424643|NCT02495389|Mirabegron|mirabegron|mesh-list
64424644|NCT02495389|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64424645|NCT02495389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64424646|NCT02495389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65081481|NCT00348413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65081482|NCT00348413|Antimetabolites|antimetabolites|mesh-ancestor
65081483|NCT00348413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081484|NCT00348413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081485|NCT00348413|Dermatologic Agents|dermatologic agents|mesh-ancestor
65081486|NCT00348413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081487|NCT00348413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64416425|NCT02612779|Antiemetics|antiemetics|mesh-ancestor
65081488|NCT00348413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65081489|NCT00348413|Immunologic Factors|immunologic factors|mesh-ancestor
65081490|NCT00348413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65081491|NCT00348413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65081492|NCT00348413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65081493|NCT00348413|Antiemetics|antiemetics|mesh-ancestor
65081494|NCT00348413|Autonomic Agents|autonomic agents|mesh-ancestor
65081495|NCT00348413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64325244|NCT03162861|Anesthetics|anesthetics|mesh-list
64325245|NCT03162861|Propofol|propofol|mesh-list
64325246|NCT03162861|Sevoflurane|sevoflurane|mesh-list
64325247|NCT03162861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64834460|NCT05704374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64834461|NCT05704374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64834462|NCT05704166|Pirfenidone|pirfenidone|mesh-list
64834463|NCT05704166|Analgesics|analgesics|mesh-ancestor
64834464|NCT05704166|Sensory System Agents|sensory system agents|mesh-ancestor
64834465|NCT05704166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64834466|NCT05704166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834467|NCT05704166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64834468|NCT05704166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64424689|NCT02495077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64424690|NCT02495077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64424691|NCT02495077|Antiemetics|antiemetics|mesh-ancestor
65081496|NCT00348413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65081497|NCT00348413|Glucocorticoids|glucocorticoids|mesh-ancestor
65081498|NCT00348413|Hormones|hormones|mesh-ancestor
65081499|NCT00348413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65081500|NCT00348413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65081501|NCT00348413|Protective Agents|protective agents|mesh-ancestor
65081502|NCT00348413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65081503|NCT00348452|Celecoxib|celecoxib|mesh-list
65081504|NCT00348452|Tramadol|tramadol|mesh-list
65081505|NCT00348452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65081506|NCT00348452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65081507|NCT00348452|Analgesics|analgesics|mesh-ancestor
65081508|NCT00348452|Sensory System Agents|sensory system agents|mesh-ancestor
65081509|NCT00348452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65081510|NCT00348452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081511|NCT00348452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65081512|NCT00348452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65081513|NCT00348452|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65081514|NCT00348452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65081515|NCT00348452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081516|NCT00348452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081517|NCT00348452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64834470|NCT05704166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64834471|NCT05704166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834472|NCT05704114|Tazarotene|tazarotene|mesh-list
64834473|NCT05704114|Dermatologic Agents|dermatologic agents|mesh-ancestor
64834474|NCT05704114|Keratolytic Agents|keratolytic agents|mesh-ancestor
64834475|NCT05704088|Dapagliflozin|dapagliflozin|mesh-list
64834476|NCT05704088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64834477|NCT05704088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834478|NCT05704088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64834479|NCT05704088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325248|NCT03162861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325249|NCT03162861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64325250|NCT03162861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64325251|NCT03162861|Anesthetics, General|anesthetics, general|mesh-ancestor
64325252|NCT03162861|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64325253|NCT03162861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64424719|NCT02494921|Prednisone|prednisone|mesh-list
65081518|NCT00348452|Narcotics|narcotics|mesh-ancestor
65081519|NCT00348452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65081520|NCT00449397|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65081521|NCT00449397|Antidepressive Agents|antidepressive agents|mesh-ancestor
65081522|NCT00449397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65081523|NCT00449397|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65081524|NCT00449397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65081525|NCT00449397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65081526|NCT00449397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081527|NCT00348491|Lumiracoxib|lumiracoxib|mesh-list
65081528|NCT00348491|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65081529|NCT00348491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65081530|NCT00348491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081531|NCT00348491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081532|NCT00348491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65081533|NCT00348491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65081534|NCT00348491|Analgesics|analgesics|mesh-ancestor
65081535|NCT00348491|Sensory System Agents|sensory system agents|mesh-ancestor
65081536|NCT00348491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65081537|NCT00348491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081538|NCT00348491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65081539|NCT00348491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65081540|NCT03274323|Travoprost|travoprost|mesh-list
65081541|NCT03274323|Latanoprost|latanoprost|mesh-list
65081542|NCT03274323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65081543|NCT03274323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65081544|NCT03274323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65081545|NCT00348530|Verapamil|verapamil|mesh-list
65081546|NCT00348530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65081547|NCT00348530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65081548|NCT00348530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65081549|NCT00348530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081550|NCT00348530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65081551|NCT00348530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081552|NCT00348530|Vasodilator Agents|vasodilator agents|mesh-ancestor
65081553|NCT00449436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
65081554|NCT00449436|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
65081555|NCT00449436|Protease Inhibitors|protease inhibitors|mesh-list
65081556|NCT00449436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65081557|NCT00449436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081558|NCT00449436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081559|NCT00449436|Antiviral Agents|antiviral agents|mesh-ancestor
65081560|NCT00449436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65081561|NCT00449436|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65081562|NCT00449436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65081563|NCT00449436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65081564|NCT00456027|Aluminum Hydroxide|aluminum hydroxide|mesh-list
65081565|NCT00456027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65081566|NCT00456027|Immunologic Factors|immunologic factors|mesh-ancestor
64834480|NCT05703997|Atezolizumab|atezolizumab|mesh-list
64834481|NCT05703997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834482|NCT05703984|Metformin|metformin|mesh-list
64834483|NCT05703984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64834484|NCT05703984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834485|NCT05703672|Varenicline|varenicline|mesh-list
64834486|NCT05703672|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64834487|NCT05703672|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64834488|NCT05703672|Cholinergic Agents|cholinergic agents|mesh-ancestor
65081567|NCT00456027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081569|NCT00456027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081570|NCT00456027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65081571|NCT00348725|Metformin|metformin|mesh-list
65081572|NCT00348725|Fenofibrate|fenofibrate|mesh-list
65081573|NCT00348725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65081574|NCT00348725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081575|NCT00348725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65081576|NCT00348725|Antimetabolites|antimetabolites|mesh-ancestor
65081577|NCT00348725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081578|NCT00348725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65081579|NCT00348764|Polidocanol|polidocanol|mesh-list
65081580|NCT00348764|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
65081581|NCT00348764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65081582|NCT03276156|Apatinib|apatinib|mesh-list
65081583|NCT03276156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081584|NCT03276156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65081585|NCT03276156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081586|NCT03276156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081587|NCT00456144|Hormones|hormones|mesh-list
65081588|NCT00456144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65081589|NCT00456144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081590|NCT00348920|Bupivacaine|bupivacaine|mesh-list
65081591|NCT00348920|Anesthetics, Local|anesthetics, local|mesh-ancestor
64834489|NCT05703672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64834490|NCT05703672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325254|NCT04506554|Nivolumab|nivolumab|mesh-list
64325255|NCT04506554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64325256|NCT04506554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325257|NCT04506554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64325258|NCT04506554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325259|NCT05476172|Dienogest|dienogest|mesh-list
64424787|NCT02491411|Antiemetics|antiemetics|mesh-ancestor
65081592|NCT00348920|Anesthetics|anesthetics|mesh-ancestor
65081593|NCT00348920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65081594|NCT00348920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081595|NCT00348920|Sensory System Agents|sensory system agents|mesh-ancestor
65081596|NCT00348920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65081597|NCT00449514|Tamoxifen|tamoxifen|mesh-list
65081598|NCT00449514|Clomiphene|clomiphene|mesh-list
65081599|NCT00449514|Enclomiphene|enclomiphene|mesh-list
65081600|NCT00449514|Zuclomiphene|zuclomiphene|mesh-list
65081601|NCT00449514|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65081602|NCT00449514|Hormone Antagonists|hormone antagonists|mesh-ancestor
65081603|NCT00449514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65081604|NCT00449514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081605|NCT00449514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65081606|NCT00449514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081607|NCT00449514|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65081608|NCT00449514|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65081609|NCT00449514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65081610|NCT00449514|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65081611|NCT00449514|Fertility Agents|fertility agents|mesh-ancestor
65081612|NCT00449514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65081613|NCT00348998|Bevacizumab|bevacizumab|mesh-list
65081614|NCT00348998|Goserelin|goserelin|mesh-list
65081615|NCT00348998|Bicalutamide|bicalutamide|mesh-list
65081616|NCT00348998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65081617|NCT00348998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081618|NCT00348998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65081619|NCT00348998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65081620|NCT00348998|Growth Substances|growth substances|mesh-ancestor
65081621|NCT00348998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081622|NCT00348998|Growth Inhibitors|growth inhibitors|mesh-ancestor
65081623|NCT00348998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65081624|NCT00348998|Androgen Antagonists|androgen antagonists|mesh-ancestor
65081625|NCT00348998|Hormone Antagonists|hormone antagonists|mesh-ancestor
65081626|NCT00348998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65081627|NCT00449553|Metformin|metformin|mesh-list
65081628|NCT00449553|Pioglitazone|pioglitazone|mesh-list
65081629|NCT00449553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64834491|NCT05703672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834493|NCT05703659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64834494|NCT05703659|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64834495|NCT05703659|Renal Agents|renal agents|mesh-ancestor
64834496|NCT05703659|Antimalarials|antimalarials|mesh-ancestor
64834497|NCT05703659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64834498|NCT05703659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64834499|NCT05703555|Maytansine|maytansine|mesh-list
64834500|NCT05703555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64834501|NCT05703555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834502|NCT05703555|Tubulin Modulators|tubulin modulators|mesh-ancestor
64834503|NCT05703555|Antimitotic Agents|antimitotic agents|mesh-ancestor
64834504|NCT05703555|Mitosis Modulators|mitosis modulators|mesh-ancestor
64834505|NCT05703555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834506|NCT05703373|Micronutrients|micronutrients|mesh-list
64445667|NCT02218736|Aticaprant|aticaprant|mesh-list
65081630|NCT00449553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081631|NCT00349076|Oxaliplatin|oxaliplatin|mesh-list
65081632|NCT00349076|Fluorouracil|fluorouracil|mesh-list
65081633|NCT00349076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081634|NCT00349076|Antimetabolites|antimetabolites|mesh-ancestor
65081635|NCT00349076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081636|NCT00349076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65081637|NCT00349076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65081638|NCT00349076|Immunologic Factors|immunologic factors|mesh-ancestor
65081639|NCT00349076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081640|NCT00349115|Thalidomide|thalidomide|mesh-list
65081641|NCT00349115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65081642|NCT00349115|Immunologic Factors|immunologic factors|mesh-ancestor
65081643|NCT00349115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081644|NCT00349115|Leprostatic Agents|leprostatic agents|mesh-ancestor
65081645|NCT00349115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65081646|NCT00349115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65081647|NCT00349115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65081648|NCT00349115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65081649|NCT00349115|Growth Substances|growth substances|mesh-ancestor
65081650|NCT00349115|Growth Inhibitors|growth inhibitors|mesh-ancestor
65081651|NCT00349115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081652|NCT00456339|Amoxicillin|amoxicillin|mesh-list
65081653|NCT00456339|Clavulanic Acid|clavulanic acid|mesh-list
65081654|NCT00456339|Clavulanic Acids|clavulanic acids|mesh-list
65081655|NCT00456339|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
65081656|NCT00456339|Prednisolone|prednisolone|mesh-list
65081657|NCT00456339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65081658|NCT00456339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65081659|NCT00456339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65081660|NCT00456339|Glucocorticoids|glucocorticoids|mesh-ancestor
65081661|NCT00456339|Hormones|hormones|mesh-ancestor
65081662|NCT00456339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65081663|NCT00456339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081664|NCT00456339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65081665|NCT00456339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081666|NCT00456339|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65081667|NCT00456339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081668|NCT00456339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081669|NCT00421421|Dutasteride|dutasteride|mesh-list
65081670|NCT00421421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65081671|NCT00421421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65081672|NCT00421421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081673|NCT00421421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081674|NCT00421421|Hormone Antagonists|hormone antagonists|mesh-ancestor
64325260|NCT05476172|Norethindrone|norethindrone|mesh-list
64325261|NCT05476172|Norethindrone Acetate|norethindrone acetate|mesh-list
64325262|NCT05476172|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64325263|NCT05476172|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64325264|NCT05476172|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64325265|NCT05476172|Contraceptive Agents|contraceptive agents|mesh-ancestor
64325266|NCT05476172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64325267|NCT05476172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325268|NCT05476172|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64325269|NCT05476172|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64834508|NCT05703373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424842|NCT04939987|Anesthetics, General|anesthetics, general|mesh-ancestor
65081675|NCT00421421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65081676|NCT00421421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081677|NCT00421460|Methyltestosterone|methyltestosterone|mesh-list
65081678|NCT00421460|Testosterone|testosterone|mesh-list
65081679|NCT00421460|Testosterone undecanoate|testosterone undecanoate|mesh-list
65081680|NCT00421460|Testosterone enanthate|testosterone enanthate|mesh-list
65081681|NCT00421460|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65081682|NCT00421460|Androgens|androgens|mesh-ancestor
65081684|NCT00421460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65081685|NCT00421460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081686|NCT00421460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65081687|NCT00421460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081688|NCT00421460|Anabolic Agents|anabolic agents|mesh-ancestor
65081689|NCT00349310|Pramipexole|pramipexole|mesh-list
65081690|NCT00349310|Antioxidants|antioxidants|mesh-ancestor
65081691|NCT00349310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081692|NCT00349310|Protective Agents|protective agents|mesh-ancestor
65081693|NCT00349310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081694|NCT00349310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65081695|NCT00349310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65081696|NCT00349310|Dopamine Agonists|dopamine agonists|mesh-ancestor
65081697|NCT00349310|Dopamine Agents|dopamine agents|mesh-ancestor
65081698|NCT00349310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65081699|NCT03274167|Gabapentin|gabapentin|mesh-list
65081700|NCT03274167|Analgesics|analgesics|mesh-ancestor
65081701|NCT03274167|Sensory System Agents|sensory system agents|mesh-ancestor
65081702|NCT03274167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65081703|NCT03274167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081704|NCT03274167|Anticonvulsants|anticonvulsants|mesh-ancestor
65081705|NCT03274167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65081706|NCT03274167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65081707|NCT03274167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65081708|NCT03274167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65081709|NCT03274167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65081710|NCT03274167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65081711|NCT03274167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65081712|NCT03274167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081713|NCT03274167|Antimanic Agents|antimanic agents|mesh-ancestor
65081714|NCT00349427|Rosiglitazone|rosiglitazone|mesh-list
65081715|NCT00349427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65081716|NCT00349427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081717|NCT00349583|Cyclosporine|cyclosporine|mesh-list
65081718|NCT00349583|Cyclosporins|cyclosporins|mesh-list
65081719|NCT00349583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081720|NCT00349583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081721|NCT00349583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65081722|NCT00349583|Immunologic Factors|immunologic factors|mesh-ancestor
65081723|NCT00349583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834509|NCT05702190|Opium|opium|mesh-list
65081724|NCT00349583|Antifungal Agents|antifungal agents|mesh-ancestor
65081725|NCT00349583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65081726|NCT00349583|Dermatologic Agents|dermatologic agents|mesh-ancestor
65081727|NCT00349583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65081728|NCT00349583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65081729|NCT00349739|Anecortave|anecortave|mesh-list
65081730|NCT00349739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65081731|NCT00349739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65081732|NCT00349739|Growth Substances|growth substances|mesh-ancestor
65081733|NCT00349739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081734|NCT00349739|Growth Inhibitors|growth inhibitors|mesh-ancestor
65081735|NCT00349739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081736|NCT00456729|Metronidazole|metronidazole|mesh-list
65081737|NCT00456729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65081738|NCT00456729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65081739|NCT00456729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65081740|NCT00456729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65081741|NCT00450099|Bupivacaine|bupivacaine|mesh-list
65081742|NCT00450099|Anesthetics, Local|anesthetics, local|mesh-ancestor
65081743|NCT00450099|Anesthetics|anesthetics|mesh-ancestor
65081744|NCT00450099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65081745|NCT00450099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081746|NCT00450099|Sensory System Agents|sensory system agents|mesh-ancestor
65081747|NCT00450099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65081748|NCT00450138|Cisplatin|cisplatin|mesh-list
65081749|NCT00450138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081750|NCT00350051|Prednisone|prednisone|mesh-list
65081751|NCT00350051|Sagopilone|sagopilone|mesh-list
65081752|NCT00350051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65081753|NCT00350051|Glucocorticoids|glucocorticoids|mesh-ancestor
65081754|NCT00350051|Hormones|hormones|mesh-ancestor
65081755|NCT00350051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65081756|NCT00350051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081757|NCT00350051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65081758|NCT00350051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081759|NCT00350090|Epoetin Alfa|epoetin alfa|mesh-list
65081760|NCT00350090|Hematinics|hematinics|mesh-ancestor
65081761|NCT04699110|Adenosine|adenosine|mesh-list
65081762|NCT04699110|Epinephrine|epinephrine|mesh-list
65081763|NCT04699110|Racepinephrine|racepinephrine|mesh-list
65081764|NCT04699110|Epinephryl borate|epinephryl borate|mesh-list
64325281|NCT02156843|Vitamin B Complex|vitamin b complex|mesh-ancestor
65081765|NCT04699110|Analgesics|analgesics|mesh-ancestor
65081766|NCT04699110|Sensory System Agents|sensory system agents|mesh-ancestor
65081767|NCT04699110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64325282|NCT02156843|Vitamins|vitamins|mesh-ancestor
64325283|NCT02156843|Micronutrients|micronutrients|mesh-ancestor
64325284|NCT02156843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325285|NCT02675907|Meloxicam|meloxicam|mesh-list
64325286|NCT02675907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64325287|NCT02675907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64325288|NCT02675907|Analgesics|analgesics|mesh-ancestor
64325289|NCT02675907|Sensory System Agents|sensory system agents|mesh-ancestor
64325290|NCT02675907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64325291|NCT02675907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325292|NCT02675907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64325293|NCT02675907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64834523|NCT05701124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64834525|NCT05701124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081768|NCT04699110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081769|NCT04699110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65081770|NCT04699110|Vasodilator Agents|vasodilator agents|mesh-ancestor
65081771|NCT04699110|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
65081772|NCT04699110|Purinergic Agonists|purinergic agonists|mesh-ancestor
65081773|NCT04699110|Purinergic Agents|purinergic agents|mesh-ancestor
65081774|NCT04699110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65081775|NCT04699110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081776|NCT04699110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65081777|NCT04699110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65081778|NCT04699110|Adrenergic Agents|adrenergic agents|mesh-ancestor
65081779|NCT04699110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65081780|NCT04699110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65081781|NCT04699110|Autonomic Agents|autonomic agents|mesh-ancestor
65081782|NCT04699110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65081783|NCT04699110|Respiratory System Agents|respiratory system agents|mesh-ancestor
65081784|NCT04699110|Mydriatics|mydriatics|mesh-ancestor
65081785|NCT04699110|Sympathomimetics|sympathomimetics|mesh-ancestor
65081786|NCT04699110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65081787|NCT00350168|Amlodipine|amlodipine|mesh-list
65081788|NCT00350168|Valsartan|valsartan|mesh-list
65081789|NCT00350168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65081790|NCT00350168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65081791|NCT00350168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65081792|NCT00350168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081793|NCT00350168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65081794|NCT00350168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081795|NCT00350168|Vasodilator Agents|vasodilator agents|mesh-ancestor
65081796|NCT00350168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65081797|NCT00350168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65081798|NCT00105534|Azithromycin|azithromycin|mesh-list
65081799|NCT00105534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65081800|NCT00105534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65081801|NCT00350441|Sildenafil Citrate|sildenafil citrate|mesh-list
65081802|NCT00350441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081803|NCT00350441|Vasodilator Agents|vasodilator agents|mesh-ancestor
65081804|NCT00350441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64834526|NCT05701124|Growth Inhibitors|growth inhibitors|mesh-ancestor
64834527|NCT05701124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834528|NCT05688085|Amlodipine|amlodipine|mesh-list
64834529|NCT05688085|Irbesartan|irbesartan|mesh-list
64834530|NCT05688085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64834531|NCT05688085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64834532|NCT05688085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64834533|NCT05688085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834534|NCT05688085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64834535|NCT05688085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834536|NCT05688085|Vasodilator Agents|vasodilator agents|mesh-ancestor
64834537|NCT05688085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64834538|NCT05688085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64834539|NCT05645380|Cyclophosphamide|cyclophosphamide|mesh-list
64834540|NCT05645380|Carboplatin|carboplatin|mesh-list
65081805|NCT00350441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65081806|NCT00350441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64723950|NCT00584935|Rituximab|rituximab|mesh-list
65081807|NCT00350441|Urological Agents|urological agents|mesh-ancestor
65081808|NCT00350480|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
65081809|NCT00350480|Contraceptives, Oral|contraceptives, oral|mesh-list
65081810|NCT00350480|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
65081811|NCT00350480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65081812|NCT00350480|Contraceptive Agents|contraceptive agents|mesh-ancestor
65081813|NCT00350480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65081814|NCT00350480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081815|NCT00350480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65081816|NCT00350480|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65081817|NCT00350480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65081818|NCT00350480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081819|NCT00456963|Losartan|losartan|mesh-list
65081820|NCT00456963|Enalapril|enalapril|mesh-list
65081821|NCT00456963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65081822|NCT00456963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65081823|NCT00456963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65081824|NCT00456963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65081825|NCT00456963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081826|NCT00456963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65081827|NCT00456963|Protease Inhibitors|protease inhibitors|mesh-ancestor
65081828|NCT00456963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081829|NCT00350597|Molgramostim|molgramostim|mesh-list
65081830|NCT00350597|Sargramostim|sargramostim|mesh-list
65081831|NCT00350597|Immunologic Factors|immunologic factors|mesh-ancestor
65081832|NCT00350597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081833|NCT00350597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081834|NCT00350753|Bevacizumab|bevacizumab|mesh-list
65081835|NCT00350753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65081836|NCT00350753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65081837|NCT00350753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081838|NCT00350753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65081839|NCT00350753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65081840|NCT00350753|Growth Substances|growth substances|mesh-ancestor
65081841|NCT00350753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081842|NCT00350753|Growth Inhibitors|growth inhibitors|mesh-ancestor
64834550|NCT05645380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834551|NCT05645380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834552|NCT05645380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64834553|NCT05645380|Tubulin Modulators|tubulin modulators|mesh-ancestor
64834554|NCT05645380|Antimitotic Agents|antimitotic agents|mesh-ancestor
64834555|NCT05645380|Mitosis Modulators|mitosis modulators|mesh-ancestor
64834556|NCT05645380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64834557|NCT05645380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64834558|NCT05645380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64834559|NCT05645380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834560|NCT05645380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64834561|NCT05641246|Diclofenac|diclofenac|mesh-list
64834562|NCT05641246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64834563|NCT05641246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64834564|NCT05641246|Analgesics|analgesics|mesh-ancestor
64834565|NCT05641246|Sensory System Agents|sensory system agents|mesh-ancestor
65081843|NCT00350753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65081844|NCT00350753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081845|NCT00350753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081846|NCT00457119|Everolimus|everolimus|mesh-list
64416443|NCT04866355|Ibuprofen|ibuprofen|mesh-list
65081847|NCT00457119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081848|NCT00457119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65081849|NCT00457119|Immunologic Factors|immunologic factors|mesh-ancestor
65081850|NCT00457119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081851|NCT00350948|Doxorubicin|doxorubicin|mesh-list
65081852|NCT00350948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65081853|NCT00350948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65081854|NCT00350948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081855|NCT00350948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65081856|NCT00350948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65081857|NCT00350948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081858|NCT00350948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081859|NCT00450567|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65081860|NCT00450567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65081861|NCT00450567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081863|NCT00421538|Calcium|calcium|mesh-list
65081864|NCT00421538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65081865|NCT00421538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081866|NCT00421538|Anticoagulants|anticoagulants|mesh-ancestor
65081867|NCT00421538|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65081868|NCT00421538|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65081869|NCT00421538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081870|NCT00351026|Methadone|methadone|mesh-list
65081871|NCT00351026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65081872|NCT00351026|Narcotics|narcotics|mesh-ancestor
65081873|NCT00351026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65081874|NCT00351026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081875|NCT00351026|Analgesics|analgesics|mesh-ancestor
65081876|NCT00351026|Sensory System Agents|sensory system agents|mesh-ancestor
65081877|NCT00351026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65081878|NCT00351026|Antitussive Agents|antitussive agents|mesh-ancestor
65081879|NCT00351026|Respiratory System Agents|respiratory system agents|mesh-ancestor
65081880|NCT00351104|Ketoprofen|ketoprofen|mesh-list
64834568|NCT05641246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64834569|NCT05641246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64834570|NCT05641246|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64834571|NCT05641246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834572|NCT05641246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834573|NCT05610735|Doxorubicin|doxorubicin|mesh-list
64834574|NCT05610735|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64834575|NCT05610735|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64834576|NCT05610735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834577|NCT05610735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64834578|NCT05610735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64834579|NCT05610735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834580|NCT05610735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834581|NCT05584709|Immunoconjugates|immunoconjugates|mesh-list
64834582|NCT05584709|Immunologic Factors|immunologic factors|mesh-ancestor
65081881|NCT00351104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65081882|NCT00351104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65081883|NCT00351104|Analgesics|analgesics|mesh-ancestor
65081884|NCT00351104|Sensory System Agents|sensory system agents|mesh-ancestor
65081885|NCT00351104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65081886|NCT00351104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081887|NCT00351104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65081888|NCT00351104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65081889|NCT00351104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65081890|NCT00351104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081891|NCT00351104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081893|NCT00351143|Xhance|xhance|mesh-list
65081894|NCT00351143|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65081895|NCT00351143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65081896|NCT00351143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65081897|NCT00351143|Autonomic Agents|autonomic agents|mesh-ancestor
65081898|NCT00351143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65081899|NCT00351143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081900|NCT00351143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65081901|NCT00351143|Respiratory System Agents|respiratory system agents|mesh-ancestor
65081902|NCT00351143|Dermatologic Agents|dermatologic agents|mesh-ancestor
65081903|NCT00351143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65081904|NCT00351143|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65081905|NCT00351143|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65081906|NCT00351143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65081907|NCT00351143|Adrenergic Agents|adrenergic agents|mesh-ancestor
65081908|NCT00351143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65081909|NCT00351143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081910|NCT00351182|Doxycycline|doxycycline|mesh-list
65081911|NCT00351182|Telithromycin|telithromycin|mesh-list
65081912|NCT00351182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65081913|NCT00351182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65081914|NCT00351182|Antimalarials|antimalarials|mesh-ancestor
65081915|NCT00351182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65081916|NCT00351182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65081917|NCT00457470|Rucaparib|rucaparib|mesh-list
65081918|NCT00457470|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65081919|NCT00457470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081920|NCT00457470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081921|NCT00457470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081922|NCT00457509|Vaccines|vaccines|mesh-list
65081923|NCT00457509|Immunologic Factors|immunologic factors|mesh-ancestor
65081924|NCT00457509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081925|NCT00450645|Heparin|heparin|mesh-list
65081926|NCT00450645|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65081927|NCT00450645|Tinzaparin|tinzaparin|mesh-list
65081928|NCT00450645|Dalteparin|dalteparin|mesh-list
65081929|NCT00450645|Anticoagulants|anticoagulants|mesh-ancestor
65081930|NCT00450645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65081931|NCT00450645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65081932|NCT00450645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081933|NCT00457860|Immunotoxin HA22|immunotoxin ha22|mesh-list
65081934|NCT00457860|Immunotoxins|immunotoxins|mesh-list
65081935|NCT00457860|Immunologic Factors|immunologic factors|mesh-ancestor
65081936|NCT00457860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081937|NCT00457860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081938|NCT00457899|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65081939|NCT00457899|Antidepressive Agents|antidepressive agents|mesh-ancestor
65081940|NCT00457899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65081941|NCT00457899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65081942|NCT00457899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65081943|NCT00457899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65081944|NCT00457899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081945|NCT00351884|Vildagliptin|vildagliptin|mesh-list
65081946|NCT00351884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65081947|NCT00351884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081948|NCT00351884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65081949|NCT00351884|Protease Inhibitors|protease inhibitors|mesh-ancestor
65081950|NCT00351884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081951|NCT00351884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081952|NCT00458055|Niacin|niacin|mesh-list
65081953|NCT00458055|Atorvastatin|atorvastatin|mesh-list
65081954|NCT00458055|Fenofibrate|fenofibrate|mesh-list
65081955|NCT00458055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65081957|NCT00458055|Antimetabolites|antimetabolites|mesh-ancestor
65081958|NCT00458055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081959|NCT00458055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65081960|NCT00458055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65081961|NCT00458055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081962|NCT00458055|Vasodilator Agents|vasodilator agents|mesh-ancestor
65081963|NCT00458055|Vitamin B Complex|vitamin b complex|mesh-ancestor
65081964|NCT00458055|Vitamins|vitamins|mesh-ancestor
65081965|NCT00458055|Micronutrients|micronutrients|mesh-ancestor
65081966|NCT00458055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081967|NCT00450762|Gemcitabine|gemcitabine|mesh-list
65081968|NCT00450762|Carboplatin|carboplatin|mesh-list
65081969|NCT00450762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081970|NCT00450762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65081971|NCT00450762|Antimetabolites|antimetabolites|mesh-ancestor
65081972|NCT00450762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834585|NCT05504486|Serotonin Agents|serotonin agents|mesh-ancestor
64834586|NCT05504486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64834587|NCT05504486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834588|NCT05504486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834589|NCT05504486|Dopamine Agonists|dopamine agonists|mesh-ancestor
64834590|NCT05504486|Dopamine Agents|dopamine agents|mesh-ancestor
64834591|NCT05476939|Everolimus|everolimus|mesh-list
64834592|NCT05476939|TIC10 compound|tic10 compound|mesh-list
64834593|NCT05476939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834594|NCT05476939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64834595|NCT05476939|Immunologic Factors|immunologic factors|mesh-ancestor
64834596|NCT05476939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081973|NCT00450762|Antiviral Agents|antiviral agents|mesh-ancestor
65081974|NCT00450762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65081975|NCT00450762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081976|NCT00450762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65081977|NCT00450762|Immunologic Factors|immunologic factors|mesh-ancestor
65081978|NCT00450762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081979|NCT00352079|Gefitinib|gefitinib|mesh-list
65081980|NCT00352079|BCG Vaccine|bcg vaccine|mesh-list
65081981|NCT00352079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65081982|NCT00352079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65081983|NCT00352079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081984|NCT00352079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081985|NCT00352079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65081986|NCT00352079|Immunologic Factors|immunologic factors|mesh-ancestor
65081987|NCT00352079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65081988|NCT00450840|Simvastatin|simvastatin|mesh-list
65081989|NCT00450840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65081990|NCT00450840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65081991|NCT00450840|Antimetabolites|antimetabolites|mesh-ancestor
65081992|NCT00450840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65081993|NCT00450840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65081994|NCT00450840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65081995|NCT00450840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65081997|NCT00352196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65081998|NCT00352196|Serotonin Agents|serotonin agents|mesh-ancestor
65081999|NCT00352196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65082000|NCT00352196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082001|NCT00352196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082002|NCT00352196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65082003|NCT00352196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65082004|NCT00352196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65082005|NCT00352196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65082006|NCT00352196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65082007|NCT00352196|Dopamine Agents|dopamine agents|mesh-ancestor
65082008|NCT00352235|KRN 7000|krn 7000|mesh-list
65082009|NCT00352235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65082010|NCT00352235|Immunologic Factors|immunologic factors|mesh-ancestor
65082011|NCT00352235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082012|NCT00352235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082013|NCT00352313|Carboplatin|carboplatin|mesh-list
65082014|NCT00352313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082015|NCT00450957|Lycopene|lycopene|mesh-list
65082016|NCT00450957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65082017|NCT00450957|Antioxidants|antioxidants|mesh-ancestor
65082018|NCT00450957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325298|NCT02152865|Lupeol|lupeol|mesh-list
64325299|NCT02152865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64325300|NCT02152943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64325301|NCT02152943|Trastuzumab|trastuzumab|mesh-list
64325302|NCT02152943|Everolimus|everolimus|mesh-list
64325303|NCT02152943|Letrozole|letrozole|mesh-list
64325304|NCT02152943|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
64325305|NCT02152943|Antibodies|antibodies|mesh-list
65082019|NCT00450957|Protective Agents|protective agents|mesh-ancestor
65082020|NCT00450957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082021|NCT00450957|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65082023|NCT00450957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082024|NCT00352430|Nitric Oxide|nitric oxide|mesh-list
65082025|NCT00352430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65082026|NCT00352430|Autonomic Agents|autonomic agents|mesh-ancestor
65082027|NCT00352430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65082028|NCT00352430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082029|NCT00352430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65082030|NCT00352430|Respiratory System Agents|respiratory system agents|mesh-ancestor
64724157|NCT00000355|Buprenorphine|buprenorphine|mesh-list
65082031|NCT00352430|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65082033|NCT00352430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082034|NCT00352430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65082035|NCT00352430|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65082036|NCT00352430|Vasodilator Agents|vasodilator agents|mesh-ancestor
65082037|NCT00352430|Gasotransmitters|gasotransmitters|mesh-ancestor
65082038|NCT00352430|Protective Agents|protective agents|mesh-ancestor
65082039|NCT00352469|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65082040|NCT00352469|Antidepressive Agents|antidepressive agents|mesh-ancestor
65082041|NCT00352469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65082042|NCT00352469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65082043|NCT00352469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65082044|NCT00352469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65082045|NCT00352469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082046|NCT00451074|Gentamicins|gentamicins|mesh-list
65082047|NCT00451074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65082048|NCT00451074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65082049|NCT00451074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65082050|NCT00451074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082051|NCT00451074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082052|NCT00465621|Latanoprost|latanoprost|mesh-list
65082053|NCT00465621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65082054|NCT00465621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65082055|NCT00352625|Ketoprofen|ketoprofen|mesh-list
65082056|NCT00352625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65082057|NCT00352625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65082058|NCT00352625|Analgesics|analgesics|mesh-ancestor
65082059|NCT00352625|Sensory System Agents|sensory system agents|mesh-ancestor
65082060|NCT00352625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65082061|NCT00352625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082062|NCT00352625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65082063|NCT00352625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65082064|NCT00352625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65082065|NCT00352625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082066|NCT00352625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082067|NCT00352742|Bortezomib|bortezomib|mesh-list
65082068|NCT00352742|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
65082069|NCT00352742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834598|NCT05458232|Vasodilator Agents|vasodilator agents|mesh-ancestor
64834599|NCT05458232|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64834600|NCT05458232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64834601|NCT05458232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834602|NCT05458232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834603|NCT05458232|Urological Agents|urological agents|mesh-ancestor
64834604|NCT05429502|Temozolomide|temozolomide|mesh-list
64834605|NCT05429502|Topotecan|topotecan|mesh-list
64834606|NCT05429502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64834607|NCT05429502|Alkylating Agents|alkylating agents|mesh-ancestor
64425262|NCT02463409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082070|NCT00352742|Chelating Agents|chelating agents|mesh-ancestor
65082071|NCT00352742|Sequestering Agents|sequestering agents|mesh-ancestor
65082072|NCT00352742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082073|NCT00352742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082074|NCT00352742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65082075|NCT00352742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65082076|NCT00352742|Growth Substances|growth substances|mesh-ancestor
65082077|NCT00352742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082078|NCT00352742|Growth Inhibitors|growth inhibitors|mesh-ancestor
65082079|NCT00352859|Gemcitabine|gemcitabine|mesh-list
65082080|NCT00352859|Interferons|interferons|mesh-list
65082081|NCT00352859|Sorafenib|sorafenib|mesh-list
65082082|NCT00352859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65082083|NCT00352859|Antimetabolites|antimetabolites|mesh-ancestor
65082084|NCT00352859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082085|NCT00352859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082086|NCT00352859|Antiviral Agents|antiviral agents|mesh-ancestor
65082087|NCT00352859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65082088|NCT00352859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082089|NCT00352859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65082090|NCT00352859|Immunologic Factors|immunologic factors|mesh-ancestor
65082091|NCT00352859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082092|NCT00352859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65082093|NCT00105183|Immunoglobulins|immunoglobulins|mesh-list
65082094|NCT00105183|Antibodies|antibodies|mesh-list
65082095|NCT00105183|gamma-Globulins|gamma-globulins|mesh-list
65082096|NCT00105183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65082097|NCT00105183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65082098|NCT00105183|Immunoglobulin G|immunoglobulin g|mesh-list
65082099|NCT00105183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65082100|NCT00105183|Immunologic Factors|immunologic factors|mesh-ancestor
65082101|NCT00105183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082102|NCT00105183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65082103|NCT00466089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65082104|NCT00466089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082105|NCT00466089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65082106|NCT00466089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082107|NCT00466089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082109|NCT00466128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65082110|NCT00466128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65082111|NCT00466128|Analgesics|analgesics|mesh-ancestor
65082112|NCT00466128|Sensory System Agents|sensory system agents|mesh-ancestor
65082113|NCT00466128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65082114|NCT00466128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082115|NCT00466128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65082116|NCT00466128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65082117|NCT00466128|Gout Suppressants|gout suppressants|mesh-ancestor
65082118|NCT00466128|Tocolytic Agents|tocolytic agents|mesh-ancestor
65082119|NCT00466128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65082120|NCT00466128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65082121|NCT00466128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082122|NCT00466128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082123|NCT00353015|Cisplatin|cisplatin|mesh-list
65082124|NCT00353015|Irinotecan|irinotecan|mesh-list
65082125|NCT00353015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082126|NCT00353015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65082127|NCT00353015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65082128|NCT00353015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082129|NCT00353015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082130|NCT00466284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65082131|NCT00466284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082132|NCT00466284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65082133|NCT00466284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082134|NCT00466284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082135|NCT00353054|Calcium Carbonate|calcium carbonate|mesh-list
65082136|NCT00353054|Antacids|antacids|mesh-ancestor
65082137|NCT00353054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082138|NCT00353054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65082139|NCT00466401|Simvastatin|simvastatin|mesh-list
65082140|NCT00466401|Ezetimibe|ezetimibe|mesh-list
65082141|NCT00466401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65082142|NCT00466401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65082143|NCT00466401|Antimetabolites|antimetabolites|mesh-ancestor
65082144|NCT00466401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082145|NCT00466401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65082146|NCT00466401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65082147|NCT00466401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082148|NCT00466479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65082149|NCT00466479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65082150|NCT00466479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65082151|NCT00466479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65082152|NCT00466479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65082153|NCT00466479|Adrenergic Agents|adrenergic agents|mesh-ancestor
65082154|NCT00466479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65082155|NCT00466479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082156|NCT00466479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082157|NCT00466518|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65082158|NCT00466518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64325306|NCT02152943|Immunoglobulins|immunoglobulins|mesh-list
64325307|NCT02152943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64325308|NCT02152943|Immunologic Factors|immunologic factors|mesh-ancestor
64325309|NCT02152943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325310|NCT02152943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325311|NCT02152943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64834608|NCT05429502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834609|NCT05429502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834610|NCT05429502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64834611|NCT05429502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64834613|NCT05274243|Phenol|phenol|mesh-list
64834614|NCT05274243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64834615|NCT05274243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64834616|NCT05274243|Disinfectants|disinfectants|mesh-ancestor
64834617|NCT05274243|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64445774|NCT01562548|Sympathomimetics|sympathomimetics|mesh-ancestor
64425366|NCT05405309|Olaparib|olaparib|mesh-list
65082159|NCT00466518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082160|NCT00466518|Incretins|incretins|mesh-ancestor
65082161|NCT00466518|Hormones|hormones|mesh-ancestor
65082162|NCT00466518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65082163|NCT00466518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65082164|NCT00466518|Protease Inhibitors|protease inhibitors|mesh-ancestor
65082165|NCT00466518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082166|NCT00466518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082167|NCT00353561|Fluconazole|fluconazole|mesh-list
65082168|NCT00353561|Antifungal Agents|antifungal agents|mesh-ancestor
65082169|NCT00353561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65082170|NCT00353561|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65082171|NCT00353561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65082172|NCT00353561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082173|NCT00353561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082174|NCT00353561|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65082175|NCT00353561|Hormone Antagonists|hormone antagonists|mesh-ancestor
65082176|NCT00353561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65082177|NCT00353561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082178|NCT00353561|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65082179|NCT00353561|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65082180|NCT00466596|Vitamins|vitamins|mesh-list
65082181|NCT00466596|Vitamin E|vitamin e|mesh-list
65082182|NCT00466596|Tocopherols|tocopherols|mesh-list
65082183|NCT00466596|Tocotrienols|tocotrienols|mesh-list
65082184|NCT00466596|alpha-Tocopherol|alpha-tocopherol|mesh-list
65082185|NCT00466596|gamma-Tocopherol|gamma-tocopherol|mesh-list
65082186|NCT00466596|Micronutrients|micronutrients|mesh-ancestor
65082187|NCT00466596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082188|NCT00466596|Antioxidants|antioxidants|mesh-ancestor
65082189|NCT00466596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082190|NCT00466596|Protective Agents|protective agents|mesh-ancestor
65082191|NCT00353678|Darexaban|darexaban|mesh-list
65082192|NCT00353678|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65082193|NCT00353678|Antithrombins|antithrombins|mesh-ancestor
65082194|NCT00353678|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65082195|NCT00353678|Protease Inhibitors|protease inhibitors|mesh-ancestor
65082196|NCT00353678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082197|NCT00353678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082198|NCT00353678|Anticoagulants|anticoagulants|mesh-ancestor
65082199|NCT00458250|Cyclosporine|cyclosporine|mesh-list
65082200|NCT00458250|Cyclophosphamide|cyclophosphamide|mesh-list
65082201|NCT00458250|Busulfan|busulfan|mesh-list
65082202|NCT00458250|Methotrexate|methotrexate|mesh-list
65082203|NCT00458250|Alemtuzumab|alemtuzumab|mesh-list
65082204|NCT00458250|Cyclosporins|cyclosporins|mesh-list
65082205|NCT00458250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65082206|NCT00458250|Immunologic Factors|immunologic factors|mesh-ancestor
65082207|NCT00458250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082208|NCT00458250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65082209|NCT00458250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65082210|NCT00458250|Alkylating Agents|alkylating agents|mesh-ancestor
65082211|NCT00458250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082212|NCT00458250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082213|NCT00458250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65082214|NCT00458250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65082215|NCT00458250|Abortifacient Agents|abortifacient agents|mesh-ancestor
65082216|NCT00458250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65082217|NCT00458250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65082218|NCT00458250|Antimetabolites|antimetabolites|mesh-ancestor
65082219|NCT00458250|Dermatologic Agents|dermatologic agents|mesh-ancestor
65082220|NCT00458250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64325313|NCT02152943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64325314|NCT02152943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834619|NCT05270733|Ustekinumab|ustekinumab|mesh-list
64834620|NCT05270733|Dermatologic Agents|dermatologic agents|mesh-ancestor
64834621|NCT05253417|Cannabidiol|cannabidiol|mesh-list
64834622|NCT05253417|Anticonvulsants|anticonvulsants|mesh-ancestor
64834623|NCT05184803|Docetaxel|docetaxel|mesh-list
64834624|NCT05184803|Oxaliplatin|oxaliplatin|mesh-list
64834625|NCT05184803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834626|NCT05184803|Tubulin Modulators|tubulin modulators|mesh-ancestor
64834627|NCT05184803|Antimitotic Agents|antimitotic agents|mesh-ancestor
64834628|NCT05184803|Mitosis Modulators|mitosis modulators|mesh-ancestor
64834629|NCT05184803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834630|NCT05062083|11C-PS13|11c-ps13|mesh-list
64834631|NCT05062083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64445784|NCT03027934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64325315|NCT02152943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325316|NCT02152943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64325317|NCT02152943|Hormone Antagonists|hormone antagonists|mesh-ancestor
64325318|NCT02152943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64325319|NCT02156999|Vitamin D|vitamin d|mesh-list
64325320|NCT02156999|Ibandronic Acid|ibandronic acid|mesh-list
64325321|NCT02156999|Vitamins|vitamins|mesh-ancestor
64325322|NCT02156999|Micronutrients|micronutrients|mesh-ancestor
64325323|NCT02156999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082221|NCT00458250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65082222|NCT00458250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65082223|NCT00458250|Antifungal Agents|antifungal agents|mesh-ancestor
65082224|NCT00458250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65082225|NCT00458250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65082226|NCT00458250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65082228|NCT00353717|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65082229|NCT00353717|Cetuximab|cetuximab|mesh-list
65082230|NCT00353717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65082231|NCT00353717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082232|NCT00353717|Tubulin Modulators|tubulin modulators|mesh-ancestor
65082233|NCT00353717|Antimitotic Agents|antimitotic agents|mesh-ancestor
65082234|NCT00353717|Mitosis Modulators|mitosis modulators|mesh-ancestor
65082235|NCT00353717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082236|NCT00353717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65082237|NCT00466713|Rosiglitazone|rosiglitazone|mesh-list
65082238|NCT00466713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65082239|NCT00466713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082240|NCT00466791|Methylphenidate|methylphenidate|mesh-list
65082241|NCT00466791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65082242|NCT00466791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082243|NCT00466791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65082244|NCT00466791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65082245|NCT00466791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65082246|NCT00466791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082247|NCT00466791|Dopamine Agents|dopamine agents|mesh-ancestor
65082248|NCT00466791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65082249|NCT00353912|Amlodipine|amlodipine|mesh-list
65082250|NCT00353912|Valsartan|valsartan|mesh-list
65082251|NCT00353912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65082252|NCT00353912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65082253|NCT00353912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65082254|NCT00353912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082255|NCT00353912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65082256|NCT00353912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082257|NCT00353912|Vasodilator Agents|vasodilator agents|mesh-ancestor
65082258|NCT00353912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65082259|NCT00353912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65082260|NCT00353990|Insulin Aspart|insulin aspart|mesh-list
65082261|NCT00353990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65082262|NCT00353990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834632|NCT05062083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834633|NCT05030506|Pembrolizumab|pembrolizumab|mesh-list
64834634|NCT05030506|Lenvatinib|lenvatinib|mesh-list
64834635|NCT05030506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64834636|NCT05030506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834637|NCT05030506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64834638|NCT05030506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834639|NCT05030506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834640|NCT04979052|Interferons|interferons|mesh-list
64834641|NCT04979052|Interferon-gamma|interferon-gamma|mesh-list
64834642|NCT04979052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834643|NCT04979052|Antiviral Agents|antiviral agents|mesh-ancestor
64834644|NCT04979052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64834645|NCT04948333|Niacinamide|niacinamide|mesh-list
64834646|NCT04948333|Vitamin B Complex|vitamin b complex|mesh-ancestor
64425476|NCT01638533|Romidepsin|romidepsin|mesh-list
65082263|NCT00458328|Z 338|z 338|mesh-list
65082264|NCT00458328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65082265|NCT00458328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082266|NCT00458328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082267|NCT00458328|Cholinergic Agents|cholinergic agents|mesh-ancestor
65082268|NCT00458328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65082269|NCT00458328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082270|NCT00458328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65082271|NCT00354068|Temozolomide|temozolomide|mesh-list
65082272|NCT00354068|Imatinib Mesylate|imatinib mesylate|mesh-list
65082273|NCT00354068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65082274|NCT00354068|Alkylating Agents|alkylating agents|mesh-ancestor
65082275|NCT00354068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082276|NCT00354068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082277|NCT00354068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65082278|NCT00354068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082279|NCT00466869|Betahistine|betahistine|mesh-list
65082280|NCT00466869|Vasodilator Agents|vasodilator agents|mesh-ancestor
65082281|NCT00466869|Histamine Agonists|histamine agonists|mesh-ancestor
65082282|NCT00466869|Histamine Agents|histamine agents|mesh-ancestor
65082283|NCT00466869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65082284|NCT00466869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082285|NCT00466869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082287|NCT00354146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082288|NCT00458367|Risperidone|risperidone|mesh-list
65082289|NCT00458367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65082290|NCT00458367|Serotonin Agents|serotonin agents|mesh-ancestor
65082291|NCT00458367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65082292|NCT00458367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082293|NCT00458367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082294|NCT00458367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65082295|NCT00458367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65082296|NCT00458367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65082297|NCT00458367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65082298|NCT00458367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65082299|NCT00458367|Dopamine Agents|dopamine agents|mesh-ancestor
65082300|NCT00354185|Belinostat|belinostat|mesh-list
65082301|NCT00354185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082302|NCT00354185|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65082303|NCT00354185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082304|NCT00354185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082305|NCT00466986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65082306|NCT00466986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082307|NCT00354302|Calcium, Dietary|calcium, dietary|mesh-list
65082308|NCT00354302|Cholecalciferol|cholecalciferol|mesh-list
65082309|NCT00354302|Alendronate|alendronate|mesh-list
65082310|NCT00354302|Risedronic Acid|risedronic acid|mesh-list
65082311|NCT00354302|Calcium Carbonate|calcium carbonate|mesh-list
65082312|NCT00354302|Calcium|calcium|mesh-list
65082313|NCT00354302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65082314|NCT00354302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082315|NCT00354302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65082316|NCT00354302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082317|NCT00354302|Vitamins|vitamins|mesh-ancestor
65082318|NCT00354302|Micronutrients|micronutrients|mesh-ancestor
64834647|NCT04948333|Vitamins|vitamins|mesh-ancestor
64834648|NCT04948333|Micronutrients|micronutrients|mesh-ancestor
64834649|NCT04948333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834650|NCT04911621|Temozolomide|temozolomide|mesh-list
64834651|NCT04911621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64834652|NCT04911621|Alkylating Agents|alkylating agents|mesh-ancestor
64834653|NCT04911621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325327|NCT05014581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65082319|NCT00354302|Antacids|antacids|mesh-ancestor
65082320|NCT00354302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65082321|NCT00354302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65082322|NCT00354302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65082323|NCT04714229|Vaccines|vaccines|mesh-list
65082324|NCT04714229|Immunologic Factors|immunologic factors|mesh-ancestor
65082325|NCT04714229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082326|NCT00458523|Alemtuzumab|alemtuzumab|mesh-list
65082327|NCT00458523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65082328|NCT00458523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082329|NCT00354380|Artesunate|artesunate|mesh-list
65082330|NCT00354380|Amodiaquine|amodiaquine|mesh-list
65082331|NCT00354380|Methylene Blue|methylene blue|mesh-list
65082332|NCT00354380|Antimalarials|antimalarials|mesh-ancestor
65082333|NCT00354380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65082334|NCT00354380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65082335|NCT00354380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65082336|NCT00354380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082337|NCT00354380|Antiviral Agents|antiviral agents|mesh-ancestor
65082338|NCT00354380|Schistosomicides|schistosomicides|mesh-ancestor
65082339|NCT00354380|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65082340|NCT00354380|Anthelmintics|anthelmintics|mesh-ancestor
65082341|NCT00354380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082342|NCT00354380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082343|NCT00354419|Cyclosporine|cyclosporine|mesh-list
65082344|NCT00354419|Mycophenolic Acid|mycophenolic acid|mesh-list
65082345|NCT00354419|Cyclophosphamide|cyclophosphamide|mesh-list
65082346|NCT00354419|Cyclosporins|cyclosporins|mesh-list
65082347|NCT00354419|Thymoglobulin|thymoglobulin|mesh-list
65082348|NCT00354419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65082349|NCT00354419|Lenograstim|lenograstim|mesh-list
65082350|NCT00354419|Immunoglobulins|immunoglobulins|mesh-list
65082351|NCT00354419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65082352|NCT00354419|Immunologic Factors|immunologic factors|mesh-ancestor
65082353|NCT00354419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082354|NCT00354419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65082355|NCT00354419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65082356|NCT00354419|Alkylating Agents|alkylating agents|mesh-ancestor
65082357|NCT00354419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082358|NCT00354419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082359|NCT00354419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65082360|NCT00354419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65082361|NCT00354419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082362|NCT00354419|Antifungal Agents|antifungal agents|mesh-ancestor
65082363|NCT00354419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65082364|NCT00354419|Dermatologic Agents|dermatologic agents|mesh-ancestor
65082365|NCT00354419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65082366|NCT00354419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65082367|NCT00354419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65082368|NCT00354419|Antitubercular Agents|antitubercular agents|mesh-ancestor
65082369|NCT00354419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65082371|NCT00354458|Diuretics|diuretics|mesh-ancestor
64325329|NCT05014581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64325330|NCT05014581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834655|NCT04877522|Niacinamide|niacinamide|mesh-list
64834656|NCT04877522|Imatinib Mesylate|imatinib mesylate|mesh-list
64834657|NCT04877522|Dasatinib|dasatinib|mesh-list
64834658|NCT04877522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834659|NCT04877522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64834660|NCT04877522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834661|NCT04877522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834662|NCT04877522|Vitamin B Complex|vitamin b complex|mesh-ancestor
64834663|NCT04877522|Vitamins|vitamins|mesh-ancestor
65082372|NCT00354458|Natriuretic Agents|natriuretic agents|mesh-ancestor
65082373|NCT00354458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082374|NCT00458718|Rimonabant|rimonabant|mesh-list
65082375|NCT00458718|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65082376|NCT00458718|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65082377|NCT00458718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65082378|NCT00458718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65082379|NCT00458718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082380|NCT00458718|Hormones|hormones|mesh-ancestor
65082381|NCT00458718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65082382|NCT00458718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082383|NCT00467181|Fenoldopam|fenoldopam|mesh-list
65082384|NCT00467181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65082385|NCT00467181|Vasodilator Agents|vasodilator agents|mesh-ancestor
65082386|NCT00467181|Dopamine Agonists|dopamine agonists|mesh-ancestor
65082387|NCT00467181|Dopamine Agents|dopamine agents|mesh-ancestor
65082388|NCT00467181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65082389|NCT00467181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082390|NCT00467181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082391|NCT00425711|Acamprosate|acamprosate|mesh-list
65082392|NCT00425711|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65082393|NCT03274011|Apatinib|apatinib|mesh-list
65082394|NCT03274011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082395|NCT03274011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65082396|NCT03274011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082397|NCT03274011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082398|NCT00425906|Nicotine|nicotine|mesh-list
65082399|NCT00425906|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65082400|NCT00425906|Autonomic Agents|autonomic agents|mesh-ancestor
65082401|NCT00425906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65082402|NCT00425906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082403|NCT00425906|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65082404|NCT00425906|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65082405|NCT00425906|Cholinergic Agents|cholinergic agents|mesh-ancestor
65082406|NCT00425906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65082407|NCT00425906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082408|NCT00467376|Insulin|insulin|mesh-list
65082409|NCT00467376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65082410|NCT00467376|Insulin Glargine|insulin glargine|mesh-list
65082411|NCT00467376|Insulin glulisine|insulin glulisine|mesh-list
65082412|NCT00467376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65082413|NCT00467376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082414|NCT00426023|Ketotifen|ketotifen|mesh-list
65082415|NCT00426023|Cyclosporine|cyclosporine|mesh-list
65082416|NCT00426023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65082417|NCT00426023|Cyclosporins|cyclosporins|mesh-list
65082418|NCT00426023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082419|NCT00426023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082420|NCT00426023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65082421|NCT00426023|Immunologic Factors|immunologic factors|mesh-ancestor
65082422|NCT00426023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834664|NCT04877522|Micronutrients|micronutrients|mesh-ancestor
64834665|NCT04877522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834666|NCT04855266|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64834667|NCT04855266|Hematinics|hematinics|mesh-ancestor
64834668|NCT04764643|Acetylcysteine|acetylcysteine|mesh-list
64834669|NCT04764643|Sodium thiosulfate|sodium thiosulfate|mesh-list
64834670|NCT04764643|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64834671|NCT04764643|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64834672|NCT04764643|Antiviral Agents|antiviral agents|mesh-ancestor
64834673|NCT04764643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64834674|NCT04764643|Expectorants|expectorants|mesh-ancestor
64425658|NCT02256969|Sulfacetamide|sulfacetamide|mesh-list
65082423|NCT00426023|Antifungal Agents|antifungal agents|mesh-ancestor
65082424|NCT00426023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65082425|NCT00426023|Dermatologic Agents|dermatologic agents|mesh-ancestor
65082426|NCT00426023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65082427|NCT00426023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65082428|NCT00426023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65082429|NCT00426023|Antipruritics|antipruritics|mesh-ancestor
65082430|NCT00426023|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65082431|NCT00426023|Histamine Antagonists|histamine antagonists|mesh-ancestor
65082432|NCT00426023|Histamine Agents|histamine agents|mesh-ancestor
65082433|NCT00426023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65082434|NCT00426023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65082435|NCT00467454|Naltrexone|naltrexone|mesh-list
65082436|NCT00467454|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65082437|NCT00467454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65082438|NCT00467454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082439|NCT00467454|Sensory System Agents|sensory system agents|mesh-ancestor
65082440|NCT00467454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65082441|NCT00426101|Cyclosporine|cyclosporine|mesh-list
65082442|NCT00426101|Dexamethasone|dexamethasone|mesh-list
65082443|NCT00426101|Etoposide|etoposide|mesh-list
65082444|NCT00426101|Cyclosporins|cyclosporins|mesh-list
65082445|NCT00426101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65082446|NCT00426101|Antiemetics|antiemetics|mesh-ancestor
65082447|NCT00426101|Autonomic Agents|autonomic agents|mesh-ancestor
65082448|NCT00426101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65082449|NCT00426101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082450|NCT00426101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65082451|NCT00426101|Glucocorticoids|glucocorticoids|mesh-ancestor
65082452|NCT00426101|Hormones|hormones|mesh-ancestor
65082453|NCT00426101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65082454|NCT00426101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65082455|NCT00426101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082456|NCT00426101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64325331|NCT05014581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325332|NCT05014581|Sympathomimetics|sympathomimetics|mesh-ancestor
64325333|NCT05014581|Autonomic Agents|autonomic agents|mesh-ancestor
64834675|NCT04764643|Respiratory System Agents|respiratory system agents|mesh-ancestor
64834676|NCT04764643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64834677|NCT04764643|Antioxidants|antioxidants|mesh-ancestor
64834678|NCT04764643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834679|NCT04764643|Protective Agents|protective agents|mesh-ancestor
64834680|NCT04764643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834681|NCT04764643|Antidotes|antidotes|mesh-ancestor
64834682|NCT04764643|Antitubercular Agents|antitubercular agents|mesh-ancestor
64834683|NCT04764643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64834684|NCT04764643|Chelating Agents|chelating agents|mesh-ancestor
64834685|NCT04764643|Sequestering Agents|sequestering agents|mesh-ancestor
64834686|NCT04706429|Trientine|trientine|mesh-list
64834687|NCT04706429|Chelating Agents|chelating agents|mesh-ancestor
64834688|NCT04706429|Sequestering Agents|sequestering agents|mesh-ancestor
64325334|NCT05014581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64325335|NCT05014581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64325336|NCT04719273|Anastrozole|anastrozole|mesh-list
64325338|NCT04719273|Progesterone|progesterone|mesh-list
64425719|NCT02255565|Dopamine Agents|dopamine agents|mesh-ancestor
65082457|NCT00426101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65082458|NCT00426101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65082459|NCT00426101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082460|NCT00426101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082461|NCT00426101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65082462|NCT00426101|Immunologic Factors|immunologic factors|mesh-ancestor
65082463|NCT00426101|Antifungal Agents|antifungal agents|mesh-ancestor
65082464|NCT00426101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65082465|NCT00426101|Dermatologic Agents|dermatologic agents|mesh-ancestor
65082466|NCT00426101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65082467|NCT00426101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65082468|NCT00426140|Epothilone B|epothilone b|mesh-list
65082469|NCT00426140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082470|NCT00426140|Tubulin Modulators|tubulin modulators|mesh-ancestor
65082471|NCT00426140|Antimitotic Agents|antimitotic agents|mesh-ancestor
65082472|NCT00426140|Mitosis Modulators|mitosis modulators|mesh-ancestor
65082473|NCT00426140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082474|NCT00467493|Anastrozole|anastrozole|mesh-list
65082475|NCT00467493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65082476|NCT00467493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082477|NCT00467493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65082478|NCT00467493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65082479|NCT00467493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082480|NCT00467493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082481|NCT00467493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65082482|NCT00467493|Hormone Antagonists|hormone antagonists|mesh-ancestor
65082483|NCT00467493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65082484|NCT00467493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082486|NCT00426179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082487|NCT00426179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65082488|NCT00426179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082489|NCT00426179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082490|NCT00458913|Bortezomib|bortezomib|mesh-list
65082491|NCT00458913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082492|NCT00458991|Dextromethorphan|dextromethorphan|mesh-list
65082493|NCT00458991|Caffeine|caffeine|mesh-list
65082494|NCT00458991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65082495|NCT00458991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082496|NCT00458991|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65082497|NCT00458991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082498|NCT00458991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082499|NCT00458991|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65082500|NCT00458991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65082501|NCT00458991|Purinergic Agents|purinergic agents|mesh-ancestor
65082502|NCT00458991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65082503|NCT00458991|Antitussive Agents|antitussive agents|mesh-ancestor
64416465|NCT02607865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65082504|NCT00458991|Respiratory System Agents|respiratory system agents|mesh-ancestor
65082505|NCT00458991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65082506|NCT00458991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65082507|NCT01059617|Vaccines|vaccines|mesh-list
65082508|NCT01059617|Immunologic Factors|immunologic factors|mesh-ancestor
65082509|NCT01059617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082510|NCT04705337|Simendan|simendan|mesh-list
65082511|NCT04705337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65082512|NCT04705337|Vasodilator Agents|vasodilator agents|mesh-ancestor
65082513|NCT04705337|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65082514|NCT04705337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65082515|NCT04705337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082516|NCT04705337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082517|NCT04705337|Protective Agents|protective agents|mesh-ancestor
65082518|NCT04705337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082519|NCT00467571|Amoxicillin|amoxicillin|mesh-list
65082520|NCT00467571|Clarithromycin|clarithromycin|mesh-list
65082521|NCT00467571|Lansoprazole|lansoprazole|mesh-list
65082522|NCT00467571|Dexlansoprazole|dexlansoprazole|mesh-list
65082523|NCT00467571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65082524|NCT00467571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65082525|NCT00467571|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65082526|NCT00467571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082527|NCT00467571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082528|NCT00467571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65082529|NCT00467571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64834689|NCT04706429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834690|NCT04625803|Apatinib|apatinib|mesh-list
64834691|NCT04625803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834692|NCT04625803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64834693|NCT04625803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834694|NCT04625803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834695|NCT04558892|Enoxaparin|enoxaparin|mesh-list
64834696|NCT04558892|Anticoagulants|anticoagulants|mesh-ancestor
64834697|NCT04558892|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64834698|NCT04558892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64325343|NCT04719273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325344|NCT04719273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64325345|NCT04719273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325346|NCT04719273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64425833|NCT01640925|Chlorhexidine|chlorhexidine|mesh-list
65082530|NCT00467571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65082531|NCT00467571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65082532|NCT00467571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65082533|NCT00426296|Ritonavir|ritonavir|mesh-list
65082534|NCT00426296|Atazanavir Sulfate|atazanavir sulfate|mesh-list
65082535|NCT00426296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65082536|NCT00426296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65082537|NCT00426296|Protease Inhibitors|protease inhibitors|mesh-ancestor
65082538|NCT00426296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082539|NCT00426296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082540|NCT00426296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65082541|NCT00426296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65082542|NCT00426296|Antiviral Agents|antiviral agents|mesh-ancestor
65082543|NCT00426296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65082544|NCT00426296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65082545|NCT00426296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65082546|NCT03271905|Bromides|bromides|mesh-list
65082547|NCT03271905|Albuterol|albuterol|mesh-list
65082548|NCT03271905|Ipratropium|ipratropium|mesh-list
65082549|NCT03271905|Anticonvulsants|anticonvulsants|mesh-ancestor
65082550|NCT03271905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65082551|NCT03271905|Autonomic Agents|autonomic agents|mesh-ancestor
65082552|NCT03271905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65082553|NCT03271905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082554|NCT03271905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65082555|NCT03271905|Respiratory System Agents|respiratory system agents|mesh-ancestor
65082556|NCT03271905|Tocolytic Agents|tocolytic agents|mesh-ancestor
65082557|NCT03271905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65082558|NCT03271905|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65082559|NCT03271905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65082560|NCT03271905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65082561|NCT03271905|Adrenergic Agents|adrenergic agents|mesh-ancestor
65082562|NCT03271905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65082563|NCT03271905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082564|NCT03271905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65082565|NCT03271905|Cholinergic Agents|cholinergic agents|mesh-ancestor
65082566|NCT00426413|Pioglitazone|pioglitazone|mesh-list
65082567|NCT00426413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65082568|NCT00426413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082569|NCT00459264|Folic Acid|folic acid|mesh-list
65082570|NCT00459264|Hematinics|hematinics|mesh-ancestor
65082571|NCT00459264|Vitamin B Complex|vitamin b complex|mesh-ancestor
65082572|NCT00459264|Vitamins|vitamins|mesh-ancestor
65082573|NCT00459264|Micronutrients|micronutrients|mesh-ancestor
65082574|NCT00459264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082575|NCT00426452|Vatalanib|vatalanib|mesh-list
65082576|NCT00426452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65082577|NCT00426452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082578|NCT00426452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082580|NCT00426491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65082581|NCT00426491|Abortifacient Agents|abortifacient agents|mesh-ancestor
65082582|NCT00426491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65082583|NCT00426491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082584|NCT00426491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65082585|NCT00426491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65082586|NCT00426491|Oxytocics|oxytocics|mesh-ancestor
65082587|NCT00426530|Everolimus|everolimus|mesh-list
65082588|NCT00426530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082589|NCT00426530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65082590|NCT00426530|Immunologic Factors|immunologic factors|mesh-ancestor
65082591|NCT00426530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082592|NCT00459420|Caffeine|caffeine|mesh-list
65082593|NCT00459420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65082594|NCT00459420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082595|NCT00459420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65082596|NCT00459420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082597|NCT00459420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082598|NCT00459420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65082599|NCT00459420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65082600|NCT00459420|Purinergic Agents|purinergic agents|mesh-ancestor
65082601|NCT00459420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65082602|NCT00467766|Donepezil|donepezil|mesh-list
65082603|NCT00467766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65082604|NCT00467766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082605|NCT00467766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082606|NCT00467766|Cholinergic Agents|cholinergic agents|mesh-ancestor
65082607|NCT00467766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65082608|NCT00467766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082609|NCT00467766|Nootropic Agents|nootropic agents|mesh-ancestor
65082610|NCT04705415|Niclosamide|niclosamide|mesh-list
65082611|NCT04705415|Anticestodal Agents|anticestodal agents|mesh-ancestor
65082612|NCT04705415|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65082613|NCT04705415|Anthelmintics|anthelmintics|mesh-ancestor
65082614|NCT04705415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65082615|NCT04705415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65082616|NCT04705415|Antinematodal Agents|antinematodal agents|mesh-ancestor
65082617|NCT00467883|Amphotericin B|amphotericin b|mesh-list
65082618|NCT00467883|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65082619|NCT00467883|Amebicides|amebicides|mesh-ancestor
65082620|NCT00467883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65082621|NCT00467883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65082622|NCT00467883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65082623|NCT00467883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65082624|NCT00467883|Antifungal Agents|antifungal agents|mesh-ancestor
65082625|NCT00426608|Alprazolam|alprazolam|mesh-list
65082626|NCT00426608|Metyrapone|metyrapone|mesh-list
65082627|NCT00426608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65082628|NCT00426608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65082629|NCT00426608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834699|NCT04558892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834700|NCT04551885|Aldesleukin|aldesleukin|mesh-list
64834701|NCT04551885|Cyclophosphamide|cyclophosphamide|mesh-list
64834702|NCT04551885|Fludarabine|fludarabine|mesh-list
64834703|NCT04551885|Avelumab|avelumab|mesh-list
64834713|NCT04551885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65082630|NCT00426608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65082631|NCT00426608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65082632|NCT00426608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65082633|NCT00426608|GABA Modulators|gaba modulators|mesh-ancestor
65082634|NCT00426608|GABA Agents|gaba agents|mesh-ancestor
65082635|NCT00426608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65082636|NCT00426608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082637|NCT00426608|Antimetabolites|antimetabolites|mesh-ancestor
65082638|NCT00426608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082639|NCT00426647|Buprenorphine|buprenorphine|mesh-list
65082640|NCT00426647|Tramadol|tramadol|mesh-list
65082641|NCT00426647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65082642|NCT00426647|Narcotics|narcotics|mesh-ancestor
65082643|NCT00426647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65082644|NCT00426647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082645|NCT00426647|Analgesics|analgesics|mesh-ancestor
65082646|NCT00426647|Sensory System Agents|sensory system agents|mesh-ancestor
65082647|NCT00426647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65082648|NCT00426647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65082649|NCT01059071|Eflornithine|eflornithine|mesh-list
65082650|NCT01059071|Etoposide|etoposide|mesh-list
65082651|NCT01059071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65082652|NCT01059071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082653|NCT01059071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65082654|NCT01059071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65082655|NCT01059071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082656|NCT01059071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082657|NCT01059071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65082658|NCT01059071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65082659|NCT01059071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65082660|NCT01059071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65082661|NCT01059071|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
65082663|NCT00468234|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65082664|NCT00468234|Autonomic Agents|autonomic agents|mesh-ancestor
65082665|NCT00468234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65082666|NCT00468234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082667|NCT00468234|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65082668|NCT00468234|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65082669|NCT00468234|Cholinergic Agents|cholinergic agents|mesh-ancestor
65082670|NCT00468234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65082671|NCT00468234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082672|NCT00459615|Artesunate|artesunate|mesh-list
65082673|NCT00459615|Antimalarials|antimalarials|mesh-ancestor
65082674|NCT00459615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65082675|NCT00459615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65082676|NCT00459615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65082677|NCT00459615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082678|NCT00459615|Antiviral Agents|antiviral agents|mesh-ancestor
65082679|NCT00459615|Schistosomicides|schistosomicides|mesh-ancestor
64834717|NCT04551885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64834718|NCT04524000|Fulvestrant|fulvestrant|mesh-list
64834719|NCT04524000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64834720|NCT04524000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834721|NCT04524000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64834722|NCT04524000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64325353|NCT04719273|Fertility Agents|fertility agents|mesh-ancestor
64325354|NCT04719273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64325355|NCT02159651|Tacrolimus|tacrolimus|mesh-list
64430025|NCT04991597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65082680|NCT00459615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65082681|NCT00459615|Anthelmintics|anthelmintics|mesh-ancestor
65082682|NCT01058642|Pregabalin|pregabalin|mesh-list
65082683|NCT01058642|Analgesics|analgesics|mesh-ancestor
65082684|NCT01058642|Sensory System Agents|sensory system agents|mesh-ancestor
65082685|NCT01058642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65082686|NCT01058642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082687|NCT01058642|Anticonvulsants|anticonvulsants|mesh-ancestor
65082688|NCT01058642|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65082689|NCT01058642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65082690|NCT01058642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082691|NCT01058642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65082692|NCT01058642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65082693|NCT01058642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65082694|NCT01058642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65082695|NCT01058642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65082696|NCT00468351|Triamcinolone|triamcinolone|mesh-list
65082697|NCT00468351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65082698|NCT00468351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65082699|NCT00468351|Bevacizumab|bevacizumab|mesh-list
65082700|NCT00468351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65082701|NCT00468351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65082702|NCT00468351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082703|NCT00468351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65082704|NCT00468351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65082705|NCT00468351|Growth Substances|growth substances|mesh-ancestor
65082706|NCT00468351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082707|NCT00468351|Growth Inhibitors|growth inhibitors|mesh-ancestor
65082708|NCT00468351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65082709|NCT00468351|Glucocorticoids|glucocorticoids|mesh-ancestor
65082711|NCT00468351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65082712|NCT00468351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65082713|NCT00468351|Immunologic Factors|immunologic factors|mesh-ancestor
65082714|NCT00468351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082715|NCT00468351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082716|NCT00459654|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
65082717|NCT00459654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082718|NCT00468429|Bevacizumab|bevacizumab|mesh-list
65082719|NCT00468429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65082720|NCT00468429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082721|NCT00468429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65082722|NCT00468429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65082723|NCT00468429|Growth Substances|growth substances|mesh-ancestor
65082724|NCT00468429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082726|NCT00459771|Candesartan|candesartan|mesh-list
65082728|NCT00459771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65082729|NCT00459771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65082730|NCT00459771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082731|NCT01058369|Deferasirox|deferasirox|mesh-list
65082732|NCT01058369|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65082733|NCT01058369|Chelating Agents|chelating agents|mesh-ancestor
65082734|NCT01058369|Sequestering Agents|sequestering agents|mesh-ancestor
65082735|NCT01058369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082736|NCT01057433|Ritonavir|ritonavir|mesh-list
65082737|NCT01057433|Lopinavir|lopinavir|mesh-list
64834723|NCT04524000|Hormone Antagonists|hormone antagonists|mesh-ancestor
64834724|NCT04524000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64834725|NCT04524000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834727|NCT04484532|Immunologic Factors|immunologic factors|mesh-ancestor
65082738|NCT01057433|Pitavastatin|pitavastatin|mesh-list
65082739|NCT01057433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65082740|NCT01057433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65082741|NCT01057433|Protease Inhibitors|protease inhibitors|mesh-ancestor
65082742|NCT01057433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082743|NCT01057433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082744|NCT01057433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65082745|NCT01057433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65082746|NCT01057433|Antiviral Agents|antiviral agents|mesh-ancestor
65082747|NCT01057433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65082748|NCT01057433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65082749|NCT01057433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65082750|NCT01057433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65082751|NCT01057433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65082752|NCT01057433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65082753|NCT01057433|Antimetabolites|antimetabolites|mesh-ancestor
65082754|NCT01057433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65082755|NCT00426920|Insulin|insulin|mesh-list
65082756|NCT00426920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65082757|NCT00426920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082758|NCT00426998|Bevacizumab|bevacizumab|mesh-list
65082759|NCT00426998|Verteporfin|verteporfin|mesh-list
65082760|NCT00426998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65082761|NCT00426998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082762|NCT00426998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65082763|NCT00426998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65082764|NCT00426998|Growth Substances|growth substances|mesh-ancestor
65082765|NCT00426998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082766|NCT00426998|Growth Inhibitors|growth inhibitors|mesh-ancestor
65082767|NCT00426998|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65082768|NCT00426998|Dermatologic Agents|dermatologic agents|mesh-ancestor
65082769|NCT00427076|Vancomycin|vancomycin|mesh-list
65082770|NCT00427076|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
65082771|NCT00427076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65082772|NCT00427076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65082773|NCT00427076|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65082774|NCT00427076|Renal Agents|renal agents|mesh-ancestor
65082775|NCT00427076|Antimalarials|antimalarials|mesh-ancestor
65082776|NCT00427076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65082777|NCT00427076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65082778|NCT00427232|BQ 788|bq 788|mesh-list
65082779|NCT00427232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65082780|NCT00427232|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65082781|NCT00427232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082782|NCT00427232|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
65082783|NCT00427271|Aspirin|aspirin|mesh-list
65082784|NCT00427271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64834738|NCT04402073|Antimitotic Agents|antimitotic agents|mesh-ancestor
64834739|NCT04402073|Mitosis Modulators|mitosis modulators|mesh-ancestor
64834740|NCT04402073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834741|NCT04402073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64834742|NCT04402073|Alkylating Agents|alkylating agents|mesh-ancestor
64834743|NCT04304820|Cyclosporine|cyclosporine|mesh-list
64834744|NCT04304820|Cyclosporins|cyclosporins|mesh-list
64834745|NCT04304820|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64445885|NCT04102618|Trastuzumab|trastuzumab|mesh-list
65082786|NCT00427271|Analgesics|analgesics|mesh-ancestor
65082787|NCT00427271|Sensory System Agents|sensory system agents|mesh-ancestor
65082788|NCT00427271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65082789|NCT00427271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082790|NCT00427271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65082791|NCT00427271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65082792|NCT00427271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65082793|NCT00427271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65082794|NCT00427271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082795|NCT00427271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65082796|NCT00427271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64615284|NCT03410446|Ketamine|ketamine|mesh-list
65082798|NCT00427271|Antipyretics|antipyretics|mesh-ancestor
65082799|NCT00460083|Pimecrolimus|pimecrolimus|mesh-list
65082800|NCT00460083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65082801|NCT00460083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65082802|NCT00460083|Analgesics|analgesics|mesh-ancestor
65082803|NCT00460083|Sensory System Agents|sensory system agents|mesh-ancestor
65082804|NCT00460083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65082805|NCT00460083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082806|NCT00460083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65082807|NCT00460083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65082808|NCT00460083|Dermatologic Agents|dermatologic agents|mesh-ancestor
65082809|NCT00460083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65082810|NCT00460083|Immunologic Factors|immunologic factors|mesh-ancestor
65082811|NCT00460083|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65082812|NCT00460083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082813|NCT00460083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082814|NCT00427310|Fluorouracil|fluorouracil|mesh-list
65082815|NCT00427310|Heparin|heparin|mesh-list
65082816|NCT00427310|Calcium heparin|calcium heparin|mesh-list
65082817|NCT00427310|Antimetabolites|antimetabolites|mesh-ancestor
64834746|NCT04304820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834747|NCT04304820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834748|NCT04304820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64834749|NCT04304820|Immunologic Factors|immunologic factors|mesh-ancestor
64834750|NCT04304820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834751|NCT04304820|Antifungal Agents|antifungal agents|mesh-ancestor
64834752|NCT04304820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64834753|NCT04304820|Dermatologic Agents|dermatologic agents|mesh-ancestor
64834754|NCT04304820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64834755|NCT04304820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64834756|NCT04231877|Prednisone|prednisone|mesh-list
64834757|NCT04231877|Cortisone|cortisone|mesh-list
64834758|NCT04231877|Cyclophosphamide|cyclophosphamide|mesh-list
64834759|NCT04231877|Rituximab|rituximab|mesh-list
64834760|NCT04231877|Doxorubicin|doxorubicin|mesh-list
65082818|NCT00427310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082819|NCT00427310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65082820|NCT00427310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082821|NCT00427310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65082822|NCT00427310|Immunologic Factors|immunologic factors|mesh-ancestor
65082823|NCT00427310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082824|NCT00427310|Anticoagulants|anticoagulants|mesh-ancestor
65082825|NCT00427310|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65082826|NCT00427310|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65082827|NCT00427388|Methylprednisolone|methylprednisolone|mesh-list
65082828|NCT00427388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64834771|NCT04231877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64834772|NCT04231877|Immunologic Factors|immunologic factors|mesh-ancestor
64834773|NCT04231877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834774|NCT04231877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64834775|NCT04231877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64834776|NCT04231877|Alkylating Agents|alkylating agents|mesh-ancestor
64834777|NCT04231877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834778|NCT04231877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834779|NCT04231877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64834780|NCT04231877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64834781|NCT04231877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64834782|NCT04231877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64834783|NCT04231877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834784|NCT04231877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65082829|NCT00427388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65082830|NCT00427388|Prednisolone|prednisolone|mesh-list
65082831|NCT00427388|Prednisolone acetate|prednisolone acetate|mesh-list
65082832|NCT00427388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65082833|NCT00427388|Prednisolone phosphate|prednisolone phosphate|mesh-list
65082834|NCT00427388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65082835|NCT00427388|Antiemetics|antiemetics|mesh-ancestor
65082836|NCT00427388|Autonomic Agents|autonomic agents|mesh-ancestor
65082837|NCT00427388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65082838|NCT00427388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082839|NCT00427388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65082840|NCT00427388|Glucocorticoids|glucocorticoids|mesh-ancestor
65082841|NCT00427388|Hormones|hormones|mesh-ancestor
65082842|NCT00427388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65082843|NCT00427388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65082844|NCT00427388|Protective Agents|protective agents|mesh-ancestor
65082845|NCT00427388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65082846|NCT00427388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082847|NCT00427427|Trastuzumab|trastuzumab|mesh-list
65082848|NCT00427427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65082849|NCT00427427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082850|NCT04704947|Alendronate|alendronate|mesh-list
65082851|NCT04704947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65082852|NCT04704947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
65082853|NCT04704947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65082854|NCT04704947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082855|NCT04704947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65082856|NCT04704947|Adrenergic Agents|adrenergic agents|mesh-ancestor
65082857|NCT04704947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65082858|NCT04704947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082860|NCT00427466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082861|NCT00427466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082862|NCT00427466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325361|NCT02159651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325362|NCT02774681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64325363|NCT02774681|Trastuzumab|trastuzumab|mesh-list
64834785|NCT04231877|Glucocorticoids|glucocorticoids|mesh-ancestor
64834786|NCT04231877|Hormones|hormones|mesh-ancestor
64834787|NCT04231877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64834788|NCT04231877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64834789|NCT04231877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64834790|NCT04231877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64834791|NCT04231877|Keratolytic Agents|keratolytic agents|mesh-ancestor
64834792|NCT04231877|Dermatologic Agents|dermatologic agents|mesh-ancestor
64834793|NCT04231877|Tubulin Modulators|tubulin modulators|mesh-ancestor
64834794|NCT04231877|Antimitotic Agents|antimitotic agents|mesh-ancestor
64834795|NCT04231877|Mitosis Modulators|mitosis modulators|mesh-ancestor
64834796|NCT04199728|Liraglutide|liraglutide|mesh-list
65082863|NCT00427466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65082864|NCT00427466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65082865|NCT00427505|Deferasirox|deferasirox|mesh-list
65082866|NCT00427505|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65082867|NCT00427505|Chelating Agents|chelating agents|mesh-ancestor
65082868|NCT00427505|Sequestering Agents|sequestering agents|mesh-ancestor
65082869|NCT00427505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082870|NCT00427583|Imatinib Mesylate|imatinib mesylate|mesh-list
65082871|NCT00427583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082872|NCT00427583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65082873|NCT00427583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082874|NCT00427583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082875|NCT00468936|Mycophenolic Acid|mycophenolic acid|mesh-list
65082876|NCT00468936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65082877|NCT00468936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082878|NCT00468936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65082879|NCT00468936|Antitubercular Agents|antitubercular agents|mesh-ancestor
65082880|NCT00468936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65082881|NCT00468936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65082882|NCT00468936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082883|NCT00468936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082884|NCT00469053|Buprenorphine|buprenorphine|mesh-list
65082885|NCT00469053|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65082886|NCT00469053|Narcotics|narcotics|mesh-ancestor
65082887|NCT00469053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65082888|NCT00469053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082889|NCT00469053|Analgesics|analgesics|mesh-ancestor
65082890|NCT00469053|Sensory System Agents|sensory system agents|mesh-ancestor
65082891|NCT00469053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65082892|NCT00469053|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65082893|NCT00469131|Mycophenolic Acid|mycophenolic acid|mesh-list
65082894|NCT00469131|Tacrolimus|tacrolimus|mesh-list
65082895|NCT00469131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65082896|NCT00469131|Immunologic Factors|immunologic factors|mesh-ancestor
65082897|NCT00469131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082898|NCT00469131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65082899|NCT00469131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082900|NCT00469131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082901|NCT00469131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65082902|NCT00469131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082903|NCT00469131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65082904|NCT00469131|Antitubercular Agents|antitubercular agents|mesh-ancestor
65082905|NCT00469131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65082906|NCT00469131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65082907|NCT04704440|Sildenafil Citrate|sildenafil citrate|mesh-list
65082908|NCT04704440|Vasodilator Agents|vasodilator agents|mesh-ancestor
65082909|NCT04704440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65082910|NCT04704440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65082911|NCT04704440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082912|NCT04704440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082913|NCT04704440|Urological Agents|urological agents|mesh-ancestor
65082914|NCT00428129|Plasminogen|plasminogen|mesh-list
65082915|NCT00428129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65082916|NCT00428129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65082917|NCT00428129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082918|NCT00428168|Betahistine|betahistine|mesh-list
65082919|NCT00428168|Vasodilator Agents|vasodilator agents|mesh-ancestor
65082920|NCT00428168|Histamine Agonists|histamine agonists|mesh-ancestor
65082921|NCT00428168|Histamine Agents|histamine agents|mesh-ancestor
65082922|NCT00428168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65082923|NCT00428168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082924|NCT00428168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082925|NCT00428480|Methamphetamine|methamphetamine|mesh-list
65082926|NCT00428480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65082927|NCT00428480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082928|NCT00428480|Sympathomimetics|sympathomimetics|mesh-ancestor
65082929|NCT00428480|Autonomic Agents|autonomic agents|mesh-ancestor
65082930|NCT00428480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65082931|NCT00428480|Dopamine Agents|dopamine agents|mesh-ancestor
65082932|NCT00428480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65082933|NCT00428480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082934|NCT00428480|Adrenergic Agents|adrenergic agents|mesh-ancestor
65082935|NCT00428480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65082936|NCT00428480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65082937|NCT00428480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65082938|NCT00428480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65082939|NCT00460473|Dexmedetomidine|dexmedetomidine|mesh-list
65082940|NCT00460473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65082941|NCT00460473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65082942|NCT00460473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082945|NCT00460473|Sensory System Agents|sensory system agents|mesh-ancestor
65082946|NCT00460473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65082947|NCT00460473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65082948|NCT00460473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65082949|NCT00460473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65082950|NCT00460473|Adrenergic Agents|adrenergic agents|mesh-ancestor
65082951|NCT00460473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65082952|NCT00460473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082953|NCT00428519|Aprepitant|aprepitant|mesh-list
65082954|NCT00428519|Fosaprepitant|fosaprepitant|mesh-list
65082955|NCT00428519|Antiemetics|antiemetics|mesh-ancestor
65082956|NCT00428519|Autonomic Agents|autonomic agents|mesh-ancestor
65082957|NCT00428519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65082958|NCT00428519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082959|NCT00428519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65082960|NCT00428519|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64834806|NCT04166435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834807|NCT04166435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834808|NCT04166435|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64834809|NCT04166435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834810|NCT04162015|Carboplatin|carboplatin|mesh-list
64834811|NCT04162015|Nivolumab|nivolumab|mesh-list
64834812|NCT04162015|Pemetrexed|pemetrexed|mesh-list
64834813|NCT04162015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834814|NCT04162015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64834815|NCT04162015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64834816|NCT04162015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834817|NCT04162015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834818|NCT04162015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65082961|NCT00428519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65082962|NCT00428519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082963|NCT00428558|Cytarabine|cytarabine|mesh-list
65082964|NCT00428558|Daunorubicin|daunorubicin|mesh-list
65082965|NCT00428558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65082966|NCT00428558|Antimetabolites|antimetabolites|mesh-ancestor
65082967|NCT00428558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082968|NCT00428558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65082969|NCT00428558|Antiviral Agents|antiviral agents|mesh-ancestor
65082970|NCT00428558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65082971|NCT00428558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65082972|NCT00428558|Immunologic Factors|immunologic factors|mesh-ancestor
65082973|NCT00428558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082974|NCT00428558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65082975|NCT00428558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65082976|NCT00428558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65082977|NCT00428558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65082978|NCT00460512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65082979|NCT00460512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65082980|NCT00460512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65082981|NCT00460512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65082982|NCT00460512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082983|NCT00460512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65082984|NCT00460512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65082985|NCT00460512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65082987|NCT00460512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65082988|NCT00460512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65082989|NCT00460512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65082990|NCT00460512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65082991|NCT00460512|Dopamine Agents|dopamine agents|mesh-ancestor
65082992|NCT01056380|Nitazoxanide|nitazoxanide|mesh-list
65082993|NCT01056380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65082994|NCT01056380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65082995|NCT01055834|Eszopiclone|eszopiclone|mesh-list
65082996|NCT01055834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65082997|NCT01055834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65082998|NCT01055834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65082999|NCT00469326|Atorvastatin|atorvastatin|mesh-list
65083000|NCT00469326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65083001|NCT00469326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65083002|NCT00469326|Antimetabolites|antimetabolites|mesh-ancestor
65083003|NCT00469326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083004|NCT00469326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65083005|NCT00469326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65083006|NCT00469326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083007|NCT04704713|Afamelanotide|afamelanotide|mesh-list
64325365|NCT02774681|Antibodies|antibodies|mesh-list
64325366|NCT02774681|Immunoglobulins|immunoglobulins|mesh-list
64325367|NCT02774681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64325368|NCT02774681|Immunologic Factors|immunologic factors|mesh-ancestor
64325369|NCT02774681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325370|NCT02774681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325371|NCT02774681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64325372|NCT02774681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426372|NCT01635153|Micronutrients|micronutrients|mesh-list
65083008|NCT04704713|Dermatologic Agents|dermatologic agents|mesh-ancestor
65083009|NCT00460707|Ketoconazole|ketoconazole|mesh-list
65083010|NCT00460707|Casopitant|casopitant|mesh-list
65083011|NCT00460707|Antifungal Agents|antifungal agents|mesh-ancestor
65083012|NCT00460707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65083013|NCT00460707|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65083014|NCT00460707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65083015|NCT00460707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083016|NCT00460707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083017|NCT00460707|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65083018|NCT00460707|Hormone Antagonists|hormone antagonists|mesh-ancestor
65083019|NCT00460707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65083020|NCT00460707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083021|NCT00460707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65083022|NCT00460707|Antiemetics|antiemetics|mesh-ancestor
65083023|NCT00460707|Autonomic Agents|autonomic agents|mesh-ancestor
65083024|NCT00460707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65083025|NCT00460707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65083026|NCT00460707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65083027|NCT00460707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65083028|NCT00469404|Buprenorphine|buprenorphine|mesh-list
65083029|NCT00469404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65083030|NCT00469404|Narcotics|narcotics|mesh-ancestor
65083031|NCT00469404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65083032|NCT00469404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083033|NCT00469404|Analgesics|analgesics|mesh-ancestor
65083034|NCT00469404|Sensory System Agents|sensory system agents|mesh-ancestor
65083035|NCT00469404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65083036|NCT00469404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65083037|NCT00460785|Analgesics, Opioid|analgesics, opioid|mesh-list
65083038|NCT00460785|Narcotics|narcotics|mesh-ancestor
65083039|NCT00460785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65083040|NCT00460785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083041|NCT00460785|Analgesics|analgesics|mesh-ancestor
65083042|NCT00460785|Sensory System Agents|sensory system agents|mesh-ancestor
65083043|NCT00460785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65083044|NCT01054976|Galantamine|galantamine|mesh-list
65083045|NCT01054976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65083046|NCT01054976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083047|NCT01054976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083048|NCT01054976|Cholinergic Agents|cholinergic agents|mesh-ancestor
65083049|NCT01054976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65083050|NCT01054976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083051|NCT01054976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65083052|NCT01054976|Autonomic Agents|autonomic agents|mesh-ancestor
65083053|NCT01054976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65083054|NCT01054976|Nootropic Agents|nootropic agents|mesh-ancestor
65083055|NCT00469443|Leucovorin|leucovorin|mesh-list
65083056|NCT00469443|Bevacizumab|bevacizumab|mesh-list
65083057|NCT00469443|Fluorouracil|fluorouracil|mesh-list
64834822|NCT04077515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64834823|NCT04077515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64834824|NCT04077515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834825|NCT04077515|Antifungal Agents|antifungal agents|mesh-ancestor
64834826|NCT04077515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64834827|NCT04077515|Immunologic Factors|immunologic factors|mesh-ancestor
64834828|NCT04077515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834829|NCT04037527|Gemcitabine|gemcitabine|mesh-list
64834830|NCT04037527|Docetaxel|docetaxel|mesh-list
64834832|NCT04037527|Antimetabolites|antimetabolites|mesh-ancestor
65083058|NCT00469443|Capecitabine|capecitabine|mesh-list
65083059|NCT00469443|Irinotecan|irinotecan|mesh-list
64615539|NCT05406388|Analgesics|analgesics|mesh-ancestor
65083060|NCT00469443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65083061|NCT00469443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083062|NCT00469443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65083063|NCT00469443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65083064|NCT00469443|Growth Substances|growth substances|mesh-ancestor
65083065|NCT00469443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083066|NCT00469443|Growth Inhibitors|growth inhibitors|mesh-ancestor
65083067|NCT00469443|Antimetabolites|antimetabolites|mesh-ancestor
65083068|NCT00469443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083069|NCT00469443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65083070|NCT00469443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65083071|NCT00469443|Immunologic Factors|immunologic factors|mesh-ancestor
65083072|NCT00469443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65083073|NCT00469443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65083074|NCT00469443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083075|NCT00469443|Antidotes|antidotes|mesh-ancestor
65083076|NCT00469443|Protective Agents|protective agents|mesh-ancestor
65083077|NCT00469443|Vitamin B Complex|vitamin b complex|mesh-ancestor
65083078|NCT00469443|Vitamins|vitamins|mesh-ancestor
65083079|NCT00469443|Micronutrients|micronutrients|mesh-ancestor
65083080|NCT00460863|Dialysis Solutions|dialysis solutions|mesh-list
65083081|NCT00460863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65083082|NCT00428909|Acetaminophen|acetaminophen|mesh-list
65083083|NCT00428909|Imatinib Mesylate|imatinib mesylate|mesh-list
65083084|NCT00428909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65083085|NCT00428909|Analgesics|analgesics|mesh-ancestor
65083086|NCT00428909|Sensory System Agents|sensory system agents|mesh-ancestor
65083087|NCT00428909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65083088|NCT00428909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083089|NCT00428909|Antipyretics|antipyretics|mesh-ancestor
65083090|NCT00428909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083091|NCT00428909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65083092|NCT00428909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083093|NCT00428909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083094|NCT00429065|Rituximab|rituximab|mesh-list
64325373|NCT02774681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083095|NCT00429065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65083096|NCT00429065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083097|NCT00429065|Immunologic Factors|immunologic factors|mesh-ancestor
65083098|NCT00429065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083099|NCT00429065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65083100|NCT00469560|Deferasirox|deferasirox|mesh-list
65083101|NCT00469560|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65083102|NCT00469560|Chelating Agents|chelating agents|mesh-ancestor
65083103|NCT00469560|Sequestering Agents|sequestering agents|mesh-ancestor
65083104|NCT00469560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083105|NCT00469599|Alfacalcidol|alfacalcidol|mesh-list
65083106|NCT00469599|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65083107|NCT00469599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65083108|NCT00469599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083109|NCT00469599|Vitamins|vitamins|mesh-ancestor
65083110|NCT00469599|Micronutrients|micronutrients|mesh-ancestor
65083111|NCT00429377|Tacrolimus|tacrolimus|mesh-list
65083112|NCT00429377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65083113|NCT00429377|Immunologic Factors|immunologic factors|mesh-ancestor
65083114|NCT00429377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083115|NCT00429377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65083116|NCT00429377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083117|NCT00429377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083118|NCT00469716|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65083119|NCT00469716|Plasma Substitutes|plasma substitutes|mesh-ancestor
65083120|NCT00469716|Blood Substitutes|blood substitutes|mesh-ancestor
65083121|NCT00429533|Dapsone|dapsone|mesh-list
65083122|NCT00429533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65083123|NCT00429533|Antimalarials|antimalarials|mesh-ancestor
65083124|NCT00429533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65083125|NCT00429533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65083126|NCT00429533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65083127|NCT00429533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083128|NCT00429533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083129|NCT00429533|Leprostatic Agents|leprostatic agents|mesh-ancestor
65083130|NCT00429533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65083131|NCT04704245|Petrolatum|petrolatum|mesh-list
65083132|NCT04704245|Mitogens|mitogens|mesh-list
65083133|NCT04704245|Mitosis Modulators|mitosis modulators|mesh-ancestor
64483192|NCT01736917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65083134|NCT04704245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083136|NCT04704245|Dermatologic Agents|dermatologic agents|mesh-ancestor
65083137|NCT00429806|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65083138|NCT00429806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65083139|NCT00429806|Immunologic Factors|immunologic factors|mesh-ancestor
65083140|NCT00429806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083141|NCT00429962|Ranibizumab|ranibizumab|mesh-list
65083142|NCT00429962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65083143|NCT00429962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65083144|NCT00429962|Growth Substances|growth substances|mesh-ancestor
65083145|NCT00429962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083146|NCT00429962|Growth Inhibitors|growth inhibitors|mesh-ancestor
65083147|NCT00429962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325374|NCT02157311|Tenofovir|tenofovir|mesh-list
64325375|NCT02157311|Lamivudine|lamivudine|mesh-list
64834837|NCT04037527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834838|NCT04037527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64834839|NCT04037527|Immunologic Factors|immunologic factors|mesh-ancestor
64834840|NCT04037527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834841|NCT04037527|Tubulin Modulators|tubulin modulators|mesh-ancestor
65083148|NCT00430001|Docetaxel|docetaxel|mesh-list
65083149|NCT00430001|Trastuzumab|trastuzumab|mesh-list
65083150|NCT00430001|Vinorelbine|vinorelbine|mesh-list
65083151|NCT00430001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083152|NCT00430001|Tubulin Modulators|tubulin modulators|mesh-ancestor
65083153|NCT00430001|Antimitotic Agents|antimitotic agents|mesh-ancestor
65083154|NCT00430001|Mitosis Modulators|mitosis modulators|mesh-ancestor
65083155|NCT00430001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64725297|NCT00002035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083156|NCT00430001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65083157|NCT00430001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65083159|NCT00430079|Imidazole|imidazole|mesh-list
65083160|NCT00430079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083161|NCT00430079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083163|NCT00430118|Cytarabine|cytarabine|mesh-list
65083164|NCT00430118|Dexamethasone|dexamethasone|mesh-list
65083165|NCT00430118|Prednisone|prednisone|mesh-list
65083166|NCT00430118|Cyclophosphamide|cyclophosphamide|mesh-list
65083167|NCT00430118|Ifosfamide|ifosfamide|mesh-list
65083168|NCT00430118|Doxorubicin|doxorubicin|mesh-list
65083169|NCT00430118|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65083170|NCT00430118|Methotrexate|methotrexate|mesh-list
65083171|NCT00430118|Etoposide|etoposide|mesh-list
65083172|NCT00430118|Vincristine|vincristine|mesh-list
65083173|NCT00430118|Daunorubicin|daunorubicin|mesh-list
65083174|NCT00430118|Asparaginase|asparaginase|mesh-list
65083175|NCT00430118|Mercaptopurine|mercaptopurine|mesh-list
65083176|NCT00430118|Thioguanine|thioguanine|mesh-list
65083177|NCT00430118|Vindesine|vindesine|mesh-list
65083178|NCT00430118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65083179|NCT00430118|Immunologic Factors|immunologic factors|mesh-ancestor
65083180|NCT00430118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083181|NCT00430118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65083182|NCT00430118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65083183|NCT00430118|Alkylating Agents|alkylating agents|mesh-ancestor
65083184|NCT00430118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083185|NCT00430118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083186|NCT00430118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65083187|NCT00430118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65083188|NCT00430118|Antiemetics|antiemetics|mesh-ancestor
65083189|NCT00430118|Autonomic Agents|autonomic agents|mesh-ancestor
65083190|NCT00430118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65083191|NCT00430118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65083192|NCT00430118|Glucocorticoids|glucocorticoids|mesh-ancestor
65083193|NCT00430118|Hormones|hormones|mesh-ancestor
65083194|NCT00430118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65083195|NCT00430118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65083196|NCT00430118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65083197|NCT00430118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65083198|NCT00430118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65083199|NCT00430118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083200|NCT00430118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65083201|NCT00430118|Abortifacient Agents|abortifacient agents|mesh-ancestor
65083202|NCT00430118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65083203|NCT00430118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65083204|NCT00430118|Antimetabolites|antimetabolites|mesh-ancestor
65083205|NCT00430118|Dermatologic Agents|dermatologic agents|mesh-ancestor
64426563|NCT02246673|Febuxostat|febuxostat|mesh-list
65083206|NCT00430118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65083207|NCT00430118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65083208|NCT00430118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65083210|NCT00430118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65083211|NCT00430118|Tubulin Modulators|tubulin modulators|mesh-ancestor
65083212|NCT00430118|Antimitotic Agents|antimitotic agents|mesh-ancestor
65083213|NCT00430118|Mitosis Modulators|mitosis modulators|mesh-ancestor
65083214|NCT00430157|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
65083215|NCT00430157|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65083216|NCT00430157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65083217|NCT00430157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083218|NCT00430157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083219|NCT00461565|Sildenafil Citrate|sildenafil citrate|mesh-list
65083220|NCT00461565|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65083221|NCT00461565|Vasodilator Agents|vasodilator agents|mesh-ancestor
65083222|NCT00461565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65083223|NCT00461565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65083224|NCT00461565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083225|NCT00461565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083226|NCT00461565|Urological Agents|urological agents|mesh-ancestor
65083227|NCT00430196|Tizanidine|tizanidine|mesh-list
65083228|NCT00430196|Analgesics|analgesics|mesh-ancestor
64725376|NCT00002407|Antimetabolites|antimetabolites|mesh-ancestor
65083229|NCT00430196|Sensory System Agents|sensory system agents|mesh-ancestor
65083230|NCT00430196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65083231|NCT00430196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416487|NCT04855279|Listerine|listerine|mesh-list
65083233|NCT00430196|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65083234|NCT00430196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65083235|NCT00430196|Parasympatholytics|parasympatholytics|mesh-ancestor
65083236|NCT00430196|Autonomic Agents|autonomic agents|mesh-ancestor
65083237|NCT00430196|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65083238|NCT00430196|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65083239|NCT00430196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65083240|NCT00430196|Adrenergic Agents|adrenergic agents|mesh-ancestor
65083241|NCT00430196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64325386|NCT02157311|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64325387|NCT02157311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64325388|NCT02157311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834843|NCT04037527|Mitosis Modulators|mitosis modulators|mesh-ancestor
64834845|NCT04009044|Afimoxifene|afimoxifene|mesh-list
64834846|NCT04009044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64834847|NCT04009044|Hormone Antagonists|hormone antagonists|mesh-ancestor
64834848|NCT04009044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64834849|NCT04009044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083242|NCT00430196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083243|NCT00430235|Sorafenib|sorafenib|mesh-list
65083244|NCT00430235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083245|NCT00430235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65083246|NCT00430235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083247|NCT00430235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083248|NCT00470340|Gemcitabine|gemcitabine|mesh-list
65083249|NCT00470340|Oxaliplatin|oxaliplatin|mesh-list
65083250|NCT00470340|Ethiodized Oil|ethiodized oil|mesh-list
65083251|NCT00470340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083252|NCT00470340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65083253|NCT00470340|Antimetabolites|antimetabolites|mesh-ancestor
65083254|NCT00470340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083255|NCT00470340|Antiviral Agents|antiviral agents|mesh-ancestor
65083256|NCT00470340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65083257|NCT00470340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083258|NCT00470340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65083259|NCT00470340|Immunologic Factors|immunologic factors|mesh-ancestor
65083260|NCT00470340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083261|NCT00430469|Lactoferrin|lactoferrin|mesh-list
65083262|NCT00430469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65083263|NCT00461643|Metformin|metformin|mesh-list
65083264|NCT00461643|Citric Acid|citric acid|mesh-list
65083265|NCT00461643|Sodium Citrate|sodium citrate|mesh-list
65083266|NCT00461643|Clomiphene|clomiphene|mesh-list
65083267|NCT00461643|Enclomiphene|enclomiphene|mesh-list
65083268|NCT00461643|Zuclomiphene|zuclomiphene|mesh-list
65083269|NCT00461643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65083270|NCT00461643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083271|NCT00461643|Anticoagulants|anticoagulants|mesh-ancestor
65083272|NCT00461643|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65083273|NCT00461643|Chelating Agents|chelating agents|mesh-ancestor
65083274|NCT00461643|Sequestering Agents|sequestering agents|mesh-ancestor
65083275|NCT00461643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083276|NCT00461643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65083277|NCT00461643|Hormone Antagonists|hormone antagonists|mesh-ancestor
65083278|NCT00461643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65083279|NCT00461643|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65083280|NCT00461643|Fertility Agents|fertility agents|mesh-ancestor
65083281|NCT00461643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65083282|NCT00461643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65083283|NCT00461643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65083284|NCT00430547|Carbimazole|carbimazole|mesh-list
65083285|NCT00430547|Antithyroid Agents|antithyroid agents|mesh-ancestor
65083286|NCT00430547|Hormone Antagonists|hormone antagonists|mesh-ancestor
65083287|NCT00430547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65083288|NCT00430547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083289|NCT00430586|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
65083290|NCT00430586|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65083291|NCT00430586|Botulinum Toxins|botulinum toxins|mesh-list
65083292|NCT00430586|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65083293|NCT00430586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65083294|NCT00430586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65083295|NCT00430586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083296|NCT00430586|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65083297|NCT00430586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65083298|NCT00430586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083299|NCT00430586|Cholinergic Agents|cholinergic agents|mesh-ancestor
65083300|NCT00430586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65083301|NCT01053962|Plecanatide|plecanatide|mesh-list
65083302|NCT01053962|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
65083303|NCT01053962|Enzyme Activators|enzyme activators|mesh-ancestor
65083304|NCT01053962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083305|NCT01053962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65083306|NCT00461799|Orlistat|orlistat|mesh-list
65083307|NCT00461799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083308|NCT00461799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083309|NCT00461799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65083310|NCT00461799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65083311|NCT00430664|Povidone-Iodine|povidone-iodine|mesh-list
65083312|NCT00430664|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65083313|NCT00430664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65083314|NCT00430742|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
65083315|NCT00430742|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
65083316|NCT00430742|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65083317|NCT00430742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65083318|NCT00430742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083319|NCT00430742|Hormones|hormones|mesh-ancestor
65083320|NCT00430742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65083321|NCT00430742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083322|NCT03271164|Vitamin E|vitamin e|mesh-list
64325393|NCT02157311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64325394|NCT02157311|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65083323|NCT03271164|Vitamins|vitamins|mesh-ancestor
65083324|NCT03271164|Micronutrients|micronutrients|mesh-ancestor
65083325|NCT03271164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083326|NCT03271164|Antioxidants|antioxidants|mesh-ancestor
65083327|NCT03271164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083328|NCT03271164|Protective Agents|protective agents|mesh-ancestor
65083329|NCT00430898|Basiliximab|basiliximab|mesh-list
65083330|NCT00430898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65083331|NCT00430898|Immunologic Factors|immunologic factors|mesh-ancestor
65083332|NCT00430898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083333|NCT00461916|Triptorelin Pamoate|triptorelin pamoate|mesh-list
65083334|NCT00461916|Buserelin|buserelin|mesh-list
65083335|NCT00461916|Luteolytic Agents|luteolytic agents|mesh-ancestor
65083336|NCT00461916|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65083337|NCT00461916|Contraceptive Agents|contraceptive agents|mesh-ancestor
65083338|NCT00461916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65083339|NCT00461916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083340|NCT00461916|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65083341|NCT00461916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65083342|NCT00461916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083343|NCT00461916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65083344|NCT00461916|Fertility Agents|fertility agents|mesh-ancestor
65083345|NCT02957409|Valsartan|valsartan|mesh-list
65083346|NCT02957409|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65083347|NCT02957409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65083348|NCT02957409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64325395|NCT02157311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64325396|NCT02157311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65083349|NCT02957409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65083350|NCT02957409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083351|NCT01053221|Mycophenolic Acid|mycophenolic acid|mesh-list
65083352|NCT01053221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65083353|NCT01053221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083354|NCT01053221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65083355|NCT01053221|Antitubercular Agents|antitubercular agents|mesh-ancestor
65083356|NCT01053221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65083357|NCT01053221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65083358|NCT01053221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083359|NCT01053221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083361|NCT00431054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083362|NCT00431054|Tubulin Modulators|tubulin modulators|mesh-ancestor
65083363|NCT00431054|Antimitotic Agents|antimitotic agents|mesh-ancestor
65083364|NCT00431054|Mitosis Modulators|mitosis modulators|mesh-ancestor
65083365|NCT00431054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083366|NCT00431171|Lithium Carbonate|lithium carbonate|mesh-list
65083367|NCT00431171|Antidepressive Agents|antidepressive agents|mesh-ancestor
65083368|NCT00431171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65083369|NCT00431171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083370|NCT00431171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083371|NCT00431171|Antimanic Agents|antimanic agents|mesh-ancestor
65083372|NCT00431171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65083373|NCT00431171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65083374|NCT00431171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083375|NCT00431249|Cilostazol|cilostazol|mesh-list
65083376|NCT00431249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65083377|NCT00431249|Autonomic Agents|autonomic agents|mesh-ancestor
65083378|NCT00431249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65083379|NCT00431249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083380|NCT00431249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65083381|NCT00431249|Respiratory System Agents|respiratory system agents|mesh-ancestor
65083382|NCT00431249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65083383|NCT00431249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65083384|NCT00431249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083385|NCT00431249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65083386|NCT00431249|Vasodilator Agents|vasodilator agents|mesh-ancestor
65083387|NCT00431249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65083388|NCT00431249|Protective Agents|protective agents|mesh-ancestor
65083389|NCT00431249|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65083390|NCT00431249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65083391|NCT00431249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083392|NCT00470886|Telmisartan|telmisartan|mesh-list
65083393|NCT00470886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65083394|NCT00470886|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65083395|NCT00470886|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65083396|NCT00470886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083397|NCT00431522|Valproic Acid|valproic acid|mesh-list
65083398|NCT00431522|Anticonvulsants|anticonvulsants|mesh-ancestor
65083399|NCT00431522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834858|NCT03999515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834859|NCT03999515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834860|NCT03999515|Hormone Antagonists|hormone antagonists|mesh-ancestor
64426821|NCT01632345|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64426822|NCT01632345|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65083400|NCT00431522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083401|NCT00431522|GABA Agents|gaba agents|mesh-ancestor
65083402|NCT00431522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65083403|NCT00431522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083404|NCT00431522|Antimanic Agents|antimanic agents|mesh-ancestor
65083405|NCT00431522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65083406|NCT00431522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65083407|NCT00431522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65083408|NCT00462111|Indomethacin|indomethacin|mesh-list
65083409|NCT00462111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65083410|NCT00462111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65083411|NCT00462111|Analgesics|analgesics|mesh-ancestor
65083412|NCT00462111|Sensory System Agents|sensory system agents|mesh-ancestor
65083413|NCT00462111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65083414|NCT00462111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083415|NCT00462111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65083416|NCT00462111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65083417|NCT00462111|Gout Suppressants|gout suppressants|mesh-ancestor
65083418|NCT00462111|Tocolytic Agents|tocolytic agents|mesh-ancestor
65083419|NCT00462111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65083420|NCT00462111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65083422|NCT00462111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083423|NCT00431561|Temozolomide|temozolomide|mesh-list
65083424|NCT00431561|Lomustine|lomustine|mesh-list
65083425|NCT00431561|Trabedersen|trabedersen|mesh-list
65083426|NCT00431561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65083427|NCT00431561|Alkylating Agents|alkylating agents|mesh-ancestor
65083428|NCT00431561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083429|NCT00431561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083430|NCT00462189|Immunotoxin HA22|immunotoxin ha22|mesh-list
65083431|NCT00462189|Immunotoxins|immunotoxins|mesh-list
65083432|NCT00462189|Immunologic Factors|immunologic factors|mesh-ancestor
65083433|NCT00462189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083434|NCT00462189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083435|NCT00431678|Moxifloxacin|moxifloxacin|mesh-list
65083436|NCT00431678|Levofloxacin|levofloxacin|mesh-list
65083437|NCT00431678|Ofloxacin|ofloxacin|mesh-list
65083438|NCT00431678|Ceftriaxone|ceftriaxone|mesh-list
65083439|NCT00431678|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65083440|NCT00431678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65083441|NCT00431678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65083442|NCT00431678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65083443|NCT00431678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65083444|NCT00431678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083445|NCT00431678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083446|NCT00431678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083447|NCT00431678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65083448|NCT00431678|Contraceptive Agents|contraceptive agents|mesh-ancestor
65083449|NCT00431678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65083450|NCT00431678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083451|NCT00431678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65083452|NCT00431678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65083453|NCT00431678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65083454|NCT00431678|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65083455|NCT00431678|Renal Agents|renal agents|mesh-ancestor
65083456|NCT00431678|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65083457|NCT00431678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65083458|NCT00471003|Telmisartan|telmisartan|mesh-list
65083459|NCT00471003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65083460|NCT00471003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65083461|NCT00471003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65083462|NCT00471003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083463|NCT00471042|Buprenorphine|buprenorphine|mesh-list
65083464|NCT00471042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65083465|NCT00471042|Narcotics|narcotics|mesh-ancestor
65083466|NCT00471042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65083467|NCT00471042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083468|NCT00471042|Analgesics|analgesics|mesh-ancestor
65083469|NCT00471042|Sensory System Agents|sensory system agents|mesh-ancestor
65083470|NCT00471042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65083471|NCT00471042|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65083472|NCT00462540|Bromides|bromides|mesh-list
65083473|NCT00462540|Albuterol|albuterol|mesh-list
65083474|NCT00462540|Formoterol Fumarate|formoterol fumarate|mesh-list
65083475|NCT00462540|Ipratropium|ipratropium|mesh-list
65083476|NCT00462540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65083477|NCT00462540|Autonomic Agents|autonomic agents|mesh-ancestor
65083478|NCT00462540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65083479|NCT00462540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083480|NCT00462540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65083481|NCT00462540|Respiratory System Agents|respiratory system agents|mesh-ancestor
65083482|NCT00462540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65083483|NCT00462540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65083484|NCT00462540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65083485|NCT00462540|Adrenergic Agents|adrenergic agents|mesh-ancestor
65083486|NCT00462540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65083487|NCT00462540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083488|NCT00462540|Anticonvulsants|anticonvulsants|mesh-ancestor
65083489|NCT00462540|Tocolytic Agents|tocolytic agents|mesh-ancestor
65083490|NCT00462540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65083491|NCT00462540|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65083492|NCT00462540|Cholinergic Agents|cholinergic agents|mesh-ancestor
65083493|NCT04703465|Tenofovir|tenofovir|mesh-list
65083494|NCT04703465|Antiviral Agents|antiviral agents|mesh-ancestor
65083495|NCT04703465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65083496|NCT04703465|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65083497|NCT04703465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65083498|NCT04703465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083499|NCT04703465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083500|NCT04703465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65083501|NCT04703465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65083503|NCT00471159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083504|NCT00471159|Tubulin Modulators|tubulin modulators|mesh-ancestor
65083505|NCT00471159|Antimitotic Agents|antimitotic agents|mesh-ancestor
65083506|NCT00471159|Mitosis Modulators|mitosis modulators|mesh-ancestor
65083507|NCT00471159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083508|NCT00462618|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65083509|NCT00462618|Antidepressive Agents|antidepressive agents|mesh-ancestor
65083510|NCT00462618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65083511|NCT00462618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65083512|NCT00462618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65083513|NCT00462618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65083514|NCT00462618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083515|NCT00431795|Doxorubicin|doxorubicin|mesh-list
65083516|NCT00431795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65083517|NCT00431795|Epirubicin|epirubicin|mesh-list
65083518|NCT00431795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65083519|NCT00431795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083520|NCT00431795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65083521|NCT00431795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65083522|NCT00431795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083523|NCT00431795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083525|NCT00462657|Chelating Agents|chelating agents|mesh-ancestor
65083526|NCT00462657|Sequestering Agents|sequestering agents|mesh-ancestor
65083527|NCT00462657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083528|NCT00431990|Dexamethasone|dexamethasone|mesh-list
65083529|NCT00431990|Bortezomib|bortezomib|mesh-list
65083530|NCT00431990|Romidepsin|romidepsin|mesh-list
64834866|NCT03980769|Thiotepa|thiotepa|mesh-list
64834867|NCT03980769|Treosulfan|treosulfan|mesh-list
64834868|NCT03980769|Busulfan|busulfan|mesh-list
64325398|NCT02157311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64325399|NCT02157311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64325400|NCT02157311|Protease Inhibitors|protease inhibitors|mesh-ancestor
64325401|NCT02157311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65083531|NCT00431990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65083532|NCT00431990|Antiemetics|antiemetics|mesh-ancestor
65083533|NCT00431990|Autonomic Agents|autonomic agents|mesh-ancestor
65083534|NCT00431990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65083535|NCT00431990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083536|NCT00431990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65083537|NCT00431990|Glucocorticoids|glucocorticoids|mesh-ancestor
65083538|NCT00431990|Hormones|hormones|mesh-ancestor
65083539|NCT00431990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65083540|NCT00431990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65083541|NCT00431990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083542|NCT00431990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65083543|NCT00462696|Docetaxel|docetaxel|mesh-list
65083544|NCT00462696|Epirubicin|epirubicin|mesh-list
65083545|NCT00462696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083546|NCT00462696|Tubulin Modulators|tubulin modulators|mesh-ancestor
65083547|NCT00462696|Antimitotic Agents|antimitotic agents|mesh-ancestor
65083548|NCT00462696|Mitosis Modulators|mitosis modulators|mesh-ancestor
65083549|NCT00462696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083550|NCT00462696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65083551|NCT00462696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65083552|NCT00462696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65083553|NCT00462696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083554|NCT00462813|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
65083555|NCT00462813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65083556|NCT00462813|Protective Agents|protective agents|mesh-ancestor
65083557|NCT00462813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083558|NCT00462813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083559|NCT01052012|Bupivacaine|bupivacaine|mesh-list
65083560|NCT01052012|Anesthetics, Local|anesthetics, local|mesh-ancestor
65083561|NCT01052012|Anesthetics|anesthetics|mesh-ancestor
65083562|NCT01052012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64325404|NCT04784039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64325405|NCT04784039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325406|NCT04784039|Hemostatics|hemostatics|mesh-ancestor
64325407|NCT04784039|Coagulants|coagulants|mesh-ancestor
64834871|NCT03980769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834872|NCT03980769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64834873|NCT03980769|Antimetabolites|antimetabolites|mesh-ancestor
64427043|NCT02457325|Sensory System Agents|sensory system agents|mesh-ancestor
65083563|NCT01052012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083564|NCT01052012|Sensory System Agents|sensory system agents|mesh-ancestor
65083565|NCT01052012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65083566|NCT00462852|Gemcitabine|gemcitabine|mesh-list
65083567|NCT00462852|Dalteparin|dalteparin|mesh-list
65083568|NCT00462852|Tinzaparin|tinzaparin|mesh-list
65083569|NCT00462852|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65083570|NCT00462852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65083571|NCT00462852|Antimetabolites|antimetabolites|mesh-ancestor
65083572|NCT00462852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083573|NCT00462852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083574|NCT00462852|Antiviral Agents|antiviral agents|mesh-ancestor
65083575|NCT00462852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65083576|NCT00462852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083577|NCT00462852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65083578|NCT00462852|Immunologic Factors|immunologic factors|mesh-ancestor
65083579|NCT00462852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083580|NCT00462852|Anticoagulants|anticoagulants|mesh-ancestor
65083581|NCT00462852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65083582|NCT00462852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65083583|NCT00471393|Diclofenac|diclofenac|mesh-list
65083584|NCT00471393|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
65083585|NCT00471393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65083586|NCT00471393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65083587|NCT00471393|Analgesics|analgesics|mesh-ancestor
65083588|NCT00471393|Sensory System Agents|sensory system agents|mesh-ancestor
65083589|NCT00471393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65083590|NCT00471393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083591|NCT00471393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65083592|NCT00471393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65083593|NCT00471393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65083594|NCT00471393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083595|NCT00471393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083596|NCT00471393|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
65083597|NCT00471393|Protective Agents|protective agents|mesh-ancestor
65083598|NCT00471393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65083599|NCT00471393|Antioxidants|antioxidants|mesh-ancestor
65083600|NCT00432068|Octreotide|octreotide|mesh-list
65083601|NCT00432068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65083602|NCT00432068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65083603|NCT00432068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083604|NCT03273231|Ketamine|ketamine|mesh-list
65083605|NCT03273231|Analgesics|analgesics|mesh-ancestor
65083606|NCT03273231|Sensory System Agents|sensory system agents|mesh-ancestor
65083607|NCT03273231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65083608|NCT03273231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083609|NCT03273231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65083610|NCT03273231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65083611|NCT03273231|Anesthetics, General|anesthetics, general|mesh-ancestor
65083612|NCT03273231|Anesthetics|anesthetics|mesh-ancestor
65083613|NCT03273231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65083614|NCT03273231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65083615|NCT03273231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65083616|NCT03273231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65083617|NCT03273231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834874|NCT03980769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834875|NCT03980769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64834876|NCT03980769|Immunologic Factors|immunologic factors|mesh-ancestor
64834877|NCT03980769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834878|NCT03980769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64834879|NCT03980769|Alkylating Agents|alkylating agents|mesh-ancestor
64325408|NCT02157467|Moxifloxacin|moxifloxacin|mesh-list
64325409|NCT02157467|BMS-955176|bms-955176|mesh-list
64427073|NCT04929535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65083618|NCT00432146|Lugol's solution|lugol's solution|mesh-list
65083619|NCT00432146|Hemostatics|hemostatics|mesh-ancestor
65083620|NCT00432146|Coagulants|coagulants|mesh-ancestor
65083621|NCT00432302|Sagopilone|sagopilone|mesh-list
65083622|NCT00432302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083623|NCT00463008|Methotrexate|methotrexate|mesh-list
65083624|NCT00463008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65083625|NCT00463008|Abortifacient Agents|abortifacient agents|mesh-ancestor
65083626|NCT00463008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65083627|NCT00463008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083628|NCT00463008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65083629|NCT00463008|Antimetabolites|antimetabolites|mesh-ancestor
65083630|NCT00463008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083631|NCT00463008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083632|NCT00463008|Dermatologic Agents|dermatologic agents|mesh-ancestor
65083633|NCT00463008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083634|NCT00463008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65083635|NCT00463008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65083636|NCT00463008|Immunologic Factors|immunologic factors|mesh-ancestor
65083637|NCT00463008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65083638|NCT00463008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65083639|NCT00471432|Docetaxel|docetaxel|mesh-list
65083640|NCT00471432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083641|NCT00471432|Tubulin Modulators|tubulin modulators|mesh-ancestor
65083642|NCT00471432|Antimitotic Agents|antimitotic agents|mesh-ancestor
65083643|NCT00471432|Mitosis Modulators|mitosis modulators|mesh-ancestor
65083644|NCT00471432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083645|NCT00463086|Isoniazid|isoniazid|mesh-list
65083646|NCT00463086|Antitubercular Agents|antitubercular agents|mesh-ancestor
65083647|NCT00463086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65083648|NCT00463086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65083649|NCT00463086|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65083650|NCT00463086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65083651|NCT00463086|Antimetabolites|antimetabolites|mesh-ancestor
65083652|NCT00463086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083653|NCT00463086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65083654|NCT02957435|Eplerenone|eplerenone|mesh-list
65083655|NCT02957435|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65083656|NCT02957435|Hormone Antagonists|hormone antagonists|mesh-ancestor
65083657|NCT02957435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65083658|NCT02957435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083659|NCT02957435|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65083660|NCT02957435|Diuretics|diuretics|mesh-ancestor
65083661|NCT02957435|Natriuretic Agents|natriuretic agents|mesh-ancestor
65083662|NCT02957435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65083663|NCT00471471|Sargramostim|sargramostim|mesh-list
65083664|NCT00471471|Immunologic Factors|immunologic factors|mesh-ancestor
65083665|NCT00471471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083666|NCT02273492|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
65083667|NCT02273492|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65083668|NCT00471510|Proteasome Inhibitors|proteasome inhibitors|mesh-list
65083669|NCT00471510|Protease Inhibitors|protease inhibitors|mesh-ancestor
65083670|NCT00471510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083671|NCT00471510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083672|NCT02273531|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
65083673|NCT02273531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65083675|NCT00463203|Irinotecan|irinotecan|mesh-list
65083676|NCT00463203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65083677|NCT00463203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083678|NCT00463203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65083679|NCT00463203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65083680|NCT00463203|Growth Substances|growth substances|mesh-ancestor
65083681|NCT00463203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083682|NCT00463203|Growth Inhibitors|growth inhibitors|mesh-ancestor
65083683|NCT00463203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64325410|NCT02157467|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64325411|NCT02157467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64325412|NCT02157467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65083684|NCT00463203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65083685|NCT00463203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083686|NCT00463203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083688|NCT00471549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65083689|NCT00471549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65083690|NCT00471549|Antimetabolites|antimetabolites|mesh-ancestor
65083691|NCT00471549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083692|NCT00471549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65083693|NCT00471549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65083694|NCT00471549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083695|NCT00432575|Surinabant|surinabant|mesh-list
65083696|NCT00432575|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65083697|NCT00432575|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65083698|NCT00432575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65083699|NCT00432575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083700|NCT00432575|Hormones|hormones|mesh-ancestor
65083701|NCT00432575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65083702|NCT00432575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083703|NCT00432614|Citalopram|citalopram|mesh-list
65083704|NCT00432614|Amibegron|amibegron|mesh-list
65083705|NCT00432614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65083706|NCT00432614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65083707|NCT00432614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65083708|NCT00432614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083709|NCT00432614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65083710|NCT00432614|Serotonin Agents|serotonin agents|mesh-ancestor
65083711|NCT00432614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083712|NCT00432614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65083713|NCT00432614|Antidepressive Agents|antidepressive agents|mesh-ancestor
65083714|NCT00432614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65083715|NCT00432614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65083716|NCT00432614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65083717|NCT00432614|Adrenergic Agents|adrenergic agents|mesh-ancestor
65083718|NCT00463320|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65083719|NCT00463320|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65083721|NCT00432653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65083722|NCT00432653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083723|NCT00432653|Immunologic Factors|immunologic factors|mesh-ancestor
65083724|NCT00432653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083725|NCT00432653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65083726|NCT00471588|Pramipexole|pramipexole|mesh-list
65083727|NCT00471588|Amisulpride|amisulpride|mesh-list
65083728|NCT00471588|Antioxidants|antioxidants|mesh-ancestor
65083729|NCT00471588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083730|NCT00471588|Protective Agents|protective agents|mesh-ancestor
65083731|NCT00471588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083732|NCT00471588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65083733|NCT00471588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65083734|NCT00471588|Dopamine Agonists|dopamine agonists|mesh-ancestor
65083735|NCT00471588|Dopamine Agents|dopamine agents|mesh-ancestor
65083736|NCT00471588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65083737|NCT00471588|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65083738|NCT00471588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65083739|NCT00471588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65083740|NCT00471588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65083741|NCT00471588|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65083742|NCT00471588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65083743|NCT00471588|Antidepressive Agents|antidepressive agents|mesh-ancestor
64427214|NCT02387983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64427215|NCT02387983|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65083745|NCT00463359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65083746|NCT00463359|Immunologic Factors|immunologic factors|mesh-ancestor
65083747|NCT00463359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083748|NCT00463359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083749|NCT00463359|Interferon Inducers|interferon inducers|mesh-ancestor
65083750|NCT00471627|Pancrelipase|pancrelipase|mesh-list
65083751|NCT00471627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65083752|NCT00432887|Caffeine|caffeine|mesh-list
65083753|NCT00432887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65083754|NCT00432887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083755|NCT00432887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65083756|NCT00432887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083757|NCT00432887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083758|NCT00432887|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65083759|NCT00432887|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65083760|NCT00432887|Purinergic Agents|purinergic agents|mesh-ancestor
65083761|NCT00432887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65083762|NCT00471744|Levetiracetam|levetiracetam|mesh-list
65083763|NCT00471744|Sulthiame|sulthiame|mesh-list
65083764|NCT00471744|Anticonvulsants|anticonvulsants|mesh-ancestor
65083765|NCT00471744|Nootropic Agents|nootropic agents|mesh-ancestor
65083766|NCT00471783|Chlorhexidine|chlorhexidine|mesh-list
65083767|NCT00471783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65083768|NCT00471783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65083769|NCT00471783|Disinfectants|disinfectants|mesh-ancestor
65083770|NCT00463515|Gemcitabine|gemcitabine|mesh-list
65083771|NCT00463515|Carboplatin|carboplatin|mesh-list
65083772|NCT00463515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083773|NCT00463515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65083774|NCT00463515|Antimetabolites|antimetabolites|mesh-ancestor
65083775|NCT00463515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083776|NCT00463515|Antiviral Agents|antiviral agents|mesh-ancestor
65083777|NCT00463515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65083778|NCT00463515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083779|NCT00463515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65083780|NCT00463515|Immunologic Factors|immunologic factors|mesh-ancestor
65083781|NCT00463515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083782|NCT00433043|Metoprolol|metoprolol|mesh-list
65083783|NCT00433043|Carvedilol|carvedilol|mesh-list
65083784|NCT00433043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
65083785|NCT00433043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65083786|NCT00433043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65083787|NCT00433043|Sympatholytics|sympatholytics|mesh-ancestor
65083788|NCT00433043|Autonomic Agents|autonomic agents|mesh-ancestor
65083789|NCT00433043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65083790|NCT00433043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083791|NCT00433043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65083792|NCT00433043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65083793|NCT00433043|Adrenergic Agents|adrenergic agents|mesh-ancestor
65083794|NCT00433043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65083795|NCT00433043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083796|NCT00433043|Antioxidants|antioxidants|mesh-ancestor
65083797|NCT00433043|Protective Agents|protective agents|mesh-ancestor
65083798|NCT00433043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65083799|NCT00433043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65083800|NCT00433043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65083801|NCT00433043|Vasodilator Agents|vasodilator agents|mesh-ancestor
65083802|NCT00433043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65083803|NCT00433043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65083804|NCT04697862|Sildenafil Citrate|sildenafil citrate|mesh-list
65083805|NCT04697862|Vasodilator Agents|vasodilator agents|mesh-ancestor
65083806|NCT04697862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65083807|NCT04697862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65083808|NCT04697862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083809|NCT04697862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083810|NCT04697862|Urological Agents|urological agents|mesh-ancestor
65083811|NCT03273075|Ticagrelor|ticagrelor|mesh-list
65083812|NCT03273075|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65083813|NCT03273075|Cangrelor|cangrelor|mesh-list
65083814|NCT03273075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65083815|NCT03273075|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65083816|NCT03273075|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65083817|NCT03273075|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65083818|NCT03273075|Purinergic Agents|purinergic agents|mesh-ancestor
65083819|NCT03273075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65083820|NCT03273075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083821|NCT03273075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083822|NCT00471900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65083823|NCT00471900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65083824|NCT00471900|Immunologic Factors|immunologic factors|mesh-ancestor
65083825|NCT00471900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083826|NCT01051661|Vaccines|vaccines|mesh-list
65083827|NCT01051661|Immunologic Factors|immunologic factors|mesh-ancestor
65083828|NCT01051661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083829|NCT01051466|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65083830|NCT01051466|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65083831|NCT01051466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65083832|NCT01051466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65083833|NCT01051466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083834|NCT01051466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65083835|NCT01051466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083836|NCT01051466|Analgesics|analgesics|mesh-ancestor
65083837|NCT01051466|Sensory System Agents|sensory system agents|mesh-ancestor
65083838|NCT01051466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65083839|NCT01051466|Antidepressive Agents|antidepressive agents|mesh-ancestor
65083840|NCT01051466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65083841|NCT01051466|Dopamine Agents|dopamine agents|mesh-ancestor
65083842|NCT04446793|Bevacizumab|bevacizumab|mesh-list
65083843|NCT04446793|Onvansertib|onvansertib|mesh-list
65083844|NCT04446793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65083845|NCT04446793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083846|NCT04446793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65083847|NCT04446793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65083848|NCT04446793|Growth Substances|growth substances|mesh-ancestor
65083849|NCT04446793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083850|NCT04446793|Growth Inhibitors|growth inhibitors|mesh-ancestor
65083851|NCT04446793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65083852|NCT04446793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083853|NCT04446793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083854|NCT01051349|Daclizumab|daclizumab|mesh-list
65083855|NCT01051349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65083856|NCT01051349|Immunologic Factors|immunologic factors|mesh-ancestor
64834880|NCT03980769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64834881|NCT03970200|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64834882|NCT03970200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64834883|NCT03958461|Anti-Infective Agents|anti-infective agents|mesh-list
64603436|NCT02038023|Iron|iron|mesh-list
64834884|NCT03936153|Abexinostat|abexinostat|mesh-list
64834885|NCT03936153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64834886|NCT03936153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834887|NCT03936153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834888|NCT03921008|Paclitaxel|paclitaxel|mesh-list
65083857|NCT01051349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083859|NCT00433121|Risperidone|risperidone|mesh-list
65083860|NCT00433121|Citalopram|citalopram|mesh-list
65083861|NCT00433121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65083862|NCT00433121|Serotonin Agents|serotonin agents|mesh-ancestor
65083863|NCT00433121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65083864|NCT00433121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083865|NCT00433121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083866|NCT00433121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65083867|NCT00433121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65083868|NCT00433121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65083869|NCT00433121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65083870|NCT00433121|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65083871|NCT00433121|Dopamine Agents|dopamine agents|mesh-ancestor
65083872|NCT00433121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65083873|NCT00433121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65083874|NCT00433121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65083875|NCT00433121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65083876|NCT00433121|Antidepressive Agents|antidepressive agents|mesh-ancestor
65083877|NCT00433121|Autonomic Agents|autonomic agents|mesh-ancestor
65083878|NCT00433121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65083879|NCT00433121|Antiemetics|antiemetics|mesh-ancestor
65083880|NCT00433121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65083881|NCT00463671|Acetylcysteine|acetylcysteine|mesh-list
65083882|NCT00463671|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65083883|NCT00463671|Antiviral Agents|antiviral agents|mesh-ancestor
65083884|NCT00463671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65083885|NCT00463671|Expectorants|expectorants|mesh-ancestor
65083886|NCT00463671|Respiratory System Agents|respiratory system agents|mesh-ancestor
65083887|NCT00463671|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65083888|NCT00463671|Antioxidants|antioxidants|mesh-ancestor
65083889|NCT00463671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083890|NCT00463671|Protective Agents|protective agents|mesh-ancestor
65083891|NCT00463671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083892|NCT00463671|Antidotes|antidotes|mesh-ancestor
65083893|NCT00591526|Cytarabine|cytarabine|mesh-list
65083894|NCT00591526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65083895|NCT00591526|Antimetabolites|antimetabolites|mesh-ancestor
65083896|NCT00591526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083897|NCT00591526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083898|NCT00591526|Antiviral Agents|antiviral agents|mesh-ancestor
65083899|NCT00591526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65083900|NCT00591526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65083901|NCT00591526|Immunologic Factors|immunologic factors|mesh-ancestor
64834897|NCT03919773|gamma-Globulins|gamma-globulins|mesh-list
64834898|NCT03919773|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64325413|NCT02157467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64325414|NCT02157467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64325415|NCT02157467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836096|NCT01611038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083902|NCT00591526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083903|NCT00463710|Interferon beta-1a|interferon beta-1a|mesh-list
65083904|NCT00463710|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65083905|NCT00463710|Immunologic Factors|immunologic factors|mesh-ancestor
65083906|NCT00463710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083907|NCT00463710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083908|NCT00463710|Antiviral Agents|antiviral agents|mesh-ancestor
65083909|NCT00463710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65083910|NCT00433277|Cyclosporine|cyclosporine|mesh-list
65083911|NCT00433277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65083912|NCT00433277|Cyclosporins|cyclosporins|mesh-list
65083913|NCT00433277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083914|NCT00433277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083915|NCT00433277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65083916|NCT00433277|Immunologic Factors|immunologic factors|mesh-ancestor
65083917|NCT00433277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083918|NCT00433277|Antifungal Agents|antifungal agents|mesh-ancestor
65083919|NCT00433277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65083920|NCT00433277|Dermatologic Agents|dermatologic agents|mesh-ancestor
65083921|NCT00433277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65083922|NCT00433277|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65083923|NCT00433277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65083924|NCT00463827|Atorvastatin|atorvastatin|mesh-list
65083925|NCT00463827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65083926|NCT00463827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65083927|NCT00463827|Antimetabolites|antimetabolites|mesh-ancestor
65083928|NCT00463827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083929|NCT00463827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65083930|NCT00463827|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65083931|NCT00463827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083932|NCT00433316|Ropivacaine|ropivacaine|mesh-list
64616432|NCT01058941|Vitamins|vitamins|mesh-ancestor
65083934|NCT00433316|Anesthetics|anesthetics|mesh-ancestor
65083935|NCT00433316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65083936|NCT00433316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083937|NCT00433316|Sensory System Agents|sensory system agents|mesh-ancestor
65083938|NCT00433316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65083939|NCT00472134|Bupivacaine|bupivacaine|mesh-list
65083940|NCT00472134|Anesthetics, Local|anesthetics, local|mesh-ancestor
65083941|NCT00472134|Anesthetics|anesthetics|mesh-ancestor
65083942|NCT00472134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65083943|NCT00472134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083944|NCT00472134|Sensory System Agents|sensory system agents|mesh-ancestor
65083945|NCT00472134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65083946|NCT00433433|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65083947|NCT00433433|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65083948|NCT00433433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083949|NCT03270969|Tenofovir|tenofovir|mesh-list
65083950|NCT03270969|Emtricitabine|emtricitabine|mesh-list
65083951|NCT03270969|Antiviral Agents|antiviral agents|mesh-ancestor
65083952|NCT03270969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65083953|NCT03270969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65083954|NCT03270969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65083955|NCT03270969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64325417|NCT02157467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083956|NCT03270969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083957|NCT03270969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65083958|NCT03270969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65083959|NCT00463983|Octreotide|octreotide|mesh-list
65083960|NCT00463983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65083961|NCT00463983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65083962|NCT00463983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083963|NCT01050998|Mavrilimumab|mavrilimumab|mesh-list
65083964|NCT01050998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65083965|NCT01050998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65083966|NCT01050998|Immunologic Factors|immunologic factors|mesh-ancestor
65083967|NCT01050998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083968|NCT00472173|Calcium|calcium|mesh-list
65083969|NCT00472173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65083970|NCT00472173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083971|NCT00472329|Fludarabine|fludarabine|mesh-list
65083972|NCT00472329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65083973|NCT00464217|Idarubicin|idarubicin|mesh-list
65083974|NCT00464217|Molgramostim|molgramostim|mesh-list
65083975|NCT00464217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65083977|NCT00464217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65083978|NCT00464217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65083979|NCT00464217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65083980|NCT00464217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083981|NCT00433784|Clopidogrel|clopidogrel|mesh-list
65083982|NCT00433784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65083983|NCT00433784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65083984|NCT00433784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65083985|NCT00433784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65083986|NCT00433784|Purinergic Agents|purinergic agents|mesh-ancestor
65083987|NCT00433784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65083988|NCT00433784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083989|NCT00433784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083990|NCT00464256|Rimonabant|rimonabant|mesh-list
65083991|NCT00464256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65083992|NCT00464256|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65083993|NCT00464256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65083994|NCT00464256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65083995|NCT00464256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65083996|NCT00464256|Hormones|hormones|mesh-ancestor
65083997|NCT00464256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65083998|NCT00464256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65083999|NCT00433823|Atorvastatin|atorvastatin|mesh-list
65084000|NCT00433823|Ezetimibe|ezetimibe|mesh-list
65084001|NCT00433823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65084002|NCT00433823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65084003|NCT00433823|Antimetabolites|antimetabolites|mesh-ancestor
65084004|NCT00433823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084005|NCT00433823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65084006|NCT00433823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65084007|NCT00433823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084008|NCT00464295|Capecitabine|capecitabine|mesh-list
65084009|NCT00464295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65084010|NCT00464295|Antimetabolites|antimetabolites|mesh-ancestor
64325421|NCT02157467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325422|NCT02157467|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64325423|NCT02157467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64325424|NCT02157467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64325426|NCT02157467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64325427|NCT02157467|Antiviral Agents|antiviral agents|mesh-ancestor
64325428|NCT01374087|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64325429|NCT01374087|Luteolytic Agents|luteolytic agents|mesh-ancestor
65084011|NCT00464295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084012|NCT00464295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084013|NCT03273036|Triamcinolone|triamcinolone|mesh-list
65084014|NCT03273036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65084015|NCT03273036|Glucocorticoids|glucocorticoids|mesh-ancestor
65084016|NCT03273036|Hormones|hormones|mesh-ancestor
65084017|NCT03273036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65084018|NCT03273036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084019|NCT03270735|Thrombin|thrombin|mesh-list
65084020|NCT03270735|Hemostatics|hemostatics|mesh-ancestor
65084021|NCT03270735|Coagulants|coagulants|mesh-ancestor
65084022|NCT04702685|Ropivacaine|ropivacaine|mesh-list
65084023|NCT04702685|Anesthetics, Local|anesthetics, local|mesh-ancestor
65084024|NCT04702685|Anesthetics|anesthetics|mesh-ancestor
65084025|NCT04702685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65084026|NCT04702685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084027|NCT04702685|Sensory System Agents|sensory system agents|mesh-ancestor
65084029|NCT00464373|Botulinum Toxins|botulinum toxins|mesh-list
65084030|NCT00464373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65084031|NCT00464373|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65084032|NCT00464373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65084033|NCT00464373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65084034|NCT00464373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084035|NCT00464373|Cholinergic Agents|cholinergic agents|mesh-ancestor
65084036|NCT00464373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65084037|NCT00464373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084038|NCT00464373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65084039|NCT00464373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65084040|NCT00472368|Panobinostat|panobinostat|mesh-list
65084041|NCT00472368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084042|NCT00472368|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65084043|NCT00472368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084044|NCT00472368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084045|NCT00106028|Risedronic Acid|risedronic acid|mesh-list
65084046|NCT00106028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65084047|NCT00106028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65084048|NCT00106028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084049|NCT00106028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65084050|NCT00106028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084051|NCT00106028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65084052|NCT00464451|Dexmedetomidine|dexmedetomidine|mesh-list
65084053|NCT00464451|Chloral Hydrate|chloral hydrate|mesh-list
65084054|NCT00464451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65084055|NCT00464451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65084056|NCT00464451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084057|NCT00464451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65084058|NCT00464451|Analgesics|analgesics|mesh-ancestor
64427674|NCT02341417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64427675|NCT02341417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427676|NCT02341417|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64427677|NCT02341417|Hormone Antagonists|hormone antagonists|mesh-ancestor
64427678|NCT02341417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64427679|NCT02340949|Leucovorin|leucovorin|mesh-list
64427680|NCT02340949|Oxaliplatin|oxaliplatin|mesh-list
64427681|NCT02340949|Aflibercept|aflibercept|mesh-list
64427682|NCT02340949|Fluorouracil|fluorouracil|mesh-list
65084059|NCT00464451|Sensory System Agents|sensory system agents|mesh-ancestor
65084060|NCT00464451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65084061|NCT00464451|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65084062|NCT00464451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65084063|NCT00464451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65084064|NCT00464451|Adrenergic Agents|adrenergic agents|mesh-ancestor
65084065|NCT00464451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65084066|NCT00464451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084067|NCT00433940|Prednisolone|prednisolone|mesh-list
65084068|NCT00433940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65084069|NCT00433940|Glucocorticoids|glucocorticoids|mesh-ancestor
65084070|NCT00433940|Hormones|hormones|mesh-ancestor
65084071|NCT00433940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65084072|NCT00433940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084073|NCT00433940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65084074|NCT00433940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084075|NCT00433979|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65084076|NCT00433979|Antiviral Agents|antiviral agents|mesh-ancestor
65084077|NCT00433979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65084079|NCT01050764|Fludarabine|fludarabine|mesh-list
65084080|NCT01050764|Fludarabine phosphate|fludarabine phosphate|mesh-list
65084081|NCT01050764|Melphalan|melphalan|mesh-list
65084082|NCT01050764|Thiotepa|thiotepa|mesh-list
65084083|NCT01050764|Thymoglobulin|thymoglobulin|mesh-list
65084084|NCT01050764|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65084085|NCT01050764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084086|NCT01050764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65084087|NCT01050764|Antimetabolites|antimetabolites|mesh-ancestor
65084088|NCT01050764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084089|NCT01050764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65084090|NCT01050764|Immunologic Factors|immunologic factors|mesh-ancestor
65084091|NCT01050764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084092|NCT01050764|Antiviral Agents|antiviral agents|mesh-ancestor
65084093|NCT01050764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65084094|NCT01050764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65084095|NCT01050764|Alkylating Agents|alkylating agents|mesh-ancestor
65084096|NCT01050764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65084097|NCT00434096|Rimonabant|rimonabant|mesh-list
65084098|NCT00434096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65084099|NCT00434096|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65084100|NCT00434096|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65084101|NCT00434096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65084102|NCT00434096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084103|NCT00434096|Hormones|hormones|mesh-ancestor
65084104|NCT00434096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65084105|NCT00434096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084106|NCT01050569|Nicotine|nicotine|mesh-list
65084107|NCT01050569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65084108|NCT01050569|Autonomic Agents|autonomic agents|mesh-ancestor
65084109|NCT01050569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64325433|NCT01374087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834914|NCT03841110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834915|NCT03841110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64834916|NCT03841110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64834917|NCT03841110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64834918|NCT03841110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64834919|NCT03841110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64834920|NCT03841110|Antiviral Agents|antiviral agents|mesh-ancestor
64834921|NCT03841110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65084110|NCT01050569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084111|NCT01050569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65084112|NCT01050569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65084113|NCT01050569|Cholinergic Agents|cholinergic agents|mesh-ancestor
65084114|NCT01050569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65084115|NCT01050569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084116|NCT04702490|Empagliflozin|empagliflozin|mesh-list
65084117|NCT04702490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65084118|NCT04702490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084119|NCT04702490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65084120|NCT04702490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084121|NCT00464763|Dexmedetomidine|dexmedetomidine|mesh-list
65084122|NCT00464763|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65084123|NCT00464763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65084124|NCT00464763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084125|NCT00464763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65084126|NCT00464763|Analgesics|analgesics|mesh-ancestor
65084127|NCT00464763|Sensory System Agents|sensory system agents|mesh-ancestor
65084128|NCT00464763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65084129|NCT00464763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65084130|NCT00464763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65084131|NCT00464763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65084132|NCT00464763|Adrenergic Agents|adrenergic agents|mesh-ancestor
65084133|NCT00464763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65084134|NCT00464763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084135|NCT00434135|Gemcitabine|gemcitabine|mesh-list
65084136|NCT00434135|Paclitaxel|paclitaxel|mesh-list
65084137|NCT00434135|Pemetrexed|pemetrexed|mesh-list
65084138|NCT00434135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65084139|NCT00434135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084140|NCT00434135|Tubulin Modulators|tubulin modulators|mesh-ancestor
65084141|NCT00434135|Antimitotic Agents|antimitotic agents|mesh-ancestor
65084142|NCT00434135|Mitosis Modulators|mitosis modulators|mesh-ancestor
65084143|NCT00434135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084144|NCT00434135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65084145|NCT00434135|Antimetabolites|antimetabolites|mesh-ancestor
65084146|NCT00434135|Antiviral Agents|antiviral agents|mesh-ancestor
65084147|NCT00434135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65084148|NCT00434135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084149|NCT00434135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65084150|NCT00434135|Immunologic Factors|immunologic factors|mesh-ancestor
65084151|NCT00434135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084152|NCT00434135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65084153|NCT00434135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65084155|NCT01050530|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65084156|NCT01050530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084157|NCT01050530|Natriuretic Agents|natriuretic agents|mesh-ancestor
65084158|NCT01050530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084159|NCT01050257|Oseltamivir|oseltamivir|mesh-list
65084160|NCT01050257|Antiviral Agents|antiviral agents|mesh-ancestor
65084161|NCT01050257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65084162|NCT01050257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084163|NCT01050257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084164|NCT03272802|Riluzole|riluzole|mesh-list
65084165|NCT03272802|Edaravone|edaravone|mesh-list
65084166|NCT03272802|Anticonvulsants|anticonvulsants|mesh-ancestor
65084167|NCT03272802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65084168|NCT03272802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65084169|NCT03272802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65084170|NCT03272802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084171|NCT03272802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084172|NCT03272802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65084173|NCT03272802|Protective Agents|protective agents|mesh-ancestor
65084174|NCT03272802|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65084176|NCT01050218|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65084177|NCT01050218|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65084178|NCT01050218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65084179|NCT01050218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65084180|NCT01050218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084181|NCT01050218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65084182|NCT01050218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084183|NCT01050218|Antidepressive Agents|antidepressive agents|mesh-ancestor
65084184|NCT01050218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65084185|NCT01050062|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65084186|NCT01050062|Telmisartan|telmisartan|mesh-list
65084187|NCT01050062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65084188|NCT01050062|Diuretics|diuretics|mesh-ancestor
65084189|NCT01050062|Natriuretic Agents|natriuretic agents|mesh-ancestor
65084190|NCT01050062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084191|NCT01050062|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64726357|NCT00002810|Melphalan|melphalan|mesh-list
65084192|NCT01050062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65084193|NCT01050062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084194|NCT01050062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65084195|NCT01050062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65084197|NCT00464919|Tegafur|tegafur|mesh-list
65084198|NCT00464919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084199|NCT00464919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65084200|NCT00464919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084201|NCT00464919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084202|NCT00464919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65084203|NCT00464919|Antimetabolites|antimetabolites|mesh-ancestor
65084204|NCT00434174|Pemetrexed|pemetrexed|mesh-list
65084205|NCT00434174|Everolimus|everolimus|mesh-list
65084206|NCT00434174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084207|NCT00434174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084208|NCT00434174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084209|NCT00434174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65084210|NCT00434174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65084211|NCT00434174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65084212|NCT00434174|Immunologic Factors|immunologic factors|mesh-ancestor
65084213|NCT00434174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084214|NCT00464958|Tizanidine|tizanidine|mesh-list
65084215|NCT00464958|Analgesics|analgesics|mesh-ancestor
65084216|NCT00464958|Sensory System Agents|sensory system agents|mesh-ancestor
65084217|NCT00464958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65084218|NCT00464958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084219|NCT00464958|Anticonvulsants|anticonvulsants|mesh-ancestor
65084220|NCT00464958|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65084221|NCT00464958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65084222|NCT00464958|Parasympatholytics|parasympatholytics|mesh-ancestor
65084223|NCT00464958|Autonomic Agents|autonomic agents|mesh-ancestor
65084224|NCT00464958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65084225|NCT00464958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65084226|NCT00464958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65084227|NCT00464958|Adrenergic Agents|adrenergic agents|mesh-ancestor
65084228|NCT00464958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65084229|NCT00464958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084230|NCT00472758|Sifalimumab|sifalimumab|mesh-list
65084231|NCT00472758|Immunologic Factors|immunologic factors|mesh-ancestor
65084232|NCT00472758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084233|NCT01055444|Lidocaine|lidocaine|mesh-list
65084234|NCT01055444|Tetracaine|tetracaine|mesh-list
65084235|NCT01055444|Anesthetics, Local|anesthetics, local|mesh-ancestor
65084236|NCT01055444|Anesthetics|anesthetics|mesh-ancestor
65084237|NCT01055444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65084238|NCT01055444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084239|NCT01055444|Sensory System Agents|sensory system agents|mesh-ancestor
65084240|NCT01055444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64834928|NCT03810313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834929|NCT03802630|Aflibercept|aflibercept|mesh-list
65084241|NCT01055444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65084242|NCT01055444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65084243|NCT01055444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65084244|NCT01055444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65084245|NCT01055444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084246|NCT01055015|Morphine|morphine|mesh-list
65084247|NCT01055015|Oxycodone|oxycodone|mesh-list
65084248|NCT01055015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65084249|NCT01055015|Narcotics|narcotics|mesh-ancestor
65084250|NCT01055015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65084251|NCT01055015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084252|NCT01055015|Analgesics|analgesics|mesh-ancestor
65084253|NCT01055015|Sensory System Agents|sensory system agents|mesh-ancestor
65084254|NCT01055015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65084255|NCT00472875|Glyburide|glyburide|mesh-list
65084256|NCT00472875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65084257|NCT00472875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084258|NCT00434447|Zoledronic Acid|zoledronic acid|mesh-list
65084259|NCT00434447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65084260|NCT00434447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084261|NCT00472953|Insulin|insulin|mesh-list
65084262|NCT00472953|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65084263|NCT00472953|Insulin Aspart|insulin aspart|mesh-list
65084264|NCT00472953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65084265|NCT00472953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084266|NCT02957630|Drospirenone|drospirenone|mesh-list
65084267|NCT02957630|Levonorgestrel|levonorgestrel|mesh-list
65084268|NCT02957630|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65084269|NCT02957630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65084270|NCT02957630|Contraceptive Agents|contraceptive agents|mesh-ancestor
65084271|NCT02957630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65084272|NCT02957630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084273|NCT02957630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65084274|NCT02957630|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65084275|NCT02957630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65084276|NCT02957630|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65084277|NCT02957630|Estrogens|estrogens|mesh-ancestor
65084278|NCT02957630|Hormones|hormones|mesh-ancestor
65084279|NCT02957630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65084280|NCT02957630|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65084281|NCT02957630|Hormone Antagonists|hormone antagonists|mesh-ancestor
65084282|NCT02957630|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65084283|NCT02957630|Diuretics|diuretics|mesh-ancestor
64834933|NCT03802630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834935|NCT03802630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427967|NCT02132949|Doxorubicin|doxorubicin|mesh-list
65084284|NCT02957630|Natriuretic Agents|natriuretic agents|mesh-ancestor
65084285|NCT00465036|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
65084286|NCT00465036|Cathartics|cathartics|mesh-ancestor
65084287|NCT00465036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65084288|NCT04702061|Anesthetics|anesthetics|mesh-list
65084289|NCT04702061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65084290|NCT04702061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084291|NCT00465075|Bazedoxifene|bazedoxifene|mesh-list
65084292|NCT00465075|Estrogens|estrogens|mesh-list
65084293|NCT00465075|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65084294|NCT00465075|Hormones|hormones|mesh-ancestor
65084295|NCT00465075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65084296|NCT00465075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084297|NCT00465075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65084298|NCT00465075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65084299|NCT00465075|Hormone Antagonists|hormone antagonists|mesh-ancestor
65084300|NCT00465075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65084301|NCT00465192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65084302|NCT00465192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65084303|NCT00465192|Estradiol|estradiol|mesh-list
65084304|NCT00465192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65084305|NCT00465192|Estrogens|estrogens|mesh-ancestor
65084306|NCT00465192|Hormones|hormones|mesh-ancestor
65084307|NCT00465192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65084308|NCT00465192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084309|NCT00465192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65084310|NCT00465192|Contraceptive Agents|contraceptive agents|mesh-ancestor
65084311|NCT00465192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65084312|NCT00465192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64657015|NCT01061528|Nicotine|nicotine|mesh-list
65084313|NCT00434681|Acetaminophen|acetaminophen|mesh-list
65084314|NCT00434681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65084315|NCT00434681|Analgesics|analgesics|mesh-ancestor
65084316|NCT00434681|Sensory System Agents|sensory system agents|mesh-ancestor
65084317|NCT00434681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65084318|NCT00434681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084319|NCT00434681|Antipyretics|antipyretics|mesh-ancestor
65084320|NCT00473070|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
65084321|NCT00473070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65084322|NCT00473070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65084323|NCT00473070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65084324|NCT00473070|Glucocorticoids|glucocorticoids|mesh-ancestor
65084325|NCT00473070|Hormones|hormones|mesh-ancestor
65084326|NCT00473070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65084327|NCT00473070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084328|NCT00473070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65084329|NCT00473070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65084330|NCT00465231|Fentanyl|fentanyl|mesh-list
65084331|NCT00465231|Bupivacaine|bupivacaine|mesh-list
65084332|NCT00465231|Anesthetics, Local|anesthetics, local|mesh-ancestor
65084333|NCT00465231|Anesthetics|anesthetics|mesh-ancestor
65084334|NCT00465231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65084335|NCT00465231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084336|NCT00465231|Sensory System Agents|sensory system agents|mesh-ancestor
65084337|NCT00465231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65084338|NCT00465231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65084339|NCT00465231|Narcotics|narcotics|mesh-ancestor
65084340|NCT00465231|Analgesics|analgesics|mesh-ancestor
64726499|NCT00002816|Antidotes|antidotes|mesh-ancestor
65084341|NCT00465231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65084342|NCT00465231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65084343|NCT00465231|Anesthetics, General|anesthetics, general|mesh-ancestor
65084344|NCT03272568|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
65084345|NCT03272568|Immunologic Factors|immunologic factors|mesh-ancestor
65084346|NCT03272568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084347|NCT04702334|Lidocaine|lidocaine|mesh-list
65084348|NCT04702334|Hyaluronic Acid|hyaluronic acid|mesh-list
65084349|NCT04702334|Anesthetics, Local|anesthetics, local|mesh-ancestor
65084350|NCT04702334|Anesthetics|anesthetics|mesh-ancestor
65084351|NCT04702334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65084352|NCT04702334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084353|NCT04702334|Sensory System Agents|sensory system agents|mesh-ancestor
65084354|NCT04702334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65084355|NCT04702334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65084356|NCT04702334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65084357|NCT04702334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65084358|NCT04702334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65084359|NCT04702334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084360|NCT04702334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65084361|NCT04702334|Immunologic Factors|immunologic factors|mesh-ancestor
65084362|NCT04702334|Viscosupplements|viscosupplements|mesh-ancestor
65084363|NCT04702334|Protective Agents|protective agents|mesh-ancestor
65084364|NCT00473460|Moxifloxacin|moxifloxacin|mesh-list
65084365|NCT00473460|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
65084366|NCT00473460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65084367|NCT00473460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65084368|NCT00473460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65084369|NCT00473460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65084370|NCT00473460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084371|NCT00473460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084372|NCT00473460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084373|NCT00473460|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65084374|NCT00473460|Contraceptive Agents|contraceptive agents|mesh-ancestor
65084375|NCT00473460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65084376|NCT00473460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084377|NCT00473460|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65084378|NCT00473460|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65084379|NCT00473460|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65084380|NCT00435305|Vancomycin|vancomycin|mesh-list
65084381|NCT00435305|Meropenem|meropenem|mesh-list
65084382|NCT00435305|Tazobactam|tazobactam|mesh-list
65084383|NCT00435305|Linezolid|linezolid|mesh-list
65084384|NCT00435305|Piperacillin|piperacillin|mesh-list
65084385|NCT00435305|Ceftazidime|ceftazidime|mesh-list
65084386|NCT00435305|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65084387|NCT00435305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65084388|NCT00435305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65084389|NCT00435305|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65084390|NCT00435305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836098|NCT01611077|Candesartan|candesartan|mesh-list
64428072|NCT02188719|Valganciclovir|valganciclovir|mesh-list
65084391|NCT00435305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084392|NCT00435305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65084394|NCT00465543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65084395|NCT00465543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65084396|NCT00465543|Analgesics|analgesics|mesh-ancestor
65084397|NCT00465543|Sensory System Agents|sensory system agents|mesh-ancestor
65084398|NCT00465543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65084399|NCT00465543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084400|NCT00465543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65084401|NCT00465543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65084402|NCT00465543|Antioxidants|antioxidants|mesh-ancestor
65084403|NCT00465543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084404|NCT00465543|Protective Agents|protective agents|mesh-ancestor
65084405|NCT00465543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65084406|NCT00465543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65084407|NCT00465543|Protease Inhibitors|protease inhibitors|mesh-ancestor
65084408|NCT00465543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084409|NCT00435500|Fluorides|fluorides|mesh-list
65084410|NCT00435500|Fluorides, Topical|fluorides, topical|mesh-list
65084411|NCT00435500|Cariostatic Agents|cariostatic agents|mesh-ancestor
65084412|NCT00435500|Protective Agents|protective agents|mesh-ancestor
65084413|NCT00435500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084414|NCT03272412|Progesterone|progesterone|mesh-list
65084415|NCT03272412|Progestins|progestins|mesh-ancestor
65084416|NCT03272412|Hormones|hormones|mesh-ancestor
65084417|NCT03272412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65084418|NCT03272412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084419|NCT00473616|Irinotecan|irinotecan|mesh-list
65084420|NCT00473616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65084421|NCT00473616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65084422|NCT00473616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084423|NCT00473616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084424|NCT00473616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084425|NCT00435851|Hormones|hormones|mesh-list
65084426|NCT00435851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65084427|NCT00435851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084428|NCT00436124|Oseltamivir|oseltamivir|mesh-list
65084429|NCT00436124|Antiviral Agents|antiviral agents|mesh-ancestor
65084430|NCT00436124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65084431|NCT00436124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084432|NCT00436124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084433|NCT02957474|Omeprazole|omeprazole|mesh-list
65084434|NCT02957474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65084435|NCT02957474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65084436|NCT02957474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65084437|NCT02957474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084438|NCT02957474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084439|NCT00436241|Capecitabine|capecitabine|mesh-list
65084440|NCT00436241|Oxaliplatin|oxaliplatin|mesh-list
65084441|NCT00436241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65084442|NCT00436241|Antimetabolites|antimetabolites|mesh-ancestor
65084443|NCT00436241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084444|NCT00436241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084445|NCT00481455|Temozolomide|temozolomide|mesh-list
65084446|NCT00481455|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
65084447|NCT00481455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65084448|NCT00481455|Alkylating Agents|alkylating agents|mesh-ancestor
65084449|NCT00481455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084450|NCT00481455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084451|NCT00481455|Tubulin Modulators|tubulin modulators|mesh-ancestor
65084452|NCT00481455|Antimitotic Agents|antimitotic agents|mesh-ancestor
65084453|NCT00481455|Mitosis Modulators|mitosis modulators|mesh-ancestor
65084454|NCT00481533|Oxytocin|oxytocin|mesh-list
65084455|NCT00481533|Ergonovine|ergonovine|mesh-list
65084456|NCT00481533|Oxytocics|oxytocics|mesh-ancestor
65084457|NCT00481533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64416537|NCT04848181|Contraceptive Agents|contraceptive agents|mesh-ancestor
65084458|NCT00481533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084459|NCT00481572|Terlipressin|terlipressin|mesh-list
65084460|NCT00481572|Vasopressins|vasopressins|mesh-list
65084461|NCT00481572|Arginine Vasopressin|arginine vasopressin|mesh-list
65084462|NCT00481572|Norepinephrine|norepinephrine|mesh-list
65084463|NCT00481572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64836099|NCT01611077|Candesartan cilexetil|candesartan cilexetil|mesh-list
65084464|NCT00481572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65084465|NCT00481572|Adrenergic Agents|adrenergic agents|mesh-ancestor
65084466|NCT00481572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65084467|NCT00481572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084468|NCT00481572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084469|NCT00481572|Sympathomimetics|sympathomimetics|mesh-ancestor
65084470|NCT00481572|Autonomic Agents|autonomic agents|mesh-ancestor
65084471|NCT00481572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65084472|NCT00481572|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65084473|NCT00481572|Hemostatics|hemostatics|mesh-ancestor
65084474|NCT00481572|Coagulants|coagulants|mesh-ancestor
65084475|NCT00481572|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65084476|NCT00481572|Natriuretic Agents|natriuretic agents|mesh-ancestor
65084477|NCT00481572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65084478|NCT00474006|Daunorubicin|daunorubicin|mesh-list
65084479|NCT00474006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65084480|NCT00474006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084481|NCT00474006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65084482|NCT00474006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65084483|NCT00474006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084484|NCT00474006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084485|NCT04697745|Dexamethasone|dexamethasone|mesh-list
65084486|NCT04697745|Dexmedetomidine|dexmedetomidine|mesh-list
65084487|NCT04697745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65084488|NCT04697745|Antiemetics|antiemetics|mesh-ancestor
65084489|NCT04697745|Autonomic Agents|autonomic agents|mesh-ancestor
65084490|NCT04697745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65084491|NCT04697745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084492|NCT04697745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65084493|NCT04697745|Glucocorticoids|glucocorticoids|mesh-ancestor
65084494|NCT04697745|Hormones|hormones|mesh-ancestor
65084495|NCT04697745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65084496|NCT04697745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65084497|NCT04697745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084498|NCT04697745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65084499|NCT04697745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65084500|NCT04697745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65084501|NCT04697745|Analgesics|analgesics|mesh-ancestor
65084502|NCT04697745|Sensory System Agents|sensory system agents|mesh-ancestor
65084503|NCT04697745|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65084504|NCT04697745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65084505|NCT04697745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65084506|NCT04697745|Adrenergic Agents|adrenergic agents|mesh-ancestor
65084507|NCT04697745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65084508|NCT04697745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084509|NCT00481689|Ciprofloxacin|ciprofloxacin|mesh-list
65084510|NCT00481689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65084511|NCT00481689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65084512|NCT00481689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65084513|NCT00481689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65084514|NCT00481689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64325441|NCT00152971|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64325442|NCT00152971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325443|NCT00152971|Antithrombins|antithrombins|mesh-ancestor
64325444|NCT00152971|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64325445|NCT00152971|Protease Inhibitors|protease inhibitors|mesh-ancestor
64325446|NCT00152971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64325447|NCT04675827|Trastuzumab|trastuzumab|mesh-list
64834951|NCT03785691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64834952|NCT03785691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64834953|NCT03785691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65084515|NCT00481689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084516|NCT00481689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084517|NCT00481689|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65084518|NCT00481689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65084519|NCT00436709|Paclitaxel|paclitaxel|mesh-list
65084520|NCT00436709|Cyclophosphamide|cyclophosphamide|mesh-list
65084521|NCT00436709|Bevacizumab|bevacizumab|mesh-list
65084522|NCT00436709|Doxorubicin|doxorubicin|mesh-list
65084523|NCT00436709|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65084524|NCT00436709|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65084525|NCT00436709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65084526|NCT00436709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084527|NCT00436709|Tubulin Modulators|tubulin modulators|mesh-ancestor
65084528|NCT00436709|Antimitotic Agents|antimitotic agents|mesh-ancestor
65084529|NCT00436709|Mitosis Modulators|mitosis modulators|mesh-ancestor
65084530|NCT00436709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084531|NCT00436709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65084532|NCT00436709|Immunologic Factors|immunologic factors|mesh-ancestor
65084533|NCT00436709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084534|NCT00436709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65084535|NCT00436709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65084536|NCT00436709|Alkylating Agents|alkylating agents|mesh-ancestor
65084537|NCT00436709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65084538|NCT00436709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65084539|NCT00436709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65084540|NCT00436709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65084541|NCT00436709|Growth Substances|growth substances|mesh-ancestor
65084542|NCT00436709|Growth Inhibitors|growth inhibitors|mesh-ancestor
65084543|NCT00436709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65084544|NCT00436709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65084545|NCT00436709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65084546|NCT00436709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084547|NCT00436787|PENTA|penta|mesh-list
65084548|NCT00436787|Fondaparinux|fondaparinux|mesh-list
65084549|NCT00436787|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65084550|NCT00436787|Antithrombins|antithrombins|mesh-ancestor
65084551|NCT00436787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65084552|NCT00436787|Protease Inhibitors|protease inhibitors|mesh-ancestor
65084553|NCT00436787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084554|NCT00436787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084555|NCT00436787|Anticoagulants|anticoagulants|mesh-ancestor
65084556|NCT00436787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65084557|NCT00436787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65084558|NCT00481728|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65084559|NCT00481728|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65084560|NCT00481728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65084561|NCT00481728|Cholinergic Agents|cholinergic agents|mesh-ancestor
65084562|NCT00481728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65084563|NCT00481728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084564|NCT00481728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084565|NCT00481728|Urological Agents|urological agents|mesh-ancestor
65084566|NCT00436943|Bupropion|bupropion|mesh-list
65084567|NCT00436943|Nicotine|nicotine|mesh-list
65084568|NCT00436943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65084569|NCT00436943|Autonomic Agents|autonomic agents|mesh-ancestor
65084570|NCT00436943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65084571|NCT00436943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084572|NCT00436943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65084573|NCT00436943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65084574|NCT00436943|Cholinergic Agents|cholinergic agents|mesh-ancestor
65084575|NCT00436943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65084576|NCT00436943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084577|NCT00436943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65084578|NCT00436943|Antidepressive Agents|antidepressive agents|mesh-ancestor
65084579|NCT00436943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64428258|NCT02187861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65084580|NCT00436943|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65084581|NCT00436943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65084582|NCT00436943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65084583|NCT00436943|Dopamine Agents|dopamine agents|mesh-ancestor
65084584|NCT00436943|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64483219|NCT01980875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084585|NCT00436943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65084586|NCT00436943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084587|NCT00474162|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
65084588|NCT00474162|Plasma Substitutes|plasma substitutes|mesh-ancestor
65084589|NCT00474162|Blood Substitutes|blood substitutes|mesh-ancestor
65084591|NCT00481884|Emollients|emollients|mesh-ancestor
65084592|NCT00481884|Dermatologic Agents|dermatologic agents|mesh-ancestor
65084593|NCT00481923|Rimonabant|rimonabant|mesh-list
65084594|NCT00481923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65084595|NCT00481923|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65084596|NCT00481923|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65084597|NCT00481923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65084598|NCT00481923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084599|NCT00481923|Hormones|hormones|mesh-ancestor
64657315|NCT04802876|Spartalizumab|spartalizumab|mesh-list
65084600|NCT00481923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65084601|NCT00481923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084602|NCT00481962|Tigecycline|tigecycline|mesh-list
65084603|NCT00481962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65084604|NCT00481962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65084605|NCT00481962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65084606|NCT00481962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084607|NCT00481962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084608|NCT00437177|Apomorphine|apomorphine|mesh-list
65084609|NCT00437177|Emetics|emetics|mesh-ancestor
65084610|NCT00437177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084611|NCT00437177|Autonomic Agents|autonomic agents|mesh-ancestor
65084612|NCT00437177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65084613|NCT00437177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65084614|NCT00437177|Dopamine Agonists|dopamine agonists|mesh-ancestor
65084615|NCT00437177|Dopamine Agents|dopamine agents|mesh-ancestor
65084616|NCT00437177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65084617|NCT00437177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084618|NCT00437333|Metformin|metformin|mesh-list
65084619|NCT00437333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65084620|NCT00437333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084621|NCT00482079|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65084622|NCT00482079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65084623|NCT00482079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084624|NCT00482079|Incretins|incretins|mesh-ancestor
65084625|NCT00482079|Hormones|hormones|mesh-ancestor
65084626|NCT00482079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65084627|NCT00482079|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65084628|NCT00482079|Protease Inhibitors|protease inhibitors|mesh-ancestor
65084629|NCT00482079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084630|NCT00482079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084631|NCT00437372|Sunitinib|sunitinib|mesh-list
65084632|NCT00437372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084633|NCT00437372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65084634|NCT00437372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65084635|NCT00437372|Growth Substances|growth substances|mesh-ancestor
65084636|NCT00437372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084637|NCT00437372|Growth Inhibitors|growth inhibitors|mesh-ancestor
65084638|NCT00437372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65084639|NCT00437372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084640|NCT00437372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084642|NCT00437450|Hematinics|hematinics|mesh-ancestor
65084643|NCT04701710|Ivermectin|ivermectin|mesh-list
65084644|NCT04701710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65084645|NCT04701710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65084646|NCT00437606|Ethanol|ethanol|mesh-list
65084647|NCT00437606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65084648|NCT00437606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65084649|NCT00437606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65084650|NCT00437606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084651|NCT00482313|Methylphenidate|methylphenidate|mesh-list
65084652|NCT00482313|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65084653|NCT00482313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084654|NCT00482313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65084655|NCT00482313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65084656|NCT00482313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65084657|NCT00482313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325449|NCT04675827|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64325450|NCT04675827|Maytansine|maytansine|mesh-list
64325451|NCT04675827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64834958|NCT03785691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64834959|NCT03785691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64834960|NCT03785691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64834961|NCT03785691|Adrenergic Agents|adrenergic agents|mesh-ancestor
64834962|NCT03785691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64834963|NCT03785691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64834964|NCT03780829|Cycloserine|cycloserine|mesh-list
64834965|NCT03780829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65084658|NCT00482313|Dopamine Agents|dopamine agents|mesh-ancestor
65084659|NCT00482313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65084660|NCT00437684|Ribavirin|ribavirin|mesh-list
65084661|NCT00437684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65084662|NCT00437684|Antimetabolites|antimetabolites|mesh-ancestor
65084663|NCT00437684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084664|NCT00437684|Antiviral Agents|antiviral agents|mesh-ancestor
65084665|NCT00437684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65084666|NCT00437723|Epoetin Alfa|epoetin alfa|mesh-list
65084667|NCT00437723|Hematinics|hematinics|mesh-ancestor
65084668|NCT00437762|Botulinum Toxins|botulinum toxins|mesh-list
65084669|NCT00437762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65084670|NCT00437762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65084671|NCT00437762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65084672|NCT00437762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65084673|NCT00437762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084675|NCT00437762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65084676|NCT00437762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084677|NCT00437762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65084678|NCT00437762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65084679|NCT00482508|Omalizumab|omalizumab|mesh-list
65084680|NCT00482508|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65084681|NCT00482508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65084682|NCT00482508|Respiratory System Agents|respiratory system agents|mesh-ancestor
65084683|NCT00437918|Acarbose|acarbose|mesh-list
65084684|NCT00437918|Nateglinide|nateglinide|mesh-list
65084685|NCT00437918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65084686|NCT00437918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084687|NCT00437918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084688|NCT00437918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65084689|NCT00437918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084690|NCT00437957|Temozolomide|temozolomide|mesh-list
65084691|NCT00437957|Valproic Acid|valproic acid|mesh-list
65084692|NCT00437957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65084693|NCT00437957|Alkylating Agents|alkylating agents|mesh-ancestor
65084694|NCT00437957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084695|NCT00437957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084696|NCT00437957|Anticonvulsants|anticonvulsants|mesh-ancestor
65084697|NCT00437957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084698|NCT00437957|GABA Agents|gaba agents|mesh-ancestor
65084699|NCT00437957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65084700|NCT00437957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084701|NCT00437957|Antimanic Agents|antimanic agents|mesh-ancestor
65084702|NCT00437957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65084703|NCT00437957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65084704|NCT00437957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65084705|NCT03270176|Avelumab|avelumab|mesh-list
65084706|NCT03270176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65084707|NCT03270176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084708|NCT00474279|Hormones|hormones|mesh-list
64834976|NCT03736863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834977|NCT03736863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834978|NCT03710564|Aflibercept|aflibercept|mesh-list
64834979|NCT03710564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64446091|NCT03919942|Chlorhexidine|chlorhexidine|mesh-list
64836100|NCT01611077|Olmesartan|olmesartan|mesh-list
65084709|NCT00474279|Secretagogues|secretagogues|mesh-list
65084710|NCT00474279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65084711|NCT00474279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084712|NCT03270696|Propofol|propofol|mesh-list
64726876|NCT00002870|Cyclophosphamide|cyclophosphamide|mesh-list
65084713|NCT03270696|Rocuronium|rocuronium|mesh-list
65084714|NCT03270696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65084715|NCT03270696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65084716|NCT03270696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084717|NCT03270696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65084718|NCT03270696|Anesthetics, General|anesthetics, general|mesh-ancestor
65084719|NCT03270696|Anesthetics|anesthetics|mesh-ancestor
65084720|NCT03270696|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
65084721|NCT03270696|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65084722|NCT03270696|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65084723|NCT03270696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65084724|NCT00437996|Clonidine|clonidine|mesh-list
65084725|NCT00437996|Sufentanil|sufentanil|mesh-list
65084726|NCT00437996|Levobupivacaine|levobupivacaine|mesh-list
65084727|NCT00437996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65084728|NCT00437996|Narcotics|narcotics|mesh-ancestor
65084729|NCT00437996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65084730|NCT00437996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084732|NCT00437996|Sensory System Agents|sensory system agents|mesh-ancestor
65084733|NCT00437996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65084734|NCT00437996|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65084735|NCT00437996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65084736|NCT00437996|Anesthetics, General|anesthetics, general|mesh-ancestor
65084737|NCT00437996|Anesthetics|anesthetics|mesh-ancestor
65084738|NCT00437996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65084739|NCT00437996|Sympatholytics|sympatholytics|mesh-ancestor
65084740|NCT00437996|Autonomic Agents|autonomic agents|mesh-ancestor
65084741|NCT00437996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65084742|NCT00437996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65084743|NCT00437996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65084744|NCT00437996|Adrenergic Agents|adrenergic agents|mesh-ancestor
65084745|NCT00437996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65084746|NCT00437996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084747|NCT00437996|Anesthetics, Local|anesthetics, local|mesh-ancestor
65084748|NCT04701242|Ezetimibe|ezetimibe|mesh-list
65084749|NCT04701242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65084750|NCT04701242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65084751|NCT04701242|Antimetabolites|antimetabolites|mesh-ancestor
65084752|NCT04701242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084753|NCT04701242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65084754|NCT00474435|Tenofovir|tenofovir|mesh-list
65084755|NCT00474435|Emtricitabine|emtricitabine|mesh-list
65084756|NCT00474435|Efavirenz|efavirenz|mesh-list
65084757|NCT00474435|Antiviral Agents|antiviral agents|mesh-ancestor
65084758|NCT00474435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65084759|NCT00474435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65084760|NCT00474435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65084761|NCT00474435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084762|NCT00474435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084763|NCT00474435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65084764|NCT00474435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65084765|NCT00474435|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64834980|NCT03710564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64834981|NCT03710564|Growth Substances|growth substances|mesh-ancestor
64834982|NCT03710564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834983|NCT03710564|Growth Inhibitors|growth inhibitors|mesh-ancestor
64834984|NCT03710564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084766|NCT00474435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65084767|NCT00474435|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65084768|NCT00474435|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65084769|NCT00474435|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65084770|NCT00474435|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65084771|NCT04701320|Methamphetamine|methamphetamine|mesh-list
65084772|NCT04701320|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65084773|NCT04701320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084774|NCT04701320|Sympathomimetics|sympathomimetics|mesh-ancestor
65084775|NCT04701320|Autonomic Agents|autonomic agents|mesh-ancestor
65084776|NCT04701320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65084777|NCT04701320|Dopamine Agents|dopamine agents|mesh-ancestor
65084778|NCT04701320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65084779|NCT04701320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084780|NCT04701320|Adrenergic Agents|adrenergic agents|mesh-ancestor
65084781|NCT04701320|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65084782|NCT04701320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65084783|NCT04701320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65084784|NCT04701320|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65084785|NCT00438113|Atenolol|atenolol|mesh-list
65084786|NCT00438113|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65084787|NCT00438113|Terazosin|terazosin|mesh-list
65084788|NCT00438113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65084790|NCT00438113|Natriuretic Agents|natriuretic agents|mesh-ancestor
65084791|NCT00438113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084792|NCT00438113|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65084793|NCT00438113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65084794|NCT00438113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084795|NCT00438113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65084796|NCT00438113|Sympatholytics|sympatholytics|mesh-ancestor
65084797|NCT00438113|Autonomic Agents|autonomic agents|mesh-ancestor
65084798|NCT00438113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65084799|NCT00438113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65084800|NCT00438113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65084801|NCT00438113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65084802|NCT00438113|Adrenergic Agents|adrenergic agents|mesh-ancestor
65084803|NCT00438113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65084804|NCT00438113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65084805|NCT00438113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65084806|NCT00438113|Urological Agents|urological agents|mesh-ancestor
65084807|NCT00438152|Ritonavir|ritonavir|mesh-list
65084808|NCT00438152|Lopinavir|lopinavir|mesh-list
65084809|NCT00438152|Saquinavir|saquinavir|mesh-list
65084810|NCT00438152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65084811|NCT00438152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65084812|NCT00438152|Protease Inhibitors|protease inhibitors|mesh-ancestor
65084813|NCT00438152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084814|NCT00438152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084815|NCT00438152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65084816|NCT00438152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64428552|NCT05331521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64428553|NCT05331521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428554|NCT05331521|Tubulin Modulators|tubulin modulators|mesh-ancestor
64428555|NCT05331521|Antimitotic Agents|antimitotic agents|mesh-ancestor
64428556|NCT05331521|Mitosis Modulators|mitosis modulators|mesh-ancestor
64428557|NCT05331521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428558|NCT05331521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64428559|NCT05331521|Alkylating Agents|alkylating agents|mesh-ancestor
64428584|NCT02525861|Protease Inhibitors|protease inhibitors|mesh-list
65084817|NCT00438152|Antiviral Agents|antiviral agents|mesh-ancestor
65084818|NCT00438152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65084819|NCT00438152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65084820|NCT00438152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65084821|NCT00438230|Warfarin|warfarin|mesh-list
65084822|NCT00438230|Anticoagulants|anticoagulants|mesh-ancestor
65084823|NCT00438269|Metronidazole|metronidazole|mesh-list
65084824|NCT00438269|Ciprofloxacin|ciprofloxacin|mesh-list
65084825|NCT00438269|Meropenem|meropenem|mesh-list
65084826|NCT00438269|Cefazolin|cefazolin|mesh-list
65084827|NCT00438269|Tazobactam|tazobactam|mesh-list
65084828|NCT00438269|Piperacillin|piperacillin|mesh-list
65084829|NCT00438269|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65084830|NCT00438269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65084831|NCT00438269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65084832|NCT00438269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65084833|NCT00438269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65084834|NCT00438269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65084835|NCT00438269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65084836|NCT00438269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084837|NCT00438269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084838|NCT00438269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084839|NCT00438269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65084840|NCT00438269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65084841|NCT00438269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65084843|NCT00474591|Fondaparinux|fondaparinux|mesh-list
65084844|NCT00474591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65084845|NCT00474591|Antithrombins|antithrombins|mesh-ancestor
65084846|NCT00474591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65084847|NCT00474591|Protease Inhibitors|protease inhibitors|mesh-ancestor
65084848|NCT00474591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084849|NCT00474591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084850|NCT00474591|Anticoagulants|anticoagulants|mesh-ancestor
65084851|NCT00474591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65084852|NCT00474591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65084853|NCT00474669|Docetaxel|docetaxel|mesh-list
65084854|NCT00474669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084855|NCT00474669|Tubulin Modulators|tubulin modulators|mesh-ancestor
65084856|NCT00474669|Antimitotic Agents|antimitotic agents|mesh-ancestor
65084857|NCT00474669|Mitosis Modulators|mitosis modulators|mesh-ancestor
65084858|NCT00474669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084859|NCT03279809|Aspirin|aspirin|mesh-list
65084860|NCT03279809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65084861|NCT03279809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65084862|NCT03279809|Analgesics|analgesics|mesh-ancestor
65084863|NCT03279809|Sensory System Agents|sensory system agents|mesh-ancestor
64727035|NCT00002599|Cobalt|cobalt|mesh-list
65084864|NCT03279809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65084865|NCT03279809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084866|NCT03279809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65084867|NCT03279809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65084868|NCT03279809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65084869|NCT03279809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65084870|NCT03279809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084871|NCT03279809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65084872|NCT03279809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65084873|NCT03279809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084874|NCT03279809|Antipyretics|antipyretics|mesh-ancestor
65084875|NCT00438386|Aripiprazole|aripiprazole|mesh-list
65084876|NCT00438386|Antidepressive Agents|antidepressive agents|mesh-ancestor
65084877|NCT00438386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65084879|NCT00438386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65084880|NCT00438386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65084881|NCT00438386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084882|NCT00438386|Dopamine Agonists|dopamine agonists|mesh-ancestor
65084883|NCT00438386|Dopamine Agents|dopamine agents|mesh-ancestor
65084884|NCT00438386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65084885|NCT00438386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084886|NCT00438386|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65084887|NCT00438386|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65084888|NCT00438386|Serotonin Agents|serotonin agents|mesh-ancestor
65084889|NCT00438386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64416571|NCT04839913|Antibodies|antibodies|mesh-list
65084890|NCT00438386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65084891|NCT00438386|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65084892|NCT00438386|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65084893|NCT00475059|Cimetidine|cimetidine|mesh-list
65084894|NCT00475059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65084895|NCT00475059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65084896|NCT00475059|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65084897|NCT00475059|Histamine Antagonists|histamine antagonists|mesh-ancestor
65084898|NCT00475059|Histamine Agents|histamine agents|mesh-ancestor
65084899|NCT00475059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65084900|NCT00475059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084901|NCT00475059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084902|NCT00475059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65084903|NCT00475059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65084904|NCT00475059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084905|NCT00475098|Tinzaparin|tinzaparin|mesh-list
65084906|NCT00475098|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65084907|NCT00475098|Dalteparin|dalteparin|mesh-list
65084908|NCT00475098|Anticoagulants|anticoagulants|mesh-ancestor
65084909|NCT00475098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65084910|NCT00475098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65084911|NCT00475098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084912|NCT00475137|Lamotrigine|lamotrigine|mesh-list
65084913|NCT00475137|Anticonvulsants|anticonvulsants|mesh-list
65084914|NCT00475137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65084915|NCT00475137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65084916|NCT00475137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084917|NCT00475137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65084918|NCT00475137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084919|NCT00475137|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65084920|NCT00475137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65084921|NCT00475137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65084922|NCT00475137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65084923|NCT00475137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65084924|NCT00438581|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65084925|NCT00438581|Immunologic Factors|immunologic factors|mesh-ancestor
65084926|NCT00438581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084927|NCT00475293|Panitumumab|panitumumab|mesh-list
65084928|NCT00475293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084929|NCT00475293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65084930|NCT00438737|Leucovorin|leucovorin|mesh-list
65084931|NCT00438737|Bevacizumab|bevacizumab|mesh-list
65084932|NCT00438737|Cetuximab|cetuximab|mesh-list
65084933|NCT00438737|Fluorouracil|fluorouracil|mesh-list
65084934|NCT00438737|Oxaliplatin|oxaliplatin|mesh-list
65084935|NCT00438737|Calcium|calcium|mesh-list
65084936|NCT00438737|Levoleucovorin|levoleucovorin|mesh-list
65084937|NCT00438737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65084938|NCT00438737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084939|NCT00438737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65084940|NCT00438737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65084941|NCT00438737|Growth Substances|growth substances|mesh-ancestor
65084942|NCT00438737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084943|NCT00438737|Growth Inhibitors|growth inhibitors|mesh-ancestor
65084944|NCT00438737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65084945|NCT00438737|Antimetabolites|antimetabolites|mesh-ancestor
64325452|NCT04675827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65084946|NCT00438737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084947|NCT00438737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65084948|NCT00438737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65084949|NCT00438737|Immunologic Factors|immunologic factors|mesh-ancestor
65084950|NCT00438737|Antidotes|antidotes|mesh-ancestor
65084951|NCT00438737|Protective Agents|protective agents|mesh-ancestor
65084952|NCT00438737|Vitamin B Complex|vitamin b complex|mesh-ancestor
65084953|NCT00438737|Vitamins|vitamins|mesh-ancestor
65084954|NCT00438737|Micronutrients|micronutrients|mesh-ancestor
65084955|NCT00438776|Olanzapine|olanzapine|mesh-list
65084956|NCT00438776|Antiemetics|antiemetics|mesh-ancestor
65084957|NCT00438776|Autonomic Agents|autonomic agents|mesh-ancestor
65084958|NCT00438776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65084959|NCT00438776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084960|NCT00438776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65084961|NCT00438776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65084962|NCT00438776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65084963|NCT00438776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65084964|NCT00438776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65084965|NCT00438776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65084966|NCT00438776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65084967|NCT00438776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65084968|NCT00438776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084969|NCT00438776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65084970|NCT00438776|Serotonin Agents|serotonin agents|mesh-ancestor
65084971|NCT00475410|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65084972|NCT00475410|Hemostatics|hemostatics|mesh-ancestor
65084973|NCT00475410|Coagulants|coagulants|mesh-ancestor
65084974|NCT00475527|Amoxicillin|amoxicillin|mesh-list
65084975|NCT00475527|Metronidazole|metronidazole|mesh-list
65084976|NCT00475527|Clarithromycin|clarithromycin|mesh-list
65084978|NCT00475527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65084979|NCT00475527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65084980|NCT00475527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65084981|NCT00475527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65084982|NCT00475527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65084983|NCT00475527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65084984|NCT00475527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65084985|NCT00475527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65084986|NCT00475527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65084987|NCT00475527|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65084988|NCT00475527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65084989|NCT00475527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65084990|NCT00439049|Naltrexone|naltrexone|mesh-list
65084991|NCT00439049|Modafinil|modafinil|mesh-list
65084992|NCT00439049|Amphetamine|amphetamine|mesh-list
65084993|NCT00439049|Dextroamphetamine|dextroamphetamine|mesh-list
65084994|NCT00439049|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65084995|NCT00439049|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65084996|NCT00439049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65084997|NCT00439049|Sensory System Agents|sensory system agents|mesh-ancestor
65084998|NCT00439049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65084999|NCT00439049|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65085000|NCT00439049|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
65085001|NCT00439049|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65085002|NCT00439049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65085003|NCT00439049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085004|NCT00439049|Sympathomimetics|sympathomimetics|mesh-ancestor
65085005|NCT00439049|Autonomic Agents|autonomic agents|mesh-ancestor
65085006|NCT00439049|Dopamine Agents|dopamine agents|mesh-ancestor
65085007|NCT00439049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65085008|NCT00439049|Adrenergic Agents|adrenergic agents|mesh-ancestor
65085009|NCT00439049|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65085010|NCT00439049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65085011|NCT00439049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65085012|NCT00439049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65085013|NCT00475566|Everolimus|everolimus|mesh-list
64727190|NCT00003950|Cyclosporine|cyclosporine|mesh-list
65085014|NCT00475566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085015|NCT00475566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65085016|NCT00475566|Immunologic Factors|immunologic factors|mesh-ancestor
65085017|NCT00475566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085018|NCT00439166|Doxycycline|doxycycline|mesh-list
65085019|NCT00439166|Rifampin|rifampin|mesh-list
65085020|NCT00439166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65085021|NCT00439166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65085022|NCT00439166|Antimalarials|antimalarials|mesh-ancestor
65085023|NCT00439166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65085024|NCT00439166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65085025|NCT00439166|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65085026|NCT00439166|Antitubercular Agents|antitubercular agents|mesh-ancestor
65085027|NCT00439166|Leprostatic Agents|leprostatic agents|mesh-ancestor
65085028|NCT00439166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65085029|NCT00439166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085030|NCT00439166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085031|NCT00439166|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65085032|NCT00439166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65085033|NCT00439166|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65085034|NCT00439166|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65085035|NCT00439166|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64416575|NCT04846621|Calcium|calcium|mesh-list
65085036|NCT00439166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65085037|NCT00439283|Methotrexate|methotrexate|mesh-list
65085038|NCT00439283|Infliximab|infliximab|mesh-list
65085039|NCT00439283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65085040|NCT00439283|Abortifacient Agents|abortifacient agents|mesh-ancestor
65085041|NCT00439283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65085042|NCT00439283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085043|NCT00439283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65085044|NCT00439283|Antimetabolites|antimetabolites|mesh-ancestor
65085045|NCT00439283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085046|NCT00439283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085047|NCT00439283|Dermatologic Agents|dermatologic agents|mesh-ancestor
65085048|NCT00439283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085049|NCT00439283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65085050|NCT00439283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65085051|NCT00439283|Immunologic Factors|immunologic factors|mesh-ancestor
65085052|NCT00439283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65085053|NCT00439283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65085054|NCT00439283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65085055|NCT00475800|Lumiracoxib|lumiracoxib|mesh-list
65085056|NCT00475800|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65085057|NCT00475800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65085058|NCT00475800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085059|NCT00475800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085060|NCT00475800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65085061|NCT00475800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65085062|NCT00475800|Analgesics|analgesics|mesh-ancestor
65085063|NCT00475800|Sensory System Agents|sensory system agents|mesh-ancestor
65085064|NCT00475800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65085065|NCT00475800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085066|NCT00475800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65085067|NCT00475800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65085068|NCT00439361|Carboplatin|carboplatin|mesh-list
65085069|NCT00439361|Etoposide|etoposide|mesh-list
65085070|NCT00439361|Bortezomib|bortezomib|mesh-list
65085071|NCT00439361|Ifosfamide|ifosfamide|mesh-list
65085072|NCT00439361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085073|NCT00439361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65085074|NCT00439361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65085075|NCT00439361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65085076|NCT00439361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085077|NCT00439361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325456|NCT04675827|Mitosis Modulators|mitosis modulators|mesh-ancestor
64325457|NCT04675827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325458|NCT02538614|Idelalisib|idelalisib|mesh-list
64325459|NCT02538614|BI 836826|bi 836826|mesh-list
64428862|NCT02161575|Ranibizumab|ranibizumab|mesh-list
64428879|NCT02161185|Anesthetics|anesthetics|mesh-ancestor
65085078|NCT00439361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65085079|NCT00439361|Alkylating Agents|alkylating agents|mesh-ancestor
65085080|NCT00475917|Gemcitabine|gemcitabine|mesh-list
65085081|NCT00475917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65085082|NCT00475917|Antimetabolites|antimetabolites|mesh-ancestor
65085083|NCT00475917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085084|NCT00475917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085085|NCT00475917|Antiviral Agents|antiviral agents|mesh-ancestor
65085086|NCT00475917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64727260|NCT00003974|Alkylating Agents|alkylating agents|mesh-ancestor
65085088|NCT00475917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65085089|NCT00475917|Immunologic Factors|immunologic factors|mesh-ancestor
65085090|NCT00475917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085091|NCT00439400|Doxycycline|doxycycline|mesh-list
65085092|NCT00439400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65085093|NCT00439400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65085094|NCT00439400|Antimalarials|antimalarials|mesh-ancestor
65085095|NCT00439400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65085096|NCT00439400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65085097|NCT00475956|Cediranib|cediranib|mesh-list
65085098|NCT00475956|Saracatinib|saracatinib|mesh-list
65085099|NCT00475956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085100|NCT00475956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65085101|NCT00475956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085102|NCT00475956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085103|NCT00476034|Lumiracoxib|lumiracoxib|mesh-list
65085104|NCT00476034|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65085105|NCT00476034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65085106|NCT00476034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085107|NCT00476034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085108|NCT00476034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65085110|NCT00476034|Analgesics|analgesics|mesh-ancestor
65085111|NCT00476034|Sensory System Agents|sensory system agents|mesh-ancestor
65085112|NCT00476034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65085113|NCT00476034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085114|NCT00476034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65085115|NCT00476034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65085116|NCT00476073|Fluticasone|fluticasone|mesh-list
65085117|NCT00476073|Xhance|xhance|mesh-list
65085118|NCT00476073|Formoterol Fumarate|formoterol fumarate|mesh-list
65085119|NCT00476073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65085120|NCT00476073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65085121|NCT00476073|Autonomic Agents|autonomic agents|mesh-ancestor
65085122|NCT00476073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65085123|NCT00476073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085124|NCT00476073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65085125|NCT00476073|Respiratory System Agents|respiratory system agents|mesh-ancestor
65085126|NCT00476073|Dermatologic Agents|dermatologic agents|mesh-ancestor
65085127|NCT00476073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65085128|NCT00476073|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65085129|NCT00476073|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65085130|NCT00476073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65085131|NCT00476073|Adrenergic Agents|adrenergic agents|mesh-ancestor
65085132|NCT00476073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65085133|NCT00476073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085134|NCT03279692|Pembrolizumab|pembrolizumab|mesh-list
65085135|NCT03279692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65085136|NCT03279692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085137|NCT00476268|Beclomethasone|beclomethasone|mesh-list
65085138|NCT00476268|Formoterol Fumarate|formoterol fumarate|mesh-list
64834992|NCT03624127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64834993|NCT03624127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65085139|NCT00476268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65085140|NCT00476268|Autonomic Agents|autonomic agents|mesh-ancestor
65085141|NCT00476268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65085142|NCT00476268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085143|NCT00476268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65085144|NCT00476268|Respiratory System Agents|respiratory system agents|mesh-ancestor
65085145|NCT00476268|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65085146|NCT00476268|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65085147|NCT00476268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65085148|NCT00476268|Adrenergic Agents|adrenergic agents|mesh-ancestor
65085149|NCT00476268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65085150|NCT00476268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085151|NCT00476268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65085152|NCT00476268|Glucocorticoids|glucocorticoids|mesh-ancestor
65085153|NCT00476268|Hormones|hormones|mesh-ancestor
65085154|NCT00476268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65085155|NCT00105989|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65085156|NCT00105989|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65085157|NCT00105989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65085158|NCT00105989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64727337|NCT00002641|Alkylating Agents|alkylating agents|mesh-ancestor
65085159|NCT00105989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085160|NCT00105989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65085161|NCT00105989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085162|NCT00105989|Analgesics|analgesics|mesh-ancestor
65085163|NCT00105989|Sensory System Agents|sensory system agents|mesh-ancestor
65085164|NCT00105989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65085165|NCT00105989|Antidepressive Agents|antidepressive agents|mesh-ancestor
65085166|NCT00105989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65085167|NCT00105989|Dopamine Agents|dopamine agents|mesh-ancestor
65085168|NCT00476346|Vitamin D|vitamin d|mesh-list
65085169|NCT00476346|Calcium|calcium|mesh-list
65085170|NCT00476346|Vitamins|vitamins|mesh-ancestor
65085171|NCT00476346|Micronutrients|micronutrients|mesh-ancestor
65085172|NCT00476346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085173|NCT00476346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65085174|NCT00476346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65085175|NCT00476424|Efavirenz|efavirenz|mesh-list
65085176|NCT00476424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65085177|NCT00476424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65085178|NCT00476424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657894|NCT02528409|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65085179|NCT00476424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085180|NCT00476424|Antiviral Agents|antiviral agents|mesh-ancestor
64835004|NCT03624127|Dermatologic Agents|dermatologic agents|mesh-ancestor
64835005|NCT03624127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64835006|NCT03602066|Chlorine dioxide|chlorine dioxide|mesh-list
64428984|NCT05279807|Zofenopril|zofenopril|mesh-list
65085181|NCT00476424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65085182|NCT00476424|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65085183|NCT00476424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65085184|NCT00476424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65085185|NCT00476424|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65085186|NCT00476424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65085187|NCT00476424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65085188|NCT00439712|Levocetirizine|levocetirizine|mesh-list
65085189|NCT00439712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65085190|NCT00439712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65085191|NCT00439712|Histamine Antagonists|histamine antagonists|mesh-ancestor
65085192|NCT00439712|Histamine Agents|histamine agents|mesh-ancestor
65085193|NCT00439712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65085194|NCT00439712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085195|NCT00439712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085196|NCT00476463|Emtricitabine|emtricitabine|mesh-list
65085197|NCT00476463|Antiviral Agents|antiviral agents|mesh-ancestor
65085198|NCT00476463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65085199|NCT00476463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65085200|NCT00476463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65085201|NCT00476463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085202|NCT00476463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085203|NCT00476463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65085204|NCT00476463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65085205|NCT00439751|Goserelin|goserelin|mesh-list
65085206|NCT00439751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65085207|NCT00439751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085208|NCT00438243|Bromfenac|bromfenac|mesh-list
65085209|NCT00438243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65085210|NCT00438243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65085211|NCT00438243|Analgesics|analgesics|mesh-ancestor
65085212|NCT00438243|Sensory System Agents|sensory system agents|mesh-ancestor
65085213|NCT00438243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65085214|NCT00438243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085215|NCT00438243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65085216|NCT00438243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65085217|NCT00439829|Cetrorelix|cetrorelix|mesh-list
65085218|NCT00439829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65085219|NCT00439829|Fertility Agents|fertility agents|mesh-ancestor
65085220|NCT00439829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65085221|NCT00439829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085222|NCT00439829|Hormone Antagonists|hormone antagonists|mesh-ancestor
65085223|NCT00439829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65085224|NCT03279861|Valsartan|valsartan|mesh-list
65085225|NCT03279861|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65085226|NCT03279861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65085227|NCT03279861|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65085228|NCT03279861|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64835008|NCT03602066|Disinfectants|disinfectants|mesh-ancestor
64835009|NCT03602066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64835010|NCT03597568|Resveratrol|resveratrol|mesh-list
64835011|NCT03597568|Antioxidants|antioxidants|mesh-ancestor
64835012|NCT03597568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835013|NCT03597568|Protective Agents|protective agents|mesh-ancestor
65085229|NCT03279861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085230|NCT03277248|Teriflunomide|teriflunomide|mesh-list
65085231|NCT03277248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65085232|NCT03277248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65085233|NCT03277248|Analgesics|analgesics|mesh-ancestor
65085234|NCT03277248|Sensory System Agents|sensory system agents|mesh-ancestor
65085235|NCT03277248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65085236|NCT03277248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085237|NCT03277248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65085239|NCT03277248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65085240|NCT03277248|Immunologic Factors|immunologic factors|mesh-ancestor
65085241|NCT00440024|Tazarotene|tazarotene|mesh-list
65085242|NCT00440024|Dermatologic Agents|dermatologic agents|mesh-ancestor
65085243|NCT00440024|Keratolytic Agents|keratolytic agents|mesh-ancestor
65085244|NCT00440063|Epoetin Alfa|epoetin alfa|mesh-list
65085245|NCT00440063|Hematinics|hematinics|mesh-ancestor
65085246|NCT00440102|Ketamine|ketamine|mesh-list
65085247|NCT00440102|Etomidate|etomidate|mesh-list
65085248|NCT00440102|Analgesics|analgesics|mesh-ancestor
65085249|NCT00440102|Sensory System Agents|sensory system agents|mesh-ancestor
65085250|NCT00440102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65085251|NCT00440102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085252|NCT00440102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65085253|NCT00440102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65085254|NCT00440102|Anesthetics, General|anesthetics, general|mesh-ancestor
65085255|NCT00440102|Anesthetics|anesthetics|mesh-ancestor
65085256|NCT00440102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65085257|NCT00440102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65085258|NCT00440102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65085259|NCT00440102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65085260|NCT00440102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085261|NCT00440102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65085262|NCT00476541|Gemtuzumab|gemtuzumab|mesh-list
65085263|NCT00476541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65085264|NCT00476541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085265|NCT00440141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65085266|NCT00440141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65085267|NCT00440141|Latanoprost|latanoprost|mesh-list
65085268|NCT00440141|Brinzolamide|brinzolamide|mesh-list
65085269|NCT00440141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65085270|NCT00440141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65085271|NCT00440141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65085272|NCT00440141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65085273|NCT00440141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65085274|NCT00440141|Adrenergic Agents|adrenergic agents|mesh-ancestor
64835014|NCT03597568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835015|NCT03597568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085275|NCT00440141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65085276|NCT00440141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085277|NCT00440141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085278|NCT00440141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65085279|NCT00440141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085280|NCT00438321|Anastrozole|anastrozole|mesh-list
65085281|NCT00438321|Goserelin|goserelin|mesh-list
65085282|NCT00438321|Testosterone|testosterone|mesh-list
65085283|NCT00438321|Androgens|androgens|mesh-ancestor
65085284|NCT00438321|Hormones|hormones|mesh-ancestor
65085285|NCT00438321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65085286|NCT00438321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085287|NCT00438321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65085288|NCT00438321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085289|NCT00438321|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65085290|NCT00438321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65085291|NCT00438321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085292|NCT00438321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085293|NCT00438321|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65085294|NCT00438321|Hormone Antagonists|hormone antagonists|mesh-ancestor
65085295|NCT00476619|Epoetin Alfa|epoetin alfa|mesh-list
65085296|NCT00476619|Hematinics|hematinics|mesh-ancestor
65085297|NCT03279536|Lactoferrin|lactoferrin|mesh-list
65085298|NCT03279536|Dextrans|dextrans|mesh-list
65085299|NCT03279536|Iron-Dextran Complex|iron-dextran complex|mesh-list
65085300|NCT03279536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65085301|NCT03279536|Anticoagulants|anticoagulants|mesh-ancestor
65085302|NCT03279536|Plasma Substitutes|plasma substitutes|mesh-ancestor
65085303|NCT03279536|Blood Substitutes|blood substitutes|mesh-ancestor
65085304|NCT03279536|Hematinics|hematinics|mesh-ancestor
65085305|NCT00440219|Prednisone|prednisone|mesh-list
65085306|NCT00440219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64727493|NCT00002665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085307|NCT00440219|Glucocorticoids|glucocorticoids|mesh-ancestor
65085309|NCT00440219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65085310|NCT00440219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085311|NCT00440219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65085312|NCT00440219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085313|NCT00438477|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
65085314|NCT00438477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65085315|NCT00438477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085316|NCT00440258|Cabergoline|cabergoline|mesh-list
65085317|NCT00440258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65085318|NCT00440258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65085319|NCT00440258|Dopamine Agonists|dopamine agonists|mesh-ancestor
65085320|NCT00440258|Dopamine Agents|dopamine agents|mesh-ancestor
65085321|NCT00440258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65085322|NCT00440258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416580|NCT04854577|Anesthetics|anesthetics|mesh-list
65085323|NCT00440258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085325|NCT00440336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65085326|NCT00440336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65085327|NCT00440375|Rosiglitazone|rosiglitazone|mesh-list
65085328|NCT00440375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65085329|NCT00440375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085330|NCT00440414|Pemetrexed|pemetrexed|mesh-list
65085331|NCT00440414|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65085332|NCT00440414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085333|NCT00440414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085334|NCT00440414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325468|NCT03504644|Tubulin Modulators|tubulin modulators|mesh-ancestor
64325469|NCT03504644|Antimitotic Agents|antimitotic agents|mesh-ancestor
64325470|NCT03504644|Mitosis Modulators|mitosis modulators|mesh-ancestor
64325471|NCT03504644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325472|NCT04620135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64835033|NCT03476642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65085335|NCT00440414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65085336|NCT00440414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65085337|NCT00440414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65085338|NCT03270462|Tacrolimus|tacrolimus|mesh-list
65085339|NCT03270462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65085340|NCT03270462|Immunologic Factors|immunologic factors|mesh-ancestor
65085341|NCT03270462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085342|NCT03270462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65085343|NCT03270462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085344|NCT03270462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085345|NCT00440609|Ranibizumab|ranibizumab|mesh-list
65085346|NCT00440609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65085347|NCT00440609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65085348|NCT00440609|Growth Substances|growth substances|mesh-ancestor
65085349|NCT00440609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085350|NCT00440609|Growth Inhibitors|growth inhibitors|mesh-ancestor
65085351|NCT00440609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085352|NCT00440648|Sevelamer|sevelamer|mesh-list
65085353|NCT00440648|Chelating Agents|chelating agents|mesh-ancestor
65085354|NCT00440648|Sequestering Agents|sequestering agents|mesh-ancestor
65085355|NCT00440648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085356|NCT00440687|Fluticasone|fluticasone|mesh-list
65085357|NCT00440687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65085358|NCT00440687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65085359|NCT00440687|Autonomic Agents|autonomic agents|mesh-ancestor
65085360|NCT00440687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65085361|NCT00440687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085362|NCT00440687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65085363|NCT00440687|Respiratory System Agents|respiratory system agents|mesh-ancestor
65085364|NCT00440687|Dermatologic Agents|dermatologic agents|mesh-ancestor
65085365|NCT00440687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65085366|NCT03271047|Nivolumab|nivolumab|mesh-list
65085367|NCT03271047|Ipilimumab|ipilimumab|mesh-list
65085368|NCT03271047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65085369|NCT03271047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085370|NCT03271047|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65085371|NCT03271047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085372|NCT00440765|Bortezomib|bortezomib|mesh-list
65085373|NCT00440765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085374|NCT00440804|Ibuprofen|ibuprofen|mesh-list
65085375|NCT00440804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65085376|NCT00440804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65085377|NCT00440804|Analgesics|analgesics|mesh-ancestor
65085378|NCT00440804|Sensory System Agents|sensory system agents|mesh-ancestor
65085379|NCT00440804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65085380|NCT00440804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64727570|NCT00004010|Hormones|hormones|mesh-ancestor
65085381|NCT00440804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65085382|NCT00440804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65085383|NCT00440804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65085384|NCT00440804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085385|NCT00440804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085387|NCT00440843|Antiemetics|antiemetics|mesh-ancestor
65085388|NCT00440843|Autonomic Agents|autonomic agents|mesh-ancestor
65085389|NCT00440843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65085390|NCT00440843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085391|NCT00440843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65085392|NCT00440843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65085393|NCT00440843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64835036|NCT03476642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64835037|NCT03476642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64835038|NCT03476642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64835039|NCT03476642|Adrenergic Agents|adrenergic agents|mesh-ancestor
64835040|NCT03476642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64835041|NCT03476642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835042|NCT03476642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65085394|NCT00440843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65085395|NCT00440843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65085396|NCT00440843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65085397|NCT00440843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65085398|NCT00440843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65085399|NCT00440843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085400|NCT00440843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65085401|NCT00440843|Serotonin Agents|serotonin agents|mesh-ancestor
65085403|NCT00438789|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65085404|NCT00438789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65085405|NCT00438789|Immunologic Factors|immunologic factors|mesh-ancestor
65085406|NCT00438789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085407|NCT00440921|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65085408|NCT00440921|Hemostatics|hemostatics|mesh-ancestor
65085409|NCT00440921|Coagulants|coagulants|mesh-ancestor
65085410|NCT00440960|Lidocaine|lidocaine|mesh-list
65085411|NCT00440960|Midazolam|midazolam|mesh-list
65085412|NCT00440960|Alfentanil|alfentanil|mesh-list
65085413|NCT00440960|Propofol|propofol|mesh-list
65085414|NCT00440960|Anesthetics, Local|anesthetics, local|mesh-ancestor
65085415|NCT00440960|Anesthetics|anesthetics|mesh-ancestor
65085416|NCT00440960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65085417|NCT00440960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085418|NCT00440960|Sensory System Agents|sensory system agents|mesh-ancestor
65085419|NCT00440960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65085420|NCT00440960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65085421|NCT00440960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65085422|NCT00440960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65085423|NCT00440960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65085424|NCT00440960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325475|NCT02160275|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64325476|NCT02160275|Pancrelipase|pancrelipase|mesh-list
64325477|NCT02160275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64325478|NCT02160275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325479|NCT02160275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64325480|NCT03126968|Epinephrine|epinephrine|mesh-list
64325481|NCT03126968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64325482|NCT03126968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64836101|NCT01611077|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64429276|NCT05248139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64429280|NCT05248139|Antiemetics|antiemetics|mesh-ancestor
65085425|NCT00440960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65085426|NCT00440960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65085427|NCT00440960|Anesthetics, General|anesthetics, general|mesh-ancestor
65085428|NCT00440960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65085429|NCT00440960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65085430|NCT00440960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65085431|NCT00440960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65085432|NCT00440960|GABA Modulators|gaba modulators|mesh-ancestor
65085433|NCT00440960|GABA Agents|gaba agents|mesh-ancestor
65085434|NCT00440960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65085435|NCT00440960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65085436|NCT00440960|Narcotics|narcotics|mesh-ancestor
65085437|NCT00440960|Analgesics|analgesics|mesh-ancestor
65085438|NCT00438828|Dexamethasone|dexamethasone|mesh-list
65085439|NCT00438828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65085440|NCT00438828|Antiemetics|antiemetics|mesh-ancestor
65085441|NCT00438828|Autonomic Agents|autonomic agents|mesh-ancestor
65085442|NCT00438828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65085443|NCT00438828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085444|NCT00438828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65085445|NCT00438828|Glucocorticoids|glucocorticoids|mesh-ancestor
65085446|NCT00438828|Hormones|hormones|mesh-ancestor
65085447|NCT00438828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65085448|NCT00438828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65085449|NCT00438828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085450|NCT00441155|Imatinib Mesylate|imatinib mesylate|mesh-list
65085451|NCT00441155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085452|NCT00441155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65085453|NCT00441155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085454|NCT00441155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085455|NCT00106002|Pemetrexed|pemetrexed|mesh-list
65085456|NCT00106002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085457|NCT00106002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085458|NCT00106002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085459|NCT00106002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65085460|NCT00106002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65085461|NCT00476853|Nevirapine|nevirapine|mesh-list
65085462|NCT00476853|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65085463|NCT00476853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65085464|NCT00476853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085465|NCT00476853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085466|NCT00476853|Antiviral Agents|antiviral agents|mesh-ancestor
65085467|NCT00476853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65085468|NCT00476853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64835044|NCT03476642|Autonomic Agents|autonomic agents|mesh-ancestor
64835045|NCT03476642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64835046|NCT03476642|Respiratory System Agents|respiratory system agents|mesh-ancestor
64835047|NCT03476642|Mydriatics|mydriatics|mesh-ancestor
64835048|NCT03476642|Sympathomimetics|sympathomimetics|mesh-ancestor
64835049|NCT03476642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64835050|NCT03460756|Ganaxolone|ganaxolone|mesh-list
64835051|NCT03460756|Neurosteroids|neurosteroids|mesh-ancestor
64835052|NCT03460756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64835053|NCT03460756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835054|NCT03460756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835055|NCT03460756|GABA Modulators|gaba modulators|mesh-ancestor
64835056|NCT03460756|GABA Agents|gaba agents|mesh-ancestor
64835057|NCT03430700|Pembrolizumab|pembrolizumab|mesh-list
64835059|NCT03430700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085469|NCT00476853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65085470|NCT00476853|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65085471|NCT00476853|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65085472|NCT00438906|Secretin|secretin|mesh-list
65085473|NCT00438906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65085474|NCT00438906|Hormones|hormones|mesh-ancestor
65085475|NCT00438906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65085476|NCT00438906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085477|NCT00438945|Eprosartan|eprosartan|mesh-list
65085478|NCT00438945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65085479|NCT00438945|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
65085480|NCT00438945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65085481|NCT00438945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085482|NCT00441428|Solifenacin Succinate|solifenacin succinate|mesh-list
65085483|NCT00441428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65085484|NCT00441428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65085485|NCT00441428|Cholinergic Agents|cholinergic agents|mesh-ancestor
65085486|NCT00441428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65085487|NCT00441428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085488|NCT00441428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085489|NCT00441428|Urological Agents|urological agents|mesh-ancestor
65085490|NCT00438984|Aldesleukin|aldesleukin|mesh-list
65085491|NCT00438984|Cyclophosphamide|cyclophosphamide|mesh-list
65085492|NCT00438984|Interleukin-2|interleukin-2|mesh-list
65085493|NCT00438984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65085494|NCT00438984|Immunologic Factors|immunologic factors|mesh-ancestor
65085495|NCT00438984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085496|NCT00438984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65085497|NCT00438984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65085498|NCT00438984|Alkylating Agents|alkylating agents|mesh-ancestor
65085499|NCT00438984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085500|NCT00438984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085501|NCT00438984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65085502|NCT00438984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65085503|NCT00438984|Analgesics|analgesics|mesh-ancestor
65085504|NCT00438984|Sensory System Agents|sensory system agents|mesh-ancestor
65085505|NCT00438984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65085506|NCT00438984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65085507|NCT00438984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65085508|NCT00438984|Antiviral Agents|antiviral agents|mesh-ancestor
65085509|NCT00438984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65085510|NCT00441506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65085511|NCT00441506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65085512|NCT00441506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085513|NCT00441662|Triamcinolone|triamcinolone|mesh-list
65085514|NCT00441662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65085515|NCT00441662|Glucocorticoids|glucocorticoids|mesh-ancestor
65085516|NCT00441662|Hormones|hormones|mesh-ancestor
65085517|NCT00441662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65085518|NCT00441662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085519|NCT00439062|Roxithromycin|roxithromycin|mesh-list
65085520|NCT00439062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65085521|NCT00439062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65085522|NCT02957162|Atorvastatin|atorvastatin|mesh-list
65085523|NCT02957162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65085524|NCT02957162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65085525|NCT02957162|Antimetabolites|antimetabolites|mesh-ancestor
65085526|NCT02957162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085527|NCT02957162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65085528|NCT02957162|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65085529|NCT02957162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085530|NCT00441740|Gemcitabine|gemcitabine|mesh-list
65085531|NCT00441740|Docetaxel|docetaxel|mesh-list
65085532|NCT00441740|Vinorelbine|vinorelbine|mesh-list
65085533|NCT00441740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65085534|NCT00441740|Antimetabolites|antimetabolites|mesh-ancestor
65085535|NCT00441740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085536|NCT00441740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085538|NCT00441740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65085539|NCT00441740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085540|NCT00441740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65085541|NCT00441740|Immunologic Factors|immunologic factors|mesh-ancestor
65085542|NCT00441740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085543|NCT00441740|Tubulin Modulators|tubulin modulators|mesh-ancestor
65085544|NCT00441740|Antimitotic Agents|antimitotic agents|mesh-ancestor
65085545|NCT00441740|Mitosis Modulators|mitosis modulators|mesh-ancestor
65085546|NCT00441740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65085547|NCT02274012|Paclitaxel|paclitaxel|mesh-list
65085548|NCT02274012|Afatinib|afatinib|mesh-list
65085549|NCT02274012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65085550|NCT02274012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085551|NCT02274012|Tubulin Modulators|tubulin modulators|mesh-ancestor
65085552|NCT02274012|Antimitotic Agents|antimitotic agents|mesh-ancestor
65085553|NCT02274012|Mitosis Modulators|mitosis modulators|mesh-ancestor
65085554|NCT02274012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085555|NCT02274012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65085556|NCT02274012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085557|NCT00477048|Saquinavir|saquinavir|mesh-list
65085558|NCT00477048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65085559|NCT00477048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65085560|NCT00477048|Protease Inhibitors|protease inhibitors|mesh-ancestor
65085561|NCT00477048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085562|NCT00477048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085563|NCT00477048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65085564|NCT00477048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65085565|NCT00477048|Antiviral Agents|antiviral agents|mesh-ancestor
65085566|NCT00477048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65085567|NCT00477048|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65085568|NCT00477048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65085569|NCT00477126|Ritonavir|ritonavir|mesh-list
65085570|NCT00477126|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65085571|NCT00477126|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65085572|NCT00477126|Protease Inhibitors|protease inhibitors|mesh-ancestor
65085573|NCT00477126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085574|NCT00477126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085575|NCT00477126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65085576|NCT00477126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65085577|NCT00477126|Antiviral Agents|antiviral agents|mesh-ancestor
65085578|NCT00477126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64835061|NCT03291028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835063|NCT03289910|Carboplatin|carboplatin|mesh-list
64835064|NCT03289910|Topotecan|topotecan|mesh-list
64835065|NCT03289910|Veliparib|veliparib|mesh-list
64835066|NCT03289910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835067|NCT03289910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64835068|NCT03289910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64835072|NCT03245151|Everolimus|everolimus|mesh-list
65085579|NCT00477126|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64483257|NCT00248170|Letrozole|letrozole|mesh-list
65085580|NCT00477126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65085581|NCT03279341|Prucalopride|prucalopride|mesh-list
65085583|NCT03279341|Laxatives|laxatives|mesh-ancestor
65085584|NCT03279341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65085585|NCT03279341|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65085586|NCT03279341|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65085587|NCT03279341|Serotonin Agents|serotonin agents|mesh-ancestor
65085588|NCT03279341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65085589|NCT03279341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085590|NCT03279341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085591|NCT03279341|Cathartics|cathartics|mesh-ancestor
65085592|NCT03279146|Tenofovir|tenofovir|mesh-list
65085593|NCT03279146|Antiviral Agents|antiviral agents|mesh-ancestor
65085594|NCT03279146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65085595|NCT03279146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65085596|NCT03279146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65085597|NCT03279146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085598|NCT03279146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085599|NCT03279146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65085600|NCT03279146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65085601|NCT00442052|Aspirin|aspirin|mesh-list
65085602|NCT00442052|Omeprazole|omeprazole|mesh-list
65085603|NCT00442052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65085604|NCT00442052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65085605|NCT00442052|Analgesics|analgesics|mesh-ancestor
65085606|NCT00442052|Sensory System Agents|sensory system agents|mesh-ancestor
65085607|NCT00442052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65085608|NCT00442052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085609|NCT00442052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65085610|NCT00442052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65085611|NCT00442052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65085612|NCT00442052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65085613|NCT00442052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085614|NCT00442052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65085615|NCT00442052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65085616|NCT00442052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085617|NCT00442052|Antipyretics|antipyretics|mesh-ancestor
65085618|NCT00442052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65085619|NCT00442052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65085620|NCT00442052|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65085621|NCT00477282|Topotecan|topotecan|mesh-list
65085622|NCT00477282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65085623|NCT00477282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65085624|NCT00477282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085625|NCT00477282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085626|NCT00477282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085627|NCT00439530|Oseltamivir|oseltamivir|mesh-list
65085628|NCT00439530|Probenecid|probenecid|mesh-list
65085629|NCT00439530|Antiviral Agents|antiviral agents|mesh-ancestor
65085630|NCT00439530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65085631|NCT00439530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085632|NCT00439530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085633|NCT00439530|Uricosuric Agents|uricosuric agents|mesh-ancestor
64835076|NCT03245151|Immunologic Factors|immunologic factors|mesh-ancestor
64835077|NCT03245151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835078|NCT03245151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64835079|NCT03245151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835080|NCT03245151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835081|NCT03171025|Nivolumab|nivolumab|mesh-list
65085634|NCT00439530|Gout Suppressants|gout suppressants|mesh-ancestor
65085635|NCT00439530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65085636|NCT00439530|Renal Agents|renal agents|mesh-ancestor
65085637|NCT00442325|Atorvastatin|atorvastatin|mesh-list
65085638|NCT00442325|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65085639|NCT00442325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65085640|NCT00442325|Antimetabolites|antimetabolites|mesh-ancestor
65085641|NCT00442325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085642|NCT00442325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65085643|NCT00442325|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65085644|NCT00442325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085645|NCT00477516|Dialysis Solutions|dialysis solutions|mesh-list
65085646|NCT00477516|Calcium|calcium|mesh-list
65085647|NCT00477516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65085648|NCT00477516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085649|NCT00477516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65085650|NCT00477711|Capecitabine|capecitabine|mesh-list
65085651|NCT00477711|Cetuximab|cetuximab|mesh-list
65085652|NCT00477711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085654|NCT00477711|Antimetabolites|antimetabolites|mesh-ancestor
65085655|NCT00477711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085656|NCT00477711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65085657|NCT00442403|Chloroquine|chloroquine|mesh-list
65085658|NCT00442403|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
65085659|NCT00442403|Amebicides|amebicides|mesh-ancestor
65085660|NCT00442403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65085661|NCT00442403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65085662|NCT00442403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65085663|NCT00442403|Antimalarials|antimalarials|mesh-ancestor
65085664|NCT00442403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65085665|NCT00442403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085666|NCT00442403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65085667|NCT00442403|Immunologic Factors|immunologic factors|mesh-ancestor
65085668|NCT00477789|Allopurinol|allopurinol|mesh-list
65085669|NCT00477789|Antimetabolites|antimetabolites|mesh-ancestor
65085670|NCT00477789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085671|NCT00477789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085672|NCT00477789|Gout Suppressants|gout suppressants|mesh-ancestor
65085673|NCT00477789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65085674|NCT00477789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65085675|NCT00477789|Antioxidants|antioxidants|mesh-ancestor
65085676|NCT00477789|Protective Agents|protective agents|mesh-ancestor
65085677|NCT00477789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085678|NCT00442481|Citalopram|citalopram|mesh-list
64325488|NCT03126968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64325489|NCT03126968|Autonomic Agents|autonomic agents|mesh-ancestor
64325491|NCT03126968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64727868|NCT00002707|Docetaxel|docetaxel|mesh-list
65085679|NCT00442481|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65085680|NCT00442481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65085681|NCT00442481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65085682|NCT00442481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085683|NCT00442481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65085684|NCT00442481|Serotonin Agents|serotonin agents|mesh-ancestor
65085685|NCT00442481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085686|NCT00442481|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65085687|NCT00442481|Antidepressive Agents|antidepressive agents|mesh-ancestor
65085688|NCT00442481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65085690|NCT00442637|Capecitabine|capecitabine|mesh-list
65085691|NCT00442637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65085692|NCT00442637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085693|NCT00442637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65085694|NCT00442637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65085695|NCT00442637|Growth Substances|growth substances|mesh-ancestor
65085696|NCT00442637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085697|NCT00442637|Growth Inhibitors|growth inhibitors|mesh-ancestor
65085698|NCT00442637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65085699|NCT00442637|Antimetabolites|antimetabolites|mesh-ancestor
65085700|NCT00442637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085701|NCT00442676|Celecoxib|celecoxib|mesh-list
65085702|NCT00442676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65085703|NCT00442676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65085704|NCT00442676|Analgesics|analgesics|mesh-ancestor
65085705|NCT00442676|Sensory System Agents|sensory system agents|mesh-ancestor
65085706|NCT00442676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65085707|NCT00442676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085708|NCT00442676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65085709|NCT00442676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65085710|NCT00442676|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65085711|NCT00442676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65085712|NCT00442676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085713|NCT00442676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085714|NCT00477945|Clofarabine|clofarabine|mesh-list
65085715|NCT00477945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65085716|NCT00477945|Antimetabolites|antimetabolites|mesh-ancestor
65085717|NCT00477945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085718|NCT00477945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085719|NCT00442793|Epoetin Alfa|epoetin alfa|mesh-list
65085720|NCT00442793|Hematinics|hematinics|mesh-ancestor
65085721|NCT00442832|Vancomycin|vancomycin|mesh-list
65085722|NCT00442832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64835104|NCT03106454|Estrogens|estrogens|mesh-ancestor
64835105|NCT03106454|Hormones|hormones|mesh-ancestor
64835106|NCT03106454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64835107|NCT03106454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429616|NCT05098457|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64429617|NCT05098457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65085723|NCT00442832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65085724|NCT00477984|Ethanol|ethanol|mesh-list
65085725|NCT00477984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65085726|NCT00477984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65085727|NCT00477984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65085728|NCT00477984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085729|NCT00478101|Fentanyl|fentanyl|mesh-list
65085730|NCT00478101|Oxycodone|oxycodone|mesh-list
65085731|NCT00478101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65085732|NCT00478101|Narcotics|narcotics|mesh-ancestor
65085733|NCT00478101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65085734|NCT00478101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085735|NCT00478101|Analgesics|analgesics|mesh-ancestor
65085736|NCT00478101|Sensory System Agents|sensory system agents|mesh-ancestor
65085737|NCT00478101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65085738|NCT00478101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65085739|NCT00478101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65085740|NCT00478101|Anesthetics, General|anesthetics, general|mesh-ancestor
65085741|NCT00478101|Anesthetics|anesthetics|mesh-ancestor
65085742|NCT00440076|Bortezomib|bortezomib|mesh-list
65085743|NCT00440076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085744|NCT00443105|Tacrolimus|tacrolimus|mesh-list
65085745|NCT00443105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65085746|NCT00443105|Immunologic Factors|immunologic factors|mesh-ancestor
65085747|NCT00443105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085748|NCT00443105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65085749|NCT00443105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085750|NCT00443105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085751|NCT00443144|Hormones|hormones|mesh-list
65085752|NCT00443144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65085753|NCT00443144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085754|NCT00440154|Ezetimibe|ezetimibe|mesh-list
64727944|NCT00003602|Cytarabine|cytarabine|mesh-list
65085755|NCT00440154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65085756|NCT00440154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65085757|NCT00440154|Antimetabolites|antimetabolites|mesh-ancestor
65085758|NCT00440154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085759|NCT00440154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65085761|NCT00478374|Sorafenib|sorafenib|mesh-list
65085762|NCT00478374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65085763|NCT00478374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835108|NCT03106454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64603618|NCT00771875|Rituximab|rituximab|mesh-list
64835109|NCT03106454|Contraceptive Agents|contraceptive agents|mesh-ancestor
64835110|NCT03106454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64835111|NCT03106454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64835112|NCT03106454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64835113|NCT03106454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64835114|NCT03106454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64835115|NCT03106454|Trace Elements|trace elements|mesh-ancestor
64835116|NCT03106454|Micronutrients|micronutrients|mesh-ancestor
64835117|NCT03040973|Gefitinib|gefitinib|mesh-list
64835118|NCT03040973|Osimertinib|osimertinib|mesh-list
64835119|NCT03040973|Nazartinib|nazartinib|mesh-list
64446244|NCT02180672|Autonomic Agents|autonomic agents|mesh-ancestor
64325500|NCT01309945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64325501|NCT01309945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64325502|NCT01309945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65085764|NCT00478374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65085765|NCT00478374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65085766|NCT00478374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085767|NCT00478374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085768|NCT00478374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65085769|NCT00478452|Cyclophosphamide|cyclophosphamide|mesh-list
65085770|NCT00478452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65085771|NCT00478452|Immunologic Factors|immunologic factors|mesh-ancestor
65085772|NCT00478452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085773|NCT00478452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65085774|NCT00478452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65085775|NCT00478452|Alkylating Agents|alkylating agents|mesh-ancestor
65085776|NCT00478452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085777|NCT00478452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085778|NCT00478452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65085779|NCT03279549|Mitogens|mitogens|mesh-list
65085780|NCT03279549|Mitosis Modulators|mitosis modulators|mesh-ancestor
65085781|NCT03279549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085782|NCT03271983|Metronidazole|metronidazole|mesh-list
65085783|NCT03271983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65085784|NCT03271983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65085785|NCT03271983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65085786|NCT03271983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65085787|NCT00443222|Infliximab|infliximab|mesh-list
65085788|NCT00443222|Dermatologic Agents|dermatologic agents|mesh-ancestor
65085789|NCT00443222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65085790|NCT00443222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65085791|NCT00440349|Tamoxifen|tamoxifen|mesh-list
65085792|NCT00440349|Prednisone|prednisone|mesh-list
65085793|NCT00440349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65085794|NCT00440349|Glucocorticoids|glucocorticoids|mesh-ancestor
65085795|NCT00440349|Hormones|hormones|mesh-ancestor
65085796|NCT00440349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64835120|NCT03040973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835121|NCT03040973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64835122|NCT03040973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835123|NCT03040973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835125|NCT02990806|Dermatologic Agents|dermatologic agents|mesh-ancestor
64835126|NCT02990806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64835127|NCT02990806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64835128|NCT02965703|Aspirin|aspirin|mesh-list
64429787|NCT05046431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085797|NCT00440349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085798|NCT00440349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65085799|NCT00440349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085800|NCT00440349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65085801|NCT00440349|Hormone Antagonists|hormone antagonists|mesh-ancestor
65085802|NCT00440349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65085803|NCT00440349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65085804|NCT00440349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65085805|NCT00443339|Darbepoetin alfa|darbepoetin alfa|mesh-list
65085806|NCT00443339|Hematinics|hematinics|mesh-ancestor
65085807|NCT04700228|Dexmedetomidine|dexmedetomidine|mesh-list
65085808|NCT04700228|Bupivacaine|bupivacaine|mesh-list
65085809|NCT04700228|Anesthetics, Local|anesthetics, local|mesh-ancestor
65085810|NCT04700228|Anesthetics|anesthetics|mesh-ancestor
65085811|NCT04700228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65085812|NCT04700228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085813|NCT04700228|Sensory System Agents|sensory system agents|mesh-ancestor
65085814|NCT04700228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65085815|NCT04700228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65085816|NCT04700228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65085817|NCT04700228|Analgesics|analgesics|mesh-ancestor
65085818|NCT04700228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65085819|NCT04700228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65085820|NCT04700228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65085821|NCT04700228|Adrenergic Agents|adrenergic agents|mesh-ancestor
65085822|NCT04700228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65085823|NCT04700228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085824|NCT00440427|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
65085825|NCT00440427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65085826|NCT00440427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65085827|NCT00440427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64728027|NCT00002737|Interferons|interferons|mesh-list
65085828|NCT00440427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085829|NCT00440427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65085830|NCT00440427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085831|NCT00440427|Antidepressive Agents|antidepressive agents|mesh-ancestor
65085832|NCT00440427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65085833|NCT03278522|Ramosetron|ramosetron|mesh-list
65085834|NCT03278522|Antiemetics|antiemetics|mesh-ancestor
65085835|NCT03278522|Autonomic Agents|autonomic agents|mesh-ancestor
65085836|NCT03278522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65085837|NCT03278522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085838|NCT03278522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65085839|NCT03278522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65085840|NCT03278522|Serotonin Agents|serotonin agents|mesh-ancestor
65085841|NCT03278522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64835129|NCT02965703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64835130|NCT02965703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64835131|NCT02965703|Analgesics|analgesics|mesh-ancestor
64835132|NCT02965703|Sensory System Agents|sensory system agents|mesh-ancestor
64835133|NCT02965703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64835134|NCT02965703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835135|NCT02965703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64835136|NCT02965703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64835137|NCT02965703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64835138|NCT02965703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64835139|NCT02965703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835140|NCT02965703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65085842|NCT03278522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085843|NCT00440622|Gemcitabine|gemcitabine|mesh-list
65085844|NCT00440622|Capecitabine|capecitabine|mesh-list
65085845|NCT00440622|Trastuzumab|trastuzumab|mesh-list
65085846|NCT00440622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65085847|NCT00440622|Antimetabolites|antimetabolites|mesh-ancestor
65085848|NCT00440622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085849|NCT00440622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085850|NCT00440622|Antiviral Agents|antiviral agents|mesh-ancestor
65085851|NCT00440622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65085852|NCT00440622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085853|NCT00440622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65085854|NCT00440622|Immunologic Factors|immunologic factors|mesh-ancestor
65085855|NCT00440622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085856|NCT00440622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65085857|NCT00440661|Diacetylrhein|diacetylrhein|mesh-list
65085858|NCT00440661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65085859|NCT03278444|Trimetazidine|trimetazidine|mesh-list
65085860|NCT03278444|Vasodilator Agents|vasodilator agents|mesh-ancestor
65085861|NCT00440739|Etoricoxib|etoricoxib|mesh-list
65085862|NCT00440739|Flavoxate|flavoxate|mesh-list
65085863|NCT00440739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65085864|NCT00440739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65085865|NCT00440739|Analgesics|analgesics|mesh-ancestor
65085866|NCT00440739|Sensory System Agents|sensory system agents|mesh-ancestor
65085867|NCT00440739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65085868|NCT00440739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085869|NCT00440739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65085870|NCT00440739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65085871|NCT00440739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65085872|NCT00440739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65085873|NCT00440739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085874|NCT00440739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085875|NCT00440739|Parasympatholytics|parasympatholytics|mesh-ancestor
65085876|NCT00440739|Autonomic Agents|autonomic agents|mesh-ancestor
65085877|NCT00440739|Urological Agents|urological agents|mesh-ancestor
65085878|NCT00443573|Protein C|protein c|mesh-list
65085879|NCT00443573|Anticoagulants|anticoagulants|mesh-list
65085880|NCT00443573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65085881|NCT00443573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65085882|NCT00443573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085883|NCT00478764|Triamcinolone|triamcinolone|mesh-list
65085884|NCT00478764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65085885|NCT00478764|Glucocorticoids|glucocorticoids|mesh-ancestor
65085886|NCT00478764|Hormones|hormones|mesh-ancestor
65085887|NCT00478764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64416628|NCT03040531|Estrogens|estrogens|mesh-ancestor
65085888|NCT00478764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085889|NCT00440778|Abciximab|abciximab|mesh-list
65085890|NCT00440778|Anticoagulants|anticoagulants|mesh-ancestor
64325504|NCT01309945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64325505|NCT01309945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325506|NCT01309945|Analgesics|analgesics|mesh-ancestor
64325507|NCT01309945|Sensory System Agents|sensory system agents|mesh-ancestor
64835141|NCT02965703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64835142|NCT02965703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835144|NCT02938442|Paclitaxel|paclitaxel|mesh-list
64835145|NCT02938442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64835146|NCT02938442|Cyclophosphamide|cyclophosphamide|mesh-list
64835147|NCT02938442|Doxorubicin|doxorubicin|mesh-list
64835148|NCT02938442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64835149|NCT02938442|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64835150|NCT02938442|Freund's Adjuvant|freund's adjuvant|mesh-list
65085891|NCT00440778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65085892|NCT03278405|Avelumab|avelumab|mesh-list
65085893|NCT03278405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65085894|NCT03278405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085895|NCT00443612|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65085896|NCT00443612|Irbesartan|irbesartan|mesh-list
65085897|NCT00443612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65085898|NCT00443612|Diuretics|diuretics|mesh-ancestor
65085899|NCT00443612|Natriuretic Agents|natriuretic agents|mesh-ancestor
65085900|NCT00443612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085901|NCT00443612|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65085902|NCT00443612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65085903|NCT00443612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085904|NCT00443612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65085905|NCT00443612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65085906|NCT00443690|Rolofylline|rolofylline|mesh-list
65085907|NCT00443690|Diuretics|diuretics|mesh-ancestor
65085908|NCT00443690|Natriuretic Agents|natriuretic agents|mesh-ancestor
65085909|NCT00443690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835153|NCT02938442|Tubulin Modulators|tubulin modulators|mesh-ancestor
64835154|NCT02938442|Antimitotic Agents|antimitotic agents|mesh-ancestor
64835155|NCT02938442|Mitosis Modulators|mitosis modulators|mesh-ancestor
64835156|NCT02938442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325508|NCT01309945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64835157|NCT02938442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64835158|NCT02938442|Immunologic Factors|immunologic factors|mesh-ancestor
64835159|NCT02938442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835160|NCT02938442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64835161|NCT02938442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64835162|NCT02938442|Alkylating Agents|alkylating agents|mesh-ancestor
64835163|NCT02938442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64835164|NCT02938442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64835165|NCT02938442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65085910|NCT00440895|Abciximab|abciximab|mesh-list
65085911|NCT00440895|Anticoagulants|anticoagulants|mesh-ancestor
65085912|NCT00440895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65085913|NCT00440973|Bevacizumab|bevacizumab|mesh-list
65085914|NCT00440973|Interleukin-2|interleukin-2|mesh-list
65085915|NCT00440973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65085916|NCT00440973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085917|NCT00440973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65085918|NCT00440973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65085919|NCT00440973|Growth Substances|growth substances|mesh-ancestor
65085920|NCT00440973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085921|NCT00440973|Growth Inhibitors|growth inhibitors|mesh-ancestor
65085922|NCT00440973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65085923|NCT00440973|Analgesics|analgesics|mesh-ancestor
65085924|NCT00440973|Sensory System Agents|sensory system agents|mesh-ancestor
65085925|NCT00440973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65085926|NCT00443924|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65085927|NCT00443924|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65085928|NCT00441051|Diclofenac|diclofenac|mesh-list
65085929|NCT00441051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65085930|NCT00441051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65085931|NCT00441051|Analgesics|analgesics|mesh-ancestor
65085932|NCT00441051|Sensory System Agents|sensory system agents|mesh-ancestor
65085933|NCT00441051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65085934|NCT00441051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085935|NCT00441051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65085936|NCT00441051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65085937|NCT00441051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65085938|NCT00441051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085939|NCT00441051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085940|NCT00443963|Esomeprazole|esomeprazole|mesh-list
65085941|NCT00443963|Ranitidine|ranitidine|mesh-list
65085942|NCT00443963|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65085943|NCT00443963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65085944|NCT00443963|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65085945|NCT00443963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65085946|NCT00443963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835166|NCT02938442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64325510|NCT01309945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64325511|NCT01309945|Dopamine Agents|dopamine agents|mesh-ancestor
64325512|NCT02153567|Citalopram|citalopram|mesh-list
64325513|NCT02153567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64325514|NCT02153567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64325515|NCT02153567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65085947|NCT00443963|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65085948|NCT00443963|Histamine Antagonists|histamine antagonists|mesh-ancestor
65085949|NCT00443963|Histamine Agents|histamine agents|mesh-ancestor
65085950|NCT00443963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65085951|NCT00443963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085952|NCT00441207|Ascorbic Acid|ascorbic acid|mesh-list
65085953|NCT00441207|Antioxidants|antioxidants|mesh-ancestor
65085954|NCT00441207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085955|NCT00441207|Protective Agents|protective agents|mesh-ancestor
65085956|NCT00441207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085957|NCT00441207|Vitamins|vitamins|mesh-ancestor
65085958|NCT00441207|Micronutrients|micronutrients|mesh-ancestor
65085959|NCT00444041|Bevacizumab|bevacizumab|mesh-list
65085960|NCT00444041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65085961|NCT00444041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085962|NCT00444041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65085963|NCT00444041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65085964|NCT00444041|Growth Substances|growth substances|mesh-ancestor
65085965|NCT00444041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085966|NCT00444041|Growth Inhibitors|growth inhibitors|mesh-ancestor
65085967|NCT00441246|Phenylpropanolamine|phenylpropanolamine|mesh-list
65085968|NCT00441246|Pseudoephedrine|pseudoephedrine|mesh-list
65085969|NCT00441246|Ephedrine|ephedrine|mesh-list
65085970|NCT00441246|Guaifenesin|guaifenesin|mesh-list
65085971|NCT00441246|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
65085972|NCT00441246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65085973|NCT00441246|Autonomic Agents|autonomic agents|mesh-ancestor
65085974|NCT00441246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65085975|NCT00441246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085976|NCT00441246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65085977|NCT00441246|Respiratory System Agents|respiratory system agents|mesh-ancestor
65085978|NCT00441246|Nasal Decongestants|nasal decongestants|mesh-ancestor
65085979|NCT00441246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65085980|NCT00441246|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65085981|NCT00441246|Sympathomimetics|sympathomimetics|mesh-ancestor
65085982|NCT00441246|Adrenergic Agents|adrenergic agents|mesh-ancestor
65085983|NCT00441246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64835167|NCT02938442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835168|NCT02938442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64835169|NCT02890329|Ipilimumab|ipilimumab|mesh-list
64835170|NCT02890329|Decitabine|decitabine|mesh-list
64835171|NCT02890329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64835172|NCT02890329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835173|NCT02890329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64835174|NCT02890329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835175|NCT02890329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64835176|NCT02890329|Antimetabolites|antimetabolites|mesh-ancestor
64835177|NCT02890329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835178|NCT02814916|Dalbavancin|dalbavancin|mesh-list
64835179|NCT02814916|Teicoplanin|teicoplanin|mesh-list
64835180|NCT02814916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64446300|NCT01920555|GABA Agents|gaba agents|mesh-ancestor
65085984|NCT00441246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65085985|NCT00441246|Expectorants|expectorants|mesh-ancestor
65085986|NCT00441246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65085987|NCT00441246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65085988|NCT00441246|Appetite Depressants|appetite depressants|mesh-ancestor
65085989|NCT00441246|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65085990|NCT00478959|Lenalidomide|lenalidomide|mesh-list
65085991|NCT00478959|Immunologic Factors|immunologic factors|mesh-ancestor
65085992|NCT00478959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65085993|NCT00478959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65085994|NCT00478959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65085995|NCT00478959|Growth Substances|growth substances|mesh-ancestor
65085996|NCT00478959|Growth Inhibitors|growth inhibitors|mesh-ancestor
65085997|NCT00478959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65085998|NCT00444236|Esomeprazole|esomeprazole|mesh-list
65085999|NCT00444236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65086000|NCT00444236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65086001|NCT00444236|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65086002|NCT00444236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086003|NCT00444236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086004|NCT00478998|Tamsulosin|tamsulosin|mesh-list
65086005|NCT00478998|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65086006|NCT00478998|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65086007|NCT00478998|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65086008|NCT00478998|Adrenergic Agents|adrenergic agents|mesh-ancestor
65086009|NCT00478998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65086010|NCT00478998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086011|NCT00478998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086012|NCT00478998|Urological Agents|urological agents|mesh-ancestor
65086013|NCT02957279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65086014|NCT02957279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65086015|NCT00479076|Aflibercept|aflibercept|mesh-list
65086016|NCT00479076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65086017|NCT00479076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65086018|NCT00479076|Growth Substances|growth substances|mesh-ancestor
65086019|NCT00479076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086020|NCT00479076|Growth Inhibitors|growth inhibitors|mesh-ancestor
65086021|NCT00479076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086022|NCT00441519|Aspirin|aspirin|mesh-list
65086023|NCT00441519|Omeprazole|omeprazole|mesh-list
65086024|NCT00441519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65086025|NCT00441519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65086026|NCT00441519|Analgesics|analgesics|mesh-ancestor
65086027|NCT00441519|Sensory System Agents|sensory system agents|mesh-ancestor
65086028|NCT00441519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65086029|NCT00441519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086030|NCT00441519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65086031|NCT00441519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65086032|NCT00441519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65086033|NCT00441519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64325516|NCT02153567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086034|NCT00441519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086035|NCT00441519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65086036|NCT00441519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65086037|NCT00441519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086038|NCT00441519|Antipyretics|antipyretics|mesh-ancestor
65086039|NCT00441519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65086040|NCT00441519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65086041|NCT00441519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65086042|NCT00441597|Atorvastatin|atorvastatin|mesh-list
65086043|NCT00441597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65086044|NCT00441597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65086045|NCT00441597|Antimetabolites|antimetabolites|mesh-ancestor
65086046|NCT00441597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086047|NCT00441597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65086048|NCT00441597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65086049|NCT00441597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086050|NCT00479193|Bacitracin|bacitracin|mesh-list
65086051|NCT00479193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65086052|NCT00479193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65086053|NCT00479193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65086054|NCT03278015|Gemcitabine|gemcitabine|mesh-list
65086055|NCT03278015|Paclitaxel|paclitaxel|mesh-list
65086056|NCT03278015|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65086057|NCT03278015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65086058|NCT03278015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086059|NCT03278015|Tubulin Modulators|tubulin modulators|mesh-ancestor
65086060|NCT03278015|Antimitotic Agents|antimitotic agents|mesh-ancestor
65086061|NCT03278015|Mitosis Modulators|mitosis modulators|mesh-ancestor
65086062|NCT03278015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086063|NCT03278015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65086064|NCT03278015|Antimetabolites|antimetabolites|mesh-ancestor
65086065|NCT03278015|Antiviral Agents|antiviral agents|mesh-ancestor
65086066|NCT03278015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65086067|NCT03278015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086068|NCT03278015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65086069|NCT03278015|Immunologic Factors|immunologic factors|mesh-ancestor
65086070|NCT03278015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086071|NCT00444314|Sunitinib|sunitinib|mesh-list
65086072|NCT00444314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086073|NCT00444314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64325517|NCT02153567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64835182|NCT02811263|Epoetin Alfa|epoetin alfa|mesh-list
64835183|NCT02811263|Hematinics|hematinics|mesh-ancestor
64835184|NCT02650271|Tenofovir|tenofovir|mesh-list
64835185|NCT02650271|Entecavir|entecavir|mesh-list
64835186|NCT02650271|Antiviral Agents|antiviral agents|mesh-ancestor
64835187|NCT02650271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64835188|NCT02650271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64835189|NCT02650271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64835191|NCT02650271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835192|NCT02650271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64835193|NCT02650271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64835194|NCT02606045|Tranexamic Acid|tranexamic acid|mesh-list
64835201|NCT02420821|Sunitinib|sunitinib|mesh-list
65086074|NCT00444314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65086075|NCT00444314|Growth Substances|growth substances|mesh-ancestor
65086076|NCT00444314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086077|NCT00444314|Growth Inhibitors|growth inhibitors|mesh-ancestor
65086078|NCT00444314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65086079|NCT00444314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086080|NCT00444314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086081|NCT04700826|Rivaroxaban|rivaroxaban|mesh-list
65086082|NCT04700826|Apixaban|apixaban|mesh-list
65086083|NCT04700826|Edoxaban|edoxaban|mesh-list
65086084|NCT04700826|Dabigatran|dabigatran|mesh-list
65086085|NCT04700826|Anticoagulants|anticoagulants|mesh-list
65086086|NCT04700826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65086087|NCT04700826|Antithrombins|antithrombins|mesh-ancestor
65086088|NCT04700826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65086089|NCT04700826|Protease Inhibitors|protease inhibitors|mesh-ancestor
65086090|NCT04700826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086091|NCT04700826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086092|NCT02274051|Kinetin|kinetin|mesh-list
65086093|NCT02274051|Plant Growth Regulators|plant growth regulators|mesh-ancestor
65086094|NCT02274051|Growth Substances|growth substances|mesh-ancestor
65086095|NCT02274051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086096|NCT00444470|Tranexamic Acid|tranexamic acid|mesh-list
65086097|NCT00444470|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
65086098|NCT00444470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64416642|NCT04838665|Nasal Decongestants|nasal decongestants|mesh-ancestor
65086099|NCT00444470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086100|NCT00444470|Hemostatics|hemostatics|mesh-ancestor
65086101|NCT00444470|Coagulants|coagulants|mesh-ancestor
65086102|NCT00444548|Reboxetine|reboxetine|mesh-list
65086103|NCT00444548|Antidepressive Agents|antidepressive agents|mesh-ancestor
65086104|NCT00444548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65086105|NCT00444548|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65086106|NCT00444548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65086107|NCT00444548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65086108|NCT00444548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086109|NCT00444548|Adrenergic Agents|adrenergic agents|mesh-ancestor
65086110|NCT00444548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65086111|NCT00444548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086112|NCT00444665|Travoprost|travoprost|mesh-list
65086113|NCT00444665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65086114|NCT04699643|Pembrolizumab|pembrolizumab|mesh-list
65086115|NCT04699643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65086116|NCT04699643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086117|NCT02274090|Metformin|metformin|mesh-list
65086118|NCT02274090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65086119|NCT02274090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086120|NCT00479661|Dexmedetomidine|dexmedetomidine|mesh-list
65086121|NCT00479661|Propofol|propofol|mesh-list
64835221|NCT02229084|Paclitaxel|paclitaxel|mesh-list
65086122|NCT00479661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65086123|NCT00479661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65086124|NCT00479661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086125|NCT00479661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65086126|NCT00479661|Anesthetics, General|anesthetics, general|mesh-ancestor
65086127|NCT00479661|Anesthetics|anesthetics|mesh-ancestor
65086128|NCT00479661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65086129|NCT00479661|Analgesics|analgesics|mesh-ancestor
65086130|NCT00479661|Sensory System Agents|sensory system agents|mesh-ancestor
65086131|NCT00479661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65086132|NCT00479661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65086133|NCT00479661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65086134|NCT00479661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65086135|NCT00479661|Adrenergic Agents|adrenergic agents|mesh-ancestor
65086136|NCT00479661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65086137|NCT00479661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086138|NCT04700670|Platelet Factor 4|platelet factor 4|mesh-list
65086139|NCT04700670|Coagulants|coagulants|mesh-ancestor
65086141|NCT00441870|Vitamin B Complex|vitamin b complex|mesh-list
65086142|NCT00441870|Hematinics|hematinics|mesh-ancestor
65086143|NCT00441870|Vitamins|vitamins|mesh-ancestor
65086144|NCT00441870|Micronutrients|micronutrients|mesh-ancestor
65086145|NCT00441870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086146|NCT04700592|Ketamine|ketamine|mesh-list
65086147|NCT04700592|Gabapentin|gabapentin|mesh-list
65086148|NCT04700592|Analgesics|analgesics|mesh-ancestor
65086149|NCT04700592|Sensory System Agents|sensory system agents|mesh-ancestor
65086150|NCT04700592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65086151|NCT04700592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086152|NCT04700592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65086153|NCT04700592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65086154|NCT04700592|Anesthetics, General|anesthetics, general|mesh-ancestor
65086155|NCT04700592|Anesthetics|anesthetics|mesh-ancestor
65086156|NCT04700592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65086157|NCT04700592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65086158|NCT04700592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65086159|NCT04700592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65086160|NCT04700592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086161|NCT04700592|Anticonvulsants|anticonvulsants|mesh-ancestor
65086162|NCT04700592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65086163|NCT04700592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65086164|NCT04700592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65086165|NCT04700592|Antimanic Agents|antimanic agents|mesh-ancestor
65086167|NCT00441909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65086168|NCT00441909|Antiviral Agents|antiviral agents|mesh-ancestor
65086169|NCT00441909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65086170|NCT00445016|Anesthetics|anesthetics|mesh-list
64835222|NCT02229084|Docetaxel|docetaxel|mesh-list
64835223|NCT02229084|Cyclophosphamide|cyclophosphamide|mesh-list
64835224|NCT02229084|Doxorubicin|doxorubicin|mesh-list
64835225|NCT02229084|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64835226|NCT02229084|Freund's Adjuvant|freund's adjuvant|mesh-list
65086171|NCT00445016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65086172|NCT00445016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086173|NCT00445055|Droperidol|droperidol|mesh-list
65086174|NCT00445055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65086176|NCT00445055|Autonomic Agents|autonomic agents|mesh-ancestor
65086177|NCT00445055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65086178|NCT00445055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086179|NCT00445055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65086180|NCT00445055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65086181|NCT00445055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65086182|NCT00445055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65086183|NCT00445055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65086184|NCT00445055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65086185|NCT00445055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65086186|NCT00445055|Dopamine Agents|dopamine agents|mesh-ancestor
65086187|NCT00445055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65086188|NCT00445055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086189|NCT00479739|Fluticasone|fluticasone|mesh-list
65086190|NCT00479739|Xhance|xhance|mesh-list
65086191|NCT00479739|Budesonide|budesonide|mesh-list
65086192|NCT00479739|Formoterol Fumarate|formoterol fumarate|mesh-list
65086193|NCT00479739|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65086194|NCT00479739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65086195|NCT00479739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65086196|NCT00479739|Autonomic Agents|autonomic agents|mesh-ancestor
65086197|NCT00479739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65086198|NCT00479739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086199|NCT00479739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65086200|NCT00479739|Respiratory System Agents|respiratory system agents|mesh-ancestor
65086201|NCT00479739|Dermatologic Agents|dermatologic agents|mesh-ancestor
65086202|NCT00479739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65086203|NCT00479739|Glucocorticoids|glucocorticoids|mesh-ancestor
65086204|NCT00479739|Hormones|hormones|mesh-ancestor
65086205|NCT00479739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65086206|NCT00479739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65086207|NCT00479739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65086208|NCT00479739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65086210|NCT00479739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65086211|NCT00479739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086212|NCT00445094|Vancomycin|vancomycin|mesh-list
65086213|NCT00445094|Imipenem|imipenem|mesh-list
65086214|NCT00445094|Amikacin|amikacin|mesh-list
65086215|NCT00445094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65086216|NCT00445094|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
65086217|NCT00445094|Cilastatin|cilastatin|mesh-list
65086218|NCT00445094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65086219|NCT00445094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65086220|NCT00445094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086221|NCT00445094|Protease Inhibitors|protease inhibitors|mesh-ancestor
65086222|NCT00445094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086223|NCT00445094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65086224|NCT00479778|Bazedoxifene|bazedoxifene|mesh-list
65086225|NCT00479778|Estrogens|estrogens|mesh-list
64835249|NCT02188121|Antimetabolites|antimetabolites|mesh-ancestor
64835251|NCT02188121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65086226|NCT00479778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65086227|NCT00479778|Hormones|hormones|mesh-ancestor
65086228|NCT00479778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65086229|NCT00479778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086230|NCT00479778|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65086231|NCT00479778|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65086232|NCT00479778|Hormone Antagonists|hormone antagonists|mesh-ancestor
65086233|NCT00479778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65086234|NCT00442026|Gemcitabine|gemcitabine|mesh-list
65086235|NCT00442026|Docetaxel|docetaxel|mesh-list
65086236|NCT00442026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65086237|NCT00442026|Antimetabolites|antimetabolites|mesh-ancestor
65086238|NCT00442026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086239|NCT00442026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086240|NCT00442026|Antiviral Agents|antiviral agents|mesh-ancestor
65086241|NCT00442026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65086242|NCT00442026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086243|NCT00442026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65086244|NCT00442026|Immunologic Factors|immunologic factors|mesh-ancestor
65086245|NCT00442026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086246|NCT00442026|Tubulin Modulators|tubulin modulators|mesh-ancestor
65086247|NCT00442026|Antimitotic Agents|antimitotic agents|mesh-ancestor
65086248|NCT00442026|Mitosis Modulators|mitosis modulators|mesh-ancestor
65086249|NCT00479895|Chrysarobin|chrysarobin|mesh-list
64416646|NCT04838665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65086251|NCT00479895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65086252|NCT00479895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65086253|NCT00479895|Analgesics|analgesics|mesh-ancestor
65086254|NCT00479895|Sensory System Agents|sensory system agents|mesh-ancestor
65086255|NCT00479895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65086256|NCT00479895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086257|NCT00479895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65086258|NCT00479895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65086259|NCT00479895|Blood Substitutes|blood substitutes|mesh-ancestor
65086260|NCT00445250|Calcipotriene|calcipotriene|mesh-list
65086261|NCT00445250|Dermatologic Agents|dermatologic agents|mesh-ancestor
65086262|NCT03279120|Tenofovir|tenofovir|mesh-list
65086263|NCT03279120|Levonorgestrel|levonorgestrel|mesh-list
65086264|NCT03279120|Antiviral Agents|antiviral agents|mesh-ancestor
65086265|NCT03279120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65086266|NCT03279120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65086267|NCT03279120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65086268|NCT03279120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086269|NCT03279120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086270|NCT03279120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65086271|NCT03279120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65086272|NCT03279120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65086273|NCT03279120|Contraceptive Agents|contraceptive agents|mesh-ancestor
64325521|NCT02153567|Antidepressive Agents|antidepressive agents|mesh-ancestor
64835274|NCT01970410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64835275|NCT01970410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64835277|NCT01970410|Sensory System Agents|sensory system agents|mesh-ancestor
64835278|NCT01970410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64835279|NCT01970410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835280|NCT01970410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64835281|NCT01970410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64835282|NCT01970410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64835283|NCT01970410|Immunologic Factors|immunologic factors|mesh-ancestor
64835284|NCT01950520|Topiramate|topiramate|mesh-list
64446393|NCT01557244|Fesoterodine|fesoterodine|mesh-list
64325523|NCT02441660|Capsaicin|capsaicin|mesh-list
65086274|NCT03279120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65086275|NCT03279120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086276|NCT03279120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65086277|NCT03279120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65086278|NCT03279120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65086279|NCT00479934|Imatinib Mesylate|imatinib mesylate|mesh-list
65086280|NCT00479934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086281|NCT00479934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65086282|NCT00479934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64728486|NCT00002785|Antiemetics|antiemetics|mesh-ancestor
65086283|NCT00479934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086284|NCT00442182|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
65086285|NCT00442182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65086286|NCT00442182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086287|NCT00442182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086288|NCT03274700|Tamsulosin|tamsulosin|mesh-list
65086289|NCT03274700|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65086290|NCT03274700|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65086291|NCT03274700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65086292|NCT03274700|Adrenergic Agents|adrenergic agents|mesh-ancestor
65086293|NCT03274700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65086294|NCT03274700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086295|NCT03274700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086296|NCT03274700|Urological Agents|urological agents|mesh-ancestor
65086297|NCT00442221|Naproxen|naproxen|mesh-list
65086298|NCT00442221|Sumatriptan|sumatriptan|mesh-list
65086299|NCT00442221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65086300|NCT00442221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65086301|NCT00442221|Analgesics|analgesics|mesh-ancestor
65086302|NCT00442221|Sensory System Agents|sensory system agents|mesh-ancestor
65086303|NCT00442221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65086304|NCT00442221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086305|NCT00442221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65086306|NCT00442221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65086307|NCT00442221|Gout Suppressants|gout suppressants|mesh-ancestor
65086308|NCT00442221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65086309|NCT00442221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086310|NCT00442221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086311|NCT00442221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65086312|NCT00442221|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65086313|NCT00442221|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65086315|NCT00442221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65086316|NCT00454259|Fentanyl|fentanyl|mesh-list
65086317|NCT00454259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65086318|NCT00454259|Narcotics|narcotics|mesh-ancestor
65086319|NCT00454259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65086320|NCT00454259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086322|NCT00454259|Sensory System Agents|sensory system agents|mesh-ancestor
65086323|NCT00454259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65086324|NCT00454259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65086325|NCT00454259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65086326|NCT00454259|Anesthetics, General|anesthetics, general|mesh-ancestor
64835294|NCT01950520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64835295|NCT01950520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835296|NCT01950520|Sensory System Agents|sensory system agents|mesh-ancestor
64835297|NCT01950520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64835298|NCT01950520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64835299|NCT01950520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64835300|NCT01950520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835301|NCT01950520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446411|NCT02155322|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
65086327|NCT00454259|Anesthetics|anesthetics|mesh-ancestor
65086328|NCT03278808|Azithromycin|azithromycin|mesh-list
65086329|NCT03278808|Chloroquine|chloroquine|mesh-list
65086330|NCT03278808|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
65086331|NCT03278808|Atovaquone|atovaquone|mesh-list
65086332|NCT03278808|Proguanil|proguanil|mesh-list
65086333|NCT03278808|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
65086334|NCT03278808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65086335|NCT03278808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65086336|NCT03278808|Amebicides|amebicides|mesh-ancestor
65086337|NCT03278808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65086338|NCT03278808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65086339|NCT03278808|Antimalarials|antimalarials|mesh-ancestor
65086340|NCT03278808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65086341|NCT03278808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65086342|NCT03278808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65086343|NCT03278808|Analgesics|analgesics|mesh-ancestor
65086344|NCT03278808|Sensory System Agents|sensory system agents|mesh-ancestor
65086345|NCT03278808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65086346|NCT03278808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086347|NCT03278808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65086348|NCT03278808|Filaricides|filaricides|mesh-ancestor
65086349|NCT03278808|Antinematodal Agents|antinematodal agents|mesh-ancestor
65086350|NCT03278808|Anthelmintics|anthelmintics|mesh-ancestor
65086351|NCT03278808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086352|NCT03278808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086353|NCT03278808|Antimetabolites|antimetabolites|mesh-ancestor
65086354|NCT00480090|Cytarabine|cytarabine|mesh-list
65086355|NCT00480090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65086356|NCT00480090|Antimetabolites|antimetabolites|mesh-ancestor
65086357|NCT00480090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086358|NCT00480090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086359|NCT00480090|Antiviral Agents|antiviral agents|mesh-ancestor
65086360|NCT00480090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65086361|NCT00480090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65086362|NCT00480090|Immunologic Factors|immunologic factors|mesh-ancestor
65086363|NCT00480090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086364|NCT00454883|Ziprasidone|ziprasidone|mesh-list
65086365|NCT00454883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65086366|NCT00454883|Serotonin Agents|serotonin agents|mesh-ancestor
65086367|NCT00454883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65086368|NCT00454883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086369|NCT00454883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086370|NCT00454883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65086371|NCT00454883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65086372|NCT00454883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65086373|NCT00454883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65086374|NCT00454883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65086375|NCT00454883|Dopamine Agents|dopamine agents|mesh-ancestor
65086376|NCT03278652|Analgesics|analgesics|mesh-list
65086377|NCT03278652|Sensory System Agents|sensory system agents|mesh-ancestor
65086378|NCT03278652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65086379|NCT03278652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086380|NCT00454961|Lumefantrine|lumefantrine|mesh-list
65086381|NCT00454961|Artemether|artemether|mesh-list
64483279|NCT01764997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086382|NCT00454961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
65086383|NCT00454961|Antimalarials|antimalarials|mesh-ancestor
65086384|NCT00454961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65086385|NCT00454961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65086386|NCT00454961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65086387|NCT00455039|Lapatinib|lapatinib|mesh-list
65086388|NCT00455039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086389|NCT00455039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65086390|NCT00455039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086391|NCT00455039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086392|NCT00480207|Folic Acid|folic acid|mesh-list
65086393|NCT00480207|Vitamin B Complex|vitamin b complex|mesh-list
65086394|NCT00480207|Hematinics|hematinics|mesh-ancestor
65086395|NCT00480207|Vitamins|vitamins|mesh-ancestor
65086396|NCT00480207|Micronutrients|micronutrients|mesh-ancestor
64586722|NCT00460993|Eszopiclone|eszopiclone|mesh-list
65086397|NCT00480207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086398|NCT00442455|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65086399|NCT00442455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086400|NCT00442455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65086401|NCT00442455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086402|NCT00442455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086403|NCT02956655|Insulin|insulin|mesh-list
65086404|NCT02956655|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65086405|NCT02956655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65086406|NCT02956655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086407|NCT00480246|Perphenazine|perphenazine|mesh-list
65086408|NCT00480246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65086409|NCT00480246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65086410|NCT00480246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65086411|NCT00480246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086412|NCT00480246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65086413|NCT00480246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65086414|NCT00480246|Dopamine Agents|dopamine agents|mesh-ancestor
65086415|NCT00480246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65086416|NCT00480246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086417|NCT00455117|Parecoxib|parecoxib|mesh-list
65086418|NCT00455117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65086419|NCT00455117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65086420|NCT00455117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086421|NCT00455117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086422|NCT00455117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65086423|NCT00455117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65086424|NCT00455117|Analgesics|analgesics|mesh-ancestor
65086425|NCT00455117|Sensory System Agents|sensory system agents|mesh-ancestor
65086426|NCT00455117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65086427|NCT00455117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086428|NCT00455117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65086429|NCT00455117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65086430|NCT00442494|Hydrocortisone|hydrocortisone|mesh-list
65086431|NCT00442494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65086432|NCT03274427|Trimetazidine|trimetazidine|mesh-list
65086433|NCT03274427|Vasodilator Agents|vasodilator agents|mesh-ancestor
64728632|NCT00004838|Succimer|succimer|mesh-list
65086434|NCT00455234|Promethazine|promethazine|mesh-list
65086435|NCT00455234|Diphenhydramine|diphenhydramine|mesh-list
65086436|NCT00455234|Haloperidol|haloperidol|mesh-list
65086437|NCT00455234|Haloperidol decanoate|haloperidol decanoate|mesh-list
65086438|NCT00455234|Antiemetics|antiemetics|mesh-ancestor
65086439|NCT00455234|Autonomic Agents|autonomic agents|mesh-ancestor
65086440|NCT00455234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65086441|NCT00455234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086442|NCT00455234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65086443|NCT00455234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65086444|NCT00455234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65086445|NCT00455234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65086446|NCT00455234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65086447|NCT00455234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65086448|NCT00455234|Dopamine Agents|dopamine agents|mesh-ancestor
65086449|NCT00455234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65086450|NCT00455234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086451|NCT00455234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65086452|NCT00455234|Antipruritics|antipruritics|mesh-ancestor
65086453|NCT00455234|Dermatologic Agents|dermatologic agents|mesh-ancestor
65086454|NCT00455234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65086455|NCT00455234|Histamine Antagonists|histamine antagonists|mesh-ancestor
65086456|NCT00455234|Histamine Agents|histamine agents|mesh-ancestor
64325524|NCT02441660|Antipruritics|antipruritics|mesh-ancestor
64325525|NCT02441660|Dermatologic Agents|dermatologic agents|mesh-ancestor
64325526|NCT02441660|Sensory System Agents|sensory system agents|mesh-ancestor
64325527|NCT02441660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64586790|NCT00374231|Mycophenolic Acid|mycophenolic acid|mesh-list
65086457|NCT00455234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65086458|NCT00455234|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65086459|NCT00455234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65086460|NCT00455234|Anesthetics, Local|anesthetics, local|mesh-ancestor
65086461|NCT00455234|Anesthetics|anesthetics|mesh-ancestor
65086462|NCT00455234|Sensory System Agents|sensory system agents|mesh-ancestor
65086463|NCT00480363|Dexamethasone|dexamethasone|mesh-list
65086464|NCT00480363|Lenalidomide|lenalidomide|mesh-list
65086465|NCT00480363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65086466|NCT00480363|Antiemetics|antiemetics|mesh-ancestor
64416655|NCT04845061|Nebivolol|nebivolol|mesh-list
65086467|NCT00480363|Autonomic Agents|autonomic agents|mesh-ancestor
65086468|NCT00480363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65086469|NCT00480363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086470|NCT00480363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65086471|NCT00480363|Glucocorticoids|glucocorticoids|mesh-ancestor
65086472|NCT00480363|Hormones|hormones|mesh-ancestor
65086473|NCT00480363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65086474|NCT00480363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65086475|NCT00480363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086476|NCT00480363|Immunologic Factors|immunologic factors|mesh-ancestor
65086477|NCT00480363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65086478|NCT00480363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65086479|NCT00480363|Growth Substances|growth substances|mesh-ancestor
65086480|NCT00480363|Growth Inhibitors|growth inhibitors|mesh-ancestor
65086481|NCT00455351|Vorinostat|vorinostat|mesh-list
65086482|NCT00455351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086483|NCT00455351|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65086484|NCT00455351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086485|NCT00455351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086486|NCT00455390|Psychotropic Drugs|psychotropic drugs|mesh-list
65086487|NCT00442845|Atorvastatin|atorvastatin|mesh-list
65086488|NCT00442845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65086489|NCT00442845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65086490|NCT00442845|Antimetabolites|antimetabolites|mesh-ancestor
65086491|NCT00442845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086492|NCT00442845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65086493|NCT00442845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65086494|NCT00442845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086495|NCT00455507|Istradefylline|istradefylline|mesh-list
65086496|NCT00455507|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
65086497|NCT00455507|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65086498|NCT00455507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65086499|NCT00455507|Purinergic Agents|purinergic agents|mesh-ancestor
65086500|NCT00455507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65086501|NCT00455507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086502|NCT00455507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086503|NCT00480402|Progesterone|progesterone|mesh-list
65086504|NCT00480402|Progestins|progestins|mesh-ancestor
65086505|NCT00480402|Hormones|hormones|mesh-ancestor
65086506|NCT00480402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65086507|NCT00480402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086508|NCT00455585|Lamivudine|lamivudine|mesh-list
65086509|NCT00455585|Nevirapine|nevirapine|mesh-list
65086511|NCT00455585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65086512|NCT00455585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65086513|NCT00455585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086514|NCT00455585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086515|NCT00455585|Antiviral Agents|antiviral agents|mesh-ancestor
65086516|NCT00455585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65086517|NCT00455585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65086518|NCT00455585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65086519|NCT00455585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65086520|NCT00455585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65086521|NCT00455585|Antimetabolites|antimetabolites|mesh-ancestor
64325528|NCT02441660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086522|NCT00455624|Androgens|androgens|mesh-list
65086523|NCT00455624|Hormones|hormones|mesh-ancestor
65086524|NCT00455624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65086525|NCT00455624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086526|NCT00455897|Rituximab|rituximab|mesh-list
65086527|NCT00455897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65086528|NCT00455897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086529|NCT00455897|Immunologic Factors|immunologic factors|mesh-ancestor
65086530|NCT00455897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086531|NCT00455897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65086532|NCT00455936|Gefitinib|gefitinib|mesh-list
65086533|NCT00455936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086534|NCT00455936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65086535|NCT00455936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086536|NCT00455936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086537|NCT00443235|Thalidomide|thalidomide|mesh-list
65086539|NCT00443235|Melphalan|melphalan|mesh-list
65086540|NCT00443235|Bortezomib|bortezomib|mesh-list
65086541|NCT00443235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65086542|NCT00443235|Glucocorticoids|glucocorticoids|mesh-ancestor
65086543|NCT00443235|Hormones|hormones|mesh-ancestor
65086544|NCT00443235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65086545|NCT00443235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086546|NCT00443235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65086547|NCT00443235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086548|NCT00443235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65086549|NCT00443235|Alkylating Agents|alkylating agents|mesh-ancestor
65086550|NCT00443235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086551|NCT00443235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65086552|NCT00443235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65086553|NCT00443235|Immunologic Factors|immunologic factors|mesh-ancestor
65086554|NCT00443235|Leprostatic Agents|leprostatic agents|mesh-ancestor
65086555|NCT00443235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64835302|NCT01950520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64835303|NCT01950520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64835304|NCT01950520|Purinergic Agents|purinergic agents|mesh-ancestor
64835305|NCT01950520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64835306|NCT01950520|Analgesics|analgesics|mesh-ancestor
64835307|NCT01950520|Anesthetics|anesthetics|mesh-ancestor
64835308|NCT01950520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64835309|NCT01950520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64835310|NCT01950520|Anticonvulsants|anticonvulsants|mesh-ancestor
64835311|NCT01950520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64835312|NCT01950520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64835313|NCT01950520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64835314|NCT01950520|Tocolytic Agents|tocolytic agents|mesh-ancestor
64446428|NCT01557166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086556|NCT00443235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65086557|NCT00443235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65086558|NCT00443235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65086559|NCT00443235|Growth Substances|growth substances|mesh-ancestor
65086560|NCT00443235|Growth Inhibitors|growth inhibitors|mesh-ancestor
65086561|NCT04700943|Anesthetics|anesthetics|mesh-list
65086562|NCT04700943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65086563|NCT04700943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086564|NCT00456248|Ribavirin|ribavirin|mesh-list
65086565|NCT00456248|Interferon alfacon-1|interferon alfacon-1|mesh-list
65086566|NCT00456248|Antimetabolites|antimetabolites|mesh-ancestor
65086567|NCT00456248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086568|NCT00456248|Antiviral Agents|antiviral agents|mesh-ancestor
65086569|NCT00456248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65086570|NCT00480558|Vaccines|vaccines|mesh-list
65086571|NCT00480558|Immunologic Factors|immunologic factors|mesh-ancestor
65086572|NCT00480558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086573|NCT04700709|Mycophenolic Acid|mycophenolic acid|mesh-list
65086574|NCT04700709|Sirolimus|sirolimus|mesh-list
65086575|NCT04700709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65086576|NCT04700709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086577|NCT04700709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65086578|NCT04700709|Antitubercular Agents|antitubercular agents|mesh-ancestor
65086579|NCT04700709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65086580|NCT04700709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65086581|NCT04700709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086582|NCT04700709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086583|NCT04700709|Antifungal Agents|antifungal agents|mesh-ancestor
64728785|NCT00004874|Iodine|iodine|mesh-list
65086584|NCT04700709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65086585|NCT04700709|Immunologic Factors|immunologic factors|mesh-ancestor
65086586|NCT04700709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086587|NCT04698317|Mitogens|mitogens|mesh-list
65086588|NCT04698317|Mitosis Modulators|mitosis modulators|mesh-ancestor
65086589|NCT04698317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086590|NCT04700475|Citric Acid|citric acid|mesh-list
65086591|NCT04700475|Sodium Citrate|sodium citrate|mesh-list
65086592|NCT04700475|Anticoagulants|anticoagulants|mesh-ancestor
65086593|NCT04700475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65086594|NCT04700475|Chelating Agents|chelating agents|mesh-ancestor
65086595|NCT04700475|Sequestering Agents|sequestering agents|mesh-ancestor
64835315|NCT01950520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64835316|NCT01950520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64835317|NCT01950520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64835318|NCT01950520|Adrenergic Agents|adrenergic agents|mesh-ancestor
64835319|NCT01950520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64835320|NCT01950520|Vasodilator Agents|vasodilator agents|mesh-ancestor
64835321|NCT01950520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64835322|NCT01950520|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64835323|NCT01950520|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64835324|NCT01950520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64835325|NCT01950520|Urological Agents|urological agents|mesh-ancestor
64835326|NCT01950520|Appetite Depressants|appetite depressants|mesh-ancestor
64835327|NCT01950520|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64835328|NCT01950520|Sympathomimetics|sympathomimetics|mesh-ancestor
64835329|NCT01950520|Autonomic Agents|autonomic agents|mesh-ancestor
64835330|NCT01950520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65086596|NCT04700475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086597|NCT04700436|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65086598|NCT04700436|Ezetimibe|ezetimibe|mesh-list
65086599|NCT04700436|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65086600|NCT04700436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65086601|NCT04700436|Antimetabolites|antimetabolites|mesh-ancestor
65086602|NCT04700436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086603|NCT04700436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65086604|NCT04700436|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65086605|NCT04700436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086606|NCT00480597|Gemcitabine|gemcitabine|mesh-list
65086607|NCT00480597|Capecitabine|capecitabine|mesh-list
65086608|NCT00480597|Vinorelbine|vinorelbine|mesh-list
65086609|NCT00480597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086610|NCT00480597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65086611|NCT00480597|Antimetabolites|antimetabolites|mesh-ancestor
65086613|NCT00480597|Antiviral Agents|antiviral agents|mesh-ancestor
65086614|NCT00480597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65086615|NCT00480597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086616|NCT00480597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65086617|NCT00480597|Immunologic Factors|immunologic factors|mesh-ancestor
65086618|NCT00480597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086619|NCT00480597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65086620|NCT00480597|Tubulin Modulators|tubulin modulators|mesh-ancestor
65086621|NCT00480597|Antimitotic Agents|antimitotic agents|mesh-ancestor
65086622|NCT00480597|Mitosis Modulators|mitosis modulators|mesh-ancestor
65086623|NCT00456482|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
64835331|NCT01950520|Serotonin Agents|serotonin agents|mesh-ancestor
64835332|NCT01950520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64835333|NCT01950520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64835334|NCT01861314|Bortezomib|bortezomib|mesh-list
64835335|NCT01861314|Sorafenib|sorafenib|mesh-list
64835336|NCT01861314|Decitabine|decitabine|mesh-list
64835337|NCT01861314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835338|NCT01861314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64835339|NCT01861314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835340|NCT01861314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835341|NCT01861314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64835342|NCT01861314|Antimetabolites|antimetabolites|mesh-ancestor
64325530|NCT01303783|Candesartan cilexetil|candesartan cilexetil|mesh-list
64325531|NCT01303783|Nifedipine|nifedipine|mesh-list
64325532|NCT01303783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65086624|NCT00456482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65086625|NCT00456482|Glucocorticoids|glucocorticoids|mesh-ancestor
65086626|NCT00456482|Hormones|hormones|mesh-ancestor
65086627|NCT00456482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65086628|NCT00456482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086629|NCT00480675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65086630|NCT00480675|Methylprednisolone|methylprednisolone|mesh-list
65086631|NCT00480675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65086632|NCT00480675|Prednisolone|prednisolone|mesh-list
65086633|NCT00480675|Prednisolone acetate|prednisolone acetate|mesh-list
65086634|NCT00480675|Bupivacaine|bupivacaine|mesh-list
65086635|NCT00480675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65086636|NCT00480675|Prednisolone phosphate|prednisolone phosphate|mesh-list
65086637|NCT00480675|Anesthetics, Local|anesthetics, local|mesh-ancestor
65086638|NCT00480675|Anesthetics|anesthetics|mesh-ancestor
65086639|NCT00480675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65086640|NCT00480675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086641|NCT00480675|Sensory System Agents|sensory system agents|mesh-ancestor
65086642|NCT00480675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65086643|NCT00480675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65086644|NCT00480675|Antiemetics|antiemetics|mesh-ancestor
65086645|NCT00480675|Autonomic Agents|autonomic agents|mesh-ancestor
65086646|NCT00480675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65086647|NCT00480675|Glucocorticoids|glucocorticoids|mesh-ancestor
65086648|NCT00480675|Hormones|hormones|mesh-ancestor
65086649|NCT00480675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65086650|NCT00480675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65086651|NCT00480675|Protective Agents|protective agents|mesh-ancestor
65086652|NCT00480675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65086653|NCT00480675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086654|NCT00456560|Fluvoxamine|fluvoxamine|mesh-list
65086655|NCT00456560|Paroxetine|paroxetine|mesh-list
65086656|NCT00456560|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65086657|NCT00456560|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65086658|NCT00456560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64728867|NCT00003728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65086659|NCT00456560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086660|NCT00456560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65086661|NCT00456560|Serotonin Agents|serotonin agents|mesh-ancestor
64835362|NCT01746173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64835363|NCT01746173|Antimetabolites|antimetabolites|mesh-ancestor
64835364|NCT01746173|Antiviral Agents|antiviral agents|mesh-ancestor
65086662|NCT00456560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086663|NCT00456560|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65086664|NCT00456560|Antidepressive Agents|antidepressive agents|mesh-ancestor
65086665|NCT00456560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65086666|NCT00456560|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65086667|NCT00456560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65086668|NCT00456560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086669|NCT00456560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65086670|NCT00456560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65086671|NCT00456560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65086672|NCT00456560|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65086673|NCT00456560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65086674|NCT00456677|Minocycline|minocycline|mesh-list
65086675|NCT00456677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65086676|NCT00456677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65086677|NCT00456716|Sorafenib|sorafenib|mesh-list
65086678|NCT00456716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086679|NCT00456716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65086680|NCT00456716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086681|NCT00456716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086682|NCT04700397|Nitroglycerin|nitroglycerin|mesh-list
65086683|NCT04700397|Vasodilator Agents|vasodilator agents|mesh-ancestor
65086684|NCT00456794|Istradefylline|istradefylline|mesh-list
65086685|NCT00456794|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
65086686|NCT00456794|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65086687|NCT00456794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65086688|NCT00456794|Purinergic Agents|purinergic agents|mesh-ancestor
65086689|NCT00456794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65086690|NCT00456794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086691|NCT00456794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086692|NCT00456833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65086693|NCT00456833|Everolimus|everolimus|mesh-list
65086694|NCT00456833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086695|NCT00456833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65086696|NCT00456833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086697|NCT00456833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086698|NCT00456833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65086699|NCT00456833|Immunologic Factors|immunologic factors|mesh-ancestor
65086700|NCT00456833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086701|NCT00456872|Lidocaine|lidocaine|mesh-list
65086702|NCT00456872|Anesthetics, Local|anesthetics, local|mesh-ancestor
65086703|NCT00456872|Anesthetics|anesthetics|mesh-ancestor
65086704|NCT00456872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65086705|NCT00456872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086706|NCT00456872|Sensory System Agents|sensory system agents|mesh-ancestor
65086707|NCT00456872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65086708|NCT00456872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65086709|NCT00456872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65086710|NCT00456872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65086711|NCT00456872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65086712|NCT00456872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086713|NCT00480753|Nitroglycerin|nitroglycerin|mesh-list
65086714|NCT00480753|Vasodilator Agents|vasodilator agents|mesh-ancestor
65086715|NCT04700046|Mexiletine|mexiletine|mesh-list
64835365|NCT01746173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65086716|NCT04700046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65086717|NCT04700046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65086718|NCT04700046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65086719|NCT04700046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65086720|NCT04700046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086721|NCT00457067|Ranibizumab|ranibizumab|mesh-list
65086722|NCT00457067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65086723|NCT00457067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65086724|NCT00457067|Growth Substances|growth substances|mesh-ancestor
65086725|NCT00457067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086726|NCT00457067|Growth Inhibitors|growth inhibitors|mesh-ancestor
65086727|NCT00457067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086728|NCT00480870|Donepezil|donepezil|mesh-list
65086729|NCT00480870|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64728938|NCT00004256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086730|NCT00480870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086731|NCT00480870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086732|NCT00480870|Cholinergic Agents|cholinergic agents|mesh-ancestor
65086733|NCT00480870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65086734|NCT00480870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086735|NCT00480870|Nootropic Agents|nootropic agents|mesh-ancestor
65086736|NCT00457106|Risperidone|risperidone|mesh-list
65086737|NCT00457106|Paroxetine|paroxetine|mesh-list
65086738|NCT00457106|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65086739|NCT00457106|Serotonin Agents|serotonin agents|mesh-ancestor
65086740|NCT00457106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65086741|NCT00457106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086742|NCT00457106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086743|NCT00457106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65086744|NCT00457106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65086745|NCT00457106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65086746|NCT00457106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65086747|NCT00457106|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65086748|NCT00457106|Dopamine Agents|dopamine agents|mesh-ancestor
65086749|NCT00457106|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65086750|NCT00457106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65086751|NCT00457106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65086752|NCT00457106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65086753|NCT00457106|Antidepressive Agents|antidepressive agents|mesh-ancestor
65086754|NCT00457106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65086755|NCT00457106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65086756|NCT00457106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086758|NCT00457145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65086759|NCT00457145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65086760|NCT00457145|Growth Substances|growth substances|mesh-ancestor
65086761|NCT00457145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086762|NCT00457145|Growth Inhibitors|growth inhibitors|mesh-ancestor
65086763|NCT00457145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086764|NCT00457223|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
65086765|NCT00457223|Hemostatics|hemostatics|mesh-ancestor
65086766|NCT00457223|Coagulants|coagulants|mesh-ancestor
64835384|NCT01694004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64835385|NCT01694004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835386|NCT01694004|Sensory System Agents|sensory system agents|mesh-ancestor
64446487|NCT02153918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64325535|NCT01303783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325536|NCT01303783|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64325537|NCT01303783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64325538|NCT01303783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64325539|NCT01303783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587109|NCT02111447|Anesthetics|anesthetics|mesh-ancestor
65086767|NCT00443508|Everolimus|everolimus|mesh-list
65086768|NCT00443508|Tacrolimus|tacrolimus|mesh-list
65086769|NCT00443508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65086770|NCT00443508|Immunologic Factors|immunologic factors|mesh-ancestor
65086771|NCT00443508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086772|NCT00443508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65086773|NCT00443508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086774|NCT00443508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086775|NCT00443508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086776|NCT00457340|Atorvastatin|atorvastatin|mesh-list
65086777|NCT00457340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65086778|NCT00457340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65086779|NCT00457340|Antimetabolites|antimetabolites|mesh-ancestor
65086780|NCT00457340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086781|NCT00457340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65086782|NCT00457340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65086783|NCT00457340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086784|NCT03278379|Avelumab|avelumab|mesh-list
65086785|NCT03278379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65086786|NCT03278379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086787|NCT02956538|Thalidomide|thalidomide|mesh-list
65086788|NCT02956538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65086789|NCT02956538|Immunologic Factors|immunologic factors|mesh-ancestor
65086790|NCT02956538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086791|NCT02956538|Leprostatic Agents|leprostatic agents|mesh-ancestor
65086792|NCT02956538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65086793|NCT02956538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65086794|NCT02956538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65086795|NCT02956538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65086796|NCT02956538|Growth Substances|growth substances|mesh-ancestor
65086797|NCT02956538|Growth Inhibitors|growth inhibitors|mesh-ancestor
65086798|NCT02956538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086799|NCT00457652|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65086800|NCT00457652|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65086801|NCT00457652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65086802|NCT00457652|Antimetabolites|antimetabolites|mesh-ancestor
64729036|NCT00004922|Irinotecan|irinotecan|mesh-list
64483300|NCT01276756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086803|NCT00457652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086804|NCT00457652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65086805|NCT00457652|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65086806|NCT00457652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086807|NCT00457769|Donepezil|donepezil|mesh-list
65086808|NCT00457769|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65086809|NCT00457769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086810|NCT00457769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086811|NCT00457769|Cholinergic Agents|cholinergic agents|mesh-ancestor
65086812|NCT00457769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65086813|NCT00457769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835387|NCT01694004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64835389|NCT01545843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64835390|NCT01545843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64835391|NCT01545843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64835392|NCT01545843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835393|NCT01545843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64835394|NCT01545843|Serotonin Agents|serotonin agents|mesh-ancestor
64835395|NCT01545843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835396|NCT01545843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64835397|NCT01545843|Antidepressive Agents|antidepressive agents|mesh-ancestor
65086814|NCT00457769|Nootropic Agents|nootropic agents|mesh-ancestor
65086815|NCT00457808|Sirolimus|sirolimus|mesh-list
65086816|NCT00457808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65086817|NCT00457808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65086818|NCT00457808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65086819|NCT00457808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086820|NCT00457808|Antifungal Agents|antifungal agents|mesh-ancestor
65086821|NCT00457808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65086823|NCT00457808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086824|NCT00481143|Deferasirox|deferasirox|mesh-list
65086825|NCT00481143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65086826|NCT00481143|Chelating Agents|chelating agents|mesh-ancestor
65086827|NCT00481143|Sequestering Agents|sequestering agents|mesh-ancestor
65086828|NCT00481143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086829|NCT00457964|Everolimus|everolimus|mesh-list
65086830|NCT00457964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086831|NCT00457964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65086832|NCT00457964|Immunologic Factors|immunologic factors|mesh-ancestor
65086833|NCT00457964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086834|NCT00458042|Treprostinil|treprostinil|mesh-list
65086835|NCT00458042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65086836|NCT00458081|Rimonabant|rimonabant|mesh-list
65086837|NCT00458081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65086838|NCT00458081|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65086839|NCT00458081|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65086840|NCT00458081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65086841|NCT00458081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086842|NCT00458081|Hormones|hormones|mesh-ancestor
65086843|NCT00458081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65086844|NCT00458081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086845|NCT00481182|Ritonavir|ritonavir|mesh-list
65086846|NCT00481182|Fosamprenavir|fosamprenavir|mesh-list
65086847|NCT00481182|Methadone|methadone|mesh-list
65086848|NCT00481182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65086849|NCT00481182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65086850|NCT00481182|Protease Inhibitors|protease inhibitors|mesh-ancestor
65086851|NCT00481182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086852|NCT00481182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086853|NCT00481182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65086854|NCT00481182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65086855|NCT00481182|Antiviral Agents|antiviral agents|mesh-ancestor
65086856|NCT00481182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65086857|NCT00481182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65086858|NCT00481182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65086859|NCT00481182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65086860|NCT00481182|Narcotics|narcotics|mesh-ancestor
65086861|NCT00481182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65086862|NCT00481182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086863|NCT00481182|Analgesics|analgesics|mesh-ancestor
65086864|NCT00481182|Sensory System Agents|sensory system agents|mesh-ancestor
65086865|NCT00481182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65086866|NCT00481182|Antitussive Agents|antitussive agents|mesh-ancestor
65086867|NCT00481182|Respiratory System Agents|respiratory system agents|mesh-ancestor
65086868|NCT00443937|Mycophenolic Acid|mycophenolic acid|mesh-list
65086869|NCT00443937|Everolimus|everolimus|mesh-list
65086870|NCT00443937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086871|NCT00443937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65086872|NCT00443937|Immunologic Factors|immunologic factors|mesh-ancestor
65086873|NCT00443937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086874|NCT00443937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64483308|NCT00246376|Niacin|niacin|mesh-list
65086875|NCT00443937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65086876|NCT00443937|Antitubercular Agents|antitubercular agents|mesh-ancestor
65086877|NCT00443937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65086878|NCT00443937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65086879|NCT00443937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086880|NCT00443937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086883|NCT00458315|Bevacizumab|bevacizumab|mesh-list
65086884|NCT00458315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65086885|NCT00458315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086886|NCT00458315|Tubulin Modulators|tubulin modulators|mesh-ancestor
65086887|NCT00458315|Antimitotic Agents|antimitotic agents|mesh-ancestor
65086888|NCT00458315|Mitosis Modulators|mitosis modulators|mesh-ancestor
65086889|NCT00458315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086890|NCT00458315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65086891|NCT00458315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65086892|NCT00458315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65086893|NCT00458315|Growth Substances|growth substances|mesh-ancestor
65086894|NCT00458315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086895|NCT00458315|Growth Inhibitors|growth inhibitors|mesh-ancestor
65086896|NCT00458315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65086897|NCT00458315|Antimetabolites|antimetabolites|mesh-ancestor
65086898|NCT00458315|Antiviral Agents|antiviral agents|mesh-ancestor
65086899|NCT00458315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65086900|NCT00458315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086901|NCT00458315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65086902|NCT00458315|Immunologic Factors|immunologic factors|mesh-ancestor
65086903|NCT00444015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65086904|NCT00444015|Dasatinib|dasatinib|mesh-list
65086905|NCT00444015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086906|NCT00444015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65086907|NCT00444015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086908|NCT00444015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086909|NCT00458510|Fentanyl|fentanyl|mesh-list
65086910|NCT00458510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65086911|NCT00458510|Narcotics|narcotics|mesh-ancestor
65086912|NCT00458510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65086913|NCT00458510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086914|NCT00458510|Analgesics|analgesics|mesh-ancestor
65086915|NCT00458510|Sensory System Agents|sensory system agents|mesh-ancestor
65086916|NCT00458510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65086917|NCT00458510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65086918|NCT00458510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65086919|NCT00458510|Anesthetics, General|anesthetics, general|mesh-ancestor
65086920|NCT00458510|Anesthetics|anesthetics|mesh-ancestor
65086921|NCT00444093|Antidiarrheals|antidiarrheals|mesh-list
65086922|NCT00444093|Loperamide|loperamide|mesh-list
64325540|NCT01303783|Vasodilator Agents|vasodilator agents|mesh-ancestor
64325541|NCT01303783|Tocolytic Agents|tocolytic agents|mesh-ancestor
64325542|NCT01303783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64325544|NCT02160587|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64325545|NCT02160587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64325546|NCT02160587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64325547|NCT02160587|Disinfectants|disinfectants|mesh-ancestor
64325548|NCT02160587|Dermatologic Agents|dermatologic agents|mesh-ancestor
64325549|NCT05476094|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
64325550|NCT05476094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65086923|NCT00444093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65086924|NCT00444132|Clopidogrel|clopidogrel|mesh-list
65086925|NCT00444132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65086926|NCT00444132|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65086927|NCT00444132|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65086928|NCT00444132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65086929|NCT00444132|Purinergic Agents|purinergic agents|mesh-ancestor
65086930|NCT00444132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65086931|NCT00444132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086932|NCT00444132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086933|NCT00444171|Insulin|insulin|mesh-list
65086934|NCT00444171|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65086935|NCT00444171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65086936|NCT00444171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086937|NCT00458900|Moxifloxacin|moxifloxacin|mesh-list
65086938|NCT00458900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65086939|NCT00458900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65086940|NCT00458900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65086941|NCT00458900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65086942|NCT00458900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65086943|NCT00458900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086944|NCT00458900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086945|NCT00488163|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65086946|NCT00488163|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65086947|NCT00488163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65086948|NCT00488163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65086949|NCT00488163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086951|NCT00488163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64729165|NCT00004346|Cathartics|cathartics|mesh-ancestor
65086952|NCT00488163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086953|NCT00459173|Rimonabant|rimonabant|mesh-list
65086954|NCT00459173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65086955|NCT00459173|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65086956|NCT00459173|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65086957|NCT00459173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65086958|NCT00459173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086959|NCT00459173|Hormones|hormones|mesh-ancestor
65086960|NCT00459173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65086961|NCT00459173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086962|NCT00444249|Dipivefrin|dipivefrin|mesh-list
65086963|NCT00444249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65086964|NCT00444249|Adrenergic Agents|adrenergic agents|mesh-ancestor
65086965|NCT00444249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65086966|NCT00444249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086967|NCT00444249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086968|NCT00459407|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65086969|NCT00459407|Antioxidants|antioxidants|mesh-ancestor
65086970|NCT00459407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086971|NCT00459407|Protective Agents|protective agents|mesh-ancestor
65086972|NCT00459407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086973|NCT00459407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64835400|NCT01545843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65086974|NCT00459407|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65086975|NCT00459407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086976|NCT00459407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65086977|NCT03278262|Aflibercept|aflibercept|mesh-list
65086978|NCT03278262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65086979|NCT03278262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65086980|NCT03278262|Growth Substances|growth substances|mesh-ancestor
65086981|NCT03278262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086982|NCT03278262|Growth Inhibitors|growth inhibitors|mesh-ancestor
65086983|NCT03278262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65086984|NCT00459485|Zinc Sulfate|zinc sulfate|mesh-list
65086985|NCT00459485|Astringents|astringents|mesh-ancestor
65086986|NCT00459485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086987|NCT00459485|Dermatologic Agents|dermatologic agents|mesh-ancestor
65086988|NCT00459563|Vitamin D|vitamin d|mesh-list
65086989|NCT00459563|Calcitriol|calcitriol|mesh-list
65086990|NCT00459563|Vitamins|vitamins|mesh-ancestor
65086991|NCT00459563|Micronutrients|micronutrients|mesh-ancestor
65086992|NCT00459563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65086993|NCT00459563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65086994|NCT00459563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65086995|NCT00459563|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
65086996|NCT00459563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65086997|NCT00459563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65086998|NCT00459563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65086999|NCT01242384|Silicon|silicon|mesh-list
65087000|NCT01242384|Trace Elements|trace elements|mesh-ancestor
65087001|NCT01242384|Micronutrients|micronutrients|mesh-ancestor
65087002|NCT01242384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087003|NCT00488436|Cyclosporine|cyclosporine|mesh-list
65087004|NCT00488436|Cyclosporins|cyclosporins|mesh-list
65087005|NCT00488436|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65087006|NCT00488436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087007|NCT00488436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087008|NCT00488436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65087009|NCT00488436|Immunologic Factors|immunologic factors|mesh-ancestor
65087010|NCT00488436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087011|NCT00488436|Antifungal Agents|antifungal agents|mesh-ancestor
65087012|NCT00488436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087013|NCT00488436|Dermatologic Agents|dermatologic agents|mesh-ancestor
65087014|NCT00488436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65087015|NCT00488436|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65087016|NCT00459719|Tacrolimus|tacrolimus|mesh-list
65087017|NCT00459719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65087018|NCT00459719|Immunologic Factors|immunologic factors|mesh-ancestor
65087019|NCT00459719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087020|NCT00459719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65087021|NCT00459719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087022|NCT00459719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087024|NCT00495183|Caffeine|caffeine|mesh-list
64835420|NCT03187769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65087025|NCT00495183|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65087026|NCT00495183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087027|NCT00495183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65087028|NCT00495183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087029|NCT00495183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087030|NCT00495183|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65087031|NCT00495183|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65087032|NCT00495183|Purinergic Agents|purinergic agents|mesh-ancestor
65087033|NCT00495183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65087034|NCT00495183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65087035|NCT00495183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65087036|NCT00495183|Parasympatholytics|parasympatholytics|mesh-ancestor
65087037|NCT00495183|Autonomic Agents|autonomic agents|mesh-ancestor
65087038|NCT00495183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65087039|NCT00495183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65087040|NCT00495183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65087041|NCT00495183|Cholinergic Agents|cholinergic agents|mesh-ancestor
65087042|NCT00488670|Citalopram|citalopram|mesh-list
65087043|NCT00488670|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65087044|NCT00488670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65087045|NCT00488670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65087046|NCT00488670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087047|NCT00488670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65087048|NCT00488670|Serotonin Agents|serotonin agents|mesh-ancestor
65087049|NCT00488670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087050|NCT00488670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65087051|NCT00488670|Antidepressive Agents|antidepressive agents|mesh-ancestor
65087052|NCT00488670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65087053|NCT00459836|Gemcitabine|gemcitabine|mesh-list
65087054|NCT00459836|Docetaxel|docetaxel|mesh-list
65087055|NCT00459836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65087056|NCT00459836|Antimetabolites|antimetabolites|mesh-ancestor
65087057|NCT00459836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087058|NCT00459836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087059|NCT00459836|Antiviral Agents|antiviral agents|mesh-ancestor
65087060|NCT00459836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087061|NCT00459836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087062|NCT00459836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65087063|NCT00459836|Immunologic Factors|immunologic factors|mesh-ancestor
65087064|NCT00459836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087065|NCT00459836|Tubulin Modulators|tubulin modulators|mesh-ancestor
65087066|NCT00459836|Antimitotic Agents|antimitotic agents|mesh-ancestor
65087067|NCT00459836|Mitosis Modulators|mitosis modulators|mesh-ancestor
65087068|NCT00488709|Cytarabine|cytarabine|mesh-list
65087069|NCT00488709|Fludarabine|fludarabine|mesh-list
65087070|NCT00488709|Topotecan|topotecan|mesh-list
65087071|NCT00488709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087072|NCT00488709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65087073|NCT00488709|Antimetabolites|antimetabolites|mesh-ancestor
64835461|NCT02939573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835462|NCT02939573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835463|NCT02939573|Antimetabolites|antimetabolites|mesh-ancestor
64835464|NCT02939573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64835465|NCT02939573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64446574|NCT01554514|Rituximab|rituximab|mesh-list
65087074|NCT00488709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087075|NCT00488709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65087076|NCT00488709|Immunologic Factors|immunologic factors|mesh-ancestor
65087077|NCT00488709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087078|NCT00488709|Antiviral Agents|antiviral agents|mesh-ancestor
65087079|NCT00488709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087080|NCT00488709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65087081|NCT00488709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65087082|NCT00488709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087083|NCT00459992|Betahistine|betahistine|mesh-list
65087084|NCT00459992|Vasodilator Agents|vasodilator agents|mesh-ancestor
65087085|NCT00459992|Histamine Agonists|histamine agonists|mesh-ancestor
65087086|NCT00459992|Histamine Agents|histamine agents|mesh-ancestor
65087087|NCT00459992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65087088|NCT00459992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087089|NCT00459992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087090|NCT00495339|Levofloxacin|levofloxacin|mesh-list
65087091|NCT00495339|Ofloxacin|ofloxacin|mesh-list
65087092|NCT00495339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65087093|NCT00495339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087094|NCT00495339|Renal Agents|renal agents|mesh-ancestor
65087095|NCT00495339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65087096|NCT00495339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65087097|NCT00495339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65087098|NCT00495339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087099|NCT00495339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087100|NCT00495339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64729322|NCT00004406|Hormones|hormones|mesh-list
65087101|NCT00495339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65087102|NCT00495339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65087103|NCT00460148|Ropinirole|ropinirole|mesh-list
65087104|NCT00460148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65087105|NCT00460148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65087106|NCT00460148|Dopamine Agonists|dopamine agonists|mesh-ancestor
65087107|NCT00460148|Dopamine Agents|dopamine agents|mesh-ancestor
65087108|NCT00460148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65087109|NCT00460148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087110|NCT00460148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087111|NCT00460226|Lamotrigine|lamotrigine|mesh-list
65087112|NCT00460226|Anticonvulsants|anticonvulsants|mesh-ancestor
65087113|NCT00460226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65087114|NCT00460226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65087115|NCT00460226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087116|NCT00460226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65087117|NCT00460226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087118|NCT00460226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65087119|NCT00460226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65087120|NCT00460226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65087121|NCT00460226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65087122|NCT00460226|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65087123|NCT00495378|Epoetin Alfa|epoetin alfa|mesh-list
65087124|NCT00495378|Hematinics|hematinics|mesh-ancestor
65087125|NCT00460304|Pramlintide|pramlintide|mesh-list
65087126|NCT00460304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65087127|NCT00460304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087128|NCT00460382|Ritonavir|ritonavir|mesh-list
65087129|NCT00460382|Darunavir|darunavir|mesh-list
65087130|NCT00460382|Raltegravir Potassium|raltegravir potassium|mesh-list
65087131|NCT00460382|Enfuvirtide|enfuvirtide|mesh-list
65087132|NCT00460382|Etravirine|etravirine|mesh-list
65087133|NCT00460382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
65087134|NCT00460382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
65087135|NCT00460382|Protease Inhibitors|protease inhibitors|mesh-ancestor
65087136|NCT00460382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087137|NCT00460382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087138|NCT00460382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65087139|NCT00460382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64587474|NCT04245865|Leucovorin|leucovorin|mesh-list
65087140|NCT00460382|Antiviral Agents|antiviral agents|mesh-ancestor
65087141|NCT00460382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087142|NCT00460382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65087143|NCT00460382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65087144|NCT00460382|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65087145|NCT00460382|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65087146|NCT00460382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65087147|NCT00460382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65087148|NCT00460382|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65087149|NCT00460382|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65087150|NCT01242579|Maraviroc|maraviroc|mesh-list
65087151|NCT01242579|Dapivirine|dapivirine|mesh-list
65087152|NCT01242579|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
65087153|NCT01242579|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
65087154|NCT01242579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087155|NCT01242579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65087156|NCT01242579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65087157|NCT01242579|Antiviral Agents|antiviral agents|mesh-ancestor
65087158|NCT01242579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087159|NCT01242579|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
65087160|NCT00460499|Insulin|insulin|mesh-list
65087161|NCT00460499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65087162|NCT00460499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087163|NCT00495573|Acyclovir|acyclovir|mesh-list
65087164|NCT00495573|Antiviral Agents|antiviral agents|mesh-ancestor
65087165|NCT00495573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087166|NCT00488787|Ketamine|ketamine|mesh-list
65087167|NCT00488787|Analgesics|analgesics|mesh-ancestor
65087168|NCT00488787|Sensory System Agents|sensory system agents|mesh-ancestor
65087169|NCT00488787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65087170|NCT00488787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087171|NCT00488787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65087172|NCT00488787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65087173|NCT00488787|Anesthetics, General|anesthetics, general|mesh-ancestor
65087174|NCT00488787|Anesthetics|anesthetics|mesh-ancestor
65087175|NCT00488787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65087176|NCT00488787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65087177|NCT00488787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65087178|NCT00488787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65087179|NCT00488787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087180|NCT00460616|Cabergoline|cabergoline|mesh-list
65087181|NCT00460616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65087182|NCT00460616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65087183|NCT00460616|Dopamine Agonists|dopamine agonists|mesh-ancestor
65087184|NCT00460616|Dopamine Agents|dopamine agents|mesh-ancestor
65087185|NCT00460616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65087186|NCT00460616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087187|NCT00460616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087189|NCT00495651|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
65087190|NCT00495651|Antitubercular Agents|antitubercular agents|mesh-ancestor
65087191|NCT00495651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65087192|NCT00495651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087193|NCT00495651|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65087194|NCT00495651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65087195|NCT00495651|Antimetabolites|antimetabolites|mesh-ancestor
64835466|NCT02939573|Immunologic Factors|immunologic factors|mesh-ancestor
64835467|NCT02939573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087196|NCT00495651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087197|NCT00495651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65087198|NCT00495651|Antiviral Agents|antiviral agents|mesh-ancestor
65087199|NCT00460733|Vitamin D|vitamin d|mesh-list
65087200|NCT00460733|Cholecalciferol|cholecalciferol|mesh-list
65087201|NCT00460733|Risedronic Acid|risedronic acid|mesh-list
65087202|NCT00460733|Calcium|calcium|mesh-list
65087203|NCT00460733|Vitamins|vitamins|mesh-ancestor
65087204|NCT00460733|Micronutrients|micronutrients|mesh-ancestor
65087205|NCT00460733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087206|NCT00460733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65087207|NCT00460733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65087208|NCT00460733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65087209|NCT00460733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65087210|NCT00460733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087211|NCT00460850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65087212|NCT00460850|Antiviral Agents|antiviral agents|mesh-ancestor
65087213|NCT00460850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087214|NCT00495729|Simvastatin|simvastatin|mesh-list
65087215|NCT00495729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65087216|NCT00495729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65087217|NCT00495729|Antimetabolites|antimetabolites|mesh-ancestor
65087218|NCT00495729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087219|NCT00495729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65087220|NCT00495729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65087221|NCT00495729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087222|NCT00460928|Immunoglobulins|immunoglobulins|mesh-list
65087223|NCT00460928|Antibodies|antibodies|mesh-list
65087224|NCT00460928|gamma-Globulins|gamma-globulins|mesh-list
65087225|NCT00460928|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65087226|NCT00460928|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65087227|NCT00460928|Immunologic Factors|immunologic factors|mesh-ancestor
65087228|NCT00460928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087229|NCT00461084|Clarithromycin|clarithromycin|mesh-list
65087230|NCT00461084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65087231|NCT00461084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087232|NCT00461084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65087233|NCT00461084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087234|NCT00461084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087235|NCT00461084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65087236|NCT00461084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65087238|NCT00495846|Lanreotide|lanreotide|mesh-list
65087239|NCT00495846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65087240|NCT00495846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65087241|NCT00495846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087242|NCT00105482|Naltrexone|naltrexone|mesh-list
65087243|NCT00105482|Nicotine|nicotine|mesh-list
65087244|NCT00105482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65087245|NCT00105482|Autonomic Agents|autonomic agents|mesh-ancestor
65087246|NCT00105482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65087247|NCT00105482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087248|NCT00105482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64729467|NCT00005048|Estramustine|estramustine|mesh-list
65087249|NCT00105482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65087250|NCT00105482|Cholinergic Agents|cholinergic agents|mesh-ancestor
65087251|NCT00105482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65087252|NCT00105482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087253|NCT00105482|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65087254|NCT00105482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65087255|NCT00105482|Sensory System Agents|sensory system agents|mesh-ancestor
65087256|NCT00496002|Adefovir|adefovir|mesh-list
65087257|NCT00496002|Clevudine|clevudine|mesh-list
65087258|NCT00496002|Antiviral Agents|antiviral agents|mesh-ancestor
65087259|NCT00496002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087260|NCT00496002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65087261|NCT00496002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65087262|NCT00496002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087263|NCT00496002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087264|NCT00489099|Vaccines|vaccines|mesh-list
64587600|NCT05368376|Metoprolol|metoprolol|mesh-list
65087265|NCT00489099|Immunologic Factors|immunologic factors|mesh-ancestor
65087266|NCT00489099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087267|NCT00496158|Adefovir|adefovir|mesh-list
65087268|NCT00496158|Clevudine|clevudine|mesh-list
65087269|NCT00496158|Antiviral Agents|antiviral agents|mesh-ancestor
65087270|NCT00496158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087271|NCT00496158|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65087272|NCT00496158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65087273|NCT00496158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087274|NCT00496158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087275|NCT00489138|Ertapenem|ertapenem|mesh-list
65087276|NCT00489138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65087277|NCT00489138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087278|NCT00461396|Interferons|interferons|mesh-list
65087279|NCT00461396|Interferon beta-1b|interferon beta-1b|mesh-list
65087280|NCT00461396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087281|NCT00461396|Antiviral Agents|antiviral agents|mesh-ancestor
65087282|NCT00461396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087283|NCT00461396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65087284|NCT00461396|Immunologic Factors|immunologic factors|mesh-ancestor
65087285|NCT00461396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087286|NCT01327651|Tenofovir|tenofovir|mesh-list
65087287|NCT01327651|Emtricitabine|emtricitabine|mesh-list
65087288|NCT01327651|Antiviral Agents|antiviral agents|mesh-ancestor
65087289|NCT01327651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087290|NCT01327651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65087291|NCT01327651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65087292|NCT01327651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087293|NCT01327651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087294|NCT01327651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65087295|NCT01327651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65087296|NCT00496275|Gemcitabine|gemcitabine|mesh-list
65087297|NCT00496275|Cisplatin|cisplatin|mesh-list
65087298|NCT00496275|Vinorelbine|vinorelbine|mesh-list
65087299|NCT00496275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087300|NCT00496275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65087301|NCT00496275|Antimetabolites|antimetabolites|mesh-ancestor
65087302|NCT00496275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087303|NCT00496275|Antiviral Agents|antiviral agents|mesh-ancestor
65087304|NCT00496275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087305|NCT00496275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087306|NCT00496275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65087307|NCT00496275|Immunologic Factors|immunologic factors|mesh-ancestor
65087308|NCT00496275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087309|NCT00496275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65087310|NCT00496275|Tubulin Modulators|tubulin modulators|mesh-ancestor
65087311|NCT00496275|Antimitotic Agents|antimitotic agents|mesh-ancestor
65087312|NCT00496275|Mitosis Modulators|mitosis modulators|mesh-ancestor
65087314|NCT00591604|Vitamins|vitamins|mesh-ancestor
65087315|NCT00591604|Micronutrients|micronutrients|mesh-ancestor
65087316|NCT00591604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087317|NCT00591604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65087318|NCT00591643|Epinephrine|epinephrine|mesh-list
65087319|NCT00591643|Racepinephrine|racepinephrine|mesh-list
65087320|NCT00591643|Epinephryl borate|epinephryl borate|mesh-list
65087321|NCT00591643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65087322|NCT00591643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65087323|NCT00591643|Adrenergic Agents|adrenergic agents|mesh-ancestor
65087324|NCT00591643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65087325|NCT00591643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64729541|NCT00004496|Hormones|hormones|mesh-list
65087326|NCT00591643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087327|NCT00591643|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65087328|NCT00591643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65087329|NCT00591643|Autonomic Agents|autonomic agents|mesh-ancestor
65087330|NCT00591643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64325551|NCT05476094|Antimetabolites|antimetabolites|mesh-ancestor
64325552|NCT05476094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325553|NCT05476094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64325554|NCT02153879|Niacin|niacin|mesh-list
64325555|NCT02153879|Fenofibrate|fenofibrate|mesh-list
65087331|NCT00591643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65087332|NCT00591643|Respiratory System Agents|respiratory system agents|mesh-ancestor
65087333|NCT00591643|Mydriatics|mydriatics|mesh-ancestor
65087334|NCT00591643|Sympathomimetics|sympathomimetics|mesh-ancestor
65087335|NCT00591643|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65087336|NCT00461747|Thalidomide|thalidomide|mesh-list
65087337|NCT00461747|Dexamethasone|dexamethasone|mesh-list
65087338|NCT00461747|Dexamethasone acetate|dexamethasone acetate|mesh-list
65087339|NCT00461747|Bortezomib|bortezomib|mesh-list
65087340|NCT00461747|BB 1101|bb 1101|mesh-list
65087341|NCT00461747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65087342|NCT00461747|Antiemetics|antiemetics|mesh-ancestor
65087343|NCT00461747|Autonomic Agents|autonomic agents|mesh-ancestor
65087344|NCT00461747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65087345|NCT00461747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087346|NCT00461747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65087347|NCT00461747|Glucocorticoids|glucocorticoids|mesh-ancestor
65087348|NCT00461747|Hormones|hormones|mesh-ancestor
65087349|NCT00461747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65087350|NCT00461747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65087351|NCT00461747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087352|NCT00461747|Protease Inhibitors|protease inhibitors|mesh-ancestor
65087353|NCT00461747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087354|NCT00461747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087355|NCT00461747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65087356|NCT00461747|Immunologic Factors|immunologic factors|mesh-ancestor
65087357|NCT00461747|Leprostatic Agents|leprostatic agents|mesh-ancestor
65087358|NCT00461747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65087359|NCT00461747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087360|NCT00461747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65087361|NCT00461747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65087362|NCT00461747|Growth Substances|growth substances|mesh-ancestor
65087363|NCT00461747|Growth Inhibitors|growth inhibitors|mesh-ancestor
65087364|NCT00461825|Cyclosporine|cyclosporine|mesh-list
65087365|NCT00461825|Mycophenolic Acid|mycophenolic acid|mesh-list
65087366|NCT00461825|Azathioprine|azathioprine|mesh-list
65087367|NCT00461825|Cyclosporins|cyclosporins|mesh-list
65087368|NCT00461825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087369|NCT00461825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087370|NCT00461825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65087371|NCT00461825|Immunologic Factors|immunologic factors|mesh-ancestor
65087372|NCT00461825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087373|NCT00461825|Antifungal Agents|antifungal agents|mesh-ancestor
65087374|NCT00461825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087375|NCT00461825|Dermatologic Agents|dermatologic agents|mesh-ancestor
65087376|NCT00461825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65087377|NCT00461825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65087378|NCT00461825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65087379|NCT00461825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087380|NCT00461825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65087381|NCT00461825|Antitubercular Agents|antitubercular agents|mesh-ancestor
65087382|NCT00461825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65087383|NCT00461825|Antimetabolites|antimetabolites|mesh-ancestor
65087384|NCT00461825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65087385|NCT04433026|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65087386|NCT04433026|Natriuretic Agents|natriuretic agents|mesh-ancestor
65087387|NCT04433026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087388|NCT00489372|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
65087389|NCT00489372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65087390|NCT00489372|Protective Agents|protective agents|mesh-ancestor
65087391|NCT00489372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087392|NCT00489372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087393|NCT00461903|Perindopril|perindopril|mesh-list
65087394|NCT00461903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65087395|NCT00461903|Protease Inhibitors|protease inhibitors|mesh-ancestor
65087396|NCT00461903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087397|NCT00461903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087398|NCT00461903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65087399|NCT00496392|Fentanyl|fentanyl|mesh-list
65087400|NCT00496392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65087401|NCT00496392|Narcotics|narcotics|mesh-ancestor
65087402|NCT00496392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65087403|NCT00496392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087404|NCT00496392|Analgesics|analgesics|mesh-ancestor
65087405|NCT00496392|Sensory System Agents|sensory system agents|mesh-ancestor
65087406|NCT00496392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65087407|NCT00496392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65087408|NCT00496392|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65087409|NCT00496392|Anesthetics, General|anesthetics, general|mesh-ancestor
65087410|NCT00496392|Anesthetics|anesthetics|mesh-ancestor
65087411|NCT02893618|Diazoxide|diazoxide|mesh-list
65087412|NCT02893618|Choline|choline|mesh-list
65087413|NCT02893618|Lipotropic Agents|lipotropic agents|mesh-ancestor
65087414|NCT02893618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65087415|NCT02893618|Antimetabolites|antimetabolites|mesh-ancestor
65087416|NCT02893618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087417|NCT02893618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65087418|NCT02893618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65087419|NCT02893618|Nootropic Agents|nootropic agents|mesh-ancestor
65087420|NCT02893618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65087421|NCT02893618|Vasodilator Agents|vasodilator agents|mesh-ancestor
65087422|NCT00496665|Cyclophosphamide|cyclophosphamide|mesh-list
65087423|NCT00496665|Methotrexate|methotrexate|mesh-list
65087424|NCT00496665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65087425|NCT00496665|Immunologic Factors|immunologic factors|mesh-ancestor
65087426|NCT00496665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087427|NCT00496665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65087428|NCT00496665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65087429|NCT00496665|Alkylating Agents|alkylating agents|mesh-ancestor
65087430|NCT00496665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087431|NCT00496665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087432|NCT00496665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65087433|NCT00496665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65087434|NCT00496665|Abortifacient Agents|abortifacient agents|mesh-ancestor
65087435|NCT00496665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65087436|NCT00496665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65087437|NCT00496665|Antimetabolites|antimetabolites|mesh-ancestor
65087438|NCT00496665|Dermatologic Agents|dermatologic agents|mesh-ancestor
65087439|NCT00496665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087440|NCT00496665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65087441|NCT00496665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65087442|NCT00496704|Gemcitabine|gemcitabine|mesh-list
65087443|NCT00496704|Capecitabine|capecitabine|mesh-list
65087444|NCT00496704|Oxaliplatin|oxaliplatin|mesh-list
65087445|NCT00496704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65087446|NCT00496704|Antimetabolites|antimetabolites|mesh-ancestor
65087447|NCT00496704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087448|NCT00496704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087449|NCT00496704|Antiviral Agents|antiviral agents|mesh-ancestor
65087450|NCT00496704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087451|NCT00496704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087452|NCT00496704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65087453|NCT00496704|Immunologic Factors|immunologic factors|mesh-ancestor
65087454|NCT00496704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087455|NCT00591916|Thrombin|thrombin|mesh-list
65087456|NCT00591916|Hyaluronic Acid|hyaluronic acid|mesh-list
65087457|NCT00591916|Hemostatics|hemostatics|mesh-ancestor
65087458|NCT00591916|Coagulants|coagulants|mesh-ancestor
65087459|NCT00591916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65087460|NCT00591916|Immunologic Factors|immunologic factors|mesh-ancestor
65087461|NCT00591916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087462|NCT00591916|Viscosupplements|viscosupplements|mesh-ancestor
65087463|NCT00591916|Protective Agents|protective agents|mesh-ancestor
65087464|NCT00462215|Vaccines|vaccines|mesh-list
65087465|NCT00462215|Immunologic Factors|immunologic factors|mesh-ancestor
65087466|NCT00462215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087467|NCT00462371|Insulin|insulin|mesh-list
65087468|NCT00462371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65087469|NCT00462371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087470|NCT00497016|Atorvastatin|atorvastatin|mesh-list
65087471|NCT00497016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65087472|NCT00497016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65087473|NCT00497016|Antimetabolites|antimetabolites|mesh-ancestor
65087474|NCT00497016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087475|NCT00497016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65087476|NCT00497016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65087477|NCT00497016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087478|NCT00222872|Hormones|hormones|mesh-list
65087479|NCT00222872|Parathyroid Hormone|parathyroid hormone|mesh-list
65087480|NCT00222872|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
65087481|NCT00222872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65087482|NCT00222872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087483|NCT00222872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65087484|NCT00497172|Sirolimus|sirolimus|mesh-list
65087485|NCT00497172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65087486|NCT00497172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087487|NCT00497172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65087488|NCT00497172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087489|NCT00497172|Antifungal Agents|antifungal agents|mesh-ancestor
65087490|NCT00497172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65087491|NCT00497172|Immunologic Factors|immunologic factors|mesh-ancestor
65087492|NCT00497172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087493|NCT03273296|Amoxicillin|amoxicillin|mesh-list
65087494|NCT03273296|Azithromycin|azithromycin|mesh-list
65087495|NCT03273296|Vancomycin|vancomycin|mesh-list
65087496|NCT03273296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65087497|NCT03273296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087498|NCT00497250|Gefitinib|gefitinib|mesh-list
65087499|NCT00497250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087500|NCT00497250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65087501|NCT00497250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087502|NCT00497250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087503|NCT00462878|Vancomycin|vancomycin|mesh-list
65087504|NCT00462878|Meropenem|meropenem|mesh-list
65087505|NCT00462878|Teicoplanin|teicoplanin|mesh-list
65087506|NCT00462878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65087507|NCT00462878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087508|NCT00462956|Lapatinib|lapatinib|mesh-list
65087509|NCT00462956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087510|NCT00462956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65087511|NCT00462956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087512|NCT00462956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087513|NCT00462995|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65087514|NCT00462995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087515|NCT00462995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65087516|NCT00462995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087517|NCT00462995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087518|NCT00489528|Hormones|hormones|mesh-list
65087519|NCT00489528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65087520|NCT00489528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087521|NCT00463073|Bevacizumab|bevacizumab|mesh-list
65087522|NCT00463073|Cetuximab|cetuximab|mesh-list
65087523|NCT00463073|Irinotecan|irinotecan|mesh-list
65087524|NCT00463073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65087525|NCT00463073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087526|NCT00463073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65087527|NCT00463073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65087528|NCT00463073|Growth Substances|growth substances|mesh-ancestor
65087529|NCT00463073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087530|NCT00463073|Growth Inhibitors|growth inhibitors|mesh-ancestor
65087531|NCT00463073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65087532|NCT00463073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65087533|NCT00463073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087534|NCT00463073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087535|NCT00463112|Sibutramine|sibutramine|mesh-list
65087536|NCT00463112|Antidepressive Agents|antidepressive agents|mesh-ancestor
65087537|NCT00463112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65087538|NCT00463112|Appetite Depressants|appetite depressants|mesh-ancestor
65087539|NCT00463112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65087540|NCT00223028|Sirolimus|sirolimus|mesh-list
65087541|NCT00223028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65087542|NCT00223028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087543|NCT00223028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65087544|NCT00223028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087545|NCT00223028|Antifungal Agents|antifungal agents|mesh-ancestor
65087546|NCT00223028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65087547|NCT00223028|Immunologic Factors|immunologic factors|mesh-ancestor
65087548|NCT00223028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087549|NCT00489645|Pramlintide|pramlintide|mesh-list
65087550|NCT00489645|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
65087551|NCT00489645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65087552|NCT00489645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087553|NCT00489645|Appetite Depressants|appetite depressants|mesh-ancestor
65087554|NCT00489645|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65087555|NCT00489645|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
64729767|NCT00004682|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
65087556|NCT00489645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087557|NCT00463268|Vitamin D|vitamin d|mesh-list
65087558|NCT00463268|Alendronate|alendronate|mesh-list
65087559|NCT00463268|Calcium|calcium|mesh-list
65087561|NCT00463268|Micronutrients|micronutrients|mesh-ancestor
65087562|NCT00463268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087563|NCT00463268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65087564|NCT00463268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65087565|NCT00489723|Tamsulosin|tamsulosin|mesh-list
65087566|NCT00489723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65087567|NCT00489723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65087568|NCT00489723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65087569|NCT00489723|Adrenergic Agents|adrenergic agents|mesh-ancestor
65087570|NCT00489723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65087571|NCT00489723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087572|NCT00489723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087573|NCT00489723|Urological Agents|urological agents|mesh-ancestor
65087574|NCT00105443|Sorafenib|sorafenib|mesh-list
65087575|NCT00105443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087576|NCT00105443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65087577|NCT00105443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087578|NCT00105443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087579|NCT00489840|Hydrocortisone|hydrocortisone|mesh-list
65087580|NCT00489840|Anecortave|anecortave|mesh-list
65087581|NCT00489840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65087582|NCT00489840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65087583|NCT00489840|Growth Substances|growth substances|mesh-ancestor
65087584|NCT00489840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087585|NCT00489840|Growth Inhibitors|growth inhibitors|mesh-ancestor
65087586|NCT00489840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087587|NCT00489840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65087588|NCT00463502|Metformin|metformin|mesh-list
65087589|NCT00463502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65087590|NCT00463502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087591|NCT00489996|Gemcitabine|gemcitabine|mesh-list
65087592|NCT00489996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087593|NCT00489996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65087594|NCT00489996|Antimetabolites|antimetabolites|mesh-ancestor
65087595|NCT00489996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087596|NCT00489996|Antiviral Agents|antiviral agents|mesh-ancestor
65087597|NCT00489996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087598|NCT00489996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087599|NCT00489996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65087600|NCT00489996|Immunologic Factors|immunologic factors|mesh-ancestor
65087601|NCT00489996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087602|NCT00463541|Solifenacin Succinate|solifenacin succinate|mesh-list
65087603|NCT00463541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65087604|NCT00463541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65087605|NCT00463541|Cholinergic Agents|cholinergic agents|mesh-ancestor
64620147|NCT04120454|Antibodies|antibodies|mesh-list
65087606|NCT00463541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65087607|NCT00463541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835483|NCT02891603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835484|NCT02891603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65087608|NCT00463541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087609|NCT00463541|Urological Agents|urological agents|mesh-ancestor
65087610|NCT00490113|Pyridoxamine|pyridoxamine|mesh-list
65087611|NCT00490113|Vitamin B Complex|vitamin b complex|mesh-ancestor
65087612|NCT00490113|Vitamins|vitamins|mesh-ancestor
65087613|NCT00490113|Micronutrients|micronutrients|mesh-ancestor
65087614|NCT00490113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087615|NCT01243203|Varenicline|varenicline|mesh-list
65087616|NCT01243203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65087617|NCT01243203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65087618|NCT01243203|Cholinergic Agents|cholinergic agents|mesh-ancestor
65087619|NCT01243203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65087620|NCT01243203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087621|NCT01243203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087622|NCT00497328|Acetylcysteine|acetylcysteine|mesh-list
65087623|NCT00497328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65087624|NCT00497328|Antiviral Agents|antiviral agents|mesh-ancestor
65087625|NCT00497328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087626|NCT00497328|Expectorants|expectorants|mesh-ancestor
65087627|NCT00497328|Respiratory System Agents|respiratory system agents|mesh-ancestor
65087628|NCT00497328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65087629|NCT00497328|Antioxidants|antioxidants|mesh-ancestor
65087630|NCT00497328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087631|NCT00497328|Protective Agents|protective agents|mesh-ancestor
65087632|NCT00497328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087634|NCT00466076|Glatiramer Acetate|glatiramer acetate|mesh-list
65087635|NCT00466076|(T,G)-A-L|(t,g)-a-l|mesh-list
65087636|NCT00466076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65087637|NCT00466076|Immunologic Factors|immunologic factors|mesh-ancestor
65087638|NCT00466076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087639|NCT00466076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65087640|NCT00466076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65087641|NCT00466154|Aspirin|aspirin|mesh-list
65087642|NCT00466154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65087643|NCT00466154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65087644|NCT00466154|Analgesics|analgesics|mesh-ancestor
65087645|NCT00466154|Sensory System Agents|sensory system agents|mesh-ancestor
65087646|NCT00466154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65087647|NCT00466154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087648|NCT00466154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65087649|NCT00466154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65087650|NCT00466154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65087651|NCT00466154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65087652|NCT00466154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087653|NCT00466154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65087654|NCT00466154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65087655|NCT00466154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087656|NCT00466154|Antipyretics|antipyretics|mesh-ancestor
65087657|NCT00490308|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65087658|NCT00490308|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65087659|NCT00490308|Estradiol|estradiol|mesh-list
65087660|NCT00490308|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65087661|NCT00490308|Estrogens|estrogens|mesh-ancestor
65087662|NCT00490308|Hormones|hormones|mesh-ancestor
65087663|NCT00490308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65087664|NCT00490308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087665|NCT00490308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65087666|NCT00490308|Contraceptive Agents|contraceptive agents|mesh-ancestor
65087667|NCT00490308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65087668|NCT00490308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65087669|NCT00463736|Magnesium Sulfate|magnesium sulfate|mesh-list
65087670|NCT00463736|Analgesics|analgesics|mesh-ancestor
65087671|NCT00463736|Sensory System Agents|sensory system agents|mesh-ancestor
65087672|NCT00463736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65087673|NCT00463736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087674|NCT00463736|Anesthetics|anesthetics|mesh-ancestor
65087675|NCT00463736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65087676|NCT00463736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65087677|NCT00463736|Anticonvulsants|anticonvulsants|mesh-ancestor
65087678|NCT00463736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65087679|NCT00463736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64483331|NCT00754546|Autonomic Agents|autonomic agents|mesh-ancestor
65087680|NCT00463736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087681|NCT00463736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65087682|NCT00463736|Tocolytic Agents|tocolytic agents|mesh-ancestor
65087683|NCT00463736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65087685|NCT00490464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65087686|NCT00490464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65087687|NCT00490464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65087688|NCT00490464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087689|NCT00490464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65087690|NCT00490464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087691|NCT00490464|Vasodilator Agents|vasodilator agents|mesh-ancestor
65087692|NCT00497523|Beclomethasone|beclomethasone|mesh-list
65087693|NCT00497523|Albuterol|albuterol|mesh-list
65087694|NCT00497523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65087695|NCT00497523|Autonomic Agents|autonomic agents|mesh-ancestor
65087696|NCT00497523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65087697|NCT00497523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087698|NCT00497523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65087699|NCT00497523|Respiratory System Agents|respiratory system agents|mesh-ancestor
65087700|NCT00497523|Tocolytic Agents|tocolytic agents|mesh-ancestor
65087701|NCT00497523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65087702|NCT00497523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65087703|NCT00497523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65087704|NCT00497523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65087705|NCT00497523|Adrenergic Agents|adrenergic agents|mesh-ancestor
65087706|NCT00497523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65087707|NCT00497523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087708|NCT00497523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65087709|NCT00497523|Glucocorticoids|glucocorticoids|mesh-ancestor
65087710|NCT00497523|Hormones|hormones|mesh-ancestor
65087711|NCT00497523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65087712|NCT00463775|Topiramate|topiramate|mesh-list
65087713|NCT00463775|Anticonvulsants|anticonvulsants|mesh-ancestor
65087714|NCT00463775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65087715|NCT00463775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087716|NCT00490620|Antiviral Agents|antiviral agents|mesh-list
65087717|NCT00490620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087718|NCT00466232|Sorafenib|sorafenib|mesh-list
65087719|NCT00466232|Topotecan|topotecan|mesh-list
65087720|NCT00466232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087721|NCT00466232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65087722|NCT00466232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087723|NCT00466232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087724|NCT00466232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65087725|NCT00466232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65087726|NCT00490659|Gemcitabine|gemcitabine|mesh-list
65087727|NCT00490659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087728|NCT00490659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65087729|NCT00490659|Antimetabolites|antimetabolites|mesh-ancestor
65087730|NCT00490659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087731|NCT00490659|Antiviral Agents|antiviral agents|mesh-ancestor
65087732|NCT00490659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087733|NCT00490659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087734|NCT00490659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65087735|NCT00490659|Immunologic Factors|immunologic factors|mesh-ancestor
65087736|NCT00490659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087737|NCT00490737|Daptomycin|daptomycin|mesh-list
65087738|NCT00490737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65087739|NCT00490737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087740|NCT00497562|Tramadol|tramadol|mesh-list
65087741|NCT00497562|Amitriptyline|amitriptyline|mesh-list
65087742|NCT00497562|Fluoxetine|fluoxetine|mesh-list
65087743|NCT00497562|Hormones|hormones|mesh-list
65087744|NCT00497562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65087745|NCT00497562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087746|NCT00497562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65087747|NCT00497562|Narcotics|narcotics|mesh-ancestor
64835489|NCT02876107|Paclitaxel|paclitaxel|mesh-list
65087748|NCT00497562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65087749|NCT00497562|Analgesics|analgesics|mesh-ancestor
65087750|NCT00497562|Sensory System Agents|sensory system agents|mesh-ancestor
65087751|NCT00497562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65087752|NCT00497562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65087753|NCT00497562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65087754|NCT00497562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65087755|NCT00497562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087757|NCT00497562|Serotonin Agents|serotonin agents|mesh-ancestor
65087758|NCT00497562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65087759|NCT00497562|Antidepressive Agents|antidepressive agents|mesh-ancestor
65087760|NCT00497562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65087761|NCT00497562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65087762|NCT00497562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65087763|NCT00497562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087764|NCT00497562|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65087765|NCT00497562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65087766|NCT00497562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65087767|NCT00497562|Adrenergic Agents|adrenergic agents|mesh-ancestor
65087768|NCT00497601|Amphotericin B|amphotericin b|mesh-list
65087769|NCT00497601|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65087770|NCT00497601|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
65087771|NCT00497601|Amebicides|amebicides|mesh-ancestor
65087772|NCT00497601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65087773|NCT00497601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65087774|NCT00497601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087775|NCT00497601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65087776|NCT00497601|Antifungal Agents|antifungal agents|mesh-ancestor
65087777|NCT00497601|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
65087778|NCT00497601|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
65087779|NCT00497601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65087780|NCT00466388|Cevimeline|cevimeline|mesh-list
65087781|NCT00466388|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65087782|NCT00466388|Autonomic Agents|autonomic agents|mesh-ancestor
65087783|NCT00466388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65087784|NCT00466388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087785|NCT00466388|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65087786|NCT00466388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65087787|NCT00466388|Cholinergic Agents|cholinergic agents|mesh-ancestor
65087788|NCT00466388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65087789|NCT00466388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087790|NCT00466466|Everolimus|everolimus|mesh-list
65087791|NCT00466466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087792|NCT00466466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65087793|NCT00466466|Immunologic Factors|immunologic factors|mesh-ancestor
65087794|NCT00466466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087795|NCT00490854|Insulin|insulin|mesh-list
65087796|NCT00490854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65087797|NCT00490854|Insulin, Isophane|insulin, isophane|mesh-list
65087798|NCT00490854|Isophane Insulin, Human|isophane insulin, human|mesh-list
65087799|NCT00490854|Isophane insulin, beef|isophane insulin, beef|mesh-list
65087800|NCT00490854|Protamines|protamines|mesh-list
65087801|NCT00490854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65087802|NCT00490854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087803|NCT00490854|Heparin Antagonists|heparin antagonists|mesh-ancestor
65087804|NCT00490854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087805|NCT00490854|Coagulants|coagulants|mesh-ancestor
65087806|NCT00490893|Insulin Detemir|insulin detemir|mesh-list
65087807|NCT00490893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65087808|NCT00490893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087809|NCT03272126|Vitamin D|vitamin d|mesh-list
65087810|NCT03272126|Vitamins|vitamins|mesh-ancestor
65087811|NCT03272126|Micronutrients|micronutrients|mesh-ancestor
65087812|NCT03272126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087813|NCT03272126|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65087814|NCT00491049|Levofloxacin|levofloxacin|mesh-list
65087815|NCT00491049|Ofloxacin|ofloxacin|mesh-list
65087816|NCT00491049|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65087817|NCT00491049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65087818|NCT00491049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65087819|NCT00491049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087820|NCT00491049|Renal Agents|renal agents|mesh-ancestor
65087821|NCT00491049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65087822|NCT00491049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65087823|NCT00491049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65087824|NCT00491049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087825|NCT00491049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087826|NCT00491049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64483334|NCT00754546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65087827|NCT00491049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65087828|NCT00491049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65087829|NCT00464165|Rimonabant|rimonabant|mesh-list
65087830|NCT00464165|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65087831|NCT00464165|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
65087832|NCT00464165|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
65087833|NCT00464165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65087834|NCT00464165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087835|NCT00464165|Hormones|hormones|mesh-ancestor
65087836|NCT00464165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65087837|NCT00464165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087838|NCT00497913|Botulinum Toxins|botulinum toxins|mesh-list
65087839|NCT00497913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65087840|NCT00497913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65087841|NCT00497913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65087842|NCT00497913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65087843|NCT00497913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087844|NCT00497913|Cholinergic Agents|cholinergic agents|mesh-ancestor
65087845|NCT00497913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65087846|NCT00497913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087847|NCT00497913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65087848|NCT00497913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65087850|NCT03272321|Oxytocics|oxytocics|mesh-ancestor
65087851|NCT03272321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65087852|NCT03272321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087853|NCT00491127|Gemcitabine|gemcitabine|mesh-list
65087854|NCT00491127|Dexamethasone|dexamethasone|mesh-list
65087855|NCT00491127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65087856|NCT00491127|Antiemetics|antiemetics|mesh-ancestor
65087857|NCT00491127|Autonomic Agents|autonomic agents|mesh-ancestor
65087858|NCT00491127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65087859|NCT00491127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087860|NCT00491127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65087861|NCT00491127|Glucocorticoids|glucocorticoids|mesh-ancestor
65087862|NCT00491127|Hormones|hormones|mesh-ancestor
65087863|NCT00491127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65087864|NCT00491127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65087865|NCT00491127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087866|NCT00491127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65087867|NCT00491127|Antimetabolites|antimetabolites|mesh-ancestor
65087868|NCT00491127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087869|NCT00491127|Antiviral Agents|antiviral agents|mesh-ancestor
65087870|NCT00491127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087871|NCT00491127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087872|NCT00491127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65087873|NCT00491127|Immunologic Factors|immunologic factors|mesh-ancestor
65087874|NCT00491166|Bromfenac|bromfenac|mesh-list
65087875|NCT00491166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65087876|NCT00491166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65087877|NCT00491166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65087878|NCT00491166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65087879|NCT00491166|Analgesics|analgesics|mesh-ancestor
65087880|NCT00491166|Sensory System Agents|sensory system agents|mesh-ancestor
65087881|NCT00491166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65087882|NCT00491166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087883|NCT00491166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65087884|NCT00491166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65087885|NCT03273062|Tolcapone|tolcapone|mesh-list
65087886|NCT03273062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65087887|NCT03273062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65087888|NCT03273062|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65087889|NCT03273062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087890|NCT03273062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087891|NCT00498108|Rotigotine|rotigotine|mesh-list
65087892|NCT00498108|Dopamine Agonists|dopamine agonists|mesh-ancestor
65087893|NCT00498108|Dopamine Agents|dopamine agents|mesh-ancestor
65087894|NCT00498108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65087895|NCT00498108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087896|NCT00498108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087897|NCT00464321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65087898|NCT00464321|Immunologic Factors|immunologic factors|mesh-ancestor
65087899|NCT00464321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087900|NCT00498225|Gemcitabine|gemcitabine|mesh-list
65087901|NCT00498225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65087902|NCT00498225|Antimetabolites|antimetabolites|mesh-ancestor
65087903|NCT00498225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087904|NCT00498225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087905|NCT00498225|Antiviral Agents|antiviral agents|mesh-ancestor
65087906|NCT00498225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087907|NCT00498225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087908|NCT00498225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65087909|NCT00498225|Immunologic Factors|immunologic factors|mesh-ancestor
65087910|NCT00498225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087911|NCT00466622|Metformin|metformin|mesh-list
65087912|NCT00466622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65087913|NCT00466622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087914|NCT01327612|Leucovorin|leucovorin|mesh-list
65087915|NCT01327612|Bevacizumab|bevacizumab|mesh-list
65087916|NCT01327612|Conatumumab|conatumumab|mesh-list
65087917|NCT01327612|Fluorouracil|fluorouracil|mesh-list
65087918|NCT01327612|Oxaliplatin|oxaliplatin|mesh-list
65087919|NCT01327612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65087920|NCT01327612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087921|NCT01327612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65087922|NCT01327612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65087923|NCT01327612|Growth Substances|growth substances|mesh-ancestor
65087924|NCT01327612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087925|NCT01327612|Growth Inhibitors|growth inhibitors|mesh-ancestor
65087926|NCT01327612|Antimetabolites|antimetabolites|mesh-ancestor
65087927|NCT01327612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087928|NCT01327612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65087929|NCT01327612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65087930|NCT01327612|Immunologic Factors|immunologic factors|mesh-ancestor
65087931|NCT01327612|Antidotes|antidotes|mesh-ancestor
65087932|NCT01327612|Protective Agents|protective agents|mesh-ancestor
65087933|NCT01327612|Vitamin B Complex|vitamin b complex|mesh-ancestor
65087934|NCT01327612|Vitamins|vitamins|mesh-ancestor
65087935|NCT01327612|Micronutrients|micronutrients|mesh-ancestor
65087936|NCT01243281|Entecavir|entecavir|mesh-list
65087937|NCT01243281|Antiviral Agents|antiviral agents|mesh-ancestor
65087938|NCT01243281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087939|NCT00464399|Everolimus|everolimus|mesh-list
65087940|NCT00464399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087941|NCT00464399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65087942|NCT00464399|Immunologic Factors|immunologic factors|mesh-ancestor
65087943|NCT00464399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087944|NCT04132882|Sodium thiosulfate|sodium thiosulfate|mesh-list
65087945|NCT04132882|Antidotes|antidotes|mesh-ancestor
65087946|NCT04132882|Protective Agents|protective agents|mesh-ancestor
65087947|NCT04132882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087948|NCT04132882|Antioxidants|antioxidants|mesh-ancestor
65087949|NCT04132882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087950|NCT04132882|Antitubercular Agents|antitubercular agents|mesh-ancestor
65087951|NCT04132882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65087952|NCT04132882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087953|NCT04132882|Chelating Agents|chelating agents|mesh-ancestor
65087954|NCT04132882|Sequestering Agents|sequestering agents|mesh-ancestor
65087955|NCT01243359|Bevacizumab|bevacizumab|mesh-list
65087956|NCT01243359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65087957|NCT01243359|Sunitinib|sunitinib|mesh-list
65087958|NCT01243359|Antibodies|antibodies|mesh-list
65087959|NCT01243359|Immunoglobulins|immunoglobulins|mesh-list
65087960|NCT01243359|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65087961|NCT01243359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087962|NCT01243359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65087963|NCT01243359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65087964|NCT01243359|Growth Substances|growth substances|mesh-ancestor
65087965|NCT01243359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087966|NCT01243359|Growth Inhibitors|growth inhibitors|mesh-ancestor
65087967|NCT01243359|Immunologic Factors|immunologic factors|mesh-ancestor
65087968|NCT01243359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65087969|NCT01243359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087970|NCT01243359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087971|NCT00498342|Acetylcysteine|acetylcysteine|mesh-list
65087972|NCT00498342|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65087973|NCT00498342|Antiviral Agents|antiviral agents|mesh-ancestor
65087974|NCT00498342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087975|NCT00498342|Expectorants|expectorants|mesh-ancestor
65087976|NCT00498342|Respiratory System Agents|respiratory system agents|mesh-ancestor
65087977|NCT00498342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65087978|NCT00498342|Antioxidants|antioxidants|mesh-ancestor
65087979|NCT00498342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087980|NCT00498342|Protective Agents|protective agents|mesh-ancestor
65087981|NCT00498342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65087982|NCT00498342|Antidotes|antidotes|mesh-ancestor
65087983|NCT00466856|Octreotide|octreotide|mesh-list
65087984|NCT00466856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65087985|NCT00466856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65087986|NCT00466856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65087987|NCT01243437|Ciprofloxacin|ciprofloxacin|mesh-list
65087988|NCT01243437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65087989|NCT01243437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65087990|NCT01243437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65087991|NCT01243437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65087992|NCT01243437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65087993|NCT01243437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65087994|NCT01243437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416696|NCT02608879|Chlorhexidine|chlorhexidine|mesh-list
65087995|NCT01243437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65087996|NCT01243437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65087997|NCT00591994|Piribedil|piribedil|mesh-list
65087998|NCT00591994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65087999|NCT00591994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65088000|NCT00591994|Dopamine Agonists|dopamine agonists|mesh-ancestor
65088001|NCT00591994|Dopamine Agents|dopamine agents|mesh-ancestor
65088002|NCT00591994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65088003|NCT00591994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088004|NCT00591994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088005|NCT00464594|Metformin|metformin|mesh-list
65088006|NCT00464594|Acarbose|acarbose|mesh-list
64730227|NCT00005798|Thiotepa|thiotepa|mesh-list
65088007|NCT00464594|Gliclazide|gliclazide|mesh-list
65088008|NCT00464594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65088009|NCT00464594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088010|NCT00464594|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
65088011|NCT00464594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65088012|NCT00464594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088013|NCT04397302|Valsartan|valsartan|mesh-list
65088014|NCT04397302|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
65088015|NCT04397302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65088016|NCT04397302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65088017|NCT04397302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65088018|NCT04397302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088019|NCT00466895|Lenalidomide|lenalidomide|mesh-list
65088020|NCT00466895|Immunologic Factors|immunologic factors|mesh-ancestor
65088021|NCT00466895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088022|NCT00466895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64835510|NCT02855229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64446607|NCT01518244|Timolol|timolol|mesh-list
65088023|NCT00466895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65088024|NCT00466895|Growth Substances|growth substances|mesh-ancestor
65088025|NCT00466895|Growth Inhibitors|growth inhibitors|mesh-ancestor
65088026|NCT00466895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088027|NCT02893540|Capecitabine|capecitabine|mesh-list
65088028|NCT02893540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65088029|NCT02893540|Antimetabolites|antimetabolites|mesh-ancestor
65088030|NCT02893540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088031|NCT02893540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088032|NCT01327573|Eculizumab|eculizumab|mesh-list
65088033|NCT01327573|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65088034|NCT01327573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65088035|NCT01327573|Immunologic Factors|immunologic factors|mesh-ancestor
65088036|NCT01327573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088037|NCT02893384|Anesthetics|anesthetics|mesh-list
65088038|NCT02893384|Anesthetics, Local|anesthetics, local|mesh-list
65088039|NCT02893384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65088040|NCT02893384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088041|NCT02893384|Sensory System Agents|sensory system agents|mesh-ancestor
65088042|NCT02893384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65088043|NCT02893228|Levobupivacaine|levobupivacaine|mesh-list
65088044|NCT02893228|Anesthetics, Local|anesthetics, local|mesh-ancestor
65088045|NCT02893228|Anesthetics|anesthetics|mesh-ancestor
65088046|NCT02893228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65088047|NCT02893228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088048|NCT02893228|Sensory System Agents|sensory system agents|mesh-ancestor
65088049|NCT02893228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65088050|NCT00498537|Spironolactone|spironolactone|mesh-list
65088051|NCT00498537|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
65088052|NCT00498537|Hormone Antagonists|hormone antagonists|mesh-ancestor
65088053|NCT00498537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65088054|NCT00498537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088055|NCT00498537|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
65088056|NCT00498537|Diuretics|diuretics|mesh-ancestor
65088057|NCT00498537|Natriuretic Agents|natriuretic agents|mesh-ancestor
65088058|NCT00491478|Sertraline|sertraline|mesh-list
65088059|NCT00491478|Antidepressive Agents|antidepressive agents|mesh-ancestor
65088060|NCT00491478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65088061|NCT00491478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64416698|NCT02608879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65088062|NCT00491478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65088063|NCT00491478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65088064|NCT00491478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088065|NCT00491478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65088066|NCT00491478|Serotonin Agents|serotonin agents|mesh-ancestor
65088067|NCT00491478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088068|NCT00491517|Sirolimus|sirolimus|mesh-list
65088069|NCT00491517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65088070|NCT00491517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65088071|NCT00491517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65088072|NCT00491517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088073|NCT00491517|Antifungal Agents|antifungal agents|mesh-ancestor
65088074|NCT00491517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65088075|NCT00491517|Immunologic Factors|immunologic factors|mesh-ancestor
65088076|NCT00491517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088077|NCT00464789|Bazedoxifene|bazedoxifene|mesh-list
65088078|NCT00464789|Estrogens|estrogens|mesh-list
65088079|NCT00464789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65088080|NCT00464789|Hormones|hormones|mesh-ancestor
65088081|NCT00464789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65088082|NCT00464789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088083|NCT00464789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65088084|NCT00464789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65088085|NCT00464789|Hormone Antagonists|hormone antagonists|mesh-ancestor
65088086|NCT00464789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65088087|NCT00467012|Paclitaxel|paclitaxel|mesh-list
65088088|NCT00467012|Bevacizumab|bevacizumab|mesh-list
64588435|NCT03340675|Ifetroban|ifetroban|mesh-list
65088089|NCT00467012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65088090|NCT00467012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088091|NCT00467012|Tubulin Modulators|tubulin modulators|mesh-ancestor
65088092|NCT00467012|Antimitotic Agents|antimitotic agents|mesh-ancestor
65088093|NCT00467012|Mitosis Modulators|mitosis modulators|mesh-ancestor
65088094|NCT00467012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088095|NCT00467012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65088096|NCT00467012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65088097|NCT00467012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65088098|NCT00467012|Growth Substances|growth substances|mesh-ancestor
65088099|NCT00467012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088100|NCT00467012|Growth Inhibitors|growth inhibitors|mesh-ancestor
65088101|NCT03272867|Mannitol|mannitol|mesh-list
65088102|NCT03272867|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
65088103|NCT03272867|Diuretics|diuretics|mesh-ancestor
65088104|NCT03272867|Natriuretic Agents|natriuretic agents|mesh-ancestor
65088105|NCT03272867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088106|NCT01327495|Methyltestosterone|methyltestosterone|mesh-list
65088107|NCT01327495|Testosterone|testosterone|mesh-list
65088108|NCT01327495|Testosterone undecanoate|testosterone undecanoate|mesh-list
65088109|NCT01327495|Testosterone enanthate|testosterone enanthate|mesh-list
65088110|NCT01327495|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65088111|NCT01327495|Acyline|acyline|mesh-list
65088112|NCT01327495|Androgens|androgens|mesh-ancestor
65088113|NCT01327495|Hormones|hormones|mesh-ancestor
65088114|NCT01327495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65088115|NCT01327495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088116|NCT01327495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65088117|NCT01327495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088118|NCT01327495|Anabolic Agents|anabolic agents|mesh-ancestor
65088119|NCT01327495|Hormone Antagonists|hormone antagonists|mesh-ancestor
65088120|NCT00491634|Treosulfan|treosulfan|mesh-list
65088121|NCT00491634|Busulfan|busulfan|mesh-list
65088122|NCT00491634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65088123|NCT00491634|Alkylating Agents|alkylating agents|mesh-ancestor
65088124|NCT00491634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088125|NCT00491634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088126|NCT00491634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65088127|NCT00491634|Immunologic Factors|immunologic factors|mesh-ancestor
65088128|NCT00491634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088129|NCT00491634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65088130|NCT01327339|Ropinirole|ropinirole|mesh-list
65088131|NCT01327339|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65088132|NCT01327339|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65088133|NCT01327339|Dopamine Agonists|dopamine agonists|mesh-ancestor
65088134|NCT01327339|Dopamine Agents|dopamine agents|mesh-ancestor
65088135|NCT01327339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65088136|NCT01327339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088137|NCT01327339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088138|NCT01327300|Mesalamine|mesalamine|mesh-list
65088139|NCT01327300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65088140|NCT01327300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65088141|NCT01327300|Analgesics|analgesics|mesh-ancestor
65088142|NCT01327300|Sensory System Agents|sensory system agents|mesh-ancestor
65088143|NCT01327300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65088144|NCT01327300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088145|NCT01327300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65088146|NCT01327300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65088147|NCT00467207|Botulinum Toxins|botulinum toxins|mesh-list
65088148|NCT00467207|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65088149|NCT00467207|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65088150|NCT00467207|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65088151|NCT00467207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65088152|NCT00467207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088153|NCT00467207|Cholinergic Agents|cholinergic agents|mesh-ancestor
65088154|NCT00467207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64835511|NCT02855229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65088155|NCT00467207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088156|NCT00467207|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65088157|NCT00467207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65088158|NCT00592111|Prednisone|prednisone|mesh-list
65088159|NCT00592111|Cyclophosphamide|cyclophosphamide|mesh-list
65088160|NCT00592111|Etoposide|etoposide|mesh-list
65088161|NCT00592111|Vincristine|vincristine|mesh-list
65088162|NCT00592111|Doxorubicin|doxorubicin|mesh-list
65088163|NCT00592111|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
65088164|NCT00592111|Bleomycin|bleomycin|mesh-list
65088165|NCT00592111|Vinblastine|vinblastine|mesh-list
65088166|NCT00592111|Procarbazine|procarbazine|mesh-list
65088167|NCT00592111|Mitogens|mitogens|mesh-list
65088168|NCT00592111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65088169|NCT00592111|Immunologic Factors|immunologic factors|mesh-ancestor
65088170|NCT00592111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088171|NCT00592111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65088172|NCT00592111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65088173|NCT00592111|Alkylating Agents|alkylating agents|mesh-ancestor
65088174|NCT00592111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088175|NCT00592111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088176|NCT00592111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65088177|NCT00592111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65088178|NCT00592111|Glucocorticoids|glucocorticoids|mesh-ancestor
65088179|NCT00592111|Hormones|hormones|mesh-ancestor
65088180|NCT00592111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65088181|NCT00592111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65088182|NCT00592111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65088183|NCT00592111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65088184|NCT00592111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65088185|NCT00592111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65088186|NCT00592111|Tubulin Modulators|tubulin modulators|mesh-ancestor
65088187|NCT00592111|Antimitotic Agents|antimitotic agents|mesh-ancestor
65088188|NCT00592111|Mitosis Modulators|mitosis modulators|mesh-ancestor
65088189|NCT00592111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65088190|NCT00592150|Fenoldopam|fenoldopam|mesh-list
65088191|NCT00592150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65088192|NCT00592150|Vasodilator Agents|vasodilator agents|mesh-ancestor
65088193|NCT00592150|Dopamine Agonists|dopamine agonists|mesh-ancestor
65088194|NCT00592150|Dopamine Agents|dopamine agents|mesh-ancestor
65088195|NCT00592150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65088196|NCT00592150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088197|NCT00592150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088198|NCT00592306|Thymoglobulin|thymoglobulin|mesh-list
65088199|NCT00592306|Antilymphocyte Serum|antilymphocyte serum|mesh-list
65088200|NCT00592306|Immunologic Factors|immunologic factors|mesh-ancestor
65088201|NCT00592306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088202|NCT00592306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65088203|NCT00467246|Insulin Detemir|insulin detemir|mesh-list
65088204|NCT00467246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65088205|NCT00467246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088206|NCT04377295|Ranibizumab|ranibizumab|mesh-list
65088207|NCT04377295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65088208|NCT04377295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65088209|NCT04377295|Growth Substances|growth substances|mesh-ancestor
65088210|NCT04377295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088211|NCT04377295|Growth Inhibitors|growth inhibitors|mesh-ancestor
65088212|NCT04377295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088213|NCT00491712|Triamcinolone|triamcinolone|mesh-list
65088214|NCT00491712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65088215|NCT00491712|Glucocorticoids|glucocorticoids|mesh-ancestor
65088216|NCT00491712|Hormones|hormones|mesh-ancestor
65088217|NCT00491712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65088218|NCT00491712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088219|NCT02893111|Bortezomib|bortezomib|mesh-list
65088220|NCT02893111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088221|NCT04328272|Azithromycin|azithromycin|mesh-list
65088222|NCT04328272|Hydroxychloroquine|hydroxychloroquine|mesh-list
65088223|NCT04328272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65088224|NCT04328272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65088225|NCT04328272|Antimalarials|antimalarials|mesh-ancestor
65088226|NCT04328272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65088227|NCT04328272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65088228|NCT04328272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65088229|NCT04328272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088230|NCT04328272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65088231|NCT04328194|Thrombin|thrombin|mesh-list
65088232|NCT04328194|Hemostatics|hemostatics|mesh-ancestor
65088233|NCT04328194|Coagulants|coagulants|mesh-ancestor
65088234|NCT00491790|Montelukast|montelukast|mesh-list
65088235|NCT00491790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65088236|NCT00491790|Respiratory System Agents|respiratory system agents|mesh-ancestor
65088237|NCT00491790|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65088238|NCT00491790|Hormone Antagonists|hormone antagonists|mesh-ancestor
65088239|NCT00491790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65088240|NCT00491790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088241|NCT00491790|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65088242|NCT00491790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65088243|NCT00491790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088244|NCT03272009|Interferons|interferons|mesh-list
65088245|NCT03272009|Interferon-alpha|interferon-alpha|mesh-list
65088246|NCT03272009|Interferon alpha-2|interferon alpha-2|mesh-list
65088247|NCT03272009|Entecavir|entecavir|mesh-list
65088248|NCT03272009|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65088249|NCT03272009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088250|NCT03272009|Antiviral Agents|antiviral agents|mesh-ancestor
65088251|NCT03272009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65088252|NCT03272009|Immunologic Factors|immunologic factors|mesh-ancestor
65088253|NCT03272009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088254|NCT00498888|Tolterodine Tartrate|tolterodine tartrate|mesh-list
65088255|NCT00498888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65088256|NCT00498888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65088257|NCT00498888|Cholinergic Agents|cholinergic agents|mesh-ancestor
65088258|NCT00498888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65088259|NCT00498888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088260|NCT00498888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088261|NCT00498888|Urological Agents|urological agents|mesh-ancestor
65088262|NCT00491868|Epoetin Alfa|epoetin alfa|mesh-list
65088263|NCT00491868|Hematinics|hematinics|mesh-ancestor
65088264|NCT00491907|Folic Acid|folic acid|mesh-list
65088265|NCT00491907|Hematinics|hematinics|mesh-ancestor
65088266|NCT00491907|Vitamin B Complex|vitamin b complex|mesh-ancestor
65088267|NCT00491907|Vitamins|vitamins|mesh-ancestor
65088268|NCT00491907|Micronutrients|micronutrients|mesh-ancestor
65088269|NCT00491907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088270|NCT00499005|Carbetocin|carbetocin|mesh-list
65088271|NCT00499005|Oxytocin|oxytocin|mesh-list
65088272|NCT00499005|Oxytocics|oxytocics|mesh-ancestor
65088273|NCT00499005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65088274|NCT00499005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088275|NCT00491946|Dactinomycin|dactinomycin|mesh-list
65088276|NCT00491946|Vincristine|vincristine|mesh-list
65088277|NCT00491946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65088278|NCT00491946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088279|NCT00491946|Tubulin Modulators|tubulin modulators|mesh-ancestor
65088280|NCT00491946|Antimitotic Agents|antimitotic agents|mesh-ancestor
65088281|NCT00491946|Mitosis Modulators|mitosis modulators|mesh-ancestor
65088282|NCT00491946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835520|NCT02829931|Ipilimumab|ipilimumab|mesh-list
64835521|NCT02829931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64835522|NCT02829931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835523|NCT02829931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64835524|NCT02829931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64835525|NCT02829931|Growth Substances|growth substances|mesh-ancestor
64835526|NCT02829931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835527|NCT02829931|Growth Inhibitors|growth inhibitors|mesh-ancestor
64835528|NCT02829931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64835530|NCT02815566|Tenofovir|tenofovir|mesh-list
65088283|NCT00491946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65088284|NCT00491946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65088285|NCT00491946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65088286|NCT00491946|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65088287|NCT00491946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65088288|NCT00491946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65088289|NCT00491985|Vaccines|vaccines|mesh-list
65088290|NCT00491985|Immunologic Factors|immunologic factors|mesh-ancestor
65088291|NCT00491985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088292|NCT02892916|Ketamine|ketamine|mesh-list
65088293|NCT02892916|Analgesics|analgesics|mesh-ancestor
65088294|NCT02892916|Sensory System Agents|sensory system agents|mesh-ancestor
65088295|NCT02892916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65088296|NCT02892916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088297|NCT02892916|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65088298|NCT02892916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65088299|NCT02892916|Anesthetics, General|anesthetics, general|mesh-ancestor
65088300|NCT02892916|Anesthetics|anesthetics|mesh-ancestor
65088301|NCT02892916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65088302|NCT02892916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65088303|NCT02892916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65088304|NCT02892916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65088305|NCT02892916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088306|NCT00492102|Montelukast|montelukast|mesh-list
65088307|NCT00492102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65088308|NCT00492102|Respiratory System Agents|respiratory system agents|mesh-ancestor
65088309|NCT00492102|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65088310|NCT00492102|Hormone Antagonists|hormone antagonists|mesh-ancestor
65088311|NCT00492102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65088312|NCT00492102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088313|NCT00492102|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65088314|NCT00492102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65088315|NCT00492102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088316|NCT00467636|Insulin glulisine|insulin glulisine|mesh-list
65088317|NCT00467636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65088318|NCT00467636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088319|NCT00492141|Temozolomide|temozolomide|mesh-list
65088320|NCT00492141|Camptothecin|camptothecin|mesh-list
65088321|NCT00492141|Rubitecan|rubitecan|mesh-list
65088322|NCT00492141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65088323|NCT00492141|Alkylating Agents|alkylating agents|mesh-ancestor
65088324|NCT00492141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088325|NCT00492141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088326|NCT00492141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65088327|NCT00492141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65088328|NCT00492141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65088329|NCT00492141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65088330|NCT04327726|Dexmedetomidine|dexmedetomidine|mesh-list
65088331|NCT04327726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65088332|NCT04327726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65088333|NCT04327726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088334|NCT04327726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65088335|NCT04327726|Analgesics|analgesics|mesh-ancestor
65088336|NCT04327726|Sensory System Agents|sensory system agents|mesh-ancestor
64325556|NCT02153879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64325557|NCT02153879|Antimetabolites|antimetabolites|mesh-ancestor
64325558|NCT02153879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325559|NCT02153879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64325560|NCT02153879|Vasodilator Agents|vasodilator agents|mesh-ancestor
64835535|NCT02815566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64835536|NCT02815566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835537|NCT02815566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088337|NCT04327726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64483344|NCT01764841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65088338|NCT04327726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65088339|NCT04327726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65088340|NCT04327726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65088341|NCT04327726|Adrenergic Agents|adrenergic agents|mesh-ancestor
65088342|NCT04327726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65088343|NCT04327726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088345|NCT00492219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65088346|NCT00492219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65088347|NCT00492219|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65088348|NCT00492219|Histamine Antagonists|histamine antagonists|mesh-ancestor
65088349|NCT00492219|Histamine Agents|histamine agents|mesh-ancestor
65088350|NCT00492219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65088351|NCT00492219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088352|NCT00492219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088353|NCT00492219|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65088354|NCT00492219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65088355|NCT00492219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65088356|NCT00465257|Artesunate|artesunate|mesh-list
65088357|NCT00465257|Amodiaquine|amodiaquine|mesh-list
65088358|NCT00465257|Antimalarials|antimalarials|mesh-ancestor
65088359|NCT00465257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65088360|NCT00465257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65088361|NCT00465257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65088362|NCT00465257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088363|NCT00465257|Antiviral Agents|antiviral agents|mesh-ancestor
65088364|NCT00465257|Schistosomicides|schistosomicides|mesh-ancestor
65088365|NCT00465257|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65088366|NCT00465257|Anthelmintics|anthelmintics|mesh-ancestor
65088367|NCT04130776|Kallikreins|kallikreins|mesh-list
65088368|NCT04130776|Coagulants|coagulants|mesh-ancestor
65088369|NCT04130776|Fertility Agents, Male|fertility agents, male|mesh-ancestor
65088370|NCT04130776|Fertility Agents|fertility agents|mesh-ancestor
65088371|NCT04130776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65088372|NCT04130776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088373|NCT00492258|Sorafenib|sorafenib|mesh-list
65088374|NCT00492258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088375|NCT00492258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65088376|NCT00492258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65088377|NCT00492258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088378|NCT02955810|Dexamethasone|dexamethasone|mesh-list
65088379|NCT02955810|Cyclophosphamide|cyclophosphamide|mesh-list
65088380|NCT02955810|Bortezomib|bortezomib|mesh-list
65088381|NCT02955810|Daratumumab|daratumumab|mesh-list
65088382|NCT02955810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64730598|NCT03228667|Nivolumab|nivolumab|mesh-list
65088383|NCT02955810|Immunologic Factors|immunologic factors|mesh-ancestor
65088384|NCT02955810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088385|NCT02955810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64835539|NCT02815566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64835540|NCT02769845|Hydroxyurea|hydroxyurea|mesh-list
64835541|NCT02769845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835542|NCT02769845|Antisickling Agents|antisickling agents|mesh-ancestor
64835543|NCT02769845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835544|NCT02769845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835545|NCT02769845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64835546|NCT02727803|Cyclophosphamide|cyclophosphamide|mesh-list
64835547|NCT02727803|Melphalan|melphalan|mesh-list
65088386|NCT02955810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65088387|NCT02955810|Alkylating Agents|alkylating agents|mesh-ancestor
65088388|NCT02955810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088389|NCT02955810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088390|NCT02955810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65088391|NCT02955810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65088392|NCT02955810|Antiemetics|antiemetics|mesh-ancestor
65088393|NCT02955810|Autonomic Agents|autonomic agents|mesh-ancestor
65088394|NCT02955810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65088395|NCT02955810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65088396|NCT02955810|Glucocorticoids|glucocorticoids|mesh-ancestor
65088397|NCT02955810|Hormones|hormones|mesh-ancestor
65088398|NCT02955810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65088399|NCT02955810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65088400|NCT00465296|Rosiglitazone|rosiglitazone|mesh-list
65088401|NCT00465296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65088402|NCT00465296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088403|NCT00492414|Paroxetine|paroxetine|mesh-list
65088404|NCT00492414|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65088405|NCT00492414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65088406|NCT00492414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65088407|NCT00492414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088408|NCT00492414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65088409|NCT00492414|Serotonin Agents|serotonin agents|mesh-ancestor
65088410|NCT00492414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088411|NCT00492414|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65088412|NCT00492414|Antidepressive Agents|antidepressive agents|mesh-ancestor
65088413|NCT00492414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65088414|NCT00492414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65088415|NCT00492414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65088416|NCT00492414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65088417|NCT01243632|Gemcitabine|gemcitabine|mesh-list
65088418|NCT01243632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65088419|NCT01243632|Antimetabolites|antimetabolites|mesh-ancestor
65088420|NCT01243632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088421|NCT01243632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088422|NCT01243632|Antiviral Agents|antiviral agents|mesh-ancestor
65088423|NCT01243632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65088424|NCT01243632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65088425|NCT01243632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65088426|NCT01243632|Immunologic Factors|immunologic factors|mesh-ancestor
65088427|NCT01243632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088428|NCT00467909|Micronutrients|micronutrients|mesh-list
65088429|NCT00467909|Trace Elements|trace elements|mesh-list
65088430|NCT00467909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088431|NCT04327453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65088432|NCT04327453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
65088433|NCT04327453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65088434|NCT04327453|Antitubercular Agents|antitubercular agents|mesh-ancestor
65088435|NCT00467948|Cefazolin|cefazolin|mesh-list
65088436|NCT00467948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65088437|NCT00467948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65088438|NCT00592579|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
65088439|NCT00592579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088440|NCT00592579|Tubulin Modulators|tubulin modulators|mesh-ancestor
65088441|NCT00592579|Antimitotic Agents|antimitotic agents|mesh-ancestor
65088442|NCT00592579|Mitosis Modulators|mitosis modulators|mesh-ancestor
65088443|NCT00592579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088444|NCT00592618|Acetylcysteine|acetylcysteine|mesh-list
65088445|NCT00592618|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65088446|NCT00592618|Antiviral Agents|antiviral agents|mesh-ancestor
65088447|NCT00592618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65088448|NCT00592618|Expectorants|expectorants|mesh-ancestor
65088449|NCT00592618|Respiratory System Agents|respiratory system agents|mesh-ancestor
65088450|NCT00592618|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65088451|NCT00592618|Antioxidants|antioxidants|mesh-ancestor
65088452|NCT00592618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088453|NCT00592618|Protective Agents|protective agents|mesh-ancestor
65088454|NCT00592618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088455|NCT00592618|Antidotes|antidotes|mesh-ancestor
64730669|NCT00002905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088456|NCT01243710|Taurolidine|taurolidine|mesh-list
65088457|NCT01243710|Heparin|heparin|mesh-list
65088458|NCT01243710|Anticoagulants|anticoagulants|mesh-ancestor
65088459|NCT01243710|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65088460|NCT01243710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65088461|NCT01243710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088462|NCT01243710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65088463|NCT01243710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65088464|NCT01243710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088465|NCT00622843|Vaccines|vaccines|mesh-list
65088466|NCT00622843|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65088467|NCT00622843|Immunologic Factors|immunologic factors|mesh-ancestor
65088468|NCT00622843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088469|NCT01245543|Docetaxel|docetaxel|mesh-list
65088470|NCT01245543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088471|NCT01245543|Tubulin Modulators|tubulin modulators|mesh-ancestor
65088472|NCT01245543|Antimitotic Agents|antimitotic agents|mesh-ancestor
65088473|NCT01245543|Mitosis Modulators|mitosis modulators|mesh-ancestor
65088474|NCT01245543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088475|NCT00592930|Olanzapine|olanzapine|mesh-list
65088476|NCT00592930|Antiemetics|antiemetics|mesh-ancestor
65088477|NCT00592930|Autonomic Agents|autonomic agents|mesh-ancestor
65088478|NCT00592930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65088479|NCT00592930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088480|NCT00592930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65088481|NCT00592930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65088482|NCT00592930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65088483|NCT00592930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65088484|NCT00592930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65088485|NCT00592930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65088486|NCT00592930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65088487|NCT00592930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65088488|NCT00592930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088489|NCT00592930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65088490|NCT00592930|Serotonin Agents|serotonin agents|mesh-ancestor
65088491|NCT00592969|Metformin|metformin|mesh-list
65088492|NCT00592969|Insulin Aspart|insulin aspart|mesh-list
65088493|NCT00592969|Biphasic Insulins|biphasic insulins|mesh-list
65088494|NCT00592969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65088495|NCT00592969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088496|NCT01245582|Capecitabine|capecitabine|mesh-list
65088497|NCT01245582|Oxaliplatin|oxaliplatin|mesh-list
65088498|NCT01245582|Sorafenib|sorafenib|mesh-list
65088499|NCT01245582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65088500|NCT01245582|Antimetabolites|antimetabolites|mesh-ancestor
65088501|NCT01245582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088502|NCT01245582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088503|NCT01245582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65088504|NCT01245582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65088505|NCT00593008|Gemcitabine|gemcitabine|mesh-list
65088506|NCT00593008|Sirolimus|sirolimus|mesh-list
65088507|NCT00593008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65088508|NCT00593008|Antimetabolites|antimetabolites|mesh-ancestor
65088509|NCT00593008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088510|NCT00593008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088511|NCT00593008|Antiviral Agents|antiviral agents|mesh-ancestor
65088512|NCT00593008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65088513|NCT00593008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65088514|NCT00593008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65088515|NCT00593008|Immunologic Factors|immunologic factors|mesh-ancestor
65088516|NCT00593008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088517|NCT00593008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65088518|NCT00593008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65088519|NCT00593008|Antifungal Agents|antifungal agents|mesh-ancestor
65088520|NCT02956200|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65088521|NCT02956200|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65088522|NCT02956200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088523|NCT02956200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65088524|NCT02956200|Immunologic Factors|immunologic factors|mesh-ancestor
65088525|NCT02956200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088526|NCT00593125|Levetiracetam|levetiracetam|mesh-list
65088527|NCT00593125|Anticonvulsants|anticonvulsants|mesh-ancestor
65088528|NCT00593125|Nootropic Agents|nootropic agents|mesh-ancestor
65088529|NCT00593164|Magnesium Sulfate|magnesium sulfate|mesh-list
65088530|NCT00593164|Analgesics|analgesics|mesh-ancestor
65088531|NCT00593164|Sensory System Agents|sensory system agents|mesh-ancestor
64730761|NCT00002935|Trioxsalen|trioxsalen|mesh-list
65088532|NCT00593164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65088533|NCT00593164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088535|NCT00593164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65088536|NCT00593164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65088537|NCT00593164|Anticonvulsants|anticonvulsants|mesh-ancestor
65088538|NCT00593164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65088539|NCT00593164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65088540|NCT00593164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088541|NCT00593164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65088542|NCT00593164|Tocolytic Agents|tocolytic agents|mesh-ancestor
65088543|NCT00593164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65088544|NCT01316107|Ipragliflozin|ipragliflozin|mesh-list
65088545|NCT01316107|Nateglinide|nateglinide|mesh-list
65088546|NCT01316107|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65088547|NCT01316107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088548|NCT01316107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65088549|NCT01316107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088550|NCT05654194|Azacitidine|azacitidine|mesh-list
65088551|NCT05654194|Venetoclax|venetoclax|mesh-list
65088552|NCT05654194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65088553|NCT05654194|Antimetabolites|antimetabolites|mesh-ancestor
65088554|NCT05654194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088555|NCT05654194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088556|NCT05654194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65088557|NCT05653453|Gemcitabine|gemcitabine|mesh-list
65088558|NCT05653453|Paclitaxel|paclitaxel|mesh-list
64621110|NCT03821714|Hydrocortisone|hydrocortisone|mesh-list
65088559|NCT05653453|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65088560|NCT05653453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65088561|NCT05653453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088563|NCT05653453|Antimitotic Agents|antimitotic agents|mesh-ancestor
65088564|NCT05653453|Mitosis Modulators|mitosis modulators|mesh-ancestor
65088565|NCT05653453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088566|NCT05653453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65088567|NCT05653453|Antimetabolites|antimetabolites|mesh-ancestor
65088568|NCT05653453|Antiviral Agents|antiviral agents|mesh-ancestor
65088569|NCT05653453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65088570|NCT05653453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65088571|NCT05653453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65088572|NCT05653453|Immunologic Factors|immunologic factors|mesh-ancestor
65088573|NCT05653453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088574|NCT00468182|Interferons|interferons|mesh-list
65088575|NCT00468182|Interferon-beta|interferon-beta|mesh-list
65088576|NCT00468182|Interferon beta-1b|interferon beta-1b|mesh-list
65088577|NCT00468182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088578|NCT00468182|Antiviral Agents|antiviral agents|mesh-ancestor
65088579|NCT00468182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65088580|NCT00468182|Immunologic Factors|immunologic factors|mesh-ancestor
65088581|NCT00468182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088582|NCT00468182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65088583|NCT00465452|Dopamine|dopamine|mesh-list
65088584|NCT00465452|Dopamine Agonists|dopamine agonists|mesh-list
65088585|NCT00465452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65088586|NCT00465452|Sympathomimetics|sympathomimetics|mesh-ancestor
65088587|NCT00465452|Autonomic Agents|autonomic agents|mesh-ancestor
65088588|NCT00465452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65088589|NCT00465452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088590|NCT00465452|Dopamine Agents|dopamine agents|mesh-ancestor
65088591|NCT00465452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65088592|NCT00465452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088593|NCT00465452|Protective Agents|protective agents|mesh-ancestor
65088594|NCT01379521|Everolimus|everolimus|mesh-list
65088595|NCT01379521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088596|NCT01379521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65088597|NCT01379521|Immunologic Factors|immunologic factors|mesh-ancestor
65088598|NCT01379521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088599|NCT00468260|Epothilone B|epothilone b|mesh-list
65088600|NCT00468260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088601|NCT00468260|Tubulin Modulators|tubulin modulators|mesh-ancestor
65088602|NCT00468260|Antimitotic Agents|antimitotic agents|mesh-ancestor
65088603|NCT00468260|Mitosis Modulators|mitosis modulators|mesh-ancestor
65088604|NCT00468260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088605|NCT01371994|Solifenacin Succinate|solifenacin succinate|mesh-list
65088606|NCT01371994|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65088607|NCT01371994|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65088608|NCT01371994|Cholinergic Agents|cholinergic agents|mesh-ancestor
65088609|NCT01371994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65088610|NCT01371994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088611|NCT01371994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088612|NCT01371994|Urological Agents|urological agents|mesh-ancestor
65088613|NCT00465608|Propranolol|propranolol|mesh-list
65088614|NCT00465608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65088615|NCT00465608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65088616|NCT00465608|Adrenergic Agents|adrenergic agents|mesh-ancestor
65088617|NCT00465608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65088618|NCT00465608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088619|NCT00465608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088620|NCT00465608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65088621|NCT00465608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65088622|NCT00465608|Vasodilator Agents|vasodilator agents|mesh-ancestor
65088623|NCT01371877|Vitamin D|vitamin d|mesh-list
65088624|NCT01371877|Ergocalciferols|ergocalciferols|mesh-list
65088625|NCT01371877|Cholecalciferol|cholecalciferol|mesh-list
65088626|NCT01371877|Vitamins|vitamins|mesh-list
65088627|NCT01371877|Micronutrients|micronutrients|mesh-ancestor
65088628|NCT01371877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088629|NCT01371877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65088630|NCT01371877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65088631|NCT01245816|Eflornithine|eflornithine|mesh-list
65088632|NCT01245816|Sulindac|sulindac|mesh-list
65088633|NCT01245816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088634|NCT01245816|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65088635|NCT01245816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65088636|NCT01245816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65088637|NCT01245816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65088638|NCT01245816|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
65088639|NCT01245816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65088640|NCT01245816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088641|NCT01245816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65088642|NCT01245816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65088643|NCT01245816|Analgesics|analgesics|mesh-ancestor
65088644|NCT01245816|Sensory System Agents|sensory system agents|mesh-ancestor
65088645|NCT01245816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65088646|NCT01245816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088647|NCT01245816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65088648|NCT01245816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65088649|NCT01245816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65088651|NCT00492687|Carboplatin|carboplatin|mesh-list
65088652|NCT00492687|Temozolomide|temozolomide|mesh-list
65088653|NCT00492687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088654|NCT00492687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088655|NCT00492687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65088656|NCT00492687|Alkylating Agents|alkylating agents|mesh-ancestor
65088657|NCT00492687|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65088658|NCT00492687|Hormone Antagonists|hormone antagonists|mesh-ancestor
65088659|NCT00492687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65088660|NCT00492687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088661|NCT00492687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65088662|NCT00492687|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65088663|NCT00492687|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65088664|NCT00492687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65088665|NCT01371838|Ceftriaxone|ceftriaxone|mesh-list
65088666|NCT01371838|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
65088667|NCT01371838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65088668|NCT01371838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65088669|NCT01245855|Alprostadil|alprostadil|mesh-list
65088670|NCT01245855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65088671|NCT01245855|Vasodilator Agents|vasodilator agents|mesh-ancestor
65088672|NCT01245855|Urological Agents|urological agents|mesh-ancestor
65088673|NCT00473603|Heparin|heparin|mesh-list
65088674|NCT00473603|Anticoagulants|anticoagulants|mesh-ancestor
65088675|NCT00473603|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65088676|NCT00473603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65088677|NCT00473603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088678|NCT00492765|Interferons|interferons|mesh-list
65088679|NCT00492765|Interferon-beta|interferon-beta|mesh-list
65088680|NCT00492765|Interferon beta-1a|interferon beta-1a|mesh-list
65088681|NCT00492765|Simvastatin|simvastatin|mesh-list
65088682|NCT00492765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088683|NCT00492765|Antiviral Agents|antiviral agents|mesh-ancestor
65088684|NCT00492765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65088685|NCT00492765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65088686|NCT00492765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65088687|NCT00492765|Antimetabolites|antimetabolites|mesh-ancestor
65088688|NCT00492765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088689|NCT00492765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65088690|NCT00492765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65088691|NCT00492765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65088692|NCT00492765|Immunologic Factors|immunologic factors|mesh-ancestor
65088693|NCT00492765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088694|NCT00492765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65088696|NCT00468533|Antidepressive Agents|antidepressive agents|mesh-ancestor
65088697|NCT00468533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65088698|NCT00468533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65088699|NCT00468533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65088700|NCT00468533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65088701|NCT00468533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088702|NCT00468533|Dopamine Agonists|dopamine agonists|mesh-ancestor
65088703|NCT00468533|Dopamine Agents|dopamine agents|mesh-ancestor
65088704|NCT00468533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65088705|NCT00468533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483349|NCT01764841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088706|NCT00468533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65088707|NCT00468533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65088708|NCT00468533|Serotonin Agents|serotonin agents|mesh-ancestor
65088709|NCT00468533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65088710|NCT00468533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65088711|NCT00468533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65088712|NCT00468533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65088713|NCT00473720|Paclitaxel|paclitaxel|mesh-list
65088714|NCT00473720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65088715|NCT00473720|Satraplatin|satraplatin|mesh-list
65088716|NCT00473720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65088717|NCT00473720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088718|NCT00473720|Tubulin Modulators|tubulin modulators|mesh-ancestor
65088720|NCT00473720|Mitosis Modulators|mitosis modulators|mesh-ancestor
65088721|NCT00473720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088722|NCT00499668|Ondansetron|ondansetron|mesh-list
65088723|NCT00499668|Aprepitant|aprepitant|mesh-list
65088724|NCT00499668|Antiemetics|antiemetics|mesh-ancestor
65088725|NCT00499668|Autonomic Agents|autonomic agents|mesh-ancestor
65088726|NCT00499668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65088727|NCT00499668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088728|NCT00499668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65088729|NCT00499668|Antipruritics|antipruritics|mesh-ancestor
65088730|NCT00499668|Dermatologic Agents|dermatologic agents|mesh-ancestor
65088731|NCT00499668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65088732|NCT00499668|Serotonin Agents|serotonin agents|mesh-ancestor
65088733|NCT00499668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65088734|NCT00499668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088735|NCT00499668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65088736|NCT00499668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65088737|NCT00499668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65088738|NCT00499668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65088739|NCT00499668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65088740|NCT00499668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
65088741|NCT00499707|Metformin|metformin|mesh-list
65088742|NCT00499707|Rosiglitazone|rosiglitazone|mesh-list
65088743|NCT00499707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65088744|NCT00499707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088745|NCT01366534|Vaccines|vaccines|mesh-list
65088746|NCT01366534|Immunologic Factors|immunologic factors|mesh-ancestor
65088747|NCT01366534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088748|NCT00492843|Ibandronic Acid|ibandronic acid|mesh-list
65088749|NCT00492843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65088750|NCT00492843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088751|NCT01605487|Cyproheptadine|cyproheptadine|mesh-list
65088752|NCT01605487|Antipruritics|antipruritics|mesh-ancestor
65088753|NCT01605487|Dermatologic Agents|dermatologic agents|mesh-ancestor
65088754|NCT01605487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65088755|NCT01605487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64730969|NCT01925131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65088756|NCT01605487|Histamine Antagonists|histamine antagonists|mesh-ancestor
65088757|NCT01605487|Histamine Agents|histamine agents|mesh-ancestor
65088758|NCT01605487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65088759|NCT01605487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088760|NCT01605487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088761|NCT01605487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65088762|NCT01605487|Serotonin Agents|serotonin agents|mesh-ancestor
65088763|NCT01605487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65088764|NCT01605526|Doxorubicin|doxorubicin|mesh-list
65088765|NCT01605526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65088766|NCT01605526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088767|NCT01605526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65088768|NCT01605526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65088769|NCT01605526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65088770|NCT01605526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088771|NCT00468689|Ketoconazole|ketoconazole|mesh-list
65088772|NCT00468689|Antifungal Agents|antifungal agents|mesh-ancestor
65088773|NCT00468689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65088774|NCT00468689|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65088775|NCT00468689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65088776|NCT00468689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64483351|NCT01764841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65088777|NCT00468689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088778|NCT00468689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65088779|NCT00468689|Hormone Antagonists|hormone antagonists|mesh-ancestor
65088780|NCT00468689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65088781|NCT00468689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088782|NCT00468689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65088783|NCT00473915|Fluticasone|fluticasone|mesh-list
65088785|NCT00473915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65088786|NCT00473915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65088787|NCT00473915|Autonomic Agents|autonomic agents|mesh-ancestor
65088788|NCT00473915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65088789|NCT00473915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088790|NCT00473915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65088791|NCT00473915|Respiratory System Agents|respiratory system agents|mesh-ancestor
65088792|NCT00473915|Dermatologic Agents|dermatologic agents|mesh-ancestor
65088793|NCT00473915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65088795|NCT00493077|Interferon-beta|interferon-beta|mesh-list
65088796|NCT00493077|Interferon beta-1a|interferon beta-1a|mesh-list
65088797|NCT00493077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088798|NCT00493077|Antiviral Agents|antiviral agents|mesh-ancestor
65088799|NCT00493077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65088800|NCT00493077|Immunologic Factors|immunologic factors|mesh-ancestor
64446670|NCT01516216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65088801|NCT00493077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088802|NCT00493077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65088803|NCT00474071|Remifentanil|remifentanil|mesh-list
65088804|NCT00474071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65088805|NCT00474071|Narcotics|narcotics|mesh-ancestor
65088806|NCT00474071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65088807|NCT00474071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088808|NCT00474071|Analgesics|analgesics|mesh-ancestor
65088809|NCT00474071|Sensory System Agents|sensory system agents|mesh-ancestor
65088810|NCT00474071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65088811|NCT00474110|Ketamine|ketamine|mesh-list
65088812|NCT00474110|Hydromorphone|hydromorphone|mesh-list
65088813|NCT00474110|Analgesics|analgesics|mesh-ancestor
65088814|NCT00474110|Sensory System Agents|sensory system agents|mesh-ancestor
65088815|NCT00474110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65088816|NCT00474110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088817|NCT00474110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65088818|NCT00474110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65088819|NCT00474110|Anesthetics, General|anesthetics, general|mesh-ancestor
65088820|NCT00474110|Anesthetics|anesthetics|mesh-ancestor
65088821|NCT00474110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65088822|NCT00474110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65088823|NCT00474110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65088824|NCT00474110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65088825|NCT00474110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088826|NCT00474110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65088827|NCT00474110|Narcotics|narcotics|mesh-ancestor
65088828|NCT00500058|Rituximab|rituximab|mesh-list
65088829|NCT00500058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65088830|NCT00500058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088831|NCT00500058|Immunologic Factors|immunologic factors|mesh-ancestor
65088832|NCT00500058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088833|NCT00500058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65088834|NCT00468923|Candesartan|candesartan|mesh-list
65088835|NCT00468923|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65088836|NCT00468923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65088837|NCT00468923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65088838|NCT00468923|Antimetabolites|antimetabolites|mesh-ancestor
65088839|NCT00468923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088840|NCT00468923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65088841|NCT00468923|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65088842|NCT00468923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65088843|NCT00468923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65088844|NCT00468923|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65088845|NCT00468923|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65088846|NCT01365481|Amlodipine|amlodipine|mesh-list
65088847|NCT01365481|Valsartan|valsartan|mesh-list
65088848|NCT01365481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65088849|NCT01365481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65088850|NCT01365481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64483354|NCT00245050|Doxorubicin|doxorubicin|mesh-list
65088851|NCT01365481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65088852|NCT01365481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088853|NCT01365481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65088854|NCT01365481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088855|NCT01365481|Vasodilator Agents|vasodilator agents|mesh-ancestor
65088856|NCT01365481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65088857|NCT01365481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65088858|NCT01365481|Diuretics|diuretics|mesh-ancestor
65088859|NCT01365481|Natriuretic Agents|natriuretic agents|mesh-ancestor
65088860|NCT01365481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65088861|NCT00493116|Interferons|interferons|mesh-list
65088862|NCT00493116|Interferon-beta|interferon-beta|mesh-list
65088863|NCT00493116|Interferon beta-1a|interferon beta-1a|mesh-list
65088864|NCT00493116|Methylprednisolone|methylprednisolone|mesh-list
65088865|NCT00493116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088866|NCT00493116|Antiviral Agents|antiviral agents|mesh-ancestor
64835551|NCT02727803|Rituximab|rituximab|mesh-list
64835552|NCT02727803|Fludarabine|fludarabine|mesh-list
64835554|NCT02727803|Clofarabine|clofarabine|mesh-list
65088867|NCT00493116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65088868|NCT00493116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65088869|NCT00493116|Antiemetics|antiemetics|mesh-ancestor
65088870|NCT00493116|Autonomic Agents|autonomic agents|mesh-ancestor
65088871|NCT00493116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65088872|NCT00493116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088873|NCT00493116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65088874|NCT00493116|Glucocorticoids|glucocorticoids|mesh-ancestor
65088875|NCT00493116|Hormones|hormones|mesh-ancestor
65088876|NCT00493116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65088877|NCT00493116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65088878|NCT00493116|Protective Agents|protective agents|mesh-ancestor
65088879|NCT00493116|Immunologic Factors|immunologic factors|mesh-ancestor
65088880|NCT00493116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65088881|NCT00493194|Cyclosporine|cyclosporine|mesh-list
65088882|NCT00493194|Sirolimus|sirolimus|mesh-list
65088883|NCT00493194|Cyclosporins|cyclosporins|mesh-list
65088884|NCT00493194|Daclizumab|daclizumab|mesh-list
65088885|NCT00493194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65088886|NCT00493194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088887|NCT00493194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65088888|NCT00493194|Immunologic Factors|immunologic factors|mesh-ancestor
65088889|NCT00493194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088890|NCT00493194|Antifungal Agents|antifungal agents|mesh-ancestor
65088891|NCT00493194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65088892|NCT00493194|Dermatologic Agents|dermatologic agents|mesh-ancestor
65088893|NCT00493194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65088894|NCT00493194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65088895|NCT00493194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65088896|NCT00493194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65088897|NCT00493194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088898|NCT01605721|Everolimus|everolimus|mesh-list
65088899|NCT01605721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088900|NCT01605721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65088901|NCT01605721|Immunologic Factors|immunologic factors|mesh-ancestor
65088902|NCT01605721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088903|NCT01350271|Mebendazole|mebendazole|mesh-list
64731120|NCT00003013|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65088904|NCT01350271|Piperazine|piperazine|mesh-list
65088905|NCT01350271|Piperazine citrate|piperazine citrate|mesh-list
65088906|NCT01350271|DMP 777|dmp 777|mesh-list
65088907|NCT01350271|Antinematodal Agents|antinematodal agents|mesh-ancestor
65088908|NCT01350271|Anthelmintics|anthelmintics|mesh-ancestor
65088909|NCT01350271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65088910|NCT01350271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65088911|NCT01350271|Tubulin Modulators|tubulin modulators|mesh-ancestor
65088912|NCT01350271|Antimitotic Agents|antimitotic agents|mesh-ancestor
65088913|NCT01350271|Mitosis Modulators|mitosis modulators|mesh-ancestor
65088914|NCT01350271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088915|NCT01350271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65088916|NCT01350271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65088917|NCT00493233|Olanzapine|olanzapine|mesh-list
65088918|NCT00493233|Risperidone|risperidone|mesh-list
65088919|NCT00493233|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65088920|NCT00493233|Antipsychotic Agents|antipsychotic agents|mesh-list
65088921|NCT00493233|Clozapine|clozapine|mesh-list
65088922|NCT00493233|Perphenazine|perphenazine|mesh-list
65088923|NCT00493233|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65088924|NCT00493233|Serotonin Agents|serotonin agents|mesh-ancestor
65088925|NCT00493233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65088926|NCT00493233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088927|NCT00493233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088928|NCT00493233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65088929|NCT00493233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65088930|NCT00493233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65088931|NCT00493233|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65088932|NCT00493233|Dopamine Agents|dopamine agents|mesh-ancestor
65088933|NCT00493233|Antiemetics|antiemetics|mesh-ancestor
65088934|NCT00493233|Autonomic Agents|autonomic agents|mesh-ancestor
64661672|NCT01366196|Pregabalin|pregabalin|mesh-list
65088935|NCT00493233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65088936|NCT00493233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65088937|NCT00493233|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65088938|NCT00493233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65088939|NCT00493233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65088940|NCT00493233|Antidepressive Agents|antidepressive agents|mesh-ancestor
65088941|NCT00493233|GABA Antagonists|gaba antagonists|mesh-ancestor
65088942|NCT00493233|GABA Agents|gaba agents|mesh-ancestor
65088943|NCT00500253|Nitric Oxide|nitric oxide|mesh-list
65088944|NCT00500253|Methacholine Chloride|methacholine chloride|mesh-list
65088945|NCT00500253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65088946|NCT00500253|Autonomic Agents|autonomic agents|mesh-ancestor
65088947|NCT00500253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65088948|NCT00500253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088949|NCT00500253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65088950|NCT00500253|Respiratory System Agents|respiratory system agents|mesh-ancestor
65088951|NCT00500253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65088952|NCT00500253|Antioxidants|antioxidants|mesh-ancestor
65088953|NCT00500253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088954|NCT00500253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65088955|NCT00500253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
65088956|NCT00500253|Vasodilator Agents|vasodilator agents|mesh-ancestor
65088957|NCT00500253|Gasotransmitters|gasotransmitters|mesh-ancestor
65088958|NCT00500253|Protective Agents|protective agents|mesh-ancestor
65088959|NCT00500253|Miotics|miotics|mesh-ancestor
65088960|NCT00500253|Parasympathomimetics|parasympathomimetics|mesh-ancestor
65088961|NCT00500253|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
65088962|NCT00500253|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
65088963|NCT00500253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65088964|NCT00500253|Cholinergic Agents|cholinergic agents|mesh-ancestor
65088965|NCT01243788|Fluticasone|fluticasone|mesh-list
65088966|NCT01243788|Xhance|xhance|mesh-list
65088967|NCT01243788|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65088968|NCT01243788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65088969|NCT01243788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65088970|NCT01243788|Autonomic Agents|autonomic agents|mesh-ancestor
65088971|NCT01243788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65088972|NCT01243788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088973|NCT01243788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65088974|NCT01243788|Respiratory System Agents|respiratory system agents|mesh-ancestor
65088975|NCT01243788|Dermatologic Agents|dermatologic agents|mesh-ancestor
65088976|NCT01243788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65088977|NCT01243788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65088978|NCT01243788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65088979|NCT01243788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65088980|NCT01243788|Adrenergic Agents|adrenergic agents|mesh-ancestor
65088981|NCT01243788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65088982|NCT01243788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088983|NCT01243827|Carvedilol|carvedilol|mesh-list
65088984|NCT01243827|Bisoprolol|bisoprolol|mesh-list
65088985|NCT01243827|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65088986|NCT01243827|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65088987|NCT01243827|Adrenergic Agents|adrenergic agents|mesh-ancestor
65088988|NCT01243827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65088989|NCT01243827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65088990|NCT01243827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65088991|NCT01243827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65088992|NCT01243827|Antioxidants|antioxidants|mesh-ancestor
65088993|NCT01243827|Protective Agents|protective agents|mesh-ancestor
65088994|NCT01243827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65088995|NCT01243827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65088996|NCT01243827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65088997|NCT01243827|Vasodilator Agents|vasodilator agents|mesh-ancestor
65088998|NCT01243827|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65088999|NCT01243827|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65089000|NCT01243827|Sympatholytics|sympatholytics|mesh-ancestor
65089001|NCT01243827|Autonomic Agents|autonomic agents|mesh-ancestor
65089002|NCT01243827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65089003|NCT01243827|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65089005|NCT00500409|Vitamins|vitamins|mesh-ancestor
65089006|NCT00500409|Micronutrients|micronutrients|mesh-ancestor
65089007|NCT00500409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325569|NCT01373931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64325570|NCT01373931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64325571|NCT01373931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089008|NCT00500409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65089009|NCT00469352|Ranibizumab|ranibizumab|mesh-list
65089010|NCT00469352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65089011|NCT00469352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65089012|NCT00469352|Growth Substances|growth substances|mesh-ancestor
65089013|NCT00469352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089014|NCT00469352|Growth Inhibitors|growth inhibitors|mesh-ancestor
65089015|NCT00469352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089016|NCT00469430|Metronidazole|metronidazole|mesh-list
65089017|NCT00469430|Cefotaxime|cefotaxime|mesh-list
65089018|NCT00469430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65089019|NCT00469430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65089020|NCT00469430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65089021|NCT00469430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65089022|NCT00469469|Bevacizumab|bevacizumab|mesh-list
65089023|NCT00469469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65089024|NCT00469469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089025|NCT00469469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65089026|NCT00469469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65089027|NCT00469469|Growth Substances|growth substances|mesh-ancestor
65089028|NCT00469469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089029|NCT00469469|Growth Inhibitors|growth inhibitors|mesh-ancestor
65089030|NCT00500565|Bupivacaine|bupivacaine|mesh-list
65089031|NCT00500565|Anesthetics, Local|anesthetics, local|mesh-ancestor
65089032|NCT00500565|Anesthetics|anesthetics|mesh-ancestor
65089033|NCT00500565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65089034|NCT00500565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089035|NCT00500565|Sensory System Agents|sensory system agents|mesh-ancestor
65089036|NCT00500565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65089037|NCT00469547|Ethanol|ethanol|mesh-list
65089038|NCT00469547|Anti-Infective Agents|anti-infective agents|mesh-list
65089039|NCT00469547|Emollients|emollients|mesh-list
65089040|NCT00469547|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65089041|NCT00469547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65089042|NCT00469547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089043|NCT00469547|Dermatologic Agents|dermatologic agents|mesh-ancestor
65089044|NCT00500604|Valsartan|valsartan|mesh-list
65089045|NCT00500604|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65089046|NCT00500604|Irbesartan|irbesartan|mesh-list
65089047|NCT00500604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65089048|NCT00500604|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65089049|NCT00500604|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65089050|NCT00500604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089051|NCT00500604|Diuretics|diuretics|mesh-ancestor
65089052|NCT00500604|Natriuretic Agents|natriuretic agents|mesh-ancestor
65089053|NCT00500604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089054|NCT00500604|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65089055|NCT00500604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65089056|NCT00493389|Hormones|hormones|mesh-list
65089057|NCT00493389|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
65089058|NCT00493389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65089059|NCT00493389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089061|NCT01605994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089062|NCT01605994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65089063|NCT00500721|Desipramine|desipramine|mesh-list
65089064|NCT00500721|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
65089065|NCT00500721|Antidepressive Agents|antidepressive agents|mesh-ancestor
65089066|NCT00500721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65089067|NCT00500721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089068|NCT00500721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089069|NCT00500721|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65089070|NCT00500721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65089071|NCT00500721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65089072|NCT00500721|Adrenergic Agents|adrenergic agents|mesh-ancestor
65089073|NCT00500721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65089074|NCT00500721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089076|NCT00469586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65089077|NCT00469586|Metformin|metformin|mesh-list
65089078|NCT00469586|Glimepiride|glimepiride|mesh-list
65089079|NCT00469586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65089080|NCT00469586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089081|NCT00469586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65089082|NCT00469586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65089083|NCT00469586|Immunologic Factors|immunologic factors|mesh-ancestor
65089084|NCT01606111|Cerebrolysin|cerebrolysin|mesh-list
65089085|NCT01606111|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65089086|NCT01606111|Protective Agents|protective agents|mesh-ancestor
65089087|NCT01606111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089088|NCT01606111|Nootropic Agents|nootropic agents|mesh-ancestor
65089089|NCT00493428|Baclofen|baclofen|mesh-list
65089090|NCT00493428|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65089091|NCT00493428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089092|NCT00493428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65089093|NCT00493428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65089094|NCT00493428|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
65089095|NCT00493428|GABA Agonists|gaba agonists|mesh-ancestor
65089096|NCT00493428|GABA Agents|gaba agents|mesh-ancestor
65089097|NCT00493428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65089098|NCT00493428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089099|NCT01342510|Lidocaine|lidocaine|mesh-list
65089100|NCT01342510|Magnesium Sulfate|magnesium sulfate|mesh-list
65089101|NCT01342510|Anesthetics, Local|anesthetics, local|mesh-ancestor
65089102|NCT01342510|Anesthetics|anesthetics|mesh-ancestor
65089103|NCT01342510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65089104|NCT01342510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089105|NCT01342510|Sensory System Agents|sensory system agents|mesh-ancestor
65089106|NCT01342510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65089107|NCT01342510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65089108|NCT01342510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65089109|NCT01342510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65089110|NCT01342510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65089111|NCT01342510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089112|NCT01342510|Analgesics|analgesics|mesh-ancestor
65089113|NCT01342510|Anticonvulsants|anticonvulsants|mesh-ancestor
65089114|NCT01342510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65089115|NCT01342510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65089116|NCT01342510|Tocolytic Agents|tocolytic agents|mesh-ancestor
65089117|NCT01342510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65089118|NCT01606345|Valrubicin|valrubicin|mesh-list
65089119|NCT01606345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089120|NCT01606345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65089121|NCT01606345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65089122|NCT01606345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089123|NCT01606345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089124|NCT01245894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65089125|NCT01245894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65089126|NCT01245894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65089127|NCT01245894|Antimetabolites|antimetabolites|mesh-ancestor
65089128|NCT01245894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089129|NCT01245894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65089130|NCT01245894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65089131|NCT01245894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089132|NCT00469664|Guanfacine|guanfacine|mesh-list
65089133|NCT00469664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65089134|NCT00469664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65089135|NCT00469664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65089136|NCT00469664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65089137|NCT00469664|Adrenergic Agents|adrenergic agents|mesh-ancestor
65089138|NCT00469664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65089139|NCT00469664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089140|NCT00469664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089141|NCT00469703|Thalidomide|thalidomide|mesh-list
65089142|NCT00469703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65089143|NCT00469703|Immunologic Factors|immunologic factors|mesh-ancestor
65089144|NCT00469703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089145|NCT00469703|Leprostatic Agents|leprostatic agents|mesh-ancestor
65089146|NCT00469703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65089147|NCT00469703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65089148|NCT00469703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65089149|NCT00469703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65089150|NCT00469703|Growth Substances|growth substances|mesh-ancestor
65089151|NCT00469703|Growth Inhibitors|growth inhibitors|mesh-ancestor
65089152|NCT00469703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089153|NCT01244100|Aspirin|aspirin|mesh-list
65089154|NCT01244100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65089155|NCT01244100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65089157|NCT01244100|Sensory System Agents|sensory system agents|mesh-ancestor
65089158|NCT01244100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65089159|NCT01244100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089160|NCT01244100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65089161|NCT01244100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65089162|NCT01244100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65089163|NCT01244100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65089164|NCT01244100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089165|NCT01244100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65089166|NCT01244100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65089167|NCT01244100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089168|NCT01244100|Antipyretics|antipyretics|mesh-ancestor
65089169|NCT01340872|Ferric maltol|ferric maltol|mesh-list
65089170|NCT01340872|Hematinics|hematinics|mesh-ancestor
65089171|NCT00469781|Bromfenac|bromfenac|mesh-list
65089172|NCT00469781|Prednisolone acetate|prednisolone acetate|mesh-list
65089173|NCT00469781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65089174|NCT00469781|Methylprednisolone|methylprednisolone|mesh-list
65089175|NCT00469781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65089176|NCT00469781|Prednisolone|prednisolone|mesh-list
65089177|NCT00469781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65089178|NCT00469781|Prednisolone phosphate|prednisolone phosphate|mesh-list
65089179|NCT00469781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65089180|NCT00469781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65089181|NCT00469781|Analgesics|analgesics|mesh-ancestor
65089182|NCT00469781|Sensory System Agents|sensory system agents|mesh-ancestor
65089183|NCT00469781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65089184|NCT00469781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089185|NCT00469781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65089186|NCT00469781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65089187|NCT00469781|Antiemetics|antiemetics|mesh-ancestor
65089188|NCT00469781|Autonomic Agents|autonomic agents|mesh-ancestor
65089189|NCT00469781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65089190|NCT00469781|Glucocorticoids|glucocorticoids|mesh-ancestor
65089191|NCT00469781|Hormones|hormones|mesh-ancestor
65089192|NCT00469781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65089193|NCT00469781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65089194|NCT00469781|Protective Agents|protective agents|mesh-ancestor
65089195|NCT00469781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65089196|NCT00469781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089197|NCT00474695|Ranibizumab|ranibizumab|mesh-list
65089198|NCT00474695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65089199|NCT00474695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65089200|NCT00474695|Growth Substances|growth substances|mesh-ancestor
65089201|NCT00474695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089202|NCT00474695|Growth Inhibitors|growth inhibitors|mesh-ancestor
65089203|NCT00474695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089204|NCT03271502|Anesthetics|anesthetics|mesh-list
65089205|NCT03271502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65089206|NCT03271502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089208|NCT00500955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65089209|NCT00500955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089210|NCT00474773|Celecoxib|celecoxib|mesh-list
65089211|NCT00474773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65089212|NCT00474773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65089213|NCT00474773|Analgesics|analgesics|mesh-ancestor
65089214|NCT00474773|Sensory System Agents|sensory system agents|mesh-ancestor
65089215|NCT00474773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65089216|NCT00474773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089217|NCT00474773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65089218|NCT00474773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65089219|NCT00474773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65089220|NCT00474773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65089221|NCT00474773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089222|NCT00474773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089223|NCT00474890|Pseudoephedrine|pseudoephedrine|mesh-list
65089224|NCT00474890|Ephedrine|ephedrine|mesh-list
65089225|NCT00474890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65089226|NCT00474890|Autonomic Agents|autonomic agents|mesh-ancestor
65089227|NCT00474890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65089228|NCT00474890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089229|NCT00474890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65089230|NCT00474890|Respiratory System Agents|respiratory system agents|mesh-ancestor
65089231|NCT00474890|Nasal Decongestants|nasal decongestants|mesh-ancestor
65089232|NCT00474890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65089233|NCT00474890|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65089234|NCT00474890|Sympathomimetics|sympathomimetics|mesh-ancestor
65089235|NCT00474890|Adrenergic Agents|adrenergic agents|mesh-ancestor
65089236|NCT00474890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65089237|NCT00474890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089238|NCT00501111|Donepezil|donepezil|mesh-list
65089239|NCT00501111|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65089240|NCT00501111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089241|NCT00501111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089242|NCT00501111|Cholinergic Agents|cholinergic agents|mesh-ancestor
65089243|NCT00501111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65089244|NCT00501111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089245|NCT00501111|Nootropic Agents|nootropic agents|mesh-ancestor
65089246|NCT00501150|Linezolid|linezolid|mesh-list
65089247|NCT00501150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65089248|NCT00501150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65089249|NCT00501150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65089250|NCT00501150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089251|NCT00501150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089252|NCT01340209|Tiotropium Bromide|tiotropium bromide|mesh-list
65089253|NCT01340209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65089254|NCT01340209|Autonomic Agents|autonomic agents|mesh-ancestor
65089255|NCT01340209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65089256|NCT01340209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089257|NCT01340209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65089258|NCT01340209|Respiratory System Agents|respiratory system agents|mesh-ancestor
65089259|NCT01340209|Parasympatholytics|parasympatholytics|mesh-ancestor
65089260|NCT01340209|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65089261|NCT01340209|Cholinergic Agents|cholinergic agents|mesh-ancestor
65089262|NCT01340209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65089263|NCT01340209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089264|NCT01246089|Ranibizumab|ranibizumab|mesh-list
65089265|NCT01246089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65089266|NCT01246089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65089267|NCT01246089|Growth Substances|growth substances|mesh-ancestor
65089268|NCT01246089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089269|NCT01246089|Growth Inhibitors|growth inhibitors|mesh-ancestor
65089270|NCT01246089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089271|NCT00598897|Clarithromycin|clarithromycin|mesh-list
65089272|NCT00598897|Rifabutin|rifabutin|mesh-list
65089273|NCT00598897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65089274|NCT00598897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65089275|NCT00598897|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65089276|NCT00598897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089277|NCT00598897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089278|NCT00598897|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65089279|NCT00598897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65089280|NCT00598897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65089281|NCT00598897|Antitubercular Agents|antitubercular agents|mesh-ancestor
65089283|NCT04697732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65089284|NCT04697732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089286|NCT00501267|Solabegron|solabegron|mesh-list
65089287|NCT00501267|Parasympatholytics|parasympatholytics|mesh-ancestor
65089288|NCT00501267|Autonomic Agents|autonomic agents|mesh-ancestor
65089289|NCT00501267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65089290|NCT00501267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089291|NCT00501267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65089292|NCT00501267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65089293|NCT00501267|Cholinergic Agents|cholinergic agents|mesh-ancestor
65089294|NCT00501267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65089295|NCT00501267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089296|NCT00501267|Urological Agents|urological agents|mesh-ancestor
65089297|NCT00501267|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
65089298|NCT00501267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65089299|NCT00501267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65089300|NCT00501267|Adrenergic Agents|adrenergic agents|mesh-ancestor
65089302|NCT00469937|Antidepressive Agents|antidepressive agents|mesh-ancestor
65089303|NCT00469937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65089304|NCT00469937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089305|NCT00469937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089306|NCT00469937|Antimanic Agents|antimanic agents|mesh-ancestor
65089307|NCT00469937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65089308|NCT00469937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65089309|NCT00469937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089310|NCT00599287|Haloperidol|haloperidol|mesh-list
65089311|NCT00599287|Haloperidol decanoate|haloperidol decanoate|mesh-list
65089312|NCT00599287|Methylphenidate|methylphenidate|mesh-list
65089313|NCT00599287|Rivastigmine|rivastigmine|mesh-list
65089314|NCT00599287|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65089315|NCT00599287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089316|NCT00599287|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65089317|NCT00599287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65089318|NCT00599287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65089319|NCT00599287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089320|NCT00599287|Dopamine Agents|dopamine agents|mesh-ancestor
65089321|NCT00599287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65089322|NCT00599287|Antiemetics|antiemetics|mesh-ancestor
65089323|NCT00599287|Autonomic Agents|autonomic agents|mesh-ancestor
65089324|NCT00599287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65089325|NCT00599287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65089326|NCT00599287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65089327|NCT00599287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65089328|NCT00599287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65089329|NCT00599287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65089330|NCT00599287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65089331|NCT00599287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65089332|NCT00599287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65089333|NCT00599287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089334|NCT00599287|Cholinergic Agents|cholinergic agents|mesh-ancestor
65089335|NCT00599287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65089336|NCT00599287|Protective Agents|protective agents|mesh-ancestor
65089337|NCT04326166|Metformin|metformin|mesh-list
65089338|NCT04326166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65089339|NCT04326166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089340|NCT00501384|Satavaptan|satavaptan|mesh-list
65089341|NCT00501384|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65089342|NCT00501384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089343|NCT00501384|Natriuretic Agents|natriuretic agents|mesh-ancestor
65089344|NCT00501384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089345|NCT00599560|Vasopressins|vasopressins|mesh-list
65089346|NCT00599560|Arginine Vasopressin|arginine vasopressin|mesh-list
65089347|NCT00599560|Hemostatics|hemostatics|mesh-ancestor
65089348|NCT00599560|Coagulants|coagulants|mesh-ancestor
65089349|NCT00599560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64483382|NCT03806374|Propofol|propofol|mesh-list
65089350|NCT00599560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
65089351|NCT00599560|Natriuretic Agents|natriuretic agents|mesh-ancestor
65089352|NCT00599560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089353|NCT00599716|Hyaluronic Acid|hyaluronic acid|mesh-list
65089354|NCT00599716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65089355|NCT00599716|Immunologic Factors|immunologic factors|mesh-ancestor
65089356|NCT00599716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089357|NCT00599716|Viscosupplements|viscosupplements|mesh-ancestor
65089358|NCT00599716|Protective Agents|protective agents|mesh-ancestor
65089359|NCT01246284|Triamcinolone|triamcinolone|mesh-list
65089360|NCT01246284|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65089361|NCT01246284|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65089362|NCT01246284|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65089363|NCT01246284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65089364|NCT01246284|Glucocorticoids|glucocorticoids|mesh-ancestor
65089366|NCT01246284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65089367|NCT01246284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089368|NCT01246284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65089369|NCT01246284|Immunologic Factors|immunologic factors|mesh-ancestor
65089370|NCT01246284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089371|NCT01246284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089372|NCT00599833|Cetuximab|cetuximab|mesh-list
65089373|NCT00599833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65089374|NCT00599833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089375|NCT00469976|Gemcitabine|gemcitabine|mesh-list
65089376|NCT00469976|Bevacizumab|bevacizumab|mesh-list
65089377|NCT00469976|Carboplatin|carboplatin|mesh-list
65089378|NCT00469976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65089379|NCT00469976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089380|NCT00469976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65089381|NCT00469976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65089382|NCT00469976|Growth Substances|growth substances|mesh-ancestor
65089383|NCT00469976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089384|NCT00469976|Growth Inhibitors|growth inhibitors|mesh-ancestor
65089385|NCT00469976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65089386|NCT00469976|Antimetabolites|antimetabolites|mesh-ancestor
65089387|NCT00469976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089388|NCT00469976|Antiviral Agents|antiviral agents|mesh-ancestor
65089389|NCT00469976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65089390|NCT00469976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089391|NCT00469976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65089392|NCT00469976|Immunologic Factors|immunologic factors|mesh-ancestor
65089393|NCT00599911|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65089394|NCT00599911|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65089395|NCT00599911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65089396|NCT00599911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65089397|NCT00599911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089398|NCT00599911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65089399|NCT00599911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089400|NCT00599911|Analgesics|analgesics|mesh-ancestor
65089401|NCT00599911|Sensory System Agents|sensory system agents|mesh-ancestor
65089402|NCT00599911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65089403|NCT00599911|Antidepressive Agents|antidepressive agents|mesh-ancestor
65089404|NCT00599911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65089405|NCT00599911|Dopamine Agents|dopamine agents|mesh-ancestor
65089406|NCT00599950|Mitomycins|mitomycins|mesh-list
65089407|NCT00599950|Mitomycin|mitomycin|mesh-list
65089408|NCT00599950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65089409|NCT00599950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089410|NCT00599950|Alkylating Agents|alkylating agents|mesh-ancestor
65089411|NCT00599950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089412|NCT00599950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65089413|NCT00599950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089414|NCT00600145|Mirtazapine|mirtazapine|mesh-list
65089415|NCT00600145|Antidepressive Agents|antidepressive agents|mesh-ancestor
65089416|NCT00600145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65089417|NCT00600145|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65089418|NCT00600145|Histamine Antagonists|histamine antagonists|mesh-ancestor
65089419|NCT00600145|Histamine Agents|histamine agents|mesh-ancestor
65089420|NCT00600145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65089421|NCT00600145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483383|NCT03806374|Cisatracurium|cisatracurium|mesh-list
65089422|NCT00600145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089423|NCT00600145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65089424|NCT00600145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65089425|NCT00600145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65089426|NCT00600145|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65089427|NCT00600145|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65089428|NCT00600145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65089429|NCT00600145|Adrenergic Agents|adrenergic agents|mesh-ancestor
65089430|NCT00600145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65089431|NCT00600145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65089432|NCT00600145|Serotonin Agents|serotonin agents|mesh-ancestor
65089433|NCT00600145|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65089434|NCT00470015|Aldesleukin|aldesleukin|mesh-list
65089435|NCT00470015|Interleukin-2|interleukin-2|mesh-list
65089436|NCT00470015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089437|NCT00470015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65089438|NCT00470015|Analgesics|analgesics|mesh-ancestor
65089439|NCT00470015|Sensory System Agents|sensory system agents|mesh-ancestor
65089440|NCT00470015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65089441|NCT00470015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089442|NCT00470015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65089443|NCT00470015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65089444|NCT00470015|Antiviral Agents|antiviral agents|mesh-ancestor
65089445|NCT00470015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65089446|NCT00600262|Bevacizumab|bevacizumab|mesh-list
65089447|NCT00600262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65089448|NCT00600262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089449|NCT00600262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65089450|NCT00600262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65089451|NCT00600262|Growth Substances|growth substances|mesh-ancestor
65089452|NCT00600262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089453|NCT00600262|Growth Inhibitors|growth inhibitors|mesh-ancestor
65089454|NCT00600301|Triamcinolone|triamcinolone|mesh-list
65089455|NCT00600301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65089456|NCT00600301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65089457|NCT00600301|Bevacizumab|bevacizumab|mesh-list
65089458|NCT00600301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65089459|NCT00600301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65089460|NCT00600301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089461|NCT00600301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65089462|NCT00600301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65089463|NCT00600301|Growth Substances|growth substances|mesh-ancestor
65089464|NCT00600301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089465|NCT00600301|Growth Inhibitors|growth inhibitors|mesh-ancestor
65089466|NCT00600301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65089467|NCT00600301|Glucocorticoids|glucocorticoids|mesh-ancestor
65089468|NCT00600301|Hormones|hormones|mesh-ancestor
65089469|NCT00600301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65089470|NCT00600301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65089471|NCT00600301|Immunologic Factors|immunologic factors|mesh-ancestor
65089472|NCT00600301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089473|NCT00600301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089474|NCT00501579|Prednisolone|prednisolone|mesh-list
65089475|NCT00501579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65089476|NCT00501579|Methylprednisolone|methylprednisolone|mesh-list
65089477|NCT00501579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65089478|NCT00501579|Prednisolone acetate|prednisolone acetate|mesh-list
65089479|NCT00501579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65089480|NCT00501579|Prednisolone phosphate|prednisolone phosphate|mesh-list
65089481|NCT00501579|Difluprednate|difluprednate|mesh-list
65089482|NCT00501579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65089483|NCT00501579|Glucocorticoids|glucocorticoids|mesh-ancestor
65089484|NCT00501579|Hormones|hormones|mesh-ancestor
64446689|NCT01950819|Prednisone|prednisone|mesh-list
64835558|NCT02727803|Immunoglobulins|immunoglobulins|mesh-list
64835559|NCT02727803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64835560|NCT02727803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64835561|NCT02727803|Immunologic Factors|immunologic factors|mesh-ancestor
64835562|NCT02727803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835563|NCT02727803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65089485|NCT00501579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65089486|NCT00501579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089487|NCT00501579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65089488|NCT00501579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089489|NCT00501579|Antiemetics|antiemetics|mesh-ancestor
65089490|NCT00501579|Autonomic Agents|autonomic agents|mesh-ancestor
65089491|NCT00501579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65089492|NCT00501579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65089493|NCT00501579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65089494|NCT00501579|Protective Agents|protective agents|mesh-ancestor
65089495|NCT00501618|Clozapine|clozapine|mesh-list
65089496|NCT00501618|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65089497|NCT00501618|Serotonin Agents|serotonin agents|mesh-ancestor
65089498|NCT00501618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65089499|NCT00501618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089500|NCT00501618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089501|NCT00501618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65089502|NCT00501618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65089503|NCT00501618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65089504|NCT00501618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65089505|NCT00501618|GABA Antagonists|gaba antagonists|mesh-ancestor
64731686|NCT00003091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65089506|NCT00501618|GABA Agents|gaba agents|mesh-ancestor
65089507|NCT00600535|Abiraterone Acetate|abiraterone acetate|mesh-list
65089508|NCT00600535|Glucocorticoids|glucocorticoids|mesh-list
65089509|NCT00600535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089510|NCT00600535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65089511|NCT00600535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089512|NCT00600535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089514|NCT00600535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65089515|NCT00600535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089516|NCT00600535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65089517|NCT00600535|Hormones|hormones|mesh-ancestor
65089518|NCT00600691|Finasteride|finasteride|mesh-list
65089519|NCT00600691|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65089520|NCT00600691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65089521|NCT00600691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089522|NCT00600691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089523|NCT00600691|Hormone Antagonists|hormone antagonists|mesh-ancestor
65089524|NCT00600691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65089525|NCT00600691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089526|NCT00600691|Urological Agents|urological agents|mesh-ancestor
65089527|NCT00623077|Etoposide|etoposide|mesh-list
65089528|NCT00623077|Melphalan|melphalan|mesh-list
65089529|NCT00623077|Busulfan|busulfan|mesh-list
65089530|NCT00623077|Ifosfamide|ifosfamide|mesh-list
65089531|NCT00623077|Thiotepa|thiotepa|mesh-list
65089532|NCT00623077|Sargramostim|sargramostim|mesh-list
65089534|NCT00623077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65089535|NCT00623077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089536|NCT00623077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65089537|NCT00623077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65089538|NCT00623077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089539|NCT00623077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089540|NCT00623077|Immunologic Factors|immunologic factors|mesh-ancestor
65089541|NCT00623077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089542|NCT00623077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65089543|NCT00623077|Alkylating Agents|alkylating agents|mesh-ancestor
65089544|NCT00623077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65089545|NCT00623077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65089546|NCT00623077|Protective Agents|protective agents|mesh-ancestor
65089547|NCT00475358|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65089548|NCT00475358|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65089549|NCT00475358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65089550|NCT00475358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65089551|NCT00475358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089552|NCT00475358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65089553|NCT00475358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089554|NCT00475358|Analgesics|analgesics|mesh-ancestor
65089555|NCT00475358|Sensory System Agents|sensory system agents|mesh-ancestor
65089556|NCT00475358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65089557|NCT00475358|Antidepressive Agents|antidepressive agents|mesh-ancestor
65089558|NCT00475358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65089559|NCT00475358|Dopamine Agents|dopamine agents|mesh-ancestor
65089560|NCT00623116|Testosterone|testosterone|mesh-list
65089561|NCT00623116|Estrogens|estrogens|mesh-list
65089562|NCT00623116|Androgens|androgens|mesh-ancestor
65089563|NCT00623116|Hormones|hormones|mesh-ancestor
65089564|NCT00623116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65089565|NCT00623116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622131|NCT04390334|Famotidine|famotidine|mesh-list
65089567|NCT00623155|Sulfadoxine|sulfadoxine|mesh-list
65089568|NCT00623155|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
65089569|NCT00623155|Antimalarials|antimalarials|mesh-ancestor
65089570|NCT00623155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65089571|NCT00623155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65089572|NCT00623155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65089573|NCT00623155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65089574|NCT00623155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089575|NCT00623155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089576|NCT00623155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64731764|NCT00003937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64731765|NCT00003937|Alkylating Agents|alkylating agents|mesh-ancestor
64731766|NCT00003937|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65089578|NCT00600730|Hypoglycemic Agents|hypoglycemic agents|mesh-list
65089579|NCT00600730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089580|NCT00600769|Clarithromycin|clarithromycin|mesh-list
65089581|NCT00600769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65089582|NCT00600769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65089583|NCT00600769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65089584|NCT00600769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089585|NCT00600769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089586|NCT00600769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65089587|NCT00600769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65089588|NCT00470210|Ribavirin|ribavirin|mesh-list
65089589|NCT00470210|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65089590|NCT00470210|Antimetabolites|antimetabolites|mesh-ancestor
65089591|NCT00470210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089592|NCT00470210|Antiviral Agents|antiviral agents|mesh-ancestor
65089593|NCT00470210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65089594|NCT00600847|Loratadine|loratadine|mesh-list
65089595|NCT00600847|Desloratadine|desloratadine|mesh-list
65089596|NCT00600847|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65089597|NCT00600847|Cholinergic Agents|cholinergic agents|mesh-ancestor
65089598|NCT00600847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65089599|NCT00600847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089600|NCT00600847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089601|NCT00600847|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65089602|NCT00600847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65089603|NCT00600847|Histamine Antagonists|histamine antagonists|mesh-ancestor
65089604|NCT00600847|Histamine Agents|histamine agents|mesh-ancestor
65089605|NCT00600847|Antipruritics|antipruritics|mesh-ancestor
65089606|NCT00600847|Dermatologic Agents|dermatologic agents|mesh-ancestor
65089607|NCT00600847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65089608|NCT04325932|Kallikreins|kallikreins|mesh-list
65089609|NCT04325932|Coagulants|coagulants|mesh-ancestor
65089610|NCT04325932|Fertility Agents, Male|fertility agents, male|mesh-ancestor
65089611|NCT04325932|Fertility Agents|fertility agents|mesh-ancestor
65089612|NCT04325932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65089613|NCT04325932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835576|NCT02702492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835577|NCT02702492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64835578|NCT02702492|Antimetabolites|antimetabolites|mesh-ancestor
65089614|NCT00501657|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65089615|NCT00501657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65089616|NCT00501657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089617|NCT00501657|Incretins|incretins|mesh-ancestor
65089618|NCT00501657|Hormones|hormones|mesh-ancestor
65089619|NCT00501657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65089620|NCT00501657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65089621|NCT00501657|Protease Inhibitors|protease inhibitors|mesh-ancestor
65089622|NCT00501657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089623|NCT00501657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089624|NCT00600964|Obatoclax|obatoclax|mesh-list
65089625|NCT00600964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089626|NCT00600964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089627|NCT00475397|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65089628|NCT00475397|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65089629|NCT00475397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65089630|NCT00475397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65089631|NCT00475397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089632|NCT00475397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65089633|NCT00475397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089634|NCT00475397|Analgesics|analgesics|mesh-ancestor
65089635|NCT00475397|Sensory System Agents|sensory system agents|mesh-ancestor
65089636|NCT00475397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65089637|NCT00475397|Antidepressive Agents|antidepressive agents|mesh-ancestor
65089638|NCT00475397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65089639|NCT00475397|Dopamine Agents|dopamine agents|mesh-ancestor
65089640|NCT00601042|Lobeline|lobeline|mesh-list
65089641|NCT00601042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65089642|NCT00601042|Autonomic Agents|autonomic agents|mesh-ancestor
65089643|NCT00601042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65089644|NCT00601042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089646|NCT00601042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65089647|NCT00601042|Cholinergic Agents|cholinergic agents|mesh-ancestor
65089648|NCT00601042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65089649|NCT00601042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089650|NCT00601042|Respiratory System Agents|respiratory system agents|mesh-ancestor
65089652|NCT00501696|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
65089653|NCT00501696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65089654|NCT00501696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089655|NCT00501696|Sensory System Agents|sensory system agents|mesh-ancestor
65089656|NCT00501696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65089657|NCT00601198|Leucovorin|leucovorin|mesh-list
65089658|NCT00601198|Oxaliplatin|oxaliplatin|mesh-list
65089659|NCT00601198|Levoleucovorin|levoleucovorin|mesh-list
65089660|NCT00601198|Amifostine|amifostine|mesh-list
65089661|NCT00601198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089662|NCT00601198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089663|NCT00601198|Antidotes|antidotes|mesh-ancestor
65089664|NCT00601198|Protective Agents|protective agents|mesh-ancestor
65089665|NCT00601198|Vitamin B Complex|vitamin b complex|mesh-ancestor
65089666|NCT00601198|Vitamins|vitamins|mesh-ancestor
65089667|NCT00601198|Micronutrients|micronutrients|mesh-ancestor
65089668|NCT00601198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65089669|NCT00601276|Leuprolide|leuprolide|mesh-list
65089670|NCT00601276|Cyproterone Acetate|cyproterone acetate|mesh-list
65089671|NCT00601276|Cyproterone|cyproterone|mesh-list
65089672|NCT00601276|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65089673|NCT00601276|Fertility Agents|fertility agents|mesh-ancestor
65089674|NCT00601276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64325576|NCT01373931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64325577|NCT01373931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325578|NCT01373931|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64325579|NCT01373931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64325580|NCT01373931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64325581|NCT02160743|Metformin|metformin|mesh-list
65089675|NCT00601276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089676|NCT00601276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65089677|NCT00601276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089678|NCT00601276|Androgen Antagonists|androgen antagonists|mesh-ancestor
65089679|NCT00601276|Hormone Antagonists|hormone antagonists|mesh-ancestor
65089680|NCT00601276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65089681|NCT00601276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
65089682|NCT00601276|Contraceptive Agents|contraceptive agents|mesh-ancestor
65089683|NCT00601315|Clarithromycin|clarithromycin|mesh-list
65089684|NCT00601315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65089685|NCT00601315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65089686|NCT00601315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65089687|NCT00601315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089688|NCT00601315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089689|NCT00601315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65089690|NCT00601315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65089691|NCT00470249|Gemcitabine|gemcitabine|mesh-list
65089692|NCT00470249|Carboplatin|carboplatin|mesh-list
65089693|NCT00470249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089694|NCT00470249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65089695|NCT00470249|Antimetabolites|antimetabolites|mesh-ancestor
65089696|NCT00470249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089697|NCT00470249|Antiviral Agents|antiviral agents|mesh-ancestor
65089698|NCT00470249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65089699|NCT00470249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089700|NCT00470249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65089701|NCT00470249|Immunologic Factors|immunologic factors|mesh-ancestor
65089702|NCT00470249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089703|NCT04325893|Hydroxychloroquine|hydroxychloroquine|mesh-list
65089704|NCT04325893|Antimalarials|antimalarials|mesh-ancestor
65089705|NCT04325893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65089706|NCT04325893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65089707|NCT04325893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65089708|NCT04325893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089709|NCT04325893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089710|NCT04325893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65089711|NCT00601432|Levofloxacin|levofloxacin|mesh-list
65089712|NCT00601432|Ofloxacin|ofloxacin|mesh-list
65089713|NCT00601432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65089714|NCT00601432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65089715|NCT00601432|Renal Agents|renal agents|mesh-ancestor
65089716|NCT00601432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65089717|NCT00601432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65089718|NCT00601432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65089720|NCT00601432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089721|NCT00601432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089722|NCT00601432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65089723|NCT00601432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65089725|NCT00475514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65089726|NCT00475514|Serotonin Agents|serotonin agents|mesh-ancestor
65089727|NCT00475514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65089728|NCT00475514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089729|NCT00475514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089730|NCT00601510|Capecitabine|capecitabine|mesh-list
65089731|NCT00601510|Imatinib Mesylate|imatinib mesylate|mesh-list
65089732|NCT00601510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089733|NCT00601510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65089734|NCT00601510|Antimetabolites|antimetabolites|mesh-ancestor
65089735|NCT00601510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089736|NCT00601510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65089737|NCT00601510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089738|NCT00601588|Sertraline|sertraline|mesh-list
65089739|NCT00601588|Antidepressive Agents|antidepressive agents|mesh-ancestor
65089740|NCT00601588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65089741|NCT00601588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65089742|NCT00601588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65089743|NCT00601588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65089744|NCT00601588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089745|NCT00601588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65089746|NCT00601588|Serotonin Agents|serotonin agents|mesh-ancestor
65089747|NCT00601588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089748|NCT00601666|Zolpidem|zolpidem|mesh-list
65089749|NCT00601666|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65089750|NCT00601666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65089751|NCT00601666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65089752|NCT00601666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089753|NCT00601666|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65089754|NCT00601666|GABA Agonists|gaba agonists|mesh-ancestor
65089755|NCT00601666|GABA Agents|gaba agents|mesh-ancestor
65089756|NCT00601666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65089757|NCT00601666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089758|NCT01246362|Etoricoxib|etoricoxib|mesh-list
65089759|NCT01246362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65089760|NCT01246362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65089761|NCT01246362|Analgesics|analgesics|mesh-ancestor
65089762|NCT01246362|Sensory System Agents|sensory system agents|mesh-ancestor
65089763|NCT01246362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65089764|NCT01246362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089765|NCT01246362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65089766|NCT01246362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65089767|NCT01246362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65089768|NCT01246362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65089769|NCT01246362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089770|NCT01246362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089771|NCT00470405|Oxaliplatin|oxaliplatin|mesh-list
65089772|NCT00470405|Pemetrexed|pemetrexed|mesh-list
65089773|NCT00470405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089774|NCT00470405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089775|NCT00470405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089776|NCT00470405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65089777|NCT00470405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65089778|NCT00601978|Levodopa|levodopa|mesh-list
65089779|NCT00601978|Carbidopa|carbidopa|mesh-list
65089780|NCT00601978|Entacapone|entacapone|mesh-list
65089781|NCT00601978|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
65089782|NCT00601978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65089784|NCT00601978|Dopamine Agents|dopamine agents|mesh-ancestor
65089785|NCT00601978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65089786|NCT00601978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089787|NCT00601978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089788|NCT00601978|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
65089789|NCT00601978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089790|NCT00601978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
65089791|NCT00601978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65089792|NCT00601978|Immunologic Factors|immunologic factors|mesh-ancestor
65089793|NCT00601978|Dopamine Agonists|dopamine agonists|mesh-ancestor
65089795|NCT00601159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089796|NCT00601159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65089797|NCT00601159|Antimetabolites|antimetabolites|mesh-ancestor
65089798|NCT00601159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089799|NCT00601159|Antiviral Agents|antiviral agents|mesh-ancestor
65089800|NCT00601159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65089801|NCT00601159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089802|NCT00601159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65089803|NCT00601159|Immunologic Factors|immunologic factors|mesh-ancestor
65089804|NCT00601159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089805|NCT00602017|Amlodipine|amlodipine|mesh-list
65089806|NCT00602017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65089807|NCT00602017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65089808|NCT00602017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65089809|NCT00602017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089810|NCT00602017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65089811|NCT00602017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089812|NCT00602017|Vasodilator Agents|vasodilator agents|mesh-ancestor
65089813|NCT00470483|Paroxetine|paroxetine|mesh-list
65089814|NCT00470483|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65089815|NCT00470483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65089816|NCT00470483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65089817|NCT00470483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089818|NCT00470483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65089819|NCT00470483|Serotonin Agents|serotonin agents|mesh-ancestor
65089820|NCT00470483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089821|NCT00470483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65089822|NCT00470483|Antidepressive Agents|antidepressive agents|mesh-ancestor
65089823|NCT00470483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65089824|NCT00470483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65089825|NCT00470483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65089826|NCT00470483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089827|NCT00602095|Misoprostol|misoprostol|mesh-list
65089828|NCT00602095|Dinoprostone|dinoprostone|mesh-list
65089829|NCT00602095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65089830|NCT00602095|Abortifacient Agents|abortifacient agents|mesh-ancestor
65089831|NCT00602095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65089832|NCT00602095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089833|NCT00602095|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65089834|NCT00602095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65089835|NCT00602095|Oxytocics|oxytocics|mesh-ancestor
65089836|NCT00475553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
65089837|NCT00475553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
65089838|NCT00475553|Ethinyl Estradiol|ethinyl estradiol|mesh-list
65089839|NCT00475553|Etonogestrel|etonogestrel|mesh-list
65089840|NCT00475553|Desogestrel|desogestrel|mesh-list
65089841|NCT00475553|NuvaRing|nuvaring|mesh-list
65089842|NCT00475553|Estradiol|estradiol|mesh-list
65089843|NCT00475553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
65089844|NCT00475553|Estrogens|estrogens|mesh-ancestor
65089845|NCT00475553|Hormones|hormones|mesh-ancestor
65089846|NCT00475553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65089847|NCT00475553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089848|NCT00475553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65089849|NCT00475553|Contraceptive Agents|contraceptive agents|mesh-ancestor
65089850|NCT00475553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65089851|NCT00475553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65089852|NCT00475553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65089853|NCT00475553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65089854|NCT00475553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65089856|NCT01326481|Capecitabine|capecitabine|mesh-list
65089857|NCT01326481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65089858|NCT01326481|Antimetabolites|antimetabolites|mesh-ancestor
65089859|NCT01326481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089860|NCT01326481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089861|NCT00502164|Cediranib|cediranib|mesh-list
65089862|NCT00502164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089863|NCT00502164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65089864|NCT00502164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089865|NCT00502164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089866|NCT00470522|Folic Acid|folic acid|mesh-list
65089867|NCT00470522|Methotrexate|methotrexate|mesh-list
65089868|NCT00470522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65089869|NCT00470522|Abortifacient Agents|abortifacient agents|mesh-ancestor
65089870|NCT00470522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65089871|NCT00470522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089872|NCT00470522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65089873|NCT00470522|Antimetabolites|antimetabolites|mesh-ancestor
65089874|NCT00470522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089875|NCT00470522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089876|NCT00470522|Dermatologic Agents|dermatologic agents|mesh-ancestor
65089877|NCT00470522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089878|NCT00470522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65089879|NCT00470522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65089880|NCT00470522|Immunologic Factors|immunologic factors|mesh-ancestor
65089881|NCT00470522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65089882|NCT00470522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65089883|NCT00470522|Hematinics|hematinics|mesh-ancestor
65089884|NCT00470522|Vitamin B Complex|vitamin b complex|mesh-ancestor
65089885|NCT00470522|Vitamins|vitamins|mesh-ancestor
65089886|NCT00470522|Micronutrients|micronutrients|mesh-ancestor
65089887|NCT01244178|Insulin|insulin|mesh-list
65089888|NCT01244178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65089889|NCT01244178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65089890|NCT01244178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089891|NCT00470561|Aspirin|aspirin|mesh-list
65089892|NCT00470561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65089893|NCT00470561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65089894|NCT00470561|Analgesics|analgesics|mesh-ancestor
65089895|NCT00470561|Sensory System Agents|sensory system agents|mesh-ancestor
65089896|NCT00470561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65089897|NCT00470561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089898|NCT00470561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65089899|NCT00470561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65089900|NCT00470561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65089901|NCT00470561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65089902|NCT00470561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089903|NCT00470561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65089904|NCT00470561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65089905|NCT00470561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089906|NCT00470561|Antipyretics|antipyretics|mesh-ancestor
65089907|NCT00475826|Ezetimibe|ezetimibe|mesh-list
65089908|NCT00475826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65089909|NCT00475826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65089910|NCT00475826|Antimetabolites|antimetabolites|mesh-ancestor
65089911|NCT00475826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089912|NCT00475826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65089913|NCT00502437|Granisetron|granisetron|mesh-list
65089914|NCT00502437|Antiemetics|antiemetics|mesh-ancestor
65089915|NCT00502437|Autonomic Agents|autonomic agents|mesh-ancestor
65089916|NCT00502437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65089917|NCT00502437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089918|NCT00502437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65089919|NCT00502437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65089920|NCT00502437|Serotonin Agents|serotonin agents|mesh-ancestor
65089921|NCT00502437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65089922|NCT00502437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089923|NCT00470678|Ranibizumab|ranibizumab|mesh-list
65089924|NCT00470678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65089925|NCT00470678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65089926|NCT00470678|Growth Substances|growth substances|mesh-ancestor
65089927|NCT00470678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089928|NCT00470678|Growth Inhibitors|growth inhibitors|mesh-ancestor
65089929|NCT00470678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089930|NCT00502476|Chlorhexidine|chlorhexidine|mesh-list
65089931|NCT00502476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65089932|NCT00502476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65089933|NCT00502476|Disinfectants|disinfectants|mesh-ancestor
65089934|NCT00493545|Poly ICLC|poly iclc|mesh-list
65089935|NCT00493545|Interferon Inducers|interferon inducers|mesh-ancestor
65089936|NCT00493545|Immunologic Factors|immunologic factors|mesh-ancestor
65089937|NCT00493545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089938|NCT00470873|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65089939|NCT00470873|Vasodilator Agents|vasodilator agents|mesh-ancestor
65089940|NCT00470873|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65089941|NCT00470873|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65089942|NCT00470873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65089943|NCT00470873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089944|NCT00470873|Urological Agents|urological agents|mesh-ancestor
65089945|NCT00493623|Ibandronic Acid|ibandronic acid|mesh-list
65089946|NCT00493623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65089947|NCT00493623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089948|NCT00476099|Budesonide|budesonide|mesh-list
65089949|NCT00476099|Beclomethasone|beclomethasone|mesh-list
65089950|NCT00476099|Formoterol Fumarate|formoterol fumarate|mesh-list
65089951|NCT00476099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65089952|NCT00476099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65089953|NCT00476099|Autonomic Agents|autonomic agents|mesh-ancestor
65089954|NCT00476099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65089955|NCT00476099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089956|NCT00476099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65089957|NCT00476099|Respiratory System Agents|respiratory system agents|mesh-ancestor
65089958|NCT00476099|Glucocorticoids|glucocorticoids|mesh-ancestor
65089959|NCT00476099|Hormones|hormones|mesh-ancestor
65089960|NCT00476099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65089961|NCT00476099|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65089962|NCT00476099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65089963|NCT00476099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65089964|NCT00476099|Adrenergic Agents|adrenergic agents|mesh-ancestor
65089965|NCT00476099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65089966|NCT00476099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089967|NCT00493662|Hyaluronic Acid|hyaluronic acid|mesh-list
65089968|NCT00493662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65089969|NCT00493662|Immunologic Factors|immunologic factors|mesh-ancestor
65089970|NCT00493662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089971|NCT00493662|Viscosupplements|viscosupplements|mesh-ancestor
65089972|NCT00493662|Protective Agents|protective agents|mesh-ancestor
65089973|NCT00470912|Sunscreening Agents|sunscreening agents|mesh-list
65089974|NCT00470912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65089975|NCT00470912|Protective Agents|protective agents|mesh-ancestor
65089976|NCT00470912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089977|NCT00470912|Dermatologic Agents|dermatologic agents|mesh-ancestor
65089978|NCT00476138|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
65089979|NCT00476138|Antioxidants|antioxidants|mesh-ancestor
65089980|NCT00476138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65089981|NCT00476138|Protective Agents|protective agents|mesh-ancestor
65089982|NCT00476138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089983|NCT00476138|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
65089984|NCT00476138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65089985|NCT00476138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65089986|NCT00476138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65089987|NCT02956083|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65089988|NCT02956083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65089989|NCT00470990|Acyline|acyline|mesh-list
65089990|NCT00470990|Hormone Antagonists|hormone antagonists|mesh-ancestor
65089991|NCT00470990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65089992|NCT00470990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65089993|NCT01246440|Catumaxomab|catumaxomab|mesh-list
65089994|NCT01246440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65089995|NCT00471029|Esomeprazole|esomeprazole|mesh-list
65089996|NCT00471029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65089997|NCT00471029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65089998|NCT00471029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65089999|NCT00471029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090000|NCT00471029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090001|NCT00476216|Fondaparinux|fondaparinux|mesh-list
65090002|NCT00476216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65090003|NCT00476216|Antithrombins|antithrombins|mesh-ancestor
65090004|NCT00476216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65090005|NCT00476216|Protease Inhibitors|protease inhibitors|mesh-ancestor
65090006|NCT00476216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090007|NCT00476216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090008|NCT00476216|Anticoagulants|anticoagulants|mesh-ancestor
65090009|NCT00471185|Acyline|acyline|mesh-list
65090010|NCT00471185|Hormone Antagonists|hormone antagonists|mesh-ancestor
65090011|NCT00471185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65090012|NCT00471185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090013|NCT00493857|Nimotuzumab|nimotuzumab|mesh-list
65090014|NCT00493857|Antibodies|antibodies|mesh-list
65090015|NCT00493857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65090016|NCT00493857|Immunologic Factors|immunologic factors|mesh-ancestor
65090017|NCT00493857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090018|NCT00493857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65090019|NCT00493857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090020|NCT00502788|Ribavirin|ribavirin|mesh-list
65090021|NCT00502788|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65090022|NCT00502788|Antimetabolites|antimetabolites|mesh-ancestor
65090023|NCT00502788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090024|NCT00502788|Antiviral Agents|antiviral agents|mesh-ancestor
65090025|NCT00502788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65090026|NCT00602134|Mercaptopurine|mercaptopurine|mesh-list
65090027|NCT00602134|Antimetabolites|antimetabolites|mesh-ancestor
65090028|NCT00602134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090029|NCT00602134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65090030|NCT00602134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090031|NCT00602134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65090032|NCT00602134|Immunologic Factors|immunologic factors|mesh-ancestor
65090033|NCT00602134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090034|NCT00602134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65090035|NCT00602134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090036|NCT00494208|Testosterone|testosterone|mesh-list
65090037|NCT00494208|Androgens|androgens|mesh-ancestor
65090038|NCT00494208|Hormones|hormones|mesh-ancestor
65090039|NCT00494208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65090040|NCT00494208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090041|NCT00471341|Celecoxib|celecoxib|mesh-list
65090042|NCT00471341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65090043|NCT00471341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65090044|NCT00471341|Analgesics|analgesics|mesh-ancestor
65090045|NCT00471341|Sensory System Agents|sensory system agents|mesh-ancestor
65090046|NCT00471341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65090047|NCT00471341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090048|NCT00471341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65090049|NCT00471341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65090050|NCT00471341|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65090051|NCT00471341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65090052|NCT00471341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090053|NCT00471341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090054|NCT01325428|Vinorelbine|vinorelbine|mesh-list
65090055|NCT01325428|Afatinib|afatinib|mesh-list
65090056|NCT01325428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65090057|NCT01325428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090058|NCT01325428|Tubulin Modulators|tubulin modulators|mesh-ancestor
65090059|NCT01325428|Antimitotic Agents|antimitotic agents|mesh-ancestor
65090060|NCT01325428|Mitosis Modulators|mitosis modulators|mesh-ancestor
65090061|NCT01325428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090062|NCT01325428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65090063|NCT01325428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090064|NCT00494247|Antibodies|antibodies|mesh-list
65090065|NCT00494247|Immunologic Factors|immunologic factors|mesh-ancestor
65090066|NCT00494247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090067|NCT00471419|Rimexolone|rimexolone|mesh-list
65090068|NCT00471419|Glucocorticoids|glucocorticoids|mesh-ancestor
65090069|NCT00471419|Hormones|hormones|mesh-ancestor
65090070|NCT00471419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65090071|NCT00471419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090072|NCT01325350|Bimatoprost|bimatoprost|mesh-list
65090073|NCT01325350|Minoxidil|minoxidil|mesh-list
65090074|NCT01325350|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64483398|NCT03806374|Analgesics|analgesics|mesh-ancestor
65090075|NCT01325350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65090076|NCT01325350|Vasodilator Agents|vasodilator agents|mesh-ancestor
65090077|NCT01324999|Tadalafil|tadalafil|mesh-list
65090078|NCT01324999|Vasodilator Agents|vasodilator agents|mesh-ancestor
65090079|NCT01324999|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65090080|NCT01324999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65090081|NCT01324999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090082|NCT01324999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090083|NCT01324999|Urological Agents|urological agents|mesh-ancestor
65090084|NCT01324570|Buprenorphine|buprenorphine|mesh-list
65090085|NCT01324570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65090086|NCT01324570|Narcotics|narcotics|mesh-ancestor
65090087|NCT01324570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65090088|NCT01324570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090089|NCT01324570|Analgesics|analgesics|mesh-ancestor
65090090|NCT01324570|Sensory System Agents|sensory system agents|mesh-ancestor
65090091|NCT01324570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65090092|NCT01324570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65090093|NCT04325698|Paclitaxel|paclitaxel|mesh-list
65090094|NCT04325698|Bevacizumab|bevacizumab|mesh-list
65090095|NCT04325698|Carboplatin|carboplatin|mesh-list
65090096|NCT04325698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65090097|NCT04325698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090098|NCT04325698|Tubulin Modulators|tubulin modulators|mesh-ancestor
64732272|NCT00003739|Lenograstim|lenograstim|mesh-list
65090099|NCT04325698|Antimitotic Agents|antimitotic agents|mesh-ancestor
65090100|NCT04325698|Mitosis Modulators|mitosis modulators|mesh-ancestor
65090101|NCT04325698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090102|NCT04325698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65090103|NCT04325698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65090104|NCT04325698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65090105|NCT04325698|Growth Substances|growth substances|mesh-ancestor
65090106|NCT04325698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090107|NCT04325698|Growth Inhibitors|growth inhibitors|mesh-ancestor
65090108|NCT01324141|Fluorouracil|fluorouracil|mesh-list
65090109|NCT01324141|Mitomycins|mitomycins|mesh-list
65090110|NCT01324141|Mitomycin|mitomycin|mesh-list
65090111|NCT01324141|Tempol|tempol|mesh-list
65090112|NCT01324141|Antimetabolites|antimetabolites|mesh-ancestor
65090113|NCT01324141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090114|NCT01324141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65090115|NCT01324141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090116|NCT01324141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65090117|NCT01324141|Immunologic Factors|immunologic factors|mesh-ancestor
65090118|NCT01324141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090119|NCT01324141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65090120|NCT01324141|Alkylating Agents|alkylating agents|mesh-ancestor
65090121|NCT01324141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65090122|NCT01324141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090123|NCT01324141|Antioxidants|antioxidants|mesh-ancestor
65090124|NCT01324141|Protective Agents|protective agents|mesh-ancestor
65090125|NCT01324141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65090126|NCT01324141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65090127|NCT01324141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65090128|NCT01324024|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
65090129|NCT01324024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65090130|NCT01324024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090131|NCT01324024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65090132|NCT01324024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65090133|NCT01324024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65090134|NCT01324024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090135|NCT01324024|Dopamine Agents|dopamine agents|mesh-ancestor
65090136|NCT01324024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65090137|NCT01244217|Fexofenadine|fexofenadine|mesh-list
65090138|NCT01244217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65090139|NCT01244217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65090140|NCT01244217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65090141|NCT01244217|Histamine Antagonists|histamine antagonists|mesh-ancestor
65090142|NCT01244217|Histamine Agents|histamine agents|mesh-ancestor
65090143|NCT01244217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65090144|NCT01244217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090145|NCT01244217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090146|NCT00471653|Temozolomide|temozolomide|mesh-list
65090147|NCT00471653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65090148|NCT00471653|Alkylating Agents|alkylating agents|mesh-ancestor
65090149|NCT00471653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090150|NCT00471653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090151|NCT00494559|Pioglitazone|pioglitazone|mesh-list
65090152|NCT00494559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65090153|NCT00494559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090154|NCT00494598|Sufentanil|sufentanil|mesh-list
65090155|NCT00494598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65090156|NCT00494598|Narcotics|narcotics|mesh-ancestor
65090157|NCT00494598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65090158|NCT00494598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090159|NCT00494598|Analgesics|analgesics|mesh-ancestor
65090160|NCT00494598|Sensory System Agents|sensory system agents|mesh-ancestor
65090161|NCT00494598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65090162|NCT00494598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65090163|NCT00494598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65090164|NCT00494598|Anesthetics, General|anesthetics, general|mesh-ancestor
65090165|NCT00494598|Anesthetics|anesthetics|mesh-ancestor
65090167|NCT00503412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090168|NCT00503412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65090169|NCT00503412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090170|NCT00503412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64732338|NCT00004099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64732340|NCT00004099|Immunologic Factors|immunologic factors|mesh-ancestor
65090171|NCT00503451|Panobinostat|panobinostat|mesh-list
65090172|NCT00503451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090173|NCT00503451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65090174|NCT00503451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090175|NCT00503451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090176|NCT00471809|Azithromycin|azithromycin|mesh-list
65090177|NCT00471809|Budesonide|budesonide|mesh-list
65090178|NCT00471809|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65090179|NCT00471809|Montelukast|montelukast|mesh-list
65090180|NCT00471809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65090181|NCT00471809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65090182|NCT00471809|Autonomic Agents|autonomic agents|mesh-ancestor
65090183|NCT00471809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65090184|NCT00471809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090185|NCT00471809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65090186|NCT00471809|Respiratory System Agents|respiratory system agents|mesh-ancestor
65090187|NCT00471809|Glucocorticoids|glucocorticoids|mesh-ancestor
65090188|NCT00471809|Hormones|hormones|mesh-ancestor
65090189|NCT00471809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65090190|NCT00471809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65090191|NCT00471809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65090192|NCT00471809|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65090193|NCT00471809|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65090194|NCT00471809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65090195|NCT00471809|Adrenergic Agents|adrenergic agents|mesh-ancestor
65090196|NCT00471809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65090197|NCT00471809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090198|NCT00471809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65090199|NCT00471809|Hormone Antagonists|hormone antagonists|mesh-ancestor
65090200|NCT00471809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65090201|NCT00471809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65090202|NCT00503490|Levofloxacin|levofloxacin|mesh-list
65090203|NCT00503490|Ofloxacin|ofloxacin|mesh-list
65090204|NCT00503490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65090205|NCT00503490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65090206|NCT00503490|Renal Agents|renal agents|mesh-ancestor
65090207|NCT00503490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65090208|NCT00503490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65090209|NCT00503490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65090210|NCT00503490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090211|NCT00503490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090212|NCT00503490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090213|NCT00503490|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
65090214|NCT00503490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65090215|NCT00471965|Leucovorin|leucovorin|mesh-list
65090216|NCT00471965|Doxorubicin|doxorubicin|mesh-list
65090217|NCT00471965|Fluorouracil|fluorouracil|mesh-list
65090218|NCT00471965|Oxaliplatin|oxaliplatin|mesh-list
65090219|NCT00471965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65090220|NCT00471965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090221|NCT00471965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65090222|NCT00471965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65090223|NCT00471965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090224|NCT00471965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090225|NCT00471965|Antimetabolites|antimetabolites|mesh-ancestor
65090226|NCT00471965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65090227|NCT00471965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65090228|NCT00471965|Immunologic Factors|immunologic factors|mesh-ancestor
65090229|NCT00471965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090230|NCT00471965|Antidotes|antidotes|mesh-ancestor
64590592|NCT03588338|Antipyretics|antipyretics|mesh-ancestor
65090231|NCT00471965|Protective Agents|protective agents|mesh-ancestor
65090232|NCT00471965|Vitamin B Complex|vitamin b complex|mesh-ancestor
65090233|NCT00471965|Vitamins|vitamins|mesh-ancestor
65090234|NCT00471965|Micronutrients|micronutrients|mesh-ancestor
65090235|NCT00472004|Tibolone|tibolone|mesh-list
65090236|NCT00472004|Estradiol|estradiol|mesh-list
65090237|NCT00472004|Estrogens|estrogens|mesh-ancestor
65090238|NCT00472004|Hormones|hormones|mesh-ancestor
65090239|NCT00472004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65090240|NCT00472004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090241|NCT00472004|Androgen Antagonists|androgen antagonists|mesh-ancestor
65090242|NCT00472004|Hormone Antagonists|hormone antagonists|mesh-ancestor
65090243|NCT00472004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65090244|NCT00472004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64732415|NCT00003187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65090245|NCT00472004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090246|NCT00472004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65090247|NCT00472004|Anabolic Agents|anabolic agents|mesh-ancestor
65090248|NCT00494715|Valsartan|valsartan|mesh-list
65090249|NCT00494715|Benazepril|benazepril|mesh-list
65090250|NCT00494715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65090251|NCT00494715|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65090252|NCT00494715|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65090253|NCT00494715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090254|NCT00494715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65090255|NCT00494715|Protease Inhibitors|protease inhibitors|mesh-ancestor
65090256|NCT00494715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090257|NCT00472043|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
65090258|NCT00472043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65090259|NCT00472043|Dermatologic Agents|dermatologic agents|mesh-ancestor
65090260|NCT03271073|Apatinib|apatinib|mesh-list
65090261|NCT03271073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090262|NCT03271073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65090263|NCT03271073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090264|NCT03271073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090265|NCT01246557|Dexamethasone|dexamethasone|mesh-list
65090266|NCT01246557|Lenalidomide|lenalidomide|mesh-list
65090267|NCT01246557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65090268|NCT01246557|Antiemetics|antiemetics|mesh-ancestor
65090269|NCT01246557|Autonomic Agents|autonomic agents|mesh-ancestor
65090270|NCT01246557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65090271|NCT01246557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090272|NCT01246557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65090273|NCT01246557|Glucocorticoids|glucocorticoids|mesh-ancestor
65090274|NCT01246557|Hormones|hormones|mesh-ancestor
65090275|NCT01246557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65090276|NCT01246557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65090277|NCT01246557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090278|NCT01246557|Immunologic Factors|immunologic factors|mesh-ancestor
65090279|NCT01246557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65090280|NCT01246557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65090281|NCT01246557|Growth Substances|growth substances|mesh-ancestor
65090282|NCT01246557|Growth Inhibitors|growth inhibitors|mesh-ancestor
65090283|NCT00476918|Triamcinolone|triamcinolone|mesh-list
65090284|NCT00476918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
65090285|NCT00476918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
65090286|NCT00476918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
65090287|NCT00476918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65090288|NCT00476918|Glucocorticoids|glucocorticoids|mesh-ancestor
65090289|NCT00476918|Hormones|hormones|mesh-ancestor
64483401|NCT03806374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65090290|NCT00476918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65090291|NCT00476918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090292|NCT00476918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65090293|NCT00476918|Immunologic Factors|immunologic factors|mesh-ancestor
65090294|NCT00476918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090295|NCT00476918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090296|NCT01323790|Naloxegol|naloxegol|mesh-list
65090297|NCT01323790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65090298|NCT01323790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090299|NCT01323790|Sensory System Agents|sensory system agents|mesh-ancestor
65090300|NCT01323790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65090301|NCT00477035|Gemcitabine|gemcitabine|mesh-list
65090302|NCT00477035|Cyclophosphamide|cyclophosphamide|mesh-list
65090303|NCT00477035|Melphalan|melphalan|mesh-list
65090304|NCT00477035|Carmustine|carmustine|mesh-list
65090305|NCT00477035|Etoposide|etoposide|mesh-list
65090306|NCT00477035|Vinorelbine|vinorelbine|mesh-list
65090307|NCT00477035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65090308|NCT00477035|Immunologic Factors|immunologic factors|mesh-ancestor
65090309|NCT00477035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090310|NCT00477035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65090311|NCT00477035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65090312|NCT00477035|Alkylating Agents|alkylating agents|mesh-ancestor
65090313|NCT00477035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090314|NCT00477035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090315|NCT00477035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65090316|NCT00477035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65090317|NCT00477035|Antimetabolites|antimetabolites|mesh-ancestor
65090318|NCT00477035|Antiviral Agents|antiviral agents|mesh-ancestor
65090319|NCT00477035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65090320|NCT00477035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64732492|NCT00003799|Antidotes|antidotes|mesh-ancestor
65090321|NCT00477035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65090322|NCT00477035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65090323|NCT00477035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65090324|NCT00477035|Tubulin Modulators|tubulin modulators|mesh-ancestor
65090325|NCT00477035|Antimitotic Agents|antimitotic agents|mesh-ancestor
65090326|NCT00477035|Mitosis Modulators|mitosis modulators|mesh-ancestor
65090327|NCT00494832|Dexmedetomidine|dexmedetomidine|mesh-list
65090328|NCT00494832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65090329|NCT00494832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65090330|NCT00494832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090331|NCT00494832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65090332|NCT00494832|Analgesics|analgesics|mesh-ancestor
65090333|NCT00494832|Sensory System Agents|sensory system agents|mesh-ancestor
65090334|NCT00494832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65090335|NCT00494832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65090336|NCT00494832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65090337|NCT00494832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65090338|NCT00494832|Adrenergic Agents|adrenergic agents|mesh-ancestor
65090339|NCT00494832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65090340|NCT00494832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090341|NCT00477074|Dimercaprol|dimercaprol|mesh-list
65090342|NCT00477074|Chelating Agents|chelating agents|mesh-ancestor
65090343|NCT00477074|Sequestering Agents|sequestering agents|mesh-ancestor
65090344|NCT00477074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090345|NCT01323673|Clobetasol|clobetasol|mesh-list
65090346|NCT01323673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65090347|NCT01323673|Glucocorticoids|glucocorticoids|mesh-ancestor
65090348|NCT01323673|Hormones|hormones|mesh-ancestor
65090349|NCT01323673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65090350|NCT01323673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090351|NCT00494949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65090352|NCT01246752|Cytarabine|cytarabine|mesh-list
65090353|NCT01246752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65090354|NCT01246752|Antimetabolites|antimetabolites|mesh-ancestor
65090355|NCT01246752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090356|NCT01246752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090357|NCT01246752|Antiviral Agents|antiviral agents|mesh-ancestor
65090358|NCT01246752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65090359|NCT01246752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65090360|NCT01246752|Immunologic Factors|immunologic factors|mesh-ancestor
65090361|NCT01246752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090362|NCT01323634|Fluticasone|fluticasone|mesh-list
65090363|NCT01323634|Xhance|xhance|mesh-list
65090364|NCT01323634|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65090365|NCT01323634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65090366|NCT01323634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65090367|NCT01323634|Autonomic Agents|autonomic agents|mesh-ancestor
65090368|NCT01323634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65090369|NCT01323634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090370|NCT01323634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65090371|NCT01323634|Respiratory System Agents|respiratory system agents|mesh-ancestor
65090372|NCT01323634|Dermatologic Agents|dermatologic agents|mesh-ancestor
65090373|NCT01323634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65090374|NCT01323634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65090375|NCT01323634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65090376|NCT01323634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65090377|NCT01323634|Adrenergic Agents|adrenergic agents|mesh-ancestor
65090378|NCT01323634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65090379|NCT01323634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090381|NCT05645302|Anesthetics, Local|anesthetics, local|mesh-ancestor
65090382|NCT05645302|Anesthetics|anesthetics|mesh-ancestor
65090383|NCT05645302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65090384|NCT05645302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090385|NCT05645302|Sensory System Agents|sensory system agents|mesh-ancestor
65090386|NCT05645302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65090387|NCT05645302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65090388|NCT05645302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65090389|NCT05645302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65090390|NCT05645302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65090391|NCT05645302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090392|NCT00494988|Insulin|insulin|mesh-list
65090393|NCT00494988|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
65090394|NCT00494988|Insulin Aspart|insulin aspart|mesh-list
65090395|NCT00494988|Isophane Insulin, Human|isophane insulin, human|mesh-list
65090396|NCT00494988|Insulin, Isophane|insulin, isophane|mesh-list
65090397|NCT00494988|Isophane insulin, beef|isophane insulin, beef|mesh-list
65090398|NCT00494988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65090399|NCT00494988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090400|NCT01323478|Vortioxetine|vortioxetine|mesh-list
65090401|NCT01323478|Antidepressive Agents|antidepressive agents|mesh-ancestor
65090402|NCT01323478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65090403|NCT01323478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65090404|NCT01323478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65090405|NCT01323478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65090406|NCT01323478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090407|NCT01323478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65090408|NCT01323478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65090409|NCT01323478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65090410|NCT01323478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090411|NCT01323478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65090412|NCT01323478|Serotonin Agents|serotonin agents|mesh-ancestor
65090413|NCT01323478|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65090414|NCT01323478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65090415|NCT01323478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65090416|NCT01323478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65090417|NCT00472355|Apomorphine|apomorphine|mesh-list
65090418|NCT00472355|Emetics|emetics|mesh-ancestor
65090419|NCT00472355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090420|NCT00472355|Autonomic Agents|autonomic agents|mesh-ancestor
65090421|NCT00472355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65090422|NCT00472355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65090423|NCT00472355|Dopamine Agonists|dopamine agonists|mesh-ancestor
65090424|NCT00472355|Dopamine Agents|dopamine agents|mesh-ancestor
65090425|NCT00472355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65090426|NCT00472355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090427|NCT04325581|Liraglutide|liraglutide|mesh-list
65090428|NCT04325581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65090429|NCT04325581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090430|NCT04325581|Incretins|incretins|mesh-ancestor
65090431|NCT04325581|Hormones|hormones|mesh-ancestor
64483406|NCT03806374|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
65090432|NCT04325581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65090434|NCT04325776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64416766|NCT04850755|Nivolumab|nivolumab|mesh-list
65090436|NCT01322386|Vancomycin|vancomycin|mesh-list
65090437|NCT01322386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65090438|NCT01322386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65090439|NCT00495066|Ipilimumab|ipilimumab|mesh-list
65090440|NCT00495066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65090441|NCT00495066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090442|NCT00495066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64590808|NCT04142840|Anesthetics|anesthetics|mesh-ancestor
65090443|NCT00495066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090444|NCT00472433|Alemtuzumab|alemtuzumab|mesh-list
65090445|NCT00472433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65090446|NCT00472433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090447|NCT00472472|Paclitaxel|paclitaxel|mesh-list
65090448|NCT00472472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65090449|NCT00472472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090450|NCT00472472|Tubulin Modulators|tubulin modulators|mesh-ancestor
65090451|NCT00472472|Antimitotic Agents|antimitotic agents|mesh-ancestor
65090452|NCT00472472|Mitosis Modulators|mitosis modulators|mesh-ancestor
65090453|NCT00472472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090454|NCT00503568|Vaccines|vaccines|mesh-list
65090455|NCT00503568|Immunologic Factors|immunologic factors|mesh-ancestor
65090456|NCT00503568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090457|NCT00472550|Esomeprazole|esomeprazole|mesh-list
65090458|NCT00472550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65090459|NCT00472550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65090460|NCT00472550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65090461|NCT00472550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090462|NCT00472550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090463|NCT00503607|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
65090464|NCT00503607|Laxatives|laxatives|mesh-ancestor
65090465|NCT00503607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65090466|NCT00477503|Pentetic Acid|pentetic acid|mesh-list
65090467|NCT00477503|Gallium citrate|gallium citrate|mesh-list
65090468|NCT00477503|Chelating Agents|chelating agents|mesh-ancestor
65090469|NCT00477503|Sequestering Agents|sequestering agents|mesh-ancestor
65090470|NCT00477503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090471|NCT00477503|Antidotes|antidotes|mesh-ancestor
65090472|NCT00477503|Protective Agents|protective agents|mesh-ancestor
65090473|NCT00477503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090474|NCT00477503|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65090475|NCT00477503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65090476|NCT01244334|Prednisolone|prednisolone|mesh-list
65090477|NCT01244334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
65090478|NCT01244334|Methylprednisolone|methylprednisolone|mesh-list
65090479|NCT01244334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
65090480|NCT01244334|Prednisolone acetate|prednisolone acetate|mesh-list
65090481|NCT01244334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
65090482|NCT01244334|Prednisolone phosphate|prednisolone phosphate|mesh-list
65090483|NCT01244334|Difluprednate|difluprednate|mesh-list
65090484|NCT01244334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65090485|NCT01244334|Glucocorticoids|glucocorticoids|mesh-ancestor
65090486|NCT01244334|Hormones|hormones|mesh-ancestor
65090487|NCT01244334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65090488|NCT01244334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090489|NCT01244334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65090490|NCT01244334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090491|NCT01244334|Antiemetics|antiemetics|mesh-ancestor
65090492|NCT01244334|Autonomic Agents|autonomic agents|mesh-ancestor
65090493|NCT01244334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65090494|NCT01244334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65090495|NCT01244334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65090496|NCT01244334|Protective Agents|protective agents|mesh-ancestor
65090497|NCT00477542|Clofarabine|clofarabine|mesh-list
65090498|NCT00477542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65090499|NCT00477542|Antimetabolites|antimetabolites|mesh-ancestor
65090500|NCT00477542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090501|NCT00477542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090502|NCT00503763|Simvastatin|simvastatin|mesh-list
65090503|NCT00503763|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65090504|NCT00503763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65090505|NCT00503763|Antimetabolites|antimetabolites|mesh-ancestor
65090506|NCT00503763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416772|NCT04842487|Prednisone|prednisone|mesh-list
65090507|NCT00503763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65090508|NCT00503763|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65090509|NCT00503763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090510|NCT00477581|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65090511|NCT00477581|Exenatide|exenatide|mesh-list
65090512|NCT00477581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65090513|NCT00477581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090514|NCT00477581|Incretins|incretins|mesh-ancestor
65090515|NCT00477581|Hormones|hormones|mesh-ancestor
65090516|NCT00477581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65090517|NCT00477581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65090518|NCT00477581|Protease Inhibitors|protease inhibitors|mesh-ancestor
65090519|NCT00477581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090520|NCT00477581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090521|NCT00477581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65090522|NCT00477737|Propofol|propofol|mesh-list
65090523|NCT00477737|Sevoflurane|sevoflurane|mesh-list
65090524|NCT00477737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65090525|NCT00477737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65090526|NCT00477737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090527|NCT00477737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65090528|NCT00477737|Anesthetics, General|anesthetics, general|mesh-ancestor
65090529|NCT00477737|Anesthetics|anesthetics|mesh-ancestor
65090530|NCT00477737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65090531|NCT00477737|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65090532|NCT00477776|Metoclopramide|metoclopramide|mesh-list
65090533|NCT00477776|Antiemetics|antiemetics|mesh-ancestor
65090534|NCT00477776|Autonomic Agents|autonomic agents|mesh-ancestor
65090535|NCT00477776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65090536|NCT00477776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090537|NCT00477776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65090538|NCT00477776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65090539|NCT00477776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65090540|NCT00477776|Dopamine Agents|dopamine agents|mesh-ancestor
65090541|NCT00477776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65090542|NCT00477776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090543|NCT00477815|Rituximab|rituximab|mesh-list
65090544|NCT00477815|Melphalan|melphalan|mesh-list
65090545|NCT00477815|Sargramostim|sargramostim|mesh-list
65090546|NCT00477815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65090547|NCT00477815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65090548|NCT00477815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090549|NCT00477815|Immunologic Factors|immunologic factors|mesh-ancestor
65090550|NCT00477815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090551|NCT00477815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65090552|NCT00477815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65090553|NCT00477815|Alkylating Agents|alkylating agents|mesh-ancestor
65090554|NCT00477815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090555|NCT00477815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65090556|NCT00477815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65090558|NCT00477854|Picolinic acid|picolinic acid|mesh-list
65090559|NCT00477854|Trace Elements|trace elements|mesh-ancestor
65090560|NCT00477854|Micronutrients|micronutrients|mesh-ancestor
65090561|NCT00477854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090562|NCT00477854|Iron Chelating Agents|iron chelating agents|mesh-ancestor
65090563|NCT00477854|Chelating Agents|chelating agents|mesh-ancestor
65090564|NCT00477854|Sequestering Agents|sequestering agents|mesh-ancestor
65090565|NCT00477854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090566|NCT00477893|Adalimumab|adalimumab|mesh-list
65090567|NCT00477893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65090568|NCT00477893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65090569|NCT01247337|Gemcitabine|gemcitabine|mesh-list
65090570|NCT01247337|Capecitabine|capecitabine|mesh-list
65090571|NCT01247337|Oxaliplatin|oxaliplatin|mesh-list
65090572|NCT01247337|Cetuximab|cetuximab|mesh-list
65090573|NCT01247337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65090574|NCT01247337|Antimetabolites|antimetabolites|mesh-ancestor
65090575|NCT01247337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090576|NCT01247337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090577|NCT01247337|Antiviral Agents|antiviral agents|mesh-ancestor
65090578|NCT01247337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65090579|NCT01247337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090580|NCT01247337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65090581|NCT01247337|Immunologic Factors|immunologic factors|mesh-ancestor
65090583|NCT01247337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65090584|NCT00478049|Docetaxel|docetaxel|mesh-list
65090585|NCT00478049|Gefitinib|gefitinib|mesh-list
65090586|NCT00478049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090587|NCT00478049|Tubulin Modulators|tubulin modulators|mesh-ancestor
65090588|NCT00478049|Antimitotic Agents|antimitotic agents|mesh-ancestor
65090589|NCT00478049|Mitosis Modulators|mitosis modulators|mesh-ancestor
65090590|NCT00478049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090591|NCT00478049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65090592|NCT00478049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090593|NCT01248975|Montelukast|montelukast|mesh-list
65090594|NCT01248975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65090595|NCT01248975|Respiratory System Agents|respiratory system agents|mesh-ancestor
65090596|NCT01248975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65090597|NCT01248975|Hormone Antagonists|hormone antagonists|mesh-ancestor
65090598|NCT01248975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65090599|NCT01248975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090600|NCT01248975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65090601|NCT01248975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65090602|NCT01248975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090603|NCT02955927|Atropine|atropine|mesh-list
65090604|NCT02955927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65090605|NCT02955927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65090606|NCT02955927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65090607|NCT02955927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65090608|NCT02955927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65090609|NCT02955927|Autonomic Agents|autonomic agents|mesh-ancestor
65090610|NCT02955927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65090611|NCT02955927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090612|NCT02955927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65090613|NCT02955927|Respiratory System Agents|respiratory system agents|mesh-ancestor
65090614|NCT02955927|Mydriatics|mydriatics|mesh-ancestor
65090615|NCT02955927|Parasympatholytics|parasympatholytics|mesh-ancestor
65090616|NCT02955927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65090617|NCT02955927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65090618|NCT02955927|Cholinergic Agents|cholinergic agents|mesh-ancestor
65090619|NCT02955927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64732795|NCT00004207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090620|NCT02955927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090621|NCT01322347|Dialysis Solutions|dialysis solutions|mesh-list
65090622|NCT01322347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65090623|NCT01247493|Cytarabine|cytarabine|mesh-list
65090624|NCT01247493|Fludarabine|fludarabine|mesh-list
65090625|NCT01247493|Idarubicin|idarubicin|mesh-list
65090626|NCT01247493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090627|NCT01247493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65090628|NCT01247493|Antimetabolites|antimetabolites|mesh-ancestor
65090629|NCT01247493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090630|NCT01247493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65090631|NCT01247493|Immunologic Factors|immunologic factors|mesh-ancestor
65090632|NCT01247493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090633|NCT01247493|Antiviral Agents|antiviral agents|mesh-ancestor
65090634|NCT01247493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65090635|NCT01247493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65090636|NCT01247493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65090637|NCT01247493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65090638|NCT01247493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090639|NCT04325425|Carboplatin|carboplatin|mesh-list
65090640|NCT04325425|Etoposide|etoposide|mesh-list
65090641|NCT04325425|Folfirinox|folfirinox|mesh-list
65090642|NCT04325425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090643|NCT04325425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65090644|NCT04325425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65090645|NCT04325425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65090646|NCT04325425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090647|NCT04325425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090648|NCT02891395|Imatinib Mesylate|imatinib mesylate|mesh-list
65090649|NCT02891395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090650|NCT02891395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65090651|NCT02891395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090652|NCT02891395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090653|NCT05645146|Nicotine|nicotine|mesh-list
65090654|NCT05645146|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65090655|NCT05645146|Autonomic Agents|autonomic agents|mesh-ancestor
65090656|NCT05645146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65090657|NCT05645146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090658|NCT05645146|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65090659|NCT05645146|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65090660|NCT05645146|Cholinergic Agents|cholinergic agents|mesh-ancestor
65090661|NCT05645146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65090662|NCT05645146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090663|NCT00478517|Epoetin Alfa|epoetin alfa|mesh-list
65090664|NCT00478517|Hematinics|hematinics|mesh-ancestor
65090665|NCT01321879|Telavancin|telavancin|mesh-list
65090666|NCT01321879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65090667|NCT01321879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65090668|NCT01321723|Teriparatide|teriparatide|mesh-list
65090669|NCT01321723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65090670|NCT01321723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090671|NCT01321723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65090672|NCT00478634|Irinotecan|irinotecan|mesh-list
65090673|NCT00478634|Cetuximab|cetuximab|mesh-list
65090674|NCT00478634|Everolimus|everolimus|mesh-list
65090675|NCT00478634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65090676|NCT00478634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65090677|NCT00478634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090678|NCT00478634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090679|NCT00478634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090680|NCT00478634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65090681|NCT00478634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65090682|NCT00478634|Immunologic Factors|immunologic factors|mesh-ancestor
65090683|NCT00478634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090684|NCT01247688|Fludarabine|fludarabine|mesh-list
65090685|NCT01247688|Cyclophosphamide|cyclophosphamide|mesh-list
65090686|NCT01247688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090687|NCT01247688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090688|NCT01247688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65090689|NCT01247688|Immunologic Factors|immunologic factors|mesh-ancestor
65090690|NCT01247688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090691|NCT01247688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65090692|NCT01247688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65090693|NCT01247688|Alkylating Agents|alkylating agents|mesh-ancestor
65090694|NCT01247688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65090695|NCT00478907|Ketamine|ketamine|mesh-list
65090696|NCT00478907|Thiopental|thiopental|mesh-list
65090697|NCT00478907|Propofol|propofol|mesh-list
65090698|NCT00478907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65090699|NCT00478907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65090700|NCT00478907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090701|NCT00478907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65090702|NCT00478907|Anesthetics, General|anesthetics, general|mesh-ancestor
65090703|NCT00478907|Anesthetics|anesthetics|mesh-ancestor
65090704|NCT00478907|Analgesics|analgesics|mesh-ancestor
65090705|NCT00478907|Sensory System Agents|sensory system agents|mesh-ancestor
65090706|NCT00478907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65090707|NCT00478907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65090708|NCT00478907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65090709|NCT00478907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65090710|NCT00478907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65090711|NCT00478907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090712|NCT00478907|Anticonvulsants|anticonvulsants|mesh-ancestor
65090713|NCT00478907|GABA Modulators|gaba modulators|mesh-ancestor
65090714|NCT00478907|GABA Agents|gaba agents|mesh-ancestor
65090715|NCT00478946|Leucovorin|leucovorin|mesh-list
65090716|NCT00478946|Antidotes|antidotes|mesh-ancestor
65090717|NCT00478946|Protective Agents|protective agents|mesh-ancestor
65090718|NCT00478946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090719|NCT00478946|Vitamin B Complex|vitamin b complex|mesh-ancestor
65090720|NCT00478946|Vitamins|vitamins|mesh-ancestor
65090721|NCT00478946|Micronutrients|micronutrients|mesh-ancestor
65090722|NCT01247961|Dexamethasone|dexamethasone|mesh-list
65090723|NCT01247961|Dexamethasone acetate|dexamethasone acetate|mesh-list
65090724|NCT01247961|BB 1101|bb 1101|mesh-list
65090725|NCT01247961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65090726|NCT01247961|Antiemetics|antiemetics|mesh-ancestor
65090727|NCT01247961|Autonomic Agents|autonomic agents|mesh-ancestor
65090728|NCT01247961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663504|NCT02735187|Vitamins|vitamins|mesh-ancestor
65090729|NCT01247961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090730|NCT01247961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65090731|NCT01247961|Glucocorticoids|glucocorticoids|mesh-ancestor
65090732|NCT01247961|Hormones|hormones|mesh-ancestor
65090733|NCT01247961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65090734|NCT01247961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65090735|NCT01247961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090736|NCT01247961|Protease Inhibitors|protease inhibitors|mesh-ancestor
65090737|NCT01247961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090738|NCT01247961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090739|NCT00478985|Imatinib Mesylate|imatinib mesylate|mesh-list
65090740|NCT00478985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090741|NCT00478985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65090742|NCT00478985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090743|NCT00478985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090744|NCT01248078|Cephalexin|cephalexin|mesh-list
65090745|NCT01248078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65090746|NCT01248078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65090747|NCT00472823|Vitamin D|vitamin d|mesh-list
65090748|NCT00472823|Cholecalciferol|cholecalciferol|mesh-list
65090749|NCT00472823|Calcium|calcium|mesh-list
65090750|NCT00472823|Vitamins|vitamins|mesh-ancestor
65090751|NCT00472823|Micronutrients|micronutrients|mesh-ancestor
65090752|NCT00472823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090753|NCT00472823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65090754|NCT00472823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65090755|NCT02275416|Ipilimumab|ipilimumab|mesh-list
65090756|NCT02275416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65090757|NCT02275416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090758|NCT02275416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65090759|NCT02275416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090760|NCT00472901|Afamelanotide|afamelanotide|mesh-list
65090761|NCT00472901|Dermatologic Agents|dermatologic agents|mesh-ancestor
65090762|NCT02483247|Paclitaxel|paclitaxel|mesh-list
65090763|NCT02483247|Doxorubicin|doxorubicin|mesh-list
65090764|NCT02483247|Pembrolizumab|pembrolizumab|mesh-list
65090765|NCT02483247|Capecitabine|capecitabine|mesh-list
65090766|NCT02483247|Nivolumab|nivolumab|mesh-list
65090767|NCT02483247|Sunitinib|sunitinib|mesh-list
65090768|NCT02483247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65090769|NCT02483247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090770|NCT02483247|Tubulin Modulators|tubulin modulators|mesh-ancestor
65090771|NCT02483247|Antimitotic Agents|antimitotic agents|mesh-ancestor
65090772|NCT02483247|Mitosis Modulators|mitosis modulators|mesh-ancestor
65090773|NCT02483247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090774|NCT02483247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65090775|NCT02483247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65090776|NCT02483247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65090777|NCT02483247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090778|NCT02483247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65090779|NCT02483247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65090780|NCT02483247|Antimetabolites|antimetabolites|mesh-ancestor
65090781|NCT02483247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65090782|NCT02483247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65090783|NCT02483247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65090784|NCT02483247|Growth Substances|growth substances|mesh-ancestor
65090785|NCT02483247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090786|NCT02483247|Growth Inhibitors|growth inhibitors|mesh-ancestor
65090787|NCT02483247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65090788|NCT02482233|Nicotine|nicotine|mesh-list
65090789|NCT02482233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65090790|NCT02482233|Autonomic Agents|autonomic agents|mesh-ancestor
65090791|NCT02482233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65090792|NCT02482233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090793|NCT02482233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65090794|NCT02482233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65090795|NCT02482233|Cholinergic Agents|cholinergic agents|mesh-ancestor
65090796|NCT02482233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65090797|NCT02482233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090798|NCT01248117|Ranibizumab|ranibizumab|mesh-list
65090799|NCT01248117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65090800|NCT01248117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65090801|NCT01248117|Growth Substances|growth substances|mesh-ancestor
65090802|NCT01248117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090804|NCT01248117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090805|NCT01248234|Propofol|propofol|mesh-list
65090806|NCT01248234|Etomidate|etomidate|mesh-list
65090807|NCT01248234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65090808|NCT01248234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65090809|NCT01248234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090810|NCT01248234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65090811|NCT01248234|Anesthetics, General|anesthetics, general|mesh-ancestor
65090812|NCT01248234|Anesthetics|anesthetics|mesh-ancestor
65090813|NCT01248273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
65090814|NCT01248273|Immunologic Factors|immunologic factors|mesh-ancestor
65090815|NCT01248273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090816|NCT00473174|Ramipril|ramipril|mesh-list
65090817|NCT00473174|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65090818|NCT00473174|Protease Inhibitors|protease inhibitors|mesh-ancestor
65090819|NCT00473174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090820|NCT00473174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090821|NCT00473174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65090822|NCT00473213|Interferons|interferons|mesh-list
65090823|NCT00473213|Interferon-beta|interferon-beta|mesh-list
65090824|NCT00473213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090825|NCT00473213|Antiviral Agents|antiviral agents|mesh-ancestor
65090826|NCT00473213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65090827|NCT00473213|Immunologic Factors|immunologic factors|mesh-ancestor
65090828|NCT00473213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090829|NCT01320202|Dialysis Solutions|dialysis solutions|mesh-list
65090830|NCT01320202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65090831|NCT01319383|Vorinostat|vorinostat|mesh-list
65090832|NCT01319383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090833|NCT01319383|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65090834|NCT01319383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090835|NCT01319383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090836|NCT05645029|Chlorhexidine|chlorhexidine|mesh-list
65090837|NCT05645029|Methamphetamine|methamphetamine|mesh-list
65090838|NCT05645029|Titanium dioxide|titanium dioxide|mesh-list
65090839|NCT05645029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65090840|NCT05645029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65090841|NCT05645029|Disinfectants|disinfectants|mesh-ancestor
65090842|NCT05645029|Dermatologic Agents|dermatologic agents|mesh-ancestor
65090843|NCT05645029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65090844|NCT05645029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090845|NCT05645029|Sympathomimetics|sympathomimetics|mesh-ancestor
65090846|NCT05645029|Autonomic Agents|autonomic agents|mesh-ancestor
65090847|NCT05645029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65090848|NCT05645029|Dopamine Agents|dopamine agents|mesh-ancestor
65090849|NCT05645029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65090850|NCT05645029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090851|NCT05645029|Adrenergic Agents|adrenergic agents|mesh-ancestor
65090852|NCT05645029|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65090853|NCT05645029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65090854|NCT05645029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65090855|NCT05645029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65090856|NCT05645029|Sunscreening Agents|sunscreening agents|mesh-ancestor
65090857|NCT05645029|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65090858|NCT05645029|Protective Agents|protective agents|mesh-ancestor
65090859|NCT05645029|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
65090860|NCT00479609|Testosterone|testosterone|mesh-list
65090861|NCT00479609|Androgens|androgens|mesh-ancestor
65090863|NCT00479609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65090864|NCT00479609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090865|NCT04325113|Levobupivacaine|levobupivacaine|mesh-list
65090866|NCT04325113|Anesthetics, Local|anesthetics, local|mesh-ancestor
65090867|NCT04325113|Anesthetics|anesthetics|mesh-ancestor
65090868|NCT04325113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65090869|NCT04325113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090870|NCT04325113|Sensory System Agents|sensory system agents|mesh-ancestor
65090871|NCT04325113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65090872|NCT05644717|Ertugliflozin|ertugliflozin|mesh-list
65090873|NCT05644717|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65090874|NCT05644717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090875|NCT05644717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65090876|NCT05644717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416780|NCT04842487|Immunologic Factors|immunologic factors|mesh-ancestor
65090878|NCT02891161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65090879|NCT02891161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090880|NCT02955732|Dexmedetomidine|dexmedetomidine|mesh-list
65090881|NCT02955732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65090882|NCT02955732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65090883|NCT02955732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090884|NCT02955732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65090885|NCT02955732|Analgesics|analgesics|mesh-ancestor
65090886|NCT02955732|Sensory System Agents|sensory system agents|mesh-ancestor
65090887|NCT02955732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65090888|NCT02955732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65090889|NCT02955732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65090890|NCT02955732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65090891|NCT02955732|Adrenergic Agents|adrenergic agents|mesh-ancestor
65090892|NCT02955732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65090893|NCT02955732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090894|NCT01315678|Tobramycin|tobramycin|mesh-list
65090895|NCT01315678|Amikacin|amikacin|mesh-list
65090896|NCT01315678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65090897|NCT01315678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65090898|NCT02955693|Dimethyl Fumarate|dimethyl fumarate|mesh-list
65090899|NCT02955693|Dermatologic Agents|dermatologic agents|mesh-ancestor
65090900|NCT02955693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65090901|NCT02955693|Immunologic Factors|immunologic factors|mesh-ancestor
65090902|NCT02955693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090903|NCT00479726|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65090904|NCT00479726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65090905|NCT00479726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65090906|NCT00479726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65090907|NCT00479726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090908|NCT00479726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65090909|NCT00479726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090910|NCT00479726|Analgesics|analgesics|mesh-ancestor
65090911|NCT00479726|Sensory System Agents|sensory system agents|mesh-ancestor
65090912|NCT00479726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65090913|NCT00479726|Antidepressive Agents|antidepressive agents|mesh-ancestor
65090914|NCT00479726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65090915|NCT00479726|Dopamine Agents|dopamine agents|mesh-ancestor
65090916|NCT01315249|Fluticasone|fluticasone|mesh-list
65090917|NCT01315249|Xhance|xhance|mesh-list
65090918|NCT01315249|Glycopyrrolate|glycopyrrolate|mesh-list
65090919|NCT01315249|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64835614|NCT02578680|Dexamethasone|dexamethasone|mesh-list
64835615|NCT02578680|Carboplatin|carboplatin|mesh-list
64835616|NCT02578680|Pembrolizumab|pembrolizumab|mesh-list
64835617|NCT02578680|Pemetrexed|pemetrexed|mesh-list
64835618|NCT02578680|Vitamins|vitamins|mesh-ancestor
64835619|NCT02578680|Micronutrients|micronutrients|mesh-ancestor
64325583|NCT02160743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64325586|NCT02160743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65090920|NCT01315249|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
65090921|NCT01315249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65090922|NCT01315249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65090923|NCT01315249|Autonomic Agents|autonomic agents|mesh-ancestor
65090924|NCT01315249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65090925|NCT01315249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090926|NCT01315249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65090927|NCT01315249|Respiratory System Agents|respiratory system agents|mesh-ancestor
65090928|NCT01315249|Dermatologic Agents|dermatologic agents|mesh-ancestor
65090929|NCT01315249|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65090930|NCT01315249|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65090931|NCT01315249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65090932|NCT01315249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65090933|NCT01315249|Adrenergic Agents|adrenergic agents|mesh-ancestor
65090934|NCT01315249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65090935|NCT01315249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090936|NCT01315249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65090937|NCT01315249|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65090938|NCT01315249|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65090939|NCT01315249|Cholinergic Agents|cholinergic agents|mesh-ancestor
65090941|NCT01315249|Hormones|hormones|mesh-ancestor
65090942|NCT01315249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65090943|NCT01315249|Sympathomimetics|sympathomimetics|mesh-ancestor
65090944|NCT04207411|Lidocaine|lidocaine|mesh-list
65090945|NCT04207411|Bupivacaine|bupivacaine|mesh-list
65090946|NCT04207411|Anesthetics, Local|anesthetics, local|mesh-ancestor
65090947|NCT04207411|Anesthetics|anesthetics|mesh-ancestor
65090948|NCT04207411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65090949|NCT04207411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090950|NCT04207411|Sensory System Agents|sensory system agents|mesh-ancestor
65090951|NCT04207411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65090952|NCT04207411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65090953|NCT04207411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65090954|NCT04207411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65090955|NCT04207411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65090956|NCT04207411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090957|NCT00473486|Carboplatin|carboplatin|mesh-list
65090958|NCT00473486|Pemetrexed|pemetrexed|mesh-list
65090959|NCT00473486|Sorafenib|sorafenib|mesh-list
65090960|NCT00473486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090961|NCT00473486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090962|NCT00473486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090963|NCT00473486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65090964|NCT00473486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65090965|NCT00473486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65090966|NCT05644483|Propofol|propofol|mesh-list
65090967|NCT05644483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65090968|NCT05644483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65090969|NCT05644483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090970|NCT05644483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65090971|NCT05644483|Anesthetics, General|anesthetics, general|mesh-ancestor
65090972|NCT05644483|Anesthetics|anesthetics|mesh-ancestor
65090973|NCT01248819|Ropivacaine|ropivacaine|mesh-list
65090974|NCT01248819|Anesthetics, Local|anesthetics, local|mesh-ancestor
65090975|NCT01248819|Anesthetics|anesthetics|mesh-ancestor
65090976|NCT01248819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65090977|NCT01248819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090978|NCT01248819|Sensory System Agents|sensory system agents|mesh-ancestor
65090979|NCT01248819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65090980|NCT01313767|Botulinum Toxins|botulinum toxins|mesh-list
65090981|NCT01313767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65090982|NCT01313767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65090983|NCT01313767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65090984|NCT01313767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65090985|NCT01313767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65090986|NCT01313767|Cholinergic Agents|cholinergic agents|mesh-ancestor
65090987|NCT01313767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65090988|NCT01313767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65090989|NCT01313767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65090990|NCT01313767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65090991|NCT01248858|Trametinib|trametinib|mesh-list
65090992|NCT01248858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090993|NCT01248858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65090994|NCT01248858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65090995|NCT01248858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733171|NCT00003343|Hormones|hormones|mesh-ancestor
65090997|NCT01313728|Tretinoin|tretinoin|mesh-list
65090998|NCT01313728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65090999|NCT01313728|Keratolytic Agents|keratolytic agents|mesh-ancestor
65091000|NCT01313728|Dermatologic Agents|dermatologic agents|mesh-ancestor
65091001|NCT01313728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65091002|NCT01313728|Antimalarials|antimalarials|mesh-ancestor
65091003|NCT01313728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65091004|NCT01313728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65091005|NCT01313728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65091006|NCT01313728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091007|NCT01313728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091008|NCT01313728|Leprostatic Agents|leprostatic agents|mesh-ancestor
65091009|NCT01313728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65091010|NCT00481364|Atorvastatin|atorvastatin|mesh-list
65091011|NCT00481364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65091012|NCT00481364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65091013|NCT00481364|Antimetabolites|antimetabolites|mesh-ancestor
65091014|NCT00481364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091015|NCT00481364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65091016|NCT00481364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65091017|NCT00481364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091018|NCT00481442|Phenylephrine|phenylephrine|mesh-list
65091019|NCT00481442|Oxymetazoline|oxymetazoline|mesh-list
65091020|NCT00481442|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65091021|NCT00481442|Mydriatics|mydriatics|mesh-ancestor
65091022|NCT00481442|Autonomic Agents|autonomic agents|mesh-ancestor
65091023|NCT00481442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65091024|NCT00481442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091025|NCT00481442|Sympathomimetics|sympathomimetics|mesh-ancestor
65091026|NCT00481442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65091027|NCT00481442|Nasal Decongestants|nasal decongestants|mesh-ancestor
65091028|NCT00481442|Respiratory System Agents|respiratory system agents|mesh-ancestor
65091029|NCT00481442|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65091030|NCT00481442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65091031|NCT00481442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65091032|NCT00481442|Adrenergic Agents|adrenergic agents|mesh-ancestor
65091033|NCT00481442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65091034|NCT00481442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091035|NCT00481442|Protective Agents|protective agents|mesh-ancestor
65091036|NCT04697537|Dexmedetomidine|dexmedetomidine|mesh-list
65091037|NCT04697537|Ropivacaine|ropivacaine|mesh-list
65091038|NCT04697537|Anesthetics|anesthetics|mesh-ancestor
65091039|NCT04697537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65091040|NCT04697537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091041|NCT04697537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65091042|NCT04697537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65091043|NCT04697537|Analgesics|analgesics|mesh-ancestor
65091044|NCT04697537|Sensory System Agents|sensory system agents|mesh-ancestor
65091045|NCT04697537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65091046|NCT04697537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65091047|NCT04697537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65091048|NCT04697537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65091049|NCT04697537|Adrenergic Agents|adrenergic agents|mesh-ancestor
65091050|NCT04697537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65091051|NCT04697537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091052|NCT04697537|Anesthetics, Local|anesthetics, local|mesh-ancestor
65091053|NCT00481481|Tacrolimus|tacrolimus|mesh-list
65091054|NCT00481481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65091055|NCT00481481|Immunologic Factors|immunologic factors|mesh-ancestor
65091056|NCT00481481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091057|NCT00481481|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65091058|NCT00481481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091059|NCT00481481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091060|NCT04516317|Artesunate|artesunate|mesh-list
65091061|NCT04516317|Quinine|quinine|mesh-list
65091062|NCT04516317|Antimalarials|antimalarials|mesh-ancestor
65091063|NCT04516317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65091064|NCT04516317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65091065|NCT04516317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65091066|NCT04516317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091067|NCT04516317|Antiviral Agents|antiviral agents|mesh-ancestor
65091068|NCT04516317|Schistosomicides|schistosomicides|mesh-ancestor
65091069|NCT04516317|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
65091070|NCT04516317|Anthelmintics|anthelmintics|mesh-ancestor
64733245|NCT04069117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091071|NCT04516317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
65091072|NCT04516317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091073|NCT04516317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65091074|NCT04516317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65091075|NCT04516317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65091077|NCT04516317|Sensory System Agents|sensory system agents|mesh-ancestor
65091078|NCT02891083|Paclitaxel|paclitaxel|mesh-list
65091079|NCT02891083|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
65091080|NCT02891083|Cisplatin|cisplatin|mesh-list
65091081|NCT02891083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65091082|NCT02891083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091083|NCT02891083|Tubulin Modulators|tubulin modulators|mesh-ancestor
65091084|NCT02891083|Antimitotic Agents|antimitotic agents|mesh-ancestor
65091085|NCT02891083|Mitosis Modulators|mitosis modulators|mesh-ancestor
65091086|NCT02891083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091088|NCT04515147|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65091089|NCT04515147|Immunologic Factors|immunologic factors|mesh-ancestor
65091090|NCT04515147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091091|NCT05661253|Bupivacaine|bupivacaine|mesh-list
65091092|NCT05661253|Anesthetics, Local|anesthetics, local|mesh-ancestor
65091093|NCT05661253|Anesthetics|anesthetics|mesh-ancestor
65091094|NCT05661253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65091095|NCT05661253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091096|NCT05661253|Sensory System Agents|sensory system agents|mesh-ancestor
65091097|NCT05661253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65091098|NCT02891005|Paclitaxel|paclitaxel|mesh-list
65091099|NCT02891005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65091100|NCT02891005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091101|NCT02891005|Tubulin Modulators|tubulin modulators|mesh-ancestor
65091102|NCT02891005|Antimitotic Agents|antimitotic agents|mesh-ancestor
65091103|NCT02891005|Mitosis Modulators|mitosis modulators|mesh-ancestor
65091104|NCT02891005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091105|NCT00504816|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
65091106|NCT00504816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
65091107|NCT00504816|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65091108|NCT00504816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65091109|NCT00504816|Contraceptive Agents|contraceptive agents|mesh-ancestor
65091110|NCT00504816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65091111|NCT00504816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091112|NCT00504816|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65091113|NCT00504816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65091114|NCT00504816|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
65091115|NCT00504816|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65091116|NCT00480116|Vaccines|vaccines|mesh-list
65091117|NCT00480116|Immunologic Factors|immunologic factors|mesh-ancestor
65091118|NCT00480116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091119|NCT00504855|Calpastatin|calpastatin|mesh-list
65091120|NCT00504855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
65091121|NCT00504855|Protease Inhibitors|protease inhibitors|mesh-ancestor
65091122|NCT00504855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091123|NCT00504855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091124|NCT00504933|Cetirizine|cetirizine|mesh-list
65091125|NCT00504933|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65091126|NCT00504933|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65091127|NCT00504933|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65091128|NCT00504933|Histamine Antagonists|histamine antagonists|mesh-ancestor
65091129|NCT00504933|Histamine Agents|histamine agents|mesh-ancestor
65091130|NCT00504933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65091131|NCT00504933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091132|NCT00504933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091133|NCT01313299|Botulinum Toxins|botulinum toxins|mesh-list
65091134|NCT01313299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
65091135|NCT01313299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
65091136|NCT01313299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
65091137|NCT01313299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65091138|NCT01313299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091139|NCT01313299|Cholinergic Agents|cholinergic agents|mesh-ancestor
65091140|NCT01313299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65091141|NCT01313299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733321|NCT00003379|Paclitaxel|paclitaxel|mesh-list
65091142|NCT01313299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
65091143|NCT01313299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65091144|NCT01313221|Etanercept|etanercept|mesh-list
65091145|NCT01313221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65091146|NCT01313221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65091147|NCT01313221|Analgesics|analgesics|mesh-ancestor
65091148|NCT01313221|Sensory System Agents|sensory system agents|mesh-ancestor
65091149|NCT01313221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65091150|NCT01313221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091151|NCT01313221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65091152|NCT01313221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65091153|NCT01313221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65091154|NCT01313221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65091155|NCT01313221|Immunologic Factors|immunologic factors|mesh-ancestor
65091156|NCT01313182|Povidone-Iodine|povidone-iodine|mesh-list
65091157|NCT01313182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
65091158|NCT01313182|Mupirocin|mupirocin|mesh-list
65091159|NCT01313182|Povidone|povidone|mesh-list
65091160|NCT01313182|Calcium|calcium|mesh-list
65091161|NCT01313182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65091162|NCT01313182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091163|NCT01313182|Plasma Substitutes|plasma substitutes|mesh-ancestor
65091164|NCT01313182|Blood Substitutes|blood substitutes|mesh-ancestor
65091165|NCT01313182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65091166|NCT01313182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65091167|NCT01313182|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65091168|NCT01313182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091169|NCT01313182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091170|NCT00480194|Xylometazoline|xylometazoline|mesh-list
65091171|NCT00480194|Bromides|bromides|mesh-list
65091172|NCT00480194|Ipratropium|ipratropium|mesh-list
65091173|NCT00480194|Anticonvulsants|anticonvulsants|mesh-ancestor
65091174|NCT00480194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65091175|NCT00480194|Autonomic Agents|autonomic agents|mesh-ancestor
65091176|NCT00480194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65091177|NCT00480194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091178|NCT00480194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65091179|NCT00480194|Respiratory System Agents|respiratory system agents|mesh-ancestor
65091180|NCT00480194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65091181|NCT00480194|Cholinergic Agents|cholinergic agents|mesh-ancestor
65091182|NCT00480194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65091183|NCT00480194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091184|NCT00480194|Nasal Decongestants|nasal decongestants|mesh-ancestor
65091185|NCT00480194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65091186|NCT00505089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65091187|NCT00505089|Immunologic Factors|immunologic factors|mesh-ancestor
65091188|NCT00505089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091189|NCT00505167|Memantine|memantine|mesh-list
65091190|NCT00505167|Donepezil|donepezil|mesh-list
65091191|NCT00505167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65091192|NCT00505167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091193|NCT00505167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091194|NCT00505167|Cholinergic Agents|cholinergic agents|mesh-ancestor
65091195|NCT00505167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64835620|NCT02578680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835621|NCT02578680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64835622|NCT02578680|Antiemetics|antiemetics|mesh-ancestor
65091196|NCT00505167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091197|NCT00505167|Nootropic Agents|nootropic agents|mesh-ancestor
65091198|NCT00505167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65091199|NCT00505167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65091200|NCT00505167|Dopamine Agents|dopamine agents|mesh-ancestor
65091201|NCT00505167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65091202|NCT00505167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65091203|NCT00480272|Prednisone|prednisone|mesh-list
65091204|NCT00480272|Adalimumab|adalimumab|mesh-list
65091205|NCT00480272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65091206|NCT00480272|Glucocorticoids|glucocorticoids|mesh-ancestor
65091207|NCT00480272|Hormones|hormones|mesh-ancestor
65091208|NCT00480272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65091209|NCT00480272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091210|NCT00480272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65091211|NCT00480272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091212|NCT00480272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65091213|NCT04517058|Antidepressive Agents|antidepressive agents|mesh-list
65091214|NCT04517058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65091215|NCT00480389|Sorafenib|sorafenib|mesh-list
65091216|NCT00480389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091217|NCT00480389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65091218|NCT00480389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091219|NCT00480389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091220|NCT04519710|Rituximab|rituximab|mesh-list
65091221|NCT04519710|Ocrelizumab|ocrelizumab|mesh-list
65091222|NCT04519710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65091223|NCT04519710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091224|NCT04519710|Immunologic Factors|immunologic factors|mesh-ancestor
65091225|NCT04519710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091226|NCT04519710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65091227|NCT00482027|Vaccines|vaccines|mesh-list
65091228|NCT00482027|Immunologic Factors|immunologic factors|mesh-ancestor
65091229|NCT00482027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091230|NCT00482066|Abatacept|abatacept|mesh-list
65091231|NCT00482066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65091232|NCT00482066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091233|NCT00482066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091234|NCT00482066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65091235|NCT00482066|Immunologic Factors|immunologic factors|mesh-ancestor
65091236|NCT00482066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091237|NCT00482066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65091238|NCT00482183|Pioglitazone|pioglitazone|mesh-list
65091239|NCT00482183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65091240|NCT00482183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091241|NCT01312909|Varenicline|varenicline|mesh-list
65091243|NCT01312909|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65091244|NCT01312909|Cholinergic Agents|cholinergic agents|mesh-ancestor
65091245|NCT01312909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65091246|NCT01312909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091247|NCT01312909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091248|NCT00482222|Leucovorin|leucovorin|mesh-list
65091249|NCT00482222|Fluorouracil|fluorouracil|mesh-list
65091250|NCT00482222|Capecitabine|capecitabine|mesh-list
65091251|NCT00482222|Oxaliplatin|oxaliplatin|mesh-list
65091252|NCT00482222|Cetuximab|cetuximab|mesh-list
65091253|NCT00482222|Calcium|calcium|mesh-list
65091254|NCT00482222|Levoleucovorin|levoleucovorin|mesh-list
65091255|NCT00482222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65091256|NCT00482222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091257|NCT00482222|Antimetabolites|antimetabolites|mesh-ancestor
65091258|NCT00482222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091259|NCT00482222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65091260|NCT00482222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091261|NCT00482222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65091262|NCT00482222|Immunologic Factors|immunologic factors|mesh-ancestor
65091263|NCT00482222|Antidotes|antidotes|mesh-ancestor
65091264|NCT00482222|Protective Agents|protective agents|mesh-ancestor
65091265|NCT00482222|Vitamin B Complex|vitamin b complex|mesh-ancestor
65091266|NCT00482222|Vitamins|vitamins|mesh-ancestor
65091267|NCT00482222|Micronutrients|micronutrients|mesh-ancestor
64835623|NCT02578680|Autonomic Agents|autonomic agents|mesh-ancestor
65091268|NCT00482222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65091269|NCT01312129|Sulfasalazine|sulfasalazine|mesh-list
65091270|NCT01312129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65091271|NCT01312129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65091272|NCT01312129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65091273|NCT01312129|Analgesics|analgesics|mesh-ancestor
65091274|NCT01312129|Sensory System Agents|sensory system agents|mesh-ancestor
65091275|NCT01312129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65091276|NCT01312129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091277|NCT01312129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65091278|NCT01312129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65091279|NCT01312129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65091280|NCT04518852|Sorafenib|sorafenib|mesh-list
65091281|NCT04518852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091282|NCT04518852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65091283|NCT04518852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091284|NCT04518852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091285|NCT01311661|Olodaterol|olodaterol|mesh-list
65091286|NCT01311661|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65091287|NCT01311661|Autonomic Agents|autonomic agents|mesh-ancestor
65091288|NCT01311661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65091289|NCT01311661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091290|NCT01311661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65091291|NCT01311661|Respiratory System Agents|respiratory system agents|mesh-ancestor
64733462|NCT00005059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733463|NCT00005059|Tubulin Modulators|tubulin modulators|mesh-ancestor
65091292|NCT04518735|Anticoagulants|anticoagulants|mesh-list
65091293|NCT00482261|Aspirin|aspirin|mesh-list
65091294|NCT00482261|Dexamethasone|dexamethasone|mesh-list
65091295|NCT00482261|Lenalidomide|lenalidomide|mesh-list
65091296|NCT00482261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65091297|NCT00482261|Antiemetics|antiemetics|mesh-ancestor
65091298|NCT00482261|Autonomic Agents|autonomic agents|mesh-ancestor
65091299|NCT00482261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65091300|NCT00482261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091301|NCT00482261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65091302|NCT00482261|Glucocorticoids|glucocorticoids|mesh-ancestor
65091303|NCT00482261|Hormones|hormones|mesh-ancestor
65091304|NCT00482261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65091305|NCT00482261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65091306|NCT00482261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091307|NCT00482261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65091308|NCT00482261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65091309|NCT00482261|Analgesics|analgesics|mesh-ancestor
65091310|NCT00482261|Sensory System Agents|sensory system agents|mesh-ancestor
65091311|NCT00482261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65091312|NCT00482261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65091313|NCT00482261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65091314|NCT00482261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091315|NCT00482261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65091317|NCT00482261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091318|NCT00482261|Antipyretics|antipyretics|mesh-ancestor
65091319|NCT00482261|Immunologic Factors|immunologic factors|mesh-ancestor
65091320|NCT00482261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65091321|NCT00482261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65091322|NCT00482261|Growth Substances|growth substances|mesh-ancestor
65091323|NCT00482261|Growth Inhibitors|growth inhibitors|mesh-ancestor
65091324|NCT04518618|Fentanyl|fentanyl|mesh-list
65091325|NCT04518618|Naloxone|naloxone|mesh-list
65091326|NCT04518618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65091327|NCT04518618|Narcotics|narcotics|mesh-ancestor
65091328|NCT04518618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65091329|NCT04518618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091330|NCT04518618|Analgesics|analgesics|mesh-ancestor
65091331|NCT04518618|Sensory System Agents|sensory system agents|mesh-ancestor
65091332|NCT04518618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65091333|NCT04518618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65091334|NCT04518618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65091335|NCT04518618|Anesthetics, General|anesthetics, general|mesh-ancestor
65091336|NCT04518618|Anesthetics|anesthetics|mesh-ancestor
65091337|NCT04518618|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
65091338|NCT00480584|Gemcitabine|gemcitabine|mesh-list
65091339|NCT00480584|Capecitabine|capecitabine|mesh-list
65091340|NCT00480584|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64591708|NCT00508469|Timolol|timolol|mesh-list
65091341|NCT00480584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65091342|NCT00480584|Antimetabolites|antimetabolites|mesh-ancestor
65091343|NCT00480584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091344|NCT00480584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091345|NCT00480584|Antiviral Agents|antiviral agents|mesh-ancestor
65091346|NCT00480584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65091347|NCT00480584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091348|NCT00480584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65091349|NCT00480584|Immunologic Factors|immunologic factors|mesh-ancestor
65091350|NCT00480584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091351|NCT00480584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65091352|NCT01311505|Rifampin|rifampin|mesh-list
65091353|NCT01311505|Isoniazid|isoniazid|mesh-list
65091354|NCT01311505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65091355|NCT01311505|Antitubercular Agents|antitubercular agents|mesh-ancestor
65091356|NCT01311505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65091357|NCT01311505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65091358|NCT01311505|Leprostatic Agents|leprostatic agents|mesh-ancestor
65091359|NCT01311505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65091360|NCT01311505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091361|NCT01311505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091362|NCT01311505|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65091363|NCT01311505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65091364|NCT01311505|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65091365|NCT01311505|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65091366|NCT01311505|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65091367|NCT01311505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65091368|NCT01311505|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65091369|NCT01311505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65091370|NCT01311505|Antimetabolites|antimetabolites|mesh-ancestor
65091371|NCT01311505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65091372|NCT01240538|Cyclophosphamide|cyclophosphamide|mesh-list
65091373|NCT01240538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65091374|NCT01240538|Immunologic Factors|immunologic factors|mesh-ancestor
65091375|NCT01240538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091376|NCT01240538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65091377|NCT01240538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65091378|NCT01240538|Alkylating Agents|alkylating agents|mesh-ancestor
65091379|NCT01240538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091380|NCT01240538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091381|NCT01240538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65091382|NCT01310803|Valrubicin|valrubicin|mesh-list
65091383|NCT01310803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091384|NCT01310803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65091385|NCT01310803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65091386|NCT01310803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091387|NCT01310803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091388|NCT04518540|Thioctic Acid|thioctic acid|mesh-list
65091389|NCT04518540|Antioxidants|antioxidants|mesh-ancestor
64664157|NCT02683161|Varenicline|varenicline|mesh-list
65091390|NCT04518540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091391|NCT04518540|Protective Agents|protective agents|mesh-ancestor
65091392|NCT04518540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091393|NCT04518540|Vitamin B Complex|vitamin b complex|mesh-ancestor
65091395|NCT04518540|Micronutrients|micronutrients|mesh-ancestor
65091396|NCT00480623|Satraplatin|satraplatin|mesh-list
65091397|NCT00480623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091398|NCT01240655|Paclitaxel|paclitaxel|mesh-list
65091399|NCT01240655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65091400|NCT01240655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091401|NCT01240655|Tubulin Modulators|tubulin modulators|mesh-ancestor
65091402|NCT01240655|Antimitotic Agents|antimitotic agents|mesh-ancestor
65091403|NCT01240655|Mitosis Modulators|mitosis modulators|mesh-ancestor
64835629|NCT02578680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64835636|NCT02578680|Hematinics|hematinics|mesh-ancestor
65091404|NCT01240655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091405|NCT04518189|Lidocaine|lidocaine|mesh-list
65091406|NCT04518189|Anesthetics, Local|anesthetics, local|mesh-ancestor
65091407|NCT04518189|Anesthetics|anesthetics|mesh-ancestor
65091408|NCT04518189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65091409|NCT04518189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091410|NCT04518189|Sensory System Agents|sensory system agents|mesh-ancestor
65091411|NCT04518189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65091412|NCT04518189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65091413|NCT04518189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65091414|NCT04518189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65091415|NCT04518189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65091416|NCT04518189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091417|NCT00482378|Zoledronic Acid|zoledronic acid|mesh-list
65091418|NCT00482378|Pamidronate|pamidronate|mesh-list
65091419|NCT00482378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65091420|NCT00482378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091421|NCT00482456|Nitrous Oxide|nitrous oxide|mesh-list
65091422|NCT00482456|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65091423|NCT00482456|Anesthetics, General|anesthetics, general|mesh-ancestor
65091424|NCT00482456|Anesthetics|anesthetics|mesh-ancestor
65091425|NCT00482456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65091426|NCT00482456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091427|NCT00482456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65091428|NCT00482456|Analgesics|analgesics|mesh-ancestor
65091429|NCT00482456|Sensory System Agents|sensory system agents|mesh-ancestor
65091430|NCT00482456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65091431|NCT00480896|Tacrolimus|tacrolimus|mesh-list
65091432|NCT00480896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65091433|NCT00480896|Immunologic Factors|immunologic factors|mesh-ancestor
65091434|NCT00480896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091435|NCT00480896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65091436|NCT00480896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091437|NCT00480896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091438|NCT01309828|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65091439|NCT01309828|Olmesartan|olmesartan|mesh-list
65091440|NCT01309828|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
65091441|NCT01309828|Chlorthalidone|chlorthalidone|mesh-list
65091442|NCT01309828|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
65091443|NCT01309828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64733612|NCT00005113|Tacrolimus|tacrolimus|mesh-list
65091445|NCT01309828|Natriuretic Agents|natriuretic agents|mesh-ancestor
65091446|NCT01309828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091447|NCT01309828|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65091448|NCT01309828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65091449|NCT01309828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091450|NCT01309828|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65091451|NCT01309828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65091452|NCT00482495|Bevacizumab|bevacizumab|mesh-list
65091453|NCT00482495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65091454|NCT00482495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091455|NCT00482495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65091456|NCT00482495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65091457|NCT00482495|Growth Substances|growth substances|mesh-ancestor
65091458|NCT00482495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091459|NCT00482495|Growth Inhibitors|growth inhibitors|mesh-ancestor
65091460|NCT00480935|Sunitinib|sunitinib|mesh-list
65091461|NCT00480935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091462|NCT00480935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65091463|NCT00480935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65091464|NCT00480935|Growth Substances|growth substances|mesh-ancestor
65091465|NCT00480935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091466|NCT00480935|Growth Inhibitors|growth inhibitors|mesh-ancestor
65091467|NCT00480935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65091468|NCT00480935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091469|NCT00480935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091470|NCT00482573|Epinephrine|epinephrine|mesh-list
65091471|NCT00482573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
65091472|NCT00482573|Anesthetics|anesthetics|mesh-list
65091473|NCT00482573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65091474|NCT00482573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091475|NCT00482573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65091476|NCT00482573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65091477|NCT00482573|Adrenergic Agents|adrenergic agents|mesh-ancestor
65091478|NCT00482573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65091479|NCT00482573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091480|NCT00482573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65091481|NCT00482573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65091482|NCT00482573|Autonomic Agents|autonomic agents|mesh-ancestor
65091483|NCT00482573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65091484|NCT00482573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65091485|NCT00482573|Respiratory System Agents|respiratory system agents|mesh-ancestor
65091486|NCT00482573|Mydriatics|mydriatics|mesh-ancestor
65091487|NCT00482573|Sympathomimetics|sympathomimetics|mesh-ancestor
65091488|NCT00482976|Ruboxistaurin|ruboxistaurin|mesh-list
65091489|NCT00482976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091490|NCT00482976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091491|NCT00481013|Valproic Acid|valproic acid|mesh-list
65091492|NCT00481013|Anticonvulsants|anticonvulsants|mesh-ancestor
65091493|NCT00481013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091494|NCT00481013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091495|NCT00481013|GABA Agents|gaba agents|mesh-ancestor
65091496|NCT00481013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65091497|NCT00481013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091498|NCT00481013|Antimanic Agents|antimanic agents|mesh-ancestor
65091499|NCT00481013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65091500|NCT00481013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65091501|NCT00481013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65091502|NCT01309243|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
65091503|NCT01309243|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
65091504|NCT01309243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65091505|NCT01309243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65091506|NCT01309243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091507|NCT01309243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091508|NCT01309243|Antiviral Agents|antiviral agents|mesh-ancestor
65091509|NCT01309243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65091510|NCT01309243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65091511|NCT01309243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65091512|NCT01240109|Remifentanil|remifentanil|mesh-list
65091513|NCT01240109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65091514|NCT01240109|Narcotics|narcotics|mesh-ancestor
64733699|NCT00005641|Antimetabolites|antimetabolites|mesh-ancestor
65091515|NCT01240109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65091516|NCT01240109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091517|NCT01240109|Analgesics|analgesics|mesh-ancestor
65091518|NCT01240109|Sensory System Agents|sensory system agents|mesh-ancestor
65091519|NCT01240109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65091520|NCT04517526|Bevacizumab|bevacizumab|mesh-list
65091521|NCT04517526|Durvalumab|durvalumab|mesh-list
65091522|NCT04517526|Carboplatin|carboplatin|mesh-list
65091523|NCT04517526|Pemetrexed|pemetrexed|mesh-list
65091524|NCT04517526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65091525|NCT04517526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091526|NCT04517526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65091527|NCT04517526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65091528|NCT04517526|Growth Substances|growth substances|mesh-ancestor
65091529|NCT04517526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091530|NCT04517526|Growth Inhibitors|growth inhibitors|mesh-ancestor
65091531|NCT04517526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091532|NCT04517526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091533|NCT04517526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65091534|NCT04517526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65091535|NCT01309204|Brimonidine Tartrate|brimonidine tartrate|mesh-list
65091536|NCT01309204|Ophthalmic Solutions|ophthalmic solutions|mesh-list
65091537|NCT01309204|Brinzolamide|brinzolamide|mesh-list
65091538|NCT01309204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65091539|NCT01309204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65091540|NCT01309204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
65091541|NCT01309204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65091542|NCT01309204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65091543|NCT01309204|Adrenergic Agents|adrenergic agents|mesh-ancestor
65091544|NCT01309204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65091545|NCT01309204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091546|NCT01309204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091547|NCT01309204|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65091548|NCT01309204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091549|NCT00482807|Docetaxel|docetaxel|mesh-list
65091550|NCT00482807|Goserelin|goserelin|mesh-list
65091551|NCT00482807|Bicalutamide|bicalutamide|mesh-list
65091552|NCT00482807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091553|NCT00482807|Tubulin Modulators|tubulin modulators|mesh-ancestor
65091554|NCT00482807|Antimitotic Agents|antimitotic agents|mesh-ancestor
65091555|NCT00482807|Mitosis Modulators|mitosis modulators|mesh-ancestor
65091556|NCT00482807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091557|NCT00482807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65091558|NCT00482807|Androgen Antagonists|androgen antagonists|mesh-ancestor
65091559|NCT00482807|Hormone Antagonists|hormone antagonists|mesh-ancestor
65091560|NCT00482807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65091561|NCT00482807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091562|NCT01240148|Lidocaine|lidocaine|mesh-list
65091563|NCT01240148|Anesthetics, Local|anesthetics, local|mesh-ancestor
65091564|NCT01240148|Anesthetics|anesthetics|mesh-ancestor
65091565|NCT01240148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65091566|NCT01240148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091567|NCT01240148|Sensory System Agents|sensory system agents|mesh-ancestor
65091568|NCT01240148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65091569|NCT01240148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65091570|NCT01240148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65091571|NCT01240148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65091572|NCT01240148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65091573|NCT01240148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091574|NCT04325191|Melatonin|melatonin|mesh-list
65091575|NCT04325191|Antioxidants|antioxidants|mesh-ancestor
65091576|NCT04325191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091577|NCT04325191|Protective Agents|protective agents|mesh-ancestor
65091578|NCT04325191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091579|NCT04325191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65091580|NCT04517292|Gemcitabine|gemcitabine|mesh-list
65091581|NCT04517292|Cisplatin|cisplatin|mesh-list
65091582|NCT04517292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091583|NCT04517292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65091584|NCT04517292|Antimetabolites|antimetabolites|mesh-ancestor
65091585|NCT04517292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091586|NCT04517292|Antiviral Agents|antiviral agents|mesh-ancestor
65091587|NCT04517292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65091588|NCT04517292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091589|NCT04517292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65091590|NCT04517292|Immunologic Factors|immunologic factors|mesh-ancestor
65091591|NCT04517292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091592|NCT00482846|Melphalan|melphalan|mesh-list
65091593|NCT00482846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65091594|NCT00482846|Alkylating Agents|alkylating agents|mesh-ancestor
65091595|NCT00482846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091596|NCT00482846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091597|NCT00482846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65091598|NCT00482846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65091599|NCT00482846|Immunologic Factors|immunologic factors|mesh-ancestor
65091600|NCT00482846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091601|NCT01308736|Varenicline|varenicline|mesh-list
65091602|NCT01308736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65091603|NCT01308736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65091604|NCT01308736|Cholinergic Agents|cholinergic agents|mesh-ancestor
65091605|NCT01308736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65091606|NCT01308736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091607|NCT01308736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091609|NCT04517214|Capecitabine|capecitabine|mesh-list
65091610|NCT04517214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091611|NCT04517214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65091612|NCT04517214|Antimetabolites|antimetabolites|mesh-ancestor
65091613|NCT04517214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091614|NCT04517214|Antiviral Agents|antiviral agents|mesh-ancestor
65091615|NCT04517214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65091616|NCT04517214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091617|NCT04517214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65091618|NCT04517214|Immunologic Factors|immunologic factors|mesh-ancestor
65091619|NCT04517214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091620|NCT00483054|Efavirenz|efavirenz|mesh-list
65091621|NCT00483054|Nevirapine|nevirapine|mesh-list
65091622|NCT00483054|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65091623|NCT00483054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65091624|NCT00483054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091625|NCT00483054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091626|NCT00483054|Antiviral Agents|antiviral agents|mesh-ancestor
65091627|NCT00483054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65091628|NCT00483054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65091629|NCT00483054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65091630|NCT00483054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65091631|NCT00483054|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65091632|NCT00483054|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65091633|NCT00483054|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65091634|NCT00483054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65091635|NCT00483054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65091636|NCT01240226|Ketoconazole|ketoconazole|mesh-list
65091637|NCT01240226|Antifungal Agents|antifungal agents|mesh-ancestor
65091638|NCT01240226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65091639|NCT01240226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65091640|NCT01240226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65091641|NCT01240226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091642|NCT01240226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091643|NCT01240226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65091644|NCT01240226|Hormone Antagonists|hormone antagonists|mesh-ancestor
65091645|NCT01240226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65091646|NCT01240226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091647|NCT01240226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65091648|NCT01240824|Aminophylline|aminophylline|mesh-list
65091649|NCT01240824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65091650|NCT01240824|Autonomic Agents|autonomic agents|mesh-ancestor
65091651|NCT01240824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65091652|NCT01240824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091653|NCT01240824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65091654|NCT01240824|Respiratory System Agents|respiratory system agents|mesh-ancestor
65091655|NCT01240824|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65091656|NCT01240824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65091657|NCT01240824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091658|NCT01240824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091659|NCT01240824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65091660|NCT01240824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65091661|NCT01240824|Purinergic Agents|purinergic agents|mesh-ancestor
65091662|NCT01240824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65091663|NCT01240824|Protective Agents|protective agents|mesh-ancestor
65091665|NCT01240941|Goserelin|goserelin|mesh-list
65091666|NCT01240941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091667|NCT01240941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65091668|NCT01240941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65091669|NCT01240941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091670|NCT01240941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091671|NCT01240941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65091672|NCT01240941|Hormone Antagonists|hormone antagonists|mesh-ancestor
65091673|NCT01240941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65091674|NCT01240941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091675|NCT01240941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65091676|NCT00482963|Efavirenz|efavirenz|mesh-list
65091678|NCT00482963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65091679|NCT00482963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65091680|NCT00482963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091681|NCT00482963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091682|NCT00482963|Antiviral Agents|antiviral agents|mesh-ancestor
65091683|NCT00482963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65091684|NCT00482963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65091685|NCT00482963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65091686|NCT00482963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65091687|NCT00482963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65091688|NCT00482963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65091689|NCT00482963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65091690|NCT00482963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65091691|NCT00482963|Contraceptive Agents|contraceptive agents|mesh-ancestor
65091692|NCT00482963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65091693|NCT00482963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091694|NCT00482963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65091695|NCT00482963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65091696|NCT00482963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65091697|NCT01241019|Topiramate|topiramate|mesh-list
65091698|NCT01241019|Anticonvulsants|anticonvulsants|mesh-ancestor
65091699|NCT01241019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65091700|NCT01241019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091701|NCT01240928|Exemestane|exemestane|mesh-list
65091702|NCT01240928|Goserelin|goserelin|mesh-list
65091703|NCT01240928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091704|NCT01240928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65091705|NCT01240928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65091706|NCT01240928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091707|NCT01240928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091708|NCT01240928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65091709|NCT01240928|Hormone Antagonists|hormone antagonists|mesh-ancestor
65091710|NCT01240928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65091711|NCT01240928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091712|NCT01240928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65091713|NCT00481169|Bazedoxifene|bazedoxifene|mesh-list
65091714|NCT00481169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65091715|NCT00481169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65091716|NCT00481169|Hormone Antagonists|hormone antagonists|mesh-ancestor
65091717|NCT00481169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65091718|NCT00481169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091719|NCT00481169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65091720|NCT00483093|Cisplatin|cisplatin|mesh-list
65091721|NCT00483093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091722|NCT00483132|Interferons|interferons|mesh-list
65091723|NCT00483132|Interferon-alpha|interferon-alpha|mesh-list
65091724|NCT00483132|Interferon alpha-2|interferon alpha-2|mesh-list
65091725|NCT00483132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091726|NCT00483132|Antiviral Agents|antiviral agents|mesh-ancestor
65091727|NCT00483132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65091728|NCT00483132|Immunologic Factors|immunologic factors|mesh-ancestor
64325589|NCT02160743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64325590|NCT02160743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64325591|NCT02160743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64325592|NCT02158013|Diltiazem|diltiazem|mesh-list
64835638|NCT02520791|Antibodies|antibodies|mesh-list
65091729|NCT00483132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091730|NCT00483210|Fenofibrate|fenofibrate|mesh-list
65091731|NCT00483210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65091732|NCT00483210|Antimetabolites|antimetabolites|mesh-ancestor
64473322|NCT00123604|Adrenergic Agents|adrenergic agents|mesh-ancestor
65091733|NCT00483210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091734|NCT00483210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65091735|NCT00487994|Atorvastatin|atorvastatin|mesh-list
65091736|NCT00487994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65091737|NCT00487994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65091738|NCT00487994|Antimetabolites|antimetabolites|mesh-ancestor
65091739|NCT00487994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091740|NCT00487994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65091741|NCT00487994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65091742|NCT00487994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091743|NCT00483158|Finafloxacin|finafloxacin|mesh-list
65091744|NCT00483158|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
65091745|NCT00483158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65091747|NCT00483158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65091748|NCT00483158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65091749|NCT00483158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65091750|NCT00483158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091751|NCT00483158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091752|NCT00483158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091753|NCT00483366|Gemcitabine|gemcitabine|mesh-list
65091754|NCT00483366|Capecitabine|capecitabine|mesh-list
65091755|NCT00483366|Imatinib Mesylate|imatinib mesylate|mesh-list
65091756|NCT00483366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65091757|NCT00483366|Antimetabolites|antimetabolites|mesh-ancestor
65091758|NCT00483366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091759|NCT00483366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091760|NCT00483366|Antiviral Agents|antiviral agents|mesh-ancestor
65091761|NCT00483366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65091762|NCT00483366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091763|NCT00483366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65091764|NCT00483366|Immunologic Factors|immunologic factors|mesh-ancestor
65091765|NCT00483366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091766|NCT00483366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65091767|NCT01308580|Prednisone|prednisone|mesh-list
65091768|NCT01308580|Prednisolone|prednisolone|mesh-list
65091769|NCT01308580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65091770|NCT01308580|Glucocorticoids|glucocorticoids|mesh-ancestor
65091771|NCT01308580|Hormones|hormones|mesh-ancestor
65091772|NCT01308580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65091773|NCT01308580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091774|NCT01308580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65091775|NCT01308580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091776|NCT00483275|Alfacalcidol|alfacalcidol|mesh-list
65091777|NCT00483275|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
65091778|NCT00483275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65091779|NCT00483275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091780|NCT00483275|Vitamins|vitamins|mesh-ancestor
65091781|NCT00483275|Micronutrients|micronutrients|mesh-ancestor
65091782|NCT00483314|Acetylcysteine|acetylcysteine|mesh-list
65091783|NCT00483314|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65091784|NCT00483314|Antiviral Agents|antiviral agents|mesh-ancestor
65091785|NCT00483314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65091786|NCT00483314|Expectorants|expectorants|mesh-ancestor
65091787|NCT00483314|Respiratory System Agents|respiratory system agents|mesh-ancestor
65091788|NCT00483314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65091789|NCT00483314|Antioxidants|antioxidants|mesh-ancestor
65091790|NCT00483314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091791|NCT00483314|Protective Agents|protective agents|mesh-ancestor
65091792|NCT00483314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091793|NCT00483314|Antidotes|antidotes|mesh-ancestor
65091794|NCT00483392|Metformin|metformin|mesh-list
65091795|NCT00483392|Rosiglitazone|rosiglitazone|mesh-list
65091796|NCT00483392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65091797|NCT00483392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091798|NCT00483431|Vitamin MK 7|vitamin mk 7|mesh-list
65091799|NCT00483431|Hemostatics|hemostatics|mesh-ancestor
65091800|NCT00483431|Coagulants|coagulants|mesh-ancestor
65091801|NCT00483600|PENTA|penta|mesh-list
65091802|NCT00483600|Fondaparinux|fondaparinux|mesh-list
65091803|NCT00483600|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65091804|NCT00483600|Antithrombins|antithrombins|mesh-ancestor
65091805|NCT00483600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65091806|NCT00483600|Protease Inhibitors|protease inhibitors|mesh-ancestor
65091807|NCT00483600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091808|NCT00483600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091809|NCT00483600|Anticoagulants|anticoagulants|mesh-ancestor
65091810|NCT00483600|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65091811|NCT00483600|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65091812|NCT00488189|Tazobactam|tazobactam|mesh-list
65091813|NCT00488189|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65091815|NCT00488189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65091816|NCT00488189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65091817|NCT00488189|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65091818|NCT00488189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091819|NCT00488189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091820|NCT02956421|Vaccines|vaccines|mesh-list
65091821|NCT02956421|Immunologic Factors|immunologic factors|mesh-ancestor
65091822|NCT02956421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091823|NCT00483470|Vaccines|vaccines|mesh-list
65091824|NCT00483470|Immunologic Factors|immunologic factors|mesh-ancestor
65091825|NCT00483470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091826|NCT00488306|Tigecycline|tigecycline|mesh-list
65091827|NCT00488306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65091828|NCT00488306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65091829|NCT00488306|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65091830|NCT00488306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091831|NCT00488306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091832|NCT00483626|Sildenafil Citrate|sildenafil citrate|mesh-list
65091833|NCT00483626|Vasodilator Agents|vasodilator agents|mesh-ancestor
65091834|NCT00483626|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65091835|NCT00483626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65091836|NCT00483626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091837|NCT00483626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091838|NCT00483626|Urological Agents|urological agents|mesh-ancestor
65091839|NCT00483795|Citric Acid|citric acid|mesh-list
65091840|NCT00483795|Sodium Citrate|sodium citrate|mesh-list
65091841|NCT00483795|Anticoagulants|anticoagulants|mesh-ancestor
65091842|NCT00483795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
65091843|NCT00483795|Chelating Agents|chelating agents|mesh-ancestor
65091844|NCT00483795|Sequestering Agents|sequestering agents|mesh-ancestor
65091845|NCT00483795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091846|NCT05644210|Aspirin|aspirin|mesh-list
65091847|NCT05644210|Hydroxychloroquine|hydroxychloroquine|mesh-list
65091848|NCT05644210|Prednisone|prednisone|mesh-list
65091849|NCT05644210|Rituximab|rituximab|mesh-list
65091850|NCT05644210|Warfarin|warfarin|mesh-list
65091851|NCT05644210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65091852|NCT05644210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091853|NCT05644210|Immunologic Factors|immunologic factors|mesh-ancestor
65091854|NCT05644210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091855|NCT05644210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65091856|NCT05644210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65091857|NCT05644210|Glucocorticoids|glucocorticoids|mesh-ancestor
65091858|NCT05644210|Hormones|hormones|mesh-ancestor
65091859|NCT05644210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65091860|NCT05644210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65091861|NCT05644210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65091862|NCT05644210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65091863|NCT05644210|Analgesics|analgesics|mesh-ancestor
65091864|NCT05644210|Sensory System Agents|sensory system agents|mesh-ancestor
65091865|NCT05644210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65091866|NCT05644210|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65091867|NCT05644210|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65091868|NCT05644210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091869|NCT05644210|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65091870|NCT05644210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65091871|NCT05644210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091872|NCT05644210|Antipyretics|antipyretics|mesh-ancestor
65091873|NCT05644210|Anticoagulants|anticoagulants|mesh-ancestor
65091874|NCT05644210|Antimalarials|antimalarials|mesh-ancestor
65091875|NCT05644210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65091876|NCT05644210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65091877|NCT05644210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65091878|NCT00488384|Acitretin|acitretin|mesh-list
65091879|NCT00488384|Keratolytic Agents|keratolytic agents|mesh-ancestor
65091880|NCT00488384|Dermatologic Agents|dermatologic agents|mesh-ancestor
65091881|NCT00483834|Bevacizumab|bevacizumab|mesh-list
65091882|NCT00483834|Capecitabine|capecitabine|mesh-list
65091883|NCT00483834|Irinotecan|irinotecan|mesh-list
65091884|NCT00483834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65091885|NCT00483834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091886|NCT00483834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65091887|NCT00483834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65091888|NCT00483834|Growth Substances|growth substances|mesh-ancestor
65091889|NCT00483834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091890|NCT00483834|Growth Inhibitors|growth inhibitors|mesh-ancestor
65091891|NCT00483834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65091892|NCT00483834|Antimetabolites|antimetabolites|mesh-ancestor
65091893|NCT00483834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091894|NCT00483834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65091895|NCT00483834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65091896|NCT00483834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091897|NCT01307449|Vaccines|vaccines|mesh-list
65091898|NCT01307449|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65091899|NCT01307449|Immunologic Factors|immunologic factors|mesh-ancestor
65091900|NCT01307449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091901|NCT01307020|Ibuprofen|ibuprofen|mesh-list
65091902|NCT01307020|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
65091903|NCT01307020|Ketoprofen|ketoprofen|mesh-list
65091904|NCT01307020|Tramadol|tramadol|mesh-list
65091905|NCT01307020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65091906|NCT01307020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65091907|NCT01307020|Analgesics|analgesics|mesh-ancestor
65091908|NCT01307020|Sensory System Agents|sensory system agents|mesh-ancestor
65091909|NCT01307020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65091910|NCT01307020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091911|NCT01307020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65091912|NCT01307020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65091913|NCT01307020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65091914|NCT01307020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091915|NCT01307020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091916|NCT01307020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65091917|NCT01307020|Narcotics|narcotics|mesh-ancestor
65091918|NCT01307020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65091919|NCT00483743|Budesonide|budesonide|mesh-list
65091920|NCT00483743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65091921|NCT00483743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65091922|NCT00483743|Autonomic Agents|autonomic agents|mesh-ancestor
65091923|NCT00483743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65091924|NCT00483743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091925|NCT00483743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65091926|NCT00483743|Respiratory System Agents|respiratory system agents|mesh-ancestor
65091927|NCT00483743|Glucocorticoids|glucocorticoids|mesh-ancestor
65091928|NCT00483743|Hormones|hormones|mesh-ancestor
65091929|NCT00483743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65091930|NCT00483782|Paclitaxel|paclitaxel|mesh-list
65091931|NCT00483782|Bevacizumab|bevacizumab|mesh-list
65091932|NCT00483782|Carboplatin|carboplatin|mesh-list
65091933|NCT00483782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65091934|NCT00483782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65091935|NCT00483782|Tubulin Modulators|tubulin modulators|mesh-ancestor
65091936|NCT00483782|Antimitotic Agents|antimitotic agents|mesh-ancestor
65091937|NCT00483782|Mitosis Modulators|mitosis modulators|mesh-ancestor
65091938|NCT00483782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091939|NCT00483782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65091940|NCT00483782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65091941|NCT00483782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65091942|NCT00483782|Growth Substances|growth substances|mesh-ancestor
65091943|NCT00483782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835648|NCT02491983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446754|NCT01512160|Analgesics|analgesics|mesh-ancestor
65091944|NCT00483782|Growth Inhibitors|growth inhibitors|mesh-ancestor
65091945|NCT02890771|Turmeric extract|turmeric extract|mesh-list
65091946|NCT02890771|Antioxidants|antioxidants|mesh-ancestor
65091947|NCT02890771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091948|NCT02890771|Protective Agents|protective agents|mesh-ancestor
65091949|NCT02890771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091950|NCT01306162|Dronedarone|dronedarone|mesh-list
65091951|NCT01306162|Dabigatran|dabigatran|mesh-list
65091952|NCT01306162|Antithrombins|antithrombins|mesh-ancestor
65091953|NCT01306162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65091954|NCT01306162|Protease Inhibitors|protease inhibitors|mesh-ancestor
65091955|NCT01306162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091956|NCT01306162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091957|NCT01306162|Anticoagulants|anticoagulants|mesh-ancestor
65091958|NCT01306162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65091959|NCT04515732|Apremilast|apremilast|mesh-list
64483446|NCT00243412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
65091960|NCT04515732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65091961|NCT04515732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65091963|NCT04515732|Sensory System Agents|sensory system agents|mesh-ancestor
65091964|NCT04515732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65091965|NCT04515732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091966|NCT04515732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65091967|NCT04515732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65091968|NCT04515732|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
65091969|NCT04515732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65091970|NCT04515732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091971|NCT04515732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091972|NCT01305577|Deoxycholic Acid|deoxycholic acid|mesh-list
65091973|NCT01305577|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
65091974|NCT01305577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65091975|NCT00483990|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
65091976|NCT00483990|Anesthetics, Local|anesthetics, local|mesh-ancestor
65091977|NCT00483990|Anesthetics|anesthetics|mesh-ancestor
65091978|NCT00483990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65091979|NCT00483990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091980|NCT00483990|Sensory System Agents|sensory system agents|mesh-ancestor
65091981|NCT00483990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65091982|NCT00483990|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
65091983|NCT01304329|Empagliflozin|empagliflozin|mesh-list
65091984|NCT01304329|Simvastatin|simvastatin|mesh-list
65091985|NCT01304329|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65091986|NCT01304329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65091987|NCT01304329|Antimetabolites|antimetabolites|mesh-ancestor
65091988|NCT01304329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65091989|NCT01304329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65091990|NCT01304329|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65091991|NCT01304329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65091992|NCT01304329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65091993|NCT01304329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65091994|NCT01304329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65091995|NCT04515420|Norepinephrine|norepinephrine|mesh-list
65091996|NCT04515420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65091997|NCT04515420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65091998|NCT04515420|Adrenergic Agents|adrenergic agents|mesh-ancestor
65091999|NCT04515420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092000|NCT04515420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092001|NCT04515420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092002|NCT04515420|Sympathomimetics|sympathomimetics|mesh-ancestor
65092003|NCT04515420|Autonomic Agents|autonomic agents|mesh-ancestor
65092004|NCT04515420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65092005|NCT04515420|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65092006|NCT00488540|Acetaminophen|acetaminophen|mesh-list
65092007|NCT00488540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65092008|NCT00488540|Analgesics|analgesics|mesh-ancestor
65092009|NCT00488540|Sensory System Agents|sensory system agents|mesh-ancestor
65092010|NCT00488540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65092011|NCT00488540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092012|NCT00488540|Antipyretics|antipyretics|mesh-ancestor
65092013|NCT00484068|Enalapril|enalapril|mesh-list
65092014|NCT00484068|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65092015|NCT00484068|Protease Inhibitors|protease inhibitors|mesh-ancestor
65092016|NCT00484068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092017|NCT00484068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092018|NCT00484068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65092019|NCT00483860|Topotecan|topotecan|mesh-list
65092020|NCT00483860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65092021|NCT00483860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65092022|NCT00483860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092023|NCT00483860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092024|NCT00483860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65092025|NCT01241097|Simvastatin|simvastatin|mesh-list
65092026|NCT01241097|Ezetimibe|ezetimibe|mesh-list
65092027|NCT01241097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65092028|NCT01241097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65092029|NCT01241097|Antimetabolites|antimetabolites|mesh-ancestor
65092030|NCT01241097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092031|NCT01241097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65092032|NCT01241097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65092033|NCT01241097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092035|NCT01303861|Nicotine|nicotine|mesh-list
65092036|NCT01303861|Varenicline|varenicline|mesh-list
65092037|NCT01303861|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65092038|NCT01303861|Autonomic Agents|autonomic agents|mesh-ancestor
65092039|NCT01303861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65092040|NCT01303861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092041|NCT01303861|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65092042|NCT01303861|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65092043|NCT01303861|Cholinergic Agents|cholinergic agents|mesh-ancestor
65092044|NCT01303861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092045|NCT01303861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092046|NCT01303861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65092047|NCT01303861|Antidepressive Agents|antidepressive agents|mesh-ancestor
65092048|NCT01303861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65092049|NCT01303861|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65092050|NCT01303861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65092051|NCT01303861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65092052|NCT01303861|Dopamine Agents|dopamine agents|mesh-ancestor
65092053|NCT01303861|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65092054|NCT01303861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65092055|NCT01303861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092056|NCT01303627|Remifentanil|remifentanil|mesh-list
65092057|NCT01303627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65092058|NCT01303627|Narcotics|narcotics|mesh-ancestor
65092059|NCT01303627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65092060|NCT01303627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092061|NCT01303627|Analgesics|analgesics|mesh-ancestor
65092062|NCT01303627|Sensory System Agents|sensory system agents|mesh-ancestor
65092063|NCT01303627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65092064|NCT01241175|Magnesium Sulfate|magnesium sulfate|mesh-list
65092065|NCT01241175|Analgesics|analgesics|mesh-ancestor
65092066|NCT01241175|Sensory System Agents|sensory system agents|mesh-ancestor
65092067|NCT01241175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65092068|NCT01241175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092069|NCT01241175|Anesthetics|anesthetics|mesh-ancestor
65092070|NCT01241175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65092071|NCT01241175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65092072|NCT01241175|Anticonvulsants|anticonvulsants|mesh-ancestor
65092073|NCT01241175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65092074|NCT01241175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65092075|NCT01241175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092076|NCT01241175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65092077|NCT01241175|Tocolytic Agents|tocolytic agents|mesh-ancestor
65092078|NCT01241175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65092079|NCT00484107|Estrogens|estrogens|mesh-list
65092080|NCT00484107|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
65092081|NCT00484107|Hormones|hormones|mesh-ancestor
65092082|NCT00484107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65092083|NCT00484107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092084|NCT01302964|Mirtazapine|mirtazapine|mesh-list
65092085|NCT01302964|Antidepressive Agents|antidepressive agents|mesh-ancestor
65092086|NCT01302964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65092087|NCT01302964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65092088|NCT01302964|Histamine Antagonists|histamine antagonists|mesh-ancestor
65092089|NCT01302964|Histamine Agents|histamine agents|mesh-ancestor
65092090|NCT01302964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092091|NCT01302964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092092|NCT01302964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092093|NCT01302964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65092094|NCT01302964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65092095|NCT01302964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65092096|NCT01302964|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
65092097|NCT01302964|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65092098|NCT01302964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65092099|NCT01302964|Adrenergic Agents|adrenergic agents|mesh-ancestor
65092100|NCT01302964|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65092101|NCT01302964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65092102|NCT01302964|Serotonin Agents|serotonin agents|mesh-ancestor
65092103|NCT01302964|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65092105|NCT00484055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65092106|NCT00484055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65092107|NCT00484055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65092108|NCT00484055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092109|NCT00484055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092110|NCT01302691|Losartan|losartan|mesh-list
65092111|NCT01302691|Amlodipine|amlodipine|mesh-list
65092112|NCT01302691|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65092113|NCT01302691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65092114|NCT01302691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65092115|NCT01302691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65092116|NCT01302691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092117|NCT01302691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65092118|NCT01302691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092119|NCT01302691|Vasodilator Agents|vasodilator agents|mesh-ancestor
65092120|NCT01302691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65092121|NCT01302691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65092122|NCT01302691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65092123|NCT01302691|Diuretics|diuretics|mesh-ancestor
65092124|NCT01302691|Natriuretic Agents|natriuretic agents|mesh-ancestor
65092125|NCT01302691|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65092126|NCT01241084|Leukotriene Antagonists|leukotriene antagonists|mesh-list
65092127|NCT01241084|Hormone Antagonists|hormone antagonists|mesh-ancestor
65092128|NCT01241084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65092129|NCT01241084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092130|NCT01241084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65092131|NCT01241084|Respiratory System Agents|respiratory system agents|mesh-ancestor
65092132|NCT05643820|Ivermectin|ivermectin|mesh-list
65092133|NCT05643820|Permethrin|permethrin|mesh-list
65092134|NCT05643820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65092135|NCT05643820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65092136|NCT05643820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092137|NCT05643820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092138|NCT01242449|Trastuzumab|trastuzumab|mesh-list
65092139|NCT01242449|Vinorelbine|vinorelbine|mesh-list
65092140|NCT01242449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65092141|NCT01242449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65092142|NCT01242449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65092143|NCT01242449|Tubulin Modulators|tubulin modulators|mesh-ancestor
65092144|NCT01242449|Antimitotic Agents|antimitotic agents|mesh-ancestor
65092145|NCT01242449|Mitosis Modulators|mitosis modulators|mesh-ancestor
65092146|NCT01242449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092147|NCT01241162|Decitabine|decitabine|mesh-list
65092148|NCT01241162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65092149|NCT01241162|Antimetabolites|antimetabolites|mesh-ancestor
65092150|NCT01241162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092151|NCT01241162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592526|NCT00641563|Midazolam|midazolam|mesh-list
65092152|NCT01241162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092153|NCT00484133|Dobutamine|dobutamine|mesh-list
65092154|NCT00484133|Dopamine|dopamine|mesh-list
65092155|NCT00484133|Enoximone|enoximone|mesh-list
65092156|NCT00484133|Norepinephrine|norepinephrine|mesh-list
65092157|NCT00484133|Nitroglycerin|nitroglycerin|mesh-list
65092158|NCT00484133|Vasodilator Agents|vasodilator agents|mesh-ancestor
65092159|NCT00484133|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65092160|NCT00484133|Sympathomimetics|sympathomimetics|mesh-ancestor
65092161|NCT00484133|Autonomic Agents|autonomic agents|mesh-ancestor
65092162|NCT00484133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65092163|NCT00484133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092164|NCT00484133|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65092165|NCT00484133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65092166|NCT00484133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65092167|NCT00484133|Adrenergic Agents|adrenergic agents|mesh-ancestor
65092168|NCT00484133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092169|NCT00484133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092170|NCT00484133|Protective Agents|protective agents|mesh-ancestor
65092171|NCT00484133|Dopamine Agents|dopamine agents|mesh-ancestor
65092172|NCT00484133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65092173|NCT00484133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65092174|NCT00484133|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64483451|NCT00765232|Analgesics|analgesics|mesh-ancestor
65092175|NCT00484133|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65092176|NCT00484133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092177|NCT00484341|Doxorubicin|doxorubicin|mesh-list
65092178|NCT00484341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65092179|NCT00484341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65092180|NCT00484341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65092181|NCT00484341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64734378|NCT02072226|Aspirin|aspirin|mesh-list
65092182|NCT00484341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092183|NCT00484341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092185|NCT01242566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65092186|NCT01242566|Alkylating Agents|alkylating agents|mesh-ancestor
65092187|NCT01242566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092188|NCT01242566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65092189|NCT04514835|Capecitabine|capecitabine|mesh-list
65092190|NCT04514835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65092191|NCT04514835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65092192|NCT04514835|Antimetabolites|antimetabolites|mesh-ancestor
65092193|NCT04514835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092194|NCT00488813|Cephalosporins|cephalosporins|mesh-list
65092195|NCT00488813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65092196|NCT00488813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65092197|NCT00484250|Metronidazole|metronidazole|mesh-list
65092198|NCT00484250|Doxycycline|doxycycline|mesh-list
65092199|NCT00484250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65092200|NCT00484250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65092201|NCT00484250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65092202|NCT00484250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65092203|NCT00484250|Antimalarials|antimalarials|mesh-ancestor
65092204|NCT00488891|Paliperidone Palmitate|paliperidone palmitate|mesh-list
65092205|NCT00488891|Antipsychotic Agents|antipsychotic agents|mesh-list
65092206|NCT00488891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65092207|NCT00488891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65092208|NCT00488891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092209|NCT00488891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65092210|NCT00488891|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
65092211|NCT00488891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65092212|NCT00488891|Serotonin Agents|serotonin agents|mesh-ancestor
65092213|NCT00488891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092214|NCT00488891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092215|NCT00488891|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65092216|NCT00488891|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65092217|NCT00488891|Dopamine Agents|dopamine agents|mesh-ancestor
65092218|NCT00484328|Ribavirin|ribavirin|mesh-list
65092219|NCT00484328|Antimetabolites|antimetabolites|mesh-ancestor
65092220|NCT00484328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092221|NCT00484328|Antiviral Agents|antiviral agents|mesh-ancestor
65092222|NCT00484328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65092223|NCT00484575|Propofol|propofol|mesh-list
65092224|NCT00484575|Sevoflurane|sevoflurane|mesh-list
65092225|NCT00484575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65092226|NCT00484575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65092227|NCT00484575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092228|NCT00484575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65092229|NCT00484575|Anesthetics, General|anesthetics, general|mesh-ancestor
65092230|NCT00484575|Anesthetics|anesthetics|mesh-ancestor
65092231|NCT00484575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65092232|NCT00484575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65092233|NCT04514796|Adalimumab|adalimumab|mesh-list
65092234|NCT04514796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65092235|NCT04514796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65092236|NCT00488969|Morphine|morphine|mesh-list
65092237|NCT00488969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65092238|NCT00488969|Narcotics|narcotics|mesh-ancestor
65092239|NCT00488969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65092240|NCT00488969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092241|NCT00488969|Analgesics|analgesics|mesh-ancestor
65092242|NCT00488969|Sensory System Agents|sensory system agents|mesh-ancestor
65092243|NCT00488969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65092244|NCT00484692|Bupropion|bupropion|mesh-list
65092245|NCT00484692|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65092246|NCT00484692|Antidepressive Agents|antidepressive agents|mesh-ancestor
65092247|NCT00484692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65092248|NCT00484692|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65092249|NCT00484692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65092250|NCT00484692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65092251|NCT00484692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092252|NCT00484692|Dopamine Agents|dopamine agents|mesh-ancestor
65092253|NCT00484692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092254|NCT00484692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092255|NCT00484692|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65092256|NCT00484692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65092257|NCT00484692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092258|NCT00484731|Bupivacaine|bupivacaine|mesh-list
65092259|NCT00484731|Anesthetics, Local|anesthetics, local|mesh-ancestor
65092260|NCT00484731|Anesthetics|anesthetics|mesh-ancestor
65092261|NCT00484731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65092262|NCT00484731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092263|NCT00484731|Sensory System Agents|sensory system agents|mesh-ancestor
65092264|NCT00484731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65092265|NCT00484484|Ketamine|ketamine|mesh-list
65092266|NCT00484484|Analgesics|analgesics|mesh-ancestor
65092267|NCT00484484|Sensory System Agents|sensory system agents|mesh-ancestor
65092268|NCT00484484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65092269|NCT00484484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092270|NCT00484484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65092271|NCT00484484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65092272|NCT00484484|Anesthetics, General|anesthetics, general|mesh-ancestor
65092273|NCT00484484|Anesthetics|anesthetics|mesh-ancestor
65092274|NCT00484484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65092275|NCT00484484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65092276|NCT00484484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65092277|NCT00484484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092278|NCT00484484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092279|NCT00484601|Doxorubicin|doxorubicin|mesh-list
65092280|NCT00484601|Ifosfamide|ifosfamide|mesh-list
65092281|NCT00484601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65092282|NCT00484601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65092283|NCT00484601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65092284|NCT00484601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65092285|NCT00484601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092286|NCT00484601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092287|NCT00484601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65092288|NCT00484601|Alkylating Agents|alkylating agents|mesh-ancestor
65092289|NCT00484770|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65092290|NCT00484770|Natriuretic Agents|natriuretic agents|mesh-ancestor
65092291|NCT00484770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092292|NCT00484640|Warfarin|warfarin|mesh-list
65092293|NCT00484640|Anticoagulants|anticoagulants|mesh-ancestor
65092294|NCT00489164|Sirolimus|sirolimus|mesh-list
65092295|NCT00489164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65092296|NCT00489164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65092297|NCT00489164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65092298|NCT00489164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65092299|NCT00489164|Antifungal Agents|antifungal agents|mesh-ancestor
65092300|NCT00489164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65092301|NCT00489164|Immunologic Factors|immunologic factors|mesh-ancestor
65092302|NCT00489164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092303|NCT00484809|Etanercept|etanercept|mesh-list
65092304|NCT00484809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65092305|NCT00484809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65092306|NCT00484809|Analgesics|analgesics|mesh-ancestor
65092307|NCT00484809|Sensory System Agents|sensory system agents|mesh-ancestor
65092308|NCT00484809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65092309|NCT00484809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092310|NCT00484809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65092311|NCT00484809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65092312|NCT00484809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65092313|NCT00484809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65092314|NCT00484809|Immunologic Factors|immunologic factors|mesh-ancestor
65092315|NCT04514094|Fluorides|fluorides|mesh-list
65092316|NCT04514094|Cariostatic Agents|cariostatic agents|mesh-ancestor
65092317|NCT04514094|Protective Agents|protective agents|mesh-ancestor
65092318|NCT04514094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092319|NCT04514289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65092320|NCT00484926|Aspirin|aspirin|mesh-list
65092321|NCT00484926|Clopidogrel|clopidogrel|mesh-list
64401030|NCT04858711|Narcotics|narcotics|mesh-ancestor
65092322|NCT00484926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65092323|NCT00484926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65092324|NCT00484926|Analgesics|analgesics|mesh-ancestor
65092325|NCT00484926|Sensory System Agents|sensory system agents|mesh-ancestor
65092326|NCT00484926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65092327|NCT00484926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092328|NCT00484926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65092329|NCT00484926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65092330|NCT00484926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65092331|NCT00484926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64734515|NCT02082912|Cycloserine|cycloserine|mesh-list
65092332|NCT00484926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092333|NCT00484926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65092334|NCT00484926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65092336|NCT00484926|Antipyretics|antipyretics|mesh-ancestor
65092337|NCT00484926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65092338|NCT00484926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65092339|NCT00484926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65092340|NCT00484926|Purinergic Agents|purinergic agents|mesh-ancestor
65092341|NCT00484926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092342|NCT02275806|Irinotecan|irinotecan|mesh-list
65092343|NCT02275806|Camptothecin|camptothecin|mesh-list
65092344|NCT02275806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65092345|NCT02275806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65092346|NCT02275806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65092347|NCT02275806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092348|NCT02275806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092349|NCT02275806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65092350|NCT01241409|Rabeprazole|rabeprazole|mesh-list
65092351|NCT01241409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65092352|NCT01241409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65092353|NCT01241409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65092354|NCT01241409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092355|NCT01241409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092356|NCT02275845|Metformin|metformin|mesh-list
65092357|NCT02275845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65092358|NCT02275845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092359|NCT00489398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
65092360|NCT00489398|Epinastine|epinastine|mesh-list
65092361|NCT00489398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65092362|NCT00489398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65092363|NCT00489398|Analgesics|analgesics|mesh-ancestor
65092364|NCT00489398|Sensory System Agents|sensory system agents|mesh-ancestor
65092365|NCT00489398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65092366|NCT00489398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092367|NCT00489398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65092368|NCT00489398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65092369|NCT00489398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65092370|NCT00489398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
65092371|NCT00489398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
65092372|NCT00489398|Histamine Antagonists|histamine antagonists|mesh-ancestor
65092373|NCT00489398|Histamine Agents|histamine agents|mesh-ancestor
65092374|NCT00489398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092375|NCT00489398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092376|NCT00485004|Sirolimus|sirolimus|mesh-list
65092377|NCT00485004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65092378|NCT00485004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65092379|NCT00485004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65092380|NCT00485004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65092381|NCT00485004|Antifungal Agents|antifungal agents|mesh-ancestor
65092382|NCT00485004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65092383|NCT00485004|Immunologic Factors|immunologic factors|mesh-ancestor
65092384|NCT00485004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092385|NCT00484991|Verapamil|verapamil|mesh-list
65092386|NCT00484991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65092387|NCT00484991|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65092388|NCT00484991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65092389|NCT00484991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092390|NCT00484991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65092391|NCT00484991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092392|NCT00484991|Vasodilator Agents|vasodilator agents|mesh-ancestor
65092393|NCT00485121|Ezetimibe|ezetimibe|mesh-list
65092394|NCT00485121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65092395|NCT00485121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65092396|NCT00485121|Antimetabolites|antimetabolites|mesh-ancestor
65092397|NCT00485121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092398|NCT00485121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65092399|NCT00489437|Heparin|heparin|mesh-list
65092400|NCT00489437|Antibodies|antibodies|mesh-list
65092401|NCT00489437|Immunologic Factors|immunologic factors|mesh-ancestor
65092402|NCT00489437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092403|NCT00489437|Anticoagulants|anticoagulants|mesh-ancestor
65092404|NCT00489437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64734604|NCT01624194|Oxytocin|oxytocin|mesh-list
65092405|NCT00489437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65092406|NCT00489437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092407|NCT00485160|Ibuprofen|ibuprofen|mesh-list
65092408|NCT00485160|Indomethacin|indomethacin|mesh-list
65092409|NCT00485160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65092410|NCT00485160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65092411|NCT00485160|Analgesics|analgesics|mesh-ancestor
65092412|NCT00485160|Sensory System Agents|sensory system agents|mesh-ancestor
65092413|NCT00485160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65092414|NCT00485160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092415|NCT00485160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65092416|NCT00485160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65092417|NCT00485160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65092418|NCT00485160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092419|NCT00485160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092420|NCT00485160|Gout Suppressants|gout suppressants|mesh-ancestor
65092421|NCT00485160|Tocolytic Agents|tocolytic agents|mesh-ancestor
65092422|NCT00485160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65092423|NCT00485030|Sirolimus|sirolimus|mesh-list
65092424|NCT00485030|Everolimus|everolimus|mesh-list
65092425|NCT00485030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592819|NCT01674218|Moxifloxacin|moxifloxacin|mesh-list
65092426|NCT00485030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65092427|NCT00485030|Immunologic Factors|immunologic factors|mesh-ancestor
65092428|NCT00485030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092429|NCT00485030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65092430|NCT00485030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65092431|NCT00485030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65092432|NCT00485030|Antifungal Agents|antifungal agents|mesh-ancestor
65092433|NCT04513821|Ethanol|ethanol|mesh-list
65092434|NCT04513821|Minocycline|minocycline|mesh-list
65092435|NCT04513821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65092436|NCT04513821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65092437|NCT04513821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65092438|NCT04513821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092439|NCT04513821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65092440|NCT00485108|Prednisolone|prednisolone|mesh-list
65092441|NCT00485108|Ketorolac|ketorolac|mesh-list
65092442|NCT00485108|Lubricant Eye Drops|lubricant eye drops|mesh-list
65092443|NCT00485108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65092444|NCT00485108|Glucocorticoids|glucocorticoids|mesh-ancestor
65092445|NCT00485108|Hormones|hormones|mesh-ancestor
65092446|NCT00485108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65092447|NCT00485108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092448|NCT00485108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65092449|NCT00485108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65092450|NCT00485108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65092451|NCT00485108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65092452|NCT00485108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65092453|NCT00485108|Analgesics|analgesics|mesh-ancestor
65092454|NCT00485108|Sensory System Agents|sensory system agents|mesh-ancestor
65092455|NCT00485108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65092456|NCT00485108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65092457|NCT00485108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092458|NCT00485108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092459|NCT00485108|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
65092460|NCT00485108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65092461|NCT00485238|Acetazolamide|acetazolamide|mesh-list
65092462|NCT00485238|Anticonvulsants|anticonvulsants|mesh-ancestor
65092463|NCT00485238|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65092464|NCT00485238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092465|NCT00485238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092466|NCT00485238|Diuretics|diuretics|mesh-ancestor
65092467|NCT00485238|Natriuretic Agents|natriuretic agents|mesh-ancestor
65092468|NCT00485238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092469|NCT04513509|Propranolol|propranolol|mesh-list
65092471|NCT04513509|Digoxin|digoxin|mesh-list
65092472|NCT04513509|Atenolol|atenolol|mesh-list
65092473|NCT04513509|Verapamil|verapamil|mesh-list
65092474|NCT04513509|Nebivolol|nebivolol|mesh-list
65092475|NCT04513509|Bisoprolol|bisoprolol|mesh-list
65092476|NCT04513509|Diltiazem|diltiazem|mesh-list
65092477|NCT04513509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65092478|NCT04513509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65092479|NCT04513509|Adrenergic Agents|adrenergic agents|mesh-ancestor
65092480|NCT04513509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092481|NCT04513509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092482|NCT04513509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092483|NCT04513509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65092484|NCT04513509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65092485|NCT04513509|Vasodilator Agents|vasodilator agents|mesh-ancestor
65092486|NCT04513509|Sympatholytics|sympatholytics|mesh-ancestor
65092487|NCT04513509|Autonomic Agents|autonomic agents|mesh-ancestor
65092488|NCT04513509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65092489|NCT04513509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65092490|NCT04513509|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65092491|NCT04513509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092492|NCT04513509|Protective Agents|protective agents|mesh-ancestor
65092493|NCT04513509|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64835649|NCT02491983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092494|NCT04513509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65092495|NCT04513509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65092496|NCT04513509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65092497|NCT04513509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65092498|NCT04513509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65092499|NCT00485342|Interferons|interferons|mesh-list
65092500|NCT00485342|Ribavirin|ribavirin|mesh-list
65092501|NCT00485342|Interferon-alpha|interferon-alpha|mesh-list
65092502|NCT00485342|Interferon alpha-2|interferon alpha-2|mesh-list
65092503|NCT00485342|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
65092504|NCT00485342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65092505|NCT00485342|Antiviral Agents|antiviral agents|mesh-ancestor
65092506|NCT00485342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65092507|NCT00485342|Antimetabolites|antimetabolites|mesh-ancestor
65092508|NCT00485342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092509|NCT00485342|Immunologic Factors|immunologic factors|mesh-ancestor
65092510|NCT00485342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092511|NCT00489593|Olanzapine|olanzapine|mesh-list
65092512|NCT00489593|Fluoxetine|fluoxetine|mesh-list
65092513|NCT00489593|Antiemetics|antiemetics|mesh-ancestor
65092514|NCT00489593|Autonomic Agents|autonomic agents|mesh-ancestor
65092515|NCT00489593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65092516|NCT00489593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092517|NCT00489593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65092518|NCT00489593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65092519|NCT00489593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65092520|NCT00489593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65092521|NCT00489593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65092522|NCT00489593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65092523|NCT00489593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65092524|NCT00489593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65092525|NCT00489593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092526|NCT00489593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092527|NCT00489593|Serotonin Agents|serotonin agents|mesh-ancestor
65092528|NCT00489593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65092529|NCT00489593|Antidepressive Agents|antidepressive agents|mesh-ancestor
65092530|NCT00489593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65092531|NCT00489593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65092532|NCT00489593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092533|NCT01241487|Amlodipine|amlodipine|mesh-list
65092534|NCT01241487|Valsartan|valsartan|mesh-list
65092535|NCT01241487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65092536|NCT01241487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65092537|NCT01241487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65092538|NCT01241487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092539|NCT01241487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65092540|NCT01241487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092541|NCT01241487|Vasodilator Agents|vasodilator agents|mesh-ancestor
64665325|NCT04895592|Protease Inhibitors|protease inhibitors|mesh-ancestor
65092542|NCT01241487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65092543|NCT01241487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65092544|NCT00505791|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
65092545|NCT00505791|Natriuretic Agents|natriuretic agents|mesh-ancestor
65092546|NCT00505791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092547|NCT04513626|Raltegravir Potassium|raltegravir potassium|mesh-list
65092548|NCT04513626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65092549|NCT04513626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65092550|NCT04513626|Antiviral Agents|antiviral agents|mesh-ancestor
65092551|NCT04513626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65092552|NCT04513626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
65092553|NCT04513626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
65092554|NCT04513626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092555|NCT04513626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092556|NCT00485459|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65092557|NCT00485459|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65092558|NCT00485459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65092559|NCT00485459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65092560|NCT00485459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092561|NCT00485459|Adrenergic Agents|adrenergic agents|mesh-ancestor
65092562|NCT00485459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092563|NCT00485459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092564|NCT00489710|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64592956|NCT03844256|Ipilimumab|ipilimumab|mesh-list
65092565|NCT00489710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092566|NCT04697511|Midazolam|midazolam|mesh-list
65092567|NCT04697511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65092568|NCT04697511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65092569|NCT04697511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65092570|NCT04697511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092571|NCT04697511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65092572|NCT04697511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65092573|NCT04697511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65092574|NCT04697511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65092575|NCT04697511|Anesthetics, General|anesthetics, general|mesh-ancestor
65092576|NCT04697511|Anesthetics|anesthetics|mesh-ancestor
65092577|NCT04697511|GABA Modulators|gaba modulators|mesh-ancestor
65092578|NCT04697511|GABA Agents|gaba agents|mesh-ancestor
65092579|NCT04697511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092580|NCT04697511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092581|NCT00485511|Hydroxyurea|hydroxyurea|mesh-list
65092582|NCT00485511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65092583|NCT00485511|Antisickling Agents|antisickling agents|mesh-ancestor
65092584|NCT00485511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092585|NCT00485511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092586|NCT00485511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65092587|NCT00485498|Olanzapine|olanzapine|mesh-list
65092588|NCT00485498|Risperidone|risperidone|mesh-list
65092589|NCT00485498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65092590|NCT00485498|Serotonin Agents|serotonin agents|mesh-ancestor
65092591|NCT00485498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092592|NCT00485498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092593|NCT00485498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092594|NCT00485498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65092595|NCT00485498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65092596|NCT00485498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65092597|NCT00485498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65092598|NCT00485498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65092599|NCT00485498|Dopamine Agents|dopamine agents|mesh-ancestor
65092600|NCT00485498|Antiemetics|antiemetics|mesh-ancestor
65092601|NCT00485498|Autonomic Agents|autonomic agents|mesh-ancestor
65092602|NCT00485498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65092603|NCT00485498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65092604|NCT00485498|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65092605|NCT00485498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65092606|NCT00485498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65092607|NCT01302067|Fesoterodine|fesoterodine|mesh-list
65092608|NCT01302067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65092609|NCT01302067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65092610|NCT01302067|Cholinergic Agents|cholinergic agents|mesh-ancestor
65092611|NCT01302067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092612|NCT01302067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092613|NCT01302067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092615|NCT00485550|Methylphenidate|methylphenidate|mesh-list
65092616|NCT00485550|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65092617|NCT00485550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65092618|NCT00485550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092619|NCT00485550|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65092620|NCT00485550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65092621|NCT00485550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65092622|NCT00485550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092624|NCT00485550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092625|NCT00485550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65092626|NCT00485550|Adrenergic Agents|adrenergic agents|mesh-ancestor
65092627|NCT00485628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64734817|NCT02058966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65092628|NCT00485628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65092629|NCT00485628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65092630|NCT00485628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65092631|NCT00485628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092632|NCT00485628|Adrenergic Agents|adrenergic agents|mesh-ancestor
65092633|NCT00485628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092634|NCT00485628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092635|NCT00485576|Eculizumab|eculizumab|mesh-list
65092636|NCT00485576|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
65092637|NCT00485576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65092638|NCT00485576|Immunologic Factors|immunologic factors|mesh-ancestor
65092639|NCT00485576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092640|NCT00485667|Moxifloxacin|moxifloxacin|mesh-list
65092641|NCT00485667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65092642|NCT00485667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65092643|NCT00485667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65092644|NCT00485667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65092645|NCT00485667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092646|NCT00485667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092647|NCT00485667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65092648|NCT00489905|Zoledronic Acid|zoledronic acid|mesh-list
65092649|NCT00489905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65092650|NCT00489905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092651|NCT00489944|Tamoxifen|tamoxifen|mesh-list
65092652|NCT00489944|Sunitinib|sunitinib|mesh-list
65092653|NCT00489944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65092654|NCT00489944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092655|NCT00489944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65092656|NCT00489944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65092657|NCT00489944|Growth Substances|growth substances|mesh-ancestor
65092658|NCT00489944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092659|NCT00489944|Growth Inhibitors|growth inhibitors|mesh-ancestor
65092660|NCT00489944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65092661|NCT00489944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092662|NCT00489944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65092663|NCT00489944|Hormone Antagonists|hormone antagonists|mesh-ancestor
65092664|NCT00489944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65092665|NCT00489944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65092666|NCT00489944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65092667|NCT00489944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65092668|NCT00489944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65092669|NCT00485706|Dialysis Solutions|dialysis solutions|mesh-list
65092670|NCT00485706|Calcium|calcium|mesh-list
65092671|NCT00485706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65092672|NCT00485706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092673|NCT00485706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
65092674|NCT00505947|Infliximab|infliximab|mesh-list
65092675|NCT00505947|Dermatologic Agents|dermatologic agents|mesh-ancestor
65092676|NCT00505947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65092677|NCT00505947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65092678|NCT00489983|Gemcitabine|gemcitabine|mesh-list
65092679|NCT00489983|Pemetrexed|pemetrexed|mesh-list
65092680|NCT00489983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65092681|NCT00489983|Antimetabolites|antimetabolites|mesh-ancestor
64835656|NCT02491983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64835657|NCT02467478|Linagliptin|linagliptin|mesh-list
64835658|NCT02467478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64835659|NCT02467478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835660|NCT02467478|Incretins|incretins|mesh-ancestor
64325593|NCT02158013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64325594|NCT02158013|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64325595|NCT02158013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64325596|NCT02158013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092682|NCT00489983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092683|NCT00489983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65092684|NCT00489983|Antiviral Agents|antiviral agents|mesh-ancestor
65092685|NCT00489983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65092686|NCT00489983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092687|NCT00489983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65092688|NCT00489983|Immunologic Factors|immunologic factors|mesh-ancestor
65092689|NCT00489983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092690|NCT00489983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65092691|NCT00489983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65092692|NCT01241682|Cyclophosphamide|cyclophosphamide|mesh-list
65092693|NCT01241682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65092694|NCT01241682|Immunologic Factors|immunologic factors|mesh-ancestor
65092695|NCT01241682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092696|NCT01241682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65092697|NCT01241682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65092698|NCT01241682|Alkylating Agents|alkylating agents|mesh-ancestor
65092699|NCT01241682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734891|NCT02014740|Metformin|metformin|mesh-list
65092700|NCT01241682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65092701|NCT01241682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65092702|NCT00490178|Metformin|metformin|mesh-list
65092703|NCT00490178|Fenofibrate|fenofibrate|mesh-list
65092704|NCT00490178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65092705|NCT00490178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092706|NCT00490178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65092707|NCT00490178|Antimetabolites|antimetabolites|mesh-ancestor
65092708|NCT00490178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092709|NCT00490178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65092710|NCT00485771|Lamotrigine|lamotrigine|mesh-list
65092711|NCT00485771|Olanzapine|olanzapine|mesh-list
65092712|NCT00485771|Fluoxetine|fluoxetine|mesh-list
65092713|NCT00485771|Antiemetics|antiemetics|mesh-ancestor
65092714|NCT00485771|Autonomic Agents|autonomic agents|mesh-ancestor
65092715|NCT00485771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65092716|NCT00485771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092717|NCT00485771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65092718|NCT00485771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65092719|NCT00485771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65092720|NCT00485771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65092721|NCT00485771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65092722|NCT00485771|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65092723|NCT00485771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65092724|NCT00485771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65092725|NCT00485771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092726|NCT00485771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092727|NCT00485771|Serotonin Agents|serotonin agents|mesh-ancestor
65092728|NCT00485771|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65092729|NCT00485771|Antidepressive Agents|antidepressive agents|mesh-ancestor
65092730|NCT00485771|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
65092731|NCT00485771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65092732|NCT00485771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092733|NCT00485771|Anticonvulsants|anticonvulsants|mesh-ancestor
65092734|NCT00485771|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65092735|NCT00485771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65092736|NCT00485771|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65092737|NCT00485810|Olanzapine|olanzapine|mesh-list
65092738|NCT00485810|Antiemetics|antiemetics|mesh-ancestor
65092739|NCT00485810|Autonomic Agents|autonomic agents|mesh-ancestor
65092740|NCT00485810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65092741|NCT00485810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092742|NCT00485810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65092743|NCT00485810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65092744|NCT00485810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65092745|NCT00485810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65092746|NCT00485810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65092747|NCT00485810|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65092748|NCT00485810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65092749|NCT00485810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65092750|NCT00485810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092751|NCT00485810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092752|NCT00485810|Serotonin Agents|serotonin agents|mesh-ancestor
65092753|NCT00490373|Pemetrexed|pemetrexed|mesh-list
65092754|NCT00490373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65092755|NCT00490373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64483458|NCT00765232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092756|NCT00490373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092757|NCT00490373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65092758|NCT00490373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65092760|NCT00485823|Antiemetics|antiemetics|mesh-ancestor
65092761|NCT00485823|Autonomic Agents|autonomic agents|mesh-ancestor
65092762|NCT00485823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65092763|NCT00485823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092764|NCT00485823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65092765|NCT00485823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65092766|NCT00485823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65092767|NCT00485823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65092768|NCT00485823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65092769|NCT00485823|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65092770|NCT00485823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65092771|NCT00485823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65092772|NCT00485823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092773|NCT00485823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092774|NCT00485823|Serotonin Agents|serotonin agents|mesh-ancestor
65092775|NCT00485849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65092776|NCT00485849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65092777|NCT00485849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65092778|NCT00485849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65092779|NCT00485849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092780|NCT00485849|Adrenergic Agents|adrenergic agents|mesh-ancestor
65092781|NCT00485849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092782|NCT00485849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092783|NCT00485888|Citalopram|citalopram|mesh-list
65092784|NCT00485888|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65092785|NCT00485888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65092786|NCT00485888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65092787|NCT00485888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092788|NCT00485888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092789|NCT00485888|Serotonin Agents|serotonin agents|mesh-ancestor
65092790|NCT00485888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092791|NCT00485888|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65092792|NCT00485888|Antidepressive Agents|antidepressive agents|mesh-ancestor
65092793|NCT00485888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65092794|NCT00485862|Sertraline|sertraline|mesh-list
65092795|NCT00485862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64835662|NCT02467478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64593215|NCT03749018|Prednisone|prednisone|mesh-list
65092796|NCT00485862|Antidepressive Agents|antidepressive agents|mesh-ancestor
65092797|NCT00485862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65092798|NCT00485862|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65092799|NCT00485862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65092800|NCT00485862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65092801|NCT00485862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092802|NCT00485862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092803|NCT00485862|Serotonin Agents|serotonin agents|mesh-ancestor
65092804|NCT00485862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092805|NCT00485862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65092806|NCT00485862|Adrenergic Agents|adrenergic agents|mesh-ancestor
65092807|NCT00485901|Haloperidol|haloperidol|mesh-list
65092808|NCT00485901|Olanzapine|olanzapine|mesh-list
65092809|NCT00485901|Haloperidol decanoate|haloperidol decanoate|mesh-list
65092810|NCT00485901|Antiemetics|antiemetics|mesh-ancestor
65092811|NCT00485901|Autonomic Agents|autonomic agents|mesh-ancestor
65092812|NCT00485901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65092813|NCT00485901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092814|NCT00485901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65092815|NCT00485901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65092816|NCT00485901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65092817|NCT00485901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65092818|NCT00485901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65092819|NCT00485901|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65092820|NCT00485901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65092821|NCT00485901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65092822|NCT00485901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092823|NCT00485901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092824|NCT00485901|Serotonin Agents|serotonin agents|mesh-ancestor
65092825|NCT00485901|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65092826|NCT00485901|Dopamine Agents|dopamine agents|mesh-ancestor
65092827|NCT00485901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65092828|NCT00490412|Vitamin D|vitamin d|mesh-list
65092829|NCT00490412|Vitamins|vitamins|mesh-ancestor
65092830|NCT00490412|Micronutrients|micronutrients|mesh-ancestor
65092831|NCT00490412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092832|NCT00490412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65092833|NCT00485940|Prucalopride|prucalopride|mesh-list
65092834|NCT00485940|Laxatives|laxatives|mesh-ancestor
65092835|NCT00485940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65092836|NCT00485940|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65092837|NCT00485940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65092838|NCT00485940|Serotonin Agents|serotonin agents|mesh-ancestor
65092839|NCT00485940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092840|NCT00485940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092841|NCT00485940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092842|NCT00486005|Olanzapine|olanzapine|mesh-list
65092843|NCT00486005|Nizatidine|nizatidine|mesh-list
65092844|NCT00486005|Antiemetics|antiemetics|mesh-ancestor
65092845|NCT00486005|Autonomic Agents|autonomic agents|mesh-ancestor
65092846|NCT00486005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65092847|NCT00486005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092848|NCT00486005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65092849|NCT00486005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65092850|NCT00486005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65092851|NCT00486005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65092852|NCT00486005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65092853|NCT00486005|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65092854|NCT00486005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65092855|NCT00486005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65092856|NCT00486005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092857|NCT00486005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092858|NCT00486005|Serotonin Agents|serotonin agents|mesh-ancestor
65092859|NCT00486005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65092860|NCT00486005|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
65092861|NCT00486005|Histamine Antagonists|histamine antagonists|mesh-ancestor
65092862|NCT00486005|Histamine Agents|histamine agents|mesh-ancestor
65092863|NCT00485979|Docetaxel|docetaxel|mesh-list
65092864|NCT00485979|Trastuzumab|trastuzumab|mesh-list
65092865|NCT00485979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65092866|NCT00485979|Tubulin Modulators|tubulin modulators|mesh-ancestor
65092867|NCT00485979|Antimitotic Agents|antimitotic agents|mesh-ancestor
65092868|NCT00485979|Mitosis Modulators|mitosis modulators|mesh-ancestor
65092869|NCT00485979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092870|NCT00485979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65092871|NCT00486083|Methylphenidate|methylphenidate|mesh-list
65092872|NCT00486083|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65092873|NCT00486083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65092874|NCT00486083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092875|NCT00486083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65092876|NCT00486083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65092877|NCT00486083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65092878|NCT00486083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092879|NCT00486083|Dopamine Agents|dopamine agents|mesh-ancestor
65092880|NCT00486083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092881|NCT00486083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65092882|NCT00486083|Adrenergic Agents|adrenergic agents|mesh-ancestor
65092883|NCT00490685|Sorafenib|sorafenib|mesh-list
65092884|NCT00490685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65092885|NCT00490685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65092886|NCT00490685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092887|NCT00490685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092888|NCT00486122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65092889|NCT00486122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65092890|NCT00486122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65092891|NCT00486122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65092892|NCT00486122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092893|NCT00486122|Adrenergic Agents|adrenergic agents|mesh-ancestor
65092894|NCT00486122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092895|NCT00486122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092896|NCT04511715|Bevacizumab|bevacizumab|mesh-list
65092897|NCT04511715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65092898|NCT04511715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65092899|NCT04511715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65092900|NCT04511715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65092901|NCT04511715|Growth Substances|growth substances|mesh-ancestor
65092902|NCT04511715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092903|NCT04511715|Growth Inhibitors|growth inhibitors|mesh-ancestor
65092905|NCT00486317|Salmon calcitonin|salmon calcitonin|mesh-list
65092906|NCT00486317|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
65092907|NCT00486317|Katacalcin|katacalcin|mesh-list
65092908|NCT00486317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65092909|NCT00486317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092910|NCT00486317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65092911|NCT00486317|Vasodilator Agents|vasodilator agents|mesh-ancestor
65092912|NCT00490880|Gemcitabine|gemcitabine|mesh-list
65092913|NCT00490880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65092914|NCT00490880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65092915|NCT00490880|Antimetabolites|antimetabolites|mesh-ancestor
65092916|NCT00490880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092917|NCT00490880|Antiviral Agents|antiviral agents|mesh-ancestor
65092918|NCT00490880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65092919|NCT00490880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092920|NCT00490880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65092921|NCT00490880|Immunologic Factors|immunologic factors|mesh-ancestor
65092922|NCT00490880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092924|NCT00486174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092925|NCT00486174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092926|NCT00486356|Carboplatin|carboplatin|mesh-list
65092927|NCT00486356|Capecitabine|capecitabine|mesh-list
65092928|NCT00486356|Epirubicin|epirubicin|mesh-list
65092929|NCT00486356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65092930|NCT00486356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65092931|NCT00486356|Antimetabolites|antimetabolites|mesh-ancestor
65092932|NCT00486356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092933|NCT00486356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65092934|NCT00486356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65092935|NCT00486356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65092936|NCT00486356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092937|NCT00490958|Telmisartan|telmisartan|mesh-list
65092938|NCT00490958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65092939|NCT00490958|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65092940|NCT00490958|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65092941|NCT00490958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092942|NCT00486213|Pyridoxine|pyridoxine|mesh-list
65092943|NCT00486213|Vitamin B 6|vitamin b 6|mesh-list
65092944|NCT00486213|Vitamin B Complex|vitamin b complex|mesh-ancestor
65092945|NCT00486213|Vitamins|vitamins|mesh-ancestor
65092946|NCT00486213|Micronutrients|micronutrients|mesh-ancestor
65092947|NCT00486213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092948|NCT00486369|Calcitonin|calcitonin|mesh-list
65092949|NCT00486369|Salmon calcitonin|salmon calcitonin|mesh-list
65092950|NCT00486369|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
65092951|NCT00486369|Katacalcin|katacalcin|mesh-list
65092952|NCT00486369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65092953|NCT00486369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092954|NCT00486369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65092955|NCT00486369|Vasodilator Agents|vasodilator agents|mesh-ancestor
65092956|NCT00490997|Ketamine|ketamine|mesh-list
65092957|NCT00490997|Propofol|propofol|mesh-list
65092958|NCT00490997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65092959|NCT00490997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65092960|NCT00490997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092961|NCT00490997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65092962|NCT00490997|Anesthetics, General|anesthetics, general|mesh-ancestor
65092963|NCT00490997|Anesthetics|anesthetics|mesh-ancestor
65092964|NCT00490997|Analgesics|analgesics|mesh-ancestor
65092965|NCT00490997|Sensory System Agents|sensory system agents|mesh-ancestor
65092966|NCT00490997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65092967|NCT00490997|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
65092968|NCT00490997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
65092969|NCT00490997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
65092970|NCT00490997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092971|NCT00490997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835686|NCT02185417|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64835687|NCT02185417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64835688|NCT02185417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835689|NCT02158234|Cisplatin|cisplatin|mesh-list
64835690|NCT02158234|Alkylating Agents|alkylating agents|mesh-list
65092973|NCT04511637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
65092974|NCT04511637|Antithrombins|antithrombins|mesh-ancestor
65092975|NCT04511637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65092976|NCT04511637|Protease Inhibitors|protease inhibitors|mesh-ancestor
65092977|NCT04511637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092978|NCT04511637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092979|NCT04511637|Anticoagulants|anticoagulants|mesh-ancestor
65092980|NCT00486486|Timolol|timolol|mesh-list
65092981|NCT00486486|Bimatoprost|bimatoprost|mesh-list
65092982|NCT00486486|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65092983|NCT00486486|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65092984|NCT00486486|Adrenergic Agents|adrenergic agents|mesh-ancestor
65092985|NCT00486486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65092986|NCT00486486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092987|NCT00486486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65092988|NCT00486486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65092989|NCT00486486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65092990|NCT00491114|Gemcitabine|gemcitabine|mesh-list
65092991|NCT00491114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65092992|NCT00491114|Antimetabolites|antimetabolites|mesh-ancestor
65092993|NCT00491114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65092994|NCT00491114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65092995|NCT00491114|Antiviral Agents|antiviral agents|mesh-ancestor
65092996|NCT00491114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65092997|NCT00491114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65092998|NCT00491114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65092999|NCT00491114|Immunologic Factors|immunologic factors|mesh-ancestor
65093000|NCT00491114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093001|NCT00486564|Nifurtimox|nifurtimox|mesh-list
65093002|NCT00486564|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
65093003|NCT00486564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65093004|NCT00486564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65093005|NCT00486564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65093006|NCT00486668|Paclitaxel|paclitaxel|mesh-list
65093007|NCT00486668|Cyclophosphamide|cyclophosphamide|mesh-list
65093008|NCT00486668|Doxorubicin|doxorubicin|mesh-list
65093009|NCT00486668|Trastuzumab|trastuzumab|mesh-list
65093010|NCT00486668|Lapatinib|lapatinib|mesh-list
65093011|NCT00486668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65093012|NCT00486668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093013|NCT00486668|Tubulin Modulators|tubulin modulators|mesh-ancestor
65093014|NCT00486668|Antimitotic Agents|antimitotic agents|mesh-ancestor
65093015|NCT00486668|Mitosis Modulators|mitosis modulators|mesh-ancestor
65093016|NCT00486668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093017|NCT00486668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65093018|NCT00486668|Immunologic Factors|immunologic factors|mesh-ancestor
65093019|NCT00486668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093020|NCT00486668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65093021|NCT00486668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65093022|NCT00486668|Alkylating Agents|alkylating agents|mesh-ancestor
65093023|NCT00486668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65093024|NCT00486668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64416837|NCT04312243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65093025|NCT00486668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65093026|NCT00486668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65093027|NCT00486668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093028|NCT00486668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65093029|NCT00486668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65093030|NCT04510935|Anesthetics|anesthetics|mesh-list
65093031|NCT04510935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65093032|NCT04510935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093033|NCT00491192|Diclofenac|diclofenac|mesh-list
65093034|NCT00491192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65093035|NCT00491192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65093036|NCT00491192|Analgesics|analgesics|mesh-ancestor
65093037|NCT00491192|Sensory System Agents|sensory system agents|mesh-ancestor
65093038|NCT00491192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65093039|NCT00491192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093040|NCT00491192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65093041|NCT00491192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65093042|NCT00491192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64835702|NCT01966731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65093043|NCT00491192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093044|NCT00491192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093045|NCT00486798|Quetiapine Fumarate|quetiapine fumarate|mesh-list
65093046|NCT00486798|Antidepressive Agents|antidepressive agents|mesh-ancestor
65093047|NCT00486798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65093048|NCT00486798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65093049|NCT00486798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65093050|NCT00486798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65093051|NCT00486798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093052|NCT01301833|Biguanides|biguanides|mesh-list
65093053|NCT01301833|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
65093054|NCT01301833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65093055|NCT01301833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093056|NCT01301833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093057|NCT01301833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093058|NCT00486785|Alfuzosin|alfuzosin|mesh-list
65093059|NCT00486785|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65093060|NCT00486785|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65093061|NCT00486785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65093062|NCT00486785|Adrenergic Agents|adrenergic agents|mesh-ancestor
65093063|NCT00486785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65093064|NCT00486785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093065|NCT00486785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093066|NCT00486785|Urological Agents|urological agents|mesh-ancestor
65093067|NCT04324411|Sirolimus|sirolimus|mesh-list
65093068|NCT04324411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65093069|NCT04324411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65093070|NCT04324411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65093071|NCT04324411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093072|NCT04324411|Antifungal Agents|antifungal agents|mesh-ancestor
65093073|NCT04324411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65093074|NCT04324411|Immunologic Factors|immunologic factors|mesh-ancestor
65093075|NCT04324411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093076|NCT00486876|Tofisopam|tofisopam|mesh-list
65093077|NCT00486876|Antidepressive Agents|antidepressive agents|mesh-ancestor
65093078|NCT00486876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65093079|NCT05643586|Ticagrelor|ticagrelor|mesh-list
65093080|NCT05643586|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
65093081|NCT05643586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65093082|NCT05643586|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65093083|NCT05643586|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65093084|NCT05643586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65093085|NCT05643586|Purinergic Agents|purinergic agents|mesh-ancestor
65093086|NCT05643586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65093087|NCT05643586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093088|NCT05643586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093089|NCT01242072|Isophosphamide mustard|isophosphamide mustard|mesh-list
64325597|NCT02158013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64325598|NCT02158013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325599|NCT02158013|Vasodilator Agents|vasodilator agents|mesh-ancestor
64593521|NCT03551522|Seladelpar|seladelpar|mesh-list
65093090|NCT01242072|Ifosfamide|ifosfamide|mesh-list
65093091|NCT01242072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65093092|NCT01242072|Alkylating Agents|alkylating agents|mesh-ancestor
65093093|NCT01242072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093094|NCT01242072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093095|NCT00491348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
65093096|NCT00491348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65093097|NCT00491348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65093098|NCT00491348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65093099|NCT00491348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093100|NCT00491348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65093101|NCT00491348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093102|NCT00491348|Analgesics|analgesics|mesh-ancestor
65093103|NCT00491348|Sensory System Agents|sensory system agents|mesh-ancestor
65093104|NCT00491348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65093105|NCT00491348|Antidepressive Agents|antidepressive agents|mesh-ancestor
65093106|NCT00491348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65093107|NCT00491348|Dopamine Agents|dopamine agents|mesh-ancestor
65093108|NCT01242098|Fluticasone|fluticasone|mesh-list
65093109|NCT01242098|Beclomethasone|beclomethasone|mesh-list
65093110|NCT01242098|Formoterol Fumarate|formoterol fumarate|mesh-list
65093111|NCT01242098|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65093112|NCT01242098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65093113|NCT01242098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65093114|NCT01242098|Autonomic Agents|autonomic agents|mesh-ancestor
65093115|NCT01242098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65093116|NCT01242098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093117|NCT01242098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65093118|NCT01242098|Respiratory System Agents|respiratory system agents|mesh-ancestor
65093119|NCT01242098|Dermatologic Agents|dermatologic agents|mesh-ancestor
65093120|NCT01242098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65093121|NCT01242098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65093122|NCT01242098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65093123|NCT01242098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65093124|NCT01242098|Adrenergic Agents|adrenergic agents|mesh-ancestor
65093125|NCT01242098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65093126|NCT01242098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093127|NCT01242098|Glucocorticoids|glucocorticoids|mesh-ancestor
65093128|NCT01242098|Hormones|hormones|mesh-ancestor
65093129|NCT01242098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65093130|NCT01301092|Dulaglutide|dulaglutide|mesh-list
65093131|NCT01301092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65093132|NCT01301092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093133|NCT04510623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
65093134|NCT04510623|Protease Inhibitors|protease inhibitors|mesh-ancestor
65093135|NCT04510623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093136|NCT04510623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093137|NCT04510818|Capecitabine|capecitabine|mesh-list
65093138|NCT04510818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65093139|NCT04510818|Antimetabolites|antimetabolites|mesh-ancestor
65093140|NCT04510818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093141|NCT04510818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093142|NCT05642845|Atorvastatin|atorvastatin|mesh-list
65093143|NCT05642845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65093144|NCT05642845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65093145|NCT05642845|Antimetabolites|antimetabolites|mesh-ancestor
65093146|NCT05642845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093147|NCT05642845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65093148|NCT05642845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65093149|NCT05642845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093150|NCT04510662|Telmisartan|telmisartan|mesh-list
65093151|NCT04510662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65093152|NCT04510662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65093153|NCT04510662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65093154|NCT04510662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093156|NCT05642689|Trace Elements|trace elements|mesh-ancestor
65093157|NCT05642689|Micronutrients|micronutrients|mesh-ancestor
65093158|NCT05642689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093159|NCT01300819|Rotigotine|rotigotine|mesh-list
65093160|NCT01300819|Dopamine Agonists|dopamine agonists|mesh-ancestor
65093161|NCT01300819|Dopamine Agents|dopamine agents|mesh-ancestor
65093162|NCT01300819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65093163|NCT01300819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093164|NCT01300819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093165|NCT00486980|Peramivir|peramivir|mesh-list
65093166|NCT00486980|Antiviral Agents|antiviral agents|mesh-ancestor
65093167|NCT00486980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65093168|NCT00486980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093169|NCT00486980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093170|NCT05642572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
65093171|NCT05642572|Osimertinib|osimertinib|mesh-list
65093172|NCT05642572|Ramucirumab|ramucirumab|mesh-list
65093173|NCT05642572|Antibodies|antibodies|mesh-list
65093174|NCT05642572|Immunoglobulins|immunoglobulins|mesh-list
65093175|NCT05642572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65093176|NCT05642572|Lexatumumab|lexatumumab|mesh-list
65093177|NCT05642572|Immunologic Factors|immunologic factors|mesh-ancestor
65093178|NCT05642572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093179|NCT05642572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093180|NCT05642572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65093181|NCT05642572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093182|NCT05642572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093183|NCT01300741|Contact Lens Solutions|contact lens solutions|mesh-list
65093184|NCT01300741|Disinfectants|disinfectants|mesh-ancestor
65093185|NCT01300741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65093186|NCT02275962|Rifampin|rifampin|mesh-list
65093187|NCT02275962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64835703|NCT01953926|Trastuzumab|trastuzumab|mesh-list
64835704|NCT01953926|Fulvestrant|fulvestrant|mesh-list
64835705|NCT01953926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65093188|NCT02275962|Antitubercular Agents|antitubercular agents|mesh-ancestor
65093189|NCT02275962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65093190|NCT02275962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65093191|NCT02275962|Leprostatic Agents|leprostatic agents|mesh-ancestor
65093192|NCT02275962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65093193|NCT02275962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093194|NCT02275962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093195|NCT02275962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65093196|NCT02275962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65093197|NCT02275962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65093198|NCT02275962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65093199|NCT02275962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65093200|NCT02275962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65093201|NCT00487032|Fluticasone|fluticasone|mesh-list
65093202|NCT00487032|Xhance|xhance|mesh-list
65093203|NCT00487032|Prazosin|prazosin|mesh-list
65093204|NCT00487032|Phenylephrine|phenylephrine|mesh-list
65093205|NCT00487032|Oxymetazoline|oxymetazoline|mesh-list
65093206|NCT00487032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65093207|NCT00487032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65093208|NCT00487032|Autonomic Agents|autonomic agents|mesh-ancestor
65093209|NCT00487032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65093210|NCT00487032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093211|NCT00487032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65093212|NCT00487032|Respiratory System Agents|respiratory system agents|mesh-ancestor
65093213|NCT00487032|Dermatologic Agents|dermatologic agents|mesh-ancestor
65093214|NCT00487032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65093215|NCT00487032|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65093216|NCT00487032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65093217|NCT00487032|Adrenergic Agents|adrenergic agents|mesh-ancestor
65093218|NCT00487032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65093219|NCT00487032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093220|NCT00487032|Sympathomimetics|sympathomimetics|mesh-ancestor
65093221|NCT00487032|Nasal Decongestants|nasal decongestants|mesh-ancestor
65093222|NCT00487032|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65093223|NCT00487032|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65093224|NCT00487032|Mydriatics|mydriatics|mesh-ancestor
65093225|NCT00487032|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65093226|NCT00487032|Protective Agents|protective agents|mesh-ancestor
65093227|NCT00487032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65093228|NCT00487032|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65093229|NCT00487032|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65093230|NCT00487032|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65093231|NCT00491426|Metronidazole|metronidazole|mesh-list
65093232|NCT00491426|Tazobactam|tazobactam|mesh-list
65093233|NCT00491426|Amphotericin B|amphotericin b|mesh-list
65093234|NCT00491426|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
65093235|NCT00491426|Piperacillin|piperacillin|mesh-list
65093236|NCT00491426|Acyclovir|acyclovir|mesh-list
65093237|NCT00491426|Ampicillin|ampicillin|mesh-list
65093238|NCT00491426|Caspofungin|caspofungin|mesh-list
65093239|NCT00491426|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
65093240|NCT00491426|Anidulafungin|anidulafungin|mesh-list
65093241|NCT00491426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65093242|NCT00491426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65093243|NCT00491426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65093244|NCT00491426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65093245|NCT00491426|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
65093246|NCT00491426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093247|NCT00491426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093248|NCT00491426|Amebicides|amebicides|mesh-ancestor
65093249|NCT00491426|Antifungal Agents|antifungal agents|mesh-ancestor
65093250|NCT00491426|Antiviral Agents|antiviral agents|mesh-ancestor
64593676|NCT03546608|Tepotinib|tepotinib|mesh-list
65093251|NCT01300546|Naproxen|naproxen|mesh-list
65093252|NCT01300546|Sumatriptan|sumatriptan|mesh-list
65093253|NCT01300546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65093254|NCT01300546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65093255|NCT01300546|Analgesics|analgesics|mesh-ancestor
65093256|NCT01300546|Sensory System Agents|sensory system agents|mesh-ancestor
65093257|NCT01300546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65093258|NCT01300546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093259|NCT01300546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65093260|NCT01300546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65093261|NCT01300546|Gout Suppressants|gout suppressants|mesh-ancestor
65093262|NCT01300546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65093263|NCT01300546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093264|NCT01300546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093265|NCT01300546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65093266|NCT01300546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65093267|NCT01300546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65093268|NCT01300546|Serotonin Agents|serotonin agents|mesh-ancestor
65093269|NCT01300546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65093270|NCT00487110|Acetaminophen|acetaminophen|mesh-list
65093271|NCT00487110|Tropisetron|tropisetron|mesh-list
65093272|NCT00487110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65093273|NCT00487110|Analgesics|analgesics|mesh-ancestor
65093274|NCT00487110|Sensory System Agents|sensory system agents|mesh-ancestor
65093275|NCT00487110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65093276|NCT00487110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093277|NCT00487110|Antipyretics|antipyretics|mesh-ancestor
65093278|NCT00487110|Antiemetics|antiemetics|mesh-ancestor
65093279|NCT00487110|Autonomic Agents|autonomic agents|mesh-ancestor
65093280|NCT00487110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65093281|NCT00487110|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65093282|NCT00487110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65093283|NCT00487110|Serotonin Agents|serotonin agents|mesh-ancestor
65093284|NCT00487110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65093285|NCT00487110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093286|NCT00487136|Warfarin|warfarin|mesh-list
65093287|NCT00487136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65093288|NCT00487136|Fenofibric acid|fenofibric acid|mesh-list
65093289|NCT00487136|Fenofibrate|fenofibrate|mesh-list
65093290|NCT00487136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65093291|NCT00487136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65093292|NCT00487136|Antimetabolites|antimetabolites|mesh-ancestor
65093293|NCT00487136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093294|NCT00487136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65093295|NCT00487136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65093296|NCT00487136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093297|NCT00487136|Anticoagulants|anticoagulants|mesh-ancestor
65093298|NCT02276001|Cyclosporine|cyclosporine|mesh-list
65093299|NCT02276001|Cyclosporins|cyclosporins|mesh-list
65093300|NCT02276001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093301|NCT02276001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093302|NCT02276001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65093303|NCT02276001|Immunologic Factors|immunologic factors|mesh-ancestor
65093304|NCT02276001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093305|NCT02276001|Antifungal Agents|antifungal agents|mesh-ancestor
65093306|NCT02276001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65093307|NCT02276001|Dermatologic Agents|dermatologic agents|mesh-ancestor
65093308|NCT02276001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65093309|NCT02276001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65093311|NCT00491582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65093312|NCT00491582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093313|NCT00487175|Tramadol|tramadol|mesh-list
65093314|NCT00487175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65093315|NCT00487175|Narcotics|narcotics|mesh-ancestor
65093316|NCT00487175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65093317|NCT00487175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093318|NCT00487175|Analgesics|analgesics|mesh-ancestor
65093319|NCT00487175|Sensory System Agents|sensory system agents|mesh-ancestor
65093320|NCT00487175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65093321|NCT00487227|Caffeine|caffeine|mesh-list
65093322|NCT00487227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65093323|NCT00487227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093324|NCT00487227|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65093325|NCT00487227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093326|NCT00487227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093327|NCT00487227|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65093328|NCT00487227|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65093329|NCT00487227|Purinergic Agents|purinergic agents|mesh-ancestor
65093330|NCT00487227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65093331|NCT01300351|Fulvestrant|fulvestrant|mesh-list
65093332|NCT01300351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65093333|NCT01300351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093334|NCT01300351|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
65093335|NCT01300351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65093336|NCT01300351|Hormone Antagonists|hormone antagonists|mesh-ancestor
65093337|NCT01300351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65093339|NCT00487253|Miltefosine|miltefosine|mesh-list
65093340|NCT00487253|Meglumine Antimoniate|meglumine antimoniate|mesh-list
65093341|NCT00487253|Antifungal Agents|antifungal agents|mesh-ancestor
65093342|NCT00487253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65093343|NCT00487253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093344|NCT00487253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65093345|NCT00487253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65093346|NCT04510233|Ivermectin|ivermectin|mesh-list
65093347|NCT04510233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65093348|NCT04510233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65093349|NCT05641909|Fentanyl|fentanyl|mesh-list
65093350|NCT05641909|Remifentanil|remifentanil|mesh-list
65093351|NCT05641909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65093352|NCT05641909|Narcotics|narcotics|mesh-ancestor
65093353|NCT05641909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65093354|NCT05641909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093355|NCT05641909|Analgesics|analgesics|mesh-ancestor
65093356|NCT05641909|Sensory System Agents|sensory system agents|mesh-ancestor
65093357|NCT05641909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65093358|NCT05641909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65093359|NCT05641909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65093360|NCT05641909|Anesthetics, General|anesthetics, general|mesh-ancestor
65093361|NCT05641909|Anesthetics|anesthetics|mesh-ancestor
65093362|NCT05641753|Atorvastatin|atorvastatin|mesh-list
65093363|NCT05641753|Ezetimibe|ezetimibe|mesh-list
65093364|NCT05641753|Evolocumab|evolocumab|mesh-list
65093365|NCT05641753|Calcium|calcium|mesh-list
65093366|NCT05641753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65093367|NCT05641753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093368|NCT05641753|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65093369|NCT05641753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65093370|NCT05641753|Antimetabolites|antimetabolites|mesh-ancestor
65093371|NCT05641753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093372|NCT05641753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65093373|NCT05641753|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65093374|NCT05641753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093375|NCT02276196|Insulin glulisine|insulin glulisine|mesh-list
65093376|NCT02276196|Lixisenatide|lixisenatide|mesh-list
65093377|NCT02276196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65093378|NCT02276196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093379|NCT00487422|Prucalopride|prucalopride|mesh-list
64835727|NCT01599468|Tranexamic Acid|tranexamic acid|mesh-list
64835728|NCT01599468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64835729|NCT01599468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65093380|NCT00487422|Laxatives|laxatives|mesh-ancestor
65093381|NCT00487422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65093382|NCT00487422|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
65093383|NCT00487422|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65093384|NCT00487422|Serotonin Agents|serotonin agents|mesh-ancestor
65093385|NCT00487422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65093386|NCT00487422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093387|NCT00487422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093388|NCT04697355|Beta Carotene|beta carotene|mesh-list
65093389|NCT04697355|Naringenin|naringenin|mesh-list
65093390|NCT04697355|Carotenoids|carotenoids|mesh-list
65093391|NCT04697355|Antioxidants|antioxidants|mesh-ancestor
65093392|NCT04697355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093393|NCT04697355|Protective Agents|protective agents|mesh-ancestor
65093394|NCT04697355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093395|NCT04697355|Provitamins|provitamins|mesh-ancestor
65093396|NCT04697355|Vitamins|vitamins|mesh-ancestor
65093397|NCT04697355|Micronutrients|micronutrients|mesh-ancestor
65093398|NCT04697355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65093399|NCT04697355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65093400|NCT04697355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65093401|NCT04697355|Hormone Antagonists|hormone antagonists|mesh-ancestor
65093402|NCT04697355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65093403|NCT00491816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65093404|NCT00491816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093405|NCT00491816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65093406|NCT00491816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093407|NCT00491816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093408|NCT00491855|Paclitaxel|paclitaxel|mesh-list
65093409|NCT00491855|Bevacizumab|bevacizumab|mesh-list
65093410|NCT00491855|Oxaliplatin|oxaliplatin|mesh-list
65093411|NCT00491855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65093412|NCT00491855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093413|NCT00491855|Tubulin Modulators|tubulin modulators|mesh-ancestor
65093414|NCT00491855|Antimitotic Agents|antimitotic agents|mesh-ancestor
65093415|NCT00491855|Mitosis Modulators|mitosis modulators|mesh-ancestor
65093416|NCT00491855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093417|NCT00491855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65093418|NCT00491855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65093419|NCT00491855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65093420|NCT00491855|Growth Substances|growth substances|mesh-ancestor
65093421|NCT00491855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093422|NCT00491855|Growth Inhibitors|growth inhibitors|mesh-ancestor
65093423|NCT04697277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
65093424|NCT04697277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65093425|NCT00487448|Cytarabine|cytarabine|mesh-list
65093426|NCT00487448|Fludarabine|fludarabine|mesh-list
65093427|NCT00487448|Idarubicin|idarubicin|mesh-list
65093428|NCT00487448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093429|NCT00487448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65093430|NCT00487448|Antimetabolites|antimetabolites|mesh-ancestor
65093431|NCT00487448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093432|NCT00487448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65093433|NCT00487448|Immunologic Factors|immunologic factors|mesh-ancestor
65093434|NCT00487448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093435|NCT00487448|Antiviral Agents|antiviral agents|mesh-ancestor
65093436|NCT00487448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65093437|NCT00487448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65093438|NCT00487448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65093439|NCT00487448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65093440|NCT00487448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093441|NCT00506259|Melatonin|melatonin|mesh-list
65093442|NCT00506259|Antioxidants|antioxidants|mesh-ancestor
65093443|NCT00506259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093444|NCT00506259|Protective Agents|protective agents|mesh-ancestor
65093445|NCT00506259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093446|NCT00506259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65093447|NCT00506298|Diflunisal|diflunisal|mesh-list
65093449|NCT00506298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65093450|NCT00506298|Antimetabolites|antimetabolites|mesh-ancestor
65093451|NCT00506298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093452|NCT00506298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65093453|NCT00506298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65093454|NCT00506298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65093455|NCT00506298|Analgesics|analgesics|mesh-ancestor
65093456|NCT00506298|Sensory System Agents|sensory system agents|mesh-ancestor
65093457|NCT00506298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65093458|NCT00506298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093459|NCT00506298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65093460|NCT00506298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65093461|NCT00506298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65093462|NCT00506298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093463|NCT01242215|Glimepiride|glimepiride|mesh-list
65093464|NCT01242215|Gliclazide|gliclazide|mesh-list
65093465|NCT01242215|Glyburide|glyburide|mesh-list
65093466|NCT01242215|Ipragliflozin|ipragliflozin|mesh-list
65093467|NCT01242215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65093468|NCT01242215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65093469|NCT01242215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093470|NCT01242215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65093471|NCT01242215|Immunologic Factors|immunologic factors|mesh-ancestor
65093472|NCT01242215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65093473|NCT01242215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093474|NCT01242228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65093475|NCT01242228|Vildagliptin|vildagliptin|mesh-list
65093476|NCT01242228|Saxagliptin|saxagliptin|mesh-list
65093477|NCT01242228|Alogliptin|alogliptin|mesh-list
65093478|NCT01242228|Ipragliflozin|ipragliflozin|mesh-list
65093479|NCT01242228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
65093480|NCT01242228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65093481|NCT01242228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093482|NCT01242228|Incretins|incretins|mesh-ancestor
65093483|NCT01242228|Hormones|hormones|mesh-ancestor
65093484|NCT01242228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65093485|NCT01242228|Protease Inhibitors|protease inhibitors|mesh-ancestor
65093486|NCT01242228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093487|NCT01242228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093488|NCT01242228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65093490|NCT01242306|Vasodilator Agents|vasodilator agents|mesh-ancestor
65093491|NCT01242306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65093492|NCT01242306|Cholinergic Agents|cholinergic agents|mesh-ancestor
65093493|NCT01242306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65093494|NCT01242306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093495|NCT01242306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093496|NCT00492128|Losartan|losartan|mesh-list
65093497|NCT00492128|Amlodipine|amlodipine|mesh-list
65093498|NCT00492128|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
65093499|NCT00492128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65093500|NCT00492128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65093501|NCT00492128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65093502|NCT00492128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093503|NCT00492128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65093504|NCT00492128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093505|NCT00492128|Vasodilator Agents|vasodilator agents|mesh-ancestor
65093506|NCT00492128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65093507|NCT00492128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65093508|NCT00492128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65093509|NCT00492128|Diuretics|diuretics|mesh-ancestor
65093510|NCT00492128|Natriuretic Agents|natriuretic agents|mesh-ancestor
65093511|NCT00492128|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
65093512|NCT00487734|Methyltestosterone|methyltestosterone|mesh-list
65093513|NCT00487734|Testosterone|testosterone|mesh-list
65093514|NCT00487734|Testosterone undecanoate|testosterone undecanoate|mesh-list
65093515|NCT00487734|Testosterone enanthate|testosterone enanthate|mesh-list
65093516|NCT00487734|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
65093517|NCT00487734|Androgens|androgens|mesh-ancestor
65093518|NCT00487734|Hormones|hormones|mesh-ancestor
65093519|NCT00487734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65093520|NCT00487734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093521|NCT00487734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65093522|NCT00487734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093523|NCT00487734|Anabolic Agents|anabolic agents|mesh-ancestor
65093524|NCT01300234|Tenofovir|tenofovir|mesh-list
65093525|NCT01300234|Adefovir|adefovir|mesh-list
65093526|NCT01300234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
65093527|NCT01300234|Antiviral Agents|antiviral agents|mesh-ancestor
65093528|NCT01300234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65093529|NCT01300234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65093530|NCT01300234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65093531|NCT01300234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093532|NCT01300234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093533|NCT01300234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65093534|NCT01300234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65093535|NCT01242332|Pregabalin|pregabalin|mesh-list
65093536|NCT01242332|Analgesics|analgesics|mesh-ancestor
65093537|NCT01242332|Sensory System Agents|sensory system agents|mesh-ancestor
65093538|NCT01242332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65093539|NCT01242332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093540|NCT01242332|Anticonvulsants|anticonvulsants|mesh-ancestor
65093541|NCT01242332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65093542|NCT01242332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65093543|NCT01242332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093544|NCT01242332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65093545|NCT01242332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65093546|NCT01242332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65093547|NCT01242332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65093548|NCT01242332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65093549|NCT00487773|Cholecalciferol|cholecalciferol|mesh-list
65093550|NCT00487773|Budesonide|budesonide|mesh-list
65093551|NCT00487773|Albuterol|albuterol|mesh-list
65093552|NCT00487773|Montelukast|montelukast|mesh-list
65093553|NCT00487773|Vitamins|vitamins|mesh-ancestor
65093554|NCT00487773|Micronutrients|micronutrients|mesh-ancestor
65093555|NCT00487773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093556|NCT00487773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65093557|NCT00487773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65093558|NCT00487773|Autonomic Agents|autonomic agents|mesh-ancestor
65093559|NCT00487773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65093560|NCT00487773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65093561|NCT00487773|Respiratory System Agents|respiratory system agents|mesh-ancestor
65093562|NCT00487773|Glucocorticoids|glucocorticoids|mesh-ancestor
65093563|NCT00487773|Hormones|hormones|mesh-ancestor
65093564|NCT00487773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65093565|NCT00487773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
65093566|NCT00487773|Hormone Antagonists|hormone antagonists|mesh-ancestor
65093567|NCT00487773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
65093568|NCT00487773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65093569|NCT00487773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093570|NCT00487773|Tocolytic Agents|tocolytic agents|mesh-ancestor
65093571|NCT00487773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65093572|NCT00487773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65093573|NCT00487773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65093574|NCT00487773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65093575|NCT00487773|Adrenergic Agents|adrenergic agents|mesh-ancestor
65093576|NCT00487773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65093577|NCT00487773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65093578|NCT00487773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65093579|NCT01299961|Abatacept|abatacept|mesh-list
65093580|NCT01299961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65093581|NCT01299961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093582|NCT01299961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093583|NCT01299961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65093584|NCT01299961|Immunologic Factors|immunologic factors|mesh-ancestor
65093585|NCT01299961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093586|NCT01299961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65093587|NCT00492245|Mitomycins|mitomycins|mesh-list
65093588|NCT00492245|Mitomycin|mitomycin|mesh-list
65093589|NCT00492245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65093590|NCT00492245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093591|NCT00492245|Alkylating Agents|alkylating agents|mesh-ancestor
65093592|NCT00492245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093593|NCT00492245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65093594|NCT00492245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093595|NCT00487812|Dobutamine|dobutamine|mesh-list
65093596|NCT00487812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65093597|NCT00487812|Sympathomimetics|sympathomimetics|mesh-ancestor
65093598|NCT00487812|Autonomic Agents|autonomic agents|mesh-ancestor
65093599|NCT00487812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64835744|NCT01599728|Substance P|substance p|mesh-list
65093600|NCT00487812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093601|NCT00487812|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65093602|NCT00487812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65093603|NCT00487812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65093604|NCT00487812|Adrenergic Agents|adrenergic agents|mesh-ancestor
65093605|NCT00487812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65093606|NCT00487812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093607|NCT00487812|Protective Agents|protective agents|mesh-ancestor
65093608|NCT01299805|Vortioxetine|vortioxetine|mesh-list
65093609|NCT01299805|Antidepressive Agents|antidepressive agents|mesh-ancestor
65093610|NCT01299805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65093611|NCT01299805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65093612|NCT01299805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65093613|NCT01299805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65093614|NCT01299805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093615|NCT01299805|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65093616|NCT01299805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65093617|NCT01299805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65093618|NCT01299805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093619|NCT01299805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65093620|NCT01299805|Serotonin Agents|serotonin agents|mesh-ancestor
65093621|NCT01299805|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
65093622|NCT01299805|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
65093623|NCT01299805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
65093624|NCT01299805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65093625|NCT00487682|Valacyclovir|valacyclovir|mesh-list
65093626|NCT00487682|Antiviral Agents|antiviral agents|mesh-ancestor
65093627|NCT00487682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65093628|NCT04512261|Pembrolizumab|pembrolizumab|mesh-list
65093629|NCT04512261|Trastuzumab|trastuzumab|mesh-list
65093630|NCT04512261|Tucatinib|tucatinib|mesh-list
65093631|NCT04512261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65093632|NCT04512261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093633|NCT04512261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65093634|NCT04512261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093635|NCT04512261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093636|NCT00487799|Ularitide|ularitide|mesh-list
65093637|NCT00487799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65093638|NCT00487799|Autonomic Agents|autonomic agents|mesh-ancestor
65093639|NCT00487799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65093640|NCT00487799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093641|NCT00487799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65093642|NCT00487799|Respiratory System Agents|respiratory system agents|mesh-ancestor
65093643|NCT00487799|Diuretics|diuretics|mesh-ancestor
65093644|NCT00487799|Natriuretic Agents|natriuretic agents|mesh-ancestor
65093645|NCT05149170|Antibodies|antibodies|mesh-list
65093646|NCT05149170|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65093647|NCT05149170|Immunologic Factors|immunologic factors|mesh-ancestor
65093648|NCT05149170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093649|NCT05149092|Caseins|caseins|mesh-list
65093650|NCT05149092|Chelating Agents|chelating agents|mesh-ancestor
65093651|NCT05149092|Sequestering Agents|sequestering agents|mesh-ancestor
65093652|NCT05149092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093653|NCT04518501|Arsenic Trioxide|arsenic trioxide|mesh-list
65093654|NCT04518501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093655|NCT00495287|Cytarabine|cytarabine|mesh-list
65093656|NCT00495287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65093657|NCT00495287|Antimetabolites|antimetabolites|mesh-ancestor
65093658|NCT00495287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093659|NCT00495287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093660|NCT00495287|Antiviral Agents|antiviral agents|mesh-ancestor
65093661|NCT00495287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65093662|NCT00495287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64594080|NCT00006170|Dopamine Agents|dopamine agents|mesh-ancestor
65093663|NCT00495287|Immunologic Factors|immunologic factors|mesh-ancestor
65093664|NCT00495287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093665|NCT04696185|Dapagliflozin|dapagliflozin|mesh-list
65093666|NCT04696185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
65093667|NCT04696185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093668|NCT04696185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65093669|NCT04696185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093670|NCT00495326|Efavirenz|efavirenz|mesh-list
65093671|NCT00495326|Nevirapine|nevirapine|mesh-list
65093672|NCT00495326|Rifampin|rifampin|mesh-list
65093673|NCT00495326|Isoniazid|isoniazid|mesh-list
65093674|NCT00495326|Ethambutol|ethambutol|mesh-list
65093675|NCT00495326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
65093676|NCT00495326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65093677|NCT00495326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093678|NCT00495326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093679|NCT00495326|Antiviral Agents|antiviral agents|mesh-ancestor
65093680|NCT00495326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65093681|NCT00495326|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
65093682|NCT00495326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65093683|NCT00495326|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
65093684|NCT00495326|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
65093685|NCT00495326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
65093686|NCT00495326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65093687|NCT00495326|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65093688|NCT00495326|Antitubercular Agents|antitubercular agents|mesh-ancestor
65093689|NCT00495326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65093690|NCT00495326|Leprostatic Agents|leprostatic agents|mesh-ancestor
65093691|NCT00495326|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
65093692|NCT00495326|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
65093693|NCT00495326|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
65093694|NCT00495326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
65093695|NCT00495326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
65093696|NCT00495326|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
65093697|NCT00495326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65093698|NCT00495326|Antimetabolites|antimetabolites|mesh-ancestor
65093699|NCT00495326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65093700|NCT00492479|Kinetin|kinetin|mesh-list
65093701|NCT00492479|Plant Growth Regulators|plant growth regulators|mesh-ancestor
65093702|NCT00492479|Growth Substances|growth substances|mesh-ancestor
65093703|NCT00492479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093704|NCT00495365|Epoetin Alfa|epoetin alfa|mesh-list
65093705|NCT00495365|Hematinics|hematinics|mesh-ancestor
65093706|NCT00492518|Acetylcysteine|acetylcysteine|mesh-list
65093707|NCT00492518|Theophylline|theophylline|mesh-list
65093709|NCT00492518|Antiviral Agents|antiviral agents|mesh-ancestor
64325600|NCT01023295|Fosbretabulin|fosbretabulin|mesh-list
64325601|NCT01023295|Combretastatin|combretastatin|mesh-list
64325602|NCT01023295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64325603|NCT01023295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325604|NCT01023295|Tubulin Modulators|tubulin modulators|mesh-ancestor
64325605|NCT01023295|Antimitotic Agents|antimitotic agents|mesh-ancestor
64325606|NCT01023295|Mitosis Modulators|mitosis modulators|mesh-ancestor
64325607|NCT01023295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835745|NCT01599728|Neurokinin A|neurokinin a|mesh-list
64835746|NCT01599728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64835747|NCT01599728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835748|NCT01599728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835749|NCT01599819|Factor VIII|factor viii|mesh-list
64835750|NCT01599819|BAX 855|bax 855|mesh-list
65093710|NCT00492518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65093711|NCT00492518|Expectorants|expectorants|mesh-ancestor
65093712|NCT00492518|Respiratory System Agents|respiratory system agents|mesh-ancestor
65093713|NCT00492518|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65093714|NCT00492518|Antioxidants|antioxidants|mesh-ancestor
65093715|NCT00492518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093716|NCT00492518|Protective Agents|protective agents|mesh-ancestor
65093717|NCT00492518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093718|NCT00492518|Antidotes|antidotes|mesh-ancestor
65093719|NCT00492518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65093720|NCT00492518|Autonomic Agents|autonomic agents|mesh-ancestor
65093721|NCT00492518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65093722|NCT00492518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65093723|NCT00492518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65093724|NCT00492518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093725|NCT00492518|Vasodilator Agents|vasodilator agents|mesh-ancestor
65093726|NCT00492518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65093727|NCT00492518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65093728|NCT00492518|Purinergic Agents|purinergic agents|mesh-ancestor
65093729|NCT00492518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65093730|NCT04513860|Cenobamate|cenobamate|mesh-list
65093731|NCT04513860|Anticonvulsants|anticonvulsants|mesh-ancestor
65093732|NCT00495560|Misoprostol|misoprostol|mesh-list
65093733|NCT00495560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65093734|NCT00495560|Abortifacient Agents|abortifacient agents|mesh-ancestor
65093735|NCT00495560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65093736|NCT00495560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093737|NCT00495560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65093738|NCT00495560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65093739|NCT00495560|Oxytocics|oxytocics|mesh-ancestor
65093740|NCT04510506|Pancrelipase|pancrelipase|mesh-list
65093741|NCT04510506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65093742|NCT00506844|Capecitabine|capecitabine|mesh-list
65093743|NCT00506844|Irinotecan|irinotecan|mesh-list
65093744|NCT00506844|Cetuximab|cetuximab|mesh-list
65093745|NCT00506844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65093746|NCT00506844|Antimetabolites|antimetabolites|mesh-ancestor
65093747|NCT00506844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093748|NCT00506844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093749|NCT00506844|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65093750|NCT00506844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65093751|NCT00506844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093752|NCT00506844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65093753|NCT00506961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65093754|NCT00506961|Simvastatin|simvastatin|mesh-list
65093755|NCT00506961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65093756|NCT00506961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65093757|NCT00506961|Antimetabolites|antimetabolites|mesh-ancestor
65093758|NCT00506961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093759|NCT00506961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65093760|NCT00506961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65093761|NCT00506961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093762|NCT00492635|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65093763|NCT00492635|Vasodilator Agents|vasodilator agents|mesh-ancestor
65093764|NCT00492635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65093765|NCT00492635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65093766|NCT00492635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093767|NCT00492635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093768|NCT00492635|Urological Agents|urological agents|mesh-ancestor
65093769|NCT00507000|Vitamin D|vitamin d|mesh-list
65093770|NCT00507000|Cholecalciferol|cholecalciferol|mesh-list
65093771|NCT00507000|Vitamins|vitamins|mesh-ancestor
65093772|NCT00507000|Micronutrients|micronutrients|mesh-ancestor
65093773|NCT00507000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093774|NCT00507000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65093775|NCT00507000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65093776|NCT00495872|Lenalidomide|lenalidomide|mesh-list
64446861|NCT01543204|Etanercept|etanercept|mesh-list
65093777|NCT00495872|Sunitinib|sunitinib|mesh-list
65093778|NCT00495872|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
65093779|NCT00495872|Sorafenib|sorafenib|mesh-list
65093780|NCT00495872|Dasatinib|dasatinib|mesh-list
65093781|NCT00495872|Lapatinib|lapatinib|mesh-list
65093782|NCT00495872|Valproic Acid|valproic acid|mesh-list
65093783|NCT00495872|Immunologic Factors|immunologic factors|mesh-ancestor
65093784|NCT00495872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093785|NCT00495872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65093786|NCT00495872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65093788|NCT00495872|Growth Inhibitors|growth inhibitors|mesh-ancestor
65093789|NCT00495872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093790|NCT00495872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65093791|NCT00495872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093792|NCT00495872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093793|NCT00495872|Anticonvulsants|anticonvulsants|mesh-ancestor
65093794|NCT00495872|GABA Agents|gaba agents|mesh-ancestor
65093795|NCT00495872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65093796|NCT00495872|Antimanic Agents|antimanic agents|mesh-ancestor
65093797|NCT00495872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65093798|NCT00495872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65093799|NCT00495872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65093800|NCT00507117|Eszopiclone|eszopiclone|mesh-list
65093801|NCT00507117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65093802|NCT00507117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65093803|NCT00507117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093804|NCT00492830|Antibodies|antibodies|mesh-list
65093805|NCT00492830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
65093806|NCT00492830|Immunologic Factors|immunologic factors|mesh-ancestor
65093807|NCT00492830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093808|NCT01299571|Dutasteride|dutasteride|mesh-list
65093809|NCT01299571|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
65093810|NCT01299571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65093811|NCT01299571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093812|NCT01299571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093813|NCT01299571|Hormone Antagonists|hormone antagonists|mesh-ancestor
65093814|NCT01299571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65093815|NCT01299571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093816|NCT01243736|Metoclopramide|metoclopramide|mesh-list
65093817|NCT01243736|Simethicone|simethicone|mesh-list
65093818|NCT01243736|Antiemetics|antiemetics|mesh-ancestor
65093819|NCT01243736|Autonomic Agents|autonomic agents|mesh-ancestor
65093820|NCT01243736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65093821|NCT01243736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093822|NCT01243736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64736015|NCT02826551|Anesthetics|anesthetics|mesh-ancestor
65093823|NCT01243736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
65093824|NCT01243736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65093825|NCT01243736|Dopamine Agents|dopamine agents|mesh-ancestor
65093826|NCT01243736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65093827|NCT01243736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093828|NCT01243736|Antifoaming Agents|antifoaming agents|mesh-ancestor
65093829|NCT01243736|Emollients|emollients|mesh-ancestor
65093830|NCT01243736|Dermatologic Agents|dermatologic agents|mesh-ancestor
65093831|NCT00492986|Sorafenib|sorafenib|mesh-list
65093832|NCT00492986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093833|NCT00492986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65093834|NCT00492986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093835|NCT00492986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093836|NCT01243970|Phenylephrine|phenylephrine|mesh-list
65093837|NCT01243970|Oxymetazoline|oxymetazoline|mesh-list
65093838|NCT01243970|Ephedrine|ephedrine|mesh-list
65093839|NCT01243970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65093840|NCT01243970|Mydriatics|mydriatics|mesh-ancestor
65093841|NCT01243970|Autonomic Agents|autonomic agents|mesh-ancestor
65093842|NCT01243970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65093843|NCT01243970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093844|NCT01243970|Sympathomimetics|sympathomimetics|mesh-ancestor
65093845|NCT01243970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65093846|NCT01243970|Nasal Decongestants|nasal decongestants|mesh-ancestor
65093847|NCT01243970|Respiratory System Agents|respiratory system agents|mesh-ancestor
65093848|NCT01243970|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65093849|NCT01243970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65093850|NCT01243970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65093851|NCT01243970|Adrenergic Agents|adrenergic agents|mesh-ancestor
65093852|NCT01243970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65093853|NCT01243970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093854|NCT01243970|Protective Agents|protective agents|mesh-ancestor
65093855|NCT01243970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65093856|NCT04515576|Dulaglutide|dulaglutide|mesh-list
65093857|NCT04515576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65093858|NCT04515576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093859|NCT01298362|Aromatase Inhibitors|aromatase inhibitors|mesh-list
65093860|NCT01298362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65093861|NCT01298362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093862|NCT01298362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093863|NCT01298362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65093864|NCT01298362|Hormone Antagonists|hormone antagonists|mesh-ancestor
65093865|NCT01298362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65093866|NCT01298362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093867|NCT00493415|Nitroglycerin|nitroglycerin|mesh-list
65093868|NCT00493415|Vasodilator Agents|vasodilator agents|mesh-ancestor
65093869|NCT01244009|Niraparib|niraparib|mesh-list
65093870|NCT01244009|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
65093871|NCT01244009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093872|NCT01244009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093873|NCT01244009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093874|NCT04511832|Diclofenac|diclofenac|mesh-list
65093875|NCT04511832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65093876|NCT04511832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65093877|NCT04511832|Analgesics|analgesics|mesh-ancestor
65093878|NCT04511832|Sensory System Agents|sensory system agents|mesh-ancestor
65093879|NCT04511832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65093880|NCT04511832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093881|NCT04511832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65093882|NCT04511832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65093883|NCT04511832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65093884|NCT04511832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093885|NCT04511832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093886|NCT01244204|Vitamin D|vitamin d|mesh-list
65093887|NCT01244204|Vitamins|vitamins|mesh-ancestor
65093888|NCT01244204|Micronutrients|micronutrients|mesh-ancestor
65093889|NCT01244204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093890|NCT01244204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65093891|NCT00496028|Paclitaxel|paclitaxel|mesh-list
65093892|NCT00496028|Carboplatin|carboplatin|mesh-list
65093893|NCT00496028|Saracatinib|saracatinib|mesh-list
65093894|NCT00496028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65093895|NCT00496028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093896|NCT00496028|Tubulin Modulators|tubulin modulators|mesh-ancestor
64736096|NCT02708849|Lamotrigine|lamotrigine|mesh-list
65093897|NCT00496028|Antimitotic Agents|antimitotic agents|mesh-ancestor
65093898|NCT00496028|Mitosis Modulators|mitosis modulators|mesh-ancestor
65093899|NCT00496028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093900|NCT00496028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093901|NCT04516278|Bevacizumab|bevacizumab|mesh-list
65093902|NCT04516278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65093903|NCT04516278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093904|NCT04516278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65093905|NCT04516278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65093906|NCT04516278|Growth Substances|growth substances|mesh-ancestor
65093907|NCT04516278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093908|NCT04516278|Growth Inhibitors|growth inhibitors|mesh-ancestor
65093909|NCT00493532|Ibandronic Acid|ibandronic acid|mesh-list
65093910|NCT00493532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65093911|NCT00493532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093912|NCT01297465|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
65093913|NCT01297465|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
65093914|NCT01297465|Hormones|hormones|mesh-ancestor
65093915|NCT01297465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65093916|NCT01297465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093917|NCT01297465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65093918|NCT04518462|Bupivacaine|bupivacaine|mesh-list
65093919|NCT04518462|Anesthetics, Local|anesthetics, local|mesh-ancestor
65093920|NCT04518462|Anesthetics|anesthetics|mesh-ancestor
65093921|NCT04518462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65093922|NCT04518462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093923|NCT04518462|Sensory System Agents|sensory system agents|mesh-ancestor
65093924|NCT04518462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65093925|NCT00496184|Nifedipine|nifedipine|mesh-list
65093926|NCT00496184|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65093927|NCT00496184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65093928|NCT00496184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093929|NCT00496184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65093930|NCT00496184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093931|NCT00496184|Vasodilator Agents|vasodilator agents|mesh-ancestor
65093932|NCT00496184|Tocolytic Agents|tocolytic agents|mesh-ancestor
65093933|NCT00496184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65093934|NCT00493610|Acetylcysteine|acetylcysteine|mesh-list
65093935|NCT00493610|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65093936|NCT00493610|Antiviral Agents|antiviral agents|mesh-ancestor
65093937|NCT00493610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65093938|NCT00493610|Expectorants|expectorants|mesh-ancestor
65093939|NCT00493610|Respiratory System Agents|respiratory system agents|mesh-ancestor
65093940|NCT00493610|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65093941|NCT00493610|Antioxidants|antioxidants|mesh-ancestor
65093942|NCT00493610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093943|NCT00493610|Protective Agents|protective agents|mesh-ancestor
65093944|NCT00493610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093945|NCT00493610|Antidotes|antidotes|mesh-ancestor
65093946|NCT02274506|Cyclophosphamide|cyclophosphamide|mesh-list
65093947|NCT02274506|Fludarabine|fludarabine|mesh-list
65093948|NCT02274506|Fludarabine phosphate|fludarabine phosphate|mesh-list
64416974|NCT02412657|Dexamethasone|dexamethasone|mesh-list
65093950|NCT02274506|Immunologic Factors|immunologic factors|mesh-ancestor
65093951|NCT02274506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093952|NCT02274506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65093953|NCT02274506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65093954|NCT02274506|Alkylating Agents|alkylating agents|mesh-ancestor
65093955|NCT02274506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093956|NCT02274506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093957|NCT02274506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65093958|NCT02274506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65093959|NCT02274506|Antimetabolites|antimetabolites|mesh-ancestor
65093960|NCT00496223|Sunitinib|sunitinib|mesh-list
65093961|NCT00496223|Dacarbazine|dacarbazine|mesh-list
65093962|NCT00496223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093963|NCT00496223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65093964|NCT00496223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65093965|NCT00496223|Growth Substances|growth substances|mesh-ancestor
65093966|NCT00496223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093967|NCT00496223|Growth Inhibitors|growth inhibitors|mesh-ancestor
65093968|NCT00496223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64594390|NCT03087968|Prednisolone|prednisolone|mesh-list
65093969|NCT00496223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093970|NCT00496223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093971|NCT00496223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64736161|NCT01216631|Glucocorticoids|glucocorticoids|mesh-ancestor
65093972|NCT00496223|Alkylating Agents|alkylating agents|mesh-ancestor
65093973|NCT00496301|Gemcitabine|gemcitabine|mesh-list
65093974|NCT00496301|Capecitabine|capecitabine|mesh-list
65093975|NCT00496301|Sorafenib|sorafenib|mesh-list
65093976|NCT00496301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65093977|NCT00496301|Antimetabolites|antimetabolites|mesh-ancestor
65093978|NCT00496301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65093979|NCT00496301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65093980|NCT00496301|Antiviral Agents|antiviral agents|mesh-ancestor
65093981|NCT00496301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65093982|NCT00496301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65093983|NCT00496301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65093984|NCT00496301|Immunologic Factors|immunologic factors|mesh-ancestor
65093985|NCT00496301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093986|NCT00496301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65093987|NCT05141838|Vitamin D|vitamin d|mesh-list
65093988|NCT05141838|Vitamins|vitamins|mesh-ancestor
65093989|NCT05141838|Micronutrients|micronutrients|mesh-ancestor
65093990|NCT05141838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65093991|NCT05141838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65093992|NCT00493727|Acetylcysteine|acetylcysteine|mesh-list
65093993|NCT00493727|N-monoacetylcystine|n-monoacetylcystine|mesh-list
65093994|NCT00493727|Antiviral Agents|antiviral agents|mesh-ancestor
65093995|NCT00493727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65093996|NCT00493727|Expectorants|expectorants|mesh-ancestor
65093997|NCT00493727|Respiratory System Agents|respiratory system agents|mesh-ancestor
65093998|NCT00493727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65093999|NCT00493727|Antioxidants|antioxidants|mesh-ancestor
65094000|NCT00493727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094001|NCT00493727|Protective Agents|protective agents|mesh-ancestor
65094002|NCT00493727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094004|NCT00493766|Panobinostat|panobinostat|mesh-list
65094005|NCT00493766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094006|NCT00493766|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65094007|NCT00493766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094008|NCT00493766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094009|NCT05146479|Fluorides|fluorides|mesh-list
65094010|NCT05146479|Fluorides, Topical|fluorides, topical|mesh-list
65094011|NCT05146479|Cariostatic Agents|cariostatic agents|mesh-ancestor
65094012|NCT05146479|Protective Agents|protective agents|mesh-ancestor
65094013|NCT05146479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094014|NCT05145621|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
65094015|NCT05145621|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
65094016|NCT05145621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094017|NCT05145621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65094018|NCT05145621|Immunologic Factors|immunologic factors|mesh-ancestor
65094019|NCT05145621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094020|NCT01296568|Gemcitabine|gemcitabine|mesh-list
65094021|NCT01296568|Pemetrexed|pemetrexed|mesh-list
64417034|NCT02408523|Lacosamide|lacosamide|mesh-list
65094022|NCT01296568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65094023|NCT01296568|Antimetabolites|antimetabolites|mesh-ancestor
65094024|NCT01296568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094025|NCT01296568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094026|NCT01296568|Antiviral Agents|antiviral agents|mesh-ancestor
65094027|NCT01296568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65094028|NCT01296568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094029|NCT01296568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65094030|NCT01296568|Immunologic Factors|immunologic factors|mesh-ancestor
65094031|NCT01296568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094032|NCT01296568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64325609|NCT05468138|Immunologic Factors|immunologic factors|mesh-ancestor
64325610|NCT05468138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325611|NCT01140217|Norethindrone|norethindrone|mesh-list
65094033|NCT01296568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65094034|NCT02598999|Lactoferrin|lactoferrin|mesh-list
65094035|NCT02598999|Hypothiocyanite ion|hypothiocyanite ion|mesh-list
65094036|NCT02598999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65094037|NCT01296412|Metformin|metformin|mesh-list
65094038|NCT01296412|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
65094039|NCT01296412|Liraglutide|liraglutide|mesh-list
65094040|NCT01296412|Glimepiride|glimepiride|mesh-list
65094041|NCT01296412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65094042|NCT01296412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094043|NCT01296412|Incretins|incretins|mesh-ancestor
65094044|NCT01296412|Hormones|hormones|mesh-ancestor
65094045|NCT01296412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65094046|NCT01296412|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
65094047|NCT01296412|Protease Inhibitors|protease inhibitors|mesh-ancestor
65094048|NCT01296412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094049|NCT01296412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094050|NCT01296412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65094051|NCT01296412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65094052|NCT01296412|Immunologic Factors|immunologic factors|mesh-ancestor
65094053|NCT00496652|Zalutumumab|zalutumumab|mesh-list
65094054|NCT00496652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65094055|NCT00496652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094056|NCT02597634|Ibuprofen|ibuprofen|mesh-list
65094057|NCT02597634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65094058|NCT02597634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65094059|NCT02597634|Analgesics|analgesics|mesh-ancestor
65094060|NCT02597634|Sensory System Agents|sensory system agents|mesh-ancestor
65094061|NCT02597634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65094062|NCT02597634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094063|NCT02597634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65094064|NCT02597634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65094065|NCT02597634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65094066|NCT02597634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094067|NCT02597634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094068|NCT02591199|Lidocaine|lidocaine|mesh-list
65094069|NCT02591199|Heparin|heparin|mesh-list
65094070|NCT02591199|Anesthetics, Local|anesthetics, local|mesh-ancestor
65094071|NCT02591199|Anesthetics|anesthetics|mesh-ancestor
65094072|NCT02591199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65094073|NCT02591199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094074|NCT02591199|Sensory System Agents|sensory system agents|mesh-ancestor
65094075|NCT02591199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65094076|NCT02591199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64835754|NCT01599858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64835755|NCT01599858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64835756|NCT01599858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835757|NCT01599858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835758|NCT01599871|Theophylline|theophylline|mesh-list
64835759|NCT01599871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64835760|NCT01599871|Autonomic Agents|autonomic agents|mesh-ancestor
64835761|NCT01599871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64835762|NCT01599871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835763|NCT01599871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64835764|NCT01599871|Respiratory System Agents|respiratory system agents|mesh-ancestor
64835765|NCT01599871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65094077|NCT02591199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65094078|NCT02591199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65094079|NCT02591199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65094080|NCT02591199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094081|NCT02591199|Anticoagulants|anticoagulants|mesh-ancestor
65094082|NCT02591199|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65094083|NCT02591199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65094084|NCT00494078|Insulin Aspart|insulin aspart|mesh-list
65094085|NCT00494078|Insulin, Long-Acting|insulin, long-acting|mesh-list
65094086|NCT00494078|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
65094087|NCT00494078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65094088|NCT00494078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094089|NCT02596035|Nivolumab|nivolumab|mesh-list
65094090|NCT02596035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65094091|NCT02596035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094092|NCT02596035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64417035|NCT02408523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
65094093|NCT02596035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094095|NCT00494156|Heparin|heparin|mesh-list
65094096|NCT00494156|Clopidogrel|clopidogrel|mesh-list
65094097|NCT00494156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65094098|NCT00494156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65094099|NCT00494156|Analgesics|analgesics|mesh-ancestor
65094100|NCT00494156|Sensory System Agents|sensory system agents|mesh-ancestor
65094101|NCT00494156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65094102|NCT00494156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094103|NCT00494156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65094104|NCT00494156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65094105|NCT00494156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65094106|NCT00494156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65094107|NCT00494156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094108|NCT00494156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65094109|NCT00494156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65094110|NCT00494156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094111|NCT00494156|Antipyretics|antipyretics|mesh-ancestor
65094112|NCT00494156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65094113|NCT00494156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
65094114|NCT00494156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65094115|NCT00494156|Purinergic Agents|purinergic agents|mesh-ancestor
65094116|NCT00494156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65094117|NCT00494156|Anticoagulants|anticoagulants|mesh-ancestor
65094118|NCT02595489|Vitamin D|vitamin d|mesh-list
65094119|NCT02595489|Ergocalciferols|ergocalciferols|mesh-list
65094120|NCT02595489|Cholecalciferol|cholecalciferol|mesh-list
64736316|NCT01094561|Secretin|secretin|mesh-list
65094121|NCT02595489|Vitamins|vitamins|mesh-list
65094122|NCT02595489|Micronutrients|micronutrients|mesh-ancestor
65094123|NCT02595489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094124|NCT02595489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65094125|NCT02595489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65094126|NCT00497003|Metoprolol|metoprolol|mesh-list
65094127|NCT00497003|Carvedilol|carvedilol|mesh-list
65094128|NCT00497003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65094129|NCT00497003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65094130|NCT00497003|Sympatholytics|sympatholytics|mesh-ancestor
65094131|NCT00497003|Autonomic Agents|autonomic agents|mesh-ancestor
65094132|NCT00497003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65094133|NCT00497003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094134|NCT00497003|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65094135|NCT00497003|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65094136|NCT00497003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65094137|NCT00497003|Adrenergic Agents|adrenergic agents|mesh-ancestor
65094138|NCT00497003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65094139|NCT00497003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64483491|NCT03804268|Miotics|miotics|mesh-ancestor
65094140|NCT00497003|Antioxidants|antioxidants|mesh-ancestor
65094141|NCT00497003|Protective Agents|protective agents|mesh-ancestor
65094142|NCT00497003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65094143|NCT00497003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65094144|NCT00497003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65094145|NCT00497003|Vasodilator Agents|vasodilator agents|mesh-ancestor
65094146|NCT00497003|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65094147|NCT00497003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65094148|NCT00494312|Pioglitazone|pioglitazone|mesh-list
65094149|NCT00494312|Glyburide|glyburide|mesh-list
65094150|NCT00494312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65094151|NCT00494312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094152|NCT02595372|Omeprazole|omeprazole|mesh-list
65094153|NCT02595372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
65094154|NCT02595372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65094155|NCT02595372|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
65094156|NCT02595372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094157|NCT02595372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094158|NCT05142969|Chlorhexidine|chlorhexidine|mesh-list
65094159|NCT05142969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65094160|NCT05142969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65094161|NCT05142969|Disinfectants|disinfectants|mesh-ancestor
65094162|NCT02596503|Cefixime|cefixime|mesh-list
65094163|NCT02596503|Irinotecan|irinotecan|mesh-list
65094164|NCT02596503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65094165|NCT02596503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65094166|NCT02596503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094167|NCT02596503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094168|NCT02596503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094169|NCT02596503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65094170|NCT02596503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65094172|NCT00494429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65094173|NCT00494429|Narcotics|narcotics|mesh-ancestor
65094174|NCT00494429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65094175|NCT00494429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094176|NCT00494429|Analgesics|analgesics|mesh-ancestor
65094177|NCT00494429|Sensory System Agents|sensory system agents|mesh-ancestor
65094178|NCT00494429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65094179|NCT00497120|Acetazolamide|acetazolamide|mesh-list
65094180|NCT00497120|Anticonvulsants|anticonvulsants|mesh-ancestor
65094181|NCT00497120|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
65094182|NCT00497120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094183|NCT00497120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094184|NCT00497120|Diuretics|diuretics|mesh-ancestor
65094185|NCT00497120|Natriuretic Agents|natriuretic agents|mesh-ancestor
65094186|NCT00497120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094187|NCT00494468|Zolpidem|zolpidem|mesh-list
65094188|NCT00494468|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
65094189|NCT00494468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
65094190|NCT00494468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65094191|NCT00494468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094192|NCT00494468|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
65094193|NCT00494468|GABA Agonists|gaba agonists|mesh-ancestor
65094194|NCT00494468|GABA Agents|gaba agents|mesh-ancestor
65094195|NCT00494468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65094196|NCT00494468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094197|NCT00497237|Fluticasone|fluticasone|mesh-list
65094198|NCT00497237|Beclomethasone|beclomethasone|mesh-list
65094199|NCT00497237|Formoterol Fumarate|formoterol fumarate|mesh-list
65094200|NCT00497237|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
65094201|NCT00497237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65094202|NCT00497237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65094203|NCT00497237|Autonomic Agents|autonomic agents|mesh-ancestor
65094204|NCT00497237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65094205|NCT00497237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094206|NCT00497237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64594636|NCT04200833|Golimumab|golimumab|mesh-list
65094207|NCT00497237|Respiratory System Agents|respiratory system agents|mesh-ancestor
65094208|NCT00497237|Dermatologic Agents|dermatologic agents|mesh-ancestor
65094209|NCT00497237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
65094210|NCT00497237|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65094211|NCT00497237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65094212|NCT00497237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65094213|NCT00497237|Adrenergic Agents|adrenergic agents|mesh-ancestor
65094214|NCT00497237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65094215|NCT00497237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094216|NCT00497237|Glucocorticoids|glucocorticoids|mesh-ancestor
65094217|NCT00497237|Hormones|hormones|mesh-ancestor
65094218|NCT00497237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65094219|NCT00497315|Pemetrexed|pemetrexed|mesh-list
65094220|NCT00497315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094221|NCT00497315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094222|NCT00497315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094223|NCT00497315|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65094224|NCT00497315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65094225|NCT05142072|Vitamin D|vitamin d|mesh-list
65094226|NCT05142072|Cholecalciferol|cholecalciferol|mesh-list
65094227|NCT05142072|Vitamins|vitamins|mesh-ancestor
65094228|NCT05142072|Micronutrients|micronutrients|mesh-ancestor
65094229|NCT05142072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094230|NCT05142072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65094231|NCT05142072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65094232|NCT00497354|Anesthetics|anesthetics|mesh-list
65094233|NCT00497354|Anesthetics, Local|anesthetics, local|mesh-list
65094234|NCT00497354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65094235|NCT00497354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417041|NCT05618353|Colchicine|colchicine|mesh-list
65094236|NCT00497354|Sensory System Agents|sensory system agents|mesh-ancestor
65094237|NCT00497354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65094238|NCT00494624|Prednisolone|prednisolone|mesh-list
65094239|NCT00494624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65094240|NCT00494624|Glucocorticoids|glucocorticoids|mesh-ancestor
65094241|NCT00494624|Hormones|hormones|mesh-ancestor
65094242|NCT00494624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65094243|NCT00494624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094244|NCT00494624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65094245|NCT00494624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094246|NCT00494663|Ketoconazole|ketoconazole|mesh-list
65094247|NCT00494663|Antifungal Agents|antifungal agents|mesh-ancestor
65094248|NCT00494663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65094249|NCT00494663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
65094250|NCT00494663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65094251|NCT00494663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094252|NCT00494663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094253|NCT00494663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65094254|NCT00494663|Hormone Antagonists|hormone antagonists|mesh-ancestor
65094255|NCT00494663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65094256|NCT00494663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094257|NCT00494663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
65094258|NCT05146674|Tadalafil|tadalafil|mesh-list
65094259|NCT05146674|Vasodilator Agents|vasodilator agents|mesh-ancestor
65094260|NCT05146674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65094261|NCT05146674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65094262|NCT05146674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094263|NCT05146674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094264|NCT05146674|Urological Agents|urological agents|mesh-ancestor
65094265|NCT00507195|Midazolam|midazolam|mesh-list
65094266|NCT00507195|Propofol|propofol|mesh-list
65094267|NCT00507195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
65094268|NCT00507195|Sevoflurane|sevoflurane|mesh-list
65094269|NCT00507195|Desflurane|desflurane|mesh-list
65094270|NCT00507195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64475876|NCT00457366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65094271|NCT00507195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094272|NCT00507195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65094273|NCT00507195|Anesthetics, General|anesthetics, general|mesh-ancestor
65094274|NCT00507195|Anesthetics|anesthetics|mesh-ancestor
65094275|NCT00507195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65094276|NCT00507195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65094277|NCT00507195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65094278|NCT00507195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65094279|NCT00507195|GABA Modulators|gaba modulators|mesh-ancestor
65094280|NCT00507195|GABA Agents|gaba agents|mesh-ancestor
65094281|NCT00507195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65094282|NCT00507195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094283|NCT00507195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65094284|NCT00507195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
65094285|NCT00497471|Pyrimethamine|pyrimethamine|mesh-list
65094286|NCT00497471|Dapsone|dapsone|mesh-list
65094287|NCT00497471|Antimalarials|antimalarials|mesh-ancestor
65094288|NCT00497471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
65094289|NCT00497471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65094290|NCT00497471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65094291|NCT00497471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65094292|NCT00497471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094293|NCT00497471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094294|NCT00497471|Leprostatic Agents|leprostatic agents|mesh-ancestor
65094295|NCT00497471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65094296|NCT05146635|Epirubicin|epirubicin|mesh-list
65094297|NCT05146635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65094298|NCT05146635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094299|NCT05146635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65094300|NCT05146635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65094301|NCT05146635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094302|NCT05146635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094303|NCT00494741|Mycophenolic Acid|mycophenolic acid|mesh-list
65094304|NCT00494741|Azathioprine|azathioprine|mesh-list
65094305|NCT00494741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65094306|NCT00494741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417071|NCT04822909|Growth Inhibitors|growth inhibitors|mesh-ancestor
65094307|NCT00494741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
65094308|NCT00494741|Antitubercular Agents|antitubercular agents|mesh-ancestor
65094309|NCT00494741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65094310|NCT00494741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65094311|NCT00494741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094312|NCT00494741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094313|NCT00494741|Antimetabolites|antimetabolites|mesh-ancestor
65094314|NCT00494741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65094315|NCT00494741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65094316|NCT00494741|Immunologic Factors|immunologic factors|mesh-ancestor
65094317|NCT00494741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094318|NCT00494741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65094319|NCT00507234|Formoterol Fumarate|formoterol fumarate|mesh-list
65094320|NCT00507234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65094321|NCT00507234|Autonomic Agents|autonomic agents|mesh-ancestor
65094322|NCT00507234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65094323|NCT00507234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094324|NCT00507234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65094325|NCT00507234|Respiratory System Agents|respiratory system agents|mesh-ancestor
65094326|NCT00507234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65094327|NCT00507234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65094328|NCT00507234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65094329|NCT00507234|Adrenergic Agents|adrenergic agents|mesh-ancestor
65094330|NCT00507234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65094331|NCT00507234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094332|NCT05148546|Nivolumab|nivolumab|mesh-list
65094333|NCT05148546|Ipilimumab|ipilimumab|mesh-list
65094334|NCT05148546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65094335|NCT05148546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094336|NCT05148546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
65094337|NCT05148546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094338|NCT00506532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
65094339|NCT00506532|Calfactant|calfactant|mesh-list
65094340|NCT00506532|Respiratory System Agents|respiratory system agents|mesh-ancestor
64594753|NCT00707863|Serotonin Agents|serotonin agents|mesh-ancestor
65094341|NCT05149560|Ticagrelor|ticagrelor|mesh-list
65094342|NCT05149560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65094343|NCT05149560|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
65094344|NCT05149560|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64736541|NCT00825227|Modafinil|modafinil|mesh-list
65094345|NCT05149560|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65094346|NCT05149560|Purinergic Agents|purinergic agents|mesh-ancestor
65094347|NCT05149560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65094348|NCT05149560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094349|NCT05149560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094350|NCT00494897|Cytarabine|cytarabine|mesh-list
65094351|NCT00494897|Prednisone|prednisone|mesh-list
65094352|NCT00494897|Cyclophosphamide|cyclophosphamide|mesh-list
65094353|NCT00494897|Methotrexate|methotrexate|mesh-list
65094354|NCT00494897|Vincristine|vincristine|mesh-list
65094355|NCT00494897|Daunorubicin|daunorubicin|mesh-list
65094356|NCT00494897|Asparaginase|asparaginase|mesh-list
65094357|NCT00494897|Mercaptopurine|mercaptopurine|mesh-list
65094358|NCT00494897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65094359|NCT00494897|Immunologic Factors|immunologic factors|mesh-ancestor
65094360|NCT00494897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094361|NCT00494897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65094362|NCT00494897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65094363|NCT00494897|Alkylating Agents|alkylating agents|mesh-ancestor
65094364|NCT00494897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094365|NCT00494897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094366|NCT00494897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65094367|NCT00494897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65094368|NCT00494897|Glucocorticoids|glucocorticoids|mesh-ancestor
65094369|NCT00494897|Hormones|hormones|mesh-ancestor
65094370|NCT00494897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65094371|NCT00494897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65094372|NCT00494897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65094373|NCT00494897|Abortifacient Agents|abortifacient agents|mesh-ancestor
65094374|NCT00494897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65094375|NCT00494897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64417073|NCT04831099|Testosterone|testosterone|mesh-list
65094376|NCT00494897|Antimetabolites|antimetabolites|mesh-ancestor
65094377|NCT00494897|Dermatologic Agents|dermatologic agents|mesh-ancestor
65094378|NCT00494897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094379|NCT00494897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65094380|NCT00494897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65094381|NCT00494897|Antiviral Agents|antiviral agents|mesh-ancestor
65094382|NCT00494897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65094383|NCT00494897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65094384|NCT00494897|Tubulin Modulators|tubulin modulators|mesh-ancestor
65094385|NCT00494897|Antimitotic Agents|antimitotic agents|mesh-ancestor
65094386|NCT00494897|Mitosis Modulators|mitosis modulators|mesh-ancestor
65094387|NCT00494897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65094388|NCT00494897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
65094389|NCT00494897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65094390|NCT00497744|Cefepime|cefepime|mesh-list
65094391|NCT00497744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65094392|NCT00497744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65094393|NCT00495092|Biperiden|biperiden|mesh-list
65094394|NCT00495092|Caffeine|caffeine|mesh-list
65094395|NCT00495092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65094396|NCT00495092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094397|NCT00495092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65094398|NCT00495092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094399|NCT00495092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094400|NCT00495092|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
65094401|NCT00495092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
65094402|NCT00495092|Purinergic Agents|purinergic agents|mesh-ancestor
65094403|NCT00495092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65094404|NCT00495092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65094405|NCT00495092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65094406|NCT00495092|Parasympatholytics|parasympatholytics|mesh-ancestor
65094407|NCT00495092|Autonomic Agents|autonomic agents|mesh-ancestor
65094408|NCT00495092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65094409|NCT00495092|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65094410|NCT00495092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65094411|NCT00495092|Cholinergic Agents|cholinergic agents|mesh-ancestor
65094412|NCT05143281|Dexamethasone|dexamethasone|mesh-list
65094413|NCT05143281|Dexamethasone acetate|dexamethasone acetate|mesh-list
65094414|NCT05143281|BB 1101|bb 1101|mesh-list
65094415|NCT05143281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65094416|NCT05143281|Antiemetics|antiemetics|mesh-ancestor
65094417|NCT05143281|Autonomic Agents|autonomic agents|mesh-ancestor
65094418|NCT05143281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65094419|NCT05143281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094420|NCT05143281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65094421|NCT05143281|Glucocorticoids|glucocorticoids|mesh-ancestor
65094422|NCT05143281|Hormones|hormones|mesh-ancestor
65094423|NCT05143281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65094424|NCT05143281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65094425|NCT05143281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094426|NCT05143281|Protease Inhibitors|protease inhibitors|mesh-ancestor
65094427|NCT05143281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094428|NCT05143281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094429|NCT01244360|Resveratrol|resveratrol|mesh-list
65094430|NCT01244360|Antioxidants|antioxidants|mesh-ancestor
65094431|NCT01244360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094432|NCT01244360|Protective Agents|protective agents|mesh-ancestor
65094433|NCT01244360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094434|NCT01244360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094435|NCT01244360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65094436|NCT00506571|Oxaliplatin|oxaliplatin|mesh-list
65094437|NCT00506571|Irinotecan|irinotecan|mesh-list
65094438|NCT00506571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094439|NCT00506571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65094440|NCT00506571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65094441|NCT00506571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094442|NCT00506571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094443|NCT00497900|Vitamin D|vitamin d|mesh-list
65094444|NCT00497900|Vitamins|vitamins|mesh-ancestor
65094445|NCT00497900|Micronutrients|micronutrients|mesh-ancestor
65094446|NCT00497900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094447|NCT00497900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65094448|NCT05143125|Decitabine|decitabine|mesh-list
65094449|NCT05143125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65094450|NCT05143125|Antimetabolites|antimetabolites|mesh-ancestor
65094451|NCT05143125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094452|NCT05143125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094453|NCT05143125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094454|NCT00497939|Saw palmetto extract|saw palmetto extract|mesh-list
65094455|NCT00497939|Urological Agents|urological agents|mesh-ancestor
65094456|NCT00498134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
65094457|NCT00498134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65094458|NCT00498134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094459|NCT00498134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094460|NCT00498134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65094461|NCT00498134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65094462|NCT00498134|Analgesics|analgesics|mesh-ancestor
65094463|NCT00498134|Sensory System Agents|sensory system agents|mesh-ancestor
65094464|NCT00498134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65094465|NCT00498134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094466|NCT00498134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65094467|NCT00498134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65094468|NCT00498251|Albuterol|albuterol|mesh-list
65094469|NCT00498251|Ipratropium|ipratropium|mesh-list
65094470|NCT00498251|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65094471|NCT00498251|Autonomic Agents|autonomic agents|mesh-ancestor
65094472|NCT00498251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65094473|NCT00498251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094474|NCT00498251|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65094475|NCT00498251|Respiratory System Agents|respiratory system agents|mesh-ancestor
65094476|NCT00498251|Tocolytic Agents|tocolytic agents|mesh-ancestor
65094477|NCT00498251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65094478|NCT00498251|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
65094479|NCT00498251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65094480|NCT00498251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65094481|NCT00498251|Adrenergic Agents|adrenergic agents|mesh-ancestor
65094482|NCT00498251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65094483|NCT00498251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094484|NCT00498251|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65094485|NCT00498251|Cholinergic Agents|cholinergic agents|mesh-ancestor
65094486|NCT00502658|Vitamins|vitamins|mesh-list
65094487|NCT00502658|Micronutrients|micronutrients|mesh-ancestor
65094488|NCT00502658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094489|NCT00502736|Ibandronic Acid|ibandronic acid|mesh-list
65094490|NCT00502736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65094491|NCT00502736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094492|NCT05146245|Risperidone|risperidone|mesh-list
65094493|NCT05146245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
65094494|NCT05146245|Serotonin Agents|serotonin agents|mesh-ancestor
65094495|NCT05146245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65094496|NCT05146245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094497|NCT05146245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094498|NCT05146245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
65094499|NCT05146245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65094500|NCT05146245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65094501|NCT05146245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65094502|NCT05146245|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
65094503|NCT05146245|Dopamine Agents|dopamine agents|mesh-ancestor
65094505|NCT05146089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65094506|NCT05146089|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
65094507|NCT05146089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094508|NCT02954913|Liver Extracts|liver extracts|mesh-list
65094509|NCT02954913|Hematinics|hematinics|mesh-ancestor
65094510|NCT00502892|Carboplatin|carboplatin|mesh-list
65094511|NCT00502892|Topotecan|topotecan|mesh-list
65094512|NCT00502892|Ifosfamide|ifosfamide|mesh-list
65094513|NCT00502892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094514|NCT00502892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65094515|NCT00502892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65094516|NCT00502892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094517|NCT00502892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094518|NCT00502892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65094519|NCT00502892|Alkylating Agents|alkylating agents|mesh-ancestor
65094520|NCT00502970|Interferons|interferons|mesh-list
65094521|NCT00502970|Ribavirin|ribavirin|mesh-list
65094522|NCT00502970|Iron-Dextran Complex|iron-dextran complex|mesh-list
65094523|NCT00502970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094524|NCT00502970|Antiviral Agents|antiviral agents|mesh-ancestor
65094525|NCT00502970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65094526|NCT00502970|Antimetabolites|antimetabolites|mesh-ancestor
65094527|NCT00502970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094528|NCT00502970|Hematinics|hematinics|mesh-ancestor
65094529|NCT05149287|Ceftriaxone|ceftriaxone|mesh-list
65094530|NCT05149287|Lidocaine|lidocaine|mesh-list
65094531|NCT05149287|Anesthetics, Local|anesthetics, local|mesh-ancestor
65094532|NCT05149287|Anesthetics|anesthetics|mesh-ancestor
65094533|NCT05149287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65094534|NCT05149287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094535|NCT05149287|Sensory System Agents|sensory system agents|mesh-ancestor
64835781|NCT01599884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835782|NCT01599884|Protective Agents|protective agents|mesh-ancestor
64835783|NCT01599884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835784|NCT01599884|Antidotes|antidotes|mesh-ancestor
64835785|NCT01599923|Antivenins|antivenins|mesh-list
64325613|NCT01140217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64325614|NCT01140217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65094536|NCT05149287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65094537|NCT05149287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65094538|NCT05149287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65094539|NCT05149287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65094540|NCT05149287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65094541|NCT05149287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094542|NCT05149287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65094543|NCT05149287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65094544|NCT00498680|Sildenafil Citrate|sildenafil citrate|mesh-list
65094545|NCT00498680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
65094546|NCT00498680|Vasodilator Agents|vasodilator agents|mesh-ancestor
65094547|NCT00498680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
65094548|NCT00498680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65094549|NCT00498680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094550|NCT00498680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094551|NCT00498680|Urological Agents|urological agents|mesh-ancestor
65094552|NCT00498953|Carboplatin|carboplatin|mesh-list
65094553|NCT00498953|Docetaxel|docetaxel|mesh-list
65094554|NCT00498953|Fluorouracil|fluorouracil|mesh-list
65094555|NCT00498953|Lapatinib|lapatinib|mesh-list
65094556|NCT00498953|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
65094557|NCT00498953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094558|NCT00498953|Tubulin Modulators|tubulin modulators|mesh-ancestor
65094559|NCT00498953|Antimitotic Agents|antimitotic agents|mesh-ancestor
65094560|NCT00498953|Mitosis Modulators|mitosis modulators|mesh-ancestor
65094561|NCT00498953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094562|NCT00498953|Antimetabolites|antimetabolites|mesh-ancestor
65094563|NCT00498953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65094564|NCT00498953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65094565|NCT00498953|Immunologic Factors|immunologic factors|mesh-ancestor
65094566|NCT00498953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094567|NCT00498953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65094568|NCT00498953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736759|NCT05599919|Nitric Oxide|nitric oxide|mesh-list
65094569|NCT00498953|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
65094570|NCT00503126|Bivalirudin|bivalirudin|mesh-list
65094571|NCT00503126|Antithrombins|antithrombins|mesh-ancestor
65094572|NCT00503126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65094573|NCT00503126|Protease Inhibitors|protease inhibitors|mesh-ancestor
65094574|NCT00503126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094575|NCT00503126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094576|NCT00503126|Anticoagulants|anticoagulants|mesh-ancestor
65094577|NCT05145543|Dexamethasone|dexamethasone|mesh-list
65094578|NCT05145543|Fentanyl|fentanyl|mesh-list
65094579|NCT05145543|Levobupivacaine|levobupivacaine|mesh-list
65094580|NCT05145543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65094581|NCT05145543|Antiemetics|antiemetics|mesh-ancestor
65094582|NCT05145543|Autonomic Agents|autonomic agents|mesh-ancestor
65094583|NCT05145543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65094584|NCT05145543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094585|NCT05145543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65094586|NCT05145543|Glucocorticoids|glucocorticoids|mesh-ancestor
65094587|NCT05145543|Hormones|hormones|mesh-ancestor
64325615|NCT01140217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64325616|NCT01140217|Contraceptive Agents|contraceptive agents|mesh-ancestor
65094588|NCT05145543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65094589|NCT05145543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65094590|NCT05145543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094591|NCT05145543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65094592|NCT05145543|Narcotics|narcotics|mesh-ancestor
65094593|NCT05145543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65094594|NCT05145543|Analgesics|analgesics|mesh-ancestor
65094595|NCT05145543|Sensory System Agents|sensory system agents|mesh-ancestor
65094596|NCT05145543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65094597|NCT05145543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65094599|NCT05145543|Anesthetics|anesthetics|mesh-ancestor
65094600|NCT05145543|Anesthetics, Local|anesthetics, local|mesh-ancestor
65094601|NCT00503204|Cediranib|cediranib|mesh-list
65094602|NCT00503204|Lomustine|lomustine|mesh-list
65094603|NCT00503204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094604|NCT00503204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65094605|NCT00503204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094606|NCT00503204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094607|NCT00503204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65094608|NCT00503204|Alkylating Agents|alkylating agents|mesh-ancestor
65094609|NCT00503243|Mesalamine|mesalamine|mesh-list
65094610|NCT00503243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65094611|NCT00503243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65094612|NCT00503243|Analgesics|analgesics|mesh-ancestor
65094613|NCT00503243|Sensory System Agents|sensory system agents|mesh-ancestor
65094614|NCT00503243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65094615|NCT00503243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094616|NCT00503243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65094617|NCT00503243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65094618|NCT00498992|Vitamin E|vitamin e|mesh-list
65094619|NCT00498992|Lidocaine|lidocaine|mesh-list
65094620|NCT00498992|Vitamins|vitamins|mesh-ancestor
65094621|NCT00498992|Micronutrients|micronutrients|mesh-ancestor
65094622|NCT00498992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094623|NCT00498992|Anesthetics, Local|anesthetics, local|mesh-ancestor
65094624|NCT00498992|Anesthetics|anesthetics|mesh-ancestor
65094625|NCT00498992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65094626|NCT00498992|Sensory System Agents|sensory system agents|mesh-ancestor
65094627|NCT00498992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65094628|NCT00498992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65094629|NCT00498992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65094630|NCT00498992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64483516|NCT00780208|Dopamine Agents|dopamine agents|mesh-ancestor
65094631|NCT00498992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65094632|NCT00498992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094633|NCT00498992|Antioxidants|antioxidants|mesh-ancestor
65094634|NCT00498992|Protective Agents|protective agents|mesh-ancestor
65094635|NCT02276391|Telmisartan|telmisartan|mesh-list
65094636|NCT02276391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65094637|NCT02276391|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
65094638|NCT02276391|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
65094639|NCT02276391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094640|NCT05145270|Sulforaphane|sulforaphane|mesh-list
65094642|NCT05145270|Citalopram|citalopram|mesh-list
65094643|NCT05145270|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65094644|NCT05145270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65094645|NCT05145270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65094646|NCT05145270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094647|NCT05145270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65094649|NCT05145270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094650|NCT05145270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65094651|NCT05145270|Antidepressive Agents|antidepressive agents|mesh-ancestor
65094652|NCT05145270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65094653|NCT05145270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
65094654|NCT05145270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
65094655|NCT05145270|Parasympatholytics|parasympatholytics|mesh-ancestor
65094656|NCT05145270|Autonomic Agents|autonomic agents|mesh-ancestor
65094657|NCT05145270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65094658|NCT05145270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65094659|NCT05145270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65094660|NCT05145270|Cholinergic Agents|cholinergic agents|mesh-ancestor
65094661|NCT05145270|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
65094662|NCT05145270|Protective Agents|protective agents|mesh-ancestor
65094663|NCT05145270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094664|NCT01245179|Panobinostat|panobinostat|mesh-list
65094665|NCT01245179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094666|NCT01245179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65094667|NCT01245179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094668|NCT01245179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094670|NCT00503321|Tegafur|tegafur|mesh-list
65094671|NCT00503321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65094672|NCT00503321|Antimetabolites|antimetabolites|mesh-ancestor
65094673|NCT00503321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094674|NCT00503321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094675|NCT00503321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
65094676|NCT00503321|Immunologic Factors|immunologic factors|mesh-ancestor
65094677|NCT00503321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094678|NCT00503321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65094679|NCT00503321|Antiviral Agents|antiviral agents|mesh-ancestor
65094680|NCT00503321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65094681|NCT00503321|Interferon Inducers|interferon inducers|mesh-ancestor
65094682|NCT00503321|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65094683|NCT00503321|Protective Agents|protective agents|mesh-ancestor
65094684|NCT00503477|Cediranib|cediranib|mesh-list
65094685|NCT00503477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094686|NCT00503477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65094687|NCT00503477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094688|NCT00503477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094689|NCT05144295|Lactulose|lactulose|mesh-list
65094690|NCT05144295|Bisacodyl|bisacodyl|mesh-list
65094691|NCT05144295|Picosulfate sodium|picosulfate sodium|mesh-list
65094692|NCT05144295|Lubiprostone|lubiprostone|mesh-list
65094693|NCT05144295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65094694|NCT05144295|Cathartics|cathartics|mesh-ancestor
65094695|NCT05144295|Laxatives|laxatives|mesh-ancestor
65094696|NCT05144295|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
65094697|NCT05144295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65094698|NCT05144295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094699|NCT01245452|Methotrexate|methotrexate|mesh-list
65094700|NCT01245452|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65094701|NCT01245452|Abortifacient Agents|abortifacient agents|mesh-ancestor
65094702|NCT01245452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65094703|NCT01245452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64483523|NCT00243022|Vitamin B Complex|vitamin b complex|mesh-ancestor
65094704|NCT01245452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65094705|NCT01245452|Antimetabolites|antimetabolites|mesh-ancestor
65094706|NCT01245452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094707|NCT01245452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094708|NCT01245452|Dermatologic Agents|dermatologic agents|mesh-ancestor
65094709|NCT01245452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094710|NCT01245452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65094711|NCT01245452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65094712|NCT01245452|Immunologic Factors|immunologic factors|mesh-ancestor
65094713|NCT01245452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65094714|NCT01245452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64446898|NCT03870022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835786|NCT01599923|Immunologic Factors|immunologic factors|mesh-ancestor
64835787|NCT01599923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835788|NCT01599936|Antivenins|antivenins|mesh-list
64835789|NCT01599936|Immunologic Factors|immunologic factors|mesh-ancestor
64835790|NCT01599936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094715|NCT00503516|Megestrol|megestrol|mesh-list
65094716|NCT00503516|Megestrol Acetate|megestrol acetate|mesh-list
65094717|NCT00503516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
65094718|NCT00503516|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
65094719|NCT00503516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65094720|NCT00503516|Contraceptive Agents|contraceptive agents|mesh-ancestor
65094721|NCT00503516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65094722|NCT00503516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094723|NCT00503516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
65094724|NCT00503516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
65094725|NCT00503516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65094726|NCT00503516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094727|NCT00503516|Appetite Stimulants|appetite stimulants|mesh-ancestor
65094728|NCT00503516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65094729|NCT05148195|Leucovorin|leucovorin|mesh-list
65094730|NCT05148195|Docetaxel|docetaxel|mesh-list
65094731|NCT05148195|Irinotecan|irinotecan|mesh-list
65094732|NCT05148195|Calcium|calcium|mesh-list
65094733|NCT05148195|Levoleucovorin|levoleucovorin|mesh-list
65094734|NCT05148195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094735|NCT05148195|Tubulin Modulators|tubulin modulators|mesh-ancestor
65094736|NCT05148195|Antimitotic Agents|antimitotic agents|mesh-ancestor
65094737|NCT05148195|Mitosis Modulators|mitosis modulators|mesh-ancestor
65094738|NCT05148195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417080|NCT04367935|Pentoxifylline|pentoxifylline|mesh-list
65094740|NCT05148195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094741|NCT05148195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65094742|NCT05148195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65094743|NCT05148195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094744|NCT05148195|Antidotes|antidotes|mesh-ancestor
65094745|NCT05148195|Protective Agents|protective agents|mesh-ancestor
65094746|NCT05148195|Vitamin B Complex|vitamin b complex|mesh-ancestor
65094747|NCT05148195|Vitamins|vitamins|mesh-ancestor
65094748|NCT05148195|Micronutrients|micronutrients|mesh-ancestor
65094749|NCT00499265|Gemcitabine|gemcitabine|mesh-list
65094750|NCT00499265|Protease Inhibitors|protease inhibitors|mesh-list
65094751|NCT00499265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-list
65094752|NCT00499265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65094753|NCT00499265|Antimetabolites|antimetabolites|mesh-ancestor
65094754|NCT00499265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094755|NCT00499265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094756|NCT00499265|Antiviral Agents|antiviral agents|mesh-ancestor
65094757|NCT00499265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65094758|NCT00499265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094759|NCT00499265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65094760|NCT00499265|Immunologic Factors|immunologic factors|mesh-ancestor
65094761|NCT00499265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094762|NCT01246622|Cytarabine|cytarabine|mesh-list
65094763|NCT01246622|Lenalidomide|lenalidomide|mesh-list
65094764|NCT01246622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65094765|NCT01246622|Antimetabolites|antimetabolites|mesh-ancestor
65094766|NCT01246622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094767|NCT01246622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094768|NCT01246622|Antiviral Agents|antiviral agents|mesh-ancestor
65094769|NCT01246622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65094770|NCT01246622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65094771|NCT01246622|Immunologic Factors|immunologic factors|mesh-ancestor
65094772|NCT01246622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094773|NCT01246622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65094774|NCT01246622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65094775|NCT01246622|Growth Substances|growth substances|mesh-ancestor
65094776|NCT01246622|Growth Inhibitors|growth inhibitors|mesh-ancestor
65094777|NCT01245530|Donepezil|donepezil|mesh-list
65094778|NCT01245530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
65094779|NCT01245530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094780|NCT01245530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094781|NCT01245530|Cholinergic Agents|cholinergic agents|mesh-ancestor
65094782|NCT01245530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65094783|NCT01245530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094784|NCT01245530|Nootropic Agents|nootropic agents|mesh-ancestor
65094785|NCT05148312|Budesonide|budesonide|mesh-list
65094786|NCT05148312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65094787|NCT05148312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65094788|NCT05148312|Autonomic Agents|autonomic agents|mesh-ancestor
65094789|NCT05148312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65094790|NCT05148312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094791|NCT05148312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65094792|NCT05148312|Respiratory System Agents|respiratory system agents|mesh-ancestor
65094793|NCT05148312|Glucocorticoids|glucocorticoids|mesh-ancestor
65094794|NCT05148312|Hormones|hormones|mesh-ancestor
65094795|NCT05148312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65094796|NCT01246817|Sirolimus|sirolimus|mesh-list
65094797|NCT01246817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65094798|NCT01246817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65094799|NCT01246817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65094800|NCT01246817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094801|NCT01246817|Antifungal Agents|antifungal agents|mesh-ancestor
65094802|NCT01246817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65094803|NCT01246817|Immunologic Factors|immunologic factors|mesh-ancestor
65094804|NCT01246817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094805|NCT01245803|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
65094806|NCT01245803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
65094807|NCT01245803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
65094808|NCT01245803|Antimetabolites|antimetabolites|mesh-ancestor
65094809|NCT01245803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094810|NCT01245803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
65094811|NCT01245803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
65094812|NCT01245803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094813|NCT05148975|Dimercaprol|dimercaprol|mesh-list
65094814|NCT05148975|Chelating Agents|chelating agents|mesh-ancestor
65094815|NCT05148975|Sequestering Agents|sequestering agents|mesh-ancestor
65094816|NCT05148975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094817|NCT00499577|Vaccines|vaccines|mesh-list
65094818|NCT00499577|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
65094819|NCT00499577|Immunologic Factors|immunologic factors|mesh-ancestor
65094820|NCT00499577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094821|NCT02274740|Metformin|metformin|mesh-list
65094822|NCT02274740|Lixisenatide|lixisenatide|mesh-list
65094823|NCT02274740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65094824|NCT02274740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094825|NCT00499733|Cyclophosphamide|cyclophosphamide|mesh-list
65094826|NCT00499733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65094827|NCT00499733|Immunologic Factors|immunologic factors|mesh-ancestor
65094828|NCT00499733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094829|NCT00499733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65094830|NCT00499733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64325617|NCT01140217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64325618|NCT01140217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325619|NCT01140217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64595252|NCT01886937|Sympathomimetics|sympathomimetics|mesh-ancestor
64595253|NCT01886937|Autonomic Agents|autonomic agents|mesh-ancestor
64595254|NCT01886937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595255|NCT01886937|Adrenergic Agents|adrenergic agents|mesh-ancestor
65094831|NCT00499733|Alkylating Agents|alkylating agents|mesh-ancestor
65094832|NCT00499733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094833|NCT00499733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094834|NCT00499733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
65094835|NCT00503594|Cytarabine|cytarabine|mesh-list
65094836|NCT00503594|Methotrexate|methotrexate|mesh-list
65094837|NCT00503594|Vincristine|vincristine|mesh-list
65094838|NCT00503594|Temozolomide|temozolomide|mesh-list
65094839|NCT00503594|Procarbazine|procarbazine|mesh-list
65094840|NCT00503594|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
65094841|NCT00503594|Abortifacient Agents|abortifacient agents|mesh-ancestor
65094842|NCT00503594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65094843|NCT00503594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094844|NCT00503594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65094845|NCT00503594|Antimetabolites|antimetabolites|mesh-ancestor
65094846|NCT00503594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094847|NCT00503594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094848|NCT00503594|Dermatologic Agents|dermatologic agents|mesh-ancestor
65094849|NCT00503594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094850|NCT00503594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65094851|NCT00503594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65094852|NCT00503594|Immunologic Factors|immunologic factors|mesh-ancestor
65094853|NCT00503594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65094854|NCT00503594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65094855|NCT00503594|Antiviral Agents|antiviral agents|mesh-ancestor
65094856|NCT00503594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65094857|NCT00503594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65094858|NCT00503594|Tubulin Modulators|tubulin modulators|mesh-ancestor
65094859|NCT00503594|Antimitotic Agents|antimitotic agents|mesh-ancestor
65094860|NCT00503594|Mitosis Modulators|mitosis modulators|mesh-ancestor
65094861|NCT00503594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
65094862|NCT00503594|Alkylating Agents|alkylating agents|mesh-ancestor
65094863|NCT00499811|Vorinostat|vorinostat|mesh-list
65094864|NCT00499811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094865|NCT00499811|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
65094866|NCT00499811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094867|NCT00499811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094868|NCT00499850|Leucovorin|leucovorin|mesh-list
65094869|NCT00499850|Fluorouracil|fluorouracil|mesh-list
65094870|NCT00499850|Oxaliplatin|oxaliplatin|mesh-list
65094871|NCT00499850|Antimetabolites|antimetabolites|mesh-ancestor
65094872|NCT00499850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094873|NCT00499850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65094874|NCT00499850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094875|NCT00499850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65094876|NCT00499850|Immunologic Factors|immunologic factors|mesh-ancestor
65094877|NCT00499850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094878|NCT00499850|Antidotes|antidotes|mesh-ancestor
65094879|NCT00499850|Protective Agents|protective agents|mesh-ancestor
65094880|NCT00499850|Vitamin B Complex|vitamin b complex|mesh-ancestor
65094881|NCT00499850|Vitamins|vitamins|mesh-ancestor
65094882|NCT00499850|Micronutrients|micronutrients|mesh-ancestor
65094883|NCT05146713|Propolis|propolis|mesh-list
65094884|NCT05146713|Sodium Hypochlorite|sodium hypochlorite|mesh-list
65094885|NCT05146713|Eusol|eusol|mesh-list
65094886|NCT05146713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65094888|NCT00503828|Naproxen|naproxen|mesh-list
65094889|NCT00503828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65094890|NCT00503828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65094891|NCT00503828|Analgesics|analgesics|mesh-ancestor
65094892|NCT00503828|Sensory System Agents|sensory system agents|mesh-ancestor
65094893|NCT00503828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65094894|NCT00503828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094895|NCT00503828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65094896|NCT00503828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65094897|NCT00503828|Gout Suppressants|gout suppressants|mesh-ancestor
65094898|NCT00503828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65094899|NCT00503828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094900|NCT00503828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094901|NCT00500006|Dasatinib|dasatinib|mesh-list
65094902|NCT00500006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094903|NCT00500006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65094904|NCT00500006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094905|NCT00500006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094906|NCT00500123|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
65094907|NCT00500123|Protein C Inhibitor|protein c inhibitor|mesh-list
65094908|NCT00500123|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
65094909|NCT00500123|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
65094910|NCT00500123|Protease Inhibitors|protease inhibitors|mesh-ancestor
65094911|NCT00500123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094912|NCT00500123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094913|NCT00506727|Amphetamine|amphetamine|mesh-list
65094914|NCT00506727|Adderall|adderall|mesh-list
65094915|NCT00506727|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
65094916|NCT00506727|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
65094917|NCT00506727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65094918|NCT00506727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65094919|NCT00506727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094920|NCT00506727|Adrenergic Agents|adrenergic agents|mesh-ancestor
65094921|NCT00506727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65094922|NCT00506727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094923|NCT00506727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65094924|NCT00506727|Sympathomimetics|sympathomimetics|mesh-ancestor
65094925|NCT00506727|Autonomic Agents|autonomic agents|mesh-ancestor
65094926|NCT00506727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65094927|NCT00506727|Dopamine Agents|dopamine agents|mesh-ancestor
65094928|NCT00506727|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
65094929|NCT03455517|Rituximab|rituximab|mesh-list
65094930|NCT03455517|Venetoclax|venetoclax|mesh-list
65094931|NCT03455517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65094932|NCT03455517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094933|NCT03455517|Immunologic Factors|immunologic factors|mesh-ancestor
65094934|NCT03455517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094935|NCT03455517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65094936|NCT04696536|Listerine|listerine|mesh-list
65094937|NCT04696536|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65094938|NCT04696536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65094939|NCT00500279|Celecoxib|celecoxib|mesh-list
65094940|NCT00500279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65094941|NCT00500279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65094942|NCT00500279|Analgesics|analgesics|mesh-ancestor
65094943|NCT00500279|Sensory System Agents|sensory system agents|mesh-ancestor
65094944|NCT00500279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65094945|NCT00500279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094946|NCT00500279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65094947|NCT00500279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65094948|NCT00500279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65094949|NCT00500279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65094950|NCT00500279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65094951|NCT00500279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094952|NCT01245881|Sunscreening Agents|sunscreening agents|mesh-list
65094953|NCT01245881|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65094954|NCT01245881|Protective Agents|protective agents|mesh-ancestor
65094955|NCT01245881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094956|NCT01245881|Dermatologic Agents|dermatologic agents|mesh-ancestor
64417106|NCT04829695|Artesunate|artesunate|mesh-list
65094957|NCT03458247|Abiraterone Acetate|abiraterone acetate|mesh-list
65094958|NCT03458247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094959|NCT03458247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65094960|NCT03458247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835794|NCT01599962|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64835795|NCT01599962|Hormone Antagonists|hormone antagonists|mesh-ancestor
64835796|NCT01599962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64835797|NCT01599975|Methylphenidate|methylphenidate|mesh-list
65094961|NCT03458247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094962|NCT03458247|Hormone Antagonists|hormone antagonists|mesh-ancestor
65094963|NCT03458247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65094964|NCT03458247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094965|NCT03458247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
65094966|NCT01247558|Vitamin B 12|vitamin b 12|mesh-list
65094967|NCT01247558|Vitamin B Complex|vitamin b complex|mesh-ancestor
65094968|NCT01247558|Vitamins|vitamins|mesh-ancestor
65094969|NCT01247558|Micronutrients|micronutrients|mesh-ancestor
65094970|NCT01247558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094971|NCT00500552|Perhexiline|perhexiline|mesh-list
65094972|NCT00500552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65094973|NCT00500552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65094974|NCT00500552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094975|NCT00500552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65094976|NCT00500552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094977|NCT00500552|Vasodilator Agents|vasodilator agents|mesh-ancestor
65094978|NCT00508209|Bortezomib|bortezomib|mesh-list
65094979|NCT00508209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094980|NCT00500669|Povidone-Iodine|povidone-iodine|mesh-list
65094981|NCT00500669|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
65094982|NCT00500669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65094983|NCT00507585|Leucovorin|leucovorin|mesh-list
65094984|NCT00507585|Bevacizumab|bevacizumab|mesh-list
65094985|NCT00507585|Fluorouracil|fluorouracil|mesh-list
65094986|NCT00507585|Oxaliplatin|oxaliplatin|mesh-list
65094987|NCT00507585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65094988|NCT00507585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65094989|NCT00507585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
65094990|NCT00507585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
65094991|NCT00507585|Growth Substances|growth substances|mesh-ancestor
65094992|NCT00507585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65094993|NCT00507585|Growth Inhibitors|growth inhibitors|mesh-ancestor
65094994|NCT00507585|Antimetabolites|antimetabolites|mesh-ancestor
65094995|NCT00507585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65094996|NCT00507585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65094997|NCT00507585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65094998|NCT00507585|Immunologic Factors|immunologic factors|mesh-ancestor
65095000|NCT00507585|Protective Agents|protective agents|mesh-ancestor
65095001|NCT00507585|Vitamin B Complex|vitamin b complex|mesh-ancestor
65095002|NCT00507585|Vitamins|vitamins|mesh-ancestor
65095003|NCT00507585|Micronutrients|micronutrients|mesh-ancestor
65095004|NCT01247714|Phentermine|phentermine|mesh-list
65095005|NCT01247714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
65095006|NCT01247714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095007|NCT01247714|Appetite Depressants|appetite depressants|mesh-ancestor
65095008|NCT01247714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65095009|NCT01247714|Sympathomimetics|sympathomimetics|mesh-ancestor
65095010|NCT01247714|Autonomic Agents|autonomic agents|mesh-ancestor
65095011|NCT01247714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095012|NCT01247714|Adrenergic Agents|adrenergic agents|mesh-ancestor
65095013|NCT01247714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65095014|NCT01247714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095015|NCT00507663|Atenolol|atenolol|mesh-list
65095016|NCT00507663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65095017|NCT00507663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65095018|NCT00507663|Sympatholytics|sympatholytics|mesh-ancestor
65095019|NCT00507663|Autonomic Agents|autonomic agents|mesh-ancestor
65095020|NCT00507663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095021|NCT00507663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095022|NCT00507663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64737211|NCT00000875|Analgesics|analgesics|mesh-ancestor
65095023|NCT00507663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65095024|NCT00507663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65095025|NCT00507663|Adrenergic Agents|adrenergic agents|mesh-ancestor
64835798|NCT01599975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64835799|NCT01599975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835800|NCT01599975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64446906|NCT02073448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65095026|NCT00507663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65095027|NCT00507663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095028|NCT00508287|Exenatide|exenatide|mesh-list
65095029|NCT00508287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65095030|NCT00508287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095031|NCT00508287|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
65095032|NCT00508287|Incretins|incretins|mesh-ancestor
65095033|NCT00508287|Hormones|hormones|mesh-ancestor
65095034|NCT00508287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65095035|NCT00508326|Paclitaxel|paclitaxel|mesh-list
65095036|NCT00508326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
65095037|NCT00508326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095038|NCT00508326|Tubulin Modulators|tubulin modulators|mesh-ancestor
65095039|NCT00508326|Antimitotic Agents|antimitotic agents|mesh-ancestor
65095040|NCT00508326|Mitosis Modulators|mitosis modulators|mesh-ancestor
65095041|NCT00508326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095042|NCT00507858|Dexamethasone|dexamethasone|mesh-list
65095043|NCT00507858|Pemetrexed|pemetrexed|mesh-list
65095044|NCT00507858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65095045|NCT00507858|Antiemetics|antiemetics|mesh-ancestor
65095046|NCT00507858|Autonomic Agents|autonomic agents|mesh-ancestor
65095047|NCT00507858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095048|NCT00507858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095049|NCT00507858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65095050|NCT00507858|Glucocorticoids|glucocorticoids|mesh-ancestor
65095051|NCT00507858|Hormones|hormones|mesh-ancestor
65095052|NCT00507858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65095053|NCT00507858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65095054|NCT00507858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095055|NCT00507858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095056|NCT00507858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095057|NCT00507858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
65095058|NCT00507858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
65095059|NCT00508365|Carvedilol|carvedilol|mesh-list
65095060|NCT00508365|Lisinopril|lisinopril|mesh-list
65095061|NCT00508365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65095062|NCT00508365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65095063|NCT00508365|Adrenergic Agents|adrenergic agents|mesh-ancestor
65095064|NCT00508365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65095065|NCT00508365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095066|NCT00508365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095067|NCT00508365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65095068|NCT00508365|Antioxidants|antioxidants|mesh-ancestor
65095069|NCT00508365|Protective Agents|protective agents|mesh-ancestor
65095070|NCT00508365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65095071|NCT00508365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65095072|NCT00508365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65095073|NCT00508365|Vasodilator Agents|vasodilator agents|mesh-ancestor
65095074|NCT00508365|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
65095075|NCT00508365|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
65095076|NCT00508365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
65095077|NCT00508365|Protease Inhibitors|protease inhibitors|mesh-ancestor
65095078|NCT00508365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095079|NCT00508365|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65095080|NCT00500864|Magnesium Sulfate|magnesium sulfate|mesh-list
65095081|NCT00500864|Analgesics|analgesics|mesh-ancestor
65095082|NCT00500864|Sensory System Agents|sensory system agents|mesh-ancestor
64595507|NCT00727597|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
65095083|NCT00500864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095084|NCT00500864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095085|NCT00500864|Anesthetics|anesthetics|mesh-ancestor
65095086|NCT00500864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65095087|NCT00500864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65095088|NCT00500864|Anticonvulsants|anticonvulsants|mesh-ancestor
65095089|NCT00500864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
65095090|NCT00500864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65095091|NCT00500864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095092|NCT00500864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65095093|NCT00500864|Tocolytic Agents|tocolytic agents|mesh-ancestor
65095094|NCT00500864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65095095|NCT00507975|Nicotine|nicotine|mesh-list
65095096|NCT00507975|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
65095097|NCT00507975|Autonomic Agents|autonomic agents|mesh-ancestor
65095098|NCT00507975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095099|NCT00507975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095100|NCT00507975|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
65095101|NCT00507975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
65095102|NCT00507975|Cholinergic Agents|cholinergic agents|mesh-ancestor
65095103|NCT00507975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65095104|NCT00507975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095105|NCT01247909|Gentamicins|gentamicins|mesh-list
65095106|NCT01247909|Ceftriaxone|ceftriaxone|mesh-list
65095107|NCT01247909|Penicillins|penicillins|mesh-list
65095108|NCT01247909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65095109|NCT01247909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65095110|NCT01247909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
65095111|NCT01247909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095112|NCT01247909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095113|NCT01245998|Dalteparin|dalteparin|mesh-list
65095114|NCT01245998|Tinzaparin|tinzaparin|mesh-list
65095115|NCT01245998|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
65095116|NCT01245998|Anticoagulants|anticoagulants|mesh-ancestor
65095117|NCT01245998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65095118|NCT01245998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65095119|NCT01245998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095120|NCT02954484|Acetaminophen|acetaminophen|mesh-list
65095121|NCT02954484|Etoricoxib|etoricoxib|mesh-list
65095122|NCT02954484|Pregabalin|pregabalin|mesh-list
65095123|NCT02954484|Morphine|morphine|mesh-list
65095124|NCT02954484|Ropivacaine|ropivacaine|mesh-list
65095125|NCT02954484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65095126|NCT02954484|Narcotics|narcotics|mesh-ancestor
65095127|NCT02954484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65095128|NCT02954484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095129|NCT02954484|Analgesics|analgesics|mesh-ancestor
65095130|NCT02954484|Sensory System Agents|sensory system agents|mesh-ancestor
65095131|NCT02954484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095132|NCT02954484|Anesthetics, Local|anesthetics, local|mesh-ancestor
65095133|NCT02954484|Anesthetics|anesthetics|mesh-ancestor
65095134|NCT02954484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65095135|NCT02954484|Antipyretics|antipyretics|mesh-ancestor
65095136|NCT02954484|Anticonvulsants|anticonvulsants|mesh-ancestor
65095137|NCT02954484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64483538|NCT00780442|Renal Agents|renal agents|mesh-ancestor
65095138|NCT02954484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64595570|NCT00571961|Protease Inhibitors|protease inhibitors|mesh-ancestor
65095139|NCT02954484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095140|NCT02954484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65095141|NCT02954484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
65095142|NCT02954484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
65095143|NCT02954484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65095144|NCT02954484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65095145|NCT02954484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65095146|NCT02954484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65095147|NCT02954484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
65095148|NCT02954484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65095149|NCT02954484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095150|NCT00501020|Rosiglitazone|rosiglitazone|mesh-list
65095151|NCT00501020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65095152|NCT00501020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095153|NCT00501098|Caspofungin|caspofungin|mesh-list
65095154|NCT00501098|Antifungal Agents|antifungal agents|mesh-ancestor
65095155|NCT00501098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65095156|NCT00501098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095157|NCT00501098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095158|NCT00508092|Anesthetics|anesthetics|mesh-list
65095159|NCT00508092|Anesthetics, Local|anesthetics, local|mesh-list
65095160|NCT00508092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65095161|NCT00508092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095162|NCT00508092|Sensory System Agents|sensory system agents|mesh-ancestor
65095163|NCT00508092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095164|NCT00501137|Vaccines|vaccines|mesh-list
65095165|NCT00501137|Immunologic Factors|immunologic factors|mesh-ancestor
65095166|NCT00501137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095167|NCT01248260|Folic Acid|folic acid|mesh-list
65095168|NCT01248260|Hematinics|hematinics|mesh-ancestor
65095169|NCT01248260|Vitamin B Complex|vitamin b complex|mesh-ancestor
65095170|NCT01248260|Vitamins|vitamins|mesh-ancestor
65095171|NCT01248260|Micronutrients|micronutrients|mesh-ancestor
65095172|NCT01248260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095173|NCT01246037|Bisoprolol|bisoprolol|mesh-list
64737367|NCT00000929|Nonoxynol|nonoxynol|mesh-list
65095174|NCT01246037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65095175|NCT01246037|Sympatholytics|sympatholytics|mesh-ancestor
65095176|NCT01246037|Autonomic Agents|autonomic agents|mesh-ancestor
65095177|NCT01246037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095178|NCT01246037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095179|NCT01246037|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65095180|NCT01246037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65095181|NCT01246037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65095182|NCT01246037|Adrenergic Agents|adrenergic agents|mesh-ancestor
65095183|NCT01246037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65095184|NCT01246037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095185|NCT00501215|Parathyroid Hormone|parathyroid hormone|mesh-list
65095186|NCT00501215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
65095187|NCT00501215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095188|NCT00509184|Rituximab|rituximab|mesh-list
65095189|NCT00509184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65095190|NCT00509184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095191|NCT00509184|Immunologic Factors|immunologic factors|mesh-ancestor
65095192|NCT00509184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095193|NCT00509184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65095194|NCT00501254|Aspirin|aspirin|mesh-list
65095195|NCT00501254|Salicylic Acid|salicylic acid|mesh-list
65095196|NCT00501254|Salicylates|salicylates|mesh-list
65095197|NCT00501254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65095198|NCT00501254|Antifungal Agents|antifungal agents|mesh-ancestor
64325621|NCT05676645|Lumefantrine|lumefantrine|mesh-list
64325622|NCT05676645|Artemether|artemether|mesh-list
64325623|NCT05676645|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64325624|NCT05676645|Antimalarials|antimalarials|mesh-ancestor
64325625|NCT05676645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64325626|NCT05676645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64325627|NCT05676645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595633|NCT04386499|Folic Acid|folic acid|mesh-list
65095199|NCT00501254|Keratolytic Agents|keratolytic agents|mesh-ancestor
65095200|NCT00501254|Dermatologic Agents|dermatologic agents|mesh-ancestor
65095201|NCT00501254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65095202|NCT00501254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65095203|NCT00501254|Analgesics|analgesics|mesh-ancestor
65095204|NCT00501254|Sensory System Agents|sensory system agents|mesh-ancestor
65095205|NCT00501254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095206|NCT00501254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095207|NCT00501254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65095208|NCT00501254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65095209|NCT00501254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
65095210|NCT00501254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095211|NCT00501254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095212|NCT00501254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
65095213|NCT00501254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
65095214|NCT00501254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65095215|NCT00501254|Antipyretics|antipyretics|mesh-ancestor
65095216|NCT01248338|Metoprolol|metoprolol|mesh-list
65095217|NCT01248338|Nebivolol|nebivolol|mesh-list
65095218|NCT01248338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65095219|NCT01248338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
65095220|NCT01248338|Sympatholytics|sympatholytics|mesh-ancestor
65095221|NCT01248338|Autonomic Agents|autonomic agents|mesh-ancestor
65095222|NCT01248338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095223|NCT01248338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095224|NCT01248338|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
65095225|NCT01248338|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
65095226|NCT01248338|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
65095227|NCT01248338|Adrenergic Agents|adrenergic agents|mesh-ancestor
65095228|NCT01248338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65095229|NCT01248338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095230|NCT01248338|Vasodilator Agents|vasodilator agents|mesh-ancestor
65095231|NCT01248338|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
65095232|NCT01248338|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65095233|NCT01248338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65095234|NCT02953743|Lenvatinib|lenvatinib|mesh-list
65095235|NCT02953743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095236|NCT02953743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65095237|NCT02953743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095238|NCT02953743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095239|NCT00509379|Rituximab|rituximab|mesh-list
65095240|NCT00509379|Bortezomib|bortezomib|mesh-list
65095241|NCT00509379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65095242|NCT00509379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095243|NCT00509379|Immunologic Factors|immunologic factors|mesh-ancestor
65095244|NCT00509379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095245|NCT00509379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65095246|NCT02274974|Lidocaine|lidocaine|mesh-list
65095247|NCT02274974|Epinephrine|epinephrine|mesh-list
65095248|NCT02274974|Anesthetics, Local|anesthetics, local|mesh-list
65095249|NCT02274974|Anesthetics|anesthetics|mesh-list
65095250|NCT02274974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65095251|NCT02274974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095252|NCT02274974|Sensory System Agents|sensory system agents|mesh-ancestor
65095253|NCT02274974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095254|NCT02274974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65095255|NCT02274974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65095256|NCT02274974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65095257|NCT02274974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65095258|NCT02274974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095259|NCT02274974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64835804|NCT01599975|Dopamine Agents|dopamine agents|mesh-ancestor
65095260|NCT02274974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65095261|NCT02274974|Adrenergic Agents|adrenergic agents|mesh-ancestor
65095262|NCT02274974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65095263|NCT02274974|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
65095264|NCT02274974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
65095265|NCT02274974|Autonomic Agents|autonomic agents|mesh-ancestor
65095266|NCT02274974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
65095267|NCT02274974|Respiratory System Agents|respiratory system agents|mesh-ancestor
65095268|NCT02274974|Mydriatics|mydriatics|mesh-ancestor
65095269|NCT02274974|Sympathomimetics|sympathomimetics|mesh-ancestor
65095270|NCT02274974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65095271|NCT02274545|Vaccines|vaccines|mesh-list
65095272|NCT02274545|Immunologic Factors|immunologic factors|mesh-ancestor
65095273|NCT02274545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095274|NCT02275013|Simendan|simendan|mesh-list
65095275|NCT02275013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65095276|NCT02275013|Vasodilator Agents|vasodilator agents|mesh-ancestor
65095277|NCT02275013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
65095278|NCT02275013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65095279|NCT02275013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095280|NCT02275013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095281|NCT02275013|Protective Agents|protective agents|mesh-ancestor
65095282|NCT02275013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095283|NCT02274623|Calcifediol|calcifediol|mesh-list
65095284|NCT02274623|Vitamins|vitamins|mesh-ancestor
65095285|NCT02274623|Micronutrients|micronutrients|mesh-ancestor
65095286|NCT02274623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095287|NCT02274623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
65095288|NCT00509613|Sirolimus|sirolimus|mesh-list
65095289|NCT00509613|Sorafenib|sorafenib|mesh-list
65095290|NCT00509613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095291|NCT00509613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65095292|NCT00509613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095293|NCT00509613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095294|NCT00509613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
65095295|NCT00509613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65095296|NCT00509613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
65095297|NCT00509613|Antifungal Agents|antifungal agents|mesh-ancestor
65095298|NCT00509613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65095299|NCT00509613|Immunologic Factors|immunologic factors|mesh-ancestor
65095300|NCT00509613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095301|NCT00501410|Leucovorin|leucovorin|mesh-list
65095302|NCT00501410|Fluorouracil|fluorouracil|mesh-list
64835815|NCT01600430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835816|NCT01600430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64835817|NCT01600430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64835818|NCT01600599|Tranexamic Acid|tranexamic acid|mesh-list
64835819|NCT01600599|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64835820|NCT01600599|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64835821|NCT01600599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835822|NCT01600599|Hemostatics|hemostatics|mesh-ancestor
64835823|NCT01600599|Coagulants|coagulants|mesh-ancestor
64835824|NCT01601028|Hydroxychloroquine|hydroxychloroquine|mesh-list
64595750|NCT05740215|Lenvatinib|lenvatinib|mesh-list
64595755|NCT01277731|Methylprednisolone|methylprednisolone|mesh-list
65095303|NCT00501410|Oxaliplatin|oxaliplatin|mesh-list
65095304|NCT00501410|Cetuximab|cetuximab|mesh-list
65095305|NCT00501410|Dasatinib|dasatinib|mesh-list
65095306|NCT00501410|Antimetabolites|antimetabolites|mesh-ancestor
65095307|NCT00501410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095308|NCT00501410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
65095309|NCT00501410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095310|NCT00501410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65095311|NCT00501410|Immunologic Factors|immunologic factors|mesh-ancestor
64417136|NCT01667731|Sofosbuvir|sofosbuvir|mesh-list
65095312|NCT00501410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095313|NCT00501410|Antidotes|antidotes|mesh-ancestor
65095314|NCT00501410|Protective Agents|protective agents|mesh-ancestor
65095315|NCT00501410|Vitamin B Complex|vitamin b complex|mesh-ancestor
65095316|NCT00501410|Vitamins|vitamins|mesh-ancestor
65095317|NCT00501410|Micronutrients|micronutrients|mesh-ancestor
65095318|NCT00501410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
65095319|NCT00501410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65095320|NCT00501410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095321|NCT02953275|Pentoxifylline|pentoxifylline|mesh-list
65095322|NCT02953275|Vedolizumab|vedolizumab|mesh-list
65095323|NCT02953275|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
65095324|NCT02953275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095325|NCT02953275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095326|NCT02953275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
65095327|NCT02953275|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
65095328|NCT02953275|Protective Agents|protective agents|mesh-ancestor
65095329|NCT02953275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095330|NCT02953275|Vasodilator Agents|vasodilator agents|mesh-ancestor
65095331|NCT02953275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
65095332|NCT02953275|Antioxidants|antioxidants|mesh-ancestor
65095333|NCT02953275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65095334|NCT00501488|Rosiglitazone|rosiglitazone|mesh-list
65095335|NCT00501488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65095336|NCT00501488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095337|NCT00508911|Contraceptive Agents|contraceptive agents|mesh-list
65095338|NCT00508911|Contraceptives, Oral|contraceptives, oral|mesh-list
65095339|NCT00508911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65095340|NCT00508911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095341|NCT00508911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
65095342|NCT02955719|Sertraline|sertraline|mesh-list
65095343|NCT02955719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
65095344|NCT02955719|Antidepressive Agents|antidepressive agents|mesh-ancestor
65095345|NCT02955719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
65095346|NCT02955719|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
65095347|NCT02955719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
65095348|NCT02955719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65095349|NCT02955719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095350|NCT02955719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65095351|NCT02955719|Serotonin Agents|serotonin agents|mesh-ancestor
65095352|NCT02955719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095353|NCT02955719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
65095354|NCT02955719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
65095355|NCT02955524|Lidocaine|lidocaine|mesh-list
65095356|NCT02955524|Tetracaine|tetracaine|mesh-list
65095357|NCT02955524|Anesthetics, Local|anesthetics, local|mesh-ancestor
65095358|NCT02955524|Anesthetics|anesthetics|mesh-ancestor
65095359|NCT02955524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65095360|NCT02955524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095361|NCT02955524|Sensory System Agents|sensory system agents|mesh-ancestor
65095362|NCT02955524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095363|NCT02955524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
65095364|NCT02955524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
65095365|NCT02955524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
65095366|NCT02955524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
65095367|NCT02955524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095368|NCT02953041|Glycopyrrolate|glycopyrrolate|mesh-list
65095369|NCT02953041|Bromides|bromides|mesh-list
64430002|NCT05055323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64835826|NCT01601028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64835827|NCT01601028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
65095370|NCT02953041|Anticonvulsants|anticonvulsants|mesh-ancestor
65095371|NCT02953041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65095372|NCT02953041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
65095373|NCT02953041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
65095374|NCT02953041|Cholinergic Agents|cholinergic agents|mesh-ancestor
65095375|NCT02953041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65095376|NCT02953041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095377|NCT02953041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095378|NCT00501566|Satavaptan|satavaptan|mesh-list
65095379|NCT00501566|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65095380|NCT00501566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095381|NCT00501566|Natriuretic Agents|natriuretic agents|mesh-ancestor
65095382|NCT00501566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095383|NCT00501605|Cediranib|cediranib|mesh-list
65095384|NCT00501605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095385|NCT00501605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
65095386|NCT00501605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095387|NCT00501605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095388|NCT00509847|Lactoferrin|lactoferrin|mesh-list
65095389|NCT00509847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65095390|NCT01248494|Letrozole|letrozole|mesh-list
65095391|NCT01248494|Dactolisib|dactolisib|mesh-list
65095392|NCT01248494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095393|NCT01248494|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
65095394|NCT01248494|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
65095395|NCT01248494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095396|NCT01248494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095397|NCT01248494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65095398|NCT01248494|Hormone Antagonists|hormone antagonists|mesh-ancestor
65095399|NCT01248494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65095400|NCT01248494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095401|NCT02952573|Dexamethasone|dexamethasone|mesh-list
65095402|NCT02952573|Dexamethasone acetate|dexamethasone acetate|mesh-list
65095403|NCT02952573|BB 1101|bb 1101|mesh-list
65095404|NCT02952573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65095405|NCT02952573|Antiemetics|antiemetics|mesh-ancestor
65095406|NCT02952573|Autonomic Agents|autonomic agents|mesh-ancestor
65095407|NCT02952573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095408|NCT02952573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095409|NCT02952573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
65095410|NCT02952573|Glucocorticoids|glucocorticoids|mesh-ancestor
65095411|NCT02952573|Hormones|hormones|mesh-ancestor
65095412|NCT02952573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65095413|NCT02952573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
65095414|NCT02952573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095415|NCT02952573|Protease Inhibitors|protease inhibitors|mesh-ancestor
65095416|NCT02952573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095417|NCT02952573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095418|NCT00501722|Satavaptan|satavaptan|mesh-list
65095419|NCT00501722|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
65095420|NCT00501722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095421|NCT00501722|Natriuretic Agents|natriuretic agents|mesh-ancestor
65095422|NCT00501722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095423|NCT01248611|Fentanyl|fentanyl|mesh-list
65095424|NCT01248611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
65095425|NCT01248611|Narcotics|narcotics|mesh-ancestor
65095426|NCT01248611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
65095427|NCT01248611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095428|NCT01248611|Analgesics|analgesics|mesh-ancestor
65095429|NCT01248611|Sensory System Agents|sensory system agents|mesh-ancestor
65095430|NCT01248611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095431|NCT01248611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
65095432|NCT01248611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
65095433|NCT01248611|Anesthetics, General|anesthetics, general|mesh-ancestor
65095435|NCT00509964|Irinotecan|irinotecan|mesh-list
65095436|NCT00509964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65095437|NCT00509964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65095438|NCT00509964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095439|NCT00509964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835829|NCT01601028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095440|NCT00509964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095441|NCT00510471|Immunoglobulins|immunoglobulins|mesh-list
64417142|NCT04828525|Autonomic Agents|autonomic agents|mesh-ancestor
64417171|NCT04360135|Antipyretics|antipyretics|mesh-ancestor
65095442|NCT00510471|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
65095443|NCT00510471|Antibodies|antibodies|mesh-list
65095444|NCT00510471|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
65095445|NCT00510471|Immunologic Factors|immunologic factors|mesh-ancestor
65095446|NCT00510471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095447|NCT00501839|Clomiphene|clomiphene|mesh-list
65095448|NCT00501839|Enclomiphene|enclomiphene|mesh-list
65095449|NCT00501839|Zuclomiphene|zuclomiphene|mesh-list
65095450|NCT00501839|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
65095451|NCT00501839|Hormone Antagonists|hormone antagonists|mesh-ancestor
65095452|NCT00501839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
65095453|NCT00501839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095454|NCT00501839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
65095455|NCT00501839|Fertility Agents|fertility agents|mesh-ancestor
65095456|NCT00501839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
65095457|NCT00501839|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
65095458|NCT00501839|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
65095459|NCT00510003|Pimecrolimus|pimecrolimus|mesh-list
65095460|NCT00510003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
65095461|NCT00510003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
65095462|NCT00510003|Analgesics|analgesics|mesh-ancestor
65095463|NCT00510003|Sensory System Agents|sensory system agents|mesh-ancestor
65095464|NCT00510003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095465|NCT00510003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095466|NCT00510003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
65095467|NCT00510003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
65095468|NCT00510003|Dermatologic Agents|dermatologic agents|mesh-ancestor
65095469|NCT00510003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
65095470|NCT00510003|Immunologic Factors|immunologic factors|mesh-ancestor
65095471|NCT00510003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
65095472|NCT00510003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095473|NCT00510003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095474|NCT00501878|Phenylephrine|phenylephrine|mesh-list
65095475|NCT00501878|Oxymetazoline|oxymetazoline|mesh-list
65095476|NCT00501878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
65095477|NCT00501878|Mydriatics|mydriatics|mesh-ancestor
65095478|NCT00501878|Autonomic Agents|autonomic agents|mesh-ancestor
65095479|NCT00501878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
65095480|NCT00501878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095481|NCT00501878|Sympathomimetics|sympathomimetics|mesh-ancestor
65095482|NCT00501878|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
65095483|NCT00501878|Nasal Decongestants|nasal decongestants|mesh-ancestor
65095484|NCT00501878|Respiratory System Agents|respiratory system agents|mesh-ancestor
65095485|NCT00501878|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
65095486|NCT00501878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
65095487|NCT00501878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
65095488|NCT00501878|Adrenergic Agents|adrenergic agents|mesh-ancestor
65095489|NCT00501878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
65095490|NCT00501878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095491|NCT00501878|Protective Agents|protective agents|mesh-ancestor
65095492|NCT00501917|Darbepoetin alfa|darbepoetin alfa|mesh-list
65095493|NCT00501917|Hematinics|hematinics|mesh-ancestor
65095494|NCT00510588|Metformin|metformin|mesh-list
65095495|NCT00510588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
65095496|NCT00510588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
65095497|NCT00510627|Oxaliplatin|oxaliplatin|mesh-list
65095498|NCT00510627|Irinotecan|irinotecan|mesh-list
65095499|NCT00510627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095500|NCT00510627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
65095501|NCT00510627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
65095502|NCT00510627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
65095503|NCT00510627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
65095504|NCT00502034|Interferons|interferons|mesh-list
64835833|NCT01602029|Simvastatin|simvastatin|mesh-list
65095505|NCT00502034|Interferon-alpha|interferon-alpha|mesh-list
65095506|NCT00502034|Interferon alpha-2|interferon alpha-2|mesh-list
65095507|NCT00502034|Interleukin-2|interleukin-2|mesh-list
65095508|NCT00502034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
65095509|NCT00502034|Antiviral Agents|antiviral agents|mesh-ancestor
65095510|NCT00502034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
65095511|NCT00502034|Immunologic Factors|immunologic factors|mesh-ancestor
64417180|NCT05617885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563441|NCT00630877|Vasodilator Agents|vasodilator agents|mesh-ancestor
64563442|NCT00630877|Vitamin B Complex|vitamin b complex|mesh-ancestor
64563445|NCT04557163|Itraconazole|itraconazole|mesh-list
64563446|NCT04557163|Antifungal Agents|antifungal agents|mesh-ancestor
64563447|NCT04557163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64563448|NCT04557163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64563449|NCT04557163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64563450|NCT04557163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563451|NCT04557163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563452|NCT04557163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64563453|NCT04557163|Hormone Antagonists|hormone antagonists|mesh-ancestor
64517146|NCT03265782|Ibuprofen|ibuprofen|mesh-list
64517147|NCT03265782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64517148|NCT03265782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64517149|NCT03265782|Analgesics|analgesics|mesh-ancestor
64517150|NCT03265782|Sensory System Agents|sensory system agents|mesh-ancestor
64517151|NCT03265782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517152|NCT03265782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517153|NCT03265782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64517154|NCT03265782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64517155|NCT03265782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64620131|NCT05604794|Analgesics|analgesics|mesh-ancestor
64565109|NCT01926197|Micronutrients|micronutrients|mesh-ancestor
64623984|NCT00000796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565110|NCT01926197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64565111|NCT01923545|Lenograstim|lenograstim|mesh-list
64565112|NCT01923545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64565113|NCT01923545|Immunologic Factors|immunologic factors|mesh-ancestor
64565114|NCT01923545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624003|NCT00000796|Vitamins|vitamins|mesh-ancestor
64565115|NCT01925027|Sirolimus|sirolimus|mesh-list
64565116|NCT01925027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64565117|NCT01925027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64565852|NCT05686564|Nootropic Agents|nootropic agents|mesh-ancestor
64627077|NCT00997139|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
64565853|NCT05675787|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64565854|NCT05675787|Atorvastatin|atorvastatin|mesh-list
64565855|NCT05675787|Medroxyprogesterone|medroxyprogesterone|mesh-list
64565856|NCT05675787|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64565857|NCT05675787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64565858|NCT05675787|Antimetabolites|antimetabolites|mesh-ancestor
64565859|NCT05675787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565860|NCT05675787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64566570|NCT04141501|Psilocybin|psilocybin|mesh-list
64566571|NCT04141501|Hallucinogens|hallucinogens|mesh-ancestor
64566572|NCT04141501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566573|NCT04141501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64566634|NCT03908307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567136|NCT02654119|Mitosis Modulators|mitosis modulators|mesh-ancestor
64567137|NCT02654119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567138|NCT02654119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64567139|NCT02654119|Immunologic Factors|immunologic factors|mesh-ancestor
64567140|NCT02654119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567141|NCT02654119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64567142|NCT02654119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64628167|NCT05749666|Antiemetics|antiemetics|mesh-ancestor
64567177|NCT03060018|Oxitropium|oxitropium|mesh-list
64567178|NCT03060018|Parasympatholytics|parasympatholytics|mesh-ancestor
64567179|NCT03060018|Autonomic Agents|autonomic agents|mesh-ancestor
64596006|NCT04341311|Panobinostat|panobinostat|mesh-list
64567180|NCT03060018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64567181|NCT03060018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567182|NCT04976088|Diclofenac|diclofenac|mesh-list
64567183|NCT04976088|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
64567184|NCT04976088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64567255|NCT03061656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567257|NCT03061656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64567258|NCT03061656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64567259|NCT03061656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64567260|NCT03061656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64567261|NCT03061656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567262|NCT02906761|Aspirin|aspirin|mesh-list
64567306|NCT03060798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64567307|NCT03060798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567365|NCT04974294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567396|NCT02637583|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64628338|NCT01313702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64567740|NCT04951752|Anesthetics, Local|anesthetics, local|mesh-ancestor
64567741|NCT04951752|Anesthetics|anesthetics|mesh-ancestor
64567742|NCT04951752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64567743|NCT04951752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567744|NCT04951752|Sensory System Agents|sensory system agents|mesh-ancestor
64567745|NCT04951752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64567746|NCT01315665|Sulforaphane|sulforaphane|mesh-list
64567747|NCT01315665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64567748|NCT01315665|Protective Agents|protective agents|mesh-ancestor
64567784|NCT04942860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64567785|NCT04942860|Immunologic Factors|immunologic factors|mesh-ancestor
64567786|NCT04942860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64567787|NCT04942860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64567825|NCT01458301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64567826|NCT01458301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567827|NCT01458301|Androgen Antagonists|androgen antagonists|mesh-ancestor
64567828|NCT01458301|Hormone Antagonists|hormone antagonists|mesh-ancestor
64567855|NCT04942002|Prednisolone|prednisolone|mesh-list
64567856|NCT04942002|Prednisolone acetate|prednisolone acetate|mesh-list
64567857|NCT04942002|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64567858|NCT04942002|Prednisolone phosphate|prednisolone phosphate|mesh-list
64567859|NCT04942002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64517492|NCT00992901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64517493|NCT00992901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517494|NCT00992901|Incretins|incretins|mesh-ancestor
64517496|NCT00992901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64517497|NCT03260088|Immunoglobulins|immunoglobulins|mesh-list
64517498|NCT03260088|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64517499|NCT03260088|Antibodies|antibodies|mesh-list
64568078|NCT05160987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64568079|NCT05160987|Anesthetics, General|anesthetics, general|mesh-ancestor
64568080|NCT05160987|Anesthetics|anesthetics|mesh-ancestor
64568081|NCT05160987|GABA Modulators|gaba modulators|mesh-ancestor
64568082|NCT05160987|GABA Agents|gaba agents|mesh-ancestor
64568200|NCT04945434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568201|NCT04945434|Dopamine Agents|dopamine agents|mesh-ancestor
64568202|NCT04945434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64568203|NCT04945434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568204|NCT04945434|Adrenergic Agents|adrenergic agents|mesh-ancestor
64568205|NCT04945434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64568206|NCT04945434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64568207|NCT04945434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64568208|NCT04945434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64568209|NCT04411758|Propolis|propolis|mesh-list
64568210|NCT04411758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64517500|NCT03260088|Immunoglobulin G|immunoglobulin g|mesh-list
64517501|NCT03260088|Immunologic Factors|immunologic factors|mesh-ancestor
64517502|NCT03260088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517503|NCT03480672|Pembrolizumab|pembrolizumab|mesh-list
64517504|NCT03480672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64517505|NCT03480672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568337|NCT01365585|Vasodilator Agents|vasodilator agents|mesh-ancestor
64568338|NCT01365585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64568339|NCT01365585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64568340|NCT01365585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568341|NCT01365585|Urological Agents|urological agents|mesh-ancestor
64568342|NCT02664181|Nivolumab|nivolumab|mesh-list
64568343|NCT02664181|Decitabine|decitabine|mesh-list
64568344|NCT02664181|Tetrahydrouridine|tetrahydrouridine|mesh-list
64568345|NCT02664181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64568346|NCT02664181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568347|NCT02664181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64568348|NCT02664181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568349|NCT02664181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64568350|NCT02664181|Antimetabolites|antimetabolites|mesh-ancestor
64568351|NCT02664181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568352|NCT04407390|Niacinamide|niacinamide|mesh-list
64568385|NCT04932564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568386|NCT04932564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568387|NCT04932564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64568388|NCT04932564|Immunologic Factors|immunologic factors|mesh-ancestor
64568389|NCT04932564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568390|NCT02782663|Upadacitinib|upadacitinib|mesh-list
64568391|NCT02782663|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64568392|NCT02782663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64568393|NCT02782663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568394|NCT02782663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568462|NCT01893541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64517543|NCT02352844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64517544|NCT02352844|Immunologic Factors|immunologic factors|mesh-ancestor
64517545|NCT02352844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517546|NCT03255642|Clonazepam|clonazepam|mesh-list
64517570|NCT03255330|Analgesics|analgesics|mesh-ancestor
64517571|NCT03255330|Sensory System Agents|sensory system agents|mesh-ancestor
64517572|NCT03255330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517573|NCT03255330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568666|NCT04919460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568667|NCT04037241|Leucovorin|leucovorin|mesh-list
64568668|NCT04037241|Gemcitabine|gemcitabine|mesh-list
64568669|NCT04037241|Paclitaxel|paclitaxel|mesh-list
64568670|NCT04037241|Capecitabine|capecitabine|mesh-list
64568697|NCT01327677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64568800|NCT02552641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64568801|NCT02552641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64568802|NCT02552641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568803|NCT02552641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568804|NCT02552641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64568805|NCT02552641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64568806|NCT02552641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64568807|NCT02620020|Fasinumab|fasinumab|mesh-list
64568808|NCT02620020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64568809|NCT02620020|Analgesics|analgesics|mesh-ancestor
64568810|NCT02620020|Sensory System Agents|sensory system agents|mesh-ancestor
64568811|NCT02620020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568843|NCT02542969|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64568845|NCT02542969|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64568846|NCT02542969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64568847|NCT02542969|Antimetabolites|antimetabolites|mesh-ancestor
64568848|NCT02542969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568849|NCT02542969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64568850|NCT02542969|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64517574|NCT03255330|Anticonvulsants|anticonvulsants|mesh-ancestor
64517575|NCT03255330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64517576|NCT03255330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64517577|NCT03255330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64517578|NCT03255330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64714089|NCT03054103|Analgesics|analgesics|mesh-ancestor
64517579|NCT03255330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64517580|NCT03255330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64517581|NCT03255330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64517582|NCT03255330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517583|NCT03255330|Antimanic Agents|antimanic agents|mesh-ancestor
64517584|NCT03255330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64568897|NCT02390869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64568898|NCT02390869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64568899|NCT02390869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64568900|NCT02390869|Growth Substances|growth substances|mesh-ancestor
64568901|NCT02390869|Growth Inhibitors|growth inhibitors|mesh-ancestor
64568902|NCT04757779|Docetaxel|docetaxel|mesh-list
64568903|NCT04757779|Irinotecan|irinotecan|mesh-list
64568904|NCT04757779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568905|NCT04757779|Tubulin Modulators|tubulin modulators|mesh-ancestor
64568936|NCT02389309|Antifungal Agents|antifungal agents|mesh-ancestor
64568937|NCT02389309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64629141|NCT00002716|Antimetabolites|antimetabolites|mesh-ancestor
64568938|NCT02389309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568939|NCT02489695|Axitinib|axitinib|mesh-list
64517592|NCT02353780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
64569033|NCT02461537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569034|NCT05028673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64569036|NCT05028673|Magnesium Hydroxide|magnesium hydroxide|mesh-list
64569037|NCT05028673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64569070|NCT02455687|Respiratory System Agents|respiratory system agents|mesh-ancestor
64569071|NCT02455687|Glucocorticoids|glucocorticoids|mesh-ancestor
64569072|NCT02455687|Hormones|hormones|mesh-ancestor
64569073|NCT02455687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64569075|NCT02455687|Sensory System Agents|sensory system agents|mesh-ancestor
64569076|NCT02455687|Anesthetics|anesthetics|mesh-ancestor
64569077|NCT02455687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64569078|NCT02455687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64569079|NCT02455687|Anticonvulsants|anticonvulsants|mesh-ancestor
64569174|NCT03012321|Prednisone|prednisone|mesh-list
64569175|NCT03012321|Olaparib|olaparib|mesh-list
64569176|NCT03012321|Abiraterone Acetate|abiraterone acetate|mesh-list
64569177|NCT03012321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64569178|NCT03012321|Glucocorticoids|glucocorticoids|mesh-ancestor
64569179|NCT03012321|Hormones|hormones|mesh-ancestor
64569180|NCT03012321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64569181|NCT03012321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569182|NCT03012321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64569183|NCT03012321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569184|NCT03012321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64569185|NCT03012321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569217|NCT03056118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569218|NCT03056118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64569219|NCT03056118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64569220|NCT03056118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64569221|NCT03056118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64517599|NCT02353780|Sensory System Agents|sensory system agents|mesh-ancestor
64517600|NCT02353780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517601|NCT02353780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517602|NCT02353780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64517603|NCT02353780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64629226|NCT00002740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517658|NCT03245970|Sympathomimetics|sympathomimetics|mesh-ancestor
64517659|NCT03245970|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64325629|NCT01297543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64325630|NCT01297543|Immunologic Factors|immunologic factors|mesh-ancestor
64325631|NCT01297543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325632|NCT03541265|Bupivacaine|bupivacaine|mesh-list
64325633|NCT03541265|Anesthetics, Local|anesthetics, local|mesh-ancestor
64325634|NCT03541265|Anesthetics|anesthetics|mesh-ancestor
64325635|NCT03541265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64517660|NCT03245970|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64517661|NCT02454348|Vasopressins|vasopressins|mesh-list
64517662|NCT02454348|Arginine Vasopressin|arginine vasopressin|mesh-list
64517663|NCT02454348|Norepinephrine|norepinephrine|mesh-list
64517664|NCT02454348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64517665|NCT02454348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64517685|NCT03245658|Analgesics|analgesics|mesh-ancestor
64517686|NCT03245658|Sensory System Agents|sensory system agents|mesh-ancestor
64570311|NCT04888728|Antidepressive Agents|antidepressive agents|mesh-ancestor
64570312|NCT04888728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64570313|NCT04888728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64570314|NCT04888728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64570315|NCT04888728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570316|NCT04888728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64570317|NCT04888728|Vasodilator Agents|vasodilator agents|mesh-ancestor
64570318|NCT04888728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64570334|NCT01428973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64570335|NCT01428973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570336|NCT01428973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570337|NCT01428973|Antifungal Agents|antifungal agents|mesh-ancestor
64630337|NCT01250977|Donepezil|donepezil|mesh-list
64570400|NCT04395222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64570402|NCT04395222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64570403|NCT04124003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64570404|NCT04124003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64570405|NCT04124003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64570406|NCT04124003|Antimetabolites|antimetabolites|mesh-ancestor
64570407|NCT04124003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570408|NCT04124003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64570441|NCT04393025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64517687|NCT03245658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517688|NCT03245658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517690|NCT03245424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630368|NCT01214083|Sensory System Agents|sensory system agents|mesh-ancestor
64570495|NCT04122599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64570496|NCT01475955|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64570497|NCT01475955|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64570498|NCT01475955|Dermatologic Agents|dermatologic agents|mesh-ancestor
64570499|NCT03048474|Nivolumab|nivolumab|mesh-list
64570500|NCT03048474|Ipilimumab|ipilimumab|mesh-list
64630403|NCT03713944|Bevacizumab|bevacizumab|mesh-list
64570571|NCT01401543|Urological Agents|urological agents|mesh-ancestor
64570572|NCT02985749|Oxytocin|oxytocin|mesh-list
64570573|NCT02985749|Oxytocics|oxytocics|mesh-ancestor
64570574|NCT02985749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64570575|NCT02985749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570576|NCT04120259|Metformin|metformin|mesh-list
64570577|NCT04120259|Acetic Acid|acetic acid|mesh-list
64570578|NCT04120259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64630433|NCT02945800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570659|NCT05205252|Antiemetics|antiemetics|mesh-ancestor
64570728|NCT02980835|Respiratory System Agents|respiratory system agents|mesh-ancestor
64570729|NCT02980835|Mydriatics|mydriatics|mesh-ancestor
64570730|NCT02980835|Sympathomimetics|sympathomimetics|mesh-ancestor
64570731|NCT02980835|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64570732|NCT03824327|Papaverine|papaverine|mesh-list
64570733|NCT03824327|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64570734|NCT03824327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570768|NCT04871646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64570769|NCT04871646|Anticoagulants|anticoagulants|mesh-ancestor
64570842|NCT03825887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64570844|NCT03825809|Celecoxib|celecoxib|mesh-list
64570845|NCT03825809|Ketorolac|ketorolac|mesh-list
64570846|NCT03825809|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64570847|NCT03825809|Diazepam|diazepam|mesh-list
64570848|NCT03825809|Gabapentin|gabapentin|mesh-list
64570849|NCT03825809|Hydrocodone|hydrocodone|mesh-list
64570850|NCT03825809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64570851|NCT03825809|Analgesics|analgesics|mesh-ancestor
64570852|NCT03825809|Sensory System Agents|sensory system agents|mesh-ancestor
64570853|NCT03825809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64570854|NCT03825809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570855|NCT03825809|Antipyretics|antipyretics|mesh-ancestor
64517707|NCT02454894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64517708|NCT02454894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64517709|NCT02454894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517710|NCT03250962|Decitabine|decitabine|mesh-list
64517711|NCT03250962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64570856|NCT03825809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64570857|NCT03825809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64570858|NCT03825809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64570976|NCT02064673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64570977|NCT02064673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64570978|NCT02064673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571007|NCT02053909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64571008|NCT02053909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64571009|NCT02053909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64571010|NCT02053909|Purinergic Agents|purinergic agents|mesh-ancestor
64571011|NCT02053909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64571013|NCT02863991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571014|NCT02860091|Ropivacaine|ropivacaine|mesh-list
64571015|NCT02860091|Anesthetics, Local|anesthetics, local|mesh-ancestor
64571016|NCT02860091|Anesthetics|anesthetics|mesh-ancestor
64630488|NCT00002926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64630489|NCT01281007|Acyclovir|acyclovir|mesh-list
64571017|NCT02860091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64630496|NCT02898610|Colchicine|colchicine|mesh-list
64571359|NCT03821987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571360|NCT03821987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571361|NCT03821987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64571362|NCT04273763|Interferons|interferons|mesh-list
64571363|NCT04273763|Bromhexine|bromhexine|mesh-list
64571364|NCT04273763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571365|NCT04273763|Antiviral Agents|antiviral agents|mesh-ancestor
64571447|NCT04873440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571449|NCT04867980|Acalabrutinib|acalabrutinib|mesh-list
64571450|NCT04867980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64571451|NCT04867980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64571452|NCT04867980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64571453|NCT04867980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64571454|NCT04867980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571455|NCT04867980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571456|NCT04867980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571464|NCT01450241|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64571465|NCT01450241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64571466|NCT04391621|Triamcinolone|triamcinolone|mesh-list
64571467|NCT04391621|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64571468|NCT04391621|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64517861|NCT02355886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64517863|NCT02355886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64517864|NCT02355886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64517865|NCT02355886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64631187|NCT01896518|Nicotine|nicotine|mesh-list
64573552|NCT04843098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64517966|NCT03242460|Autonomic Agents|autonomic agents|mesh-ancestor
64574154|NCT01501929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64574155|NCT01501929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64574156|NCT01501929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64574157|NCT01501929|Adrenergic Agents|adrenergic agents|mesh-ancestor
64631919|NCT00003202|Gemcitabine|gemcitabine|mesh-list
64574590|NCT01431755|Anesthetics, Local|anesthetics, local|mesh-ancestor
64574592|NCT01431755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64574593|NCT01431755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574594|NCT01431755|Sensory System Agents|sensory system agents|mesh-ancestor
64574595|NCT01431755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64574596|NCT01431755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64574597|NCT01431755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64574598|NCT01431755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64574599|NCT01431755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64574600|NCT01431755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574601|NCT01431755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64574602|NCT01431755|Immunologic Factors|immunologic factors|mesh-ancestor
64574603|NCT01431755|Viscosupplements|viscosupplements|mesh-ancestor
64574604|NCT01431755|Protective Agents|protective agents|mesh-ancestor
64574605|NCT00066937|Benztropine|benztropine|mesh-list
64574606|NCT00066937|Nortriptyline|nortriptyline|mesh-list
64574607|NCT00066937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64574608|NCT00066937|Antidepressive Agents|antidepressive agents|mesh-ancestor
64574609|NCT00066937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64574610|NCT00066937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64574654|NCT01061411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64518055|NCT02455362|Narcotics|narcotics|mesh-ancestor
64518056|NCT02455362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64518057|NCT02455362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518058|NCT02455362|Analgesics|analgesics|mesh-ancestor
64518059|NCT02455362|Sensory System Agents|sensory system agents|mesh-ancestor
64518060|NCT02455362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64518061|NCT03242304|Hydrocortisone|hydrocortisone|mesh-list
64518062|NCT03242304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64518063|NCT03253068|Pembrolizumab|pembrolizumab|mesh-list
64574692|NCT01896245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64574693|NCT01896245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574729|NCT01507779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574730|NCT01896323|Ketoconazole|ketoconazole|mesh-list
64574731|NCT01896323|Antifungal Agents|antifungal agents|mesh-ancestor
64574732|NCT01896323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64574733|NCT01896323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64574789|NCT01462773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574790|NCT02096029|Nicotine|nicotine|mesh-list
64574791|NCT02096029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64574792|NCT02096029|Autonomic Agents|autonomic agents|mesh-ancestor
64574793|NCT02096029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64574794|NCT02096029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574795|NCT02096029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64574796|NCT02096029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64574797|NCT02096029|Cholinergic Agents|cholinergic agents|mesh-ancestor
64574798|NCT02096029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64574799|NCT02096029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574800|NCT02205801|Bupivacaine|bupivacaine|mesh-list
64574801|NCT02205801|Anesthetics, Local|anesthetics, local|mesh-ancestor
64574802|NCT02205801|Anesthetics|anesthetics|mesh-ancestor
64574832|NCT00068575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64574833|NCT00784823|Bortezomib|bortezomib|mesh-list
64574834|NCT00784823|Melphalan|melphalan|mesh-list
64574835|NCT00784823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574836|NCT00784823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64574837|NCT00784823|Alkylating Agents|alkylating agents|mesh-ancestor
64574838|NCT00784823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574840|NCT00784823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64574841|NCT00784823|Immunologic Factors|immunologic factors|mesh-ancestor
64574842|NCT00784823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574843|NCT04428684|Goserelin|goserelin|mesh-list
64574844|NCT04428684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64574845|NCT04428684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574846|NCT01509105|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64574847|NCT01509105|Immunologic Factors|immunologic factors|mesh-ancestor
64574848|NCT01509105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835853|NCT01602029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64835854|NCT01602029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64835855|NCT01602029|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64835856|NCT01602874|Metronidazole|metronidazole|mesh-list
64574849|NCT00773357|Guanfacine|guanfacine|mesh-list
64574886|NCT04834752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64574887|NCT04834752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64574888|NCT04834752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631975|NCT00003214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64575020|NCT04819776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64575021|NCT04819776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64575022|NCT04819776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64575023|NCT04819776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575024|NCT04819776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64575025|NCT04192253|Paclitaxel|paclitaxel|mesh-list
64575026|NCT04192253|Carboplatin|carboplatin|mesh-list
64575027|NCT04192253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64575028|NCT04192253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575029|NCT04192253|Tubulin Modulators|tubulin modulators|mesh-ancestor
64575030|NCT04192253|Antimitotic Agents|antimitotic agents|mesh-ancestor
64575031|NCT04192253|Mitosis Modulators|mitosis modulators|mesh-ancestor
64632079|NCT00003682|Prednisolone|prednisolone|mesh-list
64632098|NCT00003682|Hormones|hormones|mesh-ancestor
64518105|NCT03241914|Appetite Stimulants|appetite stimulants|mesh-ancestor
64518106|NCT03241914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64518107|NCT03249168|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64518108|NCT03249168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64518109|NCT03249168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64518110|NCT03249168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64518111|NCT03249168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518112|NCT03249168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64518113|NCT03249168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518114|NCT03249168|Analgesics|analgesics|mesh-ancestor
64518115|NCT03249168|Sensory System Agents|sensory system agents|mesh-ancestor
64518116|NCT03249168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64518117|NCT03249168|Antidepressive Agents|antidepressive agents|mesh-ancestor
64518118|NCT03249168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64575425|NCT00168337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64632235|NCT00003700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64575469|NCT04354428|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64575470|NCT04354428|Protease Inhibitors|protease inhibitors|mesh-ancestor
64575471|NCT04354428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575472|NCT04354428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575563|NCT00074269|Fludarabine|fludarabine|mesh-list
64575565|NCT00074269|Cyclosporins|cyclosporins|mesh-list
64575566|NCT00074269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64575567|NCT00074269|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64575568|NCT00074269|Abortifacient Agents|abortifacient agents|mesh-ancestor
64575596|NCT00074815|Serotonin|serotonin|mesh-list
64575597|NCT00074815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64518198|NCT02357290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518199|NCT02357290|Antidotes|antidotes|mesh-ancestor
64518200|NCT02477202|Levonorgestrel|levonorgestrel|mesh-list
64518201|NCT02477202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64575816|NCT05605925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64575817|NCT05605925|Antimalarials|antimalarials|mesh-ancestor
64575818|NCT05605925|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64575819|NCT01520727|Opicapone|opicapone|mesh-list
64575820|NCT01520727|Entacapone|entacapone|mesh-list
64632344|NCT02106572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576305|NCT03006081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64576306|NCT03006081|Growth Substances|growth substances|mesh-ancestor
64576307|NCT03006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576308|NCT03006081|Growth Inhibitors|growth inhibitors|mesh-ancestor
64576309|NCT03006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576310|NCT01535937|Midazolam|midazolam|mesh-list
64576311|NCT01535937|Ketamine|ketamine|mesh-list
64576312|NCT01535937|Analgesics|analgesics|mesh-ancestor
64576313|NCT01535937|Sensory System Agents|sensory system agents|mesh-ancestor
64576339|NCT02999841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576340|NCT02999841|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64576342|NCT02999841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576343|NCT02999841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576355|NCT01537029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64632576|NCT00089102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632655|NCT04771754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64576667|NCT02597946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576668|NCT02597946|Tubulin Modulators|tubulin modulators|mesh-ancestor
64576669|NCT02597946|Antimitotic Agents|antimitotic agents|mesh-ancestor
64576704|NCT04790838|Hormones|hormones|mesh-ancestor
64576705|NCT04790838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64576734|NCT02981121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576735|NCT02597478|Fentanyl|fentanyl|mesh-list
64576736|NCT02597478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64576737|NCT02597478|Narcotics|narcotics|mesh-ancestor
64632690|NCT00003340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64632691|NCT00003340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64518274|NCT03248700|Antioxidants|antioxidants|mesh-ancestor
64518275|NCT03248700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518276|NCT03248700|Protective Agents|protective agents|mesh-ancestor
64576826|NCT04339101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576827|NCT04339101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64576828|NCT04339101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576829|NCT04339101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64576830|NCT04339101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64576831|NCT04339101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64576832|NCT04339101|Antifungal Agents|antifungal agents|mesh-ancestor
64576862|NCT05401227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576863|NCT05401227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576864|NCT05401227|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64576865|NCT05401227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64576866|NCT05401227|Anesthetics, General|anesthetics, general|mesh-ancestor
64576867|NCT05401227|Anesthetics|anesthetics|mesh-ancestor
64576868|NCT05401227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64576869|NCT05401227|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64576870|NCT05401227|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64576871|NCT05401227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64576872|NCT05401227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576873|NCT04214691|Acetaminophen|acetaminophen|mesh-list
64576874|NCT04214691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64576875|NCT04214691|Analgesics|analgesics|mesh-ancestor
64576876|NCT04214691|Sensory System Agents|sensory system agents|mesh-ancestor
64576877|NCT04214691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576903|NCT03002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576905|NCT03002493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64576906|NCT03002493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64576907|NCT03002493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64576908|NCT03002493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64576909|NCT03002493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64576910|NCT04197687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64577190|NCT02995083|Prednisolone acetate|prednisolone acetate|mesh-list
64577191|NCT02995083|Lidocaine|lidocaine|mesh-list
64577192|NCT02995083|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64577193|NCT02995083|Prednisolone phosphate|prednisolone phosphate|mesh-list
64577194|NCT02995083|Anesthetics, Local|anesthetics, local|mesh-ancestor
64577195|NCT02995083|Anesthetics|anesthetics|mesh-ancestor
64577223|NCT03794388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64577224|NCT03794388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64577225|NCT03794388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577226|NCT03794388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64577228|NCT03794388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64577229|NCT03794388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64577508|NCT00088621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64577509|NCT00088621|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64577510|NCT00088621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64577511|NCT00088621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64577512|NCT00088621|Adrenergic Agents|adrenergic agents|mesh-ancestor
64577513|NCT00088621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64577514|NCT00088621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577515|NCT00088621|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64577516|NCT00088621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64577517|NCT00088621|Serotonin Agents|serotonin agents|mesh-ancestor
64577518|NCT00088621|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64577552|NCT01642485|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64577553|NCT01642485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64577554|NCT01642485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64577555|NCT04773366|Cytarabine|cytarabine|mesh-list
64577556|NCT04773366|Prednisone|prednisone|mesh-list
64577557|NCT04773366|Vincristine|vincristine|mesh-list
64577558|NCT04773366|Mercaptopurine|mercaptopurine|mesh-list
64577559|NCT04773366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64302778|NCT02129257|Antimetabolites|antimetabolites|mesh-ancestor
64577560|NCT04773366|Glucocorticoids|glucocorticoids|mesh-ancestor
64577581|NCT04714541|Sensory System Agents|sensory system agents|mesh-ancestor
64577582|NCT04714541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64577583|NCT04714541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577584|NCT04714541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64577585|NCT04714541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64577586|NCT04714541|Anesthetics, General|anesthetics, general|mesh-ancestor
64577587|NCT04714541|Anesthetics|anesthetics|mesh-ancestor
64577588|NCT04714541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64577832|NCT05613192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64577833|NCT05613192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64577834|NCT00194779|Tamoxifen|tamoxifen|mesh-list
64577835|NCT00194779|Vinorelbine|vinorelbine|mesh-list
64577836|NCT00194779|Cyclophosphamide|cyclophosphamide|mesh-list
64577837|NCT00194779|Doxorubicin|doxorubicin|mesh-list
64577838|NCT00194779|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64577839|NCT00194779|Capecitabine|capecitabine|mesh-list
64577840|NCT00194779|Methotrexate|methotrexate|mesh-list
64577841|NCT00194779|Trastuzumab|trastuzumab|mesh-list
64577842|NCT00194779|Letrozole|letrozole|mesh-list
64518340|NCT04486092|Antimanic Agents|antimanic agents|mesh-ancestor
64518341|NCT04486092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64518342|NCT04486092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64518343|NCT04486092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64518344|NCT03238638|Pembrolizumab|pembrolizumab|mesh-list
64518345|NCT03238638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64577864|NCT00194779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64578254|NCT01246869|Imidazole|imidazole|mesh-list
64578255|NCT01246869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578256|NCT01246869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578257|NCT01246869|Antimetabolites|antimetabolites|mesh-ancestor
64578258|NCT01246869|Antiviral Agents|antiviral agents|mesh-ancestor
64578259|NCT01246869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64578260|NCT01452152|Clopidogrel|clopidogrel|mesh-list
64578261|NCT01452152|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64578262|NCT01452152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64578263|NCT01452152|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64578264|NCT01452152|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64578265|NCT01452152|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64578266|NCT01452152|Purinergic Agents|purinergic agents|mesh-ancestor
64578267|NCT01452152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64578268|NCT01452152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578269|NCT01452152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578270|NCT05557110|Blinatumomab|blinatumomab|mesh-list
64578271|NCT05557110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578272|NCT01451762|Diphenhydramine|diphenhydramine|mesh-list
64633459|NCT05775965|Aspirin|aspirin|mesh-list
64578402|NCT00033917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64578404|NCT00033917|Analgesics|analgesics|mesh-ancestor
64578405|NCT00033917|Sensory System Agents|sensory system agents|mesh-ancestor
64518361|NCT02454426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64518362|NCT02454426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518363|NCT02454426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64596583|NCT00616109|Growth Substances|growth substances|mesh-ancestor
64518365|NCT02454426|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64518366|NCT02454426|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64518367|NCT02454426|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64518368|NCT02454426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64578537|NCT02234115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578538|NCT02234115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64578575|NCT01664559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64578576|NCT01664559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578577|NCT01664559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64578578|NCT01664559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64578610|NCT00048737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64578611|NCT00048737|Immunologic Factors|immunologic factors|mesh-ancestor
64578612|NCT00048737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578613|NCT00048737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64578614|NCT00048737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64303840|NCT03567629|Antimetabolites|antimetabolites|mesh-ancestor
64578615|NCT00048737|Alkylating Agents|alkylating agents|mesh-ancestor
64578616|NCT00048737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578617|NCT00048737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578618|NCT00048737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64633829|NCT05297851|Niacin|niacin|mesh-list
64578955|NCT00217399|Anastrozole|anastrozole|mesh-list
64578956|NCT00217399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578957|NCT00217399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64578958|NCT00217399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578996|NCT05286619|Antiviral Agents|antiviral agents|mesh-ancestor
64634141|NCT04659174|Xanomeline|xanomeline|mesh-list
64579352|NCT01879085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579353|NCT01879085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579354|NCT01879085|Antiviral Agents|antiviral agents|mesh-ancestor
64634264|NCT04439188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579355|NCT01879085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64579356|NCT01879085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579357|NCT01879085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64579358|NCT01879085|Immunologic Factors|immunologic factors|mesh-ancestor
64579359|NCT01879085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579360|NCT01879085|Tubulin Modulators|tubulin modulators|mesh-ancestor
64579361|NCT01879085|Antimitotic Agents|antimitotic agents|mesh-ancestor
64579362|NCT01879085|Mitosis Modulators|mitosis modulators|mesh-ancestor
64579363|NCT01879085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64579365|NCT01439204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64579366|NCT01439204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518435|NCT03247920|Clavulanic Acids|clavulanic acids|mesh-list
64518436|NCT03247920|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64518437|NCT03247920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64518438|NCT03247920|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64518439|NCT03247920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518440|NCT03247920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580030|NCT03139305|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64580031|NCT03139305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64580032|NCT03139305|Hormones|hormones|mesh-ancestor
64580033|NCT03139305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64580034|NCT03139305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580036|NCT00084149|Ritonavir|ritonavir|mesh-list
64580037|NCT00084149|Lopinavir|lopinavir|mesh-list
64580038|NCT00084149|Lamivudine|lamivudine|mesh-list
64580039|NCT00084149|Zidovudine|zidovudine|mesh-list
64580040|NCT00084149|Abacavir|abacavir|mesh-list
64580041|NCT00084149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64580042|NCT00084149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64580043|NCT00084149|Protease Inhibitors|protease inhibitors|mesh-ancestor
64580044|NCT00084149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634644|NCT00199095|Vincristine|vincristine|mesh-list
64580053|NCT00084149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64580055|NCT02959905|Cyclophosphamide|cyclophosphamide|mesh-list
64580056|NCT02959905|Fludarabine|fludarabine|mesh-list
64580057|NCT02959905|Fludarabine phosphate|fludarabine phosphate|mesh-list
64580058|NCT02959905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64580059|NCT02959905|Immunologic Factors|immunologic factors|mesh-ancestor
64580060|NCT02959905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580061|NCT02959905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64580062|NCT02959905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64580063|NCT02959905|Alkylating Agents|alkylating agents|mesh-ancestor
64580064|NCT02959905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580065|NCT02959905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580066|NCT02959905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64580067|NCT02959905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64580068|NCT02959905|Antimetabolites|antimetabolites|mesh-ancestor
64580069|NCT00134017|Cyclophosphamide|cyclophosphamide|mesh-list
64580070|NCT00134017|Busulfan|busulfan|mesh-list
64580071|NCT00134017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64580072|NCT00134017|Immunologic Factors|immunologic factors|mesh-ancestor
64580073|NCT00134017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580074|NCT00134017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64580075|NCT00134017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64580109|NCT00245635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64580110|NCT00245635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64580111|NCT00245635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580112|NCT00245635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64580113|NCT00245635|Serotonin Agents|serotonin agents|mesh-ancestor
64580114|NCT00245635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580150|NCT00086957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64580151|NCT00086957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580152|NCT00144391|Testosterone|testosterone|mesh-list
64580153|NCT00144391|Androgens|androgens|mesh-ancestor
64580154|NCT00144391|Hormones|hormones|mesh-ancestor
64580355|NCT02098993|Anticoagulants|anticoagulants|mesh-ancestor
64580356|NCT02098993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64580357|NCT02098993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64580386|NCT00100841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580387|NCT00100841|Growth Inhibitors|growth inhibitors|mesh-ancestor
64580388|NCT00100841|Immunologic Factors|immunologic factors|mesh-ancestor
64580390|NCT00100841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580391|NCT00100841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64580392|NCT00100841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64580393|NCT00100841|Antidotes|antidotes|mesh-ancestor
64580394|NCT00100841|Protective Agents|protective agents|mesh-ancestor
64580395|NCT00100841|Vitamin B Complex|vitamin b complex|mesh-ancestor
64580396|NCT00100841|Vitamins|vitamins|mesh-ancestor
64580397|NCT00100841|Micronutrients|micronutrients|mesh-ancestor
64580398|NCT04908579|Ketamine|ketamine|mesh-list
64580399|NCT04908579|Bupivacaine|bupivacaine|mesh-list
64518537|NCT03247296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518539|NCT03247296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64518540|NCT03247218|Memantine|memantine|mesh-list
64518541|NCT03247218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64518542|NCT03247218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64518543|NCT03247218|Dopamine Agents|dopamine agents|mesh-ancestor
64518544|NCT03247218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64518545|NCT03247218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518546|NCT03247218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518547|NCT03247218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64518548|NCT03247218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64518549|NCT03237624|Chitosan|chitosan|mesh-list
64518550|NCT03237624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64580484|NCT05165485|Autonomic Agents|autonomic agents|mesh-ancestor
64580485|NCT05165485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64580486|NCT05165485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580487|NCT05165485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64580488|NCT05165485|Respiratory System Agents|respiratory system agents|mesh-ancestor
64580489|NCT05165485|Parasympatholytics|parasympatholytics|mesh-ancestor
64580490|NCT05165485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64580491|NCT05165485|Cholinergic Agents|cholinergic agents|mesh-ancestor
64580523|NCT05682339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64580524|NCT05682339|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64580525|NCT05682339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580526|NCT05682339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64580527|NCT05682339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64325657|NCT02547038|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64580528|NCT05682339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64580530|NCT05682339|Sensory System Agents|sensory system agents|mesh-ancestor
64580531|NCT01716039|Adalimumab|adalimumab|mesh-list
64518553|NCT03237624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518554|NCT03237624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64518555|NCT03237624|Chelating Agents|chelating agents|mesh-ancestor
64518556|NCT03237624|Sequestering Agents|sequestering agents|mesh-ancestor
64518558|NCT03237624|Coagulants|coagulants|mesh-ancestor
64518559|NCT03234660|Dexmedetomidine|dexmedetomidine|mesh-list
64518560|NCT03234660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64580532|NCT01716039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64580533|NCT01716039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64634768|NCT00198978|Glucocorticoids|glucocorticoids|mesh-ancestor
64518563|NCT03234660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64580742|NCT00015847|Immunologic Factors|immunologic factors|mesh-ancestor
64580743|NCT00015847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580744|NCT00015847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64580777|NCT04617457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64580779|NCT04617457|Immunologic Factors|immunologic factors|mesh-ancestor
64306008|NCT02389816|Vortioxetine|vortioxetine|mesh-list
64580781|NCT00017563|Mitoxantrone|mitoxantrone|mesh-list
64580782|NCT00017563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580783|NCT00017563|Tubulin Modulators|tubulin modulators|mesh-ancestor
64580784|NCT00017563|Antimitotic Agents|antimitotic agents|mesh-ancestor
64580785|NCT00017563|Mitosis Modulators|mitosis modulators|mesh-ancestor
64580786|NCT00017563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580787|NCT00017563|Analgesics|analgesics|mesh-ancestor
64580788|NCT00017563|Sensory System Agents|sensory system agents|mesh-ancestor
64580789|NCT00017563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64580824|NCT04476511|Vitamins|vitamins|mesh-ancestor
64580825|NCT04476511|Micronutrients|micronutrients|mesh-ancestor
64580826|NCT04476511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64580827|NCT05609565|Bupivacaine|bupivacaine|mesh-list
64580828|NCT05609565|Prilocaine|prilocaine|mesh-list
64580829|NCT05609565|Anesthetics|anesthetics|mesh-list
64580830|NCT05609565|Anesthetics, Local|anesthetics, local|mesh-ancestor
64586314|NCT00426517|Alkylating Agents|alkylating agents|mesh-ancestor
64580856|NCT00028093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580857|NCT01721967|Ranolazine|ranolazine|mesh-list
64634842|NCT00004150|Leucovorin|leucovorin|mesh-list
64580913|NCT00271219|Methadone|methadone|mesh-list
64580914|NCT00271219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64580915|NCT00271219|Narcotics|narcotics|mesh-ancestor
64580993|NCT01729845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64580994|NCT01729845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64580995|NCT01729845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580996|NCT01729845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581054|NCT02584452|Anesthetics, General|anesthetics, general|mesh-ancestor
64581055|NCT02584452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64581056|NCT02584452|Narcotics|narcotics|mesh-ancestor
64581057|NCT02584452|Analgesics|analgesics|mesh-ancestor
64581058|NCT02584452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64581059|NCT02502006|Celecoxib|celecoxib|mesh-list
64581060|NCT02502006|Naproxen|naproxen|mesh-list
64581061|NCT02502006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64518570|NCT03234660|Adrenergic Agents|adrenergic agents|mesh-ancestor
64518571|NCT03234660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64518572|NCT03234660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518573|NCT04485780|Botulinum Toxins|botulinum toxins|mesh-list
64518574|NCT04485780|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64581062|NCT02502006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64581130|NCT05536596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581131|NCT05536596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64581132|NCT05536596|Hematinics|hematinics|mesh-ancestor
64581133|NCT05536596|Vitamin B Complex|vitamin b complex|mesh-ancestor
64581134|NCT05536596|Vitamins|vitamins|mesh-ancestor
64581135|NCT05536596|Micronutrients|micronutrients|mesh-ancestor
64581136|NCT03469011|Imatinib Mesylate|imatinib mesylate|mesh-list
64581137|NCT03469011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581138|NCT03469011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64581139|NCT03469011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581140|NCT03469011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581141|NCT03430791|Nivolumab|nivolumab|mesh-list
64581142|NCT03430791|Ipilimumab|ipilimumab|mesh-list
64581143|NCT03430791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64581144|NCT03430791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581145|NCT03430791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64581146|NCT03430791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581147|NCT05536284|Bisoprolol|bisoprolol|mesh-list
64581148|NCT05536284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64581149|NCT05536284|Sympatholytics|sympatholytics|mesh-ancestor
64581150|NCT05536284|Autonomic Agents|autonomic agents|mesh-ancestor
64581151|NCT05536284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581152|NCT05536284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634965|NCT01216735|Respiratory System Agents|respiratory system agents|mesh-ancestor
64581211|NCT01739361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581212|NCT01739361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581215|NCT01743729|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64581216|NCT01743729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64581217|NCT01744353|Oxaliplatin|oxaliplatin|mesh-list
64581218|NCT01744353|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64581219|NCT01744353|Paclitaxel|paclitaxel|mesh-list
64581220|NCT01744353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581221|NCT01744353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581222|NCT01744353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64581223|NCT01744353|Tubulin Modulators|tubulin modulators|mesh-ancestor
64581224|NCT01744353|Antimitotic Agents|antimitotic agents|mesh-ancestor
64581225|NCT01744353|Mitosis Modulators|mitosis modulators|mesh-ancestor
64581226|NCT01744821|Vitamin D|vitamin d|mesh-list
64581359|NCT01748799|Anticonvulsants|anticonvulsants|mesh-ancestor
64581360|NCT01748799|Analgesics|analgesics|mesh-ancestor
64581361|NCT01748799|Sensory System Agents|sensory system agents|mesh-ancestor
64581362|NCT01748799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581363|NCT01748799|Hallucinogens|hallucinogens|mesh-ancestor
64581364|NCT01748799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64581365|NCT01748799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64581366|NCT01748799|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64581367|NCT01748799|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64581368|NCT01748799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64581369|NCT01748799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518583|NCT04485780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64518584|NCT00059475|polysaccharide-K|polysaccharide-k|mesh-list
64518585|NCT00059475|Interleukin-2|interleukin-2|mesh-list
64518586|NCT00059475|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64518587|NCT00059475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64518588|NCT00059475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64518589|NCT00059475|Analgesics|analgesics|mesh-ancestor
64518590|NCT00059475|Sensory System Agents|sensory system agents|mesh-ancestor
64635021|NCT00005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581459|NCT03899103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581460|NCT01751451|Abiraterone Acetate|abiraterone acetate|mesh-list
64581461|NCT01751451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581462|NCT01751451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64581463|NCT01751451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581464|NCT01751451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581465|NCT01751451|Hormone Antagonists|hormone antagonists|mesh-ancestor
64581501|NCT05299866|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64635049|NCT00004204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581753|NCT04129398|Antiviral Agents|antiviral agents|mesh-ancestor
64581754|NCT04129398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64581774|NCT05609682|Anticonvulsants|anticonvulsants|mesh-ancestor
64581775|NCT05609682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64581776|NCT05609682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64581777|NCT05609682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64635083|NCT00005026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64835872|NCT01602887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446970|NCT01900431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581778|NCT05609682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64581779|NCT05609682|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64581780|NCT05609682|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64581781|NCT05609682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64581782|NCT05609682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581783|NCT05609682|Antimanic Agents|antimanic agents|mesh-ancestor
64518615|NCT02453802|Antidepressive Agents|antidepressive agents|mesh-ancestor
64518616|NCT02453802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64518617|NCT02453802|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64581808|NCT05656248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64581809|NCT05656248|Antimetabolites|antimetabolites|mesh-ancestor
64581810|NCT05656248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581811|NCT05656248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581860|NCT00122447|Antioxidants|antioxidants|mesh-ancestor
64581861|NCT00122447|Protective Agents|protective agents|mesh-ancestor
64581862|NCT00122447|Vitamin B Complex|vitamin b complex|mesh-ancestor
64581863|NCT00122447|Vitamins|vitamins|mesh-ancestor
64581864|NCT00122447|Micronutrients|micronutrients|mesh-ancestor
64581865|NCT00125957|Bupropion|bupropion|mesh-list
64581866|NCT00125957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64581867|NCT00125957|Antidepressive Agents|antidepressive agents|mesh-ancestor
64581868|NCT00125957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64581869|NCT00125957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64581870|NCT00125957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64581871|NCT00125957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64582378|NCT01765803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64582379|NCT01765803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635281|NCT00004252|Micronutrients|micronutrients|mesh-ancestor
64582533|NCT01732809|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64582534|NCT01732809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64582535|NCT01732809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64518661|NCT00061893|Ifosfamide|ifosfamide|mesh-list
64518662|NCT00061893|Doxorubicin|doxorubicin|mesh-list
64518663|NCT00061893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64518664|NCT00061893|Etoposide|etoposide|mesh-list
64518665|NCT00061893|Vincristine|vincristine|mesh-list
64518666|NCT00061893|Vinblastine|vinblastine|mesh-list
64518667|NCT00061893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64518668|NCT00061893|Immunologic Factors|immunologic factors|mesh-ancestor
64518669|NCT00061893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518670|NCT00061893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64518671|NCT00061893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64518672|NCT00061893|Alkylating Agents|alkylating agents|mesh-ancestor
64635445|NCT00101036|Lapatinib|lapatinib|mesh-list
64582620|NCT01464788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64582662|NCT00256217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582663|NCT00256217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64635485|NCT00005092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64635486|NCT00005092|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64518697|NCT02957019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518698|NCT02957019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64518699|NCT02957019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64518700|NCT02957019|Analgesics|analgesics|mesh-ancestor
64518701|NCT02957019|Sensory System Agents|sensory system agents|mesh-ancestor
64596934|NCT05688020|Epinephrine|epinephrine|mesh-list
64582751|NCT00257933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64582752|NCT00257933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582753|NCT00257933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64582754|NCT00257933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582755|NCT00257933|Antiemetics|antiemetics|mesh-ancestor
64582756|NCT00257933|Autonomic Agents|autonomic agents|mesh-ancestor
64582757|NCT00257933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64582758|NCT00257933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64582759|NCT00257933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64582760|NCT00257933|Protective Agents|protective agents|mesh-ancestor
64582761|NCT01734525|Anidulafungin|anidulafungin|mesh-list
64582762|NCT01734525|Antifungal Agents|antifungal agents|mesh-ancestor
64582763|NCT01734525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64582764|NCT01819935|Vancomycin|vancomycin|mesh-list
64582928|NCT03440112|Protective Agents|protective agents|mesh-ancestor
64582929|NCT03440112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582930|NCT03440112|GABA Modulators|gaba modulators|mesh-ancestor
64582931|NCT03440112|GABA Agents|gaba agents|mesh-ancestor
64582932|NCT03440112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64582933|NCT01775865|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
64582934|NCT01775865|Sodium Salicylate|sodium salicylate|mesh-list
64582935|NCT01775865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64518718|NCT02028754|Renal Agents|renal agents|mesh-ancestor
64518719|NCT02028754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64518720|NCT02028754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64518721|NCT02028754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64518722|NCT02028754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518723|NCT02028754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64518724|NCT02028754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64518725|NCT02028754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64518726|NCT02028754|Laxatives|laxatives|mesh-ancestor
64583061|NCT00216125|Antimitotic Agents|antimitotic agents|mesh-ancestor
64583062|NCT00216125|Mitosis Modulators|mitosis modulators|mesh-ancestor
64583063|NCT00216125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583064|NCT00216125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64583065|NCT00216125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64583066|NCT00216125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64583067|NCT00216125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583068|NCT01781403|Capecitabine|capecitabine|mesh-list
64635692|NCT02197273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64635694|NCT02197273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64583296|NCT05300841|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64583298|NCT05300841|Estrogens|estrogens|mesh-ancestor
64583299|NCT05300841|Hormones|hormones|mesh-ancestor
64635939|NCT00004582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583300|NCT05300841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64583321|NCT00232739|Antifungal Agents|antifungal agents|mesh-ancestor
64583322|NCT00232739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64583323|NCT00232739|Immunologic Factors|immunologic factors|mesh-ancestor
64583324|NCT00232739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583326|NCT01789905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64583327|NCT01789905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64583328|NCT01789905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64583329|NCT01789905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64518768|NCT01552434|Endothelial Growth Factors|endothelial growth factors|mesh-list
64518770|NCT01552434|Immunoglobulins|immunoglobulins|mesh-list
64518771|NCT01552434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64518772|NCT01552434|Immunoglobulin G|immunoglobulin g|mesh-list
64583355|NCT01791465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64583356|NCT01791465|Incretins|incretins|mesh-ancestor
64583390|NCT01794039|Dexamethasone|dexamethasone|mesh-list
64583391|NCT01794039|Dexamethasone acetate|dexamethasone acetate|mesh-list
64583392|NCT01794039|Lenalidomide|lenalidomide|mesh-list
64583393|NCT01794039|Pomalidomide|pomalidomide|mesh-list
64583395|NCT01794039|BB 1101|bb 1101|mesh-list
64583396|NCT01794039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64583430|NCT00281827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64583431|NCT00281827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64583432|NCT00281827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64583433|NCT00281827|Growth Substances|growth substances|mesh-ancestor
64583434|NCT00281827|Growth Inhibitors|growth inhibitors|mesh-ancestor
64583435|NCT01898819|Dexmedetomidine|dexmedetomidine|mesh-list
64583436|NCT01898819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64583437|NCT01898819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64583438|NCT01898819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583491|NCT00287053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583492|NCT00287053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635969|NCT00004744|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64583566|NCT00285779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583567|NCT00285779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64583568|NCT00285779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64583569|NCT00285779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64583570|NCT00285779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64583571|NCT00285779|Immunologic Factors|immunologic factors|mesh-ancestor
64583572|NCT04827537|Metronidazole|metronidazole|mesh-list
64583573|NCT04827537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64583574|NCT04827537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64635995|NCT01272583|Incretins|incretins|mesh-ancestor
64518789|NCT01552434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64518790|NCT01552434|Antimanic Agents|antimanic agents|mesh-ancestor
64518791|NCT01552434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64518792|NCT01552434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64518793|NCT01552434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64518794|NCT02357836|Itraconazole|itraconazole|mesh-list
64518795|NCT02357836|Antifungal Agents|antifungal agents|mesh-ancestor
64518796|NCT02357836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64518797|NCT02357836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64518798|NCT02357836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64583580|NCT01435382|Bococizumab|bococizumab|mesh-list
64583581|NCT01435382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64583582|NCT01435382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64583583|NCT01435382|Antimetabolites|antimetabolites|mesh-ancestor
64583584|NCT01435382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583585|NCT01435382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64583587|NCT01801449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64583588|NCT00286325|Rituximab|rituximab|mesh-list
64583589|NCT00286325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64583590|NCT00286325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583591|NCT00286325|Immunologic Factors|immunologic factors|mesh-ancestor
64835873|NCT01602887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835874|NCT01603264|Trastuzumab|trastuzumab|mesh-list
64835875|NCT01603264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64835876|NCT01603264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835877|NCT01603680|Anesthetics|anesthetics|mesh-list
64835878|NCT01603680|Mepivacaine|mepivacaine|mesh-list
64835879|NCT01603680|Anesthetics, Local|anesthetics, local|mesh-list
64835880|NCT01603680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64835881|NCT01603680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835882|NCT01603680|Sensory System Agents|sensory system agents|mesh-ancestor
64597056|NCT00621179|Leuprolide|leuprolide|mesh-list
64583592|NCT00286325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583593|NCT00286325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64583594|NCT00238355|Voriconazole|voriconazole|mesh-list
64583595|NCT00238355|Caspofungin|caspofungin|mesh-list
64583623|NCT01650701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583624|NCT01650701|Immunologic Factors|immunologic factors|mesh-ancestor
64583625|NCT01650701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583626|NCT01650701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64583627|NCT01650701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64583628|NCT01650701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64583629|NCT01650701|Growth Substances|growth substances|mesh-ancestor
64518799|NCT02357836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636030|NCT01341301|Alkylating Agents|alkylating agents|mesh-ancestor
64518859|NCT01976650|Antiemetics|antiemetics|mesh-ancestor
64518860|NCT01976650|Autonomic Agents|autonomic agents|mesh-ancestor
64636210|NCT00047060|Alemtuzumab|alemtuzumab|mesh-list
64518880|NCT01978600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64518881|NCT01978600|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64518882|NCT01978600|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64636248|NCT00108524|Orlistat|orlistat|mesh-list
64583740|NCT01847469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64583741|NCT01847469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64583772|NCT01433978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583774|NCT00289211|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64583775|NCT00289211|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
64583776|NCT00289211|Immunologic Factors|immunologic factors|mesh-ancestor
64583777|NCT00289211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583778|NCT00289211|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64583779|NCT00289211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64583780|NCT01619111|Lapatinib|lapatinib|mesh-list
64583781|NCT01619111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583782|NCT01619111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64583783|NCT01619111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583812|NCT05098067|Metoclopramide|metoclopramide|mesh-list
64583813|NCT05098067|Capsaicin|capsaicin|mesh-list
64583814|NCT05098067|Antiemetics|antiemetics|mesh-ancestor
64583815|NCT05098067|Autonomic Agents|autonomic agents|mesh-ancestor
64583816|NCT05098067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583817|NCT05098067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583818|NCT05098067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64583819|NCT05098067|Antipruritics|antipruritics|mesh-ancestor
64583820|NCT05098067|Dermatologic Agents|dermatologic agents|mesh-ancestor
64583821|NCT05098067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64583822|NCT05098067|Serotonin Agents|serotonin agents|mesh-ancestor
64583823|NCT05098067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64583824|NCT05098067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583825|NCT05098067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64583826|NCT05098067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64583827|NCT05098067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64583828|NCT05098067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64583829|NCT05098067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64583830|NCT05098067|Sensory System Agents|sensory system agents|mesh-ancestor
64583865|NCT02989467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64583866|NCT02989467|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64583867|NCT02989467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64583868|NCT02989467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583928|NCT01854177|Autonomic Agents|autonomic agents|mesh-ancestor
64583929|NCT01854177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583930|NCT01854177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583931|NCT01854177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64583932|NCT01854177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64583952|NCT03858231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64583953|NCT03858231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64583954|NCT03858231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64583955|NCT03858231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583956|NCT03858231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583957|NCT00243191|Imatinib Mesylate|imatinib mesylate|mesh-list
64325659|NCT04984317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64325662|NCT04984317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64325663|NCT04984317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583958|NCT00243191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583959|NCT00243191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64583960|NCT00243191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583961|NCT00243191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583962|NCT00299221|Mycophenolic Acid|mycophenolic acid|mesh-list
64583963|NCT00299221|Tacrolimus|tacrolimus|mesh-list
64583964|NCT00299221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64583965|NCT00299221|Immunologic Factors|immunologic factors|mesh-ancestor
64518973|NCT03232398|Antithrombins|antithrombins|mesh-ancestor
64518974|NCT03232398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64518975|NCT03232398|Protease Inhibitors|protease inhibitors|mesh-ancestor
64518992|NCT00158223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64518994|NCT03228576|Tacrolimus|tacrolimus|mesh-list
64518995|NCT03228576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64636388|NCT01363843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518996|NCT03228576|Immunologic Factors|immunologic factors|mesh-ancestor
64518997|NCT03228576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64518998|NCT03228576|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64518999|NCT03228576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519000|NCT03228576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519001|NCT03228576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519002|NCT00158379|Paclitaxel|paclitaxel|mesh-list
64519003|NCT00158379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64519004|NCT00158379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519005|NCT00158379|Tubulin Modulators|tubulin modulators|mesh-ancestor
64519009|NCT03228498|Choline|choline|mesh-list
64519014|NCT03228498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64519015|NCT03228498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64519016|NCT03228498|Nootropic Agents|nootropic agents|mesh-ancestor
64519017|NCT03232320|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64519018|NCT03232320|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64519019|NCT03232320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583966|NCT00299221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583967|NCT00299221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64583968|NCT00299221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583969|NCT00299221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583970|NCT00299221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64583971|NCT00299221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583972|NCT00299221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64583973|NCT00299221|Antitubercular Agents|antitubercular agents|mesh-ancestor
64583974|NCT00299221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64583975|NCT00299221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64583976|NCT03799731|Trifluridine|trifluridine|mesh-list
64583977|NCT03799731|Antimetabolites|antimetabolites|mesh-ancestor
64583978|NCT03799731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583979|NCT03799731|Antiviral Agents|antiviral agents|mesh-ancestor
64583980|NCT03799731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64583981|NCT00299689|Denileukin diftitox|denileukin diftitox|mesh-list
64583982|NCT00299689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583983|NCT00244985|Rituximab|rituximab|mesh-list
64583984|NCT00244985|Doxorubicin|doxorubicin|mesh-list
64583985|NCT00244985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64584070|NCT00299741|Growth Inhibitors|growth inhibitors|mesh-ancestor
64584130|NCT01861665|Anesthetics, Local|anesthetics, local|mesh-ancestor
64584132|NCT01861665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64584133|NCT01861665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584158|NCT00251225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584159|NCT00251225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64584160|NCT00251225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584161|NCT02979327|Adderall|adderall|mesh-list
64584162|NCT02979327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64584163|NCT02979327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584164|NCT00251303|Riluzole|riluzole|mesh-list
64519020|NCT03232320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519021|NCT03232320|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64519022|NCT03232320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64584182|NCT00300677|Voriconazole|voriconazole|mesh-list
64584183|NCT00300677|Antifungal Agents|antifungal agents|mesh-ancestor
64584210|NCT00559845|Alkylating Agents|alkylating agents|mesh-ancestor
64584211|NCT00559845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64584212|NCT00559845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64584213|NCT00559845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64584214|NCT00559845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64584215|NCT00559845|Growth Substances|growth substances|mesh-ancestor
64584216|NCT00559845|Growth Inhibitors|growth inhibitors|mesh-ancestor
64584217|NCT00559845|Antimetabolites|antimetabolites|mesh-ancestor
64584218|NCT00559845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64636437|NCT01363999|Antimetabolites|antimetabolites|mesh-ancestor
64585505|NCT00360685|Antitubercular Agents|antitubercular agents|mesh-ancestor
64585506|NCT00360685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64636469|NCT01364623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884694|NCT04411953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64884695|NCT04411940|Haloperidol|haloperidol|mesh-list
64884696|NCT04411940|Benztropine|benztropine|mesh-list
64884697|NCT04411940|Haloperidol decanoate|haloperidol decanoate|mesh-list
64884698|NCT04411940|Antiemetics|antiemetics|mesh-ancestor
64884699|NCT04411940|Autonomic Agents|autonomic agents|mesh-ancestor
64884700|NCT04411940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64884701|NCT04411940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884702|NCT04411940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64884703|NCT04411940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64884704|NCT04411940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64884705|NCT04411940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64884706|NCT04411940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64884707|NCT04411940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64519072|NCT03228108|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64519073|NCT03228108|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64519074|NCT03228108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64519075|NCT00078897|Selenium|selenium|mesh-list
64519076|NCT00078897|Antioxidants|antioxidants|mesh-ancestor
64519077|NCT00078897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519078|NCT00078897|Protective Agents|protective agents|mesh-ancestor
64519079|NCT00078897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519080|NCT00078897|Trace Elements|trace elements|mesh-ancestor
64519081|NCT00078897|Micronutrients|micronutrients|mesh-ancestor
64519083|NCT03228030|Vitamin B Complex|vitamin b complex|mesh-ancestor
64519098|NCT00081861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64884905|NCT03069703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64884906|NCT03069703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885680|NCT05414474|Protective Agents|protective agents|mesh-ancestor
64636750|NCT01077401|Ranibizumab|ranibizumab|mesh-list
64885723|NCT05413902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64885724|NCT05413902|Glucocorticoids|glucocorticoids|mesh-ancestor
64885725|NCT05413902|Hormones|hormones|mesh-ancestor
64885726|NCT05413902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64885727|NCT05413902|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64885728|NCT05413902|Protective Agents|protective agents|mesh-ancestor
64519119|NCT03120234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64519120|NCT03120234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519121|NCT03120234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64519122|NCT03120234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64519123|NCT03120234|Anesthetics, General|anesthetics, general|mesh-ancestor
64519124|NCT03120234|Anesthetics|anesthetics|mesh-ancestor
64519125|NCT03120234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64519126|NCT03120234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64519127|NCT03120234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64519128|NCT03120234|Narcotics|narcotics|mesh-ancestor
64519129|NCT03120234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64519130|NCT03230682|Antidepressive Agents|antidepressive agents|mesh-list
64885729|NCT05413902|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64885730|NCT05413902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64885731|NCT05413902|Adrenergic Agents|adrenergic agents|mesh-ancestor
64885732|NCT05413902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64885733|NCT05413902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597225|NCT00735787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64885734|NCT05413902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64885735|NCT05413902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64885736|NCT05413902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64885748|NCT05413902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64885749|NCT05413902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64885750|NCT05413902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64885751|NCT05413902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64885752|NCT05413902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64885753|NCT05413902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64885754|NCT05413902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64885755|NCT05413902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885756|NCT05413902|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64885757|NCT05413902|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64885758|NCT05413902|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64885759|NCT05413902|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64885760|NCT05413902|Parasympatholytics|parasympatholytics|mesh-ancestor
64885761|NCT05413902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64885762|NCT05413902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64885763|NCT05413902|Cholinergic Agents|cholinergic agents|mesh-ancestor
64885764|NCT05413902|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
64885765|NCT05413902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64885766|NCT05413863|Insulin|insulin|mesh-list
64885767|NCT05413863|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64885768|NCT05413863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64885769|NCT05413863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885770|NCT05413746|Antioxidants|antioxidants|mesh-list
64885771|NCT05413746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519134|NCT03227484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519135|NCT03227484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64519136|NCT03227484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519137|NCT04555577|Temozolomide|temozolomide|mesh-list
64519138|NCT04555577|Peposertib|peposertib|mesh-list
64519139|NCT04555577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64885786|NCT05356936|Vitamins|vitamins|mesh-list
64885787|NCT05356936|Vitamin K|vitamin k|mesh-list
64885788|NCT05356936|Vitamin K 2|vitamin k 2|mesh-list
64885789|NCT05356936|Micronutrients|micronutrients|mesh-ancestor
64885790|NCT05356936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885791|NCT05356936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64885792|NCT05356936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64885793|NCT05356936|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64885794|NCT05356936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64885795|NCT05356936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885796|NCT05356936|Hemostatics|hemostatics|mesh-ancestor
64885797|NCT05356936|Coagulants|coagulants|mesh-ancestor
64885798|NCT05352178|Ascorbic Acid|ascorbic acid|mesh-list
64885799|NCT05352178|Methyltestosterone|methyltestosterone|mesh-list
64885800|NCT05352178|Androgens|androgens|mesh-list
64885801|NCT05352178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64885802|NCT05352178|Hormones|hormones|mesh-ancestor
64885829|NCT05251493|Trace Elements|trace elements|mesh-ancestor
64885830|NCT05251493|Micronutrients|micronutrients|mesh-ancestor
64885831|NCT05251493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885832|NCT05251493|Hematinics|hematinics|mesh-ancestor
64885833|NCT05233709|Fesoterodine|fesoterodine|mesh-list
64885834|NCT05233709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64885835|NCT05233709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64885836|NCT05233709|Cholinergic Agents|cholinergic agents|mesh-ancestor
64597292|NCT04771871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64885837|NCT05233709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64885838|NCT05233709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885839|NCT05233709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885840|NCT05233709|Urological Agents|urological agents|mesh-ancestor
64885841|NCT05173896|Tadalafil|tadalafil|mesh-list
64885842|NCT05173896|Vasodilator Agents|vasodilator agents|mesh-ancestor
64885843|NCT05173896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64885844|NCT05173896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64885845|NCT05173896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885846|NCT05173896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885847|NCT05173896|Urological Agents|urological agents|mesh-ancestor
64885848|NCT05150236|Nivolumab|nivolumab|mesh-list
64885849|NCT05150236|Ipilimumab|ipilimumab|mesh-list
64885850|NCT05150236|177Lu-PSMA-617|177lu-psma-617|mesh-list
64885851|NCT05150236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64636785|NCT01114997|Anesthetics, Local|anesthetics, local|mesh-ancestor
64885958|NCT04222283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885959|NCT04222283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885960|NCT04222283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64885961|NCT04222283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64885962|NCT04131504|Adalimumab|adalimumab|mesh-list
64885963|NCT04131504|Infliximab|infliximab|mesh-list
64885964|NCT04131504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64519144|NCT04555577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519145|NCT02038894|Propofol|propofol|mesh-list
64519146|NCT02038894|Sevoflurane|sevoflurane|mesh-list
64519147|NCT02038894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64519148|NCT02038894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64519149|NCT02038894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519150|NCT02038894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64519151|NCT02038894|Anesthetics, General|anesthetics, general|mesh-ancestor
64519152|NCT02038894|Anesthetics|anesthetics|mesh-ancestor
64519153|NCT02038894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64886015|NCT03712228|Immunologic Factors|immunologic factors|mesh-ancestor
64886016|NCT03712228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886018|NCT03626922|Vitamin B 12|vitamin b 12|mesh-list
64886019|NCT03626922|Dexamethasone|dexamethasone|mesh-list
64886020|NCT03626922|Pembrolizumab|pembrolizumab|mesh-list
64886021|NCT03626922|Oxaliplatin|oxaliplatin|mesh-list
64886022|NCT03626922|Pemetrexed|pemetrexed|mesh-list
64886023|NCT03626922|Vitamins|vitamins|mesh-ancestor
64886092|NCT03532477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64886093|NCT03532477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886094|NCT03532477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64886095|NCT03532477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886096|NCT03532477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64886097|NCT03532477|Antidepressive Agents|antidepressive agents|mesh-ancestor
64886098|NCT03532477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64886099|NCT03491267|Tretinoin|tretinoin|mesh-list
64519205|NCT02369068|Cholinergic Agents|cholinergic agents|mesh-ancestor
64519206|NCT02369068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64519207|NCT02452632|Ipragliflozin|ipragliflozin|mesh-list
64519208|NCT02452632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64519209|NCT02452632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886286|NCT01945892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64886287|NCT01945892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886288|NCT01945957|Oxytocin|oxytocin|mesh-list
64886289|NCT01945957|Oxytocics|oxytocics|mesh-ancestor
64886290|NCT01945957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64886291|NCT01945957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637279|NCT01381471|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64886444|NCT01946984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64886445|NCT01946984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64886446|NCT01946984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64886552|NCT01947803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64886553|NCT01947803|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64835884|NCT01604213|Metformin|metformin|mesh-list
64835885|NCT01604213|Vildagliptin|vildagliptin|mesh-list
64886554|NCT01947803|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64519260|NCT03229668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64519261|NCT03229668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519263|NCT03229668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64519264|NCT03229668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64519265|NCT03229668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519266|NCT03229668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64886555|NCT01947803|Serotonin Agents|serotonin agents|mesh-ancestor
64887016|NCT01950585|Hydroxyurea|hydroxyurea|mesh-list
64887017|NCT01950585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887018|NCT01950585|Antisickling Agents|antisickling agents|mesh-ancestor
64887019|NCT01950585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887020|NCT01950585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887021|NCT01950585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64887022|NCT01950611|Bortezomib|bortezomib|mesh-list
64887023|NCT01950611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887024|NCT01950689|Nimorazole|nimorazole|mesh-list
64887025|NCT01950689|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64887026|NCT01950689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64887027|NCT01950689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64887028|NCT01950689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64887029|NCT01950793|Triamcinolone|triamcinolone|mesh-list
64638266|NCT00206336|Topiramate|topiramate|mesh-list
64887150|NCT01951482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64887151|NCT01951482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64887152|NCT01951482|Growth Substances|growth substances|mesh-ancestor
64887153|NCT01951482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887154|NCT01951482|Growth Inhibitors|growth inhibitors|mesh-ancestor
64887155|NCT01951482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887156|NCT01951482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887157|NCT01951482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64887158|NCT01951482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64519359|NCT03220932|Bevacizumab|bevacizumab|mesh-list
64519360|NCT03220932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64519361|NCT03220932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519362|NCT03220932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64519363|NCT03220932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64519364|NCT03220932|Growth Substances|growth substances|mesh-ancestor
64519365|NCT03220932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519366|NCT03220932|Growth Inhibitors|growth inhibitors|mesh-ancestor
64519367|NCT02042872|Zoledronic Acid|zoledronic acid|mesh-list
64519368|NCT02042872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64519369|NCT02042872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519370|NCT04484688|Bisoprolol|bisoprolol|mesh-list
64519371|NCT04484688|Perindopril|perindopril|mesh-list
64519372|NCT04484688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64519373|NCT04484688|Sympatholytics|sympatholytics|mesh-ancestor
64519374|NCT04484688|Autonomic Agents|autonomic agents|mesh-ancestor
64519375|NCT04484688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64887181|NCT01951560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64887182|NCT01951560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64887183|NCT01951599|Osimertinib|osimertinib|mesh-list
64887184|NCT01951599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887185|NCT01951599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64887186|NCT01951599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887187|NCT01951599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887188|NCT01951677|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64887189|NCT01951677|Immunologic Factors|immunologic factors|mesh-ancestor
64887190|NCT01951677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887191|NCT01951677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64887192|NCT01951677|Antacids|antacids|mesh-ancestor
64887193|NCT01951677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887194|NCT01951677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64638625|NCT00298610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64887205|NCT01951729|Parasympatholytics|parasympatholytics|mesh-ancestor
64887206|NCT01951729|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64887207|NCT01951729|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64887208|NCT01951729|Cholinergic Agents|cholinergic agents|mesh-ancestor
64887209|NCT01951729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64887210|NCT01951729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887212|NCT01951846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887213|NCT01951846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64887214|NCT01951846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887215|NCT01951846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887216|NCT01951872|Caffeine|caffeine|mesh-list
64887217|NCT01951872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64887218|NCT01951872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887219|NCT01951872|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64655755|NCT03030950|Analgesics|analgesics|mesh-ancestor
64887220|NCT01951872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887221|NCT01951872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887222|NCT01951872|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64887223|NCT01951872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64887224|NCT01951872|Purinergic Agents|purinergic agents|mesh-ancestor
64887225|NCT01951872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64887232|NCT01951898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887233|NCT01951898|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64887234|NCT01951898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64887235|NCT01951898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887237|NCT01951911|Analgesics|analgesics|mesh-ancestor
64887238|NCT01951911|Sensory System Agents|sensory system agents|mesh-ancestor
64887239|NCT01951911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64887240|NCT01951911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887241|NCT01951911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64887242|NCT01951911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64887243|NCT01951911|Anesthetics, General|anesthetics, general|mesh-ancestor
64887244|NCT01951911|Anesthetics|anesthetics|mesh-ancestor
64887261|NCT01952314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887262|NCT01952314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887264|NCT01952314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64887265|NCT01952314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64519451|NCT03206658|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64519452|NCT03206658|Hormone Antagonists|hormone antagonists|mesh-ancestor
64519453|NCT03206658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64519454|NCT03206658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519455|NCT03206658|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64519456|NCT03206658|Diuretics|diuretics|mesh-ancestor
64519457|NCT03206658|Natriuretic Agents|natriuretic agents|mesh-ancestor
64519459|NCT00170157|Leuprolide|leuprolide|mesh-list
64519460|NCT00170157|Goserelin|goserelin|mesh-list
64519461|NCT00170157|Bicalutamide|bicalutamide|mesh-list
64519462|NCT00170157|Flutamide|flutamide|mesh-list
64519463|NCT00170157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64519464|NCT00170157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519465|NCT00170157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64887266|NCT01952314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64887267|NCT01952314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64887268|NCT01952561|Dapivirine|dapivirine|mesh-list
64446998|NCT01898091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446999|NCT01898091|Vitamins|vitamins|mesh-ancestor
64447000|NCT01898091|Micronutrients|micronutrients|mesh-ancestor
64447001|NCT01898091|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64887269|NCT01952561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64887270|NCT01952561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64887271|NCT01952561|Antiviral Agents|antiviral agents|mesh-ancestor
64887272|NCT01952561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64887273|NCT01952626|Ondansetron|ondansetron|mesh-list
64887274|NCT01952626|Palonosetron|palonosetron|mesh-list
64887275|NCT01952626|Antiemetics|antiemetics|mesh-ancestor
64887276|NCT01952626|Autonomic Agents|autonomic agents|mesh-ancestor
64887277|NCT01952626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64887278|NCT01952626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887279|NCT01952626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64887280|NCT01952626|Antipruritics|antipruritics|mesh-ancestor
64887281|NCT01952626|Dermatologic Agents|dermatologic agents|mesh-ancestor
64887282|NCT01952626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64887283|NCT01952626|Serotonin Agents|serotonin agents|mesh-ancestor
64887284|NCT01952626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64887285|NCT01952626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887286|NCT01952626|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64887287|NCT01952626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64887288|NCT01952626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64887359|NCT01953107|Ferrous fumarate|ferrous fumarate|mesh-list
64887360|NCT01953107|Trace Elements|trace elements|mesh-ancestor
64887361|NCT01953107|Micronutrients|micronutrients|mesh-ancestor
64887362|NCT01953107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887363|NCT01953172|Tocotrienols|tocotrienols|mesh-list
64519466|NCT00170157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519467|NCT00170157|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64519468|NCT00170157|Fertility Agents|fertility agents|mesh-ancestor
64519469|NCT00170157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64519470|NCT00170157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519471|NCT00170157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64519472|NCT00170157|Androgen Antagonists|androgen antagonists|mesh-ancestor
64519473|NCT00170157|Hormone Antagonists|hormone antagonists|mesh-ancestor
64519474|NCT00170157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64887364|NCT01953172|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
64887365|NCT01953172|Antioxidants|antioxidants|mesh-ancestor
64887366|NCT01953172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887367|NCT01953172|Protective Agents|protective agents|mesh-ancestor
64655896|NCT03017222|Ramosetron|ramosetron|mesh-list
64887368|NCT01953172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887370|NCT01953172|Micronutrients|micronutrients|mesh-ancestor
64887371|NCT01953367|Tobramycin|tobramycin|mesh-list
64887372|NCT01953367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64887373|NCT01953367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64887374|NCT01953406|Fluorouracil|fluorouracil|mesh-list
64887375|NCT01953406|Mitomycins|mitomycins|mesh-list
64887376|NCT01953406|Mitomycin|mitomycin|mesh-list
64887377|NCT01953406|Antimetabolites|antimetabolites|mesh-ancestor
64887378|NCT01953406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887379|NCT01953406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64887380|NCT01953406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325667|NCT04984317|Cholinergic Agents|cholinergic agents|mesh-ancestor
64325668|NCT04984317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64325669|NCT02161055|Insulin|insulin|mesh-list
64325670|NCT02161055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64325671|NCT02161055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64325672|NCT02161055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835894|NCT01605240|Codeine|codeine|mesh-list
64835895|NCT01605240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64835896|NCT01605240|Analgesics|analgesics|mesh-ancestor
64835897|NCT01605240|Sensory System Agents|sensory system agents|mesh-ancestor
64887381|NCT01953406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64887382|NCT01953406|Immunologic Factors|immunologic factors|mesh-ancestor
64887383|NCT01953406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887384|NCT01953406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64887426|NCT01953731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887428|NCT01953731|Antitubercular Agents|antitubercular agents|mesh-ancestor
64887429|NCT01953731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64887430|NCT01953731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64887431|NCT01953731|Leprostatic Agents|leprostatic agents|mesh-ancestor
64887432|NCT01953731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64887433|NCT01953731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64887434|NCT01953731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64887435|NCT01953731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64887436|NCT01953731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64519476|NCT03206346|Antiviral Agents|antiviral agents|mesh-ancestor
64519477|NCT03206346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64519478|NCT00170625|Topotecan|topotecan|mesh-list
64519479|NCT00170625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64519480|NCT00170625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64519481|NCT00170625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519482|NCT00170625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519483|NCT00170625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519484|NCT02043652|Chloroquine|chloroquine|mesh-list
64519485|NCT02043652|Primaquine|primaquine|mesh-list
64519486|NCT02043652|Amebicides|amebicides|mesh-ancestor
64519488|NCT02043652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64519489|NCT02043652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64519490|NCT02043652|Antimalarials|antimalarials|mesh-ancestor
64519491|NCT02043652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64519492|NCT01898169|Nicotine|nicotine|mesh-list
64887437|NCT01953731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64887438|NCT01953731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64887439|NCT01953744|Fluconazole|fluconazole|mesh-list
64887440|NCT01953744|Meglumine Antimoniate|meglumine antimoniate|mesh-list
64887441|NCT01953744|Antifungal Agents|antifungal agents|mesh-ancestor
64638708|NCT01147601|Timolol|timolol|mesh-list
64887509|NCT01953835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64887510|NCT01953835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64887511|NCT01953835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887513|NCT01953848|Solifenacin Succinate|solifenacin succinate|mesh-list
64887514|NCT01953848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64887515|NCT01953848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64656044|NCT02448810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887516|NCT01953848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64887517|NCT01953848|Adrenergic Agents|adrenergic agents|mesh-ancestor
64887518|NCT01953848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64887519|NCT01953848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887520|NCT01953848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887521|NCT01953848|Urological Agents|urological agents|mesh-ancestor
64887522|NCT01953848|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64887523|NCT01953848|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64887524|NCT01953848|Cholinergic Agents|cholinergic agents|mesh-ancestor
64887526|NCT01953887|Solifenacin Succinate|solifenacin succinate|mesh-list
64887527|NCT01953887|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64519493|NCT01898169|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64519494|NCT01898169|Autonomic Agents|autonomic agents|mesh-ancestor
64519495|NCT01898169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64519496|NCT01898169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519497|NCT01898169|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64519498|NCT01898169|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64519499|NCT01898169|Cholinergic Agents|cholinergic agents|mesh-ancestor
64519500|NCT01898169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64519501|NCT01898169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519503|NCT03227016|Veliparib|veliparib|mesh-list
64519504|NCT03227016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64887528|NCT01953887|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64887529|NCT01953887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64887530|NCT01953887|Adrenergic Agents|adrenergic agents|mesh-ancestor
64325676|NCT02764697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325677|NCT04822337|Dexamethasone|dexamethasone|mesh-list
64325678|NCT04822337|Lenalidomide|lenalidomide|mesh-list
64325679|NCT04822337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64325680|NCT04822337|Antiemetics|antiemetics|mesh-ancestor
64835902|NCT01605240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64835903|NCT01605240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64835904|NCT01605240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64835905|NCT01605240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835906|NCT01605240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835907|NCT01605240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64835908|NCT01605240|Narcotics|narcotics|mesh-ancestor
64835909|NCT01605240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64835910|NCT01605240|Antitussive Agents|antitussive agents|mesh-ancestor
64835911|NCT01605240|Respiratory System Agents|respiratory system agents|mesh-ancestor
64835912|NCT01605279|Dobutamine|dobutamine|mesh-list
64835913|NCT01605279|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64835914|NCT01605279|Sympathomimetics|sympathomimetics|mesh-ancestor
64835915|NCT01605279|Autonomic Agents|autonomic agents|mesh-ancestor
64835916|NCT01605279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64835917|NCT01605279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835918|NCT01605279|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64835919|NCT01605279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64835920|NCT01605279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64887531|NCT01953887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64887532|NCT01953887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887533|NCT01953887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887534|NCT01953887|Urological Agents|urological agents|mesh-ancestor
64887535|NCT01953887|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64887536|NCT01953887|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64887537|NCT01953887|Cholinergic Agents|cholinergic agents|mesh-ancestor
64887538|NCT01953952|Cisplatin|cisplatin|mesh-list
64887577|NCT01954030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64887578|NCT01954030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887579|NCT01954030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64887580|NCT01954043|Rifampin|rifampin|mesh-list
64887581|NCT01954043|Dabrafenib|dabrafenib|mesh-list
64887582|NCT01954043|Rabeprazole|rabeprazole|mesh-list
64887583|NCT01954043|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64887584|NCT01954043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64887585|NCT01954043|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64887586|NCT01954043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887587|NCT01954043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887588|NCT01954043|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64887589|NCT01954043|Antitubercular Agents|antitubercular agents|mesh-ancestor
64656143|NCT01685411|Busulfan|busulfan|mesh-list
64887590|NCT01954043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64887591|NCT01954043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64887592|NCT01954043|Leprostatic Agents|leprostatic agents|mesh-ancestor
64887593|NCT01954043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64519506|NCT03227016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64519507|NCT03227016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519508|NCT03227016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519509|NCT03227016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519510|NCT04748991|Amiodarone|amiodarone|mesh-list
64519511|NCT04748991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64519512|NCT04748991|Vasodilator Agents|vasodilator agents|mesh-ancestor
64887594|NCT01954043|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64887595|NCT01954043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64887604|NCT01954108|Immunologic Factors|immunologic factors|mesh-ancestor
64887605|NCT01954108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887607|NCT01954108|Protective Agents|protective agents|mesh-ancestor
64887608|NCT01954186|Oxytocin|oxytocin|mesh-list
64887609|NCT01954186|Oxytocics|oxytocics|mesh-ancestor
64887645|NCT01954368|Anesthetics, General|anesthetics, general|mesh-ancestor
64887646|NCT01954368|Anesthetics|anesthetics|mesh-ancestor
64887647|NCT01954693|Everolimus|everolimus|mesh-list
64887648|NCT01954693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887649|NCT01954693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64887650|NCT01954693|Immunologic Factors|immunologic factors|mesh-ancestor
64887656|NCT01954784|Mycophenolic Acid|mycophenolic acid|mesh-list
64887658|NCT01954784|Fludarabine phosphate|fludarabine phosphate|mesh-list
64887659|NCT01954784|Lenalidomide|lenalidomide|mesh-list
64887660|NCT01954784|Bortezomib|bortezomib|mesh-list
64887661|NCT01954784|Cyclosporins|cyclosporins|mesh-list
64519514|NCT04748991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64519515|NCT04748991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519516|NCT04748991|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64519517|NCT04748991|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64519518|NCT04748991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64519519|NCT04748991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519520|NCT04748991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64519521|NCT04748991|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64519522|NCT04748991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64519523|NCT00176865|Cyclosporine|cyclosporine|mesh-list
64519524|NCT00176865|Mycophenolic Acid|mycophenolic acid|mesh-list
64519525|NCT00176865|Fludarabine|fludarabine|mesh-list
64519526|NCT00176865|Melphalan|melphalan|mesh-list
64519527|NCT00176865|Alemtuzumab|alemtuzumab|mesh-list
64519528|NCT00176865|Cyclosporins|cyclosporins|mesh-list
64519529|NCT00176865|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64519530|NCT00176865|Immunoglobulins|immunoglobulins|mesh-list
64519531|NCT00176865|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64519532|NCT00176865|gamma-Globulins|gamma-globulins|mesh-list
64519533|NCT00176865|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64519534|NCT00176865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519535|NCT00176865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519536|NCT00176865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64519537|NCT00176865|Immunologic Factors|immunologic factors|mesh-ancestor
64519538|NCT00176865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519539|NCT00176865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519540|NCT00176865|Antifungal Agents|antifungal agents|mesh-ancestor
64519541|NCT00176865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64519542|NCT00176865|Dermatologic Agents|dermatologic agents|mesh-ancestor
64519543|NCT00176865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64519544|NCT00176865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64519545|NCT00176865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64519546|NCT00176865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64519547|NCT00176865|Antitubercular Agents|antitubercular agents|mesh-ancestor
64887662|NCT01954784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887663|NCT01954784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64519548|NCT00176865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64519549|NCT00176865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64519550|NCT00176865|Alkylating Agents|alkylating agents|mesh-ancestor
64519551|NCT00176865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64519552|NCT00176865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64887676|NCT01954784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64887677|NCT01954784|Growth Substances|growth substances|mesh-ancestor
64887678|NCT01954784|Growth Inhibitors|growth inhibitors|mesh-ancestor
64887679|NCT01954784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64887680|NCT01954784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64887681|NCT01954784|Antitubercular Agents|antitubercular agents|mesh-ancestor
64887682|NCT01954784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64887683|NCT01954914|Plerixafor|plerixafor|mesh-list
64887684|NCT01954914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64887685|NCT01954914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64887686|NCT01954914|Antiviral Agents|antiviral agents|mesh-ancestor
64887687|NCT01954914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64887688|NCT01954992|Fluorouracil|fluorouracil|mesh-list
64887689|NCT01954992|Antimetabolites|antimetabolites|mesh-ancestor
64887690|NCT01954992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835922|NCT01605279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64835923|NCT01605279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835924|NCT01605279|Protective Agents|protective agents|mesh-ancestor
64835925|NCT01606072|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64887691|NCT01954992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64887692|NCT01954992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887693|NCT01954992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64887694|NCT01954992|Immunologic Factors|immunologic factors|mesh-ancestor
64887699|NCT01955057|Gasotransmitters|gasotransmitters|mesh-ancestor
64887700|NCT01955057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64887701|NCT01955057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887702|NCT01955070|Ketamine|ketamine|mesh-list
64887703|NCT01955070|Analgesics|analgesics|mesh-ancestor
64887704|NCT01955070|Sensory System Agents|sensory system agents|mesh-ancestor
64887705|NCT01955070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64887706|NCT01955070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887707|NCT01955070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64887708|NCT01955070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64887709|NCT01955070|Anesthetics, General|anesthetics, general|mesh-ancestor
64887710|NCT01955070|Anesthetics|anesthetics|mesh-ancestor
64887711|NCT01955070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64887712|NCT01955070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64887713|NCT01955070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64887714|NCT01955070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64887715|NCT01955070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887716|NCT01955135|Ketamine|ketamine|mesh-list
64887717|NCT01955135|Propofol|propofol|mesh-list
64887718|NCT01955135|Sevoflurane|sevoflurane|mesh-list
64887719|NCT01955135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64887720|NCT01955135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64887721|NCT01955135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887722|NCT01955135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64887723|NCT01955135|Anesthetics, General|anesthetics, general|mesh-ancestor
64887724|NCT01955135|Anesthetics|anesthetics|mesh-ancestor
64887725|NCT01955135|Analgesics|analgesics|mesh-ancestor
64887726|NCT01955135|Sensory System Agents|sensory system agents|mesh-ancestor
64887742|NCT01955187|Methylprednisolone|methylprednisolone|mesh-list
64887743|NCT01955187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64887744|NCT01955187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64887745|NCT01955187|Prednisolone|prednisolone|mesh-list
64887746|NCT01955187|Prednisolone acetate|prednisolone acetate|mesh-list
64887747|NCT01955187|Cyclophosphamide|cyclophosphamide|mesh-list
64887748|NCT01955187|Rituximab|rituximab|mesh-list
64887749|NCT01955187|Tacrolimus|tacrolimus|mesh-list
64887750|NCT01955187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64887751|NCT01955187|Prednisolone phosphate|prednisolone phosphate|mesh-list
64887752|NCT01955187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64887753|NCT01955187|Immunologic Factors|immunologic factors|mesh-ancestor
64519554|NCT02451072|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
64519555|NCT02451072|Hallucinogens|hallucinogens|mesh-ancestor
64519556|NCT02451072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519557|NCT02451072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64519558|NCT02451072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64519559|NCT02451072|Serotonin Agents|serotonin agents|mesh-ancestor
64519560|NCT02451072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64519561|NCT02451072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519562|NCT02451072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64519563|NCT02451072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64519564|NCT02451072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64519565|NCT03226626|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64519566|NCT03226626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64887754|NCT01955187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887755|NCT01955187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64887756|NCT01955187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64887757|NCT01955187|Alkylating Agents|alkylating agents|mesh-ancestor
64887758|NCT01955187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887759|NCT01955187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638798|NCT03660683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64887760|NCT01955187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64887761|NCT01955187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64887762|NCT01955187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64887763|NCT01955187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887764|NCT01955187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64887765|NCT01955187|Antiemetics|antiemetics|mesh-ancestor
64887766|NCT01955187|Autonomic Agents|autonomic agents|mesh-ancestor
64638800|NCT03660683|Incretins|incretins|mesh-ancestor
64887799|NCT01955213|Methylnaltrexone|methylnaltrexone|mesh-list
64887800|NCT01955213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64887801|NCT01955213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887802|NCT01955213|Sensory System Agents|sensory system agents|mesh-ancestor
64887803|NCT01955213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64887804|NCT01955252|Azithromycin|azithromycin|mesh-list
64887805|NCT01955252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64887806|NCT01955252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64887807|NCT01955317|Chlorhexidine|chlorhexidine|mesh-list
64887808|NCT01955317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64887809|NCT01955317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64887810|NCT01955317|Disinfectants|disinfectants|mesh-ancestor
64887811|NCT01955408|Cholinergic Antagonists|cholinergic antagonists|mesh-list
64519568|NCT02450994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64519569|NCT02450994|Antiemetics|antiemetics|mesh-ancestor
64519570|NCT02450994|Autonomic Agents|autonomic agents|mesh-ancestor
64519571|NCT02450994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64519572|NCT02450994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519573|NCT02450994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64887812|NCT01955408|Cholinergic Agents|cholinergic agents|mesh-ancestor
64887813|NCT01955408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64887814|NCT01955408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887822|NCT01955512|Clopidogrel|clopidogrel|mesh-list
64887823|NCT01955512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64887824|NCT01955512|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64887825|NCT01955512|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64887826|NCT01955512|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64887827|NCT01955512|Purinergic Agents|purinergic agents|mesh-ancestor
64887828|NCT01955512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64887829|NCT01955512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887830|NCT01955512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887831|NCT01955577|Vitamin D|vitamin d|mesh-list
64887832|NCT01955577|Cholecalciferol|cholecalciferol|mesh-list
64887833|NCT01955577|Vitamins|vitamins|mesh-ancestor
64887834|NCT01955577|Micronutrients|micronutrients|mesh-ancestor
64887835|NCT01955577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887836|NCT01955577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64887837|NCT01955577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64887838|NCT01955642|Clopidogrel|clopidogrel|mesh-list
64887839|NCT01955642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64887840|NCT01955642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64887841|NCT01955642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64887842|NCT01955642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64887843|NCT01955642|Purinergic Agents|purinergic agents|mesh-ancestor
64887855|NCT01955655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64887856|NCT01955655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887857|NCT01955694|Eplerenone|eplerenone|mesh-list
64887858|NCT01955694|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64887859|NCT01955694|Hormone Antagonists|hormone antagonists|mesh-ancestor
64887860|NCT01955694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64887861|NCT01955694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887862|NCT01955694|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64887863|NCT01955694|Diuretics|diuretics|mesh-ancestor
64887864|NCT01955694|Natriuretic Agents|natriuretic agents|mesh-ancestor
64887865|NCT01955694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64887866|NCT01955759|Amiodarone|amiodarone|mesh-list
64887867|NCT01955759|Bisoprolol|bisoprolol|mesh-list
64887868|NCT01955759|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64887869|NCT01955759|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64887870|NCT01955759|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64887871|NCT01955759|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64887872|NCT01955759|Antimetabolites|antimetabolites|mesh-ancestor
64887873|NCT01955759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887874|NCT01955759|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64887875|NCT01955759|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64887876|NCT01955759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887877|NCT01955759|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64887878|NCT01955759|Adrenergic Agents|adrenergic agents|mesh-ancestor
64887879|NCT01955759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64887880|NCT01955759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887881|NCT01955759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64887882|NCT01955759|Vasodilator Agents|vasodilator agents|mesh-ancestor
64887883|NCT01955759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64519574|NCT02450994|Glucocorticoids|glucocorticoids|mesh-ancestor
64519575|NCT02450994|Hormones|hormones|mesh-ancestor
64519576|NCT02450994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64519577|NCT02450994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64519578|NCT02450994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519579|NCT00177255|Docetaxel|docetaxel|mesh-list
64519580|NCT00177255|Capecitabine|capecitabine|mesh-list
64887884|NCT01955759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64887885|NCT01955759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64638827|NCT03011177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887895|NCT01955759|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64887896|NCT01955824|Lidocaine|lidocaine|mesh-list
64887897|NCT01955824|Anesthetics, Local|anesthetics, local|mesh-ancestor
64887898|NCT01955824|Anesthetics|anesthetics|mesh-ancestor
64887899|NCT01955824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64887900|NCT01955824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887901|NCT01955824|Sensory System Agents|sensory system agents|mesh-ancestor
64887902|NCT01955824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64887903|NCT01955824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64887904|NCT01955824|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64887912|NCT01955967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887913|NCT01955967|Sensory System Agents|sensory system agents|mesh-ancestor
64887914|NCT01955967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64887915|NCT01955967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64887916|NCT01955967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64887917|NCT01955967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64887918|NCT01955967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64887919|NCT01955967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887921|NCT01956006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64887922|NCT01956006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64887923|NCT01956006|Vasodilator Agents|vasodilator agents|mesh-ancestor
64887924|NCT01956006|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64887925|NCT01956006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64887926|NCT01956006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887927|NCT01956006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887928|NCT01956006|Protective Agents|protective agents|mesh-ancestor
64887929|NCT01956006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887930|NCT01956201|Atorvastatin|atorvastatin|mesh-list
64887931|NCT01956201|Fenofibrate|fenofibrate|mesh-list
64887932|NCT01956201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64887933|NCT01956201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64887934|NCT01956201|Antimetabolites|antimetabolites|mesh-ancestor
64887935|NCT01956201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887936|NCT01956201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64887937|NCT01956201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64887938|NCT01956201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887939|NCT01956305|Metformin|metformin|mesh-list
64887940|NCT01956305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64887941|NCT01956305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887942|NCT01956474|Riboflavin|riboflavin|mesh-list
64887943|NCT01956474|Vitamin B Complex|vitamin b complex|mesh-ancestor
64887944|NCT01956474|Vitamins|vitamins|mesh-ancestor
64887945|NCT01956474|Micronutrients|micronutrients|mesh-ancestor
64887946|NCT01956474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887947|NCT01956474|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64887948|NCT01956474|Dermatologic Agents|dermatologic agents|mesh-ancestor
64887949|NCT01956487|Propafenone|propafenone|mesh-list
64887950|NCT01956487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64519581|NCT00177255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519582|NCT00177255|Tubulin Modulators|tubulin modulators|mesh-ancestor
64519583|NCT00177255|Antimitotic Agents|antimitotic agents|mesh-ancestor
64519584|NCT00177255|Mitosis Modulators|mitosis modulators|mesh-ancestor
64519585|NCT00177255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519586|NCT00177255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64835944|NCT01607983|Nitric Oxide|nitric oxide|mesh-list
64887961|NCT01956591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64887962|NCT01956591|Cholinergic Agents|cholinergic agents|mesh-ancestor
64887963|NCT01956591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64887964|NCT01956591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887965|NCT01956591|Urological Agents|urological agents|mesh-ancestor
64887966|NCT01956604|Clonidine|clonidine|mesh-list
64887967|NCT01956604|Analgesics|analgesics|mesh-ancestor
64887968|NCT01956604|Sensory System Agents|sensory system agents|mesh-ancestor
64887969|NCT01956604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64887988|NCT01956695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64887990|NCT01956695|Growth Inhibitors|growth inhibitors|mesh-ancestor
64887991|NCT01956734|Temozolomide|temozolomide|mesh-list
64887992|NCT01956734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64887993|NCT01956734|Alkylating Agents|alkylating agents|mesh-ancestor
64887994|NCT01956734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887995|NCT01956734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887996|NCT01956786|Amlodipine|amlodipine|mesh-list
64887997|NCT01956786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64887998|NCT01956786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64887999|NCT01956786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64888000|NCT01956786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888001|NCT01956786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64888002|NCT01956786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888003|NCT01956786|Vasodilator Agents|vasodilator agents|mesh-ancestor
64888004|NCT01956864|Vitamin D|vitamin d|mesh-list
64888005|NCT01956864|Vitamins|vitamins|mesh-ancestor
64888006|NCT01956864|Micronutrients|micronutrients|mesh-ancestor
64888007|NCT01956864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888008|NCT01956864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64888009|NCT01956929|Metformin|metformin|mesh-list
64888010|NCT01956929|Lactulose|lactulose|mesh-list
64888011|NCT01956929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64888012|NCT01956929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888013|NCT01956929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64888014|NCT01956955|Heparin|heparin|mesh-list
64888015|NCT01956955|Enoxaparin|enoxaparin|mesh-list
64888016|NCT01956955|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64888017|NCT01956955|Calcium heparin|calcium heparin|mesh-list
64888018|NCT01956955|Anticoagulants|anticoagulants|mesh-ancestor
64888019|NCT01956955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64888020|NCT01956955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64888021|NCT01956955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888022|NCT01956981|Magnesium Sulfate|magnesium sulfate|mesh-list
64888023|NCT01956981|Dexmedetomidine|dexmedetomidine|mesh-list
64888024|NCT01956981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64888025|NCT01956981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64888052|NCT01957046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64888053|NCT01957189|Tamsulosin|tamsulosin|mesh-list
64888054|NCT01957189|Dutasteride|dutasteride|mesh-list
64888055|NCT01957189|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64888056|NCT01957189|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64519587|NCT00177255|Antimetabolites|antimetabolites|mesh-ancestor
64519589|NCT02401048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64519590|NCT02401048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888057|NCT01957189|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64888058|NCT01957189|Adrenergic Agents|adrenergic agents|mesh-ancestor
64888065|NCT01957189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64888066|NCT01957189|Hormone Antagonists|hormone antagonists|mesh-ancestor
64888067|NCT01957189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64888068|NCT01957293|Albuterol|albuterol|mesh-list
64888069|NCT01957293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64888070|NCT01957293|Autonomic Agents|autonomic agents|mesh-ancestor
64888071|NCT01957293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64888072|NCT01957293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888101|NCT01957436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64888102|NCT01957436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64888103|NCT01957436|Hormone Antagonists|hormone antagonists|mesh-ancestor
64888104|NCT01957436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64888105|NCT01957436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888106|NCT01957436|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64656656|NCT02455050|Laxatives|laxatives|mesh-ancestor
64888107|NCT01957436|Hormones|hormones|mesh-ancestor
64888108|NCT01957449|Propranolol|propranolol|mesh-list
64888109|NCT01957449|Metoprolol|metoprolol|mesh-list
64888110|NCT01957449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64888111|NCT01957449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64888112|NCT01957449|Adrenergic Agents|adrenergic agents|mesh-ancestor
64888113|NCT01957449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888114|NCT01957449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888115|NCT01957449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888116|NCT01957449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64888117|NCT01957449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64888118|NCT01957449|Vasodilator Agents|vasodilator agents|mesh-ancestor
64888126|NCT01957540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64888127|NCT01957540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64888129|NCT01957540|Purinergic Agents|purinergic agents|mesh-ancestor
64888130|NCT01957540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888131|NCT01957540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888132|NCT01957540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888133|NCT01957631|Methylprednisolone|methylprednisolone|mesh-list
64888134|NCT01957631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64888135|NCT01957631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64888136|NCT01957631|Prednisolone|prednisolone|mesh-list
64888137|NCT01957631|Prednisolone acetate|prednisolone acetate|mesh-list
64888138|NCT01957631|Bupivacaine|bupivacaine|mesh-list
64888139|NCT01957631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64888140|NCT01957631|Prednisolone phosphate|prednisolone phosphate|mesh-list
64888141|NCT01957631|Anesthetics, Local|anesthetics, local|mesh-ancestor
64888142|NCT01957631|Anesthetics|anesthetics|mesh-ancestor
64888143|NCT01957631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64888144|NCT01957631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888145|NCT01957631|Sensory System Agents|sensory system agents|mesh-ancestor
64888146|NCT01957631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64888147|NCT01957631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64888148|NCT01957631|Antiemetics|antiemetics|mesh-ancestor
64888149|NCT01957631|Autonomic Agents|autonomic agents|mesh-ancestor
64888150|NCT01957631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64888151|NCT01957631|Glucocorticoids|glucocorticoids|mesh-ancestor
64888152|NCT01957631|Hormones|hormones|mesh-ancestor
64888153|NCT01957631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64888154|NCT01957631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64888155|NCT01957631|Protective Agents|protective agents|mesh-ancestor
64888156|NCT01957631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64888157|NCT01957631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519591|NCT02046382|Acetaminophen|acetaminophen|mesh-list
64519592|NCT02046382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64519593|NCT02046382|Analgesics|analgesics|mesh-ancestor
64888163|NCT01957839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888164|NCT01957839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888165|NCT01957839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888166|NCT01957852|Thrombin|thrombin|mesh-list
64888167|NCT01957852|Hemostatics|hemostatics|mesh-ancestor
64888168|NCT01957852|Coagulants|coagulants|mesh-ancestor
64888169|NCT01957943|SMOFlipid|smoflipid|mesh-list
64888170|NCT01957943|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64888171|NCT01957943|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64888172|NCT01957943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64888173|NCT01957995|Docetaxel|docetaxel|mesh-list
64888174|NCT01957995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888175|NCT01957995|Tubulin Modulators|tubulin modulators|mesh-ancestor
64888176|NCT01957995|Antimitotic Agents|antimitotic agents|mesh-ancestor
64888177|NCT01957995|Mitosis Modulators|mitosis modulators|mesh-ancestor
64888178|NCT01957995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888179|NCT01958138|Propofol|propofol|mesh-list
64888180|NCT01958138|Isoflurane|isoflurane|mesh-list
64888181|NCT01958138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64888182|NCT01958138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64888183|NCT01958138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888184|NCT01958138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64888185|NCT01958138|Anesthetics, General|anesthetics, general|mesh-ancestor
64888186|NCT01958138|Anesthetics|anesthetics|mesh-ancestor
64888209|NCT01958580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64888210|NCT01958580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64888211|NCT01958580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64888212|NCT01958580|Immunologic Factors|immunologic factors|mesh-ancestor
64888213|NCT01958580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888214|NCT01958580|Tubulin Modulators|tubulin modulators|mesh-ancestor
64888215|NCT01958580|Antimitotic Agents|antimitotic agents|mesh-ancestor
64888216|NCT01958580|Mitosis Modulators|mitosis modulators|mesh-ancestor
64888217|NCT01958684|Copper|copper|mesh-list
64888218|NCT01958684|Levonorgestrel|levonorgestrel|mesh-list
64888219|NCT01958684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64888220|NCT01958684|Contraceptive Agents|contraceptive agents|mesh-ancestor
64888221|NCT01958684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64888222|NCT01958684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888223|NCT01958684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64888224|NCT01958684|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64888225|NCT01958684|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64888226|NCT01958684|Trace Elements|trace elements|mesh-ancestor
64888227|NCT01958684|Micronutrients|micronutrients|mesh-ancestor
64888228|NCT01958775|Glucagon|glucagon|mesh-list
64888229|NCT01958775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64888230|NCT01958775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64888231|NCT01958775|Hormones|hormones|mesh-ancestor
64888232|NCT01958775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64888233|NCT01958775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888234|NCT01958775|Incretins|incretins|mesh-ancestor
64888235|NCT01958814|Albuterol|albuterol|mesh-list
64888236|NCT01958814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64888237|NCT01958814|Autonomic Agents|autonomic agents|mesh-ancestor
64888238|NCT01958814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64888268|NCT01958944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888269|NCT01958944|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64888270|NCT01958944|Respiratory System Agents|respiratory system agents|mesh-ancestor
64888271|NCT01958944|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64888272|NCT01958944|Antioxidants|antioxidants|mesh-ancestor
64888273|NCT01958944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888274|NCT01958944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64519596|NCT02046382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519597|NCT02046382|Antipyretics|antipyretics|mesh-ancestor
64519598|NCT03205176|Olaparib|olaparib|mesh-list
64888310|NCT01959074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64888311|NCT01959074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888312|NCT01959074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64888313|NCT01959074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64888314|NCT01959074|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64888315|NCT01959074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64888316|NCT01959074|Adrenergic Agents|adrenergic agents|mesh-ancestor
64888317|NCT01959074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888318|NCT01959074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888319|NCT01959074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64888320|NCT01959074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64888321|NCT01959074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64888322|NCT01959074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64888323|NCT01959074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64888324|NCT01959100|Azithromycin|azithromycin|mesh-list
64888325|NCT01959100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64888326|NCT01959100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64888327|NCT01959152|Imidacloprid|imidacloprid|mesh-list
64888328|NCT01959152|Cholinergic Agents|cholinergic agents|mesh-ancestor
64888329|NCT01959152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888330|NCT01959152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888331|NCT01959152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888360|NCT01959399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64888417|NCT01959854|Laxatives|laxatives|mesh-ancestor
64888418|NCT01959854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64888419|NCT01960023|Cetuximab|cetuximab|mesh-list
64888420|NCT01960023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64888421|NCT01960023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888422|NCT01960049|Ropivacaine|ropivacaine|mesh-list
64888438|NCT01960179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888439|NCT01960205|Metformin|metformin|mesh-list
64888440|NCT01960205|Saxagliptin|saxagliptin|mesh-list
64888441|NCT01960205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64519633|NCT00085293|Azacitidine|azacitidine|mesh-list
64519634|NCT00085293|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64519635|NCT00085293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64519636|NCT00085293|Antimetabolites|antimetabolites|mesh-ancestor
64519637|NCT00085293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519638|NCT00085293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519639|NCT00085293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519640|NCT00085293|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64519641|NCT02402062|Sunitinib|sunitinib|mesh-list
64519642|NCT02402062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64519643|NCT02402062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64519644|NCT02402062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64519645|NCT02402062|Growth Substances|growth substances|mesh-ancestor
64519646|NCT02402062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519647|NCT02402062|Growth Inhibitors|growth inhibitors|mesh-ancestor
64519648|NCT02402062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64519649|NCT02402062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64519650|NCT02402062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64519651|NCT02450838|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64519652|NCT02450838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64519653|NCT02450838|Immunologic Factors|immunologic factors|mesh-ancestor
64519654|NCT02450838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64519670|NCT00085839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64519672|NCT00085839|Tubulin Modulators|tubulin modulators|mesh-ancestor
64888588|NCT01961635|Histamine Agents|histamine agents|mesh-ancestor
64888589|NCT01961635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888590|NCT01961635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888591|NCT01961635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888592|NCT01961635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64888593|NCT01961635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64888594|NCT01961635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64888595|NCT01961739|Lidocaine|lidocaine|mesh-list
64888596|NCT01961739|Anesthetics, Local|anesthetics, local|mesh-ancestor
64888597|NCT01961739|Anesthetics|anesthetics|mesh-ancestor
64888598|NCT01961739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64639346|NCT01460875|Interferon alpha-2|interferon alpha-2|mesh-list
64888666|NCT01962181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64888667|NCT01962181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888668|NCT01962181|Dopamine Agents|dopamine agents|mesh-ancestor
64888669|NCT01962181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888670|NCT01962285|Propofol|propofol|mesh-list
64888671|NCT01962285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64888672|NCT01962285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64888673|NCT01962285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888674|NCT01962285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64888675|NCT01962285|Anesthetics, General|anesthetics, general|mesh-ancestor
64888676|NCT01962285|Anesthetics|anesthetics|mesh-ancestor
64888677|NCT01962363|Tocotrienols|tocotrienols|mesh-list
64888678|NCT01962363|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
64888679|NCT01962363|Antioxidants|antioxidants|mesh-ancestor
64888680|NCT01962363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888681|NCT01962363|Protective Agents|protective agents|mesh-ancestor
64888682|NCT01962363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888683|NCT01962363|Vitamins|vitamins|mesh-ancestor
64888684|NCT01962363|Micronutrients|micronutrients|mesh-ancestor
64888685|NCT01962376|Bevacizumab|bevacizumab|mesh-list
64888686|NCT01962376|Capecitabine|capecitabine|mesh-list
64888687|NCT01962376|Oxaliplatin|oxaliplatin|mesh-list
64888688|NCT01962376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64888689|NCT01962376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888690|NCT01962376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64888691|NCT01962376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64888692|NCT01962376|Growth Substances|growth substances|mesh-ancestor
64888693|NCT01962376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888694|NCT01962376|Growth Inhibitors|growth inhibitors|mesh-ancestor
64888695|NCT01962376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64888696|NCT01962376|Antimetabolites|antimetabolites|mesh-ancestor
64325685|NCT04822337|Glucocorticoids|glucocorticoids|mesh-ancestor
64325686|NCT04822337|Hormones|hormones|mesh-ancestor
64325687|NCT04822337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64639706|NCT00343460|Hormones|hormones|mesh-ancestor
64889269|NCT01966055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64889270|NCT01966055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64889286|NCT01966172|Narcotics|narcotics|mesh-ancestor
64889287|NCT01966172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64889288|NCT01966172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889289|NCT01966172|Analgesics|analgesics|mesh-ancestor
64889290|NCT01966172|Sensory System Agents|sensory system agents|mesh-ancestor
64889291|NCT01966172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889292|NCT01966172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64889293|NCT01966172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64889294|NCT01966172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64889295|NCT01966172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64889296|NCT01966172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889297|NCT01966172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889298|NCT01966172|Antipyretics|antipyretics|mesh-ancestor
64889299|NCT01966172|Anticonvulsants|anticonvulsants|mesh-ancestor
64889300|NCT01966172|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64889301|NCT01966172|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64889302|NCT01966172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64889303|NCT01966172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64889304|NCT01966172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64889305|NCT01966172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64889306|NCT01966172|Antimanic Agents|antimanic agents|mesh-ancestor
64889307|NCT01966276|Methylphenidate|methylphenidate|mesh-list
64889308|NCT01966276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64889309|NCT01966276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889679|NCT01968577|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64889680|NCT01968577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64889681|NCT01968577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64889682|NCT01968577|Antimetabolites|antimetabolites|mesh-ancestor
64889692|NCT01968616|Growth Inhibitors|growth inhibitors|mesh-ancestor
64889693|NCT01968616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889694|NCT01968655|Factor VIII|factor viii|mesh-list
64889695|NCT01968655|Coagulants|coagulants|mesh-ancestor
64889697|NCT01968759|Irbesartan|irbesartan|mesh-list
64889698|NCT01968759|Sevelamer|sevelamer|mesh-list
64889699|NCT01968759|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64889700|NCT01968759|Protease Inhibitors|protease inhibitors|mesh-ancestor
64889701|NCT01968759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889702|NCT01968759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889703|NCT01968759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64889721|NCT01968798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64889722|NCT01968798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889723|NCT01968798|Antipyretics|antipyretics|mesh-ancestor
64889725|NCT01968850|Alendronate|alendronate|mesh-list
64889727|NCT01968850|Micronutrients|micronutrients|mesh-ancestor
64889728|NCT01968850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889729|NCT01968850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64889730|NCT01968915|Paclitaxel|paclitaxel|mesh-list
64889731|NCT01968915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64889732|NCT01968915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889733|NCT01968915|Tubulin Modulators|tubulin modulators|mesh-ancestor
64643401|NCT01505179|Ranolazine|ranolazine|mesh-list
64520063|NCT04645719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64890031|NCT01970917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64890032|NCT01971034|Metformin|metformin|mesh-list
64890033|NCT01971034|Paclitaxel|paclitaxel|mesh-list
64890034|NCT01971034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64890035|NCT01971034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890036|NCT01971034|Tubulin Modulators|tubulin modulators|mesh-ancestor
64890037|NCT01971034|Antimitotic Agents|antimitotic agents|mesh-ancestor
64890038|NCT01971034|Mitosis Modulators|mitosis modulators|mesh-ancestor
64890162|NCT01971658|Antiemetics|antiemetics|mesh-ancestor
64890163|NCT01971658|Autonomic Agents|autonomic agents|mesh-ancestor
64890483|NCT01973933|Pyrimethamine|pyrimethamine|mesh-list
64890484|NCT01973933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64890485|NCT01973933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890486|NCT01973933|Antimalarials|antimalarials|mesh-ancestor
64890487|NCT01973933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64890488|NCT01973933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64890489|NCT01973933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64325690|NCT04822337|Immunologic Factors|immunologic factors|mesh-ancestor
64835945|NCT01607983|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64890490|NCT01973933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64890491|NCT01973933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890492|NCT01973933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890493|NCT01974024|Methylprednisolone|methylprednisolone|mesh-list
64890494|NCT01974024|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64890495|NCT01974024|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64890496|NCT01974024|Prednisolone|prednisolone|mesh-list
64890497|NCT01974024|Prednisolone acetate|prednisolone acetate|mesh-list
64890498|NCT01974024|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64890499|NCT01974024|Prednisolone phosphate|prednisolone phosphate|mesh-list
64890500|NCT01974024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64890559|NCT01974401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64890560|NCT01974401|Disinfectants|disinfectants|mesh-ancestor
64890561|NCT01974518|Cyclophosphamide|cyclophosphamide|mesh-list
64890562|NCT01974518|Rituximab|rituximab|mesh-list
64890732|NCT01975753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64890733|NCT01975753|Narcotics|narcotics|mesh-ancestor
64890734|NCT01975753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64890786|NCT01976078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644828|NCT00613028|Growth Substances|growth substances|mesh-ancestor
64891063|NCT01978678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64891064|NCT01978678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891065|NCT01978678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64891066|NCT01978678|Respiratory System Agents|respiratory system agents|mesh-ancestor
64891067|NCT01978678|Glucocorticoids|glucocorticoids|mesh-ancestor
64891068|NCT01978678|Hormones|hormones|mesh-ancestor
64891069|NCT01978678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64891070|NCT01978704|Insulin|insulin|mesh-list
64891071|NCT01978704|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64891072|NCT01978704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64891073|NCT01978704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891074|NCT01978717|Anesthetics|anesthetics|mesh-list
64891075|NCT01978717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64891076|NCT01978717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891077|NCT01978782|Raltegravir Potassium|raltegravir potassium|mesh-list
64891108|NCT01978873|Estrogens|estrogens|mesh-ancestor
64891109|NCT01978873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64891110|NCT01978873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891111|NCT01978873|Anabolic Agents|anabolic agents|mesh-ancestor
64891112|NCT01979341|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64891113|NCT01979341|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64891114|NCT01979341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891118|NCT01979341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64891119|NCT01979341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64645304|NCT03006835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520364|NCT03834688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520366|NCT01710527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64891465|NCT01981941|Antimanic Agents|antimanic agents|mesh-ancestor
64891466|NCT01982019|Hormones|hormones|mesh-list
64645733|NCT00588536|Leucovorin|leucovorin|mesh-list
64891742|NCT01984073|Niacin|niacin|mesh-list
64891743|NCT01984073|Niacinamide|niacinamide|mesh-list
64891744|NCT01984073|Nicotinic Acids|nicotinic acids|mesh-list
64891745|NCT01984073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64891746|NCT01984073|Antimetabolites|antimetabolites|mesh-ancestor
64891747|NCT01984073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891748|NCT01984073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64891760|NCT01984086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64891761|NCT01984086|Respiratory System Agents|respiratory system agents|mesh-ancestor
64891762|NCT01984086|Tocolytic Agents|tocolytic agents|mesh-ancestor
64891763|NCT01984086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64646102|NCT00650078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891764|NCT01984086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64891765|NCT01984086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64891766|NCT01984086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64891767|NCT01984086|Adrenergic Agents|adrenergic agents|mesh-ancestor
64891768|NCT01984086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64835949|NCT01607983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64891769|NCT01984086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891770|NCT01984086|Antidotes|antidotes|mesh-ancestor
64891771|NCT01984086|Protective Agents|protective agents|mesh-ancestor
64891772|NCT01984099|Folic Acid|folic acid|mesh-list
64891773|NCT01984099|Vitamin B Complex|vitamin b complex|mesh-list
64891774|NCT01984099|Methotrexate|methotrexate|mesh-list
64891775|NCT01984099|Vitamins|vitamins|mesh-ancestor
64891776|NCT01984099|Micronutrients|micronutrients|mesh-ancestor
64891777|NCT01984099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891778|NCT01984099|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64891779|NCT01984099|Abortifacient Agents|abortifacient agents|mesh-ancestor
64891780|NCT01984099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64891781|NCT01984099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64891782|NCT01984099|Antimetabolites|antimetabolites|mesh-ancestor
64891783|NCT01984099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891784|NCT01984099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891785|NCT01984099|Dermatologic Agents|dermatologic agents|mesh-ancestor
64891786|NCT01984099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64891787|NCT01984099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64891788|NCT01984099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64891789|NCT01984099|Immunologic Factors|immunologic factors|mesh-ancestor
64520403|NCT01709903|Glycopyrrolate|glycopyrrolate|mesh-list
64520404|NCT01709903|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64520405|NCT01709903|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64520406|NCT01709903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64520407|NCT01709903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64520408|NCT01709903|Autonomic Agents|autonomic agents|mesh-ancestor
64891790|NCT01984099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64891791|NCT01984099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64891792|NCT01984099|Hematinics|hematinics|mesh-ancestor
64891794|NCT01984177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64891795|NCT01984177|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
64891796|NCT01984177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64646105|NCT01799486|Adefovir|adefovir|mesh-list
64891835|NCT01984606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64891836|NCT01984606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64891837|NCT01984606|Protease Inhibitors|protease inhibitors|mesh-ancestor
64891838|NCT01984606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64891839|NCT01984606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891840|NCT01984606|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64891841|NCT01984749|Febuxostat|febuxostat|mesh-list
64891842|NCT01984749|Gout Suppressants|gout suppressants|mesh-ancestor
64891843|NCT01984749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64891844|NCT01984827|Moxifloxacin|moxifloxacin|mesh-list
64891845|NCT01984827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64891846|NCT01984827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64891847|NCT01984827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64891848|NCT01984827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64891849|NCT01984827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64891850|NCT01984827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891851|NCT01984827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891852|NCT01984931|Medazepam|medazepam|mesh-list
64891853|NCT01984931|Metoclopramide|metoclopramide|mesh-list
64891854|NCT01984931|Bromazepam|bromazepam|mesh-list
64891855|NCT01984931|Simethicone|simethicone|mesh-list
64891856|NCT01984931|Trimebutine|trimebutine|mesh-list
64891857|NCT01984931|Mosapride|mosapride|mesh-list
64891858|NCT01984931|Maleic acid|maleic acid|mesh-list
64891859|NCT01984931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64891860|NCT01984931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891861|NCT01984931|Antiemetics|antiemetics|mesh-ancestor
64891862|NCT01984931|Autonomic Agents|autonomic agents|mesh-ancestor
64891863|NCT01984931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64891864|NCT01984931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891865|NCT01984931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64891866|NCT01984931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64891902|NCT01985152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64891903|NCT01985152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64891904|NCT01985152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835957|NCT01607983|Gasotransmitters|gasotransmitters|mesh-ancestor
64891905|NCT01985152|Lipotropic Agents|lipotropic agents|mesh-ancestor
64891906|NCT01985152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64891907|NCT01985152|Antimetabolites|antimetabolites|mesh-ancestor
64891908|NCT01985152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64891909|NCT01985152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64891910|NCT01985152|Nootropic Agents|nootropic agents|mesh-ancestor
64891911|NCT01985256|Flucytosine|flucytosine|mesh-list
64891912|NCT01985256|Antifungal Agents|antifungal agents|mesh-ancestor
64891913|NCT01985256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64891914|NCT01985256|Antimetabolites|antimetabolites|mesh-ancestor
64891915|NCT01985256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891916|NCT01985373|Immunoglobulins|immunoglobulins|mesh-list
64891917|NCT01985373|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64891919|NCT01985373|gamma-Globulins|gamma-globulins|mesh-list
64891920|NCT01985373|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64891921|NCT01985373|Immunologic Factors|immunologic factors|mesh-ancestor
64891922|NCT01985373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891923|NCT01985451|Temozolomide|temozolomide|mesh-list
64891924|NCT01985451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64891925|NCT01985451|Alkylating Agents|alkylating agents|mesh-ancestor
64891926|NCT01985451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891927|NCT01985451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891938|NCT01985477|Hormones|hormones|mesh-ancestor
64646140|NCT00651482|Growth Substances|growth substances|mesh-ancestor
64891961|NCT01985594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64891962|NCT01985724|Cyclophosphamide|cyclophosphamide|mesh-list
64891963|NCT01985724|Docetaxel|docetaxel|mesh-list
64891964|NCT01985724|Epirubicin|epirubicin|mesh-list
64891965|NCT01985724|Fluorouracil|fluorouracil|mesh-list
64891966|NCT01985724|Lenograstim|lenograstim|mesh-list
64891967|NCT01985724|Mitogens|mitogens|mesh-list
64891968|NCT01985724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64891969|NCT01985724|Immunologic Factors|immunologic factors|mesh-ancestor
64891970|NCT01985724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891986|NCT01985724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64891987|NCT01985750|Cycloserine|cycloserine|mesh-list
64891988|NCT01985750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64891989|NCT01985750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64891990|NCT01985750|Renal Agents|renal agents|mesh-ancestor
64891991|NCT01985750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64891992|NCT01985750|Antitubercular Agents|antitubercular agents|mesh-ancestor
64891993|NCT01985750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64891994|NCT01985750|Antimetabolites|antimetabolites|mesh-ancestor
64892010|NCT01985789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64892011|NCT01985789|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64892012|NCT01985789|Histamine Antagonists|histamine antagonists|mesh-ancestor
64892014|NCT01985789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64892015|NCT01985789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892016|NCT01985789|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64892017|NCT01985789|Antipruritics|antipruritics|mesh-ancestor
64892018|NCT01985789|Dermatologic Agents|dermatologic agents|mesh-ancestor
64892019|NCT01985789|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64892020|NCT01985789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64892021|NCT01985789|Cholinergic Agents|cholinergic agents|mesh-ancestor
64520431|NCT03202446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64520432|NCT03202446|Immunologic Factors|immunologic factors|mesh-ancestor
64520433|NCT03202446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520434|NCT03202446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64520435|NCT03202446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64520436|NCT03202446|Alkylating Agents|alkylating agents|mesh-ancestor
64520437|NCT03202446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520438|NCT03202446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520439|NCT03202446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64520440|NCT03202446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64520441|NCT03202446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64520442|NCT03202446|Antimetabolites|antimetabolites|mesh-ancestor
64520443|NCT03202446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64520444|NCT03202446|Chelating Agents|chelating agents|mesh-ancestor
64520445|NCT03202446|Sequestering Agents|sequestering agents|mesh-ancestor
64520446|NCT03202446|Hemostatics|hemostatics|mesh-ancestor
64520447|NCT03202446|Coagulants|coagulants|mesh-ancestor
64520448|NCT05718934|Glycopyrrolate|glycopyrrolate|mesh-list
64520449|NCT05718934|Neostigmine|neostigmine|mesh-list
64520450|NCT05718934|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64520451|NCT05718934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520452|NCT05718934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520453|NCT05718934|Cholinergic Agents|cholinergic agents|mesh-ancestor
64892028|NCT01985841|Fluorouracil|fluorouracil|mesh-list
64892029|NCT01985841|Epirubicin|epirubicin|mesh-list
64892030|NCT01985841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64892031|NCT01985841|Immunologic Factors|immunologic factors|mesh-ancestor
64892032|NCT01985841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892033|NCT01985841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64892034|NCT01985841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64892035|NCT01985841|Alkylating Agents|alkylating agents|mesh-ancestor
64892036|NCT01985841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646213|NCT02998268|Pembrolizumab|pembrolizumab|mesh-list
64892053|NCT01985854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64892054|NCT01985854|Anesthetics, General|anesthetics, general|mesh-ancestor
64892081|NCT01986088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892082|NCT01986088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892083|NCT01986127|Adalimumab|adalimumab|mesh-list
64892084|NCT01986127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64892085|NCT01986127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64892086|NCT01986192|Warfarin|warfarin|mesh-list
64892087|NCT01986192|Rivaroxaban|rivaroxaban|mesh-list
64892088|NCT01986192|Anticoagulants|anticoagulants|mesh-ancestor
64520491|NCT05718466|Temozolomide|temozolomide|mesh-list
64520492|NCT05718466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64520493|NCT05718466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520494|NCT05718466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64520495|NCT05718466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64520496|NCT05718466|Growth Substances|growth substances|mesh-ancestor
64520497|NCT05718466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520498|NCT05718466|Growth Inhibitors|growth inhibitors|mesh-ancestor
64520499|NCT05718466|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64520500|NCT05718466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64520501|NCT05718466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520502|NCT05718466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520503|NCT05718466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64520504|NCT05718466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64520505|NCT05718466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64520506|NCT05718466|Alkylating Agents|alkylating agents|mesh-ancestor
64520507|NCT03208452|Magnesium Sulfate|magnesium sulfate|mesh-list
64892089|NCT01986192|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64892090|NCT01986192|Antithrombins|antithrombins|mesh-ancestor
64892091|NCT01986192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64892092|NCT01986192|Protease Inhibitors|protease inhibitors|mesh-ancestor
64892093|NCT01986192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64892094|NCT01986192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892095|NCT01986270|Sumatriptan|sumatriptan|mesh-list
64892096|NCT01986270|Eletriptan|eletriptan|mesh-list
64892097|NCT01986270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64892098|NCT01986270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64892099|NCT01986270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64892100|NCT01986270|Serotonin Agents|serotonin agents|mesh-ancestor
64892101|NCT01986270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64598525|NCT00696761|Alfuzosin|alfuzosin|mesh-list
64892102|NCT01986270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892103|NCT01986270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892135|NCT01986465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64892136|NCT01986465|Prednisolone|prednisolone|mesh-list
64892137|NCT01986465|Prednisolone acetate|prednisolone acetate|mesh-list
64892138|NCT01986465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64892139|NCT01986465|Prednisolone phosphate|prednisolone phosphate|mesh-list
64892140|NCT01986465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64520509|NCT03208452|Sensory System Agents|sensory system agents|mesh-ancestor
64520510|NCT03208452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520511|NCT03208452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520512|NCT03208452|Anesthetics|anesthetics|mesh-ancestor
64520513|NCT03208452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64520514|NCT03208452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64520515|NCT03208452|Anticonvulsants|anticonvulsants|mesh-ancestor
64520516|NCT03208452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64520517|NCT03208452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64520518|NCT03208452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520519|NCT03208452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64520520|NCT03208452|Tocolytic Agents|tocolytic agents|mesh-ancestor
64520521|NCT03208452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64520522|NCT05718310|Nitroglycerin|nitroglycerin|mesh-list
64520523|NCT05718310|Vasodilator Agents|vasodilator agents|mesh-ancestor
64520524|NCT03224208|Vemurafenib|vemurafenib|mesh-list
64520525|NCT03224208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520526|NCT03224208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64520527|NCT03224208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520528|NCT03224208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892141|NCT01986465|Antiemetics|antiemetics|mesh-ancestor
64892142|NCT01986465|Autonomic Agents|autonomic agents|mesh-ancestor
64892143|NCT01986465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64892144|NCT01986465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892145|NCT01986465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64892146|NCT01986465|Glucocorticoids|glucocorticoids|mesh-ancestor
64892147|NCT01986465|Hormones|hormones|mesh-ancestor
64892148|NCT01986465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64892149|NCT01986465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64892150|NCT01986465|Protective Agents|protective agents|mesh-ancestor
64892151|NCT01986465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64892152|NCT01986465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64892180|NCT01986608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64892181|NCT01986608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892183|NCT01986660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64892184|NCT01986660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64892185|NCT01986660|Analgesics|analgesics|mesh-ancestor
64892186|NCT01986660|Sensory System Agents|sensory system agents|mesh-ancestor
64892187|NCT01986660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64892188|NCT01986660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892189|NCT01986660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64892190|NCT01986660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64892191|NCT01986660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64892192|NCT01986660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64892193|NCT01986660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892194|NCT01986673|Sildenafil Citrate|sildenafil citrate|mesh-list
64892195|NCT01986673|Vasodilator Agents|vasodilator agents|mesh-ancestor
64892196|NCT01986673|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64892197|NCT01986673|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64892198|NCT01986673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64892199|NCT01986673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892200|NCT01986673|Urological Agents|urological agents|mesh-ancestor
64892201|NCT01986764|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64892202|NCT01986764|Estradiol|estradiol|mesh-list
64892203|NCT01986764|Estrogens|estrogens|mesh-list
64892204|NCT01986764|Hormones|hormones|mesh-ancestor
64892205|NCT01986764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64892206|NCT01986764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892207|NCT01986764|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64646280|NCT01194479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64892219|NCT01986777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64892220|NCT01986777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892221|NCT01986777|Dopamine Agents|dopamine agents|mesh-ancestor
64892222|NCT01986777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64892223|NCT01986894|Moxifloxacin|moxifloxacin|mesh-list
64892224|NCT01986894|Thalidomide|thalidomide|mesh-list
64892225|NCT01986894|Pomalidomide|pomalidomide|mesh-list
64892226|NCT01986894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64892227|NCT01986894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64892228|NCT01986894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64892229|NCT01986894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64892261|NCT01987076|Prednisone|prednisone|mesh-list
64892262|NCT01987076|Clobetasol|clobetasol|mesh-list
64892263|NCT01987076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64892264|NCT01987076|Glucocorticoids|glucocorticoids|mesh-ancestor
64892265|NCT01987076|Hormones|hormones|mesh-ancestor
64892266|NCT01987076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64892267|NCT01987076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892268|NCT01987076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64892269|NCT01987076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520537|NCT00355966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64520538|NCT00355966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520539|NCT00355966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64520540|NCT00355966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64520541|NCT00355966|Oxytocics|oxytocics|mesh-ancestor
64520542|NCT03208218|Lenalidomide|lenalidomide|mesh-list
64520543|NCT03208218|Immunologic Factors|immunologic factors|mesh-ancestor
64520544|NCT03208218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520545|NCT03208218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64520546|NCT03208218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64520547|NCT03208218|Growth Substances|growth substances|mesh-ancestor
64520548|NCT03208218|Growth Inhibitors|growth inhibitors|mesh-ancestor
64520549|NCT03208218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520550|NCT05372380|Atorvastatin|atorvastatin|mesh-list
64520551|NCT05372380|Ezetimibe|ezetimibe|mesh-list
64520552|NCT05372380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64520553|NCT05372380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64520554|NCT05372380|Antimetabolites|antimetabolites|mesh-ancestor
64520555|NCT05372380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520556|NCT05372380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64520557|NCT05372380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64520558|NCT05372380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520559|NCT02451774|Pentoxifylline|pentoxifylline|mesh-list
64520560|NCT02451774|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64520561|NCT02451774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520562|NCT02451774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520563|NCT02451774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64520564|NCT02451774|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64520565|NCT02451774|Protective Agents|protective agents|mesh-ancestor
64520566|NCT02451774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520581|NCT00355576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64520582|NCT00355576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520583|NCT00355576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520584|NCT00355576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64520585|NCT00355576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64520586|NCT03195582|Chlorhexidine|chlorhexidine|mesh-list
64520587|NCT03195582|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64520588|NCT03195582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64520589|NCT03195582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64520590|NCT03195582|Disinfectants|disinfectants|mesh-ancestor
64598664|NCT04277702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520591|NCT03195582|Dermatologic Agents|dermatologic agents|mesh-ancestor
64520592|NCT02448264|Berotralstat|berotralstat|mesh-list
64520593|NCT02448264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520594|NCT02448264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520595|NCT02451852|Osimertinib|osimertinib|mesh-list
64892296|NCT01987297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64892297|NCT01987297|Immunologic Factors|immunologic factors|mesh-ancestor
64892298|NCT01987297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892299|NCT01987297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64892300|NCT01987297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64892301|NCT01987297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64892302|NCT01987297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64892303|NCT01987297|Keratolytic Agents|keratolytic agents|mesh-ancestor
64892304|NCT01987297|Dermatologic Agents|dermatologic agents|mesh-ancestor
64892306|NCT01987310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64892307|NCT01987310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64892308|NCT01987310|Antimetabolites|antimetabolites|mesh-ancestor
64892309|NCT01987310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892310|NCT01987310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64892311|NCT01987310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64892312|NCT01987310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64892313|NCT01987323|Latanoprost|latanoprost|mesh-list
64892314|NCT01987323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64892315|NCT01987323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64892316|NCT01987375|Cetuximab|cetuximab|mesh-list
64892317|NCT01987375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64892318|NCT01987375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64892319|NCT01987570|Allopurinol|allopurinol|mesh-list
64892320|NCT01987570|Antimetabolites|antimetabolites|mesh-ancestor
64892321|NCT01987570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892322|NCT01987570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520597|NCT02451852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64520598|NCT02451852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646315|NCT01195025|Chrysarobin|chrysarobin|mesh-list
64520619|NCT03119454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64520620|NCT03119454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520621|NCT03119454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64520622|NCT03119454|Respiratory System Agents|respiratory system agents|mesh-ancestor
64520623|NCT04485156|Rifampin|rifampin|mesh-list
64892323|NCT01987570|Gout Suppressants|gout suppressants|mesh-ancestor
64892352|NCT01988116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64892353|NCT01988116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892355|NCT01988116|Vitamins|vitamins|mesh-ancestor
64892356|NCT01988116|Micronutrients|micronutrients|mesh-ancestor
64892357|NCT01988116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64892358|NCT01988298|Acetaminophen|acetaminophen|mesh-list
64892359|NCT01988298|Ibuprofen|ibuprofen|mesh-list
64892360|NCT01988298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64892361|NCT01988298|Analgesics|analgesics|mesh-ancestor
64892362|NCT01988298|Sensory System Agents|sensory system agents|mesh-ancestor
64892363|NCT01988298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64892364|NCT01988298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892365|NCT01988298|Antipyretics|antipyretics|mesh-ancestor
64892366|NCT01988298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64892367|NCT01988298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64520625|NCT04485156|Pyrazinamide|pyrazinamide|mesh-list
64520626|NCT04485156|Ethambutol|ethambutol|mesh-list
64520627|NCT04485156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64520628|NCT04485156|Antitubercular Agents|antitubercular agents|mesh-ancestor
64520629|NCT04485156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64520630|NCT04485156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64520631|NCT04485156|Leprostatic Agents|leprostatic agents|mesh-ancestor
64520632|NCT04485156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64520633|NCT04485156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520634|NCT04485156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520635|NCT04485156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64520636|NCT04485156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64646331|NCT01231841|Immunoglobulins|immunoglobulins|mesh-list
64646342|NCT00703664|Bortezomib|bortezomib|mesh-list
64892405|NCT01988610|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64892406|NCT01988610|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64892407|NCT01988610|Hormone Antagonists|hormone antagonists|mesh-ancestor
64892408|NCT01988610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64892409|NCT01988610|Luteolytic Agents|luteolytic agents|mesh-ancestor
64892410|NCT01988610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64892411|NCT01988610|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64892413|NCT01988649|Oxytocics|oxytocics|mesh-ancestor
64892414|NCT01988649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64892415|NCT01988649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892416|NCT01988831|Propranolol|propranolol|mesh-list
64892417|NCT01988831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64892418|NCT01988831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64892419|NCT01988831|Adrenergic Agents|adrenergic agents|mesh-ancestor
64892420|NCT01988831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64892421|NCT01988831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892422|NCT01988831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892423|NCT01988831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64520641|NCT04485156|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64520642|NCT04485156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64520643|NCT04485156|Antimetabolites|antimetabolites|mesh-ancestor
64520644|NCT04485156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64520645|NCT04637620|Sertraline|sertraline|mesh-list
64520646|NCT04637620|Antidepressive Agents|antidepressive agents|mesh-ancestor
64520647|NCT04637620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64520648|NCT04637620|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64892451|NCT01989052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64892452|NCT01989052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64892453|NCT01989052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64892454|NCT01989052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64892455|NCT01989052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892457|NCT01989078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64892458|NCT01989078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64892459|NCT01989078|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64892460|NCT01989078|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64892461|NCT01989078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892462|NCT01989091|Heparin|heparin|mesh-list
64892463|NCT01989091|Anticoagulants|anticoagulants|mesh-ancestor
64892464|NCT01989091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64892465|NCT01989091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64892466|NCT01989091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892467|NCT01989312|Lidocaine|lidocaine|mesh-list
64892468|NCT01989312|Epinephrine|epinephrine|mesh-list
64892469|NCT01989312|Midazolam|midazolam|mesh-list
64892470|NCT01989312|Levobupivacaine|levobupivacaine|mesh-list
64892471|NCT01989312|Anesthetics, Local|anesthetics, local|mesh-ancestor
64892472|NCT01989312|Anesthetics|anesthetics|mesh-ancestor
64892473|NCT01989312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64892474|NCT01989312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892475|NCT01989312|Sensory System Agents|sensory system agents|mesh-ancestor
64892476|NCT01989312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64660996|NCT01316042|Metformin|metformin|mesh-list
64892477|NCT01989312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64892478|NCT01989312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64892479|NCT01989312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64892480|NCT01989312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64520655|NCT00355108|Tranexamic Acid|tranexamic acid|mesh-list
64520656|NCT00355108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64892484|NCT01989312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64892485|NCT01989312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64646395|NCT02990078|Vasodilator Agents|vasodilator agents|mesh-ancestor
64892486|NCT01989312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64892508|NCT01989416|Dermatologic Agents|dermatologic agents|mesh-ancestor
64892509|NCT01989507|Nicotine|nicotine|mesh-list
64892510|NCT01989507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64892511|NCT01989507|Autonomic Agents|autonomic agents|mesh-ancestor
64835958|NCT01607983|Protective Agents|protective agents|mesh-ancestor
64892512|NCT01989507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64892513|NCT01989507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892514|NCT01989507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64892515|NCT01989507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64892516|NCT01989507|Cholinergic Agents|cholinergic agents|mesh-ancestor
64892517|NCT01989507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64892518|NCT01989507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892519|NCT01989559|Vaccines|vaccines|mesh-list
64892520|NCT01989559|Immunologic Factors|immunologic factors|mesh-ancestor
64892521|NCT01989559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892522|NCT01989611|Tenofovir|tenofovir|mesh-list
64892523|NCT01989611|Emtricitabine|emtricitabine|mesh-list
64892524|NCT01989611|Antiviral Agents|antiviral agents|mesh-ancestor
64892525|NCT01989611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64892526|NCT01989611|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64892527|NCT01989611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64892528|NCT01989611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64892529|NCT01989611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892530|NCT01989611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64892531|NCT01989611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64892532|NCT01989663|Tenofovir|tenofovir|mesh-list
64892533|NCT01989663|Antiviral Agents|antiviral agents|mesh-ancestor
64892534|NCT01989663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64892535|NCT01989663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64892536|NCT01989663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64892537|NCT01989663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64892538|NCT01989663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892539|NCT01989663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64892540|NCT01989663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64520671|NCT03200886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64646396|NCT02990078|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64520688|NCT05717764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520689|NCT05717764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520690|NCT05717764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64520691|NCT05717764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64520692|NCT05717764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520693|NCT03118830|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64520695|NCT03118830|Hormones|hormones|mesh-list
64520696|NCT03118830|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64520697|NCT03118830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64892541|NCT01989676|Paclitaxel|paclitaxel|mesh-list
64892542|NCT01989676|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64892543|NCT01989676|Trastuzumab|trastuzumab|mesh-list
64892550|NCT01989676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64892551|NCT01989845|Rivaroxaban|rivaroxaban|mesh-list
64892552|NCT01989845|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64892553|NCT01989845|Antithrombins|antithrombins|mesh-ancestor
64892554|NCT01989845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64892555|NCT01989845|Protease Inhibitors|protease inhibitors|mesh-ancestor
64892556|NCT01989845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64892557|NCT01989845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892558|NCT01989845|Anticoagulants|anticoagulants|mesh-ancestor
64892560|NCT01989884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64892561|NCT01989897|Phenol|phenol|mesh-list
64892562|NCT01989897|Histamine|histamine|mesh-list
64892563|NCT01989897|Histamine Agonists|histamine agonists|mesh-ancestor
64892564|NCT01989897|Histamine Agents|histamine agents|mesh-ancestor
64892565|NCT01989897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64892566|NCT01989897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892567|NCT01989897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892568|NCT01989897|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64520698|NCT03118830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520699|NCT03118830|Luteolytic Agents|luteolytic agents|mesh-ancestor
64520700|NCT03118830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64520701|NCT03118830|Contraceptive Agents|contraceptive agents|mesh-ancestor
64520702|NCT03118830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64520703|NCT03118830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64520704|NCT03118830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64520705|NCT03118830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520706|NCT03118830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64520707|NCT03118830|Fertility Agents|fertility agents|mesh-ancestor
64520708|NCT03118830|Hormone Antagonists|hormone antagonists|mesh-ancestor
64520709|NCT03223506|Acetaminophen|acetaminophen|mesh-list
64520710|NCT03223506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64892591|NCT01990079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64892592|NCT01990079|Autonomic Agents|autonomic agents|mesh-ancestor
64892593|NCT01990079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64892594|NCT01990079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892595|NCT01990079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64892596|NCT01990079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64892597|NCT01990079|Cholinergic Agents|cholinergic agents|mesh-ancestor
64892598|NCT01990079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64892599|NCT01990079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892600|NCT01990079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64892601|NCT01990079|Antidepressive Agents|antidepressive agents|mesh-ancestor
64892602|NCT01990079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64892603|NCT01990079|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64892604|NCT01990079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64892605|NCT01990079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64892606|NCT01990079|Dopamine Agents|dopamine agents|mesh-ancestor
64892607|NCT01990079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64892608|NCT01990079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64892609|NCT01990079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64892610|NCT01990118|Cyclosporine|cyclosporine|mesh-list
64892611|NCT01990118|Cyclosporins|cyclosporins|mesh-list
64892612|NCT01990118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64892623|NCT01990144|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64520713|NCT03223506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520714|NCT03223506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520716|NCT04535362|Nicotine|nicotine|mesh-list
64520717|NCT04535362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64520718|NCT04535362|Autonomic Agents|autonomic agents|mesh-ancestor
64892628|NCT01990144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64892629|NCT01990144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64892630|NCT01990144|Alkylating Agents|alkylating agents|mesh-ancestor
64892631|NCT01990144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892632|NCT01990378|Rabeprazole|rabeprazole|mesh-list
64892633|NCT01990378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64892634|NCT01990378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64892635|NCT01990378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64892636|NCT01990378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64892637|NCT01990378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892638|NCT01990404|Nitrous Oxide|nitrous oxide|mesh-list
64892639|NCT01990404|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64892640|NCT01990404|Anesthetics, General|anesthetics, general|mesh-ancestor
64892641|NCT01990404|Anesthetics|anesthetics|mesh-ancestor
64892642|NCT01990404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64892643|NCT01990404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892644|NCT01990404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64892645|NCT01990404|Analgesics|analgesics|mesh-ancestor
64892646|NCT01990404|Sensory System Agents|sensory system agents|mesh-ancestor
64892647|NCT01990404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64892649|NCT01990443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64892650|NCT01990443|Respiratory System Agents|respiratory system agents|mesh-ancestor
64892651|NCT01990586|Rabeprazole|rabeprazole|mesh-list
64892652|NCT01990586|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64892653|NCT01990586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64892654|NCT01990586|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64892655|NCT01990586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64892656|NCT01990586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892657|NCT01990690|Antioxidants|antioxidants|mesh-list
64892658|NCT01990690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892659|NCT01990690|Protective Agents|protective agents|mesh-ancestor
64520733|NCT05716516|Hormones|hormones|mesh-ancestor
64520734|NCT05716516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64520735|NCT05716516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520736|NCT02447796|Dexmedetomidine|dexmedetomidine|mesh-list
64520737|NCT02447796|Propofol|propofol|mesh-list
64520738|NCT02447796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64646458|NCT01236053|Gabapentin|gabapentin|mesh-list
64835975|NCT01608594|Ipilimumab|ipilimumab|mesh-list
64892670|NCT01990755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64892672|NCT01990755|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64892673|NCT01990755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64892674|NCT01990755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64892700|NCT01990781|Sensory System Agents|sensory system agents|mesh-ancestor
64892701|NCT01990781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64892702|NCT01990781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64892703|NCT01990781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64892704|NCT01990781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64892705|NCT01990807|Idarubicin|idarubicin|mesh-list
64892706|NCT01990807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64892707|NCT01990807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64892708|NCT01990807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64892709|NCT01990807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64892710|NCT01990807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64892711|NCT01990807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892712|NCT01990872|Vitamin D|vitamin d|mesh-list
64892713|NCT01990872|Cholecalciferol|cholecalciferol|mesh-list
64892714|NCT01990872|Vitamins|vitamins|mesh-ancestor
64892715|NCT01990872|Micronutrients|micronutrients|mesh-ancestor
64892716|NCT01990872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892717|NCT01990872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64892718|NCT01990872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64892719|NCT01990937|Midazolam|midazolam|mesh-list
64892720|NCT01990937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64892721|NCT01990937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64892722|NCT01990937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64892723|NCT01990937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892724|NCT01990937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64892736|NCT01991054|Cholecalciferol|cholecalciferol|mesh-list
64892737|NCT01991054|Vitamins|vitamins|mesh-ancestor
64892738|NCT01991054|Micronutrients|micronutrients|mesh-ancestor
64892739|NCT01991054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892740|NCT01991054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64892741|NCT01991054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64892742|NCT01991119|Dronedarone|dronedarone|mesh-list
64892743|NCT01991119|Propafenone|propafenone|mesh-list
64892744|NCT01991119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64892745|NCT01991119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64520744|NCT02447796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64520745|NCT02447796|Analgesics|analgesics|mesh-ancestor
64520746|NCT02447796|Sensory System Agents|sensory system agents|mesh-ancestor
64646475|NCT00703976|Pemetrexed|pemetrexed|mesh-list
64646480|NCT00703976|Growth Substances|growth substances|mesh-ancestor
64892758|NCT01991158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64892759|NCT01991158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892760|NCT01991158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64892761|NCT01991158|Glucocorticoids|glucocorticoids|mesh-ancestor
64892763|NCT01991158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64892764|NCT01991158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64892765|NCT01991158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64892766|NCT01991158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64892767|NCT01991158|Antimetabolites|antimetabolites|mesh-ancestor
64892768|NCT01991158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892769|NCT01991158|Antiviral Agents|antiviral agents|mesh-ancestor
64892770|NCT01991158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64892771|NCT01991158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64892772|NCT01991158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64892773|NCT01991158|Immunologic Factors|immunologic factors|mesh-ancestor
64835976|NCT01608594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64835977|NCT01608594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325692|NCT04822337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64325693|NCT04822337|Growth Substances|growth substances|mesh-ancestor
64325694|NCT04822337|Growth Inhibitors|growth inhibitors|mesh-ancestor
64325695|NCT02266927|Fluticasone|fluticasone|mesh-list
64892774|NCT01991158|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64892775|NCT01991158|Abortifacient Agents|abortifacient agents|mesh-ancestor
64892776|NCT01991158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64892777|NCT01991158|Dermatologic Agents|dermatologic agents|mesh-ancestor
64892778|NCT01991158|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64892779|NCT01991158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64892780|NCT01991158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64892781|NCT01991275|Morphine|morphine|mesh-list
64892782|NCT01991275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64892783|NCT01991275|Narcotics|narcotics|mesh-ancestor
64892784|NCT01991275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64892785|NCT01991275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892786|NCT01991275|Analgesics|analgesics|mesh-ancestor
64892787|NCT01991275|Sensory System Agents|sensory system agents|mesh-ancestor
64892788|NCT01991275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64892789|NCT01991288|Epinephrine|epinephrine|mesh-list
64892790|NCT01991288|Racepinephrine|racepinephrine|mesh-list
64892818|NCT01991327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64892819|NCT01991327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892820|NCT01991327|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64646491|NCT00661544|Micronutrients|micronutrients|mesh-ancestor
64520763|NCT03838042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64520764|NCT03838042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520765|NCT03838042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64520767|NCT03195270|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64520768|NCT03195270|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64520769|NCT03195270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520770|NCT05204836|Zoledronic Acid|zoledronic acid|mesh-list
64520771|NCT05204836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64520772|NCT05204836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520773|NCT03200184|Sofosbuvir|sofosbuvir|mesh-list
64520774|NCT03200184|Antiviral Agents|antiviral agents|mesh-ancestor
64520775|NCT03200184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64892825|NCT01991561|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64892826|NCT01991561|Vaccines|vaccines|mesh-list
64892827|NCT01991561|Immunologic Factors|immunologic factors|mesh-ancestor
64892828|NCT01991561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892829|NCT01991561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64892830|NCT01991561|Antacids|antacids|mesh-ancestor
64892831|NCT01991561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892832|NCT01991561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64892833|NCT01991574|Calcium|calcium|mesh-list
64892834|NCT01991574|Calcium acetate|calcium acetate|mesh-list
64892835|NCT01991574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64892836|NCT01991574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892837|NCT01991574|Chelating Agents|chelating agents|mesh-ancestor
64892838|NCT01991574|Sequestering Agents|sequestering agents|mesh-ancestor
64892839|NCT01991574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892844|NCT01991626|Trace Elements|trace elements|mesh-list
64892845|NCT01991626|Micronutrients|micronutrients|mesh-list
64892846|NCT01991626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892847|NCT01991678|Etirinotecan pegol|etirinotecan pegol|mesh-list
64892848|NCT01991678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64892849|NCT01991678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64892850|NCT01991678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64892851|NCT01991678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64892852|NCT01991678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892853|NCT01991834|Cefazolin|cefazolin|mesh-list
64661368|NCT01362686|Rivastigmine|rivastigmine|mesh-list
64892854|NCT01991834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64892855|NCT01991834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64892856|NCT01991873|Leucovorin|leucovorin|mesh-list
64892857|NCT01991873|Folic Acid|folic acid|mesh-list
64892858|NCT01991873|Fluorouracil|fluorouracil|mesh-list
64892859|NCT01991873|Oxaliplatin|oxaliplatin|mesh-list
64892860|NCT01991873|Panitumumab|panitumumab|mesh-list
64892861|NCT01991873|Levoleucovorin|levoleucovorin|mesh-list
64520776|NCT03222960|Propolis|propolis|mesh-list
64520777|NCT03222960|Fluorides|fluorides|mesh-list
64520778|NCT03222960|Cariostatic Agents|cariostatic agents|mesh-ancestor
64520779|NCT03222960|Protective Agents|protective agents|mesh-ancestor
64646510|NCT01511042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64892870|NCT01991873|Protective Agents|protective agents|mesh-ancestor
64892871|NCT01991873|Vitamin B Complex|vitamin b complex|mesh-ancestor
64892873|NCT01991873|Micronutrients|micronutrients|mesh-ancestor
64892874|NCT01991873|Hematinics|hematinics|mesh-ancestor
64892875|NCT01991873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64892876|NCT01991951|Warfarin|warfarin|mesh-list
64892877|NCT01991951|Anticoagulants|anticoagulants|mesh-ancestor
64892878|NCT01992133|Vitamin D|vitamin d|mesh-list
64892879|NCT01992133|Cholecalciferol|cholecalciferol|mesh-list
64892880|NCT01992133|Vitamins|vitamins|mesh-ancestor
64892881|NCT01992133|Micronutrients|micronutrients|mesh-ancestor
64892882|NCT01992133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892883|NCT01992133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64892884|NCT01992133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64892885|NCT01992146|Naloxone|naloxone|mesh-list
64892886|NCT01992146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64892887|NCT01992146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892888|NCT01992146|Sensory System Agents|sensory system agents|mesh-ancestor
64892889|NCT01992146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64892890|NCT01992198|Chlorhexidine|chlorhexidine|mesh-list
64892891|NCT01992198|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64892892|NCT01992198|Metronidazole|metronidazole|mesh-list
64892893|NCT01992198|Meropenem|meropenem|mesh-list
64892894|NCT01992198|Cefoperazone|cefoperazone|mesh-list
64892895|NCT01992198|Sulperazone|sulperazone|mesh-list
64892896|NCT01992198|Somatostatin|somatostatin|mesh-list
64892897|NCT01992198|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64892898|NCT01992198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64892899|NCT01992198|Disinfectants|disinfectants|mesh-ancestor
64892900|NCT01992198|Dermatologic Agents|dermatologic agents|mesh-ancestor
64892901|NCT01992198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64892902|NCT01992198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64892903|NCT01992198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64892904|NCT01992198|Hormones|hormones|mesh-ancestor
64892905|NCT01992198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64892906|NCT01992198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892907|NCT01992198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64892908|NCT01992198|Renal Agents|renal agents|mesh-ancestor
64520805|NCT05681260|Alkylating Agents|alkylating agents|mesh-ancestor
64520806|NCT05681260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520807|NCT05681260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520808|NCT05681260|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64892913|NCT01992211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64892914|NCT01992211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64892941|NCT01992341|Antimitotic Agents|antimitotic agents|mesh-ancestor
64892942|NCT01992341|Mitosis Modulators|mitosis modulators|mesh-ancestor
64892943|NCT01992341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892944|NCT01992341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64892945|NCT01992341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64892946|NCT01992341|Growth Substances|growth substances|mesh-ancestor
64892947|NCT01992341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892948|NCT01992341|Growth Inhibitors|growth inhibitors|mesh-ancestor
64892949|NCT01992562|Ziconotide|ziconotide|mesh-list
64892950|NCT01992562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64892951|NCT01992562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64892952|NCT01992562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892953|NCT01992562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64892954|NCT01992562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892955|NCT01992562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64892956|NCT01992562|Protective Agents|protective agents|mesh-ancestor
64892957|NCT01992562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64892958|NCT01992562|Analgesics|analgesics|mesh-ancestor
64892959|NCT01992562|Sensory System Agents|sensory system agents|mesh-ancestor
64892960|NCT01992562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64892961|NCT01992588|Insulin|insulin|mesh-list
64892962|NCT01992588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64599154|NCT02996825|Gemcitabine|gemcitabine|mesh-list
64892963|NCT01992588|Insulin Aspart|insulin aspart|mesh-list
64892964|NCT01992588|Insulin, Long-Acting|insulin, long-acting|mesh-list
64892965|NCT01992588|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64892985|NCT01992705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892986|NCT01992705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64892987|NCT01992705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64892988|NCT01992705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64892989|NCT01992705|Immunologic Factors|immunologic factors|mesh-ancestor
64892990|NCT01992705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892991|NCT01992705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64892992|NCT01992705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64892993|NCT01992705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64892994|NCT01992796|Telmisartan|telmisartan|mesh-list
64892995|NCT01992796|Candesartan|candesartan|mesh-list
64892996|NCT01992796|Olmesartan|olmesartan|mesh-list
64893010|NCT01993134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64893011|NCT01993134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64893013|NCT01993173|Immunologic Factors|immunologic factors|mesh-ancestor
64893014|NCT01993173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893015|NCT01993212|Enclomiphene|enclomiphene|mesh-list
64893016|NCT01993212|Testosterone|testosterone|mesh-list
64893017|NCT01993212|Androgens|androgens|mesh-ancestor
64893018|NCT01993212|Hormones|hormones|mesh-ancestor
64893019|NCT01993212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64893020|NCT01993212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893021|NCT01993212|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64893022|NCT01993212|Hormone Antagonists|hormone antagonists|mesh-ancestor
64893023|NCT01993212|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64893037|NCT01993225|Fertility Agents|fertility agents|mesh-ancestor
64893038|NCT01993225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64893039|NCT01993225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64893040|NCT01993225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64893042|NCT01993251|Antioxidants|antioxidants|mesh-ancestor
64893043|NCT01993251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893044|NCT01993251|Protective Agents|protective agents|mesh-ancestor
64893045|NCT01993251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893046|NCT01993251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64893047|NCT01993290|Ropivacaine|ropivacaine|mesh-list
64893048|NCT01993290|Anesthetics, Local|anesthetics, local|mesh-ancestor
64893049|NCT01993290|Anesthetics|anesthetics|mesh-ancestor
64893050|NCT01993290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64893051|NCT01993290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893052|NCT01993290|Sensory System Agents|sensory system agents|mesh-ancestor
64893053|NCT01993290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893054|NCT01993459|Midazolam|midazolam|mesh-list
64893055|NCT01993459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64893056|NCT01993459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64893057|NCT01993459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64646563|NCT00704912|Orlistat|orlistat|mesh-list
64520821|NCT05681260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64520822|NCT05681260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64520823|NCT05681260|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64520824|NCT05681260|Abortifacient Agents|abortifacient agents|mesh-ancestor
64893075|NCT01993472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64893076|NCT01993472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64893077|NCT01993472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64893078|NCT01993472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64893079|NCT01993472|Analgesics|analgesics|mesh-ancestor
64893080|NCT01993472|Sensory System Agents|sensory system agents|mesh-ancestor
64893081|NCT01993472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893082|NCT01993472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893083|NCT01993472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64893084|NCT01993472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64893114|NCT01993771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893115|NCT01993784|Nimotuzumab|nimotuzumab|mesh-list
64893116|NCT01993784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64893117|NCT01993784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64893118|NCT01993979|Gemcitabine|gemcitabine|mesh-list
64893119|NCT01993979|Cisplatin|cisplatin|mesh-list
64893120|NCT01993979|Carboplatin|carboplatin|mesh-list
64893121|NCT01993979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64893122|NCT01993979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64599221|NCT03221426|Antimetabolites|antimetabolites|mesh-ancestor
64893123|NCT01993979|Antimetabolites|antimetabolites|mesh-ancestor
64893124|NCT01993979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893125|NCT01993979|Antiviral Agents|antiviral agents|mesh-ancestor
64893126|NCT01993979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64893127|NCT01993979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64893128|NCT01993979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64893129|NCT01993979|Immunologic Factors|immunologic factors|mesh-ancestor
64893234|NCT01994759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64893235|NCT01994759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64520825|NCT05681260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64520826|NCT05681260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64520827|NCT05681260|Antimetabolites|antimetabolites|mesh-ancestor
64520828|NCT05681260|Dermatologic Agents|dermatologic agents|mesh-ancestor
64520829|NCT05681260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64520830|NCT05681260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64520831|NCT05681260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64520832|NCT05681260|Antiviral Agents|antiviral agents|mesh-ancestor
64347214|NCT03469531|Cisplatin|cisplatin|mesh-list
64893236|NCT01994759|Protective Agents|protective agents|mesh-ancestor
64893237|NCT01994824|Thymoglobulin|thymoglobulin|mesh-list
64893238|NCT01994824|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64893239|NCT01994824|Immunologic Factors|immunologic factors|mesh-ancestor
64893240|NCT01994824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893241|NCT01994824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64893242|NCT01994941|Clopidogrel|clopidogrel|mesh-list
64893243|NCT01994941|Ticagrelor|ticagrelor|mesh-list
64893244|NCT01994941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64893245|NCT01994941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64893246|NCT01994941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64646598|NCT01241903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893254|NCT01994967|Anesthetics, Local|anesthetics, local|mesh-ancestor
64893255|NCT01994967|Anesthetics|anesthetics|mesh-ancestor
64893256|NCT01994967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64893257|NCT01994967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893258|NCT01994967|Sensory System Agents|sensory system agents|mesh-ancestor
64893259|NCT01994967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893261|NCT01995006|Naproxen|naproxen|mesh-list
64893262|NCT01995006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64893263|NCT01995006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64893264|NCT01995006|Analgesics|analgesics|mesh-ancestor
64893265|NCT01995006|Sensory System Agents|sensory system agents|mesh-ancestor
64893266|NCT01995006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893267|NCT01995006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893268|NCT01995006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64893269|NCT01995006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64893270|NCT01995006|Gout Suppressants|gout suppressants|mesh-ancestor
64893271|NCT01995006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64893272|NCT01995006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64893273|NCT01995006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893287|NCT01995019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64893288|NCT01995019|Glucocorticoids|glucocorticoids|mesh-ancestor
64893289|NCT01995019|Hormones|hormones|mesh-ancestor
64893290|NCT01995019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64893291|NCT01995019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64893292|NCT01995019|Protective Agents|protective agents|mesh-ancestor
64893293|NCT01995019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64893294|NCT01995019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64893295|NCT01995032|Metformin|metformin|mesh-list
64893296|NCT01995032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64893297|NCT01995032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893298|NCT01995058|Prednisone|prednisone|mesh-list
64835978|NCT01608594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64835979|NCT01608594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835980|NCT01608854|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64893299|NCT01995058|Abiraterone Acetate|abiraterone acetate|mesh-list
64893300|NCT01995058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64893301|NCT01995058|Glucocorticoids|glucocorticoids|mesh-ancestor
64893302|NCT01995058|Hormones|hormones|mesh-ancestor
64893303|NCT01995058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64520833|NCT05681260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64520834|NCT05681260|Tubulin Modulators|tubulin modulators|mesh-ancestor
64520835|NCT05681260|Antimitotic Agents|antimitotic agents|mesh-ancestor
64520836|NCT05681260|Mitosis Modulators|mitosis modulators|mesh-ancestor
64520837|NCT03193086|Alemtuzumab|alemtuzumab|mesh-list
64520838|NCT03193086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64520839|NCT03193086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520840|NCT03199950|Haloperidol|haloperidol|mesh-list
64520841|NCT03199950|Haloperidol decanoate|haloperidol decanoate|mesh-list
64520842|NCT03199950|Antiemetics|antiemetics|mesh-ancestor
64520843|NCT03199950|Autonomic Agents|autonomic agents|mesh-ancestor
64520844|NCT03199950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520845|NCT03199950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520846|NCT03199950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64520847|NCT03199950|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64520848|NCT03199950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64520849|NCT03199950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64520850|NCT03199950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64520851|NCT03199950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64520852|NCT03199950|Dopamine Agents|dopamine agents|mesh-ancestor
64520853|NCT03199950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64520854|NCT03199950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520863|NCT05156632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64520864|NCT03118362|Plasma-lyte 148|plasma-lyte 148|mesh-list
64520865|NCT03118362|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64520866|NCT03118362|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64520867|NCT02447016|Tenofovir|tenofovir|mesh-list
64520868|NCT02447016|Emtricitabine|emtricitabine|mesh-list
64520869|NCT02447016|Efavirenz|efavirenz|mesh-list
64893304|NCT01995058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893305|NCT01995058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64893306|NCT01995058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520871|NCT02447016|Antiviral Agents|antiviral agents|mesh-ancestor
64520872|NCT02447016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64520873|NCT02447016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64520874|NCT02447016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64520875|NCT02447016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520876|NCT02447016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520877|NCT02447016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64520878|NCT02447016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64520879|NCT02447016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64520880|NCT02447016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64520881|NCT02447016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64520882|NCT02447016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64520883|NCT02447016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64520884|NCT02447016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64520885|NCT02447094|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64520886|NCT02447094|Plasminogen|plasminogen|mesh-list
64893307|NCT01995058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64893308|NCT01995058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64893309|NCT01995058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893310|NCT01995058|Hormone Antagonists|hormone antagonists|mesh-ancestor
64893311|NCT01995058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64893312|NCT01995084|Imidazole|imidazole|mesh-list
64893313|NCT01995084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64893314|NCT01995084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893315|NCT01995188|Bevacizumab|bevacizumab|mesh-list
64893316|NCT01995188|Carboplatin|carboplatin|mesh-list
64893317|NCT01995188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64893318|NCT01995188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64893319|NCT01995188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64893320|NCT01995188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64893321|NCT01995188|Growth Substances|growth substances|mesh-ancestor
64893322|NCT01995188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893323|NCT01995188|Growth Inhibitors|growth inhibitors|mesh-ancestor
64893324|NCT01995214|Propofol|propofol|mesh-list
64893325|NCT01995214|Sevoflurane|sevoflurane|mesh-list
64893326|NCT01995214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64893327|NCT01995214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64893328|NCT01995214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893329|NCT01995214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64893330|NCT01995214|Anesthetics, General|anesthetics, general|mesh-ancestor
64893331|NCT01995214|Anesthetics|anesthetics|mesh-ancestor
64893332|NCT01995214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64893333|NCT01995214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64893334|NCT01995292|Anesthetics|anesthetics|mesh-list
64893335|NCT01995292|Anesthetics, Local|anesthetics, local|mesh-list
64893336|NCT01995292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64893352|NCT01995331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64893353|NCT01995331|Antifungal Agents|antifungal agents|mesh-ancestor
64893354|NCT01995331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64520904|NCT02446782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64520905|NCT02446782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64520906|NCT02446782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64520907|NCT02446782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520908|NCT02446782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520909|NCT04745260|Fentanyl|fentanyl|mesh-list
64520910|NCT04745260|Midazolam|midazolam|mesh-list
64520911|NCT04745260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64520912|NCT04745260|Narcotics|narcotics|mesh-ancestor
64520913|NCT04745260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64520914|NCT04745260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520915|NCT04745260|Analgesics|analgesics|mesh-ancestor
64520916|NCT04745260|Sensory System Agents|sensory system agents|mesh-ancestor
64520917|NCT04745260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893362|NCT01995370|Analgesics|analgesics|mesh-ancestor
64893363|NCT01995370|Sensory System Agents|sensory system agents|mesh-ancestor
64893364|NCT01995370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893365|NCT01995370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893366|NCT01995370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64893367|NCT01995370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64893368|NCT01995370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64893369|NCT01995370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64893370|NCT01995370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893371|NCT01995370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64893372|NCT01995370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64893373|NCT01995370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520918|NCT04745260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64520919|NCT04745260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64893391|NCT01995695|Immunologic Factors|immunologic factors|mesh-ancestor
64893392|NCT01995695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893393|NCT01995734|Pasireotide|pasireotide|mesh-list
64893395|NCT01995734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64893422|NCT01996085|Vasodilator Agents|vasodilator agents|mesh-ancestor
64893423|NCT01996085|Diuretics|diuretics|mesh-ancestor
64893424|NCT01996085|Natriuretic Agents|natriuretic agents|mesh-ancestor
64893425|NCT01996085|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64893426|NCT01996085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64893427|NCT01996085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64893428|NCT01996085|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64893429|NCT01996085|Protease Inhibitors|protease inhibitors|mesh-ancestor
64893430|NCT01996085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64893431|NCT01996085|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64893432|NCT01996085|Protective Agents|protective agents|mesh-ancestor
64893433|NCT01996085|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64893434|NCT01996085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64893435|NCT01996085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64893436|NCT01996085|Adrenergic Agents|adrenergic agents|mesh-ancestor
64893437|NCT01996085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64893475|NCT01996358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64835990|NCT01609153|Antiemetics|antiemetics|mesh-ancestor
64520929|NCT04745260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520930|NCT03199482|Dexamethasone|dexamethasone|mesh-list
64520931|NCT03199482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64520932|NCT03199482|Antiemetics|antiemetics|mesh-ancestor
64520933|NCT03199482|Autonomic Agents|autonomic agents|mesh-ancestor
64520934|NCT03199482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520935|NCT03199482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520936|NCT03199482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64520937|NCT03199482|Glucocorticoids|glucocorticoids|mesh-ancestor
64520938|NCT03199482|Hormones|hormones|mesh-ancestor
64520939|NCT03199482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64520940|NCT03199482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64520941|NCT03199482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520942|NCT02446704|Temozolomide|temozolomide|mesh-list
64520943|NCT02446704|Olaparib|olaparib|mesh-list
64520944|NCT02446704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64520945|NCT02446704|Alkylating Agents|alkylating agents|mesh-ancestor
64520946|NCT02446704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520947|NCT02446704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520948|NCT02446704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64520949|NCT02446704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520950|NCT01605227|Prednisone|prednisone|mesh-list
64520951|NCT01605227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64520952|NCT01605227|Glucocorticoids|glucocorticoids|mesh-ancestor
64520953|NCT01605227|Hormones|hormones|mesh-ancestor
64520954|NCT01605227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64520955|NCT01605227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520956|NCT01605227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64520957|NCT01605227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64520958|NCT02446548|Losartan|losartan|mesh-list
64520959|NCT02446548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64520960|NCT02446548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64520961|NCT02446548|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64893476|NCT01996358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893477|NCT01996358|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
64893478|NCT01996384|Lidocaine|lidocaine|mesh-list
64893479|NCT01996384|Anesthetics, Local|anesthetics, local|mesh-ancestor
64893480|NCT01996384|Anesthetics|anesthetics|mesh-ancestor
64893481|NCT01996384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64893482|NCT01996384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64520962|NCT02446548|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64520963|NCT02446548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520964|NCT04291768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64520965|NCT04291768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64520966|NCT04291768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64520967|NCT04291768|Antitubercular Agents|antitubercular agents|mesh-ancestor
64893487|NCT01996384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64893488|NCT01996384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64893489|NCT01996384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893490|NCT01996423|Vitamin D|vitamin d|mesh-list
64893491|NCT01996423|Cholecalciferol|cholecalciferol|mesh-list
64893492|NCT01996423|Vitamins|vitamins|mesh-ancestor
64893493|NCT01996423|Micronutrients|micronutrients|mesh-ancestor
64520994|NCT05087914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64520995|NCT05087914|Gout Suppressants|gout suppressants|mesh-ancestor
64520996|NCT05087914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64520997|NCT05087914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64520998|NCT05087914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64520999|NCT05087914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64521022|NCT03198702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64521023|NCT03198702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64521024|NCT01709513|Atorvastatin|atorvastatin|mesh-list
64521025|NCT01709513|Ezetimibe|ezetimibe|mesh-list
64521026|NCT01709513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64447088|NCT01946529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64521027|NCT01709513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64521028|NCT01709513|Antimetabolites|antimetabolites|mesh-ancestor
64893494|NCT01996423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893495|NCT01996423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64893496|NCT01996423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64893497|NCT01996462|Dexetimide|dexetimide|mesh-list
64893498|NCT01996462|Citalopram|citalopram|mesh-list
64893529|NCT01996475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64893530|NCT01996475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64893531|NCT01996475|Parasympatholytics|parasympatholytics|mesh-ancestor
64521029|NCT01709513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521030|NCT01709513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64521031|NCT01709513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64521032|NCT01709513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521033|NCT02446158|Chlorhexidine|chlorhexidine|mesh-list
64521034|NCT02446158|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64521035|NCT02446158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64521036|NCT02446158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64521037|NCT02446158|Disinfectants|disinfectants|mesh-ancestor
64521038|NCT02446158|Dermatologic Agents|dermatologic agents|mesh-ancestor
64521039|NCT05631886|Cyclophosphamide|cyclophosphamide|mesh-list
64521040|NCT05631886|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64521041|NCT05631886|Paclitaxel|paclitaxel|mesh-list
64521042|NCT05631886|Antibodies|antibodies|mesh-list
64521043|NCT05631886|Immunoglobulins|immunoglobulins|mesh-list
64521044|NCT05631886|Antibodies, Blocking|antibodies, blocking|mesh-list
64521045|NCT05631886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64521046|NCT05631886|Immunologic Factors|immunologic factors|mesh-ancestor
64521047|NCT05631886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521048|NCT05631886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64521049|NCT05631886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64646743|NCT01294319|BB 1101|bb 1101|mesh-list
64893561|NCT01996501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64893562|NCT01996501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64893563|NCT01996501|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64893564|NCT01996501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64893565|NCT01996501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64893566|NCT01996501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893567|NCT01996501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64893568|NCT01996501|Serotonin Agents|serotonin agents|mesh-ancestor
64893569|NCT01996579|Lactoferrin|lactoferrin|mesh-list
64893570|NCT01996579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64893571|NCT01996618|Ranolazine|ranolazine|mesh-list
64893572|NCT01996618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64893573|NCT01996618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64893574|NCT01996618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893575|NCT01996683|Deferiprone|deferiprone|mesh-list
64893576|NCT01996683|Deferoxamine|deferoxamine|mesh-list
64893577|NCT01996683|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64893578|NCT01996683|Chelating Agents|chelating agents|mesh-ancestor
64521050|NCT05631886|Alkylating Agents|alkylating agents|mesh-ancestor
64521051|NCT05631886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521052|NCT05631886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521053|NCT05631886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64521054|NCT05631886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64521055|NCT05631886|Tubulin Modulators|tubulin modulators|mesh-ancestor
64521056|NCT05631886|Antimitotic Agents|antimitotic agents|mesh-ancestor
64521057|NCT05631886|Mitosis Modulators|mitosis modulators|mesh-ancestor
64521058|NCT02446002|Lofexidine|lofexidine|mesh-list
64521059|NCT02446002|Clonidine|clonidine|mesh-list
64521060|NCT02446002|Naltrexone|naltrexone|mesh-list
64521061|NCT02446002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64521062|NCT02446002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64521063|NCT02446002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521064|NCT02446002|Sensory System Agents|sensory system agents|mesh-ancestor
64599558|NCT03809923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521065|NCT02446002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64521066|NCT02446002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64521067|NCT02446002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64521068|NCT02446002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64521069|NCT02446002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64521070|NCT02446002|Adrenergic Agents|adrenergic agents|mesh-ancestor
64521071|NCT02446002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64521072|NCT02446002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521073|NCT02446002|Analgesics|analgesics|mesh-ancestor
64521074|NCT02446002|Sympatholytics|sympatholytics|mesh-ancestor
64521075|NCT02446002|Autonomic Agents|autonomic agents|mesh-ancestor
64893579|NCT01996683|Sequestering Agents|sequestering agents|mesh-ancestor
64893595|NCT01996761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64893596|NCT01996761|Protective Agents|protective agents|mesh-ancestor
64893597|NCT01996761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893599|NCT01996891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64893600|NCT01996930|Silver Nitrate|silver nitrate|mesh-list
64893610|NCT01997099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64521076|NCT01605071|Estradiol|estradiol|mesh-list
64521077|NCT01605071|Estrogens|estrogens|mesh-ancestor
64521078|NCT01605071|Hormones|hormones|mesh-ancestor
64521079|NCT01605071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64521080|NCT01605071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521081|NCT04345198|Epinephrine|epinephrine|mesh-list
64521082|NCT04345198|Racepinephrine|racepinephrine|mesh-list
64521083|NCT04345198|Epinephryl borate|epinephryl borate|mesh-list
64521084|NCT04345198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64521085|NCT04345198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64521086|NCT04345198|Adrenergic Agents|adrenergic agents|mesh-ancestor
64521087|NCT04345198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64521088|NCT04345198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521089|NCT04345198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521090|NCT04345198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64521091|NCT04345198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64521092|NCT04345198|Autonomic Agents|autonomic agents|mesh-ancestor
64521093|NCT04345198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64521094|NCT04345198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64521095|NCT04345198|Respiratory System Agents|respiratory system agents|mesh-ancestor
64521096|NCT04345198|Mydriatics|mydriatics|mesh-ancestor
64521097|NCT04345198|Sympathomimetics|sympathomimetics|mesh-ancestor
64521098|NCT04345198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64521100|NCT03192618|Oxaliplatin|oxaliplatin|mesh-list
64521101|NCT03192618|Calcium|calcium|mesh-list
64347617|NCT02232880|Abatacept|abatacept|mesh-list
64893611|NCT01997099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64893612|NCT01997099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64893613|NCT01997099|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64893614|NCT01997099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64893615|NCT01997099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64893616|NCT01997099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64893617|NCT01997099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64893618|NCT01997099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64893619|NCT01997099|Anesthetics, General|anesthetics, general|mesh-ancestor
64893620|NCT01997099|Anesthetics|anesthetics|mesh-ancestor
64893621|NCT01997099|GABA Modulators|gaba modulators|mesh-ancestor
64893622|NCT01997099|GABA Agents|gaba agents|mesh-ancestor
64646775|NCT00727298|Infliximab|infliximab|mesh-list
64521109|NCT03192618|Vitamins|vitamins|mesh-ancestor
64521110|NCT03192618|Micronutrients|micronutrients|mesh-ancestor
64521111|NCT04113226|Rituximab|rituximab|mesh-list
64521112|NCT04113226|Lenalidomide|lenalidomide|mesh-list
64521113|NCT04113226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64521114|NCT04113226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521115|NCT04113226|Immunologic Factors|immunologic factors|mesh-ancestor
64521116|NCT04113226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521117|NCT04113226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64599618|NCT04248998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64521118|NCT04113226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64521119|NCT04113226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64521120|NCT04113226|Growth Substances|growth substances|mesh-ancestor
64521121|NCT04113226|Growth Inhibitors|growth inhibitors|mesh-ancestor
64521122|NCT04552223|Nivolumab|nivolumab|mesh-list
64521123|NCT04552223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64521124|NCT04552223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521125|NCT04552223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64521126|NCT04552223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521127|NCT02444364|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64521128|NCT02444364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64521129|NCT02444364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893636|NCT01997164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64893637|NCT01997164|Growth Substances|growth substances|mesh-ancestor
64893638|NCT01997164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893639|NCT01997164|Growth Inhibitors|growth inhibitors|mesh-ancestor
64893640|NCT01997164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64893641|NCT01997190|Valacyclovir|valacyclovir|mesh-list
64893642|NCT01997190|Antiviral Agents|antiviral agents|mesh-ancestor
64893643|NCT01997190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64893644|NCT01997203|Vitamin D|vitamin d|mesh-list
64893645|NCT01997203|Interferons|interferons|mesh-list
64893646|NCT01997203|Ribavirin|ribavirin|mesh-list
64893647|NCT01997203|Vitamins|vitamins|mesh-ancestor
64893648|NCT01997203|Micronutrients|micronutrients|mesh-ancestor
64893649|NCT01997203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893650|NCT01997203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64893651|NCT01997203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521151|NCT00356356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64521152|NCT00356356|Immunologic Factors|immunologic factors|mesh-ancestor
64521153|NCT02443818|Sirolimus|sirolimus|mesh-list
64521154|NCT02443818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64521155|NCT02443818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64893656|NCT01997255|Everolimus|everolimus|mesh-list
64893657|NCT01997255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64893658|NCT01997255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64893659|NCT01997255|Immunologic Factors|immunologic factors|mesh-ancestor
64893660|NCT01997255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893661|NCT01997294|Atorvastatin|atorvastatin|mesh-list
64893662|NCT01997294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64893663|NCT01997294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64893664|NCT01997294|Antimetabolites|antimetabolites|mesh-ancestor
64893665|NCT01997294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893666|NCT01997294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64893667|NCT01997294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64893686|NCT01997593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893687|NCT01997632|Vaccines|vaccines|mesh-list
64893688|NCT01997632|Immunologic Factors|immunologic factors|mesh-ancestor
64893689|NCT01997632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893690|NCT01997658|Methylprednisolone|methylprednisolone|mesh-list
64893691|NCT01997658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64893692|NCT01997658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64893693|NCT01997658|Prednisolone|prednisolone|mesh-list
64893694|NCT01997658|Prednisolone acetate|prednisolone acetate|mesh-list
64893695|NCT01997658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64372098|NCT04419519|Venetoclax|venetoclax|mesh-list
64893706|NCT01997658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64893707|NCT01997658|Protective Agents|protective agents|mesh-ancestor
64893708|NCT01997658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64893709|NCT01997658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64893710|NCT01997762|Resveratrol|resveratrol|mesh-list
64893711|NCT01997762|Antioxidants|antioxidants|mesh-ancestor
64893712|NCT01997762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893713|NCT01997762|Protective Agents|protective agents|mesh-ancestor
64893714|NCT01997762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893715|NCT01997762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64893716|NCT01997762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64893717|NCT01997775|Metformin|metformin|mesh-list
64893718|NCT01997775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64893843|NCT01998503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893844|NCT01998503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893845|NCT01998503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64893846|NCT01998503|Glucocorticoids|glucocorticoids|mesh-ancestor
64893847|NCT01998503|Hormones|hormones|mesh-ancestor
64893848|NCT01998503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64893849|NCT01998503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64893850|NCT01998503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521191|NCT02450058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521192|NCT02450058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64521193|NCT02450058|Immunologic Factors|immunologic factors|mesh-ancestor
64521194|NCT02450058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521195|NCT02450058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64521196|NCT02450058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64521197|NCT02450058|Alkylating Agents|alkylating agents|mesh-ancestor
64521198|NCT02450058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64521199|NCT02450058|Antimetabolites|antimetabolites|mesh-ancestor
64521200|NCT02450058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64521201|NCT02450058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64521202|NCT02450058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64521203|NCT02450058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64521204|NCT02450058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521205|NCT02445300|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64521206|NCT02445300|Laxatives|laxatives|mesh-ancestor
64521207|NCT02445300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64521259|NCT03193944|Micronutrients|micronutrients|mesh-ancestor
64521260|NCT03193944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521261|NCT03193944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64521262|NCT03193944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64521264|NCT00357604|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64521265|NCT00357604|Moxifloxacin|moxifloxacin|mesh-list
64521266|NCT00357604|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64521267|NCT00357604|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64521268|NCT00357604|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64521269|NCT00357604|Norgestimate|norgestimate|mesh-list
64521270|NCT00357604|Norgestrel|norgestrel|mesh-list
64521271|NCT00357604|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64521272|NCT00357604|Estradiol|estradiol|mesh-list
64521273|NCT00357604|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64521274|NCT00357604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64521275|NCT00357604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64521276|NCT00357604|Protease Inhibitors|protease inhibitors|mesh-ancestor
64521277|NCT00357604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521278|NCT00357604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521279|NCT00357604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64521282|NCT00357604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64521283|NCT00357604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64521284|NCT00357604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64521286|NCT00357604|Hormones|hormones|mesh-ancestor
64521287|NCT00357604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64521288|NCT00357604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521289|NCT00357604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64521290|NCT00357604|Contraceptive Agents|contraceptive agents|mesh-ancestor
64521291|NCT00357604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64836009|NCT01610141|Warfarin|warfarin|mesh-list
64521292|NCT00357604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64521293|NCT00357604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64521294|NCT00357604|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64521295|NCT00357604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64521296|NCT00357604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64521297|NCT00357604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64521298|NCT00357604|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64646926|NCT02322242|BB 1101|bb 1101|mesh-list
64893873|NCT01998685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64893874|NCT01998685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64893892|NCT01998698|Immunologic Factors|immunologic factors|mesh-ancestor
64893893|NCT01998698|Viscosupplements|viscosupplements|mesh-ancestor
64893894|NCT01998698|Protective Agents|protective agents|mesh-ancestor
64893895|NCT01998698|Anesthetics, Local|anesthetics, local|mesh-ancestor
64893896|NCT01998698|Anesthetics|anesthetics|mesh-ancestor
64893897|NCT01998698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64893898|NCT01998698|Sensory System Agents|sensory system agents|mesh-ancestor
64893899|NCT01998698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893900|NCT01998698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64893901|NCT01998698|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64893902|NCT01998698|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64893903|NCT01998698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64893905|NCT01998763|Cholecalciferol|cholecalciferol|mesh-list
64893906|NCT01998763|Vitamins|vitamins|mesh-ancestor
64521299|NCT00357604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64521300|NCT00357604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521301|NCT03193788|Folic Acid|folic acid|mesh-list
64521302|NCT03193788|Vitamin B 12|vitamin b 12|mesh-list
64521303|NCT03193788|Dexamethasone|dexamethasone|mesh-list
64521304|NCT03193788|Pemetrexed|pemetrexed|mesh-list
64521305|NCT03193788|Vitamins|vitamins|mesh-ancestor
64521306|NCT03193788|Micronutrients|micronutrients|mesh-ancestor
64521307|NCT03193788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521308|NCT03193788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64521309|NCT03193788|Antiemetics|antiemetics|mesh-ancestor
64521310|NCT03193788|Autonomic Agents|autonomic agents|mesh-ancestor
64521311|NCT03193788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64521312|NCT03193788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64521313|NCT03193788|Glucocorticoids|glucocorticoids|mesh-ancestor
64521314|NCT03193788|Hormones|hormones|mesh-ancestor
64521315|NCT03193788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64521316|NCT03193788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64893908|NCT01998763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893909|NCT01998763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64893910|NCT01998763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64893911|NCT01998776|Misoprostol|misoprostol|mesh-list
64893912|NCT01998776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64893913|NCT01998776|Abortifacient Agents|abortifacient agents|mesh-ancestor
64662430|NCT02235909|Losartan|losartan|mesh-list
64893914|NCT01998776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64893915|NCT01998776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893916|NCT01998776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64893917|NCT01998776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64893918|NCT01998776|Oxytocics|oxytocics|mesh-ancestor
64893919|NCT01998789|Everolimus|everolimus|mesh-list
64893920|NCT01998789|Tacrolimus|tacrolimus|mesh-list
64893921|NCT01998789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64893922|NCT01998789|Immunologic Factors|immunologic factors|mesh-ancestor
64893923|NCT01998789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893924|NCT01998789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64893925|NCT01998789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64893926|NCT01998789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893927|NCT01998789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64893928|NCT01999153|Ropivacaine|ropivacaine|mesh-list
64893929|NCT01999153|Anesthetics, Local|anesthetics, local|mesh-ancestor
64893930|NCT01999153|Anesthetics|anesthetics|mesh-ancestor
64521322|NCT03193788|Hematinics|hematinics|mesh-ancestor
64521323|NCT03193788|Vitamin B Complex|vitamin b complex|mesh-ancestor
64521324|NCT02442648|Rituximab|rituximab|mesh-list
64521325|NCT02442648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64893931|NCT01999153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64893932|NCT01999153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893950|NCT01999309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64893951|NCT01999309|Antimetabolites|antimetabolites|mesh-ancestor
64893952|NCT01999309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893953|NCT01999309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64893954|NCT01999309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64893955|NCT01999309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64893956|NCT01999413|Cytarabine|cytarabine|mesh-list
64893957|NCT01999413|Daunorubicin|daunorubicin|mesh-list
64893958|NCT01999413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64893959|NCT01999413|Antimetabolites|antimetabolites|mesh-ancestor
64893960|NCT01999413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893961|NCT01999413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64893962|NCT01999413|Antiviral Agents|antiviral agents|mesh-ancestor
64893963|NCT01999413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64893964|NCT01999413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64893965|NCT01999413|Immunologic Factors|immunologic factors|mesh-ancestor
64893966|NCT01999413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893967|NCT01999413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64893968|NCT01999413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64893969|NCT01999413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64893970|NCT01999413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64893971|NCT01999647|Ropivacaine|ropivacaine|mesh-list
64893972|NCT01999647|Anesthetics, Local|anesthetics, local|mesh-list
64893973|NCT01999647|Anesthetics|anesthetics|mesh-list
64893974|NCT01999647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64893975|NCT01999647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893976|NCT01999647|Sensory System Agents|sensory system agents|mesh-ancestor
64646959|NCT01270412|Immunologic Factors|immunologic factors|mesh-ancestor
64894028|NCT02000102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64894029|NCT02000102|Growth Substances|growth substances|mesh-ancestor
64894030|NCT02000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894031|NCT02000102|Growth Inhibitors|growth inhibitors|mesh-ancestor
64894032|NCT02000102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894033|NCT02000193|Fulvestrant|fulvestrant|mesh-list
64894034|NCT02000193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64894035|NCT02000193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894036|NCT02000193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64894037|NCT02000193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64894038|NCT02000193|Hormone Antagonists|hormone antagonists|mesh-ancestor
64521326|NCT02442648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521327|NCT02442648|Immunologic Factors|immunologic factors|mesh-ancestor
64521328|NCT02442648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521329|NCT02442648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64521331|NCT00356824|Amodiaquine|amodiaquine|mesh-list
64521332|NCT00356824|Antimalarials|antimalarials|mesh-ancestor
64521333|NCT00356824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64894085|NCT02000401|Ketorolac|ketorolac|mesh-list
64894086|NCT02000401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64894087|NCT02000401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64894088|NCT02000401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64894089|NCT02000401|Analgesics|analgesics|mesh-ancestor
64894090|NCT02000401|Sensory System Agents|sensory system agents|mesh-ancestor
64894091|NCT02000401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894092|NCT02000401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894093|NCT02000401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64894094|NCT02000401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64646997|NCT01278056|Chelating Agents|chelating agents|mesh-ancestor
64894112|NCT02000700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64894113|NCT02000700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894114|NCT02000726|Antidepressive Agents|antidepressive agents|mesh-list
64894116|NCT02000726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64894117|NCT02000726|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64521334|NCT00356824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64521335|NCT00356824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64521336|NCT00356824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521337|NCT00356824|Antiviral Agents|antiviral agents|mesh-ancestor
64521338|NCT00356824|Schistosomicides|schistosomicides|mesh-ancestor
64521339|NCT00356824|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64521340|NCT00356824|Anthelmintics|anthelmintics|mesh-ancestor
64521341|NCT01705145|Ivacaftor|ivacaftor|mesh-list
64521342|NCT01705145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64521343|NCT01705145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64521344|NCT01705145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521345|NCT03716934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64521346|NCT04483830|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
64521347|NCT04483830|Anticoagulants|anticoagulants|mesh-ancestor
64521348|NCT04483830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64836027|NCT01610401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64447122|NCT01504204|Adapalene|adapalene|mesh-list
64521349|NCT04483830|Antimetabolites|antimetabolites|mesh-ancestor
64521350|NCT04483830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521351|NCT04483830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64521352|NCT04483830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64521353|NCT04483830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64521354|NCT04483830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64521355|NCT04483830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521356|NCT02442492|Sildenafil Citrate|sildenafil citrate|mesh-list
64521357|NCT02442492|Vasodilator Agents|vasodilator agents|mesh-ancestor
64521358|NCT02442492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64521359|NCT02442492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64521360|NCT02442492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521361|NCT02442492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521362|NCT02442492|Urological Agents|urological agents|mesh-ancestor
64521363|NCT01704755|Ribavirin|ribavirin|mesh-list
64521364|NCT01704755|Antimetabolites|antimetabolites|mesh-ancestor
64521365|NCT01704755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894118|NCT02000726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64894119|NCT02000726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64894120|NCT02000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894121|NCT02000726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64894122|NCT02000726|Serotonin Agents|serotonin agents|mesh-ancestor
64894123|NCT02000726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894124|NCT02000726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64894125|NCT02000804|Darapladib|darapladib|mesh-list
64521367|NCT01704755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64521368|NCT05165550|Elsulfavirine|elsulfavirine|mesh-list
64521369|NCT05165550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64521370|NCT05165550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64521371|NCT05165550|Antiviral Agents|antiviral agents|mesh-ancestor
64714093|NCT03054103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64521391|NCT04166669|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64894126|NCT02000804|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
64894127|NCT02000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64894128|NCT02000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894129|NCT02000830|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
64894130|NCT02000830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64894131|NCT02000830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894132|NCT02000947|Durvalumab|durvalumab|mesh-list
64894133|NCT02000947|Tremelimumab|tremelimumab|mesh-list
64894134|NCT02000947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64894135|NCT02000947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64894136|NCT02000947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894137|NCT02000947|Immunologic Factors|immunologic factors|mesh-ancestor
64894138|NCT02000947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894139|NCT02001012|Chloroquine|chloroquine|mesh-list
64894140|NCT02001012|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64894141|NCT02001012|Lumefantrine|lumefantrine|mesh-list
64894142|NCT02001012|Artemether|artemether|mesh-list
64521392|NCT04166669|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64521393|NCT04166669|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64521394|NCT04166669|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64521395|NCT04166669|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64521396|NCT04166669|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64521397|NCT03193710|Remifentanil|remifentanil|mesh-list
64521398|NCT03193710|Propofol|propofol|mesh-list
64521399|NCT03193710|Sevoflurane|sevoflurane|mesh-list
64521400|NCT03193710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64521401|NCT03193710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64521402|NCT03193710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521403|NCT03193710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64521404|NCT03193710|Anesthetics, General|anesthetics, general|mesh-ancestor
64521405|NCT03193710|Anesthetics|anesthetics|mesh-ancestor
64647043|NCT01271114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64894244|NCT02001428|Antimalarials|antimalarials|mesh-ancestor
64894245|NCT02001428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64894246|NCT02001428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64894247|NCT02001428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64894248|NCT02001506|Docetaxel|docetaxel|mesh-list
64521430|NCT02449278|Cyclophosphamide|cyclophosphamide|mesh-list
64521431|NCT02449278|Doxorubicin|doxorubicin|mesh-list
64521432|NCT02449278|Vincristine|vincristine|mesh-list
64521433|NCT02449278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64521434|NCT02449278|Immunologic Factors|immunologic factors|mesh-ancestor
64599964|NCT00706589|Aripiprazole|aripiprazole|mesh-list
64521435|NCT02449278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521436|NCT02449278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64521437|NCT02449278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64521438|NCT02449278|Alkylating Agents|alkylating agents|mesh-ancestor
64521439|NCT02449278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521440|NCT02449278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521441|NCT02449278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64521442|NCT02449278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64521443|NCT02449278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64521444|NCT02449278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64647135|NCT01271582|Antidotes|antidotes|mesh-ancestor
64894316|NCT02001883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64894317|NCT02001883|Antimetabolites|antimetabolites|mesh-ancestor
64894318|NCT02001883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894319|NCT02001883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64894320|NCT02001883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64894321|NCT02001883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64894322|NCT02001883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64894323|NCT02001896|Gemcitabine|gemcitabine|mesh-list
64521445|NCT02449278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521446|NCT02449278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64521449|NCT02449278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64521450|NCT02449278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64521451|NCT02449278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64647166|NCT01271894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64521469|NCT03099486|Leucovorin|leucovorin|mesh-list
64521470|NCT03099486|Antidotes|antidotes|mesh-ancestor
64521471|NCT03099486|Protective Agents|protective agents|mesh-ancestor
64521472|NCT03099486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521473|NCT03099486|Vitamin B Complex|vitamin b complex|mesh-ancestor
64521474|NCT03099486|Vitamins|vitamins|mesh-ancestor
64521475|NCT03099486|Micronutrients|micronutrients|mesh-ancestor
64521476|NCT00358228|Rimonabant|rimonabant|mesh-list
64521487|NCT05710198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64521488|NCT05710198|Nootropic Agents|nootropic agents|mesh-ancestor
64521490|NCT05709028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64521491|NCT05709028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64521492|NCT03420508|Ensartinib|ensartinib|mesh-list
64521493|NCT03420508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521494|NCT03420508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64521495|NCT03420508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521496|NCT03420508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521497|NCT03416530|TIC10 compound|tic10 compound|mesh-list
64521498|NCT03416530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521499|NCT01336530|Oxethazaine|oxethazaine|mesh-list
64521500|NCT01336530|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64521501|NCT01336530|Antacids|antacids|mesh-list
64521502|NCT01336530|Magnesium Hydroxide|magnesium hydroxide|mesh-list
64521503|NCT01336530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64521504|NCT01336530|Immunologic Factors|immunologic factors|mesh-ancestor
64521505|NCT01336530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521506|NCT01336530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521507|NCT01336530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64521508|NCT01336530|Anesthetics, Local|anesthetics, local|mesh-ancestor
64521509|NCT01336530|Anesthetics|anesthetics|mesh-ancestor
64521510|NCT01336530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64521511|NCT01336530|Sensory System Agents|sensory system agents|mesh-ancestor
64894324|NCT02001896|Carboplatin|carboplatin|mesh-list
64894325|NCT02001896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64894326|NCT02001896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894327|NCT02001896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64894328|NCT02001896|Antimetabolites|antimetabolites|mesh-ancestor
64894329|NCT02001896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894330|NCT02001896|Antiviral Agents|antiviral agents|mesh-ancestor
64894331|NCT02001896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64894332|NCT02001896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64894333|NCT02001896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64894371|NCT02001974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894373|NCT02001974|Antimitotic Agents|antimitotic agents|mesh-ancestor
64894374|NCT02001974|Mitosis Modulators|mitosis modulators|mesh-ancestor
64894375|NCT02001974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894376|NCT02002000|Vitamin D|vitamin d|mesh-list
64894377|NCT02002000|Cholecalciferol|cholecalciferol|mesh-list
64894403|NCT02002078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64521513|NCT00777348|Reproterol|reproterol|mesh-list
64521514|NCT00777348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64521515|NCT00777348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64521516|NCT00777348|Adrenergic Agents|adrenergic agents|mesh-ancestor
64521517|NCT00777348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64521518|NCT00777348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521519|NCT00777348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521520|NCT00777348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64521521|NCT00777348|Autonomic Agents|autonomic agents|mesh-ancestor
64521522|NCT00777348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64521523|NCT00777348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64521524|NCT00777348|Respiratory System Agents|respiratory system agents|mesh-ancestor
64521525|NCT03836560|Nicotine|nicotine|mesh-list
64521526|NCT03836560|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64521527|NCT03836560|Autonomic Agents|autonomic agents|mesh-ancestor
64521528|NCT03836560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64521529|NCT03836560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521530|NCT03836560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64521531|NCT03836560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64521532|NCT03836560|Cholinergic Agents|cholinergic agents|mesh-ancestor
64521533|NCT03836560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64521534|NCT03836560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521535|NCT04483596|Melatonin|melatonin|mesh-list
64521536|NCT04483596|Antioxidants|antioxidants|mesh-ancestor
64521537|NCT04483596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521538|NCT04483596|Protective Agents|protective agents|mesh-ancestor
64894405|NCT02002078|Protective Agents|protective agents|mesh-ancestor
64894406|NCT02002078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64894407|NCT02002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894408|NCT02002156|Vaccines|vaccines|mesh-list
64894409|NCT02002156|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64894410|NCT02002156|BCG Vaccine|bcg vaccine|mesh-list
64894411|NCT02002156|Immunologic Factors|immunologic factors|mesh-ancestor
64894412|NCT02002156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894413|NCT02002156|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64894414|NCT02002195|Leucovorin|leucovorin|mesh-list
64894415|NCT02002195|Fluorouracil|fluorouracil|mesh-list
64894416|NCT02002195|Capecitabine|capecitabine|mesh-list
64894417|NCT02002195|Oxaliplatin|oxaliplatin|mesh-list
64894418|NCT02002195|Antimetabolites|antimetabolites|mesh-ancestor
64894419|NCT02002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894420|NCT02002195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64894421|NCT02002195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894422|NCT02002195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64894423|NCT02002195|Immunologic Factors|immunologic factors|mesh-ancestor
64894424|NCT02002195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894425|NCT02002195|Antidotes|antidotes|mesh-ancestor
64521539|NCT04483596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521540|NCT04483596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64521541|NCT05721586|Listerine|listerine|mesh-list
64521542|NCT05721586|Fluorides|fluorides|mesh-list
64521543|NCT05721586|Fluorides, Topical|fluorides, topical|mesh-list
64894448|NCT02002260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894449|NCT02002260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64894450|NCT02002260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64894451|NCT02002260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64894452|NCT02002260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64894453|NCT02002260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64894454|NCT02002286|Triptolide|triptolide|mesh-list
64894455|NCT02002286|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
64894456|NCT02002286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894457|NCT02002286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64325700|NCT02266927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64325701|NCT02266927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325702|NCT02266927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64325703|NCT02266927|Respiratory System Agents|respiratory system agents|mesh-ancestor
64600111|NCT02999633|Analgesics|analgesics|mesh-ancestor
64600113|NCT02999633|Antipyretics|antipyretics|mesh-ancestor
64894483|NCT02002390|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64894484|NCT02002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894485|NCT02002390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64894486|NCT02002390|Immunologic Factors|immunologic factors|mesh-ancestor
64894487|NCT02002390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894489|NCT02002403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64894530|NCT02002663|Narcotics|narcotics|mesh-ancestor
64894531|NCT02002663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64894532|NCT02002663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894533|NCT02002663|Analgesics|analgesics|mesh-ancestor
64894534|NCT02002663|Sensory System Agents|sensory system agents|mesh-ancestor
64894535|NCT02002663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894536|NCT02002663|Anesthetics, Local|anesthetics, local|mesh-ancestor
64894537|NCT02002663|Anesthetics|anesthetics|mesh-ancestor
64521571|NCT00357682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521573|NCT00357682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64521574|NCT00357682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521575|NCT00357682|Antipyretics|antipyretics|mesh-ancestor
64521576|NCT00357682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64521577|NCT00357682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64894538|NCT02002663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64894539|NCT02002663|Antiemetics|antiemetics|mesh-ancestor
64894540|NCT02002663|Autonomic Agents|autonomic agents|mesh-ancestor
64894541|NCT02002663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64894542|NCT02002663|Glucocorticoids|glucocorticoids|mesh-ancestor
64894543|NCT02002663|Hormones|hormones|mesh-ancestor
64894544|NCT02002663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64894545|NCT02002663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64894546|NCT02002663|Protective Agents|protective agents|mesh-ancestor
64894547|NCT02002663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64894548|NCT02002663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894549|NCT02002715|Budesonide|budesonide|mesh-list
64894550|NCT02002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64894551|NCT02002715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64894552|NCT02002715|Autonomic Agents|autonomic agents|mesh-ancestor
64894553|NCT02002715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64647289|NCT02144714|Adalimumab|adalimumab|mesh-list
64894591|NCT02002923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64894592|NCT02002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945485|NCT05595603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663097|NCT03575013|Docetaxel|docetaxel|mesh-list
64894594|NCT02002923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64894595|NCT02002923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894596|NCT02002962|Botulinum Toxins|botulinum toxins|mesh-list
64894597|NCT02002962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64894598|NCT02002962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64894599|NCT02002962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64894600|NCT02002962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64894601|NCT02002962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894602|NCT02002962|Cholinergic Agents|cholinergic agents|mesh-ancestor
64894603|NCT02002962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64894604|NCT02002962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894605|NCT02002962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64894606|NCT02002962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894607|NCT02003001|Botulinum Toxins|botulinum toxins|mesh-list
64894638|NCT02003313|Vaccines|vaccines|mesh-list
64894639|NCT02003313|Immunologic Factors|immunologic factors|mesh-ancestor
64894640|NCT02003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894641|NCT02003456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64894642|NCT02003456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64521578|NCT00357682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64521579|NCT00105027|Triamcinolone|triamcinolone|mesh-list
64521580|NCT00105027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64521581|NCT00105027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64521582|NCT00105027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64894643|NCT02003456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894644|NCT02003495|Vaccines|vaccines|mesh-list
64894645|NCT02003495|Immunologic Factors|immunologic factors|mesh-ancestor
64894646|NCT02003495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894647|NCT02003664|Baclofen|baclofen|mesh-list
64894685|NCT02004067|Immunologic Factors|immunologic factors|mesh-ancestor
64894686|NCT02004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894687|NCT02004067|Antifungal Agents|antifungal agents|mesh-ancestor
64894688|NCT02004067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64600180|NCT01277627|Efavirenz|efavirenz|mesh-list
64894689|NCT02004067|Dermatologic Agents|dermatologic agents|mesh-ancestor
64894690|NCT02004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64894691|NCT02004067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64894692|NCT02004067|Cathartics|cathartics|mesh-ancestor
64894693|NCT02004067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64894694|NCT02004171|Nicotine|nicotine|mesh-list
64894695|NCT02004171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64894696|NCT02004171|Autonomic Agents|autonomic agents|mesh-ancestor
64894697|NCT02004171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894698|NCT02004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894699|NCT02004171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64894700|NCT02004171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64894701|NCT02004171|Cholinergic Agents|cholinergic agents|mesh-ancestor
64894702|NCT02004171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64894703|NCT02004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894704|NCT02004184|Pemetrexed|pemetrexed|mesh-list
64894705|NCT02004184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894706|NCT02004184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64894707|NCT02004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894723|NCT02004197|Histamine Agents|histamine agents|mesh-ancestor
64894724|NCT02004197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64894725|NCT02004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894726|NCT02004301|Diclofenac|diclofenac|mesh-list
64894727|NCT02004301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64894728|NCT02004301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64894729|NCT02004301|Analgesics|analgesics|mesh-ancestor
64894730|NCT02004301|Sensory System Agents|sensory system agents|mesh-ancestor
64894731|NCT02004301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894732|NCT02004301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894733|NCT02004301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64894734|NCT02004301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64894735|NCT02004301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64894736|NCT02004301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64894737|NCT02004301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894738|NCT02004314|Chloroquine|chloroquine|mesh-list
64894739|NCT02004314|Amebicides|amebicides|mesh-ancestor
64894740|NCT02004314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64894741|NCT02004314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64894742|NCT02004314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64521583|NCT00105027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64521584|NCT00105027|Glucocorticoids|glucocorticoids|mesh-ancestor
64894748|NCT02004418|Antimetabolites|antimetabolites|mesh-ancestor
64894749|NCT02004418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894750|NCT02004418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64894751|NCT02004418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64894752|NCT02004418|Nootropic Agents|nootropic agents|mesh-ancestor
64894754|NCT02004574|Betamethasone|betamethasone|mesh-list
64894755|NCT02004574|Betamethasone Valerate|betamethasone valerate|mesh-list
64894756|NCT02004574|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64894757|NCT02004574|Betamethasone benzoate|betamethasone benzoate|mesh-list
64894758|NCT02004574|Calcipotriene|calcipotriene|mesh-list
64894759|NCT02004574|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64894760|NCT02004574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64894761|NCT02004574|Glucocorticoids|glucocorticoids|mesh-ancestor
64894762|NCT02004574|Hormones|hormones|mesh-ancestor
64894763|NCT02004574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64894764|NCT02004574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894765|NCT02004574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64894766|NCT02004574|Respiratory System Agents|respiratory system agents|mesh-ancestor
64894767|NCT02004574|Dermatologic Agents|dermatologic agents|mesh-ancestor
64894768|NCT02004652|Prucalopride|prucalopride|mesh-list
64894769|NCT02004652|Laxatives|laxatives|mesh-ancestor
64894770|NCT02004652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64894786|NCT02004769|Antimetabolites|antimetabolites|mesh-ancestor
64894787|NCT02004769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64894788|NCT02004782|Prednisolone|prednisolone|mesh-list
64521641|NCT02709486|Analgesics|analgesics|mesh-ancestor
64521642|NCT02709486|Sensory System Agents|sensory system agents|mesh-ancestor
64521643|NCT02709486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64521644|NCT02709486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521645|NCT00106431|Romidepsin|romidepsin|mesh-list
64521646|NCT00106431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64521647|NCT00106431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600255|NCT02995655|Azacitidine|azacitidine|mesh-list
64521648|NCT03107416|Bumetanide|bumetanide|mesh-list
64521649|NCT03107416|Diuretics|diuretics|mesh-ancestor
64521650|NCT03107416|Natriuretic Agents|natriuretic agents|mesh-ancestor
64647373|NCT01279694|Alkylating Agents|alkylating agents|mesh-ancestor
64894801|NCT02004860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64894802|NCT02004860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64894803|NCT02004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894804|NCT02004860|Antifungal Agents|antifungal agents|mesh-ancestor
64894805|NCT02004860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64894806|NCT02004899|Fentanyl|fentanyl|mesh-list
64894807|NCT02004899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64894808|NCT02004899|Narcotics|narcotics|mesh-ancestor
64894809|NCT02004899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64894810|NCT02004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894811|NCT02004899|Analgesics|analgesics|mesh-ancestor
64894812|NCT02004899|Sensory System Agents|sensory system agents|mesh-ancestor
64894813|NCT02004899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894814|NCT02004899|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64894815|NCT02004899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64894816|NCT02004899|Anesthetics, General|anesthetics, general|mesh-ancestor
64894817|NCT02004899|Anesthetics|anesthetics|mesh-ancestor
64894818|NCT02005068|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64894819|NCT02005068|Cephalosporins|cephalosporins|mesh-list
64894820|NCT02005068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64894821|NCT02005068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64894822|NCT02005107|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64894823|NCT02005107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64894824|NCT02005107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64894825|NCT02005107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64521658|NCT02439996|Immunologic Factors|immunologic factors|mesh-ancestor
64521659|NCT02439996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521660|NCT03833596|Prednisone|prednisone|mesh-list
64521731|NCT02425774|Prucalopride|prucalopride|mesh-list
64521732|NCT02425774|Laxatives|laxatives|mesh-ancestor
64521733|NCT02425774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64521734|NCT02425774|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64521735|NCT02425774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64521736|NCT02425774|Serotonin Agents|serotonin agents|mesh-ancestor
64647399|NCT00744380|Sensory System Agents|sensory system agents|mesh-ancestor
64894828|NCT02005107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894837|NCT02005120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64894839|NCT02005120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894840|NCT02005120|Growth Inhibitors|growth inhibitors|mesh-ancestor
64894842|NCT02005302|Ergocalciferols|ergocalciferols|mesh-list
64894843|NCT02005302|Cholecalciferol|cholecalciferol|mesh-list
64894844|NCT02005302|Vitamins|vitamins|mesh-list
64894845|NCT02005302|Micronutrients|micronutrients|mesh-ancestor
64894846|NCT02005302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894847|NCT02005302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64894848|NCT02005302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64894849|NCT02005315|Gemcitabine|gemcitabine|mesh-list
64894850|NCT02005315|Paclitaxel|paclitaxel|mesh-list
64894851|NCT02005315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64894852|NCT02005315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894853|NCT02005315|Tubulin Modulators|tubulin modulators|mesh-ancestor
64894854|NCT02005315|Antimitotic Agents|antimitotic agents|mesh-ancestor
64894855|NCT02005315|Mitosis Modulators|mitosis modulators|mesh-ancestor
64894856|NCT02005315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894857|NCT02005315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64894858|NCT02005315|Antimetabolites|antimetabolites|mesh-ancestor
64894859|NCT02005315|Antiviral Agents|antiviral agents|mesh-ancestor
64894860|NCT02005315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64894861|NCT02005315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521760|NCT03187626|Botulinum Toxins|botulinum toxins|mesh-list
64521761|NCT03187626|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64521762|NCT03187626|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64521763|NCT03187626|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64521764|NCT03187626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64714094|NCT03054103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64521765|NCT03187626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521766|NCT03187626|Cholinergic Agents|cholinergic agents|mesh-ancestor
64521767|NCT03187626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64521768|NCT03187626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521769|NCT03187626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64521770|NCT03187626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64521771|NCT03117894|Acetaminophen|acetaminophen|mesh-list
64521772|NCT03117894|Etoricoxib|etoricoxib|mesh-list
64894862|NCT02005315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64894863|NCT02005315|Immunologic Factors|immunologic factors|mesh-ancestor
64894864|NCT02005315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894875|NCT02005419|Immunologic Factors|immunologic factors|mesh-ancestor
64894876|NCT02005419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894877|NCT02005419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64894879|NCT02005523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64894880|NCT02005523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64894881|NCT02005523|Analgesics|analgesics|mesh-ancestor
64894882|NCT02005523|Sensory System Agents|sensory system agents|mesh-ancestor
64894883|NCT02005523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894884|NCT02005523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894885|NCT02005523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64894886|NCT02005523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64894887|NCT02005523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64894888|NCT02005575|Dexamethasone|dexamethasone|mesh-list
64894889|NCT02005575|Bupivacaine|bupivacaine|mesh-list
64894890|NCT02005575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64894891|NCT02005575|Antiemetics|antiemetics|mesh-ancestor
64894892|NCT02005575|Autonomic Agents|autonomic agents|mesh-ancestor
64894893|NCT02005575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894894|NCT02005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894895|NCT02005575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64894896|NCT02005575|Glucocorticoids|glucocorticoids|mesh-ancestor
64894918|NCT02005653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64894919|NCT02005653|Antimalarials|antimalarials|mesh-ancestor
64894920|NCT02005653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64894921|NCT02005653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64894922|NCT02005653|Anthelmintics|anthelmintics|mesh-ancestor
64894923|NCT02005653|Anticestodal Agents|anticestodal agents|mesh-ancestor
64894924|NCT02005653|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64894925|NCT02005653|Tubulin Modulators|tubulin modulators|mesh-ancestor
64894926|NCT02005653|Antimitotic Agents|antimitotic agents|mesh-ancestor
64894927|NCT02005653|Mitosis Modulators|mitosis modulators|mesh-ancestor
64521774|NCT03117894|Remifentanil|remifentanil|mesh-list
64521775|NCT03117894|Ondansetron|ondansetron|mesh-list
64521776|NCT03117894|Propofol|propofol|mesh-list
64521777|NCT03117894|Ropivacaine|ropivacaine|mesh-list
64521778|NCT03117894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64521779|NCT03117894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64521780|NCT03117894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521781|NCT03117894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64521782|NCT03117894|Anesthetics, General|anesthetics, general|mesh-ancestor
64521783|NCT03117894|Anesthetics|anesthetics|mesh-ancestor
64521784|NCT03117894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64521785|NCT03117894|Narcotics|narcotics|mesh-ancestor
64521786|NCT03117894|Analgesics|analgesics|mesh-ancestor
64521787|NCT03117894|Sensory System Agents|sensory system agents|mesh-ancestor
64521788|NCT03117894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64521789|NCT03117894|Anesthetics, Local|anesthetics, local|mesh-ancestor
64521790|NCT03117894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64521791|NCT03117894|Antipyretics|antipyretics|mesh-ancestor
64521792|NCT03117894|Antiemetics|antiemetics|mesh-ancestor
64521793|NCT03117894|Autonomic Agents|autonomic agents|mesh-ancestor
64521794|NCT03117894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64521795|NCT03117894|Antipruritics|antipruritics|mesh-ancestor
64521796|NCT03117894|Dermatologic Agents|dermatologic agents|mesh-ancestor
64521797|NCT03117894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64521798|NCT03117894|Serotonin Agents|serotonin agents|mesh-ancestor
64521799|NCT03117894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64647437|NCT00744848|Sensory System Agents|sensory system agents|mesh-ancestor
64894945|NCT02005757|Sensory System Agents|sensory system agents|mesh-ancestor
64894946|NCT02005757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64521803|NCT03117894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64521804|NCT03117894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64521805|NCT03117894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64521806|NCT03117894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64521807|NCT03117894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64521808|NCT03117894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64894947|NCT02005757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894948|NCT02005757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64894949|NCT02005757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64894950|NCT02005757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64894975|NCT02005783|Immunologic Factors|immunologic factors|mesh-ancestor
64894976|NCT02005783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894977|NCT02005783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64894978|NCT02005783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64894979|NCT02005783|Alkylating Agents|alkylating agents|mesh-ancestor
64894980|NCT02005783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894981|NCT02005783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894982|NCT02005783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64894983|NCT02005783|Tubulin Modulators|tubulin modulators|mesh-ancestor
64894984|NCT02005783|Antimitotic Agents|antimitotic agents|mesh-ancestor
64894985|NCT02005783|Mitosis Modulators|mitosis modulators|mesh-ancestor
64894986|NCT02005783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64894987|NCT02005783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64894988|NCT02005783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64894989|NCT02005783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64894990|NCT02005822|Valganciclovir|valganciclovir|mesh-list
64894991|NCT02005822|Antiviral Agents|antiviral agents|mesh-ancestor
64894992|NCT02005822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64894993|NCT02005848|Protease Inhibitors|protease inhibitors|mesh-list
64894994|NCT02005848|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64894995|NCT02005848|Protein C Inhibitor|protein c inhibitor|mesh-list
64894996|NCT02005848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64894997|NCT02005848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647452|NCT03830606|Paclitaxel|paclitaxel|mesh-list
64895039|NCT02006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895040|NCT02006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895041|NCT02006485|Immunologic Factors|immunologic factors|mesh-ancestor
64895042|NCT02006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895044|NCT02006498|Antioxidants|antioxidants|mesh-ancestor
64895045|NCT02006498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895046|NCT02006498|Protective Agents|protective agents|mesh-ancestor
64663566|NCT01422200|Vaccines|vaccines|mesh-list
64895047|NCT02006498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895049|NCT02006589|Candesartan cilexetil|candesartan cilexetil|mesh-list
64895067|NCT02006849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64895068|NCT02006849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895070|NCT02006914|Picolinic acid|picolinic acid|mesh-list
64521809|NCT03117894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64521810|NCT03117894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521811|NCT00357292|Azithromycin|azithromycin|mesh-list
64521812|NCT00357292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64521813|NCT00357292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64647467|NCT01278134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64647468|NCT01278134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64521814|NCT05625802|Ropivacaine|ropivacaine|mesh-list
64521815|NCT05625802|Anesthetics, Local|anesthetics, local|mesh-ancestor
64521816|NCT05625802|Anesthetics|anesthetics|mesh-ancestor
64521817|NCT05625802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64521821|NCT03187548|Calcium|calcium|mesh-list
64521877|NCT03187392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64521878|NCT03187392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64521879|NCT03187392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64521880|NCT03187392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64521881|NCT03187392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521882|NCT01464268|Riboflavin|riboflavin|mesh-list
64521883|NCT01464268|Dextrans|dextrans|mesh-list
64521884|NCT01464268|Vitamin B Complex|vitamin b complex|mesh-ancestor
64521885|NCT01464268|Vitamins|vitamins|mesh-ancestor
64521886|NCT01464268|Micronutrients|micronutrients|mesh-ancestor
64521887|NCT01464268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895071|NCT02006914|Trace Elements|trace elements|mesh-ancestor
64895072|NCT02006914|Micronutrients|micronutrients|mesh-ancestor
64647469|NCT01278134|Antiviral Agents|antiviral agents|mesh-ancestor
64895095|NCT02007005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64895096|NCT02007148|Docetaxel|docetaxel|mesh-list
64895097|NCT02007148|Capecitabine|capecitabine|mesh-list
64895098|NCT02007148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895099|NCT02007148|Tubulin Modulators|tubulin modulators|mesh-ancestor
64895100|NCT02007148|Antimitotic Agents|antimitotic agents|mesh-ancestor
64895101|NCT02007148|Mitosis Modulators|mitosis modulators|mesh-ancestor
64895102|NCT02007148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895103|NCT02007148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64895132|NCT02007330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64895133|NCT02007330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64895134|NCT02007330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64895135|NCT02007330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64895136|NCT02007330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895137|NCT02007408|Lidocaine|lidocaine|mesh-list
64895138|NCT02007408|Anesthetics, Local|anesthetics, local|mesh-ancestor
64895139|NCT02007408|Anesthetics|anesthetics|mesh-ancestor
64895140|NCT02007408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64895141|NCT02007408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895142|NCT02007408|Sensory System Agents|sensory system agents|mesh-ancestor
64895143|NCT02007408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895144|NCT02007408|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64895145|NCT02007408|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64895146|NCT02007408|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64895147|NCT02007408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64521889|NCT01464268|Dermatologic Agents|dermatologic agents|mesh-ancestor
64521890|NCT01464268|Anticoagulants|anticoagulants|mesh-ancestor
64521891|NCT01464268|Plasma Substitutes|plasma substitutes|mesh-ancestor
64521892|NCT01464268|Blood Substitutes|blood substitutes|mesh-ancestor
64895184|NCT02007837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64895185|NCT02007837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64895186|NCT02007837|Analgesics|analgesics|mesh-ancestor
64895187|NCT02007837|Sensory System Agents|sensory system agents|mesh-ancestor
64895188|NCT02007837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895189|NCT02007837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895190|NCT02007837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64895191|NCT02007837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64895192|NCT02007837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64895193|NCT02007837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64895203|NCT02007850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895205|NCT02007850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895206|NCT02007915|Pamidronate|pamidronate|mesh-list
64895207|NCT02007915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64895208|NCT02007915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895209|NCT02007928|Olanzapine|olanzapine|mesh-list
64895210|NCT02007928|Risperidone|risperidone|mesh-list
64895211|NCT02007928|Aripiprazole|aripiprazole|mesh-list
64895212|NCT02007928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64895213|NCT02007928|Serotonin Agents|serotonin agents|mesh-ancestor
64895214|NCT02007928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64895215|NCT02007928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895216|NCT02007928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895217|NCT02007928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64895218|NCT02007928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64895219|NCT02007928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64895220|NCT02007928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64895221|NCT02007928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64895222|NCT02007928|Dopamine Agents|dopamine agents|mesh-ancestor
64895223|NCT02007928|Antiemetics|antiemetics|mesh-ancestor
64895224|NCT02007928|Autonomic Agents|autonomic agents|mesh-ancestor
64895225|NCT02007928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895226|NCT02007928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64895227|NCT02007928|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64895228|NCT02007928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64895229|NCT02007928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64521903|NCT00215787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521905|NCT05716906|Antioxidants|antioxidants|mesh-ancestor
64521906|NCT05716906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521907|NCT05716906|Protective Agents|protective agents|mesh-ancestor
64647511|NCT00746954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64895238|NCT02008006|Melphalan|melphalan|mesh-list
64895239|NCT02008006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64895240|NCT02008006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64895241|NCT02008006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895242|NCT02008006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64895243|NCT02008006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64895244|NCT02008006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64895245|NCT02008006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895246|NCT02008006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64895247|NCT02008006|Antimetabolites|antimetabolites|mesh-ancestor
64895248|NCT02008006|Antiviral Agents|antiviral agents|mesh-ancestor
64895249|NCT02008006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64600545|NCT01272557|Sorafenib|sorafenib|mesh-list
64895250|NCT02008006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64895251|NCT02008006|Immunologic Factors|immunologic factors|mesh-ancestor
64895252|NCT02008006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895253|NCT02008006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64895254|NCT02008006|Alkylating Agents|alkylating agents|mesh-ancestor
64895255|NCT02008006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64895256|NCT02008019|Everolimus|everolimus|mesh-list
64895257|NCT02008019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895282|NCT02008162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64895283|NCT02008162|Respiratory System Agents|respiratory system agents|mesh-ancestor
64895284|NCT02008162|Parasympatholytics|parasympatholytics|mesh-ancestor
64895285|NCT02008162|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64895286|NCT02008162|Cholinergic Agents|cholinergic agents|mesh-ancestor
64895287|NCT02008162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64895288|NCT02008162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895289|NCT02008162|Anticonvulsants|anticonvulsants|mesh-ancestor
64895290|NCT02008162|Tocolytic Agents|tocolytic agents|mesh-ancestor
64895291|NCT02008162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64895292|NCT02008162|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64895293|NCT02008162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64895294|NCT02008162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64521919|NCT00216099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521921|NCT00216099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64521922|NCT00216099|Hematinics|hematinics|mesh-ancestor
64521923|NCT00216099|Vitamin B Complex|vitamin b complex|mesh-ancestor
64647528|NCT00723632|Ribavirin|ribavirin|mesh-list
64895305|NCT02008214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64895306|NCT02008214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64895307|NCT02008214|Protective Agents|protective agents|mesh-ancestor
64895319|NCT02008422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895320|NCT02008422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64895321|NCT02008422|Antimetabolites|antimetabolites|mesh-ancestor
64895322|NCT02008422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895323|NCT02008422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64895324|NCT02008422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64895325|NCT02008422|Growth Substances|growth substances|mesh-ancestor
64895326|NCT02008422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895327|NCT02008422|Growth Inhibitors|growth inhibitors|mesh-ancestor
64895328|NCT02008461|Botulinum Toxins|botulinum toxins|mesh-list
64895329|NCT02008461|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64895330|NCT02008461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64895331|NCT02008461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895332|NCT02008461|Cholinergic Agents|cholinergic agents|mesh-ancestor
64895333|NCT02008461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64895334|NCT02008461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895335|NCT02008578|Immunoglobulins|immunoglobulins|mesh-list
64895336|NCT02008578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64895337|NCT02008578|Antibodies|antibodies|mesh-list
64895338|NCT02008578|Immunologic Factors|immunologic factors|mesh-ancestor
64895339|NCT02008578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895340|NCT02008721|Neuroprotective Agents|neuroprotective agents|mesh-list
64895341|NCT02008721|Protective Agents|protective agents|mesh-ancestor
64895342|NCT02008721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895343|NCT02008734|Palbociclib|palbociclib|mesh-list
64895344|NCT02008734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895345|NCT02008734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64895346|NCT02008734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64895347|NCT02008734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895348|NCT02008747|Magnesium Sulfate|magnesium sulfate|mesh-list
64895349|NCT02008747|Analgesics|analgesics|mesh-ancestor
64895350|NCT02008747|Sensory System Agents|sensory system agents|mesh-ancestor
64895351|NCT02008747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895352|NCT02008747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895353|NCT02008747|Anesthetics|anesthetics|mesh-ancestor
64895354|NCT02008747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64895355|NCT02008747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64521929|NCT04565925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521930|NCT04565925|Urological Agents|urological agents|mesh-ancestor
64647547|NCT01279616|Alkylating Agents|alkylating agents|mesh-ancestor
64895403|NCT02008981|Protective Agents|protective agents|mesh-ancestor
64895406|NCT02009007|Oxymetazoline|oxymetazoline|mesh-list
64895407|NCT02009007|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64895408|NCT02009007|Mydriatics|mydriatics|mesh-ancestor
64895409|NCT02009007|Autonomic Agents|autonomic agents|mesh-ancestor
64895410|NCT02009007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895411|NCT02009007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895412|NCT02009007|Sympathomimetics|sympathomimetics|mesh-ancestor
64895413|NCT02009007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64895414|NCT02009007|Nasal Decongestants|nasal decongestants|mesh-ancestor
64895415|NCT02009007|Respiratory System Agents|respiratory system agents|mesh-ancestor
64895416|NCT02009007|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64895417|NCT02009007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64895418|NCT02009007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64895419|NCT02009007|Adrenergic Agents|adrenergic agents|mesh-ancestor
64895420|NCT02009007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64521941|NCT00039195|Immunologic Factors|immunologic factors|mesh-ancestor
64521942|NCT00039195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521943|NCT00039195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64521944|NCT00039195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64521945|NCT00039195|Alkylating Agents|alkylating agents|mesh-ancestor
64521946|NCT00039195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521947|NCT00039195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521948|NCT00039195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64521949|NCT00039195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64521950|NCT00039195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64521951|NCT00039195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64521952|NCT00039195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64521953|NCT00039195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521954|NCT00039195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64521955|NCT00039195|Glucocorticoids|glucocorticoids|mesh-ancestor
64521956|NCT00039195|Hormones|hormones|mesh-ancestor
64521957|NCT00039195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64521958|NCT00039195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64521959|NCT00039195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64895452|NCT05778838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895453|NCT05778825|Minoxidil|minoxidil|mesh-list
64895454|NCT05778825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64895455|NCT05778825|Vasodilator Agents|vasodilator agents|mesh-ancestor
64895456|NCT05778760|Vitamin A|vitamin a|mesh-list
64895457|NCT05778760|Vitamins|vitamins|mesh-ancestor
64895458|NCT05778760|Micronutrients|micronutrients|mesh-ancestor
64895459|NCT05778760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895460|NCT05778591|Buprenorphine|buprenorphine|mesh-list
64895461|NCT05778591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64895462|NCT05778591|Narcotics|narcotics|mesh-ancestor
64895463|NCT05778591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64895464|NCT05778591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895465|NCT05778591|Analgesics|analgesics|mesh-ancestor
64895477|NCT05778305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64895478|NCT05778305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895479|NCT05778305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64895480|NCT05778305|Analgesics|analgesics|mesh-ancestor
64895481|NCT05778305|Sensory System Agents|sensory system agents|mesh-ancestor
64895482|NCT05778305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64521960|NCT00039195|Tubulin Modulators|tubulin modulators|mesh-ancestor
64521961|NCT00039195|Antimitotic Agents|antimitotic agents|mesh-ancestor
64521962|NCT00039195|Mitosis Modulators|mitosis modulators|mesh-ancestor
64521963|NCT05591170|Cholecalciferol|cholecalciferol|mesh-list
64521964|NCT05591170|Vitamin D|vitamin d|mesh-list
64521965|NCT05591170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64521966|NCT05591170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521967|NCT05591170|Vitamins|vitamins|mesh-ancestor
64521968|NCT05591170|Micronutrients|micronutrients|mesh-ancestor
64521969|NCT05591170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64521970|NCT00218439|Paroxetine|paroxetine|mesh-list
64521971|NCT00218439|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64521972|NCT00218439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64521973|NCT00218439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64521974|NCT00218439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64521975|NCT00218439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64895483|NCT05778305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64895484|NCT05778305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64895485|NCT05778305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64895486|NCT05778305|Adrenergic Agents|adrenergic agents|mesh-ancestor
64895487|NCT05778305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64895488|NCT05778305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895489|NCT05778227|Etidronic Acid|etidronic acid|mesh-list
64895518|NCT05778084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895519|NCT05777902|Ozanimod|ozanimod|mesh-list
64895520|NCT05777902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64895521|NCT05777902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895522|NCT05777902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64895523|NCT05777902|Immunologic Factors|immunologic factors|mesh-ancestor
64895524|NCT05777902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895525|NCT05777824|Antibodies|antibodies|mesh-list
64895526|NCT05777824|Immunologic Factors|immunologic factors|mesh-ancestor
64895527|NCT05777824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895528|NCT05777733|Acetylcysteine|acetylcysteine|mesh-list
64895529|NCT05777733|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64895530|NCT05777733|Antidotes|antidotes|mesh-ancestor
64895531|NCT05777733|Protective Agents|protective agents|mesh-ancestor
64895532|NCT05777733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895533|NCT05777733|Antioxidants|antioxidants|mesh-ancestor
64895534|NCT05777733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895535|NCT05777733|Antiviral Agents|antiviral agents|mesh-ancestor
64895536|NCT05777733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64895537|NCT05777733|Expectorants|expectorants|mesh-ancestor
64895572|NCT05777369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64647612|NCT04274426|Maytansine|maytansine|mesh-list
64521980|NCT00218439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64521981|NCT00218439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64521982|NCT00218439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64521983|NCT00218439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64521984|NCT04344730|Dexamethasone|dexamethasone|mesh-list
64895643|NCT05707273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895644|NCT05707273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895645|NCT05707273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64895647|NCT05706259|Ergocalciferols|ergocalciferols|mesh-list
64895648|NCT05706259|Cholecalciferol|cholecalciferol|mesh-list
64895649|NCT05706259|Vitamins|vitamins|mesh-list
64895650|NCT05706259|Micronutrients|micronutrients|mesh-ancestor
64895651|NCT05706259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895652|NCT05706259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64895653|NCT05706259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64895654|NCT05680129|Metformin|metformin|mesh-list
64895655|NCT05680129|Dulaglutide|dulaglutide|mesh-list
64895656|NCT05680129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64895657|NCT05680129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895658|NCT05624151|Magnesium Sulfate|magnesium sulfate|mesh-list
64895659|NCT05624151|Dexmedetomidine|dexmedetomidine|mesh-list
64895660|NCT05624151|Bupivacaine|bupivacaine|mesh-list
64895661|NCT05624151|Anesthetics, Local|anesthetics, local|mesh-ancestor
64895662|NCT05624151|Anesthetics|anesthetics|mesh-ancestor
64895663|NCT05624151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64895664|NCT05624151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895665|NCT05624151|Sensory System Agents|sensory system agents|mesh-ancestor
64895666|NCT05624151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895667|NCT05624151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64895668|NCT05624151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64895669|NCT05624151|Analgesics|analgesics|mesh-ancestor
64895670|NCT05624151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64895671|NCT05624151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64895672|NCT05624151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64895681|NCT05624151|Tocolytic Agents|tocolytic agents|mesh-ancestor
64895682|NCT05624151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64895683|NCT05616390|Bevacizumab|bevacizumab|mesh-list
64895684|NCT05616390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64895685|NCT05616390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895686|NCT05616390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64895687|NCT05616390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64895700|NCT05595460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895701|NCT05595460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64895702|NCT05595460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64895703|NCT05595460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64895705|NCT05595460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895706|NCT05592418|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
64895707|NCT05592418|Poly I-C|poly i-c|mesh-list
64521985|NCT04344730|Dexamethasone acetate|dexamethasone acetate|mesh-list
64521986|NCT04344730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64521987|NCT04344730|Antiemetics|antiemetics|mesh-ancestor
64521988|NCT04344730|Autonomic Agents|autonomic agents|mesh-ancestor
64521989|NCT04344730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64521990|NCT04344730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64521991|NCT04344730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64521992|NCT04344730|Glucocorticoids|glucocorticoids|mesh-ancestor
64521993|NCT04344730|Hormones|hormones|mesh-ancestor
64521994|NCT04344730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64521995|NCT04344730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64521996|NCT04344730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64521997|NCT05716672|Lazertinib|lazertinib|mesh-list
64521998|NCT05716672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64521999|NCT05716672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522000|NCT05716672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522001|NCT00358384|Betamethasone|betamethasone|mesh-list
64522002|NCT00358384|Betamethasone Valerate|betamethasone valerate|mesh-list
64522003|NCT00358384|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64522004|NCT00358384|Betamethasone benzoate|betamethasone benzoate|mesh-list
64895708|NCT05592418|Antiviral Agents|antiviral agents|mesh-ancestor
64895709|NCT05592418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64895710|NCT05592418|Interferon Inducers|interferon inducers|mesh-ancestor
64895711|NCT05592418|Immunologic Factors|immunologic factors|mesh-ancestor
64895712|NCT05592418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895713|NCT05590468|Niacinamide|niacinamide|mesh-list
64895714|NCT05590468|Niacin|niacin|mesh-list
64895715|NCT05590468|Nicotinic Acids|nicotinic acids|mesh-list
64895716|NCT05590468|Vitamin B Complex|vitamin b complex|mesh-ancestor
64895717|NCT05590468|Vitamins|vitamins|mesh-ancestor
64895718|NCT05590468|Micronutrients|micronutrients|mesh-ancestor
64895719|NCT05590468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895720|NCT05590468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64895721|NCT05590468|Antimetabolites|antimetabolites|mesh-ancestor
64895722|NCT05590468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895723|NCT05590468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64895724|NCT05590468|Vasodilator Agents|vasodilator agents|mesh-ancestor
64895725|NCT05587894|Ritonavir|ritonavir|mesh-list
64895726|NCT05587894|Remdesivir|remdesivir|mesh-list
64895727|NCT05587894|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64895728|NCT05587894|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64895729|NCT05587894|Protease Inhibitors|protease inhibitors|mesh-ancestor
64895730|NCT05587894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64895731|NCT05587894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895732|NCT05587894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64895733|NCT05587894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64895754|NCT05534620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895755|NCT05534620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895756|NCT05534620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64895757|NCT05534620|Alkylating Agents|alkylating agents|mesh-ancestor
64895759|NCT05514197|Antioxidants|antioxidants|mesh-ancestor
64895760|NCT05514197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895761|NCT05514197|Protective Agents|protective agents|mesh-ancestor
64895762|NCT05514197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895763|NCT05514197|Vitamins|vitamins|mesh-ancestor
64895764|NCT05514197|Micronutrients|micronutrients|mesh-ancestor
64895765|NCT05499052|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64895766|NCT05499052|Hormones|hormones|mesh-ancestor
64895767|NCT05499052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64895768|NCT05499052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895769|NCT05493735|Lidocaine|lidocaine|mesh-list
64895770|NCT05493735|Anesthetics, Local|anesthetics, local|mesh-ancestor
64895771|NCT05493735|Anesthetics|anesthetics|mesh-ancestor
64895772|NCT05493735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64895773|NCT05493735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895774|NCT05493735|Sensory System Agents|sensory system agents|mesh-ancestor
64895775|NCT05493735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895776|NCT05493735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64895777|NCT05493735|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64895778|NCT05493735|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64895779|NCT05493735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64895780|NCT05493735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895781|NCT05455424|Niraparib|niraparib|mesh-list
64895782|NCT05455424|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64522016|NCT02959060|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64522018|NCT02959060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64522019|NCT02959060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64522020|NCT02959060|Leprostatic Agents|leprostatic agents|mesh-ancestor
64522021|NCT02959060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64522022|NCT02959060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522023|NCT02959060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522024|NCT02959060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64522025|NCT02959060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64522026|NCT02959060|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64522027|NCT02959060|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64522028|NCT02959060|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64895805|NCT05410158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64895806|NCT05410158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64895822|NCT05279690|Antimitotic Agents|antimitotic agents|mesh-ancestor
64895823|NCT05279690|Mitosis Modulators|mitosis modulators|mesh-ancestor
64895824|NCT05279690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895825|NCT05279690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895826|NCT05255302|Pembrolizumab|pembrolizumab|mesh-list
64895827|NCT05255302|Pemetrexed|pemetrexed|mesh-list
64895828|NCT05255302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64895829|NCT05255302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895830|NCT05255302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64895831|NCT05255302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895832|NCT05255302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64895833|NCT05255302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64895834|NCT05185947|Paclitaxel|paclitaxel|mesh-list
64895835|NCT05185947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64895836|NCT05185947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895864|NCT05138068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64895893|NCT05103332|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64895894|NCT05091905|Ropivacaine|ropivacaine|mesh-list
64895925|NCT04983589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64895926|NCT04983589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895928|NCT04975334|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64895929|NCT04975334|Hormones|hormones|mesh-ancestor
64895930|NCT04975334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64895931|NCT04975334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895932|NCT04975334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64895933|NCT04975334|Sensory System Agents|sensory system agents|mesh-ancestor
64895934|NCT04975334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895935|NCT04961580|Ceftazidime|ceftazidime|mesh-list
64895936|NCT04961580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64895937|NCT04961580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64895938|NCT04886154|Vaccines|vaccines|mesh-list
64895939|NCT04886154|Immunologic Factors|immunologic factors|mesh-ancestor
64895940|NCT04886154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895941|NCT04861922|Heparin|heparin|mesh-list
64895942|NCT04861922|Calcium heparin|calcium heparin|mesh-list
64895943|NCT04861922|Anticoagulants|anticoagulants|mesh-ancestor
64895944|NCT04861922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64895945|NCT04861922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64895946|NCT04861922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895947|NCT04840472|Panitumumab|panitumumab|mesh-list
64895948|NCT04840472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64895949|NCT04840472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895950|NCT04794517|Dapagliflozin|dapagliflozin|mesh-list
64895951|NCT04794517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64895952|NCT04794517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895953|NCT04794517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64895954|NCT04794517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895955|NCT04789408|Cyclophosphamide|cyclophosphamide|mesh-list
64895956|NCT04789408|Fludarabine|fludarabine|mesh-list
64895957|NCT04789408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64895958|NCT04789408|Immunologic Factors|immunologic factors|mesh-ancestor
64895959|NCT04789408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895960|NCT04789408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64895961|NCT04789408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64895962|NCT04789408|Alkylating Agents|alkylating agents|mesh-ancestor
64522038|NCT05552950|Antiviral Agents|antiviral agents|mesh-list
64522039|NCT05552950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64522040|NCT05547100|Olanzapine|olanzapine|mesh-list
64522041|NCT05547100|Antiemetics|antiemetics|mesh-ancestor
64522042|NCT05547100|Autonomic Agents|autonomic agents|mesh-ancestor
64522043|NCT05547100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64522044|NCT05547100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895988|NCT04699123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64895989|NCT04699123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895990|NCT04696055|Pembrolizumab|pembrolizumab|mesh-list
64895991|NCT04696055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64895992|NCT04696055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895993|NCT04686786|PF-06372865|pf-06372865|mesh-list
64895994|NCT04686786|GABA Modulators|gaba modulators|mesh-ancestor
64895995|NCT04686786|GABA Agents|gaba agents|mesh-ancestor
64895996|NCT04686786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64895997|NCT04686786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895998|NCT04686786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895999|NCT04620382|Midodrine|midodrine|mesh-list
64896000|NCT04620382|Sympathomimetics|sympathomimetics|mesh-ancestor
64896001|NCT04620382|Autonomic Agents|autonomic agents|mesh-ancestor
64896002|NCT04620382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64896003|NCT04620382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896004|NCT04620382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64896005|NCT04620382|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64896006|NCT04620382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64896007|NCT04620382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64896008|NCT04620382|Adrenergic Agents|adrenergic agents|mesh-ancestor
64896009|NCT04620382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64896010|NCT04620382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896011|NCT04567420|Fulvestrant|fulvestrant|mesh-list
64896012|NCT04567420|Palbociclib|palbociclib|mesh-list
64896013|NCT04567420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64896014|NCT04567420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522053|NCT05547100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522055|NCT05547100|Serotonin Agents|serotonin agents|mesh-ancestor
64896053|NCT04461587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64896054|NCT04461587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64896055|NCT04461587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896056|NCT04371107|Azithromycin|azithromycin|mesh-list
64896057|NCT04371107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64896058|NCT04371107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64896059|NCT04364984|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64896060|NCT04364984|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64896061|NCT04364984|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64896062|NCT04364984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896063|NCT04364984|Protease Inhibitors|protease inhibitors|mesh-ancestor
64896064|NCT04278833|Dexamethasone|dexamethasone|mesh-list
64896065|NCT04278833|Triamcinolone|triamcinolone|mesh-list
64896066|NCT04278833|Betamethasone|betamethasone|mesh-list
64896067|NCT04278833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64896068|NCT04278833|Antiemetics|antiemetics|mesh-ancestor
64896069|NCT04278833|Autonomic Agents|autonomic agents|mesh-ancestor
64896070|NCT04278833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64896071|NCT04278833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896072|NCT04278833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64896073|NCT04278833|Glucocorticoids|glucocorticoids|mesh-ancestor
64896074|NCT04278833|Hormones|hormones|mesh-ancestor
64522079|NCT00044655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522080|NCT00044655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64522081|NCT00044655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64522082|NCT00044655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64522083|NCT00044655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64522084|NCT00044655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64522085|NCT00044655|Dopamine Agents|dopamine agents|mesh-ancestor
64522086|NCT00044655|Antiemetics|antiemetics|mesh-ancestor
64522087|NCT00044655|Autonomic Agents|autonomic agents|mesh-ancestor
64896116|NCT04200911|Antifungal Agents|antifungal agents|mesh-ancestor
64896117|NCT04200911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64896142|NCT04112641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64896143|NCT04112641|Vasodilator Agents|vasodilator agents|mesh-ancestor
64896144|NCT04062591|Piroxicam|piroxicam|mesh-list
64896145|NCT04062591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64896146|NCT04062591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64896147|NCT04062591|Analgesics|analgesics|mesh-ancestor
64896148|NCT04062591|Sensory System Agents|sensory system agents|mesh-ancestor
64896149|NCT04062591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64896150|NCT04062591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896151|NCT04062591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64896152|NCT04062591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64896153|NCT04062591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64896154|NCT04062591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64896155|NCT04062591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896156|NCT04059770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64896157|NCT04059770|Amphotericin B|amphotericin b|mesh-list
64896158|NCT04059770|Antifungal Agents|antifungal agents|mesh-ancestor
64896159|NCT04059770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64896160|NCT04059770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64896161|NCT04059770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64896162|NCT04059770|Amebicides|amebicides|mesh-ancestor
64664687|NCT02768727|Xenon|xenon|mesh-list
64896163|NCT04059770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64896164|NCT04057898|Ibudilast|ibudilast|mesh-list
64896165|NCT04057898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64896166|NCT04057898|Autonomic Agents|autonomic agents|mesh-ancestor
64896204|NCT03994731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896206|NCT03994731|Dermatologic Agents|dermatologic agents|mesh-ancestor
64896207|NCT03994731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64896208|NCT03994731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64896209|NCT03994731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64896210|NCT03994731|Immunologic Factors|immunologic factors|mesh-ancestor
64896211|NCT03994731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64896212|NCT03994731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64896213|NCT03994731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64896214|NCT03994731|Analgesics|analgesics|mesh-ancestor
64896215|NCT03994731|Sensory System Agents|sensory system agents|mesh-ancestor
64896216|NCT03994731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64896217|NCT03994731|Antipyretics|antipyretics|mesh-ancestor
64896236|NCT03994731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64522116|NCT05130892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64522117|NCT05130892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64522118|NCT05130892|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64522119|NCT05130892|Histamine Antagonists|histamine antagonists|mesh-ancestor
64522120|NCT05130892|Histamine Agents|histamine agents|mesh-ancestor
64522121|NCT05130892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64522122|NCT05130892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64522123|NCT05130892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64522125|NCT05312242|Micronutrients|micronutrients|mesh-list
64522126|NCT05312242|Trace Elements|trace elements|mesh-list
64522127|NCT05312242|Hematinics|hematinics|mesh-ancestor
64522128|NCT05312242|Vitamin B Complex|vitamin b complex|mesh-ancestor
64896250|NCT03933215|Cladribine|cladribine|mesh-list
64896251|NCT03933215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896252|NCT03933215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64896253|NCT03933215|Immunologic Factors|immunologic factors|mesh-ancestor
64896254|NCT03933215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896255|NCT03853707|Paclitaxel|paclitaxel|mesh-list
64896256|NCT03853707|Carboplatin|carboplatin|mesh-list
64896257|NCT03853707|Capecitabine|capecitabine|mesh-list
64896258|NCT03853707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64896259|NCT03853707|Atezolizumab|atezolizumab|mesh-list
64896260|NCT03853707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64896261|NCT03853707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64896262|NCT03853707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896263|NCT03853707|Tubulin Modulators|tubulin modulators|mesh-ancestor
64896264|NCT03853707|Antimitotic Agents|antimitotic agents|mesh-ancestor
64896265|NCT03853707|Mitosis Modulators|mitosis modulators|mesh-ancestor
64896266|NCT03853707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896267|NCT03853707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64896268|NCT03853707|Antimetabolites|antimetabolites|mesh-ancestor
64896269|NCT03853707|Immunologic Factors|immunologic factors|mesh-ancestor
64896270|NCT03853707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896271|NCT03829683|Ascorbic Acid|ascorbic acid|mesh-list
64896272|NCT03829683|Vitamins|vitamins|mesh-ancestor
64896273|NCT03829683|Micronutrients|micronutrients|mesh-ancestor
64647850|NCT01247285|Fluoxetine|fluoxetine|mesh-list
64647855|NCT01247285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64522138|NCT00223665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522139|NCT00223665|Androgen Antagonists|androgen antagonists|mesh-ancestor
64522140|NCT00223665|Hormone Antagonists|hormone antagonists|mesh-ancestor
64522141|NCT00223665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64522142|NCT05311540|Zinc Sulfate|zinc sulfate|mesh-list
64522143|NCT05311540|Astringents|astringents|mesh-ancestor
64522144|NCT05311540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522145|NCT05311540|Dermatologic Agents|dermatologic agents|mesh-ancestor
64522146|NCT00223821|Oxybutynin|oxybutynin|mesh-list
64522147|NCT00223821|Parasympatholytics|parasympatholytics|mesh-ancestor
64522148|NCT00223821|Autonomic Agents|autonomic agents|mesh-ancestor
64356046|NCT04737603|Naloxone|naloxone|mesh-list
64896299|NCT03725202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896300|NCT03725202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64896301|NCT03652753|Acetylcysteine|acetylcysteine|mesh-list
64896302|NCT03652753|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64896303|NCT03652753|Antiviral Agents|antiviral agents|mesh-ancestor
64896304|NCT03652753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64896305|NCT03652753|Expectorants|expectorants|mesh-ancestor
64896306|NCT03652753|Respiratory System Agents|respiratory system agents|mesh-ancestor
64896307|NCT03652753|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64896308|NCT03652753|Antioxidants|antioxidants|mesh-ancestor
64896309|NCT03652753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896310|NCT03652753|Protective Agents|protective agents|mesh-ancestor
64896311|NCT03652753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896312|NCT03652753|Antidotes|antidotes|mesh-ancestor
64896313|NCT03617458|Metformin|metformin|mesh-list
64896314|NCT03617458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64896315|NCT03617458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896316|NCT03581877|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64896317|NCT03581877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64664834|NCT02278887|Analgesics|analgesics|mesh-ancestor
64896318|NCT03581877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64896319|NCT03581877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896320|NCT03556202|Mirikizumab|mirikizumab|mesh-list
64896321|NCT03556202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64896322|NCT03556202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64647871|NCT03806582|Sympathomimetics|sympathomimetics|mesh-ancestor
64522154|NCT00223821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64522155|NCT00223821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522156|NCT00223821|Urological Agents|urological agents|mesh-ancestor
64522157|NCT00359164|Bevacizumab|bevacizumab|mesh-list
64522158|NCT00359164|Verteporfin|verteporfin|mesh-list
64522159|NCT00359164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64522160|NCT00359164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522161|NCT00359164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64896334|NCT03463876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896335|NCT03463876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64896336|NCT03463876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64896337|NCT03463876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896338|NCT03461120|Anesthetics|anesthetics|mesh-list
64896339|NCT03461120|Anesthetics, Local|anesthetics, local|mesh-list
64896358|NCT03396588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896359|NCT03396588|Analgesics|analgesics|mesh-ancestor
64896360|NCT03396588|Sensory System Agents|sensory system agents|mesh-ancestor
64896361|NCT03396588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64896362|NCT03396588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64896363|NCT03396588|Sympatholytics|sympatholytics|mesh-ancestor
64896364|NCT03396588|Autonomic Agents|autonomic agents|mesh-ancestor
64896365|NCT03396588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64896366|NCT03396588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64896367|NCT03396588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64896368|NCT03396588|Adrenergic Agents|adrenergic agents|mesh-ancestor
64896369|NCT03396588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64896370|NCT03396588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896371|NCT03361852|Rituximab|rituximab|mesh-list
64896372|NCT03361852|Pembrolizumab|pembrolizumab|mesh-list
64896373|NCT03361852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64896374|NCT03361852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896375|NCT03361852|Immunologic Factors|immunologic factors|mesh-ancestor
64896376|NCT03361852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896377|NCT03361852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64896378|NCT03350516|Calcium, Dietary|calcium, dietary|mesh-list
64896379|NCT03350516|Calcium Carbonate|calcium carbonate|mesh-list
64836041|NCT01610778|Dermatologic Agents|dermatologic agents|mesh-ancestor
64896380|NCT03350516|Calcium|calcium|mesh-list
64896381|NCT03350516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64896382|NCT03350516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896383|NCT03350516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64896384|NCT03350516|Antacids|antacids|mesh-ancestor
64896385|NCT03350516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896386|NCT03350516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64896387|NCT03350451|Lumasiran|lumasiran|mesh-list
64896388|NCT03350451|Renal Agents|renal agents|mesh-ancestor
64896389|NCT03329508|Pramipexole|pramipexole|mesh-list
64896390|NCT03329508|Rasagiline|rasagiline|mesh-list
64522187|NCT00045435|Antifungal Agents|antifungal agents|mesh-ancestor
64522188|NCT00045435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64522189|NCT00045435|Dermatologic Agents|dermatologic agents|mesh-ancestor
64522190|NCT00045435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64522191|NCT00045435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64896430|NCT03281304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64896431|NCT03281304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896432|NCT03233711|Nivolumab|nivolumab|mesh-list
64896433|NCT03233711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64522205|NCT05292586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64522206|NCT05292586|Respiratory System Agents|respiratory system agents|mesh-ancestor
64522207|NCT05292586|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64522208|NCT05292586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64522209|NCT05292586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64522210|NCT05292586|Adrenergic Agents|adrenergic agents|mesh-ancestor
64522211|NCT05292586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64522212|NCT05292586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522213|NCT05292586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64522214|NCT05292586|Glucocorticoids|glucocorticoids|mesh-ancestor
64522215|NCT05292586|Hormones|hormones|mesh-ancestor
64522216|NCT05292586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64714096|NCT03054103|Anesthetics|anesthetics|mesh-ancestor
64522217|NCT02097303|Prednisone|prednisone|mesh-list
64522218|NCT02097303|Abiraterone Acetate|abiraterone acetate|mesh-list
64522219|NCT02097303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64522220|NCT02097303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64522221|NCT02097303|Glucocorticoids|glucocorticoids|mesh-ancestor
64522222|NCT02097303|Hormones|hormones|mesh-ancestor
64896472|NCT02726711|Autonomic Agents|autonomic agents|mesh-ancestor
64896473|NCT02726711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64896474|NCT02726711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896475|NCT02726711|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64896476|NCT02726711|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64896477|NCT02726711|Cholinergic Agents|cholinergic agents|mesh-ancestor
64896478|NCT02726711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64896479|NCT02726711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896480|NCT02726711|Vasodilator Agents|vasodilator agents|mesh-ancestor
64896481|NCT02725060|Phenylephrine|phenylephrine|mesh-list
64896482|NCT02725060|Isoproterenol|isoproterenol|mesh-list
64896483|NCT02725060|Oxymetazoline|oxymetazoline|mesh-list
64647938|NCT03806036|Vitamins|vitamins|mesh-ancestor
64896522|NCT02649998|Vasodilator Agents|vasodilator agents|mesh-ancestor
64896523|NCT02649998|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64896525|NCT02595944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64896526|NCT02595944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896527|NCT02595944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64896528|NCT02595944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896529|NCT02503358|Paclitaxel|paclitaxel|mesh-list
64896530|NCT02503358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64896537|NCT02432963|Pembrolizumab|pembrolizumab|mesh-list
64896538|NCT02432963|Vaccines|vaccines|mesh-list
64896539|NCT02432963|Immunologic Factors|immunologic factors|mesh-ancestor
64896540|NCT02432963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896541|NCT02432963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64647972|NCT03809546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64896560|NCT02336087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896561|NCT02336087|Tubulin Modulators|tubulin modulators|mesh-ancestor
64896562|NCT02336087|Antimitotic Agents|antimitotic agents|mesh-ancestor
64896563|NCT02336087|Mitosis Modulators|mitosis modulators|mesh-ancestor
64896564|NCT02336087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896565|NCT02336087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64896566|NCT02336087|Antimetabolites|antimetabolites|mesh-ancestor
64896567|NCT02336087|Antiviral Agents|antiviral agents|mesh-ancestor
64896568|NCT02336087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64896569|NCT02336087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522236|NCT00703326|Antimitotic Agents|antimitotic agents|mesh-ancestor
64522237|NCT00703326|Mitosis Modulators|mitosis modulators|mesh-ancestor
64522238|NCT00703326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522239|NCT02097537|Methacholine Chloride|methacholine chloride|mesh-list
64522240|NCT02097537|Miotics|miotics|mesh-ancestor
64522241|NCT02097537|Autonomic Agents|autonomic agents|mesh-ancestor
64522242|NCT02097537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64522243|NCT02097537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522244|NCT02097537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64522245|NCT02097537|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
64522246|NCT02097537|Respiratory System Agents|respiratory system agents|mesh-ancestor
64522247|NCT02097537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64522248|NCT02097537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64522249|NCT02097537|Cholinergic Agents|cholinergic agents|mesh-ancestor
64522250|NCT02097537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64522251|NCT02097537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522252|NCT02097849|Interferons|interferons|mesh-list
64522253|NCT02097849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64522254|NCT02097849|Vaccines|vaccines|mesh-list
64896570|NCT02336087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64896571|NCT02336087|Immunologic Factors|immunologic factors|mesh-ancestor
64896572|NCT02336087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896573|NCT02336087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64896574|NCT02332980|Pembrolizumab|pembrolizumab|mesh-list
64896575|NCT02332980|Idelalisib|idelalisib|mesh-list
64896576|NCT02332980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64896577|NCT02332980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896578|NCT02332980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64896579|NCT02332980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896580|NCT02197234|Osimertinib|osimertinib|mesh-list
64896581|NCT02197234|Simvastatin|simvastatin|mesh-list
64896629|NCT02048150|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64896630|NCT02048150|Immunologic Factors|immunologic factors|mesh-ancestor
64896631|NCT02048150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896632|NCT02038452|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64896633|NCT02038452|Methylprednisolone|methylprednisolone|mesh-list
64896634|NCT02038452|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64896635|NCT02038452|Prednisolone|prednisolone|mesh-list
64896636|NCT02038452|Prednisolone acetate|prednisolone acetate|mesh-list
64522255|NCT02097849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64522257|NCT02097849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522258|NCT02097849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522259|NCT02097849|Antiviral Agents|antiviral agents|mesh-ancestor
64522260|NCT02097849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64522261|NCT02097849|Dermatologic Agents|dermatologic agents|mesh-ancestor
64522262|NCT02097849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64896637|NCT02038452|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64896638|NCT02038452|Prednisolone phosphate|prednisolone phosphate|mesh-list
64896639|NCT02038452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64896640|NCT02038452|Antiemetics|antiemetics|mesh-ancestor
64896641|NCT02038452|Autonomic Agents|autonomic agents|mesh-ancestor
64896642|NCT02038452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64896643|NCT02038452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896665|NCT01748448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896666|NCT01748448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64896667|NCT01748448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64896669|NCT01476839|Etoposide|etoposide|mesh-list
64896670|NCT01476839|Etoposide phosphate|etoposide phosphate|mesh-list
64896671|NCT01476839|Melphalan|melphalan|mesh-list
64896672|NCT01476839|Carmustine|carmustine|mesh-list
64896673|NCT01476839|Basiliximab|basiliximab|mesh-list
64896674|NCT01476839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64896675|NCT01476839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896676|NCT01476839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64896677|NCT01476839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64896678|NCT01476839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64896679|NCT01476839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896680|NCT01476839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64896739|NCT00967005|Antidotes|antidotes|mesh-ancestor
64896740|NCT00863369|Gemcitabine|gemcitabine|mesh-list
64896741|NCT00863369|Rituximab|rituximab|mesh-list
64896742|NCT00863369|Bortezomib|bortezomib|mesh-list
64896743|NCT00863369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64522264|NCT05513560|Ibudilast|ibudilast|mesh-list
64522265|NCT05513560|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64522278|NCT05513560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64522279|NCT05513560|Respiratory System Agents|respiratory system agents|mesh-ancestor
64522280|NCT00047697|Donepezil|donepezil|mesh-list
64522281|NCT00047697|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64648026|NCT01214759|Antiviral Agents|antiviral agents|mesh-ancestor
64896790|NCT00538031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64896791|NCT00538031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64896792|NCT00538031|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64896793|NCT00538031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64896794|NCT00538031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64896795|NCT00203996|Pioglitazone|pioglitazone|mesh-list
64896796|NCT00203996|Leuprolide|leuprolide|mesh-list
64896797|NCT00203996|Estrogens|estrogens|mesh-list
64896798|NCT00203996|Progestins|progestins|mesh-list
64896799|NCT00203996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64896800|NCT00203996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896801|NCT00203996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64896802|NCT00203996|Fertility Agents|fertility agents|mesh-ancestor
64896803|NCT00203996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64896804|NCT00203996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64896820|NCT02009280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896821|NCT02009280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64896822|NCT02009280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64896823|NCT02009280|Anesthetics, General|anesthetics, general|mesh-ancestor
64896854|NCT02009436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896855|NCT02009436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64896856|NCT02009462|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
64896857|NCT02009462|Vasodilator Agents|vasodilator agents|mesh-ancestor
64896858|NCT02009462|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64896859|NCT02009462|Protective Agents|protective agents|mesh-ancestor
64896894|NCT02009709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64896895|NCT02009709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64896896|NCT02009709|Vitamin B Complex|vitamin b complex|mesh-ancestor
64896897|NCT02009709|Vitamins|vitamins|mesh-ancestor
64896898|NCT02009709|Micronutrients|micronutrients|mesh-ancestor
64896899|NCT02009709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896900|NCT02009709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64896901|NCT02009709|Dermatologic Agents|dermatologic agents|mesh-ancestor
64896902|NCT02009748|Vitamin D|vitamin d|mesh-list
64896903|NCT02009748|Vitamins|vitamins|mesh-ancestor
64896904|NCT02009748|Micronutrients|micronutrients|mesh-ancestor
64896905|NCT02009748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896906|NCT02009748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64896907|NCT02009787|Vitamin D|vitamin d|mesh-list
64896908|NCT02009787|Cholecalciferol|cholecalciferol|mesh-list
64896909|NCT02009787|Vitamins|vitamins|mesh-ancestor
64896910|NCT02009787|Micronutrients|micronutrients|mesh-ancestor
64896911|NCT02009787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896912|NCT02009787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64896913|NCT02009787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64522309|NCT02437812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64522310|NCT02437812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522311|NCT02437812|Tubulin Modulators|tubulin modulators|mesh-ancestor
64522312|NCT02437812|Antimitotic Agents|antimitotic agents|mesh-ancestor
64522313|NCT02437812|Mitosis Modulators|mitosis modulators|mesh-ancestor
64522314|NCT02437812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522315|NCT02437812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64522316|NCT02437812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522317|NCT00112593|Cyclosporine|cyclosporine|mesh-list
64522318|NCT00112593|Mycophenolic Acid|mycophenolic acid|mesh-list
64522319|NCT00112593|Fludarabine|fludarabine|mesh-list
64522320|NCT00112593|Fludarabine phosphate|fludarabine phosphate|mesh-list
64522321|NCT00112593|Cyclosporins|cyclosporins|mesh-list
64522322|NCT00112593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522323|NCT00112593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64522324|NCT00112593|Antimetabolites|antimetabolites|mesh-ancestor
64522325|NCT00112593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522326|NCT00112593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64522327|NCT00112593|Immunologic Factors|immunologic factors|mesh-ancestor
64648122|NCT05316428|Ethanol|ethanol|mesh-list
64896925|NCT02010411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64896943|NCT02010788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896944|NCT02010788|Cholinergic Agents|cholinergic agents|mesh-ancestor
64896945|NCT02010788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64896946|NCT02010788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601339|NCT01272791|Gemcitabine|gemcitabine|mesh-list
64896947|NCT02010788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64896948|NCT02010788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64896950|NCT02010827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64896951|NCT02010827|Hormones|hormones|mesh-ancestor
64896952|NCT02010827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64522336|NCT00112593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64522337|NCT00112593|Antitubercular Agents|antitubercular agents|mesh-ancestor
64522338|NCT00112593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64522340|NCT05280106|Sodium Citrate|sodium citrate|mesh-list
64522341|NCT05280106|Dialysis Solutions|dialysis solutions|mesh-list
64522342|NCT05280106|Anticoagulants|anticoagulants|mesh-ancestor
64522344|NCT05280106|Chelating Agents|chelating agents|mesh-ancestor
64522345|NCT05280106|Sequestering Agents|sequestering agents|mesh-ancestor
64522346|NCT05280106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522347|NCT05280106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64522348|NCT00112671|Sorafenib|sorafenib|mesh-list
64522349|NCT00112671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522350|NCT00112671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64522351|NCT00112671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522352|NCT00112671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522353|NCT05279092|Dexamethasone|dexamethasone|mesh-list
64522354|NCT05279092|Methylprednisolone|methylprednisolone|mesh-list
64522355|NCT05279092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64522356|NCT05279092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64896953|NCT02010827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896954|NCT02010905|Losartan|losartan|mesh-list
64896955|NCT02010905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64896956|NCT02010905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64896957|NCT02010905|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64896958|NCT02010905|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64896959|NCT02010905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648143|NCT05310968|Antipyretics|antipyretics|mesh-ancestor
64896979|NCT02010957|Anesthetics|anesthetics|mesh-ancestor
64896980|NCT02010970|Itraconazole|itraconazole|mesh-list
64896981|NCT02010970|Diltiazem|diltiazem|mesh-list
64896982|NCT02010970|Calcium Channel Blockers|calcium channel blockers|mesh-list
64896983|NCT02010970|Midazolam|midazolam|mesh-list
64896984|NCT02010970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64897034|NCT02011347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522357|NCT05279092|Prednisolone|prednisolone|mesh-list
64522358|NCT05279092|Prednisolone acetate|prednisolone acetate|mesh-list
64522359|NCT05279092|Dexamethasone acetate|dexamethasone acetate|mesh-list
64522360|NCT05279092|Bupivacaine|bupivacaine|mesh-list
64522361|NCT05279092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64522362|NCT05279092|Prednisolone phosphate|prednisolone phosphate|mesh-list
64522363|NCT05279092|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64522364|NCT05279092|BB 1101|bb 1101|mesh-list
64522365|NCT05279092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64522366|NCT05279092|Antiemetics|antiemetics|mesh-ancestor
64522367|NCT05279092|Autonomic Agents|autonomic agents|mesh-ancestor
64522368|NCT05279092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64522369|NCT05279092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522370|NCT05279092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64897036|NCT02011594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64897037|NCT02011594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897038|NCT02011620|Isosorbide|isosorbide|mesh-list
64897039|NCT02011620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64897040|NCT02011620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64897041|NCT02011620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64897042|NCT02011620|Diuretics|diuretics|mesh-ancestor
64897043|NCT02011620|Natriuretic Agents|natriuretic agents|mesh-ancestor
64897044|NCT02011620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897045|NCT02011620|Vasodilator Agents|vasodilator agents|mesh-ancestor
64897046|NCT02011620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64897047|NCT02011620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897048|NCT02011633|Metformin|metformin|mesh-list
64897049|NCT02011633|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64897050|NCT02011633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64897051|NCT02011633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897052|NCT02011633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64897053|NCT02011633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64897072|NCT02011737|Adrenergic Agents|adrenergic agents|mesh-ancestor
64897073|NCT02011737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64897074|NCT02011737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897075|NCT02011737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897076|NCT02011737|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64897077|NCT02011737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64897096|NCT02011828|Vitamins|vitamins|mesh-ancestor
64897097|NCT02011828|Micronutrients|micronutrients|mesh-ancestor
64897098|NCT02011828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64897099|NCT02011841|Ciprofloxacin|ciprofloxacin|mesh-list
64897100|NCT02011841|Rifaximin|rifaximin|mesh-list
64897101|NCT02011841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64522371|NCT05279092|Glucocorticoids|glucocorticoids|mesh-ancestor
64522372|NCT05279092|Hormones|hormones|mesh-ancestor
64522373|NCT05279092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64522374|NCT05279092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64522375|NCT05279092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522376|NCT05279092|Anesthetics, Local|anesthetics, local|mesh-ancestor
64522377|NCT05279092|Anesthetics|anesthetics|mesh-ancestor
64522378|NCT05279092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64522379|NCT05279092|Sensory System Agents|sensory system agents|mesh-ancestor
64522380|NCT05279092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64522381|NCT05279092|Protective Agents|protective agents|mesh-ancestor
64522382|NCT05279092|Protease Inhibitors|protease inhibitors|mesh-ancestor
64522383|NCT05279092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522384|NCT05279092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522385|NCT02437656|Metformin|metformin|mesh-list
64522386|NCT02437656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64522387|NCT02437656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897102|NCT02011841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64897103|NCT02011841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64897104|NCT02011841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64897105|NCT02011841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897106|NCT02011841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897107|NCT02011841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897133|NCT02011958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64897134|NCT02011958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64897166|NCT02012075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64897167|NCT02012075|Adrenergic Agents|adrenergic agents|mesh-ancestor
64897168|NCT02012075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64897169|NCT02012075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897171|NCT02012075|Protective Agents|protective agents|mesh-ancestor
64897172|NCT02012075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64897173|NCT02012075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64522388|NCT05273632|Tranexamic Acid|tranexamic acid|mesh-list
64522389|NCT05273632|Oxytocin|oxytocin|mesh-list
64522390|NCT05273632|Oxytocics|oxytocics|mesh-ancestor
64522391|NCT05273632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64522392|NCT05273632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522393|NCT05273632|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64522394|NCT05273632|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64522395|NCT05273632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522396|NCT05273632|Hemostatics|hemostatics|mesh-ancestor
64522397|NCT05273632|Coagulants|coagulants|mesh-ancestor
64522398|NCT02429622|Paclitaxel|paclitaxel|mesh-list
64522399|NCT02429622|Nedaplatin|nedaplatin|mesh-list
64522400|NCT02429622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64522401|NCT02429622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522402|NCT02429622|Tubulin Modulators|tubulin modulators|mesh-ancestor
64522403|NCT02429622|Antimitotic Agents|antimitotic agents|mesh-ancestor
64522404|NCT02429622|Mitosis Modulators|mitosis modulators|mesh-ancestor
64522405|NCT02429622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897179|NCT02012088|Cyclophosphamide|cyclophosphamide|mesh-list
64897193|NCT02012088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64897194|NCT02012088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64897196|NCT02012088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897197|NCT02012088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64897198|NCT02012088|Glucocorticoids|glucocorticoids|mesh-ancestor
64897199|NCT02012088|Hormones|hormones|mesh-ancestor
64897200|NCT02012088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64897201|NCT02012088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64897202|NCT02012088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64897203|NCT02012088|Tubulin Modulators|tubulin modulators|mesh-ancestor
64897204|NCT02012088|Antimitotic Agents|antimitotic agents|mesh-ancestor
64897205|NCT02012088|Mitosis Modulators|mitosis modulators|mesh-ancestor
64897206|NCT02012140|Ticagrelor|ticagrelor|mesh-list
64897207|NCT02012140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64897208|NCT02012140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64897209|NCT02012140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64897210|NCT02012140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64897211|NCT02012140|Purinergic Agents|purinergic agents|mesh-ancestor
64897212|NCT02012140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64897213|NCT02012140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897214|NCT02012140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897215|NCT02012166|Insulin|insulin|mesh-list
64897216|NCT02012166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64522411|NCT02429466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522412|NCT02429466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522413|NCT02429388|Sodium Channel Blockers|sodium channel blockers|mesh-list
64522414|NCT02429388|Spironolactone|spironolactone|mesh-list
64522415|NCT02429388|Diuretics|diuretics|mesh-list
64522416|NCT02429388|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
64522417|NCT02429388|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64522418|NCT02429388|Hormone Antagonists|hormone antagonists|mesh-ancestor
64522419|NCT02429388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64522420|NCT02429388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522421|NCT02429388|Natriuretic Agents|natriuretic agents|mesh-ancestor
64522422|NCT02429388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64522423|NCT02429388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522425|NCT02429232|Linagliptin|linagliptin|mesh-list
64522426|NCT02429232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64522427|NCT02429232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522428|NCT02429232|Incretins|incretins|mesh-ancestor
64522429|NCT02429232|Hormones|hormones|mesh-ancestor
64522430|NCT02429232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64522431|NCT02429232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64522432|NCT02429232|Protease Inhibitors|protease inhibitors|mesh-ancestor
64522433|NCT02429232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522434|NCT02429232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522435|NCT03189732|Metformin|metformin|mesh-list
64522436|NCT03189732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64522437|NCT03189732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522438|NCT02437032|Menotropins|menotropins|mesh-list
64897239|NCT02012309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64897240|NCT02012309|Immunologic Factors|immunologic factors|mesh-ancestor
64897253|NCT02012335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64897254|NCT02012335|Anesthetics, General|anesthetics, general|mesh-ancestor
64897255|NCT02012335|Anesthetics|anesthetics|mesh-ancestor
64897256|NCT02012335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64897257|NCT02012335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64897258|NCT02012335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64897259|NCT02012335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64897260|NCT02012335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897261|NCT02012387|Omalizumab|omalizumab|mesh-list
64897292|NCT02012738|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
64897293|NCT02012738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897294|NCT02012738|Immunologic Factors|immunologic factors|mesh-ancestor
64897295|NCT02012738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522451|NCT05232994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522453|NCT02436798|Antiemetics|antiemetics|mesh-ancestor
64522454|NCT02436798|Autonomic Agents|autonomic agents|mesh-ancestor
64522455|NCT02436798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64522456|NCT02436798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522457|NCT02436798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64522458|NCT02436798|Antipruritics|antipruritics|mesh-ancestor
64522459|NCT02436798|Dermatologic Agents|dermatologic agents|mesh-ancestor
64522460|NCT02436798|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64522461|NCT02436798|Serotonin Agents|serotonin agents|mesh-ancestor
64897296|NCT02012777|Propranolol|propranolol|mesh-list
64897297|NCT02012777|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64897298|NCT02012777|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64897299|NCT02012777|Adrenergic Agents|adrenergic agents|mesh-ancestor
64648264|NCT04345406|Chloroquine|chloroquine|mesh-list
64897338|NCT02012998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897339|NCT02013089|Everolimus|everolimus|mesh-list
64897340|NCT02013089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64897341|NCT02013089|Sorafenib|sorafenib|mesh-list
64897342|NCT02013089|Sunitinib|sunitinib|mesh-list
64897343|NCT02013089|Imatinib Mesylate|imatinib mesylate|mesh-list
64897344|NCT02013089|Gefitinib|gefitinib|mesh-list
64897345|NCT02013089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897346|NCT02013089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64897347|NCT02013089|Immunologic Factors|immunologic factors|mesh-ancestor
64897348|NCT02013089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897349|NCT02013089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64897350|NCT02013089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897351|NCT02013089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897352|NCT02013089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64897353|NCT02013089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64897354|NCT02013089|Growth Substances|growth substances|mesh-ancestor
64897355|NCT02013089|Growth Inhibitors|growth inhibitors|mesh-ancestor
64897356|NCT02013102|Decitabine|decitabine|mesh-list
64897357|NCT02013102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64897358|NCT02013102|Antimetabolites|antimetabolites|mesh-ancestor
64897359|NCT02013102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522479|NCT03185130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64522481|NCT03185130|Autonomic Agents|autonomic agents|mesh-ancestor
64522482|NCT03185130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64522483|NCT03185130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64522484|NCT03185130|Histamine Antagonists|histamine antagonists|mesh-ancestor
64522485|NCT03185130|Histamine Agents|histamine agents|mesh-ancestor
64522486|NCT03185130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64522487|NCT03185130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522488|NCT03185130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64522489|NCT03185130|Antipruritics|antipruritics|mesh-ancestor
64522490|NCT03185130|Dermatologic Agents|dermatologic agents|mesh-ancestor
64522491|NCT03185130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64522492|NCT03185130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64522493|NCT03185130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64522494|NCT03185130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64522495|NCT03185130|Dopamine Agents|dopamine agents|mesh-ancestor
64522496|NCT00358618|Propofol|propofol|mesh-list
64897362|NCT02013115|Budesonide|budesonide|mesh-list
64897363|NCT02013115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64897364|NCT02013115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64897365|NCT02013115|Autonomic Agents|autonomic agents|mesh-ancestor
64522498|NCT00358618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64522499|NCT00358618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522500|NCT00358618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64522501|NCT00358618|Anesthetics, General|anesthetics, general|mesh-ancestor
64522502|NCT00358618|Anesthetics|anesthetics|mesh-ancestor
64522503|NCT02428764|Gemcitabine|gemcitabine|mesh-list
64522504|NCT02428764|Carboplatin|carboplatin|mesh-list
64522505|NCT02428764|Nimotuzumab|nimotuzumab|mesh-list
64522506|NCT02428764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522507|NCT02428764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64522508|NCT02428764|Antimetabolites|antimetabolites|mesh-ancestor
64522509|NCT02428764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522510|NCT02428764|Antiviral Agents|antiviral agents|mesh-ancestor
64522511|NCT02428764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64648317|NCT00783614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64648328|NCT01252745|Hormones|hormones|mesh-ancestor
64897401|NCT02013232|Serotonin Agents|serotonin agents|mesh-ancestor
64897402|NCT02013232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64897403|NCT02013232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64897404|NCT02013232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64897405|NCT02013232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64897406|NCT02013258|Oxytocin|oxytocin|mesh-list
64897407|NCT02013258|Oxytocics|oxytocics|mesh-ancestor
64897408|NCT02013258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64897409|NCT02013258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897410|NCT02013271|Paclitaxel|paclitaxel|mesh-list
64897411|NCT02013271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64897412|NCT02013271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897413|NCT02013271|Tubulin Modulators|tubulin modulators|mesh-ancestor
64897414|NCT02013271|Antimitotic Agents|antimitotic agents|mesh-ancestor
64897415|NCT02013271|Mitosis Modulators|mitosis modulators|mesh-ancestor
64897416|NCT02013271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897417|NCT02013362|Folic Acid|folic acid|mesh-list
64897418|NCT02013362|Vitamin B 12|vitamin b 12|mesh-list
64897419|NCT02013362|Hydroxocobalamin|hydroxocobalamin|mesh-list
64897420|NCT02013362|Vitamins|vitamins|mesh-ancestor
64897431|NCT02013453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897433|NCT02013453|Antimitotic Agents|antimitotic agents|mesh-ancestor
64897434|NCT02013453|Mitosis Modulators|mitosis modulators|mesh-ancestor
64897435|NCT02013453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897436|NCT02013453|Antimetabolites|antimetabolites|mesh-ancestor
64897437|NCT02013453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64897438|NCT02013453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64522512|NCT02428764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522513|NCT02428764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64522514|NCT02428764|Immunologic Factors|immunologic factors|mesh-ancestor
64522515|NCT02428764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522516|NCT02428764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64522517|NCT00358696|Tenofovir|tenofovir|mesh-list
64522518|NCT00358696|Antiviral Agents|antiviral agents|mesh-ancestor
64522519|NCT00358696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64522520|NCT00358696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64522521|NCT00358696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64522522|NCT00358696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522523|NCT00358696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897456|NCT02013570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64897457|NCT02013570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64897458|NCT02013570|Adrenergic Agents|adrenergic agents|mesh-ancestor
64897459|NCT02013570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64897460|NCT02013570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897461|NCT02013856|Proanthocyanidin|proanthocyanidin|mesh-list
64897462|NCT02013856|Procyanidin|procyanidin|mesh-list
64897463|NCT02013856|Antioxidants|antioxidants|mesh-ancestor
64897464|NCT02013856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897465|NCT02013856|Protective Agents|protective agents|mesh-ancestor
64897466|NCT02013856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897467|NCT02013856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64897468|NCT02013856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64897469|NCT02013856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64897470|NCT02013895|Technetium Tc 99m DTPA-galactosyl-human serum albumin|technetium tc 99m dtpa-galactosyl-human serum albumin|mesh-list
64897471|NCT02013895|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64897472|NCT02013895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897473|NCT02013960|Misoprostol|misoprostol|mesh-list
64897474|NCT02013960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64897475|NCT02013960|Abortifacient Agents|abortifacient agents|mesh-ancestor
64897476|NCT02013960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64897477|NCT02013960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897478|NCT02013960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64897479|NCT02013960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64897480|NCT02013960|Oxytocics|oxytocics|mesh-ancestor
64897481|NCT02013986|Midazolam|midazolam|mesh-list
64522529|NCT05050942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64522530|NCT05050942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522531|NCT05429476|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64522532|NCT05429476|Plasminogen|plasminogen|mesh-list
64522533|NCT05429476|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64522534|NCT05429476|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64522535|NCT05429476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522536|NCT00360178|Amlodipine|amlodipine|mesh-list
64522537|NCT00360178|Valsartan|valsartan|mesh-list
64897498|NCT02014064|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64897499|NCT02014064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64897500|NCT02014064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64897501|NCT02014064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64897502|NCT02014064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897503|NCT02014064|Adrenergic Agents|adrenergic agents|mesh-ancestor
64897504|NCT02014064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64897505|NCT02014064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897507|NCT02014103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64897508|NCT02014103|Immunologic Factors|immunologic factors|mesh-ancestor
64897509|NCT02014103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897510|NCT02014103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64897511|NCT02014103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897512|NCT02014103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897513|NCT02014337|Mifepristone|mifepristone|mesh-list
64897514|NCT02014337|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64897515|NCT02014337|Abortifacient Agents|abortifacient agents|mesh-ancestor
64897516|NCT02014337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64897517|NCT02014337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897518|NCT02014337|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64897519|NCT02014337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64897520|NCT02014337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64897521|NCT02014337|Contraceptive Agents|contraceptive agents|mesh-ancestor
64897522|NCT02014337|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64897523|NCT02014337|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64897524|NCT02014337|Hormone Antagonists|hormone antagonists|mesh-ancestor
64897525|NCT02014337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64897526|NCT02014337|Luteolytic Agents|luteolytic agents|mesh-ancestor
64897527|NCT02014337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64897528|NCT02014337|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64897529|NCT02014428|Hyaluronic Acid|hyaluronic acid|mesh-list
64897530|NCT02014428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64897531|NCT02014428|Immunologic Factors|immunologic factors|mesh-ancestor
64897532|NCT02014428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522543|NCT00360178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522544|NCT00360178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64522545|NCT00360178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522546|NCT00360178|Vasodilator Agents|vasodilator agents|mesh-ancestor
64522547|NCT00360178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64522548|NCT00360178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64522549|NCT00360178|Diuretics|diuretics|mesh-ancestor
64522550|NCT00360178|Natriuretic Agents|natriuretic agents|mesh-ancestor
64522551|NCT00360178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64522553|NCT00421720|Remifentanil|remifentanil|mesh-list
64522554|NCT00421720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64522555|NCT00421720|Narcotics|narcotics|mesh-ancestor
64522556|NCT00421720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64648376|NCT05583188|Nivolumab|nivolumab|mesh-list
64897538|NCT02014454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64897539|NCT02014454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64897540|NCT02014454|Adrenergic Agents|adrenergic agents|mesh-ancestor
64897541|NCT02014454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64897542|NCT02014454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897543|NCT02014454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897544|NCT02014454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64897545|NCT02014454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64897546|NCT02014454|Vasodilator Agents|vasodilator agents|mesh-ancestor
64897547|NCT02014506|Cyclophosphamide|cyclophosphamide|mesh-list
64897548|NCT02014506|Fludarabine|fludarabine|mesh-list
64897549|NCT02014506|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64897550|NCT02014506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64897551|NCT02014506|Immunologic Factors|immunologic factors|mesh-ancestor
64897584|NCT02014558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64897585|NCT02014558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64897586|NCT02014558|Anesthetics, General|anesthetics, general|mesh-ancestor
64522570|NCT05008276|Plasma Substitutes|plasma substitutes|mesh-ancestor
64522571|NCT05008276|Blood Substitutes|blood substitutes|mesh-ancestor
64522573|NCT00358930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64522574|NCT00358930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64522575|NCT00358930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64522576|NCT00358930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522577|NCT00358930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522578|NCT00358930|Antiviral Agents|antiviral agents|mesh-ancestor
64522579|NCT04492306|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
64522580|NCT04492306|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64522581|NCT04492306|Protective Agents|protective agents|mesh-ancestor
64522582|NCT04492306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522583|NCT04492306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64522584|NCT04492306|Antioxidants|antioxidants|mesh-ancestor
64522585|NCT04492306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522586|NCT04469842|Mycophenolic Acid|mycophenolic acid|mesh-list
64522587|NCT04469842|Prednisone|prednisone|mesh-list
64522588|NCT04469842|Azathioprine|azathioprine|mesh-list
64522589|NCT04469842|Tacrolimus|tacrolimus|mesh-list
64522590|NCT04469842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64522591|NCT04469842|Glucocorticoids|glucocorticoids|mesh-ancestor
64522592|NCT04469842|Hormones|hormones|mesh-ancestor
64522593|NCT04469842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64522594|NCT04469842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522595|NCT04469842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64522603|NCT04469842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64522604|NCT04469842|Antitubercular Agents|antitubercular agents|mesh-ancestor
64522605|NCT04469842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64522606|NCT04469842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64522608|NCT04469842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64522609|NCT04469842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64522610|NCT04941898|Factor VIII|factor viii|mesh-list
64522611|NCT04941898|BAX 855|bax 855|mesh-list
64522612|NCT04941898|Coagulants|coagulants|mesh-ancestor
64522613|NCT04468360|Pregnanolone|pregnanolone|mesh-list
64522614|NCT04468360|Brexanolone|brexanolone|mesh-list
64522615|NCT04468360|Anesthetics|anesthetics|mesh-ancestor
64897633|NCT02014753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897634|NCT02014753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64897635|NCT02014753|Immunologic Factors|immunologic factors|mesh-ancestor
64897636|NCT02014753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897637|NCT02014753|Trace Elements|trace elements|mesh-ancestor
64897669|NCT02015182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666181|NCT04311567|Tofacitinib|tofacitinib|mesh-list
64897670|NCT02015182|Sensory System Agents|sensory system agents|mesh-ancestor
64897671|NCT02015182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64897672|NCT02015260|Citric Acid|citric acid|mesh-list
64897673|NCT02015260|Anticoagulants|anticoagulants|mesh-ancestor
64897674|NCT02015260|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64897675|NCT02015260|Chelating Agents|chelating agents|mesh-ancestor
64897676|NCT02015260|Sequestering Agents|sequestering agents|mesh-ancestor
64897677|NCT02015260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897678|NCT02015299|Linagliptin|linagliptin|mesh-list
64648404|NCT05743244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64522616|NCT04468360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64522617|NCT04468360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522619|NCT04468360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64522620|NCT04468360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522621|NCT04468360|GABA Modulators|gaba modulators|mesh-ancestor
64522622|NCT04468360|GABA Agents|gaba agents|mesh-ancestor
64522623|NCT02977312|Imatinib Mesylate|imatinib mesylate|mesh-list
64522624|NCT02977312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522625|NCT02977312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64522626|NCT02977312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522627|NCT02977312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522628|NCT04907110|Niacinamide|niacinamide|mesh-list
64522629|NCT04907110|Vitamin B Complex|vitamin b complex|mesh-ancestor
64522630|NCT04907110|Vitamins|vitamins|mesh-ancestor
64522631|NCT04907110|Micronutrients|micronutrients|mesh-ancestor
64522632|NCT04907110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897734|NCT02015559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897735|NCT02015598|Carbocysteine|carbocysteine|mesh-list
64897736|NCT02015598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64897737|NCT02015598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64897738|NCT02015598|Expectorants|expectorants|mesh-ancestor
64897739|NCT02015598|Respiratory System Agents|respiratory system agents|mesh-ancestor
64897740|NCT02015650|Fluorouracil|fluorouracil|mesh-list
64897741|NCT02015650|Cetuximab|cetuximab|mesh-list
64897742|NCT02015650|Mitomycins|mitomycins|mesh-list
64897743|NCT02015650|Mitomycin|mitomycin|mesh-list
64897744|NCT02015650|Antimetabolites|antimetabolites|mesh-ancestor
64897745|NCT02015650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522640|NCT04887298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522642|NCT02977000|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64522643|NCT02977000|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64522644|NCT02977000|Adrenergic Agents|adrenergic agents|mesh-ancestor
64522645|NCT02977000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64522646|NCT02977000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522647|NCT02977000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522648|NCT02977000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64522649|NCT02977000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64522650|NCT02977000|Vasodilator Agents|vasodilator agents|mesh-ancestor
64522651|NCT02975986|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
64522652|NCT02975986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64522653|NCT02975986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522654|NCT00112827|Cyclophosphamide|cyclophosphamide|mesh-list
64522655|NCT00112827|Melphalan|melphalan|mesh-list
64897746|NCT02015650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64897754|NCT02015650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64484288|NCT00792142|Hormones|hormones|mesh-ancestor
64897755|NCT02015650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648457|NCT00794144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64897766|NCT02015728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897767|NCT02015728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897768|NCT02015728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64897769|NCT02015728|Immunologic Factors|immunologic factors|mesh-ancestor
64897770|NCT02015728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897771|NCT02015728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64897772|NCT02015728|Alkylating Agents|alkylating agents|mesh-ancestor
64897773|NCT02015728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64897774|NCT02015780|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64897775|NCT02015780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897776|NCT02015923|Panitumumab|panitumumab|mesh-list
64897777|NCT02015923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64897778|NCT02015923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897779|NCT02015949|Methylphenidate|methylphenidate|mesh-list
64897780|NCT02015949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64897781|NCT02015949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897782|NCT02015949|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64897783|NCT02015949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64897784|NCT02015949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64897785|NCT02015949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897786|NCT02015949|Dopamine Agents|dopamine agents|mesh-ancestor
64897787|NCT02015949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64897788|NCT02015988|Simvastatin|simvastatin|mesh-list
64897789|NCT02015988|Fenofibrate|fenofibrate|mesh-list
64897790|NCT02015988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64897791|NCT02015988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64897792|NCT02015988|Antimetabolites|antimetabolites|mesh-ancestor
64897793|NCT02015988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897794|NCT02015988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64522656|NCT00112827|Lenalidomide|lenalidomide|mesh-list
64522657|NCT00112827|Lenograstim|lenograstim|mesh-list
64522658|NCT00112827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64522659|NCT00112827|Immunologic Factors|immunologic factors|mesh-ancestor
64522660|NCT00112827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522661|NCT00112827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64522662|NCT00112827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64522663|NCT00112827|Alkylating Agents|alkylating agents|mesh-ancestor
64522664|NCT00112827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522665|NCT00112827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522666|NCT00112827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64522667|NCT00112827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64522668|NCT00112827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64522669|NCT00112827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64897795|NCT02015988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64897796|NCT02015988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897797|NCT02016001|Fluorides|fluorides|mesh-list
64897798|NCT02016001|Cariostatic Agents|cariostatic agents|mesh-ancestor
64897799|NCT02016001|Protective Agents|protective agents|mesh-ancestor
64897800|NCT02016001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897801|NCT02016157|Moxifloxacin|moxifloxacin|mesh-list
64897802|NCT02016157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64897803|NCT02016157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64897804|NCT02016157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64897805|NCT02016157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64897806|NCT02016157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897837|NCT02016261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897838|NCT02016261|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64897840|NCT02016274|Cisplatin|cisplatin|mesh-list
64897841|NCT02016274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64897842|NCT02016274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897843|NCT02016274|Tubulin Modulators|tubulin modulators|mesh-ancestor
64897844|NCT02016274|Antimitotic Agents|antimitotic agents|mesh-ancestor
64897845|NCT02016274|Mitosis Modulators|mitosis modulators|mesh-ancestor
64897846|NCT02016274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897847|NCT02016287|Paclitaxel|paclitaxel|mesh-list
64897848|NCT02016287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64897849|NCT02016287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897850|NCT02016287|Tubulin Modulators|tubulin modulators|mesh-ancestor
64522670|NCT00112827|Growth Substances|growth substances|mesh-ancestor
64522671|NCT00112827|Growth Inhibitors|growth inhibitors|mesh-ancestor
64522672|NCT04752111|Esmolol|esmolol|mesh-list
64522673|NCT04752111|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64522674|NCT04752111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64522675|NCT04752111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64522676|NCT04752111|Adrenergic Agents|adrenergic agents|mesh-ancestor
64522677|NCT04752111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64522678|NCT04752111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522679|NCT04752111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522680|NCT04343170|Folic Acid|folic acid|mesh-list
64522681|NCT04343170|Vitamin B 12|vitamin b 12|mesh-list
64522682|NCT04343170|Hydroxocobalamin|hydroxocobalamin|mesh-list
64897851|NCT02016287|Antimitotic Agents|antimitotic agents|mesh-ancestor
64897852|NCT02016287|Mitosis Modulators|mitosis modulators|mesh-ancestor
64897853|NCT02016287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897854|NCT02016365|Doxycycline|doxycycline|mesh-list
64897855|NCT02016365|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64897856|NCT02016365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64897857|NCT02016365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64897858|NCT02016365|Antimalarials|antimalarials|mesh-ancestor
64897859|NCT02016365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64897860|NCT02016365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64897861|NCT02016365|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64897910|NCT02016495|Thioctic Acid|thioctic acid|mesh-list
64897911|NCT02016495|Antioxidants|antioxidants|mesh-ancestor
64897912|NCT02016495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897913|NCT02016495|Protective Agents|protective agents|mesh-ancestor
64897914|NCT02016495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897915|NCT02016495|Vitamin B Complex|vitamin b complex|mesh-ancestor
64897916|NCT02016495|Vitamins|vitamins|mesh-ancestor
64897917|NCT02016495|Micronutrients|micronutrients|mesh-ancestor
64897918|NCT02016547|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64897919|NCT02016547|Abciximab|abciximab|mesh-list
64897920|NCT02016547|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64897921|NCT02016547|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64897922|NCT02016547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897923|NCT02016547|Anticoagulants|anticoagulants|mesh-ancestor
64522684|NCT04343170|Vitamins|vitamins|mesh-ancestor
64522685|NCT04343170|Micronutrients|micronutrients|mesh-ancestor
64522686|NCT04343170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522687|NCT04343170|Hematinics|hematinics|mesh-ancestor
64522688|NCT04343170|Vitamin B Complex|vitamin b complex|mesh-ancestor
64522689|NCT00226239|Docetaxel|docetaxel|mesh-list
64522690|NCT00226239|Cetuximab|cetuximab|mesh-list
64522691|NCT00226239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522692|NCT00226239|Tubulin Modulators|tubulin modulators|mesh-ancestor
64522693|NCT00226239|Antimitotic Agents|antimitotic agents|mesh-ancestor
64522694|NCT00226239|Mitosis Modulators|mitosis modulators|mesh-ancestor
64522695|NCT00226239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648514|NCT05742698|Nabilone|nabilone|mesh-list
64522708|NCT00227019|Growth Substances|growth substances|mesh-ancestor
64522709|NCT00227019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522710|NCT00227019|Growth Inhibitors|growth inhibitors|mesh-ancestor
64522711|NCT00227019|Micronutrients|micronutrients|mesh-ancestor
64897924|NCT02016547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64897926|NCT02016664|Analgesics|analgesics|mesh-ancestor
64897927|NCT02016664|Sensory System Agents|sensory system agents|mesh-ancestor
64897961|NCT02016976|Midazolam|midazolam|mesh-list
64897962|NCT02016976|Meperidine|meperidine|mesh-list
64897963|NCT02016976|Analgesics|analgesics|mesh-list
64897964|NCT02016976|Sensory System Agents|sensory system agents|mesh-ancestor
64897965|NCT02016976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64897966|NCT02016976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897967|NCT02016976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64897968|NCT02016976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64898003|NCT02017392|Anesthetics|anesthetics|mesh-ancestor
64898004|NCT02017392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64898005|NCT02017392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898006|NCT02017392|Sensory System Agents|sensory system agents|mesh-ancestor
64898007|NCT02017392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898008|NCT02017392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64898009|NCT02017392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64898010|NCT02017392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64522712|NCT00227019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64522714|NCT00227019|Autonomic Agents|autonomic agents|mesh-ancestor
64522715|NCT00227019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64522716|NCT00227019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64522717|NCT00227019|Glucocorticoids|glucocorticoids|mesh-ancestor
64522718|NCT00227019|Hormones|hormones|mesh-ancestor
64522719|NCT00227019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64522720|NCT00227019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64522721|NCT00227019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522722|NCT00227019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522723|NCT00227019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64522724|NCT00227019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64522725|NCT00227019|Hematinics|hematinics|mesh-ancestor
64522726|NCT00113217|Bevacizumab|bevacizumab|mesh-list
64898044|NCT02017639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64898045|NCT02017639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64898046|NCT02017639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64898047|NCT02017873|Carbamide Peroxide|carbamide peroxide|mesh-list
64898048|NCT02017873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64898049|NCT02017873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64898064|NCT02018055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64898065|NCT02018055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64898066|NCT02018055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64898067|NCT02018055|Antipyretics|antipyretics|mesh-ancestor
64898068|NCT02018055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64898069|NCT02018055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64898070|NCT02018055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64898080|NCT02018081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64898081|NCT02018081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64898082|NCT02018081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898083|NCT02018081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898084|NCT02018081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64898085|NCT02018081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64898086|NCT02018094|Iodine|iodine|mesh-list
64898087|NCT02018094|Chlorhexidine|chlorhexidine|mesh-list
64898088|NCT02018094|Povidone-Iodine|povidone-iodine|mesh-list
64898089|NCT02018094|Metronidazole|metronidazole|mesh-list
64898090|NCT02018094|Clindamycin|clindamycin|mesh-list
64898091|NCT02018094|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64648543|NCT00772304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898092|NCT02018094|Teicoplanin|teicoplanin|mesh-list
64898093|NCT02018094|Povidone|povidone|mesh-list
64898094|NCT02018094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64898095|NCT02018094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64898096|NCT02018094|Disinfectants|disinfectants|mesh-ancestor
64898097|NCT02018094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64898098|NCT02018094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64898099|NCT02018094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64898100|NCT02018094|Trace Elements|trace elements|mesh-ancestor
64898101|NCT02018094|Micronutrients|micronutrients|mesh-ancestor
64898102|NCT02018094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522727|NCT00113217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64522728|NCT00113217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522729|NCT00113217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64522730|NCT00113217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64522731|NCT00113217|Growth Substances|growth substances|mesh-ancestor
64522732|NCT00113217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522733|NCT00113217|Growth Inhibitors|growth inhibitors|mesh-ancestor
64522734|NCT04718116|Tramadol|tramadol|mesh-list
64522735|NCT04718116|Tapentadol|tapentadol|mesh-list
64522736|NCT04718116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64522737|NCT04718116|Narcotics|narcotics|mesh-ancestor
64522738|NCT04718116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64522739|NCT04718116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522740|NCT04718116|Analgesics|analgesics|mesh-ancestor
64898103|NCT02018094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64898104|NCT02018094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64898105|NCT02018094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898106|NCT02018094|Plasma Substitutes|plasma substitutes|mesh-ancestor
64898107|NCT02018094|Blood Substitutes|blood substitutes|mesh-ancestor
64898108|NCT02018094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64898109|NCT02018133|Vitamin D|vitamin d|mesh-list
64898110|NCT02018133|Ergocalciferols|ergocalciferols|mesh-list
64898111|NCT02018133|Vitamins|vitamins|mesh-ancestor
64898112|NCT02018133|Micronutrients|micronutrients|mesh-ancestor
64898131|NCT02018276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64898132|NCT02018276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898133|NCT02018276|Sensory System Agents|sensory system agents|mesh-ancestor
64898134|NCT02018276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898135|NCT02018276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64898136|NCT02018276|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64898137|NCT02018276|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64898138|NCT02018276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64898139|NCT02018276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898140|NCT02018289|Triclosan|triclosan|mesh-list
64898141|NCT02018289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64898151|NCT02018328|Analgesics|analgesics|mesh-ancestor
64898152|NCT02018328|Sensory System Agents|sensory system agents|mesh-ancestor
64898153|NCT02018328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898154|NCT02018328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898155|NCT02018328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64898156|NCT02018328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64898157|NCT02018328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898158|NCT02018328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64898159|NCT02018328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898160|NCT02018367|Proflavine|proflavine|mesh-list
64898161|NCT02018367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64898162|NCT02018367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64898163|NCT02018419|Vaccines|vaccines|mesh-list
64898164|NCT02018419|Immunologic Factors|immunologic factors|mesh-ancestor
64898165|NCT02018419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898166|NCT02018523|Lenalidomide|lenalidomide|mesh-list
64898167|NCT02018523|Immunologic Factors|immunologic factors|mesh-ancestor
64522741|NCT04718116|Sensory System Agents|sensory system agents|mesh-ancestor
64522742|NCT04718116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64522743|NCT04718116|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64522744|NCT04718116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64522745|NCT04718116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64522746|NCT04718116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522747|NCT04718116|Adrenergic Agents|adrenergic agents|mesh-ancestor
64522748|NCT04718116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64522749|NCT04429503|Aflibercept|aflibercept|mesh-list
64898168|NCT02018523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898194|NCT02018601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64898196|NCT02018731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64898197|NCT02018731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898198|NCT02018757|Chlorotrianisene|chlorotrianisene|mesh-list
64898199|NCT02018757|Arsenic Trioxide|arsenic trioxide|mesh-list
64898200|NCT02018757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64898201|NCT02018757|Estrogens|estrogens|mesh-ancestor
64898202|NCT02018757|Hormones|hormones|mesh-ancestor
64898203|NCT02018757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64898204|NCT02018757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898205|NCT02018757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64898206|NCT02018757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898207|NCT02018783|Listerine|listerine|mesh-list
64898208|NCT02018783|Sodium Fluoride|sodium fluoride|mesh-list
64898209|NCT02018783|Cariostatic Agents|cariostatic agents|mesh-ancestor
64898210|NCT02018783|Protective Agents|protective agents|mesh-ancestor
64898211|NCT02018783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898212|NCT02018783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64898213|NCT02018783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64898214|NCT02018796|Misoprostol|misoprostol|mesh-list
64898215|NCT02018796|Mifepristone|mifepristone|mesh-list
64898216|NCT02018796|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64898217|NCT02018796|Abortifacient Agents|abortifacient agents|mesh-ancestor
64898218|NCT02018796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64898237|NCT02018874|Antimetabolites|antimetabolites|mesh-ancestor
64898238|NCT02018874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898239|NCT02018874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898240|NCT02018874|Antiviral Agents|antiviral agents|mesh-ancestor
64898241|NCT02018874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64898249|NCT02018965|Nicotinic Acids|nicotinic acids|mesh-list
64898250|NCT02018965|Vitamin B Complex|vitamin b complex|mesh-list
64898251|NCT02018965|Micronutrients|micronutrients|mesh-ancestor
64898252|NCT02018965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898253|NCT02018965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64898254|NCT02018965|Antimetabolites|antimetabolites|mesh-ancestor
64898255|NCT02018965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898256|NCT02018965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64898257|NCT02018965|Vasodilator Agents|vasodilator agents|mesh-ancestor
64898259|NCT02018991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898260|NCT02018991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64898261|NCT02018991|Immunologic Factors|immunologic factors|mesh-ancestor
64898262|NCT02018991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898263|NCT02019017|Botulinum Toxins|botulinum toxins|mesh-list
64898264|NCT02019017|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64898265|NCT02019017|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64898266|NCT02019017|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64898267|NCT02019017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64522750|NCT04429503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64522751|NCT04429503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64522752|NCT04429503|Growth Substances|growth substances|mesh-ancestor
64522753|NCT04429503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522754|NCT04429503|Growth Inhibitors|growth inhibitors|mesh-ancestor
64522755|NCT04429503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522757|NCT04276792|Narcotics|narcotics|mesh-ancestor
64522758|NCT04276792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64522759|NCT04276792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522760|NCT04276792|Analgesics|analgesics|mesh-ancestor
64898268|NCT02019017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898269|NCT02019017|Cholinergic Agents|cholinergic agents|mesh-ancestor
64898270|NCT02019017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64898271|NCT02019017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898272|NCT02019017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64898273|NCT02019017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898336|NCT02019355|Immunologic Factors|immunologic factors|mesh-ancestor
64898337|NCT02019355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898338|NCT02019355|Dermatologic Agents|dermatologic agents|mesh-ancestor
64898340|NCT02019381|Vitamin D|vitamin d|mesh-list
64898341|NCT02019381|Ergocalciferols|ergocalciferols|mesh-list
64898342|NCT02019381|Cholecalciferol|cholecalciferol|mesh-list
64898343|NCT02019381|Vitamins|vitamins|mesh-list
64898344|NCT02019381|Micronutrients|micronutrients|mesh-ancestor
64898345|NCT02019381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898346|NCT02019381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64898347|NCT02019381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64898348|NCT02019446|Terbinafine|terbinafine|mesh-list
64898349|NCT02019446|Antifungal Agents|antifungal agents|mesh-ancestor
64898350|NCT02019446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64898351|NCT02019446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64898352|NCT02019446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898353|NCT02019459|Nicotine|nicotine|mesh-list
64898354|NCT02019459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64898355|NCT02019459|Autonomic Agents|autonomic agents|mesh-ancestor
64898356|NCT02019459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898357|NCT02019459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898358|NCT02019459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64898359|NCT02019459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64898360|NCT02019459|Cholinergic Agents|cholinergic agents|mesh-ancestor
64898361|NCT02019459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64898362|NCT02019459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898363|NCT02019485|Tapentadol|tapentadol|mesh-list
64898364|NCT02019485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64898406|NCT02019810|Sympathomimetics|sympathomimetics|mesh-ancestor
64898407|NCT02019810|Autonomic Agents|autonomic agents|mesh-ancestor
64898408|NCT02019810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898409|NCT02019810|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64898410|NCT02019810|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64898411|NCT02019810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64898412|NCT02019810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64898413|NCT02019810|Protective Agents|protective agents|mesh-ancestor
64898414|NCT02019836|Vitamin D|vitamin d|mesh-list
64898457|NCT02020161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898459|NCT02020161|Dermatologic Agents|dermatologic agents|mesh-ancestor
64898460|NCT02020161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64898461|NCT02020161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64898462|NCT02020161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64898463|NCT02020161|Immunologic Factors|immunologic factors|mesh-ancestor
64898464|NCT02020161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64898465|NCT02020161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64898466|NCT02020161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64898467|NCT02020161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64898468|NCT02020161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64898469|NCT02020200|Methylphenidate|methylphenidate|mesh-list
64898470|NCT02020200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64898471|NCT02020200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522772|NCT00053703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64522773|NCT00053703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64522774|NCT00053703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64522775|NCT00053703|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64522776|NCT00053703|Dopamine Agents|dopamine agents|mesh-ancestor
64522777|NCT00053703|Antiemetics|antiemetics|mesh-ancestor
64648605|NCT03832010|Triamcinolone|triamcinolone|mesh-list
64522790|NCT02975440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64522791|NCT02975440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64522792|NCT02975440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64522793|NCT02975440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64522794|NCT02975440|Anesthetics, General|anesthetics, general|mesh-ancestor
64522795|NCT02975440|Anesthetics|anesthetics|mesh-ancestor
64898472|NCT02020200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64898473|NCT02020200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64898474|NCT02020200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64898475|NCT02020200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898476|NCT02020200|Dopamine Agents|dopamine agents|mesh-ancestor
64898477|NCT02020200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64898478|NCT02020213|Posaconazole|posaconazole|mesh-list
64898479|NCT02020213|Antifungal Agents|antifungal agents|mesh-ancestor
64898480|NCT02020213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64898481|NCT02020213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64898510|NCT02020551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64898511|NCT02020551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64898512|NCT02020551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898514|NCT02020603|Racepinephrine|racepinephrine|mesh-list
64898515|NCT02020603|Hemostatics|hemostatics|mesh-list
64898516|NCT02020603|Epinephryl borate|epinephryl borate|mesh-list
64898517|NCT02020603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64898518|NCT02020603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64898519|NCT02020603|Adrenergic Agents|adrenergic agents|mesh-ancestor
64898520|NCT02020603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64898521|NCT02020603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898522|NCT02020603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898551|NCT02021097|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64898552|NCT02021097|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64898553|NCT02021097|Levonorgestrel|levonorgestrel|mesh-list
64522796|NCT02975440|GABA Modulators|gaba modulators|mesh-ancestor
64522797|NCT02975440|GABA Agents|gaba agents|mesh-ancestor
64522798|NCT02975440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64522799|NCT02975440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522801|NCT02975440|Antitubercular Agents|antitubercular agents|mesh-ancestor
64522802|NCT02975440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64522803|NCT02975440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64522804|NCT02975440|Leprostatic Agents|leprostatic agents|mesh-ancestor
64522805|NCT02975440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64522806|NCT02975440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522807|NCT02975440|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64522808|NCT02975440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64898554|NCT02021097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64898555|NCT02021097|Estradiol|estradiol|mesh-list
64898556|NCT02021097|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64898557|NCT02021097|Estrogens|estrogens|mesh-ancestor
64898558|NCT02021097|Hormones|hormones|mesh-ancestor
64898559|NCT02021097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64898608|NCT02021240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898609|NCT02021240|Analgesics|analgesics|mesh-ancestor
64898610|NCT02021240|Sensory System Agents|sensory system agents|mesh-ancestor
64898611|NCT02021240|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64898612|NCT02021240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64898630|NCT02021422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64898631|NCT02021422|Immunologic Factors|immunologic factors|mesh-ancestor
64898632|NCT02021422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898633|NCT02021422|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64898634|NCT02021422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64898635|NCT02021422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64898636|NCT02021422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64898637|NCT02021500|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64898638|NCT02021500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898639|NCT02021539|Tocolytic Agents|tocolytic agents|mesh-list
64898640|NCT02021539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64898641|NCT02021539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898642|NCT02021825|Mitoxantrone|mitoxantrone|mesh-list
64898643|NCT02021825|Analgesics|analgesics|mesh-ancestor
64898644|NCT02021825|Sensory System Agents|sensory system agents|mesh-ancestor
64898645|NCT02021825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898646|NCT02021825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898647|NCT02021825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898648|NCT02021825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64898649|NCT02021825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64522810|NCT02975440|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64522811|NCT02975440|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64522812|NCT02975440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64522813|NCT00231309|Lenograstim|lenograstim|mesh-list
64522814|NCT00231309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64522815|NCT00231309|Immunologic Factors|immunologic factors|mesh-ancestor
64522816|NCT00231309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522817|NCT04267120|Pembrolizumab|pembrolizumab|mesh-list
64522818|NCT04267120|Lenvatinib|lenvatinib|mesh-list
64522819|NCT04267120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64898661|NCT02021851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898663|NCT02021851|Glucocorticoids|glucocorticoids|mesh-ancestor
64898664|NCT02021851|Hormones|hormones|mesh-ancestor
64898665|NCT02021851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64898666|NCT02021851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64898667|NCT02021851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898668|NCT02021851|Protease Inhibitors|protease inhibitors|mesh-ancestor
64898669|NCT02021851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64898692|NCT02022163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898693|NCT02022163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64898695|NCT02022163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898696|NCT02022163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64898697|NCT02022215|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64898698|NCT02022228|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64898699|NCT02022228|Luteolytic Agents|luteolytic agents|mesh-ancestor
64898700|NCT02022228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64898701|NCT02022228|Contraceptive Agents|contraceptive agents|mesh-ancestor
64898702|NCT02022228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64898703|NCT02022228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898704|NCT02022228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64898705|NCT02022228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64898706|NCT02022228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898707|NCT02022241|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64898708|NCT02022241|Luteolytic Agents|luteolytic agents|mesh-ancestor
64898709|NCT02022241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64522827|NCT04265872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64522828|NCT00232479|Carboplatin|carboplatin|mesh-list
64522829|NCT00232479|Docetaxel|docetaxel|mesh-list
64522830|NCT00232479|Trastuzumab|trastuzumab|mesh-list
64522831|NCT00232479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522832|NCT00232479|Tubulin Modulators|tubulin modulators|mesh-ancestor
64522833|NCT00232479|Antimitotic Agents|antimitotic agents|mesh-ancestor
64522834|NCT00232479|Mitosis Modulators|mitosis modulators|mesh-ancestor
64522835|NCT00232479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522836|NCT00232479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64522837|NCT04710628|Pembrolizumab|pembrolizumab|mesh-list
64522838|NCT04710628|Lenvatinib|lenvatinib|mesh-list
64522839|NCT04710628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64522840|NCT04710628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898710|NCT02022241|Contraceptive Agents|contraceptive agents|mesh-ancestor
64898758|NCT02022475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898759|NCT02022475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64898760|NCT02022475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64898761|NCT02022488|Midazolam|midazolam|mesh-list
64898762|NCT02022488|Ketamine|ketamine|mesh-list
64898763|NCT02022488|Alfentanil|alfentanil|mesh-list
64898764|NCT02022488|Analgesics|analgesics|mesh-ancestor
64898765|NCT02022488|Sensory System Agents|sensory system agents|mesh-ancestor
64898766|NCT02022488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898767|NCT02022488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898768|NCT02022488|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64898769|NCT02022488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64898770|NCT02022488|Anesthetics, General|anesthetics, general|mesh-ancestor
64898771|NCT02022488|Anesthetics|anesthetics|mesh-ancestor
64898772|NCT02022488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64898773|NCT02022488|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64898774|NCT02022488|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64898775|NCT02022488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64522841|NCT04710628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64522842|NCT04710628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522843|NCT04710628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522845|NCT00233103|Antidepressive Agents|antidepressive agents|mesh-ancestor
64522846|NCT00233103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64522847|NCT00233103|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64522848|NCT00233103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64898804|NCT02022527|Antipyretics|antipyretics|mesh-ancestor
64898805|NCT02022527|Anticoagulants|anticoagulants|mesh-ancestor
64898806|NCT02022527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64898807|NCT02022527|Antifungal Agents|antifungal agents|mesh-ancestor
64898808|NCT02022527|Keratolytic Agents|keratolytic agents|mesh-ancestor
64898809|NCT02022527|Dermatologic Agents|dermatologic agents|mesh-ancestor
64898811|NCT02022540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64898812|NCT02022540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64898813|NCT02022540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64898814|NCT02022540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64898815|NCT02022540|Growth Substances|growth substances|mesh-ancestor
64898816|NCT02022540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898817|NCT02022540|Growth Inhibitors|growth inhibitors|mesh-ancestor
64898818|NCT02022540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898819|NCT02022722|Triamcinolone|triamcinolone|mesh-list
64898820|NCT02022722|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64898821|NCT02022722|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64898822|NCT02022722|Bupivacaine|bupivacaine|mesh-list
64898823|NCT02022722|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64898824|NCT02022722|Anesthetics, Local|anesthetics, local|mesh-ancestor
64898825|NCT02022722|Anesthetics|anesthetics|mesh-ancestor
64898826|NCT02022722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64522865|NCT02433522|Immunologic Factors|immunologic factors|mesh-ancestor
64522866|NCT02433522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522867|NCT02433522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64522869|NCT00118131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522870|NCT00118131|Tubulin Modulators|tubulin modulators|mesh-ancestor
64522871|NCT00118131|Antimitotic Agents|antimitotic agents|mesh-ancestor
64522872|NCT00118131|Mitosis Modulators|mitosis modulators|mesh-ancestor
64522873|NCT00118131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898852|NCT02022917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898853|NCT02022917|Growth Inhibitors|growth inhibitors|mesh-ancestor
64898854|NCT02022930|Triamcinolone|triamcinolone|mesh-list
64898855|NCT02022930|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64898856|NCT02022930|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64898857|NCT02022930|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64898858|NCT02022930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64898859|NCT02022930|Glucocorticoids|glucocorticoids|mesh-ancestor
64898860|NCT02022930|Hormones|hormones|mesh-ancestor
64898861|NCT02022930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64898862|NCT02022930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898863|NCT02022930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64898864|NCT02022930|Immunologic Factors|immunologic factors|mesh-ancestor
64898865|NCT02022930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522888|NCT02436486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64522889|NCT02436486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64522890|NCT02436486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64522891|NCT02436486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64522892|NCT02436486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522893|NCT02436486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898866|NCT02022930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898867|NCT02023021|Gemcitabine|gemcitabine|mesh-list
64898868|NCT02023021|Paclitaxel|paclitaxel|mesh-list
64836049|NCT01610921|Sensory System Agents|sensory system agents|mesh-ancestor
64898886|NCT02023047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898888|NCT02023047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898889|NCT02023047|Vasodilator Agents|vasodilator agents|mesh-ancestor
64898890|NCT02023047|Tocolytic Agents|tocolytic agents|mesh-ancestor
64898891|NCT02023047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64898899|NCT02023086|Cholinergic Agents|cholinergic agents|mesh-ancestor
64898900|NCT02023086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64898901|NCT02023086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898902|NCT02023164|Diphenhydramine|diphenhydramine|mesh-list
64898904|NCT02023164|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64898905|NCT02023164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64898906|NCT02023164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64898907|NCT02023164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898908|NCT02023164|Anesthetics, Local|anesthetics, local|mesh-ancestor
64898909|NCT02023164|Anesthetics|anesthetics|mesh-ancestor
64898910|NCT02023164|Sensory System Agents|sensory system agents|mesh-ancestor
64898911|NCT02023164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898912|NCT02023164|Antiemetics|antiemetics|mesh-ancestor
64898913|NCT02023164|Autonomic Agents|autonomic agents|mesh-ancestor
64898914|NCT02023164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64898915|NCT02023164|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64898916|NCT02023164|Histamine Antagonists|histamine antagonists|mesh-ancestor
64898917|NCT02023164|Histamine Agents|histamine agents|mesh-ancestor
64898918|NCT02023164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64898919|NCT02023164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898920|NCT02023164|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64898921|NCT02023164|Antipruritics|antipruritics|mesh-ancestor
64898922|NCT02023164|Dermatologic Agents|dermatologic agents|mesh-ancestor
64898923|NCT02023359|Everolimus|everolimus|mesh-list
64898924|NCT02023359|Exemestane|exemestane|mesh-list
64898925|NCT02023359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898926|NCT02023359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64898927|NCT02023359|Immunologic Factors|immunologic factors|mesh-ancestor
64898928|NCT02023359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898929|NCT02023359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64898930|NCT02023359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64898931|NCT02023359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64898932|NCT02023359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898958|NCT02023554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64898959|NCT02023554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64898960|NCT02023554|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64898975|NCT02023567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
64898976|NCT02023567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64898977|NCT02023567|Serotonin Agents|serotonin agents|mesh-ancestor
64898978|NCT02023567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64898979|NCT02023567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898980|NCT02023567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898981|NCT02023567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64898982|NCT02023567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64898984|NCT02023684|Ropivacaine|ropivacaine|mesh-list
64898985|NCT02023684|Anesthetics, Local|anesthetics, local|mesh-ancestor
64898989|NCT02023684|Sensory System Agents|sensory system agents|mesh-ancestor
64898990|NCT02023684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898991|NCT02023684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64898992|NCT02023684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64898993|NCT02023684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64898994|NCT02023684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64898995|NCT02023684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898997|NCT02023710|Bevacizumab|bevacizumab|mesh-list
64898998|NCT02023710|Carboplatin|carboplatin|mesh-list
64898999|NCT02023710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64899000|NCT02023710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899001|NCT02023710|Tubulin Modulators|tubulin modulators|mesh-ancestor
64899002|NCT02023710|Antimitotic Agents|antimitotic agents|mesh-ancestor
64899003|NCT02023710|Mitosis Modulators|mitosis modulators|mesh-ancestor
64899004|NCT02023710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899005|NCT02023710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64899006|NCT02023710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64899007|NCT02023710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64899008|NCT02023710|Growth Substances|growth substances|mesh-ancestor
64522902|NCT04342858|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64522903|NCT04342858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64522904|NCT02429076|Propofol|propofol|mesh-list
64522905|NCT02429076|Sevoflurane|sevoflurane|mesh-list
64522906|NCT02429076|Methylphenidate|methylphenidate|mesh-list
64522907|NCT02429076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64522908|NCT02429076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64522909|NCT02429076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522910|NCT02429076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64522911|NCT02429076|Anesthetics, General|anesthetics, general|mesh-ancestor
64522912|NCT02429076|Anesthetics|anesthetics|mesh-ancestor
64522913|NCT02429076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64522914|NCT02429076|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64522915|NCT02429076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64522916|NCT02429076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64522917|NCT02429076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64522918|NCT02429076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64522919|NCT02429076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522920|NCT02429076|Dopamine Agents|dopamine agents|mesh-ancestor
64522921|NCT02429076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64522922|NCT00255177|Mifepristone|mifepristone|mesh-list
64522923|NCT00255177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64899009|NCT02023710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899010|NCT02023710|Growth Inhibitors|growth inhibitors|mesh-ancestor
64899011|NCT02023840|Metronidazole|metronidazole|mesh-list
64899012|NCT02023840|Erythritol|erythritol|mesh-list
64899013|NCT02023840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64899014|NCT02023840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64899015|NCT02023840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64899016|NCT02023840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64899017|NCT02023840|Vasodilator Agents|vasodilator agents|mesh-ancestor
64899018|NCT02023853|Metronidazole|metronidazole|mesh-list
64899019|NCT02023853|Erythritol|erythritol|mesh-list
64899038|NCT02024009|Gemcitabine|gemcitabine|mesh-list
64899039|NCT02024009|Nelfinavir|nelfinavir|mesh-list
64899040|NCT02024009|Paclitaxel|paclitaxel|mesh-list
64899041|NCT02024009|Capecitabine|capecitabine|mesh-list
64899042|NCT02024009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64899043|NCT02024009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899044|NCT02024009|Tubulin Modulators|tubulin modulators|mesh-ancestor
64899045|NCT02024009|Antimitotic Agents|antimitotic agents|mesh-ancestor
64899046|NCT02024009|Mitosis Modulators|mitosis modulators|mesh-ancestor
64899047|NCT02024009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899048|NCT02024009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64899049|NCT02024009|Antimetabolites|antimetabolites|mesh-ancestor
64899050|NCT02024009|Antiviral Agents|antiviral agents|mesh-ancestor
64899051|NCT02024009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64899052|NCT02024009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899053|NCT02024009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64522926|NCT00255177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522927|NCT00255177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64522928|NCT00255177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64522929|NCT00255177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64522930|NCT00255177|Contraceptive Agents|contraceptive agents|mesh-ancestor
64522931|NCT00255177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64522932|NCT00255177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64522933|NCT00255177|Hormone Antagonists|hormone antagonists|mesh-ancestor
64522934|NCT00255177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64522935|NCT00255177|Luteolytic Agents|luteolytic agents|mesh-ancestor
64522936|NCT00255177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64899058|NCT02024009|Protease Inhibitors|protease inhibitors|mesh-ancestor
64899059|NCT02024009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64899060|NCT02024009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64899061|NCT02024022|Picosulfate sodium|picosulfate sodium|mesh-list
64899062|NCT02024022|Magnesium citrate|magnesium citrate|mesh-list
64899063|NCT02024022|Cathartics|cathartics|mesh-ancestor
64899064|NCT02024022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64899065|NCT02024152|Cetirizine|cetirizine|mesh-list
64899066|NCT02024152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64899067|NCT02024152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64899068|NCT02024152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64899069|NCT02024152|Histamine Antagonists|histamine antagonists|mesh-ancestor
64899070|NCT02024152|Histamine Agents|histamine agents|mesh-ancestor
64899071|NCT02024152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64899072|NCT02024152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899073|NCT02024152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899074|NCT02024217|Oxaliplatin|oxaliplatin|mesh-list
64899075|NCT02024217|Tegafur|tegafur|mesh-list
64899076|NCT02024217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899096|NCT02024295|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
64899098|NCT02024295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64899099|NCT02024295|Antimetabolites|antimetabolites|mesh-ancestor
64899100|NCT02024295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899101|NCT02024295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64899102|NCT02024295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64899103|NCT02024295|Nootropic Agents|nootropic agents|mesh-ancestor
64899104|NCT02024308|Cytarabine|cytarabine|mesh-list
64899105|NCT02024308|Fludarabine|fludarabine|mesh-list
64899106|NCT02024308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899107|NCT02024308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64667617|NCT03029715|Dexmedetomidine|dexmedetomidine|mesh-list
64899108|NCT02024308|Antimetabolites|antimetabolites|mesh-ancestor
64899109|NCT02024308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899110|NCT02024308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64899111|NCT02024308|Immunologic Factors|immunologic factors|mesh-ancestor
64899112|NCT02024308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899113|NCT02024308|Antiviral Agents|antiviral agents|mesh-ancestor
64899114|NCT02024308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64899115|NCT02024334|Leflunomide|leflunomide|mesh-list
64899116|NCT02024334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899117|NCT02024334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899118|NCT02024334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64899119|NCT02024334|Immunologic Factors|immunologic factors|mesh-ancestor
64899120|NCT02024334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899121|NCT02024373|Atorvastatin|atorvastatin|mesh-list
64899122|NCT02024373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64899123|NCT02024373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64522938|NCT04670224|Anesthetics|anesthetics|mesh-list
64522939|NCT04670224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64522940|NCT04670224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522941|NCT00361114|Pyrimethamine|pyrimethamine|mesh-list
64522942|NCT00361114|Sulfadoxine|sulfadoxine|mesh-list
64522944|NCT00361114|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64522945|NCT00361114|Chlorproguanil|chlorproguanil|mesh-list
64899124|NCT02024373|Antimetabolites|antimetabolites|mesh-ancestor
64899125|NCT02024373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899126|NCT02024373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64899127|NCT02024373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64899128|NCT02024373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899161|NCT02024568|Sensory System Agents|sensory system agents|mesh-ancestor
64899162|NCT02024568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64899163|NCT02024568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899164|NCT02024568|Anticonvulsants|anticonvulsants|mesh-ancestor
64899165|NCT02024568|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64899166|NCT02024568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64899167|NCT02024568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899168|NCT02024568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64899169|NCT02024568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64899170|NCT02024568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64899195|NCT02024659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64899196|NCT02024659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64899198|NCT02024659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64899199|NCT02024659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899200|NCT02024659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64899201|NCT02024659|Respiratory System Agents|respiratory system agents|mesh-ancestor
64899202|NCT02024659|Glucocorticoids|glucocorticoids|mesh-ancestor
64899203|NCT02024659|Hormones|hormones|mesh-ancestor
64899204|NCT02024659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64899205|NCT02024841|Docetaxel|docetaxel|mesh-list
64899206|NCT02024841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899207|NCT02024841|Tubulin Modulators|tubulin modulators|mesh-ancestor
64899208|NCT02024841|Antimitotic Agents|antimitotic agents|mesh-ancestor
64899209|NCT02024841|Mitosis Modulators|mitosis modulators|mesh-ancestor
64899210|NCT02024841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899211|NCT02024906|Caseins|caseins|mesh-list
64899212|NCT02024906|Chelating Agents|chelating agents|mesh-ancestor
64899213|NCT02024906|Sequestering Agents|sequestering agents|mesh-ancestor
64899214|NCT02024906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899215|NCT02024919|Diltiazem|diltiazem|mesh-list
64899216|NCT02024919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64899217|NCT02024919|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64899218|NCT02024919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64899219|NCT02024919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899237|NCT02024984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64899238|NCT02024984|Hormone Antagonists|hormone antagonists|mesh-ancestor
64899239|NCT02024984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64899240|NCT02024984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899241|NCT02024984|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64899242|NCT02024984|Fertility Agents|fertility agents|mesh-ancestor
64899243|NCT02024984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64522950|NCT00361114|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64522951|NCT00361114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522952|NCT00361114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522953|NCT00361114|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64522954|NCT00361114|Renal Agents|renal agents|mesh-ancestor
64522955|NCT00361114|Leprostatic Agents|leprostatic agents|mesh-ancestor
64522956|NCT00361114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64522957|NCT04665856|Carboplatin|carboplatin|mesh-list
64522958|NCT04665856|Etoposide|etoposide|mesh-list
64522959|NCT04665856|Atezolizumab|atezolizumab|mesh-list
64522960|NCT04665856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522961|NCT04665856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64522962|NCT04665856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64522963|NCT04665856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64522964|NCT04665856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522965|NCT04665856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522966|NCT05442580|Cyclophosphamide|cyclophosphamide|mesh-list
64522967|NCT05442580|Fludarabine|fludarabine|mesh-list
64899246|NCT02025023|Triamcinolone|triamcinolone|mesh-list
64899247|NCT02025023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64899248|NCT02025023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64899249|NCT02025023|Fluorouracil|fluorouracil|mesh-list
64899250|NCT02025023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64899251|NCT02025023|Antimetabolites|antimetabolites|mesh-ancestor
64899252|NCT02025023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899253|NCT02025023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64899254|NCT02025023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899255|NCT02025023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64899256|NCT02025023|Immunologic Factors|immunologic factors|mesh-ancestor
64899257|NCT02025023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899258|NCT02025023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64899259|NCT02025023|Glucocorticoids|glucocorticoids|mesh-ancestor
64899260|NCT02025023|Hormones|hormones|mesh-ancestor
64899261|NCT02025023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64899262|NCT02025023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899263|NCT02025140|Anesthetics|anesthetics|mesh-list
64899264|NCT02025140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64899265|NCT02025140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899266|NCT02025166|Acetaminophen|acetaminophen|mesh-list
64899267|NCT02025166|Lornoxicam|lornoxicam|mesh-list
64899268|NCT02025166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64522974|NCT05442580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522975|NCT05442580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64522976|NCT05442580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64522977|NCT00702624|Hormones|hormones|mesh-list
64522978|NCT00702624|Progesterone|progesterone|mesh-list
64522979|NCT00702624|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64522980|NCT00702624|Ganirelix|ganirelix|mesh-list
64522981|NCT00702624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64522982|NCT00702624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522983|NCT00702624|Progestins|progestins|mesh-ancestor
64522984|NCT00702624|Hormone Antagonists|hormone antagonists|mesh-ancestor
64522985|NCT03915496|Abrocitinib|abrocitinib|mesh-list
64522986|NCT03915496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64522987|NCT03915496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64522988|NCT03915496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64522989|NCT00702546|Hormones|hormones|mesh-list
64522990|NCT00702546|Progesterone|progesterone|mesh-list
64522991|NCT00702546|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64522992|NCT00702546|Ganirelix|ganirelix|mesh-list
64522993|NCT00702546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64899269|NCT02025166|Analgesics|analgesics|mesh-ancestor
64899270|NCT02025166|Sensory System Agents|sensory system agents|mesh-ancestor
64899271|NCT02025166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64899272|NCT02025166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899273|NCT02025166|Antipyretics|antipyretics|mesh-ancestor
64899274|NCT02025166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64899275|NCT02025166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64899276|NCT02025166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64899310|NCT02025361|Sensory System Agents|sensory system agents|mesh-ancestor
64899311|NCT02025361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64899312|NCT02025361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64899313|NCT02025361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64899314|NCT02025361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64648817|NCT05380388|Vaccines|vaccines|mesh-list
64899347|NCT02025491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64899348|NCT02025491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64899349|NCT02025491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64899350|NCT02025491|Antifungal Agents|antifungal agents|mesh-ancestor
64899351|NCT02025608|Pramipexole|pramipexole|mesh-list
64899352|NCT02025608|Antioxidants|antioxidants|mesh-ancestor
64899353|NCT02025608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899354|NCT02025608|Protective Agents|protective agents|mesh-ancestor
64899355|NCT02025608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522994|NCT00702546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522995|NCT00702546|Progestins|progestins|mesh-ancestor
64522996|NCT00702546|Hormone Antagonists|hormone antagonists|mesh-ancestor
64522997|NCT03876262|Ivermectin|ivermectin|mesh-list
64522998|NCT03876262|Moxidectin|moxidectin|mesh-list
64522999|NCT03876262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64523000|NCT03876262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64523001|NCT03876262|Anthelmintics|anthelmintics|mesh-ancestor
64899356|NCT02025608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64899357|NCT02025608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64899358|NCT02025608|Dopamine Agonists|dopamine agonists|mesh-ancestor
64899359|NCT02025608|Dopamine Agents|dopamine agents|mesh-ancestor
64899360|NCT02025608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64899361|NCT02025712|Everolimus|everolimus|mesh-list
64899362|NCT02025712|Exemestane|exemestane|mesh-list
64899363|NCT02025712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899364|NCT02025712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64899365|NCT02025712|Immunologic Factors|immunologic factors|mesh-ancestor
64899366|NCT02025712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899367|NCT02025712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64899381|NCT02025855|Narcotics|narcotics|mesh-ancestor
64899382|NCT02025855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64899383|NCT02025855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899384|NCT02025855|Analgesics|analgesics|mesh-ancestor
64899385|NCT02025855|Sensory System Agents|sensory system agents|mesh-ancestor
64899386|NCT02025855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64899387|NCT02025855|Antitussive Agents|antitussive agents|mesh-ancestor
64899388|NCT02025855|Respiratory System Agents|respiratory system agents|mesh-ancestor
64899389|NCT02025868|Raltegravir Potassium|raltegravir potassium|mesh-list
64899390|NCT02025868|Darunavir|darunavir|mesh-list
64899391|NCT02025868|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64899392|NCT02025868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64899393|NCT02025868|Antiviral Agents|antiviral agents|mesh-ancestor
64899394|NCT02025868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64899395|NCT02025868|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64899396|NCT02025868|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64899397|NCT02025868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899398|NCT02025868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899399|NCT02025868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64899400|NCT02025868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64899401|NCT02025868|Protease Inhibitors|protease inhibitors|mesh-ancestor
64899402|NCT02025881|Cyclophosphamide|cyclophosphamide|mesh-list
64899403|NCT02025881|Thiotepa|thiotepa|mesh-list
64899404|NCT02025881|Carboplatin|carboplatin|mesh-list
64899405|NCT02025881|Etoposide|etoposide|mesh-list
64899406|NCT02025881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64899408|NCT02025881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899409|NCT02025881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64899410|NCT02025881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64899411|NCT02025881|Alkylating Agents|alkylating agents|mesh-ancestor
64648820|NCT03801590|Riboflavin|riboflavin|mesh-list
64899418|NCT02025881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899420|NCT02025998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64899421|NCT02025998|Autonomic Agents|autonomic agents|mesh-ancestor
64899422|NCT02025998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64899423|NCT02025998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899424|NCT02025998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64899425|NCT02025998|Respiratory System Agents|respiratory system agents|mesh-ancestor
64899426|NCT02025998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64899427|NCT02025998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899428|NCT02025998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899460|NCT02026310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64899461|NCT02026310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899462|NCT02026310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64523002|NCT03876262|Antinematodal Agents|antinematodal agents|mesh-ancestor
64523003|NCT04648930|Omalizumab|omalizumab|mesh-list
64523004|NCT04648930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64523005|NCT04648930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64479104|NCT03950427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64523006|NCT04648930|Respiratory System Agents|respiratory system agents|mesh-ancestor
64523008|NCT01372410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64523009|NCT01372410|Autonomic Agents|autonomic agents|mesh-ancestor
64523010|NCT01372410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64523011|NCT01372410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523012|NCT01372410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64899463|NCT02026310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64899464|NCT02026310|Immunologic Factors|immunologic factors|mesh-ancestor
64899465|NCT02026479|Dexamethasone|dexamethasone|mesh-list
64899466|NCT02026479|Dexamethasone acetate|dexamethasone acetate|mesh-list
64899467|NCT02026479|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64899468|NCT02026479|BB 1101|bb 1101|mesh-list
64899469|NCT02026479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64899470|NCT02026479|Antiemetics|antiemetics|mesh-ancestor
64899471|NCT02026479|Autonomic Agents|autonomic agents|mesh-ancestor
64899472|NCT02026479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64899503|NCT02026518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64899504|NCT02026518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64899506|NCT02026583|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64899507|NCT02026583|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64899508|NCT02026583|Antimetabolites|antimetabolites|mesh-ancestor
64899509|NCT02026583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899510|NCT02026583|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64899511|NCT02026583|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64899512|NCT02026583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899513|NCT02026765|Heparin|heparin|mesh-list
64899514|NCT02026765|Anticoagulants|anticoagulants|mesh-ancestor
64899530|NCT02026778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899531|NCT02026778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64899532|NCT02026778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64899533|NCT02026778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64899534|NCT02026778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64899535|NCT02026778|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64899536|NCT02026778|Vasodilator Agents|vasodilator agents|mesh-ancestor
64899537|NCT02026778|Histamine Agonists|histamine agonists|mesh-ancestor
64899538|NCT02026778|Histamine Agents|histamine agents|mesh-ancestor
64899539|NCT02026817|Metformin|metformin|mesh-list
64899540|NCT02026817|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64899541|NCT02026817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64899542|NCT02026817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899543|NCT02026817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64899544|NCT02026817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64899545|NCT02026817|Antimetabolites|antimetabolites|mesh-ancestor
64899562|NCT02026921|Antimitotic Agents|antimitotic agents|mesh-ancestor
64899563|NCT02026921|Mitosis Modulators|mitosis modulators|mesh-ancestor
64523013|NCT01372410|Respiratory System Agents|respiratory system agents|mesh-ancestor
64523014|NCT01372410|Parasympatholytics|parasympatholytics|mesh-ancestor
64523015|NCT01372410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64523016|NCT01372410|Cholinergic Agents|cholinergic agents|mesh-ancestor
64523017|NCT01372410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64523018|NCT01372410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899564|NCT02026921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899565|NCT02026947|Sodium Benzoate|sodium benzoate|mesh-list
64899566|NCT02026947|Antifungal Agents|antifungal agents|mesh-ancestor
64899567|NCT02026947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64899569|NCT02026973|Anastrozole|anastrozole|mesh-list
64899570|NCT02026973|Somatostatin|somatostatin|mesh-list
64899571|NCT02026973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64899572|NCT02026973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899573|NCT02026973|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64899574|NCT02026973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64899575|NCT02026973|Hormone Antagonists|hormone antagonists|mesh-ancestor
64899605|NCT02027220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64899606|NCT02027220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64899607|NCT02027220|Antiemetics|antiemetics|mesh-ancestor
64899608|NCT02027220|Autonomic Agents|autonomic agents|mesh-ancestor
64899609|NCT02027220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64899610|NCT02027220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64899611|NCT02027220|Glucocorticoids|glucocorticoids|mesh-ancestor
64899612|NCT02027220|Hormones|hormones|mesh-ancestor
64899613|NCT02027220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64899614|NCT02027220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64899615|NCT02027298|Abatacept|abatacept|mesh-list
64899616|NCT02027298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64899617|NCT02027298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899618|NCT02027298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899619|NCT02027298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64899620|NCT02027298|Immunologic Factors|immunologic factors|mesh-ancestor
64899633|NCT02027337|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64899634|NCT02027337|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
64899635|NCT02027337|Cyproterone|cyproterone|mesh-list
64899636|NCT02027337|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
64899637|NCT02027337|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64899638|NCT02027337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64899639|NCT02027337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64899646|NCT02027337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64899648|NCT02027337|Hormone Antagonists|hormone antagonists|mesh-ancestor
64899649|NCT02027337|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64899650|NCT02027337|Diuretics|diuretics|mesh-ancestor
64899651|NCT02027337|Natriuretic Agents|natriuretic agents|mesh-ancestor
64899652|NCT02027337|Androgen Antagonists|androgen antagonists|mesh-ancestor
64899653|NCT02027337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899654|NCT02027337|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64899655|NCT02027363|Capecitabine|capecitabine|mesh-list
64899656|NCT02027363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64899657|NCT02027363|Antimetabolites|antimetabolites|mesh-ancestor
64899658|NCT02027363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899659|NCT02027363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899660|NCT02027454|Moxifloxacin|moxifloxacin|mesh-list
64899661|NCT02027454|Cabotegravir|cabotegravir|mesh-list
64325704|NCT02266927|Dermatologic Agents|dermatologic agents|mesh-ancestor
64325705|NCT02266927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64325706|NCT02158481|Carotenoids|carotenoids|mesh-list
64325707|NCT02158481|Antioxidants|antioxidants|mesh-ancestor
64325708|NCT02158481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325709|NCT02158481|Protective Agents|protective agents|mesh-ancestor
64602893|NCT02019069|Antimetabolites|antimetabolites|mesh-ancestor
64899662|NCT02027454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64899663|NCT02027454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64899664|NCT02027454|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64523019|NCT02428686|Epoetin Alfa|epoetin alfa|mesh-list
64523020|NCT02428686|Hematinics|hematinics|mesh-ancestor
64523021|NCT02432976|Insulin|insulin|mesh-list
64523022|NCT02432976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64523023|NCT02432976|Exenatide|exenatide|mesh-list
64523024|NCT02432976|Insulin Lispro|insulin lispro|mesh-list
64523025|NCT02432976|Incretins|incretins|mesh-list
64523026|NCT02432976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64523027|NCT02432976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523028|NCT02432976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64523030|NCT02432976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64523031|NCT02428374|Clopidogrel|clopidogrel|mesh-list
64523032|NCT02428374|Ticagrelor|ticagrelor|mesh-list
64523033|NCT02428374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64523034|NCT02428374|Simvastatin|simvastatin|mesh-list
64523035|NCT02428374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64523036|NCT02428374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64523037|NCT02428374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64899665|NCT02027454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64899666|NCT02027454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899667|NCT02027454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899668|NCT02027454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899669|NCT02027454|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64899670|NCT02027454|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64899671|NCT02027454|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64899672|NCT02027454|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64899673|NCT02027454|Antiviral Agents|antiviral agents|mesh-ancestor
64899674|NCT02027493|Interferons|interferons|mesh-list
64899675|NCT02027493|Ribavirin|ribavirin|mesh-list
64899676|NCT02027493|Interferon-alpha|interferon-alpha|mesh-list
64899677|NCT02027493|Interferon alpha-2|interferon alpha-2|mesh-list
64899678|NCT02027493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64899679|NCT02027493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899680|NCT02027493|Antiviral Agents|antiviral agents|mesh-ancestor
64899681|NCT02027493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64899682|NCT02027493|Antimetabolites|antimetabolites|mesh-ancestor
64899683|NCT02027493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899716|NCT02027870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64899717|NCT02027870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899718|NCT02027870|Antifungal Agents|antifungal agents|mesh-ancestor
64899719|NCT02027870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64899720|NCT02027870|Immunologic Factors|immunologic factors|mesh-ancestor
64899721|NCT02027870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899722|NCT02027922|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
64899723|NCT02027922|Cariostatic Agents|cariostatic agents|mesh-ancestor
64899762|NCT02028078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899763|NCT02028234|Omeprazole|omeprazole|mesh-list
64899764|NCT02028234|Pantoprazole|pantoprazole|mesh-list
64899795|NCT02028429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64899796|NCT02028429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64899797|NCT02028429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899798|NCT02028429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899799|NCT02028429|Urological Agents|urological agents|mesh-ancestor
64899800|NCT02028494|Capecitabine|capecitabine|mesh-list
64899801|NCT02028494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64523038|NCT02428374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64523039|NCT02428374|Purinergic Agents|purinergic agents|mesh-ancestor
64523040|NCT02428374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64523041|NCT02428374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523042|NCT02428374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523043|NCT02428374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64523044|NCT02428374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64523045|NCT02428374|Antimetabolites|antimetabolites|mesh-ancestor
64523046|NCT02428374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64523047|NCT02428374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64523048|NCT02428374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523049|NCT04614610|Lidocaine|lidocaine|mesh-list
64523050|NCT04614610|Anesthetics, Local|anesthetics, local|mesh-ancestor
64523051|NCT04614610|Anesthetics|anesthetics|mesh-ancestor
64523052|NCT04614610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64523053|NCT04614610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899802|NCT02028494|Antimetabolites|antimetabolites|mesh-ancestor
64899803|NCT02028494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899804|NCT02028494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899805|NCT02028507|Capecitabine|capecitabine|mesh-list
64899806|NCT02028507|Fulvestrant|fulvestrant|mesh-list
64899807|NCT02028507|Palbociclib|palbociclib|mesh-list
64899809|NCT02028507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64899830|NCT02028598|Sodium Citrate|sodium citrate|mesh-list
64899831|NCT02028598|Anticoagulants|anticoagulants|mesh-ancestor
64899832|NCT02028598|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64899833|NCT02028598|Chelating Agents|chelating agents|mesh-ancestor
64899834|NCT02028598|Sequestering Agents|sequestering agents|mesh-ancestor
64899835|NCT02028598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899836|NCT02028598|Vasodilator Agents|vasodilator agents|mesh-ancestor
64899837|NCT02028598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64899838|NCT02028598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64899839|NCT02028598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899840|NCT02028598|Urological Agents|urological agents|mesh-ancestor
64899841|NCT02028598|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64899842|NCT02028598|Antidepressive Agents|antidepressive agents|mesh-ancestor
64899843|NCT02028598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64899844|NCT02028598|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64899845|NCT02028598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64899846|NCT02028598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64899847|NCT02028598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64899848|NCT02028598|Serotonin Agents|serotonin agents|mesh-ancestor
64899849|NCT02028598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899850|NCT02028663|Esomeprazole|esomeprazole|mesh-list
64899851|NCT02028663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64899852|NCT02028663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64899853|NCT02028663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64899854|NCT02028663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899855|NCT02028663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899857|NCT02028689|Lesinurad|lesinurad|mesh-list
64899858|NCT02028689|Furosemide|furosemide|mesh-list
64899859|NCT02028689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64899860|NCT02028689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899861|NCT02028689|Diuretics|diuretics|mesh-ancestor
64899862|NCT02028689|Natriuretic Agents|natriuretic agents|mesh-ancestor
64899863|NCT02028689|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64648856|NCT01259063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899892|NCT02028910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64899893|NCT02028910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64899894|NCT02028910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64899895|NCT02028910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64899896|NCT02028910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64899897|NCT02028923|Morphine|morphine|mesh-list
64899898|NCT02028923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64899899|NCT02028923|Narcotics|narcotics|mesh-ancestor
64899900|NCT02028923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64899901|NCT02028923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899902|NCT02028923|Analgesics|analgesics|mesh-ancestor
64899903|NCT02028923|Sensory System Agents|sensory system agents|mesh-ancestor
64899904|NCT02028923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64899905|NCT02028949|Idarubicin|idarubicin|mesh-list
64899906|NCT02028949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64899907|NCT02028949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899908|NCT02028949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64899909|NCT02028949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64899910|NCT02028949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899911|NCT02028949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899912|NCT02029105|Hyaluronic Acid|hyaluronic acid|mesh-list
64899913|NCT02029105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64899914|NCT02029105|Immunologic Factors|immunologic factors|mesh-ancestor
64899915|NCT02029105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899916|NCT02029105|Viscosupplements|viscosupplements|mesh-ancestor
64899945|NCT02029118|Autonomic Agents|autonomic agents|mesh-ancestor
64899946|NCT02029118|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64899947|NCT02029118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64899948|NCT02029118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64899949|NCT02029118|Adrenergic Agents|adrenergic agents|mesh-ancestor
64899950|NCT02029118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64899951|NCT02029118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64899952|NCT02029118|Protease Inhibitors|protease inhibitors|mesh-ancestor
64899954|NCT02029313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64603021|NCT02153983|Colchicine|colchicine|mesh-list
64899955|NCT02029313|Respiratory System Agents|respiratory system agents|mesh-ancestor
64899956|NCT02029313|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64899957|NCT02029313|Hormone Antagonists|hormone antagonists|mesh-ancestor
64899958|NCT02029313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64899959|NCT02029313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899960|NCT02029313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64899961|NCT02029313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64899987|NCT02029573|Atorvastatin|atorvastatin|mesh-list
64899988|NCT02029573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64899989|NCT02029573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64899990|NCT02029573|Antimetabolites|antimetabolites|mesh-ancestor
64899991|NCT02029573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899992|NCT02029573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64648858|NCT01259063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64523070|NCT02428062|Phenylephrine|phenylephrine|mesh-list
64523071|NCT02428062|Dopamine|dopamine|mesh-list
64523072|NCT02428062|Epinephrine|epinephrine|mesh-list
64523073|NCT02428062|Oxymetazoline|oxymetazoline|mesh-list
64523074|NCT02428062|Norepinephrine|norepinephrine|mesh-list
64523075|NCT02428062|Ephedrine|ephedrine|mesh-list
64523076|NCT02428062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64523077|NCT02428062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523078|NCT02428062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64899995|NCT02029573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64899996|NCT02029573|Alkylating Agents|alkylating agents|mesh-ancestor
64899997|NCT02029573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899998|NCT02029586|Beta-lapachone|beta-lapachone|mesh-list
64899999|NCT02029586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64900000|NCT02029586|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64900001|NCT02029586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64668526|NCT01694108|BCG Vaccine|bcg vaccine|mesh-list
64900002|NCT02029586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900003|NCT02029586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900004|NCT02029586|Antiviral Agents|antiviral agents|mesh-ancestor
64900005|NCT02029599|Acetaminophen|acetaminophen|mesh-list
64900006|NCT02029599|Methotrexate|methotrexate|mesh-list
64900007|NCT02029599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64900019|NCT02029599|Immunologic Factors|immunologic factors|mesh-ancestor
64900020|NCT02029599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64900021|NCT02029599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64900022|NCT02029599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64900023|NCT02029599|Analgesics|analgesics|mesh-ancestor
64900024|NCT02029599|Sensory System Agents|sensory system agents|mesh-ancestor
64900025|NCT02029599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64900026|NCT02029599|Antipyretics|antipyretics|mesh-ancestor
64900027|NCT02029612|Nicotine|nicotine|mesh-list
64900028|NCT02029612|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64900029|NCT02029612|Autonomic Agents|autonomic agents|mesh-ancestor
64900030|NCT02029612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64900031|NCT02029612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900032|NCT02029612|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64900033|NCT02029612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64900034|NCT02029612|Cholinergic Agents|cholinergic agents|mesh-ancestor
64900035|NCT02029612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64900036|NCT02029612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900037|NCT02029625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64900038|NCT02029625|Ezetimibe|ezetimibe|mesh-list
64900039|NCT02029625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64900040|NCT02029625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64900041|NCT02029625|Antimetabolites|antimetabolites|mesh-ancestor
64900042|NCT02029625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900043|NCT02029625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64900044|NCT02029625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64900045|NCT02029625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900046|NCT02029794|Acetic Acid|acetic acid|mesh-list
64900047|NCT02029794|Retinol acetate|retinol acetate|mesh-list
64900048|NCT02029794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64523079|NCT02428062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64523080|NCT02428062|Adrenergic Agents|adrenergic agents|mesh-ancestor
64523081|NCT02428062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64648872|NCT04351763|Verapamil|verapamil|mesh-list
64523086|NCT02428062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64523088|NCT02428062|Respiratory System Agents|respiratory system agents|mesh-ancestor
64325710|NCT02158481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523089|NCT02428062|Mydriatics|mydriatics|mesh-ancestor
64523090|NCT02428062|Sympathomimetics|sympathomimetics|mesh-ancestor
64523091|NCT02428062|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64523092|NCT02428062|Nasal Decongestants|nasal decongestants|mesh-ancestor
64523093|NCT02428062|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64523094|NCT02428062|Protective Agents|protective agents|mesh-ancestor
64523095|NCT02428062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64523096|NCT02428062|Dopamine Agents|dopamine agents|mesh-ancestor
64523097|NCT04594798|Prednisone|prednisone|mesh-list
64523098|NCT04594798|Cyclophosphamide|cyclophosphamide|mesh-list
64523099|NCT04594798|Rituximab|rituximab|mesh-list
64523100|NCT04594798|Doxorubicin|doxorubicin|mesh-list
64523101|NCT04594798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64523103|NCT04594798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523104|NCT04594798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64523105|NCT04594798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64523106|NCT04594798|Alkylating Agents|alkylating agents|mesh-ancestor
64900049|NCT02029794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64900050|NCT02029794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64900051|NCT02029794|Immunologic Factors|immunologic factors|mesh-ancestor
64900052|NCT02029794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900053|NCT02029794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64900054|NCT02029794|Protective Agents|protective agents|mesh-ancestor
64900055|NCT02029794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900056|NCT02029898|Remifentanil|remifentanil|mesh-list
64900057|NCT02029898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64900058|NCT02029898|Narcotics|narcotics|mesh-ancestor
64900059|NCT02029898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64900060|NCT02029898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900061|NCT02029898|Analgesics|analgesics|mesh-ancestor
64900062|NCT02029898|Sensory System Agents|sensory system agents|mesh-ancestor
64900063|NCT02029898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64900064|NCT02029924|Insulin Lispro|insulin lispro|mesh-list
64900065|NCT02029924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64900066|NCT02029924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900067|NCT02029937|Proflavine|proflavine|mesh-list
64900068|NCT02029937|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64900069|NCT02029937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64900070|NCT02029950|Cytarabine|cytarabine|mesh-list
64900071|NCT02029950|Etoposide|etoposide|mesh-list
64900072|NCT02029950|Podophyllotoxin|podophyllotoxin|mesh-list
64523107|NCT04594798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523108|NCT04594798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523109|NCT04594798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64523110|NCT04594798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64523111|NCT04594798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64523112|NCT04594798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64523113|NCT04594798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64523114|NCT04594798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523115|NCT04594798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64523116|NCT04594798|Glucocorticoids|glucocorticoids|mesh-ancestor
64523118|NCT04594798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64523119|NCT04594798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64523120|NCT02432664|Midazolam|midazolam|mesh-list
64523121|NCT02432664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64523122|NCT02432664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64523123|NCT02432664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64523124|NCT02432664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523125|NCT02432664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64900100|NCT02030561|Trastuzumab|trastuzumab|mesh-list
64900101|NCT02030561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64900102|NCT02030561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900103|NCT02031367|Triamcinolone|triamcinolone|mesh-list
64900104|NCT02031367|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64900111|NCT02031367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900112|NCT02031367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64900113|NCT02031367|Immunologic Factors|immunologic factors|mesh-ancestor
64900114|NCT02031367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900115|NCT02031367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900116|NCT02031692|Cholecalciferol|cholecalciferol|mesh-list
64900117|NCT02031692|Vitamin D|vitamin d|mesh-list
64900118|NCT02031692|Calcium Carbonate|calcium carbonate|mesh-list
64900119|NCT02031692|Calcium|calcium|mesh-list
64900120|NCT02031692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64900150|NCT02032134|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64900151|NCT02032134|Protective Agents|protective agents|mesh-ancestor
64668679|NCT02958969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900152|NCT02032134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900153|NCT02032134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64900154|NCT02032134|Antioxidants|antioxidants|mesh-ancestor
64900155|NCT02032134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900156|NCT02032186|Magnesium citrate|magnesium citrate|mesh-list
64900157|NCT02032186|Cathartics|cathartics|mesh-ancestor
64900158|NCT02032186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64900159|NCT02033356|Lidocaine|lidocaine|mesh-list
64900160|NCT02033356|Anesthetics, Local|anesthetics, local|mesh-ancestor
64900161|NCT02033356|Anesthetics|anesthetics|mesh-ancestor
64900162|NCT02033356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64523127|NCT02432664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64523128|NCT02432664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64523129|NCT02432664|Anesthetics, General|anesthetics, general|mesh-ancestor
64523131|NCT02432664|GABA Modulators|gaba modulators|mesh-ancestor
64523132|NCT02432664|GABA Agents|gaba agents|mesh-ancestor
64523133|NCT02432664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64523134|NCT02432664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523135|NCT03189186|Pembrolizumab|pembrolizumab|mesh-list
64523136|NCT03189186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64523137|NCT03189186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523138|NCT00361894|Enoxaparin|enoxaparin|mesh-list
64523139|NCT00361894|Rivaroxaban|rivaroxaban|mesh-list
64523140|NCT00361894|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64523141|NCT00361894|Antithrombins|antithrombins|mesh-ancestor
64523142|NCT00361894|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64523143|NCT00361894|Protease Inhibitors|protease inhibitors|mesh-ancestor
64523144|NCT00361894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523145|NCT00361894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523146|NCT00361894|Anticoagulants|anticoagulants|mesh-ancestor
64523147|NCT00361894|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64900163|NCT02033356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900193|NCT02034253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64900194|NCT02034253|Dopamine Agents|dopamine agents|mesh-ancestor
64900195|NCT02035020|Interferons|interferons|mesh-list
64900196|NCT02035020|Interferon-gamma|interferon-gamma|mesh-list
64900197|NCT02035020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900198|NCT02035020|Antiviral Agents|antiviral agents|mesh-ancestor
64900199|NCT02035020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64900200|NCT02035709|Hydromorphone|hydromorphone|mesh-list
64900201|NCT02035709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64900202|NCT02035709|Narcotics|narcotics|mesh-ancestor
64900203|NCT02035709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64900204|NCT02035709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900205|NCT02035709|Analgesics|analgesics|mesh-ancestor
64900206|NCT02035709|Sensory System Agents|sensory system agents|mesh-ancestor
64900236|NCT02038062|Anesthetics, General|anesthetics, general|mesh-ancestor
64900238|NCT02038062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64900239|NCT02038062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900240|NCT02039453|Fentanyl|fentanyl|mesh-list
64900241|NCT02039453|Meperidine|meperidine|mesh-list
64900242|NCT02039453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64900243|NCT02039453|Narcotics|narcotics|mesh-ancestor
64523149|NCT03185988|Trastuzumab|trastuzumab|mesh-list
64523150|NCT03185988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64523151|NCT03185988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523152|NCT04550494|Talazoparib|talazoparib|mesh-list
64523153|NCT04550494|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64900278|NCT02040142|Alkylating Agents|alkylating agents|mesh-ancestor
64900279|NCT02040142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900280|NCT02040142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64900281|NCT02040142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900282|NCT02040220|Aflibercept|aflibercept|mesh-list
64900283|NCT02040220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64900284|NCT02040220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64900285|NCT02040220|Growth Substances|growth substances|mesh-ancestor
64900286|NCT02040220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900287|NCT02040220|Growth Inhibitors|growth inhibitors|mesh-ancestor
64900288|NCT02040220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900289|NCT02040246|Metformin|metformin|mesh-list
64900290|NCT02040246|Repaglinide|repaglinide|mesh-list
64900291|NCT02040246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64900292|NCT02040246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900293|NCT02040285|Metoclopramide|metoclopramide|mesh-list
64900294|NCT02040285|Bisacodyl|bisacodyl|mesh-list
64603246|NCT00421551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64900295|NCT02040285|Antiemetics|antiemetics|mesh-ancestor
64900296|NCT02040285|Autonomic Agents|autonomic agents|mesh-ancestor
64900297|NCT02040285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64900298|NCT02040285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900299|NCT02040285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64900300|NCT02040285|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64900301|NCT02040285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64900302|NCT02040285|Dopamine Agents|dopamine agents|mesh-ancestor
64900303|NCT02040285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64668837|NCT03837860|Oxycodone|oxycodone|mesh-list
64900304|NCT02040285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900305|NCT02040285|Cathartics|cathartics|mesh-ancestor
64900338|NCT02040441|Hormone Antagonists|hormone antagonists|mesh-ancestor
64900339|NCT02040441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64900340|NCT02040441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900341|NCT02040441|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64900342|NCT02040441|Diuretics|diuretics|mesh-ancestor
64900343|NCT02040441|Natriuretic Agents|natriuretic agents|mesh-ancestor
64900344|NCT02040454|Paclitaxel|paclitaxel|mesh-list
64900345|NCT02040454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64900346|NCT02040454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900347|NCT02040454|Tubulin Modulators|tubulin modulators|mesh-ancestor
64900382|NCT02040649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64900383|NCT02040649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64900384|NCT02040649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900385|NCT02040649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64900386|NCT02040649|Anesthetics, General|anesthetics, general|mesh-ancestor
64900387|NCT02040649|Anesthetics|anesthetics|mesh-ancestor
64900388|NCT02040649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64648893|NCT00801398|Analgesics|analgesics|mesh-ancestor
64900467|NCT02040935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900468|NCT02040987|Moxifloxacin|moxifloxacin|mesh-list
64900469|NCT02040987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64523154|NCT04550494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523155|NCT04550494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523156|NCT04550494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523157|NCT00361348|Heparin|heparin|mesh-list
64523158|NCT00361348|Anticoagulants|anticoagulants|mesh-ancestor
64479258|NCT01849783|Alkylating Agents|alkylating agents|mesh-ancestor
64523159|NCT00361348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64523160|NCT00361348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64523161|NCT00361348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523162|NCT02431728|Melatonin|melatonin|mesh-list
64523163|NCT02431728|Antioxidants|antioxidants|mesh-ancestor
64523164|NCT02431728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523165|NCT02431728|Protective Agents|protective agents|mesh-ancestor
64523166|NCT02431728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523167|NCT02431728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64523168|NCT04343326|Menthol|menthol|mesh-list
64523169|NCT04343326|Antipruritics|antipruritics|mesh-ancestor
64523170|NCT04343326|Dermatologic Agents|dermatologic agents|mesh-ancestor
64523171|NCT00362206|Simvastatin|simvastatin|mesh-list
64523172|NCT00362206|Pravastatin|pravastatin|mesh-list
64523173|NCT00362206|Fenofibrate|fenofibrate|mesh-list
64523174|NCT00362206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64523175|NCT00362206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64523176|NCT00362206|Antimetabolites|antimetabolites|mesh-ancestor
64523177|NCT00362206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523178|NCT00362206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64523179|NCT00362206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64523180|NCT00362206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523182|NCT02314468|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64523183|NCT02314468|Protective Agents|protective agents|mesh-ancestor
64523184|NCT02314468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523185|NCT01704287|Paclitaxel|paclitaxel|mesh-list
64523186|NCT01704287|Carboplatin|carboplatin|mesh-list
64523187|NCT01704287|Pembrolizumab|pembrolizumab|mesh-list
64523188|NCT01704287|Temozolomide|temozolomide|mesh-list
64523189|NCT01704287|Dacarbazine|dacarbazine|mesh-list
64523194|NCT01704287|Mitosis Modulators|mitosis modulators|mesh-ancestor
64523195|NCT01704287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523196|NCT01704287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64523197|NCT01704287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64523198|NCT01704287|Alkylating Agents|alkylating agents|mesh-ancestor
64523199|NCT00362752|Norfloxacin|norfloxacin|mesh-list
64523200|NCT00362752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64523201|NCT00362752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64648907|NCT01342757|Temozolomide|temozolomide|mesh-list
64523211|NCT00118209|Rituximab|rituximab|mesh-list
64523212|NCT00118209|Doxorubicin|doxorubicin|mesh-list
64523213|NCT00118209|Etoposide|etoposide|mesh-list
64523214|NCT00118209|Vincristine|vincristine|mesh-list
64523215|NCT00118209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64523216|NCT00118209|Immunologic Factors|immunologic factors|mesh-ancestor
64523217|NCT00118209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523218|NCT00118209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64523219|NCT00118209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64523220|NCT00118209|Alkylating Agents|alkylating agents|mesh-ancestor
64523221|NCT00118209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523222|NCT00118209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523223|NCT00118209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64523224|NCT00118209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64523225|NCT00118209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64523226|NCT00118209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64523227|NCT00118209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64523228|NCT00118209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900470|NCT02040987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64900471|NCT02040987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64900472|NCT02040987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64523230|NCT00118209|Glucocorticoids|glucocorticoids|mesh-ancestor
64523231|NCT00118209|Hormones|hormones|mesh-ancestor
64523232|NCT00118209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64714098|NCT03054103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64523233|NCT00118209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64523234|NCT00118209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64523235|NCT00118209|Tubulin Modulators|tubulin modulators|mesh-ancestor
64523236|NCT00118209|Antimitotic Agents|antimitotic agents|mesh-ancestor
64523237|NCT00118209|Mitosis Modulators|mitosis modulators|mesh-ancestor
64523238|NCT01897779|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
64523239|NCT01897779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523240|NCT01897779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523241|NCT01897779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64523242|NCT01897779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64523243|NCT04342156|Hydroxychloroquine|hydroxychloroquine|mesh-list
64523244|NCT04342156|Antimalarials|antimalarials|mesh-ancestor
64523245|NCT04342156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64523246|NCT04342156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64523247|NCT04342156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64900473|NCT02040987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900495|NCT02041338|Carboplatin|carboplatin|mesh-list
64900496|NCT02041338|Epirubicin|epirubicin|mesh-list
64900497|NCT02041338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64900498|NCT02041338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900499|NCT02041338|Tubulin Modulators|tubulin modulators|mesh-ancestor
64900500|NCT02041338|Antimitotic Agents|antimitotic agents|mesh-ancestor
64900501|NCT02041338|Mitosis Modulators|mitosis modulators|mesh-ancestor
64900502|NCT02041338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900503|NCT02041338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64900504|NCT02041338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64900505|NCT02041338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64900506|NCT02041338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900507|NCT02041351|Docetaxel|docetaxel|mesh-list
64900508|NCT02041351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900509|NCT02041351|Tubulin Modulators|tubulin modulators|mesh-ancestor
64900510|NCT02041351|Antimitotic Agents|antimitotic agents|mesh-ancestor
64900511|NCT02041351|Mitosis Modulators|mitosis modulators|mesh-ancestor
64900516|NCT02041455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900517|NCT02041455|Protective Agents|protective agents|mesh-ancestor
64900518|NCT02041455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900519|NCT02041455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64900520|NCT02041455|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64900521|NCT02041455|Antidepressive Agents|antidepressive agents|mesh-ancestor
64900522|NCT02041455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64900523|NCT02041455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64900524|NCT02041455|Analgesics|analgesics|mesh-ancestor
64900525|NCT02041455|Sensory System Agents|sensory system agents|mesh-ancestor
64900555|NCT02041650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64523248|NCT04342156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523249|NCT04342156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523250|NCT04342156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64523251|NCT01682837|Potassium Citrate|potassium citrate|mesh-list
64523252|NCT01682837|Magnesium citrate|magnesium citrate|mesh-list
64523254|NCT01682837|Sodium Citrate|sodium citrate|mesh-list
64523255|NCT01682837|Anticoagulants|anticoagulants|mesh-ancestor
64523256|NCT01682837|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64523257|NCT01682837|Chelating Agents|chelating agents|mesh-ancestor
64523258|NCT01682837|Sequestering Agents|sequestering agents|mesh-ancestor
64523259|NCT01682837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523260|NCT01682837|Diuretics|diuretics|mesh-ancestor
64900556|NCT02041650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64900557|NCT02041650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64900558|NCT02041650|Purinergic Agents|purinergic agents|mesh-ancestor
64900559|NCT02041650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64900560|NCT02041650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900561|NCT02041650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900562|NCT02041767|Ertapenem|ertapenem|mesh-list
64900563|NCT02041767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64900564|NCT02041767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64900565|NCT02041819|Nimotuzumab|nimotuzumab|mesh-list
64900566|NCT02041819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64900567|NCT02041819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900568|NCT02042027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64900569|NCT02042027|Immunologic Factors|immunologic factors|mesh-ancestor
64900570|NCT02042027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900571|NCT02042170|Hormones|hormones|mesh-list
64586282|NCT00426283|Respiratory System Agents|respiratory system agents|mesh-ancestor
64900595|NCT02042495|Metformin|metformin|mesh-list
64900596|NCT02042495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64900597|NCT02042495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900598|NCT02042573|Sertraline|sertraline|mesh-list
64900599|NCT02042573|Antidepressive Agents|antidepressive agents|mesh-ancestor
64900600|NCT02042573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64900601|NCT02042573|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64900602|NCT02042573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64900603|NCT02042573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64900604|NCT02042573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900605|NCT02042573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64900606|NCT02042573|Serotonin Agents|serotonin agents|mesh-ancestor
64900607|NCT02042573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669130|NCT02978157|Ofloxacin|ofloxacin|mesh-list
64900608|NCT02042599|Sevoflurane|sevoflurane|mesh-list
64900609|NCT02042599|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64900610|NCT02042599|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64900611|NCT02042599|Anesthetics, General|anesthetics, general|mesh-ancestor
64900612|NCT02042599|Anesthetics|anesthetics|mesh-ancestor
64900613|NCT02042599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64900614|NCT02042599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900615|NCT02042612|Sevoflurane|sevoflurane|mesh-list
64900616|NCT02042612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64900617|NCT02042612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64900618|NCT02042612|Anesthetics, General|anesthetics, general|mesh-ancestor
64900619|NCT02042612|Anesthetics|anesthetics|mesh-ancestor
64900620|NCT02042612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64900646|NCT02042690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64900647|NCT02042690|Glucocorticoids|glucocorticoids|mesh-ancestor
64900648|NCT02042690|Hormones|hormones|mesh-ancestor
64523261|NCT01682837|Natriuretic Agents|natriuretic agents|mesh-ancestor
64523262|NCT01682837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523263|NCT01682837|Expectorants|expectorants|mesh-ancestor
64523264|NCT01682837|Respiratory System Agents|respiratory system agents|mesh-ancestor
64523265|NCT01682837|Cathartics|cathartics|mesh-ancestor
64523266|NCT01682837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64523267|NCT02213068|Mycophenolic Acid|mycophenolic acid|mesh-list
64523270|NCT02213068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64523271|NCT02213068|Immunologic Factors|immunologic factors|mesh-ancestor
64523272|NCT02213068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523273|NCT02213068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64523274|NCT02213068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523275|NCT02213068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523276|NCT02213068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64523277|NCT02213068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523278|NCT02213068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64523279|NCT02213068|Antitubercular Agents|antitubercular agents|mesh-ancestor
64603472|NCT02369835|Eusol|eusol|mesh-list
64523280|NCT02213068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64523281|NCT02213068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64523282|NCT02213068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64523283|NCT02213068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64523284|NCT00702234|Progesterone|progesterone|mesh-list
64523285|NCT00702234|Progestins|progestins|mesh-ancestor
64523286|NCT00702234|Hormones|hormones|mesh-ancestor
64900649|NCT02042690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64900650|NCT02042690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64900651|NCT02042690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900652|NCT02042690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64900653|NCT02042690|Abortifacient Agents|abortifacient agents|mesh-ancestor
64900654|NCT02042690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64900655|NCT02042690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64900656|NCT02042690|Antimetabolites|antimetabolites|mesh-ancestor
64900657|NCT02042690|Dermatologic Agents|dermatologic agents|mesh-ancestor
64900658|NCT02042690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64900659|NCT02042690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64900660|NCT02042690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64900661|NCT02042690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64900662|NCT02042690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64900663|NCT02042742|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
64900664|NCT02042742|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
64900665|NCT02042742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64900666|NCT02042742|Antioxidants|antioxidants|mesh-ancestor
64900667|NCT02042742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900668|NCT02042742|Protective Agents|protective agents|mesh-ancestor
64900669|NCT02042742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900670|NCT02042742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64900671|NCT02042742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64900672|NCT02042742|Disinfectants|disinfectants|mesh-ancestor
64523287|NCT00702234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64523288|NCT00702234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523289|NCT04483284|Chlorotrianisene|chlorotrianisene|mesh-list
64523290|NCT04483284|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64523291|NCT04483284|Estrogens|estrogens|mesh-ancestor
64900673|NCT02043002|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64900674|NCT02043002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64900675|NCT02043002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900676|NCT02043054|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64900699|NCT02043223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900700|NCT02043223|Antioxidants|antioxidants|mesh-ancestor
64900701|NCT02043223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900702|NCT02043223|Protective Agents|protective agents|mesh-ancestor
64900703|NCT02043223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64900704|NCT02043223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900714|NCT02043288|Immunologic Factors|immunologic factors|mesh-ancestor
64900715|NCT02043288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900716|NCT02043314|Isoniazid|isoniazid|mesh-list
64900717|NCT02043314|Antitubercular Agents|antitubercular agents|mesh-ancestor
64900718|NCT02043314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64900719|NCT02043314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64900720|NCT02043314|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64900721|NCT02043314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64900722|NCT02043314|Antimetabolites|antimetabolites|mesh-ancestor
64900723|NCT02043314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900724|NCT02043314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64900725|NCT02043340|Photosensitizing Agents|photosensitizing agents|mesh-list
64900726|NCT02043340|Dermatologic Agents|dermatologic agents|mesh-ancestor
64900727|NCT02043665|Pembrolizumab|pembrolizumab|mesh-list
64586283|NCT00426283|Dermatologic Agents|dermatologic agents|mesh-ancestor
64900757|NCT02043756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64669280|NCT03149991|Ketamine|ketamine|mesh-list
64900758|NCT02043756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64900759|NCT02043756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900760|NCT02043756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900761|NCT02043821|Capecitabine|capecitabine|mesh-list
64900762|NCT02043821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64900763|NCT02043821|Antimetabolites|antimetabolites|mesh-ancestor
64900764|NCT02043821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900765|NCT02043821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900766|NCT02043886|Acarbose|acarbose|mesh-list
64900767|NCT02043886|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64900768|NCT02043886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900769|NCT02043886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900770|NCT02043886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64900771|NCT02043886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900772|NCT02043912|Haloperidol|haloperidol|mesh-list
64900799|NCT02044120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64900801|NCT02044120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900802|NCT02044120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900803|NCT02044120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64900804|NCT02044120|Alkylating Agents|alkylating agents|mesh-ancestor
64900805|NCT02044120|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64900806|NCT02044133|Vitamin D|vitamin d|mesh-list
64900807|NCT02044133|Vitamins|vitamins|mesh-ancestor
64900808|NCT02044133|Micronutrients|micronutrients|mesh-ancestor
64900809|NCT02044133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900810|NCT02044133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64900811|NCT02044146|Clopidogrel|clopidogrel|mesh-list
64900812|NCT02044146|Ticagrelor|ticagrelor|mesh-list
64523292|NCT04483284|Hormones|hormones|mesh-ancestor
64523293|NCT04483284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64523294|NCT04483284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523295|NCT04483284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64523296|NCT04483284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900813|NCT02044146|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64900814|NCT02044146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64900815|NCT02044146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64900816|NCT02044146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64900817|NCT02044146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64900818|NCT02044146|Purinergic Agents|purinergic agents|mesh-ancestor
64900856|NCT02044250|Purinergic Agents|purinergic agents|mesh-ancestor
64900857|NCT02044250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64900858|NCT02044354|Docetaxel|docetaxel|mesh-list
64900859|NCT02044354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900860|NCT02044354|Tubulin Modulators|tubulin modulators|mesh-ancestor
64900897|NCT02044952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64900898|NCT02044952|Analgesics|analgesics|mesh-ancestor
64900928|NCT02044965|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64900929|NCT02044965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64900931|NCT02044978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64900932|NCT02044978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900933|NCT02045017|Dexamethasone|dexamethasone|mesh-list
64900934|NCT02045017|Pomalidomide|pomalidomide|mesh-list
64900935|NCT02045017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64900936|NCT02045017|Antiemetics|antiemetics|mesh-ancestor
64900937|NCT02045017|Autonomic Agents|autonomic agents|mesh-ancestor
64900938|NCT02045017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64900939|NCT02045017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900940|NCT02045017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64900941|NCT02045017|Glucocorticoids|glucocorticoids|mesh-ancestor
64900967|NCT02045069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64900968|NCT02045069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64900969|NCT02045290|Metformin|metformin|mesh-list
64900970|NCT02045290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64900971|NCT02045290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900972|NCT02045368|Methotrexate|methotrexate|mesh-list
64900973|NCT02045368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64900974|NCT02045368|Abortifacient Agents|abortifacient agents|mesh-ancestor
64900975|NCT02045368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64900976|NCT02045368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900977|NCT02045368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64900978|NCT02045368|Antimetabolites|antimetabolites|mesh-ancestor
64900979|NCT02045368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900980|NCT02045368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669501|NCT05737199|Pembrolizumab|pembrolizumab|mesh-list
64900982|NCT02045368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900983|NCT02045368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64900984|NCT02045368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64900985|NCT02045368|Immunologic Factors|immunologic factors|mesh-ancestor
64900986|NCT02045368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64900987|NCT02045368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64900988|NCT02045589|Gemcitabine|gemcitabine|mesh-list
64900989|NCT02045589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64900990|NCT02045589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64901010|NCT02045602|Immunologic Factors|immunologic factors|mesh-ancestor
64901011|NCT02045602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901012|NCT02045667|Mexiletine|mexiletine|mesh-list
64901013|NCT02045667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64901014|NCT02045667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64901015|NCT02045667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64901016|NCT02045667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64523297|NCT00235833|Adalimumab|adalimumab|mesh-list
64523298|NCT00235833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64523299|NCT00235833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64523300|NCT00255801|Doxorubicin|doxorubicin|mesh-list
64523301|NCT00255801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64523302|NCT00255801|Bexarotene|bexarotene|mesh-list
64523303|NCT00255801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64901017|NCT02045667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901018|NCT02045693|Buprenorphine|buprenorphine|mesh-list
64901019|NCT02045693|Methadone|methadone|mesh-list
64901020|NCT02045693|Naloxone|naloxone|mesh-list
64901021|NCT02045693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64901022|NCT02045693|Narcotics|narcotics|mesh-ancestor
64901023|NCT02045693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64901026|NCT02045693|Sensory System Agents|sensory system agents|mesh-ancestor
64901027|NCT02045693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64901028|NCT02045693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64901029|NCT02045693|Antitussive Agents|antitussive agents|mesh-ancestor
64901030|NCT02045693|Respiratory System Agents|respiratory system agents|mesh-ancestor
64901031|NCT02045810|Levobupivacaine|levobupivacaine|mesh-list
64901032|NCT02045810|Anesthetics, Local|anesthetics, local|mesh-ancestor
64901033|NCT02045810|Anesthetics|anesthetics|mesh-ancestor
64901034|NCT02045810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64901035|NCT02045810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901036|NCT02045810|Sensory System Agents|sensory system agents|mesh-ancestor
64901037|NCT02045810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64901038|NCT02045849|Itraconazole|itraconazole|mesh-list
64901039|NCT02045849|Antifungal Agents|antifungal agents|mesh-ancestor
64901040|NCT02045849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64901041|NCT02045849|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64901042|NCT02045849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64901043|NCT02045849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901044|NCT02045849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901045|NCT02045849|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64901068|NCT02045953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64901069|NCT02045953|Respiratory System Agents|respiratory system agents|mesh-ancestor
64901070|NCT02045953|Tocolytic Agents|tocolytic agents|mesh-ancestor
64901071|NCT02045953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64901072|NCT02045953|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64901073|NCT02045953|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64901074|NCT02045953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64901075|NCT02045953|Adrenergic Agents|adrenergic agents|mesh-ancestor
64901076|NCT02045953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64901077|NCT02045953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901078|NCT02045992|Caffeine|caffeine|mesh-list
64901079|NCT02045992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64901080|NCT02045992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901081|NCT02045992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64901082|NCT02045992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901083|NCT02045992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901084|NCT02045992|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64901085|NCT02045992|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64901086|NCT02045992|Purinergic Agents|purinergic agents|mesh-ancestor
64901087|NCT02045992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64901088|NCT02046044|Digoxin|digoxin|mesh-list
64901089|NCT02046044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64901090|NCT02046044|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64901091|NCT02046044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901092|NCT02046044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901093|NCT02046044|Protective Agents|protective agents|mesh-ancestor
64901094|NCT02046044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901095|NCT02046109|Chlorhexidine|chlorhexidine|mesh-list
64901096|NCT02046109|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64901121|NCT02046421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901122|NCT02046421|Antiviral Agents|antiviral agents|mesh-ancestor
64523304|NCT00255801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523305|NCT00255801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64523306|NCT00255801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64523307|NCT00255801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523308|NCT00255801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523309|NCT02431416|Hormones|hormones|mesh-list
64479423|NCT04699240|Miconazole|miconazole|mesh-list
64523310|NCT02431416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64523311|NCT02431416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523312|NCT04751955|Capecitabine|capecitabine|mesh-list
64523313|NCT04751955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64523314|NCT04751955|Antimetabolites|antimetabolites|mesh-ancestor
64523315|NCT04751955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523316|NCT04751955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523317|NCT01682759|Metformin|metformin|mesh-list
64523318|NCT01682759|Insulin Glargine|insulin glargine|mesh-list
64523319|NCT01682759|Glimepiride|glimepiride|mesh-list
64523320|NCT01682759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64523327|NCT01682681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64523328|NCT01682681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523329|NCT01682603|Botulinum Toxins|botulinum toxins|mesh-list
64523330|NCT01682603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64523331|NCT01682603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64523332|NCT01682603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64523333|NCT01682603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64523334|NCT01682603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523335|NCT01682603|Cholinergic Agents|cholinergic agents|mesh-ancestor
64901123|NCT02046421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64901124|NCT02046421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901125|NCT02046421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64901126|NCT02046421|Immunologic Factors|immunologic factors|mesh-ancestor
64901127|NCT02046421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901128|NCT02046421|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64523336|NCT01682603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64523337|NCT01682603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523338|NCT01682603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64523339|NCT01682603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64523340|NCT03183024|Benralizumab|benralizumab|mesh-list
64523341|NCT03183024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64523342|NCT03183024|Respiratory System Agents|respiratory system agents|mesh-ancestor
64523343|NCT00240981|Testosterone|testosterone|mesh-list
64523344|NCT00240981|Androgens|androgens|mesh-ancestor
64523345|NCT00240981|Hormones|hormones|mesh-ancestor
64523346|NCT00240981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64523347|NCT00240981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523348|NCT01682213|Dabrafenib|dabrafenib|mesh-list
64836066|NCT01610934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64836067|NCT01610934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64836069|NCT01610947|Adalimumab|adalimumab|mesh-list
64836070|NCT01610947|Etanercept|etanercept|mesh-list
64836071|NCT01610947|Golimumab|golimumab|mesh-list
64836072|NCT01610947|Infliximab|infliximab|mesh-list
64836073|NCT01610947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64836074|NCT01610947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64836075|NCT01610947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64836076|NCT01610947|Dermatologic Agents|dermatologic agents|mesh-ancestor
64836077|NCT01610947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64836078|NCT01610947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64836079|NCT01610947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64836080|NCT01610947|Analgesics|analgesics|mesh-ancestor
64523349|NCT01682213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523350|NCT01682213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64523351|NCT01682213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523352|NCT01682213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523353|NCT04134923|Corticosterone|corticosterone|mesh-list
64523354|NCT04134923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64523355|NCT02126553|Lenalidomide|lenalidomide|mesh-list
64523356|NCT02126553|Immunologic Factors|immunologic factors|mesh-ancestor
64523357|NCT02126553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523358|NCT02126553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64523359|NCT02126553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64523360|NCT02126553|Growth Substances|growth substances|mesh-ancestor
64901129|NCT02046421|Abortifacient Agents|abortifacient agents|mesh-ancestor
64901130|NCT02046421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64901131|NCT02046421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64901132|NCT02046421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64901133|NCT02046421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64901134|NCT02046421|Contraceptive Agents|contraceptive agents|mesh-ancestor
64901135|NCT02046421|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64901136|NCT02046421|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64901137|NCT02046421|Hormone Antagonists|hormone antagonists|mesh-ancestor
64901138|NCT02046421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64901139|NCT02046421|Luteolytic Agents|luteolytic agents|mesh-ancestor
64901140|NCT02046421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64901141|NCT02046421|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64901142|NCT02046447|Trihexyphenidyl|trihexyphenidyl|mesh-list
64901143|NCT02046447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64901144|NCT02046447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64901145|NCT02046447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64901146|NCT02046447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64901174|NCT02046460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64901176|NCT02046460|Coagulants|coagulants|mesh-ancestor
64901177|NCT02046486|Ticagrelor|ticagrelor|mesh-list
64901178|NCT02046486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64648946|NCT00776594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64523368|NCT02425176|Botulinum Toxins|botulinum toxins|mesh-list
64523369|NCT02425176|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64523370|NCT02425176|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64523371|NCT02425176|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64523372|NCT02425176|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64523373|NCT02425176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64523374|NCT02425176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523375|NCT02425176|Cholinergic Agents|cholinergic agents|mesh-ancestor
64901180|NCT02046486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64901181|NCT02046486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64901182|NCT02046486|Purinergic Agents|purinergic agents|mesh-ancestor
64901183|NCT02046486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64901184|NCT02046486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901185|NCT02046486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901186|NCT02046499|Oxytocin|oxytocin|mesh-list
64901187|NCT02046499|Ergonovine|ergonovine|mesh-list
64901188|NCT02046499|Syntometrine|syntometrine|mesh-list
64901189|NCT02046499|Oxytocics|oxytocics|mesh-ancestor
64901190|NCT02046499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64901191|NCT02046499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901192|NCT02046538|Leucovorin|leucovorin|mesh-list
64901193|NCT02046538|Fluorouracil|fluorouracil|mesh-list
64901194|NCT02046538|Oxaliplatin|oxaliplatin|mesh-list
64901195|NCT02046538|Irinotecan|irinotecan|mesh-list
64901196|NCT02046538|Antimetabolites|antimetabolites|mesh-ancestor
64901228|NCT02046629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64901229|NCT02046629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64901231|NCT02046629|Sensory System Agents|sensory system agents|mesh-ancestor
64901232|NCT02046629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64901233|NCT02046629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901234|NCT02046629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64901235|NCT02046629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64901236|NCT02046629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64901237|NCT02046629|Immunologic Factors|immunologic factors|mesh-ancestor
64901238|NCT02046629|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64901264|NCT02046785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64901266|NCT02046850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64901267|NCT02046850|Antitubercular Agents|antitubercular agents|mesh-ancestor
64901268|NCT02046850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64901269|NCT02046850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64901270|NCT02046850|Leprostatic Agents|leprostatic agents|mesh-ancestor
64901271|NCT02046850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64901272|NCT02046850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901273|NCT02046850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901274|NCT02046850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64901275|NCT02046850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64901276|NCT02046850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64901277|NCT02046850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64901278|NCT02046850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64901279|NCT02046850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64901280|NCT02046915|Dexamethasone|dexamethasone|mesh-list
64901281|NCT02046915|Cyclophosphamide|cyclophosphamide|mesh-list
64523376|NCT02425176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64523377|NCT02425176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523378|NCT02425176|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64523379|NCT02425176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64523380|NCT02430714|Lenvatinib|lenvatinib|mesh-list
64523381|NCT02430714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523382|NCT02430714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64648951|NCT00776594|Hormones|hormones|mesh-ancestor
64586284|NCT00426283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64901316|NCT02047019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64901317|NCT02047019|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64901318|NCT02047019|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64901319|NCT02047019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901320|NCT02047019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64901321|NCT02047019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64901322|NCT02047019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64901323|NCT02047019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901324|NCT02047019|Vasodilator Agents|vasodilator agents|mesh-ancestor
64901325|NCT02047019|Tocolytic Agents|tocolytic agents|mesh-ancestor
64901326|NCT02047019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64901353|NCT02047149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64901355|NCT02047162|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
64901356|NCT02047162|Antacids|antacids|mesh-ancestor
64901357|NCT02047162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901358|NCT02047162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64901359|NCT02047162|Antidiarrheals|antidiarrheals|mesh-ancestor
64901361|NCT02047175|Amlodipine|amlodipine|mesh-list
64901362|NCT02047175|Telmisartan|telmisartan|mesh-list
64901363|NCT02047175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64901364|NCT02047175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64901365|NCT02047175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64901366|NCT02047175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64901367|NCT02047175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901368|NCT02047175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64901369|NCT02047175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901370|NCT02047175|Vasodilator Agents|vasodilator agents|mesh-ancestor
64901371|NCT02047175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64901372|NCT02047175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64901373|NCT02047175|Antimetabolites|antimetabolites|mesh-ancestor
64901374|NCT02047175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64901396|NCT02047292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901397|NCT02047292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901398|NCT02047292|Cholinergic Agents|cholinergic agents|mesh-ancestor
64901399|NCT02047292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64901400|NCT02047292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901401|NCT02047292|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64901402|NCT02047292|Autonomic Agents|autonomic agents|mesh-ancestor
64901403|NCT02047292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64901404|NCT02047292|Nootropic Agents|nootropic agents|mesh-ancestor
64901406|NCT00005823|Etoposide|etoposide|mesh-list
64901407|NCT00005823|Daunorubicin|daunorubicin|mesh-list
64901408|NCT00005823|Mitoxantrone|mitoxantrone|mesh-list
64901409|NCT00005823|Idarubicin|idarubicin|mesh-list
64901410|NCT00005823|Hydroxyurea|hydroxyurea|mesh-list
64523388|NCT02425254|Sensory System Agents|sensory system agents|mesh-ancestor
64523389|NCT02425254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64523390|NCT02425254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523392|NCT02426736|Dexamethasone|dexamethasone|mesh-list
64523393|NCT02426736|Bupivacaine|bupivacaine|mesh-list
64523394|NCT02426736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64523395|NCT02426736|Antiemetics|antiemetics|mesh-ancestor
64523396|NCT02426736|Autonomic Agents|autonomic agents|mesh-ancestor
64523397|NCT02426736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64523398|NCT02426736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523399|NCT02426736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64523400|NCT02426736|Glucocorticoids|glucocorticoids|mesh-ancestor
64523402|NCT02426736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64901415|NCT00005823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64901416|NCT00005823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64901417|NCT00005823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901418|NCT00005823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901419|NCT00005823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64901420|NCT00005823|Antimetabolites|antimetabolites|mesh-ancestor
64901421|NCT00005823|Antiviral Agents|antiviral agents|mesh-ancestor
64901422|NCT00005823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64901423|NCT00005823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64901424|NCT00005823|Immunologic Factors|immunologic factors|mesh-ancestor
64901425|NCT00005823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901426|NCT00005823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64901427|NCT00005823|Analgesics|analgesics|mesh-ancestor
64901428|NCT00005823|Sensory System Agents|sensory system agents|mesh-ancestor
64901451|NCT00005832|Tipifarnib|tipifarnib|mesh-list
64901452|NCT00005832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901453|NCT00005838|Paclitaxel|paclitaxel|mesh-list
64901454|NCT00005838|Vinorelbine|vinorelbine|mesh-list
64901455|NCT00005838|Carboplatin|carboplatin|mesh-list
64901456|NCT00005838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64901457|NCT00005838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901458|NCT00005838|Tubulin Modulators|tubulin modulators|mesh-ancestor
64901459|NCT00005838|Antimitotic Agents|antimitotic agents|mesh-ancestor
64901460|NCT00005838|Mitosis Modulators|mitosis modulators|mesh-ancestor
64901461|NCT00005838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901462|NCT00005841|Freund's Adjuvant|freund's adjuvant|mesh-list
64901463|NCT00005841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64901464|NCT00005841|Immunologic Factors|immunologic factors|mesh-ancestor
64901465|NCT00005841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901466|NCT00005844|Oxaliplatin|oxaliplatin|mesh-list
64901467|NCT00005844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901468|NCT00005847|Interferons|interferons|mesh-list
64901469|NCT00005847|Interferon-alpha|interferon-alpha|mesh-list
64901470|NCT00005847|Paclitaxel|paclitaxel|mesh-list
64901471|NCT00005847|Vinorelbine|vinorelbine|mesh-list
64523405|NCT02426736|Anesthetics, Local|anesthetics, local|mesh-ancestor
64523406|NCT02426736|Anesthetics|anesthetics|mesh-ancestor
64523407|NCT02426736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64523408|NCT02426736|Sensory System Agents|sensory system agents|mesh-ancestor
64523409|NCT03182634|Olaparib|olaparib|mesh-list
64523410|NCT03182634|Fulvestrant|fulvestrant|mesh-list
64523411|NCT03182634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64523412|NCT03182634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523413|NCT03182634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523414|NCT03182634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523415|NCT03182634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64603948|NCT04876131|Penicillin G|penicillin g|mesh-list
64523416|NCT03182634|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64523417|NCT03182634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64523418|NCT03182634|Hormone Antagonists|hormone antagonists|mesh-ancestor
64523419|NCT03182634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64523420|NCT03182634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523421|NCT03182322|Insulin|insulin|mesh-list
64523422|NCT03182322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64523423|NCT03182322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901472|NCT00005847|Mitoxantrone|mitoxantrone|mesh-list
64901473|NCT00005847|Estramustine|estramustine|mesh-list
64901474|NCT00005847|Isotretinoin|isotretinoin|mesh-list
64901475|NCT00005847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64901476|NCT00005847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901477|NCT00005847|Tubulin Modulators|tubulin modulators|mesh-ancestor
64901478|NCT00005847|Antimitotic Agents|antimitotic agents|mesh-ancestor
64901479|NCT00005847|Mitosis Modulators|mitosis modulators|mesh-ancestor
64901480|NCT00005847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901481|NCT00005847|Antiviral Agents|antiviral agents|mesh-ancestor
64901482|NCT00005847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64901483|NCT00005847|Immunologic Factors|immunologic factors|mesh-ancestor
64648963|NCT02193347|Alkylating Agents|alkylating agents|mesh-ancestor
64901521|NCT00005853|Analgesics|analgesics|mesh-ancestor
64901522|NCT00005853|Sensory System Agents|sensory system agents|mesh-ancestor
64901523|NCT00005853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64901550|NCT00005865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901551|NCT00005868|Docetaxel|docetaxel|mesh-list
64901552|NCT00005868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901553|NCT00005868|Tubulin Modulators|tubulin modulators|mesh-ancestor
64901554|NCT00005868|Antimitotic Agents|antimitotic agents|mesh-ancestor
64901555|NCT00005868|Mitosis Modulators|mitosis modulators|mesh-ancestor
64901556|NCT00005868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901557|NCT00005871|Fluorouracil|fluorouracil|mesh-list
64901558|NCT00005871|Rubitecan|rubitecan|mesh-list
64901559|NCT00005871|Antimetabolites|antimetabolites|mesh-ancestor
64901560|NCT00005871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901561|NCT00005871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64901562|NCT00005871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523424|NCT03185364|Sildenafil Citrate|sildenafil citrate|mesh-list
64523425|NCT03185364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523426|NCT03185364|Vasodilator Agents|vasodilator agents|mesh-ancestor
64523427|NCT03185364|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64523428|NCT03185364|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64523429|NCT03185364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523430|NCT03185364|Urological Agents|urological agents|mesh-ancestor
64523431|NCT02424552|Vitamin D|vitamin d|mesh-list
64523432|NCT02424552|Cholecalciferol|cholecalciferol|mesh-list
64523433|NCT02424552|Vitamins|vitamins|mesh-ancestor
64523434|NCT02424552|Micronutrients|micronutrients|mesh-ancestor
64523435|NCT02424552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523436|NCT02424552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64523437|NCT02424552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64523438|NCT03182088|Norepinephrine|norepinephrine|mesh-list
64523439|NCT03182088|Bupivacaine|bupivacaine|mesh-list
64523440|NCT03182088|Anesthetics, Local|anesthetics, local|mesh-ancestor
64523441|NCT03182088|Anesthetics|anesthetics|mesh-ancestor
64523442|NCT03182088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64523443|NCT03182088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523444|NCT03182088|Sensory System Agents|sensory system agents|mesh-ancestor
64523445|NCT03182088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64523446|NCT03182088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64523447|NCT03182088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64523448|NCT03182088|Adrenergic Agents|adrenergic agents|mesh-ancestor
64523449|NCT03182088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64523450|NCT03182088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523451|NCT03182088|Sympathomimetics|sympathomimetics|mesh-ancestor
64523452|NCT03182088|Autonomic Agents|autonomic agents|mesh-ancestor
64523453|NCT03182088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64901563|NCT00005871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64836087|NCT01610999|Plerixafor|plerixafor|mesh-list
64836088|NCT01610999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64901564|NCT00005871|Immunologic Factors|immunologic factors|mesh-ancestor
64901565|NCT00005871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901566|NCT00005871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64901567|NCT00005871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64901568|NCT00005871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901569|NCT00005874|Rubitecan|rubitecan|mesh-list
64901570|NCT00005874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901571|NCT00005874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64901572|NCT00005874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64901591|NCT00005880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64901592|NCT00005883|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
64901594|NCT00005883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523454|NCT02425878|Ulipristal acetate|ulipristal acetate|mesh-list
64523455|NCT02425878|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64523456|NCT02425878|Contraceptive Agents|contraceptive agents|mesh-ancestor
64523457|NCT02425878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64648968|NCT01318967|Diuretics|diuretics|mesh-ancestor
64523461|NCT02425722|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64523462|NCT02425722|Enzyme Activators|enzyme activators|mesh-ancestor
64523463|NCT02425722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523464|NCT02425722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64523465|NCT03609580|Tamsulosin|tamsulosin|mesh-list
64523466|NCT03609580|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64523467|NCT03609580|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64523468|NCT03609580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64523469|NCT03609580|Adrenergic Agents|adrenergic agents|mesh-ancestor
64523470|NCT03609580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64523471|NCT03609580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523472|NCT03609580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523473|NCT03609580|Urological Agents|urological agents|mesh-ancestor
64523474|NCT02061514|Propofol|propofol|mesh-list
64523475|NCT02061514|Desflurane|desflurane|mesh-list
64523476|NCT02061514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64523477|NCT02061514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64523478|NCT02061514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523479|NCT02061514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64523480|NCT02061514|Anesthetics, General|anesthetics, general|mesh-ancestor
64523502|NCT01681433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523503|NCT01681433|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64523504|NCT01681433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523505|NCT01681433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523506|NCT01681433|Hormone Antagonists|hormone antagonists|mesh-ancestor
64523507|NCT01681433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64523508|NCT01703117|Riluzole|riluzole|mesh-list
64523509|NCT01703117|Anticonvulsants|anticonvulsants|mesh-ancestor
64523510|NCT01703117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64523511|NCT01703117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64523512|NCT01703117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64523513|NCT01703117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523514|NCT01703117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523515|NCT01703117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64901595|NCT00005883|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64901596|NCT00005883|Protective Agents|protective agents|mesh-ancestor
64901597|NCT00005883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901598|NCT00005883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901599|NCT00005886|Tamoxifen|tamoxifen|mesh-list
64901600|NCT00005886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64901601|NCT00005886|Hormone Antagonists|hormone antagonists|mesh-ancestor
64901602|NCT00005886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64901603|NCT00005886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901604|NCT00005886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64901605|NCT00005886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901606|NCT00005886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64836089|NCT01610999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64901607|NCT00005886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64901608|NCT00005886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64901609|NCT00005889|Glucagon|glucagon|mesh-list
64901610|NCT00005889|Glycerol|glycerol|mesh-list
64901611|NCT00005889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901612|NCT00005889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64901613|NCT00005889|Hormones|hormones|mesh-ancestor
64901614|NCT00005889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64901615|NCT00005889|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64901616|NCT00005889|Protective Agents|protective agents|mesh-ancestor
64901617|NCT00005892|Cyclophosphamide|cyclophosphamide|mesh-list
64901618|NCT00005892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64901619|NCT00005892|Immunologic Factors|immunologic factors|mesh-ancestor
64901620|NCT00005892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901621|NCT00005892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64901622|NCT00005892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64901623|NCT00005892|Alkylating Agents|alkylating agents|mesh-ancestor
64901624|NCT00005892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901625|NCT00005892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901650|NCT00005898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64523526|NCT01702961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523527|NCT01702961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523528|NCT01702961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64523529|NCT01702961|Antimetabolites|antimetabolites|mesh-ancestor
64523530|NCT01702961|Antiviral Agents|antiviral agents|mesh-ancestor
64523531|NCT01702961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64901659|NCT00386412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64901660|NCT00386529|Aspirin|aspirin|mesh-list
64901661|NCT00386529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64901662|NCT00386529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64901663|NCT00386529|Analgesics|analgesics|mesh-ancestor
64901664|NCT00386529|Sensory System Agents|sensory system agents|mesh-ancestor
64901665|NCT00386529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64901666|NCT00386529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901667|NCT00386529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64901668|NCT00386529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64901669|NCT00386529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64901670|NCT00386529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64901671|NCT00386529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901672|NCT00386529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64901673|NCT00386529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64901674|NCT00386529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901675|NCT00386529|Antipyretics|antipyretics|mesh-ancestor
64901676|NCT00005922|Triamcinolone|triamcinolone|mesh-list
64901703|NCT00005931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64901704|NCT00005931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64901705|NCT00005931|Growth Substances|growth substances|mesh-ancestor
64901706|NCT00005931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901707|NCT00005931|Growth Inhibitors|growth inhibitors|mesh-ancestor
64901708|NCT00005931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901709|NCT00005931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64901710|NCT00005931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901711|NCT00005931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901713|NCT00005934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64901714|NCT00005934|Antimetabolites|antimetabolites|mesh-ancestor
64901715|NCT00005934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901716|NCT00005934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901717|NCT00005934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901718|NCT00005940|Iodine|iodine|mesh-list
64901719|NCT00005940|Cyclosporine|cyclosporine|mesh-list
64901720|NCT00005940|Cyclophosphamide|cyclophosphamide|mesh-list
64901721|NCT00005940|Busulfan|busulfan|mesh-list
64901722|NCT00005940|Methotrexate|methotrexate|mesh-list
64523536|NCT01702961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64523537|NCT01702961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64523538|NCT01702961|Alkylating Agents|alkylating agents|mesh-ancestor
64523539|NCT01702961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64523540|NCT01702025|Aminophylline|aminophylline|mesh-list
64523541|NCT01702025|Methazolamide|methazolamide|mesh-list
64523542|NCT01702025|Theophylline|theophylline|mesh-list
64523543|NCT01702025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64523544|NCT01702025|Autonomic Agents|autonomic agents|mesh-ancestor
64523545|NCT01702025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64523546|NCT01702025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523547|NCT01702025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64523548|NCT01702025|Respiratory System Agents|respiratory system agents|mesh-ancestor
64523549|NCT01702025|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64523551|NCT01702025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523552|NCT01702025|Vasodilator Agents|vasodilator agents|mesh-ancestor
64523553|NCT01702025|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64901762|NCT00005946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901763|NCT00005946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64901764|NCT00005946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64901765|NCT00005946|Alkylating Agents|alkylating agents|mesh-ancestor
64901766|NCT00005946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901767|NCT00005946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901768|NCT00005946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64901798|NCT00005958|Antimetabolites|antimetabolites|mesh-ancestor
64901799|NCT00005958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901800|NCT00005958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901801|NCT00005958|Antiviral Agents|antiviral agents|mesh-ancestor
64670334|NCT01682642|Goserelin|goserelin|mesh-list
64901802|NCT00005958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64901803|NCT00005958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901804|NCT00005958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64901805|NCT00005958|Immunologic Factors|immunologic factors|mesh-ancestor
64901806|NCT00005958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901807|NCT00005958|Tubulin Modulators|tubulin modulators|mesh-ancestor
64901808|NCT00005958|Antimitotic Agents|antimitotic agents|mesh-ancestor
64901809|NCT00005958|Mitosis Modulators|mitosis modulators|mesh-ancestor
64901810|NCT00005961|Carmustine|carmustine|mesh-list
64901811|NCT00005961|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64901812|NCT00005961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64901813|NCT00005961|Alkylating Agents|alkylating agents|mesh-ancestor
64901837|NCT00005964|Glucocorticoids|glucocorticoids|mesh-ancestor
64901838|NCT00005964|Hormones|hormones|mesh-ancestor
64901839|NCT00005964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64901840|NCT00005964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64901841|NCT00005964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64901842|NCT00005964|Tubulin Modulators|tubulin modulators|mesh-ancestor
64901843|NCT00005964|Antimitotic Agents|antimitotic agents|mesh-ancestor
64901844|NCT00005964|Mitosis Modulators|mitosis modulators|mesh-ancestor
64523557|NCT01702025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64523558|NCT01702025|Protective Agents|protective agents|mesh-ancestor
64523559|NCT01702025|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64523560|NCT01702025|Diuretics|diuretics|mesh-ancestor
64901845|NCT00005967|Tipifarnib|tipifarnib|mesh-list
64901846|NCT00005967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901847|NCT00005970|Tamoxifen|tamoxifen|mesh-list
64901848|NCT00005970|Paclitaxel|paclitaxel|mesh-list
64901849|NCT00005970|Cyclophosphamide|cyclophosphamide|mesh-list
64901850|NCT00005970|Doxorubicin|doxorubicin|mesh-list
64901851|NCT00005970|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64901852|NCT00005970|Trastuzumab|trastuzumab|mesh-list
64901853|NCT00005970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64901854|NCT00005970|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
64901855|NCT00005970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64901856|NCT00005970|Antibodies|antibodies|mesh-list
64901857|NCT00005970|Immunoglobulins|immunoglobulins|mesh-list
64901858|NCT00005970|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64901859|NCT00005970|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64901860|NCT00005970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64901861|NCT00005970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901862|NCT00005970|Tubulin Modulators|tubulin modulators|mesh-ancestor
64901863|NCT00005970|Antimitotic Agents|antimitotic agents|mesh-ancestor
64901864|NCT00005970|Mitosis Modulators|mitosis modulators|mesh-ancestor
64901865|NCT00005970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901866|NCT00005970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64901885|NCT00005976|Carboplatin|carboplatin|mesh-list
64901886|NCT00005976|NSC 366140|nsc 366140|mesh-list
64901887|NCT00005976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901888|NCT00005979|Leucovorin|leucovorin|mesh-list
64325711|NCT05445362|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64901889|NCT00005979|Fluorouracil|fluorouracil|mesh-list
64901890|NCT00005979|Irinotecan|irinotecan|mesh-list
64901891|NCT00005979|Calcium|calcium|mesh-list
64901892|NCT00005979|Levoleucovorin|levoleucovorin|mesh-list
64901893|NCT00005979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64901894|NCT00005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901895|NCT00005979|Antimetabolites|antimetabolites|mesh-ancestor
64901896|NCT00005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901897|NCT00005979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64901898|NCT00005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901899|NCT00005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64901900|NCT00005979|Immunologic Factors|immunologic factors|mesh-ancestor
64901901|NCT00005979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64901902|NCT00005979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64901903|NCT00005979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901904|NCT00005979|Antidotes|antidotes|mesh-ancestor
64901905|NCT00005979|Protective Agents|protective agents|mesh-ancestor
64901906|NCT00005979|Vitamin B Complex|vitamin b complex|mesh-ancestor
64901907|NCT00005979|Vitamins|vitamins|mesh-ancestor
64901908|NCT00005979|Micronutrients|micronutrients|mesh-ancestor
64901909|NCT00005985|Cytarabine|cytarabine|mesh-list
64901910|NCT00005985|Dexamethasone|dexamethasone|mesh-list
64901911|NCT00005985|Cyclophosphamide|cyclophosphamide|mesh-list
64901912|NCT00005985|Carmustine|carmustine|mesh-list
64901913|NCT00005985|Etoposide|etoposide|mesh-list
64901914|NCT00005985|Mitoxantrone|mitoxantrone|mesh-list
64901915|NCT00005985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64901916|NCT00005985|Immunologic Factors|immunologic factors|mesh-ancestor
64901917|NCT00005985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901918|NCT00005985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64901919|NCT00005985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64901920|NCT00005985|Alkylating Agents|alkylating agents|mesh-ancestor
64901921|NCT00005985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901950|NCT00005988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64901951|NCT00005988|Immunologic Factors|immunologic factors|mesh-ancestor
64901952|NCT00005988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901953|NCT00005988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64901954|NCT00005988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64901955|NCT00005988|Alkylating Agents|alkylating agents|mesh-ancestor
64523561|NCT01702025|Natriuretic Agents|natriuretic agents|mesh-ancestor
64523562|NCT01592747|Memantine|memantine|mesh-list
64523563|NCT01592747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64523564|NCT01592747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64523565|NCT01592747|Dopamine Agents|dopamine agents|mesh-ancestor
64901958|NCT00005988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64901959|NCT00005988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64901960|NCT00005988|Abortifacient Agents|abortifacient agents|mesh-ancestor
64901961|NCT00005988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64901962|NCT00005988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64901963|NCT00005988|Antimetabolites|antimetabolites|mesh-ancestor
64901964|NCT00005988|Dermatologic Agents|dermatologic agents|mesh-ancestor
64901965|NCT00005988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901966|NCT00005988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64901967|NCT00005988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64901968|NCT00005988|Antidotes|antidotes|mesh-ancestor
64901969|NCT00005988|Protective Agents|protective agents|mesh-ancestor
64901970|NCT00005988|Vitamin B Complex|vitamin b complex|mesh-ancestor
64901990|NCT00005991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901992|NCT00005991|Antiviral Agents|antiviral agents|mesh-ancestor
64901993|NCT00005991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64901994|NCT00005991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901995|NCT00005991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64901996|NCT00005991|Immunologic Factors|immunologic factors|mesh-ancestor
64901997|NCT00005991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901998|NCT00005991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64901999|NCT00005991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64902000|NCT00005991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64902001|NCT00005994|Ondansetron|ondansetron|mesh-list
64902002|NCT00005994|Antiemetics|antiemetics|mesh-ancestor
64902003|NCT00005994|Autonomic Agents|autonomic agents|mesh-ancestor
64902004|NCT00005994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64902005|NCT00005994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733701|NCT00005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733702|NCT00005641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64902006|NCT00005994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64902007|NCT00005994|Antipruritics|antipruritics|mesh-ancestor
64902008|NCT00005994|Dermatologic Agents|dermatologic agents|mesh-ancestor
64902009|NCT00005994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64902010|NCT00005994|Serotonin Agents|serotonin agents|mesh-ancestor
64902011|NCT00005994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64902012|NCT00005994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902013|NCT00005994|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64902014|NCT00005994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64902015|NCT00005994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64902016|NCT00005994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64902017|NCT00005994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64902018|NCT00006000|Irinotecan|irinotecan|mesh-list
64902019|NCT00006000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902020|NCT00006000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64902021|NCT00006000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64902022|NCT00006000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902023|NCT00006000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902024|NCT00006003|Semaxinib|semaxinib|mesh-list
64902025|NCT00006003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64523572|NCT02425488|Keratolytic Agents|keratolytic agents|mesh-ancestor
64523573|NCT02425488|Dermatologic Agents|dermatologic agents|mesh-ancestor
64523574|NCT02426112|Azithromycin|azithromycin|mesh-list
64523575|NCT02426112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64523576|NCT02426112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64523577|NCT03117192|Zinc Sulfate|zinc sulfate|mesh-list
64523578|NCT03117192|Astringents|astringents|mesh-ancestor
64523579|NCT03117192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649013|NCT01350245|Tacrolimus|tacrolimus|mesh-list
64523586|NCT04768439|Vitamins|vitamins|mesh-list
64523587|NCT04768439|Micronutrients|micronutrients|mesh-ancestor
64523588|NCT04768439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523589|NCT04768439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64523590|NCT04768439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64523591|NCT04768439|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64523592|NCT04768439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64523593|NCT04768439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523594|NCT04768439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64523595|NCT02421042|Lenvatinib|lenvatinib|mesh-list
64523596|NCT02421042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523597|NCT02421042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64523598|NCT02421042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523599|NCT02421042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523600|NCT03181464|Lidocaine|lidocaine|mesh-list
64902026|NCT00006003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64902027|NCT00006003|Growth Substances|growth substances|mesh-ancestor
64902051|NCT00006009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902053|NCT00006012|Etoposide|etoposide|mesh-list
64902054|NCT00006012|Topotecan|topotecan|mesh-list
64902055|NCT00006012|Amifostine|amifostine|mesh-list
64902056|NCT00006012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64902057|NCT00006012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902058|NCT00006012|Tubulin Modulators|tubulin modulators|mesh-ancestor
64902059|NCT00006012|Antimitotic Agents|antimitotic agents|mesh-ancestor
64902060|NCT00006012|Mitosis Modulators|mitosis modulators|mesh-ancestor
64902061|NCT00006012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902062|NCT00006012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64902063|NCT00006012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64902064|NCT00006012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902065|NCT00006012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902066|NCT00006012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64902067|NCT00006012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64523603|NCT03181464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64523604|NCT03181464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523605|NCT03181464|Sensory System Agents|sensory system agents|mesh-ancestor
64523606|NCT03181464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64523607|NCT03181464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64479704|NCT00997906|Paclitaxel|paclitaxel|mesh-list
64523608|NCT03181464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64523609|NCT03181464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64523610|NCT03181464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64523611|NCT03181464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523612|NCT02423928|Cyclophosphamide|cyclophosphamide|mesh-list
64523613|NCT02423928|Ipilimumab|ipilimumab|mesh-list
64523614|NCT02423928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64523615|NCT02423928|Immunologic Factors|immunologic factors|mesh-ancestor
64523616|NCT02423928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523617|NCT02423928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64523618|NCT02423928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64523619|NCT02423928|Alkylating Agents|alkylating agents|mesh-ancestor
64523620|NCT02423928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523621|NCT02423928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902068|NCT00006012|Protective Agents|protective agents|mesh-ancestor
64902069|NCT00006015|Leucovorin|leucovorin|mesh-list
64902070|NCT00006015|Fluorouracil|fluorouracil|mesh-list
64902071|NCT00006015|Oxaliplatin|oxaliplatin|mesh-list
64902072|NCT00006015|Trastuzumab|trastuzumab|mesh-list
64902073|NCT00006015|Calcium|calcium|mesh-list
64902074|NCT00006015|Levoleucovorin|levoleucovorin|mesh-list
64902075|NCT00006015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64902076|NCT00006015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902077|NCT00006015|Antimetabolites|antimetabolites|mesh-ancestor
64902078|NCT00006015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902079|NCT00006015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64902120|NCT00386646|Laxatives|laxatives|mesh-ancestor
64902152|NCT00006033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64902153|NCT00006033|Analgesics|analgesics|mesh-ancestor
64902154|NCT00006033|Sensory System Agents|sensory system agents|mesh-ancestor
64902155|NCT00006033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64902156|NCT00006036|Lurtotecan|lurtotecan|mesh-list
64902157|NCT00006036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902158|NCT00006039|Interferons|interferons|mesh-list
64902159|NCT00006039|Interferon-alpha|interferon-alpha|mesh-list
64902160|NCT00006039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902161|NCT00006039|Antiviral Agents|antiviral agents|mesh-ancestor
64902194|NCT05680857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902195|NCT05680857|Vitamins|vitamins|mesh-ancestor
64902196|NCT00386763|Lumefantrine|lumefantrine|mesh-list
64523622|NCT02423928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64523623|NCT02423928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64523624|NCT02423928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64523625|NCT02416128|Prednisolone|prednisolone|mesh-list
64523626|NCT02416128|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64523627|NCT02416128|Methylprednisolone|methylprednisolone|mesh-list
64523628|NCT02416128|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64523629|NCT02416128|Prednisolone acetate|prednisolone acetate|mesh-list
64523630|NCT02416128|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64523631|NCT02416128|Prednisolone phosphate|prednisolone phosphate|mesh-list
64523632|NCT02416128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64523633|NCT02416128|Glucocorticoids|glucocorticoids|mesh-ancestor
64523634|NCT02416128|Hormones|hormones|mesh-ancestor
64523635|NCT02416128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64523636|NCT02416128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523637|NCT02416128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64523638|NCT02416128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523639|NCT02416128|Antiemetics|antiemetics|mesh-ancestor
64523640|NCT02416128|Autonomic Agents|autonomic agents|mesh-ancestor
64523641|NCT02416128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64523642|NCT02416128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64523643|NCT02416128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64523644|NCT02416128|Protective Agents|protective agents|mesh-ancestor
64902197|NCT00386763|Artemether|artemether|mesh-list
64902198|NCT00386763|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64902199|NCT00386763|Antimalarials|antimalarials|mesh-ancestor
64733712|NCT00005641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64733713|NCT00005641|Antiemetics|antiemetics|mesh-ancestor
64733714|NCT00005641|Autonomic Agents|autonomic agents|mesh-ancestor
64902200|NCT00386763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64902201|NCT00386763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64902202|NCT00386763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902203|NCT05680662|Metformin|metformin|mesh-list
64902204|NCT05680662|Quercetin|quercetin|mesh-list
64902205|NCT05680662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64902206|NCT05680662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902207|NCT05680662|Antioxidants|antioxidants|mesh-ancestor
64902208|NCT05680662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902237|NCT00386802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64902239|NCT00386802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64902240|NCT00386802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64902241|NCT00386841|Citalopram|citalopram|mesh-list
64902242|NCT00386841|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64902243|NCT00386841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64902244|NCT00386841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64902245|NCT00386841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902246|NCT00386841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64902247|NCT00386841|Serotonin Agents|serotonin agents|mesh-ancestor
64902248|NCT00386841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902249|NCT00386841|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64902250|NCT00386841|Antidepressive Agents|antidepressive agents|mesh-ancestor
64902251|NCT00386841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64902278|NCT05679375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64523646|NCT03106740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64523647|NCT03106740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64523649|NCT03106818|Magnesium Sulfate|magnesium sulfate|mesh-list
64523650|NCT03106818|Bupivacaine|bupivacaine|mesh-list
64902279|NCT05679375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902280|NCT05679336|Cyclophosphamide|cyclophosphamide|mesh-list
64902281|NCT05679336|Rituximab|rituximab|mesh-list
64902282|NCT05679336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64902283|NCT05679336|Immunologic Factors|immunologic factors|mesh-ancestor
64902284|NCT05679336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902285|NCT05679336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64902286|NCT05679336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64902287|NCT05679336|Alkylating Agents|alkylating agents|mesh-ancestor
64902288|NCT05679336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902289|NCT05679336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902290|NCT05679336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64902291|NCT05679336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64902292|NCT05677152|Zoledronic Acid|zoledronic acid|mesh-list
64902293|NCT05677152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64902294|NCT05677152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902295|NCT05675163|Vitamin K|vitamin k|mesh-list
64902296|NCT05675163|Vitamin K 2|vitamin k 2|mesh-list
64902297|NCT05675163|Vitamins|vitamins|mesh-ancestor
64902298|NCT05675163|Micronutrients|micronutrients|mesh-ancestor
64902323|NCT05597163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64902324|NCT05597163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64902325|NCT05597163|Autonomic Agents|autonomic agents|mesh-ancestor
64902326|NCT05597163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64902327|NCT05597163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902328|NCT05597163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64902329|NCT05597163|Respiratory System Agents|respiratory system agents|mesh-ancestor
64902330|NCT05597163|Mydriatics|mydriatics|mesh-ancestor
64902331|NCT05597163|Parasympatholytics|parasympatholytics|mesh-ancestor
64902332|NCT05597163|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64670853|NCT01994993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902333|NCT05597163|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64902334|NCT05597163|Cholinergic Agents|cholinergic agents|mesh-ancestor
64902335|NCT05597163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64902336|NCT05597163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902337|NCT05550129|Metformin|metformin|mesh-list
64902338|NCT05550129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64902339|NCT05550129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902340|NCT00386958|Povidone-Iodine|povidone-iodine|mesh-list
64902341|NCT00386958|Povidone|povidone|mesh-list
64320954|NCT05502458|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64320955|NCT03534037|Febuxostat|febuxostat|mesh-list
64320956|NCT03534037|Benzbromarone|benzbromarone|mesh-list
64320957|NCT03534037|Gout Suppressants|gout suppressants|mesh-ancestor
64902342|NCT00386958|Plasma Substitutes|plasma substitutes|mesh-ancestor
64902343|NCT00386958|Blood Substitutes|blood substitutes|mesh-ancestor
64902344|NCT00386958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64902345|NCT00386958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902346|NCT00386997|Amphotericin B|amphotericin b|mesh-list
64902347|NCT00386997|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64902348|NCT00386997|Amebicides|amebicides|mesh-ancestor
64523659|NCT03106818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64523660|NCT03106818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64523661|NCT03106818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64523662|NCT03106818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64523663|NCT03106818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523664|NCT03106818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523665|NCT03106818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64523667|NCT03106818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64523668|NCT03106818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64523669|NCT03106818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64523670|NCT03106818|Tocolytic Agents|tocolytic agents|mesh-ancestor
64523671|NCT03106818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64902383|NCT04910568|Daratumumab|daratumumab|mesh-list
64902384|NCT04910568|Pomalidomide|pomalidomide|mesh-list
64902385|NCT04910568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64902386|NCT04910568|Antiemetics|antiemetics|mesh-ancestor
64902387|NCT04910568|Autonomic Agents|autonomic agents|mesh-ancestor
64902388|NCT04910568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64902389|NCT04910568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902390|NCT04910568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64902391|NCT04910568|Glucocorticoids|glucocorticoids|mesh-ancestor
64902392|NCT04910568|Hormones|hormones|mesh-ancestor
64902393|NCT04910568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64902394|NCT04910568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64902395|NCT04910568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902396|NCT04910568|Immunologic Factors|immunologic factors|mesh-ancestor
64902397|NCT04910568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64902398|NCT04910568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64902399|NCT04910568|Growth Substances|growth substances|mesh-ancestor
64902400|NCT04910568|Growth Inhibitors|growth inhibitors|mesh-ancestor
64902432|NCT04787991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902433|NCT04787991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902434|NCT04787991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64902435|NCT04787991|Immunologic Factors|immunologic factors|mesh-ancestor
64902436|NCT04787991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902437|NCT04787991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64902438|NCT04787991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64902439|NCT04787991|Antimalarials|antimalarials|mesh-ancestor
64902440|NCT04787991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64902441|NCT04787991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64902442|NCT04787991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64902443|NCT04552080|Amoxicillin|amoxicillin|mesh-list
64902468|NCT04360473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64902469|NCT04360473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64902471|NCT04360473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902472|NCT04360473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64902473|NCT04360473|Anticonvulsants|anticonvulsants|mesh-ancestor
64523674|NCT01592045|Dinutuximab|dinutuximab|mesh-list
64523675|NCT01592045|Isotretinoin|isotretinoin|mesh-list
64523676|NCT01592045|Sargramostim|sargramostim|mesh-list
64523677|NCT01592045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523678|NCT01592045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64523679|NCT01592045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64523680|NCT01592045|Antiviral Agents|antiviral agents|mesh-ancestor
64523681|NCT01592045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64714100|NCT03054103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64479785|NCT01868893|Obinutuzumab|obinutuzumab|mesh-list
64523682|NCT01592045|Dermatologic Agents|dermatologic agents|mesh-ancestor
64523683|NCT01592045|Immunologic Factors|immunologic factors|mesh-ancestor
64320958|NCT03534037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64320959|NCT03534037|Uricosuric Agents|uricosuric agents|mesh-ancestor
64320960|NCT03534037|Renal Agents|renal agents|mesh-ancestor
64604570|NCT00845195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64523684|NCT01592045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523685|NCT03178656|Sorafenib|sorafenib|mesh-list
64523686|NCT03178656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523687|NCT03178656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64523688|NCT03178656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523689|NCT03178656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523690|NCT01590797|Metformin|metformin|mesh-list
64523691|NCT01590797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64523692|NCT01590797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64902474|NCT04360473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64902475|NCT04360473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64902476|NCT04360473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64902477|NCT04360473|Tocolytic Agents|tocolytic agents|mesh-ancestor
64902478|NCT04360473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64902479|NCT04329975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64902480|NCT04329975|Hemostatics|hemostatics|mesh-ancestor
64902481|NCT04329975|Coagulants|coagulants|mesh-ancestor
64902482|NCT04329975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64902483|NCT04329975|Natriuretic Agents|natriuretic agents|mesh-ancestor
64902484|NCT04329975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902485|NCT04305795|Pembrolizumab|pembrolizumab|mesh-list
64902486|NCT04305795|Cemiplimab|cemiplimab|mesh-list
64902487|NCT04305795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64902488|NCT04305795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902489|NCT00423384|Ibandronic Acid|ibandronic acid|mesh-list
64902490|NCT00423384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64902491|NCT00423384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902492|NCT04175613|Apremilast|apremilast|mesh-list
64902514|NCT03945357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902515|NCT03945357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902516|NCT03945357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64902517|NCT03945357|Immunologic Factors|immunologic factors|mesh-ancestor
64523698|NCT01590797|Protease Inhibitors|protease inhibitors|mesh-ancestor
64523699|NCT01590797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523700|NCT01590797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523701|NCT01867606|Immunoglobulins|immunoglobulins|mesh-list
64523702|NCT01867606|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64523704|NCT01867606|Immunologic Factors|immunologic factors|mesh-ancestor
64523705|NCT01867606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523706|NCT02415192|Amlodipine|amlodipine|mesh-list
64523707|NCT02415192|Valsartan|valsartan|mesh-list
64523708|NCT02415192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64523709|NCT02415192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64523710|NCT02415192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64523711|NCT02415192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523712|NCT02415192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64523713|NCT02415192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523714|NCT02415192|Vasodilator Agents|vasodilator agents|mesh-ancestor
64523715|NCT02415192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64523716|NCT02415192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64523717|NCT02415270|Menthol|menthol|mesh-list
64523718|NCT02415270|Nicotine|nicotine|mesh-list
64902518|NCT03945357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902519|NCT03945357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64902520|NCT03945357|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64902522|NCT03913221|Caffeine citrate|caffeine citrate|mesh-list
64902523|NCT03913221|Citric Acid|citric acid|mesh-list
64902524|NCT03913221|Sodium Citrate|sodium citrate|mesh-list
64902525|NCT03913221|Anticoagulants|anticoagulants|mesh-ancestor
64902526|NCT03913221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64902527|NCT03913221|Chelating Agents|chelating agents|mesh-ancestor
64902528|NCT03913221|Sequestering Agents|sequestering agents|mesh-ancestor
64902529|NCT03913221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902530|NCT03913221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64902531|NCT03913221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902532|NCT03913221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64902533|NCT03913221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902534|NCT03913221|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64902535|NCT03913221|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64902536|NCT03913221|Purinergic Agents|purinergic agents|mesh-ancestor
64902537|NCT03913221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64902538|NCT03869736|Nitrous Oxide|nitrous oxide|mesh-list
64902539|NCT03869736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64649043|NCT01269047|Exenatide|exenatide|mesh-list
64523722|NCT02415270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523724|NCT02415270|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64523725|NCT02415270|Cholinergic Agents|cholinergic agents|mesh-ancestor
64523726|NCT02415270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64523727|NCT02415270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523728|NCT02415270|Antipruritics|antipruritics|mesh-ancestor
64523729|NCT02415270|Dermatologic Agents|dermatologic agents|mesh-ancestor
64523731|NCT02415114|Antioxidants|antioxidants|mesh-ancestor
64523732|NCT02415114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523733|NCT02415114|Protective Agents|protective agents|mesh-ancestor
64523734|NCT02415114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523735|NCT02415114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523736|NCT02415114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64902580|NCT03568656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902581|NCT03568656|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64902582|NCT03568656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902583|NCT03568656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902584|NCT03568656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64902585|NCT03568656|Hormone Antagonists|hormone antagonists|mesh-ancestor
64902586|NCT03568656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64902656|NCT02931903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902657|NCT02931903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902658|NCT02931903|Antimanic Agents|antimanic agents|mesh-ancestor
64902659|NCT02931903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64902660|NCT02931903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64902661|NCT02931903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902662|NCT02648997|Nivolumab|nivolumab|mesh-list
64902663|NCT02648997|Ipilimumab|ipilimumab|mesh-list
64902694|NCT02373813|Sensory System Agents|sensory system agents|mesh-ancestor
64902695|NCT02373813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64902696|NCT02373813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64902697|NCT02373813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64902699|NCT02373813|Vitamin B Complex|vitamin b complex|mesh-ancestor
64902700|NCT02373813|Vitamins|vitamins|mesh-ancestor
64902701|NCT02373813|Micronutrients|micronutrients|mesh-ancestor
64902702|NCT01959204|Oxycodone|oxycodone|mesh-list
64902703|NCT01959204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64902704|NCT01959204|Narcotics|narcotics|mesh-ancestor
64902734|NCT00006045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64902735|NCT00006045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64902736|NCT00006045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902737|NCT00006045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902738|NCT00006045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64902739|NCT00006045|Antimetabolites|antimetabolites|mesh-ancestor
64902740|NCT00006045|Antiviral Agents|antiviral agents|mesh-ancestor
64902741|NCT00006045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902742|NCT00006045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64902743|NCT00006045|Immunologic Factors|immunologic factors|mesh-ancestor
64649044|NCT01269047|Pramlintide|pramlintide|mesh-list
64523745|NCT03178422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64523746|NCT03178422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523747|NCT02420496|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64523748|NCT02420496|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64523749|NCT02420496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64902746|NCT00006045|Sensory System Agents|sensory system agents|mesh-ancestor
64902747|NCT00006045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64902748|NCT00006045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64902750|NCT00006048|Gefitinib|gefitinib|mesh-list
64902780|NCT00006054|Immunologic Factors|immunologic factors|mesh-ancestor
64902781|NCT00006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902782|NCT00006054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64902783|NCT00006054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64902784|NCT00006054|Alkylating Agents|alkylating agents|mesh-ancestor
64902785|NCT00006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902786|NCT00006054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902787|NCT00006054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64902788|NCT00006054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64902790|NCT00006054|Hormones|hormones|mesh-ancestor
64902791|NCT00006054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64902792|NCT00006054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64902793|NCT00006054|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64902794|NCT00006054|Abortifacient Agents|abortifacient agents|mesh-ancestor
64902795|NCT00006054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64902796|NCT00006054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64902830|NCT00006075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64902831|NCT00006075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64902832|NCT00006075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902833|NCT00006075|Disinfectants|disinfectants|mesh-ancestor
64902834|NCT00006075|Dermatologic Agents|dermatologic agents|mesh-ancestor
64902836|NCT00006078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64902837|NCT00006078|Antioxidants|antioxidants|mesh-ancestor
64902838|NCT00006078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902839|NCT00006078|Protective Agents|protective agents|mesh-ancestor
64902875|NCT00006105|Protective Agents|protective agents|mesh-ancestor
64902876|NCT00006108|Paclitaxel|paclitaxel|mesh-list
64902877|NCT00006108|Capecitabine|capecitabine|mesh-list
64902878|NCT00006108|Trastuzumab|trastuzumab|mesh-list
64902879|NCT00006108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64902903|NCT00006114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902904|NCT00006114|Analgesics|analgesics|mesh-ancestor
64902905|NCT00006114|Sensory System Agents|sensory system agents|mesh-ancestor
64902906|NCT00006114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64902907|NCT00006114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902908|NCT00006114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64902909|NCT00006114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64902910|NCT00006114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902911|NCT00006117|Gemcitabine|gemcitabine|mesh-list
64523752|NCT02414880|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64523753|NCT02414880|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64945395|NCT05664789|Respiratory System Agents|respiratory system agents|mesh-ancestor
64523754|NCT02414880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64523755|NCT02414880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649065|NCT05287724|Acetylcysteine|acetylcysteine|mesh-list
64523760|NCT02414880|Cholinergic Agents|cholinergic agents|mesh-ancestor
64523761|NCT02414880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64523762|NCT02414880|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64523763|NCT02414880|Autonomic Agents|autonomic agents|mesh-ancestor
64523765|NCT02423694|Citalopram|citalopram|mesh-list
64523766|NCT02423694|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64523767|NCT02423694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64523768|NCT02423694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64523769|NCT02423694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523770|NCT02423694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64733719|NCT00005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64733720|NCT00005641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64733721|NCT00005647|Paclitaxel|paclitaxel|mesh-list
64733722|NCT00005647|Semaxinib|semaxinib|mesh-list
64604768|NCT00364702|Methylphenidate|methylphenidate|mesh-list
64523771|NCT02423694|Serotonin Agents|serotonin agents|mesh-ancestor
64902912|NCT00006117|Oxaliplatin|oxaliplatin|mesh-list
64902913|NCT00006117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64902914|NCT00006117|Antimetabolites|antimetabolites|mesh-ancestor
64902915|NCT00006117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902916|NCT00006117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902917|NCT00006117|Antiviral Agents|antiviral agents|mesh-ancestor
64902918|NCT00006117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902919|NCT00006117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902920|NCT00006117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64902921|NCT00006117|Immunologic Factors|immunologic factors|mesh-ancestor
64902922|NCT00006117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902923|NCT00006120|Paclitaxel|paclitaxel|mesh-list
64902924|NCT00006120|Docetaxel|docetaxel|mesh-list
64902925|NCT00006120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64902926|NCT00006120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902927|NCT00006120|Tubulin Modulators|tubulin modulators|mesh-ancestor
64902928|NCT00006120|Antimitotic Agents|antimitotic agents|mesh-ancestor
64902929|NCT00006120|Mitosis Modulators|mitosis modulators|mesh-ancestor
64902949|NCT00006126|Fludarabine phosphate|fludarabine phosphate|mesh-list
64902950|NCT00006126|Etoposide|etoposide|mesh-list
64902951|NCT00006126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64902952|NCT00006126|Immunologic Factors|immunologic factors|mesh-ancestor
64902953|NCT00006126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902954|NCT00006126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64902955|NCT00006126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64902956|NCT00006126|Alkylating Agents|alkylating agents|mesh-ancestor
64902957|NCT00006126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902958|NCT00006126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902959|NCT00006126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64523773|NCT02423694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64523774|NCT02423694|Antidepressive Agents|antidepressive agents|mesh-ancestor
64523775|NCT02423694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64523776|NCT02423694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64523777|NCT02423694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64523778|NCT02423694|Parasympatholytics|parasympatholytics|mesh-ancestor
64523779|NCT02423694|Autonomic Agents|autonomic agents|mesh-ancestor
64523780|NCT02423694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64523781|NCT02423694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64523782|NCT02423694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64523783|NCT02423694|Cholinergic Agents|cholinergic agents|mesh-ancestor
64523784|NCT02420418|Acetylcysteine|acetylcysteine|mesh-list
64523785|NCT02420418|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64523786|NCT02420418|Antiviral Agents|antiviral agents|mesh-ancestor
64523787|NCT02420418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64523788|NCT02420418|Expectorants|expectorants|mesh-ancestor
64523789|NCT02420418|Respiratory System Agents|respiratory system agents|mesh-ancestor
64902960|NCT00006126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64902961|NCT00006126|Antimetabolites|antimetabolites|mesh-ancestor
64902962|NCT00006126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64902963|NCT00006126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64902964|NCT00006126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64902965|NCT00006126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902966|NCT00006129|Testosterone|testosterone|mesh-list
64902967|NCT00006129|Androgens|androgens|mesh-ancestor
64902968|NCT00006129|Hormones|hormones|mesh-ancestor
64902969|NCT00006129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64902986|NCT00006144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64903003|NCT00006168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903004|NCT00006168|Dermatologic Agents|dermatologic agents|mesh-ancestor
64903005|NCT00006168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903006|NCT00006168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64903007|NCT00006168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64903008|NCT00006168|Immunologic Factors|immunologic factors|mesh-ancestor
64903009|NCT00006168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64903010|NCT00006168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64903012|NCT00006174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903013|NCT00006174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64903014|NCT00006174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64903015|NCT00006174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523791|NCT02420418|Antioxidants|antioxidants|mesh-ancestor
64523792|NCT02420418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523793|NCT02420418|Protective Agents|protective agents|mesh-ancestor
64523794|NCT02420418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523795|NCT02420418|Antidotes|antidotes|mesh-ancestor
64523796|NCT02414802|Calcium, Dietary|calcium, dietary|mesh-list
64523798|NCT02414802|Calcium heparin|calcium heparin|mesh-list
64523799|NCT02414802|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64903016|NCT00006174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903017|NCT00006174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64903018|NCT00006174|Hormone Antagonists|hormone antagonists|mesh-ancestor
64903019|NCT00006174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64903020|NCT00006174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903021|NCT00006180|Alendronate|alendronate|mesh-list
64903022|NCT00006180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64903023|NCT00006180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903024|NCT00006195|Olanzapine|olanzapine|mesh-list
64903025|NCT00006195|Risperidone|risperidone|mesh-list
64903026|NCT00006195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64903027|NCT00006195|Serotonin Agents|serotonin agents|mesh-ancestor
64903028|NCT00006195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64903029|NCT00006195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903030|NCT00006195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903031|NCT00006195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64903032|NCT00006195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64903033|NCT00006195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64903034|NCT00006195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64903035|NCT00006195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64903036|NCT00006195|Dopamine Agents|dopamine agents|mesh-ancestor
64903037|NCT00006195|Antiemetics|antiemetics|mesh-ancestor
64903038|NCT00006195|Autonomic Agents|autonomic agents|mesh-ancestor
64903039|NCT00006195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64903087|NCT00006216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903113|NCT00006228|Antiviral Agents|antiviral agents|mesh-ancestor
64903114|NCT00006228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64903115|NCT03751800|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64903117|NCT03751800|Levonorgestrel|levonorgestrel|mesh-list
64903118|NCT03751800|Medroxyprogesterone|medroxyprogesterone|mesh-list
64523801|NCT02414802|Dalteparin|dalteparin|mesh-list
64523802|NCT02414802|Calcium|calcium|mesh-list
64523803|NCT02414802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64523804|NCT02414802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523805|NCT02414802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64523806|NCT02414802|Anticoagulants|anticoagulants|mesh-ancestor
64523807|NCT02414802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64523808|NCT02414802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64523809|NCT02414802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523810|NCT01701401|Sofosbuvir|sofosbuvir|mesh-list
64523811|NCT01701401|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64523812|NCT01701401|Ledipasvir|ledipasvir|mesh-list
64523813|NCT01701401|Antiviral Agents|antiviral agents|mesh-ancestor
64523814|NCT01701401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64523815|NCT04482504|Vitamin D|vitamin d|mesh-list
64523816|NCT04482504|Vitamins|vitamins|mesh-ancestor
64523817|NCT04482504|Micronutrients|micronutrients|mesh-ancestor
64523818|NCT04482504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523819|NCT04482504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64523820|NCT02414568|Prednisone|prednisone|mesh-list
64523821|NCT02414568|Doxorubicin|doxorubicin|mesh-list
64903119|NCT03751800|Estradiol|estradiol|mesh-list
64903120|NCT03751800|Estrogens|estrogens|mesh-ancestor
64903159|NCT00006243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64903160|NCT00006246|Busulfan|busulfan|mesh-list
64903161|NCT00006246|Alkylating Agents|alkylating agents|mesh-ancestor
64903162|NCT00006246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903163|NCT00006246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64733730|NCT00005647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64733731|NCT00005647|Growth Substances|growth substances|mesh-ancestor
64604911|NCT00821795|Insulin|insulin|mesh-list
64903164|NCT00006246|Immunologic Factors|immunologic factors|mesh-ancestor
64903165|NCT00006246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903166|NCT00006246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64903167|NCT00006246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903168|NCT00006246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64903170|NCT00006249|Interferon-alpha|interferon-alpha|mesh-list
64903171|NCT00006249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523822|NCT02414568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64523824|NCT02414568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64523896|NCT01587989|Methotrexate|methotrexate|mesh-list
64523897|NCT01587989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64523898|NCT01587989|Abortifacient Agents|abortifacient agents|mesh-ancestor
64523899|NCT01587989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64523900|NCT01587989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523901|NCT01587989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64523902|NCT01587989|Antimetabolites|antimetabolites|mesh-ancestor
64523903|NCT01587989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365522|NCT02459353|Dapagliflozin|dapagliflozin|mesh-list
64903172|NCT00006249|Antiviral Agents|antiviral agents|mesh-ancestor
64903173|NCT00006249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64903174|NCT00006249|Immunologic Factors|immunologic factors|mesh-ancestor
64903175|NCT00006249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903176|NCT00006252|Cyclophosphamide|cyclophosphamide|mesh-list
64903177|NCT00006252|Fludarabine|fludarabine|mesh-list
64903178|NCT00006252|Fludarabine phosphate|fludarabine phosphate|mesh-list
64903179|NCT00006252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64903180|NCT00006252|Immunologic Factors|immunologic factors|mesh-ancestor
64903181|NCT00006252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903182|NCT00006252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64903183|NCT00006252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64903184|NCT00006252|Alkylating Agents|alkylating agents|mesh-ancestor
64903219|NCT00006261|Docetaxel|docetaxel|mesh-list
64903220|NCT00006261|Doxorubicin|doxorubicin|mesh-list
64903221|NCT00006261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64903222|NCT00006261|Fludarabine|fludarabine|mesh-list
64903223|NCT00006261|Fludarabine phosphate|fludarabine phosphate|mesh-list
64903224|NCT00006261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64903225|NCT00006261|Immunologic Factors|immunologic factors|mesh-ancestor
64903226|NCT00006261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903227|NCT00006261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64903228|NCT00006261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64903229|NCT00006261|Alkylating Agents|alkylating agents|mesh-ancestor
64903230|NCT00006261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903231|NCT00006261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903232|NCT00006261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64903233|NCT00006261|Tubulin Modulators|tubulin modulators|mesh-ancestor
64903234|NCT00006261|Antimitotic Agents|antimitotic agents|mesh-ancestor
64671750|NCT01727726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64903235|NCT00006261|Mitosis Modulators|mitosis modulators|mesh-ancestor
64903236|NCT00006261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64903237|NCT00006261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64903238|NCT00006261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64903239|NCT00006261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903240|NCT00006261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64903241|NCT00006261|Antimetabolites|antimetabolites|mesh-ancestor
64903242|NCT00006264|Zidovudine|zidovudine|mesh-list
64903243|NCT00006264|Aldesleukin|aldesleukin|mesh-list
64903244|NCT00006264|Ganciclovir|ganciclovir|mesh-list
64649126|NCT01354145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64649127|NCT01354145|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64649128|NCT01354145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64649129|NCT01354145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649130|NCT01354145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649132|NCT05168462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64649133|NCT05168462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64649134|NCT05168462|Adrenergic Agents|adrenergic agents|mesh-ancestor
64649135|NCT05168462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64311732|NCT02094053|Cholinergic Agents|cholinergic agents|mesh-ancestor
64604968|NCT00853333|Sensory System Agents|sensory system agents|mesh-ancestor
64311733|NCT02094053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64311734|NCT02094053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903245|NCT00006264|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64903246|NCT00006264|Antimetabolites|antimetabolites|mesh-ancestor
64523904|NCT01587989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523905|NCT01587989|Dermatologic Agents|dermatologic agents|mesh-ancestor
64523915|NCT01697969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64523916|NCT01697969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64523917|NCT01697969|Analgesics|analgesics|mesh-ancestor
64523918|NCT01697969|Sensory System Agents|sensory system agents|mesh-ancestor
64523919|NCT01697969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64523920|NCT01697969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523921|NCT01697969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64523922|NCT01697969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64523923|NCT01697969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64903247|NCT00006264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903248|NCT00006264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64903249|NCT00006264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64903250|NCT00006264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903274|NCT00006276|Antimitotic Agents|antimitotic agents|mesh-ancestor
64903275|NCT00006276|Mitosis Modulators|mitosis modulators|mesh-ancestor
64903276|NCT00006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903277|NCT00006279|Nevirapine|nevirapine|mesh-list
64903278|NCT00006279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64903279|NCT00006279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64903280|NCT00006279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903281|NCT00006279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903282|NCT00006279|Antiviral Agents|antiviral agents|mesh-ancestor
64903283|NCT00006279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64903284|NCT00006279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64903285|NCT00006279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64903286|NCT00006279|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64903287|NCT00006279|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64903288|NCT00006291|Aldesleukin|aldesleukin|mesh-list
64903289|NCT00006291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903290|NCT00006291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64903291|NCT00006291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64903292|NCT00006291|Antiviral Agents|antiviral agents|mesh-ancestor
64903293|NCT00006291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64903294|NCT00006294|Amlodipine|amlodipine|mesh-list
64903295|NCT00006294|Lisinopril|lisinopril|mesh-list
64903296|NCT00006294|Chlorthalidone|chlorthalidone|mesh-list
64903297|NCT00006294|Doxazosin|doxazosin|mesh-list
64903298|NCT00006294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64903299|NCT00006294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64903300|NCT00006294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64903301|NCT00006294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903302|NCT00006294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64903335|NCT00006324|Contraceptive Agents|contraceptive agents|mesh-ancestor
64523926|NCT01697969|Histamine Antagonists|histamine antagonists|mesh-ancestor
64523928|NCT01697969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64523929|NCT01697969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523930|NCT01586819|Botulinum Toxins|botulinum toxins|mesh-list
64523931|NCT01586819|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64365751|NCT03261349|Sofosbuvir|sofosbuvir|mesh-list
64903336|NCT00006324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64903337|NCT00006324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64903338|NCT00006324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64903339|NCT00006324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64903365|NCT00005827|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64903367|NCT00005827|Hormones|hormones|mesh-ancestor
64903368|NCT00005827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64605036|NCT05236907|Antioxidants|antioxidants|mesh-ancestor
64903415|NCT00005851|Antifungal Agents|antifungal agents|mesh-ancestor
64903416|NCT00005851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64903417|NCT00005851|Dermatologic Agents|dermatologic agents|mesh-ancestor
64903418|NCT00005851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64903419|NCT00005851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64903420|NCT00005851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64903421|NCT00005851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64903422|NCT00005851|Antitubercular Agents|antitubercular agents|mesh-ancestor
64903423|NCT00005851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64903424|NCT00005854|Cyclosporine|cyclosporine|mesh-list
64903425|NCT00005854|Cyclophosphamide|cyclophosphamide|mesh-list
64903426|NCT00005854|Methotrexate|methotrexate|mesh-list
64903427|NCT00005854|Cyclosporins|cyclosporins|mesh-list
64903428|NCT00005854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64903429|NCT00005854|Immunologic Factors|immunologic factors|mesh-ancestor
64903430|NCT00005854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903431|NCT00005854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64903432|NCT00005854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64903433|NCT00005854|Alkylating Agents|alkylating agents|mesh-ancestor
64903434|NCT00005854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903435|NCT00005854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903456|NCT00005857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64903458|NCT00005860|Oxaliplatin|oxaliplatin|mesh-list
64903459|NCT00005860|Floxuridine|floxuridine|mesh-list
64903460|NCT00005860|Calcium|calcium|mesh-list
64903461|NCT00005860|Levoleucovorin|levoleucovorin|mesh-list
64523932|NCT01586819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64523933|NCT01586819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523934|NCT01586819|Cholinergic Agents|cholinergic agents|mesh-ancestor
64523935|NCT01586819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64523936|NCT01586819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523938|NCT01697579|Fosaprepitant|fosaprepitant|mesh-list
64523939|NCT01697579|Aprepitant|aprepitant|mesh-list
64523940|NCT01697579|Serotonin|serotonin|mesh-list
64523941|NCT01697579|Antiemetics|antiemetics|mesh-ancestor
64523942|NCT01697579|Autonomic Agents|autonomic agents|mesh-ancestor
64523943|NCT01697579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64523944|NCT01697579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523945|NCT01697579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64649145|NCT02196857|Antimetabolites|antimetabolites|mesh-ancestor
64523961|NCT01586195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64523962|NCT01586195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523963|NCT01586195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903462|NCT00005860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64903463|NCT00005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903464|NCT00005860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903465|NCT00005860|Antidotes|antidotes|mesh-ancestor
64903466|NCT00005860|Protective Agents|protective agents|mesh-ancestor
64903467|NCT00005860|Vitamin B Complex|vitamin b complex|mesh-ancestor
64903468|NCT00005860|Vitamins|vitamins|mesh-ancestor
64903469|NCT00005860|Micronutrients|micronutrients|mesh-ancestor
64903470|NCT00005860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64903471|NCT00005860|Antimetabolites|antimetabolites|mesh-ancestor
64903472|NCT00005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523965|NCT01697345|Androgens|androgens|mesh-ancestor
64523967|NCT01697345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64523968|NCT01697345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523969|NCT01802632|Osimertinib|osimertinib|mesh-list
64523970|NCT01802632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320962|NCT05502380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64320963|NCT02567708|Nemiralisib|nemiralisib|mesh-list
64320964|NCT02567708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64320965|NCT02567708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733732|NCT00005647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605099|NCT00860171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64523971|NCT01802632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64523972|NCT01802632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64523973|NCT01802632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523974|NCT03467386|Cyclophosphamide|cyclophosphamide|mesh-list
64523975|NCT03467386|Tacrolimus|tacrolimus|mesh-list
64523976|NCT03467386|Lenograstim|lenograstim|mesh-list
64523977|NCT03467386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64903473|NCT00005863|Cytarabine|cytarabine|mesh-list
64903474|NCT00005863|Fludarabine|fludarabine|mesh-list
64903475|NCT00005863|Fludarabine phosphate|fludarabine phosphate|mesh-list
64903476|NCT00005863|Etoposide|etoposide|mesh-list
64903477|NCT00005863|Daunorubicin|daunorubicin|mesh-list
64903478|NCT00005863|Tretinoin|tretinoin|mesh-list
64903479|NCT00005863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903480|NCT00005863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64903481|NCT00005863|Antimetabolites|antimetabolites|mesh-ancestor
64903482|NCT00005863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903483|NCT00005863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64903484|NCT00005863|Immunologic Factors|immunologic factors|mesh-ancestor
64903485|NCT00005863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903486|NCT00005863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64903487|NCT00005863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64903488|NCT00005863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64903489|NCT00005863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903490|NCT00005863|Antiviral Agents|antiviral agents|mesh-ancestor
64903517|NCT00005866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64903518|NCT00005866|Antifungal Agents|antifungal agents|mesh-ancestor
64903519|NCT00005866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64903520|NCT00005866|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64903521|NCT00005869|Gemcitabine|gemcitabine|mesh-list
64903522|NCT00005869|Rubitecan|rubitecan|mesh-list
64903523|NCT00005869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64903524|NCT00005869|Antimetabolites|antimetabolites|mesh-ancestor
64903525|NCT00005869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903526|NCT00005869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903527|NCT00005869|Antiviral Agents|antiviral agents|mesh-ancestor
64903528|NCT00005869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64903529|NCT00005869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903530|NCT00005869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64903531|NCT00005869|Immunologic Factors|immunologic factors|mesh-ancestor
64903532|NCT00005869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903533|NCT00005869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64903534|NCT00005869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64903535|NCT00005872|Rubitecan|rubitecan|mesh-list
64903536|NCT00005872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903537|NCT00005872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64903538|NCT00005872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64903539|NCT00005872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903540|NCT00005872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903569|NCT00005887|Efaproxiral|efaproxiral|mesh-list
64903570|NCT00005887|Antisickling Agents|antisickling agents|mesh-ancestor
64903571|NCT00006339|Ritonavir|ritonavir|mesh-list
64903572|NCT00006339|Indinavir|indinavir|mesh-list
64903573|NCT00006339|Didanosine|didanosine|mesh-list
64903574|NCT00006339|Stavudine|stavudine|mesh-list
64903575|NCT00006339|Hydroxyurea|hydroxyurea|mesh-list
64523979|NCT03467386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523980|NCT03467386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64523981|NCT03467386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64523982|NCT03467386|Alkylating Agents|alkylating agents|mesh-ancestor
64523983|NCT03467386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523984|NCT03467386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523985|NCT03467386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64523986|NCT03467386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64523987|NCT03467386|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64523988|NCT03467386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903576|NCT00006339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64903577|NCT00006339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64903578|NCT00006339|Protease Inhibitors|protease inhibitors|mesh-ancestor
64903579|NCT00006339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903580|NCT00006339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903581|NCT00006339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64903582|NCT00006339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64903583|NCT00006339|Antiviral Agents|antiviral agents|mesh-ancestor
64903584|NCT00006339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64903585|NCT00006339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64903586|NCT00006339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64903618|NCT00386503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903619|NCT00386503|Antiviral Agents|antiviral agents|mesh-ancestor
64903620|NCT00386503|Schistosomicides|schistosomicides|mesh-ancestor
64903621|NCT00386503|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64903622|NCT00386503|Anthelmintics|anthelmintics|mesh-ancestor
64903623|NCT00386581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64903624|NCT00386581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64903625|NCT00386581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64903626|NCT00386581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64903627|NCT00386581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903628|NCT00386581|Adrenergic Agents|adrenergic agents|mesh-ancestor
64903629|NCT00386581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64903659|NCT00005926|Immunologic Factors|immunologic factors|mesh-ancestor
64903660|NCT00005926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903661|NCT00005926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64903662|NCT00005935|Cyclosporine|cyclosporine|mesh-list
64903663|NCT00005935|Mycophenolic Acid|mycophenolic acid|mesh-list
64903664|NCT00005935|Cyclosporins|cyclosporins|mesh-list
64903665|NCT00005935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903666|NCT00005935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903667|NCT00005935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64903701|NCT00005938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903702|NCT00005938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903703|NCT00005941|Cyclosporine|cyclosporine|mesh-list
64903704|NCT00005941|Mycophenolic Acid|mycophenolic acid|mesh-list
64903705|NCT00005941|Fludarabine|fludarabine|mesh-list
64903706|NCT00005941|Fludarabine phosphate|fludarabine phosphate|mesh-list
64903707|NCT00005941|Cyclosporins|cyclosporins|mesh-list
64903708|NCT00005941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903709|NCT00005941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64903710|NCT00005941|Antimetabolites|antimetabolites|mesh-ancestor
64523989|NCT01352962|Gemcitabine|gemcitabine|mesh-list
64523990|NCT01352962|Carboplatin|carboplatin|mesh-list
64523991|NCT01352962|Lenalidomide|lenalidomide|mesh-list
64523992|NCT01352962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64523993|NCT01352962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64523994|NCT01352962|Antimetabolites|antimetabolites|mesh-ancestor
64523995|NCT01352962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64523996|NCT01352962|Antiviral Agents|antiviral agents|mesh-ancestor
64523997|NCT01352962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64523998|NCT01352962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903711|NCT00005941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903712|NCT00005941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64903713|NCT00005941|Immunologic Factors|immunologic factors|mesh-ancestor
64903714|NCT00005941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903715|NCT00005941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903716|NCT00005941|Antifungal Agents|antifungal agents|mesh-ancestor
64903717|NCT00005941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64903718|NCT00005941|Dermatologic Agents|dermatologic agents|mesh-ancestor
64733744|NCT00004669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64733745|NCT00385411|Valproic Acid|valproic acid|mesh-list
64733746|NCT00385411|Anticonvulsants|anticonvulsants|mesh-ancestor
64733747|NCT00385411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903719|NCT00005941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64903720|NCT00005941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64903721|NCT00005941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64903722|NCT00005941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64903723|NCT00005941|Antitubercular Agents|antitubercular agents|mesh-ancestor
64903724|NCT00005941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64903725|NCT00005944|Leucovorin|leucovorin|mesh-list
64903732|NCT00005944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903733|NCT00005944|Antimetabolites|antimetabolites|mesh-ancestor
64903734|NCT00005944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903735|NCT00005944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64903736|NCT00005944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903737|NCT00005944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64903738|NCT00005944|Immunologic Factors|immunologic factors|mesh-ancestor
64903739|NCT00005944|Antidotes|antidotes|mesh-ancestor
64903740|NCT00005944|Protective Agents|protective agents|mesh-ancestor
64903741|NCT00005944|Vitamin B Complex|vitamin b complex|mesh-ancestor
64903742|NCT00005944|Vitamins|vitamins|mesh-ancestor
64903743|NCT00005944|Micronutrients|micronutrients|mesh-ancestor
64903744|NCT00005944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64903745|NCT00005944|Alkylating Agents|alkylating agents|mesh-ancestor
64903746|NCT00005944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64903747|NCT00005944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903748|NCT00387699|Bevacizumab|bevacizumab|mesh-list
64903749|NCT00387699|Etoposide|etoposide|mesh-list
64903750|NCT00387699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64903751|NCT00387699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903752|NCT00387699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64903753|NCT00387699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64903754|NCT00387699|Growth Substances|growth substances|mesh-ancestor
64903755|NCT00387699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903756|NCT00387699|Growth Inhibitors|growth inhibitors|mesh-ancestor
64903761|NCT00387699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903762|NCT00005959|Prednisone|prednisone|mesh-list
64903763|NCT00005959|Cyclophosphamide|cyclophosphamide|mesh-list
64903764|NCT00005959|Rituximab|rituximab|mesh-list
64672273|NCT02386319|Melatonin|melatonin|mesh-list
64903765|NCT00005959|Doxorubicin|doxorubicin|mesh-list
64903766|NCT00005959|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64903767|NCT00005959|Vincristine|vincristine|mesh-list
64903768|NCT00005959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64903769|NCT00005959|Immunologic Factors|immunologic factors|mesh-ancestor
64903770|NCT00005959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903801|NCT00005962|Gemtuzumab|gemtuzumab|mesh-list
64523999|NCT01352962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64524000|NCT01352962|Immunologic Factors|immunologic factors|mesh-ancestor
64524001|NCT01352962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524002|NCT01352962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64524003|NCT01352962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64524004|NCT01352962|Growth Substances|growth substances|mesh-ancestor
64524005|NCT01352962|Growth Inhibitors|growth inhibitors|mesh-ancestor
64524006|NCT03465592|Nivolumab|nivolumab|mesh-list
64524007|NCT03465592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64524008|NCT03465592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64524009|NCT03465592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64524010|NCT03465592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524011|NCT02441062|Edotreotide|edotreotide|mesh-list
64524012|NCT02441062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64524013|NCT02441062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524014|NCT02442700|Pitavastatin|pitavastatin|mesh-list
64903802|NCT00005962|Sargramostim|sargramostim|mesh-list
64903803|NCT00005962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64903804|NCT00005962|Immunologic Factors|immunologic factors|mesh-ancestor
64903805|NCT00005962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903806|NCT00005962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64903807|NCT00005962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64903808|NCT00005962|Alkylating Agents|alkylating agents|mesh-ancestor
64903809|NCT00005962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903810|NCT00005962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903811|NCT00005962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64903812|NCT00005962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64903813|NCT00005962|Antimetabolites|antimetabolites|mesh-ancestor
64903814|NCT00005962|Antiviral Agents|antiviral agents|mesh-ancestor
64903815|NCT00005962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64903849|NCT00005974|Alvocidib|alvocidib|mesh-list
64903850|NCT00005974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903851|NCT00005974|Growth Inhibitors|growth inhibitors|mesh-ancestor
64903852|NCT00005974|Growth Substances|growth substances|mesh-ancestor
64903853|NCT00005974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903854|NCT00005974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64903887|NCT00005977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64903888|NCT00005977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64903889|NCT00005977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64903890|NCT00005977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903891|NCT00005977|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64903892|NCT00005977|Abortifacient Agents|abortifacient agents|mesh-ancestor
64903893|NCT00005977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64903894|NCT00005977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64903895|NCT00005977|Antimetabolites|antimetabolites|mesh-ancestor
64903896|NCT00005977|Dermatologic Agents|dermatologic agents|mesh-ancestor
64903897|NCT00005977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64903898|NCT00005977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64903931|NCT00005986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64903932|NCT00005986|Antiviral Agents|antiviral agents|mesh-ancestor
64903933|NCT00005986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64903934|NCT00005989|Tipifarnib|tipifarnib|mesh-list
64903935|NCT00005989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903936|NCT00005998|Cytarabine|cytarabine|mesh-list
64903937|NCT00005998|Dexamethasone|dexamethasone|mesh-list
64903938|NCT00005998|Cyclophosphamide|cyclophosphamide|mesh-list
64903939|NCT00005998|Carmustine|carmustine|mesh-list
64903943|NCT00005998|Immunologic Factors|immunologic factors|mesh-ancestor
64903975|NCT00006351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903976|NCT00006351|Antiviral Agents|antiviral agents|mesh-ancestor
64903977|NCT00006351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64903978|NCT00006351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903979|NCT00006351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64903980|NCT00006351|Immunologic Factors|immunologic factors|mesh-ancestor
64903981|NCT00006351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903982|NCT00006001|Semaxinib|semaxinib|mesh-list
64903983|NCT00006001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64903984|NCT00006001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64903985|NCT00006001|Growth Substances|growth substances|mesh-ancestor
64904021|NCT00006007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64904022|NCT00006007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64904023|NCT00006010|Gemcitabine|gemcitabine|mesh-list
64904024|NCT00006010|Docetaxel|docetaxel|mesh-list
64904042|NCT00006013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904043|NCT00006013|Growth Inhibitors|growth inhibitors|mesh-ancestor
64904044|NCT00006013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904045|NCT00006013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64904046|NCT00006013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904047|NCT00006013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904048|NCT00006357|Imatinib Mesylate|imatinib mesylate|mesh-list
64904049|NCT00006357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904050|NCT00006357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64904051|NCT00006357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904052|NCT00006357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904054|NCT00006016|Doxorubicin|doxorubicin|mesh-list
64904055|NCT00006016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64904056|NCT00006016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64904057|NCT00006016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904058|NCT00006016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64904059|NCT00006016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64904060|NCT00006016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904061|NCT00006016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904062|NCT00006016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64904063|NCT00006016|Immunologic Factors|immunologic factors|mesh-ancestor
64904064|NCT00006016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904065|NCT00006016|Leprostatic Agents|leprostatic agents|mesh-ancestor
64904066|NCT00006016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64904067|NCT00006016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904068|NCT00006016|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64904069|NCT00006016|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64904070|NCT00006016|Growth Substances|growth substances|mesh-ancestor
64904071|NCT00006016|Growth Inhibitors|growth inhibitors|mesh-ancestor
64904072|NCT00006019|Azacitidine|azacitidine|mesh-list
64904073|NCT00006019|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64904074|NCT00006019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64904075|NCT00006019|Antimetabolites|antimetabolites|mesh-ancestor
64524027|NCT00568672|Autonomic Agents|autonomic agents|mesh-ancestor
64524028|NCT00568672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649191|NCT00802100|Serotonin Agents|serotonin agents|mesh-ancestor
64904076|NCT00006019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904077|NCT00006019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904078|NCT00006019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904079|NCT00006022|Aldesleukin|aldesleukin|mesh-list
64904080|NCT00006022|Bryostatin 1|bryostatin 1|mesh-list
64904081|NCT00006022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904109|NCT00386659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64904110|NCT00386659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64904111|NCT00386659|Antiviral Agents|antiviral agents|mesh-ancestor
64904112|NCT00386659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904113|NCT00386659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64904114|NCT00386659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64904115|NCT00386659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64904116|NCT00386659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64904117|NCT00386659|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64904118|NCT00386659|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64904119|NCT00386659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64904120|NCT00386659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64904121|NCT00386659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64904122|NCT00386659|Antimetabolites|antimetabolites|mesh-ancestor
64904123|NCT00006028|Gemcitabine|gemcitabine|mesh-list
64904124|NCT00006028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904125|NCT00006028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64904126|NCT00006028|Antimetabolites|antimetabolites|mesh-ancestor
64904127|NCT00006028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904128|NCT00006028|Antiviral Agents|antiviral agents|mesh-ancestor
64904129|NCT00006028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904163|NCT00006037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904164|NCT00006037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64904165|NCT00006037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64904168|NCT00006040|Antibodies|antibodies|mesh-list
64904169|NCT00006040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64904170|NCT00006040|Immunologic Factors|immunologic factors|mesh-ancestor
64904202|NCT00006363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64904203|NCT00006363|Analgesics|analgesics|mesh-ancestor
64904204|NCT00006363|Sensory System Agents|sensory system agents|mesh-ancestor
64904205|NCT00006363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64904206|NCT00006363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64904207|NCT00006363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64904209|NCT05680870|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64904210|NCT05680870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64904211|NCT05680870|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64904212|NCT05680870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904213|NCT05680870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904244|NCT00006372|Gemcitabine|gemcitabine|mesh-list
64904245|NCT00006372|Doxorubicin|doxorubicin|mesh-list
64904246|NCT00006372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64904247|NCT00006372|Vinorelbine|vinorelbine|mesh-list
64904248|NCT00006372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64430835|NCT01901614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64605421|NCT02635828|Hormones|hormones|mesh-ancestor
64904249|NCT00006372|Antimetabolites|antimetabolites|mesh-ancestor
64904250|NCT00006372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904251|NCT00006372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904252|NCT00006372|Antiviral Agents|antiviral agents|mesh-ancestor
64524035|NCT00568672|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64524036|NCT00568672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64524037|NCT00568672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64524038|NCT00568672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524039|NCT00568672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64524041|NCT02448862|Fentanyl|fentanyl|mesh-list
64524042|NCT02448862|Analgesics|analgesics|mesh-list
64524043|NCT02448862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64524051|NCT02448862|Anesthetics, General|anesthetics, general|mesh-ancestor
64524053|NCT01697267|Rituximab|rituximab|mesh-list
64524054|NCT01697267|Azathioprine|azathioprine|mesh-list
64524055|NCT01697267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64524056|NCT01697267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64524057|NCT01697267|Immunologic Factors|immunologic factors|mesh-ancestor
64524058|NCT01697267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524059|NCT01697267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64524060|NCT01697267|Antimetabolites|antimetabolites|mesh-ancestor
64524061|NCT01697267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524062|NCT01697267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64524063|NCT01697267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64904253|NCT00006372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904254|NCT00006372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904255|NCT00006372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64904256|NCT00006372|Immunologic Factors|immunologic factors|mesh-ancestor
64904257|NCT00006372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904258|NCT00006372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64904279|NCT00006381|Analgesics|analgesics|mesh-ancestor
64904280|NCT00006381|Sensory System Agents|sensory system agents|mesh-ancestor
64904281|NCT00006381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64904282|NCT00006381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904283|NCT00006381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64904284|NCT00006381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64904285|NCT00006381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64904286|NCT00006381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64904287|NCT00006381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904288|NCT00006381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904289|NCT00006384|Interferons|interferons|mesh-list
64524064|NCT00362986|Sunscreening Agents|sunscreening agents|mesh-list
64524065|NCT00362986|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64524066|NCT00362986|Protective Agents|protective agents|mesh-ancestor
64524067|NCT00362986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524068|NCT00362986|Dermatologic Agents|dermatologic agents|mesh-ancestor
64524070|NCT00363376|Olanzapine|olanzapine|mesh-list
64524071|NCT00363376|Antiemetics|antiemetics|mesh-ancestor
64524072|NCT00363376|Autonomic Agents|autonomic agents|mesh-ancestor
64524073|NCT00363376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524074|NCT00363376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524075|NCT00363376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64524077|NCT00363376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64524078|NCT00363376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64524079|NCT00363376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64524080|NCT00363376|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64524081|NCT00363376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64524082|NCT00363376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64524083|NCT00363376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524084|NCT00363376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64524085|NCT00363376|Serotonin Agents|serotonin agents|mesh-ancestor
64524086|NCT00363376|Anticonvulsants|anticonvulsants|mesh-ancestor
64524087|NCT00363376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64524088|NCT00363376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64524089|NCT02451202|Rocuronium|rocuronium|mesh-list
64524090|NCT02451202|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64524091|NCT02451202|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64524092|NCT02451202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64524093|NCT02451202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524094|NCT02451202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524095|NCT02452060|Ketamine|ketamine|mesh-list
64649208|NCT00809276|Cyclophosphamide|cyclophosphamide|mesh-list
64524110|NCT01696955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64524111|NCT01696955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64524113|NCT02452528|Promethazine|promethazine|mesh-list
64524114|NCT02452528|Tenofovir|tenofovir|mesh-list
64524115|NCT02452528|Entecavir|entecavir|mesh-list
64524116|NCT02452528|Antiviral Agents|antiviral agents|mesh-ancestor
64524117|NCT02452528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64524118|NCT02452528|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64904290|NCT00006384|Interferon-alpha|interferon-alpha|mesh-list
64904291|NCT00006384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904292|NCT00006384|Antiviral Agents|antiviral agents|mesh-ancestor
64904293|NCT00006384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904294|NCT00006384|Immunologic Factors|immunologic factors|mesh-ancestor
64904295|NCT00006384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904296|NCT00386815|Pemetrexed|pemetrexed|mesh-list
64904298|NCT00386815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904299|NCT00386815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904300|NCT00386815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64904301|NCT00386815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64904302|NCT05679388|Ritonavir|ritonavir|mesh-list
64904303|NCT05679388|Itraconazole|itraconazole|mesh-list
64904304|NCT05679388|Relugolix|relugolix|mesh-list
64904305|NCT05679388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64904306|NCT05679388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64904307|NCT05679388|Protease Inhibitors|protease inhibitors|mesh-ancestor
64904308|NCT05679388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904309|NCT05679388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904310|NCT05679388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64904311|NCT05679388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64904312|NCT05679388|Antiviral Agents|antiviral agents|mesh-ancestor
64904313|NCT05679388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904329|NCT00006390|Cyclophosphamide|cyclophosphamide|mesh-list
64904330|NCT00006390|Alemtuzumab|alemtuzumab|mesh-list
64904331|NCT00006390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64904332|NCT00006390|Immunologic Factors|immunologic factors|mesh-ancestor
64904333|NCT00006390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904334|NCT00006390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64904335|NCT00006390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64904336|NCT00006390|Alkylating Agents|alkylating agents|mesh-ancestor
64904337|NCT00006390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904338|NCT00006390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904339|NCT00006390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64904340|NCT00006390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64904341|NCT05675293|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64904342|NCT05675293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904343|NCT00006396|Zidovudine|zidovudine|mesh-list
64904344|NCT00006396|Nevirapine|nevirapine|mesh-list
64904345|NCT00006396|Antimetabolites|antimetabolites|mesh-ancestor
64904346|NCT00006396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904347|NCT00006396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64904348|NCT00006396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64904349|NCT00006396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904350|NCT00006396|Antiviral Agents|antiviral agents|mesh-ancestor
64904351|NCT00006396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904352|NCT00006396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64904353|NCT00006396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64904354|NCT00006396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64904355|NCT00006396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64904356|NCT03996148|Dexmedetomidine|dexmedetomidine|mesh-list
64904357|NCT03996148|Remifentanil|remifentanil|mesh-list
64524119|NCT02452528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64524120|NCT02452528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524121|NCT02452528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524122|NCT02452528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64524123|NCT02452528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64524124|NCT02452528|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64524125|NCT02452528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64524126|NCT02452528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64524127|NCT02452528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524128|NCT02452528|Anesthetics, Local|anesthetics, local|mesh-ancestor
64904359|NCT03996148|Desflurane|desflurane|mesh-list
64904360|NCT03996148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64904361|NCT03996148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64904362|NCT03996148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904363|NCT03996148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64904364|NCT03996148|Anesthetics, General|anesthetics, general|mesh-ancestor
64904365|NCT03996148|Anesthetics|anesthetics|mesh-ancestor
64904366|NCT03996148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64904367|NCT03996148|Analgesics|analgesics|mesh-ancestor
64904368|NCT03996148|Sensory System Agents|sensory system agents|mesh-ancestor
64904369|NCT03996148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64904370|NCT03996148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64904371|NCT03996148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64904397|NCT05656027|Aceclidine|aceclidine|mesh-list
64904398|NCT05656027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64904399|NCT05656027|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64904400|NCT05656027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64904401|NCT05656027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64904402|NCT05656027|Adrenergic Agents|adrenergic agents|mesh-ancestor
64904403|NCT05656027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64904404|NCT05656027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904405|NCT05656027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904406|NCT05656027|Miotics|miotics|mesh-ancestor
64904407|NCT05656027|Autonomic Agents|autonomic agents|mesh-ancestor
64904408|NCT05656027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64904409|NCT05656027|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64904410|NCT05552404|Aminophylline|aminophylline|mesh-list
64904411|NCT05552404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64904412|NCT05552404|Autonomic Agents|autonomic agents|mesh-ancestor
64904413|NCT05552404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64904414|NCT05552404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904415|NCT05552404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64904416|NCT05552404|Respiratory System Agents|respiratory system agents|mesh-ancestor
64904417|NCT05552404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64904418|NCT05552404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64904419|NCT05552404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904420|NCT05552404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904421|NCT05552404|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64904422|NCT05552404|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64904456|NCT05546320|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64904457|NCT05546320|Sympatholytics|sympatholytics|mesh-ancestor
64524135|NCT02452528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64524136|NCT02452528|Histamine Antagonists|histamine antagonists|mesh-ancestor
64524137|NCT02452528|Histamine Agents|histamine agents|mesh-ancestor
64524138|NCT02452528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64524139|NCT02452528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64524140|NCT02452528|Antipruritics|antipruritics|mesh-ancestor
64524141|NCT02452528|Dermatologic Agents|dermatologic agents|mesh-ancestor
64524142|NCT02702388|Lenvatinib|lenvatinib|mesh-list
64524143|NCT02702388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64524144|NCT02702388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64524145|NCT02702388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733759|NCT00004705|Amiloride|amiloride|mesh-list
64733760|NCT00004705|Diuretics|diuretics|mesh-ancestor
64733761|NCT00004705|Natriuretic Agents|natriuretic agents|mesh-ancestor
64524146|NCT02702388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524147|NCT02456896|Oxcarbazepine|oxcarbazepine|mesh-list
64524148|NCT02456896|Anticonvulsants|anticonvulsants|mesh-ancestor
64524149|NCT02456896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64524150|NCT02456896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64524151|NCT02456896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64524152|NCT02456896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524153|NCT02456896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64904458|NCT05546320|Autonomic Agents|autonomic agents|mesh-ancestor
64904459|NCT05546320|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64904462|NCT05546320|Adrenergic Agents|adrenergic agents|mesh-ancestor
64904463|NCT05535595|Perindopril|perindopril|mesh-list
64904464|NCT05535595|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64904493|NCT05413018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64904494|NCT05413018|Antimetabolites|antimetabolites|mesh-ancestor
64904495|NCT05413018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904496|NCT05413018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904497|NCT05413018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904499|NCT05401786|Cemiplimab|cemiplimab|mesh-list
64904500|NCT05401786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64904501|NCT05401786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904502|NCT05401786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64904503|NCT05401786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904504|NCT05285683|Levodopa|levodopa|mesh-list
64904505|NCT05285683|Carbidopa|carbidopa|mesh-list
64904506|NCT05285683|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64904507|NCT05285683|Methylphenidate|methylphenidate|mesh-list
64904508|NCT05285683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64904509|NCT05285683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904510|NCT05285683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64904511|NCT05285683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64904546|NCT00006441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904547|NCT00006441|Antiviral Agents|antiviral agents|mesh-ancestor
64904548|NCT00006441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904549|NCT00006441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64904550|NCT00006441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64904551|NCT00006441|Antimetabolites|antimetabolites|mesh-ancestor
64524154|NCT02456896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64524155|NCT01696877|Cyclophosphamide|cyclophosphamide|mesh-list
64524156|NCT01696877|Molgramostim|molgramostim|mesh-list
64524157|NCT01696877|Sargramostim|sargramostim|mesh-list
64524158|NCT01696877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64524159|NCT01696877|Immunologic Factors|immunologic factors|mesh-ancestor
64524160|NCT01696877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524161|NCT01696877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64524162|NCT01696877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64524163|NCT01696877|Alkylating Agents|alkylating agents|mesh-ancestor
64524164|NCT01696877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524165|NCT01696877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904552|NCT00006441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904574|NCT00006453|Carboplatin|carboplatin|mesh-list
64904575|NCT00006453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904576|NCT00006453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64904577|NCT00006453|Antimetabolites|antimetabolites|mesh-ancestor
64904578|NCT00006453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904579|NCT00006453|Antiviral Agents|antiviral agents|mesh-ancestor
64904580|NCT00006453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904581|NCT00006453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904582|NCT00006453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64904583|NCT00006453|Immunologic Factors|immunologic factors|mesh-ancestor
64904584|NCT00006453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904585|NCT00387322|Pemetrexed|pemetrexed|mesh-list
64904586|NCT00387322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64904587|NCT00387322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904588|NCT00387322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904589|NCT00387322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904590|NCT00387322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64904591|NCT00387322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64904592|NCT00387322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64904593|NCT00006459|Gemcitabine|gemcitabine|mesh-list
64904594|NCT00006459|Paclitaxel|paclitaxel|mesh-list
64904595|NCT00006459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64904596|NCT00006459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904597|NCT00006459|Tubulin Modulators|tubulin modulators|mesh-ancestor
64673107|NCT03357393|Midazolam|midazolam|mesh-list
64904598|NCT00006459|Antimitotic Agents|antimitotic agents|mesh-ancestor
64904599|NCT00006459|Mitosis Modulators|mitosis modulators|mesh-ancestor
64904600|NCT00006459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649221|NCT00802412|Anticonvulsants|anticonvulsants|mesh-ancestor
64904604|NCT00006459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904605|NCT00006459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904627|NCT00388089|Topotecan|topotecan|mesh-list
64904628|NCT00388089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904629|NCT00388089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64904630|NCT00388089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64904631|NCT00388089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904632|NCT00388089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904633|NCT04742023|Insulin|insulin|mesh-list
64904634|NCT04742023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64904635|NCT04742023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904636|NCT00388128|Caffeine|caffeine|mesh-list
64904637|NCT00388128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64904638|NCT00388128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904639|NCT00388128|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64904640|NCT00388128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904641|NCT00388128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904642|NCT00388128|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64524166|NCT01696877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64524167|NCT02416102|Losartan|losartan|mesh-list
64524168|NCT02416102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64524169|NCT02416102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64524170|NCT02416102|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64524171|NCT02416102|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64524172|NCT02416102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524173|NCT02414256|Anesthetics|anesthetics|mesh-list
64524174|NCT02414256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64524175|NCT02414256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524176|NCT02458690|Dopamine|dopamine|mesh-list
64524177|NCT02458690|Norepinephrine|norepinephrine|mesh-list
64524178|NCT02458690|Antidepressive Agents|antidepressive agents|mesh-list
64524179|NCT02458690|Serotonin|serotonin|mesh-list
64524180|NCT02458690|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
64733846|NCT00385645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64733847|NCT00385645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64733848|NCT00385645|Protease Inhibitors|protease inhibitors|mesh-ancestor
64733849|NCT00385645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733850|NCT00385645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733851|NCT00385645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64733852|NCT00385645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64605737|NCT02456857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904643|NCT00388128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64904644|NCT00388128|Purinergic Agents|purinergic agents|mesh-ancestor
64904645|NCT00388128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64904646|NCT00006462|Gemcitabine|gemcitabine|mesh-list
64904647|NCT00006462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64904648|NCT00006462|Antimetabolites|antimetabolites|mesh-ancestor
64904649|NCT00006462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904650|NCT00006462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904651|NCT00006462|Antiviral Agents|antiviral agents|mesh-ancestor
64904652|NCT00006462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904653|NCT00006462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904654|NCT00006462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64904655|NCT00006462|Immunologic Factors|immunologic factors|mesh-ancestor
64904656|NCT00006462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904657|NCT04640545|Axitinib|axitinib|mesh-list
64904658|NCT04640545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904659|NCT04640545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64904678|NCT04575181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904679|NCT00006468|Leucovorin|leucovorin|mesh-list
64904680|NCT00006468|Fluorouracil|fluorouracil|mesh-list
64904681|NCT00006468|Oxaliplatin|oxaliplatin|mesh-list
64904682|NCT00006468|Calcium|calcium|mesh-list
64904683|NCT00006468|Levoleucovorin|levoleucovorin|mesh-list
64904684|NCT00006468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64904685|NCT00006468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904686|NCT00006468|Antimetabolites|antimetabolites|mesh-ancestor
64904687|NCT00006468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904688|NCT00006468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64904689|NCT00006468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904690|NCT00006468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64904691|NCT00006468|Immunologic Factors|immunologic factors|mesh-ancestor
64904692|NCT00006468|Antidotes|antidotes|mesh-ancestor
64904693|NCT00006468|Protective Agents|protective agents|mesh-ancestor
64904694|NCT00006468|Vitamin B Complex|vitamin b complex|mesh-ancestor
64904695|NCT00006468|Vitamins|vitamins|mesh-ancestor
64904696|NCT00006468|Micronutrients|micronutrients|mesh-ancestor
64904697|NCT04513522|Nivolumab|nivolumab|mesh-list
64904698|NCT04513522|Ipilimumab|ipilimumab|mesh-list
64904703|NCT00006471|Fenretinide|fenretinide|mesh-list
64904704|NCT00006471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904705|NCT00006471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64524181|NCT02458690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-list
64524182|NCT02458690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64524183|NCT02458690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64524184|NCT02458690|Adrenergic Agents|adrenergic agents|mesh-ancestor
64524185|NCT02458690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64524186|NCT02458690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524187|NCT02458690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524188|NCT02458690|Sympathomimetics|sympathomimetics|mesh-ancestor
64524189|NCT02458690|Autonomic Agents|autonomic agents|mesh-ancestor
64524190|NCT02458690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524191|NCT02458690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64524192|NCT02458690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64524193|NCT02458690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64524194|NCT02458690|Dopamine Agents|dopamine agents|mesh-ancestor
64524195|NCT02458690|Protective Agents|protective agents|mesh-ancestor
64524196|NCT02458690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64524197|NCT02458690|Serotonin Agents|serotonin agents|mesh-ancestor
64524198|NCT02458690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64904706|NCT00006471|Protective Agents|protective agents|mesh-ancestor
64904707|NCT00006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904708|NCT00006474|Temozolomide|temozolomide|mesh-list
64904709|NCT00006474|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64904710|NCT00006474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64904711|NCT00006474|Alkylating Agents|alkylating agents|mesh-ancestor
64904712|NCT00006474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904713|NCT00006474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904714|NCT00006474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605788|NCT00841555|Temozolomide|temozolomide|mesh-list
64904715|NCT04355572|Vitamin D|vitamin d|mesh-list
64904716|NCT04355572|Vitamins|vitamins|mesh-ancestor
64904717|NCT04355572|Micronutrients|micronutrients|mesh-ancestor
64904718|NCT04355572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904744|NCT04191187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904745|NCT04191187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64904747|NCT04191187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64904748|NCT04164199|Capecitabine|capecitabine|mesh-list
64904749|NCT04164199|Pemetrexed|pemetrexed|mesh-list
64904750|NCT04164199|Temozolomide|temozolomide|mesh-list
64904751|NCT04164199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64904753|NCT04164199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904754|NCT04164199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904755|NCT04164199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904756|NCT04164199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64904757|NCT04164199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64904758|NCT04164199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64904759|NCT04164199|Alkylating Agents|alkylating agents|mesh-ancestor
64904760|NCT03771157|Vaccines|vaccines|mesh-list
64904761|NCT03771157|Immunologic Factors|immunologic factors|mesh-ancestor
64904762|NCT03771157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904763|NCT03765229|Pembrolizumab|pembrolizumab|mesh-list
64904764|NCT03765229|Entinostat|entinostat|mesh-list
64904765|NCT03765229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64904766|NCT03765229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904767|NCT03765229|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64904768|NCT03765229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904799|NCT00423397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64524199|NCT02458690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64524200|NCT02458768|Menotropins|menotropins|mesh-list
64480303|NCT00615472|Anesthetics|anesthetics|mesh-ancestor
64524201|NCT02458768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64524202|NCT02458768|Fertility Agents|fertility agents|mesh-ancestor
64524203|NCT02458768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64524204|NCT02458768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524205|NCT02418676|Insulin|insulin|mesh-list
64649227|NCT01355705|Lenalidomide|lenalidomide|mesh-list
64524212|NCT02419638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524213|NCT02422836|Sunscreening Agents|sunscreening agents|mesh-list
64524214|NCT02422836|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64524215|NCT02422836|Protective Agents|protective agents|mesh-ancestor
64524216|NCT02422836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524217|NCT02422836|Dermatologic Agents|dermatologic agents|mesh-ancestor
64524218|NCT03179514|Vasodilator Agents|vasodilator agents|mesh-list
64524219|NCT03179514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64524220|NCT03179514|Lipid Regulating Agents|lipid regulating agents|mesh-list
64524221|NCT00707304|Lactoferrin|lactoferrin|mesh-list
64524222|NCT00707304|Talactoferrin alfa|talactoferrin alfa|mesh-list
64904800|NCT00423397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904801|NCT00423397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904802|NCT03352765|Rituximab|rituximab|mesh-list
64904803|NCT03352765|Melphalan|melphalan|mesh-list
64904804|NCT03352765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64904805|NCT03352765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64904806|NCT03352765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904807|NCT03352765|Immunologic Factors|immunologic factors|mesh-ancestor
64904808|NCT03352765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904809|NCT03352765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64904810|NCT03352765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64904811|NCT03352765|Alkylating Agents|alkylating agents|mesh-ancestor
64904812|NCT03352765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904813|NCT03352765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64904814|NCT03352765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64320966|NCT02567708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320968|NCT05509244|Ibuprofen|ibuprofen|mesh-list
64320969|NCT05509244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64904836|NCT03808480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64904837|NCT03808480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904838|NCT03808480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64904839|NCT03808480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904840|NCT03003325|Aspirin|aspirin|mesh-list
64904841|NCT03003325|Interferons|interferons|mesh-list
64904842|NCT03003325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904843|NCT03003325|Antiviral Agents|antiviral agents|mesh-ancestor
64904844|NCT03003325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64524223|NCT00707304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64524224|NCT00707304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64524226|NCT02423980|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64524227|NCT02423980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64524228|NCT02423980|Hormones|hormones|mesh-ancestor
64524229|NCT02423980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64524230|NCT02423980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524231|NCT02423980|Incretins|incretins|mesh-ancestor
64524232|NCT03176316|Naloxone|naloxone|mesh-list
64524233|NCT03176316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64524234|NCT03176316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524235|NCT03176316|Sensory System Agents|sensory system agents|mesh-ancestor
64524236|NCT03176316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524237|NCT02419170|Cyclophosphamide|cyclophosphamide|mesh-list
64524238|NCT02419170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64524239|NCT02419170|Immunologic Factors|immunologic factors|mesh-ancestor
64524240|NCT02419170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524241|NCT02419170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64904845|NCT03003325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64904846|NCT03003325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64904847|NCT03003325|Analgesics|analgesics|mesh-ancestor
64904848|NCT03003325|Sensory System Agents|sensory system agents|mesh-ancestor
64904849|NCT03003325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64904850|NCT03003325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904851|NCT03003325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64904852|NCT03003325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64904853|NCT03003325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64904854|NCT03003325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64904862|NCT02966548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904863|NCT02966548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64904864|NCT02966548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904865|NCT02890069|Everolimus|everolimus|mesh-list
64904866|NCT02890069|Panobinostat|panobinostat|mesh-list
64904867|NCT02890069|Spartalizumab|spartalizumab|mesh-list
64904868|NCT02890069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904869|NCT02890069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64904870|NCT02890069|Immunologic Factors|immunologic factors|mesh-ancestor
64904899|NCT00006480|Antiviral Agents|antiviral agents|mesh-ancestor
64904900|NCT00006480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904901|NCT00006480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64904902|NCT00006480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904903|NCT00006480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904904|NCT00006483|Sargramostim|sargramostim|mesh-list
64904905|NCT00006483|Immunologic Factors|immunologic factors|mesh-ancestor
64904906|NCT00006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904907|NCT00006486|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
64904908|NCT00006486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904909|NCT00006486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64904910|NCT00006486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64524244|NCT02419170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524245|NCT02419170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64524246|NCT02419170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64524247|NCT02974426|Cisplatin|cisplatin|mesh-list
64524248|NCT02974426|Carboplatin|carboplatin|mesh-list
64524249|NCT02974426|Pemetrexed|pemetrexed|mesh-list
64524250|NCT02974426|Vinorelbine|vinorelbine|mesh-list
64605918|NCT02715700|Narcotics|narcotics|mesh-ancestor
64904911|NCT00006486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904912|NCT00006486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64904913|NCT00006486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904914|NCT03606213|Vaccines|vaccines|mesh-list
64904915|NCT03606213|Immunologic Factors|immunologic factors|mesh-ancestor
64904933|NCT00006591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64904934|NCT00006591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64904935|NCT00006591|Antiviral Agents|antiviral agents|mesh-ancestor
64904936|NCT00006591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904937|NCT00006591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64904938|NCT00006591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64904939|NCT00006591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64904940|NCT00006591|Antitubercular Agents|antitubercular agents|mesh-ancestor
64904941|NCT00006591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64904942|NCT00006630|Immunoglobulins|immunoglobulins|mesh-list
64904943|NCT00006630|Antibodies|antibodies|mesh-list
64904944|NCT00006630|gamma-Globulins|gamma-globulins|mesh-list
64904945|NCT00006630|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64904946|NCT00006630|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64904947|NCT00006630|Immunologic Factors|immunologic factors|mesh-ancestor
64904948|NCT00006630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904949|NCT00006669|Prednisone|prednisone|mesh-list
64904950|NCT00006669|Cyclophosphamide|cyclophosphamide|mesh-list
64904951|NCT00006669|Rituximab|rituximab|mesh-list
64904952|NCT00006669|Doxorubicin|doxorubicin|mesh-list
64904953|NCT00006669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64904954|NCT00006669|Etoposide|etoposide|mesh-list
64904955|NCT00006669|Vincristine|vincristine|mesh-list
64904956|NCT00006669|Sargramostim|sargramostim|mesh-list
64904957|NCT00006669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64904958|NCT00006669|Immunologic Factors|immunologic factors|mesh-ancestor
64904959|NCT00006669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904960|NCT00006669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64649237|NCT01355705|Hormones|hormones|mesh-ancestor
64904969|NCT00006669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64904970|NCT00006669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904971|NCT00006669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64904972|NCT00006669|Glucocorticoids|glucocorticoids|mesh-ancestor
64905009|NCT00006747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905010|NCT00006747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905011|NCT00006747|Dermatologic Agents|dermatologic agents|mesh-ancestor
64905012|NCT00006747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905013|NCT00006747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64905014|NCT00006747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64905015|NCT00006747|Immunologic Factors|immunologic factors|mesh-ancestor
64905037|NCT00006786|Growth Substances|growth substances|mesh-ancestor
64905038|NCT00006786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905039|NCT00006786|Growth Inhibitors|growth inhibitors|mesh-ancestor
64524251|NCT02974426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64524252|NCT02974426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524253|NCT02974426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524254|NCT02974426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64524255|NCT02974426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64905040|NCT00006786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64905041|NCT00006786|Antimetabolites|antimetabolites|mesh-ancestor
64905042|NCT00006786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905043|NCT00006786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64905044|NCT00006786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64905045|NCT00006786|Immunologic Factors|immunologic factors|mesh-ancestor
64905046|NCT00006786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64905047|NCT00006786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64905048|NCT00006786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905049|NCT00006786|Antidotes|antidotes|mesh-ancestor
64733853|NCT00385645|Antiviral Agents|antiviral agents|mesh-ancestor
64733854|NCT00385645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64733855|NCT00385645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64733856|NCT00385645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64733857|NCT00385645|Antimetabolites|antimetabolites|mesh-ancestor
64733858|NCT00385957|Lamivudine|lamivudine|mesh-list
64905050|NCT00006786|Protective Agents|protective agents|mesh-ancestor
64905051|NCT00006786|Vitamin B Complex|vitamin b complex|mesh-ancestor
64905052|NCT00006786|Vitamins|vitamins|mesh-ancestor
64905053|NCT00006786|Micronutrients|micronutrients|mesh-ancestor
64905054|NCT00006825|Doxorubicin|doxorubicin|mesh-list
64905055|NCT00006825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64905056|NCT00006825|Trastuzumab|trastuzumab|mesh-list
64905057|NCT00006825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64905058|NCT00006825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905059|NCT00006825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64905060|NCT00006825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64905061|NCT00006825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905062|NCT00006825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905063|NCT00006825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64905064|NCT00006864|Aldesleukin|aldesleukin|mesh-list
64905065|NCT00006864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905066|NCT00006864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64905067|NCT00006864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64905068|NCT00006864|Antiviral Agents|antiviral agents|mesh-ancestor
64905069|NCT00006864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64905070|NCT00006942|Bryostatin 1|bryostatin 1|mesh-list
64905071|NCT00006942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905136|NCT00006052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905137|NCT00006055|Cyclosporine|cyclosporine|mesh-list
64905138|NCT00006055|Prednisone|prednisone|mesh-list
64905139|NCT00006055|Methylprednisolone|methylprednisolone|mesh-list
64905140|NCT00006055|Cyclophosphamide|cyclophosphamide|mesh-list
64905145|NCT00006055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905146|NCT00006055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64905147|NCT00006055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64905148|NCT00006055|Alkylating Agents|alkylating agents|mesh-ancestor
64905149|NCT00006055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905150|NCT00006055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905151|NCT00006055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64905152|NCT00006055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64905153|NCT00006055|Glucocorticoids|glucocorticoids|mesh-ancestor
64905186|NCT00006079|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64905187|NCT00006079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905188|NCT00006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905189|NCT00006082|Rubitecan|rubitecan|mesh-list
64905190|NCT00006082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905191|NCT00006082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64905192|NCT00006082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64905193|NCT00006082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905194|NCT00006082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905195|NCT00006088|Vinorelbine|vinorelbine|mesh-list
64905223|NCT00006100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64524256|NCT02974426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64524257|NCT02974426|Tubulin Modulators|tubulin modulators|mesh-ancestor
64524258|NCT02974426|Antimitotic Agents|antimitotic agents|mesh-ancestor
64524259|NCT02974426|Mitosis Modulators|mitosis modulators|mesh-ancestor
64524260|NCT02413554|Rivastigmine|rivastigmine|mesh-list
64524261|NCT02413554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64524262|NCT02413554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524263|NCT02413554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905224|NCT00006100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64905225|NCT00006100|Antiviral Agents|antiviral agents|mesh-ancestor
64905226|NCT00006100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64905227|NCT00006103|Leucovorin|leucovorin|mesh-list
64905228|NCT00006103|Fluorouracil|fluorouracil|mesh-list
64905229|NCT00006103|Irinotecan|irinotecan|mesh-list
64905230|NCT00006103|Calcium|calcium|mesh-list
64905231|NCT00006103|Levoleucovorin|levoleucovorin|mesh-list
64905232|NCT00006103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64905233|NCT00006103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905234|NCT00006103|Antimetabolites|antimetabolites|mesh-ancestor
64733859|NCT00385957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64905235|NCT00006103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905236|NCT00006103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64905237|NCT00006103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905238|NCT00006103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64905239|NCT00006103|Immunologic Factors|immunologic factors|mesh-ancestor
64905240|NCT00006103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64905241|NCT00006103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64905242|NCT00006103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905275|NCT00006112|Micronutrients|micronutrients|mesh-ancestor
64905276|NCT00006112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64905277|NCT00006112|Alkylating Agents|alkylating agents|mesh-ancestor
64905278|NCT00006112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64905279|NCT00006112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905280|NCT00006115|Leucovorin|leucovorin|mesh-list
64905281|NCT00006115|Fluorouracil|fluorouracil|mesh-list
64905282|NCT00006115|Oxaliplatin|oxaliplatin|mesh-list
64905283|NCT00006115|Irinotecan|irinotecan|mesh-list
64905284|NCT00006115|Calcium|calcium|mesh-list
64905285|NCT00006115|Levoleucovorin|levoleucovorin|mesh-list
64905286|NCT00006115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64905287|NCT00006115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905288|NCT00006115|Antimetabolites|antimetabolites|mesh-ancestor
64905289|NCT00006115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905290|NCT00006115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64905325|NCT00006124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64905326|NCT00006124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905327|NCT00006124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64905328|NCT00006124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64905329|NCT00006124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64905332|NCT00006124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905369|NCT00006154|Aldesleukin|aldesleukin|mesh-list
64905371|NCT00006154|Didanosine|didanosine|mesh-list
64905372|NCT00006154|Stavudine|stavudine|mesh-list
64905373|NCT00006154|Efavirenz|efavirenz|mesh-list
64905374|NCT00006154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64905375|NCT00006154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64905376|NCT00006154|Protease Inhibitors|protease inhibitors|mesh-ancestor
64905377|NCT00006154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905378|NCT00006154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905410|NCT00006190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64905411|NCT00006190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64905412|NCT00006190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905413|NCT00006190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905414|NCT00006190|Antiviral Agents|antiviral agents|mesh-ancestor
64905415|NCT00006190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64524265|NCT02413554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64524266|NCT02413554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524267|NCT02413554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64524269|NCT02422602|Rivaroxaban|rivaroxaban|mesh-list
64524270|NCT02422602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64524271|NCT02422602|Antithrombins|antithrombins|mesh-ancestor
64524272|NCT02422602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64524273|NCT02422602|Protease Inhibitors|protease inhibitors|mesh-ancestor
64524274|NCT02422602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905416|NCT00006190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64905417|NCT00006190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64905418|NCT00006190|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64905448|NCT00006205|Dermatologic Agents|dermatologic agents|mesh-ancestor
64905449|NCT00006205|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64905450|NCT00006205|Serotonin Agents|serotonin agents|mesh-ancestor
64905451|NCT00006205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64905452|NCT00006205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905453|NCT00006205|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64905454|NCT00006205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64905455|NCT00006205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64905456|NCT00006205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64905457|NCT00006205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64905458|NCT00006205|Anticonvulsants|anticonvulsants|mesh-ancestor
64905459|NCT00006205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64733868|NCT00005773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64733869|NCT00005773|Autonomic Agents|autonomic agents|mesh-ancestor
64905460|NCT00006208|Emtricitabine|emtricitabine|mesh-list
64905461|NCT00006208|Efavirenz|efavirenz|mesh-list
64905462|NCT00006208|Didanosine|didanosine|mesh-list
64905463|NCT00006208|Stavudine|stavudine|mesh-list
64905464|NCT00006208|Antiviral Agents|antiviral agents|mesh-ancestor
64905465|NCT00006208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64905466|NCT00006208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64905497|NCT00006214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64905498|NCT00006214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905499|NCT00006220|Arsenic Trioxide|arsenic trioxide|mesh-list
64905500|NCT00006220|Tretinoin|tretinoin|mesh-list
64905501|NCT00006220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905502|NCT00006220|Keratolytic Agents|keratolytic agents|mesh-ancestor
64905503|NCT00006220|Dermatologic Agents|dermatologic agents|mesh-ancestor
64905504|NCT00006223|Flt3 ligand protein|flt3 ligand protein|mesh-list
64905505|NCT00006223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64905506|NCT00006223|Immunologic Factors|immunologic factors|mesh-ancestor
64905538|NCT00006232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64905540|NCT00006232|Autonomic Agents|autonomic agents|mesh-ancestor
64905541|NCT00006232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64905542|NCT00006232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905543|NCT00006232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64905544|NCT00006232|Glucocorticoids|glucocorticoids|mesh-ancestor
64905545|NCT00006232|Hormones|hormones|mesh-ancestor
64905546|NCT00006232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64905547|NCT00006232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64905548|NCT00006232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905549|NCT00006232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64905550|NCT00006232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64905551|NCT00006232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64905589|NCT00006250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64905590|NCT00006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714101|NCT03054103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524275|NCT02422602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524277|NCT02465632|Clindamycin|clindamycin|mesh-list
64524278|NCT02465632|Clindamycin palmitate|clindamycin palmitate|mesh-list
64524279|NCT02465632|Clindamycin phosphate|clindamycin phosphate|mesh-list
64524280|NCT02465632|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64524281|NCT02465632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64524282|NCT02465632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64524283|NCT02465632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64524284|NCT02465632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905591|NCT00006250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64905592|NCT00006250|Glucocorticoids|glucocorticoids|mesh-ancestor
64905594|NCT00006250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64905595|NCT00006250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64905596|NCT00006250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905597|NCT00006250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64905626|NCT00007527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905628|NCT00007527|Sensory System Agents|sensory system agents|mesh-ancestor
64905629|NCT00007527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64905630|NCT00007527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64905632|NCT00006280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64905633|NCT00006280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64905634|NCT00006286|Fluoxetine|fluoxetine|mesh-list
64905635|NCT00006286|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64905636|NCT00006286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64905637|NCT00006286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64905638|NCT00006286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905639|NCT00006286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64905640|NCT00006286|Serotonin Agents|serotonin agents|mesh-ancestor
64905641|NCT00006286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905642|NCT00006286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64905643|NCT00006286|Antidepressive Agents|antidepressive agents|mesh-ancestor
64905675|NCT03709888|Memantine|memantine|mesh-list
64905676|NCT03709888|Analgesics|analgesics|mesh-ancestor
64905677|NCT03709888|Sensory System Agents|sensory system agents|mesh-ancestor
64905678|NCT03709888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64905679|NCT03709888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905680|NCT03709888|Anticonvulsants|anticonvulsants|mesh-ancestor
64905681|NCT03709888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64905682|NCT03709888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64905683|NCT03709888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905684|NCT03709888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64905685|NCT03709888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64905686|NCT03709888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64905719|NCT00006325|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64905720|NCT00006325|Antiviral Agents|antiviral agents|mesh-ancestor
64905721|NCT00006325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64905722|NCT00006337|Levodopa|levodopa|mesh-list
64905723|NCT00006337|Istradefylline|istradefylline|mesh-list
64905724|NCT00006337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64905725|NCT00006337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64905726|NCT00006337|Dopamine Agents|dopamine agents|mesh-ancestor
64905727|NCT00006337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64905728|NCT00006337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905756|NCT00006343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64905757|NCT00006343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905763|NCT00387868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524286|NCT02465632|Dermatologic Agents|dermatologic agents|mesh-ancestor
64524288|NCT02703636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64524289|NCT02703636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524290|NCT02703636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524291|NCT02703636|Cholinergic Agents|cholinergic agents|mesh-ancestor
64524292|NCT02703636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64524293|NCT02703636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524294|NCT02703636|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64524295|NCT02703636|Protective Agents|protective agents|mesh-ancestor
64524296|NCT02422056|Tranexamic Acid|tranexamic acid|mesh-list
64524297|NCT02422056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64524299|NCT02422056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524300|NCT02422056|Hemostatics|hemostatics|mesh-ancestor
64905764|NCT00387868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905765|NCT03616717|Modafinil|modafinil|mesh-list
64905766|NCT03616717|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64905767|NCT03616717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905768|NCT03616717|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64905769|NCT03616717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64905770|NCT03616717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64320970|NCT05509244|Analgesics|analgesics|mesh-ancestor
64320971|NCT05509244|Sensory System Agents|sensory system agents|mesh-ancestor
64320972|NCT05509244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64320973|NCT05509244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320974|NCT05509244|Antipyretics|antipyretics|mesh-ancestor
64320975|NCT05509244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64320977|NCT05509244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64905771|NCT03616717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905772|NCT00006349|Vitamin E|vitamin e|mesh-list
64905773|NCT00006349|Donepezil|donepezil|mesh-list
64905774|NCT00006349|Vitamins|vitamins|mesh-ancestor
64905811|NCT00006358|Thalidomide|thalidomide|mesh-list
64905812|NCT00006358|Temozolomide|temozolomide|mesh-list
64905813|NCT00006358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64905814|NCT00006358|Alkylating Agents|alkylating agents|mesh-ancestor
64905845|NCT00007917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64905846|NCT00007917|Antimetabolites|antimetabolites|mesh-ancestor
64905847|NCT00007917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905848|NCT00007917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905849|NCT00007917|Antiviral Agents|antiviral agents|mesh-ancestor
64905850|NCT00007917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64905851|NCT00007917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905852|NCT00007917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64905853|NCT00007917|Immunologic Factors|immunologic factors|mesh-ancestor
64905854|NCT00007917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905855|NCT00007917|Growth Inhibitors|growth inhibitors|mesh-ancestor
64905856|NCT00007917|Growth Substances|growth substances|mesh-ancestor
64905883|NCT00007956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905885|NCT00006373|Topotecan|topotecan|mesh-list
64905886|NCT00006373|Ifosfamide|ifosfamide|mesh-list
64905887|NCT00006373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64905888|NCT00006373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905889|NCT00006373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64905890|NCT00006373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64905891|NCT00006373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905892|NCT00006373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905893|NCT00006373|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64905894|NCT00006373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64905895|NCT00006373|Alkylating Agents|alkylating agents|mesh-ancestor
64905897|NCT00006376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905898|NCT00006379|Cyclophosphamide|cyclophosphamide|mesh-list
64905899|NCT00006379|Fludarabine|fludarabine|mesh-list
64524301|NCT02422056|Coagulants|coagulants|mesh-ancestor
64524302|NCT02466958|Milnacipran|milnacipran|mesh-list
64524303|NCT02466958|Levomilnacipran|levomilnacipran|mesh-list
64524304|NCT02466958|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64524305|NCT02466958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64524306|NCT02466958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64524307|NCT02466958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524308|NCT02466958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64524311|NCT02466958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64524312|NCT02466958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64524313|NCT02466958|Analgesics|analgesics|mesh-ancestor
64524314|NCT02466958|Sensory System Agents|sensory system agents|mesh-ancestor
64524315|NCT02466958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64733873|NCT00005773|Respiratory System Agents|respiratory system agents|mesh-ancestor
64733874|NCT00005773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64733875|NCT00005773|Antioxidants|antioxidants|mesh-ancestor
64733876|NCT00005773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733877|NCT00005773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64733878|NCT00005773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64733879|NCT00005773|Vasodilator Agents|vasodilator agents|mesh-ancestor
64733880|NCT00005773|Gasotransmitters|gasotransmitters|mesh-ancestor
64733881|NCT00005773|Protective Agents|protective agents|mesh-ancestor
64733882|NCT00005779|Interleukin-12|interleukin-12|mesh-list
64733883|NCT00005779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64524316|NCT02467504|Folic Acid|folic acid|mesh-list
64524317|NCT02467504|Loxoprofen|loxoprofen|mesh-list
64524318|NCT02467504|Hematinics|hematinics|mesh-ancestor
64524319|NCT02467504|Vitamin B Complex|vitamin b complex|mesh-ancestor
64524320|NCT02467504|Vitamins|vitamins|mesh-ancestor
64524321|NCT02467504|Micronutrients|micronutrients|mesh-ancestor
64524322|NCT02467504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524323|NCT02467504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64524324|NCT02467504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64524325|NCT02467504|Analgesics|analgesics|mesh-ancestor
64524326|NCT02467504|Sensory System Agents|sensory system agents|mesh-ancestor
64524327|NCT02467504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524328|NCT02467504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64905900|NCT00006379|Fludarabine phosphate|fludarabine phosphate|mesh-list
64905901|NCT00006379|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64905902|NCT00006379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64905903|NCT00006379|Immunologic Factors|immunologic factors|mesh-ancestor
64905904|NCT00006379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905905|NCT00006379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64905906|NCT00006379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64905933|NCT00007995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64905934|NCT00007995|Alkylating Agents|alkylating agents|mesh-ancestor
64905935|NCT00007995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905936|NCT00007995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905937|NCT00007995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64905938|NCT00007995|Antiviral Agents|antiviral agents|mesh-ancestor
64905939|NCT00007995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64905941|NCT00006388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64905942|NCT00006388|Hormone Antagonists|hormone antagonists|mesh-ancestor
64905943|NCT00006388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64905944|NCT00006388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524330|NCT02413086|Chitosan|chitosan|mesh-list
64524331|NCT02413086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64524332|NCT02413086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64524333|NCT02413086|Antimetabolites|antimetabolites|mesh-ancestor
64524334|NCT02413086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524335|NCT02413086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64524336|NCT02413086|Chelating Agents|chelating agents|mesh-ancestor
64524337|NCT02413086|Sequestering Agents|sequestering agents|mesh-ancestor
64524338|NCT02413086|Hemostatics|hemostatics|mesh-ancestor
64524339|NCT02413086|Coagulants|coagulants|mesh-ancestor
64524340|NCT02468830|Mirabegron|mirabegron|mesh-list
64524341|NCT02468830|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64524342|NCT02468830|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64524343|NCT02468830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64905945|NCT00006388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64905946|NCT00006388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905947|NCT00006388|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64905948|NCT00006388|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64905949|NCT00006388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64905950|NCT00008034|Cyclophosphamide|cyclophosphamide|mesh-list
64905951|NCT00008034|Capecitabine|capecitabine|mesh-list
64905952|NCT00008034|Epirubicin|epirubicin|mesh-list
64905953|NCT00008034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64905954|NCT00008034|Immunologic Factors|immunologic factors|mesh-ancestor
64905955|NCT00008034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905956|NCT00008034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64905976|NCT00006394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64905978|NCT00008073|Doxorubicin|doxorubicin|mesh-list
64905979|NCT00008073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64905980|NCT00008073|Octreotide|octreotide|mesh-list
64606356|NCT01830517|Amlodipine|amlodipine|mesh-list
64905981|NCT00008073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64905982|NCT00008073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905983|NCT00008073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64905984|NCT00008073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64905985|NCT00008073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312987|NCT03036644|Nicotine|nicotine|mesh-list
64905994|NCT00006397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64905995|NCT00006397|Protease Inhibitors|protease inhibitors|mesh-ancestor
64905996|NCT00006397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905997|NCT00006397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905998|NCT00006397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64905999|NCT00006397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64906000|NCT00006397|Antiviral Agents|antiviral agents|mesh-ancestor
64906001|NCT00006397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64906002|NCT00006397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64906003|NCT00006397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64906004|NCT00006397|Antimetabolites|antimetabolites|mesh-ancestor
64906005|NCT00006397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64906006|NCT00006397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64906007|NCT00006412|Fenofibrate|fenofibrate|mesh-list
64906008|NCT00006412|Pravastatin|pravastatin|mesh-list
64906009|NCT00006412|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64524344|NCT02468830|Adrenergic Agents|adrenergic agents|mesh-ancestor
64524345|NCT02468830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64524346|NCT02468830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524347|NCT02468830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524348|NCT02468830|Urological Agents|urological agents|mesh-ancestor
64524349|NCT02470234|Methylphenidate|methylphenidate|mesh-list
64524350|NCT02470234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64906010|NCT00006412|Antimetabolites|antimetabolites|mesh-ancestor
64906036|NCT00008151|Fludarabine phosphate|fludarabine phosphate|mesh-list
64906037|NCT00008151|Fludarabine|fludarabine|mesh-list
64906038|NCT00008151|Gemtuzumab|gemtuzumab|mesh-list
64906039|NCT00008151|Cyclosporins|cyclosporins|mesh-list
64906040|NCT00008151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64906041|NCT00008151|Abortifacient Agents|abortifacient agents|mesh-ancestor
64906042|NCT00008151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64906043|NCT00008151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733889|NCT00005779|Growth Inhibitors|growth inhibitors|mesh-ancestor
64733890|NCT00005779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733891|NCT00005791|Fluorouracil|fluorouracil|mesh-list
64733892|NCT00005791|Irinotecan|irinotecan|mesh-list
64733893|NCT00005791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733894|NCT00005791|Antimetabolites|antimetabolites|mesh-ancestor
64733895|NCT00005791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733896|NCT00005791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64733897|NCT00005791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64320979|NCT05509244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906044|NCT00008151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64906045|NCT00008151|Antimetabolites|antimetabolites|mesh-ancestor
64906046|NCT00008151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906047|NCT00008151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906048|NCT00008151|Dermatologic Agents|dermatologic agents|mesh-ancestor
64906049|NCT00008151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906050|NCT00008151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64906051|NCT00008151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64906052|NCT00008151|Immunologic Factors|immunologic factors|mesh-ancestor
64906053|NCT00008151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64906054|NCT00008151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64906055|NCT00008151|Antifungal Agents|antifungal agents|mesh-ancestor
64906056|NCT00008151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64906057|NCT00008151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64906058|NCT00008151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64906088|NCT00008190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64906089|NCT00008190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64906090|NCT00008190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906091|NCT00008190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64906092|NCT00008190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64906093|NCT00008190|Antiviral Agents|antiviral agents|mesh-ancestor
64906094|NCT00008190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64906095|NCT00006451|Cyclosporine|cyclosporine|mesh-list
64906096|NCT00006451|Methylprednisolone|methylprednisolone|mesh-list
64906097|NCT00006451|Cyclophosphamide|cyclophosphamide|mesh-list
64906098|NCT00006451|Methotrexate|methotrexate|mesh-list
64906099|NCT00006451|Cyclosporins|cyclosporins|mesh-list
64906100|NCT00006451|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64906101|NCT00006451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64906139|NCT00006454|Mitosis Modulators|mitosis modulators|mesh-ancestor
64906140|NCT00006454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906141|NCT00006454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64906142|NCT00006454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64906143|NCT00006454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906144|NCT00008229|Melphalan|melphalan|mesh-list
64906145|NCT00008229|Immunologic Factors|immunologic factors|mesh-ancestor
64906146|NCT00008229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906147|NCT00008229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64906148|NCT00008229|Alkylating Agents|alkylating agents|mesh-ancestor
64906179|NCT00006463|Alkylating Agents|alkylating agents|mesh-ancestor
64906180|NCT00006463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906181|NCT00006463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906182|NCT00008307|Cyclosporine|cyclosporine|mesh-list
64906183|NCT00008307|Mycophenolic Acid|mycophenolic acid|mesh-list
64906184|NCT00008307|Methylprednisolone|methylprednisolone|mesh-list
64524351|NCT02470234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524352|NCT02470234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64524353|NCT02470234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64524354|NCT02470234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64524355|NCT02470234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524356|NCT02470234|Dopamine Agents|dopamine agents|mesh-ancestor
64524357|NCT02470234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64906185|NCT00008307|Fludarabine|fludarabine|mesh-list
64906186|NCT00008307|Fludarabine phosphate|fludarabine phosphate|mesh-list
64906188|NCT00008307|Cyclosporins|cyclosporins|mesh-list
64906189|NCT00008307|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64906190|NCT00008307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320980|NCT05509244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320981|NCT05502068|Vitamin D|vitamin d|mesh-list
64606449|NCT03211897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64906191|NCT00008307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64906225|NCT00006469|Antimitotic Agents|antimitotic agents|mesh-ancestor
64906226|NCT00006469|Mitosis Modulators|mitosis modulators|mesh-ancestor
64906227|NCT00006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906228|NCT00006472|Paclitaxel|paclitaxel|mesh-list
64906229|NCT00006472|Carboplatin|carboplatin|mesh-list
64906230|NCT00006472|Fluorouracil|fluorouracil|mesh-list
64906231|NCT00006472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64906232|NCT00006472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906245|NCT00006475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906246|NCT00006475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906248|NCT00008424|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64906249|NCT00008424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64906250|NCT00008424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906251|NCT00008424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906252|NCT00008424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906253|NCT00006484|Paclitaxel|paclitaxel|mesh-list
64906254|NCT00006484|Carboplatin|carboplatin|mesh-list
64906255|NCT00006484|Tirapazamine|tirapazamine|mesh-list
64906256|NCT00006484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64906257|NCT00006484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906258|NCT00006484|Tubulin Modulators|tubulin modulators|mesh-ancestor
64906259|NCT00006484|Antimitotic Agents|antimitotic agents|mesh-ancestor
64906260|NCT00006484|Mitosis Modulators|mitosis modulators|mesh-ancestor
64674707|NCT00550550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64906261|NCT00006484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906262|NCT00006487|Etoposide|etoposide|mesh-list
64906263|NCT00006487|Tirapazamine|tirapazamine|mesh-list
64906264|NCT00006487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906265|NCT00006487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64906266|NCT00006487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64906267|NCT00006487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64906268|NCT00006487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906269|NCT00006487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906277|NCT00008463|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64906278|NCT00008463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906279|NCT00008463|Antiviral Agents|antiviral agents|mesh-ancestor
64906280|NCT00008463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64906281|NCT00008463|Antimetabolites|antimetabolites|mesh-ancestor
64906282|NCT00008463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906283|NCT00008463|Immunologic Factors|immunologic factors|mesh-ancestor
64906284|NCT00008463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906285|NCT00006508|Insulin|insulin|mesh-list
64906286|NCT00006508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64906287|NCT00006508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906288|NCT00006682|Docetaxel|docetaxel|mesh-list
64906289|NCT00006682|Vinorelbine|vinorelbine|mesh-list
64524360|NCT02418702|Sensory System Agents|sensory system agents|mesh-ancestor
64524361|NCT02418702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524362|NCT02418702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524363|NCT02418702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64524364|NCT02418702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64524365|NCT02418702|Anesthetics, General|anesthetics, general|mesh-ancestor
64524366|NCT02418702|Anesthetics|anesthetics|mesh-ancestor
64524367|NCT02418702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64524368|NCT02418702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64524369|NCT02418702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64524370|NCT02418702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64524371|NCT02418702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524372|NCT02412930|Tramadol|tramadol|mesh-list
64524373|NCT02412930|Bupivacaine|bupivacaine|mesh-list
64524374|NCT02412930|Anesthetics, Local|anesthetics, local|mesh-ancestor
64524375|NCT02412930|Anesthetics|anesthetics|mesh-ancestor
64524376|NCT02412930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64524377|NCT02412930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524378|NCT02412930|Sensory System Agents|sensory system agents|mesh-ancestor
64606504|NCT01832467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906290|NCT00006682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906291|NCT00006682|Tubulin Modulators|tubulin modulators|mesh-ancestor
64906292|NCT00006682|Antimitotic Agents|antimitotic agents|mesh-ancestor
64906293|NCT00006682|Mitosis Modulators|mitosis modulators|mesh-ancestor
64906294|NCT00006682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906327|NCT00006799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64906328|NCT00006799|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64906329|NCT00006799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64906330|NCT00006799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906332|NCT00006799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64906333|NCT00006877|Temozolomide|temozolomide|mesh-list
64906334|NCT00006877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64906368|NCT00007189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906370|NCT00388219|Buprenorphine|buprenorphine|mesh-list
64906371|NCT00388219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64906372|NCT00388219|Narcotics|narcotics|mesh-ancestor
64906373|NCT00388219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64906374|NCT00388219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906375|NCT00388219|Analgesics|analgesics|mesh-ancestor
64906407|NCT00007774|Haloperidol decanoate|haloperidol decanoate|mesh-list
64906409|NCT00007774|Autonomic Agents|autonomic agents|mesh-ancestor
64906410|NCT00007774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64906411|NCT00007774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906412|NCT00007774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64906413|NCT00007774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64906414|NCT00007774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64906415|NCT00007774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64906416|NCT00007774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64906417|NCT00007774|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64649286|NCT03839888|Mydriatics|mydriatics|mesh-ancestor
64524386|NCT02432716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64524387|NCT02432716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906418|NCT00007774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64906419|NCT00007774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64906438|NCT00007813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64906439|NCT00007813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64906440|NCT00007813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64906441|NCT00007813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906443|NCT00007852|Rituximab|rituximab|mesh-list
64906444|NCT00007852|Etoposide|etoposide|mesh-list
64906445|NCT00007852|Melphalan|melphalan|mesh-list
64906446|NCT00007852|Carmustine|carmustine|mesh-list
64906447|NCT00007852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64906448|NCT00007852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906449|NCT00007852|Immunologic Factors|immunologic factors|mesh-ancestor
64906450|NCT00007852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906451|NCT00007852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64906452|NCT00007852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64906453|NCT00007852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64906454|NCT00007852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64906455|NCT00007852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906456|NCT00007852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906457|NCT00007852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64906458|NCT00007852|Antimetabolites|antimetabolites|mesh-ancestor
64906459|NCT00007852|Antiviral Agents|antiviral agents|mesh-ancestor
64906460|NCT00007852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64906461|NCT00007852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64606576|NCT03216343|Chiauranib|chiauranib|mesh-list
64906462|NCT00007852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64906463|NCT00007852|Alkylating Agents|alkylating agents|mesh-ancestor
64906464|NCT00007852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64906465|NCT00007891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64906466|NCT00007891|Antibodies|antibodies|mesh-list
64906467|NCT00007891|Immunoglobulins|immunoglobulins|mesh-list
64906468|NCT00007891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64906469|NCT00007891|Immunologic Factors|immunologic factors|mesh-ancestor
64906470|NCT00007891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906471|NCT00007891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906472|NCT00007969|Verteporfin|verteporfin|mesh-list
64906473|NCT00007969|Detox adjuvant|detox adjuvant|mesh-list
64906474|NCT00007969|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64906475|NCT00007969|Dermatologic Agents|dermatologic agents|mesh-ancestor
64906476|NCT00007969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64906477|NCT00007969|Immunologic Factors|immunologic factors|mesh-ancestor
64906535|NCT00008125|Mitosis Modulators|mitosis modulators|mesh-ancestor
64906536|NCT00008203|Interferons|interferons|mesh-list
64906537|NCT00008203|Aldesleukin|aldesleukin|mesh-list
64906538|NCT00008203|Interferon-gamma|interferon-gamma|mesh-list
64906539|NCT00008203|Cyclosporine|cyclosporine|mesh-list
64906540|NCT00008203|Cyclophosphamide|cyclophosphamide|mesh-list
64906542|NCT00008203|Carboplatin|carboplatin|mesh-list
64906543|NCT00008203|Cyclosporins|cyclosporins|mesh-list
64906544|NCT00008203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64906545|NCT00008203|Immunologic Factors|immunologic factors|mesh-ancestor
64906546|NCT00008203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906547|NCT00008203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64906548|NCT00008203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64906549|NCT00008203|Alkylating Agents|alkylating agents|mesh-ancestor
64906550|NCT00008203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906551|NCT00008203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906552|NCT00008203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64906553|NCT00008203|Antiviral Agents|antiviral agents|mesh-ancestor
64524390|NCT02418624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64524391|NCT02418624|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64524392|NCT02418624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649290|NCT03839888|Cholinergic Agents|cholinergic agents|mesh-ancestor
64524402|NCT02440204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524403|NCT02440204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64524404|NCT02440204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64524405|NCT02440204|Anesthetics, General|anesthetics, general|mesh-ancestor
64906554|NCT00008203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64906555|NCT00008203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906556|NCT00008203|Antifungal Agents|antifungal agents|mesh-ancestor
64906557|NCT00008203|Dermatologic Agents|dermatologic agents|mesh-ancestor
64906558|NCT00008203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64906559|NCT00008203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64906560|NCT00008203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64906562|NCT00008242|Dexamethasone|dexamethasone|mesh-list
64906563|NCT00008242|Doxorubicin|doxorubicin|mesh-list
64906564|NCT00008242|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64906565|NCT00008242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64906566|NCT00008242|Antiemetics|antiemetics|mesh-ancestor
64906567|NCT00008242|Autonomic Agents|autonomic agents|mesh-ancestor
64906568|NCT00008242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64906569|NCT00008242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906570|NCT00008242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64906571|NCT00008242|Glucocorticoids|glucocorticoids|mesh-ancestor
64906572|NCT00008242|Hormones|hormones|mesh-ancestor
64906599|NCT00008281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64906600|NCT00008281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906601|NCT00008281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64906602|NCT00008281|Immunologic Factors|immunologic factors|mesh-ancestor
64906603|NCT00008281|Antidotes|antidotes|mesh-ancestor
64906604|NCT00008281|Protective Agents|protective agents|mesh-ancestor
64906605|NCT00008281|Vitamin B Complex|vitamin b complex|mesh-ancestor
64906606|NCT00008281|Vitamins|vitamins|mesh-ancestor
64733898|NCT00005791|Immunologic Factors|immunologic factors|mesh-ancestor
64733904|NCT00005797|Busulfan|busulfan|mesh-list
64906607|NCT00008281|Micronutrients|micronutrients|mesh-ancestor
64906608|NCT00008359|Amphotericin B|amphotericin b|mesh-list
64906609|NCT00008359|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64906610|NCT00008359|Caspofungin|caspofungin|mesh-list
64906611|NCT00008359|Amebicides|amebicides|mesh-ancestor
64906612|NCT00008359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64906613|NCT00008359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64906614|NCT00008359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64906615|NCT00008359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64906616|NCT00008359|Antifungal Agents|antifungal agents|mesh-ancestor
64906617|NCT00008359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906618|NCT00008359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906619|NCT00008398|Sargramostim|sargramostim|mesh-list
64906620|NCT00008398|Immunologic Factors|immunologic factors|mesh-ancestor
64906657|NCT05636566|Anesthetics|anesthetics|mesh-ancestor
64524407|NCT02410590|Atropine|atropine|mesh-list
64524408|NCT02410590|Rocuronium|rocuronium|mesh-list
64524409|NCT02410590|Cisatracurium|cisatracurium|mesh-list
64524410|NCT02410590|Succinylcholine|succinylcholine|mesh-list
64524411|NCT02410590|Neostigmine|neostigmine|mesh-list
64524412|NCT02410590|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64524413|NCT02410590|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64524414|NCT02410590|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64906658|NCT05636566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64906659|NCT05636566|Analgesics|analgesics|mesh-ancestor
64906660|NCT05636566|Sensory System Agents|sensory system agents|mesh-ancestor
64906723|NCT05638633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906724|NCT05638633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64906725|NCT05638633|Glucocorticoids|glucocorticoids|mesh-ancestor
64906726|NCT05638633|Hormones|hormones|mesh-ancestor
64906728|NCT05638633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64906730|NCT05638633|Antiemetics|antiemetics|mesh-ancestor
64906731|NCT05638633|Autonomic Agents|autonomic agents|mesh-ancestor
64906732|NCT05638633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64906733|NCT05638633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64906734|NCT05638633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64906735|NCT05638633|Protective Agents|protective agents|mesh-ancestor
64906736|NCT05638867|Aspirin|aspirin|mesh-list
64906737|NCT05638867|Rivaroxaban|rivaroxaban|mesh-list
64906738|NCT05638867|Clopidogrel|clopidogrel|mesh-list
64906761|NCT05638867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64906762|NCT05638867|Protease Inhibitors|protease inhibitors|mesh-ancestor
64906764|NCT05638984|Decitabine|decitabine|mesh-list
64906765|NCT05638984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64906766|NCT05638984|Antimetabolites|antimetabolites|mesh-ancestor
64906767|NCT05638984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906768|NCT05638984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906769|NCT05638984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906770|NCT05639257|Mexiletine|mexiletine|mesh-list
64906771|NCT05639257|Lamotrigine|lamotrigine|mesh-list
64906772|NCT05639257|Anticonvulsants|anticonvulsants|mesh-ancestor
64906773|NCT05639257|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64906774|NCT05639257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64906775|NCT05639257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906776|NCT05639257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64906777|NCT05639257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906778|NCT05639257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64906779|NCT05639257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64906780|NCT05639257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64906781|NCT05639257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64906782|NCT05639257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64906783|NCT05639257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64906784|NCT05639257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64906785|NCT00000115|Acetazolamide|acetazolamide|mesh-list
64906786|NCT00000115|Anticonvulsants|anticonvulsants|mesh-ancestor
64733909|NCT00005797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64906787|NCT00000115|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64906788|NCT00000115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906811|NCT00000142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906812|NCT00000142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906814|NCT00000145|Antioxidants|antioxidants|mesh-list
64906815|NCT00000145|Trace Elements|trace elements|mesh-ancestor
64906816|NCT00000145|Micronutrients|micronutrients|mesh-ancestor
64906817|NCT00000145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906818|NCT00000145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906819|NCT00000145|Protective Agents|protective agents|mesh-ancestor
64906820|NCT00000151|Aspirin|aspirin|mesh-list
64906821|NCT00000151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64906822|NCT00000151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64524415|NCT02410590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524416|NCT02410590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524417|NCT02410590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64524418|NCT02410590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64524419|NCT02410590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64906823|NCT00000151|Analgesics|analgesics|mesh-ancestor
64906824|NCT00000151|Sensory System Agents|sensory system agents|mesh-ancestor
64906825|NCT00000151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64906826|NCT00000151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906827|NCT00000151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64906828|NCT00000151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64906829|NCT00000151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64906830|NCT00000151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64906831|NCT00000151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906832|NCT00000151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64906833|NCT00000151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64906834|NCT00000151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906835|NCT00000151|Antipyretics|antipyretics|mesh-ancestor
64906836|NCT00000157|Aspirin|aspirin|mesh-list
64906837|NCT00000157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64906838|NCT00000157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64906839|NCT00000157|Analgesics|analgesics|mesh-ancestor
64906840|NCT00000157|Sensory System Agents|sensory system agents|mesh-ancestor
64906841|NCT00000157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64906910|NCT00000256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64906937|NCT00000427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64906939|NCT00000457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64906940|NCT00000457|Antidepressive Agents|antidepressive agents|mesh-ancestor
64906941|NCT00000457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64906942|NCT00000457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64906943|NCT00000457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64906944|NCT00000457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64733920|NCT00005815|Temozolomide|temozolomide|mesh-list
64606759|NCT03219853|Micronutrients|micronutrients|mesh-ancestor
64606760|NCT05330884|BCG Vaccine|bcg vaccine|mesh-list
64606761|NCT05330884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64606762|NCT05330884|Immunologic Factors|immunologic factors|mesh-ancestor
64606763|NCT05330884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606764|NCT02480998|Vaccines|vaccines|mesh-list
64606765|NCT02480998|Immunologic Factors|immunologic factors|mesh-ancestor
64606766|NCT02480998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606767|NCT00905515|Cyclosporine|cyclosporine|mesh-list
64606768|NCT00905515|Tacrolimus|tacrolimus|mesh-list
64606769|NCT00905515|Cyclosporins|cyclosporins|mesh-list
64606770|NCT00905515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64906945|NCT00000457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906946|NCT00000457|Dopamine Agents|dopamine agents|mesh-ancestor
64906947|NCT00000457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64906948|NCT00000457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906949|NCT00000457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64906950|NCT00000457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64906951|NCT00000457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906953|NCT00388479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64906954|NCT00000463|Warfarin|warfarin|mesh-list
64906955|NCT00000463|Lovastatin|lovastatin|mesh-list
64906956|NCT00000463|L 647318|l 647318|mesh-list
64906988|NCT00000472|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64906989|NCT00000472|Anticoagulants|anticoagulants|mesh-ancestor
64906990|NCT00000472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64906991|NCT00000472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64906992|NCT00000472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906993|NCT00000478|Atenolol|atenolol|mesh-list
64906994|NCT00000478|Diltiazem|diltiazem|mesh-list
64906995|NCT00000478|Nifedipine|nifedipine|mesh-list
64906996|NCT00000478|Isosorbide|isosorbide|mesh-list
64906997|NCT00000478|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64906998|NCT00000478|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64906999|NCT00000478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64907030|NCT00388882|Respiratory System Agents|respiratory system agents|mesh-ancestor
64907031|NCT00388882|Parasympatholytics|parasympatholytics|mesh-ancestor
64907032|NCT00388882|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64907033|NCT00388882|Cholinergic Agents|cholinergic agents|mesh-ancestor
64907034|NCT00388882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64907035|NCT00388882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907036|NCT00388882|Anticonvulsants|anticonvulsants|mesh-ancestor
64907037|NCT00388882|Tocolytic Agents|tocolytic agents|mesh-ancestor
64907038|NCT00388882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64907039|NCT00388882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64907040|NCT00388882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64907041|NCT00388882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64524421|NCT02410590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64524422|NCT02410590|Respiratory System Agents|respiratory system agents|mesh-ancestor
64524423|NCT02410590|Mydriatics|mydriatics|mesh-ancestor
64524424|NCT02410590|Parasympatholytics|parasympatholytics|mesh-ancestor
64524425|NCT02410590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64524426|NCT02410590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64524427|NCT02410590|Cholinergic Agents|cholinergic agents|mesh-ancestor
64524428|NCT02410590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64524429|NCT02410590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907042|NCT00388882|Adrenergic Agents|adrenergic agents|mesh-ancestor
64907044|NCT00388999|Agglutinins|agglutinins|mesh-ancestor
64907045|NCT00388999|Immunologic Factors|immunologic factors|mesh-ancestor
64907060|NCT00000493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64907061|NCT00000493|Vasodilator Agents|vasodilator agents|mesh-ancestor
64907062|NCT00000499|Metoprolol|metoprolol|mesh-list
64907063|NCT00000499|Chlorthalidone|chlorthalidone|mesh-list
64907064|NCT00000499|Hydralazine|hydralazine|mesh-list
64907065|NCT00000499|Reserpine|reserpine|mesh-list
64907066|NCT00000499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64907067|NCT00000499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64907068|NCT00000499|Sympatholytics|sympatholytics|mesh-ancestor
64907069|NCT00000499|Autonomic Agents|autonomic agents|mesh-ancestor
64907070|NCT00000499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64907071|NCT00000499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907072|NCT00000499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64733921|NCT00005815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64733922|NCT00005815|Alkylating Agents|alkylating agents|mesh-ancestor
64733924|NCT00005815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64907073|NCT00000499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64907074|NCT00000499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64907075|NCT00000499|Adrenergic Agents|adrenergic agents|mesh-ancestor
64907076|NCT00000499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64313415|NCT03180255|Dexamethasone|dexamethasone|mesh-list
64907082|NCT00000499|Vasodilator Agents|vasodilator agents|mesh-ancestor
64907083|NCT00000499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64907084|NCT00000499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64907085|NCT00000499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64907086|NCT00000499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64907087|NCT00000499|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64907088|NCT00000499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64907089|NCT00000514|Atenolol|atenolol|mesh-list
64907090|NCT00000514|Chlorthalidone|chlorthalidone|mesh-list
64907091|NCT00000514|Reserpine|reserpine|mesh-list
64907092|NCT00000514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64907093|NCT00000514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64907094|NCT00000514|Sympatholytics|sympatholytics|mesh-ancestor
64907095|NCT00000514|Autonomic Agents|autonomic agents|mesh-ancestor
64907096|NCT00000514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64907097|NCT00000514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907098|NCT00000514|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64907099|NCT00000514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64907100|NCT00000514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64907101|NCT00000514|Adrenergic Agents|adrenergic agents|mesh-ancestor
64907102|NCT00000514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64907103|NCT00000514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907104|NCT00000514|Diuretics|diuretics|mesh-ancestor
64907105|NCT00000514|Natriuretic Agents|natriuretic agents|mesh-ancestor
64907131|NCT00000520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64907132|NCT00000520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64907133|NCT00000520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64907134|NCT00000520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64907135|NCT00000520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524430|NCT02410590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64524431|NCT02410590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524432|NCT02410590|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64524433|NCT02410590|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
64524435|NCT02517580|Vitamin K 2|vitamin k 2|mesh-list
64524436|NCT02517580|Vitamins|vitamins|mesh-ancestor
64524437|NCT02517580|Micronutrients|micronutrients|mesh-ancestor
64524438|NCT02517580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524439|NCT02517580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64524440|NCT02517580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64907136|NCT00000520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64907137|NCT00000520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64907138|NCT00000520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907139|NCT00000520|Antipyretics|antipyretics|mesh-ancestor
64907140|NCT00000520|Immunologic Factors|immunologic factors|mesh-ancestor
64907142|NCT00000526|Moricizine|moricizine|mesh-list
64907143|NCT00000526|Encainide|encainide|mesh-list
64907144|NCT00000526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64907145|NCT00000526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64907146|NCT00000526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64907147|NCT00000526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64907148|NCT00000526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907149|NCT00000529|Tamoxifen|tamoxifen|mesh-list
64907150|NCT00000529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64907151|NCT00000529|Hormone Antagonists|hormone antagonists|mesh-ancestor
64907152|NCT00000529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64907153|NCT00000529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733933|NCT00005815|Growth Substances|growth substances|mesh-ancestor
64733934|NCT00005815|Growth Inhibitors|growth inhibitors|mesh-ancestor
64733935|NCT02132754|Pembrolizumab|pembrolizumab|mesh-list
64733936|NCT02132754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64733937|NCT02132754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733938|NCT02151786|Lansoprazole|lansoprazole|mesh-list
64907191|NCT00000556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907192|NCT00000556|Protective Agents|protective agents|mesh-ancestor
64907193|NCT00000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907194|NCT00000556|Vasodilator Agents|vasodilator agents|mesh-ancestor
64907195|NCT00000556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64907196|NCT00000556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64649309|NCT05089526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64907310|NCT00000640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64907312|NCT00000643|Leucovorin|leucovorin|mesh-list
64907313|NCT00000643|Pyrimethamine|pyrimethamine|mesh-list
64907314|NCT00000643|Calcium|calcium|mesh-list
64907315|NCT00000643|Levoleucovorin|levoleucovorin|mesh-list
64907316|NCT00000643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64907347|NCT00389038|Sensory System Agents|sensory system agents|mesh-ancestor
64907348|NCT00389038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64907349|NCT00389038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907350|NCT00389038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64907351|NCT00389038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64907352|NCT00389038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64907353|NCT00389038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907354|NCT00389038|Adrenergic Agents|adrenergic agents|mesh-ancestor
64907355|NCT00389038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64907357|NCT00000652|Didanosine|didanosine|mesh-list
64907358|NCT00000652|Antimetabolites|antimetabolites|mesh-ancestor
64907359|NCT00000652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907360|NCT00000652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64524443|NCT02517580|Coagulants|coagulants|mesh-ancestor
64524444|NCT02522104|Hydroxyurea|hydroxyurea|mesh-list
64524445|NCT02522104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64524446|NCT02522104|Antisickling Agents|antisickling agents|mesh-ancestor
64524447|NCT02522104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524448|NCT02522104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524449|NCT02522104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907361|NCT00000652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907393|NCT00000679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64907394|NCT00000679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907395|NCT00000682|Zidovudine|zidovudine|mesh-list
64907396|NCT00000682|Zalcitabine|zalcitabine|mesh-list
64907397|NCT00000682|Antimetabolites|antimetabolites|mesh-ancestor
64907398|NCT00000682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907399|NCT00000682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64907400|NCT00000682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907401|NCT00000682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907402|NCT00000682|Antiviral Agents|antiviral agents|mesh-ancestor
64907434|NCT00000715|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64907435|NCT00000715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907436|NCT00000715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907437|NCT00000715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64907438|NCT00000715|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64907439|NCT00000715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64907440|NCT00000715|Antifungal Agents|antifungal agents|mesh-ancestor
64907441|NCT00000715|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64907442|NCT00000715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64907444|NCT00000718|Zalcitabine|zalcitabine|mesh-list
64907445|NCT00000718|Antimetabolites|antimetabolites|mesh-ancestor
64606942|NCT01839253|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64606943|NCT01839253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64606944|NCT01839253|Adrenergic Agents|adrenergic agents|mesh-ancestor
64606945|NCT01839253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64606946|NCT01839253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606947|NCT01839253|Protease Inhibitors|protease inhibitors|mesh-ancestor
64606948|NCT01839253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907466|NCT00000742|Atevirdine|atevirdine|mesh-list
64907467|NCT00000742|Antimetabolites|antimetabolites|mesh-ancestor
64907468|NCT00000742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649317|NCT05089526|Analgesics|analgesics|mesh-ancestor
64907473|NCT00000742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907475|NCT00000742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907476|NCT00000745|Vaccines|vaccines|mesh-list
64907477|NCT00000745|Immunologic Factors|immunologic factors|mesh-ancestor
64907478|NCT00000745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907479|NCT00000748|Trimethoprim|trimethoprim|mesh-list
64907480|NCT00000748|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64907481|NCT00000748|Sulfamethoxazole|sulfamethoxazole|mesh-list
64907482|NCT00000748|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64907483|NCT00000748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907484|NCT00000748|Renal Agents|renal agents|mesh-ancestor
64907485|NCT00000748|Antimalarials|antimalarials|mesh-ancestor
64907486|NCT00000748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64907487|NCT00000748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64907488|NCT00000748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64907489|NCT00000748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907490|NCT00000748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907491|NCT00000748|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64907492|NCT00000748|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64907493|NCT00000748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64907494|NCT00000748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64907495|NCT00000751|Zidovudine|zidovudine|mesh-list
64907496|NCT00000751|Immune Sera|immune sera|mesh-list
64907497|NCT00000751|Immunoglobulins|immunoglobulins|mesh-list
64907498|NCT00000751|Antibodies|antibodies|mesh-list
64524453|NCT02412150|Anesthetics|anesthetics|mesh-list
64524454|NCT02412150|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
64524455|NCT02412150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64524456|NCT02412150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64524457|NCT02412150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524458|NCT02412150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64524459|NCT02412150|Analgesics|analgesics|mesh-ancestor
64907499|NCT00000751|Antimetabolites|antimetabolites|mesh-ancestor
64907500|NCT00000751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907501|NCT00000751|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64907536|NCT00000760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64907537|NCT00000760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907538|NCT00000790|Thalidomide|thalidomide|mesh-list
64907539|NCT00000790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64907540|NCT00000790|Immunologic Factors|immunologic factors|mesh-ancestor
64907541|NCT00000790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907542|NCT00000790|Leprostatic Agents|leprostatic agents|mesh-ancestor
64907543|NCT00000790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64907576|NCT00000793|Cholinergic Agents|cholinergic agents|mesh-ancestor
64907577|NCT00000793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64907579|NCT00000799|Cidofovir|cidofovir|mesh-list
64907580|NCT00000799|Probenecid|probenecid|mesh-list
64907581|NCT00000799|Uricosuric Agents|uricosuric agents|mesh-ancestor
64907582|NCT00000799|Gout Suppressants|gout suppressants|mesh-ancestor
64907583|NCT00000799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64907584|NCT00000799|Renal Agents|renal agents|mesh-ancestor
64907585|NCT00000799|Antiviral Agents|antiviral agents|mesh-ancestor
64907586|NCT00000799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907649|NCT00000859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907650|NCT00000859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907651|NCT00000859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64907652|NCT00000859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907653|NCT00000859|Antiviral Agents|antiviral agents|mesh-ancestor
64907654|NCT00000859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907655|NCT00000859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64907656|NCT00000859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64907657|NCT00000877|Indinavir|indinavir|mesh-list
64907658|NCT00000877|Rifabutin|rifabutin|mesh-list
64907659|NCT00000877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64907660|NCT00000877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64907689|NCT00000892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64907690|NCT00000892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64907696|NCT00000895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64907697|NCT00000895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907698|NCT00000895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64907699|NCT00000895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64320983|NCT05502068|Micronutrients|micronutrients|mesh-ancestor
64907700|NCT00000895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907701|NCT00000895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907702|NCT00000895|Antiviral Agents|antiviral agents|mesh-ancestor
64907703|NCT00000895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64907704|NCT00000895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907705|NCT00000895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64907706|NCT00000895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64907707|NCT00000895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64907708|NCT00000895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64907709|NCT00000895|Protease Inhibitors|protease inhibitors|mesh-ancestor
64907741|NCT00000904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907742|NCT00000904|Interferon Inducers|interferon inducers|mesh-ancestor
64907743|NCT00000904|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64524461|NCT02412150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524462|NCT02412150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64524463|NCT02412150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64524464|NCT02412150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64524465|NCT02412150|Adrenergic Agents|adrenergic agents|mesh-ancestor
64524466|NCT02412150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64524467|NCT02412150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524468|NCT02412150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64524470|NCT02412150|Anesthetics, General|anesthetics, general|mesh-ancestor
64524471|NCT02523196|Cholic Acids|cholic acids|mesh-list
64524472|NCT02523196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64524473|NCT02418078|Anesthetics|anesthetics|mesh-list
64524474|NCT02418078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64907744|NCT00000904|Protective Agents|protective agents|mesh-ancestor
64907746|NCT00000919|Nelfinavir|nelfinavir|mesh-list
64907747|NCT00000919|Indinavir|indinavir|mesh-list
64907748|NCT00000919|Amprenavir|amprenavir|mesh-list
64907749|NCT00000919|Lamivudine|lamivudine|mesh-list
64907750|NCT00000919|Zidovudine|zidovudine|mesh-list
64907751|NCT00000919|Abacavir|abacavir|mesh-list
64907752|NCT00000919|Didanosine|didanosine|mesh-list
64907753|NCT00000919|Stavudine|stavudine|mesh-list
64907754|NCT00000919|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64907755|NCT00000919|Efavirenz|efavirenz|mesh-list
64907756|NCT00000919|Hydroxyurea|hydroxyurea|mesh-list
64907757|NCT00000919|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64907780|NCT00000919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64907781|NCT00000922|Lamivudine|lamivudine|mesh-list
64907782|NCT00000922|Efavirenz|efavirenz|mesh-list
64907783|NCT00000922|Nevirapine|nevirapine|mesh-list
64907784|NCT00000922|Abacavir|abacavir|mesh-list
64907785|NCT00000922|Didanosine|didanosine|mesh-list
64907786|NCT00000922|Stavudine|stavudine|mesh-list
64907787|NCT00000922|Nelfinavir|nelfinavir|mesh-list
64907788|NCT00000922|Indinavir|indinavir|mesh-list
64907789|NCT00000922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64907790|NCT00000922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907791|NCT00000922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907792|NCT00000922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907793|NCT00000922|Antiviral Agents|antiviral agents|mesh-ancestor
64907794|NCT00000922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907795|NCT00000922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64907796|NCT00000922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907797|NCT00000922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64907798|NCT00000922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64907799|NCT00000922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64907800|NCT00000922|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64907801|NCT00000922|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64907802|NCT00000922|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64907803|NCT00000922|Antimetabolites|antimetabolites|mesh-ancestor
64907804|NCT00000922|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64907841|NCT00000952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907844|NCT00000952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64907845|NCT00000952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64907873|NCT00000973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64907874|NCT00000973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64320984|NCT05502068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320985|NCT05502068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64320986|NCT02030977|Resveratrol|resveratrol|mesh-list
64524475|NCT02418078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524476|NCT03175926|Budesonide|budesonide|mesh-list
64524477|NCT03175926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64524478|NCT03175926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64369780|NCT03316469|Clomiphene|clomiphene|mesh-list
64907875|NCT00000973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907876|NCT00000973|Antiviral Agents|antiviral agents|mesh-ancestor
64907877|NCT00000973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907878|NCT00000973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64907879|NCT00000973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907880|NCT00000973|Antimalarials|antimalarials|mesh-ancestor
64907881|NCT00000973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64907882|NCT00000973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64907883|NCT00000973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64907884|NCT00000985|Acyclovir|acyclovir|mesh-list
64907885|NCT00000985|Foscarnet|foscarnet|mesh-list
64907886|NCT00000985|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
64907887|NCT00000985|Vidarabine|vidarabine|mesh-list
64907888|NCT00000985|Antiviral Agents|antiviral agents|mesh-ancestor
64907889|NCT00000985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907890|NCT00000985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64907891|NCT00000985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907892|NCT00000985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907893|NCT00000985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907894|NCT00000985|Antimetabolites|antimetabolites|mesh-ancestor
64907895|NCT00001000|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
64907896|NCT00001000|Antiviral Agents|antiviral agents|mesh-ancestor
64907919|NCT00001030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907920|NCT00001030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64907921|NCT00001030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64907922|NCT00001030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64907923|NCT00001030|Antitubercular Agents|antitubercular agents|mesh-ancestor
64907924|NCT05639127|Prednisolone|prednisolone|mesh-list
64907925|NCT05639127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64907926|NCT05639127|Glucocorticoids|glucocorticoids|mesh-ancestor
64907927|NCT05639127|Hormones|hormones|mesh-ancestor
64907928|NCT05639127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64907929|NCT05639127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907930|NCT05639127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64907931|NCT05639127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64907932|NCT00001033|Pyridoxine|pyridoxine|mesh-list
64907933|NCT00001033|Vitamin B 6|vitamin b 6|mesh-list
64907934|NCT00001033|Levofloxacin|levofloxacin|mesh-list
64907935|NCT00001033|Rifampin|rifampin|mesh-list
64907936|NCT00001033|Isoniazid|isoniazid|mesh-list
64907937|NCT00001033|Pyrazinamide|pyrazinamide|mesh-list
64907938|NCT00001033|Ethambutol|ethambutol|mesh-list
64907939|NCT00001033|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64907940|NCT00001033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907941|NCT00001033|Renal Agents|renal agents|mesh-ancestor
64907942|NCT00001033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64907943|NCT00001033|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64907944|NCT00001033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64907945|NCT00001033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907946|NCT00001033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907947|NCT00001033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64907948|NCT00001033|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64907949|NCT00001033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64907950|NCT00001033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64907979|NCT00001036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64733943|NCT02151786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733944|NCT02151786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733945|NCT02106156|Interferons|interferons|mesh-list
64733946|NCT02106156|Ribavirin|ribavirin|mesh-list
64733947|NCT02106156|Interferon-alpha|interferon-alpha|mesh-list
64733948|NCT02106156|Interferon alpha-2|interferon alpha-2|mesh-list
64733949|NCT02106156|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64607151|NCT05031520|Metoprolol|metoprolol|mesh-list
64907980|NCT00001036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907981|NCT00001036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907982|NCT00001036|Antiviral Agents|antiviral agents|mesh-ancestor
64907983|NCT00001036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907984|NCT00001036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64907985|NCT00001036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907986|NCT00001036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64907987|NCT00001036|Immunologic Factors|immunologic factors|mesh-ancestor
64907988|NCT00001045|Zidovudine|zidovudine|mesh-list
64907992|NCT00001045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524480|NCT03175926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524481|NCT03175926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524482|NCT03175926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64524483|NCT03175926|Respiratory System Agents|respiratory system agents|mesh-ancestor
64524484|NCT03175926|Glucocorticoids|glucocorticoids|mesh-ancestor
64524485|NCT03175926|Hormones|hormones|mesh-ancestor
64524486|NCT03175926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64524487|NCT02524054|Furosemide|furosemide|mesh-list
64524488|NCT02524054|Diuretics|diuretics|mesh-ancestor
64524489|NCT02524054|Natriuretic Agents|natriuretic agents|mesh-ancestor
64524490|NCT02524054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524491|NCT02524054|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64524492|NCT02524054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64524493|NCT02524054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524494|NCT03106662|Cyclophosphamide|cyclophosphamide|mesh-list
64524495|NCT03106662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64524496|NCT03106662|Immunologic Factors|immunologic factors|mesh-ancestor
64524497|NCT03106662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524498|NCT03106662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64524499|NCT03106662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64524500|NCT03106662|Alkylating Agents|alkylating agents|mesh-ancestor
64524501|NCT03106662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907993|NCT00001045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64907994|NCT00001045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907995|NCT00001045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907996|NCT00001045|Antiviral Agents|antiviral agents|mesh-ancestor
64908016|NCT00001048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64908017|NCT00001048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908018|NCT00001048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64908019|NCT00001048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64908020|NCT00001066|Lamivudine|lamivudine|mesh-list
64908021|NCT00001066|Zidovudine|zidovudine|mesh-list
64908022|NCT00001066|Didanosine|didanosine|mesh-list
64908023|NCT00001066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64908024|NCT00001066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64908025|NCT00001066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908026|NCT00001066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908027|NCT00001066|Antiviral Agents|antiviral agents|mesh-ancestor
64908028|NCT00001066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64908029|NCT00001066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64908030|NCT00001066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64908031|NCT00001066|Antimetabolites|antimetabolites|mesh-ancestor
64908032|NCT00001075|Ritonavir|ritonavir|mesh-list
64908033|NCT00001075|Lamivudine|lamivudine|mesh-list
64908034|NCT00001075|Zidovudine|zidovudine|mesh-list
64908035|NCT00001075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64908036|NCT00001075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64908037|NCT00001075|Protease Inhibitors|protease inhibitors|mesh-ancestor
64908038|NCT00001075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524502|NCT03106662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64524503|NCT03106662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64524504|NCT02417610|Hyaluronic Acid|hyaluronic acid|mesh-list
64524505|NCT02417610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64524506|NCT02417610|Immunologic Factors|immunologic factors|mesh-ancestor
64733950|NCT02106156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64524507|NCT02417610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524508|NCT02417610|Viscosupplements|viscosupplements|mesh-ancestor
64524509|NCT02417610|Protective Agents|protective agents|mesh-ancestor
64524510|NCT03116490|Anesthetics|anesthetics|mesh-list
64524511|NCT03116490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64524512|NCT03116490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524513|NCT02417298|Ketamine|ketamine|mesh-list
64524514|NCT02417298|Analgesics|analgesics|mesh-ancestor
64908039|NCT00001075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908040|NCT00001075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64908041|NCT00001075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64908042|NCT00001075|Antiviral Agents|antiviral agents|mesh-ancestor
64908043|NCT00001075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64908044|NCT00001075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64908046|NCT00001075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64908047|NCT00001075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64908048|NCT00001075|Antimetabolites|antimetabolites|mesh-ancestor
64908049|NCT00001084|Lamivudine|lamivudine|mesh-list
64908050|NCT00001084|Zidovudine|zidovudine|mesh-list
64908051|NCT00001084|Stavudine|stavudine|mesh-list
64908052|NCT00001084|Indinavir|indinavir|mesh-list
64908053|NCT00001084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64908054|NCT00001084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64908089|NCT00001087|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64908090|NCT00001087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64908091|NCT00001087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64908092|NCT00001087|Protease Inhibitors|protease inhibitors|mesh-ancestor
64908093|NCT00001087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908094|NCT00001087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908095|NCT00001087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64908096|NCT00001087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64908097|NCT00001087|Antiviral Agents|antiviral agents|mesh-ancestor
64908098|NCT00001087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64908099|NCT00001087|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64908100|NCT00001087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64908101|NCT00001087|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64908102|NCT00001087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64908103|NCT00001087|Antimetabolites|antimetabolites|mesh-ancestor
64908104|NCT00001087|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64908105|NCT00001087|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64908106|NCT00001087|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64908107|NCT00001087|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64908108|NCT00001087|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64908109|NCT00001105|Antibodies|antibodies|mesh-list
64908110|NCT00001105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64908111|NCT00001105|Immunologic Factors|immunologic factors|mesh-ancestor
64908112|NCT00001105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908113|NCT00001111|Zidovudine|zidovudine|mesh-list
64908143|NCT00001165|Streptozocin|streptozocin|mesh-list
64908144|NCT00001165|Fluorouracil|fluorouracil|mesh-list
64908145|NCT00001165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64908146|NCT00001165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908147|NCT00001165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64908148|NCT00001165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64908149|NCT00001165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524516|NCT02417298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524517|NCT02417298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524518|NCT02417298|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64524519|NCT02417298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64524520|NCT02417298|Anesthetics, General|anesthetics, general|mesh-ancestor
64524521|NCT02417298|Anesthetics|anesthetics|mesh-ancestor
64524522|NCT02417298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64524523|NCT02417298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64524524|NCT02417298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64524525|NCT02417298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64524526|NCT02417298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524527|NCT02525536|Trebananib|trebananib|mesh-list
64524528|NCT02525536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64524529|NCT02525536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64524530|NCT02525536|Growth Substances|growth substances|mesh-ancestor
64524531|NCT02525536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524532|NCT02525536|Growth Inhibitors|growth inhibitors|mesh-ancestor
64524533|NCT02525536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64524534|NCT02411994|Artesunate|artesunate|mesh-list
64524535|NCT02411994|Lumefantrine|lumefantrine|mesh-list
64524536|NCT02411994|Artemether|artemether|mesh-list
64524537|NCT02411994|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64524538|NCT02411994|Pyronaridine|pyronaridine|mesh-list
64524539|NCT02411994|Antimalarials|antimalarials|mesh-ancestor
64524540|NCT02411994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64524541|NCT02411994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64524542|NCT02411994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64524543|NCT02411994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64524544|NCT02411994|Antiviral Agents|antiviral agents|mesh-ancestor
64524545|NCT02411994|Schistosomicides|schistosomicides|mesh-ancestor
64908150|NCT00001165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908151|NCT00001165|Antimetabolites|antimetabolites|mesh-ancestor
64908153|NCT00001165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64908154|NCT00001165|Immunologic Factors|immunologic factors|mesh-ancestor
64908155|NCT00001165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908156|NCT00001180|Hormones|hormones|mesh-list
64908157|NCT00001180|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64908158|NCT00001180|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
64908182|NCT00389311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64908183|NCT00001213|Cysteamine|cysteamine|mesh-list
64908184|NCT00001213|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
64524546|NCT02411994|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64524547|NCT02411994|Anthelmintics|anthelmintics|mesh-ancestor
64524548|NCT02530294|Glycopyrrolate|glycopyrrolate|mesh-list
64524549|NCT02530294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64524550|NCT02530294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64524551|NCT02530294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64524552|NCT02530294|Cholinergic Agents|cholinergic agents|mesh-ancestor
64524553|NCT02530294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64524554|NCT02530294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524555|NCT02530294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524556|NCT03177720|Ciprofloxacin|ciprofloxacin|mesh-list
64524557|NCT03177720|Imipenem|imipenem|mesh-list
64524558|NCT03177720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64524559|NCT03177720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64524560|NCT03177720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64524561|NCT03177720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64524562|NCT03177720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524563|NCT03177720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908185|NCT00001213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908186|NCT00000114|Vitamins|vitamins|mesh-list
64908187|NCT00000114|Vitamin E|vitamin e|mesh-list
64908188|NCT00000114|Vitamin A|vitamin a|mesh-list
64908189|NCT00000114|Micronutrients|micronutrients|mesh-ancestor
64908190|NCT00000114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908191|NCT00000114|Antioxidants|antioxidants|mesh-ancestor
64908192|NCT00000114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908193|NCT00000114|Protective Agents|protective agents|mesh-ancestor
64908194|NCT00001261|gamma-Globulins|gamma-globulins|mesh-list
64908195|NCT00001261|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64908196|NCT00001261|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64908197|NCT00001261|Immunologic Factors|immunologic factors|mesh-ancestor
64908198|NCT00001261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908199|NCT00001267|Zidovudine|zidovudine|mesh-list
64908200|NCT00001267|Didanosine|didanosine|mesh-list
64908201|NCT00001267|Antimetabolites|antimetabolites|mesh-ancestor
64908202|NCT00001267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908203|NCT00001267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64908204|NCT00001267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64908205|NCT00001267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908206|NCT00001267|Antiviral Agents|antiviral agents|mesh-ancestor
64908207|NCT00001267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64908208|NCT00001267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64908209|NCT00001267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64908237|NCT00001333|Topotecan|topotecan|mesh-list
64676669|NCT02294604|Povidone|povidone|mesh-list
64908238|NCT00001333|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64908239|NCT00001333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64908240|NCT00001333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908241|NCT00001333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908242|NCT00001333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908244|NCT00001378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908245|NCT00001378|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64908246|NCT00001378|Protective Agents|protective agents|mesh-ancestor
64908247|NCT00001378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908248|NCT00001387|Paclitaxel|paclitaxel|mesh-list
64908249|NCT00001387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64908250|NCT00001387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64524565|NCT03177720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64524566|NCT03177720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64524567|NCT02411604|Tacrolimus|tacrolimus|mesh-list
64524568|NCT02411604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64524569|NCT02411604|Immunologic Factors|immunologic factors|mesh-ancestor
64313788|NCT04361162|Nivolumab|nivolumab|mesh-list
64524570|NCT02411604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524571|NCT02411604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64524574|NCT03175380|BCG Vaccine|bcg vaccine|mesh-list
64908251|NCT00001387|Tubulin Modulators|tubulin modulators|mesh-ancestor
64908252|NCT00001387|Antimitotic Agents|antimitotic agents|mesh-ancestor
64908253|NCT00001387|Mitosis Modulators|mitosis modulators|mesh-ancestor
64908254|NCT00001387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908255|NCT00388557|Ketoconazole|ketoconazole|mesh-list
64908256|NCT00388557|Antifungal Agents|antifungal agents|mesh-ancestor
64908289|NCT00001474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908291|NCT00001483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64908292|NCT00001483|Bupropion|bupropion|mesh-list
64908293|NCT00001483|Antidepressive Agents|antidepressive agents|mesh-ancestor
64908294|NCT00001483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64908295|NCT00001483|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64908329|NCT00001576|Antidotes|antidotes|mesh-ancestor
64908330|NCT00001576|Protective Agents|protective agents|mesh-ancestor
64908331|NCT00001576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908332|NCT00001576|Vitamin B Complex|vitamin b complex|mesh-ancestor
64908334|NCT00001576|Micronutrients|micronutrients|mesh-ancestor
64908362|NCT00000147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64908363|NCT00000147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64908365|NCT00001624|Insulin|insulin|mesh-list
64908366|NCT00001624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64908367|NCT00001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908368|NCT00001666|Methamphetamine|methamphetamine|mesh-list
64908369|NCT00001666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64908370|NCT00001666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908371|NCT00001666|Sympathomimetics|sympathomimetics|mesh-ancestor
64908372|NCT00001666|Autonomic Agents|autonomic agents|mesh-ancestor
64908373|NCT00001666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64908374|NCT00001666|Dopamine Agents|dopamine agents|mesh-ancestor
64908375|NCT00001666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64908376|NCT00001666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908377|NCT00001666|Adrenergic Agents|adrenergic agents|mesh-ancestor
64908378|NCT00001666|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64607405|NCT04850638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908379|NCT00001666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64908380|NCT00001666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64908404|NCT00001696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908405|NCT00001696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908406|NCT00001696|Phytoestrogens|phytoestrogens|mesh-ancestor
64908407|NCT00001696|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64908408|NCT00001696|Estrogens|estrogens|mesh-ancestor
64908409|NCT00001696|Hormones|hormones|mesh-ancestor
64908410|NCT00001696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64908411|NCT00389428|Cytarabine|cytarabine|mesh-list
64908412|NCT00389428|Daunorubicin|daunorubicin|mesh-list
64908413|NCT00389428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64908414|NCT00389428|Antimetabolites|antimetabolites|mesh-ancestor
64908415|NCT00389428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908416|NCT00389428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908417|NCT00389428|Antiviral Agents|antiviral agents|mesh-ancestor
64908418|NCT00389428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64908419|NCT00389428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64524576|NCT03175380|Immunologic Factors|immunologic factors|mesh-ancestor
64524577|NCT03175380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524578|NCT02530528|Chlorhexidine|chlorhexidine|mesh-list
64524579|NCT02530528|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64524580|NCT02530528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64524581|NCT02530528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64524582|NCT02530528|Disinfectants|disinfectants|mesh-ancestor
64524583|NCT02530528|Dermatologic Agents|dermatologic agents|mesh-ancestor
64524584|NCT03174756|Chlorhexidine|chlorhexidine|mesh-list
64524585|NCT03174756|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64524586|NCT03174756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64524587|NCT03174756|Disinfectants|disinfectants|mesh-ancestor
64524588|NCT03174678|Dexmedetomidine|dexmedetomidine|mesh-list
64908420|NCT00389428|Immunologic Factors|immunologic factors|mesh-ancestor
64908421|NCT00389428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908422|NCT00389428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64908423|NCT00389428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64908424|NCT00389428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64908425|NCT00389428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908427|NCT00001720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64908428|NCT00001720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908429|NCT00001723|Orlistat|orlistat|mesh-list
64908430|NCT00001723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908452|NCT00001777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64908453|NCT00001777|Serotonin Agents|serotonin agents|mesh-ancestor
64908454|NCT00001777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908455|NCT00000171|Melatonin|melatonin|mesh-list
64908456|NCT00000171|Antioxidants|antioxidants|mesh-ancestor
64908457|NCT00000171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908458|NCT00000171|Protective Agents|protective agents|mesh-ancestor
64908459|NCT00000171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908460|NCT00000171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64908462|NCT05641636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64908463|NCT05641636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908464|NCT00000177|Estrogens|estrogens|mesh-list
64908465|NCT00000177|Hormones|hormones|mesh-ancestor
64908466|NCT00000177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64908467|NCT00000177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908468|NCT03444376|Pembrolizumab|pembrolizumab|mesh-list
64320989|NCT02030977|Protective Agents|protective agents|mesh-ancestor
64320990|NCT02030977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320991|NCT02030977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320992|NCT02030977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64320994|NCT02194855|Cisatracurium|cisatracurium|mesh-list
64733951|NCT02106156|Antiviral Agents|antiviral agents|mesh-ancestor
64908469|NCT03444376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64908470|NCT03444376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908471|NCT00000216|Buprenorphine|buprenorphine|mesh-list
64908472|NCT00000216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64908473|NCT00000216|Narcotics|narcotics|mesh-ancestor
64908474|NCT00000216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64908475|NCT00000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908476|NCT00000216|Analgesics|analgesics|mesh-ancestor
64908477|NCT00000216|Sensory System Agents|sensory system agents|mesh-ancestor
64908478|NCT00000216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64908479|NCT00000216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64908553|NCT00389506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64908554|NCT00389506|Alkylating Agents|alkylating agents|mesh-ancestor
64908555|NCT00389506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908556|NCT00389506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908557|NCT00389506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64908558|NCT00389506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64908559|NCT00389506|Antimetabolites|antimetabolites|mesh-ancestor
64908560|NCT00389584|Irinotecan|irinotecan|mesh-list
64524589|NCT03174678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64524590|NCT03174678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64524591|NCT03174678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524592|NCT03174678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64524593|NCT03174678|Analgesics|analgesics|mesh-ancestor
64524594|NCT03174678|Sensory System Agents|sensory system agents|mesh-ancestor
64524595|NCT03174678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524596|NCT03174678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64524597|NCT03174678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64524598|NCT03174678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64524599|NCT03174678|Adrenergic Agents|adrenergic agents|mesh-ancestor
64524600|NCT03174678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64524601|NCT03174678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524603|NCT02409498|Anesthetics, Local|anesthetics, local|mesh-ancestor
64908561|NCT00389584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64908562|NCT00389584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64908563|NCT00389584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908564|NCT00389584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908565|NCT00389584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908567|NCT00000324|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64908568|NCT00000324|Antidepressive Agents|antidepressive agents|mesh-ancestor
64908569|NCT00000324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64908570|NCT05640427|Dexmedetomidine|dexmedetomidine|mesh-list
64908600|NCT00000375|Antidepressive Agents|antidepressive agents|mesh-ancestor
64908601|NCT00000375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64908602|NCT00000375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908603|NCT00000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908604|NCT00000375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64908605|NCT00000375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64908606|NCT00000375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64908607|NCT00000375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64908610|NCT03295747|Peppermint oil|peppermint oil|mesh-list
64908611|NCT03295747|Antiemetics|antiemetics|mesh-ancestor
64908612|NCT03295747|Autonomic Agents|autonomic agents|mesh-ancestor
64733952|NCT02106156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64733953|NCT02106156|Antimetabolites|antimetabolites|mesh-ancestor
64733954|NCT02106156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733955|NCT02106156|Immunologic Factors|immunologic factors|mesh-ancestor
64733956|NCT02106156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908674|NCT05626621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908676|NCT05626621|Respiratory System Agents|respiratory system agents|mesh-ancestor
64908677|NCT05626621|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64908678|NCT05626621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908679|NCT05626621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908680|NCT05626621|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64908681|NCT05626621|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64908682|NCT05626621|Histamine Antagonists|histamine antagonists|mesh-ancestor
64908683|NCT05626621|Histamine Agents|histamine agents|mesh-ancestor
64908684|NCT05626621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64908685|NCT00000381|Fluoxetine|fluoxetine|mesh-list
64908686|NCT00000381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64908687|NCT00000381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64908688|NCT00000381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64908689|NCT00000381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908690|NCT00000381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64908691|NCT00000381|Serotonin Agents|serotonin agents|mesh-ancestor
64908721|NCT00000420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908722|NCT00000420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64908723|NCT00000420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64524606|NCT02409498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524607|NCT02409498|Sensory System Agents|sensory system agents|mesh-ancestor
64524608|NCT02409498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524609|NCT02409186|Paclitaxel|paclitaxel|mesh-list
64524610|NCT02409186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64524611|NCT02409186|Cisplatin|cisplatin|mesh-list
64370612|NCT02477267|Naloxone|naloxone|mesh-list
64908725|NCT00000426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64908726|NCT00000426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908727|NCT05551858|Proglumide|proglumide|mesh-list
64908728|NCT05551858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64908729|NCT05551858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64908730|NCT05530174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64908731|NCT05530174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64908732|NCT00000456|Naltrexone|naltrexone|mesh-list
64908733|NCT00000456|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64908734|NCT00000456|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64908735|NCT00000456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908802|NCT02972476|Anticonvulsants|anticonvulsants|mesh-ancestor
64908803|NCT02972476|Sympathomimetics|sympathomimetics|mesh-ancestor
64908804|NCT05418868|Cabotegravir|cabotegravir|mesh-list
64908805|NCT05418868|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64908806|NCT05418868|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64908807|NCT05418868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908808|NCT05418868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908809|NCT05418868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64908810|NCT05418868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64908811|NCT05418868|Antiviral Agents|antiviral agents|mesh-ancestor
64908812|NCT05418868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64908813|NCT02972320|Temozolomide|temozolomide|mesh-list
64908848|NCT00388986|Glyburide|glyburide|mesh-list
64908849|NCT00388986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64908850|NCT00388986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908851|NCT05233696|Paclitaxel|paclitaxel|mesh-list
64908852|NCT05233696|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64908853|NCT05233696|Pembrolizumab|pembrolizumab|mesh-list
64908885|NCT00000504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908886|NCT00000504|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64908887|NCT00000504|Antidepressive Agents|antidepressive agents|mesh-ancestor
64908888|NCT00000504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64908889|NCT00000504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64908890|NCT00000504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64908891|NCT00000504|Adrenergic Agents|adrenergic agents|mesh-ancestor
64908892|NCT00000504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64908893|NCT00000504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908894|NCT00389935|Thalidomide|thalidomide|mesh-list
64908926|NCT00423475|Goserelin|goserelin|mesh-list
64908927|NCT00423475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64649338|NCT03984188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64908931|NCT00000516|Protease Inhibitors|protease inhibitors|mesh-ancestor
64908932|NCT00000516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908933|NCT00000516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908934|NCT00000516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64908936|NCT05049616|Diuretics|diuretics|mesh-list
64908937|NCT05049616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64908966|NCT00000522|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64908967|NCT00000522|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64908968|NCT00000522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64908969|NCT00000522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64908970|NCT00000522|Adrenergic Agents|adrenergic agents|mesh-ancestor
64908971|NCT00000522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64524612|NCT02409186|Nimotuzumab|nimotuzumab|mesh-list
64524613|NCT02409186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64524614|NCT02409186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64524615|NCT02409186|Tubulin Modulators|tubulin modulators|mesh-ancestor
64524616|NCT02409186|Antimitotic Agents|antimitotic agents|mesh-ancestor
64524617|NCT02409186|Mitosis Modulators|mitosis modulators|mesh-ancestor
64524618|NCT02409186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524619|NCT02409186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64524620|NCT02410746|Ibuprofen|ibuprofen|mesh-list
64524621|NCT02410746|Morphine|morphine|mesh-list
64524622|NCT02410746|Levobupivacaine|levobupivacaine|mesh-list
64524623|NCT02410746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64524624|NCT02410746|Narcotics|narcotics|mesh-ancestor
64524625|NCT02410746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64908972|NCT00000522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64908973|NCT00000522|Sympathomimetics|sympathomimetics|mesh-ancestor
64908974|NCT00000522|Autonomic Agents|autonomic agents|mesh-ancestor
64908975|NCT00000522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64908976|NCT00000522|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64908977|NCT00000522|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64908978|NCT03126799|Bevacizumab|bevacizumab|mesh-list
64908979|NCT03126799|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64908980|NCT03126799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64908981|NCT03126799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908982|NCT03126799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64909006|NCT05019430|Zolmitriptan|zolmitriptan|mesh-list
64909007|NCT05019430|Anesthetics, Local|anesthetics, local|mesh-ancestor
64909008|NCT05019430|Anesthetics|anesthetics|mesh-ancestor
64909009|NCT05019430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64909010|NCT05019430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909011|NCT05019430|Sensory System Agents|sensory system agents|mesh-ancestor
64909012|NCT05019430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64909013|NCT05019430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64909014|NCT05019430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64909015|NCT05019430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64909016|NCT05019430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64909017|NCT05019430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909018|NCT05019430|Dopamine Agents|dopamine agents|mesh-ancestor
64909019|NCT05019430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64909020|NCT05019430|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64909021|NCT05019430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64909022|NCT05019430|Serotonin Agents|serotonin agents|mesh-ancestor
64909023|NCT00000531|Amiodarone|amiodarone|mesh-list
64909024|NCT00000531|Sotalol|sotalol|mesh-list
64909025|NCT00000531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64909026|NCT00000531|Vasodilator Agents|vasodilator agents|mesh-ancestor
64909027|NCT00000531|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64909028|NCT00000531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64909029|NCT00000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909030|NCT00000531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64909031|NCT00000531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64909062|NCT00000555|Progesterone|progesterone|mesh-list
64909063|NCT00000555|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64909064|NCT00000555|Estrogens|estrogens|mesh-list
64909065|NCT00000555|Vitamins|vitamins|mesh-ancestor
64909068|NCT00000555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64909069|NCT00000555|Progestins|progestins|mesh-ancestor
64524628|NCT02410746|Sensory System Agents|sensory system agents|mesh-ancestor
64524629|NCT02410746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524630|NCT02410746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64524631|NCT02410746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64524632|NCT02410746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64524633|NCT02410746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64909070|NCT00000555|Antioxidants|antioxidants|mesh-ancestor
64909071|NCT00000555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909072|NCT00000555|Protective Agents|protective agents|mesh-ancestor
64733967|NCT02130882|Respiratory System Agents|respiratory system agents|mesh-ancestor
64733968|NCT02149836|Ezogabine|ezogabine|mesh-list
64733969|NCT02149836|Anticonvulsants|anticonvulsants|mesh-ancestor
64733970|NCT02149836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64733971|NCT02149836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733972|NCT02130024|Ranibizumab|ranibizumab|mesh-list
64909073|NCT04888858|Fentanyl|fentanyl|mesh-list
64909074|NCT04888858|Bupivacaine|bupivacaine|mesh-list
64909075|NCT04888858|Anesthetics, Local|anesthetics, local|mesh-ancestor
64909076|NCT04888858|Anesthetics|anesthetics|mesh-ancestor
64909108|NCT04862221|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64909109|NCT04862221|Prednisolone|prednisolone|mesh-list
64909110|NCT04862221|Prednisolone acetate|prednisolone acetate|mesh-list
64909111|NCT04862221|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64909112|NCT04862221|Prednisolone phosphate|prednisolone phosphate|mesh-list
64734069|NCT02145078|Gemcitabine|gemcitabine|mesh-list
64734070|NCT02145078|Docetaxel|docetaxel|mesh-list
64734071|NCT02145078|Pemetrexed|pemetrexed|mesh-list
64734072|NCT02145078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64734073|NCT02145078|Antimetabolites|antimetabolites|mesh-ancestor
64734074|NCT02145078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734075|NCT02145078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734076|NCT02145078|Antiviral Agents|antiviral agents|mesh-ancestor
64734077|NCT02145078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64734078|NCT02145078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734079|NCT02145078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64734080|NCT02145078|Immunologic Factors|immunologic factors|mesh-ancestor
64734081|NCT02145078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734082|NCT02145078|Tubulin Modulators|tubulin modulators|mesh-ancestor
64734083|NCT02145078|Antimitotic Agents|antimitotic agents|mesh-ancestor
64734084|NCT02145078|Mitosis Modulators|mitosis modulators|mesh-ancestor
64734085|NCT02145078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64734086|NCT02145078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64734087|NCT02100228|Vitamin K|vitamin k|mesh-list
64734088|NCT02100228|Heparin|heparin|mesh-list
64320995|NCT02194855|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64320996|NCT02194855|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64320997|NCT02194855|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64909113|NCT04862221|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64909114|NCT04862221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64909115|NCT04862221|Antiemetics|antiemetics|mesh-ancestor
64909116|NCT04862221|Autonomic Agents|autonomic agents|mesh-ancestor
64909117|NCT04862221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64909146|NCT04802746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909147|NCT04802746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64909148|NCT04802746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64909149|NCT04802746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64909150|NCT04802746|GABA Modulators|gaba modulators|mesh-ancestor
64909151|NCT04802746|GABA Agents|gaba agents|mesh-ancestor
64909152|NCT04802746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64909153|NCT04802746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909154|NCT00000576|Beclomethasone|beclomethasone|mesh-list
64909155|NCT00000576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64909156|NCT00000576|Glucocorticoids|glucocorticoids|mesh-ancestor
64734094|NCT02100228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64734095|NCT02100228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64734096|NCT02100228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734097|NCT02100228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64734098|NCT02100228|Antithrombins|antithrombins|mesh-ancestor
64734099|NCT02100228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64734100|NCT02100228|Protease Inhibitors|protease inhibitors|mesh-ancestor
64734101|NCT02100228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734102|NCT02100228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64734103|NCT02100228|Hemostatics|hemostatics|mesh-ancestor
64734104|NCT02100228|Coagulants|coagulants|mesh-ancestor
64734105|NCT02099838|Metformin|metformin|mesh-list
64734106|NCT02099838|Pioglitazone|pioglitazone|mesh-list
64734107|NCT02099838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64734108|NCT02099838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734109|NCT02099682|Lansoprazole|lansoprazole|mesh-list
64321015|NCT02031211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64321016|NCT02031211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64321017|NCT02031211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64734116|NCT02098746|Pioglitazone|pioglitazone|mesh-list
64909157|NCT00000576|Hormones|hormones|mesh-ancestor
64909158|NCT00000576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64909159|NCT00000576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909160|NCT00000576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64909161|NCT00000576|Respiratory System Agents|respiratory system agents|mesh-ancestor
64909186|NCT00000579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64734133|NCT02122770|Mitosis Modulators|mitosis modulators|mesh-ancestor
64734134|NCT02122770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734135|NCT02122770|Antifungal Agents|antifungal agents|mesh-ancestor
64734136|NCT02122770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64734137|NCT02122770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64734138|NCT02122770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64734139|NCT02122770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431505|NCT02059161|Insulin|insulin|mesh-list
64321021|NCT02195089|Immunologic Factors|immunologic factors|mesh-ancestor
64321022|NCT02195089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321023|NCT02031289|Folic Acid|folic acid|mesh-list
64321024|NCT02031289|Vitamin B 12|vitamin b 12|mesh-list
64321025|NCT02031289|Hydroxocobalamin|hydroxocobalamin|mesh-list
64321026|NCT02031289|Epoetin Alfa|epoetin alfa|mesh-list
64321027|NCT02031289|Vitamins|vitamins|mesh-ancestor
64321028|NCT02031289|Micronutrients|micronutrients|mesh-ancestor
64321029|NCT02031289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909188|NCT00000579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909189|NCT00000579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64909190|NCT00000579|Hormone Antagonists|hormone antagonists|mesh-ancestor
64909191|NCT00000579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64909192|NCT00000588|Pyridoxal|pyridoxal|mesh-list
64909193|NCT00000588|Pyridoxal isonicotinoyl hydrazone|pyridoxal isonicotinoyl hydrazone|mesh-list
64909194|NCT00000588|Vitamin B Complex|vitamin b complex|mesh-ancestor
64909195|NCT00000588|Vitamins|vitamins|mesh-ancestor
64909196|NCT00000588|Micronutrients|micronutrients|mesh-ancestor
64909197|NCT00000588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734140|NCT02122770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64734141|NCT02122770|Hormone Antagonists|hormone antagonists|mesh-ancestor
64734142|NCT02122770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64734143|NCT02122770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734144|NCT02122770|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64734145|NCT02122770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64734146|NCT02122770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64734147|NCT02122380|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64734148|NCT02122380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64734149|NCT02122380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734150|NCT02122380|Incretins|incretins|mesh-ancestor
64734151|NCT02122380|Hormones|hormones|mesh-ancestor
64734152|NCT02122380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64734153|NCT02122380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64734154|NCT02122380|Protease Inhibitors|protease inhibitors|mesh-ancestor
64734155|NCT02122380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734156|NCT02122380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734157|NCT02121756|Dipyridamole|dipyridamole|mesh-list
64734158|NCT02121756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64734159|NCT02121756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734160|NCT02121756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909198|NCT00000588|Chelating Agents|chelating agents|mesh-ancestor
64909199|NCT00000588|Sequestering Agents|sequestering agents|mesh-ancestor
64909200|NCT00000588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909201|NCT00000588|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64909202|NCT04713514|Pembrolizumab|pembrolizumab|mesh-list
64909203|NCT04713514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64909205|NCT00000594|Cholestyramine Resin|cholestyramine resin|mesh-list
64909206|NCT00000594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64909207|NCT00000594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64909208|NCT00000594|Antimetabolites|antimetabolites|mesh-ancestor
64734181|NCT02096952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64734182|NCT02096952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734183|NCT02096952|Dopamine Agents|dopamine agents|mesh-ancestor
64734184|NCT02096952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64734185|NCT02120898|Imiquimod|imiquimod|mesh-list
64734186|NCT02120898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64734187|NCT02120898|Immunologic Factors|immunologic factors|mesh-ancestor
64734188|NCT02120898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734189|NCT02120898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734190|NCT02120898|Interferon Inducers|interferon inducers|mesh-ancestor
64734191|NCT02120664|Corticosterone|corticosterone|mesh-list
64321032|NCT02197741|Opiate Alkaloids|opiate alkaloids|mesh-list
64321033|NCT02197741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64321035|NCT02197741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64321036|NCT02197741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734193|NCT01627860|Topiramate|topiramate|mesh-list
64734194|NCT01627860|Anticonvulsants|anticonvulsants|mesh-ancestor
64734195|NCT01627860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64734196|NCT01627860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734197|NCT01627782|Ketamine|ketamine|mesh-list
64734198|NCT01627782|Analgesics|analgesics|mesh-ancestor
64909209|NCT00000594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909210|NCT00000594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64909211|NCT00390091|Abetimus|abetimus|mesh-list
64524634|NCT02410746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64524635|NCT02410746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524636|NCT02410746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524637|NCT02410746|Anesthetics, Local|anesthetics, local|mesh-ancestor
64524638|NCT02410746|Anesthetics|anesthetics|mesh-ancestor
64524639|NCT03177174|Docetaxel|docetaxel|mesh-list
64909236|NCT04601077|Gasotransmitters|gasotransmitters|mesh-ancestor
64909237|NCT04601077|Protective Agents|protective agents|mesh-ancestor
64909238|NCT00000609|Amiodarone|amiodarone|mesh-list
64321037|NCT02197741|Analgesics|analgesics|mesh-ancestor
64321038|NCT02197741|Sensory System Agents|sensory system agents|mesh-ancestor
64321039|NCT02197741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321040|NCT02196493|Azithromycin|azithromycin|mesh-list
64321041|NCT02196493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64734200|NCT01627782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64734201|NCT01627782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734202|NCT01627782|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64734203|NCT01627782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64734204|NCT01627782|Anesthetics, General|anesthetics, general|mesh-ancestor
64734205|NCT01627782|Anesthetics|anesthetics|mesh-ancestor
64734206|NCT01627782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64734207|NCT01627782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64734208|NCT01627782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64734209|NCT01627782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64734210|NCT01627782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734211|NCT02119650|Pemetrexed|pemetrexed|mesh-list
64734212|NCT02119650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734213|NCT02119650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64321042|NCT02196493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64321043|NCT05506592|Dermatologic Agents|dermatologic agents|mesh-list
64321044|NCT03533803|Indomethacin|indomethacin|mesh-list
64734214|NCT02119650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64473550|NCT01763918|Antimetabolites|antimetabolites|mesh-ancestor
64734216|NCT02119650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64734217|NCT02119416|Caffeine|caffeine|mesh-list
64734218|NCT02119416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64909239|NCT00000609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64909240|NCT00000609|Vasodilator Agents|vasodilator agents|mesh-ancestor
64909241|NCT00000609|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64909242|NCT00000609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64909243|NCT00000609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909244|NCT00000609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64909245|NCT00000609|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64734235|NCT02119026|Capecitabine|capecitabine|mesh-list
64734236|NCT02119026|Oxaliplatin|oxaliplatin|mesh-list
64734237|NCT02119026|Irinotecan|irinotecan|mesh-list
64734238|NCT02119026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64734239|NCT02119026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734240|NCT02119026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64734241|NCT02119026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64734242|NCT02119026|Growth Substances|growth substances|mesh-ancestor
64734243|NCT02119026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734244|NCT02119026|Growth Inhibitors|growth inhibitors|mesh-ancestor
64734245|NCT02119026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64734246|NCT02119026|Antimetabolites|antimetabolites|mesh-ancestor
64734247|NCT02119026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734248|NCT02119026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64734249|NCT02119026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64734250|NCT02119026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734251|NCT02095158|Phenylephrine|phenylephrine|mesh-list
64734252|NCT02095158|Oxymetazoline|oxymetazoline|mesh-list
64734253|NCT02095158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64734254|NCT02095158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64734255|NCT02095158|Adrenergic Agents|adrenergic agents|mesh-ancestor
64734256|NCT02095158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64734257|NCT02095158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734258|NCT02095158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734259|NCT02095158|Sympathomimetics|sympathomimetics|mesh-ancestor
64734260|NCT02095158|Autonomic Agents|autonomic agents|mesh-ancestor
64734261|NCT02095158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64734262|NCT02095158|Nasal Decongestants|nasal decongestants|mesh-ancestor
64909246|NCT00000609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64909247|NCT00000609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909248|NCT00000609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64909249|NCT00000609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64909250|NCT00000609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64909251|NCT04547530|Vitamin D|vitamin d|mesh-list
64909252|NCT04547530|Vitamins|vitamins|mesh-ancestor
64909253|NCT04547530|Micronutrients|micronutrients|mesh-ancestor
64909254|NCT04547530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909255|NCT04547530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64909256|NCT04544683|Dexamethasone|dexamethasone|mesh-list
64321049|NCT03533803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321050|NCT03533803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321051|NCT03533803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64321052|NCT03533803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64321053|NCT03533803|Gout Suppressants|gout suppressants|mesh-ancestor
64321054|NCT03533803|Tocolytic Agents|tocolytic agents|mesh-ancestor
64734279|NCT02118012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734280|NCT02118012|Antiviral Agents|antiviral agents|mesh-ancestor
64734281|NCT02118012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64734282|NCT02138838|Cinacalcet|cinacalcet|mesh-list
64734283|NCT02138838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64734284|NCT02138838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734285|NCT02138838|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64734286|NCT02138838|Hormone Antagonists|hormone antagonists|mesh-ancestor
64734287|NCT02138838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64734288|NCT02092350|Grazoprevir|grazoprevir|mesh-list
64473626|NCT01790516|Cetuximab|cetuximab|mesh-list
64734289|NCT02092350|Antiviral Agents|antiviral agents|mesh-ancestor
64734290|NCT02092350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64734291|NCT02138136|Lubiprostone|lubiprostone|mesh-list
64734292|NCT02138136|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64734293|NCT02138136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64734294|NCT02138136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734295|NCT02116608|Povidone-Iodine|povidone-iodine|mesh-list
64734296|NCT02116608|Silver Nitrate|silver nitrate|mesh-list
64734297|NCT02116608|Hydrocortisone|hydrocortisone|mesh-list
64734298|NCT02116608|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
64734299|NCT02116608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64734300|NCT02116608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64607769|NCT01722799|Paclitaxel|paclitaxel|mesh-list
64909257|NCT04544683|Dexamethasone acetate|dexamethasone acetate|mesh-list
64909258|NCT04544683|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64909259|NCT04544683|BB 1101|bb 1101|mesh-list
64909260|NCT04544683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64909261|NCT04544683|Antiemetics|antiemetics|mesh-ancestor
64909262|NCT04544683|Autonomic Agents|autonomic agents|mesh-ancestor
64909263|NCT04544683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64909264|NCT04544683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909265|NCT04544683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64909266|NCT04544683|Glucocorticoids|glucocorticoids|mesh-ancestor
64909289|NCT00000639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909290|NCT00000639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64909291|NCT00000639|Hormone Antagonists|hormone antagonists|mesh-ancestor
64909292|NCT00000639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64909293|NCT00000639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909294|NCT00000639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64909295|NCT00000639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64909296|NCT00000639|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64909297|NCT00000639|Amebicides|amebicides|mesh-ancestor
64909298|NCT00000639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64909299|NCT00000639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64321055|NCT03533803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64321056|NCT03533803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64321057|NCT03533803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64321058|NCT03533803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734301|NCT02116608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64734302|NCT02116608|Dermatologic Agents|dermatologic agents|mesh-ancestor
64734303|NCT02092116|Romidepsin|romidepsin|mesh-list
64734304|NCT02092116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64734305|NCT02092116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734306|NCT02091414|Cyclosporine|cyclosporine|mesh-list
64734307|NCT02091414|Mycophenolic Acid|mycophenolic acid|mesh-list
64734308|NCT02091414|Cyclosporins|cyclosporins|mesh-list
64734309|NCT02091414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734310|NCT02091414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734311|NCT02091414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64734312|NCT02091414|Immunologic Factors|immunologic factors|mesh-ancestor
64734313|NCT02091414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734314|NCT02091414|Antifungal Agents|antifungal agents|mesh-ancestor
64909300|NCT00000639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64909301|NCT00000639|Antimetabolites|antimetabolites|mesh-ancestor
64909302|NCT00000642|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
64909303|NCT00000642|Immunologic Factors|immunologic factors|mesh-ancestor
64909304|NCT00000642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909305|NCT00000645|Hypericin|hypericin|mesh-list
64909306|NCT00000645|Antidepressive Agents|antidepressive agents|mesh-ancestor
64909307|NCT00000645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64909308|NCT00000645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909309|NCT00000645|Antiviral Agents|antiviral agents|mesh-ancestor
64524644|NCT03177174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524645|NCT03177252|Lidocaine|lidocaine|mesh-list
64524646|NCT03177252|Bupivacaine|bupivacaine|mesh-list
64524647|NCT03177252|Anesthetics, Local|anesthetics, local|mesh-ancestor
64524648|NCT03177252|Anesthetics|anesthetics|mesh-ancestor
64321059|NCT02198209|Liraglutide|liraglutide|mesh-list
64321062|NCT02198209|Incretins|incretins|mesh-ancestor
64524649|NCT03177252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64649345|NCT03984188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64909311|NCT00000645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909312|NCT00000645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909313|NCT00000645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64909314|NCT00000645|Immunologic Factors|immunologic factors|mesh-ancestor
64909315|NCT00000645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734415|NCT04741698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64734416|NCT04741698|Adrenergic Agents|adrenergic agents|mesh-ancestor
64734417|NCT04741698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64734418|NCT04741698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734419|NCT04741698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734420|NCT04741698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64734421|NCT04741698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64734422|NCT04741698|Vasodilator Agents|vasodilator agents|mesh-ancestor
64734423|NCT02111850|Aldesleukin|aldesleukin|mesh-list
64734424|NCT02111850|Cyclophosphamide|cyclophosphamide|mesh-list
64734425|NCT02111850|Fludarabine|fludarabine|mesh-list
64734426|NCT02111850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64734427|NCT02111850|Immunologic Factors|immunologic factors|mesh-ancestor
64734428|NCT02111850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321069|NCT02195557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321070|NCT02195635|Octreotide|octreotide|mesh-list
64321071|NCT02195635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64321072|NCT02195635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64321073|NCT02195635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64321074|NCT03534505|Ketorolac|ketorolac|mesh-list
64321075|NCT03534505|Bupivacaine|bupivacaine|mesh-list
64321076|NCT03534505|Anesthetics, Local|anesthetics, local|mesh-ancestor
64321077|NCT03534505|Anesthetics|anesthetics|mesh-ancestor
64321078|NCT03534505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64607780|NCT01606176|Sensory System Agents|sensory system agents|mesh-ancestor
64321079|NCT03534505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321080|NCT03534505|Sensory System Agents|sensory system agents|mesh-ancestor
64909316|NCT04495504|Ropivacaine|ropivacaine|mesh-list
64909317|NCT04495504|Anesthetics, Local|anesthetics, local|mesh-ancestor
64909346|NCT00389025|Analgesics|analgesics|mesh-ancestor
64909347|NCT00389025|Sensory System Agents|sensory system agents|mesh-ancestor
64909348|NCT00389025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64909349|NCT00389025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909350|NCT00389025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64909351|NCT00389025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64909352|NCT00389025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64909353|NCT00389025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64909354|NCT00389025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64909355|NCT00389025|Histamine Antagonists|histamine antagonists|mesh-ancestor
64909356|NCT00389025|Histamine Agents|histamine agents|mesh-ancestor
64909357|NCT00389025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64909358|NCT00389025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909359|NCT00390247|Thalidomide|thalidomide|mesh-list
64909360|NCT00390247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64909361|NCT00390247|Immunologic Factors|immunologic factors|mesh-ancestor
64909362|NCT00390247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909383|NCT00000666|Antimalarials|antimalarials|mesh-ancestor
64909384|NCT00000666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64909385|NCT00000666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64909386|NCT00000666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909387|NCT00000666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64909388|NCT00000666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909389|NCT00000666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909391|NCT00000672|Antimetabolites|antimetabolites|mesh-ancestor
64909392|NCT00000672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909393|NCT00000672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64909394|NCT00000672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64909395|NCT00000672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909396|NCT00000672|Antiviral Agents|antiviral agents|mesh-ancestor
64909397|NCT00000672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909398|NCT00000672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64909399|NCT00000672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64909400|NCT04321954|Lenvatinib|lenvatinib|mesh-list
64909401|NCT04321954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909402|NCT04321954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64524656|NCT03177252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64524657|NCT03177252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524658|NCT02703324|Insulin Lispro|insulin lispro|mesh-list
64524659|NCT02703324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64524660|NCT02703324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524661|NCT02408562|Becaplermin|becaplermin|mesh-list
64524662|NCT02408562|Anticoagulants|anticoagulants|mesh-ancestor
64524663|NCT02408562|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
64524664|NCT02408562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64524665|NCT02408562|Growth Substances|growth substances|mesh-ancestor
64524666|NCT02408562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524667|NCT02416674|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64524668|NCT02416674|Immunologic Factors|immunologic factors|mesh-ancestor
64909414|NCT00000678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909415|NCT00000678|Antiviral Agents|antiviral agents|mesh-ancestor
64909416|NCT00000678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64734441|NCT02085252|Androgen Antagonists|androgen antagonists|mesh-ancestor
64734442|NCT02085252|Hormone Antagonists|hormone antagonists|mesh-ancestor
64734443|NCT02085252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64321081|NCT03534505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321082|NCT03534505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64321083|NCT03534505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64321084|NCT03534505|Analgesics|analgesics|mesh-ancestor
64321085|NCT03534505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64321086|NCT03534505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64909417|NCT00000678|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64909418|NCT00000678|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64909443|NCT00000681|Doxorubicin|doxorubicin|mesh-list
64909444|NCT00000681|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64909445|NCT00000681|Bleomycin|bleomycin|mesh-list
64909446|NCT00000681|Vincristine|vincristine|mesh-list
64909447|NCT00000681|Sargramostim|sargramostim|mesh-list
64909448|NCT00000681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64909449|NCT00000681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909450|NCT00000681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64909451|NCT00000681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64909452|NCT00000681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909453|NCT00000681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909454|NCT00000681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64909455|NCT00000681|Tubulin Modulators|tubulin modulators|mesh-ancestor
64909456|NCT00000681|Antimitotic Agents|antimitotic agents|mesh-ancestor
64909457|NCT00000681|Mitosis Modulators|mitosis modulators|mesh-ancestor
64909458|NCT00000681|Antimetabolites|antimetabolites|mesh-ancestor
64909459|NCT00000681|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64909460|NCT00000681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64909461|NCT00000681|Antiviral Agents|antiviral agents|mesh-ancestor
64909462|NCT00000681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909463|NCT00000681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64909464|NCT00000681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64909465|NCT00000681|Immunologic Factors|immunologic factors|mesh-ancestor
64909466|NCT00000681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909467|NCT00000684|Dextrans|dextrans|mesh-list
64909468|NCT00000684|Anticoagulants|anticoagulants|mesh-ancestor
64909469|NCT00000684|Plasma Substitutes|plasma substitutes|mesh-ancestor
64909470|NCT00000684|Blood Substitutes|blood substitutes|mesh-ancestor
64909471|NCT00000687|Interferons|interferons|mesh-list
64909506|NCT00000696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64909507|NCT00000705|Zidovudine|zidovudine|mesh-list
64909508|NCT00000705|Antimetabolites|antimetabolites|mesh-ancestor
64524669|NCT02416674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524670|NCT02701764|Pregabalin|pregabalin|mesh-list
64524671|NCT02701764|Analgesics|analgesics|mesh-ancestor
64524672|NCT02701764|Sensory System Agents|sensory system agents|mesh-ancestor
64524673|NCT02701764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524674|NCT02701764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524675|NCT02701764|Anticonvulsants|anticonvulsants|mesh-ancestor
64524676|NCT02701764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64524677|NCT02701764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64524678|NCT02701764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524679|NCT02701764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64524680|NCT02701764|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64524681|NCT02701764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64524682|NCT02701764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64524683|NCT02701764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64524686|NCT03174288|Hormone Antagonists|hormone antagonists|mesh-ancestor
64524687|NCT03174288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64524688|NCT03174288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909509|NCT00000705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909510|NCT00000705|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64909511|NCT00000705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64909512|NCT00000705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909538|NCT04205812|Paclitaxel|paclitaxel|mesh-list
64909539|NCT04205812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64909540|NCT04205812|Carboplatin|carboplatin|mesh-list
64909541|NCT04205812|Pemetrexed|pemetrexed|mesh-list
64909542|NCT04205812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64909543|NCT04205812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909544|NCT04205812|Tubulin Modulators|tubulin modulators|mesh-ancestor
64909545|NCT04205812|Antimitotic Agents|antimitotic agents|mesh-ancestor
64909546|NCT04205812|Mitosis Modulators|mitosis modulators|mesh-ancestor
64909547|NCT04205812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909548|NCT04205812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909549|NCT04205812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64909550|NCT04205812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64909551|NCT00000711|Zidovudine|zidovudine|mesh-list
64909552|NCT00000711|Sargramostim|sargramostim|mesh-list
64909553|NCT00000711|Antimetabolites|antimetabolites|mesh-ancestor
64909554|NCT00000711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909555|NCT00000711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64909556|NCT00000711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64909557|NCT00000711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909558|NCT00000711|Antiviral Agents|antiviral agents|mesh-ancestor
64909559|NCT00000711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909560|NCT00000711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64909561|NCT00000711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64909590|NCT04169347|Micronutrients|micronutrients|mesh-ancestor
64909591|NCT04169347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64909592|NCT00000720|Zidovudine|zidovudine|mesh-list
64524690|NCT03174288|Diuretics|diuretics|mesh-ancestor
64524691|NCT03174288|Natriuretic Agents|natriuretic agents|mesh-ancestor
64524692|NCT02532010|Cytarabine|cytarabine|mesh-list
64524693|NCT02532010|Decitabine|decitabine|mesh-list
64524694|NCT02532010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64524695|NCT02532010|Antimetabolites|antimetabolites|mesh-ancestor
64524696|NCT02532010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524697|NCT02532010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64524698|NCT02532010|Antiviral Agents|antiviral agents|mesh-ancestor
64524699|NCT02532010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64524700|NCT02532010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64524701|NCT02532010|Immunologic Factors|immunologic factors|mesh-ancestor
64524702|NCT02532010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524703|NCT02532010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524704|NCT02406300|Bupivacaine|bupivacaine|mesh-list
64524705|NCT02406300|Ropivacaine|ropivacaine|mesh-list
64524706|NCT02406300|Levobupivacaine|levobupivacaine|mesh-list
64524707|NCT02406300|Sevoflurane|sevoflurane|mesh-list
64524708|NCT02406300|Desflurane|desflurane|mesh-list
64524709|NCT02406300|Anesthetics, Local|anesthetics, local|mesh-ancestor
64524710|NCT02406300|Anesthetics|anesthetics|mesh-ancestor
64524711|NCT02406300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64524712|NCT02406300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524713|NCT02406300|Sensory System Agents|sensory system agents|mesh-ancestor
64524714|NCT02406300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64909593|NCT00000720|Immunoglobulins|immunoglobulins|mesh-list
64909594|NCT00000720|Antibodies|antibodies|mesh-list
64909595|NCT00000720|Antimetabolites|antimetabolites|mesh-ancestor
64909596|NCT00000720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909597|NCT00000720|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64909598|NCT00000720|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64909599|NCT00000720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909600|NCT00000720|Antiviral Agents|antiviral agents|mesh-ancestor
64909601|NCT00000720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909602|NCT00000720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64909603|NCT00000720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64909604|NCT00000720|Immunologic Factors|immunologic factors|mesh-ancestor
64649374|NCT04645550|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64909609|NCT00000726|Foscarnet|foscarnet|mesh-list
64909618|NCT04104139|Antimetabolites|antimetabolites|mesh-ancestor
64909619|NCT04104139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909620|NCT04104139|Antiviral Agents|antiviral agents|mesh-ancestor
64909621|NCT04104139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909622|NCT00000741|Methylprednisolone|methylprednisolone|mesh-list
64909623|NCT00000741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64909624|NCT00000741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64909625|NCT00000741|Prednisolone|prednisolone|mesh-list
64524715|NCT02406300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64524716|NCT02406300|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64524717|NCT02406300|Anesthetics, General|anesthetics, general|mesh-ancestor
64524718|NCT02538016|Tolvaptan|tolvaptan|mesh-list
64524719|NCT02538016|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64524720|NCT02538016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524721|NCT02538016|Natriuretic Agents|natriuretic agents|mesh-ancestor
64524722|NCT02538016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524723|NCT02406144|Dexamethasone|dexamethasone|mesh-list
64524724|NCT02406144|Lenalidomide|lenalidomide|mesh-list
64524725|NCT02406144|Ixazomib|ixazomib|mesh-list
64524726|NCT02406144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64524727|NCT02406144|Antiemetics|antiemetics|mesh-ancestor
64524728|NCT02406144|Autonomic Agents|autonomic agents|mesh-ancestor
64524729|NCT02406144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524730|NCT02406144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524731|NCT02406144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64524732|NCT02406144|Glucocorticoids|glucocorticoids|mesh-ancestor
64524733|NCT02406144|Hormones|hormones|mesh-ancestor
64524734|NCT02406144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64524735|NCT02406144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64524736|NCT02406144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64524737|NCT02406144|Immunologic Factors|immunologic factors|mesh-ancestor
64524738|NCT02406144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64524739|NCT02406144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64524740|NCT02406144|Growth Substances|growth substances|mesh-ancestor
64524741|NCT02406144|Growth Inhibitors|growth inhibitors|mesh-ancestor
64524742|NCT02406144|Protease Inhibitors|protease inhibitors|mesh-ancestor
64524743|NCT02406144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909626|NCT00000741|Prednisolone acetate|prednisolone acetate|mesh-list
64909627|NCT00000741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64909628|NCT00000741|Prednisolone phosphate|prednisolone phosphate|mesh-list
64909629|NCT00000741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64909630|NCT00000741|Antiemetics|antiemetics|mesh-ancestor
64909631|NCT00000741|Autonomic Agents|autonomic agents|mesh-ancestor
64909632|NCT00000741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64909633|NCT00000741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909634|NCT00000741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64909635|NCT00000741|Glucocorticoids|glucocorticoids|mesh-ancestor
64909636|NCT00000741|Hormones|hormones|mesh-ancestor
64909637|NCT00000741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64909638|NCT00000741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64909639|NCT00000741|Protective Agents|protective agents|mesh-ancestor
64524744|NCT02406144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524745|NCT02416752|Remifentanil|remifentanil|mesh-list
64524746|NCT02416752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64524747|NCT02416752|Narcotics|narcotics|mesh-ancestor
64524748|NCT02416752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64524749|NCT02416752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524750|NCT02416752|Analgesics|analgesics|mesh-ancestor
64524751|NCT02416752|Sensory System Agents|sensory system agents|mesh-ancestor
64524752|NCT02416752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524753|NCT02405910|Gemcitabine|gemcitabine|mesh-list
64524754|NCT02405910|Paclitaxel|paclitaxel|mesh-list
64524755|NCT02405910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64524756|NCT02405910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64524757|NCT02405910|Tubulin Modulators|tubulin modulators|mesh-ancestor
64524758|NCT02405910|Antimitotic Agents|antimitotic agents|mesh-ancestor
64524759|NCT02405910|Mitosis Modulators|mitosis modulators|mesh-ancestor
64524765|NCT02405910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524766|NCT02405910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64524767|NCT02405910|Immunologic Factors|immunologic factors|mesh-ancestor
64909640|NCT00000741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64909641|NCT00000741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909642|NCT04069897|Botulinum Toxins|botulinum toxins|mesh-list
64734444|NCT02085252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734445|NCT02085252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734446|NCT02085252|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64734448|NCT02085252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64734449|NCT02085252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64734450|NCT02084238|Interleukin-2|interleukin-2|mesh-list
64734451|NCT02084238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734452|NCT02084238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64734453|NCT02084238|Analgesics|analgesics|mesh-ancestor
64909643|NCT04069897|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64909644|NCT04069897|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64909645|NCT04069897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64909646|NCT04069897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64909647|NCT04069897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909648|NCT04069897|Cholinergic Agents|cholinergic agents|mesh-ancestor
64909649|NCT04069897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64909650|NCT04069897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909651|NCT04069897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64909652|NCT04069897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64909653|NCT00000744|Fluconazole|fluconazole|mesh-list
64909654|NCT00000744|Antifungal Agents|antifungal agents|mesh-ancestor
64909655|NCT00000744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909656|NCT00000744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64909657|NCT00000744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64909658|NCT00000744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909659|NCT00000744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909660|NCT00000744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64909661|NCT00000744|Hormone Antagonists|hormone antagonists|mesh-ancestor
64909662|NCT00000744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64909663|NCT00000744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524768|NCT02405910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524769|NCT02539108|Vaccines|vaccines|mesh-list
64524770|NCT02539108|Immunologic Factors|immunologic factors|mesh-ancestor
64524771|NCT02539108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524772|NCT02406066|Oxazepam|oxazepam|mesh-list
64524773|NCT02406066|Metyrapone|metyrapone|mesh-list
64524774|NCT02406066|Antimetabolites|antimetabolites|mesh-ancestor
64524775|NCT02406066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524776|NCT02406066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524777|NCT02406066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64524778|NCT02406066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64524779|NCT02406066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524780|NCT02406066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64524781|NCT02406066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64524782|NCT02406066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64524783|NCT02406066|GABA Modulators|gaba modulators|mesh-ancestor
64524784|NCT02406066|GABA Agents|gaba agents|mesh-ancestor
64524785|NCT02406066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64524786|NCT02408328|Caffeine|caffeine|mesh-list
64524787|NCT02408328|Caffeine citrate|caffeine citrate|mesh-list
64524788|NCT02408328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524789|NCT02408328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64524790|NCT02408328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524791|NCT02408328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64524792|NCT02408328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524793|NCT02408328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64909664|NCT00000744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64909665|NCT00000744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64909666|NCT04039204|Contraceptive Agents|contraceptive agents|mesh-list
64909667|NCT04039204|Contraceptives, Oral|contraceptives, oral|mesh-list
64909668|NCT04039204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64909669|NCT04039204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909670|NCT04039204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64909671|NCT04038346|Acetaminophen|acetaminophen|mesh-list
64909672|NCT04038346|Naproxen|naproxen|mesh-list
64909673|NCT04038346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64909712|NCT00000753|Zalcitabine|zalcitabine|mesh-list
64909713|NCT00000753|Atevirdine|atevirdine|mesh-list
64909714|NCT00000753|Antimetabolites|antimetabolites|mesh-ancestor
64734455|NCT02084238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64734456|NCT02084238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608035|NCT05530122|Dermatologic Agents|dermatologic agents|mesh-ancestor
64909715|NCT00000753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909754|NCT00000789|Stavudine|stavudine|mesh-list
64909784|NCT00390520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909785|NCT00390520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524794|NCT02408328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64524795|NCT02408328|Purinergic Agents|purinergic agents|mesh-ancestor
64524796|NCT02408328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64524798|NCT02539342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64524799|NCT02539342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524800|NCT02405988|Remifentanil|remifentanil|mesh-list
64524801|NCT02405988|Naloxone|naloxone|mesh-list
64524802|NCT02405988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64524803|NCT02405988|Narcotics|narcotics|mesh-ancestor
64524804|NCT02405988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64524805|NCT02405988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524806|NCT02405988|Analgesics|analgesics|mesh-ancestor
64524807|NCT02405988|Sensory System Agents|sensory system agents|mesh-ancestor
64524808|NCT02405988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524809|NCT02405988|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64524810|NCT02542150|Ethanol|ethanol|mesh-list
64524811|NCT02542150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64524812|NCT02542150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909786|NCT00000813|polysaccharide-K|polysaccharide-k|mesh-list
64909787|NCT00000813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64909788|NCT00000813|Immunologic Factors|immunologic factors|mesh-ancestor
64909789|NCT00000813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909790|NCT00000813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64909791|NCT00000813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909792|NCT00000813|Antiviral Agents|antiviral agents|mesh-ancestor
64909793|NCT00000813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909794|NCT00000813|Interferon Inducers|interferon inducers|mesh-ancestor
64909795|NCT00000813|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64909796|NCT00000813|Protective Agents|protective agents|mesh-ancestor
64909797|NCT03877549|Dexamethasone|dexamethasone|mesh-list
64909798|NCT03877549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64909799|NCT03877549|Antiemetics|antiemetics|mesh-ancestor
64909800|NCT03877549|Autonomic Agents|autonomic agents|mesh-ancestor
64909832|NCT03801031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64909833|NCT03801031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909834|NCT03801031|Sensory System Agents|sensory system agents|mesh-ancestor
64909835|NCT03801031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64909836|NCT03801031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64909837|NCT03801031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64909838|NCT03801031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64909839|NCT03801031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64909840|NCT03801031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909842|NCT00000822|Didanosine|didanosine|mesh-list
64909873|NCT03729271|Lactulose|lactulose|mesh-list
64909874|NCT03729271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64909875|NCT03729271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909876|NCT03729271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64909877|NCT03646123|Doxorubicin|doxorubicin|mesh-list
64909878|NCT03646123|Nivolumab|nivolumab|mesh-list
64909879|NCT03646123|Dacarbazine|dacarbazine|mesh-list
64909880|NCT03646123|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64909881|NCT03646123|Vinblastine|vinblastine|mesh-list
64909882|NCT03646123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64909883|NCT03646123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909884|NCT03646123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64909885|NCT03646123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64909886|NCT03646123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524816|NCT02542462|Immunologic Factors|immunologic factors|mesh-ancestor
64524817|NCT02542462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524825|NCT02408172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64524826|NCT02408172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524827|NCT02408172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64524828|NCT02408172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524829|NCT02408172|Vasodilator Agents|vasodilator agents|mesh-ancestor
64909921|NCT03576547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909922|NCT03576547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64909923|NCT03574402|Gemcitabine|gemcitabine|mesh-list
64909924|NCT03574402|Carboplatin|carboplatin|mesh-list
64909926|NCT03574402|Afatinib|afatinib|mesh-list
64909927|NCT03574402|Crizotinib|crizotinib|mesh-list
64909928|NCT03574402|Nimotuzumab|nimotuzumab|mesh-list
64909929|NCT03574402|Ensartinib|ensartinib|mesh-list
64909956|NCT00000831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64909957|NCT00000831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678396|NCT00002187|Fomivirsen|fomivirsen|mesh-list
64909958|NCT00000831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909959|NCT00000831|Antiviral Agents|antiviral agents|mesh-ancestor
64909960|NCT00000831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909961|NCT00000831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64909962|NCT00000831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64909963|NCT00000831|Antimetabolites|antimetabolites|mesh-ancestor
64909967|NCT00000849|Aldesleukin|aldesleukin|mesh-list
64909968|NCT00000849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909969|NCT00000849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64909970|NCT00000849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64909971|NCT00000849|Antiviral Agents|antiviral agents|mesh-ancestor
64909972|NCT00000849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909973|NCT03357952|Daratumumab|daratumumab|mesh-list
64909974|NCT03357952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909975|NCT00000855|Zidovudine|zidovudine|mesh-list
64909976|NCT00000855|Antimetabolites|antimetabolites|mesh-ancestor
64909977|NCT00000855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910014|NCT00000870|Aldesleukin|aldesleukin|mesh-list
64910015|NCT00000870|Indinavir|indinavir|mesh-list
64910016|NCT00000870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64910017|NCT00000870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64910043|NCT00390871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64910044|NCT00390871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64910045|NCT00390871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64910046|NCT00390871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64910047|NCT00390871|Adrenergic Agents|adrenergic agents|mesh-ancestor
64524830|NCT02408172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64524831|NCT02408172|Sympatholytics|sympatholytics|mesh-ancestor
64524832|NCT02408172|Autonomic Agents|autonomic agents|mesh-ancestor
64524833|NCT02408172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524834|NCT02408172|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64524835|NCT02408172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64524836|NCT02408172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64524837|NCT02408172|Adrenergic Agents|adrenergic agents|mesh-ancestor
64524838|NCT02408172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64524839|NCT04481100|Itraconazole|itraconazole|mesh-list
64524840|NCT04481100|Antifungal Agents|antifungal agents|mesh-ancestor
64524841|NCT04481100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64524842|NCT04481100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64910048|NCT00390871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64910049|NCT00390871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910050|NCT00390871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64910051|NCT00390871|Narcotics|narcotics|mesh-ancestor
64910052|NCT00390871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64910053|NCT03211741|Bevacizumab|bevacizumab|mesh-list
64910054|NCT03211741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64910055|NCT03211741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910059|NCT03211741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910060|NCT03211741|Growth Inhibitors|growth inhibitors|mesh-ancestor
64910061|NCT03206203|Carboplatin|carboplatin|mesh-list
64910062|NCT03206203|Atezolizumab|atezolizumab|mesh-list
64910063|NCT03206203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910064|NCT00000882|Lamivudine|lamivudine|mesh-list
64910065|NCT00000882|Zidovudine|zidovudine|mesh-list
64910066|NCT00000882|Stavudine|stavudine|mesh-list
64910067|NCT00000882|Delavirdine|delavirdine|mesh-list
64910068|NCT00000882|Indinavir|indinavir|mesh-list
64910069|NCT00000882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64910070|NCT00000882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64910071|NCT00000882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910072|NCT00000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910135|NCT00000903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64910136|NCT00000903|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64910137|NCT00000903|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64910138|NCT00000903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64910139|NCT00000903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64910140|NCT00000903|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64910141|NCT00000903|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64910142|NCT00000903|Protease Inhibitors|protease inhibitors|mesh-ancestor
64910143|NCT02939365|Abatacept|abatacept|mesh-list
64910144|NCT02939365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64910145|NCT02939365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910146|NCT02939365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910147|NCT02939365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64910148|NCT02939365|Immunologic Factors|immunologic factors|mesh-ancestor
64910149|NCT02939365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910150|NCT02939365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64910151|NCT00000906|Ritonavir|ritonavir|mesh-list
64910152|NCT00000906|Saquinavir|saquinavir|mesh-list
64910153|NCT00000906|Methadone|methadone|mesh-list
64910154|NCT00000906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64910155|NCT00000906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64910156|NCT00000906|Protease Inhibitors|protease inhibitors|mesh-ancestor
64910157|NCT00000906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910158|NCT00000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524844|NCT04481100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524845|NCT04481100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524846|NCT04481100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64524847|NCT04481100|Hormone Antagonists|hormone antagonists|mesh-ancestor
64910159|NCT00000906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64910160|NCT00000906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64910185|NCT00000951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910186|NCT00000951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910187|NCT00000951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64910188|NCT00000951|Hormone Antagonists|hormone antagonists|mesh-ancestor
64910189|NCT00000951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64910190|NCT00000951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910191|NCT00000951|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64910192|NCT00000951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64910193|NCT02627443|Gemcitabine|gemcitabine|mesh-list
64910194|NCT02627443|Carboplatin|carboplatin|mesh-list
64910195|NCT02627443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910196|NCT02627443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64910197|NCT02627443|Antimetabolites|antimetabolites|mesh-ancestor
64910198|NCT02627443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910199|NCT02627443|Antiviral Agents|antiviral agents|mesh-ancestor
64910200|NCT02627443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910201|NCT02627443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910202|NCT02627443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64910203|NCT02627443|Immunologic Factors|immunologic factors|mesh-ancestor
64910204|NCT02627443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910205|NCT02491099|Afatinib|afatinib|mesh-list
64910206|NCT02491099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910207|NCT02491099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649397|NCT01274897|Lactitol|lactitol|mesh-list
64910251|NCT02419495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64910253|NCT02419495|Antimetabolites|antimetabolites|mesh-ancestor
64910254|NCT02419495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64910255|NCT02419495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64910256|NCT02419495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64910257|NCT02419495|Antidotes|antidotes|mesh-ancestor
64910258|NCT02419495|Protective Agents|protective agents|mesh-ancestor
64910259|NCT02419495|Vitamin B Complex|vitamin b complex|mesh-ancestor
64910260|NCT02419495|Vitamins|vitamins|mesh-ancestor
64910261|NCT02419495|Micronutrients|micronutrients|mesh-ancestor
64910294|NCT00000969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910296|NCT00000969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64910297|NCT00000975|Itraconazole|itraconazole|mesh-list
64910298|NCT00000975|Antifungal Agents|antifungal agents|mesh-ancestor
64910299|NCT00000975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910300|NCT00000975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64910301|NCT00000975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64910302|NCT00000975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910303|NCT00000975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910332|NCT00001002|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
64524848|NCT04481100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64524849|NCT04481100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524850|NCT04481100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64524851|NCT02405598|Albuterol|albuterol|mesh-list
64524852|NCT02405598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64524853|NCT02405598|Autonomic Agents|autonomic agents|mesh-ancestor
64524854|NCT02405598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524855|NCT02405598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524856|NCT02405598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64524857|NCT02405598|Respiratory System Agents|respiratory system agents|mesh-ancestor
64524858|NCT02405598|Tocolytic Agents|tocolytic agents|mesh-ancestor
64524859|NCT02405598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64524860|NCT02405598|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64524861|NCT02405598|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64524862|NCT02405598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64524863|NCT02405598|Adrenergic Agents|adrenergic agents|mesh-ancestor
64524864|NCT02405598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64524865|NCT02405598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524866|NCT03173508|Acetazolamide|acetazolamide|mesh-list
64524867|NCT03173508|Anticonvulsants|anticonvulsants|mesh-ancestor
64910333|NCT00001002|Antimetabolites|antimetabolites|mesh-ancestor
64910334|NCT00001002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910335|NCT00001002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64910336|NCT00001002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64910337|NCT00001002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910345|NCT00005819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910346|NCT00005819|Tubulin Modulators|tubulin modulators|mesh-ancestor
64910347|NCT00005819|Antimitotic Agents|antimitotic agents|mesh-ancestor
64910348|NCT00005819|Mitosis Modulators|mitosis modulators|mesh-ancestor
64910349|NCT00005819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910381|NCT00391144|Growth Inhibitors|growth inhibitors|mesh-ancestor
64910382|NCT00391144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64910383|NCT00391144|Glucocorticoids|glucocorticoids|mesh-ancestor
64910384|NCT00391144|Hormones|hormones|mesh-ancestor
64910385|NCT00391144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64910386|NCT00005822|Tamoxifen|tamoxifen|mesh-list
64910387|NCT00005822|Doxorubicin|doxorubicin|mesh-list
64910388|NCT00005822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64910389|NCT00005822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64910390|NCT00005822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910391|NCT00005822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64910392|NCT00005822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64910393|NCT00005822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910426|NCT01889992|Sirolimus|sirolimus|mesh-list
64524868|NCT03173508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64524869|NCT03173508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524870|NCT03173508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524872|NCT03173508|Natriuretic Agents|natriuretic agents|mesh-ancestor
64714103|NCT03054103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64524873|NCT03173508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524874|NCT03173430|Blinatumomab|blinatumomab|mesh-list
64524875|NCT03173430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64524877|NCT02407782|Permethrin|permethrin|mesh-list
64524878|NCT02407782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64524879|NCT02407782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64524880|NCT02407782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524881|NCT02407782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524882|NCT02405364|Dexamethasone|dexamethasone|mesh-list
64524883|NCT02405364|Lenalidomide|lenalidomide|mesh-list
64524884|NCT02405364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64524885|NCT02405364|Antiemetics|antiemetics|mesh-ancestor
64910427|NCT01889992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64910428|NCT01889992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910429|NCT01889992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64910430|NCT01889992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910431|NCT01889992|Antifungal Agents|antifungal agents|mesh-ancestor
64910432|NCT01889992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64321088|NCT03534505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64321089|NCT03534505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321090|NCT02195791|Pioglitazone|pioglitazone|mesh-list
64608356|NCT00879359|Paclitaxel|paclitaxel|mesh-list
64910433|NCT01889992|Immunologic Factors|immunologic factors|mesh-ancestor
64910463|NCT00001014|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64910464|NCT00001014|Sulfamethoxazole|sulfamethoxazole|mesh-list
64910465|NCT00001014|Trimetrexate|trimetrexate|mesh-list
64910467|NCT00001014|Levoleucovorin|levoleucovorin|mesh-list
64910468|NCT00001014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64910469|NCT00001014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910470|NCT00001014|Antidotes|antidotes|mesh-ancestor
64910471|NCT00001014|Protective Agents|protective agents|mesh-ancestor
64910472|NCT00001014|Vitamin B Complex|vitamin b complex|mesh-ancestor
64910473|NCT00001014|Vitamins|vitamins|mesh-ancestor
64910474|NCT00001014|Micronutrients|micronutrients|mesh-ancestor
64910475|NCT00001014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64910476|NCT00001014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910477|NCT00001014|Renal Agents|renal agents|mesh-ancestor
64910478|NCT00001014|Antimalarials|antimalarials|mesh-ancestor
64910479|NCT00001014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64910480|NCT00001014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64910481|NCT00001014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64910512|NCT00005834|Dexamethasone|dexamethasone|mesh-list
64910513|NCT00005834|Cyclophosphamide|cyclophosphamide|mesh-list
64910514|NCT00005834|Etoposide|etoposide|mesh-list
64910515|NCT00005834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64910521|NCT00005834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910523|NCT00005834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64910556|NCT00001032|Zidovudine|zidovudine|mesh-list
64910557|NCT00001032|Zalcitabine|zalcitabine|mesh-list
64910558|NCT00001032|Antimetabolites|antimetabolites|mesh-ancestor
64524887|NCT02405364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524888|NCT02405364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524889|NCT02405364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64524890|NCT02405364|Glucocorticoids|glucocorticoids|mesh-ancestor
64524891|NCT02405364|Hormones|hormones|mesh-ancestor
64524892|NCT02405364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64524893|NCT02405364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64524894|NCT02405364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64524895|NCT02405364|Immunologic Factors|immunologic factors|mesh-ancestor
64524896|NCT02405364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64524897|NCT02405364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64524898|NCT02405364|Growth Substances|growth substances|mesh-ancestor
64524899|NCT02405364|Growth Inhibitors|growth inhibitors|mesh-ancestor
64524900|NCT02405130|Epinephrine|epinephrine|mesh-list
64524901|NCT02405130|Racepinephrine|racepinephrine|mesh-list
64524902|NCT02405130|Epinephryl borate|epinephryl borate|mesh-list
64524903|NCT02405130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64524904|NCT02405130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64524905|NCT02405130|Adrenergic Agents|adrenergic agents|mesh-ancestor
64524906|NCT02405130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64524907|NCT02405130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524908|NCT02405130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524909|NCT02405130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64910559|NCT00001032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910560|NCT00001032|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64910561|NCT00001032|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64910562|NCT00001032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910563|NCT00001032|Antiviral Agents|antiviral agents|mesh-ancestor
64910564|NCT00001032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910565|NCT00001032|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64910566|NCT00001032|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64910601|NCT00001047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910602|NCT00001047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910603|NCT00001047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64910604|NCT00001047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64910605|NCT00001047|Antitubercular Agents|antitubercular agents|mesh-ancestor
64910606|NCT00001047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64910607|NCT00001047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64321091|NCT02195791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64321092|NCT02195791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321093|NCT02196805|Probucol|probucol|mesh-list
64608395|NCT00883103|Sensory System Agents|sensory system agents|mesh-ancestor
64910608|NCT00001047|Leprostatic Agents|leprostatic agents|mesh-ancestor
64910609|NCT00005852|Cyclosporine|cyclosporine|mesh-list
64910610|NCT00005852|Methylprednisolone|methylprednisolone|mesh-list
64910640|NCT00001071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64910641|NCT00001071|Immunologic Factors|immunologic factors|mesh-ancestor
64910642|NCT00001071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910643|NCT00005855|Carmustine|carmustine|mesh-list
64910644|NCT00005855|Efaproxiral|efaproxiral|mesh-list
64524911|NCT02405130|Autonomic Agents|autonomic agents|mesh-ancestor
64524912|NCT02405130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524913|NCT02405130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64524914|NCT02405130|Respiratory System Agents|respiratory system agents|mesh-ancestor
64524916|NCT02405130|Sympathomimetics|sympathomimetics|mesh-ancestor
64524917|NCT02405130|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64524918|NCT03171090|Anesthetics|anesthetics|mesh-list
64524919|NCT03171090|Anesthetics, Local|anesthetics, local|mesh-list
64524920|NCT03171090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64679099|NCT00002283|Dapsone|dapsone|mesh-list
64910645|NCT00005855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64910646|NCT00005855|Alkylating Agents|alkylating agents|mesh-ancestor
64910651|NCT00001074|Hydroxyurea|hydroxyurea|mesh-list
64910652|NCT00001074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910653|NCT00001074|Antisickling Agents|antisickling agents|mesh-ancestor
64910654|NCT00001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910655|NCT00001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910690|NCT00001083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64910691|NCT00001083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64910692|NCT00001083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64910694|NCT00001083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64910695|NCT00001083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64910696|NCT00005864|Sulfanilamides|sulfanilamides|mesh-list
64649425|NCT03932162|Insulin|insulin|mesh-list
64910697|NCT00005864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910729|NCT00700258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910731|NCT00700258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910732|NCT00700258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64910733|NCT00700258|Antifungal Agents|antifungal agents|mesh-ancestor
64910734|NCT00700258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64910735|NCT00700258|Immunologic Factors|immunologic factors|mesh-ancestor
64910736|NCT00001113|Interferons|interferons|mesh-list
64910737|NCT00001113|Interferon-alpha|interferon-alpha|mesh-list
64910738|NCT00001113|Interferon alpha-2|interferon alpha-2|mesh-list
64910739|NCT00001113|Zidovudine|zidovudine|mesh-list
64910764|NCT00005867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64910766|NCT00005867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910767|NCT00005867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910768|NCT00005867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64910769|NCT00005867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64910770|NCT00005867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64910771|NCT00005867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64910772|NCT00005867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910773|NCT00005867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64910774|NCT00005867|Tubulin Modulators|tubulin modulators|mesh-ancestor
64910775|NCT00005867|Antimitotic Agents|antimitotic agents|mesh-ancestor
64910776|NCT00005867|Mitosis Modulators|mitosis modulators|mesh-ancestor
64910777|NCT00005867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64910778|NCT00005867|Glucocorticoids|glucocorticoids|mesh-ancestor
64910779|NCT00005867|Hormones|hormones|mesh-ancestor
64910780|NCT00005867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64734457|NCT02084082|Metformin|metformin|mesh-list
64734458|NCT02084082|Linagliptin|linagliptin|mesh-list
64734459|NCT02084082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64910781|NCT00005867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64910782|NCT00005867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64910783|NCT00005867|Analgesics|analgesics|mesh-ancestor
64910784|NCT00005867|Sensory System Agents|sensory system agents|mesh-ancestor
64910785|NCT00005870|Gemcitabine|gemcitabine|mesh-list
64910786|NCT00005870|Fluorouracil|fluorouracil|mesh-list
64910787|NCT00005870|Mitomycins|mitomycins|mesh-list
64524922|NCT03171090|Sensory System Agents|sensory system agents|mesh-ancestor
64524923|NCT03171090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64524924|NCT02407470|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64524925|NCT02407470|Immunologic Factors|immunologic factors|mesh-ancestor
64524926|NCT02407470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524927|NCT02407470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64524928|NCT02407626|Propofol|propofol|mesh-list
64524929|NCT02407626|Sevoflurane|sevoflurane|mesh-list
64524930|NCT02407626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64524931|NCT02407626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64524932|NCT02407626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524933|NCT02407626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64524934|NCT02407626|Anesthetics, General|anesthetics, general|mesh-ancestor
64524935|NCT02407626|Anesthetics|anesthetics|mesh-ancestor
64524936|NCT02407626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64524937|NCT02407626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64524938|NCT02407392|Acetic Acid|acetic acid|mesh-list
64524939|NCT02407392|Retinol acetate|retinol acetate|mesh-list
64524940|NCT02407392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64910788|NCT00005870|Mitomycin|mitomycin|mesh-list
64910789|NCT00005870|Rubitecan|rubitecan|mesh-list
64649427|NCT03932162|Mitogens|mitogens|mesh-list
64910829|NCT00001119|Lamivudine|lamivudine|mesh-list
64910830|NCT00001119|Zidovudine|zidovudine|mesh-list
64910831|NCT00001119|Abacavir|abacavir|mesh-list
64910832|NCT00001119|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64910833|NCT00001119|Efavirenz|efavirenz|mesh-list
64910834|NCT00001119|Vaccines|vaccines|mesh-list
64910835|NCT00001119|Immunologic Factors|immunologic factors|mesh-ancestor
64910836|NCT00001119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910837|NCT00001119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64910838|NCT00001119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64910839|NCT00001119|Protease Inhibitors|protease inhibitors|mesh-ancestor
64910840|NCT00001119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910841|NCT00001119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910842|NCT00001119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64910843|NCT00001119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64910844|NCT00001119|Antiviral Agents|antiviral agents|mesh-ancestor
64910870|NCT00009061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64910871|NCT00009061|Antiviral Agents|antiviral agents|mesh-ancestor
64910872|NCT00009061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910873|NCT00009061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64524941|NCT02407392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64524942|NCT02407392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64524943|NCT02407392|Immunologic Factors|immunologic factors|mesh-ancestor
64524944|NCT02407392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910874|NCT00009061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64910875|NCT00009061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64910876|NCT00009061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64910877|NCT00005873|Rubitecan|rubitecan|mesh-list
64910878|NCT00005873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910879|NCT00005873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64910880|NCT00005873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64910881|NCT00005873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910882|NCT00005873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734460|NCT02084082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734461|NCT02084082|Incretins|incretins|mesh-ancestor
64734462|NCT02084082|Hormones|hormones|mesh-ancestor
64734463|NCT02084082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64734464|NCT02084082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64734465|NCT02084082|Protease Inhibitors|protease inhibitors|mesh-ancestor
64910883|NCT00009178|Fluoxetine|fluoxetine|mesh-list
64910884|NCT00009178|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64910885|NCT00009178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64910886|NCT00009178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64910887|NCT00009178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910888|NCT00009178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64910889|NCT00009178|Serotonin Agents|serotonin agents|mesh-ancestor
64910890|NCT00009178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910914|NCT00005876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910915|NCT00005876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64910916|NCT00005876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64910917|NCT00005876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910918|NCT00005876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910919|NCT00001146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
64910924|NCT00009646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64910925|NCT00009646|Analgesics|analgesics|mesh-ancestor
64910926|NCT00009646|Sensory System Agents|sensory system agents|mesh-ancestor
64910927|NCT00009646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64910928|NCT00009646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910929|NCT00009646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64910930|NCT00009646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64910931|NCT00009646|Gout Suppressants|gout suppressants|mesh-ancestor
64910932|NCT00009646|Tocolytic Agents|tocolytic agents|mesh-ancestor
64910933|NCT00009646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64910934|NCT00009646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64910935|NCT00009646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910936|NCT00009646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910937|NCT00009763|Cyclosporine|cyclosporine|mesh-list
64910938|NCT00009763|Paclitaxel|paclitaxel|mesh-list
64910939|NCT00009763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64910940|NCT00009763|Antibodies|antibodies|mesh-list
64910958|NCT00009763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64910960|NCT00009802|Paclitaxel|paclitaxel|mesh-list
64910961|NCT00009802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64910962|NCT00009802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910963|NCT00009802|Tubulin Modulators|tubulin modulators|mesh-ancestor
64910964|NCT00009802|Antimitotic Agents|antimitotic agents|mesh-ancestor
64910965|NCT00009802|Mitosis Modulators|mitosis modulators|mesh-ancestor
64910966|NCT00009802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910967|NCT00009802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64910968|NCT00009802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910969|NCT00009802|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64910970|NCT00009802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64910971|NCT00009802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64910972|NCT00009802|Vitamins|vitamins|mesh-ancestor
64910973|NCT00009802|Micronutrients|micronutrients|mesh-ancestor
64910974|NCT00009802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64910975|NCT00009841|Mitogens|mitogens|mesh-list
64910976|NCT00009841|Mitosis Modulators|mitosis modulators|mesh-ancestor
64910977|NCT00009841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524945|NCT02407392|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64524946|NCT02407392|Protective Agents|protective agents|mesh-ancestor
64524947|NCT02407392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64524948|NCT02551432|Paclitaxel|paclitaxel|mesh-list
64524949|NCT02551432|Pembrolizumab|pembrolizumab|mesh-list
64524950|NCT02551432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64524951|NCT02551432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64524952|NCT02551432|Tubulin Modulators|tubulin modulators|mesh-ancestor
64524953|NCT02551432|Antimitotic Agents|antimitotic agents|mesh-ancestor
64524954|NCT02551432|Mitosis Modulators|mitosis modulators|mesh-ancestor
64524955|NCT02551432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524956|NCT02551432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64524957|NCT02407548|Vitamin E|vitamin e|mesh-list
64524958|NCT02407548|Coenzyme Q10|coenzyme q10|mesh-list
64524959|NCT02407548|Ubiquinone|ubiquinone|mesh-list
64524960|NCT02407548|Vitamins|vitamins|mesh-ancestor
64524961|NCT02407548|Micronutrients|micronutrients|mesh-ancestor
64524962|NCT02407548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524963|NCT02407548|Antioxidants|antioxidants|mesh-ancestor
64524964|NCT02407548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910978|NCT00005891|Cyclophosphamide|cyclophosphamide|mesh-list
64910979|NCT00005891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64910980|NCT00005891|Immunologic Factors|immunologic factors|mesh-ancestor
64608578|NCT04480138|Interferons|interferons|mesh-list
64910981|NCT00005891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910982|NCT00005891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64910983|NCT00005891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64910984|NCT00005891|Alkylating Agents|alkylating agents|mesh-ancestor
64910985|NCT00005891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910986|NCT00005891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910987|NCT00005891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64910988|NCT00009880|Paclitaxel|paclitaxel|mesh-list
64910997|NCT00009880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64911031|NCT00009997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911032|NCT00009997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64911033|NCT00009997|Immunologic Factors|immunologic factors|mesh-ancestor
64911034|NCT00009997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911035|NCT00009997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64911036|NCT00009997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64911037|NCT00009997|Alkylating Agents|alkylating agents|mesh-ancestor
64911038|NCT00009997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64911039|NCT00009997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64911076|NCT00010075|Analgesics|analgesics|mesh-ancestor
64911104|NCT00010192|Antiviral Agents|antiviral agents|mesh-ancestor
64911105|NCT00010192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911106|NCT00005912|Voriconazole|voriconazole|mesh-list
64911107|NCT00005912|Antifungal Agents|antifungal agents|mesh-ancestor
64911108|NCT00005912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911109|NCT00005912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64524966|NCT01695317|Acetylcarnitine|acetylcarnitine|mesh-list
64524967|NCT01695317|Vitamin B Complex|vitamin b complex|mesh-ancestor
64524969|NCT01695317|Micronutrients|micronutrients|mesh-ancestor
64524970|NCT01695317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524971|NCT01695317|Nootropic Agents|nootropic agents|mesh-ancestor
64524972|NCT02551744|Pantoprazole|pantoprazole|mesh-list
64524973|NCT02551744|Famotidine|famotidine|mesh-list
64524974|NCT02551744|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64524975|NCT02551744|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
64524977|NCT02551744|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64524978|NCT02551744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64524979|NCT02551744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524980|NCT02551744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524981|NCT02551744|Histamine Antagonists|histamine antagonists|mesh-ancestor
64524982|NCT02551744|Histamine Agents|histamine agents|mesh-ancestor
64524983|NCT02551744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64524984|NCT02551744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911110|NCT00005912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64911111|NCT00005912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911112|NCT00005912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911113|NCT00005912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64911114|NCT00005912|Hormone Antagonists|hormone antagonists|mesh-ancestor
64911115|NCT00005912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64911116|NCT00005912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911117|NCT00005912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64911118|NCT00010231|Calcitriol|calcitriol|mesh-list
64911119|NCT00010231|Dexamethasone|dexamethasone|mesh-list
64911120|NCT00010231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64911121|NCT00010231|Antiemetics|antiemetics|mesh-ancestor
64911122|NCT00010231|Autonomic Agents|autonomic agents|mesh-ancestor
64911123|NCT00010231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64911154|NCT00010426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911155|NCT00386516|Fluorouracil|fluorouracil|mesh-list
64911156|NCT00386516|Antimetabolites|antimetabolites|mesh-ancestor
64911157|NCT00386516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911158|NCT00386516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64608655|NCT03216473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64911159|NCT00386516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911160|NCT00386516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64911161|NCT00386516|Immunologic Factors|immunologic factors|mesh-ancestor
64911162|NCT00386516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911238|NCT00001212|Glucocorticoids|glucocorticoids|mesh-ancestor
64911240|NCT00001212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64911241|NCT00001212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64911242|NCT00001212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911243|NCT00001212|Antifungal Agents|antifungal agents|mesh-ancestor
64911244|NCT00001212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64524985|NCT02551744|Histamine Agonists|histamine agonists|mesh-ancestor
64524986|NCT04743544|Voriconazole|voriconazole|mesh-list
64524987|NCT04743544|Antifungal Agents|antifungal agents|mesh-ancestor
64524988|NCT04743544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64524989|NCT04743544|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64524990|NCT04743544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64524991|NCT04743544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64524992|NCT04743544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911245|NCT00001212|Dermatologic Agents|dermatologic agents|mesh-ancestor
64911278|NCT00012025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64911279|NCT00012025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911280|NCT00005942|Daunorubicin|daunorubicin|mesh-list
64911281|NCT00005942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911282|NCT00005942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64911283|NCT00005942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911284|NCT00005942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64911285|NCT00005942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64911322|NCT00005945|Mercaptopurine|mercaptopurine|mesh-list
64911323|NCT00005945|Pegaspargase|pegaspargase|mesh-list
64911325|NCT00005945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64911326|NCT00005945|Immunologic Factors|immunologic factors|mesh-ancestor
64911327|NCT00005945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911328|NCT00005945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64911329|NCT00005945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64911361|NCT01929811|Metformin|metformin|mesh-list
64911362|NCT01929811|Docetaxel|docetaxel|mesh-list
64911363|NCT01929811|Epirubicin|epirubicin|mesh-list
64911364|NCT01929811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64911365|NCT01929811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911366|NCT01929811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911367|NCT01929811|Tubulin Modulators|tubulin modulators|mesh-ancestor
64911368|NCT01929811|Antimitotic Agents|antimitotic agents|mesh-ancestor
64911369|NCT01929811|Mitosis Modulators|mitosis modulators|mesh-ancestor
64911370|NCT01929811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911371|NCT01929811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64911409|NCT00012376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64911411|NCT00001266|Antinematodal Agents|antinematodal agents|mesh-ancestor
64911412|NCT00001266|Anthelmintics|anthelmintics|mesh-ancestor
64911473|NCT00005960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911474|NCT00005960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64911475|NCT00005960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64911476|NCT00005960|Alkylating Agents|alkylating agents|mesh-ancestor
64911477|NCT00005960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911478|NCT00005960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911479|NCT00005960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64608714|NCT05519514|Autonomic Agents|autonomic agents|mesh-ancestor
64911480|NCT00005960|Tubulin Modulators|tubulin modulators|mesh-ancestor
64911481|NCT00005960|Antimitotic Agents|antimitotic agents|mesh-ancestor
64911482|NCT00005960|Mitosis Modulators|mitosis modulators|mesh-ancestor
64911483|NCT00005960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64911484|NCT00005960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64911485|NCT00005960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64911486|NCT00005960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911487|NCT00005963|Carboplatin|carboplatin|mesh-list
64911489|NCT00005963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911490|NCT00005963|Tubulin Modulators|tubulin modulators|mesh-ancestor
64911491|NCT00005963|Antimitotic Agents|antimitotic agents|mesh-ancestor
64911492|NCT00005963|Mitosis Modulators|mitosis modulators|mesh-ancestor
64911500|NCT00013585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911528|NCT00005966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911529|NCT00005966|Antiviral Agents|antiviral agents|mesh-ancestor
64524993|NCT04743544|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64524994|NCT04743544|Hormone Antagonists|hormone antagonists|mesh-ancestor
64524995|NCT04743544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64524996|NCT04743544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64524997|NCT04743544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64524998|NCT04481802|Acemannan|acemannan|mesh-list
64911530|NCT00005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911531|NCT00005966|Immunologic Factors|immunologic factors|mesh-ancestor
64911532|NCT00005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911533|NCT00005966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64911534|NCT00005966|Leprostatic Agents|leprostatic agents|mesh-ancestor
64911535|NCT00005966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64911536|NCT00005966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64911537|NCT00005966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64911538|NCT00005966|Growth Substances|growth substances|mesh-ancestor
64911539|NCT00005966|Growth Inhibitors|growth inhibitors|mesh-ancestor
64911541|NCT00005969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911542|NCT00005969|Keratolytic Agents|keratolytic agents|mesh-ancestor
64911543|NCT00005969|Dermatologic Agents|dermatologic agents|mesh-ancestor
64911544|NCT00014014|Lamivudine|lamivudine|mesh-list
64911545|NCT00014014|Zidovudine|zidovudine|mesh-list
64911546|NCT00014014|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64911547|NCT00014014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64911576|NCT00005972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911577|NCT00005972|Antiviral Agents|antiviral agents|mesh-ancestor
64911578|NCT00005972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911579|NCT00005972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911580|NCT00005972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64911581|NCT00005972|Immunologic Factors|immunologic factors|mesh-ancestor
64911582|NCT00005972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911583|NCT00005972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64911584|NCT00005972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64911585|NCT00014170|Gefitinib|gefitinib|mesh-list
64911586|NCT00014170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911587|NCT00014170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64911588|NCT00014170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911589|NCT00014170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911590|NCT00014209|Gemcitabine|gemcitabine|mesh-list
64911591|NCT00014209|Dexamethasone|dexamethasone|mesh-list
64911592|NCT00014209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64911593|NCT00014209|Antiemetics|antiemetics|mesh-ancestor
64911619|NCT00014248|Purinergic Agonists|purinergic agonists|mesh-ancestor
64911620|NCT00014248|Purinergic Agents|purinergic agents|mesh-ancestor
64911621|NCT00014248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64911622|NCT00014248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911624|NCT00005975|Megestrol Acetate|megestrol acetate|mesh-list
64911625|NCT00005975|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64911626|NCT00005975|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64911627|NCT00005975|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64680067|NCT05286814|Antiemetics|antiemetics|mesh-ancestor
64911628|NCT00005975|Contraceptive Agents|contraceptive agents|mesh-ancestor
64911629|NCT00005975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64911630|NCT00005975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911631|NCT00005975|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64911632|NCT00005975|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64911633|NCT00005975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64911634|NCT00005975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911635|NCT00005975|Appetite Stimulants|appetite stimulants|mesh-ancestor
64608773|NCT01724983|Ketamine|ketamine|mesh-list
64911636|NCT00005975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64525016|NCT02407314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525017|NCT02407314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64525018|NCT02407314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64911673|NCT00014404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911674|NCT00014404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64911675|NCT00014404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64911676|NCT00014404|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64911677|NCT00014404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64911678|NCT00014404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911679|NCT00014404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911680|NCT00001332|Cisplatin|cisplatin|mesh-list
64911681|NCT00001332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911682|NCT00014599|Paclitaxel|paclitaxel|mesh-list
64911683|NCT00014599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64321094|NCT02196805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64321095|NCT02196805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64321100|NCT02196805|Protective Agents|protective agents|mesh-ancestor
64734467|NCT02084082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734468|NCT02083926|Ketamine|ketamine|mesh-list
64734469|NCT02083926|Analgesics|analgesics|mesh-ancestor
64734470|NCT02083926|Sensory System Agents|sensory system agents|mesh-ancestor
64734471|NCT02083926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64734472|NCT02083926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734473|NCT02083926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64734474|NCT02083926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64734475|NCT02083926|Anesthetics, General|anesthetics, general|mesh-ancestor
64734476|NCT02083926|Anesthetics|anesthetics|mesh-ancestor
64734477|NCT02083926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64734478|NCT02083926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64734479|NCT02083926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64608850|NCT01047553|Autonomic Agents|autonomic agents|mesh-ancestor
64911684|NCT00014599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911685|NCT00014599|Tubulin Modulators|tubulin modulators|mesh-ancestor
64911686|NCT00014599|Antimitotic Agents|antimitotic agents|mesh-ancestor
64911687|NCT00014599|Mitosis Modulators|mitosis modulators|mesh-ancestor
64911720|NCT00391534|Anticonvulsants|anticonvulsants|mesh-ancestor
64911721|NCT00391534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64911722|NCT00391534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64911723|NCT00391534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64911724|NCT00391534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911725|NCT00391534|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64911726|NCT00391534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64911764|NCT00005987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911803|NCT00005990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64911804|NCT00005990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911805|NCT00005990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525021|NCT02407314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525022|NCT02407314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64525023|NCT02407314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64525024|NCT02407314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64525026|NCT02407314|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64525027|NCT02407314|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64911806|NCT00005990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911807|NCT00001344|Dextromethorphan|dextromethorphan|mesh-list
64911833|NCT00005993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64911834|NCT00005993|Antiviral Agents|antiviral agents|mesh-ancestor
64911835|NCT00005993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911836|NCT00015028|Buprenorphine|buprenorphine|mesh-list
64911837|NCT00015028|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64911838|NCT00015028|Naloxone|naloxone|mesh-list
64911839|NCT00015028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64911840|NCT00015028|Narcotics|narcotics|mesh-ancestor
64911841|NCT00015028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64911842|NCT00015028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911843|NCT00015028|Analgesics|analgesics|mesh-ancestor
64911844|NCT00015028|Sensory System Agents|sensory system agents|mesh-ancestor
64911845|NCT00015028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64911846|NCT00015028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64911847|NCT00015067|Methylphenidate|methylphenidate|mesh-list
64911848|NCT00015067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64911849|NCT00015067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911850|NCT00015067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64680300|NCT04735978|Nivolumab|nivolumab|mesh-list
64911851|NCT00015067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64911852|NCT00015067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64911886|NCT00015223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64911887|NCT00015223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64911888|NCT00015223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911889|NCT00015223|Dopamine Agents|dopamine agents|mesh-ancestor
64911916|NCT00015652|Antiviral Agents|antiviral agents|mesh-ancestor
64911917|NCT00015652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911918|NCT00015652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911919|NCT00015652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64911920|NCT00015652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64911921|NCT00005999|Arsenic Trioxide|arsenic trioxide|mesh-list
64911922|NCT00005999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680373|NCT04633252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64911924|NCT00015691|Rosiglitazone|rosiglitazone|mesh-list
64911925|NCT00015691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64911926|NCT00015691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911927|NCT00015769|Levetiracetam|levetiracetam|mesh-list
64911928|NCT00015769|Anticonvulsants|anticonvulsants|mesh-ancestor
64911929|NCT00015769|Nootropic Agents|nootropic agents|mesh-ancestor
64911930|NCT00015808|Idebenone|idebenone|mesh-list
64911931|NCT00015808|Antioxidants|antioxidants|mesh-ancestor
64911932|NCT00015808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911933|NCT00015808|Protective Agents|protective agents|mesh-ancestor
64911934|NCT00015808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911935|NCT00015886|Docetaxel|docetaxel|mesh-list
64911936|NCT00015886|Fluorouracil|fluorouracil|mesh-list
64911937|NCT00015886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911969|NCT00015925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64911970|NCT00015925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911971|NCT00015925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911973|NCT00006005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64911974|NCT00006005|Immunologic Factors|immunologic factors|mesh-ancestor
64525029|NCT02407314|Purinergic Agents|purinergic agents|mesh-ancestor
64525030|NCT02407314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64649494|NCT04493138|Antimetabolites|antimetabolites|mesh-ancestor
64525039|NCT02407080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525040|NCT04743622|Latanoprost|latanoprost|mesh-list
64525041|NCT04743622|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64525042|NCT04743622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64525043|NCT02701296|Epinephrine|epinephrine|mesh-list
64525044|NCT02701296|Ropivacaine|ropivacaine|mesh-list
64525045|NCT02701296|Anesthetics, Local|anesthetics, local|mesh-ancestor
64525046|NCT02701296|Anesthetics|anesthetics|mesh-ancestor
64525047|NCT02701296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64649499|NCT01275365|Testosterone|testosterone|mesh-list
64525048|NCT02701296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525049|NCT02701296|Sensory System Agents|sensory system agents|mesh-ancestor
64525050|NCT02701296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64525051|NCT02701296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64525052|NCT02701296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64525053|NCT02701296|Adrenergic Agents|adrenergic agents|mesh-ancestor
64525054|NCT02701296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64525055|NCT02701296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525056|NCT02701296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64525057|NCT02701296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64911975|NCT00006005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911976|NCT00006005|Leprostatic Agents|leprostatic agents|mesh-ancestor
64911977|NCT00006005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64912009|NCT00016042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912010|NCT00016042|Antiviral Agents|antiviral agents|mesh-ancestor
64912011|NCT00016042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64912012|NCT00016081|Ribavirin|ribavirin|mesh-list
64912013|NCT00016081|Antimetabolites|antimetabolites|mesh-ancestor
64912014|NCT00016081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912015|NCT00016081|Antiviral Agents|antiviral agents|mesh-ancestor
64912016|NCT00016081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64912017|NCT00016159|Idarubicin|idarubicin|mesh-list
64912018|NCT00016159|Arsenic Trioxide|arsenic trioxide|mesh-list
64912019|NCT00016159|Tretinoin|tretinoin|mesh-list
64912020|NCT00016159|Lintuzumab|lintuzumab|mesh-list
64912021|NCT00016159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64912022|NCT00016159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525058|NCT02701296|Autonomic Agents|autonomic agents|mesh-ancestor
64525059|NCT02701296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64525060|NCT02701296|Respiratory System Agents|respiratory system agents|mesh-ancestor
64525062|NCT02701296|Sympathomimetics|sympathomimetics|mesh-ancestor
64525063|NCT02701296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64525064|NCT02558374|Timolol|timolol|mesh-list
64525065|NCT02558374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64525066|NCT02558374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64734480|NCT02083926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64734481|NCT02083926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734482|NCT02083380|Piperaquine|piperaquine|mesh-list
64734483|NCT02083380|Artefenomel|artefenomel|mesh-list
64734484|NCT02083380|Antimalarials|antimalarials|mesh-ancestor
64734485|NCT02083380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64734486|NCT02083380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64734487|NCT02083380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64734488|NCT02109744|Decitabine|decitabine|mesh-list
64525067|NCT02558374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525068|NCT02558374|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64525069|NCT02558374|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64525070|NCT02558374|Adrenergic Agents|adrenergic agents|mesh-ancestor
64525071|NCT02558374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64525072|NCT02558374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525073|NCT02558374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64525074|NCT02558374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64525075|NCT01582451|Insulin|insulin|mesh-list
64525076|NCT01582451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64525077|NCT01582451|Insulin Glargine|insulin glargine|mesh-list
64525078|NCT01582451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64912023|NCT00016159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64912040|NCT00016198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912041|NCT00016198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64649503|NCT01275365|Androgens|androgens|mesh-ancestor
64912048|NCT00016276|Tamoxifen|tamoxifen|mesh-list
64912049|NCT00016276|Paclitaxel|paclitaxel|mesh-list
64912050|NCT00016276|Razoxane|razoxane|mesh-list
64912051|NCT00016276|Cyclophosphamide|cyclophosphamide|mesh-list
64912052|NCT00016276|Doxorubicin|doxorubicin|mesh-list
64912053|NCT00016276|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64912054|NCT00016276|Trastuzumab|trastuzumab|mesh-list
64912055|NCT00016276|Dexrazoxane|dexrazoxane|mesh-list
64912056|NCT00016276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64912057|NCT00016276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912058|NCT00016276|Tubulin Modulators|tubulin modulators|mesh-ancestor
64912059|NCT00016276|Antimitotic Agents|antimitotic agents|mesh-ancestor
64912060|NCT00016276|Mitosis Modulators|mitosis modulators|mesh-ancestor
64912061|NCT00016276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912062|NCT00016276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64912063|NCT00016276|Immunologic Factors|immunologic factors|mesh-ancestor
64912064|NCT00016276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912065|NCT00016276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64912066|NCT00016276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64912067|NCT00016276|Alkylating Agents|alkylating agents|mesh-ancestor
64912068|NCT00016276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64912069|NCT00016276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64912070|NCT00016276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64912071|NCT00016276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64912072|NCT00016276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64525080|NCT03115320|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64525081|NCT03115320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64525082|NCT03115320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525083|NCT03168828|Trospium chloride|trospium chloride|mesh-list
64525084|NCT03168828|Parasympatholytics|parasympatholytics|mesh-ancestor
64525085|NCT03168828|Autonomic Agents|autonomic agents|mesh-ancestor
64525086|NCT03168828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64525087|NCT03168828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525088|NCT03168828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64525089|NCT03168828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64525090|NCT03168828|Cholinergic Agents|cholinergic agents|mesh-ancestor
64525091|NCT03168828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64525092|NCT03168828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912073|NCT00016276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64912074|NCT00016276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64912075|NCT00016276|Hormone Antagonists|hormone antagonists|mesh-ancestor
64912076|NCT00016276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64912077|NCT00016276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64912078|NCT00016276|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64912079|NCT00016276|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64912080|NCT00016276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64912081|NCT00016276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64912082|NCT00016276|Protective Agents|protective agents|mesh-ancestor
64912113|NCT00016432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64912115|NCT00016432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912116|NCT00016432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64912117|NCT00016432|Hormone Antagonists|hormone antagonists|mesh-ancestor
64912118|NCT00016432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64734490|NCT02109744|Antimetabolites|antimetabolites|mesh-ancestor
64912119|NCT00016432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912120|NCT00389376|Silymarin|silymarin|mesh-list
64912121|NCT00389376|Antioxidants|antioxidants|mesh-ancestor
64912122|NCT00389376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912123|NCT00389376|Protective Agents|protective agents|mesh-ancestor
64912124|NCT00389376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912125|NCT00016549|Bevacizumab|bevacizumab|mesh-list
64912161|NCT00016666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64912162|NCT00016666|Vasodilator Agents|vasodilator agents|mesh-ancestor
64912163|NCT00016744|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64912164|NCT00016744|Genistein|genistein|mesh-list
64912203|NCT00386672|Calcium|calcium|mesh-list
64912204|NCT00386672|Micronutrients|micronutrients|mesh-ancestor
64912205|NCT00386672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912206|NCT00386672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64912207|NCT00386672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64912208|NCT00016978|Leucovorin|leucovorin|mesh-list
64912239|NCT00017095|Immunologic Factors|immunologic factors|mesh-ancestor
64525095|NCT02562898|Paclitaxel|paclitaxel|mesh-list
64525096|NCT02562898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64525097|NCT02562898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525098|NCT02562898|Tubulin Modulators|tubulin modulators|mesh-ancestor
64525099|NCT02562898|Antimitotic Agents|antimitotic agents|mesh-ancestor
64525100|NCT02562898|Mitosis Modulators|mitosis modulators|mesh-ancestor
64714104|NCT03054103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64481200|NCT00700336|Cisplatin|cisplatin|mesh-list
64912240|NCT00017095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912241|NCT00017095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64912242|NCT00017095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64912243|NCT00017095|Alkylating Agents|alkylating agents|mesh-ancestor
64912244|NCT00017095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912245|NCT00017095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912246|NCT00017095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64912247|NCT00017095|Tubulin Modulators|tubulin modulators|mesh-ancestor
64912248|NCT00017095|Antimitotic Agents|antimitotic agents|mesh-ancestor
64912249|NCT00017095|Mitosis Modulators|mitosis modulators|mesh-ancestor
64912251|NCT00017095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64912252|NCT00017095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64912253|NCT00017095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64912254|NCT00017095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64912255|NCT00017095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912290|NCT00001482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64912291|NCT00001482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912292|NCT00001482|Anticonvulsants|anticonvulsants|mesh-ancestor
64912293|NCT00001482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64912294|NCT00001482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64912295|NCT00001482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64912302|NCT00001482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64912303|NCT00001482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64912304|NCT00001482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64912305|NCT00001482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64912306|NCT00001482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64912307|NCT00017134|Fenretinide|fenretinide|mesh-list
64912308|NCT00017134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912309|NCT00017134|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64912310|NCT00017134|Protective Agents|protective agents|mesh-ancestor
64912311|NCT00017134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912312|NCT04734418|Dexmedetomidine|dexmedetomidine|mesh-list
64912313|NCT04734418|Remifentanil|remifentanil|mesh-list
64912314|NCT04734418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64912315|NCT04734418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64912316|NCT04734418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912317|NCT04734418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64734493|NCT02109744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734494|NCT04185402|Azithromycin|azithromycin|mesh-list
64912318|NCT04734418|Analgesics|analgesics|mesh-ancestor
64912319|NCT04734418|Sensory System Agents|sensory system agents|mesh-ancestor
64912320|NCT04734418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64912321|NCT04734418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64912322|NCT04734418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64912323|NCT04734418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64912324|NCT04734418|Adrenergic Agents|adrenergic agents|mesh-ancestor
64912332|NCT00006032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64912333|NCT00006032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912334|NCT00006032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64912335|NCT00006032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64525101|NCT02562898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525102|NCT02562898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64525104|NCT02562898|Antiviral Agents|antiviral agents|mesh-ancestor
64525105|NCT02562898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64525106|NCT02562898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64525107|NCT02562898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64525108|NCT02562898|Immunologic Factors|immunologic factors|mesh-ancestor
64525109|NCT02562898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525110|NCT03168594|Cisplatin|cisplatin|mesh-list
64525111|NCT03168594|Irinotecan|irinotecan|mesh-list
64525112|NCT03168594|Etoposide|etoposide|mesh-list
64525113|NCT03168594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525114|NCT03168594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64525115|NCT03168594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64525116|NCT03168594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64525117|NCT03168594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912336|NCT00006032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912337|NCT00006032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912338|NCT00006032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64912339|NCT00006032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64912340|NCT00006032|Alkylating Agents|alkylating agents|mesh-ancestor
64912341|NCT00017173|Cisplatin|cisplatin|mesh-list
64912342|NCT00017173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912343|NCT00001509|Tretinoin|tretinoin|mesh-list
64912344|NCT00001509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912345|NCT00001509|Keratolytic Agents|keratolytic agents|mesh-ancestor
64912346|NCT00001509|Dermatologic Agents|dermatologic agents|mesh-ancestor
64912347|NCT00006035|Bleomycin|bleomycin|mesh-list
64912348|NCT00006035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64912349|NCT00006035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912350|NCT00017212|Exatecan|exatecan|mesh-list
64912351|NCT00017212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64912352|NCT00017212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64912353|NCT00017212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912354|NCT00017212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912355|NCT00017212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912356|NCT00017251|Carboplatin|carboplatin|mesh-list
64912357|NCT00017251|Etoposide|etoposide|mesh-list
64912358|NCT00017251|Etoposide phosphate|etoposide phosphate|mesh-list
64912359|NCT00017251|Oblimersen|oblimersen|mesh-list
64912360|NCT00017251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912361|NCT00017251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64912362|NCT00017251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64912363|NCT00017251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64912364|NCT00017251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912403|NCT00017290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912436|NCT00017368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912438|NCT00017368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64912439|NCT00017368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64912440|NCT00017368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64912441|NCT00017368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64912442|NCT00017368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912443|NCT00017368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64912444|NCT00017368|Tubulin Modulators|tubulin modulators|mesh-ancestor
64912445|NCT00017368|Antimitotic Agents|antimitotic agents|mesh-ancestor
64912446|NCT00017368|Mitosis Modulators|mitosis modulators|mesh-ancestor
64321103|NCT02198443|Lopinavir|lopinavir|mesh-list
64321104|NCT02198443|Tenofovir|tenofovir|mesh-list
64321105|NCT02198443|Emtricitabine|emtricitabine|mesh-list
64912447|NCT00017368|Dermatologic Agents|dermatologic agents|mesh-ancestor
64525118|NCT03168594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64525126|NCT02564926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525127|NCT02564926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64525128|NCT02564926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525129|NCT02564926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64525130|NCT02564926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64525131|NCT02564926|Immunologic Factors|immunologic factors|mesh-ancestor
64525133|NCT02565628|Dopamine Agonists|dopamine agonists|mesh-ancestor
64525134|NCT02565628|Dopamine Agents|dopamine agents|mesh-ancestor
64912448|NCT00001524|Thalidomide|thalidomide|mesh-list
64912449|NCT00001524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64912478|NCT00001533|Cyclosporine|cyclosporine|mesh-list
64912479|NCT00001533|Cyclosporins|cyclosporins|mesh-list
64912480|NCT00001533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912481|NCT00001533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912482|NCT00001533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64912483|NCT00001533|Immunologic Factors|immunologic factors|mesh-ancestor
64912484|NCT00001533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912485|NCT00001533|Antifungal Agents|antifungal agents|mesh-ancestor
64912486|NCT00001533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64912487|NCT00001533|Dermatologic Agents|dermatologic agents|mesh-ancestor
64912488|NCT00001533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64912489|NCT00001533|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64912490|NCT00017641|Cyclophosphamide|cyclophosphamide|mesh-list
64912491|NCT00017641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64912492|NCT00017641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64912493|NCT00017641|Immunologic Factors|immunologic factors|mesh-ancestor
64912494|NCT00017641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912495|NCT00017641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64912496|NCT00017641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64912497|NCT00017641|Alkylating Agents|alkylating agents|mesh-ancestor
64912525|NCT00017719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64912526|NCT00017719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64912527|NCT00017719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64912528|NCT00017719|Protease Inhibitors|protease inhibitors|mesh-ancestor
64912529|NCT00001542|Fluconazole|fluconazole|mesh-list
64912530|NCT00001542|Antifungal Agents|antifungal agents|mesh-ancestor
64912531|NCT00001542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64912532|NCT00001542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64912533|NCT00001542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64912534|NCT00001542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912535|NCT00001542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912536|NCT00001542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64912537|NCT00001542|Hormone Antagonists|hormone antagonists|mesh-ancestor
64912538|NCT00001542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64912539|NCT00001542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912540|NCT00001542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64912541|NCT00001542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64912542|NCT00017758|Efavirenz|efavirenz|mesh-list
64912578|NCT00017992|Protease Inhibitors|protease inhibitors|mesh-ancestor
64912579|NCT00017992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64525136|NCT02565628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525137|NCT02565628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525138|NCT02567968|Caffeine|caffeine|mesh-list
64525139|NCT02567968|Caffeine citrate|caffeine citrate|mesh-list
64525140|NCT02567968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525141|NCT02567968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64525142|NCT02567968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525143|NCT02567968|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64525144|NCT02567968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609192|NCT01040689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64525145|NCT02567968|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64525152|NCT02571634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64525153|NCT02571634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525155|NCT02571634|Sensory System Agents|sensory system agents|mesh-ancestor
64525156|NCT02571634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64525157|NCT02571634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64525158|NCT02571634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64912580|NCT00017992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912581|NCT00017992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64912607|NCT00018148|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64912608|NCT00018148|Antidepressive Agents|antidepressive agents|mesh-ancestor
64912609|NCT00018148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64912610|NCT00018148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64912611|NCT00018148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64912612|NCT00018148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64912613|NCT00018148|Adrenergic Agents|adrenergic agents|mesh-ancestor
64912615|NCT00001563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64912616|NCT00001563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912617|NCT00001563|Immunologic Factors|immunologic factors|mesh-ancestor
64912618|NCT00001563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912619|NCT00001563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64912620|NCT00018187|Mecamylamine|mecamylamine|mesh-list
64912621|NCT00018187|Bupropion|bupropion|mesh-list
64912622|NCT00018187|Nicotine|nicotine|mesh-list
64912623|NCT00018187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64912624|NCT00018187|Autonomic Agents|autonomic agents|mesh-ancestor
64912625|NCT00018187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64912626|NCT00018187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912656|NCT00001566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64912657|NCT00001566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64912658|NCT00001566|Antiviral Agents|antiviral agents|mesh-ancestor
64912659|NCT00001566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64525159|NCT02571634|Anesthetics, General|anesthetics, general|mesh-ancestor
64525160|NCT02571634|Anesthetics|anesthetics|mesh-ancestor
64525161|NCT02404038|NuvaRing|nuvaring|mesh-list
64525162|NCT02404038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
64525163|NCT02404038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64525164|NCT02404038|Contraceptive Agents|contraceptive agents|mesh-ancestor
64525165|NCT02404038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64525166|NCT02404038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525167|NCT02404038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64525168|NCT02404038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64525169|NCT02404038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64525170|NCT02404038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64525171|NCT02404038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64525172|NCT02404038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
64525173|NCT02404038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64714105|NCT03054103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64525174|NCT02404038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64525175|NCT02574598|Docetaxel|docetaxel|mesh-list
64525176|NCT02574598|Pembrolizumab|pembrolizumab|mesh-list
64525177|NCT02574598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525178|NCT02574598|Tubulin Modulators|tubulin modulators|mesh-ancestor
64525179|NCT02574598|Antimitotic Agents|antimitotic agents|mesh-ancestor
64525180|NCT02574598|Mitosis Modulators|mitosis modulators|mesh-ancestor
64525181|NCT02574598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525182|NCT02574598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64525183|NCT02574832|Lidocaine|lidocaine|mesh-list
64525184|NCT02574832|Fentanyl|fentanyl|mesh-list
64525185|NCT02574832|Anesthetics, Local|anesthetics, local|mesh-ancestor
64525186|NCT02574832|Anesthetics|anesthetics|mesh-ancestor
64525187|NCT02574832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64912660|NCT00018382|Rosiglitazone|rosiglitazone|mesh-list
64649531|NCT03678506|Antithrombins|antithrombins|mesh-ancestor
64912666|NCT00018460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912667|NCT00386750|Lumefantrine|lumefantrine|mesh-list
64912668|NCT00386750|Artemether|artemether|mesh-list
64912669|NCT00386750|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64912670|NCT00386750|Antimalarials|antimalarials|mesh-ancestor
64912707|NCT03346135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64912708|NCT03346135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64912709|NCT03346135|Immunologic Factors|immunologic factors|mesh-ancestor
64525188|NCT02574832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525189|NCT02574832|Sensory System Agents|sensory system agents|mesh-ancestor
64525190|NCT02574832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64525191|NCT02574832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64525192|NCT02574832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64525193|NCT02574832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64525194|NCT02574832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64525195|NCT02574832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525196|NCT02574832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64525197|NCT02574832|Narcotics|narcotics|mesh-ancestor
64525198|NCT02574832|Analgesics|analgesics|mesh-ancestor
64525199|NCT02574832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64525200|NCT02574832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64525201|NCT02574832|Anesthetics, General|anesthetics, general|mesh-ancestor
64525202|NCT02406690|Leuprolide|leuprolide|mesh-list
64525203|NCT02406690|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64525204|NCT02406690|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64525205|NCT02406690|Estradiol|estradiol|mesh-list
64525206|NCT02406690|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64525207|NCT02406690|Progesterone|progesterone|mesh-list
64525208|NCT02406690|Estrogens|estrogens|mesh-ancestor
64525209|NCT02406690|Hormones|hormones|mesh-ancestor
64525210|NCT02406690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64525211|NCT02406690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525212|NCT02406690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64525213|NCT02406690|Contraceptive Agents|contraceptive agents|mesh-ancestor
64525214|NCT02406690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64912710|NCT03346135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912735|NCT00392080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912736|NCT00392080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64912737|NCT00392080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64912738|NCT00392080|Gout Suppressants|gout suppressants|mesh-ancestor
64912739|NCT00392080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64912740|NCT00392080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912741|NCT00392080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912742|NCT05680142|Tramadol|tramadol|mesh-list
64912743|NCT05680142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64912744|NCT05680142|Narcotics|narcotics|mesh-ancestor
64912745|NCT05680142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64912746|NCT05680142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912747|NCT05680142|Analgesics|analgesics|mesh-ancestor
64912748|NCT05680142|Sensory System Agents|sensory system agents|mesh-ancestor
64912749|NCT05680142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64912750|NCT00001644|Lamivudine|lamivudine|mesh-list
64912751|NCT00001644|Zidovudine|zidovudine|mesh-list
64525216|NCT02406690|Progestins|progestins|mesh-ancestor
64525217|NCT02406690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64525218|NCT02406690|Fertility Agents|fertility agents|mesh-ancestor
64525219|NCT02406690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64525220|NCT02406690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912752|NCT00001644|Nevirapine|nevirapine|mesh-list
64912753|NCT00001644|Indinavir|indinavir|mesh-list
64912754|NCT00001644|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64912755|NCT00001644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64912756|NCT00001644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912757|NCT00001644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912758|NCT00001644|Antiviral Agents|antiviral agents|mesh-ancestor
64912759|NCT00001644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64912760|NCT00001644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64912795|NCT05573191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64912796|NCT05573191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912798|NCT05573191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64912799|NCT05573191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64912800|NCT05573191|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64912801|NCT05573191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64912802|NCT05573191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64912803|NCT05573191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912804|NCT05679830|Cannabidiol|cannabidiol|mesh-list
64912805|NCT05679830|Anticonvulsants|anticonvulsants|mesh-ancestor
64912806|NCT05572996|Treprostinil|treprostinil|mesh-list
64912807|NCT05572996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64912808|NCT05572723|Dexmedetomidine|dexmedetomidine|mesh-list
64912809|NCT05572723|Remifentanil|remifentanil|mesh-list
64912842|NCT00389415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64912843|NCT00389415|Protease Inhibitors|protease inhibitors|mesh-ancestor
64912844|NCT00389415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912845|NCT00389415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912846|NCT05465317|Empagliflozin|empagliflozin|mesh-list
64912847|NCT05465317|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64912848|NCT05465317|Glucagon|glucagon|mesh-list
64912849|NCT05465317|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64912850|NCT05465317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912851|NCT05465317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64912852|NCT05465317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912874|NCT00386828|Growth Substances|growth substances|mesh-ancestor
64912875|NCT00386828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912876|NCT00386828|Growth Inhibitors|growth inhibitors|mesh-ancestor
64912877|NCT05367271|Dexamethasone|dexamethasone|mesh-list
64912878|NCT05367271|Cortisone|cortisone|mesh-list
64912879|NCT05367271|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64912880|NCT05367271|Botulinum Toxins|botulinum toxins|mesh-list
64912881|NCT05367271|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64912882|NCT05367271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64912883|NCT05367271|Antiemetics|antiemetics|mesh-ancestor
64912884|NCT05367271|Autonomic Agents|autonomic agents|mesh-ancestor
64912885|NCT05367271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64912886|NCT05367271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912887|NCT05367271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64912888|NCT05367271|Glucocorticoids|glucocorticoids|mesh-ancestor
64912889|NCT05367271|Hormones|hormones|mesh-ancestor
64912890|NCT05367271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64912891|NCT05367271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64912892|NCT05367271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912893|NCT05367271|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64912894|NCT05367271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64525222|NCT04440696|Chelating Agents|chelating agents|mesh-ancestor
64525223|NCT04440696|Sequestering Agents|sequestering agents|mesh-ancestor
64525224|NCT04440696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525226|NCT02974348|Amoxicillin|amoxicillin|mesh-list
64525227|NCT02974348|Artesunate|artesunate|mesh-list
64525228|NCT02974348|Lumefantrine|lumefantrine|mesh-list
64525229|NCT02974348|Piperaquine|piperaquine|mesh-list
64525230|NCT02974348|Artenimol|artenimol|mesh-list
64525231|NCT02974348|Mefloquine|mefloquine|mesh-list
64525232|NCT02974348|Quinine|quinine|mesh-list
64525233|NCT02974348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64525234|NCT02974348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64525235|NCT02974348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64525236|NCT02974348|Analgesics|analgesics|mesh-ancestor
64912895|NCT05367271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912896|NCT05367271|Cholinergic Agents|cholinergic agents|mesh-ancestor
64912901|NCT05679401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64912902|NCT05679401|Immunologic Factors|immunologic factors|mesh-ancestor
64912903|NCT05679401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912933|NCT05673629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912935|NCT00001731|Cyclosporins|cyclosporins|mesh-list
64912936|NCT00001731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912937|NCT00001731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912938|NCT00001731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64912939|NCT00001731|Immunologic Factors|immunologic factors|mesh-ancestor
64912940|NCT00001731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912941|NCT00001731|Antifungal Agents|antifungal agents|mesh-ancestor
64912942|NCT00001731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64912943|NCT00001731|Dermatologic Agents|dermatologic agents|mesh-ancestor
64912979|NCT00001749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64912980|NCT00001749|Immunologic Factors|immunologic factors|mesh-ancestor
64913013|NCT00001758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64913014|NCT00001758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64913015|NCT00001758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913016|NCT00001758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913017|NCT00001758|Antiviral Agents|antiviral agents|mesh-ancestor
64913018|NCT00001758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64913019|NCT00001758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64913020|NCT00001758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64913021|NCT00001758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64913055|NCT04983901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64913056|NCT04983901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913057|NCT04983901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913058|NCT04983901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64913059|NCT04983901|Protease Inhibitors|protease inhibitors|mesh-ancestor
64913060|NCT04978675|Fluorides|fluorides|mesh-list
64913061|NCT04978675|Cariostatic Agents|cariostatic agents|mesh-ancestor
64913062|NCT04978675|Protective Agents|protective agents|mesh-ancestor
64913063|NCT04978675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913064|NCT04971343|Antibodies|antibodies|mesh-list
64913098|NCT04887805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64913099|NCT04887805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64525237|NCT02974348|Sensory System Agents|sensory system agents|mesh-ancestor
64525238|NCT02974348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64525239|NCT02974348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525240|NCT02974348|Antipyretics|antipyretics|mesh-ancestor
64525241|NCT02974348|Antimalarials|antimalarials|mesh-ancestor
64525242|NCT02974348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64525243|NCT02974348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64525244|NCT02974348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525245|NCT02974348|Antiviral Agents|antiviral agents|mesh-ancestor
64525246|NCT02974348|Schistosomicides|schistosomicides|mesh-ancestor
64525247|NCT02974348|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64525248|NCT02974348|Anthelmintics|anthelmintics|mesh-ancestor
64525249|NCT02974348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64525250|NCT02974348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64525252|NCT03170310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525253|NCT03170310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64525254|NCT03170310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64525255|NCT03170310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525256|NCT00364000|Calcium|calcium|mesh-list
64525257|NCT00364000|Sevelamer|sevelamer|mesh-list
64913100|NCT04887805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913101|NCT00392314|Deoxyglucose|deoxyglucose|mesh-list
64913102|NCT00392314|Antimetabolites|antimetabolites|mesh-ancestor
64913103|NCT00392314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913104|NCT00392314|Antiviral Agents|antiviral agents|mesh-ancestor
64913105|NCT00392314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64913106|NCT00000102|Nifedipine|nifedipine|mesh-list
64913107|NCT00000102|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64913133|NCT04752475|Furosemide|furosemide|mesh-list
64913134|NCT04752475|Diuretics|diuretics|mesh-ancestor
64913135|NCT04752475|Natriuretic Agents|natriuretic agents|mesh-ancestor
64649547|NCT01329185|Valganciclovir|valganciclovir|mesh-list
64913139|NCT04752475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913141|NCT05641467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64913142|NCT05641467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913143|NCT05641467|Sympathomimetics|sympathomimetics|mesh-ancestor
64913144|NCT05641467|Autonomic Agents|autonomic agents|mesh-ancestor
64913145|NCT05641467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64913146|NCT05641467|Dopamine Agents|dopamine agents|mesh-ancestor
64913147|NCT05641467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64913148|NCT05641467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913149|NCT05641467|Adrenergic Agents|adrenergic agents|mesh-ancestor
64913150|NCT05641467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64913151|NCT05641467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64913184|NCT05562713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64913185|NCT05555888|Capecitabine|capecitabine|mesh-list
64913186|NCT05555888|Oxaliplatin|oxaliplatin|mesh-list
64913187|NCT05555888|Antibodies|antibodies|mesh-list
64913188|NCT05555888|Immunologic Factors|immunologic factors|mesh-ancestor
64913189|NCT05555888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913190|NCT05555888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64525258|NCT00364000|Calcium acetate|calcium acetate|mesh-list
64525259|NCT00364000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64525260|NCT00364000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525261|NCT00364000|Chelating Agents|chelating agents|mesh-ancestor
64525262|NCT00364000|Sequestering Agents|sequestering agents|mesh-ancestor
64525263|NCT00364000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525264|NCT00422188|Deoxycholic Acid|deoxycholic acid|mesh-list
64525265|NCT00422188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64525266|NCT00422188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64525267|NCT05249452|Hydroxyurea|hydroxyurea|mesh-list
64525268|NCT05249452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525269|NCT05249452|Antisickling Agents|antisickling agents|mesh-ancestor
64525270|NCT05249452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64525271|NCT05249452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525272|NCT05249452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64525273|NCT03970252|Calcium, Dietary|calcium, dietary|mesh-list
64525274|NCT03970252|Leucovorin|leucovorin|mesh-list
64525275|NCT03970252|Folic Acid|folic acid|mesh-list
64525276|NCT03970252|Fluorouracil|fluorouracil|mesh-list
64525277|NCT03970252|Oxaliplatin|oxaliplatin|mesh-list
64525278|NCT03970252|Nivolumab|nivolumab|mesh-list
64525279|NCT03970252|Irinotecan|irinotecan|mesh-list
64525280|NCT03970252|Camptothecin|camptothecin|mesh-list
64913191|NCT05555888|Antimetabolites|antimetabolites|mesh-ancestor
64913192|NCT05555888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913193|NCT05555888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913247|NCT00392431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913249|NCT00392431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64734503|NCT02066298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64734504|NCT02066298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734505|NCT02066298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64734506|NCT02066298|Respiratory System Agents|respiratory system agents|mesh-ancestor
64734508|NCT02066298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64734509|NCT02066298|Cholinergic Agents|cholinergic agents|mesh-ancestor
64734510|NCT02066298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64734511|NCT02066298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321106|NCT02198443|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64321108|NCT02198443|Elvitegravir|elvitegravir|mesh-list
64321109|NCT02198443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64321110|NCT02198443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64913250|NCT00392431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64913251|NCT00392431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913252|NCT00392431|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64913253|NCT00392431|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64913254|NCT00392431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64913255|NCT05495204|Ibalizumab|ibalizumab|mesh-list
64913256|NCT05495204|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64913257|NCT05495204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64913258|NCT05495204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64913259|NCT05495204|Antiviral Agents|antiviral agents|mesh-ancestor
64913260|NCT05495204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64913261|NCT05495204|Immunologic Factors|immunologic factors|mesh-ancestor
64913262|NCT05495204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913263|NCT00392470|Irinotecan|irinotecan|mesh-list
64913264|NCT00392470|Cetuximab|cetuximab|mesh-list
64913265|NCT00392470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64913266|NCT00392470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64913267|NCT00392470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649551|NCT01276301|Verapamil|verapamil|mesh-list
64913272|NCT05470517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64913273|NCT05470517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64913274|NCT03960151|Dexamethasone|dexamethasone|mesh-list
64525282|NCT03970252|Levoleucovorin|levoleucovorin|mesh-list
64525283|NCT03970252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64525284|NCT03970252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525285|NCT03970252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64525286|NCT03970252|Antimetabolites|antimetabolites|mesh-ancestor
64525287|NCT03970252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525288|NCT03970252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64525289|NCT03970252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525290|NCT03970252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64525291|NCT03970252|Immunologic Factors|immunologic factors|mesh-ancestor
64525292|NCT03970252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64525293|NCT03970252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64525294|NCT03970252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64525295|NCT03970252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64525296|NCT03970252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913275|NCT03960151|Olanzapine|olanzapine|mesh-list
64913276|NCT03960151|Palonosetron|palonosetron|mesh-list
64913277|NCT03960151|Rolapitant|rolapitant|mesh-list
64913278|NCT03960151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64913279|NCT03960151|Antiemetics|antiemetics|mesh-ancestor
64913280|NCT03960151|Autonomic Agents|autonomic agents|mesh-ancestor
64913281|NCT03960151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64913282|NCT03960151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913283|NCT03960151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64913309|NCT04733326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913310|NCT04733326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64913311|NCT04733326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64913312|NCT04733326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64913313|NCT04733326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913314|NCT04733326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913315|NCT00386984|Octreotide|octreotide|mesh-list
64913316|NCT00386984|Somatostatin|somatostatin|mesh-list
64913317|NCT00386984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64913318|NCT00386984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64913319|NCT00386984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913320|NCT00386984|Hormones|hormones|mesh-ancestor
64552670|NCT03216915|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64734512|NCT02066298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64734513|NCT02066298|Dermatologic Agents|dermatologic agents|mesh-ancestor
64734514|NCT02066298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64734516|NCT02082912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64734517|NCT02082912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64734518|NCT02082912|Renal Agents|renal agents|mesh-ancestor
64734519|NCT02082912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64913321|NCT00386984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64913322|NCT00386984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913323|NCT03959761|Nivolumab|nivolumab|mesh-list
64913324|NCT03959761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64913325|NCT03959761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913326|NCT03959761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64913327|NCT03959761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913328|NCT03959566|Moxifloxacin|moxifloxacin|mesh-list
64913329|NCT03959566|Bedaquiline|bedaquiline|mesh-list
64913359|NCT00387179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913360|NCT00387179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64913362|NCT03959332|Antiviral Agents|antiviral agents|mesh-ancestor
64913363|NCT03959332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64913364|NCT03959332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913365|NCT03959332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913366|NCT03959293|Durvalumab|durvalumab|mesh-list
64913367|NCT03959293|Tremelimumab|tremelimumab|mesh-list
64913368|NCT03959293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64913369|NCT03959293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913370|NCT04733521|Cisplatin|cisplatin|mesh-list
64525297|NCT03970252|Antidotes|antidotes|mesh-ancestor
64525298|NCT03970252|Protective Agents|protective agents|mesh-ancestor
64525299|NCT03970252|Vitamin B Complex|vitamin b complex|mesh-ancestor
64525300|NCT03970252|Vitamins|vitamins|mesh-ancestor
64525301|NCT03970252|Micronutrients|micronutrients|mesh-ancestor
64525302|NCT03970252|Hematinics|hematinics|mesh-ancestor
64314869|NCT02137109|Natalizumab|natalizumab|mesh-list
64913377|NCT05640726|Levoleucovorin|levoleucovorin|mesh-list
64913407|NCT03959176|Nasal Decongestants|nasal decongestants|mesh-ancestor
64913408|NCT03959176|Respiratory System Agents|respiratory system agents|mesh-ancestor
64913409|NCT03959176|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64913410|NCT03959176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64913411|NCT03959176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64913412|NCT03959176|Adrenergic Agents|adrenergic agents|mesh-ancestor
64913413|NCT03959176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64913414|NCT03959176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913415|NCT03959176|Protective Agents|protective agents|mesh-ancestor
64913416|NCT03959176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64913417|NCT03959176|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64913418|NCT03959176|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64913419|NCT03959176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64913420|NCT03959176|Cholinergic Agents|cholinergic agents|mesh-ancestor
64913421|NCT03958981|Castor Oil|castor oil|mesh-list
64913422|NCT03958981|Cathartics|cathartics|mesh-ancestor
64913423|NCT03958981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64913424|NCT03958942|Bupivacaine|bupivacaine|mesh-list
64913446|NCT05411861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64913447|NCT05411861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913449|NCT03958513|Anesthetics, Local|anesthetics, local|mesh-ancestor
64913450|NCT03958513|Anesthetics|anesthetics|mesh-ancestor
64913451|NCT03958513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64913452|NCT03958513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913453|NCT03958513|Sensory System Agents|sensory system agents|mesh-ancestor
64913454|NCT03958513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64913455|NCT03958396|Remifentanil|remifentanil|mesh-list
64913456|NCT03958396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64913457|NCT03958396|Narcotics|narcotics|mesh-ancestor
64913458|NCT03958396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64913459|NCT03958396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913460|NCT03958396|Analgesics|analgesics|mesh-ancestor
64913461|NCT03958396|Sensory System Agents|sensory system agents|mesh-ancestor
64913462|NCT03958396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64913463|NCT03958123|Moxifloxacin|moxifloxacin|mesh-list
64913464|NCT03958123|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64913465|NCT03958123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64913466|NCT03958123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64913467|NCT03958123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64913468|NCT03958123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64913469|NCT03958123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913470|NCT03958123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913471|NCT03958123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913472|NCT03958123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64913473|NCT03958123|Contraceptive Agents|contraceptive agents|mesh-ancestor
64913474|NCT03958123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64913475|NCT03958123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913511|NCT05639907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64913512|NCT05639907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913513|NCT05206175|Methamphetamine|methamphetamine|mesh-list
64913514|NCT05206175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64913515|NCT05206175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913549|NCT05637567|Sensory System Agents|sensory system agents|mesh-ancestor
64913550|NCT05637567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64913551|NCT05637567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525304|NCT02403804|Betaine|betaine|mesh-list
64525305|NCT02403804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64525306|NCT02403804|Lipotropic Agents|lipotropic agents|mesh-ancestor
64525307|NCT02403804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64525308|NCT02403804|Antimetabolites|antimetabolites|mesh-ancestor
64649560|NCT01276301|Vasodilator Agents|vasodilator agents|mesh-ancestor
64913583|NCT05636787|Treosulfan|treosulfan|mesh-list
64913584|NCT05636787|Busulfan|busulfan|mesh-list
64913585|NCT05636787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64913586|NCT05636787|Alkylating Agents|alkylating agents|mesh-ancestor
64913587|NCT05636787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913588|NCT05636787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913589|NCT05636787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64734521|NCT02082912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64734522|NCT02082912|Antimetabolites|antimetabolites|mesh-ancestor
64734523|NCT02082912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734524|NCT02082522|Gemcitabine|gemcitabine|mesh-list
64734525|NCT02082522|Cisplatin|cisplatin|mesh-list
64734526|NCT02082522|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
64734527|NCT02082522|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
64734528|NCT02082522|Trioxsalen|trioxsalen|mesh-list
64734529|NCT02082522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734530|NCT02082522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64734531|NCT02082522|Antimetabolites|antimetabolites|mesh-ancestor
64913590|NCT05636787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64913591|NCT05636787|Immunologic Factors|immunologic factors|mesh-ancestor
64913592|NCT05636787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913593|NCT03432091|Melatonin|melatonin|mesh-list
64913594|NCT03432091|Antioxidants|antioxidants|mesh-ancestor
64913595|NCT03432091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913596|NCT03432091|Protective Agents|protective agents|mesh-ancestor
64913597|NCT03432091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913598|NCT03432091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64913599|NCT05634564|Gemcitabine|gemcitabine|mesh-list
64913600|NCT05634564|Paclitaxel|paclitaxel|mesh-list
64913601|NCT05634564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64913602|NCT05634564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913603|NCT05634564|Tubulin Modulators|tubulin modulators|mesh-ancestor
64913604|NCT05634564|Antimitotic Agents|antimitotic agents|mesh-ancestor
64913636|NCT03151993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913637|NCT05633472|Vitamin D|vitamin d|mesh-list
64913638|NCT05633472|Vitamins|vitamins|mesh-ancestor
64913639|NCT05633472|Micronutrients|micronutrients|mesh-ancestor
64913640|NCT05633472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913641|NCT05633472|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64913642|NCT03151876|Gemcitabine|gemcitabine|mesh-list
64913643|NCT03151876|Busulfan|busulfan|mesh-list
64913644|NCT03151876|Cladribine|cladribine|mesh-list
64913645|NCT03151876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64913646|NCT03151876|Antimetabolites|antimetabolites|mesh-ancestor
64913681|NCT03151525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913682|NCT03151525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64913683|NCT03151525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913684|NCT03151525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64913685|NCT03151525|Immunologic Factors|immunologic factors|mesh-ancestor
64913686|NCT03151525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913712|NCT00387374|Growth Inhibitors|growth inhibitors|mesh-ancestor
64913713|NCT00387374|Immunologic Factors|immunologic factors|mesh-ancestor
64913714|NCT03151369|Morphine|morphine|mesh-list
64913715|NCT03151369|Analgesics|analgesics|mesh-list
64913716|NCT03151369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64913717|NCT03151369|Narcotics|narcotics|mesh-ancestor
64913718|NCT03151369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64913719|NCT03151369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913720|NCT03151369|Sensory System Agents|sensory system agents|mesh-ancestor
64913721|NCT03151369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64913722|NCT04712266|Insulin|insulin|mesh-list
64913723|NCT04712266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64913724|NCT04712266|Glucagon|glucagon|mesh-list
64913725|NCT04712266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64913726|NCT04712266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913727|NCT04712266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64913728|NCT04712266|Hormones|hormones|mesh-ancestor
64913729|NCT04712266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64913730|NCT03912818|Gemcitabine|gemcitabine|mesh-list
64913731|NCT03912818|Carboplatin|carboplatin|mesh-list
64913732|NCT03912818|Doxorubicin|doxorubicin|mesh-list
64913733|NCT03912818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64913734|NCT03912818|Methotrexate|methotrexate|mesh-list
64525309|NCT02403804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525310|NCT02403804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64525311|NCT03169764|Leucovorin|leucovorin|mesh-list
64525312|NCT03169764|Cyclophosphamide|cyclophosphamide|mesh-list
64525313|NCT03169764|Bevacizumab|bevacizumab|mesh-list
64525314|NCT03169764|Fluorouracil|fluorouracil|mesh-list
64525315|NCT03169764|Capecitabine|capecitabine|mesh-list
64913737|NCT03912818|Vinblastine|vinblastine|mesh-list
64913757|NCT03912818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64913758|NCT03912818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64913759|NCT03912818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64913760|NCT03912818|Tubulin Modulators|tubulin modulators|mesh-ancestor
64913761|NCT03912818|Antimitotic Agents|antimitotic agents|mesh-ancestor
64913762|NCT03912818|Mitosis Modulators|mitosis modulators|mesh-ancestor
64913763|NCT03151213|Pregabalin|pregabalin|mesh-list
64913764|NCT03151213|Analgesics|analgesics|mesh-ancestor
64913765|NCT03151213|Sensory System Agents|sensory system agents|mesh-ancestor
64913766|NCT03151213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64913767|NCT03151213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913768|NCT03151213|Anticonvulsants|anticonvulsants|mesh-ancestor
64913769|NCT03151213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64913770|NCT03151213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64913771|NCT03151213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913772|NCT03151213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64913773|NCT03151213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64913774|NCT03151213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64913775|NCT03151213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64913776|NCT03151213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64913777|NCT03151174|Vitamin D|vitamin d|mesh-list
64913778|NCT03151174|Ergocalciferols|ergocalciferols|mesh-list
64913779|NCT03151174|Cholecalciferol|cholecalciferol|mesh-list
64913780|NCT03151174|Vitamins|vitamins|mesh-list
64913781|NCT03151174|Micronutrients|micronutrients|mesh-ancestor
64913782|NCT03151174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913783|NCT03151174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64913784|NCT03151174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64913785|NCT03151096|Riboflavin|riboflavin|mesh-list
64913786|NCT03151096|Vitamin B Complex|vitamin b complex|mesh-ancestor
64913787|NCT03151096|Vitamins|vitamins|mesh-ancestor
64913788|NCT03151096|Micronutrients|micronutrients|mesh-ancestor
64913789|NCT03151096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913790|NCT03151096|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64913791|NCT03151096|Dermatologic Agents|dermatologic agents|mesh-ancestor
64913792|NCT03906539|Atorvastatin|atorvastatin|mesh-list
64734532|NCT02082522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734533|NCT02082522|Antiviral Agents|antiviral agents|mesh-ancestor
64734534|NCT02082522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64734535|NCT02082522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734536|NCT02082522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64734537|NCT02082522|Immunologic Factors|immunologic factors|mesh-ancestor
64734538|NCT02082522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734539|NCT02082522|Dermatologic Agents|dermatologic agents|mesh-ancestor
64734540|NCT02082522|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64734576|NCT01624662|Dermatologic Agents|dermatologic agents|mesh-ancestor
64734577|NCT01624662|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64734578|NCT02106390|Vaccines|vaccines|mesh-list
64734579|NCT02106390|Immunologic Factors|immunologic factors|mesh-ancestor
64734580|NCT02106390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734581|NCT02064894|Ibuprofen|ibuprofen|mesh-list
64734582|NCT02064894|Morphine|morphine|mesh-list
64321113|NCT02198443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321114|NCT02198443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64321115|NCT02198443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64321116|NCT02198443|Antiviral Agents|antiviral agents|mesh-ancestor
64321117|NCT02198443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64913813|NCT05605665|Antifungal Agents|antifungal agents|mesh-ancestor
64913814|NCT05605665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64913815|NCT05605665|Immunologic Factors|immunologic factors|mesh-ancestor
64913816|NCT05605665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913817|NCT05605665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64913818|NCT05605665|Analgesics|analgesics|mesh-ancestor
64913819|NCT05605665|Sensory System Agents|sensory system agents|mesh-ancestor
64913820|NCT05605665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64913821|NCT05605665|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64913822|NCT05605665|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64913823|NCT05605665|Antiviral Agents|antiviral agents|mesh-ancestor
64913824|NCT03150706|Avelumab|avelumab|mesh-list
64913825|NCT03150706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64913826|NCT03150706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913827|NCT03150667|Clopidogrel|clopidogrel|mesh-list
64913828|NCT03150667|Ticagrelor|ticagrelor|mesh-list
64913829|NCT03150667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64913830|NCT03150667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64913831|NCT03150667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64913832|NCT03150667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64913833|NCT03150667|Purinergic Agents|purinergic agents|mesh-ancestor
64913834|NCT03150667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64913835|NCT03150667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525317|NCT03169764|Cetuximab|cetuximab|mesh-list
64525318|NCT03169764|Fulvestrant|fulvestrant|mesh-list
64525319|NCT03169764|Avelumab|avelumab|mesh-list
64525320|NCT03169764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525321|NCT03169764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913836|NCT03150667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913837|NCT03150316|Dexamethasone|dexamethasone|mesh-list
64913838|NCT03150316|Lenalidomide|lenalidomide|mesh-list
64913839|NCT03150316|CKD-581|ckd-581|mesh-list
64913840|NCT03150316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64913841|NCT03150316|Antiemetics|antiemetics|mesh-ancestor
64913842|NCT03150316|Autonomic Agents|autonomic agents|mesh-ancestor
64913843|NCT03150316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64913847|NCT03150316|Hormones|hormones|mesh-ancestor
64913848|NCT03150316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64913876|NCT03083665|Brivaracetam|brivaracetam|mesh-list
64913877|NCT03083665|Anticonvulsants|anticonvulsants|mesh-ancestor
64913878|NCT02977468|Pembrolizumab|pembrolizumab|mesh-list
64913879|NCT02977468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64913880|NCT02977468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913881|NCT02866006|Topotecan|topotecan|mesh-list
64913882|NCT02866006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64913883|NCT02866006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64913884|NCT02866006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913885|NCT02866006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913886|NCT02866006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913887|NCT02719327|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
64913888|NCT02719327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64913889|NCT02719327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64913890|NCT02633098|Artesunate|artesunate|mesh-list
64913891|NCT02633098|Antimalarials|antimalarials|mesh-ancestor
64913892|NCT02633098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64913893|NCT02633098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64913919|NCT02250937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913920|NCT02250937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64913921|NCT02250937|Antimetabolites|antimetabolites|mesh-ancestor
64913922|NCT02250937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913923|NCT02250937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64913924|NCT02250937|Immunologic Factors|immunologic factors|mesh-ancestor
64913925|NCT02250937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913926|NCT02250937|Alkylating Agents|alkylating agents|mesh-ancestor
64913927|NCT02250937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64913928|NCT02250937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64913929|NCT02122081|Cyclophosphamide|cyclophosphamide|mesh-list
64913930|NCT02122081|Methotrexate|methotrexate|mesh-list
64913931|NCT02122081|Tacrolimus|tacrolimus|mesh-list
64913932|NCT02122081|Thymoglobulin|thymoglobulin|mesh-list
64913933|NCT02122081|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64913934|NCT02122081|Immunoglobulins|immunoglobulins|mesh-list
64913935|NCT02122081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64913936|NCT02122081|Immunologic Factors|immunologic factors|mesh-ancestor
64913937|NCT02122081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913938|NCT02122081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64913939|NCT02122081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64913940|NCT02122081|Alkylating Agents|alkylating agents|mesh-ancestor
64913941|NCT02122081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913942|NCT02122081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913974|NCT00393328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64913975|NCT00393328|Antidepressive Agents|antidepressive agents|mesh-ancestor
64913976|NCT00393328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64913977|NCT00393328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64913978|NCT00393328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64913979|NCT00393328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64913980|NCT00393328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913981|NCT00393328|Dopamine Agonists|dopamine agonists|mesh-ancestor
64525324|NCT03169764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525325|NCT03169764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64525326|NCT03169764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64525327|NCT03169764|Alkylating Agents|alkylating agents|mesh-ancestor
64525328|NCT03169764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64913982|NCT00393328|Dopamine Agents|dopamine agents|mesh-ancestor
64913983|NCT00393328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64913984|NCT00393328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64913985|NCT00393328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64914020|NCT01807078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64914021|NCT01807078|Antimetabolites|antimetabolites|mesh-ancestor
64914022|NCT01807078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914023|NCT01807078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64914025|NCT04650581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64914026|NCT04650581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649570|NCT00845000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914105|NCT04590248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914136|NCT05482542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64914137|NCT05482542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64914138|NCT05482542|Alkylating Agents|alkylating agents|mesh-ancestor
64914139|NCT05482542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914140|NCT05482542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914141|NCT05482542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64914142|NCT05482542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64914143|NCT00393445|Glucagon|glucagon|mesh-list
64914144|NCT00393445|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64914145|NCT00393445|Incretins|incretins|mesh-ancestor
64914146|NCT00393445|Hormones|hormones|mesh-ancestor
64914147|NCT00393445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64914148|NCT00393445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734583|NCT02064894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64734585|NCT02064894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64734586|NCT02064894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734587|NCT02064894|Analgesics|analgesics|mesh-ancestor
64734588|NCT02064894|Sensory System Agents|sensory system agents|mesh-ancestor
64734589|NCT02064894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64734590|NCT02064894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64734591|NCT02064894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64609921|NCT04375267|Olaparib|olaparib|mesh-list
64914149|NCT00393445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64914175|NCT04551131|Hormones|hormones|mesh-ancestor
64914176|NCT04551131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64914177|NCT04551131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64914178|NCT04551131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914179|NCT04551131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64914180|NCT04551131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64914181|NCT04551131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64914182|NCT04551131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914183|NCT04551131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914184|NCT01805908|Pertuzumab|pertuzumab|mesh-list
64914185|NCT01805908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64914186|NCT01805908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914187|NCT04527107|Aflibercept|aflibercept|mesh-list
64525330|NCT03169764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64525331|NCT03169764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64525332|NCT03169764|Growth Substances|growth substances|mesh-ancestor
64525333|NCT03169764|Growth Inhibitors|growth inhibitors|mesh-ancestor
64525334|NCT03169764|Antimetabolites|antimetabolites|mesh-ancestor
64914188|NCT04527107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64914189|NCT04527107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64914190|NCT04527107|Growth Substances|growth substances|mesh-ancestor
64914191|NCT04527107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914192|NCT04527107|Growth Inhibitors|growth inhibitors|mesh-ancestor
64914193|NCT04527107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914194|NCT05437887|Fucoidan|fucoidan|mesh-list
64914195|NCT05437887|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64914223|NCT04474223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64914225|NCT04474223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914227|NCT01466530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64914228|NCT01466530|Abortifacient Agents|abortifacient agents|mesh-ancestor
64914229|NCT01466530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64914230|NCT01466530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914231|NCT01466530|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64914232|NCT01466530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64914233|NCT01466530|Oxytocics|oxytocics|mesh-ancestor
64914234|NCT01466452|Aspirin|aspirin|mesh-list
64914235|NCT01466452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64914236|NCT01466452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64914237|NCT01466452|Analgesics|analgesics|mesh-ancestor
64914238|NCT01466452|Sensory System Agents|sensory system agents|mesh-ancestor
64914239|NCT01466452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64914240|NCT01466452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914241|NCT01466452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64914242|NCT01466452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64914243|NCT01466452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64914244|NCT01466452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64914279|NCT01466101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64914280|NCT01466101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914282|NCT01466101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64914283|NCT01466101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64914284|NCT01466101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914317|NCT01465867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914318|NCT01465867|Protective Agents|protective agents|mesh-ancestor
64914319|NCT01465867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914320|NCT01465867|Trace Elements|trace elements|mesh-ancestor
64914321|NCT01465867|Micronutrients|micronutrients|mesh-ancestor
64914322|NCT01465828|Clopidogrel|clopidogrel|mesh-list
64914323|NCT01465828|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64914324|NCT01465828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64914325|NCT01465828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64914326|NCT01465828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64914327|NCT01465828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64914328|NCT01465828|Purinergic Agents|purinergic agents|mesh-ancestor
64914358|NCT04201457|Trametinib|trametinib|mesh-list
64914359|NCT04201457|Dabrafenib|dabrafenib|mesh-list
64914360|NCT04201457|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
64914361|NCT04201457|Antimalarials|antimalarials|mesh-ancestor
64914362|NCT04201457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64914363|NCT04201457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64914364|NCT04201457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64914365|NCT04201457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914366|NCT04201457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914367|NCT04201457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64525335|NCT03169764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64525336|NCT03169764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64525338|NCT03169764|Protective Agents|protective agents|mesh-ancestor
64525339|NCT03169764|Vitamin B Complex|vitamin b complex|mesh-ancestor
64525341|NCT03169764|Micronutrients|micronutrients|mesh-ancestor
64525342|NCT03169764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64525343|NCT03169764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64525344|NCT03169764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64525345|NCT03169764|Hormone Antagonists|hormone antagonists|mesh-ancestor
64525346|NCT03169764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64525347|NCT03874936|Dexamethasone|dexamethasone|mesh-list
64525348|NCT03874936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64525349|NCT03874936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64525350|NCT03874936|Antiemetics|antiemetics|mesh-ancestor
64914368|NCT04201457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914369|NCT04201457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64914370|NCT04201457|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64914371|NCT04201457|Protective Agents|protective agents|mesh-ancestor
64914372|NCT04201457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914373|NCT04201457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64914374|NCT04201457|Antioxidants|antioxidants|mesh-ancestor
64914410|NCT05361720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914411|NCT04083950|Aspirin|aspirin|mesh-list
64914412|NCT04083950|Vaccines|vaccines|mesh-list
64914413|NCT04083950|Immunologic Factors|immunologic factors|mesh-ancestor
64914414|NCT04083950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914415|NCT04083950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64914416|NCT04083950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64914417|NCT04083950|Analgesics|analgesics|mesh-ancestor
64914418|NCT04083950|Sensory System Agents|sensory system agents|mesh-ancestor
64914419|NCT04083950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64914442|NCT00393679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914443|NCT00393679|Antiviral Agents|antiviral agents|mesh-ancestor
64914444|NCT00393679|Schistosomicides|schistosomicides|mesh-ancestor
64914445|NCT00393679|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64914446|NCT00393679|Anthelmintics|anthelmintics|mesh-ancestor
64914447|NCT00393679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64914448|NCT00393679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914449|NCT00393679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914450|NCT00393679|Leprostatic Agents|leprostatic agents|mesh-ancestor
64914451|NCT00393679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64914452|NCT00393835|Azithromycin|azithromycin|mesh-list
64914453|NCT00393835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64914454|NCT00393835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64914455|NCT04078568|Aspirin|aspirin|mesh-list
64914456|NCT04078568|Prednisolone|prednisolone|mesh-list
64914457|NCT04078568|Immunoglobulins|immunoglobulins|mesh-list
64914458|NCT04078568|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64914459|NCT04078568|gamma-Globulins|gamma-globulins|mesh-list
64914460|NCT04078568|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64914461|NCT04078568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64914462|NCT04078568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64914463|NCT04078568|Analgesics|analgesics|mesh-ancestor
64914464|NCT04078568|Sensory System Agents|sensory system agents|mesh-ancestor
64914465|NCT04078568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64525352|NCT03874936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64525353|NCT03874936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525354|NCT03874936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64525355|NCT03874936|Glucocorticoids|glucocorticoids|mesh-ancestor
64525357|NCT03874936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64525358|NCT03874936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64914466|NCT04078568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914467|NCT04078568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64914468|NCT04078568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64914469|NCT04078568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64914470|NCT04078568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64914471|NCT04078568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914472|NCT04078568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64914473|NCT04078568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64914474|NCT04078568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914475|NCT04078568|Antipyretics|antipyretics|mesh-ancestor
64914489|NCT01057069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64914491|NCT01057069|Tubulin Modulators|tubulin modulators|mesh-ancestor
64914492|NCT01057069|Antimitotic Agents|antimitotic agents|mesh-ancestor
64914493|NCT01057069|Mitosis Modulators|mitosis modulators|mesh-ancestor
64914494|NCT01057069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914495|NCT01057069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64914496|NCT01057069|Immunologic Factors|immunologic factors|mesh-ancestor
64914497|NCT01057069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914498|NCT01057069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64914499|NCT01057069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64914500|NCT01057069|Alkylating Agents|alkylating agents|mesh-ancestor
64914501|NCT01057069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64914502|NCT01057069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64914503|NCT01057069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64914504|NCT01057069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64914505|NCT01057069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914513|NCT00847834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64914514|NCT00847834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914515|NCT00847834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64914516|NCT00847834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64914517|NCT00847678|Amphotericin B|amphotericin b|mesh-list
64914518|NCT00847678|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64914519|NCT00847678|Flucytosine|flucytosine|mesh-list
64914520|NCT00847678|Efungumab|efungumab|mesh-list
64914521|NCT00847678|Amebicides|amebicides|mesh-ancestor
64914522|NCT00847678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64914523|NCT00847678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64914524|NCT00847678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64914525|NCT00847678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64914526|NCT00847678|Antifungal Agents|antifungal agents|mesh-ancestor
64914527|NCT00847678|Antimetabolites|antimetabolites|mesh-ancestor
64914528|NCT00847678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914529|NCT00847639|Lenalidomide|lenalidomide|mesh-list
64914530|NCT00847639|Immunologic Factors|immunologic factors|mesh-ancestor
64914531|NCT00847639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914532|NCT00847639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64914533|NCT00847639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64914534|NCT00847639|Growth Substances|growth substances|mesh-ancestor
64525360|NCT02399592|Bevacizumab|bevacizumab|mesh-list
64525361|NCT02399592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64525362|NCT02399592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525363|NCT02399592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64525364|NCT02399592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64525365|NCT02399592|Growth Substances|growth substances|mesh-ancestor
64525366|NCT02399592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525367|NCT02399592|Growth Inhibitors|growth inhibitors|mesh-ancestor
64525368|NCT03801304|Atezolizumab|atezolizumab|mesh-list
64525369|NCT03801304|Vinorelbine|vinorelbine|mesh-list
64525370|NCT03801304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525371|NCT03801304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64525372|NCT03801304|Tubulin Modulators|tubulin modulators|mesh-ancestor
64525373|NCT03801304|Antimitotic Agents|antimitotic agents|mesh-ancestor
64525374|NCT03801304|Mitosis Modulators|mitosis modulators|mesh-ancestor
64525375|NCT03801304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525376|NCT02696850|Budesonide|budesonide|mesh-list
64525377|NCT02696850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64525378|NCT02696850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64525379|NCT02696850|Autonomic Agents|autonomic agents|mesh-ancestor
64525380|NCT02696850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64525381|NCT02696850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914535|NCT00847639|Growth Inhibitors|growth inhibitors|mesh-ancestor
64914536|NCT00847639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914537|NCT05327127|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
64914561|NCT00847366|Trastuzumab|trastuzumab|mesh-list
64914562|NCT00847366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64914563|NCT00847366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914564|NCT00847366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64914565|NCT00847366|Hormone Antagonists|hormone antagonists|mesh-ancestor
64914566|NCT00847366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64914567|NCT00847366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914568|NCT00847366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64914569|NCT00847366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64914570|NCT00847366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64914571|NCT00847366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64914572|NCT05321160|Ketamine|ketamine|mesh-list
64914581|NCT05321160|Anesthetics, General|anesthetics, general|mesh-ancestor
64914582|NCT05321160|Anesthetics|anesthetics|mesh-ancestor
64525382|NCT02696850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64525383|NCT02696850|Respiratory System Agents|respiratory system agents|mesh-ancestor
64525385|NCT02696850|Hormones|hormones|mesh-ancestor
64525386|NCT02696850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64525387|NCT00365170|Insulin|insulin|mesh-list
64525388|NCT00365170|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64914583|NCT05321160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64914584|NCT05321160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64914585|NCT05321160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64914608|NCT00847210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64914609|NCT00847210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914610|NCT00847210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914612|NCT00847171|Trastuzumab|trastuzumab|mesh-list
64914613|NCT00847171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64914614|NCT00847171|Immunologic Factors|immunologic factors|mesh-ancestor
64914615|NCT00847171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914616|NCT00847171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64914617|NCT00847171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64914618|NCT00847171|Alkylating Agents|alkylating agents|mesh-ancestor
64914619|NCT00847171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914620|NCT00847171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914621|NCT00847171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64914622|NCT00847171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64914623|NCT03940586|Letermovir|letermovir|mesh-list
64914624|NCT03940586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64914625|NCT03940586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914626|NCT03940586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914627|NCT03940586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914628|NCT03940586|Antiviral Agents|antiviral agents|mesh-ancestor
64914629|NCT03940586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64914630|NCT00847093|Lidocaine|lidocaine|mesh-list
64914632|NCT00847093|Anesthetics|anesthetics|mesh-ancestor
64914633|NCT00847093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64914634|NCT00847093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914635|NCT00847093|Sensory System Agents|sensory system agents|mesh-ancestor
64914636|NCT00847093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64914637|NCT00847093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64914638|NCT00847093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64914639|NCT00847093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64914665|NCT00846703|Dexamethasone|dexamethasone|mesh-list
64914666|NCT00846703|Methotrexate|methotrexate|mesh-list
64914667|NCT00846703|Vincristine|vincristine|mesh-list
64914668|NCT00846703|Mercaptopurine|mercaptopurine|mesh-list
64914669|NCT00846703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64914670|NCT00846703|Antiemetics|antiemetics|mesh-ancestor
64914671|NCT00846703|Autonomic Agents|autonomic agents|mesh-ancestor
64914672|NCT00846703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64734599|NCT02064816|Immunologic Factors|immunologic factors|mesh-ancestor
64734600|NCT02064816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321118|NCT02198443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64321119|NCT02198443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64321120|NCT02198443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64321121|NCT02198443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64321122|NCT02198443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64914673|NCT00846703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914674|NCT00846703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64914675|NCT00846703|Glucocorticoids|glucocorticoids|mesh-ancestor
64914676|NCT00846703|Hormones|hormones|mesh-ancestor
64914677|NCT00846703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64914678|NCT00846703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64914679|NCT00846703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914680|NCT00846703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64914681|NCT00846703|Abortifacient Agents|abortifacient agents|mesh-ancestor
64914682|NCT00846703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64914756|NCT00846079|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64914757|NCT00846079|Purinergic Agonists|purinergic agonists|mesh-ancestor
64525389|NCT00365170|Insulin Aspart|insulin aspart|mesh-list
64525390|NCT00365170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64525391|NCT00365170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525392|NCT02403648|Glucagon|glucagon|mesh-list
64525393|NCT02403648|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64525394|NCT02403648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64525395|NCT02403648|Hormones|hormones|mesh-ancestor
64525396|NCT02403648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64525397|NCT02403648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525398|NCT02403648|Incretins|incretins|mesh-ancestor
64525399|NCT03429244|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64525400|NCT03429244|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64525401|NCT03429244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525402|NCT02396862|Factor VIII|factor viii|mesh-list
64525403|NCT02396862|Coagulants|coagulants|mesh-ancestor
64525404|NCT02377492|Vasopressins|vasopressins|mesh-list
64525405|NCT02377492|Arginine Vasopressin|arginine vasopressin|mesh-list
64525406|NCT02377492|Hemostatics|hemostatics|mesh-ancestor
64525407|NCT02377492|Coagulants|coagulants|mesh-ancestor
64525408|NCT02377492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64525409|NCT02377492|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64525410|NCT02377492|Natriuretic Agents|natriuretic agents|mesh-ancestor
64525411|NCT02377492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525412|NCT02594644|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64525413|NCT02594644|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64525414|NCT02594644|Dermatologic Agents|dermatologic agents|mesh-ancestor
64525415|NCT02601976|Ribavirin|ribavirin|mesh-list
64914758|NCT00846079|Purinergic Agents|purinergic agents|mesh-ancestor
64914759|NCT00846079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64914760|NCT00846079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914761|NCT00846079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914762|NCT00845962|Bupivacaine|bupivacaine|mesh-list
64914763|NCT00845962|Chloroprocaine|chloroprocaine|mesh-list
64914764|NCT00845962|Anesthetics, Local|anesthetics, local|mesh-ancestor
64914765|NCT00845962|Anesthetics|anesthetics|mesh-ancestor
64914791|NCT00277108|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64914792|NCT00277108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64914793|NCT00277108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64914794|NCT00277108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914796|NCT00277108|Serotonin Agents|serotonin agents|mesh-ancestor
64914797|NCT00277108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914798|NCT00277108|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64914799|NCT00277108|Antidepressive Agents|antidepressive agents|mesh-ancestor
64914800|NCT00277108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64914801|NCT00277069|Carboplatin|carboplatin|mesh-list
64914802|NCT00277069|Capecitabine|capecitabine|mesh-list
64914803|NCT00277069|Vinorelbine|vinorelbine|mesh-list
64914804|NCT00277069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914805|NCT00277069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64321123|NCT03533179|Glucagon|glucagon|mesh-list
64321124|NCT03533179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64321125|NCT03533179|Esmolol|esmolol|mesh-list
64321126|NCT03533179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64321127|NCT03533179|Hormones|hormones|mesh-ancestor
64525418|NCT02601976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525419|NCT02601976|Antiviral Agents|antiviral agents|mesh-ancestor
64525420|NCT02601976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64525421|NCT02603926|Pregnanolone|pregnanolone|mesh-list
64525422|NCT02603926|Brexanolone|brexanolone|mesh-list
64525423|NCT02603926|Anesthetics|anesthetics|mesh-ancestor
64914806|NCT00277069|Antimetabolites|antimetabolites|mesh-ancestor
64914807|NCT00277069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914808|NCT00277069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64914809|NCT00277069|Tubulin Modulators|tubulin modulators|mesh-ancestor
64914810|NCT00277069|Antimitotic Agents|antimitotic agents|mesh-ancestor
64914811|NCT00277069|Mitosis Modulators|mitosis modulators|mesh-ancestor
64914812|NCT00277030|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64914813|NCT00277030|Respiratory System Agents|respiratory system agents|mesh-ancestor
64649608|NCT02193815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914845|NCT00276835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914846|NCT00276835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64914847|NCT00276835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64914848|NCT00276835|Antiviral Agents|antiviral agents|mesh-ancestor
64914849|NCT00276835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64914850|NCT00276835|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64914851|NCT00276835|Protective Agents|protective agents|mesh-ancestor
64914852|NCT00276835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64683314|NCT00000669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914853|NCT00276835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914854|NCT00276835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914855|NCT00276835|Phytoestrogens|phytoestrogens|mesh-ancestor
64914856|NCT00276835|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64914857|NCT00276835|Estrogens|estrogens|mesh-ancestor
64914858|NCT00276835|Hormones|hormones|mesh-ancestor
64914859|NCT00276835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64914860|NCT00276796|Paclitaxel|paclitaxel|mesh-list
64914861|NCT00276796|Topotecan|topotecan|mesh-list
64914892|NCT00276757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64914893|NCT00276757|Antidotes|antidotes|mesh-ancestor
64914894|NCT00276757|Protective Agents|protective agents|mesh-ancestor
64914895|NCT00276757|Vitamin B Complex|vitamin b complex|mesh-ancestor
64914896|NCT00276757|Vitamins|vitamins|mesh-ancestor
64914897|NCT00276757|Micronutrients|micronutrients|mesh-ancestor
64914898|NCT00276757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64914899|NCT00276757|Glucocorticoids|glucocorticoids|mesh-ancestor
64914900|NCT00276757|Hormones|hormones|mesh-ancestor
64914901|NCT00276757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64914902|NCT00276757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64914903|NCT00276757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64914904|NCT00276757|Tubulin Modulators|tubulin modulators|mesh-ancestor
64914905|NCT00276757|Antimitotic Agents|antimitotic agents|mesh-ancestor
64914937|NCT00276601|Daunorubicin|daunorubicin|mesh-list
64914938|NCT00276601|Arsenic Trioxide|arsenic trioxide|mesh-list
64914939|NCT00276601|Tretinoin|tretinoin|mesh-list
64914940|NCT00276601|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64914941|NCT00276601|Abortifacient Agents|abortifacient agents|mesh-ancestor
64914942|NCT00276601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64914943|NCT00276601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914944|NCT00276601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64914945|NCT00276601|Antimetabolites|antimetabolites|mesh-ancestor
64914946|NCT00276601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914947|NCT00276601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914948|NCT00276601|Dermatologic Agents|dermatologic agents|mesh-ancestor
64525424|NCT02603926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64525425|NCT02603926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525426|NCT02603926|Neurosteroids|neurosteroids|mesh-ancestor
64525427|NCT02603926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64525428|NCT02603926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525429|NCT02603926|GABA Modulators|gaba modulators|mesh-ancestor
64525430|NCT02603926|GABA Agents|gaba agents|mesh-ancestor
64525431|NCT00365560|Tiotropium Bromide|tiotropium bromide|mesh-list
64525432|NCT00365560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64525433|NCT00365560|Autonomic Agents|autonomic agents|mesh-ancestor
64525434|NCT00365560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64525435|NCT00365560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525436|NCT00365560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64525437|NCT00365560|Respiratory System Agents|respiratory system agents|mesh-ancestor
64525438|NCT00365560|Parasympatholytics|parasympatholytics|mesh-ancestor
64525439|NCT00365560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64525440|NCT00365560|Cholinergic Agents|cholinergic agents|mesh-ancestor
64525441|NCT00365560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64914949|NCT00276601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914983|NCT00389883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914984|NCT00389922|Vinorelbine|vinorelbine|mesh-list
64914985|NCT00389922|Lapatinib|lapatinib|mesh-list
64914986|NCT00389922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64914987|NCT00389922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914988|NCT00389922|Tubulin Modulators|tubulin modulators|mesh-ancestor
64914989|NCT00389922|Antimitotic Agents|antimitotic agents|mesh-ancestor
64914990|NCT00389922|Mitosis Modulators|mitosis modulators|mesh-ancestor
64914991|NCT00389922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914992|NCT00389922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64914993|NCT00389922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914994|NCT00276289|Spironolactone|spironolactone|mesh-list
64914995|NCT00276289|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64914996|NCT00276289|Hormone Antagonists|hormone antagonists|mesh-ancestor
64914997|NCT00276289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64914998|NCT00276289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914999|NCT00276289|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64915000|NCT00276289|Diuretics|diuretics|mesh-ancestor
64915001|NCT00276289|Natriuretic Agents|natriuretic agents|mesh-ancestor
64915031|NCT00276133|Protective Agents|protective agents|mesh-ancestor
64915032|NCT00276133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915033|NCT00276055|Gemcitabine|gemcitabine|mesh-list
64915034|NCT00276055|Bevacizumab|bevacizumab|mesh-list
64915036|NCT00276055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64915037|NCT00276055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915038|NCT00276055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64915039|NCT00276055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64525442|NCT00365560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525444|NCT02395926|Lipotropic Agents|lipotropic agents|mesh-ancestor
64525445|NCT02395926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64525446|NCT02395926|Antimetabolites|antimetabolites|mesh-ancestor
64525447|NCT02395926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525448|NCT02395926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64525449|NCT02395926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64525450|NCT02395926|Nootropic Agents|nootropic agents|mesh-ancestor
64525451|NCT02402868|Ketamine|ketamine|mesh-list
64525452|NCT02402868|Analgesics|analgesics|mesh-ancestor
64525453|NCT02402868|Sensory System Agents|sensory system agents|mesh-ancestor
64525454|NCT02402868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64525455|NCT02402868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525456|NCT02402868|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64525457|NCT02402868|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64525458|NCT02402868|Anesthetics, General|anesthetics, general|mesh-ancestor
64915040|NCT00276055|Growth Substances|growth substances|mesh-ancestor
64915041|NCT00276055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915042|NCT00276055|Growth Inhibitors|growth inhibitors|mesh-ancestor
64915043|NCT00276055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64915044|NCT00276055|Antimetabolites|antimetabolites|mesh-ancestor
64915045|NCT00276055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915078|NCT00275431|Contraceptive Agents|contraceptive agents|mesh-ancestor
64915079|NCT00275431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64915080|NCT00275431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915081|NCT00275431|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
64915082|NCT00275431|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
64915083|NCT00275431|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64915085|NCT03152318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64915086|NCT03152318|Immunologic Factors|immunologic factors|mesh-ancestor
64915087|NCT03152318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915125|NCT02921555|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64734601|NCT02064816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734602|NCT02064816|Antiviral Agents|antiviral agents|mesh-ancestor
64915127|NCT02921555|Prednisolone acetate|prednisolone acetate|mesh-list
64915128|NCT02921555|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64915129|NCT02921555|Prednisolone phosphate|prednisolone phosphate|mesh-list
64915130|NCT02921555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64915131|NCT02921555|Glucocorticoids|glucocorticoids|mesh-ancestor
64915165|NCT02687906|Vaborbactam|vaborbactam|mesh-list
64915166|NCT02687906|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
64915167|NCT02687906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64915168|NCT02687906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64915169|NCT02687906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915170|NCT02687906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915171|NCT02680184|Pembrolizumab|pembrolizumab|mesh-list
64915172|NCT02680184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64915173|NCT02680184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915174|NCT00390000|Pemetrexed|pemetrexed|mesh-list
64915204|NCT04732507|Anesthetics, Local|anesthetics, local|mesh-ancestor
64915205|NCT04732507|Anesthetics|anesthetics|mesh-ancestor
64525460|NCT02402868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64525461|NCT02402868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64525462|NCT02402868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64525463|NCT02402868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64525464|NCT02402868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525465|NCT02402712|Docetaxel|docetaxel|mesh-list
64525466|NCT02402712|Trastuzumab|trastuzumab|mesh-list
64525467|NCT02402712|Pertuzumab|pertuzumab|mesh-list
64525468|NCT02402712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525469|NCT02402712|Tubulin Modulators|tubulin modulators|mesh-ancestor
64525470|NCT02402712|Antimitotic Agents|antimitotic agents|mesh-ancestor
64525471|NCT02402712|Mitosis Modulators|mitosis modulators|mesh-ancestor
64525472|NCT02402712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525473|NCT02402712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64525474|NCT02395458|Amoxicillin|amoxicillin|mesh-list
64525475|NCT02395458|Metronidazole|metronidazole|mesh-list
64915206|NCT04732507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64915207|NCT04732507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915208|NCT04732507|Sensory System Agents|sensory system agents|mesh-ancestor
64915209|NCT04732507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64915210|NCT04732507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64915211|NCT04732507|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64915212|NCT04732507|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64915213|NCT04732507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64915214|NCT04732507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915215|NCT05047770|Vaccines|vaccines|mesh-list
64915216|NCT05047770|Immunologic Factors|immunologic factors|mesh-ancestor
64915217|NCT05047770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915218|NCT02453984|Atezolizumab|atezolizumab|mesh-list
64915219|NCT02453984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915220|NCT04599478|Naltrexone|naltrexone|mesh-list
64915221|NCT04599478|Bupropion|bupropion|mesh-list
64915247|NCT04556617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64915248|NCT04556617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915249|NCT04556617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64915250|NCT04556617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915251|NCT04556617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915252|NCT04556617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64915253|NCT04556617|Hormone Antagonists|hormone antagonists|mesh-ancestor
64915254|NCT04556617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64915255|NCT04554862|Ketorolac|ketorolac|mesh-list
64649626|NCT01361633|Cycloserine|cycloserine|mesh-list
64915262|NCT04554862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64915263|NCT04554862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915264|NCT04554862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64915265|NCT04554862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64915282|NCT04379713|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64915284|NCT04379713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915285|NCT03802097|Anti-Infective Agents|anti-infective agents|mesh-list
64525476|NCT02395458|Clarithromycin|clarithromycin|mesh-list
64525477|NCT02395458|Omeprazole|omeprazole|mesh-list
64525478|NCT02395458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64525479|NCT02395458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64525480|NCT02395458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64525481|NCT02395458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64375656|NCT04902105|Ecopipam|ecopipam|mesh-list
64915286|NCT03802097|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64915287|NCT04230499|Sirolimus|sirolimus|mesh-list
64915288|NCT04230499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64915289|NCT04230499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64915290|NCT04230499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64915291|NCT04230499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915292|NCT04230499|Antifungal Agents|antifungal agents|mesh-ancestor
64915293|NCT04230499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64915294|NCT04230499|Immunologic Factors|immunologic factors|mesh-ancestor
64915295|NCT04230499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915296|NCT04712435|Acetylcysteine|acetylcysteine|mesh-list
64915297|NCT04712435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64915298|NCT04712435|Antiviral Agents|antiviral agents|mesh-ancestor
64915299|NCT04712435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64915300|NCT04712435|Expectorants|expectorants|mesh-ancestor
64915301|NCT04712435|Respiratory System Agents|respiratory system agents|mesh-ancestor
64915302|NCT04712435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64915303|NCT04712435|Antioxidants|antioxidants|mesh-ancestor
64915304|NCT04712435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915305|NCT04712435|Protective Agents|protective agents|mesh-ancestor
64915306|NCT04712435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915307|NCT04712435|Antidotes|antidotes|mesh-ancestor
64915308|NCT03977194|Paclitaxel|paclitaxel|mesh-list
64915309|NCT03977194|Carboplatin|carboplatin|mesh-list
64915310|NCT03977194|Atezolizumab|atezolizumab|mesh-list
64915311|NCT03977194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64915312|NCT03977194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915313|NCT03977194|Tubulin Modulators|tubulin modulators|mesh-ancestor
64915314|NCT03977194|Antimitotic Agents|antimitotic agents|mesh-ancestor
64915315|NCT03977194|Mitosis Modulators|mitosis modulators|mesh-ancestor
64915316|NCT03977194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915317|NCT04729465|Propofol|propofol|mesh-list
64915318|NCT04729465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64915319|NCT04729465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64915320|NCT04729465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915321|NCT04729465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64915322|NCT04729465|Anesthetics, General|anesthetics, general|mesh-ancestor
64915323|NCT04729465|Anesthetics|anesthetics|mesh-ancestor
64915359|NCT02966665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64915361|NCT02966665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915362|NCT02966665|Antioxidants|antioxidants|mesh-ancestor
64915363|NCT02966665|Protective Agents|protective agents|mesh-ancestor
64915364|NCT02966665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64915365|NCT02966665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64915366|NCT02966665|Adrenergic Agents|adrenergic agents|mesh-ancestor
64915367|NCT02966665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64915368|NCT02966665|Sympathomimetics|sympathomimetics|mesh-ancestor
64915399|NCT02832544|Antithrombins|antithrombins|mesh-ancestor
64915400|NCT02832544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64915401|NCT02832544|Protease Inhibitors|protease inhibitors|mesh-ancestor
64915402|NCT02832544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915408|NCT00006044|Testosterone|testosterone|mesh-list
64734620|NCT02079636|Immunologic Factors|immunologic factors|mesh-ancestor
64915409|NCT00006044|Androgens|androgens|mesh-ancestor
64915411|NCT00006044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64915412|NCT00006044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915413|NCT02490241|Lithium Carbonate|lithium carbonate|mesh-list
64915414|NCT02490241|Antidepressive Agents|antidepressive agents|mesh-ancestor
64915415|NCT02490241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64525483|NCT02395458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64525484|NCT02395458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64525485|NCT02395458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64525486|NCT02395458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525487|NCT02395458|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64525488|NCT02395458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64525489|NCT02395458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64915416|NCT02490241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915447|NCT00083824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64915448|NCT00083824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64915449|NCT00083824|Contraceptive Agents|contraceptive agents|mesh-ancestor
64915450|NCT00083824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64915451|NCT00083824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64915452|NCT00083824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64915453|NCT00083824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64915454|NCT00083824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64915455|NCT00083824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915456|NCT00083902|Thalidomide|thalidomide|mesh-list
64915488|NCT00006050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915489|NCT00006050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64915490|NCT00006050|Immunologic Factors|immunologic factors|mesh-ancestor
64915492|NCT00006050|Protective Agents|protective agents|mesh-ancestor
64915493|NCT00006050|Vitamin B Complex|vitamin b complex|mesh-ancestor
64915494|NCT00006050|Vitamins|vitamins|mesh-ancestor
64915495|NCT00006050|Micronutrients|micronutrients|mesh-ancestor
64915496|NCT00083980|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64915497|NCT00083980|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64915498|NCT00083980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64915499|NCT00083980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64915533|NCT00084058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64915534|NCT00084058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64915535|NCT00084058|Antiviral Agents|antiviral agents|mesh-ancestor
64915536|NCT00084058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64915537|NCT00084058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64915538|NCT00084058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64915539|NCT00006053|Imatinib Mesylate|imatinib mesylate|mesh-list
64915540|NCT00006053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915568|NCT00006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915569|NCT00006056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915570|NCT00006056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64915571|NCT00006056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64915572|NCT00006056|Abortifacient Agents|abortifacient agents|mesh-ancestor
64915573|NCT00006056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64915574|NCT00006056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64915575|NCT00006056|Antimetabolites|antimetabolites|mesh-ancestor
64915576|NCT00006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
64915577|NCT00006056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610562|NCT03409835|Antiemetics|antiemetics|mesh-ancestor
64610563|NCT03409835|Autonomic Agents|autonomic agents|mesh-ancestor
64915578|NCT00006056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64915579|NCT00006056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64915580|NCT00006056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64915581|NCT00006056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64915582|NCT00006056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64915583|NCT00006056|Antifungal Agents|antifungal agents|mesh-ancestor
64915584|NCT00006056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64649640|NCT01331213|Anticonvulsants|anticonvulsants|mesh-ancestor
64915622|NCT00084565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915623|NCT00084565|Tubulin Modulators|tubulin modulators|mesh-ancestor
64525491|NCT02402400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64525492|NCT02402400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64525493|NCT02402400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64525494|NCT02402400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64525495|NCT02402400|Purinergic Agents|purinergic agents|mesh-ancestor
64525496|NCT02402400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64915624|NCT00084565|Antimitotic Agents|antimitotic agents|mesh-ancestor
64915625|NCT00084565|Mitosis Modulators|mitosis modulators|mesh-ancestor
64915626|NCT00084565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915627|NCT00084565|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64915628|NCT00084565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64915629|NCT00084565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915630|NCT00084565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64915631|NCT00084565|Alkylating Agents|alkylating agents|mesh-ancestor
64915661|NCT00084721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64915662|NCT00084721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915663|NCT00084721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915664|NCT00084721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915665|NCT00084721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64915666|NCT00084721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64915667|NCT00084721|Analgesics|analgesics|mesh-ancestor
64915668|NCT00084721|Sensory System Agents|sensory system agents|mesh-ancestor
64915669|NCT00084721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64915670|NCT00084721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915671|NCT00084721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64915672|NCT00084721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64915673|NCT00084721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64915674|NCT00084721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64915676|NCT00084877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64915677|NCT00084877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64915706|NCT00400075|Azathioprine|azathioprine|mesh-list
64915707|NCT00400075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64915708|NCT00400075|Immunologic Factors|immunologic factors|mesh-ancestor
64915709|NCT00400075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915710|NCT00400075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64915711|NCT00400075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64915712|NCT00400075|Alkylating Agents|alkylating agents|mesh-ancestor
64915713|NCT00400075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915714|NCT00400075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915715|NCT00400075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64915716|NCT00400075|Antimetabolites|antimetabolites|mesh-ancestor
64915717|NCT00400075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64915718|NCT00400114|Irinotecan|irinotecan|mesh-list
64915719|NCT00400114|Sunitinib|sunitinib|mesh-list
64915720|NCT00400114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915721|NCT00400114|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64915722|NCT00400114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64915723|NCT00400114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915724|NCT00400114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915757|NCT00006077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915759|NCT00006077|Autonomic Agents|autonomic agents|mesh-ancestor
64915760|NCT00006077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64915761|NCT00006077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64321128|NCT03533179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64321130|NCT03533179|Incretins|incretins|mesh-ancestor
64321131|NCT03533179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64915762|NCT00006077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64915763|NCT04729348|Pembrolizumab|pembrolizumab|mesh-list
64915764|NCT04729348|Lenvatinib|lenvatinib|mesh-list
64525502|NCT02610868|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64525503|NCT02610868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64525504|NCT02610868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64525505|NCT02610868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525506|NCT02610868|Cholinergic Agents|cholinergic agents|mesh-ancestor
64525507|NCT02610868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64525508|NCT02610868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525509|NCT02610868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64525510|NCT02610868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64525511|NCT02610868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64525512|NCT02395068|Irinotecan|irinotecan|mesh-list
64525513|NCT02395068|Nimotuzumab|nimotuzumab|mesh-list
64525514|NCT02395068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64525515|NCT02395068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64525516|NCT02395068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64525517|NCT02395068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525518|NCT02395068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525519|NCT02395068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64525520|NCT02616250|Ivermectin|ivermectin|mesh-list
64525521|NCT02616250|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64525522|NCT02616250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64525523|NCT02616250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64525524|NCT02616250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64525525|NCT02616250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64525526|NCT02616250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64525527|NCT02616250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64525528|NCT02616250|Adrenergic Agents|adrenergic agents|mesh-ancestor
64915803|NCT00085462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64915804|NCT00085462|Immunologic Factors|immunologic factors|mesh-ancestor
64915805|NCT00085462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915806|NCT00085462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64915807|NCT00085462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64915808|NCT00085462|Alkylating Agents|alkylating agents|mesh-ancestor
64915809|NCT00085462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525530|NCT02616250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525531|NCT02616250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525532|NCT02698410|Temozolomide|temozolomide|mesh-list
64525533|NCT02698410|Lanreotide|lanreotide|mesh-list
64525534|NCT02698410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64525535|NCT02698410|Alkylating Agents|alkylating agents|mesh-ancestor
64525536|NCT02698410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525537|NCT02698410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525538|NCT00365638|Simvastatin|simvastatin|mesh-list
64525539|NCT00365638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64915813|NCT00085462|Antimetabolites|antimetabolites|mesh-ancestor
64915814|NCT00085462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64915815|NCT00085462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64915816|NCT00085462|Antiviral Agents|antiviral agents|mesh-ancestor
64915817|NCT00085462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64915855|NCT04798638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915856|NCT04798638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915857|NCT04798638|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64915858|NCT04798638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64915886|NCT00006092|Arsenic Trioxide|arsenic trioxide|mesh-list
64915887|NCT00006092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915889|NCT00086125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64915890|NCT00086125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64915891|NCT00086125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64915892|NCT00086125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915893|NCT00086125|Antifungal Agents|antifungal agents|mesh-ancestor
64915894|NCT00086125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64915895|NCT00086125|Immunologic Factors|immunologic factors|mesh-ancestor
64915896|NCT00086125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915897|NCT00086203|Rituximab|rituximab|mesh-list
64915898|NCT00086203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64915899|NCT00086203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915900|NCT00086203|Immunologic Factors|immunologic factors|mesh-ancestor
64915901|NCT00086203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915902|NCT00086203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64915903|NCT00006095|Irinotecan|irinotecan|mesh-list
64915904|NCT00006095|Vincristine|vincristine|mesh-list
64915905|NCT00006095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64915906|NCT00006095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64915907|NCT00006095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915940|NCT00086359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64915941|NCT00086359|Antiviral Agents|antiviral agents|mesh-ancestor
64915942|NCT00086359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64915943|NCT00086359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64915944|NCT00086359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64915945|NCT00086359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64915946|NCT00086359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64915947|NCT00086359|Antimetabolites|antimetabolites|mesh-ancestor
64915982|NCT00006104|Tubulin Modulators|tubulin modulators|mesh-ancestor
64915983|NCT00006104|Antimitotic Agents|antimitotic agents|mesh-ancestor
64915984|NCT00006104|Mitosis Modulators|mitosis modulators|mesh-ancestor
64915985|NCT00006104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915986|NCT00006104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64915987|NCT00086827|Romidepsin|romidepsin|mesh-list
64915988|NCT00086827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64525541|NCT00365638|Antimetabolites|antimetabolites|mesh-ancestor
64525542|NCT00365638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525543|NCT00365638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64525544|NCT00365638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64525545|NCT00365638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64525546|NCT02699892|Rituximab|rituximab|mesh-list
64525547|NCT02699892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64525548|NCT02699892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525549|NCT02699892|Immunologic Factors|immunologic factors|mesh-ancestor
64525550|NCT02699892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525551|NCT02699892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64525552|NCT05731258|Doxorubicin|doxorubicin|mesh-list
64525553|NCT05731258|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64525554|NCT05731258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64525555|NCT05731258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525556|NCT05731258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64525557|NCT05731258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64525558|NCT05731258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916016|NCT00086983|Oxaliplatin|oxaliplatin|mesh-list
64916017|NCT00086983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916018|NCT00087100|Pemetrexed|pemetrexed|mesh-list
64916025|NCT00006113|Aldesleukin|aldesleukin|mesh-list
64916026|NCT00006113|Interferon-gamma|interferon-gamma|mesh-list
64916027|NCT00006113|Interleukin-4|interleukin-4|mesh-list
64916028|NCT00006113|Sargramostim|sargramostim|mesh-list
64916029|NCT00006113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916030|NCT00006113|Antiviral Agents|antiviral agents|mesh-ancestor
64916031|NCT00006113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64916032|NCT00006113|Immunologic Factors|immunologic factors|mesh-ancestor
64916033|NCT00006113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916034|NCT00006113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64916035|NCT00006113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64916036|NCT00006113|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64916037|NCT00006113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64916064|NCT00006116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64916065|NCT00006116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916066|NCT00006116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64916067|NCT00006116|Immunologic Factors|immunologic factors|mesh-ancestor
64916068|NCT00006116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916069|NCT00087295|Romidepsin|romidepsin|mesh-list
64916070|NCT00087295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64916071|NCT00087295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916072|NCT04762953|Leucovorin|leucovorin|mesh-list
64916073|NCT04762953|Paclitaxel|paclitaxel|mesh-list
64916074|NCT04762953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64916075|NCT04762953|Fluorouracil|fluorouracil|mesh-list
64916076|NCT04762953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64916077|NCT04762953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916078|NCT04762953|Tubulin Modulators|tubulin modulators|mesh-ancestor
64916079|NCT04762953|Antimitotic Agents|antimitotic agents|mesh-ancestor
64916080|NCT04762953|Mitosis Modulators|mitosis modulators|mesh-ancestor
64525561|NCT04340908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64525562|NCT04340908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525564|NCT04340908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525565|NCT05730634|Atorvastatin|atorvastatin|mesh-list
64525566|NCT05730634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64525567|NCT05730634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64916081|NCT04762953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916082|NCT04762953|Antimetabolites|antimetabolites|mesh-ancestor
64916083|NCT04762953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64916084|NCT04762953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64916085|NCT04762953|Immunologic Factors|immunologic factors|mesh-ancestor
64916120|NCT00087451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64916121|NCT00087451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916122|NCT00087451|Antifungal Agents|antifungal agents|mesh-ancestor
64916123|NCT00087451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64916124|NCT00087451|Immunologic Factors|immunologic factors|mesh-ancestor
64916125|NCT00087451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916126|NCT00006122|Cytarabine|cytarabine|mesh-list
64916127|NCT00006122|Etoposide|etoposide|mesh-list
64916158|NCT00087802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916159|NCT00087802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64916160|NCT00087802|Antimetabolites|antimetabolites|mesh-ancestor
64916161|NCT00087802|Antiviral Agents|antiviral agents|mesh-ancestor
64916162|NCT00087802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64916163|NCT00087802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916164|NCT00087802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64916165|NCT00087802|Immunologic Factors|immunologic factors|mesh-ancestor
64916166|NCT00087802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916167|NCT04760613|Cannabidiol|cannabidiol|mesh-list
64916168|NCT04760613|Anticonvulsants|anticonvulsants|mesh-ancestor
64916169|NCT00006125|Doxorubicin|doxorubicin|mesh-list
64916170|NCT00006125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64916171|NCT00006125|Topotecan|topotecan|mesh-list
64649675|NCT01277159|Narcotics|narcotics|mesh-ancestor
64916200|NCT00088036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916201|NCT00088036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64916202|NCT00088036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64916203|NCT00088036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64916204|NCT00088036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64916205|NCT00088036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64916206|NCT00088036|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64916207|NCT00088036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64916208|NCT00088036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64916209|NCT00088036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916210|NCT00088036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64916211|NCT00088036|Serotonin Agents|serotonin agents|mesh-ancestor
64916212|NCT00088075|Risperidone|risperidone|mesh-list
64916213|NCT00088075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64916214|NCT00088075|Serotonin Agents|serotonin agents|mesh-ancestor
64916215|NCT00088075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64916216|NCT00088075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916217|NCT00088075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916218|NCT00088075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64916219|NCT00088075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64916252|NCT00088270|Vitamins|vitamins|mesh-ancestor
64525569|NCT05730634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525571|NCT05730634|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64525572|NCT05730634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64525573|NCT05705830|Serotonin|serotonin|mesh-list
64525574|NCT05705830|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
64525575|NCT05705830|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64916253|NCT00088270|Micronutrients|micronutrients|mesh-ancestor
64916254|NCT00088387|Valproic Acid|valproic acid|mesh-list
64916255|NCT00088387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64916256|NCT00088387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916257|NCT00088387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916258|NCT00088387|Antimanic Agents|antimanic agents|mesh-ancestor
64916259|NCT00088387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64916260|NCT00088387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64916261|NCT00088387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916262|NCT00088387|Anticonvulsants|anticonvulsants|mesh-ancestor
64916263|NCT00088387|GABA Agents|gaba agents|mesh-ancestor
64916294|NCT00088582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64916295|NCT00088582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916298|NCT00088816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64916299|NCT00088816|Antimetabolites|antimetabolites|mesh-ancestor
64916300|NCT00088816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916301|NCT04688736|Chlorpheniramine|chlorpheniramine|mesh-list
64916302|NCT04688736|Antipruritics|antipruritics|mesh-ancestor
64916303|NCT04688736|Dermatologic Agents|dermatologic agents|mesh-ancestor
64916304|NCT04688736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64916305|NCT04688736|Histamine Antagonists|histamine antagonists|mesh-ancestor
64916306|NCT04688736|Histamine Agents|histamine agents|mesh-ancestor
64916307|NCT04688736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64916308|NCT04688736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916345|NCT00006152|Protease Inhibitors|protease inhibitors|mesh-ancestor
64916346|NCT00006152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916347|NCT00006152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916348|NCT00006152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64916371|NCT00088933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64916373|NCT00088933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64916374|NCT00089050|Cyclosporine|cyclosporine|mesh-list
64916375|NCT00089050|Gemtuzumab|gemtuzumab|mesh-list
64916376|NCT00089050|Cyclosporins|cyclosporins|mesh-list
64916377|NCT00089050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916378|NCT00089050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916379|NCT00089050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64916380|NCT00089050|Immunologic Factors|immunologic factors|mesh-ancestor
64321135|NCT03533179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64321136|NCT03533179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610900|NCT01721525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610901|NCT01727843|Tranexamic Acid|tranexamic acid|mesh-list
64610902|NCT01727843|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64610903|NCT01727843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64610905|NCT01727843|Hemostatics|hemostatics|mesh-ancestor
64916387|NCT00089050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64916388|NCT00089050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916389|NCT00006155|Carboplatin|carboplatin|mesh-list
64916390|NCT00006155|Semaxinib|semaxinib|mesh-list
64916391|NCT00006155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916392|NCT00006155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64916393|NCT00006155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64916394|NCT00006155|Growth Substances|growth substances|mesh-ancestor
64916395|NCT00006155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916396|NCT00006155|Growth Inhibitors|growth inhibitors|mesh-ancestor
64916397|NCT00006155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64916398|NCT00006155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64525577|NCT05705830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64525578|NCT05705830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525579|NCT05705830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525580|NCT05705830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64525581|NCT05705830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64525583|NCT05745714|Dexamethasone|dexamethasone|mesh-list
64525584|NCT05745714|Cyclophosphamide|cyclophosphamide|mesh-list
64916399|NCT00006155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916400|NCT00089089|Decitabine|decitabine|mesh-list
64916401|NCT00089089|Azacitidine|azacitidine|mesh-list
64916435|NCT00089206|Freund's Adjuvant|freund's adjuvant|mesh-list
64916436|NCT00089206|Immunologic Factors|immunologic factors|mesh-ancestor
64916437|NCT00089206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916438|NCT00089206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64916439|NCT00400231|Metformin|metformin|mesh-list
64916440|NCT00400231|Fenofibrate|fenofibrate|mesh-list
64916441|NCT00400231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64916442|NCT00400231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916469|NCT00423826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64916470|NCT00423826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64916471|NCT00423826|Antitubercular Agents|antitubercular agents|mesh-ancestor
64916472|NCT00423826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64916473|NCT00423826|Alkylating Agents|alkylating agents|mesh-ancestor
64916474|NCT00423826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64916475|NCT00423826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64916477|NCT00423865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916478|NCT00423865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64916479|NCT00423865|Immunologic Factors|immunologic factors|mesh-ancestor
64916480|NCT00423865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916481|NCT00423982|Vancomycin|vancomycin|mesh-list
64916482|NCT00423982|Rifampin|rifampin|mesh-list
64916483|NCT00423982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64916484|NCT00423982|Cloxacillin|cloxacillin|mesh-list
64916485|NCT00423982|Anti-Infective Agents|anti-infective agents|mesh-list
64916486|NCT00423982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64916487|NCT00423982|Antitubercular Agents|antitubercular agents|mesh-ancestor
64916488|NCT00423982|Leprostatic Agents|leprostatic agents|mesh-ancestor
64916489|NCT00423982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64916490|NCT00423982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916517|NCT00390156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916519|NCT00390156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64684969|NCT00002967|Tamoxifen|tamoxifen|mesh-list
64916521|NCT00390156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916522|NCT00390156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916523|NCT00390156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64916524|NCT00390156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64916525|NCT00390156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64916526|NCT00390156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64916527|NCT00390156|Growth Substances|growth substances|mesh-ancestor
64916528|NCT00390156|Growth Inhibitors|growth inhibitors|mesh-ancestor
64916529|NCT00390156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64916566|NCT00089557|Sensory System Agents|sensory system agents|mesh-ancestor
64916567|NCT00089557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321137|NCT02201407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64321138|NCT02201407|Antiviral Agents|antiviral agents|mesh-ancestor
64321139|NCT02201407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64916568|NCT00089557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525586|NCT05745714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64525587|NCT05745714|Immunologic Factors|immunologic factors|mesh-ancestor
64525588|NCT05745714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525589|NCT05745714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64525590|NCT05745714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64525591|NCT05745714|Alkylating Agents|alkylating agents|mesh-ancestor
64525592|NCT05745714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525593|NCT05745714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525594|NCT05745714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64525595|NCT05745714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64525597|NCT05745714|Autonomic Agents|autonomic agents|mesh-ancestor
64525598|NCT05745714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64525599|NCT05745714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64525600|NCT05745714|Glucocorticoids|glucocorticoids|mesh-ancestor
64525601|NCT05745714|Hormones|hormones|mesh-ancestor
64525602|NCT05745714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64525603|NCT05745714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64525604|NCT05745714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64916569|NCT00089830|Squalamine|squalamine|mesh-list
64916570|NCT00089830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64916571|NCT00089830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64916572|NCT00089830|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64916573|NCT00089830|Protective Agents|protective agents|mesh-ancestor
64916574|NCT00089830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916575|NCT00089830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916576|NCT00089830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64916577|NCT00089830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64916578|NCT00089830|Growth Substances|growth substances|mesh-ancestor
64916607|NCT00089947|Immunologic Factors|immunologic factors|mesh-ancestor
64916608|NCT00089947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916609|NCT00089947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64916610|NCT00090025|Leucovorin|leucovorin|mesh-list
64916611|NCT00090025|Fluorouracil|fluorouracil|mesh-list
64916612|NCT00090025|Antimetabolites|antimetabolites|mesh-ancestor
64916613|NCT00090025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916614|NCT00090025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64916615|NCT00090025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916616|NCT00090025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64916617|NCT00090025|Immunologic Factors|immunologic factors|mesh-ancestor
64916618|NCT00090025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916619|NCT00090025|Antidotes|antidotes|mesh-ancestor
64916620|NCT00090025|Protective Agents|protective agents|mesh-ancestor
64916621|NCT00090025|Vitamin B Complex|vitamin b complex|mesh-ancestor
64916622|NCT00090025|Vitamins|vitamins|mesh-ancestor
64916623|NCT00090025|Micronutrients|micronutrients|mesh-ancestor
64916624|NCT04633902|Pembrolizumab|pembrolizumab|mesh-list
64916625|NCT04633902|Olaparib|olaparib|mesh-list
64916657|NCT00091078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916658|NCT00091117|Bortezomib|bortezomib|mesh-list
64916659|NCT00091117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916660|NCT00091156|Gefitinib|gefitinib|mesh-list
64916661|NCT00091156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525607|NCT05745714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64525613|NCT02974270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64916663|NCT00091156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916664|NCT00091156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916665|NCT00091195|Romidepsin|romidepsin|mesh-list
64916666|NCT00091195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64916667|NCT00091195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916668|NCT00091234|Gemtuzumab|gemtuzumab|mesh-list
64916669|NCT00091234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64916670|NCT00091234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916687|NCT00091312|Antidotes|antidotes|mesh-ancestor
64916688|NCT00091312|Protective Agents|protective agents|mesh-ancestor
64916689|NCT00091312|Vitamin B Complex|vitamin b complex|mesh-ancestor
64916690|NCT00091312|Vitamins|vitamins|mesh-ancestor
64916691|NCT00091312|Micronutrients|micronutrients|mesh-ancestor
64916692|NCT04619706|Palmidrol|palmidrol|mesh-list
64916693|NCT04619706|Analgesics|analgesics|mesh-ancestor
64916694|NCT04619706|Sensory System Agents|sensory system agents|mesh-ancestor
64916695|NCT04619706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64916696|NCT04619706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734629|NCT02045862|Mirabegron|mirabegron|mesh-list
64916697|NCT04619706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64916698|NCT04619706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64916699|NCT04619706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64916700|NCT04619706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64916701|NCT04619706|Antiviral Agents|antiviral agents|mesh-ancestor
64916702|NCT04619706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64916703|NCT04619706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64916704|NCT04619706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64916705|NCT04619706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64916706|NCT04619706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916707|NCT04619706|Hormones|hormones|mesh-ancestor
64916708|NCT04619706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64916709|NCT00091429|Ranolazine|ranolazine|mesh-list
64916710|NCT00091429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64916711|NCT00091429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64916712|NCT00091429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916713|NCT00091468|Nicotine|nicotine|mesh-list
64916714|NCT00091468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64916715|NCT00091468|Autonomic Agents|autonomic agents|mesh-ancestor
64916716|NCT00091468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64916717|NCT00091468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916718|NCT00091468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64916719|NCT00091468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64916720|NCT00091468|Cholinergic Agents|cholinergic agents|mesh-ancestor
64916721|NCT00091468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64916722|NCT00091468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916723|NCT00006200|Thalidomide|thalidomide|mesh-list
64916724|NCT00006200|Dacarbazine|dacarbazine|mesh-list
64916725|NCT00006200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64916726|NCT00006200|Immunologic Factors|immunologic factors|mesh-ancestor
64916727|NCT00006200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916728|NCT00006200|Leprostatic Agents|leprostatic agents|mesh-ancestor
64916729|NCT00006200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64916730|NCT00006200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64916759|NCT00006206|Acamprosate|acamprosate|mesh-list
64916760|NCT00006206|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64916761|NCT00006206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64525615|NCT04050540|Doxycycline|doxycycline|mesh-list
64525616|NCT04050540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64525617|NCT04050540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64525618|NCT04050540|Antimalarials|antimalarials|mesh-ancestor
64525619|NCT04050540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64525620|NCT04050540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64525621|NCT03167268|Lycopene|lycopene|mesh-list
64525622|NCT03167268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64525623|NCT03167268|Antioxidants|antioxidants|mesh-ancestor
64525624|NCT03167268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916762|NCT00006206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916763|NCT00006206|Sensory System Agents|sensory system agents|mesh-ancestor
64916764|NCT00006206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64916765|NCT00091702|Vaccines|vaccines|mesh-list
64916766|NCT00091702|Immunologic Factors|immunologic factors|mesh-ancestor
64916767|NCT00091702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916768|NCT00091741|Etanercept|etanercept|mesh-list
64916769|NCT00091741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64916770|NCT00091741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64916771|NCT00091741|Analgesics|analgesics|mesh-ancestor
64916772|NCT00091741|Sensory System Agents|sensory system agents|mesh-ancestor
64916773|NCT00091741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64916774|NCT00091741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916775|NCT00091741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64916776|NCT00091741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64916777|NCT00091741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64916812|NCT00091936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64916813|NCT00091936|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64916814|NCT00091936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64916815|NCT00091936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64916816|NCT00091936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64916817|NCT00091936|Antimetabolites|antimetabolites|mesh-ancestor
64916852|NCT00092326|Acetaminophen|acetaminophen|mesh-list
64916853|NCT00092326|Rofecoxib|rofecoxib|mesh-list
64916854|NCT00092326|Oxycodone|oxycodone|mesh-list
64916855|NCT00092326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64916856|NCT00092326|Analgesics|analgesics|mesh-ancestor
64916857|NCT00092326|Sensory System Agents|sensory system agents|mesh-ancestor
64916858|NCT00092326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64916859|NCT00092326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916890|NCT04728880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916891|NCT04728880|Antiviral Agents|antiviral agents|mesh-ancestor
64916892|NCT04728880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64916893|NCT00093028|Bortezomib|bortezomib|mesh-list
64916894|NCT00093028|Lenalidomide|lenalidomide|mesh-list
64685357|NCT03962725|Ketamine|ketamine|mesh-list
64916895|NCT00093028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916896|NCT00093028|Immunologic Factors|immunologic factors|mesh-ancestor
64916897|NCT00093028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525632|NCT04544098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525634|NCT04485052|Decitabine|decitabine|mesh-list
64525635|NCT04485052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64525636|NCT04485052|Antimetabolites|antimetabolites|mesh-ancestor
64525637|NCT04485052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525638|NCT04485052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525639|NCT04485052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64525640|NCT02393898|Paclitaxel|paclitaxel|mesh-list
64525641|NCT02393898|Bevacizumab|bevacizumab|mesh-list
64525642|NCT02393898|Carboplatin|carboplatin|mesh-list
64525643|NCT02393898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64525644|NCT02393898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525645|NCT02393898|Tubulin Modulators|tubulin modulators|mesh-ancestor
64525646|NCT02393898|Antimitotic Agents|antimitotic agents|mesh-ancestor
64525647|NCT02393898|Mitosis Modulators|mitosis modulators|mesh-ancestor
64525648|NCT02393898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525649|NCT02393898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64525650|NCT02393898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64525651|NCT02393898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64916898|NCT00093028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64916899|NCT00093028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64916900|NCT00093028|Growth Substances|growth substances|mesh-ancestor
64916941|NCT00093301|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64916942|NCT00093301|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64916943|NCT00093301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916944|NCT00093301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916945|NCT00093301|Protective Agents|protective agents|mesh-ancestor
64916975|NCT00093652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64916977|NCT00093652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916979|NCT00006230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916980|NCT00006230|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64916981|NCT00006230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64916982|NCT00006230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916983|NCT00006230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916984|NCT00093769|Rituximab|rituximab|mesh-list
64916985|NCT00093769|Bortezomib|bortezomib|mesh-list
64916986|NCT00093769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64916987|NCT00093769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916988|NCT00093769|Immunologic Factors|immunologic factors|mesh-ancestor
64916989|NCT00093769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525652|NCT02393898|Growth Substances|growth substances|mesh-ancestor
64525653|NCT02393898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525654|NCT02393898|Growth Inhibitors|growth inhibitors|mesh-ancestor
64525655|NCT04340128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
64525656|NCT04340128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64525657|NCT04340128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64525658|NCT04340128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64525659|NCT04258852|Nicotine|nicotine|mesh-list
64525660|NCT04258852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64525661|NCT04258852|Autonomic Agents|autonomic agents|mesh-ancestor
64525662|NCT04258852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64525663|NCT04258852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525664|NCT04258852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64525665|NCT04258852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64525666|NCT04258852|Cholinergic Agents|cholinergic agents|mesh-ancestor
64525667|NCT04258852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64525668|NCT04258852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525669|NCT04145674|Methadone|methadone|mesh-list
64525670|NCT04145674|D-methadone|d-methadone|mesh-list
64525671|NCT04145674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64525672|NCT04145674|Narcotics|narcotics|mesh-ancestor
64525673|NCT04145674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64525674|NCT04145674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525675|NCT04145674|Analgesics|analgesics|mesh-ancestor
64525676|NCT04145674|Sensory System Agents|sensory system agents|mesh-ancestor
64916990|NCT00093769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64916991|NCT00400348|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
64917020|NCT02964715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64917021|NCT02964715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917023|NCT02964715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917024|NCT00093886|Clevidipine|clevidipine|mesh-list
64917025|NCT00093886|Nitroglycerin|nitroglycerin|mesh-list
64917026|NCT00093886|Vasodilator Agents|vasodilator agents|mesh-ancestor
64917027|NCT00093886|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64917028|NCT00093886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64917029|NCT00093886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917030|NCT00093886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64917031|NCT00093886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917077|NCT00006245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917078|NCT00094315|Cocaine|cocaine|mesh-list
64525678|NCT04145674|Antitussive Agents|antitussive agents|mesh-ancestor
64525679|NCT04145674|Respiratory System Agents|respiratory system agents|mesh-ancestor
64525680|NCT04145674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64525681|NCT02394054|Vasopressins|vasopressins|mesh-list
64525682|NCT02394054|Arginine Vasopressin|arginine vasopressin|mesh-list
64525683|NCT02394054|Hemostatics|hemostatics|mesh-ancestor
64525684|NCT02394054|Coagulants|coagulants|mesh-ancestor
64525685|NCT02394054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64917102|NCT00094432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917104|NCT00094432|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64917105|NCT00094432|Serotonin Agents|serotonin agents|mesh-ancestor
64917106|NCT00094432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64917107|NCT00094432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64917108|NCT00094432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64917109|NCT00094432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64917110|NCT00006248|Paclitaxel|paclitaxel|mesh-list
64917111|NCT00006248|Fluorouracil|fluorouracil|mesh-list
64917112|NCT00006248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64917113|NCT00006248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917114|NCT00006248|Tubulin Modulators|tubulin modulators|mesh-ancestor
64917115|NCT00006248|Antimitotic Agents|antimitotic agents|mesh-ancestor
64917116|NCT00006248|Mitosis Modulators|mitosis modulators|mesh-ancestor
64917117|NCT00006248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917118|NCT00006248|Antimetabolites|antimetabolites|mesh-ancestor
64917119|NCT00006248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64917120|NCT00006248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64917121|NCT00006248|Immunologic Factors|immunologic factors|mesh-ancestor
64917122|NCT00006248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917123|NCT00094549|Valproic Acid|valproic acid|mesh-list
64917124|NCT00094549|Olanzapine|olanzapine|mesh-list
64917125|NCT00094549|Antiemetics|antiemetics|mesh-ancestor
64917126|NCT00094549|Autonomic Agents|autonomic agents|mesh-ancestor
64917198|NCT00095134|Serotonin Agents|serotonin agents|mesh-ancestor
64611201|NCT00373126|Nicotine|nicotine|mesh-list
64917199|NCT00095134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64917200|NCT00095134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917201|NCT00095134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917202|NCT00095134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64917203|NCT00095134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64917240|NCT00095251|Autonomic Agents|autonomic agents|mesh-ancestor
64917241|NCT00095251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64917273|NCT00006263|Temozolomide|temozolomide|mesh-list
64917274|NCT00006263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917275|NCT00006263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64917276|NCT00006263|Alkylating Agents|alkylating agents|mesh-ancestor
64917277|NCT00006263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917278|NCT00095524|Aripiprazole|aripiprazole|mesh-list
64917279|NCT00095524|Antidepressive Agents|antidepressive agents|mesh-ancestor
64917280|NCT00095524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64917281|NCT00095524|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64917282|NCT00095524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64917283|NCT00095524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64917284|NCT00095524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649719|NCT03608696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917318|NCT04476030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64917319|NCT04476030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917320|NCT04476030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64917321|NCT04476030|Serotonin Agents|serotonin agents|mesh-ancestor
64917322|NCT04476030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525686|NCT02394054|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64525687|NCT02394054|Natriuretic Agents|natriuretic agents|mesh-ancestor
64525688|NCT02394054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525689|NCT02393664|Bupivacaine|bupivacaine|mesh-list
64649730|NCT01334723|Hormone Antagonists|hormone antagonists|mesh-ancestor
64525691|NCT02393664|Sevoflurane|sevoflurane|mesh-list
64525692|NCT02393664|Rocuronium|rocuronium|mesh-list
64525693|NCT02393664|Anesthetics, Local|anesthetics, local|mesh-ancestor
64525694|NCT02393664|Anesthetics|anesthetics|mesh-ancestor
64525695|NCT02393664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64525696|NCT02393664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525697|NCT02393664|Sensory System Agents|sensory system agents|mesh-ancestor
64525698|NCT02393664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64525699|NCT02393664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64525700|NCT02393664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64525701|NCT02393664|Anesthetics, General|anesthetics, general|mesh-ancestor
64525702|NCT02393664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64525703|NCT02393664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64525704|NCT02393664|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64525705|NCT02393664|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64734656|NCT04182984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64734657|NCT04182984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64321142|NCT05261971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64734658|NCT04182984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734659|NCT04182984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64734660|NCT04182984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64734661|NCT04182984|Antitubercular Agents|antitubercular agents|mesh-ancestor
64734662|NCT04182984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64734663|NCT04182984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64611272|NCT00939211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64611273|NCT00939211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525706|NCT02393664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64525707|NCT02397642|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64525708|NCT02397642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64917323|NCT04476030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64917324|NCT04476030|Antidepressive Agents|antidepressive agents|mesh-ancestor
64917325|NCT04476030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64917326|NCT04476030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64917327|NCT04476030|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64917328|NCT04476030|Analgesics|analgesics|mesh-ancestor
64917329|NCT04476030|Sensory System Agents|sensory system agents|mesh-ancestor
64917330|NCT04476030|Dopamine Agents|dopamine agents|mesh-ancestor
64917331|NCT00095680|Bortezomib|bortezomib|mesh-list
64917332|NCT00095680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917333|NCT00095719|Aripiprazole|aripiprazole|mesh-list
64917360|NCT00095758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64917361|NCT00095758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917362|NCT00095758|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64917363|NCT00095758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64917364|NCT00095758|Serotonin Agents|serotonin agents|mesh-ancestor
64917365|NCT00095758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64917366|NCT00095758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64917367|NCT00095758|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64917368|NCT00095758|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64917369|NCT00095914|Paclitaxel|paclitaxel|mesh-list
64525709|NCT02397642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525712|NCT02397486|Vitamins|vitamins|mesh-ancestor
64525713|NCT02397486|Micronutrients|micronutrients|mesh-ancestor
64525714|NCT02397486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525715|NCT02397486|Antioxidants|antioxidants|mesh-ancestor
64525716|NCT02397486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525717|NCT02397486|Protective Agents|protective agents|mesh-ancestor
64917370|NCT00095914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64917371|NCT00095914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64917373|NCT00095914|Tubulin Modulators|tubulin modulators|mesh-ancestor
64917374|NCT00095914|Antimitotic Agents|antimitotic agents|mesh-ancestor
64917375|NCT00095914|Mitosis Modulators|mitosis modulators|mesh-ancestor
64917376|NCT00095914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917377|NCT04432428|Sufentanil|sufentanil|mesh-list
64917378|NCT04432428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64917379|NCT04432428|Narcotics|narcotics|mesh-ancestor
64917380|NCT04432428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64917415|NCT00096148|Idarubicin|idarubicin|mesh-list
64917416|NCT00096148|Antibodies|antibodies|mesh-list
64917417|NCT00096148|Immunoglobulins|immunoglobulins|mesh-list
64917418|NCT00096148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64917419|NCT00096148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685886|NCT01777945|Antimetabolites|antimetabolites|mesh-ancestor
64917420|NCT00096148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64917421|NCT00096148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64917451|NCT00096304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64917452|NCT00096304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917453|NCT00096343|Paclitaxel|paclitaxel|mesh-list
64917454|NCT00096343|Carboplatin|carboplatin|mesh-list
64917455|NCT00096343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64917456|NCT00096343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917457|NCT00096343|Tubulin Modulators|tubulin modulators|mesh-ancestor
64917458|NCT00096343|Antimitotic Agents|antimitotic agents|mesh-ancestor
64917459|NCT00096343|Mitosis Modulators|mitosis modulators|mesh-ancestor
64917460|NCT00096343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917461|NCT00096616|Albuterol|albuterol|mesh-list
64917462|NCT00096616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64917463|NCT00096616|Autonomic Agents|autonomic agents|mesh-ancestor
64734671|NCT02044302|Morphine|morphine|mesh-list
64917464|NCT00096616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64917465|NCT00096616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917466|NCT00096616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64917494|NCT00006299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685955|NCT02452931|Leuprolide|leuprolide|mesh-list
64917495|NCT00006299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64917496|NCT00006299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64917497|NCT00006299|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64917498|NCT00006299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64917499|NCT00006299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917500|NCT00006299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917501|NCT00096811|Entecavir|entecavir|mesh-list
64917502|NCT00096811|Antiviral Agents|antiviral agents|mesh-ancestor
64917503|NCT00096811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917504|NCT00096850|Ritonavir|ritonavir|mesh-list
64917505|NCT00096850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64917506|NCT00096850|Rifampin|rifampin|mesh-list
64917507|NCT00096850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64917508|NCT00096850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64917509|NCT00096850|Protease Inhibitors|protease inhibitors|mesh-ancestor
64917510|NCT00096850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917511|NCT00096850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917512|NCT00096850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64917543|NCT00097045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917544|NCT00097045|Antiviral Agents|antiviral agents|mesh-ancestor
64917545|NCT00097045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917546|NCT00097045|Antimetabolites|antimetabolites|mesh-ancestor
64917547|NCT00097045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917548|NCT00097084|Insulin|insulin|mesh-list
64525719|NCT02397486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64525720|NCT02397486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64525721|NCT02397486|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64525722|NCT02397486|Vasodilator Agents|vasodilator agents|mesh-ancestor
64525723|NCT02397486|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64525724|NCT02393586|Amoxicillin|amoxicillin|mesh-list
64525725|NCT02393586|Rifampin|rifampin|mesh-list
64525726|NCT02393586|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64525727|NCT02393586|Clavulanic Acids|clavulanic acids|mesh-list
64525728|NCT02393586|Clavulanic Acid|clavulanic acid|mesh-list
64525729|NCT02393586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64525730|NCT02393586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64525731|NCT02393586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64525732|NCT02393586|Antitubercular Agents|antitubercular agents|mesh-ancestor
64525734|NCT02393586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64525735|NCT02393586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649732|NCT01334723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917551|NCT00097084|Insulin Aspart|insulin aspart|mesh-list
64917552|NCT00097084|Insulin Detemir|insulin detemir|mesh-list
64917553|NCT00097084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64917554|NCT00097084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917555|NCT04310709|Nivolumab|nivolumab|mesh-list
64917556|NCT04310709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64917586|NCT00097318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917587|NCT00097318|Immunologic Factors|immunologic factors|mesh-ancestor
64917588|NCT00097318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917589|NCT00097318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64917590|NCT00097435|Ribavirin|ribavirin|mesh-list
64917591|NCT00097435|Antimetabolites|antimetabolites|mesh-ancestor
64917592|NCT00097435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917593|NCT00097435|Antiviral Agents|antiviral agents|mesh-ancestor
64917594|NCT00097435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917595|NCT00006326|Ritonavir|ritonavir|mesh-list
64917596|NCT00006326|Indinavir|indinavir|mesh-list
64917597|NCT00006326|Delavirdine|delavirdine|mesh-list
64917598|NCT00006326|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64917599|NCT00006326|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64917600|NCT00006326|Protease Inhibitors|protease inhibitors|mesh-ancestor
64917601|NCT00006326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917602|NCT00006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917603|NCT00006326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64917604|NCT00006326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64917605|NCT00006326|Antiviral Agents|antiviral agents|mesh-ancestor
64917640|NCT00400387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64917641|NCT00400387|Dermatologic Agents|dermatologic agents|mesh-ancestor
64917642|NCT00400387|Antioxidants|antioxidants|mesh-ancestor
64917643|NCT00400387|Protective Agents|protective agents|mesh-ancestor
64917644|NCT00400387|Hematinics|hematinics|mesh-ancestor
64917645|NCT00006332|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
64917646|NCT00006332|Chelating Agents|chelating agents|mesh-ancestor
64525740|NCT02393586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64525741|NCT02393586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64525742|NCT02393586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64525744|NCT02393430|Rebamipide|rebamipide|mesh-list
64525745|NCT02393430|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64525746|NCT02393430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64525747|NCT02393430|Antioxidants|antioxidants|mesh-ancestor
64525748|NCT02393430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525749|NCT02393430|Protective Agents|protective agents|mesh-ancestor
64525750|NCT02393430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525751|NCT02393430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64525752|NCT03453892|Pembrolizumab|pembrolizumab|mesh-list
64525753|NCT03453892|Nivolumab|nivolumab|mesh-list
64525754|NCT03453892|Ipilimumab|ipilimumab|mesh-list
64917647|NCT00006332|Sequestering Agents|sequestering agents|mesh-ancestor
64917648|NCT00006332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917649|NCT00006332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917650|NCT00006332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64917651|NCT00006332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64917683|NCT04294836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64917684|NCT04294836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64917685|NCT04294836|Analgesics|analgesics|mesh-ancestor
64917686|NCT04294836|Sensory System Agents|sensory system agents|mesh-ancestor
64917687|NCT04294836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64917688|NCT04294836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917689|NCT04294836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64917690|NCT04294836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64917691|NCT04294836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917692|NCT04294836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917719|NCT00098605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917721|NCT04290546|Ipilimumab|ipilimumab|mesh-list
64917722|NCT04290546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64649733|NCT01334723|Urological Agents|urological agents|mesh-ancestor
64917728|NCT00098683|Protective Agents|protective agents|mesh-ancestor
64917729|NCT00098683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917730|NCT00098800|Fenretinide|fenretinide|mesh-list
64917731|NCT00098800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917732|NCT00098800|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64917733|NCT00098800|Protective Agents|protective agents|mesh-ancestor
64917734|NCT00098800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917735|NCT00098878|Carboplatin|carboplatin|mesh-list
64917736|NCT00098878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917737|NCT03633305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64917738|NCT03633305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64917769|NCT00099502|Glatiramer Acetate|glatiramer acetate|mesh-list
64917770|NCT00099502|Interferon beta-1b|interferon beta-1b|mesh-list
64917771|NCT00099502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917772|NCT00099502|Antiviral Agents|antiviral agents|mesh-ancestor
64917773|NCT00099502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917774|NCT00099502|Immunologic Factors|immunologic factors|mesh-ancestor
64917775|NCT00099502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525756|NCT03453892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525757|NCT03453892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64525758|NCT03453892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525760|NCT00367120|Azithromycin|azithromycin|mesh-list
64525761|NCT00367120|Clavulanic Acid|clavulanic acid|mesh-list
64525762|NCT00367120|Clavulanic Acids|clavulanic acids|mesh-list
64525763|NCT00367120|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64525764|NCT00367120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64525765|NCT00367120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64525766|NCT00367120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64525767|NCT00367120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734680|NCT02044302|Sensory System Agents|sensory system agents|mesh-ancestor
64525768|NCT00367120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525770|NCT03103750|Amphetamine|amphetamine|mesh-list
64525771|NCT03103750|Dextroamphetamine|dextroamphetamine|mesh-list
64525772|NCT03103750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64525773|NCT03103750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917776|NCT00099502|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64917777|NCT00099502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64917778|NCT00099502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64917779|NCT00387920|Sunitinib|sunitinib|mesh-list
64917780|NCT00387920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917781|NCT00387920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64917782|NCT00387920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64917783|NCT00387920|Growth Substances|growth substances|mesh-ancestor
64917812|NCT00006350|Antitubercular Agents|antitubercular agents|mesh-ancestor
64917813|NCT00006350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64917814|NCT00006350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917815|NCT00400582|Candesartan|candesartan|mesh-list
64917816|NCT00400582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64917817|NCT00400582|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64917818|NCT00400582|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64917819|NCT00400582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917820|NCT00400621|Acetaminophen|acetaminophen|mesh-list
64917821|NCT00400621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64917822|NCT00400621|Analgesics|analgesics|mesh-ancestor
64917823|NCT00400621|Sensory System Agents|sensory system agents|mesh-ancestor
64917824|NCT00400621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64917825|NCT00400621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917826|NCT00400621|Antipyretics|antipyretics|mesh-ancestor
64917827|NCT00006353|Temozolomide|temozolomide|mesh-list
64917853|NCT00099619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917854|NCT00099619|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64917855|NCT00099619|Incretins|incretins|mesh-ancestor
64917856|NCT00099619|Hormones|hormones|mesh-ancestor
64649739|NCT04311710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734686|NCT02044302|Cholinergic Agents|cholinergic agents|mesh-ancestor
64734687|NCT02044302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64734688|NCT02062944|Sirolimus|sirolimus|mesh-list
64734689|NCT02062944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64734690|NCT02062944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64734691|NCT02062944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64734692|NCT02062944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64734693|NCT02062944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734694|NCT02062944|Antifungal Agents|antifungal agents|mesh-ancestor
64734695|NCT02062944|Immunologic Factors|immunologic factors|mesh-ancestor
64611519|NCT03403439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64611520|NCT03403439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611521|NCT03403439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611522|NCT03403439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64611523|NCT03403439|Hormone Antagonists|hormone antagonists|mesh-ancestor
64917860|NCT00006359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64525775|NCT03103750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64525776|NCT03103750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525777|NCT03103750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64525778|NCT03103750|Vitamins|vitamins|mesh-ancestor
64525779|NCT03103750|Micronutrients|micronutrients|mesh-ancestor
64525780|NCT03103750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64525781|NCT03103750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64525782|NCT03103750|Sympathomimetics|sympathomimetics|mesh-ancestor
64525783|NCT03103750|Autonomic Agents|autonomic agents|mesh-ancestor
64525784|NCT03103750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64525785|NCT03103750|Dopamine Agents|dopamine agents|mesh-ancestor
64525786|NCT03103750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64525787|NCT03103750|Adrenergic Agents|adrenergic agents|mesh-ancestor
64525788|NCT03103750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64525789|NCT03103750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64917861|NCT00006359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917862|NCT00099736|Cyclosporine|cyclosporine|mesh-list
64917863|NCT00099736|Cyclosporins|cyclosporins|mesh-list
64917864|NCT00099736|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64917865|NCT00099736|Antifungal Agents|antifungal agents|mesh-ancestor
64917866|NCT00099736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917867|NCT00099736|Dermatologic Agents|dermatologic agents|mesh-ancestor
64917868|NCT00099736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917869|NCT00099736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917870|NCT00099736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64917871|NCT00099736|Immunologic Factors|immunologic factors|mesh-ancestor
64917872|NCT00099736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917873|NCT00099736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64917874|NCT00099736|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64917875|NCT00099736|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64917877|NCT04143711|Nivolumab|nivolumab|mesh-list
64917878|NCT04143711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64917892|NCT00006362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917893|NCT00099892|Vildagliptin|vildagliptin|mesh-list
64917894|NCT00099892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64917895|NCT00099892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917896|NCT00099892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64917897|NCT00099892|Protease Inhibitors|protease inhibitors|mesh-ancestor
64917898|NCT00099892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917899|NCT00099892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917900|NCT00099931|Vildagliptin|vildagliptin|mesh-list
64917901|NCT00099931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64917902|NCT00099931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917903|NCT00099931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64917904|NCT00099931|Protease Inhibitors|protease inhibitors|mesh-ancestor
64917905|NCT00099931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917906|NCT00099931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917907|NCT00099970|Dacarbazine|dacarbazine|mesh-list
64917908|NCT00099970|Volociximab|volociximab|mesh-list
64917909|NCT00099970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64917910|NCT00099970|Alkylating Agents|alkylating agents|mesh-ancestor
64917911|NCT00099970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917912|NCT00099970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917913|NCT00099970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64525790|NCT03103750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64525792|NCT02397330|Bupivacaine|bupivacaine|mesh-list
64525793|NCT02397330|Anesthetics, Local|anesthetics, local|mesh-ancestor
64525794|NCT02397330|Anesthetics|anesthetics|mesh-ancestor
64525795|NCT02397330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64525796|NCT02397330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525797|NCT02397330|Sensory System Agents|sensory system agents|mesh-ancestor
64525798|NCT02397330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64525799|NCT02397330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64917916|NCT00099970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917917|NCT00099970|Growth Inhibitors|growth inhibitors|mesh-ancestor
64917918|NCT00100009|Triamcinolone|triamcinolone|mesh-list
64917919|NCT00100009|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64917920|NCT00100009|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64917921|NCT00100009|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64917922|NCT00100009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64917923|NCT00100009|Glucocorticoids|glucocorticoids|mesh-ancestor
64917924|NCT00100009|Hormones|hormones|mesh-ancestor
64917925|NCT00100009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64917926|NCT00100009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917927|NCT00100009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64917928|NCT00100009|Immunologic Factors|immunologic factors|mesh-ancestor
64917929|NCT00100009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917930|NCT00100009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917931|NCT00100126|Amoxicillin|amoxicillin|mesh-list
64917932|NCT00100126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64917933|NCT00100126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917934|NCT00100243|Abarelix|abarelix|mesh-list
64917935|NCT00100243|Hormone Antagonists|hormone antagonists|mesh-ancestor
64917936|NCT00100243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64917937|NCT00100243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917938|NCT04071756|Tazarotene|tazarotene|mesh-list
64917970|NCT00006371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64917971|NCT00006371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64917972|NCT00006371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917973|NCT00006371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917974|NCT00006371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64917975|NCT00006371|Hormone Antagonists|hormone antagonists|mesh-ancestor
64917976|NCT00006371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64917977|NCT00006371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917978|NCT00006371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64917979|NCT00006371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64917980|NCT00006371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918010|NCT00006374|Tubulin Modulators|tubulin modulators|mesh-ancestor
64918011|NCT00006374|Antimitotic Agents|antimitotic agents|mesh-ancestor
64918012|NCT00006374|Mitosis Modulators|mitosis modulators|mesh-ancestor
64918013|NCT00006374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525807|NCT03081052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64525808|NCT03081052|Respiratory System Agents|respiratory system agents|mesh-ancestor
64525809|NCT03081052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64525810|NCT03081052|Antioxidants|antioxidants|mesh-ancestor
64525811|NCT03081052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525812|NCT03081052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64525813|NCT03081052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64525814|NCT03081052|Vasodilator Agents|vasodilator agents|mesh-ancestor
64525815|NCT03081052|Gasotransmitters|gasotransmitters|mesh-ancestor
64525816|NCT03081052|Protective Agents|protective agents|mesh-ancestor
64525817|NCT02393196|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
64525818|NCT02393196|Plasma Substitutes|plasma substitutes|mesh-ancestor
64525819|NCT02393196|Blood Substitutes|blood substitutes|mesh-ancestor
64525820|NCT03015610|Lansoprazole|lansoprazole|mesh-list
64525821|NCT03015610|Dexlansoprazole|dexlansoprazole|mesh-list
64525822|NCT03015610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64525823|NCT03015610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64525824|NCT03015610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64918025|NCT00100750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64918062|NCT00006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918063|NCT00006380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918064|NCT00100906|Aldesleukin|aldesleukin|mesh-list
64918065|NCT00100906|Interleukin-2|interleukin-2|mesh-list
64918066|NCT00100906|Tretinoin|tretinoin|mesh-list
64918067|NCT00100906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918085|NCT00006383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64918087|NCT00006383|Tubulin Modulators|tubulin modulators|mesh-ancestor
64918088|NCT00006383|Antimitotic Agents|antimitotic agents|mesh-ancestor
64918089|NCT00006383|Mitosis Modulators|mitosis modulators|mesh-ancestor
64918090|NCT00006383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918091|NCT00100984|Enfuvirtide|enfuvirtide|mesh-list
64611626|NCT03402815|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64918092|NCT00100984|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64918093|NCT00100984|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64918094|NCT00100984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918095|NCT00100984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64918096|NCT00100984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64918097|NCT00100984|Antiviral Agents|antiviral agents|mesh-ancestor
64918098|NCT00100984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64918099|NCT00101062|Celecoxib|celecoxib|mesh-list
64918100|NCT00101062|Letrozole|letrozole|mesh-list
64918101|NCT00101062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918102|NCT00101062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64918103|NCT00101062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64918104|NCT00101062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918105|NCT00101062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918106|NCT00101062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64918107|NCT00101062|Hormone Antagonists|hormone antagonists|mesh-ancestor
64525826|NCT03015610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525828|NCT00422344|Everolimus|everolimus|mesh-list
64525829|NCT00422344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525830|NCT00422344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64525831|NCT00422344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64525832|NCT00422344|Growth Substances|growth substances|mesh-ancestor
64525833|NCT00422344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525834|NCT00422344|Growth Inhibitors|growth inhibitors|mesh-ancestor
64525835|NCT00422344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64918108|NCT00101062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64918109|NCT00101062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918142|NCT00101179|Antimetabolites|antimetabolites|mesh-ancestor
64918143|NCT00101179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918144|NCT00101179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918145|NCT00101179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918146|NCT00400777|Amlodipine|amlodipine|mesh-list
64918147|NCT00400777|Valsartan|valsartan|mesh-list
64918148|NCT00400777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64918149|NCT00400777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64918150|NCT00400777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64918176|NCT00400855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64918177|NCT00101296|Tipifarnib|tipifarnib|mesh-list
64918178|NCT00101296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918179|NCT00006398|Timolol|timolol|mesh-list
64649758|NCT01402427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918185|NCT00006398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918186|NCT00006398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64918187|NCT00006398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64918188|NCT00101335|Celecoxib|celecoxib|mesh-list
64918189|NCT00101335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64918190|NCT00101335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64918191|NCT00101335|Analgesics|analgesics|mesh-ancestor
64918192|NCT00101335|Sensory System Agents|sensory system agents|mesh-ancestor
64918193|NCT00101335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64918194|NCT00101335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918195|NCT00101335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64918223|NCT00101569|Antidepressive Agents|antidepressive agents|mesh-ancestor
64918224|NCT00101569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64918225|NCT00101569|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64918226|NCT00101569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64918227|NCT00101569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64918228|NCT00101569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918229|NCT00101569|Dopamine Agonists|dopamine agonists|mesh-ancestor
64918230|NCT00101569|Dopamine Agents|dopamine agents|mesh-ancestor
64918231|NCT00101569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64918232|NCT00101569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918233|NCT00101569|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64918234|NCT00101569|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64918235|NCT00101569|Serotonin Agents|serotonin agents|mesh-ancestor
64918236|NCT00101569|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64918237|NCT00101569|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64918238|NCT00101569|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64918239|NCT00101569|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64918252|NCT03991884|Immunologic Factors|immunologic factors|mesh-ancestor
64918253|NCT03991884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525837|NCT00422344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525838|NCT00422344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64525839|NCT00422344|Immunologic Factors|immunologic factors|mesh-ancestor
64525840|NCT02876302|Paclitaxel|paclitaxel|mesh-list
64525841|NCT02876302|Cyclophosphamide|cyclophosphamide|mesh-list
64525842|NCT02876302|Doxorubicin|doxorubicin|mesh-list
64525843|NCT02876302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64525844|NCT02876302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525845|NCT02876302|Tubulin Modulators|tubulin modulators|mesh-ancestor
64525846|NCT02876302|Antimitotic Agents|antimitotic agents|mesh-ancestor
64525847|NCT02876302|Mitosis Modulators|mitosis modulators|mesh-ancestor
64525848|NCT02876302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525849|NCT02876302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64525850|NCT02876302|Immunologic Factors|immunologic factors|mesh-ancestor
64525851|NCT02876302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525852|NCT02876302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64525853|NCT02876302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64525854|NCT02876302|Alkylating Agents|alkylating agents|mesh-ancestor
64918254|NCT03991884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64918255|NCT03991884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64918256|NCT03991884|Alkylating Agents|alkylating agents|mesh-ancestor
64918257|NCT03991884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918258|NCT03991884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918259|NCT03991884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64918260|NCT03991884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64918261|NCT03991884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64918262|NCT03991884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64918263|NCT03991884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918264|NCT03991884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64918265|NCT03991884|Glucocorticoids|glucocorticoids|mesh-ancestor
64918266|NCT03991884|Hormones|hormones|mesh-ancestor
64918267|NCT03991884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64918275|NCT03991884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64918277|NCT00101764|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64918278|NCT00101764|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64918279|NCT00101764|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64918280|NCT00101764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64918281|NCT00101764|Glucocorticoids|glucocorticoids|mesh-ancestor
64918282|NCT00101764|Hormones|hormones|mesh-ancestor
64918283|NCT00101764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64918284|NCT00101764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918303|NCT00101842|Antiviral Agents|antiviral agents|mesh-ancestor
64918304|NCT00101842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64918305|NCT00101842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64321144|NCT05261971|Sensory System Agents|sensory system agents|mesh-ancestor
64321145|NCT05261971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321146|NCT05261971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321147|NCT05261971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64321148|NCT05261971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64321149|NCT05261971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64321150|NCT05261971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64611758|NCT03871465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64611759|NCT03871465|Immunologic Factors|immunologic factors|mesh-ancestor
64918306|NCT00101842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64525855|NCT02876302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64525856|NCT02876302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64525857|NCT02876302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64525858|NCT02876302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64525859|NCT02876302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64525861|NCT00367276|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64525862|NCT00367276|Hormone Antagonists|hormone antagonists|mesh-ancestor
64918307|NCT00101842|Immunologic Factors|immunologic factors|mesh-ancestor
64918308|NCT00101842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918309|NCT00101842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64918310|NCT00101842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64918311|NCT00102115|Talaporfin|talaporfin|mesh-list
64918312|NCT00102115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918313|NCT00102115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64918314|NCT00102115|Dermatologic Agents|dermatologic agents|mesh-ancestor
64918315|NCT00102154|Gaboxadol|gaboxadol|mesh-list
64918316|NCT00102154|Analgesics|analgesics|mesh-ancestor
64918317|NCT00102154|Sensory System Agents|sensory system agents|mesh-ancestor
64918318|NCT00102154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64918319|NCT00102154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918320|NCT00102154|Anticonvulsants|anticonvulsants|mesh-ancestor
64918321|NCT00102154|GABA Agonists|gaba agonists|mesh-ancestor
64918322|NCT00102154|GABA Agents|gaba agents|mesh-ancestor
64918323|NCT00102154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64918324|NCT00102154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918325|NCT00102271|Oxypurinol|oxypurinol|mesh-list
64918326|NCT00102271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918327|NCT00102271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918328|NCT00102310|Z 338|z 338|mesh-list
64918329|NCT00102310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64918330|NCT00102310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918331|NCT00102310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918332|NCT00102310|Cholinergic Agents|cholinergic agents|mesh-ancestor
64918333|NCT00102310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64918334|NCT00102310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918335|NCT00102310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64918336|NCT00102388|Vildagliptin|vildagliptin|mesh-list
64918337|NCT00102388|Gliclazide|gliclazide|mesh-list
64918338|NCT00102388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64918339|NCT00102388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918340|NCT00102388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64918341|NCT00102388|Protease Inhibitors|protease inhibitors|mesh-ancestor
64918370|NCT00006428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64918371|NCT00006428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64918372|NCT00006428|Analgesics|analgesics|mesh-ancestor
64918380|NCT00006428|Adrenergic Agents|adrenergic agents|mesh-ancestor
64918381|NCT00006428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64918382|NCT00102661|Alemtuzumab|alemtuzumab|mesh-list
64918383|NCT00102661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64918384|NCT00102661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918385|NCT00102700|Gemcitabine|gemcitabine|mesh-list
64918386|NCT00102700|Beta-lapachone|beta-lapachone|mesh-list
64918387|NCT00102700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64918419|NCT00102856|Antioxidants|antioxidants|mesh-ancestor
64918420|NCT00102856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918421|NCT00102856|Protective Agents|protective agents|mesh-ancestor
64918422|NCT00102856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918423|NCT00102856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64918424|NCT00102856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64525864|NCT00367276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525865|NCT00367276|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64525866|NCT00367276|Diuretics|diuretics|mesh-ancestor
64525867|NCT00367276|Natriuretic Agents|natriuretic agents|mesh-ancestor
64525868|NCT02546986|Pembrolizumab|pembrolizumab|mesh-list
64525869|NCT02546986|Azacitidine|azacitidine|mesh-list
64525870|NCT02546986|Cc-486|cc-486|mesh-list
64525871|NCT02546986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64525872|NCT02546986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525873|NCT02546986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64525874|NCT02546986|Antimetabolites|antimetabolites|mesh-ancestor
64525875|NCT02546986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525876|NCT02546986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64525877|NCT02689206|Glycine|glycine|mesh-list
64525878|NCT02689206|Glycine Agents|glycine agents|mesh-ancestor
64525879|NCT02689206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64525880|NCT02689206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918425|NCT00102856|Dopamine Agonists|dopamine agonists|mesh-ancestor
64918426|NCT00102856|Dopamine Agents|dopamine agents|mesh-ancestor
64918427|NCT00102856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64918428|NCT00102856|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64918429|NCT00102856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918430|NCT00102856|Cholinergic Agents|cholinergic agents|mesh-ancestor
64918459|NCT00102973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918460|NCT00102973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64918461|NCT00102973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64918462|NCT00102973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64918463|NCT00102973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918464|NCT00102973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918465|NCT00103051|Gemcitabine|gemcitabine|mesh-list
64918466|NCT00103051|Gefitinib|gefitinib|mesh-list
64918467|NCT00103051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918468|NCT00103051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64918469|NCT00103051|Antimetabolites|antimetabolites|mesh-ancestor
64918470|NCT00103051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918471|NCT00103051|Antiviral Agents|antiviral agents|mesh-ancestor
64918472|NCT00103051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64918473|NCT00103051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918474|NCT00103051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64918476|NCT00103051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918477|NCT00103051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64918478|NCT00103168|Imatinib Mesylate|imatinib mesylate|mesh-list
64918479|NCT00103168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918507|NCT00103597|Fludrocortisone|fludrocortisone|mesh-list
64918509|NCT00103597|Antiemetics|antiemetics|mesh-ancestor
64525883|NCT01695239|Ixekizumab|ixekizumab|mesh-list
64525884|NCT01695239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64525885|NCT01695239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64525886|NCT01695239|Dermatologic Agents|dermatologic agents|mesh-ancestor
64525887|NCT02163694|Paclitaxel|paclitaxel|mesh-list
64525888|NCT02163694|Carboplatin|carboplatin|mesh-list
64525889|NCT02163694|Veliparib|veliparib|mesh-list
64525890|NCT02163694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64525891|NCT02163694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525892|NCT02163694|Tubulin Modulators|tubulin modulators|mesh-ancestor
64525893|NCT02163694|Antimitotic Agents|antimitotic agents|mesh-ancestor
64525894|NCT02163694|Mitosis Modulators|mitosis modulators|mesh-ancestor
64525895|NCT02163694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918517|NCT00103597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918518|NCT00103597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64918519|NCT00006449|Naltrexone|naltrexone|mesh-list
64918520|NCT00006449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64918521|NCT00006449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64918522|NCT00006449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918523|NCT00006449|Sensory System Agents|sensory system agents|mesh-ancestor
64918524|NCT00006449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64918525|NCT00103753|Deferiprone|deferiprone|mesh-list
64918526|NCT00103753|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64918557|NCT00103948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918558|NCT00103948|Nootropic Agents|nootropic agents|mesh-ancestor
64918559|NCT00006458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64918560|NCT00006458|Antibodies|antibodies|mesh-list
64918561|NCT00006458|Immunoglobulins|immunoglobulins|mesh-list
64918562|NCT00006458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64918563|NCT00006458|Immunologic Factors|immunologic factors|mesh-ancestor
64734700|NCT02062632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64734701|NCT02062632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734702|NCT02062632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64918564|NCT00006458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918565|NCT00006458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918566|NCT03879408|Acetaminophen|acetaminophen|mesh-list
64918567|NCT03879408|Naproxen|naproxen|mesh-list
64918568|NCT03879408|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64918569|NCT03879408|Hydrocodone|hydrocodone|mesh-list
64918570|NCT03879408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64918599|NCT00104260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64918600|NCT00104260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918601|NCT00104260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64918602|NCT00104260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918603|NCT00104260|Vasodilator Agents|vasodilator agents|mesh-ancestor
64918604|NCT00388076|Paclitaxel|paclitaxel|mesh-list
64918605|NCT00388076|Carboplatin|carboplatin|mesh-list
64918606|NCT00388076|Lapatinib|lapatinib|mesh-list
64918607|NCT00388076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64918608|NCT00388076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918609|NCT00388076|Tubulin Modulators|tubulin modulators|mesh-ancestor
64918610|NCT00388076|Antimitotic Agents|antimitotic agents|mesh-ancestor
64918611|NCT00388076|Mitosis Modulators|mitosis modulators|mesh-ancestor
64918612|NCT00388076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918613|NCT00388076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64918614|NCT00388076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918615|NCT00104689|Capecitabine|capecitabine|mesh-list
64918616|NCT00104689|Oxaliplatin|oxaliplatin|mesh-list
64918617|NCT00104689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64918684|NCT00401128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918685|NCT00401128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64918686|NCT00401128|Immunologic Factors|immunologic factors|mesh-ancestor
64525896|NCT02163694|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64525897|NCT02163694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64525900|NCT01587352|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64525901|NCT01587352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64525902|NCT01587352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525903|NCT00703222|Interleukin-2|interleukin-2|mesh-list
64525904|NCT00703222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525905|NCT00703222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64525906|NCT00703222|Analgesics|analgesics|mesh-ancestor
64525907|NCT00703222|Sensory System Agents|sensory system agents|mesh-ancestor
64525908|NCT00703222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64525909|NCT00703222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525910|NCT04449250|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
64525911|NCT04449250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64525912|NCT04449250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525913|NCT04449250|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64525914|NCT04449250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64525915|NCT04449250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64525916|NCT04449250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525917|NCT04449250|Dopamine Agents|dopamine agents|mesh-ancestor
64525918|NCT04449250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64525919|NCT04317430|Niclosamide|niclosamide|mesh-list
64525920|NCT04317430|Anticestodal Agents|anticestodal agents|mesh-ancestor
64525921|NCT04317430|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64525922|NCT04317430|Anthelmintics|anthelmintics|mesh-ancestor
64525923|NCT04317430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64525924|NCT04317430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64525925|NCT04317430|Antinematodal Agents|antinematodal agents|mesh-ancestor
64525926|NCT04277884|Firibastat|firibastat|mesh-list
64525927|NCT04277884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64525928|NCT03821272|Vaccines|vaccines|mesh-list
64525929|NCT03821272|Immunologic Factors|immunologic factors|mesh-ancestor
64525930|NCT03821272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525936|NCT00367822|Dopamine Agents|dopamine agents|mesh-ancestor
64525937|NCT00367822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64525938|NCT00367822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525939|NCT00367822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525940|NCT00367822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64525941|NCT00367822|Serotonin Agents|serotonin agents|mesh-ancestor
64525942|NCT03189706|Irinotecan|irinotecan|mesh-list
64918687|NCT00401128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918688|NCT00401128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64918689|NCT00401128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64918690|NCT00401167|Memantine|memantine|mesh-list
64918691|NCT00401167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64918692|NCT00401167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64918693|NCT00401167|Dopamine Agents|dopamine agents|mesh-ancestor
64918694|NCT00401167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64918695|NCT00401167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918719|NCT00104962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918720|NCT00006467|Gemcitabine|gemcitabine|mesh-list
64918721|NCT00006467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64918722|NCT00006467|Antimetabolites|antimetabolites|mesh-ancestor
64918723|NCT00006467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918724|NCT00006467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918725|NCT00006467|Antiviral Agents|antiviral agents|mesh-ancestor
64918726|NCT00006467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64918727|NCT00006467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918728|NCT00006467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64918729|NCT00006467|Immunologic Factors|immunologic factors|mesh-ancestor
64918730|NCT00006467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918731|NCT00105040|Levetiracetam|levetiracetam|mesh-list
64918732|NCT00105040|Anticonvulsants|anticonvulsants|mesh-ancestor
64918733|NCT00105040|Nootropic Agents|nootropic agents|mesh-ancestor
64918734|NCT00006470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64918735|NCT00006470|Vaccines|vaccines|mesh-list
64918736|NCT00006470|Antibodies|antibodies|mesh-list
64918737|NCT00006470|Immunoglobulins|immunoglobulins|mesh-list
64918738|NCT00006470|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64918739|NCT00006470|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
64918740|NCT00006470|Immunologic Factors|immunologic factors|mesh-ancestor
64918741|NCT00006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918742|NCT00006470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918743|NCT00105352|Glucagon|glucagon|mesh-list
64918746|NCT00105352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64918772|NCT00390624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64687236|NCT00558025|Dopamine Agonists|dopamine agonists|mesh-ancestor
64918773|NCT00390624|Respiratory System Agents|respiratory system agents|mesh-ancestor
64918775|NCT00006473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918776|NCT00006476|Suramin|suramin|mesh-list
64918777|NCT00006476|Antinematodal Agents|antinematodal agents|mesh-ancestor
64918778|NCT00006476|Anthelmintics|anthelmintics|mesh-ancestor
64918779|NCT00006476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64918780|NCT00006476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64918781|NCT00006476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918782|NCT00006476|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64918783|NCT00006476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64918784|NCT00105937|Fentanyl|fentanyl|mesh-list
64918785|NCT00105937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64918786|NCT00105937|Narcotics|narcotics|mesh-ancestor
64918787|NCT00105937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64918788|NCT00105937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918789|NCT00105937|Analgesics|analgesics|mesh-ancestor
64918790|NCT00105937|Sensory System Agents|sensory system agents|mesh-ancestor
64918791|NCT00105937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64525944|NCT03189706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64525946|NCT03189706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64525947|NCT03189706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525948|NCT03189706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525949|NCT03189706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64525950|NCT03189706|Alkylating Agents|alkylating agents|mesh-ancestor
64525951|NCT02643862|Omalizumab|omalizumab|mesh-list
64525952|NCT02643862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64525953|NCT02643862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64525954|NCT02643862|Respiratory System Agents|respiratory system agents|mesh-ancestor
64525955|NCT01694771|Tiotropium Bromide|tiotropium bromide|mesh-list
64525956|NCT01694771|Olodaterol|olodaterol|mesh-list
64525957|NCT01694771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64918792|NCT00105937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64918793|NCT00105937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64918794|NCT00105937|Anesthetics, General|anesthetics, general|mesh-ancestor
64918795|NCT00105937|Anesthetics|anesthetics|mesh-ancestor
64918796|NCT00006479|Leucovorin|leucovorin|mesh-list
64918797|NCT00006479|Fluorouracil|fluorouracil|mesh-list
64918830|NCT00106054|Vitamin B Complex|vitamin b complex|mesh-ancestor
64918831|NCT00106054|Vitamins|vitamins|mesh-ancestor
64918832|NCT00106054|Micronutrients|micronutrients|mesh-ancestor
64918833|NCT00106132|Triamcinolone|triamcinolone|mesh-list
64918834|NCT00106132|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64918835|NCT00106132|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64918836|NCT00106132|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64918837|NCT00106132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64918838|NCT00106132|Glucocorticoids|glucocorticoids|mesh-ancestor
64918839|NCT00106132|Hormones|hormones|mesh-ancestor
64918840|NCT00106132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64918841|NCT00106132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918879|NCT03809988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918880|NCT03809988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64918881|NCT03809988|Hormone Antagonists|hormone antagonists|mesh-ancestor
64918913|NCT00006485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64918914|NCT00106522|Methotrexate|methotrexate|mesh-list
64918915|NCT00106522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64918916|NCT00106522|Abortifacient Agents|abortifacient agents|mesh-ancestor
64918917|NCT00106522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64918918|NCT00106522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918919|NCT00106522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64918920|NCT00106522|Antimetabolites|antimetabolites|mesh-ancestor
64918921|NCT00106522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918922|NCT00106522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918956|NCT00401206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64918957|NCT00401206|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64918958|NCT00401206|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64918959|NCT00401206|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64918960|NCT00401206|Adrenergic Agents|adrenergic agents|mesh-ancestor
64918991|NCT03746106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918998|NCT03746106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64525958|NCT01694771|Autonomic Agents|autonomic agents|mesh-ancestor
64525959|NCT01694771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64525960|NCT01694771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525961|NCT01694771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64525962|NCT01694771|Respiratory System Agents|respiratory system agents|mesh-ancestor
64525963|NCT01694771|Parasympatholytics|parasympatholytics|mesh-ancestor
64525964|NCT01694771|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64525965|NCT01694771|Cholinergic Agents|cholinergic agents|mesh-ancestor
64525966|NCT01694771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64525967|NCT01694771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525968|NCT02651272|Macitentan|macitentan|mesh-list
64525969|NCT02651272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64525970|NCT02651272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64525971|NCT02651272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64525972|NCT02651272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64525973|NCT01582061|Pasireotide|pasireotide|mesh-list
64525974|NCT01582061|Hormones|hormones|mesh-ancestor
64525975|NCT01582061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64525976|NCT01582061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525977|NCT01693523|Minocycline|minocycline|mesh-list
64525978|NCT01693523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64525979|NCT01693523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64525980|NCT03924323|Citalopram|citalopram|mesh-list
64525981|NCT03924323|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64525982|NCT03924323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64525983|NCT03924323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64525984|NCT03924323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918999|NCT03746106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64919000|NCT03746106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64919001|NCT03746106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919002|NCT03746106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919003|NCT03746106|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64919004|NCT03746106|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64919005|NCT03746106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64919006|NCT00107107|Pramlintide|pramlintide|mesh-list
64919007|NCT00107107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64919008|NCT00107107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919029|NCT00107341|Paclitaxel|paclitaxel|mesh-list
64919030|NCT00107341|Carboplatin|carboplatin|mesh-list
64919031|NCT00107341|Bortezomib|bortezomib|mesh-list
64919032|NCT00107341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64919033|NCT00107341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64525985|NCT03924323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64525986|NCT03924323|Serotonin Agents|serotonin agents|mesh-ancestor
64525987|NCT03924323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612091|NCT03002974|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64525988|NCT03924323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64525989|NCT03924323|Antidepressive Agents|antidepressive agents|mesh-ancestor
64525990|NCT03924323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64919034|NCT00107341|Tubulin Modulators|tubulin modulators|mesh-ancestor
64919035|NCT00107341|Antimitotic Agents|antimitotic agents|mesh-ancestor
64919036|NCT00107341|Mitosis Modulators|mitosis modulators|mesh-ancestor
64919037|NCT00107341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919038|NCT00107419|Pemetrexed|pemetrexed|mesh-list
64919039|NCT00107419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919040|NCT00107419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919041|NCT00107419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919042|NCT00107419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64919043|NCT00107419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64919044|NCT03683667|Azithromycin|azithromycin|mesh-list
64919045|NCT03683667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64649803|NCT01472549|Disinfectants|disinfectants|mesh-ancestor
64919052|NCT00006578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64919053|NCT00006578|Protease Inhibitors|protease inhibitors|mesh-ancestor
64919054|NCT00006578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919055|NCT00006578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919056|NCT00006578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64919057|NCT00006578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64919058|NCT00006578|Antiviral Agents|antiviral agents|mesh-ancestor
64919059|NCT00006578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919060|NCT00006578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64919061|NCT00006578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64919062|NCT00006578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64919091|NCT00006617|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64919092|NCT00006617|Antitubercular Agents|antitubercular agents|mesh-ancestor
64919093|NCT00006617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64919094|NCT00006617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64919095|NCT00006617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64919096|NCT00006617|Protease Inhibitors|protease inhibitors|mesh-ancestor
64919097|NCT00107731|Valproic Acid|valproic acid|mesh-list
64919098|NCT00107731|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64919099|NCT00107731|Antidepressive Agents|antidepressive agents|mesh-ancestor
64919100|NCT00107731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64919101|NCT00107731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64919102|NCT00107731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64919103|NCT00107731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64919104|NCT00107731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919105|NCT00107731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919106|NCT00107731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919107|NCT00107731|Antimanic Agents|antimanic agents|mesh-ancestor
64919108|NCT00107731|Anticonvulsants|anticonvulsants|mesh-ancestor
64919109|NCT00107731|GABA Agents|gaba agents|mesh-ancestor
64919110|NCT00107731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64919111|NCT04712396|Itraconazole|itraconazole|mesh-list
64919112|NCT04712396|Antifungal Agents|antifungal agents|mesh-ancestor
64919144|NCT03667482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919145|NCT00107848|Modafinil|modafinil|mesh-list
64919146|NCT00107848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64919147|NCT00107848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919148|NCT00107848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64919149|NCT00107848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64919175|NCT00006695|Trace Elements|trace elements|mesh-ancestor
64919176|NCT00006695|Micronutrients|micronutrients|mesh-ancestor
64919177|NCT00108004|Pramlintide|pramlintide|mesh-list
64919178|NCT00108004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64919179|NCT00108004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919180|NCT00006734|Cyclophosphamide|cyclophosphamide|mesh-list
64525993|NCT01581281|Anticonvulsants|anticonvulsants|mesh-ancestor
64525994|NCT01581281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64525995|NCT01581281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64525996|NCT01581281|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64525997|NCT01581281|Antidepressive Agents|antidepressive agents|mesh-ancestor
64525998|NCT01581281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64525999|NCT01581281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64919182|NCT00006734|Doxorubicin|doxorubicin|mesh-list
64919183|NCT00006734|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64919184|NCT00006734|Etoposide|etoposide|mesh-list
64919185|NCT00006734|Vincristine|vincristine|mesh-list
64919186|NCT00006734|Lenograstim|lenograstim|mesh-list
64919187|NCT00006734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64612170|NCT00935311|Acetaminophen|acetaminophen|mesh-list
64919188|NCT00006734|Immunologic Factors|immunologic factors|mesh-ancestor
64919189|NCT00006734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919190|NCT00006734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64919191|NCT00006734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64919192|NCT00006734|Alkylating Agents|alkylating agents|mesh-ancestor
64919193|NCT00006734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919194|NCT00006734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649805|NCT00852644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64919228|NCT00108316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919229|NCT00108316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64919230|NCT00108316|Antidepressive Agents|antidepressive agents|mesh-ancestor
64919231|NCT00108316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64919232|NCT00108316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64919233|NCT00108316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64919234|NCT00108316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919235|NCT00108394|Pamidronate|pamidronate|mesh-list
64919236|NCT00108394|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64919237|NCT00108394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919238|NCT00108511|Gemfibrozil|gemfibrozil|mesh-list
64919239|NCT00108511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64919240|NCT00108511|Antimetabolites|antimetabolites|mesh-ancestor
64919241|NCT00108511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919242|NCT00108511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64919243|NCT00108511|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64919279|NCT03619551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919302|NCT00006890|Leprostatic Agents|leprostatic agents|mesh-ancestor
64919303|NCT00006890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64919304|NCT00006890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919305|NCT00006890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64919306|NCT00006890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64919307|NCT00006890|Growth Substances|growth substances|mesh-ancestor
64919308|NCT00006890|Growth Inhibitors|growth inhibitors|mesh-ancestor
64919310|NCT00108979|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64919311|NCT00108979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64919312|NCT00108979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64919313|NCT00108979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919314|NCT00108979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64919315|NCT00108979|Serotonin Agents|serotonin agents|mesh-ancestor
64919316|NCT00108979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919317|NCT00108979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64919318|NCT00108979|Antidepressive Agents|antidepressive agents|mesh-ancestor
64919319|NCT00108979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64919320|NCT03608397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64526000|NCT01581281|Analgesics|analgesics|mesh-ancestor
64526001|NCT01581281|Sensory System Agents|sensory system agents|mesh-ancestor
64526002|NCT01581281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526003|NCT01581281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64526004|NCT01581281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64526005|NCT01581281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64714106|NCT03054103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64526006|NCT01581281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526007|NCT01581281|Adrenergic Agents|adrenergic agents|mesh-ancestor
64526008|NCT01581281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64919321|NCT03608397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64919322|NCT03608397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64919323|NCT03608397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64919324|NCT03608397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919325|NCT03608397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64919326|NCT03608397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64919327|NCT03608397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919359|NCT00006929|Mitosis Modulators|mitosis modulators|mesh-ancestor
64919360|NCT00006929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919361|NCT00006929|Antinematodal Agents|antinematodal agents|mesh-ancestor
64919362|NCT00006929|Anthelmintics|anthelmintics|mesh-ancestor
64919363|NCT00006929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64649814|NCT01368263|Letrozole|letrozole|mesh-list
64919396|NCT00109408|Abortifacient Agents|abortifacient agents|mesh-ancestor
64919397|NCT00109408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64919398|NCT00109408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919399|NCT00109408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64919400|NCT00109408|Antimetabolites|antimetabolites|mesh-ancestor
64919401|NCT00109408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919402|NCT00109408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919403|NCT00109408|Dermatologic Agents|dermatologic agents|mesh-ancestor
64919404|NCT00109408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919405|NCT00109408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64919406|NCT00109408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64919407|NCT00109408|Immunologic Factors|immunologic factors|mesh-ancestor
64919408|NCT00109408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64919409|NCT00109408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64919410|NCT00109564|Acetylcholine|acetylcholine|mesh-list
64919411|NCT00109564|Nicotinic Agonists|nicotinic agonists|mesh-list
64919412|NCT00109564|Vasodilator Agents|vasodilator agents|mesh-ancestor
64919443|NCT00109993|Alemtuzumab|alemtuzumab|mesh-list
64919445|NCT00109993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64919446|NCT00109993|Prednisolone phosphate|prednisolone phosphate|mesh-list
64919447|NCT00109993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64919448|NCT00109993|Immunologic Factors|immunologic factors|mesh-ancestor
64919449|NCT00109993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919450|NCT00109993|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64919451|NCT00109993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919452|NCT00109993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919453|NCT00109993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64919454|NCT00109993|Antiemetics|antiemetics|mesh-ancestor
64919455|NCT00109993|Autonomic Agents|autonomic agents|mesh-ancestor
64919456|NCT00109993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64919492|NCT00110188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919493|NCT00110188|Antifungal Agents|antifungal agents|mesh-ancestor
64919494|NCT00110188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64919495|NCT00110188|Immunologic Factors|immunologic factors|mesh-ancestor
64919496|NCT00110188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919497|NCT00007202|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64526009|NCT01580969|Minocycline|minocycline|mesh-list
64526010|NCT01580969|Bevacizumab|bevacizumab|mesh-list
64526011|NCT01580969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64526012|NCT01580969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526013|NCT01580969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64526014|NCT01580969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64526015|NCT01580969|Growth Substances|growth substances|mesh-ancestor
64526016|NCT01580969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526017|NCT01580969|Growth Inhibitors|growth inhibitors|mesh-ancestor
64526018|NCT01580969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64526019|NCT01580969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64526020|NCT02696226|Aspirin|aspirin|mesh-list
64526021|NCT02696226|Warfarin|warfarin|mesh-list
64526022|NCT02696226|Clopidogrel|clopidogrel|mesh-list
64526023|NCT02696226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64526024|NCT02696226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64526025|NCT02696226|Analgesics|analgesics|mesh-ancestor
64526026|NCT02696226|Sensory System Agents|sensory system agents|mesh-ancestor
64526027|NCT02696226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526028|NCT02696226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526029|NCT02696226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64526030|NCT02696226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64526031|NCT02696226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64919523|NCT00401479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919524|NCT00401479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919525|NCT00110578|Aldesleukin|aldesleukin|mesh-list
64919526|NCT00110578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919527|NCT00110578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64919528|NCT00110578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64919529|NCT00110578|Antiviral Agents|antiviral agents|mesh-ancestor
64919530|NCT00110578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919537|NCT03434262|Antiviral Agents|antiviral agents|mesh-ancestor
64919538|NCT03434262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919539|NCT03434262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919540|NCT03434262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64919541|NCT03434262|Immunologic Factors|immunologic factors|mesh-ancestor
64919542|NCT03434262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919543|NCT03434262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64919544|NCT00388193|Rituximab|rituximab|mesh-list
64919545|NCT00388193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64919546|NCT00388193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919547|NCT00388193|Immunologic Factors|immunologic factors|mesh-ancestor
64919578|NCT00110773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64919579|NCT00110773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64919580|NCT00110773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64526032|NCT02696226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64526033|NCT02696226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526034|NCT02696226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64526035|NCT02696226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64380155|NCT05592171|Hormones|hormones|mesh-ancestor
64919581|NCT00110773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64919582|NCT00110773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64919583|NCT00110773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919584|NCT00110851|Metformin|metformin|mesh-list
64919585|NCT00110851|Rosiglitazone|rosiglitazone|mesh-list
64919586|NCT00110851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64919587|NCT00110851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919588|NCT00110929|Cinacalcet|cinacalcet|mesh-list
64919589|NCT00110929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64919590|NCT00110929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919606|NCT00111046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919608|NCT00111046|Narcotics|narcotics|mesh-ancestor
64919609|NCT00111046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64919610|NCT00388271|Alfuzosin|alfuzosin|mesh-list
64919611|NCT00388271|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64919612|NCT00388271|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64919613|NCT00388271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64919614|NCT00388271|Adrenergic Agents|adrenergic agents|mesh-ancestor
64919615|NCT00388271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64919616|NCT00388271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919617|NCT00388271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919618|NCT00388271|Urological Agents|urological agents|mesh-ancestor
64919619|NCT00111124|Etanercept|etanercept|mesh-list
64919620|NCT00111124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64919621|NCT00111124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64919622|NCT00111124|Analgesics|analgesics|mesh-ancestor
64919623|NCT00111124|Sensory System Agents|sensory system agents|mesh-ancestor
64919624|NCT00111124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64919625|NCT00111124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919626|NCT00111124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64919627|NCT00111124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64919628|NCT00111124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64919629|NCT00111124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64919630|NCT00111124|Immunologic Factors|immunologic factors|mesh-ancestor
64919631|NCT00111163|Artesunate|artesunate|mesh-list
64919632|NCT00111163|Pyrimethamine|pyrimethamine|mesh-list
64919633|NCT00111163|Sulfadoxine|sulfadoxine|mesh-list
64919634|NCT00111163|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64919635|NCT00111163|Amodiaquine|amodiaquine|mesh-list
64919636|NCT00111163|Dapsone|dapsone|mesh-list
64919637|NCT00111163|Chlorproguanil|chlorproguanil|mesh-list
64919638|NCT00111163|Antimalarials|antimalarials|mesh-ancestor
64919639|NCT00111163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64649827|NCT00815360|Triamcinolone|triamcinolone|mesh-list
64919645|NCT00111163|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64919646|NCT00111163|Anthelmintics|anthelmintics|mesh-ancestor
64919647|NCT00111163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64919648|NCT00111163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919649|NCT00111163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919678|NCT00111436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64919679|NCT00111436|Immunologic Factors|immunologic factors|mesh-ancestor
64919680|NCT00111631|Metformin|metformin|mesh-list
64919681|NCT00111631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64919682|NCT00111631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64919683|NCT00111631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919684|NCT00111631|Protease Inhibitors|protease inhibitors|mesh-ancestor
64919685|NCT00111631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919686|NCT00111631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919687|NCT00111670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64919688|NCT00111670|Protease Inhibitors|protease inhibitors|mesh-ancestor
64919689|NCT00111670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526037|NCT02696226|Antipyretics|antipyretics|mesh-ancestor
64526038|NCT02696226|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64526039|NCT02696226|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64526040|NCT02696226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64526041|NCT02696226|Purinergic Agents|purinergic agents|mesh-ancestor
64526042|NCT02696226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64526043|NCT02696226|Anticoagulants|anticoagulants|mesh-ancestor
64526044|NCT03167112|Leucovorin|leucovorin|mesh-list
64526045|NCT03167112|Fluorouracil|fluorouracil|mesh-list
64526046|NCT03167112|Oxaliplatin|oxaliplatin|mesh-list
64526047|NCT03167112|Irinotecan|irinotecan|mesh-list
64526048|NCT03167112|Antimetabolites|antimetabolites|mesh-ancestor
64526049|NCT03167112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526050|NCT03167112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64526051|NCT03167112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526052|NCT03167112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64526053|NCT03167112|Immunologic Factors|immunologic factors|mesh-ancestor
64526054|NCT03167112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526055|NCT03167112|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64526056|NCT03167112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64526057|NCT03167112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526058|NCT03167112|Antidotes|antidotes|mesh-ancestor
64526059|NCT03167112|Protective Agents|protective agents|mesh-ancestor
64526060|NCT03167112|Vitamin B Complex|vitamin b complex|mesh-ancestor
64919690|NCT00111670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919691|NCT00111670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64919692|NCT00111670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919693|NCT00111748|Thalidomide|thalidomide|mesh-list
64919694|NCT00111748|Dexamethasone|dexamethasone|mesh-list
64919695|NCT00111748|Bortezomib|bortezomib|mesh-list
64919696|NCT00111748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64919697|NCT00111748|Antiemetics|antiemetics|mesh-ancestor
64919715|NCT00111748|Growth Inhibitors|growth inhibitors|mesh-ancestor
64919717|NCT00111787|Lapatinib|lapatinib|mesh-list
64919718|NCT00111787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64919719|NCT00111787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919720|NCT00111787|Tubulin Modulators|tubulin modulators|mesh-ancestor
64919721|NCT00111787|Antimitotic Agents|antimitotic agents|mesh-ancestor
64919722|NCT00111787|Mitosis Modulators|mitosis modulators|mesh-ancestor
64919723|NCT00111787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919724|NCT00111787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64919725|NCT00111787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919726|NCT00111904|Paclitaxel|paclitaxel|mesh-list
64919727|NCT00111904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64919728|NCT00111904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919729|NCT00111904|Tubulin Modulators|tubulin modulators|mesh-ancestor
64919730|NCT00111904|Antimitotic Agents|antimitotic agents|mesh-ancestor
64919731|NCT00111904|Mitosis Modulators|mitosis modulators|mesh-ancestor
64612460|NCT03403205|Lipotropic Agents|lipotropic agents|mesh-ancestor
64612461|NCT03403205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64612462|NCT03403205|Antimetabolites|antimetabolites|mesh-ancestor
64612463|NCT03403205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919732|NCT00111904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649830|NCT00815360|Ranibizumab|ranibizumab|mesh-list
64526069|NCT01578785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64526070|NCT03167034|Acetazolamide|acetazolamide|mesh-list
64526071|NCT03167034|Anticonvulsants|anticonvulsants|mesh-ancestor
64526072|NCT03167034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64526073|NCT03167034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526074|NCT03167034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919735|NCT00111943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919736|NCT00111943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64919737|NCT00111943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64919738|NCT00111943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919739|NCT00111943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919740|NCT00111943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64919741|NCT00111943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64919743|NCT00401596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64919744|NCT00401596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64919745|NCT00401596|Respiratory System Agents|respiratory system agents|mesh-ancestor
64919746|NCT00401635|Carboplatin|carboplatin|mesh-list
64919747|NCT00401635|Doxorubicin|doxorubicin|mesh-list
64919748|NCT00401635|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64919749|NCT00401635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919750|NCT00401635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64919751|NCT00401635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64919752|NCT00401635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64919753|NCT00401635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919776|NCT00007358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919777|NCT00007358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64919778|NCT00007358|Glucocorticoids|glucocorticoids|mesh-ancestor
64649833|NCT00815360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64919779|NCT00007358|Hormones|hormones|mesh-ancestor
64919780|NCT00007358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64919781|NCT00007358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64919782|NCT00007358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919783|NCT00112138|Gabapentin|gabapentin|mesh-list
64919784|NCT00112138|Analgesics|analgesics|mesh-ancestor
64919785|NCT00112138|Sensory System Agents|sensory system agents|mesh-ancestor
64919786|NCT00112138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64919787|NCT00112138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919788|NCT00112138|Anticonvulsants|anticonvulsants|mesh-ancestor
64919789|NCT00112138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64919790|NCT00112138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64919791|NCT00112138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64919792|NCT00112138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64919793|NCT00112138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64919794|NCT00112138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64919795|NCT00112138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64919796|NCT00112138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919797|NCT00112138|Antimanic Agents|antimanic agents|mesh-ancestor
64919798|NCT03330639|Capsaicin|capsaicin|mesh-list
64919799|NCT03330639|Antipruritics|antipruritics|mesh-ancestor
64919800|NCT03330639|Dermatologic Agents|dermatologic agents|mesh-ancestor
64919801|NCT03330639|Sensory System Agents|sensory system agents|mesh-ancestor
64919802|NCT03330639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64919803|NCT03330639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526075|NCT03167034|Diuretics|diuretics|mesh-ancestor
64526076|NCT03167034|Natriuretic Agents|natriuretic agents|mesh-ancestor
64526077|NCT03167034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526078|NCT01578551|Metformin|metformin|mesh-list
64526079|NCT01578551|Biguanides|biguanides|mesh-list
64919834|NCT00112528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919836|NCT00112528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64919837|NCT00112528|Antimetabolites|antimetabolites|mesh-ancestor
64919838|NCT00112528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919839|NCT00112528|Antiviral Agents|antiviral agents|mesh-ancestor
64919840|NCT00112528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919841|NCT00112528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919842|NCT00112528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64919843|NCT00112528|Immunologic Factors|immunologic factors|mesh-ancestor
64919844|NCT00007592|Chlorthalidone|chlorthalidone|mesh-list
64919845|NCT00007592|Furosemide|furosemide|mesh-list
64919846|NCT00007592|Diuretics|diuretics|mesh-ancestor
64919847|NCT00007592|Natriuretic Agents|natriuretic agents|mesh-ancestor
64919848|NCT00007592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919849|NCT00007592|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64919850|NCT00007592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64919851|NCT00007592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919852|NCT00007592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64919853|NCT00007592|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64919854|NCT00007631|Tretinoin|tretinoin|mesh-list
64919855|NCT00007631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919856|NCT00007631|Keratolytic Agents|keratolytic agents|mesh-ancestor
64919857|NCT00007631|Dermatologic Agents|dermatologic agents|mesh-ancestor
64919885|NCT00112645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919886|NCT00112645|Dermatologic Agents|dermatologic agents|mesh-ancestor
64919887|NCT00112645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919888|NCT00112645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64919889|NCT00112645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64919890|NCT00112645|Immunologic Factors|immunologic factors|mesh-ancestor
64919891|NCT00112645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64919892|NCT00112645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64919893|NCT00112645|Antifungal Agents|antifungal agents|mesh-ancestor
64919894|NCT00112645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919895|NCT00112645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64919896|NCT00112645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64919897|NCT00112645|Antiemetics|antiemetics|mesh-ancestor
64919898|NCT00112645|Autonomic Agents|autonomic agents|mesh-ancestor
64919899|NCT00112645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64919900|NCT00112645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64919901|NCT00112645|Glucocorticoids|glucocorticoids|mesh-ancestor
64919902|NCT00112645|Hormones|hormones|mesh-ancestor
64919903|NCT00112645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64919904|NCT00112645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64919905|NCT00112645|Protective Agents|protective agents|mesh-ancestor
64919931|NCT00007670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64919932|NCT00007670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919933|NCT00007670|Antimanic Agents|antimanic agents|mesh-ancestor
64919934|NCT00007670|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64919935|NCT00007670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64919936|NCT00007670|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64526089|NCT01578551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64526090|NCT01578551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64526091|NCT01578551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64526092|NCT01578551|Growth Substances|growth substances|mesh-ancestor
64526093|NCT01578551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919937|NCT00007670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64919938|NCT00007670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64919939|NCT00007670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64919940|NCT00007670|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64919941|NCT00007670|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64919942|NCT00112879|Ascorbic Acid|ascorbic acid|mesh-list
64919943|NCT00112879|Thalidomide|thalidomide|mesh-list
64919944|NCT00112879|Dexamethasone|dexamethasone|mesh-list
64919945|NCT00112879|Arsenic Trioxide|arsenic trioxide|mesh-list
64919946|NCT00112879|Mitogens|mitogens|mesh-list
64919947|NCT00112879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64919948|NCT00112879|Antiemetics|antiemetics|mesh-ancestor
64919949|NCT00112879|Autonomic Agents|autonomic agents|mesh-ancestor
64919950|NCT00112879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64919951|NCT00112879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919952|NCT00112879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64919953|NCT00112879|Glucocorticoids|glucocorticoids|mesh-ancestor
64919954|NCT00112879|Hormones|hormones|mesh-ancestor
64919955|NCT00112879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64919985|NCT00113074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919987|NCT00113074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64919988|NCT00113074|Cholinergic Agents|cholinergic agents|mesh-ancestor
64919989|NCT00113074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64919990|NCT00113074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919991|NCT00113113|Rubitecan|rubitecan|mesh-list
64919992|NCT00113113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919993|NCT00113113|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64919994|NCT00113113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64919995|NCT00113113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919996|NCT00113113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919997|NCT00007787|Cyclosporine|cyclosporine|mesh-list
64919998|NCT00007787|Tacrolimus|tacrolimus|mesh-list
64919999|NCT00007787|Cyclosporins|cyclosporins|mesh-list
64920000|NCT00007787|Thymoglobulin|thymoglobulin|mesh-list
64920001|NCT00007787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64920002|NCT00007787|Immunologic Factors|immunologic factors|mesh-ancestor
64920003|NCT00007787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920033|NCT00113542|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
64920034|NCT00113542|Chelating Agents|chelating agents|mesh-ancestor
64920035|NCT00113542|Sequestering Agents|sequestering agents|mesh-ancestor
64920036|NCT00113542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920037|NCT00113542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920038|NCT00113542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64920039|NCT00113542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64920040|NCT00113542|Growth Substances|growth substances|mesh-ancestor
64920041|NCT00113542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920042|NCT00113542|Growth Inhibitors|growth inhibitors|mesh-ancestor
64920043|NCT00113542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920044|NCT00007826|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64920045|NCT00007826|Vaccines|vaccines|mesh-list
64526095|NCT01578551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64526096|NCT01692197|Cytarabine|cytarabine|mesh-list
64526097|NCT01692197|Dexamethasone|dexamethasone|mesh-list
64526098|NCT01692197|Idarubicin|idarubicin|mesh-list
64526099|NCT01692197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64526100|NCT01692197|Antiemetics|antiemetics|mesh-ancestor
64526101|NCT01692197|Autonomic Agents|autonomic agents|mesh-ancestor
64526102|NCT01692197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526103|NCT01692197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649856|NCT01368653|Nicotine|nicotine|mesh-list
64920077|NCT00113698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64920079|NCT00113737|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64920080|NCT00113737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64920081|NCT00113737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64920082|NCT00113737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920083|NCT00113737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64920084|NCT00113737|Serotonin Agents|serotonin agents|mesh-ancestor
64920085|NCT00113737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920086|NCT00113737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64920087|NCT00113737|Antidepressive Agents|antidepressive agents|mesh-ancestor
64920088|NCT00113737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64920089|NCT00113737|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64920090|NCT00113737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64920091|NCT00113737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920092|NCT03272295|Menthol|menthol|mesh-list
64920093|NCT03272295|Sorbitol|sorbitol|mesh-list
64920094|NCT03272295|Glycerol|glycerol|mesh-list
64920095|NCT03272295|Antipruritics|antipruritics|mesh-ancestor
64920096|NCT03272295|Dermatologic Agents|dermatologic agents|mesh-ancestor
64920097|NCT03272295|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64920098|NCT03272295|Protective Agents|protective agents|mesh-ancestor
64920129|NCT00007904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64920130|NCT00007904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64920131|NCT00007904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64920132|NCT00007904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64920133|NCT00113815|Topiramate|topiramate|mesh-list
64920134|NCT00113815|Anticonvulsants|anticonvulsants|mesh-ancestor
64920135|NCT00113815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64920136|NCT00113815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920137|NCT00113854|Mannitol|mannitol|mesh-list
64920138|NCT00113854|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64920139|NCT00113854|Diuretics|diuretics|mesh-ancestor
64920140|NCT00113854|Natriuretic Agents|natriuretic agents|mesh-ancestor
64920141|NCT00113854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920142|NCT00007943|Gemcitabine|gemcitabine|mesh-list
64920143|NCT00007943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64920176|NCT00007982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64920177|NCT00007982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64526106|NCT01692197|Hormones|hormones|mesh-ancestor
64526107|NCT01692197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64526108|NCT01692197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64526109|NCT01692197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526110|NCT01692197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64526112|NCT01692197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526113|NCT01692197|Antiviral Agents|antiviral agents|mesh-ancestor
64526114|NCT01692197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64526115|NCT01692197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64526116|NCT01692197|Immunologic Factors|immunologic factors|mesh-ancestor
64526117|NCT01692197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64526118|NCT01692197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64526119|NCT01692197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64526120|NCT01692197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526121|NCT03166644|Sufentanil|sufentanil|mesh-list
64920184|NCT00114205|Mitosis Modulators|mitosis modulators|mesh-ancestor
64920185|NCT00114205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920210|NCT00114400|Pyridoxine|pyridoxine|mesh-list
64920211|NCT00114400|Vitamin B Complex|vitamin b complex|mesh-list
64920212|NCT00114400|Micronutrients|micronutrients|mesh-ancestor
64920213|NCT00114400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920214|NCT00114400|Hematinics|hematinics|mesh-ancestor
64920215|NCT00114439|Lithium Carbonate|lithium carbonate|mesh-list
64920216|NCT00114439|Antidepressive Agents|antidepressive agents|mesh-ancestor
64920217|NCT00114439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64920218|NCT00114439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920219|NCT00114439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920220|NCT00114439|Antimanic Agents|antimanic agents|mesh-ancestor
64920221|NCT00114439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64920222|NCT00114439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64920223|NCT00114439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920224|NCT00114478|Epinephrine|epinephrine|mesh-list
64920225|NCT00114478|Albuterol|albuterol|mesh-list
64920226|NCT00114478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64920227|NCT00114478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64920228|NCT00114478|Adrenergic Agents|adrenergic agents|mesh-ancestor
64920229|NCT00114478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64920230|NCT00114478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920231|NCT00114478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920232|NCT00114478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64920233|NCT00114478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64920234|NCT00114478|Autonomic Agents|autonomic agents|mesh-ancestor
64526124|NCT03166644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64526125|NCT03166644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526126|NCT03166644|Analgesics|analgesics|mesh-ancestor
64526127|NCT03166644|Sensory System Agents|sensory system agents|mesh-ancestor
64526128|NCT03166644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526129|NCT03166644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64526130|NCT03166644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64526131|NCT03166644|Anesthetics, General|anesthetics, general|mesh-ancestor
64526132|NCT03166644|Anesthetics|anesthetics|mesh-ancestor
64526133|NCT01691885|Fluticasone|fluticasone|mesh-list
64526135|NCT01691885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64526136|NCT01691885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64526137|NCT01691885|Autonomic Agents|autonomic agents|mesh-ancestor
64526138|NCT01691885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526139|NCT01691885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526140|NCT01691885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64612730|NCT00929981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64321151|NCT05261971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734716|NCT02043366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64734717|NCT02043366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734718|NCT02043366|Analgesics|analgesics|mesh-ancestor
64526141|NCT01691885|Respiratory System Agents|respiratory system agents|mesh-ancestor
64526142|NCT01691885|Dermatologic Agents|dermatologic agents|mesh-ancestor
64526143|NCT01691885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64526144|NCT03166800|Ubiquinone|ubiquinone|mesh-list
64526145|NCT03166800|Micronutrients|micronutrients|mesh-ancestor
64920235|NCT00114478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64920236|NCT00114478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64920237|NCT00114478|Respiratory System Agents|respiratory system agents|mesh-ancestor
64920238|NCT00114478|Mydriatics|mydriatics|mesh-ancestor
64920239|NCT00114478|Sympathomimetics|sympathomimetics|mesh-ancestor
64920271|NCT03079440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64920273|NCT03079440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920274|NCT03079440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920275|NCT03079440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64920276|NCT03079440|Alkylating Agents|alkylating agents|mesh-ancestor
64920277|NCT04728178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64920278|NCT00008060|Leucovorin|leucovorin|mesh-list
64920279|NCT00008060|Fluorouracil|fluorouracil|mesh-list
64920280|NCT00008060|Oxaliplatin|oxaliplatin|mesh-list
64649867|NCT01407107|Vasodilator Agents|vasodilator agents|mesh-ancestor
64920315|NCT00114946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64920316|NCT00114946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64920317|NCT00114946|Growth Substances|growth substances|mesh-ancestor
64920318|NCT00114946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920319|NCT00114946|Growth Inhibitors|growth inhibitors|mesh-ancestor
64920320|NCT00115024|Estradiol|estradiol|mesh-list
64920321|NCT00115024|Estrogens|estrogens|mesh-ancestor
64920322|NCT00115024|Hormones|hormones|mesh-ancestor
64920323|NCT00115024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64920324|NCT00115024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920325|NCT00008177|Iodine|iodine|mesh-list
64526146|NCT03166800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526148|NCT03166254|Vaccines|vaccines|mesh-list
64526149|NCT03166254|Poly ICLC|poly iclc|mesh-list
64526150|NCT03166254|Immunologic Factors|immunologic factors|mesh-ancestor
64526151|NCT03166254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526152|NCT03166254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64526153|NCT03166254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526154|NCT03166254|Interferon Inducers|interferon inducers|mesh-ancestor
64526155|NCT02651428|Taurolidine|taurolidine|mesh-list
64526156|NCT02651428|Heparin|heparin|mesh-list
64714107|NCT03054103|GABA Modulators|gaba modulators|mesh-ancestor
64526157|NCT02651428|Calcium heparin|calcium heparin|mesh-list
64526158|NCT02651428|Anticoagulants|anticoagulants|mesh-ancestor
64714108|NCT03054103|GABA Agents|gaba agents|mesh-ancestor
64526159|NCT02651428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526160|NCT02651428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64526161|NCT02651428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64920326|NCT00008177|Cyclosporine|cyclosporine|mesh-list
64920327|NCT00008177|Mycophenolic Acid|mycophenolic acid|mesh-list
64920328|NCT00008177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64920329|NCT00008177|Fludarabine|fludarabine|mesh-list
64920330|NCT00008177|Fludarabine phosphate|fludarabine phosphate|mesh-list
64920331|NCT00008177|Antibodies|antibodies|mesh-list
64920332|NCT00008177|Immunoglobulins|immunoglobulins|mesh-list
64920333|NCT00008177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64920334|NCT00008177|Cyclosporins|cyclosporins|mesh-list
64920335|NCT00008177|Immunologic Factors|immunologic factors|mesh-ancestor
64920336|NCT00008177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920337|NCT00008177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920358|NCT03007407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688816|NCT05044871|Paclitaxel|paclitaxel|mesh-list
64920359|NCT00115102|Fentanyl|fentanyl|mesh-list
64920360|NCT00115102|Ketamine|ketamine|mesh-list
64920361|NCT00115102|Esketamine|esketamine|mesh-list
64920362|NCT00115102|Analgesics|analgesics|mesh-ancestor
64920363|NCT00115102|Sensory System Agents|sensory system agents|mesh-ancestor
64920364|NCT00115102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64920365|NCT00115102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920366|NCT00115102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64920367|NCT00115102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64920368|NCT00115102|Anesthetics, General|anesthetics, general|mesh-ancestor
64920369|NCT00115102|Anesthetics|anesthetics|mesh-ancestor
64920370|NCT00115102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64920371|NCT00115102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64920372|NCT00115102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64920373|NCT00115102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64920374|NCT00115102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920375|NCT00115102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64920376|NCT00115102|Narcotics|narcotics|mesh-ancestor
64920378|NCT00115102|Antidepressive Agents|antidepressive agents|mesh-ancestor
64920379|NCT00115102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64920381|NCT00115219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64920382|NCT00115219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64920383|NCT00115219|Analgesics|analgesics|mesh-ancestor
64920384|NCT00115219|Sensory System Agents|sensory system agents|mesh-ancestor
64920385|NCT00115219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64920386|NCT00115219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920387|NCT00115219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64526163|NCT02651428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64526164|NCT02651428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526165|NCT02686164|Lenvatinib|lenvatinib|mesh-list
64526166|NCT02686164|Midazolam|midazolam|mesh-list
64526167|NCT02686164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64526168|NCT02686164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64526169|NCT02686164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64526170|NCT02686164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526171|NCT02686164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64526172|NCT02686164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64526173|NCT02686164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64526174|NCT02686164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64526175|NCT02686164|Anesthetics, General|anesthetics, general|mesh-ancestor
64526176|NCT02686164|Anesthetics|anesthetics|mesh-ancestor
64526177|NCT02686164|GABA Modulators|gaba modulators|mesh-ancestor
64526178|NCT02686164|GABA Agents|gaba agents|mesh-ancestor
64526179|NCT02686164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64526180|NCT02686164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526181|NCT02686164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526182|NCT02686164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64526183|NCT02686164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526184|NCT02651584|Buprenorphine|buprenorphine|mesh-list
64920388|NCT00115219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64920389|NCT00115219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64920390|NCT00115219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64920391|NCT00115219|Immunologic Factors|immunologic factors|mesh-ancestor
64920392|NCT00115375|Clopidogrel|clopidogrel|mesh-list
64920427|NCT00115492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64920428|NCT00115492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920429|NCT00115492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64920430|NCT00115492|Respiratory System Agents|respiratory system agents|mesh-ancestor
64920431|NCT00115492|Dermatologic Agents|dermatologic agents|mesh-ancestor
64920458|NCT00115570|Insulin glulisine|insulin glulisine|mesh-list
64920459|NCT00115570|Insulin, Isophane|insulin, isophane|mesh-list
64920460|NCT00115570|Isophane Insulin, Human|isophane insulin, human|mesh-list
64920461|NCT00115570|Isophane insulin, beef|isophane insulin, beef|mesh-list
64920462|NCT00115570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64920463|NCT00115570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920464|NCT00115609|Tenofovir|tenofovir|mesh-list
64920465|NCT00115609|Emtricitabine|emtricitabine|mesh-list
64920466|NCT00115609|Efavirenz|efavirenz|mesh-list
64920467|NCT00115609|Antiviral Agents|antiviral agents|mesh-ancestor
64920468|NCT00115609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64920469|NCT00115609|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64920470|NCT00115609|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64920471|NCT00115609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920472|NCT00115609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920473|NCT00115609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64920474|NCT00115609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64920475|NCT00115609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64920476|NCT00115609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64526185|NCT02651584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64526186|NCT02651584|Narcotics|narcotics|mesh-ancestor
64526187|NCT02651584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64526188|NCT02651584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526189|NCT02651584|Analgesics|analgesics|mesh-ancestor
64526190|NCT02651584|Sensory System Agents|sensory system agents|mesh-ancestor
64526191|NCT02651584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526192|NCT02651584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64526193|NCT02685072|Progesterone|progesterone|mesh-list
64526194|NCT02685072|Progestins|progestins|mesh-ancestor
64526195|NCT02685072|Hormones|hormones|mesh-ancestor
64526196|NCT02685072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64526197|NCT02685072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526198|NCT04782258|Tolvaptan|tolvaptan|mesh-list
64649881|NCT01369745|Prednisolone|prednisolone|mesh-list
64526214|NCT02653144|Hormones|hormones|mesh-ancestor
64526215|NCT02653144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64526216|NCT02653144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64526228|NCT02653144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526230|NCT00118365|Eflornithine|eflornithine|mesh-list
64526231|NCT00118365|Sulindac|sulindac|mesh-list
64526232|NCT00118365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526233|NCT00118365|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64526234|NCT00118365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64526235|NCT00118365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64526236|NCT00118365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64526237|NCT00118365|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64526238|NCT00118365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526239|NCT00118365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526240|NCT00118365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64526241|NCT00118365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64526242|NCT00118365|Analgesics|analgesics|mesh-ancestor
64526243|NCT00118365|Sensory System Agents|sensory system agents|mesh-ancestor
64920477|NCT00115609|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64920478|NCT00115609|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64920512|NCT00008294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64920513|NCT00008294|Antimetabolites|antimetabolites|mesh-ancestor
64920514|NCT00008294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920515|NCT00008294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64920516|NCT00008294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64920517|NCT00008294|Immunologic Factors|immunologic factors|mesh-ancestor
64920518|NCT00008294|Antidotes|antidotes|mesh-ancestor
64920519|NCT00008294|Protective Agents|protective agents|mesh-ancestor
64920520|NCT00008294|Vitamin B Complex|vitamin b complex|mesh-ancestor
64920546|NCT00008333|Antimitotic Agents|antimitotic agents|mesh-ancestor
64920547|NCT00008333|Mitosis Modulators|mitosis modulators|mesh-ancestor
64920548|NCT00008333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920549|NCT00008372|Sulfanilamides|sulfanilamides|mesh-list
64920550|NCT00008372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64920551|NCT00115921|Antimalarials|antimalarials|mesh-list
64920552|NCT00115921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64920553|NCT00115921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64920554|NCT00115921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64920555|NCT00008411|Docetaxel|docetaxel|mesh-list
64920556|NCT00008411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920557|NCT00008411|Tubulin Modulators|tubulin modulators|mesh-ancestor
64920558|NCT00008411|Antimitotic Agents|antimitotic agents|mesh-ancestor
64920559|NCT00008411|Mitosis Modulators|mitosis modulators|mesh-ancestor
64649882|NCT01369745|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64649883|NCT01369745|Methylprednisolone|methylprednisolone|mesh-list
64920571|NCT04727671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64920597|NCT00008489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526245|NCT00118365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321157|NCT02206477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64321158|NCT02206477|Protective Agents|protective agents|mesh-ancestor
64321159|NCT02206477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321160|NCT02206477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64526246|NCT00118365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64526247|NCT00118365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64526248|NCT00118365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64526250|NCT03165240|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64526251|NCT03165240|Hormone Antagonists|hormone antagonists|mesh-ancestor
64526252|NCT03165240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64526253|NCT03165240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526254|NCT03165240|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64526255|NCT03165240|Diuretics|diuretics|mesh-ancestor
64526256|NCT03165240|Natriuretic Agents|natriuretic agents|mesh-ancestor
64526257|NCT03165240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64526258|NCT01587079|Tiotropium Bromide|tiotropium bromide|mesh-list
64526259|NCT01587079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64526260|NCT01587079|Autonomic Agents|autonomic agents|mesh-ancestor
64526261|NCT01587079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526262|NCT01587079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526263|NCT01587079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64526264|NCT01587079|Respiratory System Agents|respiratory system agents|mesh-ancestor
64920598|NCT00008489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64920599|NCT00008489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64920600|NCT00008489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920601|NCT00008489|Antiviral Agents|antiviral agents|mesh-ancestor
64920602|NCT00008489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64920603|NCT00008489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64920604|NCT00008489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64920606|NCT00116350|Oxytocin|oxytocin|mesh-list
64920607|NCT00116350|Oxytocics|oxytocics|mesh-ancestor
64920608|NCT00116350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64920609|NCT00116350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920610|NCT00116350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64920611|NCT00116350|Abortifacient Agents|abortifacient agents|mesh-ancestor
64920612|NCT00116350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64920613|NCT00116350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64920614|NCT00116389|Gemcitabine|gemcitabine|mesh-list
64920615|NCT00116389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64920616|NCT00116389|Antimetabolites|antimetabolites|mesh-ancestor
64920617|NCT00116389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920618|NCT00116389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920619|NCT00116389|Antiviral Agents|antiviral agents|mesh-ancestor
64920648|NCT00116545|Troglitazone|troglitazone|mesh-list
64920649|NCT00116545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64920650|NCT00116545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920651|NCT00116623|Indomethacin|indomethacin|mesh-list
64920652|NCT00116623|Magnesium Sulfate|magnesium sulfate|mesh-list
64920653|NCT00116623|Analgesics|analgesics|mesh-ancestor
64920654|NCT00116623|Sensory System Agents|sensory system agents|mesh-ancestor
64920655|NCT00116623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64920656|NCT00116623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526266|NCT01587079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64526273|NCT03028909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64526274|NCT03028909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526275|NCT03028909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526276|NCT02654860|Acetaminophen|acetaminophen|mesh-list
64526277|NCT02654860|Bupivacaine|bupivacaine|mesh-list
64526278|NCT02654860|Anesthetics, Local|anesthetics, local|mesh-ancestor
64526279|NCT02654860|Anesthetics|anesthetics|mesh-ancestor
64526280|NCT02654860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64526281|NCT02654860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526282|NCT02654860|Sensory System Agents|sensory system agents|mesh-ancestor
64920657|NCT00116623|Anesthetics|anesthetics|mesh-ancestor
64920658|NCT00116623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64920659|NCT00116623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64920660|NCT00116623|Anticonvulsants|anticonvulsants|mesh-ancestor
64612986|NCT00359151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920661|NCT00116623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64920662|NCT00116623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64920663|NCT00116623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920664|NCT00116623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64920689|NCT00116896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920690|NCT02752815|Prednisone|prednisone|mesh-list
64920691|NCT02752815|Cyclophosphamide|cyclophosphamide|mesh-list
64920692|NCT02752815|Rituximab|rituximab|mesh-list
64920693|NCT02752815|Vincristine|vincristine|mesh-list
64920694|NCT02752815|Epirubicin|epirubicin|mesh-list
64920695|NCT02752815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64920696|NCT02752815|Immunologic Factors|immunologic factors|mesh-ancestor
64920697|NCT02752815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920698|NCT02752815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64920699|NCT02752815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64920700|NCT02752815|Alkylating Agents|alkylating agents|mesh-ancestor
64920701|NCT02752815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920702|NCT02752815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920703|NCT02752815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64920704|NCT02752815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64920705|NCT02752815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64920706|NCT02752815|Glucocorticoids|glucocorticoids|mesh-ancestor
64920707|NCT02752815|Hormones|hormones|mesh-ancestor
64920708|NCT02752815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64920709|NCT02752815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64920710|NCT02752815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64920711|NCT02752815|Tubulin Modulators|tubulin modulators|mesh-ancestor
64920712|NCT02752815|Antimitotic Agents|antimitotic agents|mesh-ancestor
64920713|NCT02752815|Mitosis Modulators|mitosis modulators|mesh-ancestor
64920714|NCT02752815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64920715|NCT02752815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64920716|NCT02752815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64920717|NCT02752815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920718|NCT00116935|Imatinib Mesylate|imatinib mesylate|mesh-list
64526285|NCT02654860|Analgesics|analgesics|mesh-ancestor
64526286|NCT02654860|Antipyretics|antipyretics|mesh-ancestor
64526287|NCT01587001|Acetylcysteine|acetylcysteine|mesh-list
64526288|NCT01587001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64526289|NCT01587001|Antiviral Agents|antiviral agents|mesh-ancestor
64526290|NCT01587001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64526291|NCT01587001|Expectorants|expectorants|mesh-ancestor
64526292|NCT01587001|Respiratory System Agents|respiratory system agents|mesh-ancestor
64920719|NCT00116935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920751|NCT00117091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64920752|NCT02972450|Vedolizumab|vedolizumab|mesh-list
64920753|NCT02972450|Vaccines|vaccines|mesh-list
64920754|NCT02972450|Immunologic Factors|immunologic factors|mesh-ancestor
64920755|NCT02972450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920756|NCT02972450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64920757|NCT00117130|Darbepoetin alfa|darbepoetin alfa|mesh-list
64920758|NCT00117130|Hematinics|hematinics|mesh-ancestor
64920759|NCT00117208|Mannitol|mannitol|mesh-list
64920788|NCT00117403|Thioctic Acid|thioctic acid|mesh-list
64920795|NCT00117403|Protective Agents|protective agents|mesh-ancestor
64920796|NCT00117403|Vitamin B Complex|vitamin b complex|mesh-ancestor
64920797|NCT00117442|Paclitaxel|paclitaxel|mesh-list
64920798|NCT00117442|Carboplatin|carboplatin|mesh-list
64920799|NCT00117442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64920800|NCT00117442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920801|NCT00117442|Tubulin Modulators|tubulin modulators|mesh-ancestor
64920802|NCT00117442|Antimitotic Agents|antimitotic agents|mesh-ancestor
64920803|NCT00117442|Mitosis Modulators|mitosis modulators|mesh-ancestor
64920804|NCT00117442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920805|NCT00117520|Caffeine|caffeine|mesh-list
64920806|NCT00117520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64920807|NCT00117520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920808|NCT00117520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64920844|NCT00117832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64920845|NCT00117832|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64920846|NCT00117832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64920875|NCT00118027|Renal Agents|renal agents|mesh-ancestor
64920876|NCT00118066|Calcitriol|calcitriol|mesh-list
64613073|NCT03030001|Antibodies|antibodies|mesh-list
64920877|NCT00118066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64920878|NCT00118066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920879|NCT00118066|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64920880|NCT00118066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64920881|NCT00118066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920882|NCT00118066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64920883|NCT00118066|Vitamins|vitamins|mesh-ancestor
64920884|NCT00118066|Micronutrients|micronutrients|mesh-ancestor
64920885|NCT00118066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64920886|NCT00118105|Bevacizumab|bevacizumab|mesh-list
64920887|NCT00118105|Capecitabine|capecitabine|mesh-list
64920888|NCT00118105|Oxaliplatin|oxaliplatin|mesh-list
64920889|NCT00118105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64920890|NCT00118105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920891|NCT00118105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64920924|NCT00118222|Dermatologic Agents|dermatologic agents|mesh-ancestor
64920925|NCT00118222|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64920926|NCT00118222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64920927|NCT00118222|Anesthetics, General|anesthetics, general|mesh-ancestor
64920928|NCT00118222|Anesthetics|anesthetics|mesh-ancestor
64920929|NCT00118222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64526293|NCT01587001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64526294|NCT01587001|Antioxidants|antioxidants|mesh-ancestor
64526295|NCT01587001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526296|NCT01587001|Protective Agents|protective agents|mesh-ancestor
64526297|NCT01587001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526298|NCT01587001|Antidotes|antidotes|mesh-ancestor
64526299|NCT01568047|Levodopa|levodopa|mesh-list
64526300|NCT01568047|Carbidopa|carbidopa|mesh-list
64526301|NCT01568047|Opicapone|opicapone|mesh-list
64526302|NCT01568047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64526303|NCT01568047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64526304|NCT01568047|Dopamine Agents|dopamine agents|mesh-ancestor
64526305|NCT01568047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64526306|NCT01568047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526307|NCT01568047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526308|NCT01568047|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64714109|NCT03043274|Cangrelor|cangrelor|mesh-list
64526309|NCT01568047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526310|NCT01568047|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64526311|NCT02694978|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64526312|NCT02694978|Hematinics|hematinics|mesh-ancestor
64526313|NCT02694978|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64526314|NCT02694978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64526315|NCT04739566|Trametinib|trametinib|mesh-list
64526316|NCT04739566|Dabrafenib|dabrafenib|mesh-list
64920961|NCT00118300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920962|NCT00118300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920963|NCT02710734|Doxorubicin|doxorubicin|mesh-list
64920964|NCT02710734|Methotrexate|methotrexate|mesh-list
64920965|NCT02710734|Mitomycins|mitomycins|mesh-list
64920966|NCT02710734|Mitomycin|mitomycin|mesh-list
64920967|NCT02710734|Vinblastine|vinblastine|mesh-list
64920968|NCT02710734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920969|NCT02710734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64920970|NCT02710734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64920971|NCT02710734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64920972|NCT02710734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920973|NCT02710734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920974|NCT02710734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64734736|NCT02060370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734737|NCT02060370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64734738|NCT02060370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64734739|NCT02060370|Growth Substances|growth substances|mesh-ancestor
64734740|NCT02060370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920975|NCT02710734|Abortifacient Agents|abortifacient agents|mesh-ancestor
64920976|NCT02710734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64920977|NCT02710734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526318|NCT04739566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64526319|NCT04739566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526320|NCT04739566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526321|NCT01688921|Vaccines|vaccines|mesh-list
64526322|NCT01688921|Immunologic Factors|immunologic factors|mesh-ancestor
64526323|NCT01688921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526324|NCT00118755|Bevacizumab|bevacizumab|mesh-list
64526325|NCT00118755|Capecitabine|capecitabine|mesh-list
64526326|NCT00118755|Oxaliplatin|oxaliplatin|mesh-list
64526327|NCT00118755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64526328|NCT00118755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526329|NCT00118755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64526330|NCT00118755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64526331|NCT00118755|Growth Substances|growth substances|mesh-ancestor
64526332|NCT00118755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526333|NCT00118755|Growth Inhibitors|growth inhibitors|mesh-ancestor
64526334|NCT00118755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64526335|NCT00118755|Antimetabolites|antimetabolites|mesh-ancestor
64526336|NCT00118755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526337|NCT01541371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64526338|NCT01541371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64526339|NCT01541371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64526340|NCT01541371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64526341|NCT01541371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920978|NCT02710734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64920979|NCT02710734|Antimetabolites|antimetabolites|mesh-ancestor
64920980|NCT02710734|Dermatologic Agents|dermatologic agents|mesh-ancestor
64920981|NCT02710734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64920982|NCT02710734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64920983|NCT02710734|Immunologic Factors|immunologic factors|mesh-ancestor
64920984|NCT02710734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64920985|NCT02710734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64920986|NCT02710734|Alkylating Agents|alkylating agents|mesh-ancestor
64920987|NCT02710734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64920988|NCT02710734|Tubulin Modulators|tubulin modulators|mesh-ancestor
64921017|NCT00118768|Immunologic Factors|immunologic factors|mesh-ancestor
64921018|NCT00118768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921019|NCT02706873|Methotrexate|methotrexate|mesh-list
64921020|NCT02706873|Upadacitinib|upadacitinib|mesh-list
64921021|NCT02706873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64921022|NCT02706873|Abortifacient Agents|abortifacient agents|mesh-ancestor
64921023|NCT02706873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64526342|NCT01541371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64526343|NCT01541371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64526344|NCT01541371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64526345|NCT01541371|Serotonin Agents|serotonin agents|mesh-ancestor
64526346|NCT01541371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64526347|NCT01541371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526348|NCT01541371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64526349|NCT01541371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64526350|NCT01541371|Dopamine Agents|dopamine agents|mesh-ancestor
64526352|NCT02662036|Anesthetics, Local|anesthetics, local|mesh-ancestor
64526353|NCT02662036|Anesthetics|anesthetics|mesh-ancestor
64526354|NCT02662036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64526355|NCT02662036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734746|NCT01622088|Antioxidants|antioxidants|mesh-ancestor
64734747|NCT01622088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613183|NCT01008319|Citric Acid|citric acid|mesh-list
64526356|NCT02662036|Sensory System Agents|sensory system agents|mesh-ancestor
64526357|NCT02662036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526358|NCT01687673|Sirolimus|sirolimus|mesh-list
64526359|NCT01687673|Sorafenib|sorafenib|mesh-list
64526360|NCT01687673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526361|NCT01687673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64526362|NCT01687673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526363|NCT01687673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921031|NCT02706873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64921032|NCT02706873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64921033|NCT02706873|Immunologic Factors|immunologic factors|mesh-ancestor
64921034|NCT02706873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64921035|NCT02706873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64921036|NCT02706873|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64921069|NCT00119002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64921070|NCT00119002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921071|NCT00119002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64921073|NCT00119002|Hormones|hormones|mesh-ancestor
64921074|NCT00119002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64921075|NCT00119002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64921076|NCT00119002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921077|NCT00119119|Tocopherols|tocopherols|mesh-list
64921078|NCT00119119|Vitamin E|vitamin e|mesh-list
64921079|NCT00119119|Tocotrienols|tocotrienols|mesh-list
64921080|NCT00119119|alpha-Tocopherol|alpha-tocopherol|mesh-list
64921081|NCT00119119|Antioxidants|antioxidants|mesh-ancestor
64921082|NCT00119119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921083|NCT00119119|Protective Agents|protective agents|mesh-ancestor
64921084|NCT00119119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921085|NCT00119119|Vitamins|vitamins|mesh-ancestor
64921120|NCT00119626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921121|NCT00119704|Botulinum Toxins|botulinum toxins|mesh-list
64921122|NCT00119704|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64921123|NCT00119704|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64921124|NCT00119704|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64921125|NCT00119704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64921145|NCT00120055|Atorvastatin|atorvastatin|mesh-list
64921146|NCT00120055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64526364|NCT01687673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64526365|NCT01687673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64526366|NCT01687673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64526367|NCT01687673|Antifungal Agents|antifungal agents|mesh-ancestor
64526368|NCT01687673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64526369|NCT01687673|Immunologic Factors|immunologic factors|mesh-ancestor
64526370|NCT01687673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526372|NCT00121251|Capecitabine|capecitabine|mesh-list
64526377|NCT00121251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526378|NCT00121251|Antiviral Agents|antiviral agents|mesh-ancestor
64526379|NCT00121251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64526380|NCT00121251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526381|NCT00121251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64526382|NCT00121251|Immunologic Factors|immunologic factors|mesh-ancestor
64526383|NCT00121251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526384|NCT00121251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64526385|NCT02664220|Povidone-Iodine|povidone-iodine|mesh-list
64526386|NCT02664220|Povidone|povidone|mesh-list
64921147|NCT00120055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64921148|NCT00120055|Antimetabolites|antimetabolites|mesh-ancestor
64921149|NCT00120055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921150|NCT00120055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64921151|NCT00120055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64613239|NCT05466747|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64613240|NCT05466747|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64921152|NCT00120055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921153|NCT00120133|Atorvastatin|atorvastatin|mesh-list
64921154|NCT00120133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64921155|NCT00120133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64921156|NCT00120133|Antimetabolites|antimetabolites|mesh-ancestor
64921157|NCT00120133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921158|NCT00120133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64921159|NCT00120133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64921160|NCT00120133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921161|NCT00120172|Bevacizumab|bevacizumab|mesh-list
64921162|NCT00120172|Capecitabine|capecitabine|mesh-list
64921163|NCT00120172|Oxaliplatin|oxaliplatin|mesh-list
64921164|NCT00120172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64921165|NCT00120172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921166|NCT00120172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64921167|NCT00120172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64921168|NCT00120172|Growth Substances|growth substances|mesh-ancestor
64921169|NCT00120172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921170|NCT00120172|Growth Inhibitors|growth inhibitors|mesh-ancestor
64921171|NCT00120172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64921172|NCT00120172|Antimetabolites|antimetabolites|mesh-ancestor
64921173|NCT00120172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921174|NCT00402181|Dexamethasone|dexamethasone|mesh-list
64526387|NCT02664220|Plasma Substitutes|plasma substitutes|mesh-ancestor
64526388|NCT02664220|Blood Substitutes|blood substitutes|mesh-ancestor
64526389|NCT02664220|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64526390|NCT02664220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64526392|NCT04339348|Prilocaine|prilocaine|mesh-list
64526393|NCT04339348|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64526394|NCT04339348|Misoprostol|misoprostol|mesh-list
64526395|NCT04339348|Anesthetics, Local|anesthetics, local|mesh-ancestor
64526396|NCT04339348|Anesthetics|anesthetics|mesh-ancestor
64526397|NCT04339348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64526398|NCT04339348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921175|NCT00402181|Siltuximab|siltuximab|mesh-list
64921176|NCT00402181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64921177|NCT00402181|Antiemetics|antiemetics|mesh-ancestor
64921178|NCT00402181|Autonomic Agents|autonomic agents|mesh-ancestor
64921179|NCT00402181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64921216|NCT04727320|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
64921217|NCT04727320|Antiviral Agents|antiviral agents|mesh-ancestor
64921218|NCT04727320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921219|NCT04727320|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64921255|NCT00120640|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
64921256|NCT00120640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64921257|NCT00120640|Hormone Antagonists|hormone antagonists|mesh-ancestor
64921258|NCT00120640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64921259|NCT00120640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921261|NCT00120640|Hormones|hormones|mesh-ancestor
64921293|NCT00120913|Contraceptive Agents|contraceptive agents|mesh-ancestor
64921294|NCT00120913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64921295|NCT00120913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921336|NCT00121303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921337|NCT00121303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64921338|NCT00121303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64921339|NCT00121303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64921340|NCT00121303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64321162|NCT02206477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321164|NCT02201641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64321165|NCT02201641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321166|NCT02206555|Tenofovir|tenofovir|mesh-list
64321167|NCT02206555|Emtricitabine|emtricitabine|mesh-list
64613301|NCT04368377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64613302|NCT04368377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64921341|NCT00121303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64921343|NCT00121381|Tacrolimus|tacrolimus|mesh-list
64921344|NCT00121381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64921345|NCT00121381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64921346|NCT00121381|Analgesics|analgesics|mesh-ancestor
64921347|NCT00121381|Sensory System Agents|sensory system agents|mesh-ancestor
64921376|NCT00121498|Anesthetics, Local|anesthetics, local|mesh-list
64921377|NCT00121498|Anesthetics|anesthetics|mesh-list
64921378|NCT00121498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64921379|NCT00121498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921380|NCT00121498|Sensory System Agents|sensory system agents|mesh-ancestor
64921381|NCT00121498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64921382|NCT00121498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64921383|NCT00121498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64921384|NCT00121498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64921385|NCT00121498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64526399|NCT04339348|Sensory System Agents|sensory system agents|mesh-ancestor
64526400|NCT04339348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526401|NCT04339348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64526402|NCT04339348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64526403|NCT04339348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64526404|NCT04339348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64526405|NCT04339348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526406|NCT04339348|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64526407|NCT04339348|Abortifacient Agents|abortifacient agents|mesh-ancestor
64526408|NCT04339348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64921386|NCT00121498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921387|NCT00121615|Etanercept|etanercept|mesh-list
64921388|NCT00121615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64921389|NCT00121615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64921390|NCT00121615|Analgesics|analgesics|mesh-ancestor
64921391|NCT00121615|Sensory System Agents|sensory system agents|mesh-ancestor
64921392|NCT00121615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64921393|NCT00121615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921394|NCT00121615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64921421|NCT04705948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64921422|NCT04705948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64921423|NCT04705948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64649935|NCT01476449|Growth Substances|growth substances|mesh-ancestor
64921429|NCT04705948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64921430|NCT04705948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64921431|NCT04705948|Tocolytic Agents|tocolytic agents|mesh-ancestor
64921432|NCT04705948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64921434|NCT00121888|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64921435|NCT00121888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64526409|NCT04339348|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64526410|NCT04339348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64526411|NCT04339348|Oxytocics|oxytocics|mesh-ancestor
64526412|NCT04339348|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64526414|NCT02664922|Remifentanil|remifentanil|mesh-list
64526415|NCT02664922|Propofol|propofol|mesh-list
64526416|NCT02664922|Sevoflurane|sevoflurane|mesh-list
64526417|NCT02664922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64526418|NCT02664922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64734748|NCT01622088|Protective Agents|protective agents|mesh-ancestor
64734749|NCT01622088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734750|NCT01622088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64734751|NCT01622088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64734752|NCT01622088|Dopamine Agonists|dopamine agonists|mesh-ancestor
64734753|NCT01622088|Dopamine Agents|dopamine agents|mesh-ancestor
64734754|NCT01622088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64734755|NCT02021292|Macitentan|macitentan|mesh-list
64734756|NCT02021292|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64526419|NCT02664922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526420|NCT02664922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64526421|NCT02664922|Anesthetics, General|anesthetics, general|mesh-ancestor
64526422|NCT02664922|Anesthetics|anesthetics|mesh-ancestor
64526423|NCT02664922|Analgesics|analgesics|mesh-ancestor
64526424|NCT02664922|Sensory System Agents|sensory system agents|mesh-ancestor
64526425|NCT02664922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526426|NCT02664922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64526427|NCT02664922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64526428|NCT02664922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64526429|NCT02664922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64526430|NCT02664922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526431|NCT02664922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64526432|NCT02664922|Narcotics|narcotics|mesh-ancestor
64921436|NCT00121888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64921437|NCT00121888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921438|NCT00121888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64921439|NCT00121888|Serotonin Agents|serotonin agents|mesh-ancestor
64921440|NCT00121888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921474|NCT02013492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64921475|NCT02013492|Vasodilator Agents|vasodilator agents|mesh-ancestor
64921476|NCT00122356|Alendronate|alendronate|mesh-list
64921477|NCT00122356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64921478|NCT00122356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921479|NCT01931709|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64921480|NCT01931709|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64921481|NCT01931709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921514|NCT00122551|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64921515|NCT00122551|Antiviral Agents|antiviral agents|mesh-ancestor
64921516|NCT00122551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921518|NCT00122590|Lopinavir|lopinavir|mesh-list
64921519|NCT00122590|Nelfinavir|nelfinavir|mesh-list
64921520|NCT00122590|Indinavir|indinavir|mesh-list
64921521|NCT00122590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64921522|NCT00122590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64921523|NCT00122590|Protease Inhibitors|protease inhibitors|mesh-ancestor
64921555|NCT00122668|Protease Inhibitors|protease inhibitors|mesh-list
64921556|NCT00122668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64921557|NCT00122668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921558|NCT00122668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921559|NCT00122668|Antiviral Agents|antiviral agents|mesh-ancestor
64921560|NCT00122668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64526434|NCT02664922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64526436|NCT02666950|Adavosertib|adavosertib|mesh-list
64526437|NCT02666950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64526438|NCT02666950|Antimetabolites|antimetabolites|mesh-ancestor
64526439|NCT02666950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526440|NCT02666950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526448|NCT02668432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64526449|NCT02668432|Vasodilator Agents|vasodilator agents|mesh-ancestor
64526450|NCT02668432|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64526451|NCT02668432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64526452|NCT02668432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526453|NCT02668432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64921561|NCT00122668|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64921562|NCT00122668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64921563|NCT00122668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64921564|NCT00129337|Bavituximab|bavituximab|mesh-list
64921565|NCT00129337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64921566|NCT00129337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690012|NCT00371111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64921597|NCT00129142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64921598|NCT00129142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921599|NCT00129142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64921601|NCT00128947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64921602|NCT00128947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921603|NCT00128947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64921604|NCT00128947|Antitubercular Agents|antitubercular agents|mesh-ancestor
64921605|NCT00128947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64921606|NCT00128947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921607|NCT00128947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921642|NCT05638295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921643|NCT00063414|Alicaforsen|alicaforsen|mesh-list
64690093|NCT01898689|Ropivacaine|ropivacaine|mesh-list
64921645|NCT00063414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64921646|NCT00063414|Immunologic Factors|immunologic factors|mesh-ancestor
64921647|NCT00063414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921648|NCT05638451|Bevacizumab|bevacizumab|mesh-list
64921649|NCT05638451|Temozolomide|temozolomide|mesh-list
64921677|NCT05638763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921678|NCT05638763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64921680|NCT00128635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64526454|NCT02668432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64526455|NCT02668432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64526456|NCT02668432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526457|NCT02668432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64526458|NCT02668432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64921681|NCT00128635|Immunologic Factors|immunologic factors|mesh-ancestor
64921682|NCT00128635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921683|NCT00009048|Levodopa|levodopa|mesh-list
64921684|NCT00009048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64921685|NCT00009048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64921686|NCT00009048|Dopamine Agents|dopamine agents|mesh-ancestor
64921687|NCT00009048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64921688|NCT00009048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921689|NCT00009048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921690|NCT00128596|Arsenic Trioxide|arsenic trioxide|mesh-list
64921691|NCT00128596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921692|NCT00128557|Vitamin A|vitamin a|mesh-list
64921713|NCT00009204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921714|NCT00009204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64921715|NCT00009204|Serotonin Agents|serotonin agents|mesh-ancestor
64921716|NCT00009204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921717|NCT00009204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64921718|NCT00009204|Antidepressive Agents|antidepressive agents|mesh-ancestor
64921719|NCT00009204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64921720|NCT00009204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64921721|NCT00009204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64921733|NCT00394498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921735|NCT00394537|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64921736|NCT00394537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64921737|NCT00394537|Adrenergic Agents|adrenergic agents|mesh-ancestor
64921738|NCT00394537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64921739|NCT00394537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921740|NCT00394537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921741|NCT00394537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64921742|NCT00394537|Sympathomimetics|sympathomimetics|mesh-ancestor
64921743|NCT00394537|Autonomic Agents|autonomic agents|mesh-ancestor
64921744|NCT00394537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64921745|NCT00394537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64921746|NCT00394537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64921775|NCT00128440|Parasympatholytics|parasympatholytics|mesh-ancestor
64921776|NCT00128440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64921777|NCT00128440|Cholinergic Agents|cholinergic agents|mesh-ancestor
64921778|NCT00128440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64921779|NCT00128440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921780|NCT00128401|Cycloserine|cycloserine|mesh-list
64921781|NCT00128401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64921782|NCT00128401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921783|NCT00128401|Renal Agents|renal agents|mesh-ancestor
64921784|NCT00128401|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64921785|NCT00128401|Antitubercular Agents|antitubercular agents|mesh-ancestor
64921786|NCT00128401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64921787|NCT00128401|Antimetabolites|antimetabolites|mesh-ancestor
64921788|NCT00128401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921789|NCT00128323|Nystatin|nystatin|mesh-list
64526461|NCT01687283|Xhance|xhance|mesh-list
64734757|NCT02021292|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64734758|NCT02021292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734760|NCT02043132|Tranexamic Acid|tranexamic acid|mesh-list
64526462|NCT01687283|Budesonide|budesonide|mesh-list
64526463|NCT01687283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64526464|NCT01687283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64526465|NCT01687283|Autonomic Agents|autonomic agents|mesh-ancestor
64526466|NCT01687283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526467|NCT01687283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526468|NCT01687283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64526469|NCT01687283|Respiratory System Agents|respiratory system agents|mesh-ancestor
64526471|NCT01687283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64526472|NCT01687283|Glucocorticoids|glucocorticoids|mesh-ancestor
64526473|NCT01687283|Hormones|hormones|mesh-ancestor
64526474|NCT01687283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64526475|NCT02684370|Ustekinumab|ustekinumab|mesh-list
64921790|NCT00128323|Gentian Violet|gentian violet|mesh-list
64921826|NCT00018733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64921827|NCT00018733|Serotonin Agents|serotonin agents|mesh-ancestor
64921858|NCT00018850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64921859|NCT00018850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64921860|NCT00018850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64921861|NCT00018850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64921862|NCT00018850|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64921864|NCT00018850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64921865|NCT00009750|Cyclosporine|cyclosporine|mesh-list
64649953|NCT02203565|Eusol|eusol|mesh-list
64921872|NCT00009750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64921907|NCT00019123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921908|NCT00019123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64921909|NCT00019123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64921911|NCT00019123|Growth Inhibitors|growth inhibitors|mesh-ancestor
64921912|NCT00019123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921913|NCT00019240|Cidofovir|cidofovir|mesh-list
64921914|NCT00019240|Antiviral Agents|antiviral agents|mesh-ancestor
64921915|NCT00019240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921945|NCT00009828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64921946|NCT00009828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921947|NCT00009828|Antidotes|antidotes|mesh-ancestor
64921948|NCT00009828|Protective Agents|protective agents|mesh-ancestor
64921949|NCT00009828|Vitamin B Complex|vitamin b complex|mesh-ancestor
64921950|NCT00009828|Vitamins|vitamins|mesh-ancestor
64526476|NCT02684370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64526477|NCT02684370|Dermatologic Agents|dermatologic agents|mesh-ancestor
64526478|NCT02684370|Immunologic Factors|immunologic factors|mesh-ancestor
64526479|NCT02684370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526481|NCT02669914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64921951|NCT00009828|Micronutrients|micronutrients|mesh-ancestor
64921952|NCT00009828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64921953|NCT00009828|Antimetabolites|antimetabolites|mesh-ancestor
64921954|NCT00019435|Immunotoxins|immunotoxins|mesh-list
64921955|NCT00019435|Immunologic Factors|immunologic factors|mesh-ancestor
64921956|NCT00019435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921957|NCT00019474|Interferons|interferons|mesh-list
64921958|NCT00019474|Interferon-alpha|interferon-alpha|mesh-list
64921959|NCT00019474|Fluorouracil|fluorouracil|mesh-list
64921960|NCT00019474|Hydroxyurea|hydroxyurea|mesh-list
64921961|NCT00019474|Antimetabolites|antimetabolites|mesh-ancestor
64921962|NCT00019474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921990|NCT00019513|Protective Agents|protective agents|mesh-ancestor
64921991|NCT00019513|Vitamin B Complex|vitamin b complex|mesh-ancestor
64921992|NCT00019513|Vitamins|vitamins|mesh-ancestor
64921993|NCT00019513|Micronutrients|micronutrients|mesh-ancestor
64921994|NCT00019552|Irofulven|irofulven|mesh-list
64921995|NCT00019552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64921996|NCT00019552|Alkylating Agents|alkylating agents|mesh-ancestor
64921997|NCT00019552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921998|NCT00019552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921999|NCT00009867|Arsenic Trioxide|arsenic trioxide|mesh-list
64922000|NCT00009867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922001|NCT00019591|Aldesleukin|aldesleukin|mesh-list
64922002|NCT00019591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922003|NCT00019591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64922004|NCT00019591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64922005|NCT00019591|Antiviral Agents|antiviral agents|mesh-ancestor
64922006|NCT00019591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64922007|NCT00019630|Doxorubicin|doxorubicin|mesh-list
64922008|NCT00019630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64922009|NCT00019630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64922010|NCT00019630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922011|NCT00019630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64922012|NCT00019630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64922038|NCT00019825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922039|NCT00019825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922040|NCT00019825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922042|NCT00019864|Doxorubicin|doxorubicin|mesh-list
64922043|NCT00019864|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64922044|NCT00019864|Methotrexate|methotrexate|mesh-list
64922045|NCT00019864|Dexrazoxane|dexrazoxane|mesh-list
64922046|NCT00019864|Razoxane|razoxane|mesh-list
64922047|NCT00019864|Calcium|calcium|mesh-list
64922048|NCT00019864|Levoleucovorin|levoleucovorin|mesh-list
64922049|NCT00019864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922050|NCT00019864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64922051|NCT00019864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64922091|NCT00020176|Antimetabolites|antimetabolites|mesh-ancestor
64922092|NCT00020176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922093|NCT00020176|Antifungal Agents|antifungal agents|mesh-ancestor
64922094|NCT00020176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64922095|NCT00020176|Dermatologic Agents|dermatologic agents|mesh-ancestor
64922096|NCT00020176|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64922097|NCT00020254|Aldesleukin|aldesleukin|mesh-list
64922098|NCT00020254|Nilutamide|nilutamide|mesh-list
64922099|NCT00020254|Vaccines|vaccines|mesh-list
64922100|NCT00020254|Sargramostim|sargramostim|mesh-list
64526482|NCT02669914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526483|NCT01686581|Botulinum Toxins|botulinum toxins|mesh-list
64526484|NCT01686581|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64526485|NCT01686581|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64526486|NCT01686581|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64526487|NCT01686581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64526488|NCT01686581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526489|NCT01686581|Cholinergic Agents|cholinergic agents|mesh-ancestor
64526490|NCT01686581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64526491|NCT01686581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526492|NCT01686581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64922101|NCT00020254|Immunologic Factors|immunologic factors|mesh-ancestor
64922102|NCT00020254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922103|NCT00020254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922104|NCT00020254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64922105|NCT00020254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64922106|NCT00020254|Antiviral Agents|antiviral agents|mesh-ancestor
64922134|NCT00020332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922136|NCT00020332|Growth Substances|growth substances|mesh-ancestor
64922137|NCT00020332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922138|NCT00020332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64922139|NCT00020332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922140|NCT00020371|Lenograstim|lenograstim|mesh-list
64922141|NCT00020371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64922142|NCT00020371|Immunologic Factors|immunologic factors|mesh-ancestor
64922143|NCT00020371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922144|NCT00020410|Antibodies|antibodies|mesh-list
64922145|NCT00020410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64922146|NCT00020410|Immunologic Factors|immunologic factors|mesh-ancestor
64922147|NCT00020410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922148|NCT00020449|Paclitaxel|paclitaxel|mesh-list
64922149|NCT00020449|Doxorubicin|doxorubicin|mesh-list
64922150|NCT00020449|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64922151|NCT00020449|Interleukin-12|interleukin-12|mesh-list
64922152|NCT00020449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64922153|NCT00020449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922154|NCT00020449|Tubulin Modulators|tubulin modulators|mesh-ancestor
64922183|NCT00020488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64922184|NCT00020488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922185|NCT00020488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64922186|NCT00020488|Immunologic Factors|immunologic factors|mesh-ancestor
64922187|NCT00020488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64922188|NCT00020488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64922189|NCT00020488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922190|NCT00020488|Antidotes|antidotes|mesh-ancestor
64922191|NCT00020488|Protective Agents|protective agents|mesh-ancestor
64922192|NCT00020488|Vitamin B Complex|vitamin b complex|mesh-ancestor
64922193|NCT00020488|Vitamins|vitamins|mesh-ancestor
64922194|NCT00020488|Micronutrients|micronutrients|mesh-ancestor
64922234|NCT00010062|Immunologic Factors|immunologic factors|mesh-ancestor
64922235|NCT00010062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922236|NCT00020605|Naloxone|naloxone|mesh-list
64922237|NCT00020605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64922238|NCT00020605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922239|NCT00020605|Sensory System Agents|sensory system agents|mesh-ancestor
64526493|NCT01686581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526495|NCT04739410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64526496|NCT04739410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64526497|NCT02691936|Estrogens|estrogens|mesh-list
64526498|NCT02691936|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64526499|NCT02691936|Hormones|hormones|mesh-ancestor
64526500|NCT02691936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64526501|NCT02691936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526502|NCT04707742|Povidone-Iodine|povidone-iodine|mesh-list
64526503|NCT04707742|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64526504|NCT04707742|Cetylpyridinium|cetylpyridinium|mesh-list
64526505|NCT04707742|Povidone|povidone|mesh-list
64526506|NCT04707742|Plasma Substitutes|plasma substitutes|mesh-ancestor
64526507|NCT04707742|Blood Substitutes|blood substitutes|mesh-ancestor
64526508|NCT04707742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64526509|NCT04707742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64526510|NCT02680054|Insulin|insulin|mesh-list
64526511|NCT02680054|Insulin Aspart|insulin aspart|mesh-list
64526512|NCT02680054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64526513|NCT02680054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526514|NCT00367978|Amlodipine|amlodipine|mesh-list
64526515|NCT00367978|Benazepril|benazepril|mesh-list
64526517|NCT00367978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64922240|NCT00020605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64922241|NCT00020644|Gemcitabine|gemcitabine|mesh-list
64922242|NCT00020644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64922243|NCT00020644|Antimetabolites|antimetabolites|mesh-ancestor
64922244|NCT00020644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922277|NCT00020839|Alkylating Agents|alkylating agents|mesh-ancestor
64922278|NCT00020839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922279|NCT00020839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922280|NCT00010140|Tamoxifen|tamoxifen|mesh-list
64922281|NCT00010140|Docetaxel|docetaxel|mesh-list
64922282|NCT00010140|Epirubicin|epirubicin|mesh-list
64321168|NCT02206555|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64321170|NCT02206555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64321171|NCT02206555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64321172|NCT02206555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64321173|NCT02206555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922283|NCT00010140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922284|NCT00010140|Tubulin Modulators|tubulin modulators|mesh-ancestor
64922285|NCT00010140|Antimitotic Agents|antimitotic agents|mesh-ancestor
64922286|NCT00010140|Mitosis Modulators|mitosis modulators|mesh-ancestor
64922287|NCT00010140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922288|NCT00010140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64922314|NCT00020917|Fluorouracil|fluorouracil|mesh-list
64922315|NCT00020917|Irinotecan|irinotecan|mesh-list
64922316|NCT00020917|Cetuximab|cetuximab|mesh-list
64922317|NCT00020917|Calcium|calcium|mesh-list
64922318|NCT00020917|Levoleucovorin|levoleucovorin|mesh-list
64922319|NCT00020917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64922320|NCT00020917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922321|NCT00020917|Antimetabolites|antimetabolites|mesh-ancestor
64922322|NCT00020917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922323|NCT00020917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64922324|NCT00020917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526518|NCT00367978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64526519|NCT00367978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526520|NCT00367978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64922373|NCT00021112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922374|NCT00000122|Fluorouracil|fluorouracil|mesh-list
64922375|NCT00000122|Antimetabolites|antimetabolites|mesh-ancestor
64922376|NCT00000122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922377|NCT00000122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64922408|NCT00021385|Carboplatin|carboplatin|mesh-list
64922409|NCT00021385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922410|NCT00021385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64922411|NCT00021385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64922412|NCT00021385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64922413|NCT00021385|Protective Agents|protective agents|mesh-ancestor
64922414|NCT00021385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922415|NCT00021385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64922416|NCT00021385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64922417|NCT00021385|Growth Substances|growth substances|mesh-ancestor
64922418|NCT00021385|Growth Inhibitors|growth inhibitors|mesh-ancestor
64922419|NCT00021463|Lamivudine|lamivudine|mesh-list
64922420|NCT00021463|Zidovudine|zidovudine|mesh-list
64922421|NCT00021463|Efavirenz|efavirenz|mesh-list
64922422|NCT00021463|Nevirapine|nevirapine|mesh-list
64922423|NCT00021463|Abacavir|abacavir|mesh-list
64922455|NCT00000134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922456|NCT00000134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922457|NCT00000134|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64922458|NCT00010413|Cyclophosphamide|cyclophosphamide|mesh-list
64922459|NCT00010413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64922460|NCT00010413|Immunologic Factors|immunologic factors|mesh-ancestor
64922461|NCT00010413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922462|NCT00010413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64922463|NCT00010413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64922464|NCT00010413|Alkylating Agents|alkylating agents|mesh-ancestor
64922497|NCT00022009|Gemcitabine|gemcitabine|mesh-list
64922498|NCT00022009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64922499|NCT00022009|Antimetabolites|antimetabolites|mesh-ancestor
64922500|NCT00022009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922501|NCT00022009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922502|NCT00022009|Antiviral Agents|antiviral agents|mesh-ancestor
64922503|NCT00022009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64922504|NCT00022009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922505|NCT00022009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64922578|NCT00022126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64922580|NCT00022126|Glucocorticoids|glucocorticoids|mesh-ancestor
64922581|NCT00022126|Hormones|hormones|mesh-ancestor
64922582|NCT00022126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64922583|NCT00022126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64922655|NCT00022360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64922656|NCT00022360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526528|NCT00368056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64526529|NCT00368056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64526530|NCT00368056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526531|NCT01685801|Ivacaftor|ivacaftor|mesh-list
64526532|NCT01685801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64526533|NCT01685801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64526534|NCT01685801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526535|NCT01684943|Insulin|insulin|mesh-list
64526536|NCT01684943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64526537|NCT01684943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526538|NCT05339542|Methylprednisolone|methylprednisolone|mesh-list
64526539|NCT05339542|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64526540|NCT05339542|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64526541|NCT05339542|Prednisolone|prednisolone|mesh-list
64526542|NCT05339542|Prednisolone acetate|prednisolone acetate|mesh-list
64526543|NCT05339542|Lidocaine|lidocaine|mesh-list
64526544|NCT05339542|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64526545|NCT05339542|Prednisolone phosphate|prednisolone phosphate|mesh-list
64526546|NCT05339542|Anesthetics, Local|anesthetics, local|mesh-ancestor
64526547|NCT05339542|Anesthetics|anesthetics|mesh-ancestor
64922694|NCT00022555|Vincristine|vincristine|mesh-list
64922695|NCT00022555|Bryostatin 1|bryostatin 1|mesh-list
64922696|NCT00022555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64922697|NCT00022555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922698|NCT00022555|Tubulin Modulators|tubulin modulators|mesh-ancestor
64922699|NCT00022555|Antimitotic Agents|antimitotic agents|mesh-ancestor
64922700|NCT00022555|Mitosis Modulators|mitosis modulators|mesh-ancestor
64922733|NCT00000149|Adrenergic Agents|adrenergic agents|mesh-ancestor
64922734|NCT00000149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64922735|NCT00000149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922736|NCT00000149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922738|NCT00022711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64922739|NCT00022711|Alkylating Agents|alkylating agents|mesh-ancestor
64922740|NCT00022711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922741|NCT00022711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922742|NCT00010842|Vitamin E|vitamin e|mesh-list
64922743|NCT00010842|Thioctic Acid|thioctic acid|mesh-list
64922744|NCT00010842|Selenium|selenium|mesh-list
64922778|NCT00010881|Protective Agents|protective agents|mesh-ancestor
64922779|NCT00010881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922781|NCT00022906|Antibodies|antibodies|mesh-list
64922782|NCT00022906|Immunologic Factors|immunologic factors|mesh-ancestor
64922783|NCT00022906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922784|NCT00022906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922785|NCT00022945|Prednisone|prednisone|mesh-list
64922786|NCT00022945|Cyclophosphamide|cyclophosphamide|mesh-list
64526549|NCT05339542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526550|NCT05339542|Sensory System Agents|sensory system agents|mesh-ancestor
64526551|NCT05339542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526552|NCT05339542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64526553|NCT05339542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64526554|NCT05339542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64526555|NCT05339542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64922820|NCT00023218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922821|NCT00023218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64922822|NCT00023218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64922823|NCT00023218|Antiviral Agents|antiviral agents|mesh-ancestor
64922824|NCT00023218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64922825|NCT00023218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64922826|NCT00023218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64649993|NCT01376297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64922861|NCT02024607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64922862|NCT02024607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922863|NCT02024607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64922864|NCT02024607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64922865|NCT02024607|Growth Substances|growth substances|mesh-ancestor
64922866|NCT02024607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922867|NCT02024607|Growth Inhibitors|growth inhibitors|mesh-ancestor
64922868|NCT02024607|Antimetabolites|antimetabolites|mesh-ancestor
64922869|NCT02024607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922870|NCT02024607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64922871|NCT02024607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64922904|NCT00023335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922906|NCT00023335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64922907|NCT00023335|Leprostatic Agents|leprostatic agents|mesh-ancestor
64922908|NCT00000173|Vitamin E|vitamin e|mesh-list
64922909|NCT00000173|Donepezil|donepezil|mesh-list
64922910|NCT00000173|Vitamins|vitamins|mesh-ancestor
64922911|NCT00000173|Micronutrients|micronutrients|mesh-ancestor
64922912|NCT00000173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922913|NCT00000173|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64922914|NCT00000173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922944|NCT00023413|Antiviral Agents|antiviral agents|mesh-ancestor
64922945|NCT00023413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64922946|NCT00023413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64922947|NCT00023413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64922948|NCT00023413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64922949|NCT00023413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64922950|NCT00023413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64922951|NCT00023413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64922952|NCT00023413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64922953|NCT00023413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64922954|NCT00023413|Antitubercular Agents|antitubercular agents|mesh-ancestor
64922955|NCT00023530|Thalidomide|thalidomide|mesh-list
64922956|NCT00023530|Fluconazole|fluconazole|mesh-list
64922957|NCT00023530|Voriconazole|voriconazole|mesh-list
64922985|NCT00023530|Hormone Antagonists|hormone antagonists|mesh-ancestor
64922986|NCT00023530|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64922987|NCT00023530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64922988|NCT00023530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64922990|NCT00000176|Estrogens|estrogens|mesh-list
64922991|NCT00000176|Progestins|progestins|mesh-ancestor
64922992|NCT00000176|Hormones|hormones|mesh-ancestor
64526556|NCT05339542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526557|NCT05339542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64526558|NCT05339542|Antiemetics|antiemetics|mesh-ancestor
64526559|NCT05339542|Autonomic Agents|autonomic agents|mesh-ancestor
64526560|NCT05339542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64526561|NCT05339542|Glucocorticoids|glucocorticoids|mesh-ancestor
64526562|NCT05339542|Hormones|hormones|mesh-ancestor
64526563|NCT05339542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64526564|NCT05339542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64526565|NCT05339542|Protective Agents|protective agents|mesh-ancestor
64526566|NCT05339542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64526567|NCT05339542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526568|NCT03162900|Moxifloxacin|moxifloxacin|mesh-list
64526569|NCT03162900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64526570|NCT03162900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64526571|NCT03162900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64526572|NCT03162900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64526573|NCT03162900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526574|NCT03162900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526575|NCT03162900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526576|NCT05257018|Doxorubicin|doxorubicin|mesh-list
64526577|NCT05257018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64526578|NCT05257018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526579|NCT05257018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64649999|NCT02669186|Fentanyl|fentanyl|mesh-list
64650000|NCT02669186|Bupivacaine|bupivacaine|mesh-list
64922998|NCT00000179|Antiemetics|antiemetics|mesh-ancestor
64922999|NCT00000179|Autonomic Agents|autonomic agents|mesh-ancestor
64923000|NCT00000179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64923001|NCT00000179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923002|NCT00000179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64923003|NCT00000179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64923020|NCT00023725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64923021|NCT00023725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64923022|NCT00023725|Growth Substances|growth substances|mesh-ancestor
64923023|NCT00023725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923024|NCT00023725|Growth Inhibitors|growth inhibitors|mesh-ancestor
64923025|NCT00023725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923026|NCT00023725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64923027|NCT00023725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923028|NCT00023725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923029|NCT00391404|Alendronate|alendronate|mesh-list
64923030|NCT00391404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64923031|NCT00391404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923032|NCT00000191|Carbamazepine|carbamazepine|mesh-list
64923033|NCT00000191|Anticonvulsants|anticonvulsants|mesh-ancestor
64526580|NCT05257018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64526581|NCT05257018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734764|NCT02043132|Hemostatics|hemostatics|mesh-ancestor
64526582|NCT05257018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526583|NCT05248984|Ketorolac|ketorolac|mesh-list
64526584|NCT05248984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64714110|NCT03043274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64526585|NCT05248984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64526586|NCT05248984|Analgesics|analgesics|mesh-ancestor
64526587|NCT05248984|Sensory System Agents|sensory system agents|mesh-ancestor
64526588|NCT05248984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526589|NCT05248984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526590|NCT05248984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64526591|NCT05248984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64526592|NCT05248984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64526593|NCT05248984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526594|NCT05248984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526595|NCT00368602|Timolol|timolol|mesh-list
64526596|NCT00368602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64526597|NCT00368602|Adrenergic Antagonists|adrenergic antagonists|mesh-list
64526598|NCT00368602|Adrenergic Agents|adrenergic agents|mesh-ancestor
64526599|NCT00368602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64526600|NCT00368602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526601|NCT00368602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526602|NCT00368602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64526603|NCT00368602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64526604|NCT01683071|Bupivacaine|bupivacaine|mesh-list
64526605|NCT01683071|Anesthetics, Local|anesthetics, local|mesh-ancestor
64526606|NCT01683071|Anesthetics|anesthetics|mesh-ancestor
64526607|NCT01683071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64526608|NCT01683071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526609|NCT01683071|Sensory System Agents|sensory system agents|mesh-ancestor
64923034|NCT00000191|Antimanic Agents|antimanic agents|mesh-ancestor
64923035|NCT00000191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64923036|NCT00000191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64923037|NCT00000191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923038|NCT00000191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64923039|NCT00000191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64923040|NCT00000191|Analgesics|analgesics|mesh-ancestor
64923041|NCT00000191|Sensory System Agents|sensory system agents|mesh-ancestor
64923042|NCT00000191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64923043|NCT00000191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64526612|NCT04707508|Valsartan|valsartan|mesh-list
64526613|NCT04707508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64526614|NCT04707508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923045|NCT00000191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923047|NCT00000191|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64923048|NCT00023842|Mitomycins|mitomycins|mesh-list
64923049|NCT00023842|Mitomycin|mitomycin|mesh-list
64923050|NCT00023842|BCG Vaccine|bcg vaccine|mesh-list
64923051|NCT00023842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64923052|NCT00023842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923053|NCT00023842|Alkylating Agents|alkylating agents|mesh-ancestor
64923054|NCT00023842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923055|NCT00023842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64923056|NCT00023842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923057|NCT00023842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64923058|NCT00023842|Immunologic Factors|immunologic factors|mesh-ancestor
64923059|NCT00023842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923060|NCT00000221|Buprenorphine|buprenorphine|mesh-list
64923093|NCT00023920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64923094|NCT00023920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923095|NCT00023959|Bevacizumab|bevacizumab|mesh-list
64923096|NCT00023959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64923097|NCT00023959|Fluorouracil|fluorouracil|mesh-list
64734767|NCT02059434|LAS190792|las190792|mesh-list
64734768|NCT02059434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64734769|NCT02059434|Autonomic Agents|autonomic agents|mesh-ancestor
64734770|NCT02059434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321175|NCT02206555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64923098|NCT00023959|Hydroxyurea|hydroxyurea|mesh-list
64923099|NCT00023959|Antibodies|antibodies|mesh-list
64923100|NCT00023959|Immunoglobulins|immunoglobulins|mesh-list
64923101|NCT00023959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64923102|NCT00023959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923103|NCT00023959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64923139|NCT00023998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64923140|NCT00023998|Immunologic Factors|immunologic factors|mesh-ancestor
64923141|NCT00023998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64923167|NCT00011076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923168|NCT00011076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64923169|NCT00011076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64923170|NCT00011076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64923171|NCT00011076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64923172|NCT00011076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923173|NCT00000248|Pergolide|pergolide|mesh-list
64923174|NCT00000248|Dopamine Agonists|dopamine agonists|mesh-ancestor
64923175|NCT00000248|Dopamine Agents|dopamine agents|mesh-ancestor
64923176|NCT00000248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64923177|NCT00000248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923178|NCT00000248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923179|NCT00024193|Cyclophosphamide|cyclophosphamide|mesh-list
64923180|NCT00024193|Melphalan|melphalan|mesh-list
64923181|NCT00024193|Busulfan|busulfan|mesh-list
64923182|NCT00024193|Doxorubicin|doxorubicin|mesh-list
64923183|NCT00024193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64923184|NCT00024193|Etoposide|etoposide|mesh-list
64923185|NCT00024193|Vincristine|vincristine|mesh-list
64923186|NCT00024193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64923187|NCT00024193|Immunologic Factors|immunologic factors|mesh-ancestor
64923188|NCT00024193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923189|NCT00024193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64526621|NCT05145400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64526623|NCT05145400|Autonomic Agents|autonomic agents|mesh-ancestor
64526624|NCT05145400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526625|NCT05145400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526626|NCT05145400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64526627|NCT05145400|Glucocorticoids|glucocorticoids|mesh-ancestor
64526628|NCT05145400|Hormones|hormones|mesh-ancestor
64923190|NCT00024193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64650008|NCT02669186|Narcotics|narcotics|mesh-ancestor
64923234|NCT00024310|Tubulin Modulators|tubulin modulators|mesh-ancestor
64923235|NCT00024310|Antimitotic Agents|antimitotic agents|mesh-ancestor
64923236|NCT00024310|Mitosis Modulators|mitosis modulators|mesh-ancestor
64923237|NCT00024310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923238|NCT00024310|Hematinics|hematinics|mesh-ancestor
64923269|NCT00024388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923270|NCT00024388|Tubulin Modulators|tubulin modulators|mesh-ancestor
64923271|NCT00024388|Antimitotic Agents|antimitotic agents|mesh-ancestor
64923272|NCT00024388|Mitosis Modulators|mitosis modulators|mesh-ancestor
64923273|NCT00024388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923274|NCT00024427|Gemcitabine|gemcitabine|mesh-list
64923275|NCT00024427|Fluorouracil|fluorouracil|mesh-list
64923276|NCT00024427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64923277|NCT00024427|Antimetabolites|antimetabolites|mesh-ancestor
64923278|NCT00024427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923279|NCT00024427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923280|NCT00024427|Antiviral Agents|antiviral agents|mesh-ancestor
64923281|NCT00024427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64923282|NCT00024427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923283|NCT00024427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64923317|NCT00395239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64923318|NCT00395239|Respiratory System Agents|respiratory system agents|mesh-ancestor
64923319|NCT00395239|Glucocorticoids|glucocorticoids|mesh-ancestor
64923320|NCT00395239|Hormones|hormones|mesh-ancestor
64923321|NCT00395239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64923322|NCT00025012|Isotretinoin|isotretinoin|mesh-list
64923323|NCT00025012|Dermatologic Agents|dermatologic agents|mesh-ancestor
64923324|NCT00025051|Celecoxib|celecoxib|mesh-list
64923325|NCT00025051|Mitogens|mitogens|mesh-list
64923356|NCT00000368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64923357|NCT00000368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923358|NCT00000368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64923359|NCT00000368|Serotonin Agents|serotonin agents|mesh-ancestor
64923360|NCT00000368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614027|NCT02982005|Brodalumab|brodalumab|mesh-list
64923361|NCT00000368|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64923362|NCT00000368|Antidepressive Agents|antidepressive agents|mesh-ancestor
64923363|NCT00000368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64923364|NCT00000368|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64923365|NCT00000368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64923366|NCT00000368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923367|NCT00025168|Gemcitabine|gemcitabine|mesh-list
64923399|NCT00025285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64526629|NCT05145400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64526630|NCT05145400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64526631|NCT05145400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526632|NCT05145400|Immunologic Factors|immunologic factors|mesh-ancestor
64526633|NCT05145400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64526634|NCT05145400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64526635|NCT05145400|Growth Substances|growth substances|mesh-ancestor
64526636|NCT05145400|Growth Inhibitors|growth inhibitors|mesh-ancestor
64526638|NCT01567865|Immunologic Factors|immunologic factors|mesh-ancestor
64650017|NCT00859508|Estrogens|estrogens|mesh-ancestor
64923403|NCT00025285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64923404|NCT00025285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64923405|NCT00025285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64923406|NCT00025285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64923407|NCT00025285|Growth Substances|growth substances|mesh-ancestor
64923408|NCT00025285|Growth Inhibitors|growth inhibitors|mesh-ancestor
64923409|NCT00025324|Cyclophosphamide|cyclophosphamide|mesh-list
64923410|NCT00025324|Thiotepa|thiotepa|mesh-list
64923448|NCT00025363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923449|NCT00025363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64923481|NCT00025402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64923483|NCT00025441|Cyclophosphamide|cyclophosphamide|mesh-list
64923484|NCT00025441|Ifosfamide|ifosfamide|mesh-list
64923485|NCT00025441|Carboplatin|carboplatin|mesh-list
64923486|NCT00025441|Doxorubicin|doxorubicin|mesh-list
64923487|NCT00025441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64923488|NCT00025441|Etoposide|etoposide|mesh-list
64923489|NCT00025441|Vincristine|vincristine|mesh-list
64923490|NCT00025441|Epirubicin|epirubicin|mesh-list
64923491|NCT00025441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64923492|NCT00025441|Immunologic Factors|immunologic factors|mesh-ancestor
64923493|NCT00025441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923494|NCT00025441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64923495|NCT00025441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64923496|NCT00025441|Alkylating Agents|alkylating agents|mesh-ancestor
64923497|NCT00025441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923530|NCT00000395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64923532|NCT00000395|Vitamin B Complex|vitamin b complex|mesh-ancestor
64923533|NCT00000395|Vitamins|vitamins|mesh-ancestor
64923534|NCT00000395|Micronutrients|micronutrients|mesh-ancestor
64923535|NCT00000395|Antidotes|antidotes|mesh-ancestor
64923536|NCT00000395|Protective Agents|protective agents|mesh-ancestor
64923537|NCT00025480|Paclitaxel|paclitaxel|mesh-list
64923538|NCT00025480|Carboplatin|carboplatin|mesh-list
64923539|NCT00025480|Tipifarnib|tipifarnib|mesh-list
64923540|NCT00025480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64923577|NCT00025558|Alkylating Agents|alkylating agents|mesh-ancestor
64923578|NCT00025558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526648|NCT05005000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64526649|NCT05005000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64526650|NCT05005000|Glucocorticoids|glucocorticoids|mesh-ancestor
64526651|NCT05005000|Hormones|hormones|mesh-ancestor
64526652|NCT05005000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64526653|NCT05005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526654|NCT05005000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64526655|NCT05005000|Immunologic Factors|immunologic factors|mesh-ancestor
64526656|NCT05005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526657|NCT05005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526658|NCT01567163|Docetaxel|docetaxel|mesh-list
64526659|NCT01567163|Ramucirumab|ramucirumab|mesh-list
64526660|NCT01567163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526661|NCT01567163|Tubulin Modulators|tubulin modulators|mesh-ancestor
64526662|NCT01567163|Antimitotic Agents|antimitotic agents|mesh-ancestor
64923612|NCT00025636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64923613|NCT00025636|Immunologic Factors|immunologic factors|mesh-ancestor
64923614|NCT00025636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923615|NCT00025636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64923620|NCT00025636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64923621|NCT00025636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64923622|NCT00025636|Antiemetics|antiemetics|mesh-ancestor
64923623|NCT00025636|Autonomic Agents|autonomic agents|mesh-ancestor
64923654|NCT00025753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923655|NCT00025792|Pramipexole|pramipexole|mesh-list
64923656|NCT00025792|Antioxidants|antioxidants|mesh-ancestor
64923657|NCT00025792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923658|NCT00025792|Protective Agents|protective agents|mesh-ancestor
64923659|NCT00025792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923660|NCT00025792|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64923661|NCT00025792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64923662|NCT00025792|Dopamine Agonists|dopamine agonists|mesh-ancestor
64923663|NCT00025792|Dopamine Agents|dopamine agents|mesh-ancestor
64923664|NCT00025792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64923665|NCT00000419|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64923666|NCT00000419|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64923690|NCT00026104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64923691|NCT00026104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923692|NCT00026104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64923693|NCT00026104|Immunologic Factors|immunologic factors|mesh-ancestor
64923694|NCT00026104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923696|NCT00026143|Interferon-alpha|interferon-alpha|mesh-list
64923697|NCT00026143|Interferon alpha-2|interferon alpha-2|mesh-list
64923698|NCT00026143|Interleukin-12|interleukin-12|mesh-list
64923699|NCT00026143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923700|NCT00026143|Antiviral Agents|antiviral agents|mesh-ancestor
64923701|NCT00026143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64923702|NCT00026143|Immunologic Factors|immunologic factors|mesh-ancestor
64923703|NCT00026143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923704|NCT00026143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64923705|NCT00026143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64923706|NCT00026143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64923707|NCT00026143|Growth Substances|growth substances|mesh-ancestor
64526664|NCT01567163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526665|NCT05002114|Cannabidiol|cannabidiol|mesh-list
64526666|NCT05002114|Anticonvulsants|anticonvulsants|mesh-ancestor
64526667|NCT04973566|Hydroxychloroquine|hydroxychloroquine|mesh-list
64526668|NCT04973566|Etanercept|etanercept|mesh-list
64526669|NCT04973566|Antimalarials|antimalarials|mesh-ancestor
64526670|NCT04973566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64526671|NCT04973566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64526672|NCT04973566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64526673|NCT04973566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526674|NCT04973566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526675|NCT04973566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64526676|NCT04973566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64526677|NCT04973566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64526678|NCT04973566|Analgesics|analgesics|mesh-ancestor
64526679|NCT04973566|Sensory System Agents|sensory system agents|mesh-ancestor
64526680|NCT04973566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526681|NCT04973566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526682|NCT04973566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64526683|NCT04973566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64526684|NCT04973566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64526685|NCT04973566|Immunologic Factors|immunologic factors|mesh-ancestor
64526686|NCT04635826|Adderall|adderall|mesh-list
64526687|NCT04635826|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64526688|NCT04635826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526689|NCT04338802|Nintedanib|nintedanib|mesh-list
64526690|NCT04338802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526691|NCT04338802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64614170|NCT05027919|Lofexidine|lofexidine|mesh-list
64614171|NCT05027919|Clonidine|clonidine|mesh-list
64923708|NCT00026143|Growth Inhibitors|growth inhibitors|mesh-ancestor
64923709|NCT00026182|Rituximab|rituximab|mesh-list
64923710|NCT00026182|Interleukin-12|interleukin-12|mesh-list
64923711|NCT00026182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64923718|NCT00026182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64923744|NCT00026338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64923745|NCT00026338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923746|NCT00026338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64526693|NCT04338802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526694|NCT04395508|Trastuzumab|trastuzumab|mesh-list
64526695|NCT04395508|Pertuzumab|pertuzumab|mesh-list
64526696|NCT04395508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64526697|NCT04395508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526698|NCT00368914|Sirolimus|sirolimus|mesh-list
64526699|NCT00368914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64526700|NCT00368914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64526701|NCT00368914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64526702|NCT00368914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526703|NCT00368914|Antifungal Agents|antifungal agents|mesh-ancestor
64526704|NCT00368914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64526705|NCT00368914|Immunologic Factors|immunologic factors|mesh-ancestor
64526706|NCT00368914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526707|NCT01567085|Eculizumab|eculizumab|mesh-list
64526708|NCT01567085|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64526709|NCT01567085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64526710|NCT01567085|Immunologic Factors|immunologic factors|mesh-ancestor
64526711|NCT01567085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526712|NCT04344184|Ascorbic Acid|ascorbic acid|mesh-list
64526713|NCT04344184|Vitamins|vitamins|mesh-ancestor
64526714|NCT04344184|Micronutrients|micronutrients|mesh-ancestor
64526715|NCT04344184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526716|NCT04344184|Antioxidants|antioxidants|mesh-ancestor
64526717|NCT04344184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526718|NCT04344184|Protective Agents|protective agents|mesh-ancestor
64526719|NCT01566773|Bromides|bromides|mesh-list
64923747|NCT00026338|Immunologic Factors|immunologic factors|mesh-ancestor
64923748|NCT00026338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923749|NCT00026338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64923751|NCT00026377|Goserelin|goserelin|mesh-list
64923752|NCT00026377|Flutamide|flutamide|mesh-list
64923753|NCT00026377|Bicalutamide|bicalutamide|mesh-list
64923754|NCT00026377|Semaxinib|semaxinib|mesh-list
64923755|NCT00026377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64923756|NCT00026377|Fertility Agents|fertility agents|mesh-ancestor
64923757|NCT00026377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64923758|NCT00026377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923759|NCT00026377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64923760|NCT00026377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923761|NCT00026377|Androgen Antagonists|androgen antagonists|mesh-ancestor
64923762|NCT00026377|Hormone Antagonists|hormone antagonists|mesh-ancestor
64923763|NCT00026377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64923764|NCT00026377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64923765|NCT00026377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64923766|NCT00026377|Growth Substances|growth substances|mesh-ancestor
64923767|NCT00026377|Growth Inhibitors|growth inhibitors|mesh-ancestor
64923768|NCT00026377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64923790|NCT00026533|Leprostatic Agents|leprostatic agents|mesh-ancestor
64526720|NCT01566773|Tiotropium Bromide|tiotropium bromide|mesh-list
64526721|NCT01566773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64526722|NCT01566773|Autonomic Agents|autonomic agents|mesh-ancestor
64526723|NCT01566773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526724|NCT01566773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526725|NCT01566773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64526726|NCT01566773|Respiratory System Agents|respiratory system agents|mesh-ancestor
64526727|NCT01566773|Parasympatholytics|parasympatholytics|mesh-ancestor
64526728|NCT01566773|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64526729|NCT01566773|Cholinergic Agents|cholinergic agents|mesh-ancestor
64526742|NCT04116437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64526743|NCT04116437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526745|NCT04103476|Bazedoxifene|bazedoxifene|mesh-list
64526768|NCT01566149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64526769|NCT01566149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526770|NCT01566149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64526771|NCT01566149|Dermatologic Agents|dermatologic agents|mesh-ancestor
64526772|NCT01566149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64526773|NCT03417388|Aspirin|aspirin|mesh-list
64526774|NCT03417388|Losartan|losartan|mesh-list
64526775|NCT03417388|Lisinopril|lisinopril|mesh-list
64923791|NCT00026533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64923792|NCT00026533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64923793|NCT00026533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64923794|NCT00026533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64923795|NCT00026533|Growth Substances|growth substances|mesh-ancestor
64923796|NCT00026533|Growth Inhibitors|growth inhibitors|mesh-ancestor
64923797|NCT00026533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923798|NCT00026962|Estradiol|estradiol|mesh-list
64923799|NCT00026962|Progesterone|progesterone|mesh-list
64923800|NCT00026962|Estrogens|estrogens|mesh-ancestor
64923801|NCT00026962|Hormones|hormones|mesh-ancestor
64923802|NCT00026962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64923803|NCT00026962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923804|NCT00026962|Progestins|progestins|mesh-ancestor
64923805|NCT00027040|Selegiline|selegiline|mesh-list
64923806|NCT00027040|Antidepressive Agents|antidepressive agents|mesh-ancestor
64923807|NCT00027040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64923808|NCT00027040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64923809|NCT00027040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64923810|NCT00027040|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64923811|NCT00027040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923812|NCT00027040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923813|NCT00027040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64923814|NCT00027040|Protective Agents|protective agents|mesh-ancestor
64923815|NCT00027040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923816|NCT00027079|Naltrexone|naltrexone|mesh-list
64923817|NCT00027079|Ondansetron|ondansetron|mesh-list
64923818|NCT00027079|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64923819|NCT00027079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64923820|NCT00027079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923821|NCT00027079|Sensory System Agents|sensory system agents|mesh-ancestor
64923822|NCT00027079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64923823|NCT00027079|Antiemetics|antiemetics|mesh-ancestor
64923824|NCT00027079|Autonomic Agents|autonomic agents|mesh-ancestor
64923856|NCT00000428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64923857|NCT00000428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923858|NCT00000428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64923859|NCT00000428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64923860|NCT00000428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64650049|NCT01377623|Sensory System Agents|sensory system agents|mesh-ancestor
64650050|NCT01377623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64923893|NCT00000461|Vitamin B Complex|vitamin b complex|mesh-ancestor
64923894|NCT00000461|Vitamins|vitamins|mesh-ancestor
64923895|NCT00000461|Micronutrients|micronutrients|mesh-ancestor
64923896|NCT00000461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923897|NCT00000461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64923898|NCT00000461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64923899|NCT00000461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923900|NCT00000461|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64923901|NCT00000461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64923902|NCT00027508|Trabectedin|trabectedin|mesh-list
64923903|NCT00027508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64526777|NCT03417388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64526778|NCT03417388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64526779|NCT03417388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64526780|NCT03417388|Analgesics|analgesics|mesh-ancestor
64526781|NCT03417388|Sensory System Agents|sensory system agents|mesh-ancestor
64526782|NCT03417388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526783|NCT03417388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526784|NCT03417388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64526785|NCT03417388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64526786|NCT03417388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64526787|NCT03417388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64526788|NCT03417388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526789|NCT03417388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64526790|NCT03417388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64526791|NCT03417388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526792|NCT03417388|Antipyretics|antipyretics|mesh-ancestor
64923904|NCT00027508|Alkylating Agents|alkylating agents|mesh-ancestor
64923905|NCT00027508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923906|NCT00027508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923907|NCT00027547|Cytarabine|cytarabine|mesh-list
64923908|NCT00027547|Cyclosporine|cyclosporine|mesh-list
64923909|NCT00027547|Mycophenolic Acid|mycophenolic acid|mesh-list
64923910|NCT00027547|Methotrexate|methotrexate|mesh-list
64923911|NCT00027547|Fludarabine phosphate|fludarabine phosphate|mesh-list
64923912|NCT00027547|Fludarabine|fludarabine|mesh-list
64923913|NCT00027547|Cyclosporins|cyclosporins|mesh-list
64923914|NCT00027547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64923915|NCT00027547|Abortifacient Agents|abortifacient agents|mesh-ancestor
64923916|NCT00027547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64923917|NCT00027547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923918|NCT00027547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64923919|NCT00027547|Antimetabolites|antimetabolites|mesh-ancestor
64923947|NCT00011895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64923948|NCT00011895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64923949|NCT00011895|Antimetabolites|antimetabolites|mesh-ancestor
64923950|NCT00011895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64923951|NCT00011895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64923952|NCT00011895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64923953|NCT00011895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64923954|NCT00011895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64923955|NCT00011895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64923956|NCT00027586|Imatinib Mesylate|imatinib mesylate|mesh-list
64923957|NCT00027586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923958|NCT00027586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64923959|NCT00027586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923960|NCT00027586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923961|NCT00000464|Quinidine|quinidine|mesh-list
64923962|NCT00000464|Amiodarone|amiodarone|mesh-list
64923963|NCT00000464|Sotalol|sotalol|mesh-list
64923964|NCT00000464|Propafenone|propafenone|mesh-list
64526794|NCT03417388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64526795|NCT03417388|Antimetabolites|antimetabolites|mesh-ancestor
64526796|NCT03417388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64526797|NCT03417388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64526798|NCT03417388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64526799|NCT03417388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64526800|NCT03417388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64526801|NCT03417388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64734772|NCT02059434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64734773|NCT02059434|Respiratory System Agents|respiratory system agents|mesh-ancestor
64734774|NCT02059434|Parasympatholytics|parasympatholytics|mesh-ancestor
64734775|NCT02059434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64734776|NCT02059434|Cholinergic Agents|cholinergic agents|mesh-ancestor
64526802|NCT03417388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64526803|NCT03417388|Protease Inhibitors|protease inhibitors|mesh-ancestor
64526804|NCT03417388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64526805|NCT03417388|Protective Agents|protective agents|mesh-ancestor
64923995|NCT00000464|Cholinergic Agents|cholinergic agents|mesh-ancestor
64923996|NCT00000464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64923997|NCT00000464|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64923998|NCT00000464|Antidepressive Agents|antidepressive agents|mesh-ancestor
64923999|NCT00000464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64924000|NCT00000464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64924001|NCT00000464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64924002|NCT00027625|Temozolomide|temozolomide|mesh-list
64924003|NCT00027625|Gefitinib|gefitinib|mesh-list
64924004|NCT00027625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64924005|NCT00027625|Alkylating Agents|alkylating agents|mesh-ancestor
64924006|NCT00027625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924007|NCT00027625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924008|NCT00027625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64924009|NCT00027625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924010|NCT00027664|Interferons|interferons|mesh-list
64924011|NCT00027664|Interferon-alpha|interferon-alpha|mesh-list
64924012|NCT00027664|Thalidomide|thalidomide|mesh-list
64924013|NCT00027664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924014|NCT00027664|Antiviral Agents|antiviral agents|mesh-ancestor
64924015|NCT00027664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64924040|NCT00027703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924042|NCT00027703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64924043|NCT00027703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924044|NCT00027703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64924045|NCT00011934|Interferons|interferons|mesh-list
64924046|NCT00011934|Interferon-alpha|interferon-alpha|mesh-list
64924047|NCT00011934|Sargramostim|sargramostim|mesh-list
64924048|NCT00011934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924049|NCT00011934|Antiviral Agents|antiviral agents|mesh-ancestor
64924050|NCT00011934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64924051|NCT00011934|Immunologic Factors|immunologic factors|mesh-ancestor
64924052|NCT00011934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924053|NCT00027742|Interferons|interferons|mesh-list
64924054|NCT00027742|Interferon-alpha|interferon-alpha|mesh-list
64924055|NCT00027742|Temozolomide|temozolomide|mesh-list
64924056|NCT00027742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924057|NCT00027742|Antiviral Agents|antiviral agents|mesh-ancestor
64924058|NCT00027742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64924059|NCT00027742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64924060|NCT00027742|Alkylating Agents|alkylating agents|mesh-ancestor
64924061|NCT00027742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924062|NCT00027742|Immunologic Factors|immunologic factors|mesh-ancestor
64924063|NCT00027742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526808|NCT03382834|Vorinostat|vorinostat|mesh-list
64526809|NCT03382834|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64526810|NCT03382834|Hormone Antagonists|hormone antagonists|mesh-ancestor
64526811|NCT03382834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64526812|NCT03382834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526813|NCT03382834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64526816|NCT03382834|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64526817|NCT03382834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64526818|NCT03382834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64526819|NCT03382834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526820|NCT03382834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526821|NCT03382834|Antiviral Agents|antiviral agents|mesh-ancestor
64526822|NCT03382834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64526823|NCT02691702|Melatonin|melatonin|mesh-list
64526824|NCT02691702|Antioxidants|antioxidants|mesh-ancestor
64734777|NCT02059434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64924064|NCT00027820|Cyclosporine|cyclosporine|mesh-list
64924065|NCT00027820|Mycophenolic Acid|mycophenolic acid|mesh-list
64924066|NCT00027820|Fludarabine|fludarabine|mesh-list
64924067|NCT00027820|Fludarabine phosphate|fludarabine phosphate|mesh-list
64924099|NCT00027859|Tubulin Modulators|tubulin modulators|mesh-ancestor
64924100|NCT00027859|Antimitotic Agents|antimitotic agents|mesh-ancestor
64924101|NCT00027859|Mitosis Modulators|mitosis modulators|mesh-ancestor
64924102|NCT00027859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924103|NCT00027859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64924104|NCT00027859|Antifungal Agents|antifungal agents|mesh-ancestor
64924105|NCT00027859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64924106|NCT00027859|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64924107|NCT00027859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64924108|NCT00027859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924109|NCT00027859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64924110|NCT00027859|Hormone Antagonists|hormone antagonists|mesh-ancestor
64924138|NCT00027937|Mitosis Modulators|mitosis modulators|mesh-ancestor
64924139|NCT00027937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924140|NCT00027937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64924141|NCT00027937|Immunologic Factors|immunologic factors|mesh-ancestor
64924142|NCT00027937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924143|NCT00027937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64924144|NCT00027937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64924145|NCT00027937|Alkylating Agents|alkylating agents|mesh-ancestor
64924146|NCT00027937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64924147|NCT00027937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64924148|NCT00027937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64924149|NCT00027937|Antiviral Agents|antiviral agents|mesh-ancestor
64924150|NCT00027937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64924152|NCT00012051|Dexamethasone|dexamethasone|mesh-list
64924153|NCT00012051|Rituximab|rituximab|mesh-list
64924154|NCT00012051|Methotrexate|methotrexate|mesh-list
64924155|NCT00012051|Etoposide|etoposide|mesh-list
64924156|NCT00012051|Melphalan|melphalan|mesh-list
64924157|NCT00012051|Ifosfamide|ifosfamide|mesh-list
64924158|NCT00012051|Carmustine|carmustine|mesh-list
64924159|NCT00012051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64526825|NCT02691702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526827|NCT02691702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526828|NCT02691702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64526829|NCT01564277|Allopurinol|allopurinol|mesh-list
64526830|NCT01564277|Rasburicase|rasburicase|mesh-list
64526831|NCT01564277|Antimetabolites|antimetabolites|mesh-ancestor
64526832|NCT01564277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526833|NCT01564277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526834|NCT01564277|Gout Suppressants|gout suppressants|mesh-ancestor
64526835|NCT01564277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64526836|NCT01564277|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64924160|NCT00012051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924193|NCT00027976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64924194|NCT00027976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64924195|NCT00027976|Analgesics|analgesics|mesh-ancestor
64924196|NCT00027976|Sensory System Agents|sensory system agents|mesh-ancestor
64924197|NCT00027976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64924198|NCT00027976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924199|NCT00027976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64924200|NCT00027976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64924228|NCT00028132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64924229|NCT00028132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64924230|NCT00028132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64924231|NCT00028132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650074|NCT01490723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64924239|NCT00028171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64924240|NCT00028171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614480|NCT00375622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64614482|NCT03087604|Lidocaine|lidocaine|mesh-list
64924241|NCT00028171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924243|NCT00012090|Bicalutamide|bicalutamide|mesh-list
64924244|NCT00012090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64924245|NCT00012090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924246|NCT00012090|Androgen Antagonists|androgen antagonists|mesh-ancestor
64924247|NCT00012090|Hormone Antagonists|hormone antagonists|mesh-ancestor
64924248|NCT00012090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64924282|NCT00012129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924284|NCT00028288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64924285|NCT00028288|Immunologic Factors|immunologic factors|mesh-ancestor
64924286|NCT00028288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924287|NCT00012168|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
64924288|NCT00012168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64924323|NCT00028327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64924324|NCT00028327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64924325|NCT00028327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64924326|NCT00028327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64924327|NCT00028327|Protease Inhibitors|protease inhibitors|mesh-ancestor
64924328|NCT00028366|Ritonavir|ritonavir|mesh-list
64924329|NCT00028366|Lopinavir|lopinavir|mesh-list
64924363|NCT00012207|Glucocorticoids|glucocorticoids|mesh-ancestor
64924364|NCT00012207|Hormones|hormones|mesh-ancestor
64924365|NCT00012207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64526838|NCT01564277|Protective Agents|protective agents|mesh-ancestor
64526839|NCT01564277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526840|NCT03361306|Elotuzumab|elotuzumab|mesh-list
64526841|NCT03361306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526842|NCT01563185|Ibuprofen|ibuprofen|mesh-list
64526843|NCT01563185|Famotidine|famotidine|mesh-list
64526844|NCT01563185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64526845|NCT01563185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64526846|NCT01563185|Analgesics|analgesics|mesh-ancestor
64526847|NCT01563185|Sensory System Agents|sensory system agents|mesh-ancestor
64526848|NCT01563185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64924366|NCT00012207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64924367|NCT00012207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64924368|NCT00012207|Tubulin Modulators|tubulin modulators|mesh-ancestor
64924369|NCT00012207|Antimitotic Agents|antimitotic agents|mesh-ancestor
64924370|NCT00012207|Mitosis Modulators|mitosis modulators|mesh-ancestor
64924406|NCT00028600|Tacrolimus|tacrolimus|mesh-list
64924407|NCT00028600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64924408|NCT00028600|Immunologic Factors|immunologic factors|mesh-ancestor
64924409|NCT00028600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924410|NCT00028600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64924411|NCT00028600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64924412|NCT00028600|Alkylating Agents|alkylating agents|mesh-ancestor
64924413|NCT00028600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924441|NCT00012246|Immunologic Factors|immunologic factors|mesh-ancestor
64924442|NCT00012246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924443|NCT00012246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64924444|NCT00028717|Prednisone|prednisone|mesh-list
64924445|NCT00028717|Cyclophosphamide|cyclophosphamide|mesh-list
64924446|NCT00028717|Rituximab|rituximab|mesh-list
64924447|NCT00028717|Doxorubicin|doxorubicin|mesh-list
64924448|NCT00028717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64924449|NCT00028717|Vincristine|vincristine|mesh-list
64924450|NCT00028717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64924451|NCT00028717|Immunologic Factors|immunologic factors|mesh-ancestor
64924458|NCT00028717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64924459|NCT00028717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64924460|NCT00028717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64924461|NCT00028717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64924462|NCT00028717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64924492|NCT00028756|Abortifacient Agents|abortifacient agents|mesh-ancestor
64924493|NCT00028756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64924494|NCT00028756|Dermatologic Agents|dermatologic agents|mesh-ancestor
64924495|NCT00028756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64924496|NCT00028756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64924497|NCT00028756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64924498|NCT00028756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64924499|NCT00028756|Tubulin Modulators|tubulin modulators|mesh-ancestor
64924500|NCT00028756|Antimitotic Agents|antimitotic agents|mesh-ancestor
64924501|NCT00028756|Mitosis Modulators|mitosis modulators|mesh-ancestor
64924502|NCT00012324|Doxorubicin|doxorubicin|mesh-list
64924503|NCT00012324|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64924504|NCT00012324|Nolatrexed|nolatrexed|mesh-list
64924505|NCT00012324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64924506|NCT00012324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526849|NCT01563185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526850|NCT01563185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64526851|NCT01563185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64526852|NCT01563185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64526853|NCT01563185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526854|NCT01563185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526855|NCT01563185|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64526856|NCT01563185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64526857|NCT01563185|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64526858|NCT01563185|Histamine Antagonists|histamine antagonists|mesh-ancestor
64526859|NCT01563185|Histamine Agents|histamine agents|mesh-ancestor
64924507|NCT00012324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64924508|NCT00012324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64924534|NCT00388895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924535|NCT00388895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64924536|NCT00388895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924537|NCT00388895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924538|NCT00028834|Gemcitabine|gemcitabine|mesh-list
64924539|NCT00028834|Bevacizumab|bevacizumab|mesh-list
64924540|NCT00028834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64924541|NCT00028834|Antibodies|antibodies|mesh-list
64924542|NCT00028834|Immunoglobulins|immunoglobulins|mesh-list
64924543|NCT00028834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64924544|NCT00028834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924545|NCT00028834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64924546|NCT00028834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64924547|NCT00028834|Growth Substances|growth substances|mesh-ancestor
64924548|NCT00028834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924549|NCT00028834|Growth Inhibitors|growth inhibitors|mesh-ancestor
64924550|NCT00028834|Immunologic Factors|immunologic factors|mesh-ancestor
64924551|NCT00028834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64924552|NCT00028834|Antimetabolites|antimetabolites|mesh-ancestor
64924553|NCT00028834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924554|NCT00028834|Antiviral Agents|antiviral agents|mesh-ancestor
64924555|NCT00028834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64924581|NCT01803555|Respiratory System Agents|respiratory system agents|mesh-ancestor
64924583|NCT01803555|Hormones|hormones|mesh-ancestor
64924584|NCT01803555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64924585|NCT01803555|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64924586|NCT01803555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64924587|NCT01803555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64924596|NCT00028990|Antimitotic Agents|antimitotic agents|mesh-ancestor
64924597|NCT00028990|Mitosis Modulators|mitosis modulators|mesh-ancestor
64924598|NCT00028990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924599|NCT00028990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64924600|NCT00028990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64924601|NCT00028990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64614599|NCT02977065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64924602|NCT00028990|Growth Substances|growth substances|mesh-ancestor
64924603|NCT00028990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924604|NCT00028990|Growth Inhibitors|growth inhibitors|mesh-ancestor
64924605|NCT00000488|Cholestyramine Resin|cholestyramine resin|mesh-list
64924636|NCT00029380|Immunologic Factors|immunologic factors|mesh-ancestor
64924637|NCT00029380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924638|NCT00029380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64526861|NCT02974660|Protamines|protamines|mesh-list
64526862|NCT02974660|Heparin Antagonists|heparin antagonists|mesh-ancestor
64526863|NCT02974660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526864|NCT02974660|Coagulants|coagulants|mesh-ancestor
64526865|NCT03305848|Nitroglycerin|nitroglycerin|mesh-list
64526866|NCT03305848|Vasodilator Agents|vasodilator agents|mesh-ancestor
64526867|NCT01563029|Fluticasone|fluticasone|mesh-list
64526869|NCT01563029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64526870|NCT01563029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64526871|NCT01563029|Autonomic Agents|autonomic agents|mesh-ancestor
64526872|NCT01563029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526873|NCT01563029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526874|NCT01563029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64526875|NCT01563029|Respiratory System Agents|respiratory system agents|mesh-ancestor
64526876|NCT01563029|Dermatologic Agents|dermatologic agents|mesh-ancestor
64526877|NCT01563029|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64526878|NCT03295240|Rituximab|rituximab|mesh-list
64526879|NCT03295240|Venetoclax|venetoclax|mesh-list
64526880|NCT03295240|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64526881|NCT03295240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64526882|NCT03295240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526883|NCT03295240|Immunologic Factors|immunologic factors|mesh-ancestor
64526884|NCT03295240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924639|NCT00029380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64924640|NCT00029380|Alkylating Agents|alkylating agents|mesh-ancestor
64924641|NCT00029380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924642|NCT00029380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924643|NCT00029380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64924644|NCT00029380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924645|NCT00029380|Antifungal Agents|antifungal agents|mesh-ancestor
64924646|NCT00029380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64924647|NCT00029380|Dermatologic Agents|dermatologic agents|mesh-ancestor
64924648|NCT00029380|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64924649|NCT00029380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64924683|NCT00000494|Analgesics|analgesics|mesh-ancestor
64924684|NCT00000494|Sensory System Agents|sensory system agents|mesh-ancestor
64924685|NCT00000494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64924686|NCT00000494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924687|NCT00000494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64924688|NCT00000494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64924689|NCT00000494|Gout Suppressants|gout suppressants|mesh-ancestor
64924690|NCT00000494|Tocolytic Agents|tocolytic agents|mesh-ancestor
64924691|NCT00000494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64924721|NCT00029770|Analgesics|analgesics|mesh-ancestor
64924722|NCT00029770|Sensory System Agents|sensory system agents|mesh-ancestor
64924723|NCT00029770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526888|NCT03295240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526891|NCT03293368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64526892|NCT03293368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64526893|NCT03293368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64526894|NCT03293368|Glucocorticoids|glucocorticoids|mesh-ancestor
64526895|NCT03293368|Hormones|hormones|mesh-ancestor
64526896|NCT03293368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64526897|NCT03293368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526898|NCT03293368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64526899|NCT03293368|Immunologic Factors|immunologic factors|mesh-ancestor
64526900|NCT03293368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526901|NCT03293368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614671|NCT03953235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526902|NCT03273712|Octreotide|octreotide|mesh-list
64924727|NCT00029770|Narcotics|narcotics|mesh-ancestor
64924728|NCT00029770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64924729|NCT00029770|Antitussive Agents|antitussive agents|mesh-ancestor
64924730|NCT00029770|Respiratory System Agents|respiratory system agents|mesh-ancestor
64924731|NCT00029770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64924732|NCT00012558|Inositol|inositol|mesh-list
64924733|NCT00012558|Lamotrigine|lamotrigine|mesh-list
64924734|NCT00012558|Valproic Acid|valproic acid|mesh-list
64924762|NCT00012558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64924763|NCT00012558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64924764|NCT00012558|GABA Agents|gaba agents|mesh-ancestor
64924765|NCT00012558|Vitamin B Complex|vitamin b complex|mesh-ancestor
64924766|NCT00012558|Vitamins|vitamins|mesh-ancestor
64924767|NCT00012558|Micronutrients|micronutrients|mesh-ancestor
64924768|NCT00012558|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64924769|NCT00012558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64924770|NCT00395707|Ranibizumab|ranibizumab|mesh-list
64924771|NCT00395707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64924772|NCT00395707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64924773|NCT00395707|Growth Substances|growth substances|mesh-ancestor
64924774|NCT00395707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924775|NCT00395707|Growth Inhibitors|growth inhibitors|mesh-ancestor
64924776|NCT00395707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924777|NCT00000500|Aspirin|aspirin|mesh-list
64924778|NCT00000500|Carotenoids|carotenoids|mesh-list
64924779|NCT00000500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64924780|NCT00000500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64924815|NCT00000503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64924816|NCT00000503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924817|NCT00030004|Midazolam|midazolam|mesh-list
64924818|NCT00030004|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64924843|NCT00000518|Mexiletine|mexiletine|mesh-list
64924844|NCT00000518|Procainamide|procainamide|mesh-list
64924845|NCT00000518|Imipramine|imipramine|mesh-list
64924846|NCT00000518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64924847|NCT00000518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64924848|NCT00000518|Adrenergic Agents|adrenergic agents|mesh-ancestor
64924849|NCT00000518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64924850|NCT00000518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924851|NCT00000518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526904|NCT03273712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64526905|NCT03273712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64526906|NCT03273712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526907|NCT03273712|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64526908|NCT03273712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526910|NCT04113317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64526911|NCT04113317|Immunologic Factors|immunologic factors|mesh-ancestor
64526912|NCT04113317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526913|NCT04341844|Methylene Blue|methylene blue|mesh-list
64526914|NCT04341844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650096|NCT01491113|Nootropic Agents|nootropic agents|mesh-ancestor
64924860|NCT00000518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64924861|NCT00000518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924862|NCT00000518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64924863|NCT00000518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64924864|NCT00000518|Cholinergic Agents|cholinergic agents|mesh-ancestor
64924865|NCT00000518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64924866|NCT00000518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64924867|NCT00000518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64924868|NCT00000518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64924902|NCT00030433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924903|NCT00030433|Antiviral Agents|antiviral agents|mesh-ancestor
64924904|NCT00030433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64924905|NCT00030433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924906|NCT00030433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64924907|NCT00030433|Immunologic Factors|immunologic factors|mesh-ancestor
64924908|NCT00030433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924942|NCT00030511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924943|NCT00030511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64924944|NCT00030511|Immunologic Factors|immunologic factors|mesh-ancestor
64924945|NCT00030511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924946|NCT00030550|Thalidomide|thalidomide|mesh-list
64614740|NCT03096730|Dsuvia|dsuvia|mesh-list
64924947|NCT00030550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64924948|NCT00030550|Immunologic Factors|immunologic factors|mesh-ancestor
64924978|NCT00030745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924979|NCT00030745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64924980|NCT00030745|Antimetabolites|antimetabolites|mesh-ancestor
64924981|NCT00030745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924982|NCT00030745|Antiviral Agents|antiviral agents|mesh-ancestor
64924983|NCT00030745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64924984|NCT00030745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924985|NCT00030745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64924986|NCT00030745|Immunologic Factors|immunologic factors|mesh-ancestor
64924987|NCT00030745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924989|NCT00030784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64924990|NCT00030784|Ifosfamide|ifosfamide|mesh-list
64925019|NCT00000539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64925020|NCT00000539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64526917|NCT01561313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64526918|NCT01561313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64526919|NCT04111133|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64526920|NCT04111133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64526921|NCT04111133|Adrenergic Agents|adrenergic agents|mesh-ancestor
64526922|NCT04111133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64526923|NCT04111133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526924|NCT04111133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526925|NCT01561079|Buprenorphine|buprenorphine|mesh-list
64526926|NCT01561079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64526927|NCT01561079|Narcotics|narcotics|mesh-ancestor
64526928|NCT01561079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64526929|NCT01561079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526930|NCT01561079|Analgesics|analgesics|mesh-ancestor
64526931|NCT01561079|Sensory System Agents|sensory system agents|mesh-ancestor
64526932|NCT01561079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64925021|NCT00000539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64650103|NCT02252432|Methadone|methadone|mesh-list
64925031|NCT00030979|Nootropic Agents|nootropic agents|mesh-ancestor
64925032|NCT00031018|Interferon alpha-2|interferon alpha-2|mesh-list
64925033|NCT00031018|Donepezil|donepezil|mesh-list
64925034|NCT00031018|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64925035|NCT00031018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925036|NCT00031018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925037|NCT00031018|Cholinergic Agents|cholinergic agents|mesh-ancestor
64925069|NCT00031096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925070|NCT00031096|Dermatologic Agents|dermatologic agents|mesh-ancestor
64925071|NCT00031135|Choline|choline|mesh-list
64925072|NCT00031135|Lipotropic Agents|lipotropic agents|mesh-ancestor
64925073|NCT00031135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64925074|NCT00031135|Antimetabolites|antimetabolites|mesh-ancestor
64925075|NCT00031135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925076|NCT00031135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64925077|NCT00031135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64925078|NCT00031135|Nootropic Agents|nootropic agents|mesh-ancestor
64925079|NCT00031291|Immunoglobulins|immunoglobulins|mesh-list
64925080|NCT00031291|Antibodies|antibodies|mesh-list
64734781|NCT02059434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64734782|NCT02059434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64734783|NCT02059434|Adrenergic Agents|adrenergic agents|mesh-ancestor
64734784|NCT02059278|Latanoprost|latanoprost|mesh-list
64734785|NCT02059278|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64734786|NCT02059278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64734787|NCT04722354|Abscisic Acid|abscisic acid|mesh-list
64925081|NCT00031291|gamma-Globulins|gamma-globulins|mesh-list
64925082|NCT00031291|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64925083|NCT00031291|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64925107|NCT00396214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925109|NCT00000563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64925110|NCT00000563|Antiemetics|antiemetics|mesh-ancestor
64925111|NCT00000563|Autonomic Agents|autonomic agents|mesh-ancestor
64925112|NCT00000563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64925113|NCT00000563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925114|NCT00000563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64925115|NCT00000563|Glucocorticoids|glucocorticoids|mesh-ancestor
64925116|NCT00000563|Hormones|hormones|mesh-ancestor
64925117|NCT00000563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64526933|NCT01561079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64526934|NCT01559675|Hydrocortisone|hydrocortisone|mesh-list
64526935|NCT01559675|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64526936|NCT01559675|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64526937|NCT01559675|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64526938|NCT01559675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64526939|NCT01559675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64526940|NCT01559675|Methylprednisolone|methylprednisolone|mesh-list
64526941|NCT01559675|Prednisolone|prednisolone|mesh-list
64526942|NCT01559675|Prednisolone acetate|prednisolone acetate|mesh-list
64526943|NCT01559675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64526944|NCT01559675|Prednisolone phosphate|prednisolone phosphate|mesh-list
64526945|NCT01559675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64526946|NCT01559675|Glucocorticoids|glucocorticoids|mesh-ancestor
64526947|NCT01559675|Hormones|hormones|mesh-ancestor
64526948|NCT01559675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64526949|NCT01559675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526950|NCT01559675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64526951|NCT01559675|Protective Agents|protective agents|mesh-ancestor
64526952|NCT01559675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64526953|NCT01559675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64526954|NCT01559675|Antiemetics|antiemetics|mesh-ancestor
64526955|NCT01559675|Autonomic Agents|autonomic agents|mesh-ancestor
64526956|NCT01559675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64526957|NCT01559675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64526958|NCT01374906|Pasireotide|pasireotide|mesh-list
64321180|NCT02206711|Antiviral Agents|antiviral agents|mesh-ancestor
64321181|NCT02206711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64321182|NCT02206789|Cyclosporine|cyclosporine|mesh-list
64321183|NCT02206789|Prednisolone|prednisolone|mesh-list
64614867|NCT03102190|Vasodilator Agents|vasodilator agents|mesh-ancestor
64526959|NCT01374906|Hormones|hormones|mesh-ancestor
64925127|NCT00031564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64925128|NCT00031564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64925129|NCT00031564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64526964|NCT03228394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64526965|NCT03228394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526966|NCT03228394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526967|NCT03228394|GABA Modulators|gaba modulators|mesh-ancestor
64526968|NCT03228394|GABA Agents|gaba agents|mesh-ancestor
64526970|NCT00362596|Antiviral Agents|antiviral agents|mesh-ancestor
64526971|NCT00362596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64526972|NCT02974504|Linagliptin|linagliptin|mesh-list
64526973|NCT02974504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64526974|NCT02974504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526975|NCT02974504|Incretins|incretins|mesh-ancestor
64526976|NCT02974504|Hormones|hormones|mesh-ancestor
64526977|NCT02974504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64526978|NCT02974504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64526979|NCT02974504|Protease Inhibitors|protease inhibitors|mesh-ancestor
64526980|NCT02974504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64526981|NCT02974504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64526982|NCT03013504|Cyclophosphamide|cyclophosphamide|mesh-list
64526983|NCT03013504|Docetaxel|docetaxel|mesh-list
64526984|NCT03013504|Trastuzumab|trastuzumab|mesh-list
64925130|NCT00031564|Antiviral Agents|antiviral agents|mesh-ancestor
64925131|NCT00031564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64925162|NCT00031759|Imiquimod|imiquimod|mesh-list
64925163|NCT00031759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64925164|NCT00031759|Immunologic Factors|immunologic factors|mesh-ancestor
64925165|NCT00031759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925166|NCT00031759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925167|NCT00031759|Interferon Inducers|interferon inducers|mesh-ancestor
64925168|NCT01791816|Phenylephrine|phenylephrine|mesh-list
64925169|NCT01791816|Oxymetazoline|oxymetazoline|mesh-list
64925170|NCT01791816|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
64925171|NCT01791816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64925172|NCT01791816|Mydriatics|mydriatics|mesh-ancestor
64925173|NCT01791816|Autonomic Agents|autonomic agents|mesh-ancestor
64925174|NCT01791816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64925206|NCT00031837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64925207|NCT00031837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925208|NCT00031837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64925209|NCT00031837|Immunologic Factors|immunologic factors|mesh-ancestor
64526985|NCT03013504|Epirubicin|epirubicin|mesh-list
64526986|NCT03013504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64526987|NCT03013504|Immunologic Factors|immunologic factors|mesh-ancestor
64734798|NCT02019420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64734799|NCT02019420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734800|NCT02019420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734801|NCT02058966|Entacapone|entacapone|mesh-list
64734802|NCT02058966|Methamphetamine|methamphetamine|mesh-list
64734803|NCT02058966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64526988|NCT03013504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64526989|NCT03013504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64526990|NCT03013504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64526991|NCT03013504|Alkylating Agents|alkylating agents|mesh-ancestor
64526995|NCT03013504|Tubulin Modulators|tubulin modulators|mesh-ancestor
64526996|NCT03013504|Antimitotic Agents|antimitotic agents|mesh-ancestor
64526997|NCT03013504|Mitosis Modulators|mitosis modulators|mesh-ancestor
64526998|NCT03013504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64526999|NCT03013504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64527000|NCT03013504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64527001|NCT03013504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64527002|NCT03013504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527003|NCT02683746|rGLP-1 protein|rglp-1 protein|mesh-list
64527004|NCT02683746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64527005|NCT02683746|Incretins|incretins|mesh-ancestor
64527006|NCT02683746|Hormones|hormones|mesh-ancestor
64527007|NCT02683746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64527008|NCT02683746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527009|NCT01559129|Pomalidomide|pomalidomide|mesh-list
64527010|NCT01559129|Immunologic Factors|immunologic factors|mesh-ancestor
64527011|NCT01559129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527012|NCT01559129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64527013|NCT01559129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64527014|NCT01559129|Growth Substances|growth substances|mesh-ancestor
64527015|NCT01559129|Growth Inhibitors|growth inhibitors|mesh-ancestor
64527016|NCT01559129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527017|NCT02691468|Silicon|silicon|mesh-list
64527018|NCT02691468|Trace Elements|trace elements|mesh-ancestor
64527019|NCT02691468|Micronutrients|micronutrients|mesh-ancestor
64527020|NCT02691468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527021|NCT03162120|Metoprolol|metoprolol|mesh-list
64527024|NCT03162120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64527025|NCT03162120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64527026|NCT03162120|Sympatholytics|sympatholytics|mesh-ancestor
64527027|NCT03162120|Autonomic Agents|autonomic agents|mesh-ancestor
64527028|NCT03162120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64527029|NCT03162120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527030|NCT03162120|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64527031|NCT03162120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64527032|NCT03162120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64527033|NCT03162120|Adrenergic Agents|adrenergic agents|mesh-ancestor
64527034|NCT03162120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64527035|NCT03162120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527036|NCT03162120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64527037|NCT03162120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64527038|NCT03162120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64527039|NCT02683668|Tiotropium Bromide|tiotropium bromide|mesh-list
64925210|NCT00031837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925211|NCT00031837|Anticoagulants|anticoagulants|mesh-ancestor
64925212|NCT00031837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64925213|NCT00031837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64925215|NCT00031876|Capecitabine|capecitabine|mesh-list
64925243|NCT00031954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64925244|NCT00031954|Immunologic Factors|immunologic factors|mesh-ancestor
64925245|NCT00031954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925246|NCT00031993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64925247|NCT00031993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925248|NCT00031993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64925249|NCT00031993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925250|NCT00031993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925251|NCT00000575|Nedocromil|nedocromil|mesh-list
64925252|NCT00000575|Budesonide|budesonide|mesh-list
64734824|NCT02017860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734825|NCT02040870|Ceritinib|ceritinib|mesh-list
64734826|NCT02040870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734827|NCT02040870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64734828|NCT02040870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925253|NCT00000575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64925254|NCT00000575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64925255|NCT00000575|Autonomic Agents|autonomic agents|mesh-ancestor
64925256|NCT00000575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64925257|NCT00000575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925258|NCT00000575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64925259|NCT00000575|Respiratory System Agents|respiratory system agents|mesh-ancestor
64925260|NCT00000575|Glucocorticoids|glucocorticoids|mesh-ancestor
64925261|NCT00000575|Hormones|hormones|mesh-ancestor
64925291|NCT00032149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925300|NCT00032149|Mitosis Modulators|mitosis modulators|mesh-ancestor
64925301|NCT00032149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64925302|NCT00032149|Glucocorticoids|glucocorticoids|mesh-ancestor
64925303|NCT00032149|Hormones|hormones|mesh-ancestor
64925304|NCT00032149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64527040|NCT02683668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64527041|NCT02683668|Autonomic Agents|autonomic agents|mesh-ancestor
64527042|NCT02683668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64527043|NCT02683668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527044|NCT02683668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64527045|NCT02683668|Respiratory System Agents|respiratory system agents|mesh-ancestor
64527046|NCT02683668|Parasympatholytics|parasympatholytics|mesh-ancestor
64527047|NCT02683668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64527048|NCT02683668|Cholinergic Agents|cholinergic agents|mesh-ancestor
64527049|NCT02683668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64527050|NCT02683668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527051|NCT03114228|Midostaurin|midostaurin|mesh-list
64527052|NCT03114228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527053|NCT03114228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64527054|NCT03114228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527055|NCT03114228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527056|NCT02678286|Meloxicam|meloxicam|mesh-list
64527057|NCT02678286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64527058|NCT02678286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64527059|NCT02678286|Analgesics|analgesics|mesh-ancestor
64527060|NCT02678286|Sensory System Agents|sensory system agents|mesh-ancestor
64527061|NCT02678286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64527062|NCT02678286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925305|NCT00032149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64925306|NCT00032149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64925307|NCT00032149|Analgesics|analgesics|mesh-ancestor
64925308|NCT00032149|Sensory System Agents|sensory system agents|mesh-ancestor
64925342|NCT00000596|Hormones|hormones|mesh-ancestor
64925343|NCT00000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64925344|NCT00000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64925345|NCT00000596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64925346|NCT00000596|Antimalarials|antimalarials|mesh-ancestor
64925347|NCT00000596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64925348|NCT00000596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64925349|NCT00000596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64925350|NCT00000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925351|NCT00000596|Leprostatic Agents|leprostatic agents|mesh-ancestor
64925352|NCT00000596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64925375|NCT00032734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925376|NCT00032773|Pentostatin|pentostatin|mesh-list
64925377|NCT00032773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925378|NCT00032773|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
64925379|NCT00032773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925380|NCT00032773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925381|NCT00032812|Raclopride|raclopride|mesh-list
64734832|NCT04720716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64734833|NCT04720716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925382|NCT00032812|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64925383|NCT00032812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64925384|NCT00032812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64925385|NCT00032812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527063|NCT02678286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64650131|NCT01492673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527064|NCT02678286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64527073|NCT03164694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527074|NCT03164694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527075|NCT03164694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64527076|NCT03164694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64527077|NCT03164694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64527079|NCT04775550|Lenalidomide|lenalidomide|mesh-list
64527080|NCT04775550|Bortezomib|bortezomib|mesh-list
64527081|NCT04775550|Daratumumab|daratumumab|mesh-list
64527082|NCT04775550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64527083|NCT04775550|Antiemetics|antiemetics|mesh-ancestor
64527084|NCT04775550|Autonomic Agents|autonomic agents|mesh-ancestor
64527085|NCT04775550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64527086|NCT04775550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527087|NCT04775550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64527088|NCT04775550|Glucocorticoids|glucocorticoids|mesh-ancestor
64527089|NCT04775550|Hormones|hormones|mesh-ancestor
64527090|NCT04775550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64925386|NCT00032812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64925387|NCT00032812|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64925388|NCT00032812|Dopamine Agents|dopamine agents|mesh-ancestor
64925389|NCT00032812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64925390|NCT00032812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925391|NCT00032890|Celecoxib|celecoxib|mesh-list
64925392|NCT00032890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64925393|NCT00032890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64925394|NCT00032890|Analgesics|analgesics|mesh-ancestor
64925395|NCT00032890|Sensory System Agents|sensory system agents|mesh-ancestor
64925396|NCT00032890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64925397|NCT00032890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925398|NCT00032890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64925399|NCT00032890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64925400|NCT00032890|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64925401|NCT00032890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64527091|NCT04775550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64527092|NCT04775550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527093|NCT04775550|Immunologic Factors|immunologic factors|mesh-ancestor
64527094|NCT04775550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64527095|NCT04775550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64527096|NCT04775550|Growth Substances|growth substances|mesh-ancestor
64527097|NCT04775550|Growth Inhibitors|growth inhibitors|mesh-ancestor
64527098|NCT02930902|Gemcitabine|gemcitabine|mesh-list
64527099|NCT02930902|Paclitaxel|paclitaxel|mesh-list
64527100|NCT02930902|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64734844|NCT02015676|Tubulin Modulators|tubulin modulators|mesh-ancestor
64734845|NCT02015676|Antimitotic Agents|antimitotic agents|mesh-ancestor
64734846|NCT02015676|Mitosis Modulators|mitosis modulators|mesh-ancestor
64527101|NCT02930902|Pembrolizumab|pembrolizumab|mesh-list
64527102|NCT02930902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64925402|NCT00032890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925403|NCT00032890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925404|NCT00032929|Selegiline|selegiline|mesh-list
64925412|NCT00032929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64925413|NCT00032929|Protective Agents|protective agents|mesh-ancestor
64925414|NCT00032929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925415|NCT00000611|Vitamin D|vitamin d|mesh-list
64925416|NCT00000611|Calcium|calcium|mesh-list
64925417|NCT00000611|Hormones|hormones|mesh-list
64925418|NCT00000611|Estrogens|estrogens|mesh-list
64650139|NCT01492673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64925419|NCT00000611|Progestins|progestins|mesh-list
64925420|NCT00000611|Vitamins|vitamins|mesh-ancestor
64925421|NCT00000611|Micronutrients|micronutrients|mesh-ancestor
64650141|NCT00818324|Rebamipide|rebamipide|mesh-list
64925427|NCT00032968|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64925428|NCT00032968|Naloxone|naloxone|mesh-list
64925429|NCT00032968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64925431|NCT00032968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64925432|NCT00032968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925433|NCT00032968|Analgesics|analgesics|mesh-ancestor
64925434|NCT00032968|Sensory System Agents|sensory system agents|mesh-ancestor
64925435|NCT00032968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64925436|NCT00032968|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64925437|NCT00033046|Modafinil|modafinil|mesh-list
64925438|NCT00033046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64925439|NCT00033046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925440|NCT00033046|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64925441|NCT00033046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64925442|NCT00033046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64925443|NCT00033046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925444|NCT00033085|Ondansetron|ondansetron|mesh-list
64925445|NCT00033085|Antiemetics|antiemetics|mesh-ancestor
64925446|NCT00033085|Autonomic Agents|autonomic agents|mesh-ancestor
64925447|NCT00033085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64925448|NCT00033085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925449|NCT00033085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64925450|NCT00033085|Antipruritics|antipruritics|mesh-ancestor
64925451|NCT00033085|Dermatologic Agents|dermatologic agents|mesh-ancestor
64925452|NCT00033085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64925453|NCT00033085|Serotonin Agents|serotonin agents|mesh-ancestor
64925454|NCT00033085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64925455|NCT00033085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925456|NCT00033085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64925457|NCT00033085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64925458|NCT00033085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64925459|NCT00033085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64527103|NCT02930902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527104|NCT02930902|Tubulin Modulators|tubulin modulators|mesh-ancestor
64527105|NCT02930902|Antimitotic Agents|antimitotic agents|mesh-ancestor
64527106|NCT02930902|Mitosis Modulators|mitosis modulators|mesh-ancestor
64527107|NCT02930902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527108|NCT02930902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64527109|NCT02930902|Antimetabolites|antimetabolites|mesh-ancestor
64527110|NCT02930902|Antiviral Agents|antiviral agents|mesh-ancestor
64527111|NCT02930902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64527112|NCT02930902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527113|NCT02930902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64527114|NCT02930902|Immunologic Factors|immunologic factors|mesh-ancestor
64925460|NCT00033085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64925461|NCT00033163|Tenofovir|tenofovir|mesh-list
64925462|NCT00033163|Adefovir|adefovir|mesh-list
64925463|NCT00033163|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64925464|NCT00033163|Antiviral Agents|antiviral agents|mesh-ancestor
64925465|NCT00033163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64925466|NCT00033163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64925467|NCT00033163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64925468|NCT00033163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925469|NCT00033163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925470|NCT00033163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64925471|NCT00033163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64925472|NCT00033241|Gemcitabine|gemcitabine|mesh-list
64925473|NCT00033241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64925501|NCT00000620|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64925502|NCT00000620|Carvedilol|carvedilol|mesh-list
64925503|NCT00000620|Candesartan|candesartan|mesh-list
64925504|NCT00000620|Candesartan cilexetil|candesartan cilexetil|mesh-list
64925505|NCT00000620|Lisinopril|lisinopril|mesh-list
64650147|NCT00818324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925515|NCT00000620|Furosemide|furosemide|mesh-list
64925516|NCT00000620|Simvastatin|simvastatin|mesh-list
64925517|NCT00000620|Fenofibrate|fenofibrate|mesh-list
64925518|NCT00000620|Terazosin|terazosin|mesh-list
64925519|NCT00000620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925520|NCT00000620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64925521|NCT00000620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64925522|NCT00000620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925523|NCT00000620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64925524|NCT00000620|Vasodilator Agents|vasodilator agents|mesh-ancestor
64925525|NCT00000620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64925526|NCT00000620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64925527|NCT00000620|Antimetabolites|antimetabolites|mesh-ancestor
64925528|NCT00000620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64925529|NCT00000620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64925553|NCT00000620|Protease Inhibitors|protease inhibitors|mesh-ancestor
64925554|NCT00000620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64925555|NCT00000620|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64925556|NCT00000620|Urological Agents|urological agents|mesh-ancestor
64925557|NCT00000620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64925558|NCT00000620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64925559|NCT00000620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64925560|NCT00000620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64925561|NCT00000620|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64527116|NCT02930902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64527117|NCT02905318|Palbociclib|palbociclib|mesh-list
64527118|NCT02905318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527119|NCT02905318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64527120|NCT02905318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527121|NCT02905318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527122|NCT02824276|Morphine|morphine|mesh-list
64527123|NCT02824276|Oxycodone|oxycodone|mesh-list
64925562|NCT00000620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64925563|NCT00000620|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64925564|NCT00000620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64925565|NCT00000620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64925566|NCT00033280|Temozolomide|temozolomide|mesh-list
64925567|NCT00033280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64925568|NCT00033280|Alkylating Agents|alkylating agents|mesh-ancestor
64925569|NCT00033280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925570|NCT00033280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925571|NCT00033319|Aspirin|aspirin|mesh-list
64925572|NCT00033319|Folic Acid|folic acid|mesh-list
64925573|NCT00033319|Hematinics|hematinics|mesh-ancestor
64925574|NCT00033319|Vitamin B Complex|vitamin b complex|mesh-ancestor
64925575|NCT00033319|Vitamins|vitamins|mesh-ancestor
64925576|NCT00033319|Micronutrients|micronutrients|mesh-ancestor
64925577|NCT00033319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925603|NCT00033358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64925604|NCT00033358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64925605|NCT00033358|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64925606|NCT00033358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64925607|NCT00033358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64925608|NCT00033358|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64925609|NCT00033358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64925610|NCT00033358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925611|NCT02971696|Sorafenib|sorafenib|mesh-list
64734866|NCT04678050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64734870|NCT04678050|Anesthetics|anesthetics|mesh-ancestor
64925612|NCT02971696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650158|NCT01419275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64925618|NCT00033436|Nicotinic Acids|nicotinic acids|mesh-list
64925619|NCT00033436|Vitamin B Complex|vitamin b complex|mesh-ancestor
64925620|NCT00033436|Vitamins|vitamins|mesh-ancestor
64925621|NCT00033436|Micronutrients|micronutrients|mesh-ancestor
64925622|NCT00033436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925623|NCT00033436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64925624|NCT00033436|Antimetabolites|antimetabolites|mesh-ancestor
64925625|NCT00033436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925626|NCT00033436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64925627|NCT00033436|Vasodilator Agents|vasodilator agents|mesh-ancestor
64925658|NCT00033592|Autonomic Agents|autonomic agents|mesh-ancestor
64925659|NCT00033592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64925660|NCT00033592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925661|NCT00033592|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64925662|NCT00033592|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64925663|NCT00033592|Cholinergic Agents|cholinergic agents|mesh-ancestor
64925664|NCT00033592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64925665|NCT00033592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925666|NCT00033592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64925667|NCT00033592|Antidepressive Agents|antidepressive agents|mesh-ancestor
64925668|NCT00033592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64925669|NCT00033592|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64925670|NCT00033592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64925671|NCT00033592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64527125|NCT02824276|Narcotics|narcotics|mesh-ancestor
64527126|NCT02824276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64527127|NCT02824276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527128|NCT02824276|Analgesics|analgesics|mesh-ancestor
64527129|NCT02824276|Sensory System Agents|sensory system agents|mesh-ancestor
64527130|NCT02824276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64527131|NCT02767804|Crizotinib|crizotinib|mesh-list
64925672|NCT00033592|Dopamine Agents|dopamine agents|mesh-ancestor
64925673|NCT00033592|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64925702|NCT00033709|Growth Substances|growth substances|mesh-ancestor
64925703|NCT00033709|Growth Inhibitors|growth inhibitors|mesh-ancestor
64925704|NCT00033748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64925706|NCT00033748|Immunoglobulins|immunoglobulins|mesh-list
64925707|NCT00033748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64925708|NCT00033748|Immunologic Factors|immunologic factors|mesh-ancestor
64925709|NCT00033748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925710|NCT00033748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925711|NCT00000641|Azithromycin|azithromycin|mesh-list
64925712|NCT00000641|Ciprofloxacin|ciprofloxacin|mesh-list
64925713|NCT00000641|Rifampin|rifampin|mesh-list
64925714|NCT00000641|Amikacin|amikacin|mesh-list
64925715|NCT00000641|Ethambutol|ethambutol|mesh-list
64925716|NCT00000641|Clofazimine|clofazimine|mesh-list
64925717|NCT00000641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64925718|NCT00000641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64925719|NCT00000641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64925720|NCT00000641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64925728|NCT00000641|Leprostatic Agents|leprostatic agents|mesh-ancestor
64925729|NCT00000641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64925730|NCT00000641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64925731|NCT00000641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64925732|NCT00000641|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64925733|NCT00000641|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64734877|NCT04678050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64734878|NCT04678050|Adrenergic Agents|adrenergic agents|mesh-ancestor
64734879|NCT04678050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64734880|NCT04678050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734881|NCT04678050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64734882|NCT04678050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64734883|NCT04678050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64925734|NCT00000641|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64925735|NCT00000641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64925736|NCT00000641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64925737|NCT00000644|Clarithromycin|clarithromycin|mesh-list
64925738|NCT00000644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64925739|NCT00000644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64925740|NCT00000644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64925741|NCT00000644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650170|NCT02155010|Analgesics|analgesics|mesh-ancestor
64925748|NCT02971423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64925749|NCT02971423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64925750|NCT02971423|Protease Inhibitors|protease inhibitors|mesh-ancestor
64925751|NCT02971423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925752|NCT02971423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925753|NCT02971423|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64925754|NCT00389051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64925755|NCT00389051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64925756|NCT00389051|Alkylating Agents|alkylating agents|mesh-ancestor
64925757|NCT00389051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925758|NCT00389051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925759|NCT00389090|Temozolomide|temozolomide|mesh-list
64925760|NCT00389090|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64925761|NCT00389090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64925762|NCT00389090|Alkylating Agents|alkylating agents|mesh-ancestor
64925763|NCT00389090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925764|NCT00389090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925765|NCT00389090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925766|NCT00033982|Posaconazole|posaconazole|mesh-list
64527132|NCT02767804|Ensartinib|ensartinib|mesh-list
64527133|NCT02767804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527134|NCT02767804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64527135|NCT02767804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527136|NCT02767804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527137|NCT02741128|Vaccines|vaccines|mesh-list
64527138|NCT02741128|Immunologic Factors|immunologic factors|mesh-ancestor
64527139|NCT02741128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527140|NCT01566721|Trastuzumab|trastuzumab|mesh-list
64527141|NCT01566721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64527142|NCT01566721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527143|NCT01541215|Metformin|metformin|mesh-list
64527144|NCT01541215|Liraglutide|liraglutide|mesh-list
64527145|NCT01541215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64527146|NCT01541215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527147|NCT01541215|Incretins|incretins|mesh-ancestor
64527148|NCT01541215|Hormones|hormones|mesh-ancestor
64527149|NCT01541215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64527150|NCT01585987|Ipilimumab|ipilimumab|mesh-list
64527151|NCT01585987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64527152|NCT01585987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527153|NCT01585987|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64527154|NCT01585987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527155|NCT01585831|Testosterone|testosterone|mesh-list
64527156|NCT01585831|Androgens|androgens|mesh-ancestor
64527157|NCT01585831|Hormones|hormones|mesh-ancestor
64527158|NCT01585831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64321185|NCT02206789|Methylprednisolone|methylprednisolone|mesh-list
64321186|NCT02206789|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64321187|NCT02206789|Prednisolone acetate|prednisolone acetate|mesh-list
64615321|NCT03001726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615327|NCT03001726|Antimetabolites|antimetabolites|mesh-ancestor
64321188|NCT02206789|Cyclosporins|cyclosporins|mesh-list
64527159|NCT01585831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527160|NCT01565941|Insulin|insulin|mesh-list
64527161|NCT01565941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64527162|NCT01565941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64527163|NCT01565941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527164|NCT01558271|Liraglutide|liraglutide|mesh-list
64527165|NCT01558271|Dulaglutide|dulaglutide|mesh-list
64527166|NCT01558271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64527167|NCT01558271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527168|NCT01558271|Incretins|incretins|mesh-ancestor
64527170|NCT01558271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64527172|NCT01565707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64527173|NCT01565707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64527174|NCT01565707|Cholinergic Agents|cholinergic agents|mesh-ancestor
64527175|NCT01565707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64527176|NCT01565707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925767|NCT00033982|Antifungal Agents|antifungal agents|mesh-ancestor
64925768|NCT00033982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64925776|NCT00033982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64925777|NCT00033982|Hormone Antagonists|hormone antagonists|mesh-ancestor
64925778|NCT00033982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64925779|NCT00033982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925781|NCT00034060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64925782|NCT00034060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64925783|NCT00034060|Analgesics|analgesics|mesh-ancestor
64925784|NCT00034060|Sensory System Agents|sensory system agents|mesh-ancestor
64925815|NCT00389129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64925817|NCT00389129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925818|NCT00389129|Antipyretics|antipyretics|mesh-ancestor
64925820|NCT00013962|Vitamins|vitamins|mesh-ancestor
64925821|NCT00013962|Micronutrients|micronutrients|mesh-ancestor
64925822|NCT00013962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925823|NCT00013962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64925824|NCT00000665|Ganciclovir|ganciclovir|mesh-list
64925825|NCT00000665|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64925826|NCT00000665|Foscarnet|foscarnet|mesh-list
64925827|NCT00000665|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
64925857|NCT00014001|Antiemetics|antiemetics|mesh-ancestor
64925858|NCT00014001|Autonomic Agents|autonomic agents|mesh-ancestor
64925859|NCT00014001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64925860|NCT00014001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64925861|NCT00014001|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64925862|NCT00014001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64925863|NCT00014001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64925864|NCT00014001|Antidepressive Agents|antidepressive agents|mesh-ancestor
64925865|NCT00014001|GABA Antagonists|gaba antagonists|mesh-ancestor
64925866|NCT00014001|GABA Agents|gaba agents|mesh-ancestor
64925867|NCT00000671|Zidovudine|zidovudine|mesh-list
64925868|NCT00000671|Didanosine|didanosine|mesh-list
64925869|NCT00000671|Antimetabolites|antimetabolites|mesh-ancestor
64925870|NCT00000671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925871|NCT00000671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64925872|NCT00000671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64925873|NCT00000671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925874|NCT00000671|Antiviral Agents|antiviral agents|mesh-ancestor
64925875|NCT00000671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64925910|NCT00396487|Fluorouracil|fluorouracil|mesh-list
64925911|NCT00396487|Capecitabine|capecitabine|mesh-list
64925913|NCT00396487|Antimetabolites|antimetabolites|mesh-ancestor
64925914|NCT00396487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321189|NCT02206789|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64734885|NCT02038920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64734886|NCT01622868|Lapatinib|lapatinib|mesh-list
64734887|NCT01622868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734888|NCT01622868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64734889|NCT01622868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615376|NCT01023841|Bimatoprost|bimatoprost|mesh-list
64925915|NCT00396487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64925916|NCT00396487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925917|NCT00396487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64925918|NCT00396487|Immunologic Factors|immunologic factors|mesh-ancestor
64925943|NCT00000674|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64925944|NCT00000674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64925945|NCT00000674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64527177|NCT01565707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527178|NCT01565707|Urological Agents|urological agents|mesh-ancestor
64527179|NCT01557569|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64527180|NCT01557569|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64527181|NCT01557569|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64527182|NCT01557569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64527183|NCT01557569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527184|NCT01557569|Adrenergic Agents|adrenergic agents|mesh-ancestor
64527185|NCT01557569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64925953|NCT00014040|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64925955|NCT00014040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925956|NCT00014040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64925957|NCT00014040|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64925958|NCT00014040|Vasodilator Agents|vasodilator agents|mesh-ancestor
64925959|NCT00014040|Gasotransmitters|gasotransmitters|mesh-ancestor
64925960|NCT00014040|Protective Agents|protective agents|mesh-ancestor
64925961|NCT00034528|Prednisone|prednisone|mesh-list
64925962|NCT00034528|Fludarabine|fludarabine|mesh-list
64925964|NCT00034528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64925965|NCT00034528|Glucocorticoids|glucocorticoids|mesh-ancestor
64925966|NCT00034528|Hormones|hormones|mesh-ancestor
64925967|NCT00034528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64925968|NCT00034528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925969|NCT00034528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64925970|NCT00034528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925971|NCT00034528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925972|NCT00034528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64926004|NCT00034645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64926005|NCT00034645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64926006|NCT00034645|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64926007|NCT00034645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64926008|NCT00034645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926009|NCT00034645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926010|NCT00034645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64926011|NCT00034645|Hormone Antagonists|hormone antagonists|mesh-ancestor
64926012|NCT00034645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64926013|NCT00034645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926014|NCT00014118|Paclitaxel|paclitaxel|mesh-list
64926015|NCT00014118|Carboplatin|carboplatin|mesh-list
64926016|NCT00014118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64926040|NCT00000686|Antiviral Agents|antiviral agents|mesh-ancestor
64926041|NCT00000686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926042|NCT00000686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64926043|NCT00000686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64926044|NCT00034801|Olanzapine|olanzapine|mesh-list
64926045|NCT00034801|Ziprasidone|ziprasidone|mesh-list
64926046|NCT00034801|Antiemetics|antiemetics|mesh-ancestor
64926047|NCT00034801|Autonomic Agents|autonomic agents|mesh-ancestor
64926048|NCT00034801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64926049|NCT00034801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926050|NCT00034801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64527187|NCT04756271|Antibodies|antibodies|mesh-list
64527188|NCT04756271|Antibodies, Blocking|antibodies, blocking|mesh-list
64527189|NCT04756271|Immunologic Factors|immunologic factors|mesh-ancestor
64527190|NCT04756271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527191|NCT01538719|Rilonacept|rilonacept|mesh-list
64527192|NCT01538719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64527193|NCT01537783|Chlorhexidine|chlorhexidine|mesh-list
64527194|NCT01537783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64527195|NCT01537783|Mupirocin|mupirocin|mesh-list
64527196|NCT01537783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64527197|NCT01537783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64527198|NCT01537783|Disinfectants|disinfectants|mesh-ancestor
64527199|NCT01537783|Dermatologic Agents|dermatologic agents|mesh-ancestor
64527200|NCT01537783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64527201|NCT01537783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64650183|NCT01495481|Analgesics|analgesics|mesh-ancestor
64926058|NCT00034801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926059|NCT00034801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64926060|NCT00034801|Serotonin Agents|serotonin agents|mesh-ancestor
64926061|NCT00034801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64926062|NCT00034801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64926063|NCT00034801|Dopamine Agents|dopamine agents|mesh-ancestor
64926065|NCT00014196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926066|NCT00014196|Tubulin Modulators|tubulin modulators|mesh-ancestor
64926067|NCT00014196|Antimitotic Agents|antimitotic agents|mesh-ancestor
64926068|NCT00014196|Mitosis Modulators|mitosis modulators|mesh-ancestor
64926069|NCT00014196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926091|NCT00000689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64926092|NCT00000689|Alkylating Agents|alkylating agents|mesh-ancestor
64926093|NCT00000689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926094|NCT00000689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926095|NCT00000689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64926096|NCT00000689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64926098|NCT00000689|Autonomic Agents|autonomic agents|mesh-ancestor
64926099|NCT00000689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64926100|NCT00000689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64926101|NCT00000689|Glucocorticoids|glucocorticoids|mesh-ancestor
64926102|NCT00000689|Hormones|hormones|mesh-ancestor
64926103|NCT00000689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64926104|NCT00000689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64926105|NCT00000689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64926106|NCT00000689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64926107|NCT00000689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64926108|NCT00000689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926109|NCT00000689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64926110|NCT00000689|Abortifacient Agents|abortifacient agents|mesh-ancestor
64926111|NCT00000689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64694523|NCT02792465|Fulvestrant|fulvestrant|mesh-list
64926112|NCT00000689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64926113|NCT00000689|Antimetabolites|antimetabolites|mesh-ancestor
64527203|NCT01537783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527204|NCT01556165|Rasagiline|rasagiline|mesh-list
64527205|NCT01556165|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64527206|NCT01556165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734890|NCT01622868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734892|NCT02014740|Liraglutide|liraglutide|mesh-list
64734893|NCT02014740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64734894|NCT02014740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527207|NCT01556165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527208|NCT01556165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64527209|NCT01556165|Protective Agents|protective agents|mesh-ancestor
64527210|NCT01556165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527211|NCT01537549|Thioctic Acid|thioctic acid|mesh-list
64527212|NCT01537549|Acetylcarnitine|acetylcarnitine|mesh-list
64527213|NCT01537549|Antioxidants|antioxidants|mesh-ancestor
64527214|NCT01537549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527216|NCT01537549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527217|NCT01537549|Vitamin B Complex|vitamin b complex|mesh-ancestor
64527218|NCT01537549|Vitamins|vitamins|mesh-ancestor
64527219|NCT01537549|Micronutrients|micronutrients|mesh-ancestor
64527220|NCT01537549|Nootropic Agents|nootropic agents|mesh-ancestor
64527221|NCT01555931|Levonorgestrel|levonorgestrel|mesh-list
64527222|NCT01555931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64527223|NCT01555931|Contraceptive Agents|contraceptive agents|mesh-ancestor
64650191|NCT01495481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926120|NCT00000689|Protective Agents|protective agents|mesh-ancestor
64926121|NCT00000689|Vitamin B Complex|vitamin b complex|mesh-ancestor
64926122|NCT00000689|Vitamins|vitamins|mesh-ancestor
64926123|NCT00000689|Micronutrients|micronutrients|mesh-ancestor
64926124|NCT00000689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64926125|NCT00000689|Tubulin Modulators|tubulin modulators|mesh-ancestor
64926126|NCT00000689|Antimitotic Agents|antimitotic agents|mesh-ancestor
64926162|NCT00000710|Antimetabolites|antimetabolites|mesh-ancestor
64926163|NCT00000710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926164|NCT00000710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64926165|NCT00000710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64926166|NCT00000710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926167|NCT00000710|Antiviral Agents|antiviral agents|mesh-ancestor
64926189|NCT00014274|Antiviral Agents|antiviral agents|mesh-ancestor
64926190|NCT00014274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926191|NCT00014274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926192|NCT00014274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64926193|NCT00014274|Immunologic Factors|immunologic factors|mesh-ancestor
64926194|NCT00014274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926195|NCT00014274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64926196|NCT00014274|Abortifacient Agents|abortifacient agents|mesh-ancestor
64926197|NCT00014274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64926198|NCT00014274|Dermatologic Agents|dermatologic agents|mesh-ancestor
64527227|NCT01555931|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64527228|NCT01555931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64527230|NCT01583179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64527231|NCT01583179|Narcotics|narcotics|mesh-ancestor
64527232|NCT01583179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64527233|NCT01583179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527234|NCT01583179|Analgesics|analgesics|mesh-ancestor
64527235|NCT01583179|Sensory System Agents|sensory system agents|mesh-ancestor
64527236|NCT01583179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64527237|NCT01583179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64527238|NCT01582945|Ketamine|ketamine|mesh-list
64527239|NCT01582945|Analgesics|analgesics|mesh-ancestor
64527240|NCT01582945|Sensory System Agents|sensory system agents|mesh-ancestor
64527241|NCT01582945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64527242|NCT01582945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527243|NCT01582945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64527244|NCT01582945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64527245|NCT01582945|Anesthetics, General|anesthetics, general|mesh-ancestor
64926199|NCT00014274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64926200|NCT00014274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64926201|NCT00014274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64926202|NCT00014274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64926203|NCT00014274|Tubulin Modulators|tubulin modulators|mesh-ancestor
64926204|NCT00014274|Antimitotic Agents|antimitotic agents|mesh-ancestor
64926205|NCT00014274|Mitosis Modulators|mitosis modulators|mesh-ancestor
64926207|NCT00035035|Pemetrexed|pemetrexed|mesh-list
64926208|NCT00035035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64926209|NCT00035035|Antimetabolites|antimetabolites|mesh-ancestor
64926210|NCT00035035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926211|NCT00035035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926212|NCT00035035|Antiviral Agents|antiviral agents|mesh-ancestor
64926213|NCT00035035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926214|NCT00035035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926215|NCT00035035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64926216|NCT00035035|Immunologic Factors|immunologic factors|mesh-ancestor
64926217|NCT00035035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926249|NCT00035074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64926250|NCT00035074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64926251|NCT00035074|Immunologic Factors|immunologic factors|mesh-ancestor
64926252|NCT00035074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64926253|NCT00035074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64926255|NCT00035113|Epothilone B|epothilone b|mesh-list
64926256|NCT00035113|Tubulin Modulators|tubulin modulators|mesh-ancestor
64527247|NCT01582945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64527248|NCT01582945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64527249|NCT01582945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64527250|NCT01582945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64527251|NCT01582945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527252|NCT01565083|Trastuzumab|trastuzumab|mesh-list
64527254|NCT01565083|Vinorelbine|vinorelbine|mesh-list
64527255|NCT01565083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64527256|NCT01565083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527257|NCT01565083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64527258|NCT01565083|Tubulin Modulators|tubulin modulators|mesh-ancestor
64527259|NCT01565083|Antimitotic Agents|antimitotic agents|mesh-ancestor
64527260|NCT01565083|Mitosis Modulators|mitosis modulators|mesh-ancestor
64527261|NCT01565083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926257|NCT00035113|Antimitotic Agents|antimitotic agents|mesh-ancestor
64926258|NCT00035113|Mitosis Modulators|mitosis modulators|mesh-ancestor
64926259|NCT00035113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926260|NCT00035113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926261|NCT00000722|Pentamidine|pentamidine|mesh-list
64926262|NCT00000722|Antifungal Agents|antifungal agents|mesh-ancestor
64926263|NCT00000722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926264|NCT00000722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64926265|NCT00000722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64926266|NCT00000722|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64926267|NCT00035152|Paclitaxel|paclitaxel|mesh-list
64926268|NCT00035152|Carboplatin|carboplatin|mesh-list
64926269|NCT00035152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64926270|NCT00035152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926271|NCT00035152|Tubulin Modulators|tubulin modulators|mesh-ancestor
64926272|NCT00035152|Antimitotic Agents|antimitotic agents|mesh-ancestor
64926273|NCT00035152|Mitosis Modulators|mitosis modulators|mesh-ancestor
64926303|NCT00035191|Galantamine|galantamine|mesh-list
64926304|NCT00035191|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64926305|NCT00035191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926306|NCT00035191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926307|NCT00035191|Cholinergic Agents|cholinergic agents|mesh-ancestor
64926308|NCT00035191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64926309|NCT00035191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926310|NCT00035191|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64926311|NCT00035191|Autonomic Agents|autonomic agents|mesh-ancestor
64321190|NCT02206789|Prednisolone phosphate|prednisolone phosphate|mesh-list
64734895|NCT02014740|Incretins|incretins|mesh-ancestor
64734896|NCT02014740|Hormones|hormones|mesh-ancestor
64615614|NCT00634244|Sirolimus|sirolimus|mesh-list
64615615|NCT00634244|Carboplatin|carboplatin|mesh-list
64615616|NCT00634244|Etoposide|etoposide|mesh-list
64926312|NCT00035191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64926313|NCT00035191|Nootropic Agents|nootropic agents|mesh-ancestor
64926314|NCT00035230|Topiramate|topiramate|mesh-list
64926315|NCT00035230|Anticonvulsants|anticonvulsants|mesh-ancestor
64926316|NCT00035230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64527265|NCT01555151|Mometasone Furoate|mometasone furoate|mesh-list
64527266|NCT01555151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64527267|NCT01555151|Dermatologic Agents|dermatologic agents|mesh-ancestor
64527268|NCT01555151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64527269|NCT01537081|Phenylpropanolamine|phenylpropanolamine|mesh-list
64527270|NCT01537081|Guaifenesin|guaifenesin|mesh-list
64527271|NCT01537081|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
64527272|NCT01537081|Expectorants|expectorants|mesh-ancestor
64527273|NCT01537081|Respiratory System Agents|respiratory system agents|mesh-ancestor
64527274|NCT01537081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64527275|NCT01537081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64527276|NCT01537081|Adrenergic Agents|adrenergic agents|mesh-ancestor
64926358|NCT00035425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64926359|NCT00035425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926360|NCT00035425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926361|NCT00000752|Cefuroxime|cefuroxime|mesh-list
64926362|NCT00000752|Cefuroxime axetil|cefuroxime axetil|mesh-list
64926363|NCT00000752|Beclomethasone|beclomethasone|mesh-list
64926389|NCT00000752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64926390|NCT00000752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64926391|NCT00000752|Appetite Depressants|appetite depressants|mesh-ancestor
64926392|NCT00000752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64926394|NCT00035464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64926395|NCT00035464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64926396|NCT00035464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64926397|NCT00035464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926398|NCT00035464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64926399|NCT00035464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926400|NCT00014469|Methotrexate|methotrexate|mesh-list
64926401|NCT00014469|Melphalan|melphalan|mesh-list
64926402|NCT00014469|Busulfan|busulfan|mesh-list
64926403|NCT00014469|Tacrolimus|tacrolimus|mesh-list
64926404|NCT00014469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64926405|NCT00014469|Abortifacient Agents|abortifacient agents|mesh-ancestor
64926406|NCT00014469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64926407|NCT00014469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926408|NCT00014469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64926409|NCT00014469|Antimetabolites|antimetabolites|mesh-ancestor
64926410|NCT00014469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926411|NCT00014469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926446|NCT00014508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926447|NCT00014508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926448|NCT00014508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64926449|NCT00014508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64926450|NCT00014508|Antimetabolites|antimetabolites|mesh-ancestor
64926451|NCT00014508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926452|NCT00014508|Antifungal Agents|antifungal agents|mesh-ancestor
64926453|NCT00014508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926469|NCT00000758|Immunologic Factors|immunologic factors|mesh-ancestor
64926470|NCT00000758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650232|NCT00862784|Vitamins|vitamins|mesh-ancestor
64527295|NCT01555073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64527296|NCT01555073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926478|NCT02971306|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64926479|NCT02971306|Antiviral Agents|antiviral agents|mesh-ancestor
64926480|NCT02971306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926481|NCT02971306|Expectorants|expectorants|mesh-ancestor
64926482|NCT02971306|Respiratory System Agents|respiratory system agents|mesh-ancestor
64734898|NCT02014584|Dutasteride|dutasteride|mesh-list
64926483|NCT02971306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64926484|NCT02971306|Antioxidants|antioxidants|mesh-ancestor
64926485|NCT02971306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926486|NCT02971306|Protective Agents|protective agents|mesh-ancestor
64926487|NCT02971306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926488|NCT02971306|Antidotes|antidotes|mesh-ancestor
64926489|NCT00000761|Interferons|interferons|mesh-list
64926490|NCT00000761|Interferon-gamma|interferon-gamma|mesh-list
64926491|NCT00000761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926492|NCT00000761|Antiviral Agents|antiviral agents|mesh-ancestor
64926493|NCT00000761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926494|NCT00014586|Goserelin|goserelin|mesh-list
64926495|NCT00014586|Bicalutamide|bicalutamide|mesh-list
64926496|NCT00014586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64926497|NCT00014586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926498|NCT00014586|Androgen Antagonists|androgen antagonists|mesh-ancestor
64926499|NCT00014586|Hormone Antagonists|hormone antagonists|mesh-ancestor
64926500|NCT00014586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64926501|NCT00014586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926502|NCT04732390|Magnesium Sulfate|magnesium sulfate|mesh-list
64926503|NCT04732390|Bupivacaine|bupivacaine|mesh-list
64926504|NCT04732390|Anesthetics, Local|anesthetics, local|mesh-ancestor
64926505|NCT04732390|Anesthetics|anesthetics|mesh-ancestor
64527303|NCT01555073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64527304|NCT01555073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64527305|NCT01555073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64527306|NCT01555073|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64527307|NCT01555073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64527308|NCT01555073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527310|NCT01582243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64527311|NCT01582243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527312|NCT01582243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64527313|NCT01582243|Protease Inhibitors|protease inhibitors|mesh-ancestor
64527314|NCT01582243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527315|NCT01582243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527316|NCT01536535|Prednisone|prednisone|mesh-list
64527317|NCT01536535|Mesalamine|mesalamine|mesh-list
64527318|NCT01536535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64527319|NCT01536535|Glucocorticoids|glucocorticoids|mesh-ancestor
64527320|NCT01536535|Hormones|hormones|mesh-ancestor
64527321|NCT01536535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64527322|NCT01536535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527323|NCT01536535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64527324|NCT01536535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527325|NCT01536535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64527326|NCT01536535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64527327|NCT01536535|Analgesics|analgesics|mesh-ancestor
64527328|NCT01536535|Sensory System Agents|sensory system agents|mesh-ancestor
64527329|NCT01536535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64926544|NCT00035971|Hormone Antagonists|hormone antagonists|mesh-ancestor
64926545|NCT00035971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64527330|NCT01536535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64527331|NCT01553747|Eluxadoline|eluxadoline|mesh-list
64527332|NCT01553747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64527333|NCT01536379|Belimumab|belimumab|mesh-list
64527334|NCT01536379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64527335|NCT01536379|Immunologic Factors|immunologic factors|mesh-ancestor
64527336|NCT01536379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527337|NCT01536067|Bortezomib|bortezomib|mesh-list
64527338|NCT01536067|Ofatumumab|ofatumumab|mesh-list
64527339|NCT01536067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527340|NCT04410211|Midazolam|midazolam|mesh-list
64527341|NCT04410211|Sevoflurane|sevoflurane|mesh-list
64527342|NCT04410211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64527343|NCT04410211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64527344|NCT04410211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64527345|NCT04410211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527346|NCT04410211|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64527347|NCT04410211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64527348|NCT04410211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64926546|NCT00035971|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64926547|NCT00035971|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64926548|NCT00014625|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
64926550|NCT00014625|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64926551|NCT00014625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926552|NCT00014625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926554|NCT02971345|Cadexomer iodine|cadexomer iodine|mesh-list
64926555|NCT02971345|Epirubicin|epirubicin|mesh-list
64926556|NCT02971345|Ethiodized Oil|ethiodized oil|mesh-list
64926557|NCT02971345|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64926558|NCT02971345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926586|NCT00036127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64926587|NCT00036127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64926588|NCT00036127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64926589|NCT00036127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64926590|NCT00036127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926591|NCT00036127|Dopamine Agonists|dopamine agonists|mesh-ancestor
64926592|NCT00036127|Dopamine Agents|dopamine agents|mesh-ancestor
64926593|NCT00036127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64926594|NCT00036127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926595|NCT00036127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64926596|NCT00036127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64926597|NCT00036127|Serotonin Agents|serotonin agents|mesh-ancestor
64926598|NCT00036127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64926599|NCT00036127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64926600|NCT00036127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64926601|NCT00036127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64926602|NCT00000788|Fluconazole|fluconazole|mesh-list
64926633|NCT00000794|Levoleucovorin|levoleucovorin|mesh-list
64926634|NCT00000794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64926635|NCT00000794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527353|NCT04410211|GABA Agents|gaba agents|mesh-ancestor
64527354|NCT04410211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64527355|NCT04410211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527356|NCT04410211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64527357|NCT04410211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64527358|NCT01582009|Everolimus|everolimus|mesh-list
64527359|NCT01582009|Panobinostat|panobinostat|mesh-list
64527360|NCT01582009|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
64527361|NCT01582009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527362|NCT01582009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64527363|NCT01582009|Immunologic Factors|immunologic factors|mesh-ancestor
64527364|NCT01582009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527365|NCT01582009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527366|NCT01582009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527367|NCT01553591|Eluxadoline|eluxadoline|mesh-list
64527368|NCT01553591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64527369|NCT01581931|Metformin|metformin|mesh-list
64527370|NCT01581931|Linagliptin|linagliptin|mesh-list
64527371|NCT01581931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64527372|NCT01581931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527373|NCT01581931|Incretins|incretins|mesh-ancestor
64527374|NCT01581931|Hormones|hormones|mesh-ancestor
64527375|NCT01581931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64527376|NCT01581931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64527377|NCT01581931|Protease Inhibitors|protease inhibitors|mesh-ancestor
64527378|NCT01581931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527379|NCT01581931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527380|NCT01581307|Leucovorin|leucovorin|mesh-list
64527381|NCT01581307|Folic Acid|folic acid|mesh-list
64527382|NCT01581307|Fluorouracil|fluorouracil|mesh-list
64527383|NCT01581307|Oxaliplatin|oxaliplatin|mesh-list
64527384|NCT01581307|Levoleucovorin|levoleucovorin|mesh-list
64527385|NCT01581307|Antimetabolites|antimetabolites|mesh-ancestor
64527386|NCT01581307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527387|NCT01581307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64650271|NCT01499147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64926646|NCT00000794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64926682|NCT00391638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926683|NCT00391638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64926684|NCT00391638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64926685|NCT00036361|Aripiprazole|aripiprazole|mesh-list
64926717|NCT00036556|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64926719|NCT00036556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926720|NCT00000827|Immune Sera|immune sera|mesh-list
64926721|NCT00000827|Immunologic Factors|immunologic factors|mesh-ancestor
64926722|NCT00000827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926723|NCT00036634|Tenofovir|tenofovir|mesh-list
64926724|NCT00036634|Antiviral Agents|antiviral agents|mesh-ancestor
64926725|NCT00036634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926726|NCT00036634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64926727|NCT00036634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64926760|NCT00000857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64926761|NCT00000857|Immunologic Factors|immunologic factors|mesh-ancestor
64926762|NCT00000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926763|NCT00000857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64926764|NCT00000857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64926765|NCT00000857|Growth Substances|growth substances|mesh-ancestor
64926766|NCT00000857|Growth Inhibitors|growth inhibitors|mesh-ancestor
64926767|NCT00000857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650274|NCT01499147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64650275|NCT01499147|Immunologic Factors|immunologic factors|mesh-ancestor
64650276|NCT01499147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926803|NCT00036985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926804|NCT00036985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64926805|NCT00036985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64926806|NCT00036985|Alkylating Agents|alkylating agents|mesh-ancestor
64926807|NCT00036985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926808|NCT00036985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527405|NCT01562743|Dopamine Agonists|dopamine agonists|mesh-ancestor
64527406|NCT01562743|Dopamine Agents|dopamine agents|mesh-ancestor
64527407|NCT01562743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64527408|NCT01562743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527409|NCT01562743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527410|NCT03028571|Trimethaphan|trimethaphan|mesh-list
64527411|NCT03028571|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
64527412|NCT03028571|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64527413|NCT03028571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64527414|NCT03028571|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
64926809|NCT00036985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64926810|NCT00036985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64926811|NCT00036985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64926812|NCT00036985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64926847|NCT00037102|Antimetabolites|antimetabolites|mesh-ancestor
64926848|NCT00037102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926849|NCT00037102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926850|NCT00037102|Dermatologic Agents|dermatologic agents|mesh-ancestor
64926851|NCT00037102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926852|NCT00037102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64926853|NCT00037102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64926854|NCT00037102|Immunologic Factors|immunologic factors|mesh-ancestor
64926883|NCT00037180|Micronutrients|micronutrients|mesh-ancestor
64926884|NCT00037180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64926885|NCT00037180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64926886|NCT00037180|Analgesics|analgesics|mesh-ancestor
64926887|NCT00037180|Sensory System Agents|sensory system agents|mesh-ancestor
64926888|NCT00037180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64926889|NCT00037180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64926890|NCT00037180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64926891|NCT00037180|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64926892|NCT00037180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64926893|NCT00037219|Anidulafungin|anidulafungin|mesh-list
64926894|NCT00037219|Antifungal Agents|antifungal agents|mesh-ancestor
64926895|NCT00037219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926897|NCT00000893|Nelfinavir|nelfinavir|mesh-list
64926898|NCT00000893|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64926899|NCT00000893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64926900|NCT00000893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926901|NCT00000893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926902|NCT00000893|Antiviral Agents|antiviral agents|mesh-ancestor
64926903|NCT00000893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926934|NCT00037570|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64926935|NCT00037570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64926936|NCT00037570|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64926937|NCT00037570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926938|NCT00037570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926940|NCT00000899|Stavudine|stavudine|mesh-list
64926941|NCT00000899|Nelfinavir|nelfinavir|mesh-list
64926942|NCT00000899|Cyclophosphamide|cyclophosphamide|mesh-list
64926943|NCT00000899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64926944|NCT00000899|Immunologic Factors|immunologic factors|mesh-ancestor
64926945|NCT00000899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926946|NCT00000899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64927008|NCT00038077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64927009|NCT00038077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927010|NCT00038077|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64927011|NCT00038077|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64527419|NCT03028571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64527420|NCT03028571|Cholinergic Agents|cholinergic agents|mesh-ancestor
64527421|NCT03028571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64927016|NCT00038116|Dopamine|dopamine|mesh-list
64927017|NCT00038116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64927018|NCT00038116|Sympathomimetics|sympathomimetics|mesh-ancestor
64927019|NCT00038116|Autonomic Agents|autonomic agents|mesh-ancestor
64927020|NCT00038116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64927021|NCT00038116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927022|NCT00038116|Dopamine Agents|dopamine agents|mesh-ancestor
64927023|NCT00038116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64927024|NCT00038116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927025|NCT00038116|Protective Agents|protective agents|mesh-ancestor
64927026|NCT00038194|Docetaxel|docetaxel|mesh-list
64927027|NCT00038194|Imatinib Mesylate|imatinib mesylate|mesh-list
64927028|NCT00038194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927061|NCT00038272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927062|NCT00038272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927063|NCT00038272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927064|NCT05434000|Hydroxyurea|hydroxyurea|mesh-list
64927065|NCT05434000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927066|NCT05434000|Antisickling Agents|antisickling agents|mesh-ancestor
64927067|NCT05434000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927068|NCT05434000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927069|NCT05434000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64927070|NCT00000941|Ritonavir|ritonavir|mesh-list
64927102|NCT00014937|Efavirenz|efavirenz|mesh-list
64927103|NCT00014937|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64927104|NCT00014937|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64927105|NCT00014937|Protease Inhibitors|protease inhibitors|mesh-ancestor
64927106|NCT00014937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927107|NCT00014937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927108|NCT00014937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64927109|NCT00014937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64927110|NCT00014937|Antiviral Agents|antiviral agents|mesh-ancestor
64927111|NCT00014937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927112|NCT00014937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64927113|NCT00014937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64927114|NCT00014937|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64927115|NCT00014937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64927116|NCT00014937|Antimetabolites|antimetabolites|mesh-ancestor
64927117|NCT00014937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64927144|NCT00000962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927146|NCT00000962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927147|NCT00000962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64927148|NCT00000962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64927149|NCT00000962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64927150|NCT00000962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64927151|NCT00396682|Cyclophosphamide|cyclophosphamide|mesh-list
64927152|NCT00396682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64927153|NCT00396682|Immunologic Factors|immunologic factors|mesh-ancestor
64927154|NCT00396682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927155|NCT00396682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64927156|NCT00396682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64927157|NCT00396682|Alkylating Agents|alkylating agents|mesh-ancestor
64321192|NCT02206789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321193|NCT02206789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64321194|NCT02206789|Immunologic Factors|immunologic factors|mesh-ancestor
64321195|NCT02206789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321196|NCT02206789|Antifungal Agents|antifungal agents|mesh-ancestor
64615975|NCT01923818|Aspirin|aspirin|mesh-list
64927158|NCT00396682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927159|NCT00396682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650288|NCT00823082|Anticoagulants|anticoagulants|mesh-ancestor
64527426|NCT01535443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64527427|NCT01535443|Analgesics|analgesics|mesh-ancestor
64527428|NCT01535443|Sensory System Agents|sensory system agents|mesh-ancestor
64527429|NCT01535443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64527430|NCT01535443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527431|NCT01535443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64527432|NCT01535443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64527433|NCT01535287|Dexmedetomidine|dexmedetomidine|mesh-list
64527434|NCT01535287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64927162|NCT00396721|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
64927163|NCT00396721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64927196|NCT00015054|Dopamine Agents|dopamine agents|mesh-ancestor
64927197|NCT00015054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64927198|NCT00015132|Sertraline|sertraline|mesh-list
64927199|NCT00015132|Antidepressive Agents|antidepressive agents|mesh-ancestor
64927200|NCT00015132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64927201|NCT00015132|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64927233|NCT00015171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64927234|NCT00015171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64927235|NCT00015210|Nefazodone|nefazodone|mesh-list
64927236|NCT00015210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64927237|NCT00015210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64927238|NCT00015210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64927239|NCT00015210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927240|NCT00015210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64927241|NCT00015210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927242|NCT00015210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64927272|NCT00015249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64927273|NCT05195242|Dexamethasone|dexamethasone|mesh-list
64927274|NCT05195242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64927275|NCT05195242|Antiemetics|antiemetics|mesh-ancestor
64927276|NCT05195242|Autonomic Agents|autonomic agents|mesh-ancestor
64927277|NCT05195242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64927278|NCT05195242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927279|NCT05195242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64927280|NCT05195242|Glucocorticoids|glucocorticoids|mesh-ancestor
64927281|NCT05195242|Hormones|hormones|mesh-ancestor
64927282|NCT05195242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64927283|NCT05195242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64927284|NCT05195242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927285|NCT00015288|Buprenorphine|buprenorphine|mesh-list
64927286|NCT00015288|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64927287|NCT00015288|Naloxone|naloxone|mesh-list
64927288|NCT00015288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64927289|NCT00015288|Narcotics|narcotics|mesh-ancestor
64927290|NCT00015288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64927318|NCT00000998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927319|NCT00000998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64927320|NCT00000998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927321|NCT00001001|Zidovudine|zidovudine|mesh-list
64927322|NCT00001001|Antimetabolites|antimetabolites|mesh-ancestor
64927323|NCT00001001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927324|NCT00001001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64927325|NCT00001001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64927326|NCT00001001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616031|NCT03316378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527436|NCT01535287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527437|NCT01535287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64527438|NCT01535287|Analgesics|analgesics|mesh-ancestor
64527439|NCT01535287|Sensory System Agents|sensory system agents|mesh-ancestor
64527440|NCT01535287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64527441|NCT01535287|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64527442|NCT01535287|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64527443|NCT01535287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64927372|NCT00396760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927373|NCT00001007|Zidovudine|zidovudine|mesh-list
64927374|NCT00001007|Antimetabolites|antimetabolites|mesh-ancestor
64927375|NCT00001007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927376|NCT00001007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64927377|NCT00001007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64927378|NCT00001007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927379|NCT00001007|Antiviral Agents|antiviral agents|mesh-ancestor
64927380|NCT00001007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927381|NCT00001007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64927382|NCT00001007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64927383|NCT00396799|Bazedoxifene|bazedoxifene|mesh-list
64927384|NCT00396799|Estrogens|estrogens|mesh-list
64927385|NCT00396799|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64927386|NCT00396799|Hormones|hormones|mesh-ancestor
64927387|NCT00396799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64927388|NCT00396799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927389|NCT00396799|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64927390|NCT00396799|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64927424|NCT00001013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64927426|NCT00001013|Antidotes|antidotes|mesh-ancestor
64927427|NCT00001013|Protective Agents|protective agents|mesh-ancestor
64927428|NCT00001013|Vitamin B Complex|vitamin b complex|mesh-ancestor
64616094|NCT02393859|Dermatologic Agents|dermatologic agents|mesh-ancestor
64616095|NCT02393859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616096|NCT02393859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64734908|NCT02037984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734909|NCT02036580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64734910|NCT02036580|Immunologic Factors|immunologic factors|mesh-ancestor
64734911|NCT02036580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734912|NCT02057250|Hydroxychloroquine|hydroxychloroquine|mesh-list
64734913|NCT02057250|Sulfasalazine|sulfasalazine|mesh-list
64734914|NCT02057250|Methotrexate|methotrexate|mesh-list
64734915|NCT02057250|Leflunomide|leflunomide|mesh-list
64616097|NCT02393859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64616098|NCT02393859|Immunologic Factors|immunologic factors|mesh-ancestor
64616099|NCT02393859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64616100|NCT02393859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64616101|NCT02393859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64616102|NCT02393859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64616103|NCT02393859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64616104|NCT02393859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64616105|NCT02393859|Alkylating Agents|alkylating agents|mesh-ancestor
64616106|NCT03445390|Acetaminophen|acetaminophen|mesh-list
64927429|NCT00001013|Vitamins|vitamins|mesh-ancestor
64927430|NCT00001013|Micronutrients|micronutrients|mesh-ancestor
64927431|NCT00001013|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64927432|NCT00001013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927433|NCT00001013|Renal Agents|renal agents|mesh-ancestor
64927434|NCT00001013|Antimalarials|antimalarials|mesh-ancestor
64927456|NCT04680442|Tubulin Modulators|tubulin modulators|mesh-ancestor
64927457|NCT04680442|Antimitotic Agents|antimitotic agents|mesh-ancestor
64927458|NCT04680442|Mitosis Modulators|mitosis modulators|mesh-ancestor
64927459|NCT04680442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927461|NCT00015834|Imatinib Mesylate|imatinib mesylate|mesh-list
64527446|NCT01535287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527448|NCT01549613|Daptomycin|daptomycin|mesh-list
64527449|NCT01549613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64527455|NCT04106219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527456|NCT04106219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64527457|NCT04106219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64527458|NCT04106219|Alkylating Agents|alkylating agents|mesh-ancestor
64527459|NCT04106219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527460|NCT04106219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527461|NCT04106219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64527462|NCT04106219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64527463|NCT04106219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64527464|NCT04106219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527465|NCT04739189|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
64527466|NCT04739189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527467|NCT04739189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527469|NCT01546883|Antithrombins|antithrombins|mesh-ancestor
64527470|NCT01546883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64527471|NCT01546883|Protease Inhibitors|protease inhibitors|mesh-ancestor
64527472|NCT01546883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527473|NCT01546883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527474|NCT01546883|Anticoagulants|anticoagulants|mesh-ancestor
64927462|NCT00015834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64927463|NCT00015834|Antimetabolites|antimetabolites|mesh-ancestor
64927464|NCT00015834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927465|NCT00015834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695881|NCT00358358|Sympathomimetics|sympathomimetics|mesh-ancestor
64927466|NCT00015834|Antiviral Agents|antiviral agents|mesh-ancestor
64927467|NCT00015834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927468|NCT00015834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64927469|NCT00015834|Immunologic Factors|immunologic factors|mesh-ancestor
64927470|NCT00015834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927471|NCT00015834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64927472|NCT00015834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927473|NCT00001040|Zidovudine|zidovudine|mesh-list
64927474|NCT00001040|Zalcitabine|zalcitabine|mesh-list
64927475|NCT00001040|Saquinavir|saquinavir|mesh-list
64927476|NCT00001040|Antimetabolites|antimetabolites|mesh-ancestor
64527476|NCT01580293|Coagulants|coagulants|mesh-ancestor
64527477|NCT01546649|Leuprolide|leuprolide|mesh-list
64527478|NCT01546649|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64527479|NCT01546649|Fertility Agents|fertility agents|mesh-ancestor
64527480|NCT01546649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64527481|NCT01546649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527482|NCT01546649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64527483|NCT01546649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527484|NCT02985983|Brodalumab|brodalumab|mesh-list
64527485|NCT02985983|Dermatologic Agents|dermatologic agents|mesh-ancestor
64527486|NCT01544309|Atorvastatin|atorvastatin|mesh-list
64321198|NCT02206789|Dermatologic Agents|dermatologic agents|mesh-ancestor
64321199|NCT02206789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64321200|NCT02206789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64321201|NCT02206789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64527487|NCT01544309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64527488|NCT01544309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64527489|NCT01544309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64714111|NCT03043274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64527490|NCT01544309|Antimetabolites|antimetabolites|mesh-ancestor
64527491|NCT01544309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527492|NCT01544309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64927477|NCT00001040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927478|NCT00001040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64927479|NCT00001040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64927480|NCT00001040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927481|NCT00001040|Antiviral Agents|antiviral agents|mesh-ancestor
64927482|NCT00001040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927483|NCT00001040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64927484|NCT00001040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64927485|NCT00001040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64927486|NCT00001040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64927515|NCT00015873|Antimitotic Agents|antimitotic agents|mesh-ancestor
64927516|NCT00015873|Mitosis Modulators|mitosis modulators|mesh-ancestor
64927525|NCT00015912|Thalidomide|thalidomide|mesh-list
64927526|NCT00015912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927527|NCT00015912|Antiviral Agents|antiviral agents|mesh-ancestor
64927528|NCT00015912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927529|NCT00015912|Immunologic Factors|immunologic factors|mesh-ancestor
64927530|NCT00015912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927531|NCT00015912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64927532|NCT00015912|Leprostatic Agents|leprostatic agents|mesh-ancestor
64927533|NCT00015912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64927569|NCT00015951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927570|NCT00015951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64927571|NCT00015951|Immunologic Factors|immunologic factors|mesh-ancestor
64927572|NCT00015951|Analgesics|analgesics|mesh-ancestor
64927573|NCT00015951|Sensory System Agents|sensory system agents|mesh-ancestor
64927574|NCT00015951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64927607|NCT00001085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64927608|NCT00001085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64527493|NCT01544309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64527494|NCT01544309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527495|NCT01544153|Nicotine|nicotine|mesh-list
64527496|NCT01544153|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64527497|NCT01544153|Autonomic Agents|autonomic agents|mesh-ancestor
64527498|NCT01544153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64527499|NCT01544153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527500|NCT01544153|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64527501|NCT01544153|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64927609|NCT00001085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927610|NCT00001085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927611|NCT00001085|Antiviral Agents|antiviral agents|mesh-ancestor
64927612|NCT00001085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927613|NCT00001085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64927614|NCT00001085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64927615|NCT00001085|Antimetabolites|antimetabolites|mesh-ancestor
64927616|NCT00001085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64927617|NCT00001085|Antitubercular Agents|antitubercular agents|mesh-ancestor
64927618|NCT00001085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64927650|NCT00016107|Immunologic Factors|immunologic factors|mesh-ancestor
64927651|NCT00016107|Tubulin Modulators|tubulin modulators|mesh-ancestor
64927652|NCT00016107|Antimitotic Agents|antimitotic agents|mesh-ancestor
64927653|NCT00016107|Mitosis Modulators|mitosis modulators|mesh-ancestor
64927654|NCT00016107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927655|NCT00016107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64927656|NCT00016107|Alkylating Agents|alkylating agents|mesh-ancestor
64927657|NCT00016107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64927659|NCT00001118|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64927660|NCT00001118|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64321202|NCT02206789|Glucocorticoids|glucocorticoids|mesh-ancestor
64321203|NCT02206789|Hormones|hormones|mesh-ancestor
64616185|NCT03454048|Pyrimethamine|pyrimethamine|mesh-list
64927661|NCT00001118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927662|NCT00001118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64927690|NCT00016224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64927691|NCT00016224|Immunologic Factors|immunologic factors|mesh-ancestor
64927692|NCT00016224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927693|NCT00016224|Leprostatic Agents|leprostatic agents|mesh-ancestor
64927694|NCT00016224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64927695|NCT00016224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927696|NCT00016224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64927697|NCT00016224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64927698|NCT00016224|Growth Substances|growth substances|mesh-ancestor
64927699|NCT00016224|Growth Inhibitors|growth inhibitors|mesh-ancestor
64650325|NCT00865202|Tryptophan|tryptophan|mesh-list
64927710|NCT00016302|Prednisone|prednisone|mesh-list
64927711|NCT00016302|Cyclophosphamide|cyclophosphamide|mesh-list
64927742|NCT00016302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64927743|NCT00016302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927744|NCT00016302|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64927745|NCT00016302|Abortifacient Agents|abortifacient agents|mesh-ancestor
64927746|NCT00016302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64927747|NCT00016302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64927749|NCT00016302|Dermatologic Agents|dermatologic agents|mesh-ancestor
64927750|NCT00016302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64927751|NCT00016302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64927752|NCT00016302|Antiviral Agents|antiviral agents|mesh-ancestor
64927753|NCT00016302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64527502|NCT01544153|Cholinergic Agents|cholinergic agents|mesh-ancestor
64527503|NCT01544153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64527504|NCT01544153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527505|NCT01543685|Celecoxib|celecoxib|mesh-list
64527506|NCT01543685|Indomethacin|indomethacin|mesh-list
64527507|NCT01543685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64527508|NCT01543685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64527509|NCT01543685|Analgesics|analgesics|mesh-ancestor
64527510|NCT01543685|Sensory System Agents|sensory system agents|mesh-ancestor
64527511|NCT01543685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64527512|NCT01543685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527513|NCT01543685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64527514|NCT01543685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64527515|NCT01543685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64527516|NCT01543685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64527517|NCT01543685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527518|NCT01543685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527519|NCT01543685|Gout Suppressants|gout suppressants|mesh-ancestor
64527520|NCT01543685|Tocolytic Agents|tocolytic agents|mesh-ancestor
64527521|NCT01543685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64527523|NCT01540565|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64527524|NCT01540565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527525|NCT01540565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927754|NCT00016302|Antidotes|antidotes|mesh-ancestor
64927755|NCT00016302|Protective Agents|protective agents|mesh-ancestor
64927756|NCT00016302|Vitamin B Complex|vitamin b complex|mesh-ancestor
64927757|NCT00016302|Vitamins|vitamins|mesh-ancestor
64927758|NCT00016302|Micronutrients|micronutrients|mesh-ancestor
64927784|NCT00016341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927785|NCT00016341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64927786|NCT00016341|Hormone Antagonists|hormone antagonists|mesh-ancestor
64927787|NCT00016341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64927788|NCT00016341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64927789|NCT00016341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64927790|NCT00016341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64927791|NCT00016341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64927792|NCT00016341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64927793|NCT00016341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64927794|NCT00016341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64927795|NCT00016341|Contraceptive Agents|contraceptive agents|mesh-ancestor
64927796|NCT00016341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64527526|NCT01540565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527528|NCT01540487|Linagliptin|linagliptin|mesh-list
64527529|NCT01540487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64527530|NCT01540487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527531|NCT01540487|Incretins|incretins|mesh-ancestor
64527532|NCT01540487|Hormones|hormones|mesh-ancestor
64527533|NCT01540487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64527534|NCT01540487|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64527535|NCT01540487|Protease Inhibitors|protease inhibitors|mesh-ancestor
64527536|NCT01540487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527537|NCT01540487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527538|NCT01539317|Lidocaine|lidocaine|mesh-list
64527539|NCT01539317|Anesthetics, Local|anesthetics, local|mesh-ancestor
64527540|NCT01539317|Anesthetics|anesthetics|mesh-ancestor
64927804|NCT00016380|Dexamethasone|dexamethasone|mesh-list
64927805|NCT00016380|Ondansetron|ondansetron|mesh-list
64927806|NCT00016380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64927807|NCT00016380|Antiemetics|antiemetics|mesh-ancestor
64927808|NCT00016380|Autonomic Agents|autonomic agents|mesh-ancestor
64927832|NCT00001202|Spironolactone|spironolactone|mesh-list
64927834|NCT00001202|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64927835|NCT00001202|Hormone Antagonists|hormone antagonists|mesh-ancestor
64927836|NCT00001202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64927837|NCT00001202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927838|NCT00001202|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64927839|NCT00001202|Diuretics|diuretics|mesh-ancestor
64927840|NCT00001202|Natriuretic Agents|natriuretic agents|mesh-ancestor
64927841|NCT00001202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927842|NCT00001202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927843|NCT00001202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64927844|NCT00001202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927845|NCT00016419|Cyclosporine|cyclosporine|mesh-list
64927846|NCT00016419|Cyclosporins|cyclosporins|mesh-list
64927847|NCT00016419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64927848|NCT00016419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927849|NCT00016419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696279|NCT03465787|Serotonin Agents|serotonin agents|mesh-ancestor
64927851|NCT00016419|Immunologic Factors|immunologic factors|mesh-ancestor
64927852|NCT00016419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927853|NCT00016419|Antifungal Agents|antifungal agents|mesh-ancestor
64927854|NCT00016419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927855|NCT00016419|Dermatologic Agents|dermatologic agents|mesh-ancestor
64927856|NCT00016419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64927857|NCT00016419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64927858|NCT00016458|Cyclophosphamide|cyclophosphamide|mesh-list
64927860|NCT00016458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64927861|NCT00016458|Immunologic Factors|immunologic factors|mesh-ancestor
64927862|NCT00016458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927863|NCT00016458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64927864|NCT00016458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64927865|NCT00016458|Alkylating Agents|alkylating agents|mesh-ancestor
64927866|NCT00016458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927867|NCT00016458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927868|NCT00016458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64927869|NCT01156545|Afatinib|afatinib|mesh-list
64927870|NCT01156545|Simvastatin|simvastatin|mesh-list
64927871|NCT01156545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64927872|NCT01156545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64527541|NCT01539317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64650345|NCT00867932|Eculizumab|eculizumab|mesh-list
64527549|NCT01539317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527550|NCT01539083|Thalidomide|thalidomide|mesh-list
64527551|NCT01539083|Dexamethasone|dexamethasone|mesh-list
64527552|NCT01539083|Prednisolone|prednisolone|mesh-list
64527553|NCT01539083|Cyclophosphamide|cyclophosphamide|mesh-list
64927873|NCT01156545|Antimetabolites|antimetabolites|mesh-ancestor
64927874|NCT01156545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927875|NCT01156545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64927876|NCT01156545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64927877|NCT01156545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927878|NCT01156545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927879|NCT01156545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64927880|NCT01140516|Trimethoprim|trimethoprim|mesh-list
64927881|NCT01140516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64927882|NCT01140516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927883|NCT01140516|Renal Agents|renal agents|mesh-ancestor
64927884|NCT01140516|Antimalarials|antimalarials|mesh-ancestor
64927885|NCT01140516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64927886|NCT01140516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64927887|NCT01140516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64927888|NCT01140516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927889|NCT01140516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927890|NCT01140516|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64927891|NCT01140516|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64927892|NCT01140516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64927894|NCT02734771|Cyclophosphamide|cyclophosphamide|mesh-list
64927895|NCT02734771|Rituximab|rituximab|mesh-list
64927896|NCT02734771|Doxorubicin|doxorubicin|mesh-list
64927897|NCT02734771|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64927898|NCT02734771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64927899|NCT02734771|Immunologic Factors|immunologic factors|mesh-ancestor
64927900|NCT02734771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927901|NCT02734771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64927902|NCT02734771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64927903|NCT02734771|Alkylating Agents|alkylating agents|mesh-ancestor
64927904|NCT02734771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927905|NCT02734771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927906|NCT02734771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64927907|NCT02734771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64927908|NCT02734771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64927909|NCT02734771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64927910|NCT02734771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64927911|NCT02734771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927912|NCT02734771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64927913|NCT02734771|Glucocorticoids|glucocorticoids|mesh-ancestor
64927914|NCT02734771|Hormones|hormones|mesh-ancestor
64927915|NCT02734771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64927916|NCT02734771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64927917|NCT02347111|Sotalol|sotalol|mesh-list
64927918|NCT02347111|Flecainide|flecainide|mesh-list
64927919|NCT02347111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64527555|NCT01539083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64527556|NCT01539083|Immunologic Factors|immunologic factors|mesh-ancestor
64527557|NCT01539083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527558|NCT01539083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64527559|NCT01539083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64527560|NCT01539083|Alkylating Agents|alkylating agents|mesh-ancestor
64527561|NCT01539083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650350|NCT00825266|Pioglitazone|pioglitazone|mesh-list
64927965|NCT00016887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64927967|NCT00016887|Autonomic Agents|autonomic agents|mesh-ancestor
64927968|NCT00016887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64927969|NCT00016887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64927970|NCT00016887|Glucocorticoids|glucocorticoids|mesh-ancestor
64927999|NCT00038506|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64928000|NCT00038506|Antiviral Agents|antiviral agents|mesh-ancestor
64928001|NCT00038506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64616387|NCT01057225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64928002|NCT00038506|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64928003|NCT00038506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64928004|NCT00038506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928005|NCT00038506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928006|NCT00038506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64928007|NCT00038506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64928008|NCT00038506|Antimetabolites|antimetabolites|mesh-ancestor
64928009|NCT00016926|Capecitabine|capecitabine|mesh-list
64928010|NCT00016926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64928011|NCT00016926|Antimetabolites|antimetabolites|mesh-ancestor
64928012|NCT00016926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928013|NCT00016926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928015|NCT00038545|Topotecan|topotecan|mesh-list
64928016|NCT00038545|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64928017|NCT00038545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928018|NCT00038545|Tubulin Modulators|tubulin modulators|mesh-ancestor
64928049|NCT00038896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64928050|NCT00038896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64928051|NCT00038896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928053|NCT00038896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527568|NCT01539083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64527569|NCT01539083|Glucocorticoids|glucocorticoids|mesh-ancestor
64527570|NCT01539083|Hormones|hormones|mesh-ancestor
64527571|NCT01539083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64928054|NCT00038896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64928138|NCT00039364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928139|NCT00039364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64928140|NCT00039364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928141|NCT00039364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928142|NCT00039403|Gemcitabine|gemcitabine|mesh-list
64928143|NCT00039403|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
64928144|NCT00039403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64928145|NCT00039403|Antimetabolites|antimetabolites|mesh-ancestor
64928146|NCT00039403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928180|NCT00039481|Protective Agents|protective agents|mesh-ancestor
64928181|NCT00039481|Antimitotic Agents|antimitotic agents|mesh-ancestor
64928182|NCT00039481|Mitosis Modulators|mitosis modulators|mesh-ancestor
64928183|NCT00544830|Leuprolide|leuprolide|mesh-list
64928184|NCT00544830|Goserelin|goserelin|mesh-list
64928185|NCT00544830|Bicalutamide|bicalutamide|mesh-list
64928186|NCT00544830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64928187|NCT00544830|Fertility Agents|fertility agents|mesh-ancestor
64928219|NCT00039520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64928220|NCT00039520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928221|NCT00039520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64928222|NCT00039520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64928223|NCT00039520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64928224|NCT00039520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928225|NCT04731961|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64928227|NCT04731961|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64928228|NCT04731961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64928229|NCT04731961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928230|NCT04731961|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64928231|NCT04731961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64928263|NCT00039988|(T,G)-A-L|(t,g)-a-l|mesh-list
64928264|NCT00039988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64928265|NCT00039988|Autonomic Agents|autonomic agents|mesh-ancestor
64928266|NCT00039988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64928267|NCT00039988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734916|NCT02057250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64734917|NCT02057250|Abortifacient Agents|abortifacient agents|mesh-ancestor
64734918|NCT02057250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64928268|NCT00039988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64928269|NCT00039988|Respiratory System Agents|respiratory system agents|mesh-ancestor
64928270|NCT00039988|Tocolytic Agents|tocolytic agents|mesh-ancestor
64928271|NCT00039988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64527578|NCT01539083|Growth Substances|growth substances|mesh-ancestor
64527579|NCT01539083|Growth Inhibitors|growth inhibitors|mesh-ancestor
64527580|NCT01537133|Fluticasone|fluticasone|mesh-list
64527581|NCT01537133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64928305|NCT00040066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64928306|NCT00040066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64928307|NCT00040066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928308|NCT00040066|Dopamine Agents|dopamine agents|mesh-ancestor
64928309|NCT00040066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64928310|NCT00040105|Imatinib Mesylate|imatinib mesylate|mesh-list
64928312|NCT00040105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928313|NCT00040105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64928314|NCT00040105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928315|NCT00040105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928316|NCT00040144|Dexelvucitabine|dexelvucitabine|mesh-list
64928317|NCT00040144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64928318|NCT00040144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64928319|NCT00040144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928344|NCT00040378|Tocopherols|tocopherols|mesh-list
64928345|NCT00040378|Tocotrienols|tocotrienols|mesh-list
64928346|NCT00040378|alpha-Tocopherol|alpha-tocopherol|mesh-list
64928348|NCT00040378|Micronutrients|micronutrients|mesh-ancestor
64928349|NCT00040378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928350|NCT00040378|Antioxidants|antioxidants|mesh-ancestor
64928351|NCT00040378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928352|NCT00040378|Protective Agents|protective agents|mesh-ancestor
64928353|NCT00040378|Trace Elements|trace elements|mesh-ancestor
64928354|NCT00017199|Bortezomib|bortezomib|mesh-list
64928355|NCT00017199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928356|NCT00040417|Fludarabine|fludarabine|mesh-list
64928357|NCT00040417|Alemtuzumab|alemtuzumab|mesh-list
64928358|NCT00040417|Lenograstim|lenograstim|mesh-list
64928359|NCT00040417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928360|NCT00040417|Immunologic Factors|immunologic factors|mesh-ancestor
64928361|NCT00040417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928362|NCT00040417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64928363|NCT00040417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64928364|NCT00040495|Pantoprazole|pantoprazole|mesh-list
64928365|NCT00040495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64928366|NCT00040495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64928367|NCT00040495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64928368|NCT00040495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928369|NCT00040495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928370|NCT00040651|Cyclophosphamide|cyclophosphamide|mesh-list
64928371|NCT00040651|Fludarabine|fludarabine|mesh-list
64928398|NCT00040690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928399|NCT00040690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928400|NCT00040690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64650395|NCT00870896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64650397|NCT00870896|Parasympatholytics|parasympatholytics|mesh-ancestor
64928406|NCT00040690|Abortifacient Agents|abortifacient agents|mesh-ancestor
64928407|NCT00040690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64928408|NCT00040690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64928409|NCT00040690|Antimetabolites|antimetabolites|mesh-ancestor
64928410|NCT00040690|Dermatologic Agents|dermatologic agents|mesh-ancestor
64928411|NCT00040690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64527582|NCT01537133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64527583|NCT01537133|Autonomic Agents|autonomic agents|mesh-ancestor
64527584|NCT01537133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64527585|NCT01537133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928412|NCT00040690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64928413|NCT00040690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64928414|NCT00040690|Antiviral Agents|antiviral agents|mesh-ancestor
64928415|NCT00040690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64928416|NCT00040690|Antidotes|antidotes|mesh-ancestor
64928417|NCT00040690|Protective Agents|protective agents|mesh-ancestor
64928418|NCT00040690|Vitamin B Complex|vitamin b complex|mesh-ancestor
64928419|NCT00040690|Vitamins|vitamins|mesh-ancestor
64928420|NCT00040690|Micronutrients|micronutrients|mesh-ancestor
64928421|NCT00040690|Tubulin Modulators|tubulin modulators|mesh-ancestor
64928422|NCT00040690|Antimitotic Agents|antimitotic agents|mesh-ancestor
64928423|NCT00040690|Mitosis Modulators|mitosis modulators|mesh-ancestor
64928453|NCT00001421|Hormone Antagonists|hormone antagonists|mesh-ancestor
64928454|NCT00001421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64928455|NCT00001421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928457|NCT00017277|Hematinics|hematinics|mesh-ancestor
64928458|NCT00041041|Imatinib Mesylate|imatinib mesylate|mesh-list
64928459|NCT00041041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928460|NCT00041041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64928461|NCT00041041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928462|NCT00041041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928463|NCT00041197|Imatinib Mesylate|imatinib mesylate|mesh-list
64928464|NCT00041197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928465|NCT00041197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64928466|NCT00041197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928467|NCT00041197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928468|NCT00001427|9-aminocamptothecin|9-aminocamptothecin|mesh-list
64928469|NCT00001427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928470|NCT00041236|Exatecan|exatecan|mesh-list
64928500|NCT00041275|Appetite Stimulants|appetite stimulants|mesh-ancestor
64928501|NCT00041275|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64928502|NCT00041314|Gemcitabine|gemcitabine|mesh-list
64928503|NCT00041314|Sulindac sulfone|sulindac sulfone|mesh-list
64928504|NCT00041314|Carboplatin|carboplatin|mesh-list
64928505|NCT00041314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928506|NCT00041314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64928507|NCT00041314|Antimetabolites|antimetabolites|mesh-ancestor
64928508|NCT00041314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928509|NCT00041314|Antiviral Agents|antiviral agents|mesh-ancestor
64928510|NCT00041314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64928511|NCT00041314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928512|NCT00041314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64928513|NCT00041314|Immunologic Factors|immunologic factors|mesh-ancestor
64928514|NCT00041314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928546|NCT00017394|Antimitotic Agents|antimitotic agents|mesh-ancestor
64928547|NCT00017394|Mitosis Modulators|mitosis modulators|mesh-ancestor
64928548|NCT00017394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928549|NCT00041431|Hormones|hormones|mesh-list
64928550|NCT00041431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64928551|NCT00041431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928552|NCT00001436|Tamoxifen|tamoxifen|mesh-list
64928553|NCT00001436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64928554|NCT00001436|Hormone Antagonists|hormone antagonists|mesh-ancestor
64928555|NCT00001436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64928586|NCT00017472|Antibodies|antibodies|mesh-list
64928587|NCT00017472|Immunoglobulins|immunoglobulins|mesh-list
64928588|NCT00017472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64928589|NCT00017472|Immunologic Factors|immunologic factors|mesh-ancestor
64928590|NCT00017472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527586|NCT01537133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64527587|NCT01537133|Respiratory System Agents|respiratory system agents|mesh-ancestor
64527588|NCT01537133|Dermatologic Agents|dermatologic agents|mesh-ancestor
64527589|NCT01537133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64527590|NCT01536587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64527591|NCT01536587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64527592|NCT01536587|Autonomic Agents|autonomic agents|mesh-ancestor
64527593|NCT01536587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64527594|NCT01536587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527595|NCT01536587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64527596|NCT01536587|Respiratory System Agents|respiratory system agents|mesh-ancestor
64928591|NCT00017472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928592|NCT00041782|Dalteparin|dalteparin|mesh-list
64928593|NCT00041782|Tinzaparin|tinzaparin|mesh-list
64928594|NCT00041782|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64928595|NCT00041782|Anticoagulants|anticoagulants|mesh-ancestor
64928596|NCT00041782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64928597|NCT00041782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64928598|NCT00041782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928599|NCT00017511|Cevimeline|cevimeline|mesh-list
64928600|NCT00017511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64928601|NCT00017511|Autonomic Agents|autonomic agents|mesh-ancestor
64928602|NCT00017511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64928603|NCT00017511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928604|NCT00017511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64928605|NCT00017511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64928606|NCT00017511|Cholinergic Agents|cholinergic agents|mesh-ancestor
64928607|NCT00017511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64928608|NCT00017511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928609|NCT00041899|Ulipristal acetate|ulipristal acetate|mesh-list
64928638|NCT00001457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64928639|NCT00001457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64928641|NCT00042172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64928642|NCT00042172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928643|NCT00042172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928644|NCT00042172|Cholinergic Agents|cholinergic agents|mesh-ancestor
64928645|NCT00042172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64928646|NCT00042172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928647|NCT00042172|Nootropic Agents|nootropic agents|mesh-ancestor
64928648|NCT00017589|Gemtuzumab|gemtuzumab|mesh-list
64928649|NCT00017589|Oblimersen|oblimersen|mesh-list
64928650|NCT00017589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64928651|NCT00017589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928652|NCT00001475|Thalidomide|thalidomide|mesh-list
64928653|NCT00001475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64928654|NCT00001475|Immunologic Factors|immunologic factors|mesh-ancestor
64928655|NCT00001475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928687|NCT02970643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64928688|NCT02970643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64928689|NCT02970643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64928690|NCT02970643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64928691|NCT02970643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64928692|NCT02970643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64928693|NCT02970643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928694|NCT02970643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64650414|NCT01426763|Complement C1s|complement c1s|mesh-list
64527602|NCT01536587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527604|NCT02985905|Astringents|astringents|mesh-ancestor
64527605|NCT02985905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527606|NCT02985905|Dermatologic Agents|dermatologic agents|mesh-ancestor
64527607|NCT01535261|Ranibizumab|ranibizumab|mesh-list
64527608|NCT01535261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64527609|NCT01535261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64527610|NCT01535261|Growth Substances|growth substances|mesh-ancestor
64928730|NCT00042562|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64928731|NCT00042562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64928732|NCT00042562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64928733|NCT00042562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928734|NCT00042562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64928735|NCT00042562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928737|NCT00042562|Sensory System Agents|sensory system agents|mesh-ancestor
64928738|NCT00042562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64928762|NCT00042718|Azithromycin|azithromycin|mesh-list
64928763|NCT00042718|Levofloxacin|levofloxacin|mesh-list
64928764|NCT00042718|Ofloxacin|ofloxacin|mesh-list
64928765|NCT00042718|Clavulanic Acid|clavulanic acid|mesh-list
64928766|NCT00042718|Clavulanic Acids|clavulanic acids|mesh-list
64928767|NCT00042718|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64928768|NCT00042718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64928769|NCT00042718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64928770|NCT00042718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64928771|NCT00042718|Renal Agents|renal agents|mesh-ancestor
64928772|NCT00042718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64928773|NCT00042718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64928774|NCT00042718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928775|NCT00042718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928776|NCT00042718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928777|NCT00042718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64928778|NCT00042718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64928779|NCT00042718|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64928780|NCT00042796|Decitabine|decitabine|mesh-list
64928781|NCT00042796|Azacitidine|azacitidine|mesh-list
64928782|NCT00042796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64928783|NCT00042796|Antimetabolites|antimetabolites|mesh-ancestor
64928784|NCT00042796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928785|NCT00042796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928786|NCT00042796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928787|NCT00042835|Paclitaxel|paclitaxel|mesh-list
64928788|NCT00042835|Etoposide|etoposide|mesh-list
64928789|NCT00042835|Docetaxel|docetaxel|mesh-list
64928790|NCT00042835|Carboplatin|carboplatin|mesh-list
64928791|NCT00042835|Etoposide phosphate|etoposide phosphate|mesh-list
64928792|NCT00042835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64928818|NCT00042874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64928819|NCT00042874|Immunologic Factors|immunologic factors|mesh-ancestor
64928820|NCT00042874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64928821|NCT00042874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64928822|NCT00042874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928823|NCT00042874|Antidotes|antidotes|mesh-ancestor
64928824|NCT00042874|Protective Agents|protective agents|mesh-ancestor
64928825|NCT00042874|Vitamin B Complex|vitamin b complex|mesh-ancestor
64527611|NCT01535261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527612|NCT01535261|Growth Inhibitors|growth inhibitors|mesh-ancestor
64527613|NCT01535261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527614|NCT01534637|Gemcitabine|gemcitabine|mesh-list
64527624|NCT01534637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64527625|NCT01534637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527626|NCT01534637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64527627|NCT01534637|Immunologic Factors|immunologic factors|mesh-ancestor
64527628|NCT01534637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527629|NCT01534637|Autonomic Agents|autonomic agents|mesh-ancestor
64527630|NCT01534637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64527631|NCT01534637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64527632|NCT01534637|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64527633|NCT01534637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64527634|NCT02655016|Niraparib|niraparib|mesh-list
64527635|NCT02655016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64527636|NCT02655016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527637|NCT02655016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928826|NCT00042874|Vitamins|vitamins|mesh-ancestor
64928827|NCT00042874|Micronutrients|micronutrients|mesh-ancestor
64928828|NCT00042874|Growth Inhibitors|growth inhibitors|mesh-ancestor
64697241|NCT04870866|Niacinamide|niacinamide|mesh-list
64928829|NCT00042874|Growth Substances|growth substances|mesh-ancestor
64928830|NCT00042874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64928831|NCT00042913|Epratuzumab|epratuzumab|mesh-list
64928832|NCT00042913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64928833|NCT00042913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928834|NCT00042952|Imatinib Mesylate|imatinib mesylate|mesh-list
64928835|NCT00042952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928836|NCT00042952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64734941|NCT02057250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64734942|NCT02036502|Dexamethasone|dexamethasone|mesh-list
64734943|NCT02036502|Pembrolizumab|pembrolizumab|mesh-list
64734944|NCT02036502|Lenalidomide|lenalidomide|mesh-list
64734945|NCT02036502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64734946|NCT02036502|Antiemetics|antiemetics|mesh-ancestor
64734947|NCT02036502|Autonomic Agents|autonomic agents|mesh-ancestor
64928837|NCT00042952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928838|NCT00042952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928839|NCT00043069|Cholecalciferol|cholecalciferol|mesh-list
64928840|NCT00043069|Risedronic Acid|risedronic acid|mesh-list
64928841|NCT00043069|Calcium Carbonate|calcium carbonate|mesh-list
64928842|NCT00043069|Estrogens|estrogens|mesh-list
64928843|NCT00043069|Estrogen Antagonists|estrogen antagonists|mesh-list
64928869|NCT00043147|Hormones|hormones|mesh-ancestor
64928870|NCT00043147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64527639|NCT01533935|Tiotropium Bromide|tiotropium bromide|mesh-list
64527640|NCT01533935|Olodaterol|olodaterol|mesh-list
64527641|NCT01533935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64527642|NCT01533935|Autonomic Agents|autonomic agents|mesh-ancestor
64527643|NCT01533935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64527644|NCT01533935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527645|NCT01533935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64527646|NCT01533935|Respiratory System Agents|respiratory system agents|mesh-ancestor
64527647|NCT01533935|Parasympatholytics|parasympatholytics|mesh-ancestor
64527648|NCT01533935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64527649|NCT01533935|Cholinergic Agents|cholinergic agents|mesh-ancestor
64527650|NCT01533935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64527651|NCT01533935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527652|NCT02570542|Cytarabine|cytarabine|mesh-list
64527653|NCT02570542|Plerixafor|plerixafor|mesh-list
64527654|NCT02570542|Etoposide|etoposide|mesh-list
64527655|NCT02570542|Melphalan|melphalan|mesh-list
64527656|NCT02570542|Carmustine|carmustine|mesh-list
64527657|NCT02570542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64527658|NCT02570542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527659|NCT02570542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64527660|NCT02570542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64527661|NCT02570542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928871|NCT00043147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928872|NCT00043147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64928881|NCT00043147|Respiratory System Agents|respiratory system agents|mesh-ancestor
64928883|NCT00017862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64928884|NCT00017862|Respiratory System Agents|respiratory system agents|mesh-ancestor
64928885|NCT00043264|Azithromycin|azithromycin|mesh-list
64928886|NCT00043264|Rifampin|rifampin|mesh-list
64928887|NCT00043264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64928888|NCT00043264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64928889|NCT00043264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64928890|NCT00043264|Antitubercular Agents|antitubercular agents|mesh-ancestor
64928891|NCT00043264|Leprostatic Agents|leprostatic agents|mesh-ancestor
64928892|NCT00043264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64928925|NCT00043342|Interferons|interferons|mesh-list
64928926|NCT00043342|Interferon-gamma|interferon-gamma|mesh-list
64928927|NCT00043342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928928|NCT00043342|Antiviral Agents|antiviral agents|mesh-ancestor
64928929|NCT00043342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64928930|NCT00043381|Decitabine|decitabine|mesh-list
64527662|NCT02570542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527663|NCT02570542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64527664|NCT02570542|Antimetabolites|antimetabolites|mesh-ancestor
64527665|NCT02570542|Antiviral Agents|antiviral agents|mesh-ancestor
64527666|NCT02570542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64527667|NCT02570542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64527668|NCT02570542|Immunologic Factors|immunologic factors|mesh-ancestor
64527669|NCT02570542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527670|NCT02570542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64527671|NCT02570542|Alkylating Agents|alkylating agents|mesh-ancestor
64527672|NCT02570542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64527673|NCT02570542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64527674|NCT02570542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64527675|NCT01532687|Gemcitabine|gemcitabine|mesh-list
64527676|NCT01532687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64527677|NCT01532687|Antimetabolites|antimetabolites|mesh-ancestor
64527678|NCT01532687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527679|NCT01532687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527680|NCT01532687|Antiviral Agents|antiviral agents|mesh-ancestor
64527681|NCT01532687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64527682|NCT01532687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527683|NCT01532687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64527684|NCT01532687|Immunologic Factors|immunologic factors|mesh-ancestor
64527685|NCT01532687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527686|NCT02677116|Doxorubicin|doxorubicin|mesh-list
64928931|NCT00043381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64928932|NCT00043381|Antimetabolites|antimetabolites|mesh-ancestor
64928933|NCT00043381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928934|NCT00043381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928951|NCT00043537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64928952|NCT00043537|Antidepressive Agents|antidepressive agents|mesh-ancestor
64928953|NCT00043537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64928954|NCT00043537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64928955|NCT00043537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64928956|NCT00043537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928957|NCT00043576|Calcitriol|calcitriol|mesh-list
64928958|NCT00043576|Docetaxel|docetaxel|mesh-list
64928959|NCT00043576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928960|NCT00043576|Tubulin Modulators|tubulin modulators|mesh-ancestor
64928961|NCT00043576|Antimitotic Agents|antimitotic agents|mesh-ancestor
64928962|NCT00043576|Mitosis Modulators|mitosis modulators|mesh-ancestor
64650435|NCT01505933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527691|NCT02677116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64527692|NCT02677116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527693|NCT02677116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64527694|NCT02677116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64928968|NCT00043576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64928969|NCT00043576|Vitamins|vitamins|mesh-ancestor
64928970|NCT00043576|Micronutrients|micronutrients|mesh-ancestor
64928971|NCT00043576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64928972|NCT00043654|Mifepristone|mifepristone|mesh-list
64928973|NCT00043654|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64928974|NCT00043654|Abortifacient Agents|abortifacient agents|mesh-ancestor
64928975|NCT00043654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64928976|NCT00043654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697392|NCT04184999|Hormones|hormones|mesh-ancestor
64928977|NCT00043654|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64928978|NCT00043654|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64928979|NCT00043654|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64928980|NCT00043654|Contraceptive Agents|contraceptive agents|mesh-ancestor
64928981|NCT00043654|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64928982|NCT00043654|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64928983|NCT00043654|Hormone Antagonists|hormone antagonists|mesh-ancestor
64928984|NCT00043654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64928985|NCT00043654|Luteolytic Agents|luteolytic agents|mesh-ancestor
64928986|NCT00043654|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64928987|NCT00043654|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64928989|NCT00043771|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64929024|NCT00001586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64929025|NCT00001586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64929026|NCT00001586|Antimetabolites|antimetabolites|mesh-ancestor
64929027|NCT00001586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929054|NCT00018018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64929056|NCT00043927|Etoposide|etoposide|mesh-list
64929057|NCT00043927|Topotecan|topotecan|mesh-list
64929058|NCT00043927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929059|NCT00043927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64929060|NCT00043927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64929061|NCT00043927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64734956|NCT02036502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64734957|NCT02036502|Immunologic Factors|immunologic factors|mesh-ancestor
64734958|NCT02036502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64734959|NCT02036502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64929062|NCT00043927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929063|NCT00043927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929064|NCT00043927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64929065|NCT00043966|Ritonavir|ritonavir|mesh-list
64929066|NCT00043966|Lopinavir|lopinavir|mesh-list
64929067|NCT00043966|Tenofovir|tenofovir|mesh-list
64929068|NCT00043966|Emtricitabine|emtricitabine|mesh-list
64929069|NCT00043966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64929070|NCT00043966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64929071|NCT00043966|Protease Inhibitors|protease inhibitors|mesh-ancestor
64929072|NCT00043966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929073|NCT00043966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929074|NCT00043966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64929095|NCT00044278|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64929096|NCT00044278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64929097|NCT00044278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929098|NCT00044278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64929099|NCT00044278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929100|NCT00044278|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64929101|NCT00044278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64650444|NCT01505933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64527702|NCT02677116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64527703|NCT02677116|Alkylating Agents|alkylating agents|mesh-ancestor
64929106|NCT00044395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929107|NCT00044395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929108|NCT00044434|Bupropion|bupropion|mesh-list
64929109|NCT00044434|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64929110|NCT00044434|Antidepressive Agents|antidepressive agents|mesh-ancestor
64929111|NCT00044434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64929112|NCT00044434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64929113|NCT00044434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64929114|NCT00044434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64929115|NCT00044434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929116|NCT00044434|Dopamine Agents|dopamine agents|mesh-ancestor
64929117|NCT00044434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64929118|NCT00044434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929119|NCT00044434|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64929120|NCT00044434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64697542|NCT05122026|Leprostatic Agents|leprostatic agents|mesh-ancestor
64929121|NCT00044434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929122|NCT00044473|Levofloxacin|levofloxacin|mesh-list
64929123|NCT00044473|Ofloxacin|ofloxacin|mesh-list
64929124|NCT00044473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64929125|NCT00044473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64929126|NCT00044473|Renal Agents|renal agents|mesh-ancestor
64929127|NCT00044473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64929146|NCT00018135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929147|NCT00018135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64929148|NCT00018135|Immunologic Factors|immunologic factors|mesh-ancestor
64929149|NCT00018135|Antacids|antacids|mesh-ancestor
64929150|NCT00018135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64929151|NCT00397384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64929152|NCT00397384|Cetuximab|cetuximab|mesh-list
64929153|NCT00397384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64929154|NCT00397384|Antibodies|antibodies|mesh-list
64929155|NCT00397384|Immunoglobulins|immunoglobulins|mesh-list
64929156|NCT00397384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64929157|NCT00397384|Immunologic Factors|immunologic factors|mesh-ancestor
64929158|NCT00397384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929159|NCT00397384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929160|NCT00397384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64929161|NCT00397384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929162|NCT00397384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929163|NCT00397423|Lenograstim|lenograstim|mesh-list
64929164|NCT00397423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64929165|NCT00397423|Immunologic Factors|immunologic factors|mesh-ancestor
64929166|NCT00397423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929167|NCT00397501|Sodium thiosulfate|sodium thiosulfate|mesh-list
64929168|NCT00397501|Carboplatin|carboplatin|mesh-list
64929169|NCT00397501|Methotrexate|methotrexate|mesh-list
64929170|NCT00397501|Trastuzumab|trastuzumab|mesh-list
64929171|NCT00397501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929172|NCT00397501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64929173|NCT00397501|Abortifacient Agents|abortifacient agents|mesh-ancestor
64650450|NCT00825734|Epothilones|epothilones|mesh-list
64527708|NCT02689518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527709|NCT02689518|Growth Inhibitors|growth inhibitors|mesh-ancestor
64527710|NCT02689518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527711|NCT02681094|Dapagliflozin|dapagliflozin|mesh-list
64527712|NCT02681094|Saxagliptin|saxagliptin|mesh-list
64527713|NCT02681094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64527714|NCT02681094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527715|NCT02681094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64527716|NCT02681094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527717|NCT02681094|Incretins|incretins|mesh-ancestor
64527718|NCT02681094|Hormones|hormones|mesh-ancestor
64527719|NCT02681094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64527720|NCT02681094|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64527721|NCT02681094|Protease Inhibitors|protease inhibitors|mesh-ancestor
64527722|NCT02681094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527723|NCT03164304|Magnesium Sulfate|magnesium sulfate|mesh-list
64527724|NCT03164304|Analgesics|analgesics|mesh-ancestor
64527725|NCT03164304|Sensory System Agents|sensory system agents|mesh-ancestor
64929177|NCT00397501|Antimetabolites|antimetabolites|mesh-ancestor
64929178|NCT00397501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929179|NCT00397501|Dermatologic Agents|dermatologic agents|mesh-ancestor
64929180|NCT00397501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929181|NCT00397501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64929182|NCT00397501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64929183|NCT00397501|Immunologic Factors|immunologic factors|mesh-ancestor
64929184|NCT00397501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64929185|NCT00397501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64929212|NCT00044629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64929213|NCT00044629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929214|NCT00044629|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64929215|NCT00044629|GABA Agonists|gaba agonists|mesh-ancestor
64929216|NCT00044629|GABA Agents|gaba agents|mesh-ancestor
64929217|NCT00044629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64929218|NCT00044629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929219|NCT00044668|Exenatide|exenatide|mesh-list
64929220|NCT00044668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64929221|NCT00044668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929222|NCT00044668|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64929223|NCT00044668|Incretins|incretins|mesh-ancestor
64929224|NCT00044668|Hormones|hormones|mesh-ancestor
64929225|NCT00044668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64929226|NCT00044707|Pramlintide|pramlintide|mesh-list
64929227|NCT00044707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64929228|NCT00044707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929229|NCT00044746|Tazobactam|tazobactam|mesh-list
64929230|NCT00044746|Piperacillin|piperacillin|mesh-list
64929231|NCT00044746|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64929232|NCT00044746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64527726|NCT03164304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64527727|NCT03164304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527728|NCT03164304|Anesthetics|anesthetics|mesh-ancestor
64616982|NCT03503578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64321205|NCT02206789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64321206|NCT02206789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64321207|NCT02206789|Antiemetics|antiemetics|mesh-ancestor
64321208|NCT02206789|Autonomic Agents|autonomic agents|mesh-ancestor
64321209|NCT02206789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321210|NCT02206789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64321211|NCT02206789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64321212|NCT02206789|Protective Agents|protective agents|mesh-ancestor
64321213|NCT03892369|Ethanol|ethanol|mesh-list
64527729|NCT03164304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64527730|NCT03164304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64527731|NCT03164304|Anticonvulsants|anticonvulsants|mesh-ancestor
64527732|NCT03164304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64527733|NCT03164304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64527734|NCT03164304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527735|NCT03164304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64527736|NCT03164304|Tocolytic Agents|tocolytic agents|mesh-ancestor
64650461|NCT00872534|Analgesics|analgesics|mesh-ancestor
64527747|NCT03165396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64527748|NCT03165396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64527749|NCT03165396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527750|NCT03165396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64527751|NCT03165396|Anesthetics, General|anesthetics, general|mesh-ancestor
64527752|NCT03165396|Anesthetics|anesthetics|mesh-ancestor
64527753|NCT03165396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64527754|NCT03165396|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64527755|NCT03164382|Sorafenib|sorafenib|mesh-list
64527760|NCT03161340|Sirolimus|sirolimus|mesh-list
64527767|NCT03161340|Immunologic Factors|immunologic factors|mesh-ancestor
64527768|NCT03161340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527770|NCT03161574|Oxaliplatin|oxaliplatin|mesh-list
64527771|NCT03161574|Irinotecan|irinotecan|mesh-list
64527772|NCT03161574|Antimetabolites|antimetabolites|mesh-ancestor
64527773|NCT03161574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527774|NCT03161574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64527775|NCT03161574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527776|NCT03161574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64527777|NCT03161574|Immunologic Factors|immunologic factors|mesh-ancestor
64929233|NCT00044746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64929234|NCT00044746|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64929266|NCT00018213|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64929267|NCT00018213|Autonomic Agents|autonomic agents|mesh-ancestor
64929268|NCT00018213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64929269|NCT00018213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929270|NCT00018213|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64929271|NCT00018213|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64929272|NCT00018213|Cholinergic Agents|cholinergic agents|mesh-ancestor
64929273|NCT00018213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64929274|NCT00018213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929276|NCT00018213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64929277|NCT00018213|Sensory System Agents|sensory system agents|mesh-ancestor
64929278|NCT00044863|Cetuximab|cetuximab|mesh-list
64929279|NCT00044863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64929280|NCT00044863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929305|NCT00018291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64929307|NCT00018291|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64929308|NCT00018291|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64929309|NCT00018291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64929310|NCT00018291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929311|NCT00018291|Antimanic Agents|antimanic agents|mesh-ancestor
64929312|NCT00018291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64929313|NCT00018291|Serotonin Agents|serotonin agents|mesh-ancestor
64929314|NCT00018291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64929315|NCT00018291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64929316|NCT00018291|Dopamine Agents|dopamine agents|mesh-ancestor
64929317|NCT00045175|Topotecan|topotecan|mesh-list
64929318|NCT00045175|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
64929319|NCT00045175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64929320|NCT00045175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64929321|NCT00045175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929322|NCT00045175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929323|NCT00045175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650473|NCT00872534|Antipyretics|antipyretics|mesh-ancestor
64929364|NCT00045448|Growth Inhibitors|growth inhibitors|mesh-ancestor
64929365|NCT00045448|Growth Substances|growth substances|mesh-ancestor
64929366|NCT00045448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929367|NCT00045448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64929368|NCT00045448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929369|NCT00045526|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64929370|NCT00045526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929371|NCT00045526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64527779|NCT03161574|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64527780|NCT03161574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64527781|NCT03161574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527782|NCT05676216|Diphenhydramine|diphenhydramine|mesh-list
64527783|NCT05676216|Promethazine|promethazine|mesh-list
64527784|NCT05676216|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64527785|NCT05676216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64929372|NCT00045526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929373|NCT00045526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929374|NCT00045565|Arsenic Trioxide|arsenic trioxide|mesh-list
64929375|NCT00045565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929404|NCT04731766|Protective Agents|protective agents|mesh-ancestor
64929405|NCT04731766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929406|NCT04731766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64929407|NCT04731766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64929408|NCT00045760|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
64929409|NCT00045760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64929410|NCT00018447|Fluorides|fluorides|mesh-list
64929411|NCT00018447|Cariostatic Agents|cariostatic agents|mesh-ancestor
64929412|NCT00018447|Protective Agents|protective agents|mesh-ancestor
64929413|NCT00018447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929414|NCT00001688|Ritonavir|ritonavir|mesh-list
64929415|NCT00001688|Nevirapine|nevirapine|mesh-list
64929416|NCT00001688|Stavudine|stavudine|mesh-list
64929417|NCT00001688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64929418|NCT00001688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64929419|NCT00001688|Protease Inhibitors|protease inhibitors|mesh-ancestor
64929420|NCT00001688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929421|NCT00001688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929451|NCT00045799|Omeprazole|omeprazole|mesh-list
64929452|NCT00045799|Cimetidine|cimetidine|mesh-list
64929453|NCT00045799|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
64929454|NCT00045799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64929455|NCT00045799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64929456|NCT00045799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64929457|NCT00045799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929458|NCT00045799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929459|NCT00045799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64929460|NCT00045799|Histamine Antagonists|histamine antagonists|mesh-ancestor
64929461|NCT00045799|Histamine Agents|histamine agents|mesh-ancestor
64929462|NCT00045799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64929463|NCT00045799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929464|NCT00045799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64929495|NCT00045916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64929496|NCT00045916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64929497|NCT00045916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64929498|NCT00045916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64650477|NCT02513160|Beclomethasone|beclomethasone|mesh-list
64929502|NCT00045916|Adrenergic Agents|adrenergic agents|mesh-ancestor
64929503|NCT04380207|QPX7728|qpx7728|mesh-list
64929504|NCT04380207|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64929505|NCT04380207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929506|NCT04380207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929507|NCT04380207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64945509|NCT05543785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64945510|NCT05543785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64945512|NCT05543785|Sensory System Agents|sensory system agents|mesh-ancestor
64945513|NCT05543785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64945514|NCT05543785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945515|NCT05543785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64527786|NCT05676216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64527787|NCT05676216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527789|NCT05676216|Anesthetics|anesthetics|mesh-ancestor
64527806|NCT03163914|Norepinephrine|norepinephrine|mesh-list
64527807|NCT03163914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64527808|NCT03163914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64527809|NCT03163914|Adrenergic Agents|adrenergic agents|mesh-ancestor
64945516|NCT05543785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64945517|NCT05543785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64945518|NCT05543785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945519|NCT05543785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945529|NCT05457465|Cannabidiol|cannabidiol|mesh-list
64945530|NCT05457465|Anticonvulsants|anticonvulsants|mesh-ancestor
64945531|NCT05453955|Propofol|propofol|mesh-list
64945532|NCT05453955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64945533|NCT05453955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64929518|NCT00045955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64929519|NCT00045955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929520|NCT00045955|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64929521|NCT00045955|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64929522|NCT00045955|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64929523|NCT00045955|Histamine Antagonists|histamine antagonists|mesh-ancestor
64929524|NCT00045955|Histamine Agents|histamine agents|mesh-ancestor
64929525|NCT00045955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64929526|NCT00046033|Ritonavir|ritonavir|mesh-list
64929527|NCT00046033|Lopinavir|lopinavir|mesh-list
64929528|NCT00046033|Saquinavir|saquinavir|mesh-list
64929529|NCT00046033|Amprenavir|amprenavir|mesh-list
64929530|NCT00046033|Tenofovir|tenofovir|mesh-list
64929531|NCT00046033|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64929532|NCT00046033|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64929533|NCT00046033|Protease Inhibitors|protease inhibitors|mesh-ancestor
64929534|NCT00046033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929535|NCT00046033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929536|NCT00046033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64929537|NCT00046033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64929538|NCT00046033|Antiviral Agents|antiviral agents|mesh-ancestor
64929539|NCT00046033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64929540|NCT00046033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64929541|NCT00046033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64929566|NCT00001724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64929567|NCT00001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929568|NCT00001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929569|NCT00046150|Insulin glulisine|insulin glulisine|mesh-list
64929570|NCT00046150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64929571|NCT00046150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929573|NCT00046267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64929574|NCT00046267|Antimetabolites|antimetabolites|mesh-ancestor
64929575|NCT00046267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929576|NCT00046267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64929577|NCT00046267|Vasodilator Agents|vasodilator agents|mesh-ancestor
64929578|NCT00046267|Vitamin B Complex|vitamin b complex|mesh-ancestor
64929579|NCT00046267|Vitamins|vitamins|mesh-ancestor
64929580|NCT00046267|Micronutrients|micronutrients|mesh-ancestor
64929581|NCT00046267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929588|NCT00046345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64527810|NCT03163914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64527811|NCT03163914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527812|NCT03163914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527813|NCT03163914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64527814|NCT03163914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64527815|NCT03163914|Autonomic Agents|autonomic agents|mesh-ancestor
64527816|NCT03163914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64527817|NCT03163914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64527818|NCT03163914|Respiratory System Agents|respiratory system agents|mesh-ancestor
64527820|NCT03163914|Sympathomimetics|sympathomimetics|mesh-ancestor
64527821|NCT03163914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64527822|NCT03163914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64527823|NCT03163914|Nasal Decongestants|nasal decongestants|mesh-ancestor
64527824|NCT03163914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64527825|NCT03163914|Protective Agents|protective agents|mesh-ancestor
64527826|NCT03160872|Hormones|hormones|mesh-list
64527827|NCT03160872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64527828|NCT03160872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527829|NCT03163680|Omeprazole|omeprazole|mesh-list
64527830|NCT03163680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64527831|NCT03163680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64527832|NCT03163680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64527833|NCT03163680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527834|NCT03163680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527849|NCT04574232|Triamcinolone|triamcinolone|mesh-list
64527850|NCT04574232|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64527851|NCT04574232|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64527852|NCT04574232|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64527853|NCT04574232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64527854|NCT04574232|Glucocorticoids|glucocorticoids|mesh-ancestor
64527855|NCT04574232|Hormones|hormones|mesh-ancestor
64929589|NCT00046345|Protease Inhibitors|protease inhibitors|mesh-ancestor
64929621|NCT00397735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64929623|NCT00397735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64929624|NCT00397735|Expectorants|expectorants|mesh-ancestor
64929625|NCT00397735|Respiratory System Agents|respiratory system agents|mesh-ancestor
64929626|NCT00397735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64929627|NCT00397735|Antioxidants|antioxidants|mesh-ancestor
64527857|NCT04574232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527858|NCT04574232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64527859|NCT04574232|Immunologic Factors|immunologic factors|mesh-ancestor
64527860|NCT04574232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527861|NCT04574232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527862|NCT05071716|Rifaximin|rifaximin|mesh-list
64929628|NCT00397735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929629|NCT00397735|Protective Agents|protective agents|mesh-ancestor
64929630|NCT00397735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929631|NCT00397735|Antidotes|antidotes|mesh-ancestor
64929632|NCT00046384|Aripiprazole|aripiprazole|mesh-list
64929633|NCT00046384|Antidepressive Agents|antidepressive agents|mesh-ancestor
64929634|NCT00046384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64929635|NCT00046384|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64929663|NCT00001766|Ritonavir|ritonavir|mesh-list
64929664|NCT00001766|Nelfinavir|nelfinavir|mesh-list
64650488|NCT02513160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64929665|NCT00001766|Amprenavir|amprenavir|mesh-list
64929666|NCT00001766|Abacavir|abacavir|mesh-list
64929667|NCT00001766|Efavirenz|efavirenz|mesh-list
64929678|NCT00001766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64929679|NCT00001766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64929680|NCT00001766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64929681|NCT00001766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64929718|NCT00046813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64929749|NCT00047047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64929751|NCT00047047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929753|NCT04733781|Epinephrine|epinephrine|mesh-list
64929754|NCT04733781|Anesthetics, Local|anesthetics, local|mesh-ancestor
64929755|NCT04733781|Anesthetics|anesthetics|mesh-ancestor
64929756|NCT04733781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64929757|NCT04733781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929758|NCT04733781|Sensory System Agents|sensory system agents|mesh-ancestor
64929759|NCT04733781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64929760|NCT04733781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64929786|NCT00047203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929787|NCT00047203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64929788|NCT00047203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929789|NCT00047203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929790|NCT04163874|Pramlintide|pramlintide|mesh-list
64929791|NCT04163874|Pancrelipase|pancrelipase|mesh-list
64929792|NCT04163874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64929793|NCT04163874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64929794|NCT04163874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929795|NCT00047242|Irinotecan|irinotecan|mesh-list
64929796|NCT00047242|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
64929797|NCT00047242|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64929798|NCT00047242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64929799|NCT00047242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929800|NCT00047242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929801|NCT00047242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617247|NCT01084759|Hormones|hormones|mesh-ancestor
64929802|NCT00047242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64929803|NCT00047281|Thalidomide|thalidomide|mesh-list
64929804|NCT00047281|Celecoxib|celecoxib|mesh-list
64929805|NCT00047281|Cyclophosphamide|cyclophosphamide|mesh-list
64929806|NCT00047281|Etoposide|etoposide|mesh-list
64527864|NCT05071716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64527865|NCT05071716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64527866|NCT02680002|MF59 oil emulsion|mf59 oil emulsion|mesh-list
64527867|NCT02680002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64527868|NCT02680002|Immunologic Factors|immunologic factors|mesh-ancestor
64527869|NCT02680002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929807|NCT00047281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64929808|NCT00047281|Immunologic Factors|immunologic factors|mesh-ancestor
64929830|NCT00047281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64929831|NCT00047281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64929832|NCT00047281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64929833|NCT00047281|Growth Substances|growth substances|mesh-ancestor
64929834|NCT00047281|Growth Inhibitors|growth inhibitors|mesh-ancestor
64929835|NCT00047476|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
64929836|NCT00047476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64650497|NCT01507103|Cyclophosphamide|cyclophosphamide|mesh-list
64929845|NCT00047554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64929846|NCT00047554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64929847|NCT00047554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64929849|NCT00047632|Interferon-gamma|interferon-gamma|mesh-list
64929850|NCT00047632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929851|NCT00047632|Antiviral Agents|antiviral agents|mesh-ancestor
64929852|NCT00047632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64929853|NCT00047671|Citalopram|citalopram|mesh-list
64929854|NCT00047671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64929855|NCT00047671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64929856|NCT00047671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64929857|NCT00047671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929858|NCT00047671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64929879|NCT00047749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929880|NCT00047749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64929881|NCT00047749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929882|NCT00047749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64929884|NCT00047749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64929885|NCT00047749|Analgesics|analgesics|mesh-ancestor
64929886|NCT00047749|Sensory System Agents|sensory system agents|mesh-ancestor
64929887|NCT00047749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64929888|NCT00047827|Amphotericin B|amphotericin b|mesh-list
64929889|NCT00047827|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64929890|NCT00047827|Micafungin|micafungin|mesh-list
64929891|NCT00047827|Amebicides|amebicides|mesh-ancestor
64929892|NCT00047827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64929893|NCT00047827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64929894|NCT00047827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64929895|NCT00047827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64929896|NCT00047827|Antifungal Agents|antifungal agents|mesh-ancestor
64929897|NCT00393783|Trastuzumab|trastuzumab|mesh-list
64929898|NCT00393783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64929899|NCT00393783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929900|NCT00048139|Capecitabine|capecitabine|mesh-list
64929901|NCT00048139|Irinotecan|irinotecan|mesh-list
64929902|NCT00048139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64929903|NCT00048139|Antimetabolites|antimetabolites|mesh-ancestor
64929904|NCT00048139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527871|NCT04557384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527872|NCT04548648|Isavuconazole|isavuconazole|mesh-list
64527873|NCT04548648|Acalabrutinib|acalabrutinib|mesh-list
64527874|NCT04548648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527875|NCT04548648|Antifungal Agents|antifungal agents|mesh-ancestor
64527876|NCT04548648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64527877|NCT04443348|Paclitaxel|paclitaxel|mesh-list
64527878|NCT04443348|Cyclophosphamide|cyclophosphamide|mesh-list
64527879|NCT04443348|Carboplatin|carboplatin|mesh-list
64527880|NCT04443348|Doxorubicin|doxorubicin|mesh-list
64527881|NCT04443348|Pembrolizumab|pembrolizumab|mesh-list
64527882|NCT04443348|Capecitabine|capecitabine|mesh-list
64929905|NCT00048139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929906|NCT00048139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64929907|NCT00048139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64929908|NCT00048139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929909|NCT00048334|Romidepsin|romidepsin|mesh-list
64929910|NCT00048334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64929911|NCT00048334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929912|NCT00048373|Etanercept|etanercept|mesh-list
64929948|NCT00048607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64929986|NCT05576298|Insulin|insulin|mesh-list
64929987|NCT05576298|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64929988|NCT05576298|Insulin, Long-Acting|insulin, long-acting|mesh-list
64929989|NCT05576298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64929990|NCT05576298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929991|NCT00048802|Valproic Acid|valproic acid|mesh-list
64929992|NCT00048802|Olanzapine|olanzapine|mesh-list
64930009|NCT00048802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64930010|NCT00048802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64930011|NCT00048802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64930012|NCT00048802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64930013|NCT00048802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64930014|NCT00048802|Antidepressive Agents|antidepressive agents|mesh-ancestor
64930015|NCT00048802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930016|NCT00048802|Antimanic Agents|antimanic agents|mesh-ancestor
64930017|NCT00048802|Anticonvulsants|anticonvulsants|mesh-ancestor
64930018|NCT00048802|GABA Agents|gaba agents|mesh-ancestor
64930019|NCT00048841|Alendronate|alendronate|mesh-list
64930020|NCT00048841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64930021|NCT00048841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930022|NCT00048880|Antibodies|antibodies|mesh-list
64930023|NCT00048880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64930024|NCT00048880|Immunologic Factors|immunologic factors|mesh-ancestor
64930025|NCT00048880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930026|NCT05641064|Dexmedetomidine|dexmedetomidine|mesh-list
64930027|NCT05641064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64930028|NCT05641064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64930029|NCT05641064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930030|NCT05641064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64930031|NCT05641064|Analgesics|analgesics|mesh-ancestor
64930032|NCT05641064|Sensory System Agents|sensory system agents|mesh-ancestor
64930033|NCT05641064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64930034|NCT05641064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64930035|NCT05641064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64930036|NCT05641064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64930037|NCT05641064|Adrenergic Agents|adrenergic agents|mesh-ancestor
64930038|NCT05641064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64930039|NCT05641064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930040|NCT00049075|Fludarabine|fludarabine|mesh-list
64527883|NCT04443348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64527884|NCT04443348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527885|NCT04443348|Tubulin Modulators|tubulin modulators|mesh-ancestor
64527886|NCT04443348|Antimitotic Agents|antimitotic agents|mesh-ancestor
64617382|NCT04355429|Protease Inhibitors|protease inhibitors|mesh-ancestor
64617383|NCT04355429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527887|NCT04443348|Mitosis Modulators|mitosis modulators|mesh-ancestor
64527888|NCT04443348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527889|NCT04443348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64930041|NCT00049075|Fludarabine phosphate|fludarabine phosphate|mesh-list
64930042|NCT00049075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930043|NCT00049075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64930044|NCT00049075|Antimetabolites|antimetabolites|mesh-ancestor
64930045|NCT00049075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930046|NCT00049075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64930047|NCT00049075|Immunologic Factors|immunologic factors|mesh-ancestor
64930048|NCT00049075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930049|NCT00049114|Cyclophosphamide|cyclophosphamide|mesh-list
64930051|NCT00049114|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64930052|NCT00049114|Tipifarnib|tipifarnib|mesh-list
64930071|NCT00049192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930073|NCT05576181|Fludarabine|fludarabine|mesh-list
64930074|NCT05576181|Etoposide|etoposide|mesh-list
64650512|NCT00876200|Vasodilator Agents|vasodilator agents|mesh-ancestor
64930079|NCT05576181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64930080|NCT05576181|Alkylating Agents|alkylating agents|mesh-ancestor
64930081|NCT05576181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930082|NCT05576181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930083|NCT05576181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64930084|NCT05576181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64930085|NCT05576181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64930086|NCT05576181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64930087|NCT05576181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930089|NCT00049348|Fluorouracil|fluorouracil|mesh-list
64930090|NCT00049348|Epoetin Alfa|epoetin alfa|mesh-list
64930091|NCT00049348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930092|NCT00049348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64930093|NCT00049348|Antimetabolites|antimetabolites|mesh-ancestor
64930094|NCT00049348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930095|NCT00049348|Antiviral Agents|antiviral agents|mesh-ancestor
64930096|NCT00049348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64930097|NCT00049348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930098|NCT00049348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64930099|NCT00049348|Immunologic Factors|immunologic factors|mesh-ancestor
64930100|NCT00049348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930101|NCT00049348|Hematinics|hematinics|mesh-ancestor
64930102|NCT00049387|Temozolomide|temozolomide|mesh-list
64930103|NCT00049387|Tipifarnib|tipifarnib|mesh-list
64930104|NCT00049387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64930105|NCT00049387|Alkylating Agents|alkylating agents|mesh-ancestor
64930106|NCT00049387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930107|NCT00049387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930137|NCT00391911|Antidotes|antidotes|mesh-ancestor
64930138|NCT02970409|Heparin|heparin|mesh-list
64930139|NCT02970409|Anticoagulants|anticoagulants|mesh-ancestor
64930140|NCT02970409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64930141|NCT02970409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64930142|NCT02970409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930143|NCT00049582|Decitabine|decitabine|mesh-list
64930144|NCT00049582|Azacitidine|azacitidine|mesh-list
64930145|NCT00049582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64930146|NCT00049582|Antimetabolites|antimetabolites|mesh-ancestor
64930147|NCT00049582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930148|NCT00049582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527890|NCT04443348|Immunologic Factors|immunologic factors|mesh-ancestor
64527891|NCT04443348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527892|NCT04443348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64527893|NCT04443348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64527894|NCT04443348|Alkylating Agents|alkylating agents|mesh-ancestor
64527895|NCT04443348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64930149|NCT00049582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930150|NCT00049660|Capecitabine|capecitabine|mesh-list
64930151|NCT00049660|Vinorelbine|vinorelbine|mesh-list
64930152|NCT00049660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64930153|NCT00049660|Antimetabolites|antimetabolites|mesh-ancestor
64930154|NCT00049660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930187|NCT00392028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64930188|NCT00392067|Calcipotriene|calcipotriene|mesh-list
64930189|NCT00392067|Dermatologic Agents|dermatologic agents|mesh-ancestor
64930190|NCT00389558|Amikacin|amikacin|mesh-list
64930191|NCT00389558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64930192|NCT00389558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64930193|NCT00049972|Paroxetine|paroxetine|mesh-list
64930194|NCT00049972|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64930195|NCT00049972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64930196|NCT00049972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64930197|NCT00049972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930227|NCT00050206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64930228|NCT00050206|Serotonin Agents|serotonin agents|mesh-ancestor
64650520|NCT02512302|Cholinergic Agents|cholinergic agents|mesh-ancestor
64930329|NCT00050947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527896|NCT04443348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64527897|NCT04443348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64527898|NCT04443348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64527899|NCT04443348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64527900|NCT04443348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64527901|NCT04443348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64527902|NCT04443348|Antimetabolites|antimetabolites|mesh-ancestor
64527904|NCT05039736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64527905|NCT05039736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527906|NCT05039736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64527907|NCT05039736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527908|NCT03161184|Sulfamethazine|sulfamethazine|mesh-list
64527909|NCT03161184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64527910|NCT03163212|Lactoferrin|lactoferrin|mesh-list
64527911|NCT03163212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64527912|NCT05007678|Leflunomide|leflunomide|mesh-list
64527913|NCT05007678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930362|NCT05639777|Analgesics|analgesics|mesh-ancestor
64930363|NCT05639777|Sensory System Agents|sensory system agents|mesh-ancestor
64930364|NCT05639777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64930365|NCT05639777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64930366|NCT05639777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64930367|NCT05639777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64930368|NCT05639777|Adrenergic Agents|adrenergic agents|mesh-ancestor
64930369|NCT05639777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64930370|NCT05639777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930371|NCT00051298|Olanzapine|olanzapine|mesh-list
64930405|NCT00051532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64930406|NCT00051532|Immunologic Factors|immunologic factors|mesh-ancestor
64930407|NCT00051532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930408|NCT00051571|Docetaxel|docetaxel|mesh-list
64930409|NCT00051571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930410|NCT00051571|Tubulin Modulators|tubulin modulators|mesh-ancestor
64930411|NCT00051571|Antimitotic Agents|antimitotic agents|mesh-ancestor
64930412|NCT00051571|Mitosis Modulators|mitosis modulators|mesh-ancestor
64930413|NCT00051571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930446|NCT00051688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930448|NCT00051844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64930449|NCT00051844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64930450|NCT00051844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930451|NCT00051844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930452|NCT00051844|Antiviral Agents|antiviral agents|mesh-ancestor
64930453|NCT00051844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64930454|NCT00051844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64930455|NCT00051844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64930475|NCT00052117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64930476|NCT00052117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930477|NCT00052117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930478|NCT00052117|Antiviral Agents|antiviral agents|mesh-ancestor
64930479|NCT00052117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64930480|NCT00052117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64930481|NCT00052117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64930482|NCT00052273|Capecitabine|capecitabine|mesh-list
64527914|NCT05007678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527915|NCT05007678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64527916|NCT05007678|Immunologic Factors|immunologic factors|mesh-ancestor
64527917|NCT05007678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527918|NCT03161106|Lactulose|lactulose|mesh-list
64527919|NCT03161106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64527920|NCT02671500|Sofosbuvir|sofosbuvir|mesh-list
64527921|NCT02671500|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64527922|NCT02671500|Velpatasvir|velpatasvir|mesh-list
64527923|NCT02671500|Antiviral Agents|antiviral agents|mesh-ancestor
64650565|NCT01508117|Axitinib|axitinib|mesh-list
64930488|NCT00052312|Doxorubicin|doxorubicin|mesh-list
64930489|NCT00052312|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64930490|NCT00052312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64930491|NCT00052312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930492|NCT00052312|Tubulin Modulators|tubulin modulators|mesh-ancestor
64930493|NCT00052312|Antimitotic Agents|antimitotic agents|mesh-ancestor
64930494|NCT00052312|Mitosis Modulators|mitosis modulators|mesh-ancestor
64930495|NCT00052312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930496|NCT00052312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64930497|NCT00052312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64930498|NCT00052312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64930499|NCT00052312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930500|NCT00052351|Metronidazole|metronidazole|mesh-list
64930501|NCT00052351|Paclitaxel|paclitaxel|mesh-list
64930502|NCT00052351|Cyclophosphamide|cyclophosphamide|mesh-list
64930503|NCT00052351|Doxorubicin|doxorubicin|mesh-list
64930504|NCT00052351|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64930505|NCT00052351|Vaccines|vaccines|mesh-list
64930506|NCT00052351|Sargramostim|sargramostim|mesh-list
64930507|NCT00052351|Immunologic Factors|immunologic factors|mesh-ancestor
64930508|NCT00052351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930509|NCT00052351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64930510|NCT00052351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930511|NCT00052351|Tubulin Modulators|tubulin modulators|mesh-ancestor
64930512|NCT00052351|Antimitotic Agents|antimitotic agents|mesh-ancestor
64930513|NCT00052351|Mitosis Modulators|mitosis modulators|mesh-ancestor
64930540|NCT00052390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64930541|NCT00052390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930542|NCT00052390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930543|NCT00052468|Gemcitabine|gemcitabine|mesh-list
64930544|NCT00052468|Paclitaxel|paclitaxel|mesh-list
64930545|NCT00052468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64930546|NCT00052468|Carboplatin|carboplatin|mesh-list
64930547|NCT00052468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64930548|NCT00052468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930549|NCT00052468|Tubulin Modulators|tubulin modulators|mesh-ancestor
64930550|NCT00052468|Antimitotic Agents|antimitotic agents|mesh-ancestor
64930551|NCT00052468|Mitosis Modulators|mitosis modulators|mesh-ancestor
64930552|NCT00052468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930553|NCT00052468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64930554|NCT00052468|Antimetabolites|antimetabolites|mesh-ancestor
64930555|NCT00052468|Antiviral Agents|antiviral agents|mesh-ancestor
64527930|NCT03160404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64527932|NCT03160404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64527933|NCT03160404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527934|NCT03160404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64527935|NCT03160404|GABA Agonists|gaba agonists|mesh-ancestor
64527936|NCT03160404|GABA Agents|gaba agents|mesh-ancestor
64527937|NCT03160404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64527938|NCT03160404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64527939|NCT03162588|Epoetin Alfa|epoetin alfa|mesh-list
64527954|NCT04977336|Sensory System Agents|sensory system agents|mesh-ancestor
64527955|NCT04977336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64527956|NCT04977336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527958|NCT03284424|Pembrolizumab|pembrolizumab|mesh-list
64930556|NCT00052468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64930590|NCT00052780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930591|NCT00052780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930592|NCT00052780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930593|NCT00052936|Prednisone|prednisone|mesh-list
64930594|NCT00052936|Cyclophosphamide|cyclophosphamide|mesh-list
64930595|NCT00052936|Rituximab|rituximab|mesh-list
64930596|NCT00052936|Doxorubicin|doxorubicin|mesh-list
64930597|NCT00052936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64930598|NCT00052936|Vincristine|vincristine|mesh-list
64930599|NCT00052936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64930600|NCT00052936|Immunologic Factors|immunologic factors|mesh-ancestor
64930601|NCT00052936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930602|NCT00052936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64617592|NCT03398278|Oxycodone|oxycodone|mesh-list
64930603|NCT00052936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64930604|NCT00052936|Alkylating Agents|alkylating agents|mesh-ancestor
64930605|NCT00052936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930606|NCT00052936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930607|NCT00052936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64930608|NCT00052936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64930609|NCT00052936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64930610|NCT00052936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64930611|NCT00052936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64930612|NCT00052936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930613|NCT00052936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64930614|NCT00052936|Glucocorticoids|glucocorticoids|mesh-ancestor
64930615|NCT00052936|Hormones|hormones|mesh-ancestor
64930648|NCT00053131|Immunologic Factors|immunologic factors|mesh-ancestor
64930649|NCT00053131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930650|NCT00053131|Analgesics|analgesics|mesh-ancestor
64930651|NCT00053131|Sensory System Agents|sensory system agents|mesh-ancestor
64930652|NCT00053131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64930653|NCT00053131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64527959|NCT03284424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64527960|NCT03284424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64527961|NCT02674854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64527962|NCT02674854|Latanoprost|latanoprost|mesh-list
64527963|NCT02674854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64527964|NCT04036188|Vitamin D|vitamin d|mesh-list
64527965|NCT04036188|Cholecalciferol|cholecalciferol|mesh-list
64527966|NCT04036188|Triamcinolone|triamcinolone|mesh-list
64527967|NCT04036188|Vitamins|vitamins|mesh-ancestor
64527968|NCT04036188|Micronutrients|micronutrients|mesh-ancestor
64527969|NCT04036188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930654|NCT00053131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64930655|NCT00053131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930671|NCT00053248|Arsenic Trioxide|arsenic trioxide|mesh-list
64930672|NCT00053248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930673|NCT00053248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64930674|NCT00053248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930675|NCT00053248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930677|NCT00053287|Carboplatin|carboplatin|mesh-list
64930678|NCT00053287|Fludarabine|fludarabine|mesh-list
64650578|NCT00878228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64930679|NCT00053287|Fludarabine phosphate|fludarabine phosphate|mesh-list
64930680|NCT00053287|Topotecan|topotecan|mesh-list
64930681|NCT00053287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930682|NCT00053287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64930688|NCT00053287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64930689|NCT00053287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64930690|NCT00053287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930691|NCT00053287|Leprostatic Agents|leprostatic agents|mesh-ancestor
64930692|NCT00053287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64930693|NCT00053287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64930694|NCT00053287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64930695|NCT00053287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64930696|NCT00053287|Growth Substances|growth substances|mesh-ancestor
64930697|NCT00053287|Growth Inhibitors|growth inhibitors|mesh-ancestor
64930698|NCT00053326|Fenretinide|fenretinide|mesh-list
64930699|NCT00053326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930700|NCT00053326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64930701|NCT00053326|Protective Agents|protective agents|mesh-ancestor
64930702|NCT00053326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321215|NCT03892369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64321216|NCT03892369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64321217|NCT03892369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321218|NCT02206867|Adalimumab|adalimumab|mesh-list
64930703|NCT00053560|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64930704|NCT00053560|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64930705|NCT00053560|Immunologic Factors|immunologic factors|mesh-ancestor
64930706|NCT00053560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930707|NCT00053599|Simvastatin|simvastatin|mesh-list
64930708|NCT00053599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64930709|NCT00053599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64930710|NCT00053599|Antimetabolites|antimetabolites|mesh-ancestor
64930711|NCT00053599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699181|NCT05639712|Fentanyl|fentanyl|mesh-list
64930712|NCT00053599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64930713|NCT00053599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64930715|NCT00053638|Tenofovir|tenofovir|mesh-list
64930740|NCT05626478|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64930741|NCT05626478|Methylprednisolone|methylprednisolone|mesh-list
64930742|NCT05626478|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64930743|NCT05626478|Prednisolone acetate|prednisolone acetate|mesh-list
64930744|NCT05626478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64930745|NCT05626478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64930746|NCT05626478|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64930747|NCT05626478|Prednisolone phosphate|prednisolone phosphate|mesh-list
64527970|NCT04036188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64527971|NCT04036188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64527972|NCT04036188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64527974|NCT04036188|Hormones|hormones|mesh-ancestor
64527975|NCT04036188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64527990|NCT02388516|Vitamin D|vitamin d|mesh-list
64527991|NCT02388516|Cholecalciferol|cholecalciferol|mesh-list
64527992|NCT02388516|Vitamins|vitamins|mesh-ancestor
64527993|NCT02388516|Micronutrients|micronutrients|mesh-ancestor
64527994|NCT02388516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64527995|NCT02388516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64527996|NCT02388516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64527997|NCT02669862|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64527998|NCT02135874|Cytarabine|cytarabine|mesh-list
64527999|NCT02135874|Dexamethasone|dexamethasone|mesh-list
64528000|NCT02135874|Dexamethasone acetate|dexamethasone acetate|mesh-list
64528001|NCT02135874|Rituximab|rituximab|mesh-list
64528002|NCT02135874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64528003|NCT02135874|Vincristine|vincristine|mesh-list
64528004|NCT02135874|Sorafenib|sorafenib|mesh-list
64528005|NCT02135874|Idarubicin|idarubicin|mesh-list
64930748|NCT05626478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64930749|NCT05626478|Antiemetics|antiemetics|mesh-ancestor
64930750|NCT05626478|Autonomic Agents|autonomic agents|mesh-ancestor
64930751|NCT05626478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64930752|NCT05626478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930753|NCT05626478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64930754|NCT05626478|Glucocorticoids|glucocorticoids|mesh-ancestor
64930756|NCT05626478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64650587|NCT01391273|Bimatoprost|bimatoprost|mesh-list
64930796|NCT05624918|Antiviral Agents|antiviral agents|mesh-ancestor
64930797|NCT05624918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64930798|NCT05624918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930799|NCT05624918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64930800|NCT05624918|Immunologic Factors|immunologic factors|mesh-ancestor
64930801|NCT05624918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930802|NCT00053911|Tamoxifen|tamoxifen|mesh-list
64930803|NCT00053911|Cyclophosphamide|cyclophosphamide|mesh-list
64930804|NCT00053911|Docetaxel|docetaxel|mesh-list
64930805|NCT00053911|Fluorouracil|fluorouracil|mesh-list
64930806|NCT00053911|Epirubicin|epirubicin|mesh-list
64930807|NCT00053911|Anastrozole|anastrozole|mesh-list
64930808|NCT00053911|Goserelin|goserelin|mesh-list
64930809|NCT00053911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64930810|NCT00053911|Immunologic Factors|immunologic factors|mesh-ancestor
64930811|NCT00053911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930837|NCT00053950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528007|NCT02135874|Antibodies|antibodies|mesh-list
64528008|NCT02135874|Immunoglobulins|immunoglobulins|mesh-list
64528009|NCT02135874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64528010|NCT02135874|BB 1101|bb 1101|mesh-list
64528011|NCT02135874|Immunologic Factors|immunologic factors|mesh-ancestor
64528012|NCT02135874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528013|NCT02135874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528014|NCT02135874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64528015|NCT02135874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64528016|NCT02135874|Antiemetics|antiemetics|mesh-ancestor
64528018|NCT02135874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64528019|NCT02135874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64528020|NCT02135874|Glucocorticoids|glucocorticoids|mesh-ancestor
64528021|NCT02135874|Hormones|hormones|mesh-ancestor
64528022|NCT02135874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64528023|NCT02135874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64528024|NCT02135874|Protease Inhibitors|protease inhibitors|mesh-ancestor
64528025|NCT02135874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528026|NCT02135874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528027|NCT02135874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64528028|NCT02135874|Antimetabolites|antimetabolites|mesh-ancestor
64528029|NCT02135874|Antiviral Agents|antiviral agents|mesh-ancestor
64528030|NCT02135874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64528031|NCT02135874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64528032|NCT02135874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64528033|NCT02135874|Tubulin Modulators|tubulin modulators|mesh-ancestor
64528034|NCT02135874|Antimitotic Agents|antimitotic agents|mesh-ancestor
64528035|NCT02135874|Mitosis Modulators|mitosis modulators|mesh-ancestor
64930838|NCT00054067|Cisplatin|cisplatin|mesh-list
64930839|NCT00054067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930840|NCT00054106|Flutamide|flutamide|mesh-list
64930841|NCT00054106|Buserelin|buserelin|mesh-list
64930842|NCT00054106|Androgen Antagonists|androgen antagonists|mesh-ancestor
64930843|NCT00054106|Hormone Antagonists|hormone antagonists|mesh-ancestor
64930844|NCT00054106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64930845|NCT00054106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930846|NCT00054106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64930847|NCT00054106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930848|NCT00054106|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64930849|NCT00054106|Fertility Agents|fertility agents|mesh-ancestor
64930850|NCT00054106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64930851|NCT00054184|Paclitaxel|paclitaxel|mesh-list
64528041|NCT01531673|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64930856|NCT00054184|Tubulin Modulators|tubulin modulators|mesh-ancestor
64930857|NCT00054184|Antimitotic Agents|antimitotic agents|mesh-ancestor
64930858|NCT00054184|Mitosis Modulators|mitosis modulators|mesh-ancestor
64930889|NCT00054418|Calcium Carbonate|calcium carbonate|mesh-list
64930890|NCT00054418|Calcium|calcium|mesh-list
64930891|NCT00054418|Vitamins|vitamins|mesh-ancestor
64930892|NCT00054418|Micronutrients|micronutrients|mesh-ancestor
64930893|NCT00054418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930894|NCT00054418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64930895|NCT00054418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64930896|NCT00054418|Antacids|antacids|mesh-ancestor
64930897|NCT00054418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930898|NCT00054418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64930899|NCT00054418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64930900|NCT00054418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64930901|NCT05560230|Clonidine|clonidine|mesh-list
64930902|NCT05560230|Analgesics|analgesics|mesh-ancestor
64930903|NCT05560230|Sensory System Agents|sensory system agents|mesh-ancestor
64930904|NCT05560230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64930936|NCT00054535|Antiviral Agents|antiviral agents|mesh-ancestor
64930937|NCT00054535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64699415|NCT04010305|Dexmedetomidine|dexmedetomidine|mesh-list
64930939|NCT00054574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64930941|NCT00054613|Methoxsalen|methoxsalen|mesh-list
64930942|NCT00054613|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64930943|NCT00054613|Dermatologic Agents|dermatologic agents|mesh-ancestor
64930944|NCT00054808|Gallium nitrate|gallium nitrate|mesh-list
64930945|NCT00054808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64930946|NCT00054808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930947|NCT00054808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930982|NCT00398281|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64930983|NCT00398281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64930984|NCT00398281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930985|NCT00398281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930986|NCT00398281|Hormone Antagonists|hormone antagonists|mesh-ancestor
64930987|NCT00398281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64930988|NCT00398281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931020|NCT05527704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931021|NCT05527704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64931022|NCT05527704|Respiratory System Agents|respiratory system agents|mesh-ancestor
64617807|NCT04744623|Glucocorticoids|glucocorticoids|mesh-ancestor
64931024|NCT05527704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64931025|NCT05527704|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64931026|NCT05527704|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64931027|NCT05527704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64931028|NCT05527704|Adrenergic Agents|adrenergic agents|mesh-ancestor
64931029|NCT05527704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64931030|NCT05527704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931031|NCT00055159|Plasminogen|plasminogen|mesh-list
64931032|NCT00055159|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64931033|NCT00055159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64931065|NCT00055432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64931066|NCT00055432|Immunologic Factors|immunologic factors|mesh-ancestor
64931067|NCT00055432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931068|NCT00055432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64931069|NCT00055432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64931070|NCT00055549|Lorazepam|lorazepam|mesh-list
64931071|NCT00055549|Dextromethorphan|dextromethorphan|mesh-list
64931072|NCT00055549|Antitussive Agents|antitussive agents|mesh-ancestor
64528048|NCT01531205|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64528049|NCT01531205|Fertility Agents|fertility agents|mesh-ancestor
64528050|NCT01531205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64528051|NCT01531205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528052|NCT01531205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64528053|NCT01531205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528054|NCT01531205|Hormones|hormones|mesh-ancestor
64528055|NCT01531205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64528056|NCT01531205|Androgen Antagonists|androgen antagonists|mesh-ancestor
64528057|NCT01531205|Hormone Antagonists|hormone antagonists|mesh-ancestor
64528058|NCT02985671|Acetaminophen|acetaminophen|mesh-list
64528059|NCT02985671|Diclofenac|diclofenac|mesh-list
64528060|NCT02985671|Orphenadrine|orphenadrine|mesh-list
64528061|NCT02985671|Caffeine|caffeine|mesh-list
64528062|NCT02985671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64528063|NCT02985671|Analgesics|analgesics|mesh-ancestor
64528064|NCT02985671|Sensory System Agents|sensory system agents|mesh-ancestor
64528065|NCT02985671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64528066|NCT02985671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528067|NCT02985671|Antipyretics|antipyretics|mesh-ancestor
64528068|NCT02985671|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64931073|NCT00055549|Respiratory System Agents|respiratory system agents|mesh-ancestor
64931106|NCT00055822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931107|NCT00055822|Antimetabolites|antimetabolites|mesh-ancestor
64931108|NCT00055822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931109|NCT00055822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64931110|NCT00055822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931111|NCT00055822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64931112|NCT00055822|Immunologic Factors|immunologic factors|mesh-ancestor
64931113|NCT00055822|Antidotes|antidotes|mesh-ancestor
64931114|NCT00055822|Protective Agents|protective agents|mesh-ancestor
64931115|NCT00055822|Vitamin B Complex|vitamin b complex|mesh-ancestor
64931116|NCT00055822|Vitamins|vitamins|mesh-ancestor
64931117|NCT00055822|Micronutrients|micronutrients|mesh-ancestor
64931148|NCT00392106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64931149|NCT00392106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64931150|NCT00392106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64931151|NCT00392106|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64931153|NCT00055939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64931154|NCT00055939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64931155|NCT00055939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931156|NCT00055939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931157|NCT00055939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931158|NCT00055978|Celecoxib|celecoxib|mesh-list
64528069|NCT02985671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64321231|NCT05261581|Analgesics|analgesics|mesh-list
64528070|NCT02985671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528071|NCT02985671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528072|NCT02985671|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64528073|NCT02985671|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64528074|NCT02985671|Purinergic Agents|purinergic agents|mesh-ancestor
64528075|NCT02985671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64528076|NCT02985671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64528077|NCT02985671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64528078|NCT02985671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64528079|NCT02985671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64528080|NCT02985671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64528081|NCT02985671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64528082|NCT02985671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64528083|NCT02985671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64931159|NCT00055978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64931160|NCT00055978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64931161|NCT00055978|Analgesics|analgesics|mesh-ancestor
64931194|NCT00056095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931195|NCT00056095|Dermatologic Agents|dermatologic agents|mesh-ancestor
64931196|NCT00056095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64931198|NCT00056329|Tocopherols|tocopherols|mesh-list
64650611|NCT01392989|Antifungal Agents|antifungal agents|mesh-ancestor
64931223|NCT00056641|Ritonavir|ritonavir|mesh-list
64931224|NCT00056641|Lopinavir|lopinavir|mesh-list
64931225|NCT00056641|Saquinavir|saquinavir|mesh-list
64931226|NCT00056641|Amprenavir|amprenavir|mesh-list
64931227|NCT00056641|Tipranavir|tipranavir|mesh-list
64931228|NCT00056641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64931229|NCT00056641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64931230|NCT00056641|Protease Inhibitors|protease inhibitors|mesh-ancestor
64931231|NCT00056641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931232|NCT00056641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931233|NCT00056641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64931234|NCT00056641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64931235|NCT00056641|Antiviral Agents|antiviral agents|mesh-ancestor
64931236|NCT00056641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931237|NCT00056641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64931238|NCT00056641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64931239|NCT00056641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64931240|NCT00056641|Antitubercular Agents|antitubercular agents|mesh-ancestor
64931241|NCT00056641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64931242|NCT00398437|Trastuzumab|trastuzumab|mesh-list
64931243|NCT00398437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64931244|NCT00398437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931245|NCT05433675|Macitentan|macitentan|mesh-list
64931246|NCT05433675|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64931247|NCT05433675|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64931248|NCT05433675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931249|NCT05433675|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64931250|NCT00423709|Fludarabine|fludarabine|mesh-list
64931251|NCT00423709|Melphalan|melphalan|mesh-list
64528084|NCT02985671|Parasympatholytics|parasympatholytics|mesh-ancestor
64528085|NCT02985671|Autonomic Agents|autonomic agents|mesh-ancestor
64528086|NCT02985671|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64528087|NCT02985671|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64528088|NCT02985671|Cholinergic Agents|cholinergic agents|mesh-ancestor
64528089|NCT02985671|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
64528090|NCT02985671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64528091|NCT01529645|Vaccines|vaccines|mesh-list
64484197|NCT04795336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528092|NCT01529645|Immunologic Factors|immunologic factors|mesh-ancestor
64528093|NCT01529645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528094|NCT01528787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64528095|NCT01528787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64528096|NCT01528709|Atorvastatin|atorvastatin|mesh-list
64528097|NCT01528709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64528098|NCT01528709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64931252|NCT00423709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931253|NCT00423709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931254|NCT00423709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64931255|NCT00423709|Immunologic Factors|immunologic factors|mesh-ancestor
64931256|NCT00423709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931257|NCT00423709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64931258|NCT00423709|Alkylating Agents|alkylating agents|mesh-ancestor
64931259|NCT00423709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64931280|NCT05495321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64931281|NCT05495321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931283|NCT05495321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64931284|NCT05495321|Antiviral Agents|antiviral agents|mesh-ancestor
64931285|NCT05495321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931286|NCT00056875|Mitogens|mitogens|mesh-list
64931287|NCT00056875|Mitosis Modulators|mitosis modulators|mesh-ancestor
64931288|NCT00056875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931296|NCT05410197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931297|NCT05410197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931298|NCT05410197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64931299|NCT05410197|Immunologic Factors|immunologic factors|mesh-ancestor
64931300|NCT05410197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931301|NCT05410197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64931302|NCT03262454|Atezolizumab|atezolizumab|mesh-list
64931303|NCT03262454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931304|NCT00057031|Calcitriol|calcitriol|mesh-list
64931305|NCT00057031|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64931306|NCT00057031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931307|NCT00057031|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64931308|NCT00057031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64931309|NCT00057031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931310|NCT00057031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64931311|NCT00057031|Vitamins|vitamins|mesh-ancestor
64931312|NCT00057031|Micronutrients|micronutrients|mesh-ancestor
64931313|NCT00057031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64528100|NCT01528709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528101|NCT01528709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64528102|NCT01528709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64528103|NCT01528709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528105|NCT01527383|Immunologic Factors|immunologic factors|mesh-ancestor
64528106|NCT01527383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528107|NCT01526057|Rituximab|rituximab|mesh-list
64528108|NCT01526057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64528109|NCT01526057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528110|NCT01526057|Immunologic Factors|immunologic factors|mesh-ancestor
64699786|NCT03661645|Dexamethasone|dexamethasone|mesh-list
64931314|NCT02969980|Cyclophosphamide|cyclophosphamide|mesh-list
64931345|NCT00057382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931346|NCT00057382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64931347|NCT00057382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64931348|NCT00057382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931349|NCT00057382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931350|NCT00057421|Prednisolone|prednisolone|mesh-list
64931351|NCT00057421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64931352|NCT00057421|Glucocorticoids|glucocorticoids|mesh-ancestor
64931353|NCT00057421|Hormones|hormones|mesh-ancestor
64931354|NCT00057421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64931355|NCT00057421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931356|NCT00057421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64931385|NCT00057928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64931386|NCT00057928|Antimetabolites|antimetabolites|mesh-ancestor
64931387|NCT00057928|Antiviral Agents|antiviral agents|mesh-ancestor
64931388|NCT00057928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931389|NCT00057928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931390|NCT00057928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64931391|NCT00057928|Immunologic Factors|immunologic factors|mesh-ancestor
64931392|NCT00057928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931393|NCT05309304|Cefazolin|cefazolin|mesh-list
64931394|NCT05309304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64931395|NCT05309304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931396|NCT00057967|Alemtuzumab|alemtuzumab|mesh-list
64931397|NCT00057967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64931398|NCT00057967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931399|NCT00058006|Celecoxib|celecoxib|mesh-list
64931400|NCT00058006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64931401|NCT00058006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64931402|NCT00058006|Analgesics|analgesics|mesh-ancestor
64931432|NCT00058084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64931438|NCT00058084|Mitosis Modulators|mitosis modulators|mesh-ancestor
64931439|NCT02969629|Apomorphine|apomorphine|mesh-list
64931440|NCT02969629|Emetics|emetics|mesh-ancestor
64931441|NCT02969629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931442|NCT02969629|Autonomic Agents|autonomic agents|mesh-ancestor
64931443|NCT02969629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64931444|NCT02969629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64931445|NCT02969629|Dopamine Agonists|dopamine agonists|mesh-ancestor
64931446|NCT02969629|Dopamine Agents|dopamine agents|mesh-ancestor
64931447|NCT02969629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64931448|NCT02969629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931485|NCT00058318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528111|NCT01526057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528112|NCT01526057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64528113|NCT00121719|Lenvatinib|lenvatinib|mesh-list
64528114|NCT00121719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528115|NCT00121719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64528116|NCT00121719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528117|NCT00121719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528119|NCT01525901|Mecasermin|mecasermin|mesh-list
64528120|NCT01525901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528121|NCT01525901|Mitosis Modulators|mitosis modulators|mesh-ancestor
64528122|NCT01525901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528123|NCT01525901|Growth Substances|growth substances|mesh-ancestor
64528124|NCT00123123|Chlorhexidine|chlorhexidine|mesh-list
64528125|NCT00123123|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64528126|NCT00123123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64528127|NCT00123123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64735007|NCT02034162|Mebendazole|mebendazole|mesh-list
64735008|NCT02034162|Piperazine|piperazine|mesh-list
64735009|NCT02034162|Piperazine citrate|piperazine citrate|mesh-list
64321234|NCT05261581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735010|NCT02034162|DMP 777|dmp 777|mesh-list
64735011|NCT02034162|Antinematodal Agents|antinematodal agents|mesh-ancestor
64528128|NCT00123123|Disinfectants|disinfectants|mesh-ancestor
64528129|NCT00123123|Dermatologic Agents|dermatologic agents|mesh-ancestor
64528130|NCT00242385|Protease Inhibitors|protease inhibitors|mesh-list
64528131|NCT00242385|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64528132|NCT00242385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528133|NCT00242385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528134|NCT00242385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64931487|NCT00058318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931488|NCT00058318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931489|NCT00058318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64931521|NCT00392262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64931522|NCT00392262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931523|NCT00392262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64931524|NCT00392262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931526|NCT00392262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64931527|NCT00392262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64931528|NCT00058747|Imatinib Mesylate|imatinib mesylate|mesh-list
64931529|NCT00058747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931530|NCT00058747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64931554|NCT02969473|Immunologic Factors|immunologic factors|mesh-ancestor
64931555|NCT02969473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931556|NCT00059254|Palmitic Acid|palmitic acid|mesh-list
64931557|NCT00059254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931558|NCT00059254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931559|NCT01349907|Asenapine|asenapine|mesh-list
64931560|NCT01349907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64931561|NCT01349907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64931562|NCT01349907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64931563|NCT01349907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931564|NCT01349907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64931565|NCT02969278|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64931566|NCT02969278|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64528135|NCT00242385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64528136|NCT00242619|Rosiglitazone|rosiglitazone|mesh-list
64528137|NCT00242619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64318115|NCT02410863|Dabrafenib|dabrafenib|mesh-list
64528145|NCT01899027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64528146|NCT01899027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528147|NCT00264381|Dalteparin|dalteparin|mesh-list
64528148|NCT00264381|Tinzaparin|tinzaparin|mesh-list
64528149|NCT00264381|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64528150|NCT00264381|Anticoagulants|anticoagulants|mesh-ancestor
64528151|NCT00264381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64528152|NCT00264381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64528153|NCT00264381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528154|NCT00246441|Paroxetine|paroxetine|mesh-list
64528155|NCT00246441|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64528156|NCT00246441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64931567|NCT02969278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931568|NCT05223582|Prednisone|prednisone|mesh-list
64931569|NCT05223582|Abiraterone Acetate|abiraterone acetate|mesh-list
64931570|NCT05223582|Androgens|androgens|mesh-list
64931571|NCT05223582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64931572|NCT05223582|Glucocorticoids|glucocorticoids|mesh-ancestor
64931573|NCT05223582|Hormones|hormones|mesh-ancestor
64931574|NCT05223582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64931575|NCT05223582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931576|NCT05223582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64931577|NCT05223582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931578|NCT05223582|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64931579|NCT05223582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931580|NCT05223582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931612|NCT02969239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64931613|NCT02969239|Adrenergic Agents|adrenergic agents|mesh-ancestor
64931614|NCT02969239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64931615|NCT02969239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931616|NCT02969239|Protective Agents|protective agents|mesh-ancestor
64931618|NCT00059761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931619|NCT00059761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64931620|NCT00059761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64931621|NCT00059761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931622|NCT00059761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931623|NCT00059800|Boron|boron|mesh-list
64931624|NCT00059800|Trace Elements|trace elements|mesh-ancestor
64931653|NCT00059917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64931654|NCT00059917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931655|NCT00059917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528157|NCT00246441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64528158|NCT00246441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528159|NCT00246441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64528160|NCT00246441|Serotonin Agents|serotonin agents|mesh-ancestor
64528161|NCT00246441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528162|NCT00246441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64528163|NCT00246441|Antidepressive Agents|antidepressive agents|mesh-ancestor
64528164|NCT00246441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64714112|NCT03043274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64484274|NCT01719380|Cetuximab|cetuximab|mesh-list
64528165|NCT00246441|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64528166|NCT00246441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64528167|NCT00246441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528168|NCT00246519|Atenolol|atenolol|mesh-list
64528169|NCT00246519|Metoprolol|metoprolol|mesh-list
64528170|NCT00246519|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64931656|NCT00060112|Gemcitabine|gemcitabine|mesh-list
64931658|NCT00060112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64931668|NCT00060307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64931703|NCT00398515|Growth Inhibitors|growth inhibitors|mesh-ancestor
64931704|NCT00398515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931705|NCT00398515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64931706|NCT00398515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931707|NCT00398515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64931708|NCT00398515|Antifungal Agents|antifungal agents|mesh-ancestor
64931709|NCT00398515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64931746|NCT00060385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64931747|NCT00060385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64931748|NCT00060385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64931749|NCT00060385|Tubulin Modulators|tubulin modulators|mesh-ancestor
64931750|NCT00060385|Antimitotic Agents|antimitotic agents|mesh-ancestor
64931784|NCT05312372|Paclitaxel|paclitaxel|mesh-list
64931785|NCT05312372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64931786|NCT05312372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931787|NCT05312372|Tubulin Modulators|tubulin modulators|mesh-ancestor
64931788|NCT05312372|Antimitotic Agents|antimitotic agents|mesh-ancestor
64931789|NCT05312372|Mitosis Modulators|mitosis modulators|mesh-ancestor
64931790|NCT05312372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931791|NCT05038410|Wobenzym|wobenzym|mesh-list
64931823|NCT00060931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64931825|NCT00060931|Autonomic Agents|autonomic agents|mesh-ancestor
64931826|NCT00060931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650640|NCT04985760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931827|NCT00060931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931828|NCT00060931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64931829|NCT00060931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64931830|NCT00060931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64931831|NCT00060931|Adrenergic Agents|adrenergic agents|mesh-ancestor
64528171|NCT00246519|Trichlormethiazide|trichlormethiazide|mesh-list
64528172|NCT00246519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64528173|NCT00246519|Diuretics|diuretics|mesh-ancestor
64528174|NCT00246519|Natriuretic Agents|natriuretic agents|mesh-ancestor
64528175|NCT00246519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528176|NCT00246519|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64528177|NCT00246519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64931832|NCT00060931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64931833|NCT00060931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931862|NCT04711564|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
64931863|NCT04711564|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64931864|NCT04711564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64931866|NCT00061321|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64931867|NCT00061321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64931868|NCT00061321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931869|NCT00061321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931870|NCT00061321|Antiviral Agents|antiviral agents|mesh-ancestor
64931871|NCT00061321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931872|NCT00061321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64931873|NCT00061321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64931874|NCT00061321|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64931906|NCT00061477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931907|NCT00061477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64735031|NCT04675788|Androgens|androgens|mesh-ancestor
64735032|NCT04675788|Hormones|hormones|mesh-ancestor
64735033|NCT04675788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64735034|NCT04675788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735035|NCT04675788|Progestins|progestins|mesh-ancestor
64735036|NCT04675788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64735037|NCT02052960|Cisplatin|cisplatin|mesh-list
64735038|NCT02052960|Fluorouracil|fluorouracil|mesh-list
64735039|NCT02052960|Cetuximab|cetuximab|mesh-list
64735040|NCT02052960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735041|NCT02052960|Antimetabolites|antimetabolites|mesh-ancestor
64735042|NCT02052960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735043|NCT02052960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64735044|NCT02052960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64735045|NCT02052960|Immunologic Factors|immunologic factors|mesh-ancestor
64735046|NCT02052960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735048|NCT02008890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64735106|NCT02006706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64735107|NCT02006706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64735109|NCT02006706|Antiemetics|antiemetics|mesh-ancestor
64931948|NCT00061711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931949|NCT00061711|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64931950|NCT00061711|Estrogens|estrogens|mesh-ancestor
64931951|NCT00061750|Deferasirox|deferasirox|mesh-list
64931952|NCT00061750|Deferoxamine|deferoxamine|mesh-list
64931953|NCT00061750|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64931954|NCT00061750|Chelating Agents|chelating agents|mesh-ancestor
64931955|NCT00061750|Sequestering Agents|sequestering agents|mesh-ancestor
64931956|NCT00061750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931957|NCT00061750|Siderophores|siderophores|mesh-ancestor
64735123|NCT02049138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735124|NCT02049138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64735125|NCT02048904|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64735126|NCT02048904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64735127|NCT02048904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735128|NCT02048904|Incretins|incretins|mesh-ancestor
64735129|NCT02048904|Hormones|hormones|mesh-ancestor
64735130|NCT02048904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64735131|NCT02048904|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64735132|NCT02048904|Protease Inhibitors|protease inhibitors|mesh-ancestor
64735133|NCT02048904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735134|NCT02048904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735135|NCT02006628|Cannabidiol|cannabidiol|mesh-list
64321247|NCT02207335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64321248|NCT02207335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64321249|NCT02207335|Immunologic Factors|immunologic factors|mesh-ancestor
64618288|NCT02561832|Olaparib|olaparib|mesh-list
64931958|NCT00061789|Acetylcholine|acetylcholine|mesh-list
64931959|NCT00061789|Vasodilator Agents|vasodilator agents|mesh-ancestor
64931960|NCT00061789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64931961|NCT00061789|Cholinergic Agents|cholinergic agents|mesh-ancestor
64931962|NCT00061789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64931963|NCT00061789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931964|NCT00061789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931965|NCT00061867|Doxorubicin|doxorubicin|mesh-list
64931966|NCT00061867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64931967|NCT00061867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64321250|NCT02207335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321251|NCT02561078|Insulin|insulin|mesh-list
64321252|NCT02561078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64321253|NCT02561078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64735136|NCT02006628|Anticonvulsants|anticonvulsants|mesh-ancestor
64735137|NCT02029638|Acetaminophen|acetaminophen|mesh-list
64735138|NCT02029638|Diphenhydramine|diphenhydramine|mesh-list
64735139|NCT02029638|Promethazine|promethazine|mesh-list
64735140|NCT02029638|Mycophenolic Acid|mycophenolic acid|mesh-list
64735142|NCT02029638|Methylprednisolone|methylprednisolone|mesh-list
64735143|NCT02029638|Cyclophosphamide|cyclophosphamide|mesh-list
64735144|NCT02029638|Fludarabine|fludarabine|mesh-list
64735145|NCT02029638|Thymoglobulin|thymoglobulin|mesh-list
64735146|NCT02029638|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64735147|NCT02029638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64735148|NCT02029638|Immunologic Factors|immunologic factors|mesh-ancestor
64735149|NCT02029638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931968|NCT00061867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931969|NCT00061867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64931970|NCT00061867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64931971|NCT00061867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528178|NCT00246519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528180|NCT00246519|Sympatholytics|sympatholytics|mesh-ancestor
64528181|NCT00246519|Autonomic Agents|autonomic agents|mesh-ancestor
64528182|NCT00246519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321254|NCT02561078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321256|NCT02202889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64321257|NCT02202889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321258|NCT04058197|Deferoxamine|deferoxamine|mesh-list
64321259|NCT04058197|Siderophores|siderophores|mesh-ancestor
64735150|NCT02029638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64735151|NCT02029638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64735152|NCT02029638|Alkylating Agents|alkylating agents|mesh-ancestor
64735153|NCT02029638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735154|NCT02029638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735155|NCT02029638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64735156|NCT02029638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64735157|NCT02029638|Glucocorticoids|glucocorticoids|mesh-ancestor
64735158|NCT02029638|Hormones|hormones|mesh-ancestor
64528183|NCT00246519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64528184|NCT00246519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64528185|NCT00246519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64528186|NCT00246519|Adrenergic Agents|adrenergic agents|mesh-ancestor
64528187|NCT00246519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64932002|NCT00398554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64932003|NCT00398554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64932009|NCT00398554|Hormones|hormones|mesh-ancestor
64735189|NCT02047734|Interferons|interferons|mesh-list
64735190|NCT02047734|Interferon-beta|interferon-beta|mesh-list
64735191|NCT02047734|Interferon beta-1a|interferon beta-1a|mesh-list
64735192|NCT02047734|Ozanimod|ozanimod|mesh-list
64735193|NCT02047734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735194|NCT02047734|Antiviral Agents|antiviral agents|mesh-ancestor
64735195|NCT02047734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64735196|NCT02047734|Immunologic Factors|immunologic factors|mesh-ancestor
64735197|NCT02047734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735198|NCT02047734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64735199|NCT02047734|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64735200|NCT02047734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735201|NCT02047734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64735202|NCT01994850|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64735203|NCT01994850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64735204|NCT01994850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735205|NCT01994382|Rituximab|rituximab|mesh-list
64735206|NCT01994382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64735207|NCT01994382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735208|NCT01994382|Immunologic Factors|immunologic factors|mesh-ancestor
64735209|NCT01994382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735210|NCT01994382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64735211|NCT02003898|Insulin|insulin|mesh-list
64321268|NCT02202967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321269|NCT02202967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64321270|NCT02202967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64321271|NCT02202967|Oxytocics|oxytocics|mesh-ancestor
64321272|NCT03532867|Tin Fluorides|tin fluorides|mesh-list
64321273|NCT03532867|Cariostatic Agents|cariostatic agents|mesh-ancestor
64321274|NCT03532867|Protective Agents|protective agents|mesh-ancestor
64932010|NCT00398554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64932011|NCT00398554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64932012|NCT00398554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64932013|NCT00398554|Tubulin Modulators|tubulin modulators|mesh-ancestor
64932014|NCT00398554|Antimitotic Agents|antimitotic agents|mesh-ancestor
64932015|NCT00398554|Mitosis Modulators|mitosis modulators|mesh-ancestor
64932042|NCT00061984|Alkylating Agents|alkylating agents|mesh-ancestor
64932043|NCT00062023|Aspirin|aspirin|mesh-list
64932044|NCT00062023|Sulindac|sulindac|mesh-list
64735212|NCT02003898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64735213|NCT02003898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735214|NCT01994226|Naproxen|naproxen|mesh-list
64735215|NCT01994226|Colchicine|colchicine|mesh-list
64735216|NCT01994226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64735217|NCT01994226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64735218|NCT01994226|Analgesics|analgesics|mesh-ancestor
64735219|NCT01994226|Sensory System Agents|sensory system agents|mesh-ancestor
64735220|NCT01994226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64735221|NCT01994226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735222|NCT01994226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64735223|NCT01994226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64735224|NCT01994226|Gout Suppressants|gout suppressants|mesh-ancestor
64735225|NCT01994226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64735226|NCT01994226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735227|NCT01994226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735228|NCT01994226|Tubulin Modulators|tubulin modulators|mesh-ancestor
64735229|NCT01994226|Antimitotic Agents|antimitotic agents|mesh-ancestor
64735230|NCT01994226|Mitosis Modulators|mitosis modulators|mesh-ancestor
64735231|NCT01994226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735232|NCT02002884|Botulinum Toxins|botulinum toxins|mesh-list
64735233|NCT02002884|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64735264|NCT01990560|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64735265|NCT01990560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64735266|NCT01990560|Contraceptive Agents|contraceptive agents|mesh-ancestor
64735267|NCT01990560|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64735269|NCT01990560|Hormone Antagonists|hormone antagonists|mesh-ancestor
64932045|NCT00062023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64932046|NCT00062023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64932047|NCT00062023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64932048|NCT00062023|Analgesics|analgesics|mesh-ancestor
64932049|NCT00062023|Sensory System Agents|sensory system agents|mesh-ancestor
64932050|NCT00062023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64932051|NCT00062023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932052|NCT00062023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64932053|NCT00062023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64932054|NCT00062023|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64932055|NCT00062023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64932056|NCT00062023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932057|NCT00062023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64932058|NCT00062023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64932059|NCT00062023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932060|NCT00062023|Antipyretics|antipyretics|mesh-ancestor
64932061|NCT00062023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64321284|NCT02208427|Isoniazid|isoniazid|mesh-list
64321285|NCT02208427|Rifapentine|rifapentine|mesh-list
64321286|NCT02208427|Antitubercular Agents|antitubercular agents|mesh-ancestor
64321287|NCT02208427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64321288|NCT02208427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64321289|NCT02208427|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64321290|NCT02208427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64735279|NCT01999218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735281|NCT01999218|Hormones|hormones|mesh-ancestor
64735282|NCT01999218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64735283|NCT01999218|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64735284|NCT01999218|Protease Inhibitors|protease inhibitors|mesh-ancestor
64735285|NCT01999218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735286|NCT01999218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735287|NCT01999218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64735288|NCT01999218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64735289|NCT01999218|Immunologic Factors|immunologic factors|mesh-ancestor
64735290|NCT01999218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64735291|NCT01967628|Vitamin D|vitamin d|mesh-list
64735292|NCT01967628|Cholecalciferol|cholecalciferol|mesh-list
64700550|NCT03504241|Abatacept|abatacept|mesh-list
64932087|NCT00392340|Antimitotic Agents|antimitotic agents|mesh-ancestor
64932088|NCT00392340|Mitosis Modulators|mitosis modulators|mesh-ancestor
64932089|NCT00392340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64932090|NCT00062101|Celecoxib|celecoxib|mesh-list
64932091|NCT00062101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64932092|NCT00062101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932093|NCT00062101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64932094|NCT00062101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735308|NCT01998906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64735309|NCT01998906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64735310|NCT01998906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735311|NCT01998906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64735312|NCT01967550|Diclofenac|diclofenac|mesh-list
64735380|NCT01945866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64735381|NCT01945866|Antiemetics|antiemetics|mesh-ancestor
64735382|NCT01945866|Autonomic Agents|autonomic agents|mesh-ancestor
64735383|NCT01945866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64735384|NCT01945866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735385|NCT01945866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64735386|NCT01945866|Glucocorticoids|glucocorticoids|mesh-ancestor
64735394|NCT01945866|Growth Inhibitors|growth inhibitors|mesh-ancestor
64735395|NCT01986114|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64735396|NCT01986114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64735397|NCT01986114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64932095|NCT00062101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932096|NCT00062101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64932097|NCT00062101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64932098|NCT00062101|Analgesics|analgesics|mesh-ancestor
64932099|NCT00062101|Sensory System Agents|sensory system agents|mesh-ancestor
64932100|NCT00062101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64932101|NCT00062101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932102|NCT00062101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64932103|NCT00062101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64932104|NCT00062101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64735412|NCT01986114|Dopamine Agents|dopamine agents|mesh-ancestor
64735413|NCT01945242|Alogliptin|alogliptin|mesh-list
64735414|NCT01945242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64735415|NCT01945242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735416|NCT01945242|Incretins|incretins|mesh-ancestor
64735417|NCT01945242|Hormones|hormones|mesh-ancestor
64735418|NCT01945242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64735419|NCT01945242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64735420|NCT01945242|Protease Inhibitors|protease inhibitors|mesh-ancestor
64735421|NCT01945242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735422|NCT01945242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735423|NCT01945086|Ustekinumab|ustekinumab|mesh-list
64735424|NCT01945086|Dermatologic Agents|dermatologic agents|mesh-ancestor
64528189|NCT00248547|Ondansetron|ondansetron|mesh-list
64528190|NCT00248547|Aprepitant|aprepitant|mesh-list
64528191|NCT00248547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64528192|NCT00248547|Antiemetics|antiemetics|mesh-ancestor
64528193|NCT00248547|Autonomic Agents|autonomic agents|mesh-ancestor
64528194|NCT00248547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64528195|NCT00248547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528196|NCT00248547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64528197|NCT00248547|Glucocorticoids|glucocorticoids|mesh-ancestor
64528198|NCT00248547|Hormones|hormones|mesh-ancestor
64528199|NCT00248547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64528200|NCT00248547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64932105|NCT00062101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64932106|NCT00062140|Cyclophosphamide|cyclophosphamide|mesh-list
64735456|NCT01944774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64735457|NCT01944774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64735458|NCT01944774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64735459|NCT01944774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64735460|NCT01944774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735461|NCT01944774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735463|NCT04665648|Nicorandil|nicorandil|mesh-list
64735472|NCT01944462|Immunologic Factors|immunologic factors|mesh-ancestor
64735473|NCT01944462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735474|NCT01942590|Clenbuterol|clenbuterol|mesh-list
64735475|NCT01942590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64735476|NCT01942590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64735477|NCT01942590|Adrenergic Agents|adrenergic agents|mesh-ancestor
64735478|NCT01942590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64735479|NCT01942590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735480|NCT01942590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735482|NCT01942590|Autonomic Agents|autonomic agents|mesh-ancestor
64932107|NCT00062140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64932108|NCT00062140|Immunologic Factors|immunologic factors|mesh-ancestor
64932109|NCT00062140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932110|NCT00062140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64932111|NCT00062140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64932152|NCT00062296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932187|NCT00062803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64932188|NCT00062803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64932189|NCT00062803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735510|NCT01960842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735511|NCT01960842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735512|NCT01960842|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64735513|NCT01960842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735514|NCT01960842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64735515|NCT01960842|Immunologic Factors|immunologic factors|mesh-ancestor
64735516|NCT01960842|Dopamine Agonists|dopamine agonists|mesh-ancestor
64735517|NCT01984164|Candesartan|candesartan|mesh-list
64735518|NCT01984164|Lisinopril|lisinopril|mesh-list
64735519|NCT01984164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64735520|NCT01984164|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64321316|NCT02208505|Analgesics|analgesics|mesh-ancestor
64735521|NCT01984164|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64735522|NCT01984164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735523|NCT01984164|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64735524|NCT01984164|Protease Inhibitors|protease inhibitors|mesh-ancestor
64735525|NCT01984164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735526|NCT01984164|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64735527|NCT01984164|Protective Agents|protective agents|mesh-ancestor
64932190|NCT00062842|Irinotecan|irinotecan|mesh-list
64932191|NCT00062842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64932192|NCT00062842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64932193|NCT00062842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932194|NCT00062842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932225|NCT00063310|Leuprolide|leuprolide|mesh-list
64932226|NCT00063310|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64932227|NCT00063310|Fertility Agents|fertility agents|mesh-ancestor
64932228|NCT00063310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64932229|NCT00063310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932230|NCT00063310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64932231|NCT00063310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932232|NCT00063388|Cetuximab|cetuximab|mesh-list
64932233|NCT00063388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64321320|NCT02208505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64321321|NCT02208505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64321322|NCT02208505|Adrenergic Agents|adrenergic agents|mesh-ancestor
64321323|NCT02208505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64321324|NCT02208505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321325|NCT02208505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64735548|NCT01982682|Antitubercular Agents|antitubercular agents|mesh-ancestor
64735549|NCT01982682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64735550|NCT01982682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64735551|NCT01982682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932234|NCT00063388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932235|NCT00063583|Pirfenidone|pirfenidone|mesh-list
64932236|NCT00063583|Analgesics|analgesics|mesh-ancestor
64932237|NCT00063583|Sensory System Agents|sensory system agents|mesh-ancestor
64932238|NCT00063583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64932239|NCT00063583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932240|NCT00063583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64932268|NCT02967172|Epinephrine|epinephrine|mesh-list
64932269|NCT02967172|Morphine|morphine|mesh-list
64932270|NCT02967172|Ropivacaine|ropivacaine|mesh-list
64932271|NCT02967172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64932272|NCT02967172|Narcotics|narcotics|mesh-ancestor
64932273|NCT02967172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64321327|NCT02208583|Prednisone|prednisone|mesh-list
64321328|NCT02208583|Cisplatin|cisplatin|mesh-list
64321329|NCT02208583|Docetaxel|docetaxel|mesh-list
64321330|NCT02208583|Etoposide|etoposide|mesh-list
64321331|NCT02208583|Etoposide phosphate|etoposide phosphate|mesh-list
64321332|NCT02208583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64321333|NCT02208583|Tubulin Modulators|tubulin modulators|mesh-ancestor
64321334|NCT02208583|Antimitotic Agents|antimitotic agents|mesh-ancestor
64321335|NCT02208583|Mitosis Modulators|mitosis modulators|mesh-ancestor
64321336|NCT02208583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321337|NCT02208583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64735591|NCT01939158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735593|NCT01939002|Interferon-beta|interferon-beta|mesh-list
64735594|NCT01939002|Interferon beta-1a|interferon beta-1a|mesh-list
64735595|NCT01939002|Naproxen|naproxen|mesh-list
64735596|NCT01939002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64735597|NCT01939002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64735598|NCT01939002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735599|NCT01939002|Antiviral Agents|antiviral agents|mesh-ancestor
64735600|NCT01939002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64735601|NCT01939002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64735602|NCT01939002|Analgesics|analgesics|mesh-ancestor
64735603|NCT01939002|Sensory System Agents|sensory system agents|mesh-ancestor
64735604|NCT01939002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64735605|NCT01939002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735606|NCT01939002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64735607|NCT01939002|Gout Suppressants|gout suppressants|mesh-ancestor
64932274|NCT02967172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932275|NCT02967172|Analgesics|analgesics|mesh-ancestor
64932276|NCT02967172|Sensory System Agents|sensory system agents|mesh-ancestor
64528202|NCT00248547|Antipruritics|antipruritics|mesh-ancestor
64528203|NCT00248547|Dermatologic Agents|dermatologic agents|mesh-ancestor
64528204|NCT00248547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64528205|NCT00248547|Serotonin Agents|serotonin agents|mesh-ancestor
64528206|NCT00248547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64528207|NCT00248547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528208|NCT00248547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64528209|NCT00248547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64528210|NCT00248547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64528211|NCT00248547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64932277|NCT02967172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64932278|NCT02967172|Anesthetics, Local|anesthetics, local|mesh-ancestor
64932279|NCT02967172|Anesthetics|anesthetics|mesh-ancestor
64932280|NCT02967172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64932281|NCT02967172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64932282|NCT02967172|Adrenergic Agents|adrenergic agents|mesh-ancestor
64735608|NCT01939002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64735609|NCT01939002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735610|NCT01939002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735611|NCT01939002|Immunologic Factors|immunologic factors|mesh-ancestor
64735612|NCT01939002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64735613|NCT01938846|Paclitaxel|paclitaxel|mesh-list
64735614|NCT01938846|Exemestane|exemestane|mesh-list
64735615|NCT01938846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64735616|NCT01938846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735617|NCT01938846|Tubulin Modulators|tubulin modulators|mesh-ancestor
64735618|NCT01938846|Antimitotic Agents|antimitotic agents|mesh-ancestor
64735619|NCT01938846|Mitosis Modulators|mitosis modulators|mesh-ancestor
64735620|NCT01938846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735621|NCT01938846|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64735622|NCT01938846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64735623|NCT01938846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735624|NCT01938846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64735625|NCT01938846|Hormone Antagonists|hormone antagonists|mesh-ancestor
64735626|NCT01938846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64735627|NCT01938846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735628|NCT04652700|Tenofovir|tenofovir|mesh-list
64735629|NCT04652700|Emtricitabine|emtricitabine|mesh-list
64735630|NCT04652700|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64321338|NCT02208583|Glucocorticoids|glucocorticoids|mesh-ancestor
64321339|NCT02208583|Hormones|hormones|mesh-ancestor
64297797|NCT02066077|Etomidate|etomidate|mesh-list
64932283|NCT02967172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64932284|NCT02967172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932285|NCT02967172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64700777|NCT00003993|Aldesleukin|aldesleukin|mesh-list
64932286|NCT02967172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64932287|NCT02967172|Autonomic Agents|autonomic agents|mesh-ancestor
64932317|NCT00064207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932318|NCT00064207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64321342|NCT02208583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64321344|NCT02208583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64932329|NCT00064246|Immunologic Factors|immunologic factors|mesh-ancestor
64932330|NCT00064246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932331|NCT00064246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64932332|NCT00064285|Imatinib Mesylate|imatinib mesylate|mesh-list
64932333|NCT00064285|Alvocidib|alvocidib|mesh-list
64932363|NCT00064402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64932364|NCT00064402|Adrenergic Agents|adrenergic agents|mesh-ancestor
64932365|NCT00064402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64321366|NCT02199379|Lenvatinib|lenvatinib|mesh-list
64735692|NCT01980888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64735694|NCT01980888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735695|NCT01980888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735696|NCT04650282|Lidocaine|lidocaine|mesh-list
64735697|NCT04650282|Anesthetics, Local|anesthetics, local|mesh-ancestor
64735698|NCT04650282|Anesthetics|anesthetics|mesh-ancestor
64735699|NCT04650282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64735700|NCT04650282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735701|NCT04650282|Sensory System Agents|sensory system agents|mesh-ancestor
64735702|NCT04650282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64735703|NCT04650282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64735704|NCT04650282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64735705|NCT04650282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64735706|NCT04650282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64735707|NCT04650282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735708|NCT01937364|Baclofen|baclofen|mesh-list
64735709|NCT01937364|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64735710|NCT01937364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735711|NCT01937364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64735712|NCT01937364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64735713|NCT01937364|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64735714|NCT01937364|GABA Agonists|gaba agonists|mesh-ancestor
64735715|NCT01937364|GABA Agents|gaba agents|mesh-ancestor
64932366|NCT00064402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932367|NCT00423748|Ambrisentan|ambrisentan|mesh-list
64932368|NCT00423748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64932370|NCT02967211|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64932371|NCT02967211|Insulin Glargine|insulin glargine|mesh-list
64932372|NCT02967211|Insulin Detemir|insulin detemir|mesh-list
64932373|NCT02967211|Insulin, Isophane|insulin, isophane|mesh-list
64932409|NCT00398827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64932410|NCT00398827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932411|NCT00065455|Vitamin A|vitamin a|mesh-list
64932412|NCT00065455|Vitamins|vitamins|mesh-ancestor
64932413|NCT00065455|Micronutrients|micronutrients|mesh-ancestor
64932444|NCT04488081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932445|NCT04488081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64932446|NCT04488081|Immunologic Factors|immunologic factors|mesh-ancestor
64932447|NCT04488081|Antifungal Agents|antifungal agents|mesh-ancestor
64932448|NCT04488081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64932449|NCT04488081|Dermatologic Agents|dermatologic agents|mesh-ancestor
64932450|NCT04488081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64932451|NCT04488081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64528212|NCT00248547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64528213|NCT00248547|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64528214|NCT01524887|Immunoglobulins|immunoglobulins|mesh-list
64528215|NCT01524887|Antibodies|antibodies|mesh-list
64528216|NCT01524887|gamma-Globulins|gamma-globulins|mesh-list
64528217|NCT01524887|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64528218|NCT01524887|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64528219|NCT01524887|Immunologic Factors|immunologic factors|mesh-ancestor
64528220|NCT01524887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528221|NCT00266799|Doxorubicin|doxorubicin|mesh-list
64735805|NCT01932762|Grazoprevir|grazoprevir|mesh-list
64735806|NCT01932762|Antimetabolites|antimetabolites|mesh-ancestor
64735807|NCT01932762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735808|NCT01932762|Antiviral Agents|antiviral agents|mesh-ancestor
64735809|NCT01932762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64735810|NCT01977456|Eptifibatide|eptifibatide|mesh-list
64735811|NCT01977456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64735812|NCT01957644|Azacitidine|azacitidine|mesh-list
64735813|NCT01957644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64735818|NCT01931202|Citalopram|citalopram|mesh-list
64735824|NCT01931202|Serotonin Agents|serotonin agents|mesh-ancestor
64735825|NCT01931202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735826|NCT01931202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64735827|NCT01931202|Antidepressive Agents|antidepressive agents|mesh-ancestor
64735828|NCT01931202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64735829|NCT01930890|Mycophenolic Acid|mycophenolic acid|mesh-list
64735830|NCT01930890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64735831|NCT01930890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735832|NCT01930890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64735833|NCT01930890|Antitubercular Agents|antitubercular agents|mesh-ancestor
64735834|NCT01930890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64735835|NCT01930890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64735836|NCT01930890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735837|NCT01930890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735838|NCT01930188|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64735839|NCT01930188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64528222|NCT00266799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64528223|NCT00266799|Capecitabine|capecitabine|mesh-list
64528224|NCT00266799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64528225|NCT00266799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528226|NCT00266799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64528227|NCT00266799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64528228|NCT00266799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528229|NCT00266799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528230|NCT00266799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64528231|NCT00266799|Antimetabolites|antimetabolites|mesh-ancestor
64528232|NCT00249249|Atorvastatin|atorvastatin|mesh-list
64528233|NCT00249249|Pitavastatin|pitavastatin|mesh-list
64528234|NCT00249249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64528235|NCT00249249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64528236|NCT00249249|Antimetabolites|antimetabolites|mesh-ancestor
64528237|NCT00249249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735840|NCT01930188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735841|NCT01930188|Incretins|incretins|mesh-ancestor
64735842|NCT01930188|Hormones|hormones|mesh-ancestor
64735843|NCT01930188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64735844|NCT01930188|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64735845|NCT01930188|Protease Inhibitors|protease inhibitors|mesh-ancestor
64735846|NCT01930188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735847|NCT01930188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735848|NCT01976364|Methotrexate|methotrexate|mesh-list
64735849|NCT01976364|Tofacitinib|tofacitinib|mesh-list
64735850|NCT01976364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64735851|NCT01976364|Abortifacient Agents|abortifacient agents|mesh-ancestor
64735852|NCT01976364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64735853|NCT01976364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735854|NCT01976364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64735855|NCT01976364|Antimetabolites|antimetabolites|mesh-ancestor
64735856|NCT01976364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735857|NCT01976364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735858|NCT01976364|Dermatologic Agents|dermatologic agents|mesh-ancestor
64735859|NCT01976364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735860|NCT01976364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64321398|NCT03532711|Protective Agents|protective agents|mesh-ancestor
64735861|NCT01976364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64735862|NCT01976364|Immunologic Factors|immunologic factors|mesh-ancestor
64618408|NCT02981615|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64735863|NCT01976364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64528238|NCT00249249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64714113|NCT03043274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64528239|NCT00249249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64528257|NCT00267111|Anesthetics, Local|anesthetics, local|mesh-ancestor
64528258|NCT00267111|Anesthetics|anesthetics|mesh-ancestor
64528259|NCT00267111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64528260|NCT00267111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528261|NCT00267111|Sensory System Agents|sensory system agents|mesh-ancestor
64528262|NCT00267111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64528263|NCT01521923|Methotrexate|methotrexate|mesh-list
64528264|NCT01521923|Certolizumab Pegol|certolizumab pegol|mesh-list
64528265|NCT01521923|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64528266|NCT01521923|Abortifacient Agents|abortifacient agents|mesh-ancestor
64528267|NCT01521923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64528268|NCT01521923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735864|NCT01976364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64735865|NCT01976364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64735866|NCT03493152|Everolimus|everolimus|mesh-list
64735867|NCT03493152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735868|NCT03493152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64321399|NCT03532711|Vitamin B Complex|vitamin b complex|mesh-ancestor
64321400|NCT03532711|Vitamins|vitamins|mesh-ancestor
64321401|NCT03532711|Micronutrients|micronutrients|mesh-ancestor
64321402|NCT04729322|Metronidazole|metronidazole|mesh-list
64321403|NCT04729322|Vancomycin|vancomycin|mesh-list
64321404|NCT04729322|Neomycin|neomycin|mesh-list
64321405|NCT04729322|Pembrolizumab|pembrolizumab|mesh-list
64321406|NCT04729322|Nivolumab|nivolumab|mesh-list
64321407|NCT04729322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64321408|NCT04729322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64321409|NCT04729322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64321410|NCT04729322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321411|NCT04729322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64321412|NCT04729322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64735869|NCT03493152|Immunologic Factors|immunologic factors|mesh-ancestor
64735870|NCT03493152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735871|NCT01929876|Itraconazole|itraconazole|mesh-list
64735872|NCT01929876|Antifungal Agents|antifungal agents|mesh-ancestor
64735873|NCT01929876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64735874|NCT01929876|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64735875|NCT01929876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64735876|NCT01929876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735877|NCT01929876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735878|NCT01929876|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64932452|NCT04488081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64932453|NCT04488081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64932455|NCT04488081|Sensory System Agents|sensory system agents|mesh-ancestor
64932456|NCT04488081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64932457|NCT04488081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64932458|NCT04488081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64932459|NCT04488081|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64932460|NCT04488081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64932461|NCT04488081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64932462|NCT04488081|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64932492|NCT00065884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64932493|NCT00065884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932494|NCT00065884|Antimanic Agents|antimanic agents|mesh-ancestor
64932495|NCT00065884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64932496|NCT00065884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64932497|NCT00065884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64932499|NCT00065923|Anticonvulsants|anticonvulsants|mesh-ancestor
64932500|NCT00065923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64932501|NCT00065923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932502|NCT00065962|Secretin|secretin|mesh-list
64932503|NCT00065962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64932504|NCT00065962|Hormones|hormones|mesh-ancestor
64735879|NCT01929876|Hormone Antagonists|hormone antagonists|mesh-ancestor
64735880|NCT01929876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64735881|NCT01929876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735882|NCT01929876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64735883|NCT01928940|Trametinib|trametinib|mesh-list
64735884|NCT01928940|Dabrafenib|dabrafenib|mesh-list
64735885|NCT01928940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735886|NCT01928940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64735887|NCT01928940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735888|NCT01928940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735889|NCT01954056|Hydrocortisone|hydrocortisone|mesh-list
64735890|NCT01954056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64735891|NCT01975272|Iron|iron|mesh-list
64735892|NCT01975272|Ferrous fumarate|ferrous fumarate|mesh-list
64735893|NCT01975272|Ferric Compounds|ferric compounds|mesh-list
64735894|NCT01975272|Trace Elements|trace elements|mesh-ancestor
64735895|NCT01975272|Micronutrients|micronutrients|mesh-ancestor
64735897|NCT01975272|Hematinics|hematinics|mesh-ancestor
64932505|NCT00065962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64932506|NCT00065962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932577|NCT00066391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64932578|NCT00066391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64932579|NCT00066391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932580|NCT00066391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932581|NCT04388475|Temozolomide|temozolomide|mesh-list
64735916|NCT03910439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735917|NCT03895307|Anesthetics|anesthetics|mesh-list
64735918|NCT03895307|Anesthetics, Local|anesthetics, local|mesh-list
64735919|NCT03895307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64735920|NCT03895307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735921|NCT03895307|Sensory System Agents|sensory system agents|mesh-ancestor
64735922|NCT03895307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64735923|NCT03896633|Brinzolamide|brinzolamide|mesh-list
64735924|NCT03896633|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64735925|NCT03896633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735926|NCT03896633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735927|NCT03888755|Icatibant|icatibant|mesh-list
64735928|NCT03888755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64735930|NCT03888755|Analgesics|analgesics|mesh-ancestor
64735931|NCT03888755|Sensory System Agents|sensory system agents|mesh-ancestor
64735932|NCT03888755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64735933|NCT03888755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735934|NCT03888755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64735935|NCT03888755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64321413|NCT04729322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64321414|NCT04729322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64321415|NCT04729322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64321416|NCT04729322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64321417|NCT04714112|Dexamethasone|dexamethasone|mesh-list
64321418|NCT04714112|Dexamethasone acetate|dexamethasone acetate|mesh-list
64321419|NCT04714112|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64618446|NCT03019835|Cholinergic Agents|cholinergic agents|mesh-ancestor
64932582|NCT04388475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64932583|NCT04388475|Alkylating Agents|alkylating agents|mesh-ancestor
64932584|NCT04388475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932585|NCT04388475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932586|NCT00389987|Tazobactam|tazobactam|mesh-list
64932587|NCT00389987|Piperacillin|piperacillin|mesh-list
64932616|NCT04258488|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64932617|NCT04258488|Antithrombins|antithrombins|mesh-ancestor
64932618|NCT04258488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64932619|NCT04258488|Protease Inhibitors|protease inhibitors|mesh-ancestor
64932620|NCT04258488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932621|NCT04258488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932622|NCT04258488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64528269|NCT01521923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64528271|NCT01521923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528272|NCT01521923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528273|NCT01521923|Dermatologic Agents|dermatologic agents|mesh-ancestor
64528274|NCT01521923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528275|NCT01521923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64650691|NCT01510379|Antipruritics|antipruritics|mesh-ancestor
64528281|NCT05240781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64528282|NCT05240781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64735936|NCT03888755|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
64735937|NCT03888755|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
64735938|NCT03888755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735939|NCT03888755|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64735940|NCT03888755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64735941|NCT03888755|Immunologic Factors|immunologic factors|mesh-ancestor
64735942|NCT00378755|Bortezomib|bortezomib|mesh-list
64735943|NCT00378755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735944|NCT00378833|Niacin|niacin|mesh-list
64735945|NCT00378833|Niacinamide|niacinamide|mesh-list
64735946|NCT00378833|Nicotinic Acids|nicotinic acids|mesh-list
64735947|NCT00378833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64735948|NCT00378833|Antimetabolites|antimetabolites|mesh-ancestor
64735949|NCT00378833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735950|NCT00378833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64735951|NCT00378833|Vasodilator Agents|vasodilator agents|mesh-ancestor
64735952|NCT00378833|Vitamin B Complex|vitamin b complex|mesh-ancestor
64735953|NCT00378833|Vitamins|vitamins|mesh-ancestor
64735954|NCT00378833|Micronutrients|micronutrients|mesh-ancestor
64321421|NCT04714112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64321422|NCT04714112|Antiemetics|antiemetics|mesh-ancestor
64321423|NCT04714112|Autonomic Agents|autonomic agents|mesh-ancestor
64321424|NCT04714112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321425|NCT04714112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618452|NCT00955877|Morphine|morphine|mesh-list
64321426|NCT04714112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64528283|NCT05240781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64528284|NCT05240781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528285|NCT05240781|Antifungal Agents|antifungal agents|mesh-ancestor
64528286|NCT05240781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64528287|NCT05240781|Immunologic Factors|immunologic factors|mesh-ancestor
64932623|NCT04258488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64932624|NCT04258488|Hemostatics|hemostatics|mesh-ancestor
64932625|NCT04258488|Coagulants|coagulants|mesh-ancestor
64932626|NCT00066625|Oxaliplatin|oxaliplatin|mesh-list
64932627|NCT00066625|Bortezomib|bortezomib|mesh-list
64932628|NCT00066625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932629|NCT05061134|Durvalumab|durvalumab|mesh-list
64321427|NCT04714112|Glucocorticoids|glucocorticoids|mesh-ancestor
64735956|NCT02995967|Botulinum Toxins|botulinum toxins|mesh-list
64735957|NCT02995967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64735958|NCT02995967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64735959|NCT02995967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64735960|NCT02995967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64735961|NCT02995967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735962|NCT02995967|Cholinergic Agents|cholinergic agents|mesh-ancestor
64735963|NCT02995967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64735964|NCT02995967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618456|NCT00955877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618457|NCT00955877|Analgesics|analgesics|mesh-ancestor
64735965|NCT02995967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64735966|NCT02995967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64735967|NCT03888365|Treprostinil|treprostinil|mesh-list
64735968|NCT03888365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64735969|NCT00377975|Pioglitazone|pioglitazone|mesh-list
64735970|NCT00377975|Ephedrine|ephedrine|mesh-list
64735971|NCT00377975|Caffeine|caffeine|mesh-list
64932630|NCT05061134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64932631|NCT05061134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932632|NCT00066859|Sertraline|sertraline|mesh-list
64932633|NCT00066859|Antidepressive Agents|antidepressive agents|mesh-ancestor
64932634|NCT00066859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64932635|NCT00066859|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64932636|NCT00066859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64932637|NCT00066859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64932675|NCT05041127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64932677|NCT05041127|Antibodies|antibodies|mesh-list
64735972|NCT00377975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64735973|NCT00377975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735974|NCT00377975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64735975|NCT00377975|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64735976|NCT00377975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735977|NCT00377975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735978|NCT00377975|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64735979|NCT00377975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64735980|NCT00377975|Purinergic Agents|purinergic agents|mesh-ancestor
64735981|NCT00377975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64735982|NCT00377975|Sympathomimetics|sympathomimetics|mesh-ancestor
64735983|NCT00377975|Autonomic Agents|autonomic agents|mesh-ancestor
64735984|NCT00377975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321429|NCT04714112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64321430|NCT04714112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64321431|NCT04714112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64321432|NCT04714112|Protease Inhibitors|protease inhibitors|mesh-ancestor
64735985|NCT00377975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64735986|NCT00377975|Adrenergic Agents|adrenergic agents|mesh-ancestor
64735987|NCT02994251|Gemcitabine|gemcitabine|mesh-list
64735988|NCT02994251|Doxorubicin|doxorubicin|mesh-list
64735990|NCT02994251|Mitomycin|mitomycin|mesh-list
64735991|NCT02994251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735992|NCT02994251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64735993|NCT02994251|Antimetabolites|antimetabolites|mesh-ancestor
64735994|NCT02994251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618467|NCT03960658|Anesthetics, General|anesthetics, general|mesh-ancestor
64932709|NCT00067444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64932711|NCT00399022|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64932712|NCT00399022|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64932713|NCT00399022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64932714|NCT00399022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64932715|NCT00399022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932716|NCT00399022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64932717|NCT00399022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932718|NCT00399022|Analgesics|analgesics|mesh-ancestor
64932741|NCT00067561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932743|NCT00067600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64321433|NCT04714112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64321434|NCT04714112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321436|NCT02199613|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64321437|NCT02199613|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64321438|NCT02199613|Protease Inhibitors|protease inhibitors|mesh-ancestor
64321439|NCT02199613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735995|NCT02994251|Antiviral Agents|antiviral agents|mesh-ancestor
64735996|NCT02994251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64735997|NCT02994251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735998|NCT02994251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64735999|NCT02994251|Immunologic Factors|immunologic factors|mesh-ancestor
64736000|NCT02994251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736001|NCT02994251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64736002|NCT02994251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64736003|NCT02994251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64932744|NCT00067600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932745|NCT05010707|Spironolactone|spironolactone|mesh-list
64932746|NCT05010707|Hormones|hormones|mesh-list
64932747|NCT05010707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64932748|NCT05010707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932749|NCT05010707|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64932750|NCT05010707|Hormone Antagonists|hormone antagonists|mesh-ancestor
64932751|NCT05010707|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64932752|NCT05010707|Diuretics|diuretics|mesh-ancestor
64528288|NCT05240781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321440|NCT02199613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321441|NCT02199613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64321442|NCT02199613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64321443|NCT02199613|Antiviral Agents|antiviral agents|mesh-ancestor
64736004|NCT02994251|Alkylating Agents|alkylating agents|mesh-ancestor
64736005|NCT02994251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64736006|NCT02936999|Vitamin D|vitamin d|mesh-list
64736007|NCT02936999|Cholecalciferol|cholecalciferol|mesh-list
64736008|NCT02936999|Vitamins|vitamins|mesh-ancestor
64736009|NCT02936999|Micronutrients|micronutrients|mesh-ancestor
64475348|NCT00366106|Glucocorticoids|glucocorticoids|mesh-ancestor
64736010|NCT02936999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736011|NCT02936999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64736012|NCT02936999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64736013|NCT02826551|Bupivacaine|bupivacaine|mesh-list
64736014|NCT02826551|Anesthetics, Local|anesthetics, local|mesh-ancestor
64528289|NCT01520987|Opicapone|opicapone|mesh-list
64528290|NCT01520987|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64528291|NCT01520987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528292|NCT01520987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528293|NCT01520987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64528294|NCT01520987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64528356|NCT01535053|Vitamin B Complex|vitamin b complex|mesh-ancestor
64528357|NCT01535053|Vitamins|vitamins|mesh-ancestor
64528358|NCT01535053|Micronutrients|micronutrients|mesh-ancestor
64528359|NCT01535053|Hematinics|hematinics|mesh-ancestor
64736016|NCT02826551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64736017|NCT02826551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321444|NCT02199613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64321445|NCT02209441|Sorafenib|sorafenib|mesh-list
64321446|NCT02209441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64321447|NCT02209441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64321448|NCT02209441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64321449|NCT02209441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736018|NCT02826551|Sensory System Agents|sensory system agents|mesh-ancestor
64736019|NCT02826551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64736020|NCT00378443|Prednisone|prednisone|mesh-list
64736021|NCT00378443|Losartan|losartan|mesh-list
64736022|NCT00378443|Cilazapril|cilazapril|mesh-list
64736023|NCT00378443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64736024|NCT00378443|Glucocorticoids|glucocorticoids|mesh-ancestor
64736025|NCT00378443|Hormones|hormones|mesh-ancestor
64321450|NCT04772222|Dexmedetomidine|dexmedetomidine|mesh-list
64618487|NCT03633448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736026|NCT00378443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64736027|NCT00378443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736028|NCT00378443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64736029|NCT00378443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736030|NCT00378443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64736031|NCT00378443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64736033|NCT00378443|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64528360|NCT01535053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64528361|NCT01535053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64528362|NCT01535053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64528363|NCT01535053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64528364|NCT03027635|Ciprofloxacin|ciprofloxacin|mesh-list
64528365|NCT03027635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64528366|NCT03027635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64528367|NCT03027635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64321454|NCT04772222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321455|NCT04772222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64736051|NCT01340885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736053|NCT01340885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64736054|NCT01340885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736055|NCT01340885|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64736056|NCT01340885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736057|NCT01340885|Cholinergic Agents|cholinergic agents|mesh-ancestor
64736058|NCT01340885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64736059|NCT01340885|Protective Agents|protective agents|mesh-ancestor
64736060|NCT01326923|Cetuximab|cetuximab|mesh-list
64736061|NCT01326923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64736062|NCT01326923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736063|NCT03855059|Dexamethasone|dexamethasone|mesh-list
64736064|NCT03855059|Dexamethasone acetate|dexamethasone acetate|mesh-list
64736065|NCT03855059|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64736066|NCT03855059|BB 1101|bb 1101|mesh-list
64736067|NCT03855059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64736068|NCT03855059|Antiemetics|antiemetics|mesh-ancestor
64736069|NCT03855059|Autonomic Agents|autonomic agents|mesh-ancestor
64736070|NCT03855059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64528368|NCT03027635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64528369|NCT03027635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528379|NCT01520363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64528380|NCT01520363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528381|NCT01520363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528382|NCT01578499|Methotrexate|methotrexate|mesh-list
64528383|NCT01578499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64528399|NCT01578499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64736071|NCT03855059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736072|NCT03855059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64736073|NCT03855059|Glucocorticoids|glucocorticoids|mesh-ancestor
64736074|NCT03855059|Hormones|hormones|mesh-ancestor
64736075|NCT03855059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64736076|NCT03855059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64736077|NCT03855059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736078|NCT03855059|Protease Inhibitors|protease inhibitors|mesh-ancestor
64528400|NCT01578499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64528402|NCT01561963|Apremilast|apremilast|mesh-list
64528403|NCT01561963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64528404|NCT01561963|Antitubercular Agents|antitubercular agents|mesh-ancestor
64528405|NCT01561963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64528406|NCT01561963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64528407|NCT01561963|Leprostatic Agents|leprostatic agents|mesh-ancestor
64528408|NCT01561963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64528409|NCT01561963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528410|NCT01561963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528411|NCT01561963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64528412|NCT01561963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64528413|NCT01561963|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64321460|NCT04772222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64321461|NCT04772222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64321462|NCT04772222|Adrenergic Agents|adrenergic agents|mesh-ancestor
64736123|NCT01222871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64736124|NCT01222871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736125|NCT01219673|Minocycline|minocycline|mesh-list
64736126|NCT01219673|Modafinil|modafinil|mesh-list
64736127|NCT01219673|Bupropion|bupropion|mesh-list
64736128|NCT01219673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64736129|NCT01219673|Antidepressive Agents|antidepressive agents|mesh-ancestor
64736130|NCT01219673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64736131|NCT01219673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64736132|NCT01219673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64736133|NCT01219673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64736134|NCT01219673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736135|NCT01219673|Dopamine Agents|dopamine agents|mesh-ancestor
64401056|NCT02936843|Analgesics|analgesics|mesh-ancestor
64932753|NCT05010707|Natriuretic Agents|natriuretic agents|mesh-ancestor
64932754|NCT00067756|Butyric Acid|butyric acid|mesh-list
64932755|NCT00067756|Histamine Antagonists|histamine antagonists|mesh-ancestor
64932756|NCT00067756|Histamine Agents|histamine agents|mesh-ancestor
64932757|NCT00067756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64932758|NCT00067756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932759|NCT00067756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932760|NCT04091880|Vaccines|vaccines|mesh-list
64932761|NCT04091880|Immunologic Factors|immunologic factors|mesh-ancestor
64932762|NCT04091880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932763|NCT04999241|Mesalamine|mesalamine|mesh-list
64932764|NCT04999241|Infliximab|infliximab|mesh-list
64932765|NCT04999241|Dermatologic Agents|dermatologic agents|mesh-ancestor
64932766|NCT04999241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64932767|NCT04999241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64932768|NCT04999241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64932769|NCT04999241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64932795|NCT00067951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64932796|NCT00067951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932797|NCT00392457|Ketoconazole|ketoconazole|mesh-list
64932798|NCT00392457|Hormones|hormones|mesh-list
64932799|NCT00392457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64932800|NCT00392457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932801|NCT00392457|Antifungal Agents|antifungal agents|mesh-ancestor
64932802|NCT00392457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64932803|NCT00392457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64932804|NCT00392457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64932805|NCT00392457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932806|NCT00392457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932807|NCT00392457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64932808|NCT00392457|Hormone Antagonists|hormone antagonists|mesh-ancestor
64932809|NCT00392457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64932810|NCT00068029|Octreotide|octreotide|mesh-list
64528414|NCT01561963|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64528417|NCT01561963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64528419|NCT01561963|Analgesics|analgesics|mesh-ancestor
64528420|NCT01561963|Sensory System Agents|sensory system agents|mesh-ancestor
64528421|NCT01561963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64528422|NCT01561963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528423|NCT01561963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64528424|NCT01561963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64528425|NCT01561963|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64528426|NCT01561963|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64528427|NCT04852003|Morphine|morphine|mesh-list
64528428|NCT04852003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64528429|NCT04852003|Narcotics|narcotics|mesh-ancestor
64528430|NCT04852003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64932811|NCT00068029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64932812|NCT00068029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64701306|NCT00004113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932813|NCT00068029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932814|NCT00068068|Talaporfin|talaporfin|mesh-list
64932815|NCT00068068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932835|NCT00068497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932836|NCT00068497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932837|NCT00068653|Celecoxib|celecoxib|mesh-list
64932838|NCT00068653|Gefitinib|gefitinib|mesh-list
64932839|NCT00068653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64932840|NCT00068653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64932841|NCT00068653|Analgesics|analgesics|mesh-ancestor
64932842|NCT00068653|Sensory System Agents|sensory system agents|mesh-ancestor
64932843|NCT00068653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64932844|NCT00068653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736325|NCT01074437|Hormones|hormones|mesh-ancestor
64932845|NCT00068653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64932846|NCT00068653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64932847|NCT00068653|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64932848|NCT00068653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64932849|NCT00068653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932850|NCT00068653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932851|NCT00068653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932852|NCT00068653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64932853|NCT00068731|Lycopene|lycopene|mesh-list
64932854|NCT00068731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64932855|NCT00068731|Antioxidants|antioxidants|mesh-ancestor
64932856|NCT00068731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932857|NCT00068731|Protective Agents|protective agents|mesh-ancestor
64932858|NCT00068731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932859|NCT00068731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64932860|NCT00068731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64736357|NCT03793751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64736358|NCT03793751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64932861|NCT00068731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932862|NCT00068809|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64932863|NCT00068809|Antiviral Agents|antiviral agents|mesh-ancestor
64932864|NCT00068809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64932865|NCT00068848|Contraceptive Agents|contraceptive agents|mesh-list
64932866|NCT00068848|Contraceptives, Oral|contraceptives, oral|mesh-list
64528431|NCT04852003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528433|NCT04852003|Sensory System Agents|sensory system agents|mesh-ancestor
64528434|NCT04852003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64528435|NCT01534351|Tamsulosin|tamsulosin|mesh-list
64528436|NCT01534351|Finasteride|finasteride|mesh-list
64528437|NCT01534351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64528438|NCT01534351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64528439|NCT01534351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64528440|NCT01534351|Adrenergic Agents|adrenergic agents|mesh-ancestor
64528441|NCT01534351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64736454|NCT00957827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64528442|NCT01534351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528443|NCT01534351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528444|NCT01534351|Urological Agents|urological agents|mesh-ancestor
64528445|NCT01534351|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64528446|NCT01534351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64528447|NCT01534351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528448|NCT01534351|Hormone Antagonists|hormone antagonists|mesh-ancestor
64932869|NCT00068848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64932870|NCT00399061|Cyclosporine|cyclosporine|mesh-list
64402767|NCT03063827|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64402792|NCT03079999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64932871|NCT00399061|Cyclosporins|cyclosporins|mesh-list
64932900|NCT00069550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932902|NCT00069550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64932903|NCT00069550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932904|NCT00069550|Nootropic Agents|nootropic agents|mesh-ancestor
64932905|NCT00069550|Antitussive Agents|antitussive agents|mesh-ancestor
64932906|NCT00069550|Respiratory System Agents|respiratory system agents|mesh-ancestor
64932907|NCT00069550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64402884|NCT04979273|Epinephryl borate|epinephryl borate|mesh-list
64402885|NCT04979273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64402886|NCT04979273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64932908|NCT00069550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64932910|NCT02966587|Immunoglobulins|immunoglobulins|mesh-list
64932911|NCT02966587|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64932912|NCT02966587|Immunoglobulin G|immunoglobulin g|mesh-list
64932913|NCT02966587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64932914|NCT02966587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932915|NCT02966587|Immunologic Factors|immunologic factors|mesh-ancestor
64932916|NCT02966587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932941|NCT00390026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64932942|NCT00390026|Dermatologic Agents|dermatologic agents|mesh-ancestor
64932943|NCT00070057|Celecoxib|celecoxib|mesh-list
64932944|NCT00070057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64932945|NCT00070057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64932946|NCT00070057|Analgesics|analgesics|mesh-ancestor
64932947|NCT00070057|Sensory System Agents|sensory system agents|mesh-ancestor
64932948|NCT00070057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64932949|NCT00070057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932950|NCT00070057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64932951|NCT00070057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64932952|NCT00070057|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64932953|NCT00070057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64528450|NCT02120352|Rilpivirine|rilpivirine|mesh-list
64528451|NCT02120352|Cabotegravir|cabotegravir|mesh-list
64528452|NCT02120352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64528453|NCT02120352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64528454|NCT02120352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403005|NCT05164081|Clindamycin|clindamycin|mesh-list
64528455|NCT02120352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528456|NCT02120352|Antiviral Agents|antiviral agents|mesh-ancestor
64528457|NCT02120352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64528458|NCT02120352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64528459|NCT02120352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64528460|NCT02120352|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64932954|NCT00070057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932955|NCT00070057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932956|NCT00070174|Cytarabine|cytarabine|mesh-list
64932957|NCT00070174|Cyclosporine|cyclosporine|mesh-list
64932958|NCT00070174|Cyclophosphamide|cyclophosphamide|mesh-list
64932959|NCT00070174|Busulfan|busulfan|mesh-list
64932960|NCT00070174|Methotrexate|methotrexate|mesh-list
64932961|NCT00070174|Etoposide|etoposide|mesh-list
64932962|NCT00070174|Daunorubicin|daunorubicin|mesh-list
64701462|NCT00004197|Prednisone|prednisone|mesh-list
64932963|NCT00070174|Asparaginase|asparaginase|mesh-list
64932964|NCT00070174|Mitoxantrone|mitoxantrone|mesh-list
64932965|NCT00070174|Gemtuzumab|gemtuzumab|mesh-list
64932966|NCT00070174|Cyclosporins|cyclosporins|mesh-list
64932967|NCT00070174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64932968|NCT00070174|Immunologic Factors|immunologic factors|mesh-ancestor
64932969|NCT00070174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932999|NCT00070213|Capecitabine|capecitabine|mesh-list
64933000|NCT00070213|Oxaliplatin|oxaliplatin|mesh-list
64933001|NCT00070213|Calcium|calcium|mesh-list
64933002|NCT00070213|Levoleucovorin|levoleucovorin|mesh-list
64933003|NCT00070213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64933004|NCT00070213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403255|NCT03293017|Diazepam|diazepam|mesh-list
64933005|NCT00070213|Antimetabolites|antimetabolites|mesh-ancestor
64933006|NCT00070213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933007|NCT00070213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64650709|NCT01510379|Anesthetics|anesthetics|mesh-ancestor
64933044|NCT00070447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64933045|NCT00070447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933046|NCT00070447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64933047|NCT00070447|Glucocorticoids|glucocorticoids|mesh-ancestor
64933048|NCT00070447|Hormones|hormones|mesh-ancestor
64933049|NCT00070447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64933050|NCT00070447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64933051|NCT00070447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64933052|NCT00070447|Tubulin Modulators|tubulin modulators|mesh-ancestor
64933053|NCT00070447|Antimitotic Agents|antimitotic agents|mesh-ancestor
64933054|NCT00070447|Mitosis Modulators|mitosis modulators|mesh-ancestor
64933055|NCT03959865|Glucagon|glucagon|mesh-list
64933056|NCT03959865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64933057|NCT03959865|Incretins|incretins|mesh-ancestor
64933058|NCT03959865|Hormones|hormones|mesh-ancestor
64933059|NCT03959865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64403611|NCT03540901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403612|NCT03540901|Diuretics|diuretics|mesh-ancestor
64933060|NCT03959865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933061|NCT03959865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64933062|NCT00070486|Gemcitabine|gemcitabine|mesh-list
64933063|NCT00070486|Celecoxib|celecoxib|mesh-list
64933064|NCT00070486|Zileuton|zileuton|mesh-list
64933065|NCT00070486|Carboplatin|carboplatin|mesh-list
64528461|NCT02120352|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64528462|NCT01534195|Prednisolone|prednisolone|mesh-list
64528463|NCT01534195|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64528464|NCT01534195|Methylprednisolone|methylprednisolone|mesh-list
64528465|NCT01534195|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64528466|NCT01534195|Prednisolone acetate|prednisolone acetate|mesh-list
64528467|NCT01534195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64528468|NCT01534195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64528469|NCT01534195|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64528470|NCT01534195|Prednisolone phosphate|prednisolone phosphate|mesh-list
64528471|NCT01534195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64528472|NCT01534195|Glucocorticoids|glucocorticoids|mesh-ancestor
64528473|NCT01534195|Hormones|hormones|mesh-ancestor
64552671|NCT03216915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514769|NCT01996293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64514770|NCT01996293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64514771|NCT01996293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64514772|NCT01996293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64514773|NCT02986750|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64514774|NCT02986750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64514775|NCT05304364|Naltrexone|naltrexone|mesh-list
64514776|NCT05304364|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64514777|NCT05304364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64404148|NCT02807779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64404149|NCT02807779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404150|NCT04912193|Antithrombins|antithrombins|mesh-list
64404151|NCT04912193|Antithrombin III|antithrombin iii|mesh-list
64528474|NCT01534195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64528475|NCT01534195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528476|NCT01534195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64528477|NCT01534195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528478|NCT01534195|Antiemetics|antiemetics|mesh-ancestor
64528479|NCT01534195|Autonomic Agents|autonomic agents|mesh-ancestor
64528480|NCT01534195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64933091|NCT00070642|Dacarbazine|dacarbazine|mesh-list
64933092|NCT00070642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64933093|NCT00070642|Alkylating Agents|alkylating agents|mesh-ancestor
64933094|NCT00070642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933095|NCT00070642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933097|NCT00070759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64404312|NCT05229913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64404313|NCT05108155|Tacrine|tacrine|mesh-list
64404314|NCT05108155|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64404315|NCT05108155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404316|NCT05108155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404317|NCT05108155|Cholinergic Agents|cholinergic agents|mesh-ancestor
64404318|NCT05108155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64404319|NCT05108155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404320|NCT05108155|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64404321|NCT05108155|Autonomic Agents|autonomic agents|mesh-ancestor
64404322|NCT05108155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404323|NCT05108155|Nootropic Agents|nootropic agents|mesh-ancestor
64933098|NCT00070759|Immunologic Factors|immunologic factors|mesh-ancestor
64933099|NCT00070759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933100|NCT00070837|Antibodies|antibodies|mesh-list
64933101|NCT00070837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64933102|NCT00070837|Immunologic Factors|immunologic factors|mesh-ancestor
64933103|NCT00070837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933104|NCT00071071|Zanolimumab|zanolimumab|mesh-list
64933105|NCT00071071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64933106|NCT00071071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933107|NCT00071188|Paclitaxel|paclitaxel|mesh-list
64933108|NCT00071188|Carboplatin|carboplatin|mesh-list
64933113|NCT00071188|Mitosis Modulators|mitosis modulators|mesh-ancestor
64404391|NCT03906721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404392|NCT03906721|Analgesics|analgesics|mesh-ancestor
64404393|NCT03906721|Sensory System Agents|sensory system agents|mesh-ancestor
64404394|NCT03906721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404395|NCT04663711|Anesthetics|anesthetics|mesh-list
64404396|NCT04663711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64404397|NCT04663711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933135|NCT00071266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64933136|NCT00071266|Vasodilator Agents|vasodilator agents|mesh-ancestor
64933137|NCT00071266|Vitamin B Complex|vitamin b complex|mesh-ancestor
64933138|NCT00071266|Vitamins|vitamins|mesh-ancestor
64933139|NCT00071266|Micronutrients|micronutrients|mesh-ancestor
64933140|NCT00071266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933141|NCT00071266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64933142|NCT00071266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64933143|NCT00071266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933144|NCT02966743|Midazolam|midazolam|mesh-list
64404455|NCT04169191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933145|NCT02966743|Dexmedetomidine|dexmedetomidine|mesh-list
64933146|NCT02966743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64933147|NCT02966743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64933148|NCT02966743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528481|NCT01534195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64528482|NCT01534195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64528483|NCT01534195|Protective Agents|protective agents|mesh-ancestor
64528484|NCT01560949|Gemcitabine|gemcitabine|mesh-list
64528485|NCT01560949|Fluorouracil|fluorouracil|mesh-list
64528486|NCT01560949|Oxaliplatin|oxaliplatin|mesh-list
64528487|NCT01560949|Irinotecan|irinotecan|mesh-list
64528488|NCT01560949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64528489|NCT01560949|Antimetabolites|antimetabolites|mesh-ancestor
64528490|NCT01560949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528491|NCT01560949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528492|NCT01560949|Antiviral Agents|antiviral agents|mesh-ancestor
64528493|NCT01560949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64528494|NCT01560949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528495|NCT01560949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64528496|NCT01560949|Immunologic Factors|immunologic factors|mesh-ancestor
64528497|NCT01560949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528498|NCT01560949|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64404962|NCT04909151|Autonomic Agents|autonomic agents|mesh-ancestor
64404963|NCT04909151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404964|NCT04909151|Dopamine Agents|dopamine agents|mesh-ancestor
64405051|NCT04907747|Renal Agents|renal agents|mesh-ancestor
64528499|NCT01560949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64528500|NCT03113448|Capsaicin|capsaicin|mesh-list
64528501|NCT03113448|Antipruritics|antipruritics|mesh-ancestor
64528502|NCT03113448|Dermatologic Agents|dermatologic agents|mesh-ancestor
64933149|NCT02966743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64933150|NCT02966743|Analgesics|analgesics|mesh-ancestor
64933151|NCT02966743|Sensory System Agents|sensory system agents|mesh-ancestor
64933152|NCT02966743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64933153|NCT02966743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64405146|NCT04906031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64933154|NCT02966743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64933155|NCT02966743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64933156|NCT02966743|Adrenergic Agents|adrenergic agents|mesh-ancestor
64933157|NCT02966743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64405310|NCT04901117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64933158|NCT02966743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933159|NCT02966743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64933160|NCT02966743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64933161|NCT02966743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64933162|NCT02966743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64933163|NCT02966743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64933164|NCT02966743|Anesthetics, General|anesthetics, general|mesh-ancestor
64933165|NCT02966743|Anesthetics|anesthetics|mesh-ancestor
64933166|NCT02966743|GABA Modulators|gaba modulators|mesh-ancestor
64514954|NCT04776850|Thymoglobulin|thymoglobulin|mesh-list
64514955|NCT04776850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64514956|NCT04776850|Antibodies|antibodies|mesh-list
64514957|NCT04776850|Immunoglobulins|immunoglobulins|mesh-list
64514958|NCT04776850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64514959|NCT04776850|gamma-Globulins|gamma-globulins|mesh-list
64933167|NCT02966743|GABA Agents|gaba agents|mesh-ancestor
64933168|NCT00071539|Immunotoxins|immunotoxins|mesh-list
64933169|NCT00071539|Immunologic Factors|immunologic factors|mesh-ancestor
64933187|NCT00071929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933188|NCT00071968|Sirolimus|sirolimus|mesh-list
64933189|NCT00071968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64933190|NCT00071968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64933191|NCT00071968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64933192|NCT00071968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405484|NCT04817189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64933193|NCT00071968|Antifungal Agents|antifungal agents|mesh-ancestor
64933194|NCT00071968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64933195|NCT00071968|Immunologic Factors|immunologic factors|mesh-ancestor
64933196|NCT00071968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933197|NCT00390065|Nitric Oxide|nitric oxide|mesh-list
64650720|NCT01510457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64528511|NCT01533493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64405631|NCT04895657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64528512|NCT01533493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64528513|NCT01533493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528514|NCT01533493|Dopamine Agents|dopamine agents|mesh-ancestor
64528515|NCT01533493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64933200|NCT00390065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64933201|NCT00390065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933202|NCT00390065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64933203|NCT00390065|Respiratory System Agents|respiratory system agents|mesh-ancestor
64933204|NCT00390065|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64933205|NCT00390065|Antioxidants|antioxidants|mesh-ancestor
64933206|NCT00390065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933207|NCT00390065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64933208|NCT00390065|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64933209|NCT00390065|Vasodilator Agents|vasodilator agents|mesh-ancestor
64933210|NCT00390065|Gasotransmitters|gasotransmitters|mesh-ancestor
64933211|NCT00390065|Protective Agents|protective agents|mesh-ancestor
64933212|NCT00072007|Prednisone|prednisone|mesh-list
64933213|NCT00072007|Cyclophosphamide|cyclophosphamide|mesh-list
64933214|NCT00072007|Rituximab|rituximab|mesh-list
64933215|NCT00072007|Doxorubicin|doxorubicin|mesh-list
64933216|NCT00072007|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64933217|NCT00072007|Vincristine|vincristine|mesh-list
64405792|NCT03046901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64405793|NCT03046901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64933218|NCT00072007|Cladribine|cladribine|mesh-list
64933219|NCT00072007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64933220|NCT00072007|Immunologic Factors|immunologic factors|mesh-ancestor
64933221|NCT00072007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933222|NCT00072007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64933223|NCT00072007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64933224|NCT00072007|Alkylating Agents|alkylating agents|mesh-ancestor
64933225|NCT00072007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933246|NCT00072046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933247|NCT00072046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64933248|NCT00072046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64933249|NCT00072046|Growth Substances|growth substances|mesh-ancestor
64933250|NCT00072046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933251|NCT00072046|Growth Inhibitors|growth inhibitors|mesh-ancestor
64405903|NCT03049085|Aspirin|aspirin|mesh-list
64933252|NCT00072046|Antiviral Agents|antiviral agents|mesh-ancestor
64933253|NCT00072046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64933254|NCT00072046|Immunologic Factors|immunologic factors|mesh-ancestor
64933255|NCT03959514|Insulin Aspart|insulin aspart|mesh-list
64933256|NCT03959514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64933257|NCT03959514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933258|NCT04730596|Dexmedetomidine|dexmedetomidine|mesh-list
64933259|NCT04730596|Ketamine|ketamine|mesh-list
64933260|NCT04730596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64933261|NCT04730596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64933262|NCT04730596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933263|NCT04730596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64933264|NCT04730596|Analgesics|analgesics|mesh-ancestor
64933265|NCT04730596|Sensory System Agents|sensory system agents|mesh-ancestor
64933266|NCT04730596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650722|NCT01510457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64650723|NCT01510457|Analgesics|analgesics|mesh-ancestor
64528516|NCT01533493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64528586|NCT05569746|Immunoglobulins|immunoglobulins|mesh-list
64528587|NCT05569746|Immunoglobulin Fragments|immunoglobulin fragments|mesh-list
64406136|NCT04872881|Rocuronium|rocuronium|mesh-list
64933267|NCT04730596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64933268|NCT04730596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64933269|NCT04730596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64933270|NCT04730596|Adrenergic Agents|adrenergic agents|mesh-ancestor
64933271|NCT04730596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64552672|NCT03216915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64933272|NCT04730596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933273|NCT04730596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64933274|NCT04730596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64933275|NCT04730596|Anesthetics, General|anesthetics, general|mesh-ancestor
64933276|NCT04730596|Anesthetics|anesthetics|mesh-ancestor
64933277|NCT04730596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64933278|NCT04730596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64933279|NCT00072085|Aldesleukin|aldesleukin|mesh-list
64933315|NCT00072163|Thalidomide|thalidomide|mesh-list
64933316|NCT00072163|Temozolomide|temozolomide|mesh-list
64933353|NCT03959397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64933383|NCT00072553|Celecoxib|celecoxib|mesh-list
64933384|NCT00072553|Fluorouracil|fluorouracil|mesh-list
64933385|NCT00072553|Oxaliplatin|oxaliplatin|mesh-list
64933386|NCT00072553|Calcium|calcium|mesh-list
64933387|NCT00072553|Levoleucovorin|levoleucovorin|mesh-list
64515212|NCT04355832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933388|NCT00072553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64933389|NCT00072553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933390|NCT00072553|Antimetabolites|antimetabolites|mesh-ancestor
64933391|NCT00072553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933392|NCT00072553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64933393|NCT00072553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933394|NCT00072553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64933395|NCT00072553|Immunologic Factors|immunologic factors|mesh-ancestor
64933396|NCT00072553|Antidotes|antidotes|mesh-ancestor
64933397|NCT00072553|Protective Agents|protective agents|mesh-ancestor
64933398|NCT00072553|Vitamin B Complex|vitamin b complex|mesh-ancestor
64933399|NCT00072553|Vitamins|vitamins|mesh-ancestor
64933400|NCT00072553|Micronutrients|micronutrients|mesh-ancestor
64933401|NCT00072553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64933431|NCT00072670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933432|NCT00072670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933433|NCT03959358|Lenalidomide|lenalidomide|mesh-list
64933434|NCT03959358|Pomalidomide|pomalidomide|mesh-list
64933435|NCT03959358|Immunologic Factors|immunologic factors|mesh-ancestor
64933436|NCT03959358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933437|NCT03959358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64933438|NCT03959358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64933439|NCT03959358|Growth Substances|growth substances|mesh-ancestor
64933440|NCT03959358|Growth Inhibitors|growth inhibitors|mesh-ancestor
64933441|NCT03959358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933442|NCT02966704|Caseins|caseins|mesh-list
64933443|NCT02966704|Chelating Agents|chelating agents|mesh-ancestor
64933444|NCT02966704|Sequestering Agents|sequestering agents|mesh-ancestor
64933445|NCT02966704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515278|NCT02461836|Antiviral Agents|antiviral agents|mesh-ancestor
64406911|NCT04498273|Anticoagulants|anticoagulants|mesh-ancestor
64933446|NCT00072748|EKB 569|ekb 569|mesh-list
64933472|NCT00072943|Interferons|interferons|mesh-list
64933473|NCT00072943|Interferon-gamma|interferon-gamma|mesh-list
64933474|NCT00072943|Antibodies|antibodies|mesh-list
64933475|NCT00072943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64933476|NCT00072943|Immunologic Factors|immunologic factors|mesh-ancestor
64933477|NCT00072943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933478|NCT00072943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933479|NCT00072943|Antiviral Agents|antiviral agents|mesh-ancestor
64933488|NCT03959124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64933489|NCT03959124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64933491|NCT03959124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64528588|NCT05569746|Shiga Toxins|shiga toxins|mesh-list
64528589|NCT05569746|Immunologic Factors|immunologic factors|mesh-ancestor
64528590|NCT05569746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528591|NCT05569746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64528592|NCT05569746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528593|NCT05569746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528594|NCT01533181|Topotecan|topotecan|mesh-list
64528595|NCT01533181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64528596|NCT01533181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64407206|NCT03043157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407213|NCT04370483|Leflunomide|leflunomide|mesh-list
64528597|NCT01533181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528598|NCT01533181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528599|NCT01533181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528600|NCT04641507|Tadalafil|tadalafil|mesh-list
64528601|NCT04641507|Tamsulosin|tamsulosin|mesh-list
64528602|NCT04641507|Vasodilator Agents|vasodilator agents|mesh-ancestor
64528603|NCT04641507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64933492|NCT03959124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933493|NCT03959124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933494|NCT03959124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64933495|NCT03959124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64933496|NCT03959124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64933497|NCT03959124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407478|NCT03038009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407479|NCT03466801|Prednisone|prednisone|mesh-list
64407480|NCT03466801|Glucocorticoids|glucocorticoids|mesh-list
64407483|NCT03466801|Hormones|hormones|mesh-ancestor
64933529|NCT04711291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933531|NCT00073372|Anticoagulants|anticoagulants|mesh-ancestor
64933532|NCT00073372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64933533|NCT04821830|Levodopa|levodopa|mesh-list
64933534|NCT04821830|Carbidopa|carbidopa|mesh-list
64933535|NCT04821830|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64515467|NCT02464722|Narcotics|narcotics|mesh-ancestor
64933536|NCT04821830|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64933537|NCT04821830|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64933538|NCT04821830|Dopamine Agents|dopamine agents|mesh-ancestor
64933539|NCT04821830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64552673|NCT03216915|Immunologic Factors|immunologic factors|mesh-ancestor
64552674|NCT03216915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552676|NCT04007393|Phentermine|phentermine|mesh-list
64407821|NCT04822415|Carticaine|carticaine|mesh-list
64552677|NCT04007393|Anticonvulsants|anticonvulsants|mesh-ancestor
64515610|NCT01895829|Hematinics|hematinics|mesh-ancestor
64933540|NCT04821830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933541|NCT04821830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933542|NCT04821830|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64933571|NCT02966041|Dermatologic Agents|dermatologic agents|mesh-ancestor
64933572|NCT02966041|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64933574|NCT02966041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64933575|NCT02966041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933576|NCT02966041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64933577|NCT02966041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64933578|NCT02966041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64933579|NCT02966041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64933580|NCT02966041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64933581|NCT00073723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64933582|NCT00073723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408236|NCT03094663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933583|NCT00073840|Albuterol|albuterol|mesh-list
64933584|NCT00073840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64933585|NCT00073840|Autonomic Agents|autonomic agents|mesh-ancestor
64933586|NCT00073840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64933587|NCT00073840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933588|NCT00073840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64933611|NCT00073879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64528608|NCT04641507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64528609|NCT04641507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64528610|NCT04641507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64528611|NCT04641507|Adrenergic Agents|adrenergic agents|mesh-ancestor
64484766|NCT01969721|Xhance|xhance|mesh-list
64933615|NCT00074074|Dermatologic Agents|dermatologic agents|mesh-ancestor
64933616|NCT00074074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64933617|NCT00074074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64933618|NCT00392652|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
64933619|NCT00392652|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64933620|NCT00392652|Protective Agents|protective agents|mesh-ancestor
64408274|NCT04814381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64408275|NCT04814381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64408276|NCT04814381|Tocolytic Agents|tocolytic agents|mesh-ancestor
64408307|NCT05619341|Psyllium|psyllium|mesh-list
64933621|NCT00392652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933622|NCT00392652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933623|NCT00074191|Cytarabine|cytarabine|mesh-list
64933624|NCT00074191|Dexamethasone|dexamethasone|mesh-list
64933625|NCT00074191|Methotrexate|methotrexate|mesh-list
64933626|NCT00074191|Lomustine|lomustine|mesh-list
64933627|NCT00074191|Procarbazine|procarbazine|mesh-list
64933628|NCT00074191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64933629|NCT00074191|Antiemetics|antiemetics|mesh-ancestor
64933630|NCT00074191|Autonomic Agents|autonomic agents|mesh-ancestor
64933631|NCT00074191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64933632|NCT00074191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933633|NCT00074191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64933634|NCT00074191|Glucocorticoids|glucocorticoids|mesh-ancestor
64933635|NCT00074191|Hormones|hormones|mesh-ancestor
64408325|NCT05051137|Sensory System Agents|sensory system agents|mesh-ancestor
64515819|NCT01994746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64515820|NCT01994746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515821|NCT01994746|Incretins|incretins|mesh-ancestor
64515822|NCT04034238|Tofacitinib|tofacitinib|mesh-list
64408368|NCT02640157|Sofosbuvir|sofosbuvir|mesh-list
64933636|NCT00074191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64933637|NCT00074191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64933638|NCT00074191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933639|NCT00074191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64933640|NCT00074191|Abortifacient Agents|abortifacient agents|mesh-ancestor
64933664|NCT00392691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64515831|NCT01337349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515832|NCT01337349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64515833|NCT01337349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64515834|NCT01337349|Protective Agents|protective agents|mesh-ancestor
64933665|NCT00392691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933666|NCT00392691|Immunologic Factors|immunologic factors|mesh-ancestor
64933667|NCT00392691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933668|NCT00392691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64933669|NCT00392691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64933670|NCT00392691|Alkylating Agents|alkylating agents|mesh-ancestor
64933671|NCT00392691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933672|NCT00392691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64933673|NCT00392691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64933674|NCT00392691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64933675|NCT00392691|Tubulin Modulators|tubulin modulators|mesh-ancestor
64933676|NCT00392691|Antimitotic Agents|antimitotic agents|mesh-ancestor
64933677|NCT00392691|Mitosis Modulators|mitosis modulators|mesh-ancestor
64933678|NCT02966080|Heparin|heparin|mesh-list
64933679|NCT02966080|Anticoagulants|anticoagulants|mesh-ancestor
64933680|NCT02966080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64515855|NCT00280761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64515856|NCT00280761|Immunologic Factors|immunologic factors|mesh-ancestor
64515857|NCT00280761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515858|NCT02463318|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64515859|NCT02463318|Melatonin|melatonin|mesh-list
64515860|NCT02463318|Antioxidants|antioxidants|mesh-ancestor
64515861|NCT02463318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515862|NCT02463318|Protective Agents|protective agents|mesh-ancestor
64408542|NCT05021887|Respiratory System Agents|respiratory system agents|mesh-ancestor
64408543|NCT05021887|Dermatologic Agents|dermatologic agents|mesh-ancestor
64408544|NCT05021887|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64408545|NCT05021731|Rifampin|rifampin|mesh-list
64408546|NCT05021731|Rifapentine|rifapentine|mesh-list
64408547|NCT05021731|Isoniazid|isoniazid|mesh-list
64408589|NCT03079453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408590|NCT03079453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64933681|NCT02966080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64933682|NCT02966080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933683|NCT04767776|Rivaroxaban|rivaroxaban|mesh-list
64933684|NCT04767776|Charcoal|charcoal|mesh-list
64933685|NCT04767776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64933686|NCT04767776|Antithrombins|antithrombins|mesh-ancestor
64933687|NCT04767776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64933688|NCT04767776|Protease Inhibitors|protease inhibitors|mesh-ancestor
64933689|NCT04767776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515876|NCT02462772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64933690|NCT04767776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933726|NCT00074737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933727|NCT00074737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64933728|NCT00074737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64528613|NCT04641507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528614|NCT04489173|Trifluridine|trifluridine|mesh-list
64528615|NCT04489173|Antimetabolites|antimetabolites|mesh-ancestor
64528616|NCT04489173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528623|NCT00512070|Protective Agents|protective agents|mesh-ancestor
64528624|NCT00512070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515926|NCT00003270|Antiemetics|antiemetics|mesh-ancestor
64528625|NCT00512070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64528626|NCT00512070|Antiemetics|antiemetics|mesh-ancestor
64528627|NCT00512070|Autonomic Agents|autonomic agents|mesh-ancestor
64528628|NCT00512070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64528629|NCT00512070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64528630|NCT00512070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64528631|NCT00512070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64528632|NCT00512070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64933729|NCT00074737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64933730|NCT00074737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933732|NCT00074776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64933757|NCT00075010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64933758|NCT04729595|Tempol|tempol|mesh-list
64933759|NCT04729595|Antioxidants|antioxidants|mesh-ancestor
64408953|NCT05339295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64408954|NCT05339295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64408955|NCT02637037|Metformin|metformin|mesh-list
64933760|NCT04729595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933761|NCT04729595|Protective Agents|protective agents|mesh-ancestor
64933762|NCT04729595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933763|NCT04729595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64933764|NCT04729595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933765|NCT04729595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64933766|NCT04729595|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64933767|NCT00075205|Rimonabant|rimonabant|mesh-list
64933768|NCT00075205|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64933769|NCT00075205|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
64933770|NCT00075205|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64408967|NCT05306535|Keratolytic Agents|keratolytic agents|mesh-ancestor
64933771|NCT00075205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64933772|NCT00075205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933773|NCT00075205|Hormones|hormones|mesh-ancestor
64933774|NCT00075205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64933775|NCT00075205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933776|NCT00075439|Gefitinib|gefitinib|mesh-list
64933777|NCT00075439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933778|NCT00075439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64933779|NCT00075439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933780|NCT00075439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933799|NCT00075556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933801|NCT00075595|Leucovorin|leucovorin|mesh-list
64933802|NCT00075595|Fluorouracil|fluorouracil|mesh-list
64933803|NCT00075595|Irinotecan|irinotecan|mesh-list
64933804|NCT00075595|Calcium|calcium|mesh-list
64933805|NCT00075595|Levoleucovorin|levoleucovorin|mesh-list
64528634|NCT00512070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64528635|NCT00512070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64528636|NCT00512070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64528637|NCT00512070|Serotonin Agents|serotonin agents|mesh-ancestor
64409073|NCT05006209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409074|NCT05335629|Dapagliflozin|dapagliflozin|mesh-list
64409075|NCT05335629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64440757|NCT02269943|Cc-486|cc-486|mesh-list
64528638|NCT05668026|Venetoclax|venetoclax|mesh-list
64528639|NCT05668026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528640|NCT05661552|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64528641|NCT05661552|Ezetimibe|ezetimibe|mesh-list
64528642|NCT05661552|Evolocumab|evolocumab|mesh-list
64528643|NCT05661552|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64933806|NCT00075595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64933807|NCT00075595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516013|NCT03294798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516014|NCT04488744|Nicotine|nicotine|mesh-list
64516015|NCT04488744|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64516024|NCT02005666|Clindamycin|clindamycin|mesh-list
64933808|NCT00075595|Antimetabolites|antimetabolites|mesh-ancestor
64933809|NCT00075595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933810|NCT00075595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64933811|NCT00075595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933812|NCT00075595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64933813|NCT00075595|Immunologic Factors|immunologic factors|mesh-ancestor
64933814|NCT00075595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64933815|NCT00075595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64516046|NCT00494182|Paclitaxel|paclitaxel|mesh-list
64933816|NCT00075595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933817|NCT00075595|Antidotes|antidotes|mesh-ancestor
64933828|NCT00075634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64933829|NCT00075634|Immunologic Factors|immunologic factors|mesh-ancestor
64933830|NCT00075634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933831|NCT00075634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64933832|NCT00075634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64409326|NCT02524275|Docetaxel|docetaxel|mesh-list
64933833|NCT00075634|Alkylating Agents|alkylating agents|mesh-ancestor
64933834|NCT00075634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933835|NCT00075634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933836|NCT00075634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64933837|NCT00075634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64933838|NCT00075634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64933839|NCT00075634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64933840|NCT00075634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933859|NCT00075673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933860|NCT00075673|Tubulin Modulators|tubulin modulators|mesh-ancestor
64933861|NCT00075673|Antimitotic Agents|antimitotic agents|mesh-ancestor
64933862|NCT00075673|Mitosis Modulators|mitosis modulators|mesh-ancestor
64933864|NCT00075712|Carboplatin|carboplatin|mesh-list
64933865|NCT00075712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64933866|NCT00075712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933867|NCT00075712|Tubulin Modulators|tubulin modulators|mesh-ancestor
64933868|NCT00075712|Antimitotic Agents|antimitotic agents|mesh-ancestor
64933869|NCT00075712|Mitosis Modulators|mitosis modulators|mesh-ancestor
64933870|NCT00075712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516131|NCT03294252|Vitamins|vitamins|mesh-ancestor
64516165|NCT02069704|Bevacizumab|bevacizumab|mesh-list
64516166|NCT02069704|Fluorouracil|fluorouracil|mesh-list
64516168|NCT02069704|Irinotecan|irinotecan|mesh-list
64933871|NCT03958500|Methylene Blue|methylene blue|mesh-list
64933872|NCT03958500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933873|NCT03958500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933875|NCT00075751|Carboplatin|carboplatin|mesh-list
64933876|NCT00075751|Bortezomib|bortezomib|mesh-list
64933877|NCT00075751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933878|NCT00075751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64410000|NCT03069001|Sofosbuvir|sofosbuvir|mesh-list
64528646|NCT05661552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528647|NCT05661552|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64528648|NCT05661552|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64528649|NCT05661552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528650|NCT03534102|Analgesics, Opioid|analgesics, opioid|mesh-list
64528651|NCT03534102|Narcotics|narcotics|mesh-ancestor
64528652|NCT03534102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64528653|NCT03534102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528654|NCT03534102|Analgesics|analgesics|mesh-ancestor
64528655|NCT03534102|Sensory System Agents|sensory system agents|mesh-ancestor
64528656|NCT03534102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410198|NCT05370729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64410199|NCT05370729|Expectorants|expectorants|mesh-ancestor
64528657|NCT04051203|Methylprednisolone|methylprednisolone|mesh-list
64528658|NCT04051203|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64528659|NCT04051203|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64528660|NCT04051203|Prednisolone|prednisolone|mesh-list
64933879|NCT00075751|Antimetabolites|antimetabolites|mesh-ancestor
64933880|NCT00075751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933881|NCT00075751|Antiviral Agents|antiviral agents|mesh-ancestor
64933882|NCT00075751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64933883|NCT00075751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933884|NCT00075751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64933885|NCT00075751|Immunologic Factors|immunologic factors|mesh-ancestor
64410436|NCT05730439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64410437|NCT05730439|Cholinergic Agents|cholinergic agents|mesh-ancestor
64410438|NCT05730439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64410439|NCT05730439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410475|NCT05170919|Autonomic Agents|autonomic agents|mesh-ancestor
64410476|NCT05170919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410477|NCT05170919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410478|NCT05170919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64410506|NCT05613491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64410507|NCT05613491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410517|NCT05151263|Salicylates|salicylates|mesh-list
64933886|NCT00075751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933887|NCT00075868|Octreotide|octreotide|mesh-list
64933888|NCT00075868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64650760|NCT02509026|Analgesics|analgesics|mesh-ancestor
64933932|NCT00399256|Antioxidants|antioxidants|mesh-ancestor
64933933|NCT00399256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933934|NCT00399256|Protective Agents|protective agents|mesh-ancestor
64933935|NCT00399256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933936|NCT00399256|Antidotes|antidotes|mesh-ancestor
64933937|NCT00399295|Naltrexone|naltrexone|mesh-list
64933938|NCT00399295|Hydromorphone|hydromorphone|mesh-list
64933939|NCT00399295|Narcotic Antagonists|narcotic antagonists|mesh-list
64933940|NCT00399295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64410654|NCT05170113|Purinergic Agents|purinergic agents|mesh-ancestor
64516249|NCT02334436|Botulinum Toxins|botulinum toxins|mesh-list
64516250|NCT02334436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64516251|NCT02334436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64516252|NCT02334436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64516253|NCT02334436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64736748|NCT00616577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64410723|NCT05613179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64410724|NCT05613179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64410725|NCT05613179|Sensory System Agents|sensory system agents|mesh-ancestor
64410726|NCT05613179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410727|NCT05613179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410728|NCT05613179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64410729|NCT05613179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64410730|NCT05613179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64410731|NCT05613179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410745|NCT02518971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64410746|NCT02518971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64410747|NCT02518971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64410748|NCT02518971|Adrenergic Agents|adrenergic agents|mesh-ancestor
64410749|NCT02518971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64410750|NCT02518971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410751|NCT02518971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410752|NCT02518971|Urological Agents|urological agents|mesh-ancestor
64410753|NCT04733963|Bevacizumab|bevacizumab|mesh-list
64410765|NCT04222023|Immunoglobulins|immunoglobulins|mesh-list
64410766|NCT04222023|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64410767|NCT04222023|Antibodies|antibodies|mesh-list
64410768|NCT04222023|gamma-Globulins|gamma-globulins|mesh-list
64933941|NCT00399295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933942|NCT00399295|Sensory System Agents|sensory system agents|mesh-ancestor
64528662|NCT04051203|Lidocaine|lidocaine|mesh-list
64528663|NCT04051203|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64528664|NCT04051203|Prednisolone phosphate|prednisolone phosphate|mesh-list
64528665|NCT04051203|Anesthetics, Local|anesthetics, local|mesh-ancestor
64528666|NCT04051203|Anesthetics|anesthetics|mesh-ancestor
64528667|NCT04051203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64528668|NCT04051203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933943|NCT00399295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64933944|NCT00399295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64933945|NCT00399295|Narcotics|narcotics|mesh-ancestor
64933977|NCT00077077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64933978|NCT00077077|Antimetabolites|antimetabolites|mesh-ancestor
64933979|NCT00077077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933980|NCT00077077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410801|NCT04716413|Analgesics|analgesics|mesh-ancestor
64410802|NCT04716413|Sensory System Agents|sensory system agents|mesh-ancestor
64410803|NCT04716413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410804|NCT05048589|Vaccines|vaccines|mesh-list
64410805|NCT05048589|Immunologic Factors|immunologic factors|mesh-ancestor
64410806|NCT05048589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410807|NCT05728333|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64410808|NCT05728333|Tirofiban|tirofiban|mesh-list
64410809|NCT05728333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64933982|NCT00077116|Cyclophosphamide|cyclophosphamide|mesh-list
64933983|NCT00077116|Busulfan|busulfan|mesh-list
64933984|NCT00077116|Idarubicin|idarubicin|mesh-list
64933985|NCT00077116|Gemtuzumab|gemtuzumab|mesh-list
64933986|NCT00077116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64933987|NCT00077116|Immunologic Factors|immunologic factors|mesh-ancestor
64933988|NCT00077116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933989|NCT00077116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64934007|NCT03951207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64934008|NCT03951207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64934009|NCT03951207|Antimetabolites|antimetabolites|mesh-ancestor
64934010|NCT03951207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934011|NCT03951207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64934012|NCT03951207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64650778|NCT03439280|Hormones|hormones|mesh-ancestor
64934021|NCT00077194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64411408|NCT04278755|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64411409|NCT04278755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64934022|NCT00077194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934023|NCT00077233|Leucovorin|leucovorin|mesh-list
64934024|NCT00077233|Fluorouracil|fluorouracil|mesh-list
64934025|NCT00077233|Oxaliplatin|oxaliplatin|mesh-list
64934026|NCT00077233|Irinotecan|irinotecan|mesh-list
64934027|NCT00077233|Cetuximab|cetuximab|mesh-list
64934028|NCT00077233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934029|NCT00077233|Antimetabolites|antimetabolites|mesh-ancestor
64934030|NCT00077233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934031|NCT00077233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64934032|NCT00077233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934033|NCT00077233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64934034|NCT00077233|Immunologic Factors|immunologic factors|mesh-ancestor
64934035|NCT00077233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64934036|NCT00077233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64934037|NCT00077233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934038|NCT00077233|Antidotes|antidotes|mesh-ancestor
64934039|NCT00077233|Protective Agents|protective agents|mesh-ancestor
64934040|NCT00077233|Vitamin B Complex|vitamin b complex|mesh-ancestor
64934041|NCT00077233|Vitamins|vitamins|mesh-ancestor
64934042|NCT00077233|Micronutrients|micronutrients|mesh-ancestor
64934043|NCT00077233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64934044|NCT02958631|Losartan|losartan|mesh-list
64934045|NCT02958631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64516287|NCT02008942|Antipyretics|antipyretics|mesh-ancestor
64516289|NCT03288636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64516290|NCT03288636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64516291|NCT03288636|Protease Inhibitors|protease inhibitors|mesh-ancestor
64586299|NCT00365261|Eszopiclone|eszopiclone|mesh-list
64411854|NCT02518113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64411856|NCT02518113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64411857|NCT05541107|Amphotericin B|amphotericin b|mesh-list
64934046|NCT02958631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64934075|NCT00077389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934076|NCT00077389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64934077|NCT00077389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64934078|NCT00077389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64934079|NCT00077389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528669|NCT04051203|Sensory System Agents|sensory system agents|mesh-ancestor
64528670|NCT04051203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64412106|NCT04979923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64412107|NCT04979923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64528671|NCT04051203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64528672|NCT04051203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64528673|NCT04051203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64528674|NCT04051203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64528675|NCT04051203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528676|NCT04051203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64528677|NCT04051203|Antiemetics|antiemetics|mesh-ancestor
64516311|NCT02071810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516312|NCT02071810|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64516313|NCT02071810|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64516314|NCT02715258|Bexagliflozin|bexagliflozin|mesh-list
64528678|NCT04051203|Autonomic Agents|autonomic agents|mesh-ancestor
64528679|NCT04051203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64528680|NCT04051203|Glucocorticoids|glucocorticoids|mesh-ancestor
64528681|NCT04051203|Hormones|hormones|mesh-ancestor
64552678|NCT04007393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64528682|NCT04051203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64528683|NCT04051203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64934080|NCT00077389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934081|NCT00077428|Doxorubicin|doxorubicin|mesh-list
64934082|NCT00077428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64934083|NCT00077428|Bortezomib|bortezomib|mesh-list
64934084|NCT00077428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64934085|NCT00077428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934086|NCT00077428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64934087|NCT00077428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64934088|NCT00077428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934089|NCT00077428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413259|NCT04177433|Prednisolone acetate|prednisolone acetate|mesh-list
64413265|NCT04177433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413266|NCT04177433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934090|NCT00077467|Bortezomib|bortezomib|mesh-list
64934091|NCT00077467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934092|NCT03832569|Pembrolizumab|pembrolizumab|mesh-list
64934125|NCT03766581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64934126|NCT03766581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934250|NCT00078910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64934282|NCT03655002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934283|NCT03655002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64934284|NCT03655002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64934285|NCT03655002|Alkylating Agents|alkylating agents|mesh-ancestor
64934286|NCT03655002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934287|NCT03655002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934288|NCT03655002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64934289|NCT03655002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64934290|NCT03655002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64934291|NCT00079105|Prednisolone|prednisolone|mesh-list
64528684|NCT04051203|Protective Agents|protective agents|mesh-ancestor
64528685|NCT04051203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64714115|NCT03043274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64528686|NCT04051203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516456|NCT02460276|Growth Substances|growth substances|mesh-ancestor
64528687|NCT00144963|Dexamethasone|dexamethasone|mesh-list
64528688|NCT00144963|Vincristine|vincristine|mesh-list
64528689|NCT00144963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64528690|NCT00144963|Antiemetics|antiemetics|mesh-ancestor
64528691|NCT00144963|Autonomic Agents|autonomic agents|mesh-ancestor
64528692|NCT00144963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64528693|NCT00144963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528694|NCT00144963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64528695|NCT00144963|Glucocorticoids|glucocorticoids|mesh-ancestor
64528696|NCT00144963|Hormones|hormones|mesh-ancestor
64528697|NCT00144963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64528698|NCT00144963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64413832|NCT03055663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413833|NCT03055663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64413878|NCT04937101|Codeine|codeine|mesh-list
64528699|NCT00144963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528700|NCT00144963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64528701|NCT00144963|Tubulin Modulators|tubulin modulators|mesh-ancestor
64528702|NCT00144963|Antimitotic Agents|antimitotic agents|mesh-ancestor
64528703|NCT00144963|Mitosis Modulators|mitosis modulators|mesh-ancestor
64528704|NCT00144963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934292|NCT00079105|Cyclophosphamide|cyclophosphamide|mesh-list
64934293|NCT00079105|Etoposide|etoposide|mesh-list
64934294|NCT00079105|Vincristine|vincristine|mesh-list
64934295|NCT00079105|Mitoxantrone|mitoxantrone|mesh-list
64934296|NCT00079105|Bleomycin|bleomycin|mesh-list
64934297|NCT00079105|Vinblastine|vinblastine|mesh-list
64934326|NCT04472429|Carboplatin|carboplatin|mesh-list
64934327|NCT04472429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64934328|NCT04472429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934329|NCT04472429|Tubulin Modulators|tubulin modulators|mesh-ancestor
64934330|NCT04472429|Antimitotic Agents|antimitotic agents|mesh-ancestor
64934338|NCT03647124|Growth Substances|growth substances|mesh-ancestor
64934339|NCT03647124|Growth Inhibitors|growth inhibitors|mesh-ancestor
64934340|NCT03647124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934354|NCT00079144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64934355|NCT00079144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64934356|NCT00079144|Antimetabolites|antimetabolites|mesh-ancestor
64934357|NCT00079144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64934358|NCT00079144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64934359|NCT00079144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64934360|NCT00079144|Antiviral Agents|antiviral agents|mesh-ancestor
64934361|NCT00079144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64934362|NCT00079222|Itraconazole|itraconazole|mesh-list
64934363|NCT00079222|Voriconazole|voriconazole|mesh-list
64528705|NCT02662764|Sufentanil|sufentanil|mesh-list
64528707|NCT02662764|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64528708|NCT02662764|Narcotics|narcotics|mesh-ancestor
64528709|NCT02662764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64528710|NCT02662764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516574|NCT02459574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516575|NCT02459574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64528711|NCT02662764|Analgesics|analgesics|mesh-ancestor
64528712|NCT02662764|Sensory System Agents|sensory system agents|mesh-ancestor
64528713|NCT02662764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64528714|NCT02662764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64528715|NCT02662764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64528716|NCT02662764|Anesthetics, General|anesthetics, general|mesh-ancestor
64528718|NCT01519817|Vaccines|vaccines|mesh-list
64528719|NCT01519817|Immunologic Factors|immunologic factors|mesh-ancestor
64528720|NCT01519817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528721|NCT02985593|KHK4083|khk4083|mesh-list
64528722|NCT02985593|Dermatologic Agents|dermatologic agents|mesh-ancestor
64528723|NCT03478956|Etrolizumab|etrolizumab|mesh-list
64528724|NCT03478956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64528725|NCT03478956|Immunologic Factors|immunologic factors|mesh-ancestor
64528726|NCT03478956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528727|NCT05549154|Vitamin D|vitamin d|mesh-list
64528728|NCT05549154|Ergocalciferols|ergocalciferols|mesh-list
64528729|NCT05549154|Cholecalciferol|cholecalciferol|mesh-list
64528730|NCT05549154|Vitamins|vitamins|mesh-list
64557958|NCT00953199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64557959|NCT00953199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528731|NCT05549154|Micronutrients|micronutrients|mesh-ancestor
64528732|NCT05549154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528733|NCT05549154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64528734|NCT05549154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64528735|NCT01518257|Botulinum Toxins|botulinum toxins|mesh-list
64528736|NCT01518257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64528737|NCT01518257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64516621|NCT01673217|Decitabine|decitabine|mesh-list
64934364|NCT00079222|Antifungal Agents|antifungal agents|mesh-ancestor
64934365|NCT00079222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64934366|NCT00079222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64934367|NCT00079222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64934368|NCT00079222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934369|NCT00079222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934370|NCT00079222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64934371|NCT00079222|Hormone Antagonists|hormone antagonists|mesh-ancestor
64934372|NCT00079222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64934373|NCT00079222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528739|NCT01518257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64528740|NCT01518257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528741|NCT01518257|Cholinergic Agents|cholinergic agents|mesh-ancestor
64528742|NCT01518257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64528743|NCT01518257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558768|NCT03766763|Venetoclax|venetoclax|mesh-list
64934381|NCT00079261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64934382|NCT00079261|Immunologic Factors|immunologic factors|mesh-ancestor
64934383|NCT00079261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934384|NCT00079261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64934385|NCT00079261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64934386|NCT00079261|Alkylating Agents|alkylating agents|mesh-ancestor
64934387|NCT00079261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934388|NCT00079261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934389|NCT00079261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64934390|NCT00079261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64934391|NCT00079261|Antimetabolites|antimetabolites|mesh-ancestor
64934392|NCT00079261|Antiviral Agents|antiviral agents|mesh-ancestor
64934393|NCT00079261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64934394|NCT00079261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934395|NCT00079261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64934396|NCT00079261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64934397|NCT00079261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64934398|NCT00079261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64558973|NCT03725501|Ranibizumab|ranibizumab|mesh-list
64934399|NCT00079261|Glucocorticoids|glucocorticoids|mesh-ancestor
64934400|NCT00079261|Hormones|hormones|mesh-ancestor
64934401|NCT00079261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64934402|NCT00079261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64934403|NCT00079261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64934432|NCT00079456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64934433|NCT00079456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934434|NCT00079456|Antifungal Agents|antifungal agents|mesh-ancestor
64934435|NCT00079456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64934436|NCT00079456|Immunologic Factors|immunologic factors|mesh-ancestor
64934437|NCT00079456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934439|NCT04467086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64934440|NCT04467086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64934441|NCT04467086|Adrenergic Agents|adrenergic agents|mesh-ancestor
64934442|NCT04467086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64934443|NCT04467086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934444|NCT04467086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934445|NCT04467086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64934446|NCT04467086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64934447|NCT04467086|Vasodilator Agents|vasodilator agents|mesh-ancestor
64934448|NCT00079612|Sorafenib|sorafenib|mesh-list
64934449|NCT00079612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559518|NCT00005669|Metformin|metformin|mesh-list
64934450|NCT00079612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64934451|NCT00079612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934476|NCT00079807|Protective Agents|protective agents|mesh-ancestor
64934477|NCT00079807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934478|NCT00079807|Vitamin B Complex|vitamin b complex|mesh-ancestor
64934479|NCT00079807|Vitamins|vitamins|mesh-ancestor
64934480|NCT00079807|Micronutrients|micronutrients|mesh-ancestor
64934481|NCT00079885|Tigecycline|tigecycline|mesh-list
64528748|NCT02391636|Oxytocics|oxytocics|mesh-ancestor
64528749|NCT02391636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64528750|NCT02391636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528751|NCT01514357|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64528752|NCT01514357|Natriuretic Agents|natriuretic agents|mesh-ancestor
64528753|NCT01514357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528754|NCT02383212|Paclitaxel|paclitaxel|mesh-list
64528755|NCT02383212|Docetaxel|docetaxel|mesh-list
64528756|NCT02383212|Cyclophosphamide|cyclophosphamide|mesh-list
64528757|NCT02383212|Carboplatin|carboplatin|mesh-list
64560016|NCT01004991|Mitosis Modulators|mitosis modulators|mesh-ancestor
64560201|NCT01055769|Linezolid|linezolid|mesh-list
64934484|NCT00079885|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64934485|NCT00079885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934486|NCT00079885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934487|NCT00079924|Teriparatide|teriparatide|mesh-list
64934488|NCT00079924|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64934489|NCT00079924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64934490|NCT00079924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560218|NCT04972032|Protective Agents|protective agents|mesh-ancestor
64560219|NCT04432662|Darbepoetin alfa|darbepoetin alfa|mesh-list
64934491|NCT00079924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64934492|NCT00079924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64934493|NCT00079924|Hormone Antagonists|hormone antagonists|mesh-ancestor
64934494|NCT00079924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64934495|NCT00079924|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64934496|NCT00079924|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64934497|NCT00079963|Vitamins|vitamins|mesh-list
64934498|NCT00079963|Vitamin E|vitamin e|mesh-list
64934499|NCT00079963|Micronutrients|micronutrients|mesh-ancestor
64934532|NCT00392886|Tubulin Modulators|tubulin modulators|mesh-ancestor
64934533|NCT00392886|Antimitotic Agents|antimitotic agents|mesh-ancestor
64934534|NCT00392886|Mitosis Modulators|mitosis modulators|mesh-ancestor
64934535|NCT00080041|Motexafin gadolinium|motexafin gadolinium|mesh-list
64934536|NCT00080041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934537|NCT00080041|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64934538|NCT00080041|Dermatologic Agents|dermatologic agents|mesh-ancestor
64934539|NCT00080080|Docetaxel|docetaxel|mesh-list
64934540|NCT00080080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934541|NCT00080080|Tubulin Modulators|tubulin modulators|mesh-ancestor
64934542|NCT00080080|Antimitotic Agents|antimitotic agents|mesh-ancestor
64934562|NCT00080158|Dopamine Agents|dopamine agents|mesh-ancestor
64934563|NCT00080158|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64934564|NCT00080158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64560701|NCT03152981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560702|NCT03152981|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64934565|NCT00080158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934566|NCT00080158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64934567|NCT00080158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64934568|NCT00080158|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64528768|NCT02383212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64528769|NCT02383212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64528770|NCT02383212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64560792|NCT01106859|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64528771|NCT02383212|Alkylating Agents|alkylating agents|mesh-ancestor
64528772|NCT02383212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64528773|NCT02383212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528774|NCT02383212|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64528775|NCT02383212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64934569|NCT00080158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64934570|NCT00080158|Histamine Antagonists|histamine antagonists|mesh-ancestor
64561034|NCT04582383|Doxycycline|doxycycline|mesh-list
64934571|NCT00080158|Histamine Agents|histamine agents|mesh-ancestor
64934572|NCT00080158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64934573|NCT00080158|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64934574|NCT00080158|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64934575|NCT00080158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64934576|NCT00080158|Adrenergic Agents|adrenergic agents|mesh-ancestor
64934577|NCT00080158|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64650826|NCT00828542|Medroxyprogesterone|medroxyprogesterone|mesh-list
64561067|NCT01047189|Clindamycin|clindamycin|mesh-list
64561068|NCT01047189|Clindamycin palmitate|clindamycin palmitate|mesh-list
64934588|NCT00080275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64934589|NCT00080275|Antimetabolites|antimetabolites|mesh-ancestor
64934590|NCT00080275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934591|NCT00080275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64934592|NCT00080275|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64934593|NCT00080275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934594|NCT00080275|Vasodilator Agents|vasodilator agents|mesh-ancestor
64934595|NCT00080275|Vitamin B Complex|vitamin b complex|mesh-ancestor
64934626|NCT00080431|Immunologic Factors|immunologic factors|mesh-ancestor
64561380|NCT02080403|Chlorhexidine|chlorhexidine|mesh-list
64934627|NCT00080431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934628|NCT00080509|Desoxyepothilone B|desoxyepothilone b|mesh-list
64934629|NCT00080509|Tubulin Modulators|tubulin modulators|mesh-ancestor
64934630|NCT00080509|Antimitotic Agents|antimitotic agents|mesh-ancestor
64934631|NCT00080509|Mitosis Modulators|mitosis modulators|mesh-ancestor
64934632|NCT00080509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934633|NCT00080509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934635|NCT03506373|Glycine|glycine|mesh-list
64934636|NCT03506373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934637|NCT03506373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934652|NCT00080626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934653|NCT00080626|Tubulin Modulators|tubulin modulators|mesh-ancestor
64934654|NCT00080626|Antimitotic Agents|antimitotic agents|mesh-ancestor
64934655|NCT00080626|Mitosis Modulators|mitosis modulators|mesh-ancestor
64934656|NCT00080626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934658|NCT00080665|Imatinib Mesylate|imatinib mesylate|mesh-list
64934659|NCT00080665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934660|NCT00080665|Tubulin Modulators|tubulin modulators|mesh-ancestor
64561717|NCT03482297|Sympathomimetics|sympathomimetics|mesh-ancestor
64561718|NCT03482297|Autonomic Agents|autonomic agents|mesh-ancestor
64561719|NCT03482297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64561720|NCT03482297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561721|NCT03482297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64934661|NCT00080665|Antimitotic Agents|antimitotic agents|mesh-ancestor
64934662|NCT00080665|Mitosis Modulators|mitosis modulators|mesh-ancestor
64934663|NCT00080665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934664|NCT00080665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64934665|NCT00080665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934666|NCT00080743|Tamoxifen|tamoxifen|mesh-list
64934667|NCT00080743|Gefitinib|gefitinib|mesh-list
64561885|NCT04270175|Antiemetics|antiemetics|mesh-ancestor
64561886|NCT04270175|Autonomic Agents|autonomic agents|mesh-ancestor
64934668|NCT00080743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934669|NCT00080743|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64528776|NCT02383212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64528778|NCT02391480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528779|NCT01531387|Hydroxyurea|hydroxyurea|mesh-list
64528780|NCT01531387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64528781|NCT01531387|Antisickling Agents|antisickling agents|mesh-ancestor
64528782|NCT01531387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64528783|NCT01531387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64528784|NCT01531387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64517093|NCT03258372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64562101|NCT03084419|Abatacept|abatacept|mesh-list
64528785|NCT01531153|Galantamine|galantamine|mesh-list
64934670|NCT00080743|Hormone Antagonists|hormone antagonists|mesh-ancestor
64934671|NCT00080743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64934672|NCT00080743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934673|NCT00080743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64934674|NCT00080743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934675|NCT00080743|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64650840|NCT00828542|Progestins|progestins|mesh-ancestor
64934691|NCT04423367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64934692|NCT04423367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934693|NCT00080782|Celecoxib|celecoxib|mesh-list
64934694|NCT00080782|Doxorubicin|doxorubicin|mesh-list
64934695|NCT00080782|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64934696|NCT00080782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64934697|NCT00080782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64703187|NCT02519023|Sympathomimetics|sympathomimetics|mesh-ancestor
64934731|NCT00081055|Alkylating Agents|alkylating agents|mesh-ancestor
64934732|NCT00081055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562274|NCT01215123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64562275|NCT01215123|Growth Substances|growth substances|mesh-ancestor
64934733|NCT00081055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934734|NCT00081055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64934735|NCT00081055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64934736|NCT00081055|Abortifacient Agents|abortifacient agents|mesh-ancestor
64934737|NCT00081055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64934758|NCT00081172|Immunologic Factors|immunologic factors|mesh-ancestor
64934759|NCT00081172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934760|NCT03187080|Bupivacaine|bupivacaine|mesh-list
64934761|NCT03187080|Anesthetics, Local|anesthetics, local|mesh-list
64934762|NCT03187080|Anesthetics|anesthetics|mesh-list
64934763|NCT03187080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64517102|NCT03258372|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64884814|NCT03714880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64884815|NCT03714880|Luteolytic Agents|luteolytic agents|mesh-ancestor
64884935|NCT02330562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64884936|NCT02330562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64884937|NCT02330562|Growth Substances|growth substances|mesh-ancestor
64884938|NCT02330562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884939|NCT02330562|Growth Inhibitors|growth inhibitors|mesh-ancestor
64884940|NCT02053363|Tranexamic Acid|tranexamic acid|mesh-list
64884957|NCT00504712|Testosterone|testosterone|mesh-list
64884958|NCT00504712|Androgens|androgens|mesh-ancestor
64884959|NCT00504712|Hormones|hormones|mesh-ancestor
64884972|NCT05413096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64884973|NCT05413096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64884974|NCT05413096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64884975|NCT05413096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884976|NCT05413096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884977|NCT05413096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64884978|NCT05412914|Propofol|propofol|mesh-list
64884979|NCT05412914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64884980|NCT05412914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64884981|NCT05412914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334515|NCT02227745|Viscosupplements|viscosupplements|mesh-ancestor
64885004|NCT05412472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885005|NCT05412472|Protective Agents|protective agents|mesh-ancestor
64885006|NCT05412472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885007|NCT05412394|Prednisolone|prednisolone|mesh-list
64885008|NCT05412394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64885009|NCT05412394|Glucocorticoids|glucocorticoids|mesh-ancestor
64885010|NCT05412394|Hormones|hormones|mesh-ancestor
64885011|NCT05412394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64334518|NCT02227745|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64334519|NCT02227745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334520|NCT02227745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334521|NCT03517033|Nebivolol|nebivolol|mesh-list
64885026|NCT05411900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64885027|NCT05411887|Olmesartan|olmesartan|mesh-list
64885028|NCT05411887|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64885029|NCT05411887|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64885030|NCT05411887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64885088|NCT05320406|Leuprolide|leuprolide|mesh-list
64885089|NCT05320406|Relugolix|relugolix|mesh-list
64885090|NCT05320406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64885091|NCT05320406|Fertility Agents|fertility agents|mesh-ancestor
64885092|NCT05320406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64885093|NCT05320406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885094|NCT05320406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64885095|NCT05320406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885096|NCT05320406|Androgen Antagonists|androgen antagonists|mesh-ancestor
64885097|NCT05320406|Hormone Antagonists|hormone antagonists|mesh-ancestor
64885098|NCT05320406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64885101|NCT05303038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885129|NCT05062902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885130|NCT05062902|Cholinergic Agents|cholinergic agents|mesh-ancestor
64885131|NCT05062902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64885132|NCT05062902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885133|NCT05042674|Ergothioneine|ergothioneine|mesh-list
64885134|NCT05042674|Antioxidants|antioxidants|mesh-ancestor
64885135|NCT05042674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885136|NCT05042674|Protective Agents|protective agents|mesh-ancestor
64885137|NCT05042674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885138|NCT04927585|Vaccines|vaccines|mesh-list
64885139|NCT04927585|Immunologic Factors|immunologic factors|mesh-ancestor
64885140|NCT04927585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885141|NCT04917055|Dexamethasone|dexamethasone|mesh-list
64885142|NCT04917055|Epinephrine|epinephrine|mesh-list
64885143|NCT04917055|Ropivacaine|ropivacaine|mesh-list
64334524|NCT03517033|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64334526|NCT03517033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64885171|NCT04898478|Analgesics, Opioid|analgesics, opioid|mesh-list
64885172|NCT04898478|Narcotics|narcotics|mesh-ancestor
64885173|NCT04898478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64885174|NCT04898478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885175|NCT04898478|Analgesics|analgesics|mesh-ancestor
64885176|NCT04898478|Sensory System Agents|sensory system agents|mesh-ancestor
64885177|NCT04898478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64885178|NCT04777006|Amitriptyline|amitriptyline|mesh-list
64885179|NCT04777006|Fluoxetine|fluoxetine|mesh-list
64885180|NCT04777006|Antidepressive Agents|antidepressive agents|mesh-list
64885181|NCT04777006|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64885182|NCT04777006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64885183|NCT04777006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64885239|NCT04655391|Antimetabolites|antimetabolites|mesh-ancestor
64885240|NCT04655391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885241|NCT04655391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885242|NCT04655391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885244|NCT04609098|Artenimol|artenimol|mesh-list
64885245|NCT04609098|Tafenoquine|tafenoquine|mesh-list
64885246|NCT04609098|Antimalarials|antimalarials|mesh-ancestor
64885247|NCT04609098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64885248|NCT04609098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64885250|NCT04605614|Copper|copper|mesh-list
64885262|NCT04493333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885263|NCT04493333|Antidiarrheals|antidiarrheals|mesh-ancestor
64885264|NCT04493333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64885265|NCT04493333|Cathartics|cathartics|mesh-ancestor
64885266|NCT04475016|Paclitaxel|paclitaxel|mesh-list
64885267|NCT04475016|Ifosfamide|ifosfamide|mesh-list
64885268|NCT04475016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64885269|NCT04475016|Nimotuzumab|nimotuzumab|mesh-list
64885279|NCT04321551|Letrozole|letrozole|mesh-list
64885295|NCT04321551|Hormones|hormones|mesh-ancestor
64885296|NCT04321551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64885297|NCT04321551|Anabolic Agents|anabolic agents|mesh-ancestor
64885298|NCT04302324|Clarithromycin|clarithromycin|mesh-list
64885299|NCT04302324|Dexamethasone|dexamethasone|mesh-list
64885300|NCT04302324|Daratumumab|daratumumab|mesh-list
64885301|NCT04302324|Pomalidomide|pomalidomide|mesh-list
64885302|NCT04302324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64885303|NCT04302324|Antiemetics|antiemetics|mesh-ancestor
64334557|NCT02259179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334558|NCT02355093|Ropivacaine|ropivacaine|mesh-list
64334559|NCT02355093|Anesthetics, Local|anesthetics, local|mesh-ancestor
64334560|NCT02355093|Anesthetics|anesthetics|mesh-ancestor
64334561|NCT02355093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64334562|NCT02355093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885323|NCT04302324|Growth Substances|growth substances|mesh-ancestor
64885324|NCT04302324|Growth Inhibitors|growth inhibitors|mesh-ancestor
64885326|NCT04074460|Sevoflurane|sevoflurane|mesh-list
64885327|NCT04074460|Desflurane|desflurane|mesh-list
64885328|NCT04074460|Isoflurane|isoflurane|mesh-list
64885345|NCT03993327|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64885346|NCT03993327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64885347|NCT03993327|Trace Elements|trace elements|mesh-ancestor
64885348|NCT03993327|Micronutrients|micronutrients|mesh-ancestor
64885349|NCT03817125|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64885350|NCT03817125|Vancomycin|vancomycin|mesh-list
64885351|NCT03817125|Nivolumab|nivolumab|mesh-list
64885352|NCT03817125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64885353|NCT03817125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885354|NCT03817125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64885355|NCT03817125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885356|NCT03817125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64885357|NCT03747042|Letrozole|letrozole|mesh-list
64334563|NCT02355093|Sensory System Agents|sensory system agents|mesh-ancestor
64334564|NCT02355093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334565|NCT02227823|Bromides|bromides|mesh-list
64334566|NCT02227823|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
64334567|NCT02227823|Anticonvulsants|anticonvulsants|mesh-ancestor
64334568|NCT02227823|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64334569|NCT02227823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334570|NCT02227823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885360|NCT03747042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64885361|NCT03747042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885362|NCT03747042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885363|NCT03747042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64885364|NCT03747042|Hormone Antagonists|hormone antagonists|mesh-ancestor
64885365|NCT03747042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64885366|NCT03747042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885367|NCT03703102|KHK4083|khk4083|mesh-list
64334571|NCT02227823|Cholinergic Agents|cholinergic agents|mesh-ancestor
64334572|NCT02227823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64334573|NCT02227823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334575|NCT02295475|Apixaban|apixaban|mesh-list
64885376|NCT03581370|Renal Agents|renal agents|mesh-ancestor
64885377|NCT03581370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64885378|NCT03581370|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64885379|NCT03581370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885380|NCT03581370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885381|NCT03568604|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64885382|NCT03568604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64885383|NCT03568604|Immunologic Factors|immunologic factors|mesh-ancestor
64885384|NCT03568604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885385|NCT03539055|Dabigatran|dabigatran|mesh-list
64885386|NCT03539055|Antithrombins|antithrombins|mesh-ancestor
64885387|NCT03539055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64885388|NCT03539055|Protease Inhibitors|protease inhibitors|mesh-ancestor
64885389|NCT03539055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885390|NCT03539055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885391|NCT03539055|Anticoagulants|anticoagulants|mesh-ancestor
64885392|NCT03485534|Tenofovir|tenofovir|mesh-list
64885393|NCT03485534|Antiviral Agents|antiviral agents|mesh-ancestor
64885394|NCT03485534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64885395|NCT03485534|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64885396|NCT03485534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64885397|NCT03485534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885398|NCT03485534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885399|NCT03485534|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64885401|NCT03427736|Ketorolac|ketorolac|mesh-list
64885424|NCT03427736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64885425|NCT03427736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64885426|NCT03427736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64885427|NCT03427736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885429|NCT03395704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64885430|NCT03246503|Bilirubin|bilirubin|mesh-list
64885431|NCT03246503|Antioxidants|antioxidants|mesh-ancestor
64885432|NCT03246503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885433|NCT03246503|Protective Agents|protective agents|mesh-ancestor
64885434|NCT03246503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885435|NCT03115567|Triamcinolone|triamcinolone|mesh-list
64885436|NCT03115567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64334578|NCT02295475|Antithrombins|antithrombins|mesh-ancestor
64334579|NCT02295475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64334580|NCT02295475|Protease Inhibitors|protease inhibitors|mesh-ancestor
64334581|NCT02295475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334582|NCT02295475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885505|NCT02793375|Montelukast|montelukast|mesh-list
64885506|NCT02793375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64885507|NCT02793375|Respiratory System Agents|respiratory system agents|mesh-ancestor
64885508|NCT02793375|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64885509|NCT02793375|Hormone Antagonists|hormone antagonists|mesh-ancestor
64885510|NCT02793375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64885511|NCT02793375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885512|NCT02793375|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64885513|NCT02793375|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64885514|NCT02793375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885516|NCT02625610|Fluorouracil|fluorouracil|mesh-list
64885517|NCT02625610|Capecitabine|capecitabine|mesh-list
64885518|NCT02625610|Oxaliplatin|oxaliplatin|mesh-list
64885519|NCT02625610|Avelumab|avelumab|mesh-list
64885520|NCT02625610|Levoleucovorin|levoleucovorin|mesh-list
64885521|NCT02625610|Antimetabolites|antimetabolites|mesh-ancestor
64885522|NCT02625610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885523|NCT02625610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64885524|NCT02625610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885534|NCT02515591|Dimercaprol|dimercaprol|mesh-list
64885535|NCT02515591|Chelating Agents|chelating agents|mesh-ancestor
64885536|NCT02515591|Sequestering Agents|sequestering agents|mesh-ancestor
64885537|NCT02515591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885538|NCT02514447|Topotecan|topotecan|mesh-list
64885539|NCT02514447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64885540|NCT02514447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64885541|NCT02514447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885542|NCT02514447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885543|NCT02514447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885544|NCT02352883|Hormones|hormones|mesh-list
64885545|NCT02352883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64885546|NCT02352883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885547|NCT02257346|Lidocaine|lidocaine|mesh-list
64885548|NCT02257346|Anesthetics, Local|anesthetics, local|mesh-ancestor
64885549|NCT02257346|Anesthetics|anesthetics|mesh-ancestor
64885550|NCT02257346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64334591|NCT03146793|Protective Agents|protective agents|mesh-ancestor
64334592|NCT03146793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334593|NCT03146793|Antioxidants|antioxidants|mesh-ancestor
64885582|NCT01530373|Sympatholytics|sympatholytics|mesh-ancestor
64885583|NCT01530373|Autonomic Agents|autonomic agents|mesh-ancestor
64885584|NCT01530373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64885585|NCT01530373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64885586|NCT01530373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64885587|NCT01530373|Adrenergic Agents|adrenergic agents|mesh-ancestor
64885588|NCT01530373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64885590|NCT01530373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64885597|NCT01442246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64885598|NCT01442246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885599|NCT01442246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64885600|NCT01442246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885601|NCT00712322|Darifenacin|darifenacin|mesh-list
64885602|NCT00712322|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64885603|NCT00712322|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64885604|NCT00712322|Cholinergic Agents|cholinergic agents|mesh-ancestor
64885605|NCT00712322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64885606|NCT00712322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885607|NCT00712322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885608|NCT00712322|Urological Agents|urological agents|mesh-ancestor
64885640|NCT00572169|Leprostatic Agents|leprostatic agents|mesh-ancestor
64654170|NCT04371146|Methylphenidate|methylphenidate|mesh-list
64885641|NCT00572169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64885687|NCT05414292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64885703|NCT05413902|Lidocaine|lidocaine|mesh-list
64885857|NCT05111821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64885858|NCT05111821|Chelating Agents|chelating agents|mesh-ancestor
64885859|NCT05111821|Sequestering Agents|sequestering agents|mesh-ancestor
64885860|NCT05111821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885861|NCT05105282|Anesthetics|anesthetics|mesh-list
64885862|NCT05105282|Anesthetics, Local|anesthetics, local|mesh-list
64885917|NCT04641234|Aflibercept|aflibercept|mesh-list
64886047|NCT03600818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64886048|NCT03600818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886049|NCT03600818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64886317|NCT01946061|Oxaliplatin|oxaliplatin|mesh-list
64886482|NCT01947114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64886483|NCT01947114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64886484|NCT01947114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64886485|NCT01947114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886486|NCT01947114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64886519|NCT01947608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64886522|NCT01947660|Anesthetics|anesthetics|mesh-list
64886620|NCT01948115|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64886905|NCT01949857|Immunologic Factors|immunologic factors|mesh-ancestor
64886906|NCT01949857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887050|NCT01950884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887051|NCT01950884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64887052|NCT01950923|Sildenafil Citrate|sildenafil citrate|mesh-list
64887053|NCT01950923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887054|NCT01950923|Vasodilator Agents|vasodilator agents|mesh-ancestor
64887314|NCT01952756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64887315|NCT01952756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887316|NCT01952756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64887317|NCT01952756|Respiratory System Agents|respiratory system agents|mesh-ancestor
64887318|NCT01952756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64887394|NCT01953445|Paclitaxel|paclitaxel|mesh-list
64887468|NCT01953770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64887469|NCT01953770|Glucocorticoids|glucocorticoids|mesh-ancestor
64887470|NCT01953770|Hormones|hormones|mesh-ancestor
64887730|NCT01955135|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64887731|NCT01955135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64887733|NCT01955135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64888034|NCT01956981|Adrenergic Agents|adrenergic agents|mesh-ancestor
64888035|NCT01956981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888036|NCT01956981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888205|NCT01958580|Antimetabolites|antimetabolites|mesh-ancestor
64888207|NCT01958580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888348|NCT01959191|Antipyretics|antipyretics|mesh-ancestor
64888349|NCT01959191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64888350|NCT01959191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64888351|NCT01959191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64888352|NCT01959191|Purinergic Agents|purinergic agents|mesh-ancestor
64888353|NCT01959191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888496|NCT01960595|Fentanyl|fentanyl|mesh-list
64557506|NCT03584711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64557507|NCT03584711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557508|NCT05301192|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
64557509|NCT05301192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64888877|NCT01964001|Pyridoxal|pyridoxal|mesh-list
64888878|NCT01964001|Pyridoxine|pyridoxine|mesh-list
64888880|NCT01964001|Ubiquinone|ubiquinone|mesh-list
64889088|NCT01964781|Anesthetics, Local|anesthetics, local|mesh-ancestor
64889215|NCT01965522|Vitamin D|vitamin d|mesh-list
64889445|NCT01967199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889446|NCT01967199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64889447|NCT01967199|Immunologic Factors|immunologic factors|mesh-ancestor
64889448|NCT01967199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889449|NCT01967251|Udenafil|udenafil|mesh-list
64889450|NCT01967251|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64889451|NCT01967251|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64889452|NCT01967251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889453|NCT01967251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889454|NCT01967264|Udenafil|udenafil|mesh-list
64889455|NCT01967264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64889546|NCT01967823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889547|NCT01967823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64889548|NCT01967823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64889549|NCT01967823|Alkylating Agents|alkylating agents|mesh-ancestor
64889550|NCT01967823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889551|NCT01967823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889552|NCT01967823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64889553|NCT01967823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64889554|NCT01967823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64889555|NCT01967823|Antiviral Agents|antiviral agents|mesh-ancestor
64889556|NCT01967823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64889557|NCT01967875|Docetaxel|docetaxel|mesh-list
64889558|NCT01967875|Capecitabine|capecitabine|mesh-list
64889559|NCT01967875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889560|NCT01967875|Tubulin Modulators|tubulin modulators|mesh-ancestor
64889561|NCT01967875|Antimitotic Agents|antimitotic agents|mesh-ancestor
64889562|NCT01967875|Mitosis Modulators|mitosis modulators|mesh-ancestor
64889563|NCT01967875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889578|NCT01967979|Hormone Antagonists|hormone antagonists|mesh-ancestor
64889579|NCT01967979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64889580|NCT01967979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889581|NCT01967979|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64889582|NCT01967979|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64889583|NCT01967979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64889584|NCT01967979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64889585|NCT01967979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64889587|NCT01967979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64889588|NCT01967979|Antidepressive Agents|antidepressive agents|mesh-ancestor
64889604|NCT01968005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64889605|NCT01968005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64889606|NCT01968005|Analgesics|analgesics|mesh-ancestor
64889607|NCT01968005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64889608|NCT01968005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64889609|NCT01968005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64889616|NCT01968018|Sensory System Agents|sensory system agents|mesh-ancestor
64889617|NCT01968018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889618|NCT01968018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889619|NCT01968018|Antipyretics|antipyretics|mesh-ancestor
64889620|NCT01968018|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64889621|NCT01968018|Narcotics|narcotics|mesh-ancestor
64889622|NCT01968018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64889623|NCT01968044|Linagliptin|linagliptin|mesh-list
64889683|NCT01968577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889684|NCT01968577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64889685|NCT01968577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64889686|NCT01968577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889687|NCT01968616|Ranibizumab|ranibizumab|mesh-list
64889688|NCT01968616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64889689|NCT01968616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64889690|NCT01968616|Growth Substances|growth substances|mesh-ancestor
64889691|NCT01968616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889696|NCT01968759|Ramipril|ramipril|mesh-list
64889754|NCT01969019|Hormones|hormones|mesh-ancestor
64889765|NCT01969032|Paclitaxel|paclitaxel|mesh-list
64889766|NCT01969032|Doxorubicin|doxorubicin|mesh-list
64889767|NCT01969032|Capecitabine|capecitabine|mesh-list
64889789|NCT01969071|Simendan|simendan|mesh-list
64889802|NCT01969071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64889803|NCT01969071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64889804|NCT01969071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64889805|NCT01969071|Adrenergic Agents|adrenergic agents|mesh-ancestor
64889806|NCT01969071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64889807|NCT01969149|Insulin|insulin|mesh-list
64889808|NCT01969149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64889809|NCT01969149|Exenatide|exenatide|mesh-list
64889810|NCT01969149|Insulin Lispro|insulin lispro|mesh-list
64889811|NCT01969149|Incretins|incretins|mesh-list
64889812|NCT01969149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64889867|NCT01969682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64889868|NCT01969682|Leprostatic Agents|leprostatic agents|mesh-ancestor
64889869|NCT01969682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64889870|NCT01969682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889878|NCT01969695|Venetoclax|venetoclax|mesh-list
64889935|NCT01970059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889936|NCT01970059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889937|NCT01970059|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64889938|NCT01970059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64889939|NCT01970059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64889940|NCT01970059|Adrenergic Agents|adrenergic agents|mesh-ancestor
64889941|NCT01970059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64889942|NCT01970059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889943|NCT01970059|Antioxidants|antioxidants|mesh-ancestor
64889944|NCT01970059|Protective Agents|protective agents|mesh-ancestor
64890068|NCT01971268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890069|NCT01971268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890070|NCT01971268|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64890071|NCT01971268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64890072|NCT01971268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890073|NCT01971281|Gemcitabine|gemcitabine|mesh-list
64890074|NCT01971281|Paclitaxel|paclitaxel|mesh-list
64890075|NCT01971281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64890076|NCT01971281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890077|NCT01971281|Tubulin Modulators|tubulin modulators|mesh-ancestor
64890078|NCT01971281|Antimitotic Agents|antimitotic agents|mesh-ancestor
64890079|NCT01971281|Mitosis Modulators|mitosis modulators|mesh-ancestor
64890080|NCT01971281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890118|NCT01971515|Tamoxifen|tamoxifen|mesh-list
64890299|NCT01972763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890300|NCT01972828|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
64890301|NCT01972828|Plasma Substitutes|plasma substitutes|mesh-ancestor
64890302|NCT01972828|Blood Substitutes|blood substitutes|mesh-ancestor
64890303|NCT01972880|Ipragliflozin|ipragliflozin|mesh-list
64890304|NCT01972880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64890305|NCT01972880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890306|NCT01972880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64890307|NCT01972880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890308|NCT01972906|Ibuprofen|ibuprofen|mesh-list
64890309|NCT01972906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64890310|NCT01972906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64890311|NCT01972906|Analgesics|analgesics|mesh-ancestor
64890312|NCT01972906|Sensory System Agents|sensory system agents|mesh-ancestor
64890313|NCT01972906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64890314|NCT01972906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890315|NCT01972906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64890316|NCT01972906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64890351|NCT01973101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890352|NCT01973101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64890353|NCT01973101|Immunologic Factors|immunologic factors|mesh-ancestor
64890354|NCT01973101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890355|NCT01973114|Latanoprost|latanoprost|mesh-list
64890356|NCT01973114|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64890361|NCT01973140|Natriuretic Agents|natriuretic agents|mesh-ancestor
64890437|NCT01973790|Cholinergic Agents|cholinergic agents|mesh-ancestor
64890438|NCT01973790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64890439|NCT01973790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890445|NCT01973816|Estradiol|estradiol|mesh-list
64890464|NCT01973842|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64890465|NCT01973842|Contraceptive Agents|contraceptive agents|mesh-ancestor
64890466|NCT01973842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64890467|NCT01973842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890468|NCT01973842|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64890469|NCT01973842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64890470|NCT01973842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890471|NCT01973855|Ribavirin|ribavirin|mesh-list
64890472|NCT01973855|Antimetabolites|antimetabolites|mesh-ancestor
64890473|NCT01973855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890474|NCT01973855|Antiviral Agents|antiviral agents|mesh-ancestor
64890529|NCT01974258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890530|NCT01974258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890531|NCT01974297|Atorvastatin|atorvastatin|mesh-list
64890532|NCT01974297|Fenofibric acid|fenofibric acid|mesh-list
64890533|NCT01974297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64890534|NCT01974297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64890535|NCT01974297|Antimetabolites|antimetabolites|mesh-ancestor
64890536|NCT01974297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890537|NCT01974297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64890538|NCT01974297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64890539|NCT01974297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890543|NCT01974375|Fluconazole|fluconazole|mesh-list
64890589|NCT01974843|Bupivacaine|bupivacaine|mesh-list
64890590|NCT01974843|Levobupivacaine|levobupivacaine|mesh-list
64890591|NCT01974843|Anesthetics, Local|anesthetics, local|mesh-ancestor
64890592|NCT01974843|Anesthetics|anesthetics|mesh-ancestor
64890593|NCT01974843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64890647|NCT01975259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64890648|NCT01975259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890649|NCT01975259|Incretins|incretins|mesh-ancestor
64890650|NCT01975324|4-Aminopyridine|4-aminopyridine|mesh-list
64890651|NCT01975324|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64890652|NCT01975324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64890653|NCT01975324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890654|NCT01975363|Curcumin|curcumin|mesh-list
64890655|NCT01975363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64890656|NCT01975363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64890657|NCT01975363|Analgesics|analgesics|mesh-ancestor
64890658|NCT01975363|Sensory System Agents|sensory system agents|mesh-ancestor
64890659|NCT01975363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64890660|NCT01975363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890696|NCT01975480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890697|NCT01975480|Antidepressive Agents|antidepressive agents|mesh-ancestor
64890698|NCT01975480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64890700|NCT01975662|Daptomycin|daptomycin|mesh-list
64890701|NCT01975662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64890702|NCT01975662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64890703|NCT01975688|Nabiximols|nabiximols|mesh-list
64890704|NCT01975688|Analgesics|analgesics|mesh-ancestor
64890705|NCT01975688|Sensory System Agents|sensory system agents|mesh-ancestor
64890706|NCT01975688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64890707|NCT01975688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890708|NCT01975714|Bimatoprost|bimatoprost|mesh-list
64890709|NCT01975714|Latanoprost|latanoprost|mesh-list
64890710|NCT01975714|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64890711|NCT01975714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64890712|NCT01975714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64890713|NCT01975727|Dexamethasone|dexamethasone|mesh-list
64890714|NCT01975727|Dexamethasone acetate|dexamethasone acetate|mesh-list
64890738|NCT01975753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64890740|NCT01975753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64890741|NCT01975753|Anesthetics, General|anesthetics, general|mesh-ancestor
64890742|NCT01975753|Anesthetics|anesthetics|mesh-ancestor
64890743|NCT01975805|Chlorhexidine|chlorhexidine|mesh-list
64890744|NCT01975805|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64890745|NCT01975805|Povidone-Iodine|povidone-iodine|mesh-list
64890746|NCT01975805|Povidone|povidone|mesh-list
64890747|NCT01975805|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64890748|NCT01975805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64890749|NCT01975805|Disinfectants|disinfectants|mesh-ancestor
64890750|NCT01975805|Dermatologic Agents|dermatologic agents|mesh-ancestor
64890751|NCT01975805|Plasma Substitutes|plasma substitutes|mesh-ancestor
64890752|NCT01975805|Blood Substitutes|blood substitutes|mesh-ancestor
64890753|NCT01975961|Telmisartan|telmisartan|mesh-list
64890754|NCT01975961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64890755|NCT01975961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64890757|NCT01975961|Antimetabolites|antimetabolites|mesh-ancestor
64890798|NCT01976195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64982954|NCT00081614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982955|NCT00081614|Growth Inhibitors|growth inhibitors|mesh-ancestor
64982956|NCT00081614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64982957|NCT00081614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982958|NCT00081614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890799|NCT01976195|Antiemetics|antiemetics|mesh-ancestor
64890800|NCT01976195|Autonomic Agents|autonomic agents|mesh-ancestor
64890801|NCT01976195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64890802|NCT01976195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890803|NCT01976195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64890804|NCT01976195|Glucocorticoids|glucocorticoids|mesh-ancestor
64890805|NCT01976195|Hormones|hormones|mesh-ancestor
64890806|NCT01976195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64890807|NCT01976195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64890808|NCT01976195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890809|NCT01976195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64890810|NCT01976195|Immunologic Factors|immunologic factors|mesh-ancestor
64659350|NCT01650246|Lesinurad|lesinurad|mesh-list
64890811|NCT01976195|Leprostatic Agents|leprostatic agents|mesh-ancestor
64890812|NCT01976195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64890813|NCT01976195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64890814|NCT01976195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64890857|NCT01976923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64890858|NCT01976923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890859|NCT01976923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64890860|NCT01976923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64890861|NCT01976923|Growth Substances|growth substances|mesh-ancestor
64890862|NCT01976923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890863|NCT01976923|Growth Inhibitors|growth inhibitors|mesh-ancestor
64890864|NCT01976936|Lovastatin|lovastatin|mesh-list
64890865|NCT01976936|L 647318|l 647318|mesh-list
64890866|NCT01976936|Dihydromevinolin|dihydromevinolin|mesh-list
64890867|NCT01976936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64890868|NCT01976936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64890869|NCT01976936|Antimetabolites|antimetabolites|mesh-ancestor
64890870|NCT01976936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890871|NCT01976936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64890874|NCT01977118|Streptokinase|streptokinase|mesh-list
64890880|NCT01977209|Contraceptive Agents|contraceptive agents|mesh-ancestor
64890881|NCT01977209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64890882|NCT01977209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890883|NCT01977235|Irinotecan|irinotecan|mesh-list
64890884|NCT01977235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890885|NCT01977235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64890886|NCT01977235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64890887|NCT01977235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890888|NCT01977235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890993|NCT01978301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890994|NCT01978301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64890995|NCT01978301|Immunologic Factors|immunologic factors|mesh-ancestor
64890996|NCT01978301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890997|NCT01978301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890998|NCT01978405|Thioctic Acid|thioctic acid|mesh-list
64890999|NCT01978405|Antioxidants|antioxidants|mesh-ancestor
64891001|NCT01978405|Protective Agents|protective agents|mesh-ancestor
64891052|NCT01978665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64891053|NCT01978665|Glucocorticoids|glucocorticoids|mesh-ancestor
64891054|NCT01978665|Hormones|hormones|mesh-ancestor
64891055|NCT01978665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64891056|NCT01978665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891057|NCT01978665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64891058|NCT01978665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891059|NCT01978678|Budesonide|budesonide|mesh-list
64891060|NCT01978678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64891190|NCT01979965|Ranolazine|ranolazine|mesh-list
64891268|NCT01980472|Growth Inhibitors|growth inhibitors|mesh-ancestor
64891269|NCT01980498|Fentanyl|fentanyl|mesh-list
64891270|NCT01980498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64891271|NCT01980498|Narcotics|narcotics|mesh-ancestor
64891272|NCT01980498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64891300|NCT01980680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64891301|NCT01980680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891303|NCT01980745|Chloroquine|chloroquine|mesh-list
64891304|NCT01980745|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64891305|NCT01980745|Amebicides|amebicides|mesh-ancestor
64891306|NCT01980745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64891307|NCT01980745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64891308|NCT01980745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64891309|NCT01980745|Antimalarials|antimalarials|mesh-ancestor
64891310|NCT01980745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64891311|NCT01980745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64891312|NCT01980745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64891486|NCT01982396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891487|NCT01982396|Antiviral Agents|antiviral agents|mesh-ancestor
64891488|NCT01982396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64891489|NCT01982396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64891490|NCT01982396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64891491|NCT01982461|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64891492|NCT01982461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64891493|NCT01982461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64891494|NCT01982461|Antimetabolites|antimetabolites|mesh-ancestor
64891495|NCT01982461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891496|NCT01982461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64891497|NCT01982461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64891498|NCT01982461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64891499|NCT01982578|Genistein|genistein|mesh-list
64891500|NCT01982578|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64891501|NCT01982578|Protective Agents|protective agents|mesh-ancestor
64891502|NCT01982578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891503|NCT01982578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891504|NCT01982578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64891505|NCT01982578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64891506|NCT01982578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891507|NCT01982578|Phytoestrogens|phytoestrogens|mesh-ancestor
64891508|NCT01982578|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64891509|NCT01982578|Estrogens|estrogens|mesh-ancestor
64891510|NCT01982578|Hormones|hormones|mesh-ancestor
64891512|NCT01982734|Curcumin|curcumin|mesh-list
64891518|NCT01982734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891519|NCT01982734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64891520|NCT01982734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64891521|NCT01982734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891522|NCT01982734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64891523|NCT01982734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891524|NCT01982760|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64982959|NCT00303277|Simvastatin|simvastatin|mesh-list
64982960|NCT00303277|Pravastatin|pravastatin|mesh-list
64982987|NCT00120354|Lamivudine|lamivudine|mesh-list
64982988|NCT00120354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64982989|NCT00120354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64982990|NCT00120354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982991|NCT00120354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982992|NCT00120354|Antiviral Agents|antiviral agents|mesh-ancestor
64891525|NCT01982760|Hemostatics|hemostatics|mesh-ancestor
64891526|NCT01982760|Coagulants|coagulants|mesh-ancestor
64891527|NCT01982760|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64891528|NCT01982760|Natriuretic Agents|natriuretic agents|mesh-ancestor
64891529|NCT01982760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891530|NCT01982799|Acetaminophen|acetaminophen|mesh-list
64891531|NCT01982799|Ibuprofen|ibuprofen|mesh-list
64891532|NCT01982799|Naproxen|naproxen|mesh-list
64891533|NCT01982799|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64891534|NCT01982799|Hydrocodone|hydrocodone|mesh-list
64891573|NCT01982929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64891574|NCT01982929|Autonomic Agents|autonomic agents|mesh-ancestor
64891575|NCT01982929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64891576|NCT01982929|Respiratory System Agents|respiratory system agents|mesh-ancestor
64891577|NCT01982929|Mydriatics|mydriatics|mesh-ancestor
64891578|NCT01982929|Sympathomimetics|sympathomimetics|mesh-ancestor
64891579|NCT01982929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64891580|NCT01983124|Vemurafenib|vemurafenib|mesh-list
64891581|NCT01983124|Fotemustine|fotemustine|mesh-list
64891687|NCT01983761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891688|NCT01983761|Immunologic Factors|immunologic factors|mesh-ancestor
64891689|NCT01983761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891691|NCT01983761|Antimetabolites|antimetabolites|mesh-ancestor
64891749|NCT01984073|Vasodilator Agents|vasodilator agents|mesh-ancestor
64891750|NCT01984073|Vitamin B Complex|vitamin b complex|mesh-ancestor
64891751|NCT01984073|Vitamins|vitamins|mesh-ancestor
64891752|NCT01984073|Micronutrients|micronutrients|mesh-ancestor
64891753|NCT01984073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891754|NCT01984086|Albuterol|albuterol|mesh-list
64891755|NCT01984086|Charcoal|charcoal|mesh-list
64891756|NCT01984086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64891757|NCT01984086|Autonomic Agents|autonomic agents|mesh-ancestor
64891758|NCT01984086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64891759|NCT01984086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891815|NCT01984463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64891816|NCT01984463|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64891817|NCT01984463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64891818|NCT01984463|Anesthetics, General|anesthetics, general|mesh-ancestor
64891819|NCT01984463|Anesthetics|anesthetics|mesh-ancestor
64891821|NCT01984567|Thioctic Acid|thioctic acid|mesh-list
64891822|NCT01984567|Vitamins|vitamins|mesh-ancestor
64891823|NCT01984567|Micronutrients|micronutrients|mesh-ancestor
64891824|NCT01984567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891825|NCT01984567|Antioxidants|antioxidants|mesh-ancestor
64891826|NCT01984567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891827|NCT01984567|Protective Agents|protective agents|mesh-ancestor
64891828|NCT01984567|Vitamin B Complex|vitamin b complex|mesh-ancestor
64891830|NCT01984606|Empagliflozin|empagliflozin|mesh-list
64891880|NCT01984931|GABA Modulators|gaba modulators|mesh-ancestor
64891894|NCT01985061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64891895|NCT01985087|Temozolomide|temozolomide|mesh-list
64891896|NCT01985087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64891897|NCT01985087|Alkylating Agents|alkylating agents|mesh-ancestor
64891898|NCT01985087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891899|NCT01985087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891900|NCT01985152|Choline|choline|mesh-list
64891901|NCT01985152|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
64891928|NCT01985477|Dexamethasone|dexamethasone|mesh-list
64891929|NCT01985477|Lenalidomide|lenalidomide|mesh-list
64891930|NCT01985477|Tretinoin|tretinoin|mesh-list
64891931|NCT01985477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64891932|NCT01985477|Antiemetics|antiemetics|mesh-ancestor
64891933|NCT01985477|Autonomic Agents|autonomic agents|mesh-ancestor
64891934|NCT01985477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64891935|NCT01985477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891936|NCT01985477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64891937|NCT01985477|Glucocorticoids|glucocorticoids|mesh-ancestor
64891995|NCT01985750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891997|NCT01985789|Promethazine|promethazine|mesh-list
64891998|NCT01985789|Cetirizine|cetirizine|mesh-list
64891999|NCT01985789|Desloratadine|desloratadine|mesh-list
64892000|NCT01985789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64892001|NCT01985789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64892002|NCT01985789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64892003|NCT01985789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892004|NCT01985789|Anesthetics, Local|anesthetics, local|mesh-ancestor
64892005|NCT01985789|Anesthetics|anesthetics|mesh-ancestor
64892006|NCT01985789|Sensory System Agents|sensory system agents|mesh-ancestor
64892007|NCT01985789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64892008|NCT01985789|Antiemetics|antiemetics|mesh-ancestor
64892009|NCT01985789|Autonomic Agents|autonomic agents|mesh-ancestor
64892013|NCT01985789|Histamine Agents|histamine agents|mesh-ancestor
64892056|NCT01985854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64892057|NCT01985893|Trastuzumab|trastuzumab|mesh-list
64892064|NCT01986036|Calcium|calcium|mesh-list
64892066|NCT01986036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892067|NCT01986049|Bupivacaine|bupivacaine|mesh-list
64892068|NCT01986049|Anesthetics, Local|anesthetics, local|mesh-ancestor
64892069|NCT01986049|Anesthetics|anesthetics|mesh-ancestor
64892070|NCT01986049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64892071|NCT01986049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892072|NCT01986049|Sensory System Agents|sensory system agents|mesh-ancestor
64892073|NCT01986049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64892074|NCT01986088|Sumatriptan|sumatriptan|mesh-list
64892075|NCT01986088|Eletriptan|eletriptan|mesh-list
64892076|NCT01986088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64892077|NCT01986088|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64892078|NCT01986088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64892079|NCT01986088|Serotonin Agents|serotonin agents|mesh-ancestor
64892080|NCT01986088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64892107|NCT01986283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64892108|NCT01986283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892109|NCT01986283|Analgesics|analgesics|mesh-ancestor
64892110|NCT01986283|Sensory System Agents|sensory system agents|mesh-ancestor
64892111|NCT01986283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64892112|NCT01986309|Lidocaine|lidocaine|mesh-list
64892113|NCT01986309|Anesthetics, Local|anesthetics, local|mesh-ancestor
64892114|NCT01986309|Anesthetics|anesthetics|mesh-ancestor
64892115|NCT01986309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64892116|NCT01986309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892117|NCT01986309|Sensory System Agents|sensory system agents|mesh-ancestor
64892118|NCT01986309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64892119|NCT01986309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64892168|NCT01986582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64892169|NCT01986582|Nasal Decongestants|nasal decongestants|mesh-ancestor
64892170|NCT01986582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64892171|NCT01986582|Respiratory System Agents|respiratory system agents|mesh-ancestor
64892172|NCT01986582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64892173|NCT01986582|Mydriatics|mydriatics|mesh-ancestor
64892231|NCT01986894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892232|NCT01986894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64892233|NCT01986894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892234|NCT01986894|Immunologic Factors|immunologic factors|mesh-ancestor
64892235|NCT01986894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64892236|NCT01986894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64892237|NCT01986894|Growth Substances|growth substances|mesh-ancestor
64892238|NCT01986894|Growth Inhibitors|growth inhibitors|mesh-ancestor
64892239|NCT01986894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64892240|NCT01986894|Leprostatic Agents|leprostatic agents|mesh-ancestor
64892241|NCT01986998|Methylprednisolone|methylprednisolone|mesh-list
64892242|NCT01986998|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64892243|NCT01986998|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64892244|NCT01986998|Prednisolone|prednisolone|mesh-list
64892245|NCT01986998|Prednisolone acetate|prednisolone acetate|mesh-list
64892246|NCT01986998|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64892247|NCT01986998|Prednisolone phosphate|prednisolone phosphate|mesh-list
64892248|NCT01986998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64892249|NCT01986998|Antiemetics|antiemetics|mesh-ancestor
64892250|NCT01986998|Autonomic Agents|autonomic agents|mesh-ancestor
64892251|NCT01986998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64892252|NCT01986998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892253|NCT01986998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64892254|NCT01986998|Glucocorticoids|glucocorticoids|mesh-ancestor
64892255|NCT01986998|Hormones|hormones|mesh-ancestor
64892256|NCT01986998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64892257|NCT01986998|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64892258|NCT01986998|Protective Agents|protective agents|mesh-ancestor
64892259|NCT01986998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64892260|NCT01986998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64892273|NCT01987128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64892274|NCT01987128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892275|NCT01987128|Sensory System Agents|sensory system agents|mesh-ancestor
64892276|NCT01987128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64892277|NCT01987154|Caseins|caseins|mesh-list
64892278|NCT01987154|Chelating Agents|chelating agents|mesh-ancestor
64371555|NCT05727371|Viscosupplements|viscosupplements|mesh-ancestor
64982993|NCT00120354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64892279|NCT01987154|Sequestering Agents|sequestering agents|mesh-ancestor
64892280|NCT01987154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892281|NCT01987167|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64892282|NCT01987167|Hormones|hormones|mesh-ancestor
64892283|NCT01987167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64892284|NCT01987167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892285|NCT01987297|Cytarabine|cytarabine|mesh-list
64892286|NCT01987297|Daunorubicin|daunorubicin|mesh-list
64892287|NCT01987297|Idarubicin|idarubicin|mesh-list
64892288|NCT01987297|Tretinoin|tretinoin|mesh-list
64892289|NCT01987297|Arsenic Trioxide|arsenic trioxide|mesh-list
64892290|NCT01987297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64892291|NCT01987297|Antimetabolites|antimetabolites|mesh-ancestor
64892292|NCT01987297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892293|NCT01987297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64892294|NCT01987297|Antiviral Agents|antiviral agents|mesh-ancestor
64892295|NCT01987297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64892305|NCT01987310|Atorvastatin|atorvastatin|mesh-list
64892324|NCT01987570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64660851|NCT01312844|Mydriatics|mydriatics|mesh-ancestor
64892325|NCT01987570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64892326|NCT01987570|Antioxidants|antioxidants|mesh-ancestor
64892327|NCT01987570|Protective Agents|protective agents|mesh-ancestor
64892328|NCT01987570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892330|NCT01987739|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64892331|NCT01987739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64892332|NCT01987739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64892333|NCT01987739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892334|NCT01987739|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64892335|NCT01987739|GABA Agonists|gaba agonists|mesh-ancestor
64892336|NCT01987739|GABA Agents|gaba agents|mesh-ancestor
64892337|NCT01987739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64371562|NCT03302039|Anesthetics|anesthetics|mesh-ancestor
64982994|NCT00120354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64982995|NCT00120354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64982997|NCT00399698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64982998|NCT00399698|Serotonin Agents|serotonin agents|mesh-ancestor
64982999|NCT00399698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64983000|NCT00399698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983001|NCT00399698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983002|NCT00399698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64983003|NCT00399698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64983004|NCT00399698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64892338|NCT01987739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892340|NCT01987804|Oxytocics|oxytocics|mesh-ancestor
64892341|NCT01987804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64892342|NCT01987804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892343|NCT01988077|Ipilimumab|ipilimumab|mesh-list
64892344|NCT01988077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64892345|NCT01988077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64892346|NCT01988077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64892347|NCT01988077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892348|NCT01988116|Calcitriol|calcitriol|mesh-list
64892349|NCT01988116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64892350|NCT01988116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892351|NCT01988116|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64892354|NCT01988116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64892368|NCT01988298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64892369|NCT01988298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64892370|NCT01988298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64892371|NCT01988298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892372|NCT01988311|Psilocybin|psilocybin|mesh-list
64892373|NCT01988311|Hallucinogens|hallucinogens|mesh-ancestor
64892374|NCT01988311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892375|NCT01988311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64892376|NCT01988428|Ceftriaxone|ceftriaxone|mesh-list
64892377|NCT01988428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64892378|NCT01988428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64892379|NCT01988506|Interleukin-2|interleukin-2|mesh-list
64892380|NCT01988506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64892381|NCT01988506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64892382|NCT01988506|Analgesics|analgesics|mesh-ancestor
64892383|NCT01988506|Sensory System Agents|sensory system agents|mesh-ancestor
64892384|NCT01988506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64892386|NCT01988545|Exenatide|exenatide|mesh-list
64892426|NCT01988896|Atezolizumab|atezolizumab|mesh-list
64892427|NCT01988896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983005|NCT00399698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64983006|NCT00399698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64983007|NCT00399698|Dopamine Agents|dopamine agents|mesh-ancestor
64983008|NCT00303589|Lactams|lactams|mesh-list
64983009|NCT00303589|beta-Lactams|beta-lactams|mesh-list
64983010|NCT00303589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64983011|NCT00303589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64892428|NCT01988961|Golimumab|golimumab|mesh-list
64892429|NCT01988961|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64892430|NCT01988961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64892431|NCT01988961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64892432|NCT01988961|Immunologic Factors|immunologic factors|mesh-ancestor
64892433|NCT01988961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892434|NCT01989000|Gemcitabine|gemcitabine|mesh-list
64892435|NCT01989000|Imidazole|imidazole|mesh-list
64892436|NCT01989000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64892437|NCT01989000|Antimetabolites|antimetabolites|mesh-ancestor
64892440|NCT01989000|Antiviral Agents|antiviral agents|mesh-ancestor
64892487|NCT01989312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64892488|NCT01989312|Anesthetics, General|anesthetics, general|mesh-ancestor
64892489|NCT01989312|GABA Modulators|gaba modulators|mesh-ancestor
64892490|NCT01989312|GABA Agents|gaba agents|mesh-ancestor
64892491|NCT01989312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64892492|NCT01989312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64892493|NCT01989312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64892494|NCT01989312|Adrenergic Agents|adrenergic agents|mesh-ancestor
64892495|NCT01989312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64892496|NCT01989312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64892497|NCT01989312|Autonomic Agents|autonomic agents|mesh-ancestor
64892498|NCT01989312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64892499|NCT01989312|Respiratory System Agents|respiratory system agents|mesh-ancestor
64892500|NCT01989312|Mydriatics|mydriatics|mesh-ancestor
64892501|NCT01989312|Sympathomimetics|sympathomimetics|mesh-ancestor
64892502|NCT01989312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64892503|NCT01989416|Chlorhexidine|chlorhexidine|mesh-list
64892504|NCT01989416|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64892505|NCT01989416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64892506|NCT01989416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64371569|NCT03302039|Autonomic Agents|autonomic agents|mesh-ancestor
64983012|NCT00081848|Metronidazole|metronidazole|mesh-list
64983013|NCT00081848|Celecoxib|celecoxib|mesh-list
64983036|NCT00120432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64983037|NCT00120432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983038|NCT00120432|Sympathomimetics|sympathomimetics|mesh-ancestor
64983039|NCT00120432|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64983040|NCT00120432|Nasal Decongestants|nasal decongestants|mesh-ancestor
64983050|NCT00120432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64983092|NCT00304018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983093|NCT00304018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64983094|NCT00304018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983095|NCT00304018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64983096|NCT00304018|Antimetabolites|antimetabolites|mesh-ancestor
64983097|NCT00304018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983098|NCT00304018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64892507|NCT01989416|Disinfectants|disinfectants|mesh-ancestor
64892544|NCT01989676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64892545|NCT01989676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64892546|NCT01989676|Tubulin Modulators|tubulin modulators|mesh-ancestor
64892547|NCT01989676|Antimitotic Agents|antimitotic agents|mesh-ancestor
64892548|NCT01989676|Mitosis Modulators|mitosis modulators|mesh-ancestor
64892549|NCT01989676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892613|NCT01990118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892614|NCT01990118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64892615|NCT01990118|Immunologic Factors|immunologic factors|mesh-ancestor
64892616|NCT01990118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892617|NCT01990118|Antifungal Agents|antifungal agents|mesh-ancestor
64892618|NCT01990118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64892619|NCT01990118|Dermatologic Agents|dermatologic agents|mesh-ancestor
64892620|NCT01990118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64892621|NCT01990118|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64892622|NCT01990144|Rituximab|rituximab|mesh-list
64892648|NCT01990443|Reslizumab|reslizumab|mesh-list
64892675|NCT01990755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892676|NCT01990755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64892677|NCT01990755|Serotonin Agents|serotonin agents|mesh-ancestor
64892678|NCT01990755|Anticonvulsants|anticonvulsants|mesh-ancestor
64892679|NCT01990781|Dexamethasone|dexamethasone|mesh-list
64892734|NCT01991028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64892735|NCT01991054|Vitamin D|vitamin d|mesh-list
64892791|NCT01991288|Bupivacaine|bupivacaine|mesh-list
64892792|NCT01991288|Levobupivacaine|levobupivacaine|mesh-list
64892793|NCT01991288|Epinephryl borate|epinephryl borate|mesh-list
64892794|NCT01991288|Anesthetics, Local|anesthetics, local|mesh-ancestor
64892795|NCT01991288|Anesthetics|anesthetics|mesh-ancestor
64892796|NCT01991288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64892797|NCT01991288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892798|NCT01991288|Sensory System Agents|sensory system agents|mesh-ancestor
64892799|NCT01991288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64892800|NCT01991288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64892801|NCT01991288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64892802|NCT01991288|Adrenergic Agents|adrenergic agents|mesh-ancestor
64892803|NCT01991288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64892804|NCT01991288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892805|NCT01991288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64892806|NCT01991288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64892807|NCT01991288|Autonomic Agents|autonomic agents|mesh-ancestor
64892808|NCT01991288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64892809|NCT01991288|Respiratory System Agents|respiratory system agents|mesh-ancestor
64892810|NCT01991288|Mydriatics|mydriatics|mesh-ancestor
64892811|NCT01991288|Sympathomimetics|sympathomimetics|mesh-ancestor
64892812|NCT01991288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64892813|NCT01991327|Enclomiphene|enclomiphene|mesh-list
64892814|NCT01991327|Clomiphene|clomiphene|mesh-list
64892815|NCT01991327|Zuclomiphene|zuclomiphene|mesh-list
64892816|NCT01991327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64892817|NCT01991327|Hormone Antagonists|hormone antagonists|mesh-ancestor
64892841|NCT01991587|Immunologic Factors|immunologic factors|mesh-ancestor
64892842|NCT01991587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892843|NCT01991626|Iron|iron|mesh-list
64892917|NCT01992211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64892930|NCT01992328|Antibodies|antibodies|mesh-list
64892931|NCT01992328|Immunoglobulin G|immunoglobulin g|mesh-list
64892932|NCT01992328|gamma-Globulins|gamma-globulins|mesh-list
64892933|NCT01992328|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64892934|NCT01992328|Immunologic Factors|immunologic factors|mesh-ancestor
64892935|NCT01992328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892936|NCT01992341|Paclitaxel|paclitaxel|mesh-list
64892937|NCT01992341|Trebananib|trebananib|mesh-list
64892938|NCT01992341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64892939|NCT01992341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64892940|NCT01992341|Tubulin Modulators|tubulin modulators|mesh-ancestor
64892966|NCT01992588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64892967|NCT01992588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892969|NCT01992601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64892970|NCT01992601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64892971|NCT01992601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64892972|NCT01992601|Antimetabolites|antimetabolites|mesh-ancestor
64892973|NCT01992601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892974|NCT01992601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64892975|NCT01992601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64892976|NCT01992601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64892977|NCT01992601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64892978|NCT01992601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64892979|NCT01992601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64892980|NCT01992705|Fluorouracil|fluorouracil|mesh-list
64892981|NCT01992705|Oxaliplatin|oxaliplatin|mesh-list
64371652|NCT05726903|Contraceptive Agents|contraceptive agents|mesh-ancestor
64371653|NCT05726903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64983099|NCT00304018|Immunologic Factors|immunologic factors|mesh-ancestor
64983100|NCT00304018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64983101|NCT00304018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64983102|NCT00304018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64983103|NCT00304018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983104|NCT00304018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64983105|NCT00304018|Alkylating Agents|alkylating agents|mesh-ancestor
64983106|NCT00304018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64983149|NCT00082043|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64983150|NCT00082043|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64983151|NCT00082043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983152|NCT00082043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983153|NCT00082043|Hormone Antagonists|hormone antagonists|mesh-ancestor
64983154|NCT00082043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64983155|NCT00082043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983156|NCT00304291|Mitoxantrone|mitoxantrone|mesh-list
64983157|NCT00304291|Analgesics|analgesics|mesh-ancestor
64983158|NCT00304291|Sensory System Agents|sensory system agents|mesh-ancestor
64892982|NCT01992705|Irinotecan|irinotecan|mesh-list
64892983|NCT01992705|Folfirinox|folfirinox|mesh-list
64892984|NCT01992705|Antimetabolites|antimetabolites|mesh-ancestor
64893024|NCT01993212|Fertility Agents|fertility agents|mesh-ancestor
64893025|NCT01993212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64893026|NCT01993212|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64893027|NCT01993212|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64893028|NCT01993225|Enclomiphene|enclomiphene|mesh-list
64893029|NCT01993225|Testosterone|testosterone|mesh-list
64893030|NCT01993225|Androgens|androgens|mesh-ancestor
64893031|NCT01993225|Hormones|hormones|mesh-ancestor
64893032|NCT01993225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64893033|NCT01993225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893034|NCT01993225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64893035|NCT01993225|Hormone Antagonists|hormone antagonists|mesh-ancestor
64893036|NCT01993225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64893041|NCT01993251|Melatonin|melatonin|mesh-list
64893085|NCT01993472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64893086|NCT01993472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64893087|NCT01993472|Antiviral Agents|antiviral agents|mesh-ancestor
64893088|NCT01993472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64893089|NCT01993537|Vitamin D|vitamin d|mesh-list
64893090|NCT01993537|Vitamins|vitamins|mesh-ancestor
64893091|NCT01993537|Micronutrients|micronutrients|mesh-ancestor
64893092|NCT01993537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893132|NCT01994031|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64893133|NCT01994031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64893134|NCT01994031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64893135|NCT01994031|Tubulin Modulators|tubulin modulators|mesh-ancestor
64893136|NCT01994031|Antimitotic Agents|antimitotic agents|mesh-ancestor
64893137|NCT01994031|Mitosis Modulators|mitosis modulators|mesh-ancestor
64893138|NCT01994031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893139|NCT01994070|Procainamide|procainamide|mesh-list
64893140|NCT01994070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64893141|NCT01994070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64893142|NCT01994070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64893143|NCT01994070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64893144|NCT01994070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893145|NCT01994096|Caspofungin|caspofungin|mesh-list
64893146|NCT01994096|Antifungal Agents|antifungal agents|mesh-ancestor
64893147|NCT01994096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64893148|NCT01994096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64893149|NCT01994096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893150|NCT01994265|Warfarin|warfarin|mesh-list
64893151|NCT01994265|Dabigatran|dabigatran|mesh-list
64893159|NCT01994330|Hemostatics|hemostatics|mesh-ancestor
64893189|NCT01994642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64893190|NCT01994642|Protease Inhibitors|protease inhibitors|mesh-ancestor
64893191|NCT01994642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64893192|NCT01994642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893193|NCT01994642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64893194|NCT01994642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64893195|NCT01994642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64893196|NCT01994642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64893197|NCT01994642|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64893198|NCT01994642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64893199|NCT01994668|Lorazepam|lorazepam|mesh-list
64893214|NCT01994668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893215|NCT01994733|Calcium, Dietary|calcium, dietary|mesh-list
64893216|NCT01994733|Calcium Carbonate|calcium carbonate|mesh-list
64893218|NCT01994733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64893219|NCT01994733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893220|NCT01994733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64893221|NCT01994733|Antacids|antacids|mesh-ancestor
64893222|NCT01994733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893223|NCT01994733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64893224|NCT01994759|Methylprednisolone|methylprednisolone|mesh-list
64893225|NCT01994759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64893226|NCT01994759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64893227|NCT01994759|Antiemetics|antiemetics|mesh-ancestor
64893275|NCT01995019|Methylprednisolone|methylprednisolone|mesh-list
64893276|NCT01995019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64893277|NCT01995019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64893278|NCT01995019|Prednisolone|prednisolone|mesh-list
64893279|NCT01995019|Prednisolone acetate|prednisolone acetate|mesh-list
64893280|NCT01995019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64893281|NCT01995019|Prednisolone phosphate|prednisolone phosphate|mesh-list
64893344|NCT01995331|Immunologic Factors|immunologic factors|mesh-ancestor
64893345|NCT01995331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893346|NCT01995331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64893347|NCT01995331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64893348|NCT01995331|Alkylating Agents|alkylating agents|mesh-ancestor
64893349|NCT01995331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893350|NCT01995331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64893351|NCT01995331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64893396|NCT01995734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893397|NCT01995799|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64893398|NCT01995799|Hematinics|hematinics|mesh-ancestor
64893399|NCT01995799|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64893400|NCT01995799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64893401|NCT01995890|Nepafenac|nepafenac|mesh-list
64893402|NCT01995890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64893403|NCT01995890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64893404|NCT01995890|Analgesics|analgesics|mesh-ancestor
64893405|NCT01995890|Sensory System Agents|sensory system agents|mesh-ancestor
64893406|NCT01995890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893407|NCT01995890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893408|NCT01995890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64893409|NCT01995890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64893410|NCT01996085|Amlodipine|amlodipine|mesh-list
64893411|NCT01996085|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64893412|NCT01996085|Telmisartan|telmisartan|mesh-list
64893413|NCT01996085|Lisinopril|lisinopril|mesh-list
64893414|NCT01996085|Nebivolol|nebivolol|mesh-list
64893415|NCT01996085|Indapamide|indapamide|mesh-list
64893416|NCT01996085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64893417|NCT01996085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64893418|NCT01996085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64893419|NCT01996085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893420|NCT01996085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64893421|NCT01996085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893446|NCT01996306|Bevacizumab|bevacizumab|mesh-list
64893447|NCT01996306|Fluorouracil|fluorouracil|mesh-list
64371827|NCT03299387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64371828|NCT03299387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64893448|NCT01996306|Capecitabine|capecitabine|mesh-list
64893450|NCT01996306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64893451|NCT01996306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64893452|NCT01996306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64893453|NCT01996306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64893454|NCT01996306|Growth Substances|growth substances|mesh-ancestor
64893455|NCT01996306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893456|NCT01996306|Growth Inhibitors|growth inhibitors|mesh-ancestor
64893457|NCT01996306|Antimetabolites|antimetabolites|mesh-ancestor
64893458|NCT01996306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893459|NCT01996306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64893460|NCT01996306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64893461|NCT01996306|Immunologic Factors|immunologic factors|mesh-ancestor
64893462|NCT01996306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64893463|NCT01996306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64893464|NCT01996306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64893465|NCT01996306|Antidotes|antidotes|mesh-ancestor
64893466|NCT01996306|Protective Agents|protective agents|mesh-ancestor
64893467|NCT01996306|Vitamin B Complex|vitamin b complex|mesh-ancestor
64893499|NCT01996462|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64893500|NCT01996462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64893501|NCT01996462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64893502|NCT01996462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893503|NCT01996462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64893504|NCT01996462|Serotonin Agents|serotonin agents|mesh-ancestor
64893505|NCT01996462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893506|NCT01996462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64893507|NCT01996462|Antidepressive Agents|antidepressive agents|mesh-ancestor
64893508|NCT01996462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64893509|NCT01996462|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64893510|NCT01996462|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64893511|NCT01996462|Parasympatholytics|parasympatholytics|mesh-ancestor
64893512|NCT01996462|Autonomic Agents|autonomic agents|mesh-ancestor
64983159|NCT00304291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64983160|NCT00304291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983161|NCT00304291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983162|NCT00304291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64983163|NCT00304291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64983164|NCT00304291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64893513|NCT01996462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893514|NCT01996462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64893515|NCT01996462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64893516|NCT01996462|Cholinergic Agents|cholinergic agents|mesh-ancestor
64893518|NCT01996475|Citalopram|citalopram|mesh-list
64893519|NCT01996475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64893520|NCT01996475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64893521|NCT01996475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64893522|NCT01996475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893523|NCT01996475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64893524|NCT01996475|Serotonin Agents|serotonin agents|mesh-ancestor
64893525|NCT01996475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893526|NCT01996475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64893527|NCT01996475|Antidepressive Agents|antidepressive agents|mesh-ancestor
64893528|NCT01996475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64893541|NCT01996488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893542|NCT01996488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64893543|NCT01996488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64893544|NCT01996488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64893545|NCT01996488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64893546|NCT01996488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64893547|NCT01996488|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64893548|NCT01996488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64893549|NCT01996488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64893550|NCT01996488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893551|NCT01996488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64893552|NCT01996488|Serotonin Agents|serotonin agents|mesh-ancestor
64893553|NCT01996501|Olanzapine|olanzapine|mesh-list
64893601|NCT01996930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64893602|NCT01996930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983165|NCT00304291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983166|NCT00304369|Metronidazole|metronidazole|mesh-list
64983167|NCT00304369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983168|NCT00304369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64983169|NCT00304369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64983201|NCT00304681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64983202|NCT00304681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64983203|NCT00304681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983204|NCT00304681|Dopamine Agents|dopamine agents|mesh-ancestor
64983205|NCT00304681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64983206|NCT00304720|Tacrolimus|tacrolimus|mesh-list
64983207|NCT00304720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64893604|NCT01997099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64893605|NCT01997099|Anticonvulsants|anticonvulsants|mesh-ancestor
64893606|NCT01997099|Antiemetics|antiemetics|mesh-ancestor
64893607|NCT01997099|Autonomic Agents|autonomic agents|mesh-ancestor
64893608|NCT01997099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893609|NCT01997099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662132|NCT01373450|Hormones|hormones|mesh-ancestor
64893668|NCT01997294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64893669|NCT01997580|Citalopram|citalopram|mesh-list
64893670|NCT01997580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64893671|NCT01997580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64893672|NCT01997580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64893673|NCT01997580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893674|NCT01997580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64893675|NCT01997580|Serotonin Agents|serotonin agents|mesh-ancestor
64893676|NCT01997580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893677|NCT01997580|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64893678|NCT01997580|Antidepressive Agents|antidepressive agents|mesh-ancestor
64893679|NCT01997580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64893680|NCT01997593|Ropivacaine|ropivacaine|mesh-list
64893681|NCT01997593|Anesthetics, Local|anesthetics, local|mesh-ancestor
64893682|NCT01997593|Anesthetics|anesthetics|mesh-ancestor
64893683|NCT01997593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64893684|NCT01997593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893685|NCT01997593|Sensory System Agents|sensory system agents|mesh-ancestor
64893724|NCT01997788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893725|NCT01997788|Analgesics|analgesics|mesh-ancestor
64893726|NCT01997788|Sensory System Agents|sensory system agents|mesh-ancestor
64893727|NCT01997788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893728|NCT01997801|Ketamine|ketamine|mesh-list
64893738|NCT01997801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64893739|NCT01997801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64893740|NCT01997801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64893741|NCT01997801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893742|NCT01997814|Immunologic Factors|immunologic factors|mesh-list
64893743|NCT01997814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
64893744|NCT01997814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893745|NCT01997879|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64893746|NCT01997879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64893747|NCT01997944|Interferons|interferons|mesh-list
64893748|NCT01997944|Interferon-alpha|interferon-alpha|mesh-list
64893749|NCT01997944|Interferon alpha-2|interferon alpha-2|mesh-list
64893750|NCT01997944|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64893751|NCT01997944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64893752|NCT01997944|Antiviral Agents|antiviral agents|mesh-ancestor
64893753|NCT01997944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64893754|NCT01997944|Immunologic Factors|immunologic factors|mesh-ancestor
64893755|NCT01997944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893763|NCT01998113|Insulin|insulin|mesh-list
64893766|NCT01998113|Glyburide|glyburide|mesh-list
64893767|NCT01998113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64893768|NCT01998113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893769|NCT01998126|Nivolumab|nivolumab|mesh-list
64893831|NCT01998386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64893832|NCT01998451|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
64893833|NCT01998451|Antiviral Agents|antiviral agents|mesh-ancestor
64893834|NCT01998451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64893835|NCT01998451|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64893836|NCT01998451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64893837|NCT01998503|Dexamethasone|dexamethasone|mesh-list
64893838|NCT01998503|Bortezomib|bortezomib|mesh-list
64662351|NCT01335620|Tenofovir|tenofovir|mesh-list
64893839|NCT01998503|Melphalan|melphalan|mesh-list
64893840|NCT01998503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64893841|NCT01998503|Antiemetics|antiemetics|mesh-ancestor
64893842|NCT01998503|Autonomic Agents|autonomic agents|mesh-ancestor
64893875|NCT01998685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64893876|NCT01998685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64893877|NCT01998685|GABA Modulators|gaba modulators|mesh-ancestor
64893878|NCT01998685|GABA Agents|gaba agents|mesh-ancestor
64893879|NCT01998685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64893880|NCT01998685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893881|NCT01998685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64893882|NCT01998685|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64893884|NCT01998698|Dipivefrin|dipivefrin|mesh-list
64893885|NCT01998698|Hyaluronic Acid|hyaluronic acid|mesh-list
64893886|NCT01998698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64893887|NCT01998698|Adrenergic Agents|adrenergic agents|mesh-ancestor
64893888|NCT01998698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64893889|NCT01998698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893890|NCT01998698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893891|NCT01998698|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64893933|NCT01999153|Sensory System Agents|sensory system agents|mesh-ancestor
64893935|NCT01999270|Bevacizumab|bevacizumab|mesh-list
64893991|NCT01999686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893992|NCT01999738|Folic Acid|folic acid|mesh-list
64893993|NCT01999738|Hematinics|hematinics|mesh-ancestor
64893994|NCT01999738|Vitamin B Complex|vitamin b complex|mesh-ancestor
64893995|NCT01999738|Vitamins|vitamins|mesh-ancestor
64893996|NCT01999738|Micronutrients|micronutrients|mesh-ancestor
64893997|NCT01999738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893998|NCT01999829|Caffeine|caffeine|mesh-list
64893999|NCT01999829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894000|NCT01999829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64894001|NCT01999829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894002|NCT01999829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64894003|NCT01999829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64894004|NCT01999829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64894005|NCT01999829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64894006|NCT01999829|Purinergic Agents|purinergic agents|mesh-ancestor
64894007|NCT01999829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64894008|NCT01999842|Vaccines|vaccines|mesh-list
64894009|NCT01999842|Immunologic Factors|immunologic factors|mesh-ancestor
64894010|NCT01999842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894011|NCT01999907|Vitamin D|vitamin d|mesh-list
64894012|NCT01999907|Ergocalciferols|ergocalciferols|mesh-list
64894044|NCT02000206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64894045|NCT02000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64894046|NCT02000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894047|NCT02000206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64894048|NCT02000206|Anesthetics, General|anesthetics, general|mesh-ancestor
64894174|NCT02001168|Tubulin Modulators|tubulin modulators|mesh-ancestor
64894175|NCT02001168|Antimitotic Agents|antimitotic agents|mesh-ancestor
64894176|NCT02001168|Mitosis Modulators|mitosis modulators|mesh-ancestor
64894177|NCT02001168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894178|NCT02001168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64894179|NCT02001168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64894180|NCT02001168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64894181|NCT02001168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64894182|NCT02001168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64894183|NCT02001168|Growth Substances|growth substances|mesh-ancestor
64894184|NCT02001168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894185|NCT02001168|Growth Inhibitors|growth inhibitors|mesh-ancestor
64894186|NCT02001207|Hydrocortisone|hydrocortisone|mesh-list
64894187|NCT02001207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64894188|NCT02001259|Lidocaine|lidocaine|mesh-list
64894189|NCT02001259|Anesthetics, Local|anesthetics, local|mesh-ancestor
64894190|NCT02001259|Anesthetics|anesthetics|mesh-ancestor
64894191|NCT02001259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64894192|NCT02001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894193|NCT02001259|Sensory System Agents|sensory system agents|mesh-ancestor
64894194|NCT02001259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894195|NCT02001259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64894219|NCT02001298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64894220|NCT02001298|Narcotics|narcotics|mesh-ancestor
64894278|NCT02001584|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64894279|NCT02001584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64894280|NCT02001584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894281|NCT02001584|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64894282|NCT02001584|GABA Agonists|gaba agonists|mesh-ancestor
64894284|NCT02001740|Lidocaine|lidocaine|mesh-list
64894285|NCT02001740|Anesthetics, Local|anesthetics, local|mesh-ancestor
64894286|NCT02001740|Anesthetics|anesthetics|mesh-ancestor
64894334|NCT02001896|Immunologic Factors|immunologic factors|mesh-ancestor
64894335|NCT02001896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894336|NCT02001896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64894338|NCT02001909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64894339|NCT02001909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64894340|NCT02001909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64894341|NCT02001909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64894342|NCT02001909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894343|NCT02001935|Theophylline|theophylline|mesh-list
64894344|NCT02001935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64894345|NCT02001935|Autonomic Agents|autonomic agents|mesh-ancestor
64894346|NCT02001935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894347|NCT02001935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894348|NCT02001935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64894349|NCT02001935|Respiratory System Agents|respiratory system agents|mesh-ancestor
64894350|NCT02001935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64894351|NCT02001935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64894352|NCT02001935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894353|NCT02001935|Vasodilator Agents|vasodilator agents|mesh-ancestor
64894354|NCT02001935|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64894355|NCT02001935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64894356|NCT02001935|Purinergic Agents|purinergic agents|mesh-ancestor
64894357|NCT02001935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64894358|NCT02001948|Morphine|morphine|mesh-list
64894359|NCT02001948|Bupivacaine|bupivacaine|mesh-list
64894360|NCT02001948|Anesthetics, Local|anesthetics, local|mesh-ancestor
64894361|NCT02001948|Anesthetics|anesthetics|mesh-ancestor
64983208|NCT00304720|Immunologic Factors|immunologic factors|mesh-ancestor
64983209|NCT00304720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894362|NCT02001948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64894363|NCT02001948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894378|NCT02002000|Vitamins|vitamins|mesh-ancestor
64894379|NCT02002000|Micronutrients|micronutrients|mesh-ancestor
64894380|NCT02002000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894381|NCT02002000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64894382|NCT02002000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64894383|NCT02002039|Epoetin Alfa|epoetin alfa|mesh-list
64894384|NCT02002039|Hematinics|hematinics|mesh-ancestor
64894385|NCT02002065|Vaccines|vaccines|mesh-list
64894386|NCT02002065|Immunologic Factors|immunologic factors|mesh-ancestor
64894387|NCT02002065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894388|NCT02002078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64894389|NCT02002078|Methylprednisolone|methylprednisolone|mesh-list
64894390|NCT02002078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64894391|NCT02002078|Prednisolone|prednisolone|mesh-list
64894392|NCT02002078|Prednisolone acetate|prednisolone acetate|mesh-list
64894393|NCT02002078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64894394|NCT02002078|Prednisolone phosphate|prednisolone phosphate|mesh-list
64894395|NCT02002078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64894396|NCT02002078|Antiemetics|antiemetics|mesh-ancestor
64894397|NCT02002078|Autonomic Agents|autonomic agents|mesh-ancestor
64894398|NCT02002078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894399|NCT02002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894400|NCT02002078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64894401|NCT02002078|Glucocorticoids|glucocorticoids|mesh-ancestor
64894402|NCT02002078|Hormones|hormones|mesh-ancestor
64894404|NCT02002078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64894430|NCT02002247|Selenium|selenium|mesh-list
64894431|NCT02002247|Selenious Acid|selenious acid|mesh-list
64894432|NCT02002247|Sodium Selenite|sodium selenite|mesh-list
64894433|NCT02002247|Antioxidants|antioxidants|mesh-ancestor
64894434|NCT02002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894435|NCT02002247|Protective Agents|protective agents|mesh-ancestor
64894436|NCT02002247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894437|NCT02002247|Trace Elements|trace elements|mesh-ancestor
64894438|NCT02002247|Micronutrients|micronutrients|mesh-ancestor
64894493|NCT02002442|Chlorhexidine|chlorhexidine|mesh-list
64894494|NCT02002442|Cetylpyridinium|cetylpyridinium|mesh-list
64894496|NCT02002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64894497|NCT02002442|Disinfectants|disinfectants|mesh-ancestor
64894498|NCT02002598|Dexamethasone|dexamethasone|mesh-list
64894499|NCT02002598|Dexamethasone acetate|dexamethasone acetate|mesh-list
64894500|NCT02002598|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64894501|NCT02002598|BB 1101|bb 1101|mesh-list
64894502|NCT02002598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64894503|NCT02002598|Antiemetics|antiemetics|mesh-ancestor
64894504|NCT02002598|Autonomic Agents|autonomic agents|mesh-ancestor
64894505|NCT02002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894506|NCT02002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894507|NCT02002598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64894508|NCT02002598|Glucocorticoids|glucocorticoids|mesh-ancestor
64894509|NCT02002598|Hormones|hormones|mesh-ancestor
64894512|NCT02002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894554|NCT02002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894555|NCT02002715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64894556|NCT02002715|Respiratory System Agents|respiratory system agents|mesh-ancestor
64894557|NCT02002715|Glucocorticoids|glucocorticoids|mesh-ancestor
64894559|NCT02002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64894560|NCT02002741|Acetaminophen|acetaminophen|mesh-list
64894561|NCT02002741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64894562|NCT02002741|Analgesics|analgesics|mesh-ancestor
64894563|NCT02002741|Sensory System Agents|sensory system agents|mesh-ancestor
64894564|NCT02002741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894565|NCT02002741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894566|NCT02002741|Antipyretics|antipyretics|mesh-ancestor
64894567|NCT02002754|Bambuterol|bambuterol|mesh-list
64894568|NCT02002754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64894569|NCT02002754|Autonomic Agents|autonomic agents|mesh-ancestor
64894570|NCT02002754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894574|NCT02002806|Ethanol|ethanol|mesh-list
64894608|NCT02003001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64894609|NCT02003001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64894611|NCT02003001|Cholinergic Agents|cholinergic agents|mesh-ancestor
64894619|NCT02003209|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
64894620|NCT02003209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64894621|NCT02003209|Antibodies|antibodies|mesh-list
64894622|NCT02003209|Immunoglobulins|immunoglobulins|mesh-list
64894623|NCT02003209|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64894624|NCT02003209|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64894625|NCT02003209|Immunologic Factors|immunologic factors|mesh-ancestor
64894626|NCT02003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894627|NCT02003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894628|NCT02003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
64894629|NCT02003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
64894630|NCT02003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
64894631|NCT02003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894632|NCT02003209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64894633|NCT02003209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64894634|NCT02003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64894635|NCT02003209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64894636|NCT02003209|Hormone Antagonists|hormone antagonists|mesh-ancestor
64894637|NCT02003209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64894652|NCT02003664|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64894653|NCT02003664|GABA Agonists|gaba agonists|mesh-ancestor
64894654|NCT02003664|GABA Agents|gaba agents|mesh-ancestor
64894655|NCT02003664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64894656|NCT02003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894657|NCT02003677|Insulin|insulin|mesh-list
64894658|NCT02003677|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64894659|NCT02003677|Insulin Aspart|insulin aspart|mesh-list
64894660|NCT02003677|Insulin, Long-Acting|insulin, long-acting|mesh-list
64894661|NCT02003677|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64894662|NCT02003677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64894663|NCT02003677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894664|NCT02003768|Propofol|propofol|mesh-list
64894665|NCT02003768|Desflurane|desflurane|mesh-list
64894666|NCT02003768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64894670|NCT02003768|Anesthetics, General|anesthetics, general|mesh-ancestor
64894708|NCT02004184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64894709|NCT02004184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64894710|NCT02004197|Amoxicillin|amoxicillin|mesh-list
64894711|NCT02004197|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
64894712|NCT02004197|Bismuth|bismuth|mesh-list
64894713|NCT02004197|Ranitidine|ranitidine|mesh-list
64894714|NCT02004197|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
64894715|NCT02004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894716|NCT02004197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64894717|NCT02004197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64894718|NCT02004197|Antacids|antacids|mesh-ancestor
64894719|NCT02004197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64894720|NCT02004197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64894721|NCT02004197|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64894722|NCT02004197|Histamine Antagonists|histamine antagonists|mesh-ancestor
64894771|NCT02004652|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64894772|NCT02004652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64894773|NCT02004652|Serotonin Agents|serotonin agents|mesh-ancestor
64894774|NCT02004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64894775|NCT02004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894776|NCT02004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894777|NCT02004769|Docetaxel|docetaxel|mesh-list
64894778|NCT02004769|Capecitabine|capecitabine|mesh-list
64894779|NCT02004769|Trastuzumab|trastuzumab|mesh-list
64894780|NCT02004769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894781|NCT02004769|Tubulin Modulators|tubulin modulators|mesh-ancestor
64894782|NCT02004769|Antimitotic Agents|antimitotic agents|mesh-ancestor
64894783|NCT02004769|Mitosis Modulators|mitosis modulators|mesh-ancestor
64894784|NCT02004769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894785|NCT02004769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64372154|NCT04562597|Protective Agents|protective agents|mesh-ancestor
64447950|NCT01896531|Leucovorin|leucovorin|mesh-list
64983210|NCT00304720|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64983211|NCT00304720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983212|NCT00304720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983213|NCT00082199|Aripiprazole|aripiprazole|mesh-list
64983261|NCT00304993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983262|NCT00304993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64983281|NCT00082277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983282|NCT00082277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64983283|NCT00082277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64983284|NCT00082277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64983285|NCT00082277|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64894791|NCT02004782|Hormones|hormones|mesh-ancestor
64894829|NCT02005107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64894830|NCT02005107|Antidepressive Agents|antidepressive agents|mesh-ancestor
64894831|NCT02005107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64894833|NCT02005120|Endostatins|endostatins|mesh-list
64894834|NCT02005120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64894835|NCT02005120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894836|NCT02005120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64894841|NCT02005302|Vitamin D|vitamin d|mesh-list
64663412|NCT02429934|Abatacept|abatacept|mesh-list
64894897|NCT02005575|Hormones|hormones|mesh-ancestor
64894898|NCT02005575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64894899|NCT02005575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64894900|NCT02005575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894901|NCT02005575|Anesthetics, Local|anesthetics, local|mesh-ancestor
64894902|NCT02005575|Anesthetics|anesthetics|mesh-ancestor
64894903|NCT02005575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64894904|NCT02005575|Sensory System Agents|sensory system agents|mesh-ancestor
64894905|NCT02005588|Iron|iron|mesh-list
64894906|NCT02005588|Ferrous fumarate|ferrous fumarate|mesh-list
64894907|NCT02005588|Iron Chelating Agents|iron chelating agents|mesh-list
64894908|NCT02005588|Trace Elements|trace elements|mesh-ancestor
64894909|NCT02005588|Micronutrients|micronutrients|mesh-ancestor
64894910|NCT02005588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894911|NCT02005588|Chelating Agents|chelating agents|mesh-ancestor
64894912|NCT02005588|Sequestering Agents|sequestering agents|mesh-ancestor
64894913|NCT02005588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894914|NCT02005653|Doxycycline|doxycycline|mesh-list
64894915|NCT02005653|Albendazole|albendazole|mesh-list
64894916|NCT02005653|Diethylcarbamazine|diethylcarbamazine|mesh-list
64894917|NCT02005653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64894951|NCT02005757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64894952|NCT02005757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64894953|NCT02005757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64894954|NCT02005757|Antimalarials|antimalarials|mesh-ancestor
64894955|NCT02005757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64894956|NCT02005757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64894957|NCT02005757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372192|NCT05723367|Anesthetics|anesthetics|mesh-list
64894959|NCT02005757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64894960|NCT02005757|Immunologic Factors|immunologic factors|mesh-ancestor
64894961|NCT02005770|Propofol|propofol|mesh-list
64894962|NCT02005770|Sevoflurane|sevoflurane|mesh-list
64894963|NCT02005770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64894964|NCT02005770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64894965|NCT02005770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894966|NCT02005770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64894967|NCT02005770|Anesthetics, General|anesthetics, general|mesh-ancestor
64894968|NCT02005770|Anesthetics|anesthetics|mesh-ancestor
64894969|NCT02005770|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64894970|NCT02005770|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64894971|NCT02005783|Cyclophosphamide|cyclophosphamide|mesh-list
64894972|NCT02005783|Docetaxel|docetaxel|mesh-list
64663503|NCT02735187|Vitamin D|vitamin d|mesh-list
64894973|NCT02005783|Epirubicin|epirubicin|mesh-list
64894974|NCT02005783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64895002|NCT02006043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64895003|NCT02006043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64895004|NCT02006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895005|NCT02006173|Lidocaine|lidocaine|mesh-list
64895006|NCT02006173|Anesthetics, Local|anesthetics, local|mesh-ancestor
64895007|NCT02006173|Anesthetics|anesthetics|mesh-ancestor
64895008|NCT02006173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64895017|NCT02006225|Plerixafor|plerixafor|mesh-list
64895057|NCT02006602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64895058|NCT02006602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64895059|NCT02006602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895060|NCT02006745|Ribavirin|ribavirin|mesh-list
64895061|NCT02006745|Antimetabolites|antimetabolites|mesh-ancestor
64895062|NCT02006745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895063|NCT02006745|Antiviral Agents|antiviral agents|mesh-ancestor
64895064|NCT02006745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64895065|NCT02006849|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64895066|NCT02006849|Hormones|hormones|mesh-ancestor
64895069|NCT02006914|Chromium|chromium|mesh-list
64895105|NCT02007161|Diclofenac|diclofenac|mesh-list
64895106|NCT02007161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64895107|NCT02007161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64895108|NCT02007161|Analgesics|analgesics|mesh-ancestor
64895109|NCT02007161|Sensory System Agents|sensory system agents|mesh-ancestor
64895110|NCT02007161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895111|NCT02007161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895112|NCT02007161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64895113|NCT02007161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64895114|NCT02007161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64895115|NCT02007161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64895116|NCT02007161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895117|NCT02007174|Bevacizumab|bevacizumab|mesh-list
64895118|NCT02007174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64895119|NCT02007174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895120|NCT02007174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64895121|NCT02007174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64895155|NCT02007603|Clavulanic Acid|clavulanic acid|mesh-list
64895156|NCT02007603|Ampicillin|ampicillin|mesh-list
64895157|NCT02007603|Sulbactam|sulbactam|mesh-list
64895158|NCT02007603|Sultamicillin|sultamicillin|mesh-list
64895159|NCT02007603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64895160|NCT02007603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64895161|NCT02007603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64895162|NCT02007603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895163|NCT02007603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64895164|NCT02007629|Riociguat|riociguat|mesh-list
64895165|NCT02007629|Enzyme Activators|enzyme activators|mesh-ancestor
64895166|NCT02007629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895167|NCT02007746|Liver Extracts|liver extracts|mesh-list
64895168|NCT02007746|Hematinics|hematinics|mesh-ancestor
64895169|NCT02007798|Dexmedetomidine|dexmedetomidine|mesh-list
64895170|NCT02007798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64895171|NCT02007798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64895172|NCT02007798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895173|NCT02007798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64895174|NCT02007798|Analgesics|analgesics|mesh-ancestor
64895175|NCT02007798|Sensory System Agents|sensory system agents|mesh-ancestor
64895176|NCT02007798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895177|NCT02007798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64895178|NCT02007798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64895194|NCT02007837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895195|NCT02007837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64895196|NCT02007837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64895198|NCT02007837|Antipyretics|antipyretics|mesh-ancestor
64895199|NCT02007850|Ropivacaine|ropivacaine|mesh-list
64895271|NCT02008136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895272|NCT02008136|Cholinergic Agents|cholinergic agents|mesh-ancestor
64895273|NCT02008136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64895274|NCT02008136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895275|NCT02008162|Bromides|bromides|mesh-list
64895276|NCT02008162|Albuterol|albuterol|mesh-list
64895277|NCT02008162|Tiotropium Bromide|tiotropium bromide|mesh-list
64895278|NCT02008162|Bronchodilator Agents|bronchodilator agents|mesh-list
64895279|NCT02008162|Autonomic Agents|autonomic agents|mesh-ancestor
64895280|NCT02008162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895281|NCT02008162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895308|NCT02008214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895309|NCT02008214|Vasodilator Agents|vasodilator agents|mesh-ancestor
64895310|NCT02008214|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64895311|NCT02008214|Antioxidants|antioxidants|mesh-ancestor
64895312|NCT02008383|Panitumumab|panitumumab|mesh-list
64895313|NCT02008383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64895314|NCT02008383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895315|NCT02008422|Oxaliplatin|oxaliplatin|mesh-list
64895316|NCT02008422|Tegafur|tegafur|mesh-list
64895317|NCT02008422|Endostar protein|endostar protein|mesh-list
64895318|NCT02008422|Endostatins|endostatins|mesh-list
64895372|NCT02008786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64895373|NCT02008786|Protease Inhibitors|protease inhibitors|mesh-ancestor
64895374|NCT02008786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64895376|NCT02008968|Antimetabolites|antimetabolites|mesh-ancestor
64895377|NCT02008968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895378|NCT02008968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64895379|NCT02008968|Gout Suppressants|gout suppressants|mesh-ancestor
64895380|NCT02008968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64895381|NCT02008968|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64895382|NCT02008968|Antioxidants|antioxidants|mesh-ancestor
64895393|NCT02008981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64895394|NCT02008981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64895395|NCT02008981|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64895396|NCT02008981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64895405|NCT02009007|Dopamine|dopamine|mesh-list
64895422|NCT02009007|Protective Agents|protective agents|mesh-ancestor
64895425|NCT02009098|Cefuroxime axetil|cefuroxime axetil|mesh-list
64895426|NCT02009098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64895427|NCT02009098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64895428|NCT02009189|Taurolidine|taurolidine|mesh-list
64895429|NCT02009189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64895430|NCT02009189|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64895431|NCT02009189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895432|NCT02009202|Picosulfate sodium|picosulfate sodium|mesh-list
64895490|NCT05778227|Acetic Acid|acetic acid|mesh-list
64895491|NCT05778227|Sodium Hypochlorite|sodium hypochlorite|mesh-list
64895492|NCT05778227|Eusol|eusol|mesh-list
64895493|NCT05778227|Retinol acetate|retinol acetate|mesh-list
64895494|NCT05778227|Ethylene|ethylene|mesh-list
64664013|NCT01489826|HU 211|hu 211|mesh-list
64895495|NCT05778227|Maleic acid|maleic acid|mesh-list
64895497|NCT05778227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64895498|NCT05778227|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64895499|NCT05778227|Immunologic Factors|immunologic factors|mesh-ancestor
64895500|NCT05778227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895501|NCT05778227|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64895502|NCT05778227|Protective Agents|protective agents|mesh-ancestor
64895503|NCT05778227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895504|NCT05778227|Disinfectants|disinfectants|mesh-ancestor
64895505|NCT05778227|Plant Growth Regulators|plant growth regulators|mesh-ancestor
64895506|NCT05778227|Growth Substances|growth substances|mesh-ancestor
64895507|NCT05778227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64895544|NCT05777707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895545|NCT05777707|Tubulin Modulators|tubulin modulators|mesh-ancestor
64895546|NCT05777707|Antimitotic Agents|antimitotic agents|mesh-ancestor
64895547|NCT05777707|Mitosis Modulators|mitosis modulators|mesh-ancestor
64895548|NCT05777707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895549|NCT05777694|Anesthetics|anesthetics|mesh-list
64895550|NCT05777694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64895551|NCT05777694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895552|NCT05777369|Prednisone|prednisone|mesh-list
64895553|NCT05777369|Cyclophosphamide|cyclophosphamide|mesh-list
64895554|NCT05777369|Rituximab|rituximab|mesh-list
64895555|NCT05777369|Vincristine|vincristine|mesh-list
64895556|NCT05777369|Mitoxantrone|mitoxantrone|mesh-list
64895557|NCT05777369|Vindesine|vindesine|mesh-list
64895558|NCT05777369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64895559|NCT05777369|Immunologic Factors|immunologic factors|mesh-ancestor
64895560|NCT05777369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895561|NCT05777369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64895562|NCT05777369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64895563|NCT05777369|Alkylating Agents|alkylating agents|mesh-ancestor
64895564|NCT05777369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895565|NCT05777369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895566|NCT05777369|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64895567|NCT05777369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64895568|NCT05777369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64895569|NCT05777369|Glucocorticoids|glucocorticoids|mesh-ancestor
64895570|NCT05777369|Hormones|hormones|mesh-ancestor
64895571|NCT05777369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64895577|NCT05777369|Analgesics|analgesics|mesh-ancestor
64895579|NCT05777369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895594|NCT05777122|Sensory System Agents|sensory system agents|mesh-ancestor
64895595|NCT05777122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895596|NCT05777122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64895597|NCT05777122|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64895598|NCT05777122|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64895599|NCT05777122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64895601|NCT05777109|Denosumab|denosumab|mesh-list
64895819|NCT05279690|Gout Suppressants|gout suppressants|mesh-ancestor
64895820|NCT05279690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64895821|NCT05279690|Tubulin Modulators|tubulin modulators|mesh-ancestor
64895866|NCT05138068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64895867|NCT05138068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895868|NCT05138068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64895869|NCT05138068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64895870|NCT05138068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64895871|NCT05138068|Adrenergic Agents|adrenergic agents|mesh-ancestor
64895872|NCT05121168|Bupivacaine|bupivacaine|mesh-list
64895873|NCT05121168|Anesthetics, Local|anesthetics, local|mesh-ancestor
64895874|NCT05121168|Anesthetics|anesthetics|mesh-ancestor
64895875|NCT05121168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64895876|NCT05121168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895877|NCT05121168|Sensory System Agents|sensory system agents|mesh-ancestor
64895878|NCT05121168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895879|NCT05103332|Amlodipine|amlodipine|mesh-list
64895880|NCT05103332|Olmesartan|olmesartan|mesh-list
64895881|NCT05103332|Indapamide|indapamide|mesh-list
64895882|NCT05103332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64895883|NCT05103332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64895884|NCT05103332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64895885|NCT05103332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895886|NCT05103332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64895887|NCT05103332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895888|NCT05103332|Vasodilator Agents|vasodilator agents|mesh-ancestor
64895889|NCT05103332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64895890|NCT05103332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64895891|NCT05103332|Diuretics|diuretics|mesh-ancestor
64895892|NCT05103332|Natriuretic Agents|natriuretic agents|mesh-ancestor
64895907|NCT05085873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64895908|NCT05085873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64895909|NCT05085873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64895910|NCT05085873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64895911|NCT05085873|Anesthetics, General|anesthetics, general|mesh-ancestor
64895912|NCT05085873|Anesthetics|anesthetics|mesh-ancestor
64895915|NCT05085873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64895916|NCT05085873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895917|NCT04983589|Pilocarpine|pilocarpine|mesh-list
64895918|NCT04983589|Miotics|miotics|mesh-ancestor
64895919|NCT04983589|Autonomic Agents|autonomic agents|mesh-ancestor
64895920|NCT04983589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895921|NCT04983589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895967|NCT04782830|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64895968|NCT04782830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64895969|NCT04782830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64895970|NCT04782830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64895976|NCT04782830|Autonomic Agents|autonomic agents|mesh-ancestor
64896103|NCT04221087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64896104|NCT04221087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896105|NCT04221087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64896106|NCT04221087|Glucocorticoids|glucocorticoids|mesh-ancestor
64896107|NCT04221087|Hormones|hormones|mesh-ancestor
64896108|NCT04221087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64896109|NCT04221087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64896110|NCT04221087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896111|NCT04200911|Sirolimus|sirolimus|mesh-list
64896112|NCT04200911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64896119|NCT04200911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896120|NCT04170348|Vitamin D|vitamin d|mesh-list
64896121|NCT04170348|Ergocalciferols|ergocalciferols|mesh-list
64896122|NCT04170348|Cholecalciferol|cholecalciferol|mesh-list
64896123|NCT04170348|Vitamins|vitamins|mesh-list
64896124|NCT04170348|Trientine|trientine|mesh-list
64896125|NCT04170348|Micronutrients|micronutrients|mesh-ancestor
64896126|NCT04170348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896127|NCT04170348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64896128|NCT04170348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64896129|NCT04170348|Chelating Agents|chelating agents|mesh-ancestor
64896130|NCT04170348|Sequestering Agents|sequestering agents|mesh-ancestor
64896131|NCT04170348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896132|NCT04112641|Niacinamide|niacinamide|mesh-list
64896133|NCT04112641|Niacin|niacin|mesh-list
64896134|NCT04112641|Nicotinic Acids|nicotinic acids|mesh-list
64896135|NCT04112641|Vitamin B Complex|vitamin b complex|mesh-ancestor
64896136|NCT04112641|Vitamins|vitamins|mesh-ancestor
64896137|NCT04112641|Micronutrients|micronutrients|mesh-ancestor
64896138|NCT04112641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896139|NCT04112641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64896140|NCT04112641|Antimetabolites|antimetabolites|mesh-ancestor
64896141|NCT04112641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896171|NCT04057898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64896172|NCT04057898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64896181|NCT04050280|Antimetabolites|antimetabolites|mesh-ancestor
64896182|NCT04050280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896183|NCT04050280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896184|NCT04050280|Antiviral Agents|antiviral agents|mesh-ancestor
64896185|NCT04050280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64896186|NCT04050280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64896187|NCT04050280|Immunologic Factors|immunologic factors|mesh-ancestor
64896188|NCT04050280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896189|NCT04050280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64896190|NCT04050280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64896191|NCT04018755|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64896192|NCT04018755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64896193|NCT03994731|Acetaminophen|acetaminophen|mesh-list
64896194|NCT03994731|Folic Acid|folic acid|mesh-list
64896195|NCT03994731|Fexofenadine|fexofenadine|mesh-list
64896196|NCT03994731|Methylprednisolone|methylprednisolone|mesh-list
64896197|NCT03994731|Methotrexate|methotrexate|mesh-list
64896198|NCT03994731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64896218|NCT03994731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64896220|NCT03994731|Autonomic Agents|autonomic agents|mesh-ancestor
64896221|NCT03994731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64896222|NCT03994731|Glucocorticoids|glucocorticoids|mesh-ancestor
64896223|NCT03994731|Hormones|hormones|mesh-ancestor
64896224|NCT03994731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64896225|NCT03994731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64896226|NCT03994731|Protective Agents|protective agents|mesh-ancestor
64896227|NCT03994731|Hematinics|hematinics|mesh-ancestor
64896228|NCT03994731|Vitamin B Complex|vitamin b complex|mesh-ancestor
64896229|NCT03994731|Vitamins|vitamins|mesh-ancestor
64896230|NCT03994731|Micronutrients|micronutrients|mesh-ancestor
64896231|NCT03994731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64896278|NCT03824522|BAX 855|bax 855|mesh-list
64896287|NCT03812991|Vasodilator Agents|vasodilator agents|mesh-ancestor
64896288|NCT03737968|Durvalumab|durvalumab|mesh-list
64896289|NCT03737968|Tremelimumab|tremelimumab|mesh-list
64896290|NCT03737968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64896292|NCT03737968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896340|NCT03461120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64896341|NCT03461120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896342|NCT03461120|Sensory System Agents|sensory system agents|mesh-ancestor
64896343|NCT03461120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64896345|NCT03459846|Olaparib|olaparib|mesh-list
64896346|NCT03459846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64896347|NCT03459846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896348|NCT03459846|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64896349|NCT03459846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64896350|NCT03459846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896351|NCT03452137|Atezolizumab|atezolizumab|mesh-list
64896352|NCT03452137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896353|NCT03396588|Clonidine|clonidine|mesh-list
64896354|NCT03396588|Morphine|morphine|mesh-list
64896355|NCT03396588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64896356|NCT03396588|Narcotics|narcotics|mesh-ancestor
64896357|NCT03396588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64896397|NCT03329508|Dopamine Agonists|dopamine agonists|mesh-ancestor
64896398|NCT03329508|Dopamine Agents|dopamine agents|mesh-ancestor
64896399|NCT03329508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64896400|NCT03329508|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64896401|NCT03329508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64896402|NCT03329508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64896403|NCT03325972|Dexmedetomidine|dexmedetomidine|mesh-list
64896404|NCT03325972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64896405|NCT03325972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64896418|NCT03319745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64896419|NCT03319745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896420|NCT03289039|Fulvestrant|fulvestrant|mesh-list
64896421|NCT03289039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64896422|NCT03289039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896423|NCT03289039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64896424|NCT03289039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64896425|NCT03289039|Hormone Antagonists|hormone antagonists|mesh-ancestor
64896426|NCT03289039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64896441|NCT03145272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64896442|NCT03145272|Narcotics|narcotics|mesh-ancestor
64896443|NCT03145272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64896444|NCT03145272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896445|NCT03145272|Analgesics|analgesics|mesh-ancestor
64896446|NCT03145272|Sensory System Agents|sensory system agents|mesh-ancestor
64896447|NCT03145272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64896448|NCT03127007|Atezolizumab|atezolizumab|mesh-list
64896449|NCT03127007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896450|NCT03109093|Blinatumomab|blinatumomab|mesh-list
64896451|NCT03109093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896452|NCT02830594|Pembrolizumab|pembrolizumab|mesh-list
64896453|NCT02830594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64896454|NCT02830594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896455|NCT02768701|Cyclophosphamide|cyclophosphamide|mesh-list
64896456|NCT02768701|Pembrolizumab|pembrolizumab|mesh-list
64896457|NCT02768701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64896458|NCT02768701|Immunologic Factors|immunologic factors|mesh-ancestor
64896459|NCT02768701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896460|NCT02768701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64896461|NCT02768701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64896462|NCT02768701|Alkylating Agents|alkylating agents|mesh-ancestor
64896463|NCT02768701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896464|NCT02768701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896465|NCT02768701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64896492|NCT02725060|Respiratory System Agents|respiratory system agents|mesh-ancestor
64896493|NCT02725060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64896494|NCT02725060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64896495|NCT02725060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64896496|NCT02725060|Adrenergic Agents|adrenergic agents|mesh-ancestor
64896497|NCT02725060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64896498|NCT02725060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896499|NCT02725060|Protective Agents|protective agents|mesh-ancestor
64896500|NCT02725060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64896501|NCT02725060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64896502|NCT02725060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64896503|NCT02691065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
64896504|NCT02691065|Integrase Inhibitors|integrase inhibitors|mesh-list
64896505|NCT02691065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64896506|NCT02691065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896507|NCT02691065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64896508|NCT02691065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64896509|NCT02691065|Antiviral Agents|antiviral agents|mesh-ancestor
64896510|NCT02691065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64896511|NCT02649998|Furosemide|furosemide|mesh-list
64896512|NCT02649998|Isosorbide|isosorbide|mesh-list
64896513|NCT02649998|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64896514|NCT02649998|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64896616|NCT02048813|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64896617|NCT02048813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64896618|NCT02048813|Immunologic Factors|immunologic factors|mesh-ancestor
64896619|NCT02048813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896620|NCT02048813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64896621|NCT02048813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64896622|NCT02048813|Alkylating Agents|alkylating agents|mesh-ancestor
64896623|NCT02048813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896624|NCT02048813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896625|NCT02048813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64896626|NCT02048813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64896627|NCT02048813|Antimetabolites|antimetabolites|mesh-ancestor
64896644|NCT02038452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64896646|NCT02038452|Hormones|hormones|mesh-ancestor
64896647|NCT02038452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64896648|NCT02038452|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64896649|NCT02038452|Protective Agents|protective agents|mesh-ancestor
64896650|NCT02038452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64896651|NCT02038452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896652|NCT01933932|Docetaxel|docetaxel|mesh-list
64896653|NCT01933932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896658|NCT01898494|Cisplatin|cisplatin|mesh-list
64896721|NCT00978458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64896722|NCT00978458|Alkylating Agents|alkylating agents|mesh-ancestor
64896723|NCT00978458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896724|NCT00978458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896725|NCT00976963|Fosfomycin|fosfomycin|mesh-list
64896754|NCT00863369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64896755|NCT00600496|Sirolimus|sirolimus|mesh-list
64896756|NCT00600496|Docetaxel|docetaxel|mesh-list
64896757|NCT00600496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64896758|NCT00600496|Dacarbazine|dacarbazine|mesh-list
64896759|NCT00600496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896760|NCT00600496|Tubulin Modulators|tubulin modulators|mesh-ancestor
64896761|NCT00600496|Antimitotic Agents|antimitotic agents|mesh-ancestor
64896762|NCT00600496|Mitosis Modulators|mitosis modulators|mesh-ancestor
64896763|NCT00600496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896764|NCT00600496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64896765|NCT00600496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64896766|NCT00600496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64896879|NCT02009540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64896880|NCT02009592|Rifaximin|rifaximin|mesh-list
64896926|NCT02010411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896927|NCT02010437|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
64896928|NCT02010437|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64896929|NCT02010437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64896930|NCT02010723|Polidocanol|polidocanol|mesh-list
64896931|NCT02010723|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64896932|NCT02010723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64896934|NCT02010762|Vitamins|vitamins|mesh-ancestor
64896935|NCT02010762|Micronutrients|micronutrients|mesh-ancestor
64896936|NCT02010762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896937|NCT02010762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64896938|NCT02010788|Botulinum Toxins|botulinum toxins|mesh-list
64896939|NCT02010788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64896940|NCT02010788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64896941|NCT02010788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64896942|NCT02010788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64896985|NCT02010970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896986|NCT02010970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64896987|NCT02010970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64896988|NCT02010970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64896989|NCT02010970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64896990|NCT02010970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64896991|NCT02010970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64896992|NCT02010970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64896993|NCT02010970|Anesthetics, General|anesthetics, general|mesh-ancestor
64896994|NCT02010970|Anesthetics|anesthetics|mesh-ancestor
64896995|NCT02010970|GABA Modulators|gaba modulators|mesh-ancestor
64896996|NCT02010970|GABA Agents|gaba agents|mesh-ancestor
64896997|NCT02010970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64665507|NCT01447706|Paclitaxel|paclitaxel|mesh-list
64896998|NCT02010970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896999|NCT02010970|Antifungal Agents|antifungal agents|mesh-ancestor
64897000|NCT02010970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64897001|NCT02010970|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64897002|NCT02010970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64983286|NCT00305266|gamma-Globulins|gamma-globulins|mesh-list
64983287|NCT00305266|Immunologic Factors|immunologic factors|mesh-ancestor
64897003|NCT02010970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897004|NCT02010970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64897005|NCT02010970|Hormone Antagonists|hormone antagonists|mesh-ancestor
64897006|NCT02010970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64897007|NCT02010970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64897008|NCT02010970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64897009|NCT02010970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64897010|NCT02010970|Vasodilator Agents|vasodilator agents|mesh-ancestor
64897011|NCT02011126|Imetelstat|imetelstat|mesh-list
64897012|NCT02011126|Motesanib diphosphate|motesanib diphosphate|mesh-list
64897013|NCT02011126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897014|NCT02011126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897015|NCT02011126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64897017|NCT02011191|Vitamin B Complex|vitamin b complex|mesh-ancestor
64897018|NCT02011191|Vitamins|vitamins|mesh-ancestor
64897019|NCT02011191|Micronutrients|micronutrients|mesh-ancestor
64897020|NCT02011191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897021|NCT02011347|Ketamine|ketamine|mesh-list
64897022|NCT02011347|Analgesics|analgesics|mesh-ancestor
64897023|NCT02011347|Sensory System Agents|sensory system agents|mesh-ancestor
64897024|NCT02011347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64897025|NCT02011347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897026|NCT02011347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64897027|NCT02011347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64897028|NCT02011347|Anesthetics, General|anesthetics, general|mesh-ancestor
64897029|NCT02011347|Anesthetics|anesthetics|mesh-ancestor
64897030|NCT02011347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64897031|NCT02011347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64983288|NCT00305266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983289|NCT00082316|Capsaicin|capsaicin|mesh-list
64983290|NCT00082316|Antipruritics|antipruritics|mesh-ancestor
64983291|NCT00082316|Dermatologic Agents|dermatologic agents|mesh-ancestor
64983304|NCT00305422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983305|NCT00305422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983306|NCT00305422|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64983307|NCT00305422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64983308|NCT00305422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64983309|NCT00305422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64897032|NCT02011347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64897033|NCT02011347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64897035|NCT02011594|Nimotuzumab|nimotuzumab|mesh-list
64897078|NCT02011737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64897079|NCT02011737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64897080|NCT02011737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64897082|NCT02011750|Anticonvulsants|anticonvulsants|mesh-ancestor
64897083|NCT02011750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897084|NCT02011750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897085|NCT02011750|GABA Agents|gaba agents|mesh-ancestor
64897086|NCT02011750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64897087|NCT02011750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897088|NCT02011750|Antimanic Agents|antimanic agents|mesh-ancestor
64897188|NCT02012088|Alkylating Agents|alkylating agents|mesh-ancestor
64897189|NCT02012088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897190|NCT02012088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897191|NCT02012088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64897192|NCT02012088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64897195|NCT02012088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64897241|NCT02012309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897243|NCT02012322|Coenzyme Q10|coenzyme q10|mesh-list
64897244|NCT02012322|Micronutrients|micronutrients|mesh-ancestor
64897245|NCT02012322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897246|NCT02012322|Vitamins|vitamins|mesh-ancestor
64897247|NCT02012335|Ketamine|ketamine|mesh-list
64897248|NCT02012335|Analgesics|analgesics|mesh-ancestor
64897249|NCT02012335|Sensory System Agents|sensory system agents|mesh-ancestor
64897250|NCT02012335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64897251|NCT02012335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897252|NCT02012335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64897307|NCT02012920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897308|NCT02012920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64897309|NCT02012920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897310|NCT02012920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897311|NCT02012933|Amifampridine|amifampridine|mesh-list
64897312|NCT02012933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64897313|NCT02012933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64897314|NCT02012933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897315|NCT02012933|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64897316|NCT02012933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64897318|NCT02012946|Simendan|simendan|mesh-list
64897367|NCT02013115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897368|NCT02013115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64897369|NCT02013115|Respiratory System Agents|respiratory system agents|mesh-ancestor
64897371|NCT02013115|Hormones|hormones|mesh-ancestor
64372465|NCT02462525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983310|NCT00305422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64983311|NCT00305422|Dopamine Agents|dopamine agents|mesh-ancestor
64983312|NCT00305422|Antidepressive Agents|antidepressive agents|mesh-ancestor
64983313|NCT00305461|Ciclesonide|ciclesonide|mesh-list
64983314|NCT00305461|Glucocorticoids|glucocorticoids|mesh-ancestor
64983315|NCT00305461|Hormones|hormones|mesh-ancestor
64983316|NCT00305461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64983317|NCT00305461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897372|NCT02013115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64897373|NCT02013154|Paclitaxel|paclitaxel|mesh-list
64665884|NCT02633397|Riociguat|riociguat|mesh-list
64897374|NCT02013154|Pembrolizumab|pembrolizumab|mesh-list
64897375|NCT02013154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64897376|NCT02013154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897377|NCT02013154|Tubulin Modulators|tubulin modulators|mesh-ancestor
64897378|NCT02013154|Antimitotic Agents|antimitotic agents|mesh-ancestor
64897379|NCT02013154|Mitosis Modulators|mitosis modulators|mesh-ancestor
64897593|NCT02014558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64897594|NCT02014558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64897595|NCT02014558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64897596|NCT02014558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897597|NCT02014558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64897598|NCT02014558|Hormone Antagonists|hormone antagonists|mesh-ancestor
64897599|NCT02014558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64897600|NCT02014558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64897601|NCT02014558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64897602|NCT02014623|Histamine Antagonists|histamine antagonists|mesh-list
64897603|NCT02014623|Histamine Agents|histamine agents|mesh-ancestor
64897604|NCT02014623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64897605|NCT02014623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897606|NCT02014623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897607|NCT02014636|Pembrolizumab|pembrolizumab|mesh-list
64897608|NCT02014636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64897609|NCT02014636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897610|NCT02014714|Fentanyl|fentanyl|mesh-list
64897611|NCT02014714|Morphine|morphine|mesh-list
64897612|NCT02014714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64897613|NCT02014714|Narcotics|narcotics|mesh-ancestor
64897614|NCT02014714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64897615|NCT02014714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897616|NCT02014714|Analgesics|analgesics|mesh-ancestor
64897617|NCT02014714|Sensory System Agents|sensory system agents|mesh-ancestor
64897618|NCT02014714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64897619|NCT02014714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64897620|NCT02014714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64897622|NCT02014714|Anesthetics|anesthetics|mesh-ancestor
64897639|NCT02014831|Cetuximab|cetuximab|mesh-list
64897640|NCT02014831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64897641|NCT02014831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897642|NCT02014922|Vitamin E|vitamin e|mesh-list
64897643|NCT02014922|alpha-Tocopherol|alpha-tocopherol|mesh-list
64897644|NCT02014922|Tocopherols|tocopherols|mesh-list
64897645|NCT02014922|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64372478|NCT04111419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64983318|NCT00305461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64897646|NCT02014922|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64897647|NCT02014922|Lubricant Eye Drops|lubricant eye drops|mesh-list
64897648|NCT02014922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64897649|NCT02014922|Laxatives|laxatives|mesh-ancestor
64897650|NCT02014922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64897651|NCT02014922|Antioxidants|antioxidants|mesh-ancestor
64897652|NCT02014922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897653|NCT02014922|Protective Agents|protective agents|mesh-ancestor
64897654|NCT02014922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897655|NCT02014922|Vitamins|vitamins|mesh-ancestor
64897656|NCT02014922|Micronutrients|micronutrients|mesh-ancestor
64897657|NCT02015156|Trastuzumab|trastuzumab|mesh-list
64897658|NCT02015156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64897659|NCT02015156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897660|NCT02015169|Lapatinib|lapatinib|mesh-list
64897661|NCT02015169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897662|NCT02015169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64897663|NCT02015169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897664|NCT02015169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897665|NCT02015182|Bupivacaine|bupivacaine|mesh-list
64897666|NCT02015182|Anesthetics, Local|anesthetics, local|mesh-ancestor
64897876|NCT02016391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897877|NCT02016417|Gemcitabine|gemcitabine|mesh-list
64897878|NCT02016417|Cisplatin|cisplatin|mesh-list
64897879|NCT02016417|Docetaxel|docetaxel|mesh-list
64897880|NCT02016417|Fluorouracil|fluorouracil|mesh-list
64897881|NCT02016417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897882|NCT02016417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64897883|NCT02016417|Antimetabolites|antimetabolites|mesh-ancestor
64897884|NCT02016417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897885|NCT02016417|Antiviral Agents|antiviral agents|mesh-ancestor
64897886|NCT02016417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64897887|NCT02016417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897888|NCT02016417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64897889|NCT02016417|Immunologic Factors|immunologic factors|mesh-ancestor
64897890|NCT02016417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897891|NCT02016417|Tubulin Modulators|tubulin modulators|mesh-ancestor
64897892|NCT02016417|Antimitotic Agents|antimitotic agents|mesh-ancestor
64897893|NCT02016417|Mitosis Modulators|mitosis modulators|mesh-ancestor
64897894|NCT02016443|Tizanidine|tizanidine|mesh-list
64897895|NCT02016443|Analgesics|analgesics|mesh-ancestor
64897896|NCT02016443|Sensory System Agents|sensory system agents|mesh-ancestor
64897969|NCT02016976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64897971|NCT02016976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64897972|NCT02016976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64897973|NCT02016976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64897974|NCT02016976|Anesthetics, General|anesthetics, general|mesh-ancestor
64897975|NCT02016976|Anesthetics|anesthetics|mesh-ancestor
64897976|NCT02016976|GABA Modulators|gaba modulators|mesh-ancestor
64897977|NCT02016976|GABA Agents|gaba agents|mesh-ancestor
64897978|NCT02016976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64897979|NCT02016976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897980|NCT02016976|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64898043|NCT02017639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898050|NCT02018055|Aspirin|aspirin|mesh-list
64898051|NCT02018055|Clopidogrel|clopidogrel|mesh-list
64898052|NCT02018055|Ticagrelor|ticagrelor|mesh-list
64898053|NCT02018055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64898054|NCT02018055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64898055|NCT02018055|Analgesics|analgesics|mesh-ancestor
64898056|NCT02018055|Sensory System Agents|sensory system agents|mesh-ancestor
64898057|NCT02018055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898058|NCT02018055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898059|NCT02018055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64898060|NCT02018055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64898061|NCT02018055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64898062|NCT02018055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64898063|NCT02018055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898113|NCT02018133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898114|NCT02018133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64898115|NCT02018133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64898116|NCT02018159|Menotropins|menotropins|mesh-list
64898117|NCT02018159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64898118|NCT02018159|Fertility Agents|fertility agents|mesh-ancestor
64898119|NCT02018159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64898120|NCT02018159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898121|NCT02018250|Benzyl Alcohol|benzyl alcohol|mesh-list
64898122|NCT02018250|Anesthetics, Local|anesthetics, local|mesh-ancestor
64898123|NCT02018250|Anesthetics|anesthetics|mesh-ancestor
64898124|NCT02018250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64898125|NCT02018250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898182|NCT02018588|Antidepressive Agents|antidepressive agents|mesh-ancestor
64898183|NCT02018588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64898184|NCT02018601|Acetaminophen|acetaminophen|mesh-list
64898185|NCT02018601|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
64898186|NCT02018601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64898187|NCT02018601|Analgesics|analgesics|mesh-ancestor
64898188|NCT02018601|Sensory System Agents|sensory system agents|mesh-ancestor
64898189|NCT02018601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898190|NCT02018601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898191|NCT02018601|Antipyretics|antipyretics|mesh-ancestor
64898192|NCT02018601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64898193|NCT02018601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64898195|NCT02018731|Metformin|metformin|mesh-list
64898219|NCT02018796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898220|NCT02018796|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64898221|NCT02018796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64898222|NCT02018796|Oxytocics|oxytocics|mesh-ancestor
64898223|NCT02018796|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64898224|NCT02018796|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64898225|NCT02018796|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64898298|NCT02019186|Antioxidants|antioxidants|mesh-ancestor
64898299|NCT02019186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898300|NCT02019186|Protective Agents|protective agents|mesh-ancestor
64898301|NCT02019290|Midazolam|midazolam|mesh-list
64898302|NCT02019290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64898303|NCT02019290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64898304|NCT02019290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64898305|NCT02019290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898306|NCT02019290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64898307|NCT02019290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64898308|NCT02019290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64898309|NCT02019290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64898310|NCT02019290|Anesthetics, General|anesthetics, general|mesh-ancestor
64898311|NCT02019290|Anesthetics|anesthetics|mesh-ancestor
64898312|NCT02019290|GABA Modulators|gaba modulators|mesh-ancestor
64898313|NCT02019290|GABA Agents|gaba agents|mesh-ancestor
64898314|NCT02019290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64898315|NCT02019290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898316|NCT02019329|Risperidone|risperidone|mesh-list
64898317|NCT02019329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64898318|NCT02019329|Serotonin Agents|serotonin agents|mesh-ancestor
64898319|NCT02019329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64898320|NCT02019329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898321|NCT02019329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898322|NCT02019329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64898323|NCT02019329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64898324|NCT02019329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64898325|NCT02019329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64898326|NCT02019329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64898327|NCT02019329|Dopamine Agents|dopamine agents|mesh-ancestor
64898328|NCT02019355|Fluorouracil|fluorouracil|mesh-list
64898329|NCT02019355|Calcipotriene|calcipotriene|mesh-list
64898330|NCT02019355|Petrolatum|petrolatum|mesh-list
64898331|NCT02019355|Antimetabolites|antimetabolites|mesh-ancestor
64898332|NCT02019355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898333|NCT02019355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64898334|NCT02019355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983319|NCT00082394|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64983362|NCT00082472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898335|NCT02019355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64898339|NCT02019355|Emollients|emollients|mesh-ancestor
64898365|NCT02019485|Narcotics|narcotics|mesh-ancestor
64898366|NCT02019485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64898367|NCT02019485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898368|NCT02019485|Analgesics|analgesics|mesh-ancestor
64898369|NCT02019485|Sensory System Agents|sensory system agents|mesh-ancestor
64898370|NCT02019485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898371|NCT02019485|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64898372|NCT02019485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64898373|NCT02019485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64898374|NCT02019485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898375|NCT02019485|Adrenergic Agents|adrenergic agents|mesh-ancestor
64898376|NCT02019485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64898377|NCT02019524|Folic Acid|folic acid|mesh-list
64898378|NCT02019524|Vitamin B Complex|vitamin b complex|mesh-list
64898379|NCT02019524|Molgramostim|molgramostim|mesh-list
64898380|NCT02019524|Vaccines|vaccines|mesh-list
64898426|NCT02020005|Cholinergic Agents|cholinergic agents|mesh-ancestor
64898427|NCT02020005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64898428|NCT02020005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898430|NCT02020122|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64898431|NCT02020122|Analgesics|analgesics|mesh-ancestor
64898432|NCT02020122|Sensory System Agents|sensory system agents|mesh-ancestor
64898433|NCT02020122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898434|NCT02020122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898435|NCT02020122|Anticonvulsants|anticonvulsants|mesh-ancestor
64898436|NCT02020122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64898437|NCT02020122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64898440|NCT02020122|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64898491|NCT02020213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898492|NCT02020330|Lumefantrine|lumefantrine|mesh-list
64898493|NCT02020330|Artemether|artemether|mesh-list
64898494|NCT02020330|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64898495|NCT02020330|Antimalarials|antimalarials|mesh-ancestor
64898496|NCT02020330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64898497|NCT02020330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64898498|NCT02020330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64898499|NCT02020499|Lanreotide|lanreotide|mesh-list
64898500|NCT02020499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898501|NCT02020551|Lidocaine|lidocaine|mesh-list
64898502|NCT02020551|Anesthetics, Local|anesthetics, local|mesh-ancestor
64898503|NCT02020551|Anesthetics|anesthetics|mesh-ancestor
64667016|NCT03006380|Oxytocin|oxytocin|mesh-list
64898504|NCT02020551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64898505|NCT02020551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898506|NCT02020551|Sensory System Agents|sensory system agents|mesh-ancestor
64898507|NCT02020551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898508|NCT02020551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64898509|NCT02020551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64898523|NCT02020603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64898524|NCT02020603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64898525|NCT02020603|Autonomic Agents|autonomic agents|mesh-ancestor
64898527|NCT02020603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64898578|NCT02021201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64898579|NCT02021201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898580|NCT02021201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898581|NCT02021201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64898582|NCT02021201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64898583|NCT02021201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64898584|NCT02021201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64898585|NCT02021201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64898586|NCT02021201|Dopamine Agents|dopamine agents|mesh-ancestor
64898587|NCT02021214|Methylphenidate|methylphenidate|mesh-list
64898588|NCT02021214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64898589|NCT02021214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898590|NCT02021214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64898591|NCT02021214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64898592|NCT02021214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64898593|NCT02021214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898594|NCT02021214|Dopamine Agents|dopamine agents|mesh-ancestor
64898595|NCT02021214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64898596|NCT02021240|Dexamethasone|dexamethasone|mesh-list
64898597|NCT02021240|Ketamine|ketamine|mesh-list
64898599|NCT02021240|Antiemetics|antiemetics|mesh-ancestor
64898683|NCT02021864|Cholecalciferol|cholecalciferol|mesh-list
64898684|NCT02021864|Vitamins|vitamins|mesh-ancestor
64898685|NCT02021864|Micronutrients|micronutrients|mesh-ancestor
64898686|NCT02021864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898687|NCT02021864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64898688|NCT02021864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64898689|NCT02022163|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64898690|NCT02022163|Vaccines|vaccines|mesh-list
64898691|NCT02022163|Immunologic Factors|immunologic factors|mesh-ancestor
64898694|NCT02022163|Antacids|antacids|mesh-ancestor
64898723|NCT02022293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64898724|NCT02022293|Antimetabolites|antimetabolites|mesh-ancestor
64898725|NCT02022293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898726|NCT02022293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64898727|NCT02022293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64898728|NCT02022293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64898730|NCT02022358|Folic Acid|folic acid|mesh-list
64898731|NCT02022358|Methotrexate|methotrexate|mesh-list
64898732|NCT02022358|Levoleucovorin|levoleucovorin|mesh-list
64898733|NCT02022358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64898734|NCT02022358|Abortifacient Agents|abortifacient agents|mesh-ancestor
64898735|NCT02022358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64898736|NCT02022358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898737|NCT02022358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64898738|NCT02022358|Antimetabolites|antimetabolites|mesh-ancestor
64898739|NCT02022358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898740|NCT02022358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898741|NCT02022358|Dermatologic Agents|dermatologic agents|mesh-ancestor
64898777|NCT02022488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64898778|NCT02022488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64898780|NCT02022488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64898781|NCT02022488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64898782|NCT02022488|GABA Modulators|gaba modulators|mesh-ancestor
64898783|NCT02022488|GABA Agents|gaba agents|mesh-ancestor
64898784|NCT02022488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64898785|NCT02022488|Narcotics|narcotics|mesh-ancestor
64898786|NCT02022527|Aspirin|aspirin|mesh-list
64898790|NCT02022527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64898791|NCT02022527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64898792|NCT02022527|Analgesics|analgesics|mesh-ancestor
64898793|NCT02022527|Sensory System Agents|sensory system agents|mesh-ancestor
64898794|NCT02022527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898795|NCT02022527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898796|NCT02022527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64898797|NCT02022527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64899079|NCT02024217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899080|NCT02024256|Magnesium Sulfate|magnesium sulfate|mesh-list
64899081|NCT02024256|Analgesics|analgesics|mesh-ancestor
64899082|NCT02024256|Sensory System Agents|sensory system agents|mesh-ancestor
64899083|NCT02024256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64899084|NCT02024256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899085|NCT02024256|Anesthetics|anesthetics|mesh-ancestor
64899086|NCT02024256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64899087|NCT02024256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64899088|NCT02024256|Anticonvulsants|anticonvulsants|mesh-ancestor
64899186|NCT02024633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899187|NCT02024633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899188|NCT02024633|Antiviral Agents|antiviral agents|mesh-ancestor
64899189|NCT02024633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64899190|NCT02024633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899191|NCT02024633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64899192|NCT02024633|Immunologic Factors|immunologic factors|mesh-ancestor
64899193|NCT02024633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899194|NCT02024659|Budesonide|budesonide|mesh-list
64899197|NCT02024659|Autonomic Agents|autonomic agents|mesh-ancestor
64899220|NCT02024919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64899221|NCT02024919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899222|NCT02024919|Vasodilator Agents|vasodilator agents|mesh-ancestor
64899223|NCT02024945|Propiverine|propiverine|mesh-list
64899224|NCT02024945|Parasympatholytics|parasympatholytics|mesh-ancestor
64899225|NCT02024945|Autonomic Agents|autonomic agents|mesh-ancestor
64899226|NCT02024945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64899227|NCT02024945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899228|NCT02024945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64899229|NCT02024945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64899230|NCT02024945|Cholinergic Agents|cholinergic agents|mesh-ancestor
64899231|NCT02024945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64899232|NCT02024945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899233|NCT02024945|Urological Agents|urological agents|mesh-ancestor
64899234|NCT02024984|Clomiphene|clomiphene|mesh-list
64899235|NCT02024984|Enclomiphene|enclomiphene|mesh-list
64899236|NCT02024984|Zuclomiphene|zuclomiphene|mesh-list
64899298|NCT02025348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899299|NCT02025348|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64899300|NCT02025348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64899301|NCT02025348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64899302|NCT02025348|Adrenergic Agents|adrenergic agents|mesh-ancestor
64899303|NCT02025348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64899304|NCT02025348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899305|NCT02025361|Lidocaine|lidocaine|mesh-list
64899306|NCT02025361|Anesthetics, Local|anesthetics, local|mesh-ancestor
64899307|NCT02025361|Anesthetics|anesthetics|mesh-ancestor
64899308|NCT02025361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64899309|NCT02025361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899316|NCT02025361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899317|NCT02025374|Bupivacaine|bupivacaine|mesh-list
64899318|NCT02025374|Levobupivacaine|levobupivacaine|mesh-list
64899319|NCT02025374|Anesthetics, Local|anesthetics, local|mesh-ancestor
64899320|NCT02025374|Anesthetics|anesthetics|mesh-ancestor
64899321|NCT02025374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64899322|NCT02025374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899323|NCT02025374|Sensory System Agents|sensory system agents|mesh-ancestor
64899324|NCT02025374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64899325|NCT02025465|Metoprolol|metoprolol|mesh-list
64899326|NCT02025465|Diltiazem|diltiazem|mesh-list
64899327|NCT02025465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64899328|NCT02025465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64899329|NCT02025465|Sympatholytics|sympatholytics|mesh-ancestor
64899330|NCT02025465|Autonomic Agents|autonomic agents|mesh-ancestor
64899331|NCT02025465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64899332|NCT02025465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899336|NCT02025465|Adrenergic Agents|adrenergic agents|mesh-ancestor
64899377|NCT02025803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899378|NCT02025803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899379|NCT02025855|Methadone|methadone|mesh-list
64899380|NCT02025855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64899429|NCT02025998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64899430|NCT02025998|Vasodilator Agents|vasodilator agents|mesh-ancestor
64899431|NCT02026050|Dexamethasone|dexamethasone|mesh-list
64899432|NCT02026050|Dexamethasone acetate|dexamethasone acetate|mesh-list
64899433|NCT02026050|BB 1101|bb 1101|mesh-list
64899434|NCT02026050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64899435|NCT02026050|Antiemetics|antiemetics|mesh-ancestor
64899436|NCT02026050|Autonomic Agents|autonomic agents|mesh-ancestor
64899437|NCT02026050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64899438|NCT02026050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899439|NCT02026050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64899440|NCT02026050|Glucocorticoids|glucocorticoids|mesh-ancestor
64899441|NCT02026050|Hormones|hormones|mesh-ancestor
64899442|NCT02026050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64899443|NCT02026050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64899444|NCT02026050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899445|NCT02026050|Protease Inhibitors|protease inhibitors|mesh-ancestor
64899446|NCT02026050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899447|NCT02026050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899448|NCT02026219|Clopidogrel|clopidogrel|mesh-list
64899449|NCT02026219|Ticagrelor|ticagrelor|mesh-list
64899450|NCT02026219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64899451|NCT02026219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64899452|NCT02026219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64899453|NCT02026219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64899481|NCT02026479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899482|NCT02026479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899483|NCT02026492|Methacholine Chloride|methacholine chloride|mesh-list
64899484|NCT02026492|Miotics|miotics|mesh-ancestor
64899485|NCT02026492|Autonomic Agents|autonomic agents|mesh-ancestor
64899486|NCT02026492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64899487|NCT02026492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899488|NCT02026492|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64899489|NCT02026492|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
64899490|NCT02026492|Respiratory System Agents|respiratory system agents|mesh-ancestor
64899491|NCT02026492|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64899492|NCT02026492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64899493|NCT02026492|Cholinergic Agents|cholinergic agents|mesh-ancestor
64899494|NCT02026492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64899495|NCT02026492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899496|NCT02026505|Bortezomib|bortezomib|mesh-list
64899497|NCT02026505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899498|NCT02026518|Vitamin D|vitamin d|mesh-list
64899499|NCT02026518|Cholecalciferol|cholecalciferol|mesh-list
64899500|NCT02026518|Vitamins|vitamins|mesh-ancestor
64899501|NCT02026518|Micronutrients|micronutrients|mesh-ancestor
64899502|NCT02026518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899505|NCT02026583|Simvastatin|simvastatin|mesh-list
64899515|NCT02026765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64899516|NCT02026765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64899517|NCT02026765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899519|NCT02026778|Ondansetron|ondansetron|mesh-list
64899520|NCT02026778|Antiemetics|antiemetics|mesh-ancestor
64899521|NCT02026778|Autonomic Agents|autonomic agents|mesh-ancestor
64899522|NCT02026778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64899523|NCT02026778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899524|NCT02026778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64899525|NCT02026778|Antipruritics|antipruritics|mesh-ancestor
64899526|NCT02026778|Dermatologic Agents|dermatologic agents|mesh-ancestor
64899527|NCT02026778|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64372809|NCT02461121|Cyclosporine|cyclosporine|mesh-list
64372838|NCT02461043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372840|NCT02461043|Antimitotic Agents|antimitotic agents|mesh-ancestor
64983363|NCT00082472|Tubulin Modulators|tubulin modulators|mesh-ancestor
64983364|NCT00082472|Antimitotic Agents|antimitotic agents|mesh-ancestor
64899528|NCT02026778|Serotonin Agents|serotonin agents|mesh-ancestor
64899529|NCT02026778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64899576|NCT02026973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64899577|NCT02026973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899578|NCT02026973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64899579|NCT02026973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64899580|NCT02026973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899581|NCT02026973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899582|NCT02026973|Hormones|hormones|mesh-ancestor
64899583|NCT02027064|Interferons|interferons|mesh-list
64899584|NCT02027064|Interferon-alpha|interferon-alpha|mesh-list
64899585|NCT02027064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899586|NCT02027064|Antiviral Agents|antiviral agents|mesh-ancestor
64899587|NCT02027064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64899588|NCT02027064|Immunologic Factors|immunologic factors|mesh-ancestor
64899589|NCT02027064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899590|NCT02027103|Metformin|metformin|mesh-list
64899591|NCT02027103|Pioglitazone|pioglitazone|mesh-list
64899695|NCT02027753|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64899696|NCT02027753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64899697|NCT02027753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899698|NCT02027753|Protease Inhibitors|protease inhibitors|mesh-ancestor
64899699|NCT02027753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899700|NCT02027753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899701|NCT02027792|Diclofenac|diclofenac|mesh-list
64899702|NCT02027792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64899703|NCT02027792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64899775|NCT02028260|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64899776|NCT02028260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899777|NCT02028299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64899778|NCT02028312|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64899779|NCT02028312|Lubricant Eye Drops|lubricant eye drops|mesh-list
64899780|NCT02028312|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64899782|NCT02028312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64899924|NCT02029118|Analgesics|analgesics|mesh-ancestor
64899925|NCT02029118|Sensory System Agents|sensory system agents|mesh-ancestor
64899926|NCT02029118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64899927|NCT02029118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899928|NCT02029118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64899929|NCT02029118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64899930|NCT02029118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64899931|NCT02029118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64899932|NCT02029118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899933|NCT02029118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64899934|NCT02029118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64899935|NCT02029118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899936|NCT02029118|Antipyretics|antipyretics|mesh-ancestor
64900077|NCT02029950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64900078|NCT02029950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900079|NCT02029950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64900080|NCT02029950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64900081|NCT02029950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900082|NCT02029950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900083|NCT02029950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64900180|NCT02033733|Cholinergic Agents|cholinergic agents|mesh-ancestor
64900181|NCT02033733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64900182|NCT02033733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900183|NCT02034253|Risperidone|risperidone|mesh-list
64900184|NCT02034253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64900185|NCT02034253|Serotonin Agents|serotonin agents|mesh-ancestor
64900186|NCT02034253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64900187|NCT02034253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900188|NCT02034253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900189|NCT02034253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64900190|NCT02034253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64900191|NCT02034253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64900192|NCT02034253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64900208|NCT02035891|Colchicine|colchicine|mesh-list
64900209|NCT02035891|Gout Suppressants|gout suppressants|mesh-ancestor
64900210|NCT02035891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64900211|NCT02035891|Tubulin Modulators|tubulin modulators|mesh-ancestor
64900212|NCT02035891|Antimitotic Agents|antimitotic agents|mesh-ancestor
64900213|NCT02035891|Mitosis Modulators|mitosis modulators|mesh-ancestor
64900214|NCT02035891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900215|NCT02035891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900216|NCT02035956|Vaccines|vaccines|mesh-list
64900217|NCT02035956|Immunologic Factors|immunologic factors|mesh-ancestor
64900218|NCT02035956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900219|NCT02036151|Fluorides|fluorides|mesh-list
64900220|NCT02036151|Fluorides, Topical|fluorides, topical|mesh-list
64900221|NCT02036151|Cariostatic Agents|cariostatic agents|mesh-ancestor
64900222|NCT02036151|Protective Agents|protective agents|mesh-ancestor
64900223|NCT02036151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372916|NCT00701129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64372917|NCT03296189|Dexamethasone|dexamethasone|mesh-list
64372918|NCT03296189|Dexamethasone acetate|dexamethasone acetate|mesh-list
64372919|NCT03296189|Levobupivacaine|levobupivacaine|mesh-list
64983365|NCT00082472|Mitosis Modulators|mitosis modulators|mesh-ancestor
64983366|NCT00082472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983367|NCT00082472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64983368|NCT00082472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64983369|NCT00082472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64983370|NCT00082472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983478|NCT00087945|Abacavir|abacavir|mesh-list
64983479|NCT00087945|Dideoxynucleosides|dideoxynucleosides|mesh-list
64983480|NCT00087945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64983481|NCT00087945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64900224|NCT02036255|Taurolidine|taurolidine|mesh-list
64900225|NCT02036255|Heparin|heparin|mesh-list
64900226|NCT02036255|Anticoagulants|anticoagulants|mesh-ancestor
64900227|NCT02036255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64900228|NCT02036255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64900229|NCT02036255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900230|NCT02036255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64900231|NCT02036255|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64900232|NCT02036255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900233|NCT02038062|Sevoflurane|sevoflurane|mesh-list
64900234|NCT02038062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64900235|NCT02038062|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64900237|NCT02038062|Anesthetics|anesthetics|mesh-ancestor
64900254|NCT02039492|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64900256|NCT02039492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64900257|NCT02039492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900258|NCT02039492|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64900259|NCT02039492|Diuretics|diuretics|mesh-ancestor
64900260|NCT02039492|Natriuretic Agents|natriuretic agents|mesh-ancestor
64900261|NCT02039869|Omeprazole|omeprazole|mesh-list
64900262|NCT02039869|Sucralfate|sucralfate|mesh-list
64900263|NCT02039869|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64900264|NCT02039869|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64900265|NCT02039869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64900266|NCT02039869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900267|NCT02039869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900268|NCT02040064|Gefitinib|gefitinib|mesh-list
64900269|NCT02040064|Tremelimumab|tremelimumab|mesh-list
64900270|NCT02040064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900271|NCT02040064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64900272|NCT02040064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900273|NCT02040064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900274|NCT02040142|Mitomycins|mitomycins|mesh-list
64900312|NCT02040350|Antidotes|antidotes|mesh-ancestor
64900313|NCT02040350|Protective Agents|protective agents|mesh-ancestor
64900314|NCT02040350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900315|NCT02040350|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
64900316|NCT02040350|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
64900317|NCT02040350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900318|NCT02040350|Cholinergic Agents|cholinergic agents|mesh-ancestor
64900319|NCT02040350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64900320|NCT02040402|Vaccines|vaccines|mesh-list
64900321|NCT02040402|Immunologic Factors|immunologic factors|mesh-ancestor
64900322|NCT02040402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900323|NCT02040415|Eperisone|eperisone|mesh-list
64900324|NCT02040415|Anticonvulsants|anticonvulsants|mesh-ancestor
64900325|NCT02040415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64900326|NCT02040415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64900327|NCT02040415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900328|NCT02040415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64900329|NCT02040415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900330|NCT02040415|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64900331|NCT02040415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64900332|NCT02040415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64900333|NCT02040415|Parasympatholytics|parasympatholytics|mesh-ancestor
64900351|NCT02040571|Insulin|insulin|mesh-list
64900370|NCT02040597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64900371|NCT02040597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64900372|NCT02040597|Cholinergic Agents|cholinergic agents|mesh-ancestor
64900373|NCT02040597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64900374|NCT02040597|Glucocorticoids|glucocorticoids|mesh-ancestor
64900375|NCT02040597|Hormones|hormones|mesh-ancestor
64900376|NCT02040597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64900377|NCT02040636|Vaccines|vaccines|mesh-list
64900378|NCT02040636|Immunologic Factors|immunologic factors|mesh-ancestor
64900379|NCT02040636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900380|NCT02040649|Midazolam|midazolam|mesh-list
64900381|NCT02040649|Propofol|propofol|mesh-list
64900389|NCT02040649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64900390|NCT02040649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64900391|NCT02040649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64900392|NCT02040649|GABA Modulators|gaba modulators|mesh-ancestor
64900393|NCT02040649|GABA Agents|gaba agents|mesh-ancestor
64900394|NCT02040649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64900395|NCT02040649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900396|NCT02040662|Morphine|morphine|mesh-list
64900397|NCT02040662|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64900398|NCT02040662|Narcotics|narcotics|mesh-ancestor
64900399|NCT02040662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64900428|NCT02040883|Risperidone|risperidone|mesh-list
64900429|NCT02040883|Aripiprazole|aripiprazole|mesh-list
64900430|NCT02040883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64900431|NCT02040883|Ziprasidone|ziprasidone|mesh-list
64900432|NCT02040883|Tandospirone|tandospirone|mesh-list
64900433|NCT02040883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64900434|NCT02040883|Serotonin Agents|serotonin agents|mesh-ancestor
64900435|NCT02040883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64900436|NCT02040883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900437|NCT02040883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900438|NCT02040883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64900439|NCT02040883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64900440|NCT02040883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64900441|NCT02040883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64900442|NCT02040883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64900443|NCT02040883|Dopamine Agents|dopamine agents|mesh-ancestor
64900444|NCT02040883|Antiemetics|antiemetics|mesh-ancestor
64900445|NCT02040883|Autonomic Agents|autonomic agents|mesh-ancestor
64900446|NCT02040883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64900447|NCT02040883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64900448|NCT02040883|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64900449|NCT02040883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64900450|NCT02040883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64900451|NCT02040883|Antidepressive Agents|antidepressive agents|mesh-ancestor
64900452|NCT02040883|Dopamine Agonists|dopamine agonists|mesh-ancestor
64900474|NCT02040987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900475|NCT02040987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900484|NCT02041143|Caseins|caseins|mesh-list
64900526|NCT02041455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64900527|NCT02041455|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64900528|NCT02041455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64900529|NCT02041455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64900530|NCT02041455|Adrenergic Agents|adrenergic agents|mesh-ancestor
64900531|NCT02041455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64900532|NCT02041481|Leucovorin|leucovorin|mesh-list
64669056|NCT04902378|Insulin|insulin|mesh-list
64900533|NCT02041481|Fluorouracil|fluorouracil|mesh-list
64900534|NCT02041481|Oxaliplatin|oxaliplatin|mesh-list
64900536|NCT02041481|Levoleucovorin|levoleucovorin|mesh-list
64900537|NCT02041481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64900538|NCT02041481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900539|NCT02041481|Antimetabolites|antimetabolites|mesh-ancestor
64900540|NCT02041481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900541|NCT02041481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64900542|NCT02041481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900543|NCT02041481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64900544|NCT02041481|Immunologic Factors|immunologic factors|mesh-ancestor
64900545|NCT02041481|Antidotes|antidotes|mesh-ancestor
64900546|NCT02041481|Protective Agents|protective agents|mesh-ancestor
64900547|NCT02041481|Vitamin B Complex|vitamin b complex|mesh-ancestor
64900548|NCT02041481|Vitamins|vitamins|mesh-ancestor
64900549|NCT02041481|Micronutrients|micronutrients|mesh-ancestor
64900550|NCT02041546|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64900551|NCT02041546|Poractant alfa|poractant alfa|mesh-list
64900552|NCT02041546|Respiratory System Agents|respiratory system agents|mesh-ancestor
64900553|NCT02041650|Ticagrelor|ticagrelor|mesh-list
64900592|NCT02042482|Micronutrients|micronutrients|mesh-ancestor
64900593|NCT02042482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900594|NCT02042482|Vitamins|vitamins|mesh-ancestor
64900623|NCT02042638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64900624|NCT02042638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900625|NCT02042664|Metformin|metformin|mesh-list
64900626|NCT02042664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64900627|NCT02042664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900628|NCT02042690|Dexamethasone|dexamethasone|mesh-list
64900629|NCT02042690|Cyclophosphamide|cyclophosphamide|mesh-list
64900630|NCT02042690|Methotrexate|methotrexate|mesh-list
64900631|NCT02042690|Epirubicin|epirubicin|mesh-list
64900632|NCT02042690|Mercaptopurine|mercaptopurine|mesh-list
64900633|NCT02042690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64900634|NCT02042690|Immunologic Factors|immunologic factors|mesh-ancestor
64900635|NCT02042690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900636|NCT02042690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64900637|NCT02042690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64900638|NCT02042690|Alkylating Agents|alkylating agents|mesh-ancestor
64900639|NCT02042690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900640|NCT02042690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900641|NCT02042690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64900642|NCT02042690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64900643|NCT02042690|Antiemetics|antiemetics|mesh-ancestor
64900677|NCT02043054|Liraglutide|liraglutide|mesh-list
64900678|NCT02043054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64900679|NCT02043054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900680|NCT02043054|Incretins|incretins|mesh-ancestor
64900681|NCT02043054|Hormones|hormones|mesh-ancestor
64669201|NCT01706588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64900682|NCT02043054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64900683|NCT02043054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64900684|NCT02043054|Protease Inhibitors|protease inhibitors|mesh-ancestor
64900685|NCT02043054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900686|NCT02043054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900693|NCT02043171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64900694|NCT02043171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64900695|NCT02043223|Vitamins|vitamins|mesh-list
64900696|NCT02043223|Vitamin A|vitamin a|mesh-list
64900697|NCT02043223|Retinol palmitate|retinol palmitate|mesh-list
64900698|NCT02043223|Micronutrients|micronutrients|mesh-ancestor
64900728|NCT02043665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64900729|NCT02043665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900730|NCT02043717|Vitamin D|vitamin d|mesh-list
64900731|NCT02043717|Vitamins|vitamins|mesh-ancestor
64900732|NCT02043717|Micronutrients|micronutrients|mesh-ancestor
64900733|NCT02043717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900734|NCT02043717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64900735|NCT02043730|Gemcitabine|gemcitabine|mesh-list
64900736|NCT02043730|Paclitaxel|paclitaxel|mesh-list
64900737|NCT02043730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64900738|NCT02043730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900739|NCT02043730|Tubulin Modulators|tubulin modulators|mesh-ancestor
64900740|NCT02043730|Antimitotic Agents|antimitotic agents|mesh-ancestor
64900741|NCT02043730|Mitosis Modulators|mitosis modulators|mesh-ancestor
64900742|NCT02043730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900743|NCT02043730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64900744|NCT02043730|Antimetabolites|antimetabolites|mesh-ancestor
64900745|NCT02043730|Antiviral Agents|antiviral agents|mesh-ancestor
64900746|NCT02043730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64900790|NCT02043977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64900791|NCT02043977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900792|NCT02043977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64900793|NCT02043977|Anesthetics, General|anesthetics, general|mesh-ancestor
64900794|NCT02043977|Anesthetics|anesthetics|mesh-ancestor
64900795|NCT02044120|Irinotecan|irinotecan|mesh-list
64900796|NCT02044120|Temozolomide|temozolomide|mesh-list
64900797|NCT02044120|Niraparib|niraparib|mesh-list
64900798|NCT02044120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64900800|NCT02044120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900821|NCT02044146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900822|NCT02044224|Dexmedetomidine|dexmedetomidine|mesh-list
64900823|NCT02044224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64900824|NCT02044224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64900825|NCT02044224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900826|NCT02044224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64900827|NCT02044224|Analgesics|analgesics|mesh-ancestor
64900828|NCT02044224|Sensory System Agents|sensory system agents|mesh-ancestor
64900829|NCT02044224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64900830|NCT02044224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64669350|NCT01607450|Incretins|incretins|mesh-ancestor
64900831|NCT02044224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64900832|NCT02044224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64900833|NCT02044224|Adrenergic Agents|adrenergic agents|mesh-ancestor
64900834|NCT02044224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64900835|NCT02044224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900837|NCT02044250|Clopidogrel|clopidogrel|mesh-list
64900838|NCT02044250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64900839|NCT02044250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64900840|NCT02044250|Analgesics|analgesics|mesh-ancestor
64900841|NCT02044250|Sensory System Agents|sensory system agents|mesh-ancestor
64900842|NCT02044250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64900848|NCT02044250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900849|NCT02044250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64900850|NCT02044250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64900851|NCT02044250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900852|NCT02044250|Antipyretics|antipyretics|mesh-ancestor
64900862|NCT02044354|Mitosis Modulators|mitosis modulators|mesh-ancestor
64900863|NCT02044354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900864|NCT02044549|Oxytocin|oxytocin|mesh-list
64900865|NCT02044549|Carbetocin|carbetocin|mesh-list
64900866|NCT02044549|Methylergonovine|methylergonovine|mesh-list
64900867|NCT02044549|Syntometrine|syntometrine|mesh-list
64900868|NCT02044549|Oxytocics|oxytocics|mesh-ancestor
64900869|NCT02044549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64900870|NCT02044549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900871|NCT02044601|Paclitaxel|paclitaxel|mesh-list
64900872|NCT02044601|Carboplatin|carboplatin|mesh-list
64900873|NCT02044601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64900874|NCT02044601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64900875|NCT02044601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900876|NCT02044601|Tubulin Modulators|tubulin modulators|mesh-ancestor
64900877|NCT02044601|Antimitotic Agents|antimitotic agents|mesh-ancestor
64900878|NCT02044601|Mitosis Modulators|mitosis modulators|mesh-ancestor
64900879|NCT02044601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900880|NCT02044601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64900881|NCT02044601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900882|NCT02044627|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
64900883|NCT02044627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64900884|NCT02044627|Antimetabolites|antimetabolites|mesh-ancestor
64900885|NCT02044627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900886|NCT02044627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64900887|NCT02044627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900902|NCT02044952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64900903|NCT02044952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64900904|NCT02044952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900905|NCT02044952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
64900906|NCT02044952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64900907|NCT02044952|Contraceptive Agents|contraceptive agents|mesh-ancestor
64900908|NCT02044952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64900909|NCT02044952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64900910|NCT02044952|Immunologic Factors|immunologic factors|mesh-ancestor
64900911|NCT02044952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64900912|NCT02044952|Alkylating Agents|alkylating agents|mesh-ancestor
64900913|NCT02044952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900914|NCT02044965|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64900915|NCT02044965|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64900916|NCT02044965|Trimethoprim|trimethoprim|mesh-list
64900917|NCT02044965|Sulfamethoxazole|sulfamethoxazole|mesh-list
64900918|NCT02044965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64900919|NCT02044965|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64900920|NCT02044965|Renal Agents|renal agents|mesh-ancestor
64900921|NCT02044965|Antimalarials|antimalarials|mesh-ancestor
64900922|NCT02044965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64900923|NCT02044965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64900924|NCT02044965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64900925|NCT02044965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900926|NCT02044965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900927|NCT02044965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64900930|NCT02044978|Zoledronic Acid|zoledronic acid|mesh-list
64900942|NCT02045017|Hormones|hormones|mesh-ancestor
64900943|NCT02045017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64900944|NCT02045017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64900945|NCT02045017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900946|NCT02045017|Immunologic Factors|immunologic factors|mesh-ancestor
64900947|NCT02045017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64373097|NCT04429347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373098|NCT04429347|Antimanic Agents|antimanic agents|mesh-ancestor
64983482|NCT00087945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983483|NCT00087945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983484|NCT00087945|Antiviral Agents|antiviral agents|mesh-ancestor
64900948|NCT02045017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64900949|NCT02045017|Growth Substances|growth substances|mesh-ancestor
64900950|NCT02045017|Growth Inhibitors|growth inhibitors|mesh-ancestor
64900951|NCT02045030|Aflibercept|aflibercept|mesh-list
64900952|NCT02045030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64900953|NCT02045030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64900954|NCT02045030|Growth Substances|growth substances|mesh-ancestor
64900955|NCT02045030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900956|NCT02045030|Growth Inhibitors|growth inhibitors|mesh-ancestor
64900957|NCT02045030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900958|NCT02045056|Gemfibrozil|gemfibrozil|mesh-list
64900959|NCT02045056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64900960|NCT02045056|Antimetabolites|antimetabolites|mesh-ancestor
64900961|NCT02045056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900962|NCT02045056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64900963|NCT02045056|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64900964|NCT02045056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64900965|NCT02045056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901064|NCT02045953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64901065|NCT02045953|Autonomic Agents|autonomic agents|mesh-ancestor
64901066|NCT02045953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64901067|NCT02045953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901097|NCT02046109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64901098|NCT02046109|Disinfectants|disinfectants|mesh-ancestor
64901099|NCT02046187|Temozolomide|temozolomide|mesh-list
64901100|NCT02046187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64901101|NCT02046187|Alkylating Agents|alkylating agents|mesh-ancestor
64901102|NCT02046187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901103|NCT02046187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901104|NCT02046304|Gemcitabine|gemcitabine|mesh-list
64901105|NCT02046304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64901106|NCT02046304|Antimetabolites|antimetabolites|mesh-ancestor
64901107|NCT02046304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901108|NCT02046304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901109|NCT02046304|Antiviral Agents|antiviral agents|mesh-ancestor
64901110|NCT02046304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64901111|NCT02046304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901112|NCT02046304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64901113|NCT02046304|Immunologic Factors|immunologic factors|mesh-ancestor
64901114|NCT02046304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901115|NCT02046421|Gemcitabine|gemcitabine|mesh-list
64901116|NCT02046421|Carboplatin|carboplatin|mesh-list
64901117|NCT02046421|Mifepristone|mifepristone|mesh-list
64901118|NCT02046421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901119|NCT02046421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64901120|NCT02046421|Antimetabolites|antimetabolites|mesh-ancestor
64901147|NCT02046447|Cholinergic Agents|cholinergic agents|mesh-ancestor
64901148|NCT02046447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64901149|NCT02046447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901150|NCT02046447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901151|NCT02046460|Aspirin|aspirin|mesh-list
64901152|NCT02046460|Vitamin K|vitamin k|mesh-list
64901153|NCT02046460|Warfarin|warfarin|mesh-list
64983485|NCT00087945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983547|NCT00120744|Antipruritics|antipruritics|mesh-ancestor
64983548|NCT00120744|Dermatologic Agents|dermatologic agents|mesh-ancestor
64983549|NCT00120744|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64901154|NCT02046460|Acenocoumarol|acenocoumarol|mesh-list
64901155|NCT02046460|Phenprocoumon|phenprocoumon|mesh-list
64901156|NCT02046460|Vitamins|vitamins|mesh-ancestor
64901157|NCT02046460|Micronutrients|micronutrients|mesh-ancestor
64901158|NCT02046460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901159|NCT02046460|Anticoagulants|anticoagulants|mesh-ancestor
64901160|NCT02046460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64901161|NCT02046460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64901162|NCT02046460|Analgesics|analgesics|mesh-ancestor
64901163|NCT02046460|Sensory System Agents|sensory system agents|mesh-ancestor
64901164|NCT02046460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64901165|NCT02046460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64901166|NCT02046460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64901167|NCT02046460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64901168|NCT02046460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64901169|NCT02046460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901170|NCT02046460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64901171|NCT02046460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64901172|NCT02046460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901173|NCT02046460|Antipyretics|antipyretics|mesh-ancestor
64901175|NCT02046460|Hemostatics|hemostatics|mesh-ancestor
64901197|NCT02046538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901199|NCT02046538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901200|NCT02046538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64901201|NCT02046538|Immunologic Factors|immunologic factors|mesh-ancestor
64901202|NCT02046538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901203|NCT02046538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64901204|NCT02046538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64901205|NCT02046538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901206|NCT02046538|Antidotes|antidotes|mesh-ancestor
64901207|NCT02046538|Protective Agents|protective agents|mesh-ancestor
64983550|NCT00120744|Serotonin Agents|serotonin agents|mesh-ancestor
64983551|NCT00120744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64983552|NCT00120744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983553|NCT00120744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64983554|NCT00120744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64983555|NCT00120744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64983556|NCT00120744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64983557|NCT00120744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64983558|NCT00083057|Paclitaxel|paclitaxel|mesh-list
64983559|NCT00083057|Gefitinib|gefitinib|mesh-list
64983560|NCT00083057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64983561|NCT00083057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983562|NCT00083057|Tubulin Modulators|tubulin modulators|mesh-ancestor
64983563|NCT00083057|Antimitotic Agents|antimitotic agents|mesh-ancestor
64901208|NCT02046538|Vitamin B Complex|vitamin b complex|mesh-ancestor
64901209|NCT02046538|Vitamins|vitamins|mesh-ancestor
64901210|NCT02046538|Micronutrients|micronutrients|mesh-ancestor
64901211|NCT02046551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64901212|NCT02046551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64901213|NCT02046551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64901214|NCT02046551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64901215|NCT02046551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901216|NCT02046551|Adrenergic Agents|adrenergic agents|mesh-ancestor
64901217|NCT02046551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64901218|NCT02046551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901219|NCT02046577|Vitamin D|vitamin d|mesh-list
64901220|NCT02046577|Cholecalciferol|cholecalciferol|mesh-list
64901221|NCT02046577|Vitamins|vitamins|mesh-ancestor
64901222|NCT02046577|Micronutrients|micronutrients|mesh-ancestor
64901223|NCT02046577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901224|NCT02046577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64901225|NCT02046577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64901226|NCT02046629|Teriflunomide|teriflunomide|mesh-list
64901227|NCT02046629|Cholestyramine Resin|cholestyramine resin|mesh-list
64901230|NCT02046629|Analgesics|analgesics|mesh-ancestor
64901239|NCT02046629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64901289|NCT02046915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901290|NCT02046915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901291|NCT02046915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64901292|NCT02046915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64901293|NCT02046915|Antiemetics|antiemetics|mesh-ancestor
64901294|NCT02046915|Autonomic Agents|autonomic agents|mesh-ancestor
64901295|NCT02046915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64901296|NCT02046915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64901297|NCT02046915|Glucocorticoids|glucocorticoids|mesh-ancestor
64901298|NCT02046915|Hormones|hormones|mesh-ancestor
64901299|NCT02046915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64901300|NCT02046915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64901301|NCT02046915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64901302|NCT02046915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64901303|NCT02046915|Growth Substances|growth substances|mesh-ancestor
64901304|NCT02046915|Growth Inhibitors|growth inhibitors|mesh-ancestor
64901305|NCT02047006|Rivaroxaban|rivaroxaban|mesh-list
64901306|NCT02047006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64901307|NCT02047006|Antithrombins|antithrombins|mesh-ancestor
64901308|NCT02047006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64901309|NCT02047006|Protease Inhibitors|protease inhibitors|mesh-ancestor
64901313|NCT02047019|Candesartan|candesartan|mesh-list
64901351|NCT02047149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64901352|NCT02047149|Antisickling Agents|antisickling agents|mesh-ancestor
64901354|NCT02047162|Bismuth|bismuth|mesh-list
64901375|NCT02047175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64901377|NCT02047175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64901378|NCT02047175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64901379|NCT02047175|Vitamin B Complex|vitamin b complex|mesh-ancestor
64901380|NCT02047175|Vitamins|vitamins|mesh-ancestor
64901381|NCT02047175|Micronutrients|micronutrients|mesh-ancestor
64901382|NCT02047201|Docetaxel|docetaxel|mesh-list
64901383|NCT02047201|Fluorouracil|fluorouracil|mesh-list
64901384|NCT02047201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901385|NCT02047201|Tubulin Modulators|tubulin modulators|mesh-ancestor
64901386|NCT02047201|Antimitotic Agents|antimitotic agents|mesh-ancestor
64901387|NCT02047201|Mitosis Modulators|mitosis modulators|mesh-ancestor
64901388|NCT02047201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901389|NCT02047201|Antimetabolites|antimetabolites|mesh-ancestor
64901390|NCT02047201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64901391|NCT02047201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64901392|NCT02047201|Immunologic Factors|immunologic factors|mesh-ancestor
64901393|NCT02047201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901447|NCT00005829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901448|NCT00005829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64901449|NCT00005829|Immunologic Factors|immunologic factors|mesh-ancestor
64901450|NCT00005829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901484|NCT00005847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901485|NCT00005847|Analgesics|analgesics|mesh-ancestor
64901486|NCT00005847|Sensory System Agents|sensory system agents|mesh-ancestor
64901487|NCT00005847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64901488|NCT00005847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64901489|NCT00005847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64901490|NCT00005847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901491|NCT00005847|Dermatologic Agents|dermatologic agents|mesh-ancestor
64901492|NCT00005847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64901493|NCT00005847|Alkylating Agents|alkylating agents|mesh-ancestor
64901494|NCT00005847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64901495|NCT00005850|Gemcitabine|gemcitabine|mesh-list
64901496|NCT00005850|Fluoxetine|fluoxetine|mesh-list
64901497|NCT00005850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901498|NCT00005850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64901499|NCT00005850|Antimetabolites|antimetabolites|mesh-ancestor
64901500|NCT00005850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901501|NCT00005850|Antiviral Agents|antiviral agents|mesh-ancestor
64901502|NCT00005850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64901503|NCT00005850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901504|NCT00005850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64670046|NCT03282669|Morphine|morphine|mesh-list
64901505|NCT00005850|Immunologic Factors|immunologic factors|mesh-ancestor
64901506|NCT00005850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901507|NCT00005850|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64901508|NCT00005850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64901509|NCT00005850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64901510|NCT00005850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64901512|NCT00005850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64901513|NCT00005850|Antidepressive Agents|antidepressive agents|mesh-ancestor
64373153|NCT04980105|Antiemetics|antiemetics|mesh-ancestor
64983564|NCT00083057|Mitosis Modulators|mitosis modulators|mesh-ancestor
64983565|NCT00083057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983566|NCT00083057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64983567|NCT00083057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901514|NCT00005850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64901515|NCT00005850|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64901524|NCT00005853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901525|NCT00005853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64901526|NCT00005853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64901527|NCT00005853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64901528|NCT00005853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64901529|NCT00005853|Immunologic Factors|immunologic factors|mesh-ancestor
64901530|NCT00005856|Oxaliplatin|oxaliplatin|mesh-list
64901531|NCT00005856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901533|NCT00005859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901534|NCT00005862|Semaxinib|semaxinib|mesh-list
64901535|NCT00005862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64901536|NCT00005862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64901537|NCT00005862|Growth Substances|growth substances|mesh-ancestor
64901538|NCT00005862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901539|NCT00005862|Growth Inhibitors|growth inhibitors|mesh-ancestor
64901540|NCT00005862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901541|NCT00005862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64901542|NCT00005862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901543|NCT00005862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901544|NCT00005865|Vinorelbine|vinorelbine|mesh-list
64901545|NCT00005865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64901546|NCT00005865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901630|NCT00005898|Fludarabine|fludarabine|mesh-list
64901631|NCT00005898|Cyclosporins|cyclosporins|mesh-list
64901632|NCT00005898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64901633|NCT00005898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64901634|NCT00005898|Immunologic Factors|immunologic factors|mesh-ancestor
64901635|NCT00005898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901636|NCT00005898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64901637|NCT00005898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64901638|NCT00005898|Alkylating Agents|alkylating agents|mesh-ancestor
64901639|NCT00005898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901640|NCT00005898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901641|NCT00005898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64901642|NCT00005898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901643|NCT00005898|Antifungal Agents|antifungal agents|mesh-ancestor
64901644|NCT00005898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64901645|NCT00005898|Dermatologic Agents|dermatologic agents|mesh-ancestor
64901646|NCT00005898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64901647|NCT00005898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64901648|NCT00005898|Antiemetics|antiemetics|mesh-ancestor
64901649|NCT00005898|Autonomic Agents|autonomic agents|mesh-ancestor
64901651|NCT00005898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64901678|NCT00005922|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64901679|NCT00005922|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64901680|NCT00005922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64983568|NCT00307606|Methylprednisolone|methylprednisolone|mesh-list
64983569|NCT00307606|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64983648|NCT00307723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64983649|NCT00307723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983650|NCT00307723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64983651|NCT00307723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64983652|NCT00307723|Growth Substances|growth substances|mesh-ancestor
64983653|NCT00307723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983654|NCT00307723|Growth Inhibitors|growth inhibitors|mesh-ancestor
64983655|NCT00307723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64983710|NCT05446142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64983711|NCT05446142|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64983712|NCT05446142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983806|NCT00308971|Protective Agents|protective agents|mesh-ancestor
64983807|NCT00308971|Vitamin B Complex|vitamin b complex|mesh-ancestor
64983808|NCT00120939|Motexafin gadolinium|motexafin gadolinium|mesh-list
64983809|NCT00120939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983810|NCT00120939|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64983811|NCT00120939|Dermatologic Agents|dermatologic agents|mesh-ancestor
64983812|NCT00309049|Epothilones|epothilones|mesh-list
64983813|NCT00309049|Tubulin Modulators|tubulin modulators|mesh-ancestor
64983814|NCT00309049|Antimitotic Agents|antimitotic agents|mesh-ancestor
64983815|NCT00309049|Mitosis Modulators|mitosis modulators|mesh-ancestor
64983816|NCT00309049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983817|NCT00309049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983818|NCT00309088|Tacrolimus|tacrolimus|mesh-list
64983819|NCT00309088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64983859|NCT04727502|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64901681|NCT00005922|Glucocorticoids|glucocorticoids|mesh-ancestor
64901682|NCT00005922|Hormones|hormones|mesh-ancestor
64901683|NCT00005922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64901684|NCT00005922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901685|NCT00005922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64901686|NCT00005922|Immunologic Factors|immunologic factors|mesh-ancestor
64901687|NCT00005922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901688|NCT00005922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901689|NCT00005925|Muscimol|muscimol|mesh-list
64901690|NCT00005925|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64901691|NCT00005925|GABA Agonists|gaba agonists|mesh-ancestor
64901692|NCT00005925|GABA Agents|gaba agents|mesh-ancestor
64901693|NCT00005925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64901694|NCT00005925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901695|NCT00005925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901696|NCT00005928|Ramipril|ramipril|mesh-list
64901697|NCT00005928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64901698|NCT00005928|Protease Inhibitors|protease inhibitors|mesh-ancestor
64901699|NCT00005928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901700|NCT00005928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901701|NCT00005928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64901702|NCT00005931|Semaxinib|semaxinib|mesh-list
64901712|NCT00005934|Azacitidine|azacitidine|mesh-list
64901724|NCT00005940|Cyclosporins|cyclosporins|mesh-list
64901725|NCT00005940|Antibodies|antibodies|mesh-list
64901726|NCT00005940|Immunoglobulins|immunoglobulins|mesh-list
64901727|NCT00005940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64901728|NCT00005940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64901729|NCT00005940|Immunologic Factors|immunologic factors|mesh-ancestor
64901730|NCT00005940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901731|NCT00005940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64901740|NCT00005940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64901741|NCT00005940|Antimetabolites|antimetabolites|mesh-ancestor
64901742|NCT00005940|Dermatologic Agents|dermatologic agents|mesh-ancestor
64901743|NCT00005940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901744|NCT00005940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64901745|NCT00005940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64901746|NCT00005940|Antifungal Agents|antifungal agents|mesh-ancestor
64901747|NCT00005940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64901748|NCT00005940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64901749|NCT00005940|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64901750|NCT00005940|Trace Elements|trace elements|mesh-ancestor
64901751|NCT00005940|Micronutrients|micronutrients|mesh-ancestor
64901752|NCT00005943|Aldesleukin|aldesleukin|mesh-list
64901753|NCT00005943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901769|NCT00005946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64901770|NCT00005946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64901771|NCT00005946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64901772|NCT00005946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901773|NCT00005949|Aldesleukin|aldesleukin|mesh-list
64901774|NCT00005949|Interleukin-2|interleukin-2|mesh-list
64901775|NCT00005949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901776|NCT00005949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64901777|NCT00005949|Analgesics|analgesics|mesh-ancestor
64901778|NCT00005949|Sensory System Agents|sensory system agents|mesh-ancestor
64901779|NCT00005949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64901780|NCT00005949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901781|NCT00005949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64901821|NCT00005964|Etoposide|etoposide|mesh-list
64901822|NCT00005964|Vincristine|vincristine|mesh-list
64901823|NCT00005964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64901824|NCT00005964|Immunologic Factors|immunologic factors|mesh-ancestor
64901825|NCT00005964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901826|NCT00005964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64901827|NCT00005964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64901828|NCT00005964|Alkylating Agents|alkylating agents|mesh-ancestor
64901829|NCT00005964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901830|NCT00005964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901831|NCT00005964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64901832|NCT00005964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64901833|NCT00005964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64901834|NCT00005964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64901835|NCT00005964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901836|NCT00005964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64901867|NCT00005970|Immunologic Factors|immunologic factors|mesh-ancestor
64901868|NCT00005970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901869|NCT00005970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64901870|NCT00005970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64901941|NCT00005985|Analgesics|analgesics|mesh-ancestor
64901942|NCT00005985|Sensory System Agents|sensory system agents|mesh-ancestor
64901943|NCT00005988|Leucovorin|leucovorin|mesh-list
64901944|NCT00005988|Cyclosporine|cyclosporine|mesh-list
64901945|NCT00005988|Methylprednisolone|methylprednisolone|mesh-list
64901946|NCT00005988|Cyclophosphamide|cyclophosphamide|mesh-list
64901947|NCT00005988|Methotrexate|methotrexate|mesh-list
64901948|NCT00005988|Cyclosporins|cyclosporins|mesh-list
64901949|NCT00005988|Levoleucovorin|levoleucovorin|mesh-list
64901971|NCT00005988|Vitamins|vitamins|mesh-ancestor
64901972|NCT00005988|Micronutrients|micronutrients|mesh-ancestor
64901973|NCT00005988|Antifungal Agents|antifungal agents|mesh-ancestor
64901974|NCT00005988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64901975|NCT00005988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64901976|NCT00005988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64901977|NCT00005988|Antiemetics|antiemetics|mesh-ancestor
64901978|NCT00005988|Autonomic Agents|autonomic agents|mesh-ancestor
64901979|NCT00005988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64901980|NCT00005988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64901981|NCT00005988|Glucocorticoids|glucocorticoids|mesh-ancestor
64901982|NCT00005988|Hormones|hormones|mesh-ancestor
64902092|NCT00006018|Tubulin Modulators|tubulin modulators|mesh-ancestor
64902093|NCT00006018|Antimitotic Agents|antimitotic agents|mesh-ancestor
64902094|NCT00006018|Mitosis Modulators|mitosis modulators|mesh-ancestor
64902095|NCT00006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902096|NCT00006021|Ascorbic Acid|ascorbic acid|mesh-list
64902097|NCT00006021|Arsenic Trioxide|arsenic trioxide|mesh-list
64902098|NCT00006021|Antioxidants|antioxidants|mesh-ancestor
64902099|NCT00006021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902100|NCT00006021|Protective Agents|protective agents|mesh-ancestor
64902101|NCT00006021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902102|NCT00006021|Vitamins|vitamins|mesh-ancestor
64902103|NCT00006021|Micronutrients|micronutrients|mesh-ancestor
64902104|NCT00006021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902105|NCT00006024|Temozolomide|temozolomide|mesh-list
64902106|NCT00006024|Lomustine|lomustine|mesh-list
64670647|NCT01769027|Sertraline|sertraline|mesh-list
64902107|NCT00006024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64902108|NCT00006024|Alkylating Agents|alkylating agents|mesh-ancestor
64902109|NCT00006024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902110|NCT00006024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902111|NCT00006027|Paclitaxel|paclitaxel|mesh-list
64902112|NCT00006027|Cisplatin|cisplatin|mesh-list
64902140|NCT00006033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902141|NCT00006033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64902142|NCT00006033|Antimetabolites|antimetabolites|mesh-ancestor
64902143|NCT00006033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902144|NCT00006033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902145|NCT00006033|Dermatologic Agents|dermatologic agents|mesh-ancestor
64902146|NCT00006033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902147|NCT00006033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64902148|NCT00006033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64902149|NCT00006033|Immunologic Factors|immunologic factors|mesh-ancestor
64902150|NCT00006033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64902151|NCT00006033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64902162|NCT00006039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902163|NCT00006039|Immunologic Factors|immunologic factors|mesh-ancestor
64902164|NCT00006039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902165|NCT00006042|Mycophenolic Acid|mycophenolic acid|mesh-list
64902166|NCT00006042|Cyclophosphamide|cyclophosphamide|mesh-list
64902167|NCT00006042|Fludarabine|fludarabine|mesh-list
64902168|NCT00006042|Fludarabine phosphate|fludarabine phosphate|mesh-list
64902169|NCT00006042|Tacrolimus|tacrolimus|mesh-list
64902170|NCT00006042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64902171|NCT00006042|Immunologic Factors|immunologic factors|mesh-ancestor
64902172|NCT00006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902173|NCT00006042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64902174|NCT00006042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64902175|NCT00006042|Alkylating Agents|alkylating agents|mesh-ancestor
64902176|NCT00006042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902214|NCT05680545|Anesthetics|anesthetics|mesh-ancestor
64902215|NCT05680545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64902216|NCT05680545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902217|NCT05680389|Minocycline|minocycline|mesh-list
64902218|NCT05680389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64902219|NCT05680389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902220|NCT05680194|Diphosphonates|diphosphonates|mesh-list
64902221|NCT05680194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64902222|NCT05680194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902223|NCT05679921|Pembrolizumab|pembrolizumab|mesh-list
64902224|NCT05679921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64902225|NCT05679921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902226|NCT00386802|Antifungal Agents|antifungal agents|mesh-list
64902310|NCT05605509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64902311|NCT05605509|Antimetabolites|antimetabolites|mesh-ancestor
64902312|NCT05605509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902313|NCT05605509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902314|NCT05605509|Antiviral Agents|antiviral agents|mesh-ancestor
64902315|NCT05605509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902316|NCT05605509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902317|NCT05605509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64902318|NCT05605509|Immunologic Factors|immunologic factors|mesh-ancestor
64902319|NCT05605509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902320|NCT05605509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64902321|NCT05597163|Atropine|atropine|mesh-list
64902322|NCT05597163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64902424|NCT04787991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902425|NCT04787991|Tubulin Modulators|tubulin modulators|mesh-ancestor
64902426|NCT04787991|Antimitotic Agents|antimitotic agents|mesh-ancestor
64902427|NCT04787991|Mitosis Modulators|mitosis modulators|mesh-ancestor
64902428|NCT04787991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902429|NCT04787991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64902430|NCT04787991|Antimetabolites|antimetabolites|mesh-ancestor
64902431|NCT04787991|Antiviral Agents|antiviral agents|mesh-ancestor
64902444|NCT04552080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64902445|NCT04552080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902446|NCT03834909|Tenofovir|tenofovir|mesh-list
64902447|NCT03834909|Emtricitabine|emtricitabine|mesh-list
64902448|NCT03834909|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64902449|NCT03834909|Antiviral Agents|antiviral agents|mesh-ancestor
64902450|NCT03834909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902451|NCT03834909|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64902452|NCT03834909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64902453|NCT03834909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902454|NCT03834909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902455|NCT03834909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64902456|NCT03834909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64902457|NCT04360473|Magnesium Sulfate|magnesium sulfate|mesh-list
64902458|NCT04360473|Ketamine|ketamine|mesh-list
64902459|NCT04360473|Anesthetics|anesthetics|mesh-list
64902460|NCT04360473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64902461|NCT04360473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902462|NCT04360473|Analgesics|analgesics|mesh-ancestor
64902463|NCT04360473|Sensory System Agents|sensory system agents|mesh-ancestor
64902464|NCT04360473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64902501|NCT04175613|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64902502|NCT04175613|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64902503|NCT04175613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902504|NCT04175613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902505|NCT03945357|Gemcitabine|gemcitabine|mesh-list
64902506|NCT03945357|Clindamycin|clindamycin|mesh-list
64902507|NCT03945357|Clindamycin palmitate|clindamycin palmitate|mesh-list
64902508|NCT03945357|Clindamycin phosphate|clindamycin phosphate|mesh-list
64902509|NCT03945357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64902510|NCT03945357|Antimetabolites|antimetabolites|mesh-ancestor
64902511|NCT03945357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902512|NCT03945357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902513|NCT03945357|Antiviral Agents|antiviral agents|mesh-ancestor
64902546|NCT03869736|Sensory System Agents|sensory system agents|mesh-ancestor
64902547|NCT03869736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64902548|NCT03786081|Bevacizumab|bevacizumab|mesh-list
64902549|NCT03786081|Pembrolizumab|pembrolizumab|mesh-list
64902550|NCT03786081|Tisotumab vedotin|tisotumab vedotin|mesh-list
64902551|NCT03786081|Carboplatin|carboplatin|mesh-list
64902552|NCT03786081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64902553|NCT03786081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902554|NCT03786081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64902555|NCT03786081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64902556|NCT03786081|Growth Substances|growth substances|mesh-ancestor
64902557|NCT03786081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671077|NCT03245463|Immunologic Factors|immunologic factors|mesh-ancestor
64983860|NCT04727502|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64983861|NCT04727502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64983862|NCT04727502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64983863|NCT04727502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983938|NCT00121017|Tenofovir|tenofovir|mesh-list
64983939|NCT00121017|Emtricitabine|emtricitabine|mesh-list
64983940|NCT00121017|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64983941|NCT00121017|Efavirenz|efavirenz|mesh-list
64983942|NCT00121017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64983943|NCT00121017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64983944|NCT00121017|Protease Inhibitors|protease inhibitors|mesh-ancestor
64983945|NCT00121017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983946|NCT00121017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983947|NCT00121017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64983948|NCT00121017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64983973|NCT00309556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64983974|NCT00309556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64983975|NCT00309556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983976|NCT00402207|Fluticasone|fluticasone|mesh-list
64983977|NCT00402207|Beclomethasone|beclomethasone|mesh-list
64983978|NCT00402207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64983979|NCT00402207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64902558|NCT03786081|Growth Inhibitors|growth inhibitors|mesh-ancestor
64902559|NCT03782259|Dapagliflozin|dapagliflozin|mesh-list
64902560|NCT03782259|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64902561|NCT03782259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902562|NCT03782259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64902563|NCT03782259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902565|NCT03741933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64902566|NCT03741933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64902567|NCT03741933|Analgesics|analgesics|mesh-ancestor
64902568|NCT03741933|Sensory System Agents|sensory system agents|mesh-ancestor
64902569|NCT03741933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64902570|NCT03741933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902571|NCT03741933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64902572|NCT03741933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64902573|NCT03741933|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64902574|NCT03741933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64902587|NCT03568656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902588|NCT03568656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64902590|NCT03084939|Trastuzumab|trastuzumab|mesh-list
64902591|NCT03084939|Lapatinib|lapatinib|mesh-list
64902592|NCT03084939|Maytansine|maytansine|mesh-list
64902593|NCT03084939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64902594|NCT03084939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64902595|NCT03084939|Antimetabolites|antimetabolites|mesh-ancestor
64902596|NCT03084939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902597|NCT03084939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902598|NCT03084939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64902599|NCT03084939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64902600|NCT03084939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902601|NCT03084939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64902602|NCT03084939|Tubulin Modulators|tubulin modulators|mesh-ancestor
64902603|NCT03084939|Antimitotic Agents|antimitotic agents|mesh-ancestor
64902604|NCT03084939|Mitosis Modulators|mitosis modulators|mesh-ancestor
64902605|NCT03002259|Dexamethasone|dexamethasone|mesh-list
64902606|NCT03002259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64902609|NCT03002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64902610|NCT03002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902611|NCT03002259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64902612|NCT03002259|Glucocorticoids|glucocorticoids|mesh-ancestor
64902613|NCT03002259|Hormones|hormones|mesh-ancestor
64902614|NCT03002259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64902615|NCT03002259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64902616|NCT03002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902617|NCT03000387|Nicotine|nicotine|mesh-list
64902618|NCT03000387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64902619|NCT03000387|Autonomic Agents|autonomic agents|mesh-ancestor
64902620|NCT03000387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64902621|NCT03000387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902622|NCT03000387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64902623|NCT03000387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64902624|NCT03000387|Cholinergic Agents|cholinergic agents|mesh-ancestor
64902625|NCT03000387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64902626|NCT03000387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902627|NCT00387504|Fenretinide|fenretinide|mesh-list
64902628|NCT00387504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902629|NCT00387504|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64902630|NCT00387504|Protective Agents|protective agents|mesh-ancestor
64902631|NCT00387504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671160|NCT03468075|Antioxidants|antioxidants|mesh-ancestor
64902632|NCT02936505|Cyclosporine|cyclosporine|mesh-list
64902633|NCT02936505|Mycophenolic Acid|mycophenolic acid|mesh-list
64902634|NCT02936505|Tacrolimus|tacrolimus|mesh-list
64902635|NCT02936505|Cyclosporins|cyclosporins|mesh-list
64902636|NCT02936505|Thymoglobulin|thymoglobulin|mesh-list
64902637|NCT02936505|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64902638|NCT02936505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64373411|NCT03291821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64373412|NCT03291821|Contraceptive Agents|contraceptive agents|mesh-ancestor
64373413|NCT03291821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64373414|NCT03291821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64983980|NCT00402207|Autonomic Agents|autonomic agents|mesh-ancestor
64983981|NCT00402207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64983982|NCT00402207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983983|NCT00402207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64983984|NCT00402207|Respiratory System Agents|respiratory system agents|mesh-ancestor
64902639|NCT02936505|Immunologic Factors|immunologic factors|mesh-ancestor
64902640|NCT02936505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902641|NCT02936505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64902642|NCT02936505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902643|NCT02936505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902644|NCT02936505|Antifungal Agents|antifungal agents|mesh-ancestor
64902645|NCT02936505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902646|NCT02936505|Dermatologic Agents|dermatologic agents|mesh-ancestor
64902647|NCT02936505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64902648|NCT02936505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64902649|NCT02936505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902650|NCT02936505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64902651|NCT02936505|Antitubercular Agents|antitubercular agents|mesh-ancestor
64902652|NCT02936505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64902653|NCT02931903|Lithium Carbonate|lithium carbonate|mesh-list
64902654|NCT02931903|Antidepressive Agents|antidepressive agents|mesh-ancestor
64902655|NCT02931903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64902664|NCT02648997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64902665|NCT02648997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902666|NCT02648997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64902667|NCT02648997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902698|NCT02373813|Hematinics|hematinics|mesh-ancestor
64902705|NCT01959204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64902706|NCT01959204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902708|NCT01959204|Sensory System Agents|sensory system agents|mesh-ancestor
64902709|NCT01959204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64902710|NCT01853748|Paclitaxel|paclitaxel|mesh-list
64902711|NCT01853748|Maytansine|maytansine|mesh-list
64902712|NCT01853748|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64902713|NCT01853748|Trastuzumab|trastuzumab|mesh-list
64902714|NCT01853748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64902715|NCT01853748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902716|NCT01853748|Tubulin Modulators|tubulin modulators|mesh-ancestor
64902717|NCT01853748|Antimitotic Agents|antimitotic agents|mesh-ancestor
64902718|NCT01853748|Mitosis Modulators|mitosis modulators|mesh-ancestor
64902719|NCT01853748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902720|NCT01853748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64902721|NCT01756248|Aflibercept|aflibercept|mesh-list
64902722|NCT01756248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64902779|NCT00006054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64902789|NCT00006054|Glucocorticoids|glucocorticoids|mesh-ancestor
64902797|NCT00006054|Antimetabolites|antimetabolites|mesh-ancestor
64902798|NCT00006054|Dermatologic Agents|dermatologic agents|mesh-ancestor
64902799|NCT00006054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902800|NCT00006054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64902801|NCT00006054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64902802|NCT00006054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64902803|NCT00006054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64902804|NCT00006054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64902805|NCT00006054|Antifungal Agents|antifungal agents|mesh-ancestor
64902806|NCT00006054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902807|NCT00006054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64902809|NCT00006054|Autonomic Agents|autonomic agents|mesh-ancestor
64902810|NCT00006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64902811|NCT00006054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64902812|NCT00006054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64902813|NCT00006054|Protective Agents|protective agents|mesh-ancestor
64902814|NCT00006063|Pancrelipase|pancrelipase|mesh-list
64902815|NCT00006063|Pancreatin|pancreatin|mesh-list
64902816|NCT00006063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64902817|NCT00006066|Aldesleukin|aldesleukin|mesh-list
64902818|NCT00006066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902819|NCT00006066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64902820|NCT00006066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64902821|NCT00006066|Antiviral Agents|antiviral agents|mesh-ancestor
64902822|NCT00006066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902823|NCT00006072|Rituximab|rituximab|mesh-list
64902824|NCT00006072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64902825|NCT00006072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902826|NCT00006072|Immunologic Factors|immunologic factors|mesh-ancestor
64902827|NCT00006072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902829|NCT00006075|Chlorhexidine|chlorhexidine|mesh-list
64902849|NCT00006081|Antimitotic Agents|antimitotic agents|mesh-ancestor
64902850|NCT00006081|Mitosis Modulators|mitosis modulators|mesh-ancestor
64902851|NCT00006081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902852|NCT00006081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64902853|NCT00006081|Immunologic Factors|immunologic factors|mesh-ancestor
64902854|NCT00006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902855|NCT00006084|Lintuzumab|lintuzumab|mesh-list
64902856|NCT00006084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64902857|NCT00006084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902858|NCT00006090|Arsenic Trioxide|arsenic trioxide|mesh-list
64902859|NCT00006090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902860|NCT00006096|Cisplatin|cisplatin|mesh-list
64902861|NCT00006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902862|NCT00006105|Gemcitabine|gemcitabine|mesh-list
64902863|NCT00006105|Amifostine|amifostine|mesh-list
64902864|NCT00006105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902865|NCT00006105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64902866|NCT00006105|Antimetabolites|antimetabolites|mesh-ancestor
64902867|NCT00006105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902868|NCT00006105|Antiviral Agents|antiviral agents|mesh-ancestor
64902869|NCT00006105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902870|NCT00006105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902871|NCT00006105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64902872|NCT00006105|Immunologic Factors|immunologic factors|mesh-ancestor
64902873|NCT00006105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902874|NCT00006105|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64902880|NCT00006108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902881|NCT00006108|Tubulin Modulators|tubulin modulators|mesh-ancestor
64902882|NCT00006108|Antimitotic Agents|antimitotic agents|mesh-ancestor
64902883|NCT00006108|Mitosis Modulators|mitosis modulators|mesh-ancestor
64902884|NCT00006108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902885|NCT00006108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64902886|NCT00006108|Antimetabolites|antimetabolites|mesh-ancestor
64902887|NCT00006108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64902888|NCT00006111|Fluorouracil|fluorouracil|mesh-list
64373464|NCT02460107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64373473|NCT03286673|Calcium|calcium|mesh-list
64983985|NCT00402207|Dermatologic Agents|dermatologic agents|mesh-ancestor
64983986|NCT00402207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64902889|NCT00006111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902890|NCT00006111|Antimetabolites|antimetabolites|mesh-ancestor
64902891|NCT00006111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902892|NCT00006111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64902893|NCT00006111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64902894|NCT00006111|Immunologic Factors|immunologic factors|mesh-ancestor
64902895|NCT00006111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902896|NCT00006114|Vinorelbine|vinorelbine|mesh-list
64902897|NCT00006114|Mitoxantrone|mitoxantrone|mesh-list
64902898|NCT00006114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64902899|NCT00006114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902900|NCT00006114|Tubulin Modulators|tubulin modulators|mesh-ancestor
64902901|NCT00006114|Antimitotic Agents|antimitotic agents|mesh-ancestor
64902902|NCT00006114|Mitosis Modulators|mitosis modulators|mesh-ancestor
64902930|NCT00006120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902931|NCT00006123|Cyclophosphamide|cyclophosphamide|mesh-list
64902932|NCT00006123|Thiotepa|thiotepa|mesh-list
64902933|NCT00006123|Carmustine|carmustine|mesh-list
64902934|NCT00006123|Carboplatin|carboplatin|mesh-list
64902935|NCT00006123|Trastuzumab|trastuzumab|mesh-list
64902936|NCT00006123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64902937|NCT00006123|Immunologic Factors|immunologic factors|mesh-ancestor
64902938|NCT00006123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902939|NCT00006123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64902940|NCT00006123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64902941|NCT00006123|Alkylating Agents|alkylating agents|mesh-ancestor
64902942|NCT00006123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902943|NCT00006123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902944|NCT00006123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64902945|NCT00006123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64902996|NCT00006168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64902997|NCT00006168|Abortifacient Agents|abortifacient agents|mesh-ancestor
64902998|NCT00006168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64902999|NCT00006168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903000|NCT00006168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64903001|NCT00006168|Antimetabolites|antimetabolites|mesh-ancestor
64903002|NCT00006168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903011|NCT00006174|Letrozole|letrozole|mesh-list
64903042|NCT00006195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64903043|NCT00006195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64903045|NCT00006198|Doxorubicin|doxorubicin|mesh-list
64903046|NCT00006198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64903047|NCT00006198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903048|NCT00006198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64903049|NCT00006198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64903050|NCT00006198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903051|NCT00006198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903052|NCT00006198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64903053|NCT00006198|Immunologic Factors|immunologic factors|mesh-ancestor
64903054|NCT00006198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903055|NCT00006198|Leprostatic Agents|leprostatic agents|mesh-ancestor
64903056|NCT00006198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64903057|NCT00006198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64903058|NCT00006198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64903059|NCT00006198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64903060|NCT00006198|Growth Substances|growth substances|mesh-ancestor
64903061|NCT00006198|Growth Inhibitors|growth inhibitors|mesh-ancestor
64903062|NCT00006204|Naltrexone|naltrexone|mesh-list
64903063|NCT00006204|Fluoxetine|fluoxetine|mesh-list
64903064|NCT00006204|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64903065|NCT00006204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64903066|NCT00006204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903067|NCT00006204|Sensory System Agents|sensory system agents|mesh-ancestor
64983987|NCT00402207|Glucocorticoids|glucocorticoids|mesh-ancestor
64983988|NCT00402207|Hormones|hormones|mesh-ancestor
64983989|NCT00402207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64983990|NCT00399737|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64984028|NCT00309790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984029|NCT00309790|Urological Agents|urological agents|mesh-ancestor
64903089|NCT00006219|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64903090|NCT00006219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64903091|NCT00006219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64903092|NCT00006219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64903093|NCT00006219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903094|NCT00006219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903095|NCT00006219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64903096|NCT00006219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64903097|NCT00006219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64903098|NCT00006219|Immunologic Factors|immunologic factors|mesh-ancestor
64903099|NCT00006219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903100|NCT00387582|Ranibizumab|ranibizumab|mesh-list
64903101|NCT00387582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64903102|NCT00387582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64903103|NCT00387582|Growth Substances|growth substances|mesh-ancestor
64903104|NCT00387582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903105|NCT00387582|Growth Inhibitors|growth inhibitors|mesh-ancestor
64903106|NCT00387582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903107|NCT00006228|Aldesleukin|aldesleukin|mesh-list
64903108|NCT00006228|Trastuzumab|trastuzumab|mesh-list
64903109|NCT00006228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64903110|NCT00006228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903111|NCT00006228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64373486|NCT02445703|Immunologic Factors|immunologic factors|mesh-ancestor
64373487|NCT02445703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984030|NCT00418873|Risperidone|risperidone|mesh-list
64984031|NCT00418873|Zotepine|zotepine|mesh-list
64984032|NCT00418873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64984033|NCT00418873|Serotonin Agents|serotonin agents|mesh-ancestor
64984034|NCT00418873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64984035|NCT00418873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984036|NCT00418873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984037|NCT00418873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64984038|NCT00418873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64984039|NCT00418873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64984041|NCT00418873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64984042|NCT00418873|Dopamine Agents|dopamine agents|mesh-ancestor
64984043|NCT00088608|Pasireotide|pasireotide|mesh-list
64984044|NCT00088608|Hormones|hormones|mesh-ancestor
64984045|NCT00088608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64984046|NCT00088608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984047|NCT00310024|Bortezomib|bortezomib|mesh-list
64984083|NCT00083681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984084|NCT00083681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64984085|NCT00083681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64984086|NCT00083681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64984087|NCT00083681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984088|NCT00083681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984089|NCT00083681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64903116|NCT03751800|Dienogest|dienogest|mesh-list
64903138|NCT00006240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64903139|NCT00006240|Antiemetics|antiemetics|mesh-ancestor
64903140|NCT00006240|Autonomic Agents|autonomic agents|mesh-ancestor
64903141|NCT00006240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64903142|NCT00006240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903143|NCT00006240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64903144|NCT00006240|Glucocorticoids|glucocorticoids|mesh-ancestor
64903145|NCT00006240|Hormones|hormones|mesh-ancestor
64903146|NCT00006240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64903147|NCT00006240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64903148|NCT00006240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903149|NCT00006240|Immunologic Factors|immunologic factors|mesh-ancestor
64903150|NCT02972463|Immunoglobulins|immunoglobulins|mesh-list
64903151|NCT02972463|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64903152|NCT02972463|Antibodies|antibodies|mesh-list
64903153|NCT02972463|Immunologic Factors|immunologic factors|mesh-ancestor
64903154|NCT02972463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903155|NCT00006243|Sargramostim|sargramostim|mesh-list
64903156|NCT00006243|Freund's Adjuvant|freund's adjuvant|mesh-list
64903196|NCT00006258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903198|NCT00006258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64903199|NCT00006258|Alkylating Agents|alkylating agents|mesh-ancestor
64903200|NCT00006258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903201|NCT00006258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903202|NCT00006258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64903203|NCT00006258|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64903204|NCT00006258|Abortifacient Agents|abortifacient agents|mesh-ancestor
64903205|NCT00006258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64903206|NCT00006258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64903207|NCT00006258|Antimetabolites|antimetabolites|mesh-ancestor
64903208|NCT00006258|Dermatologic Agents|dermatologic agents|mesh-ancestor
64373534|NCT03285503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64373535|NCT02439697|Darbepoetin alfa|darbepoetin alfa|mesh-list
64373537|NCT05179603|Pembrolizumab|pembrolizumab|mesh-list
64984090|NCT00083681|Immunologic Factors|immunologic factors|mesh-ancestor
64984091|NCT00083681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64984092|NCT00083681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64984093|NCT00083681|Alkylating Agents|alkylating agents|mesh-ancestor
64984094|NCT00083681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64984095|NCT00083681|Leprostatic Agents|leprostatic agents|mesh-ancestor
64903209|NCT00006258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903210|NCT00006258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64903211|NCT00006258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64903212|NCT00006258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64903251|NCT00006264|Antiviral Agents|antiviral agents|mesh-ancestor
64903252|NCT00006264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64903253|NCT00006264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64903254|NCT00006264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64903255|NCT00006264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903256|NCT00006267|Rubitecan|rubitecan|mesh-list
64903257|NCT00006267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903258|NCT00006267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64903259|NCT00006267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64903260|NCT00006267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903261|NCT00006267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903262|NCT00006270|Cosyntropin|cosyntropin|mesh-list
64903263|NCT00006270|Metyrapone|metyrapone|mesh-list
64903264|NCT00006270|Hormones|hormones|mesh-ancestor
64903326|NCT00006324|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64903327|NCT00006324|Medroxyprogesterone|medroxyprogesterone|mesh-list
64903328|NCT00006324|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64903329|NCT00006324|Estradiol|estradiol|mesh-list
64903330|NCT00006324|Estrogens|estrogens|mesh-ancestor
64903331|NCT00006324|Hormones|hormones|mesh-ancestor
64903332|NCT00006324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64903333|NCT00006324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903334|NCT00006324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64903340|NCT00006324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64903341|NCT00006324|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64903342|NCT00006324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64903343|NCT00006324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903344|NCT00006324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64903345|NCT00005824|Cyclophosphamide|cyclophosphamide|mesh-list
64903346|NCT00005824|Busulfan|busulfan|mesh-list
64903347|NCT00005824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64903348|NCT00005824|Immunologic Factors|immunologic factors|mesh-ancestor
64903349|NCT00005824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903350|NCT00005824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64903351|NCT00005824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64903352|NCT00005824|Alkylating Agents|alkylating agents|mesh-ancestor
64903353|NCT00005824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903401|NCT00005848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903402|NCT00005851|Cyclosporine|cyclosporine|mesh-list
64903403|NCT00005851|Mycophenolic Acid|mycophenolic acid|mesh-list
64903404|NCT00005851|Fludarabine|fludarabine|mesh-list
64903405|NCT00005851|Fludarabine phosphate|fludarabine phosphate|mesh-list
64903406|NCT00005851|Cyclosporins|cyclosporins|mesh-list
64903407|NCT00005851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903408|NCT00005851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64903409|NCT00005851|Antimetabolites|antimetabolites|mesh-ancestor
64903410|NCT00005851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903411|NCT00005851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64903412|NCT00005851|Immunologic Factors|immunologic factors|mesh-ancestor
64903413|NCT00005851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903436|NCT00005854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64903437|NCT00005854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64903438|NCT00005854|Abortifacient Agents|abortifacient agents|mesh-ancestor
64903439|NCT00005854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64903440|NCT00005854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64903441|NCT00005854|Antimetabolites|antimetabolites|mesh-ancestor
64903442|NCT00005854|Dermatologic Agents|dermatologic agents|mesh-ancestor
64903443|NCT00005854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903510|NCT00005866|Abortifacient Agents|abortifacient agents|mesh-ancestor
64903511|NCT00005866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64903512|NCT00005866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64903513|NCT00005866|Antimetabolites|antimetabolites|mesh-ancestor
64903514|NCT00005866|Dermatologic Agents|dermatologic agents|mesh-ancestor
64903515|NCT00005866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903541|NCT00005875|Rubitecan|rubitecan|mesh-list
64903542|NCT00005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903543|NCT00005875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64903544|NCT00005875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64903545|NCT00005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903546|NCT00005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903547|NCT00005878|Celecoxib|celecoxib|mesh-list
64903548|NCT00005878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64903549|NCT00005878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64903550|NCT00005878|Analgesics|analgesics|mesh-ancestor
64903551|NCT00005878|Sensory System Agents|sensory system agents|mesh-ancestor
64903552|NCT00005878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64903553|NCT00005878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903554|NCT00005878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64903555|NCT00005878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64903606|NCT00005893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903607|NCT00005893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64903608|NCT00005896|Lenograstim|lenograstim|mesh-list
64903609|NCT00005896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64903610|NCT00005896|Immunologic Factors|immunologic factors|mesh-ancestor
64903611|NCT00005896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903612|NCT00386503|Artesunate|artesunate|mesh-list
64903613|NCT00386503|Amodiaquine|amodiaquine|mesh-list
64903614|NCT00386503|Antimalarials|antimalarials|mesh-ancestor
64903615|NCT00386503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64903616|NCT00386503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64903617|NCT00386503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64903630|NCT00386581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903631|NCT00006345|Dexamethasone|dexamethasone|mesh-list
64903632|NCT00006345|Denileukin diftitox|denileukin diftitox|mesh-list
64903633|NCT00006345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64903634|NCT00006345|Antiemetics|antiemetics|mesh-ancestor
64903635|NCT00006345|Autonomic Agents|autonomic agents|mesh-ancestor
64903636|NCT00006345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64903637|NCT00006345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903638|NCT00006345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64903639|NCT00006345|Glucocorticoids|glucocorticoids|mesh-ancestor
64903640|NCT00006345|Hormones|hormones|mesh-ancestor
64903641|NCT00006345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64903642|NCT00006345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64903643|NCT00006345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903644|NCT00005920|Caspofungin|caspofungin|mesh-list
64903645|NCT00005920|Antifungal Agents|antifungal agents|mesh-ancestor
64903646|NCT00005920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64903647|NCT00005920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903648|NCT00005920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903649|NCT00005926|Gemcitabine|gemcitabine|mesh-list
64903650|NCT00005926|Trastuzumab|trastuzumab|mesh-list
64903651|NCT00005926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64903652|NCT00005926|Antimetabolites|antimetabolites|mesh-ancestor
64903657|NCT00005926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903658|NCT00005926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64903675|NCT00005935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64903676|NCT00005935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903677|NCT00005935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64903678|NCT00005935|Antitubercular Agents|antitubercular agents|mesh-ancestor
64903679|NCT00005935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64903680|NCT00006348|Ondansetron|ondansetron|mesh-list
64903681|NCT00006348|Antiemetics|antiemetics|mesh-ancestor
64903682|NCT00006348|Autonomic Agents|autonomic agents|mesh-ancestor
64903683|NCT00006348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64903684|NCT00006348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903685|NCT00006348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64903686|NCT00006348|Antipruritics|antipruritics|mesh-ancestor
64903687|NCT00006348|Dermatologic Agents|dermatologic agents|mesh-ancestor
64903688|NCT00006348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64903689|NCT00006348|Serotonin Agents|serotonin agents|mesh-ancestor
64903690|NCT00006348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64903691|NCT00006348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903692|NCT00006348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64903693|NCT00006348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64903694|NCT00006348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64903695|NCT00006348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64903696|NCT00006348|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64903697|NCT00005938|Exatecan|exatecan|mesh-list
64903698|NCT00005938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64903700|NCT00005938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903789|NCT00005959|Antimitotic Agents|antimitotic agents|mesh-ancestor
64903790|NCT00005959|Mitosis Modulators|mitosis modulators|mesh-ancestor
64903792|NCT00387738|Histamine Agonists|histamine agonists|mesh-ancestor
64903793|NCT00387738|Histamine Agents|histamine agents|mesh-ancestor
64903794|NCT00387738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64903795|NCT00387738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903796|NCT00387738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903797|NCT00005962|Cytarabine|cytarabine|mesh-list
64903798|NCT00005962|Cyclophosphamide|cyclophosphamide|mesh-list
64903799|NCT00005962|Daunorubicin|daunorubicin|mesh-list
64903800|NCT00005962|Topotecan|topotecan|mesh-list
64903816|NCT00005962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64903817|NCT00005962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64903818|NCT00005962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64903819|NCT00005962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903820|NCT00005962|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64903821|NCT00005962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64903823|NCT00005965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903824|NCT00005965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64903825|NCT00005965|Immunologic Factors|immunologic factors|mesh-ancestor
64903826|NCT00005965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903827|NCT00005968|Irofulven|irofulven|mesh-list
64903828|NCT00005968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64903829|NCT00005968|Alkylating Agents|alkylating agents|mesh-ancestor
64903830|NCT00005968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903831|NCT00005968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903832|NCT00387777|Buprenorphine|buprenorphine|mesh-list
64903833|NCT00387777|Analgesics|analgesics|mesh-list
64903834|NCT00387777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64903835|NCT00387777|Narcotics|narcotics|mesh-ancestor
64903836|NCT00387777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64903837|NCT00387777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903838|NCT00387777|Sensory System Agents|sensory system agents|mesh-ancestor
64672350|NCT01774604|Analgesics|analgesics|mesh-ancestor
64903839|NCT00387777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64903844|NCT00005971|Growth Substances|growth substances|mesh-ancestor
64903845|NCT00005971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903846|NCT00005971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64903847|NCT00005971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903848|NCT00005971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903856|NCT00005974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903858|NCT00005977|Cytarabine|cytarabine|mesh-list
64903859|NCT00005977|Dexamethasone|dexamethasone|mesh-list
64903860|NCT00005977|Cyclophosphamide|cyclophosphamide|mesh-list
64903861|NCT00005977|Ifosfamide|ifosfamide|mesh-list
64903862|NCT00005977|Doxorubicin|doxorubicin|mesh-list
64903863|NCT00005977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64903864|NCT00005977|Methotrexate|methotrexate|mesh-list
64903865|NCT00005977|Etoposide|etoposide|mesh-list
64903866|NCT00005977|Vincristine|vincristine|mesh-list
64903867|NCT00005977|Lenograstim|lenograstim|mesh-list
64903868|NCT00005977|Levoleucovorin|levoleucovorin|mesh-list
64903869|NCT00005977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64903870|NCT00005977|Immunologic Factors|immunologic factors|mesh-ancestor
64903871|NCT00005977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903872|NCT00005977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64903873|NCT00005977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64903874|NCT00005977|Alkylating Agents|alkylating agents|mesh-ancestor
64903875|NCT00005977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903876|NCT00005977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903877|NCT00005977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64903878|NCT00005977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64903879|NCT00005977|Antiemetics|antiemetics|mesh-ancestor
64903880|NCT00005977|Autonomic Agents|autonomic agents|mesh-ancestor
64903881|NCT00005977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64903882|NCT00005977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64903883|NCT00005977|Glucocorticoids|glucocorticoids|mesh-ancestor
64903884|NCT00005977|Hormones|hormones|mesh-ancestor
64903885|NCT00005977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64903900|NCT00005977|Antiviral Agents|antiviral agents|mesh-ancestor
64903907|NCT00005977|Micronutrients|micronutrients|mesh-ancestor
64903908|NCT00005977|Tubulin Modulators|tubulin modulators|mesh-ancestor
64903909|NCT00005977|Antimitotic Agents|antimitotic agents|mesh-ancestor
64903910|NCT00005977|Mitosis Modulators|mitosis modulators|mesh-ancestor
64903911|NCT00005980|Doxorubicin|doxorubicin|mesh-list
64903912|NCT00005980|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64672423|NCT00355667|Furosemide|furosemide|mesh-list
64903913|NCT00005980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64903914|NCT00005980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903915|NCT00005980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64903916|NCT00005980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64903917|NCT00005980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903918|NCT00005980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903919|NCT00005986|Interferons|interferons|mesh-list
64903920|NCT00005986|Interferon-alpha|interferon-alpha|mesh-list
64903921|NCT00005986|Cyclophosphamide|cyclophosphamide|mesh-list
64903922|NCT00005986|Busulfan|busulfan|mesh-list
64903923|NCT00005986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64903924|NCT00005986|Immunologic Factors|immunologic factors|mesh-ancestor
64903925|NCT00005986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903926|NCT00005986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64903927|NCT00005986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64903928|NCT00005986|Alkylating Agents|alkylating agents|mesh-ancestor
64903929|NCT00005986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903930|NCT00005986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903968|NCT00005998|Analgesics|analgesics|mesh-ancestor
64903969|NCT00005998|Sensory System Agents|sensory system agents|mesh-ancestor
64903970|NCT00006351|Gemcitabine|gemcitabine|mesh-list
64903971|NCT00006351|Lonafarnib|lonafarnib|mesh-list
64903972|NCT00006351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64903973|NCT00006351|Antimetabolites|antimetabolites|mesh-ancestor
64903974|NCT00006351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903986|NCT00006001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903987|NCT00006001|Growth Inhibitors|growth inhibitors|mesh-ancestor
64903988|NCT00006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903989|NCT00006001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64903990|NCT00006001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903991|NCT00006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903993|NCT00006004|Paclitaxel|paclitaxel|mesh-list
64903994|NCT00006004|Carboplatin|carboplatin|mesh-list
64903995|NCT00006004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64903996|NCT00006004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903997|NCT00006004|Tubulin Modulators|tubulin modulators|mesh-ancestor
64903998|NCT00006004|Antimitotic Agents|antimitotic agents|mesh-ancestor
64903999|NCT00006004|Mitosis Modulators|mitosis modulators|mesh-ancestor
64904000|NCT00006004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904001|NCT00006004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64904002|NCT00006004|Antimetabolites|antimetabolites|mesh-ancestor
64904010|NCT00006007|Pemetrexed|pemetrexed|mesh-list
64904035|NCT00006010|Tubulin Modulators|tubulin modulators|mesh-ancestor
64904036|NCT00006010|Antimitotic Agents|antimitotic agents|mesh-ancestor
64904037|NCT00006010|Mitosis Modulators|mitosis modulators|mesh-ancestor
64904038|NCT00006013|Semaxinib|semaxinib|mesh-list
64904039|NCT00006013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64904040|NCT00006013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64904041|NCT00006013|Growth Substances|growth substances|mesh-ancestor
64904053|NCT00006016|Thalidomide|thalidomide|mesh-list
64904082|NCT00006022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64904083|NCT00006022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64904084|NCT00006022|Antiviral Agents|antiviral agents|mesh-ancestor
64904085|NCT00006022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904086|NCT00006022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64904087|NCT00006022|Immunologic Factors|immunologic factors|mesh-ancestor
64904088|NCT00006022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904089|NCT00006025|Irinotecan|irinotecan|mesh-list
64904090|NCT00006025|Temozolomide|temozolomide|mesh-list
64904091|NCT00006025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64904092|NCT00006025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64904093|NCT00006025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904094|NCT00006025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904095|NCT00006025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904096|NCT00006025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64904097|NCT00006025|Alkylating Agents|alkylating agents|mesh-ancestor
64904098|NCT00386659|Ritonavir|ritonavir|mesh-list
64904099|NCT00386659|Lopinavir|lopinavir|mesh-list
64904100|NCT00386659|Tenofovir|tenofovir|mesh-list
64904101|NCT00386659|Abacavir|abacavir|mesh-list
64904102|NCT00386659|Efavirenz|efavirenz|mesh-list
64904103|NCT00386659|Dideoxynucleosides|dideoxynucleosides|mesh-list
64904104|NCT00386659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64904142|NCT00387933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64904143|NCT00006034|Doxorubicin|doxorubicin|mesh-list
64904144|NCT00006034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64904145|NCT00006034|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
64904146|NCT00006034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64904147|NCT00006034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904148|NCT00006034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64904149|NCT00006034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64904150|NCT00006034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904151|NCT00006034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904152|NCT00006034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64904153|NCT00006034|Immunologic Factors|immunologic factors|mesh-ancestor
64904154|NCT00006034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904155|NCT00006037|Fluorouracil|fluorouracil|mesh-list
64904156|NCT00006037|Irinotecan|irinotecan|mesh-list
64904157|NCT00006037|Antimetabolites|antimetabolites|mesh-ancestor
64904158|NCT00006037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904159|NCT00006037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64904217|NCT00006366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904218|NCT00006366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64904219|NCT00006366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904220|NCT00006366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64904221|NCT00006366|Immunologic Factors|immunologic factors|mesh-ancestor
64904222|NCT00006366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904223|NCT00006366|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64904224|NCT00006366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64904225|NCT00006366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904226|NCT05680792|Ritonavir|ritonavir|mesh-list
64904227|NCT05680792|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64904228|NCT05680792|Nitazoxanide|nitazoxanide|mesh-list
64904229|NCT05680792|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64904230|NCT05680792|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64904231|NCT05680792|Protease Inhibitors|protease inhibitors|mesh-ancestor
64904232|NCT05680792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904233|NCT05680792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904234|NCT05680792|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64904235|NCT05680792|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64904236|NCT05680792|Antiviral Agents|antiviral agents|mesh-ancestor
64904237|NCT05680792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904238|NCT05680792|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64904239|NCT05680792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64904240|NCT05680792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64904241|NCT05680558|Methoxsalen|methoxsalen|mesh-list
64904242|NCT05680558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64904243|NCT05680558|Dermatologic Agents|dermatologic agents|mesh-ancestor
64904259|NCT00006372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64904260|NCT00006372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64904261|NCT00006372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64904262|NCT00006372|Tubulin Modulators|tubulin modulators|mesh-ancestor
64904263|NCT00006372|Antimitotic Agents|antimitotic agents|mesh-ancestor
64904264|NCT00006372|Mitosis Modulators|mitosis modulators|mesh-ancestor
64984102|NCT00121095|Docetaxel|docetaxel|mesh-list
64984116|NCT00310297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984118|NCT00310336|Ribavirin|ribavirin|mesh-list
64984119|NCT00310336|Interferon-alpha|interferon-alpha|mesh-list
64984120|NCT00310336|Interferon alpha-2|interferon alpha-2|mesh-list
64984121|NCT00310336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64984122|NCT00310336|Betaine|betaine|mesh-list
64984123|NCT00310336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984124|NCT00310336|Antiviral Agents|antiviral agents|mesh-ancestor
64904266|NCT00006378|Carboplatin|carboplatin|mesh-list
64904267|NCT00006378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64904268|NCT00006378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904269|NCT00006378|Tubulin Modulators|tubulin modulators|mesh-ancestor
64904270|NCT00006378|Antimitotic Agents|antimitotic agents|mesh-ancestor
64904271|NCT00006378|Mitosis Modulators|mitosis modulators|mesh-ancestor
64904272|NCT00006378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904273|NCT00006381|Celecoxib|celecoxib|mesh-list
64904274|NCT00006381|Trastuzumab|trastuzumab|mesh-list
64904275|NCT00006381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64904276|NCT00006381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904277|NCT00006381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64904278|NCT00006381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64904314|NCT05679388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64904315|NCT05679388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64904316|NCT05679388|Antifungal Agents|antifungal agents|mesh-ancestor
64904317|NCT05679388|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64904318|NCT05679388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64904319|NCT05679388|Hormone Antagonists|hormone antagonists|mesh-ancestor
64904320|NCT05679388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64904321|NCT05679388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904322|NCT05679388|Androgen Antagonists|androgen antagonists|mesh-ancestor
64904323|NCT05678296|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64904394|NCT05660200|Micronutrients|micronutrients|mesh-ancestor
64904395|NCT05660200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904396|NCT05656027|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64904424|NCT05552404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64904425|NCT05552404|Protective Agents|protective agents|mesh-ancestor
64904426|NCT05546320|Aspirin|aspirin|mesh-list
64904427|NCT05546320|Metoprolol|metoprolol|mesh-list
64904428|NCT05546320|Rivaroxaban|rivaroxaban|mesh-list
64904429|NCT05546320|Clopidogrel|clopidogrel|mesh-list
64904430|NCT05546320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64904431|NCT05546320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64904432|NCT05546320|Analgesics|analgesics|mesh-ancestor
64904433|NCT05546320|Sensory System Agents|sensory system agents|mesh-ancestor
64904434|NCT05546320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64904490|NCT05431543|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64904491|NCT05413018|Azacitidine|azacitidine|mesh-list
64904492|NCT05413018|Cc-486|cc-486|mesh-list
64904512|NCT05285683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64904513|NCT05285683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904514|NCT05285683|Dopamine Agents|dopamine agents|mesh-ancestor
64904515|NCT05285683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64904516|NCT05285683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64904517|NCT05285683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64904518|NCT05285683|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64904519|NCT05285683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904520|NCT05285683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64904521|NCT05285683|Immunologic Factors|immunologic factors|mesh-ancestor
64904522|NCT05285683|Dopamine Agonists|dopamine agonists|mesh-ancestor
64904523|NCT05247970|Midazolam|midazolam|mesh-list
64904524|NCT05247970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64904525|NCT05247970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64904526|NCT05247970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64904527|NCT05247970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904528|NCT05247970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64904529|NCT05247970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64904530|NCT05247970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64904531|NCT05247970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64904532|NCT05247970|Anesthetics, General|anesthetics, general|mesh-ancestor
64904533|NCT05247970|Anesthetics|anesthetics|mesh-ancestor
64904534|NCT05247970|GABA Modulators|gaba modulators|mesh-ancestor
64904535|NCT05247970|GABA Agents|gaba agents|mesh-ancestor
64904536|NCT05247970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64904537|NCT05247970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904538|NCT00006441|Lamivudine|lamivudine|mesh-list
64904539|NCT00006441|Zidovudine|zidovudine|mesh-list
64904540|NCT00006441|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64904541|NCT00006441|Aldesleukin|aldesleukin|mesh-list
64904542|NCT00006441|Nelfinavir|nelfinavir|mesh-list
64904543|NCT00006441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64373700|NCT03269747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64373710|NCT03269591|Hormones|hormones|mesh-ancestor
64984125|NCT00310336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64984180|NCT00310843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984181|NCT00310843|Antiviral Agents|antiviral agents|mesh-ancestor
64904544|NCT00006441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64904545|NCT00006441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904554|NCT00006441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64904555|NCT00006441|Protease Inhibitors|protease inhibitors|mesh-ancestor
64904556|NCT05147233|Dexamethasone|dexamethasone|mesh-list
64904557|NCT05147233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64904558|NCT05147233|Antiemetics|antiemetics|mesh-ancestor
64904559|NCT05147233|Autonomic Agents|autonomic agents|mesh-ancestor
64904560|NCT05147233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64904561|NCT05147233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904562|NCT05147233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64904563|NCT05147233|Glucocorticoids|glucocorticoids|mesh-ancestor
64904564|NCT05147233|Hormones|hormones|mesh-ancestor
64904565|NCT05147233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64904566|NCT05147233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64904677|NCT04575181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64904719|NCT04355572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64904721|NCT04201834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64904722|NCT04201834|Serotonin Agents|serotonin agents|mesh-ancestor
64904723|NCT04201834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64904724|NCT04201834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904725|NCT04201834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904726|NCT04201834|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64904727|NCT04201834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64904728|NCT04201834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64904729|NCT04201834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64904730|NCT04201834|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64904731|NCT04201834|Dopamine Agents|dopamine agents|mesh-ancestor
64904732|NCT04192435|Tranexamic Acid|tranexamic acid|mesh-list
64904733|NCT04192435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64904734|NCT04192435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64904735|NCT04192435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904736|NCT04192435|Hemostatics|hemostatics|mesh-ancestor
64904737|NCT04192435|Coagulants|coagulants|mesh-ancestor
64904738|NCT04191187|Fludarabine|fludarabine|mesh-list
64904739|NCT04191187|Melphalan|melphalan|mesh-list
64904740|NCT04191187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904741|NCT04191187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904742|NCT04191187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64904793|NCT00423397|Gefitinib|gefitinib|mesh-list
64904794|NCT00423397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904795|NCT00423397|Antiviral Agents|antiviral agents|mesh-ancestor
64904796|NCT00423397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904797|NCT00423397|Immunologic Factors|immunologic factors|mesh-ancestor
64904798|NCT00423397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904815|NCT03265405|Prednisolone|prednisolone|mesh-list
64904816|NCT03265405|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64904817|NCT03265405|Methylprednisolone|methylprednisolone|mesh-list
64904818|NCT03265405|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64904819|NCT03265405|Prednisolone acetate|prednisolone acetate|mesh-list
64904820|NCT03265405|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64904821|NCT03265405|Prednisolone phosphate|prednisolone phosphate|mesh-list
64904822|NCT03265405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64904823|NCT03265405|Glucocorticoids|glucocorticoids|mesh-ancestor
64904824|NCT03265405|Hormones|hormones|mesh-ancestor
64904825|NCT03265405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64904826|NCT03265405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904827|NCT03265405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64904828|NCT03265405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904830|NCT03265405|Autonomic Agents|autonomic agents|mesh-ancestor
64904831|NCT03265405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64904832|NCT03265405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64904833|NCT03265405|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64904834|NCT03265405|Protective Agents|protective agents|mesh-ancestor
64904835|NCT03808480|Nivolumab|nivolumab|mesh-list
64904871|NCT02890069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373831|NCT03277391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373832|NCT03277001|Enoxaparin|enoxaparin|mesh-list
64373833|NCT03277001|Rivaroxaban|rivaroxaban|mesh-list
64373844|NCT03272711|Vortioxetine|vortioxetine|mesh-list
64984182|NCT00310843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64984183|NCT00310843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64984184|NCT00310843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64984185|NCT00310843|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64984186|NCT00310843|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64984187|NCT00310921|Misoprostol|misoprostol|mesh-list
64984188|NCT00310921|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64984189|NCT00310921|Abortifacient Agents|abortifacient agents|mesh-ancestor
64984190|NCT00310921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64984191|NCT00310921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984192|NCT00310921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64984193|NCT00310921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64984194|NCT00310921|Oxytocics|oxytocics|mesh-ancestor
64984196|NCT05568212|Olaparib|olaparib|mesh-list
64984197|NCT05568212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64904872|NCT02890069|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64904873|NCT02890069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904874|NCT02890069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904875|NCT02890069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64904876|NCT02712151|Ropivacaine|ropivacaine|mesh-list
64904877|NCT02712151|Anesthetics, Local|anesthetics, local|mesh-ancestor
64904878|NCT02712151|Anesthetics|anesthetics|mesh-ancestor
64904879|NCT02712151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64904880|NCT02712151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904881|NCT02712151|Sensory System Agents|sensory system agents|mesh-ancestor
64904882|NCT02712151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64904883|NCT02425501|Aflibercept|aflibercept|mesh-list
64904884|NCT02425501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64904885|NCT02425501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64904886|NCT02425501|Growth Substances|growth substances|mesh-ancestor
64904887|NCT02425501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904888|NCT02425501|Growth Inhibitors|growth inhibitors|mesh-ancestor
64904926|NCT00006591|Ritonavir|ritonavir|mesh-list
64904987|NCT00006708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904988|NCT00006708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64904989|NCT00006708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64904990|NCT00006708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64904991|NCT00006708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64904992|NCT00006708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904993|NCT00006708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904994|NCT00006708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64904995|NCT00006708|Alkylating Agents|alkylating agents|mesh-ancestor
64904996|NCT00006747|Cytarabine|cytarabine|mesh-list
64904997|NCT00006747|Methotrexate|methotrexate|mesh-list
64904998|NCT00006747|Etoposide|etoposide|mesh-list
64904999|NCT00006747|Melphalan|melphalan|mesh-list
64905000|NCT00006747|Carmustine|carmustine|mesh-list
64905001|NCT00006747|Tacrolimus|tacrolimus|mesh-list
64905002|NCT00006747|Sargramostim|sargramostim|mesh-list
64905003|NCT00006747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64905004|NCT00006747|Abortifacient Agents|abortifacient agents|mesh-ancestor
64905005|NCT00006747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64905006|NCT00006747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905007|NCT00006747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64905008|NCT00006747|Antimetabolites|antimetabolites|mesh-ancestor
64905083|NCT00007059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64905084|NCT00007059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64905085|NCT00007059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905086|NCT00007059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905087|NCT00387556|Ondansetron|ondansetron|mesh-list
64905088|NCT00387556|Antiemetics|antiemetics|mesh-ancestor
64905089|NCT00387556|Autonomic Agents|autonomic agents|mesh-ancestor
64905090|NCT00387556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64905091|NCT00387556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905092|NCT00387556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64905093|NCT00387556|Antipruritics|antipruritics|mesh-ancestor
64905094|NCT00387556|Dermatologic Agents|dermatologic agents|mesh-ancestor
64905095|NCT00387556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64905096|NCT00387556|Serotonin Agents|serotonin agents|mesh-ancestor
64905097|NCT00387556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64905098|NCT00387556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905099|NCT00387556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64905100|NCT00387556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64905101|NCT00387556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64905102|NCT00387556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64905103|NCT00387556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64905104|NCT03780790|Bupivacaine|bupivacaine|mesh-list
64905105|NCT03780790|Anesthetics, Local|anesthetics, local|mesh-ancestor
64905106|NCT03780790|Anesthetics|anesthetics|mesh-ancestor
64905107|NCT03780790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64905108|NCT03780790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905109|NCT03780790|Sensory System Agents|sensory system agents|mesh-ancestor
64905110|NCT03780790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64905111|NCT00388167|Caspofungin|caspofungin|mesh-list
64905112|NCT00388167|Antifungal Agents|antifungal agents|mesh-ancestor
64905113|NCT00388167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64905114|NCT00388167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905115|NCT00388167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905116|NCT00006043|Temozolomide|temozolomide|mesh-list
64905122|NCT00006049|Carboplatin|carboplatin|mesh-list
64905123|NCT00006049|Gefitinib|gefitinib|mesh-list
64905124|NCT00006049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64905125|NCT00006049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905126|NCT00006049|Tubulin Modulators|tubulin modulators|mesh-ancestor
64905127|NCT00006049|Antimitotic Agents|antimitotic agents|mesh-ancestor
64905128|NCT00006049|Mitosis Modulators|mitosis modulators|mesh-ancestor
64905129|NCT00006049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905130|NCT00006049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64905131|NCT00006049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905132|NCT00006052|Imatinib Mesylate|imatinib mesylate|mesh-list
64905133|NCT00006052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905134|NCT00006052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64905135|NCT00006052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905155|NCT00006055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64905156|NCT00006055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64905157|NCT00006055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905158|NCT00006055|Antifungal Agents|antifungal agents|mesh-ancestor
64905159|NCT00006055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64905160|NCT00006055|Dermatologic Agents|dermatologic agents|mesh-ancestor
64905161|NCT00006055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64905162|NCT00006055|Antiemetics|antiemetics|mesh-ancestor
64905163|NCT00006055|Autonomic Agents|autonomic agents|mesh-ancestor
64905164|NCT00006055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64905165|NCT00006055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64905166|NCT00006055|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64905167|NCT00006055|Protective Agents|protective agents|mesh-ancestor
64905168|NCT00006070|Etanercept|etanercept|mesh-list
64905169|NCT00006070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64905170|NCT00006070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64905171|NCT00006070|Analgesics|analgesics|mesh-ancestor
64905172|NCT00006070|Sensory System Agents|sensory system agents|mesh-ancestor
64905173|NCT00006070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64905174|NCT00006070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905175|NCT00006070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64373966|NCT02458157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905176|NCT00006070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64905177|NCT00006070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64905178|NCT00006070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64905179|NCT00006070|Immunologic Factors|immunologic factors|mesh-ancestor
64905180|NCT00006079|Eflornithine|eflornithine|mesh-list
64905181|NCT00006079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905182|NCT00006079|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64905183|NCT00006079|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64905184|NCT00006079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64905185|NCT00006079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64905196|NCT00006088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64905197|NCT00006088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905198|NCT00006088|Tubulin Modulators|tubulin modulators|mesh-ancestor
64905199|NCT00006088|Antimitotic Agents|antimitotic agents|mesh-ancestor
64905200|NCT00006088|Mitosis Modulators|mitosis modulators|mesh-ancestor
64905201|NCT00006088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905202|NCT00006091|Arsenic Trioxide|arsenic trioxide|mesh-list
64905203|NCT00006091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905204|NCT00006094|Fluorouracil|fluorouracil|mesh-list
64905205|NCT00006094|Oxaliplatin|oxaliplatin|mesh-list
64905206|NCT00006094|Antimetabolites|antimetabolites|mesh-ancestor
64905207|NCT00006094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905246|NCT00006103|Vitamins|vitamins|mesh-ancestor
64905256|NCT00006106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905257|NCT00006112|Leucovorin|leucovorin|mesh-list
64905258|NCT00006112|Fluorouracil|fluorouracil|mesh-list
64905259|NCT00006112|Mitomycins|mitomycins|mesh-list
64905260|NCT00006112|Mitomycin|mitomycin|mesh-list
64905261|NCT00006112|Calcium|calcium|mesh-list
64905262|NCT00006112|Levoleucovorin|levoleucovorin|mesh-list
64905263|NCT00006112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64905264|NCT00006112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905265|NCT00006112|Antimetabolites|antimetabolites|mesh-ancestor
64905266|NCT00006112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905267|NCT00006112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64905268|NCT00006112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905269|NCT00006112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64905270|NCT00006112|Immunologic Factors|immunologic factors|mesh-ancestor
64905271|NCT00006112|Antidotes|antidotes|mesh-ancestor
64905272|NCT00006112|Protective Agents|protective agents|mesh-ancestor
64905273|NCT00006112|Vitamin B Complex|vitamin b complex|mesh-ancestor
64905274|NCT00006112|Vitamins|vitamins|mesh-ancestor
64905291|NCT00006115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905292|NCT00006115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64905293|NCT00006115|Immunologic Factors|immunologic factors|mesh-ancestor
64905294|NCT00006115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64905295|NCT00006115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64905296|NCT00006115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905297|NCT00006115|Antidotes|antidotes|mesh-ancestor
64905298|NCT00006115|Protective Agents|protective agents|mesh-ancestor
64905299|NCT00006115|Vitamin B Complex|vitamin b complex|mesh-ancestor
64905300|NCT00006115|Vitamins|vitamins|mesh-ancestor
64905301|NCT00006115|Micronutrients|micronutrients|mesh-ancestor
64905302|NCT00006118|Gemcitabine|gemcitabine|mesh-list
64905303|NCT00006118|Paclitaxel|paclitaxel|mesh-list
64905304|NCT00006118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64905305|NCT00006118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905306|NCT00006118|Tubulin Modulators|tubulin modulators|mesh-ancestor
64905307|NCT00006118|Antimitotic Agents|antimitotic agents|mesh-ancestor
64905312|NCT00006118|Antiviral Agents|antiviral agents|mesh-ancestor
64905313|NCT00006118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64905314|NCT00006118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905315|NCT00006118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64905316|NCT00006118|Immunologic Factors|immunologic factors|mesh-ancestor
64905317|NCT00006118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905318|NCT00006121|Oxaliplatin|oxaliplatin|mesh-list
64905319|NCT00006121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905320|NCT00006124|Celecoxib|celecoxib|mesh-list
64905321|NCT00006124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64905322|NCT00006124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64905323|NCT00006124|Analgesics|analgesics|mesh-ancestor
64905324|NCT00006124|Sensory System Agents|sensory system agents|mesh-ancestor
64905334|NCT00006127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64905335|NCT00006127|Protective Agents|protective agents|mesh-ancestor
64905336|NCT00006127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905337|NCT00006133|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64905338|NCT00006133|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64905339|NCT00006133|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64905340|NCT00006133|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64905341|NCT00006133|Medroxyprogesterone|medroxyprogesterone|mesh-list
64905342|NCT00006133|Norethindrone|norethindrone|mesh-list
64374023|NCT02456129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64905343|NCT00006133|Norethindrone Acetate|norethindrone acetate|mesh-list
64905344|NCT00006133|Estradiol|estradiol|mesh-list
64374024|NCT02456129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64374025|NCT02456129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984198|NCT05568212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984199|NCT05568212|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64984200|NCT05568212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984201|NCT05568212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984202|NCT00121329|Lidocaine|lidocaine|mesh-list
64984204|NCT00121329|Anesthetics|anesthetics|mesh-ancestor
64984224|NCT00311077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984225|NCT00311116|Vitamin E|vitamin e|mesh-list
64984226|NCT00311116|Vitamins|vitamins|mesh-ancestor
64984227|NCT00311116|Micronutrients|micronutrients|mesh-ancestor
64984228|NCT00311116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984229|NCT00311116|Antioxidants|antioxidants|mesh-ancestor
64984230|NCT00311116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984231|NCT00311116|Protective Agents|protective agents|mesh-ancestor
64984232|NCT00088959|Celecoxib|celecoxib|mesh-list
64984233|NCT00088959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64984290|NCT00089037|Sirolimus|sirolimus|mesh-list
64984291|NCT00089037|Methotrexate|methotrexate|mesh-list
64984292|NCT00089037|Tacrolimus|tacrolimus|mesh-list
64984293|NCT00089037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64984294|NCT00089037|Abortifacient Agents|abortifacient agents|mesh-ancestor
64984295|NCT00089037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64984296|NCT00089037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905345|NCT00006133|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64905346|NCT00006133|Estrogens|estrogens|mesh-ancestor
64905347|NCT00006133|Hormones|hormones|mesh-ancestor
64905348|NCT00006133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64905349|NCT00006133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905350|NCT00006133|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64905351|NCT00006133|Contraceptive Agents|contraceptive agents|mesh-ancestor
64905352|NCT00006133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64905353|NCT00006133|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64905354|NCT00006133|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64905355|NCT00006133|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64905356|NCT00006133|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64905357|NCT00006133|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64905358|NCT00006133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64905360|NCT00006136|Arginine butyrate|arginine butyrate|mesh-list
64905361|NCT00006136|Epoetin Alfa|epoetin alfa|mesh-list
64905362|NCT00006136|Hematinics|hematinics|mesh-ancestor
64905363|NCT00006136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905364|NCT00006145|Valganciclovir|valganciclovir|mesh-list
64905365|NCT00006145|Antiviral Agents|antiviral agents|mesh-ancestor
64905366|NCT00006145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64905367|NCT00006154|Ritonavir|ritonavir|mesh-list
64984297|NCT00089037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64984298|NCT00089037|Antimetabolites|antimetabolites|mesh-ancestor
64984299|NCT00089037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984300|NCT00089037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984301|NCT00089037|Dermatologic Agents|dermatologic agents|mesh-ancestor
64984302|NCT00089037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984303|NCT00089037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64984304|NCT00089037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64984305|NCT00089037|Immunologic Factors|immunologic factors|mesh-ancestor
64984306|NCT00089037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64984307|NCT00089037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64984346|NCT00121446|Purinergic Agents|purinergic agents|mesh-ancestor
64984347|NCT00121446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64984348|NCT00121446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984349|NCT00121446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984350|NCT00121446|Anticoagulants|anticoagulants|mesh-ancestor
64347894|NCT04579783|Glucocorticoids|glucocorticoids|mesh-ancestor
64984403|NCT00089115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64984404|NCT00089115|Antibodies|antibodies|mesh-list
64984405|NCT00089115|Sargramostim|sargramostim|mesh-list
64984406|NCT00089115|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
64984407|NCT00089115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64984408|NCT00089115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984409|NCT00089115|Immunologic Factors|immunologic factors|mesh-ancestor
64984410|NCT00089115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984411|NCT00089115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64984412|NCT00312325|Prednisolone|prednisolone|mesh-list
64984413|NCT00312325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64984414|NCT00312325|Glucocorticoids|glucocorticoids|mesh-ancestor
64905368|NCT00006154|Indinavir|indinavir|mesh-list
64905379|NCT00006154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64905380|NCT00006154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64905381|NCT00006154|Antiviral Agents|antiviral agents|mesh-ancestor
64905382|NCT00006154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64905383|NCT00006154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64905384|NCT00006154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64905385|NCT00006154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905386|NCT00006154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64905387|NCT00006154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64905388|NCT00006154|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64905389|NCT00006154|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64905390|NCT00006154|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64905391|NCT00006154|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64905392|NCT00006154|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64905393|NCT00006154|Antimetabolites|antimetabolites|mesh-ancestor
64905394|NCT00006157|Desipramine|desipramine|mesh-list
64905395|NCT00006157|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64905396|NCT00006157|Antidepressive Agents|antidepressive agents|mesh-ancestor
64905397|NCT00006157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64905398|NCT00006157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905436|NCT00006199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64905437|NCT00006199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905438|NCT00006199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905439|NCT00006199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905440|NCT00006205|Topiramate|topiramate|mesh-list
64905441|NCT00006205|Ondansetron|ondansetron|mesh-list
64905442|NCT00006205|Antiemetics|antiemetics|mesh-ancestor
64905443|NCT00006205|Autonomic Agents|autonomic agents|mesh-ancestor
64905444|NCT00006205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64905445|NCT00006205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905446|NCT00006205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64905447|NCT00006205|Antipruritics|antipruritics|mesh-ancestor
64905467|NCT00006208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64905468|NCT00006208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905469|NCT00006208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905470|NCT00006208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64905471|NCT00006208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64905472|NCT00006208|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64905473|NCT00006208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64905474|NCT00006208|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64905475|NCT00006208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64905476|NCT00006208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64905477|NCT00006208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64905478|NCT00006208|Antimetabolites|antimetabolites|mesh-ancestor
64905480|NCT00006211|Capravirine|capravirine|mesh-list
64905481|NCT00006211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64905482|NCT00006211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64905483|NCT00006211|Protease Inhibitors|protease inhibitors|mesh-ancestor
64905484|NCT00006211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905485|NCT00006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905486|NCT00006211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64374162|NCT03262727|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
64374164|NCT04975971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64374165|NCT04975971|Antiemetics|antiemetics|mesh-ancestor
64374166|NCT04975971|Autonomic Agents|autonomic agents|mesh-ancestor
64984415|NCT00312325|Hormones|hormones|mesh-ancestor
64984416|NCT00312325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64984417|NCT00312325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905487|NCT00006211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64905488|NCT00006211|Antiviral Agents|antiviral agents|mesh-ancestor
64905489|NCT00006211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64905490|NCT00006211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64905491|NCT00006211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64905492|NCT00006214|Flutamide|flutamide|mesh-list
64905493|NCT00006214|Androgen Antagonists|androgen antagonists|mesh-ancestor
64905494|NCT00006214|Hormone Antagonists|hormone antagonists|mesh-ancestor
64905495|NCT00006214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64905496|NCT00006214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905507|NCT00006223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905508|NCT00006223|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64905509|NCT00006223|Protective Agents|protective agents|mesh-ancestor
64905510|NCT03761953|Oritavancin|oritavancin|mesh-list
64905511|NCT03761953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64905512|NCT03761953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64905513|NCT00006226|Thalidomide|thalidomide|mesh-list
64905514|NCT00006226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64905515|NCT00006226|Immunologic Factors|immunologic factors|mesh-ancestor
64905516|NCT00006226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905517|NCT00006226|Leprostatic Agents|leprostatic agents|mesh-ancestor
64905518|NCT00006226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64905519|NCT00006226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64905520|NCT00006226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64905521|NCT00006226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64905522|NCT00006226|Growth Substances|growth substances|mesh-ancestor
64905523|NCT00006226|Growth Inhibitors|growth inhibitors|mesh-ancestor
64905524|NCT00006226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905525|NCT00006229|Paclitaxel|paclitaxel|mesh-list
64905526|NCT00006229|Carboplatin|carboplatin|mesh-list
64905527|NCT00006229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64905528|NCT00006229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905529|NCT00006229|Tubulin Modulators|tubulin modulators|mesh-ancestor
64905530|NCT00006229|Antimitotic Agents|antimitotic agents|mesh-ancestor
64905553|NCT00006232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905554|NCT00006232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64905555|NCT00006232|Tubulin Modulators|tubulin modulators|mesh-ancestor
64905556|NCT00006232|Antimitotic Agents|antimitotic agents|mesh-ancestor
64905557|NCT00006232|Mitosis Modulators|mitosis modulators|mesh-ancestor
64905558|NCT00006235|Carboplatin|carboplatin|mesh-list
64905559|NCT00006235|Doxorubicin|doxorubicin|mesh-list
64905560|NCT00006235|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64905561|NCT00006235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905562|NCT00006235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64905563|NCT00006235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64905564|NCT00006235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64905565|NCT00006235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905566|NCT00006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905567|NCT00006241|Lenograstim|lenograstim|mesh-list
64905568|NCT00006241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64905569|NCT00006241|Immunologic Factors|immunologic factors|mesh-ancestor
64905570|NCT00006241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905571|NCT00006247|Semaxinib|semaxinib|mesh-list
64905572|NCT00006247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64905573|NCT00006247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64905574|NCT00006247|Growth Substances|growth substances|mesh-ancestor
64905575|NCT00006247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905576|NCT00006247|Growth Inhibitors|growth inhibitors|mesh-ancestor
64905577|NCT00006247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905578|NCT00006247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64905579|NCT00006247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905581|NCT00006250|Dexamethasone|dexamethasone|mesh-list
64905599|NCT00006250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905600|NCT00006250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64905601|NCT00006250|Immunologic Factors|immunologic factors|mesh-ancestor
64374213|NCT03261635|Gout Suppressants|gout suppressants|mesh-ancestor
64374214|NCT03261635|Tocolytic Agents|tocolytic agents|mesh-ancestor
64374217|NCT03261635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984418|NCT00312325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64984419|NCT00312325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984420|NCT05567471|Vaccines|vaccines|mesh-list
64984458|NCT00312520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64984459|NCT00312520|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64984460|NCT00312520|Protective Agents|protective agents|mesh-ancestor
64984461|NCT00312520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64905602|NCT00006250|Analgesics|analgesics|mesh-ancestor
64905603|NCT00006250|Sensory System Agents|sensory system agents|mesh-ancestor
64905604|NCT00006250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64905605|NCT00006250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64905606|NCT00006250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905607|NCT00006250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64905608|NCT00006250|Alkylating Agents|alkylating agents|mesh-ancestor
64905609|NCT00006265|Cytarabine|cytarabine|mesh-list
64905610|NCT00006265|Gemtuzumab|gemtuzumab|mesh-list
64905611|NCT00006265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64905612|NCT00006265|Antimetabolites|antimetabolites|mesh-ancestor
64905613|NCT00006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905614|NCT00006265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905615|NCT00006265|Antiviral Agents|antiviral agents|mesh-ancestor
64905616|NCT00006265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64905617|NCT00006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64905618|NCT00006265|Immunologic Factors|immunologic factors|mesh-ancestor
64905619|NCT00006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905620|NCT00006265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64905621|NCT00007527|Buprenorphine|buprenorphine|mesh-list
64905622|NCT00007527|Naloxone|naloxone|mesh-list
64905623|NCT00007527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64905624|NCT00007527|Narcotics|narcotics|mesh-ancestor
64905625|NCT00007527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64905627|NCT00007527|Analgesics|analgesics|mesh-ancestor
64905644|NCT00006286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64905645|NCT00006286|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64905646|NCT00006286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64905647|NCT00006286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905649|NCT00007605|Sotalol|sotalol|mesh-list
64905650|NCT00007605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64905651|NCT00007605|Vasodilator Agents|vasodilator agents|mesh-ancestor
64905652|NCT00007605|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64905653|NCT00007605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64905654|NCT00007605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905655|NCT00007605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64374258|NCT03256487|Buprenorphine|buprenorphine|mesh-list
64984462|NCT00312520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984464|NCT00089193|Freund's Adjuvant|freund's adjuvant|mesh-list
64905656|NCT00007605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64905657|NCT00007605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64905658|NCT00007605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905659|NCT00007605|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64905660|NCT00007605|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64905661|NCT00007605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64905662|NCT00007605|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64905663|NCT00007605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64905665|NCT00007605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64905666|NCT00007605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905667|NCT00007605|Sympatholytics|sympatholytics|mesh-ancestor
64905668|NCT00007605|Autonomic Agents|autonomic agents|mesh-ancestor
64905669|NCT00007605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64905670|NCT00006292|Infliximab|infliximab|mesh-list
64905671|NCT00006292|Dermatologic Agents|dermatologic agents|mesh-ancestor
64905672|NCT00006292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64905673|NCT00006292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64905674|NCT03709888|Pregabalin|pregabalin|mesh-list
64905687|NCT03709888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64905688|NCT03709888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64905689|NCT03709888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64905690|NCT03709888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64905691|NCT03709888|Dopamine Agents|dopamine agents|mesh-ancestor
64905692|NCT03709888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64905693|NCT03709888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64905694|NCT03709888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64905695|NCT00007683|Aspirin|aspirin|mesh-list
64905696|NCT00007683|Warfarin|warfarin|mesh-list
64905697|NCT00007683|Clopidogrel|clopidogrel|mesh-list
64905698|NCT00007683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64905699|NCT00007683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64905700|NCT00007683|Analgesics|analgesics|mesh-ancestor
64905701|NCT00007683|Sensory System Agents|sensory system agents|mesh-ancestor
64905710|NCT00007683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64905711|NCT00007683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905712|NCT00007683|Antipyretics|antipyretics|mesh-ancestor
64905713|NCT00007683|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64905714|NCT00007683|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64905715|NCT00007683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64905716|NCT00007683|Purinergic Agents|purinergic agents|mesh-ancestor
64905717|NCT00007683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64905718|NCT00007683|Anticoagulants|anticoagulants|mesh-ancestor
64905729|NCT00006337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905730|NCT00006337|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
64905731|NCT00006337|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64905732|NCT00006337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64905733|NCT00006337|Purinergic Agents|purinergic agents|mesh-ancestor
64905734|NCT00006340|Ganciclovir|ganciclovir|mesh-list
64674174|NCT04041453|Albendazole|albendazole|mesh-list
64905735|NCT00006340|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64905736|NCT00006340|Arginine butyrate|arginine butyrate|mesh-list
64905737|NCT00006340|Antiviral Agents|antiviral agents|mesh-ancestor
64905738|NCT00006340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64905739|NCT00006340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64905740|NCT00006340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905741|NCT00006340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905742|NCT00006340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905743|NCT00006343|Interferons|interferons|mesh-list
64905745|NCT00006343|Interferon-alpha|interferon-alpha|mesh-list
64905746|NCT00006343|Imatinib Mesylate|imatinib mesylate|mesh-list
64905747|NCT00006343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905758|NCT00387868|Etoposide|etoposide|mesh-list
64905779|NCT00006349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905780|NCT00006349|Cholinergic Agents|cholinergic agents|mesh-ancestor
64905781|NCT00006349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64905782|NCT00006349|Nootropic Agents|nootropic agents|mesh-ancestor
64905783|NCT00006349|Antioxidants|antioxidants|mesh-ancestor
64905784|NCT00006349|Protective Agents|protective agents|mesh-ancestor
64905785|NCT00006352|Antibodies|antibodies|mesh-list
64905786|NCT00006352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64905787|NCT00006352|BCG Vaccine|bcg vaccine|mesh-list
64905788|NCT00006352|Immunologic Factors|immunologic factors|mesh-ancestor
64905789|NCT00006352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905790|NCT00006352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64905791|NCT00007878|Leucovorin|leucovorin|mesh-list
64905792|NCT00007878|Fluorouracil|fluorouracil|mesh-list
64905793|NCT00007878|Bortezomib|bortezomib|mesh-list
64905794|NCT00007878|Calcium|calcium|mesh-list
64905795|NCT00007878|Levoleucovorin|levoleucovorin|mesh-list
64905796|NCT00007878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64905797|NCT00007878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905798|NCT00007878|Antimetabolites|antimetabolites|mesh-ancestor
64905799|NCT00007878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905800|NCT00007878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64905801|NCT00007878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905802|NCT00007878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64905803|NCT00007878|Immunologic Factors|immunologic factors|mesh-ancestor
64905804|NCT00007878|Antidotes|antidotes|mesh-ancestor
64905805|NCT00007878|Protective Agents|protective agents|mesh-ancestor
64905806|NCT00007878|Vitamin B Complex|vitamin b complex|mesh-ancestor
64905807|NCT00007878|Vitamins|vitamins|mesh-ancestor
64905808|NCT00007878|Micronutrients|micronutrients|mesh-ancestor
64905809|NCT00006355|NSC 366140|nsc 366140|mesh-list
64674250|NCT02301936|Antiviral Agents|antiviral agents|mesh-ancestor
64905810|NCT00006355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905815|NCT00006358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905816|NCT00006358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374336|NCT04963881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374337|NCT04432155|Xenon|xenon|mesh-list
64374343|NCT04487951|Vitamin D|vitamin d|mesh-list
64984465|NCT00089193|Immunologic Factors|immunologic factors|mesh-ancestor
64984466|NCT00089193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984467|NCT00089193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64905817|NCT00006358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64905818|NCT00006358|Immunologic Factors|immunologic factors|mesh-ancestor
64905819|NCT00006358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905820|NCT00006358|Leprostatic Agents|leprostatic agents|mesh-ancestor
64905821|NCT00006358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64905822|NCT00006358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64905823|NCT00006358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64905824|NCT00006358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64905825|NCT00006358|Growth Substances|growth substances|mesh-ancestor
64905826|NCT00006358|Growth Inhibitors|growth inhibitors|mesh-ancestor
64905828|NCT00006361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64905829|NCT00006361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64905830|NCT00006361|Growth Substances|growth substances|mesh-ancestor
64905831|NCT00006361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905832|NCT00006361|Growth Inhibitors|growth inhibitors|mesh-ancestor
64905833|NCT00006361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905834|NCT00006361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64905835|NCT00006361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905836|NCT00006361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905837|NCT00006364|Homoharringtonine|homoharringtonine|mesh-list
64905838|NCT00006364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64905839|NCT00006364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905840|NCT00006364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64905841|NCT00006364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905842|NCT00006364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905843|NCT00007917|Gemcitabine|gemcitabine|mesh-list
64905878|NCT00006370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64905879|NCT00006370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905880|NCT00007956|Antibodies|antibodies|mesh-list
64905881|NCT00007956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64905882|NCT00007956|Immunologic Factors|immunologic factors|mesh-ancestor
64905884|NCT00006373|Etoposide|etoposide|mesh-list
64905907|NCT00006379|Alkylating Agents|alkylating agents|mesh-ancestor
64905908|NCT00006379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905909|NCT00006379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905910|NCT00006379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64905911|NCT00006379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64905912|NCT00006379|Antimetabolites|antimetabolites|mesh-ancestor
64905913|NCT00006385|Interferons|interferons|mesh-list
64905914|NCT00006385|Interferon-alpha|interferon-alpha|mesh-list
64905915|NCT00006385|Sargramostim|sargramostim|mesh-list
64905916|NCT00006385|Freund's Adjuvant|freund's adjuvant|mesh-list
64905917|NCT00006385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905918|NCT00006385|Antiviral Agents|antiviral agents|mesh-ancestor
64905919|NCT00006385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64905920|NCT00006385|Immunologic Factors|immunologic factors|mesh-ancestor
64905921|NCT00006385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905922|NCT00006385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64905923|NCT00007995|Interferons|interferons|mesh-list
64905924|NCT00007995|Interferon-alpha|interferon-alpha|mesh-list
64905925|NCT00007995|Cyclophosphamide|cyclophosphamide|mesh-list
64905926|NCT00007995|Melphalan|melphalan|mesh-list
64905927|NCT00007995|Busulfan|busulfan|mesh-list
64905928|NCT00007995|Sargramostim|sargramostim|mesh-list
64905929|NCT00007995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64905930|NCT00007995|Immunologic Factors|immunologic factors|mesh-ancestor
64905931|NCT00007995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905932|NCT00007995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64905940|NCT00006388|Tamoxifen|tamoxifen|mesh-list
64905957|NCT00008034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64905958|NCT00008034|Alkylating Agents|alkylating agents|mesh-ancestor
64905959|NCT00008034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905960|NCT00008034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905963|NCT00008034|Antimetabolites|antimetabolites|mesh-ancestor
64905964|NCT00008034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64905965|NCT00008034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64905966|NCT00008034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64905967|NCT00008034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905969|NCT00006391|Topotecan|topotecan|mesh-list
64905970|NCT00006391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905971|NCT00006391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64905972|NCT00006391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64905973|NCT00006391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905974|NCT00006391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905975|NCT00006394|Hormones|hormones|mesh-list
64905977|NCT00006394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906011|NCT00006412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906013|NCT00006412|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64906014|NCT00006412|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64906015|NCT00006412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906016|NCT00008112|Cisplatin|cisplatin|mesh-list
64906017|NCT00008112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906018|NCT00006427|Amitriptyline|amitriptyline|mesh-list
64906019|NCT00006427|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64906020|NCT00006427|Antidepressive Agents|antidepressive agents|mesh-ancestor
64906021|NCT00006427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64906022|NCT00006427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64906023|NCT00006427|Analgesics|analgesics|mesh-ancestor
64906024|NCT00006427|Sensory System Agents|sensory system agents|mesh-ancestor
64906025|NCT00006427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64906026|NCT00006427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906027|NCT00006427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64906028|NCT00006427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64906065|NCT00006448|Narcotics|narcotics|mesh-ancestor
64906066|NCT00006448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64906067|NCT00006448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906068|NCT00006448|Analgesics|analgesics|mesh-ancestor
64906069|NCT00006448|Sensory System Agents|sensory system agents|mesh-ancestor
64906070|NCT00006448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64906071|NCT00006448|Antitussive Agents|antitussive agents|mesh-ancestor
64906072|NCT00006448|Respiratory System Agents|respiratory system agents|mesh-ancestor
64906073|NCT00008190|Aldesleukin|aldesleukin|mesh-list
64906074|NCT00008190|Cyclophosphamide|cyclophosphamide|mesh-list
64906075|NCT00008190|Melphalan|melphalan|mesh-list
64906076|NCT00008190|Busulfan|busulfan|mesh-list
64906077|NCT00008190|Etoposide|etoposide|mesh-list
64906078|NCT00008190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64906079|NCT00008190|Immunologic Factors|immunologic factors|mesh-ancestor
64906080|NCT00008190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906081|NCT00008190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64906083|NCT00008190|Alkylating Agents|alkylating agents|mesh-ancestor
64906152|NCT00008229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64906154|NCT00006457|Antiviral Agents|antiviral agents|mesh-ancestor
64906155|NCT00006457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64906156|NCT00006457|Schistosomicides|schistosomicides|mesh-ancestor
64906157|NCT00006457|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64906158|NCT00006457|Anthelmintics|anthelmintics|mesh-ancestor
64906159|NCT00006457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64906160|NCT00006457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64906161|NCT00006457|Protective Agents|protective agents|mesh-ancestor
64906162|NCT00006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906163|NCT00006457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906166|NCT00006457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906238|NCT00006472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64906239|NCT00006472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64906240|NCT00006472|Immunologic Factors|immunologic factors|mesh-ancestor
64906241|NCT00006472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906242|NCT00006475|Imatinib Mesylate|imatinib mesylate|mesh-list
64906243|NCT00006475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906364|NCT00007189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64906365|NCT00007189|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64906366|NCT00007189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64906367|NCT00007189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906369|NCT00007189|Gout Suppressants|gout suppressants|mesh-ancestor
64906376|NCT00388219|Sensory System Agents|sensory system agents|mesh-ancestor
64906377|NCT00388219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64906378|NCT00388219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64906379|NCT00388258|Alvimopan|alvimopan|mesh-list
64906380|NCT00388258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64906381|NCT00388336|Epoetin Alfa|epoetin alfa|mesh-list
64906382|NCT00388336|Hematinics|hematinics|mesh-ancestor
64906383|NCT00007306|Hormones|hormones|mesh-list
64906384|NCT00007306|Parathyroid Hormone|parathyroid hormone|mesh-list
64906385|NCT00007306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64906386|NCT00007306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906387|NCT00007306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64906388|NCT00007423|polysaccharide-K|polysaccharide-k|mesh-list
64906483|NCT00008008|Immunologic Factors|immunologic factors|mesh-ancestor
64906484|NCT00008008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906485|NCT00008008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64906486|NCT00008008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64906487|NCT00008008|Alkylating Agents|alkylating agents|mesh-ancestor
64906488|NCT00008008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906489|NCT00008008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906508|NCT00008086|Calcitriol|calcitriol|mesh-list
64906586|NCT00008242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64906587|NCT00008242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64906588|NCT00008242|Growth Substances|growth substances|mesh-ancestor
64906589|NCT00008242|Growth Inhibitors|growth inhibitors|mesh-ancestor
64906590|NCT00008281|Leucovorin|leucovorin|mesh-list
64906591|NCT00008281|Fluorouracil|fluorouracil|mesh-list
64906592|NCT00008281|Oxaliplatin|oxaliplatin|mesh-list
64906593|NCT00008281|Calcium|calcium|mesh-list
64906594|NCT00008281|Levoleucovorin|levoleucovorin|mesh-list
64906595|NCT00008281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64906596|NCT00008281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906597|NCT00008281|Antimetabolites|antimetabolites|mesh-ancestor
64906598|NCT00008281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906621|NCT00008398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906674|NCT05637073|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64906675|NCT05637073|Contraceptive Agents|contraceptive agents|mesh-ancestor
64906676|NCT05637073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64906677|NCT05637073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906678|NCT05637073|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64906679|NCT05637073|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64906680|NCT05637073|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64906681|NCT05637073|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64906682|NCT05637073|Hormone Antagonists|hormone antagonists|mesh-ancestor
64906683|NCT05637073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64906684|NCT05637073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64906685|NCT05637073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906686|NCT05637268|Paclitaxel|paclitaxel|mesh-list
64906687|NCT05637268|Cisplatin|cisplatin|mesh-list
64906688|NCT05637268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64906689|NCT05637268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906690|NCT05637268|Tubulin Modulators|tubulin modulators|mesh-ancestor
64906691|NCT05637268|Antimitotic Agents|antimitotic agents|mesh-ancestor
64906692|NCT05637268|Mitosis Modulators|mitosis modulators|mesh-ancestor
64906693|NCT05637268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906694|NCT05637216|Losartan|losartan|mesh-list
64906695|NCT05637216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64906696|NCT05637216|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64906697|NCT05637216|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64675184|NCT02468583|FX006|fx006|mesh-list
64906720|NCT05638633|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64906721|NCT05638633|Prednisolone phosphate|prednisolone phosphate|mesh-list
64906722|NCT05638633|Micronutrients|micronutrients|mesh-ancestor
64906739|NCT05638867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64906740|NCT05638867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64906741|NCT05638867|Analgesics|analgesics|mesh-ancestor
64906742|NCT05638867|Sensory System Agents|sensory system agents|mesh-ancestor
64906743|NCT05638867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64906744|NCT05638867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906745|NCT05638867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64906746|NCT05638867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64906747|NCT05638867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64906748|NCT05638867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64906749|NCT05638867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906750|NCT05638867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64906751|NCT05638867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64906752|NCT05638867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906753|NCT05638867|Antipyretics|antipyretics|mesh-ancestor
64906754|NCT05638867|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64906755|NCT05638867|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64906756|NCT05638867|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64906757|NCT05638867|Purinergic Agents|purinergic agents|mesh-ancestor
64906758|NCT05638867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64906759|NCT05638867|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64906760|NCT05638867|Antithrombins|antithrombins|mesh-ancestor
64906763|NCT05638867|Anticoagulants|anticoagulants|mesh-ancestor
64906789|NCT00000115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906790|NCT00000115|Diuretics|diuretics|mesh-ancestor
64906791|NCT00000115|Natriuretic Agents|natriuretic agents|mesh-ancestor
64906805|NCT00388687|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
64906806|NCT00388687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64906807|NCT00388687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906808|NCT00000142|Cidofovir|cidofovir|mesh-list
64906809|NCT00000142|Antiviral Agents|antiviral agents|mesh-ancestor
64906810|NCT00000142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64906842|NCT00000157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906843|NCT00000157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64906844|NCT00000157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64906845|NCT00000157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64906846|NCT00000157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64906847|NCT00000157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906848|NCT00000157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64906849|NCT00000157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64906850|NCT00000157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906851|NCT00000157|Antipyretics|antipyretics|mesh-ancestor
64906852|NCT00000172|Galantamine|galantamine|mesh-list
64906853|NCT00000172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64906854|NCT00000172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906855|NCT00000172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906856|NCT00000172|Cholinergic Agents|cholinergic agents|mesh-ancestor
64906857|NCT00000172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64906858|NCT00000172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906859|NCT00000172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64906860|NCT00000172|Autonomic Agents|autonomic agents|mesh-ancestor
64906861|NCT00000172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64906862|NCT00000172|Nootropic Agents|nootropic agents|mesh-ancestor
64906863|NCT00000175|Testosterone|testosterone|mesh-list
64906864|NCT00000175|Estrogens|estrogens|mesh-list
64906865|NCT00000175|Androgens|androgens|mesh-ancestor
64906866|NCT00000175|Hormones|hormones|mesh-ancestor
64906867|NCT00000175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64906868|NCT00000175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675310|NCT03020030|Levoleucovorin|levoleucovorin|mesh-list
64906869|NCT00000187|Ritanserin|ritanserin|mesh-list
64906870|NCT00000187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64906875|NCT00000187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64906876|NCT00000187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64906877|NCT00000187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64906878|NCT00000187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64906879|NCT00000187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64906880|NCT00000187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64906881|NCT00000187|Antidepressive Agents|antidepressive agents|mesh-ancestor
64906882|NCT00000205|Buprenorphine|buprenorphine|mesh-list
64906883|NCT00000205|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64906884|NCT00000205|Narcotics|narcotics|mesh-ancestor
64906885|NCT00000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64906886|NCT00000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906887|NCT00000205|Analgesics|analgesics|mesh-ancestor
64906888|NCT00000205|Sensory System Agents|sensory system agents|mesh-ancestor
64906889|NCT00000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64906890|NCT00000205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64906891|NCT00000214|Buprenorphine|buprenorphine|mesh-list
64906892|NCT00000214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64906893|NCT00000214|Narcotics|narcotics|mesh-ancestor
64906894|NCT00000214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64906895|NCT00000214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906896|NCT00000214|Analgesics|analgesics|mesh-ancestor
64906897|NCT00000214|Sensory System Agents|sensory system agents|mesh-ancestor
64906898|NCT00000214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64906899|NCT00000214|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64906900|NCT00000220|Buprenorphine|buprenorphine|mesh-list
64906902|NCT00000220|Narcotics|narcotics|mesh-ancestor
64906912|NCT00000256|Anesthetics|anesthetics|mesh-ancestor
64906913|NCT00000256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64906914|NCT00000256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906915|NCT00000256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64906916|NCT00000256|Analgesics|analgesics|mesh-ancestor
64906917|NCT00000256|Sensory System Agents|sensory system agents|mesh-ancestor
64906918|NCT00000256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64906919|NCT03582085|BCG Vaccine|bcg vaccine|mesh-list
64906920|NCT03582085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64906921|NCT03582085|Immunologic Factors|immunologic factors|mesh-ancestor
64906922|NCT03582085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906923|NCT00000421|Prednisone|prednisone|mesh-list
64906924|NCT00000421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64906925|NCT00000421|Glucocorticoids|glucocorticoids|mesh-ancestor
64906926|NCT00000421|Hormones|hormones|mesh-ancestor
64906927|NCT00000421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64906928|NCT00000421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906929|NCT00000421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64906930|NCT00000421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906931|NCT00000427|Alendronate|alendronate|mesh-list
64906932|NCT00000427|Hormones|hormones|mesh-list
64906933|NCT00000427|Parathyroid Hormone|parathyroid hormone|mesh-list
64906934|NCT00000427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64906935|NCT00000427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906936|NCT00000427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64906938|NCT00000457|Bupropion|bupropion|mesh-list
64906957|NCT00000463|Dihydromevinolin|dihydromevinolin|mesh-list
64906958|NCT00000463|Cholestyramine Resin|cholestyramine resin|mesh-list
64906959|NCT00000463|Anticoagulants|anticoagulants|mesh-ancestor
64906960|NCT00000463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64906961|NCT00000463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64906974|NCT00000466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64906975|NCT00000466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906976|NCT00000466|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64906977|NCT00000466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64906978|NCT00000466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64906979|NCT00000466|Contraceptive Agents|contraceptive agents|mesh-ancestor
64906980|NCT00000466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64906981|NCT00000466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64906982|NCT00000466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64906983|NCT00000466|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64906984|NCT00000466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64906985|NCT00000466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906986|NCT00000472|Heparin|heparin|mesh-list
64906987|NCT00000472|Plasminogen|plasminogen|mesh-list
64907000|NCT00000478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64907001|NCT00000478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907002|NCT00000478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64907003|NCT00000478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907004|NCT00000478|Vasodilator Agents|vasodilator agents|mesh-ancestor
64907005|NCT00000478|Tocolytic Agents|tocolytic agents|mesh-ancestor
64907006|NCT00000478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64907007|NCT00000478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64907008|NCT00000478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64907009|NCT00000478|Sympatholytics|sympatholytics|mesh-ancestor
64907010|NCT00000478|Autonomic Agents|autonomic agents|mesh-ancestor
64907011|NCT00000478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64907012|NCT00000478|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64907013|NCT00000478|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64907014|NCT00000478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64907015|NCT00000478|Adrenergic Agents|adrenergic agents|mesh-ancestor
64907016|NCT00000478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64907017|NCT00000478|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64907018|NCT00000478|Diuretics|diuretics|mesh-ancestor
64907019|NCT00000478|Natriuretic Agents|natriuretic agents|mesh-ancestor
64907020|NCT00000478|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64907023|NCT00388882|Tiotropium Bromide|tiotropium bromide|mesh-list
64907024|NCT00388882|Ipratropium|ipratropium|mesh-list
64907025|NCT00388882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64907026|NCT00388882|Autonomic Agents|autonomic agents|mesh-ancestor
64907027|NCT00388882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64907028|NCT00388882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907029|NCT00388882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64907043|NCT00388999|Lectins|lectins|mesh-list
64907046|NCT00388999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907047|NCT00388999|Coagulants|coagulants|mesh-ancestor
64907048|NCT00000487|Antihypertensive Agents|antihypertensive agents|mesh-list
64907049|NCT00000487|Diuretics|diuretics|mesh-list
64907050|NCT00000487|Natriuretic Agents|natriuretic agents|mesh-ancestor
64907051|NCT00000487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907052|NCT00000493|Propranolol|propranolol|mesh-list
64907053|NCT00000493|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64907054|NCT00000493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64907055|NCT00000493|Adrenergic Agents|adrenergic agents|mesh-ancestor
64907056|NCT00000493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64907057|NCT00000493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907058|NCT00000493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907059|NCT00000493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64907106|NCT00000514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64907107|NCT00000514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64907108|NCT00000514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64907109|NCT00000514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64907110|NCT00000514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64907111|NCT00000514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64907112|NCT00000514|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64907113|NCT00000514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64907114|NCT05638425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64907115|NCT05638425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374800|NCT04947189|Antimitotic Agents|antimitotic agents|mesh-ancestor
64374858|NCT03247595|Cathartics|cathartics|mesh-ancestor
64374859|NCT03247595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64374860|NCT03247595|Laxatives|laxatives|mesh-ancestor
64984468|NCT00293098|Deferiprone|deferiprone|mesh-list
64984469|NCT00293098|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64984470|NCT00293098|Chelating Agents|chelating agents|mesh-ancestor
64907116|NCT05638425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64907118|NCT00000517|Anticoagulants|anticoagulants|mesh-ancestor
64907119|NCT00000520|Aspirin|aspirin|mesh-list
64907120|NCT00000520|Immunoglobulins|immunoglobulins|mesh-list
64907121|NCT00000520|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64907122|NCT00000520|Antibodies|antibodies|mesh-list
64907123|NCT00000520|gamma-Globulins|gamma-globulins|mesh-list
64907124|NCT00000520|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64907125|NCT00000520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64907126|NCT00000520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64907127|NCT00000520|Analgesics|analgesics|mesh-ancestor
64907128|NCT00000520|Sensory System Agents|sensory system agents|mesh-ancestor
64907129|NCT00000520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64907130|NCT00000520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907141|NCT00000526|Flecainide|flecainide|mesh-list
64907154|NCT00000529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64907155|NCT00000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64907156|NCT00000529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64907157|NCT00000529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64907158|NCT00000529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64907159|NCT00000553|Niacin|niacin|mesh-list
64907160|NCT00000553|Simvastatin|simvastatin|mesh-list
64907161|NCT00000553|Antioxidants|antioxidants|mesh-list
64907162|NCT00000553|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64907163|NCT00000553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64907164|NCT00000553|Antimetabolites|antimetabolites|mesh-ancestor
64907165|NCT00000553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907166|NCT00000553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64374872|NCT04938297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64374873|NCT04938297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374874|NCT04938297|Immunologic Factors|immunologic factors|mesh-ancestor
64374875|NCT04938297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374876|NCT04938297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64374877|NCT04938297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64374878|NCT04938297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64374879|NCT04938297|Growth Substances|growth substances|mesh-ancestor
64374880|NCT04938297|Growth Inhibitors|growth inhibitors|mesh-ancestor
64374890|NCT04937907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907167|NCT00000553|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64907168|NCT00000553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907169|NCT00000553|Vasodilator Agents|vasodilator agents|mesh-ancestor
64907170|NCT00000553|Vitamin B Complex|vitamin b complex|mesh-ancestor
64907172|NCT00000553|Micronutrients|micronutrients|mesh-ancestor
64907173|NCT00000553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907174|NCT00000553|Protective Agents|protective agents|mesh-ancestor
64907175|NCT00000556|Quinidine|quinidine|mesh-list
64907176|NCT00000556|Digoxin|digoxin|mesh-list
64907177|NCT00000556|Amiodarone|amiodarone|mesh-list
64907178|NCT00000556|Verapamil|verapamil|mesh-list
64907179|NCT00000556|Sotalol|sotalol|mesh-list
64907180|NCT00000556|Flecainide|flecainide|mesh-list
64907181|NCT00000556|Propafenone|propafenone|mesh-list
64907182|NCT00000556|Procainamide|procainamide|mesh-list
64907183|NCT00000556|Moricizine|moricizine|mesh-list
64907184|NCT00000556|Disopyramide|disopyramide|mesh-list
64907185|NCT00000556|Diltiazem|diltiazem|mesh-list
64907186|NCT00000556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64907187|NCT00000556|Adrenergic Agents|adrenergic agents|mesh-list
64907188|NCT00000556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64907189|NCT00000556|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64907190|NCT00000556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907199|NCT00000556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64907200|NCT00000556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64907201|NCT00000556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64907202|NCT00000556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64907203|NCT00000556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64907204|NCT00000556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64907205|NCT00000556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64907206|NCT00000556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64907207|NCT00000556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64907222|NCT00000559|Hormones|hormones|mesh-list
64907223|NCT00000559|Estradiol|estradiol|mesh-list
64907224|NCT00000559|Estrogens|estrogens|mesh-list
64907225|NCT00000559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64907226|NCT00000559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907227|NCT00000559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64907228|NCT00000559|Contraceptive Agents|contraceptive agents|mesh-ancestor
64907229|NCT00000559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64907237|NCT00000568|Ipratropium|ipratropium|mesh-list
64907238|NCT00000568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64907239|NCT00000568|Autonomic Agents|autonomic agents|mesh-ancestor
64907240|NCT00000568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64907241|NCT00000568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907242|NCT00000568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64907243|NCT00000568|Respiratory System Agents|respiratory system agents|mesh-ancestor
64907244|NCT00000568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64907245|NCT00000568|Cholinergic Agents|cholinergic agents|mesh-ancestor
64907246|NCT00000568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64907247|NCT00000568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907248|NCT00000586|Hydroxyurea|hydroxyurea|mesh-list
64907249|NCT00000586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64907250|NCT00000586|Antisickling Agents|antisickling agents|mesh-ancestor
64907251|NCT00000586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907252|NCT00000586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907253|NCT00000586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907254|NCT00000595|Deferoxamine|deferoxamine|mesh-list
64907255|NCT00000595|Siderophores|siderophores|mesh-ancestor
64907256|NCT00000595|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64907257|NCT00000595|Chelating Agents|chelating agents|mesh-ancestor
64907258|NCT00000595|Sequestering Agents|sequestering agents|mesh-ancestor
64907259|NCT00000595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907260|NCT00000601|Hormones|hormones|mesh-list
64907261|NCT00000601|Progesterone|progesterone|mesh-list
64907262|NCT00000601|Estrogens|estrogens|mesh-list
64907264|NCT00000601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907268|NCT00000625|Zalcitabine|zalcitabine|mesh-list
64907269|NCT00000625|Antimetabolites|antimetabolites|mesh-ancestor
64907270|NCT00000625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907271|NCT00000625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64907272|NCT00000625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907275|NCT00000625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907276|NCT00000625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64907277|NCT00000625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907278|NCT00000637|Zidovudine|zidovudine|mesh-list
64907279|NCT00000637|Didanosine|didanosine|mesh-list
64907280|NCT00000637|Antimetabolites|antimetabolites|mesh-ancestor
64907281|NCT00000637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907282|NCT00000637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64907283|NCT00000637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907284|NCT00000637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907285|NCT00000637|Antiviral Agents|antiviral agents|mesh-ancestor
64907286|NCT00000637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907287|NCT00000637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64907288|NCT00000637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907289|NCT00000640|Clindamycin|clindamycin|mesh-list
64907290|NCT00000640|Clindamycin palmitate|clindamycin palmitate|mesh-list
64907331|NCT00000646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64907332|NCT00000646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907333|NCT00000646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907334|NCT00000646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64907335|NCT00000646|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64907336|NCT00000646|Protective Agents|protective agents|mesh-ancestor
64907337|NCT00000646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907338|NCT00000646|Vasodilator Agents|vasodilator agents|mesh-ancestor
64907339|NCT00000646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64907340|NCT00000646|Antioxidants|antioxidants|mesh-ancestor
64907341|NCT00389038|Amitriptyline|amitriptyline|mesh-list
64907342|NCT00389038|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64907343|NCT00389038|Antidepressive Agents|antidepressive agents|mesh-ancestor
64907344|NCT00389038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64907345|NCT00389038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64374922|NCT03246113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374923|NCT03246113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374924|NCT04937673|Paclitaxel|paclitaxel|mesh-list
64374925|NCT04937673|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64374926|NCT04937673|Cisplatin|cisplatin|mesh-list
64374927|NCT04937673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64374928|NCT04937673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374929|NCT04937673|Tubulin Modulators|tubulin modulators|mesh-ancestor
64374930|NCT04937673|Antimitotic Agents|antimitotic agents|mesh-ancestor
64374931|NCT04937673|Mitosis Modulators|mitosis modulators|mesh-ancestor
64984471|NCT00293098|Sequestering Agents|sequestering agents|mesh-ancestor
64984472|NCT00293098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984473|NCT00293176|Donepezil|donepezil|mesh-list
64984474|NCT00293176|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64984475|NCT00293176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984476|NCT00293176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984477|NCT00293176|Cholinergic Agents|cholinergic agents|mesh-ancestor
64984478|NCT00293176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64984479|NCT00293176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984480|NCT00293176|Nootropic Agents|nootropic agents|mesh-ancestor
64984481|NCT05567315|Anesthetics|anesthetics|mesh-list
64984482|NCT05567315|Anesthetics, Local|anesthetics, local|mesh-list
64984483|NCT05567315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64984484|NCT05567315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984485|NCT05567315|Sensory System Agents|sensory system agents|mesh-ancestor
64347963|NCT02378805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64984564|NCT00293410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64984565|NCT00293410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64984566|NCT00293410|Alkylating Agents|alkylating agents|mesh-ancestor
64984567|NCT00293410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984568|NCT00293410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984569|NCT00293410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64984570|NCT00293410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64907346|NCT00389038|Analgesics|analgesics|mesh-ancestor
64907356|NCT00000652|Zidovudine|zidovudine|mesh-list
64907362|NCT00000652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907363|NCT00000652|Antiviral Agents|antiviral agents|mesh-ancestor
64907364|NCT00000652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907365|NCT00000652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64907366|NCT00000652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907367|NCT00000676|Fluconazole|fluconazole|mesh-list
64907368|NCT00000676|Clotrimazole|clotrimazole|mesh-list
64907369|NCT00000676|Miconazole|miconazole|mesh-list
64907370|NCT00000676|Antifungal Agents|antifungal agents|mesh-ancestor
64907371|NCT00000676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907372|NCT00000676|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64907373|NCT00000676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64907374|NCT00000676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907375|NCT00000676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907376|NCT00000676|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64907377|NCT00000676|Hormone Antagonists|hormone antagonists|mesh-ancestor
64907378|NCT00000676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64907379|NCT00000676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907380|NCT00000676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64907381|NCT00000676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64907382|NCT00000676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64907383|NCT00000676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64907384|NCT00000679|Zidovudine|zidovudine|mesh-list
64907385|NCT00000679|Zalcitabine|zalcitabine|mesh-list
64907416|NCT00000712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907417|NCT00000712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64907418|NCT00000712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907419|NCT00000712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907420|NCT00000712|Antiviral Agents|antiviral agents|mesh-ancestor
64907421|NCT00000712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907422|NCT00000712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64907423|NCT00000712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907424|NCT00000715|Trimethoprim|trimethoprim|mesh-list
64907425|NCT00000715|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64907426|NCT00000715|Sulfamethoxazole|sulfamethoxazole|mesh-list
64907427|NCT00000715|Pentamidine|pentamidine|mesh-list
64907428|NCT00000715|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64907429|NCT00000715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907430|NCT00000715|Renal Agents|renal agents|mesh-ancestor
64907431|NCT00000715|Antimalarials|antimalarials|mesh-ancestor
64907432|NCT00000715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64907433|NCT00000715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64907443|NCT00000718|Zidovudine|zidovudine|mesh-list
64907446|NCT00000718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907447|NCT00000718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64907448|NCT00000718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907449|NCT00000718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907450|NCT00000718|Antiviral Agents|antiviral agents|mesh-ancestor
64907451|NCT00000718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907452|NCT00000718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64907507|NCT00000751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907508|NCT00000751|Immunologic Factors|immunologic factors|mesh-ancestor
64907509|NCT00000751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907510|NCT00000754|Interferons|interferons|mesh-list
64907511|NCT00000754|Interferon-alpha|interferon-alpha|mesh-list
64907512|NCT00000754|Interferon alpha-2|interferon alpha-2|mesh-list
64907513|NCT00000754|Zidovudine|zidovudine|mesh-list
64907514|NCT00000754|Zalcitabine|zalcitabine|mesh-list
64907515|NCT00000754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64907516|NCT00000754|Antiviral Agents|antiviral agents|mesh-ancestor
64907517|NCT00000754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907518|NCT00000754|Immunologic Factors|immunologic factors|mesh-ancestor
64907519|NCT00000754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907520|NCT00000754|Antimetabolites|antimetabolites|mesh-ancestor
64907521|NCT00000754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907522|NCT00000754|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64907523|NCT00000754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907524|NCT00000754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907525|NCT00000754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64907526|NCT00000754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907527|NCT00000760|Zidovudine|zidovudine|mesh-list
64907528|NCT00000760|Didanosine|didanosine|mesh-list
64907529|NCT00000760|Antimetabolites|antimetabolites|mesh-ancestor
64907530|NCT00000760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907531|NCT00000760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64907532|NCT00000760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907533|NCT00000760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375041|NCT03241901|Antimalarials|antimalarials|mesh-ancestor
64375042|NCT03241901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64375045|NCT03241745|Nivolumab|nivolumab|mesh-list
64984571|NCT00293410|Antimetabolites|antimetabolites|mesh-ancestor
64984572|NCT00121602|Darbepoetin alfa|darbepoetin alfa|mesh-list
64984573|NCT00121602|Hematinics|hematinics|mesh-ancestor
64984574|NCT00293527|Interferons|interferons|mesh-list
64984575|NCT00293527|Interferon-alpha|interferon-alpha|mesh-list
64984576|NCT00293527|Interferon alpha-2|interferon alpha-2|mesh-list
64984577|NCT00293527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984578|NCT00293527|Antiviral Agents|antiviral agents|mesh-ancestor
64984579|NCT00293527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64984580|NCT00293527|Immunologic Factors|immunologic factors|mesh-ancestor
64984581|NCT00293527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984583|NCT04711161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64984613|NCT00293800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64984614|NCT00293800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64984616|NCT00423969|Citalopram|citalopram|mesh-list
64984617|NCT00423969|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64984706|NCT00294385|Gemcitabine|gemcitabine|mesh-list
64984707|NCT00294385|Docetaxel|docetaxel|mesh-list
64907534|NCT00000760|Antiviral Agents|antiviral agents|mesh-ancestor
64907535|NCT00000760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907544|NCT00000790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907545|NCT00000790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64907546|NCT00000790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64907547|NCT00000790|Growth Substances|growth substances|mesh-ancestor
64907548|NCT00000790|Growth Inhibitors|growth inhibitors|mesh-ancestor
64907549|NCT00000790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64907550|NCT00000793|Mexiletine|mexiletine|mesh-list
64907552|NCT00000793|Benztropine|benztropine|mesh-list
64907553|NCT00000793|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64907554|NCT00000793|Antidepressive Agents|antidepressive agents|mesh-ancestor
64907555|NCT00000793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64907556|NCT00000793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64907557|NCT00000793|Analgesics|analgesics|mesh-ancestor
64907558|NCT00000793|Sensory System Agents|sensory system agents|mesh-ancestor
64907559|NCT00000793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64907560|NCT00000793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907561|NCT00000793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64907562|NCT00000793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64907563|NCT00000793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64907564|NCT00000793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907565|NCT00000793|Adrenergic Agents|adrenergic agents|mesh-ancestor
64907566|NCT00000793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64907567|NCT00000793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64907568|NCT00000793|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64907569|NCT00000793|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64907570|NCT00000793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64907571|NCT00000793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64907572|NCT00000793|Parasympatholytics|parasympatholytics|mesh-ancestor
64907573|NCT00000793|Autonomic Agents|autonomic agents|mesh-ancestor
64907574|NCT00000793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64907575|NCT00000793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64907578|NCT00000793|Dopamine Agents|dopamine agents|mesh-ancestor
64907588|NCT00000799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907589|NCT00000817|Amitriptyline|amitriptyline|mesh-list
64907590|NCT00000817|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64907591|NCT00000817|Antidepressive Agents|antidepressive agents|mesh-ancestor
64907592|NCT00000817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64907593|NCT00000817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64907594|NCT00000817|Analgesics|analgesics|mesh-ancestor
64907595|NCT00000817|Sensory System Agents|sensory system agents|mesh-ancestor
64907596|NCT00000817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64907597|NCT00000817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907598|NCT00000817|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64907599|NCT00000817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64907600|NCT00000817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64907601|NCT00000817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907602|NCT00000817|Adrenergic Agents|adrenergic agents|mesh-ancestor
64907603|NCT00000817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64907604|NCT00000820|Aldesleukin|aldesleukin|mesh-list
64907605|NCT00000820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64907606|NCT00000820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64907631|NCT00000826|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64907632|NCT00000826|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64907633|NCT00000826|Renal Agents|renal agents|mesh-ancestor
64907634|NCT00000826|Antimalarials|antimalarials|mesh-ancestor
64907635|NCT00000826|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64907636|NCT00000826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64907637|NCT00000826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64907638|NCT00000826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64907639|NCT00000826|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64907640|NCT00000826|Leprostatic Agents|leprostatic agents|mesh-ancestor
64907641|NCT00000826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64907642|NCT00000826|Antitubercular Agents|antitubercular agents|mesh-ancestor
64907643|NCT00000859|Ritonavir|ritonavir|mesh-list
64907644|NCT00000859|Nelfinavir|nelfinavir|mesh-list
64907645|NCT00000859|Indinavir|indinavir|mesh-list
64907646|NCT00000859|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64907647|NCT00000859|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64907648|NCT00000859|Protease Inhibitors|protease inhibitors|mesh-ancestor
64907661|NCT00000877|Protease Inhibitors|protease inhibitors|mesh-ancestor
64907662|NCT00000877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907663|NCT00000877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907664|NCT00000877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64907665|NCT00000877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907666|NCT00000877|Antiviral Agents|antiviral agents|mesh-ancestor
64907667|NCT00000877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907668|NCT00000877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64907669|NCT00000877|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64907670|NCT00000877|Antitubercular Agents|antitubercular agents|mesh-ancestor
64907672|NCT00000883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64907673|NCT00000883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907674|NCT00000892|Ritonavir|ritonavir|mesh-list
64907675|NCT00000892|Nelfinavir|nelfinavir|mesh-list
64907676|NCT00000892|Saquinavir|saquinavir|mesh-list
64907677|NCT00000892|Delavirdine|delavirdine|mesh-list
64907678|NCT00000892|Adefovir|adefovir|mesh-list
64907679|NCT00000892|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64907680|NCT00000892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64907681|NCT00000892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64907682|NCT00000892|Protease Inhibitors|protease inhibitors|mesh-ancestor
64907684|NCT00000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907685|NCT00000892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64907686|NCT00000892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907687|NCT00000892|Antiviral Agents|antiviral agents|mesh-ancestor
64907688|NCT00000892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907711|NCT00000898|Nelfinavir|nelfinavir|mesh-list
64907712|NCT00000898|Saquinavir|saquinavir|mesh-list
64907713|NCT00000898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64907714|NCT00000898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64907715|NCT00000898|Protease Inhibitors|protease inhibitors|mesh-ancestor
64907716|NCT00000898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907717|NCT00000898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907718|NCT00000898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64907719|NCT00000898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907720|NCT00000898|Antiviral Agents|antiviral agents|mesh-ancestor
64907721|NCT00000898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907722|NCT00000898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64907723|NCT00000898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64907724|NCT00389233|Ascorbic Acid|ascorbic acid|mesh-list
64907725|NCT00389233|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64907726|NCT00389233|Antioxidants|antioxidants|mesh-ancestor
64907727|NCT00389233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907728|NCT00389233|Protective Agents|protective agents|mesh-ancestor
64907729|NCT00389233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907730|NCT00389233|Vitamins|vitamins|mesh-ancestor
64907731|NCT00389233|Micronutrients|micronutrients|mesh-ancestor
64907732|NCT00389233|Laxatives|laxatives|mesh-ancestor
64907733|NCT00389233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64907734|NCT00000904|polysaccharide-K|polysaccharide-k|mesh-list
64375087|NCT04930185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375088|NCT02314559|Propofol|propofol|mesh-list
64375089|NCT02314559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64375091|NCT02314559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984708|NCT00294385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64984709|NCT00294385|Antimetabolites|antimetabolites|mesh-ancestor
64984710|NCT00294385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984711|NCT00294385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984713|NCT00294385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64984714|NCT00294385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984715|NCT00294385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64984716|NCT00294385|Immunologic Factors|immunologic factors|mesh-ancestor
64984717|NCT00294385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984718|NCT00294385|Tubulin Modulators|tubulin modulators|mesh-ancestor
64907735|NCT00000904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64907736|NCT00000904|Immunologic Factors|immunologic factors|mesh-ancestor
64907737|NCT00000904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907738|NCT00000904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64907739|NCT00000904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64907740|NCT00000904|Antiviral Agents|antiviral agents|mesh-ancestor
64907745|NCT00000919|Ritonavir|ritonavir|mesh-list
64907758|NCT00000919|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64907759|NCT00000919|Protease Inhibitors|protease inhibitors|mesh-ancestor
64907760|NCT00000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907761|NCT00000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907762|NCT00000919|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64907763|NCT00000919|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907764|NCT00000919|Antiviral Agents|antiviral agents|mesh-ancestor
64907765|NCT00000919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907766|NCT00000919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64907767|NCT00000919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64907768|NCT00000919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64907769|NCT00000919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907770|NCT00000919|Antimetabolites|antimetabolites|mesh-ancestor
64907773|NCT00000919|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64907823|NCT00000940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64907824|NCT00000940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907825|NCT00000940|Antimetabolites|antimetabolites|mesh-ancestor
64907826|NCT00000940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64907827|NCT00000940|Antitubercular Agents|antitubercular agents|mesh-ancestor
64907828|NCT00000940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64907829|NCT00000943|Vaccines|vaccines|mesh-list
64907830|NCT00000943|Immunologic Factors|immunologic factors|mesh-ancestor
64907831|NCT00000943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907832|NCT00000952|Ritonavir|ritonavir|mesh-list
64907833|NCT00000952|Lamivudine|lamivudine|mesh-list
64907834|NCT00000952|Zidovudine|zidovudine|mesh-list
64907835|NCT00000952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64907836|NCT00000952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64907837|NCT00000952|Protease Inhibitors|protease inhibitors|mesh-ancestor
64907838|NCT00000952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907839|NCT00000952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907840|NCT00000952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64907846|NCT00000952|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64907847|NCT00000952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907848|NCT00000952|Antimetabolites|antimetabolites|mesh-ancestor
64907849|NCT00000970|Ganciclovir|ganciclovir|mesh-list
64907850|NCT00000970|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64907851|NCT00000970|Foscarnet|foscarnet|mesh-list
64907852|NCT00000970|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
64907853|NCT00000970|Antiviral Agents|antiviral agents|mesh-ancestor
64907854|NCT00000970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907855|NCT00000970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907856|NCT00000970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375110|NCT03238703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375111|NCT03238703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64375112|NCT03238703|Hormone Antagonists|hormone antagonists|mesh-ancestor
64375113|NCT03238703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64375114|NCT03238703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375119|NCT03238625|Lidocaine|lidocaine|mesh-list
64907857|NCT00000970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907858|NCT00000970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64907859|NCT00000973|Leucovorin|leucovorin|mesh-list
64907860|NCT00000973|Zidovudine|zidovudine|mesh-list
64907861|NCT00000973|Pyrimethamine|pyrimethamine|mesh-list
64907862|NCT00000973|Calcium|calcium|mesh-list
64907863|NCT00000973|Levoleucovorin|levoleucovorin|mesh-list
64907864|NCT00000973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64907865|NCT00000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907866|NCT00000973|Antidotes|antidotes|mesh-ancestor
64907867|NCT00000973|Protective Agents|protective agents|mesh-ancestor
64907868|NCT00000973|Vitamin B Complex|vitamin b complex|mesh-ancestor
64907869|NCT00000973|Vitamins|vitamins|mesh-ancestor
64907870|NCT00000973|Micronutrients|micronutrients|mesh-ancestor
64907871|NCT00000973|Antimetabolites|antimetabolites|mesh-ancestor
64907872|NCT00000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907897|NCT00001000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907898|NCT00001003|Zidovudine|zidovudine|mesh-list
64907899|NCT00001003|Pentamidine|pentamidine|mesh-list
64907900|NCT00001003|Antimetabolites|antimetabolites|mesh-ancestor
64907901|NCT00001003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907966|NCT00001033|Micronutrients|micronutrients|mesh-ancestor
64907967|NCT00001033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907968|NCT00001036|Zidovudine|zidovudine|mesh-list
64907969|NCT00001036|Interleukin-2|interleukin-2|mesh-list
64907970|NCT00001036|Thymalfasin|thymalfasin|mesh-list
64907971|NCT00001036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64907972|NCT00001036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64907973|NCT00001036|Analgesics|analgesics|mesh-ancestor
64907974|NCT00001036|Sensory System Agents|sensory system agents|mesh-ancestor
64907975|NCT00001036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64907976|NCT00001036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907977|NCT00001036|Antimetabolites|antimetabolites|mesh-ancestor
64907978|NCT00001036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907997|NCT00001045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907998|NCT00001045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64907999|NCT00001045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64908000|NCT00001045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64908001|NCT00001045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64908003|NCT00001048|Zidovudine|zidovudine|mesh-list
64908004|NCT00001048|Didanosine|didanosine|mesh-list
64908005|NCT00001048|Zalcitabine|zalcitabine|mesh-list
64908006|NCT00001048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64908007|NCT00001048|Antimetabolites|antimetabolites|mesh-ancestor
64908008|NCT00001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908009|NCT00001048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908010|NCT00001048|Antiviral Agents|antiviral agents|mesh-ancestor
64908011|NCT00001048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64908012|NCT00001048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64908013|NCT00001048|Immunologic Factors|immunologic factors|mesh-ancestor
64908014|NCT00001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908015|NCT00001048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64908055|NCT00001084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375197|NCT03237533|Ionophores|ionophores|mesh-ancestor
64908064|NCT00001084|Protease Inhibitors|protease inhibitors|mesh-ancestor
64908079|NCT00001087|Ritonavir|ritonavir|mesh-list
64908080|NCT00001087|Nelfinavir|nelfinavir|mesh-list
64908081|NCT00001087|Saquinavir|saquinavir|mesh-list
64908082|NCT00001087|Lamivudine|lamivudine|mesh-list
64908083|NCT00001087|Zidovudine|zidovudine|mesh-list
64908084|NCT00001087|Didanosine|didanosine|mesh-list
64908085|NCT00001087|Stavudine|stavudine|mesh-list
64908086|NCT00001087|Zalcitabine|zalcitabine|mesh-list
64908087|NCT00001087|Efavirenz|efavirenz|mesh-list
64908088|NCT00001087|Adefovir|adefovir|mesh-list
64908114|NCT00001111|Nevirapine|nevirapine|mesh-list
64908115|NCT00001111|Antimetabolites|antimetabolites|mesh-ancestor
64908116|NCT00001111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908117|NCT00001111|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64908118|NCT00001111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64908119|NCT00001111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908120|NCT00001111|Antiviral Agents|antiviral agents|mesh-ancestor
64908121|NCT00001111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64908122|NCT00001111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64908123|NCT00001111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64908124|NCT00001111|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64908125|NCT00001111|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64908126|NCT00001114|Interferons|interferons|mesh-list
64908127|NCT00001114|Interferon-alpha|interferon-alpha|mesh-list
64908128|NCT00001114|Interferon alpha-2|interferon alpha-2|mesh-list
64908169|NCT00389272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64908170|NCT00389272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64908171|NCT00389272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64908172|NCT00389272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64908173|NCT00389272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908174|NCT00389272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908175|NCT00389311|Nonoxynol|nonoxynol|mesh-list
64908176|NCT00389311|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
64908177|NCT00389311|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
64908178|NCT00389311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908179|NCT00389311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64908180|NCT00389311|Contraceptive Agents|contraceptive agents|mesh-ancestor
64908181|NCT00389311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64908211|NCT00001303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64908212|NCT00001303|Autonomic Agents|autonomic agents|mesh-ancestor
64908213|NCT00001303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64908214|NCT00001303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908215|NCT00001303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64908216|NCT00001303|Respiratory System Agents|respiratory system agents|mesh-ancestor
64908217|NCT00001303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64908218|NCT00001303|Antioxidants|antioxidants|mesh-ancestor
64908219|NCT00001303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908220|NCT00001303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64908221|NCT00001303|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64908222|NCT00001303|Vasodilator Agents|vasodilator agents|mesh-ancestor
64908223|NCT00001303|Gasotransmitters|gasotransmitters|mesh-ancestor
64908257|NCT00388557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64908258|NCT00388557|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64908259|NCT00388557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64908260|NCT00388557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908261|NCT00388557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908262|NCT00388557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64908263|NCT00388557|Hormone Antagonists|hormone antagonists|mesh-ancestor
64908264|NCT00388557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64908265|NCT00388557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908266|NCT00388557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64908267|NCT00388635|Prednisone|prednisone|mesh-list
64908268|NCT00388635|Melphalan|melphalan|mesh-list
64908269|NCT00388635|Bortezomib|bortezomib|mesh-list
64908270|NCT00388635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64908271|NCT00388635|Glucocorticoids|glucocorticoids|mesh-ancestor
64908272|NCT00388635|Hormones|hormones|mesh-ancestor
64908273|NCT00388635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64908274|NCT00388635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908275|NCT00388635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64908276|NCT00388635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908277|NCT00388635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64908278|NCT00388635|Alkylating Agents|alkylating agents|mesh-ancestor
64908279|NCT00388635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908280|NCT00388635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64908281|NCT00388635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64908282|NCT00388635|Immunologic Factors|immunologic factors|mesh-ancestor
64908283|NCT00001474|Interleukin-2|interleukin-2|mesh-list
64908284|NCT00001474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984719|NCT00294385|Antimitotic Agents|antimitotic agents|mesh-ancestor
64984720|NCT00294385|Mitosis Modulators|mitosis modulators|mesh-ancestor
64984721|NCT00294463|Tibolone|tibolone|mesh-list
64984722|NCT00294463|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64984765|NCT00089349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984766|NCT00089349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64984839|NCT00294931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64984840|NCT00294931|Growth Substances|growth substances|mesh-ancestor
64984841|NCT00294931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984842|NCT00294931|Growth Inhibitors|growth inhibitors|mesh-ancestor
64908285|NCT00001474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64908286|NCT00001474|Analgesics|analgesics|mesh-ancestor
64908287|NCT00001474|Sensory System Agents|sensory system agents|mesh-ancestor
64908288|NCT00001474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64908290|NCT00001483|Sertraline|sertraline|mesh-list
64908296|NCT00001483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64908297|NCT00001483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64908298|NCT00001483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908299|NCT00001483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64908300|NCT00001483|Serotonin Agents|serotonin agents|mesh-ancestor
64908301|NCT00001483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908302|NCT00001483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64908303|NCT00001483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64908304|NCT00001483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64908305|NCT00001483|Dopamine Agents|dopamine agents|mesh-ancestor
64908306|NCT00001483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64908307|NCT00001483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64908308|NCT00001483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908310|NCT00001495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64908311|NCT00001495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64908312|NCT00001495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908313|NCT00001495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908314|NCT00001495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908315|NCT00001507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64908316|NCT00001507|Antibodies|antibodies|mesh-list
64908317|NCT00001507|Immunoglobulins|immunoglobulins|mesh-list
64908318|NCT00001507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64908319|NCT00001507|Immunologic Factors|immunologic factors|mesh-ancestor
64908320|NCT00001507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908321|NCT00001507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908322|NCT00001567|Interferon alpha-2|interferon alpha-2|mesh-list
64908323|NCT00001567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908338|NCT00001576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908339|NCT00001576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64908340|NCT00001576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64908341|NCT00001576|Immunologic Factors|immunologic factors|mesh-ancestor
64908342|NCT00001576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64908343|NCT00001576|Antimetabolites|antimetabolites|mesh-ancestor
64908344|NCT00000147|Prednisone|prednisone|mesh-list
64908345|NCT00000147|Methylprednisolone|methylprednisolone|mesh-list
64908346|NCT00000147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64908347|NCT00000147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64908348|NCT00000147|Prednisolone|prednisolone|mesh-list
64908349|NCT00000147|Prednisolone acetate|prednisolone acetate|mesh-list
64908350|NCT00000147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64908351|NCT00000147|Prednisolone phosphate|prednisolone phosphate|mesh-list
64908352|NCT00000147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64908353|NCT00000147|Glucocorticoids|glucocorticoids|mesh-ancestor
64908354|NCT00000147|Hormones|hormones|mesh-ancestor
64908355|NCT00000147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64908356|NCT00000147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908357|NCT00000147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64908358|NCT00000147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908359|NCT00000147|Antiemetics|antiemetics|mesh-ancestor
64908360|NCT00000147|Autonomic Agents|autonomic agents|mesh-ancestor
64908361|NCT00000147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64908364|NCT00000147|Protective Agents|protective agents|mesh-ancestor
64908381|NCT00001666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64908382|NCT00001669|Mecasermin|mecasermin|mesh-list
64908383|NCT00001669|Growth Substances|growth substances|mesh-ancestor
64908384|NCT00001669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676811|NCT00000771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64908385|NCT00001693|Celecoxib|celecoxib|mesh-list
64908386|NCT00001693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64908387|NCT00001693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64908389|NCT00001693|Sensory System Agents|sensory system agents|mesh-ancestor
64908390|NCT00001693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64908391|NCT00001693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984843|NCT00294931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64984844|NCT00294931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64984846|NCT00294931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908392|NCT00001693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64908393|NCT00001693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64908394|NCT00001693|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64908395|NCT00001693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64908396|NCT00001693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908397|NCT00001693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908398|NCT00001696|Genistein|genistein|mesh-list
64908399|NCT00001696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64908400|NCT00001696|Protective Agents|protective agents|mesh-ancestor
64908401|NCT00001696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908402|NCT00001696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908403|NCT00001696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64908431|NCT00001723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908432|NCT00001723|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64908433|NCT00001723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64908434|NCT00001729|Ribavirin|ribavirin|mesh-list
64908435|NCT00001729|Antimetabolites|antimetabolites|mesh-ancestor
64908436|NCT00001729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908437|NCT00001729|Antiviral Agents|antiviral agents|mesh-ancestor
64908438|NCT00001729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64908439|NCT00001741|Losartan|losartan|mesh-list
64908440|NCT00001741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64908441|NCT00001741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64908442|NCT00001741|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64908443|NCT00001741|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64908444|NCT00001741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908445|NCT00001777|Sertraline|sertraline|mesh-list
64908446|NCT00001777|Antidepressive Agents|antidepressive agents|mesh-ancestor
64908447|NCT00001777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64908448|NCT00001777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64908449|NCT00001777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64908450|NCT00001777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64375315|NCT04920747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375316|NCT04927299|Losartan|losartan|mesh-list
64984847|NCT02958423|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
64984848|NCT02958423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64984849|NCT02958423|Serotonin Agents|serotonin agents|mesh-ancestor
64984850|NCT02958423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64908451|NCT00001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908494|NCT00000252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64908495|NCT00000252|Anesthetics, General|anesthetics, general|mesh-ancestor
64908496|NCT00000252|Anesthetics|anesthetics|mesh-ancestor
64908497|NCT00000252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64908498|NCT00000252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908499|NCT00000252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64908500|NCT00000252|Analgesics|analgesics|mesh-ancestor
64908501|NCT00000252|Sensory System Agents|sensory system agents|mesh-ancestor
64908502|NCT00000252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64908503|NCT05641051|Metoclopramide|metoclopramide|mesh-list
64908504|NCT05641051|Antiemetics|antiemetics|mesh-ancestor
64908505|NCT05641051|Autonomic Agents|autonomic agents|mesh-ancestor
64908506|NCT05641051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64908507|NCT05641051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908508|NCT05641051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64908509|NCT05641051|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64908510|NCT05641051|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64908511|NCT05641051|Dopamine Agents|dopamine agents|mesh-ancestor
64908512|NCT05641051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64908513|NCT05641051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908514|NCT05640817|Pentoxifylline|pentoxifylline|mesh-list
64908515|NCT05640817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64908516|NCT05640817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908517|NCT05640817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908518|NCT05640817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64908519|NCT05640817|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64908520|NCT05640817|Protective Agents|protective agents|mesh-ancestor
64984851|NCT02958423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984852|NCT02958423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984854|NCT00295165|Immunologic Factors|immunologic factors|mesh-ancestor
64984855|NCT00295165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984856|NCT00295243|Topotecan|topotecan|mesh-list
64984857|NCT00295243|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64984858|NCT00295243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64984859|NCT00295243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984860|NCT00295243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984861|NCT00295243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984863|NCT00295282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64984864|NCT00295282|Immunologic Factors|immunologic factors|mesh-ancestor
64984865|NCT00295282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984866|NCT00121797|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64984867|NCT00121797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64984868|NCT00089622|Levodopa|levodopa|mesh-list
64908521|NCT05640817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908522|NCT05640817|Vasodilator Agents|vasodilator agents|mesh-ancestor
64908523|NCT05640817|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64908524|NCT05640817|Antioxidants|antioxidants|mesh-ancestor
64908525|NCT00000255|Nitrous Oxide|nitrous oxide|mesh-list
64908526|NCT00000255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64908527|NCT00000255|Anesthetics, General|anesthetics, general|mesh-ancestor
64908528|NCT00000255|Anesthetics|anesthetics|mesh-ancestor
64908529|NCT00000255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64908530|NCT00000255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908531|NCT00000255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64908532|NCT00000255|Analgesics|analgesics|mesh-ancestor
64908533|NCT00000255|Sensory System Agents|sensory system agents|mesh-ancestor
64908534|NCT00000255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64908536|NCT00000258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64908537|NCT00000258|Anesthetics, General|anesthetics, general|mesh-ancestor
64908538|NCT00000258|Anesthetics|anesthetics|mesh-ancestor
64908539|NCT00000258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64908540|NCT00000258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908541|NCT00000258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64908542|NCT00000258|Analgesics|analgesics|mesh-ancestor
64908543|NCT00000258|Sensory System Agents|sensory system agents|mesh-ancestor
64908544|NCT00000258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64908545|NCT00389506|Cyclophosphamide|cyclophosphamide|mesh-list
64908546|NCT00389506|Fludarabine|fludarabine|mesh-list
64908547|NCT00389506|Fludarabine phosphate|fludarabine phosphate|mesh-list
64908548|NCT00389506|Immunotoxins|immunotoxins|mesh-list
64908549|NCT00389506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64908550|NCT00389506|Immunologic Factors|immunologic factors|mesh-ancestor
64375402|NCT03056703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64375403|NCT03056703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64375404|NCT03056703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375405|NCT03056703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64375406|NCT03056703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64984869|NCT00089622|Lisuride|lisuride|mesh-list
64984870|NCT00089622|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64984871|NCT00089622|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64984872|NCT00089622|Dopamine Agents|dopamine agents|mesh-ancestor
64348225|NCT03423355|Diuretics|diuretics|mesh-ancestor
64985082|NCT00090012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64985083|NCT00090012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908551|NCT00389506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908552|NCT00389506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64908571|NCT05640427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64908572|NCT05640427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64908573|NCT05640427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908574|NCT05640427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64908575|NCT05640427|Analgesics|analgesics|mesh-ancestor
64908576|NCT05640427|Sensory System Agents|sensory system agents|mesh-ancestor
64908577|NCT05640427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64908578|NCT05640427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64908579|NCT05640427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64908580|NCT05640427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64908581|NCT05640427|Adrenergic Agents|adrenergic agents|mesh-ancestor
64908582|NCT05640427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64908583|NCT05640427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908584|NCT00000363|Histamine Antagonists|histamine antagonists|mesh-list
64908585|NCT00000363|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
64908586|NCT00000363|Histamine Agents|histamine agents|mesh-ancestor
64908587|NCT00000363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64908588|NCT00000363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908589|NCT00000363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908590|NCT00000369|Lithium Carbonate|lithium carbonate|mesh-list
64908591|NCT00000369|Antidepressive Agents|antidepressive agents|mesh-ancestor
64908592|NCT00000369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64908593|NCT00000369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908594|NCT00000369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908595|NCT00000369|Antimanic Agents|antimanic agents|mesh-ancestor
64908596|NCT00000369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64908597|NCT00000369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64908599|NCT00000375|Nortriptyline|nortriptyline|mesh-list
64908615|NCT03295747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64908617|NCT05639959|Mometasone Furoate|mometasone furoate|mesh-list
64908618|NCT05639959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64908619|NCT05639959|Dermatologic Agents|dermatologic agents|mesh-ancestor
64908620|NCT05639959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64908621|NCT03575208|Interferons|interferons|mesh-list
64908622|NCT03575208|Interferon-alpha|interferon-alpha|mesh-list
64908623|NCT03575208|Immunoglobulins|immunoglobulins|mesh-list
64908624|NCT03575208|Antibodies|antibodies|mesh-list
64908625|NCT03575208|gamma-Globulins|gamma-globulins|mesh-list
64908626|NCT03575208|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64908627|NCT03575208|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64908628|NCT03575208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908629|NCT03575208|Antiviral Agents|antiviral agents|mesh-ancestor
64908630|NCT03575208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64908631|NCT03575208|Immunologic Factors|immunologic factors|mesh-ancestor
64908632|NCT03575208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908633|NCT03295552|Carboplatin|carboplatin|mesh-list
64908634|NCT03295552|Decitabine|decitabine|mesh-list
64908635|NCT03295552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908636|NCT03295552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64908637|NCT03295552|Antimetabolites|antimetabolites|mesh-ancestor
64908638|NCT03295552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908639|NCT03295552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908640|NCT05631925|Propofol|propofol|mesh-list
64908641|NCT05631925|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64908642|NCT05631925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64908646|NCT05631925|Anesthetics|anesthetics|mesh-ancestor
64908657|NCT00000378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64908658|NCT00000378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64908659|NCT00000378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908660|NCT00000378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64908661|NCT00000378|Serotonin Agents|serotonin agents|mesh-ancestor
64908662|NCT00000378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908663|NCT00000378|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64908664|NCT00000378|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64908665|NCT00000378|Adrenergic Agents|adrenergic agents|mesh-ancestor
64908666|NCT05626621|Mometasone Furoate|mometasone furoate|mesh-list
64908667|NCT05626621|Azelastine|azelastine|mesh-list
64908668|NCT05626621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64908669|NCT05626621|Dermatologic Agents|dermatologic agents|mesh-ancestor
64908670|NCT05626621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64908671|NCT05626621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64908672|NCT05626621|Autonomic Agents|autonomic agents|mesh-ancestor
64908673|NCT05626621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64908675|NCT05626621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64908692|NCT00000381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908693|NCT00000381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64908694|NCT00000381|Antidepressive Agents|antidepressive agents|mesh-ancestor
64908695|NCT00000381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64908696|NCT00000381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64908697|NCT00000381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64908698|NCT00000381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908699|NCT05619172|Cetuximab|cetuximab|mesh-list
64908724|NCT00000426|Calcium|calcium|mesh-list
64908736|NCT00000456|Sensory System Agents|sensory system agents|mesh-ancestor
64908737|NCT00000456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64908738|NCT05519683|Citalopram|citalopram|mesh-list
64908739|NCT05519683|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64908740|NCT05519683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64908741|NCT05519683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64908742|NCT05519683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908743|NCT05519683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64908744|NCT05519683|Serotonin Agents|serotonin agents|mesh-ancestor
64908745|NCT05519683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908746|NCT05519683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64908747|NCT05519683|Antidepressive Agents|antidepressive agents|mesh-ancestor
64908748|NCT05519683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64908749|NCT05442268|Acetaminophen|acetaminophen|mesh-list
64908750|NCT05442268|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64908751|NCT05442268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64908752|NCT05442268|Analgesics|analgesics|mesh-ancestor
64908753|NCT05442268|Sensory System Agents|sensory system agents|mesh-ancestor
64908754|NCT05442268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64908755|NCT05442268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908756|NCT05442268|Antipyretics|antipyretics|mesh-ancestor
64908757|NCT05442268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64908758|NCT05442268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64908759|NCT05442268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64908760|NCT05442268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908761|NCT05442268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64908762|NCT05442268|Antidepressive Agents|antidepressive agents|mesh-ancestor
64908763|NCT05442268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64908764|NCT05442268|Dopamine Agents|dopamine agents|mesh-ancestor
64908765|NCT05448820|Doxorubicin|doxorubicin|mesh-list
64908766|NCT05448820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64908767|NCT05448820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985085|NCT00090012|Serotonin Agents|serotonin agents|mesh-ancestor
64908771|NCT05448820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908772|NCT00000468|Plasminogen|plasminogen|mesh-list
64908773|NCT00000468|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64908774|NCT00000468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64908775|NCT00000468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64908776|NCT00000468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908777|NCT02972476|Fluticasone|fluticasone|mesh-list
64908778|NCT02972476|Xhance|xhance|mesh-list
64908779|NCT02972476|Budesonide|budesonide|mesh-list
64908780|NCT02972476|Bromides|bromides|mesh-list
64908781|NCT02972476|Formoterol Fumarate|formoterol fumarate|mesh-list
64908782|NCT02972476|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64908783|NCT02972476|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64908784|NCT02972476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64908785|NCT02972476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64908786|NCT02972476|Autonomic Agents|autonomic agents|mesh-ancestor
64908787|NCT02972476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64908788|NCT02972476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908789|NCT02972476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64908790|NCT02972476|Respiratory System Agents|respiratory system agents|mesh-ancestor
64908791|NCT02972476|Dermatologic Agents|dermatologic agents|mesh-ancestor
64908792|NCT02972476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64908793|NCT02972476|Glucocorticoids|glucocorticoids|mesh-ancestor
64908794|NCT02972476|Hormones|hormones|mesh-ancestor
64908795|NCT02972476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64908796|NCT02972476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64908797|NCT02972476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64908798|NCT02972476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64908799|NCT02972476|Adrenergic Agents|adrenergic agents|mesh-ancestor
64908800|NCT02972476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64908801|NCT02972476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908824|NCT05349838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908825|NCT05349838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908826|NCT05349838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64908827|NCT05349838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64908828|NCT05349838|Antiviral Agents|antiviral agents|mesh-ancestor
64908829|NCT05349838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64908830|NCT05349838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64677264|NCT00000963|Didanosine|didanosine|mesh-list
64908831|NCT05349838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64908833|NCT05312008|Oxytocics|oxytocics|mesh-ancestor
64908834|NCT05312008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64908835|NCT05312008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908836|NCT03164980|Trabectedin|trabectedin|mesh-list
64908837|NCT03164980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64908838|NCT03164980|Alkylating Agents|alkylating agents|mesh-ancestor
64908839|NCT03164980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908840|NCT03164980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908841|NCT05305456|Vitamins|vitamins|mesh-list
64908842|NCT05305456|Ascorbic Acid|ascorbic acid|mesh-list
64908843|NCT05305456|Micronutrients|micronutrients|mesh-ancestor
64908844|NCT05305456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908845|NCT05305456|Antioxidants|antioxidants|mesh-ancestor
64908846|NCT05305456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908847|NCT05305456|Protective Agents|protective agents|mesh-ancestor
64908854|NCT05233696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64908855|NCT05233696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908856|NCT05233696|Tubulin Modulators|tubulin modulators|mesh-ancestor
64908857|NCT05233696|Antimitotic Agents|antimitotic agents|mesh-ancestor
64908858|NCT05233696|Mitosis Modulators|mitosis modulators|mesh-ancestor
64908859|NCT05233696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908860|NCT05233696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64908861|NCT05223673|Trifluridine|trifluridine|mesh-list
64908872|NCT00000492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908873|NCT00000492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64908874|NCT00000492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64908875|NCT00000492|Vasodilator Agents|vasodilator agents|mesh-ancestor
64908876|NCT00000498|Antihypertensive Agents|antihypertensive agents|mesh-list
64908877|NCT00000504|Flecainide|flecainide|mesh-list
64908878|NCT00000504|Moricizine|moricizine|mesh-list
64908879|NCT00000504|Encainide|encainide|mesh-list
64908880|NCT00000504|Imipramine|imipramine|mesh-list
64908881|NCT00000504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64908882|NCT00000504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64908883|NCT00000504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64908884|NCT00000504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64908895|NCT00389935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64908896|NCT00389935|Immunologic Factors|immunologic factors|mesh-ancestor
64908897|NCT00389935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908898|NCT00389935|Leprostatic Agents|leprostatic agents|mesh-ancestor
64908899|NCT00389935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64908900|NCT00389935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64908901|NCT00389935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64908902|NCT00389935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64908903|NCT00389935|Growth Substances|growth substances|mesh-ancestor
64677354|NCT00001929|Eliprodil|eliprodil|mesh-list
64908906|NCT05116930|Atropine|atropine|mesh-list
64908945|NCT05049616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64908946|NCT05049616|Natriuretic Agents|natriuretic agents|mesh-ancestor
64908947|NCT05049616|Protease Inhibitors|protease inhibitors|mesh-ancestor
64908948|NCT05049616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908949|NCT00000522|Acebutolol|acebutolol|mesh-list
64908950|NCT00000522|Amlodipine|amlodipine|mesh-list
64908951|NCT00000522|Enalapril|enalapril|mesh-list
64908952|NCT00000522|Chlorthalidone|chlorthalidone|mesh-list
64908953|NCT00000522|Doxazosin|doxazosin|mesh-list
64908954|NCT00000522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64908955|NCT00000522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64908956|NCT00000522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64908957|NCT00000522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908958|NCT00000522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64908959|NCT00000522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908960|NCT00000522|Vasodilator Agents|vasodilator agents|mesh-ancestor
64908961|NCT00000522|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64908962|NCT00000522|Protease Inhibitors|protease inhibitors|mesh-ancestor
64908963|NCT00000522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908964|NCT00000522|Diuretics|diuretics|mesh-ancestor
64908965|NCT00000522|Natriuretic Agents|natriuretic agents|mesh-ancestor
64908983|NCT03126799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64908984|NCT03126799|Growth Substances|growth substances|mesh-ancestor
64909038|NCT00000531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64909039|NCT00000531|Adrenergic Agents|adrenergic agents|mesh-ancestor
64909040|NCT00000531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64909041|NCT00000531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909042|NCT00000531|Sympatholytics|sympatholytics|mesh-ancestor
64909043|NCT00000531|Autonomic Agents|autonomic agents|mesh-ancestor
64909044|NCT00000531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64909045|NCT00000534|Calcium|calcium|mesh-list
64909046|NCT00000534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64909047|NCT00000534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909048|NCT04935814|Vasopressins|vasopressins|mesh-list
64909049|NCT04935814|Arginine Vasopressin|arginine vasopressin|mesh-list
64909050|NCT04935814|Hemostatics|hemostatics|mesh-ancestor
64909051|NCT04935814|Coagulants|coagulants|mesh-ancestor
64909052|NCT04935814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64909053|NCT04935814|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64909054|NCT04935814|Natriuretic Agents|natriuretic agents|mesh-ancestor
64909055|NCT04935814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909056|NCT00000552|Fibrinolytic Agents|fibrinolytic agents|mesh-list
64909057|NCT00000552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64909058|NCT00000552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909059|NCT00000555|Ascorbic Acid|ascorbic acid|mesh-list
64909060|NCT00000555|Vitamin E|vitamin e|mesh-list
64909061|NCT00000555|Hormones|hormones|mesh-list
64909077|NCT04888858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64909102|NCT00000558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909103|NCT00000558|Protease Inhibitors|protease inhibitors|mesh-ancestor
64909104|NCT04862221|Diphenhydramine|diphenhydramine|mesh-list
64909105|NCT04862221|Promethazine|promethazine|mesh-list
64909106|NCT04862221|Methylprednisolone|methylprednisolone|mesh-list
64909107|NCT04862221|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64909118|NCT04862221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909119|NCT04862221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64909120|NCT04862221|Glucocorticoids|glucocorticoids|mesh-ancestor
64909122|NCT04862221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64909123|NCT04862221|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64909124|NCT04862221|Protective Agents|protective agents|mesh-ancestor
64909125|NCT04862221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64909126|NCT04862221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677573|NCT02294058|Interferons|interferons|mesh-list
64909127|NCT04862221|Immunologic Factors|immunologic factors|mesh-ancestor
64909128|NCT04862221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64909129|NCT04862221|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64909130|NCT04862221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64909131|NCT04862221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64909132|NCT04862221|Anesthetics, Local|anesthetics, local|mesh-ancestor
64909133|NCT04862221|Anesthetics|anesthetics|mesh-ancestor
64909134|NCT04862221|Sensory System Agents|sensory system agents|mesh-ancestor
64909135|NCT04862221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64909136|NCT04862221|Histamine Antagonists|histamine antagonists|mesh-ancestor
64909137|NCT04862221|Histamine Agents|histamine agents|mesh-ancestor
64909138|NCT04862221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64909139|NCT04862221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909140|NCT04862221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64909141|NCT04862221|Antipruritics|antipruritics|mesh-ancestor
64909142|NCT04862221|Dermatologic Agents|dermatologic agents|mesh-ancestor
64909143|NCT04802746|Alprazolam|alprazolam|mesh-list
64909144|NCT04802746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64375556|NCT04922541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909145|NCT04802746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64909162|NCT00000579|Ketoconazole|ketoconazole|mesh-list
64909163|NCT00000579|Methylprednisolone|methylprednisolone|mesh-list
64909164|NCT00000579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64909165|NCT00000579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64909166|NCT00000579|Prednisolone|prednisolone|mesh-list
64909167|NCT00000579|Prednisolone acetate|prednisolone acetate|mesh-list
64909168|NCT00000579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64909169|NCT00000579|Prednisolone phosphate|prednisolone phosphate|mesh-list
64909170|NCT00000579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64909171|NCT00000579|Antiemetics|antiemetics|mesh-ancestor
64909172|NCT00000579|Autonomic Agents|autonomic agents|mesh-ancestor
64909173|NCT00000579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64909174|NCT00000579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909175|NCT00000579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64909176|NCT00000579|Glucocorticoids|glucocorticoids|mesh-ancestor
64909177|NCT00000579|Hormones|hormones|mesh-ancestor
64909178|NCT00000579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64909179|NCT00000579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64909180|NCT00000579|Protective Agents|protective agents|mesh-ancestor
64909181|NCT00000579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64909182|NCT00000579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909183|NCT00000579|Antifungal Agents|antifungal agents|mesh-ancestor
64909184|NCT00000579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909185|NCT00000579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64909187|NCT00000579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909214|NCT00390091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909215|NCT00390130|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64909216|NCT00390130|Immunologic Factors|immunologic factors|mesh-ancestor
64909217|NCT00390130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909218|NCT04650880|Vitamin D|vitamin d|mesh-list
64909219|NCT04650880|Vitamins|vitamins|mesh-ancestor
64909220|NCT04650880|Micronutrients|micronutrients|mesh-ancestor
64375602|NCT02121262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64985086|NCT00090012|Antidepressive Agents|antidepressive agents|mesh-ancestor
64985088|NCT00296608|Fluorouracil|fluorouracil|mesh-list
64985089|NCT00296608|Calcium|calcium|mesh-list
64985090|NCT00296608|Levoleucovorin|levoleucovorin|mesh-list
64985091|NCT00296608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64985092|NCT00296608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985093|NCT00296608|Antimetabolites|antimetabolites|mesh-ancestor
64985094|NCT00296608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909221|NCT04650880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909222|NCT04650880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64909223|NCT04601077|Nitric Oxide|nitric oxide|mesh-list
64909224|NCT04601077|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64909225|NCT04601077|Autonomic Agents|autonomic agents|mesh-ancestor
64909226|NCT04601077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64909227|NCT04601077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909228|NCT04601077|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64909229|NCT04601077|Respiratory System Agents|respiratory system agents|mesh-ancestor
64909230|NCT04601077|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64909231|NCT04601077|Antioxidants|antioxidants|mesh-ancestor
64909232|NCT04601077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909267|NCT04544683|Hormones|hormones|mesh-ancestor
64909268|NCT04544683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64909269|NCT04544683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64909270|NCT04544683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909271|NCT04544683|Protease Inhibitors|protease inhibitors|mesh-ancestor
64909272|NCT04544683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909273|NCT04544683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909274|NCT00000612|Estrogens|estrogens|mesh-list
64909275|NCT00000612|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64909276|NCT00000612|Hormones|hormones|mesh-ancestor
64909277|NCT00000612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64909278|NCT00000612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909279|NCT00000639|Itraconazole|itraconazole|mesh-list
64909280|NCT00000639|Fluconazole|fluconazole|mesh-list
64909281|NCT00000639|Amphotericin B|amphotericin b|mesh-list
64909282|NCT00000639|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64375701|NCT04900311|Antimitotic Agents|antimitotic agents|mesh-ancestor
64375702|NCT04900311|Mitosis Modulators|mitosis modulators|mesh-ancestor
64375735|NCT03051945|Anesthetics, General|anesthetics, general|mesh-ancestor
64375736|NCT03051945|Anesthetics|anesthetics|mesh-ancestor
64375737|NCT03051945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64375739|NCT03051945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64909283|NCT00000639|Flucytosine|flucytosine|mesh-list
64909284|NCT00000639|Antifungal Agents|antifungal agents|mesh-ancestor
64909285|NCT00000639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909286|NCT00000639|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64909287|NCT00000639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64909288|NCT00000639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909318|NCT04495504|Anesthetics|anesthetics|mesh-ancestor
64909319|NCT04495504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64909320|NCT04495504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909321|NCT04495504|Sensory System Agents|sensory system agents|mesh-ancestor
64909322|NCT04495504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64909323|NCT00390208|Dexamethasone|dexamethasone|mesh-list
64909324|NCT00390208|Ranibizumab|ranibizumab|mesh-list
64909325|NCT00390208|Verteporfin|verteporfin|mesh-list
64909326|NCT00390208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64909327|NCT00390208|Antiemetics|antiemetics|mesh-ancestor
64909328|NCT00390208|Autonomic Agents|autonomic agents|mesh-ancestor
64909329|NCT00390208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64909330|NCT00390208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909331|NCT00390208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64909332|NCT00390208|Glucocorticoids|glucocorticoids|mesh-ancestor
64909333|NCT00390208|Hormones|hormones|mesh-ancestor
64909334|NCT00390208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64909335|NCT00390208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64909336|NCT00390208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909337|NCT00390208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64909338|NCT00390208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64909339|NCT00390208|Growth Substances|growth substances|mesh-ancestor
64909340|NCT00390208|Growth Inhibitors|growth inhibitors|mesh-ancestor
64909341|NCT00390208|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64909342|NCT00390208|Dermatologic Agents|dermatologic agents|mesh-ancestor
64909367|NCT00390247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64909368|NCT00390247|Growth Substances|growth substances|mesh-ancestor
64909369|NCT00390247|Growth Inhibitors|growth inhibitors|mesh-ancestor
64909370|NCT00390247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909371|NCT00000651|Zidovudine|zidovudine|mesh-list
64909372|NCT00000651|Zalcitabine|zalcitabine|mesh-list
64909373|NCT00000651|Antimetabolites|antimetabolites|mesh-ancestor
64909374|NCT00000651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909375|NCT00000651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64909376|NCT00000651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64909377|NCT00000651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909378|NCT00000651|Antiviral Agents|antiviral agents|mesh-ancestor
64909379|NCT00000651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909380|NCT00000651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64909381|NCT00000651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64909382|NCT00000666|Pyrimethamine|pyrimethamine|mesh-list
64909420|NCT00390403|Temozolomide|temozolomide|mesh-list
64909421|NCT00390403|Retinol acetate|retinol acetate|mesh-list
64909422|NCT00390403|Gossypol acetic acid|gossypol acetic acid|mesh-list
64909423|NCT00390403|Gossypol|gossypol|mesh-list
64909424|NCT00390403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64909425|NCT00390403|Alkylating Agents|alkylating agents|mesh-ancestor
64909426|NCT00390403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909427|NCT00390403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909428|NCT00390403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64909429|NCT00390403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909430|NCT00390403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64909431|NCT00390403|Immunologic Factors|immunologic factors|mesh-ancestor
64909432|NCT00390403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909433|NCT00390403|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64909434|NCT00390403|Protective Agents|protective agents|mesh-ancestor
64909435|NCT00390403|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64909436|NCT00390403|Contraceptive Agents|contraceptive agents|mesh-ancestor
64909437|NCT00390403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64375855|NCT04897737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909439|NCT00390403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64909440|NCT00390403|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
64909441|NCT00390403|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
64909472|NCT00000687|Interferon-alpha|interferon-alpha|mesh-list
64909473|NCT00000687|Interferon alpha-2|interferon alpha-2|mesh-list
64909474|NCT00000687|Zidovudine|zidovudine|mesh-list
64909475|NCT00000687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909476|NCT00000687|Antiviral Agents|antiviral agents|mesh-ancestor
64909477|NCT00000687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909478|NCT00000687|Immunologic Factors|immunologic factors|mesh-ancestor
64909479|NCT00000687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909480|NCT00000687|Antimetabolites|antimetabolites|mesh-ancestor
64909481|NCT00000687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909482|NCT00000687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64909483|NCT00000687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64909484|NCT00000687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909485|NCT00000687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64909486|NCT00000687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64909487|NCT00000690|Dextrans|dextrans|mesh-list
64909488|NCT00000690|Anticoagulants|anticoagulants|mesh-ancestor
64909489|NCT00000690|Plasma Substitutes|plasma substitutes|mesh-ancestor
64909490|NCT00000690|Blood Substitutes|blood substitutes|mesh-ancestor
64909491|NCT00000696|Interferons|interferons|mesh-list
64909492|NCT00000696|Interferon-alpha|interferon-alpha|mesh-list
64909493|NCT00000696|Interferon alpha-2|interferon alpha-2|mesh-list
64909527|NCT00000708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64909528|NCT00000708|Hormone Antagonists|hormone antagonists|mesh-ancestor
64909529|NCT00000708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64909530|NCT00000708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909531|NCT00000708|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64909532|NCT00000708|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64909533|NCT00000708|Amebicides|amebicides|mesh-ancestor
64909534|NCT00000708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64909535|NCT00000708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64909536|NCT00000708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64909537|NCT00000708|Antimetabolites|antimetabolites|mesh-ancestor
64909562|NCT00000711|Immunologic Factors|immunologic factors|mesh-ancestor
64909563|NCT00000711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909564|NCT00000717|Clindamycin|clindamycin|mesh-list
64909565|NCT00000717|Clindamycin palmitate|clindamycin palmitate|mesh-list
64909566|NCT00000717|Clindamycin phosphate|clindamycin phosphate|mesh-list
64909567|NCT00000717|Primaquine|primaquine|mesh-list
64909568|NCT00000717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64909569|NCT00000717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909570|NCT00000717|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64909571|NCT00000717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909572|NCT00000717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909573|NCT00000717|Antimalarials|antimalarials|mesh-ancestor
64909574|NCT00000717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64909575|NCT00000717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64909576|NCT04169347|Leucovorin|leucovorin|mesh-list
64678018|NCT00359567|Palonosetron|palonosetron|mesh-list
64909577|NCT04169347|Oxaliplatin|oxaliplatin|mesh-list
64909578|NCT04169347|Irinotecan|irinotecan|mesh-list
64909579|NCT04169347|Panitumumab|panitumumab|mesh-list
64909580|NCT04169347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909581|NCT04169347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64909582|NCT04169347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64909583|NCT04169347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375872|NCT04891497|Dermatologic Agents|dermatologic agents|mesh-ancestor
64375873|NCT04891497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64375900|NCT04906317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909584|NCT04169347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909585|NCT04169347|Antidotes|antidotes|mesh-ancestor
64909586|NCT04169347|Protective Agents|protective agents|mesh-ancestor
64909587|NCT04169347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909588|NCT04169347|Vitamin B Complex|vitamin b complex|mesh-ancestor
64909589|NCT04169347|Vitamins|vitamins|mesh-ancestor
64909610|NCT00000726|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
64909611|NCT00000726|Antiviral Agents|antiviral agents|mesh-ancestor
64909612|NCT00000726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909613|NCT00000726|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64909614|NCT00000726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64909615|NCT00000726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909616|NCT00000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909617|NCT04104139|Trifluridine|trifluridine|mesh-list
64909675|NCT04038346|Sensory System Agents|sensory system agents|mesh-ancestor
64909676|NCT04038346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64909677|NCT04038346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909678|NCT04038346|Antipyretics|antipyretics|mesh-ancestor
64909679|NCT04038346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64909680|NCT04038346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64909681|NCT04038346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64909682|NCT04038346|Gout Suppressants|gout suppressants|mesh-ancestor
64909683|NCT04038346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64909684|NCT04038346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909685|NCT04038346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909717|NCT00000753|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64909718|NCT00000753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909719|NCT00000753|Antiviral Agents|antiviral agents|mesh-ancestor
64909720|NCT00000753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909721|NCT00000753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64909722|NCT00000753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64909724|NCT04004416|Anticonvulsants|anticonvulsants|mesh-ancestor
64909725|NCT04004416|Antiemetics|antiemetics|mesh-ancestor
64909726|NCT04004416|Autonomic Agents|autonomic agents|mesh-ancestor
64909727|NCT04004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64909728|NCT04004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909729|NCT04004416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64909730|NCT04004416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64909731|NCT04004416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64909732|NCT04004416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64909733|NCT04004416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64909734|NCT04004416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64909736|NCT04004416|GABA Agents|gaba agents|mesh-ancestor
64909737|NCT04004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64909738|NCT04004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909739|NCT03991741|Interleukin-2|interleukin-2|mesh-list
64909740|NCT03991741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909741|NCT03991741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64909742|NCT03991741|Analgesics|analgesics|mesh-ancestor
64909743|NCT03991741|Sensory System Agents|sensory system agents|mesh-ancestor
64909744|NCT03991741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64909745|NCT03991741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909746|NCT00000768|Ganciclovir|ganciclovir|mesh-list
64909747|NCT00000768|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64909748|NCT00000768|Antiviral Agents|antiviral agents|mesh-ancestor
64909749|NCT00000768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909750|NCT00000768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64909758|NCT00000789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64909759|NCT00000789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909760|NCT00000789|Antiviral Agents|antiviral agents|mesh-ancestor
64909761|NCT00000789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909762|NCT00000789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64909763|NCT00000789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64909765|NCT00000792|Antidepressive Agents|antidepressive agents|mesh-ancestor
64909766|NCT00000792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64909767|NCT00000792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909768|NCT00000792|Antiviral Agents|antiviral agents|mesh-ancestor
64909769|NCT00000792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909770|NCT00000792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909771|NCT00000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909772|NCT00000792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64909773|NCT00000792|Immunologic Factors|immunologic factors|mesh-ancestor
64909774|NCT00000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909775|NCT03937609|Infliximab|infliximab|mesh-list
64909776|NCT03937609|Dermatologic Agents|dermatologic agents|mesh-ancestor
64909777|NCT03937609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64909778|NCT03937609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64909779|NCT00390520|Vildagliptin|vildagliptin|mesh-list
64909780|NCT00390520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64909781|NCT00390520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909782|NCT00390520|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64909783|NCT00390520|Protease Inhibitors|protease inhibitors|mesh-ancestor
64909801|NCT03877549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64909802|NCT03877549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376007|NCT04906161|Vitamin D|vitamin d|mesh-list
64985095|NCT00296608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64985096|NCT00296608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348305|NCT05160727|Irinotecan|irinotecan|mesh-list
64985266|NCT00297817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985268|NCT00090324|Antidepressive Agents|antidepressive agents|mesh-ancestor
64985269|NCT00090324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64985270|NCT00090324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64985274|NCT05319353|Maribavir|maribavir|mesh-list
64985299|NCT05200559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64985300|NCT05200559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985301|NCT00298012|Methotrexate|methotrexate|mesh-list
64985302|NCT00298012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64985303|NCT00298012|Abortifacient Agents|abortifacient agents|mesh-ancestor
64985304|NCT00298012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64985352|NCT00313963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985354|NCT00313963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64985355|NCT00313963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64985356|NCT00313963|Anticonvulsants|anticonvulsants|mesh-ancestor
64985357|NCT00313963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64985358|NCT00313963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64909803|NCT03877549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64909804|NCT03877549|Glucocorticoids|glucocorticoids|mesh-ancestor
64909806|NCT03877549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64909807|NCT03877549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64909808|NCT03877549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909809|NCT00390598|Sennosides|sennosides|mesh-list
64909810|NCT00390598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64909811|NCT00390598|Laxatives|laxatives|mesh-ancestor
64909812|NCT00390598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64909813|NCT00000816|Trimethoprim|trimethoprim|mesh-list
64909814|NCT00000816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64909815|NCT00000816|Sulfamethoxazole|sulfamethoxazole|mesh-list
64909816|NCT00000816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64909817|NCT00000816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909818|NCT00000816|Renal Agents|renal agents|mesh-ancestor
64909819|NCT00000816|Antimalarials|antimalarials|mesh-ancestor
64909820|NCT00000816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64909821|NCT00000816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64909822|NCT00000816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64909823|NCT00000816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909824|NCT00000816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909825|NCT00000816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64909826|NCT00000816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64909827|NCT00000816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64909828|NCT00000816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64909829|NCT03801031|Lidocaine|lidocaine|mesh-list
64909830|NCT03801031|Anesthetics, Local|anesthetics, local|mesh-ancestor
64909831|NCT03801031|Anesthetics|anesthetics|mesh-ancestor
64909841|NCT00000822|Ritonavir|ritonavir|mesh-list
64909843|NCT00000822|Stavudine|stavudine|mesh-list
64909846|NCT00000822|Protease Inhibitors|protease inhibitors|mesh-ancestor
64909853|NCT00000822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64909854|NCT00000822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64909855|NCT00000822|Antimetabolites|antimetabolites|mesh-ancestor
64909856|NCT00000822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64909857|NCT00000822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64909858|NCT03797560|Pregabalin|pregabalin|mesh-list
64909859|NCT03797560|Analgesics|analgesics|mesh-ancestor
64909860|NCT03797560|Sensory System Agents|sensory system agents|mesh-ancestor
64909861|NCT03797560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64909862|NCT03797560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909863|NCT03797560|Anticonvulsants|anticonvulsants|mesh-ancestor
64909864|NCT03797560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64909865|NCT03797560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64909866|NCT03797560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909867|NCT03797560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64909868|NCT03797560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64909869|NCT03797560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64909870|NCT03797560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64909871|NCT03797560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64909872|NCT03729271|Rifaximin|rifaximin|mesh-list
64909919|NCT03576547|Protease Inhibitors|protease inhibitors|mesh-ancestor
64909920|NCT03576547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909925|NCT03574402|Pemetrexed|pemetrexed|mesh-list
64909930|NCT03574402|Maleic acid|maleic acid|mesh-list
64909931|NCT03574402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909932|NCT03574402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64909933|NCT03574402|Antimetabolites|antimetabolites|mesh-ancestor
64909934|NCT03574402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909935|NCT03574402|Antiviral Agents|antiviral agents|mesh-ancestor
64909936|NCT03574402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909937|NCT03574402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909938|NCT03574402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64909939|NCT03574402|Immunologic Factors|immunologic factors|mesh-ancestor
64909940|NCT03574402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909941|NCT03574402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64909942|NCT03574402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64909943|NCT03574402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64909944|NCT03574402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64909945|NCT03539302|Flecainide|flecainide|mesh-list
64909946|NCT03539302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64909947|NCT03539302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64909948|NCT03539302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64909949|NCT03539302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64909950|NCT03539302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909951|NCT00000831|Lamivudine|lamivudine|mesh-list
64909952|NCT00000831|Zidovudine|zidovudine|mesh-list
64909953|NCT00000831|Didanosine|didanosine|mesh-list
64909954|NCT00000831|Stavudine|stavudine|mesh-list
64909955|NCT00000831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64909978|NCT00000855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64909979|NCT00000855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64909980|NCT00000855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909981|NCT00000855|Antiviral Agents|antiviral agents|mesh-ancestor
64909982|NCT00000855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909983|NCT00000855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64376092|NCT05154123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64376093|NCT05154123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64909984|NCT00000855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64909985|NCT03317392|Olaparib|olaparib|mesh-list
64909986|NCT03317392|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64909987|NCT03317392|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64909988|NCT03317392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909989|NCT03317392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909990|NCT03317392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909991|NCT00000867|Memantine|memantine|mesh-list
64909992|NCT00000867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64909993|NCT00000867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64909994|NCT00000867|Dopamine Agents|dopamine agents|mesh-ancestor
64909995|NCT00000867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64909996|NCT00000867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909997|NCT00000867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909998|NCT00000867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64909999|NCT00000867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64910000|NCT00390676|Carboplatin|carboplatin|mesh-list
64910001|NCT00390676|Docetaxel|docetaxel|mesh-list
64910002|NCT00390676|Capecitabine|capecitabine|mesh-list
64910003|NCT00390676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910004|NCT00390676|Tubulin Modulators|tubulin modulators|mesh-ancestor
64910005|NCT00390676|Antimitotic Agents|antimitotic agents|mesh-ancestor
64910006|NCT00390676|Mitosis Modulators|mitosis modulators|mesh-ancestor
64910007|NCT00390676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910008|NCT00390676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64910042|NCT00390871|Sensory System Agents|sensory system agents|mesh-ancestor
64910074|NCT00000882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910075|NCT00000882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64910076|NCT00000882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64910077|NCT00000882|Antimetabolites|antimetabolites|mesh-ancestor
64910078|NCT00000882|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64910079|NCT00000882|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64910080|NCT00000882|Protease Inhibitors|protease inhibitors|mesh-ancestor
64910081|NCT00000888|Ritonavir|ritonavir|mesh-list
64910082|NCT00000888|Lamivudine|lamivudine|mesh-list
64910083|NCT00000888|Zidovudine|zidovudine|mesh-list
64910084|NCT00000888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64910085|NCT00000888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64910086|NCT00000888|Protease Inhibitors|protease inhibitors|mesh-ancestor
64910087|NCT00000888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910088|NCT00000888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910089|NCT00000888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64910090|NCT00000888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64910091|NCT00000888|Antiviral Agents|antiviral agents|mesh-ancestor
64910092|NCT00000888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910093|NCT00000888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64910094|NCT00000888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64910095|NCT00000888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64910096|NCT00000888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64910097|NCT00000888|Antimetabolites|antimetabolites|mesh-ancestor
64910098|NCT00000891|Ritonavir|ritonavir|mesh-list
64910099|NCT00000891|Saquinavir|saquinavir|mesh-list
64910100|NCT00000891|Lamivudine|lamivudine|mesh-list
64910101|NCT00000891|Zidovudine|zidovudine|mesh-list
64910102|NCT00000891|Didanosine|didanosine|mesh-list
64910103|NCT00000891|Stavudine|stavudine|mesh-list
64910104|NCT00000891|Delavirdine|delavirdine|mesh-list
64910105|NCT00000891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64910106|NCT00000891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64910110|NCT00000891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64910116|NCT00000891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64910117|NCT00000891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64910118|NCT00000891|Antimetabolites|antimetabolites|mesh-ancestor
64910119|NCT00000903|Lamivudine|lamivudine|mesh-list
64910120|NCT00000903|Zidovudine|zidovudine|mesh-list
64910121|NCT00000903|Efavirenz|efavirenz|mesh-list
64910122|NCT00000903|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64910123|NCT00000903|Nelfinavir|nelfinavir|mesh-list
64910124|NCT00000903|Indinavir|indinavir|mesh-list
64910125|NCT00000903|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64910126|NCT00000903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64910127|NCT00000903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910128|NCT00000903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910129|NCT00000903|Antiviral Agents|antiviral agents|mesh-ancestor
64910130|NCT00000903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910131|NCT00000903|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64910132|NCT00000903|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64910133|NCT00000903|Antimetabolites|antimetabolites|mesh-ancestor
64910134|NCT00000903|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64910161|NCT00000906|Antiviral Agents|antiviral agents|mesh-ancestor
64910162|NCT00000906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910163|NCT00000906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64910164|NCT00000906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64910165|NCT00000906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64910166|NCT00000906|Narcotics|narcotics|mesh-ancestor
64910167|NCT00000906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64910168|NCT00000906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910169|NCT00000906|Analgesics|analgesics|mesh-ancestor
64910170|NCT00000906|Sensory System Agents|sensory system agents|mesh-ancestor
64910171|NCT00000906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64910172|NCT00000906|Antitussive Agents|antitussive agents|mesh-ancestor
64910173|NCT00000906|Respiratory System Agents|respiratory system agents|mesh-ancestor
64910174|NCT02681302|Nivolumab|nivolumab|mesh-list
64910175|NCT02681302|Ipilimumab|ipilimumab|mesh-list
64910176|NCT02681302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64910181|NCT00000951|Antifungal Agents|antifungal agents|mesh-ancestor
64910182|NCT00000951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910183|NCT00000951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64910184|NCT00000951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64910208|NCT02491099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64910209|NCT02491099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910210|NCT02419495|Calcium, Dietary|calcium, dietary|mesh-list
64910211|NCT02419495|Leucovorin|leucovorin|mesh-list
64910212|NCT02419495|Folic Acid|folic acid|mesh-list
64910213|NCT02419495|Paclitaxel|paclitaxel|mesh-list
64910214|NCT02419495|Camptothecin|camptothecin|mesh-list
64910215|NCT02419495|Cyclophosphamide|cyclophosphamide|mesh-list
64910216|NCT02419495|Carboplatin|carboplatin|mesh-list
64910217|NCT02419495|Doxorubicin|doxorubicin|mesh-list
64910218|NCT02419495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64910219|NCT02419495|Pembrolizumab|pembrolizumab|mesh-list
64910220|NCT02419495|Fluorouracil|fluorouracil|mesh-list
64910221|NCT02419495|Capecitabine|capecitabine|mesh-list
64910222|NCT02419495|Oxaliplatin|oxaliplatin|mesh-list
64910223|NCT02419495|Nivolumab|nivolumab|mesh-list
64910224|NCT02419495|Irinotecan|irinotecan|mesh-list
64910225|NCT02419495|Pemetrexed|pemetrexed|mesh-list
64910226|NCT02419495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64910227|NCT02419495|Ipilimumab|ipilimumab|mesh-list
64910228|NCT02419495|Daunorubicin|daunorubicin|mesh-list
64910229|NCT02419495|Topotecan|topotecan|mesh-list
64910230|NCT02419495|Olaparib|olaparib|mesh-list
64910231|NCT02419495|Calcium|calcium|mesh-list
64910232|NCT02419495|Levoleucovorin|levoleucovorin|mesh-list
64910233|NCT02419495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64910234|NCT02419495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910235|NCT02419495|Tubulin Modulators|tubulin modulators|mesh-ancestor
64910236|NCT02419495|Antimitotic Agents|antimitotic agents|mesh-ancestor
64910237|NCT02419495|Mitosis Modulators|mitosis modulators|mesh-ancestor
64910240|NCT02419495|Immunologic Factors|immunologic factors|mesh-ancestor
64910263|NCT02419495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64910264|NCT02419495|Hematinics|hematinics|mesh-ancestor
64910277|NCT00000966|Micronutrients|micronutrients|mesh-ancestor
64910278|NCT00000966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64910279|NCT00000966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910280|NCT00000966|Antimalarials|antimalarials|mesh-ancestor
64910281|NCT00000966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64910282|NCT00000966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64910283|NCT00000966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64910284|NCT00000966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910285|NCT00000966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910286|NCT00000969|Didanosine|didanosine|mesh-list
64910287|NCT00000969|Zalcitabine|zalcitabine|mesh-list
64910288|NCT00000969|Antimetabolites|antimetabolites|mesh-ancestor
64910289|NCT00000969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910290|NCT00000969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64910291|NCT00000969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64910292|NCT00000969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910293|NCT00000969|Antiviral Agents|antiviral agents|mesh-ancestor
64910295|NCT00000969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64910304|NCT00000975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64910305|NCT00000975|Hormone Antagonists|hormone antagonists|mesh-ancestor
64910306|NCT00000975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64910307|NCT00000975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910308|NCT00000975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64910309|NCT00000978|Zidovudine|zidovudine|mesh-list
64910310|NCT00000978|Zalcitabine|zalcitabine|mesh-list
64910311|NCT00000978|Antimetabolites|antimetabolites|mesh-ancestor
64910312|NCT00000978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910313|NCT00000978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64910314|NCT00000978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64910315|NCT00000978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910316|NCT00000978|Antiviral Agents|antiviral agents|mesh-ancestor
64910317|NCT00000978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910318|NCT00000978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64376196|NCT03049293|Anesthetics, General|anesthetics, general|mesh-ancestor
64376197|NCT03049293|Anesthetics|anesthetics|mesh-ancestor
64376276|NCT05256147|Analgesics|analgesics|mesh-ancestor
64985360|NCT00313963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64985406|NCT00322660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64985407|NCT00322660|Respiratory System Agents|respiratory system agents|mesh-ancestor
64910319|NCT00000978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64910320|NCT00000999|Zidovudine|zidovudine|mesh-list
64910321|NCT00000999|Antimetabolites|antimetabolites|mesh-ancestor
64910322|NCT00000999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910323|NCT00000999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64910324|NCT00000999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64910325|NCT00000999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910326|NCT00000999|Antiviral Agents|antiviral agents|mesh-ancestor
64910327|NCT00000999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910328|NCT00000999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64910329|NCT00000999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64910330|NCT00001002|Zidovudine|zidovudine|mesh-list
64910331|NCT00001002|Foscarnet|foscarnet|mesh-list
64910350|NCT00005819|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64910351|NCT00005819|Protective Agents|protective agents|mesh-ancestor
64910352|NCT00005819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910353|NCT00001005|Zidovudine|zidovudine|mesh-list
64910354|NCT00001005|Aldesleukin|aldesleukin|mesh-list
64910355|NCT00001005|Antimetabolites|antimetabolites|mesh-ancestor
64910405|NCT00391261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910406|NCT00001008|Zidovudine|zidovudine|mesh-list
64910407|NCT00001008|Methadone|methadone|mesh-list
64910408|NCT00001008|Antimetabolites|antimetabolites|mesh-ancestor
64910409|NCT00001008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910410|NCT00001008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64910411|NCT00001008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64910412|NCT00001008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910413|NCT00001008|Antiviral Agents|antiviral agents|mesh-ancestor
64910414|NCT00001008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910415|NCT00001008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64910416|NCT00001008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64910417|NCT00001008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64910418|NCT00001008|Narcotics|narcotics|mesh-ancestor
64910419|NCT00001008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64910420|NCT00001008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910421|NCT00001008|Analgesics|analgesics|mesh-ancestor
64910422|NCT00001008|Sensory System Agents|sensory system agents|mesh-ancestor
64910423|NCT00001008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64910424|NCT00001008|Antitussive Agents|antitussive agents|mesh-ancestor
64910425|NCT00001008|Respiratory System Agents|respiratory system agents|mesh-ancestor
64910435|NCT00005825|Vinorelbine|vinorelbine|mesh-list
64910436|NCT00005825|Mitomycins|mitomycins|mesh-list
64910437|NCT00005825|Mitomycin|mitomycin|mesh-list
64910438|NCT00005825|Tretinoin|tretinoin|mesh-list
64910439|NCT00005825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910440|NCT00005825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64910441|NCT00005825|Tubulin Modulators|tubulin modulators|mesh-ancestor
64910442|NCT00005825|Antimitotic Agents|antimitotic agents|mesh-ancestor
64910443|NCT00005825|Mitosis Modulators|mitosis modulators|mesh-ancestor
64910444|NCT00005825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910445|NCT00005825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64985409|NCT00322660|Sympathomimetics|sympathomimetics|mesh-ancestor
64985410|NCT00322660|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64985411|NCT00322699|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
64985412|NCT00322699|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
64985413|NCT00322699|Trioxsalen|trioxsalen|mesh-list
64985414|NCT00322699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910446|NCT00005825|Alkylating Agents|alkylating agents|mesh-ancestor
64910447|NCT00005825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64910448|NCT00005825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910449|NCT00005825|Keratolytic Agents|keratolytic agents|mesh-ancestor
64910450|NCT00005825|Dermatologic Agents|dermatologic agents|mesh-ancestor
64910451|NCT00001011|Zidovudine|zidovudine|mesh-list
64910452|NCT00001011|Antimetabolites|antimetabolites|mesh-ancestor
64910453|NCT00001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910454|NCT00001011|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64910455|NCT00001011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64910456|NCT00001011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910457|NCT00001011|Antiviral Agents|antiviral agents|mesh-ancestor
64910458|NCT00001011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910459|NCT00001011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64910460|NCT00001011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64910461|NCT00001014|Leucovorin|leucovorin|mesh-list
64910462|NCT00001014|Trimethoprim|trimethoprim|mesh-list
64910466|NCT00001014|Calcium|calcium|mesh-list
64910482|NCT00001014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910483|NCT00001014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910484|NCT00001014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64910485|NCT00001014|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64910486|NCT00001014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64910487|NCT00001014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64910488|NCT00001014|Antifungal Agents|antifungal agents|mesh-ancestor
64910489|NCT00001014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64910491|NCT00001014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910492|NCT00005831|Gemcitabine|gemcitabine|mesh-list
64910493|NCT00005831|Paclitaxel|paclitaxel|mesh-list
64910494|NCT00005831|Carboplatin|carboplatin|mesh-list
64910506|NCT00005831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910507|NCT00005831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64910508|NCT00005831|Immunologic Factors|immunologic factors|mesh-ancestor
64910509|NCT00005831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910510|NCT00005831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64910511|NCT00005834|Thalidomide|thalidomide|mesh-list
64910524|NCT00005834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64910525|NCT00005834|Antiemetics|antiemetics|mesh-ancestor
64910526|NCT00005834|Autonomic Agents|autonomic agents|mesh-ancestor
64910527|NCT00005834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64910528|NCT00005834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64910529|NCT00005834|Glucocorticoids|glucocorticoids|mesh-ancestor
64910530|NCT00005834|Hormones|hormones|mesh-ancestor
64910531|NCT00005834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64910532|NCT00005834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64910533|NCT00005834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64910534|NCT00005834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64910535|NCT00005834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64910536|NCT00005834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910537|NCT00005834|Leprostatic Agents|leprostatic agents|mesh-ancestor
64910538|NCT00005834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64910539|NCT00005834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910540|NCT00005834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64910541|NCT00005834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64910542|NCT00005834|Growth Substances|growth substances|mesh-ancestor
64910543|NCT00005834|Growth Inhibitors|growth inhibitors|mesh-ancestor
64910544|NCT00001029|Zidovudine|zidovudine|mesh-list
64910545|NCT00001029|Didanosine|didanosine|mesh-list
64910546|NCT00001029|Zalcitabine|zalcitabine|mesh-list
64910547|NCT00001029|Antimetabolites|antimetabolites|mesh-ancestor
64910548|NCT00001029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910549|NCT00001029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64910550|NCT00001029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64910551|NCT00001029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376400|NCT04381143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376401|NCT04381143|Antipyretics|antipyretics|mesh-ancestor
64376402|NCT04865211|Bupivacaine|bupivacaine|mesh-list
64376403|NCT04865211|Anesthetics, Local|anesthetics, local|mesh-ancestor
64910552|NCT00001029|Antiviral Agents|antiviral agents|mesh-ancestor
64910553|NCT00001029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910554|NCT00001029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64910555|NCT00001029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64910567|NCT00005837|Oxaliplatin|oxaliplatin|mesh-list
64910568|NCT00005837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910569|NCT00001038|Valacyclovir|valacyclovir|mesh-list
64910570|NCT00001038|Acyclovir|acyclovir|mesh-list
64679010|NCT00002517|Analgesics|analgesics|mesh-ancestor
64910572|NCT00001038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910573|NCT00005840|Paclitaxel|paclitaxel|mesh-list
64910574|NCT00005840|Cisplatin|cisplatin|mesh-list
64910575|NCT00005840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64910576|NCT00005840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910577|NCT00005840|Tubulin Modulators|tubulin modulators|mesh-ancestor
64910578|NCT00005840|Antimitotic Agents|antimitotic agents|mesh-ancestor
64910579|NCT00005840|Mitosis Modulators|mitosis modulators|mesh-ancestor
64910580|NCT00005840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910581|NCT00005843|Tipifarnib|tipifarnib|mesh-list
64910582|NCT00005843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910583|NCT00005849|Paclitaxel|paclitaxel|mesh-list
64910584|NCT00005849|Bryostatin 1|bryostatin 1|mesh-list
64910585|NCT00005849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64910623|NCT00005852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64910624|NCT00005852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910625|NCT00005852|Antifungal Agents|antifungal agents|mesh-ancestor
64910626|NCT00005852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910627|NCT00005852|Dermatologic Agents|dermatologic agents|mesh-ancestor
64910628|NCT00005852|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64910629|NCT00005852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64910630|NCT00005852|Antiemetics|antiemetics|mesh-ancestor
64910631|NCT00005852|Autonomic Agents|autonomic agents|mesh-ancestor
64910632|NCT00005852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64910633|NCT00005852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64910634|NCT00005852|Glucocorticoids|glucocorticoids|mesh-ancestor
64910635|NCT00005852|Hormones|hormones|mesh-ancestor
64910636|NCT00005852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64910637|NCT00005852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64910638|NCT00005852|Protective Agents|protective agents|mesh-ancestor
64910639|NCT00001071|Lenograstim|lenograstim|mesh-list
64910656|NCT00001074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64910657|NCT00001074|Antimetabolites|antimetabolites|mesh-ancestor
64910658|NCT00001074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64910659|NCT00001074|Antiviral Agents|antiviral agents|mesh-ancestor
64910660|NCT00001074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910661|NCT00001074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64910662|NCT00001074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64910663|NCT00005858|Immunotoxins|immunotoxins|mesh-list
64910664|NCT00005858|Immunologic Factors|immunologic factors|mesh-ancestor
64910665|NCT00005858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910666|NCT00005861|Doxorubicin|doxorubicin|mesh-list
64910667|NCT00005861|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64910668|NCT00005861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64910669|NCT00005861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910670|NCT00005861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64910671|NCT00005861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64910672|NCT00005861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985415|NCT00322699|Dermatologic Agents|dermatologic agents|mesh-ancestor
64985416|NCT00322699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64985417|NCT00322972|Azithromycin|azithromycin|mesh-list
64985418|NCT00322972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64910673|NCT00005861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910674|NCT00001083|Ritonavir|ritonavir|mesh-list
64910675|NCT00001083|Indinavir|indinavir|mesh-list
64910676|NCT00001083|Lamivudine|lamivudine|mesh-list
64910677|NCT00001083|Zidovudine|zidovudine|mesh-list
64910678|NCT00001083|Nevirapine|nevirapine|mesh-list
64910679|NCT00001083|Stavudine|stavudine|mesh-list
64910680|NCT00001083|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64910681|NCT00001083|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64910682|NCT00001083|Protease Inhibitors|protease inhibitors|mesh-ancestor
64910683|NCT00001083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910684|NCT00001083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910685|NCT00001083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64910686|NCT00001083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64910687|NCT00001083|Antiviral Agents|antiviral agents|mesh-ancestor
64910688|NCT00001083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910689|NCT00001083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64910693|NCT00001083|Antimetabolites|antimetabolites|mesh-ancestor
64910698|NCT00001086|Efavirenz|efavirenz|mesh-list
64910699|NCT00001086|Abacavir|abacavir|mesh-list
64910700|NCT00001086|Indinavir|indinavir|mesh-list
64910701|NCT00001086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64910702|NCT00001086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64910703|NCT00001086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910704|NCT00001086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910705|NCT00001086|Antiviral Agents|antiviral agents|mesh-ancestor
64910706|NCT00001086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910707|NCT00001086|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64910708|NCT00001086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64910709|NCT00001086|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64376488|NCT04864509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64376489|NCT04875039|Dexamethasone|dexamethasone|mesh-list
64376490|NCT04875039|Dexamethasone acetate|dexamethasone acetate|mesh-list
64985419|NCT00322972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64985420|NCT00090558|Nitroglycerin|nitroglycerin|mesh-list
64985421|NCT00090558|Vasodilator Agents|vasodilator agents|mesh-ancestor
64985422|NCT00323011|Leucovorin|leucovorin|mesh-list
64985423|NCT00323011|Folic Acid|folic acid|mesh-list
64985424|NCT00323011|Bevacizumab|bevacizumab|mesh-list
64985425|NCT00323011|Fluorouracil|fluorouracil|mesh-list
64985529|NCT00312598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985530|NCT00312598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64985532|NCT00312598|Serotonin Agents|serotonin agents|mesh-ancestor
64985533|NCT00312598|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64910710|NCT00001086|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64910711|NCT00001086|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64910712|NCT00001086|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64910713|NCT00001086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64910714|NCT00001086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64910715|NCT00001086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64910716|NCT00001086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64910717|NCT00001086|Protease Inhibitors|protease inhibitors|mesh-ancestor
64910718|NCT00700258|Sirolimus|sirolimus|mesh-list
64910719|NCT00700258|Sunitinib|sunitinib|mesh-list
64910720|NCT00700258|Axitinib|axitinib|mesh-list
64910721|NCT00700258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910722|NCT00700258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64910723|NCT00700258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64910724|NCT00700258|Growth Substances|growth substances|mesh-ancestor
64910725|NCT00700258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910726|NCT00700258|Growth Inhibitors|growth inhibitors|mesh-ancestor
64910727|NCT00700258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64910728|NCT00700258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910730|NCT00700258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64910740|NCT00001113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910741|NCT00001113|Antiviral Agents|antiviral agents|mesh-ancestor
64910742|NCT00001113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910743|NCT00001113|Immunologic Factors|immunologic factors|mesh-ancestor
64910744|NCT00001113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910745|NCT00001113|Antimetabolites|antimetabolites|mesh-ancestor
64910746|NCT00001113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910747|NCT00001113|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64910748|NCT00001113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64910749|NCT00001113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910750|NCT00001113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64910751|NCT00001113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64910752|NCT00005867|Prednisolone|prednisolone|mesh-list
64910755|NCT00005867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64910756|NCT00005867|Etoposide|etoposide|mesh-list
64910757|NCT00005867|Vincristine|vincristine|mesh-list
64910758|NCT00005867|Mitoxantrone|mitoxantrone|mesh-list
64910759|NCT00005867|Bleomycin|bleomycin|mesh-list
64910760|NCT00005867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64910761|NCT00005867|Immunologic Factors|immunologic factors|mesh-ancestor
64910762|NCT00005867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910763|NCT00005867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64910765|NCT00005867|Alkylating Agents|alkylating agents|mesh-ancestor
64910792|NCT00005870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910793|NCT00005870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910794|NCT00005870|Antiviral Agents|antiviral agents|mesh-ancestor
64910795|NCT00005870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910796|NCT00005870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910797|NCT00005870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64910798|NCT00005870|Immunologic Factors|immunologic factors|mesh-ancestor
64910799|NCT00005870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910800|NCT00005870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64910801|NCT00005870|Alkylating Agents|alkylating agents|mesh-ancestor
64910802|NCT00005870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64910803|NCT00005870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64910804|NCT00005870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64910806|NCT00017407|Carboplatin|carboplatin|mesh-list
64910807|NCT00017407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64910808|NCT00017407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910861|NCT00009061|Fosamprenavir|fosamprenavir|mesh-list
64910862|NCT00009061|Lamivudine|lamivudine|mesh-list
64910863|NCT00009061|Abacavir|abacavir|mesh-list
64910864|NCT00009061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64910865|NCT00009061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64910866|NCT00009061|Protease Inhibitors|protease inhibitors|mesh-ancestor
64910867|NCT00009061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910868|NCT00009061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910869|NCT00009061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64910891|NCT00009178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64910892|NCT00009178|Antidepressive Agents|antidepressive agents|mesh-ancestor
64910893|NCT00009178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64910894|NCT00009178|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64910895|NCT00009178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64910896|NCT00009178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910898|NCT00009217|Haloperidol decanoate|haloperidol decanoate|mesh-list
64910899|NCT00009217|Antiemetics|antiemetics|mesh-ancestor
64910900|NCT00009217|Autonomic Agents|autonomic agents|mesh-ancestor
64910901|NCT00009217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64910902|NCT00009217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910903|NCT00009217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64910904|NCT00009217|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64911003|NCT00009919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64911004|NCT00009919|Growth Substances|growth substances|mesh-ancestor
64911005|NCT00009919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911006|NCT00009919|Growth Inhibitors|growth inhibitors|mesh-ancestor
64911007|NCT00009919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911008|NCT00009919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64911009|NCT00009919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911010|NCT00009919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911011|NCT00009958|Metronidazole|metronidazole|mesh-list
64911012|NCT00009958|Vaccines|vaccines|mesh-list
64911013|NCT00009958|Sargramostim|sargramostim|mesh-list
64911014|NCT00009958|Immunologic Factors|immunologic factors|mesh-ancestor
64911015|NCT00009958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911016|NCT00009958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911017|NCT00009958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64911018|NCT00009958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64911019|NCT00009958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64911020|NCT00009997|Tamoxifen|tamoxifen|mesh-list
64911021|NCT00009997|Paclitaxel|paclitaxel|mesh-list
64911022|NCT00009997|Cyclophosphamide|cyclophosphamide|mesh-list
64911023|NCT00009997|Doxorubicin|doxorubicin|mesh-list
64911024|NCT00009997|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64679475|NCT00002637|Vaccines|vaccines|mesh-list
64911025|NCT00009997|Trastuzumab|trastuzumab|mesh-list
64911026|NCT00009997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64911027|NCT00009997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911028|NCT00009997|Tubulin Modulators|tubulin modulators|mesh-ancestor
64911029|NCT00009997|Antimitotic Agents|antimitotic agents|mesh-ancestor
64911030|NCT00009997|Mitosis Modulators|mitosis modulators|mesh-ancestor
64911040|NCT00009997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64911042|NCT00009997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911043|NCT00009997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64911044|NCT00009997|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64911056|NCT00010036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911057|NCT00010036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911058|NCT00010075|Leucovorin|leucovorin|mesh-list
64911059|NCT00010075|Fluorouracil|fluorouracil|mesh-list
64911060|NCT00010075|Mitoxantrone|mitoxantrone|mesh-list
64911061|NCT00010075|Calcium|calcium|mesh-list
64911062|NCT00010075|Levoleucovorin|levoleucovorin|mesh-list
64911063|NCT00010075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64911064|NCT00010075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911065|NCT00010075|Antimetabolites|antimetabolites|mesh-ancestor
64911066|NCT00010075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911067|NCT00010075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64911068|NCT00010075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911069|NCT00010075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64911070|NCT00010075|Immunologic Factors|immunologic factors|mesh-ancestor
64911071|NCT00010075|Antidotes|antidotes|mesh-ancestor
64911072|NCT00010075|Protective Agents|protective agents|mesh-ancestor
64911073|NCT00010075|Vitamin B Complex|vitamin b complex|mesh-ancestor
64911074|NCT00010075|Vitamins|vitamins|mesh-ancestor
64911075|NCT00010075|Micronutrients|micronutrients|mesh-ancestor
64911077|NCT00010075|Sensory System Agents|sensory system agents|mesh-ancestor
64911078|NCT00010075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64911079|NCT00010075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64911080|NCT00010075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64911081|NCT00010075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911082|NCT00010153|Fulvestrant|fulvestrant|mesh-list
64911083|NCT00010153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64911084|NCT00010153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911085|NCT00010153|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64911086|NCT00010153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64911087|NCT00010153|Hormone Antagonists|hormone antagonists|mesh-ancestor
64911088|NCT00010153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64911089|NCT00010153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911090|NCT00010192|Aldesleukin|aldesleukin|mesh-list
64911091|NCT00010192|Rituximab|rituximab|mesh-list
64911092|NCT00010192|Interleukin-2|interleukin-2|mesh-list
64376634|NCT02453009|Tubulin Modulators|tubulin modulators|mesh-ancestor
64376635|NCT02453009|Antimitotic Agents|antimitotic agents|mesh-ancestor
64911093|NCT00010192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64911094|NCT00010192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911095|NCT00010192|Immunologic Factors|immunologic factors|mesh-ancestor
64911096|NCT00010192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911097|NCT00010192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64911098|NCT00010192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64911099|NCT00010192|Analgesics|analgesics|mesh-ancestor
64679539|NCT05806515|Carboplatin|carboplatin|mesh-list
64911100|NCT00010192|Sensory System Agents|sensory system agents|mesh-ancestor
64911101|NCT00010192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64911103|NCT00010192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64911124|NCT00010231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911125|NCT00010231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64911126|NCT00010231|Glucocorticoids|glucocorticoids|mesh-ancestor
64911127|NCT00010231|Hormones|hormones|mesh-ancestor
64911128|NCT00010231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64911129|NCT00010231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64911130|NCT00010231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911131|NCT00010231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64911132|NCT00010231|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64911133|NCT00010231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64911134|NCT00010231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911135|NCT00010231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64911136|NCT00010231|Vitamins|vitamins|mesh-ancestor
64911137|NCT00010231|Micronutrients|micronutrients|mesh-ancestor
64376708|NCT04868253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64376709|NCT04868253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376710|NCT04868253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64376711|NCT04868253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64985534|NCT00312598|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64985535|NCT00312598|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64985574|NCT00122538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985575|NCT00122538|Antiviral Agents|antiviral agents|mesh-ancestor
64985678|NCT04984070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64985679|NCT04984070|Contraceptives, Oral|contraceptives, oral|mesh-list
64985680|NCT04984070|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
64985681|NCT04984070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64985682|NCT04984070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64985683|NCT04984070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985684|NCT04984070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64985685|NCT04984070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64985686|NCT04984070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64985687|NCT04984070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64911138|NCT00010231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64911139|NCT00010270|Immunotoxins|immunotoxins|mesh-list
64911140|NCT00010270|Immunologic Factors|immunologic factors|mesh-ancestor
64911141|NCT00010270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911142|NCT00010387|Cyclophosphamide|cyclophosphamide|mesh-list
64911143|NCT00010387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64911144|NCT00010387|Immunologic Factors|immunologic factors|mesh-ancestor
64911145|NCT00010387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911146|NCT00010387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64911147|NCT00010387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64911148|NCT00010387|Alkylating Agents|alkylating agents|mesh-ancestor
64911149|NCT00010387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911150|NCT00010387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911151|NCT00010387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64911152|NCT00010426|Cysteamine|cysteamine|mesh-list
64911153|NCT00010426|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
64911165|NCT00010699|Micronutrients|micronutrients|mesh-ancestor
64911166|NCT00010699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911167|NCT00010699|Antioxidants|antioxidants|mesh-ancestor
64911168|NCT00010699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911169|NCT00010699|Protective Agents|protective agents|mesh-ancestor
64911170|NCT00386555|Docetaxel|docetaxel|mesh-list
64911171|NCT00386555|Axitinib|axitinib|mesh-list
64911172|NCT00386555|Crenolanib|crenolanib|mesh-list
64911173|NCT00386555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911174|NCT00386555|Tubulin Modulators|tubulin modulators|mesh-ancestor
64911175|NCT00386555|Antimitotic Agents|antimitotic agents|mesh-ancestor
64911176|NCT00386555|Mitosis Modulators|mitosis modulators|mesh-ancestor
64911177|NCT00386555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911178|NCT00386555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64911179|NCT00386555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911180|NCT00010855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64376764|NCT03045471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376765|NCT03045471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64376766|NCT03045471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64985688|NCT04984070|Estrogens|estrogens|mesh-ancestor
64985690|NCT04984070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64985691|NCT04984070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64985692|NCT04984070|Hormone Antagonists|hormone antagonists|mesh-ancestor
64985693|NCT04984070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64911181|NCT00010855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64911182|NCT00010855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911184|NCT00001191|Pantoprazole|pantoprazole|mesh-list
64911185|NCT00001191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64911186|NCT00001191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64911187|NCT00001191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64911188|NCT00001191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911189|NCT00001191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911190|NCT00011089|Tenofovir|tenofovir|mesh-list
64911191|NCT00011089|Antiviral Agents|antiviral agents|mesh-ancestor
64911192|NCT00011089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911193|NCT00011089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64911194|NCT00011089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64911195|NCT00011089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911196|NCT00011089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911197|NCT00011089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64911198|NCT00011089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64911199|NCT00011128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64911200|NCT00011128|Antiviral Agents|antiviral agents|mesh-ancestor
64911201|NCT00011128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911204|NCT00005921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911205|NCT00005921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911206|NCT00005921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911207|NCT00011362|Dexamethasone|dexamethasone|mesh-list
64911208|NCT00011362|Dexamethasone acetate|dexamethasone acetate|mesh-list
64911209|NCT00011362|BB 1101|bb 1101|mesh-list
64911210|NCT00011362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64911211|NCT00011362|Antiemetics|antiemetics|mesh-ancestor
64911212|NCT00011362|Autonomic Agents|autonomic agents|mesh-ancestor
64911213|NCT00011362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64911214|NCT00011362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911215|NCT00011362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64911216|NCT00011362|Glucocorticoids|glucocorticoids|mesh-ancestor
64911224|NCT00001212|Cyclosporine|cyclosporine|mesh-list
64911225|NCT00001212|Prednisone|prednisone|mesh-list
64911226|NCT00001212|Cyclophosphamide|cyclophosphamide|mesh-list
64911227|NCT00001212|Cyclosporins|cyclosporins|mesh-list
64911228|NCT00001212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64911229|NCT00001212|Immunologic Factors|immunologic factors|mesh-ancestor
64911230|NCT00001212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911231|NCT00001212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64911232|NCT00001212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64911233|NCT00001212|Alkylating Agents|alkylating agents|mesh-ancestor
64911234|NCT00001212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911235|NCT00001212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911246|NCT00001212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64911247|NCT00011479|Abacavir|abacavir|mesh-list
64911248|NCT00011479|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64911302|NCT00012142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64911303|NCT00012142|Immunologic Factors|immunologic factors|mesh-ancestor
64911304|NCT00012142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911305|NCT00012181|Alvocidib|alvocidib|mesh-list
64911306|NCT00012181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911307|NCT00012181|Growth Inhibitors|growth inhibitors|mesh-ancestor
64911308|NCT00012181|Growth Substances|growth substances|mesh-ancestor
64911309|NCT00012181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911310|NCT00012181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64911311|NCT00012181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911312|NCT00012181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911313|NCT00005945|Cytarabine|cytarabine|mesh-list
64911314|NCT00005945|Dexamethasone|dexamethasone|mesh-list
64911315|NCT00005945|Cyclophosphamide|cyclophosphamide|mesh-list
64911316|NCT00005945|Doxorubicin|doxorubicin|mesh-list
64911317|NCT00005945|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64911318|NCT00005945|Methotrexate|methotrexate|mesh-list
64911319|NCT00005945|Vincristine|vincristine|mesh-list
64911320|NCT00005945|Daunorubicin|daunorubicin|mesh-list
64911321|NCT00005945|Asparaginase|asparaginase|mesh-list
64911330|NCT00005945|Alkylating Agents|alkylating agents|mesh-ancestor
64911331|NCT00005945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911332|NCT00005945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911333|NCT00005945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64911334|NCT00005945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64911335|NCT00005945|Antiemetics|antiemetics|mesh-ancestor
64911336|NCT00005945|Autonomic Agents|autonomic agents|mesh-ancestor
64911337|NCT00005945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64911338|NCT00005945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64911339|NCT00005945|Glucocorticoids|glucocorticoids|mesh-ancestor
64911340|NCT00005945|Hormones|hormones|mesh-ancestor
64911341|NCT00005945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64911342|NCT00005945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64911343|NCT00005945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64911344|NCT00005945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64376810|NCT04873479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376811|NCT04873479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376823|NCT02451527|Digoxin|digoxin|mesh-list
64985694|NCT04984070|Diuretics|diuretics|mesh-ancestor
64911345|NCT00005945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64911346|NCT00005945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911347|NCT00005945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64911348|NCT00005945|Abortifacient Agents|abortifacient agents|mesh-ancestor
64911349|NCT00005945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64911350|NCT00005945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64911351|NCT00005945|Antimetabolites|antimetabolites|mesh-ancestor
64911352|NCT00005945|Dermatologic Agents|dermatologic agents|mesh-ancestor
64911353|NCT00005945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64911354|NCT00005945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64911355|NCT00005945|Antiviral Agents|antiviral agents|mesh-ancestor
64911356|NCT00005945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911357|NCT00005945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64911358|NCT00005945|Tubulin Modulators|tubulin modulators|mesh-ancestor
64911359|NCT00005945|Antimitotic Agents|antimitotic agents|mesh-ancestor
64911360|NCT00005945|Mitosis Modulators|mitosis modulators|mesh-ancestor
64911372|NCT01929811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64911373|NCT01929811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64911374|NCT01929811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911375|NCT00012220|Gemcitabine|gemcitabine|mesh-list
64911376|NCT00012220|Docetaxel|docetaxel|mesh-list
64911377|NCT00012220|Irinotecan|irinotecan|mesh-list
64911378|NCT00012220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911379|NCT00012220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64911380|NCT00012220|Antimetabolites|antimetabolites|mesh-ancestor
64911381|NCT00012220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911382|NCT00012220|Antiviral Agents|antiviral agents|mesh-ancestor
64911383|NCT00012220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911384|NCT00012220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911385|NCT00012220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64911386|NCT00012220|Immunologic Factors|immunologic factors|mesh-ancestor
64911387|NCT00012220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911388|NCT00012220|Tubulin Modulators|tubulin modulators|mesh-ancestor
64911389|NCT00012220|Antimitotic Agents|antimitotic agents|mesh-ancestor
64911390|NCT00012220|Mitosis Modulators|mitosis modulators|mesh-ancestor
64911391|NCT00012220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64985695|NCT04984070|Natriuretic Agents|natriuretic agents|mesh-ancestor
64985716|NCT00314548|Tezosentan|tezosentan|mesh-list
64985717|NCT00314548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64985718|NCT00314548|Vasodilator Agents|vasodilator agents|mesh-ancestor
64985719|NCT00314548|Urological Agents|urological agents|mesh-ancestor
64911392|NCT00012220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64911393|NCT00012259|Troxacitabine|troxacitabine|mesh-list
64911394|NCT00012259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911395|NCT00012259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64911396|NCT00012259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64911397|NCT00012259|Antiviral Agents|antiviral agents|mesh-ancestor
64911398|NCT00012259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911399|NCT00012337|Gefitinib|gefitinib|mesh-list
64911400|NCT00012337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911401|NCT00012337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64911402|NCT00012337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911403|NCT00012337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911404|NCT00012376|Bryostatin 1|bryostatin 1|mesh-list
64911405|NCT00012376|Sargramostim|sargramostim|mesh-list
64911406|NCT00012376|Immunologic Factors|immunologic factors|mesh-ancestor
64911407|NCT00012376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911408|NCT00012376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911414|NCT00001266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911415|NCT00001266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911416|NCT00001266|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64911417|NCT00001266|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64911419|NCT00005948|Interferon-alpha|interferon-alpha|mesh-list
64911420|NCT00005948|Aldesleukin|aldesleukin|mesh-list
64911421|NCT00005948|Busulfan|busulfan|mesh-list
64911422|NCT00005948|Sargramostim|sargramostim|mesh-list
64911423|NCT00005948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911424|NCT00005948|Antiviral Agents|antiviral agents|mesh-ancestor
64911425|NCT00005948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911426|NCT00005948|Immunologic Factors|immunologic factors|mesh-ancestor
64911427|NCT00005948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911428|NCT00005948|Alkylating Agents|alkylating agents|mesh-ancestor
64985720|NCT00314548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64985721|NCT00314626|Lamivudine|lamivudine|mesh-list
64985722|NCT00314626|Efavirenz|efavirenz|mesh-list
64985723|NCT00314626|Abacavir|abacavir|mesh-list
64985724|NCT00314626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64985725|NCT00314626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64985726|NCT00314626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985727|NCT00314626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985792|NCT04943627|Antimetabolites|antimetabolites|mesh-ancestor
64985795|NCT04943627|Antiviral Agents|antiviral agents|mesh-ancestor
64985831|NCT00314743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64985832|NCT00314743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64985833|NCT00314743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64985834|NCT00314743|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64985836|NCT00314782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985837|NCT00314782|Tubulin Modulators|tubulin modulators|mesh-ancestor
64911429|NCT00005948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911430|NCT00005948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64911431|NCT00005948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64911432|NCT00005948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64911433|NCT00005948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64911434|NCT00005948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64911435|NCT00012688|Chlorhexidine|chlorhexidine|mesh-list
64911436|NCT00012688|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64911437|NCT00012688|Doxycycline|doxycycline|mesh-list
64911438|NCT00012688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64911439|NCT00012688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911440|NCT00012688|Disinfectants|disinfectants|mesh-ancestor
64911441|NCT00012688|Dermatologic Agents|dermatologic agents|mesh-ancestor
64911442|NCT00012688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64911443|NCT00012688|Antimalarials|antimalarials|mesh-ancestor
64911444|NCT00012688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64911445|NCT00012688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64911446|NCT00005951|Irinotecan|irinotecan|mesh-list
64911447|NCT00005951|Temozolomide|temozolomide|mesh-list
64911448|NCT00005951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64911449|NCT00005951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64911450|NCT00005951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911452|NCT00005951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911453|NCT00005951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64911454|NCT00005951|Alkylating Agents|alkylating agents|mesh-ancestor
64911455|NCT00001287|Immunoglobulins|immunoglobulins|mesh-list
64911456|NCT00001287|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64911457|NCT00001287|Antibodies|antibodies|mesh-list
64911458|NCT00001287|gamma-Globulins|gamma-globulins|mesh-list
64911459|NCT00001287|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64911501|NCT00013585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911502|NCT00013585|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64911503|NCT00013585|Protective Agents|protective agents|mesh-ancestor
64911504|NCT00013585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911505|NCT00013624|Levodopa|levodopa|mesh-list
64911506|NCT00013624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64911507|NCT00013624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64911508|NCT00013624|Dopamine Agents|dopamine agents|mesh-ancestor
64911509|NCT00013624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64911510|NCT00013624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911511|NCT00013624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911512|NCT00013663|Aldesleukin|aldesleukin|mesh-list
64911513|NCT00013663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911514|NCT00013663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64911515|NCT00013663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64911516|NCT00013663|Antiviral Agents|antiviral agents|mesh-ancestor
64911517|NCT00013663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911518|NCT00013702|Adefovir|adefovir|mesh-list
64911519|NCT00013702|Antiviral Agents|antiviral agents|mesh-ancestor
64911520|NCT00013702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911521|NCT00013702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64911522|NCT00013702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64911523|NCT00013702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911524|NCT00013702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911525|NCT00005966|Interferons|interferons|mesh-list
64911570|NCT00014092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64911571|NCT00005972|Gemcitabine|gemcitabine|mesh-list
64911572|NCT00005972|Irinotecan|irinotecan|mesh-list
64911573|NCT00005972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64911574|NCT00005972|Antimetabolites|antimetabolites|mesh-ancestor
64911575|NCT00005972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911595|NCT00014209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64911596|NCT00014209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911597|NCT00014209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64911598|NCT00014209|Glucocorticoids|glucocorticoids|mesh-ancestor
64911599|NCT00014209|Hormones|hormones|mesh-ancestor
64911600|NCT00014209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64911601|NCT00014209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64911602|NCT00014209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911603|NCT00014209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64911604|NCT00014209|Antimetabolites|antimetabolites|mesh-ancestor
64911605|NCT00014209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911606|NCT00014209|Antiviral Agents|antiviral agents|mesh-ancestor
64911607|NCT00014209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911608|NCT00014209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911609|NCT00014209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64911610|NCT00014209|Immunologic Factors|immunologic factors|mesh-ancestor
64911611|NCT00014248|Adenosine|adenosine|mesh-list
64911623|NCT00005975|Megestrol|megestrol|mesh-list
64911659|NCT00005978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911660|NCT00005978|Immunologic Factors|immunologic factors|mesh-ancestor
64911661|NCT00005978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911662|NCT00005978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64911663|NCT00005978|Alkylating Agents|alkylating agents|mesh-ancestor
64911664|NCT00005978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64911665|NCT00005978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64911666|NCT00005978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64911667|NCT00014404|Celecoxib|celecoxib|mesh-list
64911668|NCT00014404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64911688|NCT00014599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911690|NCT00005981|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64911691|NCT00005981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64911692|NCT00005981|Alkylating Agents|alkylating agents|mesh-ancestor
64911693|NCT00005981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911694|NCT00005981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911695|NCT00005981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911696|NCT00014638|Letrozole|letrozole|mesh-list
64911697|NCT00014638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911698|NCT00014638|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64911699|NCT00014638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64911700|NCT00014638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911701|NCT00014638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911702|NCT00014638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64911733|NCT00005984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64911734|NCT00005984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64911735|NCT00005984|Alkylating Agents|alkylating agents|mesh-ancestor
64911736|NCT00005984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911737|NCT00005984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911738|NCT00005984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64911739|NCT00005984|Antiviral Agents|antiviral agents|mesh-ancestor
64911740|NCT00005984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911741|NCT00391651|Nitrofurantoin|nitrofurantoin|mesh-list
64911742|NCT00391651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64911743|NCT00391651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911744|NCT00391651|Renal Agents|renal agents|mesh-ancestor
64911745|NCT00391651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64911746|NCT00391690|Zoledronic Acid|zoledronic acid|mesh-list
64911747|NCT00391690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64911748|NCT00391690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911749|NCT00005987|Interferons|interferons|mesh-list
64911750|NCT00005987|Interferon-alpha|interferon-alpha|mesh-list
64911751|NCT00005987|Dexamethasone|dexamethasone|mesh-list
64911752|NCT00005987|Cyclophosphamide|cyclophosphamide|mesh-list
64911753|NCT00005987|Carmustine|carmustine|mesh-list
64911754|NCT00005987|Etoposide|etoposide|mesh-list
64911755|NCT00005987|Mitoxantrone|mitoxantrone|mesh-list
64911756|NCT00005987|Sargramostim|sargramostim|mesh-list
64911757|NCT00005987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64911758|NCT00005987|Immunologic Factors|immunologic factors|mesh-ancestor
64911759|NCT00005987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911760|NCT00005987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64911761|NCT00005987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64911762|NCT00005987|Alkylating Agents|alkylating agents|mesh-ancestor
64911763|NCT00005987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911780|NCT00005987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911781|NCT00005987|Analgesics|analgesics|mesh-ancestor
64911782|NCT00005987|Sensory System Agents|sensory system agents|mesh-ancestor
64911783|NCT00014755|Prednisone|prednisone|mesh-list
64911784|NCT00014755|Cyclophosphamide|cyclophosphamide|mesh-list
64911785|NCT00014755|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64911786|NCT00014755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64911787|NCT00014755|Immunologic Factors|immunologic factors|mesh-ancestor
64911788|NCT00014755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911789|NCT00014755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64911790|NCT00014755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64911791|NCT00014755|Alkylating Agents|alkylating agents|mesh-ancestor
64911792|NCT00014755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911793|NCT00014755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911794|NCT00014755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64911795|NCT00014755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64911796|NCT00014755|Glucocorticoids|glucocorticoids|mesh-ancestor
64911797|NCT00014755|Hormones|hormones|mesh-ancestor
64911798|NCT00014755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64911799|NCT00014755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64911808|NCT00001344|Antitussive Agents|antitussive agents|mesh-ancestor
64911809|NCT00001344|Respiratory System Agents|respiratory system agents|mesh-ancestor
64911810|NCT00001344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64911811|NCT00001344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64911812|NCT00001344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64911813|NCT00001344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911814|NCT00001344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911815|NCT00014989|Magnesium Sulfate|magnesium sulfate|mesh-list
64911816|NCT00014989|Analgesics|analgesics|mesh-ancestor
64911831|NCT00005993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911832|NCT00005993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64911853|NCT00015067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911854|NCT00015067|Dopamine Agents|dopamine agents|mesh-ancestor
64911855|NCT00015067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64911856|NCT00015106|Lamotrigine|lamotrigine|mesh-list
64911857|NCT00015106|Anticonvulsants|anticonvulsants|mesh-ancestor
64911858|NCT00015106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64911859|NCT00015106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64911860|NCT00015106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911861|NCT00015106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64911862|NCT00015106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911863|NCT00015106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64911864|NCT00015106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64911865|NCT00015106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64911866|NCT00015106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64911867|NCT00015106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64911868|NCT00005996|Gemcitabine|gemcitabine|mesh-list
64911869|NCT00005996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911870|NCT00005996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64911871|NCT00005996|Antimetabolites|antimetabolites|mesh-ancestor
64911872|NCT00005996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911873|NCT00005996|Antiviral Agents|antiviral agents|mesh-ancestor
64911874|NCT00005996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911875|NCT00005996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911876|NCT00005996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64911877|NCT00005996|Immunologic Factors|immunologic factors|mesh-ancestor
64911878|NCT00005996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911879|NCT00001359|Penicillins|penicillins|mesh-list
64911880|NCT00001359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64911881|NCT00001359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911882|NCT00015223|Methylphenidate|methylphenidate|mesh-list
64911883|NCT00015223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64911896|NCT00015301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64911897|NCT00015301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911898|NCT00015301|Dopamine Agents|dopamine agents|mesh-ancestor
64911899|NCT00015301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64911900|NCT00015340|Buprenorphine|buprenorphine|mesh-list
64911901|NCT00015340|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64911902|NCT00015340|Naloxone|naloxone|mesh-list
64911903|NCT00015340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64911904|NCT00015340|Narcotics|narcotics|mesh-ancestor
64911905|NCT00015340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64911906|NCT00015340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911907|NCT00015340|Analgesics|analgesics|mesh-ancestor
64911908|NCT00015340|Sensory System Agents|sensory system agents|mesh-ancestor
64911909|NCT00015340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64911910|NCT00015340|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64911911|NCT00015652|Ribavirin|ribavirin|mesh-list
64911912|NCT00015652|Aldesleukin|aldesleukin|mesh-list
64911913|NCT00015652|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64911914|NCT00015652|Antimetabolites|antimetabolites|mesh-ancestor
64911915|NCT00015652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911923|NCT00015691|Metformin|metformin|mesh-list
64911938|NCT00015886|Tubulin Modulators|tubulin modulators|mesh-ancestor
64911939|NCT00015886|Antimitotic Agents|antimitotic agents|mesh-ancestor
64911940|NCT00015886|Mitosis Modulators|mitosis modulators|mesh-ancestor
64911941|NCT00015886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911942|NCT00015886|Antimetabolites|antimetabolites|mesh-ancestor
64911943|NCT00015886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64911944|NCT00015886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64911945|NCT00015886|Immunologic Factors|immunologic factors|mesh-ancestor
64911946|NCT00015886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911947|NCT00006002|Dexamethasone|dexamethasone|mesh-list
64911948|NCT00006002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64911949|NCT00006002|Antiemetics|antiemetics|mesh-ancestor
64911950|NCT00006002|Autonomic Agents|autonomic agents|mesh-ancestor
64377168|NCT03209219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985838|NCT00314782|Antimitotic Agents|antimitotic agents|mesh-ancestor
64985839|NCT00314782|Mitosis Modulators|mitosis modulators|mesh-ancestor
64985840|NCT00314782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985852|NCT00314821|Ropinirole|ropinirole|mesh-list
64985863|NCT00314860|Dopamine Agonists|dopamine agonists|mesh-ancestor
64911951|NCT00006002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64911952|NCT00006002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911953|NCT00006002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64911954|NCT00006002|Glucocorticoids|glucocorticoids|mesh-ancestor
64911955|NCT00006002|Hormones|hormones|mesh-ancestor
64911956|NCT00006002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64911957|NCT00006002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64911958|NCT00006002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911959|NCT00001365|Dextromethorphan|dextromethorphan|mesh-list
64911960|NCT00001365|Antitussive Agents|antitussive agents|mesh-ancestor
64911961|NCT00001365|Respiratory System Agents|respiratory system agents|mesh-ancestor
64911962|NCT00001365|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64911963|NCT00001365|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64911964|NCT00001365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64911965|NCT00001365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911966|NCT00001365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911967|NCT00015925|Entinostat|entinostat|mesh-list
64911968|NCT00015925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911972|NCT00006005|Thalidomide|thalidomide|mesh-list
64911979|NCT00006005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64911980|NCT00006005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64911981|NCT00006005|Growth Substances|growth substances|mesh-ancestor
64911982|NCT00006005|Growth Inhibitors|growth inhibitors|mesh-ancestor
64911983|NCT00006005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911984|NCT00015964|Gefitinib|gefitinib|mesh-list
64912025|NCT00016159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912026|NCT00016159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912027|NCT00016159|Keratolytic Agents|keratolytic agents|mesh-ancestor
64912028|NCT00016159|Dermatologic Agents|dermatologic agents|mesh-ancestor
64912029|NCT00016159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64912030|NCT00016198|Leucovorin|leucovorin|mesh-list
64912031|NCT00016198|Fluorouracil|fluorouracil|mesh-list
64912032|NCT00016198|Oxaliplatin|oxaliplatin|mesh-list
64912033|NCT00016198|Calcium|calcium|mesh-list
64912034|NCT00016198|Levoleucovorin|levoleucovorin|mesh-list
64912035|NCT00016198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64912036|NCT00016198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912037|NCT00016198|Antimetabolites|antimetabolites|mesh-ancestor
64912038|NCT00016198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912039|NCT00016198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64912083|NCT00016315|Gemcitabine|gemcitabine|mesh-list
64912084|NCT00016315|Paclitaxel|paclitaxel|mesh-list
64912085|NCT00016315|Carboplatin|carboplatin|mesh-list
64912086|NCT00016315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64912087|NCT00016315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912088|NCT00016315|Tubulin Modulators|tubulin modulators|mesh-ancestor
64912089|NCT00016315|Antimitotic Agents|antimitotic agents|mesh-ancestor
64912090|NCT00016315|Mitosis Modulators|mitosis modulators|mesh-ancestor
64912091|NCT00016315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912092|NCT00016315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64912093|NCT00016315|Antimetabolites|antimetabolites|mesh-ancestor
64912094|NCT00016315|Antiviral Agents|antiviral agents|mesh-ancestor
64912095|NCT00016315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64912096|NCT00016315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912097|NCT00016315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64912098|NCT00016315|Immunologic Factors|immunologic factors|mesh-ancestor
64912100|NCT00006014|Semaxinib|semaxinib|mesh-list
64912104|NCT00006014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912105|NCT00006014|Growth Inhibitors|growth inhibitors|mesh-ancestor
64912106|NCT00006014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912107|NCT00006014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64912108|NCT00006014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912109|NCT00006014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912110|NCT00016432|Exemestane|exemestane|mesh-list
64912111|NCT00016432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912112|NCT00016432|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64912114|NCT00016432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912126|NCT00016549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64912127|NCT00016549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912128|NCT00016549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64912129|NCT00016549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64912130|NCT00016549|Growth Substances|growth substances|mesh-ancestor
64912131|NCT00016549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912132|NCT00016549|Growth Inhibitors|growth inhibitors|mesh-ancestor
64912133|NCT00006023|Capecitabine|capecitabine|mesh-list
64912134|NCT00006023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64912135|NCT00006023|Antimetabolites|antimetabolites|mesh-ancestor
64912136|NCT00006023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912137|NCT00006023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912138|NCT00016588|Tenofovir|tenofovir|mesh-list
64912139|NCT00016588|Antiviral Agents|antiviral agents|mesh-ancestor
64912140|NCT00016588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64912141|NCT00016588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64912142|NCT00016588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64912143|NCT00016588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912144|NCT00016588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912145|NCT00016588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64377186|NCT04872231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377216|NCT01594827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64985864|NCT00314860|Dopamine Agents|dopamine agents|mesh-ancestor
64985865|NCT00314860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64985866|NCT00314860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985867|NCT00314860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985868|NCT04928339|Bupivacaine|bupivacaine|mesh-list
64985869|NCT04928339|Anesthetics, Local|anesthetics, local|mesh-ancestor
64985870|NCT04928339|Anesthetics|anesthetics|mesh-ancestor
64985871|NCT04928339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64985872|NCT04928339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912146|NCT00016588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64912147|NCT00006026|Rubitecan|rubitecan|mesh-list
64912148|NCT00006026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912149|NCT00006026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64912150|NCT00006026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64912152|NCT00006026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912153|NCT00016666|Propranolol|propranolol|mesh-list
64912154|NCT00016666|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64912155|NCT00016666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64912156|NCT00016666|Adrenergic Agents|adrenergic agents|mesh-ancestor
64912157|NCT00016666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64912158|NCT00016666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912159|NCT00016666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912160|NCT00016666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64912165|NCT00016744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912166|NCT00016744|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64912167|NCT00016744|Protective Agents|protective agents|mesh-ancestor
64912168|NCT00016744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912169|NCT00016744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64912170|NCT00016744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912171|NCT00016744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912172|NCT00016744|Phytoestrogens|phytoestrogens|mesh-ancestor
64912173|NCT00016744|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64912174|NCT00016744|Estrogens|estrogens|mesh-ancestor
64912175|NCT00016744|Hormones|hormones|mesh-ancestor
64912176|NCT00016744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64912214|NCT00016978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912215|NCT00016978|Antimetabolites|antimetabolites|mesh-ancestor
64912216|NCT00016978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912217|NCT00016978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64912218|NCT00016978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912219|NCT00016978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64912220|NCT00016978|Immunologic Factors|immunologic factors|mesh-ancestor
64912221|NCT00016978|Antidotes|antidotes|mesh-ancestor
64912222|NCT00016978|Protective Agents|protective agents|mesh-ancestor
64912223|NCT00016978|Vitamin B Complex|vitamin b complex|mesh-ancestor
64912224|NCT00016978|Vitamins|vitamins|mesh-ancestor
64912225|NCT00016978|Micronutrients|micronutrients|mesh-ancestor
64912226|NCT00017017|Paclitaxel|paclitaxel|mesh-list
64912227|NCT00017017|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
64912228|NCT00017017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64912229|NCT00017017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912230|NCT00017017|Tubulin Modulators|tubulin modulators|mesh-ancestor
64912231|NCT00017017|Antimitotic Agents|antimitotic agents|mesh-ancestor
64912232|NCT00017017|Mitosis Modulators|mitosis modulators|mesh-ancestor
64912233|NCT00017017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912234|NCT00017095|Cyclophosphamide|cyclophosphamide|mesh-list
64912235|NCT00017095|Docetaxel|docetaxel|mesh-list
64912236|NCT00017095|Fluorouracil|fluorouracil|mesh-list
64912237|NCT00017095|Epirubicin|epirubicin|mesh-list
64912238|NCT00017095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64912250|NCT00017095|Antimetabolites|antimetabolites|mesh-ancestor
64912282|NCT00371059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912283|NCT00371059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912284|NCT00371059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64912285|NCT00371059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64912286|NCT00001482|Lamotrigine|lamotrigine|mesh-list
64912287|NCT00001482|Gabapentin|gabapentin|mesh-list
64912288|NCT00001482|Analgesics|analgesics|mesh-ancestor
64912289|NCT00001482|Sensory System Agents|sensory system agents|mesh-ancestor
64912297|NCT00001482|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64912298|NCT00001482|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64912299|NCT00001482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64912300|NCT00001482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912301|NCT00001482|Antimanic Agents|antimanic agents|mesh-ancestor
64912365|NCT00017251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912367|NCT00006038|Docetaxel|docetaxel|mesh-list
64912368|NCT00006038|Fluorouracil|fluorouracil|mesh-list
64912369|NCT00006038|Floxuridine|floxuridine|mesh-list
64912370|NCT00006038|Calcium|calcium|mesh-list
64912371|NCT00006038|Levoleucovorin|levoleucovorin|mesh-list
64912383|NCT00006038|Antidotes|antidotes|mesh-ancestor
64912411|NCT00017290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64912412|NCT00017290|Tubulin Modulators|tubulin modulators|mesh-ancestor
64912413|NCT00017290|Antimitotic Agents|antimitotic agents|mesh-ancestor
64912414|NCT00017290|Mitosis Modulators|mitosis modulators|mesh-ancestor
64912415|NCT00017290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64912416|NCT00017329|Bortezomib|bortezomib|mesh-list
64912417|NCT00017329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912418|NCT00017368|Cyclophosphamide|cyclophosphamide|mesh-list
64912419|NCT00017368|Melphalan|melphalan|mesh-list
64912420|NCT00017368|Ifosfamide|ifosfamide|mesh-list
64912421|NCT00017368|Thiotepa|thiotepa|mesh-list
64912422|NCT00017368|Carboplatin|carboplatin|mesh-list
64912423|NCT00017368|Doxorubicin|doxorubicin|mesh-list
64912424|NCT00017368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64912425|NCT00017368|Etoposide|etoposide|mesh-list
64912426|NCT00017368|Etoposide phosphate|etoposide phosphate|mesh-list
64912427|NCT00017368|Vincristine|vincristine|mesh-list
64912428|NCT00017368|Isotretinoin|isotretinoin|mesh-list
64912429|NCT00017368|Sargramostim|sargramostim|mesh-list
64912430|NCT00017368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64912431|NCT00017368|Immunologic Factors|immunologic factors|mesh-ancestor
64912432|NCT00017368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912433|NCT00017368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64912434|NCT00017368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64912435|NCT00017368|Alkylating Agents|alkylating agents|mesh-ancestor
64912437|NCT00017368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912450|NCT00001524|Immunologic Factors|immunologic factors|mesh-ancestor
64912451|NCT00001524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912452|NCT00001524|Leprostatic Agents|leprostatic agents|mesh-ancestor
64912453|NCT00001524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64912454|NCT00001524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64912455|NCT00001524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64912456|NCT00001524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64912457|NCT00001524|Growth Substances|growth substances|mesh-ancestor
64912458|NCT00001524|Growth Inhibitors|growth inhibitors|mesh-ancestor
64985873|NCT04928339|Sensory System Agents|sensory system agents|mesh-ancestor
64985874|NCT04928339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64985875|NCT00091104|Aldesleukin|aldesleukin|mesh-list
64912459|NCT00001524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912460|NCT00006041|Vaccines|vaccines|mesh-list
64912461|NCT00006041|Saponin QA-21V1|saponin qa-21v1|mesh-list
64912462|NCT00006041|Immunologic Factors|immunologic factors|mesh-ancestor
64912463|NCT00006041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912464|NCT00006041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64912465|NCT00017602|Dexamethasone|dexamethasone|mesh-list
64912466|NCT00017602|Oblimersen|oblimersen|mesh-list
64912467|NCT00017602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64912468|NCT00017602|Antiemetics|antiemetics|mesh-ancestor
64912469|NCT00017602|Autonomic Agents|autonomic agents|mesh-ancestor
64912470|NCT00017602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64912471|NCT00017602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912472|NCT00017602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64912473|NCT00017602|Glucocorticoids|glucocorticoids|mesh-ancestor
64912474|NCT00017602|Hormones|hormones|mesh-ancestor
64912475|NCT00017602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64912476|NCT00017602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64912477|NCT00017602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912498|NCT00017641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912499|NCT00017641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912500|NCT00017641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64912501|NCT00017680|Melphalan|melphalan|mesh-list
64912502|NCT00017680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64912503|NCT00017680|Alkylating Agents|alkylating agents|mesh-ancestor
64912504|NCT00017680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912505|NCT00017680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912506|NCT00017680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64912507|NCT00017680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64912508|NCT00017680|Immunologic Factors|immunologic factors|mesh-ancestor
64912509|NCT00017680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912510|NCT00017719|Lamivudine|lamivudine|mesh-list
64912511|NCT00017719|Zidovudine|zidovudine|mesh-list
64912512|NCT00017719|Nevirapine|nevirapine|mesh-list
64912513|NCT00017719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64912519|NCT00017719|Antiviral Agents|antiviral agents|mesh-ancestor
64912520|NCT00017719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64912521|NCT00017719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64912522|NCT00017719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64912523|NCT00017719|Antimetabolites|antimetabolites|mesh-ancestor
64912524|NCT00017719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64912543|NCT00017758|Nelfinavir|nelfinavir|mesh-list
64912544|NCT00017758|Atorvastatin|atorvastatin|mesh-list
64912545|NCT00017758|Simvastatin|simvastatin|mesh-list
64912546|NCT00017758|Pravastatin|pravastatin|mesh-list
64912547|NCT00017758|Calcium|calcium|mesh-list
64912548|NCT00017758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64912549|NCT00017758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912550|NCT00017758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64912551|NCT00017758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64912552|NCT00017758|Antimetabolites|antimetabolites|mesh-ancestor
64912553|NCT00017758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912554|NCT00017758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64912555|NCT00017758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64912556|NCT00017758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912557|NCT00017758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64912558|NCT00017758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64912559|NCT00017758|Antiviral Agents|antiviral agents|mesh-ancestor
64912560|NCT00017758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64912561|NCT00017758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64912562|NCT00017758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64912563|NCT00017758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64912564|NCT00017758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64912565|NCT00017758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64985876|NCT00091104|Cyclophosphamide|cyclophosphamide|mesh-list
64985877|NCT00091104|Fludarabine|fludarabine|mesh-list
64985878|NCT00091104|Fludarabine phosphate|fludarabine phosphate|mesh-list
64985923|NCT00313690|Antimitotic Agents|antimitotic agents|mesh-ancestor
64985924|NCT00313690|Mitosis Modulators|mitosis modulators|mesh-ancestor
64985925|NCT00313690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985926|NCT00313885|SR 46349B|sr 46349b|mesh-list
64985927|NCT00313885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64985928|NCT00313885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64985929|NCT00313885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985930|NCT00313885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64985931|NCT00313885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64985932|NCT00313885|Serotonin Agents|serotonin agents|mesh-ancestor
64985933|NCT00313885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64985934|NCT00313885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985935|NCT00091143|Fludarabine|fludarabine|mesh-list
64912566|NCT00017758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64912567|NCT00017758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64912568|NCT00017758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64912569|NCT00017758|Protease Inhibitors|protease inhibitors|mesh-ancestor
64912570|NCT00017758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64912571|NCT00017758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64912572|NCT00017992|Ritonavir|ritonavir|mesh-list
64912573|NCT00017992|Lopinavir|lopinavir|mesh-list
64912574|NCT00017992|Emtricitabine|emtricitabine|mesh-list
64912575|NCT00017992|Stavudine|stavudine|mesh-list
64912576|NCT00017992|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64912577|NCT00017992|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64912584|NCT00017992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64912585|NCT00017992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64912586|NCT00017992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64912587|NCT00017992|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64912588|NCT00017992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64912590|NCT04734067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64912591|NCT04734067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912592|NCT04734067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912593|NCT05680805|Metformin|metformin|mesh-list
64912594|NCT05680805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64912595|NCT05680805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912596|NCT00018148|Nortriptyline|nortriptyline|mesh-list
64912597|NCT00018148|Nicotine|nicotine|mesh-list
64912598|NCT00018148|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64912599|NCT00018148|Autonomic Agents|autonomic agents|mesh-ancestor
64912600|NCT00018148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64912601|NCT00018148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912602|NCT00018148|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64912603|NCT00018148|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64912604|NCT00018148|Cholinergic Agents|cholinergic agents|mesh-ancestor
64912605|NCT00018148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64912606|NCT00018148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985936|NCT00091143|Fludarabine phosphate|fludarabine phosphate|mesh-list
64985937|NCT00091143|Freund's Adjuvant|freund's adjuvant|mesh-list
64985938|NCT00091143|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
64985939|NCT00091143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985940|NCT00091143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64985941|NCT00091143|Antimetabolites|antimetabolites|mesh-ancestor
64912627|NCT00018187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64912628|NCT00018187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64912629|NCT00018187|Cholinergic Agents|cholinergic agents|mesh-ancestor
64912630|NCT00018187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64912631|NCT00018187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912632|NCT00018187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64912633|NCT00018187|Antidepressive Agents|antidepressive agents|mesh-ancestor
64912634|NCT00018187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64912635|NCT00018187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64912636|NCT00018187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64912637|NCT00018187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64912638|NCT00018187|Dopamine Agents|dopamine agents|mesh-ancestor
64912639|NCT00018187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64912640|NCT00018187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64912641|NCT00018187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912642|NCT00018187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64912643|NCT00018187|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
64912644|NCT00018187|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64912645|NCT00018187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64912646|NCT00018343|Estrogens|estrogens|mesh-list
64912647|NCT00018343|Hormones|hormones|mesh-ancestor
64912648|NCT00018343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64912649|NCT00018343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912650|NCT00001566|Indinavir|indinavir|mesh-list
64912651|NCT00001566|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64912652|NCT00001566|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64912653|NCT00001566|Protease Inhibitors|protease inhibitors|mesh-ancestor
64912654|NCT00001566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912655|NCT00001566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912671|NCT00386750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64912672|NCT00386750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64985976|NCT04432012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64985977|NCT04432012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912673|NCT00386750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64912674|NCT00001575|Edetic Acid|edetic acid|mesh-list
64912675|NCT00001575|Calcium|calcium|mesh-list
64912676|NCT00001575|Pentetic Acid|pentetic acid|mesh-list
64912677|NCT00001575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64912678|NCT00001575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912679|NCT00001575|Antidotes|antidotes|mesh-ancestor
64912680|NCT00001575|Protective Agents|protective agents|mesh-ancestor
64912681|NCT00001575|Chelating Agents|chelating agents|mesh-ancestor
64912682|NCT00001575|Sequestering Agents|sequestering agents|mesh-ancestor
64912683|NCT00001575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912684|NCT00001575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64912685|NCT00001575|Anticoagulants|anticoagulants|mesh-ancestor
64912686|NCT00001575|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64912687|NCT00001596|Pirfenidone|pirfenidone|mesh-list
64912688|NCT00001596|Analgesics|analgesics|mesh-ancestor
64912689|NCT00001596|Sensory System Agents|sensory system agents|mesh-ancestor
64912690|NCT00001596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64912691|NCT00001596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912692|NCT00001596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64912693|NCT00001596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64912694|NCT00001596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64912695|NCT00001596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64912696|NCT00001596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912697|NCT03366103|Navitoclax|navitoclax|mesh-list
64912698|NCT03366103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912699|NCT03346135|Melphalan|melphalan|mesh-list
64912700|NCT03346135|Mechlorethamine|mechlorethamine|mesh-list
64912701|NCT03346135|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64912702|NCT03346135|Daratumumab|daratumumab|mesh-list
64912703|NCT03346135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64912704|NCT03346135|Alkylating Agents|alkylating agents|mesh-ancestor
64912705|NCT03346135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912706|NCT03346135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912711|NCT05576194|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64912716|NCT00391885|Anesthetics|anesthetics|mesh-list
64912717|NCT00391885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64912718|NCT00391885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912719|NCT00391924|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64912720|NCT00391924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64912721|NCT00391924|Immunologic Factors|immunologic factors|mesh-ancestor
64912722|NCT00391924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912723|NCT00392002|Esomeprazole|esomeprazole|mesh-list
64912724|NCT00392002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64912725|NCT00392002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64912726|NCT00392002|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64912727|NCT00392002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912728|NCT00392002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912729|NCT00392080|Naproxen|naproxen|mesh-list
64912730|NCT00392080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64912731|NCT00392080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64912732|NCT00392080|Analgesics|analgesics|mesh-ancestor
64912733|NCT00392080|Sensory System Agents|sensory system agents|mesh-ancestor
64912734|NCT00392080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64912762|NCT00001644|Antimetabolites|antimetabolites|mesh-ancestor
64912763|NCT00001644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64912764|NCT00001644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64912765|NCT00001644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64912766|NCT00001644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64912767|NCT00001644|Protease Inhibitors|protease inhibitors|mesh-ancestor
64912768|NCT05573386|Lenograstim|lenograstim|mesh-list
64912769|NCT05573386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64912770|NCT05573386|Immunologic Factors|immunologic factors|mesh-ancestor
64912771|NCT05573386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912772|NCT00001656|Olanzapine|olanzapine|mesh-list
64912773|NCT00001656|Clozapine|clozapine|mesh-list
64912774|NCT00001656|Antiemetics|antiemetics|mesh-ancestor
64912775|NCT00001656|Autonomic Agents|autonomic agents|mesh-ancestor
64912779|NCT00001656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64912784|NCT00001656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64912785|NCT00001656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64912786|NCT00001656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912787|NCT00001656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64912788|NCT00001656|Serotonin Agents|serotonin agents|mesh-ancestor
64912810|NCT05572723|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64912811|NCT05572723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64912812|NCT05572723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912813|NCT05572723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64912814|NCT05572723|Analgesics|analgesics|mesh-ancestor
64912815|NCT05572723|Sensory System Agents|sensory system agents|mesh-ancestor
64912816|NCT05572723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64912817|NCT05572723|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64912818|NCT05572723|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64912819|NCT05572723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64912820|NCT05572723|Adrenergic Agents|adrenergic agents|mesh-ancestor
64912821|NCT05572723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64912822|NCT05572723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912823|NCT05572723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64912824|NCT05572723|Narcotics|narcotics|mesh-ancestor
64912825|NCT05563753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64912826|NCT05563753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64912827|NCT05485558|Acetylcysteine|acetylcysteine|mesh-list
64912828|NCT05485558|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64912829|NCT05485558|Antiviral Agents|antiviral agents|mesh-ancestor
64912830|NCT05485558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64912831|NCT05485558|Expectorants|expectorants|mesh-ancestor
64912832|NCT05485558|Respiratory System Agents|respiratory system agents|mesh-ancestor
64912833|NCT05485558|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64912834|NCT05485558|Antioxidants|antioxidants|mesh-ancestor
64912835|NCT05485558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912836|NCT05485558|Protective Agents|protective agents|mesh-ancestor
64912837|NCT05485558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912839|NCT00389415|Vildagliptin|vildagliptin|mesh-list
64912840|NCT00389415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64912853|NCT05465317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64912854|NCT05465317|Hormones|hormones|mesh-ancestor
64912855|NCT05465317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64912856|NCT05465317|Incretins|incretins|mesh-ancestor
64912857|NCT05419921|Lidocaine|lidocaine|mesh-list
64912858|NCT05419921|Anesthetics, Local|anesthetics, local|mesh-ancestor
64912859|NCT05419921|Anesthetics|anesthetics|mesh-ancestor
64912860|NCT05419921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64912861|NCT05419921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912862|NCT05419921|Sensory System Agents|sensory system agents|mesh-ancestor
64912863|NCT05419921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64912864|NCT05419921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64912865|NCT05419921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64912866|NCT05419921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64912867|NCT05419921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64912868|NCT05419921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912869|NCT00386828|Bevacizumab|bevacizumab|mesh-list
64912870|NCT00386828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64912871|NCT00386828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912872|NCT00386828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64912873|NCT00386828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64912904|NCT05679401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64912905|NCT05679401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64912906|NCT05679401|Alkylating Agents|alkylating agents|mesh-ancestor
64681361|NCT00002643|Cobalt|cobalt|mesh-list
64912907|NCT05679401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912908|NCT05679401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912909|NCT05679401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64912910|NCT05679401|Hormones|hormones|mesh-ancestor
64912911|NCT05679401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64912922|NCT05311618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912923|NCT00001728|Alendronate|alendronate|mesh-list
64912924|NCT00001728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64912925|NCT00001728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912926|NCT05290207|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64912927|NCT05290207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912928|NCT05673629|Docetaxel|docetaxel|mesh-list
64912929|NCT05673629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912930|NCT05673629|Tubulin Modulators|tubulin modulators|mesh-ancestor
64912931|NCT05673629|Antimitotic Agents|antimitotic agents|mesh-ancestor
64912932|NCT05673629|Mitosis Modulators|mitosis modulators|mesh-ancestor
64912934|NCT00001731|Cyclosporine|cyclosporine|mesh-list
64912944|NCT00001731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64912945|NCT00001731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64912947|NCT00392158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64912948|NCT00392158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912949|NCT04007276|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64912950|NCT04007276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64912951|NCT04007276|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64912952|NCT04007276|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64912953|NCT04007276|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64912954|NCT04007276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64912955|NCT04007276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64912956|NCT04007276|Adrenergic Agents|adrenergic agents|mesh-ancestor
64912957|NCT04007276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64912958|NCT04007276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912959|NCT04007276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912960|NCT00392275|Ciprofloxacin|ciprofloxacin|mesh-list
64912961|NCT00392275|Levofloxacin|levofloxacin|mesh-list
64912962|NCT00392275|Ofloxacin|ofloxacin|mesh-list
64912963|NCT00392275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64912964|NCT00392275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64912973|NCT00392275|Renal Agents|renal agents|mesh-ancestor
64912974|NCT00001749|Cyclosporine|cyclosporine|mesh-list
64912975|NCT00001749|Cyclosporins|cyclosporins|mesh-list
64912976|NCT00001749|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64912977|NCT00001749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912978|NCT00001749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912981|NCT00001749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912983|NCT00001749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64912984|NCT00001749|Dermatologic Agents|dermatologic agents|mesh-ancestor
64912985|NCT00001749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64912986|NCT00001749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64912987|NCT00001752|Estrogens|estrogens|mesh-list
64912988|NCT00001752|Hormones|hormones|mesh-ancestor
64912989|NCT00001752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64912990|NCT00001752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912991|NCT05171179|Lidocaine|lidocaine|mesh-list
64912992|NCT05171179|Bupivacaine|bupivacaine|mesh-list
64912993|NCT05171179|Anesthetics, Local|anesthetics, local|mesh-ancestor
64912994|NCT05171179|Anesthetics|anesthetics|mesh-ancestor
64912995|NCT05171179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64912996|NCT05171179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912997|NCT05171179|Sensory System Agents|sensory system agents|mesh-ancestor
64912998|NCT05171179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64912999|NCT05171179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64913001|NCT05171179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64913036|NCT00001764|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64913037|NCT00001764|Antitubercular Agents|antitubercular agents|mesh-ancestor
64913038|NCT00001764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64913039|NCT00001764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64913040|NCT00001764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913041|NCT00001764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913042|NCT04983901|Vancomycin|vancomycin|mesh-list
64913043|NCT04983901|Meropenem|meropenem|mesh-list
64913044|NCT04983901|Tazobactam|tazobactam|mesh-list
64913045|NCT04983901|Linezolid|linezolid|mesh-list
64913046|NCT04983901|Piperacillin|piperacillin|mesh-list
64913047|NCT04983901|Daptomycin|daptomycin|mesh-list
64913048|NCT04983901|Imipenem|imipenem|mesh-list
64913049|NCT04983901|Cefepime|cefepime|mesh-list
64913050|NCT04983901|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64913051|NCT04983901|Relebactam|relebactam|mesh-list
64913052|NCT04983901|Cilastatin|cilastatin|mesh-list
64913053|NCT04983901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64913054|NCT04983901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64681512|NCT00002691|Abortifacient Agents|abortifacient agents|mesh-ancestor
64913065|NCT04971343|Immunoglobulins|immunoglobulins|mesh-list
64913066|NCT04971343|Immunologic Factors|immunologic factors|mesh-ancestor
64913067|NCT04971343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913068|NCT04951804|Bupivacaine|bupivacaine|mesh-list
64913069|NCT04951804|Anesthetics, Local|anesthetics, local|mesh-ancestor
64913070|NCT04951804|Anesthetics|anesthetics|mesh-ancestor
64913071|NCT04951804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64913072|NCT04951804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913073|NCT04951804|Sensory System Agents|sensory system agents|mesh-ancestor
64913074|NCT04951804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64913075|NCT05620628|Durvalumab|durvalumab|mesh-list
64913076|NCT05620628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64913077|NCT05620628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913078|NCT05591651|Hyaluronic Acid|hyaluronic acid|mesh-list
64913079|NCT05591651|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64913080|NCT05591651|Immunologic Factors|immunologic factors|mesh-ancestor
64913084|NCT04905121|Psilocybin|psilocybin|mesh-list
64913087|NCT04905121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64913088|NCT00001818|Hydroxyurea|hydroxyurea|mesh-list
64913089|NCT00001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913090|NCT00001818|Antisickling Agents|antisickling agents|mesh-ancestor
64913091|NCT00001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913092|NCT00001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913093|NCT00001818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64913094|NCT04887805|Pembrolizumab|pembrolizumab|mesh-list
64913095|NCT04887805|Lenvatinib|lenvatinib|mesh-list
64913096|NCT04887805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64913097|NCT04887805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913108|NCT00000102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64913109|NCT00000102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913110|NCT00000102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64913111|NCT00000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913112|NCT00000102|Vasodilator Agents|vasodilator agents|mesh-ancestor
64913113|NCT00000102|Tocolytic Agents|tocolytic agents|mesh-ancestor
64913114|NCT00000102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64913164|NCT04734730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64913165|NCT04734730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913166|NCT04734730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64913167|NCT04734730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913168|NCT04734730|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64913169|NCT04734730|Fertility Agents|fertility agents|mesh-ancestor
64913170|NCT04734730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64913171|NCT04734730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64913172|NCT04734730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913173|NCT04734730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913174|NCT04734730|Hormone Antagonists|hormone antagonists|mesh-ancestor
64913175|NCT04734730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64913176|NCT04734730|Androgen Antagonists|androgen antagonists|mesh-ancestor
64913177|NCT04734730|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64913178|NCT05562713|Denatonium|denatonium|mesh-list
64913179|NCT05562713|Aversive Agents|aversive agents|mesh-ancestor
64913180|NCT05562713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913181|NCT05562713|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
64913182|NCT05562713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913183|NCT05562713|Sensory System Agents|sensory system agents|mesh-ancestor
64913195|NCT04619680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913196|NCT04619680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64913197|NCT04619680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913198|NCT04619680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913199|NCT04604782|Regadenoson|regadenoson|mesh-list
64913200|NCT04604782|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64913201|NCT04604782|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64913202|NCT04604782|Purinergic Agonists|purinergic agonists|mesh-ancestor
64913203|NCT04604782|Purinergic Agents|purinergic agents|mesh-ancestor
64913210|NCT00386867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64913211|NCT00386867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913212|NCT00386867|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64913213|NCT00386867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64913214|NCT00386867|Oxytocics|oxytocics|mesh-ancestor
64913215|NCT04526119|Z 338|z 338|mesh-list
64913216|NCT04526119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64913217|NCT04526119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913218|NCT04526119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913219|NCT04526119|Cholinergic Agents|cholinergic agents|mesh-ancestor
64913220|NCT04526119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64913221|NCT04526119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913222|NCT04526119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64913223|NCT04495894|Ketorolac|ketorolac|mesh-list
64913224|NCT04495894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64913225|NCT04495894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64913226|NCT04495894|Analgesics|analgesics|mesh-ancestor
64913227|NCT04495894|Sensory System Agents|sensory system agents|mesh-ancestor
64913228|NCT04495894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64913229|NCT04495894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913230|NCT04495894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64913231|NCT04495894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64913232|NCT04495894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64913233|NCT04495894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913234|NCT04495894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913235|NCT04487236|Capecitabine|capecitabine|mesh-list
64913236|NCT04487236|Trastuzumab|trastuzumab|mesh-list
64913237|NCT04487236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64913238|NCT04487236|Antimetabolites|antimetabolites|mesh-ancestor
64913239|NCT04487236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913240|NCT04487236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913241|NCT04487236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64913242|NCT00392431|Amiodarone|amiodarone|mesh-list
64913244|NCT00392431|Vasodilator Agents|vasodilator agents|mesh-ancestor
64913245|NCT00392431|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64913246|NCT00392431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64913248|NCT00392431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64913284|NCT03960151|Glucocorticoids|glucocorticoids|mesh-ancestor
64913285|NCT03960151|Hormones|hormones|mesh-ancestor
64913286|NCT03960151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64913287|NCT03960151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64913288|NCT03960151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913289|NCT03960151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64913290|NCT03960151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64913291|NCT03960151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64913292|NCT03960151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64913293|NCT03960151|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64913294|NCT03960151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64913295|NCT03960151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64913296|NCT03960151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913297|NCT03960151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64913298|NCT03960151|Serotonin Agents|serotonin agents|mesh-ancestor
64913299|NCT03960151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64913300|NCT03960151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64913301|NCT03960151|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64913302|NCT04733326|Ketorolac|ketorolac|mesh-list
64913303|NCT04733326|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64913304|NCT04733326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64913306|NCT04733326|Analgesics|analgesics|mesh-ancestor
64913340|NCT03959566|Anesthetics|anesthetics|mesh-ancestor
64913341|NCT03959566|GABA Modulators|gaba modulators|mesh-ancestor
64913342|NCT03959566|GABA Agents|gaba agents|mesh-ancestor
64913343|NCT03959566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64913344|NCT03959566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913345|NCT03959566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64913346|NCT03959566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64913347|NCT03959566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64913348|NCT03959566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64913349|NCT03959566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913350|NCT03959566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913351|NCT03959566|Antitubercular Agents|antitubercular agents|mesh-ancestor
64913352|NCT03959488|Palivizumab|palivizumab|mesh-list
64913353|NCT03959488|Antiviral Agents|antiviral agents|mesh-ancestor
64913354|NCT03959488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64913355|NCT00387179|Melatonin|melatonin|mesh-list
64913356|NCT00387179|Antioxidants|antioxidants|mesh-ancestor
64913357|NCT00387179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913358|NCT00387179|Protective Agents|protective agents|mesh-ancestor
64913361|NCT03959332|Baloxavir|baloxavir|mesh-list
64913378|NCT05640726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64913379|NCT05640726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913380|NCT05640726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64913381|NCT05640726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64913382|NCT05640726|Growth Substances|growth substances|mesh-ancestor
64913383|NCT05640726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913384|NCT05640726|Growth Inhibitors|growth inhibitors|mesh-ancestor
64913385|NCT05640726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64913386|NCT05640726|Antimetabolites|antimetabolites|mesh-ancestor
64913387|NCT05640726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913388|NCT05640726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64913389|NCT05640726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64913390|NCT05640726|Immunologic Factors|immunologic factors|mesh-ancestor
64913391|NCT05640726|Antidotes|antidotes|mesh-ancestor
64913392|NCT05640726|Protective Agents|protective agents|mesh-ancestor
64913394|NCT05640726|Vitamins|vitamins|mesh-ancestor
64913398|NCT03959176|Oxymetazoline|oxymetazoline|mesh-list
64913399|NCT03959176|Tropicamide|tropicamide|mesh-list
64913400|NCT03959176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64913401|NCT03959176|Mydriatics|mydriatics|mesh-ancestor
64913402|NCT03959176|Autonomic Agents|autonomic agents|mesh-ancestor
64913403|NCT03959176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64913404|NCT03959176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913405|NCT03959176|Sympathomimetics|sympathomimetics|mesh-ancestor
64913406|NCT03959176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64913425|NCT03958942|Anesthetics, Local|anesthetics, local|mesh-ancestor
64681898|NCT04003649|Nivolumab|nivolumab|mesh-list
64913426|NCT03958942|Anesthetics|anesthetics|mesh-ancestor
64913427|NCT03958942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64913428|NCT03958942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913429|NCT03958942|Sensory System Agents|sensory system agents|mesh-ancestor
64913430|NCT03958942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64913431|NCT03958708|Rifaximin|rifaximin|mesh-list
64913432|NCT03958708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64913433|NCT03958708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64913434|NCT03958708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64913435|NCT05640609|Bevacizumab|bevacizumab|mesh-list
64913436|NCT05640609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64913437|NCT05640609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913438|NCT05640609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64913439|NCT05640609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64913440|NCT05640609|Growth Substances|growth substances|mesh-ancestor
64913441|NCT05640609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913442|NCT05640609|Growth Inhibitors|growth inhibitors|mesh-ancestor
64913443|NCT05411861|Analgesics|analgesics|mesh-list
64913444|NCT05411861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
64913479|NCT03933865|Ketamine|ketamine|mesh-list
64913489|NCT03933865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64913490|NCT03933865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64913491|NCT03933865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64913492|NCT03933865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64913493|NCT03933865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913494|NCT03933865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64913495|NCT03933865|Narcotics|narcotics|mesh-ancestor
64913496|NCT03819322|Sofosbuvir|sofosbuvir|mesh-list
64913497|NCT03819322|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64913498|NCT03819322|Velpatasvir|velpatasvir|mesh-list
64913499|NCT03819322|Antiviral Agents|antiviral agents|mesh-ancestor
64913500|NCT03819322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64913501|NCT03758950|Mometasone Furoate|mometasone furoate|mesh-list
64913502|NCT03758950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64913503|NCT03758950|Dermatologic Agents|dermatologic agents|mesh-ancestor
64913504|NCT03758950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64913505|NCT03564340|Cemiplimab|cemiplimab|mesh-list
64913506|NCT03564340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64913507|NCT03564340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913508|NCT05639907|Ethanol|ethanol|mesh-list
64913509|NCT05639907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64913510|NCT05639907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64913516|NCT05206175|Sympathomimetics|sympathomimetics|mesh-ancestor
64913517|NCT05206175|Autonomic Agents|autonomic agents|mesh-ancestor
64913518|NCT05206175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64913519|NCT05206175|Dopamine Agents|dopamine agents|mesh-ancestor
64913520|NCT05206175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64913522|NCT05206175|Adrenergic Agents|adrenergic agents|mesh-ancestor
64913540|NCT00392938|Mitosis Modulators|mitosis modulators|mesh-ancestor
64913541|NCT00392938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913542|NCT00392938|Hormone Antagonists|hormone antagonists|mesh-ancestor
64913543|NCT00392938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64913544|NCT00392938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913545|NCT05637567|Aspirin|aspirin|mesh-list
64913546|NCT05637567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64913547|NCT05637567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64913548|NCT05637567|Analgesics|analgesics|mesh-ancestor
64913554|NCT05637567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64913555|NCT05637567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64913556|NCT05637567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913557|NCT05637567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64913558|NCT05637567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64913559|NCT05637567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913560|NCT05637567|Antipyretics|antipyretics|mesh-ancestor
64913561|NCT03514108|Metformin|metformin|mesh-list
64913562|NCT03514108|Hydralazine|hydralazine|mesh-list
64913563|NCT03514108|Isosorbide|isosorbide|mesh-list
64913564|NCT03514108|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64913565|NCT03514108|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64913566|NCT03514108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64913567|NCT03514108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913568|NCT03514108|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64913569|NCT03514108|Diuretics|diuretics|mesh-ancestor
64913570|NCT03514108|Natriuretic Agents|natriuretic agents|mesh-ancestor
64913571|NCT03514108|Vasodilator Agents|vasodilator agents|mesh-ancestor
64913572|NCT03514108|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64913573|NCT03514108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913574|NCT03514108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64913575|NCT03508726|Ascorbic Acid|ascorbic acid|mesh-list
64913576|NCT03508726|Vitamins|vitamins|mesh-ancestor
64913577|NCT03508726|Micronutrients|micronutrients|mesh-ancestor
64913612|NCT05634564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64913613|NCT05634564|Immunologic Factors|immunologic factors|mesh-ancestor
64913614|NCT05634564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913615|NCT03152149|Fluticasone|fluticasone|mesh-list
64913616|NCT03152149|Xhance|xhance|mesh-list
64913617|NCT03152149|Tiotropium Bromide|tiotropium bromide|mesh-list
64913618|NCT03152149|Olodaterol|olodaterol|mesh-list
64913619|NCT03152149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64913620|NCT03152149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64913621|NCT03152149|Autonomic Agents|autonomic agents|mesh-ancestor
64913622|NCT03152149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64913623|NCT03152149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913624|NCT03152149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64913625|NCT03152149|Respiratory System Agents|respiratory system agents|mesh-ancestor
64913626|NCT03152149|Dermatologic Agents|dermatologic agents|mesh-ancestor
64913627|NCT03152149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64913628|NCT03152149|Parasympatholytics|parasympatholytics|mesh-ancestor
64913629|NCT03152149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64913630|NCT03152149|Cholinergic Agents|cholinergic agents|mesh-ancestor
64913631|NCT03152149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64913632|NCT03152149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913633|NCT03151993|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64913634|NCT03151993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64913635|NCT03151993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64913647|NCT03151876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913648|NCT03151876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913649|NCT03151876|Antiviral Agents|antiviral agents|mesh-ancestor
64913650|NCT03151876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64913669|NCT05632809|Durvalumab|durvalumab|mesh-list
64913670|NCT05632809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64913671|NCT05632809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913672|NCT03151603|Fosfomycin|fosfomycin|mesh-list
64913673|NCT03151603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64913674|NCT03151603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64913675|NCT03151525|Azathioprine|azathioprine|mesh-list
64913676|NCT03151525|Infliximab|infliximab|mesh-list
64913677|NCT03151525|Dermatologic Agents|dermatologic agents|mesh-ancestor
64913678|NCT03151525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64913679|NCT03151525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64913680|NCT03151525|Antimetabolites|antimetabolites|mesh-ancestor
64913687|NCT03151486|JNJ-55308942|jnj-55308942|mesh-list
64913688|NCT03151486|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
64913689|NCT03151486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64913690|NCT03151486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64913691|NCT03151486|Purinergic Agents|purinergic agents|mesh-ancestor
64913692|NCT03151486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64913693|NCT03151486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913694|NCT03151486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913695|NCT00387374|Paclitaxel|paclitaxel|mesh-list
64913696|NCT00387374|Bevacizumab|bevacizumab|mesh-list
64913697|NCT00387374|Carboplatin|carboplatin|mesh-list
64913698|NCT00387374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64913699|NCT00387374|Antibodies|antibodies|mesh-list
64913700|NCT00387374|Immunoglobulins|immunoglobulins|mesh-list
64913701|NCT00387374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64377829|NCT03036891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64985978|NCT04432012|Protease Inhibitors|protease inhibitors|mesh-ancestor
64985979|NCT04432012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985980|NCT04432012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985981|NCT00091299|Warfarin|warfarin|mesh-list
64985982|NCT00091299|Anticoagulants|anticoagulants|mesh-ancestor
64985983|NCT04607603|Cannabidiol|cannabidiol|mesh-list
64985984|NCT04607603|Anticonvulsants|anticonvulsants|mesh-ancestor
64985985|NCT00122772|Cisplatin|cisplatin|mesh-list
64985986|NCT00122772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985987|NCT00091338|Freund's Adjuvant|freund's adjuvant|mesh-list
64985988|NCT00091338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64985989|NCT00091338|Immunologic Factors|immunologic factors|mesh-ancestor
64985990|NCT00091338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986013|NCT04551170|Vasodilator Agents|vasodilator agents|mesh-ancestor
64986014|NCT04551170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64986015|NCT04551170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64986016|NCT04551170|Purinergic Agents|purinergic agents|mesh-ancestor
64986017|NCT04551170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64986018|NCT00122850|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64986019|NCT00122850|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64986020|NCT00122850|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64986021|NCT00122850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64913702|NCT00387374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64913703|NCT00387374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913704|NCT00387374|Tubulin Modulators|tubulin modulators|mesh-ancestor
64913705|NCT00387374|Antimitotic Agents|antimitotic agents|mesh-ancestor
64913706|NCT00387374|Mitosis Modulators|mitosis modulators|mesh-ancestor
64913707|NCT00387374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913708|NCT00387374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64913709|NCT00387374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64913710|NCT00387374|Growth Substances|growth substances|mesh-ancestor
64913711|NCT00387374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913738|NCT03912818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913739|NCT03912818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64913740|NCT03912818|Antimetabolites|antimetabolites|mesh-ancestor
64913741|NCT03912818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913742|NCT03912818|Antiviral Agents|antiviral agents|mesh-ancestor
64913743|NCT03912818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64913744|NCT03912818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913745|NCT03912818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64913746|NCT03912818|Immunologic Factors|immunologic factors|mesh-ancestor
64913747|NCT03912818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913748|NCT03912818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64913749|NCT03912818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64913750|NCT03912818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64913751|NCT03912818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64913752|NCT03912818|Abortifacient Agents|abortifacient agents|mesh-ancestor
64913753|NCT03912818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64913754|NCT03912818|Dermatologic Agents|dermatologic agents|mesh-ancestor
64913755|NCT03912818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64913756|NCT03912818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64913793|NCT03906539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64913794|NCT03906539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64913795|NCT03906539|Antimetabolites|antimetabolites|mesh-ancestor
64913796|NCT03906539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913800|NCT00389688|Pemetrexed|pemetrexed|mesh-list
64913803|NCT00389688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913804|NCT00389688|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64913805|NCT00389688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64913806|NCT05605665|Sirolimus|sirolimus|mesh-list
64913807|NCT05605665|Aldesleukin|aldesleukin|mesh-list
64913809|NCT05605665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64913810|NCT05605665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64913811|NCT05605665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64913812|NCT05605665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913849|NCT03150316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64913850|NCT03150316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913852|NCT03150316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913853|NCT03150316|Immunologic Factors|immunologic factors|mesh-ancestor
64913854|NCT03150316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64913855|NCT03150316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64913856|NCT03150316|Growth Substances|growth substances|mesh-ancestor
64913857|NCT03150316|Growth Inhibitors|growth inhibitors|mesh-ancestor
64913858|NCT03150316|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64913910|NCT02285179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64913911|NCT02285179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64913912|NCT02285179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64913913|NCT02250937|Fludarabine|fludarabine|mesh-list
64913914|NCT02250937|Fludarabine phosphate|fludarabine phosphate|mesh-list
64913915|NCT02250937|Busulfan|busulfan|mesh-list
64913916|NCT02250937|Venetoclax|venetoclax|mesh-list
64913917|NCT02250937|Cladribine|cladribine|mesh-list
64913918|NCT02250937|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
64913943|NCT02122081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64913944|NCT02122081|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64913945|NCT02122081|Abortifacient Agents|abortifacient agents|mesh-ancestor
64914009|NCT01807429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64914010|NCT01807429|Narcotics|narcotics|mesh-ancestor
64914011|NCT01807429|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64914012|NCT01807429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64914013|NCT01807429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64914014|NCT01807429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64914015|NCT01807429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64914016|NCT01807429|GABA Modulators|gaba modulators|mesh-ancestor
64914017|NCT01807429|GABA Agents|gaba agents|mesh-ancestor
64914018|NCT01807078|Ezetimibe|ezetimibe|mesh-list
64914019|NCT01807078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64914028|NCT04650581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64914029|NCT04650581|Hormone Antagonists|hormone antagonists|mesh-ancestor
64914030|NCT04650581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64914031|NCT04650581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914081|NCT05517291|Paclitaxel|paclitaxel|mesh-list
64914082|NCT05517291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64914083|NCT05517291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914084|NCT05517291|Tubulin Modulators|tubulin modulators|mesh-ancestor
64914085|NCT05517291|Antimitotic Agents|antimitotic agents|mesh-ancestor
64914086|NCT05517291|Mitosis Modulators|mitosis modulators|mesh-ancestor
64914174|NCT04551131|Glucocorticoids|glucocorticoids|mesh-ancestor
64914198|NCT05437887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914199|NCT01805596|Clopidogrel|clopidogrel|mesh-list
64914200|NCT01805596|Ticagrelor|ticagrelor|mesh-list
64914201|NCT01805596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64914202|NCT01805596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64914203|NCT01805596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64914204|NCT01805596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64914205|NCT01805596|Purinergic Agents|purinergic agents|mesh-ancestor
64914206|NCT01805596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64914207|NCT01805596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914208|NCT01805596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914209|NCT04477343|Nivolumab|nivolumab|mesh-list
64914210|NCT04477343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64914211|NCT04477343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914212|NCT04477343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64914213|NCT04477343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914214|NCT04474223|Dexamethasone|dexamethasone|mesh-list
64914274|NCT04390763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914275|NCT04390763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64914276|NCT01466101|Pregabalin|pregabalin|mesh-list
64914277|NCT01466101|Analgesics|analgesics|mesh-ancestor
64914278|NCT01466101|Sensory System Agents|sensory system agents|mesh-ancestor
64914281|NCT01466101|Anticonvulsants|anticonvulsants|mesh-ancestor
64914285|NCT01466101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64914286|NCT01466101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64914287|NCT01466101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64914288|NCT01466101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64914289|NCT01466101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64914290|NCT01465984|Acetaminophen|acetaminophen|mesh-list
64914291|NCT01465984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64914292|NCT01465984|Analgesics|analgesics|mesh-ancestor
64914293|NCT01465984|Sensory System Agents|sensory system agents|mesh-ancestor
64914294|NCT01465984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64914295|NCT01465984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914296|NCT01465984|Antipyretics|antipyretics|mesh-ancestor
64914297|NCT01465906|Bromides|bromides|mesh-list
64914299|NCT01465906|Tulobuterol|tulobuterol|mesh-list
64914346|NCT05393505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64914347|NCT05393505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64914348|NCT05393505|Renal Agents|renal agents|mesh-ancestor
64914349|NCT05393505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64914350|NCT05393505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64914351|NCT05393505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914352|NCT05393505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914353|NCT05393505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914354|NCT05393505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64914355|NCT05393505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64914356|NCT05393505|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64914357|NCT04201457|Hydroxychloroquine|hydroxychloroquine|mesh-list
64914376|NCT01465009|Acetaminophen|acetaminophen|mesh-list
64914377|NCT01465009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64914378|NCT01465009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64914379|NCT01465009|Analgesics|analgesics|mesh-ancestor
64914380|NCT01465009|Sensory System Agents|sensory system agents|mesh-ancestor
64914381|NCT01465009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64914382|NCT01465009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914383|NCT01465009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64914384|NCT01465009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64914385|NCT01465009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64914424|NCT04083950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914425|NCT04083950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64914426|NCT04083950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64914427|NCT04083950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914428|NCT04083950|Antipyretics|antipyretics|mesh-ancestor
64914429|NCT00393679|Artesunate|artesunate|mesh-list
64914430|NCT00393679|Lumefantrine|lumefantrine|mesh-list
64914431|NCT00393679|Artemether|artemether|mesh-list
64914432|NCT00393679|Piperaquine|piperaquine|mesh-list
64914433|NCT00393679|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64914434|NCT00393679|Amodiaquine|amodiaquine|mesh-list
64914435|NCT00393679|Artenimol|artenimol|mesh-list
64914436|NCT00393679|Dapsone|dapsone|mesh-list
64914437|NCT00393679|Chlorproguanil|chlorproguanil|mesh-list
64914438|NCT00393679|Antimalarials|antimalarials|mesh-ancestor
64914439|NCT00393679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64914440|NCT00393679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64914441|NCT00393679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64914476|NCT04078568|Glucocorticoids|glucocorticoids|mesh-ancestor
64914477|NCT04078568|Hormones|hormones|mesh-ancestor
64914478|NCT04078568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64914480|NCT04078568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914587|NCT05321160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914588|NCT05321160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64914589|NCT05321160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64914590|NCT05321160|Antidepressive Agents|antidepressive agents|mesh-ancestor
64914591|NCT05321160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64914592|NCT04009343|Lumefantrine|lumefantrine|mesh-list
64914593|NCT04009343|Artemether|artemether|mesh-list
64914594|NCT04009343|Piperaquine|piperaquine|mesh-list
64914595|NCT04009343|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64378010|NCT04829565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64378011|NCT04829565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378012|NCT04829565|Cholinergic Agents|cholinergic agents|mesh-ancestor
64378042|NCT04821063|Moxifloxacin|moxifloxacin|mesh-list
64986022|NCT00122850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64986032|NCT00122850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64986033|NCT04542278|Prednisone|prednisone|mesh-list
64986034|NCT04542278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64986035|NCT04542278|Glucocorticoids|glucocorticoids|mesh-ancestor
64986036|NCT04542278|Hormones|hormones|mesh-ancestor
64986037|NCT04542278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64986038|NCT04542278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986039|NCT04542278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64986057|NCT00091377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986059|NCT03897868|Amlodipine|amlodipine|mesh-list
64986060|NCT03897868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64986061|NCT03897868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64986062|NCT03897868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64986063|NCT03897868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986064|NCT03897868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64986065|NCT03897868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986066|NCT03897868|Vasodilator Agents|vasodilator agents|mesh-ancestor
64986067|NCT03897868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64986068|NCT03897868|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64986069|NCT03897868|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64986070|NCT03878524|Vitamins|vitamins|mesh-list
64986071|NCT03878524|Leucovorin|leucovorin|mesh-list
64986072|NCT03878524|Vitamin A|vitamin a|mesh-list
64986073|NCT03878524|Sirolimus|sirolimus|mesh-list
64986074|NCT03878524|Celecoxib|celecoxib|mesh-list
64986075|NCT03878524|Paclitaxel|paclitaxel|mesh-list
64986076|NCT03878524|Maytansine|maytansine|mesh-list
64986077|NCT03878524|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64986078|NCT03878524|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64986079|NCT03878524|Bevacizumab|bevacizumab|mesh-list
64986080|NCT03878524|Carboplatin|carboplatin|mesh-list
64986081|NCT03878524|Doxorubicin|doxorubicin|mesh-list
64986082|NCT03878524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64986083|NCT03878524|Pembrolizumab|pembrolizumab|mesh-list
64986084|NCT03878524|Fluorouracil|fluorouracil|mesh-list
64986085|NCT03878524|Capecitabine|capecitabine|mesh-list
64986086|NCT03878524|Oxaliplatin|oxaliplatin|mesh-list
64986087|NCT03878524|Nivolumab|nivolumab|mesh-list
64986088|NCT03878524|Trastuzumab|trastuzumab|mesh-list
64986089|NCT03878524|Everolimus|everolimus|mesh-list
64986090|NCT03878524|Bortezomib|bortezomib|mesh-list
64986091|NCT03878524|Ipilimumab|ipilimumab|mesh-list
64986092|NCT03878524|Sorafenib|sorafenib|mesh-list
64986093|NCT03878524|Durvalumab|durvalumab|mesh-list
64986104|NCT03878524|Tretinoin|tretinoin|mesh-list
64986105|NCT03878524|Retinol palmitate|retinol palmitate|mesh-list
64986106|NCT03878524|Bicalutamide|bicalutamide|mesh-list
64986107|NCT03878524|Afatinib|afatinib|mesh-list
64986108|NCT03878524|Vemurafenib|vemurafenib|mesh-list
64986109|NCT03878524|Panobinostat|panobinostat|mesh-list
64986110|NCT03878524|Dabrafenib|dabrafenib|mesh-list
64986111|NCT03878524|Ponatinib|ponatinib|mesh-list
64986112|NCT03878524|Idelalisib|idelalisib|mesh-list
64914596|NCT04009343|Artenimol|artenimol|mesh-list
64914597|NCT04009343|Antimalarials|antimalarials|mesh-ancestor
64914598|NCT04009343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64914599|NCT04009343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64914600|NCT04009343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64914601|NCT03969641|Vaccines|vaccines|mesh-list
64914602|NCT03969641|Immunologic Factors|immunologic factors|mesh-ancestor
64914603|NCT03969641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914604|NCT00847210|Dexlansoprazole|dexlansoprazole|mesh-list
64914605|NCT00847210|Lansoprazole|lansoprazole|mesh-list
64914606|NCT00847210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64914607|NCT00847210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64914611|NCT00847171|Cyclophosphamide|cyclophosphamide|mesh-list
64378186|NCT02601027|Sensory System Agents|sensory system agents|mesh-ancestor
64378214|NCT02600871|Povidone-Iodine|povidone-iodine|mesh-list
64378215|NCT02600871|Povidone|povidone|mesh-list
64378216|NCT02600871|Plasma Substitutes|plasma substitutes|mesh-ancestor
64378217|NCT02600871|Blood Substitutes|blood substitutes|mesh-ancestor
64378218|NCT02600871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64378219|NCT02600871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64378220|NCT04817865|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64378221|NCT04817865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64378222|NCT04818099|Vortioxetine|vortioxetine|mesh-list
64378223|NCT04818099|Antidepressive Agents|antidepressive agents|mesh-ancestor
64378224|NCT04818099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64378225|NCT04818099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64986113|NCT03878524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64986114|NCT03878524|Losartan|losartan|mesh-list
64986115|NCT03878524|Endothelial Growth Factors|endothelial growth factors|mesh-list
64986116|NCT03878524|Antibodies|antibodies|mesh-list
64986117|NCT03878524|Immunoglobulins|immunoglobulins|mesh-list
64986118|NCT03878524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64986119|NCT03878524|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64986120|NCT03878524|Immunoglobulin G|immunoglobulin g|mesh-list
64986121|NCT03878524|Immunoconjugates|immunoconjugates|mesh-list
64986145|NCT03878524|Antidotes|antidotes|mesh-ancestor
64986151|NCT03878524|Antifungal Agents|antifungal agents|mesh-ancestor
64986152|NCT03878524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64986153|NCT03878524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64986154|NCT03878524|Analgesics|analgesics|mesh-ancestor
64986155|NCT03878524|Sensory System Agents|sensory system agents|mesh-ancestor
64986156|NCT03878524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64986157|NCT03878524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64986158|NCT03878524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64986159|NCT03878524|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64986160|NCT03878524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64986161|NCT03878524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64986162|NCT03878524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64986163|NCT03878524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64986164|NCT03878524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64986165|NCT03878524|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64986166|NCT03878524|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64986167|NCT03878524|Keratolytic Agents|keratolytic agents|mesh-ancestor
64914640|NCT00847093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64914641|NCT00847093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914642|NCT00847054|Antibodies|antibodies|mesh-list
64914643|NCT00847054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64914644|NCT00847054|Immunologic Factors|immunologic factors|mesh-ancestor
64914645|NCT00847054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914646|NCT00846976|Bicalutamide|bicalutamide|mesh-list
64914647|NCT00846976|Androgen Antagonists|androgen antagonists|mesh-ancestor
64914648|NCT00846976|Hormone Antagonists|hormone antagonists|mesh-ancestor
64914649|NCT00846976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64914650|NCT00846976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914651|NCT00846976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914652|NCT00846859|Varenicline|varenicline|mesh-list
64914653|NCT00846859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64914654|NCT00846859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64914655|NCT00846859|Cholinergic Agents|cholinergic agents|mesh-ancestor
64914656|NCT00846859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64914657|NCT00846859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378315|NCT04805775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64378316|NCT04805775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378317|NCT04805775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64378380|NCT02595723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64378381|NCT02595723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986168|NCT03878524|Dermatologic Agents|dermatologic agents|mesh-ancestor
64986169|NCT03878524|Antioxidants|antioxidants|mesh-ancestor
64986206|NCT04729868|Adrenergic Agents|adrenergic agents|mesh-ancestor
64986207|NCT04729868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64986208|NCT04729868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986209|NCT03715972|Hydroxyurea|hydroxyurea|mesh-list
64986210|NCT03715972|Acetazolamide|acetazolamide|mesh-list
64986211|NCT03715972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986212|NCT03715972|Antisickling Agents|antisickling agents|mesh-ancestor
64986213|NCT03715972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986214|NCT03715972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986215|NCT03715972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64986216|NCT03715972|Anticonvulsants|anticonvulsants|mesh-ancestor
64986217|NCT03715972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64986218|NCT03715972|Diuretics|diuretics|mesh-ancestor
64986219|NCT03715972|Natriuretic Agents|natriuretic agents|mesh-ancestor
64986220|NCT03715972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986221|NCT00419887|Vildagliptin|vildagliptin|mesh-list
64986222|NCT00419887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64986223|NCT00419887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986224|NCT00419887|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64986225|NCT00419887|Protease Inhibitors|protease inhibitors|mesh-ancestor
64986226|NCT00419887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986227|NCT00419887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986228|NCT03690544|Apremilast|apremilast|mesh-list
64986229|NCT03690544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64914658|NCT00846859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914659|NCT03885830|Imatinib Mesylate|imatinib mesylate|mesh-list
64914660|NCT03885830|Dasatinib|dasatinib|mesh-list
64914661|NCT03885830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914662|NCT03885830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64914663|NCT03885830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914664|NCT03885830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914688|NCT00846703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64914689|NCT00846703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64914690|NCT00846703|Immunologic Factors|immunologic factors|mesh-ancestor
64914691|NCT00846703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64914692|NCT00846703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64914693|NCT00846703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64914694|NCT00846703|Tubulin Modulators|tubulin modulators|mesh-ancestor
64914695|NCT00846703|Antimitotic Agents|antimitotic agents|mesh-ancestor
64914696|NCT00846703|Mitosis Modulators|mitosis modulators|mesh-ancestor
64914697|NCT03772964|Metformin|metformin|mesh-list
64914698|NCT03772964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64378433|NCT04802967|Antimanic Agents|antimanic agents|mesh-ancestor
64378434|NCT04802967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64378435|NCT04802967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64378436|NCT04802967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64914699|NCT03772964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914700|NCT00846625|Triamcinolone|triamcinolone|mesh-list
64914701|NCT00846625|Ranibizumab|ranibizumab|mesh-list
64378437|NCT04802967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64378438|NCT04802967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64378439|NCT04802967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378440|NCT04282785|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64378441|NCT04282785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64378442|NCT05616117|Vitamin D|vitamin d|mesh-list
64378443|NCT05616117|Vitamins|vitamins|mesh-list
64378444|NCT05616117|Micronutrients|micronutrients|mesh-ancestor
64986230|NCT03690544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64986231|NCT03690544|Analgesics|analgesics|mesh-ancestor
64986232|NCT03690544|Sensory System Agents|sensory system agents|mesh-ancestor
64986250|NCT00314977|Alkylating Agents|alkylating agents|mesh-ancestor
64986251|NCT00314977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986252|NCT00314977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986253|NCT00314977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64986301|NCT02965196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64986302|NCT02965196|Glucocorticoids|glucocorticoids|mesh-ancestor
64986304|NCT02965196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64914702|NCT00846625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64914703|NCT00846625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64914704|NCT00846625|Growth Substances|growth substances|mesh-ancestor
64914705|NCT00846625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914706|NCT00846625|Growth Inhibitors|growth inhibitors|mesh-ancestor
64914707|NCT00846625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914708|NCT00846625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64914709|NCT00846625|Glucocorticoids|glucocorticoids|mesh-ancestor
64914710|NCT00846625|Hormones|hormones|mesh-ancestor
64914711|NCT00846625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64914712|NCT00846508|Cisplatin|cisplatin|mesh-list
64914713|NCT00846508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914714|NCT03721172|Apremilast|apremilast|mesh-list
64378546|NCT04808739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64378547|NCT04808739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64378548|NCT04808895|Aspirin|aspirin|mesh-list
64378549|NCT04808895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64378550|NCT04808895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64378551|NCT04808895|Analgesics|analgesics|mesh-ancestor
64378552|NCT04808895|Sensory System Agents|sensory system agents|mesh-ancestor
64378553|NCT04808895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64378554|NCT04808895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378555|NCT04808895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64378556|NCT04808895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64378557|NCT04808895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64378558|NCT04808895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64378559|NCT04808895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378562|NCT04808895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986346|NCT03031483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64986347|NCT03031483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64986348|NCT03031483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64986349|NCT03031483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986350|NCT03031483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986351|NCT03031483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64986352|NCT03031483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64986354|NCT00091650|Antiemetics|antiemetics|mesh-ancestor
64986355|NCT00091650|Autonomic Agents|autonomic agents|mesh-ancestor
64986356|NCT00091650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64986357|NCT00091650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986358|NCT00091650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64986359|NCT00091650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64986360|NCT00091650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64986361|NCT00091650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64986362|NCT00091650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64986363|NCT00091650|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64914715|NCT03721172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64914716|NCT03721172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64914717|NCT03721172|Analgesics|analgesics|mesh-ancestor
64914718|NCT03721172|Sensory System Agents|sensory system agents|mesh-ancestor
64914719|NCT03721172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64914720|NCT03721172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914721|NCT03721172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64914722|NCT03721172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64914723|NCT03721172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64914724|NCT03721172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64914725|NCT03721172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914726|NCT03721172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914727|NCT00846274|Antithrombins|antithrombins|mesh-list
64914728|NCT00846274|Antithrombin III|antithrombin iii|mesh-list
64914729|NCT00846274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64914730|NCT00846274|Protease Inhibitors|protease inhibitors|mesh-ancestor
64914731|NCT00846274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914732|NCT00846274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914733|NCT00846274|Anticoagulants|anticoagulants|mesh-ancestor
64914734|NCT00846235|Glycerol|glycerol|mesh-list
64378586|NCT03107429|Diuretics|diuretics|mesh-ancestor
64378614|NCT03202979|Antidepressive Agents|antidepressive agents|mesh-ancestor
64378616|NCT04799925|Gout Suppressants|gout suppressants|mesh-ancestor
64378617|NCT04799925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64986364|NCT00091650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64986365|NCT00091650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64986366|NCT00091650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986367|NCT00091650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64986368|NCT00091650|Serotonin Agents|serotonin agents|mesh-ancestor
64986369|NCT02645149|Trametinib|trametinib|mesh-list
64986370|NCT02645149|Ceritinib|ceritinib|mesh-list
64986371|NCT02645149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986372|NCT02645149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64986373|NCT02645149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986374|NCT02645149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986375|NCT01808599|Rituximab|rituximab|mesh-list
64986376|NCT01808599|Chlorambucil|chlorambucil|mesh-list
64986385|NCT01691833|Vitamin D|vitamin d|mesh-list
64986386|NCT01691833|Vitamins|vitamins|mesh-ancestor
64986387|NCT01691833|Micronutrients|micronutrients|mesh-ancestor
64914735|NCT00846235|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64914736|NCT00846235|Protective Agents|protective agents|mesh-ancestor
64914737|NCT00846235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914738|NCT00846196|Risedronic Acid|risedronic acid|mesh-list
64914739|NCT00846196|Etidronic Acid|etidronic acid|mesh-list
64914740|NCT00846196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64914741|NCT00846196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64378712|NCT04798443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64378713|NCT04798443|Immunologic Factors|immunologic factors|mesh-ancestor
64378714|NCT04798443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378765|NCT03195569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914742|NCT00846196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914743|NCT00846196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64914744|NCT00846196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914745|NCT00846196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64914746|NCT00846118|Pitavastatin|pitavastatin|mesh-list
64914747|NCT00846118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64914748|NCT00846118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64914749|NCT00846118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64378766|NCT03195569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64986388|NCT01691833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986389|NCT01691833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64986390|NCT00091728|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64986391|NCT00091728|Contraceptive Agents|contraceptive agents|mesh-list
64986392|NCT00091728|Medroxyprogesterone|medroxyprogesterone|mesh-list
64986393|NCT00091728|Contraceptives, Oral|contraceptives, oral|mesh-list
64986394|NCT00091728|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64986395|NCT00091728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64986396|NCT00091728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986397|NCT00091728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64986398|NCT00091728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64986399|NCT00091728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64986400|NCT00091728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64986401|NCT00091728|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64986402|NCT00091728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64986403|NCT00091728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986404|NCT03972488|Octreotide|octreotide|mesh-list
64986405|NCT03972488|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64986406|NCT03972488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64986407|NCT03972488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64986408|NCT03972488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986409|NCT03972488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64986410|NCT03972488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986463|NCT00327730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64986464|NCT00327730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986465|NCT00327730|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64986466|NCT00327730|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64986467|NCT00327730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64986468|NCT00327730|Parasympatholytics|parasympatholytics|mesh-ancestor
64986469|NCT00327730|Autonomic Agents|autonomic agents|mesh-ancestor
64914750|NCT00846118|Antimetabolites|antimetabolites|mesh-ancestor
64914751|NCT00846118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914752|NCT00846118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914753|NCT00846118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64914754|NCT00846079|Regadenoson|regadenoson|mesh-list
64914755|NCT00846079|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64914766|NCT00845962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64914767|NCT00845962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914768|NCT00845962|Sensory System Agents|sensory system agents|mesh-ancestor
64914769|NCT00845962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64914770|NCT03620942|Phenylephrine|phenylephrine|mesh-list
64914771|NCT03620942|Oxymetazoline|oxymetazoline|mesh-list
64914772|NCT03620942|Ephedrine|ephedrine|mesh-list
64914773|NCT03620942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64914774|NCT03620942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64914775|NCT03620942|Mydriatics|mydriatics|mesh-ancestor
64914776|NCT03620942|Autonomic Agents|autonomic agents|mesh-ancestor
64914777|NCT03620942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64914778|NCT03620942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914779|NCT03620942|Sympathomimetics|sympathomimetics|mesh-ancestor
64914780|NCT03620942|Nasal Decongestants|nasal decongestants|mesh-ancestor
64914781|NCT03620942|Respiratory System Agents|respiratory system agents|mesh-ancestor
64914782|NCT03620942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64914783|NCT03620942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64914784|NCT03620942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64914785|NCT03620942|Adrenergic Agents|adrenergic agents|mesh-ancestor
64914786|NCT03620942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64914787|NCT03620942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914788|NCT03620942|Protective Agents|protective agents|mesh-ancestor
64914789|NCT03620942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64914790|NCT00277108|Citalopram|citalopram|mesh-list
64914795|NCT00277108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64914815|NCT03521570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64914816|NCT03521570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378909|NCT04791345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64914818|NCT03521570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914819|NCT00276874|Aripiprazole|aripiprazole|mesh-list
64914820|NCT00276874|Antidepressive Agents|antidepressive agents|mesh-ancestor
64914821|NCT00276874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64914822|NCT00276874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64914823|NCT00276874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64914824|NCT00276874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64914825|NCT00276874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914826|NCT00276874|Dopamine Agonists|dopamine agonists|mesh-ancestor
64914827|NCT00276874|Dopamine Agents|dopamine agents|mesh-ancestor
64914828|NCT00276874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64914829|NCT00276874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914830|NCT00276874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64914831|NCT00276874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64914832|NCT00276874|Serotonin Agents|serotonin agents|mesh-ancestor
64914833|NCT00276874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64914834|NCT00276874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64914835|NCT00276874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64914836|NCT00276874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64914837|NCT00276835|Aldesleukin|aldesleukin|mesh-list
64914862|NCT00276796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64914863|NCT00276796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914864|NCT00276796|Tubulin Modulators|tubulin modulators|mesh-ancestor
64914865|NCT00276796|Antimitotic Agents|antimitotic agents|mesh-ancestor
64914866|NCT00276796|Mitosis Modulators|mitosis modulators|mesh-ancestor
64914867|NCT00276796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914868|NCT00276796|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64914869|NCT00276796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64914870|NCT00276796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914871|NCT00276757|Leucovorin|leucovorin|mesh-list
64914872|NCT00276757|Prednisolone|prednisolone|mesh-list
64914873|NCT00276757|Methotrexate|methotrexate|mesh-list
64914874|NCT00276757|Vinblastine|vinblastine|mesh-list
64914875|NCT00276757|Calcium|calcium|mesh-list
64914876|NCT00276757|Levoleucovorin|levoleucovorin|mesh-list
64914877|NCT00276757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64914879|NCT00276757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64914880|NCT00276757|Abortifacient Agents|abortifacient agents|mesh-ancestor
64914881|NCT00276757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64914882|NCT00276757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64914883|NCT00276757|Antimetabolites|antimetabolites|mesh-ancestor
64914884|NCT00276757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914885|NCT00276757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914886|NCT00276757|Dermatologic Agents|dermatologic agents|mesh-ancestor
64914887|NCT00276757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914888|NCT00276757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64914889|NCT00276757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64914890|NCT00276757|Immunologic Factors|immunologic factors|mesh-ancestor
64914891|NCT00276757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64914907|NCT00276718|Carboplatin|carboplatin|mesh-list
64914908|NCT00276718|Etoposide|etoposide|mesh-list
64914909|NCT00276718|Bleomycin|bleomycin|mesh-list
64914910|NCT00276718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914911|NCT00276718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64914912|NCT00276718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64914913|NCT00276718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64914914|NCT00276718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914915|NCT00276718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914916|NCT00276718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64914917|NCT00276679|Temozolomide|temozolomide|mesh-list
64914918|NCT00276679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64914919|NCT00276679|Alkylating Agents|alkylating agents|mesh-ancestor
64914920|NCT00276679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914921|NCT00276679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914922|NCT00276640|Carboplatin|carboplatin|mesh-list
64914923|NCT00276640|Etoposide|etoposide|mesh-list
64914924|NCT00276640|Vincristine|vincristine|mesh-list
64914925|NCT00276640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379048|NCT04790331|Vasodilator Agents|vasodilator agents|mesh-ancestor
64379049|NCT04790331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64379050|NCT04789941|Irinotecan|irinotecan|mesh-list
64379051|NCT04789941|Cisplatin|cisplatin|mesh-list
64986470|NCT00327730|Vasodilator Agents|vasodilator agents|mesh-ancestor
64986471|NCT04716868|Levan|levan|mesh-list
64914926|NCT00276640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64914927|NCT00276640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64914928|NCT00276640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64914930|NCT00276640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914931|NCT00276640|Tubulin Modulators|tubulin modulators|mesh-ancestor
64914932|NCT00276640|Antimitotic Agents|antimitotic agents|mesh-ancestor
64914933|NCT00276640|Mitosis Modulators|mitosis modulators|mesh-ancestor
64914934|NCT00276601|Cytarabine|cytarabine|mesh-list
64914935|NCT00276601|Methotrexate|methotrexate|mesh-list
64914936|NCT00276601|Mercaptopurine|mercaptopurine|mesh-list
64914954|NCT00276601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64914955|NCT00276601|Antiviral Agents|antiviral agents|mesh-ancestor
64914956|NCT00276601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64914957|NCT00276601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64914958|NCT00276601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64914959|NCT00276601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64914960|NCT00276601|Keratolytic Agents|keratolytic agents|mesh-ancestor
64379090|NCT03016533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986472|NCT04716868|Psyllium|psyllium|mesh-list
64986473|NCT04716868|Cathartics|cathartics|mesh-ancestor
64986623|NCT00315874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64986624|NCT00315874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986625|NCT00315874|Analgesics|analgesics|mesh-ancestor
64986629|NCT00315913|Propranolol|propranolol|mesh-list
64986656|NCT00092313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64986657|NCT00092313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64986658|NCT00399971|Immunologic Factors|immunologic factors|mesh-list
64986659|NCT00399971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986661|NCT00316030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986662|NCT00123552|Artesunate|artesunate|mesh-list
64986663|NCT00123552|Lumefantrine|lumefantrine|mesh-list
64986664|NCT00123552|Artemether|artemether|mesh-list
64986665|NCT00123552|Pyrimethamine|pyrimethamine|mesh-list
64986666|NCT00123552|Sulfadoxine|sulfadoxine|mesh-list
64986667|NCT00123552|Amodiaquine|amodiaquine|mesh-list
64986668|NCT00123552|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64986669|NCT00123552|Antimalarials|antimalarials|mesh-ancestor
64986670|NCT00123552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64986671|NCT00123552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64986672|NCT00123552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64986673|NCT00123552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986674|NCT00123552|Antiviral Agents|antiviral agents|mesh-ancestor
64986786|NCT03272477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64986787|NCT03272477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64986788|NCT03272477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64986789|NCT03272477|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64986790|NCT03272477|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64986791|NCT03272477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64986792|NCT03272477|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64986793|NCT03272477|Fertility Agents|fertility agents|mesh-ancestor
64986795|NCT02959957|Cefotaxime|cefotaxime|mesh-list
64986832|NCT00123669|Progestins|progestins|mesh-ancestor
64986833|NCT00123669|Hormones|hormones|mesh-ancestor
64986834|NCT00123669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64986835|NCT00123669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986836|NCT00123669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64986837|NCT00123669|Hormone Antagonists|hormone antagonists|mesh-ancestor
64986838|NCT00317200|Paclitaxel|paclitaxel|mesh-list
64986839|NCT00317200|Bevacizumab|bevacizumab|mesh-list
64914961|NCT00276523|Interferons|interferons|mesh-list
64914962|NCT00276523|Interferon-alpha|interferon-alpha|mesh-list
64914963|NCT00276523|Interferon alpha-2|interferon alpha-2|mesh-list
64914964|NCT00276523|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64914965|NCT00276523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914966|NCT00276523|Antiviral Agents|antiviral agents|mesh-ancestor
64914967|NCT00276523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64914968|NCT00276523|Immunologic Factors|immunologic factors|mesh-ancestor
64914969|NCT00276523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914970|NCT00276445|Beta-1,3-glucan|beta-1,3-glucan|mesh-list
64914971|NCT00276445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64914972|NCT00276445|Immunologic Factors|immunologic factors|mesh-ancestor
64914973|NCT00276445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914974|NCT00276406|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
64914975|NCT00276406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64914976|NCT00276406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914977|NCT00276406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915003|NCT00276250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64915004|NCT00276250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915005|NCT00276250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915006|NCT00276250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64915007|NCT00276250|Immunologic Factors|immunologic factors|mesh-ancestor
64915008|NCT00276250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915009|NCT00276250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64915010|NCT00394186|Solabegron|solabegron|mesh-list
64915011|NCT00394186|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64915012|NCT00394186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64915013|NCT00394186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64915014|NCT00394186|Adrenergic Agents|adrenergic agents|mesh-ancestor
64915015|NCT00394186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64915018|NCT00276172|Natalizumab|natalizumab|mesh-list
64379232|NCT05474937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64379233|NCT05474937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64379234|NCT05474937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64379235|NCT05474937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379236|NCT05474937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64379237|NCT05474937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64379238|NCT05474937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64379239|NCT05474937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64915019|NCT00276172|Immunologic Factors|immunologic factors|mesh-ancestor
64915020|NCT00276172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915021|NCT00276133|Atorvastatin|atorvastatin|mesh-list
64915022|NCT00276133|Probucol|probucol|mesh-list
64915023|NCT00276133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64915024|NCT00276133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64915025|NCT00276133|Antimetabolites|antimetabolites|mesh-ancestor
64915026|NCT00276133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915027|NCT00276133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64379240|NCT05474937|GABA Modulators|gaba modulators|mesh-ancestor
64379241|NCT05474937|GABA Agents|gaba agents|mesh-ancestor
64379242|NCT05474937|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64986840|NCT00317200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64986841|NCT00317200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986842|NCT00317200|Tubulin Modulators|tubulin modulators|mesh-ancestor
64986843|NCT00317200|Antimitotic Agents|antimitotic agents|mesh-ancestor
64986844|NCT00317200|Mitosis Modulators|mitosis modulators|mesh-ancestor
64986894|NCT02571725|Tremelimumab|tremelimumab|mesh-list
64986905|NCT00328549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986907|NCT00092508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64986908|NCT00092508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64986909|NCT00092508|Analgesics|analgesics|mesh-ancestor
64986910|NCT00092508|Sensory System Agents|sensory system agents|mesh-ancestor
64986911|NCT00092508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64986912|NCT00092508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986913|NCT00092508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64986914|NCT00092508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64986915|NCT00328822|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64986916|NCT00328822|Antidepressive Agents|antidepressive agents|mesh-ancestor
64986917|NCT00328822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64986918|NCT00328822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64986919|NCT00328822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64986920|NCT00328822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64986922|NCT00420043|Imatinib Mesylate|imatinib mesylate|mesh-list
64986938|NCT01821833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64986939|NCT01821833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986940|NCT01821833|Tubulin Modulators|tubulin modulators|mesh-ancestor
64986941|NCT01821833|Antimitotic Agents|antimitotic agents|mesh-ancestor
64986942|NCT01821833|Mitosis Modulators|mitosis modulators|mesh-ancestor
64986943|NCT01821833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986945|NCT00328900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64986946|NCT00328900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64986947|NCT00328900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64986948|NCT00328900|Autonomic Agents|autonomic agents|mesh-ancestor
64915028|NCT00276133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64915029|NCT00276133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915030|NCT00276133|Antioxidants|antioxidants|mesh-ancestor
64915035|NCT00276055|Docetaxel|docetaxel|mesh-list
64915047|NCT00276055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64915048|NCT00276055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915049|NCT00276055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64915050|NCT00276055|Immunologic Factors|immunologic factors|mesh-ancestor
64915051|NCT00276055|Tubulin Modulators|tubulin modulators|mesh-ancestor
64915052|NCT00276055|Antimitotic Agents|antimitotic agents|mesh-ancestor
64915053|NCT00276055|Mitosis Modulators|mitosis modulators|mesh-ancestor
64915054|NCT00275938|Interferons|interferons|mesh-list
64915055|NCT00275938|Ribavirin|ribavirin|mesh-list
64915056|NCT00275938|Interferon-alpha|interferon-alpha|mesh-list
64915057|NCT00275938|Interferon alpha-2|interferon alpha-2|mesh-list
64379377|NCT05611593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64379378|NCT05611593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379379|NCT05611593|Hormone Antagonists|hormone antagonists|mesh-ancestor
64379380|NCT05611593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64379381|NCT05611593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379382|NCT05611593|Urological Agents|urological agents|mesh-ancestor
64379383|NCT05612451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64379384|NCT05612451|Calcium|calcium|mesh-list
64379385|NCT05612451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64379386|NCT05612451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915058|NCT00275938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915059|NCT00275938|Antiviral Agents|antiviral agents|mesh-ancestor
64915060|NCT00275938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64915061|NCT00275938|Antimetabolites|antimetabolites|mesh-ancestor
64915062|NCT00275938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915063|NCT00275938|Immunologic Factors|immunologic factors|mesh-ancestor
64915064|NCT00275938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915065|NCT00275665|Valganciclovir|valganciclovir|mesh-list
64915066|NCT00275665|Antiviral Agents|antiviral agents|mesh-ancestor
64915067|NCT00275665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64915071|NCT00275548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915072|NCT00275548|Antiviral Agents|antiviral agents|mesh-ancestor
64915073|NCT00275548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64915074|NCT00275431|Gossypol acetic acid|gossypol acetic acid|mesh-list
64915075|NCT00275431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64915076|NCT00275431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683541|NCT02975219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915077|NCT00275431|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64915089|NCT03152318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64915090|NCT03152318|Alkylating Agents|alkylating agents|mesh-ancestor
64915091|NCT03152318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915092|NCT03152318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915093|NCT03152318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64915094|NCT05566054|Azacitidine|azacitidine|mesh-list
64915095|NCT05566054|Venetoclax|venetoclax|mesh-list
64915096|NCT05566054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64915097|NCT05566054|Antimetabolites|antimetabolites|mesh-ancestor
64915098|NCT05566054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915099|NCT05566054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915100|NCT05566054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915101|NCT05565430|Cholinergic Antagonists|cholinergic antagonists|mesh-list
64915102|NCT05565430|Cholinergic Agents|cholinergic agents|mesh-ancestor
64915103|NCT05565430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64915104|NCT05565430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915105|NCT05565430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915106|NCT03089606|Pembrolizumab|pembrolizumab|mesh-list
64915107|NCT03089606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64379408|NCT05350215|Adrenergic Agents|adrenergic agents|mesh-ancestor
64915108|NCT03089606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379409|NCT05350215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64379410|NCT05350215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379411|NCT04331691|Amiloride|amiloride|mesh-list
64379412|NCT04331691|Spironolactone|spironolactone|mesh-list
64379447|NCT05304273|Contraceptive Agents|contraceptive agents|mesh-ancestor
64915109|NCT05140746|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64915110|NCT05140746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64915111|NCT05140746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915112|NCT02979977|Cetuximab|cetuximab|mesh-list
64915113|NCT02979977|Afatinib|afatinib|mesh-list
64915114|NCT02979977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64915115|NCT02979977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915116|NCT02979977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64915117|NCT02979977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915119|NCT05424757|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64915133|NCT02921555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64379487|NCT05610969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379489|NCT05557149|Anesthetics, Local|anesthetics, local|mesh-ancestor
64986949|NCT00328900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64986950|NCT00328900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986951|NCT00328900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64986952|NCT00328900|Respiratory System Agents|respiratory system agents|mesh-ancestor
64986953|NCT00328900|Mydriatics|mydriatics|mesh-ancestor
64986954|NCT00328900|Parasympatholytics|parasympatholytics|mesh-ancestor
64986955|NCT00328900|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64986956|NCT00328900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64986957|NCT00328900|Cholinergic Agents|cholinergic agents|mesh-ancestor
64986958|NCT00328900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64986959|NCT00328900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986960|NCT00328939|Enoxaparin|enoxaparin|mesh-list
64986962|NCT00328939|Fondaparinux|fondaparinux|mesh-list
64986963|NCT00328939|Anticoagulants|anticoagulants|mesh-ancestor
64986964|NCT00328939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64986965|NCT00328939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64986966|NCT00328939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986967|NCT00328939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64986968|NCT00328939|Antithrombins|antithrombins|mesh-ancestor
64986970|NCT00328939|Protease Inhibitors|protease inhibitors|mesh-ancestor
64986982|NCT00329095|Latanoprost|latanoprost|mesh-list
64986983|NCT00329095|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64986984|NCT00329095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64986985|NCT00329134|Quinine|quinine|mesh-list
64986986|NCT00329134|Antimalarials|antimalarials|mesh-ancestor
64986987|NCT00329134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64986988|NCT00329134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64987161|NCT00093093|Interferon-alpha|interferon-alpha|mesh-list
64987162|NCT00093093|Interferon alpha-2|interferon alpha-2|mesh-list
64987163|NCT00093093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64987164|NCT00093093|Taribavirin|taribavirin|mesh-list
64987165|NCT00093093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987166|NCT00093093|Antiviral Agents|antiviral agents|mesh-ancestor
64987167|NCT00093093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64987168|NCT00093093|Antimetabolites|antimetabolites|mesh-ancestor
64987169|NCT00093093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987170|NCT00093093|Immunologic Factors|immunologic factors|mesh-ancestor
64987171|NCT00093093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987172|NCT00330304|Isoniazid|isoniazid|mesh-list
64987203|NCT00330577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64987204|NCT00330577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987205|NCT00330577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64987206|NCT00330577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64987207|NCT00330577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64987208|NCT00330577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64987210|NCT00083993|Letrozole|letrozole|mesh-list
64987211|NCT00083993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915134|NCT02921555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379723|NCT05558319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64379724|NCT05558319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64379742|NCT05553717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64379744|NCT05553717|Vasodilator Agents|vasodilator agents|mesh-ancestor
64379745|NCT05553717|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64379746|NCT05553717|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64379747|NCT02147158|Ulipristal acetate|ulipristal acetate|mesh-list
64379748|NCT02147158|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64379749|NCT02147158|Contraceptive Agents|contraceptive agents|mesh-ancestor
64379750|NCT02147158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64915135|NCT02921555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64379751|NCT02147158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379752|NCT02147158|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64915136|NCT02921555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915137|NCT02921555|Antiemetics|antiemetics|mesh-ancestor
64915138|NCT02921555|Autonomic Agents|autonomic agents|mesh-ancestor
64915139|NCT02921555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64915140|NCT02921555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64915141|NCT02921555|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64915142|NCT02921555|Protective Agents|protective agents|mesh-ancestor
64915143|NCT05327530|Avelumab|avelumab|mesh-list
64915144|NCT05327530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64915145|NCT05327530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915146|NCT05262556|Nivolumab|nivolumab|mesh-list
64915147|NCT05262556|Ipilimumab|ipilimumab|mesh-list
64379756|NCT05553093|Tirzepatide|tirzepatide|mesh-list
64987212|NCT00083993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64987213|NCT00083993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64987214|NCT00083993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987215|NCT00083993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987216|NCT00083993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64987217|NCT00083993|Hormone Antagonists|hormone antagonists|mesh-ancestor
64987218|NCT00083993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64987219|NCT00083993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987466|NCT00324766|Protective Agents|protective agents|mesh-ancestor
64987467|NCT00324766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987468|NCT00084578|Rosiglitazone|rosiglitazone|mesh-list
64987469|NCT00084578|Celecoxib|celecoxib|mesh-list
64987470|NCT00084578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64987471|NCT00084578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64987472|NCT00084578|Analgesics|analgesics|mesh-ancestor
64987473|NCT00084578|Sensory System Agents|sensory system agents|mesh-ancestor
64987530|NCT00084695|Methylprednisolone|methylprednisolone|mesh-list
64987531|NCT00084695|Cyclophosphamide|cyclophosphamide|mesh-list
64987532|NCT00084695|Melphalan|melphalan|mesh-list
64987533|NCT00084695|Busulfan|busulfan|mesh-list
64915148|NCT05262556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64915149|NCT05262556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915150|NCT05262556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64915151|NCT05262556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915152|NCT05070585|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
64915153|NCT05070585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915154|NCT05070585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915155|NCT05070585|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64915156|NCT05070585|Protective Agents|protective agents|mesh-ancestor
64915157|NCT05070585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915158|NCT05070585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915160|NCT00387530|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64915161|NCT00387530|Antiviral Agents|antiviral agents|mesh-ancestor
64915162|NCT00387530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64915163|NCT00387530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915164|NCT02687906|Meropenem|meropenem|mesh-list
64915175|NCT00390000|Vatalanib|vatalanib|mesh-list
64915176|NCT00390000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915177|NCT00390000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915178|NCT00390000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915179|NCT00390000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64915180|NCT00390000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64915181|NCT00390000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64915182|NCT04856176|Paclitaxel|paclitaxel|mesh-list
64915183|NCT04856176|Carboplatin|carboplatin|mesh-list
64915184|NCT04856176|Pembrolizumab|pembrolizumab|mesh-list
64915185|NCT04856176|Pemetrexed|pemetrexed|mesh-list
64915186|NCT04856176|Molgramostim|molgramostim|mesh-list
64915187|NCT04856176|Sargramostim|sargramostim|mesh-list
64915188|NCT04856176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64915189|NCT04856176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915190|NCT04856176|Tubulin Modulators|tubulin modulators|mesh-ancestor
64379780|NCT04757740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379781|NCT04757740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64987534|NCT00084695|Fludarabine|fludarabine|mesh-list
64987535|NCT00084695|Fludarabine phosphate|fludarabine phosphate|mesh-list
64987554|NCT00084695|Hormones|hormones|mesh-ancestor
64987566|NCT00093483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987567|NCT00093483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987568|NCT00093483|Antiviral Agents|antiviral agents|mesh-ancestor
64987569|NCT00093483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64915191|NCT04856176|Antimitotic Agents|antimitotic agents|mesh-ancestor
64915192|NCT04856176|Mitosis Modulators|mitosis modulators|mesh-ancestor
64915193|NCT04856176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915194|NCT04856176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64915195|NCT04856176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915196|NCT04856176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64915197|NCT04856176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64915198|NCT04856176|Immunologic Factors|immunologic factors|mesh-ancestor
64915199|NCT04856176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915200|NCT02632760|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
64915201|NCT02632760|Hematinics|hematinics|mesh-ancestor
64915202|NCT04732507|Lidocaine|lidocaine|mesh-list
64915203|NCT04732507|Bupivacaine|bupivacaine|mesh-list
64915223|NCT04599478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64987570|NCT00093483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64987571|NCT00093483|Immunologic Factors|immunologic factors|mesh-ancestor
64987572|NCT00093483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987573|NCT00093483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64987574|NCT00093483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64987575|NCT00093483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64987576|NCT00093483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987577|NCT00084734|Docetaxel|docetaxel|mesh-list
64987578|NCT00084734|Capecitabine|capecitabine|mesh-list
64987579|NCT00084734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987580|NCT00084734|Tubulin Modulators|tubulin modulators|mesh-ancestor
64987581|NCT00084734|Antimitotic Agents|antimitotic agents|mesh-ancestor
64987582|NCT00084734|Mitosis Modulators|mitosis modulators|mesh-ancestor
64987583|NCT00084734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987621|NCT00084773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987622|NCT00084773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64987623|NCT00325546|Rimonabant|rimonabant|mesh-list
64987624|NCT00325546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64987671|NCT00084890|Antimitotic Agents|antimitotic agents|mesh-ancestor
64987672|NCT00084890|Mitosis Modulators|mitosis modulators|mesh-ancestor
64987673|NCT00084890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987674|NCT00318838|Azimilide|azimilide|mesh-list
64987675|NCT00318838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64987676|NCT00318838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64987677|NCT00318838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64987678|NCT00318838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987679|NCT00318838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64987680|NCT00318838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987681|NCT00085124|Cytarabine|cytarabine|mesh-list
64987682|NCT00085124|Daunorubicin|daunorubicin|mesh-list
64987883|NCT00319306|Glucocorticoids|glucocorticoids|mesh-ancestor
64987884|NCT00319306|Hormones|hormones|mesh-ancestor
64987885|NCT00319306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64987886|NCT00319306|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64987887|NCT00319306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64987888|NCT00319306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64987889|NCT00319306|Adrenergic Agents|adrenergic agents|mesh-ancestor
64987890|NCT00319306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64987891|NCT00319306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987892|NCT00085358|Paclitaxel|paclitaxel|mesh-list
64987893|NCT00085358|Docetaxel|docetaxel|mesh-list
64987894|NCT00085358|Bevacizumab|bevacizumab|mesh-list
64987895|NCT00085358|Carboplatin|carboplatin|mesh-list
64987896|NCT00085358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64987897|NCT00085358|Antibodies|antibodies|mesh-list
64987898|NCT00085358|Immunoglobulins|immunoglobulins|mesh-list
64915224|NCT04599478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915225|NCT04599478|Sensory System Agents|sensory system agents|mesh-ancestor
64915226|NCT04599478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64915227|NCT04599478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64683692|NCT04342247|Testosterone|testosterone|mesh-list
64915228|NCT04599478|Antidepressive Agents|antidepressive agents|mesh-ancestor
64915229|NCT04599478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64915230|NCT04599478|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64915231|NCT04599478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64915232|NCT04599478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64915233|NCT04599478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915234|NCT04599478|Dopamine Agents|dopamine agents|mesh-ancestor
64915235|NCT04599478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64915236|NCT04599478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64915237|NCT04599478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64915238|NCT04599478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380114|NCT05546853|Irinotecan|irinotecan|mesh-list
64987899|NCT00085358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64987900|NCT00085358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64987901|NCT00085358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987902|NCT00085358|Tubulin Modulators|tubulin modulators|mesh-ancestor
64987903|NCT00085358|Antimitotic Agents|antimitotic agents|mesh-ancestor
64987904|NCT00085358|Mitosis Modulators|mitosis modulators|mesh-ancestor
64987905|NCT00085358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988039|NCT00085748|Dopamine Agents|dopamine agents|mesh-ancestor
64988041|NCT04717102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64988043|NCT04717102|Anesthetics|anesthetics|mesh-ancestor
64988089|NCT00327106|Coagulants|coagulants|mesh-ancestor
64988090|NCT00320359|Cisplatin|cisplatin|mesh-list
64988091|NCT00320359|Etoposide|etoposide|mesh-list
64988092|NCT00320359|Topotecan|topotecan|mesh-list
64988093|NCT00320359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988094|NCT00320359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64988095|NCT00320359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64988096|NCT00320359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64988097|NCT00320359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988098|NCT00320359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988099|NCT00320359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64988100|NCT00093912|Nitroprusside|nitroprusside|mesh-list
64988101|NCT00093912|Clevidipine|clevidipine|mesh-list
64915239|NCT04556617|Prednisone|prednisone|mesh-list
64915240|NCT04556617|Olaparib|olaparib|mesh-list
64915241|NCT04556617|Abiraterone Acetate|abiraterone acetate|mesh-list
64915242|NCT04556617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64915243|NCT04556617|Glucocorticoids|glucocorticoids|mesh-ancestor
64915244|NCT04556617|Hormones|hormones|mesh-ancestor
64915245|NCT04556617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64915246|NCT04556617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915266|NCT04554862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64915267|NCT04554862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915268|NCT04554862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915269|NCT04554862|Anesthetics|anesthetics|mesh-ancestor
64915270|NCT04554862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64915271|NCT04554862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64915272|NCT04554862|Anticonvulsants|anticonvulsants|mesh-ancestor
64915273|NCT04554862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64915274|NCT04554862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64915275|NCT04554862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64915276|NCT04554862|Tocolytic Agents|tocolytic agents|mesh-ancestor
64915277|NCT04554862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64915278|NCT02337686|Pembrolizumab|pembrolizumab|mesh-list
64915279|NCT02337686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64380149|NCT05592327|Chelating Agents|chelating agents|mesh-ancestor
64915280|NCT02337686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915281|NCT04379713|Vaccines|vaccines|mesh-list
64915283|NCT04379713|Immunologic Factors|immunologic factors|mesh-ancestor
64915324|NCT04712357|Tenofovir|tenofovir|mesh-list
64915325|NCT04712357|Emtricitabine|emtricitabine|mesh-list
64915326|NCT04712357|Antiviral Agents|antiviral agents|mesh-ancestor
64915327|NCT04712357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64915328|NCT04712357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64915331|NCT04712357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915332|NCT04712357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64915333|NCT04712357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64915334|NCT00390039|Morphine|morphine|mesh-list
64915335|NCT00390039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64915336|NCT00390039|Narcotics|narcotics|mesh-ancestor
64915337|NCT00390039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64915338|NCT00390039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915339|NCT00390039|Analgesics|analgesics|mesh-ancestor
64915340|NCT00390039|Sensory System Agents|sensory system agents|mesh-ancestor
64915341|NCT00390039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64915342|NCT02966665|Vitamins|vitamins|mesh-list
64915343|NCT02966665|Vitamin E|vitamin e|mesh-list
64915344|NCT02966665|Thioctic Acid|thioctic acid|mesh-list
64915345|NCT02966665|Fexofenadine|fexofenadine|mesh-list
64915346|NCT02966665|Valsartan|valsartan|mesh-list
64915347|NCT02966665|Nitroprusside|nitroprusside|mesh-list
64915348|NCT02966665|Phentolamine|phentolamine|mesh-list
64915349|NCT02966665|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
64915350|NCT02966665|Norepinephrine|norepinephrine|mesh-list
64915351|NCT02966665|Angiotensin II|angiotensin ii|mesh-list
64915352|NCT02966665|Giapreza|giapreza|mesh-list
64380198|NCT01666119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64380199|NCT01666119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380200|NCT01666119|Analgesics|analgesics|mesh-ancestor
64380201|NCT01666119|Sensory System Agents|sensory system agents|mesh-ancestor
64380202|NCT01666119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64380203|NCT01666119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64380204|NCT05361993|Aripiprazole|aripiprazole|mesh-list
64380205|NCT05361993|Antidepressive Agents|antidepressive agents|mesh-ancestor
64380206|NCT05361993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64380207|NCT05361993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64988102|NCT00093912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64988103|NCT00093912|Vasodilator Agents|vasodilator agents|mesh-ancestor
64988104|NCT00093912|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64988105|NCT00093912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988106|NCT00093912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64988107|NCT00093912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64988108|NCT00093912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64988109|NCT00093912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988110|NCT00327145|Amlodipine|amlodipine|mesh-list
64988111|NCT00327145|Valsartan|valsartan|mesh-list
64988141|NCT00085943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64988142|NCT00327184|PENTA|penta|mesh-list
64988143|NCT00327184|Anticoagulants|anticoagulants|mesh-ancestor
64988144|NCT00327184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64988145|NCT00327184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64988146|NCT00327184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915353|NCT02966665|Acetylcholine|acetylcholine|mesh-list
64915354|NCT02966665|Ranitidine|ranitidine|mesh-list
64915355|NCT02966665|Angiotensinogen|angiotensinogen|mesh-list
64915356|NCT02966665|Micronutrients|micronutrients|mesh-ancestor
64915357|NCT02966665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915358|NCT02966665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64915360|NCT02966665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64915369|NCT02966665|Autonomic Agents|autonomic agents|mesh-ancestor
64915370|NCT02966665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64915371|NCT02966665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64915372|NCT02966665|Vitamin B Complex|vitamin b complex|mesh-ancestor
64915373|NCT02966665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64915374|NCT02966665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64915375|NCT02966665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64915376|NCT02966665|Histamine Antagonists|histamine antagonists|mesh-ancestor
64915377|NCT02966665|Histamine Agents|histamine agents|mesh-ancestor
64915378|NCT02966665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64915379|NCT02966665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64915380|NCT02966665|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64915381|NCT02966665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64915382|NCT02966665|Protease Inhibitors|protease inhibitors|mesh-ancestor
64915383|NCT02966665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915384|NCT02966665|Vasodilator Agents|vasodilator agents|mesh-ancestor
64915385|NCT02966665|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64915386|NCT02966665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64915387|NCT02966665|Cholinergic Agents|cholinergic agents|mesh-ancestor
64915388|NCT02966665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64915389|NCT02966665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64915390|NCT02966665|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64988147|NCT00419302|Insulin|insulin|mesh-list
64915391|NCT02832544|Vitamin K|vitamin k|mesh-list
64915392|NCT02832544|Warfarin|warfarin|mesh-list
64915393|NCT02832544|Rivaroxaban|rivaroxaban|mesh-list
64915394|NCT02832544|Vitamins|vitamins|mesh-ancestor
64915395|NCT02832544|Micronutrients|micronutrients|mesh-ancestor
64915396|NCT02832544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915397|NCT02832544|Anticoagulants|anticoagulants|mesh-ancestor
64915398|NCT02832544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64915417|NCT02490241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915419|NCT02490241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64915420|NCT02490241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64380337|NCT03784677|SOR-C13|sor-c13|mesh-list
64380338|NCT03784677|Calcium|calcium|mesh-list
64380339|NCT03784677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64380340|NCT03784677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380341|NCT03784677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380342|NCT03784677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64380343|NCT03784677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64380371|NCT02584257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988148|NCT00419302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64988149|NCT00419302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988166|NCT00327262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988167|NCT00093990|Tipifarnib|tipifarnib|mesh-list
64988168|NCT00093990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988169|NCT00327379|Aprotinin|aprotinin|mesh-list
64988187|NCT00094029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64988188|NCT00094029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64988189|NCT00094029|Growth Substances|growth substances|mesh-ancestor
64988190|NCT00094029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988191|NCT00094029|Growth Inhibitors|growth inhibitors|mesh-ancestor
64988192|NCT00094029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64988193|NCT00094029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988194|NCT00094029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988195|NCT00086099|Amifostine|amifostine|mesh-list
64988196|NCT00086099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64988197|NCT00086099|Protective Agents|protective agents|mesh-ancestor
64988198|NCT00086099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988199|NCT00320632|Desipramine|desipramine|mesh-list
64988200|NCT00320632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64988201|NCT00320632|Antidepressive Agents|antidepressive agents|mesh-ancestor
64988202|NCT00320632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64988203|NCT00320632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988204|NCT00320632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988205|NCT00320632|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64988211|NCT00320827|Antibodies|antibodies|mesh-list
64988240|NCT00094146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988241|NCT00086255|Tiagabine|tiagabine|mesh-list
64988242|NCT00086255|Anticonvulsants|anticonvulsants|mesh-ancestor
64988243|NCT00086255|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
64988244|NCT00086255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64988245|NCT00086255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64988246|NCT00086255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988247|NCT00086255|GABA Agents|gaba agents|mesh-ancestor
64988248|NCT00086255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64988249|NCT00086255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988250|NCT00321178|Clarithromycin|clarithromycin|mesh-list
64915421|NCT02490241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915422|NCT02395705|Paclitaxel|paclitaxel|mesh-list
64915423|NCT02395705|Cisplatin|cisplatin|mesh-list
64915424|NCT02395705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64915425|NCT02395705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915426|NCT02395705|Tubulin Modulators|tubulin modulators|mesh-ancestor
64915427|NCT02395705|Antimitotic Agents|antimitotic agents|mesh-ancestor
64915428|NCT02395705|Mitosis Modulators|mitosis modulators|mesh-ancestor
64915429|NCT02395705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915430|NCT00006047|Etoposide|etoposide|mesh-list
64915431|NCT00006047|Rubitecan|rubitecan|mesh-list
64915432|NCT00006047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
64915433|NCT00006047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64915434|NCT00006047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915435|NCT00006047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64915436|NCT00006047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64915437|NCT00006047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915438|NCT00006047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915439|NCT00083824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64915440|NCT00083824|Medroxyprogesterone|medroxyprogesterone|mesh-list
64380497|NCT03569085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64380498|NCT03569085|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64380500|NCT03569085|Anesthetics|anesthetics|mesh-ancestor
64988251|NCT00321178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64988252|NCT00321178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64988253|NCT00321178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64988254|NCT00321178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988256|NCT00321178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64988296|NCT05458180|Prednisone|prednisone|mesh-list
64988297|NCT05458180|Cyclophosphamide|cyclophosphamide|mesh-list
64988299|NCT05458180|Vincristine|vincristine|mesh-list
64988354|NCT00094341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64988355|NCT00094341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988356|NCT00094341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64988357|NCT00094341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64988358|NCT00094341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64988359|NCT00094341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64988360|NCT00094341|Immunologic Factors|immunologic factors|mesh-ancestor
64988362|NCT00086489|Ipilimumab|ipilimumab|mesh-list
64988363|NCT00086489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988364|NCT00086489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64988365|NCT00086489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64988366|NCT00086489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988367|NCT00094380|Cyclophosphamide|cyclophosphamide|mesh-list
64988368|NCT00094380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64988369|NCT00094380|Immunologic Factors|immunologic factors|mesh-ancestor
64988370|NCT00094380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988371|NCT00094380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64988372|NCT00094380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64988373|NCT00094380|Alkylating Agents|alkylating agents|mesh-ancestor
64988374|NCT00094380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915441|NCT00083824|Estrogens|estrogens|mesh-list
64915442|NCT00083824|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64915443|NCT00083824|Hormones|hormones|mesh-ancestor
64915444|NCT00083824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64915445|NCT00083824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380608|NCT02581995|Growth Substances|growth substances|mesh-ancestor
64380609|NCT02581995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380638|NCT03192527|Contraceptive Agents|contraceptive agents|mesh-ancestor
64380639|NCT03192527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64380641|NCT03192527|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64380642|NCT03192527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64380643|NCT03192527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380644|NCT02444351|Botulinum Toxins|botulinum toxins|mesh-list
64380645|NCT02444351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64915446|NCT00083824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64915457|NCT00083902|Dexamethasone|dexamethasone|mesh-list
64915458|NCT00083902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64915459|NCT00083902|Antiemetics|antiemetics|mesh-ancestor
64915460|NCT00083902|Autonomic Agents|autonomic agents|mesh-ancestor
64915461|NCT00083902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64915462|NCT00083902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915463|NCT00083902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64915464|NCT00083902|Glucocorticoids|glucocorticoids|mesh-ancestor
64915465|NCT00083902|Hormones|hormones|mesh-ancestor
64380646|NCT02444351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64380647|NCT02444351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64380648|NCT02444351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64380687|NCT05676411|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64988375|NCT00094380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988376|NCT00094380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64988377|NCT00321490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64988458|NCT00086645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64988459|NCT00086645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988460|NCT00086645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64988461|NCT00086645|Serotonin Agents|serotonin agents|mesh-ancestor
64988462|NCT00086645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988463|NCT00086645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64988464|NCT00086645|Antidepressive Agents|antidepressive agents|mesh-ancestor
64988465|NCT00086645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64988466|NCT00086645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64988467|NCT00086645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64988468|NCT00086645|Parasympatholytics|parasympatholytics|mesh-ancestor
64988469|NCT00086645|Autonomic Agents|autonomic agents|mesh-ancestor
64988470|NCT00086645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64988471|NCT00086645|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64988472|NCT00086645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64915466|NCT00083902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64915467|NCT00083902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64915468|NCT00083902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915469|NCT00083902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64915470|NCT00083902|Immunologic Factors|immunologic factors|mesh-ancestor
64915471|NCT00083902|Leprostatic Agents|leprostatic agents|mesh-ancestor
64915472|NCT00083902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64915473|NCT00083902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64915474|NCT00083902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64915475|NCT00083902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64915476|NCT00083902|Growth Substances|growth substances|mesh-ancestor
64915477|NCT00083902|Growth Inhibitors|growth inhibitors|mesh-ancestor
64915478|NCT00006050|Leucovorin|leucovorin|mesh-list
64915479|NCT00006050|Fluorouracil|fluorouracil|mesh-list
64915480|NCT00006050|Oxaliplatin|oxaliplatin|mesh-list
64915481|NCT00006050|Calcium|calcium|mesh-list
64915482|NCT00006050|Levoleucovorin|levoleucovorin|mesh-list
64915483|NCT00006050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64915484|NCT00006050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915485|NCT00006050|Antimetabolites|antimetabolites|mesh-ancestor
64915486|NCT00006050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915487|NCT00006050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64915491|NCT00006050|Antidotes|antidotes|mesh-ancestor
64915500|NCT00083980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915501|NCT00083980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64380840|NCT03192293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380841|NCT03192293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64988473|NCT00086645|Cholinergic Agents|cholinergic agents|mesh-ancestor
64988474|NCT00321802|Simvastatin|simvastatin|mesh-list
64988475|NCT00321802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64988476|NCT00321802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64988494|NCT05457361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64988495|NCT05457361|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64988496|NCT00086801|Gemcitabine|gemcitabine|mesh-list
64988497|NCT00086801|Doxorubicin|doxorubicin|mesh-list
64988498|NCT00086801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64988499|NCT00086801|Vinblastine|vinblastine|mesh-list
64988500|NCT00086801|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64988501|NCT00086801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64988502|NCT00086801|Antimetabolites|antimetabolites|mesh-ancestor
64988612|NCT00094614|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64988613|NCT00094614|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64988615|NCT00094614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64988616|NCT00094614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988617|NCT00087035|Docetaxel|docetaxel|mesh-list
64988618|NCT00087035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64988619|NCT00087035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988620|NCT00087035|Tubulin Modulators|tubulin modulators|mesh-ancestor
64915502|NCT00083980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915503|NCT00083980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64915504|NCT00083980|Antidepressive Agents|antidepressive agents|mesh-ancestor
64915505|NCT00083980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64915506|NCT04893174|Hyaluronic Acid|hyaluronic acid|mesh-list
64380934|NCT03192059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64380935|NCT03192059|Alkylating Agents|alkylating agents|mesh-ancestor
64915507|NCT04893174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64915508|NCT04893174|Immunologic Factors|immunologic factors|mesh-ancestor
64915509|NCT04893174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915510|NCT04893174|Viscosupplements|viscosupplements|mesh-ancestor
64915511|NCT04893174|Protective Agents|protective agents|mesh-ancestor
64915512|NCT00084019|Ritonavir|ritonavir|mesh-list
64915513|NCT00084019|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64915514|NCT00084019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64915515|NCT00084019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64380936|NCT03192059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380937|NCT03192059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380938|NCT03192059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64380941|NCT03192059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64380942|NCT03192059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64380943|NCT03192059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64380944|NCT03192059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64380945|NCT03192059|Analgesics|analgesics|mesh-ancestor
64380946|NCT03192059|Sensory System Agents|sensory system agents|mesh-ancestor
64380947|NCT03192059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64988621|NCT00087035|Antimitotic Agents|antimitotic agents|mesh-ancestor
64988622|NCT00087035|Mitosis Modulators|mitosis modulators|mesh-ancestor
64988623|NCT00087035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988624|NCT00087035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64988625|NCT00087035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988626|NCT00322075|Insulin Glargine|insulin glargine|mesh-list
64988627|NCT00322075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64988715|NCT00124839|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64988716|NCT00124839|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64988717|NCT00124839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988718|NCT00124839|Sensory System Agents|sensory system agents|mesh-ancestor
64988719|NCT00124839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64988720|NCT00087269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64988721|NCT00087269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988722|NCT00087269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64988723|NCT00087269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988724|NCT00087269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915516|NCT00084019|Protease Inhibitors|protease inhibitors|mesh-ancestor
64915517|NCT00084019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915518|NCT00084019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915519|NCT00084019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64915520|NCT00084019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64915521|NCT00084019|Antiviral Agents|antiviral agents|mesh-ancestor
64915522|NCT00084019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64915523|NCT00084019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64915524|NCT00084019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64915525|NCT00084058|Ritonavir|ritonavir|mesh-list
64915526|NCT00084058|Lopinavir|lopinavir|mesh-list
64915527|NCT00084058|Saquinavir|saquinavir|mesh-list
64915528|NCT00084058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64915529|NCT00084058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64915530|NCT00084058|Protease Inhibitors|protease inhibitors|mesh-ancestor
64915531|NCT00084058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915532|NCT00084058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915541|NCT00006053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64915542|NCT00006053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915543|NCT00006053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915544|NCT00084097|Omalizumab|omalizumab|mesh-list
64915545|NCT00084097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64915546|NCT00084097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64915547|NCT00084097|Respiratory System Agents|respiratory system agents|mesh-ancestor
64381067|NCT04303689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64915548|NCT00084214|Paclitaxel|paclitaxel|mesh-list
64381068|NCT04303689|Tubulin Modulators|tubulin modulators|mesh-ancestor
64381069|NCT04303689|Antimitotic Agents|antimitotic agents|mesh-ancestor
64381070|NCT04303689|Mitosis Modulators|mitosis modulators|mesh-ancestor
64381071|NCT04303689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381072|NCT04303689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381073|NCT02437955|Ferrous fumarate|ferrous fumarate|mesh-list
64381074|NCT02437955|Trace Elements|trace elements|mesh-ancestor
64381075|NCT02437955|Micronutrients|micronutrients|mesh-ancestor
64381076|NCT02437955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988767|NCT00419731|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64988768|NCT00419731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64988769|NCT00419731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64988770|NCT00419731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988771|NCT00419731|Dopamine Agents|dopamine agents|mesh-ancestor
64915549|NCT00084214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64915550|NCT00084214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915551|NCT00084214|Tubulin Modulators|tubulin modulators|mesh-ancestor
64915552|NCT00084214|Antimitotic Agents|antimitotic agents|mesh-ancestor
64915553|NCT00084214|Mitosis Modulators|mitosis modulators|mesh-ancestor
64915554|NCT00084214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915555|NCT00006056|Cyclosporine|cyclosporine|mesh-list
64915556|NCT00006056|Cyclophosphamide|cyclophosphamide|mesh-list
64915557|NCT00006056|Busulfan|busulfan|mesh-list
64915558|NCT00006056|Methotrexate|methotrexate|mesh-list
64915559|NCT00006056|Etoposide|etoposide|mesh-list
64915560|NCT00006056|Cyclosporins|cyclosporins|mesh-list
64915561|NCT00006056|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64915562|NCT00006056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64915563|NCT00006056|Immunologic Factors|immunologic factors|mesh-ancestor
64915564|NCT00006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915565|NCT00006056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64915566|NCT00006056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64915567|NCT00006056|Alkylating Agents|alkylating agents|mesh-ancestor
64915590|NCT00084370|Sensory System Agents|sensory system agents|mesh-ancestor
64915591|NCT00084370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64915592|NCT00084370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381117|NCT02436083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64915593|NCT00084370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64915594|NCT00084370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64915595|NCT00084370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64915596|NCT00084370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64915597|NCT00084370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915598|NCT00084370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915599|NCT00084448|Celecoxib|celecoxib|mesh-list
64915600|NCT00084448|Paclitaxel|paclitaxel|mesh-list
64915601|NCT00084448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64915602|NCT00084448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915603|NCT00084448|Tubulin Modulators|tubulin modulators|mesh-ancestor
64988772|NCT00419731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64988773|NCT00419731|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64988774|NCT00419731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64988775|NCT00419731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988776|NCT00419848|Azithromycin|azithromycin|mesh-list
64988777|NCT00419848|Doxycycline|doxycycline|mesh-list
64988778|NCT00419848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64988779|NCT00419848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64915604|NCT00084448|Antimitotic Agents|antimitotic agents|mesh-ancestor
64915605|NCT00084448|Mitosis Modulators|mitosis modulators|mesh-ancestor
64915606|NCT00084448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915607|NCT00084448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64915608|NCT00084448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64915609|NCT00084448|Analgesics|analgesics|mesh-ancestor
64915610|NCT00084448|Sensory System Agents|sensory system agents|mesh-ancestor
64915611|NCT00084448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64915612|NCT00084448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915613|NCT00084448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64915614|NCT00084448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64915615|NCT00084448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64915616|NCT00084448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64915617|NCT00084448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915618|NCT00084565|Paclitaxel|paclitaxel|mesh-list
64915619|NCT00084565|Topotecan|topotecan|mesh-list
64915620|NCT00084565|Estramustine|estramustine|mesh-list
64915632|NCT00084565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64915633|NCT00084604|Bevacizumab|bevacizumab|mesh-list
64915634|NCT00084604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64915635|NCT00084604|Irinotecan|irinotecan|mesh-list
64915636|NCT00084604|Antibodies|antibodies|mesh-list
64915637|NCT00084604|Immunoglobulins|immunoglobulins|mesh-list
64915638|NCT00084604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64915639|NCT00084604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915640|NCT00084604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64915641|NCT00084604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64915642|NCT00084604|Growth Substances|growth substances|mesh-ancestor
64915643|NCT00084604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915644|NCT00084604|Growth Inhibitors|growth inhibitors|mesh-ancestor
64915645|NCT00084604|Immunologic Factors|immunologic factors|mesh-ancestor
64988780|NCT00419848|Antimalarials|antimalarials|mesh-ancestor
64988781|NCT00419848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64988782|NCT00419848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64988817|NCT00330772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988819|NCT00330772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64988820|NCT00330772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64988821|NCT00330772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64988822|NCT00330772|Purinergic Agents|purinergic agents|mesh-ancestor
64988823|NCT00330772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64988824|NCT00094926|Risperidone|risperidone|mesh-list
64988825|NCT00094926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64988826|NCT00094926|Serotonin Agents|serotonin agents|mesh-ancestor
64988827|NCT00094926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64988828|NCT00094926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915646|NCT00084604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64915647|NCT00084604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64915648|NCT00084604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915649|NCT00084604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915650|NCT00084643|Capecitabine|capecitabine|mesh-list
64915651|NCT00084643|Oxaliplatin|oxaliplatin|mesh-list
64915652|NCT00084643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64915653|NCT00084643|Antimetabolites|antimetabolites|mesh-ancestor
64915654|NCT00084643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915655|NCT00084643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915656|NCT00006062|Oxaliplatin|oxaliplatin|mesh-list
64915657|NCT00006062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915658|NCT00084721|Celecoxib|celecoxib|mesh-list
64915659|NCT00084721|Irinotecan|irinotecan|mesh-list
64915660|NCT00084721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64915678|NCT00084877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915679|NCT00084877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915680|NCT00084877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915682|NCT00084916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64915683|NCT00084916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64915684|NCT00084916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64915685|NCT00084916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915686|NCT00084916|Antifungal Agents|antifungal agents|mesh-ancestor
64381215|NCT05199909|Zanubrutinib|zanubrutinib|mesh-list
64988829|NCT00094926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988830|NCT00094926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64988831|NCT00094926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64988832|NCT00094926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64988833|NCT00094926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64988834|NCT00094926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64988835|NCT00094926|Dopamine Agents|dopamine agents|mesh-ancestor
64988836|NCT00087464|Tenofovir|tenofovir|mesh-list
64988837|NCT00087464|Emtricitabine|emtricitabine|mesh-list
64988838|NCT00087464|Nevirapine|nevirapine|mesh-list
64988839|NCT00087464|Antiviral Agents|antiviral agents|mesh-ancestor
64988840|NCT00087464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64988841|NCT00087464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64988842|NCT00087464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64988843|NCT00087464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988844|NCT00087464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988845|NCT00087464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64915687|NCT00084916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64915688|NCT00084916|Immunologic Factors|immunologic factors|mesh-ancestor
64915689|NCT00084916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915690|NCT00085111|Bevacizumab|bevacizumab|mesh-list
64915691|NCT00085111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64915692|NCT00085111|Antibodies|antibodies|mesh-list
64915693|NCT00085111|Immunoglobulins|immunoglobulins|mesh-list
64915694|NCT00085111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64915695|NCT00085111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915696|NCT00085111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64915697|NCT00085111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64915698|NCT00085111|Growth Substances|growth substances|mesh-ancestor
64381240|NCT03189329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64381241|NCT03189329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64381242|NCT03189329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64381243|NCT03189329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381244|NCT02575833|Erenumab|erenumab|mesh-list
64381245|NCT02575833|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64381267|NCT03188471|Sensory System Agents|sensory system agents|mesh-ancestor
64381268|NCT03188471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64381269|NCT03188471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64381271|NCT03188471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64988846|NCT00087464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64988847|NCT00087464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64988848|NCT00087464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64988849|NCT00331045|Alvimopan|alvimopan|mesh-list
64988861|NCT00331084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988862|NCT00331084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64988863|NCT00331084|Glucocorticoids|glucocorticoids|mesh-ancestor
64988864|NCT00331084|Hormones|hormones|mesh-ancestor
64988865|NCT00331084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64988866|NCT00331084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64988867|NCT00331084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988868|NCT00331084|Protease Inhibitors|protease inhibitors|mesh-ancestor
64349231|NCT02322671|Montelukast|montelukast|mesh-list
64988939|NCT00087581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64988941|NCT00087581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988951|NCT00094965|Oxaliplatin|oxaliplatin|mesh-list
64988964|NCT00331513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64988966|NCT00087620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64988967|NCT00087620|Antimetabolites|antimetabolites|mesh-ancestor
64988968|NCT00087620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988969|NCT00087620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988970|NCT00124995|Terbutaline|terbutaline|mesh-list
64988971|NCT00124995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64989086|NCT00331981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64989087|NCT00331981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64915699|NCT00085111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915700|NCT00085111|Growth Inhibitors|growth inhibitors|mesh-ancestor
64915701|NCT00085111|Immunologic Factors|immunologic factors|mesh-ancestor
64915702|NCT00085150|Immunotoxins|immunotoxins|mesh-list
64915703|NCT00085150|Immunologic Factors|immunologic factors|mesh-ancestor
64915704|NCT00085150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915705|NCT00400075|Cyclophosphamide|cyclophosphamide|mesh-list
64915725|NCT00400114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64915726|NCT00400114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64915727|NCT00400114|Growth Substances|growth substances|mesh-ancestor
64915728|NCT00400114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915729|NCT00400114|Growth Inhibitors|growth inhibitors|mesh-ancestor
64915730|NCT00400114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64915731|NCT00085189|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64915732|NCT00085189|Freund's Adjuvant|freund's adjuvant|mesh-list
64915733|NCT00085189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64915734|NCT00085189|Immunologic Factors|immunologic factors|mesh-ancestor
64915735|NCT00085189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915736|NCT00085228|Docetaxel|docetaxel|mesh-list
64915737|NCT00085228|Oblimersen|oblimersen|mesh-list
64915738|NCT00085228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381290|NCT03188159|Antimitotic Agents|antimitotic agents|mesh-ancestor
64381291|NCT03188159|Mitosis Modulators|mitosis modulators|mesh-ancestor
64381292|NCT03188159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381293|NCT05532501|Oxytocin|oxytocin|mesh-list
64381294|NCT05532501|Oxytocics|oxytocics|mesh-ancestor
64381295|NCT05532501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64381296|NCT05532501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381330|NCT05192889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64381331|NCT05192889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64381332|NCT05192889|Glucocorticoids|glucocorticoids|mesh-ancestor
64381333|NCT05192889|Hormones|hormones|mesh-ancestor
64989088|NCT00331981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989089|NCT00331981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64989090|NCT00331981|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64989091|NCT00331981|Dopamine Agents|dopamine agents|mesh-ancestor
64989092|NCT00331981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64989093|NCT00331981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989094|NCT00331981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64989095|NCT00331981|Antidepressive Agents|antidepressive agents|mesh-ancestor
64989096|NCT00126633|Gemcitabine|gemcitabine|mesh-list
64989097|NCT00126633|Bevacizumab|bevacizumab|mesh-list
64989332|NCT05830396|Respiratory System Agents|respiratory system agents|mesh-ancestor
64915739|NCT00085228|Tubulin Modulators|tubulin modulators|mesh-ancestor
64915740|NCT00085228|Antimitotic Agents|antimitotic agents|mesh-ancestor
64915741|NCT00085228|Mitosis Modulators|mitosis modulators|mesh-ancestor
64915742|NCT00085228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915743|NCT00085306|Interferons|interferons|mesh-list
64915744|NCT00085306|Interferon-beta|interferon-beta|mesh-list
64915745|NCT00085306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915746|NCT00085306|Antiviral Agents|antiviral agents|mesh-ancestor
64915747|NCT00085306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64915748|NCT00085306|Immunologic Factors|immunologic factors|mesh-ancestor
64915749|NCT00085306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915750|NCT00006077|Levodopa|levodopa|mesh-list
64915751|NCT00006077|Domperidone|domperidone|mesh-list
64915752|NCT00006077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64915753|NCT00006077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64915754|NCT00006077|Dopamine Agents|dopamine agents|mesh-ancestor
64915755|NCT00006077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64915756|NCT00006077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915758|NCT00006077|Antiemetics|antiemetics|mesh-ancestor
64915769|NCT04729348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915770|NCT00085345|Ascorbic Acid|ascorbic acid|mesh-list
64915771|NCT00085345|Melphalan|melphalan|mesh-list
64381381|NCT02433899|Mepivacaine|mepivacaine|mesh-list
64381382|NCT02433899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64381383|NCT02433899|Antiemetics|antiemetics|mesh-ancestor
64915791|NCT00085384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64381384|NCT02433899|Autonomic Agents|autonomic agents|mesh-ancestor
64381385|NCT02433899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64915792|NCT00085384|Immunologic Factors|immunologic factors|mesh-ancestor
64915793|NCT00085384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915794|NCT00006080|Fenretinide|fenretinide|mesh-list
64915795|NCT00006080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915796|NCT00006080|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64915818|NCT00085501|Paclitaxel|paclitaxel|mesh-list
64915819|NCT00085501|Carboplatin|carboplatin|mesh-list
64915820|NCT00085501|Cetuximab|cetuximab|mesh-list
64915821|NCT00085501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64915822|NCT00085501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915823|NCT00085501|Tubulin Modulators|tubulin modulators|mesh-ancestor
64915824|NCT00085501|Antimitotic Agents|antimitotic agents|mesh-ancestor
64915825|NCT00085501|Mitosis Modulators|mitosis modulators|mesh-ancestor
64915826|NCT00085501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915827|NCT00085501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64915828|NCT00006083|Dalteparin|dalteparin|mesh-list
64915847|NCT00085696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915848|NCT00085696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64915849|NCT00006086|Carboplatin|carboplatin|mesh-list
64915850|NCT00006086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915851|NCT04798638|Osimertinib|osimertinib|mesh-list
64915852|NCT04798638|Complement Factor H|complement factor h|mesh-list
64915853|NCT04798638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915854|NCT04798638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64915859|NCT04798638|Immunologic Factors|immunologic factors|mesh-ancestor
64915860|NCT04798638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915861|NCT00006089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64915862|NCT00006089|Trastuzumab|trastuzumab|mesh-list
64915863|NCT00006089|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
64915864|NCT00006089|Antibodies|antibodies|mesh-list
64915865|NCT00006089|Immunoglobulins|immunoglobulins|mesh-list
64915866|NCT00006089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64915867|NCT00006089|Immunologic Factors|immunologic factors|mesh-ancestor
64915868|NCT00006089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915869|NCT00006089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915870|NCT00085891|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64915871|NCT00085891|Antidepressive Agents|antidepressive agents|mesh-ancestor
64915872|NCT00085891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64915873|NCT00085891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64915874|NCT00085891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64915875|NCT00085891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64915876|NCT00085891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915877|NCT00085969|Exenatide|exenatide|mesh-list
64915878|NCT00085969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64381398|NCT02433899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64915879|NCT00085969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915880|NCT00085969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64915881|NCT00085969|Incretins|incretins|mesh-ancestor
64915882|NCT00085969|Hormones|hormones|mesh-ancestor
64915883|NCT00085969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64915884|NCT00086086|Darbepoetin alfa|darbepoetin alfa|mesh-list
64915885|NCT00086086|Hematinics|hematinics|mesh-ancestor
64915908|NCT00006095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915909|NCT00006095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915910|NCT00006095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64915911|NCT00006095|Tubulin Modulators|tubulin modulators|mesh-ancestor
64915912|NCT00006095|Antimitotic Agents|antimitotic agents|mesh-ancestor
64915913|NCT00006095|Mitosis Modulators|mitosis modulators|mesh-ancestor
64684377|NCT01715233|Antidotes|antidotes|mesh-ancestor
64915914|NCT00086320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64915915|NCT00086320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64915916|NCT00086320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64915917|NCT00086320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64915918|NCT00086320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915919|NCT00086320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64915920|NCT00086320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64915921|NCT00086320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64915922|NCT00086320|Serotonin Agents|serotonin agents|mesh-ancestor
64915923|NCT00086320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64915924|NCT00086320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915925|NCT00086320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64915926|NCT00086320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64915927|NCT00086320|Dopamine Agents|dopamine agents|mesh-ancestor
64915928|NCT00086359|Ritonavir|ritonavir|mesh-list
64915929|NCT00086359|Lopinavir|lopinavir|mesh-list
64915930|NCT00086359|Lamivudine|lamivudine|mesh-list
64915931|NCT00086359|Zidovudine|zidovudine|mesh-list
64915932|NCT00086359|Abacavir|abacavir|mesh-list
64915933|NCT00086359|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64915934|NCT00086359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64381518|NCT02432885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381519|NCT02432885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64381520|NCT02433041|Ketamine|ketamine|mesh-list
64915935|NCT00086359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64915936|NCT00086359|Protease Inhibitors|protease inhibitors|mesh-ancestor
64915937|NCT00086359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64915938|NCT00086359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915939|NCT00086359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64915949|NCT00006098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915950|NCT00086593|Lamotrigine|lamotrigine|mesh-list
64915951|NCT00086593|Anticonvulsants|anticonvulsants|mesh-ancestor
64915952|NCT00086593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64915953|NCT00086593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64915954|NCT00086593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915955|NCT00086593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64915956|NCT00086593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915957|NCT00086593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64915958|NCT00086593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64915959|NCT00086593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64915960|NCT00086593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64915961|NCT00086593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64915962|NCT00387569|Vaccines|vaccines|mesh-list
64915963|NCT00387569|Immunologic Factors|immunologic factors|mesh-ancestor
64915964|NCT00387569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915965|NCT04784637|Insulin|insulin|mesh-list
64915966|NCT04784637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64915967|NCT04784637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915968|NCT00086632|Oregovomab|oregovomab|mesh-list
64915969|NCT00086632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64915970|NCT00086632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915971|NCT00086710|Enfuvirtide|enfuvirtide|mesh-list
64915972|NCT00086710|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64915973|NCT00086710|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64915974|NCT00086710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915975|NCT00086710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64915976|NCT00086710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64915977|NCT00086710|Antiviral Agents|antiviral agents|mesh-ancestor
64915978|NCT00086710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64381638|NCT02428751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64989366|NCT05830071|Respiratory System Agents|respiratory system agents|mesh-ancestor
64915979|NCT00006104|Docetaxel|docetaxel|mesh-list
64915980|NCT00006104|Trastuzumab|trastuzumab|mesh-list
64915981|NCT00006104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915989|NCT00086827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915991|NCT00086944|Carboplatin|carboplatin|mesh-list
64915992|NCT00086944|Etoposide|etoposide|mesh-list
64915993|NCT00086944|Etoposide phosphate|etoposide phosphate|mesh-list
64915994|NCT00086944|Ifosfamide|ifosfamide|mesh-list
64915995|NCT00086944|Oblimersen|oblimersen|mesh-list
64915996|NCT00086944|Lenograstim|lenograstim|mesh-list
64915997|NCT00086944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64915998|NCT00086944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915999|NCT00086944|Immunologic Factors|immunologic factors|mesh-ancestor
64381692|NCT03184805|Analgesics|analgesics|mesh-ancestor
64381693|NCT03184805|Sensory System Agents|sensory system agents|mesh-ancestor
64381694|NCT03184805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64381695|NCT03184805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381736|NCT05518383|Hormones|hormones|mesh-ancestor
64989367|NCT05830071|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64989368|NCT05830071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64989370|NCT05830071|Adrenergic Agents|adrenergic agents|mesh-ancestor
64989371|NCT05830071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64989372|NCT05830071|Anticonvulsants|anticonvulsants|mesh-ancestor
64989373|NCT05830071|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64989374|NCT05830071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64989375|NCT05830071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64989376|NCT05830071|Cholinergic Agents|cholinergic agents|mesh-ancestor
64989377|NCT05830071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64989378|NCT05830071|Glucocorticoids|glucocorticoids|mesh-ancestor
64989379|NCT05830071|Hormones|hormones|mesh-ancestor
64989380|NCT05830071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64989420|NCT05828303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64989421|NCT05828303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989422|NCT05828303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64989423|NCT05828303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64989424|NCT05828303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64989425|NCT05828303|Antimetabolites|antimetabolites|mesh-ancestor
64989426|NCT05828303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989427|NCT05828303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64989428|NCT05828303|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64989429|NCT05828303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349395|NCT03493841|Thioctic Acid|thioctic acid|mesh-list
64989472|NCT05803382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989492|NCT05793905|Lidocaine|lidocaine|mesh-list
64989493|NCT05793905|Anesthetics, Local|anesthetics, local|mesh-ancestor
64989494|NCT05793905|Anesthetics|anesthetics|mesh-ancestor
64989495|NCT05793905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64989496|NCT05793905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989497|NCT05793905|Sensory System Agents|sensory system agents|mesh-ancestor
64989498|NCT05793905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64989499|NCT05793905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64989500|NCT05793905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64989501|NCT05793905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64989502|NCT05793905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64989503|NCT05793905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989504|NCT05790252|Buprenorphine|buprenorphine|mesh-list
64989505|NCT05790252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64989506|NCT05790252|Narcotics|narcotics|mesh-ancestor
64989507|NCT05790252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64916000|NCT00086944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916001|NCT00086944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64916002|NCT00086944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64916003|NCT00086944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64916004|NCT00086944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64916005|NCT00086944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916006|NCT00086944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916007|NCT00086944|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64916008|NCT00086944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64916009|NCT00086944|Alkylating Agents|alkylating agents|mesh-ancestor
64916010|NCT00006107|Docetaxel|docetaxel|mesh-list
64916011|NCT00006107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916012|NCT00006107|Tubulin Modulators|tubulin modulators|mesh-ancestor
64916013|NCT00006107|Antimitotic Agents|antimitotic agents|mesh-ancestor
64916014|NCT00006107|Mitosis Modulators|mitosis modulators|mesh-ancestor
64916015|NCT00006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916039|NCT00087217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64916040|NCT00087217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916041|NCT00087217|Tubulin Modulators|tubulin modulators|mesh-ancestor
64916042|NCT00087217|Antimitotic Agents|antimitotic agents|mesh-ancestor
64916043|NCT00087217|Mitosis Modulators|mitosis modulators|mesh-ancestor
64916044|NCT00087217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916045|NCT00087256|Celecoxib|celecoxib|mesh-list
64916046|NCT00087256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64916047|NCT00087256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64916048|NCT00087256|Analgesics|analgesics|mesh-ancestor
64916049|NCT00087256|Sensory System Agents|sensory system agents|mesh-ancestor
64916050|NCT00087256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64381976|NCT03185351|GABA Agents|gaba agents|mesh-ancestor
64989508|NCT05790252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989509|NCT05790252|Analgesics|analgesics|mesh-ancestor
64989527|NCT05779007|Pirfenidone|pirfenidone|mesh-list
64989528|NCT05779007|Nintedanib|nintedanib|mesh-list
64989529|NCT05779007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989530|NCT05779007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64989531|NCT05779007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64989532|NCT05779007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989533|NCT05779007|Analgesics|analgesics|mesh-ancestor
64989534|NCT05779007|Sensory System Agents|sensory system agents|mesh-ancestor
64989535|NCT05779007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64989536|NCT05779007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989537|NCT05779007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64916051|NCT00087256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916052|NCT00087256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64916053|NCT00087256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64916054|NCT00087256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64916055|NCT00087256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64916056|NCT00087256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916057|NCT00087256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916058|NCT00006116|Gemcitabine|gemcitabine|mesh-list
64916059|NCT00006116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916060|NCT00006116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64916061|NCT00006116|Antimetabolites|antimetabolites|mesh-ancestor
64916062|NCT00006116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916063|NCT00006116|Antiviral Agents|antiviral agents|mesh-ancestor
64916087|NCT04762953|Antidotes|antidotes|mesh-ancestor
64916088|NCT04762953|Protective Agents|protective agents|mesh-ancestor
64916089|NCT04762953|Vitamin B Complex|vitamin b complex|mesh-ancestor
64916090|NCT04762953|Vitamins|vitamins|mesh-ancestor
64916091|NCT04762953|Micronutrients|micronutrients|mesh-ancestor
64916092|NCT00087334|Capecitabine|capecitabine|mesh-list
64916093|NCT00087334|Oxaliplatin|oxaliplatin|mesh-list
64916094|NCT00087334|Gefitinib|gefitinib|mesh-list
64916095|NCT00087334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64916096|NCT00087334|Antimetabolites|antimetabolites|mesh-ancestor
64916097|NCT00087334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916098|NCT00087334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916099|NCT00087334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64916100|NCT00087334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64989538|NCT05779007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64989539|NCT05779007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64989540|NCT05779007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64989548|NCT05776017|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64989549|NCT05776017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64989550|NCT05776017|Immunologic Factors|immunologic factors|mesh-ancestor
64989551|NCT05776017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989552|NCT05776017|Antacids|antacids|mesh-ancestor
64989553|NCT05776017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989554|NCT05776017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64989555|NCT05774951|Tamoxifen|tamoxifen|mesh-list
64989556|NCT05774951|Letrozole|letrozole|mesh-list
64989557|NCT05774951|Anastrozole|anastrozole|mesh-list
64989558|NCT05774951|Exemestane|exemestane|mesh-list
64989559|NCT05774951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989560|NCT05774951|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64989561|NCT05774951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64989573|NCT05773274|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64989574|NCT05773274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989575|NCT05773274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64989576|NCT05773274|Immunologic Factors|immunologic factors|mesh-ancestor
64916101|NCT00087373|Metronidazole|metronidazole|mesh-list
64916102|NCT00087373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64916103|NCT00087373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64916104|NCT00087373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64916105|NCT00087373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64916106|NCT00006119|Hydroxyurea|hydroxyurea|mesh-list
64916107|NCT00006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916108|NCT00006119|Antisickling Agents|antisickling agents|mesh-ancestor
64916109|NCT00006119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916110|NCT00006119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916111|NCT00006119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64916112|NCT00087412|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64916113|NCT00087412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916114|NCT00087412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64916115|NCT00087412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916116|NCT00087412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916117|NCT00087451|Sirolimus|sirolimus|mesh-list
64916118|NCT00087451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64916119|NCT00087451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64916128|NCT00006122|Mitoxantrone|mitoxantrone|mesh-list
64916129|NCT00006122|Idarubicin|idarubicin|mesh-list
64916130|NCT00006122|Gemtuzumab|gemtuzumab|mesh-list
64916132|NCT00006122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916174|NCT00006125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64916175|NCT00006125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64916176|NCT00006125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916177|NCT00006125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916178|NCT00006125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64916179|NCT00087841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64916180|NCT00087841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64916181|NCT00087841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916182|NCT00087880|Bupropion|bupropion|mesh-list
64916183|NCT00087880|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64916184|NCT00087880|Antidepressive Agents|antidepressive agents|mesh-ancestor
64916185|NCT00087880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64916190|NCT00087880|Dopamine Agents|dopamine agents|mesh-ancestor
64916244|NCT00088270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64916245|NCT00088270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916246|NCT00088270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64916247|NCT00088270|Immunologic Factors|immunologic factors|mesh-ancestor
64916248|NCT00088270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916249|NCT00088270|Antidotes|antidotes|mesh-ancestor
64916250|NCT00088270|Protective Agents|protective agents|mesh-ancestor
64916251|NCT00088270|Vitamin B Complex|vitamin b complex|mesh-ancestor
64916264|NCT00088387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64916265|NCT00088504|Interferons|interferons|mesh-list
64916266|NCT00088504|Ribavirin|ribavirin|mesh-list
64916267|NCT00088504|Interferon-alpha|interferon-alpha|mesh-list
64916268|NCT00088504|Interferon alpha-2|interferon alpha-2|mesh-list
64916269|NCT00088504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64916270|NCT00088504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916271|NCT00088504|Antiviral Agents|antiviral agents|mesh-ancestor
64916272|NCT00088504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64916273|NCT00088504|Antimetabolites|antimetabolites|mesh-ancestor
64916274|NCT00088504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916275|NCT00088504|Immunologic Factors|immunologic factors|mesh-ancestor
64916276|NCT00088504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916277|NCT00006137|Enalapril|enalapril|mesh-list
64916321|NCT00088894|Bevacizumab|bevacizumab|mesh-list
64916322|NCT00088894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64916323|NCT00088894|Antibodies|antibodies|mesh-list
64916324|NCT00088894|Immunoglobulins|immunoglobulins|mesh-list
64916325|NCT00088894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64916326|NCT00088894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916327|NCT00088894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64916328|NCT00088894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64916329|NCT00088894|Growth Substances|growth substances|mesh-ancestor
64916330|NCT00088894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916331|NCT00088894|Growth Inhibitors|growth inhibitors|mesh-ancestor
64916332|NCT00088894|Immunologic Factors|immunologic factors|mesh-ancestor
64916333|NCT00088894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64916334|NCT00088894|Antimetabolites|antimetabolites|mesh-ancestor
64916335|NCT00088894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916336|NCT00088894|Antiviral Agents|antiviral agents|mesh-ancestor
64916337|NCT00088894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64916338|NCT00088894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916339|NCT00088894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64916340|NCT00006152|Ritonavir|ritonavir|mesh-list
64916341|NCT00006152|Amprenavir|amprenavir|mesh-list
64916342|NCT00006152|Abacavir|abacavir|mesh-list
64916343|NCT00006152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64916344|NCT00006152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64916349|NCT00006152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64916350|NCT00006152|Antiviral Agents|antiviral agents|mesh-ancestor
64916351|NCT00006152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64916352|NCT00006152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64916353|NCT00006152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64916354|NCT00006152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64916355|NCT00006152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64916356|NCT00006152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64916357|NCT00006152|Antitubercular Agents|antitubercular agents|mesh-ancestor
64916358|NCT00006152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64916359|NCT00088933|Metronidazole|metronidazole|mesh-list
64916367|NCT00088933|Antimitotic Agents|antimitotic agents|mesh-ancestor
64916368|NCT00088933|Mitosis Modulators|mitosis modulators|mesh-ancestor
64916369|NCT00088933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916370|NCT00088933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64684824|NCT04635241|Heparin|heparin|mesh-list
64916402|NCT00089089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64916404|NCT00089089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916405|NCT00089089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916406|NCT00089089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916407|NCT00089167|Thalidomide|thalidomide|mesh-list
64916408|NCT00089167|Dexamethasone|dexamethasone|mesh-list
64916409|NCT00089167|Melphalan|melphalan|mesh-list
64916410|NCT00089167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64916411|NCT00089167|Antiemetics|antiemetics|mesh-ancestor
64916412|NCT00089167|Autonomic Agents|autonomic agents|mesh-ancestor
64916413|NCT00089167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64916417|NCT00089167|Hormones|hormones|mesh-ancestor
64916464|NCT00423826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916465|NCT00423826|Antiviral Agents|antiviral agents|mesh-ancestor
64916466|NCT00423826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64916467|NCT00423826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64916468|NCT00423826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916476|NCT00423865|Everolimus|everolimus|mesh-list
64916491|NCT00423982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916492|NCT00423982|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64916493|NCT00423982|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64916494|NCT00423982|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64916495|NCT00423982|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64916496|NCT00423982|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64916497|NCT00423982|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64916498|NCT02965261|Fluoxetine|fluoxetine|mesh-list
64916499|NCT02965261|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64916500|NCT02965261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64916501|NCT02965261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64916502|NCT02965261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916503|NCT02965261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64916504|NCT02965261|Serotonin Agents|serotonin agents|mesh-ancestor
64916505|NCT02965261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916506|NCT02965261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64916507|NCT02965261|Antidepressive Agents|antidepressive agents|mesh-ancestor
64916508|NCT02965261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64916543|NCT00089440|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64916544|NCT00089440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64916545|NCT00089440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64916546|NCT00089440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916547|NCT00089440|Dopamine Agonists|dopamine agonists|mesh-ancestor
64916548|NCT00089440|Dopamine Agents|dopamine agents|mesh-ancestor
64916549|NCT00089440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64916550|NCT00089440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916551|NCT00089440|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64916552|NCT00089440|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64916553|NCT00089440|Serotonin Agents|serotonin agents|mesh-ancestor
64916554|NCT00089440|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64916555|NCT00089440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64916556|NCT00089440|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64916557|NCT00089440|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64916558|NCT00089518|Valsartan|valsartan|mesh-list
64916559|NCT00089518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64916560|NCT00089518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64916579|NCT00089830|Growth Inhibitors|growth inhibitors|mesh-ancestor
64916635|NCT00006185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916636|NCT00091039|Metronidazole|metronidazole|mesh-list
64916637|NCT00091039|Paclitaxel|paclitaxel|mesh-list
64916638|NCT00091039|Carboplatin|carboplatin|mesh-list
64916639|NCT00091039|Vaccines|vaccines|mesh-list
64916640|NCT00091039|Immunologic Factors|immunologic factors|mesh-ancestor
64916641|NCT00091039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916642|NCT00091039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64916643|NCT00091039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916644|NCT00091039|Tubulin Modulators|tubulin modulators|mesh-ancestor
64916645|NCT00091039|Antimitotic Agents|antimitotic agents|mesh-ancestor
64916646|NCT00091039|Mitosis Modulators|mitosis modulators|mesh-ancestor
64916647|NCT00091039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916648|NCT00091039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64916649|NCT00091039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64916650|NCT00091039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64916651|NCT00091039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64916652|NCT00091078|Imatinib Mesylate|imatinib mesylate|mesh-list
64916653|NCT00091078|Oblimersen|oblimersen|mesh-list
64916654|NCT00091078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916655|NCT00091078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64916656|NCT00091078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916673|NCT00091312|Irinotecan|irinotecan|mesh-list
64916674|NCT00091312|Calcium|calcium|mesh-list
64916675|NCT00091312|Levoleucovorin|levoleucovorin|mesh-list
64916676|NCT00091312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64916677|NCT00091312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916678|NCT00091312|Antimetabolites|antimetabolites|mesh-ancestor
64916679|NCT00091312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916680|NCT00091312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64916681|NCT00091312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916682|NCT00091312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64916683|NCT00091312|Immunologic Factors|immunologic factors|mesh-ancestor
64989577|NCT05773274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349416|NCT03492827|Chlorhexidine|chlorhexidine|mesh-list
64989622|NCT05743270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989623|NCT05743270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64989624|NCT05743270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64989625|NCT05735353|Methamphetamine|methamphetamine|mesh-list
64989626|NCT05735353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64989627|NCT05735353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989628|NCT05735353|Sympathomimetics|sympathomimetics|mesh-ancestor
64989629|NCT05735353|Autonomic Agents|autonomic agents|mesh-ancestor
64916684|NCT00091312|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64916685|NCT00091312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64916686|NCT00091312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916731|NCT00006200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64916732|NCT00006200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64916733|NCT00006200|Growth Substances|growth substances|mesh-ancestor
64916734|NCT00006200|Growth Inhibitors|growth inhibitors|mesh-ancestor
64916735|NCT00006200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916736|NCT00006200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64916737|NCT00006200|Alkylating Agents|alkylating agents|mesh-ancestor
64916738|NCT00006200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916739|NCT00006203|Naltrexone|naltrexone|mesh-list
64916740|NCT00006203|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64916741|NCT00006203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64916742|NCT00006203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916743|NCT00006203|Sensory System Agents|sensory system agents|mesh-ancestor
64916744|NCT00006203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64916745|NCT00091624|Lenalidomide|lenalidomide|mesh-list
64916746|NCT00091624|Immunologic Factors|immunologic factors|mesh-ancestor
64916747|NCT00091624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916748|NCT00091624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64916749|NCT00091624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64916750|NCT00091624|Growth Substances|growth substances|mesh-ancestor
64916751|NCT00091624|Growth Inhibitors|growth inhibitors|mesh-ancestor
64916752|NCT00091624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916753|NCT00091663|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64916754|NCT00091663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916755|NCT00091663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64916756|NCT00091663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916757|NCT00091663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916778|NCT00091741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64916787|NCT00091897|Rituximab|rituximab|mesh-list
64916788|NCT00091897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64916789|NCT00091897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916790|NCT00091897|Immunologic Factors|immunologic factors|mesh-ancestor
64916791|NCT00091897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916792|NCT00091897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64916793|NCT00006212|Vinblastine|vinblastine|mesh-list
64916794|NCT00006212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916795|NCT00006212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64916796|NCT00006212|Tubulin Modulators|tubulin modulators|mesh-ancestor
64916797|NCT00006212|Antimitotic Agents|antimitotic agents|mesh-ancestor
64916798|NCT00006212|Mitosis Modulators|mitosis modulators|mesh-ancestor
64916799|NCT00006212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916800|NCT00091936|Lamivudine|lamivudine|mesh-list
64916801|NCT00091936|Efavirenz|efavirenz|mesh-list
64916802|NCT00091936|Didanosine|didanosine|mesh-list
64916803|NCT00091936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64916804|NCT00091936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64916805|NCT00091936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916806|NCT00091936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916841|NCT00006215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916842|NCT00006215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64916843|NCT00092287|Lanreotide|lanreotide|mesh-list
64916844|NCT00092287|Octreotide|octreotide|mesh-list
64916845|NCT00092287|Somatostatin|somatostatin|mesh-list
64916846|NCT00092287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916847|NCT00092287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64916848|NCT00092287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64916849|NCT00092287|Hormones|hormones|mesh-ancestor
64916850|NCT00092287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64916851|NCT00092287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916860|NCT00092326|Antipyretics|antipyretics|mesh-ancestor
64916861|NCT00092326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64916862|NCT00092326|Narcotics|narcotics|mesh-ancestor
64916863|NCT00092326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64916864|NCT00092326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64916865|NCT00092326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64916866|NCT00092326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916867|NCT00092326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916868|NCT00092326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64916869|NCT00092326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64916870|NCT00092326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64916871|NCT00092365|Celecoxib|celecoxib|mesh-list
64916872|NCT00092365|Rofecoxib|rofecoxib|mesh-list
64916875|NCT00092365|Analgesics|analgesics|mesh-ancestor
64916907|NCT00093184|Antithrombins|antithrombins|mesh-ancestor
64916908|NCT00093184|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64916909|NCT00093184|Protease Inhibitors|protease inhibitors|mesh-ancestor
64916910|NCT00093184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916911|NCT00093184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916912|NCT00006224|Gemcitabine|gemcitabine|mesh-list
64916913|NCT00006224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64916914|NCT00006224|Antimetabolites|antimetabolites|mesh-ancestor
64916915|NCT00006224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916916|NCT00006224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916917|NCT00006224|Antiviral Agents|antiviral agents|mesh-ancestor
64916918|NCT00006224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64916919|NCT00006224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916920|NCT00006224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64916921|NCT00006224|Immunologic Factors|immunologic factors|mesh-ancestor
64916922|NCT00006224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916923|NCT00093223|Paclitaxel|paclitaxel|mesh-list
64916924|NCT00093223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64916925|NCT00093223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64916926|NCT00093223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916927|NCT00093223|Tubulin Modulators|tubulin modulators|mesh-ancestor
64916928|NCT00093223|Antimitotic Agents|antimitotic agents|mesh-ancestor
64916929|NCT00093223|Mitosis Modulators|mitosis modulators|mesh-ancestor
64916930|NCT00093223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916931|NCT00093262|Clevidipine|clevidipine|mesh-list
64916932|NCT00093262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64916933|NCT00093262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64916934|NCT00093262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916946|NCT00093301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916948|NCT00093301|Autonomic Agents|autonomic agents|mesh-ancestor
64916949|NCT00093301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64916950|NCT00093301|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64916951|NCT00093301|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64916952|NCT00093301|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64916955|NCT00093418|Tipifarnib|tipifarnib|mesh-list
64916956|NCT00093418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916957|NCT00387608|Veliparib|veliparib|mesh-list
64916958|NCT00387608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64916959|NCT00387608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916960|NCT00387608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916961|NCT00387608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916962|NCT00093457|Sorafenib|sorafenib|mesh-list
64916963|NCT00093457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916964|NCT00093457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64916965|NCT00093457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916966|NCT00093457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916967|NCT00093613|Sorafenib|sorafenib|mesh-list
64916968|NCT00093613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916969|NCT00093613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64916970|NCT00093613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916971|NCT00093613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916972|NCT00093652|Oxaliplatin|oxaliplatin|mesh-list
64916974|NCT00093652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916976|NCT00093652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916992|NCT00400348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916993|NCT00400348|Tubulin Modulators|tubulin modulators|mesh-ancestor
64916994|NCT00400348|Antimitotic Agents|antimitotic agents|mesh-ancestor
64916995|NCT00400348|Mitosis Modulators|mitosis modulators|mesh-ancestor
64916998|NCT00006233|Mycophenolic Acid|mycophenolic acid|mesh-list
64917042|NCT00006239|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64917043|NCT00006239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917044|NCT00006239|Keratolytic Agents|keratolytic agents|mesh-ancestor
64917045|NCT00006239|Dermatologic Agents|dermatologic agents|mesh-ancestor
64917047|NCT00094003|Antiviral Agents|antiviral agents|mesh-ancestor
64917048|NCT00094003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917049|NCT00094003|Interferon Inducers|interferon inducers|mesh-ancestor
64917050|NCT00094003|Immunologic Factors|immunologic factors|mesh-ancestor
64917051|NCT00094003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917052|NCT00094081|Tirapazamine|tirapazamine|mesh-list
64917053|NCT00094081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917054|NCT00094120|Squalamine|squalamine|mesh-list
64917055|NCT00094120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64917056|NCT00094120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917057|NCT00094120|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64917058|NCT00094120|Protective Agents|protective agents|mesh-ancestor
64917059|NCT00094120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917060|NCT00094120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917061|NCT00094120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64917062|NCT00094120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64917063|NCT00094120|Growth Substances|growth substances|mesh-ancestor
64917064|NCT00094120|Growth Inhibitors|growth inhibitors|mesh-ancestor
64917065|NCT00006245|Paclitaxel|paclitaxel|mesh-list
64917066|NCT00006245|Alvocidib|alvocidib|mesh-list
64917067|NCT00006245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64917068|NCT00006245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917069|NCT00006245|Tubulin Modulators|tubulin modulators|mesh-ancestor
64917070|NCT00006245|Antimitotic Agents|antimitotic agents|mesh-ancestor
64917071|NCT00006245|Mitosis Modulators|mitosis modulators|mesh-ancestor
64917072|NCT00006245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917079|NCT00094315|Anesthetics, Local|anesthetics, local|mesh-ancestor
64917080|NCT00094315|Anesthetics|anesthetics|mesh-ancestor
64917094|NCT00094432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64917095|NCT00094432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64917096|NCT00094432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64917097|NCT00094432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64917098|NCT00094432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917099|NCT00094432|Dopamine Agonists|dopamine agonists|mesh-ancestor
64917100|NCT00094432|Dopamine Agents|dopamine agents|mesh-ancestor
64917101|NCT00094432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64917103|NCT00094432|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64917127|NCT00094549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64917128|NCT00094549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917129|NCT00094549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64917130|NCT00094549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64917131|NCT00094549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64917132|NCT00094549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64917133|NCT00094549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64917134|NCT00094549|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64917135|NCT00094549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64917136|NCT00094549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64917169|NCT00006251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917170|NCT00006251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64917171|NCT00006251|Antimetabolites|antimetabolites|mesh-ancestor
64917172|NCT00006251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917173|NCT00006251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64917174|NCT00006251|Immunologic Factors|immunologic factors|mesh-ancestor
64917175|NCT00006251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917176|NCT00006251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917177|NCT00006251|Antifungal Agents|antifungal agents|mesh-ancestor
64917178|NCT00006251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917179|NCT00006251|Dermatologic Agents|dermatologic agents|mesh-ancestor
64917180|NCT00006251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64917181|NCT00006251|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64917182|NCT00006251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64917183|NCT00006251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64917184|NCT00006251|Antitubercular Agents|antitubercular agents|mesh-ancestor
64917185|NCT00006251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64917187|NCT00094978|Romidepsin|romidepsin|mesh-list
64917188|NCT00094978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917189|NCT00094978|Growth Inhibitors|growth inhibitors|mesh-ancestor
64917190|NCT00094978|Growth Substances|growth substances|mesh-ancestor
64917191|NCT00094978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917192|NCT00094978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64917193|NCT00094978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917194|NCT00094978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917225|NCT00095251|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64917226|NCT00095251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64917227|NCT00095251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917228|NCT00095251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64917229|NCT00095251|Analgesics|analgesics|mesh-ancestor
64917230|NCT00095251|Sensory System Agents|sensory system agents|mesh-ancestor
64917231|NCT00095251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64917232|NCT00095251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64917233|NCT00095251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64917234|NCT00095251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64917235|NCT00095251|Adrenergic Agents|adrenergic agents|mesh-ancestor
64917236|NCT00095251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64917237|NCT00095251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917302|NCT00095641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917303|NCT00006269|Irinotecan|irinotecan|mesh-list
64917304|NCT00006269|Octreotide|octreotide|mesh-list
64917305|NCT00006269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64917306|NCT00006269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64917307|NCT00006269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917308|NCT00006269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917309|NCT00006269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917310|NCT00006269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64917311|NCT00006269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64917335|NCT00095719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64917336|NCT00095719|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64917337|NCT00095719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64917338|NCT00095719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64917339|NCT00095719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917340|NCT00095719|Dopamine Agonists|dopamine agonists|mesh-ancestor
64917341|NCT00095719|Dopamine Agents|dopamine agents|mesh-ancestor
64917342|NCT00095719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64917343|NCT00095719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917344|NCT00095719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64917345|NCT00095719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64917346|NCT00095719|Serotonin Agents|serotonin agents|mesh-ancestor
64917347|NCT00095719|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64917348|NCT00095719|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64917349|NCT00095719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64917350|NCT00095719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64917351|NCT00095758|Aripiprazole|aripiprazole|mesh-list
64917352|NCT00095758|Antidepressive Agents|antidepressive agents|mesh-list
64917353|NCT00095758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64917354|NCT00095758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64917355|NCT00095758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64917356|NCT00095758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64989630|NCT05735353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64989631|NCT05735353|Dopamine Agents|dopamine agents|mesh-ancestor
64989632|NCT05735353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64989634|NCT05735353|Adrenergic Agents|adrenergic agents|mesh-ancestor
64989677|NCT05712941|Letrozole|letrozole|mesh-list
64989734|NCT05685602|Mitosis Modulators|mitosis modulators|mesh-ancestor
64989735|NCT05685602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989736|NCT05685602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64989737|NCT05685602|Antimetabolites|antimetabolites|mesh-ancestor
64989738|NCT05685602|Antiviral Agents|antiviral agents|mesh-ancestor
64917357|NCT00095758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917358|NCT00095758|Dopamine Agonists|dopamine agonists|mesh-ancestor
64917359|NCT00095758|Dopamine Agents|dopamine agents|mesh-ancestor
64917381|NCT04432428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917382|NCT04432428|Analgesics|analgesics|mesh-ancestor
64917383|NCT04432428|Sensory System Agents|sensory system agents|mesh-ancestor
64917384|NCT04432428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64917385|NCT04432428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64917386|NCT04432428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64917387|NCT04432428|Anesthetics, General|anesthetics, general|mesh-ancestor
64917388|NCT04432428|Anesthetics|anesthetics|mesh-ancestor
64917389|NCT00096070|Gemcitabine|gemcitabine|mesh-list
64917390|NCT00096070|Fluorouracil|fluorouracil|mesh-list
64917391|NCT00096070|Oxaliplatin|oxaliplatin|mesh-list
64917392|NCT00096070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64917393|NCT00096070|Antimetabolites|antimetabolites|mesh-ancestor
64917394|NCT00096070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917395|NCT00096070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917396|NCT00096070|Antiviral Agents|antiviral agents|mesh-ancestor
64917397|NCT00096070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917398|NCT00096070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917399|NCT00096070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64917400|NCT00096070|Immunologic Factors|immunologic factors|mesh-ancestor
64917401|NCT00096070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917402|NCT00006275|Calcitriol|calcitriol|mesh-list
64917403|NCT00006275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64917404|NCT00006275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917405|NCT00006275|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64917406|NCT00006275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64917407|NCT00006275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917408|NCT00006275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64917409|NCT00006275|Vitamins|vitamins|mesh-ancestor
64917410|NCT00006275|Micronutrients|micronutrients|mesh-ancestor
64917411|NCT00006275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64917412|NCT00096148|Cytarabine|cytarabine|mesh-list
64917413|NCT00096148|Bevacizumab|bevacizumab|mesh-list
64989739|NCT05685602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64989794|NCT05675410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64917414|NCT00096148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64917422|NCT00096148|Growth Substances|growth substances|mesh-ancestor
64917423|NCT00096148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917424|NCT00096148|Growth Inhibitors|growth inhibitors|mesh-ancestor
64917425|NCT00096148|Immunologic Factors|immunologic factors|mesh-ancestor
64917426|NCT00096148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64917427|NCT00096148|Antimetabolites|antimetabolites|mesh-ancestor
64917428|NCT00096148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917429|NCT00096148|Antiviral Agents|antiviral agents|mesh-ancestor
64917430|NCT00096148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917431|NCT00096148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64917432|NCT00096148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64917433|NCT00096148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64917434|NCT00096148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64917435|NCT00096148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917437|NCT00096187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917438|NCT00096187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917439|NCT00096187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917440|NCT00096187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64917441|NCT00096187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64917442|NCT00096304|Docetaxel|docetaxel|mesh-list
64917443|NCT00096304|Epirubicin|epirubicin|mesh-list
64917487|NCT00096694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64917488|NCT00006299|Celecoxib|celecoxib|mesh-list
64917489|NCT00006299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64917490|NCT00006299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64917491|NCT00006299|Analgesics|analgesics|mesh-ancestor
64917492|NCT00006299|Sensory System Agents|sensory system agents|mesh-ancestor
64917493|NCT00006299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64917513|NCT00096850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64917514|NCT00096850|Antiviral Agents|antiviral agents|mesh-ancestor
64917515|NCT00096850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917516|NCT00096850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64917517|NCT00096850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64917518|NCT00096850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64917519|NCT00096850|Antitubercular Agents|antitubercular agents|mesh-ancestor
64917520|NCT00096850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64917521|NCT00096850|Leprostatic Agents|leprostatic agents|mesh-ancestor
64917522|NCT00096850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64917523|NCT00096850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64917524|NCT00096850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64917525|NCT00096850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64917526|NCT00096850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64917527|NCT00096850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64917528|NCT00096850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64917529|NCT00096967|Bevacizumab|bevacizumab|mesh-list
64917530|NCT00096967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64917531|NCT00096967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917532|NCT00096967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64917533|NCT00096967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64917534|NCT00096967|Growth Substances|growth substances|mesh-ancestor
64917535|NCT00096967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917536|NCT00096967|Growth Inhibitors|growth inhibitors|mesh-ancestor
64917537|NCT04340076|Ixekizumab|ixekizumab|mesh-list
64917538|NCT04340076|Brodalumab|brodalumab|mesh-list
64917539|NCT04340076|Dermatologic Agents|dermatologic agents|mesh-ancestor
64917540|NCT00097045|Interferons|interferons|mesh-list
64917541|NCT00097045|Ribavirin|ribavirin|mesh-list
64917558|NCT04310709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64917559|NCT04310709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917560|NCT00006320|Anti-HIV Agents|anti-hiv agents|mesh-list
64917561|NCT00006320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64917562|NCT00006320|Antiviral Agents|antiviral agents|mesh-ancestor
64917563|NCT00006320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917564|NCT00097123|Misoprostol|misoprostol|mesh-list
64917565|NCT00097123|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64917566|NCT00097123|Abortifacient Agents|abortifacient agents|mesh-ancestor
64917567|NCT00097123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64917568|NCT00097123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917569|NCT00097123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64686032|NCT02115997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64917570|NCT00097123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64917572|NCT00097279|Metformin|metformin|mesh-list
64917573|NCT00097279|Pioglitazone|pioglitazone|mesh-list
64917574|NCT00097279|Insulin Aspart|insulin aspart|mesh-list
64917575|NCT00097279|Biphasic Insulins|biphasic insulins|mesh-list
64917576|NCT00097279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64917577|NCT00097279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917578|NCT00390273|Metformin|metformin|mesh-list
64917634|NCT00400387|Anticoagulants|anticoagulants|mesh-ancestor
64917635|NCT00400387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64917636|NCT00400387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64917637|NCT00400387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917638|NCT00400387|Vitamins|vitamins|mesh-ancestor
64917639|NCT00400387|Micronutrients|micronutrients|mesh-ancestor
64917652|NCT00006332|Growth Substances|growth substances|mesh-ancestor
64917653|NCT00006332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917654|NCT00006332|Growth Inhibitors|growth inhibitors|mesh-ancestor
64917655|NCT00006332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917656|NCT00390390|Lansoprazole|lansoprazole|mesh-list
64917657|NCT00390390|Dexlansoprazole|dexlansoprazole|mesh-list
64917658|NCT00390390|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64917659|NCT00390390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64917660|NCT00390390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64917661|NCT00390390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917662|NCT00390390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917663|NCT00097825|Zoledronic Acid|zoledronic acid|mesh-list
64917664|NCT00097825|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64917665|NCT00097825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917666|NCT00097903|Camptothecin|camptothecin|mesh-list
64917667|NCT00097903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64917668|NCT00097903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917669|NCT00097903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64917670|NCT00097903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64917671|NCT00097903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917702|NCT00098488|Immunologic Factors|immunologic factors|mesh-ancestor
64917703|NCT00098488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917704|NCT00098488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64917705|NCT00098527|Romidepsin|romidepsin|mesh-list
64917706|NCT00098527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64917707|NCT00098527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917708|NCT00006347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64917709|NCT00006347|Antibodies|antibodies|mesh-list
64917710|NCT00006347|Immunoglobulins|immunoglobulins|mesh-list
64917711|NCT00006347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64917712|NCT00006347|Immunologic Factors|immunologic factors|mesh-ancestor
64917713|NCT00006347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917714|NCT00006347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917715|NCT00098605|Lapatinib|lapatinib|mesh-list
64917716|NCT00098605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917717|NCT00098605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64917718|NCT00098605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917720|NCT04290546|Cetuximab|cetuximab|mesh-list
64917739|NCT03633305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917740|NCT00098917|Vaccines|vaccines|mesh-list
64917741|NCT00098917|Immunologic Factors|immunologic factors|mesh-ancestor
64917742|NCT00098917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917743|NCT00098995|Tirapazamine|tirapazamine|mesh-list
64917744|NCT00098995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917745|NCT00099190|Beta-lapachone|beta-lapachone|mesh-list
64917746|NCT00099190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917747|NCT00099190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64917748|NCT00099190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64917749|NCT00099190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917750|NCT00099190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917751|NCT00099190|Antiviral Agents|antiviral agents|mesh-ancestor
64917752|NCT04231851|Cytarabine|cytarabine|mesh-list
64917753|NCT04231851|Daunorubicin|daunorubicin|mesh-list
64917754|NCT04231851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64917755|NCT04231851|Antimetabolites|antimetabolites|mesh-ancestor
64382455|NCT02046616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64989795|NCT05675410|Immunologic Factors|immunologic factors|mesh-ancestor
64989796|NCT05675410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989797|NCT05675410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64989798|NCT05675410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64989799|NCT05675410|Alkylating Agents|alkylating agents|mesh-ancestor
64917756|NCT04231851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917757|NCT04231851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917758|NCT04231851|Antiviral Agents|antiviral agents|mesh-ancestor
64917759|NCT04231851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917760|NCT04231851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64917761|NCT04231851|Immunologic Factors|immunologic factors|mesh-ancestor
64917762|NCT04231851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917763|NCT04231851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64917764|NCT04231851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64917765|NCT04231851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64917766|NCT04231851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917767|NCT00099502|Interferons|interferons|mesh-list
64917768|NCT00099502|Interferon-beta|interferon-beta|mesh-list
64917784|NCT00387920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917785|NCT00387920|Growth Inhibitors|growth inhibitors|mesh-ancestor
64917786|NCT00387920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64917787|NCT00387920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917788|NCT00387920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917789|NCT00099541|Zoledronic Acid|zoledronic acid|mesh-list
64917790|NCT00099541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64917791|NCT00099541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917792|NCT02888067|Bromides|bromides|mesh-list
64917793|NCT02888067|Rocuronium|rocuronium|mesh-list
64917838|NCT00400738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917839|NCT00400738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917840|NCT00400738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64917841|NCT00400738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64917842|NCT00400738|Antiviral Agents|antiviral agents|mesh-ancestor
64917843|NCT00400738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917844|NCT00400738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64917845|NCT00400738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64917846|NCT00006356|Carboplatin|carboplatin|mesh-list
64917847|NCT00006356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917848|NCT00099619|Insulin|insulin|mesh-list
64917849|NCT00099619|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64917850|NCT00099619|Insulin Glargine|insulin glargine|mesh-list
64917851|NCT00099619|Exenatide|exenatide|mesh-list
64917852|NCT00099619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64917879|NCT04143711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917880|NCT04143711|Tubulin Modulators|tubulin modulators|mesh-ancestor
64917881|NCT04143711|Antimitotic Agents|antimitotic agents|mesh-ancestor
64917882|NCT04143711|Mitosis Modulators|mitosis modulators|mesh-ancestor
64917883|NCT04143711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917884|NCT04143711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64917885|NCT04143711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64917886|NCT00099775|Caspofungin|caspofungin|mesh-list
64917964|NCT00006371|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64917965|NCT00006371|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64917966|NCT00006371|Aminoglutethimide|aminoglutethimide|mesh-list
64917967|NCT00006371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64917968|NCT00006371|Antifungal Agents|antifungal agents|mesh-ancestor
64917969|NCT00006371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917981|NCT00006371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64917982|NCT00006371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64917983|NCT04062708|Durvalumab|durvalumab|mesh-list
64917984|NCT04062708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64917985|NCT04062708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917986|NCT00100594|Lamivudine|lamivudine|mesh-list
64917987|NCT00100594|Zidovudine|zidovudine|mesh-list
64917988|NCT00100594|Efavirenz|efavirenz|mesh-list
64917989|NCT00100594|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64917990|NCT00100594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64917991|NCT00100594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64917992|NCT00100594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917993|NCT00100594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917994|NCT00100594|Antiviral Agents|antiviral agents|mesh-ancestor
64917995|NCT00100594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917996|NCT00100594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64917997|NCT00100594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64917998|NCT00100594|Antimetabolites|antimetabolites|mesh-ancestor
64917999|NCT00100594|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64918000|NCT00100594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64918001|NCT00100594|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64918002|NCT00100594|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64918003|NCT00100594|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64918004|NCT00100594|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64918005|NCT00006374|Paclitaxel|paclitaxel|mesh-list
64918006|NCT00006374|Etoposide|etoposide|mesh-list
64918007|NCT00006374|Topotecan|topotecan|mesh-list
64918008|NCT00006374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64918009|NCT00006374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918026|NCT00100750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918027|NCT00100750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64918028|NCT00100750|Immunologic Factors|immunologic factors|mesh-ancestor
64918029|NCT00100750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918031|NCT00006377|Carboplatin|carboplatin|mesh-list
64918032|NCT00006377|Doxorubicin|doxorubicin|mesh-list
64918033|NCT00006377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64918034|NCT00006377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64918035|NCT00006377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918036|NCT00006377|Tubulin Modulators|tubulin modulators|mesh-ancestor
64918037|NCT00006377|Antimitotic Agents|antimitotic agents|mesh-ancestor
64918038|NCT00006377|Mitosis Modulators|mitosis modulators|mesh-ancestor
64918039|NCT00006377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918040|NCT00006377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64918041|NCT00006377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64918042|NCT00006377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64918043|NCT00006377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918044|NCT01350102|Ascorbic Acid|ascorbic acid|mesh-list
64918045|NCT01350102|Bacitracin|bacitracin|mesh-list
64918046|NCT01350102|Vitamins|vitamins|mesh-ancestor
64918047|NCT01350102|Micronutrients|micronutrients|mesh-ancestor
64918048|NCT01350102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918049|NCT01350102|Antioxidants|antioxidants|mesh-ancestor
64918050|NCT01350102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918051|NCT01350102|Protective Agents|protective agents|mesh-ancestor
64918052|NCT01350102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64918053|NCT01350102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64918054|NCT01350102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64918055|NCT00424060|Sagopilone|sagopilone|mesh-list
64918056|NCT00424060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918057|NCT00006380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64918058|NCT00006380|Antibodies|antibodies|mesh-list
64918059|NCT00006380|Immunoglobulins|immunoglobulins|mesh-list
64918060|NCT00006380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64918083|NCT00100945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918084|NCT00006383|Vincristine|vincristine|mesh-list
64918086|NCT00006383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918110|NCT00101062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64918111|NCT00101062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64918113|NCT00101062|Sensory System Agents|sensory system agents|mesh-ancestor
64918114|NCT00101062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64918115|NCT00101062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64918116|NCT00101062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64918117|NCT00101062|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64918118|NCT00101062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64918120|NCT00006386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64918121|NCT00006386|Alkylating Agents|alkylating agents|mesh-ancestor
64918174|NCT00400855|Respiratory System Agents|respiratory system agents|mesh-ancestor
64918175|NCT00400855|Dermatologic Agents|dermatologic agents|mesh-ancestor
64918196|NCT00101335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64918197|NCT00101335|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64918198|NCT00101335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64918199|NCT00101335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918200|NCT00101335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918201|NCT00101374|Leflunomide|leflunomide|mesh-list
64918202|NCT00101374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918203|NCT00101374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918204|NCT00101374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64918205|NCT00101374|Immunologic Factors|immunologic factors|mesh-ancestor
64918206|NCT00101374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918207|NCT00006401|Nitric Oxide|nitric oxide|mesh-list
64918208|NCT00006401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64918209|NCT00006401|Autonomic Agents|autonomic agents|mesh-ancestor
64918210|NCT00006401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64918211|NCT00006401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918212|NCT00006401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64918213|NCT00006401|Respiratory System Agents|respiratory system agents|mesh-ancestor
64918214|NCT00006401|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64918215|NCT00006401|Antioxidants|antioxidants|mesh-ancestor
64918216|NCT00006401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918217|NCT00006401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64918218|NCT00006401|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64918219|NCT00006401|Vasodilator Agents|vasodilator agents|mesh-ancestor
64918220|NCT00006401|Gasotransmitters|gasotransmitters|mesh-ancestor
64918221|NCT00006401|Protective Agents|protective agents|mesh-ancestor
64918222|NCT00101569|Aripiprazole|aripiprazole|mesh-list
64918240|NCT03991884|Prednisone|prednisone|mesh-list
64918285|NCT00101764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64918286|NCT00101764|Immunologic Factors|immunologic factors|mesh-ancestor
64918287|NCT00101764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918289|NCT00101803|Vildagliptin|vildagliptin|mesh-list
64918295|NCT00101803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918296|NCT00101842|Gemcitabine|gemcitabine|mesh-list
64918297|NCT00101842|Pemetrexed|pemetrexed|mesh-list
64918298|NCT00101842|Cisplatin|cisplatin|mesh-list
64918299|NCT00101842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64918300|NCT00101842|Antimetabolites|antimetabolites|mesh-ancestor
64918301|NCT00101842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918302|NCT00101842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918342|NCT00102388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918343|NCT00102388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918344|NCT00102505|Motexafin gadolinium|motexafin gadolinium|mesh-list
64918345|NCT00102505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918346|NCT00102505|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64918347|NCT00102505|Dermatologic Agents|dermatologic agents|mesh-ancestor
64918348|NCT00102583|Cyclosporine|cyclosporine|mesh-list
64918349|NCT00102583|Cyclosporins|cyclosporins|mesh-list
64918350|NCT00102583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918351|NCT00102583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918352|NCT00102583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64918353|NCT00102583|Immunologic Factors|immunologic factors|mesh-ancestor
64918354|NCT00102583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918355|NCT00102583|Antifungal Agents|antifungal agents|mesh-ancestor
64918356|NCT00102583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64918357|NCT00102583|Dermatologic Agents|dermatologic agents|mesh-ancestor
64918358|NCT00102583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64918359|NCT00102583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64918360|NCT00102622|Paclitaxel|paclitaxel|mesh-list
64918361|NCT00102622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64918362|NCT00102622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918395|NCT00102700|Immunologic Factors|immunologic factors|mesh-ancestor
64918396|NCT00102700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918397|NCT00102700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64918398|NCT00102700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64918399|NCT00102778|Ritonavir|ritonavir|mesh-list
64918400|NCT00102778|Lopinavir|lopinavir|mesh-list
64918401|NCT00102778|Aplaviroc|aplaviroc|mesh-list
64918402|NCT00102778|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64918403|NCT00102778|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64918404|NCT00102778|Protease Inhibitors|protease inhibitors|mesh-ancestor
64918405|NCT00102778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918406|NCT00102778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918407|NCT00102778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64918408|NCT00102778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64918409|NCT00102778|Antiviral Agents|antiviral agents|mesh-ancestor
64918410|NCT00102778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64918411|NCT00102778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64918412|NCT00102778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64918415|NCT00101998|Alvimopan|alvimopan|mesh-list
64918485|NCT02697474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918486|NCT00103246|Silicon|silicon|mesh-list
64918487|NCT00103246|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
64918488|NCT00103246|Trace Elements|trace elements|mesh-ancestor
64918489|NCT00103246|Micronutrients|micronutrients|mesh-ancestor
64918490|NCT00103246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918491|NCT00103246|Antimalarials|antimalarials|mesh-ancestor
64918492|NCT00103246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64918493|NCT00103246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64918494|NCT00103246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64918495|NCT00103246|Antiviral Agents|antiviral agents|mesh-ancestor
64918496|NCT00103246|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64918497|NCT00103246|Dermatologic Agents|dermatologic agents|mesh-ancestor
64918498|NCT00103324|Lapatinib|lapatinib|mesh-list
64918499|NCT00103324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918500|NCT00103324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64918501|NCT00103324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918502|NCT00103324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918503|NCT00103519|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
64918504|NCT00103519|Hormones|hormones|mesh-ancestor
64918505|NCT00103519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64918506|NCT00103519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918508|NCT00103597|Domperidone|domperidone|mesh-list
64918527|NCT00103753|Chelating Agents|chelating agents|mesh-ancestor
64918528|NCT00103753|Sequestering Agents|sequestering agents|mesh-ancestor
64918529|NCT00103753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918530|NCT00006452|Motexafin gadolinium|motexafin gadolinium|mesh-list
64918531|NCT00006452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918532|NCT00006452|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64918533|NCT00006452|Dermatologic Agents|dermatologic agents|mesh-ancestor
64918534|NCT00103792|Mycophenolic Acid|mycophenolic acid|mesh-list
64918535|NCT00103792|Cyclophosphamide|cyclophosphamide|mesh-list
64918536|NCT00103792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64918537|NCT00103792|Immunologic Factors|immunologic factors|mesh-ancestor
64918543|NCT00103792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918544|NCT00103792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64918545|NCT00103792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64918546|NCT00103792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64918547|NCT00103792|Antitubercular Agents|antitubercular agents|mesh-ancestor
64918548|NCT00103792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64687011|NCT02505269|Doxorubicin|doxorubicin|mesh-list
64918549|NCT00103792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64918551|NCT00103948|Donepezil|donepezil|mesh-list
64918552|NCT00103948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64918553|NCT00103948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918554|NCT00103948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918555|NCT00103948|Cholinergic Agents|cholinergic agents|mesh-ancestor
64918556|NCT00103948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64918571|NCT03879408|Analgesics|analgesics|mesh-ancestor
64918572|NCT03879408|Sensory System Agents|sensory system agents|mesh-ancestor
64918573|NCT03879408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64918574|NCT03879408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918575|NCT03879408|Antipyretics|antipyretics|mesh-ancestor
64918576|NCT03879408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64918577|NCT03879408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64918578|NCT03879408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64918579|NCT03879408|Gout Suppressants|gout suppressants|mesh-ancestor
64918580|NCT03879408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64918581|NCT03879408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918582|NCT03879408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918583|NCT03879408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64918584|NCT03879408|Narcotics|narcotics|mesh-ancestor
64918585|NCT03879408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64918586|NCT03879408|Antitussive Agents|antitussive agents|mesh-ancestor
64918620|NCT00104689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918621|NCT00006461|Cyclophosphamide|cyclophosphamide|mesh-list
64918622|NCT00006461|Etoposide|etoposide|mesh-list
64918623|NCT00006461|Vincristine|vincristine|mesh-list
64918624|NCT00006461|Etoposide phosphate|etoposide phosphate|mesh-list
64918625|NCT00006461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64918626|NCT00006461|Immunologic Factors|immunologic factors|mesh-ancestor
64918627|NCT00006461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918628|NCT00006461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64918629|NCT00006461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64918630|NCT00006461|Alkylating Agents|alkylating agents|mesh-ancestor
64918631|NCT00006461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918632|NCT00006461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918633|NCT00006461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64918634|NCT00006461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64918635|NCT00006461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64918636|NCT00006461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64918637|NCT00006461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918638|NCT00006461|Tubulin Modulators|tubulin modulators|mesh-ancestor
64918639|NCT00006461|Antimitotic Agents|antimitotic agents|mesh-ancestor
64918640|NCT00006461|Mitosis Modulators|mitosis modulators|mesh-ancestor
64918641|NCT00104767|Celecoxib|celecoxib|mesh-list
64918644|NCT00104767|Analgesics|analgesics|mesh-ancestor
64918661|NCT02972268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918662|NCT02972268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918663|NCT02972268|Urological Agents|urological agents|mesh-ancestor
64918664|NCT02972268|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64918665|NCT02972268|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64918666|NCT02972268|Cholinergic Agents|cholinergic agents|mesh-ancestor
64918667|NCT00104806|Cholecalciferol|cholecalciferol|mesh-list
64918668|NCT00104806|Vitamin D|vitamin d|mesh-list
64918669|NCT00104806|Arsenic Trioxide|arsenic trioxide|mesh-list
64918670|NCT00104806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64918671|NCT00104806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918672|NCT00104806|Vitamins|vitamins|mesh-ancestor
64918673|NCT00104806|Micronutrients|micronutrients|mesh-ancestor
64918674|NCT00104806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64918675|NCT00104806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918676|NCT00401128|Gemcitabine|gemcitabine|mesh-list
64918677|NCT00401128|Irinotecan|irinotecan|mesh-list
64918678|NCT00401128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64918755|NCT00105547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918756|NCT00105547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64918757|NCT00105547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64918758|NCT00105547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64918759|NCT00105547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64918760|NCT00105547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64918761|NCT00105547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918762|NCT00105547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918763|NCT00390624|Mannitol|mannitol|mesh-list
64918764|NCT00390624|Ularitide|ularitide|mesh-list
64918765|NCT00390624|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64918766|NCT00390624|Diuretics|diuretics|mesh-ancestor
64918767|NCT00390624|Natriuretic Agents|natriuretic agents|mesh-ancestor
64918768|NCT00390624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918769|NCT00390624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64918770|NCT00390624|Autonomic Agents|autonomic agents|mesh-ancestor
64918771|NCT00390624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64918798|NCT00006479|Oxaliplatin|oxaliplatin|mesh-list
64918799|NCT00006479|Calcium|calcium|mesh-list
64918800|NCT00006479|Levoleucovorin|levoleucovorin|mesh-list
64918801|NCT00006479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64918802|NCT00006479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918803|NCT00006479|Antimetabolites|antimetabolites|mesh-ancestor
64918804|NCT00006479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918805|NCT00006479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64918806|NCT00006479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918807|NCT00006479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64918808|NCT00006479|Immunologic Factors|immunologic factors|mesh-ancestor
64918809|NCT00006479|Antidotes|antidotes|mesh-ancestor
64918810|NCT00006479|Protective Agents|protective agents|mesh-ancestor
64918811|NCT00006479|Vitamin B Complex|vitamin b complex|mesh-ancestor
64918812|NCT00006479|Vitamins|vitamins|mesh-ancestor
64918813|NCT00006479|Micronutrients|micronutrients|mesh-ancestor
64918814|NCT00106054|Leucovorin|leucovorin|mesh-list
64918815|NCT00106054|Bevacizumab|bevacizumab|mesh-list
64918816|NCT00106054|Irinotecan|irinotecan|mesh-list
64918818|NCT00106054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918819|NCT00106054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64918820|NCT00106054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64918821|NCT00106054|Growth Substances|growth substances|mesh-ancestor
64918822|NCT00106054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918823|NCT00106054|Growth Inhibitors|growth inhibitors|mesh-ancestor
64918824|NCT00106054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64918825|NCT00106054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64918826|NCT00106054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918827|NCT00106054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918828|NCT00106054|Antidotes|antidotes|mesh-ancestor
64918829|NCT00106054|Protective Agents|protective agents|mesh-ancestor
64918842|NCT00106132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64918843|NCT00106132|Immunologic Factors|immunologic factors|mesh-ancestor
64918844|NCT00106132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918845|NCT00106132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918846|NCT00106171|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64918847|NCT00106171|Antiviral Agents|antiviral agents|mesh-ancestor
64918848|NCT00106171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64918849|NCT03815682|Pembrolizumab|pembrolizumab|mesh-list
64918850|NCT03815682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64918851|NCT03815682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918852|NCT00106288|Amphotericin B|amphotericin b|mesh-list
64918853|NCT00106288|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64918855|NCT00106288|Amebicides|amebicides|mesh-ancestor
64918885|NCT03809988|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64918886|NCT03809988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64918887|NCT00106366|Insulin|insulin|mesh-list
64918888|NCT00106366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64918889|NCT00106366|Insulin Glargine|insulin glargine|mesh-list
64918890|NCT00106366|Insulin Aspart|insulin aspart|mesh-list
64918891|NCT00106366|Insulin Detemir|insulin detemir|mesh-list
64918892|NCT00106366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64918893|NCT00106366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918894|NCT00106405|Memantine|memantine|mesh-list
64918895|NCT00106405|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64918896|NCT00106405|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64918897|NCT00106405|Dopamine Agents|dopamine agents|mesh-ancestor
64918898|NCT00106405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64918899|NCT00106405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918900|NCT00106405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918901|NCT00106405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64918902|NCT00106405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64918903|NCT00006485|Irinotecan|irinotecan|mesh-list
64918904|NCT00006485|Alvocidib|alvocidib|mesh-list
64918905|NCT00006485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64918906|NCT00006485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64918907|NCT00006485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918908|NCT00006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918942|NCT00106561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918943|NCT00106600|Pixantrone|pixantrone|mesh-list
64918944|NCT00106600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64918945|NCT00106600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64918946|NCT00106600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918947|NCT00106600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918948|NCT00106600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918949|NCT00401206|Dexmedetomidine|dexmedetomidine|mesh-list
64918950|NCT00401206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64918951|NCT00401206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64918952|NCT00401206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918953|NCT00401206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64918954|NCT00401206|Analgesics|analgesics|mesh-ancestor
64918955|NCT00401206|Sensory System Agents|sensory system agents|mesh-ancestor
64918961|NCT00401206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64918962|NCT00401206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918963|NCT00401323|Docetaxel|docetaxel|mesh-list
64918964|NCT00401323|Fluorouracil|fluorouracil|mesh-list
64918965|NCT00401323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918966|NCT00401323|Tubulin Modulators|tubulin modulators|mesh-ancestor
64918967|NCT00401323|Antimitotic Agents|antimitotic agents|mesh-ancestor
64918968|NCT00401323|Mitosis Modulators|mitosis modulators|mesh-ancestor
64918969|NCT00401323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918970|NCT00401323|Antimetabolites|antimetabolites|mesh-ancestor
64918971|NCT00401323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64918972|NCT00401323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64918973|NCT00401323|Immunologic Factors|immunologic factors|mesh-ancestor
64918974|NCT00401323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918975|NCT00401362|Naltrexone|naltrexone|mesh-list
64918976|NCT00401362|Methylnaltrexone|methylnaltrexone|mesh-list
64918987|NCT03746106|Metformin|metformin|mesh-list
64918988|NCT03746106|Trimethoprim|trimethoprim|mesh-list
64918989|NCT03746106|Vitamins|vitamins|mesh-ancestor
64918990|NCT03746106|Micronutrients|micronutrients|mesh-ancestor
64919009|NCT00107263|Zoledronic Acid|zoledronic acid|mesh-list
64919011|NCT00107263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919012|NCT00107263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64919013|NCT00107263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64919014|NCT00107263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919015|NCT00107263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919016|NCT00107263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64919017|NCT00107263|Hormone Antagonists|hormone antagonists|mesh-ancestor
64919018|NCT00107263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64919019|NCT00107263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919020|NCT00107263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64919021|NCT02964949|Edoxaban|edoxaban|mesh-list
64919022|NCT02964949|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64919023|NCT02964949|Antithrombins|antithrombins|mesh-ancestor
64919024|NCT02964949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64919025|NCT02964949|Protease Inhibitors|protease inhibitors|mesh-ancestor
64919026|NCT02964949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919027|NCT02964949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919028|NCT02964949|Anticoagulants|anticoagulants|mesh-ancestor
64919063|NCT00006578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64919064|NCT00006578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64919065|NCT00006578|Antitubercular Agents|antitubercular agents|mesh-ancestor
64919066|NCT00006578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64919072|NCT00107458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64919073|NCT00107458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919074|NCT00107458|Antimanic Agents|antimanic agents|mesh-ancestor
64919075|NCT00107458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64919076|NCT00107458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64919077|NCT00107458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64919078|NCT00006617|Lamivudine|lamivudine|mesh-list
64919079|NCT00006617|Zidovudine|zidovudine|mesh-list
64919081|NCT00006617|Amprenavir|amprenavir|mesh-list
64919082|NCT00006617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64919083|NCT00006617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64919084|NCT00006617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919085|NCT00006617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919086|NCT00006617|Antiviral Agents|antiviral agents|mesh-ancestor
64919087|NCT00006617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919088|NCT00006617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64919089|NCT00006617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64919090|NCT00006617|Antimetabolites|antimetabolites|mesh-ancestor
64919113|NCT04712396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919114|NCT04712396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64919115|NCT04712396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64919116|NCT04712396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919118|NCT04712396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64919151|NCT00107848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919152|NCT00006695|Iodine|iodine|mesh-list
64919153|NCT00006695|Cytarabine|cytarabine|mesh-list
64919154|NCT00006695|Etoposide|etoposide|mesh-list
64919155|NCT00006695|Melphalan|melphalan|mesh-list
64919156|NCT00006695|Carmustine|carmustine|mesh-list
64919157|NCT00006695|Tositumomab I-131|tositumomab i-131|mesh-list
64919158|NCT00006695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64919159|NCT00006695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919160|NCT00006695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64919161|NCT00006695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64919162|NCT00006695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919163|NCT00006695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919164|NCT00006695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64919165|NCT00006695|Antimetabolites|antimetabolites|mesh-ancestor
64919166|NCT00006695|Antiviral Agents|antiviral agents|mesh-ancestor
64919167|NCT00006695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919168|NCT00006695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64919169|NCT00006695|Immunologic Factors|immunologic factors|mesh-ancestor
64919170|NCT00006695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919171|NCT00006695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64919181|NCT00006734|Ifosfamide|ifosfamide|mesh-list
64919245|NCT00108511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919246|NCT00401440|Misoprostol|misoprostol|mesh-list
64919247|NCT00401440|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64919248|NCT00401440|Abortifacient Agents|abortifacient agents|mesh-ancestor
64919249|NCT00401440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64919250|NCT00401440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919251|NCT00401440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64919252|NCT00401440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64919253|NCT00401440|Oxytocics|oxytocics|mesh-ancestor
64919254|NCT03620019|Denosumab|denosumab|mesh-list
64919255|NCT03620019|Pembrolizumab|pembrolizumab|mesh-list
64919256|NCT03620019|Nivolumab|nivolumab|mesh-list
64919257|NCT03620019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64919258|NCT03620019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919259|NCT03620019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64919260|NCT03620019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919261|NCT03620019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64919262|NCT03620019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919301|NCT00006890|Immunologic Factors|immunologic factors|mesh-ancestor
64919309|NCT00108979|Citalopram|citalopram|mesh-list
64919328|NCT03608397|Cholinergic Agents|cholinergic agents|mesh-ancestor
64919329|NCT03608397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64919330|NCT00109057|Bevacizumab|bevacizumab|mesh-list
64919331|NCT00109057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64919332|NCT00109057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919333|NCT00109057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64919334|NCT00109057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64919335|NCT00109057|Growth Substances|growth substances|mesh-ancestor
64919336|NCT00109057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919337|NCT00109057|Growth Inhibitors|growth inhibitors|mesh-ancestor
64919338|NCT00109096|Pemetrexed|pemetrexed|mesh-list
64919339|NCT00109096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919340|NCT00109096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919341|NCT00109096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919342|NCT00109096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64919343|NCT00109096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64919344|NCT00109135|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
64919345|NCT00109135|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64919346|NCT00109135|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64919347|NCT00109135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64919348|NCT00109135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919349|NCT00109135|Hormones|hormones|mesh-ancestor
64919350|NCT00109135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64919351|NCT00109135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919352|NCT00006929|Suramin|suramin|mesh-list
64919353|NCT00006929|Paclitaxel|paclitaxel|mesh-list
64919354|NCT00006929|Carboplatin|carboplatin|mesh-list
64919355|NCT00006929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64919356|NCT00006929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919357|NCT00006929|Tubulin Modulators|tubulin modulators|mesh-ancestor
64919373|NCT00006968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919374|NCT00006968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64919375|NCT00006968|Antifungal Agents|antifungal agents|mesh-ancestor
64919376|NCT00006968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919377|NCT00006968|Dermatologic Agents|dermatologic agents|mesh-ancestor
64919378|NCT00006968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64919379|NCT00006968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64919380|NCT00006968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919381|NCT00006968|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
64919382|NCT03595917|Prednisone|prednisone|mesh-list
64919383|NCT03595917|Dasatinib|dasatinib|mesh-list
64919384|NCT03595917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64919385|NCT03595917|Glucocorticoids|glucocorticoids|mesh-ancestor
64919386|NCT03595917|Hormones|hormones|mesh-ancestor
64919387|NCT03595917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64919388|NCT03595917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919389|NCT03595917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64919390|NCT03595917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919418|NCT00109603|Tenofovir|tenofovir|mesh-list
64919460|NCT00109993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64919461|NCT00109993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64919462|NCT00109993|Protective Agents|protective agents|mesh-ancestor
64919463|NCT00109993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64919464|NCT00109993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919465|NCT00109993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64919466|NCT00110032|Etanidazole|etanidazole|mesh-list
64919467|NCT00110032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919468|NCT00110071|Iodine|iodine|mesh-list
64919469|NCT00110071|Cadexomer iodine|cadexomer iodine|mesh-list
64919470|NCT00110071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64919471|NCT00110071|Fludarabine|fludarabine|mesh-list
64919472|NCT00110071|Fludarabine phosphate|fludarabine phosphate|mesh-list
64919473|NCT00110071|Tositumomab I-131|tositumomab i-131|mesh-list
64919474|NCT00110071|Antibodies|antibodies|mesh-list
64919475|NCT00110071|Immunoglobulins|immunoglobulins|mesh-list
64919476|NCT00110071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64919477|NCT00110071|Immunologic Factors|immunologic factors|mesh-ancestor
64919478|NCT00110071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919479|NCT00110071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919480|NCT00110071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64919481|NCT00110071|Antimetabolites|antimetabolites|mesh-ancestor
64919482|NCT00110071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919483|NCT00110071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64919484|NCT00110071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64919485|NCT00110071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919486|NCT00110071|Trace Elements|trace elements|mesh-ancestor
64919487|NCT00110071|Micronutrients|micronutrients|mesh-ancestor
64919488|NCT00110188|Sirolimus|sirolimus|mesh-list
64919489|NCT00110188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64919490|NCT00110188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919491|NCT00110188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64919498|NCT00007202|Didanosine|didanosine|mesh-list
64919499|NCT00007202|Stavudine|stavudine|mesh-list
64919500|NCT00007202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64919501|NCT00007202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64919506|NCT00007202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64919507|NCT00007202|Antiviral Agents|antiviral agents|mesh-ancestor
64919508|NCT00007202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919509|NCT00007202|Antimetabolites|antimetabolites|mesh-ancestor
64919510|NCT00007202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64919511|NCT00007202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64919512|NCT00110344|Sorafenib|sorafenib|mesh-list
64919513|NCT00110344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919514|NCT00110344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64919515|NCT00110344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919516|NCT00110344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919517|NCT00401479|Solabegron|solabegron|mesh-list
64919518|NCT00401479|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64919519|NCT00401479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64919520|NCT00401479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64919521|NCT00401479|Adrenergic Agents|adrenergic agents|mesh-ancestor
64919522|NCT00401479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64919548|NCT00388193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919549|NCT00388193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64919550|NCT00110695|Paclitaxel|paclitaxel|mesh-list
64919551|NCT00110695|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64919552|NCT00110695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64919553|NCT00110695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919554|NCT00110695|Tubulin Modulators|tubulin modulators|mesh-ancestor
64919555|NCT00110695|Antimitotic Agents|antimitotic agents|mesh-ancestor
64919556|NCT00110695|Mitosis Modulators|mitosis modulators|mesh-ancestor
64919557|NCT00110695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919577|NCT00110773|Sensory System Agents|sensory system agents|mesh-ancestor
64919591|NCT00110929|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64919592|NCT00110929|Hormone Antagonists|hormone antagonists|mesh-ancestor
64919593|NCT00110929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64919595|NCT00111046|Tramadol|tramadol|mesh-list
64919596|NCT00111046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64919597|NCT00111046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64919598|NCT00111046|Analgesics|analgesics|mesh-ancestor
64919599|NCT00111046|Sensory System Agents|sensory system agents|mesh-ancestor
64919600|NCT00111046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64919601|NCT00111046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919602|NCT00111046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64919603|NCT00111046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64919604|NCT00111046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64919605|NCT00111046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919607|NCT00111046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64919650|NCT00111163|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64919651|NCT00111163|Renal Agents|renal agents|mesh-ancestor
64919652|NCT00111163|Leprostatic Agents|leprostatic agents|mesh-ancestor
64919654|NCT00111280|Etravirine|etravirine|mesh-list
64919709|NCT00111748|Leprostatic Agents|leprostatic agents|mesh-ancestor
64919710|NCT00111748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64919711|NCT00111748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919712|NCT00111748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64919713|NCT00111748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64919714|NCT00111748|Growth Substances|growth substances|mesh-ancestor
64919716|NCT00111787|Paclitaxel|paclitaxel|mesh-list
64919754|NCT00401635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919756|NCT00401674|Carboplatin|carboplatin|mesh-list
64919757|NCT00401674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64919758|NCT00401674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919759|NCT00401674|Tubulin Modulators|tubulin modulators|mesh-ancestor
64919760|NCT00401674|Antimitotic Agents|antimitotic agents|mesh-ancestor
64919761|NCT00401674|Mitosis Modulators|mitosis modulators|mesh-ancestor
64919762|NCT00401674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919763|NCT00112021|Pramlintide|pramlintide|mesh-list
64919764|NCT00112021|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
64919765|NCT00112021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64919766|NCT00112021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919767|NCT00112021|Appetite Depressants|appetite depressants|mesh-ancestor
64919768|NCT00112021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64919769|NCT00112021|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
64919771|NCT00007358|Dexamethasone|dexamethasone|mesh-list
64919861|NCT00112567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919862|NCT00112567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64919863|NCT00112567|Antimetabolites|antimetabolites|mesh-ancestor
64919864|NCT00112567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919865|NCT00112567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64919866|NCT00112567|Immunologic Factors|immunologic factors|mesh-ancestor
64919867|NCT00112567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919868|NCT00112567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64919869|NCT00112567|Alkylating Agents|alkylating agents|mesh-ancestor
64919870|NCT00112567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64919871|NCT00112645|Cyclosporine|cyclosporine|mesh-list
64919872|NCT00112645|Methylprednisolone|methylprednisolone|mesh-list
64919873|NCT00112645|Methotrexate|methotrexate|mesh-list
64919874|NCT00112645|Melphalan|melphalan|mesh-list
64919875|NCT00112645|Busulfan|busulfan|mesh-list
64919876|NCT00112645|Cyclosporins|cyclosporins|mesh-list
64919877|NCT00112645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64919878|NCT00112645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64919879|NCT00112645|Abortifacient Agents|abortifacient agents|mesh-ancestor
64919880|NCT00112645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64919881|NCT00112645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919882|NCT00112645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64919883|NCT00112645|Antimetabolites|antimetabolites|mesh-ancestor
64919884|NCT00112645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919906|NCT00112645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64919907|NCT00112645|Alkylating Agents|alkylating agents|mesh-ancestor
64919908|NCT00112645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64919909|NCT00112684|Alvocidib|alvocidib|mesh-list
64919910|NCT00112684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919911|NCT00112684|Growth Inhibitors|growth inhibitors|mesh-ancestor
64919912|NCT00112684|Growth Substances|growth substances|mesh-ancestor
64919913|NCT00112684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919914|NCT00112684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64919915|NCT00112684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919916|NCT00112684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382916|NCT02415179|Sympathomimetics|sympathomimetics|mesh-ancestor
64382918|NCT02415023|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64919917|NCT00007670|Lamotrigine|lamotrigine|mesh-list
64919918|NCT00007670|Carbamazepine|carbamazepine|mesh-list
64919919|NCT00007670|Gabapentin|gabapentin|mesh-list
64919920|NCT00007670|Analgesics|analgesics|mesh-ancestor
64919921|NCT00007670|Sensory System Agents|sensory system agents|mesh-ancestor
64919922|NCT00007670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64919923|NCT00007670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919924|NCT00007670|Anticonvulsants|anticonvulsants|mesh-ancestor
64919925|NCT00007670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64919926|NCT00007670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64919927|NCT00007670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64919928|NCT00007670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64919929|NCT00007670|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64919930|NCT00007670|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64919956|NCT00112879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64919957|NCT00112879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919958|NCT00112879|Mitosis Modulators|mitosis modulators|mesh-ancestor
64919959|NCT00112879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919960|NCT00112879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64919961|NCT00112879|Immunologic Factors|immunologic factors|mesh-ancestor
64919962|NCT00112879|Leprostatic Agents|leprostatic agents|mesh-ancestor
64919963|NCT00112879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64919964|NCT00112879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919965|NCT00112879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64919966|NCT00112879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64920011|NCT00390897|Interferons|interferons|mesh-list
64920012|NCT00390897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920013|NCT00390897|Antiviral Agents|antiviral agents|mesh-ancestor
64920014|NCT00390897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64920015|NCT00113347|Docetaxel|docetaxel|mesh-list
64920016|NCT00113347|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64920017|NCT00113347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920018|NCT00113347|Tubulin Modulators|tubulin modulators|mesh-ancestor
64920019|NCT00113347|Antimitotic Agents|antimitotic agents|mesh-ancestor
64920020|NCT00113347|Mitosis Modulators|mitosis modulators|mesh-ancestor
64920021|NCT00113347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920022|NCT00113347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64920023|NCT00113347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920024|NCT00113503|Azathioprine|azathioprine|mesh-list
64920025|NCT00113503|Antimetabolites|antimetabolites|mesh-ancestor
64920026|NCT00113503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920027|NCT00113503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64920028|NCT00113503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920029|NCT00113503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64920030|NCT00113503|Immunologic Factors|immunologic factors|mesh-ancestor
64920031|NCT00113503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920032|NCT00113503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64920050|NCT00007826|Immunologic Factors|immunologic factors|mesh-ancestor
64920051|NCT00007826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920052|NCT00007826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64920053|NCT00007826|Antacids|antacids|mesh-ancestor
64920054|NCT00007826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920055|NCT00007826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64920056|NCT00007865|Rituximab|rituximab|mesh-list
64920057|NCT00007865|Carboplatin|carboplatin|mesh-list
64920058|NCT00007865|Etoposide|etoposide|mesh-list
64920059|NCT00007865|Ifosfamide|ifosfamide|mesh-list
64920060|NCT00007865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64920061|NCT00007865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920062|NCT00007865|Immunologic Factors|immunologic factors|mesh-ancestor
64383032|NCT02094898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64989800|NCT05675410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989801|NCT05675410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989802|NCT05675410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64989803|NCT05675410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64920063|NCT00007865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920064|NCT00007865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64920065|NCT00007865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64920066|NCT00007865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64920067|NCT00007865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64920068|NCT00007865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920069|NCT00007865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920070|NCT00007865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64920071|NCT00007865|Alkylating Agents|alkylating agents|mesh-ancestor
64920072|NCT00113698|Enalapril|enalapril|mesh-list
64920073|NCT00113698|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64920099|NCT03272295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920100|NCT03272295|Cathartics|cathartics|mesh-ancestor
64920102|NCT00007904|Tamoxifen|tamoxifen|mesh-list
64920158|NCT00114010|Immunologic Factors|immunologic factors|mesh-ancestor
64920159|NCT00114010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920160|NCT00114010|Antacids|antacids|mesh-ancestor
64920161|NCT00114010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920162|NCT00114010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64920163|NCT00007982|Cyclophosphamide|cyclophosphamide|mesh-list
64920164|NCT00007982|Thiotepa|thiotepa|mesh-list
64920165|NCT00007982|Carmustine|carmustine|mesh-list
64920166|NCT00007982|Etoposide|etoposide|mesh-list
64920167|NCT00007982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64920168|NCT00007982|Immunologic Factors|immunologic factors|mesh-ancestor
64920169|NCT00007982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920170|NCT00007982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64920171|NCT00007982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64920172|NCT00007982|Alkylating Agents|alkylating agents|mesh-ancestor
64920173|NCT00007982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920174|NCT00007982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920175|NCT00007982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64920180|NCT00114205|Docetaxel|docetaxel|mesh-list
64920186|NCT03094884|Paclitaxel|paclitaxel|mesh-list
64920187|NCT03094884|Carboplatin|carboplatin|mesh-list
64920188|NCT03094884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64920189|NCT03094884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920190|NCT03094884|Tubulin Modulators|tubulin modulators|mesh-ancestor
64920191|NCT03094884|Antimitotic Agents|antimitotic agents|mesh-ancestor
64920192|NCT03094884|Mitosis Modulators|mitosis modulators|mesh-ancestor
64920193|NCT03094884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920194|NCT00114283|Lapatinib|lapatinib|mesh-list
64920195|NCT00114283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920196|NCT00114283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64920197|NCT00114283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920198|NCT00114283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920199|NCT00114361|Ribavirin|ribavirin|mesh-list
64920200|NCT00114361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64383103|NCT04596189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64383104|NCT03176537|Testosterone|testosterone|mesh-list
64383105|NCT03176537|Androgens|androgens|mesh-ancestor
64920201|NCT00114361|Antimetabolites|antimetabolites|mesh-ancestor
64920202|NCT00114361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920203|NCT00114361|Antiviral Agents|antiviral agents|mesh-ancestor
64920204|NCT00114361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64920205|NCT00114400|Vitamins|vitamins|mesh-list
64920206|NCT00114400|Folic Acid|folic acid|mesh-list
64920207|NCT00114400|Vitamin B 12|vitamin b 12|mesh-list
64920208|NCT00114400|Vitamin B 6|vitamin b 6|mesh-list
64920209|NCT00114400|Pyridoxal|pyridoxal|mesh-list
64920240|NCT00114478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64920241|NCT00114478|Tocolytic Agents|tocolytic agents|mesh-ancestor
64920242|NCT00114478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64920243|NCT00114478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64920244|NCT00114556|Zoledronic Acid|zoledronic acid|mesh-list
64920245|NCT00114556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64920246|NCT00114556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920247|NCT00008021|Cyclosporine|cyclosporine|mesh-list
64920248|NCT00008021|Paclitaxel|paclitaxel|mesh-list
64920249|NCT00008021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64920250|NCT00008021|Antibodies|antibodies|mesh-list
64920251|NCT00008021|Immunoglobulins|immunoglobulins|mesh-list
64920252|NCT00008021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64920253|NCT00008021|Cyclosporins|cyclosporins|mesh-list
64920254|NCT00008021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64920255|NCT00008021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920256|NCT00008021|Tubulin Modulators|tubulin modulators|mesh-ancestor
64920257|NCT00008021|Antimitotic Agents|antimitotic agents|mesh-ancestor
64920258|NCT00008021|Mitosis Modulators|mitosis modulators|mesh-ancestor
64920259|NCT00008021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920260|NCT00008021|Immunologic Factors|immunologic factors|mesh-ancestor
64920261|NCT00008021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920262|NCT00008021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920263|NCT00008021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64920264|NCT00008021|Antifungal Agents|antifungal agents|mesh-ancestor
64920265|NCT00008021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64920266|NCT00008021|Dermatologic Agents|dermatologic agents|mesh-ancestor
64920286|NCT00008060|Antimetabolites|antimetabolites|mesh-ancestor
64920287|NCT00008060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920288|NCT00008060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64920289|NCT00008060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920290|NCT00008060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64920291|NCT00008060|Immunologic Factors|immunologic factors|mesh-ancestor
64920292|NCT00008060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64920293|NCT00008060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64920294|NCT00008060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920295|NCT00008060|Antidotes|antidotes|mesh-ancestor
64920296|NCT00008060|Protective Agents|protective agents|mesh-ancestor
64920297|NCT00008060|Vitamin B Complex|vitamin b complex|mesh-ancestor
64920298|NCT00008060|Vitamins|vitamins|mesh-ancestor
64920299|NCT00008060|Micronutrients|micronutrients|mesh-ancestor
64920300|NCT00114868|Vitamins|vitamins|mesh-list
64920301|NCT00114868|Vitamin A|vitamin a|mesh-list
64920302|NCT00114868|Retinol palmitate|retinol palmitate|mesh-list
64920303|NCT00114868|Micronutrients|micronutrients|mesh-ancestor
64920304|NCT00114868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920305|NCT00114868|Antioxidants|antioxidants|mesh-ancestor
64920306|NCT00114868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920307|NCT00114868|Protective Agents|protective agents|mesh-ancestor
64920308|NCT00114868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64920338|NCT00008177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64920339|NCT00008177|Antimetabolites|antimetabolites|mesh-ancestor
64920340|NCT00008177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920341|NCT00008177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64920342|NCT00008177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920343|NCT00008177|Antifungal Agents|antifungal agents|mesh-ancestor
64920344|NCT00008177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64920345|NCT00008177|Dermatologic Agents|dermatologic agents|mesh-ancestor
64920346|NCT00008177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64920393|NCT00115375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64920394|NCT00115375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64920395|NCT00115375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64920396|NCT00115375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64920397|NCT00115375|Purinergic Agents|purinergic agents|mesh-ancestor
64920398|NCT00115375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64920399|NCT00115375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920400|NCT00115375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920401|NCT00115414|Cyclophosphamide|cyclophosphamide|mesh-list
64920402|NCT00115414|Docetaxel|docetaxel|mesh-list
64920403|NCT00115414|Doxorubicin|doxorubicin|mesh-list
64920404|NCT00115414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64920405|NCT00115414|Immunologic Factors|immunologic factors|mesh-ancestor
64920406|NCT00115414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920407|NCT00115414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64920408|NCT00115414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64920409|NCT00115414|Alkylating Agents|alkylating agents|mesh-ancestor
64920410|NCT00115414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920411|NCT00115414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920412|NCT00115414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64920413|NCT00115414|Tubulin Modulators|tubulin modulators|mesh-ancestor
64920414|NCT00115414|Antimitotic Agents|antimitotic agents|mesh-ancestor
64920415|NCT00115414|Mitosis Modulators|mitosis modulators|mesh-ancestor
64920416|NCT00115414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64920417|NCT00115414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64920418|NCT00115414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64920419|NCT00115414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920420|NCT00115492|Fluticasone|fluticasone|mesh-list
64920421|NCT00115492|Xhance|xhance|mesh-list
64920422|NCT00115492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64920423|NCT00115492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64920424|NCT00115492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64920425|NCT00115492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64920426|NCT00115492|Autonomic Agents|autonomic agents|mesh-ancestor
64920432|NCT00115492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64920436|NCT00115492|Adrenergic Agents|adrenergic agents|mesh-ancestor
64920437|NCT00115492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64920438|NCT00115492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920439|NCT00115492|Glucocorticoids|glucocorticoids|mesh-ancestor
64920440|NCT00115492|Hormones|hormones|mesh-ancestor
64920441|NCT00115492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64920442|NCT00115492|Sympathomimetics|sympathomimetics|mesh-ancestor
64920443|NCT02993406|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
64920444|NCT02993406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64920445|NCT02993406|Antimetabolites|antimetabolites|mesh-ancestor
64920446|NCT02993406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920447|NCT02993406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64920448|NCT02993406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920449|NCT02993406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64920450|NCT02993406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920451|NCT00115531|Vaccines|vaccines|mesh-list
64920452|NCT00115531|Immunologic Factors|immunologic factors|mesh-ancestor
64920453|NCT00115531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920454|NCT00115570|Insulin|insulin|mesh-list
64920455|NCT00115570|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64920456|NCT00115570|Insulin Glargine|insulin glargine|mesh-list
64920457|NCT00115570|Insulin Lispro|insulin lispro|mesh-list
64920479|NCT00115609|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64920480|NCT00115609|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64920481|NCT00115648|Zidovudine|zidovudine|mesh-list
64920482|NCT00115648|Nevirapine|nevirapine|mesh-list
64920483|NCT00115648|Antimetabolites|antimetabolites|mesh-ancestor
64920484|NCT00115648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920485|NCT00115648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64920486|NCT00115648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64920487|NCT00115648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920488|NCT00115648|Antiviral Agents|antiviral agents|mesh-ancestor
64989804|NCT05675410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64989805|NCT05675410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64920489|NCT00115648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64920490|NCT00115648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64920491|NCT00115648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64920492|NCT00115648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64920493|NCT00115648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64920494|NCT00008294|Leucovorin|leucovorin|mesh-list
64920495|NCT00008294|Dexamethasone|dexamethasone|mesh-list
64920496|NCT00008294|Fluorouracil|fluorouracil|mesh-list
64920497|NCT00008294|Oxaliplatin|oxaliplatin|mesh-list
64920498|NCT00008294|Floxuridine|floxuridine|mesh-list
64920499|NCT00008294|Calcium|calcium|mesh-list
64920500|NCT00008294|Levoleucovorin|levoleucovorin|mesh-list
64920501|NCT00008294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64920502|NCT00008294|Antiemetics|antiemetics|mesh-ancestor
64920503|NCT00008294|Autonomic Agents|autonomic agents|mesh-ancestor
64920504|NCT00008294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64920505|NCT00008294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920506|NCT00008294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64920507|NCT00008294|Glucocorticoids|glucocorticoids|mesh-ancestor
64920508|NCT00008294|Hormones|hormones|mesh-ancestor
64920509|NCT00008294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64920510|NCT00008294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64920511|NCT00008294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920521|NCT00008294|Vitamins|vitamins|mesh-ancestor
64920522|NCT00008294|Micronutrients|micronutrients|mesh-ancestor
64920523|NCT00115687|Nicotine|nicotine|mesh-list
64920524|NCT00115687|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64920525|NCT00115687|Autonomic Agents|autonomic agents|mesh-ancestor
64920526|NCT00115687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64920527|NCT00115687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920528|NCT00115687|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64920529|NCT00115687|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64920530|NCT00115687|Cholinergic Agents|cholinergic agents|mesh-ancestor
64920533|NCT00115726|Furosemide|furosemide|mesh-list
64920543|NCT00008333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64920544|NCT00008333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920545|NCT00008333|Tubulin Modulators|tubulin modulators|mesh-ancestor
64920572|NCT04727671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920573|NCT04727671|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64920574|NCT04727671|Fertility Agents|fertility agents|mesh-ancestor
64920575|NCT04727671|Hormone Antagonists|hormone antagonists|mesh-ancestor
64920576|NCT04727671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64920577|NCT00008450|Cyclosporine|cyclosporine|mesh-list
64920578|NCT00008450|Mycophenolic Acid|mycophenolic acid|mesh-list
64920579|NCT00008450|Cyclosporins|cyclosporins|mesh-list
64920580|NCT00008450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920581|NCT00008450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920582|NCT00008450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64920583|NCT00008450|Immunologic Factors|immunologic factors|mesh-ancestor
64920584|NCT00008450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920585|NCT00008450|Antifungal Agents|antifungal agents|mesh-ancestor
64920586|NCT00008450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64689033|NCT02283294|Warfarin|warfarin|mesh-list
64920587|NCT00008450|Dermatologic Agents|dermatologic agents|mesh-ancestor
64920588|NCT00008450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64920645|NCT00116506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64920646|NCT00116506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920647|NCT00116506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920665|NCT00116623|Tocolytic Agents|tocolytic agents|mesh-ancestor
64920666|NCT00116623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64920667|NCT00116623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64920668|NCT00116623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64920669|NCT00116623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64920670|NCT00116623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64920671|NCT00116623|Gout Suppressants|gout suppressants|mesh-ancestor
64920672|NCT00116623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64920673|NCT00116623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920675|NCT02909322|Bupivacaine|bupivacaine|mesh-list
64920676|NCT02909322|Ropivacaine|ropivacaine|mesh-list
64920677|NCT02909322|Anesthetics, Local|anesthetics, local|mesh-ancestor
64920678|NCT02909322|Anesthetics|anesthetics|mesh-ancestor
64920679|NCT02909322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64920680|NCT02909322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920681|NCT02909322|Sensory System Agents|sensory system agents|mesh-ancestor
64920682|NCT02909322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64383187|NCT02412059|Glucocorticoids|glucocorticoids|mesh-ancestor
64383383|NCT02410031|Cyproterone Acetate|cyproterone acetate|mesh-list
64989806|NCT05675410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64989807|NCT05675410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64989808|NCT05675410|Glucocorticoids|glucocorticoids|mesh-ancestor
64989810|NCT05675410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64989857|NCT05660447|Lubricant Eye Drops|lubricant eye drops|mesh-list
64989859|NCT05660447|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64989860|NCT05660447|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64989861|NCT05660447|Protective Agents|protective agents|mesh-ancestor
64989862|NCT05660447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989891|NCT05646719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989892|NCT05646719|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64989893|NCT05646719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64989894|NCT05646719|Cholinergic Agents|cholinergic agents|mesh-ancestor
64989895|NCT05646719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64989896|NCT05646719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989897|NCT05646719|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64989898|NCT05646719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64989899|NCT05646719|Adrenergic Agents|adrenergic agents|mesh-ancestor
64989900|NCT05646719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64989905|NCT05641142|Anticoagulants|anticoagulants|mesh-list
64989906|NCT05633992|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64989907|NCT05633992|Immunologic Factors|immunologic factors|mesh-ancestor
64989908|NCT05633992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989909|NCT05628363|Androgens|androgens|mesh-list
64989910|NCT05628363|Hormones|hormones|mesh-ancestor
64989911|NCT05628363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64990053|NCT05564377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64990054|NCT05555862|Artesunate|artesunate|mesh-list
64990055|NCT05555862|Artenimol|artenimol|mesh-list
64990056|NCT05555862|Artemisinins|artemisinins|mesh-list
64920683|NCT02909322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64920684|NCT02909322|Narcotics|narcotics|mesh-ancestor
64920685|NCT02909322|Analgesics|analgesics|mesh-ancestor
64920686|NCT00116701|Darbepoetin alfa|darbepoetin alfa|mesh-list
64920687|NCT00116701|Hematinics|hematinics|mesh-ancestor
64920720|NCT00116935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64920721|NCT00116935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920722|NCT00116935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920723|NCT00388388|Losartan|losartan|mesh-list
64920724|NCT00388388|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64920725|NCT00388388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64920726|NCT00388388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64920786|NCT00117403|Vitamins|vitamins|mesh-list
64920787|NCT00117403|Vitamin E|vitamin e|mesh-list
64920810|NCT00117520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920811|NCT00117520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64689261|NCT05109143|Analgesics|analgesics|mesh-ancestor
64920813|NCT00117520|Purinergic Agents|purinergic agents|mesh-ancestor
64920815|NCT04727515|Fentanyl|fentanyl|mesh-list
64920816|NCT04727515|Isoflurane|isoflurane|mesh-list
64920817|NCT04727515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64920818|NCT04727515|Narcotics|narcotics|mesh-ancestor
64920819|NCT04727515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64920820|NCT04727515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920821|NCT04727515|Analgesics|analgesics|mesh-ancestor
64920822|NCT04727515|Sensory System Agents|sensory system agents|mesh-ancestor
64920823|NCT04727515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64920824|NCT04727515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64920825|NCT04727515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64920826|NCT04727515|Anesthetics, General|anesthetics, general|mesh-ancestor
64920827|NCT04727515|Anesthetics|anesthetics|mesh-ancestor
64920828|NCT04727515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64920829|NCT00117754|Terbinafine|terbinafine|mesh-list
64920830|NCT00117754|Antifungal Agents|antifungal agents|mesh-ancestor
64920831|NCT00117754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64920832|NCT00117754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920833|NCT00117754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920834|NCT00117832|Azelastine|azelastine|mesh-list
64920864|NCT00118027|Pyrimethamine|pyrimethamine|mesh-list
64920865|NCT00118027|Sulfadoxine|sulfadoxine|mesh-list
64920866|NCT00118027|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64920867|NCT00118027|Antimalarials|antimalarials|mesh-ancestor
64920868|NCT00118027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64920869|NCT00118027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64920870|NCT00118027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64920871|NCT00118027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64920872|NCT00118027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920873|NCT00118027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920874|NCT00118027|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64920892|NCT00118105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64920893|NCT00118105|Growth Substances|growth substances|mesh-ancestor
64920894|NCT00118105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920895|NCT00118105|Growth Inhibitors|growth inhibitors|mesh-ancestor
64920896|NCT00118105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64920897|NCT00118105|Antimetabolites|antimetabolites|mesh-ancestor
64920898|NCT00118105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920899|NCT00118183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64920900|NCT00118183|Cetuximab|cetuximab|mesh-list
64920901|NCT00118183|Docetaxel|docetaxel|mesh-list
64920902|NCT00118183|Bortezomib|bortezomib|mesh-list
64920903|NCT00118183|Antibodies|antibodies|mesh-list
64920904|NCT00118183|Immunoglobulins|immunoglobulins|mesh-list
64920905|NCT00118183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64920944|NCT00118261|Growth Inhibitors|growth inhibitors|mesh-ancestor
64920945|NCT00118261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64920946|NCT00118261|Antimetabolites|antimetabolites|mesh-ancestor
64920947|NCT00118261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920948|NCT00118261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64920949|NCT00118261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64920950|NCT00118261|Immunologic Factors|immunologic factors|mesh-ancestor
64920951|NCT00118261|Antidotes|antidotes|mesh-ancestor
64920952|NCT00118261|Protective Agents|protective agents|mesh-ancestor
64920953|NCT00118261|Vitamin B Complex|vitamin b complex|mesh-ancestor
64920954|NCT00118261|Vitamins|vitamins|mesh-ancestor
64920955|NCT00118261|Micronutrients|micronutrients|mesh-ancestor
64920956|NCT00118261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64920957|NCT00118261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920958|NCT00118300|Capecitabine|capecitabine|mesh-list
64920960|NCT00118300|Antimetabolites|antimetabolites|mesh-ancestor
64920989|NCT02710734|Antimitotic Agents|antimitotic agents|mesh-ancestor
64920990|NCT02710734|Mitosis Modulators|mitosis modulators|mesh-ancestor
64920991|NCT00118690|Fluticasone|fluticasone|mesh-list
64920992|NCT00118690|Xhance|xhance|mesh-list
64920993|NCT00118690|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64921051|NCT00118807|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64921052|NCT00118807|Anthelmintics|anthelmintics|mesh-ancestor
64921053|NCT00118807|Amebicides|amebicides|mesh-ancestor
64921054|NCT00118807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64921055|NCT00118807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64921056|NCT00118807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921057|NCT00118807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921058|NCT00118807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64921059|NCT00118807|Renal Agents|renal agents|mesh-ancestor
64921060|NCT00118963|Metformin|metformin|mesh-list
64921061|NCT00118963|Insulin Aspart|insulin aspart|mesh-list
64921062|NCT00118963|Repaglinide|repaglinide|mesh-list
64921063|NCT00118963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64921064|NCT00118963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921065|NCT00119002|Dexamethasone|dexamethasone|mesh-list
64921066|NCT00119002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64921067|NCT00119002|Antiemetics|antiemetics|mesh-ancestor
64921068|NCT00119002|Autonomic Agents|autonomic agents|mesh-ancestor
64921072|NCT00119002|Glucocorticoids|glucocorticoids|mesh-ancestor
64921086|NCT00119119|Micronutrients|micronutrients|mesh-ancestor
64921087|NCT00119236|Irinotecan|irinotecan|mesh-list
64921088|NCT00119236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64921089|NCT00119236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64921090|NCT00119236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921091|NCT00119236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921092|NCT00119236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921093|NCT00119314|Gemcitabine|gemcitabine|mesh-list
64921094|NCT00119314|Capecitabine|capecitabine|mesh-list
64921095|NCT00119314|Docetaxel|docetaxel|mesh-list
64921096|NCT00119314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64921097|NCT00119314|Antimetabolites|antimetabolites|mesh-ancestor
64921098|NCT00119314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921099|NCT00119314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921110|NCT00119431|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64921111|NCT00119431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64921112|NCT00119431|Immunologic Factors|immunologic factors|mesh-ancestor
64921113|NCT00119431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921114|NCT00119587|Darbepoetin alfa|darbepoetin alfa|mesh-list
64921115|NCT00119587|Hematinics|hematinics|mesh-ancestor
64921116|NCT00119626|Disufenton sodium|disufenton sodium|mesh-list
64921117|NCT00119626|Antioxidants|antioxidants|mesh-ancestor
64921118|NCT00119626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921119|NCT00119626|Protective Agents|protective agents|mesh-ancestor
64689561|NCT05446727|Ropivacaine|ropivacaine|mesh-list
64921126|NCT00119704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921208|NCT00120367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64921209|NCT00120367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64921210|NCT00120367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921211|NCT00120367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921212|NCT00120367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64921213|NCT00120367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64921214|NCT00120367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64921215|NCT00120367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64921220|NCT04727320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64921222|NCT00120484|Hydroxocobalamin|hydroxocobalamin|mesh-list
64921223|NCT00120484|Vitamins|vitamins|mesh-ancestor
64921224|NCT00120484|Micronutrients|micronutrients|mesh-ancestor
64921225|NCT00120484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921226|NCT00120484|Vitamin B Complex|vitamin b complex|mesh-ancestor
64921227|NCT00120484|Hematinics|hematinics|mesh-ancestor
64921228|NCT00391014|Amphotericin B|amphotericin b|mesh-list
64921229|NCT00391014|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64921230|NCT00391014|Amebicides|amebicides|mesh-ancestor
64921231|NCT00391014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64921232|NCT00391014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64921233|NCT00391014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921234|NCT00391014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64921235|NCT00391014|Antifungal Agents|antifungal agents|mesh-ancestor
64921236|NCT00120601|Naltrexone|naltrexone|mesh-list
64921267|NCT00120718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64921268|NCT00120718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921269|NCT00120718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64921270|NCT00120718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921271|NCT00120718|Vasodilator Agents|vasodilator agents|mesh-ancestor
64921272|NCT00120718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64921273|NCT00120718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921274|NCT00120757|Alendronate|alendronate|mesh-list
64921275|NCT00120757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64921276|NCT00120757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921277|NCT00120796|Lamivudine|lamivudine|mesh-list
64921278|NCT00120796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64921279|NCT00120796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64921280|NCT00120796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921281|NCT00120796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921282|NCT00120796|Antiviral Agents|antiviral agents|mesh-ancestor
64921283|NCT00120796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921284|NCT00120796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64921285|NCT00120796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64921286|NCT00120835|Interferons|interferons|mesh-list
64921287|NCT00120835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921288|NCT00120835|Antiviral Agents|antiviral agents|mesh-ancestor
64921289|NCT00120835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921290|NCT00120913|Contraceptives, Oral|contraceptives, oral|mesh-list
64921291|NCT00120913|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64921292|NCT00120913|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64921305|NCT00121069|Serotonin Agents|serotonin agents|mesh-ancestor
64921306|NCT00121069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921307|NCT00121069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64921308|NCT00121069|Antidepressive Agents|antidepressive agents|mesh-ancestor
64921309|NCT00121069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64921310|NCT00121147|Travoprost|travoprost|mesh-list
64921319|NCT00121147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921320|NCT00121264|Sorafenib|sorafenib|mesh-list
64921321|NCT00121264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921322|NCT00121264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64921323|NCT00121264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921324|NCT00121264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921325|NCT00121303|Cytarabine|cytarabine|mesh-list
64921326|NCT00121303|Daunorubicin|daunorubicin|mesh-list
64921327|NCT00121303|Gemtuzumab|gemtuzumab|mesh-list
64921328|NCT00121303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64921329|NCT00121303|Antimetabolites|antimetabolites|mesh-ancestor
64921330|NCT00121303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921331|NCT00121303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921332|NCT00121303|Antiviral Agents|antiviral agents|mesh-ancestor
64921333|NCT00121303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921334|NCT00121303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64921335|NCT00121303|Immunologic Factors|immunologic factors|mesh-ancestor
64921348|NCT00121381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64921349|NCT00121381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921350|NCT00121381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64921351|NCT00121381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64921352|NCT00121381|Dermatologic Agents|dermatologic agents|mesh-ancestor
64921353|NCT00121381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64921354|NCT00121381|Immunologic Factors|immunologic factors|mesh-ancestor
64921355|NCT00121381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64921356|NCT00121381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921357|NCT00121381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921358|NCT00121420|Motexafin gadolinium|motexafin gadolinium|mesh-list
64921359|NCT00121420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921360|NCT00121420|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64921361|NCT00121420|Dermatologic Agents|dermatologic agents|mesh-ancestor
64921362|NCT00121459|Psyllium|psyllium|mesh-list
64921363|NCT00121459|Calcium polycarbophil|calcium polycarbophil|mesh-list
64921364|NCT00121459|Cathartics|cathartics|mesh-ancestor
64921365|NCT00121459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64921366|NCT00121459|Antidiarrheals|antidiarrheals|mesh-ancestor
64921367|NCT05637398|Colchicine|colchicine|mesh-list
64990057|NCT05555862|Artemisinin|artemisinin|mesh-list
64990058|NCT05555862|Antimalarials|antimalarials|mesh-ancestor
64990059|NCT05555862|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64990060|NCT05555862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64921368|NCT05637398|Gout Suppressants|gout suppressants|mesh-ancestor
64921369|NCT05637398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64921370|NCT05637398|Tubulin Modulators|tubulin modulators|mesh-ancestor
64921371|NCT05637398|Antimitotic Agents|antimitotic agents|mesh-ancestor
64921372|NCT05637398|Mitosis Modulators|mitosis modulators|mesh-ancestor
64921373|NCT05637398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921374|NCT05637398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921375|NCT00121498|Lidocaine|lidocaine|mesh-list
64921395|NCT00121615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64921396|NCT00121615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64921397|NCT00121615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64921398|NCT00121615|Immunologic Factors|immunologic factors|mesh-ancestor
64921399|NCT00391248|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64921400|NCT00391248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921401|NCT00391248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64921402|NCT00391248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921403|NCT00391248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921404|NCT04711096|Bupivacaine|bupivacaine|mesh-list
64921405|NCT04711096|Anesthetics, Local|anesthetics, local|mesh-ancestor
64921406|NCT04711096|Anesthetics|anesthetics|mesh-ancestor
64921407|NCT04711096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64921408|NCT04711096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921409|NCT04711096|Sensory System Agents|sensory system agents|mesh-ancestor
64921410|NCT04711096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64921411|NCT04705948|Magnesium Sulfate|magnesium sulfate|mesh-list
64921412|NCT04705948|Ketamine|ketamine|mesh-list
64921413|NCT04705948|Analgesics|analgesics|mesh-ancestor
64921414|NCT04705948|Sensory System Agents|sensory system agents|mesh-ancestor
64921415|NCT04705948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64921416|NCT04705948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921417|NCT04705948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64921418|NCT04705948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64921419|NCT04705948|Anesthetics, General|anesthetics, general|mesh-ancestor
64921448|NCT00121966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64921449|NCT00121966|Metformin|metformin|mesh-list
64921450|NCT00121966|Insulin Aspart|insulin aspart|mesh-list
64921451|NCT00121966|Rosiglitazone|rosiglitazone|mesh-list
64921452|NCT00121966|Isophane Insulin, Human|isophane insulin, human|mesh-list
64921453|NCT00121966|Insulin, Isophane|insulin, isophane|mesh-list
64921454|NCT00121966|Isophane insulin, beef|isophane insulin, beef|mesh-list
64921455|NCT00121966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64921456|NCT00121966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921457|NCT00122044|Trihexyphenidyl|trihexyphenidyl|mesh-list
64921458|NCT00122044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64921459|NCT00122044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64921460|NCT00122044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64921461|NCT00122044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64921462|NCT00122044|Cholinergic Agents|cholinergic agents|mesh-ancestor
64921463|NCT00122044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64921464|NCT00122044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921465|NCT00122044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921466|NCT02013492|Propranolol|propranolol|mesh-list
64921467|NCT02013492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64921468|NCT02013492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64921469|NCT02013492|Adrenergic Agents|adrenergic agents|mesh-ancestor
64921470|NCT02013492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64921471|NCT02013492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921472|NCT02013492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921473|NCT02013492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64921483|NCT00122434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64921484|NCT00122434|Autonomic Agents|autonomic agents|mesh-ancestor
64921485|NCT00122434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64921486|NCT00122434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921487|NCT00122434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64921488|NCT00122434|Respiratory System Agents|respiratory system agents|mesh-ancestor
64921489|NCT00122434|Parasympatholytics|parasympatholytics|mesh-ancestor
64921490|NCT00122434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64921491|NCT00122434|Cholinergic Agents|cholinergic agents|mesh-ancestor
64990061|NCT05555862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64990062|NCT05555862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990063|NCT05555862|Antiviral Agents|antiviral agents|mesh-ancestor
64990064|NCT05555862|Schistosomicides|schistosomicides|mesh-ancestor
64990065|NCT05555862|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64990066|NCT05555862|Anthelmintics|anthelmintics|mesh-ancestor
64921492|NCT00122434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64921493|NCT00122434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921494|NCT00122473|Imatinib Mesylate|imatinib mesylate|mesh-list
64921495|NCT00122473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921496|NCT00122473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64921497|NCT00122473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921498|NCT00122473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921499|NCT00122512|Tenofovir|tenofovir|mesh-list
64921500|NCT00122512|Antiviral Agents|antiviral agents|mesh-ancestor
64921501|NCT00122512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921502|NCT00122512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64921503|NCT00122512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64921504|NCT00122512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921505|NCT00122512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921506|NCT00122512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64921507|NCT00122512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64921508|NCT01720407|Imiquimod|imiquimod|mesh-list
64921509|NCT01720407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64921510|NCT01720407|Immunologic Factors|immunologic factors|mesh-ancestor
64921511|NCT01720407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921512|NCT01720407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921513|NCT01720407|Interferon Inducers|interferon inducers|mesh-ancestor
64921517|NCT00122590|Ritonavir|ritonavir|mesh-list
64921524|NCT00122590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921525|NCT00122590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921526|NCT00122590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64921527|NCT00122590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64921528|NCT00122590|Antiviral Agents|antiviral agents|mesh-ancestor
64921529|NCT00122590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921530|NCT00122590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64921531|NCT00122590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64921532|NCT00122629|Interferons|interferons|mesh-list
64921533|NCT00122629|Ribavirin|ribavirin|mesh-list
64921534|NCT00122629|Interferon-alpha|interferon-alpha|mesh-list
64990067|NCT05554380|Paclitaxel|paclitaxel|mesh-list
64921535|NCT00122629|Interferon alpha-2|interferon alpha-2|mesh-list
64921536|NCT00122629|Amantadine|amantadine|mesh-list
64921537|NCT00122629|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64921538|NCT00122629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921539|NCT00122629|Antiviral Agents|antiviral agents|mesh-ancestor
64921540|NCT00122629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921541|NCT00122629|Antimetabolites|antimetabolites|mesh-ancestor
64921542|NCT00122629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921543|NCT00122629|Immunologic Factors|immunologic factors|mesh-ancestor
64921544|NCT00122629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921545|NCT00122629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64921546|NCT00122629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64921547|NCT00122629|Dopamine Agents|dopamine agents|mesh-ancestor
64921548|NCT00122629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64921549|NCT00122629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64921550|NCT00122629|Analgesics|analgesics|mesh-ancestor
64921551|NCT00122629|Sensory System Agents|sensory system agents|mesh-ancestor
64921552|NCT00122629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64921553|NCT00122668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
64921554|NCT00122668|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
64921568|NCT00129298|Anticonvulsants|anticonvulsants|mesh-ancestor
64921569|NCT00129298|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
64921570|NCT00129298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64921571|NCT00129298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64921572|NCT00129298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921573|NCT00129298|GABA Agents|gaba agents|mesh-ancestor
64921574|NCT00129298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64921575|NCT00129298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921576|NCT00129181|Levodopa|levodopa|mesh-list
64921577|NCT00129181|Carbidopa|carbidopa|mesh-list
64921578|NCT00129181|Cabergoline|cabergoline|mesh-list
64921579|NCT00129181|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64921580|NCT00129181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64383501|NCT04292223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383502|NCT04292223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64383505|NCT04292223|Serotonin Agents|serotonin agents|mesh-ancestor
64990075|NCT05554354|Fulvestrant|fulvestrant|mesh-list
64990082|NCT05554354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990084|NCT05554328|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64990085|NCT05554328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921581|NCT00129181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64921582|NCT00129181|Dopamine Agents|dopamine agents|mesh-ancestor
64921583|NCT00129181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64921584|NCT00129181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921585|NCT00129181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921586|NCT00129181|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64921587|NCT00129181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921588|NCT00129181|Dopamine Agonists|dopamine agonists|mesh-ancestor
64921589|NCT00129181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64921590|NCT00129181|Immunologic Factors|immunologic factors|mesh-ancestor
64921591|NCT00129142|Toremifene|toremifene|mesh-list
64921592|NCT00129142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64921593|NCT00129142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921594|NCT00129142|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64921595|NCT00129142|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64921596|NCT00129142|Hormone Antagonists|hormone antagonists|mesh-ancestor
64921600|NCT00128947|Mycophenolic Acid|mycophenolic acid|mesh-list
64921608|NCT00128947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921609|NCT00819780|Bevacizumab|bevacizumab|mesh-list
64921610|NCT00819780|Panitumumab|panitumumab|mesh-list
64921611|NCT00819780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64921612|NCT00819780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921633|NCT00128752|Vitamins|vitamins|mesh-ancestor
64921641|NCT05638295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921650|NCT05638451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64921651|NCT05638451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921652|NCT05638451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64921653|NCT05638451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64921654|NCT05638451|Growth Substances|growth substances|mesh-ancestor
64921655|NCT05638451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921656|NCT05638451|Growth Inhibitors|growth inhibitors|mesh-ancestor
64921657|NCT05638451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64921658|NCT05638451|Alkylating Agents|alkylating agents|mesh-ancestor
64921659|NCT05638451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921660|NCT00009009|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64921661|NCT00009009|Complement System Proteins|complement system proteins|mesh-list
64921662|NCT00009009|Immunologic Factors|immunologic factors|mesh-ancestor
64921663|NCT00009009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921664|NCT05638763|Ketoconazole|ketoconazole|mesh-list
64921665|NCT05638763|Dasatinib|dasatinib|mesh-list
64921666|NCT05638763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921667|NCT05638763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64921668|NCT05638763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921679|NCT00128635|Antibodies|antibodies|mesh-list
64921750|NCT00009555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64921751|NCT00009555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921752|NCT00128479|Mifepristone|mifepristone|mesh-list
64921753|NCT00128479|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64921754|NCT00128479|Abortifacient Agents|abortifacient agents|mesh-ancestor
64921755|NCT00128479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64921756|NCT00128479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921757|NCT00128479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64921758|NCT00128479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64921759|NCT00128479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64921760|NCT00128479|Contraceptive Agents|contraceptive agents|mesh-ancestor
64921761|NCT00128479|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64921762|NCT00128479|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64921763|NCT00128479|Hormone Antagonists|hormone antagonists|mesh-ancestor
64921764|NCT00128479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64921765|NCT00128479|Luteolytic Agents|luteolytic agents|mesh-ancestor
64921766|NCT00128479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64921767|NCT00128479|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64921768|NCT00128440|Tiotropium Bromide|tiotropium bromide|mesh-list
64921769|NCT00128440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64921770|NCT00128440|Autonomic Agents|autonomic agents|mesh-ancestor
64921771|NCT00128440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64921772|NCT00128440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921773|NCT00128440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64921774|NCT00128440|Respiratory System Agents|respiratory system agents|mesh-ancestor
64921792|NCT00128323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64921793|NCT00128323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921794|NCT00128323|Antifungal Agents|antifungal agents|mesh-ancestor
64921795|NCT00128323|Ionophores|ionophores|mesh-ancestor
64921808|NCT00009672|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64921809|NCT00009672|Antidepressive Agents|antidepressive agents|mesh-ancestor
64921810|NCT00009672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64921811|NCT00009672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64921812|NCT00009672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64921813|NCT00009672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64921814|NCT00009672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921815|NCT00009672|Adrenergic Agents|adrenergic agents|mesh-ancestor
64921816|NCT00009672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64921817|NCT00018694|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
64921818|NCT00018694|Cathartics|cathartics|mesh-ancestor
64921819|NCT00018694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64921820|NCT00018733|Paroxetine|paroxetine|mesh-list
64921821|NCT00018733|Desipramine|desipramine|mesh-list
64921822|NCT00018733|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64921823|NCT00018733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64921824|NCT00018733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64921825|NCT00018733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921828|NCT00018733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921829|NCT00018733|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64921830|NCT00018733|Antidepressive Agents|antidepressive agents|mesh-ancestor
64921831|NCT00018733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64921832|NCT00018733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64921833|NCT00018733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64921834|NCT00018733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921836|NCT00018733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64921857|NCT00018850|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64921863|NCT00018850|Dopamine Agents|dopamine agents|mesh-ancestor
64921873|NCT00009750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921874|NCT00009750|Tubulin Modulators|tubulin modulators|mesh-ancestor
64921875|NCT00009750|Antimitotic Agents|antimitotic agents|mesh-ancestor
64921876|NCT00009750|Mitosis Modulators|mitosis modulators|mesh-ancestor
64921877|NCT00009750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921878|NCT00009750|Immunologic Factors|immunologic factors|mesh-ancestor
64921879|NCT00009750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921880|NCT00009750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921881|NCT00009750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64921882|NCT00009750|Antifungal Agents|antifungal agents|mesh-ancestor
64921883|NCT00009750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921884|NCT00009750|Dermatologic Agents|dermatologic agents|mesh-ancestor
64921885|NCT00009750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64921886|NCT00009750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64921887|NCT00019006|Detox adjuvant|detox adjuvant|mesh-list
64921888|NCT00019006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64921889|NCT00019006|Immunologic Factors|immunologic factors|mesh-ancestor
64921890|NCT00019006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921891|NCT00019084|Aldesleukin|aldesleukin|mesh-list
64921892|NCT00019084|Vaccines|vaccines|mesh-list
64921893|NCT00019084|Sargramostim|sargramostim|mesh-list
64921894|NCT00019084|Immunologic Factors|immunologic factors|mesh-ancestor
64921895|NCT00019084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921896|NCT00019084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921897|NCT00019084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64921898|NCT00019084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64921899|NCT00019084|Antiviral Agents|antiviral agents|mesh-ancestor
64921900|NCT00019084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921901|NCT00019123|Thalidomide|thalidomide|mesh-list
64921902|NCT00019123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64921903|NCT00019123|Immunologic Factors|immunologic factors|mesh-ancestor
64921904|NCT00019123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921905|NCT00019123|Leprostatic Agents|leprostatic agents|mesh-ancestor
64921906|NCT00019123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64921916|NCT00019240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383578|NCT03173417|Immunologic Factors|immunologic factors|mesh-ancestor
64921917|NCT00019240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921918|NCT00019318|Romidepsin|romidepsin|mesh-list
64921919|NCT00019318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64921920|NCT00019318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921921|NCT00019357|Aldesleukin|aldesleukin|mesh-list
64921922|NCT00019357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921923|NCT00019357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64921924|NCT00019357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64921925|NCT00019357|Antiviral Agents|antiviral agents|mesh-ancestor
64921926|NCT00019357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921927|NCT00019396|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64921928|NCT00019396|Flt3 ligand protein|flt3 ligand protein|mesh-list
64921929|NCT00019396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64921930|NCT00019396|Immunologic Factors|immunologic factors|mesh-ancestor
64921931|NCT00019396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921932|NCT00019396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64921933|NCT00019396|Protective Agents|protective agents|mesh-ancestor
64921934|NCT00009828|Leucovorin|leucovorin|mesh-list
64921935|NCT00009828|Paclitaxel|paclitaxel|mesh-list
64921936|NCT00009828|Tegafur|tegafur|mesh-list
64921937|NCT00009828|Calcium|calcium|mesh-list
64921938|NCT00009828|Levoleucovorin|levoleucovorin|mesh-list
64921939|NCT00009828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64690388|NCT01910311|Rifampin|rifampin|mesh-list
64921940|NCT00009828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921941|NCT00009828|Tubulin Modulators|tubulin modulators|mesh-ancestor
64921942|NCT00009828|Antimitotic Agents|antimitotic agents|mesh-ancestor
64921943|NCT00009828|Mitosis Modulators|mitosis modulators|mesh-ancestor
64921944|NCT00009828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921963|NCT00019474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64921964|NCT00019474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921965|NCT00019474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64921966|NCT00019474|Immunologic Factors|immunologic factors|mesh-ancestor
64921967|NCT00019474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921968|NCT00019474|Antiviral Agents|antiviral agents|mesh-ancestor
64921970|NCT00019474|Antisickling Agents|antisickling agents|mesh-ancestor
64921974|NCT00019513|Gemcitabine|gemcitabine|mesh-list
64921975|NCT00019513|Fluorouracil|fluorouracil|mesh-list
64921976|NCT00019513|Calcium|calcium|mesh-list
64921977|NCT00019513|Levoleucovorin|levoleucovorin|mesh-list
64921978|NCT00019513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64921979|NCT00019513|Antimetabolites|antimetabolites|mesh-ancestor
64921980|NCT00019513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921981|NCT00019513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921982|NCT00019513|Antiviral Agents|antiviral agents|mesh-ancestor
64921983|NCT00019513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921984|NCT00019513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921985|NCT00019513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64921986|NCT00019513|Immunologic Factors|immunologic factors|mesh-ancestor
64921987|NCT00019513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921988|NCT00019513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64921989|NCT00019513|Antidotes|antidotes|mesh-ancestor
64922014|NCT00019630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922015|NCT00019669|Aldesleukin|aldesleukin|mesh-list
64922016|NCT00019669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922017|NCT00019669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64922018|NCT00019669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64922019|NCT00019669|Antiviral Agents|antiviral agents|mesh-ancestor
64922020|NCT00019669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64922021|NCT00009906|Imatinib Mesylate|imatinib mesylate|mesh-list
64922022|NCT00009906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922023|NCT00009906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64922024|NCT00009906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922025|NCT00009906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922026|NCT00019786|Melphalan|melphalan|mesh-list
64922027|NCT00019786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64922028|NCT00019786|Alkylating Agents|alkylating agents|mesh-ancestor
64922029|NCT00019786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922030|NCT00019786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922031|NCT00019786|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64922032|NCT00019786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64383768|NCT04742283|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64383769|NCT04742283|Adrenergic Agents|adrenergic agents|mesh-ancestor
64922033|NCT00019786|Immunologic Factors|immunologic factors|mesh-ancestor
64922034|NCT00019786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922035|NCT00019825|Decitabine|decitabine|mesh-list
64922036|NCT00019825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64922037|NCT00019825|Antimetabolites|antimetabolites|mesh-ancestor
64922041|NCT00019864|Leucovorin|leucovorin|mesh-list
64922060|NCT00019864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64922061|NCT00019864|Antimetabolites|antimetabolites|mesh-ancestor
64922062|NCT00019864|Dermatologic Agents|dermatologic agents|mesh-ancestor
64922063|NCT00019864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64922064|NCT00019864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64922065|NCT00019864|Immunologic Factors|immunologic factors|mesh-ancestor
64922066|NCT00019864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64922067|NCT00019864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64922068|NCT00019864|Antidotes|antidotes|mesh-ancestor
64922069|NCT00019864|Protective Agents|protective agents|mesh-ancestor
64922070|NCT00019864|Vitamin B Complex|vitamin b complex|mesh-ancestor
64922071|NCT00019864|Vitamins|vitamins|mesh-ancestor
64922072|NCT00019864|Micronutrients|micronutrients|mesh-ancestor
64922073|NCT00019864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64922074|NCT00019864|Antimitotic Agents|antimitotic agents|mesh-ancestor
64922075|NCT00019864|Mitosis Modulators|mitosis modulators|mesh-ancestor
64922076|NCT00020176|Cyclosporine|cyclosporine|mesh-list
64922077|NCT00020176|Cyclophosphamide|cyclophosphamide|mesh-list
64922078|NCT00020176|Fludarabine|fludarabine|mesh-list
64922079|NCT00020176|Fludarabine phosphate|fludarabine phosphate|mesh-list
64922080|NCT00020176|Cyclosporins|cyclosporins|mesh-list
64922121|NCT00009984|Leprostatic Agents|leprostatic agents|mesh-ancestor
64922122|NCT00009984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64922123|NCT00009984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64922124|NCT00009984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64922125|NCT00009984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64922126|NCT00009984|Growth Substances|growth substances|mesh-ancestor
64922127|NCT00009984|Growth Inhibitors|growth inhibitors|mesh-ancestor
64922128|NCT00020332|Docetaxel|docetaxel|mesh-list
64922129|NCT00020332|Alvocidib|alvocidib|mesh-list
64922130|NCT00020332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922131|NCT00020332|Tubulin Modulators|tubulin modulators|mesh-ancestor
64922132|NCT00020332|Antimitotic Agents|antimitotic agents|mesh-ancestor
64922133|NCT00020332|Mitosis Modulators|mitosis modulators|mesh-ancestor
64922135|NCT00020332|Growth Inhibitors|growth inhibitors|mesh-ancestor
64922155|NCT00020449|Antimitotic Agents|antimitotic agents|mesh-ancestor
64922156|NCT00020449|Mitosis Modulators|mitosis modulators|mesh-ancestor
64922157|NCT00020449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922158|NCT00020449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64922159|NCT00020449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64922160|NCT00020449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64922161|NCT00020449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922162|NCT00020449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64922163|NCT00020449|Immunologic Factors|immunologic factors|mesh-ancestor
64922164|NCT00020449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922165|NCT00020449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64922166|NCT00020449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64922167|NCT00020449|Growth Substances|growth substances|mesh-ancestor
64922168|NCT00020449|Growth Inhibitors|growth inhibitors|mesh-ancestor
64922169|NCT00010023|Capecitabine|capecitabine|mesh-list
64922170|NCT00010023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922171|NCT00010023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64922172|NCT00010023|Antimetabolites|antimetabolites|mesh-ancestor
64922173|NCT00010023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922174|NCT00020488|Leucovorin|leucovorin|mesh-list
64922175|NCT00020488|Fluorouracil|fluorouracil|mesh-list
64922182|NCT00020488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922202|NCT00020566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64922204|NCT00020566|Vincristine|vincristine|mesh-list
64922205|NCT00020566|Melphalan|melphalan|mesh-list
64922206|NCT00020566|Busulfan|busulfan|mesh-list
64922207|NCT00020566|Ifosfamide|ifosfamide|mesh-list
64922208|NCT00020566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64922209|NCT00020566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922210|NCT00020566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64922211|NCT00020566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64922212|NCT00020566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922213|NCT00020566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922214|NCT00020566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64922215|NCT00020566|Tubulin Modulators|tubulin modulators|mesh-ancestor
64922216|NCT00020566|Antimitotic Agents|antimitotic agents|mesh-ancestor
64922217|NCT00020566|Mitosis Modulators|mitosis modulators|mesh-ancestor
64922218|NCT00020566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64922219|NCT00020566|Alkylating Agents|alkylating agents|mesh-ancestor
64922220|NCT00020566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64922221|NCT00020566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64922222|NCT00020566|Immunologic Factors|immunologic factors|mesh-ancestor
64922223|NCT00020566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922224|NCT00020566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64922225|NCT00020566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64922226|NCT00020566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64922227|NCT00020566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64922228|NCT00010062|Fluorouracil|fluorouracil|mesh-list
64922229|NCT00010062|Antimetabolites|antimetabolites|mesh-ancestor
64922232|NCT00010062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922262|NCT00020761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922263|NCT00020800|Rituximab|rituximab|mesh-list
64922264|NCT00020800|Fludarabine|fludarabine|mesh-list
64922265|NCT00020800|Fludarabine phosphate|fludarabine phosphate|mesh-list
64922266|NCT00020800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64922267|NCT00020800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922268|NCT00020800|Immunologic Factors|immunologic factors|mesh-ancestor
64922269|NCT00020800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922270|NCT00020800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64922271|NCT00020800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64922272|NCT00020800|Antimetabolites|antimetabolites|mesh-ancestor
64922273|NCT00020800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922274|NCT00020800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64922275|NCT00020839|Temozolomide|temozolomide|mesh-list
64922276|NCT00020839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64922289|NCT00010140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64922300|NCT00020878|Celecoxib|celecoxib|mesh-list
64922351|NCT00021073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922352|NCT00021073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64922353|NCT00021073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922354|NCT00021073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64922355|NCT00021073|Immunologic Factors|immunologic factors|mesh-ancestor
64922356|NCT00021073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64922357|NCT00021073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64922358|NCT00021073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922359|NCT00021073|Antidotes|antidotes|mesh-ancestor
64922360|NCT00021073|Protective Agents|protective agents|mesh-ancestor
64922361|NCT00021073|Vitamin B Complex|vitamin b complex|mesh-ancestor
64922362|NCT00021073|Vitamins|vitamins|mesh-ancestor
64922363|NCT00021073|Micronutrients|micronutrients|mesh-ancestor
64922364|NCT00021073|Growth Inhibitors|growth inhibitors|mesh-ancestor
64922365|NCT00021073|Growth Substances|growth substances|mesh-ancestor
64922366|NCT00021073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64922367|NCT00021112|Etoposide|etoposide|mesh-list
64922368|NCT00021112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922371|NCT00021112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64922378|NCT00000122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922379|NCT00000122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64922380|NCT00000122|Immunologic Factors|immunologic factors|mesh-ancestor
64922381|NCT00000122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922383|NCT00021151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64922384|NCT00021151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922385|NCT00021268|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
64922386|NCT00021268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922387|NCT00021268|Immunologic Factors|immunologic factors|mesh-ancestor
64922388|NCT00021268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922404|NCT00021346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64922405|NCT00021346|Immunologic Factors|immunologic factors|mesh-ancestor
64922406|NCT00021346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922425|NCT00021463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64922426|NCT00021463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64922427|NCT00021463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922428|NCT00021463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922429|NCT00021463|Antiviral Agents|antiviral agents|mesh-ancestor
64922430|NCT00021463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64922431|NCT00021463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64922432|NCT00021463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64922433|NCT00021463|Antimetabolites|antimetabolites|mesh-ancestor
64922434|NCT00021463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64922435|NCT00021463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64922436|NCT00021463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64922437|NCT00021463|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64922438|NCT00021463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64922439|NCT00021463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64922440|NCT00021502|Chrysarobin|chrysarobin|mesh-list
64922441|NCT00021502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64922442|NCT00021502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64922443|NCT00021502|Analgesics|analgesics|mesh-ancestor
64922444|NCT00021502|Sensory System Agents|sensory system agents|mesh-ancestor
64922445|NCT00021502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64922446|NCT00021502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922447|NCT00021502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64922448|NCT00021502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64922474|NCT00394693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64922475|NCT00394810|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
64922476|NCT00394810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922477|NCT00394810|Tubulin Modulators|tubulin modulators|mesh-ancestor
64922478|NCT00394810|Antimitotic Agents|antimitotic agents|mesh-ancestor
64922479|NCT00394810|Mitosis Modulators|mitosis modulators|mesh-ancestor
64922480|NCT00394810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922481|NCT00021814|Doxazosin|doxazosin|mesh-list
64922482|NCT00021814|Finasteride|finasteride|mesh-list
64922483|NCT00021814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64922484|NCT00021814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64922485|NCT00021814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922486|NCT00021814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922487|NCT00021814|Hormone Antagonists|hormone antagonists|mesh-ancestor
64922488|NCT00021814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64922489|NCT00021814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922490|NCT00021814|Urological Agents|urological agents|mesh-ancestor
64922491|NCT00021814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64922492|NCT00021814|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64922493|NCT00021814|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64922494|NCT00021814|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64922495|NCT00021814|Adrenergic Agents|adrenergic agents|mesh-ancestor
64922496|NCT00021814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64922507|NCT00022009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922508|NCT00388661|Melatonin|melatonin|mesh-list
64922509|NCT00388661|Antioxidants|antioxidants|mesh-ancestor
64922510|NCT00388661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922511|NCT00388661|Protective Agents|protective agents|mesh-ancestor
64922512|NCT00388661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922513|NCT00388661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64922514|NCT00022048|Bevacizumab|bevacizumab|mesh-list
64922515|NCT00022048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64922525|NCT00022087|Calcium|calcium|mesh-list
64922526|NCT00022087|Vitamins|vitamins|mesh-ancestor
64922527|NCT00022087|Micronutrients|micronutrients|mesh-ancestor
64922528|NCT00022087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922529|NCT00022087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64922530|NCT00022087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64922531|NCT00388700|Leucovorin|leucovorin|mesh-list
64922532|NCT00388700|Bevacizumab|bevacizumab|mesh-list
64922533|NCT00388700|Fluorouracil|fluorouracil|mesh-list
64922534|NCT00388700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64922535|NCT00388700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922536|NCT00388700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64922537|NCT00388700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64922538|NCT00388700|Growth Substances|growth substances|mesh-ancestor
64922539|NCT00388700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922540|NCT00388700|Growth Inhibitors|growth inhibitors|mesh-ancestor
64922541|NCT00388700|Antimetabolites|antimetabolites|mesh-ancestor
64922542|NCT00388700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922543|NCT00388700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64922544|NCT00388700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64922545|NCT00388700|Immunologic Factors|immunologic factors|mesh-ancestor
64922587|NCT00022126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922588|NCT00022126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64922589|NCT00022126|Abortifacient Agents|abortifacient agents|mesh-ancestor
64922590|NCT00022126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64922591|NCT00022126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64922592|NCT00022126|Antimetabolites|antimetabolites|mesh-ancestor
64922593|NCT00022126|Dermatologic Agents|dermatologic agents|mesh-ancestor
64922594|NCT00022126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64922595|NCT00022126|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64922596|NCT00022126|Antiviral Agents|antiviral agents|mesh-ancestor
64922597|NCT00022126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64922598|NCT00022126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64922599|NCT00022126|Tubulin Modulators|tubulin modulators|mesh-ancestor
64922600|NCT00022126|Antimitotic Agents|antimitotic agents|mesh-ancestor
64922601|NCT00022126|Mitosis Modulators|mitosis modulators|mesh-ancestor
64922602|NCT00022126|Antifungal Agents|antifungal agents|mesh-ancestor
64922603|NCT00022126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64922604|NCT00022126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64922605|NCT00022126|Protective Agents|protective agents|mesh-ancestor
64922606|NCT00022165|Selenium|selenium|mesh-list
64922607|NCT00022165|Antioxidants|antioxidants|mesh-ancestor
64922608|NCT00022165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922609|NCT00022165|Protective Agents|protective agents|mesh-ancestor
64922610|NCT00022165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922611|NCT00022165|Trace Elements|trace elements|mesh-ancestor
64922612|NCT00022165|Micronutrients|micronutrients|mesh-ancestor
64922613|NCT00022204|Vitamin E|vitamin e|mesh-list
64922635|NCT00388739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64922636|NCT00388739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922638|NCT00388739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64922639|NCT00388739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64922640|NCT00388739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64922641|NCT00388739|Respiratory System Agents|respiratory system agents|mesh-ancestor
64922642|NCT00388739|Tocolytic Agents|tocolytic agents|mesh-ancestor
64922643|NCT00388739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64922644|NCT00388739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64922645|NCT00388739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64922646|NCT00388739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64922647|NCT00388739|Adrenergic Agents|adrenergic agents|mesh-ancestor
64922648|NCT00388739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64922649|NCT00388739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922650|NCT00022321|Gemtuzumab|gemtuzumab|mesh-list
64922651|NCT00022321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64922652|NCT00022321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922653|NCT00022360|Taurolidine|taurolidine|mesh-list
64922654|NCT00022360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64922661|NCT00022399|Sensory System Agents|sensory system agents|mesh-ancestor
64922662|NCT00022399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64922663|NCT00022399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922664|NCT00022399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64922665|NCT00022399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64922666|NCT00022399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64922667|NCT00022399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64922668|NCT00022399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922670|NCT00000143|Ganciclovir|ganciclovir|mesh-list
64922687|NCT00022438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922688|NCT00010686|Phytoestrogens|phytoestrogens|mesh-list
64922689|NCT00010686|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64922690|NCT00010686|Estrogens|estrogens|mesh-ancestor
64922691|NCT00010686|Hormones|hormones|mesh-ancestor
64922692|NCT00010686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64922693|NCT00010686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922701|NCT00022555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922702|NCT00022555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64922703|NCT00022555|Immunologic Factors|immunologic factors|mesh-ancestor
64922704|NCT00022555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922705|NCT00000146|Prednisone|prednisone|mesh-list
64922706|NCT00000146|Methylprednisolone|methylprednisolone|mesh-list
64922707|NCT00000146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64922708|NCT00000146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64922709|NCT00000146|Prednisolone|prednisolone|mesh-list
64922710|NCT00000146|Prednisolone acetate|prednisolone acetate|mesh-list
64922711|NCT00000146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64922712|NCT00000146|Prednisolone phosphate|prednisolone phosphate|mesh-list
64922713|NCT00000146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64922714|NCT00000146|Glucocorticoids|glucocorticoids|mesh-ancestor
64922716|NCT00000146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64922717|NCT00000146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922718|NCT00000146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64922719|NCT00000146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922720|NCT00000146|Antiemetics|antiemetics|mesh-ancestor
64922721|NCT00000146|Autonomic Agents|autonomic agents|mesh-ancestor
64922722|NCT00000146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64922723|NCT00000146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64922724|NCT00000146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64922725|NCT00000146|Protective Agents|protective agents|mesh-ancestor
64922726|NCT00010725|Vitamins|vitamins|mesh-list
64922727|NCT00010725|Micronutrients|micronutrients|mesh-ancestor
64922749|NCT00010842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922750|NCT00010842|Protective Agents|protective agents|mesh-ancestor
64922751|NCT00010842|Trace Elements|trace elements|mesh-ancestor
64922752|NCT00010842|Vitamin B Complex|vitamin b complex|mesh-ancestor
64922753|NCT00000152|Aspirin|aspirin|mesh-list
64922754|NCT00000152|Beta Carotene|beta carotene|mesh-list
64922755|NCT00000152|Carotenoids|carotenoids|mesh-list
64922756|NCT00000152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64922757|NCT00000152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64922758|NCT00000152|Analgesics|analgesics|mesh-ancestor
64922759|NCT00000152|Sensory System Agents|sensory system agents|mesh-ancestor
64922760|NCT00000152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64922761|NCT00000152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922762|NCT00000152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64922763|NCT00000152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64922764|NCT00000152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64922765|NCT00000152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64922766|NCT00000152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922767|NCT00000152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64922768|NCT00000152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64922769|NCT00000152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922770|NCT00000152|Antipyretics|antipyretics|mesh-ancestor
64922771|NCT00000152|Antioxidants|antioxidants|mesh-ancestor
64922772|NCT00000152|Protective Agents|protective agents|mesh-ancestor
64922773|NCT00000152|Provitamins|provitamins|mesh-ancestor
64922774|NCT00000152|Vitamins|vitamins|mesh-ancestor
64922775|NCT00000152|Micronutrients|micronutrients|mesh-ancestor
64922776|NCT00010881|Antioxidants|antioxidants|mesh-list
64922777|NCT00010881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922780|NCT00022906|Tositumomab I-131|tositumomab i-131|mesh-list
64922789|NCT00022945|Tositumomab I-131|tositumomab i-131|mesh-list
64922790|NCT00022945|Antibodies|antibodies|mesh-list
64922791|NCT00022945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64922792|NCT00022945|Immunologic Factors|immunologic factors|mesh-ancestor
64922793|NCT00022945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384010|NCT04916613|Hormones|hormones|mesh-ancestor
64990086|NCT05554328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990087|NCT05554328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990088|NCT05552976|Dexamethasone|dexamethasone|mesh-list
64990089|NCT05552976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64990091|NCT05552976|Autonomic Agents|autonomic agents|mesh-ancestor
64922794|NCT00022945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64922795|NCT00022945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64922796|NCT00022945|Alkylating Agents|alkylating agents|mesh-ancestor
64922797|NCT00022945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922798|NCT00022945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922799|NCT00022945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64922800|NCT00022945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64922801|NCT00022945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64922802|NCT00022945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64922803|NCT00022945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922804|NCT00022945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64922805|NCT00022945|Glucocorticoids|glucocorticoids|mesh-ancestor
64922806|NCT00022945|Hormones|hormones|mesh-ancestor
64922807|NCT00022945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64922877|NCT02024607|Protective Agents|protective agents|mesh-ancestor
64922878|NCT02024607|Vitamin B Complex|vitamin b complex|mesh-ancestor
64922879|NCT02024607|Vitamins|vitamins|mesh-ancestor
64922880|NCT02024607|Micronutrients|micronutrients|mesh-ancestor
64922881|NCT00023296|Nitric Oxide|nitric oxide|mesh-list
64922882|NCT00023296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64922883|NCT00023296|Autonomic Agents|autonomic agents|mesh-ancestor
64922884|NCT00023296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64922885|NCT00023296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922886|NCT00023296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64922887|NCT00023296|Respiratory System Agents|respiratory system agents|mesh-ancestor
64922888|NCT00023296|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64922889|NCT00023296|Antioxidants|antioxidants|mesh-ancestor
64922890|NCT00023296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922891|NCT00023296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64922892|NCT00023296|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64922893|NCT00023296|Vasodilator Agents|vasodilator agents|mesh-ancestor
64922894|NCT00023296|Gasotransmitters|gasotransmitters|mesh-ancestor
64922895|NCT00023296|Protective Agents|protective agents|mesh-ancestor
64922896|NCT00023335|Isoniazid|isoniazid|mesh-list
64922897|NCT00023335|Rifapentine|rifapentine|mesh-list
64922898|NCT00023335|Antitubercular Agents|antitubercular agents|mesh-ancestor
64922899|NCT00023335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64922900|NCT00023335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64922901|NCT00023335|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64922902|NCT00023335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64922903|NCT00023335|Antimetabolites|antimetabolites|mesh-ancestor
64922905|NCT00023335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64922915|NCT00000173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384051|NCT04596579|Antibodies|antibodies|mesh-list
64990092|NCT05552976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64990093|NCT05552976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990094|NCT05552976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64990095|NCT05552976|Glucocorticoids|glucocorticoids|mesh-ancestor
64990144|NCT05538897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990145|NCT05538897|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64990146|NCT05538897|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64990147|NCT05538897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64990149|NCT05538897|Appetite Stimulants|appetite stimulants|mesh-ancestor
64990150|NCT05538897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64990151|NCT05510115|Empagliflozin|empagliflozin|mesh-list
64990152|NCT05510115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64990153|NCT05510115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990154|NCT05510115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64990155|NCT05510115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990156|NCT05509777|Mirikizumab|mirikizumab|mesh-list
64922916|NCT00000173|Cholinergic Agents|cholinergic agents|mesh-ancestor
64922917|NCT00000173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64922918|NCT00000173|Nootropic Agents|nootropic agents|mesh-ancestor
64922919|NCT00000173|Antioxidants|antioxidants|mesh-ancestor
64922920|NCT00000173|Protective Agents|protective agents|mesh-ancestor
64922921|NCT00023374|Rifampin|rifampin|mesh-list
64922922|NCT00023374|Pyrazinamide|pyrazinamide|mesh-list
64922923|NCT00023374|Ethambutol|ethambutol|mesh-list
64922924|NCT00023374|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64922925|NCT00023374|Antitubercular Agents|antitubercular agents|mesh-ancestor
64922926|NCT00023374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64922927|NCT00023374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64922928|NCT00023374|Leprostatic Agents|leprostatic agents|mesh-ancestor
64922929|NCT00023374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64922930|NCT00023374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922931|NCT00023374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922932|NCT00023374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64922933|NCT00023374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64922934|NCT00023374|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64922935|NCT00023374|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64922936|NCT00023374|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64922937|NCT00023374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64922938|NCT00023413|Efavirenz|efavirenz|mesh-list
64922939|NCT00023413|Rifabutin|rifabutin|mesh-list
64922940|NCT00023413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64922941|NCT00023413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64922942|NCT00023413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922943|NCT00023413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922958|NCT00023530|Dexamethasone|dexamethasone|mesh-list
64922959|NCT00023530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64922960|NCT00023530|Antiemetics|antiemetics|mesh-ancestor
64922961|NCT00023530|Autonomic Agents|autonomic agents|mesh-ancestor
64922962|NCT00023530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64922963|NCT00023530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922964|NCT00023530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64922965|NCT00023530|Glucocorticoids|glucocorticoids|mesh-ancestor
64922968|NCT00023530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64922969|NCT00023530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922970|NCT00023530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64922971|NCT00023530|Immunologic Factors|immunologic factors|mesh-ancestor
64922972|NCT00023530|Leprostatic Agents|leprostatic agents|mesh-ancestor
64922973|NCT00023530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64922974|NCT00023530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64922975|NCT00023530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64922976|NCT00023530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64922977|NCT00023530|Growth Substances|growth substances|mesh-ancestor
64922978|NCT00023530|Growth Inhibitors|growth inhibitors|mesh-ancestor
64922979|NCT00023530|Antifungal Agents|antifungal agents|mesh-ancestor
64922980|NCT00023530|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64922981|NCT00023530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64922982|NCT00023530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922983|NCT00023530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922984|NCT00023530|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64922989|NCT00000176|Progesterone|progesterone|mesh-list
64923005|NCT00000179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64923006|NCT00000179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64923007|NCT00000179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64691463|NCT00373061|Omalizumab|omalizumab|mesh-list
64923008|NCT00000179|Dopamine Agents|dopamine agents|mesh-ancestor
64923009|NCT00000179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64923010|NCT00000179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923011|NCT00000179|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64923071|NCT00023920|Cytarabine|cytarabine|mesh-list
64923072|NCT00023920|Bevacizumab|bevacizumab|mesh-list
64923073|NCT00023920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64923074|NCT00023920|Idarubicin|idarubicin|mesh-list
64923075|NCT00023920|Antibodies|antibodies|mesh-list
64923076|NCT00023920|Immunoglobulins|immunoglobulins|mesh-list
64923077|NCT00023920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64923078|NCT00023920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923079|NCT00023920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64923080|NCT00023920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64923081|NCT00023920|Growth Substances|growth substances|mesh-ancestor
64691523|NCT02303977|Antimetabolites|antimetabolites|mesh-ancestor
64923082|NCT00023920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923083|NCT00023920|Growth Inhibitors|growth inhibitors|mesh-ancestor
64923084|NCT00023920|Immunologic Factors|immunologic factors|mesh-ancestor
64923085|NCT00023920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64923086|NCT00023920|Antimetabolites|antimetabolites|mesh-ancestor
64923087|NCT00023920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923088|NCT00023920|Antiviral Agents|antiviral agents|mesh-ancestor
64923089|NCT00023920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64923090|NCT00023920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64923091|NCT00023920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64923092|NCT00023920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64923104|NCT00023959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64923105|NCT00023959|Growth Substances|growth substances|mesh-ancestor
64923106|NCT00023959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923107|NCT00023959|Growth Inhibitors|growth inhibitors|mesh-ancestor
64923108|NCT00023959|Immunologic Factors|immunologic factors|mesh-ancestor
64923109|NCT00023959|Antimetabolites|antimetabolites|mesh-ancestor
64923110|NCT00023959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923111|NCT00023959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64923112|NCT00023959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64923113|NCT00023959|Antisickling Agents|antisickling agents|mesh-ancestor
64923114|NCT00023959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923124|NCT00023998|Levoleucovorin|levoleucovorin|mesh-list
64923125|NCT00023998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923126|NCT00023998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64923127|NCT00023998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64923128|NCT00023998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64923129|NCT00023998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923130|NCT00023998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923131|NCT00023998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923132|NCT00023998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64923133|NCT00023998|Abortifacient Agents|abortifacient agents|mesh-ancestor
64923134|NCT00023998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64923135|NCT00023998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64923136|NCT00023998|Antimetabolites|antimetabolites|mesh-ancestor
64923137|NCT00023998|Dermatologic Agents|dermatologic agents|mesh-ancestor
64923138|NCT00023998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64923142|NCT00023998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64923143|NCT00023998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64923207|NCT00024271|Gemcitabine|gemcitabine|mesh-list
64923208|NCT00024271|Interferons|interferons|mesh-list
64923209|NCT00024271|Interferon-gamma|interferon-gamma|mesh-list
64923210|NCT00024271|Doxorubicin|doxorubicin|mesh-list
64923211|NCT00024271|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64923212|NCT00024271|Mitomycins|mitomycins|mesh-list
64923213|NCT00024271|Mitomycin|mitomycin|mesh-list
64923214|NCT00024271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923215|NCT00024271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64923216|NCT00024271|Antimetabolites|antimetabolites|mesh-ancestor
64923217|NCT00024271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923218|NCT00024271|Antiviral Agents|antiviral agents|mesh-ancestor
64923219|NCT00024271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64923220|NCT00024271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923221|NCT00024271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64923222|NCT00024271|Immunologic Factors|immunologic factors|mesh-ancestor
64923223|NCT00024271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923229|NCT00024310|Folic Acid|folic acid|mesh-list
64923239|NCT00024310|Vitamin B Complex|vitamin b complex|mesh-ancestor
64923241|NCT00024310|Micronutrients|micronutrients|mesh-ancestor
64923242|NCT00024310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923292|NCT00000257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64923293|NCT00000257|Analgesics|analgesics|mesh-ancestor
64923294|NCT00000257|Sensory System Agents|sensory system agents|mesh-ancestor
64923295|NCT00000257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64923296|NCT00024466|Vaccines|vaccines|mesh-list
64923297|NCT00024466|Immunologic Factors|immunologic factors|mesh-ancestor
64923298|NCT00024466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923299|NCT04733131|Abatacept|abatacept|mesh-list
64923300|NCT04733131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64923301|NCT04733131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923302|NCT04733131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923303|NCT04733131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64923304|NCT04733131|Immunologic Factors|immunologic factors|mesh-ancestor
64923305|NCT04733131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923306|NCT04733131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64923307|NCT00024544|Antibodies|antibodies|mesh-list
64923308|NCT00024544|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64923309|NCT00024544|Immunologic Factors|immunologic factors|mesh-ancestor
64923310|NCT00024544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923311|NCT00395239|Budesonide|budesonide|mesh-list
64923312|NCT00395239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64923313|NCT00395239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64923314|NCT00395239|Autonomic Agents|autonomic agents|mesh-ancestor
64923315|NCT00395239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64923316|NCT00395239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923326|NCT00025051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64384139|NCT04417582|Orlistat|orlistat|mesh-list
64990157|NCT05509777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64990158|NCT05509777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64990159|NCT05509777|Analgesics|analgesics|mesh-ancestor
64990160|NCT05509777|Sensory System Agents|sensory system agents|mesh-ancestor
64990161|NCT05509777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64990162|NCT05509777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990163|NCT05509777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64990164|NCT05509777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64990165|NCT05509777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64990166|NCT05509777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64990167|NCT05480306|Bevacizumab|bevacizumab|mesh-list
64990168|NCT05480306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64990169|NCT05480306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990170|NCT05480306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64990171|NCT05480306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64990172|NCT05480306|Growth Substances|growth substances|mesh-ancestor
64990173|NCT05480306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990174|NCT05480306|Growth Inhibitors|growth inhibitors|mesh-ancestor
64990175|NCT05478837|Cyclophosphamide|cyclophosphamide|mesh-list
64923327|NCT00025051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64923328|NCT00025051|Analgesics|analgesics|mesh-ancestor
64923329|NCT00025051|Sensory System Agents|sensory system agents|mesh-ancestor
64923330|NCT00025051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64923331|NCT00025051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923332|NCT00025051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64923333|NCT00025051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64923334|NCT00025051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64923335|NCT00025051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64923336|NCT00025051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923337|NCT00025051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923338|NCT00025051|Mitosis Modulators|mitosis modulators|mesh-ancestor
64923339|NCT00025090|Fluorouracil|fluorouracil|mesh-list
64923340|NCT00025090|Mitomycins|mitomycins|mesh-list
64923341|NCT00025090|Mitomycin|mitomycin|mesh-list
64923342|NCT00025090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923343|NCT00025090|Antimetabolites|antimetabolites|mesh-ancestor
64923344|NCT00025090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923345|NCT00025090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64923346|NCT00025090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64923347|NCT00025090|Immunologic Factors|immunologic factors|mesh-ancestor
64923348|NCT00025090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923349|NCT00025090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64923350|NCT00025090|Alkylating Agents|alkylating agents|mesh-ancestor
64923351|NCT00025090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64923352|NCT00025090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923353|NCT00000368|Paroxetine|paroxetine|mesh-list
64923354|NCT00000368|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64923355|NCT00000368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64923383|NCT00025207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64923384|NCT00025207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923385|NCT00025207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923386|NCT00025246|Imatinib Mesylate|imatinib mesylate|mesh-list
64691831|NCT04349696|Mitiglinide|mitiglinide|mesh-list
64923387|NCT00025246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923388|NCT00025246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64923389|NCT00025246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923390|NCT00025246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923392|NCT00025285|Carboplatin|carboplatin|mesh-list
64923393|NCT00025285|Irinotecan|irinotecan|mesh-list
64923394|NCT00025285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923461|NCT00025402|Hydroxyurea|hydroxyurea|mesh-list
64923462|NCT00025402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64923463|NCT00025402|Immunologic Factors|immunologic factors|mesh-ancestor
64923464|NCT00025402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923465|NCT00025402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64923466|NCT00025402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64923467|NCT00025402|Alkylating Agents|alkylating agents|mesh-ancestor
64923468|NCT00025402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923469|NCT00025402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923470|NCT00025402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64923471|NCT00025402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64923472|NCT00025402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64923473|NCT00025402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64923474|NCT00025402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923475|NCT00025402|Antiviral Agents|antiviral agents|mesh-ancestor
64923476|NCT00025402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64923477|NCT00025402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64923478|NCT00025402|Antimetabolites|antimetabolites|mesh-ancestor
64923479|NCT00025402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64923480|NCT00025402|Antisickling Agents|antisickling agents|mesh-ancestor
64923498|NCT00025441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923499|NCT00025441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64923500|NCT00025441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64923501|NCT00025441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64923502|NCT00025441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64923503|NCT00025441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923504|NCT00025441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64923505|NCT00025441|Tubulin Modulators|tubulin modulators|mesh-ancestor
64923506|NCT00025441|Antimitotic Agents|antimitotic agents|mesh-ancestor
64923507|NCT00025441|Mitosis Modulators|mitosis modulators|mesh-ancestor
64923508|NCT00025441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64923509|NCT00025441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64990176|NCT05478837|Fludarabine|fludarabine|mesh-list
64349598|NCT04923295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349599|NCT04923295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64349600|NCT04923295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349601|NCT05396209|Dimenhydrinate|dimenhydrinate|mesh-list
64990241|NCT05413330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990242|NCT05413330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990282|NCT05384119|Palbociclib|palbociclib|mesh-list
64990283|NCT05384119|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64923510|NCT00025441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64923511|NCT00025441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64923512|NCT00000395|Folic Acid|folic acid|mesh-list
64923513|NCT00000395|Leucovorin|leucovorin|mesh-list
64923514|NCT00000395|Methotrexate|methotrexate|mesh-list
64923515|NCT00000395|Levoleucovorin|levoleucovorin|mesh-list
64923516|NCT00000395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64923517|NCT00000395|Abortifacient Agents|abortifacient agents|mesh-ancestor
64923518|NCT00000395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64923519|NCT00000395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923520|NCT00000395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64923521|NCT00000395|Antimetabolites|antimetabolites|mesh-ancestor
64923522|NCT00000395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923523|NCT00000395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923524|NCT00000395|Dermatologic Agents|dermatologic agents|mesh-ancestor
64923525|NCT00000395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923526|NCT00000395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64923527|NCT00000395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64923528|NCT00000395|Immunologic Factors|immunologic factors|mesh-ancestor
64923529|NCT00000395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64923531|NCT00000395|Hematinics|hematinics|mesh-ancestor
64923541|NCT00025480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923542|NCT00025480|Tubulin Modulators|tubulin modulators|mesh-ancestor
64923543|NCT00025480|Antimitotic Agents|antimitotic agents|mesh-ancestor
64923544|NCT00025480|Mitosis Modulators|mitosis modulators|mesh-ancestor
64923545|NCT00025480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923546|NCT00025519|Mycophenolic Acid|mycophenolic acid|mesh-list
64923547|NCT00025519|Thalidomide|thalidomide|mesh-list
64923548|NCT00025519|Fludarabine|fludarabine|mesh-list
64923549|NCT00025519|Fludarabine phosphate|fludarabine phosphate|mesh-list
64990284|NCT05384119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990285|NCT05384119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64990286|NCT05384119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990287|NCT05384119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990288|NCT05384119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64990289|NCT05384119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64990305|NCT05372354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990306|NCT05372354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64990307|NCT05372354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990308|NCT05372354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990309|NCT05368558|Cariprazine|cariprazine|mesh-list
64990310|NCT05368558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64990311|NCT05368558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64990312|NCT05368558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64990313|NCT05368558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990314|NCT05368558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64923550|NCT00025519|Tacrolimus|tacrolimus|mesh-list
64923551|NCT00025519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923552|NCT00025519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64923553|NCT00025519|Antimetabolites|antimetabolites|mesh-ancestor
64923554|NCT00025519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923555|NCT00025519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64923556|NCT00025519|Immunologic Factors|immunologic factors|mesh-ancestor
64923557|NCT00025519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923558|NCT00025519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64923559|NCT00025519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923560|NCT00025519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64923561|NCT00025519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64923562|NCT00025519|Antitubercular Agents|antitubercular agents|mesh-ancestor
64923563|NCT00025519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64923564|NCT00025519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64923565|NCT00025519|Leprostatic Agents|leprostatic agents|mesh-ancestor
64923566|NCT00025519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64923567|NCT00025519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64923568|NCT00025519|Growth Substances|growth substances|mesh-ancestor
64923569|NCT00025519|Growth Inhibitors|growth inhibitors|mesh-ancestor
64923570|NCT00025558|Carboplatin|carboplatin|mesh-list
64923571|NCT00025558|Temozolomide|temozolomide|mesh-list
64923572|NCT00025558|Thiotepa|thiotepa|mesh-list
64923573|NCT00025558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923574|NCT00025558|Immunologic Factors|immunologic factors|mesh-ancestor
64923575|NCT00025558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923576|NCT00025558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64923579|NCT00025558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64923580|NCT00025558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64923581|NCT00025597|Cyclophosphamide|cyclophosphamide|mesh-list
64923582|NCT00025597|Carboplatin|carboplatin|mesh-list
64923583|NCT00025597|Doxorubicin|doxorubicin|mesh-list
64923584|NCT00025597|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64923585|NCT00025597|Etoposide|etoposide|mesh-list
64923586|NCT00025597|Vincristine|vincristine|mesh-list
64923587|NCT00025597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64923588|NCT00025597|Immunologic Factors|immunologic factors|mesh-ancestor
64923592|NCT00025597|Alkylating Agents|alkylating agents|mesh-ancestor
64923593|NCT00025597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923594|NCT00025597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923595|NCT00025597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64923596|NCT00025597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64923597|NCT00025597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64923598|NCT00025597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64923599|NCT00025597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923600|NCT00025597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64923601|NCT00025597|Tubulin Modulators|tubulin modulators|mesh-ancestor
64923602|NCT00025597|Antimitotic Agents|antimitotic agents|mesh-ancestor
64923603|NCT00025597|Mitosis Modulators|mitosis modulators|mesh-ancestor
64923604|NCT00025636|Cytarabine|cytarabine|mesh-list
64923605|NCT00025636|Dexamethasone|dexamethasone|mesh-list
64923606|NCT00025636|Cyclophosphamide|cyclophosphamide|mesh-list
64923607|NCT00025636|Melphalan|melphalan|mesh-list
64923608|NCT00025636|Carmustine|carmustine|mesh-list
64923609|NCT00025636|Methotrexate|methotrexate|mesh-list
64923610|NCT00025636|Etoposide|etoposide|mesh-list
64923611|NCT00025636|Vincristine|vincristine|mesh-list
64923625|NCT00025636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64923626|NCT00025636|Glucocorticoids|glucocorticoids|mesh-ancestor
64923627|NCT00025636|Hormones|hormones|mesh-ancestor
64923628|NCT00025636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64923631|NCT00025636|Abortifacient Agents|abortifacient agents|mesh-ancestor
64923670|NCT00000419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923671|NCT00000419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64923672|NCT00000419|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64923673|NCT00000419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64923674|NCT00000419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923675|NCT00000419|Estrogens|estrogens|mesh-ancestor
64923676|NCT00000419|Hormones|hormones|mesh-ancestor
64923677|NCT00000419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64923827|NCT00027079|Dermatologic Agents|dermatologic agents|mesh-ancestor
64923828|NCT00027079|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64923829|NCT00027079|Serotonin Agents|serotonin agents|mesh-ancestor
64923830|NCT00027079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64923831|NCT00027079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923832|NCT00027079|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64923833|NCT00027079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64923834|NCT00027079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64923835|NCT00027079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64923836|NCT00027079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64923837|NCT00011778|Bortezomib|bortezomib|mesh-list
64923838|NCT00011778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923839|NCT00000425|Acetaminophen|acetaminophen|mesh-list
64923840|NCT00000425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64923841|NCT00000425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64923842|NCT00000425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64923843|NCT00000425|Analgesics|analgesics|mesh-ancestor
64923844|NCT00000425|Sensory System Agents|sensory system agents|mesh-ancestor
64923845|NCT00000425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64923846|NCT00000425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923847|NCT00000425|Antipyretics|antipyretics|mesh-ancestor
64923848|NCT00000425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64923849|NCT00000428|Amitriptyline|amitriptyline|mesh-list
64923891|NCT00000461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64923920|NCT00027547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923921|NCT00027547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923922|NCT00027547|Dermatologic Agents|dermatologic agents|mesh-ancestor
64923923|NCT00027547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923924|NCT00027547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64923925|NCT00027547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64923926|NCT00027547|Immunologic Factors|immunologic factors|mesh-ancestor
64923927|NCT00027547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64923928|NCT00027547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64923929|NCT00027547|Antiviral Agents|antiviral agents|mesh-ancestor
64923930|NCT00027547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64923931|NCT00027547|Antifungal Agents|antifungal agents|mesh-ancestor
64923932|NCT00027547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64923933|NCT00027547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64923934|NCT00027547|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64923935|NCT00027547|Antitubercular Agents|antitubercular agents|mesh-ancestor
64923936|NCT00027547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64923937|NCT00011895|Lamivudine|lamivudine|mesh-list
64923938|NCT00011895|Zidovudine|zidovudine|mesh-list
64923939|NCT00011895|Efavirenz|efavirenz|mesh-list
64923940|NCT00011895|Abacavir|abacavir|mesh-list
64923941|NCT00011895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64923942|NCT00011895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64923943|NCT00011895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923944|NCT00011895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923945|NCT00011895|Antiviral Agents|antiviral agents|mesh-ancestor
64923946|NCT00011895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64923969|NCT00000464|Vasodilator Agents|vasodilator agents|mesh-ancestor
64923970|NCT00000464|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64923971|NCT00000464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64923972|NCT00000464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923980|NCT00000464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64923981|NCT00000464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64923982|NCT00000464|Adrenergic Agents|adrenergic agents|mesh-ancestor
64923983|NCT00000464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64923984|NCT00000464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923985|NCT00000464|Sympatholytics|sympatholytics|mesh-ancestor
64923986|NCT00000464|Autonomic Agents|autonomic agents|mesh-ancestor
64923987|NCT00000464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64923988|NCT00000464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64923989|NCT00000464|Antimalarials|antimalarials|mesh-ancestor
64923990|NCT00000464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64923991|NCT00000464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64923992|NCT00000464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64924016|NCT00027664|Immunologic Factors|immunologic factors|mesh-ancestor
64924017|NCT00027664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924018|NCT00027664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64924019|NCT00027664|Leprostatic Agents|leprostatic agents|mesh-ancestor
64924020|NCT00027664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64924021|NCT00027664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64924022|NCT00027664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64924023|NCT00027664|Growth Substances|growth substances|mesh-ancestor
64924024|NCT00027664|Growth Inhibitors|growth inhibitors|mesh-ancestor
64924025|NCT00027703|Gemcitabine|gemcitabine|mesh-list
64924026|NCT00027703|Bevacizumab|bevacizumab|mesh-list
64924027|NCT00027703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64924029|NCT00027703|Immunoglobulins|immunoglobulins|mesh-list
64924030|NCT00027703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64924031|NCT00027703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924032|NCT00027703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64924033|NCT00027703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64924034|NCT00027703|Growth Substances|growth substances|mesh-ancestor
64924075|NCT00027820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924076|NCT00027820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924077|NCT00027820|Antifungal Agents|antifungal agents|mesh-ancestor
64924078|NCT00027820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64924079|NCT00027820|Dermatologic Agents|dermatologic agents|mesh-ancestor
64924080|NCT00027820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64924081|NCT00027820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64924082|NCT00027820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64924083|NCT00027820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64924084|NCT00027820|Antitubercular Agents|antitubercular agents|mesh-ancestor
64924085|NCT00027820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64924086|NCT00011973|Fenretinide|fenretinide|mesh-list
64924087|NCT00011973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924088|NCT00011973|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64924089|NCT00011973|Protective Agents|protective agents|mesh-ancestor
64924090|NCT00011973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924091|NCT00027859|Ketoconazole|ketoconazole|mesh-list
64924092|NCT00027859|Hydrocortisone|hydrocortisone|mesh-list
64924093|NCT00027859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64924094|NCT00027859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64924095|NCT00027859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64924167|NCT00012051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64924168|NCT00012051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64924169|NCT00012051|Glucocorticoids|glucocorticoids|mesh-ancestor
64924170|NCT00012051|Hormones|hormones|mesh-ancestor
64924171|NCT00012051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64924172|NCT00012051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64924173|NCT00012051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64924174|NCT00012051|Abortifacient Agents|abortifacient agents|mesh-ancestor
64924175|NCT00012051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64924176|NCT00012051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64924177|NCT00012051|Antimetabolites|antimetabolites|mesh-ancestor
64924178|NCT00012051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924179|NCT00012051|Dermatologic Agents|dermatologic agents|mesh-ancestor
64924180|NCT00012051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924181|NCT00012051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64924182|NCT00012051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64924183|NCT00012051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64924184|NCT00012051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64924185|NCT00012051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64924186|NCT00012051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64924187|NCT00012051|Antiviral Agents|antiviral agents|mesh-ancestor
64924188|NCT00012051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64924190|NCT00012051|Alkylating Agents|alkylating agents|mesh-ancestor
64924224|NCT00000479|Antioxidants|antioxidants|mesh-ancestor
64924225|NCT00000479|Protective Agents|protective agents|mesh-ancestor
64924226|NCT00028132|Tenofovir|tenofovir|mesh-list
64924227|NCT00028132|Antiviral Agents|antiviral agents|mesh-ancestor
64924249|NCT00012090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924250|NCT00395395|Calcitonin|calcitonin|mesh-list
64924251|NCT00395395|Salmon calcitonin|salmon calcitonin|mesh-list
64924252|NCT00395395|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
64924253|NCT00395395|Katacalcin|katacalcin|mesh-list
64924254|NCT00395395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64924255|NCT00395395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924256|NCT00395395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64924257|NCT00395395|Vasodilator Agents|vasodilator agents|mesh-ancestor
64924258|NCT00395434|Bevacizumab|bevacizumab|mesh-list
64924259|NCT00395434|Combretastatin|combretastatin|mesh-list
64924260|NCT00395434|Fosbretabulin|fosbretabulin|mesh-list
64924261|NCT00395434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64924262|NCT00395434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924263|NCT00395434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64924264|NCT00395434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64924265|NCT00395434|Growth Substances|growth substances|mesh-ancestor
64924266|NCT00395434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924267|NCT00395434|Growth Inhibitors|growth inhibitors|mesh-ancestor
64924268|NCT00395434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64924269|NCT00395434|Tubulin Modulators|tubulin modulators|mesh-ancestor
64924270|NCT00395434|Antimitotic Agents|antimitotic agents|mesh-ancestor
64924271|NCT00395434|Mitosis Modulators|mitosis modulators|mesh-ancestor
64924272|NCT00395434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924273|NCT00395551|Ranibizumab|ranibizumab|mesh-list
64924274|NCT00395551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64924275|NCT00395551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64924276|NCT00395551|Growth Substances|growth substances|mesh-ancestor
64924295|NCT00000482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924296|NCT00000482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64924297|NCT00000482|Antimetabolites|antimetabolites|mesh-ancestor
64924298|NCT00000482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924299|NCT00000482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64924300|NCT00000482|Vasodilator Agents|vasodilator agents|mesh-ancestor
64924301|NCT00000482|Vitamin B Complex|vitamin b complex|mesh-ancestor
64924302|NCT00000482|Vitamins|vitamins|mesh-ancestor
64924303|NCT00000482|Micronutrients|micronutrients|mesh-ancestor
64924304|NCT00000482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64924305|NCT00028327|Lamivudine|lamivudine|mesh-list
64924306|NCT00028327|Zidovudine|zidovudine|mesh-list
64924307|NCT00028327|Efavirenz|efavirenz|mesh-list
64924308|NCT00028327|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64924309|NCT00028327|Nelfinavir|nelfinavir|mesh-list
64924310|NCT00028327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64924311|NCT00028327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64924312|NCT00028327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924313|NCT00028327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924314|NCT00028327|Antiviral Agents|antiviral agents|mesh-ancestor
64924315|NCT00028327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64924316|NCT00028327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64924317|NCT00028327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64924318|NCT00028327|Antimetabolites|antimetabolites|mesh-ancestor
64924319|NCT00028327|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64924320|NCT00028327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64924321|NCT00028327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64924322|NCT00028327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64924330|NCT00028366|Fosamprenavir|fosamprenavir|mesh-list
64924331|NCT00028366|Tenofovir|tenofovir|mesh-list
64924332|NCT00028366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64924333|NCT00028366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64924334|NCT00028366|Protease Inhibitors|protease inhibitors|mesh-ancestor
64384513|NCT02400281|Cytarabine|cytarabine|mesh-list
64990315|NCT05360966|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64990316|NCT05360966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64990317|NCT05357690|Bupivacaine|bupivacaine|mesh-list
64990318|NCT05357690|Anesthetics, Local|anesthetics, local|mesh-ancestor
64990319|NCT05357690|Anesthetics|anesthetics|mesh-ancestor
64990320|NCT05357690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64990321|NCT05357690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990322|NCT05357690|Sensory System Agents|sensory system agents|mesh-ancestor
64924335|NCT00028366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924336|NCT00028366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924337|NCT00028366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64924338|NCT00028366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64924339|NCT00028366|Antiviral Agents|antiviral agents|mesh-ancestor
64924340|NCT00028366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64924341|NCT00028366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64924342|NCT00028366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64924343|NCT00028366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64924344|NCT00028366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64924345|NCT00028405|Talaporfin|talaporfin|mesh-list
64924346|NCT00028405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924347|NCT00028405|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64924348|NCT00028405|Dermatologic Agents|dermatologic agents|mesh-ancestor
64924349|NCT00012207|Aldesleukin|aldesleukin|mesh-list
64924350|NCT00012207|Prednisone|prednisone|mesh-list
64924351|NCT00012207|Cyclophosphamide|cyclophosphamide|mesh-list
64924352|NCT00012207|Vincristine|vincristine|mesh-list
64924353|NCT00012207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64924354|NCT00012207|Immunologic Factors|immunologic factors|mesh-ancestor
64924355|NCT00012207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924356|NCT00012207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64924357|NCT00012207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64924358|NCT00012207|Alkylating Agents|alkylating agents|mesh-ancestor
64924359|NCT00012207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924360|NCT00012207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924361|NCT00012207|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64924362|NCT00012207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64924371|NCT00012207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64924372|NCT00012207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64924387|NCT00028483|Immunologic Factors|immunologic factors|mesh-ancestor
64924388|NCT00028483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924389|NCT00000485|Antihypertensive Agents|antihypertensive agents|mesh-list
64924390|NCT00000485|Diuretics|diuretics|mesh-list
64924391|NCT00000485|Natriuretic Agents|natriuretic agents|mesh-ancestor
64924392|NCT00000485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924393|NCT00028561|Carboplatin|carboplatin|mesh-list
64924394|NCT00028561|Epothilone B|epothilone b|mesh-list
64924395|NCT00028561|Epothilones|epothilones|mesh-list
64924396|NCT00028561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924397|NCT00028561|Tubulin Modulators|tubulin modulators|mesh-ancestor
64924398|NCT00028561|Antimitotic Agents|antimitotic agents|mesh-ancestor
64924399|NCT00028561|Mitosis Modulators|mitosis modulators|mesh-ancestor
64924484|NCT00028756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924485|NCT00028756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64924486|NCT00028756|Immunologic Factors|immunologic factors|mesh-ancestor
64924487|NCT00028756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924488|NCT00028756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64924489|NCT00028756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64924490|NCT00028756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64924491|NCT00028756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64924510|NCT00012324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924511|NCT00012324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64924512|NCT00012324|Antimetabolites|antimetabolites|mesh-ancestor
64924513|NCT00012324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64924514|NCT00028795|Temozolomide|temozolomide|mesh-list
64924515|NCT00028795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64924516|NCT00028795|Alkylating Agents|alkylating agents|mesh-ancestor
64924517|NCT00028795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924518|NCT00028795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924519|NCT00012363|Gemcitabine|gemcitabine|mesh-list
64924520|NCT00012363|Irinotecan|irinotecan|mesh-list
64924521|NCT00012363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64924522|NCT00012363|Antimetabolites|antimetabolites|mesh-ancestor
64924523|NCT00012363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924524|NCT00012363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924525|NCT00012363|Antiviral Agents|antiviral agents|mesh-ancestor
64924526|NCT00012363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64924527|NCT00012363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924528|NCT00012363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64924571|NCT00028951|Coagulants|coagulants|mesh-ancestor
64924572|NCT01803555|Budesonide|budesonide|mesh-list
64924573|NCT01803555|Formoterol Fumarate|formoterol fumarate|mesh-list
64924574|NCT01803555|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64924575|NCT01803555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64924576|NCT01803555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64924577|NCT01803555|Autonomic Agents|autonomic agents|mesh-ancestor
64924578|NCT01803555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64924579|NCT01803555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924580|NCT01803555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64924582|NCT01803555|Glucocorticoids|glucocorticoids|mesh-ancestor
64924606|NCT00000488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64924607|NCT00000488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64924608|NCT00000488|Antimetabolites|antimetabolites|mesh-ancestor
64924609|NCT00000488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924610|NCT00000488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64924611|NCT00029224|Zoledronic Acid|zoledronic acid|mesh-list
64924612|NCT00029224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64924613|NCT00029224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924614|NCT00000491|Aspirin|aspirin|mesh-list
64924615|NCT00000491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64924616|NCT00000491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64924617|NCT00000491|Analgesics|analgesics|mesh-ancestor
64924618|NCT00000491|Sensory System Agents|sensory system agents|mesh-ancestor
64924621|NCT00000491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64924660|NCT00029458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64924661|NCT00029458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64924662|NCT00029458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64924663|NCT00029458|GABA Antagonists|gaba antagonists|mesh-ancestor
64924664|NCT00029458|GABA Agents|gaba agents|mesh-ancestor
64924665|NCT00029497|Amitriptyline|amitriptyline|mesh-list
64924666|NCT00029497|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64924667|NCT00029497|Antidepressive Agents|antidepressive agents|mesh-ancestor
64924668|NCT00029497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64924669|NCT00029497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64924670|NCT00029497|Analgesics|analgesics|mesh-ancestor
64924671|NCT00029497|Sensory System Agents|sensory system agents|mesh-ancestor
64924672|NCT00029497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64924673|NCT00029497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924674|NCT00029497|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64924675|NCT00029497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64924676|NCT00029497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64924677|NCT00029497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924678|NCT00029497|Adrenergic Agents|adrenergic agents|mesh-ancestor
64924680|NCT00000494|Indomethacin|indomethacin|mesh-list
64924681|NCT00000494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64924682|NCT00000494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64924692|NCT00000494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64924693|NCT00000494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924694|NCT00000494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924695|NCT00012519|Ritonavir|ritonavir|mesh-list
64924696|NCT00012519|Indinavir|indinavir|mesh-list
64924697|NCT00012519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64924698|NCT00012519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64924699|NCT00012519|Protease Inhibitors|protease inhibitors|mesh-ancestor
64924712|NCT00029614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924713|NCT00029614|Adrenergic Agents|adrenergic agents|mesh-ancestor
64924714|NCT00029614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64924715|NCT00029614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924716|NCT00029770|Acetaminophen|acetaminophen|mesh-list
64924717|NCT00029770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64924718|NCT00029770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64924810|NCT00029848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924811|NCT00000503|Streptokinase|streptokinase|mesh-list
64924812|NCT00000503|Nitroglycerin|nitroglycerin|mesh-list
64924813|NCT00000503|Vasodilator Agents|vasodilator agents|mesh-ancestor
64924814|NCT00000503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64924819|NCT00030004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64924820|NCT00030004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64924821|NCT00030004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924822|NCT00030004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64924823|NCT00030004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64924824|NCT00030004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64924825|NCT00030004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64924826|NCT00030004|Anesthetics, General|anesthetics, general|mesh-ancestor
64924827|NCT00030004|Anesthetics|anesthetics|mesh-ancestor
64924909|NCT00030433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64924910|NCT00030433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64924911|NCT00030472|Doxorubicin|doxorubicin|mesh-list
64924912|NCT00030472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64924913|NCT00030472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64924914|NCT00030472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924915|NCT00030472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64924916|NCT00030472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64924994|NCT00030784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64924995|NCT00030784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924996|NCT00030784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924997|NCT00030784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64924998|NCT00030784|Alkylating Agents|alkylating agents|mesh-ancestor
64925000|NCT00030862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925001|NCT00030862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64925002|NCT00030862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64925003|NCT00030862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925004|NCT00030862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925005|NCT00000539|Vitamins|vitamins|mesh-list
64925006|NCT00000539|Vitamin E|vitamin e|mesh-list
64925007|NCT00000539|Beta Carotene|beta carotene|mesh-list
64925008|NCT00000539|Warfarin|warfarin|mesh-list
64925009|NCT00000539|Pravastatin|pravastatin|mesh-list
64925010|NCT00000539|Carotenoids|carotenoids|mesh-list
64925011|NCT00000539|Micronutrients|micronutrients|mesh-ancestor
64925012|NCT00000539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925013|NCT00000539|Anticoagulants|anticoagulants|mesh-ancestor
64925014|NCT00000539|Antioxidants|antioxidants|mesh-ancestor
64925015|NCT00000539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925016|NCT00000539|Protective Agents|protective agents|mesh-ancestor
64925017|NCT00000539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64925018|NCT00000539|Antimetabolites|antimetabolites|mesh-ancestor
64925038|NCT00031018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64925064|NCT00000554|Protective Agents|protective agents|mesh-ancestor
64925065|NCT00012909|Hormones|hormones|mesh-list
64925066|NCT00012909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64925067|NCT00012909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925068|NCT00031096|Azelaic acid|azelaic acid|mesh-list
64925084|NCT00031291|Immunologic Factors|immunologic factors|mesh-ancestor
64925085|NCT00031291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925086|NCT00000560|Adrenergic Agents|adrenergic agents|mesh-list
64925087|NCT00000560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64925088|NCT00000560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64925089|NCT00000560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925090|NCT00000560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925091|NCT00000560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64925092|NCT00396058|Methylphenidate|methylphenidate|mesh-list
64925093|NCT00396058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64925099|NCT00396058|Dopamine Agents|dopamine agents|mesh-ancestor
64925160|NCT00000569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64925161|NCT00000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925175|NCT01791816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925176|NCT01791816|Sympathomimetics|sympathomimetics|mesh-ancestor
64925177|NCT01791816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64925178|NCT01791816|Nasal Decongestants|nasal decongestants|mesh-ancestor
64925179|NCT01791816|Respiratory System Agents|respiratory system agents|mesh-ancestor
64925180|NCT01791816|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64925181|NCT01791816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64925182|NCT01791816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64925183|NCT01791816|Adrenergic Agents|adrenergic agents|mesh-ancestor
64925184|NCT01791816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64925262|NCT00000575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64925263|NCT00000575|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
64925264|NCT00000575|Immunologic Factors|immunologic factors|mesh-ancestor
64925265|NCT00000575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64925266|NCT00032032|Paclitaxel|paclitaxel|mesh-list
64925267|NCT00032032|Carboplatin|carboplatin|mesh-list
64925268|NCT00032032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64925269|NCT00032032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925270|NCT00032032|Tubulin Modulators|tubulin modulators|mesh-ancestor
64925271|NCT00032032|Antimitotic Agents|antimitotic agents|mesh-ancestor
64925272|NCT00032032|Mitosis Modulators|mitosis modulators|mesh-ancestor
64925273|NCT00032032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925274|NCT00032110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64925275|NCT00032110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925353|NCT00000599|Niacin|niacin|mesh-list
64925354|NCT00000599|Colestipol|colestipol|mesh-list
64925355|NCT00000599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64925356|NCT00000599|Antimetabolites|antimetabolites|mesh-ancestor
64925357|NCT00000599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925358|NCT00000599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64925359|NCT00000599|Vasodilator Agents|vasodilator agents|mesh-ancestor
64925360|NCT00000599|Vitamin B Complex|vitamin b complex|mesh-ancestor
64925361|NCT00000599|Vitamins|vitamins|mesh-ancestor
64925362|NCT00000599|Micronutrients|micronutrients|mesh-ancestor
64925363|NCT00000599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925364|NCT00000599|Sequestering Agents|sequestering agents|mesh-ancestor
64925365|NCT00000602|Hydroxyurea|hydroxyurea|mesh-list
64925366|NCT00000602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925367|NCT00000602|Antisickling Agents|antisickling agents|mesh-ancestor
64925368|NCT00000602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925371|NCT00032734|Satavaptan|satavaptan|mesh-list
64925537|NCT00000620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64925538|NCT00000620|Immunologic Factors|immunologic factors|mesh-ancestor
64925539|NCT00000620|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64925540|NCT00000620|Sympatholytics|sympatholytics|mesh-ancestor
64925541|NCT00000620|Autonomic Agents|autonomic agents|mesh-ancestor
64925542|NCT00000620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64925543|NCT00000620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64925544|NCT00000620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64925545|NCT00000620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64925546|NCT00000620|Adrenergic Agents|adrenergic agents|mesh-ancestor
64925547|NCT00000620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64925548|NCT00000620|Antioxidants|antioxidants|mesh-ancestor
64925549|NCT00000620|Protective Agents|protective agents|mesh-ancestor
64925550|NCT00000620|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64925551|NCT00000620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64925552|NCT00000620|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64925578|NCT00033319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64925579|NCT00033319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64925581|NCT00033319|Sensory System Agents|sensory system agents|mesh-ancestor
64925582|NCT00033319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693990|NCT05304455|Dipyridamole|dipyridamole|mesh-list
64925583|NCT00033319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64925585|NCT00033319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64925586|NCT00033319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64925587|NCT00033319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925588|NCT00033319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64925589|NCT00033319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64925590|NCT00033319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925591|NCT00033319|Antipyretics|antipyretics|mesh-ancestor
64925592|NCT00033358|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64925593|NCT00033358|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64925594|NCT00033358|Medroxyprogesterone|medroxyprogesterone|mesh-list
64925595|NCT00033358|Norgestrel|norgestrel|mesh-list
64925596|NCT00033358|Estradiol|estradiol|mesh-list
64925597|NCT00033358|Estrogens|estrogens|mesh-ancestor
64925598|NCT00033358|Hormones|hormones|mesh-ancestor
64384612|NCT02400047|Autonomic Agents|autonomic agents|mesh-ancestor
64990323|NCT05357690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64925599|NCT00033358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64925600|NCT00033358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925601|NCT00033358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64925602|NCT00033358|Contraceptive Agents|contraceptive agents|mesh-ancestor
64925629|NCT00000635|Polymyxins|polymyxins|mesh-list
64925630|NCT00000635|Bacitracin|bacitracin|mesh-list
64925631|NCT00000635|Polymyxin B|polymyxin b|mesh-list
64925632|NCT00000635|Antimetabolites|antimetabolites|mesh-ancestor
64925633|NCT00000635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925634|NCT00000635|Antiviral Agents|antiviral agents|mesh-ancestor
64925635|NCT00000635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64925638|NCT00033553|Gemcitabine|gemcitabine|mesh-list
64925723|NCT00000641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925724|NCT00000641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64925725|NCT00000641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64925726|NCT00000641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64925727|NCT00000641|Antitubercular Agents|antitubercular agents|mesh-ancestor
64925785|NCT00034060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64925786|NCT00034060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925787|NCT00034060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64925788|NCT00034060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64925789|NCT00034060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64925790|NCT00034060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64925791|NCT00034060|Immunologic Factors|immunologic factors|mesh-ancestor
64925793|NCT00034138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64925794|NCT00034138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925795|NCT00034177|Paclitaxel|paclitaxel|mesh-list
64925796|NCT00034177|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64925797|NCT00034177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64925798|NCT00034177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925799|NCT00034177|Tubulin Modulators|tubulin modulators|mesh-ancestor
64925800|NCT00034177|Antimitotic Agents|antimitotic agents|mesh-ancestor
64925801|NCT00034177|Mitosis Modulators|mitosis modulators|mesh-ancestor
64925802|NCT00034177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925803|NCT00389129|Aspirin|aspirin|mesh-list
64925804|NCT00389129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64925805|NCT00389129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64925806|NCT00389129|Analgesics|analgesics|mesh-ancestor
64925807|NCT00389129|Sensory System Agents|sensory system agents|mesh-ancestor
64925808|NCT00389129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64925836|NCT00034372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925837|NCT00014001|Olanzapine|olanzapine|mesh-list
64925838|NCT00014001|Risperidone|risperidone|mesh-list
64925839|NCT00014001|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64925840|NCT00014001|Ziprasidone|ziprasidone|mesh-list
64925841|NCT00014001|Clozapine|clozapine|mesh-list
64925842|NCT00014001|Perphenazine|perphenazine|mesh-list
64925843|NCT00014001|Fluphenazine|fluphenazine|mesh-list
64925844|NCT00014001|Fluphenazine depot|fluphenazine depot|mesh-list
64925845|NCT00014001|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
64925846|NCT00014001|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64925847|NCT00014001|Serotonin Agents|serotonin agents|mesh-ancestor
64925848|NCT00014001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64925849|NCT00014001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925850|NCT00014001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925851|NCT00014001|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64925852|NCT00014001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64925853|NCT00014001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64925854|NCT00014001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64925855|NCT00014001|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64925856|NCT00014001|Dopamine Agents|dopamine agents|mesh-ancestor
64925876|NCT00000671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64925877|NCT00000671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64925878|NCT02971540|Dipyrone|dipyrone|mesh-list
64925879|NCT02971540|Tramadol|tramadol|mesh-list
64925880|NCT02971540|Bupivacaine|bupivacaine|mesh-list
64925881|NCT02971540|Ropivacaine|ropivacaine|mesh-list
64925882|NCT02971540|Anesthetics, Local|anesthetics, local|mesh-ancestor
64925883|NCT02971540|Anesthetics|anesthetics|mesh-ancestor
64925884|NCT02971540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64925885|NCT02971540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925886|NCT02971540|Sensory System Agents|sensory system agents|mesh-ancestor
64925887|NCT02971540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64925888|NCT02971540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64925889|NCT02971540|Narcotics|narcotics|mesh-ancestor
64925890|NCT02971540|Analgesics|analgesics|mesh-ancestor
64925891|NCT02971540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64925892|NCT02971540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64925893|NCT02971540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64990324|NCT05353439|Pembrolizumab|pembrolizumab|mesh-list
64925894|NCT02971540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64925895|NCT02971540|Antipyretics|antipyretics|mesh-ancestor
64926021|NCT00014118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926022|NCT00034762|Risperidone|risperidone|mesh-list
64926023|NCT00034762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64926024|NCT00034762|Serotonin Agents|serotonin agents|mesh-ancestor
64926025|NCT00034762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64926026|NCT00034762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926034|NCT00000686|Stavudine|stavudine|mesh-list
64926157|NCT00014235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64926158|NCT00014235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64926159|NCT00014235|Antitubercular Agents|antitubercular agents|mesh-ancestor
64926160|NCT00014235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64926161|NCT00000710|Didanosine|didanosine|mesh-list
64926168|NCT00000710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926169|NCT00000710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64926170|NCT00000710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64926172|NCT00000716|Antimetabolites|antimetabolites|mesh-ancestor
64926173|NCT00000716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926174|NCT00000716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64926175|NCT00000716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64926176|NCT00000716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926177|NCT00000716|Antiviral Agents|antiviral agents|mesh-ancestor
64926178|NCT00000716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926179|NCT00000716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64926180|NCT00000716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64926181|NCT00014274|Gemcitabine|gemcitabine|mesh-list
64926182|NCT00014274|Carboplatin|carboplatin|mesh-list
64926183|NCT00014274|Methotrexate|methotrexate|mesh-list
64926184|NCT00014274|Vinblastine|vinblastine|mesh-list
64926206|NCT00035035|Gemcitabine|gemcitabine|mesh-list
64926283|NCT00014352|Antimitotic Agents|antimitotic agents|mesh-ancestor
64926284|NCT00014352|Mitosis Modulators|mitosis modulators|mesh-ancestor
64926285|NCT00014352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926286|NCT00014352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64926287|NCT00014352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64926288|NCT00014352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64926289|NCT00014352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926290|NCT00014352|Anticoagulants|anticoagulants|mesh-ancestor
64926291|NCT00014352|Antifungal Agents|antifungal agents|mesh-ancestor
64926292|NCT00014352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926293|NCT00014352|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64926294|NCT00014352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64926295|NCT00014352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64926296|NCT00014352|Hormone Antagonists|hormone antagonists|mesh-ancestor
64926297|NCT00014352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64926298|NCT00014352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926372|NCT00000752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64926373|NCT00000752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926521|NCT00035854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926522|NCT00035854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64926523|NCT00035854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926524|NCT00035854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926525|NCT00000779|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64926526|NCT00000779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64926527|NCT00000779|Immunologic Factors|immunologic factors|mesh-ancestor
64926528|NCT00000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926529|NCT00000779|Antacids|antacids|mesh-ancestor
64926530|NCT00000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926531|NCT00000779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64926532|NCT00035893|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
64926533|NCT00035893|Poly I-C|poly i-c|mesh-list
64926534|NCT00035893|Antiviral Agents|antiviral agents|mesh-ancestor
64926535|NCT00035893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926536|NCT00035893|Interferon Inducers|interferon inducers|mesh-ancestor
64926537|NCT00035893|Immunologic Factors|immunologic factors|mesh-ancestor
64926538|NCT00035893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926539|NCT00035971|Alendronate|alendronate|mesh-list
64926540|NCT00035971|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64926541|NCT00035971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64926542|NCT00035971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926605|NCT00000788|Narcotics|narcotics|mesh-ancestor
64926606|NCT00000788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64926607|NCT00000788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926608|NCT00000788|Analgesics|analgesics|mesh-ancestor
64926609|NCT00000788|Sensory System Agents|sensory system agents|mesh-ancestor
64926610|NCT00000788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64926611|NCT00000788|Antitussive Agents|antitussive agents|mesh-ancestor
64926612|NCT00000788|Respiratory System Agents|respiratory system agents|mesh-ancestor
64926613|NCT00000788|Antifungal Agents|antifungal agents|mesh-ancestor
64926614|NCT00000788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926615|NCT00000788|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64926616|NCT00000788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64926617|NCT00000788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926618|NCT00000788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926619|NCT00000788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64926620|NCT00000788|Hormone Antagonists|hormone antagonists|mesh-ancestor
64926621|NCT00000788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64926622|NCT00000788|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64926624|NCT00036166|Micafungin|micafungin|mesh-list
64926671|NCT00391638|Interferons|interferons|mesh-list
64926672|NCT00391638|Tenofovir|tenofovir|mesh-list
64926673|NCT00391638|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64926674|NCT00391638|Emtricitabine|emtricitabine|mesh-list
64926675|NCT00391638|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64926676|NCT00391638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926677|NCT00391638|Antiviral Agents|antiviral agents|mesh-ancestor
64926678|NCT00391638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926679|NCT00391638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64926680|NCT00391638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64926686|NCT00036361|Antidepressive Agents|antidepressive agents|mesh-ancestor
64926687|NCT00036361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64926688|NCT00036361|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64926689|NCT00036361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64926690|NCT00036361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64926691|NCT00036361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926692|NCT00036361|Dopamine Agonists|dopamine agonists|mesh-ancestor
64926693|NCT00036361|Dopamine Agents|dopamine agents|mesh-ancestor
64926694|NCT00036361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64926743|NCT00036751|Imatinib Mesylate|imatinib mesylate|mesh-list
64926744|NCT00036751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926745|NCT00036751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64926746|NCT00036751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926747|NCT00036751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926748|NCT00036790|Doxorubicin|doxorubicin|mesh-list
64926749|NCT00036790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64926750|NCT00036790|Motexafin gadolinium|motexafin gadolinium|mesh-list
64926751|NCT00036790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64926752|NCT00036790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926753|NCT00036790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64926754|NCT00036790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64926755|NCT00036790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926756|NCT00036790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926757|NCT00036790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64926827|NCT00000869|Nevirapine|nevirapine|mesh-list
64926828|NCT00000869|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64926829|NCT00000869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64926830|NCT00000869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926831|NCT00000869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926832|NCT00000869|Antiviral Agents|antiviral agents|mesh-ancestor
64926833|NCT00000869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926834|NCT00000869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64926835|NCT00000869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64926836|NCT00000869|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64926837|NCT00000869|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64926838|NCT00037102|Interferons|interferons|mesh-list
64926839|NCT00037102|Interferon-beta|interferon-beta|mesh-list
64926840|NCT00037102|Interferon beta-1a|interferon beta-1a|mesh-list
64926841|NCT00037102|Methotrexate|methotrexate|mesh-list
64926842|NCT00037102|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64926843|NCT00037102|Abortifacient Agents|abortifacient agents|mesh-ancestor
64926844|NCT00037102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64926845|NCT00037102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926846|NCT00037102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64926855|NCT00037102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64926856|NCT00037102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64926857|NCT00037102|Antiviral Agents|antiviral agents|mesh-ancestor
64926858|NCT00037102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926859|NCT00037102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64926861|NCT00037141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64926862|NCT00037141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926863|NCT00037141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64926864|NCT00037141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926865|NCT00037180|Leucovorin|leucovorin|mesh-list
64926866|NCT00037180|Celecoxib|celecoxib|mesh-list
64926867|NCT00037180|Fluorouracil|fluorouracil|mesh-list
64926868|NCT00037180|Irinotecan|irinotecan|mesh-list
64926869|NCT00037180|Antimetabolites|antimetabolites|mesh-ancestor
64384807|NCT04272801|Letrozole|letrozole|mesh-list
64990326|NCT05353439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64990327|NCT05353439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990328|NCT05353439|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64990329|NCT05353439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64990330|NCT05353439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990331|NCT05353439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926870|NCT00037180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926871|NCT00037180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64926872|NCT00037180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926873|NCT00037180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64926874|NCT00037180|Immunologic Factors|immunologic factors|mesh-ancestor
64926875|NCT00037180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926876|NCT00037180|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64926877|NCT00037180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64926878|NCT00037180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926879|NCT00037180|Antidotes|antidotes|mesh-ancestor
64926880|NCT00037180|Protective Agents|protective agents|mesh-ancestor
64926881|NCT00037180|Vitamin B Complex|vitamin b complex|mesh-ancestor
64926882|NCT00037180|Vitamins|vitamins|mesh-ancestor
64926904|NCT00000893|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64926905|NCT00000893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64926906|NCT00000893|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64926907|NCT00000893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64926908|NCT00000893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64926909|NCT00000893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64926910|NCT00000893|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64926911|NCT00000893|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64926912|NCT00000893|Protease Inhibitors|protease inhibitors|mesh-ancestor
64926913|NCT00000893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64926914|NCT00000893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64926915|NCT00396526|Amoxicillin|amoxicillin|mesh-list
64926916|NCT00396526|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64926917|NCT00396526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64926918|NCT00396526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926919|NCT00396526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64926920|NCT00396526|Renal Agents|renal agents|mesh-ancestor
64926921|NCT00396526|Antimalarials|antimalarials|mesh-ancestor
64926922|NCT00396526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64384863|NCT02397551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64384865|NCT03168191|Menthol|menthol|mesh-list
64990339|NCT05350202|Empagliflozin|empagliflozin|mesh-list
64990351|NCT05322954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990352|NCT05322954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64990358|NCT05286801|Deoxyglucose|deoxyglucose|mesh-list
64990359|NCT05286801|Atezolizumab|atezolizumab|mesh-list
64990360|NCT05286801|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64990361|NCT05286801|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64926923|NCT00396526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64926924|NCT00037531|Sirolimus|sirolimus|mesh-list
64926925|NCT00037531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64926926|NCT00037531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926927|NCT00037531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64926928|NCT00037531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926929|NCT00037531|Antifungal Agents|antifungal agents|mesh-ancestor
64926930|NCT00037531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64926931|NCT00037531|Immunologic Factors|immunologic factors|mesh-ancestor
64926932|NCT00037531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926933|NCT00037570|Pantoprazole|pantoprazole|mesh-list
64926939|NCT00000899|Lamivudine|lamivudine|mesh-list
64926948|NCT00000899|Alkylating Agents|alkylating agents|mesh-ancestor
64926949|NCT00000899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926950|NCT00000899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926951|NCT00000899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64926952|NCT00000899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64926953|NCT00000899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64926954|NCT00000899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926955|NCT00000899|Antiviral Agents|antiviral agents|mesh-ancestor
64926956|NCT00000899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926957|NCT00000899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64926958|NCT00000899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64926959|NCT00000899|Antimetabolites|antimetabolites|mesh-ancestor
64926960|NCT00000899|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64926961|NCT00000899|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64926962|NCT00000899|Protease Inhibitors|protease inhibitors|mesh-ancestor
64926963|NCT00037609|Sulindac sulfone|sulindac sulfone|mesh-list
64926964|NCT00037609|Capecitabine|capecitabine|mesh-list
64926965|NCT00037609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64926966|NCT00037609|Antimetabolites|antimetabolites|mesh-ancestor
64384878|NCT05496075|Orlistat|orlistat|mesh-list
64990362|NCT05286801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990363|NCT05286801|Immunologic Factors|immunologic factors|mesh-ancestor
64990364|NCT05286801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990365|NCT05286801|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64990366|NCT05286801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990367|NCT05286801|Antimetabolites|antimetabolites|mesh-ancestor
64990368|NCT05286801|Antiviral Agents|antiviral agents|mesh-ancestor
64990560|NCT05141474|Interleukin-2|interleukin-2|mesh-list
64990561|NCT05141474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64990625|NCT05119140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64990626|NCT05112601|Nivolumab|nivolumab|mesh-list
64990627|NCT05112601|Ipilimumab|ipilimumab|mesh-list
64990628|NCT05112601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64990629|NCT05112601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926967|NCT00037609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926968|NCT00037609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926969|NCT00037609|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64926970|NCT00037609|Protective Agents|protective agents|mesh-ancestor
64926971|NCT00037609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926972|NCT00037609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64926973|NCT00037609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926974|NCT00037609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64926975|NCT00037609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64926976|NCT00037609|Analgesics|analgesics|mesh-ancestor
64926977|NCT00037609|Sensory System Agents|sensory system agents|mesh-ancestor
64926978|NCT00037609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64926979|NCT00037609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64926980|NCT00037609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64926981|NCT00037648|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64926982|NCT00037648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64926983|NCT00037804|Irinotecan|irinotecan|mesh-list
64926984|NCT00037804|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64926985|NCT00037804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64926986|NCT00037804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926987|NCT00037804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926988|NCT00037804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926989|NCT00037882|Interferons|interferons|mesh-list
64926990|NCT00037882|Interferon-alpha|interferon-alpha|mesh-list
64926991|NCT00037882|Interferon alpha-2|interferon alpha-2|mesh-list
64926992|NCT00037882|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64926993|NCT00037882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926994|NCT00037882|Antiviral Agents|antiviral agents|mesh-ancestor
64926995|NCT00037882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926996|NCT00037882|Immunologic Factors|immunologic factors|mesh-ancestor
64926997|NCT00037882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926998|NCT00037999|Testosterone|testosterone|mesh-list
64990630|NCT05112601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64990631|NCT05112601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990632|NCT05111574|Nivolumab|nivolumab|mesh-list
64990633|NCT05111574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64990634|NCT05111574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990635|NCT05111574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64990639|NCT05097261|Ketamine|ketamine|mesh-list
64990685|NCT05037032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926999|NCT00037999|Androgens|androgens|mesh-ancestor
64927000|NCT00037999|Hormones|hormones|mesh-ancestor
64927001|NCT00037999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64927002|NCT00037999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927003|NCT00038077|Metoprolol|metoprolol|mesh-list
64927004|NCT00038077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64927006|NCT00038077|Sympatholytics|sympatholytics|mesh-ancestor
64927101|NCT00014937|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64927118|NCT00014937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64927119|NCT00014937|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64927120|NCT00014937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64927121|NCT00014937|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64927123|NCT00000959|Vitamin B 6|vitamin b 6|mesh-list
64927124|NCT00000959|Isoniazid|isoniazid|mesh-list
64927125|NCT00000959|Antitubercular Agents|antitubercular agents|mesh-ancestor
64927126|NCT00000959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64927207|NCT00015132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927208|NCT00000971|Zidovudine|zidovudine|mesh-list
64927209|NCT00000971|Didanosine|didanosine|mesh-list
64927210|NCT00000971|Clarithromycin|clarithromycin|mesh-list
64927211|NCT00000971|Antimetabolites|antimetabolites|mesh-ancestor
64927212|NCT00000971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927213|NCT00000971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64927214|NCT00000971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64927215|NCT00000971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927216|NCT00000971|Antiviral Agents|antiviral agents|mesh-ancestor
64927217|NCT00000971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927218|NCT00000971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64927219|NCT00000971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64927220|NCT00000971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64927221|NCT00000971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64927222|NCT00000971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64927224|NCT00015171|Buprenorphine|buprenorphine|mesh-list
64927295|NCT00015288|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64927296|NCT05083975|Anesthetics|anesthetics|mesh-list
64927297|NCT05083975|Anesthetics, Local|anesthetics, local|mesh-list
64927298|NCT05083975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64927299|NCT05083975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927300|NCT05083975|Sensory System Agents|sensory system agents|mesh-ancestor
64927301|NCT05083975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64927302|NCT00000998|Leucovorin|leucovorin|mesh-list
64927303|NCT00000998|Trimetrexate|trimetrexate|mesh-list
64927304|NCT00000998|Calcium|calcium|mesh-list
64927305|NCT00000998|Levoleucovorin|levoleucovorin|mesh-list
64927306|NCT00000998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64927307|NCT00000998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927308|NCT00000998|Antidotes|antidotes|mesh-ancestor
64927311|NCT00000998|Vitamins|vitamins|mesh-ancestor
64927408|NCT00001010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927409|NCT00001010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64927410|NCT00001010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64927411|NCT00001010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927412|NCT00001010|Antiviral Agents|antiviral agents|mesh-ancestor
64927413|NCT00001010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927414|NCT00001010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64927415|NCT00001010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64927416|NCT00001013|Leucovorin|leucovorin|mesh-list
64927417|NCT00001013|Trimethoprim|trimethoprim|mesh-list
64927418|NCT00001013|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64927419|NCT00001013|Sulfamethoxazole|sulfamethoxazole|mesh-list
64927420|NCT00001013|Pentamidine|pentamidine|mesh-list
64927421|NCT00001013|Trimetrexate|trimetrexate|mesh-list
64927422|NCT00001013|Calcium|calcium|mesh-list
64927423|NCT00001013|Levoleucovorin|levoleucovorin|mesh-list
64927425|NCT00001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927435|NCT00001013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64927436|NCT00001013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64927437|NCT00001013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64927438|NCT00001013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927439|NCT00001013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927440|NCT00001013|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64927441|NCT00001013|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64927442|NCT00001013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64927443|NCT00001013|Antifungal Agents|antifungal agents|mesh-ancestor
64927444|NCT00001013|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64927445|NCT00001013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64927446|NCT00001013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64927447|NCT00001013|Antimetabolites|antimetabolites|mesh-ancestor
64927448|NCT00001013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927449|NCT04680442|Trastuzumab|trastuzumab|mesh-list
64927450|NCT04680442|Pertuzumab|pertuzumab|mesh-list
64927451|NCT04680442|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64927452|NCT04680442|Maytansine|maytansine|mesh-list
64990687|NCT05037032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64990758|NCT04981509|Fluorides|fluorides|mesh-list
64990759|NCT04981509|Sodium Fluoride|sodium fluoride|mesh-list
64990760|NCT04981509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990761|NCT04981509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64990762|NCT04981509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64990763|NCT04981509|Growth Substances|growth substances|mesh-ancestor
64927453|NCT04680442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64927454|NCT04680442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927455|NCT04680442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64927460|NCT00015834|Cytarabine|cytarabine|mesh-list
64927487|NCT00001040|Protease Inhibitors|protease inhibitors|mesh-ancestor
64927488|NCT00001040|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64927489|NCT00001040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64927490|NCT00015873|Cytarabine|cytarabine|mesh-list
64927491|NCT00015873|Prednisolone|prednisolone|mesh-list
64927492|NCT00015873|Methotrexate|methotrexate|mesh-list
64927493|NCT00015873|Mercaptopurine|mercaptopurine|mesh-list
64927494|NCT00015873|Vincristine|vincristine|mesh-list
64927495|NCT00015873|Asparaginase|asparaginase|mesh-list
64927496|NCT00015873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64927497|NCT00015873|Abortifacient Agents|abortifacient agents|mesh-ancestor
64927498|NCT00015873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64927499|NCT00015873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927500|NCT00015873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64927501|NCT00015873|Antimetabolites|antimetabolites|mesh-ancestor
64927502|NCT00015873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927503|NCT00015873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927504|NCT00015873|Dermatologic Agents|dermatologic agents|mesh-ancestor
64927505|NCT00015873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927506|NCT00015873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64927507|NCT00015873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64927508|NCT00015873|Immunologic Factors|immunologic factors|mesh-ancestor
64927509|NCT00015873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64927510|NCT00015873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64927511|NCT00015873|Antiviral Agents|antiviral agents|mesh-ancestor
64927512|NCT00015873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927513|NCT00015873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64927514|NCT00015873|Tubulin Modulators|tubulin modulators|mesh-ancestor
64927534|NCT00015912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64927535|NCT00015912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64927536|NCT00015912|Growth Substances|growth substances|mesh-ancestor
64927537|NCT00015912|Growth Inhibitors|growth inhibitors|mesh-ancestor
64927539|NCT03668431|Dabrafenib|dabrafenib|mesh-list
64927540|NCT03668431|Spartalizumab|spartalizumab|mesh-list
64927541|NCT03668431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927542|NCT03668431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64927543|NCT03668431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927544|NCT03668431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927545|NCT03668431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64927546|NCT00001073|Isotretinoin|isotretinoin|mesh-list
64927547|NCT00001073|Dermatologic Agents|dermatologic agents|mesh-ancestor
64927548|NCT02970721|Antipsychotic Agents|antipsychotic agents|mesh-list
64927549|NCT02970721|Antidepressive Agents|antidepressive agents|mesh-list
64927550|NCT02970721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64927551|NCT02970721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64927552|NCT02970721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64927553|NCT02970721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927554|NCT03636958|Anticonvulsants|anticonvulsants|mesh-list
64927555|NCT00015951|Cytarabine|cytarabine|mesh-list
64927556|NCT00015951|Bevacizumab|bevacizumab|mesh-list
64927557|NCT00015951|Mitoxantrone|mitoxantrone|mesh-list
64927558|NCT00015951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64927559|NCT00015951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927560|NCT00015951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64927561|NCT00015951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64927562|NCT00015951|Growth Substances|growth substances|mesh-ancestor
64927563|NCT00015951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927564|NCT00015951|Growth Inhibitors|growth inhibitors|mesh-ancestor
64927565|NCT00015951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64927566|NCT00015951|Antimetabolites|antimetabolites|mesh-ancestor
64927567|NCT00015951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927568|NCT00015951|Antiviral Agents|antiviral agents|mesh-ancestor
64927575|NCT00015951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64927576|NCT00015951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64927577|NCT00015951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927578|NCT03603223|Pembrolizumab|pembrolizumab|mesh-list
64927579|NCT03603223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64927580|NCT03603223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927581|NCT00001076|polysaccharide-K|polysaccharide-k|mesh-list
64927582|NCT00001076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64927583|NCT00001076|Immunologic Factors|immunologic factors|mesh-ancestor
64927585|NCT00001076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64927586|NCT00001076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927587|NCT00001076|Antiviral Agents|antiviral agents|mesh-ancestor
64927588|NCT00001076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927589|NCT00001076|Interferon Inducers|interferon inducers|mesh-ancestor
64927590|NCT00001076|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64927591|NCT00001076|Protective Agents|protective agents|mesh-ancestor
64927592|NCT00015990|Thalidomide|thalidomide|mesh-list
64927593|NCT00015990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64927594|NCT00015990|Immunologic Factors|immunologic factors|mesh-ancestor
64927595|NCT00015990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927596|NCT00015990|Leprostatic Agents|leprostatic agents|mesh-ancestor
64927597|NCT00015990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64927598|NCT00015990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927599|NCT00015990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64927600|NCT00015990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64927601|NCT00015990|Growth Substances|growth substances|mesh-ancestor
64927602|NCT00015990|Growth Inhibitors|growth inhibitors|mesh-ancestor
64927603|NCT00015990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927604|NCT00001085|Lamivudine|lamivudine|mesh-list
64927605|NCT00001085|Zidovudine|zidovudine|mesh-list
64927606|NCT00001085|Amprenavir|amprenavir|mesh-list
64927619|NCT00001085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64927620|NCT00001085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64927621|NCT00001085|Protease Inhibitors|protease inhibitors|mesh-ancestor
64927663|NCT00001118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64927664|NCT00001118|Antiviral Agents|antiviral agents|mesh-ancestor
64927665|NCT00001118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927666|NCT00016185|Docetaxel|docetaxel|mesh-list
64927667|NCT00016185|Alvocidib|alvocidib|mesh-list
64927668|NCT00016185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927669|NCT00016185|Tubulin Modulators|tubulin modulators|mesh-ancestor
64927670|NCT00016185|Antimitotic Agents|antimitotic agents|mesh-ancestor
64927671|NCT00016185|Mitosis Modulators|mitosis modulators|mesh-ancestor
64927672|NCT00016185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927673|NCT00016185|Growth Inhibitors|growth inhibitors|mesh-ancestor
64927674|NCT00016185|Growth Substances|growth substances|mesh-ancestor
64927675|NCT00016185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927676|NCT00016185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64927677|NCT00016185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927678|NCT00001151|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
64927679|NCT00001151|Calcitriol|calcitriol|mesh-list
64927680|NCT00001151|Vitamins|vitamins|mesh-ancestor
64927760|NCT00016302|Tubulin Modulators|tubulin modulators|mesh-ancestor
64927761|NCT00016302|Antimitotic Agents|antimitotic agents|mesh-ancestor
64927762|NCT00016302|Mitosis Modulators|mitosis modulators|mesh-ancestor
64927763|NCT00389285|Sorafenib|sorafenib|mesh-list
64927764|NCT00389285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927765|NCT00389285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64927766|NCT00389285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927767|NCT00389285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927768|NCT00016341|Tamoxifen|tamoxifen|mesh-list
64927949|NCT00016887|Cytarabine|cytarabine|mesh-list
64927950|NCT00016887|Interferon-alpha|interferon-alpha|mesh-list
64927951|NCT00016887|Dexamethasone|dexamethasone|mesh-list
64927952|NCT00016887|Cyclophosphamide|cyclophosphamide|mesh-list
64927953|NCT00016887|Melphalan|melphalan|mesh-list
64927954|NCT00016887|Carmustine|carmustine|mesh-list
64927955|NCT00016887|Etoposide|etoposide|mesh-list
64927956|NCT00016887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64927957|NCT00016887|Immunologic Factors|immunologic factors|mesh-ancestor
64927971|NCT00016887|Hormones|hormones|mesh-ancestor
64928043|NCT00038701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64928044|NCT00038701|Growth Substances|growth substances|mesh-ancestor
64928045|NCT00038701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928046|NCT00038701|Growth Inhibitors|growth inhibitors|mesh-ancestor
64928047|NCT00038896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64928048|NCT00038896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64928052|NCT00038896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64928058|NCT00038935|Coagulants|coagulants|mesh-ancestor
64928059|NCT00017004|Epoetin Alfa|epoetin alfa|mesh-list
64928060|NCT00017004|Hematinics|hematinics|mesh-ancestor
64928061|NCT00038974|Ribavirin|ribavirin|mesh-list
64928062|NCT00038974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64928063|NCT00038974|Antimetabolites|antimetabolites|mesh-ancestor
64928064|NCT00038974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928065|NCT00038974|Antiviral Agents|antiviral agents|mesh-ancestor
64928066|NCT00038974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64928067|NCT00039013|Exenatide|exenatide|mesh-list
64928068|NCT00039013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64928069|NCT00039013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928070|NCT00039013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64928071|NCT00039013|Incretins|incretins|mesh-ancestor
64928072|NCT00039013|Hormones|hormones|mesh-ancestor
64928073|NCT00039013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64928074|NCT00039052|Interleukin-4|interleukin-4|mesh-list
64928075|NCT00039052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64928076|NCT00039052|Immunologic Factors|immunologic factors|mesh-ancestor
64928077|NCT00039052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928078|NCT00039052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928079|NCT00039052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64928105|NCT00001304|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64928106|NCT00001304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64928107|NCT00001304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928108|NCT00001304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64928109|NCT00039208|Leucovorin|leucovorin|mesh-list
64928110|NCT00039208|Fluorouracil|fluorouracil|mesh-list
64928111|NCT00039208|Oxaliplatin|oxaliplatin|mesh-list
64928112|NCT00039208|Irinotecan|irinotecan|mesh-list
64928113|NCT00039208|Calcium|calcium|mesh-list
64928114|NCT00039208|Levoleucovorin|levoleucovorin|mesh-list
64928115|NCT00039208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64928116|NCT00039208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928117|NCT00039208|Antimetabolites|antimetabolites|mesh-ancestor
64928118|NCT00039208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928119|NCT00039208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64928120|NCT00039208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928121|NCT00039208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64928122|NCT00039208|Immunologic Factors|immunologic factors|mesh-ancestor
64928123|NCT00039208|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64928124|NCT00039208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64928125|NCT00039208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928126|NCT00039208|Antidotes|antidotes|mesh-ancestor
64928127|NCT00039208|Protective Agents|protective agents|mesh-ancestor
64928128|NCT00039208|Vitamin B Complex|vitamin b complex|mesh-ancestor
64928148|NCT00039403|Antiviral Agents|antiviral agents|mesh-ancestor
64928149|NCT00039403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64928150|NCT00039403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928151|NCT00039403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64928152|NCT00039403|Immunologic Factors|immunologic factors|mesh-ancestor
64928155|NCT00039442|Capecitabine|capecitabine|mesh-list
64928170|NCT00039481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64928171|NCT00039481|Alkylating Agents|alkylating agents|mesh-ancestor
64928172|NCT00039481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928173|NCT00039481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928174|NCT00039481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64928175|NCT00039481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64928176|NCT00039481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64928177|NCT00039481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64928178|NCT00039481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928179|NCT00039481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64928188|NCT00544830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64928189|NCT00544830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928190|NCT00544830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64928191|NCT00544830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928192|NCT00544830|Androgen Antagonists|androgen antagonists|mesh-ancestor
64928193|NCT00544830|Hormone Antagonists|hormone antagonists|mesh-ancestor
64928194|NCT00544830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64928195|NCT00001322|Leuprolide|leuprolide|mesh-list
64928196|NCT00001322|Estradiol|estradiol|mesh-list
64928197|NCT00001322|Progesterone|progesterone|mesh-list
64928198|NCT00001322|Estrogens|estrogens|mesh-ancestor
64928199|NCT00001322|Hormones|hormones|mesh-ancestor
64928200|NCT00001322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64928201|NCT00001322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928202|NCT00001322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64928203|NCT00001322|Progestins|progestins|mesh-ancestor
64928204|NCT00001322|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64928205|NCT00001322|Fertility Agents|fertility agents|mesh-ancestor
64928206|NCT00001322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64928207|NCT00001322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928208|NCT00039520|Sulindac|sulindac|mesh-list
64928209|NCT00039520|Docetaxel|docetaxel|mesh-list
64928210|NCT00039520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928232|NCT04731961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928234|NCT04731961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64928235|NCT00001328|Ganciclovir|ganciclovir|mesh-list
64928236|NCT00001328|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64928237|NCT00001328|Antiviral Agents|antiviral agents|mesh-ancestor
64928238|NCT00001328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64928239|NCT00001328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64928240|NCT00001328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928241|NCT00001328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928242|NCT00017160|Doxorubicin|doxorubicin|mesh-list
64928243|NCT00017160|Ifosfamide|ifosfamide|mesh-list
64928244|NCT00017160|Immunologic Factors|immunologic factors|mesh-list
64928245|NCT00017160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64928246|NCT00017160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928247|NCT00017160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64928248|NCT00017160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64928249|NCT00017160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928250|NCT00017160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928251|NCT00017160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928252|NCT00017160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64928253|NCT00017160|Alkylating Agents|alkylating agents|mesh-ancestor
64928254|NCT00039832|Reteplase|reteplase|mesh-list
64928255|NCT00039832|Abciximab|abciximab|mesh-list
64928256|NCT00039832|Anticoagulants|anticoagulants|mesh-ancestor
64928257|NCT00039832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64928258|NCT00039832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64928259|NCT00039832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64385171|NCT05487261|Protease Inhibitors|protease inhibitors|mesh-ancestor
64990764|NCT04981509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990765|NCT04981509|Growth Inhibitors|growth inhibitors|mesh-ancestor
64990766|NCT04981509|Immunologic Factors|immunologic factors|mesh-ancestor
64990767|NCT04981509|Cariostatic Agents|cariostatic agents|mesh-ancestor
64990768|NCT04981509|Protective Agents|protective agents|mesh-ancestor
64990769|NCT04981509|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64990770|NCT04981509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64990771|NCT04970901|Obinutuzumab|obinutuzumab|mesh-list
64990772|NCT04970901|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
64990773|NCT04970901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64990774|NCT04970901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990775|NCT04941287|Atezolizumab|atezolizumab|mesh-list
64990776|NCT04941287|Immunoglobulins|immunoglobulins|mesh-list
64990777|NCT04941287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64990782|NCT04929041|Paclitaxel|paclitaxel|mesh-list
64990787|NCT04929041|Pemetrexed|pemetrexed|mesh-list
64990788|NCT04929041|Ipilimumab|ipilimumab|mesh-list
64990789|NCT04929041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64990790|NCT04929041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990791|NCT04929041|Tubulin Modulators|tubulin modulators|mesh-ancestor
64928260|NCT00039832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928261|NCT00039988|Glatiramer Acetate|glatiramer acetate|mesh-list
64928262|NCT00039988|Albuterol|albuterol|mesh-list
64928274|NCT00039988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64928275|NCT00039988|Adrenergic Agents|adrenergic agents|mesh-ancestor
64928276|NCT00039988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64928277|NCT00039988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928278|NCT00039988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64928279|NCT00039988|Immunologic Factors|immunologic factors|mesh-ancestor
64928280|NCT00039988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64928281|NCT00039988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64928282|NCT00040027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64928283|NCT00040027|Interferon-alpha|interferon-alpha|mesh-list
64928284|NCT00040027|Thymalfasin|thymalfasin|mesh-list
64928285|NCT00040027|Antiviral Agents|antiviral agents|mesh-ancestor
64928286|NCT00040027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64928287|NCT00040027|Immunologic Factors|immunologic factors|mesh-ancestor
64928288|NCT00040027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928289|NCT00040027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64928290|NCT00001343|Oxandrolone|oxandrolone|mesh-list
64928291|NCT00001343|Androgens|androgens|mesh-ancestor
64928292|NCT00001343|Hormones|hormones|mesh-ancestor
64928293|NCT00001343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64928294|NCT00001343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928340|NCT00040300|Antiviral Agents|antiviral agents|mesh-ancestor
64928341|NCT00040300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64928342|NCT00040378|Vitamins|vitamins|mesh-list
64928343|NCT00040378|Vitamin E|vitamin e|mesh-list
64928347|NCT00040378|Selenium|selenium|mesh-list
64928372|NCT00040651|Thymoglobulin|thymoglobulin|mesh-list
64928373|NCT00040651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64928374|NCT00040651|Immunologic Factors|immunologic factors|mesh-ancestor
64928375|NCT00040651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928376|NCT00040651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64928377|NCT00040651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64928378|NCT00040651|Alkylating Agents|alkylating agents|mesh-ancestor
64928379|NCT00040651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928380|NCT00040651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928381|NCT00040651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64928382|NCT00040690|Leucovorin|leucovorin|mesh-list
64928383|NCT00040690|Cytarabine|cytarabine|mesh-list
64928474|NCT00041236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928475|NCT00041236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928476|NCT00017316|Thalidomide|thalidomide|mesh-list
64928477|NCT00017316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64928478|NCT00017316|Immunologic Factors|immunologic factors|mesh-ancestor
64928479|NCT00017316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928480|NCT00017316|Leprostatic Agents|leprostatic agents|mesh-ancestor
64928481|NCT00017316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64928482|NCT00017316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64928483|NCT00017316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64928484|NCT00017316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64928485|NCT00017316|Growth Substances|growth substances|mesh-ancestor
64928486|NCT00017316|Growth Inhibitors|growth inhibitors|mesh-ancestor
64928560|NCT00001436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64928561|NCT00001436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64928562|NCT00041548|Nitric Oxide|nitric oxide|mesh-list
64928563|NCT00041548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64928564|NCT00041548|Autonomic Agents|autonomic agents|mesh-ancestor
64928565|NCT00041548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64928566|NCT00041548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928567|NCT00041548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64928568|NCT00041548|Respiratory System Agents|respiratory system agents|mesh-ancestor
64928569|NCT00041548|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64928570|NCT00041548|Antioxidants|antioxidants|mesh-ancestor
64928571|NCT00041548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928572|NCT00041548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64928573|NCT00041548|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64928574|NCT00041548|Vasodilator Agents|vasodilator agents|mesh-ancestor
64928575|NCT00041548|Gasotransmitters|gasotransmitters|mesh-ancestor
64928576|NCT00041548|Protective Agents|protective agents|mesh-ancestor
64928577|NCT00017433|Arsenic Trioxide|arsenic trioxide|mesh-list
64928578|NCT00017433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928579|NCT00041665|Mitogens|mitogens|mesh-list
64928580|NCT00041665|Mitosis Modulators|mitosis modulators|mesh-ancestor
64928581|NCT00041665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928610|NCT00041899|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64928612|NCT00041899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64928613|NCT00041899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928614|NCT00041899|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64928615|NCT00041977|Doxycycline|doxycycline|mesh-list
64928616|NCT00041977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64928617|NCT00041977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64928618|NCT00041977|Antimalarials|antimalarials|mesh-ancestor
64928619|NCT00041977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64928620|NCT00041977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64928632|NCT00001457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64928633|NCT00001457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64928634|NCT00001457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928635|NCT00001457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928636|NCT00001457|Antiviral Agents|antiviral agents|mesh-ancestor
64928637|NCT00001457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64928640|NCT00042172|Donepezil|donepezil|mesh-list
64928656|NCT00001475|Leprostatic Agents|leprostatic agents|mesh-ancestor
64928741|NCT00042562|Dopamine Agents|dopamine agents|mesh-ancestor
64928742|NCT00001487|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64928743|NCT00001487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64928744|NCT00001487|Immunologic Factors|immunologic factors|mesh-ancestor
64928745|NCT00001487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928746|NCT00042601|Pramlintide|pramlintide|mesh-list
64928747|NCT00042601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64928748|NCT00042601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928749|NCT00042679|Gemcitabine|gemcitabine|mesh-list
64928750|NCT00042679|Carboplatin|carboplatin|mesh-list
64928751|NCT00042679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928752|NCT00042679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64928753|NCT00042679|Antimetabolites|antimetabolites|mesh-ancestor
64928754|NCT00042679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928755|NCT00042679|Antiviral Agents|antiviral agents|mesh-ancestor
64928756|NCT00042679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64928757|NCT00042679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928758|NCT00042679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64928759|NCT00042679|Immunologic Factors|immunologic factors|mesh-ancestor
64928760|NCT00042679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928761|NCT00042718|Amoxicillin|amoxicillin|mesh-list
64928793|NCT00042835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64928794|NCT00042835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928795|NCT00042835|Tubulin Modulators|tubulin modulators|mesh-ancestor
64928796|NCT00042835|Antimitotic Agents|antimitotic agents|mesh-ancestor
64928797|NCT00042835|Mitosis Modulators|mitosis modulators|mesh-ancestor
64928798|NCT00042835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928799|NCT00042835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64928800|NCT00042835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64928801|NCT00042835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928802|NCT00042835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64928803|NCT00017784|Valganciclovir|valganciclovir|mesh-list
64928804|NCT00017784|Antiviral Agents|antiviral agents|mesh-ancestor
64928816|NCT00042874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64928817|NCT00042874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928844|NCT00043069|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
64928845|NCT00043069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64928846|NCT00043069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928847|NCT00043069|Vitamins|vitamins|mesh-ancestor
64928848|NCT00043069|Micronutrients|micronutrients|mesh-ancestor
64928849|NCT00043069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64928850|NCT00043069|Hormones|hormones|mesh-ancestor
64928851|NCT00043069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64928940|NCT00001568|Antiviral Agents|antiviral agents|mesh-ancestor
64928941|NCT00001568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64928942|NCT00001568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64928943|NCT00043537|Fluoxetine|fluoxetine|mesh-list
64928944|NCT00043537|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64928945|NCT00043537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64928946|NCT00043537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64928947|NCT00043537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928948|NCT00043537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64928949|NCT00043537|Serotonin Agents|serotonin agents|mesh-ancestor
64928950|NCT00043537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928990|NCT00043771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928991|NCT00043771|Natriuretic Agents|natriuretic agents|mesh-ancestor
64928992|NCT00043771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928993|NCT00043810|Fludarabine|fludarabine|mesh-list
64928994|NCT00043810|Fludarabine phosphate|fludarabine phosphate|mesh-list
64928995|NCT00043810|Busulfan|busulfan|mesh-list
64928996|NCT00043810|GEL protein, Gelonium multiflorum|gel protein, gelonium multiflorum|mesh-list
64928997|NCT00043810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928998|NCT00043810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64928999|NCT00043810|Antimetabolites|antimetabolites|mesh-ancestor
64929000|NCT00043810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929001|NCT00043810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64929002|NCT00043810|Immunologic Factors|immunologic factors|mesh-ancestor
64929003|NCT00043810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929004|NCT00043810|Alkylating Agents|alkylating agents|mesh-ancestor
64929005|NCT00043810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64929006|NCT00043810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64929007|NCT00043810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64929008|NCT00043810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64929009|NCT00043810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929010|NCT00043849|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64929011|NCT00043849|Antidepressive Agents|antidepressive agents|mesh-ancestor
64990792|NCT04929041|Antimitotic Agents|antimitotic agents|mesh-ancestor
64990793|NCT04929041|Mitosis Modulators|mitosis modulators|mesh-ancestor
64990794|NCT04929041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990795|NCT04929041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64990796|NCT04929041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64929012|NCT00043849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64929013|NCT00043849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64929014|NCT00043849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64929015|NCT00043849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64929016|NCT00043849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929017|NCT00001586|Rituximab|rituximab|mesh-list
64929018|NCT00001586|Fludarabine|fludarabine|mesh-list
64929019|NCT00001586|Fludarabine phosphate|fludarabine phosphate|mesh-list
64929020|NCT00001586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64929021|NCT00001586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929022|NCT00001586|Immunologic Factors|immunologic factors|mesh-ancestor
64929023|NCT00001586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929028|NCT00001586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64929029|NCT00043888|Ritonavir|ritonavir|mesh-list
64929030|NCT00043888|Fosamprenavir|fosamprenavir|mesh-list
64929031|NCT00043888|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64929032|NCT00043888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64929033|NCT00043888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64929034|NCT00043888|Protease Inhibitors|protease inhibitors|mesh-ancestor
64929035|NCT00043888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929036|NCT00043888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929037|NCT00043888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64929038|NCT00043888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64929039|NCT00043888|Antiviral Agents|antiviral agents|mesh-ancestor
64929040|NCT00043888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64929041|NCT00043888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64929042|NCT00043888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64929043|NCT00043888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64929044|NCT00043888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64929045|NCT00018018|Zidovudine|zidovudine|mesh-list
64929046|NCT00018018|Antimetabolites|antimetabolites|mesh-ancestor
64385434|NCT02392169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64990797|NCT04929041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990798|NCT04929041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64990799|NCT04929041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64990800|NCT04929028|Fluorouracil|fluorouracil|mesh-list
64990801|NCT04929028|Capecitabine|capecitabine|mesh-list
64990802|NCT04929028|Nivolumab|nivolumab|mesh-list
64990803|NCT04929028|Mitomycins|mitomycins|mesh-list
64990804|NCT04929028|Mitomycin|mitomycin|mesh-list
64990805|NCT04929028|Antimetabolites|antimetabolites|mesh-ancestor
64990806|NCT04929028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990841|NCT04909450|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64929047|NCT00018018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697467|NCT04172402|Immunologic Factors|immunologic factors|mesh-ancestor
64929048|NCT00018018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64929049|NCT00018018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64929050|NCT00018018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929051|NCT00018018|Antiviral Agents|antiviral agents|mesh-ancestor
64929052|NCT00018018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64929210|NCT00044629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64929211|NCT00044629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64929235|NCT00044746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929236|NCT00044746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929238|NCT00044785|Fluorouracil|fluorouracil|mesh-list
64929239|NCT00044785|Irinotecan|irinotecan|mesh-list
64929240|NCT00044785|Antimetabolites|antimetabolites|mesh-ancestor
64929241|NCT00044785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929242|NCT00044785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64929243|NCT00044785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929244|NCT00044785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64929245|NCT00044785|Immunologic Factors|immunologic factors|mesh-ancestor
64929246|NCT00044785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929247|NCT00044785|Antidotes|antidotes|mesh-ancestor
64929248|NCT00044785|Protective Agents|protective agents|mesh-ancestor
64929249|NCT00044785|Vitamin B Complex|vitamin b complex|mesh-ancestor
64929250|NCT00044785|Vitamins|vitamins|mesh-ancestor
64929251|NCT00044785|Micronutrients|micronutrients|mesh-ancestor
64929252|NCT00044785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64929253|NCT00044785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64929254|NCT00044785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929255|NCT00044824|Fexofenadine|fexofenadine|mesh-list
64929256|NCT00044824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64929257|NCT00044824|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64929258|NCT00044824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64929259|NCT00044824|Histamine Antagonists|histamine antagonists|mesh-ancestor
64929264|NCT00018213|Naltrexone|naltrexone|mesh-list
64929299|NCT00018291|Sensory System Agents|sensory system agents|mesh-ancestor
64929300|NCT00018291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64929301|NCT00018291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929302|NCT00018291|Anticonvulsants|anticonvulsants|mesh-ancestor
64929303|NCT00018291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64929304|NCT00018291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64929306|NCT00018291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64929333|NCT00045370|Antiviral Agents|antiviral agents|mesh-ancestor
64929334|NCT00045370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64929335|NCT00045370|Immunologic Factors|immunologic factors|mesh-ancestor
64929336|NCT00045370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929337|NCT00045370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64929338|NCT00045370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64929339|NCT00045370|Antifungal Agents|antifungal agents|mesh-ancestor
64929340|NCT00045370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64929341|NCT02970682|Tamoxifen|tamoxifen|mesh-list
64929342|NCT02970682|Fulvestrant|fulvestrant|mesh-list
64929357|NCT00045448|Docetaxel|docetaxel|mesh-list
64929397|NCT00045721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929398|NCT00045721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929399|NCT00045721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929400|NCT04731766|Listerine|listerine|mesh-list
64929401|NCT04731766|Fluorides|fluorides|mesh-list
64929402|NCT04731766|Sodium Fluoride|sodium fluoride|mesh-list
64929403|NCT04731766|Cariostatic Agents|cariostatic agents|mesh-ancestor
64697842|NCT05369364|Hormones|hormones|mesh-ancestor
64929422|NCT00001688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64929423|NCT00001688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64929424|NCT00001688|Antiviral Agents|antiviral agents|mesh-ancestor
64929425|NCT00001688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64929426|NCT00001688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64929427|NCT00001688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64929428|NCT00001688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64929429|NCT00001688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64929430|NCT00001688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64929431|NCT00001688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64929432|NCT00001688|Antimetabolites|antimetabolites|mesh-ancestor
64929433|NCT00389402|Ritonavir|ritonavir|mesh-list
64929434|NCT00389402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64929435|NCT00389402|Saquinavir|saquinavir|mesh-list
64929436|NCT00389402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64929437|NCT00389402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64929438|NCT00389402|Protease Inhibitors|protease inhibitors|mesh-ancestor
64929439|NCT00389402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929440|NCT00389402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929441|NCT00389402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64929442|NCT00389402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64929443|NCT00389402|Antiviral Agents|antiviral agents|mesh-ancestor
64929444|NCT00389402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64929445|NCT00389402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64929446|NCT00389402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64929447|NCT00001703|Freund's Adjuvant|freund's adjuvant|mesh-list
64929448|NCT00001703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64929449|NCT00001703|Immunologic Factors|immunologic factors|mesh-ancestor
64929450|NCT00001703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990842|NCT04909450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64990843|NCT04906395|Tamoxifen|tamoxifen|mesh-list
64929465|NCT00045799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64929466|NCT04394130|Ropivacaine|ropivacaine|mesh-list
64929467|NCT04394130|Anesthetics, Local|anesthetics, local|mesh-ancestor
64929468|NCT04394130|Anesthetics|anesthetics|mesh-ancestor
64929469|NCT04394130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64929470|NCT04394130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929471|NCT04394130|Sensory System Agents|sensory system agents|mesh-ancestor
64929472|NCT04394130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64929473|NCT00045877|Aldesleukin|aldesleukin|mesh-list
64929474|NCT00045877|Rituximab|rituximab|mesh-list
64929475|NCT00045877|Interleukin-2|interleukin-2|mesh-list
64929476|NCT00045877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64929477|NCT00045877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929478|NCT00045877|Immunologic Factors|immunologic factors|mesh-ancestor
64929479|NCT00045877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929480|NCT00045877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64929481|NCT00045877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64929482|NCT00045877|Analgesics|analgesics|mesh-ancestor
64929483|NCT00045877|Sensory System Agents|sensory system agents|mesh-ancestor
64929484|NCT00045877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64929485|NCT00045877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64929486|NCT00045877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64929487|NCT00045877|Antiviral Agents|antiviral agents|mesh-ancestor
64929488|NCT00045877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64929489|NCT00045916|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64929490|NCT00045916|Nortriptyline|nortriptyline|mesh-list
64929491|NCT00045916|Antidepressive Agents|antidepressive agents|mesh-ancestor
64929492|NCT00045916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64929493|NCT00045916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929494|NCT00045916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929508|NCT04380207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64945486|NCT05595603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945487|NCT05595603|Vasodilator Agents|vasodilator agents|mesh-ancestor
64945488|NCT05595603|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64990844|NCT04906395|Letrozole|letrozole|mesh-list
64990845|NCT04906395|Anastrozole|anastrozole|mesh-list
64990846|NCT04906395|Exemestane|exemestane|mesh-list
64990847|NCT04906395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990848|NCT04906395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64990849|NCT04906395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64990850|NCT04906395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945489|NCT05595603|Protective Agents|protective agents|mesh-ancestor
64945490|NCT05595603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945491|NCT05568940|Tibolone|tibolone|mesh-list
64945492|NCT05568940|Androgen Antagonists|androgen antagonists|mesh-ancestor
64945493|NCT05568940|Hormone Antagonists|hormone antagonists|mesh-ancestor
64945494|NCT05568940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64945495|NCT05568940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945496|NCT05568940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64945497|NCT05568940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64945498|NCT05568940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945499|NCT05568940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64945500|NCT05568940|Anabolic Agents|anabolic agents|mesh-ancestor
64945501|NCT05568940|Hormones|hormones|mesh-ancestor
64945502|NCT05562973|Psilocybin|psilocybin|mesh-list
64945503|NCT05562973|Hallucinogens|hallucinogens|mesh-ancestor
64945504|NCT05562973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945505|NCT05562973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64945506|NCT05551299|Photosensitizing Agents|photosensitizing agents|mesh-list
64945507|NCT05551299|Dermatologic Agents|dermatologic agents|mesh-ancestor
64945508|NCT05543785|Ketorolac|ketorolac|mesh-list
64945511|NCT05543785|Analgesics|analgesics|mesh-ancestor
64945534|NCT05453955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945535|NCT05453955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64945536|NCT05453955|Anesthetics, General|anesthetics, general|mesh-ancestor
64945537|NCT05453955|Anesthetics|anesthetics|mesh-ancestor
64945538|NCT05452772|Niacin|niacin|mesh-list
64945539|NCT05452772|Psilocybin|psilocybin|mesh-list
64945540|NCT05452772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64945541|NCT05452772|Antimetabolites|antimetabolites|mesh-ancestor
64945542|NCT05452772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929517|NCT00045955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64929542|NCT00046033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64929543|NCT00046033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64929544|NCT00046033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64929545|NCT00046033|Antitubercular Agents|antitubercular agents|mesh-ancestor
64929546|NCT00046033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64929547|NCT04369560|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64929548|NCT04369560|Hematinics|hematinics|mesh-ancestor
64929549|NCT04369560|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64929550|NCT04369560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64929551|NCT00046111|Topotecan|topotecan|mesh-list
64929552|NCT00046111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64929553|NCT00046111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64929554|NCT00046111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929555|NCT00046111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929556|NCT00046111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929557|NCT00001724|Flurbiprofen|flurbiprofen|mesh-list
64929558|NCT00001724|Analgesics|analgesics|mesh-ancestor
64929559|NCT00001724|Sensory System Agents|sensory system agents|mesh-ancestor
64929560|NCT00001724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64929561|NCT00001724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929562|NCT00001724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64929563|NCT00001724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64929564|NCT00001724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64929565|NCT00001724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64929590|NCT00046345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929591|NCT00046345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929592|NCT00046345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64929593|NCT00046345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64929594|NCT00046345|Antiviral Agents|antiviral agents|mesh-ancestor
64929595|NCT00046345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64929596|NCT00397657|Niacin|niacin|mesh-list
64929597|NCT00397657|Ezetimibe|ezetimibe|mesh-list
64929598|NCT00397657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64929599|NCT00397657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64929600|NCT00397657|Antimetabolites|antimetabolites|mesh-ancestor
64929602|NCT00397657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64929603|NCT00397657|Vasodilator Agents|vasodilator agents|mesh-ancestor
64929604|NCT00397657|Vitamin B Complex|vitamin b complex|mesh-ancestor
64929605|NCT00397657|Vitamins|vitamins|mesh-ancestor
64929606|NCT00397657|Micronutrients|micronutrients|mesh-ancestor
64929607|NCT00397657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929608|NCT04305405|Benralizumab|benralizumab|mesh-list
64929609|NCT04305405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64929610|NCT04305405|Respiratory System Agents|respiratory system agents|mesh-ancestor
64929611|NCT00001763|Interleukin-12|interleukin-12|mesh-list
64929612|NCT00001763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64929613|NCT00001763|Immunologic Factors|immunologic factors|mesh-ancestor
64929614|NCT00001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929615|NCT00001763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64929616|NCT00001763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64929617|NCT00001763|Growth Substances|growth substances|mesh-ancestor
64929618|NCT00001763|Growth Inhibitors|growth inhibitors|mesh-ancestor
64929619|NCT00001763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929620|NCT00397735|Acetylcysteine|acetylcysteine|mesh-list
64929622|NCT00397735|Antiviral Agents|antiviral agents|mesh-ancestor
64929636|NCT00046384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64929637|NCT00046384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64929638|NCT00046384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929639|NCT00046384|Dopamine Agonists|dopamine agonists|mesh-ancestor
64929640|NCT00046384|Dopamine Agents|dopamine agents|mesh-ancestor
64929641|NCT00046384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64929642|NCT00046384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929643|NCT00046384|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64929644|NCT00046384|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64929653|NCT04258410|Antioxidants|antioxidants|mesh-ancestor
64929682|NCT00001766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64929683|NCT00001766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64929684|NCT00001766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64929685|NCT00001766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64929686|NCT00001766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64929687|NCT00001766|Antitubercular Agents|antitubercular agents|mesh-ancestor
64929688|NCT00001766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64929689|NCT00046501|Insulin|insulin|mesh-list
64929690|NCT00046501|Insulin Glargine|insulin glargine|mesh-list
64929691|NCT00046501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64929692|NCT00046501|Insulin, Isophane|insulin, isophane|mesh-list
64929693|NCT00046501|Isophane Insulin, Human|isophane insulin, human|mesh-list
64929694|NCT00046501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64929695|NCT00046501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929696|NCT00046735|Lenalidomide|lenalidomide|mesh-list
64929697|NCT00046735|Immunologic Factors|immunologic factors|mesh-ancestor
64929698|NCT00046735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929699|NCT00046735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64929700|NCT00046735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64929701|NCT00046735|Growth Substances|growth substances|mesh-ancestor
64929702|NCT00046735|Growth Inhibitors|growth inhibitors|mesh-ancestor
64929703|NCT00046735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929704|NCT00001784|Mexiletine|mexiletine|mesh-list
64929705|NCT00001784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64929706|NCT00001784|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64929707|NCT00001784|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64929708|NCT00001784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64929709|NCT00001784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929710|NCT00046813|Nicotine|nicotine|mesh-list
64929711|NCT00046813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64929712|NCT00046813|Autonomic Agents|autonomic agents|mesh-ancestor
64929713|NCT00046813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64929714|NCT00046813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929715|NCT00046813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64929716|NCT00046813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64929717|NCT00046813|Cholinergic Agents|cholinergic agents|mesh-ancestor
64929719|NCT00046813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929720|NCT00046852|Cyclophosphamide|cyclophosphamide|mesh-list
64929721|NCT00046852|Melphalan|melphalan|mesh-list
64929722|NCT00046852|Carmustine|carmustine|mesh-list
64929723|NCT00046852|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64929724|NCT00046852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64929725|NCT00046852|Immunologic Factors|immunologic factors|mesh-ancestor
64929726|NCT00046852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929727|NCT00046852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64929728|NCT00046852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64929729|NCT00046852|Alkylating Agents|alkylating agents|mesh-ancestor
64929730|NCT00046852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929731|NCT00046852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929732|NCT00046852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64698212|NCT05722951|Metformin|metformin|mesh-list
64929733|NCT00046969|Cisplatin|cisplatin|mesh-list
64929734|NCT00046969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929735|NCT00001805|Rituximab|rituximab|mesh-list
64929736|NCT00001805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64929737|NCT00001805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929738|NCT00001805|Immunologic Factors|immunologic factors|mesh-ancestor
64929739|NCT00001805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929740|NCT00001805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64929741|NCT00047047|Gemcitabine|gemcitabine|mesh-list
64929742|NCT00047047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929743|NCT00047047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64929744|NCT00047047|Antimetabolites|antimetabolites|mesh-ancestor
64929745|NCT00047047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929746|NCT00047047|Antiviral Agents|antiviral agents|mesh-ancestor
64929747|NCT00047047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64929748|NCT00047047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929750|NCT00047047|Immunologic Factors|immunologic factors|mesh-ancestor
64929761|NCT04733781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64929762|NCT04733781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64929763|NCT04733781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64990908|NCT04870112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64990909|NCT04870112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64990910|NCT04870112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64990911|NCT04870112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990912|NCT04870112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929764|NCT04733781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929765|NCT04733781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64929766|NCT04733781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64929767|NCT04733781|Adrenergic Agents|adrenergic agents|mesh-ancestor
64929768|NCT04733781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64929769|NCT04733781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64929770|NCT04733781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64929771|NCT04733781|Autonomic Agents|autonomic agents|mesh-ancestor
64929772|NCT04733781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64929773|NCT04733781|Respiratory System Agents|respiratory system agents|mesh-ancestor
64929775|NCT04733781|Sympathomimetics|sympathomimetics|mesh-ancestor
64929776|NCT04733781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64929777|NCT00047164|Ipilimumab|ipilimumab|mesh-list
64929778|NCT00047164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64929779|NCT00047164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929780|NCT00047164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64929781|NCT00047164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929782|NCT00047203|Alvocidib|alvocidib|mesh-list
64929783|NCT00047203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929784|NCT00047203|Growth Inhibitors|growth inhibitors|mesh-ancestor
64929785|NCT00047203|Growth Substances|growth substances|mesh-ancestor
64929809|NCT00047281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929810|NCT00047281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64929811|NCT00047281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64929812|NCT00047281|Alkylating Agents|alkylating agents|mesh-ancestor
64929813|NCT00047281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929814|NCT00047281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929815|NCT00047281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64929816|NCT00047281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64929817|NCT00047281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64929818|NCT00047281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64929819|NCT00047281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929820|NCT00047281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64929821|NCT00047281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64990913|NCT04870112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64990919|NCT04857931|Colchicine|colchicine|mesh-list
64990920|NCT04857931|Gout Suppressants|gout suppressants|mesh-ancestor
64929822|NCT00047281|Analgesics|analgesics|mesh-ancestor
64929823|NCT00047281|Sensory System Agents|sensory system agents|mesh-ancestor
64929824|NCT00047281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64929825|NCT00047281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64929826|NCT00047281|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64929827|NCT00047281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64929828|NCT00047281|Leprostatic Agents|leprostatic agents|mesh-ancestor
64929829|NCT00047281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64929859|NCT00047671|Serotonin Agents|serotonin agents|mesh-ancestor
64929860|NCT00047671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929861|NCT00047671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64929862|NCT00047671|Antidepressive Agents|antidepressive agents|mesh-ancestor
64929863|NCT00047671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64929864|NCT00047710|Bevacizumab|bevacizumab|mesh-list
64929865|NCT00047710|Capecitabine|capecitabine|mesh-list
64929945|NCT00048607|Paroxetine|paroxetine|mesh-list
64929946|NCT00048607|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64929947|NCT00048607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64929952|NCT00048607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929953|NCT00048607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64929954|NCT00048607|Antidepressive Agents|antidepressive agents|mesh-ancestor
64698430|NCT02460133|Antimetabolites|antimetabolites|mesh-ancestor
64929955|NCT00048607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64929956|NCT00048607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64929957|NCT00048607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64929958|NCT00048607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929959|NCT00048607|Antiemetics|antiemetics|mesh-ancestor
64929960|NCT00048607|Autonomic Agents|autonomic agents|mesh-ancestor
64930064|NCT00049114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64930065|NCT00049114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930066|NCT00049192|Imatinib Mesylate|imatinib mesylate|mesh-list
64930067|NCT00049192|Oblimersen|oblimersen|mesh-list
64930068|NCT00049192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930069|NCT00049192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64930070|NCT00049192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930072|NCT05576181|Cyclophosphamide|cyclophosphamide|mesh-list
64930108|NCT05640791|Gemcitabine|gemcitabine|mesh-list
64930109|NCT05640791|Paclitaxel|paclitaxel|mesh-list
64930110|NCT05640791|Durvalumab|durvalumab|mesh-list
64930111|NCT05640791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64930112|NCT05640791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930113|NCT05640791|Tubulin Modulators|tubulin modulators|mesh-ancestor
64930114|NCT05640791|Antimitotic Agents|antimitotic agents|mesh-ancestor
64930115|NCT05640791|Mitosis Modulators|mitosis modulators|mesh-ancestor
64930116|NCT05640791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930117|NCT05640791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64930118|NCT05640791|Antimetabolites|antimetabolites|mesh-ancestor
64930119|NCT05640791|Antiviral Agents|antiviral agents|mesh-ancestor
64930120|NCT05640791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64930121|NCT05640791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930122|NCT05640791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64930123|NCT05640791|Immunologic Factors|immunologic factors|mesh-ancestor
64930124|NCT05640791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930125|NCT05640791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64930126|NCT00391911|Acetylcysteine|acetylcysteine|mesh-list
64930127|NCT00391911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64930128|NCT00391911|Antiviral Agents|antiviral agents|mesh-ancestor
64930129|NCT00391911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64930130|NCT00391911|Expectorants|expectorants|mesh-ancestor
64930131|NCT00391911|Respiratory System Agents|respiratory system agents|mesh-ancestor
64930132|NCT00391911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64930133|NCT00391911|Antioxidants|antioxidants|mesh-ancestor
64930134|NCT00391911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930135|NCT00391911|Protective Agents|protective agents|mesh-ancestor
64930136|NCT00391911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990921|NCT04857931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64990922|NCT04857931|Tubulin Modulators|tubulin modulators|mesh-ancestor
64990923|NCT04857931|Antimitotic Agents|antimitotic agents|mesh-ancestor
64930155|NCT00049660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930156|NCT00049660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64930157|NCT00049660|Tubulin Modulators|tubulin modulators|mesh-ancestor
64930158|NCT00049660|Antimitotic Agents|antimitotic agents|mesh-ancestor
64930159|NCT00049660|Mitosis Modulators|mitosis modulators|mesh-ancestor
64930160|NCT05640713|Cyclophosphamide|cyclophosphamide|mesh-list
64930161|NCT05640713|Fludarabine|fludarabine|mesh-list
64930162|NCT05640713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64930163|NCT05640713|Immunologic Factors|immunologic factors|mesh-ancestor
64930164|NCT05640713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930165|NCT05640713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64930166|NCT05640713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64930167|NCT05640713|Alkylating Agents|alkylating agents|mesh-ancestor
64930168|NCT05640713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930169|NCT05640713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930170|NCT05640713|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64930171|NCT00391950|Zoledronic Acid|zoledronic acid|mesh-list
64930172|NCT00391950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64930173|NCT00391950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930174|NCT00049777|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
64930175|NCT00049777|Heparin|heparin|mesh-list
64930176|NCT00049777|Calcium heparin|calcium heparin|mesh-list
64930177|NCT00049777|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64930178|NCT00049777|Tinzaparin|tinzaparin|mesh-list
64930179|NCT00049777|Dalteparin|dalteparin|mesh-list
64930180|NCT00049777|Anticoagulants|anticoagulants|mesh-ancestor
64930181|NCT00049777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64930182|NCT00049777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64930183|NCT00049777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930184|NCT00049777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64930185|NCT00392028|Ertapenem|ertapenem|mesh-list
64930186|NCT00392028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64930198|NCT00049972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64930199|NCT00049972|Serotonin Agents|serotonin agents|mesh-ancestor
64930208|NCT00389636|Anticoagulants|anticoagulants|mesh-ancestor
64930209|NCT00389636|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
64930210|NCT00389636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64930211|NCT00389636|Growth Substances|growth substances|mesh-ancestor
64930212|NCT00389636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930213|NCT00050206|Olanzapine|olanzapine|mesh-list
64930214|NCT00050206|Antiemetics|antiemetics|mesh-ancestor
64930215|NCT00050206|Autonomic Agents|autonomic agents|mesh-ancestor
64930216|NCT00050206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64930303|NCT00050674|Immunologic Factors|immunologic factors|mesh-ancestor
64930304|NCT00050674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930305|NCT00050713|Sirolimus|sirolimus|mesh-list
64930306|NCT00050713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64930307|NCT00050713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64930308|NCT00050713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64930309|NCT00050713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930310|NCT00050713|Antifungal Agents|antifungal agents|mesh-ancestor
64930311|NCT00050713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64930312|NCT00050713|Immunologic Factors|immunologic factors|mesh-ancestor
64930313|NCT00050713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930314|NCT00050830|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
64930330|NCT00050947|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64930331|NCT00050947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64930332|NCT00051103|Antineoplastic Agents|antineoplastic agents|mesh-list
64930333|NCT00051142|Travoprost|travoprost|mesh-list
64930334|NCT00051142|Latanoprost|latanoprost|mesh-list
64930335|NCT00051142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64930336|NCT00051142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64930337|NCT00051142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64930338|NCT00051181|Travoprost|travoprost|mesh-list
64930339|NCT00051181|Latanoprost|latanoprost|mesh-list
64930340|NCT00051181|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64930341|NCT00051181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64930342|NCT00051181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64930343|NCT00051259|Bupropion|bupropion|mesh-list
64930344|NCT00051259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64930345|NCT00051259|Antidepressive Agents|antidepressive agents|mesh-ancestor
64930346|NCT00051259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64990924|NCT04857931|Mitosis Modulators|mitosis modulators|mesh-ancestor
64990925|NCT04857931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990926|NCT04857931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990927|NCT04857138|Atezolizumab|atezolizumab|mesh-list
64990928|NCT04857138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990929|NCT04856189|Pembrolizumab|pembrolizumab|mesh-list
64990936|NCT04847557|Hormones|hormones|mesh-ancestor
64990937|NCT04847557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64990938|NCT04847453|Dexamethasone|dexamethasone|mesh-list
64991002|NCT04768296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991005|NCT04759586|Prednisolone|prednisolone|mesh-list
64991006|NCT04759586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64991007|NCT04759586|Methylprednisolone|methylprednisolone|mesh-list
64991008|NCT04759586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64991009|NCT04759586|Prednisolone acetate|prednisolone acetate|mesh-list
64991010|NCT04759586|Hydrocortisone|hydrocortisone|mesh-list
64991011|NCT04759586|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64991012|NCT04759586|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64930347|NCT00051259|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64930348|NCT00051259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64930349|NCT00051259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64930350|NCT00051259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930351|NCT00051259|Dopamine Agents|dopamine agents|mesh-ancestor
64930352|NCT00051259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64930353|NCT00051259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930354|NCT00051259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64930355|NCT00051259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64930356|NCT00051259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930357|NCT05639777|Dexmedetomidine|dexmedetomidine|mesh-list
64930429|NCT05573958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64930430|NCT05573958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930431|NCT05573958|Antipyretics|antipyretics|mesh-ancestor
64930432|NCT05573958|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64930433|NCT05573958|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64930434|NCT05573958|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64930435|NCT05573958|Purinergic Agents|purinergic agents|mesh-ancestor
64930436|NCT05573958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64930437|NCT05573958|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64930438|NCT05573958|Antithrombins|antithrombins|mesh-ancestor
64930439|NCT05573958|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64930440|NCT05573958|Protease Inhibitors|protease inhibitors|mesh-ancestor
64930441|NCT05573958|Anticoagulants|anticoagulants|mesh-ancestor
64930442|NCT00051688|Oxaliplatin|oxaliplatin|mesh-list
64930443|NCT00051688|Tezacitabine|tezacitabine|mesh-list
64930444|NCT00051688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930445|NCT00051688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930447|NCT00051844|Capravirine|capravirine|mesh-list
64930456|NCT00052000|Antibodies|antibodies|mesh-list
64930457|NCT00052000|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64930458|NCT00052000|Immunologic Factors|immunologic factors|mesh-ancestor
64930459|NCT00052000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930460|NCT00052039|Interferons|interferons|mesh-list
64930461|NCT00052039|Interferon-gamma|interferon-gamma|mesh-list
64930462|NCT00052039|Azathioprine|azathioprine|mesh-list
64930463|NCT00052039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930464|NCT00052039|Antiviral Agents|antiviral agents|mesh-ancestor
64930528|NCT00052390|Bevacizumab|bevacizumab|mesh-list
64930529|NCT00052390|Doxorubicin|doxorubicin|mesh-list
64930530|NCT00052390|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64930531|NCT00052390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64930532|NCT00052390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930533|NCT00052390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64930534|NCT00052390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64930535|NCT00052390|Growth Substances|growth substances|mesh-ancestor
64930536|NCT00052390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930537|NCT00052390|Growth Inhibitors|growth inhibitors|mesh-ancestor
64930656|NCT00053209|Gemcitabine|gemcitabine|mesh-list
64930657|NCT00053209|Pemetrexed|pemetrexed|mesh-list
64930658|NCT00053209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64930659|NCT00053209|Antimetabolites|antimetabolites|mesh-ancestor
64930660|NCT00053209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930661|NCT00053209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930662|NCT00053209|Antiviral Agents|antiviral agents|mesh-ancestor
64930663|NCT00053209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64930664|NCT00053209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930665|NCT00053209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64930666|NCT00053209|Immunologic Factors|immunologic factors|mesh-ancestor
64930667|NCT00053209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930668|NCT00053209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64930669|NCT00053209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64930670|NCT00053248|Imatinib Mesylate|imatinib mesylate|mesh-list
64930676|NCT00053287|Thalidomide|thalidomide|mesh-list
64930717|NCT00053638|Efavirenz|efavirenz|mesh-list
64930718|NCT00053638|Abacavir|abacavir|mesh-list
64930719|NCT00053638|Antiviral Agents|antiviral agents|mesh-ancestor
64930720|NCT00053638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64930721|NCT00053638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64930722|NCT00053638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64930723|NCT00053638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930724|NCT00053638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930725|NCT00053638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64930726|NCT00053638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64930727|NCT00053638|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64930728|NCT00053638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64930729|NCT00053638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64930730|NCT00053638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64930731|NCT00053638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64930732|NCT00053638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64930768|NCT02970175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64930769|NCT02970175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64930770|NCT00053833|Irinotecan|irinotecan|mesh-list
64930771|NCT00053833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64930772|NCT00053833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64930773|NCT00053833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930774|NCT00053833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930775|NCT00053833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930776|NCT00053872|Vincristine|vincristine|mesh-list
64930777|NCT00053872|Lomustine|lomustine|mesh-list
64930778|NCT00053872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930779|NCT00053872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64930780|NCT00053872|Tubulin Modulators|tubulin modulators|mesh-ancestor
64930781|NCT00053872|Antimitotic Agents|antimitotic agents|mesh-ancestor
64930782|NCT00053872|Mitosis Modulators|mitosis modulators|mesh-ancestor
64930783|NCT00053872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930784|NCT00053872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64930863|NCT00054340|Methotrexate|methotrexate|mesh-list
64930864|NCT00054340|Cyclosporins|cyclosporins|mesh-list
64930866|NCT00054340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64930867|NCT00054340|Immunologic Factors|immunologic factors|mesh-ancestor
64930868|NCT00054340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930869|NCT00054340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64930870|NCT00054340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64930871|NCT00054340|Alkylating Agents|alkylating agents|mesh-ancestor
64930872|NCT00054340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930873|NCT00054340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930874|NCT00054340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64930875|NCT00054340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64930876|NCT00054340|Abortifacient Agents|abortifacient agents|mesh-ancestor
64930877|NCT00054340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64930878|NCT00054340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64930879|NCT00054340|Antimetabolites|antimetabolites|mesh-ancestor
64930880|NCT00054340|Dermatologic Agents|dermatologic agents|mesh-ancestor
64930881|NCT00054340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930882|NCT00054340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64930883|NCT00054340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64930884|NCT00054340|Antifungal Agents|antifungal agents|mesh-ancestor
64930885|NCT00054340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64930886|NCT00054340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64930887|NCT00054418|Vitamin D|vitamin d|mesh-list
64930888|NCT00054418|Risedronic Acid|risedronic acid|mesh-list
64930905|NCT05560230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930928|NCT00054496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930929|NCT00054535|Aldesleukin|aldesleukin|mesh-list
64930930|NCT00054535|Vaccines|vaccines|mesh-list
64930931|NCT00054535|Immunologic Factors|immunologic factors|mesh-ancestor
64930932|NCT00054535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930933|NCT00054535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930934|NCT00054535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64930935|NCT00054535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64930938|NCT00054574|Panitumumab|panitumumab|mesh-list
64930948|NCT00054886|Sunitinib|sunitinib|mesh-list
64930949|NCT00054886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930950|NCT00054886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64930951|NCT00054886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64930952|NCT00054886|Growth Substances|growth substances|mesh-ancestor
64930953|NCT00054886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930954|NCT00054886|Growth Inhibitors|growth inhibitors|mesh-ancestor
64930955|NCT00054886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64930956|NCT00054886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930957|NCT00054886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930958|NCT02970097|Fentanyl|fentanyl|mesh-list
64931003|NCT00055120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64931004|NCT00055120|Protease Inhibitors|protease inhibitors|mesh-ancestor
64931005|NCT00055120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931006|NCT00055120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931007|NCT00055120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64931008|NCT00055120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64931009|NCT00055120|Antiviral Agents|antiviral agents|mesh-ancestor
64931010|NCT00055120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931011|NCT00055120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64931012|NCT00055120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64931013|NCT00055120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64931014|NCT00055120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64931015|NCT00055120|Antimetabolites|antimetabolites|mesh-ancestor
64931017|NCT05527704|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64931018|NCT05527704|Autonomic Agents|autonomic agents|mesh-ancestor
64931019|NCT05527704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64931023|NCT05527704|Tocolytic Agents|tocolytic agents|mesh-ancestor
64931034|NCT00055159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64931035|NCT00055159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931036|NCT00055198|Daptomycin|daptomycin|mesh-list
64931037|NCT00055198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64931038|NCT00055198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931039|NCT05525325|Anesthetics|anesthetics|mesh-list
64931040|NCT05525325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64931041|NCT05525325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931042|NCT00055393|Bupropion|bupropion|mesh-list
64931043|NCT00055393|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64931044|NCT00055393|Antidepressive Agents|antidepressive agents|mesh-ancestor
64931045|NCT00055393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64931046|NCT00055393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64931047|NCT00055393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64931048|NCT00055393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64931049|NCT00055393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931050|NCT00055393|Dopamine Agents|dopamine agents|mesh-ancestor
64385749|NCT03165929|Sensory System Agents|sensory system agents|mesh-ancestor
64385788|NCT03142893|BB 1101|bb 1101|mesh-list
64991013|NCT04759586|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64931051|NCT00055393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64931052|NCT00055393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931053|NCT00055393|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64931054|NCT00055393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64931055|NCT00055393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931056|NCT00055432|Gemcitabine|gemcitabine|mesh-list
64931057|NCT00055432|Pemetrexed|pemetrexed|mesh-list
64931058|NCT00055432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64931059|NCT00055432|Antimetabolites|antimetabolites|mesh-ancestor
64931061|NCT00055432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931140|NCT00392106|Vasodilator Agents|vasodilator agents|mesh-ancestor
64931141|NCT00392106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64931142|NCT00392106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64931143|NCT00392106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931144|NCT00392106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64931145|NCT00392106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64931146|NCT00392106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64931147|NCT00392106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931152|NCT00055939|Exatecan|exatecan|mesh-list
64931162|NCT00055978|Sensory System Agents|sensory system agents|mesh-ancestor
64931163|NCT00055978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64931164|NCT00055978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931165|NCT00055978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64931171|NCT00056056|Bexarotene|bexarotene|mesh-list
64931261|NCT00056797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931262|NCT00056797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64931263|NCT00056797|Analgesics|analgesics|mesh-ancestor
64931264|NCT00056797|Sensory System Agents|sensory system agents|mesh-ancestor
64931265|NCT00056797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64931266|NCT00056797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931267|NCT00056836|Ranibizumab|ranibizumab|mesh-list
64931268|NCT00056836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64931269|NCT00056836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64931270|NCT00056836|Growth Substances|growth substances|mesh-ancestor
64931271|NCT00056836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931272|NCT00056836|Growth Inhibitors|growth inhibitors|mesh-ancestor
64931273|NCT00056836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931274|NCT05495321|Aldesleukin|aldesleukin|mesh-list
64931275|NCT05495321|Interleukin-2|interleukin-2|mesh-list
64931276|NCT05495321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931277|NCT05495321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64931278|NCT05495321|Analgesics|analgesics|mesh-ancestor
64931279|NCT05495321|Sensory System Agents|sensory system agents|mesh-ancestor
64931282|NCT05495321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64931319|NCT02969980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64931320|NCT02969980|Alkylating Agents|alkylating agents|mesh-ancestor
64931321|NCT02969980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931322|NCT02969980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931323|NCT02969980|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64931324|NCT00057265|Lamivudine|lamivudine|mesh-list
64931325|NCT00057265|Telbivudine|telbivudine|mesh-list
64931326|NCT00057265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64931327|NCT00057265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64931328|NCT00057265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931329|NCT00057265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931330|NCT00057265|Antiviral Agents|antiviral agents|mesh-ancestor
64931331|NCT00057265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931332|NCT00057265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64991014|NCT04759586|Cortisone|cortisone|mesh-list
64991015|NCT04759586|Cyclophosphamide|cyclophosphamide|mesh-list
64991016|NCT04759586|Rituximab|rituximab|mesh-list
64991017|NCT04759586|Doxorubicin|doxorubicin|mesh-list
64991018|NCT04759586|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64991019|NCT04759586|Nivolumab|nivolumab|mesh-list
64991059|NCT04759586|Protective Agents|protective agents|mesh-ancestor
64991060|NCT04756037|Relugolix|relugolix|mesh-list
64991061|NCT04756037|Androgen Antagonists|androgen antagonists|mesh-ancestor
64931333|NCT00057265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64931337|NCT00057343|Rituximab|rituximab|mesh-list
64931338|NCT00057343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64931339|NCT00057343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931340|NCT00057343|Immunologic Factors|immunologic factors|mesh-ancestor
64931341|NCT00057343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931342|NCT00057343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64931343|NCT00057382|Doxorubicin|doxorubicin|mesh-list
64931344|NCT00057382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64931358|NCT00057616|Lenalidomide|lenalidomide|mesh-list
64931451|NCT00058201|Fluorouracil|fluorouracil|mesh-list
64931540|NCT00058903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64931541|NCT00058903|Serotonin Agents|serotonin agents|mesh-ancestor
64931542|NCT00058903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931543|NCT02969473|Cisplatin|cisplatin|mesh-list
64931544|NCT02969473|Docetaxel|docetaxel|mesh-list
64931545|NCT02969473|Fluorouracil|fluorouracil|mesh-list
64931546|NCT02969473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931547|NCT02969473|Tubulin Modulators|tubulin modulators|mesh-ancestor
64931548|NCT02969473|Antimitotic Agents|antimitotic agents|mesh-ancestor
64931549|NCT02969473|Mitosis Modulators|mitosis modulators|mesh-ancestor
64931550|NCT02969473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931551|NCT02969473|Antimetabolites|antimetabolites|mesh-ancestor
64931552|NCT02969473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64931553|NCT02969473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64931581|NCT05223582|Hormone Antagonists|hormone antagonists|mesh-ancestor
64931582|NCT05223582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64931584|NCT00059722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931640|NCT00059878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64931641|NCT00059878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64931642|NCT00059878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931643|NCT00059878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931644|NCT00059878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64931645|NCT00059878|Hormone Antagonists|hormone antagonists|mesh-ancestor
64931646|NCT00059878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64931647|NCT00059878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931729|NCT00060385|Vincristine|vincristine|mesh-list
64931730|NCT00060385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64931731|NCT00060385|Immunologic Factors|immunologic factors|mesh-ancestor
64931732|NCT00060385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931733|NCT00060385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64931734|NCT00060385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64931735|NCT00060385|Alkylating Agents|alkylating agents|mesh-ancestor
64931736|NCT00060385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931737|NCT00060385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931738|NCT00060385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64931739|NCT00060385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64931740|NCT00060385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64931741|NCT00060385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64931742|NCT00060385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931743|NCT00060385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64931744|NCT00060385|Glucocorticoids|glucocorticoids|mesh-ancestor
64931745|NCT00060385|Hormones|hormones|mesh-ancestor
64931751|NCT00060385|Mitosis Modulators|mitosis modulators|mesh-ancestor
64931752|NCT00060463|Contraceptive Agents|contraceptive agents|mesh-list
64931753|NCT00060463|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
64931754|NCT00060463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64931755|NCT00060463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931756|NCT00060463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64931757|NCT02968693|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64931758|NCT02968693|Vancomycin|vancomycin|mesh-list
64931759|NCT02968693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64931760|NCT02968693|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
64931761|NCT02968693|Calcium|calcium|mesh-list
64931762|NCT02968693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64931763|NCT02968693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700248|NCT00002835|Leucovorin|leucovorin|mesh-list
64931764|NCT02968693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931765|NCT02968693|Antitubercular Agents|antitubercular agents|mesh-ancestor
64931766|NCT02968693|Vasodilator Agents|vasodilator agents|mesh-ancestor
64931767|NCT02968693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64931768|NCT02968693|Protective Agents|protective agents|mesh-ancestor
64931769|NCT00060502|Gemcitabine|gemcitabine|mesh-list
64931772|NCT00060502|Antimetabolites|antimetabolites|mesh-ancestor
64931773|NCT00060502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931774|NCT00060502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931775|NCT00060502|Antiviral Agents|antiviral agents|mesh-ancestor
64931776|NCT00060502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931777|NCT00060502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931778|NCT00060502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64931779|NCT00060502|Immunologic Factors|immunologic factors|mesh-ancestor
64931780|NCT00060502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931781|NCT00060502|Dermatologic Agents|dermatologic agents|mesh-ancestor
64931782|NCT00060502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64931783|NCT00060502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64931792|NCT05038410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64931793|NCT05038410|Immunologic Factors|immunologic factors|mesh-ancestor
64931794|NCT05038410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931795|NCT05030493|Bevacizumab|bevacizumab|mesh-list
64931796|NCT05030493|Panitumumab|panitumumab|mesh-list
64931797|NCT05030493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64931798|NCT05030493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931799|NCT05030493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64931800|NCT05030493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64931801|NCT05030493|Growth Substances|growth substances|mesh-ancestor
64931802|NCT05030493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931803|NCT05030493|Growth Inhibitors|growth inhibitors|mesh-ancestor
64931804|NCT02968498|Methamphetamine|methamphetamine|mesh-list
64931805|NCT02968498|Lactulose|lactulose|mesh-list
64931806|NCT02968498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64931807|NCT02968498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64931808|NCT02968498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931836|NCT00060931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64931837|NCT00060931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64931838|NCT00060931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64931839|NCT00060931|Vasodilator Agents|vasodilator agents|mesh-ancestor
64931840|NCT00060931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64931841|NCT00060931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64931842|NCT00061087|Methylphenidate|methylphenidate|mesh-list
64931844|NCT00061087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64931845|NCT00061087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931846|NCT00061087|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64931847|NCT00061087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64931848|NCT00061087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64931849|NCT00061087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931850|NCT00061087|Dopamine Agents|dopamine agents|mesh-ancestor
64931851|NCT00061087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64931852|NCT00061087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64931853|NCT00061087|Antidepressive Agents|antidepressive agents|mesh-ancestor
64931854|NCT00061087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64931903|NCT00061477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931904|NCT00061477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64931905|NCT00061477|Immunologic Factors|immunologic factors|mesh-ancestor
64931909|NCT02968342|Progesterone|progesterone|mesh-list
64931919|NCT04997304|Albuterol|albuterol|mesh-list
64931920|NCT04997304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64931921|NCT04997304|Autonomic Agents|autonomic agents|mesh-ancestor
64931922|NCT04997304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64931923|NCT04997304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931924|NCT04997304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64931925|NCT04997304|Respiratory System Agents|respiratory system agents|mesh-ancestor
64931926|NCT04997304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64931927|NCT04997304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64931928|NCT04997304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64931929|NCT04997304|Adrenergic Agents|adrenergic agents|mesh-ancestor
64932022|NCT04917900|Antimitotic Agents|antimitotic agents|mesh-ancestor
64932023|NCT04917900|Mitosis Modulators|mitosis modulators|mesh-ancestor
64932024|NCT04917900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932025|NCT04917900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64932026|NCT05219435|Nivolumab|nivolumab|mesh-list
64932027|NCT05219435|Ipilimumab|ipilimumab|mesh-list
64932028|NCT05219435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64932029|NCT05219435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932030|NCT05219435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64932031|NCT05219435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932032|NCT00061984|Doxorubicin|doxorubicin|mesh-list
64932033|NCT00061984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64932034|NCT00061984|Ifosfamide|ifosfamide|mesh-list
64932035|NCT00061984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64932036|NCT00061984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932037|NCT00061984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64932038|NCT00061984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64932039|NCT00061984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932040|NCT00061984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932041|NCT00061984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64932062|NCT00062023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64932063|NCT00062023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932064|NCT00062062|Paclitaxel|paclitaxel|mesh-list
64932065|NCT00062062|Carboplatin|carboplatin|mesh-list
64932066|NCT00062062|Gefitinib|gefitinib|mesh-list
64932067|NCT00062062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64932068|NCT00062062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932069|NCT00062062|Tubulin Modulators|tubulin modulators|mesh-ancestor
64932070|NCT00062062|Antimitotic Agents|antimitotic agents|mesh-ancestor
64932071|NCT00062062|Mitosis Modulators|mitosis modulators|mesh-ancestor
64932072|NCT00062062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932074|NCT00062062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932085|NCT00392340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64932086|NCT00392340|Tubulin Modulators|tubulin modulators|mesh-ancestor
64932112|NCT00062140|Alkylating Agents|alkylating agents|mesh-ancestor
64932113|NCT00062140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932114|NCT00062140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932115|NCT00062140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64932116|NCT00062179|Celecoxib|celecoxib|mesh-list
64932117|NCT00062179|Paclitaxel|paclitaxel|mesh-list
64932118|NCT00062179|Carboplatin|carboplatin|mesh-list
64932119|NCT00062179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64932120|NCT00062179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932121|NCT00062179|Tubulin Modulators|tubulin modulators|mesh-ancestor
64932122|NCT00062179|Antimitotic Agents|antimitotic agents|mesh-ancestor
64932123|NCT00062179|Mitosis Modulators|mitosis modulators|mesh-ancestor
64932124|NCT00062179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932125|NCT00062179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64932126|NCT00062179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64932127|NCT00062179|Analgesics|analgesics|mesh-ancestor
64932128|NCT00062179|Sensory System Agents|sensory system agents|mesh-ancestor
64932129|NCT00062179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64932130|NCT00062179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932131|NCT00062179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64932132|NCT00062179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64932133|NCT00062179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64932134|NCT00062179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64932135|NCT00062179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932136|NCT00062257|Irofulven|irofulven|mesh-list
64932137|NCT00062257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64932138|NCT00062257|Alkylating Agents|alkylating agents|mesh-ancestor
64932139|NCT00062257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932140|NCT00062257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932142|NCT00062296|Epirubicin|epirubicin|mesh-list
64991062|NCT04756037|Hormone Antagonists|hormone antagonists|mesh-ancestor
64991063|NCT04756037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64991064|NCT04756037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991065|NCT04751383|Dinutuximab|dinutuximab|mesh-list
64991066|NCT04751383|Magrolimab|magrolimab|mesh-list
64991067|NCT04751383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64991068|NCT04751383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991069|NCT04751383|Immunologic Factors|immunologic factors|mesh-ancestor
64991070|NCT04751383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991124|NCT04736173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64932143|NCT00062296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64932144|NCT00062296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932153|NCT05183984|Bevacizumab|bevacizumab|mesh-list
64932154|NCT05183984|Niraparib|niraparib|mesh-list
64932155|NCT05183984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64932156|NCT05183984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932157|NCT05183984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64932158|NCT05183984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64932159|NCT05183984|Growth Substances|growth substances|mesh-ancestor
64932160|NCT05183984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932161|NCT05183984|Growth Inhibitors|growth inhibitors|mesh-ancestor
64932162|NCT05183984|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64932163|NCT05183984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932164|NCT05183984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932165|NCT02967874|Hyaluronic Acid|hyaluronic acid|mesh-list
64932166|NCT02967874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64932167|NCT02967874|Immunologic Factors|immunologic factors|mesh-ancestor
64932168|NCT02967874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932169|NCT02967874|Viscosupplements|viscosupplements|mesh-ancestor
64932170|NCT02967874|Protective Agents|protective agents|mesh-ancestor
64932171|NCT04733625|Vitamin D|vitamin d|mesh-list
64932172|NCT04733625|Cholecalciferol|cholecalciferol|mesh-list
64932173|NCT04733625|Vitamins|vitamins|mesh-ancestor
64932174|NCT04733625|Micronutrients|micronutrients|mesh-ancestor
64932175|NCT04733625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932176|NCT04733625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64932177|NCT04733625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64932178|NCT00062686|Lapatinib|lapatinib|mesh-list
64932179|NCT00062686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932180|NCT00062686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64932181|NCT00062686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932182|NCT00062686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932183|NCT00062803|Heparin|heparin|mesh-list
64932184|NCT00062803|Warfarin|warfarin|mesh-list
64932185|NCT00062803|Acenocoumarol|acenocoumarol|mesh-list
64932195|NCT00062842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932196|NCT00062881|Mafosfamide|mafosfamide|mesh-list
64991125|NCT04736173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64991126|NCT04729959|Atezolizumab|atezolizumab|mesh-list
64991127|NCT04729959|Immunoglobulins|immunoglobulins|mesh-list
64932197|NCT00062881|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64932198|NCT00062881|Immunologic Factors|immunologic factors|mesh-ancestor
64932199|NCT00062881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932200|NCT00062881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932201|NCT00389909|Doxapram|doxapram|mesh-list
64932202|NCT00389909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64932203|NCT00389909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932204|NCT00389909|Respiratory System Agents|respiratory system agents|mesh-ancestor
64932205|NCT00063076|Bexarotene|bexarotene|mesh-list
64932206|NCT00063076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932207|NCT04744662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64932208|NCT04744662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64932209|NCT00063193|Minocycline|minocycline|mesh-list
64932210|NCT00063193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64700697|NCT00003951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932211|NCT00063193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64932213|NCT04736823|Docetaxel|docetaxel|mesh-list
64932214|NCT04736823|Carboplatin|carboplatin|mesh-list
64932215|NCT04736823|Pemetrexed|pemetrexed|mesh-list
64932216|NCT04736823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64932217|NCT04736823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932218|NCT04736823|Tubulin Modulators|tubulin modulators|mesh-ancestor
64932219|NCT04736823|Antimitotic Agents|antimitotic agents|mesh-ancestor
64932220|NCT04736823|Mitosis Modulators|mitosis modulators|mesh-ancestor
64932221|NCT04736823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932222|NCT04736823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932223|NCT04736823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64932224|NCT04736823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64932241|NCT00063583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64932242|NCT00063583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64932244|NCT00063583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932245|NCT00063895|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64932246|NCT00063895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932247|NCT00063895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64932250|NCT00064012|Docetaxel|docetaxel|mesh-list
64932255|NCT00064012|Mitosis Modulators|mitosis modulators|mesh-ancestor
64932256|NCT00064012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932257|NCT00064051|Gemcitabine|gemcitabine|mesh-list
64932258|NCT00064051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64932259|NCT00064051|Antimetabolites|antimetabolites|mesh-ancestor
64932260|NCT00064051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932261|NCT00064051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932262|NCT00064051|Antiviral Agents|antiviral agents|mesh-ancestor
64932263|NCT00064051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64932264|NCT00064051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932265|NCT00064051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64932266|NCT00064051|Immunologic Factors|immunologic factors|mesh-ancestor
64932355|NCT00064402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64932356|NCT00064402|Autonomic Agents|autonomic agents|mesh-ancestor
64932357|NCT00064402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64932358|NCT00064402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932359|NCT00064402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64932360|NCT00064402|Respiratory System Agents|respiratory system agents|mesh-ancestor
64700848|NCT00003573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64932361|NCT00064402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64932362|NCT00064402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64932369|NCT02967211|Insulin|insulin|mesh-list
64932374|NCT02967211|Isophane Insulin, Human|isophane insulin, human|mesh-list
64932375|NCT02967211|Isophane insulin, beef|isophane insulin, beef|mesh-list
64932376|NCT02967211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64932377|NCT02967211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932379|NCT00064636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932380|NCT05113394|Immunologic Factors|immunologic factors|mesh-list
64932381|NCT05113394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932382|NCT00065143|Clofarabine|clofarabine|mesh-list
64932383|NCT00065143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64932384|NCT00065143|Antimetabolites|antimetabolites|mesh-ancestor
64932385|NCT00065143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932386|NCT00065143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932387|NCT00398749|Epoetin Alfa|epoetin alfa|mesh-list
64932388|NCT00398749|Hematinics|hematinics|mesh-ancestor
64932389|NCT00398788|Hydromorphone|hydromorphone|mesh-list
64932390|NCT00398788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64932391|NCT00398788|Narcotics|narcotics|mesh-ancestor
64932392|NCT00398788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64932393|NCT00398788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932394|NCT00398788|Analgesics|analgesics|mesh-ancestor
64932395|NCT00398788|Sensory System Agents|sensory system agents|mesh-ancestor
64932396|NCT00398788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64932397|NCT00398827|Dexmedetomidine|dexmedetomidine|mesh-list
64385918|NCT05324501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385919|NCT05324501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385920|NCT05286437|Pembrolizumab|pembrolizumab|mesh-list
64385921|NCT05286437|Letrozole|letrozole|mesh-list
64991128|NCT04729959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64991129|NCT04729959|Immunoglobulin G|immunoglobulin g|mesh-list
64932398|NCT00398827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64932399|NCT00398827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64932400|NCT00398827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932401|NCT00398827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64932402|NCT00398827|Analgesics|analgesics|mesh-ancestor
64932403|NCT00398827|Sensory System Agents|sensory system agents|mesh-ancestor
64932404|NCT00398827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64932491|NCT00065884|GABA Agents|gaba agents|mesh-ancestor
64932508|NCT05083754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64932510|NCT05083754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932511|NCT05083754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932512|NCT00066001|Metronidazole|metronidazole|mesh-list
64932513|NCT00066001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64932514|NCT00066001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64932515|NCT00066001|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64932516|NCT00066001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64932517|NCT00066157|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64932518|NCT00066157|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64932519|NCT00066157|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64932520|NCT00066157|Medroxyprogesterone|medroxyprogesterone|mesh-list
64932521|NCT00066157|Estradiol|estradiol|mesh-list
64932522|NCT00066157|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64932523|NCT00066157|Estrogens|estrogens|mesh-list
64932524|NCT00066157|Progesterone|progesterone|mesh-list
64932569|NCT04401150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932570|NCT04401150|Antioxidants|antioxidants|mesh-ancestor
64932571|NCT04401150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932572|NCT04401150|Protective Agents|protective agents|mesh-ancestor
64932573|NCT00066352|Bortezomib|bortezomib|mesh-list
64932574|NCT00066352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932575|NCT00066391|Irinotecan|irinotecan|mesh-list
64932576|NCT00066391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932588|NCT00389987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932589|NCT00389987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64932590|NCT00389987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64932591|NCT00389987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64932592|NCT00389987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932594|NCT00066508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932595|NCT00066547|Antibodies|antibodies|mesh-list
64932596|NCT00066547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64932597|NCT00066547|Immunologic Factors|immunologic factors|mesh-ancestor
64932598|NCT00066547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932599|NCT00066586|Exemestane|exemestane|mesh-list
64932600|NCT00066586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932601|NCT00066586|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64932602|NCT00066586|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64932603|NCT00066586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932604|NCT00066586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932605|NCT00066586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64932606|NCT00066586|Hormone Antagonists|hormone antagonists|mesh-ancestor
64932607|NCT00066586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64932608|NCT00066586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932609|NCT04258488|Vitamin K|vitamin k|mesh-list
64932610|NCT04258488|Warfarin|warfarin|mesh-list
64932611|NCT04258488|Rivaroxaban|rivaroxaban|mesh-list
64932612|NCT04258488|Vitamins|vitamins|mesh-ancestor
64932613|NCT04258488|Micronutrients|micronutrients|mesh-ancestor
64932614|NCT04258488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386037|NCT03959241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64991130|NCT04729959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991131|NCT04729959|Immunologic Factors|immunologic factors|mesh-ancestor
64991132|NCT04729959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991133|NCT04720963|Dexmedetomidine|dexmedetomidine|mesh-list
64991134|NCT04720963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64991135|NCT04720963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64932615|NCT04258488|Anticoagulants|anticoagulants|mesh-ancestor
64932638|NCT00066859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932639|NCT00066859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64932640|NCT00066859|Serotonin Agents|serotonin agents|mesh-ancestor
64932641|NCT00066859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932642|NCT04235673|Melatonin|melatonin|mesh-list
64932643|NCT04235673|Antioxidants|antioxidants|mesh-ancestor
64932644|NCT04235673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932645|NCT04235673|Protective Agents|protective agents|mesh-ancestor
64932646|NCT04235673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932647|NCT04235673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64932648|NCT00067015|Goserelin|goserelin|mesh-list
64932649|NCT00067015|Bicalutamide|bicalutamide|mesh-list
64932650|NCT00067015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64932651|NCT00067015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932652|NCT00067015|Androgen Antagonists|androgen antagonists|mesh-ancestor
64932653|NCT00067015|Hormone Antagonists|hormone antagonists|mesh-ancestor
64932654|NCT00067015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64932655|NCT00067015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932656|NCT00067093|Vitamin K|vitamin k|mesh-list
64932657|NCT00067093|Heparin|heparin|mesh-list
64932658|NCT00067093|Calcium heparin|calcium heparin|mesh-list
64932659|NCT00067093|Idraparinux|idraparinux|mesh-list
64932660|NCT00067093|Vitamins|vitamins|mesh-ancestor
64932661|NCT00067093|Micronutrients|micronutrients|mesh-ancestor
64932662|NCT00067093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932663|NCT00067093|Anticoagulants|anticoagulants|mesh-ancestor
64932664|NCT00067093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64932665|NCT00067093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64932689|NCT00398905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932690|NCT00398905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932691|NCT00398905|Anticoagulants|anticoagulants|mesh-ancestor
64932692|NCT00398905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64932693|NCT00398905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64932694|NCT00067405|Micronutrients|micronutrients|mesh-list
64932695|NCT00067405|Trace Elements|trace elements|mesh-list
64932696|NCT00067405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932697|NCT00067444|Paroxetine|paroxetine|mesh-list
64932698|NCT00067444|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64932699|NCT00067444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64932700|NCT00067444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64932701|NCT00067444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932702|NCT00067444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64932703|NCT00067444|Serotonin Agents|serotonin agents|mesh-ancestor
64932704|NCT00067444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932705|NCT00067444|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64932706|NCT00067444|Antidepressive Agents|antidepressive agents|mesh-ancestor
64932707|NCT00067444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64932708|NCT00067444|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64932710|NCT00067444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932719|NCT00399022|Sensory System Agents|sensory system agents|mesh-ancestor
64932720|NCT00399022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64932721|NCT00399022|Antidepressive Agents|antidepressive agents|mesh-ancestor
64932722|NCT00399022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64932723|NCT00399022|Dopamine Agents|dopamine agents|mesh-ancestor
64932724|NCT05027633|Carboplatin|carboplatin|mesh-list
64932725|NCT05027633|Docetaxel|docetaxel|mesh-list
64932726|NCT05027633|Pembrolizumab|pembrolizumab|mesh-list
64932727|NCT05027633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932728|NCT05027633|Tubulin Modulators|tubulin modulators|mesh-ancestor
64932729|NCT05027633|Antimitotic Agents|antimitotic agents|mesh-ancestor
64932730|NCT05027633|Mitosis Modulators|mitosis modulators|mesh-ancestor
64932731|NCT05027633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932732|NCT05027633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64991136|NCT04720963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991137|NCT04720963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64932733|NCT02967094|Expectorants|expectorants|mesh-list
64932734|NCT02967094|Respiratory System Agents|respiratory system agents|mesh-ancestor
64932735|NCT00067561|Alosetron|alosetron|mesh-list
64932736|NCT00067561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64932737|NCT00067561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64932738|NCT00067561|Serotonin Agents|serotonin agents|mesh-ancestor
64932739|NCT00067561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64932740|NCT00067561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701230|NCT00004941|Dermatologic Agents|dermatologic agents|mesh-ancestor
64932742|NCT00067600|Calcium|calcium|mesh-list
64932770|NCT04999241|Analgesics|analgesics|mesh-ancestor
64932771|NCT04999241|Sensory System Agents|sensory system agents|mesh-ancestor
64932772|NCT04999241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64932773|NCT04999241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932774|NCT04999241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64932775|NCT00067912|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64932776|NCT00067912|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64932777|NCT00067912|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64932778|NCT00067912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64932779|NCT00067912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64932780|NCT00067912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932781|NCT00067912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64932782|NCT00067912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932783|NCT00067912|Analgesics|analgesics|mesh-ancestor
64932784|NCT00067912|Sensory System Agents|sensory system agents|mesh-ancestor
64932785|NCT00067912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64932786|NCT00067912|Antidepressive Agents|antidepressive agents|mesh-ancestor
64932787|NCT00067912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64932788|NCT00067912|Dopamine Agents|dopamine agents|mesh-ancestor
64932789|NCT00067912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64932825|NCT00068302|Immunologic Factors|immunologic factors|mesh-ancestor
64932826|NCT00068302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932827|NCT00068458|Calcium, Dietary|calcium, dietary|mesh-list
64932828|NCT00068458|Calcium|calcium|mesh-list
64932829|NCT00068458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64932830|NCT00068458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932831|NCT00068458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64932832|NCT00068497|Gefitinib|gefitinib|mesh-list
64932833|NCT00068497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932834|NCT00068497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64932872|NCT00399061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932873|NCT00399061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932874|NCT00399061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64932875|NCT00399061|Immunologic Factors|immunologic factors|mesh-ancestor
64932876|NCT00399061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932877|NCT00399061|Antifungal Agents|antifungal agents|mesh-ancestor
64932878|NCT00399061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64932879|NCT00399061|Dermatologic Agents|dermatologic agents|mesh-ancestor
64932880|NCT00399061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64932881|NCT00399061|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64932883|NCT00069355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64932884|NCT00069355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64932885|NCT00069355|Adrenergic Agents|adrenergic agents|mesh-ancestor
64932886|NCT00069355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64932887|NCT00069355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932889|NCT00069355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64932925|NCT00069901|Tubulin Modulators|tubulin modulators|mesh-ancestor
64932926|NCT00069901|Antimitotic Agents|antimitotic agents|mesh-ancestor
64932927|NCT00069901|Mitosis Modulators|mitosis modulators|mesh-ancestor
64932928|NCT00069901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932929|NCT00069940|Sargramostim|sargramostim|mesh-list
64932930|NCT00069940|Immunologic Factors|immunologic factors|mesh-ancestor
64932931|NCT00069940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932932|NCT00390026|Bevacizumab|bevacizumab|mesh-list
64932933|NCT00390026|Verteporfin|verteporfin|mesh-list
64932934|NCT00390026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64932935|NCT00390026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932936|NCT00390026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64932937|NCT00390026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64932938|NCT00390026|Growth Substances|growth substances|mesh-ancestor
64932939|NCT00390026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932940|NCT00390026|Growth Inhibitors|growth inhibitors|mesh-ancestor
64932970|NCT00070174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64932971|NCT00070174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64932972|NCT00070174|Alkylating Agents|alkylating agents|mesh-ancestor
64932973|NCT00070174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932974|NCT00070174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932975|NCT00070174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64932976|NCT00070174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64932977|NCT00070174|Abortifacient Agents|abortifacient agents|mesh-ancestor
64932978|NCT00070174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64932979|NCT00070174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64932980|NCT00070174|Antimetabolites|antimetabolites|mesh-ancestor
64932981|NCT00070174|Dermatologic Agents|dermatologic agents|mesh-ancestor
64932982|NCT00070174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932983|NCT00070174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64932984|NCT00070174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64386132|NCT02055820|Tubulin Modulators|tubulin modulators|mesh-ancestor
64991138|NCT04720963|Analgesics|analgesics|mesh-ancestor
64991139|NCT04720963|Sensory System Agents|sensory system agents|mesh-ancestor
64991140|NCT04720963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64991141|NCT04720963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64991142|NCT04720963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64991143|NCT04720963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64991144|NCT04720963|Adrenergic Agents|adrenergic agents|mesh-ancestor
64991145|NCT04720963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64991146|NCT04720963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932985|NCT00070174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64932986|NCT00070174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64932987|NCT00070174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64932988|NCT00070174|Antiviral Agents|antiviral agents|mesh-ancestor
64932989|NCT00070174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64932990|NCT00070174|Antifungal Agents|antifungal agents|mesh-ancestor
64932991|NCT00070174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64932992|NCT00070174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64932993|NCT00070174|Analgesics|analgesics|mesh-ancestor
64932994|NCT00070174|Sensory System Agents|sensory system agents|mesh-ancestor
64932995|NCT00070174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64932996|NCT00070174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64932997|NCT00070213|Leucovorin|leucovorin|mesh-list
64932998|NCT00070213|Fluorouracil|fluorouracil|mesh-list
64933015|NCT00070213|Micronutrients|micronutrients|mesh-ancestor
64933017|NCT00070252|Capecitabine|capecitabine|mesh-list
64933018|NCT00070252|Tipifarnib|tipifarnib|mesh-list
64933019|NCT00070252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933020|NCT00070252|Tubulin Modulators|tubulin modulators|mesh-ancestor
64933021|NCT00070252|Antimitotic Agents|antimitotic agents|mesh-ancestor
64933022|NCT00070252|Mitosis Modulators|mitosis modulators|mesh-ancestor
64933023|NCT00070252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933024|NCT00070252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64933025|NCT00070252|Antimetabolites|antimetabolites|mesh-ancestor
64933026|NCT00070447|Prednisone|prednisone|mesh-list
64933027|NCT00070447|Cyclophosphamide|cyclophosphamide|mesh-list
64933028|NCT00070447|Rituximab|rituximab|mesh-list
64933029|NCT00070447|Doxorubicin|doxorubicin|mesh-list
64933030|NCT00070447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64933031|NCT00070447|Vincristine|vincristine|mesh-list
64933032|NCT00070447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64991147|NCT04718220|Antibodies|antibodies|mesh-list
64991148|NCT04718220|Immunologic Factors|immunologic factors|mesh-ancestor
64349794|NCT02252536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64991168|NCT04685135|Tubulin Modulators|tubulin modulators|mesh-ancestor
64991169|NCT04685135|Antimitotic Agents|antimitotic agents|mesh-ancestor
64991181|NCT04668300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64991183|NCT04668300|Immunologic Factors|immunologic factors|mesh-ancestor
64991184|NCT04668300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991185|NCT04662255|Acalabrutinib|acalabrutinib|mesh-list
64991186|NCT04662255|Zanubrutinib|zanubrutinib|mesh-list
64991187|NCT04662255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991188|NCT04662255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64991189|NCT04662255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991190|NCT04662255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933033|NCT00070447|Immunologic Factors|immunologic factors|mesh-ancestor
64933034|NCT00070447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933035|NCT00070447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64933036|NCT00070447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64933037|NCT00070447|Alkylating Agents|alkylating agents|mesh-ancestor
64933038|NCT00070447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933039|NCT00070447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933040|NCT00070447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64933042|NCT00070447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64933066|NCT00070486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933067|NCT00070486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64933068|NCT00070486|Antimetabolites|antimetabolites|mesh-ancestor
64933069|NCT00070486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933126|NCT00071227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933127|NCT00071227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933129|NCT00071266|Lovastatin|lovastatin|mesh-list
64933130|NCT00071266|L 647318|l 647318|mesh-list
64933131|NCT00071266|Dihydromevinolin|dihydromevinolin|mesh-list
64933132|NCT00071266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64933133|NCT00071266|Antimetabolites|antimetabolites|mesh-ancestor
64933134|NCT00071266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933170|NCT00071539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933171|NCT00071695|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64933172|NCT00071695|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64933173|NCT00071695|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64933174|NCT00071695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64933175|NCT00071695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64933176|NCT00071695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933177|NCT00071695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64933178|NCT00071695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933179|NCT00071695|Analgesics|analgesics|mesh-ancestor
64933180|NCT00071695|Sensory System Agents|sensory system agents|mesh-ancestor
64933181|NCT00071695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64933182|NCT00071695|Antidepressive Agents|antidepressive agents|mesh-ancestor
64933183|NCT00071695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64933184|NCT00071695|Dopamine Agents|dopamine agents|mesh-ancestor
64933185|NCT00071695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64933186|NCT00071929|Oxaliplatin|oxaliplatin|mesh-list
64933226|NCT00072007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933227|NCT00072007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64933228|NCT00072007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64991275|NCT04576091|Pembrolizumab|pembrolizumab|mesh-list
64991276|NCT04576091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64991277|NCT04576091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991278|NCT04572295|Fulvestrant|fulvestrant|mesh-list
64991279|NCT04572295|Exemestane|exemestane|mesh-list
64991280|NCT04572295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64991281|NCT04572295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991282|NCT04572295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64991283|NCT04572295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64991284|NCT04572295|Hormone Antagonists|hormone antagonists|mesh-ancestor
64991336|NCT04537715|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64991337|NCT04537715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64991338|NCT04537715|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64991339|NCT04537715|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64991340|NCT04537715|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64991341|NCT04537715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64933229|NCT00072007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64933230|NCT00072007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64933231|NCT00072007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64933233|NCT00072007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64933234|NCT00072007|Glucocorticoids|glucocorticoids|mesh-ancestor
64933235|NCT00072007|Hormones|hormones|mesh-ancestor
64933236|NCT00072007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64933237|NCT00072007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64933238|NCT00072007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64933239|NCT00072007|Tubulin Modulators|tubulin modulators|mesh-ancestor
64933240|NCT00072007|Antimitotic Agents|antimitotic agents|mesh-ancestor
64933241|NCT00072007|Mitosis Modulators|mitosis modulators|mesh-ancestor
64933242|NCT00072046|Interferons|interferons|mesh-list
64933243|NCT00072046|Interferon-alpha|interferon-alpha|mesh-list
64933244|NCT00072046|Bevacizumab|bevacizumab|mesh-list
64933245|NCT00072046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64933280|NCT00072085|Freund's Adjuvant|freund's adjuvant|mesh-list
64933281|NCT00072085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933282|NCT00072085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64933283|NCT00072085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64933284|NCT00072085|Antiviral Agents|antiviral agents|mesh-ancestor
64933285|NCT00072085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64933286|NCT00072085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64933287|NCT00072085|Immunologic Factors|immunologic factors|mesh-ancestor
64933288|NCT00072085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933289|NCT04730674|Tetracycline|tetracycline|mesh-list
64933290|NCT04730674|Lidocaine|lidocaine|mesh-list
64933291|NCT04730674|Anesthetics, Local|anesthetics, local|mesh-ancestor
64933292|NCT04730674|Anesthetics|anesthetics|mesh-ancestor
64933293|NCT04730674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64933294|NCT04730674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933295|NCT04730674|Sensory System Agents|sensory system agents|mesh-ancestor
64933296|NCT04730674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64933297|NCT04730674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64933298|NCT04730674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64933299|NCT04730674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64933300|NCT04730674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64991342|NCT04533750|Peposertib|peposertib|mesh-list
64933301|NCT04730674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933302|NCT04730674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64933303|NCT04730674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64933304|NCT04730674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64933305|NCT04730674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933306|NCT03959436|Carbetocin|carbetocin|mesh-list
64933307|NCT03959436|Oxytocics|oxytocics|mesh-ancestor
64933308|NCT03959436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64933309|NCT03959436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933310|NCT00072124|Dacarbazine|dacarbazine|mesh-list
64933311|NCT00072124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933312|NCT00072124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64933313|NCT00072124|Alkylating Agents|alkylating agents|mesh-ancestor
64933314|NCT00072124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933318|NCT00072163|Alkylating Agents|alkylating agents|mesh-ancestor
64933319|NCT00072163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933320|NCT00072163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933321|NCT00072163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64933322|NCT00072163|Immunologic Factors|immunologic factors|mesh-ancestor
64933323|NCT00072163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933324|NCT00072163|Leprostatic Agents|leprostatic agents|mesh-ancestor
64933325|NCT00072163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64933326|NCT00072163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64933327|NCT00072163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64933328|NCT00072163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64933329|NCT00072163|Growth Substances|growth substances|mesh-ancestor
64933330|NCT00072163|Growth Inhibitors|growth inhibitors|mesh-ancestor
64933349|NCT00072319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64933350|NCT00072319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933351|NCT03959397|Paclitaxel|paclitaxel|mesh-list
64933352|NCT03959397|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64933354|NCT03959397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933355|NCT03959397|Tubulin Modulators|tubulin modulators|mesh-ancestor
64933356|NCT03959397|Antimitotic Agents|antimitotic agents|mesh-ancestor
64933357|NCT03959397|Mitosis Modulators|mitosis modulators|mesh-ancestor
64933358|NCT03959397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933359|NCT00072436|Gemcitabine|gemcitabine|mesh-list
64933360|NCT00072436|Alvocidib|alvocidib|mesh-list
64933361|NCT00072436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64933362|NCT00072436|Antimetabolites|antimetabolites|mesh-ancestor
64933363|NCT00072436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933364|NCT00072436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933365|NCT00072436|Antiviral Agents|antiviral agents|mesh-ancestor
64933366|NCT00072436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64933367|NCT00072436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933368|NCT00072436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64933369|NCT00072436|Immunologic Factors|immunologic factors|mesh-ancestor
64933370|NCT00072436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933371|NCT00072436|Growth Inhibitors|growth inhibitors|mesh-ancestor
64933372|NCT00072436|Growth Substances|growth substances|mesh-ancestor
64933373|NCT00072436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64933374|NCT04843904|Rituximab|rituximab|mesh-list
64933375|NCT04843904|Obinutuzumab|obinutuzumab|mesh-list
64933376|NCT04843904|Venetoclax|venetoclax|mesh-list
64933377|NCT04843904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64933378|NCT04843904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933379|NCT04843904|Immunologic Factors|immunologic factors|mesh-ancestor
64933380|NCT04843904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933381|NCT04843904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64933382|NCT00072553|Leucovorin|leucovorin|mesh-list
64933402|NCT00072553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64933404|NCT00072553|Sensory System Agents|sensory system agents|mesh-ancestor
64933405|NCT00072553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64933406|NCT00072553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64933407|NCT00072553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64933408|NCT00072553|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64933409|NCT00072553|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64933410|NCT00072553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933411|NCT00072592|Rituximab|rituximab|mesh-list
64933412|NCT00072592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64933413|NCT00072592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933414|NCT00072592|Immunologic Factors|immunologic factors|mesh-ancestor
64933415|NCT00072592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933416|NCT00072592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64933417|NCT04840589|Nivolumab|nivolumab|mesh-list
64933418|NCT04840589|Ipilimumab|ipilimumab|mesh-list
64933419|NCT04840589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64933451|NCT00072787|Cisplatin|cisplatin|mesh-list
64933516|NCT04827953|Antimetabolites|antimetabolites|mesh-ancestor
64933517|NCT04827953|Antiviral Agents|antiviral agents|mesh-ancestor
64933518|NCT04827953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64933519|NCT04827953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933520|NCT04827953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64933521|NCT04827953|Immunologic Factors|immunologic factors|mesh-ancestor
64933522|NCT04827953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933523|NCT04711291|Tacrolimus|tacrolimus|mesh-list
64933524|NCT04711291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64933525|NCT04711291|Immunologic Factors|immunologic factors|mesh-ancestor
64933526|NCT04711291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933527|NCT04711291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64933528|NCT04711291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933530|NCT00073372|Abciximab|abciximab|mesh-list
64933543|NCT04821830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933544|NCT04821830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64933545|NCT04821830|Immunologic Factors|immunologic factors|mesh-ancestor
64933546|NCT04821830|Dopamine Agonists|dopamine agonists|mesh-ancestor
64933547|NCT00073411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64933549|NCT00073411|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64933550|NCT00073411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64933551|NCT00073411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64933552|NCT00073411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933553|NCT00073411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64933554|NCT00073411|Serotonin Agents|serotonin agents|mesh-ancestor
64933555|NCT00073411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933556|NCT00073411|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64933557|NCT00073411|Antidepressive Agents|antidepressive agents|mesh-ancestor
64933558|NCT00073411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64933559|NCT00073411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64991343|NCT04533750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64991344|NCT04533750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991345|NCT04533750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991346|NCT04521868|Sulforaphane|sulforaphane|mesh-list
64991406|NCT04442022|Gemcitabine|gemcitabine|mesh-list
64991407|NCT04442022|Dexamethasone|dexamethasone|mesh-list
64991408|NCT04442022|Rituximab|rituximab|mesh-list
64991409|NCT04442022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64991410|NCT04442022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991411|NCT04442022|Immunologic Factors|immunologic factors|mesh-ancestor
64991412|NCT04442022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991413|NCT04442022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64933560|NCT00073411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64933561|NCT00073411|Analgesics|analgesics|mesh-ancestor
64933562|NCT00073411|Sensory System Agents|sensory system agents|mesh-ancestor
64933563|NCT00073411|Dopamine Agents|dopamine agents|mesh-ancestor
64933564|NCT02966041|Ondansetron|ondansetron|mesh-list
64933565|NCT02966041|Antiemetics|antiemetics|mesh-ancestor
64933566|NCT02966041|Autonomic Agents|autonomic agents|mesh-ancestor
64933567|NCT02966041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64933568|NCT02966041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933569|NCT02966041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64933570|NCT02966041|Antipruritics|antipruritics|mesh-ancestor
64933589|NCT00073840|Respiratory System Agents|respiratory system agents|mesh-ancestor
64933590|NCT00073840|Tocolytic Agents|tocolytic agents|mesh-ancestor
64933591|NCT00073840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64933592|NCT00073840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64933593|NCT00073840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64933594|NCT00073840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64933595|NCT00073840|Adrenergic Agents|adrenergic agents|mesh-ancestor
64933596|NCT00073840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64933597|NCT00073840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933598|NCT00073879|Cyclophosphamide|cyclophosphamide|mesh-list
64933599|NCT00073879|Fludarabine|fludarabine|mesh-list
64933600|NCT00073879|Fludarabine phosphate|fludarabine phosphate|mesh-list
64933601|NCT00073879|Alemtuzumab|alemtuzumab|mesh-list
64933602|NCT00073879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64933603|NCT00073879|Immunologic Factors|immunologic factors|mesh-ancestor
64933604|NCT00073879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933605|NCT00073879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64933606|NCT00073879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64933651|NCT00074191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64933652|NCT00074191|Antiviral Agents|antiviral agents|mesh-ancestor
64933653|NCT00074191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64933654|NCT00074191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64933655|NCT00074191|Alkylating Agents|alkylating agents|mesh-ancestor
64933656|NCT00074230|BIRC5 protein, human|birc5 protein, human|mesh-list
64933657|NCT00074230|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64933658|NCT00074230|Protease Inhibitors|protease inhibitors|mesh-ancestor
64933659|NCT00074230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933660|NCT00074230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933661|NCT00392691|Rituximab|rituximab|mesh-list
64933662|NCT00392691|Melphalan|melphalan|mesh-list
64933663|NCT00392691|Vinorelbine|vinorelbine|mesh-list
64933691|NCT04767776|Anticoagulants|anticoagulants|mesh-ancestor
64933692|NCT04767776|Antidotes|antidotes|mesh-ancestor
64933693|NCT04767776|Protective Agents|protective agents|mesh-ancestor
64933694|NCT04767776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933695|NCT04754321|Pembrolizumab|pembrolizumab|mesh-list
64933696|NCT04754321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64933697|NCT04754321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933698|NCT04730245|Rifaximin|rifaximin|mesh-list
64933699|NCT04730245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64933700|NCT04730245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64933701|NCT04730245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64933702|NCT00074620|Hirudins|hirudins|mesh-list
64933703|NCT00074620|Antithrombins|antithrombins|mesh-ancestor
64933704|NCT00074620|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64933705|NCT00074620|Protease Inhibitors|protease inhibitors|mesh-ancestor
64933706|NCT00074620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933707|NCT00074620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933708|NCT00074620|Anticoagulants|anticoagulants|mesh-ancestor
64933709|NCT00074620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64933710|NCT00074620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64933711|NCT02972333|Osimertinib|osimertinib|mesh-list
64933712|NCT02972333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991414|NCT04442022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64991415|NCT04442022|Antiemetics|antiemetics|mesh-ancestor
64991416|NCT04442022|Autonomic Agents|autonomic agents|mesh-ancestor
64991418|NCT04442022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64991465|NCT04394975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991466|NCT04394858|Temozolomide|temozolomide|mesh-list
64933713|NCT02972333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64933714|NCT02972333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933715|NCT02972333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933716|NCT00074737|Cytarabine|cytarabine|mesh-list
64933717|NCT00074737|Idarubicin|idarubicin|mesh-list
64933718|NCT00074737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64933719|NCT00074737|Antimetabolites|antimetabolites|mesh-ancestor
64933720|NCT00074737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933721|NCT00074737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933722|NCT00074737|Antiviral Agents|antiviral agents|mesh-ancestor
64933723|NCT00074737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64933724|NCT00074737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64933731|NCT00074776|Lamotrigine|lamotrigine|mesh-list
64933733|NCT00074776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933734|NCT00074776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64933735|NCT00074776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64933736|NCT00074776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933737|NCT00074776|Anticonvulsants|anticonvulsants|mesh-ancestor
64933738|NCT00074776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64933739|NCT00074776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64933740|NCT00074776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64933741|NCT00074776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64933742|NCT00074776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64933743|NCT00075010|Decitabine|decitabine|mesh-list
64933744|NCT00075010|Valproic Acid|valproic acid|mesh-list
64933794|NCT00075517|Antimitotic Agents|antimitotic agents|mesh-ancestor
64933795|NCT00075517|Mitosis Modulators|mitosis modulators|mesh-ancestor
64933796|NCT00075556|Capecitabine|capecitabine|mesh-list
64933797|NCT00075556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64933800|NCT00075556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933842|NCT00075634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64933843|NCT00075634|Antimetabolites|antimetabolites|mesh-ancestor
64933844|NCT00075673|Celecoxib|celecoxib|mesh-list
64933845|NCT00075673|Vinorelbine|vinorelbine|mesh-list
64933846|NCT00075673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64933847|NCT00075673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64933848|NCT00075673|Analgesics|analgesics|mesh-ancestor
64933963|NCT00076531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933964|NCT00076609|Capecitabine|capecitabine|mesh-list
64933965|NCT00076609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64933966|NCT00076609|Antimetabolites|antimetabolites|mesh-ancestor
64933967|NCT00076609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933968|NCT00076609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933969|NCT00076726|Infliximab|infliximab|mesh-list
64933970|NCT00076726|Dermatologic Agents|dermatologic agents|mesh-ancestor
64933971|NCT00076726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64933972|NCT00076726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64933973|NCT00076960|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
64933974|NCT00076960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933975|NCT00076960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934093|NCT03832569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64934094|NCT03832569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934096|NCT04551482|Oxytocics|oxytocics|mesh-ancestor
64934097|NCT04551482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64934098|NCT04551482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702585|NCT01689987|Antiemetics|antiemetics|mesh-ancestor
64934099|NCT00077545|Cisplatin|cisplatin|mesh-list
64934100|NCT00077545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934101|NCT00077584|Bosentan|bosentan|mesh-list
64934102|NCT00077584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64934103|NCT00077584|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64934167|NCT00078247|Lamivudine|lamivudine|mesh-list
64934168|NCT00078247|Zidovudine|zidovudine|mesh-list
64934169|NCT00078247|Abacavir|abacavir|mesh-list
64934170|NCT00078247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64934171|NCT00078247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64934173|NCT00078247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934175|NCT00078247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64934176|NCT00078247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64934177|NCT00078247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64934178|NCT00078247|Antimetabolites|antimetabolites|mesh-ancestor
64934180|NCT00078442|Interferon-alpha|interferon-alpha|mesh-list
64934181|NCT00078442|Interferon alpha-2|interferon alpha-2|mesh-list
64934182|NCT00078442|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64934183|NCT00078442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934184|NCT00078442|Antiviral Agents|antiviral agents|mesh-ancestor
64934185|NCT00078442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64934186|NCT00078442|Immunologic Factors|immunologic factors|mesh-ancestor
64934187|NCT00078442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934188|NCT00078481|Idebenone|idebenone|mesh-list
64934189|NCT00078481|Antioxidants|antioxidants|mesh-ancestor
64934190|NCT00078481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934191|NCT00078481|Protective Agents|protective agents|mesh-ancestor
64934192|NCT00078481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934193|NCT00078598|Rituximab|rituximab|mesh-list
64934194|NCT00078598|Tositumomab I-131|tositumomab i-131|mesh-list
64934195|NCT00078598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64934196|NCT00078598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934197|NCT00078598|Immunologic Factors|immunologic factors|mesh-ancestor
64934198|NCT00078598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934199|NCT00078598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64934200|NCT00078793|Etanercept|etanercept|mesh-list
64934201|NCT00078793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64934202|NCT00078793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64934203|NCT00078793|Analgesics|analgesics|mesh-ancestor
64991467|NCT04394858|Olaparib|olaparib|mesh-list
64934219|NCT00078832|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64934220|NCT00078832|Hormone Antagonists|hormone antagonists|mesh-ancestor
64934221|NCT00078832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64934222|NCT00078832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934224|NCT01350128|Ipratropium|ipratropium|mesh-list
64934225|NCT01350128|Anticonvulsants|anticonvulsants|mesh-ancestor
64934226|NCT01350128|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64934227|NCT01350128|Autonomic Agents|autonomic agents|mesh-ancestor
64934228|NCT01350128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64934229|NCT01350128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934230|NCT01350128|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64934231|NCT01350128|Respiratory System Agents|respiratory system agents|mesh-ancestor
64934232|NCT01350128|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64934233|NCT01350128|Cholinergic Agents|cholinergic agents|mesh-ancestor
64934234|NCT01350128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64934235|NCT01350128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934281|NCT03655002|Immunologic Factors|immunologic factors|mesh-ancestor
64934298|NCT00079105|Procarbazine|procarbazine|mesh-list
64934299|NCT00079105|Prednisolone phosphate|prednisolone phosphate|mesh-list
64934300|NCT00079105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64934301|NCT00079105|Immunologic Factors|immunologic factors|mesh-ancestor
64934302|NCT00079105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934303|NCT00079105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64934304|NCT00079105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64934305|NCT00079105|Alkylating Agents|alkylating agents|mesh-ancestor
64934306|NCT00079105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934307|NCT00079105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934308|NCT00079105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64934309|NCT00079105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64934310|NCT00079105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64934311|NCT00079105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64934312|NCT00079105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934313|NCT00079105|Tubulin Modulators|tubulin modulators|mesh-ancestor
64934314|NCT00079105|Antimitotic Agents|antimitotic agents|mesh-ancestor
64934315|NCT00079105|Mitosis Modulators|mitosis modulators|mesh-ancestor
64934316|NCT00079105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64934317|NCT00079105|Glucocorticoids|glucocorticoids|mesh-ancestor
64934318|NCT00079105|Hormones|hormones|mesh-ancestor
64934319|NCT00079105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64934320|NCT00079105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64934322|NCT00079105|Analgesics|analgesics|mesh-ancestor
64934410|NCT00079300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934411|NCT00079300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934412|NCT00079300|Interferon Inducers|interferon inducers|mesh-ancestor
64934413|NCT00079378|Decitabine|decitabine|mesh-list
64934414|NCT00079378|Azacitidine|azacitidine|mesh-list
64934415|NCT00079378|Valproic Acid|valproic acid|mesh-list
64934416|NCT00079378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64934417|NCT00079378|Antimetabolites|antimetabolites|mesh-ancestor
64934418|NCT00079378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934419|NCT00079378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934420|NCT00079378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934421|NCT00079378|Anticonvulsants|anticonvulsants|mesh-ancestor
64934422|NCT00079378|GABA Agents|gaba agents|mesh-ancestor
64934423|NCT00079378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64934424|NCT00079378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934425|NCT00079378|Antimanic Agents|antimanic agents|mesh-ancestor
64934513|NCT00392886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934514|NCT00392886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64934515|NCT00392886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64934639|NCT03506373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934640|NCT03506373|Glycine Agents|glycine agents|mesh-ancestor
64934641|NCT03506373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64934642|NCT03506373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934643|NCT02972411|Acetazolamide|acetazolamide|mesh-list
64934644|NCT02972411|Anticonvulsants|anticonvulsants|mesh-ancestor
64934645|NCT02972411|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64934646|NCT02972411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934647|NCT02972411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934648|NCT02972411|Diuretics|diuretics|mesh-ancestor
64934649|NCT02972411|Natriuretic Agents|natriuretic agents|mesh-ancestor
64934650|NCT02972411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934651|NCT00080626|Docetaxel|docetaxel|mesh-list
64934657|NCT00080665|Docetaxel|docetaxel|mesh-list
64934699|NCT00080782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64934700|NCT00080782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934701|NCT00080782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934702|NCT00080782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64934703|NCT00080782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64934704|NCT00080782|Analgesics|analgesics|mesh-ancestor
64934705|NCT00080782|Sensory System Agents|sensory system agents|mesh-ancestor
64934706|NCT00080782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64934707|NCT00080782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934708|NCT00080782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64934709|NCT00080782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64934710|NCT00080782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64934711|NCT00080782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64934741|NCT00081055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934742|NCT00081055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64934743|NCT00081055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64934744|NCT00081055|Antifungal Agents|antifungal agents|mesh-ancestor
64934745|NCT00081055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64934746|NCT00081055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64934747|NCT00081094|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64934748|NCT00081094|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64934749|NCT00081094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934750|NCT00081133|Imatinib Mesylate|imatinib mesylate|mesh-list
64934751|NCT00081133|Arsenic Trioxide|arsenic trioxide|mesh-list
64934752|NCT00081133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934753|NCT00081133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64934754|NCT00081133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934755|NCT00081133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934756|NCT00081172|Antibodies|antibodies|mesh-list
64934757|NCT00081172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64934770|NCT00390260|Rofecoxib|rofecoxib|mesh-list
64934793|NCT00081757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934839|NCT00399685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934840|NCT00399685|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64934841|NCT00399685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64934842|NCT00399685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64934844|NCT00081835|Antibodies|antibodies|mesh-list
64934845|NCT00081835|gamma-Globulins|gamma-globulins|mesh-list
64934846|NCT00081835|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64703342|NCT02536040|Fluorides|fluorides|mesh-list
64934847|NCT00081835|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64934848|NCT00081835|Immunologic Factors|immunologic factors|mesh-ancestor
64934849|NCT00081835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934850|NCT00081874|Everolimus|everolimus|mesh-list
64934851|NCT00081874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934852|NCT00081874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64934853|NCT00081874|Immunologic Factors|immunologic factors|mesh-ancestor
64934933|NCT03151863|Dexmedetomidine|dexmedetomidine|mesh-list
64934934|NCT03151863|Analgesics, Opioid|analgesics, opioid|mesh-list
64934935|NCT03151863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64934936|NCT03151863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64934937|NCT03151863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934938|NCT03151863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64934939|NCT03151863|Analgesics|analgesics|mesh-ancestor
64934940|NCT03151863|Sensory System Agents|sensory system agents|mesh-ancestor
64934941|NCT03151863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64934942|NCT03151863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64934976|NCT00083590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64934977|NCT00083590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934978|NCT00083590|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64934979|NCT00083590|Protective Agents|protective agents|mesh-ancestor
64934980|NCT03151746|Gabapentin|gabapentin|mesh-list
64934981|NCT03151746|Analgesics|analgesics|mesh-ancestor
64934982|NCT03151746|Sensory System Agents|sensory system agents|mesh-ancestor
64934983|NCT03151746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64934984|NCT03151746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934985|NCT03151746|Anticonvulsants|anticonvulsants|mesh-ancestor
64934986|NCT03151746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64934987|NCT03151746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64934988|NCT03151746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64934989|NCT03151746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64934990|NCT03151746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64934991|NCT03151746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64934992|NCT03151746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64934993|NCT03151746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934994|NCT03151746|Antimanic Agents|antimanic agents|mesh-ancestor
64934995|NCT00399724|Insulin Glargine|insulin glargine|mesh-list
64934996|NCT00399724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64934997|NCT00399724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991468|NCT04394858|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64991469|NCT04394858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64991470|NCT04394858|Alkylating Agents|alkylating agents|mesh-ancestor
64991471|NCT04394858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991472|NCT04394858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991473|NCT04394858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991474|NCT04381910|Irinotecan|irinotecan|mesh-list
64349802|NCT03490487|Carbamazepine|carbamazepine|mesh-list
64991744|NCT04214249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64934998|NCT00083668|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64703513|NCT02439164|Midazolam|midazolam|mesh-list
64934999|NCT00083668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64935000|NCT00083668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64935001|NCT00083668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64935002|NCT00083668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935021|NCT00083707|Growth Substances|growth substances|mesh-ancestor
64935022|NCT00083707|Growth Inhibitors|growth inhibitors|mesh-ancestor
64935023|NCT00083707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935025|NCT00083785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935026|NCT00083785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64935027|NCT00083785|Dermatologic Agents|dermatologic agents|mesh-ancestor
64935028|NCT03151707|Niacinamide|niacinamide|mesh-list
64935029|NCT03151707|Niacin|niacin|mesh-list
64935030|NCT03151707|Nicotinic Acids|nicotinic acids|mesh-list
64935031|NCT03151707|Vitamin B Complex|vitamin b complex|mesh-ancestor
64935032|NCT03151707|Vitamins|vitamins|mesh-ancestor
64935033|NCT03151707|Micronutrients|micronutrients|mesh-ancestor
64935034|NCT03151707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935035|NCT03151707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64935036|NCT03151707|Antimetabolites|antimetabolites|mesh-ancestor
64935037|NCT03151707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935038|NCT03151707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64935039|NCT03151707|Vasodilator Agents|vasodilator agents|mesh-ancestor
64935040|NCT03151668|Dexmedetomidine|dexmedetomidine|mesh-list
64935041|NCT03151668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64935042|NCT03151668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64935043|NCT03151668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935044|NCT03151668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64935045|NCT03151668|Analgesics|analgesics|mesh-ancestor
64935046|NCT03151668|Sensory System Agents|sensory system agents|mesh-ancestor
64935071|NCT05567653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64935072|NCT05567653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64935073|NCT04733508|Exenatide|exenatide|mesh-list
64935074|NCT04733508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64935075|NCT04733508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935076|NCT04733508|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64935082|NCT00135304|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
64935083|NCT00135304|Cinacalcet|cinacalcet|mesh-list
64935084|NCT00135304|Vitamins|vitamins|mesh-ancestor
64935085|NCT00135304|Micronutrients|micronutrients|mesh-ancestor
64935086|NCT00135304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935087|NCT00135304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64935088|NCT00135304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64935089|NCT00135304|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64935090|NCT00135304|Hormone Antagonists|hormone antagonists|mesh-ancestor
64935091|NCT00135304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64935092|NCT00135499|Prednisone|prednisone|mesh-list
64935093|NCT00135499|Cyclophosphamide|cyclophosphamide|mesh-list
64935094|NCT00135499|Rituximab|rituximab|mesh-list
64935095|NCT00135499|Doxorubicin|doxorubicin|mesh-list
64935096|NCT00135499|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64935097|NCT00135499|Vincristine|vincristine|mesh-list
64935098|NCT00135499|Bleomycin|bleomycin|mesh-list
64935099|NCT00135499|Vindesine|vindesine|mesh-list
64935100|NCT00135499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64935101|NCT00135499|Immunologic Factors|immunologic factors|mesh-ancestor
64935102|NCT00135499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935103|NCT00135499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64935104|NCT00135499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64935105|NCT00135499|Alkylating Agents|alkylating agents|mesh-ancestor
64935113|NCT00135499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935114|NCT00135499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64935115|NCT00135499|Glucocorticoids|glucocorticoids|mesh-ancestor
64935116|NCT00135499|Hormones|hormones|mesh-ancestor
64935117|NCT00135499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64935118|NCT00135499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64935174|NCT00135967|Methylprednisolone|methylprednisolone|mesh-list
64935175|NCT00135967|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64935176|NCT00135967|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64935177|NCT00135967|Prednisolone|prednisolone|mesh-list
64935178|NCT00135967|Prednisolone acetate|prednisolone acetate|mesh-list
64935179|NCT00135967|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64935180|NCT00135967|Prednisolone phosphate|prednisolone phosphate|mesh-list
64935181|NCT00135967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64935182|NCT00135967|Glucocorticoids|glucocorticoids|mesh-ancestor
64935294|NCT00136825|Protective Agents|protective agents|mesh-ancestor
64935295|NCT00136825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935296|NCT00136825|Antidotes|antidotes|mesh-ancestor
64935297|NCT00393198|Misoprostol|misoprostol|mesh-list
64935298|NCT00393198|Levonorgestrel|levonorgestrel|mesh-list
64935299|NCT00393198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64935300|NCT00393198|Contraceptive Agents|contraceptive agents|mesh-ancestor
64935301|NCT00393198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64935302|NCT00393198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935314|NCT03968822|Anesthetics, Local|anesthetics, local|mesh-ancestor
64935315|NCT03968822|Anesthetics|anesthetics|mesh-ancestor
64935316|NCT03968822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64935317|NCT03968822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935318|NCT03968822|Sensory System Agents|sensory system agents|mesh-ancestor
64935319|NCT03968822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64935320|NCT03968822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64935321|NCT03968822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64935322|NCT03968822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64935323|NCT03968822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64935324|NCT03968822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935325|NCT00136942|Atorvastatin|atorvastatin|mesh-list
64935326|NCT00136942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64935327|NCT00136942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64935328|NCT00136942|Antimetabolites|antimetabolites|mesh-ancestor
64935329|NCT00136942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935330|NCT00136942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64935331|NCT00136942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64935332|NCT00136942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935333|NCT00136981|Atorvastatin|atorvastatin|mesh-list
64935334|NCT00136981|Torcetrapib|torcetrapib|mesh-list
64935335|NCT00136981|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64935336|NCT00136981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64935337|NCT00136981|Antimetabolites|antimetabolites|mesh-ancestor
64935338|NCT00136981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935342|NCT00137020|Ziprasidone|ziprasidone|mesh-list
64935360|NCT00137059|Antipyretics|antipyretics|mesh-ancestor
64935361|NCT00137098|Caffeine|caffeine|mesh-list
64935362|NCT00137098|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64935363|NCT00137098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935364|NCT00137098|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64935365|NCT00137098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935366|NCT00137098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935367|NCT00137098|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64935368|NCT00137098|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64935369|NCT00137098|Purinergic Agents|purinergic agents|mesh-ancestor
64935370|NCT00137098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64935371|NCT00137254|Insulin|insulin|mesh-list
64935372|NCT00137254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64935373|NCT00137254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935374|NCT03151044|Rituximab|rituximab|mesh-list
64935471|NCT00137995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64935472|NCT00137995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935473|NCT00137995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935474|NCT00137995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64935475|NCT00137995|Antimetabolites|antimetabolites|mesh-ancestor
64935476|NCT00137995|Antiviral Agents|antiviral agents|mesh-ancestor
64935477|NCT00137995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64935478|NCT00137995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64935479|NCT00137995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64935609|NCT00138970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64935610|NCT00138970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64935611|NCT00138970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935612|NCT00138970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935613|NCT00138970|Antifungal Agents|antifungal agents|mesh-ancestor
64935614|NCT00138970|Dermatologic Agents|dermatologic agents|mesh-ancestor
64935615|NCT00138970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64935616|NCT00138970|Immunologic Factors|immunologic factors|mesh-ancestor
64935617|NCT00138970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64935618|NCT00138970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64935619|NCT00139009|Cyclosporine|cyclosporine|mesh-list
64935620|NCT00139009|Cyclosporins|cyclosporins|mesh-list
64935621|NCT00139009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935622|NCT00139009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935623|NCT00139009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64935624|NCT00139009|Immunologic Factors|immunologic factors|mesh-ancestor
64935625|NCT00139009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935626|NCT00139009|Antifungal Agents|antifungal agents|mesh-ancestor
64935627|NCT00139009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64935628|NCT00139009|Dermatologic Agents|dermatologic agents|mesh-ancestor
64935629|NCT00139009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64935630|NCT00139009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64935631|NCT03890666|Albuterol|albuterol|mesh-list
64935632|NCT03890666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64935633|NCT03890666|Autonomic Agents|autonomic agents|mesh-ancestor
64935634|NCT03890666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64935635|NCT03890666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935636|NCT03890666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64935637|NCT03890666|Respiratory System Agents|respiratory system agents|mesh-ancestor
64935649|NCT00139165|Autonomic Agents|autonomic agents|mesh-ancestor
64935650|NCT00139165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64935651|NCT00139165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935652|NCT00139165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64935653|NCT00139165|Respiratory System Agents|respiratory system agents|mesh-ancestor
64991745|NCT04214249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991747|NCT04214067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64991748|NCT04214067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991751|NCT04190433|Spironolactone|spironolactone|mesh-list
64991752|NCT04190433|Pravastatin|pravastatin|mesh-list
64991753|NCT04190433|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64991754|NCT04190433|Hormone Antagonists|hormone antagonists|mesh-ancestor
64935654|NCT00139165|Glucocorticoids|glucocorticoids|mesh-ancestor
64935655|NCT00139165|Hormones|hormones|mesh-ancestor
64935656|NCT00139165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64935657|NCT00139204|Carbon-11 methionine|carbon-11 methionine|mesh-list
64935658|NCT00139204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64935659|NCT00139204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935660|NCT00139243|Leucovorin|leucovorin|mesh-list
64935661|NCT00139243|Fluorouracil|fluorouracil|mesh-list
64935662|NCT00139243|Docetaxel|docetaxel|mesh-list
64935816|NCT03150459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64935817|NCT03150459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64935818|NCT03150459|Antimetabolites|antimetabolites|mesh-ancestor
64935819|NCT03150459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935820|NCT03150459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64935821|NCT03150459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64935822|NCT03150459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935823|NCT03150459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64935824|NCT03150459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64704320|NCT02629094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935825|NCT03150459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64935826|NCT00140023|Azithromycin|azithromycin|mesh-list
64935827|NCT00140023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64935828|NCT00140023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64935829|NCT00140062|Latanoprost|latanoprost|mesh-list
64935859|NCT00140218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64935860|NCT00140257|Citalopram|citalopram|mesh-list
64935861|NCT00140257|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64935862|NCT00140257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64935863|NCT00140257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64935864|NCT00140257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935865|NCT00140257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64935866|NCT00140257|Serotonin Agents|serotonin agents|mesh-ancestor
64935867|NCT00140257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935868|NCT00140257|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64935869|NCT00140257|Antidepressive Agents|antidepressive agents|mesh-ancestor
64935870|NCT00140257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64935871|NCT00140296|Contraceptive Agents|contraceptive agents|mesh-list
64935872|NCT00140296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64935873|NCT00140296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935887|NCT00140530|Paclitaxel|paclitaxel|mesh-list
64935904|NCT00140569|Antiviral Agents|antiviral agents|mesh-ancestor
64935905|NCT00140569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64935906|NCT00140647|Rosiglitazone|rosiglitazone|mesh-list
64935907|NCT00140647|Ramipril|ramipril|mesh-list
64935908|NCT00140647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64935909|NCT00140647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935910|NCT00140647|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64935911|NCT00140647|Protease Inhibitors|protease inhibitors|mesh-ancestor
64935912|NCT00140647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935913|NCT00140647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935914|NCT00140647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64935915|NCT00140725|Interferons|interferons|mesh-list
64935916|NCT00140725|Interferon-alpha|interferon-alpha|mesh-list
64935917|NCT00140725|Lamivudine|lamivudine|mesh-list
64935918|NCT00140725|Interferon alpha-2|interferon alpha-2|mesh-list
64935919|NCT00140725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935920|NCT00140725|Antiviral Agents|antiviral agents|mesh-ancestor
64935921|NCT00140725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64935922|NCT00140725|Immunologic Factors|immunologic factors|mesh-ancestor
64935923|NCT00140725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935924|NCT00140725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64935925|NCT00140725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64935926|NCT00140725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935927|NCT00140725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935928|NCT00140725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64935929|NCT00140725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64935930|NCT00140764|Metronidazole|metronidazole|mesh-list
64935931|NCT00140764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64935952|NCT00140920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64935953|NCT00140920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935954|NCT00140920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64935955|NCT00140920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64935960|NCT03136497|Rituximab|rituximab|mesh-list
64935965|NCT03136497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935966|NCT03136497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64936010|NCT00141232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64936011|NCT00141232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64936012|NCT00141232|Antimetabolites|antimetabolites|mesh-ancestor
64936013|NCT00141232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936014|NCT00141232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64936015|NCT00141232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64936016|NCT00141232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936017|NCT02315534|Temozolomide|temozolomide|mesh-list
64936018|NCT02315534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64936019|NCT02315534|Alkylating Agents|alkylating agents|mesh-ancestor
64936020|NCT02315534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936021|NCT02315534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936022|NCT00141310|Sildenafil Citrate|sildenafil citrate|mesh-list
64936023|NCT00141310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936024|NCT00141310|Vasodilator Agents|vasodilator agents|mesh-ancestor
64936025|NCT00141310|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64936026|NCT00141310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64936027|NCT00141310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936029|NCT00141388|Pregabalin|pregabalin|mesh-list
64936063|NCT00404482|Immunologic Factors|immunologic factors|mesh-ancestor
64936064|NCT00404482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936065|NCT00404482|Antifungal Agents|antifungal agents|mesh-ancestor
64936066|NCT00404482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64936067|NCT00404482|Dermatologic Agents|dermatologic agents|mesh-ancestor
64936068|NCT00404482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64936069|NCT00404482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64936070|NCT03073941|Cimetidine|cimetidine|mesh-list
64936071|NCT03073941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64936072|NCT03073941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64936073|NCT03073941|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64936074|NCT03073941|Histamine Antagonists|histamine antagonists|mesh-ancestor
64936075|NCT03073941|Histamine Agents|histamine agents|mesh-ancestor
64936076|NCT03073941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64936077|NCT03073941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936078|NCT03073941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936079|NCT03073941|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64936080|NCT03073941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64936081|NCT03073941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936085|NCT00141427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64936086|NCT00141427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936087|NCT00141427|Anticonvulsants|anticonvulsants|mesh-ancestor
64936088|NCT00141427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64936089|NCT00141427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64936090|NCT00141427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936091|NCT00141427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64936092|NCT00141427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64936093|NCT00141427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64936094|NCT00141427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64936095|NCT00141427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64936096|NCT00141544|Methyltestosterone|methyltestosterone|mesh-list
64936097|NCT00141544|Estrogens|estrogens|mesh-list
64936098|NCT00141544|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
64936099|NCT00141544|Estrone|estrone|mesh-list
64936100|NCT00141544|Testosterone|testosterone|mesh-list
64936101|NCT00141544|Testosterone undecanoate|testosterone undecanoate|mesh-list
64936104|NCT00141544|Hormones|hormones|mesh-ancestor
64936105|NCT00141544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64936106|NCT00141544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936107|NCT00141544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64936135|NCT00141895|Misoprostol|misoprostol|mesh-list
64936136|NCT00141895|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64936137|NCT00141895|Abortifacient Agents|abortifacient agents|mesh-ancestor
64936138|NCT00141895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64936139|NCT00141895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936140|NCT00141895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64936141|NCT00141895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64936142|NCT00141895|Oxytocics|oxytocics|mesh-ancestor
64936143|NCT00142051|Nitric Oxide|nitric oxide|mesh-list
64936144|NCT00142051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64936145|NCT00142051|Autonomic Agents|autonomic agents|mesh-ancestor
64936146|NCT00142051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64936147|NCT00142051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936148|NCT00142051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64936149|NCT00142051|Respiratory System Agents|respiratory system agents|mesh-ancestor
64936150|NCT00142051|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64936242|NCT00142870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64936243|NCT00142870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64936244|NCT00142870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64936245|NCT00142870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64936246|NCT00142870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936247|NCT00142870|Dopamine Agents|dopamine agents|mesh-ancestor
64936248|NCT00142870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64936249|NCT00142870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936250|NCT00142870|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64936251|NCT00142870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64936423|NCT00143689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64936424|NCT00143689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64936425|NCT00143728|Lamivudine|lamivudine|mesh-list
64936426|NCT00143728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64936427|NCT00143728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64936428|NCT00143728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936429|NCT00143728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936430|NCT00143728|Antiviral Agents|antiviral agents|mesh-ancestor
64936431|NCT00143728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64936432|NCT00143728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64936433|NCT00143728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64936434|NCT00143806|Cyclosporine|cyclosporine|mesh-list
64936435|NCT00143806|Alefacept|alefacept|mesh-list
64936436|NCT00143806|Cyclosporins|cyclosporins|mesh-list
64936455|NCT00144118|Isoflurane|isoflurane|mesh-list
64936526|NCT00404716|Protective Agents|protective agents|mesh-ancestor
64936527|NCT00404716|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64936528|NCT00404716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64936529|NCT00404716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936530|NCT00404794|Mycophenolic Acid|mycophenolic acid|mesh-list
64936531|NCT00404794|Prednisolone|prednisolone|mesh-list
64936532|NCT00404794|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64936542|NCT00404794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64936543|NCT00404794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936544|NCT00404794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936545|NCT00404794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64936546|NCT00404794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936547|NCT00404794|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64936548|NCT00404794|Antitubercular Agents|antitubercular agents|mesh-ancestor
64936549|NCT00404794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64936550|NCT00404794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64936551|NCT00404794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64936552|NCT00404794|Glucocorticoids|glucocorticoids|mesh-ancestor
64936553|NCT00404794|Hormones|hormones|mesh-ancestor
64936554|NCT00404794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64936555|NCT00404794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64936556|NCT00404794|Antiemetics|antiemetics|mesh-ancestor
64936557|NCT00404794|Autonomic Agents|autonomic agents|mesh-ancestor
64936558|NCT00404794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64936559|NCT00404794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64936560|NCT00404794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64936561|NCT00404794|Protective Agents|protective agents|mesh-ancestor
64936562|NCT03191786|Gemcitabine|gemcitabine|mesh-list
64936563|NCT03191786|Atezolizumab|atezolizumab|mesh-list
64936564|NCT03191786|Vinorelbine|vinorelbine|mesh-list
64936565|NCT03191786|Antibodies|antibodies|mesh-list
64936566|NCT03191786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64936567|NCT03191786|Immunologic Factors|immunologic factors|mesh-ancestor
64936594|NCT00404833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64936595|NCT00404833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64936596|NCT00404833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936597|NCT00404833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936598|NCT00404833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64936599|NCT00404833|Glucocorticoids|glucocorticoids|mesh-ancestor
64936600|NCT00404833|Hormones|hormones|mesh-ancestor
64936601|NCT00404833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64936602|NCT00404833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936603|NCT00404833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64936604|NCT00404833|Antiemetics|antiemetics|mesh-ancestor
64936605|NCT00404833|Autonomic Agents|autonomic agents|mesh-ancestor
64936606|NCT00404833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64936607|NCT00404833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64936608|NCT00404833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64936640|NCT03128021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64936642|NCT03128021|Sensory System Agents|sensory system agents|mesh-ancestor
64936643|NCT01919619|Lenalidomide|lenalidomide|mesh-list
64936644|NCT01919619|Ipilimumab|ipilimumab|mesh-list
64936645|NCT01919619|Immunologic Factors|immunologic factors|mesh-ancestor
64705144|NCT02977286|Magnesium citrate|magnesium citrate|mesh-list
64936646|NCT01919619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936647|NCT01919619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64936648|NCT01919619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64936649|NCT01919619|Growth Substances|growth substances|mesh-ancestor
64936650|NCT01919619|Growth Inhibitors|growth inhibitors|mesh-ancestor
64936651|NCT01919619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936652|NCT01919619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64936653|NCT01919619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64936654|NCT01919619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334600|NCT03133195|Vitamin D|vitamin d|mesh-list
64991755|NCT04190433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64991756|NCT04190433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991757|NCT04190433|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64991758|NCT04190433|Diuretics|diuretics|mesh-ancestor
64991759|NCT04190433|Natriuretic Agents|natriuretic agents|mesh-ancestor
64991962|NCT04064697|Valganciclovir|valganciclovir|mesh-list
64334601|NCT03133195|Teriparatide|teriparatide|mesh-list
64334602|NCT03133195|Calcium|calcium|mesh-list
64334603|NCT03133195|Parathyroid Hormone|parathyroid hormone|mesh-list
64334604|NCT03133195|Vitamins|vitamins|mesh-ancestor
64334605|NCT03133195|Micronutrients|micronutrients|mesh-ancestor
64334606|NCT03133195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334607|NCT03133195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64334608|NCT03133195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64334609|NCT03159741|Glucagon|glucagon|mesh-list
64936696|NCT01807494|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64936789|NCT03092453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936790|NCT03092453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64936791|NCT03092453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64936792|NCT03092453|Alkylating Agents|alkylating agents|mesh-ancestor
64936793|NCT03092453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936794|NCT03092453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936795|NCT03092453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64936796|NCT03092453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64936798|NCT01807377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64936799|NCT01807377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64936800|NCT01807377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64936801|NCT01807377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936802|NCT01807377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64936803|NCT01807377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64936804|NCT01807377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64936805|NCT01807377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64936807|NCT01807377|Anesthetics|anesthetics|mesh-ancestor
64936829|NCT05468671|Anesthetics, General|anesthetics, general|mesh-ancestor
64936830|NCT05468671|Anesthetics|anesthetics|mesh-ancestor
64936831|NCT05468671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64936832|NCT05468671|Narcotics|narcotics|mesh-ancestor
64936833|NCT05468671|Analgesics|analgesics|mesh-ancestor
64936834|NCT05468671|Sensory System Agents|sensory system agents|mesh-ancestor
64936835|NCT05468671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64936836|NCT05468671|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64936837|NCT05468671|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64936838|NCT05468671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64936839|NCT05468671|Antidotes|antidotes|mesh-ancestor
64936840|NCT05468671|Protective Agents|protective agents|mesh-ancestor
64936841|NCT05468671|GABA Modulators|gaba modulators|mesh-ancestor
64936842|NCT05468671|GABA Agents|gaba agents|mesh-ancestor
64936843|NCT05468671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64991963|NCT04064697|Antiviral Agents|antiviral agents|mesh-ancestor
64991964|NCT04064697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64991968|NCT04036435|BMS-986165|bms-986165|mesh-list
64991969|NCT04036435|Dermatologic Agents|dermatologic agents|mesh-ancestor
64991970|NCT04036435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64991971|NCT04036435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991972|NCT04036435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991973|NCT04006288|Aspirin|aspirin|mesh-list
64991974|NCT04006288|Rivaroxaban|rivaroxaban|mesh-list
64991975|NCT04006288|Clopidogrel|clopidogrel|mesh-list
64936844|NCT05468671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936845|NCT03087071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64936846|NCT03087071|Panitumumab|panitumumab|mesh-list
64936848|NCT03087071|Antibodies|antibodies|mesh-list
64936849|NCT03087071|Immunoglobulins|immunoglobulins|mesh-list
64936850|NCT03087071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64936851|NCT03087071|Immunologic Factors|immunologic factors|mesh-ancestor
64936852|NCT03087071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936853|NCT03087071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936854|NCT03087071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64936855|NCT03087071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936857|NCT05461807|Rivaroxaban|rivaroxaban|mesh-list
64936919|NCT05374525|Cabotegravir|cabotegravir|mesh-list
64936920|NCT05374525|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64936921|NCT05374525|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64936922|NCT05374525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936924|NCT05374525|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64937070|NCT02739035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64937071|NCT02739035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64937072|NCT02739035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937073|NCT02739035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64937074|NCT02739035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64937075|NCT02739035|Analgesics|analgesics|mesh-ancestor
64937076|NCT02739035|Sensory System Agents|sensory system agents|mesh-ancestor
64937077|NCT02739035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64937078|NCT02739035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64937079|NCT02739035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64937080|NCT02739035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937081|NCT02739035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937082|NCT04958044|Calcium|calcium|mesh-list
64937085|NCT04953754|Melatonin|melatonin|mesh-list
64937107|NCT04861051|Sensory System Agents|sensory system agents|mesh-ancestor
64937108|NCT04861051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64937109|NCT04861051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937110|NCT04861051|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64937111|NCT04861051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64937112|NCT04861051|Anesthetics, General|anesthetics, general|mesh-ancestor
64937114|NCT04861051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64937115|NCT04861051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64937116|NCT04861051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64937117|NCT04861051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64937118|NCT04861051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937119|NCT01806363|Telmisartan|telmisartan|mesh-list
64937120|NCT01806363|Chlorthalidone|chlorthalidone|mesh-list
64937121|NCT01806363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64937122|NCT01806363|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64937123|NCT01806363|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64937124|NCT01806363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937125|NCT01806363|Diuretics|diuretics|mesh-ancestor
64937157|NCT02964403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64937158|NCT02964403|Gout Suppressants|gout suppressants|mesh-ancestor
64937159|NCT02964403|Tocolytic Agents|tocolytic agents|mesh-ancestor
64937160|NCT02964403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64937161|NCT02964403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64937162|NCT02964403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937163|NCT02964403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937164|NCT04749043|Nitrous Oxide|nitrous oxide|mesh-list
64937165|NCT04749043|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64937166|NCT04749043|Anesthetics, General|anesthetics, general|mesh-ancestor
64937167|NCT04749043|Anesthetics|anesthetics|mesh-ancestor
64705672|NCT04622839|Sensory System Agents|sensory system agents|mesh-ancestor
64937168|NCT04749043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64937169|NCT04749043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937170|NCT04749043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64937171|NCT04749043|Analgesics|analgesics|mesh-ancestor
64937172|NCT04749043|Sensory System Agents|sensory system agents|mesh-ancestor
64937173|NCT04749043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64937174|NCT00393393|Hylan|hylan|mesh-list
64937175|NCT00393393|Viscosupplements|viscosupplements|mesh-ancestor
64937176|NCT00393393|Protective Agents|protective agents|mesh-ancestor
64937177|NCT00393393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937178|NCT00405262|Ketorolac|ketorolac|mesh-list
64937179|NCT00405262|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64937180|NCT00405262|Bupivacaine|bupivacaine|mesh-list
64937181|NCT00405262|Anesthetics, Local|anesthetics, local|mesh-ancestor
64937182|NCT00405262|Anesthetics|anesthetics|mesh-ancestor
64937183|NCT00405262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64937184|NCT00405262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937185|NCT00405262|Sensory System Agents|sensory system agents|mesh-ancestor
64937186|NCT00405262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64937194|NCT00405262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937196|NCT00405301|Pyrazinamide|pyrazinamide|mesh-list
64937205|NCT00405301|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64937206|NCT00405301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64937207|NCT00405301|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64937208|NCT00405301|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64937209|NCT00405301|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64937210|NCT00405301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64937211|NCT00405340|Rituximab|rituximab|mesh-list
64937212|NCT00405340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64937213|NCT00405340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937214|NCT00405340|Immunologic Factors|immunologic factors|mesh-ancestor
64937215|NCT00405340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937216|NCT00405340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64937217|NCT04713319|Calcium|calcium|mesh-list
64937218|NCT04713319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64937219|NCT04713319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937220|NCT00393471|Etanercept|etanercept|mesh-list
64937222|NCT00393471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64937237|NCT02647892|Sensory System Agents|sensory system agents|mesh-ancestor
64937238|NCT02647892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64937239|NCT02647892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64937240|NCT02647892|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64937241|NCT02647892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64937242|NCT02647892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64937243|NCT02647892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937244|NCT02646683|Vedolizumab|vedolizumab|mesh-list
64937245|NCT02646683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64937247|NCT02593175|Carboplatin|carboplatin|mesh-list
64937248|NCT02593175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64937249|NCT02593175|Panitumumab|panitumumab|mesh-list
64937250|NCT02593175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64937251|NCT02593175|Antibodies|antibodies|mesh-list
64937252|NCT02593175|Immunoglobulins|immunoglobulins|mesh-list
64937253|NCT02593175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64937291|NCT04341181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64937292|NCT04341181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937293|NCT04341181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937294|NCT04341181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64937295|NCT04341181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64937296|NCT04341181|Tubulin Modulators|tubulin modulators|mesh-ancestor
64937297|NCT04341181|Antimitotic Agents|antimitotic agents|mesh-ancestor
64937298|NCT04341181|Mitosis Modulators|mitosis modulators|mesh-ancestor
64937299|NCT02423876|Hydromorphone|hydromorphone|mesh-list
64937300|NCT02423876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64937301|NCT02423876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937302|NCT02423876|Sensory System Agents|sensory system agents|mesh-ancestor
64937303|NCT02423876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64937304|NCT02423876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64937305|NCT02423876|Narcotics|narcotics|mesh-ancestor
64937306|NCT02423876|Analgesics|analgesics|mesh-ancestor
64937307|NCT02316002|Pembrolizumab|pembrolizumab|mesh-list
64937308|NCT02316002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64937310|NCT01805895|Minocycline|minocycline|mesh-list
64937390|NCT03969823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937391|NCT03969823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937392|NCT00391157|Dexamethasone|dexamethasone|mesh-list
64937394|NCT00391157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64937395|NCT00391157|Antiemetics|antiemetics|mesh-ancestor
64705907|NCT04054375|Prednisone|prednisone|mesh-list
64937396|NCT00391157|Autonomic Agents|autonomic agents|mesh-ancestor
64937397|NCT00391157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64937398|NCT00391157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937399|NCT00391157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64937400|NCT00391157|Glucocorticoids|glucocorticoids|mesh-ancestor
64937401|NCT00391157|Hormones|hormones|mesh-ancestor
64937402|NCT00391157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64937403|NCT00391157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64937404|NCT00391157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937405|NCT03781063|Fulvestrant|fulvestrant|mesh-list
64937443|NCT01903421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64937444|NCT01903421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64937445|NCT01903421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64937446|NCT03734731|Analgesics, Opioid|analgesics, opioid|mesh-list
64937447|NCT03734731|Narcotics|narcotics|mesh-ancestor
64937448|NCT03734731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64937449|NCT03734731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937450|NCT03734731|Analgesics|analgesics|mesh-ancestor
64937451|NCT03734731|Sensory System Agents|sensory system agents|mesh-ancestor
64937452|NCT03734731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64937453|NCT01902173|Trametinib|trametinib|mesh-list
64937454|NCT01902173|Dabrafenib|dabrafenib|mesh-list
64937455|NCT01902173|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
64937456|NCT01902173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937510|NCT01878617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64937511|NCT01878617|Antimetabolites|antimetabolites|mesh-ancestor
64937512|NCT01878617|Antiviral Agents|antiviral agents|mesh-ancestor
64937513|NCT01878617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64937514|NCT01878617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937515|NCT01878617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64937516|NCT01878617|Tubulin Modulators|tubulin modulators|mesh-ancestor
64937555|NCT02993029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64937556|NCT02993029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937557|NCT02993029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937558|NCT02825641|Oxytocin|oxytocin|mesh-list
64937559|NCT02825641|Dinoprostone|dinoprostone|mesh-list
64937560|NCT02825641|Oxytocics|oxytocics|mesh-ancestor
64937561|NCT02825641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64937562|NCT02825641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937563|NCT01646034|Gemcitabine|gemcitabine|mesh-list
64937564|NCT01646034|Paclitaxel|paclitaxel|mesh-list
64937565|NCT01646034|Docetaxel|docetaxel|mesh-list
64937566|NCT01646034|Cyclophosphamide|cyclophosphamide|mesh-list
64937567|NCT01646034|Carboplatin|carboplatin|mesh-list
64937568|NCT01646034|Doxorubicin|doxorubicin|mesh-list
64937569|NCT01646034|Thiotepa|thiotepa|mesh-list
64937570|NCT01646034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64937571|NCT01646034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937572|NCT01646034|Tubulin Modulators|tubulin modulators|mesh-ancestor
64937573|NCT01646034|Antimitotic Agents|antimitotic agents|mesh-ancestor
64937574|NCT01646034|Mitosis Modulators|mitosis modulators|mesh-ancestor
64937575|NCT01646034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937598|NCT02638519|Xenon|xenon|mesh-list
64937612|NCT01466517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64937613|NCT01466517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64937614|NCT01466517|Analgesics|analgesics|mesh-ancestor
64937615|NCT01466517|Sensory System Agents|sensory system agents|mesh-ancestor
64937616|NCT01466517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64991976|NCT04006288|Ticagrelor|ticagrelor|mesh-list
64991977|NCT04006288|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64991978|NCT04006288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64991979|NCT04006288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64991980|NCT04006288|Analgesics|analgesics|mesh-ancestor
64991981|NCT04006288|Sensory System Agents|sensory system agents|mesh-ancestor
64991982|NCT04006288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64991983|NCT04006288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937617|NCT01466517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937618|NCT01466517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64937619|NCT01466517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64937620|NCT01466517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64937621|NCT01466517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937622|NCT01466517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937623|NCT01466478|Calcitriol|calcitriol|mesh-list
64937624|NCT01466478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64706131|NCT04776096|Histamine Agents|histamine agents|mesh-ancestor
64937625|NCT01466478|Calcipotriene|calcipotriene|mesh-list
64937626|NCT01466478|Dermatologic Agents|dermatologic agents|mesh-ancestor
64937627|NCT01466478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64937628|NCT01466478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937629|NCT01466478|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64937630|NCT01466478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64937631|NCT01466478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937632|NCT01466478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64937633|NCT01466478|Vitamins|vitamins|mesh-ancestor
64937634|NCT01466478|Micronutrients|micronutrients|mesh-ancestor
64937635|NCT01466478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64937636|NCT01466478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64937637|NCT00063830|Alicaforsen|alicaforsen|mesh-list
64937638|NCT00063830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64937639|NCT00063830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64937640|NCT00063830|Immunologic Factors|immunologic factors|mesh-ancestor
64937641|NCT00063830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937653|NCT01466361|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64937655|NCT01466361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64937656|NCT01466361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937657|NCT01466361|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64937658|NCT01466361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64937659|NCT01466361|Cholinergic Agents|cholinergic agents|mesh-ancestor
64937669|NCT00001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64937670|NCT00001832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64937671|NCT00001832|Alkylating Agents|alkylating agents|mesh-ancestor
64937673|NCT00001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937706|NCT01466088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937707|NCT01466088|Cholinergic Agents|cholinergic agents|mesh-ancestor
64937708|NCT01466088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64937710|NCT01466088|Nootropic Agents|nootropic agents|mesh-ancestor
64937809|NCT00009815|Vitamins|vitamins|mesh-ancestor
64937810|NCT00009815|Micronutrients|micronutrients|mesh-ancestor
64937811|NCT00009815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64937812|NCT00009815|Antimetabolites|antimetabolites|mesh-ancestor
64937813|NCT01465815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64937814|NCT01465815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937815|NCT01465815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64937816|NCT01465815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937908|NCT01465503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64937909|NCT01465503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64937947|NCT01465074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64937948|NCT01465074|Autonomic Agents|autonomic agents|mesh-ancestor
64937949|NCT01465074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64937950|NCT01465074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937951|NCT01465074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64937952|NCT01465074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64937953|NCT01465074|Cholinergic Agents|cholinergic agents|mesh-ancestor
64937954|NCT01465074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64937955|NCT01465074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938002|NCT00010400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938003|NCT00010400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938004|NCT00010400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64938005|NCT01464840|Azithromycin|azithromycin|mesh-list
64938023|NCT01464723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938024|NCT01464723|Growth Inhibitors|growth inhibitors|mesh-ancestor
64938025|NCT01464723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938026|NCT01464606|Dactinomycin|dactinomycin|mesh-list
64938027|NCT01464606|Cyclophosphamide|cyclophosphamide|mesh-list
64938028|NCT01464606|Ifosfamide|ifosfamide|mesh-list
64938029|NCT01464606|Doxorubicin|doxorubicin|mesh-list
64938030|NCT01464606|Vincristine|vincristine|mesh-list
64938031|NCT01464606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64938032|NCT01464606|Immunologic Factors|immunologic factors|mesh-ancestor
64938033|NCT01464606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938034|NCT01464606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64938035|NCT01464606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64938036|NCT01464606|Alkylating Agents|alkylating agents|mesh-ancestor
64938037|NCT01464606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938038|NCT01464606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938039|NCT01464606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64938040|NCT01464606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64938041|NCT01464606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64938042|NCT01464606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64938043|NCT01464606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938044|NCT01464606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64938045|NCT01464606|Tubulin Modulators|tubulin modulators|mesh-ancestor
64938046|NCT01464606|Antimitotic Agents|antimitotic agents|mesh-ancestor
64938047|NCT01464606|Mitosis Modulators|mitosis modulators|mesh-ancestor
64938048|NCT01464606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64938049|NCT01464606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64938050|NCT01464606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64938051|NCT01464606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64938052|NCT01464528|Hyaluronic Acid|hyaluronic acid|mesh-list
64938053|NCT01464528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64938054|NCT01464528|Immunologic Factors|immunologic factors|mesh-ancestor
64938066|NCT01280994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64938067|NCT01280994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938069|NCT00011297|Lorazepam|lorazepam|mesh-list
64938070|NCT00011297|Analgesics|analgesics|mesh-ancestor
64938071|NCT00011297|Sensory System Agents|sensory system agents|mesh-ancestor
64938072|NCT00011297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64938073|NCT00011297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938074|NCT00011297|Anticonvulsants|anticonvulsants|mesh-ancestor
64938075|NCT00011297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64938076|NCT00011297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64938077|NCT00011297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64938078|NCT00011297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64938079|NCT00011297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64938080|NCT00011297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64938081|NCT00011297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64938082|NCT00011297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938083|NCT00011297|Antimanic Agents|antimanic agents|mesh-ancestor
64938084|NCT00011297|Antiemetics|antiemetics|mesh-ancestor
64938085|NCT00011297|Autonomic Agents|autonomic agents|mesh-ancestor
64938120|NCT00847860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64938121|NCT00847860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64938122|NCT00847860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64938123|NCT00847860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938124|NCT00847860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64938125|NCT00847860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64938126|NCT00847860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938127|NCT00847860|Antipyretics|antipyretics|mesh-ancestor
64938128|NCT00847860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64938129|NCT00847860|Autonomic Agents|autonomic agents|mesh-ancestor
64938130|NCT00847860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64938131|NCT00847860|Respiratory System Agents|respiratory system agents|mesh-ancestor
64938132|NCT00847860|Vasodilator Agents|vasodilator agents|mesh-ancestor
64938133|NCT00847860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64992001|NCT04006288|Protease Inhibitors|protease inhibitors|mesh-ancestor
64992002|NCT04006288|Anticoagulants|anticoagulants|mesh-ancestor
64992003|NCT03984448|Prednisone|prednisone|mesh-list
64992004|NCT03984448|Cortisone|cortisone|mesh-list
64992005|NCT03984448|Cyclophosphamide|cyclophosphamide|mesh-list
64992006|NCT03984448|Rituximab|rituximab|mesh-list
64992007|NCT03984448|Doxorubicin|doxorubicin|mesh-list
64992008|NCT03984448|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64992009|NCT03984448|Etoposide|etoposide|mesh-list
64938134|NCT00847860|Protective Agents|protective agents|mesh-ancestor
64938135|NCT00847860|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64938136|NCT00847860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64938137|NCT00847821|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64938138|NCT00847821|Bazedoxifene|bazedoxifene|mesh-list
64938139|NCT00847821|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64938171|NCT00011765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64938172|NCT00011765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938173|NCT00011804|Topiramate|topiramate|mesh-list
64938174|NCT00011804|Anticonvulsants|anticonvulsants|mesh-ancestor
64938175|NCT00011804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64938176|NCT00011804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938177|NCT00011921|Paclitaxel|paclitaxel|mesh-list
64938178|NCT00011921|Etoposide|etoposide|mesh-list
64938179|NCT00011921|Carboplatin|carboplatin|mesh-list
64938180|NCT00011921|Etoposide phosphate|etoposide phosphate|mesh-list
64938181|NCT00011921|Epirubicin|epirubicin|mesh-list
64938182|NCT00011921|Ifosfamide|ifosfamide|mesh-list
64938183|NCT00011921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64938184|NCT00011921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938185|NCT00011921|Tubulin Modulators|tubulin modulators|mesh-ancestor
64938186|NCT00011921|Antimitotic Agents|antimitotic agents|mesh-ancestor
64938187|NCT00011921|Mitosis Modulators|mitosis modulators|mesh-ancestor
64938188|NCT00011921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938189|NCT00011921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64938256|NCT00012194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938257|NCT00012194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64938258|NCT00012194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938260|NCT00012311|Cyclophosphamide|cyclophosphamide|mesh-list
64938271|NCT00012311|Immunologic Factors|immunologic factors|mesh-ancestor
64938272|NCT00012311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938273|NCT00012311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64938274|NCT00012311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64938275|NCT00012311|Alkylating Agents|alkylating agents|mesh-ancestor
64938276|NCT00012311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938277|NCT00012311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938278|NCT00012311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64938279|NCT00012311|Tubulin Modulators|tubulin modulators|mesh-ancestor
64938280|NCT00012311|Antimitotic Agents|antimitotic agents|mesh-ancestor
64938281|NCT00012311|Mitosis Modulators|mitosis modulators|mesh-ancestor
64938282|NCT00012311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64938283|NCT00012311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64938284|NCT00012311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64938285|NCT00012311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938286|NCT00012311|Antimetabolites|antimetabolites|mesh-ancestor
64938287|NCT00012311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64938288|NCT00012311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64938289|NCT00012311|Abortifacient Agents|abortifacient agents|mesh-ancestor
64938290|NCT00012311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64938291|NCT00012311|Dermatologic Agents|dermatologic agents|mesh-ancestor
64938292|NCT00012311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64938293|NCT00012311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64938294|NCT00012311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64938295|NCT00847002|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64938296|NCT00847002|Laxatives|laxatives|mesh-ancestor
64938297|NCT00847002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64938298|NCT00012350|Tipifarnib|tipifarnib|mesh-list
64706806|NCT02656069|Hormones|hormones|mesh-ancestor
64938314|NCT00846885|Serotonin Agents|serotonin agents|mesh-ancestor
64938315|NCT00846885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64938316|NCT00846885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992010|NCT03984448|Vincristine|vincristine|mesh-list
64992011|NCT03984448|Etoposide phosphate|etoposide phosphate|mesh-list
64992012|NCT03984448|Venetoclax|venetoclax|mesh-list
64938317|NCT00846885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938318|NCT00012467|Interferons|interferons|mesh-list
64938319|NCT00012467|Interferon-gamma|interferon-gamma|mesh-list
64938320|NCT00012467|Itraconazole|itraconazole|mesh-list
64938321|NCT00012467|Fluconazole|fluconazole|mesh-list
64938322|NCT00012467|Amphotericin B|amphotericin b|mesh-list
64938323|NCT00012467|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64938324|NCT00012467|Flucytosine|flucytosine|mesh-list
64938325|NCT00012467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938326|NCT00012467|Antiviral Agents|antiviral agents|mesh-ancestor
64938327|NCT00012467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64938328|NCT00012467|Antifungal Agents|antifungal agents|mesh-ancestor
64938329|NCT00012467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64938330|NCT00012467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64938331|NCT00012467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938332|NCT00012467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938333|NCT00012467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64938334|NCT00012467|Hormone Antagonists|hormone antagonists|mesh-ancestor
64938335|NCT00012467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64938367|NCT00012584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64938368|NCT00012584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64938369|NCT00012584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64938370|NCT00012584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64938371|NCT00012584|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64938372|NCT00012584|Serotonin Agents|serotonin agents|mesh-ancestor
64938373|NCT00012584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64938374|NCT00012584|Antidepressive Agents|antidepressive agents|mesh-ancestor
64938375|NCT00012584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64938376|NCT00012584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64938377|NCT00012584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938378|NCT00012584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64938379|NCT00846690|Lidocaine|lidocaine|mesh-list
64938380|NCT00846690|Phenylephrine|phenylephrine|mesh-list
64938381|NCT00846690|Benzocaine|benzocaine|mesh-list
64938382|NCT00846690|Tetracaine|tetracaine|mesh-list
64938387|NCT00846690|Sensory System Agents|sensory system agents|mesh-ancestor
64938388|NCT00846690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64938389|NCT00846690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64938390|NCT00846690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64938391|NCT00846690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64938392|NCT00846690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64938393|NCT00846690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938394|NCT00846690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64938395|NCT00846690|Mydriatics|mydriatics|mesh-ancestor
64938396|NCT00846690|Autonomic Agents|autonomic agents|mesh-ancestor
64938397|NCT00846690|Sympathomimetics|sympathomimetics|mesh-ancestor
64938398|NCT00846690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64938399|NCT00846690|Nasal Decongestants|nasal decongestants|mesh-ancestor
64938400|NCT00846690|Respiratory System Agents|respiratory system agents|mesh-ancestor
64938401|NCT00846690|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64938402|NCT00846690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64938403|NCT00846690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64938404|NCT00846690|Adrenergic Agents|adrenergic agents|mesh-ancestor
64938405|NCT00846690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64938406|NCT00846690|Protective Agents|protective agents|mesh-ancestor
64938407|NCT00846651|Phenylephrine|phenylephrine|mesh-list
64938408|NCT00846651|Oxymetazoline|oxymetazoline|mesh-list
64938409|NCT00846651|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64938410|NCT00846651|Mydriatics|mydriatics|mesh-ancestor
64938411|NCT00846651|Autonomic Agents|autonomic agents|mesh-ancestor
64938412|NCT00846651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64938413|NCT00846651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938463|NCT00846339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64938464|NCT00846339|Antidepressive Agents|antidepressive agents|mesh-ancestor
64938465|NCT00846339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64938466|NCT00846339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64938467|NCT00846339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64938468|NCT00846339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64938470|NCT00846339|Dopamine Agents|dopamine agents|mesh-ancestor
64938507|NCT00845910|Capecitabine|capecitabine|mesh-list
64938508|NCT00845910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64938509|NCT00845910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938510|NCT00845910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64938511|NCT00845910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64938512|NCT00845910|Growth Substances|growth substances|mesh-ancestor
64938513|NCT00845910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938514|NCT00845910|Growth Inhibitors|growth inhibitors|mesh-ancestor
64938515|NCT00845910|Tubulin Modulators|tubulin modulators|mesh-ancestor
64938516|NCT00845910|Antimitotic Agents|antimitotic agents|mesh-ancestor
64938517|NCT00845910|Mitosis Modulators|mitosis modulators|mesh-ancestor
64938518|NCT00845910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938520|NCT00845910|Antimetabolites|antimetabolites|mesh-ancestor
64938571|NCT00277017|Growth Substances|growth substances|mesh-ancestor
64938572|NCT00277017|Growth Inhibitors|growth inhibitors|mesh-ancestor
64938573|NCT00276978|Aripiprazole|aripiprazole|mesh-list
64938574|NCT00276978|Antidepressive Agents|antidepressive agents|mesh-ancestor
64938575|NCT00276978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64938576|NCT00276978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64938577|NCT00276978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64938578|NCT00276978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64938579|NCT00276978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938580|NCT00276978|Dopamine Agonists|dopamine agonists|mesh-ancestor
64938581|NCT00276978|Dopamine Agents|dopamine agents|mesh-ancestor
64938582|NCT00276978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64938583|NCT00276978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938584|NCT00276978|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64938589|NCT00276978|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64938590|NCT00276978|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64938591|NCT00276900|Sertraline|sertraline|mesh-list
64938592|NCT00276900|Antidepressive Agents|antidepressive agents|mesh-ancestor
64938593|NCT00276900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64938594|NCT00276900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64938595|NCT00276900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64938596|NCT00276900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64938597|NCT00276900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938598|NCT00276900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64938613|NCT00013871|Vaccines|vaccines|mesh-list
64938616|NCT00013871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938617|NCT00276783|Pemetrexed|pemetrexed|mesh-list
64938618|NCT00276783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938619|NCT00276783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938620|NCT00276783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938621|NCT00276783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64938622|NCT00276783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64938623|NCT00276705|Thalidomide|thalidomide|mesh-list
64938624|NCT00276705|Cyclophosphamide|cyclophosphamide|mesh-list
64938625|NCT00276705|Doxorubicin|doxorubicin|mesh-list
64938626|NCT00276705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64938627|NCT00276705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64938628|NCT00276705|Immunologic Factors|immunologic factors|mesh-ancestor
64938629|NCT00276705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938630|NCT00276705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64938631|NCT00276705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64938688|NCT00276588|Immunologic Factors|immunologic factors|mesh-ancestor
64938689|NCT00276588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938725|NCT00014339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64938726|NCT00014339|Glucocorticoids|glucocorticoids|mesh-ancestor
64938727|NCT00014339|Hormones|hormones|mesh-ancestor
64938728|NCT00014339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64938729|NCT00014339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938730|NCT00014339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64938731|NCT00014339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938732|NCT00014339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64938733|NCT00014339|Alkylating Agents|alkylating agents|mesh-ancestor
64938734|NCT00014339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938735|NCT00014339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64938736|NCT00014339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64938737|NCT00014339|Immunologic Factors|immunologic factors|mesh-ancestor
64938738|NCT00014456|Gemcitabine|gemcitabine|mesh-list
64938739|NCT00014456|Docetaxel|docetaxel|mesh-list
64938740|NCT00014456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64938741|NCT00014456|Antimetabolites|antimetabolites|mesh-ancestor
64938753|NCT00276393|Insulin|insulin|mesh-list
64938781|NCT00014573|Mitosis Modulators|mitosis modulators|mesh-ancestor
64938782|NCT00014573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938842|NCT00276081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64938843|NCT00276081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64938844|NCT00276081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64938845|NCT00276081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938846|NCT00276081|Antimanic Agents|antimanic agents|mesh-ancestor
64938847|NCT00276081|Hormones|hormones|mesh-ancestor
64938848|NCT00276081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64938849|NCT00276003|Gemcitabine|gemcitabine|mesh-list
64938890|NCT00015080|Sensory System Agents|sensory system agents|mesh-ancestor
64938891|NCT00015080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64938892|NCT00015236|Amantadine|amantadine|mesh-list
64938893|NCT00015236|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64938894|NCT00015236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64938895|NCT00015236|Antiviral Agents|antiviral agents|mesh-ancestor
64707417|NCT05315947|Brivaracetam|brivaracetam|mesh-list
64938896|NCT00015236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64938897|NCT00015236|Dopamine Agents|dopamine agents|mesh-ancestor
64938898|NCT00015236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64938899|NCT00015236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938900|NCT00015236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938901|NCT00015236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64938902|NCT00015236|Analgesics|analgesics|mesh-ancestor
64938903|NCT00015236|Sensory System Agents|sensory system agents|mesh-ancestor
64938904|NCT00015236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64938947|NCT00275613|Immunologic Factors|immunologic factors|mesh-ancestor
64938948|NCT00275613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938949|NCT00275613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64938950|NCT00015548|Olanzapine|olanzapine|mesh-list
64938951|NCT00015548|Risperidone|risperidone|mesh-list
64938952|NCT00015548|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64938953|NCT00015548|Citalopram|citalopram|mesh-list
64938954|NCT00015548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64938955|NCT00015548|Serotonin Agents|serotonin agents|mesh-ancestor
64938956|NCT00015548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64938959|NCT00015548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64938960|NCT00015548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64938961|NCT00015548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64938962|NCT00015548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64938963|NCT00015548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64938964|NCT00015548|Dopamine Agents|dopamine agents|mesh-ancestor
64938965|NCT00015548|Antiemetics|antiemetics|mesh-ancestor
64939006|NCT00015665|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64939007|NCT00015665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64939008|NCT00015665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939009|NCT00015665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939010|NCT00015665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64939011|NCT00015665|Hormone Antagonists|hormone antagonists|mesh-ancestor
64939012|NCT00015665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64939013|NCT00015665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939014|NCT00015665|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64939015|NCT00275457|Pramipexole|pramipexole|mesh-list
64939016|NCT00275457|Antioxidants|antioxidants|mesh-ancestor
64939017|NCT00275457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939018|NCT00275457|Protective Agents|protective agents|mesh-ancestor
64939019|NCT00275457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939020|NCT00275457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64939021|NCT00275457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64939022|NCT00275457|Dopamine Agonists|dopamine agonists|mesh-ancestor
64939062|NCT00015821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64939063|NCT00015821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64939069|NCT00275184|Antiemetics|antiemetics|mesh-ancestor
64939085|NCT00015860|Hormones|hormones|mesh-ancestor
64939086|NCT00015860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64939087|NCT00015860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939088|NCT00015860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64939089|NCT00015860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939111|NCT00275106|Vincristine|vincristine|mesh-list
64939112|NCT00275106|Daunorubicin|daunorubicin|mesh-list
64939113|NCT00275106|Asparaginase|asparaginase|mesh-list
64939114|NCT00275106|Mercaptopurine|mercaptopurine|mesh-list
64939115|NCT00275106|Thioguanine|thioguanine|mesh-list
64939116|NCT00275106|Levoleucovorin|levoleucovorin|mesh-list
64939117|NCT00275106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64939118|NCT00275106|Immunologic Factors|immunologic factors|mesh-ancestor
64939119|NCT00275106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939120|NCT00275106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64939121|NCT00275106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64939122|NCT00275106|Alkylating Agents|alkylating agents|mesh-ancestor
64939123|NCT00275106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939124|NCT00275106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939125|NCT00275106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64939126|NCT00275106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64939127|NCT00275106|Antiemetics|antiemetics|mesh-ancestor
64939128|NCT00275106|Autonomic Agents|autonomic agents|mesh-ancestor
64939129|NCT00275106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64939130|NCT00275106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64939131|NCT00275106|Glucocorticoids|glucocorticoids|mesh-ancestor
64939132|NCT00275106|Hormones|hormones|mesh-ancestor
64939133|NCT00275106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64939134|NCT00275106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64939135|NCT00275106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64939136|NCT00275106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64939137|NCT00275106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64939160|NCT00015938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939161|NCT00015938|Tubulin Modulators|tubulin modulators|mesh-ancestor
64939162|NCT00015938|Antimitotic Agents|antimitotic agents|mesh-ancestor
64939163|NCT00015938|Mitosis Modulators|mitosis modulators|mesh-ancestor
64939164|NCT00015938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939165|NCT00015938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64939166|NCT00275067|Temozolomide|temozolomide|mesh-list
64939167|NCT00275067|Arsenic Trioxide|arsenic trioxide|mesh-list
64939168|NCT00275067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64939169|NCT00275067|Alkylating Agents|alkylating agents|mesh-ancestor
64939170|NCT00275067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939171|NCT00275067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939172|NCT00274989|Rituximab|rituximab|mesh-list
64939173|NCT00274989|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64939208|NCT01678586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64939210|NCT01678586|Anesthetics|anesthetics|mesh-ancestor
64939211|NCT01678586|Antiemetics|antiemetics|mesh-ancestor
64939212|NCT01678586|Autonomic Agents|autonomic agents|mesh-ancestor
64939213|NCT01678586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64939266|NCT00130455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64939267|NCT00016055|Temozolomide|temozolomide|mesh-list
64939268|NCT00016055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64939269|NCT00016055|Alkylating Agents|alkylating agents|mesh-ancestor
64939270|NCT00016055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939271|NCT00016055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939272|NCT00016094|Bevacizumab|bevacizumab|mesh-list
64939273|NCT00016094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64939274|NCT00016094|Antibodies|antibodies|mesh-list
64939275|NCT00016094|Immunoglobulins|immunoglobulins|mesh-list
64939276|NCT00016094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64939277|NCT00016094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939278|NCT00016094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64939279|NCT00016094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64939301|NCT00016133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64939302|NCT00016133|Antimetabolites|antimetabolites|mesh-ancestor
64939303|NCT00016133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939304|NCT00016133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64939305|NCT00016133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939306|NCT00016133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64939307|NCT00016133|Antidotes|antidotes|mesh-ancestor
64939308|NCT00016133|Protective Agents|protective agents|mesh-ancestor
64939309|NCT00016133|Vitamin B Complex|vitamin b complex|mesh-ancestor
64939310|NCT00016133|Vitamins|vitamins|mesh-ancestor
64939311|NCT00016133|Micronutrients|micronutrients|mesh-ancestor
64939312|NCT00016133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64939313|NCT00016172|Doxorubicin|doxorubicin|mesh-list
64939314|NCT00016172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64939315|NCT00016172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64939316|NCT00016172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939317|NCT00016172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64939318|NCT00016172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64939333|NCT00394368|Xhance|xhance|mesh-list
64939357|NCT01441349|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64939358|NCT01441349|Antimetabolites|antimetabolites|mesh-ancestor
64992013|NCT03984448|Podophyllotoxin|podophyllotoxin|mesh-list
64992014|NCT03984448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64992015|NCT03984448|Antibodies|antibodies|mesh-list
64992016|NCT03984448|Immunoglobulins|immunoglobulins|mesh-list
64992017|NCT03984448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64992018|NCT03984448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64992019|NCT03984448|Immunologic Factors|immunologic factors|mesh-ancestor
64939359|NCT01441349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939360|NCT01441349|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64939361|NCT01441349|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64939362|NCT01441349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939363|NCT00394407|Insulin|insulin|mesh-list
64939364|NCT00394407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64939365|NCT00394407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64939366|NCT00394407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939367|NCT00130143|Amifostine|amifostine|mesh-list
64939368|NCT00130143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64939369|NCT00130143|Protective Agents|protective agents|mesh-ancestor
64939370|NCT00130143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939371|NCT00016289|Interleukin-12|interleukin-12|mesh-list
64939372|NCT00016289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64939373|NCT00016289|Immunologic Factors|immunologic factors|mesh-ancestor
64939374|NCT00016289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939375|NCT00016289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64939376|NCT00016289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64939377|NCT00016289|Growth Substances|growth substances|mesh-ancestor
64939378|NCT00016289|Growth Inhibitors|growth inhibitors|mesh-ancestor
64939379|NCT00016289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939380|NCT00130065|Folic Acid|folic acid|mesh-list
64939381|NCT00130065|Pyrimethamine|pyrimethamine|mesh-list
64939382|NCT00130065|Sulfadoxine|sulfadoxine|mesh-list
64939384|NCT00130065|Hematinics|hematinics|mesh-ancestor
64939406|NCT00016328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939407|NCT00130026|Caffeine|caffeine|mesh-list
64939408|NCT00130026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64939409|NCT00130026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939410|NCT00130026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64939411|NCT00130026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939412|NCT00130026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992020|NCT03984448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992021|NCT03984448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64992022|NCT03984448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64992023|NCT03984448|Alkylating Agents|alkylating agents|mesh-ancestor
64992033|NCT03984448|Hormones|hormones|mesh-ancestor
64992059|NCT03970096|Alkylating Agents|alkylating agents|mesh-ancestor
64992188|NCT03914625|Vincristine|vincristine|mesh-list
64992189|NCT03914625|Asparaginase|asparaginase|mesh-list
64992190|NCT03914625|Mercaptopurine|mercaptopurine|mesh-list
64992191|NCT03914625|Pegaspargase|pegaspargase|mesh-list
64939413|NCT00130026|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64939414|NCT00130026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64939415|NCT00130026|Purinergic Agents|purinergic agents|mesh-ancestor
64939416|NCT00130026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64939417|NCT00016367|Gemcitabine|gemcitabine|mesh-list
64939418|NCT00016367|Cisplatin|cisplatin|mesh-list
64939419|NCT00016367|Trastuzumab|trastuzumab|mesh-list
64939420|NCT00016367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939421|NCT00016367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64939422|NCT00016367|Antimetabolites|antimetabolites|mesh-ancestor
64939423|NCT00016367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939463|NCT00129753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64939464|NCT00129753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939465|NCT00016523|Nitric Oxide|nitric oxide|mesh-list
64939466|NCT00016523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64939467|NCT00016523|Autonomic Agents|autonomic agents|mesh-ancestor
64939468|NCT00016523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64939469|NCT00016523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939470|NCT00016523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64939471|NCT00016523|Respiratory System Agents|respiratory system agents|mesh-ancestor
64939472|NCT00016523|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64939473|NCT00016523|Antioxidants|antioxidants|mesh-ancestor
64939474|NCT00016523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939475|NCT00016523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64939476|NCT00016523|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64939477|NCT00016523|Vasodilator Agents|vasodilator agents|mesh-ancestor
64939478|NCT00016523|Gasotransmitters|gasotransmitters|mesh-ancestor
64939479|NCT00016523|Protective Agents|protective agents|mesh-ancestor
64939536|NCT00129519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939537|NCT00129519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939573|NCT00016952|Vitamins|vitamins|mesh-ancestor
64939574|NCT00016952|Micronutrients|micronutrients|mesh-ancestor
64939575|NCT00129363|Carvedilol|carvedilol|mesh-list
64939576|NCT00129363|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64939577|NCT00129363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64939578|NCT00129363|Adrenergic Agents|adrenergic agents|mesh-ancestor
64939579|NCT00129363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64708079|NCT05377424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939580|NCT00129363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939581|NCT00129363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939582|NCT00129363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64939584|NCT00129363|Protective Agents|protective agents|mesh-ancestor
64939585|NCT00129363|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64939586|NCT00129363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64939587|NCT00129363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64939588|NCT00129363|Vasodilator Agents|vasodilator agents|mesh-ancestor
64939589|NCT00129363|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64939590|NCT00129363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64939591|NCT00016991|Gefitinib|gefitinib|mesh-list
64939592|NCT00016991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939593|NCT00016991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64939594|NCT00016991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939595|NCT00016991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939596|NCT00017030|Trabectedin|trabectedin|mesh-list
64939597|NCT00017030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64939598|NCT00017030|Alkylating Agents|alkylating agents|mesh-ancestor
64939599|NCT00017030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939600|NCT00017030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939601|NCT00017069|Dexamethasone|dexamethasone|mesh-list
64939602|NCT00017069|Arsenic Trioxide|arsenic trioxide|mesh-list
64939603|NCT00017069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64939614|NCT00129285|Modafinil|modafinil|mesh-list
64992192|NCT03914625|Thioguanine|thioguanine|mesh-list
64992193|NCT03914625|Blinatumomab|blinatumomab|mesh-list
64992194|NCT03914625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64992195|NCT03914625|Muromonab-CD3|muromonab-cd3|mesh-list
64992196|NCT03914625|Antibodies|antibodies|mesh-list
64992197|NCT03914625|Immunoglobulins|immunoglobulins|mesh-list
64939615|NCT00129285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64939616|NCT00129285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939617|NCT00129285|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64939618|NCT00129285|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64939619|NCT00129285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64939620|NCT00129285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939621|NCT00017108|Cyclophosphamide|cyclophosphamide|mesh-list
64939622|NCT00017108|Chlorambucil|chlorambucil|mesh-list
64939623|NCT00017108|Fludarabine|fludarabine|mesh-list
64939624|NCT00017108|Fludarabine phosphate|fludarabine phosphate|mesh-list
64939625|NCT00017108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64939626|NCT00017108|Immunologic Factors|immunologic factors|mesh-ancestor
64939627|NCT00017108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939628|NCT00017108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64939629|NCT00017108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64939630|NCT00017108|Alkylating Agents|alkylating agents|mesh-ancestor
64939632|NCT00017108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939757|NCT00128895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64939758|NCT00017303|Paclitaxel|paclitaxel|mesh-list
64939759|NCT00017303|Carboplatin|carboplatin|mesh-list
64939760|NCT00017303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64939761|NCT00017303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939762|NCT00017303|Tubulin Modulators|tubulin modulators|mesh-ancestor
64939766|NCT00017342|Cytarabine|cytarabine|mesh-list
64939773|NCT00017342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64939774|NCT00017342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64939775|NCT00017342|Immunologic Factors|immunologic factors|mesh-ancestor
64939776|NCT00017342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939777|NCT00017342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64939779|NCT00128739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64939780|NCT00128739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64939781|NCT00128739|Autonomic Agents|autonomic agents|mesh-ancestor
64939782|NCT00128739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64939783|NCT00128739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939784|NCT00128739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64939785|NCT00128739|Respiratory System Agents|respiratory system agents|mesh-ancestor
64939786|NCT00128739|Glucocorticoids|glucocorticoids|mesh-ancestor
64939787|NCT00128739|Hormones|hormones|mesh-ancestor
64939788|NCT00128739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64939789|NCT00017381|Cyclophosphamide|cyclophosphamide|mesh-list
64939790|NCT00017381|Rituximab|rituximab|mesh-list
64939791|NCT00017381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64939792|NCT00017381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64939793|NCT00017381|Immunologic Factors|immunologic factors|mesh-ancestor
64939794|NCT00017381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939795|NCT00017381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64939796|NCT00017381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64939830|NCT00017498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939831|NCT00128544|Telbivudine|telbivudine|mesh-list
64939832|NCT00128544|Antiviral Agents|antiviral agents|mesh-ancestor
64939833|NCT00128544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64939834|NCT00128544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64939835|NCT00128544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939836|NCT00128544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939837|NCT00128505|Mifepristone|mifepristone|mesh-list
64939838|NCT00128505|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64939839|NCT00128505|Abortifacient Agents|abortifacient agents|mesh-ancestor
64939840|NCT00128505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64939841|NCT00128505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939842|NCT00128505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64939843|NCT00128505|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64939844|NCT00128505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64939845|NCT00128505|Contraceptive Agents|contraceptive agents|mesh-ancestor
64939846|NCT00128505|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64939847|NCT00128505|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64939848|NCT00128505|Hormone Antagonists|hormone antagonists|mesh-ancestor
64939849|NCT00128505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64939850|NCT00128505|Luteolytic Agents|luteolytic agents|mesh-ancestor
64939851|NCT00128505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64939852|NCT00128505|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64939858|NCT00017576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64939859|NCT00017576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64939860|NCT00017576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939861|NCT00017576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64992198|NCT03914625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64992199|NCT03914625|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64992200|NCT03914625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64992201|NCT03914625|Prednisolone phosphate|prednisolone phosphate|mesh-list
64992202|NCT03914625|BB 1101|bb 1101|mesh-list
64992203|NCT03914625|Calcium|calcium|mesh-list
64992204|NCT03914625|2-Aminopurine|2-aminopurine|mesh-list
64992205|NCT03914625|Levoleucovorin|levoleucovorin|mesh-list
64992206|NCT03914625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64992207|NCT03914625|Immunologic Factors|immunologic factors|mesh-ancestor
64992208|NCT03914625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992209|NCT03914625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64992210|NCT03914625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64992254|NCT03914612|Pembrolizumab|pembrolizumab|mesh-list
64992255|NCT03914612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64992283|NCT03907488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992284|NCT03907488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939863|NCT00017576|Micronutrients|micronutrients|mesh-ancestor
64939864|NCT00017576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64939865|NCT00017654|Cyclosporine|cyclosporine|mesh-list
64939866|NCT00017654|Methylprednisolone|methylprednisolone|mesh-list
64939867|NCT00017654|Cyclophosphamide|cyclophosphamide|mesh-list
64939868|NCT00017654|Cyclosporins|cyclosporins|mesh-list
64939869|NCT00017654|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64939870|NCT00017654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64939871|NCT00017654|Immunologic Factors|immunologic factors|mesh-ancestor
64939872|NCT00017654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939873|NCT00017654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64939874|NCT00017654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64939875|NCT00017654|Alkylating Agents|alkylating agents|mesh-ancestor
64945553|NCT05450692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939885|NCT00017654|Antiemetics|antiemetics|mesh-ancestor
64939911|NCT00394485|Adrenergic Agents|adrenergic agents|mesh-ancestor
64939912|NCT00017693|Interleukin-4|interleukin-4|mesh-list
64939913|NCT00017693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64939914|NCT00017693|Immunologic Factors|immunologic factors|mesh-ancestor
64939915|NCT00017693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939916|NCT00017693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939917|NCT00017693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64939918|NCT00128466|Gentamicins|gentamicins|mesh-list
64939919|NCT00128466|Streptomycin|streptomycin|mesh-list
64939920|NCT00128466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64939921|NCT00128466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64939923|NCT00128466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939976|NCT00018642|Dopamine Agents|dopamine agents|mesh-ancestor
64939977|NCT00018642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64939978|NCT00018642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939979|NCT00018642|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64939980|NCT00018083|Efavirenz|efavirenz|mesh-list
64939981|NCT00018083|Isoniazid|isoniazid|mesh-list
64939982|NCT00018083|Rifabutin|rifabutin|mesh-list
64939983|NCT00018083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64939984|NCT00018083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64939985|NCT00018083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939986|NCT00018083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992285|NCT03907488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64992286|NCT03907488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64939987|NCT00018083|Antiviral Agents|antiviral agents|mesh-ancestor
64939988|NCT00018083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64939989|NCT00018083|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64939990|NCT00018083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64939991|NCT00018083|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64939992|NCT00018083|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64939993|NCT00018083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64939994|NCT00018083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64939995|NCT00018083|Antitubercular Agents|antitubercular agents|mesh-ancestor
64939996|NCT00018083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64939997|NCT00018083|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64939998|NCT00018083|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64939999|NCT00018083|Antimetabolites|antimetabolites|mesh-ancestor
64940000|NCT00018083|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64940001|NCT00018083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64940002|NCT00018161|Mecamylamine|mecamylamine|mesh-list
64940003|NCT00018161|Nicotine|nicotine|mesh-list
64940004|NCT00018161|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64940005|NCT00018161|Autonomic Agents|autonomic agents|mesh-ancestor
64940006|NCT00018161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64940008|NCT00018161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64940016|NCT00018161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64940017|NCT00018200|Benztropine|benztropine|mesh-list
64940018|NCT00018200|Fluoxetine|fluoxetine|mesh-list
64940019|NCT00018200|Desipramine|desipramine|mesh-list
64940020|NCT00018200|Clomipramine|clomipramine|mesh-list
64940021|NCT00018200|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64940022|NCT00018200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64940023|NCT00018200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64940024|NCT00018200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945554|NCT05450692|Tubulin Modulators|tubulin modulators|mesh-ancestor
64708523|NCT04330040|Olaparib|olaparib|mesh-list
64940025|NCT00018200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64940026|NCT00018200|Serotonin Agents|serotonin agents|mesh-ancestor
64992287|NCT03907488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64992288|NCT03907488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992289|NCT03907488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992290|NCT03907488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64992291|NCT03907488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64940027|NCT00018200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940028|NCT00018200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64940029|NCT00018200|Antidepressive Agents|antidepressive agents|mesh-ancestor
64940030|NCT00018200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64940031|NCT00018200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64940032|NCT00018200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64940033|NCT00018200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64940067|NCT04734353|Purinergic Agents|purinergic agents|mesh-ancestor
64940068|NCT04734353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64940069|NCT04734353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940070|NCT04734353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940071|NCT00018954|Cytarabine|cytarabine|mesh-list
64940072|NCT00018954|Prednisone|prednisone|mesh-list
64940073|NCT00018954|Cyclophosphamide|cyclophosphamide|mesh-list
64940074|NCT00018954|Ifosfamide|ifosfamide|mesh-list
64940075|NCT00018954|Doxorubicin|doxorubicin|mesh-list
64940076|NCT00018954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64940077|NCT00018954|Methotrexate|methotrexate|mesh-list
64940078|NCT00018954|Etoposide|etoposide|mesh-list
64940079|NCT00018954|Vincristine|vincristine|mesh-list
64940080|NCT00018954|Daunorubicin|daunorubicin|mesh-list
64940081|NCT00018954|Asparaginase|asparaginase|mesh-list
64940082|NCT00018954|Mercaptopurine|mercaptopurine|mesh-list
64940083|NCT00018954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64940084|NCT00018954|Immunologic Factors|immunologic factors|mesh-ancestor
64940085|NCT00018954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940086|NCT00018954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64940087|NCT00018954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64940088|NCT00018954|Alkylating Agents|alkylating agents|mesh-ancestor
64940089|NCT00018954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940090|NCT00018954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940118|NCT00018278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940119|NCT00018278|Cholinergic Agents|cholinergic agents|mesh-ancestor
64940120|NCT00018278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64940121|NCT00018278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992292|NCT03907488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64992341|NCT03843645|Anesthetics|anesthetics|mesh-list
64992342|NCT03843645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64940122|NCT00018278|Nootropic Agents|nootropic agents|mesh-ancestor
64940123|NCT00019032|Antibodies|antibodies|mesh-list
64940124|NCT00019032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64940125|NCT00019032|Immunologic Factors|immunologic factors|mesh-ancestor
64940127|NCT00019071|Cladribine|cladribine|mesh-list
64940188|NCT00018551|Micronutrients|micronutrients|mesh-ancestor
64940189|NCT00018551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940190|NCT00019461|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
64940191|NCT00019461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940192|NCT00019461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64940193|NCT00019461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64940194|NCT00019461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940195|NCT00019461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64940196|NCT00019461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940197|NCT00019500|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64940198|NCT00019500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64940199|NCT00019500|Hormone Antagonists|hormone antagonists|mesh-ancestor
64940200|NCT00019500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64940201|NCT00019500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940202|NCT00019500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64940203|NCT00019500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64940204|NCT00019500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64940205|NCT00019539|Thalidomide|thalidomide|mesh-list
64940206|NCT00019539|Bevacizumab|bevacizumab|mesh-list
64940239|NCT00019734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64940240|NCT00019734|Antiviral Agents|antiviral agents|mesh-ancestor
64940241|NCT00019734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64940242|NCT04146935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64940243|NCT04146935|Immunologic Factors|immunologic factors|mesh-ancestor
64940244|NCT04146935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940245|NCT00019773|Capecitabine|capecitabine|mesh-list
64940246|NCT00019773|Oxaliplatin|oxaliplatin|mesh-list
64992343|NCT03843645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992344|NCT03842228|Durvalumab|durvalumab|mesh-list
64992345|NCT03842228|Olaparib|olaparib|mesh-list
64992346|NCT03842228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64992347|NCT03842228|Immunoglobulins|immunoglobulins|mesh-list
64992520|NCT03643822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64992521|NCT03643822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992522|NCT03643822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64992523|NCT03643822|Glucocorticoids|glucocorticoids|mesh-ancestor
64992743|NCT03321643|Oxaliplatin|oxaliplatin|mesh-list
64992744|NCT03321643|Atezolizumab|atezolizumab|mesh-list
64940247|NCT00019773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64940248|NCT00019773|Antimetabolites|antimetabolites|mesh-ancestor
64940249|NCT00019773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940250|NCT00019773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940251|NCT03370406|Fluorouracil|fluorouracil|mesh-list
64940252|NCT03370406|Imiquimod|imiquimod|mesh-list
64940301|NCT00020046|Tubulin Modulators|tubulin modulators|mesh-ancestor
64940302|NCT00020046|Antimitotic Agents|antimitotic agents|mesh-ancestor
64940303|NCT00020046|Mitosis Modulators|mitosis modulators|mesh-ancestor
64940304|NCT00020046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940378|NCT00020631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64940379|NCT00020631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64940380|NCT00020631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64940381|NCT00020631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64940388|NCT05576324|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64940389|NCT05576324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64940390|NCT05576324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940392|NCT00020709|Etoposide|etoposide|mesh-list
64940393|NCT00020709|Etoposide phosphate|etoposide phosphate|mesh-list
64940394|NCT00020709|Gefitinib|gefitinib|mesh-list
64940395|NCT00020709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940396|NCT00020709|Tubulin Modulators|tubulin modulators|mesh-ancestor
64940397|NCT00020709|Antimitotic Agents|antimitotic agents|mesh-ancestor
64940398|NCT00020709|Mitosis Modulators|mitosis modulators|mesh-ancestor
64940406|NCT00020748|Epirubicin|epirubicin|mesh-list
64940558|NCT05574179|GABA Agents|gaba agents|mesh-ancestor
64940559|NCT00021216|Bortezomib|bortezomib|mesh-list
64940560|NCT00021216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940561|NCT00021294|Eflornithine|eflornithine|mesh-list
64940562|NCT00021294|Triamcinolone|triamcinolone|mesh-list
64940679|NCT00021996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64940680|NCT00021996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940681|NCT00021996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64940682|NCT00021996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64940683|NCT00021996|Analgesics|analgesics|mesh-ancestor
64940697|NCT00022074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64940698|NCT00022074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64940699|NCT00022074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64940700|NCT00022074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64940701|NCT00022074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64940702|NCT00022074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709200|NCT04064684|Budesonide|budesonide|mesh-list
64940703|NCT00022074|Antimanic Agents|antimanic agents|mesh-ancestor
64940704|NCT00022152|Vinorelbine|vinorelbine|mesh-list
64940705|NCT00022152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64940706|NCT00022152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940707|NCT00022152|Tubulin Modulators|tubulin modulators|mesh-ancestor
64940708|NCT00022152|Antimitotic Agents|antimitotic agents|mesh-ancestor
64940756|NCT00022308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64940757|NCT00022308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64940758|NCT00022308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64940759|NCT00022308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940760|NCT00022386|Epoetin Alfa|epoetin alfa|mesh-list
64940761|NCT00022386|Hematinics|hematinics|mesh-ancestor
64940762|NCT00022425|Perillyl alcohol|perillyl alcohol|mesh-list
64940763|NCT00022425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940764|NCT00022425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64940765|NCT00022425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940766|NCT00022464|Sirolimus|sirolimus|mesh-list
64940767|NCT00022464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64940768|NCT00022464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64940769|NCT00022464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64940770|NCT00022464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940771|NCT00022464|Antifungal Agents|antifungal agents|mesh-ancestor
64940775|NCT00022542|Epothilones|epothilones|mesh-list
64940780|NCT00022542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940781|NCT00022542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940787|NCT00022581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64940788|NCT00022581|Immunologic Factors|immunologic factors|mesh-ancestor
64940789|NCT00022581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940790|NCT00022581|Leprostatic Agents|leprostatic agents|mesh-ancestor
64940791|NCT00022581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64940792|NCT00022581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64940793|NCT00022581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64940794|NCT00022581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64940795|NCT00022581|Growth Substances|growth substances|mesh-ancestor
64940796|NCT00022581|Growth Inhibitors|growth inhibitors|mesh-ancestor
64940829|NCT00022737|Levoleucovorin|levoleucovorin|mesh-list
64940830|NCT00022737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64940831|NCT00022737|Immunologic Factors|immunologic factors|mesh-ancestor
64940832|NCT00022737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940833|NCT00022737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64940834|NCT00022737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64940835|NCT00022737|Alkylating Agents|alkylating agents|mesh-ancestor
64940836|NCT00022737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940837|NCT00022737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940838|NCT00022737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64940839|NCT00022737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64940840|NCT00022737|Antiemetics|antiemetics|mesh-ancestor
64940841|NCT00022737|Autonomic Agents|autonomic agents|mesh-ancestor
64940842|NCT00022737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64940843|NCT00022737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64940844|NCT00022737|Glucocorticoids|glucocorticoids|mesh-ancestor
64940874|NCT00022893|Tositumomab I-131|tositumomab i-131|mesh-list
64940875|NCT00022893|Antibodies|antibodies|mesh-list
64940876|NCT00022893|Immunologic Factors|immunologic factors|mesh-ancestor
64940877|NCT00022893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940878|NCT00022893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940879|NCT05514860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64940880|NCT00022932|Tositumomab I-131|tositumomab i-131|mesh-list
64940881|NCT00022932|Antibodies|antibodies|mesh-list
64940882|NCT00022932|Immunologic Factors|immunologic factors|mesh-ancestor
64940883|NCT00022932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940884|NCT00022932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940885|NCT00022971|Rituximab|rituximab|mesh-list
64940886|NCT00022971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64940887|NCT00022971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940888|NCT00022971|Immunologic Factors|immunologic factors|mesh-ancestor
64940889|NCT00022971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940890|NCT00022971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64940891|NCT05512754|Ibuprofen|ibuprofen|mesh-list
64992788|NCT03269669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64992789|NCT03269669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992790|NCT03269669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64992791|NCT03269669|Glucocorticoids|glucocorticoids|mesh-ancestor
64992793|NCT03269669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64992794|NCT03269669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64992795|NCT03269669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64992796|NCT03269669|Tubulin Modulators|tubulin modulators|mesh-ancestor
64992797|NCT03269669|Antimitotic Agents|antimitotic agents|mesh-ancestor
64940892|NCT05512754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64940893|NCT05512754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64940894|NCT05512754|Analgesics|analgesics|mesh-ancestor
64940912|NCT02971878|Vitamins|vitamins|mesh-ancestor
64940929|NCT00394992|Capecitabine|capecitabine|mesh-list
64940930|NCT00394992|Oxaliplatin|oxaliplatin|mesh-list
64940931|NCT00394992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64940932|NCT00394992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940933|NCT00394992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64940934|NCT00394992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64940935|NCT00394992|Growth Substances|growth substances|mesh-ancestor
64940936|NCT00394992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940937|NCT00394992|Growth Inhibitors|growth inhibitors|mesh-ancestor
64940938|NCT00394992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64940939|NCT00394992|Antimetabolites|antimetabolites|mesh-ancestor
64940940|NCT00394992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940941|NCT00395031|Ziprasidone|ziprasidone|mesh-list
64940942|NCT00395031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64940943|NCT00395031|Serotonin Agents|serotonin agents|mesh-ancestor
64940944|NCT00395031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64940945|NCT00395031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940946|NCT00395031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940947|NCT00395031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64940948|NCT00395031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64940949|NCT00395031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64940950|NCT00395031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64940951|NCT00395031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64940952|NCT00395031|Dopamine Agents|dopamine agents|mesh-ancestor
64940953|NCT00395070|Temozolomide|temozolomide|mesh-list
64940954|NCT00395070|Dacarbazine|dacarbazine|mesh-list
64940955|NCT00395070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64940956|NCT00395070|Alkylating Agents|alkylating agents|mesh-ancestor
64940957|NCT00395070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940958|NCT00395070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940959|NCT00023244|Cyclosporine|cyclosporine|mesh-list
64940960|NCT00023244|Sirolimus|sirolimus|mesh-list
64940972|NCT00023244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64940973|NCT00023244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940974|NCT00023244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64940975|NCT00023244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940976|NCT00023244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64940977|NCT00023244|Immunologic Factors|immunologic factors|mesh-ancestor
64940978|NCT00023244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64940979|NCT00023244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64940980|NCT00023244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940981|NCT00023244|Antifungal Agents|antifungal agents|mesh-ancestor
64940982|NCT00023244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64940983|NCT00023244|Dermatologic Agents|dermatologic agents|mesh-ancestor
64940984|NCT00023244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64940985|NCT00023244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64940986|NCT00023244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64940987|NCT00023244|Antiemetics|antiemetics|mesh-ancestor
64940988|NCT00023244|Autonomic Agents|autonomic agents|mesh-ancestor
64940989|NCT00023244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64940990|NCT00023244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64940991|NCT00023244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64940992|NCT00023244|Protective Agents|protective agents|mesh-ancestor
64940993|NCT00023244|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64940994|NCT00023244|Renal Agents|renal agents|mesh-ancestor
64940995|NCT00023244|Antimalarials|antimalarials|mesh-ancestor
64940996|NCT00023244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64941023|NCT00023400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64941075|NCT02971982|Immunologic Factors|immunologic factors|mesh-ancestor
64941076|NCT02971982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941077|NCT02971982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64941078|NCT02971982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64941079|NCT02971982|Alkylating Agents|alkylating agents|mesh-ancestor
64941080|NCT02971982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941081|NCT02971982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941082|NCT02971982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64941083|NCT02971982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64941084|NCT02971982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64941085|NCT02971982|Antiemetics|antiemetics|mesh-ancestor
64941086|NCT02971982|Autonomic Agents|autonomic agents|mesh-ancestor
64941087|NCT02971982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64941088|NCT02971982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64941089|NCT02971982|Glucocorticoids|glucocorticoids|mesh-ancestor
64941090|NCT02971982|Hormones|hormones|mesh-ancestor
64941091|NCT02971982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64941092|NCT02971982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64941093|NCT02971982|Protease Inhibitors|protease inhibitors|mesh-ancestor
64941094|NCT02971982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941095|NCT00023829|Bicalutamide|bicalutamide|mesh-list
64941096|NCT00023829|Flutamide|flutamide|mesh-list
64941097|NCT00023829|Hormones|hormones|mesh-list
64941125|NCT00023868|Protective Agents|protective agents|mesh-ancestor
64941126|NCT00023868|Vitamin B Complex|vitamin b complex|mesh-ancestor
64941127|NCT00023868|Vitamins|vitamins|mesh-ancestor
64941152|NCT00024141|Fluorouracil|fluorouracil|mesh-list
64941153|NCT00024141|Irinotecan|irinotecan|mesh-list
64941154|NCT00024141|Antimetabolites|antimetabolites|mesh-ancestor
64941172|NCT00024336|Tamoxifen|tamoxifen|mesh-list
64941173|NCT00024336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64941174|NCT00024336|Hormone Antagonists|hormone antagonists|mesh-ancestor
64941175|NCT00024336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64941176|NCT00024336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941177|NCT00024336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64941178|NCT00024336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941179|NCT00024336|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64941180|NCT00024336|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64941181|NCT00024336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64941182|NCT00024375|Paclitaxel|paclitaxel|mesh-list
64941183|NCT00024375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64941184|NCT00024375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941185|NCT00024375|Tubulin Modulators|tubulin modulators|mesh-ancestor
64941186|NCT00024375|Antimitotic Agents|antimitotic agents|mesh-ancestor
64941187|NCT00024375|Mitosis Modulators|mitosis modulators|mesh-ancestor
64941188|NCT00024375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941189|NCT00024414|Paclitaxel|paclitaxel|mesh-list
64941190|NCT00024414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64941191|NCT00024414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941192|NCT00024414|Tubulin Modulators|tubulin modulators|mesh-ancestor
64941196|NCT00024453|Teicoplanin|teicoplanin|mesh-list
64941238|NCT00025038|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64941239|NCT00025038|Immunoglobulins|immunoglobulins|mesh-list
64941240|NCT00025038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64941273|NCT05055830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64941274|NCT05055830|Antitussive Agents|antitussive agents|mesh-ancestor
64941275|NCT05055830|Respiratory System Agents|respiratory system agents|mesh-ancestor
64941276|NCT00025077|Cyclophosphamide|cyclophosphamide|mesh-list
64941277|NCT00025077|Thiotepa|thiotepa|mesh-list
64941278|NCT00025077|Carboplatin|carboplatin|mesh-list
64941279|NCT00025077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64941280|NCT00025077|Immunologic Factors|immunologic factors|mesh-ancestor
64941408|NCT04964414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64941409|NCT04964414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941430|NCT00025545|Dermatologic Agents|dermatologic agents|mesh-ancestor
64941431|NCT00025545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941432|NCT00025545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64941433|NCT00025545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64941434|NCT00025584|Bortezomib|bortezomib|mesh-list
64941435|NCT00025584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941553|NCT00026364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941554|NCT00026364|Antimetabolites|antimetabolites|mesh-ancestor
64941555|NCT00026364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941556|NCT00026364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64941557|NCT00026364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941558|NCT00026364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64941559|NCT00026364|Immunologic Factors|immunologic factors|mesh-ancestor
64941560|NCT00026364|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64941561|NCT00026364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64941562|NCT00026364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941563|NCT00026364|Antidotes|antidotes|mesh-ancestor
64941564|NCT00026364|Protective Agents|protective agents|mesh-ancestor
64941643|NCT00027066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64941644|NCT00027066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941645|NCT00027066|Antipyretics|antipyretics|mesh-ancestor
64941646|NCT00027066|Anticoagulants|anticoagulants|mesh-ancestor
64941647|NCT04473950|Naloxone|naloxone|mesh-list
64941648|NCT04473950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64941649|NCT04473950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941650|NCT04473950|Sensory System Agents|sensory system agents|mesh-ancestor
64941651|NCT04473950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64941652|NCT04473482|Ethanol|ethanol|mesh-list
64941666|NCT00027339|Fosamprenavir|fosamprenavir|mesh-list
64941667|NCT00027339|Tenofovir|tenofovir|mesh-list
64941668|NCT00027339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64941669|NCT00027339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64941670|NCT00027339|Protease Inhibitors|protease inhibitors|mesh-ancestor
64941671|NCT00027339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941672|NCT00027339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941673|NCT00027339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64941674|NCT00027339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64941675|NCT00027339|Antiviral Agents|antiviral agents|mesh-ancestor
64941676|NCT00027339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64941677|NCT00027339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64941678|NCT00027339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64941679|NCT00027339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64941680|NCT00027339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64941792|NCT00027885|Antimitotic Agents|antimitotic agents|mesh-ancestor
64941793|NCT00027885|Mitosis Modulators|mitosis modulators|mesh-ancestor
64941794|NCT00027885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64941795|NCT00027885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64941796|NCT00027885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64941797|NCT00027885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941798|NCT00027924|Cyclosporine|cyclosporine|mesh-list
64941799|NCT00027924|Methotrexate|methotrexate|mesh-list
64941800|NCT00027924|Fludarabine phosphate|fludarabine phosphate|mesh-list
64941801|NCT00027924|Fludarabine|fludarabine|mesh-list
64941802|NCT00027924|Busulfan|busulfan|mesh-list
64941803|NCT00027924|Cyclosporins|cyclosporins|mesh-list
64941804|NCT00027924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64941805|NCT00027924|Abortifacient Agents|abortifacient agents|mesh-ancestor
64941806|NCT00027924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64941807|NCT00027924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941808|NCT00027924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64941809|NCT00027924|Antimetabolites|antimetabolites|mesh-ancestor
64941831|NCT04022876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64941832|NCT04022876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64941833|NCT04022876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64941834|NCT04022876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64941835|NCT00027963|Gabapentin|gabapentin|mesh-list
64941836|NCT00027963|Analgesics|analgesics|mesh-ancestor
64941837|NCT00027963|Sensory System Agents|sensory system agents|mesh-ancestor
64941838|NCT00027963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64941839|NCT00027963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941840|NCT00027963|Anticonvulsants|anticonvulsants|mesh-ancestor
64941841|NCT00027963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64941842|NCT00027963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64941843|NCT00027963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64941844|NCT00027963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64941845|NCT00027963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64941846|NCT00027963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64941847|NCT00027963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64941848|NCT00027963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992798|NCT03269669|Mitosis Modulators|mitosis modulators|mesh-ancestor
64992799|NCT03269669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64992800|NCT03269669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64941849|NCT00027963|Antimanic Agents|antimanic agents|mesh-ancestor
64941850|NCT00395421|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64941851|NCT00395421|Antiviral Agents|antiviral agents|mesh-ancestor
64941852|NCT00395421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64941853|NCT00395499|Risperidone|risperidone|mesh-list
64941854|NCT00395499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64941855|NCT00395499|Serotonin Agents|serotonin agents|mesh-ancestor
64941880|NCT00395655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941881|NCT00395655|GABA Agents|gaba agents|mesh-ancestor
64941882|NCT00395655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64941883|NCT00395655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941884|NCT00395655|Antimanic Agents|antimanic agents|mesh-ancestor
64941885|NCT00395655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64941886|NCT00395655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64941887|NCT00395655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64941888|NCT00395655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64941889|NCT00395655|Vasodilator Agents|vasodilator agents|mesh-ancestor
64941890|NCT00392561|Vitamin E|vitamin e|mesh-list
64941891|NCT00392561|Selenium|selenium|mesh-list
64941892|NCT00392561|Vitamins|vitamins|mesh-ancestor
64941893|NCT00392561|Micronutrients|micronutrients|mesh-ancestor
64941894|NCT00392561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941895|NCT00392561|Antioxidants|antioxidants|mesh-ancestor
64941904|NCT03959969|Ibuprofen|ibuprofen|mesh-list
64941942|NCT00028353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941943|NCT00028353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64941944|NCT00028353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64941945|NCT00028353|Hormone Antagonists|hormone antagonists|mesh-ancestor
64941946|NCT00028353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64941947|NCT00028353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941948|NCT00028353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64941949|NCT03959852|Fentanyl|fentanyl|mesh-list
64941950|NCT03959852|Ketamine|ketamine|mesh-list
64941951|NCT03959852|Analgesics|analgesics|mesh-ancestor
64941952|NCT03959852|Sensory System Agents|sensory system agents|mesh-ancestor
64941953|NCT03959852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64941954|NCT03959852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941955|NCT03959852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64941958|NCT03959852|Anesthetics|anesthetics|mesh-ancestor
64941968|NCT00028431|Antibodies|antibodies|mesh-list
64941969|NCT00028431|Immunologic Factors|immunologic factors|mesh-ancestor
64941970|NCT00028431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941971|NCT00028431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64941972|NCT00028431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941973|NCT00028431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64941974|NCT00028431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941975|NCT00028587|Paclitaxel|paclitaxel|mesh-list
64941976|NCT00028587|Carboplatin|carboplatin|mesh-list
64942025|NCT00028743|Antimitotic Agents|antimitotic agents|mesh-ancestor
64942026|NCT00028743|Mitosis Modulators|mitosis modulators|mesh-ancestor
64942027|NCT00028743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942028|NCT00028743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64942029|NCT00028743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64942030|NCT00028743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942031|NCT03959501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64942032|NCT03959501|Dapagliflozin|dapagliflozin|mesh-list
64942033|NCT03959501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64942034|NCT03959501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942035|NCT03959501|Incretins|incretins|mesh-ancestor
64942036|NCT03959501|Hormones|hormones|mesh-ancestor
64942037|NCT03959501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64942038|NCT03959501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64942039|NCT03959501|Protease Inhibitors|protease inhibitors|mesh-ancestor
64942071|NCT00028860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942072|NCT00028860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64942073|NCT00028860|Antimetabolites|antimetabolites|mesh-ancestor
64942074|NCT00028860|Antiviral Agents|antiviral agents|mesh-ancestor
64942075|NCT00028860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64942076|NCT00028860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942077|NCT00028860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64942078|NCT00028860|Immunologic Factors|immunologic factors|mesh-ancestor
64942079|NCT00028860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942080|NCT00028860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64942081|NCT00028860|Alkylating Agents|alkylating agents|mesh-ancestor
64942082|NCT00028899|Cytarabine|cytarabine|mesh-list
64942083|NCT00028899|Asparaginase|asparaginase|mesh-list
64942084|NCT00028899|Mitoxantrone|mitoxantrone|mesh-list
64942140|NCT00029328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64942141|NCT00029328|Immunologic Factors|immunologic factors|mesh-ancestor
64942142|NCT00029523|Cytarabine|cytarabine|mesh-list
64942143|NCT00029523|Methotrexate|methotrexate|mesh-list
64942144|NCT00029523|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64942145|NCT00029523|Abortifacient Agents|abortifacient agents|mesh-ancestor
64942146|NCT00029523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64942147|NCT00029523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942148|NCT00029523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64710643|NCT05829187|Primaquine|primaquine|mesh-list
64942149|NCT00029523|Antimetabolites|antimetabolites|mesh-ancestor
64942150|NCT00029523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942151|NCT00029523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942152|NCT00029523|Dermatologic Agents|dermatologic agents|mesh-ancestor
64942153|NCT00029523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942154|NCT00029523|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64942155|NCT00029523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64942172|NCT03958799|Immunologic Factors|immunologic factors|mesh-ancestor
64942173|NCT03958799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942174|NCT00029757|Estrogens|estrogens|mesh-list
64942175|NCT00029757|Hormones|hormones|mesh-ancestor
64942176|NCT00029757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64942177|NCT00029757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942178|NCT03958721|Capecitabine|capecitabine|mesh-list
64942179|NCT03958721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64942180|NCT03958721|Antimetabolites|antimetabolites|mesh-ancestor
64942181|NCT03958721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942182|NCT03958721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942183|NCT00029835|Rimonabant|rimonabant|mesh-list
64942184|NCT00029835|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64942185|NCT00029835|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
64942186|NCT00029835|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64942187|NCT00029835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64942194|NCT00395772|Rivaroxaban|rivaroxaban|mesh-list
64942195|NCT00395772|Vitamins|vitamins|mesh-ancestor
64942196|NCT00395772|Micronutrients|micronutrients|mesh-ancestor
64942197|NCT00395772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942198|NCT00395772|Anticoagulants|anticoagulants|mesh-ancestor
64942199|NCT00395772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64942200|NCT00395772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64942201|NCT00395772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942202|NCT00395772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64942215|NCT00030030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942216|NCT00030030|Protective Agents|protective agents|mesh-ancestor
64942217|NCT00030030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942218|NCT00030069|Calcitriol|calcitriol|mesh-list
64942219|NCT00030069|Dexamethasone|dexamethasone|mesh-list
64942220|NCT00030069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64942221|NCT00030069|Antiemetics|antiemetics|mesh-ancestor
64942222|NCT00030069|Autonomic Agents|autonomic agents|mesh-ancestor
64942223|NCT00030069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64942224|NCT00030069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942225|NCT00030069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64942226|NCT00030069|Glucocorticoids|glucocorticoids|mesh-ancestor
64942227|NCT00030069|Hormones|hormones|mesh-ancestor
64942228|NCT00030069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64942229|NCT00030069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64942338|NCT00030654|Mitosis Modulators|mitosis modulators|mesh-ancestor
64942339|NCT00030654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942340|NCT00030654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64942341|NCT00030654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64942342|NCT00030654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64942343|NCT00030654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942344|NCT00030654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64942346|NCT00030654|Antifungal Agents|antifungal agents|mesh-ancestor
64942420|NCT00030849|Bexarotene|bexarotene|mesh-list
64942421|NCT00030849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942422|NCT00030849|Antiviral Agents|antiviral agents|mesh-ancestor
64942423|NCT00030849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64942424|NCT00030849|Immunologic Factors|immunologic factors|mesh-ancestor
64942425|NCT00030849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942426|NCT03779789|Vortioxetine|vortioxetine|mesh-list
64942427|NCT03779789|Fluvoxamine|fluvoxamine|mesh-list
64942428|NCT03779789|Citalopram|citalopram|mesh-list
64942429|NCT03779789|Fluoxetine|fluoxetine|mesh-list
64942430|NCT03779789|Paroxetine|paroxetine|mesh-list
64942431|NCT03779789|Sertraline|sertraline|mesh-list
64942432|NCT03779789|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64942433|NCT03779789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64942567|NCT04711668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64942568|NCT04711668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64942569|NCT00031161|Nitisinone|nitisinone|mesh-list
64942570|NCT00031161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942571|NCT00031161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942572|NCT00031278|Trastuzumab|trastuzumab|mesh-list
64942573|NCT00031278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64942574|NCT00031278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942575|NCT00031317|Clozapine|clozapine|mesh-list
64942576|NCT00031317|Paroxetine|paroxetine|mesh-list
64942577|NCT00031317|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64942578|NCT00031317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64942579|NCT00031317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64942582|NCT00031317|Serotonin Agents|serotonin agents|mesh-ancestor
64942617|NCT00031395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64942618|NCT00031395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64942619|NCT00031395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942620|NCT00031395|Dopamine Agents|dopamine agents|mesh-ancestor
64942621|NCT00031395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64942622|NCT00031395|Analgesics|analgesics|mesh-ancestor
64942623|NCT00031395|Sensory System Agents|sensory system agents|mesh-ancestor
64942624|NCT00031395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64942684|NCT00031707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64942685|NCT00031707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942686|NCT00031707|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64942687|NCT00031707|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64942688|NCT00031707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64942689|NCT00031707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942690|NCT00031707|Appetite Stimulants|appetite stimulants|mesh-ancestor
64942692|NCT00031746|Caseins|caseins|mesh-list
64942743|NCT00031824|Antimalarials|antimalarials|mesh-ancestor
64942744|NCT00031824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64942745|NCT00031824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64942746|NCT00031863|Rofecoxib|rofecoxib|mesh-list
64942747|NCT00031863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64711242|NCT05615311|Vitamin D|vitamin d|mesh-list
64942748|NCT00031863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64942749|NCT00031863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942750|NCT00031863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942751|NCT00031863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64942752|NCT00031863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64942754|NCT00031863|Sensory System Agents|sensory system agents|mesh-ancestor
64942755|NCT00031863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64942756|NCT00031863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942757|NCT00031863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64942758|NCT00031863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64942797|NCT00031980|Immunologic Factors|immunologic factors|mesh-ancestor
64942798|NCT00031980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942799|NCT00031980|Antifungal Agents|antifungal agents|mesh-ancestor
64942800|NCT00031980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64942801|NCT00031980|Dermatologic Agents|dermatologic agents|mesh-ancestor
64942802|NCT00031980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64942803|NCT00031980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64942920|NCT04712279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64942922|NCT00032292|Immunologic Factors|immunologic factors|mesh-ancestor
64942923|NCT00032292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942924|NCT03150914|Sirolimus|sirolimus|mesh-list
64942925|NCT03150914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64942979|NCT00032955|Buprenorphine|buprenorphine|mesh-list
64942980|NCT00032955|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64942981|NCT00032955|Naloxone|naloxone|mesh-list
64942982|NCT00032955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64942983|NCT00032955|Narcotics|narcotics|mesh-ancestor
64942984|NCT00032955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64942985|NCT00032955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942986|NCT00032955|Analgesics|analgesics|mesh-ancestor
64942987|NCT00032955|Sensory System Agents|sensory system agents|mesh-ancestor
64942988|NCT00032955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64942990|NCT03150524|Verapamil|verapamil|mesh-list
64943042|NCT00033189|Coenzyme Q10|coenzyme q10|mesh-list
64943043|NCT00033189|Micronutrients|micronutrients|mesh-ancestor
64943044|NCT00033189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943045|NCT00033189|Vitamins|vitamins|mesh-ancestor
64943046|NCT03110978|Nivolumab|nivolumab|mesh-list
64943047|NCT03110978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64943048|NCT03110978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943049|NCT03110978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64943050|NCT03110978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943051|NCT00033267|Sirolimus|sirolimus|mesh-list
64943052|NCT00033267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64943108|NCT00393263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64943109|NCT00393263|Glucocorticoids|glucocorticoids|mesh-ancestor
64943110|NCT00393263|Hormones|hormones|mesh-ancestor
64943111|NCT00393263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64943112|NCT00393263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943113|NCT00393263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64943114|NCT00393263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64943115|NCT00393263|Analgesics|analgesics|mesh-ancestor
64943116|NCT00393263|Sensory System Agents|sensory system agents|mesh-ancestor
64992855|NCT03191864|Fluticasone|fluticasone|mesh-list
64992856|NCT03191864|Xhance|xhance|mesh-list
64992857|NCT03191864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64992858|NCT03191864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64992859|NCT03191864|Autonomic Agents|autonomic agents|mesh-ancestor
64943117|NCT00393263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64711606|NCT05322252|Oxytocics|oxytocics|mesh-ancestor
64943118|NCT00393263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64943119|NCT00393263|Dermatologic Agents|dermatologic agents|mesh-ancestor
64943120|NCT00393263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64943121|NCT00393263|Immunologic Factors|immunologic factors|mesh-ancestor
64943122|NCT00393263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64943123|NCT00393263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943124|NCT00393263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943125|NCT00033618|Epothilones|epothilones|mesh-list
64943126|NCT00033618|Epothilone B|epothilone b|mesh-list
64943127|NCT00033618|Tubulin Modulators|tubulin modulators|mesh-ancestor
64943128|NCT00033618|Antimitotic Agents|antimitotic agents|mesh-ancestor
64943129|NCT00033618|Mitosis Modulators|mitosis modulators|mesh-ancestor
64943130|NCT00033618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943131|NCT00033618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943132|NCT00033696|Paclitaxel|paclitaxel|mesh-list
64943133|NCT00033696|Etoposide|etoposide|mesh-list
64943134|NCT00033696|Carboplatin|carboplatin|mesh-list
64943339|NCT01806857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64943340|NCT01806857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64943341|NCT01806857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943342|NCT01806857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943343|NCT01806857|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64943344|NCT01806857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64943345|NCT01806857|Adrenergic Agents|adrenergic agents|mesh-ancestor
64943346|NCT01806857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64943360|NCT00034710|Capsaicin|capsaicin|mesh-list
64943399|NCT00034905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943400|NCT00034905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943401|NCT00034905|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64943402|NCT00034905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64943403|NCT00034905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64943404|NCT00034905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64943406|NCT00034905|Dopamine Agents|dopamine agents|mesh-ancestor
64943469|NCT00035100|Epothilones|epothilones|mesh-list
64943655|NCT01805570|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64943656|NCT01805570|Purinergic Agents|purinergic agents|mesh-ancestor
64943657|NCT01805570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64943658|NCT01805570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943659|NCT01805570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943660|NCT01805531|Rivaroxaban|rivaroxaban|mesh-list
64943661|NCT01805531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64943662|NCT01805531|Antithrombins|antithrombins|mesh-ancestor
64943663|NCT01805531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64943664|NCT01805531|Protease Inhibitors|protease inhibitors|mesh-ancestor
64943665|NCT01805531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943666|NCT01805531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943667|NCT01805531|Anticoagulants|anticoagulants|mesh-ancestor
64943668|NCT00036114|Aripiprazole|aripiprazole|mesh-list
64943669|NCT00036114|Antidepressive Agents|antidepressive agents|mesh-ancestor
64943670|NCT00036114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64943745|NCT00036348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64943746|NCT00036387|Infliximab|infliximab|mesh-list
64943747|NCT00036387|Dermatologic Agents|dermatologic agents|mesh-ancestor
64943748|NCT00036387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64943749|NCT00036387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64943750|NCT01466543|Udenafil|udenafil|mesh-list
64943751|NCT01466543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64943752|NCT01466543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64943753|NCT01466543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943754|NCT01466543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943755|NCT01466465|Vitamin D|vitamin d|mesh-list
64943756|NCT01466465|Cholecalciferol|cholecalciferol|mesh-list
64943757|NCT01466465|Vitamins|vitamins|mesh-ancestor
64943758|NCT01466465|Micronutrients|micronutrients|mesh-ancestor
64943759|NCT01466465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943875|NCT00037050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64943876|NCT00037050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64943878|NCT00037050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943931|NCT01464983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64943932|NCT01464983|Analgesics|analgesics|mesh-ancestor
64943933|NCT01464983|Sensory System Agents|sensory system agents|mesh-ancestor
64943934|NCT01464983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64943935|NCT01464983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943937|NCT01464983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64943938|NCT01464983|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64943939|NCT01464983|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64943940|NCT01464983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943941|NCT01464983|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64943942|NCT01464983|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64943945|NCT00037518|Cinacalcet|cinacalcet|mesh-list
64943999|NCT01464671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64944001|NCT01464671|Antithrombins|antithrombins|mesh-ancestor
64944059|NCT00038220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64944060|NCT00038220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64944061|NCT00038220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64944062|NCT00038220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64944063|NCT00038220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64944064|NCT00038220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64944065|NCT00038220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64944066|NCT00038220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64944068|NCT00038259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944069|NCT00038259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64944073|NCT00847418|Esketamine|esketamine|mesh-list
64944118|NCT00846989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64944119|NCT00846989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64944120|NCT00396747|Methylprednisolone|methylprednisolone|mesh-list
64944121|NCT00396747|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64944122|NCT00396747|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64944123|NCT00396747|Prednisolone|prednisolone|mesh-list
64944124|NCT00396747|Prednisolone acetate|prednisolone acetate|mesh-list
64944125|NCT00396747|Methotrexate|methotrexate|mesh-list
64944126|NCT00396747|Infliximab|infliximab|mesh-list
64944127|NCT00396747|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64944128|NCT00396747|Prednisolone phosphate|prednisolone phosphate|mesh-list
64944129|NCT00396747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64944130|NCT00396747|Abortifacient Agents|abortifacient agents|mesh-ancestor
64944131|NCT00396747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64944359|NCT00276965|Antimanic Agents|antimanic agents|mesh-ancestor
64944360|NCT00276965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64944361|NCT00276965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64944362|NCT00276926|Imatinib Mesylate|imatinib mesylate|mesh-list
64944363|NCT00276926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944367|NCT00396786|Enoxaparin|enoxaparin|mesh-list
64944412|NCT00276809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64944413|NCT00276809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64944414|NCT00276809|Antiemetics|antiemetics|mesh-ancestor
64944415|NCT00276809|Autonomic Agents|autonomic agents|mesh-ancestor
64944580|NCT00275951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944581|NCT00275912|Oxcarbazepine|oxcarbazepine|mesh-list
64944582|NCT00275912|Anticonvulsants|anticonvulsants|mesh-ancestor
64944583|NCT00275912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64944584|NCT00275912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64944585|NCT00275912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64944586|NCT00275912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944587|NCT00275912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64944588|NCT00275912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64944589|NCT00397098|Amibegron|amibegron|mesh-list
64944596|NCT00275834|Zonisamide|zonisamide|mesh-list
64944635|NCT00275639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64944636|NCT00275639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64944637|NCT00275639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64944638|NCT00275639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64944639|NCT00275639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944640|NCT03957057|Iron|iron|mesh-list
64944641|NCT03957057|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
64944642|NCT03957057|Trace Elements|trace elements|mesh-ancestor
64944702|NCT00275249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64944703|NCT00275249|Narcotics|narcotics|mesh-ancestor
64944704|NCT00275249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64944705|NCT00275249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944706|NCT00275249|Analgesics|analgesics|mesh-ancestor
64944707|NCT00275249|Sensory System Agents|sensory system agents|mesh-ancestor
64944708|NCT00275249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64944709|NCT00275210|Oxaliplatin|oxaliplatin|mesh-list
64944838|NCT00130403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64944839|NCT00130403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944897|NCT00394394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64944898|NCT00394394|Diuretics|diuretics|mesh-ancestor
64944899|NCT00394394|Natriuretic Agents|natriuretic agents|mesh-ancestor
64944900|NCT00394394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944901|NCT00394394|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
64944902|NCT00394394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64944903|NCT00394394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64944904|NCT00394394|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64944905|NCT00394394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64944906|NCT00130091|Clonidine|clonidine|mesh-list
64944907|NCT00130091|Analgesics|analgesics|mesh-ancestor
64944908|NCT00130091|Sensory System Agents|sensory system agents|mesh-ancestor
64944909|NCT00130091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64944912|NCT00130091|Sympatholytics|sympatholytics|mesh-ancestor
64944957|NCT00129506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64944958|NCT00129506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64944959|NCT00129506|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64944960|NCT00129506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64944961|NCT00129506|Oxytocics|oxytocics|mesh-ancestor
64945017|NCT00129038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64945018|NCT00129038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64945019|NCT00129038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945020|NCT00129038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64945021|NCT00129038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64945022|NCT00129038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945023|NCT00129038|Antipyretics|antipyretics|mesh-ancestor
64945024|NCT00129038|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64945025|NCT00129038|Vasodilator Agents|vasodilator agents|mesh-ancestor
64945026|NCT00470223|Zoledronic Acid|zoledronic acid|mesh-list
64945030|NCT00470223|Etoposide|etoposide|mesh-list
64945057|NCT00103389|Antimitotic Agents|antimitotic agents|mesh-ancestor
64945058|NCT00103389|Mitosis Modulators|mitosis modulators|mesh-ancestor
64945059|NCT00103389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945060|NCT00128921|Bortezomib|bortezomib|mesh-list
64945061|NCT00128921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945062|NCT00128804|Beta Carotene|beta carotene|mesh-list
64945063|NCT00128804|Carotenoids|carotenoids|mesh-list
64945064|NCT00128804|Antioxidants|antioxidants|mesh-ancestor
64945128|NCT00038532|Amprenavir|amprenavir|mesh-list
64945129|NCT00038532|Efavirenz|efavirenz|mesh-list
64945189|NCT05769855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945190|NCT05769855|Sensory System Agents|sensory system agents|mesh-ancestor
64945191|NCT05769855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64945195|NCT05769738|Furosemide|furosemide|mesh-list
64945196|NCT05769738|Diuretics|diuretics|mesh-list
64945197|NCT05769738|Natriuretic Agents|natriuretic agents|mesh-ancestor
64945198|NCT05769738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945199|NCT05769738|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64945200|NCT05769738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64945201|NCT05769738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945202|NCT05769725|Docetaxel|docetaxel|mesh-list
64945225|NCT05769530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64945226|NCT05769530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64945227|NCT05769530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64945228|NCT05769530|Adrenergic Agents|adrenergic agents|mesh-ancestor
64945229|NCT05769530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64945230|NCT05769530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945231|NCT05769530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64945232|NCT05769530|Narcotics|narcotics|mesh-ancestor
64945233|NCT05769478|Amifampridine|amifampridine|mesh-list
64945234|NCT05769478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64945235|NCT05769478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64945237|NCT05769478|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64945288|NCT05762146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64945289|NCT05762146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64945290|NCT05762146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64945291|NCT05762146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945292|NCT05762146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64945293|NCT05762146|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64945294|NCT05762146|Dopamine Agents|dopamine agents|mesh-ancestor
64557629|NCT03067896|Sensory System Agents|sensory system agents|mesh-ancestor
64557630|NCT03067896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64557631|NCT03067896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64557632|NCT03067896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64557633|NCT03067896|Analgesics|analgesics|mesh-ancestor
64945360|NCT05697783|Narcotics|narcotics|mesh-ancestor
64484381|NCT01729819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484382|NCT01729819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484383|NCT01729819|Urological Agents|urological agents|mesh-ancestor
64484385|NCT01729819|Coagulants|coagulants|mesh-ancestor
64484433|NCT01709084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64484434|NCT01709084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64484435|NCT01709084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64484436|NCT01709084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64484437|NCT01709084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64484438|NCT01709084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64484439|NCT01776307|Capecitabine|capecitabine|mesh-list
64484440|NCT01776307|Cetuximab|cetuximab|mesh-list
64484441|NCT01776307|Panitumumab|panitumumab|mesh-list
64484442|NCT01776307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64484443|NCT01776307|Antimetabolites|antimetabolites|mesh-ancestor
64453643|NCT01438060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453645|NCT01438060|Dopamine Agents|dopamine agents|mesh-ancestor
64453646|NCT01438060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64453647|NCT01438060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453648|NCT01438060|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64453649|NCT01438060|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64453650|NCT01438060|Serotonin Agents|serotonin agents|mesh-ancestor
64453651|NCT01438060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64453652|NCT01438060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64453721|NCT01959139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64453722|NCT01959139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453771|NCT02000882|Capecitabine|capecitabine|mesh-list
64453772|NCT02000882|Trastuzumab|trastuzumab|mesh-list
64453773|NCT02000882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64453774|NCT02000882|Antimetabolites|antimetabolites|mesh-ancestor
64453775|NCT02000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453776|NCT02000882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453777|NCT02000882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64453778|NCT01958671|Metformin|metformin|mesh-list
64453779|NCT01958671|Glimepiride|glimepiride|mesh-list
64453780|NCT01958671|Ertugliflozin|ertugliflozin|mesh-list
64453781|NCT01958671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64453782|NCT01958671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453783|NCT01958671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64453784|NCT01958671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64453785|NCT01958671|Immunologic Factors|immunologic factors|mesh-ancestor
64453786|NCT01958671|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64453787|NCT01958671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453788|NCT04666129|Prednisone|prednisone|mesh-list
64453789|NCT04666129|Methylprednisolone|methylprednisolone|mesh-list
64453790|NCT04666129|Docetaxel|docetaxel|mesh-list
64453791|NCT04666129|Relugolix|relugolix|mesh-list
64453958|NCT01998919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64453959|NCT01998919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454249|NCT02029235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64454250|NCT02029235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64454251|NCT02029235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454252|NCT02029235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454253|NCT02029235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64454254|NCT02029235|Narcotics|narcotics|mesh-ancestor
64454255|NCT02029235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64454306|NCT01938716|Antimetabolites|antimetabolites|mesh-ancestor
64454472|NCT01959698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454473|NCT01959698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454474|NCT01959698|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64454475|NCT01959698|Alkylating Agents|alkylating agents|mesh-ancestor
64454476|NCT01959698|Keratolytic Agents|keratolytic agents|mesh-ancestor
64454477|NCT01959698|Dermatologic Agents|dermatologic agents|mesh-ancestor
64454478|NCT01959698|Tubulin Modulators|tubulin modulators|mesh-ancestor
64454479|NCT01959698|Antimitotic Agents|antimitotic agents|mesh-ancestor
64454480|NCT01959698|Mitosis Modulators|mitosis modulators|mesh-ancestor
64454481|NCT04650698|Tranexamic Acid|tranexamic acid|mesh-list
64454543|NCT01959230|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64454544|NCT01959230|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64454545|NCT01959230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64454546|NCT01959230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64454547|NCT01959230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64454548|NCT01959230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64454549|NCT01959230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64454550|NCT01959230|Adrenergic Agents|adrenergic agents|mesh-ancestor
64454551|NCT01959230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64454552|NCT01959230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454553|NCT01959230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454554|NCT01978093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64454555|NCT01978093|Immunologic Factors|immunologic factors|mesh-ancestor
64454579|NCT01951105|Sensory System Agents|sensory system agents|mesh-ancestor
64454580|NCT01951105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64454581|NCT01951105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454582|NCT01951105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64454583|NCT01951105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64454584|NCT01951105|Gout Suppressants|gout suppressants|mesh-ancestor
64454585|NCT01951105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64454598|NCT01958918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64454631|NCT01950169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64454632|NCT01950169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454633|NCT01909466|Aripiprazole|aripiprazole|mesh-list
64454634|NCT01909466|Antidepressive Agents|antidepressive agents|mesh-ancestor
64454635|NCT01909466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64454636|NCT01909466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64454637|NCT01909466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64454638|NCT01909466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64454640|NCT01909466|Dopamine Agonists|dopamine agonists|mesh-ancestor
64454732|NCT02008877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64945365|NCT05697783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64454734|NCT02008877|Antifungal Agents|antifungal agents|mesh-ancestor
64454735|NCT02008877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64454736|NCT02008877|Immunologic Factors|immunologic factors|mesh-ancestor
64454737|NCT02008877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454738|NCT01933334|Pirfenidone|pirfenidone|mesh-list
64454739|NCT01933334|Analgesics|analgesics|mesh-ancestor
64454746|NCT01933334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64454777|NCT02008565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64454778|NCT01931150|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64454779|NCT01931150|Dapsone|dapsone|mesh-list
64454780|NCT01931150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64454781|NCT01931150|Antimalarials|antimalarials|mesh-ancestor
64454782|NCT01931150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64454783|NCT01931150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64454784|NCT01931150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64454785|NCT01931150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454786|NCT01931150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454787|NCT01931150|Leprostatic Agents|leprostatic agents|mesh-ancestor
64454788|NCT01906346|Cocaine|cocaine|mesh-list
64454789|NCT01906346|Anesthetics, Local|anesthetics, local|mesh-ancestor
64454802|NCT04645004|Aspirin|aspirin|mesh-list
64454841|NCT01929044|Autonomic Agents|autonomic agents|mesh-ancestor
64454842|NCT01929044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64454843|NCT01929044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454844|NCT01929044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64454845|NCT01929044|Mydriatics|mydriatics|mesh-ancestor
64454846|NCT01929044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64454847|NCT01929044|Cholinergic Agents|cholinergic agents|mesh-ancestor
64454848|NCT01929044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64454914|NCT04069156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64454915|NCT04069156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64454967|NCT04060342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454968|NCT04060342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64454969|NCT04060030|Calcium, Dietary|calcium, dietary|mesh-list
64454971|NCT04060030|Calcium|calcium|mesh-list
64454972|NCT04060030|Levoleucovorin|levoleucovorin|mesh-list
64454973|NCT04060030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64454974|NCT04060030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454975|NCT04060030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64454976|NCT04060030|Antidotes|antidotes|mesh-ancestor
64454977|NCT04060030|Protective Agents|protective agents|mesh-ancestor
64454978|NCT04060030|Vitamin B Complex|vitamin b complex|mesh-ancestor
64454979|NCT04060030|Vitamins|vitamins|mesh-ancestor
64454980|NCT04060030|Micronutrients|micronutrients|mesh-ancestor
64454981|NCT01435018|Tenofovir|tenofovir|mesh-list
64454983|NCT01435018|Efavirenz|efavirenz|mesh-list
64455028|NCT01417078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64455029|NCT01417078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64455030|NCT01417078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64455031|NCT01417078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64455033|NCT01417078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64455034|NCT01417078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64455035|NCT01417078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64455036|NCT01417078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64455038|NCT01417078|Anesthetics|anesthetics|mesh-ancestor
64455148|NCT01432600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64455149|NCT01432600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64455150|NCT01432600|Glucocorticoids|glucocorticoids|mesh-ancestor
64455151|NCT01432600|Hormones|hormones|mesh-ancestor
64455152|NCT01432600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64455153|NCT01432600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64455154|NCT01432600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64455155|NCT01432600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64455156|NCT01432600|Growth Substances|growth substances|mesh-ancestor
64455415|NCT01431274|Tiotropium Bromide|tiotropium bromide|mesh-list
64455416|NCT01431274|Olodaterol|olodaterol|mesh-list
64455417|NCT01431274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64455641|NCT01390402|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64455642|NCT01390402|Abortifacient Agents|abortifacient agents|mesh-ancestor
64455643|NCT01390402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64455644|NCT01390402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455645|NCT01390402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64455646|NCT01390402|Antimetabolites|antimetabolites|mesh-ancestor
64455647|NCT01390402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455648|NCT01390402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455649|NCT01390402|Dermatologic Agents|dermatologic agents|mesh-ancestor
64455658|NCT01390402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64455659|NCT01390402|Alkylating Agents|alkylating agents|mesh-ancestor
64455660|NCT01390402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64455661|NCT01390402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64455662|NCT01390402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64455663|NCT01390402|Analgesics|analgesics|mesh-ancestor
64455664|NCT01390402|Sensory System Agents|sensory system agents|mesh-ancestor
64455665|NCT01390402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64455666|NCT01390402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64455667|NCT01390402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64455668|NCT04661683|Charcoal|charcoal|mesh-list
64455669|NCT04661683|Antidotes|antidotes|mesh-ancestor
64455670|NCT04661683|Protective Agents|protective agents|mesh-ancestor
64455671|NCT04661683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455672|NCT01428076|Polidocanol|polidocanol|mesh-list
64455673|NCT01428076|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64455674|NCT01428076|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64455675|NCT01900652|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64455676|NCT01900652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455677|NCT01900652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64993064|NCT02912559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64993065|NCT02912559|Immunologic Factors|immunologic factors|mesh-ancestor
64993066|NCT02912559|Antidotes|antidotes|mesh-ancestor
64993067|NCT02912559|Protective Agents|protective agents|mesh-ancestor
64993068|NCT02912559|Vitamin B Complex|vitamin b complex|mesh-ancestor
64993102|NCT02839707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64993103|NCT02839707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64993104|NCT02839707|Growth Substances|growth substances|mesh-ancestor
64993105|NCT02839707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993106|NCT02839707|Growth Inhibitors|growth inhibitors|mesh-ancestor
64993107|NCT02839707|Immunologic Factors|immunologic factors|mesh-ancestor
64993108|NCT02839707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64993109|NCT02839707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64993110|NCT02839707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64455678|NCT01900652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455679|NCT01900652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455680|NCT02093351|Tamoxifen|tamoxifen|mesh-list
64455681|NCT02093351|Letrozole|letrozole|mesh-list
64455682|NCT02093351|Olaparib|olaparib|mesh-list
64455683|NCT02093351|Anastrozole|anastrozole|mesh-list
64455684|NCT02093351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455685|NCT02093351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64455686|NCT02093351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64455687|NCT02093351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455688|NCT02093351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455689|NCT02093351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64455690|NCT02093351|Hormone Antagonists|hormone antagonists|mesh-ancestor
64455700|NCT02078284|Protective Agents|protective agents|mesh-ancestor
64455701|NCT02078284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455702|NCT02078284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64455703|NCT02078284|Antioxidants|antioxidants|mesh-ancestor
64455704|NCT02078284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455706|NCT02092961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64455707|NCT02092961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64455708|NCT01940497|Paclitaxel|paclitaxel|mesh-list
64455709|NCT01940497|Docetaxel|docetaxel|mesh-list
64455739|NCT01938625|Ribavirin|ribavirin|mesh-list
64455769|NCT01975285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64455770|NCT01975285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455771|NCT01974817|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64455772|NCT01974817|Immunologic Factors|immunologic factors|mesh-ancestor
64455773|NCT01974817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455775|NCT04624399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455776|NCT01915849|Licogliflozin|licogliflozin|mesh-list
64455777|NCT01915849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64455778|NCT01915849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455779|NCT01915849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64455780|NCT01915849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455782|NCT01915303|Pasireotide|pasireotide|mesh-list
64455783|NCT01915303|Hormones|hormones|mesh-ancestor
64993111|NCT02839707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993112|NCT02839707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993114|NCT02830724|Cyclophosphamide|cyclophosphamide|mesh-list
64993115|NCT02830724|Fludarabine|fludarabine|mesh-list
64455830|NCT01597557|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64455831|NCT01597557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64455832|NCT01597557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455833|NCT01597557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64455835|NCT01597557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64455836|NCT01914757|Benralizumab|benralizumab|mesh-list
64455837|NCT01914757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64455838|NCT01914757|Respiratory System Agents|respiratory system agents|mesh-ancestor
64455839|NCT02003573|Decitabine|decitabine|mesh-list
64455950|NCT01786551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64455951|NCT01786551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455952|NCT01786551|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64455953|NCT01786551|Diuretics|diuretics|mesh-ancestor
64455954|NCT01786551|Natriuretic Agents|natriuretic agents|mesh-ancestor
64455955|NCT01786551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64455956|NCT01973569|Denosumab|denosumab|mesh-list
64455960|NCT01951586|Denosumab|denosumab|mesh-list
64455978|NCT01785615|Atorvastatin|atorvastatin|mesh-list
64455979|NCT01785615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64455980|NCT01785615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64455981|NCT01785615|Antimetabolites|antimetabolites|mesh-ancestor
64455982|NCT01785615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455983|NCT01785615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64455984|NCT01785615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64455985|NCT01785615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455986|NCT04172779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64455987|NCT04172779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455988|NCT04172779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64455989|NCT04172779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455990|NCT04172779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455991|NCT01784523|Hydroxychloroquine|hydroxychloroquine|mesh-list
64455992|NCT01784523|Antimalarials|antimalarials|mesh-ancestor
64455993|NCT01784523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64455994|NCT01784523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64455995|NCT01784523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64455999|NCT01784211|Insulin Glargine|insulin glargine|mesh-list
64456034|NCT01912807|Autonomic Agents|autonomic agents|mesh-ancestor
64456035|NCT01912807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456036|NCT01912807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456037|NCT01912807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64456103|NCT01427920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64456115|NCT01427608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64456116|NCT01427608|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64456117|NCT01427608|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64456118|NCT01427608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64456166|NCT01896128|Modafinil|modafinil|mesh-list
64456263|NCT01405768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64456264|NCT01405768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456265|NCT01405768|Sensory System Agents|sensory system agents|mesh-ancestor
64456266|NCT01405768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456267|NCT01405768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64456268|NCT01405768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64456269|NCT01405768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64456270|NCT01405768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64456271|NCT01405768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456272|NCT01754259|Ranolazine|ranolazine|mesh-list
64456273|NCT01754259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64456274|NCT01754259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64456275|NCT01754259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456276|NCT01405456|Eplerenone|eplerenone|mesh-list
64456277|NCT01405456|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64456278|NCT01405456|Hormone Antagonists|hormone antagonists|mesh-ancestor
64456279|NCT01405456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64456280|NCT01405456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456295|NCT01617668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64456296|NCT01617668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456297|NCT01617668|Tubulin Modulators|tubulin modulators|mesh-ancestor
64456298|NCT01617668|Antimitotic Agents|antimitotic agents|mesh-ancestor
64456299|NCT01617668|Mitosis Modulators|mitosis modulators|mesh-ancestor
64456300|NCT01617668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456301|NCT01896050|Tamoxifen|tamoxifen|mesh-list
64456302|NCT01896050|Letrozole|letrozole|mesh-list
64456303|NCT01896050|Anastrozole|anastrozole|mesh-list
64456304|NCT01896050|Exemestane|exemestane|mesh-list
64456305|NCT01896050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456316|NCT01896050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64456317|NCT01896050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64456318|NCT01895270|Isradipine|isradipine|mesh-list
64456319|NCT01895270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64456320|NCT01895270|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64456321|NCT01895270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64456322|NCT01895270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456323|NCT01895270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64456324|NCT01895270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456325|NCT01895270|Vasodilator Agents|vasodilator agents|mesh-ancestor
64456326|NCT01424644|Vaccines|vaccines|mesh-list
64456327|NCT01424644|Immunologic Factors|immunologic factors|mesh-ancestor
64456334|NCT01403116|Androgens|androgens|mesh-ancestor
64456335|NCT01403116|Hormones|hormones|mesh-ancestor
64456336|NCT01403116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64456337|NCT01403116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456338|NCT01403116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64456339|NCT01403116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456340|NCT01403116|Anabolic Agents|anabolic agents|mesh-ancestor
64456341|NCT01753401|Prednisone|prednisone|mesh-list
64456472|NCT01387516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456473|NCT01387516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64456498|NCT01386970|Lamivudine|lamivudine|mesh-list
64456514|NCT05365984|Antimetabolites|antimetabolites|mesh-ancestor
64456515|NCT05365984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456516|NCT05365984|Gasotransmitters|gasotransmitters|mesh-ancestor
64456517|NCT05365984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64456518|NCT05365984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456519|NCT01780545|Docetaxel|docetaxel|mesh-list
64484478|NCT04658927|Glucocorticoids|glucocorticoids|mesh-ancestor
64456521|NCT01780545|Tubulin Modulators|tubulin modulators|mesh-ancestor
64456522|NCT01780545|Antimitotic Agents|antimitotic agents|mesh-ancestor
64456523|NCT01780545|Mitosis Modulators|mitosis modulators|mesh-ancestor
64456524|NCT01780545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456525|NCT01780389|Milnacipran|milnacipran|mesh-list
64456526|NCT01780389|Levomilnacipran|levomilnacipran|mesh-list
64456527|NCT01780389|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64456528|NCT01780389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64456529|NCT01780389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64456530|NCT01780389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456531|NCT01780389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64456532|NCT01780389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456533|NCT01780389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64456534|NCT01780389|Analgesics|analgesics|mesh-ancestor
64456535|NCT01780389|Sensory System Agents|sensory system agents|mesh-ancestor
64456566|NCT01399372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456702|NCT01775787|Autonomic Agents|autonomic agents|mesh-ancestor
64456703|NCT01775787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456704|NCT01775787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456705|NCT01775787|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64456706|NCT01775787|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64456707|NCT01775787|Cholinergic Agents|cholinergic agents|mesh-ancestor
64456708|NCT01775787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64456709|NCT01775787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456710|NCT01775787|Antipruritics|antipruritics|mesh-ancestor
64456711|NCT01775787|Dermatologic Agents|dermatologic agents|mesh-ancestor
64456712|NCT01775475|Prednisone|prednisone|mesh-list
64456713|NCT01775475|Cyclophosphamide|cyclophosphamide|mesh-list
64456714|NCT01775475|Lomustine|lomustine|mesh-list
64456715|NCT01775475|Doxorubicin|doxorubicin|mesh-list
64456716|NCT01775475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64456717|NCT01775475|Etoposide|etoposide|mesh-list
64456718|NCT01775475|Vincristine|vincristine|mesh-list
64456719|NCT01775475|Etoposide phosphate|etoposide phosphate|mesh-list
64456720|NCT01775475|Procarbazine|procarbazine|mesh-list
64456721|NCT01775475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64456736|NCT01775475|Hormones|hormones|mesh-ancestor
64456740|NCT01775475|Tubulin Modulators|tubulin modulators|mesh-ancestor
64456741|NCT01775475|Antimitotic Agents|antimitotic agents|mesh-ancestor
64456742|NCT01775475|Mitosis Modulators|mitosis modulators|mesh-ancestor
64456744|NCT01774929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64456745|NCT01774929|Narcotics|narcotics|mesh-ancestor
64456793|NCT01747629|Autonomic Agents|autonomic agents|mesh-ancestor
64456794|NCT01747629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456795|NCT01747629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456796|NCT01747629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64456797|NCT01747629|Respiratory System Agents|respiratory system agents|mesh-ancestor
64456798|NCT01747629|Tocolytic Agents|tocolytic agents|mesh-ancestor
64456799|NCT01747629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64456800|NCT01747629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64456801|NCT01747629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64456802|NCT01747629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64456812|NCT01886690|Laxatives|laxatives|mesh-ancestor
64456895|NCT01745367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456897|NCT01733121|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64456898|NCT01733121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64456899|NCT01733121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64456900|NCT01733121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456901|NCT01733121|Adrenergic Agents|adrenergic agents|mesh-ancestor
64456902|NCT01733121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64456903|NCT01733121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456904|NCT01383928|Dexamethasone|dexamethasone|mesh-list
64456905|NCT01383928|Lenalidomide|lenalidomide|mesh-list
64456906|NCT01383928|Ixazomib|ixazomib|mesh-list
64456907|NCT01383928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64456908|NCT01383928|Antiemetics|antiemetics|mesh-ancestor
64456909|NCT01383928|Autonomic Agents|autonomic agents|mesh-ancestor
64456910|NCT01383928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442668|NCT04794842|Phenol|phenol|mesh-list
64456911|NCT01383928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456925|NCT01383928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456926|NCT04023604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64456927|NCT04023604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64456928|NCT05368012|Dexamethasone|dexamethasone|mesh-list
64456929|NCT05368012|Bupivacaine|bupivacaine|mesh-list
64456930|NCT05368012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64456931|NCT05368012|Antiemetics|antiemetics|mesh-ancestor
64456932|NCT05368012|Autonomic Agents|autonomic agents|mesh-ancestor
64456933|NCT05368012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456934|NCT05368012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456935|NCT05368012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64456936|NCT05368012|Glucocorticoids|glucocorticoids|mesh-ancestor
64456937|NCT05368012|Hormones|hormones|mesh-ancestor
64456997|NCT01743027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64456998|NCT01743027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64457000|NCT01743027|Sensory System Agents|sensory system agents|mesh-ancestor
64457001|NCT01743027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64457143|NCT01726335|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64457144|NCT01726335|Dopamine Agents|dopamine agents|mesh-ancestor
64457146|NCT04563273|BCG Vaccine|bcg vaccine|mesh-list
64457147|NCT04563273|Immunologic Factors|immunologic factors|mesh-ancestor
64457148|NCT04563273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457149|NCT04563273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64457150|NCT01726023|Metronidazole|metronidazole|mesh-list
64457151|NCT01726023|Meropenem|meropenem|mesh-list
64457152|NCT01726023|Ceftazidime|ceftazidime|mesh-list
64457153|NCT01726023|Avibactam|avibactam|mesh-list
64457252|NCT01875237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64457253|NCT01875237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64457254|NCT01875237|Immunologic Factors|immunologic factors|mesh-ancestor
64457255|NCT01875237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64457256|NCT01875237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64457257|NCT01875237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64457258|NCT01875237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64457259|NCT01875237|Antiemetics|antiemetics|mesh-ancestor
64457260|NCT01875237|Autonomic Agents|autonomic agents|mesh-ancestor
64457269|NCT01875237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64457270|NCT01875237|Alkylating Agents|alkylating agents|mesh-ancestor
64457271|NCT01875237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64457272|NCT01875237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64457274|NCT01874535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64457275|NCT01874535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64457276|NCT01874535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64457277|NCT01874535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457278|NCT01874535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457280|NCT01722045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64457281|NCT01722045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64457282|NCT01722045|Growth Substances|growth substances|mesh-ancestor
64443007|NCT02049866|Denosumab|denosumab|mesh-list
64457283|NCT01722045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457342|NCT01856114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64457343|NCT01856114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64457344|NCT01856114|Anesthetics, General|anesthetics, general|mesh-ancestor
64457345|NCT01856114|Anesthetics|anesthetics|mesh-ancestor
64457346|NCT01614470|Ivacaftor|ivacaftor|mesh-list
64457347|NCT01614470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64457348|NCT01614470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64457349|NCT01614470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457350|NCT01880528|Lisinopril|lisinopril|mesh-list
64457351|NCT01880528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64457352|NCT01880528|Protease Inhibitors|protease inhibitors|mesh-ancestor
64457353|NCT01880528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457354|NCT01880528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457358|NCT01880528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457359|NCT01854944|Brexpiprazole|brexpiprazole|mesh-list
64457360|NCT01854944|Serotonin Agents|serotonin agents|mesh-ancestor
64457361|NCT01854944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64457362|NCT01854944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457363|NCT01854944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457364|NCT01854944|Dopamine Agonists|dopamine agonists|mesh-ancestor
64457365|NCT01854944|Dopamine Agents|dopamine agents|mesh-ancestor
64457366|NCT01854710|Moxifloxacin|moxifloxacin|mesh-list
64457367|NCT01854710|Loxapine|loxapine|mesh-list
64457368|NCT01854710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64457369|NCT01854710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64457370|NCT01854710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64457371|NCT01854710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64457372|NCT01854710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457373|NCT01854710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457374|NCT01854710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457375|NCT01854710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457406|NCT01853696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457407|NCT01853696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64457408|NCT01853696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457409|NCT01853696|Antiemetics|antiemetics|mesh-ancestor
64457410|NCT01853696|Autonomic Agents|autonomic agents|mesh-ancestor
64457411|NCT01853696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64457412|NCT01853696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64457413|NCT01853696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64457414|NCT01853696|Protective Agents|protective agents|mesh-ancestor
64457415|NCT01853696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64457416|NCT01719861|Desipramine|desipramine|mesh-list
64513623|NCT01457001|Micronutrients|micronutrients|mesh-ancestor
64457417|NCT01719861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64457418|NCT01719861|Antidepressive Agents|antidepressive agents|mesh-ancestor
64457518|NCT01717287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457519|NCT04605393|Dronabinol|dronabinol|mesh-list
64457650|NCT01393990|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64457651|NCT01393990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64457652|NCT00210184|Leucovorin|leucovorin|mesh-list
64457654|NCT00210184|Irinotecan|irinotecan|mesh-list
64457655|NCT00210184|Antimetabolites|antimetabolites|mesh-ancestor
64457656|NCT00210184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457660|NCT00210184|Immunologic Factors|immunologic factors|mesh-ancestor
64457824|NCT03024580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64457825|NCT03024580|Contraceptive Agents|contraceptive agents|mesh-ancestor
64457826|NCT03024580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64457827|NCT03024580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64457967|NCT00216736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64457968|NCT00216736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64457969|NCT00216736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457970|NCT01850030|Progesterone|progesterone|mesh-list
64457971|NCT01850030|Dydrogesterone|dydrogesterone|mesh-list
64457972|NCT01850030|Progestins|progestins|mesh-ancestor
64457973|NCT01850030|Hormones|hormones|mesh-ancestor
64457974|NCT01850030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64458120|NCT04191382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64458121|NCT04191382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458122|NCT01703091|Docetaxel|docetaxel|mesh-list
64458123|NCT01703091|Ramucirumab|ramucirumab|mesh-list
64458124|NCT01703091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458125|NCT01703091|Tubulin Modulators|tubulin modulators|mesh-ancestor
64458126|NCT01703091|Antimitotic Agents|antimitotic agents|mesh-ancestor
64458127|NCT01703091|Mitosis Modulators|mitosis modulators|mesh-ancestor
64458128|NCT01703091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458129|NCT04196998|Tenofovir|tenofovir|mesh-list
64458130|NCT04196998|Entecavir|entecavir|mesh-list
64458131|NCT04196998|Antiviral Agents|antiviral agents|mesh-ancestor
64458132|NCT04196998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64458133|NCT04196998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64458137|NCT04196998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64458230|NCT03970954|Analgesics|analgesics|mesh-ancestor
64458231|NCT03970954|Sensory System Agents|sensory system agents|mesh-ancestor
64458232|NCT03970954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458233|NCT03970954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458234|NCT03970720|Metoclopramide|metoclopramide|mesh-list
64458235|NCT03970720|Antiemetics|antiemetics|mesh-ancestor
64458236|NCT03970720|Autonomic Agents|autonomic agents|mesh-ancestor
64458237|NCT03970720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458238|NCT03970720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458239|NCT03970720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64458242|NCT03970720|Dopamine Agents|dopamine agents|mesh-ancestor
64458374|NCT04020328|Glucocorticoids|glucocorticoids|mesh-ancestor
64458375|NCT04020328|Hormones|hormones|mesh-ancestor
64458377|NCT04020328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458512|NCT04023292|Tamoxifen|tamoxifen|mesh-list
64458513|NCT04023292|Letrozole|letrozole|mesh-list
64458514|NCT04023292|Exemestane|exemestane|mesh-list
64458515|NCT04023292|Anastrozole|anastrozole|mesh-list
64458516|NCT04023292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458517|NCT04023292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64458518|NCT04023292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64458519|NCT04023292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458520|NCT04023292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458521|NCT04023292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64458522|NCT04023292|Hormone Antagonists|hormone antagonists|mesh-ancestor
64458523|NCT04023292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64458524|NCT04023292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458529|NCT03022240|Ondansetron|ondansetron|mesh-list
64458571|NCT04147390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64458572|NCT04147390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458573|NCT04147390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64458574|NCT04147390|Antitubercular Agents|antitubercular agents|mesh-ancestor
64458575|NCT04147390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64458634|NCT01711359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458635|NCT01711359|Dermatologic Agents|dermatologic agents|mesh-ancestor
64458636|NCT01711359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458637|NCT01711359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64458779|NCT03944434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64458994|NCT03896230|Anesthetics|anesthetics|mesh-ancestor
64458995|NCT03896230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64513629|NCT01457469|Nicotine|nicotine|mesh-list
64459126|NCT03891706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459127|NCT03891706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64459128|NCT03891706|Analgesics|analgesics|mesh-ancestor
64459293|NCT03026062|Ipilimumab|ipilimumab|mesh-list
64459307|NCT03584074|Sensory System Agents|sensory system agents|mesh-ancestor
64459308|NCT03584074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459309|NCT03584074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459310|NCT03584074|Anticonvulsants|anticonvulsants|mesh-ancestor
64459311|NCT03584074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64459312|NCT03584074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64459313|NCT03584074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459326|NCT03583138|Buprenorphine|buprenorphine|mesh-list
64459390|NCT01818752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64459391|NCT01818752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64459392|NCT01818752|Immunologic Factors|immunologic factors|mesh-ancestor
64459527|NCT01670890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64459528|NCT01670890|Alkylating Agents|alkylating agents|mesh-ancestor
64459530|NCT04551196|Acetaminophen|acetaminophen|mesh-list
64459672|NCT03806452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459673|NCT03806452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64459675|NCT01672450|Interleukin-2|interleukin-2|mesh-list
64459676|NCT01672450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64459677|NCT01672450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459678|NCT01672450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64459679|NCT01672450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459680|NCT01672450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64459681|NCT01672450|Analgesics|analgesics|mesh-ancestor
64459898|NCT02081638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459899|NCT02081638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64459900|NCT02081638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64460024|NCT01675648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64460025|NCT01675648|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64460179|NCT03844048|Venetoclax|venetoclax|mesh-list
64460328|NCT03814954|Respiratory System Agents|respiratory system agents|mesh-ancestor
64460329|NCT03814954|Mydriatics|mydriatics|mesh-ancestor
64460330|NCT03814954|Sympathomimetics|sympathomimetics|mesh-ancestor
64460331|NCT03814954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64460332|NCT03814954|Tocolytic Agents|tocolytic agents|mesh-ancestor
64460335|NCT03813160|Dronabinol|dronabinol|mesh-list
64460463|NCT03802240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460472|NCT01587651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64460473|NCT01587651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64460474|NCT01587651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64460475|NCT01587651|Purinergic Agents|purinergic agents|mesh-ancestor
64460476|NCT01587651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64460477|NCT01587651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460478|NCT01587651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460479|NCT04763434|Dexamethasone|dexamethasone|mesh-list
64460480|NCT04763434|Dexmedetomidine|dexmedetomidine|mesh-list
64460481|NCT04763434|Ropivacaine|ropivacaine|mesh-list
64460482|NCT04763434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64460489|NCT04763434|Hormones|hormones|mesh-ancestor
64460569|NCT01561755|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64460570|NCT01561755|Immunologic Factors|immunologic factors|mesh-ancestor
64460571|NCT01561755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460572|NCT03789214|Suvorexant|suvorexant|mesh-list
64460573|NCT03789214|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64460574|NCT03789214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64460575|NCT03789214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64460576|NCT03789214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460577|NCT03789214|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64460578|NCT03789214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64460579|NCT03789214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460580|NCT04124367|Cerebrolysin|cerebrolysin|mesh-list
64460581|NCT04124367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64460582|NCT04124367|Protective Agents|protective agents|mesh-ancestor
64460583|NCT04124367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460584|NCT04124367|Nootropic Agents|nootropic agents|mesh-ancestor
64460585|NCT01560507|Bupropion|bupropion|mesh-list
64945377|NCT05672225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64460586|NCT01560507|Nicotine|nicotine|mesh-list
64460587|NCT01560507|Varenicline|varenicline|mesh-list
64460588|NCT01560507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64460608|NCT03694834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64460610|NCT03587740|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64460611|NCT03587740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64460612|NCT03587740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460613|NCT03587740|Tubulin Modulators|tubulin modulators|mesh-ancestor
64460614|NCT03587740|Antimitotic Agents|antimitotic agents|mesh-ancestor
64460615|NCT03587740|Mitosis Modulators|mitosis modulators|mesh-ancestor
64993116|NCT02830724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64993117|NCT02830724|Immunologic Factors|immunologic factors|mesh-ancestor
64993118|NCT02830724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993169|NCT02737046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64993170|NCT02737046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993171|NCT02737046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64993172|NCT02737046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64993173|NCT02737046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64993174|NCT02707926|Anti-HIV Agents|anti-hiv agents|mesh-list
64993175|NCT02707926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64993176|NCT02707926|Antiviral Agents|antiviral agents|mesh-ancestor
64993177|NCT02707926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64993178|NCT02682485|Metronidazole|metronidazole|mesh-list
64993179|NCT02682485|Ciprofloxacin|ciprofloxacin|mesh-list
64993180|NCT02682485|Neomycin|neomycin|mesh-list
64993181|NCT02682485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64993182|NCT02682485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64993183|NCT02682485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64460616|NCT03587740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460618|NCT03586414|Micronutrients|micronutrients|mesh-ancestor
64460619|NCT03586414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460620|NCT03684538|Zinc|zinc|mesh-list
64460621|NCT03684538|Trace Elements|trace elements|mesh-ancestor
64460622|NCT03684538|Micronutrients|micronutrients|mesh-ancestor
64460623|NCT03684538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460624|NCT03682978|Baclofen|baclofen|mesh-list
64460625|NCT03682978|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64460752|NCT03673072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460753|NCT03673072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64460754|NCT03673072|Immunologic Factors|immunologic factors|mesh-ancestor
64460755|NCT03673072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460757|NCT03557008|Vancomycin|vancomycin|mesh-list
64460758|NCT03557008|Neomycin|neomycin|mesh-list
64460759|NCT03557008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64460760|NCT03557008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64460761|NCT03557008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64460762|NCT03557008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64460763|NCT03557008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64460764|NCT03557008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460765|NCT03557008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460766|NCT03572530|Azacitidine|azacitidine|mesh-list
64460767|NCT03572530|Decitabine|decitabine|mesh-list
64460768|NCT03572530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64460769|NCT03572530|Antimetabolites|antimetabolites|mesh-ancestor
64460770|NCT03572530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460771|NCT03572530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460772|NCT03572530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460773|NCT01690299|Etanercept|etanercept|mesh-list
64460774|NCT01690299|Apremilast|apremilast|mesh-list
64460775|NCT01690299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64460776|NCT01690299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64460777|NCT01690299|Analgesics|analgesics|mesh-ancestor
64460778|NCT01690299|Sensory System Agents|sensory system agents|mesh-ancestor
64460779|NCT01690299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64460780|NCT01690299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460781|NCT01690299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64460782|NCT01690299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64460783|NCT01690299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64460784|NCT01690299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64460785|NCT01690299|Immunologic Factors|immunologic factors|mesh-ancestor
64460786|NCT01690299|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64460787|NCT01690299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64460788|NCT01690299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460791|NCT03570814|Ivermectin|ivermectin|mesh-list
64460792|NCT03570814|Albendazole|albendazole|mesh-list
64460795|NCT03570814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64460796|NCT03570814|Anthelmintics|anthelmintics|mesh-ancestor
64460797|NCT03570814|Anticestodal Agents|anticestodal agents|mesh-ancestor
64460798|NCT03570814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64460799|NCT03570814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64460800|NCT03570814|Tubulin Modulators|tubulin modulators|mesh-ancestor
64460801|NCT03570814|Antimitotic Agents|antimitotic agents|mesh-ancestor
64460802|NCT03570814|Mitosis Modulators|mitosis modulators|mesh-ancestor
64460803|NCT03570814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460804|NCT03570814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460805|NCT00723736|Desloratadine|desloratadine|mesh-list
64460806|NCT00723736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64460807|NCT00723736|Cholinergic Agents|cholinergic agents|mesh-ancestor
64460808|NCT00723736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64945378|NCT05672225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64460809|NCT00723736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460818|NCT01690143|Melphalan|melphalan|mesh-list
64460845|NCT03563248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64460846|NCT03563248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460847|NCT03563248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64460848|NCT03563248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64460849|NCT03563248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64460850|NCT03563248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64460851|NCT04403776|Tofacitinib|tofacitinib|mesh-list
64460852|NCT04403776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64460853|NCT04403776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460854|NCT04403776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460855|NCT03662074|Gemcitabine|gemcitabine|mesh-list
64460856|NCT03662074|Nivolumab|nivolumab|mesh-list
64460857|NCT03662074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64460858|NCT03662074|Antimetabolites|antimetabolites|mesh-ancestor
64460860|NCT03662074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460871|NCT03559348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64460872|NCT03559348|Antimetabolites|antimetabolites|mesh-ancestor
64460873|NCT03559348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460891|NCT04762030|Tubulin Modulators|tubulin modulators|mesh-ancestor
64460892|NCT04762030|Antimitotic Agents|antimitotic agents|mesh-ancestor
64460893|NCT04762030|Mitosis Modulators|mitosis modulators|mesh-ancestor
64460894|NCT04762030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460895|NCT04762030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64460896|NCT01559259|Acetaminophen|acetaminophen|mesh-list
64460897|NCT01559259|Ibuprofen|ibuprofen|mesh-list
64460898|NCT01559259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64460998|NCT01678612|Micronutrients|micronutrients|mesh-ancestor
64460999|NCT01678612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461000|NCT03525574|Ivacaftor|ivacaftor|mesh-list
64461001|NCT03525574|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64461002|NCT03525574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64461004|NCT02402920|Cisplatin|cisplatin|mesh-list
64461051|NCT03087136|Immunologic Factors|immunologic factors|mesh-ancestor
64461052|NCT03087136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461053|NCT03087136|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64461054|NCT03087136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64461055|NCT03087136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461056|NCT03087136|Antiviral Agents|antiviral agents|mesh-ancestor
64461057|NCT03087136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64461058|NCT03087136|Interferon Inducers|interferon inducers|mesh-ancestor
64461059|NCT03087136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64461060|NCT03087136|Protective Agents|protective agents|mesh-ancestor
64461061|NCT01689519|Vemurafenib|vemurafenib|mesh-list
64461062|NCT01689519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461063|NCT01689519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64461064|NCT01689519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461065|NCT01689519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461066|NCT01689363|Histamine|histamine|mesh-list
64461067|NCT01689363|Histamine Agonists|histamine agonists|mesh-ancestor
64461068|NCT01689363|Histamine Agents|histamine agents|mesh-ancestor
64461069|NCT01689363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64461070|NCT01689363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461071|NCT01689363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461072|NCT03455140|BCT-100|bct-100|mesh-list
64461073|NCT03455140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461074|NCT03502018|Bupivacaine|bupivacaine|mesh-list
64461075|NCT03502018|Anesthetics, Local|anesthetics, local|mesh-ancestor
64461101|NCT01688973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461102|NCT00087646|Ribavirin|ribavirin|mesh-list
64461103|NCT00087646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64461104|NCT00087646|Interferon-alpha|interferon-alpha|mesh-list
64461105|NCT00087646|Antimetabolites|antimetabolites|mesh-ancestor
64461106|NCT00087646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993184|NCT02682485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64993185|NCT02682485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64461107|NCT00087646|Antiviral Agents|antiviral agents|mesh-ancestor
64461108|NCT00087646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64461109|NCT00087646|Immunologic Factors|immunologic factors|mesh-ancestor
64461110|NCT00087646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461111|NCT03492658|Methotrexate|methotrexate|mesh-list
64461112|NCT03492658|Abatacept|abatacept|mesh-list
64461113|NCT03492658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64461114|NCT03492658|Abortifacient Agents|abortifacient agents|mesh-ancestor
64461115|NCT03492658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64461116|NCT03492658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461117|NCT03492658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64461118|NCT03492658|Antimetabolites|antimetabolites|mesh-ancestor
64461119|NCT03492658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461120|NCT03492658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461121|NCT03492658|Dermatologic Agents|dermatologic agents|mesh-ancestor
64461122|NCT03492658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461123|NCT03492658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64461124|NCT03492658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64461125|NCT03492658|Immunologic Factors|immunologic factors|mesh-ancestor
64461126|NCT03492658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64461127|NCT03492658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64461128|NCT03492658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64461129|NCT03085654|Oxytocin|oxytocin|mesh-list
64461130|NCT03085654|Oxytocics|oxytocics|mesh-ancestor
64461146|NCT04402762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461147|NCT00085540|Romidepsin|romidepsin|mesh-list
64461148|NCT00085540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64461149|NCT00085540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461150|NCT01688739|Erenumab|erenumab|mesh-list
64461151|NCT01688739|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64461167|NCT00084838|Cisplatin|cisplatin|mesh-list
64461168|NCT00084838|Doxorubicin|doxorubicin|mesh-list
64461169|NCT00084838|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64461170|NCT00084838|Methotrexate|methotrexate|mesh-list
64461171|NCT00084838|Etoposide|etoposide|mesh-list
64461172|NCT00084838|Vincristine|vincristine|mesh-list
64461173|NCT00084838|Dexrazoxane|dexrazoxane|mesh-list
64461174|NCT00084838|Razoxane|razoxane|mesh-list
64461175|NCT00084838|Lenograstim|lenograstim|mesh-list
64461176|NCT00084838|Calcium|calcium|mesh-list
64461177|NCT00084838|Levoleucovorin|levoleucovorin|mesh-list
64461178|NCT00084838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64461179|NCT00084838|Immunologic Factors|immunologic factors|mesh-ancestor
64461180|NCT00084838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461190|NCT00084838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461191|NCT00084838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64461192|NCT00084838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64461193|NCT00084838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64461194|NCT00084838|Abortifacient Agents|abortifacient agents|mesh-ancestor
64461195|NCT00084838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64461197|NCT00084838|Antimetabolites|antimetabolites|mesh-ancestor
64461269|NCT03084952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64461290|NCT03443128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461291|NCT03443128|Tubulin Modulators|tubulin modulators|mesh-ancestor
64461292|NCT03443128|Antimitotic Agents|antimitotic agents|mesh-ancestor
64461293|NCT03443128|Mitosis Modulators|mitosis modulators|mesh-ancestor
64461294|NCT03443128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461295|NCT03437746|Methylprednisolone|methylprednisolone|mesh-list
64461296|NCT03437746|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64461297|NCT03437746|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64461359|NCT03435718|Antimitotic Agents|antimitotic agents|mesh-ancestor
64461360|NCT03435718|Mitosis Modulators|mitosis modulators|mesh-ancestor
64461361|NCT03435718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461362|NCT03435718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461364|NCT01678690|Gemcitabine|gemcitabine|mesh-list
64461412|NCT03083704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64461413|NCT03471442|Bupivacaine|bupivacaine|mesh-list
64461414|NCT03471442|Ropivacaine|ropivacaine|mesh-list
64461415|NCT03471442|Anesthetics, Local|anesthetics, local|mesh-list
64461416|NCT03471442|Anesthetics|anesthetics|mesh-list
64461417|NCT03471442|Anesthetics, General|anesthetics, general|mesh-list
64461418|NCT03471442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64461419|NCT03471442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557637|NCT03067896|Adrenergic Agents|adrenergic agents|mesh-ancestor
64461447|NCT03083080|Mydriatics|mydriatics|mesh-ancestor
64461448|NCT03083080|Sympathomimetics|sympathomimetics|mesh-ancestor
64461449|NCT03083080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64461450|NCT03087760|Pembrolizumab|pembrolizumab|mesh-list
64461451|NCT03087760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64461452|NCT03087760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461453|NCT03466294|Azacitidine|azacitidine|mesh-list
64461455|NCT03466294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64461456|NCT03466294|Antimetabolites|antimetabolites|mesh-ancestor
64461457|NCT03466294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461458|NCT03466294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461459|NCT03466294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461461|NCT03082300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461462|NCT03082300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64461463|NCT03082300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461464|NCT03082300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461465|NCT03435250|Gemcitabine|gemcitabine|mesh-list
64461466|NCT03435250|Paclitaxel|paclitaxel|mesh-list
64461467|NCT03435250|Docetaxel|docetaxel|mesh-list
64461505|NCT03431194|Autonomic Agents|autonomic agents|mesh-ancestor
64461506|NCT03431194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64461507|NCT03431194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461508|NCT03431194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64461509|NCT03431194|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64461510|NCT03431194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64461511|NCT03431194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64461512|NCT03431194|Adrenergic Agents|adrenergic agents|mesh-ancestor
64461513|NCT03431194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64993186|NCT02682485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64993187|NCT02682485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993188|NCT02682485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461514|NCT03431194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461516|NCT03080740|Clindamycin|clindamycin|mesh-list
64461517|NCT03080740|Clindamycin palmitate|clindamycin palmitate|mesh-list
64461518|NCT03080740|Clindamycin phosphate|clindamycin phosphate|mesh-list
64461519|NCT03080740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64461520|NCT03080740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64461521|NCT03080740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64461522|NCT03080740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64461523|NCT03080740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64461560|NCT03080194|Serotonin Agents|serotonin agents|mesh-ancestor
64461561|NCT03080194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64461562|NCT03080194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461563|NCT03080194|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64461564|NCT03080194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64461565|NCT03080194|Dopamine Agents|dopamine agents|mesh-ancestor
64461566|NCT01610336|Gefitinib|gefitinib|mesh-list
64461567|NCT01610336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461568|NCT01610336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64461569|NCT01610336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461570|NCT01610336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461571|NCT03323866|Mometasone Furoate|mometasone furoate|mesh-list
64461572|NCT03323866|Budesonide|budesonide|mesh-list
64461573|NCT03323866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64461574|NCT03323866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64461575|NCT03323866|Autonomic Agents|autonomic agents|mesh-ancestor
64461576|NCT03323866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64461577|NCT03323866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461578|NCT03323866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64461579|NCT03323866|Respiratory System Agents|respiratory system agents|mesh-ancestor
64461580|NCT03323866|Glucocorticoids|glucocorticoids|mesh-ancestor
64461581|NCT03323866|Hormones|hormones|mesh-ancestor
64461612|NCT03366298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64461613|NCT03366298|Respiratory System Agents|respiratory system agents|mesh-ancestor
64461614|NCT03366298|Mydriatics|mydriatics|mesh-ancestor
64461618|NCT05688436|Interferon-beta|interferon-beta|mesh-list
64461619|NCT05688436|Alemtuzumab|alemtuzumab|mesh-list
64461620|NCT05688436|Glatiramer Acetate|glatiramer acetate|mesh-list
64461621|NCT05688436|Ocrelizumab|ocrelizumab|mesh-list
64461622|NCT05688436|Natalizumab|natalizumab|mesh-list
64461623|NCT05688436|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64461624|NCT05688436|(T,G)-A-L|(t,g)-a-l|mesh-list
64461625|NCT05688436|Siponimod|siponimod|mesh-list
64461626|NCT05688436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461627|NCT05688436|Antiviral Agents|antiviral agents|mesh-ancestor
64461628|NCT05688436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64461629|NCT05688436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64461630|NCT05688436|Immunologic Factors|immunologic factors|mesh-ancestor
64461631|NCT05688436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461632|NCT05688436|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64461633|NCT05688436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461634|NCT05688436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64461635|NCT05688436|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64461637|NCT03386578|Tenofovir|tenofovir|mesh-list
64461638|NCT03386578|Emtricitabine|emtricitabine|mesh-list
64461639|NCT03386578|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64461640|NCT03386578|Antiviral Agents|antiviral agents|mesh-ancestor
64461641|NCT03386578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64461699|NCT05687344|Nifedipine|nifedipine|mesh-list
64461700|NCT05687344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64461701|NCT05687344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64461702|NCT05687344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461703|NCT05687344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64461704|NCT05687344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461705|NCT05687344|Vasodilator Agents|vasodilator agents|mesh-ancestor
64461706|NCT05687344|Tocolytic Agents|tocolytic agents|mesh-ancestor
64461707|NCT05687344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64461708|NCT04760704|Antibodies|antibodies|mesh-list
64461709|NCT04760704|Immunologic Factors|immunologic factors|mesh-ancestor
64461710|NCT04760704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461711|NCT03356860|Paclitaxel|paclitaxel|mesh-list
64993189|NCT02682485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993196|NCT02649790|Autonomic Agents|autonomic agents|mesh-ancestor
64993197|NCT02649790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64461712|NCT03356860|Cyclophosphamide|cyclophosphamide|mesh-list
64461713|NCT03356860|Durvalumab|durvalumab|mesh-list
64461714|NCT03356860|Epirubicin|epirubicin|mesh-list
64461715|NCT03356860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64461716|NCT03356860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461717|NCT03356860|Tubulin Modulators|tubulin modulators|mesh-ancestor
64461718|NCT03356860|Antimitotic Agents|antimitotic agents|mesh-ancestor
64461719|NCT03356860|Mitosis Modulators|mitosis modulators|mesh-ancestor
64461720|NCT03356860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461721|NCT03356860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64461722|NCT03356860|Immunologic Factors|immunologic factors|mesh-ancestor
64461723|NCT03356860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461724|NCT03356860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64461725|NCT03356860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64461726|NCT03356860|Alkylating Agents|alkylating agents|mesh-ancestor
64461727|NCT03356860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64461728|NCT03356860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64461729|NCT03356860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64461741|NCT01842308|Alkylating Agents|alkylating agents|mesh-ancestor
64461742|NCT01842308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461743|NCT01842308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461744|NCT01842308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64461745|NCT01842308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64461746|NCT01842308|Immunologic Factors|immunologic factors|mesh-ancestor
64461747|NCT01842308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461749|NCT01931059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64461750|NCT01931059|Serotonin Agents|serotonin agents|mesh-ancestor
64461760|NCT01841762|Macitentan|macitentan|mesh-list
64461839|NCT04171700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461840|NCT04171700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461841|NCT04171700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461842|NCT05604742|Belimumab|belimumab|mesh-list
64461843|NCT05604742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64461844|NCT05604742|Immunologic Factors|immunologic factors|mesh-ancestor
64461845|NCT05604742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461846|NCT03350386|Oxaprozin|oxaprozin|mesh-list
64461847|NCT03350386|Dotinurad|dotinurad|mesh-list
64461848|NCT03350386|Uricosuric Agents|uricosuric agents|mesh-ancestor
64461849|NCT03350386|Gout Suppressants|gout suppressants|mesh-ancestor
64461850|NCT03350386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64461851|NCT03350386|Renal Agents|renal agents|mesh-ancestor
64461852|NCT03350386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64461853|NCT03350386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64461854|NCT03350386|Analgesics|analgesics|mesh-ancestor
64461855|NCT03350386|Sensory System Agents|sensory system agents|mesh-ancestor
64461856|NCT03350386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64461857|NCT03350386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461858|NCT03350386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64461859|NCT03350386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64461860|NCT03350386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461861|NCT03350386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461862|NCT05567458|Luspatercept|luspatercept|mesh-list
64461863|NCT05567458|Hematinics|hematinics|mesh-ancestor
64461864|NCT05305924|Fulvestrant|fulvestrant|mesh-list
64461876|NCT05548582|Analgesics|analgesics|mesh-ancestor
64461877|NCT05548582|Sensory System Agents|sensory system agents|mesh-ancestor
64461878|NCT05548582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64461879|NCT05548582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461880|NCT05548582|Antipyretics|antipyretics|mesh-ancestor
64461881|NCT05548582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64461882|NCT05548582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64993198|NCT02649790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993199|NCT02649790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64993200|NCT02649790|Glucocorticoids|glucocorticoids|mesh-ancestor
64993201|NCT02649790|Hormones|hormones|mesh-ancestor
64993202|NCT02649790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64993203|NCT02649790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64993204|NCT02649790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461883|NCT05548582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64461884|NCT05548582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64461885|NCT05548582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461886|NCT05548582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461887|NCT05548582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64461888|NCT05548582|Narcotics|narcotics|mesh-ancestor
64461889|NCT05548582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64461890|NCT03274258|Nivolumab|nivolumab|mesh-list
64461972|NCT05139004|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
64461973|NCT05139004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461974|NCT05139004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64461975|NCT05139004|Antimetabolites|antimetabolites|mesh-ancestor
64461976|NCT05139004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461977|NCT05139004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64461978|NCT05139004|Immunologic Factors|immunologic factors|mesh-ancestor
64461979|NCT05139004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461980|NCT05139004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64461981|NCT05139004|Alkylating Agents|alkylating agents|mesh-ancestor
64461984|NCT05139004|Chelating Agents|chelating agents|mesh-ancestor
64462113|NCT04805944|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64462114|NCT04805944|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64462115|NCT04805944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462116|NCT04805944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462117|NCT04805944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64462118|NCT04805944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64462119|NCT04805944|Antiviral Agents|antiviral agents|mesh-ancestor
64462120|NCT04805944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64462121|NCT03906292|Niacinamide|niacinamide|mesh-list
64462122|NCT03906292|Imatinib Mesylate|imatinib mesylate|mesh-list
64462123|NCT03906292|Dasatinib|dasatinib|mesh-list
64462124|NCT03906292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462125|NCT03906292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64462126|NCT03906292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462127|NCT03906292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462128|NCT03906292|Vitamin B Complex|vitamin b complex|mesh-ancestor
64462129|NCT03906292|Vitamins|vitamins|mesh-ancestor
64462130|NCT03906292|Micronutrients|micronutrients|mesh-ancestor
64462131|NCT03906292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462132|NCT03229174|Droxidopa|droxidopa|mesh-list
64462133|NCT03229174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64462134|NCT03229174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64462135|NCT03227926|Panitumumab|panitumumab|mesh-list
64462136|NCT03227926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64462137|NCT03227926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462138|NCT03615742|Budesonide|budesonide|mesh-list
64462139|NCT03615742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64462140|NCT03615742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64462141|NCT03615742|Autonomic Agents|autonomic agents|mesh-ancestor
64462142|NCT03615742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462143|NCT03615742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993205|NCT02636725|Pembrolizumab|pembrolizumab|mesh-list
64993206|NCT02636725|Axitinib|axitinib|mesh-list
64993207|NCT02636725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64993208|NCT02636725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993209|NCT02636725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64993210|NCT02636725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993211|NCT02636725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993212|NCT02631733|Irinotecan|irinotecan|mesh-list
64993213|NCT02631733|Veliparib|veliparib|mesh-list
64993286|NCT02521493|Dermatologic Agents|dermatologic agents|mesh-ancestor
64993287|NCT02521493|Tubulin Modulators|tubulin modulators|mesh-ancestor
64993288|NCT02521493|Antimitotic Agents|antimitotic agents|mesh-ancestor
64993289|NCT02521493|Mitosis Modulators|mitosis modulators|mesh-ancestor
64993291|NCT02502266|Doxorubicin|doxorubicin|mesh-list
64993292|NCT02502266|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64462144|NCT03615742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64462146|NCT03615742|Glucocorticoids|glucocorticoids|mesh-ancestor
64462150|NCT01363297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64462151|NCT01363297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462152|NCT01363297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64462153|NCT04756804|Ethanol|ethanol|mesh-list
64462154|NCT04756804|Chlorhexidine|chlorhexidine|mesh-list
64462155|NCT04756804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64462156|NCT04756804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64462157|NCT04756804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64462158|NCT04756804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64462159|NCT04756804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462160|NCT04756804|Disinfectants|disinfectants|mesh-ancestor
64462161|NCT04756804|Dermatologic Agents|dermatologic agents|mesh-ancestor
64462162|NCT03829462|Irinotecan|irinotecan|mesh-list
64462163|NCT03829462|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64462164|NCT03829462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64462165|NCT03829462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462166|NCT03829462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462167|NCT03829462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462168|NCT03199924|Diclofenac|diclofenac|mesh-list
64462169|NCT03199924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64462170|NCT03199924|Lidocaine|lidocaine|mesh-list
64462171|NCT03199924|Magnesium Sulfate|magnesium sulfate|mesh-list
64462172|NCT03199924|Anesthetics, Local|anesthetics, local|mesh-ancestor
64462173|NCT03199924|Anesthetics|anesthetics|mesh-ancestor
64462174|NCT03199924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64462175|NCT03199924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462176|NCT03199924|Sensory System Agents|sensory system agents|mesh-ancestor
64462177|NCT03199924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462195|NCT03199300|Bleomycin|bleomycin|mesh-list
64993293|NCT02502266|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64993294|NCT02502266|Topotecan|topotecan|mesh-list
64993295|NCT02502266|Olaparib|olaparib|mesh-list
64993296|NCT02502266|Cediranib|cediranib|mesh-list
64993297|NCT02502266|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64993298|NCT02502266|Maleic acid|maleic acid|mesh-list
64993299|NCT02502266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64993300|NCT02502266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993301|NCT02502266|Tubulin Modulators|tubulin modulators|mesh-ancestor
64993302|NCT02502266|Antimitotic Agents|antimitotic agents|mesh-ancestor
64993303|NCT02502266|Mitosis Modulators|mitosis modulators|mesh-ancestor
64993304|NCT02502266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993338|NCT02496208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993339|NCT02466971|Cisplatin|cisplatin|mesh-list
64462196|NCT03199300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462197|NCT03199300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64462198|NCT03199300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64462199|NCT04746430|Dexamethasone|dexamethasone|mesh-list
64462200|NCT04746430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64462201|NCT04746430|Antiemetics|antiemetics|mesh-ancestor
64462202|NCT04746430|Autonomic Agents|autonomic agents|mesh-ancestor
64462203|NCT04746430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462206|NCT04746430|Glucocorticoids|glucocorticoids|mesh-ancestor
64462287|NCT01908829|Urological Agents|urological agents|mesh-ancestor
64462288|NCT01908829|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64462289|NCT01908829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64462290|NCT01908829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64462291|NCT01908829|Adrenergic Agents|adrenergic agents|mesh-ancestor
64462292|NCT03764098|Guanfacine|guanfacine|mesh-list
64462293|NCT03764098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64462294|NCT03764098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64462295|NCT03764098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64462296|NCT03764098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64462297|NCT03764098|Adrenergic Agents|adrenergic agents|mesh-ancestor
64462298|NCT03764098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64462299|NCT03764098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462300|NCT03764098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462301|NCT01773122|Dapsone|dapsone|mesh-list
64462302|NCT01773122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64462303|NCT01773122|Antimalarials|antimalarials|mesh-ancestor
64462304|NCT01773122|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64462305|NCT01773122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64462306|NCT01773122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64462307|NCT01773122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462309|NCT01773122|Leprostatic Agents|leprostatic agents|mesh-ancestor
64462326|NCT03621904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-list
64462380|NCT03568708|Contraceptive Agents|contraceptive agents|mesh-ancestor
64462381|NCT03568708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64462382|NCT03568708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64462383|NCT04305106|Dexamethasone|dexamethasone|mesh-list
64462384|NCT04305106|Dexamethasone acetate|dexamethasone acetate|mesh-list
64462385|NCT04305106|Bevacizumab|bevacizumab|mesh-list
64462386|NCT04305106|Heparin|heparin|mesh-list
64462387|NCT04305106|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64462388|NCT04305106|Tinzaparin|tinzaparin|mesh-list
64462389|NCT04305106|Dalteparin|dalteparin|mesh-list
64462390|NCT04305106|Anticoagulants|anticoagulants|mesh-list
64462391|NCT04305106|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64462392|NCT04305106|BB 1101|bb 1101|mesh-list
64462393|NCT04305106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64462394|NCT04305106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462395|NCT04305106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64462396|NCT04305106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64462397|NCT04305106|Growth Substances|growth substances|mesh-ancestor
64462398|NCT04305106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462399|NCT04305106|Growth Inhibitors|growth inhibitors|mesh-ancestor
64462400|NCT04305106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64462402|NCT04305106|Autonomic Agents|autonomic agents|mesh-ancestor
64462403|NCT04305106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462404|NCT04305106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64462405|NCT04305106|Glucocorticoids|glucocorticoids|mesh-ancestor
64462406|NCT04305106|Hormones|hormones|mesh-ancestor
64462407|NCT04305106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64462409|NCT04305106|Protease Inhibitors|protease inhibitors|mesh-ancestor
64462417|NCT01770392|Antitubercular Agents|antitubercular agents|mesh-ancestor
64462418|NCT01770392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64462419|NCT01770392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64462420|NCT01770392|Leprostatic Agents|leprostatic agents|mesh-ancestor
64462421|NCT01770392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64462429|NCT01770392|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64462430|NCT01770392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462431|NCT01770392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64462432|NCT01603641|Botulinum Toxins|botulinum toxins|mesh-list
64462433|NCT01603641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64462434|NCT01603641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64462438|NCT01603641|Cholinergic Agents|cholinergic agents|mesh-ancestor
64462469|NCT04397458|Sensory System Agents|sensory system agents|mesh-ancestor
64462471|NCT04398316|Hydromorphone|hydromorphone|mesh-list
64462472|NCT04398316|Anesthetics, Local|anesthetics, local|mesh-ancestor
64462473|NCT04398316|Anesthetics|anesthetics|mesh-ancestor
64462474|NCT04398316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64462475|NCT04398316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462534|NCT04276090|Glucocorticoids|glucocorticoids|mesh-ancestor
64462535|NCT04276090|Hormones|hormones|mesh-ancestor
64462536|NCT04276090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64462537|NCT04276090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64462538|NCT04276090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462539|NCT04276090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64462540|NCT04276090|Antimetabolites|antimetabolites|mesh-ancestor
64462541|NCT04276090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462542|NCT04226248|Rivastigmine|rivastigmine|mesh-list
64462543|NCT04226248|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64462544|NCT04226248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462545|NCT04226248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462546|NCT04226248|Cholinergic Agents|cholinergic agents|mesh-ancestor
64462547|NCT04226248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64462548|NCT04226248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462549|NCT04226248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64462550|NCT04226248|Protective Agents|protective agents|mesh-ancestor
64462551|NCT01892722|Interferons|interferons|mesh-list
64462552|NCT01892722|Interferon-beta|interferon-beta|mesh-list
64462553|NCT01892722|Interferon beta-1a|interferon beta-1a|mesh-list
64462554|NCT01892722|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64462564|NCT04398004|Clarithromycin|clarithromycin|mesh-list
64462579|NCT01555671|Analgesics|analgesics|mesh-ancestor
64462580|NCT01555671|Sensory System Agents|sensory system agents|mesh-ancestor
64462581|NCT01555671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462582|NCT01555671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64462583|NCT03226756|Nivolumab|nivolumab|mesh-list
64462584|NCT03226756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64462585|NCT03226756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462586|NCT03226756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64462587|NCT03226756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462588|NCT01807598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64462589|NCT01807598|Immunoconjugates|immunoconjugates|mesh-list
64462590|NCT01807598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64462591|NCT01807598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462592|NCT01807598|Immunologic Factors|immunologic factors|mesh-ancestor
64462593|NCT01807598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462594|NCT01801280|Mycophenolic Acid|mycophenolic acid|mesh-list
64462595|NCT01801280|Pantoprazole|pantoprazole|mesh-list
64462596|NCT01801280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64462597|NCT01801280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462598|NCT01801280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64462599|NCT01801280|Antitubercular Agents|antitubercular agents|mesh-ancestor
64462600|NCT01801280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64462601|NCT01801280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64462602|NCT01801280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462603|NCT01801280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462646|NCT01806740|Sequestering Agents|sequestering agents|mesh-ancestor
64462647|NCT01806740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462648|NCT01687101|Menthol|menthol|mesh-list
64462649|NCT01687101|Antipruritics|antipruritics|mesh-ancestor
64462650|NCT01687101|Dermatologic Agents|dermatologic agents|mesh-ancestor
64462651|NCT01968967|Bococizumab|bococizumab|mesh-list
64462652|NCT01968967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64462653|NCT01968967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64462671|NCT04631263|Hyaluronic Acid|hyaluronic acid|mesh-list
64462672|NCT04631263|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64462673|NCT04631263|Immunologic Factors|immunologic factors|mesh-ancestor
64462674|NCT04631263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462675|NCT04631263|Viscosupplements|viscosupplements|mesh-ancestor
64462676|NCT04631263|Protective Agents|protective agents|mesh-ancestor
64462677|NCT01929343|Lidocaine|lidocaine|mesh-list
64462678|NCT01929343|Anesthetics, Local|anesthetics, local|mesh-ancestor
64462679|NCT01929343|Anesthetics|anesthetics|mesh-ancestor
64462680|NCT01929343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64462681|NCT01929343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462682|NCT01929343|Sensory System Agents|sensory system agents|mesh-ancestor
64462683|NCT01929343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462684|NCT01929343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64462685|NCT01929343|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64462686|NCT01929343|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64462687|NCT01929343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64462688|NCT01929343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462689|NCT01806584|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
64462690|NCT01806584|Hemostatics|hemostatics|mesh-ancestor
64462691|NCT01806584|Coagulants|coagulants|mesh-ancestor
64462721|NCT04276636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462722|NCT04276636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64462723|NCT00002644|Tamoxifen|tamoxifen|mesh-list
64462724|NCT00002644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64462725|NCT00002644|Hormone Antagonists|hormone antagonists|mesh-ancestor
64462726|NCT00002644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64462727|NCT00002644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993340|NCT02466971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462728|NCT00002644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64462729|NCT00002644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462730|NCT00002644|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64462731|NCT00002644|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64462732|NCT00002644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64462733|NCT01575561|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64462734|NCT01575561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64462735|NCT01575561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64462736|NCT01575561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64462737|NCT01575561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462738|NCT01575561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64462774|NCT05249920|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64462775|NCT05249920|Protective Agents|protective agents|mesh-ancestor
64462776|NCT05249920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462777|NCT01609790|Bevacizumab|bevacizumab|mesh-list
64462778|NCT01609790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64462779|NCT01609790|Trebananib|trebananib|mesh-list
64462780|NCT01609790|Endothelial Growth Factors|endothelial growth factors|mesh-list
64462781|NCT01609790|Antibodies|antibodies|mesh-list
64462782|NCT01609790|Immunoglobulins|immunoglobulins|mesh-list
64462783|NCT01609790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64462784|NCT01609790|Immunoglobulin G|immunoglobulin g|mesh-list
64462785|NCT01609790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462786|NCT01609790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64462787|NCT01609790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64462788|NCT01609790|Growth Substances|growth substances|mesh-ancestor
64462789|NCT01609790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462790|NCT01609790|Growth Inhibitors|growth inhibitors|mesh-ancestor
64462791|NCT01609790|Immunologic Factors|immunologic factors|mesh-ancestor
64462792|NCT01767116|Ribavirin|ribavirin|mesh-list
64462793|NCT01767116|Antimetabolites|antimetabolites|mesh-ancestor
64462794|NCT01767116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993341|NCT02465268|Molgramostim|molgramostim|mesh-list
64993342|NCT02465268|Sargramostim|sargramostim|mesh-list
64993343|NCT02465268|Immunologic Factors|immunologic factors|mesh-ancestor
64993344|NCT02465268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993345|NCT02465268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993346|NCT02465060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64993347|NCT02465060|Nivolumab|nivolumab|mesh-list
64993348|NCT02465060|Trastuzumab|trastuzumab|mesh-list
64993349|NCT02465060|Pertuzumab|pertuzumab|mesh-list
64993350|NCT02465060|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64462795|NCT01767116|Antiviral Agents|antiviral agents|mesh-ancestor
64462796|NCT01767116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64462797|NCT01574703|Bupropion|bupropion|mesh-list
64462798|NCT01574703|Nicotine|nicotine|mesh-list
64462799|NCT01574703|Varenicline|varenicline|mesh-list
64462800|NCT01574703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64462801|NCT01574703|Autonomic Agents|autonomic agents|mesh-ancestor
64462802|NCT01574703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462822|NCT01686633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64462823|NCT01686633|Autonomic Agents|autonomic agents|mesh-ancestor
64462824|NCT01686633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462825|NCT01686633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462826|NCT01686633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64462827|NCT01686633|Respiratory System Agents|respiratory system agents|mesh-ancestor
64462828|NCT01686633|Dermatologic Agents|dermatologic agents|mesh-ancestor
64462829|NCT01686633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64462831|NCT02511106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462933|NCT01685073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64462934|NCT01685073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462935|NCT01685073|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64462936|NCT01685073|GABA Agonists|gaba agonists|mesh-ancestor
64462937|NCT01685073|GABA Agents|gaba agents|mesh-ancestor
64462938|NCT01685073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64462939|NCT01685073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462940|NCT05241028|Ensartinib|ensartinib|mesh-list
64462941|NCT05241028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462942|NCT05241028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64462943|NCT05241028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462944|NCT05241028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462945|NCT01572675|Celecoxib|celecoxib|mesh-list
64462946|NCT01572675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64462947|NCT01572675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64462948|NCT01572675|Analgesics|analgesics|mesh-ancestor
64462949|NCT01572675|Sensory System Agents|sensory system agents|mesh-ancestor
64462958|NCT01550289|Vaccines|vaccines|mesh-list
64463043|NCT01548573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64463044|NCT01548573|Leprostatic Agents|leprostatic agents|mesh-ancestor
64463045|NCT01548573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64463046|NCT01548573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64463047|NCT01548573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64463048|NCT01548573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64463049|NCT01548573|Growth Substances|growth substances|mesh-ancestor
64463050|NCT01548573|Growth Inhibitors|growth inhibitors|mesh-ancestor
64463051|NCT01570491|Anesthetics|anesthetics|mesh-list
64463052|NCT01570491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64463053|NCT01570491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463079|NCT01518153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64463080|NCT04620343|Anesthetics|anesthetics|mesh-list
64463081|NCT04620343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64463082|NCT04620343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463083|NCT01517373|Glimepiride|glimepiride|mesh-list
64463084|NCT01517373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64463085|NCT01517373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64463086|NCT01517373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463087|NCT01517373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64463088|NCT01517373|Immunologic Factors|immunologic factors|mesh-ancestor
64463089|NCT01517295|Hydrocodone|hydrocodone|mesh-list
64993351|NCT02465060|Sunitinib|sunitinib|mesh-list
64463133|NCT01515423|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64463134|NCT01515423|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64463135|NCT01515423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64463137|NCT00637000|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64463138|NCT00637000|Naloxone|naloxone|mesh-list
64463139|NCT00637000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64463140|NCT00637000|Narcotics|narcotics|mesh-ancestor
64463141|NCT00637000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64463142|NCT00637000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463143|NCT00637000|Analgesics|analgesics|mesh-ancestor
64463144|NCT00637000|Sensory System Agents|sensory system agents|mesh-ancestor
64463145|NCT00637000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64463146|NCT00637000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64463148|NCT01515189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64463149|NCT01515189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463150|NCT01515189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64463165|NCT00636610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463167|NCT00635050|Paclitaxel|paclitaxel|mesh-list
64463168|NCT00635050|Cyclophosphamide|cyclophosphamide|mesh-list
64463169|NCT00635050|Bevacizumab|bevacizumab|mesh-list
64463170|NCT00635050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64463171|NCT00635050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463172|NCT00635050|Tubulin Modulators|tubulin modulators|mesh-ancestor
64463173|NCT00635050|Antimitotic Agents|antimitotic agents|mesh-ancestor
64463174|NCT00635050|Mitosis Modulators|mitosis modulators|mesh-ancestor
64463175|NCT00635050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463176|NCT00635050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64463177|NCT00635050|Immunologic Factors|immunologic factors|mesh-ancestor
64463178|NCT00635050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463179|NCT00635050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64463224|NCT03101254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64463225|NCT03101254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64463226|NCT03101254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463227|NCT00634114|Esomeprazole|esomeprazole|mesh-list
64463228|NCT00634114|Omeprazole|omeprazole|mesh-list
64463229|NCT00634114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64463230|NCT00634114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64463231|NCT00634114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64463232|NCT00634114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64463233|NCT00634114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463234|NCT00634036|Pioglitazone|pioglitazone|mesh-list
64463235|NCT00634036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64463236|NCT00634036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463237|NCT05241496|Lidocaine|lidocaine|mesh-list
64463238|NCT05241496|Anesthetics, Local|anesthetics, local|mesh-ancestor
64463268|NCT01923844|Respiratory System Agents|respiratory system agents|mesh-ancestor
64463270|NCT01924000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64463271|NCT01924000|Vasodilator Agents|vasodilator agents|mesh-ancestor
64463272|NCT01924078|Capecitabine|capecitabine|mesh-list
64463273|NCT01924078|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64463274|NCT01924078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64463275|NCT01924078|Antimetabolites|antimetabolites|mesh-ancestor
64463276|NCT01924078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463277|NCT01924078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463278|NCT01924078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64463279|NCT01924078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64463280|NCT01924078|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64463281|NCT01924078|Hormone Antagonists|hormone antagonists|mesh-ancestor
64463283|NCT01924078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463324|NCT01924468|Antiemetics|antiemetics|mesh-ancestor
64463325|NCT01924468|Autonomic Agents|autonomic agents|mesh-ancestor
64463326|NCT01924468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64463327|NCT01924468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64463328|NCT01924468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64463329|NCT01924468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64463330|NCT01924468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64463331|NCT01924468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64463332|NCT01924468|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64463333|NCT01924468|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64463334|NCT01923064|Ethiodized Oil|ethiodized oil|mesh-list
64463335|NCT01923064|Polidocanol|polidocanol|mesh-list
64463336|NCT01923064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463337|NCT01923064|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64463338|NCT01923064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64463339|NCT01924624|Thalidomide|thalidomide|mesh-list
64463340|NCT01924624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64463341|NCT01924624|Immunologic Factors|immunologic factors|mesh-ancestor
64463342|NCT01924624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463351|NCT01929382|Interferons|interferons|mesh-list
64463366|NCT03121456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64463367|NCT03121456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463368|NCT01925092|Mifepristone|mifepristone|mesh-list
64463415|NCT01929031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64463416|NCT01929031|Purinergic Agents|purinergic agents|mesh-ancestor
64463417|NCT01929031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64463418|NCT00989092|Darbepoetin alfa|darbepoetin alfa|mesh-list
64463419|NCT00989092|Hematinics|hematinics|mesh-ancestor
64463420|NCT00988858|Pemetrexed|pemetrexed|mesh-list
64463421|NCT00988858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463422|NCT00988858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64463423|NCT00988858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463424|NCT00988858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64463425|NCT00988858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64463426|NCT01920334|Zolpidem|zolpidem|mesh-list
64463427|NCT01920334|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64463428|NCT01920334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64463429|NCT01920334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64463430|NCT01920334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463431|NCT01920334|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64463433|NCT01920334|GABA Agents|gaba agents|mesh-ancestor
64463434|NCT01920334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64463458|NCT01928719|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64463459|NCT01928719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64463460|NCT01928719|Cholinergic Agents|cholinergic agents|mesh-ancestor
64463503|NCT01904149|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
64463505|NCT01904149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64463506|NCT01904149|Narcotics|narcotics|mesh-ancestor
64463507|NCT01904149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64463508|NCT01904149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463509|NCT01904149|Analgesics|analgesics|mesh-ancestor
64463510|NCT01904149|Sensory System Agents|sensory system agents|mesh-ancestor
64463511|NCT01904149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64463512|NCT01904149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64463513|NCT01904149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64463514|NCT01904149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64463627|NCT00984568|Hormones|hormones|mesh-ancestor
64463628|NCT00984568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64463629|NCT00984568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463630|NCT00984568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64463631|NCT00984568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463761|NCT03088540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64463762|NCT01903993|Docetaxel|docetaxel|mesh-list
64463763|NCT01903993|Atezolizumab|atezolizumab|mesh-list
64463764|NCT01903993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463765|NCT01903993|Tubulin Modulators|tubulin modulators|mesh-ancestor
64463766|NCT01903993|Antimitotic Agents|antimitotic agents|mesh-ancestor
64463767|NCT01903993|Mitosis Modulators|mitosis modulators|mesh-ancestor
64463768|NCT01903993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463769|NCT00980044|Tramadol|tramadol|mesh-list
64463770|NCT00980044|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64463771|NCT00980044|Narcotics|narcotics|mesh-ancestor
64463772|NCT00980044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64463773|NCT00980044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463774|NCT00980044|Analgesics|analgesics|mesh-ancestor
64463775|NCT00980044|Sensory System Agents|sensory system agents|mesh-ancestor
64463801|NCT05601700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64463802|NCT05601700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463803|NCT01927588|Prednisone|prednisone|mesh-list
64463804|NCT01927588|Everolimus|everolimus|mesh-list
64463806|NCT01927588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64463807|NCT01927588|Glucocorticoids|glucocorticoids|mesh-ancestor
64463808|NCT01927588|Hormones|hormones|mesh-ancestor
64463809|NCT01927588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64463810|NCT01927588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463811|NCT01927588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64463812|NCT01927588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463813|NCT01927588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64463814|NCT01927588|Immunologic Factors|immunologic factors|mesh-ancestor
64463815|NCT01927588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64463816|NCT01927588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64463817|NCT01927588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463818|NCT05601466|Cytarabine|cytarabine|mesh-list
64463819|NCT05601466|Cyclophosphamide|cyclophosphamide|mesh-list
64463820|NCT05601466|Fludarabine|fludarabine|mesh-list
64463821|NCT05601466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64463822|NCT05601466|Immunologic Factors|immunologic factors|mesh-ancestor
64463823|NCT05601466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463825|NCT05601466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64463826|NCT05601466|Alkylating Agents|alkylating agents|mesh-ancestor
64463827|NCT05601466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463828|NCT05601466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463829|NCT05601466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64463830|NCT05601466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64463831|NCT05601466|Antimetabolites|antimetabolites|mesh-ancestor
64463832|NCT05601466|Antiviral Agents|antiviral agents|mesh-ancestor
64463833|NCT05601466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64463835|NCT01903837|Olanzapine|olanzapine|mesh-list
64463841|NCT01903837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64463842|NCT01903837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64463843|NCT01903837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64463844|NCT01903837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64463845|NCT01903837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64463846|NCT01903837|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64463847|NCT01903837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64463848|NCT01903837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64463849|NCT01903837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463850|NCT01903837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64463851|NCT01903837|Serotonin Agents|serotonin agents|mesh-ancestor
64463852|NCT01903837|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64463853|NCT01903837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64463854|NCT01903837|Sensory System Agents|sensory system agents|mesh-ancestor
64463855|NCT00982696|Analgesics, Opioid|analgesics, opioid|mesh-list
64463856|NCT00982696|Mitogens|mitogens|mesh-list
64463857|NCT00982696|Enkephalins|enkephalins|mesh-list
64463858|NCT00982696|Opioid Peptides|opioid peptides|mesh-list
64463859|NCT00982696|Narcotics|narcotics|mesh-ancestor
64463860|NCT00982696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64463861|NCT00982696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463862|NCT00982696|Analgesics|analgesics|mesh-ancestor
64463863|NCT00982696|Sensory System Agents|sensory system agents|mesh-ancestor
64463869|NCT00981526|Olanzapine|olanzapine|mesh-list
64463891|NCT00981526|GABA Agents|gaba agents|mesh-ancestor
64993352|NCT02465060|Dasatinib|dasatinib|mesh-list
64993353|NCT02465060|Palbociclib|palbociclib|mesh-list
64993354|NCT02465060|Trametinib|trametinib|mesh-list
64993355|NCT02465060|Osimertinib|osimertinib|mesh-list
64993356|NCT02465060|Afatinib|afatinib|mesh-list
64993357|NCT02465060|Dabrafenib|dabrafenib|mesh-list
64993358|NCT02465060|Crizotinib|crizotinib|mesh-list
64463893|NCT04274920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64463894|NCT04274920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463895|NCT04274608|Botulinum Toxins|botulinum toxins|mesh-list
64463896|NCT04274608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64463898|NCT04274608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64463899|NCT04274608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64463900|NCT04274608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463901|NCT04274608|Cholinergic Agents|cholinergic agents|mesh-ancestor
64463902|NCT04274608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64463903|NCT04274608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463904|NCT04274608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64463905|NCT04274608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64463906|NCT05607940|Chrysarobin|chrysarobin|mesh-list
64463907|NCT05607940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64463908|NCT05607940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64463947|NCT03044314|Respiratory System Agents|respiratory system agents|mesh-ancestor
64463948|NCT03044314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64463949|NCT03044314|Antioxidants|antioxidants|mesh-ancestor
64463950|NCT03044314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463951|NCT03044314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64463952|NCT03044314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64463954|NCT03044314|Gasotransmitters|gasotransmitters|mesh-ancestor
64463955|NCT03044314|Protective Agents|protective agents|mesh-ancestor
64463956|NCT05608642|Prednisolone|prednisolone|mesh-list
64463958|NCT05608642|Anesthetics, Local|anesthetics, local|mesh-ancestor
64463959|NCT05608642|Anesthetics|anesthetics|mesh-ancestor
64463960|NCT05608642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64463961|NCT05608642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463962|NCT05608642|Sensory System Agents|sensory system agents|mesh-ancestor
64463963|NCT05608642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64463964|NCT05608642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64463965|NCT05608642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64463966|NCT05608642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64463967|NCT05608642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64993359|NCT02465060|Maytansine|maytansine|mesh-list
64463968|NCT05608642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463969|NCT05608642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64463970|NCT05608642|Glucocorticoids|glucocorticoids|mesh-ancestor
64463971|NCT05608642|Hormones|hormones|mesh-ancestor
64463972|NCT05608642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64463973|NCT05608642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64463974|NCT05608642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463976|NCT05608564|Metronidazole|metronidazole|mesh-list
64463977|NCT05608564|Tazobactam|tazobactam|mesh-list
64463978|NCT05608564|Piperacillin|piperacillin|mesh-list
64463979|NCT05608564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64463981|NCT05608564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64463994|NCT03036904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64463995|NCT03036904|Immunologic Factors|immunologic factors|mesh-ancestor
64463996|NCT03036904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463997|NCT03036904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64463998|NCT03036904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64463999|NCT03036904|Alkylating Agents|alkylating agents|mesh-ancestor
64464000|NCT03036904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464001|NCT03036904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464002|NCT03036904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64464003|NCT03036904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64464004|NCT03036904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64464005|NCT03036904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64464006|NCT03036904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64464007|NCT03036904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464009|NCT03036904|Glucocorticoids|glucocorticoids|mesh-ancestor
64464060|NCT03827122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64464061|NCT03827122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464062|NCT03827122|Cholinergic Agents|cholinergic agents|mesh-ancestor
64464063|NCT03827122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64464065|NCT03827200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64464066|NCT02983630|Penicillins|penicillins|mesh-list
64464069|NCT03827278|Itraconazole|itraconazole|mesh-list
64464100|NCT03109990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64464101|NCT03109990|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64464103|NCT03109990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64464104|NCT03109990|Adrenergic Agents|adrenergic agents|mesh-ancestor
64464105|NCT03109990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64464106|NCT03109990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464108|NCT03071536|Diuretics|diuretics|mesh-ancestor
64464109|NCT03071536|Natriuretic Agents|natriuretic agents|mesh-ancestor
64464110|NCT03071536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464111|NCT03071536|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64464112|NCT03071536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64464113|NCT03071536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464114|NCT01513317|Siltuximab|siltuximab|mesh-list
64464115|NCT01513317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464116|NCT03825250|Valproic Acid|valproic acid|mesh-list
64464117|NCT03825250|Anticonvulsants|anticonvulsants|mesh-ancestor
64464118|NCT03825250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464119|NCT03825250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464120|NCT03825250|GABA Agents|gaba agents|mesh-ancestor
64464121|NCT03825250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64464122|NCT03825250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464123|NCT03825250|Antimanic Agents|antimanic agents|mesh-ancestor
64464124|NCT03825250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64464125|NCT03825250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64464126|NCT03825250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64464127|NCT03825328|Gemcitabine|gemcitabine|mesh-list
64464128|NCT03825328|Paclitaxel|paclitaxel|mesh-list
64993360|NCT02465060|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
64993361|NCT02465060|GSK2636771|gsk2636771|mesh-list
64993362|NCT02465060|Antibodies|antibodies|mesh-list
64993363|NCT02465060|Immunoglobulins|immunoglobulins|mesh-list
64993364|NCT02465060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64464129|NCT03825328|Oxaliplatin|oxaliplatin|mesh-list
64464130|NCT03825328|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64464131|NCT03825328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64464143|NCT03825328|Immunologic Factors|immunologic factors|mesh-ancestor
64464144|NCT03825328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464145|NCT03825016|Diclofenac|diclofenac|mesh-list
64464146|NCT03825016|Lidocaine|lidocaine|mesh-list
64464147|NCT03825016|Anesthetics, Local|anesthetics, local|mesh-ancestor
64464148|NCT03825016|Anesthetics|anesthetics|mesh-ancestor
64464149|NCT03825016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64464150|NCT03825016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464151|NCT03825016|Sensory System Agents|sensory system agents|mesh-ancestor
64464152|NCT03825016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64464153|NCT03825016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64464154|NCT03825016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64464212|NCT03824002|Insulin Glargine|insulin glargine|mesh-list
64464213|NCT03824002|Insulin Aspart|insulin aspart|mesh-list
64464214|NCT03824002|Dulaglutide|dulaglutide|mesh-list
64464215|NCT03824002|Repaglinide|repaglinide|mesh-list
64464232|NCT03823846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64464233|NCT03823846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464234|NCT03823846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464235|NCT03823846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64464236|NCT03823846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64464237|NCT03823846|Narcotics|narcotics|mesh-ancestor
64464238|NCT03823846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64464239|NCT02908750|Fexofenadine|fexofenadine|mesh-list
64464240|NCT02908750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464241|NCT02908750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64464242|NCT02908750|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64464243|NCT02908750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64464244|NCT02908750|Histamine Antagonists|histamine antagonists|mesh-ancestor
64464245|NCT02908750|Histamine Agents|histamine agents|mesh-ancestor
64464246|NCT02908750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64464247|NCT02908750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464248|NCT03823612|Calcium|calcium|mesh-list
64464249|NCT03823612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64464250|NCT03823612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464251|NCT02810704|Aspirin|aspirin|mesh-list
64464252|NCT02810704|Warfarin|warfarin|mesh-list
64464253|NCT02810704|Rivaroxaban|rivaroxaban|mesh-list
64464254|NCT02810704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64464255|NCT02810704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64464256|NCT02810704|Analgesics|analgesics|mesh-ancestor
64464257|NCT02810704|Sensory System Agents|sensory system agents|mesh-ancestor
64464261|NCT02810704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64464280|NCT02735902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64464281|NCT02735902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64464282|NCT02735902|Analgesics|analgesics|mesh-ancestor
64464283|NCT02735902|Sensory System Agents|sensory system agents|mesh-ancestor
64464284|NCT02735902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64993365|NCT02465060|Immunoglobulin G|immunoglobulin g|mesh-list
64993366|NCT02465060|Immunoconjugates|immunoconjugates|mesh-list
64350349|NCT04928222|Doxorubicin|doxorubicin|mesh-list
64993367|NCT02465060|Adavosertib|adavosertib|mesh-list
64993383|NCT02408861|Nivolumab|nivolumab|mesh-list
64464285|NCT02735902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64464286|NCT02735902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64464287|NCT02735902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64464288|NCT02735902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64464289|NCT02735902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464290|NCT02735902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64464291|NCT02735902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64464292|NCT02735902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464293|NCT02735902|Antipyretics|antipyretics|mesh-ancestor
64464294|NCT02735902|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64464295|NCT02735902|Hemostatics|hemostatics|mesh-ancestor
64464296|NCT02735902|Coagulants|coagulants|mesh-ancestor
64464297|NCT02926222|Lomustine|lomustine|mesh-list
64464298|NCT02926222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64464299|NCT02926222|Alkylating Agents|alkylating agents|mesh-ancestor
64464300|NCT02926222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464301|NCT02926222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464302|NCT04273282|Moxifloxacin|moxifloxacin|mesh-list
64464303|NCT04273282|Dexamethasone|dexamethasone|mesh-list
64464304|NCT04273282|Prednisolone|prednisolone|mesh-list
64464305|NCT04273282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64464306|NCT04273282|Methylprednisolone|methylprednisolone|mesh-list
64464307|NCT04273282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64464308|NCT04273282|Prednisolone acetate|prednisolone acetate|mesh-list
64464309|NCT04273282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64464310|NCT04273282|Prednisolone phosphate|prednisolone phosphate|mesh-list
64464311|NCT04273282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64464312|NCT04273282|Antiemetics|antiemetics|mesh-ancestor
64464313|NCT04273282|Autonomic Agents|autonomic agents|mesh-ancestor
64464314|NCT04273282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64464320|NCT04273282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64464321|NCT04273282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464322|NCT04273282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64464334|NCT01454518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64464335|NCT01454518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464336|NCT01454518|Sensory System Agents|sensory system agents|mesh-ancestor
64464337|NCT01454518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64464338|NCT02983084|Copper|copper|mesh-list
64464339|NCT02983084|Nickel|nickel|mesh-list
64464340|NCT02983084|Trace Elements|trace elements|mesh-ancestor
64464341|NCT02983084|Micronutrients|micronutrients|mesh-ancestor
64464342|NCT02983084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464343|NCT01455142|Insulin|insulin|mesh-list
64464344|NCT01455142|Insulin Aspart|insulin aspart|mesh-list
64464345|NCT01455142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64464431|NCT01457716|Hormones|hormones|mesh-ancestor
64464432|NCT01457716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64464433|NCT01457716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64464434|NCT01457716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64464435|NCT01457716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64464436|NCT01457716|Adrenergic Agents|adrenergic agents|mesh-ancestor
64464439|NCT02880982|Vitamin D|vitamin d|mesh-list
64464460|NCT02490904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464461|NCT02490904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64464462|NCT02490904|Diuretics|diuretics|mesh-ancestor
64464463|NCT02490904|Natriuretic Agents|natriuretic agents|mesh-ancestor
64464464|NCT02490904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64464465|NCT04390984|Apatinib|apatinib|mesh-list
64464466|NCT04390984|Gefitinib|gefitinib|mesh-list
64464467|NCT04390984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464468|NCT04390984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64464469|NCT04390984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464470|NCT04390984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464471|NCT01453660|Cisplatin|cisplatin|mesh-list
64464472|NCT01453660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464473|NCT02873806|Tobramycin|tobramycin|mesh-list
64464474|NCT02873806|Dexamethasone|dexamethasone|mesh-list
64464475|NCT02873806|Travoprost|travoprost|mesh-list
64464476|NCT02873806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64464477|NCT02873806|Antiemetics|antiemetics|mesh-ancestor
64464478|NCT02873806|Autonomic Agents|autonomic agents|mesh-ancestor
64464479|NCT02873806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64464480|NCT02873806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464517|NCT01891708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464518|NCT01891708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64464519|NCT01891708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64464520|NCT01891708|Growth Substances|growth substances|mesh-ancestor
64993391|NCT02394834|Bevacizumab|bevacizumab|mesh-list
64993392|NCT02394834|Panitumumab|panitumumab|mesh-list
64993393|NCT02394834|Oxaliplatin|oxaliplatin|mesh-list
64993394|NCT02394834|Fluorouracil|fluorouracil|mesh-list
64993395|NCT02394834|Calcium|calcium|mesh-list
64993396|NCT02394834|Levoleucovorin|levoleucovorin|mesh-list
64993453|NCT02304458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64993454|NCT02304458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993455|NCT02304458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64993456|NCT02304458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993457|NCT02298959|Pembrolizumab|pembrolizumab|mesh-list
64993458|NCT02298959|Aflibercept|aflibercept|mesh-list
64993459|NCT02298959|Endothelial Growth Factors|endothelial growth factors|mesh-list
64464521|NCT01891708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464522|NCT01891708|Growth Inhibitors|growth inhibitors|mesh-ancestor
64464523|NCT01892098|Zinc Sulfate|zinc sulfate|mesh-list
64464524|NCT01892098|Astringents|astringents|mesh-ancestor
64464525|NCT01892098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464526|NCT01892098|Dermatologic Agents|dermatologic agents|mesh-ancestor
64464527|NCT01892176|Ubiquinone|ubiquinone|mesh-list
64464528|NCT01892176|Coenzyme Q10|coenzyme q10|mesh-list
64464529|NCT01892176|Micronutrients|micronutrients|mesh-ancestor
64464530|NCT01892176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464531|NCT01892176|Vitamins|vitamins|mesh-ancestor
64464532|NCT01892254|Metformin|metformin|mesh-list
64464533|NCT01892254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64464534|NCT01892254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464535|NCT01892332|Lidocaine|lidocaine|mesh-list
64464536|NCT01892332|Fentanyl|fentanyl|mesh-list
64464537|NCT01892332|Anesthetics, Local|anesthetics, local|mesh-ancestor
64464538|NCT01892332|Anesthetics|anesthetics|mesh-ancestor
64464539|NCT01892332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64464540|NCT01892332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464541|NCT01892332|Sensory System Agents|sensory system agents|mesh-ancestor
64464542|NCT01892332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64464543|NCT01892332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64464619|NCT01893424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64464620|NCT01893424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64464621|NCT01893424|Analgesics|analgesics|mesh-ancestor
64464622|NCT01893424|Sensory System Agents|sensory system agents|mesh-ancestor
64464623|NCT01893424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64464624|NCT01893424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64464625|NCT01893424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64464626|NCT01893424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64464627|NCT01893424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464628|NCT01893424|Hormones|hormones|mesh-ancestor
64464631|NCT01893424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464724|NCT02717962|Alkylating Agents|alkylating agents|mesh-ancestor
64464725|NCT02717962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464726|NCT02717962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464728|NCT01893658|Prednisone|prednisone|mesh-list
64464729|NCT01893658|Prednisolone|prednisolone|mesh-list
64464730|NCT01893658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64464731|NCT01893658|Glucocorticoids|glucocorticoids|mesh-ancestor
64464732|NCT01893658|Hormones|hormones|mesh-ancestor
64464733|NCT01893658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64464734|NCT01893658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450453|NCT02060383|Incretins|incretins|mesh-ancestor
64464758|NCT02703610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64464759|NCT02688556|Cyclosporine|cyclosporine|mesh-list
64464760|NCT02688556|Cyclosporins|cyclosporins|mesh-list
64464761|NCT02688556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464762|NCT02688556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464763|NCT02688556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64464764|NCT02688556|Immunologic Factors|immunologic factors|mesh-ancestor
64464765|NCT02688556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464766|NCT02688556|Antifungal Agents|antifungal agents|mesh-ancestor
64464767|NCT02688556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64464768|NCT02688556|Dermatologic Agents|dermatologic agents|mesh-ancestor
64464769|NCT02688556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64464770|NCT02688556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64464771|NCT02684578|Metformin|metformin|mesh-list
64464772|NCT02684578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64464773|NCT02684578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464774|NCT02684032|Letrozole|letrozole|mesh-list
64464775|NCT02684032|Fulvestrant|fulvestrant|mesh-list
64464776|NCT02684032|Palbociclib|palbociclib|mesh-list
64464777|NCT02684032|Gedatolisib|gedatolisib|mesh-list
64464778|NCT02684032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464779|NCT02684032|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64464780|NCT02684032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64464781|NCT02684032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464782|NCT02684032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464806|NCT01924429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464807|NCT01924429|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64464808|NCT01924429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64464809|NCT01924429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64557638|NCT03067896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64945386|NCT05672225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64464810|NCT01924429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464811|NCT01924429|Dopamine Agents|dopamine agents|mesh-ancestor
64464812|NCT01924429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64464814|NCT01886287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64464815|NCT01886287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64464816|NCT01886287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464817|NCT02707588|Pembrolizumab|pembrolizumab|mesh-list
64464819|NCT02707588|Antibodies|antibodies|mesh-list
64464820|NCT02707588|Immunoglobulins|immunoglobulins|mesh-list
64464821|NCT02707588|Immunologic Factors|immunologic factors|mesh-ancestor
64464868|NCT05604118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64464869|NCT05604118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64464870|NCT05604118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464871|NCT05604118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64464872|NCT05604118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64464873|NCT05604118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464874|NCT05604118|Antipyretics|antipyretics|mesh-ancestor
64464887|NCT05603884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464888|NCT05603884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464889|NCT05603884|Analgesics|analgesics|mesh-ancestor
64464890|NCT05603884|Sensory System Agents|sensory system agents|mesh-ancestor
64464891|NCT05603884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64464892|NCT05603884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64464893|NCT05603884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64464894|NCT05603650|Listerine|listerine|mesh-list
64464895|NCT05603650|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64464896|NCT05603650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64464897|NCT04129060|Cholinergic Agents|cholinergic agents|mesh-list
64464898|NCT04129060|Cholinergic Antagonists|cholinergic antagonists|mesh-list
64464899|NCT04129060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64464900|NCT04129060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464901|NCT04129060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464902|NCT04126096|Lactams|lactams|mesh-list
64464903|NCT04126096|beta-Lactams|beta-lactams|mesh-list
64464904|NCT04126096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64464905|NCT04126096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64464906|NCT03337594|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
64464907|NCT03337594|Chelating Agents|chelating agents|mesh-ancestor
64464908|NCT03337594|Sequestering Agents|sequestering agents|mesh-ancestor
64464909|NCT03337594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464910|NCT03313804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64464911|NCT03313804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993460|NCT02298959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64993461|NCT02298959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993462|NCT02298959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64993463|NCT02298959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64993464|NCT02298959|Growth Substances|growth substances|mesh-ancestor
64993465|NCT02298959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464912|NCT03313804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464913|NCT04393792|Povidone-Iodine|povidone-iodine|mesh-list
64464914|NCT04393792|Povidone|povidone|mesh-list
64464915|NCT04393792|Plasma Substitutes|plasma substitutes|mesh-ancestor
64464916|NCT04393792|Blood Substitutes|blood substitutes|mesh-ancestor
64464917|NCT04393792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64464918|NCT04393792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64464925|NCT01896895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464926|NCT01896895|Cholinergic Agents|cholinergic agents|mesh-ancestor
64464927|NCT01896895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64464928|NCT01896895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464929|NCT01896895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64464930|NCT01896895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64464931|NCT02315872|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64464932|NCT02315872|Hormones|hormones|mesh-ancestor
64464933|NCT02315872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64464934|NCT02315872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464935|NCT04127500|Dexmedetomidine|dexmedetomidine|mesh-list
64464936|NCT04127500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64464937|NCT04127500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64464938|NCT04127500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464939|NCT04127500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64513639|NCT01457547|Edetic Acid|edetic acid|mesh-list
64464940|NCT04127500|Analgesics|analgesics|mesh-ancestor
64464941|NCT04127500|Sensory System Agents|sensory system agents|mesh-ancestor
64464942|NCT04127500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64464989|NCT03012880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464990|NCT03012880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64464991|NCT03012880|Glucocorticoids|glucocorticoids|mesh-ancestor
64464992|NCT03012880|Hormones|hormones|mesh-ancestor
64464993|NCT03012880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64464994|NCT03012880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64465027|NCT04125862|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64465028|NCT04125862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465030|NCT03007732|Prednisone|prednisone|mesh-list
64465031|NCT03007732|Pembrolizumab|pembrolizumab|mesh-list
64465032|NCT03007732|Leuprolide|leuprolide|mesh-list
64465033|NCT03007732|Abiraterone Acetate|abiraterone acetate|mesh-list
64465034|NCT03007732|Methyltestosterone|methyltestosterone|mesh-list
64465035|NCT03007732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64465036|NCT03007732|Androgens|androgens|mesh-list
64713968|NCT02834624|Poractant alfa|poractant alfa|mesh-list
64465037|NCT03007732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64465038|NCT03007732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465039|NCT03007732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64465040|NCT03007732|Glucocorticoids|glucocorticoids|mesh-ancestor
64465041|NCT03007732|Hormones|hormones|mesh-ancestor
64465042|NCT03007732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64465043|NCT03007732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465044|NCT03007732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64465045|NCT03007732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64465046|NCT03007732|Fertility Agents|fertility agents|mesh-ancestor
64465047|NCT03007732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64465048|NCT03007732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64465049|NCT03007732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465078|NCT03005782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64465079|NCT03005782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465080|NCT04125394|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64465081|NCT04125394|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64465082|NCT04125082|Insulin|insulin|mesh-list
64465083|NCT04125082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64465084|NCT04125082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64465085|NCT04125082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465086|NCT04393246|Dapagliflozin|dapagliflozin|mesh-list
64465087|NCT04393246|Ambrisentan|ambrisentan|mesh-list
64465128|NCT01884571|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64465130|NCT01884571|Basiliximab|basiliximab|mesh-list
64465131|NCT01884571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64465132|NCT01884571|Glucocorticoids|glucocorticoids|mesh-ancestor
64465133|NCT01884571|Hormones|hormones|mesh-ancestor
64465134|NCT01884571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64465135|NCT01884571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465136|NCT01884571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64465137|NCT01884571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465138|NCT01884571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64465139|NCT01884571|Immunologic Factors|immunologic factors|mesh-ancestor
64465140|NCT01884571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64465141|NCT01884571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465142|NCT01884571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465143|NCT01884571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64465144|NCT01884571|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64465145|NCT01884571|Antitubercular Agents|antitubercular agents|mesh-ancestor
64465146|NCT01884571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64465147|NCT01884571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64465148|NCT01884571|Antiemetics|antiemetics|mesh-ancestor
64465149|NCT01884571|Autonomic Agents|autonomic agents|mesh-ancestor
64465150|NCT01884571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64465151|NCT01884571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64465152|NCT01884571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64993466|NCT02298959|Growth Inhibitors|growth inhibitors|mesh-ancestor
64993467|NCT02224781|Nivolumab|nivolumab|mesh-list
64993468|NCT02224781|Ipilimumab|ipilimumab|mesh-list
64993469|NCT02224781|Trametinib|trametinib|mesh-list
64993491|NCT02219373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64993512|NCT02196181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993513|NCT02196181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64993514|NCT02196181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465153|NCT01884571|Protective Agents|protective agents|mesh-ancestor
64465154|NCT01884337|Apixaban|apixaban|mesh-list
64465155|NCT01884337|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64465156|NCT01884337|Antithrombins|antithrombins|mesh-ancestor
64465157|NCT01884337|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64465172|NCT01922089|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64465173|NCT01922089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64465174|NCT01922089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465264|NCT04124614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64465265|NCT04124614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64465266|NCT04124614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64465267|NCT04124614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64465268|NCT04124614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465269|NCT04124614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64465270|NCT04124614|Serotonin Agents|serotonin agents|mesh-ancestor
64465271|NCT04124614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465272|NCT04124614|Dopamine Agonists|dopamine agonists|mesh-ancestor
64465273|NCT04124614|Dopamine Agents|dopamine agents|mesh-ancestor
64465274|NCT01895335|Teriflunomide|teriflunomide|mesh-list
64465275|NCT01895335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64465276|NCT01895335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64465277|NCT01895335|Analgesics|analgesics|mesh-ancestor
64465278|NCT01895335|Sensory System Agents|sensory system agents|mesh-ancestor
64465279|NCT01895335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64465280|NCT01895335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465281|NCT01895335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64465282|NCT01895335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64465283|NCT01895335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64465315|NCT03829696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465316|NCT03829696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64465317|NCT03829696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64465318|NCT03829696|Oxytocics|oxytocics|mesh-ancestor
64465319|NCT03829696|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64465340|NCT02977780|Alkylating Agents|alkylating agents|mesh-ancestor
64465341|NCT02977780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465342|NCT02977780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465343|NCT02972398|Acetylcysteine|acetylcysteine|mesh-list
64465344|NCT02972398|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64465345|NCT02972398|Antiviral Agents|antiviral agents|mesh-ancestor
64465346|NCT02972398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64465347|NCT02972398|Expectorants|expectorants|mesh-ancestor
64465353|NCT02972398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465354|NCT02972398|Antidotes|antidotes|mesh-ancestor
64465355|NCT01617655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64465356|NCT01617655|Immunologic Factors|immunologic factors|mesh-ancestor
64465357|NCT01617655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465465|NCT03820180|Dermatologic Agents|dermatologic agents|mesh-ancestor
64465466|NCT03820180|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64465467|NCT03820180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64465468|NCT03820180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64465469|NCT03820180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64465470|NCT03820180|Adrenergic Agents|adrenergic agents|mesh-ancestor
64465471|NCT03820180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64465473|NCT03820180|Glucocorticoids|glucocorticoids|mesh-ancestor
64465568|NCT03553810|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64465601|NCT01452568|Anticoagulants|anticoagulants|mesh-ancestor
64465602|NCT01452568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64465603|NCT01452568|Antifungal Agents|antifungal agents|mesh-ancestor
64465604|NCT01452568|Keratolytic Agents|keratolytic agents|mesh-ancestor
64465605|NCT01452568|Dermatologic Agents|dermatologic agents|mesh-ancestor
64465606|NCT01452724|Lansoprazole|lansoprazole|mesh-list
64465607|NCT01452724|Dexlansoprazole|dexlansoprazole|mesh-list
64465608|NCT01452724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64465609|NCT01452724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64465610|NCT01452724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64465611|NCT01452724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465612|NCT01452724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465613|NCT02620072|Insulin|insulin|mesh-list
64465614|NCT02620072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64465615|NCT02620072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465616|NCT01452880|Remifentanil|remifentanil|mesh-list
64465661|NCT04847752|Sensory System Agents|sensory system agents|mesh-ancestor
64465662|NCT04847752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64465663|NCT04847752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465664|NCT04847752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64465665|NCT04847752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64465666|NCT04847752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64465667|NCT04847752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64465668|NCT04847752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465669|NCT04847752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64465670|NCT04847752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64465671|NCT04847752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465672|NCT04847752|Antipyretics|antipyretics|mesh-ancestor
64465673|NCT04847752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64465674|NCT04847752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64465675|NCT04847752|Antimetabolites|antimetabolites|mesh-ancestor
64465676|NCT04847752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64465677|NCT04847752|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64465678|NCT04847752|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64465679|NCT04847752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64465680|NCT04847752|Purinergic Agents|purinergic agents|mesh-ancestor
64465682|NCT04847752|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64465683|NCT04847752|Antithrombins|antithrombins|mesh-ancestor
64465684|NCT04847752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64465685|NCT04847752|Protease Inhibitors|protease inhibitors|mesh-ancestor
64465688|NCT04847206|Hallucinogens|hallucinogens|mesh-ancestor
64465708|NCT04840264|Oxaliplatin|oxaliplatin|mesh-list
64465709|NCT04840264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465710|NCT04840264|Tubulin Modulators|tubulin modulators|mesh-ancestor
64465711|NCT04840264|Antimitotic Agents|antimitotic agents|mesh-ancestor
64465712|NCT04840264|Mitosis Modulators|mitosis modulators|mesh-ancestor
64465713|NCT04840264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465714|NCT04840264|Antimetabolites|antimetabolites|mesh-ancestor
64465715|NCT04840264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64465716|NCT04840264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64465717|NCT04840264|Immunologic Factors|immunologic factors|mesh-ancestor
64465718|NCT04840264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465719|NCT04841434|Methotrexate|methotrexate|mesh-list
64465720|NCT04841434|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64465721|NCT04841434|Abortifacient Agents|abortifacient agents|mesh-ancestor
64465722|NCT04841434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64465835|NCT02818894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64465836|NCT02818894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465837|NCT02818894|Sensory System Agents|sensory system agents|mesh-ancestor
64465838|NCT02818894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64465839|NCT02818894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64465840|NCT02818894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64465841|NCT02818894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64465842|NCT02818894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64465843|NCT02818894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465844|NCT02668666|Tamoxifen|tamoxifen|mesh-list
64465845|NCT02668666|Palbociclib|palbociclib|mesh-list
64465846|NCT02668666|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64465847|NCT02668666|Hormone Antagonists|hormone antagonists|mesh-ancestor
64465848|NCT02668666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64465849|NCT02668666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465850|NCT02668666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64465851|NCT02668666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465877|NCT05586568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64465878|NCT05586568|Leprostatic Agents|leprostatic agents|mesh-ancestor
64465879|NCT05586568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64465880|NCT05586568|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64465881|NCT05586568|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64465882|NCT05586568|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64465883|NCT05586568|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64465884|NCT05586568|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64465925|NCT02608216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64465926|NCT02608216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465927|NCT02608216|Tubulin Modulators|tubulin modulators|mesh-ancestor
64465928|NCT02608216|Antimitotic Agents|antimitotic agents|mesh-ancestor
64465929|NCT02608216|Mitosis Modulators|mitosis modulators|mesh-ancestor
64465931|NCT02587000|Ulipristal acetate|ulipristal acetate|mesh-list
64466104|NCT02514382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466105|NCT02514382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64466106|NCT02514382|Glucocorticoids|glucocorticoids|mesh-ancestor
64466107|NCT02514382|Hormones|hormones|mesh-ancestor
64466108|NCT02514382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64466109|NCT02514382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64466110|NCT02514382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466111|NCT02514382|Protease Inhibitors|protease inhibitors|mesh-ancestor
64466112|NCT02514382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466113|NCT02514382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713971|NCT02834624|Respiratory System Agents|respiratory system agents|mesh-ancestor
64466114|NCT02514382|Dermatologic Agents|dermatologic agents|mesh-ancestor
64466115|NCT02495896|Gemcitabine|gemcitabine|mesh-list
64466116|NCT02495896|Paclitaxel|paclitaxel|mesh-list
64466117|NCT02495896|Docetaxel|docetaxel|mesh-list
64466119|NCT02495896|Cisplatin|cisplatin|mesh-list
64466138|NCT02493322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64466140|NCT02493322|Natriuretic Agents|natriuretic agents|mesh-ancestor
64466141|NCT02493322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466142|NCT02493322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64466209|NCT02420314|Micronutrients|micronutrients|mesh-ancestor
64466210|NCT02420314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466211|NCT02420314|Antioxidants|antioxidants|mesh-ancestor
64466212|NCT02420314|Protective Agents|protective agents|mesh-ancestor
64466213|NCT02403778|Ipilimumab|ipilimumab|mesh-list
64466214|NCT02403778|Tretinoin|tretinoin|mesh-list
64466215|NCT02403778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64466216|NCT02403778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466217|NCT02403778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64466218|NCT02403778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466235|NCT04746040|Respiratory System Agents|respiratory system agents|mesh-ancestor
64466236|NCT04746040|Dermatologic Agents|dermatologic agents|mesh-ancestor
64466237|NCT04746040|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64466238|NCT04746040|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64466239|NCT04746040|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64466240|NCT04746040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64466241|NCT04746040|Adrenergic Agents|adrenergic agents|mesh-ancestor
64466242|NCT04746040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64466252|NCT02400814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466253|NCT02400814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466254|NCT02398240|Rituximab|rituximab|mesh-list
64466255|NCT02398240|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64466256|NCT02398240|Doxorubicin|doxorubicin|mesh-list
64466257|NCT02398240|Vincristine|vincristine|mesh-list
64466258|NCT02398240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64466259|NCT02398240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466260|NCT02398240|Immunologic Factors|immunologic factors|mesh-ancestor
64466261|NCT02398240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466262|NCT02398240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64466263|NCT02398240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64466264|NCT02398240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64466265|NCT02398240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64466266|NCT02398240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466267|NCT02398240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466268|NCT02398240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64466269|NCT02398240|Tubulin Modulators|tubulin modulators|mesh-ancestor
64466270|NCT02398240|Antimitotic Agents|antimitotic agents|mesh-ancestor
64466271|NCT02398240|Mitosis Modulators|mitosis modulators|mesh-ancestor
64466272|NCT02022280|Lansoprazole|lansoprazole|mesh-list
64466273|NCT02022280|Dexlansoprazole|dexlansoprazole|mesh-list
64466274|NCT02022280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64466277|NCT02022280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993515|NCT02196181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993549|NCT02187224|Progesterone|progesterone|mesh-list
64993550|NCT02187224|Progestins|progestins|mesh-ancestor
64993552|NCT02187224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64993553|NCT02187224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993554|NCT02159066|Infigratinib|infigratinib|mesh-list
64993555|NCT02159066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993556|NCT02099825|Cycloserine|cycloserine|mesh-list
64993557|NCT02099825|Mifepristone|mifepristone|mesh-list
64993558|NCT02099825|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64993559|NCT02099825|Abortifacient Agents|abortifacient agents|mesh-ancestor
64466305|NCT02344186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64466306|NCT02344186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466307|NCT02344186|Incretins|incretins|mesh-ancestor
64513643|NCT01457547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466309|NCT02344186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64466310|NCT01537887|Moxifloxacin|moxifloxacin|mesh-list
64466311|NCT01537887|Evacetrapib|evacetrapib|mesh-list
64466312|NCT01537887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64466364|NCT01928134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64466365|NCT01928134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466366|NCT01928134|Antacids|antacids|mesh-ancestor
64466367|NCT01928134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466368|NCT01928134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64466369|NCT02285140|Vancomycin|vancomycin|mesh-list
64466370|NCT02285140|Cefazolin|cefazolin|mesh-list
64466371|NCT02285140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64466427|NCT01928914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64466428|NCT01928914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64466429|NCT01928914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466430|NCT01928914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466432|NCT01928914|Antimalarials|antimalarials|mesh-ancestor
64466493|NCT01916278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466494|NCT01905046|Metformin|metformin|mesh-list
64466495|NCT01905046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64466496|NCT01905046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466497|NCT03084640|Pembrolizumab|pembrolizumab|mesh-list
64466498|NCT03084640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64466499|NCT03084640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466500|NCT04409691|Sirolimus|sirolimus|mesh-list
64466501|NCT04409691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64466502|NCT04409691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64466558|NCT01516606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64993560|NCT02099825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64993561|NCT02099825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993562|NCT02099825|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64993563|NCT02099825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64993564|NCT02099825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64993565|NCT02099825|Contraceptive Agents|contraceptive agents|mesh-ancestor
64993566|NCT02099825|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64466560|NCT02209636|Nitroglycerin|nitroglycerin|mesh-list
64466561|NCT02209636|Vitamins|vitamins|mesh-ancestor
64466562|NCT02209636|Micronutrients|micronutrients|mesh-ancestor
64466563|NCT02209636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466564|NCT02209636|Antioxidants|antioxidants|mesh-ancestor
64466565|NCT02209636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466566|NCT02209636|Protective Agents|protective agents|mesh-ancestor
64466567|NCT02209636|Vasodilator Agents|vasodilator agents|mesh-ancestor
64466568|NCT01508325|Metoprolol|metoprolol|mesh-list
64466569|NCT01508325|Bisoprolol|bisoprolol|mesh-list
64466797|NCT01407562|Mitosis Modulators|mitosis modulators|mesh-ancestor
64466798|NCT01407562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466799|NCT01406548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64466800|NCT01406548|Immunologic Factors|immunologic factors|mesh-ancestor
64466801|NCT01406548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466802|NCT01393522|Milnacipran|milnacipran|mesh-list
64466803|NCT01393522|Levomilnacipran|levomilnacipran|mesh-list
64466804|NCT01393522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64466805|NCT01393522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64466806|NCT01393522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64466807|NCT01393522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466808|NCT01393522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64466809|NCT01393522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466810|NCT01393522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64466811|NCT01393522|Analgesics|analgesics|mesh-ancestor
64466812|NCT01393522|Sensory System Agents|sensory system agents|mesh-ancestor
64466813|NCT01393522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64466814|NCT01393522|Antidepressive Agents|antidepressive agents|mesh-ancestor
64466815|NCT01393522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64466816|NCT02086786|Risperidone|risperidone|mesh-list
64466921|NCT01659658|Ixazomib|ixazomib|mesh-list
64466922|NCT01659658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64466923|NCT01659658|Immunologic Factors|immunologic factors|mesh-ancestor
64466924|NCT01659658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466925|NCT01659658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64466926|NCT01659658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64466927|NCT01659658|Alkylating Agents|alkylating agents|mesh-ancestor
64466928|NCT01659658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466941|NCT01659658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64466942|NCT01659658|Growth Substances|growth substances|mesh-ancestor
64466943|NCT01659658|Growth Inhibitors|growth inhibitors|mesh-ancestor
64466944|NCT01659658|Leprostatic Agents|leprostatic agents|mesh-ancestor
64466945|NCT01659658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64466946|NCT01659658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64466947|NCT01659658|Protease Inhibitors|protease inhibitors|mesh-ancestor
64466948|NCT01659658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466949|NCT01639690|Busulfan|busulfan|mesh-list
64466950|NCT01639690|Alkylating Agents|alkylating agents|mesh-ancestor
64466951|NCT01639690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466952|NCT01639690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64466953|NCT01639690|Immunologic Factors|immunologic factors|mesh-ancestor
64466954|NCT01639690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467002|NCT04283656|Estrogens|estrogens|mesh-ancestor
64467003|NCT04283656|Hormones|hormones|mesh-ancestor
64467004|NCT04283656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64467005|NCT04283656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467007|NCT04283656|Hormone Antagonists|hormone antagonists|mesh-ancestor
64467023|NCT01209364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64467025|NCT01209364|Hormones|hormones|mesh-ancestor
64467055|NCT00472966|Glycolic acid|glycolic acid|mesh-list
64467056|NCT00472966|Hydroquinone|hydroquinone|mesh-list
64467057|NCT00472966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467058|NCT00472966|Keratolytic Agents|keratolytic agents|mesh-ancestor
64467059|NCT00472966|Dermatologic Agents|dermatologic agents|mesh-ancestor
64467060|NCT00472966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64467061|NCT00472966|Glucocorticoids|glucocorticoids|mesh-ancestor
64467062|NCT00472966|Hormones|hormones|mesh-ancestor
64467063|NCT00472966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64467064|NCT00472966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467065|NCT00472966|Antioxidants|antioxidants|mesh-ancestor
64467066|NCT00472966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467147|NCT00436540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64467148|NCT00436540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467149|NCT00425230|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64467150|NCT00425230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64467151|NCT00425230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64467152|NCT00425230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64467156|NCT00425230|Analgesics|analgesics|mesh-ancestor
64467379|NCT04776226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467380|NCT04776226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64467381|NCT04776226|Serotonin Agents|serotonin agents|mesh-ancestor
64467382|NCT04776226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467383|NCT04776226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64467384|NCT04776226|Antidepressive Agents|antidepressive agents|mesh-ancestor
64467385|NCT04776226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64467386|NCT02319304|Leucovorin|leucovorin|mesh-list
64467387|NCT02319304|Fluorouracil|fluorouracil|mesh-list
64467388|NCT02319304|Oxaliplatin|oxaliplatin|mesh-list
64467396|NCT02319304|Antidotes|antidotes|mesh-ancestor
64467418|NCT00885664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64467419|NCT04784104|Epinephrine|epinephrine|mesh-list
64467420|NCT04784104|Racepinephrine|racepinephrine|mesh-list
64467421|NCT04784104|Bupivacaine|bupivacaine|mesh-list
64467422|NCT04784104|Prilocaine|prilocaine|mesh-list
64467423|NCT04784104|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64467424|NCT04784104|Epinephryl borate|epinephryl borate|mesh-list
64467425|NCT04784104|Anesthetics, Local|anesthetics, local|mesh-ancestor
64467426|NCT04784104|Anesthetics|anesthetics|mesh-ancestor
64467427|NCT04784104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64467428|NCT04784104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467429|NCT04784104|Sensory System Agents|sensory system agents|mesh-ancestor
64467430|NCT04784104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64467431|NCT04784104|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64467432|NCT04784104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64467433|NCT04784104|Adrenergic Agents|adrenergic agents|mesh-ancestor
64467491|NCT00878254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64467492|NCT00878254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64467493|NCT00878254|Antiviral Agents|antiviral agents|mesh-ancestor
64467494|NCT00878254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64467495|NCT00878254|Antidotes|antidotes|mesh-ancestor
64467496|NCT00878254|Protective Agents|protective agents|mesh-ancestor
64467527|NCT03364348|Antimitotic Agents|antimitotic agents|mesh-ancestor
64467528|NCT03364348|Mitosis Modulators|mitosis modulators|mesh-ancestor
64467529|NCT03364348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467530|NCT04782622|Apatinib|apatinib|mesh-list
64467531|NCT04782622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467532|NCT04782622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64467533|NCT04782622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467534|NCT04782622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467535|NCT04775212|Sevoflurane|sevoflurane|mesh-list
64467536|NCT04775212|Desflurane|desflurane|mesh-list
64467537|NCT04775212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64467538|NCT04775212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64467539|NCT04775212|Anesthetics, General|anesthetics, general|mesh-ancestor
64467540|NCT04775212|Anesthetics|anesthetics|mesh-ancestor
64467541|NCT04775212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64467542|NCT04775212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467543|NCT04774822|Mydriatics|mydriatics|mesh-list
64467544|NCT04774822|Autonomic Agents|autonomic agents|mesh-ancestor
64467545|NCT04774822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64467546|NCT04774822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467547|NCT04782388|Alprazolam|alprazolam|mesh-list
64467548|NCT04782388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64467549|NCT04782388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64467550|NCT04782388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467590|NCT04781998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64467591|NCT03300544|Leucovorin|leucovorin|mesh-list
64467592|NCT03300544|Fluorouracil|fluorouracil|mesh-list
64467593|NCT03300544|Capecitabine|capecitabine|mesh-list
64467594|NCT03300544|Oxaliplatin|oxaliplatin|mesh-list
64467595|NCT03300544|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
64467596|NCT03300544|Antimetabolites|antimetabolites|mesh-ancestor
64467597|NCT03300544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467598|NCT03300544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64467599|NCT03300544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467600|NCT03300544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64467601|NCT03300544|Immunologic Factors|immunologic factors|mesh-ancestor
64467602|NCT03300544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467606|NCT03300544|Vitamins|vitamins|mesh-ancestor
64467624|NCT03249844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64467625|NCT03249844|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64467626|NCT03249844|Protective Agents|protective agents|mesh-ancestor
64467628|NCT03249844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467681|NCT02390284|Brinzolamide|brinzolamide|mesh-list
64467682|NCT02390284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64467683|NCT02390284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64467684|NCT02390284|Adrenergic Agents|adrenergic agents|mesh-ancestor
64467685|NCT02390284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64467758|NCT04389424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467759|NCT04389424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467803|NCT05390476|Antimetabolites|antimetabolites|mesh-ancestor
64467804|NCT05390476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467805|NCT05390476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467806|NCT05324332|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64467807|NCT05324332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64467808|NCT05324332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467810|NCT04769908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467811|NCT04769908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64467812|NCT04769908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467813|NCT04769908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467814|NCT00054028|Suramin|suramin|mesh-list
64467815|NCT00054028|Paclitaxel|paclitaxel|mesh-list
64467816|NCT00054028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64467817|NCT00054028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467818|NCT00054028|Tubulin Modulators|tubulin modulators|mesh-ancestor
64467819|NCT00054028|Antimitotic Agents|antimitotic agents|mesh-ancestor
64467820|NCT00054028|Mitosis Modulators|mitosis modulators|mesh-ancestor
64467821|NCT00054028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467822|NCT00054028|Antinematodal Agents|antinematodal agents|mesh-ancestor
64467823|NCT00054028|Anthelmintics|anthelmintics|mesh-ancestor
64956113|NCT00040040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956114|NCT00040040|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64956115|NCT00040040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64956116|NCT00040040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956117|NCT00068523|Cyclosporine|cyclosporine|mesh-list
64956120|NCT00068523|Fludarabine|fludarabine|mesh-list
64956175|NCT00206947|Dopamine Agents|dopamine agents|mesh-ancestor
64494781|NCT02189122|Antipyretics|antipyretics|mesh-ancestor
64956176|NCT00068757|Paclitaxel|paclitaxel|mesh-list
64956177|NCT00068757|Trastuzumab|trastuzumab|mesh-list
64956178|NCT00068757|Lonafarnib|lonafarnib|mesh-list
64956179|NCT00068757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64956180|NCT00068757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956181|NCT00068757|Tubulin Modulators|tubulin modulators|mesh-ancestor
64956182|NCT00068757|Antimitotic Agents|antimitotic agents|mesh-ancestor
64956183|NCT00068757|Mitosis Modulators|mitosis modulators|mesh-ancestor
64956184|NCT00068757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956185|NCT00068757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64956186|NCT00068757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956187|NCT00206986|Clonidine|clonidine|mesh-list
64956188|NCT00206986|Analgesics|analgesics|mesh-ancestor
64956189|NCT00206986|Sensory System Agents|sensory system agents|mesh-ancestor
64956190|NCT00206986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64956191|NCT00206986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956192|NCT00206986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64956193|NCT00206986|Sympatholytics|sympatholytics|mesh-ancestor
64956194|NCT00206986|Autonomic Agents|autonomic agents|mesh-ancestor
64956195|NCT00206986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64956196|NCT00206986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64956197|NCT00206986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64956198|NCT00206986|Adrenergic Agents|adrenergic agents|mesh-ancestor
64956199|NCT00206986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64956201|NCT00207064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64956212|NCT00040274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993567|NCT02099825|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64993568|NCT02099825|Hormone Antagonists|hormone antagonists|mesh-ancestor
64993569|NCT02099825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64993570|NCT02099825|Luteolytic Agents|luteolytic agents|mesh-ancestor
64993574|NCT02099825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64993589|NCT02032823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993645|NCT02003222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64993646|NCT02003222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64993648|NCT02003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64993649|NCT02003222|Tubulin Modulators|tubulin modulators|mesh-ancestor
64993650|NCT02003222|Antimitotic Agents|antimitotic agents|mesh-ancestor
64993651|NCT02003222|Mitosis Modulators|mitosis modulators|mesh-ancestor
64993652|NCT02003222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64993653|NCT02003222|Keratolytic Agents|keratolytic agents|mesh-ancestor
64993654|NCT01989585|Trametinib|trametinib|mesh-list
64993655|NCT01989585|Dabrafenib|dabrafenib|mesh-list
64993656|NCT01989585|Navitoclax|navitoclax|mesh-list
64993657|NCT01989585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956213|NCT00040274|Antiviral Agents|antiviral agents|mesh-ancestor
64956214|NCT00040274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64956215|NCT00040274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64956216|NCT00040274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64956217|NCT00072852|Irinotecan|irinotecan|mesh-list
64956218|NCT00072852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64956219|NCT00072852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64956220|NCT00072852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956221|NCT00072852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956222|NCT00072852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956223|NCT00207532|Folic Acid|folic acid|mesh-list
64956224|NCT00207532|Hematinics|hematinics|mesh-ancestor
64956225|NCT00207532|Vitamin B Complex|vitamin b complex|mesh-ancestor
64956226|NCT00207532|Vitamins|vitamins|mesh-ancestor
64956227|NCT00207532|Micronutrients|micronutrients|mesh-ancestor
64956228|NCT00207532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956229|NCT00040391|Leucovorin|leucovorin|mesh-list
64956230|NCT00040391|Fluorouracil|fluorouracil|mesh-list
64956231|NCT00040391|Irinotecan|irinotecan|mesh-list
64956232|NCT00040391|Antimetabolites|antimetabolites|mesh-ancestor
64956233|NCT00040391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956234|NCT00040391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64956235|NCT00040391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956236|NCT00040391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64956237|NCT00040391|Immunologic Factors|immunologic factors|mesh-ancestor
64956238|NCT00040391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956239|NCT00040391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64956240|NCT00040391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64956241|NCT00040391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956242|NCT00040391|Antidotes|antidotes|mesh-ancestor
64956243|NCT00040391|Protective Agents|protective agents|mesh-ancestor
64956244|NCT00040391|Vitamin B Complex|vitamin b complex|mesh-ancestor
64956245|NCT00040391|Vitamins|vitamins|mesh-ancestor
64956263|NCT00040469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64956264|NCT00040469|Alkylating Agents|alkylating agents|mesh-ancestor
64956265|NCT00040469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956266|NCT00040469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956267|NCT00040469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64956268|NCT00040469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64956269|NCT00040469|Anticonvulsants|anticonvulsants|mesh-ancestor
64956270|NCT00040469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64956271|NCT00040469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64956272|NCT00040469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64956302|NCT00411307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64956303|NCT00411307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956304|NCT00411307|Analgesics|analgesics|mesh-ancestor
64956305|NCT00411307|Sensory System Agents|sensory system agents|mesh-ancestor
64956307|NCT00040508|Sirolimus|sirolimus|mesh-list
64956365|NCT00208117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64956366|NCT00208117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64956367|NCT00208117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64956368|NCT00208117|Serotonin Agents|serotonin agents|mesh-ancestor
64956369|NCT00208117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956370|NCT00208156|Mifepristone|mifepristone|mesh-list
64956371|NCT00208156|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64956372|NCT00208156|Abortifacient Agents|abortifacient agents|mesh-ancestor
64956373|NCT00208156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64956374|NCT00208156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956375|NCT00208156|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64956376|NCT00208156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64956377|NCT00208156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64956378|NCT00208156|Contraceptive Agents|contraceptive agents|mesh-ancestor
64956379|NCT00208156|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64956380|NCT00208156|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64956416|NCT00208273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64956417|NCT00208273|Hormone Antagonists|hormone antagonists|mesh-ancestor
64956418|NCT00208273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64956419|NCT00208273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956420|NCT00208312|Adenosine|adenosine|mesh-list
64956421|NCT00208312|Regadenoson|regadenoson|mesh-list
64956422|NCT00208312|Analgesics|analgesics|mesh-ancestor
64956423|NCT00208312|Sensory System Agents|sensory system agents|mesh-ancestor
64956424|NCT00208312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64956425|NCT00208312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956426|NCT00208312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64956427|NCT00208312|Vasodilator Agents|vasodilator agents|mesh-ancestor
64956428|NCT00208312|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64956429|NCT00208312|Purinergic Agonists|purinergic agonists|mesh-ancestor
64956430|NCT00208312|Purinergic Agents|purinergic agents|mesh-ancestor
64956431|NCT00208312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64956432|NCT00208312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956433|NCT00208312|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64956434|NCT00040781|Gefitinib|gefitinib|mesh-list
64956437|NCT00040781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956583|NCT00209014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956584|NCT00041054|Sulindac sulfone|sulindac sulfone|mesh-list
64956585|NCT00041054|Carboplatin|carboplatin|mesh-list
64956587|NCT00041054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956588|NCT00041054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64956589|NCT00041054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64956590|NCT00041054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64956591|NCT00041054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956592|NCT00041054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956593|NCT00041054|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64956594|NCT00041054|Protective Agents|protective agents|mesh-ancestor
64956595|NCT00041054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956596|NCT00041054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64956597|NCT00041054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64956598|NCT00041054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64956599|NCT00041054|Analgesics|analgesics|mesh-ancestor
64956600|NCT00041054|Sensory System Agents|sensory system agents|mesh-ancestor
64956601|NCT00041054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64956602|NCT00041054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64956603|NCT00041054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64956604|NCT00209209|Interferons|interferons|mesh-list
64956605|NCT00209209|Interferon-alpha|interferon-alpha|mesh-list
64956606|NCT00209209|Interferon alpha-2|interferon alpha-2|mesh-list
64956607|NCT00209209|Prednisone|prednisone|mesh-list
64956608|NCT00209209|Cyclophosphamide|cyclophosphamide|mesh-list
64956609|NCT00209209|Rituximab|rituximab|mesh-list
64956610|NCT00209209|Doxorubicin|doxorubicin|mesh-list
64956611|NCT00209209|Fludarabine|fludarabine|mesh-list
64495257|NCT01103440|Tirofiban|tirofiban|mesh-list
64956621|NCT00209209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64956622|NCT00209209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64956623|NCT00209209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64956624|NCT00209209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64956625|NCT00209209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64956628|NCT00209209|Glucocorticoids|glucocorticoids|mesh-ancestor
64956634|NCT00209209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64956635|NCT00209209|Tubulin Modulators|tubulin modulators|mesh-ancestor
64956636|NCT00209209|Antimitotic Agents|antimitotic agents|mesh-ancestor
64956637|NCT00209209|Mitosis Modulators|mitosis modulators|mesh-ancestor
64956638|NCT00041093|Docetaxel|docetaxel|mesh-list
64956639|NCT00041093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956640|NCT00041093|Tubulin Modulators|tubulin modulators|mesh-ancestor
64956644|NCT00399087|Prednisone|prednisone|mesh-list
64956674|NCT00209599|Fospropofol|fospropofol|mesh-list
64956675|NCT00209599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64956676|NCT00209599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64956747|NCT00209833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956749|NCT00209833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64956750|NCT00209833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64956751|NCT00041210|Prednisone|prednisone|mesh-list
64495380|NCT03451734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64495381|NCT03451734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495382|NCT03451734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64495383|NCT03451734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64495384|NCT03451734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64495385|NCT03130218|Peppermint oil|peppermint oil|mesh-list
64495386|NCT03130218|Antiemetics|antiemetics|mesh-ancestor
64495387|NCT03130218|Autonomic Agents|autonomic agents|mesh-ancestor
64495388|NCT03130218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64495389|NCT03130218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495390|NCT03130218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64495391|NCT03130218|Parasympatholytics|parasympatholytics|mesh-ancestor
64495392|NCT01199146|Abiraterone Acetate|abiraterone acetate|mesh-list
64956786|NCT00209872|Sensory System Agents|sensory system agents|mesh-ancestor
64956787|NCT00209872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64956788|NCT00209872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64956789|NCT00209872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64956790|NCT00209872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64956791|NCT00209872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64956793|NCT00209872|Analgesics|analgesics|mesh-ancestor
64956797|NCT00209872|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64956798|NCT00209872|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64956799|NCT00209872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64956800|NCT00209872|Anticonvulsants|anticonvulsants|mesh-ancestor
64956801|NCT00209872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64956802|NCT00209872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64956803|NCT00209872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64956804|NCT00209872|Antimanic Agents|antimanic agents|mesh-ancestor
64956805|NCT00209872|Antidepressive Agents|antidepressive agents|mesh-ancestor
64956806|NCT00209950|Gaboxadol|gaboxadol|mesh-list
64956861|NCT00041288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64956862|NCT00073164|Valproic Acid|valproic acid|mesh-list
64956863|NCT00073164|Olanzapine|olanzapine|mesh-list
64956864|NCT00073164|Risperidone|risperidone|mesh-list
64956865|NCT00073164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64956866|NCT00073164|Serotonin Agents|serotonin agents|mesh-ancestor
64956867|NCT00073164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64956868|NCT00073164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956869|NCT00073164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956870|NCT00073164|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64956871|NCT00073164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64956872|NCT00073164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64956873|NCT00073164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64956874|NCT00073164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64956875|NCT00073164|Dopamine Agents|dopamine agents|mesh-ancestor
64956876|NCT00073164|Antiemetics|antiemetics|mesh-ancestor
64956877|NCT00073164|Autonomic Agents|autonomic agents|mesh-ancestor
64956878|NCT00073164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64956879|NCT00073164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64956880|NCT00073164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64956881|NCT00073164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64956882|NCT00073164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64956883|NCT00073164|Anticonvulsants|anticonvulsants|mesh-ancestor
64956884|NCT00073164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956904|NCT00411541|Autonomic Agents|autonomic agents|mesh-ancestor
64956905|NCT00411541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64956906|NCT00411541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956907|NCT00411541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64956908|NCT00411541|Glucocorticoids|glucocorticoids|mesh-ancestor
64956909|NCT00411541|Hormones|hormones|mesh-ancestor
64993658|NCT01989585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64993659|NCT01989585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993660|NCT01989585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993661|NCT01958021|Letrozole|letrozole|mesh-list
64993662|NCT01958021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993663|NCT01958021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64993664|NCT01958021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64993665|NCT01958021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993666|NCT01958021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993667|NCT01958021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64993668|NCT01958021|Hormone Antagonists|hormone antagonists|mesh-ancestor
64993669|NCT01958021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64993696|NCT01935921|Immunologic Factors|immunologic factors|mesh-ancestor
64956910|NCT00411541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64956911|NCT00411541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64956912|NCT00411541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956913|NCT00411541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64956914|NCT00411541|Tubulin Modulators|tubulin modulators|mesh-ancestor
64956915|NCT00411541|Antimitotic Agents|antimitotic agents|mesh-ancestor
64956916|NCT00411541|Mitosis Modulators|mitosis modulators|mesh-ancestor
64956917|NCT00411541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956918|NCT00210379|Rituximab|rituximab|mesh-list
64956919|NCT00210379|Methotrexate|methotrexate|mesh-list
64956920|NCT00210379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64956921|NCT00210379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956922|NCT00210379|Immunologic Factors|immunologic factors|mesh-ancestor
64956923|NCT00210379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956924|NCT00210379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64956925|NCT00210379|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64956926|NCT00210379|Abortifacient Agents|abortifacient agents|mesh-ancestor
64956927|NCT00210379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64956928|NCT00210379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64956929|NCT00210379|Antimetabolites|antimetabolites|mesh-ancestor
64956930|NCT00210379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956931|NCT00210379|Dermatologic Agents|dermatologic agents|mesh-ancestor
64956932|NCT00210379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956933|NCT00210379|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64956934|NCT00210379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64956953|NCT00041327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956954|NCT00041327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64956955|NCT00041327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64956956|NCT00041327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64956957|NCT00041327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64956958|NCT00041327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956959|NCT00041327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64956991|NCT00210574|Anticonvulsants|anticonvulsants|mesh-ancestor
64956992|NCT00210574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64956993|NCT00210574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956995|NCT00210691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64956996|NCT00210691|Serotonin Agents|serotonin agents|mesh-ancestor
64956997|NCT00210691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64956998|NCT00210691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956999|NCT00210691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957000|NCT00210691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64957001|NCT00210691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64957097|NCT00211471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64957098|NCT00211471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64957099|NCT00211471|Growth Substances|growth substances|mesh-ancestor
64957100|NCT00211471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957101|NCT00211471|Growth Inhibitors|growth inhibitors|mesh-ancestor
64957102|NCT00211471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957103|NCT00211588|Galantamine|galantamine|mesh-list
64957104|NCT00211588|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64957105|NCT00211588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957106|NCT00211588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957107|NCT00211588|Cholinergic Agents|cholinergic agents|mesh-ancestor
64957108|NCT00211588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957109|NCT00211588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957110|NCT00211588|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64957111|NCT00211588|Autonomic Agents|autonomic agents|mesh-ancestor
64957112|NCT00211588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957113|NCT00211588|Nootropic Agents|nootropic agents|mesh-ancestor
64957114|NCT00211705|Pravastatin|pravastatin|mesh-list
64957115|NCT00211705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64957116|NCT00211705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64957117|NCT00211705|Antimetabolites|antimetabolites|mesh-ancestor
64957118|NCT00211705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957119|NCT00211705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64957120|NCT00211705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64957121|NCT00211705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957122|NCT00211744|Topiramate|topiramate|mesh-list
64957136|NCT00211939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64957137|NCT00211939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64957138|NCT00211939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957139|NCT00211939|Chelating Agents|chelating agents|mesh-ancestor
64957140|NCT00211939|Sequestering Agents|sequestering agents|mesh-ancestor
64957141|NCT00211978|Calcium|calcium|mesh-list
64957142|NCT00211978|Calcium acetate|calcium acetate|mesh-list
64957143|NCT00211978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64957144|NCT00211978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957145|NCT00211978|Chelating Agents|chelating agents|mesh-ancestor
64957147|NCT00211978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957148|NCT00212017|Voglibose|voglibose|mesh-list
64957149|NCT00212017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64957150|NCT00212017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957151|NCT00212017|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64957152|NCT00212017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957190|NCT00073203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64957191|NCT00073203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957192|NCT00073203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957193|NCT00073203|Serotonin Agents|serotonin agents|mesh-ancestor
64957194|NCT00073203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957256|NCT00213538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64957257|NCT00213538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957258|NCT00213538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64957260|NCT00213538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957261|NCT00213538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957262|NCT00213538|Dermatologic Agents|dermatologic agents|mesh-ancestor
64957263|NCT00213538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957264|NCT00213538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64957265|NCT00213538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64957266|NCT00213538|Immunologic Factors|immunologic factors|mesh-ancestor
64957267|NCT00213538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64957268|NCT00213538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64957317|NCT00214318|Autonomic Agents|autonomic agents|mesh-ancestor
64957318|NCT00214318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957370|NCT00214630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957371|NCT00214630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64957372|NCT00214630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64957373|NCT00214630|Antimetabolites|antimetabolites|mesh-ancestor
64957374|NCT00214630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957375|NCT00214630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64957376|NCT00214630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64957377|NCT00214630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957378|NCT00214825|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64957379|NCT00214825|Eplerenone|eplerenone|mesh-list
64957380|NCT00214825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64957381|NCT00214825|Diuretics|diuretics|mesh-ancestor
64957382|NCT00214825|Natriuretic Agents|natriuretic agents|mesh-ancestor
64957383|NCT00214825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957384|NCT00214825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64957385|NCT00214825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64957386|NCT00214825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957387|NCT00214825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64957388|NCT00214825|Hormone Antagonists|hormone antagonists|mesh-ancestor
64957389|NCT00214825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64957390|NCT00214825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64957412|NCT00069498|Aminosalicylic Acid|aminosalicylic acid|mesh-list
64957413|NCT00069498|Mesalamine|mesalamine|mesh-list
64957414|NCT00069498|Antitubercular Agents|antitubercular agents|mesh-ancestor
64957415|NCT00069498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64957416|NCT00069498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64957417|NCT00069498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64957418|NCT00069498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64957419|NCT00069498|Analgesics|analgesics|mesh-ancestor
64957420|NCT00069498|Sensory System Agents|sensory system agents|mesh-ancestor
64957421|NCT00069498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957430|NCT00214981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64957466|NCT00215176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64957467|NCT00215176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64957468|NCT00215176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957469|NCT00215254|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64957470|NCT00215254|Antidepressive Agents|antidepressive agents|mesh-ancestor
64957471|NCT00215254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64957472|NCT00215254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64957473|NCT00215254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64957474|NCT00215254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64957475|NCT00215254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957476|NCT00041483|Anecortave|anecortave|mesh-list
64957477|NCT00041483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64957478|NCT00041483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64957479|NCT00041483|Growth Substances|growth substances|mesh-ancestor
64957480|NCT00041483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957481|NCT00041483|Growth Inhibitors|growth inhibitors|mesh-ancestor
64957482|NCT00041483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957483|NCT00215371|Formoterol Fumarate|formoterol fumarate|mesh-list
64957484|NCT00215371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64957485|NCT00215371|Autonomic Agents|autonomic agents|mesh-ancestor
64957486|NCT00215371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957498|NCT00215410|Autonomic Agents|autonomic agents|mesh-ancestor
64957514|NCT00215449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64957515|NCT00215449|Respiratory System Agents|respiratory system agents|mesh-ancestor
64957516|NCT00215449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64957517|NCT00215449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64957518|NCT00215449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64957535|NCT00215956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64957536|NCT00215956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957537|NCT00215956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957538|NCT00215956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957539|NCT00215995|Cisplatin|cisplatin|mesh-list
64957540|NCT00215995|Irinotecan|irinotecan|mesh-list
64957541|NCT00215995|Gefitinib|gefitinib|mesh-list
64957542|NCT00215995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957543|NCT00215995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64957563|NCT00216073|Capecitabine|capecitabine|mesh-list
64957659|NCT00216580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957660|NCT00216580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957661|NCT00216580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64957662|NCT00216580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64957663|NCT00216580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64957664|NCT00216580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64957665|NCT00216580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64957666|NCT00216580|Dopamine Agents|dopamine agents|mesh-ancestor
64957667|NCT00041561|Nitric Oxide|nitric oxide|mesh-list
64957668|NCT00041561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64957669|NCT00041561|Autonomic Agents|autonomic agents|mesh-ancestor
64957670|NCT00041561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957671|NCT00041561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957672|NCT00041561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64957673|NCT00041561|Respiratory System Agents|respiratory system agents|mesh-ancestor
64957674|NCT00041561|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64957675|NCT00041561|Antioxidants|antioxidants|mesh-ancestor
64957676|NCT00041561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957677|NCT00041561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957678|NCT00041561|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64957679|NCT00041561|Vasodilator Agents|vasodilator agents|mesh-ancestor
64957680|NCT00041561|Gasotransmitters|gasotransmitters|mesh-ancestor
64957681|NCT00041561|Protective Agents|protective agents|mesh-ancestor
64957703|NCT00216775|Interferon alpha-2|interferon alpha-2|mesh-list
64957760|NCT00412204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957761|NCT00412204|Anticonvulsants|anticonvulsants|mesh-ancestor
64957762|NCT00041678|Aripiprazole|aripiprazole|mesh-list
64957763|NCT00041678|Antidepressive Agents|antidepressive agents|mesh-ancestor
64957764|NCT00041678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64957765|NCT00041678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64957766|NCT00041678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64957767|NCT00041678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64957768|NCT00041678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957769|NCT00041678|Dopamine Agonists|dopamine agonists|mesh-ancestor
64957770|NCT00041678|Dopamine Agents|dopamine agents|mesh-ancestor
64957771|NCT00041678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957772|NCT00041678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957773|NCT00041678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64957774|NCT00041678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64957775|NCT00041678|Serotonin Agents|serotonin agents|mesh-ancestor
64957776|NCT00041678|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64957777|NCT00041678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64957778|NCT00041678|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64957779|NCT00041678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64957780|NCT00217243|Lidocaine|lidocaine|mesh-list
64957781|NCT00217243|Anesthetics, Local|anesthetics, local|mesh-ancestor
64957782|NCT00217243|Anesthetics|anesthetics|mesh-ancestor
64957783|NCT00217243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64957784|NCT00217243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957785|NCT00217243|Sensory System Agents|sensory system agents|mesh-ancestor
64957796|NCT00217282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957797|NCT00217282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64957798|NCT00217282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64957799|NCT00217282|Growth Substances|growth substances|mesh-ancestor
64957812|NCT00217477|Antimetabolites|antimetabolites|mesh-ancestor
64957813|NCT00217477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957853|NCT00217789|Chelating Agents|chelating agents|mesh-ancestor
64957854|NCT00217789|Sequestering Agents|sequestering agents|mesh-ancestor
64957855|NCT00217789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957857|NCT00217828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64957858|NCT00217828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64957859|NCT00217828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64957860|NCT00217828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957861|NCT00217828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957862|NCT00217828|Serotonin Agents|serotonin agents|mesh-ancestor
64957863|NCT00217828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957864|NCT00217828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64957867|NCT00041990|Decitabine|decitabine|mesh-list
64957956|NCT00218530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957957|NCT00218530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957958|NCT00218569|Naltrexone|naltrexone|mesh-list
64957959|NCT00218569|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64957960|NCT00218569|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64957961|NCT00218569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957962|NCT00218569|Sensory System Agents|sensory system agents|mesh-ancestor
64957963|NCT00218569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957964|NCT00218608|Disulfiram|disulfiram|mesh-list
64957965|NCT00218608|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64957966|NCT00218608|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
64957967|NCT00218608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957968|NCT00218608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957969|NCT00042146|Zolpidem|zolpidem|mesh-list
64957970|NCT00042146|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64957971|NCT00042146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64957972|NCT00042146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64957976|NCT00042146|GABA Agents|gaba agents|mesh-ancestor
64958039|NCT00219700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958040|NCT00219700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64958041|NCT00219700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64958042|NCT00219700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64958043|NCT00219700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958044|NCT00219700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958045|NCT00219739|Interferons|interferons|mesh-list
64958046|NCT00219739|Cytarabine|cytarabine|mesh-list
64958047|NCT00219739|Imatinib Mesylate|imatinib mesylate|mesh-list
64958048|NCT00219739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958049|NCT00219739|Antiviral Agents|antiviral agents|mesh-ancestor
64958050|NCT00219739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64958051|NCT00219739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64958052|NCT00219739|Antimetabolites|antimetabolites|mesh-ancestor
64958053|NCT00219739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958054|NCT00219739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64958055|NCT00219739|Immunologic Factors|immunologic factors|mesh-ancestor
64958056|NCT00219739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958057|NCT00219739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64958058|NCT00219739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958059|NCT00219778|Mifepristone|mifepristone|mesh-list
64958060|NCT00219778|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64958085|NCT00042458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64958086|NCT00042458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958087|NCT00219895|Ibuprofen|ibuprofen|mesh-list
64958088|NCT00219895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64958089|NCT00219895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64958090|NCT00219895|Analgesics|analgesics|mesh-ancestor
64958091|NCT00219895|Sensory System Agents|sensory system agents|mesh-ancestor
64958092|NCT00219895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64958093|NCT00219895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958095|NCT00219895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64958096|NCT00219895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64958097|NCT00219895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958099|NCT00077337|Romidepsin|romidepsin|mesh-list
64958103|NCT00219934|Antiviral Agents|antiviral agents|mesh-ancestor
64958104|NCT00219934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64958105|NCT00219973|Bemiparin|bemiparin|mesh-list
64958106|NCT00219973|Anticoagulants|anticoagulants|mesh-ancestor
64958107|NCT00220051|Capecitabine|capecitabine|mesh-list
64958108|NCT00220051|Oxaliplatin|oxaliplatin|mesh-list
64958138|NCT00042536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958139|NCT00042536|Urological Agents|urological agents|mesh-ancestor
64958140|NCT00220129|Capecitabine|capecitabine|mesh-list
64958141|NCT00220129|Epirubicin|epirubicin|mesh-list
64958142|NCT00220129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958143|NCT00220129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64958144|NCT00220129|Antimetabolites|antimetabolites|mesh-ancestor
64958145|NCT00220129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958146|NCT00220129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64958147|NCT00220129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64958148|NCT00220129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64958149|NCT00220129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958150|NCT00220168|Capecitabine|capecitabine|mesh-list
64958151|NCT00220168|Irinotecan|irinotecan|mesh-list
64958152|NCT00220168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64958153|NCT00220168|Antimetabolites|antimetabolites|mesh-ancestor
64958154|NCT00220168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958155|NCT00220168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958156|NCT00220168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64958157|NCT00220168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64958158|NCT00220168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958159|NCT00042575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64958160|NCT00042575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64958161|NCT00042575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64958184|NCT00220324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64958185|NCT00220324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64958186|NCT00220324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64958193|NCT00220324|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
64958194|NCT00220324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64958195|NCT00220324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64958196|NCT00412555|Oseltamivir|oseltamivir|mesh-list
64958197|NCT00412555|Antiviral Agents|antiviral agents|mesh-ancestor
64958198|NCT00412555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64958199|NCT00412555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958200|NCT00412555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958201|NCT00412633|Sulfamethazine|sulfamethazine|mesh-list
64958202|NCT00412633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64958203|NCT00042653|Cinacalcet|cinacalcet|mesh-list
64958237|NCT00042731|Antioxidants|antioxidants|mesh-ancestor
64958238|NCT00042731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958239|NCT00042731|Protective Agents|protective agents|mesh-ancestor
64958240|NCT00042731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958241|NCT00042731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64958242|NCT00042731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64958243|NCT00042731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958244|NCT00220714|Antipsychotic Agents|antipsychotic agents|mesh-list
64958245|NCT00220714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64958246|NCT00220714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64958247|NCT00220714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958248|NCT00220714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64958249|NCT00077493|Antibodies|antibodies|mesh-list
64958250|NCT00077493|Immunoglobulins|immunoglobulins|mesh-list
64958251|NCT00077493|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64958252|NCT00077493|Immunoconjugates|immunoconjugates|mesh-list
64958296|NCT00073710|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64958297|NCT00073710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64958298|NCT00073710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958299|NCT00073710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64958300|NCT00073710|Vitamins|vitamins|mesh-ancestor
64958301|NCT00073710|Micronutrients|micronutrients|mesh-ancestor
64958302|NCT00073710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64958303|NCT00042848|Modafinil|modafinil|mesh-list
64958304|NCT00042848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64958305|NCT00042848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958306|NCT00042848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64958307|NCT00042848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64958308|NCT00042848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64958334|NCT00402376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958335|NCT00402376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958336|NCT00402376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64958337|NCT00402376|Antioxidants|antioxidants|mesh-ancestor
64958338|NCT00402376|Protective Agents|protective agents|mesh-ancestor
64958339|NCT00402376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64958340|NCT00402376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64958341|NCT00402376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64958342|NCT00402376|Vasodilator Agents|vasodilator agents|mesh-ancestor
64958343|NCT00402376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64958383|NCT00122824|Sensory System Agents|sensory system agents|mesh-ancestor
64958384|NCT00122824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64958440|NCT00042965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64958441|NCT00042965|Antimetabolites|antimetabolites|mesh-ancestor
64958442|NCT00042965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958443|NCT00042965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958444|NCT00042965|Antiviral Agents|antiviral agents|mesh-ancestor
64958445|NCT00042965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64958446|NCT00042965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958447|NCT00042965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64958448|NCT00042965|Immunologic Factors|immunologic factors|mesh-ancestor
64958449|NCT00042965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958450|NCT00123175|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64958451|NCT00123175|Medroxyprogesterone|medroxyprogesterone|mesh-list
64958453|NCT00123175|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64958454|NCT00123175|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64958455|NCT00123175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64958456|NCT00123175|Contraceptive Agents|contraceptive agents|mesh-ancestor
64958457|NCT00123175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64958458|NCT00123175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958459|NCT00123175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64958549|NCT00077805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64958550|NCT00077805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958551|NCT00043082|Carboplatin|carboplatin|mesh-list
64958552|NCT00043082|Doxorubicin|doxorubicin|mesh-list
64958553|NCT00043082|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64958554|NCT00043082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958555|NCT00043082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64958556|NCT00043082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64958694|NCT00402415|Sirolimus|sirolimus|mesh-list
64958695|NCT00402415|Sunitinib|sunitinib|mesh-list
64958696|NCT00402415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64958697|NCT00402415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64958698|NCT00402415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64958699|NCT00402415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958700|NCT00402415|Antifungal Agents|antifungal agents|mesh-ancestor
64958701|NCT00402415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64958702|NCT00402415|Immunologic Factors|immunologic factors|mesh-ancestor
64958703|NCT00402415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958704|NCT00402415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64958705|NCT00402415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64958706|NCT00402415|Growth Substances|growth substances|mesh-ancestor
64958707|NCT00402415|Growth Inhibitors|growth inhibitors|mesh-ancestor
64958803|NCT00124930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64958804|NCT00124930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64958805|NCT00124930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64958806|NCT00124930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958807|NCT00124930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64958808|NCT00124930|Serotonin Agents|serotonin agents|mesh-ancestor
64958809|NCT00124969|Amlodipine|amlodipine|mesh-list
64958810|NCT00124969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64958811|NCT00124969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64958812|NCT00124969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64958813|NCT00124969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958814|NCT00124969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64958815|NCT00124969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958834|NCT00078000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64958835|NCT00078000|Growth Substances|growth substances|mesh-ancestor
64958836|NCT00078000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958837|NCT00078000|Growth Inhibitors|growth inhibitors|mesh-ancestor
64958838|NCT00078000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64958839|NCT00078000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958840|NCT00078000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958841|NCT00125203|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
64958842|NCT00125203|Botulinum Toxins|botulinum toxins|mesh-list
64958843|NCT00125203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64958844|NCT00125203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64958845|NCT00125203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64958846|NCT00125203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64958847|NCT00125203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958848|NCT00125203|Cholinergic Agents|cholinergic agents|mesh-ancestor
64958849|NCT00125203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64958850|NCT00125203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958851|NCT00125203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64958852|NCT00125203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64958853|NCT00125203|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64958887|NCT00125671|Anticoagulants|anticoagulants|mesh-ancestor
64993697|NCT01935921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958889|NCT00125827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64958890|NCT00125827|Antimetabolites|antimetabolites|mesh-ancestor
64958891|NCT00125827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958892|NCT00125827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958893|NCT00078039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64958894|NCT00078039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64958895|NCT00078039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64958896|NCT00078039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64958897|NCT00078039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958898|NCT00078039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64958899|NCT00078039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64958900|NCT00078039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64958901|NCT00078039|Serotonin Agents|serotonin agents|mesh-ancestor
64958902|NCT00078039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64497562|NCT03422796|Cilostazol|cilostazol|mesh-list
64958903|NCT00078039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958904|NCT00078039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64958905|NCT00078039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64958906|NCT00078039|Dopamine Agents|dopamine agents|mesh-ancestor
64958907|NCT00125905|Bupropion|bupropion|mesh-list
64958908|NCT00125905|Nicotine|nicotine|mesh-list
64958909|NCT00125905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64958910|NCT00125905|Autonomic Agents|autonomic agents|mesh-ancestor
64958911|NCT00125905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64958912|NCT00125905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958913|NCT00125905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64958932|NCT00078117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958933|NCT00078117|Analgesics|analgesics|mesh-ancestor
64958934|NCT00078117|Sensory System Agents|sensory system agents|mesh-ancestor
64958935|NCT00078117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64958936|NCT00078117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64958937|NCT00125983|Ritonavir|ritonavir|mesh-list
64958938|NCT00125983|Lopinavir|lopinavir|mesh-list
64958939|NCT00125983|Norinyl|norinyl|mesh-list
64958940|NCT00125983|Ortho Evra|ortho evra|mesh-list
64958947|NCT00125983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64958948|NCT00125983|Antiviral Agents|antiviral agents|mesh-ancestor
64958949|NCT00125983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64958950|NCT00125983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64958951|NCT00125983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64958952|NCT00125983|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64958953|NCT00125983|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64958954|NCT00125983|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64958955|NCT00125983|Contraceptive Agents|contraceptive agents|mesh-ancestor
64958981|NCT00402454|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64958982|NCT00402454|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64958984|NCT00402454|Antimetabolites|antimetabolites|mesh-ancestor
64958985|NCT00402454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64958987|NCT00402493|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64958988|NCT00402493|Latanoprost|latanoprost|mesh-list
64958989|NCT00402493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64958990|NCT00402493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64958991|NCT00402493|Analgesics|analgesics|mesh-ancestor
64958992|NCT00402493|Sensory System Agents|sensory system agents|mesh-ancestor
64958993|NCT00402493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64958994|NCT00402493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958995|NCT00402493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64958996|NCT00402493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64958997|NCT00402493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64958998|NCT00402493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958999|NCT00402493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959000|NCT00402493|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64959021|NCT00043589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959022|NCT00043589|Cholinergic Agents|cholinergic agents|mesh-ancestor
64959023|NCT00043589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64959024|NCT00043589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959025|NCT00043589|Nootropic Agents|nootropic agents|mesh-ancestor
64959026|NCT00399399|Cyclophosphamide|cyclophosphamide|mesh-list
64959027|NCT00399399|Azathioprine|azathioprine|mesh-list
64959028|NCT00399399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64959029|NCT00399399|Immunologic Factors|immunologic factors|mesh-ancestor
64959030|NCT00399399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959031|NCT00399399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64959032|NCT00399399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64959033|NCT00399399|Alkylating Agents|alkylating agents|mesh-ancestor
64959034|NCT00399399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959035|NCT00399399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959036|NCT00399399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64959037|NCT00399399|Antimetabolites|antimetabolites|mesh-ancestor
64959043|NCT00126139|Abciximab|abciximab|mesh-list
64959078|NCT00074139|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64959079|NCT00074139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64959080|NCT00074139|Immunologic Factors|immunologic factors|mesh-ancestor
64959081|NCT00074139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959082|NCT00074139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64959083|NCT00074139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64959084|NCT00074139|Alkylating Agents|alkylating agents|mesh-ancestor
64959085|NCT00074139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959086|NCT00074139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959087|NCT00074139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64959088|NCT00074139|Tubulin Modulators|tubulin modulators|mesh-ancestor
64959089|NCT00074139|Antimitotic Agents|antimitotic agents|mesh-ancestor
64959090|NCT00074139|Mitosis Modulators|mitosis modulators|mesh-ancestor
64959091|NCT00074139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64959092|NCT00074139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64959093|NCT00074139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64993698|NCT01935921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993699|NCT01935921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64993700|NCT01935921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993702|NCT01912625|Carboplatin|carboplatin|mesh-list
64993703|NCT01912625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64993704|NCT01912625|Trametinib|trametinib|mesh-list
64959094|NCT00074139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959095|NCT00126373|Bupropion|bupropion|mesh-list
64959096|NCT00126373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64959097|NCT00126373|Antidepressive Agents|antidepressive agents|mesh-ancestor
64959098|NCT00126373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64959099|NCT00126373|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64959100|NCT00126373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64959101|NCT00126373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64959166|NCT00074178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64959215|NCT00127114|Dopamine Agents|dopamine agents|mesh-ancestor
64959216|NCT00127114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64959217|NCT00127114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959218|NCT00127114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959219|NCT00127114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64959220|NCT00127114|Analgesics|analgesics|mesh-ancestor
64959221|NCT00127114|Sensory System Agents|sensory system agents|mesh-ancestor
64959222|NCT00127114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64959224|NCT00043784|Anticoagulants|anticoagulants|mesh-ancestor
64959225|NCT00043784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64959226|NCT00043784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64959227|NCT00043784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959228|NCT00127153|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64959380|NCT00402766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959381|NCT00402766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64959382|NCT00402766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64959383|NCT00402766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64959384|NCT00127972|Lamivudine|lamivudine|mesh-list
64959385|NCT00127972|Efavirenz|efavirenz|mesh-list
64959386|NCT00127972|Nevirapine|nevirapine|mesh-list
64959387|NCT00127972|Stavudine|stavudine|mesh-list
64959388|NCT00127972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64959389|NCT00127972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64959390|NCT00127972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959391|NCT00127972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959392|NCT00127972|Antiviral Agents|antiviral agents|mesh-ancestor
64959393|NCT00127972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64959394|NCT00127972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64959395|NCT00127972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64959396|NCT00127972|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64959397|NCT00127972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64959398|NCT00127972|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64959399|NCT00127972|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64959400|NCT00127972|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64959427|NCT00128245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959428|NCT00044057|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64959429|NCT00044057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64959430|NCT00044057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64959431|NCT00044057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959433|NCT00044135|Antiviral Agents|antiviral agents|mesh-ancestor
64959434|NCT00044135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64959435|NCT05561725|Dexamethasone|dexamethasone|mesh-list
64959436|NCT05561725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64959437|NCT05561725|Antiemetics|antiemetics|mesh-ancestor
64959438|NCT05561725|Autonomic Agents|autonomic agents|mesh-ancestor
64959439|NCT05561725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64959440|NCT05561725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959441|NCT05561725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64959444|NCT05561725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64959445|NCT05561725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64959446|NCT05561725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959447|NCT00078195|Omalizumab|omalizumab|mesh-list
64959448|NCT00078195|Immunoglobulins|immunoglobulins|mesh-list
64959449|NCT00078195|Immunologic Factors|immunologic factors|mesh-list
64959450|NCT00078195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64959451|NCT00078195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959452|NCT00078195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64959453|NCT00078195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64959454|NCT00078195|Respiratory System Agents|respiratory system agents|mesh-ancestor
64959484|NCT00078351|Hylan|hylan|mesh-list
64959578|NCT00044642|Anticonvulsants|anticonvulsants|mesh-ancestor
64959579|NCT00044642|Antiemetics|antiemetics|mesh-ancestor
64959580|NCT00044642|Autonomic Agents|autonomic agents|mesh-ancestor
64959581|NCT00044642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64959582|NCT00044642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959583|NCT00044642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64959584|NCT00044642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64959585|NCT00044642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64959586|NCT00044642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64959587|NCT00044642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64959588|NCT00044642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64959589|NCT00044642|GABA Modulators|gaba modulators|mesh-ancestor
64959590|NCT00044642|GABA Agents|gaba agents|mesh-ancestor
64959591|NCT00044642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64959592|NCT00044642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959593|NCT00044681|Risperidone|risperidone|mesh-list
64959594|NCT00044681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64959595|NCT00044681|Serotonin Agents|serotonin agents|mesh-ancestor
64959596|NCT00044681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64959597|NCT00044681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959598|NCT00044681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959599|NCT00044681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64959600|NCT00044681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64959601|NCT00044681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64959602|NCT00044681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64959608|NCT00044720|Sirolimus|sirolimus|mesh-list
64959613|NCT00044720|Antifungal Agents|antifungal agents|mesh-ancestor
64959614|NCT00044720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64959615|NCT00044720|Immunologic Factors|immunologic factors|mesh-ancestor
64959616|NCT00044720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959618|NCT04938466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64959619|NCT04938466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959620|NCT00403000|Dutasteride|dutasteride|mesh-list
64959621|NCT00403000|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64959623|NCT00403000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959627|NCT00403000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959628|NCT00397553|Insulin glulisine|insulin glulisine|mesh-list
64959629|NCT00397553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64959630|NCT00397553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959631|NCT00403039|Ranibizumab|ranibizumab|mesh-list
64959632|NCT00403039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64959633|NCT00403039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64959634|NCT00403039|Growth Substances|growth substances|mesh-ancestor
64959635|NCT00403039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959636|NCT00403039|Growth Inhibitors|growth inhibitors|mesh-ancestor
64959637|NCT00403039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959638|NCT00078858|Cyclosporine|cyclosporine|mesh-list
64959639|NCT00078858|Mycophenolic Acid|mycophenolic acid|mesh-list
64959640|NCT00078858|Fludarabine|fludarabine|mesh-list
64959641|NCT00078858|Fludarabine phosphate|fludarabine phosphate|mesh-list
64959642|NCT00078858|Cyclosporins|cyclosporins|mesh-list
64959656|NCT00078858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64959657|NCT00078858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64959658|NCT00078858|Antitubercular Agents|antitubercular agents|mesh-ancestor
64959659|NCT00078858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64959661|NCT00044759|Piperacillin|piperacillin|mesh-list
64959662|NCT00044759|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64959663|NCT00044759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64959664|NCT00044759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64959715|NCT00078975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64959716|NCT00078975|Immunologic Factors|immunologic factors|mesh-ancestor
64959717|NCT00078975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959718|NCT00044837|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64959719|NCT00044837|Medroxyprogesterone|medroxyprogesterone|mesh-list
64959720|NCT00044837|Estradiol|estradiol|mesh-list
64959721|NCT00044837|Estrogens|estrogens|mesh-ancestor
64959722|NCT00044837|Hormones|hormones|mesh-ancestor
64498373|NCT01361620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64959723|NCT00044837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64959724|NCT00044837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959725|NCT00044837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64959726|NCT00044837|Contraceptive Agents|contraceptive agents|mesh-ancestor
64959727|NCT00044837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64959728|NCT00044837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64959729|NCT00044837|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64959730|NCT00044837|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64959731|NCT00044837|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64959732|NCT00044837|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64959733|NCT00044837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64959734|NCT00044837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959746|NCT00044876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959747|NCT00044876|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64959749|NCT00079014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64959773|NCT04321408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959774|NCT04321408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64959779|NCT04321408|Analgesics|analgesics|mesh-ancestor
64959786|NCT00079053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959788|NCT04263298|Fulvestrant|fulvestrant|mesh-list
64959789|NCT04263298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64959790|NCT04263298|Antimetabolites|antimetabolites|mesh-ancestor
64959791|NCT04263298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959792|NCT04263298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959793|NCT04263298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64959794|NCT04263298|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64959796|NCT04263298|Hormone Antagonists|hormone antagonists|mesh-ancestor
64959797|NCT04263298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64959798|NCT04263298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959799|NCT00044954|Cyclosporine|cyclosporine|mesh-list
64959800|NCT00044954|Mycophenolic Acid|mycophenolic acid|mesh-list
64959801|NCT00044954|Fludarabine|fludarabine|mesh-list
64959802|NCT00044954|Fludarabine phosphate|fludarabine phosphate|mesh-list
64959803|NCT00044954|Cyclosporins|cyclosporins|mesh-list
64959804|NCT00044954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959805|NCT00044954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64959806|NCT00044954|Antimetabolites|antimetabolites|mesh-ancestor
64959807|NCT00044954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959808|NCT00044954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64959809|NCT00044954|Immunologic Factors|immunologic factors|mesh-ancestor
64959810|NCT00044954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836113|NCT01611311|BI 409306|bi 409306|mesh-list
64836114|NCT01611311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64836115|NCT01611311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836126|NCT01611324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64836128|NCT01611324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64836129|NCT01611324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64836130|NCT01611324|Respiratory System Agents|respiratory system agents|mesh-ancestor
64836131|NCT01611324|Mydriatics|mydriatics|mesh-ancestor
64836132|NCT01611324|Sympathomimetics|sympathomimetics|mesh-ancestor
64836133|NCT01611324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64836134|NCT01611324|Anesthetics, Local|anesthetics, local|mesh-ancestor
64836135|NCT01611324|Anesthetics|anesthetics|mesh-ancestor
64836136|NCT01611324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64836137|NCT01611324|Sensory System Agents|sensory system agents|mesh-ancestor
64836138|NCT01611363|Ipragliflozin|ipragliflozin|mesh-list
64836148|NCT01611415|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64836149|NCT01611415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64325732|NCT04965597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959811|NCT00044954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959812|NCT00044954|Antifungal Agents|antifungal agents|mesh-ancestor
64959813|NCT00044954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64959814|NCT00044954|Dermatologic Agents|dermatologic agents|mesh-ancestor
64959815|NCT00044954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64959830|NCT00079092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64959832|NCT00079092|Growth Inhibitors|growth inhibitors|mesh-ancestor
64959833|NCT00079092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959834|NCT00044993|Docetaxel|docetaxel|mesh-list
64959835|NCT00044993|Doxorubicin|doxorubicin|mesh-list
64959836|NCT00044993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64959837|NCT00044993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959838|NCT00044993|Tubulin Modulators|tubulin modulators|mesh-ancestor
64959839|NCT00044993|Antimitotic Agents|antimitotic agents|mesh-ancestor
64959840|NCT00044993|Mitosis Modulators|mitosis modulators|mesh-ancestor
64959841|NCT00044993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959842|NCT00044993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64959843|NCT00044993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64959844|NCT00044993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64959845|NCT00044993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959855|NCT04162210|Hormones|hormones|mesh-ancestor
64959890|NCT00045227|Sargramostim|sargramostim|mesh-list
64959891|NCT00045227|Immunologic Factors|immunologic factors|mesh-ancestor
64959892|NCT00045227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959893|NCT00045227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959894|NCT00045227|Tubulin Modulators|tubulin modulators|mesh-ancestor
64959895|NCT00045227|Antimitotic Agents|antimitotic agents|mesh-ancestor
64959896|NCT00045227|Mitosis Modulators|mitosis modulators|mesh-ancestor
64959897|NCT00045227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959898|NCT00075075|Infliximab|infliximab|mesh-list
64959899|NCT00075075|Dermatologic Agents|dermatologic agents|mesh-ancestor
64959900|NCT00075075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64959901|NCT00075075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64959902|NCT04065451|Epinephrine|epinephrine|mesh-list
64959903|NCT04065451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64959904|NCT04065451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64325733|NCT04965597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64959905|NCT04065451|Adrenergic Agents|adrenergic agents|mesh-ancestor
64959906|NCT04065451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64959908|NCT04065451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959946|NCT03928366|Remifentanil|remifentanil|mesh-list
64959947|NCT03928366|Propofol|propofol|mesh-list
64959948|NCT03928366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64959949|NCT03928366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64959950|NCT03928366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959951|NCT03928366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64959952|NCT03928366|Anesthetics, General|anesthetics, general|mesh-ancestor
64959953|NCT03928366|Anesthetics|anesthetics|mesh-ancestor
64959954|NCT03928366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64959955|NCT03928366|Narcotics|narcotics|mesh-ancestor
64959956|NCT03928366|Analgesics|analgesics|mesh-ancestor
64959957|NCT03928366|Sensory System Agents|sensory system agents|mesh-ancestor
64959958|NCT03928366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64959959|NCT00045422|Interferons|interferons|mesh-list
64959960|NCT00045422|Interferon-alpha|interferon-alpha|mesh-list
64959961|NCT00045422|Imatinib Mesylate|imatinib mesylate|mesh-list
64959962|NCT00045422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959963|NCT00045422|Antiviral Agents|antiviral agents|mesh-ancestor
64959964|NCT00045422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64959965|NCT00045422|Immunologic Factors|immunologic factors|mesh-ancestor
64959966|NCT00045422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959967|NCT00045422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64959968|NCT00045422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959969|NCT00045422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959970|NCT00075192|Leuprolide|leuprolide|mesh-list
64959971|NCT00075192|Bicalutamide|bicalutamide|mesh-list
64960002|NCT00075231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960048|NCT00045539|Thiotepa|thiotepa|mesh-list
64960049|NCT00045539|Calcium|calcium|mesh-list
64960050|NCT00045539|Levoleucovorin|levoleucovorin|mesh-list
64960051|NCT00045539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64960052|NCT00045539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960053|NCT00045539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64960054|NCT00045539|Abortifacient Agents|abortifacient agents|mesh-ancestor
64960055|NCT00045539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64960056|NCT00045539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64960057|NCT00045539|Antimetabolites|antimetabolites|mesh-ancestor
64960058|NCT00045539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960059|NCT00045539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960060|NCT00045539|Dermatologic Agents|dermatologic agents|mesh-ancestor
64960061|NCT00045539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960062|NCT00045539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64960063|NCT00045539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64960064|NCT00045539|Immunologic Factors|immunologic factors|mesh-ancestor
64960065|NCT00045539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64960066|NCT00045539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64960067|NCT00045539|Antidotes|antidotes|mesh-ancestor
64960068|NCT00045539|Protective Agents|protective agents|mesh-ancestor
64960069|NCT00045539|Vitamin B Complex|vitamin b complex|mesh-ancestor
64960100|NCT03442309|Protective Agents|protective agents|mesh-ancestor
64960101|NCT03442309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960102|NCT03399838|Midazolam|midazolam|mesh-list
64960103|NCT03399838|Dexmedetomidine|dexmedetomidine|mesh-list
64960104|NCT03399838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64960105|NCT03399838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64960106|NCT03399838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960107|NCT03399838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64960108|NCT03399838|Analgesics|analgesics|mesh-ancestor
64960109|NCT03399838|Sensory System Agents|sensory system agents|mesh-ancestor
64960110|NCT03399838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64960111|NCT03399838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64325734|NCT04965597|Antimetabolites|antimetabolites|mesh-ancestor
64325735|NCT04965597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325736|NCT04965597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325737|NCT04965597|Dermatologic Agents|dermatologic agents|mesh-ancestor
64325738|NCT04965597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960112|NCT03399838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64960113|NCT03399838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64960114|NCT03399838|Adrenergic Agents|adrenergic agents|mesh-ancestor
64960115|NCT03399838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64960116|NCT03399838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960117|NCT03399838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64960118|NCT03399838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64960119|NCT03399838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64960120|NCT03399838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64960121|NCT03399838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64960122|NCT03399838|Anesthetics, General|anesthetics, general|mesh-ancestor
64960123|NCT03399838|Anesthetics|anesthetics|mesh-ancestor
64960124|NCT03399838|GABA Modulators|gaba modulators|mesh-ancestor
64960125|NCT03399838|GABA Agents|gaba agents|mesh-ancestor
64960126|NCT00079287|Gemcitabine|gemcitabine|mesh-list
64960127|NCT00079287|Paclitaxel|paclitaxel|mesh-list
64960128|NCT00079287|Vinorelbine|vinorelbine|mesh-list
64960129|NCT00079287|Docetaxel|docetaxel|mesh-list
64960130|NCT00079287|Carboplatin|carboplatin|mesh-list
64960131|NCT00079287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64960132|NCT00079287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960133|NCT00079287|Tubulin Modulators|tubulin modulators|mesh-ancestor
64960134|NCT00079287|Antimitotic Agents|antimitotic agents|mesh-ancestor
64960142|NCT00079287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64960143|NCT00079287|Immunologic Factors|immunologic factors|mesh-ancestor
64960144|NCT00079287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960145|NCT00045695|Bortezomib|bortezomib|mesh-list
64960146|NCT00045695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960147|NCT00079365|Gemcitabine|gemcitabine|mesh-list
64960148|NCT00079365|Fluorouracil|fluorouracil|mesh-list
64960149|NCT00079365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64960150|NCT00079365|Antimetabolites|antimetabolites|mesh-ancestor
64960151|NCT00079365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960152|NCT00079365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960153|NCT00079365|Antiviral Agents|antiviral agents|mesh-ancestor
64960154|NCT00079365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64960155|NCT00079365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960156|NCT00079365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64325739|NCT04965597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64836164|NCT01611506|Capecitabine|capecitabine|mesh-list
64836165|NCT01611506|Cetuximab|cetuximab|mesh-list
64960157|NCT00079365|Immunologic Factors|immunologic factors|mesh-ancestor
64960158|NCT00079365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960159|NCT02962414|Everolimus|everolimus|mesh-list
64960160|NCT02962414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960161|NCT02962414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64960162|NCT02962414|Immunologic Factors|immunologic factors|mesh-ancestor
64960163|NCT02962414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960164|NCT00045773|Sertraline|sertraline|mesh-list
64960165|NCT00045773|Antidepressive Agents|antidepressive agents|mesh-ancestor
64960166|NCT00045773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64960167|NCT00045773|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64960168|NCT00045773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64960169|NCT00045773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64960170|NCT00045773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960171|NCT00045773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64960188|NCT00045812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960189|NCT00045812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64960190|NCT00079443|Rituximab|rituximab|mesh-list
64960191|NCT00079443|Fludarabine|fludarabine|mesh-list
64960192|NCT00079443|Fludarabine phosphate|fludarabine phosphate|mesh-list
64960193|NCT00079443|Romidepsin|romidepsin|mesh-list
64960194|NCT00079443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64960195|NCT00079443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960196|NCT00079443|Immunologic Factors|immunologic factors|mesh-ancestor
64960197|NCT00079443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960198|NCT00079443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64960199|NCT00079443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64960200|NCT00079443|Antimetabolites|antimetabolites|mesh-ancestor
64960201|NCT00079443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960202|NCT00079443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64960203|NCT00079443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64960204|NCT02599363|Paclitaxel|paclitaxel|mesh-list
64960205|NCT02599363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64960206|NCT02599363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960213|NCT02580838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64960214|NCT02580838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64960234|NCT00079560|Sensory System Agents|sensory system agents|mesh-ancestor
64960235|NCT00079560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64960236|NCT00079560|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64960237|NCT00079560|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64960238|NCT00079560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64960239|NCT00079560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960240|NCT00079560|Hormones|hormones|mesh-ancestor
64960241|NCT00079560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64960242|NCT00046163|Midodrine|midodrine|mesh-list
64960243|NCT00046163|Sympathomimetics|sympathomimetics|mesh-ancestor
64960244|NCT00046163|Autonomic Agents|autonomic agents|mesh-ancestor
64960245|NCT00046163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498977|NCT03419442|Mitosis Modulators|mitosis modulators|mesh-ancestor
64960246|NCT00046163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960247|NCT00046163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64960248|NCT00046163|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64960249|NCT00046163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64960250|NCT00046163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64960251|NCT00046163|Adrenergic Agents|adrenergic agents|mesh-ancestor
64960252|NCT00046163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64960253|NCT00046163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960254|NCT01409161|Vitamins|vitamins|mesh-list
64960255|NCT01409161|Vitamin A|vitamin a|mesh-list
64960256|NCT01409161|Tretinoin|tretinoin|mesh-list
64960257|NCT01409161|Retinol palmitate|retinol palmitate|mesh-list
64836166|NCT01611506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836167|NCT01611506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64836168|NCT01611506|Antimetabolites|antimetabolites|mesh-ancestor
64836169|NCT01611506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604665|NCT05372536|Cytarabine|cytarabine|mesh-list
64836170|NCT01611506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64836171|NCT01611675|Vemurafenib|vemurafenib|mesh-list
64325743|NCT04965597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64325744|NCT04965597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64836172|NCT01611675|Leflunomide|leflunomide|mesh-list
64836173|NCT01611675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836174|NCT01611675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64836175|NCT01611675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836176|NCT01611675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836177|NCT01611675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64836178|NCT01611675|Immunologic Factors|immunologic factors|mesh-ancestor
64836179|NCT01611675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836180|NCT01611688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64836181|NCT01611688|Immunologic Factors|immunologic factors|mesh-ancestor
64836182|NCT01611688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960258|NCT01409161|Arsenic Trioxide|arsenic trioxide|mesh-list
64960259|NCT01409161|Gemtuzumab|gemtuzumab|mesh-list
64960260|NCT01409161|Calicheamicins|calicheamicins|mesh-list
64960261|NCT01409161|Micronutrients|micronutrients|mesh-ancestor
64960262|NCT01409161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960263|NCT01409161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960278|NCT00079638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64960280|NCT00079638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960281|NCT00079638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64960282|NCT00079638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64960283|NCT00079638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960284|NCT00079638|Vasodilator Agents|vasodilator agents|mesh-ancestor
64960285|NCT00079638|Vitamin B Complex|vitamin b complex|mesh-ancestor
64960286|NCT00079638|Vitamins|vitamins|mesh-ancestor
64960287|NCT00079638|Micronutrients|micronutrients|mesh-ancestor
64960288|NCT00079638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960289|NCT00046241|Bupropion|bupropion|mesh-list
64960290|NCT00046241|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64960291|NCT00046241|Antidepressive Agents|antidepressive agents|mesh-ancestor
64960292|NCT00046241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64960293|NCT00046241|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64960294|NCT00046241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64960295|NCT00046241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64960296|NCT00046241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960297|NCT00046241|Dopamine Agents|dopamine agents|mesh-ancestor
64960298|NCT00046241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64960299|NCT00046241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960300|NCT00046241|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64960301|NCT00046241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64960302|NCT00046241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960303|NCT00079716|Dacetuzumab|dacetuzumab|mesh-list
64960304|NCT00079716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64960305|NCT00079716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960306|NCT00130468|Hyaluronic Acid|hyaluronic acid|mesh-list
64960307|NCT00130468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64836183|NCT01611727|Cisplatin|cisplatin|mesh-list
64836184|NCT01611727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836185|NCT01611896|Selenium|selenium|mesh-list
64836186|NCT01611896|Antioxidants|antioxidants|mesh-ancestor
64960308|NCT00130468|Immunologic Factors|immunologic factors|mesh-ancestor
64960318|NCT00130507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960319|NCT00130507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64960320|NCT00130507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64960456|NCT00131053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64960457|NCT00131053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64960468|NCT00397592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64960469|NCT00397592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960471|NCT00131326|Viscosupplements|viscosupplements|mesh-ancestor
64960472|NCT00131326|Protective Agents|protective agents|mesh-ancestor
64960473|NCT00131326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960474|NCT00131404|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
64960475|NCT00131404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64960476|NCT00131404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64960477|NCT00131404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64960478|NCT00131404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960480|NCT00131404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64960481|NCT00131404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960482|NCT00131443|Topiramate|topiramate|mesh-list
64960483|NCT00131443|Anticonvulsants|anticonvulsants|mesh-ancestor
64960484|NCT00131443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64960485|NCT00131443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960492|NCT00131482|Thrombin|thrombin|mesh-list
64960520|NCT00131521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64960521|NCT00131521|Antioxidants|antioxidants|mesh-ancestor
64960522|NCT00131521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960523|NCT00131521|Protective Agents|protective agents|mesh-ancestor
64960524|NCT00131521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960525|NCT00080028|Motexafin gadolinium|motexafin gadolinium|mesh-list
64960526|NCT00080028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960527|NCT00080028|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64960528|NCT00080028|Dermatologic Agents|dermatologic agents|mesh-ancestor
64960529|NCT00131716|Pyrimethamine|pyrimethamine|mesh-list
64960530|NCT00131716|Sulfadoxine|sulfadoxine|mesh-list
64960583|NCT00403780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64960584|NCT00403780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64960585|NCT00046514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64960586|NCT00046514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960587|NCT00403819|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64960588|NCT00403819|Laxatives|laxatives|mesh-ancestor
64960589|NCT00403819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64960590|NCT00403858|Lactulose|lactulose|mesh-list
64960591|NCT00403858|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64960592|NCT00403858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64960593|NCT00403858|Laxatives|laxatives|mesh-ancestor
64960594|NCT00046553|Mifepristone|mifepristone|mesh-list
64960595|NCT00046553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64960596|NCT00046553|Abortifacient Agents|abortifacient agents|mesh-ancestor
64960597|NCT00046553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64960598|NCT00046553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960599|NCT00046553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64960600|NCT00046553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64960601|NCT00046553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64960602|NCT00046553|Contraceptive Agents|contraceptive agents|mesh-ancestor
64960603|NCT00046553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64960604|NCT00046553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64960605|NCT00046553|Hormone Antagonists|hormone antagonists|mesh-ancestor
64960606|NCT00046553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64960607|NCT00046553|Luteolytic Agents|luteolytic agents|mesh-ancestor
64960610|NCT00131989|Sorafenib|sorafenib|mesh-list
64960621|NCT00132106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64960622|NCT00132106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64960623|NCT00132106|Adrenergic Agents|adrenergic agents|mesh-ancestor
64960624|NCT00132106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64960633|NCT00132184|Vitamin D|vitamin d|mesh-list
64960680|NCT00132652|Antiviral Agents|antiviral agents|mesh-ancestor
64960681|NCT00132652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64960682|NCT00132652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64960683|NCT00132652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64960685|NCT00046748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64960686|NCT00046748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64960687|NCT00046748|Respiratory System Agents|respiratory system agents|mesh-ancestor
64960688|NCT00132886|Tolvaptan|tolvaptan|mesh-list
64960689|NCT00132886|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64960690|NCT00132886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960691|NCT00132886|Natriuretic Agents|natriuretic agents|mesh-ancestor
64960692|NCT00132886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960693|NCT00080418|Paclitaxel|paclitaxel|mesh-list
64960694|NCT00080418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64960695|NCT00080418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960737|NCT00046826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64960738|NCT00046826|Immunologic Factors|immunologic factors|mesh-ancestor
64960739|NCT00046826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960740|NCT00046826|Leprostatic Agents|leprostatic agents|mesh-ancestor
64960741|NCT00046826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64960742|NCT00046826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64960743|NCT00046826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64960744|NCT00046826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64960751|NCT00133237|Paclitaxel|paclitaxel|mesh-list
64960805|NCT00080496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960806|NCT00080496|Protease Inhibitors|protease inhibitors|mesh-ancestor
64960807|NCT00133354|Anastrozole|anastrozole|mesh-list
64960808|NCT00133354|Hormones|hormones|mesh-list
64960844|NCT00403897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64960845|NCT00403975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64960846|NCT00403975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64960847|NCT00046943|Atrasentan|atrasentan|mesh-list
64960848|NCT00046943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960849|NCT00046943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64960850|NCT00046943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64960851|NCT00046943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960852|NCT00133549|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64960853|NCT00133549|Immunologic Factors|immunologic factors|mesh-ancestor
64960854|NCT00133549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960855|NCT00080613|Exemestane|exemestane|mesh-list
64960856|NCT00080613|Hormones|hormones|mesh-list
64960857|NCT00080613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64960904|NCT00080808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960905|NCT00080808|Vasodilator Agents|vasodilator agents|mesh-ancestor
64960906|NCT00080808|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64960907|NCT00080808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64960908|NCT00080808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960909|NCT00080808|Urological Agents|urological agents|mesh-ancestor
64960910|NCT00080808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64960911|NCT00080808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64960912|NCT00080808|Adrenergic Agents|adrenergic agents|mesh-ancestor
64960913|NCT00080808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64960914|NCT00080808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960915|NCT00080808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64960916|NCT00080808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64960917|NCT00047099|Tamoxifen|tamoxifen|mesh-list
64499591|NCT01829477|Glimepiride|glimepiride|mesh-list
64960918|NCT00047099|Cyclophosphamide|cyclophosphamide|mesh-list
64960919|NCT00047099|Docetaxel|docetaxel|mesh-list
64960920|NCT00047099|Fluorouracil|fluorouracil|mesh-list
64836187|NCT01611896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836188|NCT01611896|Protective Agents|protective agents|mesh-ancestor
64960921|NCT00047099|Epirubicin|epirubicin|mesh-list
64960922|NCT00047099|Goserelin|goserelin|mesh-list
64960923|NCT00047099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64960924|NCT00047099|Immunologic Factors|immunologic factors|mesh-ancestor
64960925|NCT00047099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960926|NCT00047099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64960928|NCT00047099|Alkylating Agents|alkylating agents|mesh-ancestor
64960953|NCT00133822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960954|NCT00133822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960955|NCT00133822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64961074|NCT00134212|Norepinephrine|norepinephrine|mesh-list
64961075|NCT00134212|Dopexamine|dopexamine|mesh-list
64961076|NCT00134212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64961077|NCT00134212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64961078|NCT00134212|Adrenergic Agents|adrenergic agents|mesh-ancestor
64961079|NCT00134212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64961080|NCT00134212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961081|NCT00134212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961082|NCT00134212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64961083|NCT00134212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64961084|NCT00134212|Autonomic Agents|autonomic agents|mesh-ancestor
64961085|NCT00134212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64961086|NCT00134212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64961232|NCT00134680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64961233|NCT00134680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961234|NCT00134758|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64961235|NCT00134758|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64961236|NCT00134758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64961237|NCT00081042|Paclitaxel|paclitaxel|mesh-list
64961238|NCT00081042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64961239|NCT00081042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64961240|NCT00081042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961241|NCT00081042|Tubulin Modulators|tubulin modulators|mesh-ancestor
64961242|NCT00081042|Antimitotic Agents|antimitotic agents|mesh-ancestor
64961243|NCT00081042|Mitosis Modulators|mitosis modulators|mesh-ancestor
64961263|NCT00134914|Narcotics|narcotics|mesh-ancestor
64961342|NCT00047450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64961353|NCT00145171|Emetics|emetics|mesh-ancestor
64961364|NCT00145210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64961365|NCT00145210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64961366|NCT00145210|Sympatholytics|sympatholytics|mesh-ancestor
64961367|NCT00145210|Autonomic Agents|autonomic agents|mesh-ancestor
64500031|NCT03391830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64500037|NCT03391830|Vitamins|vitamins|mesh-ancestor
64961368|NCT00145210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64961369|NCT00145210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961370|NCT00145210|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64961371|NCT00145210|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64961372|NCT00145210|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64961373|NCT00145210|Adrenergic Agents|adrenergic agents|mesh-ancestor
64961374|NCT00145210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64961375|NCT00145210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961422|NCT00145522|Androgen Antagonists|androgen antagonists|mesh-ancestor
64961423|NCT00145522|Hormone Antagonists|hormone antagonists|mesh-ancestor
64961424|NCT00145522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64961425|NCT00145522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64961426|NCT00145522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961427|NCT00145522|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64961428|NCT00145522|Anabolic Agents|anabolic agents|mesh-ancestor
64961429|NCT00081315|Amifostine|amifostine|mesh-list
64961430|NCT00081315|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64961431|NCT00081315|Protective Agents|protective agents|mesh-ancestor
64961432|NCT00081315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961433|NCT00145561|Ritonavir|ritonavir|mesh-list
64961434|NCT00145561|Saquinavir|saquinavir|mesh-list
64961435|NCT00145561|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64961436|NCT00145561|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64961437|NCT00145561|Protease Inhibitors|protease inhibitors|mesh-ancestor
64961438|NCT00145561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961439|NCT00145561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961440|NCT00145561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64961441|NCT00145561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64961442|NCT00145561|Antiviral Agents|antiviral agents|mesh-ancestor
64836189|NCT01611896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961443|NCT00145561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64500102|NCT01486810|Dopamine Agents|dopamine agents|mesh-ancestor
64961444|NCT00145561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64961445|NCT00145561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64961446|NCT00145639|Carboplatin|carboplatin|mesh-list
64961447|NCT00145639|Doxorubicin|doxorubicin|mesh-list
64961449|NCT00145639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961450|NCT00145639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64961451|NCT00145639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64961452|NCT00145639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64961453|NCT00145639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961464|NCT00145873|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64961465|NCT00145873|Natriuretic Agents|natriuretic agents|mesh-ancestor
64961466|NCT00145873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961467|NCT00145990|Methacholine Chloride|methacholine chloride|mesh-list
64961469|NCT00145990|Autonomic Agents|autonomic agents|mesh-ancestor
64961470|NCT00145990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64961471|NCT00145990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961472|NCT00145990|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64961473|NCT00145990|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
64961474|NCT00145990|Respiratory System Agents|respiratory system agents|mesh-ancestor
64961475|NCT00145990|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64961476|NCT00145990|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64961477|NCT00145990|Cholinergic Agents|cholinergic agents|mesh-ancestor
64961478|NCT00145990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64961479|NCT00145990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961480|NCT00146068|Interferon beta-1a|interferon beta-1a|mesh-list
64961481|NCT00146068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64961482|NCT00146068|Immunologic Factors|immunologic factors|mesh-ancestor
64961483|NCT00146068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961484|NCT00146068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961518|NCT00081549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961519|NCT00146341|Telmisartan|telmisartan|mesh-list
64961520|NCT00146341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64961521|NCT00146341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64836190|NCT01611896|Trace Elements|trace elements|mesh-ancestor
64836191|NCT01611896|Micronutrients|micronutrients|mesh-ancestor
64836192|NCT01611909|Terpin|terpin|mesh-list
64836193|NCT01611909|Expectorants|expectorants|mesh-ancestor
64836194|NCT01611909|Respiratory System Agents|respiratory system agents|mesh-ancestor
64961522|NCT00146341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64961523|NCT00146341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961524|NCT00146380|Lamivudine|lamivudine|mesh-list
64961525|NCT00146380|Zidovudine|zidovudine|mesh-list
64961526|NCT00146380|Nevirapine|nevirapine|mesh-list
64961527|NCT00146380|Nelfinavir|nelfinavir|mesh-list
64961528|NCT00146380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64961529|NCT00146380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64961530|NCT00146380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961531|NCT00146380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961532|NCT00146380|Antiviral Agents|antiviral agents|mesh-ancestor
64961533|NCT00146380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64961534|NCT00146380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64961535|NCT00146380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64961536|NCT00146380|Antimetabolites|antimetabolites|mesh-ancestor
64961537|NCT00146380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64961538|NCT00146380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64961539|NCT00146380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64961540|NCT00146380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64961541|NCT00146380|Protease Inhibitors|protease inhibitors|mesh-ancestor
64961542|NCT00081588|Darunavir|darunavir|mesh-list
64961568|NCT00146497|Hormones|hormones|mesh-ancestor
64961569|NCT00146497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64961570|NCT02957890|Vaccines|vaccines|mesh-list
64961571|NCT02957890|Immunologic Factors|immunologic factors|mesh-ancestor
64961572|NCT02957890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961573|NCT00146575|Sirolimus|sirolimus|mesh-list
64961574|NCT00146575|Paclitaxel|paclitaxel|mesh-list
64961575|NCT00146575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64961576|NCT00146575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961577|NCT00146575|Tubulin Modulators|tubulin modulators|mesh-ancestor
64961578|NCT00146575|Antimitotic Agents|antimitotic agents|mesh-ancestor
64961579|NCT00146575|Mitosis Modulators|mitosis modulators|mesh-ancestor
64961580|NCT00146575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961581|NCT00146575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64961582|NCT00146575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64961583|NCT00146575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64836195|NCT01611961|Docetaxel|docetaxel|mesh-list
64961584|NCT00146575|Antifungal Agents|antifungal agents|mesh-ancestor
64961585|NCT00146575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64961623|NCT00042978|Carboplatin|carboplatin|mesh-list
64961625|NCT00042978|Etoposide phosphate|etoposide phosphate|mesh-list
64961626|NCT00042978|Oblimersen|oblimersen|mesh-list
64961627|NCT00042978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961628|NCT00042978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64961629|NCT00042978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64961630|NCT00042978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64961631|NCT00042978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961632|NCT00042978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961633|NCT00405730|Ketorolac|ketorolac|mesh-list
64961634|NCT00405730|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64961635|NCT00405730|Nepafenac|nepafenac|mesh-list
64961636|NCT00405730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64961637|NCT00405730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64961638|NCT00405730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64961639|NCT00405730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64961640|NCT00405730|Analgesics|analgesics|mesh-ancestor
64961641|NCT00405730|Sensory System Agents|sensory system agents|mesh-ancestor
64961642|NCT00405730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64961643|NCT00405730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961644|NCT00405730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64961645|NCT00405730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64961646|NCT00405730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64961647|NCT00405730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961649|NCT00405769|Red yeast rice|red yeast rice|mesh-list
64961697|NCT00146926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64961698|NCT00146926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64961699|NCT00146926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64961700|NCT00146926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961701|NCT00146926|Analgesics|analgesics|mesh-ancestor
64961702|NCT00146926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64961703|NCT00146926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64961704|NCT00146926|Anesthetics, General|anesthetics, general|mesh-ancestor
64961705|NCT00146926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64961715|NCT00147004|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64961716|NCT00147004|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64961717|NCT00147004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64961718|NCT00147121|Rituximab|rituximab|mesh-list
64961719|NCT00147121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64961720|NCT00147121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961721|NCT00147121|Immunologic Factors|immunologic factors|mesh-ancestor
64961722|NCT00147121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961723|NCT00147121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64961724|NCT00147160|Temozolomide|temozolomide|mesh-list
64961725|NCT00147160|Cisplatin|cisplatin|mesh-list
64961726|NCT00147160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64961727|NCT00147160|Alkylating Agents|alkylating agents|mesh-ancestor
64961728|NCT00147160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961729|NCT00147160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961730|NCT04732104|Lidocaine|lidocaine|mesh-list
64961731|NCT04732104|Xylometazoline|xylometazoline|mesh-list
64961732|NCT04732104|Nasal Decongestants|nasal decongestants|mesh-list
64961733|NCT04732104|Anesthetics, Local|anesthetics, local|mesh-ancestor
64961734|NCT04732104|Anesthetics|anesthetics|mesh-ancestor
64961735|NCT04732104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64836204|NCT01612065|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64836205|NCT01612065|Abortifacient Agents|abortifacient agents|mesh-ancestor
64836206|NCT01612065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64836207|NCT01612065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836208|NCT01612065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64836209|NCT01612065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64836210|NCT01612065|Oxytocics|oxytocics|mesh-ancestor
64447297|NCT04757636|Growth Substances|growth substances|mesh-ancestor
64325746|NCT04965597|Alkylating Agents|alkylating agents|mesh-ancestor
64447320|NCT02150954|Oxytocics|oxytocics|mesh-ancestor
64447323|NCT04188392|Pimavanserin|pimavanserin|mesh-list
64836316|NCT01612741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64836317|NCT01612741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836318|NCT01612832|Pregabalin|pregabalin|mesh-list
64836319|NCT01612832|Analgesics|analgesics|mesh-ancestor
64961770|NCT00147355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64961771|NCT00147355|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64961772|NCT00147355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64961773|NCT00147355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64961774|NCT00147355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64961775|NCT00147355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64961776|NCT00147355|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64961777|NCT00147355|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64961778|NCT00147355|Dopamine Agents|dopamine agents|mesh-ancestor
64961779|NCT00147355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64961780|NCT00147355|Narcotics|narcotics|mesh-ancestor
64961781|NCT00147355|Antitussive Agents|antitussive agents|mesh-ancestor
64961782|NCT00147355|Respiratory System Agents|respiratory system agents|mesh-ancestor
64961783|NCT00048152|Mycophenolic Acid|mycophenolic acid|mesh-list
64961784|NCT00048152|Cyclosporine|cyclosporine|mesh-list
64961785|NCT00048152|Cyclosporins|cyclosporins|mesh-list
64961786|NCT00048152|Daclizumab|daclizumab|mesh-list
64961787|NCT00048152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64961788|NCT00048152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961789|NCT00048152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64961790|NCT00048152|Antitubercular Agents|antitubercular agents|mesh-ancestor
64961791|NCT00048152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64961792|NCT00048152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64961793|NCT00048152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961794|NCT00048152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961795|NCT00048152|Antifungal Agents|antifungal agents|mesh-ancestor
64961802|NCT00147394|Risperidone|risperidone|mesh-list
64961820|NCT04725682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500487|NCT01498744|Clindamycin|clindamycin|mesh-list
64961821|NCT00147511|Linezolid|linezolid|mesh-list
64961822|NCT00147511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64961823|NCT00147511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64961824|NCT00147511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64961825|NCT00147511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961835|NCT00043095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64961836|NCT00043095|Immunologic Factors|immunologic factors|mesh-ancestor
64961837|NCT00043095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961875|NCT00147667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961876|NCT00147784|Interferons|interferons|mesh-list
64961877|NCT00147784|Ribavirin|ribavirin|mesh-list
64961878|NCT00147784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961879|NCT00147784|Antiviral Agents|antiviral agents|mesh-ancestor
64961880|NCT00147784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64961881|NCT00147784|Antimetabolites|antimetabolites|mesh-ancestor
64961882|NCT00147784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961883|NCT00081744|Tigecycline|tigecycline|mesh-list
64961884|NCT00081744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64961885|NCT00081744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64961886|NCT00081744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64961887|NCT00081744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961888|NCT00081744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961889|NCT00147862|Tranexamic Acid|tranexamic acid|mesh-list
64961890|NCT00147862|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64961891|NCT00147862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64961892|NCT00147862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961893|NCT00147862|Hemostatics|hemostatics|mesh-ancestor
64961894|NCT00147862|Coagulants|coagulants|mesh-ancestor
64961895|NCT00147901|Cyclophosphamide|cyclophosphamide|mesh-list
64961896|NCT00147901|Fludarabine|fludarabine|mesh-list
64500551|NCT01557868|Hylan|hylan|mesh-list
64961897|NCT00147901|Alemtuzumab|alemtuzumab|mesh-list
64961898|NCT00147901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64500622|NCT01468012|Dopamine Agonists|dopamine agonists|mesh-ancestor
64961899|NCT00147901|Immunologic Factors|immunologic factors|mesh-ancestor
64961923|NCT00147979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961924|NCT00148018|Dexamethasone|dexamethasone|mesh-list
64961925|NCT00148018|Bortezomib|bortezomib|mesh-list
64961927|NCT00148018|Antiemetics|antiemetics|mesh-ancestor
64961935|NCT00148018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64961936|NCT00148018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961937|NCT00081822|Cytarabine|cytarabine|mesh-list
64961938|NCT00081822|Clofarabine|clofarabine|mesh-list
64961939|NCT00081822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64961940|NCT00081822|Antimetabolites|antimetabolites|mesh-ancestor
64961941|NCT00081822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961942|NCT00081822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961943|NCT00081822|Antiviral Agents|antiviral agents|mesh-ancestor
64961984|NCT00148291|Docetaxel|docetaxel|mesh-list
64962046|NCT00148447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64962048|NCT00043134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64962049|NCT00043134|Antimetabolites|antimetabolites|mesh-ancestor
64962050|NCT00043134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962051|NCT00043134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962059|NCT00148564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64962060|NCT00148564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64962061|NCT00148564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64962062|NCT00148564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64962063|NCT00148564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64962064|NCT00148564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64962065|NCT00148564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64962066|NCT00148564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64962067|NCT00148564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962068|NCT00148564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64962069|NCT00148564|Serotonin Agents|serotonin agents|mesh-ancestor
64962070|NCT00148564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64962071|NCT00148564|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64962072|NCT00148564|Dopamine Agents|dopamine agents|mesh-ancestor
64962073|NCT00148603|Montelukast|montelukast|mesh-list
64962115|NCT00148837|Ribavirin|ribavirin|mesh-list
64962116|NCT00148837|Interferon-alpha|interferon-alpha|mesh-list
64962117|NCT00148837|Interferon alpha-2|interferon alpha-2|mesh-list
64962118|NCT00148837|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64962119|NCT00148837|Prazosin|prazosin|mesh-list
64962120|NCT00148837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962121|NCT00148837|Antiviral Agents|antiviral agents|mesh-ancestor
64962122|NCT00148837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64962123|NCT00148837|Antimetabolites|antimetabolites|mesh-ancestor
64962125|NCT00148837|Immunologic Factors|immunologic factors|mesh-ancestor
64962172|NCT00048776|Vasodilator Agents|vasodilator agents|mesh-ancestor
64962173|NCT00048776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64962174|NCT00048776|Protective Agents|protective agents|mesh-ancestor
64962175|NCT00048776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64962176|NCT00048776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64962177|NCT00048776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962178|NCT00149383|Rosiglitazone|rosiglitazone|mesh-list
64962179|NCT00149383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64962180|NCT00149383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962182|NCT00048854|Antidepressive Agents|antidepressive agents|mesh-ancestor
64962183|NCT00048854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64962184|NCT00048854|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64962185|NCT00048854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64962186|NCT00048854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64962187|NCT00048854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962188|NCT00048854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64500843|NCT03125616|Vaccines|vaccines|mesh-list
64962221|NCT00149578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962223|NCT00149578|Protective Agents|protective agents|mesh-ancestor
64962224|NCT00149578|Vitamin B Complex|vitamin b complex|mesh-ancestor
64962225|NCT00149578|Vitamins|vitamins|mesh-ancestor
64962226|NCT00149578|Micronutrients|micronutrients|mesh-ancestor
64962227|NCT00149617|Buspirone|buspirone|mesh-list
64962228|NCT00149617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64962229|NCT00149617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64962230|NCT00149617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64962231|NCT00149617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962232|NCT00149617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64962233|NCT00149617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64962234|NCT00149617|Serotonin Agents|serotonin agents|mesh-ancestor
64962235|NCT00149617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64962236|NCT00149617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962237|NCT00043329|Interferon-gamma|interferon-gamma|mesh-list
64962238|NCT00043329|Antiviral Agents|antiviral agents|mesh-ancestor
64962239|NCT00043329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64962240|NCT00149656|Selenium|selenium|mesh-list
64962241|NCT00149656|Antioxidants|antioxidants|mesh-ancestor
64962242|NCT00149656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962243|NCT00149656|Protective Agents|protective agents|mesh-ancestor
64962244|NCT00149656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962245|NCT00149656|Trace Elements|trace elements|mesh-ancestor
64962246|NCT00149656|Micronutrients|micronutrients|mesh-ancestor
64962247|NCT00082095|Doxorubicin|doxorubicin|mesh-list
64962248|NCT00082095|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64962249|NCT00082095|Capecitabine|capecitabine|mesh-list
64962250|NCT00082095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64962251|NCT00082095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962252|NCT00082095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64962253|NCT00082095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64962254|NCT00082095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962336|NCT00150007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64962337|NCT00150007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962338|NCT00150007|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64501006|NCT03380130|Nivolumab|nivolumab|mesh-list
64962340|NCT00150007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64962341|NCT00150007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64962353|NCT00150085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64962354|NCT00150085|Immunologic Factors|immunologic factors|mesh-ancestor
64962355|NCT00150085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962356|NCT00150085|Antifungal Agents|antifungal agents|mesh-ancestor
64962486|NCT00049439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962487|NCT00049439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962488|NCT00049439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64962489|NCT00049439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64962490|NCT00049439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64962491|NCT00049439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64962492|NCT00049439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962493|NCT00150670|Cisplatin|cisplatin|mesh-list
64962494|NCT00150670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962506|NCT00150826|Protease Inhibitors|protease inhibitors|mesh-ancestor
64962507|NCT00150826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962508|NCT00150826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962509|NCT00150826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64962511|NCT00150865|Anesthetics, Local|anesthetics, local|mesh-ancestor
64962512|NCT00150865|Anesthetics|anesthetics|mesh-ancestor
64962513|NCT00150865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64962514|NCT00150865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962515|NCT00150865|Sensory System Agents|sensory system agents|mesh-ancestor
64962516|NCT00150865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962517|NCT00049556|Gefitinib|gefitinib|mesh-list
64962568|NCT00151138|Lisinopril|lisinopril|mesh-list
64962766|NCT00397787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962767|NCT00397787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64962768|NCT00397787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64962769|NCT00397787|Growth Substances|growth substances|mesh-ancestor
64962770|NCT00397787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962939|NCT00152308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64962940|NCT00152308|Immunologic Factors|immunologic factors|mesh-ancestor
64962941|NCT00152308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962942|NCT00152308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64962944|NCT00152386|Certolizumab Pegol|certolizumab pegol|mesh-list
64962973|NCT00152542|Gasotransmitters|gasotransmitters|mesh-ancestor
64962974|NCT00152542|Protective Agents|protective agents|mesh-ancestor
64962975|NCT00043680|Celecoxib|celecoxib|mesh-list
64962976|NCT00043680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64962977|NCT00043680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64962978|NCT00043680|Analgesics|analgesics|mesh-ancestor
64962979|NCT00043680|Sensory System Agents|sensory system agents|mesh-ancestor
64962980|NCT00043680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962981|NCT00043680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962988|NCT00152581|Interferons|interferons|mesh-list
64963085|NCT00050297|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
64963086|NCT00050297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64963087|NCT00050297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963088|NCT00152893|Chromium|chromium|mesh-list
64963136|NCT00043758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963137|NCT00043758|Natriuretic Agents|natriuretic agents|mesh-ancestor
64963138|NCT00043758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963139|NCT00050375|Oregovomab|oregovomab|mesh-list
64963140|NCT00050375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64963141|NCT00050375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963142|NCT00153049|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64963143|NCT00153049|Telmisartan|telmisartan|mesh-list
64963144|NCT00153049|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
64963145|NCT00153049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64963146|NCT00153049|Diuretics|diuretics|mesh-ancestor
64963147|NCT00153049|Natriuretic Agents|natriuretic agents|mesh-ancestor
64963148|NCT00153049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963191|NCT00083109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963192|NCT00083109|Antinematodal Agents|antinematodal agents|mesh-ancestor
64963193|NCT00083109|Anthelmintics|anthelmintics|mesh-ancestor
64963194|NCT00083109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64963195|NCT00083109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64963196|NCT00083109|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64963197|NCT00083109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64963198|NCT00153244|Lamotrigine|lamotrigine|mesh-list
64963199|NCT00153244|Anticonvulsants|anticonvulsants|mesh-ancestor
64963200|NCT00153244|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64963201|NCT00153244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64963202|NCT00153244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963203|NCT00153244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64963204|NCT00153244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963210|NCT00153283|Gabapentin|gabapentin|mesh-list
64963253|NCT00153517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64963254|NCT00153517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64963255|NCT00153556|Vaccines|vaccines|mesh-list
64963256|NCT00153556|Immunologic Factors|immunologic factors|mesh-ancestor
64963257|NCT00153556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963258|NCT00083187|Hydroxyurea|hydroxyurea|mesh-list
64963259|NCT00083187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963360|NCT00154180|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64963361|NCT00154180|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64963362|NCT00154180|Estradiol|estradiol|mesh-list
64963363|NCT00154180|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64963364|NCT00154180|Estrogens|estrogens|mesh-list
64963365|NCT00154180|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64963366|NCT00154180|Progesterone|progesterone|mesh-list
64963367|NCT00154180|Hormones|hormones|mesh-ancestor
64963368|NCT00154180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64963389|NCT00043875|Anticonvulsants|anticonvulsants|mesh-ancestor
64963390|NCT00043875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64963391|NCT00043875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64963392|NCT00043875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963393|NCT00043875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64963394|NCT00043875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963395|NCT00043875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64963396|NCT00043875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64963397|NCT00043875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64963398|NCT00043875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64963399|NCT00043875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64963401|NCT00154258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64963402|NCT00154258|Serotonin Agents|serotonin agents|mesh-ancestor
64963403|NCT00154258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64963404|NCT00154258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963405|NCT00154258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963406|NCT00154258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64963407|NCT00154258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64963408|NCT00154258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64963409|NCT00154258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64963410|NCT00154258|GABA Antagonists|gaba antagonists|mesh-ancestor
64963411|NCT00154258|GABA Agents|gaba agents|mesh-ancestor
64963412|NCT00154336|Methotrexate|methotrexate|mesh-list
64963413|NCT00154336|Imatinib Mesylate|imatinib mesylate|mesh-list
64963430|NCT00050804|Sertraline|sertraline|mesh-list
64963434|NCT00050804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64836320|NCT01612832|Sensory System Agents|sensory system agents|mesh-ancestor
64836321|NCT01612832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64963435|NCT00050804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64963436|NCT00050804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963437|NCT00050804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64963438|NCT00050804|Serotonin Agents|serotonin agents|mesh-ancestor
64963439|NCT00050804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963440|NCT00043914|Lamotrigine|lamotrigine|mesh-list
64963441|NCT00043914|Anticonvulsants|anticonvulsants|mesh-ancestor
64963442|NCT00043914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64963443|NCT00043914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64963444|NCT00043914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963445|NCT00043914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64963446|NCT00043914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963447|NCT00043914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64963448|NCT00043914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64963449|NCT00043914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64963614|NCT00051077|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64963615|NCT00051077|Antimetabolites|antimetabolites|mesh-ancestor
64963616|NCT00051077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963617|NCT00051077|Antiviral Agents|antiviral agents|mesh-ancestor
64963618|NCT00051077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64963619|NCT00051077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64963620|NCT00051077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64963754|NCT00156403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64963884|NCT00406978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64963893|NCT00406978|Growth Inhibitors|growth inhibitors|mesh-ancestor
64963894|NCT00406978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64963895|NCT00406978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64963896|NCT00406978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64963897|NCT00157651|Warfarin|warfarin|mesh-list
64963898|NCT00157651|Anticoagulants|anticoagulants|mesh-ancestor
64963899|NCT00044343|Lapatinib|lapatinib|mesh-list
64963900|NCT00044343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963901|NCT00044343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64963902|NCT00044343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963903|NCT00044343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964018|NCT00158509|Valacyclovir|valacyclovir|mesh-list
64964019|NCT00158509|Antiviral Agents|antiviral agents|mesh-ancestor
64964020|NCT00158509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964021|NCT00158548|Artesunate|artesunate|mesh-list
64964023|NCT00158548|Primaquine|primaquine|mesh-list
64964057|NCT00158821|Antiviral Agents|antiviral agents|mesh-ancestor
64964058|NCT00158821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964059|NCT00158821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64964060|NCT00158821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64964061|NCT00158821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964062|NCT00158821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964063|NCT00158821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64964064|NCT00158821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64964065|NCT00158821|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64964066|NCT00158821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64964067|NCT00158821|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64964068|NCT00158821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64964069|NCT00158821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64964070|NCT00158821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64964071|NCT00158821|Antimetabolites|antimetabolites|mesh-ancestor
64964072|NCT05568147|Aspirin|aspirin|mesh-list
64964073|NCT05568147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64964074|NCT05568147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64964121|NCT00159133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64964122|NCT00159133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964123|NCT00159133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64964124|NCT00159133|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64964125|NCT00159133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64964126|NCT00159133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64502780|NCT03123744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964127|NCT00159133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64964128|NCT00159133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64964129|NCT00159133|GABA Modulators|gaba modulators|mesh-ancestor
64964144|NCT00052013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964145|NCT00159445|Gemcitabine|gemcitabine|mesh-list
64964146|NCT00159445|Capecitabine|capecitabine|mesh-list
64964147|NCT00159445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64964148|NCT00159445|Antimetabolites|antimetabolites|mesh-ancestor
64964149|NCT00159445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964150|NCT00159445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964151|NCT00159445|Antiviral Agents|antiviral agents|mesh-ancestor
64964152|NCT00159445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964153|NCT00159445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964154|NCT00159445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64964155|NCT00159445|Immunologic Factors|immunologic factors|mesh-ancestor
64964156|NCT00159445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964157|NCT00044460|Rosiglitazone|rosiglitazone|mesh-list
64964158|NCT00044460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64964159|NCT00044460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964160|NCT00159484|Celecoxib|celecoxib|mesh-list
64964161|NCT00159484|Epothilone B|epothilone b|mesh-list
64964162|NCT00159484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64836322|NCT01612832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836323|NCT01612832|Anticonvulsants|anticonvulsants|mesh-ancestor
64836324|NCT01612832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64836325|NCT01612832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64447406|NCT02129192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447408|NCT02128490|Naproxen|naproxen|mesh-list
64836376|NCT01613040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836377|NCT01613040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836378|NCT01613040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836379|NCT01613040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64836380|NCT01613040|Contraceptive Agents|contraceptive agents|mesh-ancestor
64836381|NCT01613040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64836382|NCT01613040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964163|NCT00159484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64964164|NCT00159484|Analgesics|analgesics|mesh-ancestor
64964165|NCT00159484|Sensory System Agents|sensory system agents|mesh-ancestor
64964166|NCT00159484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64964167|NCT00159484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964168|NCT00159484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64964169|NCT00159484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64964170|NCT00159484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64964171|NCT00159484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64964172|NCT00159484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964178|NCT00052052|Interferons|interferons|mesh-list
64964190|NCT00159679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964191|NCT00159679|Anticonvulsants|anticonvulsants|mesh-ancestor
64964192|NCT00159679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64964193|NCT00159679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64964291|NCT00052286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964292|NCT00160186|Pancreatin|pancreatin|mesh-list
64964293|NCT00160186|Pancrelipase|pancrelipase|mesh-list
64964294|NCT00160186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64964295|NCT05567484|Itraconazole|itraconazole|mesh-list
64964296|NCT05567484|Antifungal Agents|antifungal agents|mesh-ancestor
64964297|NCT05567484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964298|NCT05567484|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64964307|NCT00160264|Vitamin D|vitamin d|mesh-list
64964445|NCT00044577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64964446|NCT00044577|Antimetabolites|antimetabolites|mesh-ancestor
64964447|NCT00161122|Vaccines|vaccines|mesh-list
64964448|NCT00161122|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64964449|NCT00161122|Immunologic Factors|immunologic factors|mesh-ancestor
64964450|NCT00161122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964451|NCT00161200|Pantoprazole|pantoprazole|mesh-list
64964452|NCT00161200|Ranitidine|ranitidine|mesh-list
64964453|NCT00161200|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
64964454|NCT00161200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64964455|NCT00161200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64964456|NCT00161200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64964457|NCT00161200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964458|NCT00161200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964459|NCT00161200|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64964460|NCT00161200|Histamine Antagonists|histamine antagonists|mesh-ancestor
64964461|NCT00161200|Histamine Agents|histamine agents|mesh-ancestor
64964462|NCT00161200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64964463|NCT00161200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964464|NCT00161239|Prednisone|prednisone|mesh-list
64964465|NCT00161239|Methotrexate|methotrexate|mesh-list
64964466|NCT00161239|Asparaginase|asparaginase|mesh-list
64964467|NCT00161239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64964468|NCT00161239|Glucocorticoids|glucocorticoids|mesh-ancestor
64964469|NCT00161239|Hormones|hormones|mesh-ancestor
64964470|NCT00161239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64964471|NCT00161239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964472|NCT00161239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64964473|NCT00161239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964491|NCT00161278|Tubulin Modulators|tubulin modulators|mesh-ancestor
64964492|NCT00161278|Antimitotic Agents|antimitotic agents|mesh-ancestor
64964493|NCT00161278|Mitosis Modulators|mitosis modulators|mesh-ancestor
64964494|NCT00161278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964495|NCT00044616|Fluoxetine|fluoxetine|mesh-list
64964496|NCT00044616|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64964497|NCT00044616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64964501|NCT00044616|Serotonin Agents|serotonin agents|mesh-ancestor
64503171|NCT03146962|Vitamins|vitamins|mesh-ancestor
64964502|NCT00044616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964503|NCT00044616|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64964504|NCT00044616|Antidepressive Agents|antidepressive agents|mesh-ancestor
64964505|NCT00044616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64964517|NCT00161434|Valacyclovir|valacyclovir|mesh-list
64964546|NCT00161707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64964547|NCT00161707|Protease Inhibitors|protease inhibitors|mesh-ancestor
64964548|NCT00161707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964549|NCT00161707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964550|NCT00044733|Gemtuzumab|gemtuzumab|mesh-list
64964551|NCT00044733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64964552|NCT00044733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964553|NCT00052949|Imatinib Mesylate|imatinib mesylate|mesh-list
64964554|NCT00052949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964555|NCT00052949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64964556|NCT00052949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964557|NCT00052949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964558|NCT00161902|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64964559|NCT00161902|Hemostatics|hemostatics|mesh-ancestor
64964560|NCT00161902|Coagulants|coagulants|mesh-ancestor
64964561|NCT00053027|Rituximab|rituximab|mesh-list
64964562|NCT00053027|Cladribine|cladribine|mesh-list
64964563|NCT00053027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64964564|NCT00053027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964598|NCT00405457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964599|NCT00405457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964600|NCT00405457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64964648|NCT00162409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964649|NCT00053144|Cytarabine|cytarabine|mesh-list
64964650|NCT00053144|Irinotecan|irinotecan|mesh-list
64964651|NCT00053144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64964652|NCT00053144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64964653|NCT00053144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964654|NCT00053144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964655|NCT00053144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964656|NCT00053144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64964657|NCT00053144|Antimetabolites|antimetabolites|mesh-ancestor
64964658|NCT00053144|Antiviral Agents|antiviral agents|mesh-ancestor
64964659|NCT00053144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964783|NCT00162916|Serotonin Agents|serotonin agents|mesh-ancestor
64964784|NCT00162916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964785|NCT00162916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64964811|NCT00163111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964812|NCT00163111|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64964813|NCT00163111|Hormone Antagonists|hormone antagonists|mesh-ancestor
64964814|NCT00163111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64964815|NCT00163111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964816|NCT00163111|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64964817|NCT00163111|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64964818|NCT00163150|Atorvastatin|atorvastatin|mesh-list
64964819|NCT00163150|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64964820|NCT00163150|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64964821|NCT00163150|Antimetabolites|antimetabolites|mesh-ancestor
64964822|NCT00163150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964823|NCT00163150|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64964824|NCT00163150|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64964825|NCT00163150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964826|NCT00163267|Clopidogrel|clopidogrel|mesh-list
64964827|NCT00163267|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64964828|NCT00163267|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64964829|NCT00163267|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64964830|NCT00163267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64964831|NCT00163267|Purinergic Agents|purinergic agents|mesh-ancestor
64964832|NCT00163267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64964833|NCT00163267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964834|NCT00163267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964835|NCT00163306|Pantoprazole|pantoprazole|mesh-list
64964836|NCT00163306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64964851|NCT00163345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64964852|NCT00163384|Ciclesonide|ciclesonide|mesh-list
64964853|NCT00163384|Glucocorticoids|glucocorticoids|mesh-ancestor
64964854|NCT00163384|Hormones|hormones|mesh-ancestor
64964911|NCT00163618|Formaldehyde|formaldehyde|mesh-list
64965069|NCT00164788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64965070|NCT00164788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965071|NCT00164788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965073|NCT00053768|Cyclophosphamide|cyclophosphamide|mesh-list
64965074|NCT00053768|Doxorubicin|doxorubicin|mesh-list
64965075|NCT00053768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64965076|NCT00053768|Etoposide|etoposide|mesh-list
64965077|NCT00053768|Vincristine|vincristine|mesh-list
64965078|NCT00053768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64965079|NCT00053768|Immunologic Factors|immunologic factors|mesh-ancestor
64965081|NCT00053768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64965170|NCT00165178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64965171|NCT00165178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965172|NCT00165178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64965173|NCT00165178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64965174|NCT00165178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64965175|NCT00165178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965176|NCT00165178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965177|NCT00165178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64965178|NCT00165178|Abortifacient Agents|abortifacient agents|mesh-ancestor
64965179|NCT00165178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64965180|NCT00165178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64965181|NCT00165178|Antimetabolites|antimetabolites|mesh-ancestor
64965182|NCT00165178|Dermatologic Agents|dermatologic agents|mesh-ancestor
64965183|NCT00165178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64965184|NCT00165178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64965185|NCT00165178|Immunologic Factors|immunologic factors|mesh-ancestor
64965186|NCT00165178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64965187|NCT00165178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64965188|NCT00165178|Antiviral Agents|antiviral agents|mesh-ancestor
64965189|NCT00165178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64965190|NCT00165178|Antidotes|antidotes|mesh-ancestor
64965191|NCT00165178|Protective Agents|protective agents|mesh-ancestor
64965231|NCT00165334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64965232|NCT00165334|Tubulin Modulators|tubulin modulators|mesh-ancestor
64965236|NCT00165373|Endostatins|endostatins|mesh-list
64965242|NCT00165373|Growth Inhibitors|growth inhibitors|mesh-ancestor
64965243|NCT00165451|Thalidomide|thalidomide|mesh-list
64965244|NCT00165451|Celecoxib|celecoxib|mesh-list
64965245|NCT00165451|Cyclophosphamide|cyclophosphamide|mesh-list
64965246|NCT00165451|Etoposide|etoposide|mesh-list
64965247|NCT00165451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64965248|NCT00165451|Immunologic Factors|immunologic factors|mesh-ancestor
64503906|NCT02515734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64965249|NCT00165451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503983|NCT03344952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64965250|NCT00165451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64965251|NCT00165451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64965252|NCT00165451|Alkylating Agents|alkylating agents|mesh-ancestor
64965305|NCT00053963|Romidepsin|romidepsin|mesh-list
64965368|NCT00166426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965369|NCT00166426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64965370|NCT00166426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965371|NCT00166426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965372|NCT00166426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64965373|NCT00166426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64965374|NCT00166426|Analgesics|analgesics|mesh-ancestor
64965375|NCT00166426|Sensory System Agents|sensory system agents|mesh-ancestor
64965376|NCT00166426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64965377|NCT00166426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64965378|NCT00166426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64965379|NCT00166465|Leucovorin|leucovorin|mesh-list
64965380|NCT00166465|Fluorouracil|fluorouracil|mesh-list
64965396|NCT00166621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64965397|NCT00166621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64965398|NCT00166621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965399|NCT00166621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64965400|NCT00166621|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64965401|NCT00166621|Serotonin Agents|serotonin agents|mesh-ancestor
64965402|NCT00166621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64965403|NCT00166621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965404|NCT00054236|Methylprednisolone|methylprednisolone|mesh-list
64965405|NCT00054236|Cyclophosphamide|cyclophosphamide|mesh-list
64965406|NCT00054236|Fludarabine|fludarabine|mesh-list
64965407|NCT00054236|Fludarabine phosphate|fludarabine phosphate|mesh-list
64965408|NCT00054236|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64965409|NCT00054236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64965410|NCT00054236|Immunologic Factors|immunologic factors|mesh-ancestor
64965411|NCT00054236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965412|NCT00054236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64965413|NCT00054236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64965414|NCT00054236|Alkylating Agents|alkylating agents|mesh-ancestor
64836383|NCT01613040|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64325794|NCT04475887|Micronutrients|micronutrients|mesh-ancestor
64325795|NCT04475887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836393|NCT01613079|Abortifacient Agents|abortifacient agents|mesh-ancestor
64836394|NCT01613079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64965415|NCT00054236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965416|NCT00054236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965417|NCT00054236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64965418|NCT00054236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64965419|NCT00054236|Antimetabolites|antimetabolites|mesh-ancestor
64965420|NCT00054236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64965421|NCT00054236|Antiemetics|antiemetics|mesh-ancestor
64965422|NCT00054236|Autonomic Agents|autonomic agents|mesh-ancestor
64965423|NCT00054236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64965441|NCT00054392|Antiviral Agents|antiviral agents|mesh-ancestor
64965442|NCT00054392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64965443|NCT00054392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965444|NCT00054392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64965445|NCT00054392|Immunologic Factors|immunologic factors|mesh-ancestor
64965446|NCT00054392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965447|NCT00166816|Cyclosporine|cyclosporine|mesh-list
64965448|NCT00166816|Sirolimus|sirolimus|mesh-list
64965449|NCT00166816|Tacrolimus|tacrolimus|mesh-list
64965450|NCT00166816|Cyclosporins|cyclosporins|mesh-list
64965451|NCT00166816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64965452|NCT00166816|Immunologic Factors|immunologic factors|mesh-ancestor
64965453|NCT00166816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965454|NCT00166816|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64965455|NCT00166816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965456|NCT00166816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965457|NCT00166816|Antifungal Agents|antifungal agents|mesh-ancestor
64965458|NCT00166816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64965459|NCT00166816|Dermatologic Agents|dermatologic agents|mesh-ancestor
64965460|NCT00166816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64965461|NCT00166816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64965462|NCT00166816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64965463|NCT00166816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965464|NCT04723732|Chlorhexidine|chlorhexidine|mesh-list
64965465|NCT04723732|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64965494|NCT00045513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965495|NCT00045513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64965496|NCT00045513|Antimetabolites|antimetabolites|mesh-ancestor
64965500|NCT00045513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965501|NCT00045513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64965502|NCT00045513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965503|NCT00167401|Docetaxel|docetaxel|mesh-list
64965504|NCT00167401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965505|NCT00167401|Tubulin Modulators|tubulin modulators|mesh-ancestor
64965506|NCT00167401|Antimitotic Agents|antimitotic agents|mesh-ancestor
64965507|NCT00167401|Mitosis Modulators|mitosis modulators|mesh-ancestor
64965508|NCT00167401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965509|NCT00167479|Risperidone|risperidone|mesh-list
64965510|NCT00167479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64965511|NCT00167479|Serotonin Agents|serotonin agents|mesh-ancestor
64965512|NCT00167479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64965513|NCT00167479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965514|NCT00167479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965515|NCT00167479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64965516|NCT00167479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64965517|NCT00167479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64965518|NCT00167479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64965519|NCT00167479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64965520|NCT00167479|Dopamine Agents|dopamine agents|mesh-ancestor
64965542|NCT00054587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64965592|NCT00167713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965593|NCT00167713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965594|NCT00167791|Rituximab|rituximab|mesh-list
64965595|NCT00167791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64965596|NCT00167791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965597|NCT00167791|Immunologic Factors|immunologic factors|mesh-ancestor
64965598|NCT00167791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965599|NCT00167791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64965600|NCT00045591|Celecoxib|celecoxib|mesh-list
64965601|NCT00045591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64965602|NCT00045591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64965603|NCT00045591|Analgesics|analgesics|mesh-ancestor
64965604|NCT00045591|Sensory System Agents|sensory system agents|mesh-ancestor
64965605|NCT00045591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64965606|NCT00045591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965607|NCT00045591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64965608|NCT00045591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64965609|NCT00045591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64965703|NCT00168493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64965704|NCT00168532|Trimethoprim|trimethoprim|mesh-list
64965705|NCT00168532|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64965706|NCT00168532|Sulfamethoxazole|sulfamethoxazole|mesh-list
64965707|NCT00168532|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64965708|NCT00168532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64965709|NCT00168532|Renal Agents|renal agents|mesh-ancestor
64965710|NCT00168532|Antimalarials|antimalarials|mesh-ancestor
64965711|NCT00168532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64965712|NCT00168532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64965713|NCT00168532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64965714|NCT00168532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965716|NCT00168532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64965808|NCT00169000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965809|NCT00169000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64965828|NCT00169039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965829|NCT00169039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64965830|NCT00169039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64965831|NCT00169039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64965832|NCT00169039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64965833|NCT00169039|GABA Antagonists|gaba antagonists|mesh-ancestor
64965834|NCT00169039|GABA Agents|gaba agents|mesh-ancestor
64965835|NCT00169039|Antiemetics|antiemetics|mesh-ancestor
64965910|NCT00169546|Xhance|xhance|mesh-list
64965946|NCT00169585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64965947|NCT00169624|Metformin|metformin|mesh-list
64965948|NCT00169624|Gliclazide|gliclazide|mesh-list
64965949|NCT00169624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64965950|NCT00169624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965951|NCT00407641|Heparin|heparin|mesh-list
64965952|NCT00407641|Tinzaparin|tinzaparin|mesh-list
64965953|NCT00407641|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64965954|NCT00407641|Dalteparin|dalteparin|mesh-list
64965955|NCT00407641|Anticoagulants|anticoagulants|mesh-ancestor
64965956|NCT00407641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64965976|NCT00170053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64965977|NCT00170053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64965978|NCT00170053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965979|NCT00170053|Antifungal Agents|antifungal agents|mesh-ancestor
64965980|NCT00170053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64965981|NCT00170053|Immunologic Factors|immunologic factors|mesh-ancestor
64966053|NCT00170833|Everolimus|everolimus|mesh-list
64966054|NCT00170833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966055|NCT00170833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64966056|NCT00170833|Immunologic Factors|immunologic factors|mesh-ancestor
64966057|NCT00170833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966058|NCT00170872|Lumiracoxib|lumiracoxib|mesh-list
64966059|NCT00170872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64966072|NCT00170989|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64966073|NCT00170989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64504739|NCT01709422|Midazolam|midazolam|mesh-list
64966074|NCT00170989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64966075|NCT00170989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64966076|NCT00170989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966077|NCT00170989|Diuretics|diuretics|mesh-ancestor
64966078|NCT00170989|Natriuretic Agents|natriuretic agents|mesh-ancestor
64966079|NCT00170989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966080|NCT00170989|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64966081|NCT00170989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64966082|NCT00171028|Valsartan|valsartan|mesh-list
64966127|NCT00055523|Adalimumab|adalimumab|mesh-list
64966187|NCT00171535|Vasodilator Agents|vasodilator agents|mesh-ancestor
64966188|NCT00171535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64966189|NCT00171535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64966190|NCT00171574|Valsartan|valsartan|mesh-list
64966191|NCT00171574|Lisinopril|lisinopril|mesh-list
64966192|NCT00171574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64966193|NCT00171574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64966194|NCT00171574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64966195|NCT00171574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966196|NCT00171574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64966197|NCT00171574|Protease Inhibitors|protease inhibitors|mesh-ancestor
64966198|NCT00171574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966278|NCT00171847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64966279|NCT00171847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966280|NCT00171847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966281|NCT00171847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64966282|NCT00171847|Hormone Antagonists|hormone antagonists|mesh-ancestor
64966317|NCT00055718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966318|NCT00055757|Gemcitabine|gemcitabine|mesh-list
64966319|NCT00055757|Tipifarnib|tipifarnib|mesh-list
64966320|NCT00055757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966321|NCT00055757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64966322|NCT00055757|Antimetabolites|antimetabolites|mesh-ancestor
64966323|NCT00055757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966324|NCT00055757|Antiviral Agents|antiviral agents|mesh-ancestor
64966325|NCT00055757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64966326|NCT00055757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966327|NCT00055757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64966328|NCT00055757|Immunologic Factors|immunologic factors|mesh-ancestor
64966329|NCT00055757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966330|NCT00399867|Simvastatin|simvastatin|mesh-list
64966331|NCT00399867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64966332|NCT00399867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64966333|NCT00399867|Antimetabolites|antimetabolites|mesh-ancestor
64966335|NCT00399867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64966375|NCT00407719|Bevacizumab|bevacizumab|mesh-list
64966376|NCT00407719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64966377|NCT00407719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966378|NCT00407719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64966379|NCT00407719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64966380|NCT00407719|Growth Substances|growth substances|mesh-ancestor
64966381|NCT00407719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966382|NCT00407719|Growth Inhibitors|growth inhibitors|mesh-ancestor
64966383|NCT04732845|Cyclophosphamide|cyclophosphamide|mesh-list
64966384|NCT04732845|Fludarabine|fludarabine|mesh-list
64966385|NCT04732845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64966386|NCT04732845|Immunologic Factors|immunologic factors|mesh-ancestor
64966435|NCT04631484|Niacinamide|niacinamide|mesh-list
64966437|NCT04631484|Nicotinic Acids|nicotinic acids|mesh-list
64966438|NCT04631484|Vitamin B Complex|vitamin b complex|mesh-ancestor
64966439|NCT04631484|Vitamins|vitamins|mesh-ancestor
64966440|NCT04631484|Micronutrients|micronutrients|mesh-ancestor
64966441|NCT04631484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966442|NCT04631484|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64966443|NCT04631484|Dermatologic Agents|dermatologic agents|mesh-ancestor
64966444|NCT04631484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64966446|NCT04631484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966447|NCT04631484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64966448|NCT04631484|Vasodilator Agents|vasodilator agents|mesh-ancestor
64966449|NCT00056030|Leucovorin|leucovorin|mesh-list
64966450|NCT00056030|Fluorouracil|fluorouracil|mesh-list
64966451|NCT00056030|Oxaliplatin|oxaliplatin|mesh-list
64966452|NCT00056030|Cetuximab|cetuximab|mesh-list
64966453|NCT00056030|Calcium|calcium|mesh-list
64966454|NCT00056030|Levoleucovorin|levoleucovorin|mesh-list
64966455|NCT00056030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64966456|NCT00056030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966540|NCT00174304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64966541|NCT00174304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966542|NCT00174304|Vasodilator Agents|vasodilator agents|mesh-ancestor
64966543|NCT00174343|Exemestane|exemestane|mesh-list
64966544|NCT00174343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966545|NCT00174343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64966547|NCT00174343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966595|NCT00056225|Vitamins|vitamins|mesh-list
64966709|NCT00175357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966710|NCT00175357|Analgesics|analgesics|mesh-ancestor
64966711|NCT00175357|Sensory System Agents|sensory system agents|mesh-ancestor
64966712|NCT00175357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64966713|NCT00175357|Antitussive Agents|antitussive agents|mesh-ancestor
64966714|NCT00175357|Respiratory System Agents|respiratory system agents|mesh-ancestor
64966715|NCT00046254|Zoledronic Acid|zoledronic acid|mesh-list
64966716|NCT00046254|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64966717|NCT00046254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966718|NCT00175396|Ascorbic Acid|ascorbic acid|mesh-list
64966719|NCT00175396|Leuprolide|leuprolide|mesh-list
64966720|NCT00175396|Methyltestosterone|methyltestosterone|mesh-list
64966721|NCT00175396|Flutamide|flutamide|mesh-list
64966722|NCT00175396|Bicalutamide|bicalutamide|mesh-list
64966723|NCT00175396|Nilutamide|nilutamide|mesh-list
64966724|NCT00175396|Buserelin|buserelin|mesh-list
64966725|NCT00175396|Androgens|androgens|mesh-list
64966726|NCT00175396|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64966727|NCT00175396|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64966736|NCT00175396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966737|NCT00175396|Protective Agents|protective agents|mesh-ancestor
64966738|NCT00175396|Vitamins|vitamins|mesh-ancestor
64966739|NCT00175396|Micronutrients|micronutrients|mesh-ancestor
64966740|NCT00175396|Estrogens|estrogens|mesh-ancestor
64966741|NCT00175396|Anabolic Agents|anabolic agents|mesh-ancestor
64966742|NCT00175396|Androgen Antagonists|androgen antagonists|mesh-ancestor
64966743|NCT00175396|Hormone Antagonists|hormone antagonists|mesh-ancestor
64966744|NCT00056459|Vatalanib|vatalanib|mesh-list
64966745|NCT00056459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64966746|NCT00056459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966747|NCT00056459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966748|NCT00175435|Vaccines|vaccines|mesh-list
64966749|NCT00175435|Immunologic Factors|immunologic factors|mesh-ancestor
64966750|NCT00175435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966751|NCT00175513|Valacyclovir|valacyclovir|mesh-list
64966752|NCT00175513|Antiviral Agents|antiviral agents|mesh-ancestor
64966753|NCT00175513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64966754|NCT00175591|Bupivacaine|bupivacaine|mesh-list
64966755|NCT00175591|Anesthetics, Local|anesthetics, local|mesh-ancestor
64966758|NCT00175591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966759|NCT00175591|Sensory System Agents|sensory system agents|mesh-ancestor
64966760|NCT00175591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64966761|NCT00175630|Bupivacaine|bupivacaine|mesh-list
64966762|NCT00175630|Anesthetics, Local|anesthetics, local|mesh-ancestor
64966763|NCT00175630|Anesthetics|anesthetics|mesh-ancestor
64966764|NCT00175630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64966765|NCT00175630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966766|NCT00175630|Sensory System Agents|sensory system agents|mesh-ancestor
64966767|NCT00175630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64966768|NCT00408031|Cycloserine|cycloserine|mesh-list
64966769|NCT00408031|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64966770|NCT00408031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64966777|NCT00175747|Budesonide|budesonide|mesh-list
64966778|NCT00175747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64966779|NCT00175747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64966780|NCT00175747|Autonomic Agents|autonomic agents|mesh-ancestor
64966781|NCT00175747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64966782|NCT00175747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966783|NCT00175747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64966784|NCT00175747|Respiratory System Agents|respiratory system agents|mesh-ancestor
64966785|NCT00175747|Glucocorticoids|glucocorticoids|mesh-ancestor
64966786|NCT00175747|Hormones|hormones|mesh-ancestor
64966787|NCT00175747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64966788|NCT04493619|Carboplatin|carboplatin|mesh-list
64966789|NCT04493619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966790|NCT00056576|Zonisamide|zonisamide|mesh-list
64966852|NCT04420533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64966853|NCT04420533|Adrenergic Agents|adrenergic agents|mesh-ancestor
64966854|NCT04420533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64966855|NCT04420533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966856|NCT04420533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966857|NCT04420533|Urological Agents|urological agents|mesh-ancestor
64966858|NCT00176020|Nicotinic Acids|nicotinic acids|mesh-list
64966859|NCT00176020|Niacin|niacin|mesh-list
64966860|NCT00176020|Niacinamide|niacinamide|mesh-list
64966861|NCT00176020|Vitamin B Complex|vitamin b complex|mesh-ancestor
64966862|NCT00176020|Vitamins|vitamins|mesh-ancestor
64966863|NCT00176020|Micronutrients|micronutrients|mesh-ancestor
64966879|NCT00176098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966880|NCT00176293|Dexamethasone|dexamethasone|mesh-list
64966881|NCT00176293|Doxorubicin|doxorubicin|mesh-list
64966882|NCT00176293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64966883|NCT00176293|Antiemetics|antiemetics|mesh-ancestor
64966884|NCT00176293|Autonomic Agents|autonomic agents|mesh-ancestor
64966885|NCT00176293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64966886|NCT00176293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966887|NCT00176293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64966888|NCT00176293|Glucocorticoids|glucocorticoids|mesh-ancestor
64966890|NCT00176293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64966891|NCT00176293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64966892|NCT00176293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505553|NCT01723696|Antioxidants|antioxidants|mesh-ancestor
64966893|NCT00176293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64966894|NCT00176293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64966895|NCT00176293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64966896|NCT00176293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966897|NCT00176293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966899|NCT00056693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966900|NCT00056693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64966902|NCT00056693|Growth Substances|growth substances|mesh-ancestor
64966928|NCT00176449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64966929|NCT00176449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966930|NCT00398450|Interferons|interferons|mesh-list
64967092|NCT00178048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967093|NCT00056966|Fludarabine|fludarabine|mesh-list
64967094|NCT00056966|Alemtuzumab|alemtuzumab|mesh-list
64967095|NCT00056966|Tacrolimus|tacrolimus|mesh-list
64967096|NCT00056966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967097|NCT00056966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967098|NCT00056966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64967099|NCT00056966|Immunologic Factors|immunologic factors|mesh-ancestor
64967100|NCT00056966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967101|NCT00056966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64967102|NCT00056966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967103|NCT00056966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64967104|NCT00178828|Bupropion|bupropion|mesh-list
64967105|NCT00178828|Sertraline|sertraline|mesh-list
64967106|NCT00178828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64967107|NCT00178828|Antidepressive Agents|antidepressive agents|mesh-ancestor
64967108|NCT00178828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64967109|NCT00178828|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64967110|NCT00178828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64967111|NCT00178828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64967121|NCT00408187|Cyclosporine|cyclosporine|mesh-list
64967123|NCT00408187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967124|NCT00408187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967125|NCT00408187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64967126|NCT00408187|Immunologic Factors|immunologic factors|mesh-ancestor
64967127|NCT00408187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967128|NCT00408187|Antifungal Agents|antifungal agents|mesh-ancestor
64967129|NCT00408187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64967130|NCT00408187|Dermatologic Agents|dermatologic agents|mesh-ancestor
64967131|NCT00408187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64967132|NCT00408187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64967174|NCT00179023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64967175|NCT00179023|Autonomic Agents|autonomic agents|mesh-ancestor
64967176|NCT00179023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64967177|NCT00179023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967178|NCT00179023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64967179|NCT00179023|Respiratory System Agents|respiratory system agents|mesh-ancestor
64967180|NCT00179023|Nasal Decongestants|nasal decongestants|mesh-ancestor
64967181|NCT00179023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64967182|NCT00179023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64967239|NCT00408382|Atorvastatin|atorvastatin|mesh-list
64967414|NCT00180973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64967415|NCT04729491|Azithromycin|azithromycin|mesh-list
64967416|NCT04729491|Nitazoxanide|nitazoxanide|mesh-list
64967417|NCT04729491|Dutasteride|dutasteride|mesh-list
64967418|NCT04729491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64967419|NCT04729491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64967420|NCT04729491|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64967468|NCT00181597|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64967469|NCT00181597|Abortifacient Agents|abortifacient agents|mesh-ancestor
64967470|NCT00181597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64967471|NCT00181597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967472|NCT00181597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967473|NCT00181597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967474|NCT00181597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967475|NCT00181636|Galantamine|galantamine|mesh-list
64967476|NCT00181636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64967477|NCT00181636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506223|NCT05127928|Protective Agents|protective agents|mesh-ancestor
64967478|NCT00181636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967479|NCT00181636|Cholinergic Agents|cholinergic agents|mesh-ancestor
64967480|NCT00181636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64967481|NCT00181636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967648|NCT00182884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967649|NCT00182884|Cholinergic Agents|cholinergic agents|mesh-ancestor
64967650|NCT00182884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64967651|NCT00182884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967652|NCT00182884|Nootropic Agents|nootropic agents|mesh-ancestor
64967653|NCT00183001|Vitamin K|vitamin k|mesh-list
64967654|NCT00183001|Vitamins|vitamins|mesh-ancestor
64967655|NCT00183001|Micronutrients|micronutrients|mesh-ancestor
64967656|NCT00183001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967657|NCT00183001|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64967658|NCT00183001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64967659|NCT00183001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967660|NCT00183001|Hemostatics|hemostatics|mesh-ancestor
64967661|NCT00183001|Coagulants|coagulants|mesh-ancestor
64967662|NCT00183040|Hormones|hormones|mesh-list
64967663|NCT00183040|Testosterone|testosterone|mesh-list
64967705|NCT00183742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967706|NCT00183742|Tubulin Modulators|tubulin modulators|mesh-ancestor
64967707|NCT00183742|Antimitotic Agents|antimitotic agents|mesh-ancestor
64967708|NCT00183742|Mitosis Modulators|mitosis modulators|mesh-ancestor
64967755|NCT02969720|Protective Agents|protective agents|mesh-ancestor
64967756|NCT02969720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967757|NCT02969720|Dermatologic Agents|dermatologic agents|mesh-ancestor
64967758|NCT02969720|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64967759|NCT00183859|Irinotecan|irinotecan|mesh-list
64967765|NCT00183898|Capecitabine|capecitabine|mesh-list
64967810|NCT00046683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64967811|NCT00046683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967812|NCT00184015|Bevacizumab|bevacizumab|mesh-list
64967983|NCT00185185|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64967984|NCT00185185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64967985|NCT00185185|Diuretics|diuretics|mesh-ancestor
64967986|NCT00185185|Natriuretic Agents|natriuretic agents|mesh-ancestor
64967987|NCT00185185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967988|NCT00185185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64967989|NCT00185185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64967990|NCT00185185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967991|NCT00185185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64968138|NCT00186277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968139|NCT00186316|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
64968140|NCT00186316|Immunologic Factors|immunologic factors|mesh-ancestor
64968141|NCT00186316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968142|NCT03611595|Tretinoin|tretinoin|mesh-list
64968143|NCT03611595|Isotretinoin|isotretinoin|mesh-list
64968144|NCT03611595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968145|NCT03611595|Keratolytic Agents|keratolytic agents|mesh-ancestor
64968146|NCT03611595|Dermatologic Agents|dermatologic agents|mesh-ancestor
64968147|NCT00058682|Anidulafungin|anidulafungin|mesh-list
64968148|NCT00058682|Antifungal Agents|antifungal agents|mesh-ancestor
64968149|NCT00058682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64968150|NCT00186589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64968151|NCT00186589|Immunologic Factors|immunologic factors|mesh-ancestor
64968152|NCT00186589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968153|NCT00186706|Selenium|selenium|mesh-list
64968186|NCT00186823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968187|NCT00186862|Interleukin-2|interleukin-2|mesh-list
64968188|NCT00186862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968189|NCT00186862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64968190|NCT00186862|Analgesics|analgesics|mesh-ancestor
64968191|NCT00186862|Sensory System Agents|sensory system agents|mesh-ancestor
64968192|NCT00186862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64968194|NCT03551964|Ticagrelor|ticagrelor|mesh-list
64968254|NCT00187057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64968280|NCT00046917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968285|NCT00187174|Everolimus|everolimus|mesh-list
64968299|NCT03538938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968300|NCT00187330|Acetylcysteine|acetylcysteine|mesh-list
64968301|NCT00187330|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64968302|NCT00187330|Antiviral Agents|antiviral agents|mesh-ancestor
64968303|NCT00187330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64968304|NCT00187330|Expectorants|expectorants|mesh-ancestor
64968305|NCT00187330|Respiratory System Agents|respiratory system agents|mesh-ancestor
64968306|NCT00187330|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64968307|NCT00187330|Antioxidants|antioxidants|mesh-ancestor
64968308|NCT00187330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968309|NCT00187330|Protective Agents|protective agents|mesh-ancestor
64968310|NCT00187330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968311|NCT00187330|Antidotes|antidotes|mesh-ancestor
64968312|NCT00187408|Heparin|heparin|mesh-list
64968313|NCT00187408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64968314|NCT00187408|Tinzaparin|tinzaparin|mesh-list
64968315|NCT00187408|Dalteparin|dalteparin|mesh-list
64968316|NCT00187408|Anticoagulants|anticoagulants|mesh-ancestor
64968317|NCT00187408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64968318|NCT00187408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64968488|NCT00188383|Analgesics|analgesics|mesh-ancestor
64968489|NCT00188383|Sensory System Agents|sensory system agents|mesh-ancestor
64968490|NCT00188383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64968491|NCT02969447|Oxytocin|oxytocin|mesh-list
64968492|NCT02969447|Oxytocics|oxytocics|mesh-ancestor
64968493|NCT02969447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64968494|NCT02969447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968495|NCT00188617|Gefitinib|gefitinib|mesh-list
64968496|NCT00188617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968497|NCT00188617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64968498|NCT00188617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968499|NCT00188617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968500|NCT00047112|Fluorouracil|fluorouracil|mesh-list
64968501|NCT00047112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968502|NCT00047112|Antimetabolites|antimetabolites|mesh-ancestor
64968503|NCT00047112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968504|NCT00047112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64968505|NCT00047112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64968506|NCT00047112|Immunologic Factors|immunologic factors|mesh-ancestor
64968507|NCT00047112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968508|NCT00409318|Etanercept|etanercept|mesh-list
64968509|NCT00409318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64968510|NCT00409318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64968511|NCT00409318|Analgesics|analgesics|mesh-ancestor
64968512|NCT00409318|Sensory System Agents|sensory system agents|mesh-ancestor
64968513|NCT00409318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64968518|NCT00409318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64968519|NCT00409318|Immunologic Factors|immunologic factors|mesh-ancestor
64968521|NCT00409357|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64968522|NCT00409357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64968523|NCT00409357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64968524|NCT00409357|Adrenergic Agents|adrenergic agents|mesh-ancestor
64507190|NCT02989558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64968525|NCT00409357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64968526|NCT00409357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836395|NCT01613079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836396|NCT01613079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64836397|NCT01613079|Antimetabolites|antimetabolites|mesh-ancestor
64507259|NCT01806623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968527|NCT00409357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968528|NCT00409357|Urological Agents|urological agents|mesh-ancestor
64968529|NCT00059267|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64968632|NCT00189124|Immunologic Factors|immunologic factors|mesh-ancestor
64968655|NCT00189397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968656|NCT00189397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64968657|NCT00189397|Immunologic Factors|immunologic factors|mesh-ancestor
64968658|NCT00189397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968659|NCT00189397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64968660|NCT00189514|Pramlintide|pramlintide|mesh-list
64968661|NCT00189514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64968662|NCT00189514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968663|NCT00189553|Paclitaxel|paclitaxel|mesh-list
64968664|NCT00189553|Carboplatin|carboplatin|mesh-list
64968665|NCT00189553|Doxorubicin|doxorubicin|mesh-list
64968666|NCT00189553|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64968667|NCT00189553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64968668|NCT00189553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968669|NCT00189553|Tubulin Modulators|tubulin modulators|mesh-ancestor
64968670|NCT00189553|Antimitotic Agents|antimitotic agents|mesh-ancestor
64968671|NCT00189553|Mitosis Modulators|mitosis modulators|mesh-ancestor
64968672|NCT00189553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968673|NCT00189553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64968674|NCT00189553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64507332|NCT01798264|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64968675|NCT00189553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64968676|NCT00189553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968677|NCT00189709|Fluconazole|fluconazole|mesh-list
64968678|NCT00189709|Micafungin|micafungin|mesh-list
64968679|NCT00189709|Antifungal Agents|antifungal agents|mesh-ancestor
64968702|NCT00189787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968703|NCT00189787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64968704|NCT00189787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968705|NCT00189787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968706|NCT00059462|Interleukin-2|interleukin-2|mesh-list
64836398|NCT01613079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836399|NCT01613079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836400|NCT01613079|Dermatologic Agents|dermatologic agents|mesh-ancestor
64836401|NCT01613079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836402|NCT01613079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64836403|NCT01613079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64836404|NCT01613079|Immunologic Factors|immunologic factors|mesh-ancestor
64836405|NCT01613079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64447483|NCT01598090|Antimetabolites|antimetabolites|mesh-ancestor
64447485|NCT01598090|Antiviral Agents|antiviral agents|mesh-ancestor
64836406|NCT01613079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64836407|NCT01613092|Vancomycin|vancomycin|mesh-list
64968707|NCT00059462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968708|NCT00059462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64968709|NCT00059462|Analgesics|analgesics|mesh-ancestor
64968710|NCT00059462|Sensory System Agents|sensory system agents|mesh-ancestor
64968711|NCT00059462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64968712|NCT00059462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968713|NCT00189826|Tacrolimus|tacrolimus|mesh-list
64968714|NCT00189826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64968715|NCT00189826|Immunologic Factors|immunologic factors|mesh-ancestor
64968716|NCT00189826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968717|NCT00189826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64968718|NCT00189826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968719|NCT00189826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968720|NCT00047190|Tipifarnib|tipifarnib|mesh-list
64968721|NCT00047190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968722|NCT00189982|Factor VIII|factor viii|mesh-list
64968820|NCT00190333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64968821|NCT00190333|Antidepressive Agents|antidepressive agents|mesh-ancestor
64507559|NCT05166876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968822|NCT00190333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64968823|NCT00190372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64968852|NCT00047307|Growth Inhibitors|growth inhibitors|mesh-ancestor
64968853|NCT00047307|Growth Substances|growth substances|mesh-ancestor
64968854|NCT00047307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64968855|NCT00190489|Docetaxel|docetaxel|mesh-list
64968856|NCT00190489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968857|NCT00190489|Tubulin Modulators|tubulin modulators|mesh-ancestor
64968858|NCT00190489|Antimitotic Agents|antimitotic agents|mesh-ancestor
64968859|NCT00190489|Mitosis Modulators|mitosis modulators|mesh-ancestor
64968860|NCT00190489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968861|NCT00190567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64968874|NCT02969252|Rifamycins|rifamycins|mesh-list
64969022|NCT00191464|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64969023|NCT00191464|Metformin|metformin|mesh-list
64969024|NCT00191464|Insulin Glargine|insulin glargine|mesh-list
64969025|NCT00191464|Insulin Lispro|insulin lispro|mesh-list
64969026|NCT00191464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64969027|NCT00191464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969028|NCT04723030|Paclitaxel|paclitaxel|mesh-list
64969029|NCT04723030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64969030|NCT04723030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969031|NCT04723030|Tubulin Modulators|tubulin modulators|mesh-ancestor
64969032|NCT04723030|Antimitotic Agents|antimitotic agents|mesh-ancestor
64969033|NCT04723030|Mitosis Modulators|mitosis modulators|mesh-ancestor
64969074|NCT00191620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969075|NCT00191620|Antiviral Agents|antiviral agents|mesh-ancestor
64969076|NCT00191620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969077|NCT00191620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969078|NCT00191620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64969079|NCT00191620|Immunologic Factors|immunologic factors|mesh-ancestor
64969080|NCT00191620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969081|NCT00191659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64969082|NCT00191659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64969083|NCT00191659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64969084|NCT00191659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64969086|NCT00191659|Adrenergic Agents|adrenergic agents|mesh-ancestor
64969137|NCT00059813|Oblimersen|oblimersen|mesh-list
64969175|NCT00192049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64969177|NCT00192088|Pemetrexed|pemetrexed|mesh-list
64969178|NCT00192088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969179|NCT00192088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969180|NCT00192088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969181|NCT00192088|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64969182|NCT00192088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64969183|NCT00059852|Gemcitabine|gemcitabine|mesh-list
64969184|NCT00059852|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64969185|NCT00059852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64969186|NCT00059852|Antimetabolites|antimetabolites|mesh-ancestor
64969187|NCT00059852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969188|NCT00059852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969189|NCT00059852|Antiviral Agents|antiviral agents|mesh-ancestor
64969190|NCT00059852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969191|NCT00059852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969192|NCT00059852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64969193|NCT00059852|Immunologic Factors|immunologic factors|mesh-ancestor
64969194|NCT00059852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969195|NCT00059852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64969228|NCT00192595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969229|NCT00192595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64969230|NCT00192595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64969231|NCT00192595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969232|NCT00192595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969233|NCT00192595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64969234|NCT00192595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64969235|NCT00192595|Antimetabolites|antimetabolites|mesh-ancestor
64969236|NCT00192595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64969237|NCT00192595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64836408|NCT01613092|Clindamycin|clindamycin|mesh-list
64836409|NCT01613092|Cefazolin|cefazolin|mesh-list
64836410|NCT01613092|Cephalexin|cephalexin|mesh-list
64836411|NCT01613092|Bacitracin|bacitracin|mesh-list
64836412|NCT01613092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64836413|NCT01613092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64836414|NCT01613092|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64836415|NCT01613092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836416|NCT01613092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836417|NCT01613092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64836418|NCT01613105|Acarbose|acarbose|mesh-list
64836447|NCT01613365|Disinfectants|disinfectants|mesh-ancestor
64969238|NCT00192595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64969239|NCT00192595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64969240|NCT00192595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64969241|NCT00192595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64969242|NCT00192634|Tenofovir|tenofovir|mesh-list
64969243|NCT00192634|Lamivudine|lamivudine|mesh-list
64969244|NCT00192634|Emtricitabine|emtricitabine|mesh-list
64969245|NCT00192634|Abacavir|abacavir|mesh-list
64969246|NCT00192634|Antiviral Agents|antiviral agents|mesh-ancestor
64969247|NCT00192634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969248|NCT00192634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64969249|NCT00192634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64969250|NCT00192634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969252|NCT00192634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64969278|NCT00193024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969279|NCT00193024|Tubulin Modulators|tubulin modulators|mesh-ancestor
64969280|NCT00193024|Antimitotic Agents|antimitotic agents|mesh-ancestor
64969281|NCT00193024|Mitosis Modulators|mitosis modulators|mesh-ancestor
64969282|NCT00193024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969283|NCT00193024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64969284|NCT00193024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64969285|NCT00193024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64969286|NCT00193024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969287|NCT00193102|Thalidomide|thalidomide|mesh-list
64969288|NCT00193102|Capecitabine|capecitabine|mesh-list
64969289|NCT00193102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64969290|NCT00193102|Antimetabolites|antimetabolites|mesh-ancestor
64969291|NCT00193102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969292|NCT00193102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969293|NCT00193102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64969294|NCT00193102|Immunologic Factors|immunologic factors|mesh-ancestor
64969295|NCT00193102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969296|NCT00193102|Leprostatic Agents|leprostatic agents|mesh-ancestor
64836448|NCT01613365|Dermatologic Agents|dermatologic agents|mesh-ancestor
64836449|NCT01613469|Leucovorin|leucovorin|mesh-list
64836450|NCT01613469|Antidotes|antidotes|mesh-ancestor
64836451|NCT01613469|Protective Agents|protective agents|mesh-ancestor
64447533|NCT02123966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836476|NCT01613690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64836477|NCT01613690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836478|NCT01613690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836479|NCT01613729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64836480|NCT01613729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64969297|NCT00193102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64969298|NCT00193102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969299|NCT00193102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64969300|NCT00193102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64969301|NCT00193102|Growth Substances|growth substances|mesh-ancestor
64969302|NCT00193102|Growth Inhibitors|growth inhibitors|mesh-ancestor
64969303|NCT00193141|Paclitaxel|paclitaxel|mesh-list
64969304|NCT00193141|Carboplatin|carboplatin|mesh-list
64969305|NCT00193141|Fluorouracil|fluorouracil|mesh-list
64969306|NCT00193141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64969307|NCT00193141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969312|NCT00193141|Antimetabolites|antimetabolites|mesh-ancestor
64969320|NCT00193297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64969321|NCT00193297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969322|NCT00193297|Tubulin Modulators|tubulin modulators|mesh-ancestor
64969323|NCT00193297|Antimitotic Agents|antimitotic agents|mesh-ancestor
64969324|NCT00193297|Mitosis Modulators|mitosis modulators|mesh-ancestor
64969325|NCT00193297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969326|NCT00193297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64969327|NCT00193297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64969328|NCT00193297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969329|NCT00193336|Gefitinib|gefitinib|mesh-list
64969330|NCT00193336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969331|NCT00193336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64969332|NCT00193336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969333|NCT00193336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969335|NCT00193531|Etoposide|etoposide|mesh-list
64969336|NCT00193531|Carboplatin|carboplatin|mesh-list
64969337|NCT00193531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64969338|NCT00193531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969339|NCT00193531|Tubulin Modulators|tubulin modulators|mesh-ancestor
64969340|NCT00193531|Antimitotic Agents|antimitotic agents|mesh-ancestor
64969341|NCT00193531|Mitosis Modulators|mitosis modulators|mesh-ancestor
64969342|NCT00193531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969343|NCT00193531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64969367|NCT00409591|Protease Inhibitors|protease inhibitors|mesh-ancestor
64969368|NCT00409591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969369|NCT00409591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969370|NCT00409591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64969371|NCT00409591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64969372|NCT00409591|Antiviral Agents|antiviral agents|mesh-ancestor
64969373|NCT00409591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969374|NCT00409591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64969375|NCT00409591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64969376|NCT00409591|Antimetabolites|antimetabolites|mesh-ancestor
64969377|NCT00409591|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64969378|NCT00409591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64969379|NCT00409591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64969380|NCT00409591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64969381|NCT00409630|Fluticasone|fluticasone|mesh-list
64969382|NCT00409630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64969494|NCT00398528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969495|NCT00398528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64969496|NCT00398528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64969497|NCT00194467|Valganciclovir|valganciclovir|mesh-list
64969498|NCT00194467|Antiviral Agents|antiviral agents|mesh-ancestor
64969499|NCT00194467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969500|NCT00060398|Dexamethasone|dexamethasone|mesh-list
64969501|NCT00060398|Epoetin Alfa|epoetin alfa|mesh-list
64969502|NCT00060398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64969503|NCT00060398|Antiemetics|antiemetics|mesh-ancestor
64969521|NCT00194623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64969522|NCT00194623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969523|NCT00194623|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64969524|NCT00194623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64969526|NCT00194740|Vinorelbine|vinorelbine|mesh-list
64969527|NCT00194740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969528|NCT00194740|Tubulin Modulators|tubulin modulators|mesh-ancestor
64969529|NCT00194740|Antimitotic Agents|antimitotic agents|mesh-ancestor
64969530|NCT00194740|Mitosis Modulators|mitosis modulators|mesh-ancestor
64969585|NCT02963116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64969618|NCT00195481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64969619|NCT00195481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969620|NCT00195481|Antifungal Agents|antifungal agents|mesh-ancestor
64969621|NCT00195481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64969622|NCT00195481|Immunologic Factors|immunologic factors|mesh-ancestor
64969623|NCT00195481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969624|NCT00195559|Levonorgestrel|levonorgestrel|mesh-list
64969625|NCT00195559|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64969626|NCT00195559|Estradiol|estradiol|mesh-list
64969627|NCT00195559|Estrogens|estrogens|mesh-ancestor
64969628|NCT00195559|Hormones|hormones|mesh-ancestor
64969629|NCT00195559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64508309|NCT01993810|Durvalumab|durvalumab|mesh-list
64969630|NCT00195559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969631|NCT00195559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64969632|NCT00195559|Contraceptive Agents|contraceptive agents|mesh-ancestor
64969633|NCT00195559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64969634|NCT00195559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64969635|NCT00195559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64969636|NCT00195559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64969637|NCT00195559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64969638|NCT00084240|Azithromycin|azithromycin|mesh-list
64969670|NCT00195598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64969729|NCT00195871|Hormones|hormones|mesh-ancestor
64969730|NCT00195871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64969731|NCT00195871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64969732|NCT00195871|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64969733|NCT00195871|Abortifacient Agents|abortifacient agents|mesh-ancestor
64969734|NCT00195871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64969735|NCT00195871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64969736|NCT00195871|Antimetabolites|antimetabolites|mesh-ancestor
64969737|NCT00195871|Dermatologic Agents|dermatologic agents|mesh-ancestor
64969738|NCT00195871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969739|NCT00195871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64969740|NCT00195871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64969741|NCT00195871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64969787|NCT00084279|Ribavirin|ribavirin|mesh-list
64969836|NCT00048126|Irinotecan|irinotecan|mesh-list
64969837|NCT00048126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64969838|NCT00048126|Antimetabolites|antimetabolites|mesh-ancestor
64969839|NCT00048126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969840|NCT00048126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969875|NCT00084396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64969876|NCT00084396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969877|NCT00084396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970065|NCT00048360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970066|NCT00048360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64970067|NCT00048360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64970068|NCT00048360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970069|NCT00198055|Aripiprazole|aripiprazole|mesh-list
64970070|NCT00198055|Antidepressive Agents|antidepressive agents|mesh-ancestor
64970071|NCT00198055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64970072|NCT00198055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64970073|NCT00198055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64970074|NCT00198055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64970075|NCT00198055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970076|NCT00198055|Dopamine Agonists|dopamine agonists|mesh-ancestor
64970077|NCT00198055|Dopamine Agents|dopamine agents|mesh-ancestor
64970078|NCT00198055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970079|NCT00198055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970080|NCT00198055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64970081|NCT00198055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64970082|NCT00198055|Serotonin Agents|serotonin agents|mesh-ancestor
64970085|NCT00198055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64970086|NCT00198055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64970087|NCT00198094|Alprazolam|alprazolam|mesh-list
64970088|NCT00198094|Sertraline|sertraline|mesh-list
64970089|NCT00198094|Antidepressive Agents|antidepressive agents|mesh-ancestor
64970090|NCT00198094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64970091|NCT00198094|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64970092|NCT00198094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64970093|NCT00198094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64970094|NCT00198094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970095|NCT00198094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970096|NCT00198094|Serotonin Agents|serotonin agents|mesh-ancestor
64970097|NCT00198094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970098|NCT00198094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64970099|NCT00198094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64970100|NCT00198094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64970101|NCT00198094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64970102|NCT00198094|GABA Modulators|gaba modulators|mesh-ancestor
64836481|NCT01613729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64970103|NCT00198094|GABA Agents|gaba agents|mesh-ancestor
64970104|NCT00198172|Epirubicin|epirubicin|mesh-list
64970105|NCT00198172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970106|NCT00198172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64970107|NCT00198172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64970108|NCT00198172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64970109|NCT00198172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970110|NCT00198172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970111|NCT00198250|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64970230|NCT00084786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970231|NCT00409981|Paclitaxel|paclitaxel|mesh-list
64970232|NCT00409981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64970233|NCT00409981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970234|NCT00409981|Tubulin Modulators|tubulin modulators|mesh-ancestor
64970235|NCT00409981|Antimitotic Agents|antimitotic agents|mesh-ancestor
64970236|NCT00409981|Mitosis Modulators|mitosis modulators|mesh-ancestor
64970237|NCT00409981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970238|NCT00198601|Gentamicins|gentamicins|mesh-list
64970239|NCT00198601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64970240|NCT00198601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64970241|NCT00198601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64970242|NCT00198601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970243|NCT00198601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970244|NCT00198640|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64970245|NCT00198640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64970246|NCT00198679|Chlorhexidine|chlorhexidine|mesh-list
64970247|NCT00198679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64970248|NCT00198679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64970249|NCT00198679|Disinfectants|disinfectants|mesh-ancestor
64970250|NCT00084825|Docetaxel|docetaxel|mesh-list
64970251|NCT00084825|Imatinib Mesylate|imatinib mesylate|mesh-list
64970261|NCT00048477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970262|NCT00199147|Cytarabine|cytarabine|mesh-list
64970263|NCT00199147|Fludarabine|fludarabine|mesh-list
64970264|NCT00199147|Etoposide|etoposide|mesh-list
64970265|NCT00199147|Idarubicin|idarubicin|mesh-list
64970266|NCT00199147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970267|NCT00199147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64970268|NCT00199147|Antimetabolites|antimetabolites|mesh-ancestor
64970269|NCT00199147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970270|NCT00199147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64970271|NCT00199147|Immunologic Factors|immunologic factors|mesh-ancestor
64970272|NCT00199147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970273|NCT00199147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64970279|NCT00199147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64970280|NCT00199186|Cytarabine|cytarabine|mesh-list
64970281|NCT00199186|Dexamethasone|dexamethasone|mesh-list
64970282|NCT00199186|Dexamethasone acetate|dexamethasone acetate|mesh-list
64970283|NCT00199186|Cyclophosphamide|cyclophosphamide|mesh-list
64970284|NCT00199186|Methotrexate|methotrexate|mesh-list
64970314|NCT00199186|Dermatologic Agents|dermatologic agents|mesh-ancestor
64970315|NCT00199186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64970316|NCT00199186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64970317|NCT00199186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64970318|NCT00199186|Tubulin Modulators|tubulin modulators|mesh-ancestor
64970319|NCT00199186|Antimitotic Agents|antimitotic agents|mesh-ancestor
64970320|NCT00199186|Mitosis Modulators|mitosis modulators|mesh-ancestor
64970321|NCT00199186|Antiviral Agents|antiviral agents|mesh-ancestor
64970322|NCT00199186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64970323|NCT00199186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64970324|NCT00199186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64970325|NCT00199186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64970326|NCT00199186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64970327|NCT00199225|Moxifloxacin|moxifloxacin|mesh-list
64970328|NCT00199225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64970329|NCT00199225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64970330|NCT00199225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64970331|NCT00199225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64970332|NCT00199225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970333|NCT00199225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970334|NCT00199225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970364|NCT00199576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64970365|NCT00199576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970366|NCT00199576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64970367|NCT00199576|Glucocorticoids|glucocorticoids|mesh-ancestor
64970368|NCT00199576|Hormones|hormones|mesh-ancestor
64836482|NCT01613729|Antimetabolites|antimetabolites|mesh-ancestor
64836483|NCT01613729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836484|NCT01613729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64836485|NCT01613729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64836486|NCT01613729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836487|NCT01613755|Metformin|metformin|mesh-list
64836750|NCT01614964|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64836752|NCT01614964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64836753|NCT01614964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64836754|NCT01614964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64970369|NCT00199576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64970370|NCT00199576|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64970371|NCT00199576|Protective Agents|protective agents|mesh-ancestor
64970372|NCT00199576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64970373|NCT00199576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970374|NCT00084942|Gemcitabine|gemcitabine|mesh-list
64970375|NCT00084942|Capecitabine|capecitabine|mesh-list
64970376|NCT00084942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64970377|NCT00084942|Antimetabolites|antimetabolites|mesh-ancestor
64970378|NCT00084942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970379|NCT00084942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970380|NCT00084942|Antiviral Agents|antiviral agents|mesh-ancestor
64970381|NCT00084942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64970382|NCT00084942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970383|NCT00084942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64970384|NCT00084942|Immunologic Factors|immunologic factors|mesh-ancestor
64970385|NCT00084942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970386|NCT02968394|Omalizumab|omalizumab|mesh-list
64970387|NCT02968394|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64970388|NCT02968394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64970389|NCT02968394|Respiratory System Agents|respiratory system agents|mesh-ancestor
64970390|NCT00199771|Dextrans|dextrans|mesh-list
64970391|NCT00199771|Anticoagulants|anticoagulants|mesh-ancestor
64970392|NCT00199771|Plasma Substitutes|plasma substitutes|mesh-ancestor
64970394|NCT00084981|Decitabine|decitabine|mesh-list
64970427|NCT00085020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970428|NCT00410215|Bisacodyl|bisacodyl|mesh-list
64970432|NCT00410254|Midazolam|midazolam|mesh-list
64970456|NCT00200395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970457|NCT00200395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64970458|NCT00200395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970459|NCT00200395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970460|NCT00200434|Nebivolol|nebivolol|mesh-list
64970461|NCT00200434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64970462|NCT00200434|Vasodilator Agents|vasodilator agents|mesh-ancestor
64970463|NCT00200434|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64970464|NCT00200434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64970465|NCT00200434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64970466|NCT00200434|Adrenergic Agents|adrenergic agents|mesh-ancestor
64970467|NCT00200434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970468|NCT00200434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970470|NCT00200473|Nebivolol|nebivolol|mesh-list
64970515|NCT00200551|Antitubercular Agents|antitubercular agents|mesh-ancestor
64970516|NCT00200551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64970519|NCT00061256|Calcium Carbonate|calcium carbonate|mesh-list
64970551|NCT00200629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970552|NCT00200629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970553|NCT00200668|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64970554|NCT00200668|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64970555|NCT00200668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970556|NCT00048594|Aprepitant|aprepitant|mesh-list
64970557|NCT00048594|Antiemetics|antiemetics|mesh-ancestor
64970558|NCT00048594|Autonomic Agents|autonomic agents|mesh-ancestor
64970559|NCT00048594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64970560|NCT00048594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970561|NCT00048594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64970562|NCT00048594|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64970563|NCT00048594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970564|NCT00048594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970565|NCT00200941|Topiramate|topiramate|mesh-list
64970566|NCT00200941|Anticonvulsants|anticonvulsants|mesh-ancestor
64970567|NCT00200941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64970568|NCT00200941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970606|NCT00410371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970607|NCT00410371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64970608|NCT00410371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64970609|NCT00410371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64970610|NCT00410371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64970611|NCT00410371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64970612|NCT00410449|Tocopherols|tocopherols|mesh-list
64970613|NCT00410449|Vitamin E|vitamin e|mesh-list
64970614|NCT00410449|Tocotrienols|tocotrienols|mesh-list
64970615|NCT00410449|alpha-Tocopherol|alpha-tocopherol|mesh-list
64970616|NCT00410449|Antioxidants|antioxidants|mesh-ancestor
64970617|NCT00410449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836755|NCT01615016|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64836756|NCT01615016|Respiratory System Agents|respiratory system agents|mesh-ancestor
64836758|NCT01615042|Immunologic Factors|immunologic factors|mesh-ancestor
64836759|NCT01615042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836760|NCT01615042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64836761|NCT01615042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64836762|NCT01615042|Growth Substances|growth substances|mesh-ancestor
64836763|NCT01615042|Growth Inhibitors|growth inhibitors|mesh-ancestor
64836764|NCT01615042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970618|NCT00410449|Protective Agents|protective agents|mesh-ancestor
64970619|NCT00410449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970620|NCT00410449|Vitamins|vitamins|mesh-ancestor
64970621|NCT00410449|Micronutrients|micronutrients|mesh-ancestor
64970622|NCT00061451|Gemcitabine|gemcitabine|mesh-list
64970623|NCT00061451|Pemetrexed|pemetrexed|mesh-list
64970624|NCT00061451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64970625|NCT00061451|Antimetabolites|antimetabolites|mesh-ancestor
64970626|NCT00061451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970627|NCT00061451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970628|NCT00061451|Antiviral Agents|antiviral agents|mesh-ancestor
64970629|NCT00061451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64970657|NCT00221416|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64970659|NCT00221416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64970661|NCT00221494|Citalopram|citalopram|mesh-list
64970662|NCT00221494|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64970663|NCT00221494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64970664|NCT00221494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64970665|NCT00221494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970666|NCT00221494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970667|NCT00221494|Serotonin Agents|serotonin agents|mesh-ancestor
64970668|NCT00221494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970669|NCT00221494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64970670|NCT00221494|Antidepressive Agents|antidepressive agents|mesh-ancestor
64970671|NCT00221494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64970672|NCT00221494|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64970673|NCT00221494|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64970674|NCT00221494|Adrenergic Agents|adrenergic agents|mesh-ancestor
64970675|NCT00221494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64970676|NCT00221494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64970677|NCT00221494|Vasodilator Agents|vasodilator agents|mesh-ancestor
64970678|NCT00221611|Baclofen|baclofen|mesh-list
64970679|NCT00221611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64970680|NCT00221611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970681|NCT00221611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64836765|NCT01615055|Fluoxetine|fluoxetine|mesh-list
64836766|NCT01615055|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64836767|NCT01615055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64836768|NCT01615055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64970688|NCT00221650|Ribavirin|ribavirin|mesh-list
64970707|NCT02968121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970708|NCT02968121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970709|NCT02968121|Dopamine Agonists|dopamine agonists|mesh-ancestor
64970710|NCT02968121|Dopamine Agents|dopamine agents|mesh-ancestor
64970711|NCT00412789|Epothilone B|epothilone b|mesh-list
64970712|NCT00412789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970713|NCT00412789|Tubulin Modulators|tubulin modulators|mesh-ancestor
64970714|NCT00412789|Antimitotic Agents|antimitotic agents|mesh-ancestor
64970715|NCT00412789|Mitosis Modulators|mitosis modulators|mesh-ancestor
64970716|NCT00412789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970717|NCT00048828|Olanzapine|olanzapine|mesh-list
64970718|NCT00048828|Clozapine|clozapine|mesh-list
64970719|NCT00048828|Antiemetics|antiemetics|mesh-ancestor
64970720|NCT00048828|Autonomic Agents|autonomic agents|mesh-ancestor
64970723|NCT00048828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64970789|NCT00222079|Esomeprazole|esomeprazole|mesh-list
64970790|NCT00222079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64970791|NCT00222079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64970792|NCT00222079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64970793|NCT00222079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970794|NCT00222079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970795|NCT00222235|Cycloserine|cycloserine|mesh-list
64970796|NCT00222235|Glycine|glycine|mesh-list
64970797|NCT00222235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64970798|NCT00222235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64970799|NCT00222235|Renal Agents|renal agents|mesh-ancestor
64970800|NCT00222235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64970801|NCT00222235|Antitubercular Agents|antitubercular agents|mesh-ancestor
64970802|NCT00222235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64509502|NCT02987218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970803|NCT00222235|Antimetabolites|antimetabolites|mesh-ancestor
64970804|NCT00222235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970805|NCT00222235|Glycine Agents|glycine agents|mesh-ancestor
64970806|NCT00222235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970807|NCT00222235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970808|NCT00061646|Carboplatin|carboplatin|mesh-list
64970809|NCT00061646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970810|NCT00222469|Gemcitabine|gemcitabine|mesh-list
64970811|NCT00222469|Bevacizumab|bevacizumab|mesh-list
64970812|NCT00222469|Oxaliplatin|oxaliplatin|mesh-list
64970813|NCT00222469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64970814|NCT00222469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970821|NCT00222469|Antimetabolites|antimetabolites|mesh-ancestor
64970837|NCT00222547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64970852|NCT02968082|Autonomic Agents|autonomic agents|mesh-ancestor
64970853|NCT02968082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64970854|NCT02968082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970855|NCT02968082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64970856|NCT02968082|Mydriatics|mydriatics|mesh-ancestor
64970857|NCT02968082|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64970890|NCT00222976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64970891|NCT00222976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970892|NCT00222976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970894|NCT00223015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64970895|NCT00223015|Immunologic Factors|immunologic factors|mesh-ancestor
64970896|NCT00223015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970897|NCT00223015|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64970898|NCT00223015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971013|NCT00223717|Prazosin|prazosin|mesh-list
64971014|NCT00223717|Hydralazine|hydralazine|mesh-list
64971015|NCT00223717|Captopril|captopril|mesh-list
64971016|NCT00223717|Nifedipine|nifedipine|mesh-list
64971017|NCT00223717|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64971018|NCT00223717|Sildenafil Citrate|sildenafil citrate|mesh-list
64971173|NCT00224419|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64971174|NCT00224419|Autonomic Agents|autonomic agents|mesh-ancestor
64971175|NCT00224419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64971176|NCT00224419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971177|NCT00224419|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64971178|NCT00224419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64509878|NCT01451229|Protective Agents|protective agents|mesh-ancestor
64971377|NCT00095355|GABA Agents|gaba agents|mesh-ancestor
64971378|NCT00095355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64971544|NCT00225979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64971545|NCT00225979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971546|NCT02967731|Mometasone Furoate|mometasone furoate|mesh-list
64971547|NCT02967731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64510264|NCT04840641|Anesthetics|anesthetics|mesh-ancestor
64971548|NCT02967731|Dermatologic Agents|dermatologic agents|mesh-ancestor
64971549|NCT02967731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64971550|NCT00095745|Aripiprazole|aripiprazole|mesh-list
64971551|NCT00095745|Antidepressive Agents|antidepressive agents|mesh-list
64971580|NCT00226096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64971581|NCT00226096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64971582|NCT00226096|Sympatholytics|sympatholytics|mesh-ancestor
64971583|NCT00226096|Autonomic Agents|autonomic agents|mesh-ancestor
64971584|NCT00226096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64971698|NCT00095823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64510485|NCT05826964|Hormone Antagonists|hormone antagonists|mesh-ancestor
64971699|NCT00095823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64971700|NCT00095823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64971701|NCT00095823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64971702|NCT00226564|Alfentanil|alfentanil|mesh-list
64971703|NCT00226564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64971704|NCT00226564|Narcotics|narcotics|mesh-ancestor
64971736|NCT00226837|Nitrous Oxide|nitrous oxide|mesh-list
64971838|NCT00227656|Antimetabolites|antimetabolites|mesh-ancestor
64971839|NCT00227656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971840|NCT00227656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971841|NCT00227656|Antiviral Agents|antiviral agents|mesh-ancestor
64971842|NCT00227656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64971843|NCT00227656|Immunologic Factors|immunologic factors|mesh-ancestor
64971844|NCT00227656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971845|NCT00227695|Rituximab|rituximab|mesh-list
64972040|NCT00228397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64510785|NCT05824767|Giapreza|giapreza|mesh-list
64972041|NCT00228397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64972042|NCT00228397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64972043|NCT00228397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972044|NCT00228397|Antifungal Agents|antifungal agents|mesh-ancestor
64972045|NCT00228397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64972046|NCT00228397|Immunologic Factors|immunologic factors|mesh-ancestor
64972047|NCT00228397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972048|NCT00075543|Docetaxel|docetaxel|mesh-list
64972049|NCT00075543|Oxaliplatin|oxaliplatin|mesh-list
64972050|NCT00075543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972145|NCT02967653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972146|NCT00229333|Citalopram|citalopram|mesh-list
64972277|NCT00229996|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64972278|NCT00229996|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64972279|NCT00229996|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64972410|NCT00075738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511427|NCT05382338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511428|NCT05382338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64972551|NCT00231829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972552|NCT00231829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64972558|NCT00075933|Beta-lapachone|beta-lapachone|mesh-list
64972725|NCT00232687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64972726|NCT00232687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64972727|NCT00232687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64972728|NCT00232687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64972729|NCT00232687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972730|NCT00232687|Dopamine Agonists|dopamine agonists|mesh-ancestor
64972731|NCT00232687|Dopamine Agents|dopamine agents|mesh-ancestor
64972749|NCT00232765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972750|NCT02958566|Acetaminophen|acetaminophen|mesh-list
64972751|NCT02958566|Ketorolac|ketorolac|mesh-list
64972752|NCT02958566|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64972753|NCT02958566|Lidocaine|lidocaine|mesh-list
64972754|NCT02958566|Fentanyl|fentanyl|mesh-list
64972755|NCT02958566|Ketamine|ketamine|mesh-list
64972756|NCT02958566|Morphine|morphine|mesh-list
64972757|NCT02958566|Gabapentin|gabapentin|mesh-list
64972758|NCT02958566|Tramadol|tramadol|mesh-list
64972759|NCT02958566|Methadone|methadone|mesh-list
64972760|NCT02958566|Hydrocodone|hydrocodone|mesh-list
64972761|NCT02958566|Hydromorphone|hydromorphone|mesh-list
64972762|NCT02958566|Orphenadrine|orphenadrine|mesh-list
64972763|NCT02958566|Bupivacaine|bupivacaine|mesh-list
64972764|NCT02958566|Anesthetics, Local|anesthetics, local|mesh-ancestor
64972861|NCT00413686|Gemcitabine|gemcitabine|mesh-list
64972997|NCT00233818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972998|NCT00233818|Antifungal Agents|antifungal agents|mesh-ancestor
64973131|NCT00234637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64973132|NCT00234637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973296|NCT00235729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64973406|NCT00236587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64973407|NCT00236587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64973408|NCT00236587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64973409|NCT00236587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64973410|NCT00236587|Dopamine Agents|dopamine agents|mesh-ancestor
64973411|NCT00236626|Topiramate|topiramate|mesh-list
64973412|NCT00236626|Anticonvulsants|anticonvulsants|mesh-ancestor
64973696|NCT00237913|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64973697|NCT00237913|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64973698|NCT00237952|Chelating Agents|chelating agents|mesh-list
64973699|NCT00237952|Sequestering Agents|sequestering agents|mesh-ancestor
64973701|NCT00098241|Everolimus|everolimus|mesh-list
64973865|NCT00239083|Mycophenolic Acid|mycophenolic acid|mesh-list
64973866|NCT00239083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64973872|NCT00239083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973977|NCT00239434|Parasympatholytics|parasympatholytics|mesh-ancestor
64974037|NCT00239707|Incretins|incretins|mesh-ancestor
64974153|NCT00240409|Hormone Antagonists|hormone antagonists|mesh-ancestor
64974154|NCT00240409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64974155|NCT00240448|Valsartan|valsartan|mesh-list
64974171|NCT00098631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974172|NCT00240604|Rosiglitazone|rosiglitazone|mesh-list
64974249|NCT00241111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974250|NCT00241150|Valsartan|valsartan|mesh-list
64974251|NCT00241150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64974289|NCT00066248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64974290|NCT00066248|Serotonin Agents|serotonin agents|mesh-ancestor
64974291|NCT00066248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64974292|NCT00241189|Sirolimus|sirolimus|mesh-list
64974293|NCT00241189|Methotrexate|methotrexate|mesh-list
64974295|NCT00241189|Abortifacient Agents|abortifacient agents|mesh-ancestor
64974450|NCT02962024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64974451|NCT02962024|Narcotics|narcotics|mesh-ancestor
64974452|NCT02962024|Analgesics|analgesics|mesh-ancestor
64974453|NCT00066638|Romidepsin|romidepsin|mesh-list
64974454|NCT00066638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64974455|NCT00066638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974456|NCT00242203|Zoledronic Acid|zoledronic acid|mesh-list
64974485|NCT00242359|Omalizumab|omalizumab|mesh-list
64974601|NCT00099216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974602|NCT00099216|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64974603|NCT00099216|Protective Agents|protective agents|mesh-ancestor
64974604|NCT00066989|Immunoglobulins|immunoglobulins|mesh-list
64974620|NCT00243256|Cholecalciferol|cholecalciferol|mesh-list
64974621|NCT00243256|Vitamin D|vitamin d|mesh-list
64974622|NCT00243256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64974623|NCT00243256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974624|NCT00243256|Vitamins|vitamins|mesh-ancestor
64974625|NCT00243256|Micronutrients|micronutrients|mesh-ancestor
64974789|NCT00067262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64974790|NCT00067262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974791|NCT00067262|Antimanic Agents|antimanic agents|mesh-ancestor
64974926|NCT00245674|Amisulpride|amisulpride|mesh-list
64974927|NCT00245674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64974928|NCT00245674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64974929|NCT00245674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64974930|NCT00245674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974931|NCT00245674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64974932|NCT00245674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64974933|NCT00245674|Dopamine Agents|dopamine agents|mesh-ancestor
64975107|NCT00424801|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64975108|NCT00424801|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64975109|NCT00424801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64975110|NCT00424801|Adrenergic Agents|adrenergic agents|mesh-ancestor
64975111|NCT00424801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64975147|NCT00246610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64975148|NCT00246610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64975149|NCT00246610|Antiviral Agents|antiviral agents|mesh-ancestor
64975150|NCT00246610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64975151|NCT00246688|Sagopilone|sagopilone|mesh-list
64975152|NCT00246688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975153|NCT04728516|Amoxicillin|amoxicillin|mesh-list
64975154|NCT04728516|Pantoprazole|pantoprazole|mesh-list
64975155|NCT04728516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64975156|NCT04728516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64975157|NCT04728516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64975158|NCT04728516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64975255|NCT00099684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64975256|NCT00067730|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
64975257|NCT00067730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64975258|NCT00248053|Curcumin|curcumin|mesh-list
64975259|NCT00248053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64975260|NCT00248053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64975261|NCT00248053|Analgesics|analgesics|mesh-ancestor
64975262|NCT00248053|Sensory System Agents|sensory system agents|mesh-ancestor
64975263|NCT00248053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64975264|NCT00248053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975265|NCT00248053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64975266|NCT00248053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64975267|NCT00248053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975268|NCT00248053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975269|NCT00248053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975270|NCT00248092|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64975277|NCT00248092|Dopamine Agents|dopamine agents|mesh-ancestor
64975298|NCT00248248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64975299|NCT00248248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64975300|NCT00248248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975301|NCT00248248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64975302|NCT00248248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64975303|NCT00248248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975304|NCT00248248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975309|NCT00248482|Cisplatin|cisplatin|mesh-list
64975349|NCT00249145|Serotonin Agents|serotonin agents|mesh-ancestor
64975350|NCT00249145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64975351|NCT00249145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975352|NCT00249145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975353|NCT00249145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64975358|NCT00249145|Dopamine Agents|dopamine agents|mesh-ancestor
64975513|NCT04720573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64975514|NCT04720573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975515|NCT04720573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64975516|NCT04720573|Autonomic Agents|autonomic agents|mesh-ancestor
64975517|NCT04720573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64975902|NCT00251953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64975903|NCT00251953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976089|NCT00253552|Cyclophosphamide|cyclophosphamide|mesh-list
64976090|NCT00253552|Busulfan|busulfan|mesh-list
64976091|NCT00253552|Methotrexate|methotrexate|mesh-list
64976092|NCT00253552|Etoposide|etoposide|mesh-list
64976093|NCT00253552|Cyclosporins|cyclosporins|mesh-list
64976094|NCT00253552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64976161|NCT00254137|Irinotecan|irinotecan|mesh-list
64976310|NCT00255268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64976311|NCT00255268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976313|NCT00104442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64976314|NCT00104442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976405|NCT00100581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64976406|NCT00100581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64976407|NCT00100581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64976411|NCT00100581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64976453|NCT00070187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64976472|NCT00415285|Docetaxel|docetaxel|mesh-list
64976608|NCT00256828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64976609|NCT00256828|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64976610|NCT00256828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64976769|NCT00257569|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64976902|NCT00101088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64976903|NCT00101088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977068|NCT00105105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977069|NCT00105105|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64977070|NCT00105105|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64977071|NCT00105105|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64977072|NCT00105105|Contraceptive Agents|contraceptive agents|mesh-ancestor
64977073|NCT00105105|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64977074|NCT00105105|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64977075|NCT00105105|Hormone Antagonists|hormone antagonists|mesh-ancestor
64977076|NCT00105105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64977077|NCT00105105|Luteolytic Agents|luteolytic agents|mesh-ancestor
64977222|NCT00261352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64977223|NCT00261352|Antimetabolites|antimetabolites|mesh-ancestor
64977224|NCT00261352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977225|NCT00261352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64977226|NCT00261391|Marimastat|marimastat|mesh-list
64977227|NCT00261391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977228|NCT00261391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977229|NCT00071942|Metronidazole|metronidazole|mesh-list
64977230|NCT00071942|Vaccines|vaccines|mesh-list
64977231|NCT00071942|Immunologic Factors|immunologic factors|mesh-ancestor
64977232|NCT00071942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977233|NCT00071942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64977234|NCT00071942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64977235|NCT00071942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64977236|NCT00071942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64977237|NCT00261469|Topiramate|topiramate|mesh-list
64977265|NCT00261586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64977266|NCT00261586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64977267|NCT00261586|Analgesics|analgesics|mesh-ancestor
64977268|NCT00261586|Sensory System Agents|sensory system agents|mesh-ancestor
64977269|NCT00261586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64977270|NCT00261586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977271|NCT00261586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64977272|NCT00261586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64977273|NCT00261586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64977274|NCT00261586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64977275|NCT00261586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977318|NCT00261820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977486|NCT00262561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64977487|NCT00262561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977690|NCT00264628|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64977691|NCT00264628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64977692|NCT00264628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977693|NCT00264901|Insulin Detemir|insulin detemir|mesh-list
64977694|NCT00264901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64977695|NCT00264901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977696|NCT00265018|Doxorubicin|doxorubicin|mesh-list
64977748|NCT00265408|Warfarin|warfarin|mesh-list
64977849|NCT00102141|Diuretics|diuretics|mesh-ancestor
64977902|NCT01349569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977903|NCT01349569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64978037|NCT00268216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64978038|NCT00268216|Autonomic Agents|autonomic agents|mesh-ancestor
64978039|NCT00268216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64978040|NCT00268216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978148|NCT00268411|Antimetabolites|antimetabolites|mesh-ancestor
64978149|NCT00268411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978150|NCT00268411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978151|NCT00268411|Antiviral Agents|antiviral agents|mesh-ancestor
64978152|NCT00268411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64978153|NCT00268411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978154|NCT00268411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64978187|NCT00268528|Antimetabolites|antimetabolites|mesh-ancestor
64978371|NCT00269542|Trace Elements|trace elements|mesh-ancestor
64978424|NCT00416221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64978425|NCT00416221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978426|NCT00416221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64978427|NCT00416221|Serotonin Agents|serotonin agents|mesh-ancestor
64978428|NCT00416221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978429|NCT00416221|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64978612|NCT00074438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978613|NCT00074438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64978812|NCT00272701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978934|NCT00273481|Maleic acid|maleic acid|mesh-list
64978935|NCT00273481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978936|NCT00273481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978937|NCT00273481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64334610|NCT03159741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64334611|NCT03159741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64334612|NCT03159741|Hormones|hormones|mesh-ancestor
64334613|NCT03159741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64979049|NCT00108186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64979050|NCT00108186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64979051|NCT00108186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979052|NCT00108186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979053|NCT00274339|Lansoprazole|lansoprazole|mesh-list
64979054|NCT00274339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64979055|NCT00274339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64979056|NCT00274339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64979187|NCT00108420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979188|NCT00108420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979189|NCT00075413|Arsenic Trioxide|arsenic trioxide|mesh-list
64979190|NCT00075413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979191|NCT00277342|Insulin|insulin|mesh-list
64979192|NCT00277342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64979193|NCT00277342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979194|NCT00277498|Timolol|timolol|mesh-list
64979195|NCT00277498|Latanoprost|latanoprost|mesh-list
64979196|NCT00277498|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64979197|NCT00277498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64979242|NCT00075452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979243|NCT00108537|Bupropion|bupropion|mesh-list
64979244|NCT00108537|Nicotine|nicotine|mesh-list
64979245|NCT00108537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64979328|NCT00278122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979329|NCT00075647|Sirolimus|sirolimus|mesh-list
64979337|NCT00075647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979338|NCT00278278|Prednisone|prednisone|mesh-list
64979339|NCT00278278|Methotrexate|methotrexate|mesh-list
64979340|NCT00278278|Etoposide|etoposide|mesh-list
64979341|NCT00278278|Vincristine|vincristine|mesh-list
64979342|NCT00278278|Ifosfamide|ifosfamide|mesh-list
64979343|NCT00278278|Lomustine|lomustine|mesh-list
64979344|NCT00278278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979507|NCT00279565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979508|NCT00279565|Immunologic Factors|immunologic factors|mesh-ancestor
64979509|NCT00279565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979792|NCT00416923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64979793|NCT00416923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979794|NCT00416923|Immunologic Factors|immunologic factors|mesh-ancestor
64979948|NCT00110058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64979949|NCT00110058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64979950|NCT00110058|Antitubercular Agents|antitubercular agents|mesh-ancestor
64979951|NCT00110058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64979952|NCT00110058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64979954|NCT00281944|Fluorouracil|fluorouracil|mesh-list
64979955|NCT00281944|Oxaliplatin|oxaliplatin|mesh-list
64979956|NCT00281944|Calcium|calcium|mesh-list
64980182|NCT00283621|Alkylating Agents|alkylating agents|mesh-ancestor
64980183|NCT00283621|Hematinics|hematinics|mesh-ancestor
64980184|NCT00283660|Zinc Oxide|zinc oxide|mesh-list
64980185|NCT00283660|Dermatologic Agents|dermatologic agents|mesh-ancestor
64980186|NCT00283660|Sunscreening Agents|sunscreening agents|mesh-ancestor
64980187|NCT00283660|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64980383|NCT00285181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980384|NCT00285181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64980547|NCT00286351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980548|NCT00286351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64980549|NCT00286351|Hormone Antagonists|hormone antagonists|mesh-ancestor
64980550|NCT00286351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64980551|NCT00286351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980552|NCT00110955|Darbepoetin alfa|darbepoetin alfa|mesh-list
64980553|NCT00110955|Hematinics|hematinics|mesh-ancestor
64980554|NCT00286585|Propofol|propofol|mesh-list
64980555|NCT00286585|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
64980556|NCT00286585|Anesthetics|anesthetics|mesh-list
64980557|NCT00286585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64980558|NCT00286585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64980559|NCT00286585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980560|NCT00286585|Anesthetics, General|anesthetics, general|mesh-ancestor
64980561|NCT00111072|Dexamethasone|dexamethasone|mesh-list
64980562|NCT00111072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64980563|NCT00111072|Antiemetics|antiemetics|mesh-ancestor
64980564|NCT00111072|Autonomic Agents|autonomic agents|mesh-ancestor
64980639|NCT00417430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64980640|NCT00417430|Hormone Antagonists|hormone antagonists|mesh-ancestor
64980641|NCT00417430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64980642|NCT00417430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980643|NCT00077753|Enoxaparin|enoxaparin|mesh-list
64980644|NCT00077753|Enoxaparin sodium|enoxaparin sodium|mesh-list
64980645|NCT00077753|Anticoagulants|anticoagulants|mesh-ancestor
64980646|NCT00077753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64980647|NCT00077753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64980851|NCT00287950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980852|NCT00287950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64980853|NCT00287950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64980854|NCT00287950|Alkylating Agents|alkylating agents|mesh-ancestor
64980855|NCT00287950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980856|NCT00287950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981114|NCT00290641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981115|NCT00290641|Antifungal Agents|antifungal agents|mesh-ancestor
64981116|NCT00290641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64981117|NCT00290641|Dermatologic Agents|dermatologic agents|mesh-ancestor
64981143|NCT02960815|Interferon Inducers|interferon inducers|mesh-ancestor
64981144|NCT00112281|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
64981256|NCT00291616|Interferon alpha-2|interferon alpha-2|mesh-list
64981257|NCT00291616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64981395|NCT00275080|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64981396|NCT00078962|Gemcitabine|gemcitabine|mesh-list
64981397|NCT00078962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64981398|NCT00078962|Antimetabolites|antimetabolites|mesh-ancestor
64981447|NCT00102765|Glucocorticoids|glucocorticoids|mesh-ancestor
64981603|NCT00130156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64981604|NCT00130156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64981605|NCT00130156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64982054|NCT00300079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982055|NCT00300118|Budesonide|budesonide|mesh-list
64982056|NCT00300118|Mesalamine|mesalamine|mesh-list
64982257|NCT00301405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982258|NCT00301405|Leprostatic Agents|leprostatic agents|mesh-ancestor
64982259|NCT00301405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64982260|NCT00301405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64982328|NCT00086736|Bicalutamide|bicalutamide|mesh-list
64982497|NCT00120081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982498|NCT00120081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64982499|NCT00201994|Tolvaptan|tolvaptan|mesh-list
64982500|NCT00201994|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64982502|NCT00201994|Natriuretic Agents|natriuretic agents|mesh-ancestor
64982673|NCT00301912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64982674|NCT00301951|Mycophenolic Acid|mycophenolic acid|mesh-list
64982675|NCT00301951|Fludarabine|fludarabine|mesh-list
64982676|NCT00301951|Fludarabine phosphate|fludarabine phosphate|mesh-list
64982677|NCT00301951|Busulfan|busulfan|mesh-list
64982678|NCT00301951|Tacrolimus|tacrolimus|mesh-list
64982679|NCT00301951|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64982680|NCT00301951|Sargramostim|sargramostim|mesh-list
64982681|NCT00301951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982754|NCT00302341|Antimalarials|antimalarials|mesh-ancestor
64982755|NCT00302341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64982756|NCT00302341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64982757|NCT00302341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64982758|NCT00302341|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64982882|NCT00302692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64982883|NCT00302692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64982884|NCT00302692|Sympatholytics|sympatholytics|mesh-ancestor
64982885|NCT00302692|Autonomic Agents|autonomic agents|mesh-ancestor
64982906|NCT00303004|Bosentan|bosentan|mesh-list
64982938|NCT00087399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64982939|NCT00087399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64982940|NCT00087399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64982941|NCT00087399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64982942|NCT00087399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64982943|NCT00087399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64982944|NCT00087399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64982945|NCT00087399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982947|NCT00081614|Bevacizumab|bevacizumab|mesh-list
64982948|NCT00081614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64982949|NCT00081614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64982950|NCT00081614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983041|NCT00120432|Respiratory System Agents|respiratory system agents|mesh-ancestor
64983042|NCT00120432|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64983043|NCT00120432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64983044|NCT00120432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64983045|NCT00120432|Adrenergic Agents|adrenergic agents|mesh-ancestor
64983046|NCT00120432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64983047|NCT00120432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983048|NCT00120432|Protective Agents|protective agents|mesh-ancestor
64983049|NCT00120432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64983264|NCT00304993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983265|NCT00304993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64983266|NCT00304993|Vasodilator Agents|vasodilator agents|mesh-ancestor
64983267|NCT00304993|Vitamin B Complex|vitamin b complex|mesh-ancestor
64983268|NCT00304993|Vitamins|vitamins|mesh-ancestor
64983269|NCT00304993|Micronutrients|micronutrients|mesh-ancestor
64983270|NCT00082277|Risedronic Acid|risedronic acid|mesh-list
64983271|NCT00082277|Anastrozole|anastrozole|mesh-list
64983272|NCT00082277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64983273|NCT00082277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983274|NCT00082277|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64983275|NCT00082277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64983276|NCT00082277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983277|NCT00082277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983278|NCT00082277|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64983279|NCT00082277|Hormone Antagonists|hormone antagonists|mesh-ancestor
64983280|NCT00082277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64983372|NCT00087867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983373|NCT00305812|Dexamethasone|dexamethasone|mesh-list
64983374|NCT00305812|Lenalidomide|lenalidomide|mesh-list
64983375|NCT00305812|Melphalan|melphalan|mesh-list
64983376|NCT00305812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64983377|NCT00305812|Antiemetics|antiemetics|mesh-ancestor
64983378|NCT00305812|Autonomic Agents|autonomic agents|mesh-ancestor
64983379|NCT00305812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64983419|NCT00082589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64983420|NCT00313924|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64983421|NCT00313924|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64983422|NCT00313924|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64983423|NCT00313924|Cholinergic Agents|cholinergic agents|mesh-ancestor
64983424|NCT00313924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64983425|NCT00313924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983426|NCT00313924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983427|NCT00313924|Urological Agents|urological agents|mesh-ancestor
64983428|NCT00306475|Valproic Acid|valproic acid|mesh-list
64983429|NCT00306475|Anticonvulsants|anticonvulsants|mesh-ancestor
64983430|NCT00306475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983431|NCT00306475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983432|NCT00306475|GABA Agents|gaba agents|mesh-ancestor
64983433|NCT00306475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64983571|NCT00307606|Prednisolone|prednisolone|mesh-list
64983599|NCT00307645|Azathioprine|azathioprine|mesh-list
64983600|NCT00307645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64983601|NCT00307645|Immunologic Factors|immunologic factors|mesh-ancestor
64983602|NCT00307645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983603|NCT00307645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64983604|NCT00307645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64983605|NCT00307645|Alkylating Agents|alkylating agents|mesh-ancestor
64983606|NCT00307645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983607|NCT00307645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983608|NCT00307645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64983609|NCT00307645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64983610|NCT00307645|Glucocorticoids|glucocorticoids|mesh-ancestor
64983611|NCT00307645|Hormones|hormones|mesh-ancestor
64983612|NCT00307645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64983613|NCT00307645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64983614|NCT00307645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64983615|NCT00307645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64983616|NCT00307645|Antitubercular Agents|antitubercular agents|mesh-ancestor
64983617|NCT00307645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64983618|NCT00307645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983619|NCT00307645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983620|NCT00307645|Antiemetics|antiemetics|mesh-ancestor
64983621|NCT00307645|Autonomic Agents|autonomic agents|mesh-ancestor
64983622|NCT00307645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64983623|NCT00307645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64983624|NCT00307645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64983625|NCT00307645|Protective Agents|protective agents|mesh-ancestor
64983626|NCT00307645|Antimetabolites|antimetabolites|mesh-ancestor
64983628|NCT00120783|Ritonavir|ritonavir|mesh-list
64983644|NCT00307723|Gemcitabine|gemcitabine|mesh-list
64983645|NCT00307723|Bevacizumab|bevacizumab|mesh-list
64983646|NCT00307723|Fluorouracil|fluorouracil|mesh-list
64983647|NCT00307723|Oxaliplatin|oxaliplatin|mesh-list
64983656|NCT00307723|Antimetabolites|antimetabolites|mesh-ancestor
64983657|NCT00307723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983658|NCT00307723|Antiviral Agents|antiviral agents|mesh-ancestor
64983659|NCT00307723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983660|NCT00307723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983661|NCT00307723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64983662|NCT00307723|Immunologic Factors|immunologic factors|mesh-ancestor
64983663|NCT00083135|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64983664|NCT00083135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983665|NCT00083135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983666|NCT00083135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983667|NCT00083135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64983669|NCT00120822|Hematinics|hematinics|mesh-ancestor
64983670|NCT00120822|Vitamin B Complex|vitamin b complex|mesh-ancestor
64983671|NCT00120822|Vitamins|vitamins|mesh-ancestor
64983672|NCT00120822|Micronutrients|micronutrients|mesh-ancestor
64983673|NCT00120822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983674|NCT00083213|Aflibercept|aflibercept|mesh-list
64983675|NCT00083213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64983692|NCT00418678|Antiemetics|antiemetics|mesh-ancestor
64983693|NCT00418678|Autonomic Agents|autonomic agents|mesh-ancestor
64983694|NCT00418678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64983695|NCT00418678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983696|NCT00418678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64983697|NCT00418678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64983698|NCT00418678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64983699|NCT00418678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64983700|NCT00418678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64983701|NCT00120861|Interferons|interferons|mesh-list
64983702|NCT00120861|Ribavirin|ribavirin|mesh-list
64983703|NCT00120861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983704|NCT00120861|Antiviral Agents|antiviral agents|mesh-ancestor
64983705|NCT00120861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983706|NCT00120861|Antimetabolites|antimetabolites|mesh-ancestor
64983707|NCT00120861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983708|NCT05446142|Rabeprazole|rabeprazole|mesh-list
64983709|NCT05446142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64983713|NCT05446142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983714|NCT00308191|Bromides|bromides|mesh-list
64983715|NCT00308191|Formoterol Fumarate|formoterol fumarate|mesh-list
64983716|NCT00308191|Tiotropium Bromide|tiotropium bromide|mesh-list
64983717|NCT00308191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64983718|NCT00308191|Autonomic Agents|autonomic agents|mesh-ancestor
64983719|NCT00308191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64983725|NCT00308191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64983740|NCT00308269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983741|NCT00308269|Tubulin Modulators|tubulin modulators|mesh-ancestor
64983742|NCT00308269|Antimitotic Agents|antimitotic agents|mesh-ancestor
64983743|NCT00308269|Mitosis Modulators|mitosis modulators|mesh-ancestor
64983744|NCT00308269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983745|NCT00308425|Mycophenolic Acid|mycophenolic acid|mesh-list
64983746|NCT00308425|Valsartan|valsartan|mesh-list
64983747|NCT00308425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64983748|NCT00308425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64983749|NCT00308425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64983750|NCT00308425|Antitubercular Agents|antitubercular agents|mesh-ancestor
64983751|NCT00308425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64983752|NCT00308425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64983753|NCT00308425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64983758|NCT00308503|SR 46349B|sr 46349b|mesh-list
64983801|NCT00308971|Vitamins|vitamins|mesh-ancestor
64983802|NCT00308971|Micronutrients|micronutrients|mesh-ancestor
64983803|NCT00308971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983804|NCT00308971|Antioxidants|antioxidants|mesh-ancestor
64983805|NCT00308971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64983864|NCT04727502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64983924|NCT00309478|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64983925|NCT00309478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64983926|NCT00309517|Leucovorin|leucovorin|mesh-list
64983927|NCT00309517|Edrecolomab|edrecolomab|mesh-list
64983928|NCT00309517|Antidotes|antidotes|mesh-ancestor
64983929|NCT00309517|Protective Agents|protective agents|mesh-ancestor
64983930|NCT00309517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64983931|NCT00309517|Vitamin B Complex|vitamin b complex|mesh-ancestor
64983932|NCT00309517|Vitamins|vitamins|mesh-ancestor
64983933|NCT00309517|Micronutrients|micronutrients|mesh-ancestor
64983934|NCT00309517|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64983935|NCT00309517|Immunologic Factors|immunologic factors|mesh-ancestor
64983936|NCT00121017|Ritonavir|ritonavir|mesh-list
64983937|NCT00121017|Lopinavir|lopinavir|mesh-list
64984048|NCT00310024|Vorinostat|vorinostat|mesh-list
64984049|NCT00310024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984050|NCT00310024|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64984051|NCT00310024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984052|NCT00310024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984053|NCT00310141|Nicotine|nicotine|mesh-list
64984054|NCT00310141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64984055|NCT00310141|Autonomic Agents|autonomic agents|mesh-ancestor
64984056|NCT00310141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64984057|NCT00310141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984058|NCT00310141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64984059|NCT00310141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64984060|NCT00310141|Cholinergic Agents|cholinergic agents|mesh-ancestor
64984061|NCT00310141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64984071|NCT00083681|Etoposide|etoposide|mesh-list
64984072|NCT00083681|Cyclophosphamide|cyclophosphamide|mesh-list
64984073|NCT00083681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64984074|NCT00083681|Antiemetics|antiemetics|mesh-ancestor
64984075|NCT00083681|Autonomic Agents|autonomic agents|mesh-ancestor
64984076|NCT00083681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64984077|NCT00083681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984078|NCT00083681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64984079|NCT00083681|Glucocorticoids|glucocorticoids|mesh-ancestor
64984080|NCT00083681|Hormones|hormones|mesh-ancestor
64984081|NCT00083681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64984082|NCT00083681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64984126|NCT00310336|Antimetabolites|antimetabolites|mesh-ancestor
64984127|NCT00310336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984128|NCT00310336|Immunologic Factors|immunologic factors|mesh-ancestor
64984129|NCT00310336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984130|NCT00310336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64984131|NCT00310336|Lipotropic Agents|lipotropic agents|mesh-ancestor
64984178|NCT00310843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64984179|NCT00310843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984195|NCT05568212|Durvalumab|durvalumab|mesh-list
64984351|NCT00121446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64984352|NCT00121446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64984353|NCT00311974|Dihydralazine|dihydralazine|mesh-list
64984354|NCT00311974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64984355|NCT00312013|Nadroparin|nadroparin|mesh-list
64984356|NCT00312013|Anticoagulants|anticoagulants|mesh-ancestor
64984357|NCT00312013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64984358|NCT00312013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64984359|NCT00312013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984360|NCT00121524|Atropine|atropine|mesh-list
64984361|NCT00121524|Amiodarone|amiodarone|mesh-list
64984362|NCT00121524|Epinephrine|epinephrine|mesh-list
64984363|NCT00121524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64984364|NCT00121524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64984402|NCT00089115|Immunoglobulins|immunoglobulins|mesh-list
64984486|NCT05567315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64984487|NCT00121563|Thalidomide|thalidomide|mesh-list
64984488|NCT00121563|Ibuprofen|ibuprofen|mesh-list
64984489|NCT00121563|Diazepam|diazepam|mesh-list
64984492|NCT00121563|Analgesics|analgesics|mesh-ancestor
64984497|NCT00121563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64984498|NCT00121563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64984499|NCT00121563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984500|NCT00121563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984501|NCT00121563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64984502|NCT00121563|Immunologic Factors|immunologic factors|mesh-ancestor
64984503|NCT00121563|Leprostatic Agents|leprostatic agents|mesh-ancestor
64984504|NCT00121563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64984505|NCT00121563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64984506|NCT00121563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64984507|NCT00121563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64984508|NCT00121563|Growth Substances|growth substances|mesh-ancestor
64984509|NCT00121563|Growth Inhibitors|growth inhibitors|mesh-ancestor
64984510|NCT00121563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984511|NCT00121563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64984512|NCT00121563|Anticonvulsants|anticonvulsants|mesh-ancestor
64984513|NCT00121563|Antiemetics|antiemetics|mesh-ancestor
64984514|NCT00121563|Autonomic Agents|autonomic agents|mesh-ancestor
64984515|NCT00121563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64984516|NCT00121563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64984517|NCT00121563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64984518|NCT00121563|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64984519|NCT00121563|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64984520|NCT00121563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64984521|NCT00121563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64984522|NCT00121563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64984523|NCT00121563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64984524|NCT00121563|Anesthetics, General|anesthetics, general|mesh-ancestor
64836775|NCT01615055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64836776|NCT01615055|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64836777|NCT01615055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64836778|NCT01615055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836780|NCT01615081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64836781|NCT01615081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836782|NCT01615107|Oxytocin|oxytocin|mesh-list
64984545|NCT00293371|Vatalanib|vatalanib|mesh-list
64984546|NCT00293371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984547|NCT00293371|Tubulin Modulators|tubulin modulators|mesh-ancestor
64984548|NCT00293371|Antimitotic Agents|antimitotic agents|mesh-ancestor
64984549|NCT00293371|Mitosis Modulators|mitosis modulators|mesh-ancestor
64984550|NCT00293371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984551|NCT00293371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64984552|NCT00293371|Glucocorticoids|glucocorticoids|mesh-ancestor
64984553|NCT00293371|Hormones|hormones|mesh-ancestor
64984554|NCT00293371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64984555|NCT00293371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984556|NCT00293371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64984557|NCT00293371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64984558|NCT00293371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984559|NCT00293410|Cyclophosphamide|cyclophosphamide|mesh-list
64984560|NCT00293410|Clofarabine|clofarabine|mesh-list
64984561|NCT00293410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64984562|NCT00293410|Immunologic Factors|immunologic factors|mesh-ancestor
64984563|NCT00293410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984584|NCT04711161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984585|NCT04711161|Tubulin Modulators|tubulin modulators|mesh-ancestor
64984586|NCT04711161|Antimitotic Agents|antimitotic agents|mesh-ancestor
64984587|NCT04711161|Mitosis Modulators|mitosis modulators|mesh-ancestor
64984588|NCT04711161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984589|NCT00293644|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
64984590|NCT00293644|Antiemetics|antiemetics|mesh-ancestor
64984591|NCT00293644|Autonomic Agents|autonomic agents|mesh-ancestor
64984592|NCT00293644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64984593|NCT00293644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984594|NCT00293644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64984595|NCT00293644|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64984596|NCT00293644|Histamine Antagonists|histamine antagonists|mesh-ancestor
64984597|NCT00293644|Histamine Agents|histamine agents|mesh-ancestor
64984598|NCT00293644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64984599|NCT00293644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984600|NCT00293761|Travoprost|travoprost|mesh-list
64984601|NCT00293761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64984602|NCT00293800|Timolol|timolol|mesh-list
64984603|NCT00293800|Travoprost|travoprost|mesh-list
64984604|NCT00293800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64984605|NCT00293800|Latanoprost|latanoprost|mesh-list
64984606|NCT00293800|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64984607|NCT00293800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64984608|NCT00293800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64984609|NCT00293800|Adrenergic Agents|adrenergic agents|mesh-ancestor
64984610|NCT00293800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64984611|NCT00293800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984612|NCT00293800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984615|NCT00423969|Galantamine|galantamine|mesh-list
64984618|NCT00423969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64984619|NCT00423969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64984620|NCT00423969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984621|NCT00423969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64984622|NCT00423969|Serotonin Agents|serotonin agents|mesh-ancestor
64984623|NCT00423969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984624|NCT00423969|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64984625|NCT00423969|Antidepressive Agents|antidepressive agents|mesh-ancestor
64984626|NCT00423969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64984627|NCT00423969|Autonomic Agents|autonomic agents|mesh-ancestor
64984628|NCT00423969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64984647|NCT00293917|Immunologic Factors|immunologic factors|mesh-ancestor
64984648|NCT00293917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984649|NCT00293917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64984650|NCT00293917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984651|NCT00293917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984652|NCT05567081|Triamcinolone|triamcinolone|mesh-list
64984653|NCT05567081|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64984654|NCT05567081|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64984655|NCT05567081|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64984656|NCT05567081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64984657|NCT05567081|Glucocorticoids|glucocorticoids|mesh-ancestor
64984658|NCT05567081|Hormones|hormones|mesh-ancestor
64984659|NCT05567081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64984660|NCT05567081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984665|NCT04710927|Fluorides|fluorides|mesh-list
64984705|NCT04706091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984767|NCT00089349|Abortifacient Agents|abortifacient agents|mesh-ancestor
64984768|NCT00089349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64984769|NCT00089349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64984770|NCT00089349|Antimetabolites|antimetabolites|mesh-ancestor
64984771|NCT00089349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984772|NCT00089349|Dermatologic Agents|dermatologic agents|mesh-ancestor
64984773|NCT00089349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984774|NCT00089349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64984775|NCT00089349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64984776|NCT00089349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64984777|NCT00089349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64984778|NCT00294580|Maloprim|maloprim|mesh-list
64984779|NCT00294580|Antimalarials|antimalarials|mesh-ancestor
64984780|NCT00294580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64984781|NCT00294580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64984782|NCT00294580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64984783|NCT00294619|Hormones|hormones|mesh-list
64984784|NCT00294619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64984785|NCT00294619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984786|NCT00294736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64984787|NCT00294736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984788|NCT00294736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64984789|NCT00294736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984791|NCT00294775|Candesartan|candesartan|mesh-list
64984809|NCT00294892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984810|NCT00294892|Antiviral Agents|antiviral agents|mesh-ancestor
64984811|NCT00294892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64984812|NCT00294892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64984813|NCT00294892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64984814|NCT00294892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64984815|NCT00294892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64984816|NCT00294892|Anticonvulsants|anticonvulsants|mesh-ancestor
64984817|NCT00294892|Antimanic Agents|antimanic agents|mesh-ancestor
64984818|NCT00294892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64836783|NCT01615107|Oxytocics|oxytocics|mesh-ancestor
64836784|NCT01615107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64836815|NCT01615224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64836816|NCT01615224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836817|NCT01615224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64836818|NCT01615224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64984819|NCT00294892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64984820|NCT00294892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984821|NCT00294892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64984822|NCT00294892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64984823|NCT00294892|Analgesics|analgesics|mesh-ancestor
64984824|NCT00294892|Sensory System Agents|sensory system agents|mesh-ancestor
64984825|NCT00294892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64984826|NCT00294892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64984827|NCT00294892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64984828|NCT00089427|Temozolomide|temozolomide|mesh-list
64984829|NCT00089427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64984830|NCT00089427|Alkylating Agents|alkylating agents|mesh-ancestor
64984831|NCT00089427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984832|NCT00089427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984833|NCT00294931|Bevacizumab|bevacizumab|mesh-list
64984834|NCT00294931|Carboplatin|carboplatin|mesh-list
64984835|NCT00294931|Irinotecan|irinotecan|mesh-list
64984836|NCT00294931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64984837|NCT00294931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64984838|NCT00294931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64984873|NCT00089622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64984874|NCT00089622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984875|NCT00089622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984876|NCT00089622|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64984886|NCT00295555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984887|NCT00295555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984888|NCT00295594|Tacrolimus|tacrolimus|mesh-list
64984889|NCT00295594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64984890|NCT00295594|Immunologic Factors|immunologic factors|mesh-ancestor
64984891|NCT00295594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984892|NCT00295594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64984893|NCT00295594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64984894|NCT00295594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64984895|NCT00121875|Hormones|hormones|mesh-list
64984896|NCT00121875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64984898|NCT00295672|Vinorelbine|vinorelbine|mesh-list
64984949|NCT00121914|Ethanol|ethanol|mesh-list
64984950|NCT00121914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64984951|NCT00121914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64984952|NCT00121914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64984953|NCT00121914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984954|NCT00295984|Nicotine|nicotine|mesh-list
64984955|NCT00295984|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64984956|NCT00295984|Autonomic Agents|autonomic agents|mesh-ancestor
64984957|NCT00295984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64984958|NCT00295984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64984959|NCT00295984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64984960|NCT00295984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64984961|NCT00295984|Cholinergic Agents|cholinergic agents|mesh-ancestor
64985012|NCT00296179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64985013|NCT00296179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985014|NCT00296179|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64985015|NCT00296179|GABA Agonists|gaba agonists|mesh-ancestor
64985016|NCT00296179|GABA Agents|gaba agents|mesh-ancestor
64985017|NCT00296179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64985018|NCT00296179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985019|NCT00296218|Irbesartan|irbesartan|mesh-list
64985020|NCT00296218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64985021|NCT00296218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64985022|NCT00296218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64985023|NCT00296218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985024|NCT00089856|Prednisone|prednisone|mesh-list
64985025|NCT00089856|Docetaxel|docetaxel|mesh-list
64985026|NCT00089856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64985027|NCT00089856|Glucocorticoids|glucocorticoids|mesh-ancestor
64985028|NCT00089856|Hormones|hormones|mesh-ancestor
64985029|NCT00089856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64985030|NCT00089856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985065|NCT00296530|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64985066|NCT00296530|Glucocorticoids|glucocorticoids|mesh-ancestor
64985067|NCT00296530|Hormones|hormones|mesh-ancestor
64985068|NCT00296530|Sympathomimetics|sympathomimetics|mesh-ancestor
64985069|NCT00090012|Olanzapine|olanzapine|mesh-list
64985070|NCT00090012|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64985071|NCT00090012|Antiemetics|antiemetics|mesh-ancestor
64985072|NCT00090012|Autonomic Agents|autonomic agents|mesh-ancestor
64985073|NCT00090012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64985074|NCT00090012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985075|NCT00090012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64985076|NCT00090012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64985077|NCT00090012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64985078|NCT00090012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64985079|NCT00090012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64985080|NCT00090012|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64985081|NCT00090012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64985084|NCT00090012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64985097|NCT00296608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64985098|NCT00296608|Immunologic Factors|immunologic factors|mesh-ancestor
64985099|NCT00296608|Antidotes|antidotes|mesh-ancestor
64985102|NCT00296608|Vitamins|vitamins|mesh-ancestor
64985107|NCT00296686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985108|NCT00296686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64985109|NCT00296686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64985110|NCT00296686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64985111|NCT00296686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985112|NCT00296686|Dopamine Agents|dopamine agents|mesh-ancestor
64985113|NCT00296686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64985114|NCT00296686|Antidepressive Agents|antidepressive agents|mesh-ancestor
64985115|NCT00296686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64985116|NCT00296686|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64985117|NCT00296686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985118|NCT00296686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64985119|NCT00296686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64985120|NCT00296686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64985121|NCT00122070|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64985122|NCT00122070|Antidepressive Agents|antidepressive agents|mesh-ancestor
64985123|NCT00122070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64985124|NCT00122070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64985125|NCT00122070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64985126|NCT00122070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64985127|NCT00122070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985128|NCT00296803|Clopidogrel|clopidogrel|mesh-list
64985129|NCT00296803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64985130|NCT00296803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64985131|NCT00296803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64985132|NCT00296803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64985133|NCT00296803|Purinergic Agents|purinergic agents|mesh-ancestor
64985134|NCT00296803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64985135|NCT00296803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985136|NCT00296803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985137|NCT00090090|Elsamicin A|elsamicin a|mesh-list
64836819|NCT01615224|Oxytocics|oxytocics|mesh-ancestor
64985147|NCT00297076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985148|NCT00297076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64985149|NCT00297076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64985150|NCT00297076|Antiviral Agents|antiviral agents|mesh-ancestor
64985151|NCT00297076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64985152|NCT00297349|Topiramate|topiramate|mesh-list
64985153|NCT00297349|Anticonvulsants|anticonvulsants|mesh-ancestor
64985154|NCT00297349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64985155|NCT00297349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985156|NCT00297388|Risperidone|risperidone|mesh-list
64985157|NCT00297388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64985159|NCT00297388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64985160|NCT00297388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985161|NCT00297388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985162|NCT00297388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64985163|NCT00297388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64985203|NCT00297661|Tubulin Modulators|tubulin modulators|mesh-ancestor
64985204|NCT00297661|Antimitotic Agents|antimitotic agents|mesh-ancestor
64985205|NCT00297661|Mitosis Modulators|mitosis modulators|mesh-ancestor
64985206|NCT00297661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985207|NCT00297661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64985208|NCT00297661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64985209|NCT00297661|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64985210|NCT00297661|Antifungal Agents|antifungal agents|mesh-ancestor
64985211|NCT00297661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64985212|NCT00297661|Immunologic Factors|immunologic factors|mesh-ancestor
64985213|NCT00297661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985214|NCT00090207|Ondansetron|ondansetron|mesh-list
64985215|NCT00090207|Aprepitant|aprepitant|mesh-list
64985216|NCT00090207|Antiemetics|antiemetics|mesh-ancestor
64985217|NCT00090207|Autonomic Agents|autonomic agents|mesh-ancestor
64985218|NCT00090207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64985219|NCT00090207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836820|NCT01615289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64836821|NCT01615354|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64836822|NCT01615354|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
64836823|NCT01615354|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64836824|NCT01615354|Contraceptive Agents|contraceptive agents|mesh-ancestor
64836825|NCT01615354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64836826|NCT01615354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985220|NCT00090207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64985221|NCT00090207|Antipruritics|antipruritics|mesh-ancestor
64985222|NCT00090207|Dermatologic Agents|dermatologic agents|mesh-ancestor
64985223|NCT00090207|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64985224|NCT00090207|Serotonin Agents|serotonin agents|mesh-ancestor
64985225|NCT00090207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64985226|NCT00090207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985227|NCT00090207|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64985228|NCT00090207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64985229|NCT00090207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64985230|NCT00090207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64985231|NCT00090207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64985232|NCT00090207|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64985234|NCT00297739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64985249|NCT00090246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64985250|NCT00090246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985251|NCT00090246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64985252|NCT00090246|Antipruritics|antipruritics|mesh-ancestor
64985253|NCT00090246|Dermatologic Agents|dermatologic agents|mesh-ancestor
64985254|NCT00090246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64985255|NCT00090246|Serotonin Agents|serotonin agents|mesh-ancestor
64985256|NCT00090246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64985257|NCT00090246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985258|NCT00090246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64985259|NCT00090246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64985260|NCT00090246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64985261|NCT00090246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64985262|NCT00090246|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64985263|NCT00090246|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64985264|NCT00297817|Vaccines|vaccines|mesh-list
64985265|NCT00297817|Immunologic Factors|immunologic factors|mesh-ancestor
64985267|NCT00090324|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64985305|NCT00298012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985306|NCT00298012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64985307|NCT00298012|Antimetabolites|antimetabolites|mesh-ancestor
64985308|NCT00298012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985309|NCT00298012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985310|NCT00298012|Dermatologic Agents|dermatologic agents|mesh-ancestor
64985311|NCT00298012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985312|NCT00298012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64985313|NCT00298012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64985314|NCT00298012|Immunologic Factors|immunologic factors|mesh-ancestor
64985315|NCT00298012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64985316|NCT00298012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64985317|NCT00298168|polysaccharide-K|polysaccharide-k|mesh-list
64985318|NCT00298168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64985319|NCT00298168|Immunologic Factors|immunologic factors|mesh-ancestor
64985320|NCT00298168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985321|NCT00298168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64985322|NCT00298168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985347|NCT00322543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985348|NCT00313963|Magnesium Sulfate|magnesium sulfate|mesh-list
64985349|NCT00313963|Analgesics|analgesics|mesh-ancestor
64985350|NCT00313963|Sensory System Agents|sensory system agents|mesh-ancestor
64985351|NCT00313963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64985353|NCT00313963|Anesthetics|anesthetics|mesh-ancestor
64985426|NCT00323011|Irinotecan|irinotecan|mesh-list
64985427|NCT00323011|Dalteparin|dalteparin|mesh-list
64985428|NCT00323011|Levoleucovorin|levoleucovorin|mesh-list
64985429|NCT00323011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64985430|NCT00323011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985461|NCT00323206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985462|NCT04717531|Cyclophosphamide|cyclophosphamide|mesh-list
64985463|NCT04717531|Docetaxel|docetaxel|mesh-list
64985464|NCT04717531|Trastuzumab|trastuzumab|mesh-list
64985465|NCT04717531|Epirubicin|epirubicin|mesh-list
64985466|NCT04717531|Pertuzumab|pertuzumab|mesh-list
64985467|NCT04717531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64985468|NCT04717531|Immunologic Factors|immunologic factors|mesh-ancestor
64985469|NCT04717531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985470|NCT04717531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64985471|NCT04717531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64985472|NCT04717531|Alkylating Agents|alkylating agents|mesh-ancestor
64985473|NCT04717531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985474|NCT04717531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985475|NCT04717531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64985476|NCT04717531|Tubulin Modulators|tubulin modulators|mesh-ancestor
64985477|NCT04717531|Antimitotic Agents|antimitotic agents|mesh-ancestor
64985478|NCT04717531|Mitosis Modulators|mitosis modulators|mesh-ancestor
64985518|NCT00122499|Urological Agents|urological agents|mesh-ancestor
64985519|NCT00312598|Aripiprazole|aripiprazole|mesh-list
64985520|NCT00312598|Antidepressive Agents|antidepressive agents|mesh-ancestor
64985521|NCT00312598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64985522|NCT00312598|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64985523|NCT00312598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64985524|NCT00312598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64985525|NCT00312598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985526|NCT00312598|Dopamine Agonists|dopamine agonists|mesh-ancestor
64985527|NCT00312598|Dopamine Agents|dopamine agents|mesh-ancestor
64985528|NCT00312598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64985531|NCT00312598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64985576|NCT00122538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64985577|NCT00122538|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64985578|NCT00122538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64985579|NCT00122538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64985580|NCT00122538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64985581|NCT00122538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64985582|NCT00122538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64985583|NCT00122538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64985584|NCT00122538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64985585|NCT00122538|Antimetabolites|antimetabolites|mesh-ancestor
64985586|NCT00313105|Lobeline|lobeline|mesh-list
64985587|NCT00313105|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64985588|NCT00313105|Autonomic Agents|autonomic agents|mesh-ancestor
64985589|NCT00313105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64985590|NCT00313105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985591|NCT00313105|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64985592|NCT00313105|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64985593|NCT00313105|Cholinergic Agents|cholinergic agents|mesh-ancestor
64985594|NCT00313105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64985595|NCT00313105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985596|NCT00313105|Respiratory System Agents|respiratory system agents|mesh-ancestor
64985597|NCT00313183|Pramlintide|pramlintide|mesh-list
64985598|NCT00313183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64985599|NCT00313183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985600|NCT00122577|Ritonavir|ritonavir|mesh-list
64985601|NCT00122577|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64985602|NCT00122577|Tenofovir|tenofovir|mesh-list
64985603|NCT00122577|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64985605|NCT00122577|Protease Inhibitors|protease inhibitors|mesh-ancestor
64985615|NCT00122577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64985617|NCT00313261|Antiviral Agents|antiviral agents|mesh-ancestor
64985618|NCT00313261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64985619|NCT00425074|Aspirin|aspirin|mesh-list
64985620|NCT00425074|Salicylic Acid|salicylic acid|mesh-list
64985621|NCT00425074|Salicylates|salicylates|mesh-list
64985622|NCT00425074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64985623|NCT00425074|Antifungal Agents|antifungal agents|mesh-ancestor
64836827|NCT01615354|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64985624|NCT00425074|Keratolytic Agents|keratolytic agents|mesh-ancestor
64985625|NCT00425074|Dermatologic Agents|dermatologic agents|mesh-ancestor
64985626|NCT00425074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64985627|NCT00425074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64985628|NCT00425074|Analgesics|analgesics|mesh-ancestor
64985629|NCT00425074|Sensory System Agents|sensory system agents|mesh-ancestor
64985630|NCT00425074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64985631|NCT00425074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985632|NCT00425074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64985633|NCT00425074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64985634|NCT00425074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64985635|NCT00425074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985636|NCT00425074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985637|NCT00425074|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64985670|NCT00122616|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64985671|NCT00122616|Antimetabolites|antimetabolites|mesh-ancestor
64985672|NCT00122616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985673|NCT00122616|Antiviral Agents|antiviral agents|mesh-ancestor
64985674|NCT00122616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64985676|NCT04984070|Drospirenone|drospirenone|mesh-list
64985677|NCT04984070|Contraceptive Agents|contraceptive agents|mesh-list
64985689|NCT04984070|Hormones|hormones|mesh-ancestor
64985728|NCT00314626|Antiviral Agents|antiviral agents|mesh-ancestor
64985729|NCT00314626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64985730|NCT00314626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64985731|NCT00314626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64985732|NCT00314626|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64985733|NCT00314626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64985734|NCT00314626|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64985735|NCT00314626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64985736|NCT00314626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64985737|NCT00314626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64985738|NCT00314665|Thalidomide|thalidomide|mesh-list
64985767|NCT00090909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64985768|NCT00090909|Antiemetics|antiemetics|mesh-ancestor
64985769|NCT00090909|Autonomic Agents|autonomic agents|mesh-ancestor
64985770|NCT00090909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64985771|NCT00090909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985772|NCT00090909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64985773|NCT00090909|Glucocorticoids|glucocorticoids|mesh-ancestor
64985774|NCT00090909|Hormones|hormones|mesh-ancestor
64985775|NCT00090909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64985776|NCT00090909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64985777|NCT00090909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985778|NCT00090909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64985779|NCT00090909|Antimetabolites|antimetabolites|mesh-ancestor
64985780|NCT00090909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985781|NCT00090909|Antiviral Agents|antiviral agents|mesh-ancestor
64985782|NCT00090909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64985783|NCT00090909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64985784|NCT00090909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64985785|NCT00090909|Immunologic Factors|immunologic factors|mesh-ancestor
64985786|NCT04943627|Gemcitabine|gemcitabine|mesh-list
64985787|NCT04943627|Irinotecan|irinotecan|mesh-list
64985788|NCT04943627|Pemetrexed|pemetrexed|mesh-list
64985789|NCT04943627|Topotecan|topotecan|mesh-list
64985790|NCT04943627|Vinorelbine|vinorelbine|mesh-list
64985791|NCT04943627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64985817|NCT00314743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64985818|NCT00314743|Glucocorticoids|glucocorticoids|mesh-ancestor
64985819|NCT00314743|Hormones|hormones|mesh-ancestor
64985820|NCT00314743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64985821|NCT00314743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64985822|NCT00314743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985823|NCT00314743|Antipruritics|antipruritics|mesh-ancestor
64985824|NCT00314743|Dermatologic Agents|dermatologic agents|mesh-ancestor
64985825|NCT00314743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64985826|NCT00314743|Serotonin Agents|serotonin agents|mesh-ancestor
64985827|NCT00314743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64985828|NCT00314743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985829|NCT00314743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64985830|NCT00314743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64985942|NCT00091143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64985943|NCT00091143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64985944|NCT00091143|Immunologic Factors|immunologic factors|mesh-ancestor
64985945|NCT00091143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985946|NCT00091143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64985947|NCT00091182|Oxaliplatin|oxaliplatin|mesh-list
64985948|NCT00091182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985949|NCT04646395|Acalabrutinib|acalabrutinib|mesh-list
64985950|NCT04646395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64985951|NCT04635280|Pancrelipase|pancrelipase|mesh-list
64985952|NCT04635280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64985953|NCT00122733|Loxapine|loxapine|mesh-list
64985954|NCT00122733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64985955|NCT00122733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64985964|NCT04432012|Dexamethasone acetate|dexamethasone acetate|mesh-list
64985965|NCT04432012|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64985966|NCT04432012|BB 1101|bb 1101|mesh-list
64985967|NCT04432012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64985968|NCT04432012|Antiemetics|antiemetics|mesh-ancestor
64985969|NCT04432012|Autonomic Agents|autonomic agents|mesh-ancestor
64985970|NCT04432012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64985971|NCT04432012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64985972|NCT04432012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64985973|NCT04432012|Glucocorticoids|glucocorticoids|mesh-ancestor
64985974|NCT04432012|Hormones|hormones|mesh-ancestor
64985975|NCT04432012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64986023|NCT00122850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986024|NCT00122850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64986025|NCT00122850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986026|NCT00122850|Analgesics|analgesics|mesh-ancestor
64986027|NCT00122850|Sensory System Agents|sensory system agents|mesh-ancestor
64986028|NCT00122850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64986029|NCT00122850|Antidepressive Agents|antidepressive agents|mesh-ancestor
64986030|NCT00122850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64986031|NCT00122850|Dopamine Agents|dopamine agents|mesh-ancestor
64986122|NCT03878524|Entrectinib|entrectinib|mesh-list
64986123|NCT03878524|Benzenesulfonamide|benzenesulfonamide|mesh-list
64986124|NCT03878524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64986125|NCT03878524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986126|NCT03878524|Tubulin Modulators|tubulin modulators|mesh-ancestor
64986127|NCT03878524|Antimitotic Agents|antimitotic agents|mesh-ancestor
64986128|NCT03878524|Mitosis Modulators|mitosis modulators|mesh-ancestor
64986129|NCT03878524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986130|NCT03878524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64986131|NCT03878524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64986254|NCT00314977|Tubulin Modulators|tubulin modulators|mesh-ancestor
64986255|NCT00314977|Antimitotic Agents|antimitotic agents|mesh-ancestor
64986256|NCT00314977|Mitosis Modulators|mitosis modulators|mesh-ancestor
64986257|NCT00314977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64986258|NCT00314977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64986259|NCT00314977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64986260|NCT00314977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986262|NCT00315016|Fosinopril|fosinopril|mesh-list
64986263|NCT00315016|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64986264|NCT00315016|Hormone Antagonists|hormone antagonists|mesh-ancestor
64986265|NCT00315016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64986266|NCT00315016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986267|NCT00315016|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64986268|NCT00315016|Diuretics|diuretics|mesh-ancestor
64986269|NCT00315016|Natriuretic Agents|natriuretic agents|mesh-ancestor
64986270|NCT00315016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64986271|NCT00315016|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64986272|NCT00315016|Protease Inhibitors|protease inhibitors|mesh-ancestor
64986273|NCT00315016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986274|NCT00315016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986275|NCT00419068|Cholecalciferol|cholecalciferol|mesh-list
64986276|NCT00419068|Vitamin D|vitamin d|mesh-list
64986277|NCT00419068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64986278|NCT00419068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986279|NCT00419068|Vitamins|vitamins|mesh-ancestor
64986292|NCT00419146|Protective Agents|protective agents|mesh-ancestor
64986293|NCT00419146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64986294|NCT00419146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64986295|NCT02965196|Dexamethasone|dexamethasone|mesh-list
64986296|NCT02965196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64986297|NCT02965196|Antiemetics|antiemetics|mesh-ancestor
64986298|NCT02965196|Autonomic Agents|autonomic agents|mesh-ancestor
64986299|NCT02965196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64986300|NCT02965196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986303|NCT02965196|Hormones|hormones|mesh-ancestor
64986305|NCT02965196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64986306|NCT02965196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986307|NCT00091611|Cyclophosphamide|cyclophosphamide|mesh-list
64986308|NCT00091611|Fludarabine|fludarabine|mesh-list
64986309|NCT00091611|Interleukin-2|interleukin-2|mesh-list
64986310|NCT00091611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64986311|NCT00091611|Immunologic Factors|immunologic factors|mesh-ancestor
64986312|NCT00091611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986353|NCT00091650|Olanzapine|olanzapine|mesh-list
64986431|NCT00123318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986432|NCT00327535|Epoetin Alfa|epoetin alfa|mesh-list
64986433|NCT00327535|Darbepoetin alfa|darbepoetin alfa|mesh-list
64986434|NCT00327535|Hematinics|hematinics|mesh-ancestor
64986435|NCT00327691|Atorvastatin|atorvastatin|mesh-list
64986436|NCT00327691|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64986437|NCT00327691|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64986438|NCT00327691|Antimetabolites|antimetabolites|mesh-ancestor
64986439|NCT00327691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986440|NCT00327691|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64986441|NCT00327691|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64986442|NCT00327691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986443|NCT03913832|Sirolimus|sirolimus|mesh-list
64986444|NCT03913832|Paclitaxel|paclitaxel|mesh-list
64986445|NCT03913832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64986446|NCT03913832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986447|NCT03913832|Tubulin Modulators|tubulin modulators|mesh-ancestor
64986448|NCT03913832|Antimitotic Agents|antimitotic agents|mesh-ancestor
64986449|NCT03913832|Mitosis Modulators|mitosis modulators|mesh-ancestor
64986450|NCT03913832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986451|NCT03913832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64986452|NCT03913832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64986453|NCT03913832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64986454|NCT03913832|Antifungal Agents|antifungal agents|mesh-ancestor
64986455|NCT03913832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64986456|NCT03913832|Immunologic Factors|immunologic factors|mesh-ancestor
64986457|NCT03913832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986458|NCT00327730|Eperisone|eperisone|mesh-list
64986459|NCT00327730|Anticonvulsants|anticonvulsants|mesh-ancestor
64986460|NCT00327730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64986461|NCT00327730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64986462|NCT00327730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986474|NCT04716868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64986475|NCT04716868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986476|NCT00327769|Fulvestrant|fulvestrant|mesh-list
64986477|NCT00327769|Anastrozole|anastrozole|mesh-list
64986478|NCT00327769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64986479|NCT00327769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986480|NCT00327769|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64986481|NCT00327769|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64986482|NCT00327769|Hormone Antagonists|hormone antagonists|mesh-ancestor
64986483|NCT00327769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64986484|NCT00327769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986485|NCT00327769|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64986486|NCT00327769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64986487|NCT00327769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986488|NCT00327769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986489|NCT00092001|Sunitinib|sunitinib|mesh-list
64986517|NCT03883919|Protective Agents|protective agents|mesh-ancestor
64986518|NCT03883919|Vitamin B Complex|vitamin b complex|mesh-ancestor
64986519|NCT00327808|Budesonide|budesonide|mesh-list
64986520|NCT00327808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64986521|NCT00327808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64986522|NCT00327808|Autonomic Agents|autonomic agents|mesh-ancestor
64986523|NCT00327808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64986524|NCT00327808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986525|NCT00327808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64986526|NCT00327808|Respiratory System Agents|respiratory system agents|mesh-ancestor
64986527|NCT00327808|Glucocorticoids|glucocorticoids|mesh-ancestor
64986528|NCT00327808|Hormones|hormones|mesh-ancestor
64986529|NCT00327808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64986530|NCT00092079|Cholecalciferol|cholecalciferol|mesh-list
64986531|NCT00092079|Vitamin D|vitamin d|mesh-list
64986532|NCT00092079|Alendronate|alendronate|mesh-list
64986533|NCT00092079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64986534|NCT00092079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986535|NCT00092079|Vitamins|vitamins|mesh-ancestor
64986536|NCT00092079|Micronutrients|micronutrients|mesh-ancestor
64986537|NCT00092079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64986538|NCT00327847|Vitamin D|vitamin d|mesh-list
64986539|NCT00327847|Vitamins|vitamins|mesh-ancestor
64986540|NCT00327847|Micronutrients|micronutrients|mesh-ancestor
64986541|NCT00327847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986542|NCT00327847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64986543|NCT00327925|Antibodies|antibodies|mesh-list
64986544|NCT00327925|Immunologic Factors|immunologic factors|mesh-ancestor
64986545|NCT00327925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986546|NCT03709550|Decitabine|decitabine|mesh-list
64986547|NCT03709550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64986548|NCT03709550|Antimetabolites|antimetabolites|mesh-ancestor
64986549|NCT03709550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986550|NCT03709550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986551|NCT03709550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986552|NCT00315211|Docetaxel|docetaxel|mesh-list
64986553|NCT00315211|Topotecan|topotecan|mesh-list
64986558|NCT00315211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986559|NCT00315211|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64986560|NCT00315211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64986561|NCT00315211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986562|NCT00315367|Donepezil|donepezil|mesh-list
64986563|NCT00315367|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64986564|NCT00315367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986565|NCT00315367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986566|NCT00315367|Cholinergic Agents|cholinergic agents|mesh-ancestor
64986567|NCT00315367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64986568|NCT00315367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986569|NCT00315367|Nootropic Agents|nootropic agents|mesh-ancestor
64986570|NCT00315484|Epoetin Alfa|epoetin alfa|mesh-list
64986571|NCT00315484|Darbepoetin alfa|darbepoetin alfa|mesh-list
64986572|NCT00315484|Hematinics|hematinics|mesh-ancestor
64986573|NCT00315523|Levocetirizine|levocetirizine|mesh-list
64986574|NCT00315523|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64986575|NCT00315523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64986576|NCT00315523|Histamine Antagonists|histamine antagonists|mesh-ancestor
64986577|NCT00315523|Histamine Agents|histamine agents|mesh-ancestor
64836828|NCT01615354|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64836829|NCT01615354|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64986578|NCT00315523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64986579|NCT00315523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986580|NCT00315523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986581|NCT00092196|Aprepitant|aprepitant|mesh-list
64986582|NCT00092196|Antiemetics|antiemetics|mesh-ancestor
64986583|NCT00092196|Autonomic Agents|autonomic agents|mesh-ancestor
64986584|NCT00092196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64986585|NCT00092196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986603|NCT00315679|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64986604|NCT00315679|Protective Agents|protective agents|mesh-ancestor
64986605|NCT00315679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986606|NCT00315679|Vasodilator Agents|vasodilator agents|mesh-ancestor
64986607|NCT00315679|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64986608|NCT00315679|Antioxidants|antioxidants|mesh-ancestor
64986609|NCT00092274|Ofatumumab|ofatumumab|mesh-list
64986610|NCT00092274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986611|NCT00315835|Buprenorphine|buprenorphine|mesh-list
64986612|NCT00315835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64986613|NCT00315835|Narcotics|narcotics|mesh-ancestor
64986614|NCT00315835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64986615|NCT00315835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986616|NCT00315835|Analgesics|analgesics|mesh-ancestor
64986617|NCT00315835|Sensory System Agents|sensory system agents|mesh-ancestor
64986618|NCT00315835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64986619|NCT00315835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64986620|NCT00315874|Buprenorphine|buprenorphine|mesh-list
64986621|NCT00315874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64986622|NCT00315874|Narcotics|narcotics|mesh-ancestor
64986716|NCT00092352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986717|NCT00092352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986718|NCT00316498|Miglustat|miglustat|mesh-list
64986719|NCT00316498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986720|NCT00316498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986721|NCT00316498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64986722|NCT00316498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64986723|NCT00316498|Antiviral Agents|antiviral agents|mesh-ancestor
64986724|NCT00316498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64986725|NCT00316498|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64986726|NCT00316498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64986727|NCT00316498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986728|NCT03319901|Venetoclax|venetoclax|mesh-list
64986729|NCT03319901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986730|NCT00316810|Alemtuzumab|alemtuzumab|mesh-list
64986731|NCT00316810|Thymoglobulin|thymoglobulin|mesh-list
64986776|NCT03272477|Alkylating Agents|alkylating agents|mesh-ancestor
64986777|NCT03272477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64986778|NCT03272477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64986779|NCT03272477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64986780|NCT03272477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64986781|NCT03272477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986782|NCT03272477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64986783|NCT03272477|Hormone Antagonists|hormone antagonists|mesh-ancestor
64986784|NCT03272477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64986785|NCT03272477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64986895|NCT02571725|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64986896|NCT02571725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64986897|NCT02571725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64986898|NCT02571725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986899|NCT00328549|Interferons|interferons|mesh-list
64986900|NCT00328549|Ribavirin|ribavirin|mesh-list
64986901|NCT00328549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64986902|NCT00328549|Antiviral Agents|antiviral agents|mesh-ancestor
64986903|NCT00328549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64986904|NCT00328549|Antimetabolites|antimetabolites|mesh-ancestor
64986906|NCT00092508|Mesalamine|mesalamine|mesh-list
64986961|NCT00328939|PENTA|penta|mesh-list
64986989|NCT00329134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64986990|NCT00329134|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64986991|NCT00329134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64986992|NCT00329134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64986993|NCT00329134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64986994|NCT00329134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64986995|NCT00329134|Analgesics|analgesics|mesh-ancestor
64986996|NCT00329134|Sensory System Agents|sensory system agents|mesh-ancestor
64986997|NCT00329173|Atorvastatin|atorvastatin|mesh-list
64986998|NCT00329173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64986999|NCT00329173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64987000|NCT00329173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64987001|NCT00329173|Antimetabolites|antimetabolites|mesh-ancestor
64987002|NCT00329173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987003|NCT00329173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64987037|NCT00329368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64987038|NCT00329368|Hematinics|hematinics|mesh-ancestor
64987039|NCT00329368|Vitamins|vitamins|mesh-ancestor
64987040|NCT00329368|Micronutrients|micronutrients|mesh-ancestor
64987041|NCT00329368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64987042|NCT00329446|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64987044|NCT00329446|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64987045|NCT00329446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64987046|NCT00329446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64987047|NCT00329446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987048|NCT00329446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64987049|NCT00329446|Serotonin Agents|serotonin agents|mesh-ancestor
64987050|NCT00329446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987051|NCT00329446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64987052|NCT00329446|Antidepressive Agents|antidepressive agents|mesh-ancestor
64987053|NCT00329446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64987095|NCT00123903|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64987096|NCT00123903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64987097|NCT00123903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64987098|NCT00123903|Vasodilator Agents|vasodilator agents|mesh-ancestor
64836830|NCT01615354|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64836831|NCT01615354|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64987099|NCT00123903|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64987100|NCT00123903|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64987101|NCT00123903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64987102|NCT00123903|Protease Inhibitors|protease inhibitors|mesh-ancestor
64987103|NCT00123903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987104|NCT00123903|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64987105|NCT00329680|Evening primrose oil|evening primrose oil|mesh-list
64987106|NCT00329680|Antioxidants|antioxidants|mesh-list
64987107|NCT00329680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987108|NCT00329680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987109|NCT00329680|Protective Agents|protective agents|mesh-ancestor
64987149|NCT00330148|Nifurtimox|nifurtimox|mesh-list
64987150|NCT00330148|Melarsoprol|melarsoprol|mesh-list
64987151|NCT00330148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987152|NCT00330148|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64987153|NCT00330148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64987154|NCT00330148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64987155|NCT00330148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64987156|NCT00330148|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64987157|NCT00330148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987158|NCT00330148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987159|NCT00093093|Interferons|interferons|mesh-list
64987160|NCT00093093|Ribavirin|ribavirin|mesh-list
64987220|NCT00083993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64987258|NCT00124059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64987259|NCT00124059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64987260|NCT00124059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64987261|NCT00124059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987262|NCT00084032|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64987263|NCT00084032|Antiviral Agents|antiviral agents|mesh-ancestor
64987264|NCT00084032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64987265|NCT00323947|Methylphenidate|methylphenidate|mesh-list
64987266|NCT00323947|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64987267|NCT00323947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987268|NCT00323947|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64987269|NCT00323947|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64987270|NCT00323947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64987271|NCT00323947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987272|NCT00323947|Dopamine Agents|dopamine agents|mesh-ancestor
64987273|NCT00323947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64987274|NCT00323986|Azithromycin|azithromycin|mesh-list
64987275|NCT00323986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64987276|NCT00323986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64987277|NCT00324025|Efungumab|efungumab|mesh-list
64987278|NCT00324025|Antifungal Agents|antifungal agents|mesh-ancestor
64987279|NCT00324025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64987280|NCT00317629|Meglumine Antimoniate|meglumine antimoniate|mesh-list
64987281|NCT00317629|Nitric Oxide|nitric oxide|mesh-list
64987282|NCT00317629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64987283|NCT00317629|Autonomic Agents|autonomic agents|mesh-ancestor
64987284|NCT00317629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64987302|NCT00093249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987303|NCT00093249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64987304|NCT00093249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987305|NCT00124098|Darbepoetin alfa|darbepoetin alfa|mesh-list
64987306|NCT00124098|Hematinics|hematinics|mesh-ancestor
64987307|NCT00324142|Tinidazole|tinidazole|mesh-list
64987308|NCT00324142|Alkylating Agents|alkylating agents|mesh-ancestor
64836832|NCT01615354|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
64987309|NCT00324142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987310|NCT00324142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64987311|NCT00324142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64987312|NCT00324142|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64987313|NCT00324142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64987314|NCT00324142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64987315|NCT00324298|Etoposide|etoposide|mesh-list
64987316|NCT00324298|Bleomycin|bleomycin|mesh-list
64987317|NCT00324298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987318|NCT00324298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64987324|NCT00124137|Diuretics|diuretics|mesh-list
64987358|NCT00317785|Sirolimus|sirolimus|mesh-list
64987359|NCT00317785|Mycophenolic Acid|mycophenolic acid|mesh-list
64987360|NCT00317785|Cyclophosphamide|cyclophosphamide|mesh-list
64987361|NCT00317785|Methotrexate|methotrexate|mesh-list
64987362|NCT00317785|Tacrolimus|tacrolimus|mesh-list
64987363|NCT00317785|Cyclosporins|cyclosporins|mesh-list
64987364|NCT00317785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64987365|NCT00317785|Immunologic Factors|immunologic factors|mesh-ancestor
64987366|NCT00317785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987367|NCT00317785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64987368|NCT00317785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64987369|NCT00317785|Alkylating Agents|alkylating agents|mesh-ancestor
64987370|NCT00317785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987371|NCT00317785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987372|NCT00317785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64987373|NCT00317785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64987374|NCT00317785|Abortifacient Agents|abortifacient agents|mesh-ancestor
64987375|NCT00317785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64987376|NCT00317785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64987377|NCT00317785|Antimetabolites|antimetabolites|mesh-ancestor
64836833|NCT01615354|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64836834|NCT01615354|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64836835|NCT01615393|Ribavirin|ribavirin|mesh-list
64836836|NCT01615393|Antimetabolites|antimetabolites|mesh-ancestor
64447915|NCT02095106|Calpastatin|calpastatin|mesh-list
64325926|NCT00992563|Ranibizumab|ranibizumab|mesh-list
64325927|NCT00992563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64836855|NCT01615601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836856|NCT01615601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64836857|NCT01615601|Antiviral Agents|antiviral agents|mesh-ancestor
64836858|NCT01615601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64325954|NCT01373229|Immunologic Factors|immunologic factors|mesh-ancestor
64836943|NCT01616108|Anesthetics|anesthetics|mesh-ancestor
64836965|NCT01616355|Sodium Hypochlorite|sodium hypochlorite|mesh-list
64836967|NCT01616355|Disinfectants|disinfectants|mesh-ancestor
64837049|NCT01616927|Hormones|hormones|mesh-ancestor
64987378|NCT00317785|Dermatologic Agents|dermatologic agents|mesh-ancestor
64987379|NCT00317785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987380|NCT00317785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64987381|NCT00317785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64987382|NCT00317785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64987383|NCT00317785|Antifungal Agents|antifungal agents|mesh-ancestor
64987384|NCT00317785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64987385|NCT00317785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64987386|NCT00317785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64987387|NCT00317785|Antitubercular Agents|antitubercular agents|mesh-ancestor
64987402|NCT00093288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987403|NCT00324454|Levetiracetam|levetiracetam|mesh-list
64987404|NCT00324454|Anticonvulsants|anticonvulsants|mesh-ancestor
64987405|NCT00324454|Nootropic Agents|nootropic agents|mesh-ancestor
64987406|NCT00317902|Epoetin Alfa|epoetin alfa|mesh-list
64987407|NCT00317902|Hematinics|hematinics|mesh-ancestor
64987408|NCT00317980|Meglumine Antimoniate|meglumine antimoniate|mesh-list
64987409|NCT00317980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64987410|NCT00317980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64987411|NCT00317980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64987412|NCT00324571|Calcium|calcium|mesh-list
64987413|NCT00324571|Sevelamer|sevelamer|mesh-list
64987414|NCT00324571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64987415|NCT00324571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987416|NCT00324571|Chelating Agents|chelating agents|mesh-ancestor
64987417|NCT00324571|Sequestering Agents|sequestering agents|mesh-ancestor
64987418|NCT00324571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987419|NCT00084461|Romidepsin|romidepsin|mesh-list
64987427|NCT00093366|Etanercept|etanercept|mesh-list
64987461|NCT00324766|Vasodilator Agents|vasodilator agents|mesh-ancestor
64987462|NCT00324766|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64987463|NCT00324766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64987464|NCT00324766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987465|NCT00324766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987474|NCT00084578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64987475|NCT00084578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987476|NCT00084578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64987477|NCT00084578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64987478|NCT00084578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64987479|NCT00084578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64987514|NCT00318448|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64987515|NCT00318448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64987516|NCT00318448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64987517|NCT00318448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987518|NCT00318448|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64987519|NCT00318448|GABA Agonists|gaba agonists|mesh-ancestor
64987520|NCT00318448|GABA Agents|gaba agents|mesh-ancestor
64987521|NCT00318448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64987522|NCT00318448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987523|NCT00325117|Vildagliptin|vildagliptin|mesh-list
64987524|NCT00325117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64987525|NCT00325117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987526|NCT00325117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64987527|NCT00325117|Protease Inhibitors|protease inhibitors|mesh-ancestor
64987528|NCT00325117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987529|NCT00325117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987625|NCT00325546|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
64987626|NCT00325546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64987627|NCT00325546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64987628|NCT00325546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987629|NCT00325546|Hormones|hormones|mesh-ancestor
64987630|NCT00325546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64987631|NCT00325546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987632|NCT00084812|Safingol|safingol|mesh-list
64987633|NCT00084812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987634|NCT00084812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987636|NCT02959879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987637|NCT04717609|Ropivacaine|ropivacaine|mesh-list
64987638|NCT04717609|Anesthetics, Local|anesthetics, local|mesh-ancestor
64987639|NCT04717609|Anesthetics|anesthetics|mesh-ancestor
64987640|NCT04717609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64987641|NCT04717609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987642|NCT04717609|Sensory System Agents|sensory system agents|mesh-ancestor
64987643|NCT04717609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64987644|NCT00318760|Clonidine|clonidine|mesh-list
64987645|NCT00318760|Analgesics|analgesics|mesh-ancestor
64987646|NCT00318760|Sensory System Agents|sensory system agents|mesh-ancestor
64987647|NCT00318760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64987648|NCT00318760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987649|NCT00318760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64987650|NCT00318760|Sympatholytics|sympatholytics|mesh-ancestor
64987665|NCT00093561|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64987666|NCT00093561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987667|NCT00084890|Carboplatin|carboplatin|mesh-list
64987668|NCT00084890|Docetaxel|docetaxel|mesh-list
64987669|NCT00084890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987670|NCT00084890|Tubulin Modulators|tubulin modulators|mesh-ancestor
64987683|NCT00085124|Oblimersen|oblimersen|mesh-list
64987684|NCT00085124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64987685|NCT00085124|Antimetabolites|antimetabolites|mesh-ancestor
64987686|NCT00085124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987687|NCT00085124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987688|NCT00085124|Antiviral Agents|antiviral agents|mesh-ancestor
64987689|NCT00085124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64987714|NCT00318955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64987715|NCT00318955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64987716|NCT00318955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987717|NCT00318955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64987719|NCT00318955|Anesthetics|anesthetics|mesh-ancestor
64987720|NCT00318955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64987721|NCT00318955|Analgesics|analgesics|mesh-ancestor
64987722|NCT00318955|Sensory System Agents|sensory system agents|mesh-ancestor
64987723|NCT00318955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64987724|NCT00318955|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64987725|NCT00318955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64987726|NCT00318955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64987727|NCT00318955|Adrenergic Agents|adrenergic agents|mesh-ancestor
64987728|NCT00318955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64987729|NCT00318955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987730|NCT00325936|Cilnidipine|cilnidipine|mesh-list
64987731|NCT00325936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64987732|NCT00325936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64987733|NCT00325936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987734|NCT00325936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64987735|NCT00325936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987736|NCT00318994|Meropenem|meropenem|mesh-list
64987737|NCT00318994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64987738|NCT00318994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64987739|NCT00093600|Cytarabine|cytarabine|mesh-list
64987740|NCT00093600|Daunorubicin|daunorubicin|mesh-list
64987759|NCT00319033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987760|NCT00085163|Leucovorin|leucovorin|mesh-list
64987761|NCT00085163|Celecoxib|celecoxib|mesh-list
64987762|NCT00085163|Fluorouracil|fluorouracil|mesh-list
64987763|NCT00085163|Calcium|calcium|mesh-list
64987764|NCT00085163|Levoleucovorin|levoleucovorin|mesh-list
64987765|NCT00085163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64987766|NCT00085163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987767|NCT00085163|Antimetabolites|antimetabolites|mesh-ancestor
64987768|NCT00085163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987769|NCT00085163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64987770|NCT00085163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987771|NCT00085163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64987772|NCT00085163|Immunologic Factors|immunologic factors|mesh-ancestor
64987773|NCT00085163|Antidotes|antidotes|mesh-ancestor
64987774|NCT00085163|Protective Agents|protective agents|mesh-ancestor
64987819|NCT00326053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987820|NCT00400088|Lithium Carbonate|lithium carbonate|mesh-list
64987821|NCT00400088|Paroxetine|paroxetine|mesh-list
64987822|NCT00400088|Antidepressive Agents|antidepressive agents|mesh-ancestor
64987823|NCT00400088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64987824|NCT00400088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987825|NCT00400088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987826|NCT00400088|Antimanic Agents|antimanic agents|mesh-ancestor
64987827|NCT00400088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64987828|NCT00400088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64987834|NCT00400088|Serotonin Agents|serotonin agents|mesh-ancestor
64987880|NCT00319306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987881|NCT00319306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64987882|NCT00319306|Respiratory System Agents|respiratory system agents|mesh-ancestor
64987906|NCT00085358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64987907|NCT00085358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64987908|NCT00085358|Growth Substances|growth substances|mesh-ancestor
64987909|NCT00085358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987910|NCT00085358|Growth Inhibitors|growth inhibitors|mesh-ancestor
64987911|NCT00085358|Immunologic Factors|immunologic factors|mesh-ancestor
64987922|NCT00093678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64987923|NCT00093678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987924|NCT00093678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987925|NCT00319345|Mannitol|mannitol|mesh-list
64987926|NCT00319345|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64987991|NCT00124332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64987992|NCT00085553|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64987994|NCT00085553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64987995|NCT00085553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64987996|NCT00085553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64987997|NCT00085553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64987998|NCT00400335|Methyltestosterone|methyltestosterone|mesh-list
64987999|NCT00400335|Testosterone|testosterone|mesh-list
64988000|NCT00400335|Testosterone undecanoate|testosterone undecanoate|mesh-list
64988001|NCT00400335|Testosterone enanthate|testosterone enanthate|mesh-list
64988002|NCT00400335|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64988003|NCT00400335|Dutasteride|dutasteride|mesh-list
64988004|NCT00400335|Androgens|androgens|mesh-ancestor
64988005|NCT00400335|Hormones|hormones|mesh-ancestor
64988006|NCT00400335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64988007|NCT00400335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988008|NCT00400335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64988009|NCT00400335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988010|NCT00400335|Anabolic Agents|anabolic agents|mesh-ancestor
64988011|NCT00400335|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64988012|NCT00400335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64988013|NCT00400335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837050|NCT01616927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64837051|NCT01616927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837052|NCT01616966|Remifentanil|remifentanil|mesh-list
64837053|NCT01616966|Propofol|propofol|mesh-list
64837054|NCT01616966|Sevoflurane|sevoflurane|mesh-list
64988014|NCT00400335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988015|NCT00400335|Hormone Antagonists|hormone antagonists|mesh-ancestor
64988016|NCT00319852|Vaccines|vaccines|mesh-list
64988017|NCT00319852|Immunologic Factors|immunologic factors|mesh-ancestor
64988018|NCT00319852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988019|NCT00326833|Vitamin B 12|vitamin b 12|mesh-list
64988020|NCT00326833|Hydroxocobalamin|hydroxocobalamin|mesh-list
64988021|NCT00326833|Vitamins|vitamins|mesh-ancestor
64988022|NCT00326833|Micronutrients|micronutrients|mesh-ancestor
64988023|NCT00326833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988024|NCT00326833|Vitamin B Complex|vitamin b complex|mesh-ancestor
64988030|NCT00085748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988031|NCT00085748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64988032|NCT00085748|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64988033|NCT00085748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64988034|NCT00085748|Serotonin Agents|serotonin agents|mesh-ancestor
64988035|NCT00085748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64988036|NCT00085748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988037|NCT00085748|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64988038|NCT00085748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64988040|NCT04717102|Desflurane|desflurane|mesh-list
64988150|NCT00093951|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
64988151|NCT00093951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64988152|NCT00093951|Protective Agents|protective agents|mesh-ancestor
64988153|NCT00093951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988154|NCT00093951|GABA Antagonists|gaba antagonists|mesh-ancestor
64988155|NCT00093951|GABA Agents|gaba agents|mesh-ancestor
64988156|NCT00093951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64988157|NCT00093951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988158|NCT00419419|Nitroglycerin|nitroglycerin|mesh-list
64988159|NCT00419419|Vasodilator Agents|vasodilator agents|mesh-ancestor
64988160|NCT00320476|Bortezomib|bortezomib|mesh-list
64988161|NCT00320476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988162|NCT00327262|Imatinib Mesylate|imatinib mesylate|mesh-list
64988163|NCT00327262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988164|NCT00327262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64988165|NCT00327262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988300|NCT05458180|Mitoxantrone|mitoxantrone|mesh-list
64988301|NCT05458180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64988302|NCT05458180|Immunologic Factors|immunologic factors|mesh-ancestor
64988303|NCT05458180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988304|NCT05458180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64988305|NCT05458180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64988306|NCT05458180|Alkylating Agents|alkylating agents|mesh-ancestor
64988307|NCT05458180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988308|NCT05458180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988309|NCT05458180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64988310|NCT05458180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64988311|NCT05458180|Glucocorticoids|glucocorticoids|mesh-ancestor
64988312|NCT05458180|Hormones|hormones|mesh-ancestor
64988313|NCT05458180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64988314|NCT05458180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64988315|NCT05458180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64988316|NCT05458180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64988317|NCT05458180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64988318|NCT05458180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988348|NCT00419653|Antidepressive Agents|antidepressive agents|mesh-ancestor
64988350|NCT00094341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64988351|NCT00094341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64988352|NCT00094341|Analgesics|analgesics|mesh-ancestor
64988353|NCT00094341|Sensory System Agents|sensory system agents|mesh-ancestor
64988361|NCT00086489|Tremelimumab|tremelimumab|mesh-list
64988378|NCT00321490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64988379|NCT00321490|Antidepressive Agents|antidepressive agents|mesh-ancestor
64988388|NCT00321490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988389|NCT00321490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64988390|NCT00321490|Analgesics|analgesics|mesh-ancestor
64988391|NCT00321490|Sensory System Agents|sensory system agents|mesh-ancestor
64988392|NCT00321490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64988393|NCT00321490|Dopamine Agents|dopamine agents|mesh-ancestor
64988394|NCT00086528|XL647|xl647|mesh-list
64988395|NCT00086528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988396|NCT00086528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64988397|NCT00086528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988398|NCT00086528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988399|NCT05457829|Doxorubicin|doxorubicin|mesh-list
64988400|NCT05457829|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64988450|NCT00321724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988451|NCT00321724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988452|NCT00321724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988453|NCT00321724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64988454|NCT00086645|Dexetimide|dexetimide|mesh-list
64988455|NCT00086645|Citalopram|citalopram|mesh-list
64988456|NCT00086645|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64988457|NCT00086645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64988503|NCT00086801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988504|NCT00086801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988505|NCT00086801|Antiviral Agents|antiviral agents|mesh-ancestor
64988506|NCT00086801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64988507|NCT00086801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988508|NCT00086801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64988509|NCT00086801|Immunologic Factors|immunologic factors|mesh-ancestor
64988555|NCT00124683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64988556|NCT00124683|Cholinergic Agents|cholinergic agents|mesh-ancestor
64988557|NCT00124683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64988558|NCT00124683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988559|NCT00124683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64988560|NCT00124683|Antidepressive Agents|antidepressive agents|mesh-ancestor
64988561|NCT00124683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64988562|NCT00124683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64988563|NCT00124683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64988564|NCT00124683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64988565|NCT00124683|Dopamine Agents|dopamine agents|mesh-ancestor
64988566|NCT00124683|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64988567|NCT00124683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64988568|NCT00124683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988569|NCT04717063|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64988570|NCT04717063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64988571|NCT04717063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64988572|NCT00086879|Temozolomide|temozolomide|mesh-list
64988609|NCT00094614|Respiratory System Agents|respiratory system agents|mesh-ancestor
64988610|NCT00094614|Mydriatics|mydriatics|mesh-ancestor
64988611|NCT00094614|Parasympatholytics|parasympatholytics|mesh-ancestor
64988614|NCT00094614|Cholinergic Agents|cholinergic agents|mesh-ancestor
64988628|NCT00322075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988629|NCT00322114|Lycopene|lycopene|mesh-list
64988664|NCT00332293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64988665|NCT00332293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64988666|NCT00332293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64988667|NCT00332293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64988668|NCT00332293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64988669|NCT00332293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988670|NCT00332293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988671|NCT00332293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988672|NCT00332293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64988673|NCT00332293|Contraceptive Agents|contraceptive agents|mesh-ancestor
64988674|NCT00332293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64988675|NCT00332293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988676|NCT00332293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64988677|NCT00332293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64988678|NCT00332293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64988679|NCT00087191|Motexafin lutetium|motexafin lutetium|mesh-list
64988680|NCT00087191|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64988681|NCT00087191|Dermatologic Agents|dermatologic agents|mesh-ancestor
64988682|NCT05222152|Hydrocortisone|hydrocortisone|mesh-list
64988683|NCT05222152|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64988684|NCT05222152|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64988685|NCT05222152|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64988686|NCT05222152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64988687|NCT00094692|Atropine|atropine|mesh-list
64988696|NCT00094692|Mydriatics|mydriatics|mesh-ancestor
64988710|NCT05181007|Antimanic Agents|antimanic agents|mesh-ancestor
64988711|NCT05181007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64988712|NCT05181007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64988713|NCT05181007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64988714|NCT00124839|Naltrexone|naltrexone|mesh-list
64988725|NCT05126836|Cilostazol|cilostazol|mesh-list
64988726|NCT05126836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64988727|NCT05126836|Autonomic Agents|autonomic agents|mesh-ancestor
64988728|NCT05126836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64988729|NCT05126836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988749|NCT00419692|Ropinirole|ropinirole|mesh-list
64988764|NCT00419731|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64988765|NCT00419731|Antidepressive Agents|antidepressive agents|mesh-ancestor
64988766|NCT00419731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64988869|NCT00331084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988870|NCT00331084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988871|NCT00331084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64988872|NCT00331084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64988873|NCT00331084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64988874|NCT00331084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64988875|NCT00331084|Contraceptive Agents|contraceptive agents|mesh-ancestor
64988876|NCT00331084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64988877|NCT00331084|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64988917|NCT00331240|Adrenergic Agents|adrenergic agents|mesh-ancestor
64988918|NCT00331240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64988919|NCT00331240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988920|NCT00331240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988921|NCT00331240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64988922|NCT00331240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64988923|NCT00331240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64988924|NCT00331240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64988925|NCT00124956|Doxorubicin|doxorubicin|mesh-list
64988926|NCT00124956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64988927|NCT00124956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64988928|NCT00124956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64988929|NCT00124956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64988930|NCT00124956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988931|NCT00124956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64988932|NCT00087581|Cyclosporine|cyclosporine|mesh-list
64988933|NCT00087581|Mycophenolic Acid|mycophenolic acid|mesh-list
64988934|NCT00087581|Tacrolimus|tacrolimus|mesh-list
64988935|NCT00087581|Cyclosporins|cyclosporins|mesh-list
64988936|NCT00087581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64988937|NCT00087581|Immunologic Factors|immunologic factors|mesh-ancestor
64988938|NCT00087581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988940|NCT00087581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64988972|NCT00124995|Autonomic Agents|autonomic agents|mesh-ancestor
64988973|NCT00124995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64988974|NCT00124995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64988975|NCT00124995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64988976|NCT00124995|Respiratory System Agents|respiratory system agents|mesh-ancestor
64988977|NCT00124995|Sympathomimetics|sympathomimetics|mesh-ancestor
64988978|NCT00124995|Tocolytic Agents|tocolytic agents|mesh-ancestor
64988979|NCT00124995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64988986|NCT00331708|Artesunate|artesunate|mesh-list
64989026|NCT00331786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64989027|NCT00331786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989028|NCT00331786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64989029|NCT00331786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64989030|NCT00331786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64989031|NCT00331786|Antipyretics|antipyretics|mesh-ancestor
64989032|NCT00331786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64989033|NCT00331786|Autonomic Agents|autonomic agents|mesh-ancestor
64989034|NCT00331786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64989035|NCT00331786|Respiratory System Agents|respiratory system agents|mesh-ancestor
64989036|NCT00331786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64989037|NCT00331786|Antioxidants|antioxidants|mesh-ancestor
64989038|NCT00331786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64989039|NCT00331786|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64989040|NCT00331786|Vasodilator Agents|vasodilator agents|mesh-ancestor
64989041|NCT00331786|Gasotransmitters|gasotransmitters|mesh-ancestor
64989080|NCT00087737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989081|NCT00087737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64989082|NCT00087737|Antidepressive Agents|antidepressive agents|mesh-ancestor
64989083|NCT00087737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64989084|NCT00331981|Amisulpride|amisulpride|mesh-list
64989085|NCT00331981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64989098|NCT00126633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64989133|NCT02965274|Antidepressive Agents|antidepressive agents|mesh-ancestor
64989134|NCT02965274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64989135|NCT02965274|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64989136|NCT02965274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64989137|NCT02965274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64989138|NCT00332059|Timolol|timolol|mesh-list
64989139|NCT00332059|Bimatoprost|bimatoprost|mesh-list
64989140|NCT00332059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64989141|NCT00332059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64989142|NCT00332059|Adrenergic Agents|adrenergic agents|mesh-ancestor
64989143|NCT00332059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64989146|NCT00332059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64989196|NCT05831566|Formoterol Fumarate|formoterol fumarate|mesh-list
64989197|NCT05831566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64989198|NCT05831566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64989199|NCT05831566|Autonomic Agents|autonomic agents|mesh-ancestor
64989200|NCT05831566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64989201|NCT05831566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989202|NCT05831566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64989203|NCT05831566|Respiratory System Agents|respiratory system agents|mesh-ancestor
64989204|NCT05831566|Glucocorticoids|glucocorticoids|mesh-ancestor
64989205|NCT05831566|Hormones|hormones|mesh-ancestor
64989206|NCT05831566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64989207|NCT05831566|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64989208|NCT05831566|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64989209|NCT05831566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64989210|NCT05831566|Adrenergic Agents|adrenergic agents|mesh-ancestor
64989254|NCT05831176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837055|NCT01616966|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64837056|NCT01616966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64837057|NCT01616966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837058|NCT01616966|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64837059|NCT01616966|Anesthetics, General|anesthetics, general|mesh-ancestor
64837060|NCT01616966|Anesthetics|anesthetics|mesh-ancestor
64325988|NCT04196283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64325989|NCT04196283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325990|NCT04196283|Tubulin Modulators|tubulin modulators|mesh-ancestor
64325991|NCT04196283|Antimitotic Agents|antimitotic agents|mesh-ancestor
64325992|NCT04196283|Mitosis Modulators|mitosis modulators|mesh-ancestor
64325993|NCT04196283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325994|NCT02268019|Epinephrine|epinephrine|mesh-list
64325995|NCT02268019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64325996|NCT02268019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64325997|NCT02268019|Adrenergic Agents|adrenergic agents|mesh-ancestor
64989255|NCT05831124|Vaccines|vaccines|mesh-list
64989256|NCT05831124|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64989257|NCT05831124|Immunologic Factors|immunologic factors|mesh-ancestor
64989258|NCT05831124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989259|NCT05831098|Antibodies|antibodies|mesh-list
64989260|NCT05831098|Immunologic Factors|immunologic factors|mesh-ancestor
64989261|NCT05831098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989263|NCT05830916|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
64989264|NCT05830916|Immunologic Factors|immunologic factors|mesh-ancestor
64989265|NCT05830916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989266|NCT05830864|Isoflurane|isoflurane|mesh-list
64989267|NCT05830864|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64989268|NCT05830864|Anesthetics, General|anesthetics, general|mesh-ancestor
64989269|NCT05830864|Anesthetics|anesthetics|mesh-ancestor
64989270|NCT05830864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64989271|NCT05830864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989272|NCT05830799|Tolbutamide|tolbutamide|mesh-list
64989273|NCT05830799|Nintedanib|nintedanib|mesh-list
64989274|NCT05830799|Midazolam|midazolam|mesh-list
64989319|NCT05830604|Antifungal Agents|antifungal agents|mesh-ancestor
64989320|NCT05830604|Keratolytic Agents|keratolytic agents|mesh-ancestor
64989321|NCT05830604|Dermatologic Agents|dermatologic agents|mesh-ancestor
64989330|NCT05830396|Ambroxol|ambroxol|mesh-list
64989331|NCT05830396|Expectorants|expectorants|mesh-ancestor
64989365|NCT05830071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64989430|NCT05828303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64989431|NCT05828303|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64989432|NCT05828303|Protective Agents|protective agents|mesh-ancestor
64989433|NCT05827523|Cisplatin|cisplatin|mesh-list
64989434|NCT05827523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989441|NCT05821725|Hyaluronic Acid|hyaluronic acid|mesh-list
64989442|NCT05821725|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64989443|NCT05821725|Immunologic Factors|immunologic factors|mesh-ancestor
64989444|NCT05821725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989445|NCT05821725|Viscosupplements|viscosupplements|mesh-ancestor
64989446|NCT05821725|Protective Agents|protective agents|mesh-ancestor
64989447|NCT05820997|Ropivacaine|ropivacaine|mesh-list
64989578|NCT05773274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989579|NCT05773274|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64989580|NCT05773066|Lidocaine|lidocaine|mesh-list
64989581|NCT05773066|Anesthetics, Local|anesthetics, local|mesh-ancestor
64989582|NCT05773066|Anesthetics|anesthetics|mesh-ancestor
64989583|NCT05773066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64989584|NCT05773066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989585|NCT05773066|Sensory System Agents|sensory system agents|mesh-ancestor
64989586|NCT05773066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64989587|NCT05773066|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64989588|NCT05773066|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64989589|NCT05773066|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64989590|NCT05773066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64989591|NCT05773066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989592|NCT05773053|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64989593|NCT05773053|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64989594|NCT05773053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64989595|NCT05773053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64989596|NCT05773053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989597|NCT05773053|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64989598|NCT05773053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64989599|NCT05773053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989602|NCT05746559|Ravulizumab|ravulizumab|mesh-list
64989617|NCT05743270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64989618|NCT05743270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989619|NCT05743270|Tubulin Modulators|tubulin modulators|mesh-ancestor
64989620|NCT05743270|Antimitotic Agents|antimitotic agents|mesh-ancestor
64989621|NCT05743270|Mitosis Modulators|mitosis modulators|mesh-ancestor
64989678|NCT05712941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989679|NCT05712941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64989680|NCT05712941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64989681|NCT05712941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64989682|NCT05712941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989683|NCT05712941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64989684|NCT05712941|Hormone Antagonists|hormone antagonists|mesh-ancestor
64989685|NCT05712941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64989686|NCT05712941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989687|NCT05709821|Pembrolizumab|pembrolizumab|mesh-list
64989688|NCT05709821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64989689|NCT05709821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989707|NCT05691517|Exatecan|exatecan|mesh-list
64989708|NCT05691517|Camptothecin|camptothecin|mesh-list
64989709|NCT05691517|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64989710|NCT05691517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64989711|NCT05691517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64989713|NCT05691517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989727|NCT05685602|Gemcitabine|gemcitabine|mesh-list
64989728|NCT05685602|Paclitaxel|paclitaxel|mesh-list
64989729|NCT05685602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64989730|NCT05685602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64989731|NCT05685602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989732|NCT05685602|Tubulin Modulators|tubulin modulators|mesh-ancestor
64989733|NCT05685602|Antimitotic Agents|antimitotic agents|mesh-ancestor
64989809|NCT05675410|Hormones|hormones|mesh-ancestor
64989811|NCT05675410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64989812|NCT05675410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64989813|NCT05675410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64989814|NCT05675410|Tubulin Modulators|tubulin modulators|mesh-ancestor
64989815|NCT05675410|Antimitotic Agents|antimitotic agents|mesh-ancestor
64989816|NCT05675410|Mitosis Modulators|mitosis modulators|mesh-ancestor
64989817|NCT05675410|Antiemetics|antiemetics|mesh-ancestor
64989818|NCT05675410|Autonomic Agents|autonomic agents|mesh-ancestor
64989840|NCT05665270|Prednisolone acetate|prednisolone acetate|mesh-list
64989841|NCT05665270|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64989842|NCT05665270|Prednisolone phosphate|prednisolone phosphate|mesh-list
64989843|NCT05665270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64989844|NCT05665270|Glucocorticoids|glucocorticoids|mesh-ancestor
64989845|NCT05665270|Hormones|hormones|mesh-ancestor
64989846|NCT05665270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64989847|NCT05665270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989848|NCT05665270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64989849|NCT05665270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989850|NCT05665270|Antiemetics|antiemetics|mesh-ancestor
64989851|NCT05665270|Autonomic Agents|autonomic agents|mesh-ancestor
64989852|NCT05665270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64989853|NCT05665270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64989854|NCT05665270|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64989855|NCT05665270|Protective Agents|protective agents|mesh-ancestor
64989856|NCT05660447|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64989858|NCT05660447|Glycerol|glycerol|mesh-list
64989912|NCT05628363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989949|NCT05581589|Immunologic Factors|immunologic factors|mesh-ancestor
64989950|NCT05581589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64989951|NCT05581589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64989952|NCT05581589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989953|NCT05581589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64989954|NCT05581589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64989955|NCT05581589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64989956|NCT05581589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989957|NCT05580666|Azithromycin|azithromycin|mesh-list
64989958|NCT05580666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64989959|NCT05580666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64989989|NCT05578092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64989990|NCT05574400|Caffeine|caffeine|mesh-list
64989991|NCT05574400|Caffeine citrate|caffeine citrate|mesh-list
64989992|NCT05574400|Citric Acid|citric acid|mesh-list
64326000|NCT02268019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326001|NCT02268019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64837121|NCT01617213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64837122|NCT01617213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64837124|NCT01617226|Vorinostat|vorinostat|mesh-list
64837132|NCT01617317|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64837134|NCT01617317|gamma-Globulins|gamma-globulins|mesh-list
64837135|NCT01617317|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64837136|NCT01617317|Immunologic Factors|immunologic factors|mesh-ancestor
64837137|NCT01617317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326021|NCT01106989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64326022|NCT01106989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326023|NCT01106989|Sensory System Agents|sensory system agents|mesh-ancestor
64326024|NCT01106989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64326025|NCT01106989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64326026|NCT01106989|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64326027|NCT01106989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64326028|NCT01106989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64326029|NCT01106989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326031|NCT00975091|Antiviral Agents|antiviral agents|mesh-ancestor
64989993|NCT05574400|Sodium Citrate|sodium citrate|mesh-list
64989994|NCT05574400|Anticoagulants|anticoagulants|mesh-ancestor
64989995|NCT05574400|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64989996|NCT05574400|Chelating Agents|chelating agents|mesh-ancestor
64989997|NCT05574400|Sequestering Agents|sequestering agents|mesh-ancestor
64989998|NCT05574400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64989999|NCT05574400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64990000|NCT05574400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990001|NCT05574400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64990002|NCT05574400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990003|NCT05574400|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64990004|NCT05574400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64990005|NCT05574400|Purinergic Agents|purinergic agents|mesh-ancestor
64990006|NCT05574400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64990007|NCT05571514|Calcium Carbonate|calcium carbonate|mesh-list
64990008|NCT05571514|Calcium|calcium|mesh-list
64990009|NCT05571514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64990010|NCT05571514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990011|NCT05571514|Antacids|antacids|mesh-ancestor
64990012|NCT05571514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990013|NCT05571514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64990014|NCT05568888|Thrombin|thrombin|mesh-list
64990037|NCT05564377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990038|NCT05564377|Antimetabolites|antimetabolites|mesh-ancestor
64990039|NCT05564377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64990040|NCT05564377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64990041|NCT05564377|Antidotes|antidotes|mesh-ancestor
64990042|NCT05564377|Protective Agents|protective agents|mesh-ancestor
64990043|NCT05564377|Vitamin B Complex|vitamin b complex|mesh-ancestor
64990044|NCT05564377|Vitamins|vitamins|mesh-ancestor
64990045|NCT05564377|Micronutrients|micronutrients|mesh-ancestor
64990046|NCT05564377|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64990047|NCT05564377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326032|NCT00975091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64837138|NCT01617356|Lidocaine|lidocaine|mesh-list
64837139|NCT01617356|Anesthetics, Local|anesthetics, local|mesh-ancestor
64837140|NCT01617356|Anesthetics|anesthetics|mesh-ancestor
64837141|NCT01617356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64837142|NCT01617356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837143|NCT01617356|Sensory System Agents|sensory system agents|mesh-ancestor
64990048|NCT05564377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64990049|NCT05564377|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64990050|NCT05564377|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64990051|NCT05564377|Hormone Antagonists|hormone antagonists|mesh-ancestor
64990052|NCT05564377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64990182|NCT05478837|Alkylating Agents|alkylating agents|mesh-ancestor
64990183|NCT05478837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990184|NCT05478837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990185|NCT05478837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64990186|NCT05478499|BMS-986165|bms-986165|mesh-list
64990187|NCT05478499|Dermatologic Agents|dermatologic agents|mesh-ancestor
64990188|NCT05478499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64990189|NCT05478499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990190|NCT05478499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990191|NCT05440708|Bevacizumab|bevacizumab|mesh-list
64990192|NCT05440708|Pembrolizumab|pembrolizumab|mesh-list
64990193|NCT05440708|Atezolizumab|atezolizumab|mesh-list
64990325|NCT05353439|Topotecan|topotecan|mesh-list
64990414|NCT05243940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990415|NCT05243940|Sensory System Agents|sensory system agents|mesh-ancestor
64990416|NCT05243940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64990417|NCT05243940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64990418|NCT05243940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64990419|NCT05243940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64990420|NCT05243940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64990421|NCT05243940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990422|NCT05243940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64990423|NCT05243940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64990424|NCT05243940|Analgesics|analgesics|mesh-ancestor
64990425|NCT05243940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64990427|NCT05243940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64990536|NCT05172258|Pembrolizumab|pembrolizumab|mesh-list
64990537|NCT05172258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64990538|NCT05172258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990539|NCT05167734|Dextrans|dextrans|mesh-list
64990540|NCT05167734|Epoetin Alfa|epoetin alfa|mesh-list
64990541|NCT05167734|Iron-Dextran Complex|iron-dextran complex|mesh-list
64990542|NCT05167734|Hematinics|hematinics|mesh-ancestor
64990543|NCT05167734|Anticoagulants|anticoagulants|mesh-ancestor
64990544|NCT05167734|Plasma Substitutes|plasma substitutes|mesh-ancestor
64990545|NCT05167734|Blood Substitutes|blood substitutes|mesh-ancestor
64990546|NCT05145309|Magnesium citrate|magnesium citrate|mesh-list
64990547|NCT05145309|Cathartics|cathartics|mesh-ancestor
64990548|NCT05145309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64990549|NCT05142241|Temozolomide|temozolomide|mesh-list
64990550|NCT05142241|Talazoparib|talazoparib|mesh-list
64990551|NCT05142241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64990552|NCT05142241|Alkylating Agents|alkylating agents|mesh-ancestor
64990553|NCT05142241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990554|NCT05142241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990555|NCT05142241|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64990556|NCT05142241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990557|NCT05141474|Aldesleukin|aldesleukin|mesh-list
64990558|NCT05141474|Cyclophosphamide|cyclophosphamide|mesh-list
64990559|NCT05141474|Fludarabine|fludarabine|mesh-list
64990562|NCT05141474|Immunologic Factors|immunologic factors|mesh-ancestor
64990563|NCT05141474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990564|NCT05141474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64990565|NCT05141474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64990566|NCT05141474|Alkylating Agents|alkylating agents|mesh-ancestor
64990567|NCT05141474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990568|NCT05141474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990569|NCT05141474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64990570|NCT05141474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64990571|NCT05141474|Analgesics|analgesics|mesh-ancestor
64990578|NCT05140811|Azacitidine|azacitidine|mesh-list
64990579|NCT05140811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64990580|NCT05140811|Antimetabolites|antimetabolites|mesh-ancestor
64990581|NCT05140811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990582|NCT05140811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990583|NCT05140811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990589|NCT05130463|Empagliflozin|empagliflozin|mesh-list
64990590|NCT05130463|Linagliptin|linagliptin|mesh-list
64990591|NCT05130463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64990592|NCT05130463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990593|NCT05130463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64990594|NCT05130463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990620|NCT05119140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64990621|NCT05119140|Analgesics|analgesics|mesh-ancestor
64990622|NCT05119140|Sensory System Agents|sensory system agents|mesh-ancestor
64990623|NCT05119140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64990624|NCT05119140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990689|NCT05019716|Etoposide|etoposide|mesh-list
64990744|NCT04989283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64990745|NCT04989283|Immunologic Factors|immunologic factors|mesh-ancestor
64990746|NCT04989283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990747|NCT04989283|Keratolytic Agents|keratolytic agents|mesh-ancestor
64990748|NCT04989283|Dermatologic Agents|dermatologic agents|mesh-ancestor
64990750|NCT04981509|Bevacizumab|bevacizumab|mesh-list
64990751|NCT04981509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64990752|NCT04981509|Atezolizumab|atezolizumab|mesh-list
64990753|NCT04981509|Endothelial Growth Factors|endothelial growth factors|mesh-list
64990754|NCT04981509|Antibodies|antibodies|mesh-list
64990755|NCT04981509|Immunoglobulins|immunoglobulins|mesh-list
64990756|NCT04981509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64990757|NCT04981509|Immunoglobulin G|immunoglobulin g|mesh-list
64990851|NCT04906395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990852|NCT04906395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64990853|NCT04906395|Hormone Antagonists|hormone antagonists|mesh-ancestor
64990854|NCT04906395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64990855|NCT04906395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64990856|NCT04906395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64990857|NCT04906395|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64990858|NCT04906395|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64990859|NCT04906395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64990860|NCT04904588|Mycophenolic Acid|mycophenolic acid|mesh-list
64990861|NCT04904588|Cyclophosphamide|cyclophosphamide|mesh-list
64990862|NCT04904588|Melphalan|melphalan|mesh-list
64990863|NCT04904588|Busulfan|busulfan|mesh-list
64990864|NCT04904588|Fludarabine|fludarabine|mesh-list
64990865|NCT04904588|Tacrolimus|tacrolimus|mesh-list
64990866|NCT04904588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64990867|NCT04904588|Immunologic Factors|immunologic factors|mesh-ancestor
64990869|NCT04904588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64990888|NCT04903197|Growth Inhibitors|growth inhibitors|mesh-ancestor
64990889|NCT04903197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990900|NCT04876781|Tofacitinib|tofacitinib|mesh-list
64990901|NCT04876781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64990902|NCT04876781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64990903|NCT04876781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64990904|NCT04870112|Carboplatin|carboplatin|mesh-list
64990905|NCT04870112|Etoposide|etoposide|mesh-list
64990906|NCT04870112|Durvalumab|durvalumab|mesh-list
64990907|NCT04870112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64990939|NCT04847453|Dexamethasone acetate|dexamethasone acetate|mesh-list
64990940|NCT04847453|Venetoclax|venetoclax|mesh-list
64990941|NCT04847453|Ixazomib|ixazomib|mesh-list
64990942|NCT04847453|Ichthammol|ichthammol|mesh-list
64990943|NCT04847453|BB 1101|bb 1101|mesh-list
64990944|NCT04847453|Glycine|glycine|mesh-list
64990945|NCT04847453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64990946|NCT04847453|Antiemetics|antiemetics|mesh-ancestor
64990947|NCT04847453|Autonomic Agents|autonomic agents|mesh-ancestor
64991001|NCT04768296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991003|NCT04768296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991170|NCT04685135|Mitosis Modulators|mitosis modulators|mesh-ancestor
64991171|NCT04685135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991172|NCT04671667|Cisplatin|cisplatin|mesh-list
64991173|NCT04671667|Carboplatin|carboplatin|mesh-list
64991174|NCT04671667|Pembrolizumab|pembrolizumab|mesh-list
64991175|NCT04671667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991176|NCT04671667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64991177|NCT04668300|Durvalumab|durvalumab|mesh-list
64991178|NCT04668300|Immunoglobulins|immunoglobulins|mesh-list
64991179|NCT04668300|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64991180|NCT04668300|Immunoglobulin G|immunoglobulin g|mesh-list
64991182|NCT04668300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991475|NCT04381910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64991476|NCT04381910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64991494|NCT04363801|Leucovorin|leucovorin|mesh-list
64991536|NCT04334941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64991537|NCT04334941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991538|NCT04334941|Immunologic Factors|immunologic factors|mesh-ancestor
64991539|NCT04334941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991540|NCT04334941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64991541|NCT04334941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991542|NCT04334941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991543|NCT04334876|Antibodies|antibodies|mesh-list
64991544|NCT04334876|Immunoglobulin G|immunoglobulin g|mesh-list
64991545|NCT04334876|Immunologic Factors|immunologic factors|mesh-ancestor
64991546|NCT04334876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991578|NCT04302870|Amantadine|amantadine|mesh-list
64991579|NCT04302870|Memantine|memantine|mesh-list
64991580|NCT04302870|Trazodone|trazodone|mesh-list
64991581|NCT04302870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64991582|NCT04302870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64991583|NCT04302870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64991584|NCT04302870|Dopamine Agents|dopamine agents|mesh-ancestor
64991585|NCT04302870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64991586|NCT04302870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991587|NCT04302870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991588|NCT04302870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64991589|NCT04302870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64991606|NCT04294628|Trastuzumab|trastuzumab|mesh-list
64991648|NCT04234568|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64991649|NCT04234568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991650|NCT04234568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64991651|NCT04231214|Tiotropium Bromide|tiotropium bromide|mesh-list
64991652|NCT04231214|Olodaterol|olodaterol|mesh-list
64991653|NCT04231214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64991654|NCT04231214|Autonomic Agents|autonomic agents|mesh-ancestor
64991655|NCT04231214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64991656|NCT04231214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991657|NCT04231214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64991658|NCT04231214|Respiratory System Agents|respiratory system agents|mesh-ancestor
64991664|NCT04229095|Suvorexant|suvorexant|mesh-list
64991701|NCT04216290|Cisplatin|cisplatin|mesh-list
64991702|NCT04216290|Fluorouracil|fluorouracil|mesh-list
64991703|NCT04216290|Durvalumab|durvalumab|mesh-list
64991704|NCT04216290|Mitomycins|mitomycins|mesh-list
64991705|NCT04216290|Mitomycin|mitomycin|mesh-list
64991706|NCT04216290|Immunoglobulins|immunoglobulins|mesh-list
64991707|NCT04216290|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64991708|NCT04216290|Immunoglobulin G|immunoglobulin g|mesh-list
64991709|NCT04216290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991710|NCT04216290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64991711|NCT04216290|Antimetabolites|antimetabolites|mesh-ancestor
64991712|NCT04216290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991713|NCT04216290|Antiviral Agents|antiviral agents|mesh-ancestor
64991714|NCT04216290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64991715|NCT04216290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991716|NCT04216290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64991717|NCT04216290|Immunologic Factors|immunologic factors|mesh-ancestor
64991718|NCT04216290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991719|NCT04216290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64991720|NCT04216290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64991721|NCT04216290|Alkylating Agents|alkylating agents|mesh-ancestor
64991722|NCT04216290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64991741|NCT04214249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991742|NCT04214249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64991743|NCT04214249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64991746|NCT04214067|Pembrolizumab|pembrolizumab|mesh-list
64991760|NCT04190433|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64991761|NCT04190433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64991762|NCT04190433|Adrenergic Agents|adrenergic agents|mesh-ancestor
64991763|NCT04190433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64991766|NCT04190433|Antioxidants|antioxidants|mesh-ancestor
64991802|NCT04172532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64991803|NCT04172532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991804|NCT04172532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991805|NCT04166409|Carboplatin|carboplatin|mesh-list
64991806|NCT04166409|Vincristine|vincristine|mesh-list
64991807|NCT04166409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991808|NCT04166409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64991809|NCT04166409|Tubulin Modulators|tubulin modulators|mesh-ancestor
64991810|NCT04166409|Antimitotic Agents|antimitotic agents|mesh-ancestor
64991811|NCT04166409|Mitosis Modulators|mitosis modulators|mesh-ancestor
64991812|NCT04166409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64991813|NCT04164069|Calcium, Dietary|calcium, dietary|mesh-list
64991814|NCT04164069|Leucovorin|leucovorin|mesh-list
64991815|NCT04164069|Folic Acid|folic acid|mesh-list
64991816|NCT04164069|Bevacizumab|bevacizumab|mesh-list
64991818|NCT04164069|Fluorouracil|fluorouracil|mesh-list
64991847|NCT04164069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991848|NCT04164069|Hematinics|hematinics|mesh-ancestor
64991849|NCT04163016|Certolizumab Pegol|certolizumab pegol|mesh-list
64991850|NCT04163016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64991851|NCT04163016|Immunologic Factors|immunologic factors|mesh-ancestor
64991852|NCT04163016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991853|NCT04163016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64991876|NCT04098744|Artesunate|artesunate|mesh-list
64991877|NCT04098744|Artemisinins|artemisinins|mesh-list
64991878|NCT04098744|Artemisinin|artemisinin|mesh-list
64991879|NCT04098744|Antimalarials|antimalarials|mesh-ancestor
64991880|NCT04098744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64991881|NCT04098744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64991882|NCT04098744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64991883|NCT04098744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991884|NCT04098744|Antiviral Agents|antiviral agents|mesh-ancestor
64991885|NCT04098744|Schistosomicides|schistosomicides|mesh-ancestor
64991886|NCT04098744|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64991887|NCT04098744|Anthelmintics|anthelmintics|mesh-ancestor
64991888|NCT04092283|Paclitaxel|paclitaxel|mesh-list
64991889|NCT04092283|Etoposide|etoposide|mesh-list
64991890|NCT04092283|Podophyllotoxin|podophyllotoxin|mesh-list
64991891|NCT04092283|Cisplatin|cisplatin|mesh-list
64991892|NCT04092283|Carboplatin|carboplatin|mesh-list
64991914|NCT04092283|Keratolytic Agents|keratolytic agents|mesh-ancestor
64991915|NCT04092283|Dermatologic Agents|dermatologic agents|mesh-ancestor
64991926|NCT04090398|Paclitaxel|paclitaxel|mesh-list
64991927|NCT04090398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64991935|NCT04088604|Fluorouracil|fluorouracil|mesh-list
64991955|NCT04068194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64991956|NCT04068194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64991957|NCT04068194|Immunologic Factors|immunologic factors|mesh-ancestor
64991958|NCT04068194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64991959|NCT04068194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64991960|NCT04068194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64991961|NCT04068194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992060|NCT03970096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992061|NCT03970096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992062|NCT03970096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64992063|NCT03970096|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64992064|NCT03970096|Abortifacient Agents|abortifacient agents|mesh-ancestor
64992065|NCT03970096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64992066|NCT03970096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64992067|NCT03970096|Antimetabolites|antimetabolites|mesh-ancestor
64992068|NCT03970096|Dermatologic Agents|dermatologic agents|mesh-ancestor
64992069|NCT03970096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992070|NCT03970096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64992071|NCT03970096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64992120|NCT03941860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64992121|NCT03941860|Growth Substances|growth substances|mesh-ancestor
64992122|NCT03941860|Growth Inhibitors|growth inhibitors|mesh-ancestor
64992123|NCT03941860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992124|NCT03941860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992125|NCT03941860|Protease Inhibitors|protease inhibitors|mesh-ancestor
64992126|NCT03941860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992127|NCT03941860|Glycine Agents|glycine agents|mesh-ancestor
64992128|NCT03941860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64992129|NCT03927989|Nicotine|nicotine|mesh-list
64992130|NCT03927989|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64992131|NCT03927989|Autonomic Agents|autonomic agents|mesh-ancestor
64992139|NCT03923725|Artesunate|artesunate|mesh-list
64992186|NCT03914625|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64992187|NCT03914625|Methotrexate|methotrexate|mesh-list
64992211|NCT03914625|Alkylating Agents|alkylating agents|mesh-ancestor
64992212|NCT03914625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992213|NCT03914625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992214|NCT03914625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64992215|NCT03914625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64992216|NCT03914625|Antiemetics|antiemetics|mesh-ancestor
64992217|NCT03914625|Autonomic Agents|autonomic agents|mesh-ancestor
64992218|NCT03914625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64992220|NCT03914625|Glucocorticoids|glucocorticoids|mesh-ancestor
64992231|NCT03914625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64992232|NCT03914625|Abortifacient Agents|abortifacient agents|mesh-ancestor
64992233|NCT03914625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64992234|NCT03914625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64992235|NCT03914625|Antimetabolites|antimetabolites|mesh-ancestor
64992236|NCT03914625|Dermatologic Agents|dermatologic agents|mesh-ancestor
64992237|NCT03914625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64992238|NCT03914625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64992239|NCT03914625|Antiviral Agents|antiviral agents|mesh-ancestor
64992240|NCT03914625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64992241|NCT03914625|Antidotes|antidotes|mesh-ancestor
64992242|NCT03914625|Protective Agents|protective agents|mesh-ancestor
64992243|NCT03914625|Vitamin B Complex|vitamin b complex|mesh-ancestor
64992244|NCT03914625|Vitamins|vitamins|mesh-ancestor
64992245|NCT03914625|Micronutrients|micronutrients|mesh-ancestor
64992246|NCT03914625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64992247|NCT03914625|Tubulin Modulators|tubulin modulators|mesh-ancestor
64992248|NCT03914625|Antimitotic Agents|antimitotic agents|mesh-ancestor
64992249|NCT03914625|Mitosis Modulators|mitosis modulators|mesh-ancestor
64992250|NCT03914625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64992251|NCT03914625|Hematinics|hematinics|mesh-ancestor
64992252|NCT03914612|Paclitaxel|paclitaxel|mesh-list
64992253|NCT03914612|Carboplatin|carboplatin|mesh-list
64992293|NCT03907488|Alkylating Agents|alkylating agents|mesh-ancestor
64992294|NCT03907488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64992295|NCT03907488|Tubulin Modulators|tubulin modulators|mesh-ancestor
64992296|NCT03907488|Antimitotic Agents|antimitotic agents|mesh-ancestor
64992297|NCT03907488|Mitosis Modulators|mitosis modulators|mesh-ancestor
64992298|NCT03896503|Topotecan|topotecan|mesh-list
64992299|NCT03896503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64992300|NCT03896503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64992301|NCT03896503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992302|NCT03896503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992303|NCT03896503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992304|NCT03880019|Temozolomide|temozolomide|mesh-list
64992305|NCT03880019|Olaparib|olaparib|mesh-list
64992306|NCT03880019|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64992307|NCT03880019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64992308|NCT03880019|Alkylating Agents|alkylating agents|mesh-ancestor
64992309|NCT03880019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992310|NCT03880019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992311|NCT03880019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992327|NCT03866382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64992328|NCT03866382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992329|NCT03866382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64992330|NCT03866382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992332|NCT03861091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64992333|NCT03861091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64992334|NCT03861091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992335|NCT03861091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64992336|NCT03861091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992337|NCT03861091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64992338|NCT03854474|Pembrolizumab|pembrolizumab|mesh-list
64992339|NCT03854474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64992340|NCT03854474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992348|NCT03842228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64992349|NCT03842228|Immunoglobulin G|immunoglobulin g|mesh-list
64992350|NCT03842228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64992351|NCT03842228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992352|NCT03842228|Immunologic Factors|immunologic factors|mesh-ancestor
64992353|NCT03842228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992354|NCT03842228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992355|NCT03842228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992423|NCT03775265|Mitomycin|mitomycin|mesh-list
64992424|NCT03775265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64992425|NCT03775265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992426|NCT03775265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64992427|NCT03775265|Antimetabolites|antimetabolites|mesh-ancestor
64992428|NCT03775265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992429|NCT03775265|Antiviral Agents|antiviral agents|mesh-ancestor
64992430|NCT03775265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64992431|NCT03775265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992432|NCT03775265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64992433|NCT03775265|Immunologic Factors|immunologic factors|mesh-ancestor
64992434|NCT03775265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992435|NCT03775265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64992436|NCT03775265|Alkylating Agents|alkylating agents|mesh-ancestor
64992437|NCT03775265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64992438|NCT03765788|Prednisolone|prednisolone|mesh-list
64992439|NCT03765788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64992440|NCT03765788|Glucocorticoids|glucocorticoids|mesh-ancestor
64992441|NCT03765788|Hormones|hormones|mesh-ancestor
64992442|NCT03765788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64837144|NCT01617356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64837145|NCT01617356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64837146|NCT01617356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64837147|NCT01617356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64837165|NCT01617564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837166|NCT01617564|Sensory System Agents|sensory system agents|mesh-ancestor
64837167|NCT01617564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64837168|NCT01617590|Methotrexate|methotrexate|mesh-list
64837169|NCT01617590|Leflunomide|leflunomide|mesh-list
64837170|NCT01617590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64448306|NCT01500226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837234|NCT01617798|Diuretics|diuretics|mesh-ancestor
64837235|NCT01617798|Natriuretic Agents|natriuretic agents|mesh-ancestor
64992443|NCT03765788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992444|NCT03765788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64992445|NCT03765788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992446|NCT03742414|Fluticasone|fluticasone|mesh-list
64992448|NCT03742414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64992449|NCT03742414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64992450|NCT03742414|Autonomic Agents|autonomic agents|mesh-ancestor
64992451|NCT03742414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64992452|NCT03742414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992453|NCT03742414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64992454|NCT03742414|Respiratory System Agents|respiratory system agents|mesh-ancestor
64992455|NCT03742414|Dermatologic Agents|dermatologic agents|mesh-ancestor
64992465|NCT03728881|Vaccines|vaccines|mesh-list
64992466|NCT03728881|Immunologic Factors|immunologic factors|mesh-ancestor
64992467|NCT03728881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992468|NCT03712605|Pembrolizumab|pembrolizumab|mesh-list
64992469|NCT03712605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64992470|NCT03712605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992471|NCT03711253|Tenofovir|tenofovir|mesh-list
64992472|NCT03711253|Emtricitabine|emtricitabine|mesh-list
64992473|NCT03711253|Antiviral Agents|antiviral agents|mesh-ancestor
64992474|NCT03711253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64992475|NCT03711253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64992476|NCT03711253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64992477|NCT03711253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992478|NCT03711253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992479|NCT03711253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64992480|NCT03711253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64992481|NCT03701282|Venetoclax|venetoclax|mesh-list
64992482|NCT03701282|Obinutuzumab|obinutuzumab|mesh-list
64992483|NCT03701282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992484|NCT03701282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64992485|NCT03698019|Pembrolizumab|pembrolizumab|mesh-list
64992516|NCT03643822|BB 1101|bb 1101|mesh-list
64992517|NCT03643822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64992518|NCT03643822|Antiemetics|antiemetics|mesh-ancestor
64992519|NCT03643822|Autonomic Agents|autonomic agents|mesh-ancestor
64992524|NCT03643822|Hormones|hormones|mesh-ancestor
64992525|NCT03643822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64992526|NCT03643822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64992527|NCT03643822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992528|NCT03643822|Protease Inhibitors|protease inhibitors|mesh-ancestor
64992529|NCT03643822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992530|NCT03643822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992531|NCT03643822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64992532|NCT03643822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64992533|NCT03643822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64992534|NCT03643822|Analgesics|analgesics|mesh-ancestor
64992535|NCT03643822|Sensory System Agents|sensory system agents|mesh-ancestor
64992536|NCT03643822|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64992537|NCT03643822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64992538|NCT03643822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64992539|NCT03643822|Adrenergic Agents|adrenergic agents|mesh-ancestor
64992540|NCT03643822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64992541|NCT03641313|Irinotecan|irinotecan|mesh-list
64992542|NCT03641313|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64992543|NCT03641313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64992544|NCT03641313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992546|NCT03641313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992560|NCT03606967|Tremelimumab|tremelimumab|mesh-list
64992561|NCT03606967|Ipilimumab|ipilimumab|mesh-list
64992562|NCT03606967|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64992563|NCT03606967|Vaccines|vaccines|mesh-list
64992564|NCT03606967|Immunoglobulins|immunoglobulins|mesh-list
64992565|NCT03606967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64992566|NCT03606967|Immunoglobulin G|immunoglobulin g|mesh-list
64992567|NCT03606967|Poly ICLC|poly iclc|mesh-list
64992568|NCT03606967|Immunologic Factors|immunologic factors|mesh-ancestor
64992569|NCT03606967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992570|NCT03606967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64992571|NCT03606967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992572|NCT03606967|Tubulin Modulators|tubulin modulators|mesh-ancestor
64992573|NCT03606967|Antimitotic Agents|antimitotic agents|mesh-ancestor
64326093|NCT00971035|Immunologic Factors|immunologic factors|mesh-ancestor
64326094|NCT00971035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326096|NCT04310059|Hematinics|hematinics|mesh-ancestor
64326097|NCT04310059|Vitamin B Complex|vitamin b complex|mesh-ancestor
64992574|NCT03606967|Mitosis Modulators|mitosis modulators|mesh-ancestor
64992575|NCT03606967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992576|NCT03606967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64992577|NCT03606967|Antimetabolites|antimetabolites|mesh-ancestor
64992578|NCT03606967|Antiviral Agents|antiviral agents|mesh-ancestor
64992579|NCT03606967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64992580|NCT03606967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992581|NCT03606967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64992582|NCT03606967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64992613|NCT03599622|BMS-986165|bms-986165|mesh-list
64992614|NCT03599622|Dermatologic Agents|dermatologic agents|mesh-ancestor
64992615|NCT03599622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64992616|NCT03599622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992617|NCT03599622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992618|NCT03598257|Olaparib|olaparib|mesh-list
64992619|NCT03598257|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64992620|NCT03598257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992621|NCT03598257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992622|NCT03598257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992623|NCT03582176|Ketotifen|ketotifen|mesh-list
64992624|NCT03582176|Antipruritics|antipruritics|mesh-ancestor
64992625|NCT03582176|Dermatologic Agents|dermatologic agents|mesh-ancestor
64992626|NCT03582176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64992627|NCT03582176|Histamine Antagonists|histamine antagonists|mesh-ancestor
64992628|NCT03582176|Histamine Agents|histamine agents|mesh-ancestor
64992629|NCT03582176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64326098|NCT04310059|Vitamins|vitamins|mesh-ancestor
64326099|NCT04310059|Micronutrients|micronutrients|mesh-ancestor
64326100|NCT04310059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326101|NCT04787965|Opicapone|opicapone|mesh-list
64326102|NCT04787965|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64326103|NCT04787965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326104|NCT04787965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837264|NCT01617928|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64837265|NCT01617928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837266|NCT01618006|Aspirin|aspirin|mesh-list
64837267|NCT01618006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64837268|NCT01618006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64837269|NCT01618006|Analgesics|analgesics|mesh-ancestor
64837270|NCT01618006|Sensory System Agents|sensory system agents|mesh-ancestor
64837271|NCT01618006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64837272|NCT01618006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837273|NCT01618006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64837274|NCT01618006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64837275|NCT01618006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64837276|NCT01618006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64837277|NCT01618006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992630|NCT03582176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992631|NCT03582176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992632|NCT03582176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64992633|NCT03575000|Bromocriptine|bromocriptine|mesh-list
64992664|NCT03513952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992665|NCT03513952|Immunologic Factors|immunologic factors|mesh-ancestor
64992666|NCT03513952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992668|NCT03502733|Ipilimumab|ipilimumab|mesh-list
64992669|NCT03502733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64992670|NCT03502733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992671|NCT03502733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64992672|NCT03502733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992728|NCT03456700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992729|NCT03456700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64992730|NCT03440372|Ozanimod|ozanimod|mesh-list
64992731|NCT03440372|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64992732|NCT03440372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992733|NCT03440372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64992735|NCT03440372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992736|NCT03422822|Abrocitinib|abrocitinib|mesh-list
64992737|NCT03422822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64992738|NCT03422822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992739|NCT03422822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992740|NCT03321643|Gemcitabine|gemcitabine|mesh-list
64992741|NCT03321643|Rituximab|rituximab|mesh-list
64992742|NCT03321643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64992792|NCT03269669|Hormones|hormones|mesh-ancestor
64992860|NCT03191864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64992861|NCT03191864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992862|NCT03191864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64992863|NCT03191864|Respiratory System Agents|respiratory system agents|mesh-ancestor
64992864|NCT03191864|Dermatologic Agents|dermatologic agents|mesh-ancestor
64992865|NCT03191864|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64992871|NCT03190915|Trametinib|trametinib|mesh-list
64992872|NCT03190915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992873|NCT03190915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64992874|NCT03190915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992875|NCT03190915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992879|NCT03178149|Tacrolimus|tacrolimus|mesh-list
64992895|NCT03155620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64992896|NCT03141684|Bevacizumab|bevacizumab|mesh-list
64992897|NCT03141684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64992898|NCT03141684|Atezolizumab|atezolizumab|mesh-list
64992899|NCT03141684|Endothelial Growth Factors|endothelial growth factors|mesh-list
64992900|NCT03141684|Antibodies|antibodies|mesh-list
64992901|NCT03141684|Immunoglobulins|immunoglobulins|mesh-list
64992902|NCT03141684|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64992903|NCT03141684|Immunoglobulin G|immunoglobulin g|mesh-list
64992904|NCT03141684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992905|NCT03141684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64992906|NCT03141684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64992907|NCT03141684|Growth Substances|growth substances|mesh-ancestor
64992908|NCT03141684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992909|NCT03141684|Growth Inhibitors|growth inhibitors|mesh-ancestor
64992910|NCT03141684|Immunologic Factors|immunologic factors|mesh-ancestor
64992911|NCT03123978|Niclosamide|niclosamide|mesh-list
64992912|NCT03123978|Anticestodal Agents|anticestodal agents|mesh-ancestor
64992913|NCT03123978|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64992914|NCT03123978|Anthelmintics|anthelmintics|mesh-ancestor
64992915|NCT03123978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64992916|NCT03123978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64837278|NCT01618006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64837279|NCT01618006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64358905|NCT03684213|Norepinephrine|norepinephrine|mesh-list
64837290|NCT01618188|Insulin|insulin|mesh-list
64605798|NCT00868309|Antivenins|antivenins|mesh-list
64837291|NCT01618188|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64837292|NCT01618188|Insulin Aspart|insulin aspart|mesh-list
64992917|NCT03123978|Antinematodal Agents|antinematodal agents|mesh-ancestor
64992918|NCT03114072|Methamphetamine|methamphetamine|mesh-list
64992947|NCT03030378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64992948|NCT03030378|Immunologic Factors|immunologic factors|mesh-ancestor
64992949|NCT03030378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64992950|NCT03030378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64992951|NCT03030378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64992952|NCT03030378|Growth Substances|growth substances|mesh-ancestor
64992953|NCT03030378|Growth Inhibitors|growth inhibitors|mesh-ancestor
64992954|NCT03002103|Gemcitabine|gemcitabine|mesh-list
64992955|NCT03002103|Paclitaxel|paclitaxel|mesh-list
64992956|NCT03002103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64992957|NCT03002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64992958|NCT03002103|Tubulin Modulators|tubulin modulators|mesh-ancestor
64992959|NCT03002103|Antimitotic Agents|antimitotic agents|mesh-ancestor
64992960|NCT03002103|Mitosis Modulators|mitosis modulators|mesh-ancestor
64992961|NCT03002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64992962|NCT03002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64992963|NCT03002103|Antimetabolites|antimetabolites|mesh-ancestor
64992964|NCT03002103|Antiviral Agents|antiviral agents|mesh-ancestor
64992965|NCT03002103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64992966|NCT03002103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64992998|NCT02978625|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
64992999|NCT02978625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64993000|NCT02978625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993001|NCT02978625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64993002|NCT02978625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993003|NCT02975882|Sirolimus|sirolimus|mesh-list
64993004|NCT02975882|Irinotecan|irinotecan|mesh-list
64993005|NCT02975882|Camptothecin|camptothecin|mesh-list
64993006|NCT02975882|Temozolomide|temozolomide|mesh-list
64993007|NCT02975882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64993008|NCT02975882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64837293|NCT01618188|Insulin, Long-Acting|insulin, long-acting|mesh-list
64837294|NCT01618188|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64837295|NCT01618188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64837296|NCT01618188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993009|NCT02975882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993010|NCT02975882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993011|NCT02975882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993012|NCT02975882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64993013|NCT02975882|Alkylating Agents|alkylating agents|mesh-ancestor
64993014|NCT02975882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64993015|NCT02975882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64993016|NCT02975882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64993017|NCT02975882|Antifungal Agents|antifungal agents|mesh-ancestor
64993018|NCT02975882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64993047|NCT02923778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993048|NCT02912559|Calcium, Dietary|calcium, dietary|mesh-list
64993049|NCT02912559|Leucovorin|leucovorin|mesh-list
64993050|NCT02912559|Folic Acid|folic acid|mesh-list
64993051|NCT02912559|Fluorouracil|fluorouracil|mesh-list
64993052|NCT02912559|Oxaliplatin|oxaliplatin|mesh-list
64993053|NCT02912559|Atezolizumab|atezolizumab|mesh-list
64993054|NCT02912559|Calcium|calcium|mesh-list
64993055|NCT02912559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64993056|NCT02912559|Levoleucovorin|levoleucovorin|mesh-list
64993057|NCT02912559|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64993058|NCT02912559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993059|NCT02912559|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64993060|NCT02912559|Antimetabolites|antimetabolites|mesh-ancestor
64993061|NCT02912559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993062|NCT02912559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64993063|NCT02912559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837297|NCT01618253|Sorafenib|sorafenib|mesh-list
64993119|NCT02830724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64993120|NCT02830724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64993125|NCT02830724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64993155|NCT02737046|Interferon-alpha|interferon-alpha|mesh-list
64993156|NCT02737046|Interferon alpha-2|interferon alpha-2|mesh-list
64993157|NCT02737046|Zidovudine|zidovudine|mesh-list
64993158|NCT02737046|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64993159|NCT02737046|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
64993160|NCT02737046|Belinostat|belinostat|mesh-list
64993161|NCT02737046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993162|NCT02737046|Antiviral Agents|antiviral agents|mesh-ancestor
64993163|NCT02737046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64993164|NCT02737046|Immunologic Factors|immunologic factors|mesh-ancestor
64993165|NCT02737046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993166|NCT02737046|Antimetabolites|antimetabolites|mesh-ancestor
64993167|NCT02737046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993168|NCT02737046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64993214|NCT02631733|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64993215|NCT02631733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64993216|NCT02631733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64993217|NCT02631733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993218|NCT02631733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993219|NCT02631733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993220|NCT02631733|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64993221|NCT02631733|Hematinics|hematinics|mesh-ancestor
64993222|NCT02631733|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64993223|NCT02631733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64993224|NCT02595931|Irinotecan|irinotecan|mesh-list
64993225|NCT02595931|Camptothecin|camptothecin|mesh-list
64993226|NCT02595931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64993240|NCT02595879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64993241|NCT02595866|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64993242|NCT02595866|Pembrolizumab|pembrolizumab|mesh-list
64993243|NCT02595866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64993244|NCT02595866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993245|NCT02595866|Antiviral Agents|antiviral agents|mesh-ancestor
64993246|NCT02595866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64993247|NCT02573493|Paclitaxel|paclitaxel|mesh-list
64993248|NCT02573493|Cisplatin|cisplatin|mesh-list
64993249|NCT02573493|Cetuximab|cetuximab|mesh-list
64993250|NCT02573493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64993251|NCT02573493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993252|NCT02573493|Tubulin Modulators|tubulin modulators|mesh-ancestor
64993253|NCT02573493|Antimitotic Agents|antimitotic agents|mesh-ancestor
64993254|NCT02573493|Mitosis Modulators|mitosis modulators|mesh-ancestor
64993255|NCT02573493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993256|NCT02573493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64993257|NCT02521493|Cytarabine|cytarabine|mesh-list
64993258|NCT02521493|Etoposide|etoposide|mesh-list
64993259|NCT02521493|Podophyllotoxin|podophyllotoxin|mesh-list
64993260|NCT02521493|Daunorubicin|daunorubicin|mesh-list
64993261|NCT02521493|Mitoxantrone|mitoxantrone|mesh-list
64837298|NCT01618253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837299|NCT01618253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64837300|NCT01618253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448354|NCT01859715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64326111|NCT02670915|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64993262|NCT02521493|Etoposide phosphate|etoposide phosphate|mesh-list
64993263|NCT02521493|Asparaginase|asparaginase|mesh-list
64993264|NCT02521493|Mercaptopurine|mercaptopurine|mesh-list
64993265|NCT02521493|Thioguanine|thioguanine|mesh-list
64993266|NCT02521493|2-Aminopurine|2-aminopurine|mesh-list
64993267|NCT02521493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64993268|NCT02521493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993269|NCT02521493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64993270|NCT02521493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64993271|NCT02521493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993283|NCT02521493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64993284|NCT02521493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64993285|NCT02521493|Keratolytic Agents|keratolytic agents|mesh-ancestor
64993290|NCT02502266|Paclitaxel|paclitaxel|mesh-list
64993397|NCT02394834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64993398|NCT02394834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993399|NCT02394834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64993400|NCT02394834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64993401|NCT02394834|Growth Substances|growth substances|mesh-ancestor
64993402|NCT02394834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993403|NCT02394834|Growth Inhibitors|growth inhibitors|mesh-ancestor
64993404|NCT02394834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64993405|NCT02394834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64993406|NCT02394834|Antimetabolites|antimetabolites|mesh-ancestor
64993407|NCT02394834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993408|NCT02394834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64993409|NCT02394834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64993410|NCT02394834|Immunologic Factors|immunologic factors|mesh-ancestor
64993411|NCT02394834|Antidotes|antidotes|mesh-ancestor
64993412|NCT02394834|Protective Agents|protective agents|mesh-ancestor
64993413|NCT02394834|Vitamin B Complex|vitamin b complex|mesh-ancestor
64993443|NCT02327078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64993444|NCT02327078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993445|NCT02314169|Nivolumab|nivolumab|mesh-list
64993446|NCT02314169|Ipilimumab|ipilimumab|mesh-list
64993447|NCT02314169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64993448|NCT02314169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993449|NCT02314169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64993450|NCT02314169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993451|NCT02304458|Nivolumab|nivolumab|mesh-list
64993452|NCT02304458|Ipilimumab|ipilimumab|mesh-list
64993492|NCT02219373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64993493|NCT02219373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64993494|NCT02219373|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64993495|NCT02219373|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64993496|NCT02219373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64993497|NCT02219373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993498|NCT02219373|Antimanic Agents|antimanic agents|mesh-ancestor
64993499|NCT02219373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64993500|NCT02219373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64993501|NCT02219373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64993502|NCT02219373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64993503|NCT02219373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64993504|NCT02208375|Olaparib|olaparib|mesh-list
64993505|NCT02208375|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64993506|NCT02208375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993507|NCT02208375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993508|NCT02208375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993509|NCT02196181|Trametinib|trametinib|mesh-list
64993510|NCT02196181|Dabrafenib|dabrafenib|mesh-list
64993511|NCT02196181|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
64993551|NCT02187224|Hormones|hormones|mesh-ancestor
64993590|NCT02032823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993591|NCT02032823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993592|NCT02003222|Cytarabine|cytarabine|mesh-list
64993593|NCT02003222|Dexamethasone|dexamethasone|mesh-list
64993594|NCT02003222|Dexamethasone acetate|dexamethasone acetate|mesh-list
64993595|NCT02003222|Prednisone|prednisone|mesh-list
64993596|NCT02003222|Cortisone|cortisone|mesh-list
64993597|NCT02003222|Cyclophosphamide|cyclophosphamide|mesh-list
64993598|NCT02003222|Rituximab|rituximab|mesh-list
64993599|NCT02003222|Methotrexate|methotrexate|mesh-list
64993600|NCT02003222|Etoposide|etoposide|mesh-list
64993601|NCT02003222|Vincristine|vincristine|mesh-list
64993602|NCT02003222|Etoposide phosphate|etoposide phosphate|mesh-list
64993603|NCT02003222|Daunorubicin|daunorubicin|mesh-list
64993604|NCT02003222|Asparaginase|asparaginase|mesh-list
64993605|NCT02003222|Mercaptopurine|mercaptopurine|mesh-list
64993606|NCT02003222|Podophyllotoxin|podophyllotoxin|mesh-list
64993607|NCT02003222|Pegaspargase|pegaspargase|mesh-list
64993608|NCT02003222|Blinatumomab|blinatumomab|mesh-list
64993609|NCT02003222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64993610|NCT02003222|Muromonab-CD3|muromonab-cd3|mesh-list
64993611|NCT02003222|Antibodies|antibodies|mesh-list
64993612|NCT02003222|Immunoglobulins|immunoglobulins|mesh-list
64993613|NCT02003222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64993615|NCT02003222|BB 1101|bb 1101|mesh-list
64993705|NCT01912625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64993706|NCT01912625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993707|NCT01912625|Tubulin Modulators|tubulin modulators|mesh-ancestor
64993708|NCT01912625|Antimitotic Agents|antimitotic agents|mesh-ancestor
64993760|NCT00567580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993761|NCT00567580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64993762|NCT00567580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993763|NCT00567580|Androgen Antagonists|androgen antagonists|mesh-ancestor
64993764|NCT00567580|Hormone Antagonists|hormone antagonists|mesh-ancestor
64993765|NCT00567580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64993766|NCT00567580|Luteolytic Agents|luteolytic agents|mesh-ancestor
64993767|NCT00567580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64993768|NCT00567580|Contraceptive Agents|contraceptive agents|mesh-ancestor
64993769|NCT00567580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64993770|NCT00268385|Temozolomide|temozolomide|mesh-list
64993771|NCT00268385|Vorinostat|vorinostat|mesh-list
64993772|NCT00268385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64993773|NCT00268385|Alkylating Agents|alkylating agents|mesh-ancestor
64993774|NCT00268385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993775|NCT00268385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993776|NCT00268385|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64993777|NCT00268385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326112|NCT02670915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64358969|NCT04509583|Vitamin E|vitamin e|mesh-list
64837311|NCT01618396|Anesthetics|anesthetics|mesh-ancestor
64837312|NCT01618396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64837313|NCT01618396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64837314|NCT01618396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64837315|NCT01618396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64326113|NCT02670915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326114|NCT02545868|Vaccines|vaccines|mesh-list
64326115|NCT02545868|Immunologic Factors|immunologic factors|mesh-ancestor
64326116|NCT02545868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350406|NCT03486353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64837327|NCT01618474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837328|NCT01618474|Tubulin Modulators|tubulin modulators|mesh-ancestor
64837329|NCT01618474|Antimitotic Agents|antimitotic agents|mesh-ancestor
64837330|NCT01618474|Mitosis Modulators|mitosis modulators|mesh-ancestor
64837331|NCT01618474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837332|NCT01618474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64837333|NCT01618474|Antimetabolites|antimetabolites|mesh-ancestor
64837335|NCT01618513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64837336|NCT01618513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64837337|NCT01618513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837338|NCT01618539|Propofol|propofol|mesh-list
64837339|NCT01618539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64837340|NCT01618539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64837341|NCT01618539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837342|NCT01618539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64837343|NCT01618539|Anesthetics, General|anesthetics, general|mesh-ancestor
64837344|NCT01618539|Anesthetics|anesthetics|mesh-ancestor
64837345|NCT01618591|Azithromycin|azithromycin|mesh-list
64837346|NCT01618591|Levofloxacin|levofloxacin|mesh-list
64837347|NCT01618591|Ofloxacin|ofloxacin|mesh-list
64837348|NCT01618591|Rifaximin|rifaximin|mesh-list
64837349|NCT01618591|Loperamide|loperamide|mesh-list
64837350|NCT01618591|Antidiarrheals|antidiarrheals|mesh-list
64837351|NCT01618591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64837352|NCT01618591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64837353|NCT01618591|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64837354|NCT01618591|Renal Agents|renal agents|mesh-ancestor
64837355|NCT01618591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64837356|NCT01618591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64837357|NCT01618591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837358|NCT01618591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448436|NCT01499368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837396|NCT01618799|Lamotrigine|lamotrigine|mesh-list
64837397|NCT01618799|Anticonvulsants|anticonvulsants|mesh-list
64837398|NCT01618799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64837399|NCT01618799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64837400|NCT01618799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837401|NCT01618799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64837402|NCT01618799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837403|NCT01618799|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64326120|NCT00821977|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64326121|NCT00821977|Protease Inhibitors|protease inhibitors|mesh-ancestor
64326122|NCT00821977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837405|NCT01618799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64837406|NCT01618799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64837407|NCT01618799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64837408|NCT01618825|Lamotrigine|lamotrigine|mesh-list
64837409|NCT01618825|Anticonvulsants|anticonvulsants|mesh-list
64837410|NCT01618825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64837411|NCT01618825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64448481|NCT01833897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64326123|NCT00821977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326124|NCT04474327|Montelukast|montelukast|mesh-list
64837418|NCT01618825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64837419|NCT01618825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64837420|NCT01618877|Levetiracetam|levetiracetam|mesh-list
64837421|NCT01618877|Anticonvulsants|anticonvulsants|mesh-ancestor
64326125|NCT04474327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64326126|NCT04474327|Respiratory System Agents|respiratory system agents|mesh-ancestor
64326127|NCT04474327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64326128|NCT04474327|Hormone Antagonists|hormone antagonists|mesh-ancestor
64326129|NCT04474327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64837430|NCT01618890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64837431|NCT01618890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64837432|NCT01618890|Vasodilator Agents|vasodilator agents|mesh-ancestor
64837433|NCT01618903|Levetiracetam|levetiracetam|mesh-list
64326130|NCT04474327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326131|NCT04474327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64326132|NCT04474327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64326133|NCT04474327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326135|NCT04745949|Cortisone|cortisone|mesh-list
64326136|NCT04745949|Cyclophosphamide|cyclophosphamide|mesh-list
64326137|NCT04745949|Rituximab|rituximab|mesh-list
64837450|NCT01619007|Protease Inhibitors|protease inhibitors|mesh-ancestor
64837451|NCT01619007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837452|NCT01619007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837453|NCT01619007|Anticoagulants|anticoagulants|mesh-ancestor
64837454|NCT01619046|Factor VIII|factor viii|mesh-list
64837455|NCT01619046|Coagulants|coagulants|mesh-ancestor
64837456|NCT01619072|Misoprostol|misoprostol|mesh-list
64837457|NCT01619072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64837458|NCT01619072|Abortifacient Agents|abortifacient agents|mesh-ancestor
64837459|NCT01619072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64837460|NCT01619072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837461|NCT01619072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64837506|NCT01619176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64837507|NCT01619176|Immunologic Factors|immunologic factors|mesh-ancestor
64837508|NCT01619176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64837509|NCT01619176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64837510|NCT01619176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64837552|NCT01619566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64837553|NCT01619566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837555|NCT01619566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837556|NCT01619566|Analgesics|analgesics|mesh-ancestor
64837557|NCT01619566|Sensory System Agents|sensory system agents|mesh-ancestor
64837558|NCT01619566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64837559|NCT01619566|Antidepressive Agents|antidepressive agents|mesh-ancestor
64837560|NCT01619566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64837561|NCT01619566|Dopamine Agents|dopamine agents|mesh-ancestor
64837562|NCT01619644|Valproic Acid|valproic acid|mesh-list
64837563|NCT01619644|Anticonvulsants|anticonvulsants|mesh-ancestor
64837564|NCT01619644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837565|NCT01619644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837566|NCT01619644|GABA Agents|gaba agents|mesh-ancestor
64837567|NCT01619644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64837568|NCT01619644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837569|NCT01619644|Antimanic Agents|antimanic agents|mesh-ancestor
64837570|NCT01619644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64837571|NCT01619644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64448643|NCT03026842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64326194|NCT00961675|Blood Substitutes|blood substitutes|mesh-ancestor
64326195|NCT00961675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64326196|NCT00819169|Conatumumab|conatumumab|mesh-list
64326197|NCT00819169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64326198|NCT00819169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326199|NCT02161679|Carboplatin|carboplatin|mesh-list
64360607|NCT03343873|GABA Modulators|gaba modulators|mesh-ancestor
64837603|NCT01619761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64837604|NCT01619761|Alkylating Agents|alkylating agents|mesh-ancestor
64837605|NCT01619761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837606|NCT01619761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837607|NCT01619761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64448662|NCT01497262|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64326216|NCT04729725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326217|NCT04262492|Rivaroxaban|rivaroxaban|mesh-list
64326218|NCT04262492|Apixaban|apixaban|mesh-list
64326219|NCT04262492|Edoxaban|edoxaban|mesh-list
64326220|NCT04262492|Dabigatran|dabigatran|mesh-list
64326221|NCT04262492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64326222|NCT04262492|Antithrombins|antithrombins|mesh-ancestor
64326223|NCT04262492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64326224|NCT04262492|Protease Inhibitors|protease inhibitors|mesh-ancestor
64326225|NCT04262492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837608|NCT01619761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64837609|NCT01619761|Antimetabolites|antimetabolites|mesh-ancestor
64837610|NCT01619761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64837611|NCT01619761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837612|NCT01619761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64837613|NCT01619761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64837614|NCT01619761|Growth Substances|growth substances|mesh-ancestor
64837615|NCT01619761|Growth Inhibitors|growth inhibitors|mesh-ancestor
64837616|NCT01619761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64837617|NCT01619761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64837618|NCT01619761|Antitubercular Agents|antitubercular agents|mesh-ancestor
64837619|NCT01619761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64326226|NCT04262492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326227|NCT04262492|Anticoagulants|anticoagulants|mesh-ancestor
64326229|NCT00955981|Gout Suppressants|gout suppressants|mesh-ancestor
64326230|NCT00955981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64326231|NCT00955981|Uricosuric Agents|uricosuric agents|mesh-ancestor
64326232|NCT00955981|Renal Agents|renal agents|mesh-ancestor
64326233|NCT03541031|Micronutrients|micronutrients|mesh-list
64326234|NCT03541031|Trace Elements|trace elements|mesh-list
64326235|NCT03541031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837628|NCT01619813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64837629|NCT01619813|Glucocorticoids|glucocorticoids|mesh-ancestor
64837630|NCT01619813|Hormones|hormones|mesh-ancestor
64837631|NCT01619813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64837632|NCT01619813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837633|NCT01619813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64837634|NCT01619891|Vitamin D|vitamin d|mesh-list
64837635|NCT01619891|Vitamins|vitamins|mesh-ancestor
64837636|NCT01619891|Micronutrients|micronutrients|mesh-ancestor
64837637|NCT01619891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448692|NCT02224157|Budesonide|budesonide|mesh-list
64837638|NCT01619891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64837639|NCT01620112|Lidocaine|lidocaine|mesh-list
64837640|NCT01620112|Clonidine|clonidine|mesh-list
64837653|NCT01620112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64837654|NCT01620112|Sympatholytics|sympatholytics|mesh-ancestor
64837655|NCT01620112|Autonomic Agents|autonomic agents|mesh-ancestor
64837656|NCT01620112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64326236|NCT05454709|Glucagon|glucagon|mesh-list
64326237|NCT05454709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64326238|NCT05454709|Hormones|hormones|mesh-ancestor
64326239|NCT05454709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64326240|NCT05454709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837657|NCT01620112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64837658|NCT01620112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64837659|NCT01620112|Adrenergic Agents|adrenergic agents|mesh-ancestor
64837660|NCT01620112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64837661|NCT01620229|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64837662|NCT01620229|Antibodies|antibodies|mesh-list
64837663|NCT01620229|Immunoglobulins|immunoglobulins|mesh-list
64837664|NCT01620229|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64837665|NCT01620229|Immunoconjugates|immunoconjugates|mesh-list
64837666|NCT01620229|Immunologic Factors|immunologic factors|mesh-ancestor
64837667|NCT01620229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837668|NCT01620229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64837669|NCT01620229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837670|NCT01620268|Leflunomide|leflunomide|mesh-list
64837680|NCT01620307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837681|NCT01620307|Antifungal Agents|antifungal agents|mesh-ancestor
64837682|NCT01620307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64837683|NCT01620307|Immunologic Factors|immunologic factors|mesh-ancestor
64837684|NCT01620307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837685|NCT01620320|Dobutamine|dobutamine|mesh-list
64837686|NCT01620320|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64837687|NCT01620320|Sympathomimetics|sympathomimetics|mesh-ancestor
64837688|NCT01620320|Autonomic Agents|autonomic agents|mesh-ancestor
64837689|NCT01620320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64837690|NCT01620320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837691|NCT01620320|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64837710|NCT01620424|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64837711|NCT01620424|Biphasic Insulins|biphasic insulins|mesh-list
64837712|NCT01620424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64837713|NCT01620424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64448764|NCT01623752|Analgesics|analgesics|mesh-ancestor
64837725|NCT01620463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837726|NCT01620463|Incretins|incretins|mesh-ancestor
64837727|NCT01620463|Hormones|hormones|mesh-ancestor
64837728|NCT01620463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64837730|NCT01620476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64837744|NCT01620736|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64837745|NCT01620736|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64326282|NCT02154737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64326283|NCT00813163|Irinotecan|irinotecan|mesh-list
64326284|NCT00813163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64326285|NCT00813163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64326286|NCT00813163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326287|NCT00813163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837746|NCT01620736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837747|NCT01620736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837748|NCT01620814|Misoprostol|misoprostol|mesh-list
64837749|NCT01620814|Dinoprostone|dinoprostone|mesh-list
64837750|NCT01620814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64837751|NCT01620814|Abortifacient Agents|abortifacient agents|mesh-ancestor
64837752|NCT01620814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64837753|NCT01620814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837754|NCT01620814|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64837755|NCT01620814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64837756|NCT01620814|Oxytocics|oxytocics|mesh-ancestor
64837757|NCT01620840|Lacosamide|lacosamide|mesh-list
64837758|NCT01620840|Anticonvulsants|anticonvulsants|mesh-ancestor
64837759|NCT01620840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64837772|NCT01620944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837773|NCT01620944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64837774|NCT01620944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64837775|NCT01620944|Antiviral Agents|antiviral agents|mesh-ancestor
64837776|NCT01620944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64837777|NCT01620944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64837778|NCT01620944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64837779|NCT01620944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64837780|NCT01620944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64837781|NCT01621022|Bupropion|bupropion|mesh-list
64837782|NCT01621022|Nicotine|nicotine|mesh-list
64837783|NCT01621022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64448827|NCT02219009|Aripiprazole|aripiprazole|mesh-list
64326288|NCT00813163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326290|NCT04030455|Carboplatin|carboplatin|mesh-list
64326291|NCT04030455|Docetaxel|docetaxel|mesh-list
64326292|NCT04030455|Pembrolizumab|pembrolizumab|mesh-list
64326293|NCT04030455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64448845|NCT01456936|Bupropion|bupropion|mesh-list
64326294|NCT04030455|Tubulin Modulators|tubulin modulators|mesh-ancestor
64296071|NCT02926586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326295|NCT04030455|Antimitotic Agents|antimitotic agents|mesh-ancestor
64326296|NCT04030455|Mitosis Modulators|mitosis modulators|mesh-ancestor
64837795|NCT01621022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64837796|NCT01621022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64837797|NCT01621022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64837799|NCT01621022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64837800|NCT01621022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64837801|NCT01621022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837802|NCT01621100|Hydromorphone|hydromorphone|mesh-list
64837803|NCT01621100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64837804|NCT01621100|Narcotics|narcotics|mesh-ancestor
64837805|NCT01621100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64837806|NCT01621100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837811|NCT01621113|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64837812|NCT01621113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64837813|NCT01621113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837814|NCT01621165|Prazosin|prazosin|mesh-list
64837815|NCT01621165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64837816|NCT01621165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64837817|NCT01621165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64837818|NCT01621165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64837827|NCT01621204|Immunologic Factors|immunologic factors|mesh-ancestor
64837828|NCT01621204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837830|NCT01621217|Mitomycins|mitomycins|mesh-list
64837831|NCT01621217|Mitomycin|mitomycin|mesh-list
64837832|NCT01621217|Fluorouracil|fluorouracil|mesh-list
64837833|NCT01621217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64837834|NCT01621217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837835|NCT01621217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64837836|NCT01621217|Alkylating Agents|alkylating agents|mesh-ancestor
64837837|NCT01621217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448872|NCT01456780|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64326312|NCT04474093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64837838|NCT01621217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64837839|NCT01621217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837840|NCT01621217|Antimetabolites|antimetabolites|mesh-ancestor
64837841|NCT01621217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64837842|NCT01621217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64837843|NCT01621217|Immunologic Factors|immunologic factors|mesh-ancestor
64837844|NCT01621217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837845|NCT01621256|Ancrod|ancrod|mesh-list
64837846|NCT01621256|Anticoagulants|anticoagulants|mesh-ancestor
64837847|NCT01621256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64837848|NCT01621256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64837849|NCT01621256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837850|NCT01621269|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64837851|NCT01621269|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64448893|NCT01455220|Natalizumab|natalizumab|mesh-list
64837857|NCT01621308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64837858|NCT01621308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837859|NCT01621321|Voriconazole|voriconazole|mesh-list
64837860|NCT01621321|Prednisolone|prednisolone|mesh-list
64837861|NCT01621321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64837862|NCT01621321|Glucocorticoids|glucocorticoids|mesh-ancestor
64837863|NCT01621321|Hormones|hormones|mesh-ancestor
64837864|NCT01621321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64334616|NCT02292277|Ticagrelor|ticagrelor|mesh-list
64334617|NCT02292277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64334618|NCT02292277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64334619|NCT02292277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64334620|NCT02292277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64837865|NCT01621321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837866|NCT01621321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64837867|NCT01621321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837868|NCT01621321|Antifungal Agents|antifungal agents|mesh-ancestor
64837869|NCT01621321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64837870|NCT01621321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64448907|NCT01454596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326316|NCT04474093|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64837880|NCT01621373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837881|NCT01621373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64326317|NCT04474093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64326318|NCT04474093|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64326319|NCT04474093|Antidepressive Agents|antidepressive agents|mesh-ancestor
64326320|NCT04474093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64837894|NCT01621386|Respiratory System Agents|respiratory system agents|mesh-ancestor
64837895|NCT01621386|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64837896|NCT01621386|Hormone Antagonists|hormone antagonists|mesh-ancestor
64837897|NCT01621386|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64837898|NCT01621386|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64837899|NCT01621386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837901|NCT01621451|Clopidogrel|clopidogrel|mesh-list
64837902|NCT01621451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64837903|NCT01621451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64837904|NCT01621451|Analgesics|analgesics|mesh-ancestor
64837905|NCT01621451|Sensory System Agents|sensory system agents|mesh-ancestor
64837918|NCT01621451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64837919|NCT01621451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64837920|NCT01621451|Purinergic Agents|purinergic agents|mesh-ancestor
64837921|NCT01621451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64837922|NCT01621620|Yohimbine|yohimbine|mesh-list
64837923|NCT01621620|Mydriatics|mydriatics|mesh-ancestor
64837924|NCT01621620|Autonomic Agents|autonomic agents|mesh-ancestor
64837925|NCT01621620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64837926|NCT01621620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837927|NCT01621620|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64837928|NCT01621620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64837929|NCT01621620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64837930|NCT01621620|Adrenergic Agents|adrenergic agents|mesh-ancestor
64837931|NCT01621620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64837932|NCT01621620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837940|NCT01621698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64837941|NCT01621698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837942|NCT01621698|Sensory System Agents|sensory system agents|mesh-ancestor
64837943|NCT01621698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64837944|NCT01621698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64837945|NCT01621698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64837946|NCT01621698|Anesthetics, General|anesthetics, general|mesh-ancestor
64837947|NCT01621698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64837948|NCT01621698|Narcotics|narcotics|mesh-ancestor
64837949|NCT01621698|Analgesics|analgesics|mesh-ancestor
64837950|NCT01621698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64837951|NCT01621698|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64837952|NCT01621698|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64837953|NCT01621698|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64837954|NCT01621698|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64837955|NCT01621698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64837956|NCT01621698|Cholinergic Agents|cholinergic agents|mesh-ancestor
64837957|NCT01621698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64837958|NCT01621698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837959|NCT01621750|Clopidogrel|clopidogrel|mesh-list
64837960|NCT01621750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64837961|NCT01621750|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64837962|NCT01621750|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64837963|NCT01621750|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64837964|NCT01621750|Purinergic Agents|purinergic agents|mesh-ancestor
64326323|NCT04474093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64326324|NCT04474093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64326325|NCT02159027|Maraviroc|maraviroc|mesh-list
64837973|NCT01621763|Purinergic Agents|purinergic agents|mesh-ancestor
64837974|NCT01621763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64837975|NCT01621763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837976|NCT01621763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837977|NCT01621789|Diminazene aceturate|diminazene aceturate|mesh-list
64837978|NCT01621789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64837979|NCT01621789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64837980|NCT01621789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64837981|NCT01621789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64837982|NCT01621893|Calcium|calcium|mesh-list
64837983|NCT01621893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64837984|NCT01621893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837985|NCT01621971|Milrinone|milrinone|mesh-list
64837986|NCT01621971|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64837987|NCT01621971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64837988|NCT01621971|Vasodilator Agents|vasodilator agents|mesh-ancestor
64449018|NCT02169791|Protease Inhibitors|protease inhibitors|mesh-ancestor
64837989|NCT01621971|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64837990|NCT01621971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64837991|NCT01621971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837992|NCT01621971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837993|NCT01621971|Protective Agents|protective agents|mesh-ancestor
64837994|NCT01621971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837995|NCT01622075|Paclitaxel|paclitaxel|mesh-list
64837996|NCT01622075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64326335|NCT02161991|Antiemetics|antiemetics|mesh-ancestor
64837999|NCT01622075|Tubulin Modulators|tubulin modulators|mesh-ancestor
64838000|NCT01622075|Antimitotic Agents|antimitotic agents|mesh-ancestor
64838001|NCT01622075|Mitosis Modulators|mitosis modulators|mesh-ancestor
64838002|NCT01622075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838003|NCT01622283|Cetirizine|cetirizine|mesh-list
64838004|NCT01622283|Levocetirizine|levocetirizine|mesh-list
64838005|NCT01622283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64838006|NCT01622283|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64838007|NCT01622283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64838008|NCT01622283|Histamine Antagonists|histamine antagonists|mesh-ancestor
64838009|NCT01622283|Histamine Agents|histamine agents|mesh-ancestor
64838010|NCT01622283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64326343|NCT05439356|Colchicine|colchicine|mesh-list
64326344|NCT05439356|Gout Suppressants|gout suppressants|mesh-ancestor
64326349|NCT05439356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838012|NCT01622283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838013|NCT01622361|Tamoxifen|tamoxifen|mesh-list
64838014|NCT01622361|Cyclophosphamide|cyclophosphamide|mesh-list
64838015|NCT01622361|Docetaxel|docetaxel|mesh-list
64838016|NCT01622361|Doxorubicin|doxorubicin|mesh-list
64838017|NCT01622361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64838018|NCT01622361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64838019|NCT01622361|Immunologic Factors|immunologic factors|mesh-ancestor
64838020|NCT01622361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838021|NCT01622361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64838022|NCT01622361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64838023|NCT01622361|Alkylating Agents|alkylating agents|mesh-ancestor
64838024|NCT01622361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838025|NCT01622361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838026|NCT01622361|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64838027|NCT01622361|Tubulin Modulators|tubulin modulators|mesh-ancestor
64838028|NCT01622361|Antimitotic Agents|antimitotic agents|mesh-ancestor
64838029|NCT01622361|Mitosis Modulators|mitosis modulators|mesh-ancestor
64838030|NCT01622361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64838031|NCT01622361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64838032|NCT01622361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64838033|NCT01622361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838034|NCT01622361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64838035|NCT01622361|Hormone Antagonists|hormone antagonists|mesh-ancestor
64838036|NCT01622361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64838045|NCT01622439|Vincristine|vincristine|mesh-list
64838046|NCT01622439|Valproic Acid|valproic acid|mesh-list
64838047|NCT01622439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64838048|NCT01622439|Immunologic Factors|immunologic factors|mesh-ancestor
64838049|NCT01622439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838050|NCT01622439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64326350|NCT05439356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326352|NCT00948961|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64326353|NCT00948961|Poly ICLC|poly iclc|mesh-list
64326354|NCT00948961|Interferon Inducers|interferon inducers|mesh-ancestor
64838057|NCT01622439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64838058|NCT01622439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64838060|NCT01622439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838061|NCT01622439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64838062|NCT01622439|Glucocorticoids|glucocorticoids|mesh-ancestor
64838063|NCT01622439|Hormones|hormones|mesh-ancestor
64449104|NCT02168387|Antidotes|antidotes|mesh-ancestor
64326355|NCT00948961|Immunologic Factors|immunologic factors|mesh-ancestor
64326356|NCT00948961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326357|NCT00948961|Laxatives|laxatives|mesh-ancestor
64326358|NCT00948961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64838074|NCT01622439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64838075|NCT01622439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64838077|NCT01622504|Naloxone|naloxone|mesh-list
64838078|NCT01622504|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64838079|NCT01622504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838080|NCT01622504|Sensory System Agents|sensory system agents|mesh-ancestor
64326360|NCT00948961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64326362|NCT02159105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64838091|NCT01622556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64838092|NCT01622556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64838093|NCT01622777|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64838094|NCT01622777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64838095|NCT01622777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64838096|NCT01622777|Antimetabolites|antimetabolites|mesh-ancestor
64838097|NCT01622777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838107|NCT01622790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838108|NCT01622790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838109|NCT01622790|Antiviral Agents|antiviral agents|mesh-ancestor
64326363|NCT02159105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64326365|NCT02159105|Sensory System Agents|sensory system agents|mesh-ancestor
64838110|NCT01622790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64838111|NCT01622790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64606609|NCT04380181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838112|NCT01622790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64838113|NCT01622790|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64838114|NCT01622790|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64838115|NCT01622790|Antimetabolites|antimetabolites|mesh-ancestor
64838116|NCT01622881|Nefopam|nefopam|mesh-list
64838117|NCT01622881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64838118|NCT01622881|Analgesics|analgesics|mesh-ancestor
64838119|NCT01622881|Sensory System Agents|sensory system agents|mesh-ancestor
64838120|NCT01622881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64838121|NCT01622881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838122|NCT01622933|Interferons|interferons|mesh-list
64838123|NCT01622933|Interferon-alpha|interferon-alpha|mesh-list
64838124|NCT01622933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838125|NCT01622933|Antiviral Agents|antiviral agents|mesh-ancestor
64838126|NCT01622933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449160|NCT02116309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64838135|NCT01622972|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64838136|NCT01622972|Laxatives|laxatives|mesh-ancestor
64838137|NCT01622972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64838138|NCT01623024|Vitamin D|vitamin d|mesh-list
64838139|NCT01623024|Vitamins|vitamins|mesh-ancestor
64838140|NCT01623024|Micronutrients|micronutrients|mesh-ancestor
64838141|NCT01623024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838142|NCT01623024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64326367|NCT02159105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326368|NCT02159105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64838153|NCT01623102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64838154|NCT01623102|Antimetabolites|antimetabolites|mesh-ancestor
64326374|NCT01661972|Aflibercept|aflibercept|mesh-list
64326375|NCT01661972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64326376|NCT01661972|Antimetabolites|antimetabolites|mesh-ancestor
64326377|NCT01661972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326378|NCT01661972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838170|NCT01623336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64838171|NCT01623336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64449202|NCT02071225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838172|NCT01623336|Interferon-alpha|interferon-alpha|mesh-list
64838173|NCT01623336|Antiviral Agents|antiviral agents|mesh-ancestor
64838174|NCT01623336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64838175|NCT01623336|Immunologic Factors|immunologic factors|mesh-ancestor
64838176|NCT01623336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838177|NCT01623349|Olaparib|olaparib|mesh-list
64838178|NCT01623349|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64838179|NCT01623349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838180|NCT01623349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838181|NCT01623349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838188|NCT01623375|Insulin, Long-Acting|insulin, long-acting|mesh-list
64838189|NCT01623375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64838190|NCT01623375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449227|NCT01490086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838194|NCT01623401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64838195|NCT01623440|Naltrexone|naltrexone|mesh-list
64838196|NCT01623440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64838197|NCT01623440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64838198|NCT01623440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838199|NCT01623440|Sensory System Agents|sensory system agents|mesh-ancestor
64326402|NCT02155049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64838204|NCT01623505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64838205|NCT01623505|Cholinergic Agents|cholinergic agents|mesh-ancestor
64838206|NCT01623505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64838207|NCT01623505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838208|NCT01623505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838209|NCT01623505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64838210|NCT01623505|Autonomic Agents|autonomic agents|mesh-ancestor
64838211|NCT01623505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64838212|NCT01623570|Menotropins|menotropins|mesh-list
64326409|NCT03540953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64326410|NCT03540953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326411|NCT00888355|Losartan|losartan|mesh-list
64326412|NCT00888355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64326413|NCT00888355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64326414|NCT00888355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64326415|NCT00888355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64326416|NCT00888355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326417|NCT00794677|Ezetimibe|ezetimibe|mesh-list
64326418|NCT00794677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64326421|NCT00794677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326422|NCT00794677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64326424|NCT00792727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64326425|NCT00792727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64326426|NCT00792727|Analgesics|analgesics|mesh-ancestor
64326427|NCT00792727|Sensory System Agents|sensory system agents|mesh-ancestor
64326428|NCT00792727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64838231|NCT01623713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64838232|NCT01623713|Serotonin Agents|serotonin agents|mesh-ancestor
64838233|NCT01623713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64838234|NCT01623713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838235|NCT01623713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838236|NCT01623713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64838237|NCT01623713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64838238|NCT01623713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64838239|NCT01623713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64838240|NCT01623713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64449267|NCT04075240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64326434|NCT00792727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326436|NCT00945763|Meloxicam|meloxicam|mesh-list
64326437|NCT00945763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64326438|NCT00945763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64838254|NCT01623908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64838255|NCT01623908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838257|NCT01623921|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64838258|NCT01623921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64838259|NCT01623921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64838260|NCT01623921|Antimetabolites|antimetabolites|mesh-ancestor
64838261|NCT01623921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838262|NCT01623921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64838263|NCT01623921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64838264|NCT01623921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838265|NCT01623921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64838266|NCT01623921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64838268|NCT01623921|Sensory System Agents|sensory system agents|mesh-ancestor
64838269|NCT01623921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64838270|NCT01623921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838271|NCT01623921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64838272|NCT01623921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64838273|NCT01623921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64838274|NCT01623921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64838275|NCT01624025|Docetaxel|docetaxel|mesh-list
64838276|NCT01624025|Epirubicin|epirubicin|mesh-list
64838277|NCT01624025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838278|NCT01624025|Tubulin Modulators|tubulin modulators|mesh-ancestor
64838280|NCT01624025|Mitosis Modulators|mitosis modulators|mesh-ancestor
64838281|NCT01624025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838282|NCT01624025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64838283|NCT01624025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64838284|NCT01624025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64838285|NCT01624025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838286|NCT01624038|Hydroxyurea|hydroxyurea|mesh-list
64838287|NCT01624038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838288|NCT01624038|Antisickling Agents|antisickling agents|mesh-ancestor
64838289|NCT01624038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838290|NCT01624038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838291|NCT01624038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64838292|NCT01624051|Cisplatin|cisplatin|mesh-list
64838293|NCT01624051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838294|NCT01624064|Calcium, Dietary|calcium, dietary|mesh-list
64838295|NCT01624064|Enalapril|enalapril|mesh-list
64838296|NCT01624064|Calcium|calcium|mesh-list
64838297|NCT01624064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64838298|NCT01624064|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64838299|NCT01624064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64838300|NCT01624064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838301|NCT01624064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64838302|NCT01624064|Protease Inhibitors|protease inhibitors|mesh-ancestor
64838303|NCT01624064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449315|NCT01473940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64838314|NCT01624103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64838315|NCT01624103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64838316|NCT01624103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64838317|NCT01624103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838318|NCT01624116|Metformin|metformin|mesh-list
64838319|NCT01624116|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64838320|NCT01624116|Acarbose|acarbose|mesh-list
64838321|NCT01624116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64838322|NCT01624116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326441|NCT00945763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64326442|NCT00945763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326443|NCT00945763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64326444|NCT00945763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64838331|NCT01624129|Fluticasone|fluticasone|mesh-list
64838332|NCT01624129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64838333|NCT01624129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64838334|NCT01624129|Autonomic Agents|autonomic agents|mesh-ancestor
64838335|NCT01624129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64449357|NCT01449682|Antiemetics|antiemetics|mesh-ancestor
64838336|NCT01624129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838337|NCT01624129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64838338|NCT01624129|Respiratory System Agents|respiratory system agents|mesh-ancestor
64606842|NCT01834885|Hormones|hormones|mesh-ancestor
64838339|NCT01624129|Dermatologic Agents|dermatologic agents|mesh-ancestor
64838340|NCT01624129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64838341|NCT01624207|Atorvastatin|atorvastatin|mesh-list
64326447|NCT00945763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838353|NCT01624246|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64838354|NCT01624246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838355|NCT01624246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838356|NCT01624337|Piperaquine|piperaquine|mesh-list
64838357|NCT01624337|Antimalarials|antimalarials|mesh-ancestor
64838358|NCT01624337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64838359|NCT01624337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64838360|NCT01624337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64838361|NCT01624428|Varenicline|varenicline|mesh-list
64838362|NCT01624428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64838363|NCT01624428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64838364|NCT01624428|Cholinergic Agents|cholinergic agents|mesh-ancestor
64838365|NCT01624428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64838366|NCT01624428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449387|NCT01857531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64838371|NCT01624441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64838372|NCT01624441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64838373|NCT01624441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838374|NCT01624441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838375|NCT01624493|Gemcitabine|gemcitabine|mesh-list
64838376|NCT01624493|Carboplatin|carboplatin|mesh-list
64838377|NCT01624493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838378|NCT01624493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64838379|NCT01624493|Antimetabolites|antimetabolites|mesh-ancestor
64838380|NCT01624493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838381|NCT01624493|Antiviral Agents|antiviral agents|mesh-ancestor
64838382|NCT01624493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64838383|NCT01624493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838384|NCT01624493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64449417|NCT02111785|Hormones|hormones|mesh-ancestor
64838394|NCT01624649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838395|NCT01624649|Dopamine Agents|dopamine agents|mesh-ancestor
64838396|NCT01624649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64838397|NCT01624649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64838398|NCT01624649|Adrenergic Agents|adrenergic agents|mesh-ancestor
64449421|NCT02068495|Amlodipine|amlodipine|mesh-list
64326455|NCT02770391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326456|NCT02155205|Moxifloxacin|moxifloxacin|mesh-list
64838424|NCT01624857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64838425|NCT01624857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64838426|NCT01624857|Antimetabolites|antimetabolites|mesh-ancestor
64838427|NCT01624857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838428|NCT01624857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64838429|NCT01624857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64838430|NCT01624857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838431|NCT01625026|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
64838432|NCT01625026|Cathartics|cathartics|mesh-ancestor
64838433|NCT01625026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64838434|NCT01625156|Sirolimus|sirolimus|mesh-list
64838435|NCT01625156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64838436|NCT01625156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64838437|NCT01625156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64838438|NCT01625156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838439|NCT01625156|Antifungal Agents|antifungal agents|mesh-ancestor
64838440|NCT01625156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64838441|NCT01625156|Immunologic Factors|immunologic factors|mesh-ancestor
64838442|NCT01625156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838443|NCT01625260|Gemcitabine|gemcitabine|mesh-list
64838444|NCT01625260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64838445|NCT01625260|Antimetabolites|antimetabolites|mesh-ancestor
64838446|NCT01625260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838447|NCT01625260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838448|NCT01625260|Antiviral Agents|antiviral agents|mesh-ancestor
64838449|NCT01625260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64838450|NCT01625260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838451|NCT01625260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64838452|NCT01625260|Immunologic Factors|immunologic factors|mesh-ancestor
64838453|NCT01625260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838454|NCT01625351|Sirolimus|sirolimus|mesh-list
64838455|NCT01625351|Fludarabine|fludarabine|mesh-list
64838456|NCT01625351|Melphalan|melphalan|mesh-list
64838457|NCT01625351|Busulfan|busulfan|mesh-list
64838458|NCT01625351|Mechlorethamine|mechlorethamine|mesh-list
64838459|NCT01625351|Alemtuzumab|alemtuzumab|mesh-list
64838460|NCT01625351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838461|NCT01625351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838482|NCT01625494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64838483|NCT01625494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64838484|NCT01625494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64606983|NCT04380025|Pycnogenols|pycnogenols|mesh-list
64838485|NCT01625494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326461|NCT02155205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326462|NCT02155205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326463|NCT02155205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326468|NCT00938587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64326470|NCT00938587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64326471|NCT00938587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326472|NCT02162303|Colchicine|colchicine|mesh-list
64838500|NCT01625572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64838502|NCT01625572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64838503|NCT01625572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838514|NCT01625715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838516|NCT01625715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64838517|NCT01625741|Rituximab|rituximab|mesh-list
64838518|NCT01625741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64838519|NCT01625741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838520|NCT01625741|Immunologic Factors|immunologic factors|mesh-ancestor
64838521|NCT01625741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838522|NCT01625741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64838523|NCT01625793|Interferons|interferons|mesh-list
64838524|NCT01625793|Interferon-alpha|interferon-alpha|mesh-list
64838525|NCT01625793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838526|NCT01625793|Antiviral Agents|antiviral agents|mesh-ancestor
64838527|NCT01625793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64838528|NCT01625793|Immunologic Factors|immunologic factors|mesh-ancestor
64838529|NCT01625793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838530|NCT01625806|Ketoconazole|ketoconazole|mesh-list
64838531|NCT01625806|Antifungal Agents|antifungal agents|mesh-ancestor
64838532|NCT01625806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64838533|NCT01625806|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64838534|NCT01625806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64449554|NCT02162771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64838542|NCT01625871|Lumefantrine|lumefantrine|mesh-list
64838543|NCT01625871|Artemether|artemether|mesh-list
64838544|NCT01625871|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64838545|NCT01625871|Antimalarials|antimalarials|mesh-ancestor
64838546|NCT01625871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64838547|NCT01625871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64838548|NCT01625871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64838549|NCT01625936|Bevacizumab|bevacizumab|mesh-list
64336785|NCT02313337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64838550|NCT01625936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64838551|NCT01625936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838552|NCT01625936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64838553|NCT01625936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64838554|NCT01625936|Growth Substances|growth substances|mesh-ancestor
64838555|NCT01625936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838556|NCT01625936|Growth Inhibitors|growth inhibitors|mesh-ancestor
64838557|NCT01626222|Everolimus|everolimus|mesh-list
64838558|NCT01626222|Exemestane|exemestane|mesh-list
64838559|NCT01626222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838560|NCT01626222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64607056|NCT03218059|Antimetabolites|antimetabolites|mesh-ancestor
64838561|NCT01626222|Immunologic Factors|immunologic factors|mesh-ancestor
64449561|NCT02162771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64838571|NCT01626339|Ranibizumab|ranibizumab|mesh-list
64838572|NCT01626339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64838573|NCT01626339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838574|NCT01626339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64838575|NCT01626339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64838576|NCT01626339|Growth Substances|growth substances|mesh-ancestor
64838577|NCT01626339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838578|NCT01626339|Growth Inhibitors|growth inhibitors|mesh-ancestor
64838579|NCT01626443|Folic Acid|folic acid|mesh-list
64838580|NCT01626443|Vitamin B Complex|vitamin b complex|mesh-list
64838581|NCT01626443|Inositol|inositol|mesh-list
64838582|NCT01626443|Hematinics|hematinics|mesh-ancestor
64838584|NCT01626443|Micronutrients|micronutrients|mesh-ancestor
64352161|NCT01328951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838585|NCT01626443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838586|NCT01626469|Captopril|captopril|mesh-list
64838587|NCT01626469|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64838588|NCT01626469|Protease Inhibitors|protease inhibitors|mesh-ancestor
64838589|NCT01626469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838590|NCT01626469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838591|NCT01626469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64838592|NCT01626534|Clopidogrel|clopidogrel|mesh-list
64838593|NCT01626534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64838594|NCT01626534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64838595|NCT01626534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64334622|NCT02292277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64334623|NCT02292277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334624|NCT02292277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838596|NCT01626534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64838597|NCT01626534|Purinergic Agents|purinergic agents|mesh-ancestor
64838598|NCT01626534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64838599|NCT01626534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838604|NCT01626560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64838605|NCT01626612|Anti-Infective Agents|anti-infective agents|mesh-list
64838606|NCT01626612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64838608|NCT01626651|Antifungal Agents|antifungal agents|mesh-ancestor
64838609|NCT01626651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64838610|NCT01626651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64449635|NCT02109133|Atracurium|atracurium|mesh-list
64838623|NCT01626911|Anticoagulants|anticoagulants|mesh-ancestor
64838624|NCT01626911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64449638|NCT02109133|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64449639|NCT02109133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64449640|NCT02109133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64449641|NCT02109133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449642|NCT02109133|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64449643|NCT02109133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449644|NCT02109133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449645|NCT02109133|Cholinergic Agents|cholinergic agents|mesh-ancestor
64449646|NCT02109133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64449652|NCT01623271|Analgesics|analgesics|mesh-ancestor
64449653|NCT01623271|Sensory System Agents|sensory system agents|mesh-ancestor
64449654|NCT01623271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64326490|NCT00877903|Antiviral Agents|antiviral agents|mesh-ancestor
64326491|NCT00877903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64326493|NCT04729387|Doxorubicin|doxorubicin|mesh-list
64326494|NCT04729387|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64326495|NCT04729387|Olaparib|olaparib|mesh-list
64326496|NCT04729387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64326497|NCT04729387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326498|NCT04729387|Tubulin Modulators|tubulin modulators|mesh-ancestor
64326499|NCT04729387|Antimitotic Agents|antimitotic agents|mesh-ancestor
64326500|NCT04729387|Mitosis Modulators|mitosis modulators|mesh-ancestor
64326501|NCT04729387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326502|NCT04729387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64326503|NCT04729387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64326504|NCT04729387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64326505|NCT04729387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838643|NCT01627106|Amiodarone|amiodarone|mesh-list
64838644|NCT01627106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64838645|NCT01627106|Vasodilator Agents|vasodilator agents|mesh-ancestor
64838646|NCT01627106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64838647|NCT01627106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64838648|NCT01627106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838649|NCT01627106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64838650|NCT01627106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64838651|NCT01627106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64838652|NCT01627106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838653|NCT01627106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64838654|NCT01627106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64838655|NCT01627106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64838656|NCT01627132|Dasatinib|dasatinib|mesh-list
64838657|NCT01627132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838658|NCT01627132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64838659|NCT01627132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838660|NCT01627132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838661|NCT01627145|Solifenacin Succinate|solifenacin succinate|mesh-list
64838662|NCT01627145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64838663|NCT01627145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64838664|NCT01627145|Cholinergic Agents|cholinergic agents|mesh-ancestor
64838665|NCT01627145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64838666|NCT01627145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838667|NCT01627145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838668|NCT01627145|Urological Agents|urological agents|mesh-ancestor
64326510|NCT04681105|Acetaminophen|acetaminophen|mesh-list
64326511|NCT04681105|Diphenhydramine|diphenhydramine|mesh-list
64326512|NCT04681105|Promethazine|promethazine|mesh-list
64326513|NCT04681105|Dexamethasone|dexamethasone|mesh-list
64326514|NCT04681105|Dexamethasone acetate|dexamethasone acetate|mesh-list
64326515|NCT04681105|Ibuprofen|ibuprofen|mesh-list
64838669|NCT01627158|Budesonide|budesonide|mesh-list
64838670|NCT01627158|Formoterol Fumarate|formoterol fumarate|mesh-list
64838671|NCT01627158|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64838672|NCT01627158|Charcoal|charcoal|mesh-list
64838673|NCT01627158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64838674|NCT01627158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64838675|NCT01627158|Autonomic Agents|autonomic agents|mesh-ancestor
64838676|NCT01627158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64838677|NCT01627158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838678|NCT01627158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64838679|NCT01627158|Respiratory System Agents|respiratory system agents|mesh-ancestor
64838680|NCT01627158|Glucocorticoids|glucocorticoids|mesh-ancestor
64838681|NCT01627158|Hormones|hormones|mesh-ancestor
64838682|NCT01627158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64838683|NCT01627158|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64838684|NCT01627158|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64838685|NCT01627158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64838686|NCT01627158|Adrenergic Agents|adrenergic agents|mesh-ancestor
64838687|NCT01627158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64838688|NCT01627158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838698|NCT01627223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64838699|NCT01627223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64838700|NCT01627223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838701|NCT01627223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838702|NCT01627223|Antiviral Agents|antiviral agents|mesh-ancestor
64838703|NCT01627223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64838704|NCT01627223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64838705|NCT01627223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64838706|NCT01627236|Methylprednisolone|methylprednisolone|mesh-list
64449717|NCT02066389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64838734|NCT01627262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64838735|NCT01627353|Dexamethasone|dexamethasone|mesh-list
64838737|NCT01627353|Magnesium Sulfate|magnesium sulfate|mesh-list
64838738|NCT01627353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64838739|NCT01627353|Antiemetics|antiemetics|mesh-ancestor
64838740|NCT01627353|Autonomic Agents|autonomic agents|mesh-ancestor
64838741|NCT01627353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64838742|NCT01627353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838743|NCT01627353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64838744|NCT01627353|Glucocorticoids|glucocorticoids|mesh-ancestor
64838745|NCT01627353|Hormones|hormones|mesh-ancestor
64838746|NCT01627353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64838747|NCT01627353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64838748|NCT01627353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838749|NCT01627353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838750|NCT01627353|Anesthetics, Local|anesthetics, local|mesh-ancestor
64838751|NCT01627353|Anesthetics|anesthetics|mesh-ancestor
64838752|NCT01627353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64838753|NCT01627353|Sensory System Agents|sensory system agents|mesh-ancestor
64838754|NCT01627353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64838755|NCT01627353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64838756|NCT01627353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64838765|NCT01627379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838766|NCT01627379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64326526|NCT04681105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64326527|NCT04681105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64326529|NCT04681105|Hormones|hormones|mesh-ancestor
64326530|NCT04681105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64326531|NCT04681105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64838767|NCT01627431|Aspirin|aspirin|mesh-list
64838768|NCT01627431|Clopidogrel|clopidogrel|mesh-list
64838769|NCT01627431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64838770|NCT01627431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64838771|NCT01627431|Analgesics|analgesics|mesh-ancestor
64838772|NCT01627431|Sensory System Agents|sensory system agents|mesh-ancestor
64838773|NCT01627431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64838774|NCT01627431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838775|NCT01627431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64838779|NCT01627431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838780|NCT01627431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64838781|NCT01627431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64838782|NCT01627431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838783|NCT01627431|Antipyretics|antipyretics|mesh-ancestor
64838784|NCT01627431|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64838785|NCT01627431|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64326537|NCT04681105|Analgesics|analgesics|mesh-ancestor
64326538|NCT04681105|Sensory System Agents|sensory system agents|mesh-ancestor
64326539|NCT04681105|Antipyretics|antipyretics|mesh-ancestor
64326540|NCT04681105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64326541|NCT04681105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64838800|NCT01627587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64838802|NCT01627626|Miotics|miotics|mesh-ancestor
64838803|NCT01627626|Autonomic Agents|autonomic agents|mesh-ancestor
64838804|NCT01627626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64838805|NCT01627626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838806|NCT01627626|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64838807|NCT01627626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64838808|NCT01627626|Cholinergic Agents|cholinergic agents|mesh-ancestor
64838809|NCT01627626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64352505|NCT03461081|Atorvastatin|atorvastatin|mesh-list
64838810|NCT01627626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838811|NCT01627639|Acetazolamide|acetazolamide|mesh-list
64838812|NCT01627639|Anticonvulsants|anticonvulsants|mesh-ancestor
64838813|NCT01627639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64838814|NCT01627639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838824|NCT01627678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838825|NCT01627678|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64838826|NCT01627678|Antacids|antacids|mesh-ancestor
64838827|NCT01627678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838828|NCT01627678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64838829|NCT01627717|Maraviroc|maraviroc|mesh-list
64838830|NCT01627717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64838831|NCT01627717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64838832|NCT01627717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838833|NCT01627717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64838834|NCT01627717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64326543|NCT04681105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64326544|NCT04681105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64326545|NCT04681105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64326546|NCT04681105|Anesthetics, Local|anesthetics, local|mesh-ancestor
64326547|NCT04681105|Anesthetics|anesthetics|mesh-ancestor
64326548|NCT04681105|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64326549|NCT04681105|Histamine Antagonists|histamine antagonists|mesh-ancestor
64326550|NCT04681105|Histamine Agents|histamine agents|mesh-ancestor
64326551|NCT04681105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64326552|NCT04681105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64326553|NCT04681105|Antipruritics|antipruritics|mesh-ancestor
64326560|NCT00936871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64326561|NCT00936871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64326562|NCT00936871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326563|NCT00936871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326564|NCT00936871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326565|NCT00934921|Ondansetron|ondansetron|mesh-list
64326566|NCT00934921|Antiemetics|antiemetics|mesh-ancestor
64326567|NCT00934921|Autonomic Agents|autonomic agents|mesh-ancestor
64326568|NCT00934921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64326569|NCT00934921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326570|NCT00934921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64326571|NCT00934921|Antipruritics|antipruritics|mesh-ancestor
64326572|NCT00934921|Dermatologic Agents|dermatologic agents|mesh-ancestor
64326573|NCT00934921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64326574|NCT00934921|Serotonin Agents|serotonin agents|mesh-ancestor
64326575|NCT00934921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64326576|NCT00934921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326577|NCT00934921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64326578|NCT00934921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64838845|NCT01627834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838846|NCT01627847|Ropinirole|ropinirole|mesh-list
64838847|NCT01627847|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64838848|NCT01627847|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64838849|NCT01627847|Dopamine Agonists|dopamine agonists|mesh-ancestor
64838850|NCT01627847|Dopamine Agents|dopamine agents|mesh-ancestor
64838864|NCT01627873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64838865|NCT01627873|Anesthetics, General|anesthetics, general|mesh-ancestor
64838866|NCT01627873|Anesthetics|anesthetics|mesh-ancestor
64838867|NCT01627886|Ibandronic Acid|ibandronic acid|mesh-list
64838868|NCT01627886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64838869|NCT01627886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838870|NCT01627938|Mitoxantrone|mitoxantrone|mesh-list
64838871|NCT01627938|Dexrazoxane|dexrazoxane|mesh-list
64449869|NCT02131259|Afatinib|afatinib|mesh-list
64326579|NCT00934921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64326580|NCT00934921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64326581|NCT00934921|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64838872|NCT01627938|Razoxane|razoxane|mesh-list
64838873|NCT01627938|Analgesics|analgesics|mesh-ancestor
64838874|NCT01627938|Sensory System Agents|sensory system agents|mesh-ancestor
64838875|NCT01627938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64838876|NCT01627938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838877|NCT01627938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838878|NCT01627938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64838879|NCT01627938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64838880|NCT01627938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838881|NCT01627938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838882|NCT01627938|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64838883|NCT01627938|Protective Agents|protective agents|mesh-ancestor
64838884|NCT01627938|Antimitotic Agents|antimitotic agents|mesh-ancestor
64326585|NCT05429450|Methotrexate|methotrexate|mesh-list
64326586|NCT05429450|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64326587|NCT05429450|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64326588|NCT05429450|Abortifacient Agents|abortifacient agents|mesh-ancestor
64326589|NCT05429450|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64838905|NCT01628445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64838906|NCT01628445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838908|NCT01628445|Hormones|hormones|mesh-ancestor
64838909|NCT01628445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64838910|NCT01628471|Decitabine|decitabine|mesh-list
64838911|NCT01628471|Genistein|genistein|mesh-list
64838912|NCT01628471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64838913|NCT01628471|Antimetabolites|antimetabolites|mesh-ancestor
64838914|NCT01628471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838915|NCT01628471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838916|NCT01628471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838917|NCT01628471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64838918|NCT01628471|Protective Agents|protective agents|mesh-ancestor
64838919|NCT01628471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838920|NCT01628471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64838921|NCT01628471|Phytoestrogens|phytoestrogens|mesh-ancestor
64838922|NCT01628471|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64838923|NCT01628471|Estrogens|estrogens|mesh-ancestor
64838932|NCT01628562|Analgesics|analgesics|mesh-ancestor
64838933|NCT01628562|Sensory System Agents|sensory system agents|mesh-ancestor
64607471|NCT01727401|PENTA|penta|mesh-list
64449946|NCT02045875|Mometasone Furoate|mometasone furoate|mesh-list
64326591|NCT05429450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64326592|NCT05429450|Antimetabolites|antimetabolites|mesh-ancestor
64326593|NCT05429450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326594|NCT05429450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326596|NCT05429450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326597|NCT05429450|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64326598|NCT05429450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64326599|NCT05429450|Immunologic Factors|immunologic factors|mesh-ancestor
64326600|NCT05429450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64326601|NCT05429450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64326602|NCT05429450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64326603|NCT05429450|Glucocorticoids|glucocorticoids|mesh-ancestor
64326604|NCT05429450|Hormones|hormones|mesh-ancestor
64430009|NCT04991597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64326606|NCT00103259|Irinotecan|irinotecan|mesh-list
64326607|NCT00103259|Bortezomib|bortezomib|mesh-list
64326608|NCT00103259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64326609|NCT00103259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64838963|NCT01628783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838964|NCT01628783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64838965|NCT01628783|Serotonin Agents|serotonin agents|mesh-ancestor
64838966|NCT01628783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838967|NCT01628783|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64838968|NCT01628783|Antidepressive Agents|antidepressive agents|mesh-ancestor
64838975|NCT01628952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838978|NCT01628952|Cholinergic Agents|cholinergic agents|mesh-ancestor
64838979|NCT01628952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64838980|NCT01628952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838981|NCT01629082|Lenalidomide|lenalidomide|mesh-list
64838982|NCT01629082|Clofarabine|clofarabine|mesh-list
64838983|NCT01629082|Immunologic Factors|immunologic factors|mesh-ancestor
64838984|NCT01629082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449999|NCT02064439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64450000|NCT02064439|Protease Inhibitors|protease inhibitors|mesh-ancestor
64450001|NCT02064439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450002|NCT02064439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450003|NCT02064439|Anticoagulants|anticoagulants|mesh-ancestor
64450004|NCT02130557|Imatinib Mesylate|imatinib mesylate|mesh-list
64450005|NCT02130557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326613|NCT02162381|Methylphenidate|methylphenidate|mesh-list
64326614|NCT02162381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64326615|NCT02162381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326616|NCT02162381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64326617|NCT02162381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64838991|NCT01629082|Antimetabolites|antimetabolites|mesh-ancestor
64838992|NCT01629082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838993|NCT01629173|Ethylene|ethylene|mesh-list
64838994|NCT01629173|Plant Growth Regulators|plant growth regulators|mesh-ancestor
64838995|NCT01629173|Growth Substances|growth substances|mesh-ancestor
64450006|NCT02130557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64839003|NCT01629212|Anticonvulsants|anticonvulsants|mesh-ancestor
64839004|NCT01629212|Parasympatholytics|parasympatholytics|mesh-ancestor
64839005|NCT01629212|Autonomic Agents|autonomic agents|mesh-ancestor
64839006|NCT01629212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64839007|NCT01629212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839008|NCT01629212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64380700|NCT02600897|Growth Inhibitors|growth inhibitors|mesh-ancestor
64839058|NCT01629446|Sensory System Agents|sensory system agents|mesh-ancestor
64839059|NCT01629446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64839060|NCT01629446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64839061|NCT01629446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64839087|NCT01629511|Dermatologic Agents|dermatologic agents|mesh-ancestor
64839088|NCT01629511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64839089|NCT01629511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64839090|NCT01629511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64839091|NCT01629511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64839092|NCT01629511|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64839093|NCT01629511|Alkylating Agents|alkylating agents|mesh-ancestor
64839094|NCT01629511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64839095|NCT01629511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64839097|NCT01629628|Mercaptopurine|mercaptopurine|mesh-list
64839098|NCT01629628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64839099|NCT01629628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64839100|NCT01629628|Antimetabolites|antimetabolites|mesh-ancestor
64839101|NCT01629628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839102|NCT01629628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64839103|NCT01629628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64450094|NCT02155829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64839128|NCT01629875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839129|NCT01629875|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64326646|NCT02544152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64326647|NCT02544152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326649|NCT02162537|Pemetrexed|pemetrexed|mesh-list
64326650|NCT02162537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64326651|NCT02162537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326652|NCT02162537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64450144|NCT02178059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64839130|NCT01629875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64839131|NCT01629875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839132|NCT01629875|Cholinergic Agents|cholinergic agents|mesh-ancestor
64839133|NCT01629875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64839134|NCT01630018|Topotecan|topotecan|mesh-list
64839135|NCT01630018|Belotecan|belotecan|mesh-list
64839143|NCT01630057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64839144|NCT01630057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64839145|NCT01630057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839146|NCT01630057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64839147|NCT01630057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839148|NCT01630070|Paclitaxel|paclitaxel|mesh-list
64839149|NCT01630070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64839150|NCT01630070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839151|NCT01630070|Tubulin Modulators|tubulin modulators|mesh-ancestor
64839152|NCT01630070|Antimitotic Agents|antimitotic agents|mesh-ancestor
64839153|NCT01630070|Mitosis Modulators|mitosis modulators|mesh-ancestor
64839154|NCT01630070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839155|NCT01630083|Capecitabine|capecitabine|mesh-list
64839156|NCT01630083|Oxaliplatin|oxaliplatin|mesh-list
64839157|NCT01630083|Epirubicin|epirubicin|mesh-list
64839158|NCT01630083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64839159|NCT01630083|Antimetabolites|antimetabolites|mesh-ancestor
64839160|NCT01630083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839162|NCT01630083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64839163|NCT01630083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64839182|NCT01630278|Sensory System Agents|sensory system agents|mesh-ancestor
64839183|NCT01630278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64839184|NCT01630278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839185|NCT01630278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64839186|NCT01630278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64839187|NCT01630278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64839188|NCT01630278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839189|NCT01630278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839191|NCT01630343|Tramadol|tramadol|mesh-list
64839192|NCT01630343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64839193|NCT01630343|Analgesics|analgesics|mesh-ancestor
64839194|NCT01630343|Sensory System Agents|sensory system agents|mesh-ancestor
64839195|NCT01630343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64839196|NCT01630343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839197|NCT01630343|Antipyretics|antipyretics|mesh-ancestor
64839198|NCT01630343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64839199|NCT01630343|Narcotics|narcotics|mesh-ancestor
64839200|NCT01630343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64839201|NCT01630369|Insulin|insulin|mesh-list
64839202|NCT01630369|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64839203|NCT01630369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64839204|NCT01630369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326655|NCT02162537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326657|NCT02162537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326658|NCT02162537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326659|NCT02162537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64326660|NCT02162537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64326661|NCT04597411|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64326662|NCT04597411|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64326663|NCT04597411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326664|NCT02534324|Antihypertensive Agents|antihypertensive agents|mesh-list
64326665|NCT00864175|Docetaxel|docetaxel|mesh-list
64326666|NCT00864175|Trastuzumab|trastuzumab|mesh-list
64326667|NCT00864175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326668|NCT00864175|Tubulin Modulators|tubulin modulators|mesh-ancestor
64326669|NCT00864175|Antimitotic Agents|antimitotic agents|mesh-ancestor
64839205|NCT01630538|Cyclophosphamide|cyclophosphamide|mesh-list
64839206|NCT01630538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64839207|NCT01630538|Immunologic Factors|immunologic factors|mesh-ancestor
64839208|NCT01630538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839209|NCT01630538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64839210|NCT01630538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64839211|NCT01630538|Alkylating Agents|alkylating agents|mesh-ancestor
64839212|NCT01630538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839213|NCT01630538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839214|NCT01630538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64839215|NCT01630564|Aldesleukin|aldesleukin|mesh-list
64839216|NCT01630564|Interleukin-2|interleukin-2|mesh-list
64839217|NCT01630564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839218|NCT01630564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64839219|NCT01630564|Analgesics|analgesics|mesh-ancestor
64839220|NCT01630564|Sensory System Agents|sensory system agents|mesh-ancestor
64839221|NCT01630564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64839222|NCT01630564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839223|NCT01630564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64839224|NCT01630564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64839225|NCT01630564|Antiviral Agents|antiviral agents|mesh-ancestor
64839226|NCT01630564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64839227|NCT01630642|Clopidogrel|clopidogrel|mesh-list
64839228|NCT01630642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64839229|NCT01630642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64839230|NCT01630642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64353434|NCT03797469|Niacin|niacin|mesh-list
64839231|NCT01630642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64839232|NCT01630642|Purinergic Agents|purinergic agents|mesh-ancestor
64839233|NCT01630642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64839234|NCT01630642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607740|NCT00913003|Lidocaine|lidocaine|mesh-list
64839235|NCT01630642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326670|NCT00864175|Mitosis Modulators|mitosis modulators|mesh-ancestor
64326671|NCT00864175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326672|NCT00864175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64326673|NCT02166593|Atorvastatin|atorvastatin|mesh-list
64326674|NCT02166593|Pravastatin|pravastatin|mesh-list
64326675|NCT02166593|Fenofibrate|fenofibrate|mesh-list
64326676|NCT02166593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64326677|NCT02166593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64326678|NCT02166593|Antimetabolites|antimetabolites|mesh-ancestor
64839237|NCT01630655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64839238|NCT01630655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64839239|NCT01630655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64839240|NCT01630655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64326679|NCT02166593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326680|NCT02166593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64353489|NCT03432767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64326681|NCT02166593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64326682|NCT02166593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326683|NCT00858871|Sorafenib|sorafenib|mesh-list
64326684|NCT00858871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326685|NCT00858871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64326686|NCT00858871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326687|NCT00858871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326688|NCT02162693|Hyaluronic Acid|hyaluronic acid|mesh-list
64326689|NCT02162693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64326690|NCT02162693|Immunologic Factors|immunologic factors|mesh-ancestor
64326691|NCT02162693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326692|NCT02162693|Viscosupplements|viscosupplements|mesh-ancestor
64326693|NCT02162693|Protective Agents|protective agents|mesh-ancestor
64326694|NCT02163161|Abrocitinib|abrocitinib|mesh-list
64326695|NCT02163161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64326696|NCT02163161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326697|NCT02163161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326699|NCT00917293|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
64326700|NCT00917293|Vitamin B Complex|vitamin b complex|mesh-ancestor
64326701|NCT00917293|Vitamins|vitamins|mesh-ancestor
64839252|NCT01630733|Tubulin Modulators|tubulin modulators|mesh-ancestor
64839253|NCT01630733|Antimitotic Agents|antimitotic agents|mesh-ancestor
64839254|NCT01630733|Mitosis Modulators|mitosis modulators|mesh-ancestor
64839255|NCT01630733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839256|NCT01630902|Felodipine|felodipine|mesh-list
64839257|NCT01630902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64839258|NCT01630902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64839259|NCT01630902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64839260|NCT01630902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64839261|NCT01630902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839262|NCT01630902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64839263|NCT01630902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839264|NCT01630902|Vasodilator Agents|vasodilator agents|mesh-ancestor
64839265|NCT01630915|Clopidogrel|clopidogrel|mesh-list
64839266|NCT01630915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64839267|NCT01630915|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64839268|NCT01630915|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64450266|NCT01824693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64450276|NCT01824693|Antimetabolites|antimetabolites|mesh-ancestor
64839276|NCT01630941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839277|NCT01631058|Prednisone|prednisone|mesh-list
64839278|NCT01631058|Everolimus|everolimus|mesh-list
64839279|NCT01631058|Lactitol|lactitol|mesh-list
64839280|NCT01631058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64839281|NCT01631058|Glucocorticoids|glucocorticoids|mesh-ancestor
64839282|NCT01631058|Hormones|hormones|mesh-ancestor
64839283|NCT01631058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64839284|NCT01631058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839285|NCT01631058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64839286|NCT01631058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839287|NCT01631058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64839288|NCT01631058|Immunologic Factors|immunologic factors|mesh-ancestor
64839289|NCT01631058|Cathartics|cathartics|mesh-ancestor
64839290|NCT01631058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64839291|NCT01631136|Gemcitabine|gemcitabine|mesh-list
64839292|NCT01631136|Cisplatin|cisplatin|mesh-list
64839293|NCT01631136|Pemetrexed|pemetrexed|mesh-list
64839294|NCT01631136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839295|NCT01631136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64839296|NCT01631136|Antimetabolites|antimetabolites|mesh-ancestor
64839297|NCT01631136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839298|NCT01631136|Antiviral Agents|antiviral agents|mesh-ancestor
64839299|NCT01631136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64839300|NCT01631136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839301|NCT01631136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64839302|NCT01631136|Immunologic Factors|immunologic factors|mesh-ancestor
64839303|NCT01631136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326707|NCT00845299|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64326708|NCT00845299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64326709|NCT00845299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64326710|NCT00845299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64326711|NCT02255591|Lidocaine|lidocaine|mesh-list
64326712|NCT02255591|Epinephrine|epinephrine|mesh-list
64839305|NCT01631136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64839306|NCT01631201|Azithromycin|azithromycin|mesh-list
64839378|NCT01631409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64839379|NCT01631409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64839380|NCT01631409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64839381|NCT01631409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839382|NCT01631409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64839383|NCT01631409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64839384|NCT01631409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839385|NCT01631409|Antipyretics|antipyretics|mesh-ancestor
64839386|NCT01631409|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64839387|NCT01631409|Protease Inhibitors|protease inhibitors|mesh-ancestor
64839388|NCT01631409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64839389|NCT01631409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64839390|NCT01631409|Sympatholytics|sympatholytics|mesh-ancestor
64839391|NCT01631409|Autonomic Agents|autonomic agents|mesh-ancestor
64839394|NCT01631409|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64839395|NCT01631409|Adrenergic Agents|adrenergic agents|mesh-ancestor
64839396|NCT01631409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64839397|NCT01631409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64839398|NCT01631409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64839399|NCT01631409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64839400|NCT01631409|Vasodilator Agents|vasodilator agents|mesh-ancestor
64839408|NCT01631513|Tapentadol|tapentadol|mesh-list
64839418|NCT01631513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64839419|NCT01631513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839420|NCT01631513|Adrenergic Agents|adrenergic agents|mesh-ancestor
64839421|NCT01631513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64839422|NCT01631526|Vitamin D|vitamin d|mesh-list
64839423|NCT01631526|Vitamins|vitamins|mesh-ancestor
64839424|NCT01631526|Micronutrients|micronutrients|mesh-ancestor
64839425|NCT01631526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839426|NCT01631526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64839427|NCT01631539|Irinotecan|irinotecan|mesh-list
64839428|NCT01631539|Cetuximab|cetuximab|mesh-list
64839429|NCT01631539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64839430|NCT01631539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64839431|NCT01631539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839432|NCT01631539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839433|NCT01631539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839434|NCT01631539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64839435|NCT01631604|Botulinum Toxins|botulinum toxins|mesh-list
64839436|NCT01631604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64839437|NCT01631604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64839438|NCT01631604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839439|NCT01631604|Cholinergic Agents|cholinergic agents|mesh-ancestor
64839440|NCT01631604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64839441|NCT01631604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839442|NCT01631669|Celecoxib|celecoxib|mesh-list
64326739|NCT00913393|Immunologic Factors|immunologic factors|mesh-ancestor
64326740|NCT00913393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326741|NCT02167061|Metformin|metformin|mesh-list
64326742|NCT02167061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64326743|NCT02167061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326744|NCT03715465|Melatonin|melatonin|mesh-list
64326745|NCT03715465|Antioxidants|antioxidants|mesh-ancestor
64326746|NCT03715465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326747|NCT03715465|Protective Agents|protective agents|mesh-ancestor
64326748|NCT03715465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839443|NCT01631669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64839444|NCT01631669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64839445|NCT01631669|Analgesics|analgesics|mesh-ancestor
64839446|NCT01631669|Sensory System Agents|sensory system agents|mesh-ancestor
64839447|NCT01631669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64839448|NCT01631669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839449|NCT01631669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64839450|NCT01631669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64839451|NCT01631669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64839452|NCT01631669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64839453|NCT01631669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839511|NCT01632371|Tubulin Modulators|tubulin modulators|mesh-ancestor
64839512|NCT01632371|Antimitotic Agents|antimitotic agents|mesh-ancestor
64839513|NCT01632371|Mitosis Modulators|mitosis modulators|mesh-ancestor
64839514|NCT01632371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839515|NCT01632436|Pixantrone|pixantrone|mesh-list
64839516|NCT01632436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64839517|NCT01632436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64839518|NCT01632436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839519|NCT01632436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839520|NCT01632436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839521|NCT01632514|Cholecalciferol|cholecalciferol|mesh-list
64839522|NCT01632514|Vitamin D|vitamin d|mesh-list
64839523|NCT01632514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64839524|NCT01632514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839525|NCT01632514|Vitamins|vitamins|mesh-ancestor
64839526|NCT01632514|Micronutrients|micronutrients|mesh-ancestor
64839527|NCT01632514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64839528|NCT01632540|Beclomethasone|beclomethasone|mesh-list
64839529|NCT01632540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64839530|NCT01632540|Glucocorticoids|glucocorticoids|mesh-ancestor
64839531|NCT01632540|Hormones|hormones|mesh-ancestor
64839532|NCT01632540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64839533|NCT01632540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839534|NCT01632540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64839535|NCT01632540|Respiratory System Agents|respiratory system agents|mesh-ancestor
64608063|NCT05518500|Vaccines|vaccines|mesh-list
64839536|NCT01632592|Tesamorelin|tesamorelin|mesh-list
64839537|NCT01632592|Growth Substances|growth substances|mesh-ancestor
64839538|NCT01632592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839539|NCT01632605|Sirolimus|sirolimus|mesh-list
64839557|NCT01632761|Ergocalciferols|ergocalciferols|mesh-list
64839558|NCT01632761|Cholecalciferol|cholecalciferol|mesh-list
64839559|NCT01632761|Vitamins|vitamins|mesh-list
64839560|NCT01632761|Micronutrients|micronutrients|mesh-ancestor
64839561|NCT01632761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839562|NCT01632761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64839563|NCT01632761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64839564|NCT01632826|Pomalidomide|pomalidomide|mesh-list
64839565|NCT01632826|Immunologic Factors|immunologic factors|mesh-ancestor
64839566|NCT01632826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839567|NCT01632826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64839568|NCT01632826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64839569|NCT01632826|Growth Substances|growth substances|mesh-ancestor
64839570|NCT01632826|Growth Inhibitors|growth inhibitors|mesh-ancestor
64839571|NCT01632826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839572|NCT01633086|Nitric Oxide|nitric oxide|mesh-list
64839573|NCT01633086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64839617|NCT01633294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839618|NCT01633359|Atorvastatin|atorvastatin|mesh-list
64450613|NCT02090114|Testosterone|testosterone|mesh-list
64326780|NCT02261207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64326781|NCT02261207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839638|NCT01633593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64839639|NCT01633593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839641|NCT01633645|Gemcitabine|gemcitabine|mesh-list
64839643|NCT01633645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839644|NCT01633645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64839645|NCT01633645|Antimetabolites|antimetabolites|mesh-ancestor
64839646|NCT01633645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839647|NCT01633645|Antiviral Agents|antiviral agents|mesh-ancestor
64839648|NCT01633645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64839649|NCT01633645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839650|NCT01633645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64839651|NCT01633645|Immunologic Factors|immunologic factors|mesh-ancestor
64839652|NCT01633645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839653|NCT01633658|Cholecalciferol|cholecalciferol|mesh-list
64839654|NCT01633658|Vitamin D|vitamin d|mesh-list
64839655|NCT01633658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64839656|NCT01633658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839711|NCT01633983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839712|NCT01633983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64839713|NCT01633983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64839714|NCT01633983|Immunologic Factors|immunologic factors|mesh-ancestor
64839715|NCT01633983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64839716|NCT01633983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64839717|NCT01634061|Dactolisib|dactolisib|mesh-list
64839718|NCT01634061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839719|NCT01634230|Phenylacetic acid|phenylacetic acid|mesh-list
64839720|NCT01634230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64839721|NCT01634230|Antimetabolites|antimetabolites|mesh-ancestor
64839722|NCT01634230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839723|NCT01634230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839724|NCT01634295|Niacin|niacin|mesh-list
64839725|NCT01634295|Amlodipine|amlodipine|mesh-list
64839726|NCT01634295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64839727|NCT01634295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64839728|NCT01634295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64326787|NCT00838279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326788|NCT00838279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64839729|NCT01634295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839730|NCT01634295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64839731|NCT01634295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839732|NCT01634295|Vasodilator Agents|vasodilator agents|mesh-ancestor
64839733|NCT01634295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64839734|NCT01634295|Antimetabolites|antimetabolites|mesh-ancestor
64839758|NCT01634373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64839759|NCT01634373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64839760|NCT01634373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64839761|NCT01634373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64839762|NCT01634373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839763|NCT01634386|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64839764|NCT01634386|Antidepressive Agents|antidepressive agents|mesh-ancestor
64839765|NCT01634386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64839766|NCT01634386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64839767|NCT01634386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64839768|NCT01634386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64839769|NCT01634386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839770|NCT01634399|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64839771|NCT01634399|Antidepressive Agents|antidepressive agents|mesh-ancestor
64839772|NCT01634399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64839797|NCT01634438|Heparin|heparin|mesh-list
64839798|NCT01634438|Calcium heparin|calcium heparin|mesh-list
64839799|NCT01634438|Anticoagulants|anticoagulants|mesh-ancestor
64839800|NCT01634438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64326802|NCT00769795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326803|NCT00769795|Androgen Antagonists|androgen antagonists|mesh-ancestor
64326804|NCT00769795|Hormone Antagonists|hormone antagonists|mesh-ancestor
64839873|NCT01634893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64839874|NCT01634893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64839875|NCT01634893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64839876|NCT01634893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64839877|NCT01634906|Atorvastatin|atorvastatin|mesh-list
64839878|NCT01634906|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64839879|NCT01634906|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64839880|NCT01634906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64839881|NCT01634906|Antimetabolites|antimetabolites|mesh-ancestor
64839882|NCT01634906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839883|NCT01634906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64839884|NCT01634906|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64839911|NCT01635114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839912|NCT01635114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64839913|NCT01635205|Anesthetics|anesthetics|mesh-list
64839914|NCT01635205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64839915|NCT01635205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839916|NCT01635296|Cytarabine|cytarabine|mesh-list
64839917|NCT01635296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64839918|NCT01635296|Antimetabolites|antimetabolites|mesh-ancestor
64839919|NCT01635296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839920|NCT01635296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839921|NCT01635296|Antiviral Agents|antiviral agents|mesh-ancestor
64839922|NCT01635296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64839923|NCT01635296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64839924|NCT01635296|Immunologic Factors|immunologic factors|mesh-ancestor
64839925|NCT01635296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839926|NCT01635400|Irinotecan|irinotecan|mesh-list
64839927|NCT01635400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64839928|NCT01635400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64839929|NCT01635400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326811|NCT03134677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64326812|NCT03134677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840058|NCT01635946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64840059|NCT01635946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840060|NCT01635946|Antifungal Agents|antifungal agents|mesh-ancestor
64840061|NCT01635946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64840062|NCT01635972|Isavuconazole|isavuconazole|mesh-list
64840063|NCT01635972|Bupropion|bupropion|mesh-list
64840064|NCT01635972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64840065|NCT01635972|Antidepressive Agents|antidepressive agents|mesh-ancestor
64840066|NCT01635972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64840067|NCT01635972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64840068|NCT01635972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64840069|NCT01635972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64840070|NCT01635972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840072|NCT01635972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64840073|NCT01635972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840074|NCT01635972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64840075|NCT01635972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64840076|NCT01635972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840077|NCT01635972|Antifungal Agents|antifungal agents|mesh-ancestor
64840100|NCT01636128|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64840101|NCT01636128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840102|NCT01636128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840103|NCT01636128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64840104|NCT01636128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64840105|NCT01636128|Analgesics|analgesics|mesh-ancestor
64840106|NCT01636128|Sensory System Agents|sensory system agents|mesh-ancestor
64840107|NCT01636128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64840108|NCT01636128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840109|NCT01636128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64840166|NCT01636505|Cetrorelix|cetrorelix|mesh-list
64840167|NCT01636505|Buserelin|buserelin|mesh-list
64840168|NCT01636505|Ganirelix|ganirelix|mesh-list
64840169|NCT01636505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64840170|NCT01636505|Fertility Agents|fertility agents|mesh-ancestor
64840171|NCT01636505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64840172|NCT01636505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840173|NCT01636505|Hormone Antagonists|hormone antagonists|mesh-ancestor
64840174|NCT01636505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64840175|NCT01636531|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64840291|NCT01636908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64840292|NCT01636908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64608791|NCT02973958|Ibuprofen|ibuprofen|mesh-list
64840293|NCT01636908|Growth Substances|growth substances|mesh-ancestor
64840294|NCT01636908|Growth Inhibitors|growth inhibitors|mesh-ancestor
64840295|NCT01636999|Nitrous Oxide|nitrous oxide|mesh-list
64840297|NCT01636999|Anesthetics, General|anesthetics, general|mesh-ancestor
64840298|NCT01636999|Anesthetics|anesthetics|mesh-ancestor
64840299|NCT01636999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64840300|NCT01636999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840301|NCT01636999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64840302|NCT01636999|Analgesics|analgesics|mesh-ancestor
64840303|NCT01636999|Sensory System Agents|sensory system agents|mesh-ancestor
64840304|NCT01636999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64840305|NCT01637025|Cellulose, Oxidized|cellulose, oxidized|mesh-list
64840306|NCT01637025|Hemostatics|hemostatics|mesh-ancestor
64840307|NCT01637025|Coagulants|coagulants|mesh-ancestor
64840308|NCT01637155|Vitamin D|vitamin d|mesh-list
64840309|NCT01637155|Cholecalciferol|cholecalciferol|mesh-list
64840310|NCT01637155|Vitamins|vitamins|mesh-ancestor
64840311|NCT01637155|Micronutrients|micronutrients|mesh-ancestor
64840312|NCT01637155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840313|NCT01637155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64840314|NCT01637155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64840315|NCT01637194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64840316|NCT01637194|Cetuximab|cetuximab|mesh-list
64840317|NCT01637194|Everolimus|everolimus|mesh-list
64840318|NCT01637194|Antibodies|antibodies|mesh-list
64840319|NCT01637194|Immunoglobulins|immunoglobulins|mesh-list
64840320|NCT01637194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64840321|NCT01637194|Immunologic Factors|immunologic factors|mesh-ancestor
64840323|NCT01637194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840341|NCT01637233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840342|NCT01637233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840343|NCT01637233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64840344|NCT01637233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64840345|NCT01637233|Antiviral Agents|antiviral agents|mesh-ancestor
64840346|NCT01637233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64840347|NCT01637233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64840348|NCT01637233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64840349|NCT01637233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64840350|NCT01637233|Antimetabolites|antimetabolites|mesh-ancestor
64840351|NCT01637233|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64840352|NCT01637233|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64840353|NCT01637233|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64840354|NCT01637259|Ritonavir|ritonavir|mesh-list
64840355|NCT01637259|Lopinavir|lopinavir|mesh-list
64840356|NCT01637259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64840357|NCT01637259|Darunavir|darunavir|mesh-list
64840358|NCT01637259|Fosamprenavir|fosamprenavir|mesh-list
64840359|NCT01637259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
64840360|NCT01637259|Tenofovir|tenofovir|mesh-list
64840361|NCT01637259|Lamivudine|lamivudine|mesh-list
64840397|NCT01637454|Sympathomimetics|sympathomimetics|mesh-ancestor
64840398|NCT01637454|Autonomic Agents|autonomic agents|mesh-ancestor
64840399|NCT01637454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64840400|NCT01637532|Interferons|interferons|mesh-list
64840401|NCT01637532|Interferon-alpha|interferon-alpha|mesh-list
64840402|NCT01637532|Interferon alpha-2|interferon alpha-2|mesh-list
64840403|NCT01637532|Carboplatin|carboplatin|mesh-list
64840464|NCT01637636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64840465|NCT01637636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64840466|NCT01637636|Antifungal Agents|antifungal agents|mesh-ancestor
64840467|NCT01637636|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64840468|NCT01637636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64840469|NCT01637636|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64840470|NCT01637636|Hormone Antagonists|hormone antagonists|mesh-ancestor
64840471|NCT01637636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64840472|NCT01637636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840473|NCT01637636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64840474|NCT01637675|Tanshinone|tanshinone|mesh-list
64840475|NCT01637675|Sildenafil Citrate|sildenafil citrate|mesh-list
64840524|NCT01637818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64840529|NCT01637844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840530|NCT01637844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840531|NCT01637883|Benzydamine|benzydamine|mesh-list
64840532|NCT01637883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64840533|NCT01637948|Listerine|listerine|mesh-list
64840534|NCT01637948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64840535|NCT01637948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64840536|NCT01638026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64840537|NCT01638026|Luteolytic Agents|luteolytic agents|mesh-ancestor
64840538|NCT01638026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64840539|NCT01638026|Contraceptive Agents|contraceptive agents|mesh-ancestor
64840540|NCT01638026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64840541|NCT01638026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840542|NCT01638026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64840543|NCT01638026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64840544|NCT01638026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840545|NCT01638078|Thalidomide|thalidomide|mesh-list
64840546|NCT01638078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64840547|NCT01638078|Immunologic Factors|immunologic factors|mesh-ancestor
64840548|NCT01638078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354482|NCT01559363|XL647|xl647|mesh-list
64840549|NCT01638078|Leprostatic Agents|leprostatic agents|mesh-ancestor
64840550|NCT01638078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64840551|NCT01638078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64840552|NCT01638078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64840553|NCT01638078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64840554|NCT01638078|Growth Substances|growth substances|mesh-ancestor
64840555|NCT01638078|Growth Inhibitors|growth inhibitors|mesh-ancestor
64840556|NCT01638078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840557|NCT01638182|Vitamins|vitamins|mesh-list
64840558|NCT01638182|Vitamin K|vitamin k|mesh-list
64840559|NCT01638182|Vitamin K 2|vitamin k 2|mesh-list
64840560|NCT01638182|Vitamin K 1|vitamin k 1|mesh-list
64840561|NCT01638182|Micronutrients|micronutrients|mesh-ancestor
64840562|NCT01638182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840563|NCT01638182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64840564|NCT01638182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64840565|NCT01638182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840566|NCT01638182|Hemostatics|hemostatics|mesh-ancestor
64840567|NCT01638182|Coagulants|coagulants|mesh-ancestor
64840568|NCT01638234|Melatonin|melatonin|mesh-list
64840569|NCT01638234|Antioxidants|antioxidants|mesh-ancestor
64840570|NCT01638234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334629|NCT02228135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334630|NCT02228135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334631|NCT02228135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64840571|NCT01638234|Protective Agents|protective agents|mesh-ancestor
64840572|NCT01638234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840573|NCT01638234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64840574|NCT01638247|Tamoxifen|tamoxifen|mesh-list
64840575|NCT01638247|Goserelin|goserelin|mesh-list
64840576|NCT01638247|Exemestane|exemestane|mesh-list
64840577|NCT01638247|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64840578|NCT01638247|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64840579|NCT01638247|Hormone Antagonists|hormone antagonists|mesh-ancestor
64840580|NCT01638247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64840581|NCT01638247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840582|NCT01638247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64840583|NCT01638247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840584|NCT01638247|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64840585|NCT01638247|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64840586|NCT01638247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64840587|NCT01638247|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64840588|NCT01638247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64326865|NCT00758563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840618|NCT01638325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64840619|NCT01638325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840620|NCT01638364|Ethanol|ethanol|mesh-list
64840621|NCT01638364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64840622|NCT01638364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64840688|NCT01638689|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64840689|NCT01638689|Antidepressive Agents|antidepressive agents|mesh-ancestor
64840690|NCT01638689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64840691|NCT01638715|Rituximab|rituximab|mesh-list
64840692|NCT01638715|Abatacept|abatacept|mesh-list
64840693|NCT01638715|Infliximab|infliximab|mesh-list
64840694|NCT01638715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64840695|NCT01638715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840696|NCT01638715|Immunologic Factors|immunologic factors|mesh-ancestor
64840697|NCT01638715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840698|NCT01638715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64836105|NCT01611077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836106|NCT01611077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64836107|NCT01611077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836108|NCT01611077|Vasodilator Agents|vasodilator agents|mesh-ancestor
64325714|NCT01020565|Antiviral Agents|antiviral agents|mesh-ancestor
64325715|NCT01020565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64325716|NCT04965597|Methotrexate|methotrexate|mesh-list
64325717|NCT04965597|Fludarabine phosphate|fludarabine phosphate|mesh-list
64325718|NCT04965597|Fludarabine|fludarabine|mesh-list
64325719|NCT04965597|Treosulfan|treosulfan|mesh-list
64836109|NCT01611077|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64836110|NCT01611077|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64836111|NCT01611142|Mogamulizumab|mogamulizumab|mesh-list
64836112|NCT01611142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836116|NCT01611311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836117|NCT01611324|Epinephrine|epinephrine|mesh-list
64836118|NCT01611324|Mepivacaine|mepivacaine|mesh-list
64836119|NCT01611324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64836120|NCT01611324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64836121|NCT01611324|Adrenergic Agents|adrenergic agents|mesh-ancestor
64836122|NCT01611324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64836123|NCT01611324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840699|NCT01638715|Dermatologic Agents|dermatologic agents|mesh-ancestor
64840700|NCT01638715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64840701|NCT01638715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64840702|NCT01638715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840703|NCT01638715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64840704|NCT01638767|Contraceptive Agents|contraceptive agents|mesh-list
64840705|NCT01638767|NuvaRing|nuvaring|mesh-list
64840706|NCT01638767|Contraceptives, Oral|contraceptives, oral|mesh-list
64840707|NCT01638767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64840708|NCT01638767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840709|NCT01638767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64840710|NCT01638767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64840711|NCT01638780|Resveratrol|resveratrol|mesh-list
64840712|NCT01638780|Antioxidants|antioxidants|mesh-ancestor
64840713|NCT01638780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840714|NCT01638780|Protective Agents|protective agents|mesh-ancestor
64840715|NCT01638780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840716|NCT01638780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840717|NCT01638780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64840750|NCT01638962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64840751|NCT01638962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840753|NCT01638962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64840754|NCT01638962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64840755|NCT01638962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64840779|NCT01638988|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64840781|NCT01639027|Analgesics|analgesics|mesh-ancestor
64840782|NCT01639027|Sensory System Agents|sensory system agents|mesh-ancestor
64840783|NCT01639027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64840784|NCT01639027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840785|NCT01639027|Parasympatholytics|parasympatholytics|mesh-ancestor
64840786|NCT01639027|Autonomic Agents|autonomic agents|mesh-ancestor
64840787|NCT01639027|Vasodilator Agents|vasodilator agents|mesh-ancestor
64840788|NCT01639066|Tenofovir|tenofovir|mesh-list
64840789|NCT01639066|Entecavir|entecavir|mesh-list
64840790|NCT01639066|Antiviral Agents|antiviral agents|mesh-ancestor
64325720|NCT04965597|Busulfan|busulfan|mesh-list
64325721|NCT04965597|Tacrolimus|tacrolimus|mesh-list
64325722|NCT04965597|Thymoglobulin|thymoglobulin|mesh-list
64325723|NCT04965597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64325724|NCT04965597|Immunoglobulins|immunoglobulins|mesh-list
64325725|NCT04965597|Antibodies|antibodies|mesh-list
64325726|NCT04965597|gamma-Globulins|gamma-globulins|mesh-list
64325727|NCT04965597|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64325728|NCT04965597|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64325729|NCT04965597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64325730|NCT04965597|Abortifacient Agents|abortifacient agents|mesh-ancestor
64325731|NCT04965597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64836124|NCT01611324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836125|NCT01611324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64836127|NCT01611324|Autonomic Agents|autonomic agents|mesh-ancestor
64836139|NCT01611363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64836140|NCT01611363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836141|NCT01611363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64836142|NCT01611363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836143|NCT01611415|Ipragliflozin|ipragliflozin|mesh-list
64836144|NCT01611415|Furosemide|furosemide|mesh-list
64836145|NCT01611415|Diuretics|diuretics|mesh-ancestor
64836146|NCT01611415|Natriuretic Agents|natriuretic agents|mesh-ancestor
64836147|NCT01611415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836151|NCT01611415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64836152|NCT01611415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64836153|NCT01611428|Ipragliflozin|ipragliflozin|mesh-list
64836154|NCT01611428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64836155|NCT01611428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836156|NCT01611428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64836157|NCT01611428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836158|NCT01611480|Imiquimod|imiquimod|mesh-list
64836159|NCT01611480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64836160|NCT01611480|Immunologic Factors|immunologic factors|mesh-ancestor
64836161|NCT01611480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836162|NCT01611480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836163|NCT01611480|Interferon Inducers|interferon inducers|mesh-ancestor
64836196|NCT01611961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836197|NCT01611961|Tubulin Modulators|tubulin modulators|mesh-ancestor
64836198|NCT01611961|Antimitotic Agents|antimitotic agents|mesh-ancestor
64836199|NCT01611961|Mitosis Modulators|mitosis modulators|mesh-ancestor
64836200|NCT01611961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836201|NCT01612052|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64836202|NCT01612052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64836203|NCT01612065|Misoprostol|misoprostol|mesh-list
64325747|NCT04965597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64836211|NCT01612078|Droxidopa|droxidopa|mesh-list
64836212|NCT01612078|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64836213|NCT01612078|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64836214|NCT01612247|Aspirin|aspirin|mesh-list
64836215|NCT01612247|Cyclophosphamide|cyclophosphamide|mesh-list
64836216|NCT01612247|Methotrexate|methotrexate|mesh-list
64836217|NCT01612247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64836218|NCT01612247|Immunologic Factors|immunologic factors|mesh-ancestor
64836219|NCT01612247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836220|NCT01612247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64836221|NCT01612247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64836222|NCT01612247|Alkylating Agents|alkylating agents|mesh-ancestor
64447319|NCT02150954|Oxytocin|oxytocin|mesh-list
64840791|NCT01639066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64840792|NCT01639066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64840793|NCT01639066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64840794|NCT01639066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840795|NCT01639066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840796|NCT01639066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64840797|NCT01639066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64325755|NCT02154269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325759|NCT04914741|Doxorubicin|doxorubicin|mesh-list
64325760|NCT04914741|Vincristine|vincristine|mesh-list
64836223|NCT01612247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836224|NCT01612247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836225|NCT01612247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64836226|NCT01612247|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64836227|NCT01612247|Abortifacient Agents|abortifacient agents|mesh-ancestor
64836228|NCT01612247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64836229|NCT01612247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64836230|NCT01612247|Antimetabolites|antimetabolites|mesh-ancestor
64836231|NCT01612247|Dermatologic Agents|dermatologic agents|mesh-ancestor
64836232|NCT01612247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836233|NCT01612247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64325761|NCT04914741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64325762|NCT04914741|Immunologic Factors|immunologic factors|mesh-ancestor
64325763|NCT04914741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836235|NCT01612247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64836236|NCT01612247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64836237|NCT01612247|Analgesics|analgesics|mesh-ancestor
64836238|NCT01612247|Sensory System Agents|sensory system agents|mesh-ancestor
64836239|NCT01612247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64836240|NCT01612247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64836241|NCT01612247|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64447333|NCT04188392|Serotonin Agents|serotonin agents|mesh-ancestor
64325764|NCT04914741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64325765|NCT04914741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64325766|NCT04914741|Alkylating Agents|alkylating agents|mesh-ancestor
64325767|NCT04914741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325768|NCT04914741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840842|NCT01639521|Antimetabolites|antimetabolites|mesh-ancestor
64840843|NCT01639521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840859|NCT01639521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64840860|NCT01639521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64840862|NCT01639521|Antimitotic Agents|antimitotic agents|mesh-ancestor
64840863|NCT01639521|Mitosis Modulators|mitosis modulators|mesh-ancestor
64840864|NCT01639547|Ribavirin|ribavirin|mesh-list
64840865|NCT01639547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64840866|NCT01639547|Antimetabolites|antimetabolites|mesh-ancestor
64840867|NCT01639547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840868|NCT01639547|Antiviral Agents|antiviral agents|mesh-ancestor
64840869|NCT01639547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64840870|NCT01639573|Alemtuzumab|alemtuzumab|mesh-list
64840871|NCT01639573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64840872|NCT01639573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840873|NCT01639794|Solifenacin Succinate|solifenacin succinate|mesh-list
64840893|NCT01639898|Dexamethasone acetate|dexamethasone acetate|mesh-list
64840894|NCT01639898|Lenalidomide|lenalidomide|mesh-list
64840895|NCT01639898|BB 1101|bb 1101|mesh-list
64840896|NCT01639898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64840897|NCT01639898|Antiemetics|antiemetics|mesh-ancestor
64840898|NCT01639898|Autonomic Agents|autonomic agents|mesh-ancestor
64840899|NCT01639898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64840900|NCT01639898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840901|NCT01639898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64840902|NCT01639898|Glucocorticoids|glucocorticoids|mesh-ancestor
64840903|NCT01639898|Hormones|hormones|mesh-ancestor
64840904|NCT01639898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64840905|NCT01639898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64840906|NCT01639898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840907|NCT01639898|Protease Inhibitors|protease inhibitors|mesh-ancestor
64840908|NCT01639898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840909|NCT01639898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840910|NCT01639898|Immunologic Factors|immunologic factors|mesh-ancestor
64840911|NCT01639898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64840912|NCT01639898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64840913|NCT01639898|Growth Substances|growth substances|mesh-ancestor
64840914|NCT01639898|Growth Inhibitors|growth inhibitors|mesh-ancestor
64840915|NCT01640743|Methylprednisolone|methylprednisolone|mesh-list
64840916|NCT01640743|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64840917|NCT01640743|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64840918|NCT01640743|Prednisolone|prednisolone|mesh-list
64840919|NCT01640743|Prednisolone acetate|prednisolone acetate|mesh-list
64325772|NCT04914741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64325773|NCT04914741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64325774|NCT04914741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836242|NCT01612247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64836243|NCT01612247|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64836244|NCT01612247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64836245|NCT01612247|Antipyretics|antipyretics|mesh-ancestor
64836246|NCT01612273|Aspirin|aspirin|mesh-list
64836247|NCT01612273|Triflusal|triflusal|mesh-list
64836248|NCT01612273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64836249|NCT01612273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64836250|NCT01612273|Analgesics|analgesics|mesh-ancestor
64836251|NCT01612273|Sensory System Agents|sensory system agents|mesh-ancestor
64836252|NCT01612273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64836253|NCT01612273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836254|NCT01612273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64836255|NCT01612273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64836256|NCT01612273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64836257|NCT01612273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64836258|NCT01612273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836259|NCT01612273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64836260|NCT01612273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64836261|NCT01612273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836262|NCT01612273|Antipyretics|antipyretics|mesh-ancestor
64836263|NCT01612286|Endostatins|endostatins|mesh-list
64836264|NCT01612286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64836265|NCT01612286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64836266|NCT01612286|Growth Substances|growth substances|mesh-ancestor
64836267|NCT01612286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836268|NCT01612286|Growth Inhibitors|growth inhibitors|mesh-ancestor
64836269|NCT01612286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325775|NCT04914741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64840920|NCT01640743|Everolimus|everolimus|mesh-list
64840921|NCT01640743|Tacrolimus|tacrolimus|mesh-list
64836271|NCT01612299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836272|NCT01612299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64836273|NCT01612299|Immunologic Factors|immunologic factors|mesh-ancestor
64836274|NCT01612299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836275|NCT01612377|Prednisone|prednisone|mesh-list
64836276|NCT01612377|Prednisolone|prednisolone|mesh-list
64836277|NCT01612377|Dipyridamole|dipyridamole|mesh-list
64836278|NCT01612377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64836279|NCT01612377|Glucocorticoids|glucocorticoids|mesh-ancestor
64836280|NCT01612377|Hormones|hormones|mesh-ancestor
64836281|NCT01612377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64836282|NCT01612377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447370|NCT04739150|Nintedanib|nintedanib|mesh-list
64840922|NCT01640743|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64840923|NCT01640743|Prednisolone phosphate|prednisolone phosphate|mesh-list
64840924|NCT01640743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64840925|NCT01640743|Immunologic Factors|immunologic factors|mesh-ancestor
64840926|NCT01640743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840927|NCT01640743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64840928|NCT01640743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840929|NCT01640743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840930|NCT01640743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840931|NCT01640743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64325776|NCT04914741|Tubulin Modulators|tubulin modulators|mesh-ancestor
64325777|NCT04914741|Antimitotic Agents|antimitotic agents|mesh-ancestor
64325778|NCT04914741|Mitosis Modulators|mitosis modulators|mesh-ancestor
64836284|NCT01612377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836285|NCT01612377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64836286|NCT01612377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836287|NCT01612377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836288|NCT01612377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64836289|NCT01612377|Vasodilator Agents|vasodilator agents|mesh-ancestor
64836290|NCT01612403|Zinc Sulfate|zinc sulfate|mesh-list
64430003|NCT04991597|Lidocaine|lidocaine|mesh-list
64840932|NCT01640743|Antiemetics|antiemetics|mesh-ancestor
64840933|NCT01640743|Autonomic Agents|autonomic agents|mesh-ancestor
64840934|NCT01640743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64840935|NCT01640743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64840936|NCT01640743|Glucocorticoids|glucocorticoids|mesh-ancestor
64840937|NCT01640743|Hormones|hormones|mesh-ancestor
64836291|NCT01612403|Astringents|astringents|mesh-ancestor
64836292|NCT01612403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836293|NCT01612403|Dermatologic Agents|dermatologic agents|mesh-ancestor
64836294|NCT01612468|Liraglutide|liraglutide|mesh-list
64836295|NCT01612468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64836296|NCT01612468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836297|NCT01612468|Incretins|incretins|mesh-ancestor
64836298|NCT01612468|Hormones|hormones|mesh-ancestor
64836299|NCT01612468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64836300|NCT01612507|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64836301|NCT01612507|Cephalosporins|cephalosporins|mesh-list
64836302|NCT01612507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64836303|NCT01612507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64836304|NCT01612728|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64836305|NCT01612728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64836306|NCT01612728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836307|NCT01612728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836308|NCT01612728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64840938|NCT01640743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64840939|NCT01640743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64840951|NCT01641016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64840952|NCT01641016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64840953|NCT01641016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64840954|NCT01641016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64840955|NCT01641718|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64840956|NCT01641718|Hemostatics|hemostatics|mesh-ancestor
64840957|NCT01641718|Coagulants|coagulants|mesh-ancestor
64840958|NCT01642771|Docetaxel|docetaxel|mesh-list
64840959|NCT01642771|Fluorouracil|fluorouracil|mesh-list
64840960|NCT01642771|Capecitabine|capecitabine|mesh-list
64840961|NCT01642771|Epirubicin|epirubicin|mesh-list
64840962|NCT01642771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836309|NCT01612728|Hormone Antagonists|hormone antagonists|mesh-ancestor
64836310|NCT01612728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64836311|NCT01612728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836312|NCT01612741|Acarbose|acarbose|mesh-list
64836313|NCT01612741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64325779|NCT04914741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64325780|NCT04914741|Glucocorticoids|glucocorticoids|mesh-ancestor
64325781|NCT04914741|Hormones|hormones|mesh-ancestor
64325782|NCT04914741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64325783|NCT04914741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64325784|NCT03738683|Tazobactam|tazobactam|mesh-list
64325785|NCT03738683|Piperacillin|piperacillin|mesh-list
64836314|NCT01612741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836315|NCT01612741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836326|NCT01612832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836327|NCT01612832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64836328|NCT01612832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64836329|NCT01612832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64836330|NCT01612832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64836331|NCT01612832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64840963|NCT01642771|Tubulin Modulators|tubulin modulators|mesh-ancestor
64840964|NCT01642771|Antimitotic Agents|antimitotic agents|mesh-ancestor
64840965|NCT01642771|Mitosis Modulators|mitosis modulators|mesh-ancestor
64840966|NCT01642771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840967|NCT01642771|Antimetabolites|antimetabolites|mesh-ancestor
64840968|NCT01642771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64840969|NCT01642771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64840970|NCT01642771|Immunologic Factors|immunologic factors|mesh-ancestor
64840971|NCT01642771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840972|NCT01642771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64840973|NCT01642771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64326881|NCT02171585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64326882|NCT02171585|Antithrombins|antithrombins|mesh-ancestor
64326883|NCT02171585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64326884|NCT02171585|Protease Inhibitors|protease inhibitors|mesh-ancestor
64326885|NCT02171585|Anticoagulants|anticoagulants|mesh-ancestor
64326886|NCT03134443|Andrographolide|andrographolide|mesh-list
64326887|NCT03134443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64326888|NCT03134443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64326889|NCT03134443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64326890|NCT03134443|Analgesics|analgesics|mesh-ancestor
64326891|NCT03134443|Sensory System Agents|sensory system agents|mesh-ancestor
64326892|NCT03134443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64326893|NCT03134443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326894|NCT03134443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64326895|NCT03134443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64326896|NCT03134443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64840988|NCT01642979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64836333|NCT01612871|Letrozole|letrozole|mesh-list
64836334|NCT01612871|Anastrozole|anastrozole|mesh-list
64836335|NCT01612871|Exemestane|exemestane|mesh-list
64836336|NCT01612871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836337|NCT01612871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64836338|NCT01612871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64836339|NCT01612871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836340|NCT01612871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836341|NCT01612871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64836342|NCT01612871|Hormone Antagonists|hormone antagonists|mesh-ancestor
64325786|NCT03738683|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64325787|NCT03738683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64325788|NCT03738683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64325790|NCT03738683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840989|NCT01642979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64840990|NCT01642979|Hormones|hormones|mesh-ancestor
64840991|NCT01642979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64840992|NCT01642979|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64840993|NCT01642979|Antinematodal Agents|antinematodal agents|mesh-ancestor
64840994|NCT01642979|Anthelmintics|anthelmintics|mesh-ancestor
64840995|NCT01642979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64840996|NCT01643031|Clopidogrel|clopidogrel|mesh-list
64840997|NCT01643031|Ticagrelor|ticagrelor|mesh-list
64840998|NCT01643031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64840999|NCT01643031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64841000|NCT01643031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64841001|NCT01643031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64841002|NCT01643031|Purinergic Agents|purinergic agents|mesh-ancestor
64841003|NCT01643031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64836343|NCT01612871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64836344|NCT01612871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836345|NCT01612871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64836346|NCT01612871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64836347|NCT01612871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64836348|NCT01612871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64836349|NCT01612910|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
64836350|NCT01612910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64836351|NCT01612910|Protective Agents|protective agents|mesh-ancestor
64836352|NCT01612910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836353|NCT01612910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836354|NCT01612936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64836355|NCT01612936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64836356|NCT01612936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836357|NCT01612975|Naproxen|naproxen|mesh-list
64836358|NCT01612975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64836359|NCT01612975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64836360|NCT01612975|Analgesics|analgesics|mesh-ancestor
64836361|NCT01612975|Sensory System Agents|sensory system agents|mesh-ancestor
64836362|NCT01612975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64447438|NCT02105636|Antimitotic Agents|antimitotic agents|mesh-ancestor
64841004|NCT01643031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841005|NCT01643031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841006|NCT01643434|Clonidine|clonidine|mesh-list
64325791|NCT03738683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325792|NCT04475887|Iron|iron|mesh-list
64325793|NCT04475887|Trace Elements|trace elements|mesh-ancestor
64836363|NCT01612975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836364|NCT01612975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64836365|NCT01612975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64836366|NCT01612975|Gout Suppressants|gout suppressants|mesh-ancestor
64836367|NCT01612975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64836368|NCT01612975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836369|NCT01612975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836370|NCT01613040|Moxifloxacin|moxifloxacin|mesh-list
64836371|NCT01613040|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64836372|NCT01613040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64836373|NCT01613040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64836374|NCT01613040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64836375|NCT01613040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64325796|NCT02267239|Chlorhexidine|chlorhexidine|mesh-list
64836384|NCT01613040|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64836385|NCT01613040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64836387|NCT01613053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836388|NCT01613053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64836389|NCT01613053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836390|NCT01613053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836391|NCT01613079|Methotrexate|methotrexate|mesh-list
64836392|NCT01613079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64325801|NCT02267239|Sodium Fluoride|sodium fluoride|mesh-list
64325802|NCT02267239|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64325803|NCT02267239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64325804|NCT02267239|Disinfectants|disinfectants|mesh-ancestor
64325805|NCT02267239|Dermatologic Agents|dermatologic agents|mesh-ancestor
64325806|NCT02267239|Cariostatic Agents|cariostatic agents|mesh-ancestor
64841007|NCT01643434|Spironolactone|spironolactone|mesh-list
64841008|NCT01643434|Analgesics|analgesics|mesh-ancestor
64841009|NCT01643434|Sensory System Agents|sensory system agents|mesh-ancestor
64451953|NCT02027311|Anesthetics|anesthetics|mesh-ancestor
64841010|NCT01643434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64841011|NCT01643434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841012|NCT01643434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64841013|NCT01643434|Sympatholytics|sympatholytics|mesh-ancestor
64841014|NCT01643434|Autonomic Agents|autonomic agents|mesh-ancestor
64841015|NCT01643434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64841016|NCT01643434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64841017|NCT01643434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64841018|NCT01643434|Adrenergic Agents|adrenergic agents|mesh-ancestor
64841019|NCT01643434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64841020|NCT01643434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841021|NCT01643434|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64841022|NCT01643434|Hormone Antagonists|hormone antagonists|mesh-ancestor
64841023|NCT01643434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64841024|NCT01643434|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64841025|NCT01643434|Diuretics|diuretics|mesh-ancestor
64841026|NCT01643434|Natriuretic Agents|natriuretic agents|mesh-ancestor
64841027|NCT01643941|Vaccines|vaccines|mesh-list
64841028|NCT01643941|Immunologic Factors|immunologic factors|mesh-ancestor
64841102|NCT01648218|Coagulants|coagulants|mesh-ancestor
64841103|NCT01648465|Everolimus|everolimus|mesh-list
64841104|NCT01648465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841105|NCT01648465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64841106|NCT01648465|Immunologic Factors|immunologic factors|mesh-ancestor
64841107|NCT01648465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841108|NCT01648777|Bupivacaine|bupivacaine|mesh-list
64452056|NCT01812057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64841138|NCT01650090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841139|NCT01650129|Insulin|insulin|mesh-list
64841140|NCT01650129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64841141|NCT01650129|Insulin Aspart|insulin aspart|mesh-list
64841142|NCT01650129|Biphasic Insulins|biphasic insulins|mesh-list
64841143|NCT01650129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64836419|NCT01613105|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64836420|NCT01613105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836421|NCT01613105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836422|NCT01613105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64836423|NCT01613105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836425|NCT01613170|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64836426|NCT01613170|Hormones|hormones|mesh-ancestor
64836427|NCT01613170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64836428|NCT01613170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836429|NCT01613196|Deoxyglucose|deoxyglucose|mesh-list
64836430|NCT01613196|Antimetabolites|antimetabolites|mesh-ancestor
64836431|NCT01613196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836432|NCT01613196|Antiviral Agents|antiviral agents|mesh-ancestor
64836433|NCT01613196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64836434|NCT01613209|Candesartan|candesartan|mesh-list
64836435|NCT01613209|Candesartan cilexetil|candesartan cilexetil|mesh-list
64841144|NCT01650129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841145|NCT01650181|Selenium|selenium|mesh-list
64841146|NCT01650181|Thioctic Acid|thioctic acid|mesh-list
64841147|NCT01650181|Metformin|metformin|mesh-list
64841148|NCT01650181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64452093|NCT01841697|Immunologic Factors|immunologic factors|mesh-ancestor
64326911|NCT02171741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841149|NCT01650181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841150|NCT01650181|Antioxidants|antioxidants|mesh-ancestor
64841151|NCT01650181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841152|NCT01650181|Protective Agents|protective agents|mesh-ancestor
64841153|NCT01650181|Trace Elements|trace elements|mesh-ancestor
64841154|NCT01650181|Micronutrients|micronutrients|mesh-ancestor
64841155|NCT01650181|Vitamin B Complex|vitamin b complex|mesh-ancestor
64325807|NCT02267239|Protective Agents|protective agents|mesh-ancestor
64325808|NCT02267239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325809|NCT02267239|Antipruritics|antipruritics|mesh-ancestor
64325810|NCT02267239|Antifungal Agents|antifungal agents|mesh-ancestor
64836436|NCT01613209|Olmesartan|olmesartan|mesh-list
64836437|NCT01613209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64836438|NCT01613209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64836439|NCT01613209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64836440|NCT01613209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836441|NCT01613300|Ofatumumab|ofatumumab|mesh-list
64836442|NCT01613300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836443|NCT01613365|Chlorhexidine|chlorhexidine|mesh-list
64836444|NCT01613365|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64836445|NCT01613365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64836446|NCT01613365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64836452|NCT01613469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836453|NCT01613469|Vitamin B Complex|vitamin b complex|mesh-ancestor
64836454|NCT01613469|Vitamins|vitamins|mesh-ancestor
64836455|NCT01613469|Micronutrients|micronutrients|mesh-ancestor
64836456|NCT01613482|Trastuzumab|trastuzumab|mesh-list
64836457|NCT01613482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64836458|NCT01613482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836459|NCT01613534|Sucralfate|sucralfate|mesh-list
64836460|NCT01613534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64836461|NCT01613534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64836462|NCT01613547|Amoxicillin|amoxicillin|mesh-list
64836463|NCT01613547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64841157|NCT01650272|Minoxidil|minoxidil|mesh-list
64841158|NCT01650272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64841159|NCT01650272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64841237|NCT01650649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64841238|NCT01650649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841239|NCT01650649|Sensory System Agents|sensory system agents|mesh-ancestor
64841240|NCT01650649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64841241|NCT01650649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64841242|NCT01650649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64841243|NCT01650649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64841244|NCT01650649|Adrenergic Agents|adrenergic agents|mesh-ancestor
64841245|NCT01650649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64841246|NCT01650649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841247|NCT01650649|Analgesics|analgesics|mesh-ancestor
64841248|NCT01650649|Sympatholytics|sympatholytics|mesh-ancestor
64841249|NCT01650649|Autonomic Agents|autonomic agents|mesh-ancestor
64841251|NCT01650662|Cyclosporins|cyclosporins|mesh-list
64841252|NCT01650662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841253|NCT01650662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841254|NCT01650662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64841255|NCT01650662|Immunologic Factors|immunologic factors|mesh-ancestor
64841256|NCT01650662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841257|NCT01650662|Antifungal Agents|antifungal agents|mesh-ancestor
64841258|NCT01650662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64841259|NCT01650662|Dermatologic Agents|dermatologic agents|mesh-ancestor
64841260|NCT01650662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64836464|NCT01613547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64836465|NCT01613573|Hormones|hormones|mesh-list
64447548|NCT02123576|Antioxidants|antioxidants|mesh-ancestor
64325824|NCT02766023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64325825|NCT02766023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64836466|NCT01613573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64836467|NCT01613573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836468|NCT01613664|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64836469|NCT01613664|Hemostatics|hemostatics|mesh-ancestor
64836470|NCT01613664|Coagulants|coagulants|mesh-ancestor
64836471|NCT01613690|Glycopyrrolate|glycopyrrolate|mesh-list
64836472|NCT01613690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64836473|NCT01613690|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64836474|NCT01613690|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64836475|NCT01613690|Cholinergic Agents|cholinergic agents|mesh-ancestor
64836488|NCT01613755|Dipyridamole|dipyridamole|mesh-list
64447563|NCT02140970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64325826|NCT02766023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64325827|NCT05466500|Dexamethasone|dexamethasone|mesh-list
64325828|NCT05466500|Dexamethasone acetate|dexamethasone acetate|mesh-list
64836489|NCT01613755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64836490|NCT01613755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836491|NCT01613755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64836492|NCT01613755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836493|NCT01613755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836494|NCT01613755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64836495|NCT01613755|Vasodilator Agents|vasodilator agents|mesh-ancestor
64836496|NCT01613794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64325829|NCT05466500|Bupivacaine|bupivacaine|mesh-list
64325830|NCT05466500|BB 1101|bb 1101|mesh-list
64325831|NCT05466500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64325832|NCT05466500|Antiemetics|antiemetics|mesh-ancestor
64325833|NCT05466500|Autonomic Agents|autonomic agents|mesh-ancestor
64325834|NCT05466500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64325835|NCT05466500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836498|NCT01613794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64841261|NCT01650662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64841262|NCT01650727|Rituximab|rituximab|mesh-list
64841263|NCT01650727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64841264|NCT01650727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841265|NCT01650727|Immunologic Factors|immunologic factors|mesh-ancestor
64841266|NCT01650727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326934|NCT02938520|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64841354|NCT01651377|Pramipexole|pramipexole|mesh-list
64841355|NCT01651377|Antioxidants|antioxidants|mesh-ancestor
64841356|NCT01651377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841357|NCT01651377|Protective Agents|protective agents|mesh-ancestor
64841358|NCT01651377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841359|NCT01651377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64841360|NCT01651377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64841361|NCT01651377|Dopamine Agonists|dopamine agonists|mesh-ancestor
64841362|NCT01651377|Dopamine Agents|dopamine agents|mesh-ancestor
64841363|NCT01651377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64326959|NCT00755287|Insulin Glargine|insulin glargine|mesh-list
64326960|NCT00755287|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64326961|NCT00755287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64326962|NCT00755287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326963|NCT00755287|Incretins|incretins|mesh-ancestor
64841387|NCT01651416|Artenimol|artenimol|mesh-list
64841388|NCT01651416|Antimalarials|antimalarials|mesh-ancestor
64841389|NCT01651416|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64841390|NCT01651416|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64841391|NCT01651416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64841392|NCT01651416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64841393|NCT01651416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841394|NCT01651416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841395|NCT01651416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64841396|NCT01651416|Renal Agents|renal agents|mesh-ancestor
64841397|NCT01651481|Montelukast|montelukast|mesh-list
64841398|NCT01651481|Levocetirizine|levocetirizine|mesh-list
64836499|NCT01613794|Antimetabolites|antimetabolites|mesh-ancestor
64836500|NCT01613794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836501|NCT01613794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64836502|NCT01613794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64836503|NCT01613794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836504|NCT01613807|Insulin|insulin|mesh-list
64836505|NCT01613807|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64836506|NCT01613807|Insulin Lispro|insulin lispro|mesh-list
64836507|NCT01613807|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
64836508|NCT01613807|Insulin, Long-Acting|insulin, long-acting|mesh-list
64841401|NCT01651481|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64841402|NCT01651481|Hormone Antagonists|hormone antagonists|mesh-ancestor
64841403|NCT01651481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64841404|NCT01651481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841405|NCT01651481|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64841406|NCT01651481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64841407|NCT01651481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841408|NCT01651481|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64841409|NCT01651481|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64841410|NCT01651481|Histamine Antagonists|histamine antagonists|mesh-ancestor
64841411|NCT01651481|Histamine Agents|histamine agents|mesh-ancestor
64841412|NCT01651481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64841413|NCT01651520|Flumazenil|flumazenil|mesh-list
64841414|NCT01651520|Antidotes|antidotes|mesh-ancestor
64325836|NCT05466500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64325838|NCT05466500|Hormones|hormones|mesh-ancestor
64836509|NCT01613807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64836510|NCT01613807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836511|NCT01613820|Scopolamine|scopolamine|mesh-list
64836512|NCT01613820|Ketamine|ketamine|mesh-list
64836513|NCT01613820|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64836514|NCT01613820|Analgesics|analgesics|mesh-ancestor
64836515|NCT01613820|Sensory System Agents|sensory system agents|mesh-ancestor
64836516|NCT01613820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64836517|NCT01613820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836518|NCT01613820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64836519|NCT01613820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64836520|NCT01613820|Anesthetics, General|anesthetics, general|mesh-ancestor
64836521|NCT01613820|Anesthetics|anesthetics|mesh-ancestor
64836522|NCT01613820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64836523|NCT01613820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64836524|NCT01613820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64836525|NCT01613820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64836526|NCT01613820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836527|NCT01613820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64836528|NCT01613820|Antiemetics|antiemetics|mesh-ancestor
64836529|NCT01613820|Autonomic Agents|autonomic agents|mesh-ancestor
64836530|NCT01613820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64841415|NCT01651520|Protective Agents|protective agents|mesh-ancestor
64841416|NCT01651520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841423|NCT01651572|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64841424|NCT01651572|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64841425|NCT01651572|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64841426|NCT01651572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64841427|NCT01651572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841428|NCT01651585|Valacyclovir|valacyclovir|mesh-list
64836532|NCT01613820|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64836533|NCT01613820|Cholinergic Agents|cholinergic agents|mesh-ancestor
64836534|NCT01613820|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64836535|NCT01613820|Parasympatholytics|parasympatholytics|mesh-ancestor
64836537|NCT01613846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836538|NCT01613846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64836539|NCT01613846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836540|NCT01613846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836541|NCT01613924|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64836542|NCT01613924|Dermatologic Agents|dermatologic agents|mesh-ancestor
64356859|NCT03389321|Macitentan|macitentan|mesh-list
64841429|NCT01651585|Antiviral Agents|antiviral agents|mesh-ancestor
64841430|NCT01651585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64841431|NCT01651637|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64841432|NCT01651637|Respiratory System Agents|respiratory system agents|mesh-ancestor
64841434|NCT01651715|Immunologic Factors|immunologic factors|mesh-ancestor
64841435|NCT01651715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841436|NCT01651728|Simvastatin|simvastatin|mesh-list
64841437|NCT01651728|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64841438|NCT01651728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64841439|NCT01651728|Antimetabolites|antimetabolites|mesh-ancestor
64841440|NCT01651728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841441|NCT01651728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64841442|NCT01651728|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64841443|NCT01651728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841444|NCT01651923|Heparin|heparin|mesh-list
64841445|NCT01651923|Calcium heparin|calcium heparin|mesh-list
64841446|NCT01651923|Anticoagulants|anticoagulants|mesh-ancestor
64841447|NCT01651923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64841448|NCT01651923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64841449|NCT01651923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841450|NCT01651962|Fentanyl|fentanyl|mesh-list
64841451|NCT01651962|Terbutaline|terbutaline|mesh-list
64841452|NCT01651962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64841453|NCT01651962|Narcotics|narcotics|mesh-ancestor
64841454|NCT01651962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64841455|NCT01651962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841456|NCT01651962|Analgesics|analgesics|mesh-ancestor
64841457|NCT01651962|Sensory System Agents|sensory system agents|mesh-ancestor
64841458|NCT01651962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64841459|NCT01651962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64841460|NCT01651962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64836543|NCT01613963|Cyclosporine|cyclosporine|mesh-list
64836544|NCT01613963|Mycophenolic Acid|mycophenolic acid|mesh-list
64836545|NCT01613963|Prednisolone|prednisolone|mesh-list
64836546|NCT01613963|Adalimumab|adalimumab|mesh-list
64836547|NCT01613963|Etanercept|etanercept|mesh-list
64836548|NCT01613963|Methotrexate|methotrexate|mesh-list
64836549|NCT01613963|Azathioprine|azathioprine|mesh-list
64836550|NCT01613963|Infliximab|infliximab|mesh-list
64836551|NCT01613963|Cyclosporins|cyclosporins|mesh-list
64836552|NCT01613963|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64836553|NCT01613963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325840|NCT05466500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64325841|NCT05466500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325842|NCT05466500|Protease Inhibitors|protease inhibitors|mesh-ancestor
64325843|NCT05466500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64325844|NCT05466500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325845|NCT05466500|Anesthetics, Local|anesthetics, local|mesh-ancestor
64325846|NCT05466500|Anesthetics|anesthetics|mesh-ancestor
64325847|NCT05466500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64325848|NCT05466500|Sensory System Agents|sensory system agents|mesh-ancestor
64836554|NCT01613963|Immunologic Factors|immunologic factors|mesh-ancestor
64841461|NCT01651962|Anesthetics, General|anesthetics, general|mesh-ancestor
64841462|NCT01651962|Anesthetics|anesthetics|mesh-ancestor
64841463|NCT01651962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64841464|NCT01651962|Autonomic Agents|autonomic agents|mesh-ancestor
64841465|NCT01651962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64841466|NCT01651962|Respiratory System Agents|respiratory system agents|mesh-ancestor
64841467|NCT01651962|Sympathomimetics|sympathomimetics|mesh-ancestor
64841468|NCT01651962|Tocolytic Agents|tocolytic agents|mesh-ancestor
64841469|NCT01651962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64841470|NCT01651962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64326964|NCT00755287|Hormones|hormones|mesh-ancestor
64326965|NCT00755287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64326966|NCT02168075|Mannitol|mannitol|mesh-list
64836555|NCT01613963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836556|NCT01613963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64836557|NCT01613963|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64836558|NCT01613963|Abortifacient Agents|abortifacient agents|mesh-ancestor
64836559|NCT01613963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64836560|NCT01613963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64836562|NCT01613963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836563|NCT01613963|Dermatologic Agents|dermatologic agents|mesh-ancestor
64836564|NCT01613963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836565|NCT01613963|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64836566|NCT01613963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64836567|NCT01613963|Antifungal Agents|antifungal agents|mesh-ancestor
64836568|NCT01613963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64836569|NCT01613963|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64836570|NCT01613963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64836571|NCT01613963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64836572|NCT01613963|Antitubercular Agents|antitubercular agents|mesh-ancestor
64836573|NCT01613963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64836574|NCT01613963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64836575|NCT01613963|Glucocorticoids|glucocorticoids|mesh-ancestor
64836576|NCT01613963|Hormones|hormones|mesh-ancestor
64447647|NCT04073303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64447649|NCT04070573|Aspirin|aspirin|mesh-list
64325849|NCT04475107|Artesunate|artesunate|mesh-list
64325850|NCT04475107|Pyronaridine|pyronaridine|mesh-list
64325851|NCT04475107|Antimalarials|antimalarials|mesh-ancestor
64325852|NCT04475107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64325853|NCT04475107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64325854|NCT04475107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64430004|NCT04991597|Epinephrine|epinephrine|mesh-list
64326967|NCT02168075|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64326968|NCT02168075|Diuretics|diuretics|mesh-ancestor
64326969|NCT02168075|Natriuretic Agents|natriuretic agents|mesh-ancestor
64841488|NCT01652014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64841489|NCT01652014|Immunologic Factors|immunologic factors|mesh-ancestor
64841490|NCT01652014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841491|NCT01652014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64836577|NCT01613963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64836578|NCT01613963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64836579|NCT01613963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64836580|NCT01613963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64836581|NCT01613963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64836582|NCT01613963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64836583|NCT01613963|Analgesics|analgesics|mesh-ancestor
64836584|NCT01613963|Sensory System Agents|sensory system agents|mesh-ancestor
64836585|NCT01613976|Panobinostat|panobinostat|mesh-list
64836586|NCT01613976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836587|NCT01613976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64836588|NCT01613976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836589|NCT01613976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836590|NCT01614041|Tandospirone|tandospirone|mesh-list
64836591|NCT01614041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64836592|NCT01614041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64836593|NCT01614041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64836594|NCT01614041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836595|NCT01614041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64836596|NCT01614041|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64836597|NCT01614041|Serotonin Agents|serotonin agents|mesh-ancestor
64841492|NCT01652014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64841493|NCT01652014|Alkylating Agents|alkylating agents|mesh-ancestor
64841494|NCT01652014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841495|NCT01652014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841496|NCT01652014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64841497|NCT01652014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64841499|NCT01652014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64841500|NCT01652014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841501|NCT01652014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64841502|NCT01652014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64325856|NCT04475107|Antiviral Agents|antiviral agents|mesh-ancestor
64325857|NCT04475107|Schistosomicides|schistosomicides|mesh-ancestor
64325858|NCT04475107|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64325859|NCT04475107|Anthelmintics|anthelmintics|mesh-ancestor
64325860|NCT02254967|Vancomycin|vancomycin|mesh-list
64325861|NCT02254967|Fidaxomicin|fidaxomicin|mesh-list
64325862|NCT02254967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64836598|NCT01614041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64836599|NCT01614041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836600|NCT01614132|Cisplatin|cisplatin|mesh-list
64841503|NCT01652014|Antitubercular Agents|antitubercular agents|mesh-ancestor
64841504|NCT01652014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64841505|NCT01652014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64841506|NCT01652118|Clarithromycin|clarithromycin|mesh-list
64841507|NCT01652118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64841508|NCT01652118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64326971|NCT00712699|Adderall|adderall|mesh-list
64326972|NCT00712699|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64326973|NCT00712699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326974|NCT03945825|Vaccines|vaccines|mesh-list
64610071|NCT01833611|Entecavir|entecavir|mesh-list
64841583|NCT01652339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64841584|NCT01652339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841585|NCT01652339|Vasodilator Agents|vasodilator agents|mesh-ancestor
64841586|NCT01652339|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64841587|NCT01652339|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64841588|NCT01652378|Lidocaine|lidocaine|mesh-list
64841589|NCT01652378|Ondansetron|ondansetron|mesh-list
64841590|NCT01652378|Anesthetics, Local|anesthetics, local|mesh-ancestor
64841591|NCT01652378|Anesthetics|anesthetics|mesh-ancestor
64841592|NCT01652378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64841593|NCT01652378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836601|NCT01614132|Vincristine|vincristine|mesh-list
64836602|NCT01614132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836603|NCT01614132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836604|NCT01614132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64836605|NCT01614132|Tubulin Modulators|tubulin modulators|mesh-ancestor
64836606|NCT01614132|Antimitotic Agents|antimitotic agents|mesh-ancestor
64836607|NCT01614132|Mitosis Modulators|mitosis modulators|mesh-ancestor
64836608|NCT01614197|Cytarabine|cytarabine|mesh-list
64836609|NCT01614197|Hydrocortisone|hydrocortisone|mesh-list
64836610|NCT01614197|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64836611|NCT01614197|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64836612|NCT01614197|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64836613|NCT01614197|Cyclophosphamide|cyclophosphamide|mesh-list
64836614|NCT01614197|Methotrexate|methotrexate|mesh-list
64836615|NCT01614197|Etoposide|etoposide|mesh-list
64836616|NCT01614197|Etoposide phosphate|etoposide phosphate|mesh-list
64836617|NCT01614197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64836618|NCT01614197|Immunologic Factors|immunologic factors|mesh-ancestor
64836619|NCT01614197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836620|NCT01614197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64836621|NCT01614197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64836622|NCT01614197|Alkylating Agents|alkylating agents|mesh-ancestor
64836623|NCT01614197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836624|NCT01614197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836625|NCT01614197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64836626|NCT01614197|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64841594|NCT01652378|Sensory System Agents|sensory system agents|mesh-ancestor
64841595|NCT01652378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64841596|NCT01652378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64841597|NCT01652378|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64841598|NCT01652378|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64841599|NCT01652378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64841600|NCT01652378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841601|NCT01652378|Antiemetics|antiemetics|mesh-ancestor
64841602|NCT01652378|Autonomic Agents|autonomic agents|mesh-ancestor
64841603|NCT01652378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64841604|NCT01652378|Antipruritics|antipruritics|mesh-ancestor
64841605|NCT01652378|Dermatologic Agents|dermatologic agents|mesh-ancestor
64841606|NCT01652378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64841607|NCT01652378|Serotonin Agents|serotonin agents|mesh-ancestor
64836627|NCT01614197|Abortifacient Agents|abortifacient agents|mesh-ancestor
64836628|NCT01614197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64836629|NCT01614197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64836630|NCT01614197|Antimetabolites|antimetabolites|mesh-ancestor
64836631|NCT01614197|Dermatologic Agents|dermatologic agents|mesh-ancestor
64836632|NCT01614197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836633|NCT01614197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64836634|NCT01614197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64836635|NCT01614197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64836636|NCT01614197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64836637|NCT01614197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64836638|NCT01614197|Antiviral Agents|antiviral agents|mesh-ancestor
64836639|NCT01614197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64841608|NCT01652378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64841609|NCT01652378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64841610|NCT01652378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64841615|NCT01652417|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64841617|NCT01652417|Prednisolone acetate|prednisolone acetate|mesh-list
64841618|NCT01652417|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64841619|NCT01652417|Prednisolone phosphate|prednisolone phosphate|mesh-list
64841620|NCT01652417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64841621|NCT01652417|Antiemetics|antiemetics|mesh-ancestor
64841622|NCT01652417|Autonomic Agents|autonomic agents|mesh-ancestor
64325863|NCT02254967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64325864|NCT05444036|Ketamine|ketamine|mesh-list
64325865|NCT05444036|Analgesics|analgesics|mesh-ancestor
64325866|NCT05444036|Sensory System Agents|sensory system agents|mesh-ancestor
64325867|NCT05444036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64325868|NCT05444036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325869|NCT05444036|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64325870|NCT05444036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64836641|NCT01614223|Betamethasone|betamethasone|mesh-list
64836642|NCT01614223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64836643|NCT01614223|Glucocorticoids|glucocorticoids|mesh-ancestor
64836644|NCT01614223|Hormones|hormones|mesh-ancestor
64836645|NCT01614223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64836646|NCT01614223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836647|NCT01614223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64836648|NCT01614223|Respiratory System Agents|respiratory system agents|mesh-ancestor
64836649|NCT01614236|Pregabalin|pregabalin|mesh-list
64836650|NCT01614236|Analgesics|analgesics|mesh-ancestor
64836651|NCT01614236|Sensory System Agents|sensory system agents|mesh-ancestor
64836652|NCT01614236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64836653|NCT01614236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836654|NCT01614236|Anticonvulsants|anticonvulsants|mesh-ancestor
64836655|NCT01614236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64447741|NCT02072096|Metformin|metformin|mesh-list
64841623|NCT01652417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64841624|NCT01652417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841625|NCT01652417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64841626|NCT01652417|Glucocorticoids|glucocorticoids|mesh-ancestor
64841627|NCT01652417|Hormones|hormones|mesh-ancestor
64841628|NCT01652417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64841629|NCT01652417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64841630|NCT01652417|Protective Agents|protective agents|mesh-ancestor
64841631|NCT01652417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64841632|NCT01652417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841633|NCT01652534|Amantadine|amantadine|mesh-list
64841634|NCT01652534|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64841635|NCT01652534|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64841703|NCT01652638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841704|NCT01652781|Azacitidine|azacitidine|mesh-list
64841705|NCT01652781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64325872|NCT05444036|Anesthetics|anesthetics|mesh-ancestor
64836656|NCT01614236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64841706|NCT01652781|Antimetabolites|antimetabolites|mesh-ancestor
64841707|NCT01652781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841708|NCT01652781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841709|NCT01652781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841710|NCT01652794|Gemcitabine|gemcitabine|mesh-list
64841711|NCT01652794|Carboplatin|carboplatin|mesh-list
64841712|NCT01652794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841713|NCT01652794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64841714|NCT01652794|Antimetabolites|antimetabolites|mesh-ancestor
64452647|NCT01837719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64841715|NCT01652794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841717|NCT01652794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64841718|NCT01652794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841719|NCT01652794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64841720|NCT01652794|Immunologic Factors|immunologic factors|mesh-ancestor
64841721|NCT01652794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841722|NCT01652820|Gemcitabine|gemcitabine|mesh-list
64841723|NCT01652820|Carboplatin|carboplatin|mesh-list
64841724|NCT01652820|Docetaxel|docetaxel|mesh-list
64841725|NCT01652820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841726|NCT01652820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64841727|NCT01652820|Antimetabolites|antimetabolites|mesh-ancestor
64841728|NCT01652820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841729|NCT01652820|Antiviral Agents|antiviral agents|mesh-ancestor
64841730|NCT01652820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64841753|NCT01652898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841754|NCT01652924|Anesthetics|anesthetics|mesh-list
64836657|NCT01614236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836658|NCT01614236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64836659|NCT01614236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64836660|NCT01614236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64836661|NCT01614236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64836662|NCT01614236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64836663|NCT01614301|Pioglitazone|pioglitazone|mesh-list
64836664|NCT01614301|Sirolimus|sirolimus|mesh-list
64836665|NCT01614301|Etoricoxib|etoricoxib|mesh-list
64836666|NCT01614301|Dacarbazine|dacarbazine|mesh-list
64836667|NCT01614301|Trofosfamide|trofosfamide|mesh-list
64836668|NCT01614301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64836669|NCT01614301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325873|NCT05444036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64325874|NCT05444036|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64325875|NCT05444036|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64325876|NCT05444036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64325877|NCT05444036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841755|NCT01652924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64841756|NCT01652924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841757|NCT01653015|Vaccines|vaccines|mesh-list
64841758|NCT01653015|Immunologic Factors|immunologic factors|mesh-ancestor
64841759|NCT01653015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841760|NCT01653041|Everolimus|everolimus|mesh-list
64841761|NCT01653041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841762|NCT01653041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64841763|NCT01653041|Immunologic Factors|immunologic factors|mesh-ancestor
64841764|NCT01653041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841765|NCT01653067|Cytarabine|cytarabine|mesh-list
64841766|NCT01653067|Sirolimus|sirolimus|mesh-list
64836670|NCT01614301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64836671|NCT01614301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64836672|NCT01614301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64836673|NCT01614301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836674|NCT01614301|Antifungal Agents|antifungal agents|mesh-ancestor
64836675|NCT01614301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64836676|NCT01614301|Immunologic Factors|immunologic factors|mesh-ancestor
64447766|NCT01631825|Dopamine Agents|dopamine agents|mesh-ancestor
64325879|NCT03923959|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64325880|NCT03923959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64325881|NCT03923959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325882|NCT03923959|Hemostatics|hemostatics|mesh-ancestor
64325883|NCT03923959|Coagulants|coagulants|mesh-ancestor
64325884|NCT02161367|Simethicone|simethicone|mesh-list
64841767|NCT01653067|Dexamethasone|dexamethasone|mesh-list
64841768|NCT01653067|Dexamethasone acetate|dexamethasone acetate|mesh-list
64841769|NCT01653067|Rituximab|rituximab|mesh-list
64841770|NCT01653067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64841771|NCT01653067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452718|NCT01802775|Antipyretics|antipyretics|mesh-ancestor
64841777|NCT01653067|Autonomic Agents|autonomic agents|mesh-ancestor
64841778|NCT01653067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64841779|NCT01653067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64841780|NCT01653067|Glucocorticoids|glucocorticoids|mesh-ancestor
64841781|NCT01653067|Hormones|hormones|mesh-ancestor
64841782|NCT01653067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64841783|NCT01653067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64841784|NCT01653067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841785|NCT01653067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64841786|NCT01653067|Antimetabolites|antimetabolites|mesh-ancestor
64841787|NCT01653067|Antiviral Agents|antiviral agents|mesh-ancestor
64841788|NCT01653067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64841789|NCT01653067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64357219|NCT02732015|Dexamethasone acetate|dexamethasone acetate|mesh-list
64841790|NCT01653067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64841791|NCT01653067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64841792|NCT01653067|Antifungal Agents|antifungal agents|mesh-ancestor
64841793|NCT01653119|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64841794|NCT01653119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64841795|NCT01653119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64841796|NCT01653119|Antimetabolites|antimetabolites|mesh-ancestor
64841797|NCT01653119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841798|NCT01653119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64841799|NCT01653119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64841800|NCT01653119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841801|NCT01653171|Acetylcysteine|acetylcysteine|mesh-list
64841802|NCT01653171|Simethicone|simethicone|mesh-list
64326996|NCT04265534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326997|NCT04265534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64326998|NCT04265534|Antiemetics|antiemetics|mesh-ancestor
64326999|NCT04265534|Autonomic Agents|autonomic agents|mesh-ancestor
64841803|NCT01653171|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64841804|NCT01653171|Antiviral Agents|antiviral agents|mesh-ancestor
64841805|NCT01653171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64841806|NCT01653171|Expectorants|expectorants|mesh-ancestor
64841807|NCT01653171|Respiratory System Agents|respiratory system agents|mesh-ancestor
64841808|NCT01653171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64841809|NCT01653171|Antioxidants|antioxidants|mesh-ancestor
64610299|NCT01836575|Pemetrexed|pemetrexed|mesh-list
64841810|NCT01653171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841811|NCT01653171|Protective Agents|protective agents|mesh-ancestor
64841812|NCT01653171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841813|NCT01653171|Antidotes|antidotes|mesh-ancestor
64841814|NCT01653171|Antifoaming Agents|antifoaming agents|mesh-ancestor
64841815|NCT01653171|Emollients|emollients|mesh-ancestor
64841816|NCT01653171|Dermatologic Agents|dermatologic agents|mesh-ancestor
64841817|NCT01653236|Ribavirin|ribavirin|mesh-list
64836677|NCT01614301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64836678|NCT01614301|Alkylating Agents|alkylating agents|mesh-ancestor
64836679|NCT01614301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836680|NCT01614301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64836681|NCT01614301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64836682|NCT01614301|Analgesics|analgesics|mesh-ancestor
64836683|NCT01614301|Sensory System Agents|sensory system agents|mesh-ancestor
64836684|NCT01614301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64836685|NCT01614301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64836686|NCT01614301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64447771|NCT02071082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64325885|NCT02161367|Antifoaming Agents|antifoaming agents|mesh-ancestor
64325886|NCT02161367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325887|NCT02161367|Emollients|emollients|mesh-ancestor
64325888|NCT02161367|Dermatologic Agents|dermatologic agents|mesh-ancestor
64325889|NCT03542825|Iron|iron|mesh-list
64325890|NCT03542825|Lactoferrin|lactoferrin|mesh-list
64325891|NCT03542825|Iron Chelating Agents|iron chelating agents|mesh-list
64325892|NCT03542825|Trace Elements|trace elements|mesh-ancestor
64325893|NCT03542825|Micronutrients|micronutrients|mesh-ancestor
64325894|NCT03542825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325895|NCT03542825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64325896|NCT03542825|Chelating Agents|chelating agents|mesh-ancestor
64325897|NCT03542825|Sequestering Agents|sequestering agents|mesh-ancestor
64841818|NCT01653236|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64841819|NCT01653236|Antimetabolites|antimetabolites|mesh-ancestor
64841820|NCT01653236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841821|NCT01653236|Antiviral Agents|antiviral agents|mesh-ancestor
64327004|NCT04265534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64327005|NCT04265534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64327006|NCT04265534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841833|NCT01653457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841834|NCT01653457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841835|NCT01653457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64841836|NCT01653457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64841837|NCT01653470|Leucovorin|leucovorin|mesh-list
64841838|NCT01653470|Paclitaxel|paclitaxel|mesh-list
64841839|NCT01653470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64841840|NCT01653470|Carboplatin|carboplatin|mesh-list
64836687|NCT01614301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64836688|NCT01614301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64836689|NCT01614301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836691|NCT01614366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64836692|NCT01614366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64836693|NCT01614366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64836694|NCT01614366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836695|NCT01614366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64836696|NCT01614366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841841|NCT01653470|Fluorouracil|fluorouracil|mesh-list
64841842|NCT01653470|Irinotecan|irinotecan|mesh-list
64841843|NCT01653470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64841844|NCT01653470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841845|NCT01653470|Tubulin Modulators|tubulin modulators|mesh-ancestor
64841846|NCT01653470|Antimitotic Agents|antimitotic agents|mesh-ancestor
64841847|NCT01653470|Mitosis Modulators|mitosis modulators|mesh-ancestor
64841848|NCT01653470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841849|NCT01653470|Antimetabolites|antimetabolites|mesh-ancestor
64841850|NCT01653470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64841851|NCT01653470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64841852|NCT01653470|Immunologic Factors|immunologic factors|mesh-ancestor
64841853|NCT01653470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841854|NCT01653470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64841855|NCT01653470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64841856|NCT01653470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841857|NCT01653470|Antidotes|antidotes|mesh-ancestor
64841858|NCT01653470|Protective Agents|protective agents|mesh-ancestor
64841859|NCT01653470|Vitamin B Complex|vitamin b complex|mesh-ancestor
64325898|NCT03542825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325900|NCT01001923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64325902|NCT01001923|Sensory System Agents|sensory system agents|mesh-ancestor
64841860|NCT01653470|Vitamins|vitamins|mesh-ancestor
64841883|NCT01653717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841885|NCT01653717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64841886|NCT01653717|Alkylating Agents|alkylating agents|mesh-ancestor
64841887|NCT01653717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841888|NCT01653717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841889|NCT01653717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64841890|NCT01653717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64841892|NCT01653977|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64841893|NCT01653990|Moxifloxacin|moxifloxacin|mesh-list
64841894|NCT01653990|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64841895|NCT01653990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64841896|NCT01653990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64841897|NCT01653990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64841898|NCT01653990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64841899|NCT01653990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841900|NCT01653990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841901|NCT01653990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841902|NCT01653990|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64841903|NCT01653990|Contraceptive Agents|contraceptive agents|mesh-ancestor
64841904|NCT01653990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64841905|NCT01653990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841906|NCT01653990|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64841907|NCT01653990|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64841908|NCT01653990|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64836697|NCT01614366|Vasodilator Agents|vasodilator agents|mesh-ancestor
64836699|NCT01614405|Lopinavir|lopinavir|mesh-list
64836700|NCT01614405|Tenofovir|tenofovir|mesh-list
64836701|NCT01614405|Emtricitabine|emtricitabine|mesh-list
64836702|NCT01614405|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64836703|NCT01614405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64836704|NCT01614405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64836705|NCT01614405|Protease Inhibitors|protease inhibitors|mesh-ancestor
64836706|NCT01614405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836707|NCT01614405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836708|NCT01614405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64836709|NCT01614405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64836710|NCT01614405|Antiviral Agents|antiviral agents|mesh-ancestor
64836711|NCT01614405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64836712|NCT01614405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64836713|NCT01614405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64836714|NCT01614405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64836715|NCT01614405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64836716|NCT01614431|Acetylcysteine|acetylcysteine|mesh-list
64836717|NCT01614431|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64836718|NCT01614431|Antiviral Agents|antiviral agents|mesh-ancestor
64836719|NCT01614431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64836720|NCT01614431|Expectorants|expectorants|mesh-ancestor
64836721|NCT01614431|Respiratory System Agents|respiratory system agents|mesh-ancestor
64836722|NCT01614431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64836723|NCT01614431|Antioxidants|antioxidants|mesh-ancestor
64836724|NCT01614431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836725|NCT01614431|Protective Agents|protective agents|mesh-ancestor
64841909|NCT01654003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64841910|NCT01654081|Irinotecan|irinotecan|mesh-list
64841911|NCT01654081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64841912|NCT01654081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64841913|NCT01654081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841914|NCT01654081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841915|NCT01654081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841916|NCT01654120|Liraglutide|liraglutide|mesh-list
64841917|NCT01654120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64841918|NCT01654120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841919|NCT01654120|Incretins|incretins|mesh-ancestor
64841920|NCT01654120|Hormones|hormones|mesh-ancestor
64836726|NCT01614431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836727|NCT01614431|Antidotes|antidotes|mesh-ancestor
64836728|NCT01614496|Insulin|insulin|mesh-list
64836729|NCT01614496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64836730|NCT01614496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836731|NCT01614535|Remifentanil|remifentanil|mesh-list
64836732|NCT01614535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64447831|NCT02096900|Midazolam|midazolam|mesh-list
64836737|NCT01614535|Sensory System Agents|sensory system agents|mesh-ancestor
64836738|NCT01614535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64836739|NCT01614938|Cisplatin|cisplatin|mesh-list
64836740|NCT01614938|Docetaxel|docetaxel|mesh-list
64836741|NCT01614938|Cetuximab|cetuximab|mesh-list
64836742|NCT01614938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836743|NCT01614938|Tubulin Modulators|tubulin modulators|mesh-ancestor
64836744|NCT01614938|Antimitotic Agents|antimitotic agents|mesh-ancestor
64836745|NCT01614938|Mitosis Modulators|mitosis modulators|mesh-ancestor
64836746|NCT01614938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836747|NCT01614938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64836748|NCT01614964|Lumefantrine|lumefantrine|mesh-list
64836749|NCT01614964|Artemether|artemether|mesh-list
64430005|NCT04991597|Racepinephrine|racepinephrine|mesh-list
64841921|NCT01654120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64841922|NCT01654146|Paclitaxel|paclitaxel|mesh-list
64841923|NCT01654146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64841924|NCT01654146|Carboplatin|carboplatin|mesh-list
64841925|NCT01654146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64841926|NCT01654146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841927|NCT01654146|Tubulin Modulators|tubulin modulators|mesh-ancestor
64841928|NCT01654146|Antimitotic Agents|antimitotic agents|mesh-ancestor
64841929|NCT01654146|Mitosis Modulators|mitosis modulators|mesh-ancestor
64841947|NCT01654211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841948|NCT01654211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841949|NCT01654211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64841950|NCT01654211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64841951|NCT01654211|Antiviral Agents|antiviral agents|mesh-ancestor
64325904|NCT01001923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325906|NCT02154503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64325907|NCT02154503|Vasodilator Agents|vasodilator agents|mesh-ancestor
64325908|NCT02536976|Mirabegron|mirabegron|mesh-list
64325909|NCT02536976|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64325910|NCT02536976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64325911|NCT02536976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64325912|NCT02536976|Adrenergic Agents|adrenergic agents|mesh-ancestor
64325913|NCT02536976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64325914|NCT02536976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325915|NCT02536976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325916|NCT02536976|Urological Agents|urological agents|mesh-ancestor
64325917|NCT04310397|Trametinib|trametinib|mesh-list
64325918|NCT04310397|Dabrafenib|dabrafenib|mesh-list
64325919|NCT04310397|Spartalizumab|spartalizumab|mesh-list
64325920|NCT04310397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836757|NCT01615042|Lenalidomide|lenalidomide|mesh-list
64325921|NCT04310397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64325922|NCT04310397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64325923|NCT04310397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325924|NCT04310397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64325925|NCT05526703|Antihypertensive Agents|antihypertensive agents|mesh-list
64836769|NCT01615055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836770|NCT01615055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64836771|NCT01615055|Serotonin Agents|serotonin agents|mesh-ancestor
64836772|NCT01615055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836773|NCT01615055|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64836774|NCT01615055|Antidepressive Agents|antidepressive agents|mesh-ancestor
64836786|NCT01615185|Amisulpride|amisulpride|mesh-list
64836787|NCT01615185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64836788|NCT01615185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64836789|NCT01615185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64836790|NCT01615185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836791|NCT01615185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64836792|NCT01615185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64836793|NCT01615185|Dopamine Agents|dopamine agents|mesh-ancestor
64836794|NCT01615185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64841952|NCT01654211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64841953|NCT01654211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64841954|NCT01654211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64841955|NCT01654211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64841956|NCT01654367|Zoledronic Acid|zoledronic acid|mesh-list
64841957|NCT01654367|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64841958|NCT01654367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64841959|NCT01654367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841960|NCT01654367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64841961|NCT01654367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841962|NCT01654367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841963|NCT01654367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64841964|NCT01654367|Hormone Antagonists|hormone antagonists|mesh-ancestor
64841965|NCT01654367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64841966|NCT01654497|HU 211|hu 211|mesh-list
64841967|NCT01654497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64841968|NCT01654497|Antiemetics|antiemetics|mesh-ancestor
64841994|NCT01654575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841995|NCT01654575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841996|NCT01654575|Dermatologic Agents|dermatologic agents|mesh-ancestor
64841997|NCT01654575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841998|NCT01654575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64841999|NCT01654575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64842001|NCT01654575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64842002|NCT01654575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64842003|NCT01654640|Metformin|metformin|mesh-list
64842005|NCT01654640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842006|NCT01654692|Ipilimumab|ipilimumab|mesh-list
64842007|NCT01654692|Fotemustine|fotemustine|mesh-list
64842008|NCT01654692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64842009|NCT01654692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842010|NCT01654692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64842011|NCT01654692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842012|NCT01654705|Pantoprazole|pantoprazole|mesh-list
64836795|NCT01615185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836796|NCT01615185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64836797|NCT01615185|Antidepressive Agents|antidepressive agents|mesh-ancestor
64836798|NCT01615211|Letrozole|letrozole|mesh-list
64836799|NCT01615211|Trilostane|trilostane|mesh-list
64836800|NCT01615211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836801|NCT01615211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64836802|NCT01615211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64836803|NCT01615211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836804|NCT01615211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836805|NCT01615211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64836806|NCT01615211|Hormone Antagonists|hormone antagonists|mesh-ancestor
64836807|NCT01615211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64836808|NCT01615211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836809|NCT01615211|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64836810|NCT01615211|Abortifacient Agents|abortifacient agents|mesh-ancestor
64836811|NCT01615211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64836812|NCT01615224|Misoprostol|misoprostol|mesh-list
64836813|NCT01615224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64836814|NCT01615224|Abortifacient Agents|abortifacient agents|mesh-ancestor
64325928|NCT00992563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64325929|NCT00992563|Growth Substances|growth substances|mesh-ancestor
64325930|NCT00992563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325931|NCT00992563|Growth Inhibitors|growth inhibitors|mesh-ancestor
64836837|NCT01615393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836838|NCT01615393|Antiviral Agents|antiviral agents|mesh-ancestor
64836839|NCT01615393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64836840|NCT01615445|Resveratrol|resveratrol|mesh-list
64836841|NCT01615445|Antioxidants|antioxidants|mesh-ancestor
64836842|NCT01615445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836843|NCT01615445|Protective Agents|protective agents|mesh-ancestor
64836844|NCT01615445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836845|NCT01615445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836846|NCT01615445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64836847|NCT01615601|Ritonavir|ritonavir|mesh-list
64836848|NCT01615601|Darunavir|darunavir|mesh-list
64836849|NCT01615601|Etravirine|etravirine|mesh-list
64836850|NCT01615601|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64836851|NCT01615601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64836852|NCT01615601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64836853|NCT01615601|Protease Inhibitors|protease inhibitors|mesh-ancestor
64836854|NCT01615601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842013|NCT01654705|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64842014|NCT01654705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64842015|NCT01654705|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64842016|NCT01654705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842017|NCT01654705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842018|NCT01654718|Pantoprazole|pantoprazole|mesh-list
64842019|NCT01654718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64842020|NCT01654718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64842021|NCT01654718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64842022|NCT01654718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842023|NCT01654718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842024|NCT01654809|Vaccines|vaccines|mesh-list
64842025|NCT01654809|Immunologic Factors|immunologic factors|mesh-ancestor
64842026|NCT01654809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842027|NCT01654913|Chrysarobin|chrysarobin|mesh-list
64842028|NCT01654913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64842029|NCT01654913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64842030|NCT01654913|Analgesics|analgesics|mesh-ancestor
64842031|NCT01654913|Sensory System Agents|sensory system agents|mesh-ancestor
64842045|NCT01654965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64842046|NCT01654965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64842047|NCT01654965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842048|NCT01654965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842049|NCT01654965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842050|NCT01655004|Exemestane|exemestane|mesh-list
64842051|NCT01655004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842052|NCT01655004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64842053|NCT01655004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64842054|NCT01655004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842055|NCT01655004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842056|NCT01655004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64842057|NCT01655004|Hormone Antagonists|hormone antagonists|mesh-ancestor
64842058|NCT01655004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64842059|NCT01655004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842060|NCT01655056|Darexaban|darexaban|mesh-list
64842061|NCT01655056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64842062|NCT01655056|Antithrombins|antithrombins|mesh-ancestor
64842063|NCT01655056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64842064|NCT01655056|Protease Inhibitors|protease inhibitors|mesh-ancestor
64842065|NCT01655056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842066|NCT01655056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842067|NCT01655056|Anticoagulants|anticoagulants|mesh-ancestor
64842068|NCT01655082|Nicotine|nicotine|mesh-list
64836859|NCT01615601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64836860|NCT01615601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64836861|NCT01615601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64836862|NCT01615601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64836864|NCT01615614|Rifabutin|rifabutin|mesh-list
64836865|NCT01615614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64836866|NCT01615614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64836867|NCT01615614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836868|NCT01615614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836869|NCT01615614|Antiviral Agents|antiviral agents|mesh-ancestor
64447951|NCT01896531|Fluorouracil|fluorouracil|mesh-list
64325932|NCT00992563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325933|NCT02267707|Gemcitabine|gemcitabine|mesh-list
64325934|NCT02267707|Paclitaxel|paclitaxel|mesh-list
64325935|NCT02267707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64325936|NCT02267707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325937|NCT02267707|Tubulin Modulators|tubulin modulators|mesh-ancestor
64325938|NCT02267707|Antimitotic Agents|antimitotic agents|mesh-ancestor
64842069|NCT01655082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64842070|NCT01655082|Autonomic Agents|autonomic agents|mesh-ancestor
64842071|NCT01655082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842072|NCT01655082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327011|NCT04265534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64327012|NCT04265534|Hematinics|hematinics|mesh-ancestor
64327013|NCT04265534|Vitamin B Complex|vitamin b complex|mesh-ancestor
64327014|NCT00697099|Enoxaparin|enoxaparin|mesh-list
64327015|NCT00697099|Semuloparin|semuloparin|mesh-list
64842074|NCT01655082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64842075|NCT01655082|Cholinergic Agents|cholinergic agents|mesh-ancestor
64842076|NCT01655082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842100|NCT01655147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842101|NCT01655147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64842102|NCT01655147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64842103|NCT01655147|Antitubercular Agents|antitubercular agents|mesh-ancestor
64842104|NCT01655147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64842105|NCT01655147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64842106|NCT01655147|Leprostatic Agents|leprostatic agents|mesh-ancestor
64842107|NCT01655147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64842108|NCT01655147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64842109|NCT01655147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64842110|NCT01655147|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64842111|NCT01655147|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64842112|NCT01655147|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64836870|NCT01615614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64836871|NCT01615614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64836872|NCT01615614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64836873|NCT01615614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64836874|NCT01615614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64836875|NCT01615614|Antitubercular Agents|antitubercular agents|mesh-ancestor
64836877|NCT01615627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64836878|NCT01615627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64836879|NCT01615757|Cytarabine|cytarabine|mesh-list
64836880|NCT01615757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64836881|NCT01615757|Antimetabolites|antimetabolites|mesh-ancestor
64842113|NCT01655147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64842116|NCT01655199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64842117|NCT01655199|Autonomic Agents|autonomic agents|mesh-ancestor
64453049|NCT02069093|Hormones|hormones|mesh-ancestor
64842151|NCT01655303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64842152|NCT01655303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64842153|NCT01655303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64842154|NCT01655303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64842156|NCT01655316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64842157|NCT01655316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64842192|NCT01655641|Tranexamic Acid|tranexamic acid|mesh-list
64842193|NCT01655641|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64842194|NCT01655641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64842195|NCT01655641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842197|NCT01655641|Coagulants|coagulants|mesh-ancestor
64842198|NCT01655706|Aripiprazole|aripiprazole|mesh-list
64842199|NCT01655706|Citalopram|citalopram|mesh-list
64842200|NCT01655706|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64325939|NCT02267707|Mitosis Modulators|mitosis modulators|mesh-ancestor
64325940|NCT02267707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325941|NCT02267707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64325942|NCT02267707|Antimetabolites|antimetabolites|mesh-ancestor
64325943|NCT02267707|Antiviral Agents|antiviral agents|mesh-ancestor
64325944|NCT02267707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64842201|NCT01655706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64842202|NCT01655706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64842203|NCT01655706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842204|NCT01655706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842205|NCT01655706|Serotonin Agents|serotonin agents|mesh-ancestor
64842206|NCT01655706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842207|NCT01655706|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64842208|NCT01655706|Antidepressive Agents|antidepressive agents|mesh-ancestor
64842209|NCT01655706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64842210|NCT01655706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64842211|NCT01655706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64842212|NCT01655706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64842213|NCT01655706|Dopamine Agonists|dopamine agonists|mesh-ancestor
64842214|NCT01655706|Dopamine Agents|dopamine agents|mesh-ancestor
64842215|NCT01655706|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64842216|NCT01655706|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64836882|NCT01615757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836883|NCT01615757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836884|NCT01615757|Antiviral Agents|antiviral agents|mesh-ancestor
64836885|NCT01615757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64836886|NCT01615757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64836887|NCT01615757|Immunologic Factors|immunologic factors|mesh-ancestor
64836888|NCT01615757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836889|NCT01615913|Ketoconazole|ketoconazole|mesh-list
64836890|NCT01615913|Terbinafine|terbinafine|mesh-list
64836891|NCT01615913|Antifungal Agents|antifungal agents|mesh-ancestor
64836892|NCT01615913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64836893|NCT01615913|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64836894|NCT01615913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64836895|NCT01615913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836896|NCT01615913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836897|NCT01615913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64836898|NCT01615913|Hormone Antagonists|hormone antagonists|mesh-ancestor
64447975|NCT01618305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64447976|NCT01618305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64357826|NCT03090997|Vitamins|vitamins|mesh-list
64842217|NCT01655706|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64842218|NCT01655706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64842219|NCT01655706|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64842220|NCT01655706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64842251|NCT01655810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842253|NCT01655862|Botulinum Toxins|botulinum toxins|mesh-list
64842254|NCT01655862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64327031|NCT05630859|Vaccines|vaccines|mesh-list
64327032|NCT05630859|Immunologic Factors|immunologic factors|mesh-ancestor
64327033|NCT05630859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842282|NCT01655927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842300|NCT01655992|Antimetabolites|antimetabolites|mesh-ancestor
64325946|NCT02267707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64325947|NCT02267707|Immunologic Factors|immunologic factors|mesh-ancestor
64325948|NCT02267707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325949|NCT01373229|Plerixafor|plerixafor|mesh-list
64325950|NCT01373229|Rituximab|rituximab|mesh-list
64836899|NCT01615913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64836900|NCT01615913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836901|NCT01615913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64836902|NCT01615978|Liraglutide|liraglutide|mesh-list
64836903|NCT01615978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64836904|NCT01615978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836905|NCT01615978|Incretins|incretins|mesh-ancestor
64836906|NCT01615978|Hormones|hormones|mesh-ancestor
64836907|NCT01615978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64836908|NCT01616004|Nitrous Oxide|nitrous oxide|mesh-list
64836909|NCT01616004|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64836910|NCT01616004|Anesthetics, General|anesthetics, general|mesh-ancestor
64836911|NCT01616004|Anesthetics|anesthetics|mesh-ancestor
64836912|NCT01616004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64836913|NCT01616004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836914|NCT01616004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64836915|NCT01616004|Analgesics|analgesics|mesh-ancestor
64836916|NCT01616004|Sensory System Agents|sensory system agents|mesh-ancestor
64836917|NCT01616004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64836918|NCT01616069|Simendan|simendan|mesh-list
64836919|NCT01616069|Epinephrine|epinephrine|mesh-list
64325951|NCT01373229|Lenalidomide|lenalidomide|mesh-list
64325952|NCT01373229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64325953|NCT01373229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836920|NCT01616069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64836921|NCT01616069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64836922|NCT01616069|Adrenergic Agents|adrenergic agents|mesh-ancestor
64836923|NCT01616069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64836924|NCT01616069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836925|NCT01616069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842301|NCT01655992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842302|NCT01655992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842303|NCT01656005|Beclomethasone|beclomethasone|mesh-list
64842304|NCT01656005|Carvedilol|carvedilol|mesh-list
64842305|NCT01656005|Bisoprolol|bisoprolol|mesh-list
64842306|NCT01656005|Formoterol Fumarate|formoterol fumarate|mesh-list
64842307|NCT01656005|Tiotropium Bromide|tiotropium bromide|mesh-list
64842308|NCT01656005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64842309|NCT01656005|Autonomic Agents|autonomic agents|mesh-ancestor
64842310|NCT01656005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842311|NCT01656005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842312|NCT01656005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64842313|NCT01656005|Respiratory System Agents|respiratory system agents|mesh-ancestor
64842314|NCT01656005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64842315|NCT01656005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64842316|NCT01656005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64842317|NCT01656005|Adrenergic Agents|adrenergic agents|mesh-ancestor
64842318|NCT01656005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842319|NCT01656005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842320|NCT01656005|Parasympatholytics|parasympatholytics|mesh-ancestor
64842321|NCT01656005|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64842322|NCT01656005|Cholinergic Agents|cholinergic agents|mesh-ancestor
64842323|NCT01656005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64842324|NCT01656005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64842325|NCT01656005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64842326|NCT01656005|Antioxidants|antioxidants|mesh-ancestor
64842327|NCT01656005|Protective Agents|protective agents|mesh-ancestor
64842328|NCT01656005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64842329|NCT01656005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64842330|NCT01656005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64842331|NCT01656005|Vasodilator Agents|vasodilator agents|mesh-ancestor
64842332|NCT01656005|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64842449|NCT01656720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836926|NCT01616069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64836927|NCT01616069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64836928|NCT01616069|Autonomic Agents|autonomic agents|mesh-ancestor
64836929|NCT01616069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64836930|NCT01616069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64836931|NCT01616069|Respiratory System Agents|respiratory system agents|mesh-ancestor
64836932|NCT01616069|Mydriatics|mydriatics|mesh-ancestor
64836933|NCT01616069|Sympathomimetics|sympathomimetics|mesh-ancestor
64836934|NCT01616069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64836935|NCT01616069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64836936|NCT01616069|Vasodilator Agents|vasodilator agents|mesh-ancestor
64836937|NCT01616069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64836938|NCT01616069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64325957|NCT01373229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64325958|NCT01373229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64325959|NCT01373229|Growth Substances|growth substances|mesh-ancestor
64325960|NCT01373229|Growth Inhibitors|growth inhibitors|mesh-ancestor
64325961|NCT01373229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64325962|NCT01373229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64836939|NCT01616069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836940|NCT01616069|Protective Agents|protective agents|mesh-ancestor
64836941|NCT01616108|Bupivacaine|bupivacaine|mesh-list
64836942|NCT01616108|Anesthetics, Local|anesthetics, local|mesh-ancestor
64836944|NCT01616108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64836945|NCT01616108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836946|NCT01616108|Sensory System Agents|sensory system agents|mesh-ancestor
64836947|NCT01616108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64836948|NCT01616186|Everolimus|everolimus|mesh-list
64836949|NCT01616186|Sorafenib|sorafenib|mesh-list
64836950|NCT01616186|Sunitinib|sunitinib|mesh-list
64836951|NCT01616186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836952|NCT01616186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64836953|NCT01616186|Immunologic Factors|immunologic factors|mesh-ancestor
64836954|NCT01616186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836955|NCT01616186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64836956|NCT01616186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836957|NCT01616186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836958|NCT01616186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64836959|NCT01616186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64836960|NCT01616186|Growth Substances|growth substances|mesh-ancestor
64836961|NCT01616186|Growth Inhibitors|growth inhibitors|mesh-ancestor
64836962|NCT01616225|Hormones|hormones|mesh-list
64448032|NCT02203331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64836963|NCT01616225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64836964|NCT01616225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836966|NCT01616355|Eusol|eusol|mesh-list
64836968|NCT01616355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64836969|NCT01616381|Sildenafil Citrate|sildenafil citrate|mesh-list
64836970|NCT01616381|Vasodilator Agents|vasodilator agents|mesh-ancestor
64836971|NCT01616381|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64836972|NCT01616381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64836973|NCT01616381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836974|NCT01616381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836975|NCT01616381|Urological Agents|urological agents|mesh-ancestor
64836976|NCT01616407|Methylphenidate|methylphenidate|mesh-list
64836977|NCT01616407|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
64836978|NCT01616407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64325963|NCT01373229|Antiviral Agents|antiviral agents|mesh-ancestor
64325964|NCT01373229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64325965|NCT02671461|Aspirin|aspirin|mesh-list
64842450|NCT01656720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64842451|NCT01656720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64842452|NCT01656720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64842453|NCT01656720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64842454|NCT01656720|Adrenergic Agents|adrenergic agents|mesh-ancestor
64842513|NCT01657071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842514|NCT01657071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64842516|NCT01657071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842517|NCT01657071|Antipyretics|antipyretics|mesh-ancestor
64842518|NCT01657071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64842519|NCT01657071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64453460|NCT04717973|Hydroxocobalamin|hydroxocobalamin|mesh-list
64842543|NCT01657201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64842544|NCT01657240|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64842545|NCT01657240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64842546|NCT01657240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64842547|NCT01657240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64842548|NCT01657240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64842549|NCT01657240|Analgesics|analgesics|mesh-ancestor
64842550|NCT01657240|Sensory System Agents|sensory system agents|mesh-ancestor
64842551|NCT01657240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842552|NCT01657240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842553|NCT01657240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64842554|NCT01657240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64842555|NCT01657240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64836979|NCT01616407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836980|NCT01616407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64836981|NCT01616407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64836982|NCT01616407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64836983|NCT01616407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836984|NCT01616407|Dopamine Agents|dopamine agents|mesh-ancestor
64836985|NCT01616407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64836986|NCT01616407|Hallucinogens|hallucinogens|mesh-ancestor
64836987|NCT01616407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64836988|NCT01616407|Serotonin Agents|serotonin agents|mesh-ancestor
64836989|NCT01616407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64836990|NCT01616407|Adrenergic Agents|adrenergic agents|mesh-ancestor
64836991|NCT01616485|Sildenafil Citrate|sildenafil citrate|mesh-list
64836992|NCT01616485|Nitroglycerin|nitroglycerin|mesh-list
64836993|NCT01616485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836994|NCT01616485|Vasodilator Agents|vasodilator agents|mesh-ancestor
64836995|NCT01616485|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64836996|NCT01616485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64842556|NCT01657240|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64842557|NCT01657240|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64842558|NCT01657240|Histamine Antagonists|histamine antagonists|mesh-ancestor
64842559|NCT01657240|Histamine Agents|histamine agents|mesh-ancestor
64842560|NCT01657240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64453485|NCT02040779|Beclomethasone|beclomethasone|mesh-list
64842561|NCT01657240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842562|NCT01657318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
64842563|NCT01657318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64842564|NCT01657331|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64842565|NCT01657331|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64842566|NCT01657331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64842567|NCT01657331|Alkylating Agents|alkylating agents|mesh-ancestor
64842568|NCT01657331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842569|NCT01657331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842570|NCT01657331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64842571|NCT01657396|Chlorhexidine|chlorhexidine|mesh-list
64836997|NCT01616485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836998|NCT01616485|Urological Agents|urological agents|mesh-ancestor
64837000|NCT01616615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64837001|NCT01616615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64837002|NCT01616615|Analgesics|analgesics|mesh-ancestor
64837003|NCT01616615|Sensory System Agents|sensory system agents|mesh-ancestor
64837004|NCT01616615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64837005|NCT01616615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837006|NCT01616615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64837007|NCT01616615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64837008|NCT01616615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64837009|NCT01616615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64837010|NCT01616615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837011|NCT01616615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64837012|NCT01616615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64837013|NCT01616615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837014|NCT01616615|Antipyretics|antipyretics|mesh-ancestor
64842572|NCT01657396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64842573|NCT01657396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64842619|NCT01657487|Sympathomimetics|sympathomimetics|mesh-ancestor
64842621|NCT01657578|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64842622|NCT01657578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64842623|NCT01657578|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64837015|NCT01616680|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64837016|NCT01616680|Antibodies|antibodies|mesh-list
64837017|NCT01616680|Immunoglobulins|immunoglobulins|mesh-list
64837018|NCT01616680|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64837019|NCT01616680|Immunoconjugates|immunoconjugates|mesh-list
64837020|NCT01616680|Immunologic Factors|immunologic factors|mesh-ancestor
64448083|NCT02202551|Amantadine|amantadine|mesh-list
64325966|NCT02671461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64325967|NCT02671461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64325968|NCT02671461|Analgesics|analgesics|mesh-ancestor
64325969|NCT02671461|Sensory System Agents|sensory system agents|mesh-ancestor
64842624|NCT01657578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842625|NCT01657578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842626|NCT01657656|Vitamin D|vitamin d|mesh-list
64842627|NCT01657656|Vitamins|vitamins|mesh-ancestor
64842628|NCT01657656|Micronutrients|micronutrients|mesh-ancestor
64842629|NCT01657656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842630|NCT01657656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64842631|NCT01657669|Aflibercept|aflibercept|mesh-list
64842632|NCT01657669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64842633|NCT01657669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64842634|NCT01657669|Growth Substances|growth substances|mesh-ancestor
64842635|NCT01657669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842636|NCT01657669|Growth Inhibitors|growth inhibitors|mesh-ancestor
64842637|NCT01657669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842638|NCT01657682|Crenolanib|crenolanib|mesh-list
64842639|NCT01657682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842640|NCT01657747|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64842641|NCT01657747|Parasympatholytics|parasympatholytics|mesh-ancestor
64842642|NCT01657747|Autonomic Agents|autonomic agents|mesh-ancestor
64842643|NCT01657747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842644|NCT01657747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842645|NCT01657747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64453581|NCT01445080|Sorafenib|sorafenib|mesh-list
64842653|NCT01657812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842654|NCT01657812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64842655|NCT01657812|Analgesics|analgesics|mesh-ancestor
64842656|NCT01657812|Sensory System Agents|sensory system agents|mesh-ancestor
64842657|NCT01657812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842658|NCT01657812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64842659|NCT01657812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64837021|NCT01616680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837022|NCT01616680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64837023|NCT01616680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837024|NCT01616732|Testosterone|testosterone|mesh-list
64837025|NCT01616732|Androgens|androgens|mesh-ancestor
64837027|NCT01616732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64837028|NCT01616732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837029|NCT01616784|Insulin|insulin|mesh-list
64837030|NCT01616784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64837031|NCT01616784|Insulin Detemir|insulin detemir|mesh-list
64448109|NCT02105467|Grazoprevir|grazoprevir|mesh-list
64325970|NCT02671461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64325971|NCT02671461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325972|NCT02671461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64325973|NCT02671461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64325974|NCT02671461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64325975|NCT02671461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64325976|NCT02671461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325977|NCT02671461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64325978|NCT02671461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64325979|NCT02671461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64325980|NCT02671461|Antipyretics|antipyretics|mesh-ancestor
64325981|NCT05467033|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64325982|NCT05467033|Hemostatics|hemostatics|mesh-ancestor
64325983|NCT05467033|Coagulants|coagulants|mesh-ancestor
64325984|NCT05467033|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64325985|NCT05467033|Natriuretic Agents|natriuretic agents|mesh-ancestor
64325986|NCT05467033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325987|NCT04196283|Paclitaxel|paclitaxel|mesh-list
64837032|NCT01616784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64837033|NCT01616784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837034|NCT01616849|Nimotuzumab|nimotuzumab|mesh-list
64837035|NCT01616849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837036|NCT01616849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64837037|NCT01616875|Cisplatin|cisplatin|mesh-list
64837038|NCT01616875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837039|NCT01616888|Paclitaxel|paclitaxel|mesh-list
64837040|NCT01616888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64837041|NCT01616888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837042|NCT01616888|Tubulin Modulators|tubulin modulators|mesh-ancestor
64837043|NCT01616888|Antimitotic Agents|antimitotic agents|mesh-ancestor
64837044|NCT01616888|Mitosis Modulators|mitosis modulators|mesh-ancestor
64837045|NCT01616888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837046|NCT01616927|Lanreotide|lanreotide|mesh-list
64837047|NCT01616927|Somatostatin|somatostatin|mesh-list
64837048|NCT01616927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326002|NCT02268019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64837061|NCT01616966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64837062|NCT01616966|Narcotics|narcotics|mesh-ancestor
64837063|NCT01616966|Analgesics|analgesics|mesh-ancestor
64837064|NCT01616966|Sensory System Agents|sensory system agents|mesh-ancestor
64837065|NCT01616966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64837066|NCT01616966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64837067|NCT01616966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64837068|NCT01616992|Bupivacaine|bupivacaine|mesh-list
64837069|NCT01616992|Anesthetics, Local|anesthetics, local|mesh-ancestor
64837070|NCT01616992|Anesthetics|anesthetics|mesh-ancestor
64837071|NCT01616992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64837072|NCT01616992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837073|NCT01616992|Sensory System Agents|sensory system agents|mesh-ancestor
64837074|NCT01616992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64837075|NCT01617057|Tiludronic acid|tiludronic acid|mesh-list
64837076|NCT01617057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64837077|NCT01617057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837078|NCT01617135|Levodopa|levodopa|mesh-list
64837079|NCT01617135|Carbidopa|carbidopa|mesh-list
64837080|NCT01617135|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64837081|NCT01617135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64448142|NCT02623205|Citalopram|citalopram|mesh-list
64326005|NCT02268019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64326006|NCT02268019|Respiratory System Agents|respiratory system agents|mesh-ancestor
64326007|NCT02268019|Mydriatics|mydriatics|mesh-ancestor
64326008|NCT02268019|Sympathomimetics|sympathomimetics|mesh-ancestor
64326009|NCT02268019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64326010|NCT03114111|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64842660|NCT01657812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64842661|NCT01657812|Adrenergic Agents|adrenergic agents|mesh-ancestor
64842662|NCT01657812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842663|NCT01657812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842664|NCT01657825|Isavuconazole|isavuconazole|mesh-list
64842665|NCT01657825|Warfarin|warfarin|mesh-list
64842666|NCT01657825|Anticoagulants|anticoagulants|mesh-ancestor
64448160|NCT01500694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837082|NCT01617135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64837084|NCT01617135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64837085|NCT01617135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837086|NCT01617135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837087|NCT01617135|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64837088|NCT01617135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837089|NCT01617135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64837090|NCT01617135|Immunologic Factors|immunologic factors|mesh-ancestor
64837091|NCT01617135|Dopamine Agonists|dopamine agonists|mesh-ancestor
64837092|NCT01617200|Olanzapine|olanzapine|mesh-list
64837093|NCT01617200|Asenapine|asenapine|mesh-list
64837094|NCT01617200|Antiemetics|antiemetics|mesh-ancestor
64842667|NCT01657825|Antifungal Agents|antifungal agents|mesh-ancestor
64842668|NCT01657825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64842806|NCT01658215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842807|NCT01658215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842808|NCT01658319|Fludarabine|fludarabine|mesh-list
64842809|NCT01658319|Fludarabine phosphate|fludarabine phosphate|mesh-list
64842810|NCT01658319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842811|NCT01658319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64842812|NCT01658319|Antimetabolites|antimetabolites|mesh-ancestor
64842813|NCT01658319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842814|NCT01658319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64842815|NCT01658319|Immunologic Factors|immunologic factors|mesh-ancestor
64842816|NCT01658319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842817|NCT01658358|Doxorubicin|doxorubicin|mesh-list
64837096|NCT01617200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842818|NCT01658358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64842819|NCT01658358|Lapatinib|lapatinib|mesh-list
64842820|NCT01658358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64842821|NCT01658358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383598|NCT03173339|Anesthetics|anesthetics|mesh-ancestor
64383599|NCT03172871|Aripiprazole|aripiprazole|mesh-list
64383600|NCT03172871|Antidepressive Agents|antidepressive agents|mesh-ancestor
64383601|NCT03172871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64383602|NCT03172871|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64383603|NCT03172871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64383604|NCT03172871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64383607|NCT03172871|Dopamine Agents|dopamine agents|mesh-ancestor
64327104|NCT04239859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327105|NCT04239859|Dermatologic Agents|dermatologic agents|mesh-ancestor
64327106|NCT04239859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327107|NCT04239859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64842911|NCT01659086|Immunologic Factors|immunologic factors|mesh-ancestor
64842912|NCT01659086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842914|NCT01659099|Cyclophosphamide|cyclophosphamide|mesh-list
64842915|NCT01659099|Rituximab|rituximab|mesh-list
64842916|NCT01659099|Doxorubicin|doxorubicin|mesh-list
64842917|NCT01659099|Vincristine|vincristine|mesh-list
64842918|NCT01659099|Obinutuzumab|obinutuzumab|mesh-list
64842919|NCT01659099|Bleomycin|bleomycin|mesh-list
64842920|NCT01659099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64842921|NCT01659099|Immunologic Factors|immunologic factors|mesh-ancestor
64842922|NCT01659099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842923|NCT01659099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64842924|NCT01659099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64842925|NCT01659099|Alkylating Agents|alkylating agents|mesh-ancestor
64842926|NCT01659099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842927|NCT01659099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842928|NCT01659099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64842929|NCT01659099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64842930|NCT01659099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64842936|NCT01659099|Hormones|hormones|mesh-ancestor
64842941|NCT01659099|Antimitotic Agents|antimitotic agents|mesh-ancestor
64842942|NCT01659099|Mitosis Modulators|mitosis modulators|mesh-ancestor
64842943|NCT01659190|Calcium Carbonate|calcium carbonate|mesh-list
64842944|NCT01659190|Antacids|antacids|mesh-ancestor
64837097|NCT01617200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837098|NCT01617200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64837099|NCT01617200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64837100|NCT01617200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64837101|NCT01617200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64837102|NCT01617200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64837103|NCT01617200|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64837104|NCT01617200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64837105|NCT01617200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64837106|NCT01617200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837107|NCT01617200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64837108|NCT01617200|Serotonin Agents|serotonin agents|mesh-ancestor
64837109|NCT01617213|Lenalidomide|lenalidomide|mesh-list
64837110|NCT01617213|Melphalan|melphalan|mesh-list
64837111|NCT01617213|Immunologic Factors|immunologic factors|mesh-ancestor
64837112|NCT01617213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837113|NCT01617213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64837114|NCT01617213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64837115|NCT01617213|Growth Substances|growth substances|mesh-ancestor
64837116|NCT01617213|Growth Inhibitors|growth inhibitors|mesh-ancestor
64837117|NCT01617213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837118|NCT01617213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64837119|NCT01617213|Alkylating Agents|alkylating agents|mesh-ancestor
64837120|NCT01617213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837123|NCT01617226|Azacitidine|azacitidine|mesh-list
64837125|NCT01617226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64837126|NCT01617226|Antimetabolites|antimetabolites|mesh-ancestor
64837127|NCT01617226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837128|NCT01617226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837129|NCT01617226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837130|NCT01617226|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64837131|NCT01617317|Immunoglobulins|immunoglobulins|mesh-list
64837133|NCT01617317|Antibodies|antibodies|mesh-list
64837148|NCT01617356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64837149|NCT01617356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837151|NCT01617538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64837152|NCT01617538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64837153|NCT01617538|Antimetabolites|antimetabolites|mesh-ancestor
64837154|NCT01617538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837155|NCT01617538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64837156|NCT01617538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64837157|NCT01617538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837158|NCT01617551|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
64837159|NCT01617551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448213|NCT01483690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64326033|NCT02535416|Diphenhydramine|diphenhydramine|mesh-list
64326034|NCT02535416|Promethazine|promethazine|mesh-list
64326035|NCT02535416|Cetirizine|cetirizine|mesh-list
64326036|NCT02535416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64326037|NCT02535416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64837160|NCT01617551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837161|NCT01617564|Bupivacaine|bupivacaine|mesh-list
64837162|NCT01617564|Anesthetics, Local|anesthetics, local|mesh-ancestor
64837163|NCT01617564|Anesthetics|anesthetics|mesh-ancestor
64837164|NCT01617564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64837171|NCT01617590|Abortifacient Agents|abortifacient agents|mesh-ancestor
64837172|NCT01617590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64837173|NCT01617590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837174|NCT01617590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64837175|NCT01617590|Antimetabolites|antimetabolites|mesh-ancestor
64837176|NCT01617590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837177|NCT01617590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837178|NCT01617590|Dermatologic Agents|dermatologic agents|mesh-ancestor
64837179|NCT01617590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837180|NCT01617590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64837181|NCT01617590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64837182|NCT01617590|Immunologic Factors|immunologic factors|mesh-ancestor
64837183|NCT01617590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64837184|NCT01617590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64837185|NCT01617694|Dexmedetomidine|dexmedetomidine|mesh-list
64837186|NCT01617694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64837187|NCT01617694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64837188|NCT01617694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837189|NCT01617694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64837190|NCT01617694|Analgesics|analgesics|mesh-ancestor
64837191|NCT01617694|Sensory System Agents|sensory system agents|mesh-ancestor
64837192|NCT01617694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64837193|NCT01617694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64837194|NCT01617694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64837195|NCT01617694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64837196|NCT01617694|Adrenergic Agents|adrenergic agents|mesh-ancestor
64837197|NCT01617694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842945|NCT01659190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842946|NCT01659190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64842947|NCT01659242|Sulfasalazine|sulfasalazine|mesh-list
64842948|NCT01659242|Methotrexate|methotrexate|mesh-list
64842949|NCT01659242|Leflunomide|leflunomide|mesh-list
64842950|NCT01659242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64842951|NCT01659242|Abortifacient Agents|abortifacient agents|mesh-ancestor
64842952|NCT01659242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64842953|NCT01659242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842954|NCT01659242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64842955|NCT01659242|Antimetabolites|antimetabolites|mesh-ancestor
64842956|NCT01659242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384087|NCT02093026|Folic Acid|folic acid|mesh-list
64843041|NCT01659476|Respiratory System Agents|respiratory system agents|mesh-ancestor
64843042|NCT01659476|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64843043|NCT01659476|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64843044|NCT01659476|Cholinergic Agents|cholinergic agents|mesh-ancestor
64843045|NCT01659476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64843046|NCT01659476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843047|NCT01659515|Arbekacin|arbekacin|mesh-list
64843048|NCT01659515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64843063|NCT01659684|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64843064|NCT01659684|Immunologic Factors|immunologic factors|mesh-ancestor
64843065|NCT01659684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843066|NCT01659775|Ondansetron|ondansetron|mesh-list
64843067|NCT01659775|Antiemetics|antiemetics|mesh-ancestor
64843068|NCT01659775|Autonomic Agents|autonomic agents|mesh-ancestor
64843069|NCT01659775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843070|NCT01659775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843071|NCT01659775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64843072|NCT01659775|Antipruritics|antipruritics|mesh-ancestor
64843073|NCT01659775|Dermatologic Agents|dermatologic agents|mesh-ancestor
64843074|NCT01659775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64326039|NCT02535416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326041|NCT02535416|Anesthetics|anesthetics|mesh-ancestor
64326042|NCT02535416|Sensory System Agents|sensory system agents|mesh-ancestor
64326043|NCT02535416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64326044|NCT02535416|Antiemetics|antiemetics|mesh-ancestor
64326045|NCT02535416|Autonomic Agents|autonomic agents|mesh-ancestor
64326046|NCT02535416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64326047|NCT02535416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64326048|NCT02535416|Histamine Antagonists|histamine antagonists|mesh-ancestor
64326049|NCT02535416|Histamine Agents|histamine agents|mesh-ancestor
64837198|NCT01617694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837200|NCT01617707|Propofol|propofol|mesh-list
64837201|NCT01617707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64837202|NCT01617707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64837203|NCT01617707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837204|NCT01617707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64837205|NCT01617707|Anesthetics, General|anesthetics, general|mesh-ancestor
64837206|NCT01617707|Anesthetics|anesthetics|mesh-ancestor
64837207|NCT01617707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64326050|NCT02535416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64326051|NCT02535416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326052|NCT02535416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64326053|NCT02535416|Antipruritics|antipruritics|mesh-ancestor
64326054|NCT02535416|Dermatologic Agents|dermatologic agents|mesh-ancestor
64326055|NCT02535416|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64326056|NCT00911443|Interferons|interferons|mesh-list
64326057|NCT00911443|Interferon-alpha|interferon-alpha|mesh-list
64326058|NCT00911443|Interferon alpha-2|interferon alpha-2|mesh-list
64326059|NCT00911443|Dacarbazine|dacarbazine|mesh-list
64326060|NCT00911443|Thymalfasin|thymalfasin|mesh-list
64326061|NCT00911443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326062|NCT00911443|Antiviral Agents|antiviral agents|mesh-ancestor
64326063|NCT00911443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64326064|NCT00911443|Immunologic Factors|immunologic factors|mesh-ancestor
64326065|NCT00911443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843075|NCT01659775|Serotonin Agents|serotonin agents|mesh-ancestor
64843082|NCT01659775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64843083|NCT01659788|Ubiquinone|ubiquinone|mesh-list
64843084|NCT01659788|Coenzyme Q10|coenzyme q10|mesh-list
64843085|NCT01659788|Micronutrients|micronutrients|mesh-ancestor
64326066|NCT00911443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64326067|NCT00911443|Alkylating Agents|alkylating agents|mesh-ancestor
64326068|NCT00911443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326069|NCT00911443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64326071|NCT03949478|Nifedipine|nifedipine|mesh-list
64326072|NCT03949478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64326073|NCT03949478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64326074|NCT03949478|Analgesics|analgesics|mesh-ancestor
64326075|NCT03949478|Sensory System Agents|sensory system agents|mesh-ancestor
64843086|NCT01659788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843087|NCT01659788|Vitamins|vitamins|mesh-ancestor
64843088|NCT01659827|Bupivacaine|bupivacaine|mesh-list
64843089|NCT01659827|Anesthetics, Local|anesthetics, local|mesh-ancestor
64843090|NCT01659827|Anesthetics|anesthetics|mesh-ancestor
64843091|NCT01659827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64843092|NCT01659827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843093|NCT01659827|Sensory System Agents|sensory system agents|mesh-ancestor
64843094|NCT01659827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843095|NCT01659892|Montelukast|montelukast|mesh-list
64843105|NCT01659905|Montelukast|montelukast|mesh-list
64843106|NCT01659905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64843107|NCT01659905|Respiratory System Agents|respiratory system agents|mesh-ancestor
64843108|NCT01659905|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64843109|NCT01659905|Hormone Antagonists|hormone antagonists|mesh-ancestor
64843110|NCT01659905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64843111|NCT01659905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843112|NCT01659905|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64843113|NCT01659905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64843114|NCT01659905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843115|NCT01659918|Montelukast|montelukast|mesh-list
64327157|NCT02261129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64327158|NCT02261129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64327159|NCT02261129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64327160|NCT02261129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327161|NCT00694135|Dexamethasone|dexamethasone|mesh-list
64843130|NCT01659931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64843132|NCT01659931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64843133|NCT01659931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64843134|NCT01659931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843135|NCT01659944|Metoprolol|metoprolol|mesh-list
64837208|NCT01617707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64837209|NCT01617707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64837210|NCT01617707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64837211|NCT01617707|GABA Modulators|gaba modulators|mesh-ancestor
64837212|NCT01617707|GABA Agents|gaba agents|mesh-ancestor
64837213|NCT01617707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64837214|NCT01617707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837215|NCT01617733|Pasireotide|pasireotide|mesh-list
64837216|NCT01617733|Hormones|hormones|mesh-ancestor
64837217|NCT01617733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64605705|NCT00867451|Melatonin|melatonin|mesh-list
64837218|NCT01617733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837219|NCT01617746|Bosentan|bosentan|mesh-list
64327187|NCT03540095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64327188|NCT03071185|Dexmedetomidine|dexmedetomidine|mesh-list
64327189|NCT03071185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64327190|NCT03071185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64327192|NCT03071185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64327193|NCT03071185|Analgesics|analgesics|mesh-ancestor
64327194|NCT03071185|Sensory System Agents|sensory system agents|mesh-ancestor
64327195|NCT03071185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843136|NCT01659944|Eliglustat|eliglustat|mesh-list
64843137|NCT01659944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64843138|NCT01659944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64843139|NCT01659944|Sympatholytics|sympatholytics|mesh-ancestor
64843140|NCT01659944|Autonomic Agents|autonomic agents|mesh-ancestor
64843141|NCT01659944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843142|NCT01659944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843143|NCT01659944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64843144|NCT01659944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64843145|NCT01659944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64843185|NCT01660386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64843186|NCT01660386|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64843187|NCT01660386|Protease Inhibitors|protease inhibitors|mesh-ancestor
64843188|NCT01660386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843189|NCT01660386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843190|NCT01660386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64327196|NCT03071185|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64327197|NCT03071185|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64327198|NCT03071185|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64327199|NCT03071185|Adrenergic Agents|adrenergic agents|mesh-ancestor
64327200|NCT03071185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64326076|NCT03949478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64326077|NCT03949478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326078|NCT03949478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64326079|NCT03949478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64326080|NCT03949478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64326081|NCT03949478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326082|NCT03949478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326083|NCT03949478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64326084|NCT03949478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64837220|NCT01617746|Ambrisentan|ambrisentan|mesh-list
64837221|NCT01617746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64837222|NCT01617746|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64837223|NCT01617746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327201|NCT03071185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327202|NCT00741715|Atorvastatin|atorvastatin|mesh-list
64327203|NCT00741715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64327204|NCT00741715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64327205|NCT00741715|Antimetabolites|antimetabolites|mesh-ancestor
64327206|NCT00741715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327207|NCT00741715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64327208|NCT00741715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64327209|NCT00741715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327210|NCT02169167|Octenidine|octenidine|mesh-list
64327211|NCT02169167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64327212|NCT02169167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64327213|NCT02172443|Tiotropium Bromide|tiotropium bromide|mesh-list
64837224|NCT01617772|Atorvastatin|atorvastatin|mesh-list
64837225|NCT01617772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64837226|NCT01617772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64837227|NCT01617772|Antimetabolites|antimetabolites|mesh-ancestor
64837228|NCT01617772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837229|NCT01617772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64837230|NCT01617772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64837231|NCT01617772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326085|NCT03949478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64326086|NCT03949478|Vasodilator Agents|vasodilator agents|mesh-ancestor
64326087|NCT03949478|Tocolytic Agents|tocolytic agents|mesh-ancestor
64326088|NCT03949478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64326089|NCT00909649|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64326090|NCT00909649|Hemostatics|hemostatics|mesh-ancestor
64837233|NCT01617798|Furosemide|furosemide|mesh-list
64837236|NCT01617798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837237|NCT01617798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64837238|NCT01617798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64837239|NCT01617798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837240|NCT01617798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64326091|NCT00909649|Coagulants|coagulants|mesh-ancestor
64327214|NCT02172443|Ipratropium|ipratropium|mesh-list
64327215|NCT02172443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64327216|NCT02172443|Autonomic Agents|autonomic agents|mesh-ancestor
64843242|NCT01660750|Alkylating Agents|alkylating agents|mesh-ancestor
64843243|NCT01660750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843244|NCT01660750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843245|NCT01660750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64843246|NCT01660750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64843247|NCT01660750|Antiemetics|antiemetics|mesh-ancestor
64843248|NCT01660750|Autonomic Agents|autonomic agents|mesh-ancestor
64843249|NCT01660750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843250|NCT01660750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64843251|NCT01660750|Glucocorticoids|glucocorticoids|mesh-ancestor
64843252|NCT01660750|Hormones|hormones|mesh-ancestor
64843253|NCT01660750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64843254|NCT01660750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64843255|NCT01660854|Proguanil|proguanil|mesh-list
64843256|NCT01660854|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
64843257|NCT01660854|Antimalarials|antimalarials|mesh-ancestor
64843272|NCT01660867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64843273|NCT01660867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64843274|NCT01660867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843275|NCT01660919|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64843276|NCT01660919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64843277|NCT01660919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64843278|NCT01660919|Antimetabolites|antimetabolites|mesh-ancestor
64843279|NCT01660919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843280|NCT01660919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64843281|NCT01660919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64843282|NCT01660919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843283|NCT01660945|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
64837242|NCT01617811|Anesthetics|anesthetics|mesh-list
64837243|NCT01617811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64837244|NCT01617811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837245|NCT01617824|Linagliptin|linagliptin|mesh-list
64837246|NCT01617824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64837247|NCT01617824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837248|NCT01617824|Incretins|incretins|mesh-ancestor
64837249|NCT01617824|Hormones|hormones|mesh-ancestor
64837250|NCT01617824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64837251|NCT01617824|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64837252|NCT01617824|Protease Inhibitors|protease inhibitors|mesh-ancestor
64837253|NCT01617824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837254|NCT01617824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837255|NCT01617928|Paclitaxel|paclitaxel|mesh-list
64843284|NCT01660945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64843285|NCT01660945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64843286|NCT01660945|Antimetabolites|antimetabolites|mesh-ancestor
64843287|NCT01660945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843288|NCT01660945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64843289|NCT01660997|Dexamethasone|dexamethasone|mesh-list
64843368|NCT01661335|Antiemetics|antiemetics|mesh-ancestor
64843369|NCT01661335|Autonomic Agents|autonomic agents|mesh-ancestor
64843370|NCT01661335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843371|NCT01661335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843372|NCT01661335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64843373|NCT01661335|Glucocorticoids|glucocorticoids|mesh-ancestor
64843374|NCT01661335|Hormones|hormones|mesh-ancestor
64843375|NCT01661335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64843376|NCT01661335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64843377|NCT01661335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843378|NCT01661335|Protease Inhibitors|protease inhibitors|mesh-ancestor
64843379|NCT01661335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843380|NCT01661335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843381|NCT01661335|Antipruritics|antipruritics|mesh-ancestor
64837256|NCT01617928|Carboplatin|carboplatin|mesh-list
64837257|NCT01617928|Veliparib|veliparib|mesh-list
64837258|NCT01617928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64837259|NCT01617928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837260|NCT01617928|Tubulin Modulators|tubulin modulators|mesh-ancestor
64837261|NCT01617928|Antimitotic Agents|antimitotic agents|mesh-ancestor
64837262|NCT01617928|Mitosis Modulators|mitosis modulators|mesh-ancestor
64837263|NCT01617928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448318|NCT02075047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64326092|NCT00971035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64326105|NCT04787965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64326106|NCT04787965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64326108|NCT02670915|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64326109|NCT02670915|Insulin Aspart|insulin aspart|mesh-list
64326110|NCT02670915|Insulin, Long-Acting|insulin, long-acting|mesh-list
64837280|NCT01618006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837281|NCT01618006|Antipyretics|antipyretics|mesh-ancestor
64837282|NCT01618136|Paclitaxel|paclitaxel|mesh-list
64837283|NCT01618136|Carboplatin|carboplatin|mesh-list
64837284|NCT01618136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64837285|NCT01618136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837286|NCT01618136|Tubulin Modulators|tubulin modulators|mesh-ancestor
64837287|NCT01618136|Antimitotic Agents|antimitotic agents|mesh-ancestor
64837288|NCT01618136|Mitosis Modulators|mitosis modulators|mesh-ancestor
64837289|NCT01618136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837301|NCT01618253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837302|NCT01618370|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64837303|NCT01618370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837304|NCT01618396|Midazolam|midazolam|mesh-list
64837305|NCT01618396|Propofol|propofol|mesh-list
64837306|NCT01618396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64837307|NCT01618396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64837308|NCT01618396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837309|NCT01618396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64837310|NCT01618396|Anesthetics, General|anesthetics, general|mesh-ancestor
64837316|NCT01618396|GABA Modulators|gaba modulators|mesh-ancestor
64837317|NCT01618396|GABA Agents|gaba agents|mesh-ancestor
64837318|NCT01618396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64837319|NCT01618396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837320|NCT01618448|Tolvaptan|tolvaptan|mesh-list
64837321|NCT01618448|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64837322|NCT01618448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837323|NCT01618448|Natriuretic Agents|natriuretic agents|mesh-ancestor
64837324|NCT01618448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837325|NCT01618474|Docetaxel|docetaxel|mesh-list
64837326|NCT01618474|Capecitabine|capecitabine|mesh-list
64837334|NCT01618513|Octreotide|octreotide|mesh-list
64837359|NCT01618591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837360|NCT01618591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64837361|NCT01618591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64448414|NCT02229539|Histamine Antagonists|histamine antagonists|mesh-ancestor
64326117|NCT00821977|Vildagliptin|vildagliptin|mesh-list
64326118|NCT00821977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64326119|NCT00821977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837362|NCT01618591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64837363|NCT01618643|Acetic Acid|acetic acid|mesh-list
64837364|NCT01618643|Retinol acetate|retinol acetate|mesh-list
64837365|NCT01618643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64837366|NCT01618643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64837367|NCT01618643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64837368|NCT01618643|Immunologic Factors|immunologic factors|mesh-ancestor
64837369|NCT01618643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837370|NCT01618643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64837371|NCT01618643|Protective Agents|protective agents|mesh-ancestor
64837372|NCT01618643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837374|NCT01618760|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64837375|NCT01618760|Serotonin Agents|serotonin agents|mesh-ancestor
64837376|NCT01618760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64837377|NCT01618760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837378|NCT01618760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837379|NCT01618760|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64837380|NCT01618760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64837381|NCT01618760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64837382|NCT01618760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64837383|NCT01618760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64837384|NCT01618760|Dopamine Agents|dopamine agents|mesh-ancestor
64837385|NCT01618773|Adapalene|adapalene|mesh-list
64843382|NCT01661335|Dermatologic Agents|dermatologic agents|mesh-ancestor
64843383|NCT01661335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64843384|NCT01661335|Serotonin Agents|serotonin agents|mesh-ancestor
64843385|NCT01661335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64843386|NCT01661335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64843387|NCT01661335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64843388|NCT01661335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64843389|NCT01661335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64843390|NCT01661335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64843391|NCT01661335|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64843392|NCT01661439|Heparin|heparin|mesh-list
64837386|NCT01618773|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64837387|NCT01618773|Dermatologic Agents|dermatologic agents|mesh-ancestor
64837388|NCT01618773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64837389|NCT01618773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64837390|NCT01618773|Analgesics|analgesics|mesh-ancestor
64837391|NCT01618773|Sensory System Agents|sensory system agents|mesh-ancestor
64837392|NCT01618773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64837393|NCT01618773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837394|NCT01618773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64837395|NCT01618773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64359351|NCT04038489|Aspirin|aspirin|mesh-list
64430006|NCT04991597|Epinephryl borate|epinephryl borate|mesh-list
64837412|NCT01618825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837413|NCT01618825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64837414|NCT01618825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837415|NCT01618825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64837416|NCT01618825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64837417|NCT01618825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64837422|NCT01618877|Nootropic Agents|nootropic agents|mesh-ancestor
64837423|NCT01618890|Propranolol|propranolol|mesh-list
64837424|NCT01618890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64837425|NCT01618890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64837426|NCT01618890|Adrenergic Agents|adrenergic agents|mesh-ancestor
64837427|NCT01618890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64837428|NCT01618890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837429|NCT01618890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837434|NCT01618903|Anticonvulsants|anticonvulsants|mesh-ancestor
64837435|NCT01618903|Nootropic Agents|nootropic agents|mesh-ancestor
64837436|NCT01618929|Montelukast|montelukast|mesh-list
64837437|NCT01618929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64837438|NCT01618929|Respiratory System Agents|respiratory system agents|mesh-ancestor
64837439|NCT01618929|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64837440|NCT01618929|Hormone Antagonists|hormone antagonists|mesh-ancestor
64837441|NCT01618929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64837442|NCT01618929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837443|NCT01618929|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64837444|NCT01618929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64837445|NCT01618929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837446|NCT01619007|Rivaroxaban|rivaroxaban|mesh-list
64837447|NCT01619007|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64837448|NCT01619007|Antithrombins|antithrombins|mesh-ancestor
64448506|NCT02226653|Evacetrapib|evacetrapib|mesh-list
64843393|NCT01661439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64843394|NCT01661439|Tinzaparin|tinzaparin|mesh-list
64843395|NCT01661439|Dalteparin|dalteparin|mesh-list
64843396|NCT01661439|Anticoagulants|anticoagulants|mesh-ancestor
64326138|NCT04745949|Doxorubicin|doxorubicin|mesh-list
64326139|NCT04745949|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64326141|NCT04745949|Daunorubicin|daunorubicin|mesh-list
64326142|NCT04745949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64326143|NCT04745949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64326144|NCT04745949|Antibodies|antibodies|mesh-list
64326145|NCT04745949|Immunoglobulins|immunoglobulins|mesh-list
64326146|NCT04745949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64326147|NCT04745949|Immunoconjugates|immunoconjugates|mesh-list
64837449|NCT01619007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64837462|NCT01619072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64837463|NCT01619072|Oxytocics|oxytocics|mesh-ancestor
64837464|NCT01619137|Povidone-Iodine|povidone-iodine|mesh-list
64837465|NCT01619137|Povidone|povidone|mesh-list
64837466|NCT01619137|Plasma Substitutes|plasma substitutes|mesh-ancestor
64837467|NCT01619137|Blood Substitutes|blood substitutes|mesh-ancestor
64837468|NCT01619137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64837469|NCT01619137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64837470|NCT01619150|Etoricoxib|etoricoxib|mesh-list
64837471|NCT01619150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64837472|NCT01619150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64837473|NCT01619150|Analgesics|analgesics|mesh-ancestor
64837474|NCT01619150|Sensory System Agents|sensory system agents|mesh-ancestor
64326150|NCT04745949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326151|NCT04745949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64326152|NCT04745949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64843397|NCT01661439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64843398|NCT01661439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64843399|NCT01661439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843400|NCT01661530|Vitamin E|vitamin e|mesh-list
64843401|NCT01661530|Vitamins|vitamins|mesh-ancestor
64843402|NCT01661530|Micronutrients|micronutrients|mesh-ancestor
64843403|NCT01661530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843404|NCT01661530|Antioxidants|antioxidants|mesh-ancestor
64843405|NCT01661530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843406|NCT01661530|Protective Agents|protective agents|mesh-ancestor
64843407|NCT01661556|Miconazole|miconazole|mesh-list
64843408|NCT01661556|Hydroquinone|hydroquinone|mesh-list
64843409|NCT01661556|Antifungal Agents|antifungal agents|mesh-ancestor
64843410|NCT01661556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64843411|NCT01661556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64843412|NCT01661556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64843413|NCT01661556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843414|NCT01661556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843415|NCT01661556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64843437|NCT01661855|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64843438|NCT01661855|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64843439|NCT01661855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64843440|NCT01661855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843441|NCT01661855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843442|NCT01661855|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64843443|NCT01661855|Protective Agents|protective agents|mesh-ancestor
64843444|NCT01661868|Olaparib|olaparib|mesh-list
64843445|NCT01661868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64327264|NCT00834067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64327266|NCT00834067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327267|NCT00682981|Carboplatin|carboplatin|mesh-list
64327268|NCT00682981|Etoposide|etoposide|mesh-list
64327269|NCT00682981|Obatoclax|obatoclax|mesh-list
64327270|NCT00682981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327271|NCT00682981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64327272|NCT00682981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64327273|NCT00682981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64327274|NCT00682981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843466|NCT01662128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64843467|NCT01662128|Antimetabolites|antimetabolites|mesh-ancestor
64843511|NCT01662466|Immunologic Factors|immunologic factors|mesh-ancestor
64843512|NCT01662518|Dexamethasone|dexamethasone|mesh-list
64843513|NCT01662518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64327318|NCT02165033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64327319|NCT02165033|Respiratory System Agents|respiratory system agents|mesh-ancestor
64843529|NCT01662622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64843530|NCT01662622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843546|NCT01662700|Antimalarials|antimalarials|mesh-ancestor
64843547|NCT01662700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64843548|NCT01662700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64843549|NCT01662700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64843550|NCT01662700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843551|NCT01662700|Antiviral Agents|antiviral agents|mesh-ancestor
64843552|NCT01662700|Schistosomicides|schistosomicides|mesh-ancestor
64843553|NCT01662700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64843554|NCT01662700|Anthelmintics|anthelmintics|mesh-ancestor
64837476|NCT01619150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837477|NCT01619150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64837478|NCT01619150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64837479|NCT01619150|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64837480|NCT01619150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64837481|NCT01619150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837482|NCT01619150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837483|NCT01619163|Prednisolone|prednisolone|mesh-list
64837484|NCT01619163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64448544|NCT02200445|Antiviral Agents|antiviral agents|mesh-ancestor
64326157|NCT04745949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64326158|NCT04745949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64326159|NCT04745949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64326160|NCT04745949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326161|NCT04745949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64326162|NCT04745949|Glucocorticoids|glucocorticoids|mesh-ancestor
64326163|NCT04745949|Hormones|hormones|mesh-ancestor
64326164|NCT04745949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64843555|NCT01662700|Amebicides|amebicides|mesh-ancestor
64843556|NCT01662700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64843557|NCT01662804|Interleukin-2|interleukin-2|mesh-list
64843558|NCT01662804|Antibodies|antibodies|mesh-list
64843559|NCT01662804|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64843560|NCT01662804|Immunologic Factors|immunologic factors|mesh-ancestor
64843561|NCT01662804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843562|NCT01662804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843563|NCT01662804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64843564|NCT01662804|Analgesics|analgesics|mesh-ancestor
64843565|NCT01662804|Sensory System Agents|sensory system agents|mesh-ancestor
64843566|NCT01662804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843567|NCT01662869|Leucovorin|leucovorin|mesh-list
64843568|NCT01662869|Folic Acid|folic acid|mesh-list
64843569|NCT01662869|Oxaliplatin|oxaliplatin|mesh-list
64326165|NCT04745949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64326166|NCT04745949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64326167|NCT00961675|Ciprofloxacin|ciprofloxacin|mesh-list
64326168|NCT00961675|Povidone-Iodine|povidone-iodine|mesh-list
64326169|NCT00961675|Dexamethasone|dexamethasone|mesh-list
64326170|NCT00961675|Dexamethasone acetate|dexamethasone acetate|mesh-list
64837485|NCT01619163|Glucocorticoids|glucocorticoids|mesh-ancestor
64837486|NCT01619163|Hormones|hormones|mesh-ancestor
64837487|NCT01619163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64837488|NCT01619163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837489|NCT01619163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64837490|NCT01619163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837491|NCT01619176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64837492|NCT01619176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64837493|NCT01619176|Methotrexate|methotrexate|mesh-list
64837494|NCT01619176|Leflunomide|leflunomide|mesh-list
64837495|NCT01619176|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64837496|NCT01619176|Abortifacient Agents|abortifacient agents|mesh-ancestor
64843570|NCT01662869|Fluorouracil|fluorouracil|mesh-list
64843571|NCT01662869|Levoleucovorin|levoleucovorin|mesh-list
64843572|NCT01662869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843573|NCT01662869|Antidotes|antidotes|mesh-ancestor
64843574|NCT01662869|Protective Agents|protective agents|mesh-ancestor
64843575|NCT01662869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843576|NCT01662869|Vitamin B Complex|vitamin b complex|mesh-ancestor
64843577|NCT01662869|Vitamins|vitamins|mesh-ancestor
64843578|NCT01662869|Micronutrients|micronutrients|mesh-ancestor
64326171|NCT00961675|Povidone|povidone|mesh-list
64326172|NCT00961675|BB 1101|bb 1101|mesh-list
64326173|NCT00961675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64326174|NCT00961675|Antiemetics|antiemetics|mesh-ancestor
64326175|NCT00961675|Autonomic Agents|autonomic agents|mesh-ancestor
64326176|NCT00961675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64837497|NCT01619176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64837498|NCT01619176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837499|NCT01619176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64837500|NCT01619176|Antimetabolites|antimetabolites|mesh-ancestor
64837501|NCT01619176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837502|NCT01619176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837503|NCT01619176|Dermatologic Agents|dermatologic agents|mesh-ancestor
64837504|NCT01619176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837505|NCT01619176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64326177|NCT00961675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326178|NCT00961675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64837512|NCT01619176|Sensory System Agents|sensory system agents|mesh-ancestor
64837513|NCT01619176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64837515|NCT01619280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64837516|NCT01619280|Vasodilator Agents|vasodilator agents|mesh-ancestor
64837517|NCT01619280|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64837518|NCT01619280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837519|NCT01619436|Clonidine|clonidine|mesh-list
64837520|NCT01619436|Analgesics|analgesics|mesh-ancestor
64430007|NCT04991597|Anesthetics, Local|anesthetics, local|mesh-ancestor
64843579|NCT01662869|Hematinics|hematinics|mesh-ancestor
64843580|NCT01662869|Antimetabolites|antimetabolites|mesh-ancestor
64843581|NCT01662869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327334|NCT00734461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64843616|NCT01663077|Serotonin Agents|serotonin agents|mesh-ancestor
64843617|NCT01663077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64843618|NCT01663077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326180|NCT00961675|Hormones|hormones|mesh-ancestor
64326181|NCT00961675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64326182|NCT00961675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64837522|NCT01619436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64837523|NCT01619436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837524|NCT01619436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64837525|NCT01619436|Sympatholytics|sympatholytics|mesh-ancestor
64837526|NCT01619436|Autonomic Agents|autonomic agents|mesh-ancestor
64837527|NCT01619436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64837528|NCT01619436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64843619|NCT01663077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843620|NCT01663077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64843621|NCT01663077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64843629|NCT01663090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64843630|NCT01663168|Rifabutin|rifabutin|mesh-list
64843631|NCT01663168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64843635|NCT01663441|Oprelvekin|oprelvekin|mesh-list
64843675|NCT01664013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843676|NCT01664013|Cholinergic Agents|cholinergic agents|mesh-ancestor
64843677|NCT01664013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64843678|NCT01664013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843679|NCT01664013|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64843680|NCT01664013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843681|NCT01664065|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64612173|NCT00935311|Oxycodone|oxycodone|mesh-list
64843682|NCT01664065|Cephalosporins|cephalosporins|mesh-list
64843683|NCT01664065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64843684|NCT01664065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64843685|NCT01664195|Epoetin Alfa|epoetin alfa|mesh-list
64843686|NCT01664195|Hematinics|hematinics|mesh-ancestor
64843687|NCT01664221|Epoetin Alfa|epoetin alfa|mesh-list
64843688|NCT01664221|Hematinics|hematinics|mesh-ancestor
64843689|NCT01664260|Acetylcysteine|acetylcysteine|mesh-list
64843690|NCT01664260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64837529|NCT01619436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64837530|NCT01619436|Adrenergic Agents|adrenergic agents|mesh-ancestor
64837531|NCT01619436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64837532|NCT01619436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837533|NCT01619462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64837534|NCT01619462|Immunologic Factors|immunologic factors|mesh-ancestor
64448590|NCT02199509|Nootropic Agents|nootropic agents|mesh-ancestor
64326183|NCT00961675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326184|NCT00961675|Protease Inhibitors|protease inhibitors|mesh-ancestor
64837535|NCT01619462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837536|NCT01619527|Darunavir|darunavir|mesh-list
64837537|NCT01619527|Cobicistat|cobicistat|mesh-list
64837538|NCT01619527|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64843691|NCT01664260|Antiviral Agents|antiviral agents|mesh-ancestor
64843692|NCT01664260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64843693|NCT01664260|Expectorants|expectorants|mesh-ancestor
64843694|NCT01664260|Respiratory System Agents|respiratory system agents|mesh-ancestor
64843695|NCT01664260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64843696|NCT01664260|Antioxidants|antioxidants|mesh-ancestor
64327335|NCT00734461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327337|NCT00734461|Sensory System Agents|sensory system agents|mesh-ancestor
64837539|NCT01619527|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64837540|NCT01619527|Protease Inhibitors|protease inhibitors|mesh-ancestor
64837541|NCT01619527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837542|NCT01619527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837543|NCT01619527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64837544|NCT01619527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64837545|NCT01619527|Antiviral Agents|antiviral agents|mesh-ancestor
64837546|NCT01619527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64837547|NCT01619527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64837548|NCT01619527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64837549|NCT01619566|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64837550|NCT01619566|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64837551|NCT01619566|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64326185|NCT00961675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326186|NCT00961675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326187|NCT00961675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64326188|NCT00961675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64326189|NCT00961675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64326190|NCT00961675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64326191|NCT00961675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64326192|NCT00961675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64326193|NCT00961675|Plasma Substitutes|plasma substitutes|mesh-ancestor
64837554|NCT01619566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64837572|NCT01619644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64837573|NCT01619683|Enclomiphene|enclomiphene|mesh-list
64837574|NCT01619683|Clomiphene|clomiphene|mesh-list
64837575|NCT01619683|Zuclomiphene|zuclomiphene|mesh-list
64837576|NCT01619683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64837577|NCT01619683|Hormone Antagonists|hormone antagonists|mesh-ancestor
64837578|NCT01619683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64837579|NCT01619683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837580|NCT01619683|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64837581|NCT01619683|Fertility Agents|fertility agents|mesh-ancestor
64837582|NCT01619683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64837583|NCT01619683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64837584|NCT01619683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64837585|NCT01619761|Mycophenolic Acid|mycophenolic acid|mesh-list
64837586|NCT01619761|Cyclophosphamide|cyclophosphamide|mesh-list
64837587|NCT01619761|Melphalan|melphalan|mesh-list
64837588|NCT01619761|Mechlorethamine|mechlorethamine|mesh-list
64837589|NCT01619761|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64837590|NCT01619761|Rituximab|rituximab|mesh-list
64837591|NCT01619761|Fludarabine|fludarabine|mesh-list
64837592|NCT01619761|Fludarabine phosphate|fludarabine phosphate|mesh-list
64326201|NCT02161679|Immunoconjugates|immunoconjugates|mesh-list
64326202|NCT02161679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326203|NCT02161679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64326204|NCT02161679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64326205|NCT02161679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64326206|NCT02161679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837593|NCT01619761|Lenalidomide|lenalidomide|mesh-list
64837594|NCT01619761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64837596|NCT01619761|Antibodies|antibodies|mesh-list
64837597|NCT01619761|Immunoglobulins|immunoglobulins|mesh-list
64837598|NCT01619761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64837599|NCT01619761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64837600|NCT01619761|Immunologic Factors|immunologic factors|mesh-ancestor
64837601|NCT01619761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837602|NCT01619761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64326207|NCT02161679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326209|NCT02161679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326210|NCT04729725|Cemiplimab|cemiplimab|mesh-list
64326211|NCT04729725|Antibodies|antibodies|mesh-list
64326212|NCT04729725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64326213|NCT04729725|Immunologic Factors|immunologic factors|mesh-ancestor
64326214|NCT04729725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326215|NCT04729725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64837620|NCT01619761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64837621|NCT01619813|Prednisone|prednisone|mesh-list
64837622|NCT01619813|Docetaxel|docetaxel|mesh-list
64837623|NCT01619813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837624|NCT01619813|Tubulin Modulators|tubulin modulators|mesh-ancestor
64837625|NCT01619813|Antimitotic Agents|antimitotic agents|mesh-ancestor
64837626|NCT01619813|Mitosis Modulators|mitosis modulators|mesh-ancestor
64837627|NCT01619813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837641|NCT01620112|Anesthetics, Local|anesthetics, local|mesh-ancestor
64837642|NCT01620112|Anesthetics|anesthetics|mesh-ancestor
64837643|NCT01620112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64837644|NCT01620112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837645|NCT01620112|Sensory System Agents|sensory system agents|mesh-ancestor
64837646|NCT01620112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64837647|NCT01620112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64837648|NCT01620112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64837649|NCT01620112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64837650|NCT01620112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64837651|NCT01620112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837652|NCT01620112|Analgesics|analgesics|mesh-ancestor
64430008|NCT04991597|Anesthetics|anesthetics|mesh-ancestor
64837671|NCT01620268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837672|NCT01620268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837673|NCT01620268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64837674|NCT01620268|Immunologic Factors|immunologic factors|mesh-ancestor
64837675|NCT01620268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837676|NCT01620307|Sirolimus|sirolimus|mesh-list
64837677|NCT01620307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64837678|NCT01620307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64837679|NCT01620307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64837692|NCT01620320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64837693|NCT01620320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64837694|NCT01620320|Adrenergic Agents|adrenergic agents|mesh-ancestor
64837695|NCT01620320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64837696|NCT01620320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837697|NCT01620320|Protective Agents|protective agents|mesh-ancestor
64837698|NCT01620333|Insulin|insulin|mesh-list
64837699|NCT01620333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64837700|NCT01620333|Insulin Aspart|insulin aspart|mesh-list
64837701|NCT01620333|Insulin, Long-Acting|insulin, long-acting|mesh-list
64837702|NCT01620333|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64837703|NCT01620333|Biphasic Insulins|biphasic insulins|mesh-list
64837704|NCT01620333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64837705|NCT01620333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837706|NCT01620424|Insulin|insulin|mesh-list
64837707|NCT01620424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64837708|NCT01620424|Insulin Aspart|insulin aspart|mesh-list
64837709|NCT01620424|Insulin, Long-Acting|insulin, long-acting|mesh-list
64326270|NCT02154737|Gemcitabine|gemcitabine|mesh-list
64326271|NCT02154737|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64326272|NCT02154737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64837714|NCT01620424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837715|NCT01620437|Insulin Aspart|insulin aspart|mesh-list
64837716|NCT01620437|Biphasic Insulins|biphasic insulins|mesh-list
64837717|NCT01620437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64837718|NCT01620437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837719|NCT01620450|Insulin|insulin|mesh-list
64837720|NCT01620450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64837721|NCT01620450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64837722|NCT01620450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837723|NCT01620463|Liraglutide|liraglutide|mesh-list
64837724|NCT01620463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64837731|NCT01620476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837732|NCT01620476|Incretins|incretins|mesh-ancestor
64837733|NCT01620476|Hormones|hormones|mesh-ancestor
64837734|NCT01620476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64837735|NCT01620684|Metyrapone|metyrapone|mesh-list
64837736|NCT01620684|Antimetabolites|antimetabolites|mesh-ancestor
64837737|NCT01620684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837738|NCT01620684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837739|NCT01620736|Raltegravir Potassium|raltegravir potassium|mesh-list
64606242|NCT02879695|Nivolumab|nivolumab|mesh-list
64837740|NCT01620736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64837741|NCT01620736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64837742|NCT01620736|Antiviral Agents|antiviral agents|mesh-ancestor
64837743|NCT01620736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64448793|NCT02093390|Fluconazole|fluconazole|mesh-list
64837760|NCT01620840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64837761|NCT01620840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64837762|NCT01620840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837763|NCT01620944|Ritonavir|ritonavir|mesh-list
64837764|NCT01620944|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64837765|NCT01620944|Tenofovir|tenofovir|mesh-list
64837766|NCT01620944|Lamivudine|lamivudine|mesh-list
64837767|NCT01620944|Emtricitabine|emtricitabine|mesh-list
64837768|NCT01620944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64837769|NCT01620944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64837770|NCT01620944|Protease Inhibitors|protease inhibitors|mesh-ancestor
64837771|NCT01620944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837784|NCT01621022|Autonomic Agents|autonomic agents|mesh-ancestor
64837785|NCT01621022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64837786|NCT01621022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837787|NCT01621022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64837788|NCT01621022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64837789|NCT01621022|Cholinergic Agents|cholinergic agents|mesh-ancestor
64837790|NCT01621022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64837791|NCT01621022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837792|NCT01621022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64837793|NCT01621022|Antidepressive Agents|antidepressive agents|mesh-ancestor
64837794|NCT01621022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64326297|NCT04030455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326298|NCT04030455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64326299|NCT05440916|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64326300|NCT05440916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326301|NCT05440916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326302|NCT00901693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64837798|NCT01621022|Dopamine Agents|dopamine agents|mesh-ancestor
64326303|NCT00901693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64326309|NCT04474093|Autonomic Agents|autonomic agents|mesh-ancestor
64326310|NCT04474093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64326311|NCT04474093|Dopamine Agents|dopamine agents|mesh-ancestor
64837807|NCT01621100|Analgesics|analgesics|mesh-ancestor
64837808|NCT01621100|Sensory System Agents|sensory system agents|mesh-ancestor
64837809|NCT01621100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64837810|NCT01621113|4-Aminopyridine|4-aminopyridine|mesh-list
64837819|NCT01621165|Adrenergic Agents|adrenergic agents|mesh-ancestor
64837820|NCT01621165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64837821|NCT01621165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837822|NCT01621165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837823|NCT01621204|Immunoglobulins|immunoglobulins|mesh-list
64837824|NCT01621204|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64837825|NCT01621204|gamma-Globulins|gamma-globulins|mesh-list
64837826|NCT01621204|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64837829|NCT01621217|Cetuximab|cetuximab|mesh-list
64326314|NCT04474093|Adrenergic Agents|adrenergic agents|mesh-ancestor
64326315|NCT04474093|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64837852|NCT01621269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837853|NCT01621269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64837854|NCT01621269|Immunologic Factors|immunologic factors|mesh-ancestor
64837855|NCT01621269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837856|NCT01621308|Insulin|insulin|mesh-list
64837871|NCT01621321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64837873|NCT01621321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837874|NCT01621321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64837875|NCT01621321|Hormone Antagonists|hormone antagonists|mesh-ancestor
64837876|NCT01621321|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64837877|NCT01621373|Propofol|propofol|mesh-list
64837878|NCT01621373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64837879|NCT01621373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64362856|NCT02725411|Celecoxib|celecoxib|mesh-list
64837882|NCT01621373|Anesthetics, General|anesthetics, general|mesh-ancestor
64837883|NCT01621373|Anesthetics|anesthetics|mesh-ancestor
64837884|NCT01621386|Prednisone|prednisone|mesh-list
64837885|NCT01621386|Montelukast|montelukast|mesh-list
64837886|NCT01621386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64837887|NCT01621386|Glucocorticoids|glucocorticoids|mesh-ancestor
64837888|NCT01621386|Hormones|hormones|mesh-ancestor
64837889|NCT01621386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64837890|NCT01621386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837891|NCT01621386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64837892|NCT01621386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64837893|NCT01621386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64837906|NCT01621451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64837907|NCT01621451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837908|NCT01621451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64837909|NCT01621451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64837910|NCT01621451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64837911|NCT01621451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64837912|NCT01621451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837913|NCT01621451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64837914|NCT01621451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64837915|NCT01621451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64837916|NCT01621451|Antipyretics|antipyretics|mesh-ancestor
64837917|NCT01621451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64837965|NCT01621750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64837966|NCT01621750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64837967|NCT01621750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64837968|NCT01621763|Clopidogrel|clopidogrel|mesh-list
64837969|NCT01621763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64837970|NCT01621763|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64837971|NCT01621763|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64837972|NCT01621763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64837997|NCT01622075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64837998|NCT01622075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64449049|NCT02216123|Chloroquine|chloroquine|mesh-list
64326330|NCT02159027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64326331|NCT02159027|Antiviral Agents|antiviral agents|mesh-ancestor
64326332|NCT02159027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64326333|NCT02159027|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64326334|NCT02161991|Aprepitant|aprepitant|mesh-list
64838011|NCT01622283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449053|NCT02216123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64326337|NCT02161991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64326338|NCT02161991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326339|NCT02161991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64326340|NCT02161991|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64326341|NCT02161991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64326342|NCT02161991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838037|NCT01622361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64838038|NCT01622361|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64838039|NCT01622361|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64838040|NCT01622361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64838042|NCT01622439|Cyclophosphamide|cyclophosphamide|mesh-list
64838043|NCT01622439|Rituximab|rituximab|mesh-list
64838044|NCT01622439|Doxorubicin|doxorubicin|mesh-list
64326351|NCT00948961|Poly I-C|poly i-c|mesh-list
64838051|NCT01622439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64838052|NCT01622439|Alkylating Agents|alkylating agents|mesh-ancestor
64838053|NCT01622439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838054|NCT01622439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838055|NCT01622439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64838056|NCT01622439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64838059|NCT01622439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64838064|NCT01622439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64838065|NCT01622439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64838066|NCT01622439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64838067|NCT01622439|Tubulin Modulators|tubulin modulators|mesh-ancestor
64838068|NCT01622439|Antimitotic Agents|antimitotic agents|mesh-ancestor
64838069|NCT01622439|Mitosis Modulators|mitosis modulators|mesh-ancestor
64838070|NCT01622439|Anticonvulsants|anticonvulsants|mesh-ancestor
64838072|NCT01622439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64838073|NCT01622439|Antimanic Agents|antimanic agents|mesh-ancestor
64838081|NCT01622504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64838082|NCT01622556|Fludarabine|fludarabine|mesh-list
64838083|NCT01622556|Busulfan|busulfan|mesh-list
64838084|NCT01622556|Thymoglobulin|thymoglobulin|mesh-list
64838085|NCT01622556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838086|NCT01622556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838087|NCT01622556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64838088|NCT01622556|Immunologic Factors|immunologic factors|mesh-ancestor
64838089|NCT01622556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838090|NCT01622556|Alkylating Agents|alkylating agents|mesh-ancestor
64326359|NCT00948961|Antiviral Agents|antiviral agents|mesh-ancestor
64326361|NCT02159105|Chrysarobin|chrysarobin|mesh-list
64838098|NCT01622777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64838099|NCT01622777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64838100|NCT01622777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838101|NCT01622790|Lamivudine|lamivudine|mesh-list
64838102|NCT01622790|Abacavir|abacavir|mesh-list
64838103|NCT01622790|Dideoxynucleosides|dideoxynucleosides|mesh-list
64838104|NCT01622790|Dolutegravir|dolutegravir|mesh-list
64838105|NCT01622790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64838106|NCT01622790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64326364|NCT02159105|Analgesics|analgesics|mesh-ancestor
64838127|NCT01622933|Immunologic Factors|immunologic factors|mesh-ancestor
64838128|NCT01622933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838129|NCT01622946|Tranexamic Acid|tranexamic acid|mesh-list
64838130|NCT01622946|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64838131|NCT01622946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64838132|NCT01622946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838133|NCT01622946|Hemostatics|hemostatics|mesh-ancestor
64838134|NCT01622946|Coagulants|coagulants|mesh-ancestor
64326369|NCT02159105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64326370|NCT00890305|Pidilizumab|pidilizumab|mesh-list
64326371|NCT00890305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64326372|NCT00890305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326373|NCT01661972|Capecitabine|capecitabine|mesh-list
64449190|NCT01451398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64838143|NCT01623102|Gemcitabine|gemcitabine|mesh-list
64838144|NCT01623102|Bevacizumab|bevacizumab|mesh-list
64838145|NCT01623102|Cisplatin|cisplatin|mesh-list
64838146|NCT01623102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64838147|NCT01623102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838148|NCT01623102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64838149|NCT01623102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64838150|NCT01623102|Growth Substances|growth substances|mesh-ancestor
64838151|NCT01623102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838152|NCT01623102|Growth Inhibitors|growth inhibitors|mesh-ancestor
64326379|NCT01661972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64326380|NCT01661972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64326381|NCT01661972|Growth Substances|growth substances|mesh-ancestor
64838155|NCT01623102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838157|NCT01623102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64838158|NCT01623102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838159|NCT01623102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64838160|NCT01623102|Immunologic Factors|immunologic factors|mesh-ancestor
64838161|NCT01623206|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64838162|NCT01623206|Hemostatics|hemostatics|mesh-ancestor
64838163|NCT01623206|Coagulants|coagulants|mesh-ancestor
64838164|NCT01623206|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64838165|NCT01623206|Natriuretic Agents|natriuretic agents|mesh-ancestor
64838166|NCT01623206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838167|NCT01623284|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64838168|NCT01623284|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64838169|NCT01623284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838182|NCT01623362|Fluorides|fluorides|mesh-list
64326382|NCT01661972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326383|NCT01661972|Growth Inhibitors|growth inhibitors|mesh-ancestor
64326384|NCT00890149|Ondansetron|ondansetron|mesh-list
64326385|NCT00890149|Antiemetics|antiemetics|mesh-ancestor
64326386|NCT00890149|Autonomic Agents|autonomic agents|mesh-ancestor
64326387|NCT00890149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64326388|NCT00890149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838184|NCT01623362|Protective Agents|protective agents|mesh-ancestor
64838185|NCT01623362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838187|NCT01623375|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64326389|NCT00890149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64326390|NCT00890149|Antipruritics|antipruritics|mesh-ancestor
64326391|NCT00890149|Dermatologic Agents|dermatologic agents|mesh-ancestor
64326392|NCT00890149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64326393|NCT00890149|Serotonin Agents|serotonin agents|mesh-ancestor
64326394|NCT00890149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64326395|NCT00890149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326396|NCT00890149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64838193|NCT01623401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64326403|NCT03540953|Mitomycins|mitomycins|mesh-list
64326404|NCT03540953|Mitomycin|mitomycin|mesh-list
64326405|NCT03540953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64326406|NCT03540953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326407|NCT03540953|Alkylating Agents|alkylating agents|mesh-ancestor
64326408|NCT03540953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838200|NCT01623440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64838201|NCT01623505|Varenicline|varenicline|mesh-list
64838202|NCT01623505|Nicotine|nicotine|mesh-list
64838203|NCT01623505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64326419|NCT00794677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64838213|NCT01623570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64838215|NCT01623570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64838216|NCT01623570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838217|NCT01623609|Naloxegol|naloxegol|mesh-list
64838218|NCT01623609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64838219|NCT01623609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838220|NCT01623609|Sensory System Agents|sensory system agents|mesh-ancestor
64838221|NCT01623609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64838222|NCT01623635|Ropivacaine|ropivacaine|mesh-list
64838223|NCT01623635|Anesthetics, Local|anesthetics, local|mesh-ancestor
64838224|NCT01623635|Anesthetics|anesthetics|mesh-ancestor
64838225|NCT01623635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64838226|NCT01623635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326423|NCT00792727|Ketoprofen|ketoprofen|mesh-list
64326429|NCT00792727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326430|NCT00792727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64326431|NCT00792727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64326432|NCT00792727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64326433|NCT00792727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838227|NCT01623635|Sensory System Agents|sensory system agents|mesh-ancestor
64838228|NCT01623635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64838229|NCT01623713|Risperidone|risperidone|mesh-list
64838230|NCT01623713|Iloperidone|iloperidone|mesh-list
64326435|NCT00945763|Ibuprofen|ibuprofen|mesh-list
64326439|NCT00945763|Analgesics|analgesics|mesh-ancestor
64838241|NCT01623713|Dopamine Agents|dopamine agents|mesh-ancestor
64838242|NCT01623778|Interferons|interferons|mesh-list
64838243|NCT01623778|Interferon-alpha|interferon-alpha|mesh-list
64838244|NCT01623778|Interferon alpha-2|interferon alpha-2|mesh-list
64838245|NCT01623778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838246|NCT01623778|Antiviral Agents|antiviral agents|mesh-ancestor
64838247|NCT01623778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64838248|NCT01623778|Immunologic Factors|immunologic factors|mesh-ancestor
64838249|NCT01623778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838251|NCT01623817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64838252|NCT01623817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64838253|NCT01623908|Zoledronic Acid|zoledronic acid|mesh-list
64838256|NCT01623921|Celecoxib|celecoxib|mesh-list
64838304|NCT01624064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64838305|NCT01624103|Lidocaine|lidocaine|mesh-list
64838306|NCT01624103|Levobupivacaine|levobupivacaine|mesh-list
64838307|NCT01624103|Anesthetics, Local|anesthetics, local|mesh-ancestor
64838308|NCT01624103|Anesthetics|anesthetics|mesh-ancestor
64838309|NCT01624103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64838310|NCT01624103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838311|NCT01624103|Sensory System Agents|sensory system agents|mesh-ancestor
64838312|NCT01624103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64838313|NCT01624103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64326445|NCT00945763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64838323|NCT01624116|Incretins|incretins|mesh-ancestor
64838324|NCT01624116|Hormones|hormones|mesh-ancestor
64838325|NCT01624116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64838326|NCT01624116|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64838327|NCT01624116|Protease Inhibitors|protease inhibitors|mesh-ancestor
64838328|NCT01624116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838329|NCT01624116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838330|NCT01624116|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64838342|NCT01624207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64838343|NCT01624207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64838344|NCT01624207|Antimetabolites|antimetabolites|mesh-ancestor
64838345|NCT01624207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838346|NCT01624207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64838347|NCT01624207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64838348|NCT01624207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838349|NCT01624246|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64838350|NCT01624246|Avibactam|avibactam|mesh-list
64838351|NCT01624246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64838352|NCT01624246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64326446|NCT00945763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326448|NCT00945763|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64326449|NCT02770391|Leuprolide|leuprolide|mesh-list
64326450|NCT02770391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64326451|NCT02770391|Fertility Agents|fertility agents|mesh-ancestor
64326452|NCT02770391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64326453|NCT02770391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838367|NCT01624428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838368|NCT01624441|Epirubicin|epirubicin|mesh-list
64838369|NCT01624441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64838370|NCT01624441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838385|NCT01624493|Immunologic Factors|immunologic factors|mesh-ancestor
64838386|NCT01624493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838387|NCT01624649|Methylphenidate|methylphenidate|mesh-list
64838388|NCT01624649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64838389|NCT01624649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64838390|NCT01624649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838391|NCT01624649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64838392|NCT01624649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64838393|NCT01624649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64838399|NCT01624675|Risperidone|risperidone|mesh-list
64838400|NCT01624675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64838401|NCT01624675|Serotonin Agents|serotonin agents|mesh-ancestor
64838402|NCT01624675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64838403|NCT01624675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838404|NCT01624675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838405|NCT01624675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64838406|NCT01624675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64838407|NCT01624675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64449433|NCT02097823|Olanzapine|olanzapine|mesh-list
64326458|NCT02155205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64326459|NCT02155205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64326460|NCT02155205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64327338|NCT00734461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64838408|NCT01624675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64838409|NCT01624675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64838410|NCT01624675|Dopamine Agents|dopamine agents|mesh-ancestor
64838411|NCT01624714|Alemtuzumab|alemtuzumab|mesh-list
64838412|NCT01624714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64838414|NCT01624766|Denosumab|denosumab|mesh-list
64838415|NCT01624766|Everolimus|everolimus|mesh-list
64838416|NCT01624766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64838417|NCT01624766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838418|NCT01624766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64838419|NCT01624766|Immunologic Factors|immunologic factors|mesh-ancestor
64838420|NCT01624766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838421|NCT01624766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64838422|NCT01624766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64838423|NCT01624857|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64838462|NCT01625351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64838463|NCT01625351|Immunologic Factors|immunologic factors|mesh-ancestor
64838464|NCT01625351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838465|NCT01625351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64838466|NCT01625351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64838467|NCT01625351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64449472|NCT02097745|Rituximab|rituximab|mesh-list
64838469|NCT01625351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64838470|NCT01625351|Alkylating Agents|alkylating agents|mesh-ancestor
64838471|NCT01625351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64838472|NCT01625351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64838473|NCT01625429|Paclitaxel|paclitaxel|mesh-list
64838474|NCT01625429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64838475|NCT01625429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838476|NCT01625429|Tubulin Modulators|tubulin modulators|mesh-ancestor
64838477|NCT01625429|Antimitotic Agents|antimitotic agents|mesh-ancestor
64838478|NCT01625429|Mitosis Modulators|mitosis modulators|mesh-ancestor
64838479|NCT01625429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838480|NCT01625494|Amlodipine|amlodipine|mesh-list
64838481|NCT01625494|Irbesartan|irbesartan|mesh-list
64326464|NCT00938587|Prednisone|prednisone|mesh-list
64326465|NCT00938587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64326466|NCT00938587|Glucocorticoids|glucocorticoids|mesh-ancestor
64326467|NCT00938587|Hormones|hormones|mesh-ancestor
64838486|NCT01625494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64838487|NCT01625494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838488|NCT01625494|Vasodilator Agents|vasodilator agents|mesh-ancestor
64838489|NCT01625494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64838490|NCT01625494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64838491|NCT01625520|Everolimus|everolimus|mesh-list
64838492|NCT01625520|Pasireotide|pasireotide|mesh-list
64838493|NCT01625520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838494|NCT01625520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64838495|NCT01625520|Immunologic Factors|immunologic factors|mesh-ancestor
64838496|NCT01625520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838497|NCT01625520|Hormones|hormones|mesh-ancestor
64838498|NCT01625520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64838499|NCT01625572|Morphine|morphine|mesh-list
64449512|NCT02187809|Anticonvulsants|anticonvulsants|mesh-ancestor
64326469|NCT00938587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838504|NCT01625572|Analgesics|analgesics|mesh-ancestor
64838505|NCT01625572|Sensory System Agents|sensory system agents|mesh-ancestor
64838506|NCT01625572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64838507|NCT01625715|Ketotifen|ketotifen|mesh-list
64838508|NCT01625715|Antipruritics|antipruritics|mesh-ancestor
64838509|NCT01625715|Dermatologic Agents|dermatologic agents|mesh-ancestor
64838510|NCT01625715|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64838511|NCT01625715|Histamine Antagonists|histamine antagonists|mesh-ancestor
64838512|NCT01625715|Histamine Agents|histamine agents|mesh-ancestor
64838513|NCT01625715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64838515|NCT01625715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326473|NCT02162303|Gout Suppressants|gout suppressants|mesh-ancestor
64326474|NCT02162303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64326475|NCT02162303|Tubulin Modulators|tubulin modulators|mesh-ancestor
64326476|NCT02162303|Antimitotic Agents|antimitotic agents|mesh-ancestor
64838535|NCT01625806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838536|NCT01625806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838537|NCT01625806|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64838538|NCT01625806|Hormone Antagonists|hormone antagonists|mesh-ancestor
64838539|NCT01625806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64838540|NCT01625806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838541|NCT01625806|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64449562|NCT02162771|Glucocorticoids|glucocorticoids|mesh-ancestor
64449563|NCT02162771|Hormones|hormones|mesh-ancestor
64449565|NCT02162771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64838562|NCT01626222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838563|NCT01626222|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64838564|NCT01626222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64838565|NCT01626222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838566|NCT01626222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838567|NCT01626222|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64838568|NCT01626222|Hormone Antagonists|hormone antagonists|mesh-ancestor
64838569|NCT01626222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64838570|NCT01626339|Bevacizumab|bevacizumab|mesh-list
64838600|NCT01626534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838601|NCT01626560|Vancomycin|vancomycin|mesh-list
64326477|NCT02162303|Mitosis Modulators|mitosis modulators|mesh-ancestor
64326478|NCT02162303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326479|NCT02162303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326480|NCT05430308|Chlorhexidine|chlorhexidine|mesh-list
64838603|NCT01626560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64838607|NCT01626651|Ketoconazole|ketoconazole|mesh-list
64326481|NCT05430308|Povidone-Iodine|povidone-iodine|mesh-list
64326482|NCT05430308|Povidone|povidone|mesh-list
64326483|NCT05430308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64326484|NCT05430308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64326485|NCT05430308|Disinfectants|disinfectants|mesh-ancestor
64326486|NCT05430308|Plasma Substitutes|plasma substitutes|mesh-ancestor
64326487|NCT05430308|Blood Substitutes|blood substitutes|mesh-ancestor
64326488|NCT00877903|Remestemcel-l|remestemcel-l|mesh-list
64326489|NCT00877903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64838611|NCT01626651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64838612|NCT01626651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838613|NCT01626651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838614|NCT01626651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64838615|NCT01626651|Hormone Antagonists|hormone antagonists|mesh-ancestor
64838616|NCT01626651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64838617|NCT01626651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838618|NCT01626651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64838619|NCT01626911|Heparin|heparin|mesh-list
64838620|NCT01626911|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64838621|NCT01626911|Tinzaparin|tinzaparin|mesh-list
64838622|NCT01626911|Dalteparin|dalteparin|mesh-list
64838625|NCT01626911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64838626|NCT01626911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838627|NCT01627041|Cytarabine|cytarabine|mesh-list
64838628|NCT01627041|Decitabine|decitabine|mesh-list
64838629|NCT01627041|Daunorubicin|daunorubicin|mesh-list
64838630|NCT01627041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64838631|NCT01627041|Antimetabolites|antimetabolites|mesh-ancestor
64838632|NCT01627041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838633|NCT01627041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838634|NCT01627041|Antiviral Agents|antiviral agents|mesh-ancestor
64838635|NCT01627041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64838636|NCT01627041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64838637|NCT01627041|Immunologic Factors|immunologic factors|mesh-ancestor
64326506|NCT04729387|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64326507|NCT04707703|Isavuconazole|isavuconazole|mesh-list
64326508|NCT04707703|Antifungal Agents|antifungal agents|mesh-ancestor
64326509|NCT04707703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64838638|NCT01627041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838639|NCT01627041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64838640|NCT01627041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64838641|NCT01627041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64838642|NCT01627041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326516|NCT04681105|Ranitidine|ranitidine|mesh-list
64326517|NCT04681105|Antibodies|antibodies|mesh-list
64326518|NCT04681105|Immunoglobulins|immunoglobulins|mesh-list
64838689|NCT01627158|Antidotes|antidotes|mesh-ancestor
64838690|NCT01627158|Protective Agents|protective agents|mesh-ancestor
64838691|NCT01627171|Bisacodyl|bisacodyl|mesh-list
64838692|NCT01627171|Picosulfate sodium|picosulfate sodium|mesh-list
64838693|NCT01627171|Cathartics|cathartics|mesh-ancestor
64838694|NCT01627171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64838695|NCT01627171|Laxatives|laxatives|mesh-ancestor
64838696|NCT01627223|Lamivudine|lamivudine|mesh-list
64838697|NCT01627223|Entecavir|entecavir|mesh-list
64838707|NCT01627236|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64838708|NCT01627236|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64838709|NCT01627236|Prednisolone|prednisolone|mesh-list
64838710|NCT01627236|Prednisolone acetate|prednisolone acetate|mesh-list
64838712|NCT01627236|Prednisolone phosphate|prednisolone phosphate|mesh-list
64838713|NCT01627236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64838714|NCT01627236|Antiemetics|antiemetics|mesh-ancestor
64838715|NCT01627236|Autonomic Agents|autonomic agents|mesh-ancestor
64838716|NCT01627236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64838717|NCT01627236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838718|NCT01627236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64838719|NCT01627236|Glucocorticoids|glucocorticoids|mesh-ancestor
64838720|NCT01627236|Hormones|hormones|mesh-ancestor
64326519|NCT04681105|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64326520|NCT04681105|BB 1101|bb 1101|mesh-list
64326521|NCT04681105|Immunologic Factors|immunologic factors|mesh-ancestor
64326522|NCT04681105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326523|NCT04681105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64326524|NCT04681105|Antiemetics|antiemetics|mesh-ancestor
64326525|NCT04681105|Autonomic Agents|autonomic agents|mesh-ancestor
64843697|NCT01664260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843698|NCT01664260|Protective Agents|protective agents|mesh-ancestor
64838721|NCT01627236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64838722|NCT01627236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64838724|NCT01627236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64838725|NCT01627236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838726|NCT01627262|Mesalamine|mesalamine|mesh-list
64838727|NCT01627262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64838728|NCT01627262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64838729|NCT01627262|Analgesics|analgesics|mesh-ancestor
64838730|NCT01627262|Sensory System Agents|sensory system agents|mesh-ancestor
64838731|NCT01627262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64838732|NCT01627262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838733|NCT01627262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64838736|NCT01627353|Lidocaine|lidocaine|mesh-list
64838757|NCT01627353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64838758|NCT01627353|Analgesics|analgesics|mesh-ancestor
64838759|NCT01627353|Anticonvulsants|anticonvulsants|mesh-ancestor
64838760|NCT01627353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64838761|NCT01627353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64838762|NCT01627353|Tocolytic Agents|tocolytic agents|mesh-ancestor
64838763|NCT01627353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64838764|NCT01627379|Panitumumab|panitumumab|mesh-list
64326532|NCT04681105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326533|NCT04681105|Protease Inhibitors|protease inhibitors|mesh-ancestor
64326534|NCT04681105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326535|NCT04681105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326536|NCT04681105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64838776|NCT01627431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64838777|NCT01627431|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64838778|NCT01627431|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64838787|NCT01627431|Purinergic Agents|purinergic agents|mesh-ancestor
64838788|NCT01627431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64838790|NCT01627587|Antifungal Agents|antifungal agents|mesh-ancestor
64838791|NCT01627587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64838792|NCT01627587|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64838793|NCT01627587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64838794|NCT01627587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838795|NCT01627587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838796|NCT01627587|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64838797|NCT01627587|Hormone Antagonists|hormone antagonists|mesh-ancestor
64838798|NCT01627587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64838799|NCT01627587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838801|NCT01627626|Pilocarpine|pilocarpine|mesh-list
64838815|NCT01627639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838816|NCT01627639|Diuretics|diuretics|mesh-ancestor
64838817|NCT01627639|Natriuretic Agents|natriuretic agents|mesh-ancestor
64838818|NCT01627639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838819|NCT01627678|Molgramostim|molgramostim|mesh-list
64838820|NCT01627678|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64838821|NCT01627678|Sargramostim|sargramostim|mesh-list
64838822|NCT01627678|Immunologic Factors|immunologic factors|mesh-ancestor
64838835|NCT01627717|Antiviral Agents|antiviral agents|mesh-ancestor
64838836|NCT01627717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64838837|NCT01627717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64838838|NCT01627834|Ropinirole|ropinirole|mesh-list
64838839|NCT01627834|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64838840|NCT01627834|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64838841|NCT01627834|Dopamine Agonists|dopamine agonists|mesh-ancestor
64838842|NCT01627834|Dopamine Agents|dopamine agents|mesh-ancestor
64838843|NCT01627834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64838844|NCT01627834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326554|NCT04681105|Dermatologic Agents|dermatologic agents|mesh-ancestor
64326555|NCT04681105|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64326556|NCT04681105|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64326557|NCT00936871|Moxifloxacin|moxifloxacin|mesh-list
64326558|NCT00936871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64326559|NCT00936871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64838851|NCT01627847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64838852|NCT01627847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838853|NCT01627847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838854|NCT01627873|Fentanyl|fentanyl|mesh-list
64838855|NCT01627873|Remifentanil|remifentanil|mesh-list
64838856|NCT01627873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64838857|NCT01627873|Narcotics|narcotics|mesh-ancestor
64838858|NCT01627873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64838859|NCT01627873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838860|NCT01627873|Analgesics|analgesics|mesh-ancestor
64838861|NCT01627873|Sensory System Agents|sensory system agents|mesh-ancestor
64838862|NCT01627873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64838863|NCT01627873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64838885|NCT01627938|Mitosis Modulators|mitosis modulators|mesh-ancestor
64838886|NCT01628055|Immunoglobulins|immunoglobulins|mesh-list
64838887|NCT01628055|Antibodies|antibodies|mesh-list
64838888|NCT01628055|gamma-Globulins|gamma-globulins|mesh-list
64838889|NCT01628055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64838890|NCT01628055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64838891|NCT01628055|Immunoglobulin G|immunoglobulin g|mesh-list
64838892|NCT01628055|Immunologic Factors|immunologic factors|mesh-ancestor
64326583|NCT05429450|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64326584|NCT05429450|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64326590|NCT05429450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838893|NCT01628055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838894|NCT01628341|Insulin|insulin|mesh-list
64838895|NCT01628341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64838896|NCT01628341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838897|NCT01628354|Ranibizumab|ranibizumab|mesh-list
64838898|NCT01628354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64838899|NCT01628354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64838900|NCT01628354|Growth Substances|growth substances|mesh-ancestor
64838901|NCT01628354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838902|NCT01628354|Growth Inhibitors|growth inhibitors|mesh-ancestor
64838903|NCT01628354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838904|NCT01628445|Liraglutide|liraglutide|mesh-list
64838907|NCT01628445|Incretins|incretins|mesh-ancestor
64838924|NCT01628471|Hormones|hormones|mesh-ancestor
64838925|NCT01628471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64838926|NCT01628562|Remifentanil|remifentanil|mesh-list
64838927|NCT01628562|Esmolol|esmolol|mesh-list
64838928|NCT01628562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64838929|NCT01628562|Narcotics|narcotics|mesh-ancestor
64838930|NCT01628562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64838931|NCT01628562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838934|NCT01628562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64838935|NCT01628562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64838936|NCT01628562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64838937|NCT01628562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64838938|NCT01628562|Adrenergic Agents|adrenergic agents|mesh-ancestor
64838939|NCT01628562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64838940|NCT01628562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449955|NCT02045875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64838941|NCT01628666|Vancomycin|vancomycin|mesh-list
64838942|NCT01628666|Cefazolin|cefazolin|mesh-list
64838943|NCT01628666|Cephalexin|cephalexin|mesh-list
64838944|NCT01628666|Bacitracin|bacitracin|mesh-list
64838945|NCT01628666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64838946|NCT01628666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64838947|NCT01628666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64838948|NCT01628731|Furosemide|furosemide|mesh-list
64838949|NCT01628731|Ethacrynic Acid|ethacrynic acid|mesh-list
64838950|NCT01628731|Diuretics|diuretics|mesh-ancestor
64838951|NCT01628731|Natriuretic Agents|natriuretic agents|mesh-ancestor
64838952|NCT01628731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838953|NCT01628731|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64838954|NCT01628731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64449963|NCT04731103|Lamivudine|lamivudine|mesh-list
64449964|NCT04731103|Zidovudine|zidovudine|mesh-list
64449965|NCT04731103|Abacavir|abacavir|mesh-list
64326610|NCT00103259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326611|NCT00103259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838955|NCT01628731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64838956|NCT01628731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64838957|NCT01628770|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
64838958|NCT01628770|Hematinics|hematinics|mesh-ancestor
64838959|NCT01628783|Citalopram|citalopram|mesh-list
64838960|NCT01628783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64838961|NCT01628783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64838962|NCT01628783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64838969|NCT01628783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64838970|NCT01628952|Curare|curare|mesh-list
64838971|NCT01628952|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64838972|NCT01628952|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64838973|NCT01628952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64838974|NCT01628952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64449985|NCT01827111|Paclitaxel|paclitaxel|mesh-list
64838977|NCT01628952|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64326618|NCT02162381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64430010|NCT04991597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838986|NCT01629082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64838987|NCT01629082|Growth Substances|growth substances|mesh-ancestor
64838988|NCT01629082|Growth Inhibitors|growth inhibitors|mesh-ancestor
64838989|NCT01629082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64838990|NCT01629082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64326619|NCT02162381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326621|NCT02162381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64326622|NCT00782431|Vaccines|vaccines|mesh-list
64326623|NCT00782431|Immunologic Factors|immunologic factors|mesh-ancestor
64326624|NCT00782431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838996|NCT01629173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64838997|NCT01629199|Mitogens|mitogens|mesh-list
64838998|NCT01629199|Mitosis Modulators|mitosis modulators|mesh-ancestor
64838999|NCT01629199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839000|NCT01629212|Octylonium|octylonium|mesh-list
64839001|NCT01629212|Bromides|bromides|mesh-list
64839002|NCT01629212|Tiropramide|tiropramide|mesh-list
64552688|NCT04007393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552690|NCT05368805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64552691|NCT05368805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64552692|NCT05368805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64552693|NCT05368805|Antimetabolites|antimetabolites|mesh-ancestor
64552694|NCT05368805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552695|NCT05368805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64326626|NCT02155439|Fluorouracil|fluorouracil|mesh-list
64326627|NCT02155439|Antimetabolites|antimetabolites|mesh-ancestor
64839009|NCT01629212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64839010|NCT01629212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839011|NCT01629212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64839012|NCT01629212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64839013|NCT01629212|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64839014|NCT01629212|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64839015|NCT01629212|Cholinergic Agents|cholinergic agents|mesh-ancestor
64326628|NCT02155439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326629|NCT02155439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64326630|NCT02155439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326631|NCT02155439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64326632|NCT02155439|Immunologic Factors|immunologic factors|mesh-ancestor
64370092|NCT05002101|Zinc|zinc|mesh-list
64317728|NCT04728230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64317729|NCT04728230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993475|NCT02224781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993476|NCT02224781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64993477|NCT02224781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993478|NCT02224781|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64993479|NCT02224781|Protective Agents|protective agents|mesh-ancestor
64993480|NCT02224781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993481|NCT02224781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64839016|NCT01629212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64993482|NCT02224781|Antioxidants|antioxidants|mesh-ancestor
64839017|NCT01629225|Candesartan|candesartan|mesh-list
64839018|NCT01629225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64839019|NCT01629225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64839020|NCT01629225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64839021|NCT01629225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839022|NCT01629251|Insulin|insulin|mesh-list
64839023|NCT01629251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64839024|NCT01629251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839025|NCT01629277|Insulin|insulin|mesh-list
64839026|NCT01629277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64839027|NCT01629277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839028|NCT01629368|Carbamazepine|carbamazepine|mesh-list
64839029|NCT01629368|Anticonvulsants|anticonvulsants|mesh-ancestor
64326633|NCT02155439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326634|NCT02155439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64326635|NCT02155439|Glucocorticoids|glucocorticoids|mesh-ancestor
64993483|NCT02219373|Oxcarbazepine|oxcarbazepine|mesh-list
64993484|NCT02219373|Gabapentin|gabapentin|mesh-list
64993485|NCT02219373|Analgesics|analgesics|mesh-ancestor
64993486|NCT02219373|Sensory System Agents|sensory system agents|mesh-ancestor
64993487|NCT02219373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64993488|NCT02219373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993489|NCT02219373|Anticonvulsants|anticonvulsants|mesh-ancestor
64993490|NCT02219373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64993516|NCT02196181|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64993517|NCT02196181|Protective Agents|protective agents|mesh-ancestor
64993518|NCT02196181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993519|NCT02196181|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64839030|NCT01629368|Antimanic Agents|antimanic agents|mesh-ancestor
64839031|NCT01629368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64839032|NCT01629368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64839033|NCT01629368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839034|NCT01629368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64839035|NCT01629368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64839036|NCT01629368|Analgesics|analgesics|mesh-ancestor
64839037|NCT01629368|Sensory System Agents|sensory system agents|mesh-ancestor
64839038|NCT01629368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64839039|NCT01629368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64839040|NCT01629368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64839041|NCT01629368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839042|NCT01629368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64839043|NCT01629368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64839044|NCT01629394|Neostigmine|neostigmine|mesh-list
64839045|NCT01629394|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64839046|NCT01629394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839047|NCT01629394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839048|NCT01629394|Cholinergic Agents|cholinergic agents|mesh-ancestor
64839049|NCT01629394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64839050|NCT01629394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839051|NCT01629394|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64839052|NCT01629394|Autonomic Agents|autonomic agents|mesh-ancestor
64839053|NCT01629394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64839054|NCT01629446|Lofexidine|lofexidine|mesh-list
64839055|NCT01629446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64839056|NCT01629446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64839057|NCT01629446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993520|NCT02196181|Antioxidants|antioxidants|mesh-ancestor
64993571|NCT02099825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64993572|NCT02099825|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64993573|NCT02099825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64993575|NCT02099825|Renal Agents|renal agents|mesh-ancestor
64993576|NCT02099825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64993577|NCT02099825|Antitubercular Agents|antitubercular agents|mesh-ancestor
64993578|NCT02099825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64839062|NCT01629446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64839063|NCT01629446|Adrenergic Agents|adrenergic agents|mesh-ancestor
64839064|NCT01629446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64326637|NCT02155439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64326638|NCT04627285|Lacosamide|lacosamide|mesh-list
64326639|NCT04627285|Anticonvulsants|anticonvulsants|mesh-ancestor
64326640|NCT04627285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64326641|NCT04627285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64839065|NCT01629446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839067|NCT01629511|Methotrexate|methotrexate|mesh-list
64839068|NCT01629511|Clofarabine|clofarabine|mesh-list
64839069|NCT01629511|Busulfan|busulfan|mesh-list
64839070|NCT01629511|Tacrolimus|tacrolimus|mesh-list
64839071|NCT01629511|Thymoglobulin|thymoglobulin|mesh-list
64839072|NCT01629511|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64839073|NCT01629511|Lenograstim|lenograstim|mesh-list
64839074|NCT01629511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64839075|NCT01629511|Antimetabolites|antimetabolites|mesh-ancestor
64839076|NCT01629511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839077|NCT01629511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839078|NCT01629511|Antiviral Agents|antiviral agents|mesh-ancestor
64839079|NCT01629511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64839080|NCT01629511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839081|NCT01629511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64326642|NCT04627285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64326643|NCT04627285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326644|NCT02544152|Lubiprostone|lubiprostone|mesh-list
64326645|NCT02544152|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64839082|NCT01629511|Immunologic Factors|immunologic factors|mesh-ancestor
64839083|NCT01629511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839084|NCT01629511|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64839085|NCT01629511|Abortifacient Agents|abortifacient agents|mesh-ancestor
64839086|NCT01629511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64993579|NCT02099825|Antimetabolites|antimetabolites|mesh-ancestor
64993580|NCT02099825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993581|NCT02057978|Chlorhexidine|chlorhexidine|mesh-list
64993582|NCT02057978|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64993583|NCT02057978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64993584|NCT02057978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64993585|NCT02057978|Disinfectants|disinfectants|mesh-ancestor
64993586|NCT02057978|Dermatologic Agents|dermatologic agents|mesh-ancestor
64552696|NCT05368805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64552697|NCT05368805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839104|NCT01629628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64839105|NCT01629628|Immunologic Factors|immunologic factors|mesh-ancestor
64839106|NCT01629628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839107|NCT01629628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64839108|NCT01629628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839110|NCT01629680|Parasympatholytics|parasympatholytics|mesh-ancestor
64839111|NCT01629680|Autonomic Agents|autonomic agents|mesh-ancestor
64839112|NCT01629680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64839113|NCT01629680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839114|NCT01629732|Ribavirin|ribavirin|mesh-list
64839115|NCT01629732|Antimetabolites|antimetabolites|mesh-ancestor
64839116|NCT01629732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839117|NCT01629732|Antiviral Agents|antiviral agents|mesh-ancestor
64839118|NCT01629732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64839119|NCT01629758|Nivolumab|nivolumab|mesh-list
64839120|NCT01629758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64839121|NCT01629758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839122|NCT01629758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64839123|NCT01629758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839124|NCT01629875|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64839125|NCT01629875|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64839126|NCT01629875|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64839127|NCT01629875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64326648|NCT02162537|Bevacizumab|bevacizumab|mesh-list
64552698|NCT05368805|Antithrombins|antithrombins|mesh-ancestor
64552699|NCT05368805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64552700|NCT05368805|Protease Inhibitors|protease inhibitors|mesh-ancestor
64552701|NCT05368805|Anticoagulants|anticoagulants|mesh-ancestor
64552703|NCT03304717|Emtricitabine|emtricitabine|mesh-list
64552704|NCT03304717|Antiviral Agents|antiviral agents|mesh-ancestor
64552705|NCT03304717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64552706|NCT03304717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64552707|NCT03304717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64552708|NCT03304717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552709|NCT03304717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552710|NCT03304717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64552711|NCT03304717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64552712|NCT01839981|Thioctic Acid|thioctic acid|mesh-list
64552713|NCT01839981|Antioxidants|antioxidants|mesh-ancestor
64993587|NCT02032823|Olaparib|olaparib|mesh-list
64993588|NCT02032823|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64993614|NCT02003222|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64993616|NCT02003222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64839136|NCT01630018|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64839137|NCT01630018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64839138|NCT01630018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839139|NCT01630018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839140|NCT01630018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839141|NCT01630057|Zonisamide|zonisamide|mesh-list
64839142|NCT01630057|Anticonvulsants|anticonvulsants|mesh-ancestor
64993617|NCT02003222|Immunologic Factors|immunologic factors|mesh-ancestor
64993618|NCT02003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993619|NCT02003222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64993620|NCT02003222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64993621|NCT02003222|Alkylating Agents|alkylating agents|mesh-ancestor
64993622|NCT02003222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993623|NCT02003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993624|NCT02003222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64993625|NCT02003222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64326653|NCT02162537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64326654|NCT02162537|Growth Substances|growth substances|mesh-ancestor
64326656|NCT02162537|Growth Inhibitors|growth inhibitors|mesh-ancestor
64839241|NCT01630655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993626|NCT02003222|Antiemetics|antiemetics|mesh-ancestor
64993627|NCT02003222|Autonomic Agents|autonomic agents|mesh-ancestor
64993628|NCT02003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64993629|NCT02003222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64993630|NCT02003222|Glucocorticoids|glucocorticoids|mesh-ancestor
64993631|NCT02003222|Hormones|hormones|mesh-ancestor
64993632|NCT02003222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64993633|NCT02003222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64993634|NCT02003222|Protease Inhibitors|protease inhibitors|mesh-ancestor
64993635|NCT02003222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993636|NCT02003222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64993637|NCT02003222|Abortifacient Agents|abortifacient agents|mesh-ancestor
64839242|NCT01630655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64839243|NCT01630655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839245|NCT01630720|Vitamin D|vitamin d|mesh-list
64839246|NCT01630720|Vitamins|vitamins|mesh-list
64839247|NCT01630720|Micronutrients|micronutrients|mesh-ancestor
64839248|NCT01630720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839249|NCT01630720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64839250|NCT01630733|Docetaxel|docetaxel|mesh-list
64450249|NCT01598753|Tramadol|tramadol|mesh-list
64993638|NCT02003222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64993639|NCT02003222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64993640|NCT02003222|Antimetabolites|antimetabolites|mesh-ancestor
64993641|NCT02003222|Dermatologic Agents|dermatologic agents|mesh-ancestor
64993642|NCT02003222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64993643|NCT02003222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64993644|NCT02003222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64993670|NCT01958021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993671|NCT01946477|Dexamethasone|dexamethasone|mesh-list
64993672|NCT01946477|Daratumumab|daratumumab|mesh-list
64993673|NCT01946477|Pomalidomide|pomalidomide|mesh-list
64993674|NCT01946477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64993675|NCT01946477|Antiemetics|antiemetics|mesh-ancestor
64993676|NCT01946477|Autonomic Agents|autonomic agents|mesh-ancestor
64552714|NCT01839981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552715|NCT01839981|Protective Agents|protective agents|mesh-ancestor
64326702|NCT00917293|Micronutrients|micronutrients|mesh-ancestor
64326703|NCT00917293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326704|NCT00845299|Benzalkonium Compounds|benzalkonium compounds|mesh-list
64326705|NCT00845299|Latanoprost|latanoprost|mesh-list
64326706|NCT00845299|Lubricant Eye Drops|lubricant eye drops|mesh-list
64839269|NCT01630915|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64839270|NCT01630915|Purinergic Agents|purinergic agents|mesh-ancestor
64839271|NCT01630915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64839272|NCT01630915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839273|NCT01630915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839274|NCT01630941|Denosumab|denosumab|mesh-list
64839275|NCT01630941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64552716|NCT01839981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552717|NCT01839981|Vitamin B Complex|vitamin b complex|mesh-ancestor
64552718|NCT01839981|Vitamins|vitamins|mesh-ancestor
64552719|NCT01839981|Micronutrients|micronutrients|mesh-ancestor
64552720|NCT03081156|Glycopyrrolate|glycopyrrolate|mesh-list
64552721|NCT03081156|Formoterol Fumarate|formoterol fumarate|mesh-list
64552722|NCT03081156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64552723|NCT03081156|Autonomic Agents|autonomic agents|mesh-ancestor
64552724|NCT03081156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64552725|NCT03081156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552726|NCT03081156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64552727|NCT03081156|Respiratory System Agents|respiratory system agents|mesh-ancestor
64552728|NCT03081156|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64317765|NCT02405715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64993677|NCT01946477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64993678|NCT01946477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993679|NCT01946477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64993680|NCT01946477|Glucocorticoids|glucocorticoids|mesh-ancestor
64993681|NCT01946477|Hormones|hormones|mesh-ancestor
64839307|NCT01631201|KRM 1648|krm 1648|mesh-list
64839308|NCT01631201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64839309|NCT01631201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64839310|NCT01631201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64839311|NCT01631201|Antitubercular Agents|antitubercular agents|mesh-ancestor
64839312|NCT01631201|Leprostatic Agents|leprostatic agents|mesh-ancestor
64839313|NCT01631305|Magnesium Oxide|magnesium oxide|mesh-list
64839314|NCT01631305|Calcium|calcium|mesh-list
64839315|NCT01631305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64839316|NCT01631305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326713|NCT02255591|Racepinephrine|racepinephrine|mesh-list
64326714|NCT02255591|Epinephryl borate|epinephryl borate|mesh-list
64326715|NCT02255591|Anesthetics, Local|anesthetics, local|mesh-ancestor
64326716|NCT02255591|Anesthetics|anesthetics|mesh-ancestor
64326717|NCT02255591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64326718|NCT02255591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326719|NCT02255591|Sensory System Agents|sensory system agents|mesh-ancestor
64326720|NCT02255591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301379|NCT02457585|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
64993682|NCT01946477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64993684|NCT01946477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993685|NCT01946477|Immunologic Factors|immunologic factors|mesh-ancestor
64993686|NCT01946477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64993687|NCT01946477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64993688|NCT01946477|Growth Substances|growth substances|mesh-ancestor
64993689|NCT01946477|Growth Inhibitors|growth inhibitors|mesh-ancestor
64993690|NCT01935921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64993691|NCT01935921|Cetuximab|cetuximab|mesh-list
64993692|NCT01935921|Ipilimumab|ipilimumab|mesh-list
64993693|NCT01935921|Antibodies|antibodies|mesh-list
64993694|NCT01935921|Immunoglobulins|immunoglobulins|mesh-list
64993695|NCT01935921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64993709|NCT01912625|Mitosis Modulators|mitosis modulators|mesh-ancestor
64326721|NCT02255591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64326722|NCT02255591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64839318|NCT01631305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839319|NCT01631305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64839320|NCT01631357|Gemcitabine|gemcitabine|mesh-list
64839321|NCT01631357|Cisplatin|cisplatin|mesh-list
64839322|NCT01631357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839323|NCT01631357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64839324|NCT01631357|Antimetabolites|antimetabolites|mesh-ancestor
64839325|NCT01631357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839326|NCT01631357|Antiviral Agents|antiviral agents|mesh-ancestor
64839327|NCT01631357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64839328|NCT01631357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839329|NCT01631357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64839330|NCT01631357|Immunologic Factors|immunologic factors|mesh-ancestor
64839331|NCT01631357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326723|NCT02255591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64326724|NCT02255591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64326725|NCT02255591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326726|NCT02255591|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64326727|NCT02255591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64326728|NCT02255591|Adrenergic Agents|adrenergic agents|mesh-ancestor
64993710|NCT01912625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993711|NCT01912625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64993712|NCT01912625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993713|NCT01810913|Cisplatin|cisplatin|mesh-list
64993714|NCT01810913|Docetaxel|docetaxel|mesh-list
64993715|NCT01810913|Cetuximab|cetuximab|mesh-list
64993716|NCT01810913|Atezolizumab|atezolizumab|mesh-list
64993717|NCT01810913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64993718|NCT01810913|Antibodies|antibodies|mesh-list
64993719|NCT01810913|Immunoglobulins|immunoglobulins|mesh-list
64993720|NCT01810913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64993721|NCT01810913|Immunologic Factors|immunologic factors|mesh-ancestor
64839332|NCT01631383|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
64839333|NCT01631383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64839334|NCT01631383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64839335|NCT01631383|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64839336|NCT01631383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64839337|NCT01631383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839338|NCT01631383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64839339|NCT01631383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839340|NCT01631383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64839341|NCT01631383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64839342|NCT01631383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64839343|NCT01631383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64839344|NCT01631383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64839345|NCT01631383|Dopamine Agents|dopamine agents|mesh-ancestor
64839346|NCT01631383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64450352|NCT02151851|Methotrexate|methotrexate|mesh-list
64326729|NCT02255591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64326730|NCT02255591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64326731|NCT02255591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64326732|NCT02255591|Autonomic Agents|autonomic agents|mesh-ancestor
64326733|NCT02255591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64326734|NCT02255591|Respiratory System Agents|respiratory system agents|mesh-ancestor
64326735|NCT02255591|Mydriatics|mydriatics|mesh-ancestor
64326736|NCT02255591|Sympathomimetics|sympathomimetics|mesh-ancestor
64326737|NCT02255591|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64326738|NCT00913393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64839347|NCT01631383|Adrenergic Agents|adrenergic agents|mesh-ancestor
64839348|NCT01631383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64839349|NCT01631383|Analgesics|analgesics|mesh-ancestor
64839350|NCT01631383|Sensory System Agents|sensory system agents|mesh-ancestor
64839351|NCT01631383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64993722|NCT01810913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64993723|NCT01810913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993724|NCT01810913|Tubulin Modulators|tubulin modulators|mesh-ancestor
64993725|NCT01810913|Antimitotic Agents|antimitotic agents|mesh-ancestor
64993726|NCT01810913|Mitosis Modulators|mitosis modulators|mesh-ancestor
64993727|NCT01810913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993728|NCT01742299|Imatinib Mesylate|imatinib mesylate|mesh-list
64993729|NCT01742299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64993730|NCT01742299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64993731|NCT01742299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552729|NCT03081156|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64839352|NCT01631396|Neostigmine|neostigmine|mesh-list
64839353|NCT01631396|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64839354|NCT01631396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839355|NCT01631396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839356|NCT01631396|Cholinergic Agents|cholinergic agents|mesh-ancestor
64839357|NCT01631396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64839358|NCT01631396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839359|NCT01631396|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64839360|NCT01631396|Autonomic Agents|autonomic agents|mesh-ancestor
64839361|NCT01631396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64839362|NCT01631409|Aspirin|aspirin|mesh-list
64839363|NCT01631409|Atenolol|atenolol|mesh-list
64839364|NCT01631409|Enalapril|enalapril|mesh-list
64839365|NCT01631409|Enalaprilat|enalaprilat|mesh-list
64839366|NCT01631409|Amlodipine|amlodipine|mesh-list
64839367|NCT01631409|Isosorbide|isosorbide|mesh-list
64839368|NCT01631409|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64839369|NCT01631409|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64839370|NCT01631409|Nitroglycerin|nitroglycerin|mesh-list
64839371|NCT01631409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64839372|NCT01631409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64839373|NCT01631409|Analgesics|analgesics|mesh-ancestor
64839374|NCT01631409|Sensory System Agents|sensory system agents|mesh-ancestor
64839375|NCT01631409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64839376|NCT01631409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839377|NCT01631409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64552730|NCT03081156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64552731|NCT03081156|Adrenergic Agents|adrenergic agents|mesh-ancestor
64552732|NCT03081156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64552733|NCT03081156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552734|NCT03081156|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64552735|NCT03081156|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64552736|NCT03081156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64552737|NCT03081156|Cholinergic Agents|cholinergic agents|mesh-ancestor
64552738|NCT01494350|Gentamicins|gentamicins|mesh-list
64552739|NCT01494350|Paromomycin|paromomycin|mesh-list
64993732|NCT01742299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993733|NCT00856947|Vitamin D|vitamin d|mesh-list
64993734|NCT00856947|Cholecalciferol|cholecalciferol|mesh-list
64993735|NCT00856947|Vitamins|vitamins|mesh-ancestor
64993736|NCT00856947|Micronutrients|micronutrients|mesh-ancestor
64993737|NCT00856947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839392|NCT01631409|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64839393|NCT01631409|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64993738|NCT00856947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64993739|NCT00856947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64993740|NCT00832429|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
64993741|NCT00832429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64993742|NCT00832429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993743|NCT00655993|Simvastatin|simvastatin|mesh-list
64993744|NCT00655993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64993745|NCT00655993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64839454|NCT01631669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839455|NCT01631838|Tocotrienols|tocotrienols|mesh-list
64839456|NCT01631838|Vitamin E|vitamin e|mesh-list
64839457|NCT01631838|Tocopherols|tocopherols|mesh-list
64839458|NCT01631838|Tocovid|tocovid|mesh-list
64450460|NCT02086591|Doxycycline|doxycycline|mesh-list
64450461|NCT02086591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64450462|NCT02086591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64450463|NCT02086591|Antimalarials|antimalarials|mesh-ancestor
64326749|NCT03715465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64326750|NCT04706741|Prednisone|prednisone|mesh-list
64326751|NCT04706741|Prednisolone|prednisolone|mesh-list
64326752|NCT04706741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64326753|NCT04706741|Glucocorticoids|glucocorticoids|mesh-ancestor
64839460|NCT01631838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839461|NCT01631838|Protective Agents|protective agents|mesh-ancestor
64839462|NCT01631838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839463|NCT01631838|Vitamins|vitamins|mesh-ancestor
64839464|NCT01631838|Micronutrients|micronutrients|mesh-ancestor
64839465|NCT01631877|Enoxaparin|enoxaparin|mesh-list
64839466|NCT01631877|Acenocoumarol|acenocoumarol|mesh-list
64839467|NCT01631877|Anticoagulants|anticoagulants|mesh-ancestor
64839468|NCT01631877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64839469|NCT01631877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64839470|NCT01631877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839471|NCT01631968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64839472|NCT01631968|Colistin|colistin|mesh-list
64839473|NCT01631968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64839474|NCT01631994|Metoclopramide|metoclopramide|mesh-list
64839475|NCT01631994|Antiemetics|antiemetics|mesh-ancestor
64839476|NCT01631994|Autonomic Agents|autonomic agents|mesh-ancestor
64839477|NCT01631994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64839478|NCT01631994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839479|NCT01631994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64993746|NCT00655993|Antimetabolites|antimetabolites|mesh-ancestor
64993747|NCT00655993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64993748|NCT00655993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64993749|NCT00655993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64993750|NCT00655993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64993751|NCT00567580|Leuprolide|leuprolide|mesh-list
64993752|NCT00567580|Goserelin|goserelin|mesh-list
64993753|NCT00567580|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64993754|NCT00567580|Flutamide|flutamide|mesh-list
64993755|NCT00567580|Bicalutamide|bicalutamide|mesh-list
64993756|NCT00567580|Buserelin|buserelin|mesh-list
64552803|NCT05366777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64326755|NCT04706741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64326756|NCT04706741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326757|NCT04706741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64326758|NCT04706741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326759|NCT02171039|Dabigatran|dabigatran|mesh-list
64326760|NCT02171039|Atorvastatin|atorvastatin|mesh-list
64326761|NCT02171039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64326762|NCT02171039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64839480|NCT01631994|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64839481|NCT01631994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64839482|NCT01631994|Dopamine Agents|dopamine agents|mesh-ancestor
64839483|NCT01631994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64839484|NCT01631994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839485|NCT01632007|Alogliptin|alogliptin|mesh-list
64839486|NCT01632007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64839487|NCT01632007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839488|NCT01632007|Incretins|incretins|mesh-ancestor
64839489|NCT01632007|Hormones|hormones|mesh-ancestor
64839490|NCT01632007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64839491|NCT01632007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64839492|NCT01632007|Protease Inhibitors|protease inhibitors|mesh-ancestor
64839493|NCT01632007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839494|NCT01632007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839495|NCT01632046|Dialysis Solutions|dialysis solutions|mesh-list
64839496|NCT01632046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64839497|NCT01632163|Lixisenatide|lixisenatide|mesh-list
64839498|NCT01632163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64839499|NCT01632163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64552804|NCT05366777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64552805|NCT05366777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64552806|NCT05366777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64552807|NCT05366777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64552808|NCT05366777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552809|NCT04021043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64552810|NCT04021043|Nivolumab|nivolumab|mesh-list
64552811|NCT04021043|Ipilimumab|ipilimumab|mesh-list
64552812|NCT04021043|Antibodies|antibodies|mesh-list
64552813|NCT04021043|Immunoglobulins|immunoglobulins|mesh-list
64552814|NCT04021043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64552815|NCT04021043|Immunologic Factors|immunologic factors|mesh-ancestor
64552816|NCT04021043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317880|NCT02412033|Misoprostol|misoprostol|mesh-list
64552884|NCT05247619|Growth Inhibitors|growth inhibitors|mesh-ancestor
64552885|NCT04018937|Fludarabine|fludarabine|mesh-list
64552887|NCT04018937|Alemtuzumab|alemtuzumab|mesh-list
64552888|NCT04018937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552889|NCT04018937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552890|NCT04018937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64317944|NCT02401425|Letrozole|letrozole|mesh-list
64552975|NCT05242705|Cystatins|cystatins|mesh-list
64552976|NCT05242705|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64552977|NCT05242705|Protease Inhibitors|protease inhibitors|mesh-ancestor
64839500|NCT01632189|Varenicline|varenicline|mesh-list
64839501|NCT01632189|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64839502|NCT01632189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64839503|NCT01632189|Cholinergic Agents|cholinergic agents|mesh-ancestor
64839504|NCT01632189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64839505|NCT01632189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839506|NCT01632189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839507|NCT01632371|Paclitaxel|paclitaxel|mesh-list
64839508|NCT01632371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64839509|NCT01632371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64839510|NCT01632371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64552978|NCT05242705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736763|NCT05599919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318036|NCT03169569|Hemostatics|hemostatics|mesh-list
64552995|NCT00783354|Loratadine|loratadine|mesh-list
64552996|NCT00783354|Desloratadine|desloratadine|mesh-list
64552997|NCT00783354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64553028|NCT01720875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64553029|NCT01720875|Glucocorticoids|glucocorticoids|mesh-ancestor
64839540|NCT01632605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64839541|NCT01632605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64839542|NCT01632605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64839543|NCT01632605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839544|NCT01632605|Antifungal Agents|antifungal agents|mesh-ancestor
64839545|NCT01632605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64839546|NCT01632605|Immunologic Factors|immunologic factors|mesh-ancestor
64839547|NCT01632605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839548|NCT01632722|Bevacizumab|bevacizumab|mesh-list
64450548|NCT02064920|Donepezil|donepezil|mesh-list
64326764|NCT02171039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326765|NCT02171039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64326766|NCT02171039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64326767|NCT02171039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326768|NCT02171039|Antithrombins|antithrombins|mesh-ancestor
64326769|NCT02171039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64326770|NCT02171039|Protease Inhibitors|protease inhibitors|mesh-ancestor
64839549|NCT01632722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64839550|NCT01632722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839551|NCT01632722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64839552|NCT01632722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64839553|NCT01632722|Growth Substances|growth substances|mesh-ancestor
64839554|NCT01632722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839555|NCT01632722|Growth Inhibitors|growth inhibitors|mesh-ancestor
64839556|NCT01632761|Vitamin D|vitamin d|mesh-list
64553030|NCT01720875|Hormones|hormones|mesh-ancestor
64318086|NCT05537558|Antidepressive Agents|antidepressive agents|mesh-list
64318087|NCT05537558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64553113|NCT01833819|Anesthetics|anesthetics|mesh-ancestor
64553114|NCT01833819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64553115|NCT01833819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553117|NCT01833819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64553118|NCT01833819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64553119|NCT01833819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64553120|NCT01833819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64553121|NCT01833819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64553122|NCT01833819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553123|NCT01833819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64839574|NCT01633086|Autonomic Agents|autonomic agents|mesh-ancestor
64839575|NCT01633086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64839576|NCT01633086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839577|NCT01633086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64839578|NCT01633086|Respiratory System Agents|respiratory system agents|mesh-ancestor
64839579|NCT01633086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64839581|NCT01633086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839582|NCT01633086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64839583|NCT01633086|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64839584|NCT01633086|Vasodilator Agents|vasodilator agents|mesh-ancestor
64839585|NCT01633086|Gasotransmitters|gasotransmitters|mesh-ancestor
64839586|NCT01633086|Protective Agents|protective agents|mesh-ancestor
64839587|NCT01633099|Decitabine|decitabine|mesh-list
64839588|NCT01633099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64839589|NCT01633099|Antimetabolites|antimetabolites|mesh-ancestor
64839590|NCT01633099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326771|NCT02171039|Anticoagulants|anticoagulants|mesh-ancestor
64326772|NCT00840073|Trandolapril|trandolapril|mesh-list
64326773|NCT00840073|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64326774|NCT00840073|Protease Inhibitors|protease inhibitors|mesh-ancestor
64326775|NCT00840073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372085|NCT03069183|Ropivacaine|ropivacaine|mesh-list
64553124|NCT01833819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64553125|NCT01833819|Analgesics|analgesics|mesh-ancestor
64553126|NCT01833819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64553127|NCT01833819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64553128|NCT01833819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64553129|NCT01833819|Adrenergic Agents|adrenergic agents|mesh-ancestor
64553130|NCT01833819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64553131|NCT01833819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64553201|NCT00904995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64553202|NCT00904995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553203|NCT00904995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553204|NCT00904995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64553205|NCT00904995|Hormone Antagonists|hormone antagonists|mesh-ancestor
64553206|NCT00904995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64553207|NCT00904995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553208|NCT00904995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64553209|NCT05249725|Irsogladine|irsogladine|mesh-list
64553210|NCT05249725|Hydrotalcite|hydrotalcite|mesh-list
64553211|NCT05249725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553212|NCT05249725|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64839591|NCT01633099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839592|NCT01633099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839593|NCT01633177|Vitamin D|vitamin d|mesh-list
64839594|NCT01633177|Ergocalciferols|ergocalciferols|mesh-list
64839595|NCT01633177|Cholecalciferol|cholecalciferol|mesh-list
64839596|NCT01633177|Vitamins|vitamins|mesh-list
64839597|NCT01633177|Micronutrients|micronutrients|mesh-ancestor
64839598|NCT01633177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839599|NCT01633177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64839600|NCT01633177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64839601|NCT01633203|Capecitabine|capecitabine|mesh-list
64839602|NCT01633203|Epirubicin|epirubicin|mesh-list
64839603|NCT01633203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839604|NCT01633203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64839605|NCT01633203|Antimetabolites|antimetabolites|mesh-ancestor
64839606|NCT01633203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839607|NCT01633203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64839608|NCT01633203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64839609|NCT01633203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64839610|NCT01633203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839611|NCT01633294|Gentamicins|gentamicins|mesh-list
64839612|NCT01633294|Ampicillin|ampicillin|mesh-list
64839613|NCT01633294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64839614|NCT01633294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64839615|NCT01633294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64839616|NCT01633294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553213|NCT05249725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64553214|NCT05249725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553215|NCT05249725|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64553216|NCT05249725|Protective Agents|protective agents|mesh-ancestor
64553217|NCT05249725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553218|NCT05249725|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64553219|NCT05249725|Antacids|antacids|mesh-ancestor
64553220|NCT01834209|Prednisone|prednisone|mesh-list
64553221|NCT01834209|Prednisolone|prednisolone|mesh-list
64553222|NCT01834209|Abiraterone Acetate|abiraterone acetate|mesh-list
64839619|NCT01633359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
64839620|NCT01633359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64839621|NCT01633359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64839622|NCT01633359|Antimetabolites|antimetabolites|mesh-ancestor
64839623|NCT01633359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839624|NCT01633359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64839625|NCT01633359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839626|NCT01633450|Zinc|zinc|mesh-list
64839627|NCT01633450|Trace Elements|trace elements|mesh-ancestor
64839628|NCT01633450|Micronutrients|micronutrients|mesh-ancestor
64839629|NCT01633450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839630|NCT01633476|Valacyclovir|valacyclovir|mesh-list
64839631|NCT01633476|Antiviral Agents|antiviral agents|mesh-ancestor
64839632|NCT01633476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64839633|NCT01633593|Donepezil|donepezil|mesh-list
64839634|NCT01633593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64839635|NCT01633593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839636|NCT01633593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839637|NCT01633593|Cholinergic Agents|cholinergic agents|mesh-ancestor
64326776|NCT00840073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326777|NCT00840073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64326779|NCT02261207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839640|NCT01633593|Nootropic Agents|nootropic agents|mesh-ancestor
64553223|NCT01834209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64553224|NCT01834209|Glucocorticoids|glucocorticoids|mesh-ancestor
64553225|NCT01834209|Hormones|hormones|mesh-ancestor
64553226|NCT01834209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64553227|NCT01834209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553255|NCT03100734|Sensory System Agents|sensory system agents|mesh-ancestor
64553256|NCT03100734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64553257|NCT03100734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553258|NCT03100734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64553259|NCT03100734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64839657|NCT01633658|Vitamins|vitamins|mesh-ancestor
64839659|NCT01633658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64839660|NCT01633749|Vaccines|vaccines|mesh-list
64839661|NCT01633749|Immunologic Factors|immunologic factors|mesh-ancestor
64839662|NCT01633749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839663|NCT01633762|Vancomycin|vancomycin|mesh-list
64839664|NCT01633762|Gentamicins|gentamicins|mesh-list
64839665|NCT01633762|Meropenem|meropenem|mesh-list
64839666|NCT01633762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64839667|NCT01633762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64839668|NCT01633762|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64839669|NCT01633762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839670|NCT01633762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839671|NCT01633957|Warfarin|warfarin|mesh-list
64839672|NCT01633957|Anticoagulants|anticoagulants|mesh-ancestor
64839673|NCT01633970|Leucovorin|leucovorin|mesh-list
64839674|NCT01633970|Paclitaxel|paclitaxel|mesh-list
64839675|NCT01633970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64839676|NCT01633970|Bevacizumab|bevacizumab|mesh-list
64839677|NCT01633970|Carboplatin|carboplatin|mesh-list
64839678|NCT01633970|Oxaliplatin|oxaliplatin|mesh-list
64839679|NCT01633970|Pemetrexed|pemetrexed|mesh-list
64839680|NCT01633970|Atezolizumab|atezolizumab|mesh-list
64839681|NCT01633970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64839682|NCT01633970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553260|NCT03100734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64553261|NCT03100734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64553262|NCT03100734|Immunologic Factors|immunologic factors|mesh-ancestor
64553263|NCT05243706|Loratadine|loratadine|mesh-list
64553264|NCT05243706|Antipruritics|antipruritics|mesh-ancestor
64553265|NCT05243706|Dermatologic Agents|dermatologic agents|mesh-ancestor
64553266|NCT05243706|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64553267|NCT05243706|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64553268|NCT05243706|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64553269|NCT05243706|Histamine Antagonists|histamine antagonists|mesh-ancestor
64553270|NCT05243706|Histamine Agents|histamine agents|mesh-ancestor
64553271|NCT05243706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64553272|NCT05243706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326782|NCT02261207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326783|NCT00838279|Lamotrigine|lamotrigine|mesh-list
64326784|NCT00838279|Anticonvulsants|anticonvulsants|mesh-ancestor
64326785|NCT00838279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64326786|NCT00838279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64839683|NCT01633970|Tubulin Modulators|tubulin modulators|mesh-ancestor
64839684|NCT01633970|Antimitotic Agents|antimitotic agents|mesh-ancestor
64839685|NCT01633970|Mitosis Modulators|mitosis modulators|mesh-ancestor
64839686|NCT01633970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839687|NCT01633970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64839688|NCT01633970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64839689|NCT01633970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64839690|NCT01633970|Growth Substances|growth substances|mesh-ancestor
64839691|NCT01633970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839692|NCT01633970|Growth Inhibitors|growth inhibitors|mesh-ancestor
64839694|NCT01633970|Protective Agents|protective agents|mesh-ancestor
64839695|NCT01633970|Vitamin B Complex|vitamin b complex|mesh-ancestor
64839696|NCT01633970|Vitamins|vitamins|mesh-ancestor
64839697|NCT01633970|Micronutrients|micronutrients|mesh-ancestor
64450696|NCT02121509|Metformin|metformin|mesh-list
64553273|NCT05243706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553274|NCT01728051|Melphalan|melphalan|mesh-list
64553275|NCT01728051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64553276|NCT01728051|Alkylating Agents|alkylating agents|mesh-ancestor
64839698|NCT01633970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553342|NCT05059782|Dermatologic Agents|dermatologic agents|mesh-ancestor
64839699|NCT01633970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64553343|NCT05242081|Sufentanil|sufentanil|mesh-list
64553344|NCT05242081|Ketamine|ketamine|mesh-list
64553345|NCT05242081|Esketamine|esketamine|mesh-list
64553346|NCT05242081|Analgesics|analgesics|mesh-ancestor
64553347|NCT05242081|Sensory System Agents|sensory system agents|mesh-ancestor
64553348|NCT05242081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64553349|NCT05242081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553350|NCT05242081|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64553351|NCT05242081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64553352|NCT05242081|Anesthetics, General|anesthetics, general|mesh-ancestor
64553353|NCT05242081|Anesthetics|anesthetics|mesh-ancestor
64553354|NCT05242081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64553355|NCT05242081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64318404|NCT02757625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64553356|NCT05242081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64553357|NCT05242081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64839700|NCT01633970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64839701|NCT01633983|Methotrexate|methotrexate|mesh-list
64839702|NCT01633983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64839703|NCT01633983|Abortifacient Agents|abortifacient agents|mesh-ancestor
64839704|NCT01633983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64839705|NCT01633983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839706|NCT01633983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64839707|NCT01633983|Antimetabolites|antimetabolites|mesh-ancestor
64839708|NCT01633983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839709|NCT01633983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839710|NCT01633983|Dermatologic Agents|dermatologic agents|mesh-ancestor
64553358|NCT05242081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553360|NCT05242081|Narcotics|narcotics|mesh-ancestor
64553361|NCT05242081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64553362|NCT05242081|Antidepressive Agents|antidepressive agents|mesh-ancestor
64553363|NCT05242081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64553364|NCT03149029|Pembrolizumab|pembrolizumab|mesh-list
64553365|NCT03149029|Trametinib|trametinib|mesh-list
64553366|NCT03149029|Dabrafenib|dabrafenib|mesh-list
64553367|NCT03149029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64553368|NCT03149029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553369|NCT03149029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64553370|NCT03149029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553371|NCT03149029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553372|NCT04412304|Dalteparin|dalteparin|mesh-list
64839735|NCT01634295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64839736|NCT01634295|Vitamin B Complex|vitamin b complex|mesh-ancestor
64839737|NCT01634295|Vitamins|vitamins|mesh-ancestor
64839738|NCT01634295|Micronutrients|micronutrients|mesh-ancestor
64839739|NCT01634321|Leuprolide|leuprolide|mesh-list
64839740|NCT01634321|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64839741|NCT01634321|Fertility Agents|fertility agents|mesh-ancestor
64839742|NCT01634321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64839743|NCT01634321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839744|NCT01634321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64839745|NCT01634321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839746|NCT01634347|Propranolol|propranolol|mesh-list
64839747|NCT01634347|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64839748|NCT01634347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64839749|NCT01634347|Adrenergic Agents|adrenergic agents|mesh-ancestor
64839750|NCT01634347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64839751|NCT01634347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839752|NCT01634347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839753|NCT01634347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64839754|NCT01634347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64839755|NCT01634347|Vasodilator Agents|vasodilator agents|mesh-ancestor
64839756|NCT01634373|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64839757|NCT01634373|Antidepressive Agents|antidepressive agents|mesh-ancestor
64553373|NCT04412304|Tinzaparin|tinzaparin|mesh-list
64553374|NCT04412304|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64553404|NCT01929265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553405|NCT01929421|Gemcitabine|gemcitabine|mesh-list
64553406|NCT01929421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64553407|NCT01929421|Antimetabolites|antimetabolites|mesh-ancestor
64553408|NCT01929421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553409|NCT01929421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553410|NCT01929421|Antiviral Agents|antiviral agents|mesh-ancestor
64553411|NCT01929421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64553412|NCT01929421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553413|NCT01929421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64553414|NCT01929421|Immunologic Factors|immunologic factors|mesh-ancestor
64318469|NCT02172469|Parasympatholytics|parasympatholytics|mesh-ancestor
64553415|NCT01929421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553416|NCT04474002|Picosulfate sodium|picosulfate sodium|mesh-list
64553418|NCT04474002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64553419|NCT01929577|Peficitinib|peficitinib|mesh-list
64553420|NCT01929577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553421|NCT01929577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553422|NCT01929577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64839773|NCT01634399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64839774|NCT01634399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64839775|NCT01634399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64839776|NCT01634399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839777|NCT01634412|Amitriptyline|amitriptyline|mesh-list
64839778|NCT01634412|Cyclobenzaprine|cyclobenzaprine|mesh-list
64839779|NCT01634412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64839780|NCT01634412|Antidepressive Agents|antidepressive agents|mesh-ancestor
64839781|NCT01634412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64839782|NCT01634412|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64839783|NCT01634412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839784|NCT01634412|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64839785|NCT01634412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64839786|NCT01634412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64839787|NCT01634412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64839788|NCT01634412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64839789|NCT01634412|Analgesics|analgesics|mesh-ancestor
64839790|NCT01634412|Sensory System Agents|sensory system agents|mesh-ancestor
64839791|NCT01634412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64839792|NCT01634412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64839793|NCT01634412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64839794|NCT01634412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839795|NCT01634412|Adrenergic Agents|adrenergic agents|mesh-ancestor
64839796|NCT01634412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64553423|NCT01929577|Immunologic Factors|immunologic factors|mesh-ancestor
64553424|NCT01929577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553425|NCT03142321|Vedolizumab|vedolizumab|mesh-list
64553426|NCT03142321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64553427|NCT01929655|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64553428|NCT01929655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553429|NCT03836703|Iron|iron|mesh-list
64553430|NCT03836703|Trace Elements|trace elements|mesh-ancestor
64553431|NCT03836703|Micronutrients|micronutrients|mesh-ancestor
64553432|NCT03836703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318507|NCT05142319|Vaccines|vaccines|mesh-list
64553475|NCT05061732|Clarithromycin|clarithromycin|mesh-list
64553476|NCT05061732|Doxycycline|doxycycline|mesh-list
64553477|NCT05061732|Levofloxacin|levofloxacin|mesh-list
64326789|NCT00838279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326791|NCT00838279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64839801|NCT01634438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64839802|NCT01634438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839803|NCT01634594|Nicardipine|nicardipine|mesh-list
64839804|NCT01634594|Dexmedetomidine|dexmedetomidine|mesh-list
64839805|NCT01634594|Remifentanil|remifentanil|mesh-list
64839806|NCT01634594|Sevoflurane|sevoflurane|mesh-list
64839807|NCT01634594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64839808|NCT01634594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64839809|NCT01634594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450805|NCT02081690|Macitentan|macitentan|mesh-list
64553478|NCT05061732|Tetracycline|tetracycline|mesh-list
64553479|NCT05061732|Potassium Citrate|potassium citrate|mesh-list
64553480|NCT05061732|Rabeprazole|rabeprazole|mesh-list
64553481|NCT05061732|Bismuth|bismuth|mesh-list
64553482|NCT05061732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553483|NCT05061732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64553484|NCT05061732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64318534|NCT00100711|Motexafin gadolinium|motexafin gadolinium|mesh-list
64553486|NCT05061732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64553487|NCT05061732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64553488|NCT05061732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553489|NCT05061732|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64326792|NCT00838279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64326793|NCT00838279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64326794|NCT00838279|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64326795|NCT02163707|Psilocybin|psilocybin|mesh-list
64326796|NCT02163707|Hallucinogens|hallucinogens|mesh-ancestor
64326797|NCT02163707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839810|NCT01634594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64839811|NCT01634594|Analgesics|analgesics|mesh-ancestor
64839812|NCT01634594|Sensory System Agents|sensory system agents|mesh-ancestor
64839813|NCT01634594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64839814|NCT01634594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64839815|NCT01634594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64839816|NCT01634594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64839817|NCT01634594|Adrenergic Agents|adrenergic agents|mesh-ancestor
64839818|NCT01634594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64839819|NCT01634594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839820|NCT01634594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64839821|NCT01634594|Narcotics|narcotics|mesh-ancestor
64839822|NCT01634594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64839823|NCT01634594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64839824|NCT01634594|Anesthetics, General|anesthetics, general|mesh-ancestor
64839825|NCT01634594|Anesthetics|anesthetics|mesh-ancestor
64839826|NCT01634594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64553490|NCT05061732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64553491|NCT05061732|Antimalarials|antimalarials|mesh-ancestor
64553492|NCT05061732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64553493|NCT05061732|Renal Agents|renal agents|mesh-ancestor
64553494|NCT05061732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64553495|NCT05061732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64553496|NCT05061732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553497|NCT05061732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64553571|NCT01723371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64839827|NCT01634594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64839828|NCT01634594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64839829|NCT01634594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64839830|NCT01634594|Vasodilator Agents|vasodilator agents|mesh-ancestor
64839831|NCT01634685|Capecitabine|capecitabine|mesh-list
64839832|NCT01634685|Bavituximab|bavituximab|mesh-list
64839833|NCT01634685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64839834|NCT01634685|Antimetabolites|antimetabolites|mesh-ancestor
64839835|NCT01634685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839836|NCT01634685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839837|NCT01634685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64839838|NCT01634698|Vitamin A|vitamin a|mesh-list
64839839|NCT01634698|Retinol palmitate|retinol palmitate|mesh-list
64839840|NCT01634698|Vitamins|vitamins|mesh-ancestor
64839841|NCT01634698|Micronutrients|micronutrients|mesh-ancestor
64839842|NCT01634698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839844|NCT01634698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839845|NCT01634698|Protective Agents|protective agents|mesh-ancestor
64839846|NCT01634698|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64839847|NCT01634698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839848|NCT01634763|Ceritinib|ceritinib|mesh-list
64839849|NCT01634763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839850|NCT01634763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64839851|NCT01634763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839852|NCT01634763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839853|NCT01634789|Bazedoxifene|bazedoxifene|mesh-list
64553572|NCT01723371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64553573|NCT01723371|Vasodilator Agents|vasodilator agents|mesh-ancestor
64553574|NCT01723371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64553575|NCT01723371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64553576|NCT00639457|Pioglitazone|pioglitazone|mesh-list
64553577|NCT00639457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64553578|NCT00639457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553579|NCT05057286|Botulinum Toxins|botulinum toxins|mesh-list
64553580|NCT05057286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64553581|NCT05057286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64553582|NCT05057286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64553583|NCT05057286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553584|NCT05057286|Cholinergic Agents|cholinergic agents|mesh-ancestor
64326798|NCT02163707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64839854|NCT01634789|Estrogens|estrogens|mesh-list
64839855|NCT01634789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64839856|NCT01634789|Hormones|hormones|mesh-ancestor
64839857|NCT01634789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64839858|NCT01634789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839859|NCT01634789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64839860|NCT01634789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64839861|NCT01634789|Hormone Antagonists|hormone antagonists|mesh-ancestor
64839862|NCT01634789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64839863|NCT01634880|Panitumumab|panitumumab|mesh-list
64839864|NCT01634880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64839865|NCT01634880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839866|NCT01634893|Hydroxychloroquine|hydroxychloroquine|mesh-list
64839867|NCT01634893|Sorafenib|sorafenib|mesh-list
64839868|NCT01634893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839869|NCT01634893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64839870|NCT01634893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839871|NCT01634893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450865|NCT04726592|GABA Agents|gaba agents|mesh-ancestor
64326800|NCT00769795|Bicalutamide|bicalutamide|mesh-list
64326801|NCT00769795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64553585|NCT05057286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64553586|NCT05057286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553587|NCT05057286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64553588|NCT05057286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64553590|NCT01723527|Methadone|methadone|mesh-list
64553591|NCT01723527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64553592|NCT01723527|Narcotics|narcotics|mesh-ancestor
64553593|NCT01723527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64553594|NCT01723527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839885|NCT01634906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839886|NCT01634932|Iron|iron|mesh-list
64450881|NCT02080832|Dexetimide|dexetimide|mesh-list
64326805|NCT00769795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64326806|NCT00769795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326807|NCT03134677|Bupivacaine|bupivacaine|mesh-list
64326808|NCT03134677|Sevoflurane|sevoflurane|mesh-list
64326809|NCT03134677|Anesthetics, Local|anesthetics, local|mesh-ancestor
64839887|NCT01634932|Trace Elements|trace elements|mesh-ancestor
64839888|NCT01634932|Micronutrients|micronutrients|mesh-ancestor
64839889|NCT01634932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839890|NCT01634945|Amodiaquine|amodiaquine|mesh-list
64839891|NCT01634945|Antimalarials|antimalarials|mesh-ancestor
64839892|NCT01634945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64839893|NCT01634945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64839894|NCT01634945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64839895|NCT01634958|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64839896|NCT01634958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64839897|NCT01634958|Immunologic Factors|immunologic factors|mesh-ancestor
64839898|NCT01634958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839899|NCT01634958|Antacids|antacids|mesh-ancestor
64839900|NCT01634958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839901|NCT01634958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64839902|NCT01635088|Mometasone Furoate|mometasone furoate|mesh-list
64839903|NCT01635088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64839904|NCT01635088|Dermatologic Agents|dermatologic agents|mesh-ancestor
64839905|NCT01635088|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64839906|NCT01635114|Resveratrol|resveratrol|mesh-list
64839907|NCT01635114|Antioxidants|antioxidants|mesh-ancestor
64839908|NCT01635114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839909|NCT01635114|Protective Agents|protective agents|mesh-ancestor
64839910|NCT01635114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553595|NCT01723527|Analgesics|analgesics|mesh-ancestor
64553596|NCT01723527|Sensory System Agents|sensory system agents|mesh-ancestor
64553597|NCT01723527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64553608|NCT00639223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64553610|NCT01723683|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64553611|NCT01723683|Respiratory System Agents|respiratory system agents|mesh-ancestor
64553612|NCT03519984|Cytarabine|cytarabine|mesh-list
64553613|NCT03519984|Vincristine|vincristine|mesh-list
64318681|NCT02170597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64318686|NCT02170675|Ketoconazole|ketoconazole|mesh-list
64553614|NCT03519984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64839930|NCT01635400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839931|NCT01635400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64839932|NCT01635426|Aspirin|aspirin|mesh-list
64839933|NCT01635426|Clopidogrel|clopidogrel|mesh-list
64839934|NCT01635426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64839935|NCT01635426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64839936|NCT01635426|Analgesics|analgesics|mesh-ancestor
64839937|NCT01635426|Sensory System Agents|sensory system agents|mesh-ancestor
64839938|NCT01635426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64839939|NCT01635426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839940|NCT01635426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64839941|NCT01635426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64553616|NCT03519984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553617|NCT03519984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553618|NCT03519984|Antiviral Agents|antiviral agents|mesh-ancestor
64553619|NCT03519984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64553620|NCT03519984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64553621|NCT03519984|Immunologic Factors|immunologic factors|mesh-ancestor
64553622|NCT03519984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553623|NCT03519984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64553624|NCT03519984|Tubulin Modulators|tubulin modulators|mesh-ancestor
64553625|NCT03519984|Antimitotic Agents|antimitotic agents|mesh-ancestor
64553626|NCT03519984|Mitosis Modulators|mitosis modulators|mesh-ancestor
64553627|NCT05056896|Aspirin|aspirin|mesh-list
64553628|NCT05056896|Salicylic Acid|salicylic acid|mesh-list
64553629|NCT05056896|Salicylates|salicylates|mesh-list
64383236|NCT05515185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64383238|NCT05515185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553683|NCT00637273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553685|NCT00637273|Hormones|hormones|mesh-ancestor
64553686|NCT00637273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64553687|NCT00637273|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64553688|NCT00637273|Protease Inhibitors|protease inhibitors|mesh-ancestor
64553689|NCT00637273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553690|NCT00637273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839942|NCT01635426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64839943|NCT01635426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64839944|NCT01635426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839945|NCT01635426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64839946|NCT01635426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64839947|NCT01635426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64839948|NCT01635426|Antipyretics|antipyretics|mesh-ancestor
64839949|NCT01635426|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64839950|NCT01635426|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64839951|NCT01635426|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64839952|NCT01635426|Purinergic Agents|purinergic agents|mesh-ancestor
64839953|NCT01635426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64839954|NCT01635530|Doxycycline|doxycycline|mesh-list
64839955|NCT01635530|Ceftriaxone|ceftriaxone|mesh-list
64450942|NCT02044094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64326814|NCT03134677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64326815|NCT03134677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64326816|NCT03134677|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64326817|NCT03134677|Anesthetics, General|anesthetics, general|mesh-ancestor
64326818|NCT00722917|Pioglitazone|pioglitazone|mesh-list
64326819|NCT00722917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64326820|NCT00722917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318747|NCT05438186|Incretins|incretins|mesh-ancestor
64318748|NCT05438186|Hormones|hormones|mesh-ancestor
64553691|NCT00637273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64553692|NCT01923259|Donepezil|donepezil|mesh-list
64553693|NCT01923259|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64553694|NCT01923259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553695|NCT01923259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553696|NCT01923259|Cholinergic Agents|cholinergic agents|mesh-ancestor
64553697|NCT01923259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64553698|NCT01923259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553699|NCT01923259|Nootropic Agents|nootropic agents|mesh-ancestor
64553700|NCT01923337|Irinotecan|irinotecan|mesh-list
64553701|NCT01923337|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64553702|NCT01923337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64553703|NCT01923337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553704|NCT01923337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553705|NCT01923337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553706|NCT03098160|Ipilimumab|ipilimumab|mesh-list
64553762|NCT00637195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553763|NCT05045274|Aspirin|aspirin|mesh-list
64553764|NCT05045274|Dapagliflozin|dapagliflozin|mesh-list
64553765|NCT05045274|Angiotensin II|angiotensin ii|mesh-list
64553766|NCT05045274|Giapreza|giapreza|mesh-list
64553767|NCT05045274|Clopidogrel|clopidogrel|mesh-list
64553768|NCT05045274|Ticagrelor|ticagrelor|mesh-list
64553769|NCT05045274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
64553770|NCT05045274|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64553771|NCT05045274|Angiotensinogen|angiotensinogen|mesh-list
64553772|NCT05045274|Diuretics|diuretics|mesh-list
64553773|NCT05045274|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64553774|NCT05045274|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64553775|NCT05045274|Mineralocorticoids|mineralocorticoids|mesh-list
64553776|NCT05045274|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
64553777|NCT05045274|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64553778|NCT05045274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64553779|NCT05045274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64553780|NCT05045274|Analgesics|analgesics|mesh-ancestor
64553781|NCT05045274|Sensory System Agents|sensory system agents|mesh-ancestor
64553782|NCT05045274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64839956|NCT01635530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64839957|NCT01635530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64839958|NCT01635530|Antimalarials|antimalarials|mesh-ancestor
64839959|NCT01635530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64839960|NCT01635530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64839962|NCT01635608|Amoxicillin|amoxicillin|mesh-list
64839963|NCT01635608|Talinolol|talinolol|mesh-list
64839964|NCT01635608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64839965|NCT01635608|Analgesics|analgesics|mesh-ancestor
64839966|NCT01635608|Sensory System Agents|sensory system agents|mesh-ancestor
64839967|NCT01635608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64553783|NCT05045274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553791|NCT05045274|Antipyretics|antipyretics|mesh-ancestor
64553804|NCT05045274|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64553805|NCT05045274|Adrenergic Agents|adrenergic agents|mesh-ancestor
64553806|NCT05045274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64553807|NCT05045274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64553808|NCT05045274|Protease Inhibitors|protease inhibitors|mesh-ancestor
64553809|NCT05045274|Hormones|hormones|mesh-ancestor
64553810|NCT05045274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64553811|NCT05045274|Hormone Antagonists|hormone antagonists|mesh-ancestor
64553812|NCT05045274|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64553813|NCT01721733|Ubiquinone|ubiquinone|mesh-list
64326823|NCT02164097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64553814|NCT01721733|Micronutrients|micronutrients|mesh-ancestor
64553815|NCT01721733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553816|NCT01720485|Prednisolone|prednisolone|mesh-list
64326824|NCT02164097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64839968|NCT01635608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839969|NCT01635608|Antipyretics|antipyretics|mesh-ancestor
64839970|NCT01635608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64839971|NCT01635608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64839972|NCT01635608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64839973|NCT01635608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64839974|NCT01635608|Adrenergic Agents|adrenergic agents|mesh-ancestor
64839975|NCT01635608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64839976|NCT01635608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64839977|NCT01635608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64839978|NCT01635608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64839979|NCT01635686|Etanercept|etanercept|mesh-list
64839980|NCT01635686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64839981|NCT01635686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64839982|NCT01635686|Analgesics|analgesics|mesh-ancestor
64839983|NCT01635686|Sensory System Agents|sensory system agents|mesh-ancestor
64839984|NCT01635686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64839985|NCT01635686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553817|NCT01720485|Betamethasone|betamethasone|mesh-list
64553818|NCT01720485|Desloratadine|desloratadine|mesh-list
64553819|NCT01720485|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
64553820|NCT01720485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64553821|NCT01720485|Glucocorticoids|glucocorticoids|mesh-ancestor
64553822|NCT01720485|Hormones|hormones|mesh-ancestor
64553823|NCT01720485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64553824|NCT01720485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839986|NCT01635686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64839987|NCT01635686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64839988|NCT01635686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64450971|NCT04701008|Anesthetics|anesthetics|mesh-ancestor
64839989|NCT01635686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64839990|NCT01635686|Immunologic Factors|immunologic factors|mesh-ancestor
64839991|NCT01635751|Pregabalin|pregabalin|mesh-list
64839992|NCT01635751|Analgesics|analgesics|mesh-ancestor
64839993|NCT01635751|Sensory System Agents|sensory system agents|mesh-ancestor
64839994|NCT01635751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64839995|NCT01635751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64839997|NCT01635751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64839998|NCT01635751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64839999|NCT01635751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840000|NCT01635751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64840001|NCT01635751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64840002|NCT01635751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64840003|NCT01635751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64326825|NCT02164097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326827|NCT00717457|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64326828|NCT00717457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64326829|NCT00717457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326830|NCT00717457|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64553825|NCT01720485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64553826|NCT01720485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553827|NCT01720485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64553828|NCT01720485|Respiratory System Agents|respiratory system agents|mesh-ancestor
64553829|NCT01720485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64553831|NCT01720485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64553832|NCT01720485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553833|NCT01720485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64840004|NCT01635751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64840005|NCT01635777|Miltefosine|miltefosine|mesh-list
64840006|NCT01635777|Antifungal Agents|antifungal agents|mesh-ancestor
64840007|NCT01635777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64840008|NCT01635777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840009|NCT01635777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64840010|NCT01635777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64840011|NCT01635790|Bevacizumab|bevacizumab|mesh-list
64840012|NCT01635790|Ranibizumab|ranibizumab|mesh-list
64840013|NCT01635790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64451007|NCT01621880|Antiemetics|antiemetics|mesh-ancestor
64326831|NCT00717457|Incretins|incretins|mesh-ancestor
64553834|NCT01720485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64553835|NCT01720485|Histamine Antagonists|histamine antagonists|mesh-ancestor
64553836|NCT01720485|Histamine Agents|histamine agents|mesh-ancestor
64553837|NCT01726725|Desflurane|desflurane|mesh-list
64553838|NCT01726725|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64553839|NCT01726725|Anesthetics, General|anesthetics, general|mesh-ancestor
64553842|NCT01726725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553843|NCT05044728|Paclitaxel|paclitaxel|mesh-list
64553844|NCT05044728|Carboplatin|carboplatin|mesh-list
64553845|NCT05044728|Antibodies|antibodies|mesh-list
64326832|NCT00717457|Hormones|hormones|mesh-ancestor
64326833|NCT00717457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64326834|NCT02171507|Diclofenac|diclofenac|mesh-list
64326835|NCT02171507|Dabigatran|dabigatran|mesh-list
64840015|NCT01635790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64840016|NCT01635790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64840017|NCT01635790|Growth Substances|growth substances|mesh-ancestor
64840018|NCT01635790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840019|NCT01635790|Growth Inhibitors|growth inhibitors|mesh-ancestor
64840020|NCT01635803|Bevacizumab|bevacizumab|mesh-list
64840021|NCT01635803|Ranibizumab|ranibizumab|mesh-list
64840022|NCT01635803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64840023|NCT01635803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840024|NCT01635803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64840025|NCT01635803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64840026|NCT01635803|Growth Substances|growth substances|mesh-ancestor
64840027|NCT01635803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840028|NCT01635803|Growth Inhibitors|growth inhibitors|mesh-ancestor
64840029|NCT01635816|Vaccines|vaccines|mesh-list
64840030|NCT01635816|Immunologic Factors|immunologic factors|mesh-ancestor
64840031|NCT01635816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840032|NCT01635829|Carbamazepine|carbamazepine|mesh-list
64840033|NCT01635829|Phenytoin|phenytoin|mesh-list
64840034|NCT01635829|Anticonvulsants|anticonvulsants|mesh-ancestor
64840035|NCT01635829|Antimanic Agents|antimanic agents|mesh-ancestor
64840036|NCT01635829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64840037|NCT01635829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64553846|NCT05044728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64553847|NCT05044728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553848|NCT05044728|Tubulin Modulators|tubulin modulators|mesh-ancestor
64553849|NCT05044728|Antimitotic Agents|antimitotic agents|mesh-ancestor
64553850|NCT05044728|Mitosis Modulators|mitosis modulators|mesh-ancestor
64553851|NCT05044728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553852|NCT05044728|Immunologic Factors|immunologic factors|mesh-ancestor
64553853|NCT05044728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553854|NCT05054478|Daratumumab|daratumumab|mesh-list
64553855|NCT05054478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553856|NCT01041807|Losartan|losartan|mesh-list
64553857|NCT01041807|Amlodipine|amlodipine|mesh-list
64840038|NCT01635829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840039|NCT01635829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64840040|NCT01635829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64840041|NCT01635829|Analgesics|analgesics|mesh-ancestor
64840042|NCT01635829|Sensory System Agents|sensory system agents|mesh-ancestor
64840043|NCT01635829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64840044|NCT01635829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64840045|NCT01635829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64840046|NCT01635829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840047|NCT01635829|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64840048|NCT01635829|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64840049|NCT01635829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64840050|NCT01635829|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64840051|NCT01635946|Isavuconazole|isavuconazole|mesh-list
64840052|NCT01635946|Atorvastatin|atorvastatin|mesh-list
64840053|NCT01635946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64840054|NCT01635946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64840055|NCT01635946|Antimetabolites|antimetabolites|mesh-ancestor
64840056|NCT01635946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840057|NCT01635946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64553858|NCT01041807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64553874|NCT00635089|Respiratory System Agents|respiratory system agents|mesh-ancestor
64553875|NCT01725009|Levetiracetam|levetiracetam|mesh-list
64553876|NCT01725009|Anticonvulsants|anticonvulsants|mesh-ancestor
64553877|NCT01725009|Nootropic Agents|nootropic agents|mesh-ancestor
64553879|NCT01725087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64840078|NCT01635972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64553880|NCT01725087|Narcotics|narcotics|mesh-ancestor
64553881|NCT01725087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64553882|NCT01725087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553883|NCT01725087|Analgesics|analgesics|mesh-ancestor
64553884|NCT01725087|Sensory System Agents|sensory system agents|mesh-ancestor
64553885|NCT01725087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64840079|NCT01636037|Levodopa|levodopa|mesh-list
64840080|NCT01636037|Carbidopa|carbidopa|mesh-list
64840081|NCT01636037|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64840082|NCT01636037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64840083|NCT01636037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64840084|NCT01636037|Dopamine Agents|dopamine agents|mesh-ancestor
64840085|NCT01636037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64451065|NCT04695769|Velpatasvir|velpatasvir|mesh-list
64326836|NCT02171507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64326838|NCT02171507|Analgesics|analgesics|mesh-ancestor
64326839|NCT02171507|Sensory System Agents|sensory system agents|mesh-ancestor
64326840|NCT02171507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64840086|NCT01636037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840087|NCT01636037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840088|NCT01636037|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64840089|NCT01636037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840090|NCT01636037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64840091|NCT01636037|Immunologic Factors|immunologic factors|mesh-ancestor
64840092|NCT01636037|Dopamine Agonists|dopamine agonists|mesh-ancestor
64840094|NCT01636128|Sulindac|sulindac|mesh-list
64840095|NCT01636128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840096|NCT01636128|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64840097|NCT01636128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64840098|NCT01636128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64840099|NCT01636128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64553886|NCT01725087|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64553887|NCT01725087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64553888|NCT01725087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64553889|NCT01725087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553890|NCT01725087|Adrenergic Agents|adrenergic agents|mesh-ancestor
64553891|NCT01725087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64553892|NCT04151082|Prednisone|prednisone|mesh-list
64840110|NCT01636128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64840111|NCT01636128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64840112|NCT01636141|Dapansutrile|dapansutrile|mesh-list
64840113|NCT01636141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64840114|NCT01636180|Clopidogrel|clopidogrel|mesh-list
64840115|NCT01636180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64840116|NCT01636180|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64840117|NCT01636180|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64840118|NCT01636180|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64840123|NCT01636245|Vaccines|vaccines|mesh-list
64840124|NCT01636245|Immunologic Factors|immunologic factors|mesh-ancestor
64840125|NCT01636245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840126|NCT01636271|Darapladib|darapladib|mesh-list
64840127|NCT01636271|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
64840128|NCT01636271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840129|NCT01636271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840130|NCT01636310|Nicotine|nicotine|mesh-list
64840131|NCT01636310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64840132|NCT01636310|Autonomic Agents|autonomic agents|mesh-ancestor
64840133|NCT01636310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64840134|NCT01636310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840135|NCT01636310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64840136|NCT01636310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64840137|NCT01636310|Cholinergic Agents|cholinergic agents|mesh-ancestor
64326841|NCT02171507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326843|NCT02171507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64326844|NCT02171507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64326845|NCT02171507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326846|NCT02171507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553893|NCT04151082|Methylprednisolone|methylprednisolone|mesh-list
64553894|NCT04151082|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64553895|NCT04151082|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64553896|NCT04151082|Prednisolone|prednisolone|mesh-list
64553897|NCT04151082|Prednisolone acetate|prednisolone acetate|mesh-list
64553898|NCT04151082|Cortisone|cortisone|mesh-list
64553899|NCT04151082|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64553900|NCT04151082|Prednisolone phosphate|prednisolone phosphate|mesh-list
64553904|NCT04151082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64301425|NCT04940390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64301427|NCT04940390|Sensory System Agents|sensory system agents|mesh-ancestor
64840139|NCT01636310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840140|NCT01636323|Nicotine|nicotine|mesh-list
64840141|NCT01636323|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64840142|NCT01636323|Autonomic Agents|autonomic agents|mesh-ancestor
64840143|NCT01636323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64840144|NCT01636323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840145|NCT01636323|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64840146|NCT01636323|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64840147|NCT01636323|Cholinergic Agents|cholinergic agents|mesh-ancestor
64840148|NCT01636323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64840149|NCT01636323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840150|NCT01636336|Nicotine|nicotine|mesh-list
64840151|NCT01636336|Progesterone|progesterone|mesh-list
64840152|NCT01636336|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64840153|NCT01636336|Autonomic Agents|autonomic agents|mesh-ancestor
64840154|NCT01636336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64840155|NCT01636336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840156|NCT01636336|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64840157|NCT01636336|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64840158|NCT01636336|Cholinergic Agents|cholinergic agents|mesh-ancestor
64840159|NCT01636336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64840160|NCT01636336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451145|NCT02034565|Apixaban|apixaban|mesh-list
64840162|NCT01636336|Hormones|hormones|mesh-ancestor
64840163|NCT01636336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64840164|NCT01636401|Bromides|bromides|mesh-list
64840165|NCT01636401|Anticonvulsants|anticonvulsants|mesh-ancestor
64553952|NCT03097380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64553953|NCT03097380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553954|NCT03097380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64553955|NCT03097380|Respiratory System Agents|respiratory system agents|mesh-ancestor
64553956|NCT03097380|Parasympatholytics|parasympatholytics|mesh-ancestor
64553957|NCT03097380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64553958|NCT03097380|Cholinergic Agents|cholinergic agents|mesh-ancestor
64553959|NCT03097380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64326847|NCT02171507|Antithrombins|antithrombins|mesh-ancestor
64326848|NCT02171507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64326849|NCT02171507|Protease Inhibitors|protease inhibitors|mesh-ancestor
64326850|NCT02171507|Anticoagulants|anticoagulants|mesh-ancestor
64326851|NCT03539159|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64840177|NCT01636531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840178|NCT01636557|Vitamin K|vitamin k|mesh-list
64840179|NCT01636557|Midazolam|midazolam|mesh-list
64840180|NCT01636557|Caffeine|caffeine|mesh-list
64840181|NCT01636557|Omeprazole|omeprazole|mesh-list
64840182|NCT01636557|Warfarin|warfarin|mesh-list
64840183|NCT01636557|Vitamins|vitamins|mesh-ancestor
64840184|NCT01636557|Micronutrients|micronutrients|mesh-ancestor
64840185|NCT01636557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840186|NCT01636557|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64840187|NCT01636557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64840188|NCT01636557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64840189|NCT01636557|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64840190|NCT01636557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64840191|NCT01636557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64840192|NCT01636557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64840193|NCT01636557|Anesthetics, General|anesthetics, general|mesh-ancestor
64451172|NCT04417543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64553960|NCT03097380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553961|NCT04759729|Vitamin D|vitamin d|mesh-list
64553962|NCT04759729|Ergocalciferols|ergocalciferols|mesh-list
64553963|NCT04759729|Cholecalciferol|cholecalciferol|mesh-list
64553964|NCT04759729|Vitamins|vitamins|mesh-list
64553965|NCT04759729|Micronutrients|micronutrients|mesh-ancestor
64553966|NCT04759729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64553967|NCT04759729|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64553968|NCT04759729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64553969|NCT05053386|Epirubicin|epirubicin|mesh-list
64553994|NCT03096990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64553995|NCT03096990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64553996|NCT03096990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64553998|NCT01725555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64554037|NCT01360866|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64554038|NCT01360866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64554039|NCT01360866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64840195|NCT01636557|GABA Modulators|gaba modulators|mesh-ancestor
64840196|NCT01636557|GABA Agents|gaba agents|mesh-ancestor
64840197|NCT01636557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64840198|NCT01636557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840199|NCT01636557|Anticoagulants|anticoagulants|mesh-ancestor
64840200|NCT01636557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64840201|NCT01636557|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64840202|NCT01636557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840203|NCT01636557|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64840204|NCT01636557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64840205|NCT01636557|Purinergic Agents|purinergic agents|mesh-ancestor
64840206|NCT01636557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64840207|NCT01636557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64840208|NCT01636557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64840209|NCT01636557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64840210|NCT01636557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64326852|NCT03539159|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64326853|NCT00758953|Danazol|danazol|mesh-list
64326854|NCT00758953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64554040|NCT01360866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554041|NCT01360866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64554042|NCT01360866|Serotonin Agents|serotonin agents|mesh-ancestor
64554043|NCT01360866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554044|NCT01360866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64554045|NCT01360866|Antidepressive Agents|antidepressive agents|mesh-ancestor
64554046|NCT01360866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64554047|NCT01360866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64554048|NCT01360866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64554049|NCT01360866|Analgesics|analgesics|mesh-ancestor
64554050|NCT01360866|Sensory System Agents|sensory system agents|mesh-ancestor
64554051|NCT01360866|Dopamine Agents|dopamine agents|mesh-ancestor
64554052|NCT01360866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64554053|NCT01360866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64554054|NCT01360866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554055|NCT00984061|Clarithromycin|clarithromycin|mesh-list
64554056|NCT00984061|Colchicine|colchicine|mesh-list
64326855|NCT00758953|Hormone Antagonists|hormone antagonists|mesh-ancestor
64840211|NCT01636557|Hemostatics|hemostatics|mesh-ancestor
64840212|NCT01636557|Coagulants|coagulants|mesh-ancestor
64840213|NCT01636570|Vitamin D|vitamin d|mesh-list
64840214|NCT01636570|Cholecalciferol|cholecalciferol|mesh-list
64840215|NCT01636570|Vitamins|vitamins|mesh-ancestor
64840216|NCT01636570|Micronutrients|micronutrients|mesh-ancestor
64840217|NCT01636570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840218|NCT01636570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64840219|NCT01636570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64840221|NCT01636596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64840222|NCT01636596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840223|NCT01636609|Cytarabine|cytarabine|mesh-list
64840224|NCT01636609|Azacitidine|azacitidine|mesh-list
64840225|NCT01636609|Tosedostat|tosedostat|mesh-list
64840226|NCT01636609|Glycine|glycine|mesh-list
64840227|NCT01636609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64840228|NCT01636609|Antimetabolites|antimetabolites|mesh-ancestor
64840229|NCT01636609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840230|NCT01636609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840231|NCT01636609|Antiviral Agents|antiviral agents|mesh-ancestor
64840232|NCT01636609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64554057|NCT00984061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64383239|NCT05515185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64554058|NCT00984061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64554059|NCT00984061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64554060|NCT00984061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554061|NCT00984061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554062|NCT00984061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64326856|NCT00758953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64326857|NCT00758953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451227|NCT02022007|Incretins|incretins|mesh-ancestor
64840233|NCT01636609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64840234|NCT01636609|Immunologic Factors|immunologic factors|mesh-ancestor
64840235|NCT01636609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840236|NCT01636609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840237|NCT01636609|Glycine Agents|glycine agents|mesh-ancestor
64840238|NCT01636609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64840239|NCT01636622|Paclitaxel|paclitaxel|mesh-list
64840240|NCT01636622|Carboplatin|carboplatin|mesh-list
64840241|NCT01636622|Vemurafenib|vemurafenib|mesh-list
64840242|NCT01636622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64840243|NCT01636622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840244|NCT01636622|Tubulin Modulators|tubulin modulators|mesh-ancestor
64840245|NCT01636622|Antimitotic Agents|antimitotic agents|mesh-ancestor
64840246|NCT01636622|Mitosis Modulators|mitosis modulators|mesh-ancestor
64840247|NCT01636622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840248|NCT01636622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64554063|NCT00984061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64554064|NCT00984061|Gout Suppressants|gout suppressants|mesh-ancestor
64554065|NCT00984061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64554066|NCT00984061|Tubulin Modulators|tubulin modulators|mesh-ancestor
64554067|NCT00984061|Antimitotic Agents|antimitotic agents|mesh-ancestor
64554068|NCT00984061|Mitosis Modulators|mitosis modulators|mesh-ancestor
64554069|NCT00984061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64554070|NCT01046643|Estradiol|estradiol|mesh-list
64554071|NCT01046643|Progesterone|progesterone|mesh-list
64554072|NCT01046643|Estrogens|estrogens|mesh-ancestor
64554073|NCT01046643|Hormones|hormones|mesh-ancestor
64554074|NCT01046643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64554075|NCT01046643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554076|NCT01046643|Progestins|progestins|mesh-ancestor
64554077|NCT03096756|Avasopasem manganese|avasopasem manganese|mesh-list
64554078|NCT03096756|Antioxidants|antioxidants|mesh-ancestor
64554079|NCT03096756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554080|NCT03096756|Protective Agents|protective agents|mesh-ancestor
64554081|NCT03096756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554103|NCT00983905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64554104|NCT01046565|Adapalene|adapalene|mesh-list
64554105|NCT01046565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64554106|NCT01046565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64840250|NCT01636700|Tramadol|tramadol|mesh-list
64840251|NCT01636700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64840252|NCT01636700|Narcotics|narcotics|mesh-ancestor
64840253|NCT01636700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64840254|NCT01636700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840255|NCT01636700|Analgesics|analgesics|mesh-ancestor
64840256|NCT01636700|Sensory System Agents|sensory system agents|mesh-ancestor
64840257|NCT01636700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64840258|NCT01636869|Bupivacaine|bupivacaine|mesh-list
64840259|NCT01636869|Anesthetics, Local|anesthetics, local|mesh-ancestor
64840260|NCT01636869|Anesthetics|anesthetics|mesh-ancestor
64840261|NCT01636869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64840262|NCT01636869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840263|NCT01636869|Sensory System Agents|sensory system agents|mesh-ancestor
64840264|NCT01636869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64840265|NCT01636895|Pyrimethamine|pyrimethamine|mesh-list
64430011|NCT04991597|Sensory System Agents|sensory system agents|mesh-ancestor
64554107|NCT01046565|Analgesics|analgesics|mesh-ancestor
64554108|NCT01046565|Sensory System Agents|sensory system agents|mesh-ancestor
64554109|NCT01046565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64554110|NCT01046565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554111|NCT01046565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64554112|NCT01046565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64554113|NCT01046565|Dermatologic Agents|dermatologic agents|mesh-ancestor
64554114|NCT01046253|Lansoprazole|lansoprazole|mesh-list
64554115|NCT01046253|Dexlansoprazole|dexlansoprazole|mesh-list
64554116|NCT01046253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64554117|NCT01046253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64554118|NCT01046253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64554119|NCT01046253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554120|NCT01046253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554121|NCT05050656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64326858|NCT02167685|Brincidofovir|brincidofovir|mesh-list
64326859|NCT02167685|Antiviral Agents|antiviral agents|mesh-ancestor
64326860|NCT02167685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64326861|NCT00758563|Triclosan|triclosan|mesh-list
64326862|NCT00758563|Fluorides|fluorides|mesh-list
64840266|NCT01636895|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64840267|NCT01636895|Sulfadoxine|sulfadoxine|mesh-list
64840268|NCT01636895|Antimalarials|antimalarials|mesh-ancestor
64840269|NCT01636895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64840270|NCT01636895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64840271|NCT01636895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64840272|NCT01636895|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64840273|NCT01636895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840274|NCT01636895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840275|NCT01636895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64840276|NCT01636895|Renal Agents|renal agents|mesh-ancestor
64840277|NCT01636908|Everolimus|everolimus|mesh-list
64840278|NCT01636908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64840279|NCT01636908|Sorafenib|sorafenib|mesh-list
64840280|NCT01636908|Sunitinib|sunitinib|mesh-list
64840281|NCT01636908|Dasatinib|dasatinib|mesh-list
64840282|NCT01636908|Lapatinib|lapatinib|mesh-list
64840283|NCT01636908|Vemurafenib|vemurafenib|mesh-list
64840284|NCT01636908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840285|NCT01636908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64840286|NCT01636908|Immunologic Factors|immunologic factors|mesh-ancestor
64840287|NCT01636908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840288|NCT01636908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64840289|NCT01636908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840290|NCT01636908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451261|NCT02019667|GABA Agents|gaba agents|mesh-ancestor
64554122|NCT05050656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64554123|NCT05050656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64554124|NCT05050656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64554125|NCT05050656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554126|NCT05050656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64554127|NCT05050656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554128|NCT05050656|Analgesics|analgesics|mesh-ancestor
64554129|NCT05050656|Sensory System Agents|sensory system agents|mesh-ancestor
64554130|NCT05050656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64554131|NCT05050656|Antidepressive Agents|antidepressive agents|mesh-ancestor
64554132|NCT05050656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64554133|NCT05050656|Dopamine Agents|dopamine agents|mesh-ancestor
64840525|NCT01637844|Telbivudine|telbivudine|mesh-list
64840526|NCT01637844|Antiviral Agents|antiviral agents|mesh-ancestor
64840527|NCT01637844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64840528|NCT01637844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64554135|NCT00983515|Colchicine|colchicine|mesh-list
64554136|NCT00983515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64554137|NCT00983515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64554138|NCT00983515|Protease Inhibitors|protease inhibitors|mesh-ancestor
64554139|NCT00983515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554140|NCT00983515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554141|NCT00983515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64554142|NCT00983515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64840589|NCT01638247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554143|NCT00983515|Antiviral Agents|antiviral agents|mesh-ancestor
64840590|NCT01638247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840591|NCT01638247|Hormones|hormones|mesh-ancestor
64840592|NCT01638260|Liraglutide|liraglutide|mesh-list
64840593|NCT01638260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64840594|NCT01638260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840595|NCT01638260|Incretins|incretins|mesh-ancestor
64840596|NCT01638260|Hormones|hormones|mesh-ancestor
64840597|NCT01638260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64840598|NCT01638273|Pregabalin|pregabalin|mesh-list
64840599|NCT01638273|Analgesics|analgesics|mesh-ancestor
64840600|NCT01638273|Sensory System Agents|sensory system agents|mesh-ancestor
64840601|NCT01638273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64840602|NCT01638273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840603|NCT01638273|Anticonvulsants|anticonvulsants|mesh-ancestor
64840604|NCT01638273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64840605|NCT01638273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64840606|NCT01638273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840607|NCT01638273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64840608|NCT01638273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64840609|NCT01638273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64840610|NCT01638273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64840611|NCT01638273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64840612|NCT01638299|Insulin|insulin|mesh-list
64840613|NCT01638299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64840614|NCT01638299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840615|NCT01638325|Insulin|insulin|mesh-list
64840616|NCT01638325|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64840617|NCT01638325|Insulin Lispro|insulin lispro|mesh-list
64326864|NCT00758563|Protective Agents|protective agents|mesh-ancestor
64554144|NCT00983515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64554145|NCT00983515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64554146|NCT00983515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64554147|NCT00983515|Gout Suppressants|gout suppressants|mesh-ancestor
64554148|NCT00983515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64554173|NCT05050188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64554174|NCT05050188|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64554176|NCT05050188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554178|NCT04434378|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64554179|NCT04434378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64554180|NCT04434378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64554181|NCT04434378|Adrenergic Agents|adrenergic agents|mesh-ancestor
64554182|NCT04434378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64554183|NCT04434378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554184|NCT04434378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554185|NCT04434378|Urological Agents|urological agents|mesh-ancestor
64554186|NCT00981799|Cyclophosphamide|cyclophosphamide|mesh-list
64554187|NCT00981799|Methotrexate|methotrexate|mesh-list
64554188|NCT00981799|Etoposide|etoposide|mesh-list
64554189|NCT00981799|Lenograstim|lenograstim|mesh-list
64554190|NCT00981799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64554191|NCT00981799|Immunologic Factors|immunologic factors|mesh-ancestor
64840623|NCT01638364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64840624|NCT01638364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840625|NCT01638377|Naltrexone|naltrexone|mesh-list
64840626|NCT01638377|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64840627|NCT01638377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64451605|NCT04594239|Lidocaine|lidocaine|mesh-list
64840629|NCT01638377|Sensory System Agents|sensory system agents|mesh-ancestor
64840630|NCT01638377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64840631|NCT01638403|Modafinil|modafinil|mesh-list
64840632|NCT01638403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64840633|NCT01638403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840634|NCT01638403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64840635|NCT01638403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64840636|NCT01638403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64554192|NCT00981799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554388|NCT01837329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64319488|NCT04510285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64319489|NCT04510285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319491|NCT05450432|Esketamine|esketamine|mesh-list
64319492|NCT05450432|Analgesics|analgesics|mesh-ancestor
64554429|NCT00983437|Modafinil|modafinil|mesh-list
64319532|NCT02182375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64554628|NCT01040169|Cariostatic Agents|cariostatic agents|mesh-ancestor
64338932|NCT04662723|Antiemetics|antiemetics|mesh-ancestor
64554932|NCT00919035|Antifungal Agents|antifungal agents|mesh-ancestor
64320082|NCT02177851|Iron|iron|mesh-list
64554961|NCT04374981|Hormone Antagonists|hormone antagonists|mesh-ancestor
64554962|NCT04374981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64554963|NCT04374981|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64554964|NCT04374981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64554965|NCT03092544|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64554966|NCT03092544|Dermatologic Agents|dermatologic agents|mesh-ancestor
64554967|NCT03092544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64554968|NCT03092544|Immunologic Factors|immunologic factors|mesh-ancestor
64554969|NCT03092544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840637|NCT01638403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840638|NCT01638442|Tosedostat|tosedostat|mesh-list
64840639|NCT01638442|Glycine|glycine|mesh-list
64840640|NCT01638442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840641|NCT01638442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840642|NCT01638442|Glycine Agents|glycine agents|mesh-ancestor
64451622|NCT04585737|Tenofovir|tenofovir|mesh-list
64326866|NCT00758563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64326867|NCT00758563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64326868|NCT00758563|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64840643|NCT01638442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64840644|NCT01638442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840646|NCT01638624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64840647|NCT01638624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64840648|NCT01638624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840649|NCT01638624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64840650|NCT01638624|Anesthetics, General|anesthetics, general|mesh-ancestor
64554970|NCT03090516|Donepezil|donepezil|mesh-list
64320107|NCT02180737|Adrenergic Agents|adrenergic agents|mesh-ancestor
64554971|NCT03090516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64554972|NCT03090516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64554973|NCT03090516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64554974|NCT03090516|Cholinergic Agents|cholinergic agents|mesh-ancestor
64554975|NCT03090516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64554976|NCT03090516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64554978|NCT04198571|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64554979|NCT04198571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64554980|NCT04198571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64554981|NCT03092310|Pancrelipase|pancrelipase|mesh-list
64554982|NCT03092310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64774765|NCT01728636|Coagulants|coagulants|mesh-ancestor
64774766|NCT01729338|Cyclophosphamide|cyclophosphamide|mesh-list
64774767|NCT01729338|Lenalidomide|lenalidomide|mesh-list
64774768|NCT01729338|Bortezomib|bortezomib|mesh-list
64774769|NCT01729338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64774770|NCT01729338|Immunologic Factors|immunologic factors|mesh-ancestor
64774771|NCT01729338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774772|NCT01729338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64774773|NCT01729338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64774774|NCT01729338|Alkylating Agents|alkylating agents|mesh-ancestor
64774775|NCT01729338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774776|NCT01729338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774777|NCT01729338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64774778|NCT01729338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64774779|NCT01729338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64774780|NCT01729338|Growth Substances|growth substances|mesh-ancestor
64774781|NCT01729338|Growth Inhibitors|growth inhibitors|mesh-ancestor
64774782|NCT01729494|Mycophenolic Acid|mycophenolic acid|mesh-list
64774783|NCT01729494|Prednisone|prednisone|mesh-list
64774784|NCT01729494|Alemtuzumab|alemtuzumab|mesh-list
64774785|NCT01729494|Abatacept|abatacept|mesh-list
64774786|NCT01729494|Tacrolimus|tacrolimus|mesh-list
64774787|NCT01729494|Thymoglobulin|thymoglobulin|mesh-list
64774788|NCT01729494|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64774789|NCT01729494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64774790|NCT01729494|Glucocorticoids|glucocorticoids|mesh-ancestor
64774800|NCT01729494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774801|NCT01729494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64774802|NCT01729494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64774803|NCT01729494|Antitubercular Agents|antitubercular agents|mesh-ancestor
64774804|NCT01729494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64774805|NCT01729494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64774806|NCT01729494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64774807|NCT01729494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64774808|NCT01729494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64774809|NCT05317260|Antiviral Agents|antiviral agents|mesh-list
64840651|NCT01638624|Anesthetics|anesthetics|mesh-ancestor
64840652|NCT01638650|Ritonavir|ritonavir|mesh-list
64840653|NCT01638650|Saquinavir|saquinavir|mesh-list
64840654|NCT01638650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
64840655|NCT01638650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64840656|NCT01638650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64840657|NCT01638650|Protease Inhibitors|protease inhibitors|mesh-ancestor
64840658|NCT01638650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840659|NCT01638650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840660|NCT01638650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64840661|NCT01638650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64840662|NCT01638650|Antiviral Agents|antiviral agents|mesh-ancestor
64840663|NCT01638650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64774810|NCT05317260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64774811|NCT05316480|Nimotuzumab|nimotuzumab|mesh-list
64774812|NCT05316480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64774813|NCT05316480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774814|NCT05316246|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64774815|NCT05316246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64774816|NCT05316246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774817|NCT05316168|Dexamethasone|dexamethasone|mesh-list
64774818|NCT05316168|Bupivacaine|bupivacaine|mesh-list
64774819|NCT05316168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64774820|NCT05316168|Antiemetics|antiemetics|mesh-ancestor
64774821|NCT05316168|Autonomic Agents|autonomic agents|mesh-ancestor
64774822|NCT05316168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774832|NCT05316168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64774833|NCT05316168|Sensory System Agents|sensory system agents|mesh-ancestor
64774834|NCT05315388|Vitamins|vitamins|mesh-list
64774835|NCT05315388|Micronutrients|micronutrients|mesh-ancestor
64774836|NCT05315388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774837|NCT04894188|Goserelin|goserelin|mesh-list
64774838|NCT04894188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64840664|NCT01638650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64774839|NCT04894188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840665|NCT01638650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64840666|NCT01638650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64840668|NCT01638663|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64840669|NCT01638663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840670|NCT01638663|Natriuretic Agents|natriuretic agents|mesh-ancestor
64840671|NCT01638663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840672|NCT01638676|Metformin|metformin|mesh-list
64840673|NCT01638676|Vemurafenib|vemurafenib|mesh-list
64840674|NCT01638676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64840675|NCT01638676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840676|NCT01638676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840677|NCT01638676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64840678|NCT01638676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326869|NCT00758563|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64326870|NCT00758563|Antimetabolites|antimetabolites|mesh-ancestor
64326871|NCT00758563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326872|NCT00758563|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64774840|NCT04724772|Tranexamic Acid|tranexamic acid|mesh-list
64774841|NCT04724772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64774842|NCT04724772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64774843|NCT04724772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774844|NCT04724772|Hemostatics|hemostatics|mesh-ancestor
64774845|NCT04724772|Coagulants|coagulants|mesh-ancestor
64774846|NCT04196868|Metformin|metformin|mesh-list
64840679|NCT01638676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774847|NCT04196868|Methotrexate|methotrexate|mesh-list
64774848|NCT04196868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64774849|NCT04196868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774850|NCT04196868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64774851|NCT04196868|Abortifacient Agents|abortifacient agents|mesh-ancestor
64774852|NCT04196868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64774853|NCT04196868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64774854|NCT04196868|Antimetabolites|antimetabolites|mesh-ancestor
64774855|NCT04196868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774856|NCT04196868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774857|NCT04196868|Dermatologic Agents|dermatologic agents|mesh-ancestor
64774858|NCT04196868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323594|NCT05496764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64323595|NCT05496764|Glucocorticoids|glucocorticoids|mesh-ancestor
64323596|NCT05496764|Hormones|hormones|mesh-ancestor
64323598|NCT05496764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64323599|NCT05496764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323600|NCT05496530|Triamcinolone|triamcinolone|mesh-list
64774859|NCT04196868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64840681|NCT01638689|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64840682|NCT01638689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64840683|NCT01638689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64840684|NCT01638689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840685|NCT01638689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64840686|NCT01638689|Serotonin Agents|serotonin agents|mesh-ancestor
64840687|NCT01638689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774860|NCT04196868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64774861|NCT04196868|Immunologic Factors|immunologic factors|mesh-ancestor
64774862|NCT04196868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64774863|NCT04196868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64774864|NCT04007874|Vitamin E|vitamin e|mesh-list
64774865|NCT04007874|Levonorgestrel|levonorgestrel|mesh-list
64774866|NCT04007874|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64774867|NCT04007874|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64774868|NCT04007874|Vitamins|vitamins|mesh-ancestor
64774869|NCT04007874|Micronutrients|micronutrients|mesh-ancestor
64774870|NCT04007874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840718|NCT01638858|Ranibizumab|ranibizumab|mesh-list
64840719|NCT01638858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64840720|NCT01638858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64840721|NCT01638858|Growth Substances|growth substances|mesh-ancestor
64840722|NCT01638858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840723|NCT01638858|Growth Inhibitors|growth inhibitors|mesh-ancestor
64840724|NCT01638858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840726|NCT01638936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64840727|NCT01638936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840728|NCT01638936|Tubulin Modulators|tubulin modulators|mesh-ancestor
64840729|NCT01638936|Antimitotic Agents|antimitotic agents|mesh-ancestor
64326873|NCT02171585|Clarithromycin|clarithromycin|mesh-list
64326874|NCT02171585|Dabigatran|dabigatran|mesh-list
64840730|NCT01638936|Mitosis Modulators|mitosis modulators|mesh-ancestor
64840731|NCT01638936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840732|NCT01638962|Acetaminophen|acetaminophen|mesh-list
64840733|NCT01638962|Aspirin|aspirin|mesh-list
64840734|NCT01638962|Ibuprofen|ibuprofen|mesh-list
64840735|NCT01638962|Celecoxib|celecoxib|mesh-list
64840736|NCT01638962|Diclofenac|diclofenac|mesh-list
64840737|NCT01638962|Naproxen|naproxen|mesh-list
64840738|NCT01638962|Indomethacin|indomethacin|mesh-list
64840739|NCT01638962|Etoricoxib|etoricoxib|mesh-list
64840740|NCT01638962|Meloxicam|meloxicam|mesh-list
64840741|NCT01638962|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
64840742|NCT01638962|Etodolac|etodolac|mesh-list
64840743|NCT01638962|Lornoxicam|lornoxicam|mesh-list
64840744|NCT01638962|Nabumetone|nabumetone|mesh-list
64840745|NCT01638962|Tenoxicam|tenoxicam|mesh-list
64840746|NCT01638962|Tiaprofenic acid|tiaprofenic acid|mesh-list
64840747|NCT01638962|Analgesics|analgesics|mesh-list
64840748|NCT01638962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64840749|NCT01638962|Sensory System Agents|sensory system agents|mesh-ancestor
64774871|NCT04007874|Antioxidants|antioxidants|mesh-ancestor
64774872|NCT04007874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774873|NCT04007874|Protective Agents|protective agents|mesh-ancestor
64774874|NCT04007874|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64774875|NCT04007874|Contraceptive Agents|contraceptive agents|mesh-ancestor
64774876|NCT04007874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64774877|NCT04007874|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64774878|NCT04007874|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64774879|NCT04007874|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64774880|NCT04007874|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64840756|NCT01638962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64840757|NCT01638962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840758|NCT01638962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840759|NCT01638962|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64840760|NCT01638962|Gout Suppressants|gout suppressants|mesh-ancestor
64840761|NCT01638962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64840762|NCT01638962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64840763|NCT01638962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64840764|NCT01638962|Tocolytic Agents|tocolytic agents|mesh-ancestor
64840765|NCT01638962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64840766|NCT01638988|Metformin|metformin|mesh-list
64840767|NCT01638988|Clomiphene|clomiphene|mesh-list
64840769|NCT01638988|Zuclomiphene|zuclomiphene|mesh-list
64840770|NCT01638988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64840771|NCT01638988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840772|NCT01638988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64840773|NCT01638988|Hormone Antagonists|hormone antagonists|mesh-ancestor
64840774|NCT01638988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64840775|NCT01638988|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64840776|NCT01638988|Fertility Agents|fertility agents|mesh-ancestor
64840777|NCT01638988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64840778|NCT01638988|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64840780|NCT01639027|Drotaverin|drotaverin|mesh-list
64774881|NCT04007874|Estrogens|estrogens|mesh-ancestor
64774882|NCT04007874|Hormones|hormones|mesh-ancestor
64774883|NCT04007874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64774884|NCT04007874|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64774885|NCT03878472|Oxaliplatin|oxaliplatin|mesh-list
64774886|NCT03878472|Apatinib|apatinib|mesh-list
64774887|NCT03878472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774888|NCT03878472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64774889|NCT03878472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64774890|NCT03878472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774891|NCT03162510|Paclitaxel|paclitaxel|mesh-list
64774892|NCT03162510|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64774893|NCT03162510|Oxaliplatin|oxaliplatin|mesh-list
64774894|NCT03162510|Tegafur|tegafur|mesh-list
64386338|NCT03163121|Immunologic Factors|immunologic factors|mesh-ancestor
64774895|NCT03162510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64774897|NCT03162510|Tubulin Modulators|tubulin modulators|mesh-ancestor
64774898|NCT03162510|Antimitotic Agents|antimitotic agents|mesh-ancestor
64840798|NCT01639092|Tenofovir|tenofovir|mesh-list
64840799|NCT01639092|Entecavir|entecavir|mesh-list
64840800|NCT01639092|Antiviral Agents|antiviral agents|mesh-ancestor
64840801|NCT01639092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64840802|NCT01639092|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64840803|NCT01639092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64840804|NCT01639092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840805|NCT01639092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840806|NCT01639092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64840807|NCT01639092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64840808|NCT01639261|Interferons|interferons|mesh-list
64840809|NCT01639261|Interferon-gamma|interferon-gamma|mesh-list
64840810|NCT01639261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840811|NCT01639261|Antiviral Agents|antiviral agents|mesh-ancestor
64840812|NCT01639261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64840813|NCT01639326|Irinotecan|irinotecan|mesh-list
64326875|NCT02171585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64840814|NCT01639326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64840815|NCT01639326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64774899|NCT03162510|Mitosis Modulators|mitosis modulators|mesh-ancestor
64774900|NCT03162510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774901|NCT03162510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64774902|NCT03162510|Antimetabolites|antimetabolites|mesh-ancestor
64774903|NCT02996760|Mitogens|mitogens|mesh-list
64774904|NCT02996760|Mitosis Modulators|mitosis modulators|mesh-ancestor
64774905|NCT02996760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840816|NCT01639326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840817|NCT01639326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840818|NCT01639326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840819|NCT01639456|Aldesleukin|aldesleukin|mesh-list
64840820|NCT01639456|Cyclophosphamide|cyclophosphamide|mesh-list
64840821|NCT01639456|Fludarabine|fludarabine|mesh-list
64840822|NCT01639456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64840823|NCT01639456|Immunologic Factors|immunologic factors|mesh-ancestor
64840824|NCT01639456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840825|NCT01639456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64840826|NCT01639456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64840827|NCT01639456|Alkylating Agents|alkylating agents|mesh-ancestor
64840828|NCT01639456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840829|NCT01639456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840830|NCT01639456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64840831|NCT01639456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64840832|NCT01639456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64840833|NCT01639456|Antiviral Agents|antiviral agents|mesh-ancestor
64840834|NCT01639456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64840835|NCT01639521|Gemcitabine|gemcitabine|mesh-list
64840836|NCT01639521|Doxorubicin|doxorubicin|mesh-list
64840837|NCT01639521|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64840838|NCT01639521|Methotrexate|methotrexate|mesh-list
64840839|NCT01639521|Vinblastine|vinblastine|mesh-list
64840840|NCT01639521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840841|NCT01639521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64774906|NCT02987946|Nadroparin|nadroparin|mesh-list
64774907|NCT02987946|Anticoagulants|anticoagulants|mesh-ancestor
64774908|NCT02987946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64774909|NCT02987946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64774910|NCT02987946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774911|NCT02394132|Imiquimod|imiquimod|mesh-list
64774912|NCT02394132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64840874|NCT01639794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64774913|NCT02394132|Immunologic Factors|immunologic factors|mesh-ancestor
64774914|NCT02394132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774915|NCT02394132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774916|NCT02394132|Interferon Inducers|interferon inducers|mesh-ancestor
64301481|NCT03077828|Etoposide phosphate|etoposide phosphate|mesh-list
64301482|NCT03077828|Ifosfamide|ifosfamide|mesh-list
64840875|NCT01639794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64840876|NCT01639794|Cholinergic Agents|cholinergic agents|mesh-ancestor
64840877|NCT01639794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64840878|NCT01639794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840879|NCT01639794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840880|NCT01639794|Urological Agents|urological agents|mesh-ancestor
64840881|NCT01639807|Latanoprost|latanoprost|mesh-list
64840882|NCT01639807|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64840883|NCT01639807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64840884|NCT01639885|Interferons|interferons|mesh-list
64326877|NCT02171585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64326878|NCT02171585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326880|NCT02171585|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64774940|NCT01736358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774941|NCT01736358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64774942|NCT01736358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64774943|NCT01736358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64774944|NCT01736358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64774945|NCT01736358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774947|NCT01740258|Temozolomide|temozolomide|mesh-list
64774948|NCT01740258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64342491|NCT02260492|Autonomic Agents|autonomic agents|mesh-ancestor
64774964|NCT01740414|Respiratory System Agents|respiratory system agents|mesh-ancestor
64774965|NCT01740414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64774966|NCT01740414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64774967|NCT01740414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774968|NCT01740414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64840886|NCT01639885|Interferon alpha-2|interferon alpha-2|mesh-list
64840887|NCT01639885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64840888|NCT01639885|Antiviral Agents|antiviral agents|mesh-ancestor
64840889|NCT01639885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64840890|NCT01639885|Immunologic Factors|immunologic factors|mesh-ancestor
64840891|NCT01639885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840892|NCT01639898|Dexamethasone|dexamethasone|mesh-list
64323601|NCT05496530|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64323602|NCT05496530|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64323603|NCT05496530|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64323604|NCT05496530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64323605|NCT05496530|Glucocorticoids|glucocorticoids|mesh-ancestor
64323606|NCT05496530|Hormones|hormones|mesh-ancestor
64323607|NCT05496530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64323608|NCT05496530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323609|NCT05496530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64323610|NCT05496530|Immunologic Factors|immunologic factors|mesh-ancestor
64323611|NCT05496530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323612|NCT05496530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323613|NCT02744833|Enoxaparin|enoxaparin|mesh-list
64323614|NCT02744833|Enoxaparin sodium|enoxaparin sodium|mesh-list
64840940|NCT01640743|Protective Agents|protective agents|mesh-ancestor
64840941|NCT01640743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64840942|NCT01641016|Efavirenz|efavirenz|mesh-list
64840943|NCT01641016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64840944|NCT01641016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64840945|NCT01641016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840946|NCT01641016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840947|NCT01641016|Antiviral Agents|antiviral agents|mesh-ancestor
64840949|NCT01641016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64840950|NCT01641016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64323615|NCT02744833|Anticoagulants|anticoagulants|mesh-ancestor
64323616|NCT02744833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64323617|NCT02744833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64774969|NCT01740414|Vasodilator Agents|vasodilator agents|mesh-ancestor
64774970|NCT01740726|Fluoxetine|fluoxetine|mesh-list
64774971|NCT01740726|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64774972|NCT01740726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64774973|NCT01740726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64840974|NCT01642771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64840975|NCT01642771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840976|NCT01642979|Cyclosporine|cyclosporine|mesh-list
64840977|NCT01642979|Levamisole|levamisole|mesh-list
64840978|NCT01642979|Cyclosporins|cyclosporins|mesh-list
64840979|NCT01642979|Glucocorticoids|glucocorticoids|mesh-list
64840980|NCT01642979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64840981|NCT01642979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64840983|NCT01642979|Immunologic Factors|immunologic factors|mesh-ancestor
64840984|NCT01642979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64840985|NCT01642979|Antifungal Agents|antifungal agents|mesh-ancestor
64840986|NCT01642979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64840987|NCT01642979|Dermatologic Agents|dermatologic agents|mesh-ancestor
64774974|NCT01740726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774975|NCT01740726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64774976|NCT01740726|Serotonin Agents|serotonin agents|mesh-ancestor
64774977|NCT01740726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774978|NCT01740726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64774979|NCT01740726|Antidepressive Agents|antidepressive agents|mesh-ancestor
64774980|NCT01740726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64774993|NCT01746264|Cholecalciferol|cholecalciferol|mesh-list
64774994|NCT01746264|Vitamins|vitamins|mesh-ancestor
64774995|NCT01746264|Micronutrients|micronutrients|mesh-ancestor
64774996|NCT01746264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326897|NCT03134443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64326898|NCT03134443|Antiviral Agents|antiviral agents|mesh-ancestor
64841029|NCT01643941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841030|NCT01643980|Progesterone|progesterone|mesh-list
64841031|NCT01643980|Progestins|progestins|mesh-ancestor
64841033|NCT01643980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64841034|NCT01643980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841035|NCT01645228|Calcium|calcium|mesh-list
64841036|NCT01645228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64841037|NCT01645228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841038|NCT01645839|Cytarabine|cytarabine|mesh-list
64841039|NCT01645839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64841040|NCT01645839|Antimetabolites|antimetabolites|mesh-ancestor
64841041|NCT01645839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841042|NCT01645839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841043|NCT01645839|Antiviral Agents|antiviral agents|mesh-ancestor
64841044|NCT01645839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64841045|NCT01645839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64841046|NCT01645839|Immunologic Factors|immunologic factors|mesh-ancestor
64841047|NCT01645839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841048|NCT01646437|Aspirin|aspirin|mesh-list
64841049|NCT01646437|Vitamin D|vitamin d|mesh-list
64841050|NCT01646437|Cholecalciferol|cholecalciferol|mesh-list
64841051|NCT01646437|Vitamins|vitamins|mesh-ancestor
64841052|NCT01646437|Micronutrients|micronutrients|mesh-ancestor
64841053|NCT01646437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841054|NCT01646437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64841055|NCT01646437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64841056|NCT01646437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64841057|NCT01646437|Analgesics|analgesics|mesh-ancestor
64774997|NCT01746264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64774998|NCT01746264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64774999|NCT01746420|Becaplermin|becaplermin|mesh-list
64775000|NCT01746420|Anticoagulants|anticoagulants|mesh-ancestor
64775001|NCT01746420|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
64775002|NCT01746420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64775003|NCT01746420|Growth Substances|growth substances|mesh-ancestor
64775004|NCT01746420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841058|NCT01646437|Sensory System Agents|sensory system agents|mesh-ancestor
64841059|NCT01646437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64841060|NCT01646437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64841061|NCT01646437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64841062|NCT01646437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64841063|NCT01646437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64841064|NCT01646437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841065|NCT01646437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64841066|NCT01646437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64841067|NCT01646437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841069|NCT01646437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64841070|NCT01646619|Magnesium Sulfate|magnesium sulfate|mesh-list
64841071|NCT01646619|Analgesics|analgesics|mesh-ancestor
64841072|NCT01646619|Sensory System Agents|sensory system agents|mesh-ancestor
64841073|NCT01646619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64841074|NCT01646619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841075|NCT01646619|Anesthetics|anesthetics|mesh-ancestor
64841076|NCT01646619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64841077|NCT01646619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64841078|NCT01646619|Anticonvulsants|anticonvulsants|mesh-ancestor
64841079|NCT01646619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64841080|NCT01646619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64841081|NCT01646619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841082|NCT01646619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64841083|NCT01646619|Tocolytic Agents|tocolytic agents|mesh-ancestor
64841084|NCT01646619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64841085|NCT01647880|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64841086|NCT01647880|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64452046|NCT01812057|Dexamethasone|dexamethasone|mesh-list
64452047|NCT01812057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64377754|NCT04836819|Anesthetics|anesthetics|mesh-ancestor
64775005|NCT01749930|Timolol|timolol|mesh-list
64775006|NCT01749930|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64775007|NCT01749930|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64775008|NCT01749930|Adrenergic Agents|adrenergic agents|mesh-ancestor
64775009|NCT01749930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64775010|NCT01749930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775011|NCT01749930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775012|NCT01749930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64775013|NCT01749930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64775014|NCT01750086|Denosumab|denosumab|mesh-list
64775015|NCT01750086|Alendronate|alendronate|mesh-list
64775016|NCT01750086|Teriparatide|teriparatide|mesh-list
64775017|NCT01750086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64775018|NCT01750086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775019|NCT01750086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64775020|NCT01750398|Methyltestosterone|methyltestosterone|mesh-list
64775021|NCT01750398|Leuprolide|leuprolide|mesh-list
64775022|NCT01750398|Goserelin|goserelin|mesh-list
64775023|NCT01750398|Testosterone|testosterone|mesh-list
64775024|NCT01750398|Testosterone undecanoate|testosterone undecanoate|mesh-list
64323629|NCT05499026|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
64323630|NCT05499026|Cathartics|cathartics|mesh-ancestor
64323631|NCT05499026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64775045|NCT01753362|Incretins|incretins|mesh-ancestor
64775046|NCT01753362|Hormones|hormones|mesh-ancestor
64775047|NCT01753362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64775048|NCT01758432|Apixaban|apixaban|mesh-list
64775049|NCT01758432|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64326899|NCT03134443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64326900|NCT02171663|Afatinib|afatinib|mesh-list
64326901|NCT02171663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326902|NCT02171663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64326903|NCT02171663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841087|NCT01647880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841088|NCT01647880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64841089|NCT01647880|Immunologic Factors|immunologic factors|mesh-ancestor
64841090|NCT01647880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841091|NCT01648218|Insulin|insulin|mesh-list
64841092|NCT01648218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64841093|NCT01648218|Insulin Glargine|insulin glargine|mesh-list
64841094|NCT01648218|Insulin Aspart|insulin aspart|mesh-list
64841095|NCT01648218|Insulin, Isophane|insulin, isophane|mesh-list
64841096|NCT01648218|Isophane Insulin, Human|isophane insulin, human|mesh-list
64841097|NCT01648218|Protamines|protamines|mesh-list
64841098|NCT01648218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64841099|NCT01648218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841100|NCT01648218|Heparin Antagonists|heparin antagonists|mesh-ancestor
64841101|NCT01648218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775050|NCT01758432|Antithrombins|antithrombins|mesh-ancestor
64775051|NCT01758432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64775052|NCT01758432|Protease Inhibitors|protease inhibitors|mesh-ancestor
64775053|NCT01758432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64775070|NCT01759602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64775071|NCT01760304|Budesonide|budesonide|mesh-list
64775072|NCT01760304|Formoterol Fumarate|formoterol fumarate|mesh-list
64775073|NCT01760304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64775074|NCT01760304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64775075|NCT01760304|Autonomic Agents|autonomic agents|mesh-ancestor
64775076|NCT01760304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64775077|NCT01760304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775078|NCT01760304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64775079|NCT01760304|Respiratory System Agents|respiratory system agents|mesh-ancestor
64775080|NCT01760304|Glucocorticoids|glucocorticoids|mesh-ancestor
64775081|NCT01760304|Hormones|hormones|mesh-ancestor
64841109|NCT01648777|Anesthetics, Local|anesthetics, local|mesh-ancestor
64841110|NCT01648777|Anesthetics|anesthetics|mesh-ancestor
64841111|NCT01648777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64841112|NCT01648777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841113|NCT01648777|Sensory System Agents|sensory system agents|mesh-ancestor
64841114|NCT01648777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64841115|NCT01648998|Fludrocortisone|fludrocortisone|mesh-list
64841116|NCT01648998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64841117|NCT01649024|Tremelimumab|tremelimumab|mesh-list
64841118|NCT01649024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841119|NCT01649960|Sirolimus|sirolimus|mesh-list
64841120|NCT01649960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64841121|NCT01649960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64841122|NCT01649960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64841123|NCT01649960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841124|NCT01649960|Antifungal Agents|antifungal agents|mesh-ancestor
64841125|NCT01649960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64326904|NCT02171663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326906|NCT02171741|Afatinib|afatinib|mesh-list
64326907|NCT02171741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326908|NCT02171741|Tubulin Modulators|tubulin modulators|mesh-ancestor
64326909|NCT02171741|Antimitotic Agents|antimitotic agents|mesh-ancestor
64326910|NCT02171741|Mitosis Modulators|mitosis modulators|mesh-ancestor
64841126|NCT01649960|Immunologic Factors|immunologic factors|mesh-ancestor
64841127|NCT01649960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841128|NCT01650012|Eplerenone|eplerenone|mesh-list
64841129|NCT01650012|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64841130|NCT01650012|Hormone Antagonists|hormone antagonists|mesh-ancestor
64841131|NCT01650012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64841132|NCT01650012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841133|NCT01650012|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64841134|NCT01650012|Diuretics|diuretics|mesh-ancestor
64841135|NCT01650012|Natriuretic Agents|natriuretic agents|mesh-ancestor
64841136|NCT01650012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64841137|NCT01650090|Cisplatin|cisplatin|mesh-list
64775082|NCT01760304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64775083|NCT01760304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64775084|NCT01760304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64775085|NCT01760304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64775086|NCT01760304|Adrenergic Agents|adrenergic agents|mesh-ancestor
64775087|NCT01760304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64775088|NCT01760304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775089|NCT01763346|Metformin|metformin|mesh-list
64775090|NCT01763346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64775091|NCT01763346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775092|NCT01766076|Atorvastatin|atorvastatin|mesh-list
64775093|NCT01766076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64775094|NCT01766076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64775095|NCT01766076|Antimetabolites|antimetabolites|mesh-ancestor
64841160|NCT01650272|Vasodilator Agents|vasodilator agents|mesh-ancestor
64841161|NCT01650376|Paclitaxel|paclitaxel|mesh-list
64841162|NCT01650376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64841163|NCT01650376|Carboplatin|carboplatin|mesh-list
64841164|NCT01650376|Olaparib|olaparib|mesh-list
64841165|NCT01650376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64326912|NCT02171741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64326913|NCT02171741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326915|NCT00835705|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64326916|NCT00835705|Clavulanic Acids|clavulanic acids|mesh-list
64841166|NCT01650376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841167|NCT01650376|Tubulin Modulators|tubulin modulators|mesh-ancestor
64841168|NCT01650376|Antimitotic Agents|antimitotic agents|mesh-ancestor
64841169|NCT01650376|Mitosis Modulators|mitosis modulators|mesh-ancestor
64841170|NCT01650376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841171|NCT01650376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64841172|NCT01650376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841173|NCT01650389|BCG Vaccine|bcg vaccine|mesh-list
64841174|NCT01650389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64841175|NCT01650389|Immunologic Factors|immunologic factors|mesh-ancestor
64841176|NCT01650389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841177|NCT01650415|Epoetin Alfa|epoetin alfa|mesh-list
64841178|NCT01650415|Hematinics|hematinics|mesh-ancestor
64841179|NCT01650428|Bevacizumab|bevacizumab|mesh-list
64841180|NCT01650428|Fluorouracil|fluorouracil|mesh-list
64841181|NCT01650428|Oxaliplatin|oxaliplatin|mesh-list
64841182|NCT01650428|Irinotecan|irinotecan|mesh-list
64841183|NCT01650428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64841184|NCT01650428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841185|NCT01650428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64452129|NCT02013817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64775096|NCT01766076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775097|NCT01766076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64775098|NCT01766076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64775099|NCT01766076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64775100|NCT01766466|Ticagrelor|ticagrelor|mesh-list
64775102|NCT01766466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64775103|NCT01766466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64775104|NCT01766466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64775105|NCT01766466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64775106|NCT01766466|Purinergic Agents|purinergic agents|mesh-ancestor
64775107|NCT01766466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64775108|NCT01766466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775109|NCT01766466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775110|NCT01767792|Bevacizumab|bevacizumab|mesh-list
64775111|NCT01767792|Endothelial Growth Factors|endothelial growth factors|mesh-list
64775112|NCT01767792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64326917|NCT00835705|Clavulanic Acid|clavulanic acid|mesh-list
64841186|NCT01650428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64841188|NCT01650428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841189|NCT01650428|Growth Inhibitors|growth inhibitors|mesh-ancestor
64841190|NCT01650428|Antimetabolites|antimetabolites|mesh-ancestor
64841191|NCT01650428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841192|NCT01650428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64841193|NCT01650428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64841194|NCT01650428|Immunologic Factors|immunologic factors|mesh-ancestor
64841195|NCT01650428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64841196|NCT01650428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64841197|NCT01650428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841198|NCT01650441|Beclomethasone|beclomethasone|mesh-list
64841199|NCT01650441|Formoterol Fumarate|formoterol fumarate|mesh-list
64841200|NCT01650441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64841201|NCT01650441|Autonomic Agents|autonomic agents|mesh-ancestor
64841202|NCT01650441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64841203|NCT01650441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841204|NCT01650441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64841205|NCT01650441|Respiratory System Agents|respiratory system agents|mesh-ancestor
64841206|NCT01650441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64841207|NCT01650441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64841209|NCT01650441|Adrenergic Agents|adrenergic agents|mesh-ancestor
64452147|NCT02023099|Antiviral Agents|antiviral agents|mesh-ancestor
64775113|NCT01767792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775114|NCT01767792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64775115|NCT01767792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64775116|NCT01767792|Growth Substances|growth substances|mesh-ancestor
64775117|NCT01767792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775118|NCT01767792|Growth Inhibitors|growth inhibitors|mesh-ancestor
64775119|NCT01769352|Prednisolone acetate|prednisolone acetate|mesh-list
64775120|NCT01769352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64775121|NCT01769586|Diphenhydramine|diphenhydramine|mesh-list
64775122|NCT01769586|Promethazine|promethazine|mesh-list
64775123|NCT01769586|Midazolam|midazolam|mesh-list
64775124|NCT01769586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64775125|NCT01769586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64775126|NCT01769586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64775127|NCT01769586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841210|NCT01650441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64841211|NCT01650441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841212|NCT01650441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64841213|NCT01650441|Glucocorticoids|glucocorticoids|mesh-ancestor
64841215|NCT01650441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64841216|NCT01650493|Listerine|listerine|mesh-list
64841217|NCT01650493|Sodium Fluoride|sodium fluoride|mesh-list
64841218|NCT01650493|Cariostatic Agents|cariostatic agents|mesh-ancestor
64841219|NCT01650493|Protective Agents|protective agents|mesh-ancestor
64841220|NCT01650493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326918|NCT00835705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64326919|NCT00835705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64326920|NCT00835705|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64326921|NCT00835705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326922|NCT00835705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326925|NCT02938520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64326926|NCT02938520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64326927|NCT02938520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326928|NCT02938520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326929|NCT02938520|Antiviral Agents|antiviral agents|mesh-ancestor
64775128|NCT01769586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64775129|NCT01769586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64775130|NCT01769586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64775131|NCT01769586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64323638|NCT05490836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64323639|NCT05490836|Immunologic Factors|immunologic factors|mesh-ancestor
64323640|NCT05490836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323641|NCT05490836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323642|NCT01338025|Lamivudine|lamivudine|mesh-list
64323643|NCT01338025|Emtricitabine|emtricitabine|mesh-list
64775132|NCT01769586|Anesthetics, General|anesthetics, general|mesh-ancestor
64775133|NCT01769586|Anesthetics|anesthetics|mesh-ancestor
64775134|NCT01769586|GABA Modulators|gaba modulators|mesh-ancestor
64775135|NCT01769586|GABA Agents|gaba agents|mesh-ancestor
64775136|NCT01769586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64841221|NCT01650493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64841222|NCT01650493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64841223|NCT01650506|Metformin|metformin|mesh-list
64841224|NCT01650506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64841225|NCT01650506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64841226|NCT01650506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841227|NCT01650506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841228|NCT01650506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64841229|NCT01650506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841230|NCT01650506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841231|NCT01650597|JNJ-42165279|jnj-42165279|mesh-list
64841232|NCT01650597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841233|NCT01650597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841234|NCT01650649|Lofexidine|lofexidine|mesh-list
64841235|NCT01650649|Clonidine|clonidine|mesh-list
64841236|NCT01650649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64775137|NCT01769586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775138|NCT01769586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64775139|NCT01769586|Anesthetics, Local|anesthetics, local|mesh-ancestor
64775140|NCT01769586|Sensory System Agents|sensory system agents|mesh-ancestor
64841267|NCT01650727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64775141|NCT01769586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64775142|NCT01769586|Antiemetics|antiemetics|mesh-ancestor
64775143|NCT01769586|Autonomic Agents|autonomic agents|mesh-ancestor
64775144|NCT01769586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64775145|NCT01769586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64775146|NCT01769586|Histamine Antagonists|histamine antagonists|mesh-ancestor
64775147|NCT01769586|Histamine Agents|histamine agents|mesh-ancestor
64775148|NCT01769586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64841268|NCT01650740|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64841269|NCT01650740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64841270|NCT01650740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64841271|NCT01650740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64841272|NCT01650740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841273|NCT01650740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64841274|NCT01650740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841275|NCT01650740|Analgesics|analgesics|mesh-ancestor
64841276|NCT01650740|Sensory System Agents|sensory system agents|mesh-ancestor
64841277|NCT01650740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64841278|NCT01650740|Antidepressive Agents|antidepressive agents|mesh-ancestor
64841279|NCT01650740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64841280|NCT01650740|Dopamine Agents|dopamine agents|mesh-ancestor
64841281|NCT01650870|Lactulose|lactulose|mesh-list
64841282|NCT01650870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64841284|NCT01650883|Ergocalciferols|ergocalciferols|mesh-list
64841285|NCT01650883|Cholecalciferol|cholecalciferol|mesh-list
64841286|NCT01650883|Vitamins|vitamins|mesh-list
64841287|NCT01650883|Micronutrients|micronutrients|mesh-ancestor
64841288|NCT01650883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841289|NCT01650883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64841290|NCT01650883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64841291|NCT01650961|Palonosetron|palonosetron|mesh-list
64841292|NCT01650961|Antiemetics|antiemetics|mesh-ancestor
64841293|NCT01650961|Autonomic Agents|autonomic agents|mesh-ancestor
64326930|NCT02938520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64326931|NCT02938520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64326932|NCT02938520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64326933|NCT02938520|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64326936|NCT00713401|Tecadenoson|tecadenoson|mesh-list
64775149|NCT01769586|Antipruritics|antipruritics|mesh-ancestor
64775150|NCT01769586|Dermatologic Agents|dermatologic agents|mesh-ancestor
64775151|NCT01773954|Aflibercept|aflibercept|mesh-list
64775152|NCT01773954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64775153|NCT01773954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64775157|NCT01773954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775158|NCT01778634|Azithromycin|azithromycin|mesh-list
64775159|NCT01778634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64775160|NCT01778634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64775161|NCT01783236|Acetaminophen|acetaminophen|mesh-list
64775162|NCT01783236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64775177|NCT01783860|Azithromycin|azithromycin|mesh-list
64775178|NCT01783860|Doxycycline|doxycycline|mesh-list
64775179|NCT01783860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64775180|NCT01783860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64775181|NCT01783860|Antimalarials|antimalarials|mesh-ancestor
64775182|NCT01783860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64775183|NCT01783860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64775185|NCT01785186|Moxifloxacin|moxifloxacin|mesh-list
64775186|NCT01785186|Rifampin|rifampin|mesh-list
64775187|NCT01785186|Isoniazid|isoniazid|mesh-list
64775188|NCT01785186|Pyrazinamide|pyrazinamide|mesh-list
64775189|NCT01785186|Ethambutol|ethambutol|mesh-list
64841294|NCT01650961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64841295|NCT01650961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841297|NCT01650961|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64841298|NCT01650961|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64841299|NCT01650961|Serotonin Agents|serotonin agents|mesh-ancestor
64841300|NCT01650961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64841301|NCT01650961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841302|NCT01651130|Carbetocin|carbetocin|mesh-list
64841303|NCT01651130|Oxytocics|oxytocics|mesh-ancestor
64841304|NCT01651130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64841305|NCT01651130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841306|NCT01651156|Tolvaptan|tolvaptan|mesh-list
64775190|NCT01785186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64775191|NCT01785186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64775192|NCT01785186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64775193|NCT01785186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64775194|NCT01785186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64775195|NCT01785186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775196|NCT01785186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775197|NCT01785186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775198|NCT01785186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64775199|NCT01785186|Antitubercular Agents|antitubercular agents|mesh-ancestor
64775200|NCT01785186|Leprostatic Agents|leprostatic agents|mesh-ancestor
64775201|NCT01785186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64775202|NCT01785186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64775203|NCT01785186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64775204|NCT01785186|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64775205|NCT01785186|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64775206|NCT01785186|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64775223|NCT01785810|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64775225|NCT01786902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64775226|NCT01786902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775227|NCT01787916|Liraglutide|liraglutide|mesh-list
64775228|NCT01787916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64775229|NCT01787916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775230|NCT01787916|Incretins|incretins|mesh-ancestor
64775231|NCT01787916|Hormones|hormones|mesh-ancestor
64775232|NCT01787916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64775233|NCT01790490|Ketamine|ketamine|mesh-list
64775234|NCT01790490|Lorazepam|lorazepam|mesh-list
64775235|NCT01790490|Analgesics|analgesics|mesh-ancestor
64775236|NCT01790490|Sensory System Agents|sensory system agents|mesh-ancestor
64775237|NCT01790490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64775238|NCT01790490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775239|NCT01790490|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64775240|NCT01790490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64775241|NCT01790490|Anesthetics, General|anesthetics, general|mesh-ancestor
64326937|NCT00713401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64841307|NCT01651156|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64841308|NCT01651156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841309|NCT01651156|Natriuretic Agents|natriuretic agents|mesh-ancestor
64841310|NCT01651156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841311|NCT01651169|Methylphenidate|methylphenidate|mesh-list
64841312|NCT01651169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64841313|NCT01651169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841314|NCT01651169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64841315|NCT01651169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64841316|NCT01651169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64841317|NCT01651169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841318|NCT01651169|Dopamine Agents|dopamine agents|mesh-ancestor
64775242|NCT01790490|Anesthetics|anesthetics|mesh-ancestor
64775243|NCT01790490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64775244|NCT01790490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64386711|NCT02388581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64775260|NCT01791972|Autonomic Agents|autonomic agents|mesh-ancestor
64775261|NCT01791972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64775262|NCT01791972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775263|NCT01791972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64775264|NCT01791972|Respiratory System Agents|respiratory system agents|mesh-ancestor
64775265|NCT01791972|Tocolytic Agents|tocolytic agents|mesh-ancestor
64775266|NCT01791972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64841319|NCT01651169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64841320|NCT01651182|Tranexamic Acid|tranexamic acid|mesh-list
64841321|NCT01651182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64841322|NCT01651182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64841323|NCT01651182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841324|NCT01651182|Hemostatics|hemostatics|mesh-ancestor
64841325|NCT01651182|Coagulants|coagulants|mesh-ancestor
64841326|NCT01651312|Mirabegron|mirabegron|mesh-list
64841327|NCT01651312|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64841328|NCT01651312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64841329|NCT01651312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64841330|NCT01651312|Adrenergic Agents|adrenergic agents|mesh-ancestor
64841331|NCT01651312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64841332|NCT01651312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841333|NCT01651312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841334|NCT01651312|Urological Agents|urological agents|mesh-ancestor
64841335|NCT01651325|Isavuconazole|isavuconazole|mesh-list
64841336|NCT01651325|Dextromethorphan|dextromethorphan|mesh-list
64841337|NCT01651325|Antitussive Agents|antitussive agents|mesh-ancestor
64841338|NCT01651325|Respiratory System Agents|respiratory system agents|mesh-ancestor
64841339|NCT01651325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64841340|NCT01651325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64841341|NCT01651325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64452277|NCT02010775|Cholinergic Agents|cholinergic agents|mesh-ancestor
64326945|NCT00713401|Purinergic Agonists|purinergic agonists|mesh-ancestor
64326946|NCT00713401|Purinergic Agents|purinergic agents|mesh-ancestor
64775267|NCT01791972|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64775268|NCT01791972|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64775269|NCT01791972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64775270|NCT01791972|Adrenergic Agents|adrenergic agents|mesh-ancestor
64775271|NCT01791972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64775272|NCT01791972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775273|NCT01794702|Cytarabine|cytarabine|mesh-list
64775274|NCT01794702|Decitabine|decitabine|mesh-list
64775275|NCT01794702|Clofarabine|clofarabine|mesh-list
64775276|NCT01794702|Idarubicin|idarubicin|mesh-list
64775278|NCT01794702|Antimetabolites|antimetabolites|mesh-ancestor
64326947|NCT02171975|Anesthetics|anesthetics|mesh-list
64326948|NCT02171975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64326949|NCT02171975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326950|NCT00835549|Cefdinir|cefdinir|mesh-list
64326951|NCT00835549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64326952|NCT00835549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64326953|NCT02164253|Deferiprone|deferiprone|mesh-list
64326954|NCT02164253|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64326955|NCT02164253|Chelating Agents|chelating agents|mesh-ancestor
64326956|NCT02164253|Sequestering Agents|sequestering agents|mesh-ancestor
64326957|NCT02164253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326958|NCT00755287|Metformin|metformin|mesh-list
64841342|NCT01651325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841343|NCT01651325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841344|NCT01651325|Antifungal Agents|antifungal agents|mesh-ancestor
64841345|NCT01651325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64841346|NCT01651364|Cabergoline|cabergoline|mesh-list
64841347|NCT01651364|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64841348|NCT01651364|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64841349|NCT01651364|Dopamine Agonists|dopamine agonists|mesh-ancestor
64841350|NCT01651364|Dopamine Agents|dopamine agents|mesh-ancestor
64841351|NCT01651364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64841352|NCT01651364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841353|NCT01651364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841364|NCT01651390|Sirolimus|sirolimus|mesh-list
64775287|NCT01794702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64775288|NCT01794702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64775289|NCT01794702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64775290|NCT01795716|Imatinib Mesylate|imatinib mesylate|mesh-list
64775291|NCT01795716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775292|NCT01795716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64775293|NCT01795716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64775294|NCT01795716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775295|NCT01797822|Dexamethasone|dexamethasone|mesh-list
64775296|NCT01797822|Lubricant Eye Drops|lubricant eye drops|mesh-list
64775297|NCT01797822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64775298|NCT01797822|Antiemetics|antiemetics|mesh-ancestor
64775299|NCT01797822|Autonomic Agents|autonomic agents|mesh-ancestor
64775300|NCT01797822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64775301|NCT01797822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775302|NCT01797822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64775303|NCT01797822|Glucocorticoids|glucocorticoids|mesh-ancestor
64775304|NCT01797822|Hormones|hormones|mesh-ancestor
64775305|NCT01797822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64841366|NCT01651390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64841367|NCT01651390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841368|NCT01651390|Tubulin Modulators|tubulin modulators|mesh-ancestor
64841369|NCT01651390|Antimitotic Agents|antimitotic agents|mesh-ancestor
64841370|NCT01651390|Mitosis Modulators|mitosis modulators|mesh-ancestor
64841371|NCT01651390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841372|NCT01651390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64841373|NCT01651390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64841374|NCT01651390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64841375|NCT01651390|Antifungal Agents|antifungal agents|mesh-ancestor
64841376|NCT01651390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64841377|NCT01651390|Immunologic Factors|immunologic factors|mesh-ancestor
64841378|NCT01651390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841379|NCT01651416|Lumefantrine|lumefantrine|mesh-list
64841380|NCT01651416|Artemether|artemether|mesh-list
64841381|NCT01651416|Pyrimethamine|pyrimethamine|mesh-list
64841382|NCT01651416|Piperaquine|piperaquine|mesh-list
64841383|NCT01651416|Sulfadoxine|sulfadoxine|mesh-list
64452323|NCT01966003|Tubulin Modulators|tubulin modulators|mesh-ancestor
64841384|NCT01651416|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64841385|NCT01651416|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64841386|NCT01651416|Amodiaquine|amodiaquine|mesh-list
64775306|NCT01797822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64775307|NCT01797822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775308|NCT01797822|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64775309|NCT01797822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64775310|NCT01809054|Aspirin|aspirin|mesh-list
64775311|NCT01809054|Fondaparinux|fondaparinux|mesh-list
64841399|NCT01651481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64775312|NCT01809054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64343393|NCT00429923|Difluprednate|difluprednate|mesh-list
64841400|NCT01651481|Respiratory System Agents|respiratory system agents|mesh-ancestor
64775317|NCT01809054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775318|NCT01809054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64775319|NCT01809054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64775320|NCT01809054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64775321|NCT01809054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64775322|NCT01809054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775323|NCT01809054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64775324|NCT01809054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64775325|NCT01809054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64775326|NCT01809054|Antipyretics|antipyretics|mesh-ancestor
64775327|NCT01809054|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64775328|NCT01809054|Antithrombins|antithrombins|mesh-ancestor
64775329|NCT01809054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64775330|NCT01809054|Protease Inhibitors|protease inhibitors|mesh-ancestor
64775331|NCT01809054|Anticoagulants|anticoagulants|mesh-ancestor
64775332|NCT01810692|Tiotropium Bromide|tiotropium bromide|mesh-list
64841471|NCT01651962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64841472|NCT01651962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64841473|NCT01651962|Adrenergic Agents|adrenergic agents|mesh-ancestor
64841474|NCT01651962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64841475|NCT01651962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841476|NCT01651988|Propofol|propofol|mesh-list
64841477|NCT01651988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64841478|NCT01651988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64841479|NCT01651988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841480|NCT01651988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64841481|NCT01651988|Anesthetics, General|anesthetics, general|mesh-ancestor
64841482|NCT01651988|Anesthetics|anesthetics|mesh-ancestor
64841483|NCT01652014|Mycophenolic Acid|mycophenolic acid|mesh-list
64841484|NCT01652014|Cyclophosphamide|cyclophosphamide|mesh-list
64841485|NCT01652014|Fludarabine|fludarabine|mesh-list
64841486|NCT01652014|Fludarabine phosphate|fludarabine phosphate|mesh-list
64841487|NCT01652014|Tacrolimus|tacrolimus|mesh-list
64775333|NCT01810692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64775334|NCT01810692|Autonomic Agents|autonomic agents|mesh-ancestor
64775335|NCT01810692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64775336|NCT01810692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775337|NCT01810692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64775338|NCT01810692|Respiratory System Agents|respiratory system agents|mesh-ancestor
64775339|NCT01810692|Parasympatholytics|parasympatholytics|mesh-ancestor
64775340|NCT01810692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64775369|NCT01820754|Carboplatin|carboplatin|mesh-list
64775370|NCT01820754|Ipilimumab|ipilimumab|mesh-list
64775371|NCT01820754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64841509|NCT01652118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64841510|NCT01652118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841511|NCT01652118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841512|NCT01652118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64841513|NCT01652118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64841515|NCT01652157|Pancreatin|pancreatin|mesh-list
64841516|NCT01652157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64841517|NCT01652183|Acetaminophen|acetaminophen|mesh-list
64841518|NCT01652183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64841519|NCT01652183|Analgesics|analgesics|mesh-ancestor
64841520|NCT01652183|Sensory System Agents|sensory system agents|mesh-ancestor
64841521|NCT01652183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64841522|NCT01652183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841523|NCT01652183|Antipyretics|antipyretics|mesh-ancestor
64841524|NCT01652196|Leucovorin|leucovorin|mesh-list
64841525|NCT01652196|Fluorouracil|fluorouracil|mesh-list
64841526|NCT01652196|Oxaliplatin|oxaliplatin|mesh-list
64841527|NCT01652196|Aflibercept|aflibercept|mesh-list
64841528|NCT01652196|Endothelial Growth Factors|endothelial growth factors|mesh-list
64841529|NCT01652196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64841530|NCT01652196|Antimetabolites|antimetabolites|mesh-ancestor
64841531|NCT01652196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841532|NCT01652196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64841533|NCT01652196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841534|NCT01652196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64841535|NCT01652196|Immunologic Factors|immunologic factors|mesh-ancestor
64841536|NCT01652196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775372|NCT01820754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775373|NCT01820754|Tubulin Modulators|tubulin modulators|mesh-ancestor
64775374|NCT01820754|Antimitotic Agents|antimitotic agents|mesh-ancestor
64775375|NCT01820754|Mitosis Modulators|mitosis modulators|mesh-ancestor
64775376|NCT01820754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775377|NCT01820754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64775378|NCT01820754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64775379|NCT01821378|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64775380|NCT01821378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64775381|NCT01821378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64775382|NCT01821378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64775383|NCT01821378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775384|NCT01821378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64775385|NCT01821378|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64775386|NCT01821378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64775387|NCT01821378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64775388|NCT01821378|Adrenergic Agents|adrenergic agents|mesh-ancestor
64775389|NCT01821378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64775390|NCT01821378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775391|NCT01821378|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64775392|NCT01821378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64841538|NCT01652196|Protective Agents|protective agents|mesh-ancestor
64841539|NCT01652196|Vitamin B Complex|vitamin b complex|mesh-ancestor
64841540|NCT01652196|Vitamins|vitamins|mesh-ancestor
64841541|NCT01652196|Micronutrients|micronutrients|mesh-ancestor
64841542|NCT01652196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64841543|NCT01652196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64841544|NCT01652196|Growth Substances|growth substances|mesh-ancestor
64841545|NCT01652196|Growth Inhibitors|growth inhibitors|mesh-ancestor
64841546|NCT01652196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64841547|NCT01652313|Rasagiline|rasagiline|mesh-list
64841548|NCT01652313|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64841549|NCT01652313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841550|NCT01652313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841551|NCT01652313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64841552|NCT01652313|Protective Agents|protective agents|mesh-ancestor
64841553|NCT01652313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841554|NCT01652326|Diazepam|diazepam|mesh-list
64841555|NCT01652326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64841556|NCT01652326|Anticonvulsants|anticonvulsants|mesh-ancestor
64841557|NCT01652326|Antiemetics|antiemetics|mesh-ancestor
64841558|NCT01652326|Autonomic Agents|autonomic agents|mesh-ancestor
64841559|NCT01652326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64841560|NCT01652326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452503|NCT04676204|Ozanimod|ozanimod|mesh-list
64326970|NCT02168075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775393|NCT01821378|Serotonin Agents|serotonin agents|mesh-ancestor
64775394|NCT01821378|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64775395|NCT01821378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64775396|NCT01821378|Dopamine Agents|dopamine agents|mesh-ancestor
64775397|NCT01822548|Metformin|metformin|mesh-list
64775398|NCT01822548|Vildagliptin|vildagliptin|mesh-list
64775399|NCT01822548|Glyburide|glyburide|mesh-list
64775400|NCT01822548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64775401|NCT01822548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775408|NCT01825122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64775409|NCT01825122|Adrenergic Agents|adrenergic agents|mesh-ancestor
64775410|NCT01825122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64841561|NCT01652326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64775411|NCT01825122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775412|NCT01825122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775413|NCT01825122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64775414|NCT01825122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64775415|NCT01825122|Sympatholytics|sympatholytics|mesh-ancestor
64775416|NCT01825122|Autonomic Agents|autonomic agents|mesh-ancestor
64775417|NCT01825122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64775418|NCT01825512|Deferasirox|deferasirox|mesh-list
64775419|NCT01825512|Deferiprone|deferiprone|mesh-list
64775420|NCT01825512|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64841562|NCT01652326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64841563|NCT01652326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64841564|NCT01652326|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64841565|NCT01652326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64841566|NCT01652326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64841567|NCT01652326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64841568|NCT01652326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64841569|NCT01652326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64841570|NCT01652326|Anesthetics, General|anesthetics, general|mesh-ancestor
64841571|NCT01652326|Anesthetics|anesthetics|mesh-ancestor
64841572|NCT01652326|GABA Modulators|gaba modulators|mesh-ancestor
64841573|NCT01652326|GABA Agents|gaba agents|mesh-ancestor
64841574|NCT01652326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64841575|NCT01652326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841576|NCT01652339|Amlodipine|amlodipine|mesh-list
64841577|NCT01652339|Valsartan|valsartan|mesh-list
64775421|NCT01825512|Chelating Agents|chelating agents|mesh-ancestor
64775422|NCT01825512|Sequestering Agents|sequestering agents|mesh-ancestor
64775423|NCT01825512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775424|NCT01827462|Vaccines|vaccines|mesh-list
64775425|NCT01827462|Immunologic Factors|immunologic factors|mesh-ancestor
64775426|NCT01827462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775427|NCT01827930|Imatinib Mesylate|imatinib mesylate|mesh-list
64775428|NCT01827930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775429|NCT01827930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64775430|NCT01827930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64775431|NCT01827930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775432|NCT01828476|Hydroxychloroquine|hydroxychloroquine|mesh-list
64775433|NCT01828476|Navitoclax|navitoclax|mesh-list
64386901|NCT02385227|Nicotine|nicotine|mesh-list
64323644|NCT01338025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64841578|NCT01652339|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
64841579|NCT01652339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64841580|NCT01652339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64841581|NCT01652339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64841582|NCT01652339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323645|NCT01338025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64323646|NCT01338025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323647|NCT01338025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323648|NCT01338025|Antiviral Agents|antiviral agents|mesh-ancestor
64323649|NCT01338025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64323650|NCT01338025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64323651|NCT01338025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64323653|NCT05498636|Etoposide|etoposide|mesh-list
64841636|NCT01652534|Antiviral Agents|antiviral agents|mesh-ancestor
64841637|NCT01652534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64841638|NCT01652534|Dopamine Agents|dopamine agents|mesh-ancestor
64841639|NCT01652534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64841640|NCT01652534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841641|NCT01652534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452582|NCT01984892|Poly ICLC|poly iclc|mesh-list
64326976|NCT03945825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326977|NCT03819517|Resveratrol|resveratrol|mesh-list
64326978|NCT03819517|Antioxidants|antioxidants|mesh-ancestor
64326979|NCT03819517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326980|NCT03819517|Protective Agents|protective agents|mesh-ancestor
64841642|NCT01652534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64841643|NCT01652534|Analgesics|analgesics|mesh-ancestor
64841644|NCT01652534|Sensory System Agents|sensory system agents|mesh-ancestor
64841645|NCT01652534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64841646|NCT01652547|Pasireotide|pasireotide|mesh-list
64841647|NCT01652547|Somatostatin|somatostatin|mesh-list
64841649|NCT01652547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64841650|NCT01652547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841651|NCT01652560|Bevacizumab|bevacizumab|mesh-list
64452605|NCT01610037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64323654|NCT05498636|Lenalidomide|lenalidomide|mesh-list
64323655|NCT05498636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64323656|NCT05498636|Glucocorticoids|glucocorticoids|mesh-ancestor
64323657|NCT05498636|Hormones|hormones|mesh-ancestor
64323658|NCT05498636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64323659|NCT05498636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323660|NCT05498636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64323661|NCT05498636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323662|NCT05498636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64323663|NCT05498636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64323664|NCT05498636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64775435|NCT01828476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64775436|NCT01828476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64775437|NCT01828476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64775438|NCT01828476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64775439|NCT01828476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775440|NCT01828476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64841652|NCT01652560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64841653|NCT01652560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841654|NCT01652560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64841655|NCT01652560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64841656|NCT01652560|Growth Substances|growth substances|mesh-ancestor
64841657|NCT01652560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841658|NCT01652560|Growth Inhibitors|growth inhibitors|mesh-ancestor
64841659|NCT01652586|Midazolam|midazolam|mesh-list
64841660|NCT01652586|Dexmedetomidine|dexmedetomidine|mesh-list
64841661|NCT01652586|Remifentanil|remifentanil|mesh-list
64841662|NCT01652586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64841663|NCT01652586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64841664|NCT01652586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326981|NCT03819517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326982|NCT03819517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326983|NCT03819517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64326984|NCT02759315|Uprifosbuvir|uprifosbuvir|mesh-list
64326985|NCT02759315|Ruzasvir|ruzasvir|mesh-list
64326986|NCT02759315|Antiviral Agents|antiviral agents|mesh-ancestor
64326987|NCT02759315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64326988|NCT04265534|Folic Acid|folic acid|mesh-list
64326989|NCT04265534|Vitamin B 12|vitamin b 12|mesh-list
64326990|NCT04265534|Dexamethasone|dexamethasone|mesh-list
64326991|NCT04265534|Carboplatin|carboplatin|mesh-list
64775441|NCT01828476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775442|NCT01828554|Capecitabine|capecitabine|mesh-list
64775443|NCT01828554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64775444|NCT01828554|Antimetabolites|antimetabolites|mesh-ancestor
64775445|NCT01828554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775446|NCT01828554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775447|NCT01833546|Gemcitabine|gemcitabine|mesh-list
64775448|NCT01833546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64775449|NCT01833546|Antimetabolites|antimetabolites|mesh-ancestor
64775450|NCT01833546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775451|NCT01833546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775452|NCT01833546|Antiviral Agents|antiviral agents|mesh-ancestor
64775453|NCT01833546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64775454|NCT01833546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64775455|NCT01833546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64775456|NCT01833546|Immunologic Factors|immunologic factors|mesh-ancestor
64343658|NCT02480114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64775461|NCT01834404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64775462|NCT01834404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775463|NCT01834404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64775464|NCT01834404|Appetite Depressants|appetite depressants|mesh-ancestor
64775465|NCT01834404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64775467|NCT01834404|Autonomic Agents|autonomic agents|mesh-ancestor
64775468|NCT01834404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64775469|NCT01834404|Adrenergic Agents|adrenergic agents|mesh-ancestor
64775470|NCT01834404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64841666|NCT01652586|Analgesics|analgesics|mesh-ancestor
64841667|NCT01652586|Sensory System Agents|sensory system agents|mesh-ancestor
64841668|NCT01652586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64841669|NCT01652586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64841670|NCT01652586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64841671|NCT01652586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64841672|NCT01652586|Adrenergic Agents|adrenergic agents|mesh-ancestor
64841673|NCT01652586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64841674|NCT01652586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841675|NCT01652586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64841676|NCT01652586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64841677|NCT01652586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64841678|NCT01652586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64841679|NCT01652586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64841680|NCT01652586|Anesthetics, General|anesthetics, general|mesh-ancestor
64841681|NCT01652586|Anesthetics|anesthetics|mesh-ancestor
64841682|NCT01652586|GABA Modulators|gaba modulators|mesh-ancestor
64841683|NCT01652586|GABA Agents|gaba agents|mesh-ancestor
64841684|NCT01652586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64841685|NCT01652586|Narcotics|narcotics|mesh-ancestor
64841686|NCT01652599|Dexamethasone|dexamethasone|mesh-list
64775471|NCT01834404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775473|NCT01835262|Morphine|morphine|mesh-list
64775474|NCT01835262|Analgesics|analgesics|mesh-ancestor
64775475|NCT01835262|Sensory System Agents|sensory system agents|mesh-ancestor
64775476|NCT01835262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64775477|NCT01835262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775478|NCT01835262|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64544155|NCT04148599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64775480|NCT01835262|Anesthetics, General|anesthetics, general|mesh-ancestor
64326993|NCT04265534|Pemetrexed|pemetrexed|mesh-list
64326994|NCT04265534|Vitamins|vitamins|mesh-ancestor
64326995|NCT04265534|Micronutrients|micronutrients|mesh-ancestor
64841687|NCT01652599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64841688|NCT01652599|Antiemetics|antiemetics|mesh-ancestor
64841689|NCT01652599|Autonomic Agents|autonomic agents|mesh-ancestor
64841690|NCT01652599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64841691|NCT01652599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841692|NCT01652599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64841693|NCT01652599|Glucocorticoids|glucocorticoids|mesh-ancestor
64841694|NCT01652599|Hormones|hormones|mesh-ancestor
64841695|NCT01652599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64841696|NCT01652599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64841697|NCT01652599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841698|NCT01652638|Heparin|heparin|mesh-list
64841699|NCT01652638|Calcium heparin|calcium heparin|mesh-list
64841700|NCT01652638|Anticoagulants|anticoagulants|mesh-ancestor
64841701|NCT01652638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64841702|NCT01652638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64452649|NCT01984268|Hormones|hormones|mesh-ancestor
64775481|NCT01835262|Anesthetics|anesthetics|mesh-ancestor
64775482|NCT01835262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64775483|NCT01835262|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64775484|NCT01835262|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64775485|NCT01835262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64775486|NCT01835262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775487|NCT01835262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64775488|NCT01835262|Narcotics|narcotics|mesh-ancestor
64775489|NCT01835496|Deferiprone|deferiprone|mesh-list
64775490|NCT01835496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64775491|NCT01835496|Chelating Agents|chelating agents|mesh-ancestor
64841731|NCT01652820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841732|NCT01652820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64841733|NCT01652820|Immunologic Factors|immunologic factors|mesh-ancestor
64841734|NCT01652820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841735|NCT01652820|Tubulin Modulators|tubulin modulators|mesh-ancestor
64610222|NCT01838993|Lidocaine|lidocaine|mesh-list
64841736|NCT01652820|Antimitotic Agents|antimitotic agents|mesh-ancestor
64841737|NCT01652820|Mitosis Modulators|mitosis modulators|mesh-ancestor
64841738|NCT01652859|Amphotericin B|amphotericin b|mesh-list
64841739|NCT01652859|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64841740|NCT01652859|Amebicides|amebicides|mesh-ancestor
64841741|NCT01652859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64841742|NCT01652859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64841743|NCT01652859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64841744|NCT01652859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64841745|NCT01652859|Antifungal Agents|antifungal agents|mesh-ancestor
64841746|NCT01652898|Esmolol|esmolol|mesh-list
64841747|NCT01652898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64841748|NCT01652898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64841749|NCT01652898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64841750|NCT01652898|Adrenergic Agents|adrenergic agents|mesh-ancestor
64841751|NCT01652898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64841752|NCT01652898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775492|NCT01835496|Sequestering Agents|sequestering agents|mesh-ancestor
64775493|NCT01835496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775494|NCT01842594|Sirolimus|sirolimus|mesh-list
64775495|NCT01842594|Hydroxychloroquine|hydroxychloroquine|mesh-list
64775496|NCT01842594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64775497|NCT01842594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64775498|NCT01842594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64775499|NCT01842594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775500|NCT01842594|Antifungal Agents|antifungal agents|mesh-ancestor
64775501|NCT01842594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64775504|NCT01842594|Antimalarials|antimalarials|mesh-ancestor
64775515|NCT01843920|Dorzolamide|dorzolamide|mesh-list
64775516|NCT01843920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64775517|NCT01843920|Glucocorticoids|glucocorticoids|mesh-ancestor
64775518|NCT01843920|Hormones|hormones|mesh-ancestor
64775519|NCT01843920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64841772|NCT01653067|Immunologic Factors|immunologic factors|mesh-ancestor
64841773|NCT01653067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841774|NCT01653067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64841775|NCT01653067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64841776|NCT01653067|Antiemetics|antiemetics|mesh-ancestor
64775520|NCT01843920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775521|NCT01843920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64775522|NCT01843920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775523|NCT01843920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64775524|NCT01843920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64775525|NCT01843920|Adrenergic Agents|adrenergic agents|mesh-ancestor
64775526|NCT01843920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64775527|NCT01843920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775528|NCT01843920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64775529|NCT01843920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64775530|NCT01843920|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64775531|NCT01843920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64775532|NCT01843920|Renal Agents|renal agents|mesh-ancestor
64775533|NCT01843920|Antimalarials|antimalarials|mesh-ancestor
64841822|NCT01653236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64841823|NCT01653314|Imatinib Mesylate|imatinib mesylate|mesh-list
64841824|NCT01653314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841825|NCT01653314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64841826|NCT01653314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841827|NCT01653314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841828|NCT01653457|Memantine|memantine|mesh-list
64841829|NCT01653457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64841830|NCT01653457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64841831|NCT01653457|Dopamine Agents|dopamine agents|mesh-ancestor
64841832|NCT01653457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64327000|NCT04265534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64327001|NCT04265534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64327002|NCT04265534|Glucocorticoids|glucocorticoids|mesh-ancestor
64327003|NCT04265534|Hormones|hormones|mesh-ancestor
64841861|NCT01653470|Micronutrients|micronutrients|mesh-ancestor
64775534|NCT01843920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64775535|NCT01843920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64775536|NCT01843920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64775537|NCT01843920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64775538|NCT01843920|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64775539|NCT01843920|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64775540|NCT01843920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64775541|NCT01843920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64323665|NCT05498636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323666|NCT05498636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323667|NCT05498636|Immunologic Factors|immunologic factors|mesh-ancestor
64323668|NCT05498636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64323669|NCT05498636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64323670|NCT05498636|Growth Substances|growth substances|mesh-ancestor
64841862|NCT01653522|Doxycycline|doxycycline|mesh-list
64841863|NCT01653522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64841864|NCT01653522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64841865|NCT01653522|Antimalarials|antimalarials|mesh-ancestor
64841866|NCT01653522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64841867|NCT01653522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64841868|NCT01653561|Apatinib|apatinib|mesh-list
64841869|NCT01653561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841870|NCT01653561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64841871|NCT01653561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841872|NCT01653561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841873|NCT01653639|Factor VIII|factor viii|mesh-list
64841874|NCT01653639|Coagulants|coagulants|mesh-ancestor
64841875|NCT01653665|Sargramostim|sargramostim|mesh-list
64841876|NCT01653665|Immunologic Factors|immunologic factors|mesh-ancestor
64327007|NCT04265534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64327008|NCT04265534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327009|NCT04265534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327010|NCT04265534|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64841877|NCT01653665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841878|NCT01653717|Cyclophosphamide|cyclophosphamide|mesh-list
64841879|NCT01653717|Fludarabine|fludarabine|mesh-list
64841880|NCT01653717|Fludarabine phosphate|fludarabine phosphate|mesh-list
64323671|NCT05498636|Growth Inhibitors|growth inhibitors|mesh-ancestor
64323672|NCT02262715|Oseltamivir|oseltamivir|mesh-list
64323673|NCT02262715|Antiviral Agents|antiviral agents|mesh-ancestor
64323674|NCT02262715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64323675|NCT02262715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323676|NCT02262715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323677|NCT03137407|Botulinum Toxins|botulinum toxins|mesh-list
64323678|NCT03137407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64323680|NCT03137407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64323681|NCT03137407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64775542|NCT01843920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64775543|NCT01844388|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64775544|NCT01844388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64775545|NCT01844388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64775546|NCT01844388|Laxatives|laxatives|mesh-ancestor
64775547|NCT01844388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64775548|NCT01845636|Atropine|atropine|mesh-list
64775549|NCT01845636|Donepezil|donepezil|mesh-list
64775550|NCT01845636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64775551|NCT01845636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64775552|NCT01845636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64775553|NCT01845636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64544238|NCT04143451|Imiquimod|imiquimod|mesh-list
64775554|NCT01845636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841881|NCT01653717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64841882|NCT01653717|Immunologic Factors|immunologic factors|mesh-ancestor
64841884|NCT01653717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64775555|NCT01845636|Cholinergic Agents|cholinergic agents|mesh-ancestor
64775556|NCT01845636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64775557|NCT01845636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775558|NCT01845636|Nootropic Agents|nootropic agents|mesh-ancestor
64775559|NCT01845636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64775560|NCT01845636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64775561|NCT01845636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64775562|NCT01845636|Autonomic Agents|autonomic agents|mesh-ancestor
64775563|NCT01845636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64775564|NCT01845636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64775565|NCT01845636|Respiratory System Agents|respiratory system agents|mesh-ancestor
64775566|NCT01845636|Mydriatics|mydriatics|mesh-ancestor
64775567|NCT01845636|Parasympatholytics|parasympatholytics|mesh-ancestor
64775568|NCT01845636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64323682|NCT03137407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841930|NCT01654146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841931|NCT01654185|Letrozole|letrozole|mesh-list
64841932|NCT01654185|Exemestane|exemestane|mesh-list
64841933|NCT01654185|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64841934|NCT01654185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64841935|NCT01654185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64841936|NCT01654185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841937|NCT01654185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841938|NCT01654185|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64841939|NCT01654185|Hormone Antagonists|hormone antagonists|mesh-ancestor
64452866|NCT02029274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64841940|NCT01654185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64841941|NCT01654185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841942|NCT01654211|Ritonavir|ritonavir|mesh-list
64841943|NCT01654211|Lactams|lactams|mesh-list
64841944|NCT01654211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64841945|NCT01654211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64841946|NCT01654211|Protease Inhibitors|protease inhibitors|mesh-ancestor
64323683|NCT03137407|Cholinergic Agents|cholinergic agents|mesh-ancestor
64323684|NCT03137407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64323685|NCT03137407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323686|NCT03137407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64775569|NCT01845636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64775570|NCT01845792|Abiraterone Acetate|abiraterone acetate|mesh-list
64775571|NCT01845792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775590|NCT01848054|Analgesics|analgesics|mesh-ancestor
64775591|NCT01848054|Sensory System Agents|sensory system agents|mesh-ancestor
64775592|NCT01848054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64775593|NCT01848054|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64775594|NCT01849068|Ezetimibe|ezetimibe|mesh-list
64775595|NCT01849068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64775596|NCT01849068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64775597|NCT01849068|Antimetabolites|antimetabolites|mesh-ancestor
64775598|NCT01849068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775599|NCT01849068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64841969|NCT01654497|Autonomic Agents|autonomic agents|mesh-ancestor
64841970|NCT01654497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64841971|NCT01654497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841972|NCT01654497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64841973|NCT01654497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64841974|NCT01654497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64841976|NCT01654497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841977|NCT01654497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64841979|NCT01654562|Simvastatin|simvastatin|mesh-list
64841980|NCT01654562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64841981|NCT01654562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64841982|NCT01654562|Antimetabolites|antimetabolites|mesh-ancestor
64841983|NCT01654562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64841984|NCT01654562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64841985|NCT01654562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64841986|NCT01654562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64841987|NCT01654575|Methotrexate|methotrexate|mesh-list
64841988|NCT01654575|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64841989|NCT01654575|Abortifacient Agents|abortifacient agents|mesh-ancestor
64841990|NCT01654575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64841991|NCT01654575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64841992|NCT01654575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64841993|NCT01654575|Antimetabolites|antimetabolites|mesh-ancestor
64775600|NCT01849692|Ranibizumab|ranibizumab|mesh-list
64775601|NCT01849692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64775602|NCT01849692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64775603|NCT01849692|Growth Substances|growth substances|mesh-ancestor
64775604|NCT01849692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775605|NCT01849692|Growth Inhibitors|growth inhibitors|mesh-ancestor
64775606|NCT01849692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775607|NCT01849770|Mexiletine|mexiletine|mesh-list
64775608|NCT01849770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64775609|NCT01849770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64842004|NCT01654640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64775610|NCT01849770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64775611|NCT01849770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64775612|NCT01849770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775613|NCT01850394|Tranexamic Acid|tranexamic acid|mesh-list
64775614|NCT01850394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64775615|NCT01850394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64775616|NCT01850394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775617|NCT01850394|Hemostatics|hemostatics|mesh-ancestor
64775618|NCT01850394|Coagulants|coagulants|mesh-ancestor
64842077|NCT01655082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842078|NCT01655095|Prucalopride|prucalopride|mesh-list
64842079|NCT01655095|Bisacodyl|bisacodyl|mesh-list
64842080|NCT01655095|Laxatives|laxatives|mesh-ancestor
64842081|NCT01655095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64842082|NCT01655095|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64842083|NCT01655095|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64842084|NCT01655095|Serotonin Agents|serotonin agents|mesh-ancestor
64842085|NCT01655095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842086|NCT01655095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842087|NCT01655095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842088|NCT01655095|Cathartics|cathartics|mesh-ancestor
64842089|NCT01655108|Minoxidil|minoxidil|mesh-list
64842090|NCT01655108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64842091|NCT01655108|Vasodilator Agents|vasodilator agents|mesh-ancestor
64842092|NCT01655147|Rifampin|rifampin|mesh-list
64842093|NCT01655147|Abiraterone Acetate|abiraterone acetate|mesh-list
64842094|NCT01655147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842095|NCT01655147|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64842096|NCT01655147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842097|NCT01655147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842098|NCT01655147|Hormone Antagonists|hormone antagonists|mesh-ancestor
64842099|NCT01655147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64775619|NCT01852344|Methylphenidate|methylphenidate|mesh-list
64775620|NCT01852344|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64775650|NCT01861002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64775651|NCT01861002|Antimetabolites|antimetabolites|mesh-ancestor
64775652|NCT01861002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775653|NCT01861002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775654|NCT01861002|Dermatologic Agents|dermatologic agents|mesh-ancestor
64842118|NCT01655199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842119|NCT01655199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842120|NCT01655199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64842121|NCT01655199|Respiratory System Agents|respiratory system agents|mesh-ancestor
64842122|NCT01655199|Tocolytic Agents|tocolytic agents|mesh-ancestor
64842123|NCT01655199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64842124|NCT01655199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64842125|NCT01655199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64842126|NCT01655199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64842127|NCT01655199|Adrenergic Agents|adrenergic agents|mesh-ancestor
64842128|NCT01655199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842129|NCT01655199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842130|NCT01655199|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64842131|NCT01655199|Cholinergic Agents|cholinergic agents|mesh-ancestor
64842133|NCT01655212|Antiviral Agents|antiviral agents|mesh-ancestor
64842134|NCT01655212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64842135|NCT01655303|Propranolol|propranolol|mesh-list
64842136|NCT01655303|Metoprolol|metoprolol|mesh-list
64842137|NCT01655303|Verapamil|verapamil|mesh-list
64842138|NCT01655303|Diltiazem|diltiazem|mesh-list
64453072|NCT02007278|Immunologic Factors|immunologic factors|mesh-ancestor
64453073|NCT02007278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64327017|NCT00697099|Anticoagulants|anticoagulants|mesh-ancestor
64327018|NCT00697099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64327019|NCT00697099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64327020|NCT00697099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775655|NCT01861002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64775656|NCT01861002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64775657|NCT01861002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64775658|NCT01861002|Immunologic Factors|immunologic factors|mesh-ancestor
64775659|NCT01861002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64775660|NCT01861002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64775661|NCT01861002|Antiviral Agents|antiviral agents|mesh-ancestor
64775662|NCT01861002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64323692|NCT02588677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64323693|NCT02588677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323694|NCT02588677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323695|NCT02588677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64842139|NCT01655303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64842140|NCT01655303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64842141|NCT01655303|Adrenergic Agents|adrenergic agents|mesh-ancestor
64842142|NCT01655303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842143|NCT01655303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842144|NCT01655303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842145|NCT01655303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64842146|NCT01655303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64842147|NCT01655303|Vasodilator Agents|vasodilator agents|mesh-ancestor
64842148|NCT01655303|Sympatholytics|sympatholytics|mesh-ancestor
64842149|NCT01655303|Autonomic Agents|autonomic agents|mesh-ancestor
64842150|NCT01655303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842155|NCT01655316|Verapamil|verapamil|mesh-list
64323696|NCT02588677|Protective Agents|protective agents|mesh-ancestor
64323697|NCT05490680|Sildenafil Citrate|sildenafil citrate|mesh-list
64323698|NCT05490680|Vasodilator Agents|vasodilator agents|mesh-ancestor
64323699|NCT05490680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64775663|NCT01870596|Cytarabine|cytarabine|mesh-list
64775664|NCT01870596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64775665|NCT01870596|Antimetabolites|antimetabolites|mesh-ancestor
64775666|NCT01870596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775667|NCT01870596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775668|NCT01870596|Antiviral Agents|antiviral agents|mesh-ancestor
64775669|NCT01870596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64775670|NCT01870596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64775671|NCT01870596|Immunologic Factors|immunologic factors|mesh-ancestor
64775672|NCT01870596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775673|NCT01875510|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64775674|NCT01875510|SMOFlipid|smoflipid|mesh-list
64842222|NCT01655745|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64842223|NCT01655745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842225|NCT01655758|Bimatoprost|bimatoprost|mesh-list
64842226|NCT01655758|Travoprost|travoprost|mesh-list
64842227|NCT01655758|Dorzolamide|dorzolamide|mesh-list
64842228|NCT01655758|Latanoprost|latanoprost|mesh-list
64842229|NCT01655758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64842230|NCT01655758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64842231|NCT01655758|Adrenergic Agents|adrenergic agents|mesh-ancestor
64842232|NCT01655758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842233|NCT01655758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842234|NCT01655758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842235|NCT01655758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64453177|NCT01448824|Evacetrapib|evacetrapib|mesh-list
64327021|NCT02172131|Olodaterol|olodaterol|mesh-list
64327022|NCT02172131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64327023|NCT02172131|Autonomic Agents|autonomic agents|mesh-ancestor
64327024|NCT02172131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64327025|NCT02172131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327026|NCT02172131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64842244|NCT01655810|Vitamins|vitamins|mesh-list
64842245|NCT01655810|Calcium Carbonate|calcium carbonate|mesh-list
64842246|NCT01655810|Micronutrients|micronutrients|mesh-ancestor
64842247|NCT01655810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842248|NCT01655810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64842249|NCT01655810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64842250|NCT01655810|Antacids|antacids|mesh-ancestor
64842252|NCT01655810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64775675|NCT01875510|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64775676|NCT01875510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64775677|NCT01875510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64775678|NCT01876212|Dasatinib|dasatinib|mesh-list
64775679|NCT01876212|Vaccines|vaccines|mesh-list
64775680|NCT01876212|Immunologic Factors|immunologic factors|mesh-ancestor
64301483|NCT03077828|Isophosphamide mustard|isophosphamide mustard|mesh-list
64775713|NCT05328102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775714|NCT05328102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64775715|NCT05328102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64775716|NCT05328102|Growth Substances|growth substances|mesh-ancestor
64842255|NCT01655862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64842256|NCT01655862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64842257|NCT01655862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64842258|NCT01655862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842260|NCT01655862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842261|NCT01655862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842262|NCT01655862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64842263|NCT01655862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842264|NCT01655875|Plerixafor|plerixafor|mesh-list
64842265|NCT01655875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64842266|NCT01655875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64842267|NCT01655875|Antiviral Agents|antiviral agents|mesh-ancestor
64842268|NCT01655875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64842269|NCT01655888|Tremelimumab|tremelimumab|mesh-list
64842270|NCT01655888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842271|NCT01655914|Flumazenil|flumazenil|mesh-list
64842272|NCT01655914|Antidotes|antidotes|mesh-ancestor
64842273|NCT01655914|Protective Agents|protective agents|mesh-ancestor
64842274|NCT01655914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842275|NCT01655914|GABA Modulators|gaba modulators|mesh-ancestor
64842276|NCT01655914|GABA Agents|gaba agents|mesh-ancestor
64842277|NCT01655914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842278|NCT01655914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842279|NCT01655927|Tranexamic Acid|tranexamic acid|mesh-list
64842280|NCT01655927|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64842281|NCT01655927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64453208|NCT02005562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64327028|NCT05435768|Denosumab|denosumab|mesh-list
64327029|NCT05435768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64327030|NCT05435768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775717|NCT05328102|Growth Inhibitors|growth inhibitors|mesh-ancestor
64775718|NCT05328102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775719|NCT05327088|Dexmedetomidine|dexmedetomidine|mesh-list
64775721|NCT05327088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64775722|NCT05327088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64775723|NCT05327088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775724|NCT05327088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64775725|NCT05327088|Analgesics|analgesics|mesh-ancestor
64775726|NCT05327088|Sensory System Agents|sensory system agents|mesh-ancestor
64775727|NCT05327088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842283|NCT01655927|Hemostatics|hemostatics|mesh-ancestor
64842284|NCT01655927|Coagulants|coagulants|mesh-ancestor
64842285|NCT01655966|Vitamin D|vitamin d|mesh-list
64842286|NCT01655966|Interferons|interferons|mesh-list
64842287|NCT01655966|Ribavirin|ribavirin|mesh-list
64842288|NCT01655966|Vitamins|vitamins|mesh-ancestor
64842289|NCT01655966|Micronutrients|micronutrients|mesh-ancestor
64842290|NCT01655966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842291|NCT01655966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64842292|NCT01655966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842293|NCT01655966|Antiviral Agents|antiviral agents|mesh-ancestor
64842294|NCT01655966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64842295|NCT01655966|Antimetabolites|antimetabolites|mesh-ancestor
64842296|NCT01655966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842297|NCT01655992|Capecitabine|capecitabine|mesh-list
64842298|NCT01655992|Tegafur|tegafur|mesh-list
64842299|NCT01655992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64775728|NCT05327088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64775729|NCT05327088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64775730|NCT05327088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64775731|NCT05327088|Adrenergic Agents|adrenergic agents|mesh-ancestor
64775732|NCT05327088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64387207|NCT02376335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64323700|NCT05490680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64323701|NCT05490680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323702|NCT05490680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323703|NCT05490680|Urological Agents|urological agents|mesh-ancestor
64842333|NCT01656005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64610819|NCT01726829|Pancrelipase|pancrelipase|mesh-list
64842334|NCT01656005|Sympatholytics|sympatholytics|mesh-ancestor
64453260|NCT01447420|Antiviral Agents|antiviral agents|mesh-ancestor
64842336|NCT01656005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64842337|NCT01656005|Glucocorticoids|glucocorticoids|mesh-ancestor
64842338|NCT01656005|Hormones|hormones|mesh-ancestor
64842339|NCT01656005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64842340|NCT01656018|Rilpivirine|rilpivirine|mesh-list
64842341|NCT01656018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64842342|NCT01656018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64842343|NCT01656018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842344|NCT01656018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842345|NCT01656018|Antiviral Agents|antiviral agents|mesh-ancestor
64842346|NCT01656018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64842347|NCT01656018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64842348|NCT01656018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64453291|NCT01471054|Glucocorticoids|glucocorticoids|mesh-ancestor
64327034|NCT00835081|Cefadroxil|cefadroxil|mesh-list
64327035|NCT00835081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64327036|NCT00835081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64327037|NCT02543918|Ixekizumab|ixekizumab|mesh-list
64775733|NCT05327088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775734|NCT05327088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64775735|NCT05327088|Narcotics|narcotics|mesh-ancestor
64775736|NCT05290194|Capecitabine|capecitabine|mesh-list
64775737|NCT05290194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64775738|NCT05290194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64775739|NCT05290194|Antimetabolites|antimetabolites|mesh-ancestor
64775740|NCT05290194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775741|NCT05290194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775742|NCT05228574|Amiloride|amiloride|mesh-list
64775743|NCT05228574|Diuretics|diuretics|mesh-ancestor
64775744|NCT05228574|Natriuretic Agents|natriuretic agents|mesh-ancestor
64775751|NCT05228574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64775752|NCT04986072|Nitroprusside|nitroprusside|mesh-list
64775753|NCT04986072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64775754|NCT04986072|Vasodilator Agents|vasodilator agents|mesh-ancestor
64775755|NCT04986072|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64842350|NCT01656057|Metformin|metformin|mesh-list
64842351|NCT01656057|Cholecystokinin|cholecystokinin|mesh-list
64842352|NCT01656057|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
64842353|NCT01656057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64842354|NCT01656057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842355|NCT01656057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64842356|NCT01656057|Analgesics|analgesics|mesh-ancestor
64842357|NCT01656057|Sensory System Agents|sensory system agents|mesh-ancestor
64842358|NCT01656057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842359|NCT01656057|Antipyretics|antipyretics|mesh-ancestor
64842360|NCT01656057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64842361|NCT01656057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64842362|NCT01656057|Antimetabolites|antimetabolites|mesh-ancestor
64453304|NCT01978184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453308|NCT01978184|Antimalarials|antimalarials|mesh-ancestor
64843699|NCT01664260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843700|NCT01664260|Antidotes|antidotes|mesh-ancestor
64843701|NCT01664520|Dexmedetomidine|dexmedetomidine|mesh-list
64843702|NCT01664520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64843703|NCT01664520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64843704|NCT01664520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843705|NCT01664520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64843706|NCT01664520|Analgesics|analgesics|mesh-ancestor
64327351|NCT02169713|Urological Agents|urological agents|mesh-ancestor
64843711|NCT01664520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64843712|NCT01664520|Adrenergic Agents|adrenergic agents|mesh-ancestor
64843713|NCT01664520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64843714|NCT01664520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843715|NCT01664650|Genistein|genistein|mesh-list
64843716|NCT01664650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64843717|NCT01664650|Protective Agents|protective agents|mesh-ancestor
64843718|NCT01664650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843719|NCT01664650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843720|NCT01664650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64327352|NCT02169713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64327353|NCT02169713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64327354|NCT02169713|Cholinergic Agents|cholinergic agents|mesh-ancestor
64327355|NCT02169713|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64327356|NCT02169713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64327357|NCT02169713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64327358|NCT03980041|Nivolumab|nivolumab|mesh-list
64327359|NCT03980041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64294235|NCT01362296|Docetaxel|docetaxel|mesh-list
64843860|NCT01665378|Folic Acid|folic acid|mesh-list
64843861|NCT01665378|Vitamin B Complex|vitamin b complex|mesh-list
64775756|NCT04986072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775757|NCT04774068|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64775758|NCT04774068|Romidepsin|romidepsin|mesh-list
64775759|NCT04774068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64775760|NCT04774068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64775761|NCT04774068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775762|NCT04103034|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64775763|NCT04103034|Hemostatics|hemostatics|mesh-ancestor
64775764|NCT04103034|Coagulants|coagulants|mesh-ancestor
64775765|NCT04103034|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64775766|NCT04103034|Natriuretic Agents|natriuretic agents|mesh-ancestor
64327038|NCT02543918|Vaccines|vaccines|mesh-list
64327039|NCT02543918|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64327040|NCT02543918|Immunologic Factors|immunologic factors|mesh-ancestor
64842363|NCT01656057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842364|NCT01656057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64842365|NCT01656057|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64842366|NCT01656057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64842368|NCT01656070|Cholecalciferol|cholecalciferol|mesh-list
64842369|NCT01656070|Vitamins|vitamins|mesh-ancestor
64842370|NCT01656070|Micronutrients|micronutrients|mesh-ancestor
64842371|NCT01656070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842372|NCT01656070|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64842373|NCT01656070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64842374|NCT01656109|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64842375|NCT01656109|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64842376|NCT01656109|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64842377|NCT01656109|Protease Inhibitors|protease inhibitors|mesh-ancestor
64775767|NCT04103034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775768|NCT03776760|Sofosbuvir|sofosbuvir|mesh-list
64775769|NCT03776760|Antiviral Agents|antiviral agents|mesh-ancestor
64775770|NCT03776760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64775771|NCT03222570|Serotonin|serotonin|mesh-list
64775772|NCT03222570|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
64775773|NCT03222570|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64775774|NCT03222570|Serotonin Agents|serotonin agents|mesh-ancestor
64775775|NCT03222570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64775776|NCT03222570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775777|NCT03222570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775778|NCT03222570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64775779|NCT03222570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64775780|NCT03191526|Mogamulizumab|mogamulizumab|mesh-list
64775781|NCT03191526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775782|NCT02766582|Paclitaxel|paclitaxel|mesh-list
64775783|NCT02766582|Carboplatin|carboplatin|mesh-list
64775784|NCT02766582|Pembrolizumab|pembrolizumab|mesh-list
64775785|NCT02766582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64775786|NCT02766582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775787|NCT02766582|Tubulin Modulators|tubulin modulators|mesh-ancestor
64775788|NCT02766582|Antimitotic Agents|antimitotic agents|mesh-ancestor
64775789|NCT02766582|Mitosis Modulators|mitosis modulators|mesh-ancestor
64775790|NCT02766582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842378|NCT01656109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842379|NCT01656109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842380|NCT01656109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64842381|NCT01656109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64842382|NCT01656109|Antiviral Agents|antiviral agents|mesh-ancestor
64842383|NCT01656109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64842384|NCT01656122|Abacavir|abacavir|mesh-list
64842385|NCT01656122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64842386|NCT01656122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64842387|NCT01656122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842388|NCT01656122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842389|NCT01656122|Antiviral Agents|antiviral agents|mesh-ancestor
64327041|NCT02543918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327042|NCT02543918|Dermatologic Agents|dermatologic agents|mesh-ancestor
64327043|NCT03539003|Remifentanil|remifentanil|mesh-list
64327044|NCT03539003|Propofol|propofol|mesh-list
64775791|NCT02766582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64775792|NCT01643460|Ethanol|ethanol|mesh-list
64775793|NCT01643460|Paclitaxel|paclitaxel|mesh-list
64775805|NCT00954876|Capecitabine|capecitabine|mesh-list
64775807|NCT00954876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64775808|NCT00954876|Antimetabolites|antimetabolites|mesh-ancestor
64775809|NCT00954876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775810|NCT00954876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775811|NCT00954876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64775812|NCT05748366|Analgesics|analgesics|mesh-list
64775813|NCT05748366|Sensory System Agents|sensory system agents|mesh-ancestor
64775814|NCT05748366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301488|NCT03077828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64775815|NCT05748366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842390|NCT01656122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64775817|NCT05747352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64842391|NCT01656122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64842392|NCT01656122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64842393|NCT01656148|4-Aminopyridine|4-aminopyridine|mesh-list
64842394|NCT01656148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64842395|NCT01656148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64842396|NCT01656148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842397|NCT01656226|Sunscreening Agents|sunscreening agents|mesh-list
64842398|NCT01656226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64842399|NCT01656226|Protective Agents|protective agents|mesh-ancestor
64842400|NCT01656226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775818|NCT05747352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775819|NCT05714670|Curcumin|curcumin|mesh-list
64327045|NCT03539003|Sevoflurane|sevoflurane|mesh-list
64775820|NCT05714670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64775821|NCT05714670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64775822|NCT05714670|Analgesics|analgesics|mesh-ancestor
64775823|NCT05714670|Sensory System Agents|sensory system agents|mesh-ancestor
64775824|NCT05714670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64775825|NCT05714670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775826|NCT05714670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64775827|NCT05714670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64327046|NCT03539003|Desflurane|desflurane|mesh-list
64327047|NCT03539003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64842401|NCT01656226|Dermatologic Agents|dermatologic agents|mesh-ancestor
64842402|NCT01656330|Rivaroxaban|rivaroxaban|mesh-list
64842403|NCT01656330|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64842404|NCT01656330|Antithrombins|antithrombins|mesh-ancestor
64842405|NCT01656330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64842406|NCT01656330|Protease Inhibitors|protease inhibitors|mesh-ancestor
64842407|NCT01656330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842408|NCT01656330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842409|NCT01656330|Anticoagulants|anticoagulants|mesh-ancestor
64842410|NCT01656512|Vitamin D|vitamin d|mesh-list
64842411|NCT01656512|Diphosphonates|diphosphonates|mesh-list
64842412|NCT01656512|Calcium|calcium|mesh-list
64842413|NCT01656512|Vitamins|vitamins|mesh-ancestor
64842414|NCT01656512|Micronutrients|micronutrients|mesh-ancestor
64842415|NCT01656512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842416|NCT01656512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64842417|NCT01656512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64842418|NCT01656525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64842419|NCT01656525|Immunologic Factors|immunologic factors|mesh-ancestor
64842420|NCT01656525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842421|NCT01656538|Paclitaxel|paclitaxel|mesh-list
64842422|NCT01656538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64842423|NCT01656538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843862|NCT01665378|Micronutrients|micronutrients|mesh-list
64843863|NCT01665378|Trace Elements|trace elements|mesh-list
64843865|NCT01665378|Vitamins|vitamins|mesh-ancestor
64843866|NCT01665378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843867|NCT01665404|Fluvoxamine|fluvoxamine|mesh-list
64843868|NCT01665404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64843869|NCT01665404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64843870|NCT01665404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64843871|NCT01665404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843872|NCT01665404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64843873|NCT01665404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64327410|NCT03607539|Pemetrexed|pemetrexed|mesh-list
64327411|NCT03607539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327412|NCT03607539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327413|NCT03607539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775828|NCT05714670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775829|NCT05714670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64775830|NCT05714670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775831|NCT05712018|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
64775832|NCT05712018|Plasma Substitutes|plasma substitutes|mesh-ancestor
64775833|NCT05712018|Blood Substitutes|blood substitutes|mesh-ancestor
64775834|NCT05606718|Dapagliflozin|dapagliflozin|mesh-list
64775835|NCT05606718|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64842424|NCT01656538|Tubulin Modulators|tubulin modulators|mesh-ancestor
64842425|NCT01656538|Antimitotic Agents|antimitotic agents|mesh-ancestor
64842426|NCT01656538|Mitosis Modulators|mitosis modulators|mesh-ancestor
64842427|NCT01656538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842428|NCT01656616|Antidotes|antidotes|mesh-list
64842429|NCT01656616|Protective Agents|protective agents|mesh-ancestor
64842430|NCT01656616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842431|NCT01656642|Atezolizumab|atezolizumab|mesh-list
64842432|NCT01656642|Vemurafenib|vemurafenib|mesh-list
64842433|NCT01656642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842434|NCT01656642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64842435|NCT01656642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842436|NCT01656642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842437|NCT01656668|Theobromine|theobromine|mesh-list
64842438|NCT01656668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64842439|NCT01656668|Autonomic Agents|autonomic agents|mesh-ancestor
64842440|NCT01656668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842441|NCT01656668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842442|NCT01656668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64327048|NCT03539003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64327049|NCT03539003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327051|NCT03539003|Anesthetics, General|anesthetics, general|mesh-ancestor
64327052|NCT03539003|Anesthetics|anesthetics|mesh-ancestor
64327053|NCT03539003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64327054|NCT03539003|Narcotics|narcotics|mesh-ancestor
64842443|NCT01656668|Respiratory System Agents|respiratory system agents|mesh-ancestor
64842444|NCT01656668|Vasodilator Agents|vasodilator agents|mesh-ancestor
64842446|NCT01656720|Sympathomimetics|sympathomimetics|mesh-ancestor
64842447|NCT01656720|Autonomic Agents|autonomic agents|mesh-ancestor
64842448|NCT01656720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64775836|NCT05606718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775837|NCT05606718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64775838|NCT05606718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775839|NCT05505630|Midazolam|midazolam|mesh-list
64775840|NCT05505630|Ketamine|ketamine|mesh-list
64775841|NCT05505630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-list
64775842|NCT05505630|Anesthetics|anesthetics|mesh-list
64775843|NCT05505630|Analgesics|analgesics|mesh-ancestor
64775844|NCT05505630|Sensory System Agents|sensory system agents|mesh-ancestor
64775845|NCT05505630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64775846|NCT05505630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775847|NCT05505630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64842455|NCT01656720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842456|NCT01656720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842457|NCT01656798|Sildenafil Citrate|sildenafil citrate|mesh-list
64842458|NCT01656798|Citric Acid|citric acid|mesh-list
64842459|NCT01656798|Sodium Citrate|sodium citrate|mesh-list
64842460|NCT01656798|Anticoagulants|anticoagulants|mesh-ancestor
64430012|NCT04991597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842461|NCT01656798|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64842462|NCT01656798|Chelating Agents|chelating agents|mesh-ancestor
64842463|NCT01656798|Sequestering Agents|sequestering agents|mesh-ancestor
64842464|NCT01656798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842465|NCT01656798|Vasodilator Agents|vasodilator agents|mesh-ancestor
64842466|NCT01656798|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64842467|NCT01656798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64842468|NCT01656798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842469|NCT01656798|Urological Agents|urological agents|mesh-ancestor
64842470|NCT01656811|Albuterol|albuterol|mesh-list
64842471|NCT01656811|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64842472|NCT01656811|Autonomic Agents|autonomic agents|mesh-ancestor
64842473|NCT01656811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842474|NCT01656811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842475|NCT01656811|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64842476|NCT01656811|Respiratory System Agents|respiratory system agents|mesh-ancestor
64842477|NCT01656811|Tocolytic Agents|tocolytic agents|mesh-ancestor
64842478|NCT01656811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64842479|NCT01656811|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64453417|NCT02023112|Ritonavir|ritonavir|mesh-list
64327055|NCT03539003|Analgesics|analgesics|mesh-ancestor
64327056|NCT03539003|Sensory System Agents|sensory system agents|mesh-ancestor
64775848|NCT05505630|Anesthetics, General|anesthetics, general|mesh-ancestor
64775849|NCT05505630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64775850|NCT05505630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64775851|NCT05505630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64775852|NCT05505630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64775853|NCT05505630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775854|NCT05505630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64775855|NCT05505630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64775856|NCT05505630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64775857|NCT05505630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64775858|NCT05505630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64775860|NCT05505630|GABA Agents|gaba agents|mesh-ancestor
64775861|NCT05472948|Capecitabine|capecitabine|mesh-list
64775862|NCT05472948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64775863|NCT05472948|Antimetabolites|antimetabolites|mesh-ancestor
64775864|NCT05472948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775865|NCT05472948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775866|NCT05215470|Nivolumab|nivolumab|mesh-list
64775867|NCT05215470|Ipilimumab|ipilimumab|mesh-list
64775868|NCT05215470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64775869|NCT05215470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775870|NCT05215470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64775871|NCT05215470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775872|NCT05206500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64301489|NCT03077828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64301490|NCT03077828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64301491|NCT03077828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344639|NCT03529253|Antimetabolites|antimetabolites|mesh-ancestor
64323705|NCT04424420|Ibuprofen|ibuprofen|mesh-list
64323706|NCT04424420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64323707|NCT04424420|Analgesics|analgesics|mesh-ancestor
64775873|NCT05206500|Amoxicillin|amoxicillin|mesh-list
64775874|NCT05206500|Metronidazole|metronidazole|mesh-list
64775875|NCT05206500|Clindamycin|clindamycin|mesh-list
64775876|NCT05206500|Linezolid|linezolid|mesh-list
64327057|NCT03539003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64775877|NCT05206500|Tetracycline|tetracycline|mesh-list
64775878|NCT05206500|Penicillins|penicillins|mesh-list
64775879|NCT05206500|Ampicillin|ampicillin|mesh-list
64775880|NCT05206500|Fosfomycin|fosfomycin|mesh-list
64775881|NCT05206500|Nitrofurantoin|nitrofurantoin|mesh-list
64775882|NCT05206500|Cephalosporins|cephalosporins|mesh-list
64775883|NCT05206500|Fluoroquinolones|fluoroquinolones|mesh-list
64775884|NCT05206500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64327058|NCT03539003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64327059|NCT03539003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64327060|NCT00751231|Clopidogrel|clopidogrel|mesh-list
64842480|NCT01656811|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64842481|NCT01656811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64842482|NCT01656811|Adrenergic Agents|adrenergic agents|mesh-ancestor
64842483|NCT01656811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842484|NCT01656811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842485|NCT01656980|Carmustine|carmustine|mesh-list
64775885|NCT05206500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64775886|NCT05206500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64775887|NCT05206500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64775888|NCT05206500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64775889|NCT05206500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775890|NCT05206500|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64775891|NCT05206500|Renal Agents|renal agents|mesh-ancestor
64775892|NCT05206500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64775893|NCT05169372|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64775894|NCT05169372|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64842486|NCT01656980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64842487|NCT01656980|Alkylating Agents|alkylating agents|mesh-ancestor
64842488|NCT01656980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842489|NCT01656980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842490|NCT01657058|Dimenhydrinate|dimenhydrinate|mesh-list
64842491|NCT01657058|Antiemetics|antiemetics|mesh-ancestor
64842492|NCT01657058|Autonomic Agents|autonomic agents|mesh-ancestor
64842493|NCT01657058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842494|NCT01657058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842495|NCT01657058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64842496|NCT01657058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64842497|NCT01657058|Histamine Antagonists|histamine antagonists|mesh-ancestor
64842498|NCT01657058|Histamine Agents|histamine agents|mesh-ancestor
64842499|NCT01657058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842500|NCT01657058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842501|NCT01657071|Aspirin|aspirin|mesh-list
64842502|NCT01657071|Clopidogrel|clopidogrel|mesh-list
64842503|NCT01657071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64842504|NCT01657071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64842505|NCT01657071|Analgesics|analgesics|mesh-ancestor
64842506|NCT01657071|Sensory System Agents|sensory system agents|mesh-ancestor
64842507|NCT01657071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842508|NCT01657071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842509|NCT01657071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64842510|NCT01657071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64842511|NCT01657071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64842512|NCT01657071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64842515|NCT01657071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64775895|NCT05169372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775896|NCT05163522|Midazolam|midazolam|mesh-list
64387376|NCT03773237|SMOFlipid|smoflipid|mesh-list
64323708|NCT04424420|Sensory System Agents|sensory system agents|mesh-ancestor
64323709|NCT04424420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64323710|NCT04424420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327061|NCT00751231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64323711|NCT04424420|Antipyretics|antipyretics|mesh-ancestor
64323712|NCT04424420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64775897|NCT05163522|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64775898|NCT05163522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64775899|NCT05163522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64327062|NCT00751231|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64327063|NCT00751231|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64327064|NCT00751231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64327065|NCT00751231|Purinergic Agents|purinergic agents|mesh-ancestor
64327066|NCT00751231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64327067|NCT00751231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842520|NCT01657071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64842521|NCT01657071|Purinergic Agents|purinergic agents|mesh-ancestor
64842522|NCT01657071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842523|NCT01657110|Tea Tree Oil|tea tree oil|mesh-list
64842524|NCT01657110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64842525|NCT01657110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64842526|NCT01657136|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64842527|NCT01657136|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64842528|NCT01657136|Adrenergic Agents|adrenergic agents|mesh-ancestor
64775900|NCT05163522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775901|NCT05163522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64775902|NCT05163522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64775903|NCT05163522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64775904|NCT05163522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64775905|NCT05163522|Anesthetics, General|anesthetics, general|mesh-ancestor
64775906|NCT05163522|Anesthetics|anesthetics|mesh-ancestor
64775907|NCT05163522|GABA Modulators|gaba modulators|mesh-ancestor
64775908|NCT05163522|GABA Agents|gaba agents|mesh-ancestor
64775909|NCT05163522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64775910|NCT05163522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775912|NCT05151588|Fluorouracil|fluorouracil|mesh-list
64775913|NCT05151588|Cisplatin|cisplatin|mesh-list
64775914|NCT05151588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775915|NCT05151588|Tubulin Modulators|tubulin modulators|mesh-ancestor
64775916|NCT05151588|Antimitotic Agents|antimitotic agents|mesh-ancestor
64775918|NCT05151588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775919|NCT05151588|Antimetabolites|antimetabolites|mesh-ancestor
64775920|NCT05151588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64775921|NCT05151588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64775922|NCT05151588|Immunologic Factors|immunologic factors|mesh-ancestor
64544612|NCT03021421|Bupivacaine|bupivacaine|mesh-list
64775923|NCT05151588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775924|NCT04929834|Emollients|emollients|mesh-list
64775925|NCT04929834|Dermatologic Agents|dermatologic agents|mesh-ancestor
64775926|NCT04886232|Lidocaine|lidocaine|mesh-list
64775927|NCT04886232|Anesthetics, Local|anesthetics, local|mesh-ancestor
64775928|NCT04886232|Anesthetics|anesthetics|mesh-ancestor
64775929|NCT04886232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64327068|NCT00751231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327070|NCT02164565|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64327071|NCT02164565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64327072|NCT02164565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327073|NCT02164565|Hemostatics|hemostatics|mesh-ancestor
64327074|NCT02164565|Coagulants|coagulants|mesh-ancestor
64327075|NCT00750295|Ferric Compounds|ferric compounds|mesh-list
64842529|NCT01657136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842530|NCT01657136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842531|NCT01657136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842532|NCT01657201|Voriconazole|voriconazole|mesh-list
64842533|NCT01657201|Antifungal Agents|antifungal agents|mesh-ancestor
64842534|NCT01657201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64842535|NCT01657201|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64842536|NCT01657201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64842537|NCT01657201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64775930|NCT04886232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775931|NCT04886232|Sensory System Agents|sensory system agents|mesh-ancestor
64775932|NCT04886232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64775933|NCT04886232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64775934|NCT04886232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64775935|NCT04886232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64775936|NCT04886232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64775937|NCT04886232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775938|NCT04556838|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64775939|NCT04556838|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64775940|NCT04470804|Cyclosporine|cyclosporine|mesh-list
64775941|NCT04470804|Sirolimus|sirolimus|mesh-list
64775942|NCT04470804|Cyclosporins|cyclosporins|mesh-list
64775943|NCT04470804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64775944|NCT04470804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775945|NCT04470804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64775946|NCT04470804|Immunologic Factors|immunologic factors|mesh-ancestor
64775947|NCT04470804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775948|NCT04470804|Antifungal Agents|antifungal agents|mesh-ancestor
64775949|NCT04470804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64775950|NCT04470804|Dermatologic Agents|dermatologic agents|mesh-ancestor
64775951|NCT04470804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64775952|NCT04470804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64775953|NCT04470804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64775954|NCT04470804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64775955|NCT04470804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775956|NCT04418466|Risperidone|risperidone|mesh-list
64775957|NCT04418466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64775958|NCT04418466|Serotonin Agents|serotonin agents|mesh-ancestor
64842538|NCT01657201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842539|NCT01657201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64842540|NCT01657201|Hormone Antagonists|hormone antagonists|mesh-ancestor
64842541|NCT01657201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64842542|NCT01657201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775959|NCT04418466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64775960|NCT04418466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327077|NCT02172209|Empagliflozin|empagliflozin|mesh-list
64775961|NCT04418466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775962|NCT04418466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64775963|NCT04418466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64775964|NCT04418466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64775966|NCT04418466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64775967|NCT04418466|Dopamine Agents|dopamine agents|mesh-ancestor
64775968|NCT04360044|Dronabinol|dronabinol|mesh-list
64775969|NCT04360044|Cannabidiol|cannabidiol|mesh-list
64775970|NCT04360044|Anticonvulsants|anticonvulsants|mesh-ancestor
64775971|NCT04360044|Hallucinogens|hallucinogens|mesh-ancestor
64775972|NCT04360044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327078|NCT02172209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64327079|NCT02172209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327080|NCT02172209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64327081|NCT02172209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842574|NCT01657396|Disinfectants|disinfectants|mesh-ancestor
64842575|NCT01657409|Botulinum Toxins|botulinum toxins|mesh-list
64842576|NCT01657409|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64842577|NCT01657409|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64842578|NCT01657409|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64842579|NCT01657409|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64842580|NCT01657409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64842581|NCT01657409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842582|NCT01657409|Cholinergic Agents|cholinergic agents|mesh-ancestor
64775973|NCT04360044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64775974|NCT04360044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64775975|NCT04360044|Analgesics|analgesics|mesh-ancestor
64775976|NCT04360044|Sensory System Agents|sensory system agents|mesh-ancestor
64775977|NCT04360044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64775983|NCT04360044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64775984|NCT04337814|Ibuprofen|ibuprofen|mesh-list
64842583|NCT01657409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842584|NCT01657409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842585|NCT01657409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64842586|NCT01657409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842587|NCT01657448|Methenamine|methenamine|mesh-list
64775985|NCT04337814|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64775986|NCT04337814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64775987|NCT04337814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64775988|NCT04337814|Analgesics|analgesics|mesh-ancestor
64842588|NCT01657448|Methenamine hippurate|methenamine hippurate|mesh-list
64842589|NCT01657448|Methenamine mandelate|methenamine mandelate|mesh-list
64842590|NCT01657448|Methylene Blue|methylene blue|mesh-list
64842591|NCT01657448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64842592|NCT01657448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64842593|NCT01657448|Renal Agents|renal agents|mesh-ancestor
64842594|NCT01657448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64842595|NCT01657448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842596|NCT01657448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842597|NCT01657487|Fluticasone|fluticasone|mesh-list
64842599|NCT01657487|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64842600|NCT01657487|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64842601|NCT01657487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64842602|NCT01657487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64842603|NCT01657487|Autonomic Agents|autonomic agents|mesh-ancestor
64842604|NCT01657487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842605|NCT01657487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842606|NCT01657487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64842607|NCT01657487|Respiratory System Agents|respiratory system agents|mesh-ancestor
64842608|NCT01657487|Dermatologic Agents|dermatologic agents|mesh-ancestor
64382987|NCT04992065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64775989|NCT04337814|Sensory System Agents|sensory system agents|mesh-ancestor
64775990|NCT04337814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64775991|NCT04337814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64775992|NCT04337814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64775993|NCT04337814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64387459|NCT02365415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64775994|NCT04337814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64775995|NCT04337814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64775996|NCT04337814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64775997|NCT04337814|Anesthetics, Local|anesthetics, local|mesh-ancestor
64775998|NCT04337814|Anesthetics|anesthetics|mesh-ancestor
64775999|NCT04337814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64776000|NCT04337814|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64776001|NCT04336332|Azithromycin|azithromycin|mesh-list
64776002|NCT04336332|Hydroxychloroquine|hydroxychloroquine|mesh-list
64776003|NCT04336332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64776004|NCT04336332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64776005|NCT04336332|Antimalarials|antimalarials|mesh-ancestor
64776006|NCT04336332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64776007|NCT04336332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64776008|NCT04336332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776009|NCT04336332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776010|NCT04336332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64776011|NCT04318548|Vaccines|vaccines|mesh-list
64776012|NCT04318548|Immunologic Factors|immunologic factors|mesh-ancestor
64776013|NCT04318548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776014|NCT04230408|Paclitaxel|paclitaxel|mesh-list
64776015|NCT04230408|Carboplatin|carboplatin|mesh-list
64776016|NCT04230408|Durvalumab|durvalumab|mesh-list
64776017|NCT04230408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64776018|NCT04230408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776019|NCT04230408|Tubulin Modulators|tubulin modulators|mesh-ancestor
64776020|NCT04230408|Antimitotic Agents|antimitotic agents|mesh-ancestor
64776021|NCT04230408|Mitosis Modulators|mitosis modulators|mesh-ancestor
64776022|NCT04230408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776023|NCT04230408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64776024|NCT04205838|Vidarabine|vidarabine|mesh-list
64776025|NCT04205838|Cyclophosphamide|cyclophosphamide|mesh-list
64776026|NCT04205838|Fludarabine|fludarabine|mesh-list
64776027|NCT04205838|Fludarabine phosphate|fludarabine phosphate|mesh-list
64776029|NCT04205838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64842609|NCT01657487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64842610|NCT01657487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64842611|NCT01657487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64842612|NCT01657487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64327083|NCT02168543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64327084|NCT02168543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327086|NCT01372995|Ergocalciferols|ergocalciferols|mesh-list
64842613|NCT01657487|Adrenergic Agents|adrenergic agents|mesh-ancestor
64842614|NCT01657487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842615|NCT01657487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842616|NCT01657487|Glucocorticoids|glucocorticoids|mesh-ancestor
64842617|NCT01657487|Hormones|hormones|mesh-ancestor
64842618|NCT01657487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64842620|NCT01657578|Omeprazole|omeprazole|mesh-list
64776035|NCT04205838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776036|NCT04205838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776037|NCT04205838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64776038|NCT04205838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64776039|NCT04205838|Antimetabolites|antimetabolites|mesh-ancestor
64776040|NCT04205838|Antiviral Agents|antiviral agents|mesh-ancestor
64776041|NCT04205838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64776042|NCT03734016|Zanubrutinib|zanubrutinib|mesh-list
64345003|NCT04221035|Ifosfamide|ifosfamide|mesh-list
64776043|NCT03734016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776044|NCT03734016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64776045|NCT03734016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776046|NCT03734016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776047|NCT03064542|Carbimazole|carbimazole|mesh-list
64776048|NCT03064542|Antithyroid Agents|antithyroid agents|mesh-ancestor
64776049|NCT03064542|Hormone Antagonists|hormone antagonists|mesh-ancestor
64776050|NCT03064542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64776051|NCT03064542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776053|NCT02718066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64776054|NCT02718066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776055|NCT02718066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64776056|NCT02718066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776057|NCT02004522|Ofatumumab|ofatumumab|mesh-list
64776058|NCT02004522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776059|NCT02000622|Olaparib|olaparib|mesh-list
64776060|NCT02000622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64776061|NCT02000622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776062|NCT02000622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776063|NCT02000622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776064|NCT01724346|Chlorambucil|chlorambucil|mesh-list
64776065|NCT01724346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64776066|NCT01724346|Alkylating Agents|alkylating agents|mesh-ancestor
64776068|NCT01724346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776073|NCT01472562|Immunologic Factors|immunologic factors|mesh-ancestor
64776074|NCT01472562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776075|NCT01472562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64776076|NCT01472562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64776077|NCT01472562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64776079|NCT01472562|Growth Inhibitors|growth inhibitors|mesh-ancestor
64776080|NCT01430442|Sumatriptan|sumatriptan|mesh-list
64776081|NCT01430442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64776082|NCT01430442|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64776083|NCT01430442|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64776084|NCT01430442|Serotonin Agents|serotonin agents|mesh-ancestor
64776085|NCT01430442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64776086|NCT01430442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776087|NCT01430442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776089|NCT01420926|Decitabine|decitabine|mesh-list
64842669|NCT01657838|Ketoconazole|ketoconazole|mesh-list
64842670|NCT01657838|Isavuconazole|isavuconazole|mesh-list
64842671|NCT01657838|Antifungal Agents|antifungal agents|mesh-ancestor
64776090|NCT01420926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776091|NCT01420926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64776092|NCT01420926|Antimetabolites|antimetabolites|mesh-ancestor
64776093|NCT01420926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776094|NCT01420926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776095|NCT01881828|Metformin|metformin|mesh-list
64776096|NCT01881828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64776097|NCT01881828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776098|NCT01887132|Donepezil|donepezil|mesh-list
64323713|NCT04424420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64323714|NCT04424420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64323715|NCT04424420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64323716|NCT04424420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842672|NCT01657838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64842673|NCT01657838|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64842674|NCT01657838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64842675|NCT01657838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842676|NCT01657838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842677|NCT01657838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64842678|NCT01657838|Hormone Antagonists|hormone antagonists|mesh-ancestor
64842679|NCT01657838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64842680|NCT01657838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842681|NCT01657838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64842682|NCT01657851|Tamsulosin|tamsulosin|mesh-list
64842683|NCT01657851|Dutasteride|dutasteride|mesh-list
64842684|NCT01657851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64842685|NCT01657851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64842686|NCT01657851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64842687|NCT01657851|Adrenergic Agents|adrenergic agents|mesh-ancestor
64323717|NCT04424420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323718|NCT05495750|Bupivacaine|bupivacaine|mesh-list
64323719|NCT05495750|Anesthetics, Local|anesthetics, local|mesh-ancestor
64323720|NCT05495750|Anesthetics|anesthetics|mesh-ancestor
64323721|NCT05495750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64323722|NCT05495750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323723|NCT05495750|Sensory System Agents|sensory system agents|mesh-ancestor
64323724|NCT05495750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64323725|NCT02233075|Interferons|interferons|mesh-list
64323726|NCT02233075|Interferon-alpha|interferon-alpha|mesh-list
64323727|NCT02233075|Interferon alpha-2|interferon alpha-2|mesh-list
64323728|NCT02233075|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64323729|NCT02233075|REP 2139|rep 2139|mesh-list
64323730|NCT02233075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323731|NCT02233075|Antiviral Agents|antiviral agents|mesh-ancestor
64323732|NCT02233075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64776099|NCT01887132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64776100|NCT01887132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776101|NCT01887132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776102|NCT01887132|Cholinergic Agents|cholinergic agents|mesh-ancestor
64776103|NCT01887132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64776104|NCT01887132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776106|NCT01887990|Ketamine|ketamine|mesh-list
64776107|NCT01887990|Analgesics|analgesics|mesh-ancestor
64776108|NCT01887990|Sensory System Agents|sensory system agents|mesh-ancestor
64842688|NCT01657851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842689|NCT01657851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842690|NCT01657851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842691|NCT01657851|Urological Agents|urological agents|mesh-ancestor
64842692|NCT01657851|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64327088|NCT01372995|Vitamins|vitamins|mesh-list
64327089|NCT01372995|Micronutrients|micronutrients|mesh-ancestor
64327090|NCT01372995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327091|NCT01372995|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64842694|NCT01657851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842695|NCT01657851|Hormone Antagonists|hormone antagonists|mesh-ancestor
64842696|NCT01657851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64842697|NCT01657864|Lamotrigine|lamotrigine|mesh-list
64842698|NCT01657864|Anticonvulsants|anticonvulsants|mesh-ancestor
64842699|NCT01657864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64842700|NCT01657864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64776109|NCT01887990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776110|NCT01887990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776111|NCT01887990|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64776112|NCT01887990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64776113|NCT01887990|Anesthetics, General|anesthetics, general|mesh-ancestor
64776114|NCT01887990|Anesthetics|anesthetics|mesh-ancestor
64776115|NCT01887990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64776116|NCT01887990|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64776117|NCT01887990|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64776118|NCT01887990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64776119|NCT01887990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776120|NCT01890642|Lidocaine|lidocaine|mesh-list
64776121|NCT01890642|Anesthetics, Local|anesthetics, local|mesh-ancestor
64776122|NCT01890642|Anesthetics|anesthetics|mesh-ancestor
64776123|NCT01890642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64776124|NCT01890642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776146|NCT01904526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776147|NCT01904526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776148|NCT01906866|Melatonin|melatonin|mesh-list
64776149|NCT01906866|Antioxidants|antioxidants|mesh-ancestor
64776150|NCT01906866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776151|NCT01906866|Protective Agents|protective agents|mesh-ancestor
64776152|NCT01906866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776153|NCT01906866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64776154|NCT01907334|Fluticasone|fluticasone|mesh-list
64776155|NCT01907334|Xhance|xhance|mesh-list
64776156|NCT01907334|Albuterol|albuterol|mesh-list
64776157|NCT01907334|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64776158|NCT01907334|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64776159|NCT01907334|Methacholine Chloride|methacholine chloride|mesh-list
64776160|NCT01907334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64776161|NCT01907334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64776162|NCT01907334|Autonomic Agents|autonomic agents|mesh-ancestor
64776163|NCT01907334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776164|NCT01907334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776165|NCT01907334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64776166|NCT01907334|Respiratory System Agents|respiratory system agents|mesh-ancestor
64776167|NCT01907334|Dermatologic Agents|dermatologic agents|mesh-ancestor
64776168|NCT01907334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64776169|NCT01907334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64776170|NCT01907334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64776171|NCT01907334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64842701|NCT01657864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842702|NCT01657864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64776172|NCT01907334|Adrenergic Agents|adrenergic agents|mesh-ancestor
64776173|NCT01907334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64776174|NCT01907334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323733|NCT02233075|Immunologic Factors|immunologic factors|mesh-ancestor
64323734|NCT02233075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323735|NCT04300244|Nivolumab|nivolumab|mesh-list
64323736|NCT04300244|Ipilimumab|ipilimumab|mesh-list
64323737|NCT04300244|Sargramostim|sargramostim|mesh-list
64323738|NCT04300244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64323764|NCT02804035|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64323765|NCT02804035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64323766|NCT02804035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323767|NCT02262793|Telmisartan|telmisartan|mesh-list
64323768|NCT02262793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64323769|NCT02262793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64323770|NCT02262793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64776176|NCT01907334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64776177|NCT01907334|Glucocorticoids|glucocorticoids|mesh-ancestor
64776178|NCT01907334|Hormones|hormones|mesh-ancestor
64776182|NCT01907334|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64776183|NCT01907334|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
64776184|NCT01907334|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64776185|NCT01907334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64776186|NCT01907334|Cholinergic Agents|cholinergic agents|mesh-ancestor
64776187|NCT01907490|Benzyl Alcohol|benzyl alcohol|mesh-list
64776188|NCT01907490|Anesthetics, Local|anesthetics, local|mesh-ancestor
64776189|NCT01907490|Anesthetics|anesthetics|mesh-ancestor
64776190|NCT01907490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64776191|NCT01907490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327095|NCT04239859|Acitretin|acitretin|mesh-list
64327096|NCT04239859|Cyclosporins|cyclosporins|mesh-list
64776192|NCT01907490|Sensory System Agents|sensory system agents|mesh-ancestor
64776193|NCT01907490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842703|NCT01657864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842704|NCT01657864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64842705|NCT01657864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64842706|NCT01657864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64842707|NCT01657864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64842708|NCT01657864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64842709|NCT01657890|Isavuconazole|isavuconazole|mesh-list
64842710|NCT01657890|Antifungal Agents|antifungal agents|mesh-ancestor
64842711|NCT01657890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64842712|NCT01657929|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64842713|NCT01657929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64842714|NCT01657929|Immunologic Factors|immunologic factors|mesh-ancestor
64842715|NCT01657929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842716|NCT01657929|Antacids|antacids|mesh-ancestor
64842717|NCT01657929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842718|NCT01657929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64776194|NCT01908972|Prednisolone|prednisolone|mesh-list
64776195|NCT01908972|Propranolol|propranolol|mesh-list
64776196|NCT01908972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64776197|NCT01908972|Glucocorticoids|glucocorticoids|mesh-ancestor
64776198|NCT01908972|Hormones|hormones|mesh-ancestor
64776199|NCT01908972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64776200|NCT01908972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776201|NCT01908972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64776202|NCT01908972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776203|NCT01908972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64776204|NCT01908972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64323771|NCT02262793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323772|NCT02559206|Linaclotide|linaclotide|mesh-list
64842762|NCT01658033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64842763|NCT01658033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64842764|NCT01658033|Growth Substances|growth substances|mesh-ancestor
64842765|NCT01658033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842766|NCT01658033|Growth Inhibitors|growth inhibitors|mesh-ancestor
64842767|NCT01658033|Antidotes|antidotes|mesh-ancestor
64842768|NCT01658033|Protective Agents|protective agents|mesh-ancestor
64842769|NCT01658033|Vitamin B Complex|vitamin b complex|mesh-ancestor
64842770|NCT01658033|Vitamins|vitamins|mesh-ancestor
64842771|NCT01658033|Micronutrients|micronutrients|mesh-ancestor
64842772|NCT01658124|Tranexamic Acid|tranexamic acid|mesh-list
64842773|NCT01658124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64842774|NCT01658124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64383332|NCT02410499|Immunologic Factors|immunologic factors|mesh-ancestor
64383333|NCT02410499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383334|NCT05510505|Antibodies|antibodies|mesh-list
64383335|NCT05510505|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64383336|NCT05510505|Immunologic Factors|immunologic factors|mesh-ancestor
64383337|NCT05510505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383338|NCT04987775|Acetylcysteine|acetylcysteine|mesh-list
64383339|NCT04987775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64383340|NCT04987775|Antiviral Agents|antiviral agents|mesh-ancestor
64323773|NCT02559206|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64323774|NCT02559206|Enzyme Activators|enzyme activators|mesh-ancestor
64323775|NCT02559206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323776|NCT02559206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64323778|NCT05485766|Carboplatin|carboplatin|mesh-list
64323779|NCT05485766|Pembrolizumab|pembrolizumab|mesh-list
64323780|NCT05485766|Olaparib|olaparib|mesh-list
64323781|NCT05485766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64323783|NCT05485766|Tubulin Modulators|tubulin modulators|mesh-ancestor
64323784|NCT05485766|Antimitotic Agents|antimitotic agents|mesh-ancestor
64323785|NCT05485766|Mitosis Modulators|mitosis modulators|mesh-ancestor
64323786|NCT05485766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776205|NCT01908972|Adrenergic Agents|adrenergic agents|mesh-ancestor
64776206|NCT01908972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64776207|NCT01908972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776208|NCT01908972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64776209|NCT01908972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64842775|NCT01658124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842776|NCT01658124|Hemostatics|hemostatics|mesh-ancestor
64842777|NCT01658124|Coagulants|coagulants|mesh-ancestor
64842778|NCT01658176|Exemestane|exemestane|mesh-list
64842779|NCT01658176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842780|NCT01658176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64842781|NCT01658176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64842782|NCT01658176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842783|NCT01658176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842784|NCT01658176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64842785|NCT01658176|Hormone Antagonists|hormone antagonists|mesh-ancestor
64842786|NCT01658176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64842787|NCT01658176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327097|NCT04239859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64327098|NCT04239859|Abortifacient Agents|abortifacient agents|mesh-ancestor
64327099|NCT04239859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64327100|NCT04239859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327101|NCT04239859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64842788|NCT01658202|Nicotine|nicotine|mesh-list
64842789|NCT01658202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64842790|NCT01658202|Autonomic Agents|autonomic agents|mesh-ancestor
64842791|NCT01658202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64383435|NCT02409563|Budesonide|budesonide|mesh-list
64776210|NCT01908972|Vasodilator Agents|vasodilator agents|mesh-ancestor
64776211|NCT01910064|Adapalene|adapalene|mesh-list
64776212|NCT01910064|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64776213|NCT01910064|Dermatologic Agents|dermatologic agents|mesh-ancestor
64776214|NCT01910064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64776215|NCT01910064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64776216|NCT01910064|Analgesics|analgesics|mesh-ancestor
64776217|NCT01910064|Sensory System Agents|sensory system agents|mesh-ancestor
64776218|NCT01910064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776219|NCT01910064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776220|NCT01910064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64776221|NCT01910064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64776222|NCT01912716|Indomethacin|indomethacin|mesh-list
64776223|NCT01912716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64544905|NCT03583255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776224|NCT01912716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64842792|NCT01658202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776225|NCT01912716|Analgesics|analgesics|mesh-ancestor
64776226|NCT01912716|Sensory System Agents|sensory system agents|mesh-ancestor
64776227|NCT01912716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776228|NCT01912716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776229|NCT01912716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64776230|NCT01912716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64776231|NCT01912716|Gout Suppressants|gout suppressants|mesh-ancestor
64842793|NCT01658202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64842794|NCT01658202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64842795|NCT01658202|Cholinergic Agents|cholinergic agents|mesh-ancestor
64842796|NCT01658202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842797|NCT01658202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842798|NCT01658215|Nicotine|nicotine|mesh-list
64842799|NCT01658215|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64842800|NCT01658215|Autonomic Agents|autonomic agents|mesh-ancestor
64842801|NCT01658215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842802|NCT01658215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842803|NCT01658215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64842804|NCT01658215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64842805|NCT01658215|Cholinergic Agents|cholinergic agents|mesh-ancestor
64776232|NCT01912716|Tocolytic Agents|tocolytic agents|mesh-ancestor
64776233|NCT01912716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64776234|NCT01912716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64776235|NCT01912716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776246|NCT01920282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776247|NCT01921296|Cyclobenzaprine|cyclobenzaprine|mesh-list
64776248|NCT01921296|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64776249|NCT01921296|Antidepressive Agents|antidepressive agents|mesh-ancestor
64776250|NCT01921296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64776251|NCT01921296|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64776252|NCT01921296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776253|NCT01921296|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64776254|NCT01921296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776255|NCT01921296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64776256|NCT01921296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64776258|NCT01929642|Everolimus|everolimus|mesh-list
64776259|NCT01929642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776260|NCT01929642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64776261|NCT01929642|Immunologic Factors|immunologic factors|mesh-ancestor
64776262|NCT01929642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776263|NCT01929642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64776264|NCT01929642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64776265|NCT01929642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64776266|NCT01929642|Antifungal Agents|antifungal agents|mesh-ancestor
64776267|NCT01932060|Oxytocin|oxytocin|mesh-list
64776268|NCT01932060|Oxytocics|oxytocics|mesh-ancestor
64776269|NCT01932060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64776270|NCT01932060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323787|NCT05485766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64323788|NCT05485766|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64323789|NCT05485766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842822|NCT01658358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64842823|NCT01658358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64842824|NCT01658358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842825|NCT01658358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842826|NCT01658358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64842827|NCT01658410|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
64842828|NCT01658410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64842829|NCT01658410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64842830|NCT01658410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842831|NCT01658449|Hyaluronic Acid|hyaluronic acid|mesh-list
64842832|NCT01658449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64842833|NCT01658449|Immunologic Factors|immunologic factors|mesh-ancestor
64842834|NCT01658449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842835|NCT01658449|Viscosupplements|viscosupplements|mesh-ancestor
64842836|NCT01658449|Protective Agents|protective agents|mesh-ancestor
64842837|NCT01658462|Docetaxel|docetaxel|mesh-list
64842838|NCT01658462|Nintedanib|nintedanib|mesh-list
64842839|NCT01658462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327103|NCT04239859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323791|NCT04402723|Daunorubicin|daunorubicin|mesh-list
64323792|NCT04402723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64323793|NCT04402723|Antimetabolites|antimetabolites|mesh-ancestor
64323794|NCT04402723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323795|NCT04402723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323796|NCT04402723|Antiviral Agents|antiviral agents|mesh-ancestor
64323797|NCT04402723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64323799|NCT04402723|Immunologic Factors|immunologic factors|mesh-ancestor
64323800|NCT04402723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323801|NCT04402723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64323802|NCT04402723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64323803|NCT04402723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64323804|NCT04402723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323805|NCT02235337|Riboflavin|riboflavin|mesh-list
64323806|NCT02235337|Vitamins|vitamins|mesh-ancestor
64323807|NCT02235337|Micronutrients|micronutrients|mesh-ancestor
64323808|NCT02235337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323809|NCT02235337|Vitamin B Complex|vitamin b complex|mesh-ancestor
64776272|NCT01933464|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
64776273|NCT01933464|Immunologic Factors|immunologic factors|mesh-ancestor
64776274|NCT01933464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776275|NCT01933464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64776276|NCT01933464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64776277|NCT01933464|Respiratory System Agents|respiratory system agents|mesh-ancestor
64776278|NCT01933776|Vaccines|vaccines|mesh-list
64776279|NCT01933776|Immunologic Factors|immunologic factors|mesh-ancestor
64776280|NCT01933776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776281|NCT01936896|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64776282|NCT01936896|Protein C Inhibitor|protein c inhibitor|mesh-list
64776283|NCT01936896|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64842840|NCT01658462|Tubulin Modulators|tubulin modulators|mesh-ancestor
64842841|NCT01658462|Antimitotic Agents|antimitotic agents|mesh-ancestor
64842842|NCT01658462|Mitosis Modulators|mitosis modulators|mesh-ancestor
64842843|NCT01658462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842844|NCT01658462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64842845|NCT01658462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842846|NCT01658527|Bicalutamide|bicalutamide|mesh-list
64842847|NCT01658527|Androgen Antagonists|androgen antagonists|mesh-ancestor
64842848|NCT01658527|Hormone Antagonists|hormone antagonists|mesh-ancestor
64842849|NCT01658527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64842850|NCT01658527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842851|NCT01658527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842852|NCT01658553|Trametinib|trametinib|mesh-list
64842853|NCT01658553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842854|NCT01658553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64842855|NCT01658553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842856|NCT01658553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842857|NCT01658774|Albendazole|albendazole|mesh-list
64842858|NCT01658774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842859|NCT01658774|Anthelmintics|anthelmintics|mesh-ancestor
64842860|NCT01658774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64776284|NCT01936896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64776285|NCT01936896|Protease Inhibitors|protease inhibitors|mesh-ancestor
64776286|NCT01936896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776287|NCT01936896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776288|NCT01937598|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64776289|NCT01937598|Liraglutide|liraglutide|mesh-list
64776290|NCT01937598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64776291|NCT01937598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776292|NCT01937598|Incretins|incretins|mesh-ancestor
64776293|NCT01937598|Hormones|hormones|mesh-ancestor
64776294|NCT01937598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64776295|NCT01937598|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64776296|NCT01937598|Protease Inhibitors|protease inhibitors|mesh-ancestor
64776318|NCT01948518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776319|NCT01948518|Urological Agents|urological agents|mesh-ancestor
64776320|NCT01948986|Ertugliflozin|ertugliflozin|mesh-list
64776321|NCT01948986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64776322|NCT01948986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776323|NCT01948986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64776324|NCT01948986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776325|NCT01949844|Regadenoson|regadenoson|mesh-list
64776326|NCT01949844|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64776327|NCT01949844|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64776328|NCT01949844|Purinergic Agonists|purinergic agonists|mesh-ancestor
64842861|NCT01658774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64842862|NCT01658774|Anticestodal Agents|anticestodal agents|mesh-ancestor
64842863|NCT01658774|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64842864|NCT01658774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64842865|NCT01658774|Tubulin Modulators|tubulin modulators|mesh-ancestor
64842866|NCT01658774|Antimitotic Agents|antimitotic agents|mesh-ancestor
64842867|NCT01658774|Mitosis Modulators|mitosis modulators|mesh-ancestor
64842868|NCT01658774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842869|NCT01658852|Metronidazole|metronidazole|mesh-list
64842870|NCT01658852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64842871|NCT01658852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64327108|NCT04239859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64327109|NCT04239859|Immunologic Factors|immunologic factors|mesh-ancestor
64327110|NCT04239859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64327111|NCT04239859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64776329|NCT01949844|Purinergic Agents|purinergic agents|mesh-ancestor
64776330|NCT01949844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64776331|NCT01949844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776332|NCT01949844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776333|NCT01951950|Nicardipine|nicardipine|mesh-list
64776335|NCT01951950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64776336|NCT01951950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64776337|NCT01951950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64776338|NCT01951950|Adrenergic Agents|adrenergic agents|mesh-ancestor
64776339|NCT01951950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64776340|NCT01951950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842872|NCT01658852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64842873|NCT01658852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64842875|NCT01658878|Ipilimumab|ipilimumab|mesh-list
64842876|NCT01658878|Sorafenib|sorafenib|mesh-list
64842877|NCT01658878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64842878|NCT01658878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842879|NCT01658878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64842880|NCT01658878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842881|NCT01658878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64842882|NCT01658878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842883|NCT01658891|Beclomethasone|beclomethasone|mesh-list
64842884|NCT01658891|Formoterol Fumarate|formoterol fumarate|mesh-list
64842885|NCT01658891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64842886|NCT01658891|Autonomic Agents|autonomic agents|mesh-ancestor
64327112|NCT04239859|Antifungal Agents|antifungal agents|mesh-ancestor
64327113|NCT04239859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64327114|NCT04239859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64327115|NCT04239859|Keratolytic Agents|keratolytic agents|mesh-ancestor
64842887|NCT01658891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776341|NCT01951950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776342|NCT01951950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64776343|NCT01951950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64776344|NCT01951950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64776345|NCT01951950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64776346|NCT01951950|Vasodilator Agents|vasodilator agents|mesh-ancestor
64776360|NCT01955382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64776361|NCT01955382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64776362|NCT01955382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64776363|NCT01955382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776364|NCT01955382|Antiviral Agents|antiviral agents|mesh-ancestor
64776365|NCT01955382|Schistosomicides|schistosomicides|mesh-ancestor
64776366|NCT01955382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64776367|NCT01955382|Anthelmintics|anthelmintics|mesh-ancestor
64776368|NCT01955382|Antidotes|antidotes|mesh-ancestor
64776369|NCT01955382|Protective Agents|protective agents|mesh-ancestor
64776370|NCT01955382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776371|NCT01957410|Ketamine|ketamine|mesh-list
64776372|NCT01957410|Analgesics|analgesics|mesh-ancestor
64776373|NCT01957410|Sensory System Agents|sensory system agents|mesh-ancestor
64776374|NCT01957410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776375|NCT01957410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776376|NCT01957410|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64776377|NCT01957410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64776378|NCT01957410|Anesthetics, General|anesthetics, general|mesh-ancestor
64776379|NCT01957410|Anesthetics|anesthetics|mesh-ancestor
64842888|NCT01658891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842889|NCT01658891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64842890|NCT01658891|Respiratory System Agents|respiratory system agents|mesh-ancestor
64842891|NCT01658891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64842892|NCT01658891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64842893|NCT01658891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64842894|NCT01658891|Adrenergic Agents|adrenergic agents|mesh-ancestor
64842895|NCT01658891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842896|NCT01658891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842897|NCT01658891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64776380|NCT01957410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64776381|NCT01957410|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64776382|NCT01957410|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64776383|NCT01957410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64776384|NCT01957410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776385|NCT01958112|Trametinib|trametinib|mesh-list
64776386|NCT01958112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776387|NCT01958112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64776388|NCT01958112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776389|NCT01958112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776390|NCT05740098|Nicotine|nicotine|mesh-list
64842898|NCT01658891|Glucocorticoids|glucocorticoids|mesh-ancestor
64842899|NCT01658891|Hormones|hormones|mesh-ancestor
64842900|NCT01658891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64842901|NCT01659008|Estradiol|estradiol|mesh-list
64842902|NCT01659008|Estrogens|estrogens|mesh-ancestor
64842903|NCT01659008|Hormones|hormones|mesh-ancestor
64842904|NCT01659008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64842905|NCT01659008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842906|NCT01659047|Idelalisib|idelalisib|mesh-list
64842907|NCT01659047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842908|NCT01659047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842909|NCT01659047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842910|NCT01659086|Vaccines|vaccines|mesh-list
64842913|NCT01659099|Prednisone|prednisone|mesh-list
64776391|NCT05740098|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64776392|NCT05740098|Autonomic Agents|autonomic agents|mesh-ancestor
64776393|NCT05740098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776394|NCT05740098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776398|NCT05740098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64327116|NCT02938923|Testosterone|testosterone|mesh-list
64776399|NCT05740098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776401|NCT05739786|Cholecalciferol|cholecalciferol|mesh-list
64776402|NCT05739786|Vitamins|vitamins|mesh-ancestor
64776403|NCT05739786|Micronutrients|micronutrients|mesh-ancestor
64776404|NCT05739786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776405|NCT05739786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64776406|NCT05739786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64776408|NCT05739630|Cyclophosphamide|cyclophosphamide|mesh-list
64776409|NCT05739630|Busulfan|busulfan|mesh-list
64776410|NCT05739630|Fludarabine|fludarabine|mesh-list
64776411|NCT05739630|Mitoxantrone|mitoxantrone|mesh-list
64776412|NCT05739630|Tacrolimus|tacrolimus|mesh-list
64776413|NCT05739630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64776414|NCT05739630|Immunologic Factors|immunologic factors|mesh-ancestor
64327117|NCT02938923|Androgens|androgens|mesh-ancestor
64327118|NCT02938923|Hormones|hormones|mesh-ancestor
64327119|NCT02938923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64327120|NCT02938923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327121|NCT02757521|Nitrous Oxide|nitrous oxide|mesh-list
64842957|NCT01659242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842958|NCT01659242|Dermatologic Agents|dermatologic agents|mesh-ancestor
64842959|NCT01659242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64842960|NCT01659242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64842961|NCT01659242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64842962|NCT01659242|Immunologic Factors|immunologic factors|mesh-ancestor
64842963|NCT01659242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64842964|NCT01659242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64842965|NCT01659242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64842966|NCT01659242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64384119|NCT02093026|Vitamins|vitamins|mesh-ancestor
64776415|NCT05739630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776416|NCT05739630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64776417|NCT05739630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64776418|NCT05739630|Alkylating Agents|alkylating agents|mesh-ancestor
64776419|NCT05739630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776420|NCT05739630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776421|NCT05739630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64776422|NCT05739630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64776423|NCT05739630|Antimetabolites|antimetabolites|mesh-ancestor
64776424|NCT05739630|Antiviral Agents|antiviral agents|mesh-ancestor
64776447|NCT05738460|Antitubercular Agents|antitubercular agents|mesh-ancestor
64776449|NCT05738382|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64776450|NCT05738382|Fertility Agents|fertility agents|mesh-ancestor
64776451|NCT05738382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64842967|NCT01659242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64842968|NCT01659242|Analgesics|analgesics|mesh-ancestor
64842969|NCT01659242|Sensory System Agents|sensory system agents|mesh-ancestor
64842970|NCT01659242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64842971|NCT01659242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64842972|NCT01659242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64842973|NCT01659281|Artesunate|artesunate|mesh-list
64842974|NCT01659281|Mefloquine|mefloquine|mesh-list
64842975|NCT01659281|Antimalarials|antimalarials|mesh-ancestor
64842976|NCT01659281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64842977|NCT01659281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64842978|NCT01659281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64842979|NCT01659281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64842980|NCT01659281|Antiviral Agents|antiviral agents|mesh-ancestor
64842981|NCT01659281|Schistosomicides|schistosomicides|mesh-ancestor
64842982|NCT01659281|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64842983|NCT01659281|Anthelmintics|anthelmintics|mesh-ancestor
64842984|NCT01659346|Carvedilol|carvedilol|mesh-list
64842985|NCT01659346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64842986|NCT01659346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64842987|NCT01659346|Adrenergic Agents|adrenergic agents|mesh-ancestor
64842988|NCT01659346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64842989|NCT01659346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64842990|NCT01659346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64842991|NCT01659346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64776452|NCT05738382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776453|NCT05738382|Hormone Antagonists|hormone antagonists|mesh-ancestor
64776454|NCT05738382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64776455|NCT05737680|Hydroxychloroquine|hydroxychloroquine|mesh-list
64776457|NCT05737680|Antimalarials|antimalarials|mesh-ancestor
64776458|NCT05737680|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64776459|NCT05737680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64776460|NCT05737680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64776461|NCT05737680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776462|NCT05737680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776463|NCT05737680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64776464|NCT05737680|Gout Suppressants|gout suppressants|mesh-ancestor
64327126|NCT02757521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327127|NCT02757521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64327128|NCT02757521|Analgesics|analgesics|mesh-ancestor
64842992|NCT01659346|Antioxidants|antioxidants|mesh-ancestor
64842993|NCT01659346|Protective Agents|protective agents|mesh-ancestor
64842994|NCT01659346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64842995|NCT01659346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64842996|NCT01659346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64842997|NCT01659346|Vasodilator Agents|vasodilator agents|mesh-ancestor
64842998|NCT01659346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64842999|NCT01659346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64843000|NCT01659359|Lidocaine|lidocaine|mesh-list
64843001|NCT01659359|Anesthetics, Local|anesthetics, local|mesh-ancestor
64843002|NCT01659359|Anesthetics|anesthetics|mesh-ancestor
64843003|NCT01659359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64843004|NCT01659359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611496|NCT00939367|GABA Agents|gaba agents|mesh-ancestor
64843005|NCT01659359|Sensory System Agents|sensory system agents|mesh-ancestor
64843006|NCT01659359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843007|NCT01659359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64843008|NCT01659359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64843009|NCT01659359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64843010|NCT01659359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64843011|NCT01659359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843013|NCT01659372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64843014|NCT01659372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64843015|NCT01659372|Analgesics|analgesics|mesh-ancestor
64776465|NCT05737680|Tubulin Modulators|tubulin modulators|mesh-ancestor
64776466|NCT05737680|Antimitotic Agents|antimitotic agents|mesh-ancestor
64776467|NCT05737680|Mitosis Modulators|mitosis modulators|mesh-ancestor
64776468|NCT05737680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776469|NCT05736198|Dexmedetomidine|dexmedetomidine|mesh-list
64776470|NCT05736198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64776471|NCT05736198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64776472|NCT05736198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776473|NCT05736198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64776474|NCT05736198|Analgesics|analgesics|mesh-ancestor
64776475|NCT05736198|Sensory System Agents|sensory system agents|mesh-ancestor
64776476|NCT05736198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776492|NCT05733624|Immunologic Factors|immunologic factors|mesh-ancestor
64776493|NCT05733624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776494|NCT05733624|Antifungal Agents|antifungal agents|mesh-ancestor
64776495|NCT05733624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64843016|NCT01659372|Sensory System Agents|sensory system agents|mesh-ancestor
64843017|NCT01659372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843018|NCT01659372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843019|NCT01659372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64843020|NCT01659372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64843021|NCT01659372|Gout Suppressants|gout suppressants|mesh-ancestor
64843022|NCT01659372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64843023|NCT01659372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843024|NCT01659372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843025|NCT01659437|Clarithromycin|clarithromycin|mesh-list
64843026|NCT01659437|Streptomycin|streptomycin|mesh-list
64843027|NCT01659437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64843028|NCT01659437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64843029|NCT01659437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64843030|NCT01659437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843031|NCT01659437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843032|NCT01659437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64843033|NCT01659437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64843034|NCT01659476|Methacholine Chloride|methacholine chloride|mesh-list
64843036|NCT01659476|Autonomic Agents|autonomic agents|mesh-ancestor
64843037|NCT01659476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843038|NCT01659476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843039|NCT01659476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64843040|NCT01659476|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
64776496|NCT05733624|Dermatologic Agents|dermatologic agents|mesh-ancestor
64776497|NCT05733624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64776498|NCT05733624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64776499|NCT05733624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64776500|NCT05725200|Gemcitabine|gemcitabine|mesh-list
64776501|NCT05725200|Methotrexate|methotrexate|mesh-list
64776502|NCT05725200|Pembrolizumab|pembrolizumab|mesh-list
64776503|NCT05725200|Trastuzumab|trastuzumab|mesh-list
64776504|NCT05725200|Cetuximab|cetuximab|mesh-list
64776505|NCT05725200|Everolimus|everolimus|mesh-list
64776506|NCT05725200|Venetoclax|venetoclax|mesh-list
64776507|NCT05725200|Dasatinib|dasatinib|mesh-list
64776508|NCT05725200|Palbociclib|palbociclib|mesh-list
64776509|NCT05725200|Panobinostat|panobinostat|mesh-list
64776510|NCT05725200|Crizotinib|crizotinib|mesh-list
64776511|NCT05725200|Talazoparib|talazoparib|mesh-list
64776512|NCT05725200|Idelalisib|idelalisib|mesh-list
64776513|NCT05725200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64776514|NCT05725200|Antimetabolites|antimetabolites|mesh-ancestor
64776515|NCT05725200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776516|NCT05725200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776517|NCT05725200|Antiviral Agents|antiviral agents|mesh-ancestor
64776518|NCT05725200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64776519|NCT05725200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776520|NCT05725200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64776521|NCT05725200|Immunologic Factors|immunologic factors|mesh-ancestor
64843049|NCT01659619|Erythromycin|erythromycin|mesh-list
64843050|NCT01659619|Erythromycin Estolate|erythromycin estolate|mesh-list
64843051|NCT01659619|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64843052|NCT01659619|Erythromycin stearate|erythromycin stearate|mesh-list
64843053|NCT01659619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64843054|NCT01659619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64843055|NCT01659619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64843056|NCT01659619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64843057|NCT01659619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843058|NCT01659619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843059|NCT01659684|Immunoglobulins|immunoglobulins|mesh-list
64843060|NCT01659684|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64843061|NCT01659684|Antibodies|antibodies|mesh-list
64843062|NCT01659684|gamma-Globulins|gamma-globulins|mesh-list
64776522|NCT05725200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776523|NCT05725200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64776524|NCT05725200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64776525|NCT05725200|Abortifacient Agents|abortifacient agents|mesh-ancestor
64776526|NCT05725200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64776527|NCT05725200|Dermatologic Agents|dermatologic agents|mesh-ancestor
64776535|NCT05721144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64776537|NCT05721144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776538|NCT05721144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776539|NCT05721144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64776540|NCT05721144|Respiratory System Agents|respiratory system agents|mesh-ancestor
64776541|NCT05721144|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64776542|NCT05721144|Antioxidants|antioxidants|mesh-ancestor
64776543|NCT05721144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776544|NCT05721144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64776545|NCT05721144|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64327129|NCT02757521|Sensory System Agents|sensory system agents|mesh-ancestor
64327130|NCT02757521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64327131|NCT00744367|Metformin|metformin|mesh-list
64327132|NCT00744367|Pioglitazone|pioglitazone|mesh-list
64327133|NCT00744367|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64327134|NCT00744367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64327135|NCT00744367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843096|NCT01659892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64843097|NCT01659892|Respiratory System Agents|respiratory system agents|mesh-ancestor
64843098|NCT01659892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64843099|NCT01659892|Hormone Antagonists|hormone antagonists|mesh-ancestor
64843100|NCT01659892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64843101|NCT01659892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843102|NCT01659892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64843103|NCT01659892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64776546|NCT05721144|Vasodilator Agents|vasodilator agents|mesh-ancestor
64776547|NCT05721144|Gasotransmitters|gasotransmitters|mesh-ancestor
64776548|NCT05721144|Protective Agents|protective agents|mesh-ancestor
64776549|NCT05685732|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
64776550|NCT05685732|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64776551|NCT05685732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776552|NCT05685732|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64776553|NCT05685732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64776554|NCT05685732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64776555|NCT05685732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776556|NCT05685732|Dopamine Agents|dopamine agents|mesh-ancestor
64776557|NCT05685732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64327137|NCT00744367|Hormones|hormones|mesh-ancestor
64327138|NCT00744367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64327139|NCT02172287|Tiotropium Bromide|tiotropium bromide|mesh-list
64327140|NCT02172287|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64327141|NCT02172287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64327142|NCT02172287|Autonomic Agents|autonomic agents|mesh-ancestor
64327143|NCT02172287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64327144|NCT02172287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327145|NCT02172287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64327146|NCT02172287|Respiratory System Agents|respiratory system agents|mesh-ancestor
64327147|NCT02172287|Parasympatholytics|parasympatholytics|mesh-ancestor
64327148|NCT02172287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64327149|NCT02172287|Cholinergic Agents|cholinergic agents|mesh-ancestor
64327150|NCT02172287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64327151|NCT02172287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327152|NCT02172287|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64327153|NCT02172287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64327154|NCT02172287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64327155|NCT02172287|Adrenergic Agents|adrenergic agents|mesh-ancestor
64327156|NCT02261129|Telmisartan|telmisartan|mesh-list
64843104|NCT01659892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776558|NCT05664750|Immunoglobulins|immunoglobulins|mesh-list
64776559|NCT05664750|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64776560|NCT05664750|Antibodies|antibodies|mesh-list
64776561|NCT05664750|Immunologic Factors|immunologic factors|mesh-ancestor
64776562|NCT05664750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776563|NCT05650008|Anesthetics|anesthetics|mesh-list
64776564|NCT05650008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64776565|NCT05650008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776566|NCT05574894|Hormones|hormones|mesh-list
64776567|NCT05574894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64776569|NCT05567952|Ritonavir|ritonavir|mesh-list
64776571|NCT05567952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64776573|NCT05567952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776574|NCT05567952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776575|NCT05567952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64776576|NCT05567952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64776577|NCT05567952|Antiviral Agents|antiviral agents|mesh-ancestor
64776578|NCT05567952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64776579|NCT05567952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64776580|NCT05567952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64776581|NCT05530278|Midazolam|midazolam|mesh-list
64776582|NCT05530278|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64776583|NCT05530278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64776584|NCT05530278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64776585|NCT05530278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776586|NCT05530278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64776587|NCT05530278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64776588|NCT05530278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64776589|NCT05530278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64776590|NCT05530278|Anesthetics, General|anesthetics, general|mesh-ancestor
64776591|NCT05530278|Anesthetics|anesthetics|mesh-ancestor
64776592|NCT05530278|GABA Modulators|gaba modulators|mesh-ancestor
64776593|NCT05530278|GABA Agents|gaba agents|mesh-ancestor
64776594|NCT05530278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64776595|NCT05530278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776596|NCT05459298|Vitamin D|vitamin d|mesh-list
64776597|NCT05459298|Cholecalciferol|cholecalciferol|mesh-list
64776598|NCT05459298|Vitamins|vitamins|mesh-ancestor
64776599|NCT05459298|Micronutrients|micronutrients|mesh-ancestor
64776600|NCT05459298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776601|NCT05459298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64327162|NCT00694135|Dexamethasone acetate|dexamethasone acetate|mesh-list
64327163|NCT00694135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64327164|NCT00694135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64327165|NCT00694135|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64327166|NCT00694135|BB 1101|bb 1101|mesh-list
64327167|NCT00694135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64327168|NCT00694135|Antiemetics|antiemetics|mesh-ancestor
64327169|NCT00694135|Autonomic Agents|autonomic agents|mesh-ancestor
64327170|NCT00694135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64327171|NCT00694135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327172|NCT00694135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64327173|NCT00694135|Glucocorticoids|glucocorticoids|mesh-ancestor
64327174|NCT00694135|Hormones|hormones|mesh-ancestor
64327175|NCT00694135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64327176|NCT00694135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64327179|NCT00694135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327180|NCT00694135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776602|NCT05459298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64776603|NCT05436288|Hyaluronic Acid|hyaluronic acid|mesh-list
64776604|NCT05436288|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64776605|NCT05436288|Immunologic Factors|immunologic factors|mesh-ancestor
64776606|NCT05436288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776607|NCT05436288|Viscosupplements|viscosupplements|mesh-ancestor
64776608|NCT05436288|Protective Agents|protective agents|mesh-ancestor
64776609|NCT05312268|Rasburicase|rasburicase|mesh-list
64327181|NCT03540095|Bupivacaine|bupivacaine|mesh-list
64327182|NCT03540095|Anesthetics, Local|anesthetics, local|mesh-ancestor
64327183|NCT03540095|Anesthetics|anesthetics|mesh-ancestor
64327184|NCT03540095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64327185|NCT03540095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327186|NCT03540095|Sensory System Agents|sensory system agents|mesh-ancestor
64843117|NCT01659918|Respiratory System Agents|respiratory system agents|mesh-ancestor
64843118|NCT01659918|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64843119|NCT01659918|Hormone Antagonists|hormone antagonists|mesh-ancestor
64843120|NCT01659918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64843121|NCT01659918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843122|NCT01659918|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64843123|NCT01659918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64843124|NCT01659918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843125|NCT01659931|Montelukast|montelukast|mesh-list
64843126|NCT01659931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64843127|NCT01659931|Respiratory System Agents|respiratory system agents|mesh-ancestor
64843128|NCT01659931|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64843129|NCT01659931|Hormone Antagonists|hormone antagonists|mesh-ancestor
64843131|NCT01659931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776610|NCT05312268|Gout Suppressants|gout suppressants|mesh-ancestor
64776611|NCT05312268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64843146|NCT01659944|Adrenergic Agents|adrenergic agents|mesh-ancestor
64843147|NCT01659944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64776612|NCT05245734|Immunoglobulins|immunoglobulins|mesh-list
64776613|NCT05245734|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64776614|NCT05245734|Antibodies|antibodies|mesh-list
64776615|NCT05245734|gamma-Globulins|gamma-globulins|mesh-list
64776616|NCT05245734|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64776617|NCT05245734|Immunologic Factors|immunologic factors|mesh-ancestor
64776618|NCT05245734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776619|NCT05242692|Dexmedetomidine|dexmedetomidine|mesh-list
64776620|NCT05242692|Ketamine|ketamine|mesh-list
64776621|NCT05242692|Esketamine|esketamine|mesh-list
64776622|NCT05242692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64776623|NCT05242692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64776624|NCT05242692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776625|NCT05242692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64776626|NCT05242692|Analgesics|analgesics|mesh-ancestor
64776627|NCT05242692|Sensory System Agents|sensory system agents|mesh-ancestor
64843148|NCT01659944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843149|NCT01659944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843150|NCT01660295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64843151|NCT01660295|Dihydroergotamine|dihydroergotamine|mesh-list
64843152|NCT01660295|Certoparin|certoparin|mesh-list
64843153|NCT01660295|Anticoagulants|anticoagulants|mesh-ancestor
64843154|NCT01660295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64843155|NCT01660295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64843156|NCT01660295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843157|NCT01660295|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64843158|NCT01660295|Dopamine Agonists|dopamine agonists|mesh-ancestor
64843159|NCT01660295|Dopamine Agents|dopamine agents|mesh-ancestor
64843160|NCT01660295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64776628|NCT05242692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776629|NCT05242692|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64776630|NCT05242692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64776631|NCT05242692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64776632|NCT05242692|Adrenergic Agents|adrenergic agents|mesh-ancestor
64776633|NCT05242692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64776634|NCT05242692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776635|NCT05242692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64776636|NCT05242692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64776649|NCT05087940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776650|NCT05087940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64776651|NCT05087940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776652|NCT04964934|Letrozole|letrozole|mesh-list
64776653|NCT04964934|Palbociclib|palbociclib|mesh-list
64776654|NCT04964934|Anastrozole|anastrozole|mesh-list
64776655|NCT04964934|Hormones|hormones|mesh-list
64776656|NCT04964934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64327217|NCT02172443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64327218|NCT02172443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327219|NCT02172443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64327220|NCT02172443|Respiratory System Agents|respiratory system agents|mesh-ancestor
64327221|NCT02172443|Parasympatholytics|parasympatholytics|mesh-ancestor
64327222|NCT02172443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64327223|NCT02172443|Cholinergic Agents|cholinergic agents|mesh-ancestor
64327224|NCT02172443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64843191|NCT01660386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64843192|NCT01660386|Immunologic Factors|immunologic factors|mesh-ancestor
64843193|NCT01660399|Docetaxel|docetaxel|mesh-list
64843194|NCT01660399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843195|NCT01660399|Tubulin Modulators|tubulin modulators|mesh-ancestor
64843196|NCT01660399|Antimitotic Agents|antimitotic agents|mesh-ancestor
64843197|NCT01660399|Mitosis Modulators|mitosis modulators|mesh-ancestor
64843198|NCT01660399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843199|NCT01660477|Ritonavir|ritonavir|mesh-list
64843200|NCT01660477|Lopinavir|lopinavir|mesh-list
64843201|NCT01660477|Isavuconazole|isavuconazole|mesh-list
64843202|NCT01660477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64294189|NCT03833323|Treprostinil|treprostinil|mesh-list
64776657|NCT04964934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64776658|NCT04964934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776659|NCT04964934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776660|NCT04964934|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64776661|NCT04964934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64776662|NCT04964934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776663|NCT04964934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776664|NCT04964934|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64327225|NCT02172443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327227|NCT00834613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64327228|NCT00834613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327229|NCT02172521|Bromides|bromides|mesh-list
64843203|NCT01660477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64843204|NCT01660477|Protease Inhibitors|protease inhibitors|mesh-ancestor
64843205|NCT01660477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843206|NCT01660477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843208|NCT01660477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64843209|NCT01660477|Antiviral Agents|antiviral agents|mesh-ancestor
64843210|NCT01660477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64843211|NCT01660477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64843212|NCT01660477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64843213|NCT01660477|Antifungal Agents|antifungal agents|mesh-ancestor
64843214|NCT01660542|Docetaxel|docetaxel|mesh-list
64843215|NCT01660542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843216|NCT01660542|Tubulin Modulators|tubulin modulators|mesh-ancestor
64843217|NCT01660542|Antimitotic Agents|antimitotic agents|mesh-ancestor
64843218|NCT01660542|Mitosis Modulators|mitosis modulators|mesh-ancestor
64843219|NCT01660542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843220|NCT01660594|Calcium|calcium|mesh-list
64843221|NCT01660594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64843222|NCT01660594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843223|NCT01660620|Betaxolol|betaxolol|mesh-list
64843224|NCT01660620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64843225|NCT01660620|Sympatholytics|sympatholytics|mesh-ancestor
64843226|NCT01660620|Autonomic Agents|autonomic agents|mesh-ancestor
64843227|NCT01660620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843228|NCT01660620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776665|NCT04964934|Hormone Antagonists|hormone antagonists|mesh-ancestor
64776666|NCT04964934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64776667|NCT04964934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64776668|NCT04922658|Vinorelbine|vinorelbine|mesh-list
64776669|NCT04922658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64776670|NCT04922658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776671|NCT04922658|Tubulin Modulators|tubulin modulators|mesh-ancestor
64776672|NCT04922658|Antimitotic Agents|antimitotic agents|mesh-ancestor
64776673|NCT04922658|Mitosis Modulators|mitosis modulators|mesh-ancestor
64776674|NCT04922658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776676|NCT04883346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64776677|NCT04883346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776678|NCT04883346|Incretins|incretins|mesh-ancestor
64776705|NCT04764942|Dermatologic Agents|dermatologic agents|mesh-ancestor
64843229|NCT01660620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64843231|NCT01660620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64843232|NCT01660620|Adrenergic Agents|adrenergic agents|mesh-ancestor
64843233|NCT01660620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64843234|NCT01660620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843235|NCT01660750|Dexamethasone|dexamethasone|mesh-list
64843236|NCT01660750|Cyclophosphamide|cyclophosphamide|mesh-list
64843237|NCT01660750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64843238|NCT01660750|Immunologic Factors|immunologic factors|mesh-ancestor
64843239|NCT01660750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843240|NCT01660750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64843241|NCT01660750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64776707|NCT04544436|Ocrelizumab|ocrelizumab|mesh-list
64776708|NCT04544436|Histamine Antagonists|histamine antagonists|mesh-list
64776709|NCT04544436|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
64776710|NCT04544436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64776711|NCT04544436|Antiemetics|antiemetics|mesh-ancestor
64776712|NCT04544436|Autonomic Agents|autonomic agents|mesh-ancestor
64776713|NCT04544436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776714|NCT04544436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776715|NCT04544436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64776716|NCT04544436|Glucocorticoids|glucocorticoids|mesh-ancestor
64776717|NCT04544436|Hormones|hormones|mesh-ancestor
64776718|NCT04544436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64776719|NCT04544436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64776729|NCT04538742|Tucatinib|tucatinib|mesh-list
64776730|NCT04538742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64776731|NCT04538742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776732|NCT04538742|Tubulin Modulators|tubulin modulators|mesh-ancestor
64776733|NCT04538742|Antimitotic Agents|antimitotic agents|mesh-ancestor
64776734|NCT04538742|Mitosis Modulators|mitosis modulators|mesh-ancestor
64843290|NCT01660997|Ixazomib|ixazomib|mesh-list
64843291|NCT01660997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64843292|NCT01660997|Antiemetics|antiemetics|mesh-ancestor
64843293|NCT01660997|Autonomic Agents|autonomic agents|mesh-ancestor
64843294|NCT01660997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843295|NCT01660997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843296|NCT01660997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64843297|NCT01660997|Glucocorticoids|glucocorticoids|mesh-ancestor
64843298|NCT01660997|Hormones|hormones|mesh-ancestor
64945453|NCT05619627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64611801|NCT03317899|Lenograstim|lenograstim|mesh-list
64843299|NCT01660997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64843300|NCT01660997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64843301|NCT01660997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843302|NCT01660997|Protease Inhibitors|protease inhibitors|mesh-ancestor
64843303|NCT01660997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843304|NCT01660997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843305|NCT01661101|Omeprazole|omeprazole|mesh-list
64843306|NCT01661101|Dabigatran|dabigatran|mesh-list
64327230|NCT02172521|Tiotropium Bromide|tiotropium bromide|mesh-list
64327231|NCT02172521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64327232|NCT02172521|Autonomic Agents|autonomic agents|mesh-ancestor
64327233|NCT02172521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64327234|NCT02172521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327414|NCT03607539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64843903|NCT01664507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64843904|NCT01664507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64843905|NCT01664507|Adrenergic Agents|adrenergic agents|mesh-ancestor
64843906|NCT01664507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64843907|NCT01664507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843908|NCT01664507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843909|NCT01664507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64776735|NCT04538742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776736|NCT04538742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64776737|NCT04538742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64776744|NCT04346394|Yohimbine|yohimbine|mesh-list
64776749|NCT04346394|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64776751|NCT04346394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64776752|NCT04346394|Adrenergic Agents|adrenergic agents|mesh-ancestor
64776753|NCT04346394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64327235|NCT02172521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64327236|NCT02172521|Respiratory System Agents|respiratory system agents|mesh-ancestor
64327237|NCT02172521|Parasympatholytics|parasympatholytics|mesh-ancestor
64327238|NCT02172521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64327239|NCT02172521|Cholinergic Agents|cholinergic agents|mesh-ancestor
64327240|NCT02172521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64327241|NCT02172521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327242|NCT02172521|Anticonvulsants|anticonvulsants|mesh-ancestor
64327243|NCT00834535|Cefdinir|cefdinir|mesh-list
64843311|NCT01661101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843312|NCT01661101|Antithrombins|antithrombins|mesh-ancestor
64843313|NCT01661101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64843314|NCT01661101|Protease Inhibitors|protease inhibitors|mesh-ancestor
64843315|NCT01661101|Anticoagulants|anticoagulants|mesh-ancestor
64843316|NCT01661192|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64843317|NCT01661192|Protein C Inhibitor|protein c inhibitor|mesh-list
64327245|NCT00834535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64327246|NCT00691717|Hydrocortisone|hydrocortisone|mesh-list
64327247|NCT00691717|Anecortave|anecortave|mesh-list
64385378|NCT05745233|Pembrolizumab|pembrolizumab|mesh-list
64776754|NCT04346394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776755|NCT04346394|Urological Agents|urological agents|mesh-ancestor
64776756|NCT04329390|Anticoagulants|anticoagulants|mesh-list
64776757|NCT04177602|Trifluridine|trifluridine|mesh-list
64776758|NCT04177602|Capecitabine|capecitabine|mesh-list
64776759|NCT04177602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64776760|NCT04177602|Antimetabolites|antimetabolites|mesh-ancestor
64776761|NCT04177602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776762|NCT04177602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776763|NCT04177602|Antiviral Agents|antiviral agents|mesh-ancestor
64776764|NCT04177602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64327248|NCT00691717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64327249|NCT00691717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64327250|NCT00691717|Growth Substances|growth substances|mesh-ancestor
64327251|NCT00691717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327252|NCT00691717|Growth Inhibitors|growth inhibitors|mesh-ancestor
64327253|NCT00691717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327254|NCT00691717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64327255|NCT00834067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64843318|NCT01661192|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64843319|NCT01661192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64843320|NCT01661192|Protease Inhibitors|protease inhibitors|mesh-ancestor
64843321|NCT01661192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843322|NCT01661192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843324|NCT01661257|Dermatologic Agents|dermatologic agents|mesh-ancestor
64843325|NCT01661257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64843326|NCT01661257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64843327|NCT01661296|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
64843328|NCT01661296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64843329|NCT01661296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64843330|NCT01661296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64843331|NCT01661296|Schistosomicides|schistosomicides|mesh-ancestor
64843332|NCT01661296|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64327256|NCT00834067|Moexipril|moexipril|mesh-list
64327257|NCT00834067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64327258|NCT00834067|Diuretics|diuretics|mesh-ancestor
64327259|NCT00834067|Natriuretic Agents|natriuretic agents|mesh-ancestor
64776765|NCT04158258|Bevacizumab|bevacizumab|mesh-list
64776766|NCT04158258|Trastuzumab|trastuzumab|mesh-list
64776767|NCT04158258|Pertuzumab|pertuzumab|mesh-list
64776768|NCT04158258|Capecitabine|capecitabine|mesh-list
64776769|NCT04158258|Atezolizumab|atezolizumab|mesh-list
64776770|NCT04158258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64323810|NCT02235337|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64323811|NCT02235337|Dermatologic Agents|dermatologic agents|mesh-ancestor
64323812|NCT02233231|Varenicline|varenicline|mesh-list
64323813|NCT02233231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64323814|NCT02233231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64323815|NCT02233231|Cholinergic Agents|cholinergic agents|mesh-ancestor
64323816|NCT02233231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64323817|NCT02233231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323818|NCT02233231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323820|NCT02263027|Immunologic Factors|immunologic factors|mesh-ancestor
64323821|NCT02263027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323822|NCT02263105|Temozolomide|temozolomide|mesh-list
64327260|NCT00834067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327261|NCT00834067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64327262|NCT00834067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64327263|NCT00834067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843334|NCT01661309|Vitamin B 12|vitamin b 12|mesh-list
64843335|NCT01661309|Vitamins|vitamins|mesh-ancestor
64843336|NCT01661309|Micronutrients|micronutrients|mesh-ancestor
64843337|NCT01661309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843338|NCT01661309|Vitamin B Complex|vitamin b complex|mesh-ancestor
64843339|NCT01661322|Aspirin|aspirin|mesh-list
64843340|NCT01661322|Clopidogrel|clopidogrel|mesh-list
64843341|NCT01661322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64843342|NCT01661322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64843343|NCT01661322|Analgesics|analgesics|mesh-ancestor
64843344|NCT01661322|Sensory System Agents|sensory system agents|mesh-ancestor
64843345|NCT01661322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843346|NCT01661322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843347|NCT01661322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64843348|NCT01661322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64843349|NCT01661322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64843350|NCT01661322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64843351|NCT01661322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843352|NCT01661322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64843353|NCT01661322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64843354|NCT01661322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843355|NCT01661322|Antipyretics|antipyretics|mesh-ancestor
64843356|NCT01661322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64843357|NCT01661322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64323823|NCT02263105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64323824|NCT02263105|Alkylating Agents|alkylating agents|mesh-ancestor
64323825|NCT02263105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323826|NCT02263105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323827|NCT05485064|Fentanyl|fentanyl|mesh-list
64323828|NCT05485064|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64323829|NCT05485064|Narcotics|narcotics|mesh-ancestor
64323846|NCT02235415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64843358|NCT01661322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64843359|NCT01661322|Purinergic Agents|purinergic agents|mesh-ancestor
64843360|NCT01661322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64843361|NCT01661335|Dexamethasone|dexamethasone|mesh-list
64843362|NCT01661335|Dexamethasone acetate|dexamethasone acetate|mesh-list
64843363|NCT01661335|Ondansetron|ondansetron|mesh-list
64843364|NCT01661335|Aprepitant|aprepitant|mesh-list
64843365|NCT01661335|Fosaprepitant|fosaprepitant|mesh-list
64843366|NCT01661335|BB 1101|bb 1101|mesh-list
64843367|NCT01661335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64323847|NCT02235415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64323848|NCT02235415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64323849|NCT02235415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323850|NCT02235415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64323851|NCT02235415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323853|NCT03995017|Ramucirumab|ramucirumab|mesh-list
64323854|NCT03995017|Rucaparib|rucaparib|mesh-list
64323855|NCT03995017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64323856|NCT03995017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323857|NCT03995017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64323858|NCT03995017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843416|NCT01661556|Hormone Antagonists|hormone antagonists|mesh-ancestor
64843417|NCT01661556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64843418|NCT01661556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843419|NCT01661556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64843420|NCT01661556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64843421|NCT01661556|Antioxidants|antioxidants|mesh-ancestor
64843422|NCT01661556|Protective Agents|protective agents|mesh-ancestor
64843423|NCT01661556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64843424|NCT01661751|Vaccines|vaccines|mesh-list
64843425|NCT01661751|Immunologic Factors|immunologic factors|mesh-ancestor
64843426|NCT01661751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843427|NCT01661777|Diuretics|diuretics|mesh-list
64843428|NCT01661777|Histamine Antagonists|histamine antagonists|mesh-list
64843429|NCT01661777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
64843430|NCT01661777|Natriuretic Agents|natriuretic agents|mesh-ancestor
64843431|NCT01661777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843432|NCT01661777|Histamine Agents|histamine agents|mesh-ancestor
64843433|NCT01661777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64843434|NCT01661777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843435|NCT01661855|Riluzole|riluzole|mesh-list
64843436|NCT01661855|Anticonvulsants|anticonvulsants|mesh-ancestor
64323859|NCT03995017|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64323860|NCT03995017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323861|NCT02558894|Durvalumab|durvalumab|mesh-list
64323862|NCT02558894|Tremelimumab|tremelimumab|mesh-list
64776789|NCT03847428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64776790|NCT03847428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64776791|NCT03847428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64776792|NCT03847428|Growth Substances|growth substances|mesh-ancestor
64776793|NCT03847428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776794|NCT03847428|Growth Inhibitors|growth inhibitors|mesh-ancestor
64776795|NCT03816618|Fusidic Acid|fusidic acid|mesh-list
64776796|NCT03816618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64776797|NCT03816618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64776798|NCT03816618|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64776799|NCT03816618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323867|NCT02558894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323887|NCT02510599|Solithromycin|solithromycin|mesh-list
64323888|NCT02510599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64323889|NCT02510599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64323890|NCT02235805|Magnesium citrate|magnesium citrate|mesh-list
64323891|NCT02235805|Cathartics|cathartics|mesh-ancestor
64323892|NCT02235805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64776800|NCT03816618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776801|NCT03616236|Buprenorphine|buprenorphine|mesh-list
64776802|NCT03616236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64776804|NCT03616236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64776805|NCT03616236|Narcotics|narcotics|mesh-ancestor
64776806|NCT03616236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64776807|NCT03616236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776808|NCT03616236|Analgesics|analgesics|mesh-ancestor
64776809|NCT03616236|Sensory System Agents|sensory system agents|mesh-ancestor
64776810|NCT03616236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64776811|NCT03616236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64776812|NCT03551730|Enoxaparin|enoxaparin|mesh-list
64388294|NCT02354261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64388295|NCT02354261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64388296|NCT02354261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843447|NCT01661868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843448|NCT01661868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843449|NCT01661985|Azithromycin|azithromycin|mesh-list
64843450|NCT01661985|Doxycycline|doxycycline|mesh-list
64843451|NCT01661985|Lymecycline|lymecycline|mesh-list
64843452|NCT01661985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64843453|NCT01661985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64843454|NCT01661985|Antimalarials|antimalarials|mesh-ancestor
64843455|NCT01661985|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64843456|NCT01661985|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64843457|NCT01662037|Bosentan|bosentan|mesh-list
64843458|NCT01662037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64843459|NCT01662037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64843460|NCT01662037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843461|NCT01662089|Zinc|zinc|mesh-list
64843462|NCT01662089|Trace Elements|trace elements|mesh-ancestor
64843463|NCT01662089|Micronutrients|micronutrients|mesh-ancestor
64843464|NCT01662089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843465|NCT01662128|Capecitabine|capecitabine|mesh-list
64388297|NCT02354261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388298|NCT02354261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64388299|NCT02354261|Hormone Antagonists|hormone antagonists|mesh-ancestor
64323901|NCT02688387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323902|NCT02688387|Urological Agents|urological agents|mesh-ancestor
64323903|NCT02688387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64323904|NCT05489900|Dexmedetomidine|dexmedetomidine|mesh-list
64388329|NCT02354027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388330|NCT03149393|Mosapride|mosapride|mesh-list
64388331|NCT03149393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388332|NCT03149393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64388333|NCT03149393|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64388334|NCT03149393|Serotonin Agents|serotonin agents|mesh-ancestor
64388335|NCT03149393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64388336|NCT03149393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388337|NCT02353715|Abiraterone Acetate|abiraterone acetate|mesh-list
64388338|NCT02353715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388339|NCT02353715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64388340|NCT02353715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388341|NCT02353715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388343|NCT02353715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64388344|NCT02353715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388345|NCT02353715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64388346|NCT02353325|Ascorbic Acid|ascorbic acid|mesh-list
64388347|NCT02353325|Fesoterodine|fesoterodine|mesh-list
64388348|NCT02353325|Antioxidants|antioxidants|mesh-ancestor
64776882|NCT02723994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64843468|NCT01662128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843469|NCT01662128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843470|NCT01662180|Hormones|hormones|mesh-list
64843471|NCT01662180|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64843472|NCT01662180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64843473|NCT01662180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843474|NCT01662193|Calcium, Dietary|calcium, dietary|mesh-list
64843475|NCT01662193|Vitamin D|vitamin d|mesh-list
64843476|NCT01662193|Ergocalciferols|ergocalciferols|mesh-list
64843477|NCT01662193|Cholecalciferol|cholecalciferol|mesh-list
64327275|NCT00682981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327277|NCT00833521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64327278|NCT00833521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64327279|NCT00833521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64327280|NCT00833521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327281|NCT00833521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64327282|NCT00833521|GABA Agonists|gaba agonists|mesh-ancestor
64327283|NCT00833521|GABA Agents|gaba agents|mesh-ancestor
64776883|NCT02723994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64776884|NCT02723994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64776885|NCT02723994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64776886|NCT02723994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64776887|NCT02723994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776888|NCT02723994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64776889|NCT02723994|Abortifacient Agents|abortifacient agents|mesh-ancestor
64776890|NCT02723994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64388349|NCT02353325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388350|NCT02353325|Protective Agents|protective agents|mesh-ancestor
64388351|NCT02353325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388352|NCT02353325|Vitamins|vitamins|mesh-ancestor
64388353|NCT02353325|Micronutrients|micronutrients|mesh-ancestor
64388354|NCT02353325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64388355|NCT02353325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64388356|NCT02353325|Cholinergic Agents|cholinergic agents|mesh-ancestor
64388357|NCT02353325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64388358|NCT02353325|Urological Agents|urological agents|mesh-ancestor
64388359|NCT03157505|Immunologic Factors|immunologic factors|mesh-list
64388361|NCT03157193|Hyaluronic Acid|hyaluronic acid|mesh-list
64388372|NCT03149159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388374|NCT03155477|Vitamin D|vitamin d|mesh-list
64388375|NCT03155477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64388376|NCT03155477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388377|NCT03155477|Vitamins|vitamins|mesh-ancestor
64388378|NCT03155477|Micronutrients|micronutrients|mesh-ancestor
64388379|NCT03155477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64388384|NCT02349581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327284|NCT00833521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64327285|NCT00833521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327286|NCT00832507|Cicletanine|cicletanine|mesh-list
64327287|NCT00832507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64327288|NCT00832507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64327289|NCT00832507|Diuretics|diuretics|mesh-ancestor
64327290|NCT00832507|Natriuretic Agents|natriuretic agents|mesh-ancestor
64327291|NCT00832507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327292|NCT04862143|Fulvestrant|fulvestrant|mesh-list
64327293|NCT04862143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64327294|NCT04862143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843479|NCT01662193|Calcium Carbonate|calcium carbonate|mesh-list
64843480|NCT01662193|Calcium|calcium|mesh-list
64843481|NCT01662193|Micronutrients|micronutrients|mesh-ancestor
64843482|NCT01662193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843483|NCT01662193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64843484|NCT01662193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64843485|NCT01662193|Antacids|antacids|mesh-ancestor
64843486|NCT01662193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388386|NCT02349581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64388387|NCT03154385|Rituximab|rituximab|mesh-list
64388388|NCT03154385|Belimumab|belimumab|mesh-list
64388389|NCT03154385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64776914|NCT02534376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64776915|NCT02534376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776916|NCT02216838|Botulinum Toxins|botulinum toxins|mesh-list
64776917|NCT02216838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64776918|NCT02216838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64323915|NCT05489900|Adrenergic Agents|adrenergic agents|mesh-ancestor
64843487|NCT01662193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64843488|NCT01662349|Anti-Infective Agents|anti-infective agents|mesh-list
64843489|NCT01662349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64843490|NCT01662401|Bupivacaine|bupivacaine|mesh-list
64843491|NCT01662401|Anesthetics, Local|anesthetics, local|mesh-ancestor
64843492|NCT01662401|Anesthetics|anesthetics|mesh-ancestor
64843493|NCT01662401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64843494|NCT01662401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843495|NCT01662401|Sensory System Agents|sensory system agents|mesh-ancestor
64843496|NCT01662401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64327295|NCT04862143|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64327296|NCT04862143|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64327297|NCT04862143|Hormone Antagonists|hormone antagonists|mesh-ancestor
64327298|NCT04862143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64327299|NCT04862143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327301|NCT02721459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327302|NCT02721459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64843498|NCT01662466|Testosterone|testosterone|mesh-list
64843499|NCT01662466|Testosterone undecanoate|testosterone undecanoate|mesh-list
64843500|NCT01662466|Testosterone enanthate|testosterone enanthate|mesh-list
64843501|NCT01662466|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64843502|NCT01662466|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64843503|NCT01662466|Androgens|androgens|mesh-ancestor
64843504|NCT01662466|Hormones|hormones|mesh-ancestor
64843505|NCT01662466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64843506|NCT01662466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843507|NCT01662466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64843508|NCT01662466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843509|NCT01662466|Anabolic Agents|anabolic agents|mesh-ancestor
64843510|NCT01662466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64323916|NCT05489900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64323917|NCT05489900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323918|NCT05542849|Acarbose|acarbose|mesh-list
64323919|NCT05542849|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64323920|NCT05542849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64776930|NCT02065596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64776931|NCT02065596|Antimetabolites|antimetabolites|mesh-ancestor
64776932|NCT02065596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64776933|NCT02065596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64776934|NCT02065596|Immunologic Factors|immunologic factors|mesh-ancestor
64843514|NCT01662518|Antiemetics|antiemetics|mesh-ancestor
64843515|NCT01662518|Autonomic Agents|autonomic agents|mesh-ancestor
64843516|NCT01662518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843517|NCT01662518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843518|NCT01662518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64843519|NCT01662518|Glucocorticoids|glucocorticoids|mesh-ancestor
64843520|NCT01662518|Hormones|hormones|mesh-ancestor
64843521|NCT01662518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64843522|NCT01662518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64843523|NCT01662518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843524|NCT01662622|Sevoflurane|sevoflurane|mesh-list
64843525|NCT01662622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64843526|NCT01662622|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64843527|NCT01662622|Anesthetics, General|anesthetics, general|mesh-ancestor
64327303|NCT02721459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327304|NCT02721459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327305|NCT02802943|Imiquimod|imiquimod|mesh-list
64327306|NCT02802943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64327307|NCT02802943|Immunologic Factors|immunologic factors|mesh-ancestor
64327308|NCT02802943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327309|NCT02802943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327310|NCT02802943|Interferon Inducers|interferon inducers|mesh-ancestor
64327311|NCT02165033|Budesonide|budesonide|mesh-list
64327312|NCT02165033|Procaterol|procaterol|mesh-list
64327313|NCT02165033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64327314|NCT02165033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64327315|NCT02165033|Autonomic Agents|autonomic agents|mesh-ancestor
64327316|NCT02165033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64327317|NCT02165033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843531|NCT01662674|Metformin|metformin|mesh-list
64776935|NCT02065596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64776936|NCT02058420|Tocotrienols|tocotrienols|mesh-list
64776937|NCT02058420|Vitamin E|vitamin e|mesh-list
64843532|NCT01662674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64776938|NCT02058420|Tocopherols|tocopherols|mesh-list
64776939|NCT02058420|Antioxidants|antioxidants|mesh-ancestor
64776940|NCT02058420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388408|NCT03147677|Vitamins|vitamins|mesh-ancestor
64323952|NCT01621243|Antiviral Agents|antiviral agents|mesh-ancestor
64323953|NCT01621243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64323954|NCT01621243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323955|NCT01621243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64323956|NCT01621243|Immunologic Factors|immunologic factors|mesh-ancestor
64323957|NCT01621243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777026|NCT01086540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777028|NCT01086540|Antiemetics|antiemetics|mesh-ancestor
64777029|NCT01086540|Autonomic Agents|autonomic agents|mesh-ancestor
64843533|NCT01662674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843534|NCT01662687|Granisetron|granisetron|mesh-list
64843535|NCT01662687|Antiemetics|antiemetics|mesh-ancestor
64843536|NCT01662687|Autonomic Agents|autonomic agents|mesh-ancestor
64843537|NCT01662687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843538|NCT01662687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843539|NCT01662687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64843540|NCT01662687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64843541|NCT01662687|Serotonin Agents|serotonin agents|mesh-ancestor
64843542|NCT01662687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64843543|NCT01662687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843544|NCT01662700|Artesunate|artesunate|mesh-list
64843545|NCT01662700|Chloroquine|chloroquine|mesh-list
64777030|NCT01086540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64777031|NCT01086540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64777032|NCT01086540|Protective Agents|protective agents|mesh-ancestor
64777033|NCT01086540|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64777034|NCT01086540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64777035|NCT01086540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64777036|NCT01086540|Anesthetics, Local|anesthetics, local|mesh-ancestor
64388483|NCT02343419|Autonomic Agents|autonomic agents|mesh-ancestor
64388484|NCT02343419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64388485|NCT02343419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388486|NCT02343419|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64388487|NCT02343419|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
64388488|NCT02343419|Respiratory System Agents|respiratory system agents|mesh-ancestor
64388489|NCT02343419|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64388490|NCT02343419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64388491|NCT02343419|Cholinergic Agents|cholinergic agents|mesh-ancestor
64388492|NCT02343419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64327321|NCT02165033|Hormones|hormones|mesh-ancestor
64327322|NCT02165033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64327323|NCT02165033|Sympathomimetics|sympathomimetics|mesh-ancestor
64327324|NCT02165033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64327325|NCT02165033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64327326|NCT02165033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64327327|NCT02165033|Adrenergic Agents|adrenergic agents|mesh-ancestor
64843582|NCT01662869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64843584|NCT01662869|Immunologic Factors|immunologic factors|mesh-ancestor
64843585|NCT01662921|Insulin|insulin|mesh-list
64843586|NCT01662921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64843587|NCT01662921|Insulin Lispro|insulin lispro|mesh-list
64843588|NCT01662921|Insulin glulisine|insulin glulisine|mesh-list
64843589|NCT01662921|Isophane Insulin, Human|isophane insulin, human|mesh-list
64843590|NCT01662921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64843591|NCT01662921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843592|NCT01663038|Aspirin|aspirin|mesh-list
64843593|NCT01663038|Clopidogrel|clopidogrel|mesh-list
64843594|NCT01663038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64843595|NCT01663038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64843596|NCT01663038|Analgesics|analgesics|mesh-ancestor
64843597|NCT01663038|Sensory System Agents|sensory system agents|mesh-ancestor
64843598|NCT01663038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843599|NCT01663038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843600|NCT01663038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64843601|NCT01663038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64843602|NCT01663038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64843603|NCT01663038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64843604|NCT01663038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843605|NCT01663038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64843606|NCT01663038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64843607|NCT01663038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843608|NCT01663038|Antipyretics|antipyretics|mesh-ancestor
64843609|NCT01663038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64843610|NCT01663038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64843611|NCT01663038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64843612|NCT01663038|Purinergic Agents|purinergic agents|mesh-ancestor
64843613|NCT01663038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64843614|NCT01663077|Clozapine|clozapine|mesh-list
64843615|NCT01663077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64327328|NCT02165033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64327329|NCT02165033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327331|NCT00734461|Oxycodone|oxycodone|mesh-list
64327332|NCT00734461|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64327333|NCT00734461|Narcotics|narcotics|mesh-ancestor
64388493|NCT02343419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388494|NCT02342717|Itraconazole|itraconazole|mesh-list
64323958|NCT04076761|Trifluridine|trifluridine|mesh-list
64323959|NCT04076761|Antimetabolites|antimetabolites|mesh-ancestor
64323960|NCT04076761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323961|NCT04076761|Antiviral Agents|antiviral agents|mesh-ancestor
64323962|NCT04076761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64323963|NCT04046887|Gemcitabine|gemcitabine|mesh-list
64323964|NCT04046887|Paclitaxel|paclitaxel|mesh-list
64323965|NCT04046887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64777045|NCT01086540|Dermatologic Agents|dermatologic agents|mesh-ancestor
64777046|NCT01962870|Vasopressins|vasopressins|mesh-list
64777047|NCT01962870|Arginine Vasopressin|arginine vasopressin|mesh-list
64388496|NCT02342717|Antifungal Agents|antifungal agents|mesh-ancestor
64388497|NCT02342717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64388498|NCT02342717|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64388499|NCT02342717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64388500|NCT02342717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388501|NCT02342717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388502|NCT02342717|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64388503|NCT02342717|Hormone Antagonists|hormone antagonists|mesh-ancestor
64388504|NCT02342717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64843622|NCT01663077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64843623|NCT01663077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64843624|NCT01663077|GABA Antagonists|gaba antagonists|mesh-ancestor
64843625|NCT01663077|GABA Agents|gaba agents|mesh-ancestor
64843626|NCT01663090|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64843627|NCT01663090|Hematinics|hematinics|mesh-ancestor
64843628|NCT01663090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64843707|NCT01664520|Sensory System Agents|sensory system agents|mesh-ancestor
64843708|NCT01664520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843709|NCT01664520|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64843710|NCT01664520|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64327339|NCT00734461|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64327340|NCT00734461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64327341|NCT02169713|Tamsulosin|tamsulosin|mesh-list
64327342|NCT02169713|Solifenacin Succinate|solifenacin succinate|mesh-list
64327343|NCT02169713|Mirabegron|mirabegron|mesh-list
64327344|NCT02169713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64327345|NCT02169713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64327346|NCT02169713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64327347|NCT02169713|Adrenergic Agents|adrenergic agents|mesh-ancestor
64327348|NCT02169713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64327349|NCT02169713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327350|NCT02169713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323966|NCT04046887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323967|NCT04046887|Tubulin Modulators|tubulin modulators|mesh-ancestor
64323968|NCT04046887|Antimitotic Agents|antimitotic agents|mesh-ancestor
64323969|NCT04046887|Mitosis Modulators|mitosis modulators|mesh-ancestor
64323970|NCT04046887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323971|NCT04046887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64323972|NCT04046887|Antimetabolites|antimetabolites|mesh-ancestor
64323973|NCT04046887|Antiviral Agents|antiviral agents|mesh-ancestor
64323974|NCT04046887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64323975|NCT04046887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323976|NCT04046887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64323977|NCT04046887|Immunologic Factors|immunologic factors|mesh-ancestor
64323978|NCT04046887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323979|NCT02235961|Liraglutide|liraglutide|mesh-list
64327360|NCT03980041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327361|NCT03980041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64327362|NCT03980041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327363|NCT02756819|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
64327364|NCT02756819|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64843721|NCT01664650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843722|NCT01664650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843724|NCT01664650|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64843725|NCT01664650|Estrogens|estrogens|mesh-ancestor
64843726|NCT01664650|Hormones|hormones|mesh-ancestor
64843727|NCT01664650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64843728|NCT01664676|Liraglutide|liraglutide|mesh-list
64843729|NCT01664676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64843730|NCT01664676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843731|NCT01664676|Incretins|incretins|mesh-ancestor
64843732|NCT01664676|Hormones|hormones|mesh-ancestor
64843733|NCT01664676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64843734|NCT01664728|Abiraterone Acetate|abiraterone acetate|mesh-list
64843735|NCT01664728|Glucocorticoids|glucocorticoids|mesh-list
64843736|NCT01664728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843737|NCT01664728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64843738|NCT01664728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843739|NCT01664728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843740|NCT01664728|Hormone Antagonists|hormone antagonists|mesh-ancestor
64843741|NCT01664728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64843742|NCT01664728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294236|NCT01362296|Trametinib|trametinib|mesh-list
64323980|NCT02235961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64323981|NCT02235961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323982|NCT02235961|Incretins|incretins|mesh-ancestor
64323983|NCT02235961|Hormones|hormones|mesh-ancestor
64323984|NCT02235961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64323985|NCT01610245|Oseltamivir|oseltamivir|mesh-list
64323986|NCT01610245|Nitazoxanide|nitazoxanide|mesh-list
64777054|NCT01965366|Dexamethasone|dexamethasone|mesh-list
64777055|NCT01965366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64777056|NCT01965366|Antiemetics|antiemetics|mesh-ancestor
64777057|NCT01965366|Autonomic Agents|autonomic agents|mesh-ancestor
64388505|NCT02342717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388506|NCT02342717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64388507|NCT02342717|Nootropic Agents|nootropic agents|mesh-ancestor
64327365|NCT02756819|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64327366|NCT02756819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327367|NCT00829309|Pravastatin|pravastatin|mesh-list
64327368|NCT00829309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64327369|NCT00829309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64327370|NCT00829309|Antimetabolites|antimetabolites|mesh-ancestor
64327371|NCT00829309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327372|NCT00829309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64327376|NCT02165189|Sofosbuvir|sofosbuvir|mesh-list
64327377|NCT02165189|Simeprevir|simeprevir|mesh-list
64327378|NCT02165189|Antimetabolites|antimetabolites|mesh-ancestor
64843743|NCT01664728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64843744|NCT01664728|Hormones|hormones|mesh-ancestor
64843745|NCT01664754|Carboplatin|carboplatin|mesh-list
64843746|NCT01664754|Pemetrexed|pemetrexed|mesh-list
64843747|NCT01664754|Exemestane|exemestane|mesh-list
64843748|NCT01664754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843749|NCT01664754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843750|NCT01664754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843751|NCT01664754|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64843752|NCT01664754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64843753|NCT01664754|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64843754|NCT01664754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64388508|NCT04478357|Fesoterodine|fesoterodine|mesh-list
64388509|NCT04478357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64388510|NCT04478357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64388511|NCT04478357|Cholinergic Agents|cholinergic agents|mesh-ancestor
64388512|NCT04478357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64388513|NCT04478357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323994|NCT04138394|Ascorbic Acid|ascorbic acid|mesh-list
64323995|NCT04138394|Vitamins|vitamins|mesh-ancestor
64323996|NCT04138394|Micronutrients|micronutrients|mesh-ancestor
64323997|NCT04138394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777095|NCT01984398|Chelating Agents|chelating agents|mesh-ancestor
64388537|NCT02342093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64388538|NCT02342093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388539|NCT02342093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64388540|NCT02342093|Diuretics|diuretics|mesh-ancestor
64388541|NCT02342093|Natriuretic Agents|natriuretic agents|mesh-ancestor
64388542|NCT02347319|Silymarin|silymarin|mesh-list
64388543|NCT02347319|Antioxidants|antioxidants|mesh-ancestor
64388544|NCT02347319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388545|NCT02347319|Protective Agents|protective agents|mesh-ancestor
64388546|NCT02347319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777100|NCT01984398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64777102|NCT01984398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64327379|NCT02165189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327380|NCT02165189|Antiviral Agents|antiviral agents|mesh-ancestor
64327381|NCT02165189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64327382|NCT02165189|Protease Inhibitors|protease inhibitors|mesh-ancestor
64327383|NCT02165189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327384|NCT00725881|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
64327386|NCT00725881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327387|NCT00725881|Protective Agents|protective agents|mesh-ancestor
64843755|NCT01664754|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64843756|NCT01664754|Hormone Antagonists|hormone antagonists|mesh-ancestor
64945454|NCT05619627|Analgesics|analgesics|mesh-ancestor
64843757|NCT01664754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64843758|NCT01664754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843759|NCT01664819|Antioxidants|antioxidants|mesh-list
64843760|NCT01664819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843761|NCT01664819|Protective Agents|protective agents|mesh-ancestor
64843762|NCT01664819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843763|NCT01664845|Metformin|metformin|mesh-list
64843764|NCT01664845|Ribavirin|ribavirin|mesh-list
64327388|NCT00725881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327389|NCT00725881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64777103|NCT01984398|Fertility Agents|fertility agents|mesh-ancestor
64777104|NCT01984398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64388547|NCT02347163|Zoledronic Acid|zoledronic acid|mesh-list
64388548|NCT02347163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64388549|NCT02347163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388550|NCT02341703|Metformin|metformin|mesh-list
64388551|NCT02341703|Pioglitazone|pioglitazone|mesh-list
64388552|NCT02341703|Letrozole|letrozole|mesh-list
64388553|NCT02341703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64388554|NCT02341703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388555|NCT02341703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843765|NCT01664845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64843766|NCT01664845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843767|NCT01664845|Antimetabolites|antimetabolites|mesh-ancestor
64843768|NCT01664845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843769|NCT01664845|Antiviral Agents|antiviral agents|mesh-ancestor
64843770|NCT01664845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64843771|NCT01664871|Fluorides|fluorides|mesh-list
64843772|NCT01664871|Cariostatic Agents|cariostatic agents|mesh-ancestor
64327390|NCT00725881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327392|NCT02292225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64327393|NCT02292225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324019|NCT05436535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64324020|NCT05436535|Glucocorticoids|glucocorticoids|mesh-ancestor
64416665|NCT03040765|Zoledronic Acid|zoledronic acid|mesh-list
64388589|NCT02340455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64388590|NCT02340455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64388591|NCT02340455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388592|NCT02340455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64388593|NCT02340455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64388594|NCT02340455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64388595|NCT02340455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64388596|NCT02340455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64843773|NCT01664871|Protective Agents|protective agents|mesh-ancestor
64843774|NCT01664871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843775|NCT01664936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64843776|NCT01664936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64843777|NCT01664936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843778|NCT01665066|Nicotine|nicotine|mesh-list
64843779|NCT01665066|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64843780|NCT01665066|Autonomic Agents|autonomic agents|mesh-ancestor
64843781|NCT01665066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843782|NCT01665066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843783|NCT01665066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64843784|NCT01665066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64843785|NCT01665066|Cholinergic Agents|cholinergic agents|mesh-ancestor
64843786|NCT01665066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64843787|NCT01665066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843788|NCT01665079|Propofol|propofol|mesh-list
64843789|NCT01665079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64843790|NCT01665079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64843791|NCT01665079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843792|NCT01665079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64843793|NCT01665079|Anesthetics, General|anesthetics, general|mesh-ancestor
64843794|NCT01665079|Anesthetics|anesthetics|mesh-ancestor
64843795|NCT01665196|Deoxyglucose|deoxyglucose|mesh-list
64843796|NCT01665196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64843797|NCT01665196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64843798|NCT01665196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327397|NCT00677053|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
64327399|NCT00677053|Antithrombins|antithrombins|mesh-ancestor
64327400|NCT00677053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64777165|NCT01999920|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
64777166|NCT01999920|Antidepressive Agents|antidepressive agents|mesh-ancestor
64777167|NCT01999920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64777168|NCT01999920|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64777169|NCT01999920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64777170|NCT01999920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64388597|NCT02345837|Clomiphene|clomiphene|mesh-list
64388598|NCT02345837|Enclomiphene|enclomiphene|mesh-list
64388599|NCT02345837|Zuclomiphene|zuclomiphene|mesh-list
64388600|NCT02345837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64388601|NCT02345837|Hormone Antagonists|hormone antagonists|mesh-ancestor
64388602|NCT02345837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64388603|NCT02345837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388604|NCT02345837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64843800|NCT01665196|Antiviral Agents|antiviral agents|mesh-ancestor
64843801|NCT01665196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64843802|NCT01665209|Morphine|morphine|mesh-list
64843803|NCT01665209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64843804|NCT01665209|Narcotics|narcotics|mesh-ancestor
64843805|NCT01665209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64843806|NCT01665209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843807|NCT01665209|Analgesics|analgesics|mesh-ancestor
64843808|NCT01665209|Sensory System Agents|sensory system agents|mesh-ancestor
64843809|NCT01665209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843810|NCT01665222|Morphine|morphine|mesh-list
64843811|NCT01665222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64843812|NCT01665222|Narcotics|narcotics|mesh-ancestor
64843813|NCT01665222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64843814|NCT01665222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843815|NCT01665222|Analgesics|analgesics|mesh-ancestor
64843816|NCT01665222|Sensory System Agents|sensory system agents|mesh-ancestor
64843817|NCT01665222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843818|NCT01665235|Aspirin|aspirin|mesh-list
64388605|NCT02345837|Fertility Agents|fertility agents|mesh-ancestor
64388606|NCT02345837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64388607|NCT02345837|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64388608|NCT02345837|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64388609|NCT02345993|Beclomethasone|beclomethasone|mesh-list
64388610|NCT02345993|Formoterol Fumarate|formoterol fumarate|mesh-list
64388612|NCT02345993|Autonomic Agents|autonomic agents|mesh-ancestor
64324029|NCT04275518|Azacitidine|azacitidine|mesh-list
64324030|NCT04275518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64324031|NCT04275518|Antimetabolites|antimetabolites|mesh-ancestor
64324032|NCT04275518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324033|NCT04275518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324034|NCT04275518|Antiviral Agents|antiviral agents|mesh-ancestor
64324035|NCT04275518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64843819|NCT01665235|Amlodipine|amlodipine|mesh-list
64843820|NCT01665235|Clopidogrel|clopidogrel|mesh-list
64843821|NCT01665235|Atorvastatin|atorvastatin|mesh-list
64843822|NCT01665235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64843823|NCT01665235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64843824|NCT01665235|Analgesics|analgesics|mesh-ancestor
64843825|NCT01665235|Sensory System Agents|sensory system agents|mesh-ancestor
64843826|NCT01665235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64327403|NCT00677053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327405|NCT01950403|Linaclotide|linaclotide|mesh-list
64327406|NCT01950403|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64327407|NCT01950403|Enzyme Activators|enzyme activators|mesh-ancestor
64327408|NCT01950403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327409|NCT01950403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64843828|NCT01665235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64843829|NCT01665235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64843830|NCT01665235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64843831|NCT01665235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64843832|NCT01665235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843833|NCT01665235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64843834|NCT01665235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64843835|NCT01665235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843836|NCT01665235|Antipyretics|antipyretics|mesh-ancestor
64324036|NCT04275518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64388617|NCT02345993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64388618|NCT02345993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64388619|NCT02345993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64388620|NCT02345993|Adrenergic Agents|adrenergic agents|mesh-ancestor
64388621|NCT02345993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64388622|NCT02345993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388623|NCT02345993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64777181|NCT02002650|Sensory System Agents|sensory system agents|mesh-ancestor
64777182|NCT02002650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843837|NCT01665235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64843838|NCT01665235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64843839|NCT01665235|Antimetabolites|antimetabolites|mesh-ancestor
64843840|NCT01665235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64843841|NCT01665235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64843842|NCT01665235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64843843|NCT01665235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64843844|NCT01665235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64843845|NCT01665235|Purinergic Agents|purinergic agents|mesh-ancestor
64843846|NCT01665235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64843847|NCT01665235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64843848|NCT01665235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64843849|NCT01665235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64843850|NCT01665235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64843851|NCT01665235|Vasodilator Agents|vasodilator agents|mesh-ancestor
64843852|NCT01665248|Listerine|listerine|mesh-list
64843853|NCT01665248|Fluorides|fluorides|mesh-list
64843854|NCT01665248|Sodium Fluoride|sodium fluoride|mesh-list
64843855|NCT01665248|Cariostatic Agents|cariostatic agents|mesh-ancestor
64843856|NCT01665248|Protective Agents|protective agents|mesh-ancestor
64843857|NCT01665248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843858|NCT01665248|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64843859|NCT01665248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64777183|NCT02002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777184|NCT02002650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64777185|NCT02002650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64777186|NCT02002650|Gout Suppressants|gout suppressants|mesh-ancestor
64777187|NCT02002650|Tocolytic Agents|tocolytic agents|mesh-ancestor
64777188|NCT02002650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64777189|NCT02002650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64777190|NCT02002650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64777191|NCT02002650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777192|NCT02004132|Testosterone|testosterone|mesh-list
64777212|NCT02004990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64777213|NCT02004990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64777214|NCT02006160|4-Aminopyridine|4-aminopyridine|mesh-list
64777215|NCT02006160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64777216|NCT02006160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64843874|NCT01665404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64843875|NCT01665404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64843876|NCT01665404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843877|NCT01665404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64843878|NCT01665404|Serotonin Agents|serotonin agents|mesh-ancestor
64843879|NCT01665404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64843880|NCT01665404|Antidepressive Agents|antidepressive agents|mesh-ancestor
64843881|NCT01665404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64843882|NCT01665404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64843883|NCT01665404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843884|NCT01665404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64843885|NCT01665417|Docetaxel|docetaxel|mesh-list
64843886|NCT01665417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843887|NCT01665417|Tubulin Modulators|tubulin modulators|mesh-ancestor
64843888|NCT01665417|Antimitotic Agents|antimitotic agents|mesh-ancestor
64843889|NCT01665417|Mitosis Modulators|mitosis modulators|mesh-ancestor
64843890|NCT01665417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777217|NCT02006160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777218|NCT02011464|Bupivacaine|bupivacaine|mesh-list
64777219|NCT02011464|Anesthetics, Local|anesthetics, local|mesh-ancestor
64777220|NCT02011464|Anesthetics|anesthetics|mesh-ancestor
64777221|NCT02011464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64388651|NCT02345213|Nootropic Agents|nootropic agents|mesh-ancestor
64777230|NCT02024646|Brodalumab|brodalumab|mesh-list
64777231|NCT02024646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64777232|NCT02024646|Dermatologic Agents|dermatologic agents|mesh-ancestor
64388666|NCT02339441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64324070|NCT02557646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324072|NCT03859687|Vitamin A|vitamin a|mesh-list
64324073|NCT03859687|Retinol palmitate|retinol palmitate|mesh-list
64324074|NCT03859687|Micronutrients|micronutrients|mesh-ancestor
64324075|NCT03859687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324076|NCT03859687|Antioxidants|antioxidants|mesh-ancestor
64843891|NCT01665469|Lycopene|lycopene|mesh-list
64843892|NCT01665469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64843893|NCT01665469|Antioxidants|antioxidants|mesh-ancestor
64843894|NCT01665469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843895|NCT01665469|Protective Agents|protective agents|mesh-ancestor
64843896|NCT01665469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843897|NCT01665469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64843898|NCT01665469|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64843899|NCT01665469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843900|NCT01664507|Epinephrine|epinephrine|mesh-list
64843901|NCT01664507|Racepinephrine|racepinephrine|mesh-list
64843902|NCT01664507|Epinephryl borate|epinephryl borate|mesh-list
64324077|NCT03859687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324078|NCT03859687|Protective Agents|protective agents|mesh-ancestor
64324079|NCT03859687|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64324080|NCT03859687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324081|NCT02679573|Moxifloxacin|moxifloxacin|mesh-list
64324082|NCT02679573|Linezolid|linezolid|mesh-list
64324083|NCT02679573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64324084|NCT02679573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324085|NCT02679573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64324086|NCT02679573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64324087|NCT02679573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324088|NCT02679573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324089|NCT02679573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64777245|NCT02024724|Hormones|hormones|mesh-ancestor
64777246|NCT02024724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64777247|NCT02024724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64777248|NCT02024724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388676|NCT02339441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64388677|NCT02339441|Antitubercular Agents|antitubercular agents|mesh-ancestor
64388678|NCT02339441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64388679|NCT02339441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64388680|NCT02344823|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
64843933|NCT01665638|Somatostatin|somatostatin|mesh-list
64843934|NCT01665638|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64843935|NCT01665638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843936|NCT01665638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64843937|NCT01665638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843938|NCT01665638|Hormones|hormones|mesh-ancestor
64843939|NCT01665638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64843940|NCT01665703|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64843941|NCT01665703|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64843942|NCT01665703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843943|NCT01665742|Tocopherols|tocopherols|mesh-list
64843944|NCT01665742|Vitamin E|vitamin e|mesh-list
64843945|NCT01665742|alpha-Tocopherol|alpha-tocopherol|mesh-list
64843946|NCT01665742|Lycopene|lycopene|mesh-list
64843947|NCT01665742|Vitamins|vitamins|mesh-ancestor
64843948|NCT01665742|Micronutrients|micronutrients|mesh-ancestor
64843949|NCT01665742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843950|NCT01665742|Antioxidants|antioxidants|mesh-ancestor
64843951|NCT01665742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843952|NCT01665742|Protective Agents|protective agents|mesh-ancestor
64843953|NCT01665742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64843954|NCT01665742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64843955|NCT01665742|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64843956|NCT01665742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843957|NCT01665781|Epoetin Alfa|epoetin alfa|mesh-list
64843958|NCT01665781|Hematinics|hematinics|mesh-ancestor
64324090|NCT02679573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64324091|NCT05493332|Leucovorin|leucovorin|mesh-list
64324092|NCT05493332|Fluorouracil|fluorouracil|mesh-list
64324093|NCT05493332|Oxaliplatin|oxaliplatin|mesh-list
64324094|NCT05493332|Antimetabolites|antimetabolites|mesh-ancestor
64324095|NCT05493332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324096|NCT05493332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64324097|NCT05493332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327425|NCT00629551|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64327426|NCT00629551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64327427|NCT00629551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64327428|NCT00629551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327429|NCT00629551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64327430|NCT00629551|Serotonin Agents|serotonin agents|mesh-ancestor
64843977|NCT01666171|Metformin|metformin|mesh-list
64843978|NCT01666171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64843979|NCT01666171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843980|NCT01666223|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
64843981|NCT01666223|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
64843982|NCT01666223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64843983|NCT01666223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64843984|NCT01666223|Antimetabolites|antimetabolites|mesh-ancestor
64843985|NCT01666223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843986|NCT01666223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64843987|NCT01666223|Cathartics|cathartics|mesh-ancestor
64843988|NCT01666223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64843989|NCT01666236|Triamcinolone|triamcinolone|mesh-list
64843990|NCT01666236|Ranibizumab|ranibizumab|mesh-list
64843992|NCT01666236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64843993|NCT01666236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64843994|NCT01666236|Growth Substances|growth substances|mesh-ancestor
64843995|NCT01666236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843996|NCT01666236|Growth Inhibitors|growth inhibitors|mesh-ancestor
64843997|NCT01666236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64843998|NCT01666236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64843999|NCT01666236|Glucocorticoids|glucocorticoids|mesh-ancestor
64844000|NCT01666236|Hormones|hormones|mesh-ancestor
64844001|NCT01666236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64844002|NCT01666236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64844003|NCT01666236|Dermatologic Agents|dermatologic agents|mesh-ancestor
64844006|NCT01666249|Antibodies|antibodies|mesh-list
64324098|NCT05493332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64324099|NCT05493332|Immunologic Factors|immunologic factors|mesh-ancestor
64324100|NCT05493332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324101|NCT05493332|Antidotes|antidotes|mesh-ancestor
64324102|NCT05493332|Protective Agents|protective agents|mesh-ancestor
64324103|NCT05493332|Vitamin B Complex|vitamin b complex|mesh-ancestor
64324104|NCT05493332|Vitamins|vitamins|mesh-ancestor
64324105|NCT05493332|Micronutrients|micronutrients|mesh-ancestor
64324106|NCT01591447|Solithromycin|solithromycin|mesh-list
64324107|NCT01591447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64777249|NCT02024724|Anesthetics, Local|anesthetics, local|mesh-ancestor
64777250|NCT02024724|Anesthetics|anesthetics|mesh-ancestor
64327432|NCT00629551|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64327433|NCT00629551|Antidepressive Agents|antidepressive agents|mesh-ancestor
64327434|NCT00629551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64327435|NCT00629551|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64327436|NCT00629551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64327437|NCT00629551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327438|NCT00625651|Bevacizumab|bevacizumab|mesh-list
64327439|NCT00625651|Conatumumab|conatumumab|mesh-list
64844018|NCT01666379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64844019|NCT01666379|Narcotics|narcotics|mesh-ancestor
64844020|NCT01666379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64844021|NCT01666379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844022|NCT01666379|Analgesics|analgesics|mesh-ancestor
64844023|NCT01666379|Sensory System Agents|sensory system agents|mesh-ancestor
64844024|NCT01666379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844025|NCT01666379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64844026|NCT01666379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64844027|NCT01666379|Anesthetics, General|anesthetics, general|mesh-ancestor
64327440|NCT00625651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64777251|NCT02024724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64777252|NCT02024724|Sensory System Agents|sensory system agents|mesh-ancestor
64777253|NCT02025426|Phenylephrine|phenylephrine|mesh-list
64777254|NCT02025426|Oxymetazoline|oxymetazoline|mesh-list
64777255|NCT02025426|Ephedrine|ephedrine|mesh-list
64777256|NCT02025426|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64777257|NCT02025426|Mydriatics|mydriatics|mesh-ancestor
64777258|NCT02025426|Autonomic Agents|autonomic agents|mesh-ancestor
64777259|NCT02025426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777260|NCT02025426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777261|NCT02025426|Sympathomimetics|sympathomimetics|mesh-ancestor
64777262|NCT02025426|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64777276|NCT02028780|Protease Inhibitors|protease inhibitors|mesh-ancestor
64777277|NCT02028780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388708|NCT02344589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64388709|NCT02344589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64388710|NCT02344589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64327441|NCT00625651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327442|NCT00625651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64327443|NCT00625651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64327444|NCT00625651|Growth Substances|growth substances|mesh-ancestor
64327445|NCT00625651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844028|NCT01666379|Anesthetics|anesthetics|mesh-ancestor
64844029|NCT01666418|Paclitaxel|paclitaxel|mesh-list
64844030|NCT01666418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64844031|NCT01666418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844032|NCT01666418|Tubulin Modulators|tubulin modulators|mesh-ancestor
64844033|NCT01666418|Antimitotic Agents|antimitotic agents|mesh-ancestor
64844034|NCT01666418|Mitosis Modulators|mitosis modulators|mesh-ancestor
64844035|NCT01666418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844036|NCT01666431|Lapatinib|lapatinib|mesh-list
64844037|NCT01666431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844038|NCT01666431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64844039|NCT01666431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294247|NCT01338415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388711|NCT02344589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388712|NCT02338115|Paclitaxel|paclitaxel|mesh-list
64388713|NCT02338115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64388714|NCT02338115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388715|NCT02338115|Tubulin Modulators|tubulin modulators|mesh-ancestor
64388716|NCT02338115|Antimitotic Agents|antimitotic agents|mesh-ancestor
64388717|NCT02338115|Mitosis Modulators|mitosis modulators|mesh-ancestor
64388718|NCT02338115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777278|NCT02028780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777279|NCT02028780|Anticoagulants|anticoagulants|mesh-ancestor
64777280|NCT02029872|Chlorhexidine|chlorhexidine|mesh-list
64844040|NCT01666431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844042|NCT01666522|Cholecalciferol|cholecalciferol|mesh-list
64844043|NCT01666522|Vitamins|vitamins|mesh-ancestor
64844044|NCT01666522|Micronutrients|micronutrients|mesh-ancestor
64844045|NCT01666522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844046|NCT01666522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64844047|NCT01666522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64844048|NCT01666587|Ibuprofen|ibuprofen|mesh-list
64844049|NCT01666587|Antioxidants|antioxidants|mesh-list
64844050|NCT01666587|Prostaglandin Antagonists|prostaglandin antagonists|mesh-list
64844051|NCT01666587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64844052|NCT01666587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64844053|NCT01666587|Analgesics|analgesics|mesh-ancestor
64844054|NCT01666587|Sensory System Agents|sensory system agents|mesh-ancestor
64844055|NCT01666587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844056|NCT01666587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844057|NCT01666587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64327446|NCT00625651|Growth Inhibitors|growth inhibitors|mesh-ancestor
64327447|NCT00672997|Timolol|timolol|mesh-list
64327448|NCT00672997|Travoprost|travoprost|mesh-list
64327449|NCT00672997|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64327450|NCT00672997|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64327451|NCT00672997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64327452|NCT00672997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64327453|NCT00672997|Adrenergic Agents|adrenergic agents|mesh-ancestor
64844058|NCT01666587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64844059|NCT01666587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64777281|NCT02029872|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64777282|NCT02029872|Mupirocin|mupirocin|mesh-list
64777283|NCT02029872|Calcium|calcium|mesh-list
64777284|NCT02029872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64777285|NCT02029872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777286|NCT02029872|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64777287|NCT02029872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64777288|NCT02029872|Disinfectants|disinfectants|mesh-ancestor
64777289|NCT02029872|Dermatologic Agents|dermatologic agents|mesh-ancestor
64777290|NCT02029872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64844060|NCT01666587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844061|NCT01666587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844062|NCT01666587|Protective Agents|protective agents|mesh-ancestor
64844063|NCT01666587|Hormone Antagonists|hormone antagonists|mesh-ancestor
64844064|NCT01666587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64844065|NCT01666600|Nintedanib|nintedanib|mesh-list
64844066|NCT01666600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844067|NCT01666600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64844068|NCT01666600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844069|NCT01666600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844070|NCT01666665|Metformin|metformin|mesh-list
64844071|NCT01666665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64844072|NCT01666665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844073|NCT01666678|Diphenhydramine|diphenhydramine|mesh-list
64844074|NCT01666678|Promethazine|promethazine|mesh-list
64844075|NCT01666678|Naproxen|naproxen|mesh-list
64844076|NCT01666678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64844077|NCT01666678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64844078|NCT01666678|Analgesics|analgesics|mesh-ancestor
64844079|NCT01666678|Sensory System Agents|sensory system agents|mesh-ancestor
64844080|NCT01666678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844081|NCT01666678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844082|NCT01666678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64844083|NCT01666678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64844084|NCT01666678|Gout Suppressants|gout suppressants|mesh-ancestor
64844085|NCT01666678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64844086|NCT01666678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844087|NCT01666678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844088|NCT01666678|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64844089|NCT01666678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64777291|NCT02029872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64777292|NCT02029872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64777293|NCT02029872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777294|NCT02030574|Gemcitabine|gemcitabine|mesh-list
64777295|NCT02030574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64777296|NCT02030574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64777297|NCT02030574|Antimetabolites|antimetabolites|mesh-ancestor
64777311|NCT02032212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64777312|NCT02032212|Cholinergic Agents|cholinergic agents|mesh-ancestor
64777313|NCT02032212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64777314|NCT02032212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777315|NCT02032758|Propranolol|propranolol|mesh-list
64777316|NCT02032758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64777317|NCT02032758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64777318|NCT02032758|Adrenergic Agents|adrenergic agents|mesh-ancestor
64777319|NCT02032758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64844092|NCT01666678|Anesthetics|anesthetics|mesh-ancestor
64844093|NCT01666678|Antiemetics|antiemetics|mesh-ancestor
64844094|NCT01666678|Autonomic Agents|autonomic agents|mesh-ancestor
64844095|NCT01666678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64844096|NCT01666678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64844097|NCT01666678|Histamine Antagonists|histamine antagonists|mesh-ancestor
64844098|NCT01666678|Histamine Agents|histamine agents|mesh-ancestor
64844099|NCT01666678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64844100|NCT01666678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64844101|NCT01666678|Antipruritics|antipruritics|mesh-ancestor
64844102|NCT01666678|Dermatologic Agents|dermatologic agents|mesh-ancestor
64327455|NCT00672997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327456|NCT00672997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327457|NCT00672997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64327458|NCT00672997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64327459|NCT02130453|Regadenoson|regadenoson|mesh-list
64327460|NCT02130453|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64327461|NCT02130453|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64844103|NCT01666691|CKD732|ckd732|mesh-list
64844104|NCT01666691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64844105|NCT01666691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64844106|NCT01666691|Growth Substances|growth substances|mesh-ancestor
64844107|NCT01666691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844108|NCT01666691|Growth Inhibitors|growth inhibitors|mesh-ancestor
64844109|NCT01666691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844110|NCT01666743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64844111|NCT01666743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64844112|NCT01666743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64844113|NCT01666756|Sorafenib|sorafenib|mesh-list
64327462|NCT02130453|Purinergic Agonists|purinergic agonists|mesh-ancestor
64327463|NCT02130453|Purinergic Agents|purinergic agents|mesh-ancestor
64327464|NCT02130453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64327465|NCT02130453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327466|NCT02130453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327467|NCT02669043|Ketamine|ketamine|mesh-list
64327468|NCT02669043|Analgesics|analgesics|mesh-ancestor
64327469|NCT02669043|Sensory System Agents|sensory system agents|mesh-ancestor
64327470|NCT02669043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777320|NCT02032758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777321|NCT02032758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777322|NCT02032758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64777323|NCT02032758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64777324|NCT02032758|Vasodilator Agents|vasodilator agents|mesh-ancestor
64777325|NCT02036424|Dexamethasone|dexamethasone|mesh-list
64388750|NCT04850495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388751|NCT04850495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64388753|NCT04850495|Alkylating Agents|alkylating agents|mesh-ancestor
64324121|NCT05361447|Anticonvulsants|anticonvulsants|mesh-ancestor
64324122|NCT05361447|Antiemetics|antiemetics|mesh-ancestor
64324123|NCT05361447|Autonomic Agents|autonomic agents|mesh-ancestor
64844129|NCT01667094|Ticarcillin|ticarcillin|mesh-list
64844130|NCT01667094|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
64844131|NCT01667094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64844132|NCT01667094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64844133|NCT01667094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64844134|NCT01667094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844135|NCT01667094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844136|NCT01667211|Paclitaxel|paclitaxel|mesh-list
64844137|NCT01667211|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64844138|NCT01667211|Nedaplatin|nedaplatin|mesh-list
64844139|NCT01667211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64352744|NCT02194595|Exenatide|exenatide|mesh-list
64388776|NCT04477811|Vitamin K 2|vitamin k 2|mesh-list
64388777|NCT04477811|Vitamin K 1|vitamin k 1|mesh-list
64388778|NCT04477811|Micronutrients|micronutrients|mesh-ancestor
64388779|NCT04477811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388780|NCT04477811|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64388781|NCT04477811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64777344|NCT02044380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64777345|NCT02044380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64777346|NCT02044380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64777347|NCT02044380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777348|NCT02047032|Solifenacin Succinate|solifenacin succinate|mesh-list
64777349|NCT02047032|Cholinergic Antagonists|cholinergic antagonists|mesh-list
64777350|NCT02047032|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64844140|NCT01667211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844141|NCT01667211|Tubulin Modulators|tubulin modulators|mesh-ancestor
64844142|NCT01667211|Antimitotic Agents|antimitotic agents|mesh-ancestor
64844143|NCT01667211|Mitosis Modulators|mitosis modulators|mesh-ancestor
64844144|NCT01667211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844145|NCT01667263|Tretinoin|tretinoin|mesh-list
64844146|NCT01667263|Danazol|danazol|mesh-list
64844147|NCT01667263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844148|NCT01667263|Keratolytic Agents|keratolytic agents|mesh-ancestor
64844149|NCT01667263|Dermatologic Agents|dermatologic agents|mesh-ancestor
64327506|NCT02281045|Sodium Citrate|sodium citrate|mesh-list
64327507|NCT02281045|Anticoagulants|anticoagulants|mesh-ancestor
64327509|NCT02281045|Chelating Agents|chelating agents|mesh-ancestor
64327510|NCT02281045|Sequestering Agents|sequestering agents|mesh-ancestor
64327511|NCT02281045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388782|NCT04477811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388783|NCT04477811|Hemostatics|hemostatics|mesh-ancestor
64388784|NCT04477811|Coagulants|coagulants|mesh-ancestor
64388785|NCT02332031|Sorafenib|sorafenib|mesh-list
64844151|NCT01667263|Hormone Antagonists|hormone antagonists|mesh-ancestor
64388786|NCT02332031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388787|NCT02332031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64388788|NCT02332031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843910|NCT01664507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64844152|NCT01667263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64844153|NCT01667263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844154|NCT01667315|Bupivacaine|bupivacaine|mesh-list
64844155|NCT01667315|Anesthetics, Local|anesthetics, local|mesh-ancestor
64844156|NCT01667315|Anesthetics|anesthetics|mesh-ancestor
64844157|NCT01667315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64844158|NCT01667315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844159|NCT01667315|Sensory System Agents|sensory system agents|mesh-ancestor
64844160|NCT01667315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844161|NCT01667445|Morphine|morphine|mesh-list
64327514|NCT04472689|Anesthetics|anesthetics|mesh-ancestor
64327515|NCT04472689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64327516|NCT04472689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327517|NCT04472689|Sensory System Agents|sensory system agents|mesh-ancestor
64327518|NCT04472689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64327519|NCT04472689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64844162|NCT01667445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64844163|NCT01667445|Narcotics|narcotics|mesh-ancestor
64844164|NCT01667445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64844165|NCT01667445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388789|NCT02332031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388790|NCT03112031|Tamoxifen|tamoxifen|mesh-list
64388791|NCT03112031|Fluconazole|fluconazole|mesh-list
64388792|NCT03112031|Amphotericin B|amphotericin b|mesh-list
64388793|NCT03112031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64388794|NCT03112031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64388795|NCT03112031|Hormone Antagonists|hormone antagonists|mesh-ancestor
64777356|NCT02047500|Gemcitabine|gemcitabine|mesh-list
64777357|NCT02047500|Paclitaxel|paclitaxel|mesh-list
64777358|NCT02047500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64777359|NCT02047500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64777360|NCT02047500|Tubulin Modulators|tubulin modulators|mesh-ancestor
64777361|NCT02047500|Antimitotic Agents|antimitotic agents|mesh-ancestor
64388796|NCT03112031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64388797|NCT03112031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388798|NCT03112031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64388799|NCT03112031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388800|NCT03112031|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64388801|NCT03112031|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64388802|NCT03112031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64388803|NCT03112031|Antifungal Agents|antifungal agents|mesh-ancestor
64844166|NCT01667445|Analgesics|analgesics|mesh-ancestor
64844167|NCT01667445|Sensory System Agents|sensory system agents|mesh-ancestor
64844168|NCT01667445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844169|NCT01667484|Adderall|adderall|mesh-list
64844170|NCT01667484|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64844171|NCT01667484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844172|NCT01667497|4-Aminopyridine|4-aminopyridine|mesh-list
64327520|NCT04472689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64327521|NCT04472689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64327522|NCT04472689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64327523|NCT04472689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388804|NCT03112031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324124|NCT05361447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64324133|NCT05361447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64324134|NCT05361447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64777362|NCT02047500|Mitosis Modulators|mitosis modulators|mesh-ancestor
64777363|NCT02047500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777364|NCT02047500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64844173|NCT01667497|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64844174|NCT01667497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64844175|NCT01667497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844177|NCT01667523|Capsaicin|capsaicin|mesh-list
64844178|NCT01667523|Antipruritics|antipruritics|mesh-ancestor
64844179|NCT01667523|Dermatologic Agents|dermatologic agents|mesh-ancestor
64844180|NCT01667523|Sensory System Agents|sensory system agents|mesh-ancestor
64844181|NCT01667523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844182|NCT01667523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844183|NCT01667523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64844184|NCT01667523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844185|NCT01667523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64844186|NCT01667523|Protective Agents|protective agents|mesh-ancestor
64844187|NCT01667575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64844188|NCT01667575|Amoxicillin|amoxicillin|mesh-list
64844189|NCT01667575|Clarithromycin|clarithromycin|mesh-list
64844190|NCT01667575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64844191|NCT01667575|Potassium Citrate|potassium citrate|mesh-list
64844192|NCT01667575|Esomeprazole|esomeprazole|mesh-list
64844193|NCT01667575|Bismuth|bismuth|mesh-list
64844194|NCT01667575|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64844195|NCT01667575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844196|NCT01667575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64844197|NCT01667575|Antitubercular Agents|antitubercular agents|mesh-ancestor
64844198|NCT01667575|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64844199|NCT01667575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64844200|NCT01667575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844201|NCT01667575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64844202|NCT01667575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64844203|NCT01667575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64844204|NCT01667575|Antacids|antacids|mesh-ancestor
64777365|NCT02047500|Antimetabolites|antimetabolites|mesh-ancestor
64777366|NCT02047500|Antiviral Agents|antiviral agents|mesh-ancestor
64777367|NCT02047500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64777368|NCT02047500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64777369|NCT02047500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64777370|NCT02047500|Immunologic Factors|immunologic factors|mesh-ancestor
64777371|NCT02047500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777372|NCT02054754|HU 211|hu 211|mesh-list
64777373|NCT02054754|Dronabinol|dronabinol|mesh-list
64777374|NCT02054754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64777375|NCT02054754|Antiemetics|antiemetics|mesh-ancestor
64777376|NCT02054754|Autonomic Agents|autonomic agents|mesh-ancestor
64777377|NCT02054754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777378|NCT02054754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388806|NCT03112031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64388807|NCT03112031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844209|NCT01667575|Respiratory System Agents|respiratory system agents|mesh-ancestor
64388808|NCT03112031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388809|NCT03112031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64388810|NCT03112031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64388811|NCT03112031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64388812|NCT03112031|Amebicides|amebicides|mesh-ancestor
64388813|NCT03112031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64388814|NCT03112031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64388815|NCT03112031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64388816|NCT03111797|Morphine|morphine|mesh-list
64388817|NCT03111797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64388818|NCT03111797|Narcotics|narcotics|mesh-ancestor
64777385|NCT02054754|Protective Agents|protective agents|mesh-ancestor
64777386|NCT02054754|Hallucinogens|hallucinogens|mesh-ancestor
64777387|NCT02054754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64844210|NCT01667614|Losartan|losartan|mesh-list
64612699|NCT04358341|Antimetabolites|antimetabolites|mesh-ancestor
64844211|NCT01667614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64844212|NCT01667614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64844213|NCT01667614|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64844214|NCT01667614|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64327525|NCT02405013|Sofosbuvir|sofosbuvir|mesh-list
64327526|NCT02405013|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64327527|NCT02405013|Ledipasvir|ledipasvir|mesh-list
64327528|NCT02405013|Antimetabolites|antimetabolites|mesh-ancestor
64327529|NCT02405013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327530|NCT02405013|Antiviral Agents|antiviral agents|mesh-ancestor
64327531|NCT02405013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64327532|NCT02173145|Azithromycin|azithromycin|mesh-list
64844217|NCT01667692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64844218|NCT01667692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64844219|NCT01667718|Amoxicillin|amoxicillin|mesh-list
64777388|NCT02054754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64777389|NCT02054754|Analgesics|analgesics|mesh-ancestor
64388820|NCT03111797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388821|NCT03111797|Analgesics|analgesics|mesh-ancestor
64388822|NCT03111797|Sensory System Agents|sensory system agents|mesh-ancestor
64388823|NCT03111797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64388824|NCT02938013|Sofosbuvir|sofosbuvir|mesh-list
64388825|NCT02938013|Velpatasvir|velpatasvir|mesh-list
64388826|NCT02938013|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64844220|NCT01667718|Levofloxacin|levofloxacin|mesh-list
64844221|NCT01667718|Ofloxacin|ofloxacin|mesh-list
64844222|NCT01667718|Potassium Citrate|potassium citrate|mesh-list
64844223|NCT01667718|Lansoprazole|lansoprazole|mesh-list
64844224|NCT01667718|Dexlansoprazole|dexlansoprazole|mesh-list
64844225|NCT01667718|Bismuth|bismuth|mesh-list
64327533|NCT02173145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64327534|NCT02173145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64327535|NCT00670033|Travoprost|travoprost|mesh-list
64327536|NCT00670033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64327537|NCT00670033|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64327538|NCT00670033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64327539|NCT02283775|Dexamethasone|dexamethasone|mesh-list
64844226|NCT01667718|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64844227|NCT01667718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844228|NCT01667718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64844229|NCT01667718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64844230|NCT01667718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64844231|NCT01667718|Renal Agents|renal agents|mesh-ancestor
64388827|NCT02938013|Antiviral Agents|antiviral agents|mesh-ancestor
64388828|NCT02938013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64388829|NCT02820311|Moxifloxacin|moxifloxacin|mesh-list
64388830|NCT02820311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64416667|NCT03040765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64777410|NCT02057640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64777411|NCT02057640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388841|NCT02336633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844232|NCT01667718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64844233|NCT01667718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64844234|NCT01667718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844235|NCT01667718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844236|NCT01667718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64844237|NCT01667718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64844238|NCT01667718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64844239|NCT01667718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64844240|NCT01667718|Antacids|antacids|mesh-ancestor
64844241|NCT01667718|Diuretics|diuretics|mesh-ancestor
64844242|NCT01667718|Natriuretic Agents|natriuretic agents|mesh-ancestor
64844243|NCT01667718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844244|NCT01667718|Expectorants|expectorants|mesh-ancestor
64844245|NCT01667718|Respiratory System Agents|respiratory system agents|mesh-ancestor
64844246|NCT01667874|Gentamicins|gentamicins|mesh-list
64844247|NCT01667874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64844248|NCT01667874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64844249|NCT01667874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64844250|NCT01667874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844251|NCT01667874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388842|NCT02336633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388843|NCT02336633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64388845|NCT02336477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64388846|NCT02336477|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64388847|NCT02336477|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64844252|NCT01668043|UB-421|ub-421|mesh-list
64388848|NCT02336477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64388849|NCT02336477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388851|NCT04624451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64324135|NCT05361447|Anesthetics, General|anesthetics, general|mesh-ancestor
64324137|NCT05361447|GABA Modulators|gaba modulators|mesh-ancestor
64324138|NCT05361447|GABA Agents|gaba agents|mesh-ancestor
64324139|NCT05361447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64324140|NCT05361447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324141|NCT01577173|Cetuximab|cetuximab|mesh-list
64324142|NCT01577173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64324143|NCT01577173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324144|NCT01573351|Interferons|interferons|mesh-list
64324145|NCT01573351|Ribavirin|ribavirin|mesh-list
64324146|NCT01573351|Interferon-alpha|interferon-alpha|mesh-list
64324147|NCT01573351|Interferon alpha-2|interferon alpha-2|mesh-list
64324148|NCT01573351|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64324149|NCT01573351|Asunaprevir|asunaprevir|mesh-list
64844253|NCT01668043|Antibodies|antibodies|mesh-list
64844254|NCT01668043|Immunologic Factors|immunologic factors|mesh-ancestor
64844255|NCT01668043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844256|NCT01668043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64327540|NCT02283775|Pomalidomide|pomalidomide|mesh-list
64327541|NCT02283775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64327542|NCT02283775|Antiemetics|antiemetics|mesh-ancestor
64327543|NCT02283775|Autonomic Agents|autonomic agents|mesh-ancestor
64327544|NCT02283775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64327545|NCT02283775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327546|NCT02283775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64844257|NCT01668043|Antiviral Agents|antiviral agents|mesh-ancestor
64844258|NCT01668043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64844259|NCT01668056|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64844260|NCT01668056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64844261|NCT01668056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844262|NCT01668069|Ondansetron|ondansetron|mesh-list
64844263|NCT01668069|Antiemetics|antiemetics|mesh-ancestor
64844264|NCT01668069|Autonomic Agents|autonomic agents|mesh-ancestor
64844265|NCT01668069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844266|NCT01668069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844267|NCT01668069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64844268|NCT01668069|Antipruritics|antipruritics|mesh-ancestor
64844269|NCT01668069|Dermatologic Agents|dermatologic agents|mesh-ancestor
64430013|NCT04991597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64777418|NCT02059902|Sensory System Agents|sensory system agents|mesh-ancestor
64388885|NCT02709889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388886|NCT02709889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64301492|NCT03077828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64388894|NCT03189901|Vasodilator Agents|vasodilator agents|mesh-ancestor
64388895|NCT03189901|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64388896|NCT03189901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64388897|NCT03189901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388898|NCT03189901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388899|NCT03189901|Protective Agents|protective agents|mesh-ancestor
64388900|NCT03189901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777462|NCT02062710|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64777463|NCT02062710|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64777464|NCT02062710|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64777465|NCT02062710|Adrenergic Agents|adrenergic agents|mesh-ancestor
64777466|NCT02062710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64777467|NCT02062710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777468|NCT02062710|Protective Agents|protective agents|mesh-ancestor
64777469|NCT02062710|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64327549|NCT02283775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64327550|NCT02283775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64327552|NCT02283775|Immunologic Factors|immunologic factors|mesh-ancestor
64327553|NCT02283775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64844270|NCT01668069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64844271|NCT01668069|Serotonin Agents|serotonin agents|mesh-ancestor
64844272|NCT01668069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64844273|NCT01668069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844274|NCT01668069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64844275|NCT01668069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64844276|NCT01668069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64844277|NCT01668069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64844278|NCT01668069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64844279|NCT01668121|Budesonide|budesonide|mesh-list
64844280|NCT01668121|Formoterol Fumarate|formoterol fumarate|mesh-list
64844281|NCT01668121|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64844282|NCT01668121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64844283|NCT01668121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64844284|NCT01668121|Autonomic Agents|autonomic agents|mesh-ancestor
64844285|NCT01668121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844286|NCT01668121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844287|NCT01668121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64844288|NCT01668121|Respiratory System Agents|respiratory system agents|mesh-ancestor
64844289|NCT01668121|Glucocorticoids|glucocorticoids|mesh-ancestor
64777470|NCT02062710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64777471|NCT02062710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64777472|NCT02062710|Anesthetics, Local|anesthetics, local|mesh-ancestor
64777473|NCT02062710|Anesthetics|anesthetics|mesh-ancestor
64777474|NCT02062710|Sensory System Agents|sensory system agents|mesh-ancestor
64777475|NCT02062710|Antiemetics|antiemetics|mesh-ancestor
64777476|NCT02062710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64777477|NCT02062710|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64388901|NCT02711995|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64388902|NCT02711995|Botulinum Toxins|botulinum toxins|mesh-list
64388903|NCT02711995|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64844291|NCT01668121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64844292|NCT01668121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64844293|NCT01668121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64844294|NCT01668121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64844295|NCT01668121|Adrenergic Agents|adrenergic agents|mesh-ancestor
64844296|NCT01668121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64844297|NCT01668121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844298|NCT01668433|Primaquine|primaquine|mesh-list
64844299|NCT01668433|Methylene Blue|methylene blue|mesh-list
64844300|NCT01668433|Antimalarials|antimalarials|mesh-ancestor
64844301|NCT01668433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64844302|NCT01668433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64844303|NCT01668433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64844304|NCT01668433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844305|NCT01668433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844306|NCT01668446|Sildenafil Citrate|sildenafil citrate|mesh-list
64844307|NCT01668446|Estradiol|estradiol|mesh-list
64327554|NCT02283775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64327555|NCT02283775|Growth Substances|growth substances|mesh-ancestor
64327556|NCT02283775|Growth Inhibitors|growth inhibitors|mesh-ancestor
64327557|NCT04479891|Itraconazole|itraconazole|mesh-list
64844308|NCT01668446|Estrogens|estrogens|mesh-ancestor
64844309|NCT01668446|Hormones|hormones|mesh-ancestor
64388904|NCT02711995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64388905|NCT02711995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388906|NCT02711995|Cholinergic Agents|cholinergic agents|mesh-ancestor
64388907|NCT02711995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64388908|NCT02711995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388909|NCT02711995|Laxatives|laxatives|mesh-ancestor
64388910|NCT02711995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64388911|NCT03193723|Anesthetics|anesthetics|mesh-list
64388912|NCT03193723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64388913|NCT03193723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388914|NCT02437825|Octreotide|octreotide|mesh-list
64388915|NCT02437825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64777478|NCT02062710|Histamine Antagonists|histamine antagonists|mesh-ancestor
64844310|NCT01668446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64844311|NCT01668446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844312|NCT01668446|Vasodilator Agents|vasodilator agents|mesh-ancestor
64844313|NCT01668446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64844314|NCT01668446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64844315|NCT01668446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844316|NCT01668446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844317|NCT01668446|Urological Agents|urological agents|mesh-ancestor
64844318|NCT01668485|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64844319|NCT01668485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844320|NCT01668498|Doxycycline|doxycycline|mesh-list
64844321|NCT01668498|Erythromycin|erythromycin|mesh-list
64777480|NCT02062710|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64777481|NCT02062710|Antipruritics|antipruritics|mesh-ancestor
64777482|NCT02062710|Dermatologic Agents|dermatologic agents|mesh-ancestor
64777483|NCT02062710|Antitussive Agents|antitussive agents|mesh-ancestor
64777484|NCT02062710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64777485|NCT02062710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64777486|NCT02064582|Leuprolide|leuprolide|mesh-list
64777487|NCT02064582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64777488|NCT02064582|Fertility Agents|fertility agents|mesh-ancestor
64327558|NCT04479891|Antifungal Agents|antifungal agents|mesh-ancestor
64327559|NCT04479891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64327560|NCT04479891|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64844367|NCT01668680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64844368|NCT01668901|Aspirin|aspirin|mesh-list
64844369|NCT01668901|Warfarin|warfarin|mesh-list
64844370|NCT01668901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64844371|NCT01668901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64844372|NCT01668901|Analgesics|analgesics|mesh-ancestor
64844373|NCT01668901|Sensory System Agents|sensory system agents|mesh-ancestor
64844374|NCT01668901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844375|NCT01668901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844376|NCT01668901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64844377|NCT01668901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64844378|NCT01668901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64844379|NCT01668901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64327561|NCT04479891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64327562|NCT04479891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844380|NCT01668901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844381|NCT01668901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64844382|NCT01668901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64844383|NCT01668901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844385|NCT01668901|Anticoagulants|anticoagulants|mesh-ancestor
64844386|NCT01668927|Amoxicillin|amoxicillin|mesh-list
64844387|NCT01668927|Metronidazole|metronidazole|mesh-list
64844388|NCT01668927|Tetracycline|tetracycline|mesh-list
64844389|NCT01668927|Furazolidone|furazolidone|mesh-list
64844390|NCT01668927|Potassium Citrate|potassium citrate|mesh-list
64844391|NCT01668927|Lansoprazole|lansoprazole|mesh-list
64844392|NCT01668927|Bismuth|bismuth|mesh-list
64844393|NCT01668927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64844394|NCT01668927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844395|NCT01668927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64844396|NCT01668927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64844397|NCT01668927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64844398|NCT01668927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64327564|NCT04479891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64843911|NCT01664507|Autonomic Agents|autonomic agents|mesh-ancestor
64843912|NCT01664507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843913|NCT01664507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64327415|NCT03607539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64327417|NCT00629941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64327418|NCT00629941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64327419|NCT02404779|Cisatracurium|cisatracurium|mesh-list
64327420|NCT02404779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64843914|NCT01664507|Respiratory System Agents|respiratory system agents|mesh-ancestor
64843916|NCT01664507|Sympathomimetics|sympathomimetics|mesh-ancestor
64843917|NCT01664507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64844400|NCT01668927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64844401|NCT01668927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844402|NCT01668927|Antacids|antacids|mesh-ancestor
64844403|NCT01668927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64844404|NCT01668927|Diuretics|diuretics|mesh-ancestor
64844405|NCT01668927|Natriuretic Agents|natriuretic agents|mesh-ancestor
64844406|NCT01668927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844407|NCT01668927|Expectorants|expectorants|mesh-ancestor
64844408|NCT01668927|Respiratory System Agents|respiratory system agents|mesh-ancestor
64844409|NCT01668927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64844410|NCT01668927|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64844411|NCT01668927|Renal Agents|renal agents|mesh-ancestor
64844412|NCT01668927|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64844413|NCT01668927|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64844414|NCT01669044|Dexmedetomidine|dexmedetomidine|mesh-list
64844415|NCT01669044|Propofol|propofol|mesh-list
64844416|NCT01669044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64844417|NCT01669044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64844418|NCT01669044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844419|NCT01669044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64844420|NCT01669044|Anesthetics, General|anesthetics, general|mesh-ancestor
64844421|NCT01669044|Anesthetics|anesthetics|mesh-ancestor
64844422|NCT01669044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64844423|NCT01669044|Analgesics|analgesics|mesh-ancestor
64844424|NCT01669044|Sensory System Agents|sensory system agents|mesh-ancestor
64844425|NCT01669044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844426|NCT01669044|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64777489|NCT02064582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64777490|NCT02064582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777492|NCT02064582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64777493|NCT02069184|Acetaminophen|acetaminophen|mesh-list
64777494|NCT02069184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64777495|NCT02069184|Analgesics|analgesics|mesh-ancestor
64777496|NCT02069184|Sensory System Agents|sensory system agents|mesh-ancestor
64777497|NCT02069184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777498|NCT02069184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546180|NCT03661411|Antipyretics|antipyretics|mesh-ancestor
64777499|NCT02069184|Antipyretics|antipyretics|mesh-ancestor
64844437|NCT01669135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844438|NCT01669213|Ondansetron|ondansetron|mesh-list
64844439|NCT01669213|Ramosetron|ramosetron|mesh-list
64844440|NCT01669213|Antiemetics|antiemetics|mesh-ancestor
64844441|NCT01669213|Autonomic Agents|autonomic agents|mesh-ancestor
64844442|NCT01669213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844443|NCT01669213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844444|NCT01669213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64844445|NCT01669213|Antipruritics|antipruritics|mesh-ancestor
64844446|NCT01669213|Dermatologic Agents|dermatologic agents|mesh-ancestor
64844447|NCT01669213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64844448|NCT01669213|Serotonin Agents|serotonin agents|mesh-ancestor
64844449|NCT01669213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64844450|NCT01669213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327572|NCT02281279|Rituximab|rituximab|mesh-list
64327573|NCT02281279|Lenalidomide|lenalidomide|mesh-list
64327574|NCT02281279|Romidepsin|romidepsin|mesh-list
64844451|NCT01669213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64844452|NCT01669213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64844453|NCT01669213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64844454|NCT01669213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64844455|NCT01669213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64777500|NCT02134314|Complement C1s|complement c1s|mesh-list
64388917|NCT02437825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388918|NCT03512197|Midostaurin|midostaurin|mesh-list
64388919|NCT03512197|Staurosporine|staurosporine|mesh-list
64388920|NCT03512197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388921|NCT03512197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64388924|NCT02442817|Linagliptin|linagliptin|mesh-list
64777510|NCT02135016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64388941|NCT02442739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388942|NCT02442739|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64388943|NCT02442739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64388945|NCT02442739|Anesthetics|anesthetics|mesh-ancestor
64388946|NCT02442739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64388947|NCT02442739|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64388948|NCT02442739|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64388949|NCT02442739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64388950|NCT02442739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324167|NCT05579223|Analgesics|analgesics|mesh-ancestor
64324168|NCT05579223|Sensory System Agents|sensory system agents|mesh-ancestor
64844473|NCT01669291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844474|NCT01669291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64844475|NCT01669291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844476|NCT01669291|Hormone Antagonists|hormone antagonists|mesh-ancestor
64844477|NCT01669291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64844478|NCT01669304|Verapamil|verapamil|mesh-list
64844479|NCT01669304|Sertraline|sertraline|mesh-list
64844480|NCT01669304|Antidepressive Agents|antidepressive agents|mesh-ancestor
64844481|NCT01669304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64844482|NCT01669304|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64844483|NCT01669304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64844484|NCT01669304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64844485|NCT01669304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844486|NCT01669304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64844487|NCT01669304|Serotonin Agents|serotonin agents|mesh-ancestor
64844488|NCT01669304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324169|NCT05579223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64324170|NCT00258427|Methylprednisolone|methylprednisolone|mesh-list
64324171|NCT00258427|Cyclophosphamide|cyclophosphamide|mesh-list
64324172|NCT00258427|Busulfan|busulfan|mesh-list
64324173|NCT00258427|Fludarabine|fludarabine|mesh-list
64324174|NCT00258427|Fludarabine phosphate|fludarabine phosphate|mesh-list
64324175|NCT00258427|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64324176|NCT00258427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64324177|NCT00258427|Immunologic Factors|immunologic factors|mesh-ancestor
64324178|NCT00258427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388954|NCT02437045|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64327583|NCT02281279|Growth Inhibitors|growth inhibitors|mesh-ancestor
64327584|NCT02281279|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64327585|NCT02173457|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64327586|NCT02173457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64327587|NCT02173457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327588|NCT02173457|Incretins|incretins|mesh-ancestor
64327589|NCT02173457|Hormones|hormones|mesh-ancestor
64327590|NCT02173457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64844491|NCT01669304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64844493|NCT01669369|Lithium Carbonate|lithium carbonate|mesh-list
64844494|NCT01669369|Antidepressive Agents|antidepressive agents|mesh-ancestor
64844495|NCT01669369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64844496|NCT01669369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327591|NCT02173457|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64327592|NCT02173457|Protease Inhibitors|protease inhibitors|mesh-ancestor
64327593|NCT02173457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327594|NCT02173457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388955|NCT02437045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64388956|NCT02437045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64388957|NCT02437045|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64388958|NCT02437045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388959|NCT02437045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301497|NCT03077828|Antimitotic Agents|antimitotic agents|mesh-ancestor
64301498|NCT03077828|Mitosis Modulators|mitosis modulators|mesh-ancestor
64301499|NCT02126995|Metadoxine|metadoxine|mesh-list
64301500|NCT02126995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64354029|NCT03424889|Xylometazoline|xylometazoline|mesh-list
64388960|NCT03022903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64388961|NCT03022903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64327599|NCT00805129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327600|NCT00805129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64327601|NCT00805129|Immunologic Factors|immunologic factors|mesh-ancestor
64844497|NCT01669369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844498|NCT01669369|Antimanic Agents|antimanic agents|mesh-ancestor
64844499|NCT01669369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64844500|NCT01669369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64844501|NCT01669369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844502|NCT01669447|Ranibizumab|ranibizumab|mesh-list
64844503|NCT01669447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64844504|NCT01669447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64844505|NCT01669447|Growth Substances|growth substances|mesh-ancestor
64844506|NCT01669447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844507|NCT01669447|Growth Inhibitors|growth inhibitors|mesh-ancestor
64844508|NCT01669447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844509|NCT01669499|Dexamethasone|dexamethasone|mesh-list
64844510|NCT01669499|Dexamethasone acetate|dexamethasone acetate|mesh-list
64844511|NCT01669499|BB 1101|bb 1101|mesh-list
64388965|NCT02442427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64388966|NCT03189043|Anti-Infective Agents|anti-infective agents|mesh-list
64388967|NCT03189043|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64388969|NCT05233735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64388970|NCT05233735|Glucocorticoids|glucocorticoids|mesh-ancestor
64388971|NCT05233735|Hormones|hormones|mesh-ancestor
64388972|NCT05233735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64777543|NCT02148588|Anesthetics, Local|anesthetics, local|mesh-ancestor
64777544|NCT02148588|Anesthetics|anesthetics|mesh-ancestor
64388974|NCT05233735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64844512|NCT01669499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64844513|NCT01669499|Antiemetics|antiemetics|mesh-ancestor
64844514|NCT01669499|Autonomic Agents|autonomic agents|mesh-ancestor
64844515|NCT01669499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844516|NCT01669499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613008|NCT00359229|Zolpidem|zolpidem|mesh-list
64844517|NCT01669499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64844518|NCT01669499|Glucocorticoids|glucocorticoids|mesh-ancestor
64844519|NCT01669499|Hormones|hormones|mesh-ancestor
64844520|NCT01669499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64844521|NCT01669499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64844522|NCT01669499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844523|NCT01669499|Protease Inhibitors|protease inhibitors|mesh-ancestor
64844524|NCT01669499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844525|NCT01669499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844526|NCT01669707|Endostar protein|endostar protein|mesh-list
64844527|NCT01669707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64327602|NCT00805129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327603|NCT02165813|Nitazoxanide|nitazoxanide|mesh-list
64327604|NCT02165813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64327605|NCT02165813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64327606|NCT00501709|Abatacept|abatacept|mesh-list
64327607|NCT00501709|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64327608|NCT00501709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64327609|NCT00501709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327610|NCT00501709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327611|NCT00501709|Immunologic Factors|immunologic factors|mesh-ancestor
64844528|NCT01669707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64844529|NCT01669707|Growth Substances|growth substances|mesh-ancestor
64388975|NCT05233735|Respiratory System Agents|respiratory system agents|mesh-ancestor
64388976|NCT02436499|Botulinum Toxins|botulinum toxins|mesh-list
64388977|NCT02436499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64388978|NCT02436499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64301502|NCT04459052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64301503|NCT04459052|Antiviral Agents|antiviral agents|mesh-ancestor
64301504|NCT04459052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64301506|NCT04459052|Respiratory System Agents|respiratory system agents|mesh-ancestor
64301507|NCT04459052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64301508|NCT04459052|Antioxidants|antioxidants|mesh-ancestor
64301509|NCT04459052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301510|NCT04459052|Protective Agents|protective agents|mesh-ancestor
64844537|NCT01669824|Sensory System Agents|sensory system agents|mesh-ancestor
64844538|NCT01669824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844539|NCT01669824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844540|NCT01669824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64327613|NCT00501709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64327614|NCT02273635|Andrographolide|andrographolide|mesh-list
64327615|NCT02273635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64327616|NCT02273635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64844541|NCT01669824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64844542|NCT01669824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64844543|NCT01669824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64844544|NCT01669824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844545|NCT01669824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64844546|NCT01669824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64844547|NCT01669824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844548|NCT01669824|Antipyretics|antipyretics|mesh-ancestor
64301511|NCT04459052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301512|NCT04459052|Antidotes|antidotes|mesh-ancestor
64301513|NCT05257291|Melatonin|melatonin|mesh-list
64301514|NCT05257291|Antioxidants|antioxidants|mesh-ancestor
64301515|NCT05257291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301516|NCT05257291|Protective Agents|protective agents|mesh-ancestor
64301517|NCT05257291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301518|NCT05257291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64301519|NCT04930900|Epinephrine|epinephrine|mesh-list
64301520|NCT04930900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64301521|NCT04930900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64301522|NCT04930900|Adrenergic Agents|adrenergic agents|mesh-ancestor
64301524|NCT04930900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301525|NCT04930900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844549|NCT01669941|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64301526|NCT04930900|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64301527|NCT04930900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64301528|NCT04930900|Autonomic Agents|autonomic agents|mesh-ancestor
64301529|NCT04930900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777547|NCT02148588|Sensory System Agents|sensory system agents|mesh-ancestor
64777548|NCT02148588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777549|NCT02148588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64777550|NCT02148588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64777551|NCT02148588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64301558|NCT03077516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354116|NCT03441373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777552|NCT02148588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64777553|NCT02148588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844550|NCT01669941|Antimalarials|antimalarials|mesh-ancestor
64844551|NCT01669941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64844552|NCT01669941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64844553|NCT01669941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64844554|NCT01669967|Diphenhydramine|diphenhydramine|mesh-list
64844555|NCT01669967|Promethazine|promethazine|mesh-list
64777554|NCT02149524|Trastuzumab|trastuzumab|mesh-list
64777555|NCT02149524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64777556|NCT02149524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64777557|NCT02154048|Dexamethasone|dexamethasone|mesh-list
64777558|NCT02154048|Ropivacaine|ropivacaine|mesh-list
64844556|NCT01669967|Lidocaine|lidocaine|mesh-list
64777559|NCT02154048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64777560|NCT02154048|Antiemetics|antiemetics|mesh-ancestor
64777561|NCT02154048|Autonomic Agents|autonomic agents|mesh-ancestor
64301566|NCT04993040|Mitosis Modulators|mitosis modulators|mesh-ancestor
64301567|NCT04993040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301569|NCT05300035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64301570|NCT05300035|Immunologic Factors|immunologic factors|mesh-ancestor
64301571|NCT05300035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301572|NCT03072992|Curcumin|curcumin|mesh-list
64388987|NCT02331563|Dexmedetomidine|dexmedetomidine|mesh-list
64844557|NCT01669967|Anesthetics, Local|anesthetics, local|mesh-ancestor
64844558|NCT01669967|Anesthetics|anesthetics|mesh-ancestor
64844559|NCT01669967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64844560|NCT01669967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844561|NCT01669967|Sensory System Agents|sensory system agents|mesh-ancestor
64844562|NCT01669967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844563|NCT01669967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64844564|NCT01669967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64844565|NCT01669967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64844566|NCT01669967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64844567|NCT01669967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844568|NCT01669967|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64844569|NCT01669967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64844570|NCT01669967|Antiemetics|antiemetics|mesh-ancestor
64327617|NCT02273635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64327619|NCT02273635|Sensory System Agents|sensory system agents|mesh-ancestor
64327620|NCT02273635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64327621|NCT02273635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327622|NCT02273635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64327623|NCT02273635|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64844572|NCT01669967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64844573|NCT01669967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64844574|NCT01669967|Histamine Antagonists|histamine antagonists|mesh-ancestor
64844575|NCT01669967|Histamine Agents|histamine agents|mesh-ancestor
64388988|NCT02331563|Bupivacaine|bupivacaine|mesh-list
64844576|NCT01669967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64844577|NCT01669967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64388989|NCT02331563|Anesthetics, Local|anesthetics, local|mesh-ancestor
64388990|NCT02331563|Anesthetics|anesthetics|mesh-ancestor
64388991|NCT02331563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64388992|NCT02331563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388993|NCT02331563|Sensory System Agents|sensory system agents|mesh-ancestor
64388994|NCT02331563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64388995|NCT02331563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64777562|NCT02154048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777563|NCT02154048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844578|NCT01669967|Antipruritics|antipruritics|mesh-ancestor
64844579|NCT01669967|Dermatologic Agents|dermatologic agents|mesh-ancestor
64844580|NCT01670149|Rifaximin|rifaximin|mesh-list
64844581|NCT01670149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64327624|NCT02273635|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64327625|NCT02273635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64327626|NCT02273635|Antiviral Agents|antiviral agents|mesh-ancestor
64327627|NCT02273635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64327628|NCT02170415|Pregabalin|pregabalin|mesh-list
64327629|NCT02170415|Anesthetics|anesthetics|mesh-list
64327630|NCT02170415|Anesthetics, Local|anesthetics, local|mesh-list
64327631|NCT02170415|Analgesics|analgesics|mesh-ancestor
64327632|NCT02170415|Sensory System Agents|sensory system agents|mesh-ancestor
64327633|NCT02170415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844583|NCT01670149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64844585|NCT01670370|Oxaliplatin|oxaliplatin|mesh-list
64844586|NCT01670370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844587|NCT01670370|Immunologic Factors|immunologic factors|mesh-ancestor
64844588|NCT01670370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844589|NCT01670370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64844590|NCT01670370|Antimetabolites|antimetabolites|mesh-ancestor
64844591|NCT01670370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844593|NCT01670370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64844594|NCT01670370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64777564|NCT02154048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64777565|NCT02154048|Glucocorticoids|glucocorticoids|mesh-ancestor
64777566|NCT02154048|Hormones|hormones|mesh-ancestor
64777567|NCT02154048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64354250|NCT03432793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64354251|NCT03432793|Hormone Antagonists|hormone antagonists|mesh-ancestor
64777574|NCT02156154|Acetaminophen|acetaminophen|mesh-list
64777575|NCT02156154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64777576|NCT02156154|Analgesics|analgesics|mesh-ancestor
64777577|NCT02156154|Sensory System Agents|sensory system agents|mesh-ancestor
64777578|NCT02156154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777579|NCT02156154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777580|NCT02156154|Antipyretics|antipyretics|mesh-ancestor
64777581|NCT02158572|Contraceptive Agents|contraceptive agents|mesh-list
64777582|NCT02158572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64388996|NCT02331563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64388997|NCT02331563|Analgesics|analgesics|mesh-ancestor
64388998|NCT02331563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64388999|NCT02331563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64777588|NCT02159976|Pantoprazole|pantoprazole|mesh-list
64777589|NCT02159976|Bismuth|bismuth|mesh-list
64777590|NCT02159976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64777591|NCT02159976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64777592|NCT02159976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64327634|NCT02170415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327635|NCT02170415|Anticonvulsants|anticonvulsants|mesh-ancestor
64327636|NCT02170415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64327637|NCT02170415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64327638|NCT02170415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327639|NCT02170415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64844595|NCT01670370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64844596|NCT01670552|Naproxen|naproxen|mesh-list
64844597|NCT01670552|Nimesulide|nimesulide|mesh-list
64844598|NCT01670552|Esomeprazole|esomeprazole|mesh-list
64777593|NCT02159976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64777594|NCT02159976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64777595|NCT02159976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389019|NCT02441803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64389020|NCT02441803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64389021|NCT02441803|Alkylating Agents|alkylating agents|mesh-ancestor
64389022|NCT02441803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389023|NCT02441803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64389024|NCT02441803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64389025|NCT02441803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64389026|NCT02441803|Antimetabolites|antimetabolites|mesh-ancestor
64389027|NCT02441803|Antiviral Agents|antiviral agents|mesh-ancestor
64389028|NCT02441803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64389029|NCT02441803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64301574|NCT03072992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64301575|NCT03072992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301576|NCT03072992|Tubulin Modulators|tubulin modulators|mesh-ancestor
64301577|NCT03072992|Antimitotic Agents|antimitotic agents|mesh-ancestor
64301578|NCT03072992|Mitosis Modulators|mitosis modulators|mesh-ancestor
64301579|NCT03072992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301580|NCT03072992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64301581|NCT03072992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64301582|NCT03072992|Analgesics|analgesics|mesh-ancestor
64301583|NCT03072992|Sensory System Agents|sensory system agents|mesh-ancestor
64301584|NCT03072992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777603|NCT02160288|Botulinum Toxins|botulinum toxins|mesh-list
64777604|NCT02160288|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64777605|NCT02160288|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64777606|NCT02160288|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64777607|NCT02160288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64777608|NCT02160288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777609|NCT02160288|Cholinergic Agents|cholinergic agents|mesh-ancestor
64389030|NCT02441803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844599|NCT01670552|Pantoprazole|pantoprazole|mesh-list
64844600|NCT01670552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64844601|NCT01670552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64844602|NCT01670552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64844603|NCT01670552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389031|NCT02441803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64389032|NCT02441803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64389033|NCT02441803|Antitubercular Agents|antitubercular agents|mesh-ancestor
64389034|NCT02441803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64389035|NCT02441803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64389036|NCT02441803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64389037|NCT02331173|Dorzolamide|dorzolamide|mesh-list
64389038|NCT02331173|Brinzolamide|brinzolamide|mesh-list
64389039|NCT02331173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64389040|NCT02331173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389041|NCT02331173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389042|NCT02331173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64389043|NCT02709109|Ivacaftor|ivacaftor|mesh-list
64324182|NCT00258427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327640|NCT02170415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64327641|NCT02170415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64324183|NCT00258427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301598|NCT03550651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64327642|NCT02170415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64327643|NCT02170415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64327644|NCT00622063|Beta-lapachone|beta-lapachone|mesh-list
64844604|NCT01670552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844605|NCT01670552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64844607|NCT01670552|Analgesics|analgesics|mesh-ancestor
64844608|NCT01670552|Sensory System Agents|sensory system agents|mesh-ancestor
64844609|NCT01670552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844610|NCT01670552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844611|NCT01670552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64844612|NCT01670552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64844613|NCT01670552|Gout Suppressants|gout suppressants|mesh-ancestor
64327645|NCT00622063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64301599|NCT03550651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64301600|NCT03550651|Disinfectants|disinfectants|mesh-ancestor
64301601|NCT03550651|Dermatologic Agents|dermatologic agents|mesh-ancestor
64301602|NCT02456961|Riboflavin|riboflavin|mesh-list
64301603|NCT02456961|Vitamin B Complex|vitamin b complex|mesh-ancestor
64301604|NCT02456961|Vitamins|vitamins|mesh-ancestor
64301605|NCT02456961|Micronutrients|micronutrients|mesh-ancestor
64301606|NCT02456961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301607|NCT02456961|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64301608|NCT02456961|Dermatologic Agents|dermatologic agents|mesh-ancestor
64301609|NCT03551197|Budesonide|budesonide|mesh-list
64301621|NCT03551197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64301622|NCT03551197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64301623|NCT03551197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64301624|NCT03551197|Adrenergic Agents|adrenergic agents|mesh-ancestor
64844614|NCT01670552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64844615|NCT01670578|Hyaluronic Acid|hyaluronic acid|mesh-list
64844616|NCT01670578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64844617|NCT01670578|Immunologic Factors|immunologic factors|mesh-ancestor
64844618|NCT01670578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844619|NCT01670578|Viscosupplements|viscosupplements|mesh-ancestor
64844620|NCT01670578|Protective Agents|protective agents|mesh-ancestor
64844621|NCT01670812|Methylprednisolone|methylprednisolone|mesh-list
64844622|NCT01670812|Rituximab|rituximab|mesh-list
64844623|NCT01670812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64844624|NCT01670812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844625|NCT01670812|Immunologic Factors|immunologic factors|mesh-ancestor
64844626|NCT01670812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327646|NCT00622063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64327647|NCT00622063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64327648|NCT00622063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327649|NCT00622063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327650|NCT00622063|Antiviral Agents|antiviral agents|mesh-ancestor
64327651|NCT02173691|Tiotropium Bromide|tiotropium bromide|mesh-list
64327652|NCT02173691|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64389047|NCT04233749|Tranexamic Acid|tranexamic acid|mesh-list
64389048|NCT04233749|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64389049|NCT04233749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64389050|NCT04233749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389051|NCT04233749|Hemostatics|hemostatics|mesh-ancestor
64389052|NCT04233749|Coagulants|coagulants|mesh-ancestor
64389053|NCT03117595|Fentanyl|fentanyl|mesh-list
64389054|NCT03117595|Morphine|morphine|mesh-list
64389055|NCT03117595|Bupivacaine|bupivacaine|mesh-list
64301625|NCT03551197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64301626|NCT03551197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301627|NCT02435836|Aripiprazole|aripiprazole|mesh-list
64301628|NCT02435836|Antidepressive Agents|antidepressive agents|mesh-ancestor
64301629|NCT02435836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64301630|NCT02435836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64301631|NCT02435836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64301632|NCT02435836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64301633|NCT02435836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301634|NCT02435836|Dopamine Agonists|dopamine agonists|mesh-ancestor
64301635|NCT02435836|Dopamine Agents|dopamine agents|mesh-ancestor
64301636|NCT02435836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64301637|NCT02435836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301638|NCT02435836|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64301639|NCT02435836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64301640|NCT02435836|Serotonin Agents|serotonin agents|mesh-ancestor
64301641|NCT02435836|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64301642|NCT02435836|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64301651|NCT05075265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301653|NCT05075265|Sensory System Agents|sensory system agents|mesh-ancestor
64301654|NCT05075265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301655|NCT05075265|Antitussive Agents|antitussive agents|mesh-ancestor
64301656|NCT05075265|Respiratory System Agents|respiratory system agents|mesh-ancestor
64301657|NCT02127541|Exenatide|exenatide|mesh-list
64301658|NCT02127541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64301660|NCT02127541|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64301661|NCT02127541|Incretins|incretins|mesh-ancestor
64844627|NCT01670812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64844628|NCT01670812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64844629|NCT01670812|Antiemetics|antiemetics|mesh-ancestor
64844630|NCT01670812|Autonomic Agents|autonomic agents|mesh-ancestor
64844631|NCT01670812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844632|NCT01670812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64844633|NCT01670812|Glucocorticoids|glucocorticoids|mesh-ancestor
64844634|NCT01670812|Hormones|hormones|mesh-ancestor
64294298|NCT03023462|Droperidol|droperidol|mesh-list
64301662|NCT02127541|Hormones|hormones|mesh-ancestor
64301663|NCT02127541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64301664|NCT03263871|Micronutrients|micronutrients|mesh-list
64301665|NCT03263871|Trace Elements|trace elements|mesh-list
64301666|NCT03263871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301667|NCT04992182|Vaccines|vaccines|mesh-list
64301668|NCT04992182|Immunologic Factors|immunologic factors|mesh-ancestor
64354560|NCT03416777|Protective Agents|protective agents|mesh-ancestor
64354561|NCT03416777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354562|NCT03416777|Vitamins|vitamins|mesh-ancestor
64354563|NCT03416777|Micronutrients|micronutrients|mesh-ancestor
64354566|NCT03422887|Flurbiprofen|flurbiprofen|mesh-list
64777628|NCT02164422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777629|NCT02164422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777630|NCT02170662|Bimatoprost|bimatoprost|mesh-list
64777631|NCT02170662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64777632|NCT02173392|Brodalumab|brodalumab|mesh-list
64844635|NCT01670812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64777633|NCT02173392|Dermatologic Agents|dermatologic agents|mesh-ancestor
64777634|NCT02178540|Tobramycin|tobramycin|mesh-list
64777635|NCT02178540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64777636|NCT02178540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64777637|NCT02178696|Antidepressive Agents|antidepressive agents|mesh-list
64777638|NCT02178696|Citalopram|citalopram|mesh-list
64844636|NCT01670812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64844637|NCT01670812|Protective Agents|protective agents|mesh-ancestor
64844638|NCT01671449|Oxaliplatin|oxaliplatin|mesh-list
64844639|NCT01671449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844640|NCT01671800|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
64844641|NCT01671800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64844642|NCT01671800|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64844643|NCT01671800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64844644|NCT01671800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844645|NCT01671800|Cholinergic Agents|cholinergic agents|mesh-ancestor
64844646|NCT01671800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64844647|NCT01671800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327653|NCT02173691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64327654|NCT02173691|Autonomic Agents|autonomic agents|mesh-ancestor
64327655|NCT02173691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844648|NCT01672359|Choline|choline|mesh-list
64844649|NCT01672359|Lipotropic Agents|lipotropic agents|mesh-ancestor
64844650|NCT01672359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64844651|NCT01672359|Antimetabolites|antimetabolites|mesh-ancestor
64844652|NCT01672359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844653|NCT01672359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64844654|NCT01672359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64844655|NCT01672359|Nootropic Agents|nootropic agents|mesh-ancestor
64844656|NCT01673308|Lenalidomide|lenalidomide|mesh-list
64777639|NCT02178696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64301669|NCT04992182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301670|NCT02124655|Chlorhexidine|chlorhexidine|mesh-list
64301671|NCT02124655|Listerine|listerine|mesh-list
64301672|NCT02124655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64301675|NCT03263715|Glucocorticoids|glucocorticoids|mesh-list
64301676|NCT03263715|Hormones|hormones|mesh-ancestor
64301677|NCT03263715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64301678|NCT03263715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301679|NCT02457039|Cyclophosphamide|cyclophosphamide|mesh-list
64301680|NCT02457039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64301681|NCT02457039|Immunologic Factors|immunologic factors|mesh-ancestor
64301682|NCT02457039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301683|NCT02457039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64301684|NCT02457039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64301685|NCT02457039|Alkylating Agents|alkylating agents|mesh-ancestor
64301686|NCT02457039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301687|NCT02457039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354573|NCT03422887|Analgesics|analgesics|mesh-ancestor
64777640|NCT02178696|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64777641|NCT02178696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64777642|NCT02178696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64546327|NCT03644485|Immunologic Factors|immunologic factors|mesh-ancestor
64546328|NCT03644485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64546329|NCT03644485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64546330|NCT03644485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389056|NCT03117595|Anesthetics, Local|anesthetics, local|mesh-ancestor
64389057|NCT03117595|Anesthetics|anesthetics|mesh-ancestor
64389058|NCT03117595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64389059|NCT03117595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389060|NCT03117595|Sensory System Agents|sensory system agents|mesh-ancestor
64389061|NCT03117595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777649|NCT02179788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64777650|NCT02179788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389084|NCT02331251|Irinotecan|irinotecan|mesh-list
64389085|NCT02331251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64389086|NCT02331251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64389087|NCT02331251|Tubulin Modulators|tubulin modulators|mesh-ancestor
64389088|NCT02331251|Antimitotic Agents|antimitotic agents|mesh-ancestor
64389089|NCT02331251|Mitosis Modulators|mitosis modulators|mesh-ancestor
64389090|NCT02331251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389091|NCT02331251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64844657|NCT01673308|Immunologic Factors|immunologic factors|mesh-ancestor
64844658|NCT01673308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844659|NCT01673308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64844660|NCT01673308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64389092|NCT02331251|Antimetabolites|antimetabolites|mesh-ancestor
64389093|NCT02331251|Antiviral Agents|antiviral agents|mesh-ancestor
64389094|NCT02331251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64301688|NCT02457039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64301689|NCT03266991|Isoniazid|isoniazid|mesh-list
64301690|NCT03266991|Rifapentine|rifapentine|mesh-list
64301691|NCT03266991|Antitubercular Agents|antitubercular agents|mesh-ancestor
64301692|NCT03266991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64301693|NCT03266991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64301694|NCT03266991|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64301695|NCT03266991|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64301696|NCT03266991|Antimetabolites|antimetabolites|mesh-ancestor
64301697|NCT03266991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301698|NCT03266991|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64301699|NCT03266991|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64301700|NCT03266991|Leprostatic Agents|leprostatic agents|mesh-ancestor
64301701|NCT02456740|Erenumab|erenumab|mesh-list
64301702|NCT02456740|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64301704|NCT02456740|Analgesics|analgesics|mesh-ancestor
64301734|NCT04462406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64301735|NCT04462406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301736|NCT02400580|Acetaminophen|acetaminophen|mesh-list
64301737|NCT02400580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64301738|NCT02400580|Analgesics|analgesics|mesh-ancestor
64301739|NCT02400580|Sensory System Agents|sensory system agents|mesh-ancestor
64389096|NCT02331251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64389097|NCT02331251|Immunologic Factors|immunologic factors|mesh-ancestor
64389098|NCT02331251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389099|NCT02331251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64389100|NCT02331251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64389101|NCT02331251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64301748|NCT03262857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301749|NCT03262857|Sensory System Agents|sensory system agents|mesh-ancestor
64844678|NCT01674556|Immunologic Factors|immunologic factors|mesh-ancestor
64301750|NCT03262857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301751|NCT03262857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64301752|NCT03262857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64844679|NCT01674556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844681|NCT01675115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64844682|NCT01675115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64844683|NCT01675115|Analgesics|analgesics|mesh-ancestor
64844684|NCT01675115|Sensory System Agents|sensory system agents|mesh-ancestor
64844685|NCT01675115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844686|NCT01675115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844687|NCT01675115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64844688|NCT01675115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64844689|NCT01675115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64844690|NCT01675115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64844691|NCT01675115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844692|NCT01675115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64301753|NCT03262857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64301754|NCT03262857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64324186|NCT00258427|Antimetabolites|antimetabolites|mesh-ancestor
64324187|NCT00258427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64324188|NCT00258427|Antiemetics|antiemetics|mesh-ancestor
64301755|NCT03262857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301757|NCT03262857|Anticonvulsants|anticonvulsants|mesh-ancestor
64301758|NCT03262857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64301759|NCT03262857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64301760|NCT03262857|Tocolytic Agents|tocolytic agents|mesh-ancestor
64301761|NCT03262857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64301762|NCT02127697|Glycopyrrolate|glycopyrrolate|mesh-list
64301763|NCT02127697|Albuterol|albuterol|mesh-list
64301764|NCT02127697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64301765|NCT02127697|Autonomic Agents|autonomic agents|mesh-ancestor
64301766|NCT02127697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301767|NCT02127697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301768|NCT02127697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64301769|NCT02127697|Respiratory System Agents|respiratory system agents|mesh-ancestor
64301770|NCT02127697|Tocolytic Agents|tocolytic agents|mesh-ancestor
64777679|NCT02192814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64777681|NCT02192814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64843918|NCT01665586|Dexmedetomidine|dexmedetomidine|mesh-list
64844693|NCT01675115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64844694|NCT01675115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844695|NCT01675115|Antipyretics|antipyretics|mesh-ancestor
64844696|NCT01675310|Metformin|metformin|mesh-list
64844697|NCT01675310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64844698|NCT01675310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844699|NCT01676649|Paclitaxel|paclitaxel|mesh-list
64844700|NCT01676649|Carboplatin|carboplatin|mesh-list
64844701|NCT01676649|Ipilimumab|ipilimumab|mesh-list
64844702|NCT01676649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64844703|NCT01676649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844704|NCT01676649|Tubulin Modulators|tubulin modulators|mesh-ancestor
64844705|NCT01676649|Antimitotic Agents|antimitotic agents|mesh-ancestor
64844706|NCT01676649|Mitosis Modulators|mitosis modulators|mesh-ancestor
64844707|NCT01676649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844708|NCT01676649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64844709|NCT01676649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64844710|NCT01676987|Budesonide|budesonide|mesh-list
64844711|NCT01676987|Formoterol Fumarate|formoterol fumarate|mesh-list
64844712|NCT01676987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64844713|NCT01676987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64844714|NCT01676987|Autonomic Agents|autonomic agents|mesh-ancestor
64844715|NCT01676987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844716|NCT01676987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777682|NCT02192814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777683|NCT02195232|Quercetin|quercetin|mesh-list
64389113|NCT02330705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64389114|NCT02330705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389115|NCT02330783|Bevacizumab|bevacizumab|mesh-list
64389116|NCT02330783|Sorafenib|sorafenib|mesh-list
64389117|NCT02330783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64389118|NCT02330783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64389119|NCT02330783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64389120|NCT02330783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64389121|NCT02330783|Growth Substances|growth substances|mesh-ancestor
64389122|NCT02330783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389123|NCT02330783|Growth Inhibitors|growth inhibitors|mesh-ancestor
64389124|NCT02330783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64389125|NCT02330783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389126|NCT02330783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389127|NCT02335151|Desflurane|desflurane|mesh-list
64389129|NCT02335151|Anesthetics, General|anesthetics, general|mesh-ancestor
64389130|NCT02335151|Anesthetics|anesthetics|mesh-ancestor
64389131|NCT02335151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64301771|NCT02127697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64301772|NCT02127697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64301773|NCT02127697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64354726|NCT03128203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64777718|NCT02206776|Midazolam|midazolam|mesh-list
64389151|NCT02709655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64389152|NCT02709655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64389153|NCT02709655|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64389154|NCT02709655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64389155|NCT02334605|Capsaicin|capsaicin|mesh-list
64844717|NCT01676987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64389156|NCT02334605|Antipruritics|antipruritics|mesh-ancestor
64389157|NCT02334605|Dermatologic Agents|dermatologic agents|mesh-ancestor
64389158|NCT02334605|Sensory System Agents|sensory system agents|mesh-ancestor
64389159|NCT02334605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844718|NCT01676987|Respiratory System Agents|respiratory system agents|mesh-ancestor
64327660|NCT02173691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64327661|NCT02173691|Cholinergic Agents|cholinergic agents|mesh-ancestor
64327662|NCT02173691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64844720|NCT01676987|Hormones|hormones|mesh-ancestor
64844721|NCT01676987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64844722|NCT01676987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64844723|NCT01676987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64844724|NCT01676987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64844725|NCT01676987|Adrenergic Agents|adrenergic agents|mesh-ancestor
64844726|NCT01676987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64844727|NCT01676987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844728|NCT01677039|Ethanol|ethanol|mesh-list
64844729|NCT01677039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64294359|NCT05707819|Antibodies|antibodies|mesh-list
64389160|NCT02334605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389161|NCT02329535|Progesterone|progesterone|mesh-list
64301774|NCT02127697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64301775|NCT02127697|Adrenergic Agents|adrenergic agents|mesh-ancestor
64777727|NCT02206776|Anesthetics|anesthetics|mesh-ancestor
64777728|NCT02206776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64777729|NCT02206776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64777730|NCT02206776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64777731|NCT02206776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64777732|NCT02206776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777733|NCT02206776|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64777734|NCT02206776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64777735|NCT02206776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64777736|NCT02206776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64777737|NCT02206776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64777738|NCT02206776|GABA Modulators|gaba modulators|mesh-ancestor
64777739|NCT02206776|GABA Agents|gaba agents|mesh-ancestor
64389162|NCT02329535|Progestins|progestins|mesh-ancestor
64389163|NCT02329535|Hormones|hormones|mesh-ancestor
64389164|NCT02329535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64389165|NCT02329535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389166|NCT03187795|Mirabegron|mirabegron|mesh-list
64389167|NCT03187795|Oxybutynin|oxybutynin|mesh-list
64389168|NCT03187795|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64389169|NCT03187795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64389170|NCT03187795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64389171|NCT03187795|Adrenergic Agents|adrenergic agents|mesh-ancestor
64777764|NCT02215200|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64301793|NCT02252341|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64844730|NCT01677039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64844731|NCT01677039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64844732|NCT01677039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844733|NCT01677065|Oxycodone|oxycodone|mesh-list
64844734|NCT01677065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64844735|NCT01677065|Narcotics|narcotics|mesh-ancestor
64844736|NCT01677065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64844737|NCT01677065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844738|NCT01677065|Analgesics|analgesics|mesh-ancestor
64844739|NCT01677065|Sensory System Agents|sensory system agents|mesh-ancestor
64844740|NCT01677065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844741|NCT01677247|Glimepiride|glimepiride|mesh-list
64613241|NCT02245295|Anesthetics|anesthetics|mesh-list
64844742|NCT01677247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64844743|NCT01677247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64844744|NCT01677247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844745|NCT01677247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64844746|NCT01677247|Immunologic Factors|immunologic factors|mesh-ancestor
64844748|NCT01677260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64844749|NCT01677260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844750|NCT01677572|Immunoglobulin G|immunoglobulin g|mesh-list
64844751|NCT01677572|Immunologic Factors|immunologic factors|mesh-ancestor
64301794|NCT02252341|Antioxidants|antioxidants|mesh-ancestor
64301795|NCT02252341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301796|NCT02252341|Protective Agents|protective agents|mesh-ancestor
64301797|NCT02252341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301798|NCT02252341|Antidotes|antidotes|mesh-ancestor
64301799|NCT02127853|Gabapentin|gabapentin|mesh-list
64301800|NCT02127853|Analgesics|analgesics|mesh-ancestor
64301801|NCT02127853|Sensory System Agents|sensory system agents|mesh-ancestor
64301802|NCT02127853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301803|NCT02127853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301804|NCT02127853|Anticonvulsants|anticonvulsants|mesh-ancestor
64301805|NCT02127853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64301806|NCT02127853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64777765|NCT02215200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64389195|NCT02435563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64389196|NCT02435563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64389197|NCT02435563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64389198|NCT02435563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64389199|NCT02435563|Purinergic Agents|purinergic agents|mesh-ancestor
64389200|NCT02435563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64389201|NCT02435563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301807|NCT02127853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64301808|NCT02127853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64844752|NCT01677572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844753|NCT01677650|Methadone|methadone|mesh-list
64844754|NCT01677650|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64844755|NCT01677650|Narcotics|narcotics|mesh-ancestor
64844756|NCT01677650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64844757|NCT01677650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844758|NCT01677650|Analgesics|analgesics|mesh-ancestor
64844759|NCT01677650|Sensory System Agents|sensory system agents|mesh-ancestor
64844760|NCT01677650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844761|NCT01677650|Antitussive Agents|antitussive agents|mesh-ancestor
64844762|NCT01677650|Respiratory System Agents|respiratory system agents|mesh-ancestor
64844763|NCT01678053|Omeprazole|omeprazole|mesh-list
64844764|NCT01678053|Botulinum Toxins|botulinum toxins|mesh-list
64844765|NCT01678053|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64844766|NCT01678053|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64844767|NCT01678053|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64844768|NCT01678053|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64844769|NCT01678053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64844770|NCT01678053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844771|NCT01678053|Cholinergic Agents|cholinergic agents|mesh-ancestor
64844772|NCT01678053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64844773|NCT01678053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844774|NCT01678053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64844775|NCT01678053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64844776|NCT01678053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64301809|NCT02127853|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64301810|NCT02127853|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64301811|NCT02127853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64301812|NCT02127853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301813|NCT02127853|Antimanic Agents|antimanic agents|mesh-ancestor
64301814|NCT03266445|Buprenorphine|buprenorphine|mesh-list
64301815|NCT03266445|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64389203|NCT04031729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64389204|NCT04031729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64389206|NCT04031729|Sensory System Agents|sensory system agents|mesh-ancestor
64389207|NCT04031729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777767|NCT02215200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777768|NCT02215200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64777769|NCT02218320|Raltegravir Potassium|raltegravir potassium|mesh-list
64777770|NCT02218320|Dolutegravir|dolutegravir|mesh-list
64777771|NCT02218320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64777772|NCT02218320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64777773|NCT02218320|Antiviral Agents|antiviral agents|mesh-ancestor
64777774|NCT02218320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64777775|NCT02218320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64844778|NCT01678053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844779|NCT01678937|Cyclosporine|cyclosporine|mesh-list
64844780|NCT01678937|Sirolimus|sirolimus|mesh-list
64844781|NCT01678937|Mycophenolic Acid|mycophenolic acid|mesh-list
64844782|NCT01678937|Tacrolimus|tacrolimus|mesh-list
64844783|NCT01678937|Cyclosporins|cyclosporins|mesh-list
64844784|NCT01678937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64844785|NCT01678937|Immunologic Factors|immunologic factors|mesh-ancestor
64844786|NCT01678937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844787|NCT01678937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64844788|NCT01678937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844789|NCT01678937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327663|NCT02173691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327665|NCT02173691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64327666|NCT02173691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64327667|NCT02173691|Adrenergic Agents|adrenergic agents|mesh-ancestor
64327668|NCT02274259|Ranibizumab|ranibizumab|mesh-list
64327669|NCT02274259|Aflibercept|aflibercept|mesh-list
64327670|NCT02274259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64327671|NCT02274259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64327672|NCT02274259|Growth Substances|growth substances|mesh-ancestor
64327673|NCT02274259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327674|NCT02274259|Growth Inhibitors|growth inhibitors|mesh-ancestor
64777776|NCT02218320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64777777|NCT02218320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64777778|NCT02218320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777779|NCT02222610|Ranibizumab|ranibizumab|mesh-list
64777780|NCT02222610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64301816|NCT03266445|Naloxone|naloxone|mesh-list
64301817|NCT03266445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64301818|NCT03266445|Narcotics|narcotics|mesh-ancestor
64301819|NCT03266445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64301820|NCT03266445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301821|NCT03266445|Analgesics|analgesics|mesh-ancestor
64301822|NCT03266445|Sensory System Agents|sensory system agents|mesh-ancestor
64301823|NCT03266445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301824|NCT03266445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64301825|NCT01367119|Ketamine|ketamine|mesh-list
64301826|NCT01367119|Methohexital|methohexital|mesh-list
64301827|NCT01367119|Analgesics|analgesics|mesh-ancestor
64301828|NCT01367119|Sensory System Agents|sensory system agents|mesh-ancestor
64301829|NCT01367119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301830|NCT01367119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301831|NCT01367119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64301832|NCT01367119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64301833|NCT01367119|Anesthetics, General|anesthetics, general|mesh-ancestor
64301834|NCT01367119|Anesthetics|anesthetics|mesh-ancestor
64354998|NCT04699591|Domperidone|domperidone|mesh-list
64777781|NCT02222610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64777782|NCT02222610|Growth Substances|growth substances|mesh-ancestor
64777783|NCT02222610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777784|NCT02222610|Growth Inhibitors|growth inhibitors|mesh-ancestor
64389208|NCT04031729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389209|NCT04031729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64389210|NCT04031729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64389211|NCT04031729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64389212|NCT04031729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64389213|NCT04031729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389214|NCT04031729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64389215|NCT04031729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64389216|NCT04031729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64777794|NCT02223702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844796|NCT01678937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64844797|NCT01678937|Antitubercular Agents|antitubercular agents|mesh-ancestor
64844798|NCT01678937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64844799|NCT01679041|Cyclophosphamide|cyclophosphamide|mesh-list
64844800|NCT01679041|Fludarabine|fludarabine|mesh-list
64844801|NCT01679041|Alemtuzumab|alemtuzumab|mesh-list
64844802|NCT01679041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64844803|NCT01679041|Immunologic Factors|immunologic factors|mesh-ancestor
64844804|NCT01679041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777795|NCT02223702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64777796|NCT02223702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64301836|NCT01367119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64301837|NCT01367119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64301838|NCT01367119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64301839|NCT01367119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301840|NCT02252107|Decitabine|decitabine|mesh-list
64301841|NCT02252107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64301842|NCT02252107|Antimetabolites|antimetabolites|mesh-ancestor
64301843|NCT02252107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355049|NCT03127189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389227|NCT02435095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64389228|NCT02435095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389230|NCT02328521|Nicorandil|nicorandil|mesh-list
64389231|NCT02328521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64389232|NCT02328521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64389233|NCT02328521|Vasodilator Agents|vasodilator agents|mesh-ancestor
64389234|NCT02328521|Vitamin B Complex|vitamin b complex|mesh-ancestor
64389235|NCT02328521|Vitamins|vitamins|mesh-ancestor
64389236|NCT02328521|Micronutrients|micronutrients|mesh-ancestor
64389237|NCT02328521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389238|NCT03831503|Antibodies|antibodies|mesh-list
64389239|NCT03831503|Immunologic Factors|immunologic factors|mesh-ancestor
64389240|NCT03831503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301844|NCT02252107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301845|NCT02252107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389245|NCT03187093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64389246|NCT03187093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389247|NCT03187093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64389248|NCT03187093|Serotonin Agents|serotonin agents|mesh-ancestor
64389249|NCT03187093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389250|NCT03187093|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64777810|NCT02233296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64777811|NCT02233296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301847|NCT03262545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301848|NCT03262545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64301849|NCT03262545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64301850|NCT03262545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301851|NCT03262077|Methylene Blue|methylene blue|mesh-list
64301852|NCT03262077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64301853|NCT03262077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301854|NCT03265899|Lactitol|lactitol|mesh-list
64301855|NCT03265899|Oxytocin|oxytocin|mesh-list
64301856|NCT03265899|Oxytocics|oxytocics|mesh-ancestor
64301857|NCT03265899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64301858|NCT03265899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301859|NCT03265899|Cathartics|cathartics|mesh-ancestor
64301860|NCT03265899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64301861|NCT04459988|Ocrelizumab|ocrelizumab|mesh-list
64301862|NCT04459988|Immunologic Factors|immunologic factors|mesh-ancestor
64301863|NCT04459988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327678|NCT05571111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327679|NCT02404623|Vitamin D|vitamin d|mesh-list
64327680|NCT02404623|Vitamins|vitamins|mesh-ancestor
64327681|NCT02404623|Micronutrients|micronutrients|mesh-ancestor
64327682|NCT02404623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327683|NCT02404623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64327684|NCT02170571|Dabigatran|dabigatran|mesh-list
64327685|NCT02170571|Antithrombins|antithrombins|mesh-ancestor
64327686|NCT02170571|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64327687|NCT02170571|Protease Inhibitors|protease inhibitors|mesh-ancestor
64327688|NCT02170571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64301864|NCT03934905|Sulforaphane|sulforaphane|mesh-list
64301865|NCT03934905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64301866|NCT03934905|Protective Agents|protective agents|mesh-ancestor
64301867|NCT03934905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301868|NCT03934905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301869|NCT02125201|Fentanyl|fentanyl|mesh-list
64301870|NCT02125201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64355085|NCT01239797|Growth Substances|growth substances|mesh-ancestor
64777812|NCT02233296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777813|NCT02233998|Listerine|listerine|mesh-list
64777814|NCT02233998|Sodium Fluoride|sodium fluoride|mesh-list
64777815|NCT02233998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64844805|NCT01679041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64844806|NCT01679041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64844807|NCT01679041|Alkylating Agents|alkylating agents|mesh-ancestor
64844808|NCT01679041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844809|NCT01679041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844810|NCT01679041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64844811|NCT01679041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64844812|NCT01679093|Dexamethasone|dexamethasone|mesh-list
64844813|NCT01679093|Droperidol|droperidol|mesh-list
64844814|NCT01679093|Ondansetron|ondansetron|mesh-list
64844815|NCT01679093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64844816|NCT01679093|Antiemetics|antiemetics|mesh-ancestor
64844817|NCT01679093|Autonomic Agents|autonomic agents|mesh-ancestor
64844818|NCT01679093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844819|NCT01679093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844820|NCT01679093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64844821|NCT01679093|Glucocorticoids|glucocorticoids|mesh-ancestor
64844822|NCT01679093|Hormones|hormones|mesh-ancestor
64844823|NCT01679093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64844824|NCT01679093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64294420|NCT03954379|Glucocorticoids|glucocorticoids|mesh-ancestor
64294421|NCT03954379|Hormones|hormones|mesh-ancestor
64777816|NCT02233998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64777817|NCT02233998|Cariostatic Agents|cariostatic agents|mesh-ancestor
64777818|NCT02233998|Protective Agents|protective agents|mesh-ancestor
64777819|NCT02233998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777820|NCT02237898|Carbon Monoxide|carbon monoxide|mesh-list
64777821|NCT02237898|Antimetabolites|antimetabolites|mesh-ancestor
64777822|NCT02237898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777823|NCT02237898|Gasotransmitters|gasotransmitters|mesh-ancestor
64777824|NCT02237898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64777825|NCT02237898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777826|NCT02239380|Lorazepam|lorazepam|mesh-list
64777827|NCT02239380|Anticonvulsants|anticonvulsants|mesh-ancestor
64844825|NCT01679093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844826|NCT01679093|Antipruritics|antipruritics|mesh-ancestor
64327689|NCT02170571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327690|NCT02170571|Anticoagulants|anticoagulants|mesh-ancestor
64327691|NCT04481841|Vitamins|vitamins|mesh-list
64327692|NCT04481841|Vitamin E|vitamin e|mesh-list
64327693|NCT04481841|Riboflavin|riboflavin|mesh-list
64844827|NCT01679093|Dermatologic Agents|dermatologic agents|mesh-ancestor
64844828|NCT01679093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64294426|NCT03954379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294427|NCT03954379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777828|NCT02239380|Antiemetics|antiemetics|mesh-ancestor
64301873|NCT02125201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301874|NCT02125201|Analgesics|analgesics|mesh-ancestor
64301875|NCT02125201|Sensory System Agents|sensory system agents|mesh-ancestor
64301876|NCT02125201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301877|NCT02125201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64301878|NCT02125201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64301879|NCT02125201|Anesthetics, General|anesthetics, general|mesh-ancestor
64301880|NCT02125201|Anesthetics|anesthetics|mesh-ancestor
64301881|NCT02125357|Abiraterone Acetate|abiraterone acetate|mesh-list
64301882|NCT02125357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301883|NCT02125357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64301884|NCT02125357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64301885|NCT02125357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301886|NCT02125357|Hormone Antagonists|hormone antagonists|mesh-ancestor
64355098|NCT02735707|Interferon beta-1a|interferon beta-1a|mesh-list
64844829|NCT01679093|Serotonin Agents|serotonin agents|mesh-ancestor
64844830|NCT01679093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64844831|NCT01679093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844832|NCT01679093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64844833|NCT01679093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64844834|NCT01679093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64844835|NCT01679093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64844836|NCT01679093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64844837|NCT01679093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64844838|NCT01679093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64844839|NCT01679093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64844840|NCT01679093|Dopamine Agents|dopamine agents|mesh-ancestor
64844841|NCT01679743|Trastuzumab|trastuzumab|mesh-list
64844842|NCT01679743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64327694|NCT04481841|Micronutrients|micronutrients|mesh-ancestor
64327695|NCT04481841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327696|NCT04481841|Vitamin B Complex|vitamin b complex|mesh-ancestor
64327697|NCT04481841|Antioxidants|antioxidants|mesh-ancestor
64327698|NCT04481841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327699|NCT04481841|Protective Agents|protective agents|mesh-ancestor
64327700|NCT04481841|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64327701|NCT04481841|Dermatologic Agents|dermatologic agents|mesh-ancestor
64327702|NCT02388477|Doxycycline|doxycycline|mesh-list
64327703|NCT02388477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64327704|NCT02388477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64844843|NCT01679743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844844|NCT01680094|Panobinostat|panobinostat|mesh-list
64844845|NCT01680094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64389251|NCT03187093|Antidepressive Agents|antidepressive agents|mesh-ancestor
64389252|NCT03187093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64389253|NCT03187093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64389254|NCT03187093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64389255|NCT03187093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64389256|NCT03187093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64389257|NCT03187093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64389258|NCT03187093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64389259|NCT03187093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64389260|NCT02039999|Citric Acid|citric acid|mesh-list
64389261|NCT02039999|Sodium Citrate|sodium citrate|mesh-list
64389262|NCT02039999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64389263|NCT02039999|Anticoagulants|anticoagulants|mesh-ancestor
64389264|NCT02039999|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64389265|NCT02039999|Chelating Agents|chelating agents|mesh-ancestor
64301887|NCT02125357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64389268|NCT02434861|Sulfasalazine|sulfasalazine|mesh-list
64777834|NCT02239380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64844846|NCT01680094|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64844847|NCT01680094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844848|NCT01680094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844849|NCT01680120|Anesthetics|anesthetics|mesh-list
64844850|NCT01680120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64844851|NCT01680120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844852|NCT01680198|Vitamin D|vitamin d|mesh-list
64844853|NCT01680198|Vitamins|vitamins|mesh-ancestor
64844854|NCT01680198|Micronutrients|micronutrients|mesh-ancestor
64844855|NCT01680198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844856|NCT01680198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64844857|NCT05597215|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
64844858|NCT05597215|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64844859|NCT05597215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777835|NCT02239380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64777836|NCT02239380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64777837|NCT02239380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64389270|NCT02434861|Rolapitant|rolapitant|mesh-list
64389271|NCT02434861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64301890|NCT03074942|Reslizumab|reslizumab|mesh-list
64301891|NCT03074942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64301892|NCT03074942|Respiratory System Agents|respiratory system agents|mesh-ancestor
64301893|NCT02458911|Paclitaxel|paclitaxel|mesh-list
64844888|NCT05596669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844889|NCT05596669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844890|NCT05596669|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64844891|NCT05596669|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64844892|NCT05596669|Anesthetics, General|anesthetics, general|mesh-ancestor
64327705|NCT02388477|Antimalarials|antimalarials|mesh-ancestor
64327706|NCT02388477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64327707|NCT02388477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64327708|NCT02166359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64327710|NCT02166359|Dialysis Solutions|dialysis solutions|mesh-ancestor
64327711|NCT00488839|Baclofen|baclofen|mesh-list
64327712|NCT00488839|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64327713|NCT00488839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327714|NCT00488839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64327715|NCT00488839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64327716|NCT00488839|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64327717|NCT00488839|GABA Agonists|gaba agonists|mesh-ancestor
64327718|NCT00488839|GABA Agents|gaba agents|mesh-ancestor
64844893|NCT05596669|Anesthetics|anesthetics|mesh-ancestor
64844894|NCT05596669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64844895|NCT05596669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64844896|NCT05596669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64844897|NCT05596669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64844898|NCT05596669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844899|NCT05596669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64844900|NCT05596669|Narcotics|narcotics|mesh-ancestor
64844902|NCT05596617|Antioxidants|antioxidants|mesh-ancestor
64844903|NCT05596617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844904|NCT05596617|Protective Agents|protective agents|mesh-ancestor
64844905|NCT05596617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844906|NCT05596617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64844907|NCT05596552|Fentanyl|fentanyl|mesh-list
64844908|NCT05596552|Dexmedetomidine|dexmedetomidine|mesh-list
64844909|NCT05596552|Bupivacaine|bupivacaine|mesh-list
64844910|NCT05596552|Anesthetics, Local|anesthetics, local|mesh-ancestor
64844911|NCT05596552|Anesthetics|anesthetics|mesh-ancestor
64844912|NCT05596552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64844913|NCT05596552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844914|NCT05596552|Sensory System Agents|sensory system agents|mesh-ancestor
64844915|NCT05596552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844916|NCT05596552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64844917|NCT05596552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64844918|NCT05596552|Analgesics|analgesics|mesh-ancestor
64844919|NCT05596552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64844920|NCT05596552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64301894|NCT02458911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64844939|NCT05596227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64301895|NCT02458911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301896|NCT02458911|Tubulin Modulators|tubulin modulators|mesh-ancestor
64301897|NCT02458911|Antimitotic Agents|antimitotic agents|mesh-ancestor
64301898|NCT02458911|Mitosis Modulators|mitosis modulators|mesh-ancestor
64301899|NCT02458911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301900|NCT03075020|Carbon Monoxide|carbon monoxide|mesh-list
64301901|NCT03075020|Antimetabolites|antimetabolites|mesh-ancestor
64301902|NCT03075020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301903|NCT03075020|Gasotransmitters|gasotransmitters|mesh-ancestor
64844940|NCT05596227|Anesthetics, General|anesthetics, general|mesh-ancestor
64844941|NCT05596227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64844942|NCT05596227|Analgesics|analgesics|mesh-ancestor
64844943|NCT05596227|Sensory System Agents|sensory system agents|mesh-ancestor
64844944|NCT05596227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844945|NCT05596227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64844946|NCT05596227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64844947|NCT05596227|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64844948|NCT05596227|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64844949|NCT05596227|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64844950|NCT05596227|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64844951|NCT05596214|Curcumin|curcumin|mesh-list
64844952|NCT05596214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64844953|NCT05596214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64844954|NCT05596214|Analgesics|analgesics|mesh-ancestor
64844955|NCT05596214|Sensory System Agents|sensory system agents|mesh-ancestor
64844956|NCT05596214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844957|NCT05596214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844958|NCT05596214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64328023|NCT00492999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328024|NCT00492999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64301904|NCT03075020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64301905|NCT03075020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301906|NCT04998344|Vaccines|vaccines|mesh-list
64301907|NCT04998344|Immunologic Factors|immunologic factors|mesh-ancestor
64301908|NCT04998344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301909|NCT02128243|Leucovorin|leucovorin|mesh-list
64301910|NCT02128243|Cisplatin|cisplatin|mesh-list
64301911|NCT02128243|Docetaxel|docetaxel|mesh-list
64301912|NCT02128243|Fluorouracil|fluorouracil|mesh-list
64328233|NCT00659191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64389276|NCT02434861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389277|NCT02434861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324195|NCT00258427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64324196|NCT00258427|Protective Agents|protective agents|mesh-ancestor
64324197|NCT01531699|Povidone-Iodine|povidone-iodine|mesh-list
64324198|NCT01531699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64328395|NCT02742649|Timolol|timolol|mesh-list
64324199|NCT01531699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64324200|NCT01531699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324201|NCT02233621|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64301913|NCT02128243|Capecitabine|capecitabine|mesh-list
64301914|NCT02128243|Oxaliplatin|oxaliplatin|mesh-list
64301915|NCT02128243|Epirubicin|epirubicin|mesh-list
64301916|NCT02128243|Levoleucovorin|levoleucovorin|mesh-list
64301917|NCT02128243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301918|NCT02128243|Tubulin Modulators|tubulin modulators|mesh-ancestor
64301919|NCT02128243|Antimitotic Agents|antimitotic agents|mesh-ancestor
64301920|NCT02128243|Mitosis Modulators|mitosis modulators|mesh-ancestor
64301921|NCT02128243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301922|NCT02128243|Antimetabolites|antimetabolites|mesh-ancestor
64301923|NCT02128243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64777841|NCT02239380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777842|NCT02239770|Nicotine|nicotine|mesh-list
64777843|NCT02239770|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64777844|NCT02239770|Autonomic Agents|autonomic agents|mesh-ancestor
64777845|NCT02239770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777846|NCT02239770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777847|NCT02239770|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64777848|NCT02239770|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64777849|NCT02239770|Cholinergic Agents|cholinergic agents|mesh-ancestor
64777850|NCT02239770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64777851|NCT02239770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777852|NCT02241486|Fentanyl|fentanyl|mesh-list
64328639|NCT02183909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64777853|NCT02241486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64777854|NCT02241486|Narcotics|narcotics|mesh-ancestor
64389278|NCT02434861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64301932|NCT02128243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64301933|NCT02128243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64301934|NCT02128243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64301935|NCT02128243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64301936|NCT04998500|Hormones|hormones|mesh-list
64301937|NCT04998500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64301938|NCT04998500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328832|NCT02386059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64301939|NCT03072290|Triamcinolone|triamcinolone|mesh-list
64301940|NCT03072290|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64301941|NCT03072290|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64301942|NCT03072290|Lidocaine|lidocaine|mesh-list
64301943|NCT03072290|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64301944|NCT03072290|Anesthetics, Local|anesthetics, local|mesh-ancestor
64301945|NCT03072290|Anesthetics|anesthetics|mesh-ancestor
64301946|NCT03072290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64301947|NCT03072290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301948|NCT03072290|Sensory System Agents|sensory system agents|mesh-ancestor
64301949|NCT03072290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301950|NCT03072290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64301951|NCT03072290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64301952|NCT03072290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64389279|NCT02434861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64389280|NCT02434861|Analgesics|analgesics|mesh-ancestor
64389281|NCT02434861|Sensory System Agents|sensory system agents|mesh-ancestor
64389282|NCT02434861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64389283|NCT02434861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64328833|NCT02386059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64328834|NCT02386059|Protease Inhibitors|protease inhibitors|mesh-ancestor
64328835|NCT02386059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328837|NCT02386059|Antipruritics|antipruritics|mesh-ancestor
64389284|NCT02434861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64389285|NCT02434861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64389286|NCT02434861|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64389287|NCT02434861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64389288|NCT03187015|Entinostat|entinostat|mesh-list
64389289|NCT03187015|Midazolam|midazolam|mesh-list
64777857|NCT02241486|Analgesics|analgesics|mesh-ancestor
64777858|NCT02241486|Sensory System Agents|sensory system agents|mesh-ancestor
64777859|NCT02241486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777860|NCT02241486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64777861|NCT02241486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64777862|NCT02241486|Anesthetics, General|anesthetics, general|mesh-ancestor
64777863|NCT02241486|Anesthetics|anesthetics|mesh-ancestor
64777864|NCT02244918|Nicotine|nicotine|mesh-list
64777865|NCT02244918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64777866|NCT02244918|Autonomic Agents|autonomic agents|mesh-ancestor
64546564|NCT00246753|Lapatinib|lapatinib|mesh-list
64845398|NCT04504331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64777867|NCT02244918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301953|NCT03072290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64301954|NCT03072290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301955|NCT03072290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64301956|NCT03072290|Glucocorticoids|glucocorticoids|mesh-ancestor
64416668|NCT03040765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777868|NCT02244918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777869|NCT02244918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64389295|NCT03187015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64389296|NCT03187015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64845399|NCT04504331|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64845402|NCT04463368|Nivolumab|nivolumab|mesh-list
64389297|NCT03187015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64389298|NCT03187015|Anesthetics, General|anesthetics, general|mesh-ancestor
64389299|NCT03187015|Anesthetics|anesthetics|mesh-ancestor
64389300|NCT03187015|GABA Modulators|gaba modulators|mesh-ancestor
64389301|NCT03187015|GABA Agents|gaba agents|mesh-ancestor
64389302|NCT03187015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64389303|NCT03187015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389304|NCT03187015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301958|NCT03072290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64301959|NCT03072290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64301960|NCT03072290|Immunologic Factors|immunologic factors|mesh-ancestor
64301961|NCT03072290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64301962|NCT02132689|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64301963|NCT02132689|Fibrinolytic Agents|fibrinolytic agents|mesh-list
64301965|NCT02132689|Calcium heparin|calcium heparin|mesh-list
64389306|NCT03187015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389307|NCT02328053|Voriconazole|voriconazole|mesh-list
64389308|NCT02328053|Natamycin|natamycin|mesh-list
64389309|NCT02328053|Antifungal Agents|antifungal agents|mesh-list
64389310|NCT02328053|Clotrimazole|clotrimazole|mesh-list
64389311|NCT02328053|Miconazole|miconazole|mesh-list
64777870|NCT02244918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64329985|NCT00004897|Antisickling Agents|antisickling agents|mesh-ancestor
64777871|NCT02244918|Cholinergic Agents|cholinergic agents|mesh-ancestor
64777872|NCT02244918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64777873|NCT02244918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777874|NCT02250612|Timolol|timolol|mesh-list
64777875|NCT02250612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329986|NCT00004897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64777876|NCT02250612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64777877|NCT02250612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64777878|NCT02250612|Adrenergic Agents|adrenergic agents|mesh-ancestor
64777879|NCT02250612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64777880|NCT02250612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777881|NCT02250612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64777882|NCT02250612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64777883|NCT02251236|Tenofovir|tenofovir|mesh-list
64777884|NCT02251236|Emtricitabine|emtricitabine|mesh-list
64777885|NCT02251236|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64777886|NCT02251236|Cobicistat|cobicistat|mesh-list
64777887|NCT02251236|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64389312|NCT02328053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64389313|NCT02328053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64389314|NCT02328053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64389315|NCT02328053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389316|NCT02328053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389317|NCT02328053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64389318|NCT02328053|Hormone Antagonists|hormone antagonists|mesh-ancestor
64389319|NCT02328053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64777889|NCT02251236|Elvitegravir|elvitegravir|mesh-list
64777890|NCT02251236|Antiviral Agents|antiviral agents|mesh-ancestor
64777891|NCT02251236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64330042|NCT04681131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330043|NCT04681131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330044|NCT03535259|Sorafenib|sorafenib|mesh-list
64301967|NCT02132689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301968|NCT02132689|Anticoagulants|anticoagulants|mesh-ancestor
64301969|NCT02128321|Repaglinide|repaglinide|mesh-list
64301970|NCT02128321|Isavuconazole|isavuconazole|mesh-list
64301971|NCT02128321|Caffeine|caffeine|mesh-list
64301972|NCT02128321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64301973|NCT02128321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301974|NCT02128321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64301975|NCT02128321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64301976|NCT02128321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301977|NCT02128321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64301978|NCT02128321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64301979|NCT02128321|Purinergic Agents|purinergic agents|mesh-ancestor
64301980|NCT02128321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64301981|NCT02128321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64301982|NCT02128321|Antifungal Agents|antifungal agents|mesh-ancestor
64301983|NCT02128321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64301984|NCT02457975|Ranibizumab|ranibizumab|mesh-list
64777892|NCT02251236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64777893|NCT02251236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64777894|NCT02251236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64777895|NCT02251236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777896|NCT02251236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64389329|NCT02022748|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64389330|NCT02022748|Purinergic Agents|purinergic agents|mesh-ancestor
64389331|NCT02022748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64389332|NCT02022748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301986|NCT02457975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301987|NCT02457975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64301988|NCT02457975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64301989|NCT02457975|Growth Substances|growth substances|mesh-ancestor
64301990|NCT02457975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301991|NCT02457975|Growth Inhibitors|growth inhibitors|mesh-ancestor
64301992|NCT03074864|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64330434|NCT02200991|Lixisenatide|lixisenatide|mesh-list
64301993|NCT03074864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301994|NCT03074864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64301995|NCT03074864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64301996|NCT03074864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301997|NCT02125903|Ropivacaine|ropivacaine|mesh-list
64301999|NCT02125903|Anesthetics|anesthetics|mesh-ancestor
64302000|NCT02125903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64302001|NCT02125903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302002|NCT02125903|Sensory System Agents|sensory system agents|mesh-ancestor
64845603|NCT03571308|Tubulin Modulators|tubulin modulators|mesh-ancestor
64845604|NCT03571308|Antimitotic Agents|antimitotic agents|mesh-ancestor
64845605|NCT03571308|Mitosis Modulators|mitosis modulators|mesh-ancestor
64845606|NCT03571308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64845607|NCT03571308|Glucocorticoids|glucocorticoids|mesh-ancestor
64302003|NCT02125903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302004|NCT04997564|Tenofovir|tenofovir|mesh-list
64302005|NCT04997564|Sofosbuvir|sofosbuvir|mesh-list
64302006|NCT04997564|Velpatasvir|velpatasvir|mesh-list
64302007|NCT04997564|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64302008|NCT04997564|Antiviral Agents|antiviral agents|mesh-ancestor
64302042|NCT03261921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64302043|NCT03261921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302044|NCT03261921|Anesthetics, Local|anesthetics, local|mesh-ancestor
64302045|NCT03261921|Anesthetics|anesthetics|mesh-ancestor
64302046|NCT03261921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64302047|NCT03261921|Sensory System Agents|sensory system agents|mesh-ancestor
64389349|NCT02434549|Cholinergic Agents|cholinergic agents|mesh-ancestor
64845625|NCT03518086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64845626|NCT03518086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64845627|NCT03517176|Gemcitabine|gemcitabine|mesh-list
64845628|NCT03517176|Paclitaxel|paclitaxel|mesh-list
64845629|NCT03517176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64845630|NCT03517176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845631|NCT03517176|Tubulin Modulators|tubulin modulators|mesh-ancestor
64845632|NCT03517176|Antimitotic Agents|antimitotic agents|mesh-ancestor
64845633|NCT03517176|Mitosis Modulators|mitosis modulators|mesh-ancestor
64845634|NCT03517176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845635|NCT03517176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64845636|NCT03517176|Antimetabolites|antimetabolites|mesh-ancestor
64845637|NCT03517176|Antiviral Agents|antiviral agents|mesh-ancestor
64845638|NCT03517176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64330782|NCT02203097|Anesthetics|anesthetics|mesh-ancestor
64330783|NCT04439487|Anesthetics|anesthetics|mesh-list
64330784|NCT04439487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64330785|NCT04439487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330786|NCT03528967|Aspirin|aspirin|mesh-list
64389350|NCT02434549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64389351|NCT02434549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777919|NCT02260440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64777920|NCT02260440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64389352|NCT02328209|Ranibizumab|ranibizumab|mesh-list
64389353|NCT02328209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64389354|NCT02328209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64389355|NCT02328209|Growth Substances|growth substances|mesh-ancestor
64302060|NCT02635724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302061|NCT02635724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302063|NCT02133469|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64302064|NCT02133469|Immunologic Factors|immunologic factors|mesh-ancestor
64302065|NCT02133469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302066|NCT03905265|Moxidectin|moxidectin|mesh-list
64302067|NCT03905265|Anthelmintics|anthelmintics|mesh-ancestor
64330787|NCT03528967|Enoxaparin|enoxaparin|mesh-list
64330788|NCT03528967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64330789|NCT03528967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64330790|NCT03528967|Analgesics|analgesics|mesh-ancestor
64330791|NCT03528967|Sensory System Agents|sensory system agents|mesh-ancestor
64330792|NCT03528967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330793|NCT03528967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330794|NCT03528967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64330795|NCT03528967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64330796|NCT03528967|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64302068|NCT03905265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64389359|NCT03977363|Anticoagulants|anticoagulants|mesh-list
64389360|NCT02328443|Itraconazole|itraconazole|mesh-list
64389363|NCT02328443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64389364|NCT02328443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64324210|NCT02233621|Contraceptive Agents|contraceptive agents|mesh-ancestor
64324211|NCT02233621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64302069|NCT03905265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64302070|NCT03905265|Antinematodal Agents|antinematodal agents|mesh-ancestor
64302071|NCT05001854|Fludrocortisone|fludrocortisone|mesh-list
64302072|NCT05001854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64302073|NCT02126527|Sirolimus|sirolimus|mesh-list
64302074|NCT02126527|Auranofin|auranofin|mesh-list
64302075|NCT02126527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64302076|NCT02126527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64302077|NCT02126527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64302078|NCT02126527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845676|NCT03404193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64845677|NCT03404193|Antimetabolites|antimetabolites|mesh-ancestor
64330801|NCT03528967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330802|NCT03528967|Antipyretics|antipyretics|mesh-ancestor
64330803|NCT03528967|Anticoagulants|anticoagulants|mesh-ancestor
64330804|NCT05287321|Hydroxychloroquine|hydroxychloroquine|mesh-list
64330805|NCT05287321|Antimalarials|antimalarials|mesh-ancestor
64330806|NCT05287321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64330807|NCT05287321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64330808|NCT05287321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64330809|NCT05287321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330810|NCT05287321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845678|NCT03404193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845680|NCT03404193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845681|NCT03366974|Clarithromycin|clarithromycin|mesh-list
64845682|NCT03366974|Midazolam|midazolam|mesh-list
64845683|NCT03366974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64845684|NCT03366974|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64845685|NCT03366974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64845686|NCT03366974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845687|NCT03366974|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64845688|NCT03366974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64302139|NCT02252731|Anticoagulants|anticoagulants|mesh-ancestor
64302140|NCT02128633|Listerine|listerine|mesh-list
64302141|NCT02128633|Fluorides|fluorides|mesh-list
64302142|NCT02128633|Sodium Fluoride|sodium fluoride|mesh-list
64302143|NCT02128633|Cariostatic Agents|cariostatic agents|mesh-ancestor
64302144|NCT02128633|Protective Agents|protective agents|mesh-ancestor
64302145|NCT02128633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302146|NCT02128633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64302147|NCT02128633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64302148|NCT02126683|Hydroxychloroquine|hydroxychloroquine|mesh-list
64845704|NCT03362515|Diuretics|diuretics|mesh-ancestor
64845705|NCT03362515|Natriuretic Agents|natriuretic agents|mesh-ancestor
64845706|NCT03362515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845707|NCT03362515|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64845708|NCT03362515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64845710|NCT03340129|Nivolumab|nivolumab|mesh-list
64845711|NCT03340129|Ipilimumab|ipilimumab|mesh-list
64845718|NCT03307746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845719|NCT03307746|Immunologic Factors|immunologic factors|mesh-ancestor
64845720|NCT03307746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845721|NCT03307746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64845723|NCT03294083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64845724|NCT03294083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845725|NCT03222076|Nivolumab|nivolumab|mesh-list
64845726|NCT03222076|Ipilimumab|ipilimumab|mesh-list
64845727|NCT03222076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64845728|NCT03222076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845729|NCT03222076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64845730|NCT03222076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845731|NCT03128398|Domperidone|domperidone|mesh-list
64845732|NCT03128398|Antiemetics|antiemetics|mesh-ancestor
64845733|NCT03128398|Autonomic Agents|autonomic agents|mesh-ancestor
64845734|NCT03128398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845735|NCT03128398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845736|NCT03128398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64845737|NCT03128398|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64845738|NCT03128398|Dopamine Agents|dopamine agents|mesh-ancestor
64845739|NCT03128398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64845741|NCT03119038|Ketorolac|ketorolac|mesh-list
64302149|NCT02126683|Antimalarials|antimalarials|mesh-ancestor
64302150|NCT02126683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64302151|NCT02126683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64302152|NCT02126683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64302153|NCT02126683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302154|NCT02126683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777921|NCT02260440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64777922|NCT02260440|Antimetabolites|antimetabolites|mesh-ancestor
64777923|NCT02260440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777924|NCT02260440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64777925|NCT02267538|Dexmedetomidine|dexmedetomidine|mesh-list
64777926|NCT02267538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64777927|NCT02267538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64777928|NCT02267538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777929|NCT02267538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64777930|NCT02267538|Analgesics|analgesics|mesh-ancestor
64777931|NCT02267538|Sensory System Agents|sensory system agents|mesh-ancestor
64777932|NCT02267538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64777933|NCT02267538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64845750|NCT03119038|Sensory System Agents|sensory system agents|mesh-ancestor
64845751|NCT03119038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845752|NCT03119038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64845753|NCT03119038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64845754|NCT03119038|Adrenergic Agents|adrenergic agents|mesh-ancestor
64330811|NCT05287321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64330812|NCT02363985|Vitamin A|vitamin a|mesh-list
64330813|NCT02363985|Vitamins|vitamins|mesh-ancestor
64330814|NCT02363985|Micronutrients|micronutrients|mesh-ancestor
64330815|NCT02363985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330816|NCT05723731|Laxatives|laxatives|mesh-list
64845756|NCT03119038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845757|NCT03119038|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64845758|NCT03119038|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64845759|NCT03119038|Autonomic Agents|autonomic agents|mesh-ancestor
64845760|NCT03119038|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64845761|NCT03119038|Respiratory System Agents|respiratory system agents|mesh-ancestor
64845762|NCT03119038|Mydriatics|mydriatics|mesh-ancestor
64845763|NCT03119038|Sympathomimetics|sympathomimetics|mesh-ancestor
64777934|NCT02267538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64777935|NCT02267538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64777936|NCT02267538|Adrenergic Agents|adrenergic agents|mesh-ancestor
64777937|NCT02267538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64777938|NCT02267538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777940|NCT02267772|Morphine|morphine|mesh-list
64389365|NCT02328443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64389366|NCT02328443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330818|NCT02363829|Nelfinavir|nelfinavir|mesh-list
64330819|NCT02363829|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64330820|NCT02363829|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64330821|NCT02363829|Protease Inhibitors|protease inhibitors|mesh-ancestor
64330822|NCT02363829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845765|NCT03119038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64845766|NCT03119038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64845767|NCT03119038|Analgesics|analgesics|mesh-ancestor
64845768|NCT03119038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64845769|NCT03119038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64845770|NCT03119038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64845771|NCT03119038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845772|NCT03119038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64845773|NCT03119038|Sympatholytics|sympatholytics|mesh-ancestor
64845774|NCT03119038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64845775|NCT03099265|Leucovorin|leucovorin|mesh-list
64845776|NCT03099265|Fluorouracil|fluorouracil|mesh-list
64845777|NCT03099265|Oxaliplatin|oxaliplatin|mesh-list
64845778|NCT03099265|Irinotecan|irinotecan|mesh-list
64845779|NCT03099265|Antimetabolites|antimetabolites|mesh-ancestor
64845780|NCT03099265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845781|NCT03099265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64389367|NCT02328443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64389368|NCT02328443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64389369|NCT02328443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64389370|NCT02328443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64389371|NCT02328443|Anesthetics, General|anesthetics, general|mesh-ancestor
64389372|NCT02328443|Anesthetics|anesthetics|mesh-ancestor
64389373|NCT02328443|GABA Modulators|gaba modulators|mesh-ancestor
64389374|NCT02328443|GABA Agents|gaba agents|mesh-ancestor
64389375|NCT02328443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64302155|NCT02126683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64302156|NCT03252561|Anesthetics|anesthetics|mesh-list
64302157|NCT03252561|Anesthetics, Local|anesthetics, local|mesh-list
64330824|NCT02363829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64330825|NCT02363829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64330826|NCT02363829|Antiviral Agents|antiviral agents|mesh-ancestor
64330827|NCT02363829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64330828|NCT03113019|Vaccines|vaccines|mesh-list
64330829|NCT03113019|Immunologic Factors|immunologic factors|mesh-ancestor
64330830|NCT03113019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845783|NCT03099265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64845784|NCT03099265|Immunologic Factors|immunologic factors|mesh-ancestor
64845785|NCT03099265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845786|NCT03099265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64845787|NCT03099265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64845788|NCT03099265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845789|NCT03099265|Antidotes|antidotes|mesh-ancestor
64845790|NCT03099265|Protective Agents|protective agents|mesh-ancestor
64845791|NCT03099265|Vitamin B Complex|vitamin b complex|mesh-ancestor
64845792|NCT03099265|Vitamins|vitamins|mesh-ancestor
64845793|NCT03099265|Micronutrients|micronutrients|mesh-ancestor
64845794|NCT03065387|Everolimus|everolimus|mesh-list
64845795|NCT03065387|Palbociclib|palbociclib|mesh-list
64845796|NCT03065387|Trametinib|trametinib|mesh-list
64845797|NCT03065387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845798|NCT03065387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64845799|NCT03065387|Immunologic Factors|immunologic factors|mesh-ancestor
64845800|NCT03065387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845801|NCT03065387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64845802|NCT03065387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845803|NCT03065387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302158|NCT03252561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64302159|NCT03252561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302160|NCT03252561|Sensory System Agents|sensory system agents|mesh-ancestor
64302161|NCT03252561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302162|NCT02252263|Elotuzumab|elotuzumab|mesh-list
64302163|NCT02252263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302164|NCT04996550|Metoprolol|metoprolol|mesh-list
64302165|NCT04996550|Carvedilol|carvedilol|mesh-list
64302166|NCT04996550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64302167|NCT04996550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64302168|NCT04996550|Sympatholytics|sympatholytics|mesh-ancestor
64302169|NCT04996550|Autonomic Agents|autonomic agents|mesh-ancestor
64302170|NCT04996550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302171|NCT04996550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302172|NCT04996550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64302173|NCT04996550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64302174|NCT04996550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64302175|NCT04996550|Adrenergic Agents|adrenergic agents|mesh-ancestor
64302176|NCT04996550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64302177|NCT04996550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302178|NCT04996550|Antioxidants|antioxidants|mesh-ancestor
64355539|NCT03413059|Morphine|morphine|mesh-list
64389376|NCT02328443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389377|NCT02328443|Antifungal Agents|antifungal agents|mesh-ancestor
64389378|NCT02328443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64330833|NCT02363751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330834|NCT02363751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64845813|NCT03007589|Sunscreening Agents|sunscreening agents|mesh-list
64845814|NCT03007589|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64845815|NCT03007589|Protective Agents|protective agents|mesh-ancestor
64845816|NCT03007589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845817|NCT03007589|Dermatologic Agents|dermatologic agents|mesh-ancestor
64845818|NCT02975037|Clarithromycin|clarithromycin|mesh-list
64845819|NCT02975037|Itraconazole|itraconazole|mesh-list
64845820|NCT02975037|Sildenafil Citrate|sildenafil citrate|mesh-list
64845821|NCT02975037|Vasodilator Agents|vasodilator agents|mesh-ancestor
64845822|NCT02975037|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64845823|NCT02975037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64845824|NCT02975037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845825|NCT02975037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845826|NCT02975037|Urological Agents|urological agents|mesh-ancestor
64845827|NCT02975037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64845828|NCT02975037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64845829|NCT02975037|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64845830|NCT02975037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64389379|NCT02328443|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64389380|NCT02328443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64389384|NCT02328443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64389385|NCT02328443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64389387|NCT02328443|Antitubercular Agents|antitubercular agents|mesh-ancestor
64389388|NCT02328443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64389389|NCT02328443|Leprostatic Agents|leprostatic agents|mesh-ancestor
64389390|NCT02328443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64302179|NCT04996550|Protective Agents|protective agents|mesh-ancestor
64302180|NCT04996550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64302181|NCT04996550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64302182|NCT04996550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64302183|NCT04996550|Vasodilator Agents|vasodilator agents|mesh-ancestor
64302184|NCT04996550|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64302185|NCT04996550|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64845833|NCT02975037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64845834|NCT02975037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64845835|NCT02975037|Hormone Antagonists|hormone antagonists|mesh-ancestor
64845836|NCT02975037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64845837|NCT02975037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845838|NCT02931890|Paclitaxel|paclitaxel|mesh-list
64845839|NCT02931890|Docetaxel|docetaxel|mesh-list
64845840|NCT02931890|Carboplatin|carboplatin|mesh-list
64845841|NCT02931890|Capecitabine|capecitabine|mesh-list
64845842|NCT02931890|Oxaliplatin|oxaliplatin|mesh-list
64845843|NCT02931890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64845844|NCT02931890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845845|NCT02931890|Tubulin Modulators|tubulin modulators|mesh-ancestor
64845846|NCT02931890|Antimitotic Agents|antimitotic agents|mesh-ancestor
64330835|NCT02363751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64330836|NCT02363751|Growth Substances|growth substances|mesh-ancestor
64302186|NCT02133937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64302187|NCT02133937|Immunologic Factors|immunologic factors|mesh-ancestor
64302188|NCT02133937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302190|NCT02135965|Albuterol|albuterol|mesh-list
64302191|NCT02135965|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64302192|NCT02135965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302193|NCT02135965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64302194|NCT02135965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302195|NCT02135965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302196|NCT02135965|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64302197|NCT02135965|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64302198|NCT02135965|Purinergic Agents|purinergic agents|mesh-ancestor
64302224|NCT03260829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302227|NCT02134093|Sufentanil|sufentanil|mesh-list
64302228|NCT02134093|Dexmedetomidine|dexmedetomidine|mesh-list
64302229|NCT02134093|Remifentanil|remifentanil|mesh-list
64302230|NCT02134093|Anesthetics|anesthetics|mesh-list
64302231|NCT02134093|Propofol|propofol|mesh-list
64302232|NCT02134093|Etomidate|etomidate|mesh-list
64302233|NCT02134093|Vecuronium Bromide|vecuronium bromide|mesh-list
64302234|NCT02134093|Rocuronium|rocuronium|mesh-list
64302235|NCT02134093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64302236|NCT02134093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845847|NCT02931890|Mitosis Modulators|mitosis modulators|mesh-ancestor
64845848|NCT02931890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845849|NCT02931890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64845850|NCT02931890|Antimetabolites|antimetabolites|mesh-ancestor
64330841|NCT03279471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64330842|NCT03279471|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64330843|NCT03279471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64330844|NCT03279471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64302237|NCT02134093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64302264|NCT03074786|Tenofovir|tenofovir|mesh-list
64302269|NCT03074786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64302270|NCT03074786|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64302271|NCT03074786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64302272|NCT03074786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302273|NCT03074786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302274|NCT03074786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64302275|NCT03074786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64302276|NCT03377049|Acetazolamide|acetazolamide|mesh-list
64845852|NCT02914405|Dinutuximab|dinutuximab|mesh-list
64845853|NCT02914405|Immunoglobulins|immunoglobulins|mesh-list
64845854|NCT02914405|Immunoglobulin G|immunoglobulin g|mesh-list
64845855|NCT02914405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64845856|NCT02914405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845857|NCT02914405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64845858|NCT02914405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845859|NCT02914405|Immunologic Factors|immunologic factors|mesh-ancestor
64845860|NCT02914405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845861|NCT02812862|Tiotropium Bromide|tiotropium bromide|mesh-list
64845862|NCT02812862|Olodaterol|olodaterol|mesh-list
64845863|NCT02812862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64845864|NCT02812862|Autonomic Agents|autonomic agents|mesh-ancestor
64845865|NCT02812862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845866|NCT02812862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845867|NCT02812862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64845868|NCT02812862|Respiratory System Agents|respiratory system agents|mesh-ancestor
64845869|NCT02812862|Parasympatholytics|parasympatholytics|mesh-ancestor
64845870|NCT02812862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64845871|NCT02812862|Cholinergic Agents|cholinergic agents|mesh-ancestor
64845872|NCT02812862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64614352|NCT05394415|Paclitaxel|paclitaxel|mesh-list
64845873|NCT02812862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845875|NCT02587312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64330846|NCT03279471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64302277|NCT03377049|Anticonvulsants|anticonvulsants|mesh-ancestor
64302278|NCT03377049|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64302279|NCT03377049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64777967|NCT02276274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64302280|NCT03377049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302282|NCT03377049|Natriuretic Agents|natriuretic agents|mesh-ancestor
64302283|NCT03377049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777968|NCT02276274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64777969|NCT02276274|Protease Inhibitors|protease inhibitors|mesh-ancestor
64777970|NCT02276274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64777971|NCT02276274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777972|NCT02281422|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64777973|NCT02281422|Anticonvulsants|anticonvulsants|mesh-ancestor
64389401|NCT02039765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64389402|NCT02039765|Adrenergic Agents|adrenergic agents|mesh-ancestor
64389403|NCT02039765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64302284|NCT03070028|Phenol|phenol|mesh-list
64302285|NCT03070028|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64302286|NCT03070028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64302287|NCT03070028|Disinfectants|disinfectants|mesh-ancestor
64302288|NCT03070028|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64302289|NCT03070028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64302290|NCT03260439|Tramadol|tramadol|mesh-list
64302291|NCT03260439|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64302292|NCT03260439|Narcotics|narcotics|mesh-ancestor
64302293|NCT03260439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64302294|NCT03260439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302295|NCT03260439|Analgesics|analgesics|mesh-ancestor
64302296|NCT03260439|Sensory System Agents|sensory system agents|mesh-ancestor
64302297|NCT03260439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302298|NCT02634788|Buprenorphine|buprenorphine|mesh-list
64302299|NCT02634788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64355604|NCT01111565|Aripiprazole|aripiprazole|mesh-list
64389411|NCT03191539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64389412|NCT03191539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389413|NCT03191539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64777974|NCT02281422|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64777975|NCT02281422|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64777976|NCT02281422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64777977|NCT02281422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777978|NCT02282514|Methylprednisolone|methylprednisolone|mesh-list
64302311|NCT03260283|Anesthetics|anesthetics|mesh-ancestor
64302312|NCT03260283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64302313|NCT03260283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302314|NCT03260283|Sensory System Agents|sensory system agents|mesh-ancestor
64302315|NCT03260283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302316|NCT03260283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64777979|NCT02282514|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64777981|NCT02282514|Rituximab|rituximab|mesh-list
64777982|NCT02282514|Thymoglobulin|thymoglobulin|mesh-list
64845888|NCT02549677|Immunologic Factors|immunologic factors|mesh-ancestor
64845889|NCT02549677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845890|NCT02549677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64845891|NCT02549677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64845892|NCT02549677|Alkylating Agents|alkylating agents|mesh-ancestor
64845893|NCT02549677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845894|NCT02549677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845895|NCT02549677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64845896|NCT02549677|Tubulin Modulators|tubulin modulators|mesh-ancestor
64845897|NCT02549677|Antimitotic Agents|antimitotic agents|mesh-ancestor
64845898|NCT02549677|Mitosis Modulators|mitosis modulators|mesh-ancestor
64845899|NCT02549677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64845900|NCT02549677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64845901|NCT02549677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64845902|NCT02549677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845903|NCT02536300|Idelalisib|idelalisib|mesh-list
64845904|NCT02536300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845905|NCT02536300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845906|NCT02536300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845907|NCT02450253|Tadalafil|tadalafil|mesh-list
64330848|NCT03279471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330850|NCT03240861|Plerixafor|plerixafor|mesh-list
64330851|NCT03240861|Fludarabine|fludarabine|mesh-list
64845909|NCT02450253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64845910|NCT02450253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64777983|NCT02282514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64777984|NCT02282514|Immunologic Factors|immunologic factors|mesh-ancestor
64777985|NCT02282514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64777986|NCT02282514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64777987|NCT02282514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64302318|NCT03260283|Analgesics|analgesics|mesh-ancestor
64302319|NCT03260283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64302320|NCT03260283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64302321|NCT03260283|Anesthetics, General|anesthetics, general|mesh-ancestor
64302322|NCT03251469|Tranexamic Acid|tranexamic acid|mesh-list
64777988|NCT02282514|Alkylating Agents|alkylating agents|mesh-ancestor
64777989|NCT02282514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64777990|NCT02282514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64777991|NCT02282514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64845911|NCT02450253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845912|NCT02450253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845913|NCT02450253|Urological Agents|urological agents|mesh-ancestor
64845915|NCT02257970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64845916|NCT02257970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64845917|NCT02257970|Analgesics|analgesics|mesh-ancestor
64845918|NCT02257970|Sensory System Agents|sensory system agents|mesh-ancestor
64845919|NCT02257970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845920|NCT02257970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845921|NCT02257970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64845922|NCT02257970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64845923|NCT02257970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64845924|NCT02257970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845925|NCT02257970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845926|NCT02177578|Temozolomide|temozolomide|mesh-list
64845927|NCT02177578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64845928|NCT02177578|Alkylating Agents|alkylating agents|mesh-ancestor
64845929|NCT02177578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294471|NCT05704933|Nivolumab|nivolumab|mesh-list
64777992|NCT02282514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64777993|NCT02282514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64777994|NCT02282514|Antiemetics|antiemetics|mesh-ancestor
64777995|NCT02282514|Autonomic Agents|autonomic agents|mesh-ancestor
64777996|NCT02282514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64389414|NCT03191539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64389415|NCT03191539|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64777998|NCT02282514|Glucocorticoids|glucocorticoids|mesh-ancestor
64777999|NCT02282514|Hormones|hormones|mesh-ancestor
64778000|NCT02282514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64778001|NCT02282514|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64302324|NCT03251469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64845930|NCT02177578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330853|NCT03240861|Interleukin-2|interleukin-2|mesh-list
64330854|NCT03240861|Lenograstim|lenograstim|mesh-list
64330855|NCT03240861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330856|NCT03240861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330857|NCT03240861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64330858|NCT03240861|Immunologic Factors|immunologic factors|mesh-ancestor
64330859|NCT03240861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330860|NCT03240861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64330861|NCT03240861|Alkylating Agents|alkylating agents|mesh-ancestor
64330862|NCT03240861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64330863|NCT03240861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64330864|NCT03240861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64330865|NCT03240861|Analgesics|analgesics|mesh-ancestor
64330866|NCT03240861|Sensory System Agents|sensory system agents|mesh-ancestor
64845931|NCT02098512|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64845932|NCT02098512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64845933|NCT02098512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845935|NCT02066636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64845936|NCT02066636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845937|NCT02066636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64845938|NCT02066636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845939|NCT02036086|Vemurafenib|vemurafenib|mesh-list
64845940|NCT02036086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845941|NCT02036086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64845942|NCT02036086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302325|NCT03251469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302326|NCT03251469|Hemostatics|hemostatics|mesh-ancestor
64302327|NCT03251469|Coagulants|coagulants|mesh-ancestor
64302328|NCT04986644|Hyaluronic Acid|hyaluronic acid|mesh-list
64302329|NCT04986644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64302330|NCT04986644|Immunologic Factors|immunologic factors|mesh-ancestor
64302331|NCT04986644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330867|NCT03240861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330868|NCT03240861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64330869|NCT03240861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64330870|NCT03240861|Antiviral Agents|antiviral agents|mesh-ancestor
64330871|NCT03240861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64330872|NCT03527251|Ipilimumab|ipilimumab|mesh-list
64330873|NCT03527251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64330874|NCT03527251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330875|NCT03527251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64330876|NCT03527251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330877|NCT02363517|Sofosbuvir|sofosbuvir|mesh-list
64330878|NCT02363517|Antiviral Agents|antiviral agents|mesh-ancestor
64330879|NCT02363517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64330880|NCT04467463|Levobupivacaine|levobupivacaine|mesh-list
64330881|NCT04467463|Anesthetics, Local|anesthetics, local|mesh-ancestor
64330882|NCT04467463|Anesthetics|anesthetics|mesh-ancestor
64330883|NCT04467463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64302332|NCT04986644|Viscosupplements|viscosupplements|mesh-ancestor
64302333|NCT04986644|Protective Agents|protective agents|mesh-ancestor
64778003|NCT02282514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64778005|NCT02282904|Cyclophosphamide|cyclophosphamide|mesh-list
64778006|NCT02282904|Busulfan|busulfan|mesh-list
64778007|NCT02282904|Fludarabine|fludarabine|mesh-list
64778008|NCT02282904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64778009|NCT02282904|Immunologic Factors|immunologic factors|mesh-ancestor
64778010|NCT02282904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778011|NCT02282904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64778012|NCT02282904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64778013|NCT02282904|Alkylating Agents|alkylating agents|mesh-ancestor
64389438|NCT02333123|Aspirin|aspirin|mesh-list
64389439|NCT02333123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64389440|NCT02333123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64355633|NCT03412513|Mirabegron|mirabegron|mesh-list
64330895|NCT04594915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64330896|NCT04594915|Protease Inhibitors|protease inhibitors|mesh-ancestor
64330897|NCT04594915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330898|NCT04594915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330899|NCT04594915|Anticoagulants|anticoagulants|mesh-ancestor
64389441|NCT02333123|Analgesics|analgesics|mesh-ancestor
64389442|NCT02333123|Sensory System Agents|sensory system agents|mesh-ancestor
64389443|NCT02333123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64389444|NCT02333123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389445|NCT02333123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64389446|NCT02333123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64389447|NCT02333123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64389448|NCT02333123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64389449|NCT02333123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846000|NCT01684813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64846001|NCT01684813|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64846002|NCT01684813|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64846003|NCT01684813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64846004|NCT01684813|Purinergic Agents|purinergic agents|mesh-ancestor
64846005|NCT01684813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64846006|NCT01684813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846007|NCT01684813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846008|NCT01684982|Sirolimus|sirolimus|mesh-list
64846009|NCT01684982|Everolimus|everolimus|mesh-list
64778014|NCT02282904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778015|NCT02282904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778016|NCT02282904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64778017|NCT02282904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64778018|NCT02282904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64778019|NCT02282904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64778020|NCT02282904|Antifungal Agents|antifungal agents|mesh-ancestor
64778021|NCT02283840|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64778023|NCT02283840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64846055|NCT01686386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846056|NCT01686594|Methoxsalen|methoxsalen|mesh-list
64846057|NCT01686594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64846058|NCT01686594|Dermatologic Agents|dermatologic agents|mesh-ancestor
64846059|NCT01687517|Vaccines|vaccines|mesh-list
64846060|NCT01687517|Immunologic Factors|immunologic factors|mesh-ancestor
64846061|NCT01687517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846062|NCT01687751|Midazolam|midazolam|mesh-list
64846063|NCT01687751|Dexmedetomidine|dexmedetomidine|mesh-list
64846064|NCT01687751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64846065|NCT01687751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64846066|NCT01687751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846067|NCT01687751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64778024|NCT02283840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64302335|NCT02785939|Palbociclib|palbociclib|mesh-list
64302336|NCT02785939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302337|NCT02785939|Tubulin Modulators|tubulin modulators|mesh-ancestor
64302338|NCT02785939|Antimitotic Agents|antimitotic agents|mesh-ancestor
64302339|NCT02785939|Mitosis Modulators|mitosis modulators|mesh-ancestor
64302340|NCT02785939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302341|NCT02785939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64302342|NCT02785939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302344|NCT03583229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64302345|NCT03583229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64846137|NCT01690104|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64846138|NCT01690104|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64846139|NCT01690104|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64846140|NCT01690221|Diltiazem|diltiazem|mesh-list
64846141|NCT01690221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64846142|NCT01690221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64846143|NCT01690221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64330914|NCT02367027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330915|NCT02367027|Anticoagulants|anticoagulants|mesh-ancestor
64330916|NCT04462471|Vemurafenib|vemurafenib|mesh-list
64330919|NCT04462471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846144|NCT01690221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846145|NCT01690221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64846146|NCT01690221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846147|NCT01690221|Vasodilator Agents|vasodilator agents|mesh-ancestor
64846148|NCT01690247|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64846149|NCT01690247|Immunologic Factors|immunologic factors|mesh-ancestor
64846150|NCT01690247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846151|NCT01690286|Ketoconazole|ketoconazole|mesh-list
64846152|NCT01690286|Antifungal Agents|antifungal agents|mesh-ancestor
64846153|NCT01690286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64846154|NCT01690286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64846155|NCT01690286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64846156|NCT01690286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846157|NCT01690286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846158|NCT01690286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64846159|NCT01690286|Hormone Antagonists|hormone antagonists|mesh-ancestor
64846160|NCT01690286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64846161|NCT01690286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302346|NCT03583229|Analgesics|analgesics|mesh-ancestor
64355665|NCT03126877|Alkylating Agents|alkylating agents|mesh-ancestor
64778028|NCT02284386|Anesthetics, Local|anesthetics, local|mesh-ancestor
64778029|NCT02284386|Anesthetics|anesthetics|mesh-ancestor
64778030|NCT02284386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64778031|NCT02284386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778032|NCT02284386|Sensory System Agents|sensory system agents|mesh-ancestor
64389454|NCT02332811|Sevelamer|sevelamer|mesh-list
64302347|NCT03583229|Sensory System Agents|sensory system agents|mesh-ancestor
64846162|NCT01690286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64846163|NCT01690325|Cyclophosphamide|cyclophosphamide|mesh-list
64846164|NCT01690325|Bevacizumab|bevacizumab|mesh-list
64846165|NCT01690325|Docetaxel|docetaxel|mesh-list
64846166|NCT01690325|Trastuzumab|trastuzumab|mesh-list
64846167|NCT01690325|Epirubicin|epirubicin|mesh-list
64846168|NCT01690325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64846169|NCT01690325|Immunologic Factors|immunologic factors|mesh-ancestor
64846170|NCT01690325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846171|NCT01690325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64846172|NCT01690325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64846173|NCT01690325|Alkylating Agents|alkylating agents|mesh-ancestor
64846174|NCT01690325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846175|NCT01690325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846176|NCT01690325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64846177|NCT01690325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64846178|NCT01690325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64846179|NCT01690325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64846180|NCT01690325|Growth Substances|growth substances|mesh-ancestor
64846181|NCT01690325|Growth Inhibitors|growth inhibitors|mesh-ancestor
64846182|NCT01690325|Tubulin Modulators|tubulin modulators|mesh-ancestor
64846183|NCT01690325|Antimitotic Agents|antimitotic agents|mesh-ancestor
64846184|NCT01690325|Mitosis Modulators|mitosis modulators|mesh-ancestor
64846185|NCT01690325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64846186|NCT01690325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64846187|NCT01690325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64846188|NCT01690325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302348|NCT03583229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64389460|NCT02433457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64389461|NCT02433457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64389462|NCT02433457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389463|NCT02433457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389464|NCT02021656|Sofosbuvir|sofosbuvir|mesh-list
64389465|NCT02021656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64330920|NCT04462471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330921|NCT03043599|Nivolumab|nivolumab|mesh-list
64330922|NCT03043599|Ipilimumab|ipilimumab|mesh-list
64330923|NCT03043599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64846189|NCT01690338|Bromides|bromides|mesh-list
64846190|NCT01690338|Rocuronium|rocuronium|mesh-list
64846191|NCT01690338|Vecuronium Bromide|vecuronium bromide|mesh-list
64846192|NCT01690338|Cisatracurium|cisatracurium|mesh-list
64846193|NCT01690338|Anticonvulsants|anticonvulsants|mesh-ancestor
64846194|NCT01690338|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64846195|NCT01690338|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64846196|NCT01690338|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64846197|NCT01690338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64846226|NCT01690507|Cytarabine|cytarabine|mesh-list
64389466|NCT02021656|Ledipasvir|ledipasvir|mesh-list
64389467|NCT02021656|Antiviral Agents|antiviral agents|mesh-ancestor
64389468|NCT02021656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64778039|NCT02284464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778040|NCT02284464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64778042|NCT02284854|Carbamazepine|carbamazepine|mesh-list
64778043|NCT02284854|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64778044|NCT02284854|Anticonvulsants|anticonvulsants|mesh-ancestor
64389474|NCT03145025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389475|NCT03144947|Docetaxel|docetaxel|mesh-list
64389476|NCT03144947|Trastuzumab|trastuzumab|mesh-list
64389477|NCT03144947|Pertuzumab|pertuzumab|mesh-list
64389478|NCT03144947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64389479|NCT03144947|Tubulin Modulators|tubulin modulators|mesh-ancestor
64389480|NCT03144947|Antimitotic Agents|antimitotic agents|mesh-ancestor
64389481|NCT03144947|Mitosis Modulators|mitosis modulators|mesh-ancestor
64389482|NCT03144947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389483|NCT03144947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64389484|NCT02433535|Simvastatin|simvastatin|mesh-list
64846241|NCT01690507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64614722|NCT00361959|Dermatologic Agents|dermatologic agents|mesh-ancestor
64846242|NCT01690533|Moxifloxacin|moxifloxacin|mesh-list
64846243|NCT01690533|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64846244|NCT01690533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64846245|NCT01690533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64846246|NCT01690533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64846247|NCT01690533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64846248|NCT01690533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846249|NCT01690533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846250|NCT01690533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846251|NCT01690533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64846252|NCT01690533|Contraceptive Agents|contraceptive agents|mesh-ancestor
64846253|NCT01690533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64846254|NCT01690533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846255|NCT01690533|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64846256|NCT01690533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64846257|NCT01690533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64846258|NCT01690559|Ciprofloxacin|ciprofloxacin|mesh-list
64846259|NCT01690559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64846260|NCT01690559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64846261|NCT01690559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64389485|NCT02433535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64389486|NCT02433535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64302349|NCT03583229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302350|NCT03583229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64302352|NCT03583229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64302353|NCT03583229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64302354|NCT03583229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302355|NCT03583229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64302356|NCT03583229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64302357|NCT03583229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302358|NCT03583229|Antipyretics|antipyretics|mesh-ancestor
64330924|NCT03043599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330925|NCT03043599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64330926|NCT03043599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330927|NCT02366949|Paclitaxel|paclitaxel|mesh-list
64330928|NCT02366949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64330929|NCT02366949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330930|NCT02366949|Tubulin Modulators|tubulin modulators|mesh-ancestor
64330931|NCT02366949|Antimitotic Agents|antimitotic agents|mesh-ancestor
64330932|NCT02366949|Mitosis Modulators|mitosis modulators|mesh-ancestor
64330934|NCT03532919|Cystatins|cystatins|mesh-list
64302359|NCT02259803|Amlodipine|amlodipine|mesh-list
64302360|NCT02259803|Telmisartan|telmisartan|mesh-list
64302361|NCT02259803|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
64302362|NCT02259803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64302363|NCT02259803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64302364|NCT02259803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64416671|NCT01668667|Sensory System Agents|sensory system agents|mesh-ancestor
64778054|NCT02284854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64846308|NCT01690702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64846309|NCT01690702|Alkylating Agents|alkylating agents|mesh-ancestor
64846310|NCT01690702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64846311|NCT01690702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64846312|NCT01690702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64846313|NCT01690702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64846314|NCT01690702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846315|NCT01690767|Lidocaine|lidocaine|mesh-list
64846316|NCT01690767|Anesthetics, Local|anesthetics, local|mesh-ancestor
64846317|NCT01690767|Anesthetics|anesthetics|mesh-ancestor
64846318|NCT01690767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64846383|NCT01691001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64846384|NCT01691001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64846385|NCT01691001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64846386|NCT01691001|Adrenergic Agents|adrenergic agents|mesh-ancestor
64846387|NCT01691001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64846388|NCT01691001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614869|NCT03254667|Dermatologic Agents|dermatologic agents|mesh-ancestor
64846389|NCT01691053|Spironolactone|spironolactone|mesh-list
64846390|NCT01691053|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64846391|NCT01691053|Hormone Antagonists|hormone antagonists|mesh-ancestor
64846392|NCT01691053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64330935|NCT03532919|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64778055|NCT02284854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64778056|NCT02284854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302365|NCT02259803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302366|NCT02259803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64302367|NCT02259803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302368|NCT02259803|Vasodilator Agents|vasodilator agents|mesh-ancestor
64302369|NCT02259803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64302370|NCT02259803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64302371|NCT03260049|Antiviral Agents|antiviral agents|mesh-list
64778057|NCT02284854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64778058|NCT02284854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64389487|NCT02433535|Antimetabolites|antimetabolites|mesh-ancestor
64389488|NCT02433535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389489|NCT02433535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64846492|NCT01691976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843919|NCT01665586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64846522|NCT01692483|Prednisone|prednisone|mesh-list
64389490|NCT02433535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64389491|NCT02433535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389492|NCT03144713|Terlipressin|terlipressin|mesh-list
64389494|NCT03144713|Sympathomimetics|sympathomimetics|mesh-ancestor
64389495|NCT03144713|Autonomic Agents|autonomic agents|mesh-ancestor
64389496|NCT03144713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64389497|NCT03144713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302372|NCT03260049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64302373|NCT03069950|Leucovorin|leucovorin|mesh-list
64302374|NCT03069950|Dexamethasone|dexamethasone|mesh-list
64302375|NCT03069950|Fluorouracil|fluorouracil|mesh-list
64302376|NCT03069950|Irinotecan|irinotecan|mesh-list
64302377|NCT03069950|Panitumumab|panitumumab|mesh-list
64302378|NCT03069950|Floxuridine|floxuridine|mesh-list
64302379|NCT03069950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64302380|NCT03069950|Antiemetics|antiemetics|mesh-ancestor
64302381|NCT03069950|Autonomic Agents|autonomic agents|mesh-ancestor
64302382|NCT03069950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302383|NCT03069950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302384|NCT03069950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64302385|NCT03069950|Glucocorticoids|glucocorticoids|mesh-ancestor
64302386|NCT03069950|Hormones|hormones|mesh-ancestor
64302387|NCT03069950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64302388|NCT03069950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64302389|NCT03069950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302390|NCT03069950|Antimetabolites|antimetabolites|mesh-ancestor
64846624|NCT01693289|Metformin|metformin|mesh-list
64846625|NCT01693289|Letrozole|letrozole|mesh-list
64846626|NCT01693289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64846627|NCT01693289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846628|NCT01693289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302391|NCT03069950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302392|NCT03069950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64302393|NCT03069950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64302394|NCT03069950|Immunologic Factors|immunologic factors|mesh-ancestor
64302395|NCT03069950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64302396|NCT03069950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64302400|NCT03069950|Vitamin B Complex|vitamin b complex|mesh-ancestor
64302401|NCT03069950|Vitamins|vitamins|mesh-ancestor
64846671|NCT01693419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64846672|NCT01693419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302402|NCT03069950|Micronutrients|micronutrients|mesh-ancestor
64846673|NCT01693419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64846674|NCT01693419|Immunologic Factors|immunologic factors|mesh-ancestor
64846675|NCT01693419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846676|NCT01693419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64846678|NCT01693432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846679|NCT01693432|Tubulin Modulators|tubulin modulators|mesh-ancestor
64846693|NCT01693601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846694|NCT01693601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846695|NCT01693640|Abatacept|abatacept|mesh-list
64846696|NCT01693640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64846697|NCT01693640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846698|NCT01693640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846699|NCT01693640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64846700|NCT01693640|Immunologic Factors|immunologic factors|mesh-ancestor
64846701|NCT01693640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846702|NCT01693640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64846703|NCT01693679|Lamivudine|lamivudine|mesh-list
64302403|NCT03069950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64302404|NCT04913870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64302406|NCT03577457|Oxytocin|oxytocin|mesh-list
64389498|NCT03144713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64389499|NCT03144713|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64389500|NCT03144713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64389501|NCT03144713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64389505|NCT03144713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64389506|NCT03191383|Vaccines|vaccines|mesh-list
64389507|NCT03191383|Immunologic Factors|immunologic factors|mesh-ancestor
64389508|NCT03191383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389509|NCT04682158|Paclitaxel|paclitaxel|mesh-list
64389510|NCT04682158|Carboplatin|carboplatin|mesh-list
64389511|NCT04682158|Propranolol|propranolol|mesh-list
64846813|NCT05288192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64846814|NCT05288192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64846815|NCT05288192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64846816|NCT05288192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64846817|NCT05288192|Glucocorticoids|glucocorticoids|mesh-ancestor
64846818|NCT05288192|Hormones|hormones|mesh-ancestor
64846819|NCT05288192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64846820|NCT05288192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846821|NCT05288192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64846822|NCT05288192|Immunologic Factors|immunologic factors|mesh-ancestor
64846823|NCT05288192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846824|NCT05288192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846825|NCT05288179|Pirfenidone|pirfenidone|mesh-list
64846826|NCT05288179|Analgesics|analgesics|mesh-ancestor
64389512|NCT04682158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64302408|NCT03577457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64302409|NCT03577457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302410|NCT02455245|Carboplatin|carboplatin|mesh-list
64302411|NCT02455245|Vincristine|vincristine|mesh-list
64302412|NCT02455245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302413|NCT02455245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64302414|NCT02455245|Tubulin Modulators|tubulin modulators|mesh-ancestor
64302415|NCT02455245|Antimitotic Agents|antimitotic agents|mesh-ancestor
64302416|NCT02455245|Mitosis Modulators|mitosis modulators|mesh-ancestor
64302417|NCT02455245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302418|NCT03537599|Daratumumab|daratumumab|mesh-list
64302419|NCT03537599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302420|NCT04986254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64302428|NCT04986254|Penicillin G Procaine|penicillin g procaine|mesh-list
64302429|NCT04986254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64302430|NCT04986254|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64778077|NCT02285634|Adrenergic Agents|adrenergic agents|mesh-ancestor
64778078|NCT02285634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64778079|NCT02285634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64778080|NCT02285634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64778081|NCT02285634|Autonomic Agents|autonomic agents|mesh-ancestor
64389513|NCT04682158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64389514|NCT04682158|Tubulin Modulators|tubulin modulators|mesh-ancestor
64846947|NCT05290324|GABA Agents|gaba agents|mesh-ancestor
64846948|NCT05290324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64846949|NCT05290324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846950|NCT05290090|Rituximab|rituximab|mesh-list
64846992|NCT05291793|Tenoxicam|tenoxicam|mesh-list
64389515|NCT04682158|Antimitotic Agents|antimitotic agents|mesh-ancestor
64389516|NCT04682158|Mitosis Modulators|mitosis modulators|mesh-ancestor
64302445|NCT04996160|Autonomic Agents|autonomic agents|mesh-ancestor
64302446|NCT04996160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64389517|NCT04682158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389518|NCT04682158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64389520|NCT04682158|Adrenergic Agents|adrenergic agents|mesh-ancestor
64389521|NCT04682158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64389522|NCT04682158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847027|NCT05294887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64847028|NCT05294887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847029|NCT05294887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847030|NCT05294887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64847031|NCT05294887|Sympatholytics|sympatholytics|mesh-ancestor
64847032|NCT05294887|Autonomic Agents|autonomic agents|mesh-ancestor
64847033|NCT05294887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64847034|NCT05294887|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64847035|NCT05294887|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64847036|NCT05294887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64847037|NCT05294887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64847038|NCT05294887|Vasodilator Agents|vasodilator agents|mesh-ancestor
64847039|NCT05294822|Insulin|insulin|mesh-list
64847040|NCT05294822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64847041|NCT05294822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847042|NCT05294744|Acetylcysteine|acetylcysteine|mesh-list
64847046|NCT05294744|Expectorants|expectorants|mesh-ancestor
64847096|NCT05294640|Mydriatics|mydriatics|mesh-ancestor
64847097|NCT05294640|Sympathomimetics|sympathomimetics|mesh-ancestor
64847098|NCT05294640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64847099|NCT05294536|Liraglutide|liraglutide|mesh-list
64847100|NCT05294536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64847101|NCT05294536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847102|NCT05294536|Incretins|incretins|mesh-ancestor
64847103|NCT05294536|Hormones|hormones|mesh-ancestor
64847104|NCT05294536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64847105|NCT05294484|Indapamide|indapamide|mesh-list
64847106|NCT05294484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64389523|NCT04682158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64389524|NCT04682158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64302447|NCT04996160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302448|NCT04996160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64302449|NCT04996160|Glucocorticoids|glucocorticoids|mesh-ancestor
64302451|NCT04996160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64302452|NCT04996160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64302453|NCT04996160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302454|NCT04996160|Protease Inhibitors|protease inhibitors|mesh-ancestor
64847181|NCT05293574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847182|NCT05293574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64847183|NCT05293574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64847185|NCT05293132|Ubiquinone|ubiquinone|mesh-list
64847186|NCT05293132|Montelukast|montelukast|mesh-list
64847187|NCT05293132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64847188|NCT05293132|Respiratory System Agents|respiratory system agents|mesh-ancestor
64847189|NCT05293132|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64847190|NCT05293132|Hormone Antagonists|hormone antagonists|mesh-ancestor
64847191|NCT05293132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64847192|NCT05293132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330965|NCT05791799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330966|NCT05791799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64330969|NCT05791721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64330970|NCT05791721|Antiemetics|antiemetics|mesh-ancestor
64330971|NCT05791721|Autonomic Agents|autonomic agents|mesh-ancestor
64330972|NCT05791721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330973|NCT05791721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330976|NCT05791721|Hormones|hormones|mesh-ancestor
64302455|NCT04996160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302456|NCT04996160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302457|NCT04996160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64302458|NCT04996160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64302459|NCT04996160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64302460|NCT04996160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64302461|NCT04986098|Paclitaxel|paclitaxel|mesh-list
64847214|NCT05296564|Immunologic Factors|immunologic factors|mesh-ancestor
64847215|NCT05296564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847216|NCT05296564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64847217|NCT05296564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64847218|NCT05296564|Alkylating Agents|alkylating agents|mesh-ancestor
64847219|NCT05296564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847220|NCT05296564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847221|NCT05296564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64847222|NCT05296564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64847223|NCT05296564|Analgesics|analgesics|mesh-ancestor
64847224|NCT05296564|Sensory System Agents|sensory system agents|mesh-ancestor
64847225|NCT05296564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64847226|NCT05296564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64847227|NCT05296564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64847228|NCT05296564|Antiviral Agents|antiviral agents|mesh-ancestor
64847229|NCT05296564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64847230|NCT05296369|Folic Acid|folic acid|mesh-list
64847231|NCT05296369|Hematinics|hematinics|mesh-ancestor
64847232|NCT05296369|Vitamin B Complex|vitamin b complex|mesh-ancestor
64847233|NCT05296369|Vitamins|vitamins|mesh-ancestor
64847234|NCT05296369|Micronutrients|micronutrients|mesh-ancestor
64330980|NCT05791721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64330981|NCT05791721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64330982|NCT05791721|Analgesics|analgesics|mesh-ancestor
64330984|NCT05791721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64330985|NCT05791721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64302462|NCT04986098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64302463|NCT04986098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302464|NCT04986098|Tubulin Modulators|tubulin modulators|mesh-ancestor
64302465|NCT04986098|Antimitotic Agents|antimitotic agents|mesh-ancestor
64302466|NCT04986098|Mitosis Modulators|mitosis modulators|mesh-ancestor
64324217|NCT02557100|Abortifacient Agents|abortifacient agents|mesh-ancestor
64324218|NCT02557100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64778092|NCT02287350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64778093|NCT02287350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64778095|NCT02287350|Sensory System Agents|sensory system agents|mesh-ancestor
64778096|NCT02287350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778097|NCT02287350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778098|NCT02287350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64847235|NCT05296369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847237|NCT05296317|Epirubicin|epirubicin|mesh-list
64847238|NCT05296317|Lenograstim|lenograstim|mesh-list
64847239|NCT05296317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64847240|NCT05296317|Immunologic Factors|immunologic factors|mesh-ancestor
64847241|NCT05296317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847242|NCT05296317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64847243|NCT05296317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64847244|NCT05296317|Alkylating Agents|alkylating agents|mesh-ancestor
64847245|NCT05296317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847246|NCT05296317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847247|NCT05296317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64847248|NCT05296317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64847249|NCT05296317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64847250|NCT05296317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64847251|NCT05296317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64847252|NCT05296317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64847253|NCT05296005|Leucovorin|leucovorin|mesh-list
64847254|NCT05296005|Docetaxel|docetaxel|mesh-list
64331105|NCT05790577|Vasodilator Agents|vasodilator agents|mesh-ancestor
64331106|NCT05790525|Bismuth|bismuth|mesh-list
64331107|NCT05790525|Antacids|antacids|mesh-ancestor
64294506|NCT05121038|Oxaliplatin|oxaliplatin|mesh-list
64294507|NCT05121038|Irinotecan|irinotecan|mesh-list
64294509|NCT05121038|Folfirinox|folfirinox|mesh-list
64778099|NCT02287350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64778100|NCT02287350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64778101|NCT02287350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64778102|NCT02287350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778103|NCT02288364|Lidocaine|lidocaine|mesh-list
64302467|NCT04986098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302469|NCT02239445|Chloral Hydrate|chloral hydrate|mesh-list
64302470|NCT02239445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64302471|NCT02239445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64302472|NCT02239445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302473|NCT02239445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64302474|NCT02239445|Analgesics|analgesics|mesh-ancestor
64302475|NCT02239445|Sensory System Agents|sensory system agents|mesh-ancestor
64847255|NCT05296005|Fluorouracil|fluorouracil|mesh-list
64847256|NCT05296005|Capecitabine|capecitabine|mesh-list
64847257|NCT05296005|Oxaliplatin|oxaliplatin|mesh-list
64847258|NCT05296005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847259|NCT05296005|Tubulin Modulators|tubulin modulators|mesh-ancestor
64847260|NCT05296005|Antimitotic Agents|antimitotic agents|mesh-ancestor
64847261|NCT05296005|Mitosis Modulators|mitosis modulators|mesh-ancestor
64847262|NCT05296005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847263|NCT05296005|Antimetabolites|antimetabolites|mesh-ancestor
64847264|NCT05296005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64847265|NCT05296005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64847266|NCT05296005|Immunologic Factors|immunologic factors|mesh-ancestor
64847267|NCT05296005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847268|NCT05296005|Antidotes|antidotes|mesh-ancestor
64847269|NCT05296005|Protective Agents|protective agents|mesh-ancestor
64847270|NCT05296005|Vitamin B Complex|vitamin b complex|mesh-ancestor
64847272|NCT05296005|Micronutrients|micronutrients|mesh-ancestor
64847273|NCT05295836|Glycerol|glycerol|mesh-list
64847274|NCT05295836|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64847275|NCT05295836|Protective Agents|protective agents|mesh-ancestor
64847276|NCT05295836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847277|NCT05294900|Paclitaxel|paclitaxel|mesh-list
64847278|NCT05294900|Carboplatin|carboplatin|mesh-list
64847279|NCT05294900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64847280|NCT05294900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847282|NCT05294900|Antimitotic Agents|antimitotic agents|mesh-ancestor
64847283|NCT05294900|Mitosis Modulators|mitosis modulators|mesh-ancestor
64615771|NCT01000285|Alkylating Agents|alkylating agents|mesh-ancestor
64847284|NCT05294900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847285|NCT05280405|Infliximab|infliximab|mesh-list
64847286|NCT05280405|Dermatologic Agents|dermatologic agents|mesh-ancestor
64302476|NCT02239445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302477|NCT02239445|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64302478|NCT02239445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64302479|NCT02239445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64302480|NCT02239445|Adrenergic Agents|adrenergic agents|mesh-ancestor
64302481|NCT02239445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64389538|NCT02430259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64847299|NCT05273242|Infliximab|infliximab|mesh-list
64389539|NCT02430259|Antimetabolites|antimetabolites|mesh-ancestor
64389540|NCT02430259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389541|NCT02430259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64389542|NCT02430259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64389543|NCT02430259|Leprostatic Agents|leprostatic agents|mesh-ancestor
64389544|NCT02327039|Dapagliflozin|dapagliflozin|mesh-list
64389545|NCT02327039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64389546|NCT02327039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778111|NCT02288364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64778112|NCT02288364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64778113|NCT02288364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64302532|NCT02134249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302534|NCT03245853|Flavin Mononucleotide|flavin mononucleotide|mesh-list
64302535|NCT03245853|Vitamin B Complex|vitamin b complex|mesh-ancestor
64847401|NCT05262686|Belimumab|belimumab|mesh-list
64847402|NCT05262686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847403|NCT05262686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64847404|NCT05262686|Analgesics|analgesics|mesh-ancestor
64847405|NCT05262686|Sensory System Agents|sensory system agents|mesh-ancestor
64331108|NCT05790525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331109|NCT05790525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64331110|NCT05790499|Atorvastatin|atorvastatin|mesh-list
64331111|NCT05790499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64331112|NCT05790499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64847406|NCT05262686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64847407|NCT05262686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847408|NCT05262686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64847426|NCT05236608|Nivolumab|nivolumab|mesh-list
64302536|NCT03245853|Vitamins|vitamins|mesh-ancestor
64302537|NCT03245853|Micronutrients|micronutrients|mesh-ancestor
64302538|NCT03245853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302539|NCT03245853|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64302540|NCT03245853|Dermatologic Agents|dermatologic agents|mesh-ancestor
64302541|NCT03574649|Paclitaxel|paclitaxel|mesh-list
64302542|NCT03574649|Docetaxel|docetaxel|mesh-list
64778114|NCT02288364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778115|NCT02289222|Dexamethasone|dexamethasone|mesh-list
64778116|NCT02289222|Pembrolizumab|pembrolizumab|mesh-list
64778117|NCT02289222|Pomalidomide|pomalidomide|mesh-list
64778118|NCT02289222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64778119|NCT02289222|Antiemetics|antiemetics|mesh-ancestor
64778120|NCT02289222|Autonomic Agents|autonomic agents|mesh-ancestor
64778121|NCT02289222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778122|NCT02289222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778123|NCT02289222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64778124|NCT02289222|Glucocorticoids|glucocorticoids|mesh-ancestor
64778125|NCT02289222|Hormones|hormones|mesh-ancestor
64778126|NCT02289222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64778127|NCT02289222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64847451|NCT05210413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64847452|NCT05210413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847453|NCT05210413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847454|NCT05203705|Enoxaparin|enoxaparin|mesh-list
64847455|NCT05203705|Anticoagulants|anticoagulants|mesh-ancestor
64847456|NCT05203705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64847457|NCT05203705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64847458|NCT05203705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847459|NCT05202561|Vaccines|vaccines|mesh-list
64847460|NCT05202561|Immunologic Factors|immunologic factors|mesh-ancestor
64847461|NCT05202561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847462|NCT05192629|Midazolam|midazolam|mesh-list
64847463|NCT05192629|Dexmedetomidine|dexmedetomidine|mesh-list
64847464|NCT05192629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64847465|NCT05192629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64847466|NCT05192629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847468|NCT05192629|Analgesics|analgesics|mesh-ancestor
64302544|NCT03574649|Carboplatin|carboplatin|mesh-list
64302545|NCT03574649|Fluorouracil|fluorouracil|mesh-list
64302546|NCT03574649|Avelumab|avelumab|mesh-list
64847501|NCT05189444|Antacids|antacids|mesh-ancestor
64302547|NCT03574649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64389556|NCT03142607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64389557|NCT03142607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64389558|NCT03142607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64389559|NCT03186547|Botulinum Toxins|botulinum toxins|mesh-list
64389560|NCT03186547|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64389561|NCT03186547|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64389562|NCT03186547|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64389563|NCT03186547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64389564|NCT03186547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389565|NCT03186547|Cholinergic Agents|cholinergic agents|mesh-ancestor
64389566|NCT03186547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64302548|NCT03574649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302549|NCT03574649|Tubulin Modulators|tubulin modulators|mesh-ancestor
64302550|NCT03574649|Antimitotic Agents|antimitotic agents|mesh-ancestor
64302551|NCT03574649|Mitosis Modulators|mitosis modulators|mesh-ancestor
64302552|NCT03574649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302553|NCT03574649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64302554|NCT03574649|Immunologic Factors|immunologic factors|mesh-ancestor
64302555|NCT03574649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302556|NCT03574649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64302557|NCT03574649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64302558|NCT03574649|Alkylating Agents|alkylating agents|mesh-ancestor
64302559|NCT03574649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64847584|NCT05096065|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64847585|NCT05096065|Fertility Agents|fertility agents|mesh-ancestor
64847586|NCT05096065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64847587|NCT05096065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847588|NCT05096065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64847589|NCT05096065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847590|NCT05083572|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64847591|NCT05083572|Rifaximin|rifaximin|mesh-list
64847592|NCT05083572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64847593|NCT05083572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64847594|NCT05057273|Adalimumab|adalimumab|mesh-list
64847595|NCT05057273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64847596|NCT05057273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64847598|NCT05033743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64847599|NCT05033743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64847600|NCT05033743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64847601|NCT05030025|Lamivudine|lamivudine|mesh-list
64847602|NCT05030025|Abacavir|abacavir|mesh-list
64847603|NCT05030025|Dideoxynucleosides|dideoxynucleosides|mesh-list
64847604|NCT05030025|Dolutegravir|dolutegravir|mesh-list
64847605|NCT05030025|Triumeq|triumeq|mesh-list
64389567|NCT03186547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389568|NCT03186547|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64389569|NCT03186547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64389570|NCT05077475|Cryptophycin 52|cryptophycin 52|mesh-list
64778128|NCT02289222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778129|NCT02289222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64778130|NCT02289222|Immunologic Factors|immunologic factors|mesh-ancestor
64778131|NCT02289222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64778132|NCT02289222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64778133|NCT02289222|Growth Substances|growth substances|mesh-ancestor
64778134|NCT02289222|Growth Inhibitors|growth inhibitors|mesh-ancestor
64778135|NCT02291016|Formoterol Fumarate|formoterol fumarate|mesh-list
64778136|NCT02291016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64778137|NCT02291016|Autonomic Agents|autonomic agents|mesh-ancestor
64778138|NCT02291016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778139|NCT02291016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389572|NCT05077475|Mitosis Modulators|mitosis modulators|mesh-ancestor
64389573|NCT05077475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389574|NCT05077475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64389576|NCT02326727|Nitrous Oxide|nitrous oxide|mesh-list
64389577|NCT02326727|Propofol|propofol|mesh-list
64302560|NCT03574649|Antimetabolites|antimetabolites|mesh-ancestor
64302561|NCT03574649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64302562|NCT03574649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64302563|NCT02128945|Fludarabine|fludarabine|mesh-list
64302564|NCT02128945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302565|NCT02136277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64302566|NCT03073928|Ropivacaine|ropivacaine|mesh-list
64302567|NCT03073928|Anesthetics, Local|anesthetics, local|mesh-ancestor
64302568|NCT03073928|Anesthetics|anesthetics|mesh-ancestor
64302569|NCT03073928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64302570|NCT03073928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302571|NCT03073928|Sensory System Agents|sensory system agents|mesh-ancestor
64302572|NCT03073928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302573|NCT02134327|Midazolam|midazolam|mesh-list
64302574|NCT02134327|Dexmedetomidine|dexmedetomidine|mesh-list
64302575|NCT02134327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64302576|NCT02134327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64847618|NCT05013567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64847619|NCT05013567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64847621|NCT05013567|Sensory System Agents|sensory system agents|mesh-ancestor
64847622|NCT05013567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64847623|NCT05013567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847624|NCT05013567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64847625|NCT05013567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64847626|NCT05013567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64847627|NCT05013567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64847628|NCT05013567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847629|NCT05008926|Naloxegol|naloxegol|mesh-list
64847630|NCT05008926|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64847631|NCT05008926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847632|NCT05008926|Sensory System Agents|sensory system agents|mesh-ancestor
64302577|NCT02134327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302578|NCT02134327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64302579|NCT02134327|Analgesics|analgesics|mesh-ancestor
64302580|NCT02134327|Sensory System Agents|sensory system agents|mesh-ancestor
64302581|NCT02134327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356274|NCT03407027|Hormones|hormones|mesh-ancestor
64389578|NCT02326727|Ropivacaine|ropivacaine|mesh-list
64389579|NCT02326727|Isoflurane|isoflurane|mesh-list
64847633|NCT05008926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64847634|NCT04989621|Rituximab|rituximab|mesh-list
64847635|NCT04989621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64847636|NCT04989621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847637|NCT04989621|Immunologic Factors|immunologic factors|mesh-ancestor
64847638|NCT04989621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847639|NCT04989621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64847640|NCT04989049|Folic Acid|folic acid|mesh-list
64847641|NCT04989049|Hematinics|hematinics|mesh-ancestor
64847642|NCT04989049|Vitamin B Complex|vitamin b complex|mesh-ancestor
64847643|NCT04989049|Vitamins|vitamins|mesh-ancestor
64847644|NCT04989049|Micronutrients|micronutrients|mesh-ancestor
64847645|NCT04989049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847646|NCT04984044|Vitamin D|vitamin d|mesh-list
64389580|NCT02326727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64389581|NCT02326727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64389582|NCT02326727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389583|NCT02326727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64389584|NCT02326727|Anesthetics, General|anesthetics, general|mesh-ancestor
64324219|NCT02557100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302582|NCT02134327|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64302583|NCT02134327|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64302584|NCT02134327|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64302585|NCT02134327|Adrenergic Agents|adrenergic agents|mesh-ancestor
64302586|NCT02134327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64331136|NCT05790330|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64331137|NCT05790330|Abortifacient Agents|abortifacient agents|mesh-ancestor
64331138|NCT05790330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64847665|NCT04964700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847666|NCT04950868|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64847667|NCT04950868|Antidepressive Agents|antidepressive agents|mesh-ancestor
64847668|NCT04950868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64847669|NCT04950868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64847670|NCT04950868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64847671|NCT04950868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64847672|NCT04950868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847673|NCT04940767|Minocycline|minocycline|mesh-list
64847674|NCT04940767|Isotretinoin|isotretinoin|mesh-list
64302587|NCT02134327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302588|NCT02134327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64302589|NCT02134327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64302590|NCT02134327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64302591|NCT02134327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64302592|NCT02134327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64302593|NCT02134327|Anesthetics, General|anesthetics, general|mesh-ancestor
64302594|NCT02134327|Anesthetics|anesthetics|mesh-ancestor
64302595|NCT02134327|GABA Modulators|gaba modulators|mesh-ancestor
64302596|NCT02134327|GABA Agents|gaba agents|mesh-ancestor
64302597|NCT02134405|Esomeprazole|esomeprazole|mesh-list
64302598|NCT02134405|Rebamipide|rebamipide|mesh-list
64331145|NCT05790330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331146|NCT05790330|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64331147|NCT05790330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64331148|NCT05790330|Immunologic Factors|immunologic factors|mesh-ancestor
64847675|NCT04940767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64847676|NCT04940767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64847677|NCT04940767|Dermatologic Agents|dermatologic agents|mesh-ancestor
64847679|NCT04921527|Chiauranib|chiauranib|mesh-list
64847680|NCT04921527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64847681|NCT04921527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847682|NCT04921527|Tubulin Modulators|tubulin modulators|mesh-ancestor
64847683|NCT04921527|Antimitotic Agents|antimitotic agents|mesh-ancestor
64847684|NCT04921527|Mitosis Modulators|mitosis modulators|mesh-ancestor
64847685|NCT04921527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847686|NCT04921527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64847687|NCT04921527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64847688|NCT04899843|Zinc Sulfate|zinc sulfate|mesh-list
64847689|NCT04899843|Astringents|astringents|mesh-ancestor
64847690|NCT04899843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847691|NCT04899843|Dermatologic Agents|dermatologic agents|mesh-ancestor
64847692|NCT04897802|Exenatide|exenatide|mesh-list
64847693|NCT04897802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64847694|NCT04897802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331162|NCT05790239|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
64331163|NCT05790239|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64302599|NCT02134405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64302600|NCT02134405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64324220|NCT02557100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64324222|NCT02557100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324223|NCT02557100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324224|NCT02557100|Dermatologic Agents|dermatologic agents|mesh-ancestor
64324225|NCT02557100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324226|NCT02557100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64324227|NCT02557100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64302601|NCT02134405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64331164|NCT05790239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331166|NCT05790239|Autonomic Agents|autonomic agents|mesh-ancestor
64331167|NCT05790239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64331168|NCT05790239|Dopamine Agents|dopamine agents|mesh-ancestor
64331169|NCT05790239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64847713|NCT04882202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847714|NCT04882202|Antipyretics|antipyretics|mesh-ancestor
64847715|NCT04871425|Fentanyl|fentanyl|mesh-list
64847716|NCT04871425|Ketamine|ketamine|mesh-list
64847717|NCT04871425|Analgesics|analgesics|mesh-ancestor
64847718|NCT04871425|Sensory System Agents|sensory system agents|mesh-ancestor
64847719|NCT04871425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64847720|NCT04871425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847721|NCT04871425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64331170|NCT05790239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331171|NCT05790239|Adrenergic Agents|adrenergic agents|mesh-ancestor
64331172|NCT05790239|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64331173|NCT05790239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64302602|NCT02134405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302603|NCT02134405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302604|NCT02134405|Antioxidants|antioxidants|mesh-ancestor
64302605|NCT02134405|Protective Agents|protective agents|mesh-ancestor
64302606|NCT02134405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302607|NCT02456025|Tacrolimus|tacrolimus|mesh-list
64302608|NCT02456025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64302609|NCT02456025|Immunologic Factors|immunologic factors|mesh-ancestor
64302610|NCT02456025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302611|NCT02456025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64302612|NCT02456025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331174|NCT05790239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64847722|NCT04871425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64847723|NCT04871425|Anesthetics, General|anesthetics, general|mesh-ancestor
64847724|NCT04871425|Anesthetics|anesthetics|mesh-ancestor
64847725|NCT04871425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64847726|NCT04871425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64847727|NCT04871425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64847728|NCT04871425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64847729|NCT04871425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847730|NCT04871425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64847731|NCT04871425|Narcotics|narcotics|mesh-ancestor
64847732|NCT04871425|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64847733|NCT04869605|Chrysarobin|chrysarobin|mesh-list
64847734|NCT04869605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64847735|NCT04869605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64416672|NCT01668667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302621|NCT03576911|Vitamins|vitamins|mesh-ancestor
64302622|NCT02136511|Rituximab|rituximab|mesh-list
64302623|NCT02136511|Idelalisib|idelalisib|mesh-list
64302624|NCT02136511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64302625|NCT02136511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302626|NCT02136511|Immunologic Factors|immunologic factors|mesh-ancestor
64302627|NCT02136511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302628|NCT02136511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64302629|NCT02136511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302630|NCT02136511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302632|NCT02136589|Travoprost|travoprost|mesh-list
64302633|NCT02136589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64302634|NCT02136589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64331175|NCT05790239|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64331176|NCT05790239|Hallucinogens|hallucinogens|mesh-ancestor
64331177|NCT05790239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64331178|NCT05790239|Serotonin Agents|serotonin agents|mesh-ancestor
64331184|NCT05790161|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64331185|NCT05790161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331186|NCT05790161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64331187|NCT05790161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331188|NCT05790161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331189|NCT05790161|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64331190|NCT05790161|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64847736|NCT04869605|Analgesics|analgesics|mesh-ancestor
64847737|NCT04869605|Sensory System Agents|sensory system agents|mesh-ancestor
64847738|NCT04869605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64847739|NCT04869605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847740|NCT04869605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64847741|NCT04869605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64847742|NCT04835584|Dasatinib|dasatinib|mesh-list
64847743|NCT04835584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847744|NCT04835584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64847745|NCT04835584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64847746|NCT04835584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847748|NCT04793867|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64847749|NCT04793867|Anesthetics, General|anesthetics, general|mesh-ancestor
64847750|NCT04793867|Anesthetics|anesthetics|mesh-ancestor
64847751|NCT04793867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64847752|NCT04793867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847753|NCT04774315|Omalizumab|omalizumab|mesh-list
64847754|NCT04774315|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64302635|NCT02136589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64302636|NCT02136589|Analgesics|analgesics|mesh-ancestor
64302637|NCT02136589|Sensory System Agents|sensory system agents|mesh-ancestor
64302638|NCT02136589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302639|NCT02136589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302640|NCT02136589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64302641|NCT02136589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64302642|NCT02136589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64302643|NCT02136589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331191|NCT05790161|Purinergic Agents|purinergic agents|mesh-ancestor
64331192|NCT05790161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64331194|NCT05789173|Clonidine|clonidine|mesh-list
64331195|NCT05789173|Methadone|methadone|mesh-list
64847756|NCT04774315|Respiratory System Agents|respiratory system agents|mesh-ancestor
64847757|NCT04767503|Propofol|propofol|mesh-list
64847758|NCT04767503|Desflurane|desflurane|mesh-list
64847759|NCT04767503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64847760|NCT04767503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64847761|NCT04767503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847762|NCT04767503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64847763|NCT04767503|Anesthetics, General|anesthetics, general|mesh-ancestor
64847764|NCT04767503|Anesthetics|anesthetics|mesh-ancestor
64847765|NCT04767503|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64847766|NCT04760496|Oxytocin|oxytocin|mesh-list
64847767|NCT04760496|Oxytocics|oxytocics|mesh-ancestor
64847768|NCT04760496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64847769|NCT04760496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847770|NCT04750967|Lidocaine|lidocaine|mesh-list
64847771|NCT04750967|Amitriptyline|amitriptyline|mesh-list
64847772|NCT04750967|Anesthetics, Local|anesthetics, local|mesh-ancestor
64847773|NCT04750967|Anesthetics|anesthetics|mesh-ancestor
64847774|NCT04750967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64847775|NCT04750967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847776|NCT04750967|Sensory System Agents|sensory system agents|mesh-ancestor
64847777|NCT04750967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64331196|NCT05789173|Tizanidine|tizanidine|mesh-list
64331197|NCT05789173|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64843920|NCT01665586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64843921|NCT01665586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64843922|NCT01665586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64843923|NCT01665586|Analgesics|analgesics|mesh-ancestor
64843924|NCT01665586|Sensory System Agents|sensory system agents|mesh-ancestor
64843925|NCT01665586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843926|NCT01665586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64843927|NCT01665586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64843928|NCT01665586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64843929|NCT01665586|Adrenergic Agents|adrenergic agents|mesh-ancestor
64843930|NCT01665586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64843931|NCT01665586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327421|NCT02404779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64327422|NCT02404779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64843959|NCT01665846|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64843960|NCT01665846|Hematinics|hematinics|mesh-ancestor
64843961|NCT01665846|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64843962|NCT01665846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64847778|NCT04750967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64847779|NCT04750967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64847780|NCT04750967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64847781|NCT04750967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64847782|NCT04750967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847783|NCT04750967|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64847784|NCT04750967|Antidepressive Agents|antidepressive agents|mesh-ancestor
64847785|NCT04750967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64847786|NCT04750967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64847787|NCT04750967|Analgesics|analgesics|mesh-ancestor
64847788|NCT04750967|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64847789|NCT04750967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64331198|NCT05789173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64331199|NCT05789173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331200|NCT05789173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331201|NCT05789173|Antiviral Agents|antiviral agents|mesh-ancestor
64331202|NCT05789173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64331203|NCT05789173|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64331204|NCT05789173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64331205|NCT05789173|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64331206|NCT05789173|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64302644|NCT02136589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302645|NCT02134639|Edotreotide|edotreotide|mesh-list
64302646|NCT02134639|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64302647|NCT02134639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302648|NCT02129101|Azacitidine|azacitidine|mesh-list
64302649|NCT02129101|Decitabine|decitabine|mesh-list
64778154|NCT02297100|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64778155|NCT02297100|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64778156|NCT02297100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778157|NCT02297100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778158|NCT02297100|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64778159|NCT02297100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64389597|NCT02432911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64389598|NCT02432911|Antimetabolites|antimetabolites|mesh-ancestor
64302661|NCT02134717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64302662|NCT02134717|Antiviral Agents|antiviral agents|mesh-ancestor
64302663|NCT02134717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64302664|NCT02134717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64302665|NCT02134717|Chelating Agents|chelating agents|mesh-ancestor
64302666|NCT02134717|Sequestering Agents|sequestering agents|mesh-ancestor
64302668|NCT03245385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64302669|NCT02136823|Isradipine|isradipine|mesh-list
64302670|NCT02136823|Riluzole|riluzole|mesh-list
64356339|NCT03397069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64847792|NCT04733547|Furosemide|furosemide|mesh-list
64847793|NCT04733547|Diuretics|diuretics|mesh-ancestor
64847794|NCT04733547|Natriuretic Agents|natriuretic agents|mesh-ancestor
64847795|NCT04733547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847796|NCT04733547|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64847797|NCT04733547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64847798|NCT04733547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847799|NCT04722679|Anticoagulants|anticoagulants|mesh-list
64847800|NCT04707235|Hydroxyurea|hydroxyurea|mesh-list
64847801|NCT04707235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324230|NCT02557100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64324231|NCT02557100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64324232|NCT02557100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64324234|NCT02233777|Analgesics|analgesics|mesh-ancestor
64324235|NCT02233777|Sensory System Agents|sensory system agents|mesh-ancestor
64324236|NCT02233777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64324237|NCT02233777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302679|NCT02136823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64302680|NCT02136823|Anticonvulsants|anticonvulsants|mesh-ancestor
64302681|NCT02136823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64302682|NCT02136823|Protective Agents|protective agents|mesh-ancestor
64302683|NCT02136823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64302684|NCT02136823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64302685|NCT02136823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64331235|NCT05786599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64331237|NCT05786599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64331238|NCT05786599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331239|NCT05786599|Analgesics|analgesics|mesh-ancestor
64331240|NCT05786599|Sensory System Agents|sensory system agents|mesh-ancestor
64331241|NCT05786599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64331242|NCT05786599|Antitussive Agents|antitussive agents|mesh-ancestor
64331243|NCT05786599|Respiratory System Agents|respiratory system agents|mesh-ancestor
64847813|NCT04696380|Cholinergic Agents|cholinergic agents|mesh-ancestor
64847814|NCT04696380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64847815|NCT04696380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847817|NCT04672772|Cetuximab|cetuximab|mesh-list
64847818|NCT04672772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64847819|NCT04672772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847820|NCT04672772|Tubulin Modulators|tubulin modulators|mesh-ancestor
64847821|NCT04672772|Antimitotic Agents|antimitotic agents|mesh-ancestor
64847822|NCT04672772|Mitosis Modulators|mitosis modulators|mesh-ancestor
64847823|NCT04672772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847824|NCT04672772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64294531|NCT05097794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64843963|NCT01666041|Fenofibrate|fenofibrate|mesh-list
64843964|NCT01666041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64843965|NCT01666041|Antimetabolites|antimetabolites|mesh-ancestor
64843966|NCT01666041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327423|NCT02404779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327424|NCT00629551|Paroxetine|paroxetine|mesh-list
64843967|NCT01666041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64843968|NCT01666067|Simvastatin|simvastatin|mesh-list
64843969|NCT01666067|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
64843970|NCT01666067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64843971|NCT01666067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64843972|NCT01666067|Antimetabolites|antimetabolites|mesh-ancestor
64847825|NCT04671082|Tolperisone|tolperisone|mesh-list
64847826|NCT04671082|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64847827|NCT04671082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847828|NCT04671082|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64847829|NCT04671082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64847830|NCT04669587|Palbociclib|palbociclib|mesh-list
64847831|NCT04669587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847832|NCT04669587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64847833|NCT04669587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64847834|NCT04669587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847835|NCT04659941|BCG Vaccine|bcg vaccine|mesh-list
64331244|NCT05785767|Cemiplimab|cemiplimab|mesh-list
64331245|NCT05785767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64331248|NCT05782361|Tepotinib|tepotinib|mesh-list
64302708|NCT03073850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302709|NCT03073850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64302710|NCT03073850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302711|NCT03073850|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64302712|NCT03073850|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64302713|NCT03073850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64302714|NCT03073850|Purinergic Agents|purinergic agents|mesh-ancestor
64302715|NCT03073850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64302716|NCT03073850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64778172|NCT02299050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778173|NCT02302092|Cefepime|cefepime|mesh-list
64847850|NCT04658823|Tocotrienols|tocotrienols|mesh-list
64847851|NCT04658823|Tocovid|tocovid|mesh-list
64847852|NCT04658823|Vitamins|vitamins|mesh-ancestor
64847853|NCT04658823|Micronutrients|micronutrients|mesh-ancestor
64847854|NCT04658823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847855|NCT04658823|Antioxidants|antioxidants|mesh-ancestor
64847856|NCT04658823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847857|NCT04658823|Protective Agents|protective agents|mesh-ancestor
64847858|NCT04648241|Vaccines|vaccines|mesh-list
64847859|NCT04648241|Immunologic Factors|immunologic factors|mesh-ancestor
64847860|NCT04648241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847861|NCT04640818|Rituximab|rituximab|mesh-list
64847862|NCT04640818|Cladribine|cladribine|mesh-list
64847863|NCT04640818|Ocrelizumab|ocrelizumab|mesh-list
64847864|NCT04640818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64847865|NCT04640818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331273|NCT05729139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331274|NCT05704725|Aflibercept|aflibercept|mesh-list
64331275|NCT05704725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64331276|NCT05704725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64331277|NCT05704725|Growth Substances|growth substances|mesh-ancestor
64778174|NCT02302092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64778175|NCT02302092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64778176|NCT02303184|Aflibercept|aflibercept|mesh-list
64778177|NCT02303184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64778178|NCT02303184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64778179|NCT02303184|Growth Substances|growth substances|mesh-ancestor
64778180|NCT02303184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847866|NCT04640818|Immunologic Factors|immunologic factors|mesh-ancestor
64847867|NCT04640818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847868|NCT04640818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64389608|NCT03588767|Vitamin D|vitamin d|mesh-list
64389609|NCT03588767|Ergocalciferols|ergocalciferols|mesh-list
64389610|NCT03588767|Cholecalciferol|cholecalciferol|mesh-list
64389611|NCT03588767|Vitamins|vitamins|mesh-list
64389612|NCT03588767|Testosterone Congeners|testosterone congeners|mesh-list
64389613|NCT03588767|Micronutrients|micronutrients|mesh-ancestor
64778182|NCT02303184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778183|NCT02304432|Cycloserine|cycloserine|mesh-list
64847869|NCT04640818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64847870|NCT04640493|Dapagliflozin|dapagliflozin|mesh-list
64847871|NCT04640493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64847872|NCT04640493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847873|NCT04640493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64847874|NCT04640493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847875|NCT04602078|Gemcitabine|gemcitabine|mesh-list
64847876|NCT04602078|Atezolizumab|atezolizumab|mesh-list
64847877|NCT04602078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847878|NCT04602078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64847879|NCT04602078|Antimetabolites|antimetabolites|mesh-ancestor
64847880|NCT04602078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778184|NCT02304432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64302718|NCT03073850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64302719|NCT03073850|Protease Inhibitors|protease inhibitors|mesh-ancestor
64302720|NCT03257319|Morphine|morphine|mesh-list
64302721|NCT03257319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64302722|NCT03257319|Narcotics|narcotics|mesh-ancestor
64302723|NCT03257319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64302724|NCT03257319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302726|NCT03257319|Sensory System Agents|sensory system agents|mesh-ancestor
64302727|NCT03257319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302728|NCT03070574|Aminosalicylic Acid|aminosalicylic acid|mesh-list
64331278|NCT05704725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847884|NCT04602078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64847885|NCT04602078|Immunologic Factors|immunologic factors|mesh-ancestor
64847886|NCT04602078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847887|NCT04588857|Dexamethasone|dexamethasone|mesh-list
64847888|NCT04588857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64847889|NCT04588857|Antiemetics|antiemetics|mesh-ancestor
64847890|NCT04588857|Autonomic Agents|autonomic agents|mesh-ancestor
64847891|NCT04588857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64331279|NCT05704725|Growth Inhibitors|growth inhibitors|mesh-ancestor
64331280|NCT05704725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331283|NCT05683444|Octreotide|octreotide|mesh-list
64331284|NCT05683444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64331285|NCT05683444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64331286|NCT05683444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331287|NCT05681195|Pemetrexed|pemetrexed|mesh-list
64847892|NCT04588857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847894|NCT04588857|Glucocorticoids|glucocorticoids|mesh-ancestor
64416673|NCT01668667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778185|NCT02304432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64778187|NCT02304432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64778188|NCT02304432|Antitubercular Agents|antitubercular agents|mesh-ancestor
64778189|NCT02304432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64778190|NCT02304432|Antimetabolites|antimetabolites|mesh-ancestor
64778191|NCT02304432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778192|NCT02307318|Hemostatics|hemostatics|mesh-list
64778193|NCT02307318|Coagulants|coagulants|mesh-ancestor
64616377|NCT01057225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64847895|NCT04588857|Hormones|hormones|mesh-ancestor
64945455|NCT05619627|Sensory System Agents|sensory system agents|mesh-ancestor
64847896|NCT04588857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64847897|NCT04588857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64847898|NCT04588857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847899|NCT04569448|Brexpiprazole|brexpiprazole|mesh-list
64847900|NCT04569448|Serotonin Agents|serotonin agents|mesh-ancestor
64847901|NCT04569448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64847902|NCT04569448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847903|NCT04569448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847904|NCT04569448|Dopamine Agonists|dopamine agonists|mesh-ancestor
64847905|NCT04569448|Dopamine Agents|dopamine agents|mesh-ancestor
64331288|NCT05681195|Zanubrutinib|zanubrutinib|mesh-list
64331289|NCT05681195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847907|NCT04566887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847908|NCT04562831|Niacinamide|niacinamide|mesh-list
64847909|NCT04562831|Niacin|niacin|mesh-list
64847910|NCT04562831|Nicotinic Acids|nicotinic acids|mesh-list
64847911|NCT04562831|Vitamin B Complex|vitamin b complex|mesh-ancestor
64847912|NCT04562831|Vitamins|vitamins|mesh-ancestor
64847913|NCT04562831|Micronutrients|micronutrients|mesh-ancestor
64847914|NCT04562831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847915|NCT04562831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64778194|NCT02312622|Irinotecan|irinotecan|mesh-list
64778195|NCT02312622|Etirinotecan pegol|etirinotecan pegol|mesh-list
64778196|NCT02312622|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64847916|NCT04562831|Antimetabolites|antimetabolites|mesh-ancestor
64847917|NCT04562831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778197|NCT02312622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64389631|NCT02440399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64389632|NCT02440399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64389633|NCT02440399|Antipyretics|antipyretics|mesh-ancestor
64416674|NCT01668667|Anticonvulsants|anticonvulsants|mesh-ancestor
64847918|NCT04562831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64847919|NCT04562831|Vasodilator Agents|vasodilator agents|mesh-ancestor
64847920|NCT04545242|Dexamethasone|dexamethasone|mesh-list
64847921|NCT04545242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64847922|NCT04545242|Antiemetics|antiemetics|mesh-ancestor
64847923|NCT04545242|Autonomic Agents|autonomic agents|mesh-ancestor
64847924|NCT04545242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64847926|NCT04545242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64847927|NCT04545242|Glucocorticoids|glucocorticoids|mesh-ancestor
64847928|NCT04545242|Hormones|hormones|mesh-ancestor
64847929|NCT04545242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64847930|NCT04545242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64847931|NCT04545242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847932|NCT04542980|Autoantibodies|autoantibodies|mesh-list
64847933|NCT04542980|Immunologic Factors|immunologic factors|mesh-ancestor
64847934|NCT04542980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847935|NCT04529499|Favipiravir|favipiravir|mesh-list
64847936|NCT04529499|Antiviral Agents|antiviral agents|mesh-ancestor
64847937|NCT04529499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64847938|NCT04526132|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
64847939|NCT04526132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64847940|NCT04526132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64847941|NCT04526132|Analgesics|analgesics|mesh-ancestor
64331291|NCT05681195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331292|NCT05681195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64389634|NCT02440399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64389635|NCT02440399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64389636|NCT02440399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64389637|NCT02440399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64389638|NCT02440399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389639|NCT02440399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389640|NCT03574571|Docetaxel|docetaxel|mesh-list
64331293|NCT05681195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64331294|NCT05681195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64331297|NCT05669274|Sequestering Agents|sequestering agents|mesh-ancestor
64331298|NCT05669274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331299|NCT05667090|Vitamin D|vitamin d|mesh-list
64331300|NCT05667090|Vitamins|vitamins|mesh-ancestor
64847942|NCT04526132|Sensory System Agents|sensory system agents|mesh-ancestor
64847943|NCT04526132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64847944|NCT04526132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847945|NCT04526132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64847946|NCT04526132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64847947|NCT04523428|Venetoclax|venetoclax|mesh-list
64847948|NCT04523428|Acalabrutinib|acalabrutinib|mesh-list
64847949|NCT04523428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847950|NCT04521920|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64847951|NCT04521920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64847952|NCT04521920|Narcotics|narcotics|mesh-ancestor
64847953|NCT04521920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64847954|NCT04521920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847955|NCT04521920|Analgesics|analgesics|mesh-ancestor
64847956|NCT04521920|Sensory System Agents|sensory system agents|mesh-ancestor
64847957|NCT04521920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64847958|NCT04521920|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64847959|NCT04508504|Ropivacaine|ropivacaine|mesh-list
64847960|NCT04508504|Anesthetics, Local|anesthetics, local|mesh-ancestor
64847961|NCT04508504|Anesthetics|anesthetics|mesh-ancestor
64847962|NCT04508504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64302730|NCT03070574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64302731|NCT03070574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64302732|NCT03070574|Analgesics|analgesics|mesh-ancestor
64331301|NCT05667090|Micronutrients|micronutrients|mesh-ancestor
64331302|NCT05667090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302733|NCT03070574|Sensory System Agents|sensory system agents|mesh-ancestor
64302734|NCT03070574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302735|NCT03070574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389645|NCT03574571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356715|NCT04330183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64778205|NCT02314104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64778206|NCT02314104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778208|NCT02314104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778209|NCT02321748|Montelukast|montelukast|mesh-list
64331303|NCT05667090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64331305|NCT05660681|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64331306|NCT05660681|Protective Agents|protective agents|mesh-ancestor
64331307|NCT05660681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331308|NCT05650164|Avelumab|avelumab|mesh-list
64331309|NCT05650164|Axitinib|axitinib|mesh-list
64331310|NCT05650164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64331311|NCT05650164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331312|NCT05650164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64331313|NCT05650164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64847963|NCT04508504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847964|NCT04508504|Sensory System Agents|sensory system agents|mesh-ancestor
64847965|NCT04508504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64847966|NCT04490707|Lenalidomide|lenalidomide|mesh-list
64847967|NCT04490707|Azacitidine|azacitidine|mesh-list
64847968|NCT04490707|Immunologic Factors|immunologic factors|mesh-ancestor
64847969|NCT04490707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847970|NCT04490707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64616455|NCT04395638|Vitamin D|vitamin d|mesh-list
64847971|NCT04490707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64847972|NCT04490707|Growth Substances|growth substances|mesh-ancestor
64847973|NCT04490707|Growth Inhibitors|growth inhibitors|mesh-ancestor
64331314|NCT05650164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331315|NCT05647343|Ciclopirox|ciclopirox|mesh-list
64331316|NCT05647343|Antifungal Agents|antifungal agents|mesh-ancestor
64331317|NCT05647343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64331318|NCT05644561|Ravulizumab|ravulizumab|mesh-list
64778210|NCT02321748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64778211|NCT02321748|Respiratory System Agents|respiratory system agents|mesh-ancestor
64302750|NCT03257241|Antimetabolites|antimetabolites|mesh-ancestor
64302751|NCT03257241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302752|NCT03257241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64302753|NCT03257241|Immunologic Factors|immunologic factors|mesh-ancestor
64302754|NCT03257241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302755|NCT03257241|Antiviral Agents|antiviral agents|mesh-ancestor
64302756|NCT03257241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64302757|NCT03257241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64302758|NCT03257241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64302759|NCT03257241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64302760|NCT03257241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64331323|NCT05643170|Xanomeline|xanomeline|mesh-list
64331324|NCT05643170|Trospium chloride|trospium chloride|mesh-list
64331325|NCT05643170|Parasympatholytics|parasympatholytics|mesh-ancestor
64331326|NCT05643170|Autonomic Agents|autonomic agents|mesh-ancestor
64331327|NCT05643170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64331328|NCT05643170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331329|NCT05643170|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64331330|NCT05643170|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64331331|NCT05643170|Cholinergic Agents|cholinergic agents|mesh-ancestor
64847975|NCT04490707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64847976|NCT04490707|Antimetabolites|antimetabolites|mesh-ancestor
64847977|NCT04490707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847978|NCT04490707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64847979|NCT04464577|Itraconazole|itraconazole|mesh-list
64847980|NCT04464577|Fluconazole|fluconazole|mesh-list
64847981|NCT04464577|Bupropion|bupropion|mesh-list
64847982|NCT04464577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64847983|NCT04464577|Antidepressive Agents|antidepressive agents|mesh-ancestor
64847984|NCT04464577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64302761|NCT03257241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302762|NCT03257241|Analgesics|analgesics|mesh-ancestor
64302763|NCT03257241|Sensory System Agents|sensory system agents|mesh-ancestor
64778212|NCT02321748|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64778213|NCT02321748|Hormone Antagonists|hormone antagonists|mesh-ancestor
64778214|NCT02321748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64778215|NCT02321748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389652|NCT02429713|Oxymetazoline|oxymetazoline|mesh-list
64389653|NCT02429713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64389654|NCT02429713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64302764|NCT03257241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64848001|NCT04464577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64848002|NCT04464577|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64848003|NCT04464577|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64848004|NCT04460924|Integrase Inhibitors|integrase inhibitors|mesh-list
64848005|NCT04460924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848006|NCT04460924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848007|NCT04402658|Albuterol|albuterol|mesh-list
64848008|NCT04402658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64848009|NCT04402658|Autonomic Agents|autonomic agents|mesh-ancestor
64848010|NCT04402658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64848011|NCT04402658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848012|NCT04402658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64331342|NCT05617625|Fludarabine|fludarabine|mesh-list
64331343|NCT05617625|Melphalan|melphalan|mesh-list
64331344|NCT05617625|Busulfan|busulfan|mesh-list
64331345|NCT05617625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331346|NCT05617625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848013|NCT04402658|Respiratory System Agents|respiratory system agents|mesh-ancestor
64848014|NCT04402658|Tocolytic Agents|tocolytic agents|mesh-ancestor
64848015|NCT04402658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64848016|NCT04402658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64848017|NCT04402658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64848018|NCT04402658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64848019|NCT04402658|Adrenergic Agents|adrenergic agents|mesh-ancestor
64848020|NCT04402658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64848021|NCT04402658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848022|NCT04391179|Dipyridamole|dipyridamole|mesh-list
64848023|NCT04391179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64848024|NCT04391179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302765|NCT02129179|Glucagon|glucagon|mesh-list
64302766|NCT02129179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64302767|NCT02129179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64302768|NCT02129179|Hormones|hormones|mesh-ancestor
64302769|NCT02129179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64302770|NCT02129179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302771|NCT02129179|Incretins|incretins|mesh-ancestor
64356784|NCT03391219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302772|NCT02129257|Leucovorin|leucovorin|mesh-list
64302773|NCT02129257|Folic Acid|folic acid|mesh-list
64302774|NCT02129257|Fluorouracil|fluorouracil|mesh-list
64302775|NCT02129257|Irinotecan|irinotecan|mesh-list
64331347|NCT05617625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64331348|NCT05617625|Immunologic Factors|immunologic factors|mesh-ancestor
64331349|NCT05617625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848027|NCT04391179|Vasodilator Agents|vasodilator agents|mesh-ancestor
64848028|NCT04375683|HH-GV-678|hh-gv-678|mesh-list
64848029|NCT04375683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64848030|NCT04375683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848031|NCT04375683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848032|NCT04356742|Metformin|metformin|mesh-list
64848033|NCT04356742|Dapagliflozin|dapagliflozin|mesh-list
64848034|NCT04356742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64848035|NCT04356742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848036|NCT04356742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64331350|NCT05617625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64331351|NCT05617625|Alkylating Agents|alkylating agents|mesh-ancestor
64294542|NCT02036359|Tubulin Modulators|tubulin modulators|mesh-ancestor
64302776|NCT02129257|Aflibercept|aflibercept|mesh-list
64302777|NCT02129257|Levoleucovorin|levoleucovorin|mesh-list
64302779|NCT02129257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302780|NCT02129257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64302781|NCT02129257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302782|NCT02129257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64302783|NCT02129257|Immunologic Factors|immunologic factors|mesh-ancestor
64302784|NCT02129257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302785|NCT02129257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64302786|NCT02129257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64848037|NCT04356742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848038|NCT04353284|Gabexate|gabexate|mesh-list
64848039|NCT04353284|Camostat|camostat|mesh-list
64848040|NCT04353284|Protease Inhibitors|protease inhibitors|mesh-ancestor
64848041|NCT04353284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848042|NCT04353284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848043|NCT04353284|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64848044|NCT04353284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64848045|NCT04353284|Anticoagulants|anticoagulants|mesh-ancestor
64331357|NCT05553392|Dermatologic Agents|dermatologic agents|mesh-ancestor
64331358|NCT05530421|Dexamethasone|dexamethasone|mesh-list
64331360|NCT05530421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64331361|NCT05530421|Antiemetics|antiemetics|mesh-ancestor
64331362|NCT05530421|Autonomic Agents|autonomic agents|mesh-ancestor
64331363|NCT05530421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302787|NCT02129257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389655|NCT02429713|Adrenergic Agents|adrenergic agents|mesh-ancestor
64848047|NCT04348864|Immunologic Factors|immunologic factors|mesh-ancestor
64389656|NCT02429713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64778216|NCT02321748|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64778217|NCT02321748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64778218|NCT02321748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778220|NCT02322528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64778221|NCT02330094|Gabapentin|gabapentin|mesh-list
64848048|NCT04348864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848049|NCT04328012|Losartan|losartan|mesh-list
64848050|NCT04328012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64848051|NCT04328012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64848052|NCT04328012|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64848053|NCT04328012|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64848054|NCT04328012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848055|NCT04310150|Hemostatics|hemostatics|mesh-list
64848056|NCT04310150|Coagulants|coagulants|mesh-ancestor
64848057|NCT04305444|Everolimus|everolimus|mesh-list
64848058|NCT04305444|Pomalidomide|pomalidomide|mesh-list
64848059|NCT04305444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848060|NCT04305444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64848061|NCT04305444|Immunologic Factors|immunologic factors|mesh-ancestor
64848062|NCT04305444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848063|NCT04305444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64848064|NCT04305444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64848065|NCT04305444|Growth Substances|growth substances|mesh-ancestor
64848066|NCT04305444|Growth Inhibitors|growth inhibitors|mesh-ancestor
64848067|NCT04294914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64848068|NCT04294147|Erenumab|erenumab|mesh-list
64848071|NCT04294147|Analgesics|analgesics|mesh-ancestor
64778222|NCT02330094|Analgesics|analgesics|mesh-ancestor
64778223|NCT02330094|Sensory System Agents|sensory system agents|mesh-ancestor
64778224|NCT02330094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778225|NCT02330094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778226|NCT02330094|Anticonvulsants|anticonvulsants|mesh-ancestor
64778227|NCT02330094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64778228|NCT02330094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64848091|NCT04264637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64848092|NCT04264637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64848093|NCT04264637|Histamine Antagonists|histamine antagonists|mesh-ancestor
64848094|NCT04264637|Histamine Agents|histamine agents|mesh-ancestor
64848095|NCT04264637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64848096|NCT04262687|Bevacizumab|bevacizumab|mesh-list
64848097|NCT04262687|Pembrolizumab|pembrolizumab|mesh-list
64848098|NCT04262687|Capecitabine|capecitabine|mesh-list
64848099|NCT04262687|Oxaliplatin|oxaliplatin|mesh-list
64848100|NCT04262687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64848101|NCT04262687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848102|NCT04262687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64848103|NCT04262687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64331364|NCT05530421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331365|NCT05530421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64331366|NCT05530421|Glucocorticoids|glucocorticoids|mesh-ancestor
64331367|NCT05530421|Hormones|hormones|mesh-ancestor
64331368|NCT05530421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64331371|NCT05526755|Osimertinib|osimertinib|mesh-list
64778229|NCT02330094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64778230|NCT02330094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64302788|NCT02129257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64302789|NCT02129257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64302790|NCT02129257|Growth Substances|growth substances|mesh-ancestor
64302791|NCT02129257|Growth Inhibitors|growth inhibitors|mesh-ancestor
64302792|NCT02129257|Antidotes|antidotes|mesh-ancestor
64302793|NCT02129257|Protective Agents|protective agents|mesh-ancestor
64302794|NCT02129257|Vitamin B Complex|vitamin b complex|mesh-ancestor
64302795|NCT02129257|Vitamins|vitamins|mesh-ancestor
64848129|NCT04223570|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64848130|NCT04223570|Dermatologic Agents|dermatologic agents|mesh-ancestor
64848131|NCT04223570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848132|NCT04223570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848134|NCT04180085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64848135|NCT04180085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848136|NCT04180085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848137|NCT04180085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64848138|NCT04180085|Immunologic Factors|immunologic factors|mesh-ancestor
64848139|NCT04180085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848140|NCT04180085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64848141|NCT04169451|Letrozole|letrozole|mesh-list
64848142|NCT04169451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848143|NCT04169451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64848144|NCT04169451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64848145|NCT04169451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848146|NCT04169451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848147|NCT04169451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64848148|NCT04169451|Hormone Antagonists|hormone antagonists|mesh-ancestor
64331377|NCT05523596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64331378|NCT05523596|Immunologic Factors|immunologic factors|mesh-ancestor
64331379|NCT05523596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331380|NCT05523596|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64331381|NCT05523596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64331382|NCT05523596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64331383|NCT05523596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64331385|NCT05518734|Midazolam|midazolam|mesh-list
64848150|NCT04169451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302796|NCT02129257|Micronutrients|micronutrients|mesh-ancestor
64302797|NCT02129257|Hematinics|hematinics|mesh-ancestor
64302798|NCT03245307|Apatinib|apatinib|mesh-list
64302799|NCT03245307|Nifedipine|nifedipine|mesh-list
64302800|NCT03245307|Warfarin|warfarin|mesh-list
64302801|NCT03245307|Anticoagulants|anticoagulants|mesh-ancestor
64302802|NCT03245307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302803|NCT03245307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64302804|NCT03245307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302805|NCT03245307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848151|NCT04169438|Petrolatum|petrolatum|mesh-list
64848152|NCT04169438|Emollients|emollients|mesh-ancestor
64848153|NCT04169438|Dermatologic Agents|dermatologic agents|mesh-ancestor
64848154|NCT04159818|Doxorubicin|doxorubicin|mesh-list
64848155|NCT04159818|Nivolumab|nivolumab|mesh-list
64848156|NCT04159818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848157|NCT04159818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64848158|NCT04159818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64848159|NCT04159818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64848160|NCT04159818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848161|NCT04159818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848162|NCT04159818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64848163|NCT04159818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64848164|NCT04157881|Rabeprazole|rabeprazole|mesh-list
64848165|NCT04157881|Dabigatran|dabigatran|mesh-list
64848166|NCT04157881|Antithrombins|antithrombins|mesh-ancestor
64848167|NCT04157881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64848168|NCT04157881|Protease Inhibitors|protease inhibitors|mesh-ancestor
64848169|NCT04157881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848170|NCT04157881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848171|NCT04157881|Anticoagulants|anticoagulants|mesh-ancestor
64848172|NCT04157881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64848173|NCT04157881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64848174|NCT04157881|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64848175|NCT04151563|Docetaxel|docetaxel|mesh-list
64848176|NCT04151563|Nivolumab|nivolumab|mesh-list
64848177|NCT04151563|Ipilimumab|ipilimumab|mesh-list
64848178|NCT04151563|Ramucirumab|ramucirumab|mesh-list
64848179|NCT04151563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848180|NCT04151563|Tubulin Modulators|tubulin modulators|mesh-ancestor
64302806|NCT03245307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64302807|NCT03245307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64302808|NCT03245307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64302809|NCT03245307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302810|NCT03245307|Vasodilator Agents|vasodilator agents|mesh-ancestor
64302811|NCT03245307|Tocolytic Agents|tocolytic agents|mesh-ancestor
64302812|NCT03245307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64302813|NCT02136979|Propofol|propofol|mesh-list
64302814|NCT02136979|Sevoflurane|sevoflurane|mesh-list
64302815|NCT02136979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64848181|NCT04151563|Antimitotic Agents|antimitotic agents|mesh-ancestor
64848182|NCT04151563|Mitosis Modulators|mitosis modulators|mesh-ancestor
64848183|NCT04151563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331386|NCT05518734|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64331387|NCT05518734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64331388|NCT05518734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64848184|NCT04151563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64848185|NCT04151563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64848186|NCT04136262|Methotrexate|methotrexate|mesh-list
64848187|NCT04136262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64848188|NCT04136262|Abortifacient Agents|abortifacient agents|mesh-ancestor
64848189|NCT04136262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64848190|NCT04136262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848191|NCT04136262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64848192|NCT04136262|Antimetabolites|antimetabolites|mesh-ancestor
64848193|NCT04136262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848194|NCT04136262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848195|NCT04136262|Dermatologic Agents|dermatologic agents|mesh-ancestor
64848196|NCT04136262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848197|NCT04136262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64848198|NCT04136262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64848199|NCT04136262|Immunologic Factors|immunologic factors|mesh-ancestor
64848200|NCT04136262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64848201|NCT04136262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64848202|NCT04133922|Insulin|insulin|mesh-list
64848203|NCT04133922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64848204|NCT04133922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848205|NCT04115059|Dasatinib|dasatinib|mesh-list
64848206|NCT04115059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848207|NCT04115059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64848208|NCT04115059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302816|NCT02136979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64778231|NCT02330094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64778232|NCT02330094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64778233|NCT02330094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64778234|NCT02330094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778235|NCT02330094|Antimanic Agents|antimanic agents|mesh-ancestor
64778236|NCT02330172|Neostigmine|neostigmine|mesh-list
64778237|NCT02330172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64778238|NCT02330172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64778239|NCT02330172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389667|NCT03144401|Misoprostol|misoprostol|mesh-list
64778252|NCT02331108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64778253|NCT02331108|Anesthetics, General|anesthetics, general|mesh-ancestor
64389693|NCT04996199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64848209|NCT04115059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848210|NCT04114890|Tenofovir|tenofovir|mesh-list
64848211|NCT04114890|Antiviral Agents|antiviral agents|mesh-ancestor
64848212|NCT04114890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64848213|NCT04114890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64848214|NCT04114890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64848215|NCT04114890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848216|NCT04114890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848217|NCT04114890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64848218|NCT04114890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64848219|NCT04096066|Dexamethasone|dexamethasone|mesh-list
64848220|NCT04096066|Lenalidomide|lenalidomide|mesh-list
64848221|NCT04096066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64848222|NCT04096066|Antiemetics|antiemetics|mesh-ancestor
64848223|NCT04096066|Autonomic Agents|autonomic agents|mesh-ancestor
64848224|NCT04096066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64848225|NCT04096066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848226|NCT04096066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64848227|NCT04096066|Glucocorticoids|glucocorticoids|mesh-ancestor
64848228|NCT04096066|Hormones|hormones|mesh-ancestor
64302821|NCT02136979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64302822|NCT02136979|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64302824|NCT04983836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64302825|NCT04983836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302826|NCT02455011|Volagidemab|volagidemab|mesh-list
64302827|NCT02455011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64302828|NCT02455011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302829|NCT03249285|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64302830|NCT03249285|Perindopril|perindopril|mesh-list
64302831|NCT03249285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64302832|NCT03249285|Diuretics|diuretics|mesh-ancestor
64389694|NCT04996199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389695|NCT04996199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64389696|NCT04996199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64389698|NCT04996199|Sensory System Agents|sensory system agents|mesh-ancestor
64389699|NCT04996199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64389700|NCT04996199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64389701|NCT04996199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64389702|NCT04996199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848250|NCT04012177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64848251|NCT04012177|Lipotropic Agents|lipotropic agents|mesh-ancestor
64848252|NCT04012177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64848253|NCT04012177|Antimetabolites|antimetabolites|mesh-ancestor
64848254|NCT04012177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848255|NCT04012177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64848256|NCT04012177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64848257|NCT04012177|Nootropic Agents|nootropic agents|mesh-ancestor
64848258|NCT04012177|Vitamin B Complex|vitamin b complex|mesh-ancestor
64848259|NCT04012177|Vitamins|vitamins|mesh-ancestor
64848260|NCT04012177|Micronutrients|micronutrients|mesh-ancestor
64848261|NCT04012177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848262|NCT04012177|Vasodilator Agents|vasodilator agents|mesh-ancestor
64848263|NCT04007289|Apixaban|apixaban|mesh-list
64848264|NCT04007289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64848265|NCT04007289|Antithrombins|antithrombins|mesh-ancestor
64848266|NCT04007289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64848267|NCT04007289|Protease Inhibitors|protease inhibitors|mesh-ancestor
64848268|NCT04007289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848269|NCT04007289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848270|NCT04007289|Anticoagulants|anticoagulants|mesh-ancestor
64331389|NCT05518734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331390|NCT05518734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64331391|NCT05518734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64389703|NCT04996199|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64778254|NCT02331108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64778255|NCT02331108|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64778256|NCT02332902|Everolimus|everolimus|mesh-list
64778257|NCT02332902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778258|NCT02332902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64778259|NCT02332902|Immunologic Factors|immunologic factors|mesh-ancestor
64778260|NCT02332902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778261|NCT02340156|Temozolomide|temozolomide|mesh-list
64778262|NCT02340156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64778263|NCT02340156|Alkylating Agents|alkylating agents|mesh-ancestor
64778264|NCT02340156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778265|NCT02340156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778266|NCT02343276|Nitroglycerin|nitroglycerin|mesh-list
64302833|NCT03249285|Natriuretic Agents|natriuretic agents|mesh-ancestor
64302834|NCT03249285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302835|NCT03249285|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64302836|NCT03249285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64302837|NCT03249285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302838|NCT03249285|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64848276|NCT04002518|Histamine Antagonists|histamine antagonists|mesh-ancestor
64848277|NCT04002518|Histamine Agents|histamine agents|mesh-ancestor
64302839|NCT03249285|Protease Inhibitors|protease inhibitors|mesh-ancestor
64848278|NCT04002518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64848279|NCT04002518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848280|NCT04002518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848281|NCT04002518|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64848282|NCT04002518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64848283|NCT04002518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848285|NCT03993249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64848286|NCT03993249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848287|NCT03993249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64848288|NCT03993249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848289|NCT03990883|Lidocaine|lidocaine|mesh-list
64848290|NCT03990883|Anesthetics, Local|anesthetics, local|mesh-ancestor
64848291|NCT03990883|Anesthetics|anesthetics|mesh-ancestor
64848292|NCT03990883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64848293|NCT03990883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848294|NCT03990883|Sensory System Agents|sensory system agents|mesh-ancestor
64848295|NCT03990883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302840|NCT03249285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302841|NCT03249519|Cisplatin|cisplatin|mesh-list
64302842|NCT03249519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302843|NCT04983524|Propolis|propolis|mesh-list
64302844|NCT04983524|Calcium|calcium|mesh-list
64302845|NCT04983524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64302846|NCT04983524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302847|NCT04983524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64302848|NCT02634320|Aripiprazole|aripiprazole|mesh-list
64389705|NCT04996199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64389706|NCT04996199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64389707|NCT04996199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64389709|NCT04996199|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64389710|NCT04996199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389711|NCT04996199|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64389712|NCT04996199|Hormone Antagonists|hormone antagonists|mesh-ancestor
64389713|NCT04996199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64302887|NCT03256071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64302888|NCT03256071|Antimetabolites|antimetabolites|mesh-ancestor
64302889|NCT03256071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848307|NCT03984890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64848308|NCT03926091|Cyclophosphamide|cyclophosphamide|mesh-list
64848309|NCT03926091|Docetaxel|docetaxel|mesh-list
64331396|NCT05518734|GABA Modulators|gaba modulators|mesh-ancestor
64331397|NCT05518734|GABA Agents|gaba agents|mesh-ancestor
64331398|NCT05518734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64331399|NCT05518734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331400|NCT05518734|Antifungal Agents|antifungal agents|mesh-ancestor
64331401|NCT05518734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64331402|NCT05518734|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64302890|NCT03256071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302891|NCT03256071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302892|NCT04912856|Ezogabine|ezogabine|mesh-list
64302893|NCT04912856|Anticonvulsants|anticonvulsants|mesh-ancestor
64302894|NCT04912856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64302895|NCT04912856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302896|NCT03248817|Phenylephrine|phenylephrine|mesh-list
64302897|NCT03248817|Oxymetazoline|oxymetazoline|mesh-list
64331403|NCT05518734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64848311|NCT03926091|Immunologic Factors|immunologic factors|mesh-ancestor
64848312|NCT03926091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848313|NCT03926091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64848314|NCT03926091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64848315|NCT03926091|Alkylating Agents|alkylating agents|mesh-ancestor
64848316|NCT03926091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848317|NCT03926091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848318|NCT03926091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64848319|NCT03926091|Tubulin Modulators|tubulin modulators|mesh-ancestor
64848320|NCT03926091|Antimitotic Agents|antimitotic agents|mesh-ancestor
64848321|NCT03926091|Mitosis Modulators|mitosis modulators|mesh-ancestor
64848322|NCT03924427|BMS-986165|bms-986165|mesh-list
64848323|NCT03924427|Dermatologic Agents|dermatologic agents|mesh-ancestor
64848324|NCT03924427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64848325|NCT03924427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848326|NCT03924427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848327|NCT03922451|Cefazolin|cefazolin|mesh-list
64848329|NCT03922451|Piperacillin|piperacillin|mesh-list
64848330|NCT03922451|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64848331|NCT03922451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64848332|NCT03922451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64848333|NCT03922451|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64848334|NCT03922451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848335|NCT03922451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848336|NCT05802693|Mitogens|mitogens|mesh-list
64848337|NCT05802693|Mitosis Modulators|mitosis modulators|mesh-ancestor
64848338|NCT05802693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848339|NCT05802628|Cetylpyridinium|cetylpyridinium|mesh-list
64302898|NCT03248817|Bupivacaine|bupivacaine|mesh-list
64302899|NCT03248817|Anesthetics, Local|anesthetics, local|mesh-ancestor
64389715|NCT02432833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64778273|NCT02351700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64778274|NCT02351700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64778275|NCT02351700|Analgesics|analgesics|mesh-ancestor
64778276|NCT02351700|Sensory System Agents|sensory system agents|mesh-ancestor
64778277|NCT02351700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778278|NCT02351700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778279|NCT02351700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64778280|NCT02351700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64778281|NCT02351700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64778282|NCT02351700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64778283|NCT02351700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778284|NCT02353806|Amlodipine|amlodipine|mesh-list
64778285|NCT02353806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64778286|NCT02353806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64778287|NCT02353806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64778288|NCT02353806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302901|NCT03248817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64302902|NCT03248817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302903|NCT03248817|Sensory System Agents|sensory system agents|mesh-ancestor
64302904|NCT03248817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302905|NCT03248817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64302906|NCT03248817|Mydriatics|mydriatics|mesh-ancestor
64302907|NCT03248817|Autonomic Agents|autonomic agents|mesh-ancestor
64302908|NCT03248817|Sympathomimetics|sympathomimetics|mesh-ancestor
64778289|NCT02353806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64778290|NCT02353806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778291|NCT02353806|Vasodilator Agents|vasodilator agents|mesh-ancestor
64848340|NCT05802628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64848341|NCT05802628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64848342|NCT05802433|Vitamin D|vitamin d|mesh-list
64848343|NCT05802433|Cholecalciferol|cholecalciferol|mesh-list
64848344|NCT05802433|Vitamins|vitamins|mesh-ancestor
64848345|NCT05802433|Micronutrients|micronutrients|mesh-ancestor
64848346|NCT05802433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848347|NCT05802433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64848348|NCT05802433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64848349|NCT05802303|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64848350|NCT05802303|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64778292|NCT02354352|Eplerenone|eplerenone|mesh-list
64778293|NCT02354352|Spironolactone|spironolactone|mesh-list
64389722|NCT02429323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64389723|NCT02429323|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64389724|NCT02429323|Anesthetics, General|anesthetics, general|mesh-ancestor
64389725|NCT02429323|Anesthetics|anesthetics|mesh-ancestor
64389726|NCT02429323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64389727|NCT02429323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389728|NCT02326103|Ciprofloxacin|ciprofloxacin|mesh-list
64389729|NCT02326103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64389730|NCT02326103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64778294|NCT02354352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64778295|NCT02354352|Hormone Antagonists|hormone antagonists|mesh-ancestor
64302909|NCT03248817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64302910|NCT03248817|Nasal Decongestants|nasal decongestants|mesh-ancestor
64302911|NCT03248817|Respiratory System Agents|respiratory system agents|mesh-ancestor
64302912|NCT03248817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64302913|NCT03248817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64302914|NCT03248817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64302915|NCT03248817|Adrenergic Agents|adrenergic agents|mesh-ancestor
64302916|NCT03248817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64848381|NCT05802121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64331405|NCT05518734|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64331406|NCT05518734|Hormone Antagonists|hormone antagonists|mesh-ancestor
64331407|NCT05518734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64331408|NCT05518734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64331410|NCT05513365|Bicalutamide|bicalutamide|mesh-list
64331411|NCT05513365|Dutasteride|dutasteride|mesh-list
64331412|NCT05513365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64331413|NCT05513365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331414|NCT05513365|Androgen Antagonists|androgen antagonists|mesh-ancestor
64331415|NCT05513365|Hormone Antagonists|hormone antagonists|mesh-ancestor
64848383|NCT05802108|Evolocumab|evolocumab|mesh-list
64848384|NCT05802108|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64848385|NCT05802108|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64848386|NCT05802108|Antimetabolites|antimetabolites|mesh-ancestor
64848387|NCT05802108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848388|NCT05802108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848389|NCT05802108|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64848390|NCT05802082|Anesthetics|anesthetics|mesh-list
64848391|NCT05802082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64848392|NCT05802082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848393|NCT05801913|Vaccines|vaccines|mesh-list
64848394|NCT05801913|Immunologic Factors|immunologic factors|mesh-ancestor
64778296|NCT02354352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64778297|NCT02354352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778298|NCT02354352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64778299|NCT02354352|Diuretics|diuretics|mesh-ancestor
64778300|NCT02354352|Natriuretic Agents|natriuretic agents|mesh-ancestor
64778301|NCT02354352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64778302|NCT02355210|DEFB1 protein, human|defb1 protein, human|mesh-list
64331416|NCT05513365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64331417|NCT05513365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848403|NCT05801900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848404|NCT05801900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64848405|NCT05801900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64848406|NCT05801900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64848407|NCT05801900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848408|NCT05801900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848409|NCT05801835|Cytarabine|cytarabine|mesh-list
64848410|NCT05801835|Daunorubicin|daunorubicin|mesh-list
64848411|NCT05801835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64848412|NCT05801835|Antimetabolites|antimetabolites|mesh-ancestor
64848413|NCT05801835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848414|NCT05801835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848415|NCT05801835|Antiviral Agents|antiviral agents|mesh-ancestor
64848416|NCT05801835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64848417|NCT05801835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64848418|NCT05801835|Immunologic Factors|immunologic factors|mesh-ancestor
64848419|NCT05801835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848420|NCT05801835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64616903|NCT03822013|Miglustat|miglustat|mesh-list
64848421|NCT05801835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64848422|NCT05801835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64848423|NCT05801835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302917|NCT03248817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302919|NCT03647774|Naltrexone|naltrexone|mesh-list
64302920|NCT03647774|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64302921|NCT03647774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64302922|NCT03647774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302923|NCT03647774|Sensory System Agents|sensory system agents|mesh-ancestor
64302924|NCT03647774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302925|NCT03248973|Ampicillin|ampicillin|mesh-list
64302926|NCT03248973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64302927|NCT03248973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64302928|NCT05635916|Bupivacaine|bupivacaine|mesh-list
64302929|NCT05635916|Anesthetics, Local|anesthetics, local|mesh-ancestor
64302931|NCT05635916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64302932|NCT05635916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302933|NCT05635916|Sensory System Agents|sensory system agents|mesh-ancestor
64302934|NCT05635916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64848427|NCT05801757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848428|NCT05801757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64848429|NCT05801757|Anesthetics, General|anesthetics, general|mesh-ancestor
64848431|NCT05801705|Tamoxifen|tamoxifen|mesh-list
64848432|NCT05801705|Toremifene|toremifene|mesh-list
64848433|NCT05801705|Hormones|hormones|mesh-list
64848434|NCT05801705|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64848435|NCT05801705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64848436|NCT05801705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848437|NCT05801705|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64848438|NCT05801705|Hormone Antagonists|hormone antagonists|mesh-ancestor
64848439|NCT05801705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64848440|NCT05801705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848441|NCT05801705|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64848442|NCT05801705|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64848443|NCT05801705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64848444|NCT05801705|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64848445|NCT05801705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331432|NCT05478174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64331433|NCT05478174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331434|NCT05478174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64331435|NCT05478174|Anesthetics, General|anesthetics, general|mesh-ancestor
64302936|NCT02832531|Rivaroxaban|rivaroxaban|mesh-list
64302937|NCT02832531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64302938|NCT02832531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64302939|NCT02832531|Analgesics|analgesics|mesh-ancestor
64778304|NCT02357706|Acetaminophen|acetaminophen|mesh-list
64778305|NCT02357706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64547008|NCT04187898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778306|NCT02357706|Analgesics|analgesics|mesh-ancestor
64778307|NCT02357706|Sensory System Agents|sensory system agents|mesh-ancestor
64778308|NCT02357706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778309|NCT02357706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302940|NCT02832531|Sensory System Agents|sensory system agents|mesh-ancestor
64302941|NCT02832531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302942|NCT02832531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302943|NCT02832531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64302944|NCT02832531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64302945|NCT02832531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64331436|NCT05478174|Anesthetics|anesthetics|mesh-ancestor
64848446|NCT05801705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302946|NCT02832531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64848447|NCT05801523|Ethanol|ethanol|mesh-list
64302947|NCT02832531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302948|NCT02832531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64302949|NCT02832531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64302950|NCT02832531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302951|NCT02832531|Antipyretics|antipyretics|mesh-ancestor
64302952|NCT02832531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64302953|NCT02832531|Antithrombins|antithrombins|mesh-ancestor
64302954|NCT02832531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64302955|NCT02832531|Protease Inhibitors|protease inhibitors|mesh-ancestor
64302956|NCT02832531|Anticoagulants|anticoagulants|mesh-ancestor
64302957|NCT03582488|Corticosterone|corticosterone|mesh-list
64302958|NCT03582488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64302959|NCT03248427|Paclitaxel|paclitaxel|mesh-list
64302960|NCT03248427|Cyclophosphamide|cyclophosphamide|mesh-list
64848506|NCT05801172|Lidocaine|lidocaine|mesh-list
64848507|NCT05801172|Anesthetics|anesthetics|mesh-list
64848508|NCT05801172|Anesthetics, Local|anesthetics, local|mesh-ancestor
64848509|NCT05801172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64848510|NCT05801172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848511|NCT05801172|Sensory System Agents|sensory system agents|mesh-ancestor
64848512|NCT05801172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64848513|NCT05801172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64848514|NCT05801172|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64848515|NCT05801172|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64848516|NCT05801172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64848517|NCT05801172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848518|NCT05801172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64848519|NCT05801172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64848520|NCT05801172|Analgesics|analgesics|mesh-ancestor
64848521|NCT05801172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64848522|NCT05801172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64848523|NCT05801172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64848524|NCT05801172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848525|NCT05801133|Pirfenidone|pirfenidone|mesh-list
64848526|NCT05801133|Analgesics|analgesics|mesh-ancestor
64848527|NCT05801133|Sensory System Agents|sensory system agents|mesh-ancestor
64848528|NCT05801133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64848529|NCT05801133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848530|NCT05801133|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64848531|NCT05801133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64848532|NCT05801133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64302961|NCT03248427|Doxorubicin|doxorubicin|mesh-list
64302962|NCT03248427|Letrozole|letrozole|mesh-list
64302963|NCT03248427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64302964|NCT03248427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302965|NCT03248427|Tubulin Modulators|tubulin modulators|mesh-ancestor
64302966|NCT03248427|Antimitotic Agents|antimitotic agents|mesh-ancestor
64302967|NCT03248427|Mitosis Modulators|mitosis modulators|mesh-ancestor
64416675|NCT01668667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64778310|NCT02357706|Antipyretics|antipyretics|mesh-ancestor
64389742|NCT04984733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64389743|NCT04984733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389744|NCT04984733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64389745|NCT04984733|Alkylating Agents|alkylating agents|mesh-ancestor
64389747|NCT02707861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64389748|NCT02707861|Antiviral Agents|antiviral agents|mesh-ancestor
64389749|NCT02707861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64389750|NCT02707861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64389751|NCT02432599|Choline|choline|mesh-list
64302968|NCT03248427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302969|NCT03248427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64302970|NCT03248427|Immunologic Factors|immunologic factors|mesh-ancestor
64302971|NCT03248427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302972|NCT03248427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64302973|NCT03248427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64302974|NCT03248427|Alkylating Agents|alkylating agents|mesh-ancestor
64302975|NCT03248427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64302976|NCT03248427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64302977|NCT03248427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64302978|NCT03248427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64302979|NCT03248427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848533|NCT05801133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64848550|NCT05800860|Hallucinogens|hallucinogens|mesh-ancestor
64302980|NCT03248427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64848551|NCT05800860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848552|NCT05800860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64848553|NCT05800860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64848554|NCT05800860|Serotonin Agents|serotonin agents|mesh-ancestor
64848555|NCT05800860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64848556|NCT05800860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848557|NCT05800860|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64848558|NCT05800847|Gabapentin|gabapentin|mesh-list
64848559|NCT05800847|Analgesics|analgesics|mesh-ancestor
64848560|NCT05800847|Sensory System Agents|sensory system agents|mesh-ancestor
64848561|NCT05800847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302981|NCT03248427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64302982|NCT03248427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64302983|NCT03248427|Hormone Antagonists|hormone antagonists|mesh-ancestor
64302984|NCT03248427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64302985|NCT03248349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64302986|NCT03248349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64302987|NCT05635370|Cilostazol|cilostazol|mesh-list
64302999|NCT05635370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64303000|NCT05635370|Autonomic Agents|autonomic agents|mesh-ancestor
64303001|NCT05635370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303002|NCT05635370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64303003|NCT05635370|Respiratory System Agents|respiratory system agents|mesh-ancestor
64303005|NCT05635370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64303006|NCT05635370|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64778312|NCT02359110|Analgesics|analgesics|mesh-ancestor
64778313|NCT02359110|Sensory System Agents|sensory system agents|mesh-ancestor
64778314|NCT02359110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778315|NCT02359110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778316|NCT02359110|Anticonvulsants|anticonvulsants|mesh-ancestor
64778317|NCT02359110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64778318|NCT02359110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64778319|NCT02359110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64778320|NCT02359110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64331460|NCT05457257|Prednisone|prednisone|mesh-list
64331461|NCT05457257|Olaparib|olaparib|mesh-list
64331462|NCT05457257|Abiraterone Acetate|abiraterone acetate|mesh-list
64331463|NCT05457257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64331464|NCT05457257|Glucocorticoids|glucocorticoids|mesh-ancestor
64331465|NCT05457257|Hormones|hormones|mesh-ancestor
64331466|NCT05457257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64331467|NCT05457257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848562|NCT05800847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848564|NCT05800847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64848565|NCT05800847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64848566|NCT05800847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64848567|NCT05800847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64848568|NCT05800847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64617050|NCT01078363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64848569|NCT05800847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64848570|NCT05800847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64848571|NCT05800847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848572|NCT05800847|Antimanic Agents|antimanic agents|mesh-ancestor
64848574|NCT05800834|Morphine|morphine|mesh-list
64294588|NCT02475135|Tenofovir|tenofovir|mesh-list
64303008|NCT03240068|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
64303009|NCT03240068|Angiotensin II|angiotensin ii|mesh-list
64303010|NCT03240068|Angiotensinogen|angiotensinogen|mesh-list
64303011|NCT03240068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64303012|NCT03240068|Vasodilator Agents|vasodilator agents|mesh-ancestor
64303013|NCT03240068|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64303014|NCT03240068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64303015|NCT03240068|Protease Inhibitors|protease inhibitors|mesh-ancestor
64303016|NCT03240068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303017|NCT03240068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303018|NCT03243903|Insulin|insulin|mesh-list
64303019|NCT03243903|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64303020|NCT03243903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64303021|NCT03243903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303022|NCT03576677|Simendan|simendan|mesh-list
64356961|NCT00380705|Montelukast|montelukast|mesh-list
64778321|NCT02359110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64848583|NCT05800834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64848584|NCT05800834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64848585|NCT05800834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848586|NCT05800834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64848587|NCT05800834|Narcotics|narcotics|mesh-ancestor
64848588|NCT05800834|Analgesics|analgesics|mesh-ancestor
64848589|NCT05800756|Trastuzumab|trastuzumab|mesh-list
64848590|NCT05800756|Letrozole|letrozole|mesh-list
64848591|NCT05800756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64848592|NCT05800756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848593|NCT05800756|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64848594|NCT05800756|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64848595|NCT05800756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848596|NCT05800756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848597|NCT05800756|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64848598|NCT05800756|Hormone Antagonists|hormone antagonists|mesh-ancestor
64848599|NCT05800756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64848600|NCT05800756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848601|NCT05800197|Tamoxifen|tamoxifen|mesh-list
64848602|NCT05800197|Letrozole|letrozole|mesh-list
64331469|NCT05457257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331470|NCT05457257|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64331471|NCT05457257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64778322|NCT02359110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64778324|NCT02359110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778325|NCT02359110|Antimanic Agents|antimanic agents|mesh-ancestor
64778326|NCT02360124|Fluorides|fluorides|mesh-list
64778327|NCT02360124|Cariostatic Agents|cariostatic agents|mesh-ancestor
64778328|NCT02360124|Protective Agents|protective agents|mesh-ancestor
64778329|NCT02360124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778330|NCT02369172|Bupropion|bupropion|mesh-list
64778331|NCT02369172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64778332|NCT02369172|Antidepressive Agents|antidepressive agents|mesh-ancestor
64778333|NCT02369172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64778334|NCT02369172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64778335|NCT02369172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64303024|NCT03576677|Vasodilator Agents|vasodilator agents|mesh-ancestor
64303025|NCT03576677|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64848603|NCT05800197|Anastrozole|anastrozole|mesh-list
64848604|NCT05800197|Goserelin|goserelin|mesh-list
64848605|NCT05800197|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64848606|NCT05800197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848607|NCT05800197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64848608|NCT05800197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64848609|NCT05800197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848610|NCT05800197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848611|NCT05800197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64848612|NCT05800197|Hormone Antagonists|hormone antagonists|mesh-ancestor
64848613|NCT05800197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64303026|NCT03576677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64303027|NCT03576677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303028|NCT03576677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303029|NCT03576677|Protective Agents|protective agents|mesh-ancestor
64303030|NCT03576677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303031|NCT03247257|Lidocaine|lidocaine|mesh-list
64303032|NCT03247257|Anesthetics|anesthetics|mesh-list
64303033|NCT03247257|Propofol|propofol|mesh-list
64303034|NCT03247257|Anesthetics, Local|anesthetics, local|mesh-ancestor
64303035|NCT03247257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64331472|NCT05457257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331473|NCT05457257|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64331474|NCT05457257|Hormone Antagonists|hormone antagonists|mesh-ancestor
64331475|NCT05457257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64331476|NCT05456685|Carboplatin|carboplatin|mesh-list
64331477|NCT05456685|Maytansine|maytansine|mesh-list
64331478|NCT05456685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331479|NCT05456685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64848614|NCT05800197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848615|NCT05800197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64848616|NCT05800197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64848617|NCT05800197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64848618|NCT05800197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64848619|NCT05800197|Luteolytic Agents|luteolytic agents|mesh-ancestor
64848620|NCT05800197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64848621|NCT05800197|Contraceptive Agents|contraceptive agents|mesh-ancestor
64848622|NCT05800197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64848623|NCT05800197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64848624|NCT05798663|Atezolizumab|atezolizumab|mesh-list
64848625|NCT05798663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848627|NCT05797597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64848628|NCT05797597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64848629|NCT05797597|Analgesics|analgesics|mesh-ancestor
64848630|NCT05797597|Sensory System Agents|sensory system agents|mesh-ancestor
64294600|NCT02475135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294601|NCT02475135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303036|NCT03247257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303037|NCT03247257|Sensory System Agents|sensory system agents|mesh-ancestor
64303038|NCT03247257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303039|NCT03247257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64303040|NCT03247257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64303041|NCT03247257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64303042|NCT03247257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64303043|NCT03247257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303044|NCT03247257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64303045|NCT03247257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64303046|NCT03247257|Anesthetics, General|anesthetics, general|mesh-ancestor
64303047|NCT03576599|Zoledronic Acid|zoledronic acid|mesh-list
64848631|NCT05797597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64848632|NCT05797597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848633|NCT05797597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64848634|NCT05797597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64848635|NCT05797597|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64848636|NCT05797597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64848637|NCT05797597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848638|NCT05797597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64848639|NCT05797597|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64848640|NCT05797597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617124|NCT03520348|Pantothenic Acid|pantothenic acid|mesh-list
64848642|NCT05797506|Sulforaphane|sulforaphane|mesh-list
64848643|NCT05797506|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64848644|NCT05797506|Protective Agents|protective agents|mesh-ancestor
64848645|NCT05797506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848646|NCT05797506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848647|NCT05796661|Citric Acid|citric acid|mesh-list
64848648|NCT05796661|Sodium Citrate|sodium citrate|mesh-list
64848649|NCT05796661|Anticoagulants|anticoagulants|mesh-ancestor
64848650|NCT05796661|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64848651|NCT05796661|Chelating Agents|chelating agents|mesh-ancestor
64848652|NCT05796661|Sequestering Agents|sequestering agents|mesh-ancestor
64848653|NCT05796661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848654|NCT05794750|Capecitabine|capecitabine|mesh-list
64848655|NCT05794750|Oxaliplatin|oxaliplatin|mesh-list
64848656|NCT05794750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64848657|NCT05794750|Antimetabolites|antimetabolites|mesh-ancestor
64848659|NCT05794750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303048|NCT03576599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64416676|NCT01668667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64778337|NCT02369172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778338|NCT02369172|Dopamine Agents|dopamine agents|mesh-ancestor
64389759|NCT03185143|Acetaminophen|acetaminophen|mesh-list
64389777|NCT05076773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64389778|NCT05076773|Narcotics|narcotics|mesh-ancestor
64389779|NCT05076773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64303050|NCT02239835|Ritonavir|ritonavir|mesh-list
64303051|NCT02239835|Saquinavir|saquinavir|mesh-list
64303052|NCT02239835|Tipranavir|tipranavir|mesh-list
64303053|NCT02239835|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64303054|NCT02239835|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64303055|NCT02239835|Protease Inhibitors|protease inhibitors|mesh-ancestor
64303056|NCT02239835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303057|NCT02239835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303058|NCT02239835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64303059|NCT02239835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64303060|NCT02239835|Antiviral Agents|antiviral agents|mesh-ancestor
64303061|NCT02239835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64303062|NCT02239835|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64303063|NCT02239835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64303064|NCT02239913|Topiramate|topiramate|mesh-list
64303065|NCT02239913|Phentermine|phentermine|mesh-list
64303066|NCT02239913|Cocaine|cocaine|mesh-list
64848665|NCT05792293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64848666|NCT05792293|Antimetabolites|antimetabolites|mesh-ancestor
64848667|NCT05792293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848668|NCT05792293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64848669|NCT05792293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64848670|NCT05792293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848671|NCT05785689|Dexmedetomidine|dexmedetomidine|mesh-list
64848672|NCT05785689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64848673|NCT05785689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64848674|NCT05785689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848675|NCT05785689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64848676|NCT05785689|Analgesics|analgesics|mesh-ancestor
64848677|NCT05785689|Sensory System Agents|sensory system agents|mesh-ancestor
64848678|NCT05785689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64848679|NCT05785689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64331480|NCT05456685|Tubulin Modulators|tubulin modulators|mesh-ancestor
64331481|NCT05456685|Antimitotic Agents|antimitotic agents|mesh-ancestor
64331482|NCT05456685|Mitosis Modulators|mitosis modulators|mesh-ancestor
64331483|NCT05456685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331484|NCT05442749|Niraparib|niraparib|mesh-list
64848680|NCT05785689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64848681|NCT05785689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64303067|NCT02239913|Anticonvulsants|anticonvulsants|mesh-ancestor
64303068|NCT02239913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64303069|NCT02239913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303073|NCT02239913|Sensory System Agents|sensory system agents|mesh-ancestor
64303074|NCT02239913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303075|NCT02239913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64303076|NCT02239913|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64303077|NCT02239913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64303078|NCT02239913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64303079|NCT02239913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303080|NCT02239913|Dopamine Agents|dopamine agents|mesh-ancestor
64303081|NCT02239913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64303082|NCT02239913|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64303083|NCT02239913|Appetite Depressants|appetite depressants|mesh-ancestor
64303084|NCT02239913|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64303085|NCT02239913|Sympathomimetics|sympathomimetics|mesh-ancestor
64303086|NCT02239913|Autonomic Agents|autonomic agents|mesh-ancestor
64303087|NCT02239913|Adrenergic Agents|adrenergic agents|mesh-ancestor
64303089|NCT03576287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64357438|NCT03379103|Propofol|propofol|mesh-list
64848682|NCT05785689|Adrenergic Agents|adrenergic agents|mesh-ancestor
64778359|NCT02377752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64778360|NCT02377752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778361|NCT02379858|Alvimopan|alvimopan|mesh-list
64778362|NCT02379858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64778363|NCT02384070|Aspirin|aspirin|mesh-list
64778364|NCT02384070|Bivalirudin|bivalirudin|mesh-list
64778365|NCT02384070|Clopidogrel|clopidogrel|mesh-list
64778366|NCT02384070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64778367|NCT02384070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64778368|NCT02384070|Analgesics|analgesics|mesh-ancestor
64303090|NCT03576287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64303091|NCT03576287|Analgesics|analgesics|mesh-ancestor
64303092|NCT03576287|Sensory System Agents|sensory system agents|mesh-ancestor
64303093|NCT03576287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303094|NCT03576287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303095|NCT03576287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64303096|NCT03576287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64303097|NCT03576287|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64303098|NCT03576287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64303099|NCT03576287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303100|NCT03576287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303102|NCT02455869|Atorvastatin|atorvastatin|mesh-list
64303103|NCT02455869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64848768|NCT05697510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848769|NCT05691478|Cisplatin|cisplatin|mesh-list
64848770|NCT05691478|Doxorubicin|doxorubicin|mesh-list
64848771|NCT05691478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64848772|NCT05691478|Methotrexate|methotrexate|mesh-list
64848773|NCT05691478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848774|NCT05691478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64848775|NCT05691478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64848776|NCT05691478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64848777|NCT05691478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848778|NCT05691478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848779|NCT05691478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64848780|NCT05691478|Abortifacient Agents|abortifacient agents|mesh-ancestor
64848781|NCT05691478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64848782|NCT05691478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848783|NCT05691478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64848784|NCT05691478|Antimetabolites|antimetabolites|mesh-ancestor
64303104|NCT02455869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64303105|NCT02455869|Antimetabolites|antimetabolites|mesh-ancestor
64303106|NCT02455869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303107|NCT02455869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64303108|NCT02455869|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64303109|NCT02455869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303110|NCT02455869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64303111|NCT02455869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303112|NCT03246555|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64303113|NCT03246555|Perindopril|perindopril|mesh-list
64778369|NCT02384070|Sensory System Agents|sensory system agents|mesh-ancestor
64778370|NCT02384070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778371|NCT02384070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778372|NCT02384070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64389783|NCT05076773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64389784|NCT02432677|Remifentanil|remifentanil|mesh-list
64389785|NCT02432677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64389786|NCT02432677|Narcotics|narcotics|mesh-ancestor
64303130|NCT03576053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64303131|NCT03576053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303132|NCT03576053|Sensory System Agents|sensory system agents|mesh-ancestor
64303133|NCT03576053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303134|NCT03576053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64303135|NCT03576053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64303136|NCT03576053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64303137|NCT03576053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64303138|NCT03576053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303139|NCT03576053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64303140|NCT03576053|Serotonin Agents|serotonin agents|mesh-ancestor
64303141|NCT03576053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64848802|NCT05657925|Autonomic Agents|autonomic agents|mesh-ancestor
64848803|NCT05657925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64848804|NCT05657925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848805|NCT05657925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64848806|NCT05657925|Antipruritics|antipruritics|mesh-ancestor
64848807|NCT05657925|Dermatologic Agents|dermatologic agents|mesh-ancestor
64848808|NCT05657925|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64848809|NCT05657925|Serotonin Agents|serotonin agents|mesh-ancestor
64848810|NCT05657925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64848811|NCT05657925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848812|NCT05657925|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64848813|NCT05657925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64848814|NCT05657925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64848815|NCT05657925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64848816|NCT05657925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64848817|NCT05656508|Vaccines|vaccines|mesh-list
64848818|NCT05656508|Immunologic Factors|immunologic factors|mesh-ancestor
64303142|NCT03576053|Histamine Agonists|histamine agonists|mesh-ancestor
64303143|NCT03576053|Histamine Agents|histamine agents|mesh-ancestor
64303144|NCT03242967|Darbepoetin alfa|darbepoetin alfa|mesh-list
64303145|NCT03242967|Hematinics|hematinics|mesh-ancestor
64303147|NCT03239457|Mitosis Modulators|mitosis modulators|mesh-ancestor
64303148|NCT03239457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303149|NCT00075803|Fluconazole|fluconazole|mesh-list
64303150|NCT00075803|Voriconazole|voriconazole|mesh-list
64303151|NCT00075803|Antifungal Agents|antifungal agents|mesh-ancestor
64303152|NCT00075803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64303153|NCT00075803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64303154|NCT00075803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64303155|NCT00075803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303156|NCT00075803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303157|NCT00075803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64303158|NCT00075803|Hormone Antagonists|hormone antagonists|mesh-ancestor
64303159|NCT00075803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64389790|NCT02432677|Sensory System Agents|sensory system agents|mesh-ancestor
64389791|NCT02432677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64389792|NCT03442673|Gemcitabine|gemcitabine|mesh-list
64389793|NCT03442673|Vinorelbine|vinorelbine|mesh-list
64389811|NCT02432365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331487|NCT05442749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331488|NCT05442749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848826|NCT05622812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64848827|NCT05622812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64848828|NCT05622812|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64848829|NCT05622812|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64848830|NCT05622812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64848831|NCT05622812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848832|NCT05615220|Ecopipam|ecopipam|mesh-list
64848833|NCT05615220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64848834|NCT05615220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64848835|NCT05615220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64848836|NCT05615220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848837|NCT05615220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64848838|NCT05615220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64848839|NCT05615220|Dopamine Agents|dopamine agents|mesh-ancestor
64848840|NCT05615220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64389813|NCT02432365|Antimitotic Agents|antimitotic agents|mesh-ancestor
64389814|NCT02432365|Mitosis Modulators|mitosis modulators|mesh-ancestor
64389815|NCT02432365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389817|NCT05076695|Fulvestrant|fulvestrant|mesh-list
64389818|NCT05076695|Palbociclib|palbociclib|mesh-list
64324240|NCT02233777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64324241|NCT02233777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303162|NCT00075803|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64303163|NCT00075803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64303164|NCT03242499|Lovastatin|lovastatin|mesh-list
64303165|NCT03242499|L 647318|l 647318|mesh-list
64303166|NCT03242499|Dihydromevinolin|dihydromevinolin|mesh-list
64324244|NCT02233777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64324245|NCT02233777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64848854|NCT05607407|Methimazole|methimazole|mesh-list
64778382|NCT02384070|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64778383|NCT02384070|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64778384|NCT02384070|Purinergic Agents|purinergic agents|mesh-ancestor
64778385|NCT02384070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64778386|NCT02384070|Antithrombins|antithrombins|mesh-ancestor
64303167|NCT03242499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64303168|NCT03242499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64303169|NCT03242499|Antimetabolites|antimetabolites|mesh-ancestor
64303170|NCT03242499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303171|NCT03242499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64303172|NCT03242499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64303173|NCT03242499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303174|NCT02523911|Magnesium Sulfate|magnesium sulfate|mesh-list
64303175|NCT02523911|Simethicone|simethicone|mesh-list
64303176|NCT02523911|Sodium sulfate|sodium sulfate|mesh-list
64303177|NCT02523911|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64303178|NCT02523911|Analgesics|analgesics|mesh-ancestor
64303179|NCT02523911|Sensory System Agents|sensory system agents|mesh-ancestor
64303180|NCT02523911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303181|NCT02523911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303182|NCT02523911|Anesthetics|anesthetics|mesh-ancestor
64303183|NCT02523911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64778387|NCT02384070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64778388|NCT02384070|Protease Inhibitors|protease inhibitors|mesh-ancestor
64778390|NCT02385240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64778391|NCT02385240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64778392|NCT02385240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64778393|NCT02385240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64778394|NCT02385240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64778395|NCT02385240|Adrenergic Agents|adrenergic agents|mesh-ancestor
64848927|NCT05518110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848928|NCT05518110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64848929|NCT05518110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848930|NCT05518110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64848932|NCT05516498|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64848933|NCT05516498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848934|NCT05516498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64848935|NCT05516498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848936|NCT05514912|Gemcitabine|gemcitabine|mesh-list
64848937|NCT05514912|Paclitaxel|paclitaxel|mesh-list
64848938|NCT05514912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64617426|NCT04341779|Tenofovir|tenofovir|mesh-list
64848939|NCT05514912|Cisplatin|cisplatin|mesh-list
64848940|NCT05514912|Infigratinib|infigratinib|mesh-list
64848941|NCT05514912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64848942|NCT05514912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848943|NCT05514912|Tubulin Modulators|tubulin modulators|mesh-ancestor
64848944|NCT05514912|Antimitotic Agents|antimitotic agents|mesh-ancestor
64778396|NCT02385240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64778397|NCT02385240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778398|NCT02385240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778399|NCT02391714|Chlorhexidine|chlorhexidine|mesh-list
64778400|NCT02391714|Povidone-Iodine|povidone-iodine|mesh-list
64778401|NCT02391714|Nitrous Oxide|nitrous oxide|mesh-list
64778402|NCT02391714|Povidone|povidone|mesh-list
64389819|NCT05076695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64389820|NCT05076695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64389821|NCT05076695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64389822|NCT05076695|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64389823|NCT05076695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64303185|NCT02523911|Anticonvulsants|anticonvulsants|mesh-ancestor
64303186|NCT02523911|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64303187|NCT02523911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64303188|NCT02523911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303189|NCT02523911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64303190|NCT02523911|Tocolytic Agents|tocolytic agents|mesh-ancestor
64303191|NCT02523911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64303192|NCT02523911|Antifoaming Agents|antifoaming agents|mesh-ancestor
64303193|NCT02523911|Emollients|emollients|mesh-ancestor
64303194|NCT02523911|Dermatologic Agents|dermatologic agents|mesh-ancestor
64303195|NCT02523911|Cathartics|cathartics|mesh-ancestor
64331492|NCT05370911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64331493|NCT05361655|Palbociclib|palbociclib|mesh-list
64331494|NCT05361655|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64331495|NCT05361655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331496|NCT05361655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64331497|NCT05361655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331498|NCT05361655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848945|NCT05514912|Mitosis Modulators|mitosis modulators|mesh-ancestor
64848946|NCT05514912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848947|NCT05514912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64848948|NCT05514912|Antimetabolites|antimetabolites|mesh-ancestor
64848949|NCT05514912|Antiviral Agents|antiviral agents|mesh-ancestor
64848950|NCT05514912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64848951|NCT05514912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848952|NCT05514912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64848953|NCT05514912|Immunologic Factors|immunologic factors|mesh-ancestor
64848954|NCT05514912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848955|NCT05497323|Adapalene|adapalene|mesh-list
64848956|NCT05497323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64848957|NCT05497323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64848958|NCT05497323|Analgesics|analgesics|mesh-ancestor
64303196|NCT02523911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64303197|NCT03572231|Solifenacin Succinate|solifenacin succinate|mesh-list
64303198|NCT03572231|Mirabegron|mirabegron|mesh-list
64303199|NCT03572231|Fesoterodine|fesoterodine|mesh-list
64303200|NCT03572231|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64303201|NCT03572231|Oxybutynin|oxybutynin|mesh-list
64303202|NCT03572231|Darifenacin|darifenacin|mesh-list
64303203|NCT03572231|Propiverine|propiverine|mesh-list
64303204|NCT03572231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64303205|NCT03572231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64303206|NCT03572231|Cholinergic Agents|cholinergic agents|mesh-ancestor
64303207|NCT03572231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64389824|NCT05076695|Hormone Antagonists|hormone antagonists|mesh-ancestor
64778403|NCT02391714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64778404|NCT02391714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64778405|NCT02391714|Disinfectants|disinfectants|mesh-ancestor
64778406|NCT02391714|Plasma Substitutes|plasma substitutes|mesh-ancestor
64778407|NCT02391714|Blood Substitutes|blood substitutes|mesh-ancestor
64778408|NCT02391714|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64778409|NCT02391714|Anesthetics, General|anesthetics, general|mesh-ancestor
64778410|NCT02391714|Anesthetics|anesthetics|mesh-ancestor
64778411|NCT02391714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64778412|NCT02391714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778413|NCT02391714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64778414|NCT02391714|Analgesics|analgesics|mesh-ancestor
64778415|NCT02391714|Sensory System Agents|sensory system agents|mesh-ancestor
64778416|NCT02391714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778417|NCT02395692|Temozolomide|temozolomide|mesh-list
64778418|NCT02395692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64778419|NCT02395692|Alkylating Agents|alkylating agents|mesh-ancestor
64778420|NCT02395692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848964|NCT05497323|Dermatologic Agents|dermatologic agents|mesh-ancestor
64848965|NCT05463965|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64848967|NCT05463965|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64848968|NCT05463965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64848969|NCT05463965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848970|NCT05463965|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64848971|NCT05463965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64848972|NCT05463965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848973|NCT05463965|Cholinergic Agents|cholinergic agents|mesh-ancestor
64848974|NCT05463965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64848975|NCT05446129|Pembrolizumab|pembrolizumab|mesh-list
64848976|NCT05446129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64848977|NCT05446129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778421|NCT02395692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778422|NCT02397954|Ranibizumab|ranibizumab|mesh-list
64778423|NCT02397954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64778424|NCT02397954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64389841|NCT03143933|Sensory System Agents|sensory system agents|mesh-ancestor
64389842|NCT03143933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64389843|NCT03143933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64389863|NCT05076461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64778425|NCT02397954|Growth Substances|growth substances|mesh-ancestor
64778426|NCT02397954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778427|NCT02397954|Growth Inhibitors|growth inhibitors|mesh-ancestor
64778428|NCT02397954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778429|NCT02401464|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
64303208|NCT03572231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303209|NCT03572231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303210|NCT03572231|Urological Agents|urological agents|mesh-ancestor
64848994|NCT05371886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64848995|NCT05371886|Narcotics|narcotics|mesh-ancestor
64848996|NCT05371886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64848997|NCT05371886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848998|NCT05371886|Analgesics|analgesics|mesh-ancestor
64848999|NCT05371886|Sensory System Agents|sensory system agents|mesh-ancestor
64849000|NCT05371886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64849001|NCT05371886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64849002|NCT05371886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64849003|NCT05371886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64849004|NCT05371886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64389870|NCT02428933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64389871|NCT02428933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389872|NCT02428933|Dopamine Agonists|dopamine agonists|mesh-ancestor
64389873|NCT02428933|Dopamine Agents|dopamine agents|mesh-ancestor
64389874|NCT02428933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64389875|NCT02428933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389876|NCT02428777|Diclofenac|diclofenac|mesh-list
64389877|NCT02428777|Tramadol|tramadol|mesh-list
64389878|NCT02428777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64303211|NCT03572231|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64303212|NCT03572231|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64303213|NCT03572231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64303214|NCT03572231|Adrenergic Agents|adrenergic agents|mesh-ancestor
64303215|NCT03572231|Parasympatholytics|parasympatholytics|mesh-ancestor
64303216|NCT03572231|Autonomic Agents|autonomic agents|mesh-ancestor
64303217|NCT03572231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303218|NCT02135029|Atorvastatin|atorvastatin|mesh-list
64778447|NCT02413320|Paclitaxel|paclitaxel|mesh-list
64778448|NCT02413320|Docetaxel|docetaxel|mesh-list
64778449|NCT02413320|Cyclophosphamide|cyclophosphamide|mesh-list
64778450|NCT02413320|Carboplatin|carboplatin|mesh-list
64778451|NCT02413320|Doxorubicin|doxorubicin|mesh-list
64778452|NCT02413320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64778453|NCT02413320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849052|NCT05321420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64849053|NCT05321420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849054|NCT05321420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64849055|NCT05321420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64849056|NCT05321420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64849057|NCT05321420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64849058|NCT05321420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849059|NCT05309655|Adenosine|adenosine|mesh-list
64849060|NCT05309655|Analgesics|analgesics|mesh-ancestor
64849061|NCT05309655|Sensory System Agents|sensory system agents|mesh-ancestor
64849062|NCT05309655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64849063|NCT05309655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331502|NCT05361655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64331503|NCT05361655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331505|NCT05355740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64331506|NCT05355740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64778454|NCT02413320|Tubulin Modulators|tubulin modulators|mesh-ancestor
64547160|NCT03807921|Aspirin|aspirin|mesh-list
64778455|NCT02413320|Antimitotic Agents|antimitotic agents|mesh-ancestor
64778456|NCT02413320|Mitosis Modulators|mitosis modulators|mesh-ancestor
64778457|NCT02413320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778458|NCT02413320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64778459|NCT02413320|Immunologic Factors|immunologic factors|mesh-ancestor
64778460|NCT02413320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778461|NCT02413320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64778462|NCT02413320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64778463|NCT02413320|Alkylating Agents|alkylating agents|mesh-ancestor
64778464|NCT02413320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64778465|NCT02413320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64778466|NCT02413320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64778467|NCT02413320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64778468|NCT02413320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64778469|NCT05718882|Lenvatinib|lenvatinib|mesh-list
64778470|NCT05718882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778471|NCT05718882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64778472|NCT05718882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64778473|NCT05718882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778474|NCT05718492|Leucovorin|leucovorin|mesh-list
64778481|NCT05718492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64778482|NCT05718492|Immunologic Factors|immunologic factors|mesh-ancestor
64778483|NCT05718492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778484|NCT05718492|Antidotes|antidotes|mesh-ancestor
64778485|NCT05718492|Protective Agents|protective agents|mesh-ancestor
64778486|NCT05718492|Vitamin B Complex|vitamin b complex|mesh-ancestor
64331519|NCT05320887|Autonomic Agents|autonomic agents|mesh-ancestor
64331520|NCT05320887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64331521|NCT05320887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849080|NCT05265767|Coagulants|coagulants|mesh-ancestor
64849081|NCT05261139|Ritonavir|ritonavir|mesh-list
64849082|NCT05261139|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64849083|NCT05261139|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64849084|NCT05261139|Protease Inhibitors|protease inhibitors|mesh-ancestor
64849085|NCT05261139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849086|NCT05261139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849087|NCT05261139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64849088|NCT05261139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64303219|NCT02135029|Bococizumab|bococizumab|mesh-list
64778493|NCT05718024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64778494|NCT05718024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64778495|NCT05718024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778496|NCT05718024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64778497|NCT05718024|Anesthetics, General|anesthetics, general|mesh-ancestor
64778499|NCT05718024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64778500|NCT05718024|Analgesics|analgesics|mesh-ancestor
64778501|NCT05718024|Sensory System Agents|sensory system agents|mesh-ancestor
64778502|NCT05718024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64849089|NCT05261139|Antiviral Agents|antiviral agents|mesh-ancestor
64849090|NCT05261139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64849091|NCT05261139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64849092|NCT05261139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64849093|NCT05249101|Capecitabine|capecitabine|mesh-list
64849094|NCT05249101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64849095|NCT05249101|Antimetabolites|antimetabolites|mesh-ancestor
64849096|NCT05249101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849097|NCT05249101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849098|NCT05222555|Lenalidomide|lenalidomide|mesh-list
64849099|NCT05222555|Immunologic Factors|immunologic factors|mesh-ancestor
64849100|NCT05222555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849101|NCT05222555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64849102|NCT05222555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64849103|NCT05222555|Growth Substances|growth substances|mesh-ancestor
64849104|NCT05222555|Growth Inhibitors|growth inhibitors|mesh-ancestor
64849105|NCT05222555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849106|NCT05219799|Propranolol|propranolol|mesh-list
64849107|NCT05219799|Phentolamine|phentolamine|mesh-list
64849108|NCT05219799|Isoproterenol|isoproterenol|mesh-list
64849109|NCT05219799|Norepinephrine|norepinephrine|mesh-list
64849110|NCT05219799|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64849111|NCT05219799|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64849112|NCT05219799|Adrenergic Agents|adrenergic agents|mesh-ancestor
64778503|NCT05718024|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64389917|NCT03186001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64389918|NCT03186001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389919|NCT03186001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64389920|NCT03186001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64389921|NCT04593563|Psilocybin|psilocybin|mesh-list
64389922|NCT04593563|Hallucinogens|hallucinogens|mesh-ancestor
64389923|NCT04593563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389924|NCT04593563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64389925|NCT04551911|Calcifediol|calcifediol|mesh-list
64389926|NCT04551911|Vitamins|vitamins|mesh-ancestor
64389927|NCT04551911|Micronutrients|micronutrients|mesh-ancestor
64389928|NCT04551911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389929|NCT04551911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64389930|NCT02431975|Ritonavir|ritonavir|mesh-list
64389944|NCT02431975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64389945|NCT02431975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64389946|NCT02431975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64778514|NCT05717790|Nimotuzumab|nimotuzumab|mesh-list
64778515|NCT05717790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778516|NCT05717790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64778517|NCT05717790|Antimetabolites|antimetabolites|mesh-ancestor
64778518|NCT05717790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778519|NCT05717790|Antiviral Agents|antiviral agents|mesh-ancestor
64849130|NCT05219799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64778520|NCT05717790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64849132|NCT05216952|Misoprostol|misoprostol|mesh-list
64778521|NCT05717790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64778522|NCT05717790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64778523|NCT05717790|Immunologic Factors|immunologic factors|mesh-ancestor
64303220|NCT02135029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64303221|NCT02135029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64303222|NCT02135029|Antimetabolites|antimetabolites|mesh-ancestor
64303223|NCT02135029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303224|NCT02135029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64303225|NCT02135029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64303226|NCT02135029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849205|NCT05085002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849206|NCT05085002|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64849207|NCT05085002|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64849208|NCT05085002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849209|NCT05085002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849210|NCT05085002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64849211|NCT05085002|Hormone Antagonists|hormone antagonists|mesh-ancestor
64849212|NCT05085002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64849213|NCT05085002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849214|NCT05085002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64849215|NCT05085002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64849216|NCT05083312|Fluticasone|fluticasone|mesh-list
64849217|NCT05083312|Xhance|xhance|mesh-list
64849218|NCT05083312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64849219|NCT05083312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64849220|NCT05083312|Autonomic Agents|autonomic agents|mesh-ancestor
64849221|NCT05083312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64849222|NCT05083312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849223|NCT05083312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64849224|NCT05083312|Respiratory System Agents|respiratory system agents|mesh-ancestor
64849225|NCT05083312|Dermatologic Agents|dermatologic agents|mesh-ancestor
64849226|NCT05083312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64849230|NCT05027425|Durvalumab|durvalumab|mesh-list
64849231|NCT05027425|Tremelimumab|tremelimumab|mesh-list
64849232|NCT05027425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64849233|NCT05027425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849234|NCT05003648|Pramipexole|pramipexole|mesh-list
64849235|NCT05003648|Antioxidants|antioxidants|mesh-ancestor
64849236|NCT05003648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849237|NCT05003648|Protective Agents|protective agents|mesh-ancestor
64849238|NCT05003648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303227|NCT03573245|Tranexamic Acid|tranexamic acid|mesh-list
64303228|NCT03573245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64303229|NCT03573245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64303230|NCT03573245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303231|NCT03573245|Hemostatics|hemostatics|mesh-ancestor
64778525|NCT05717790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64778527|NCT05679258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64778528|NCT05679258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778529|NCT05679258|Immunologic Factors|immunologic factors|mesh-ancestor
64778530|NCT05679258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778531|NCT05602272|Anesthetics|anesthetics|mesh-list
64778532|NCT05602272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64778533|NCT05602272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778534|NCT05589792|Acetazolamide|acetazolamide|mesh-list
64778535|NCT05589792|Anticonvulsants|anticonvulsants|mesh-ancestor
64778536|NCT05589792|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64778537|NCT05589792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64778538|NCT05589792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778539|NCT05589792|Diuretics|diuretics|mesh-ancestor
64778540|NCT05589792|Natriuretic Agents|natriuretic agents|mesh-ancestor
64778541|NCT05589792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778542|NCT05543694|Bupivacaine|bupivacaine|mesh-list
64778543|NCT05543694|Anesthetics, Local|anesthetics, local|mesh-ancestor
64778544|NCT05543694|Anesthetics|anesthetics|mesh-ancestor
64778545|NCT05543694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64778546|NCT05543694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778547|NCT05543694|Sensory System Agents|sensory system agents|mesh-ancestor
64778557|NCT05358834|Melatonin|melatonin|mesh-list
64778558|NCT05358834|Antioxidants|antioxidants|mesh-ancestor
64778559|NCT05358834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778560|NCT05358834|Protective Agents|protective agents|mesh-ancestor
64778561|NCT05358834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849240|NCT05003648|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64617727|NCT01093417|Vitamin D|vitamin d|mesh-list
64849242|NCT05003648|Dopamine Agents|dopamine agents|mesh-ancestor
64849243|NCT05003648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64331523|NCT05320887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64331524|NCT05320887|Cholinergic Agents|cholinergic agents|mesh-ancestor
64331525|NCT05320887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64331526|NCT05320887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849244|NCT05000216|Mycophenolic Acid|mycophenolic acid|mesh-list
64849245|NCT05000216|Methotrexate|methotrexate|mesh-list
64849246|NCT05000216|Vaccines|vaccines|mesh-list
64849247|NCT05000216|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64849248|NCT05000216|Immunologic Factors|immunologic factors|mesh-ancestor
64849249|NCT05000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849250|NCT05000216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64778562|NCT05358834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64389986|NCT02431663|Ketamine|ketamine|mesh-list
64389987|NCT02431663|Analgesics|analgesics|mesh-ancestor
64389988|NCT02431663|Sensory System Agents|sensory system agents|mesh-ancestor
64389989|NCT02431663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64389990|NCT02431663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389991|NCT02431663|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64389992|NCT02431663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64389993|NCT02431663|Anesthetics, General|anesthetics, general|mesh-ancestor
64389994|NCT02431663|Anesthetics|anesthetics|mesh-ancestor
64389995|NCT02431663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64303232|NCT03573245|Coagulants|coagulants|mesh-ancestor
64303233|NCT02241161|Bacteriocins|bacteriocins|mesh-list
64303234|NCT02241161|Antioxidants|antioxidants|mesh-list
64778568|NCT05273346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778569|NCT05273346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778570|NCT05159934|Nicotine|nicotine|mesh-list
64778571|NCT05159934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64778572|NCT05159934|Autonomic Agents|autonomic agents|mesh-ancestor
64778573|NCT05159934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778574|NCT05159934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778575|NCT05159934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64849264|NCT05000216|Antitubercular Agents|antitubercular agents|mesh-ancestor
64849265|NCT05000216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64849266|NCT05000216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64849268|NCT04991480|Talazoparib|talazoparib|mesh-list
64849269|NCT04991480|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64849270|NCT04991480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849271|NCT04991480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849272|NCT04991480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778576|NCT05159934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64778577|NCT05159934|Cholinergic Agents|cholinergic agents|mesh-ancestor
64778578|NCT05159934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64778579|NCT05159934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778580|NCT05105256|Prednisolone|prednisolone|mesh-list
64778581|NCT05105256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64778582|NCT05105256|Glucocorticoids|glucocorticoids|mesh-ancestor
64778583|NCT05105256|Hormones|hormones|mesh-ancestor
64849303|NCT04977453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64849304|NCT04977453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849305|NCT04977453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64849306|NCT04977453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849307|NCT04977453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849308|NCT04958785|Paclitaxel|paclitaxel|mesh-list
64849309|NCT04958785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64849310|NCT04958785|Magrolimab|magrolimab|mesh-list
64849311|NCT04958785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64849312|NCT04958785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849313|NCT04958785|Tubulin Modulators|tubulin modulators|mesh-ancestor
64849314|NCT04958785|Antimitotic Agents|antimitotic agents|mesh-ancestor
64849315|NCT04958785|Mitosis Modulators|mitosis modulators|mesh-ancestor
64849316|NCT04958785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849317|NCT04958785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64331547|NCT05276284|Thioguanine|thioguanine|mesh-list
64331548|NCT05276284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331549|NCT05276284|Antimetabolites|antimetabolites|mesh-ancestor
64331550|NCT05276284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331551|NCT05276284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64331552|NCT05276284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64331553|NCT05276284|Immunologic Factors|immunologic factors|mesh-ancestor
64331554|NCT05276284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331555|NCT05276284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64331556|NCT05276284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849323|NCT04931342|Cyclophosphamide|cyclophosphamide|mesh-list
64849324|NCT04931342|Bevacizumab|bevacizumab|mesh-list
64849325|NCT04931342|Trastuzumab|trastuzumab|mesh-list
64778584|NCT05105256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64778585|NCT05105256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778586|NCT05105256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64778587|NCT05105256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778588|NCT04967196|Nivolumab|nivolumab|mesh-list
64778594|NCT04916886|Vaccines|vaccines|mesh-list
64778595|NCT04916886|Immunologic Factors|immunologic factors|mesh-ancestor
64849326|NCT04931342|Atezolizumab|atezolizumab|mesh-list
64849327|NCT04931342|Letrozole|letrozole|mesh-list
64778596|NCT04916886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778597|NCT04907682|Ribavirin|ribavirin|mesh-list
64778598|NCT04907682|Favipiravir|favipiravir|mesh-list
64778599|NCT04907682|Antimetabolites|antimetabolites|mesh-ancestor
64778600|NCT04907682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778601|NCT04907682|Antiviral Agents|antiviral agents|mesh-ancestor
64778602|NCT04907682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64778603|NCT04840992|Vaccines|vaccines|mesh-list
64778604|NCT04840992|Immunologic Factors|immunologic factors|mesh-ancestor
64778605|NCT04840992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64547354|NCT00758667|Mesna|mesna|mesh-list
64778606|NCT04793022|Anesthetics|anesthetics|mesh-list
64849328|NCT04931342|Olaparib|olaparib|mesh-list
64849329|NCT04931342|Palbociclib|palbociclib|mesh-list
64849330|NCT04931342|Hormones|hormones|mesh-list
64849331|NCT04931342|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64849332|NCT04931342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64849333|NCT04931342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849334|NCT04931342|Tubulin Modulators|tubulin modulators|mesh-ancestor
64849335|NCT04931342|Antimitotic Agents|antimitotic agents|mesh-ancestor
64849336|NCT04931342|Mitosis Modulators|mitosis modulators|mesh-ancestor
64849337|NCT04931342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849338|NCT04931342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64849339|NCT04931342|Immunologic Factors|immunologic factors|mesh-ancestor
64331557|NCT05244226|Fentanyl|fentanyl|mesh-list
64778607|NCT04793022|Propofol|propofol|mesh-list
64778608|NCT04793022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64778609|NCT04793022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778610|NCT04793022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64778611|NCT04793022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64778612|NCT04793022|Anesthetics, General|anesthetics, general|mesh-ancestor
64778613|NCT04776018|Daratumumab|daratumumab|mesh-list
64778614|NCT04776018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778615|NCT04750902|Listerine|listerine|mesh-list
64778616|NCT04750902|Fluorides|fluorides|mesh-list
64778617|NCT04750902|Sodium Fluoride|sodium fluoride|mesh-list
64778618|NCT04750902|Cariostatic Agents|cariostatic agents|mesh-ancestor
64778619|NCT04750902|Protective Agents|protective agents|mesh-ancestor
64778620|NCT04750902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778621|NCT04750902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64778622|NCT04750902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64778623|NCT04711824|Gemcitabine|gemcitabine|mesh-list
64778625|NCT04711824|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64778627|NCT04711824|Carboplatin|carboplatin|mesh-list
64778628|NCT04711824|Capecitabine|capecitabine|mesh-list
64778629|NCT04711824|Durvalumab|durvalumab|mesh-list
64778630|NCT04711824|Olaparib|olaparib|mesh-list
64778631|NCT04711824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64778632|NCT04711824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778633|NCT04711824|Tubulin Modulators|tubulin modulators|mesh-ancestor
64778634|NCT04711824|Antimitotic Agents|antimitotic agents|mesh-ancestor
64303239|NCT02241161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64303240|NCT02135263|Enalapril|enalapril|mesh-list
64303241|NCT02135263|Methylphenidate|methylphenidate|mesh-list
64303242|NCT02135263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64303243|NCT02135263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303244|NCT02135263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64303245|NCT02135263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64849402|NCT04845035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849403|NCT04845035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849404|NCT04845035|Dermatologic Agents|dermatologic agents|mesh-ancestor
64849405|NCT04845035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849406|NCT04845035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64849407|NCT04845035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64849408|NCT04845035|Immunologic Factors|immunologic factors|mesh-ancestor
64849409|NCT04845035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64849410|NCT04845035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64849411|NCT04845035|Antiviral Agents|antiviral agents|mesh-ancestor
64849412|NCT04845035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64849413|NCT04845035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64849414|NCT04835506|Infliximab|infliximab|mesh-list
64849415|NCT04835506|Dermatologic Agents|dermatologic agents|mesh-ancestor
64849416|NCT04835506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64778635|NCT04711824|Mitosis Modulators|mitosis modulators|mesh-ancestor
64778636|NCT04711824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778637|NCT04711824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64778638|NCT04711824|Antimetabolites|antimetabolites|mesh-ancestor
64778639|NCT04711824|Antiviral Agents|antiviral agents|mesh-ancestor
64778640|NCT04711824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64778641|NCT04711824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64778642|NCT04711824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64778643|NCT04711824|Immunologic Factors|immunologic factors|mesh-ancestor
64778644|NCT04711824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778645|NCT04711824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64778646|NCT04711824|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64778647|NCT04621500|Vitamin D|vitamin d|mesh-list
64390057|NCT03184363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64331567|NCT05244226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64331568|NCT05244226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64849431|NCT04824092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390058|NCT03184363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390059|NCT03184363|Cholinergic Agents|cholinergic agents|mesh-ancestor
64390060|NCT03184363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64778648|NCT04621500|Cholecalciferol|cholecalciferol|mesh-list
64778649|NCT04621500|Vitamins|vitamins|mesh-ancestor
64778650|NCT04621500|Micronutrients|micronutrients|mesh-ancestor
64778651|NCT04621500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778652|NCT04621500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64778653|NCT04621500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64778654|NCT04567524|Risperidone|risperidone|mesh-list
64778655|NCT04567524|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64778656|NCT04567524|Serotonin Agents|serotonin agents|mesh-ancestor
64778657|NCT04567524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64778658|NCT04567524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778659|NCT04567524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778660|NCT04567524|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64778661|NCT04567524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64303246|NCT02135263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64331576|NCT05237960|Metformin|metformin|mesh-list
64331577|NCT05237960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64331578|NCT05237960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331601|NCT05179356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849499|NCT04665895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64849500|NCT04665895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64849501|NCT04665895|Autonomic Agents|autonomic agents|mesh-ancestor
64849502|NCT04665895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64849503|NCT04665895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849504|NCT04665895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64849505|NCT04665895|Respiratory System Agents|respiratory system agents|mesh-ancestor
64849506|NCT04665895|Dermatologic Agents|dermatologic agents|mesh-ancestor
64849507|NCT04665895|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64849508|NCT04632992|Paclitaxel|paclitaxel|mesh-list
64849509|NCT04632992|Maytansine|maytansine|mesh-list
64849510|NCT04632992|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64849511|NCT04632992|Trastuzumab|trastuzumab|mesh-list
64849512|NCT04632992|Atezolizumab|atezolizumab|mesh-list
64849513|NCT04632992|Pertuzumab|pertuzumab|mesh-list
64849514|NCT04632992|Tucatinib|tucatinib|mesh-list
64849515|NCT04632992|Pralsetinib|pralsetinib|mesh-list
64849516|NCT04632992|Entrectinib|entrectinib|mesh-list
64849517|NCT04632992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64849518|NCT04632992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849519|NCT04632992|Tubulin Modulators|tubulin modulators|mesh-ancestor
64849520|NCT04632992|Antimitotic Agents|antimitotic agents|mesh-ancestor
64849521|NCT04632992|Mitosis Modulators|mitosis modulators|mesh-ancestor
64294772|NCT01335997|Micronutrients|micronutrients|mesh-ancestor
64303247|NCT02135263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303248|NCT02135263|Dopamine Agents|dopamine agents|mesh-ancestor
64303249|NCT02135263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64303250|NCT02135263|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64303251|NCT02135263|Protease Inhibitors|protease inhibitors|mesh-ancestor
64303252|NCT02135263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303253|NCT02135263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64303254|NCT02135341|Botulinum Toxins|botulinum toxins|mesh-list
64778662|NCT04567524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64778663|NCT04567524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64778664|NCT04567524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64778665|NCT04567524|Dopamine Agents|dopamine agents|mesh-ancestor
64778666|NCT04547790|Psyllium|psyllium|mesh-list
64778667|NCT04547790|Cathartics|cathartics|mesh-ancestor
64778668|NCT04547790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64849522|NCT04632992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849523|NCT04632992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64849524|NCT04632992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64849526|NCT04623216|Azacitidine|azacitidine|mesh-list
64849527|NCT04623216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64849528|NCT04623216|Antimetabolites|antimetabolites|mesh-ancestor
64849529|NCT04623216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849530|NCT04623216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849531|NCT04623216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849532|NCT04549792|Ustekinumab|ustekinumab|mesh-list
64849533|NCT04549792|Dermatologic Agents|dermatologic agents|mesh-ancestor
64849534|NCT04545554|Vitamin D|vitamin d|mesh-list
64849535|NCT04545554|Calcium|calcium|mesh-list
64849536|NCT04545554|Vitamins|vitamins|mesh-ancestor
64849537|NCT04545554|Micronutrients|micronutrients|mesh-ancestor
64849538|NCT04545554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849539|NCT04545554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64849540|NCT04545554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64849541|NCT04530058|Metformin|metformin|mesh-list
64849542|NCT04530058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64849543|NCT04530058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849544|NCT04510311|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64849545|NCT04510311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849546|NCT04510311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849547|NCT04510311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778669|NCT04481412|Cetirizine|cetirizine|mesh-list
64778670|NCT04481412|Ethanol|ethanol|mesh-list
64778671|NCT04481412|Minoxidil|minoxidil|mesh-list
64778672|NCT04481412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64390080|NCT04102241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390081|NCT03576443|Idelalisib|idelalisib|mesh-list
64390082|NCT03576443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390083|NCT03576443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64390084|NCT03576443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390085|NCT02427529|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64390086|NCT02427529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64390087|NCT02427529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778673|NCT04481412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64778674|NCT04481412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64778675|NCT04481412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778676|NCT04481412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64778677|NCT04481412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64849560|NCT04483505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849561|NCT04483505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64849562|NCT04483505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849563|NCT04483505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849564|NCT04461535|Hormones|hormones|mesh-list
64849565|NCT04461535|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64849566|NCT04461535|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64849567|NCT04461535|beta-Endorphin|beta-endorphin|mesh-list
64849568|NCT04461535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64849569|NCT04461535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849570|NCT04461535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64849571|NCT04461535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849572|NCT04459715|Cisplatin|cisplatin|mesh-list
64849573|NCT04459715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849574|NCT04445662|Varenicline|varenicline|mesh-list
64778678|NCT04481412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64778679|NCT04481412|Histamine Antagonists|histamine antagonists|mesh-ancestor
64778680|NCT04481412|Histamine Agents|histamine agents|mesh-ancestor
64778681|NCT04481412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64778682|NCT04481412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778683|NCT04481412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64778684|NCT04481412|Vasodilator Agents|vasodilator agents|mesh-ancestor
64778685|NCT04317300|Varenicline|varenicline|mesh-list
64778686|NCT04317300|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64778687|NCT04317300|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64778688|NCT04317300|Cholinergic Agents|cholinergic agents|mesh-ancestor
64778689|NCT04317300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64778690|NCT04317300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778691|NCT04317300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778692|NCT04143204|Insulin|insulin|mesh-list
64778693|NCT04143204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64778694|NCT04143204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778695|NCT04031508|SMOFlipid|smoflipid|mesh-list
64778696|NCT04031508|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64778697|NCT04031508|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64390103|NCT04438733|Hormone Antagonists|hormone antagonists|mesh-ancestor
64390106|NCT04438811|Anesthetics|anesthetics|mesh-list
64778698|NCT04031508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64778699|NCT03876288|Immunoglobulins|immunoglobulins|mesh-list
64778700|NCT03876288|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64778701|NCT03876288|gamma-Globulins|gamma-globulins|mesh-list
64778702|NCT03876288|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64778703|NCT03876288|Immunologic Factors|immunologic factors|mesh-ancestor
64778704|NCT03876288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778705|NCT03252522|Micronutrients|micronutrients|mesh-list
64778706|NCT03252522|Trace Elements|trace elements|mesh-list
64849575|NCT04445662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64849576|NCT04445662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64849577|NCT04445662|Cholinergic Agents|cholinergic agents|mesh-ancestor
64849578|NCT04445662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64849579|NCT04445662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778707|NCT03252522|Antioxidants|antioxidants|mesh-list
64778708|NCT03252522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778709|NCT03252522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778710|NCT03252522|Protective Agents|protective agents|mesh-ancestor
64778711|NCT03191370|Anesthetics|anesthetics|mesh-list
64778712|NCT03191370|Anesthetics, Local|anesthetics, local|mesh-list
64778713|NCT03191370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64303288|NCT03571919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778731|NCT02834052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390147|NCT03183739|Sensory System Agents|sensory system agents|mesh-ancestor
64390148|NCT03183739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64849615|NCT04192981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849616|NCT04188418|Fentanyl|fentanyl|mesh-list
64849617|NCT04188418|Morphine|morphine|mesh-list
64849618|NCT04188418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64849619|NCT04188418|Narcotics|narcotics|mesh-ancestor
64618102|NCT02574078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64849620|NCT04188418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64849621|NCT04188418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849622|NCT04188418|Analgesics|analgesics|mesh-ancestor
64849623|NCT04188418|Sensory System Agents|sensory system agents|mesh-ancestor
64849624|NCT04188418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64849625|NCT04188418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64849626|NCT04188418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64849627|NCT04188418|Anesthetics, General|anesthetics, general|mesh-ancestor
64849628|NCT04188418|Anesthetics|anesthetics|mesh-ancestor
64331618|NCT05144698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64331619|NCT05144698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64331620|NCT05144698|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64331621|NCT05144698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331622|NCT05144698|Antifungal Agents|antifungal agents|mesh-ancestor
64331623|NCT05144698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64331624|NCT05144698|Immunologic Factors|immunologic factors|mesh-ancestor
64331626|NCT05122182|Proxigermanium|proxigermanium|mesh-list
64390149|NCT03183739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390150|NCT03183739|GABA Modulators|gaba modulators|mesh-ancestor
64390151|NCT03183739|GABA Agents|gaba agents|mesh-ancestor
64849665|NCT04152551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849666|NCT04152551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64849667|NCT04152551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390152|NCT03183739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64390153|NCT03183739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390154|NCT03117439|Antifungal Agents|antifungal agents|mesh-list
64390155|NCT03117439|Clotrimazole|clotrimazole|mesh-list
64390156|NCT03117439|Miconazole|miconazole|mesh-list
64390157|NCT03117439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64303289|NCT02252809|Methylprednisolone|methylprednisolone|mesh-list
64303290|NCT02252809|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64303291|NCT02252809|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64303292|NCT02252809|Prednisolone|prednisolone|mesh-list
64303293|NCT02252809|Prednisolone acetate|prednisolone acetate|mesh-list
64303294|NCT02252809|Adalimumab|adalimumab|mesh-list
64390160|NCT03117439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64849668|NCT04152551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64849669|NCT04112498|Nivolumab|nivolumab|mesh-list
64849670|NCT04112498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64849671|NCT04112498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849672|NCT04112498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64849673|NCT04112498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849674|NCT04104893|Pembrolizumab|pembrolizumab|mesh-list
64849675|NCT04104893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64849676|NCT04104893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849677|NCT04042051|Trastuzumab|trastuzumab|mesh-list
64849678|NCT04042051|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64849679|NCT04042051|Maytansine|maytansine|mesh-list
64849680|NCT04042051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64849681|NCT04042051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849682|NCT04042051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64849683|NCT04042051|Tubulin Modulators|tubulin modulators|mesh-ancestor
64390161|NCT03117439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64390162|NCT03117439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390163|NCT03117439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64390164|NCT03117439|Hormone Antagonists|hormone antagonists|mesh-ancestor
64390165|NCT03117439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64390166|NCT03117439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390167|NCT03117439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64390168|NCT03117439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64390169|NCT02426905|Trientine|trientine|mesh-list
64324246|NCT02233777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64324247|NCT02634853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64324248|NCT02634853|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64324249|NCT01520545|Baclofen|baclofen|mesh-list
64324250|NCT01520545|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64324251|NCT01520545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324252|NCT01520545|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64778754|NCT02828358|Vincristine|vincristine|mesh-list
64778755|NCT02828358|Azacitidine|azacitidine|mesh-list
64778756|NCT02828358|Daunorubicin|daunorubicin|mesh-list
64778757|NCT02828358|Asparaginase|asparaginase|mesh-list
64778758|NCT02828358|Mercaptopurine|mercaptopurine|mesh-list
64778759|NCT02828358|Pegaspargase|pegaspargase|mesh-list
64778760|NCT02828358|Thioguanine|thioguanine|mesh-list
64778761|NCT02828358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64778762|NCT02828358|Prednisolone phosphate|prednisolone phosphate|mesh-list
64390170|NCT02426905|Chelating Agents|chelating agents|mesh-ancestor
64390171|NCT02426905|Sequestering Agents|sequestering agents|mesh-ancestor
64390172|NCT02426905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390173|NCT02421289|Efavirenz|efavirenz|mesh-list
64390174|NCT02421289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64390175|NCT02421289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64331649|NCT05092360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331650|NCT05092360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64331651|NCT05092360|Antimetabolites|antimetabolites|mesh-ancestor
64331652|NCT05092360|Antiviral Agents|antiviral agents|mesh-ancestor
64849703|NCT04002947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849705|NCT03975231|Trametinib|trametinib|mesh-list
64849706|NCT03975231|Dabrafenib|dabrafenib|mesh-list
64849707|NCT03975231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849708|NCT03975231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64849709|NCT03975231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849710|NCT03975231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849711|NCT03961360|Aspirin|aspirin|mesh-list
64849712|NCT03961360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64849713|NCT03961360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64849714|NCT03961360|Analgesics|analgesics|mesh-ancestor
64849715|NCT03961360|Sensory System Agents|sensory system agents|mesh-ancestor
64331653|NCT05092360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64331654|NCT05092360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331655|NCT05092360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64331656|NCT05092360|Immunologic Factors|immunologic factors|mesh-ancestor
64390176|NCT02421289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64390177|NCT02421289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390178|NCT02421289|Antiviral Agents|antiviral agents|mesh-ancestor
64390179|NCT02421289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64390180|NCT02421289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64778763|NCT02828358|BB 1101|bb 1101|mesh-list
64778764|NCT02828358|Calcium|calcium|mesh-list
64778766|NCT02828358|Levoleucovorin|levoleucovorin|mesh-list
64778767|NCT02828358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64778768|NCT02828358|Immunologic Factors|immunologic factors|mesh-ancestor
64778769|NCT02828358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778770|NCT02828358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64778771|NCT02828358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64778772|NCT02828358|Alkylating Agents|alkylating agents|mesh-ancestor
64778773|NCT02828358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778774|NCT02828358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778775|NCT02828358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64778776|NCT02828358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64778777|NCT02828358|Antiemetics|antiemetics|mesh-ancestor
64778778|NCT02828358|Autonomic Agents|autonomic agents|mesh-ancestor
64778779|NCT02828358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778780|NCT02828358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64778781|NCT02828358|Glucocorticoids|glucocorticoids|mesh-ancestor
64778782|NCT02828358|Hormones|hormones|mesh-ancestor
64778783|NCT02828358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64778784|NCT02828358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64778785|NCT02828358|Protease Inhibitors|protease inhibitors|mesh-ancestor
64778786|NCT02828358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64778787|NCT02828358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64778788|NCT02828358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64778789|NCT02828358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64778813|NCT02768532|Vedolizumab|vedolizumab|mesh-list
64778814|NCT02768532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64778815|NCT02756364|Fulvestrant|fulvestrant|mesh-list
64778816|NCT02756364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64778817|NCT02756364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849717|NCT03961360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849718|NCT03961360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64849719|NCT03961360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64849720|NCT03961360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64849721|NCT03961360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64849722|NCT03961360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778818|NCT02756364|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64778819|NCT02756364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64778820|NCT02756364|Hormone Antagonists|hormone antagonists|mesh-ancestor
64778821|NCT02756364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64778822|NCT02756364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778823|NCT02519322|Nivolumab|nivolumab|mesh-list
64778824|NCT02519322|Ipilimumab|ipilimumab|mesh-list
64778825|NCT02519322|Immunoglobulins|immunoglobulins|mesh-list
64778826|NCT02519322|Immunoglobulin G|immunoglobulin g|mesh-list
64778827|NCT02519322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64778828|NCT02519322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778829|NCT02519322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64778830|NCT02519322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778831|NCT02519322|Immunologic Factors|immunologic factors|mesh-ancestor
64778832|NCT02519322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778833|NCT02460042|Paclitaxel|paclitaxel|mesh-list
64778834|NCT02460042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64778835|NCT02460042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778836|NCT02460042|Tubulin Modulators|tubulin modulators|mesh-ancestor
64849723|NCT03961360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64849724|NCT03961360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64849725|NCT03961360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849726|NCT03961360|Antipyretics|antipyretics|mesh-ancestor
64849727|NCT03924401|Abatacept|abatacept|mesh-list
64849728|NCT03924401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64331661|NCT05092360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64331663|NCT05065801|Folfirinox|folfirinox|mesh-list
64331664|NCT05065801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331665|NCT05045066|Vitamin D|vitamin d|mesh-list
64331666|NCT05045066|Cholecalciferol|cholecalciferol|mesh-list
64331667|NCT05045066|Vitamins|vitamins|mesh-ancestor
64331668|NCT05045066|Micronutrients|micronutrients|mesh-ancestor
64331669|NCT05045066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331670|NCT05045066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64331671|NCT05045066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64331672|NCT04979442|Trabectedin|trabectedin|mesh-list
64331673|NCT04979442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64331674|NCT04979442|Alkylating Agents|alkylating agents|mesh-ancestor
64849729|NCT03924401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849730|NCT03924401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303295|NCT02252809|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64303297|NCT02252809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64303298|NCT02252809|Antiemetics|antiemetics|mesh-ancestor
64303299|NCT02252809|Autonomic Agents|autonomic agents|mesh-ancestor
64303300|NCT02252809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303301|NCT02252809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303302|NCT02252809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64303303|NCT02252809|Glucocorticoids|glucocorticoids|mesh-ancestor
64303305|NCT02252809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64778837|NCT02460042|Antimitotic Agents|antimitotic agents|mesh-ancestor
64778838|NCT02460042|Mitosis Modulators|mitosis modulators|mesh-ancestor
64778839|NCT02460042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778841|NCT02272842|Hydroxocobalamin|hydroxocobalamin|mesh-list
64778842|NCT02272842|Vitamins|vitamins|mesh-ancestor
64778843|NCT02272842|Micronutrients|micronutrients|mesh-ancestor
64778844|NCT02272842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778845|NCT02272842|Vitamin B Complex|vitamin b complex|mesh-ancestor
64778846|NCT02272842|Hematinics|hematinics|mesh-ancestor
64778847|NCT01955460|Aldesleukin|aldesleukin|mesh-list
64778848|NCT01955460|Cyclophosphamide|cyclophosphamide|mesh-list
64778849|NCT01955460|Fludarabine|fludarabine|mesh-list
64849731|NCT03924401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64849732|NCT03924401|Immunologic Factors|immunologic factors|mesh-ancestor
64849733|NCT03924401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849734|NCT03924401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64849739|NCT03769285|Niacinamide|niacinamide|mesh-list
64849741|NCT03769285|Nicotinic Acids|nicotinic acids|mesh-list
64849742|NCT03769285|Vitamin B Complex|vitamin b complex|mesh-ancestor
64849743|NCT03769285|Vitamins|vitamins|mesh-ancestor
64849744|NCT03769285|Micronutrients|micronutrients|mesh-ancestor
64849745|NCT03769285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849746|NCT03769285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64849747|NCT03769285|Antimetabolites|antimetabolites|mesh-ancestor
64331675|NCT04979442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331676|NCT04979442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331678|NCT04971785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331679|NCT04971785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849748|NCT03769285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849749|NCT03769285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64849750|NCT03769285|Vasodilator Agents|vasodilator agents|mesh-ancestor
64778850|NCT01955460|Fludarabine phosphate|fludarabine phosphate|mesh-list
64778851|NCT01955460|Interleukin-2|interleukin-2|mesh-list
64778852|NCT01955460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64778853|NCT01955460|Immunologic Factors|immunologic factors|mesh-ancestor
64778854|NCT01955460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778855|NCT01955460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64778856|NCT01955460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64778857|NCT01955460|Alkylating Agents|alkylating agents|mesh-ancestor
64778858|NCT01955460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778859|NCT01955460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778860|NCT01955460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64778861|NCT01955460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64778862|NCT01955460|Antimetabolites|antimetabolites|mesh-ancestor
64778863|NCT01955460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64778864|NCT01955460|Analgesics|analgesics|mesh-ancestor
64778865|NCT01955460|Sensory System Agents|sensory system agents|mesh-ancestor
64778866|NCT01955460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778867|NCT01955460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64778868|NCT01955460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64778869|NCT01955460|Antiviral Agents|antiviral agents|mesh-ancestor
64849752|NCT03749187|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64849753|NCT03749187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64778870|NCT01955460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64778871|NCT01869114|Sirolimus|sirolimus|mesh-list
64778872|NCT01869114|Azacitidine|azacitidine|mesh-list
64778873|NCT01869114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64849754|NCT03749187|Alkylating Agents|alkylating agents|mesh-ancestor
64849755|NCT03749187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849756|NCT03749187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849757|NCT03749187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849758|NCT03748641|Prednisone|prednisone|mesh-list
64849759|NCT03748641|Abiraterone Acetate|abiraterone acetate|mesh-list
64849760|NCT03748641|Niraparib|niraparib|mesh-list
64849761|NCT03748641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64849762|NCT03748641|Glucocorticoids|glucocorticoids|mesh-ancestor
64849763|NCT03748641|Hormones|hormones|mesh-ancestor
64849764|NCT03748641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64849765|NCT03748641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849766|NCT03748641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64849767|NCT03748641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849768|NCT03748641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64849769|NCT03748641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64778874|NCT01869114|Antimetabolites|antimetabolites|mesh-ancestor
64778875|NCT01869114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778876|NCT01869114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778877|NCT01869114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64778878|NCT01869114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64778879|NCT01869114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64778880|NCT01869114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64778881|NCT01869114|Antifungal Agents|antifungal agents|mesh-ancestor
64778889|NCT05722782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64778890|NCT05722782|Analgesics|analgesics|mesh-ancestor
64778891|NCT05722782|Sensory System Agents|sensory system agents|mesh-ancestor
64778892|NCT05722782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778893|NCT05722782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778894|NCT05722782|Antipyretics|antipyretics|mesh-ancestor
64778895|NCT05722782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64778896|NCT05722782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64778897|NCT05722782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64778898|NCT05722782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64778899|NCT05722782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64778900|NCT05722782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778901|NCT05722548|Indomethacin|indomethacin|mesh-list
64778902|NCT05722548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64778903|NCT05722548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64778904|NCT05722548|Analgesics|analgesics|mesh-ancestor
64849770|NCT03748641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849771|NCT03748641|Hormone Antagonists|hormone antagonists|mesh-ancestor
64849772|NCT03748641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64849773|NCT03748641|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64849774|NCT03738553|Trastuzumab|trastuzumab|mesh-list
64849775|NCT03738553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64849776|NCT03738553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849777|NCT03710902|Antihypertensive Agents|antihypertensive agents|mesh-list
64849778|NCT03642132|Bevacizumab|bevacizumab|mesh-list
64849779|NCT03642132|Avelumab|avelumab|mesh-list
64849780|NCT03642132|Talazoparib|talazoparib|mesh-list
64849781|NCT03642132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64849782|NCT03642132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849783|NCT03642132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64849784|NCT03642132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64849785|NCT03642132|Growth Substances|growth substances|mesh-ancestor
64331680|NCT04969133|Levobupivacaine|levobupivacaine|mesh-list
64331681|NCT04969133|Anesthetics, Local|anesthetics, local|mesh-ancestor
64331682|NCT04969133|Anesthetics|anesthetics|mesh-ancestor
64331683|NCT04969133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64294866|NCT04812002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64778905|NCT05722548|Sensory System Agents|sensory system agents|mesh-ancestor
64778906|NCT05722548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778907|NCT05722548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778908|NCT05722548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64778909|NCT05722548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64303307|NCT02252809|Protective Agents|protective agents|mesh-ancestor
64303308|NCT02252809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64303309|NCT02252809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303310|NCT02252809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64303311|NCT02137525|Fentanyl|fentanyl|mesh-list
64778910|NCT05722548|Gout Suppressants|gout suppressants|mesh-ancestor
64778911|NCT05722548|Tocolytic Agents|tocolytic agents|mesh-ancestor
64778912|NCT05722548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64778913|NCT05722548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64778921|NCT05722002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778924|NCT05721846|Ipilimumab|ipilimumab|mesh-list
64778925|NCT05721846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64778926|NCT05721846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778927|NCT05721846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64390331|NCT02019472|Adalimumab|adalimumab|mesh-list
64390332|NCT02019472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64390333|NCT02019472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64849786|NCT03642132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849788|NCT03642132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64849789|NCT03642132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849790|NCT03642132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849791|NCT03635983|Nivolumab|nivolumab|mesh-list
64849792|NCT03635983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64849793|NCT03635983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849794|NCT03635983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64849795|NCT03635983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849796|NCT03632330|Midazolam|midazolam|mesh-list
64849797|NCT03632330|Dexmedetomidine|dexmedetomidine|mesh-list
64849798|NCT03632330|Propofol|propofol|mesh-list
64390334|NCT02019472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64390335|NCT02019472|Immunologic Factors|immunologic factors|mesh-ancestor
64390336|NCT02019472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390337|NCT00157937|Theophylline|theophylline|mesh-list
64390338|NCT00157937|Montelukast|montelukast|mesh-list
64390339|NCT00157937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64390340|NCT00157937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390341|NCT00157937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390342|NCT00157937|Autonomic Agents|autonomic agents|mesh-ancestor
64390343|NCT00157937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64849827|NCT03575949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64849828|NCT03572764|Cytarabine|cytarabine|mesh-list
64849829|NCT03572764|Daunorubicin|daunorubicin|mesh-list
64849830|NCT03572764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64849831|NCT03572764|Antimetabolites|antimetabolites|mesh-ancestor
64849832|NCT03572764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849833|NCT03572764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849834|NCT03572764|Antiviral Agents|antiviral agents|mesh-ancestor
64849835|NCT03572764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64849836|NCT03572764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64849837|NCT03572764|Immunologic Factors|immunologic factors|mesh-ancestor
64849838|NCT03572764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849839|NCT03572764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64849840|NCT03572764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64849841|NCT03572764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64849842|NCT03572764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849843|NCT03560752|Vaccines|vaccines|mesh-list
64618341|NCT03022253|Ibuprofen|ibuprofen|mesh-list
64849844|NCT03560752|Immunologic Factors|immunologic factors|mesh-ancestor
64849845|NCT03560752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849848|NCT03506061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64849849|NCT03506061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64849850|NCT03506061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778928|NCT05721846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778929|NCT05721456|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64778930|NCT05721456|Immunologic Factors|immunologic factors|mesh-ancestor
64778931|NCT05721456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778932|NCT05721300|Interferons|interferons|mesh-list
64778933|NCT05721300|Tenofovir|tenofovir|mesh-list
64778934|NCT05721300|Entecavir|entecavir|mesh-list
64778935|NCT05721300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849870|NCT03466151|Antifungal Agents|antifungal agents|mesh-ancestor
64849871|NCT03466151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64849872|NCT03466151|Immunologic Factors|immunologic factors|mesh-ancestor
64849873|NCT03466151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849874|NCT03452930|Benzimidazole|benzimidazole|mesh-list
64849875|NCT03452930|Anthelmintics|anthelmintics|mesh-ancestor
64849876|NCT03452930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64849877|NCT03452930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64849878|NCT03445845|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
64849879|NCT03445845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64849880|NCT03418818|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
64778936|NCT05721300|Antiviral Agents|antiviral agents|mesh-ancestor
64778937|NCT05721300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64778938|NCT05721300|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64778939|NCT05721300|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64778940|NCT05721300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64778941|NCT05721300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778942|NCT05721300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64778943|NCT05721300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64778944|NCT05720442|Mosapride|mosapride|mesh-list
64778945|NCT05720442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778946|NCT05720442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64778947|NCT05720442|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64778948|NCT05720442|Serotonin Agents|serotonin agents|mesh-ancestor
64331697|NCT04919629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64778949|NCT05720442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64331698|NCT04919629|Pembrolizumab|pembrolizumab|mesh-list
64331699|NCT04919629|Endothelial Growth Factors|endothelial growth factors|mesh-list
64331700|NCT04919629|Antibodies|antibodies|mesh-list
64331701|NCT04919629|Immunoglobulins|immunoglobulins|mesh-list
64331702|NCT04919629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64331703|NCT04919629|Immunoglobulin G|immunoglobulin g|mesh-list
64849881|NCT03418818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64849882|NCT03418818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849884|NCT03331341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64849885|NCT03331341|Pembrolizumab|pembrolizumab|mesh-list
64849886|NCT03331341|Dacarbazine|dacarbazine|mesh-list
64849887|NCT03331341|Vinblastine|vinblastine|mesh-list
64849888|NCT03331341|Imidazole|imidazole|mesh-list
64849889|NCT03331341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64849890|NCT03331341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849891|NCT03331341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64849892|NCT03331341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64849893|NCT03331341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849894|NCT03331341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849895|NCT03331341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64849896|NCT03331341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64849897|NCT03331341|Alkylating Agents|alkylating agents|mesh-ancestor
64849898|NCT03331341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64849899|NCT03331341|Tubulin Modulators|tubulin modulators|mesh-ancestor
64849900|NCT03331341|Antimitotic Agents|antimitotic agents|mesh-ancestor
64849901|NCT03331341|Mitosis Modulators|mitosis modulators|mesh-ancestor
64849902|NCT03253289|Meclizine|meclizine|mesh-list
64331704|NCT04919629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778950|NCT05720442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778951|NCT05719818|Diphosphonates|diphosphonates|mesh-list
64303313|NCT02137525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64303314|NCT02137525|Narcotics|narcotics|mesh-ancestor
64303315|NCT02137525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64303316|NCT02137525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303317|NCT02137525|Analgesics|analgesics|mesh-ancestor
64303318|NCT02137525|Sensory System Agents|sensory system agents|mesh-ancestor
64303319|NCT02137525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303324|NCT02137681|Rituximab|rituximab|mesh-list
64778956|NCT05719506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64778957|NCT05719506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64778958|NCT05719506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778959|NCT05719506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64778960|NCT05719506|Analgesics|analgesics|mesh-ancestor
64778961|NCT05719506|Sensory System Agents|sensory system agents|mesh-ancestor
64778962|NCT05719506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64778963|NCT05719506|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64778964|NCT05719506|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64778965|NCT05719506|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64778966|NCT05719506|Adrenergic Agents|adrenergic agents|mesh-ancestor
64778967|NCT05719506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64778968|NCT05719506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778969|NCT05719506|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64778970|NCT05719506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64778971|NCT05719506|Anesthetics, General|anesthetics, general|mesh-ancestor
64778972|NCT05719506|Anesthetics|anesthetics|mesh-ancestor
64778973|NCT05719506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64778974|NCT05719506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64849903|NCT03253289|Antiemetics|antiemetics|mesh-ancestor
64849904|NCT03253289|Autonomic Agents|autonomic agents|mesh-ancestor
64849905|NCT03253289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64849906|NCT03253289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849907|NCT03253289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64849908|NCT03253289|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64849909|NCT03253289|Histamine Antagonists|histamine antagonists|mesh-ancestor
64849910|NCT03253289|Histamine Agents|histamine agents|mesh-ancestor
64849911|NCT03253289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64849912|NCT03253289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849913|NCT03253289|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64849914|NCT03227705|Progesterone|progesterone|mesh-list
64849915|NCT03227705|Progestins|progestins|mesh-ancestor
64849917|NCT03227705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64849918|NCT03227705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849919|NCT03219268|Margetuximab|margetuximab|mesh-list
64849920|NCT03219268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849921|NCT03188432|Carboplatin|carboplatin|mesh-list
64778975|NCT05717166|Hormones|hormones|mesh-list
64778976|NCT05717166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64390368|NCT03139331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64390369|NCT03139331|Alkylating Agents|alkylating agents|mesh-ancestor
64390370|NCT04423601|Itraconazole|itraconazole|mesh-list
64390371|NCT04423601|Antifungal Agents|antifungal agents|mesh-ancestor
64390375|NCT04423601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64778977|NCT05717166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778978|NCT05716932|Ranibizumab|ranibizumab|mesh-list
64778979|NCT05716932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64778980|NCT05716932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64778981|NCT05716932|Growth Substances|growth substances|mesh-ancestor
64778982|NCT05716932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64778983|NCT05716932|Growth Inhibitors|growth inhibitors|mesh-ancestor
64778984|NCT05716932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778985|NCT05716854|Moxifloxacin|moxifloxacin|mesh-list
64778986|NCT05716854|Clarithromycin|clarithromycin|mesh-list
64778987|NCT05716854|Cobicistat|cobicistat|mesh-list
64778988|NCT05716854|Pimozide|pimozide|mesh-list
64778989|NCT05716854|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64778990|NCT05716854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64778991|NCT05716854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64778992|NCT05716854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64778993|NCT05716854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64778994|NCT05716854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64778995|NCT05716854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64778996|NCT05716854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64778997|NCT05716854|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64778998|NCT05716854|Contraceptive Agents|contraceptive agents|mesh-ancestor
64390391|NCT05022563|Protease Inhibitors|protease inhibitors|mesh-ancestor
64390392|NCT05022563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64360166|NCT04481451|Anesthetics, Local|anesthetics, local|mesh-ancestor
64303333|NCT02842073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64390393|NCT05022563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390395|NCT04983095|Androgens|androgens|mesh-list
64390396|NCT04983095|Hormone Antagonists|hormone antagonists|mesh-list
64390397|NCT04983095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64778999|NCT05716854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64779000|NCT05716854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779001|NCT05716854|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64779002|NCT05716854|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64779003|NCT05716854|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64779004|NCT05716854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64849923|NCT03176953|Topiramate|topiramate|mesh-list
64849924|NCT03176953|Anticonvulsants|anticonvulsants|mesh-ancestor
64849925|NCT03176953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64849926|NCT03176953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849927|NCT03172975|Albendazole|albendazole|mesh-list
64849928|NCT03172975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64849929|NCT03172975|Anthelmintics|anthelmintics|mesh-ancestor
64849930|NCT03172975|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64849931|NCT03172975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64849932|NCT03172975|Anticestodal Agents|anticestodal agents|mesh-ancestor
64849933|NCT03172975|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64849934|NCT03172975|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64849935|NCT03172975|Tubulin Modulators|tubulin modulators|mesh-ancestor
64331708|NCT04919629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294899|NCT02472249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294900|NCT02472249|Sympathomimetics|sympathomimetics|mesh-ancestor
64779005|NCT05716854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64779006|NCT05716854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64779007|NCT05716854|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64779008|NCT05716854|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64779009|NCT05716854|Antiviral Agents|antiviral agents|mesh-ancestor
64779010|NCT05716854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64779011|NCT05716854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64779012|NCT05716854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64779013|NCT05716854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64779014|NCT05716854|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64779015|NCT05716854|Dopamine Agents|dopamine agents|mesh-ancestor
64779016|NCT05716854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64779017|NCT05716854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64779019|NCT05715840|Bevacizumab|bevacizumab|mesh-list
64779020|NCT05715840|Carboplatin|carboplatin|mesh-list
64779021|NCT05715840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64779022|NCT05715840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779023|NCT05715840|Tubulin Modulators|tubulin modulators|mesh-ancestor
64779024|NCT05715840|Antimitotic Agents|antimitotic agents|mesh-ancestor
64779025|NCT05715840|Mitosis Modulators|mitosis modulators|mesh-ancestor
64331709|NCT04919629|Growth Inhibitors|growth inhibitors|mesh-ancestor
64331710|NCT04919629|Immunologic Factors|immunologic factors|mesh-ancestor
64331711|NCT04910061|Niacinamide|niacinamide|mesh-list
64331713|NCT04910061|Nicotinic Acids|nicotinic acids|mesh-list
64331714|NCT04910061|Vitamin B Complex|vitamin b complex|mesh-ancestor
64331715|NCT04910061|Vitamins|vitamins|mesh-ancestor
64849936|NCT03172975|Antimitotic Agents|antimitotic agents|mesh-ancestor
64849937|NCT03172975|Mitosis Modulators|mitosis modulators|mesh-ancestor
64849938|NCT03172975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849939|NCT03172975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849940|NCT03172975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64849941|NCT03172975|Immunologic Factors|immunologic factors|mesh-ancestor
64849942|NCT03172975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849943|NCT03172975|Antacids|antacids|mesh-ancestor
64849944|NCT03172975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64849945|NCT03151811|Dexamethasone|dexamethasone|mesh-list
64849946|NCT03151811|Dexamethasone acetate|dexamethasone acetate|mesh-list
64849947|NCT03151811|Melphalan|melphalan|mesh-list
64849948|NCT03151811|Pomalidomide|pomalidomide|mesh-list
64849949|NCT03151811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64849950|NCT03151811|Antiemetics|antiemetics|mesh-ancestor
64849951|NCT03151811|Autonomic Agents|autonomic agents|mesh-ancestor
64849952|NCT03151811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64849953|NCT03151811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849954|NCT03151811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64849955|NCT03151811|Glucocorticoids|glucocorticoids|mesh-ancestor
64849956|NCT03151811|Hormones|hormones|mesh-ancestor
64849957|NCT03151811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64390412|NCT05083793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390413|NCT05083793|Anticonvulsants|anticonvulsants|mesh-ancestor
64390414|NCT05083793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64390415|NCT05083793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64390416|NCT05083793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390417|NCT05083793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64390418|NCT05083793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64779026|NCT05715840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779027|NCT05715840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64779028|NCT05715840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64779029|NCT05715840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64779031|NCT05715840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779032|NCT05715840|Growth Inhibitors|growth inhibitors|mesh-ancestor
64779033|NCT05713734|Thrombin|thrombin|mesh-list
64303334|NCT02842073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303335|NCT02842073|Sensory System Agents|sensory system agents|mesh-ancestor
64303336|NCT02842073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303337|NCT02842073|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64303338|NCT02842073|Antidepressive Agents|antidepressive agents|mesh-ancestor
64303339|NCT02842073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64779035|NCT05713734|Coagulants|coagulants|mesh-ancestor
64779036|NCT05698758|Dexmedetomidine|dexmedetomidine|mesh-list
64779037|NCT05698758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64779038|NCT05698758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64779039|NCT05698758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779040|NCT05698758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64779041|NCT05698758|Analgesics|analgesics|mesh-ancestor
64331716|NCT04910061|Micronutrients|micronutrients|mesh-ancestor
64331717|NCT04910061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849958|NCT03151811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64849960|NCT03151811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64849961|NCT03151811|Alkylating Agents|alkylating agents|mesh-ancestor
64849962|NCT03151811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849963|NCT03151811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64849964|NCT03151811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64849965|NCT03151811|Immunologic Factors|immunologic factors|mesh-ancestor
64849966|NCT03151811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64849967|NCT03151811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64849968|NCT03151811|Growth Substances|growth substances|mesh-ancestor
64849969|NCT03151811|Growth Inhibitors|growth inhibitors|mesh-ancestor
64849970|NCT03150004|Cytarabine|cytarabine|mesh-list
64849971|NCT03150004|Mitoxantrone|mitoxantrone|mesh-list
64849972|NCT03150004|Cladribine|cladribine|mesh-list
64779042|NCT05698758|Sensory System Agents|sensory system agents|mesh-ancestor
64779043|NCT05698758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64779044|NCT05698758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64779045|NCT05698758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64779046|NCT05698758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64779047|NCT05698758|Adrenergic Agents|adrenergic agents|mesh-ancestor
64779048|NCT05698758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64779049|NCT05698758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779050|NCT05683392|Insulin|insulin|mesh-list
64390438|NCT03223883|Sensory System Agents|sensory system agents|mesh-ancestor
64390439|NCT03223883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64390440|NCT03223883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390441|NCT03223883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64390442|NCT03223883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64849976|NCT03150004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849977|NCT03150004|Antiviral Agents|antiviral agents|mesh-ancestor
64849978|NCT03150004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64849979|NCT03150004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64849980|NCT03150004|Immunologic Factors|immunologic factors|mesh-ancestor
64849981|NCT03150004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849982|NCT03150004|Analgesics|analgesics|mesh-ancestor
64849983|NCT03150004|Sensory System Agents|sensory system agents|mesh-ancestor
64849984|NCT03150004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64849985|NCT03150004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64849986|NCT03150004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64849987|NCT03150004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849988|NCT03149822|Pembrolizumab|pembrolizumab|mesh-list
64849989|NCT03149822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64849990|NCT03149822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331735|NCT04892264|Antiemetics|antiemetics|mesh-ancestor
64331736|NCT04892264|Autonomic Agents|autonomic agents|mesh-ancestor
64331737|NCT04892264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64331738|NCT04892264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331739|NCT04892264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64331740|NCT04892264|Glucocorticoids|glucocorticoids|mesh-ancestor
64331741|NCT04892264|Hormones|hormones|mesh-ancestor
64331742|NCT04892264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64331743|NCT04892264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64331744|NCT04892264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331745|NCT04892264|Protease Inhibitors|protease inhibitors|mesh-ancestor
64390443|NCT03223883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390444|NCT03223883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779051|NCT05683392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64779052|NCT05683392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779053|NCT05676294|Olanzapine|olanzapine|mesh-list
64779054|NCT05676294|Antiemetics|antiemetics|mesh-ancestor
64779055|NCT05676294|Autonomic Agents|autonomic agents|mesh-ancestor
64850037|NCT03082534|Pembrolizumab|pembrolizumab|mesh-list
64779056|NCT05676294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64779057|NCT05676294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779058|NCT05676294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64779059|NCT05676294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64850038|NCT03082534|Cetuximab|cetuximab|mesh-list
64850039|NCT03082534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64850040|NCT03082534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850041|NCT03056339|Cyclophosphamide|cyclophosphamide|mesh-list
64850043|NCT03056339|Fludarabine phosphate|fludarabine phosphate|mesh-list
64850044|NCT03056339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64850045|NCT03056339|Immunologic Factors|immunologic factors|mesh-ancestor
64850046|NCT03056339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850047|NCT03056339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64850048|NCT03056339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64850049|NCT03056339|Alkylating Agents|alkylating agents|mesh-ancestor
64850050|NCT03056339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850051|NCT03056339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850052|NCT03056339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64850053|NCT03056339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64850054|NCT03056339|Antimetabolites|antimetabolites|mesh-ancestor
64850055|NCT02960230|Nivolumab|nivolumab|mesh-list
64779060|NCT05676294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64779061|NCT05676294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64779062|NCT05676294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64779063|NCT05676294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64779064|NCT05676294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64779065|NCT05676294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64779066|NCT05676294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779067|NCT05676294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64779068|NCT05676294|Serotonin Agents|serotonin agents|mesh-ancestor
64779069|NCT05665062|Cyclophosphamide|cyclophosphamide|mesh-list
64779070|NCT05665062|Fludarabine|fludarabine|mesh-list
64779071|NCT05665062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64303355|NCT02135887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303356|NCT02135887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64303357|NCT02135887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779100|NCT05579730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64779101|NCT05579730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64779102|NCT05579730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64390489|NCT04065113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64390490|NCT04065113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390491|NCT03116737|Benzocaine|benzocaine|mesh-list
64390492|NCT03116737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64390493|NCT03116737|Anesthetics, Local|anesthetics, local|mesh-ancestor
64390494|NCT03116737|Anesthetics|anesthetics|mesh-ancestor
64390495|NCT03116737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64390496|NCT03116737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390497|NCT03116737|Sensory System Agents|sensory system agents|mesh-ancestor
64390498|NCT03116737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64390499|NCT03116659|Doxycycline|doxycycline|mesh-list
64390500|NCT03116659|Imiquimod|imiquimod|mesh-list
64779103|NCT05579730|Adrenergic Agents|adrenergic agents|mesh-ancestor
64779104|NCT05579730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64779105|NCT05579730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303358|NCT02135887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64303359|NCT02135887|Immunologic Factors|immunologic factors|mesh-ancestor
64331746|NCT04892264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331747|NCT04892264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331748|NCT04892264|Immunologic Factors|immunologic factors|mesh-ancestor
64331749|NCT04892264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64294956|NCT00071552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303360|NCT02135887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303361|NCT02135887|Antidotes|antidotes|mesh-ancestor
64303362|NCT02135887|Protective Agents|protective agents|mesh-ancestor
64303363|NCT02135887|Vitamin B Complex|vitamin b complex|mesh-ancestor
64303365|NCT02135887|Micronutrients|micronutrients|mesh-ancestor
64303366|NCT02135887|Hematinics|hematinics|mesh-ancestor
64303367|NCT02137759|Temozolomide|temozolomide|mesh-list
64303368|NCT02137759|Belinostat|belinostat|mesh-list
64779106|NCT05579730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850056|NCT02960230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64850057|NCT02960230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850058|NCT02960230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64850059|NCT02960230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850060|NCT02915198|Metformin|metformin|mesh-list
64850061|NCT02915198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64850062|NCT02915198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850063|NCT02816021|Pembrolizumab|pembrolizumab|mesh-list
64850064|NCT02816021|Azacitidine|azacitidine|mesh-list
64850065|NCT02816021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64850066|NCT02816021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850067|NCT02816021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64850068|NCT02816021|Antimetabolites|antimetabolites|mesh-ancestor
64850069|NCT02816021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850070|NCT02816021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850071|NCT02777385|Pembrolizumab|pembrolizumab|mesh-list
64850072|NCT02777385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618556|NCT01010009|Resveratrol|resveratrol|mesh-list
64850073|NCT02777385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64850074|NCT02744053|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
64850075|NCT02744053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64850077|NCT02701699|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
64850078|NCT02701699|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64850079|NCT02701699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850080|NCT02682511|Ifetroban|ifetroban|mesh-list
64850081|NCT02682511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64850082|NCT02584634|Avelumab|avelumab|mesh-list
64850083|NCT02584634|Crizotinib|crizotinib|mesh-list
64850084|NCT02584634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64850085|NCT02584634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779107|NCT05579730|Antipruritics|antipruritics|mesh-ancestor
64779108|NCT05579730|Dermatologic Agents|dermatologic agents|mesh-ancestor
64779109|NCT05579730|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64779110|NCT05579730|Histamine Antagonists|histamine antagonists|mesh-ancestor
64779111|NCT05579730|Histamine Agents|histamine agents|mesh-ancestor
64779112|NCT05579730|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64779113|NCT05570292|Folic Acid|folic acid|mesh-list
64779114|NCT05570292|Domperidone|domperidone|mesh-list
64779115|NCT05570292|Hematinics|hematinics|mesh-ancestor
64779116|NCT05570292|Vitamin B Complex|vitamin b complex|mesh-ancestor
64779117|NCT05570292|Vitamins|vitamins|mesh-ancestor
64779118|NCT05570292|Micronutrients|micronutrients|mesh-ancestor
64779119|NCT05570292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850086|NCT02584634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64850087|NCT02584634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850088|NCT02584634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850089|NCT02395666|Eflornithine|eflornithine|mesh-list
64850090|NCT02395666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850091|NCT02395666|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64331750|NCT04892264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64331751|NCT04892264|Growth Substances|growth substances|mesh-ancestor
64331752|NCT04892264|Growth Inhibitors|growth inhibitors|mesh-ancestor
64331753|NCT04892264|Dermatologic Agents|dermatologic agents|mesh-ancestor
64331756|NCT04887467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331757|NCT04887467|Autonomic Agents|autonomic agents|mesh-ancestor
64850093|NCT02395666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64850094|NCT02395666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64850095|NCT02395666|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64850096|NCT02395666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850097|NCT02395666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850098|NCT02351869|Midazolam|midazolam|mesh-list
64850099|NCT02351869|Nitrous Oxide|nitrous oxide|mesh-list
64850100|NCT02351869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64850101|NCT02351869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64850102|NCT02351869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64850103|NCT02351869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850104|NCT02351869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64850105|NCT02351869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64850106|NCT02351869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64850107|NCT02351869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64779120|NCT05570292|Antiemetics|antiemetics|mesh-ancestor
64779121|NCT05570292|Autonomic Agents|autonomic agents|mesh-ancestor
64779122|NCT05570292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64779123|NCT05570292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64779124|NCT05570292|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64390516|NCT02425813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64390517|NCT02425813|Prednisolone|prednisolone|mesh-list
64390518|NCT02425813|Prednisolone acetate|prednisolone acetate|mesh-list
64390519|NCT02425813|Budesonide|budesonide|mesh-list
64331758|NCT04887467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64331759|NCT04887467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64331760|NCT04887467|Dopamine Agonists|dopamine agonists|mesh-ancestor
64850108|NCT02351869|Anesthetics, General|anesthetics, general|mesh-ancestor
64850110|NCT02351869|GABA Modulators|gaba modulators|mesh-ancestor
64850111|NCT02351869|GABA Agents|gaba agents|mesh-ancestor
64850112|NCT02351869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64850113|NCT02351869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850114|NCT02351869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64850115|NCT02351869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64850116|NCT02351869|Analgesics|analgesics|mesh-ancestor
64850117|NCT02351869|Sensory System Agents|sensory system agents|mesh-ancestor
64850118|NCT02351869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64850119|NCT02311582|Pembrolizumab|pembrolizumab|mesh-list
64850120|NCT02311582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64390520|NCT02425813|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64390521|NCT02425813|Prednisolone phosphate|prednisolone phosphate|mesh-list
64390522|NCT02425813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64390523|NCT02425813|Antiemetics|antiemetics|mesh-ancestor
64390524|NCT02425813|Autonomic Agents|autonomic agents|mesh-ancestor
64390525|NCT02425813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64390526|NCT02425813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390528|NCT02425813|Glucocorticoids|glucocorticoids|mesh-ancestor
64779125|NCT05570292|Dopamine Agents|dopamine agents|mesh-ancestor
64779126|NCT05570292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64779127|NCT05570292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779128|NCT05558982|Pembrolizumab|pembrolizumab|mesh-list
64779129|NCT05558982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64779130|NCT05558982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779131|NCT05557812|Eugenol|eugenol|mesh-list
64779132|NCT05557812|Zinc Oxide|zinc oxide|mesh-list
64779133|NCT05557812|Ferric Compounds|ferric compounds|mesh-list
64779134|NCT05557812|Dermatologic Agents|dermatologic agents|mesh-ancestor
64850121|NCT02311582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850122|NCT02237820|Dexamethasone|dexamethasone|mesh-list
64850123|NCT02237820|Prednisone|prednisone|mesh-list
64850124|NCT02237820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64850125|NCT02237820|Antiemetics|antiemetics|mesh-ancestor
64850126|NCT02237820|Autonomic Agents|autonomic agents|mesh-ancestor
64850127|NCT02237820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64850128|NCT02237820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850129|NCT02237820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64850130|NCT02237820|Glucocorticoids|glucocorticoids|mesh-ancestor
64850131|NCT02237820|Hormones|hormones|mesh-ancestor
64850132|NCT02237820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64850133|NCT02237820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64850134|NCT02237820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779135|NCT05557812|Sunscreening Agents|sunscreening agents|mesh-ancestor
64547843|NCT00088465|Olanzapine|olanzapine|mesh-list
64779136|NCT05557812|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64779137|NCT05557812|Protective Agents|protective agents|mesh-ancestor
64779138|NCT05557812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779139|NCT05557812|Hematinics|hematinics|mesh-ancestor
64779140|NCT05557812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64779141|NCT05549466|Gemcitabine|gemcitabine|mesh-list
64779142|NCT05549466|Capecitabine|capecitabine|mesh-list
64779143|NCT05549466|Docetaxel|docetaxel|mesh-list
64303369|NCT02137759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64303370|NCT02137759|Alkylating Agents|alkylating agents|mesh-ancestor
64303371|NCT02137759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303372|NCT02137759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303373|NCT02137759|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64331770|NCT04868409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303374|NCT02137759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303375|NCT02137993|Olanzapine|olanzapine|mesh-list
64303376|NCT02137993|Antiemetics|antiemetics|mesh-ancestor
64331771|NCT04868409|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
64331773|NCT04861064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64850253|NCT00217425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64850254|NCT00217425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64850255|NCT00217425|Alkylating Agents|alkylating agents|mesh-ancestor
64850256|NCT00217425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850257|NCT00217425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850258|NCT00217425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64850259|NCT00217425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64850260|NCT00217425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64850261|NCT00217425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64850262|NCT00217425|Growth Substances|growth substances|mesh-ancestor
64850263|NCT00217425|Growth Inhibitors|growth inhibitors|mesh-ancestor
64850264|NCT00217425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64850265|NCT00217425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64850266|NCT00217425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64850267|NCT00217425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331774|NCT04861064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64303377|NCT02137993|Autonomic Agents|autonomic agents|mesh-ancestor
64303378|NCT02137993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303379|NCT02137993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390540|NCT03106831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64390541|NCT03106831|Adrenergic Agents|adrenergic agents|mesh-ancestor
64390542|NCT03106831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64390543|NCT03106831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390544|NCT03106831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779150|NCT05549466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64779151|NCT05549466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779152|NCT05549466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64779153|NCT05549466|Immunologic Factors|immunologic factors|mesh-ancestor
64779154|NCT05549466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779155|NCT05549466|Tubulin Modulators|tubulin modulators|mesh-ancestor
64779156|NCT05549466|Antimitotic Agents|antimitotic agents|mesh-ancestor
64779157|NCT05549466|Mitosis Modulators|mitosis modulators|mesh-ancestor
64779158|NCT05549466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64779159|NCT05436678|Ciprofloxacin|ciprofloxacin|mesh-list
64779160|NCT05436678|Celecoxib|celecoxib|mesh-list
64779161|NCT05436678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64779162|NCT05436678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64779163|NCT05436678|Analgesics|analgesics|mesh-ancestor
64779164|NCT05436678|Sensory System Agents|sensory system agents|mesh-ancestor
64331775|NCT04861064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64331776|NCT04861064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331777|NCT04861064|Antifungal Agents|antifungal agents|mesh-ancestor
64331778|NCT04861064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64850268|NCT00217425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64850270|NCT00217425|Hormones|hormones|mesh-ancestor
64850271|NCT00217425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64850272|NCT00217425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64850273|NCT00217425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64850274|NCT00217425|Tubulin Modulators|tubulin modulators|mesh-ancestor
64850275|NCT00217425|Antimitotic Agents|antimitotic agents|mesh-ancestor
64850276|NCT00217425|Mitosis Modulators|mitosis modulators|mesh-ancestor
64294961|NCT00071552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64294962|NCT05164263|Empagliflozin|empagliflozin|mesh-list
64779165|NCT05436678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64779166|NCT05436678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779167|NCT05436678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64779180|NCT05425056|Sirolimus|sirolimus|mesh-list
64779206|NCT05352282|Sensory System Agents|sensory system agents|mesh-ancestor
64779207|NCT05352282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64779208|NCT05352282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64779209|NCT05352282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64779210|NCT05352282|Anesthetics, General|anesthetics, general|mesh-ancestor
64779211|NCT05352282|Anesthetics|anesthetics|mesh-ancestor
64547932|NCT00087685|Everolimus|everolimus|mesh-list
64779212|NCT05322330|Cyclophosphamide|cyclophosphamide|mesh-list
64779213|NCT05322330|Fludarabine|fludarabine|mesh-list
64779214|NCT05322330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64779215|NCT05322330|Immunologic Factors|immunologic factors|mesh-ancestor
64850277|NCT00188539|Anesthetics|anesthetics|mesh-list
64850278|NCT00188539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64850279|NCT00188539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850280|NCT03893448|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64850281|NCT03893448|Immunologic Factors|immunologic factors|mesh-ancestor
64850282|NCT03893448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850283|NCT03889314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64850284|NCT03889314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64850285|NCT03889314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64331779|NCT04861064|Immunologic Factors|immunologic factors|mesh-ancestor
64331780|NCT04861064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331781|NCT04846335|Doxycycline|doxycycline|mesh-list
64331782|NCT04846335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64850286|NCT03889314|Antimetabolites|antimetabolites|mesh-ancestor
64850287|NCT03889314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850288|NCT03889314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64850289|NCT03889314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64850290|NCT03889314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850291|NCT03870880|Risperidone|risperidone|mesh-list
64850292|NCT03870880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64850293|NCT03870880|Serotonin Agents|serotonin agents|mesh-ancestor
64850294|NCT03870880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64850295|NCT03870880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850296|NCT03870880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850297|NCT03870880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64850298|NCT03870880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64779216|NCT05322330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779217|NCT05322330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64303385|NCT02137993|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64779218|NCT05322330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64779219|NCT05322330|Alkylating Agents|alkylating agents|mesh-ancestor
64779220|NCT05322330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779221|NCT05322330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779222|NCT05322330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64779223|NCT05312892|Amlodipine|amlodipine|mesh-list
64779224|NCT05312892|Antihypertensive Agents|antihypertensive agents|mesh-list
64779225|NCT05312892|Moxonidine|moxonidine|mesh-list
64779226|NCT05312892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64779227|NCT05312892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64779228|NCT05312892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779229|NCT05312892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64779230|NCT05312892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390618|NCT02423863|Poly ICLC|poly iclc|mesh-list
64390619|NCT02423863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64390620|NCT02423863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390621|NCT02423863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64390622|NCT02423863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779257|NCT05278494|Dextromethorphan|dextromethorphan|mesh-list
64779258|NCT05278494|Antitussive Agents|antitussive agents|mesh-ancestor
64850300|NCT03870880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64850301|NCT03870880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64850302|NCT03870880|Dopamine Agents|dopamine agents|mesh-ancestor
64850303|NCT03861377|Remifentanil|remifentanil|mesh-list
64850304|NCT03861377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64850305|NCT03861377|Narcotics|narcotics|mesh-ancestor
64850306|NCT03861377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64850307|NCT03861377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850308|NCT03861377|Analgesics|analgesics|mesh-ancestor
64850309|NCT03861377|Sensory System Agents|sensory system agents|mesh-ancestor
64850310|NCT03861377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64850311|NCT03844100|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64850312|NCT03844100|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64850313|NCT03844100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64779259|NCT05278494|Respiratory System Agents|respiratory system agents|mesh-ancestor
64779260|NCT05278494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64779261|NCT05278494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64779262|NCT05278494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64390643|NCT02425579|Gasotransmitters|gasotransmitters|mesh-ancestor
64390644|NCT02425579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64390646|NCT03178591|Dapagliflozin|dapagliflozin|mesh-list
64779263|NCT05278494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850314|NCT03836144|Potassium Citrate|potassium citrate|mesh-list
64850315|NCT03836144|Diuretics|diuretics|mesh-ancestor
64850316|NCT03836144|Natriuretic Agents|natriuretic agents|mesh-ancestor
64331785|NCT04846335|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64331786|NCT04846335|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64331787|NCT04821310|Pantoprazole|pantoprazole|mesh-list
64331788|NCT04821310|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64331789|NCT04821310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64331790|NCT04821310|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64331791|NCT04821310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331792|NCT04821310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331793|NCT04817241|Cytarabine|cytarabine|mesh-list
64850317|NCT03836144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850318|NCT03836144|Expectorants|expectorants|mesh-ancestor
64850319|NCT03836144|Respiratory System Agents|respiratory system agents|mesh-ancestor
64850320|NCT03796416|Misoprostol|misoprostol|mesh-list
64850321|NCT03796416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64850322|NCT03796416|Abortifacient Agents|abortifacient agents|mesh-ancestor
64850323|NCT03796416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64850324|NCT03796416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850325|NCT03796416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64850326|NCT03796416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64850327|NCT03796416|Oxytocics|oxytocics|mesh-ancestor
64850328|NCT03785106|Vitamins|vitamins|mesh-list
64850329|NCT03785106|Pyridoxine|pyridoxine|mesh-list
64850330|NCT03785106|Pyridoxal|pyridoxal|mesh-list
64850331|NCT03785106|Vitamin B 6|vitamin b 6|mesh-list
64850332|NCT03785106|Vitamin B Complex|vitamin b complex|mesh-list
64850333|NCT03785106|Isoniazid|isoniazid|mesh-list
64850334|NCT03785106|Rifapentine|rifapentine|mesh-list
64850335|NCT03785106|Rifampin|rifampin|mesh-list
64850336|NCT03785106|Micronutrients|micronutrients|mesh-ancestor
64850337|NCT03785106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779264|NCT05278494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779266|NCT05251038|Gemcitabine|gemcitabine|mesh-list
64779267|NCT05251038|Paclitaxel|paclitaxel|mesh-list
64779268|NCT05251038|Fluorouracil|fluorouracil|mesh-list
64779269|NCT05251038|Irinotecan|irinotecan|mesh-list
64779270|NCT05251038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64779271|NCT05251038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779272|NCT05251038|Tubulin Modulators|tubulin modulators|mesh-ancestor
64779273|NCT05251038|Antimitotic Agents|antimitotic agents|mesh-ancestor
64779274|NCT05251038|Mitosis Modulators|mitosis modulators|mesh-ancestor
64779275|NCT05251038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779276|NCT05251038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64850345|NCT03785106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64303408|NCT02784535|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64303409|NCT02784535|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64303410|NCT02784535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64303411|NCT02784535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64303412|NCT02784535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303413|NCT02784535|Adrenergic Agents|adrenergic agents|mesh-ancestor
64303414|NCT02784535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64779282|NCT05251038|Immunologic Factors|immunologic factors|mesh-ancestor
64779283|NCT05251038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779284|NCT05251038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64779285|NCT05251038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64779286|NCT05251038|Antidotes|antidotes|mesh-ancestor
64779287|NCT05251038|Protective Agents|protective agents|mesh-ancestor
64779288|NCT05251038|Vitamin B Complex|vitamin b complex|mesh-ancestor
64779289|NCT05251038|Vitamins|vitamins|mesh-ancestor
64779291|NCT05217498|Istradefylline|istradefylline|mesh-list
64850406|NCT03760835|Glucocorticoids|glucocorticoids|mesh-list
64850407|NCT03760835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64850408|NCT03760835|Antiemetics|antiemetics|mesh-ancestor
64850409|NCT03760835|Autonomic Agents|autonomic agents|mesh-ancestor
64850410|NCT03760835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64850411|NCT03760835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850412|NCT03760835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64850413|NCT03760835|Hormones|hormones|mesh-ancestor
64850414|NCT03760835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64850415|NCT03760835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64850416|NCT03760835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850417|NCT03759496|Durvalumab|durvalumab|mesh-list
64850418|NCT03759496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64850419|NCT03759496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850420|NCT03759184|Obinutuzumab|obinutuzumab|mesh-list
64850421|NCT03759184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64850422|NCT03759184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850423|NCT03748784|Aflibercept|aflibercept|mesh-list
64850424|NCT03748784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64850425|NCT03748784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64850426|NCT03748784|Growth Substances|growth substances|mesh-ancestor
64850427|NCT03748784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850428|NCT03748784|Growth Inhibitors|growth inhibitors|mesh-ancestor
64850429|NCT03748784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779292|NCT05217498|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
64390676|NCT02016898|Mitomycins|mitomycins|mesh-list
64390677|NCT02016898|Mitomycin|mitomycin|mesh-list
64390678|NCT02016898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64390679|NCT02016898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390680|NCT02016898|Alkylating Agents|alkylating agents|mesh-ancestor
64390681|NCT02016898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850431|NCT03727750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64850432|NCT03727750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850433|NCT03724409|Octreotide|octreotide|mesh-list
64850434|NCT03724409|Edotreotide|edotreotide|mesh-list
64850435|NCT03724409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64850436|NCT03724409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64850437|NCT03724409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850438|NCT03724409|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64850439|NCT03724409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850440|NCT03715829|PF-06700841|pf-06700841|mesh-list
64850442|NCT03715829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64390682|NCT02016898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64779293|NCT05217498|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64779294|NCT05217498|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64850488|NCT03673826|Immunologic Factors|immunologic factors|mesh-ancestor
64779295|NCT05217498|Purinergic Agents|purinergic agents|mesh-ancestor
64779296|NCT05217498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64779297|NCT05217498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779298|NCT05217498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779299|NCT05206266|Turmeric extract|turmeric extract|mesh-list
64779300|NCT05206266|Antioxidants|antioxidants|mesh-ancestor
64850489|NCT03673826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64850490|NCT03673826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64850491|NCT03673826|Growth Substances|growth substances|mesh-ancestor
64850492|NCT03673826|Growth Inhibitors|growth inhibitors|mesh-ancestor
64850498|NCT03660839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64850499|NCT03660241|Abrocitinib|abrocitinib|mesh-list
64850500|NCT03660241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64850501|NCT03660241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850502|NCT03660241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850503|NCT03651102|Thalidomide|thalidomide|mesh-list
64850504|NCT03651102|Hydroxyurea|hydroxyurea|mesh-list
64850505|NCT03651102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64360698|NCT02504359|Antimitotic Agents|antimitotic agents|mesh-ancestor
64360700|NCT02504359|Glycine Agents|glycine agents|mesh-ancestor
64779301|NCT05206266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779303|NCT05206266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779304|NCT05205486|Cefazolin|cefazolin|mesh-list
64779305|NCT05205486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64779306|NCT05205486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64779307|NCT05150340|Immunoglobulins|immunoglobulins|mesh-list
64779308|NCT05150340|Immunologic Factors|immunologic factors|mesh-ancestor
64850538|NCT03643198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850541|NCT03606980|Dexamethasone|dexamethasone|mesh-list
64779309|NCT05150340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779310|NCT05091372|Lenalidomide|lenalidomide|mesh-list
64779311|NCT05091372|Immunologic Factors|immunologic factors|mesh-ancestor
64779312|NCT05091372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779313|NCT05091372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64779314|NCT05091372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64390706|NCT03193853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390707|NCT03193853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779315|NCT05091372|Growth Substances|growth substances|mesh-ancestor
64779316|NCT05091372|Growth Inhibitors|growth inhibitors|mesh-ancestor
64779317|NCT05091372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779318|NCT05027646|Granisetron|granisetron|mesh-list
64779319|NCT05027646|Antiemetics|antiemetics|mesh-ancestor
64779320|NCT05027646|Autonomic Agents|autonomic agents|mesh-ancestor
64779321|NCT05027646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303415|NCT02784535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303416|NCT03570281|Enoxaparin|enoxaparin|mesh-list
64303417|NCT03570281|Edoxaban|edoxaban|mesh-list
64850611|NCT03523520|Naltrexone|naltrexone|mesh-list
64850612|NCT03523520|Bromides|bromides|mesh-list
64331812|NCT04796220|Antimetabolites|antimetabolites|mesh-ancestor
64331813|NCT04796220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331814|NCT04796220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850614|NCT03523520|Naloxegol|naloxegol|mesh-list
64850615|NCT03523520|Anticonvulsants|anticonvulsants|mesh-ancestor
64850616|NCT03523520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64850617|NCT03523520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850618|NCT03523520|Sensory System Agents|sensory system agents|mesh-ancestor
64850619|NCT03523520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64850620|NCT03523520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64850621|NCT03518242|Cyclophosphamide|cyclophosphamide|mesh-list
64850622|NCT03518242|Capecitabine|capecitabine|mesh-list
64850623|NCT03518242|Methotrexate|methotrexate|mesh-list
64850624|NCT03518242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64850625|NCT03518242|Immunologic Factors|immunologic factors|mesh-ancestor
64294979|NCT02473809|Hormones|hormones|mesh-ancestor
64294980|NCT02473809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64303418|NCT03570281|Anticoagulants|anticoagulants|mesh-ancestor
64303419|NCT03570281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64303420|NCT03570281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64303421|NCT03570281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303422|NCT03570281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64303423|NCT03570281|Antithrombins|antithrombins|mesh-ancestor
64303424|NCT03570281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64303425|NCT03570281|Protease Inhibitors|protease inhibitors|mesh-ancestor
64303426|NCT03570281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850626|NCT03518242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850627|NCT03518242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64850628|NCT03518242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64850629|NCT03518242|Alkylating Agents|alkylating agents|mesh-ancestor
64850630|NCT03518242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850631|NCT03518242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850632|NCT03518242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64850633|NCT03518242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64850634|NCT03518242|Antimetabolites|antimetabolites|mesh-ancestor
64850635|NCT03518242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64850636|NCT03518242|Abortifacient Agents|abortifacient agents|mesh-ancestor
64850637|NCT03518242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64850638|NCT03518242|Dermatologic Agents|dermatologic agents|mesh-ancestor
64850639|NCT03518242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850640|NCT03518242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64850641|NCT03518242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64850642|NCT03500549|Eculizumab|eculizumab|mesh-list
64850643|NCT03500549|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64850644|NCT03500549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64850645|NCT03500549|Immunologic Factors|immunologic factors|mesh-ancestor
64850646|NCT03500549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850647|NCT03435185|Lidocaine|lidocaine|mesh-list
64850648|NCT03435185|Anesthetics, Local|anesthetics, local|mesh-ancestor
64850649|NCT03435185|Anesthetics|anesthetics|mesh-ancestor
64850650|NCT03435185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64850651|NCT03435185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850652|NCT03435185|Sensory System Agents|sensory system agents|mesh-ancestor
64303428|NCT02242799|Lumefantrine|lumefantrine|mesh-list
64303429|NCT02242799|Artemether|artemether|mesh-list
64303430|NCT02242799|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64303431|NCT02242799|Amodiaquine|amodiaquine|mesh-list
64303432|NCT02242799|Dolutegravir|dolutegravir|mesh-list
64303433|NCT02242799|Antimalarials|antimalarials|mesh-ancestor
64303434|NCT02242799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64303435|NCT02242799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64303436|NCT02242799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64303437|NCT02242799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303438|NCT02242799|Antiviral Agents|antiviral agents|mesh-ancestor
64850653|NCT03435185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64850654|NCT03435185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64850655|NCT03435185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64850656|NCT03435185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64850657|NCT03435185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64850658|NCT03435185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850660|NCT03426293|Anticoagulants|anticoagulants|mesh-ancestor
64850661|NCT03426293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64850662|NCT03426293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64850663|NCT03426293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303439|NCT02242799|Schistosomicides|schistosomicides|mesh-ancestor
64779322|NCT05027646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779323|NCT05027646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64779324|NCT05027646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64779325|NCT05027646|Serotonin Agents|serotonin agents|mesh-ancestor
64779326|NCT05027646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64779327|NCT05027646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779328|NCT05005728|Carboplatin|carboplatin|mesh-list
64779329|NCT05005728|Docetaxel|docetaxel|mesh-list
64779330|NCT05005728|Olaparib|olaparib|mesh-list
64779331|NCT05005728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779332|NCT05005728|Tubulin Modulators|tubulin modulators|mesh-ancestor
64779333|NCT05005728|Antimitotic Agents|antimitotic agents|mesh-ancestor
64779334|NCT05005728|Mitosis Modulators|mitosis modulators|mesh-ancestor
64850707|NCT03234686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850708|NCT03223974|Paclitaxel|paclitaxel|mesh-list
64779335|NCT05005728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779336|NCT05005728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64779337|NCT05005728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779338|NCT04988646|Acyclovir|acyclovir|mesh-list
64779339|NCT04988646|Antiviral Agents|antiviral agents|mesh-ancestor
64779340|NCT04988646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64779341|NCT04972110|Olaparib|olaparib|mesh-list
64779342|NCT04972110|Niraparib|niraparib|mesh-list
64850784|NCT05437432|Antimanic Agents|antimanic agents|mesh-ancestor
64850785|NCT05437432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64850786|NCT05437432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64850787|NCT05437224|Ambrisentan|ambrisentan|mesh-list
64850788|NCT05437224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64850789|NCT05436990|Pembrolizumab|pembrolizumab|mesh-list
64850790|NCT05436990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64850791|NCT05436990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850792|NCT05436964|Dexmedetomidine|dexmedetomidine|mesh-list
64850793|NCT05436964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64850794|NCT05436964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64850797|NCT05436964|Analgesics|analgesics|mesh-ancestor
64850801|NCT05436964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64850803|NCT05436964|Adrenergic Agents|adrenergic agents|mesh-ancestor
64850804|NCT05436964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64850805|NCT05436964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850806|NCT05426811|Raltitrexed|raltitrexed|mesh-list
64850807|NCT05426811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64850808|NCT05426811|Antimetabolites|antimetabolites|mesh-ancestor
64850809|NCT05426811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779343|NCT04972110|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64779344|NCT04972110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779346|NCT04972110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303446|NCT02242799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64303447|NCT02242799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64303448|NCT02138383|Gemcitabine|gemcitabine|mesh-list
64303449|NCT02138383|Paclitaxel|paclitaxel|mesh-list
64303450|NCT02138383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64303451|NCT02138383|Androgens|androgens|mesh-list
64303452|NCT02138383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64303453|NCT02138383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303458|NCT02138383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64303460|NCT02138383|Antiviral Agents|antiviral agents|mesh-ancestor
64303461|NCT02138383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64303462|NCT02138383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850837|NCT05006079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64850838|NCT05006079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850839|NCT05006079|Analgesics|analgesics|mesh-ancestor
64850840|NCT05006079|Sensory System Agents|sensory system agents|mesh-ancestor
64850841|NCT05006079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64850842|NCT05006079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64850843|NCT05006079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64850844|NCT05006079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64850845|NCT05006079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64850846|NCT05006079|GABA Modulators|gaba modulators|mesh-ancestor
64850847|NCT05006079|GABA Agents|gaba agents|mesh-ancestor
64850855|NCT04970381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850856|NCT04970381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850857|NCT04970381|Anticoagulants|anticoagulants|mesh-ancestor
64850858|NCT04950270|Arginine Vasopressin|arginine vasopressin|mesh-list
64850859|NCT04950270|Hemostatics|hemostatics|mesh-ancestor
64850860|NCT04950270|Coagulants|coagulants|mesh-ancestor
64850865|NCT04895046|Niraparib|niraparib|mesh-list
64303463|NCT02138383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64303464|NCT02138383|Immunologic Factors|immunologic factors|mesh-ancestor
64303465|NCT02138383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303467|NCT02138383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64303468|NCT02243735|Ferrous fumarate|ferrous fumarate|mesh-list
64303469|NCT02243735|Trace Elements|trace elements|mesh-ancestor
64303470|NCT02243735|Micronutrients|micronutrients|mesh-ancestor
64779362|NCT04924062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850890|NCT04590586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64850891|NCT04590586|Immunologic Factors|immunologic factors|mesh-ancestor
64850892|NCT04590586|Leprostatic Agents|leprostatic agents|mesh-ancestor
64850893|NCT04590586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64850894|NCT04590586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64850895|NCT04590586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64850896|NCT04590586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64850897|NCT04590586|Growth Substances|growth substances|mesh-ancestor
64850898|NCT04590586|Growth Inhibitors|growth inhibitors|mesh-ancestor
64850899|NCT04590586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850900|NCT04312009|Losartan|losartan|mesh-list
64850901|NCT04312009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64850902|NCT04312009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64850903|NCT04312009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64850904|NCT04312009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64850905|NCT04312009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850906|NCT04100096|Brexpiprazole|brexpiprazole|mesh-list
64850907|NCT04100096|Serotonin Agents|serotonin agents|mesh-ancestor
64850908|NCT04100096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64850909|NCT04100096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850910|NCT04100096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850911|NCT04100096|Dopamine Agonists|dopamine agonists|mesh-ancestor
64850912|NCT04100096|Dopamine Agents|dopamine agents|mesh-ancestor
64850913|NCT03850483|PF-06700841|pf-06700841|mesh-list
64850914|NCT03850483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64850915|NCT03850483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850916|NCT03850483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548057|NCT01479374|Histamine Agents|histamine agents|mesh-ancestor
64779363|NCT04924062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64779364|NCT04924062|Immunologic Factors|immunologic factors|mesh-ancestor
64779365|NCT04924062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779366|NCT04924062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64779367|NCT04911660|Empagliflozin|empagliflozin|mesh-list
64779368|NCT04911660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64779369|NCT04911660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779370|NCT04911660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64779371|NCT04911660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779372|NCT04876638|Minocycline|minocycline|mesh-list
64779373|NCT04876638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64779374|NCT04876638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64850917|NCT03819296|Prednisone|prednisone|mesh-list
64850918|NCT03819296|Cortisone|cortisone|mesh-list
64850919|NCT03819296|Infliximab|infliximab|mesh-list
64850920|NCT03819296|Vedolizumab|vedolizumab|mesh-list
64850921|NCT03819296|Immunoglobulins|immunoglobulins|mesh-list
64850922|NCT03819296|Immunoglobulin G|immunoglobulin g|mesh-list
64850923|NCT03819296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64850924|NCT03819296|Glucocorticoids|glucocorticoids|mesh-ancestor
64850925|NCT03819296|Hormones|hormones|mesh-ancestor
64850926|NCT03819296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64850927|NCT03819296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850928|NCT03819296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64850929|NCT03819296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779376|NCT04754334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64779377|NCT04754334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779378|NCT04748796|Landiolol|landiolol|mesh-list
64779379|NCT04748796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64779380|NCT04748796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64779381|NCT04748796|Adrenergic Agents|adrenergic agents|mesh-ancestor
64779382|NCT04748796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64390773|NCT02415829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64390774|NCT02415829|Antimetabolites|antimetabolites|mesh-ancestor
64390775|NCT02415829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390776|NCT02415829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390777|NCT04631393|Alfentanil|alfentanil|mesh-list
64390778|NCT04631393|Propofol|propofol|mesh-list
64850986|NCT02968940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850987|NCT02679144|Eflornithine|eflornithine|mesh-list
64850988|NCT02679144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850989|NCT02679144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64850990|NCT02679144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64850991|NCT02679144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64850992|NCT02679144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64850994|NCT02679144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64851003|NCT02333292|Ritonavir|ritonavir|mesh-list
64851004|NCT02333292|Sofosbuvir|sofosbuvir|mesh-list
64851005|NCT02333292|Grazoprevir|grazoprevir|mesh-list
64851006|NCT02333292|Ledipasvir|ledipasvir|mesh-list
64851007|NCT02333292|Velpatasvir|velpatasvir|mesh-list
64851008|NCT02333292|Simeprevir|simeprevir|mesh-list
64851009|NCT02333292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64851010|NCT02333292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64851011|NCT02333292|Protease Inhibitors|protease inhibitors|mesh-ancestor
64851012|NCT02333292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64851013|NCT02333292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851014|NCT02333292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64851015|NCT02333292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64851016|NCT02333292|Antiviral Agents|antiviral agents|mesh-ancestor
64851017|NCT02333292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64851018|NCT02333292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64851019|NCT02333292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64851021|NCT02203773|Azacitidine|azacitidine|mesh-list
64851022|NCT02203773|Decitabine|decitabine|mesh-list
64851023|NCT02203773|Venetoclax|venetoclax|mesh-list
64851024|NCT02203773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64851025|NCT02203773|Antimetabolites|antimetabolites|mesh-ancestor
64851026|NCT02203773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851027|NCT02203773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390779|NCT04631393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64390780|NCT04631393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64390781|NCT04631393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390782|NCT04631393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64390783|NCT04631393|Anesthetics, General|anesthetics, general|mesh-ancestor
64390784|NCT04631393|Anesthetics|anesthetics|mesh-ancestor
64390786|NCT04631393|Narcotics|narcotics|mesh-ancestor
64779383|NCT04748796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779384|NCT04748796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779385|NCT04748796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64779386|NCT04677816|Vitamin D|vitamin d|mesh-list
64303488|NCT02252419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64303489|NCT02252419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64303490|NCT02252419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303491|NCT02252419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64303492|NCT02252419|Analgesics|analgesics|mesh-ancestor
64303493|NCT02252419|Sensory System Agents|sensory system agents|mesh-ancestor
64303494|NCT02252419|Antipyretics|antipyretics|mesh-ancestor
64303495|NCT02252497|Tranexamic Acid|tranexamic acid|mesh-list
64303496|NCT02252497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64303497|NCT02252497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64303498|NCT02252497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303499|NCT02252497|Hemostatics|hemostatics|mesh-ancestor
64303500|NCT02252497|Coagulants|coagulants|mesh-ancestor
64303501|NCT02138773|Tamsulosin|tamsulosin|mesh-list
64779387|NCT04677816|Cholecalciferol|cholecalciferol|mesh-list
64779388|NCT04677816|Vitamins|vitamins|mesh-ancestor
64779389|NCT04677816|Micronutrients|micronutrients|mesh-ancestor
64779390|NCT04677816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779391|NCT04677816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64851066|NCT01734512|Immunologic Factors|immunologic factors|mesh-ancestor
64851087|NCT01398852|Micronutrients|micronutrients|mesh-ancestor
64851088|NCT01398852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851089|NCT01398852|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64851090|NCT01398852|Dermatologic Agents|dermatologic agents|mesh-ancestor
64851092|NCT01398839|Vitamin B Complex|vitamin b complex|mesh-ancestor
64851093|NCT01398839|Vitamins|vitamins|mesh-ancestor
64851094|NCT01398839|Micronutrients|micronutrients|mesh-ancestor
64851095|NCT01398839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851096|NCT01398839|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64851097|NCT01398839|Dermatologic Agents|dermatologic agents|mesh-ancestor
64851098|NCT00496795|Docetaxel|docetaxel|mesh-list
64851099|NCT00496795|Epirubicin|epirubicin|mesh-list
64851100|NCT00496795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851101|NCT00496795|Tubulin Modulators|tubulin modulators|mesh-ancestor
64851102|NCT00496795|Antimitotic Agents|antimitotic agents|mesh-ancestor
64851103|NCT00496795|Mitosis Modulators|mitosis modulators|mesh-ancestor
64851104|NCT00496795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851105|NCT00496795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64851106|NCT00496795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64851107|NCT00496795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64851108|NCT00496795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64851109|NCT00316888|Cisplatin|cisplatin|mesh-list
64851110|NCT00316888|Fluorouracil|fluorouracil|mesh-list
64851111|NCT00316888|Cetuximab|cetuximab|mesh-list
64779392|NCT04677816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64779393|NCT04676334|Rucaparib|rucaparib|mesh-list
64779394|NCT04676334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64779395|NCT04676334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779396|NCT04676334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779397|NCT04676334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779398|NCT04661358|Fenofibrate|fenofibrate|mesh-list
64779399|NCT04661358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64779400|NCT04661358|Antimetabolites|antimetabolites|mesh-ancestor
64779401|NCT04661358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779402|NCT04661358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64779403|NCT04625946|Metformin|metformin|mesh-list
64548116|NCT01500434|Purinergic Agents|purinergic agents|mesh-ancestor
64779404|NCT04625946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64779405|NCT04625946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779406|NCT04599816|Simendan|simendan|mesh-list
64779407|NCT04599816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64779408|NCT04599816|Vasodilator Agents|vasodilator agents|mesh-ancestor
64779409|NCT04599816|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64779410|NCT04599816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64779411|NCT04599816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64851129|NCT03133260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64619601|NCT03011905|Ropivacaine|ropivacaine|mesh-list
64851130|NCT03133260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64851131|NCT03133260|Analgesics|analgesics|mesh-ancestor
64851132|NCT03133260|Sensory System Agents|sensory system agents|mesh-ancestor
64851133|NCT03133260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64851134|NCT03133260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779413|NCT04599816|Protective Agents|protective agents|mesh-ancestor
64779429|NCT04534218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64779430|NCT04534218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64779431|NCT04534218|Antimetabolites|antimetabolites|mesh-ancestor
64779432|NCT04534218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64779433|NCT04534218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64779434|NCT04534218|Analgesics|analgesics|mesh-ancestor
64779435|NCT04534218|Sensory System Agents|sensory system agents|mesh-ancestor
64779436|NCT04534218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64779437|NCT04534218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64779438|NCT04534218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64779439|NCT04534218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64779440|NCT04534218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64779441|NCT04534218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64779442|NCT04534218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779443|NCT04534218|Antipyretics|antipyretics|mesh-ancestor
64779444|NCT04531878|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64779445|NCT04531878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390843|NCT05106517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390844|NCT03140033|Misoprostol|misoprostol|mesh-list
64779459|NCT04509414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303502|NCT02138773|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64303503|NCT02138773|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64303504|NCT02138773|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64303505|NCT02138773|Adrenergic Agents|adrenergic agents|mesh-ancestor
64303506|NCT02138773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64303507|NCT02138773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851175|NCT03056014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64851176|NCT03056014|Expectorants|expectorants|mesh-ancestor
64851177|NCT03056014|Respiratory System Agents|respiratory system agents|mesh-ancestor
64851178|NCT03056014|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64851179|NCT03056014|Antioxidants|antioxidants|mesh-ancestor
64851180|NCT03056014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851181|NCT03056014|Protective Agents|protective agents|mesh-ancestor
64851182|NCT03056014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851183|NCT03056014|Antidotes|antidotes|mesh-ancestor
64851184|NCT03054181|Immunoglobulins|immunoglobulins|mesh-list
64851185|NCT03054181|Immunologic Factors|immunologic factors|mesh-ancestor
64851186|NCT03054181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851187|NCT03026972|Vaccines|vaccines|mesh-list
64851188|NCT03026972|Immunologic Factors|immunologic factors|mesh-ancestor
64851189|NCT03026972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851190|NCT03012815|Chlordiazepoxide|chlordiazepoxide|mesh-list
64851191|NCT03012815|Gabapentin|gabapentin|mesh-list
64851192|NCT03012815|Lorazepam|lorazepam|mesh-list
64851193|NCT03012815|Valproic Acid|valproic acid|mesh-list
64851194|NCT03012815|Analgesics|analgesics|mesh-ancestor
64294997|NCT02416180|Glucocorticoids|glucocorticoids|mesh-ancestor
64303508|NCT02138773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303509|NCT02138773|Urological Agents|urological agents|mesh-ancestor
64779460|NCT04509414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64779462|NCT04509414|Sensory System Agents|sensory system agents|mesh-ancestor
64779463|NCT04509414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64779464|NCT04509414|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64779465|NCT04509414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64779466|NCT04509414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64779467|NCT04509414|Adrenergic Agents|adrenergic agents|mesh-ancestor
64851195|NCT03012815|Sensory System Agents|sensory system agents|mesh-ancestor
64851196|NCT03012815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64851197|NCT03012815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851198|NCT03012815|Anticonvulsants|anticonvulsants|mesh-ancestor
64851199|NCT03012815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64851200|NCT03012815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64851201|NCT03012815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64851202|NCT03012815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64851203|NCT03012815|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64851204|NCT03012815|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64851205|NCT03012815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64851206|NCT03012815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851208|NCT03012815|Antiemetics|antiemetics|mesh-ancestor
64851209|NCT03012815|Autonomic Agents|autonomic agents|mesh-ancestor
64851210|NCT03012815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64851211|NCT03012815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64851212|NCT03012815|GABA Modulators|gaba modulators|mesh-ancestor
64851213|NCT03012815|GABA Agents|gaba agents|mesh-ancestor
64851214|NCT03012815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64851215|NCT03012815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64851216|NCT03006432|Leucovorin|leucovorin|mesh-list
64851217|NCT03006432|Folic Acid|folic acid|mesh-list
64851218|NCT03006432|Docetaxel|docetaxel|mesh-list
64851219|NCT03006432|Fluorouracil|fluorouracil|mesh-list
64851220|NCT03006432|Oxaliplatin|oxaliplatin|mesh-list
64851221|NCT03006432|Levoleucovorin|levoleucovorin|mesh-list
64851222|NCT03006432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851223|NCT03006432|Tubulin Modulators|tubulin modulators|mesh-ancestor
64331843|NCT04597190|Sympathomimetics|sympathomimetics|mesh-ancestor
64331844|NCT04597190|Autonomic Agents|autonomic agents|mesh-ancestor
64331845|NCT04597190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64331846|NCT04597190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64331847|NCT04597190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64851224|NCT03006432|Antimitotic Agents|antimitotic agents|mesh-ancestor
64779468|NCT04509414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64779469|NCT04509414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779470|NCT04509414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64779471|NCT04509414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64779472|NCT04509414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64779473|NCT04509414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64779474|NCT04509414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64779475|NCT04509414|Anesthetics, General|anesthetics, general|mesh-ancestor
64390869|NCT05338931|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64779476|NCT04509414|Anesthetics|anesthetics|mesh-ancestor
64779477|NCT04509414|GABA Modulators|gaba modulators|mesh-ancestor
64779478|NCT04509414|GABA Agents|gaba agents|mesh-ancestor
64779479|NCT04480554|Naltrexone|naltrexone|mesh-list
64779480|NCT04480554|Buprenorphine|buprenorphine|mesh-list
64779481|NCT04480554|Methadone|methadone|mesh-list
64779482|NCT04480554|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64779483|NCT04480554|Naloxone|naloxone|mesh-list
64779484|NCT04480554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64779485|NCT04480554|Narcotics|narcotics|mesh-ancestor
64851225|NCT03006432|Mitosis Modulators|mitosis modulators|mesh-ancestor
64851226|NCT03006432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779486|NCT04480554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64779487|NCT04480554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779488|NCT04480554|Analgesics|analgesics|mesh-ancestor
64779489|NCT04480554|Sensory System Agents|sensory system agents|mesh-ancestor
64779490|NCT04480554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64779491|NCT04480554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64779492|NCT04480554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64779493|NCT04480554|Antitussive Agents|antitussive agents|mesh-ancestor
64779494|NCT04480554|Respiratory System Agents|respiratory system agents|mesh-ancestor
64779495|NCT04437108|Solifenacin Succinate|solifenacin succinate|mesh-list
64779496|NCT04437108|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64779497|NCT04437108|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64779498|NCT04437108|Cholinergic Agents|cholinergic agents|mesh-ancestor
64779499|NCT04437108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64851280|NCT02943785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851282|NCT02908334|Sertraline|sertraline|mesh-list
64619756|NCT03872947|Vitamins|vitamins|mesh-ancestor
64851283|NCT02908334|Antidepressive Agents|antidepressive agents|mesh-ancestor
64851284|NCT02908334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64851285|NCT02908334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64851286|NCT02908334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64851287|NCT02908334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64851288|NCT02908334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851289|NCT02908334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64851290|NCT02908334|Serotonin Agents|serotonin agents|mesh-ancestor
64851291|NCT02908334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851314|NCT02886286|Fentanyl|fentanyl|mesh-list
64851315|NCT02886286|Morphine|morphine|mesh-list
64851316|NCT02886286|Hydromorphone|hydromorphone|mesh-list
64851318|NCT02886286|Anesthetics, Local|anesthetics, local|mesh-ancestor
64851319|NCT02886286|Anesthetics|anesthetics|mesh-ancestor
64851320|NCT02886286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64851321|NCT02886286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851322|NCT02886286|Sensory System Agents|sensory system agents|mesh-ancestor
64851323|NCT02886286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64851324|NCT02886286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64851325|NCT02886286|Narcotics|narcotics|mesh-ancestor
64779500|NCT04437108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779501|NCT04437108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779502|NCT04437108|Urological Agents|urological agents|mesh-ancestor
64779503|NCT04416984|Cyclophosphamide|cyclophosphamide|mesh-list
64779504|NCT04416984|Fludarabine|fludarabine|mesh-list
64779505|NCT04416984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64779506|NCT04416984|Immunologic Factors|immunologic factors|mesh-ancestor
64779514|NCT04320342|Beclomethasone|beclomethasone|mesh-list
64779522|NCT04320342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64779523|NCT04320342|Respiratory System Agents|respiratory system agents|mesh-ancestor
64779524|NCT04320342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64779525|NCT04320342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64779526|NCT04320342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64779527|NCT04320342|Adrenergic Agents|adrenergic agents|mesh-ancestor
64779528|NCT04320342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64303520|NCT02138929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303521|NCT02253199|Dexmedetomidine|dexmedetomidine|mesh-list
64303522|NCT02253199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64851326|NCT02886286|Analgesics|analgesics|mesh-ancestor
64851327|NCT02886286|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64851328|NCT02886286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64851329|NCT02886286|Anesthetics, General|anesthetics, general|mesh-ancestor
64851330|NCT02865187|Vitamin D|vitamin d|mesh-list
64851331|NCT02865187|Vitamins|vitamins|mesh-ancestor
64851332|NCT02865187|Micronutrients|micronutrients|mesh-ancestor
64851333|NCT02865187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851334|NCT02865187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64331849|NCT04597190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64331850|NCT04597190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64331851|NCT04577638|Nivolumab|nivolumab|mesh-list
64331852|NCT04577638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64331853|NCT04577638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303523|NCT02253199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64303524|NCT02253199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303525|NCT02253199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64303527|NCT02253199|Sensory System Agents|sensory system agents|mesh-ancestor
64779535|NCT04320342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64779536|NCT04320342|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64779537|NCT04320342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64779538|NCT04320342|Cholinergic Agents|cholinergic agents|mesh-ancestor
64779539|NCT04307550|Ethanol|ethanol|mesh-list
64779540|NCT04307550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64779541|NCT04307550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64779542|NCT04307550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64390939|NCT05087693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64851366|NCT02654314|Protective Agents|protective agents|mesh-ancestor
64851382|NCT02623998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64851383|NCT02623998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64851384|NCT02623998|Protease Inhibitors|protease inhibitors|mesh-ancestor
64851385|NCT02623998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64851386|NCT02623998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851388|NCT02608684|Pembrolizumab|pembrolizumab|mesh-list
64851389|NCT02608684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390940|NCT05087693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64390941|NCT05087693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64390942|NCT05087693|Adrenergic Agents|adrenergic agents|mesh-ancestor
64390943|NCT05087693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64390944|NCT05087693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851437|NCT02499367|Doxorubicin|doxorubicin|mesh-list
64390945|NCT01990768|Tranexamic Acid|tranexamic acid|mesh-list
64390946|NCT01990768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64390947|NCT01990768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64390948|NCT01990768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390949|NCT01990768|Hemostatics|hemostatics|mesh-ancestor
64390950|NCT01990768|Coagulants|coagulants|mesh-ancestor
64779543|NCT04307550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779544|NCT04164732|Valsartan|valsartan|mesh-list
64779545|NCT04164732|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64779546|NCT04164732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64851512|NCT02368301|Growth Substances|growth substances|mesh-ancestor
64851513|NCT02368301|Growth Inhibitors|growth inhibitors|mesh-ancestor
64851514|NCT02367794|Paclitaxel|paclitaxel|mesh-list
64851515|NCT02367794|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64851516|NCT02367794|Carboplatin|carboplatin|mesh-list
64851517|NCT02367794|Atezolizumab|atezolizumab|mesh-list
64851518|NCT02367794|Antibodies|antibodies|mesh-list
64851519|NCT02367794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64851520|NCT02367794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851521|NCT02367794|Tubulin Modulators|tubulin modulators|mesh-ancestor
64851522|NCT02367794|Antimitotic Agents|antimitotic agents|mesh-ancestor
64851523|NCT02367794|Mitosis Modulators|mitosis modulators|mesh-ancestor
64851524|NCT02367794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851525|NCT02367794|Immunologic Factors|immunologic factors|mesh-ancestor
64851526|NCT02367794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851527|NCT02363998|Lofexidine|lofexidine|mesh-list
64851528|NCT02363998|Clonidine|clonidine|mesh-list
64851529|NCT02363998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64851530|NCT02363998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64851531|NCT02363998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851532|NCT02363998|Sensory System Agents|sensory system agents|mesh-ancestor
64851533|NCT02363998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64851534|NCT02363998|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64851535|NCT02363998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64851536|NCT02363998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64851537|NCT02363998|Adrenergic Agents|adrenergic agents|mesh-ancestor
64851538|NCT02363998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64851539|NCT02363998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851540|NCT02363998|Analgesics|analgesics|mesh-ancestor
64851541|NCT02363998|Sympatholytics|sympatholytics|mesh-ancestor
64851542|NCT02363998|Autonomic Agents|autonomic agents|mesh-ancestor
64851543|NCT02355379|Capecitabine|capecitabine|mesh-list
64851547|NCT02355379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779547|NCT04164732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64779548|NCT04164732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64779549|NCT04164732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779550|NCT04134000|Atezolizumab|atezolizumab|mesh-list
64779551|NCT04134000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779552|NCT04095858|Methotrexate|methotrexate|mesh-list
64779553|NCT04095858|Tacrolimus|tacrolimus|mesh-list
64779554|NCT04095858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64779555|NCT04095858|Abortifacient Agents|abortifacient agents|mesh-ancestor
64779556|NCT04095858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64779557|NCT04095858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779558|NCT04095858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64303528|NCT02253199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303529|NCT02253199|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64303530|NCT02253199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64851548|NCT02355379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851549|NCT02355379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64851550|NCT02355379|Immunologic Factors|immunologic factors|mesh-ancestor
64851551|NCT02355379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851552|NCT02325466|Aspirin|aspirin|mesh-list
64851553|NCT02325466|Ticagrelor|ticagrelor|mesh-list
64851554|NCT02325466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64851555|NCT02325466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64851556|NCT02325466|Analgesics|analgesics|mesh-ancestor
64851557|NCT02325466|Sensory System Agents|sensory system agents|mesh-ancestor
64851558|NCT02325466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64851559|NCT02325466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851560|NCT02325466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64851561|NCT02325466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64851575|NCT02323100|Glycerol|glycerol|mesh-list
64303531|NCT02253199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64303532|NCT02253199|Adrenergic Agents|adrenergic agents|mesh-ancestor
64779559|NCT04095858|Antimetabolites|antimetabolites|mesh-ancestor
64779560|NCT04095858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779561|NCT04095858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779562|NCT04095858|Dermatologic Agents|dermatologic agents|mesh-ancestor
64779563|NCT04095858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64851592|NCT02283281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64851593|NCT02283281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64851594|NCT02283281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851596|NCT02283281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64851597|NCT02204241|Dexamethasone|dexamethasone|mesh-list
64851598|NCT02204241|Cyclophosphamide|cyclophosphamide|mesh-list
64851599|NCT02204241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64851600|NCT02204241|Immunologic Factors|immunologic factors|mesh-ancestor
64851601|NCT02204241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851602|NCT02204241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64851603|NCT02204241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64851604|NCT02204241|Alkylating Agents|alkylating agents|mesh-ancestor
64851605|NCT02204241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851606|NCT02204241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851607|NCT02204241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64851608|NCT02204241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64851609|NCT02204241|Antiemetics|antiemetics|mesh-ancestor
64851610|NCT02204241|Autonomic Agents|autonomic agents|mesh-ancestor
64779564|NCT04095858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64779565|NCT04095858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64779566|NCT04095858|Immunologic Factors|immunologic factors|mesh-ancestor
64779567|NCT04095858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64779568|NCT04095858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64779569|NCT04095858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64779570|NCT04052568|Psilocybin|psilocybin|mesh-list
64779571|NCT04052568|Hallucinogens|hallucinogens|mesh-ancestor
64851642|NCT02162563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64851643|NCT02162563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851644|NCT02162563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64851645|NCT02162563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64851646|NCT02162563|Growth Substances|growth substances|mesh-ancestor
64851647|NCT02162563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851648|NCT02162563|Growth Inhibitors|growth inhibitors|mesh-ancestor
64851649|NCT02162563|Antimetabolites|antimetabolites|mesh-ancestor
64851650|NCT02162563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851651|NCT02162563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64851657|NCT02162563|Antidotes|antidotes|mesh-ancestor
64390963|NCT02624765|Protective Agents|protective agents|mesh-ancestor
64779572|NCT04052568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779573|NCT04052568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64779574|NCT03937986|Cocaine|cocaine|mesh-list
64779575|NCT03937986|Suvorexant|suvorexant|mesh-list
64779576|NCT03937986|Anesthetics, Local|anesthetics, local|mesh-ancestor
64779577|NCT03937986|Anesthetics|anesthetics|mesh-ancestor
64779578|NCT03937986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64779579|NCT03937986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851703|NCT02050919|Alkylating Agents|alkylating agents|mesh-ancestor
64851704|NCT02040857|Tamoxifen|tamoxifen|mesh-list
64851705|NCT02040857|Letrozole|letrozole|mesh-list
64851706|NCT02040857|Palbociclib|palbociclib|mesh-list
64851707|NCT02040857|Anastrozole|anastrozole|mesh-list
64851708|NCT02040857|Exemestane|exemestane|mesh-list
64851709|NCT02040857|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64851712|NCT02040857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779580|NCT03937986|Sensory System Agents|sensory system agents|mesh-ancestor
64779581|NCT03937986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64779582|NCT03937986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64779583|NCT03937986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64779584|NCT03937986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64779585|NCT03937986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64779586|NCT03937986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548230|NCT00086281|Zolpidem|zolpidem|mesh-list
64779587|NCT03937986|Dopamine Agents|dopamine agents|mesh-ancestor
64779588|NCT03937986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64851746|NCT01976754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64851747|NCT01976754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64851748|NCT01976754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64851749|NCT01976754|Adrenergic Agents|adrenergic agents|mesh-ancestor
64851750|NCT01976754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64851751|NCT01976754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851753|NCT01943825|Immunologic Factors|immunologic factors|mesh-ancestor
64851754|NCT01943825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851755|NCT01916317|Lidocaine|lidocaine|mesh-list
64851756|NCT01916317|Anesthetics, Local|anesthetics, local|mesh-ancestor
64851757|NCT01916317|Anesthetics|anesthetics|mesh-ancestor
64851758|NCT01916317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64851759|NCT01916317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851760|NCT01916317|Sensory System Agents|sensory system agents|mesh-ancestor
64851761|NCT01916317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64851762|NCT01916317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64851763|NCT01916317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64851764|NCT01916317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64851765|NCT01916317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64851766|NCT01916317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851768|NCT01913730|Bortezomib|bortezomib|mesh-list
64851769|NCT01913730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64851770|NCT01913730|Antiemetics|antiemetics|mesh-ancestor
64851771|NCT01913730|Autonomic Agents|autonomic agents|mesh-ancestor
64851772|NCT01913730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64851773|NCT01913730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851774|NCT01913730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64851775|NCT01913730|Glucocorticoids|glucocorticoids|mesh-ancestor
64851776|NCT01913730|Hormones|hormones|mesh-ancestor
64851777|NCT01913730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64779589|NCT03937986|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64779590|NCT03937986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64779591|NCT03937986|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64303548|NCT03569579|Memantine|memantine|mesh-list
64303549|NCT03569579|Donepezil|donepezil|mesh-list
64303550|NCT03569579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64303551|NCT03569579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303552|NCT03569579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851778|NCT01913730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64851784|NCT01863186|Lofexidine|lofexidine|mesh-list
64303565|NCT02130661|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64303566|NCT02130661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64303567|NCT02130661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303568|NCT02130661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303569|NCT02130661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64303570|NCT02130661|Hormone Antagonists|hormone antagonists|mesh-ancestor
64303571|NCT02130661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64303572|NCT02130661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851845|NCT01499095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64851846|NCT01499095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851847|NCT01499082|Insulin|insulin|mesh-list
64851848|NCT01499082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64851849|NCT01499082|Insulin Glargine|insulin glargine|mesh-list
64851850|NCT01499082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64851851|NCT01499082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851852|NCT01488890|Vaccines|vaccines|mesh-list
64851853|NCT01488890|Immunologic Factors|immunologic factors|mesh-ancestor
64851854|NCT01488890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851855|NCT01436396|Vaccines|vaccines|mesh-list
64851856|NCT01436396|Immunologic Factors|immunologic factors|mesh-ancestor
64851857|NCT01436396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851858|NCT01414777|Ondansetron|ondansetron|mesh-list
64851859|NCT01414777|Antiemetics|antiemetics|mesh-ancestor
64851860|NCT01414777|Autonomic Agents|autonomic agents|mesh-ancestor
64851861|NCT01414777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64851862|NCT01414777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851863|NCT01414777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64851864|NCT01414777|Antipruritics|antipruritics|mesh-ancestor
64851865|NCT01414777|Dermatologic Agents|dermatologic agents|mesh-ancestor
64851866|NCT01414777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64851867|NCT01414777|Serotonin Agents|serotonin agents|mesh-ancestor
64851868|NCT01414777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64851869|NCT01414777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851870|NCT01414777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64851871|NCT01414777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64851872|NCT01414777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64851873|NCT01414777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64851875|NCT01411241|Vaccines|vaccines|mesh-list
64303574|NCT02130739|Fentanyl|fentanyl|mesh-list
64779594|NCT03873402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64390993|NCT05085587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390994|NCT05085587|Glucocorticoids|glucocorticoids|mesh-ancestor
64390995|NCT05085587|Hormones|hormones|mesh-ancestor
64390996|NCT05085587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64390997|NCT05085587|Sympathomimetics|sympathomimetics|mesh-ancestor
64331878|NCT04529772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64331879|NCT04529772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64331880|NCT04529772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64851883|NCT01380938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851884|NCT01380938|Antiviral Agents|antiviral agents|mesh-ancestor
64851885|NCT01380938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64851886|NCT01380938|Immunologic Factors|immunologic factors|mesh-ancestor
64851887|NCT01380938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851888|NCT01374516|Vaccines|vaccines|mesh-list
64851889|NCT01374516|Immunologic Factors|immunologic factors|mesh-ancestor
64851890|NCT01374516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851891|NCT01373281|Vaccines|vaccines|mesh-list
64851892|NCT01373281|Immunologic Factors|immunologic factors|mesh-ancestor
64851893|NCT01373281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620363|NCT00977171|Droxidopa|droxidopa|mesh-list
64851894|NCT01346787|Dexamethasone|dexamethasone|mesh-list
64851895|NCT01346787|Cyclophosphamide|cyclophosphamide|mesh-list
64851896|NCT01346787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64851897|NCT01346787|Immunologic Factors|immunologic factors|mesh-ancestor
64851898|NCT01346787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851899|NCT01346787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64851900|NCT01346787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64851901|NCT01346787|Alkylating Agents|alkylating agents|mesh-ancestor
64851902|NCT01346787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851903|NCT01346787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851904|NCT01346787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64851905|NCT01346787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64851906|NCT01346787|Antiemetics|antiemetics|mesh-ancestor
64851907|NCT01346787|Autonomic Agents|autonomic agents|mesh-ancestor
64851908|NCT01346787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64851909|NCT01346787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64851910|NCT01346787|Glucocorticoids|glucocorticoids|mesh-ancestor
64390998|NCT01990534|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64390999|NCT01990534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64391000|NCT01990534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64391001|NCT05084573|Bupivacaine|bupivacaine|mesh-list
64779595|NCT03873402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779596|NCT03873402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64779597|NCT03873402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779598|NCT03815058|Pembrolizumab|pembrolizumab|mesh-list
64779599|NCT03815058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64851912|NCT01346787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64851913|NCT01346787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64851915|NCT01254422|Immunologic Factors|immunologic factors|mesh-ancestor
64851916|NCT01254422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851917|NCT01204242|Lidocaine|lidocaine|mesh-list
64851918|NCT01204242|Anesthetics, Local|anesthetics, local|mesh-ancestor
64851919|NCT01204242|Anesthetics|anesthetics|mesh-ancestor
64851920|NCT01204242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64851921|NCT01204242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851922|NCT01204242|Sensory System Agents|sensory system agents|mesh-ancestor
64851923|NCT01204242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64851924|NCT01204242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64851925|NCT01204242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64851926|NCT01204242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64851927|NCT01204242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64779600|NCT03815058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779601|NCT03813030|Lidocaine|lidocaine|mesh-list
64779602|NCT03813030|Prilocaine|prilocaine|mesh-list
64779603|NCT03813030|Anesthetics, Local|anesthetics, local|mesh-ancestor
64779604|NCT03813030|Anesthetics|anesthetics|mesh-ancestor
64779605|NCT03813030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64779606|NCT03813030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779607|NCT03813030|Sensory System Agents|sensory system agents|mesh-ancestor
64779608|NCT03813030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64779609|NCT03813030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64779610|NCT03813030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64779611|NCT03813030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64779612|NCT03813030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64851928|NCT01204242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851930|NCT01187433|Immunologic Factors|immunologic factors|mesh-ancestor
64851931|NCT01187433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851932|NCT01166113|Prednisone|prednisone|mesh-list
64851933|NCT01166113|Cyclophosphamide|cyclophosphamide|mesh-list
64851934|NCT01166113|Pomalidomide|pomalidomide|mesh-list
64851935|NCT01166113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64851936|NCT01166113|Immunologic Factors|immunologic factors|mesh-ancestor
64851937|NCT01166113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851938|NCT01166113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64851939|NCT01166113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64851940|NCT01166113|Alkylating Agents|alkylating agents|mesh-ancestor
64851941|NCT01166113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851942|NCT01166113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851943|NCT01166113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64851944|NCT01166113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64851945|NCT01166113|Glucocorticoids|glucocorticoids|mesh-ancestor
64851946|NCT01166113|Hormones|hormones|mesh-ancestor
64851947|NCT01166113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64779613|NCT03813030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779614|NCT03778944|Dopamine|dopamine|mesh-list
64779615|NCT03778944|Mannitol|mannitol|mesh-list
64779616|NCT03778944|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64779617|NCT03778944|Diuretics|diuretics|mesh-ancestor
64779618|NCT03778944|Natriuretic Agents|natriuretic agents|mesh-ancestor
64779619|NCT03778944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779620|NCT03778944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64779621|NCT03778944|Sympathomimetics|sympathomimetics|mesh-ancestor
64391015|NCT05088707|Oxytocics|oxytocics|mesh-ancestor
64851959|NCT01160107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391016|NCT05028257|Vaccines|vaccines|mesh-list
64779622|NCT03778944|Autonomic Agents|autonomic agents|mesh-ancestor
64779623|NCT03778944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303584|NCT02130739|Sensory System Agents|sensory system agents|mesh-ancestor
64303585|NCT02130739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303586|NCT02130739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64303587|NCT02130739|Narcotics|narcotics|mesh-ancestor
64303588|NCT02130739|Analgesics|analgesics|mesh-ancestor
64303589|NCT02130739|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64303590|NCT02248493|Acetaminophen|acetaminophen|mesh-list
64303591|NCT02248493|Ketoprofen|ketoprofen|mesh-list
64303592|NCT02248493|Morphine|morphine|mesh-list
64852029|NCT01093196|Growth Substances|growth substances|mesh-ancestor
64852030|NCT01093196|Growth Inhibitors|growth inhibitors|mesh-ancestor
64852031|NCT00945009|Dactinomycin|dactinomycin|mesh-list
64852032|NCT00945009|Cactinomycin|cactinomycin|mesh-list
64852033|NCT00945009|Doxorubicin|doxorubicin|mesh-list
64852034|NCT00945009|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64852035|NCT00945009|Vincristine|vincristine|mesh-list
64852036|NCT00945009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64852037|NCT00945009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852038|NCT00945009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64852039|NCT00945009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64852040|NCT00945009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852041|NCT00945009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852042|NCT00945009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64852043|NCT00945009|Tubulin Modulators|tubulin modulators|mesh-ancestor
64852044|NCT00945009|Antimitotic Agents|antimitotic agents|mesh-ancestor
64852045|NCT00945009|Mitosis Modulators|mitosis modulators|mesh-ancestor
64852046|NCT00945009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64852047|NCT00945009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64852048|NCT00945009|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64852049|NCT00945009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64852050|NCT00942877|Cediranib|cediranib|mesh-list
64852051|NCT00942877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852052|NCT00942877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64852053|NCT00942877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852054|NCT00942877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852055|NCT00896389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64852056|NCT00896389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64295033|NCT04646967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64295034|NCT04646967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303615|NCT05577871|Analgesics|analgesics|mesh-ancestor
64779625|NCT03778944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64779626|NCT03778944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779627|NCT03778944|Protective Agents|protective agents|mesh-ancestor
64779628|NCT03653052|Durvalumab|durvalumab|mesh-list
64779629|NCT03653052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64779630|NCT03653052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779631|NCT03640728|Tenofovir|tenofovir|mesh-list
64779632|NCT03640728|Entecavir|entecavir|mesh-list
64779633|NCT03640728|Antiviral Agents|antiviral agents|mesh-ancestor
64779634|NCT03640728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64779635|NCT03640728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64779636|NCT03640728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64779637|NCT03640728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779638|NCT03640728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779639|NCT03640728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64779640|NCT03640728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64779641|NCT03606174|Pembrolizumab|pembrolizumab|mesh-list
64779642|NCT03606174|Nivolumab|nivolumab|mesh-list
64779643|NCT03606174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64779644|NCT03606174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779645|NCT03606174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64779646|NCT03606174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779647|NCT03546582|Pembrolizumab|pembrolizumab|mesh-list
64779648|NCT03546582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64779649|NCT03546582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779650|NCT03535272|Bismuth|bismuth|mesh-list
64779651|NCT03535272|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
64779652|NCT03535272|Antacids|antacids|mesh-ancestor
64779653|NCT03535272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779654|NCT03535272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64779656|NCT03534180|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64779657|NCT03534180|Venetoclax|venetoclax|mesh-list
64779658|NCT03534180|Romidepsin|romidepsin|mesh-list
64779659|NCT03534180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64779660|NCT03534180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779661|NCT03534180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64548305|NCT00085423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64779662|NCT03529110|Trastuzumab|trastuzumab|mesh-list
64779663|NCT03529110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64779664|NCT03529110|Maytansine|maytansine|mesh-list
64779665|NCT03529110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64779666|NCT03529110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779667|NCT03529110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64852057|NCT00896389|Diuretics|diuretics|mesh-ancestor
64852058|NCT00896389|Natriuretic Agents|natriuretic agents|mesh-ancestor
64852059|NCT00896389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852060|NCT00896389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64852063|NCT00880893|Vaccines|vaccines|mesh-list
64779668|NCT03529110|Tubulin Modulators|tubulin modulators|mesh-ancestor
64779669|NCT03529110|Antimitotic Agents|antimitotic agents|mesh-ancestor
64779670|NCT03529110|Mitosis Modulators|mitosis modulators|mesh-ancestor
64779671|NCT03529110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779672|NCT03502746|Nivolumab|nivolumab|mesh-list
64779673|NCT03502746|Ramucirumab|ramucirumab|mesh-list
64779674|NCT03502746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64779675|NCT03502746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779676|NCT03502746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64331899|NCT04495296|Nivolumab|nivolumab|mesh-list
64331900|NCT04495296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64779677|NCT03502746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779678|NCT03436368|Anesthetics|anesthetics|mesh-list
64779679|NCT03436368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64303630|NCT02130817|Mycophenolic Acid|mycophenolic acid|mesh-list
64303631|NCT02130817|Dexamethasone|dexamethasone|mesh-list
64303632|NCT02130817|Prednisone|prednisone|mesh-list
64779687|NCT03367572|Olanzapine|olanzapine|mesh-list
64779688|NCT03367572|Palonosetron|palonosetron|mesh-list
64779689|NCT03367572|Prochlorperazine|prochlorperazine|mesh-list
64779690|NCT03367572|Ichthammol|ichthammol|mesh-list
64779691|NCT03367572|BB 1101|bb 1101|mesh-list
64852144|NCT00379340|Alkylating Agents|alkylating agents|mesh-ancestor
64852145|NCT00379340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852146|NCT00379340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852160|NCT00066950|Chlorhexidine|chlorhexidine|mesh-list
64779692|NCT03367572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64779693|NCT03367572|Antiemetics|antiemetics|mesh-ancestor
64779694|NCT03367572|Autonomic Agents|autonomic agents|mesh-ancestor
64779695|NCT03367572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64779696|NCT03367572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779697|NCT03367572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64779698|NCT03367572|Glucocorticoids|glucocorticoids|mesh-ancestor
64779699|NCT03367572|Hormones|hormones|mesh-ancestor
64779700|NCT03367572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64779701|NCT03367572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64779702|NCT03367572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779703|NCT03367572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64779704|NCT03367572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64391091|NCT02419105|Hormones|hormones|mesh-ancestor
64391092|NCT02419105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64391093|NCT04643249|Repaglinide|repaglinide|mesh-list
64391094|NCT04643249|Flurbiprofen|flurbiprofen|mesh-list
64391095|NCT04643249|Midazolam|midazolam|mesh-list
64391096|NCT04643249|Dextromethorphan|dextromethorphan|mesh-list
64779705|NCT03367572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64779707|NCT03367572|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64361297|NCT02130466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779708|NCT03367572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64779710|NCT03367572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779711|NCT03367572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64779712|NCT03367572|Serotonin Agents|serotonin agents|mesh-ancestor
64779713|NCT03367572|Protease Inhibitors|protease inhibitors|mesh-ancestor
64779714|NCT03367572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779715|NCT03367572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64779716|NCT03367572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64779717|NCT03367572|Dermatologic Agents|dermatologic agents|mesh-ancestor
64779718|NCT03367572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64779719|NCT03367572|Dopamine Agents|dopamine agents|mesh-ancestor
64779720|NCT03321630|Pembrolizumab|pembrolizumab|mesh-list
64779721|NCT03321630|Lenvatinib|lenvatinib|mesh-list
64779722|NCT03321630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64779723|NCT03321630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852213|NCT01694212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852214|NCT01694212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852215|NCT01694264|Entecavir|entecavir|mesh-list
64852216|NCT01694264|Antiviral Agents|antiviral agents|mesh-ancestor
64852217|NCT01694264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64852218|NCT01694355|Vitamin D|vitamin d|mesh-list
64852219|NCT01694355|Vitamins|vitamins|mesh-ancestor
64852220|NCT01694355|Micronutrients|micronutrients|mesh-ancestor
64852221|NCT01694355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852226|NCT01694381|Immunologic Factors|immunologic factors|mesh-ancestor
64779724|NCT03321630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64779725|NCT03321630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779726|NCT03321630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779727|NCT03249870|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
64779728|NCT03249870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64779729|NCT03249870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64391114|NCT04643249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64852242|NCT01694459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64852243|NCT01694459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852244|NCT01694498|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64852246|NCT01694498|Coagulants|coagulants|mesh-ancestor
64852247|NCT01694498|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64852248|NCT01694498|Natriuretic Agents|natriuretic agents|mesh-ancestor
64852249|NCT01694498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852250|NCT01694576|Paclitaxel|paclitaxel|mesh-list
64852251|NCT01694576|Nedaplatin|nedaplatin|mesh-list
64852252|NCT01694576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64852253|NCT01694576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852254|NCT01694576|Tubulin Modulators|tubulin modulators|mesh-ancestor
64852255|NCT01694576|Antimitotic Agents|antimitotic agents|mesh-ancestor
64852256|NCT01694576|Mitosis Modulators|mitosis modulators|mesh-ancestor
64852257|NCT01694576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852258|NCT01694693|Abatacept|abatacept|mesh-list
64852259|NCT01694693|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64852260|NCT01694693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852261|NCT01694693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852262|NCT01694693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64852263|NCT01694693|Immunologic Factors|immunologic factors|mesh-ancestor
64852264|NCT01694693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852265|NCT01694693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64852266|NCT01694732|Varenicline|varenicline|mesh-list
64852267|NCT01694732|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64852268|NCT01694732|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64391115|NCT04643249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64391116|NCT04643249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391117|NCT04643249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64779730|NCT03249870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64779731|NCT03212742|Temozolomide|temozolomide|mesh-list
64779732|NCT03212742|Olaparib|olaparib|mesh-list
64779733|NCT03212742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64779734|NCT03212742|Alkylating Agents|alkylating agents|mesh-ancestor
64852269|NCT01694732|Cholinergic Agents|cholinergic agents|mesh-ancestor
64852270|NCT01694732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64852271|NCT01694732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331901|NCT04495296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331904|NCT04495296|Mitosis Modulators|mitosis modulators|mesh-ancestor
64852272|NCT01694732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852274|NCT01694797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64852275|NCT01694797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64852276|NCT01694797|Sympatholytics|sympatholytics|mesh-ancestor
64852277|NCT01694797|Autonomic Agents|autonomic agents|mesh-ancestor
64852278|NCT01694797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64852279|NCT01694797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852280|NCT01694797|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64852281|NCT01694797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64852282|NCT01694797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64852283|NCT01694797|Adrenergic Agents|adrenergic agents|mesh-ancestor
64852284|NCT01694797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64779735|NCT03212742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64548390|NCT03483883|Gemcitabine|gemcitabine|mesh-list
64779736|NCT03212742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779737|NCT03212742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64779738|NCT03212742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779739|NCT03202758|Durvalumab|durvalumab|mesh-list
64779740|NCT03202758|Tremelimumab|tremelimumab|mesh-list
64779741|NCT03202758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64852285|NCT01694797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779742|NCT03202758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779743|NCT03122262|Tenofovir|tenofovir|mesh-list
64779744|NCT03122262|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64779745|NCT03122262|Dolutegravir|dolutegravir|mesh-list
64779746|NCT03122262|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64779747|NCT03122262|Antiviral Agents|antiviral agents|mesh-ancestor
64779748|NCT03122262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64852287|NCT01695005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64852288|NCT01695005|Glucocorticoids|glucocorticoids|mesh-ancestor
64852289|NCT01695005|Hormones|hormones|mesh-ancestor
64852290|NCT01695005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64852291|NCT01695005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852292|NCT01695005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64852293|NCT01695005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852294|NCT01695057|Vorinostat|vorinostat|mesh-list
64852297|NCT01695057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779749|NCT03122262|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64779750|NCT03122262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64779751|NCT03122262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779752|NCT03122262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779753|NCT03122262|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64779754|NCT03122262|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64779755|NCT03122262|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64303636|NCT02130817|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64852336|NCT01695226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64852337|NCT01695226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64852338|NCT01695226|Analgesics|analgesics|mesh-ancestor
64852339|NCT01695226|Sensory System Agents|sensory system agents|mesh-ancestor
64852340|NCT01695226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64852341|NCT01695226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852342|NCT01695226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64620830|NCT03825068|Anesthetics|anesthetics|mesh-list
64852343|NCT01695226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64852344|NCT01695226|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64852345|NCT01695226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64852346|NCT01695226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852347|NCT01695226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852348|NCT01695356|Sunscreening Agents|sunscreening agents|mesh-list
64852349|NCT01695356|Zinc Oxide|zinc oxide|mesh-list
64303637|NCT02130817|Immunoglobulins|immunoglobulins|mesh-list
64303638|NCT02130817|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64303639|NCT02130817|Immunoglobulin G|immunoglobulin g|mesh-list
64303640|NCT02130817|gamma-Globulins|gamma-globulins|mesh-list
64303641|NCT02130817|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64303642|NCT02130817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64779765|NCT03042546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779766|NCT02772588|Leuprolide|leuprolide|mesh-list
64779767|NCT02772588|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64779768|NCT02772588|Fertility Agents|fertility agents|mesh-ancestor
64852411|NCT01696383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64852412|NCT01696383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64852413|NCT01696383|Adrenergic Agents|adrenergic agents|mesh-ancestor
64852414|NCT01696383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64852415|NCT01696383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852416|NCT01696383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852417|NCT01696383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64852418|NCT01696383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64852419|NCT01696409|Vitamin D|vitamin d|mesh-list
64852420|NCT01696409|Ergocalciferols|ergocalciferols|mesh-list
64852421|NCT01696409|Cholecalciferol|cholecalciferol|mesh-list
64331905|NCT04495296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779769|NCT02772588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64779770|NCT02772588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779771|NCT02772588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64779772|NCT02772588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779773|NCT02748564|Aldesleukin|aldesleukin|mesh-list
64779774|NCT02748564|Pembrolizumab|pembrolizumab|mesh-list
64779775|NCT02748564|Interleukin-2|interleukin-2|mesh-list
64779776|NCT02748564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64779777|NCT02748564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779778|NCT02748564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64779779|NCT02748564|Analgesics|analgesics|mesh-ancestor
64852466|NCT01696552|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64852467|NCT01696552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64852468|NCT01696552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852469|NCT01696617|Aripiprazole|aripiprazole|mesh-list
64852470|NCT01696617|Antidepressive Agents|antidepressive agents|mesh-ancestor
64852471|NCT01696617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64852472|NCT01696617|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64852473|NCT01696617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64852474|NCT01696617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64852475|NCT01696617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852476|NCT01696617|Dopamine Agonists|dopamine agonists|mesh-ancestor
64852477|NCT01696617|Dopamine Agents|dopamine agents|mesh-ancestor
64852478|NCT01696617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64852483|NCT01696617|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64852484|NCT01696617|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64852485|NCT01696617|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64852486|NCT01696617|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64852487|NCT01696630|Desflurane|desflurane|mesh-list
64852488|NCT01696630|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64852489|NCT01696630|Anesthetics, General|anesthetics, general|mesh-ancestor
64852490|NCT01696630|Anesthetics|anesthetics|mesh-ancestor
64331935|NCT04404062|Antibodies|antibodies|mesh-list
64331936|NCT04404062|Immunoglobulins|immunoglobulins|mesh-list
64331937|NCT04404062|Immunologic Factors|immunologic factors|mesh-ancestor
64779780|NCT02748564|Sensory System Agents|sensory system agents|mesh-ancestor
64779781|NCT02748564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64779782|NCT02748564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779783|NCT02748564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64779784|NCT02748564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64391166|NCT03116893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779785|NCT02748564|Antiviral Agents|antiviral agents|mesh-ancestor
64779786|NCT02748564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64779787|NCT02734602|Ketamine|ketamine|mesh-list
64779788|NCT02734602|Analgesics|analgesics|mesh-ancestor
64303643|NCT02130817|Antiemetics|antiemetics|mesh-ancestor
64303644|NCT02130817|Autonomic Agents|autonomic agents|mesh-ancestor
64303645|NCT02130817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303646|NCT02130817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416679|NCT01668667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64779789|NCT02734602|Sensory System Agents|sensory system agents|mesh-ancestor
64779790|NCT02734602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64779791|NCT02734602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779792|NCT02734602|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64779793|NCT02734602|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64779794|NCT02734602|Anesthetics, General|anesthetics, general|mesh-ancestor
64779795|NCT02734602|Anesthetics|anesthetics|mesh-ancestor
64779796|NCT02734602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64779797|NCT02734602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64779798|NCT02734602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64779799|NCT02734602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64779800|NCT02734602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779801|NCT02663622|Methotrexate|methotrexate|mesh-list
64779802|NCT02663622|Tacrolimus|tacrolimus|mesh-list
64779803|NCT02663622|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64779804|NCT02663622|Abortifacient Agents|abortifacient agents|mesh-ancestor
64779805|NCT02663622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64779806|NCT02663622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779807|NCT02663622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64779808|NCT02663622|Antimetabolites|antimetabolites|mesh-ancestor
64548459|NCT01425281|Everolimus|everolimus|mesh-list
64391198|NCT05737511|Paroxetine|paroxetine|mesh-list
64391199|NCT05737511|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64331938|NCT04404062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391200|NCT05737511|Reboxetine|reboxetine|mesh-list
64391201|NCT05737511|Imipramine|imipramine|mesh-list
64331940|NCT04352777|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64331941|NCT04352777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64852495|NCT01696656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64620968|NCT02925650|Phenserine|phenserine|mesh-list
64852497|NCT01696799|Antifungal Agents|antifungal agents|mesh-ancestor
64852498|NCT01696799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64852499|NCT01696799|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64295084|NCT02445586|Antimitotic Agents|antimitotic agents|mesh-ancestor
64295085|NCT02445586|Mitosis Modulators|mitosis modulators|mesh-ancestor
64391202|NCT05737511|Clomipramine|clomipramine|mesh-list
64391203|NCT05737511|Phenelzine|phenelzine|mesh-list
64391204|NCT05737511|Moclobemide|moclobemide|mesh-list
64391205|NCT05737511|Hydroxyzine|hydroxyzine|mesh-list
64391206|NCT05737511|Analgesics|analgesics|mesh-ancestor
64391210|NCT05737511|Anticonvulsants|anticonvulsants|mesh-ancestor
64779809|NCT02663622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779810|NCT02663622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779811|NCT02663622|Dermatologic Agents|dermatologic agents|mesh-ancestor
64779812|NCT02663622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779813|NCT02663622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64779814|NCT02663622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64779815|NCT02663622|Immunologic Factors|immunologic factors|mesh-ancestor
64779816|NCT02663622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64779817|NCT02663622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64779818|NCT02663622|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64779819|NCT02486718|Gemcitabine|gemcitabine|mesh-list
64779820|NCT02486718|Docetaxel|docetaxel|mesh-list
64779821|NCT02486718|Pemetrexed|pemetrexed|mesh-list
64779822|NCT02486718|Atezolizumab|atezolizumab|mesh-list
64779823|NCT02486718|Vinorelbine|vinorelbine|mesh-list
64779824|NCT02486718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779825|NCT02486718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64779826|NCT02486718|Antimetabolites|antimetabolites|mesh-ancestor
64779827|NCT02486718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779828|NCT02486718|Antiviral Agents|antiviral agents|mesh-ancestor
64779829|NCT02486718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64779830|NCT02486718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779831|NCT02486718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64779832|NCT02486718|Immunologic Factors|immunologic factors|mesh-ancestor
64779833|NCT02486718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852500|NCT01696799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64391225|NCT05737511|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64391227|NCT05737511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64779834|NCT02486718|Tubulin Modulators|tubulin modulators|mesh-ancestor
64779835|NCT02486718|Antimitotic Agents|antimitotic agents|mesh-ancestor
64779836|NCT02486718|Mitosis Modulators|mitosis modulators|mesh-ancestor
64779837|NCT02486718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64779838|NCT02486718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64779839|NCT02486718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64779840|NCT02420652|Aspirin|aspirin|mesh-list
64779841|NCT02420652|Metformin|metformin|mesh-list
64852501|NCT01696799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852503|NCT01696799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64779842|NCT02420652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64779843|NCT02420652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779844|NCT02420652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64779845|NCT02420652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64779846|NCT02420652|Analgesics|analgesics|mesh-ancestor
64779847|NCT02420652|Sensory System Agents|sensory system agents|mesh-ancestor
64779848|NCT02420652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64779849|NCT02420652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64852529|NCT01697020|Mercaptopurine|mercaptopurine|mesh-list
64852530|NCT01697020|Antimetabolites|antimetabolites|mesh-ancestor
64852531|NCT01697020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331962|NCT04276363|Nicotine|nicotine|mesh-list
64331963|NCT04276363|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64331964|NCT04276363|Autonomic Agents|autonomic agents|mesh-ancestor
64331965|NCT04276363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64331966|NCT04276363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331967|NCT04276363|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64331968|NCT04276363|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64331969|NCT04276363|Cholinergic Agents|cholinergic agents|mesh-ancestor
64331970|NCT04276363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64331971|NCT04276363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331972|NCT04260854|Bupivacaine|bupivacaine|mesh-list
64331973|NCT04260854|Anesthetics, Local|anesthetics, local|mesh-ancestor
64331974|NCT04260854|Anesthetics|anesthetics|mesh-ancestor
64331975|NCT04260854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64331976|NCT04260854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331977|NCT04260854|Sensory System Agents|sensory system agents|mesh-ancestor
64331978|NCT04260854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64852532|NCT01697020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64852533|NCT01697020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852534|NCT01697020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64852536|NCT01697020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852537|NCT01697020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64852538|NCT01697020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852539|NCT01697046|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64852540|NCT01697046|Raltegravir Potassium|raltegravir potassium|mesh-list
64852541|NCT01697046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64852543|NCT01697046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779850|NCT02420652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64779851|NCT02420652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64779852|NCT02420652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64779853|NCT02420652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779889|NCT02037048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64779890|NCT02037048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64779891|NCT02037048|Immunologic Factors|immunologic factors|mesh-ancestor
64779892|NCT02037048|Antidotes|antidotes|mesh-ancestor
64779893|NCT02037048|Protective Agents|protective agents|mesh-ancestor
64779894|NCT02037048|Vitamin B Complex|vitamin b complex|mesh-ancestor
64779895|NCT02037048|Vitamins|vitamins|mesh-ancestor
64779896|NCT02037048|Micronutrients|micronutrients|mesh-ancestor
64779897|NCT02034630|Busulfan|busulfan|mesh-list
64779898|NCT02034630|Alkylating Agents|alkylating agents|mesh-ancestor
64779899|NCT02034630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779900|NCT02034630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64779901|NCT02034630|Immunologic Factors|immunologic factors|mesh-ancestor
64779902|NCT02034630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779903|NCT02034630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64779904|NCT02034630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779905|NCT02034630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64779906|NCT02025036|Capecitabine|capecitabine|mesh-list
64779907|NCT02025036|Oxaliplatin|oxaliplatin|mesh-list
64779908|NCT02025036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64779909|NCT02025036|Antimetabolites|antimetabolites|mesh-ancestor
64331981|NCT04175912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64331982|NCT04175912|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64331983|NCT04175912|Pevonedistat|pevonedistat|mesh-list
64331984|NCT04175912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64331985|NCT04175912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331986|NCT04175912|Tubulin Modulators|tubulin modulators|mesh-ancestor
64331987|NCT04175912|Antimitotic Agents|antimitotic agents|mesh-ancestor
64331988|NCT04175912|Mitosis Modulators|mitosis modulators|mesh-ancestor
64852546|NCT01697046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64852548|NCT01697046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64852549|NCT01697046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64852550|NCT01697046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64852551|NCT01697059|Amoxicillin|amoxicillin|mesh-list
64852552|NCT01697059|Piperacillin|piperacillin|mesh-list
64852553|NCT01697059|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64852554|NCT01697059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64852555|NCT01697059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64852556|NCT01697059|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64852557|NCT01697059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852558|NCT01697059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852559|NCT01697098|Dexamethasone|dexamethasone|mesh-list
64852560|NCT01697098|Dexamethasone acetate|dexamethasone acetate|mesh-list
64852561|NCT01697098|Glucocorticoids|glucocorticoids|mesh-list
64852562|NCT01697098|BB 1101|bb 1101|mesh-list
64779939|NCT00819546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64779940|NCT00819546|Immunologic Factors|immunologic factors|mesh-ancestor
64779941|NCT00819546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779942|NCT00819546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64779943|NCT00819546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779944|NCT00819546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779945|NCT00777036|Dasatinib|dasatinib|mesh-list
64331989|NCT04175912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779946|NCT00777036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64779947|NCT00777036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64852564|NCT01697098|Antiemetics|antiemetics|mesh-ancestor
64852565|NCT01697098|Autonomic Agents|autonomic agents|mesh-ancestor
64852566|NCT01697098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64852567|NCT01697098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852568|NCT01697098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64852569|NCT01697098|Hormones|hormones|mesh-ancestor
64852570|NCT01697098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64852571|NCT01697098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64852572|NCT01697098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852573|NCT01697098|Protease Inhibitors|protease inhibitors|mesh-ancestor
64852574|NCT01697098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852575|NCT01697098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852577|NCT01697111|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64852578|NCT01697111|Contraceptive Agents|contraceptive agents|mesh-ancestor
64852579|NCT01697111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64852580|NCT01697111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852581|NCT01697111|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64852582|NCT01697111|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64852583|NCT01697111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64779948|NCT00777036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779949|NCT00777036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779950|NCT00596154|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64779951|NCT00596154|Cyclophosphamide|cyclophosphamide|mesh-list
64779952|NCT00596154|Busulfan|busulfan|mesh-list
64779953|NCT00596154|Thiotepa|thiotepa|mesh-list
64779954|NCT00596154|Rituximab|rituximab|mesh-list
64779955|NCT00596154|Methotrexate|methotrexate|mesh-list
64779956|NCT00596154|Vincristine|vincristine|mesh-list
64331991|NCT04147546|Antimalarials|antimalarials|mesh-ancestor
64331992|NCT04147546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64331993|NCT04147546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64331994|NCT04147546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64331995|NCT04141579|Evolocumab|evolocumab|mesh-list
64331996|NCT04141579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64331997|NCT04141579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64331998|NCT04141579|Antimetabolites|antimetabolites|mesh-ancestor
64331999|NCT04141579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332000|NCT04141579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64332001|NCT04128072|Mogamulizumab|mogamulizumab|mesh-list
64332002|NCT04128072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332003|NCT04095689|Docetaxel|docetaxel|mesh-list
64332004|NCT04095689|Pembrolizumab|pembrolizumab|mesh-list
64332005|NCT04095689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332006|NCT04095689|Tubulin Modulators|tubulin modulators|mesh-ancestor
64332007|NCT04095689|Antimitotic Agents|antimitotic agents|mesh-ancestor
64852584|NCT01697111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64852585|NCT01697111|Hormone Antagonists|hormone antagonists|mesh-ancestor
64852586|NCT01697111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64852587|NCT01697111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64852588|NCT01697111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852589|NCT01697150|Pancrelipase|pancrelipase|mesh-list
64852590|NCT01697150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64852592|NCT01697228|Vitamins|vitamins|mesh-ancestor
64852593|NCT01697228|Micronutrients|micronutrients|mesh-ancestor
64852594|NCT01697228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852595|NCT01697228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64852596|NCT01697293|Paclitaxel|paclitaxel|mesh-list
64852597|NCT01697293|Cyclophosphamide|cyclophosphamide|mesh-list
64332008|NCT04095689|Mitosis Modulators|mitosis modulators|mesh-ancestor
64332009|NCT04095689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332010|NCT04095689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64779957|NCT00596154|Procarbazine|procarbazine|mesh-list
64779958|NCT00596154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64779959|NCT00596154|Immunologic Factors|immunologic factors|mesh-ancestor
64779960|NCT00596154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64779961|NCT00596154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64779962|NCT00596154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64779963|NCT00596154|Alkylating Agents|alkylating agents|mesh-ancestor
64779964|NCT00596154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779965|NCT00596154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332013|NCT04077723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332014|NCT04059484|Tamoxifen|tamoxifen|mesh-list
64332015|NCT04059484|Letrozole|letrozole|mesh-list
64332016|NCT04059484|Fulvestrant|fulvestrant|mesh-list
64332017|NCT04059484|Anastrozole|anastrozole|mesh-list
64332018|NCT04059484|Exemestane|exemestane|mesh-list
64332019|NCT04059484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332020|NCT04059484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64332021|NCT04059484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64332022|NCT04059484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852598|NCT01697293|Doxorubicin|doxorubicin|mesh-list
64852599|NCT01697293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64852600|NCT01697293|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64852601|NCT01697293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64852602|NCT01697293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852603|NCT01697293|Tubulin Modulators|tubulin modulators|mesh-ancestor
64852604|NCT01697293|Antimitotic Agents|antimitotic agents|mesh-ancestor
64852605|NCT01697293|Mitosis Modulators|mitosis modulators|mesh-ancestor
64852606|NCT01697293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852607|NCT01697293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64852608|NCT01697293|Immunologic Factors|immunologic factors|mesh-ancestor
64852609|NCT01697293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852610|NCT01697293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64852611|NCT01697293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64852612|NCT01697293|Alkylating Agents|alkylating agents|mesh-ancestor
64852613|NCT01697293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64852614|NCT01697293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64852615|NCT01697293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64852616|NCT01697293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64852617|NCT01697293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779966|NCT00596154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64779967|NCT00596154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64303647|NCT02130817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64303648|NCT02130817|Glucocorticoids|glucocorticoids|mesh-ancestor
64303649|NCT02130817|Hormones|hormones|mesh-ancestor
64779969|NCT00596154|Abortifacient Agents|abortifacient agents|mesh-ancestor
64779971|NCT00596154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64779972|NCT00596154|Antimetabolites|antimetabolites|mesh-ancestor
64779973|NCT00596154|Dermatologic Agents|dermatologic agents|mesh-ancestor
64779974|NCT00596154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779975|NCT00596154|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64779976|NCT00596154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64779977|NCT00596154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64779978|NCT00596154|Tubulin Modulators|tubulin modulators|mesh-ancestor
64779979|NCT00596154|Antimitotic Agents|antimitotic agents|mesh-ancestor
64779980|NCT00596154|Mitosis Modulators|mitosis modulators|mesh-ancestor
64779981|NCT00596154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64779983|NCT00281658|Lapatinib|lapatinib|mesh-list
64779984|NCT00281658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64779985|NCT00281658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852625|NCT01697306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64779986|NCT00281658|Tubulin Modulators|tubulin modulators|mesh-ancestor
64852626|NCT01697306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852627|NCT01697306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64852628|NCT01697306|Immunologic Factors|immunologic factors|mesh-ancestor
64852629|NCT01697306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852630|NCT01697306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64852631|NCT01697410|Terlipressin|terlipressin|mesh-list
64852632|NCT01697410|Norepinephrine|norepinephrine|mesh-list
64852633|NCT01697410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64852634|NCT01697410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64852635|NCT01697410|Adrenergic Agents|adrenergic agents|mesh-ancestor
64779987|NCT00281658|Antimitotic Agents|antimitotic agents|mesh-ancestor
64779988|NCT00281658|Mitosis Modulators|mitosis modulators|mesh-ancestor
64779989|NCT00281658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64779990|NCT00281658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64779991|NCT00281658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64779992|NCT02417844|Tamsulosin|tamsulosin|mesh-list
64779993|NCT02417844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64779994|NCT02417844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64779995|NCT02417844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64779996|NCT02417844|Adrenergic Agents|adrenergic agents|mesh-ancestor
64779997|NCT02417844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64779998|NCT02417844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391386|NCT02423239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64391389|NCT02423239|Protective Agents|protective agents|mesh-ancestor
64779999|NCT02417844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780000|NCT02417844|Urological Agents|urological agents|mesh-ancestor
64780001|NCT02418312|Famotidine|famotidine|mesh-list
64780002|NCT02418312|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
64780003|NCT02418312|Histamine|histamine|mesh-list
64780004|NCT02418312|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64780005|NCT02418312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64780006|NCT02418312|Histamine Antagonists|histamine antagonists|mesh-ancestor
64780007|NCT02418312|Histamine Agents|histamine agents|mesh-ancestor
64780008|NCT02418312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64780009|NCT02418312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780010|NCT02418312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780011|NCT02418312|Histamine Agonists|histamine agonists|mesh-ancestor
64780012|NCT02421354|Nivolumab|nivolumab|mesh-list
64852671|NCT01697657|Isophane Insulin, Human|isophane insulin, human|mesh-list
64852672|NCT01697657|Insulin, Isophane|insulin, isophane|mesh-list
64852673|NCT01697657|Isophane insulin, beef|isophane insulin, beef|mesh-list
64852674|NCT01697657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64852675|NCT01697657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852676|NCT01697670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64852677|NCT01697670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64852678|NCT01697670|Dermatologic Agents|dermatologic agents|mesh-ancestor
64780013|NCT02421354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64303650|NCT02130817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64303651|NCT02130817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64303652|NCT02130817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303653|NCT02130817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303654|NCT02130817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780019|NCT02422290|Sensory System Agents|sensory system agents|mesh-ancestor
64780020|NCT02422290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780021|NCT02422290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332023|NCT04059484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332024|NCT04059484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64332025|NCT04059484|Hormone Antagonists|hormone antagonists|mesh-ancestor
64332026|NCT04059484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64332027|NCT04059484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332028|NCT04059484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64332029|NCT04059484|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64332030|NCT04059484|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64332031|NCT04059484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64332032|NCT04059484|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64332033|NCT04038502|Carboplatin|carboplatin|mesh-list
64332034|NCT04038502|Olaparib|olaparib|mesh-list
64332035|NCT04038502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332036|NCT04038502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64332037|NCT04038502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852715|NCT01697826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64852716|NCT01697826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64621190|NCT05564286|Hormones|hormones|mesh-ancestor
64852717|NCT01697826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64852718|NCT01697826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852719|NCT01697826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852720|NCT01697826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64852721|NCT01697826|Antifungal Agents|antifungal agents|mesh-ancestor
64852722|NCT01697826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64852732|NCT01698164|Estradiol|estradiol|mesh-list
64391415|NCT02417389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64391416|NCT02417389|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64391417|NCT02417389|Hormone Antagonists|hormone antagonists|mesh-ancestor
64391418|NCT02417389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64391419|NCT02413021|Cytarabine|cytarabine|mesh-list
64391420|NCT02413021|Deferasirox|deferasirox|mesh-list
64391421|NCT02413021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64391422|NCT02413021|Antimetabolites|antimetabolites|mesh-ancestor
64391423|NCT02413021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391424|NCT02413021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64391425|NCT02413021|Antiviral Agents|antiviral agents|mesh-ancestor
64780022|NCT02422290|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64780023|NCT02422290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64780024|NCT02422290|Anesthetics, General|anesthetics, general|mesh-ancestor
64780026|NCT02422290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64332038|NCT04038502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780027|NCT02422290|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64332039|NCT04008030|Leucovorin|leucovorin|mesh-list
64332040|NCT04008030|Bevacizumab|bevacizumab|mesh-list
64332041|NCT04008030|Nivolumab|nivolumab|mesh-list
64852733|NCT01698164|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64852734|NCT01698164|Progesterone|progesterone|mesh-list
64852735|NCT01698164|Estrogens|estrogens|mesh-ancestor
64852736|NCT01698164|Hormones|hormones|mesh-ancestor
64852737|NCT01698164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64852738|NCT01698164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852739|NCT01698164|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64852740|NCT01698164|Contraceptive Agents|contraceptive agents|mesh-ancestor
64852741|NCT01698164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64852742|NCT01698164|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64852743|NCT01698164|Progestins|progestins|mesh-ancestor
64852744|NCT01698177|Vaccines|vaccines|mesh-list
64852745|NCT01698177|Immunologic Factors|immunologic factors|mesh-ancestor
64852746|NCT01698177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852747|NCT01698203|Ropivacaine|ropivacaine|mesh-list
64852748|NCT01698203|Anesthetics, Local|anesthetics, local|mesh-ancestor
64852749|NCT01698203|Anesthetics|anesthetics|mesh-ancestor
64852750|NCT01698203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64852752|NCT01698203|Sensory System Agents|sensory system agents|mesh-ancestor
64780028|NCT02422290|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64780029|NCT02422290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64780030|NCT02422290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852766|NCT01698541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780031|NCT02430090|Fentanyl|fentanyl|mesh-list
64780032|NCT02430090|Sufentanil|sufentanil|mesh-list
64303655|NCT02130817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64303656|NCT02130817|Immunologic Factors|immunologic factors|mesh-ancestor
64303657|NCT02130817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64303658|NCT02130817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64303660|NCT02130817|Antitubercular Agents|antitubercular agents|mesh-ancestor
64852768|NCT01698541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852769|NCT01698541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852770|NCT01698567|Antithrombins|antithrombins|mesh-list
64852771|NCT01698567|Antithrombin III|antithrombin iii|mesh-list
64852772|NCT01698567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64852773|NCT01698567|Protease Inhibitors|protease inhibitors|mesh-ancestor
64852774|NCT01698567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852775|NCT01698567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852776|NCT01698567|Anticoagulants|anticoagulants|mesh-ancestor
64852777|NCT01698593|Epinephrine|epinephrine|mesh-list
64852778|NCT01698593|Bupivacaine|bupivacaine|mesh-list
64852779|NCT01698593|Anesthetics, Local|anesthetics, local|mesh-ancestor
64852780|NCT01698593|Anesthetics|anesthetics|mesh-ancestor
64852781|NCT01698593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64852782|NCT01698593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852783|NCT01698593|Sensory System Agents|sensory system agents|mesh-ancestor
64852784|NCT01698593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64852785|NCT01698593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64852786|NCT01698593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64852787|NCT01698593|Adrenergic Agents|adrenergic agents|mesh-ancestor
64852788|NCT01698593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64303661|NCT02130817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64303662|NCT02130817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64303663|NCT02130817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64303664|NCT02130817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64303665|NCT02400346|Brexpiprazole|brexpiprazole|mesh-list
64303666|NCT02400346|Serotonin Agents|serotonin agents|mesh-ancestor
64303667|NCT02400346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64416680|NCT01668667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64852789|NCT01698593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852790|NCT01698593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64852791|NCT01698593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64852792|NCT01698593|Autonomic Agents|autonomic agents|mesh-ancestor
64852793|NCT01698593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64852794|NCT01698593|Respiratory System Agents|respiratory system agents|mesh-ancestor
64852795|NCT01698593|Mydriatics|mydriatics|mesh-ancestor
64621278|NCT02564796|Iron|iron|mesh-list
64852796|NCT01698593|Sympathomimetics|sympathomimetics|mesh-ancestor
64852797|NCT01698593|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64852798|NCT01698645|Fentanyl|fentanyl|mesh-list
64852799|NCT01698645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64852800|NCT01698645|Narcotics|narcotics|mesh-ancestor
64852801|NCT01698645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64852802|NCT01698645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852803|NCT01698645|Analgesics|analgesics|mesh-ancestor
64852804|NCT01698645|Sensory System Agents|sensory system agents|mesh-ancestor
64852805|NCT01698645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64852806|NCT01698645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64852807|NCT01698645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64852809|NCT01698645|Anesthetics|anesthetics|mesh-ancestor
64332143|NCT03805607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64332144|NCT03805607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332145|NCT03805607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64332146|NCT03805607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64332147|NCT03805607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64332148|NCT03805607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64332149|NCT03805607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332154|NCT03678545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64332155|NCT03678545|Immunologic Factors|immunologic factors|mesh-ancestor
64332156|NCT03678545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332157|NCT03671018|Rituximab|rituximab|mesh-list
64332158|NCT03671018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64780033|NCT02430090|Levobupivacaine|levobupivacaine|mesh-list
64780034|NCT02430090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64780036|NCT02430090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64548690|NCT00084253|Ritonavir|ritonavir|mesh-list
64780037|NCT02430090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780039|NCT02430090|Sensory System Agents|sensory system agents|mesh-ancestor
64780040|NCT02430090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780041|NCT02430090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64780042|NCT02430090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64780043|NCT02430090|Anesthetics, General|anesthetics, general|mesh-ancestor
64780044|NCT02430090|Anesthetics|anesthetics|mesh-ancestor
64780045|NCT02430090|Anesthetics, Local|anesthetics, local|mesh-ancestor
64780046|NCT02431572|Vaccines|vaccines|mesh-list
64780047|NCT02431572|Immunologic Factors|immunologic factors|mesh-ancestor
64332162|NCT03671018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64852870|NCT01699204|Respiratory System Agents|respiratory system agents|mesh-ancestor
64621340|NCT05562882|Daratumumab|daratumumab|mesh-list
64852871|NCT01699204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64852873|NCT01699204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852874|NCT01699204|Protective Agents|protective agents|mesh-ancestor
64852875|NCT01699204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852876|NCT01699204|Antidotes|antidotes|mesh-ancestor
64852877|NCT01699282|Antivitamins K|antivitamins k|mesh-list
64852878|NCT01699282|Anticoagulants|anticoagulants|mesh-ancestor
64852879|NCT01699347|Picibanil|picibanil|mesh-list
64852880|NCT01699347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64391438|NCT01680341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64780048|NCT02431572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780049|NCT02431650|Primaquine|primaquine|mesh-list
64780050|NCT02431650|Antimalarials|antimalarials|mesh-ancestor
64780051|NCT02431650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64780052|NCT02431650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64780053|NCT02431650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64780054|NCT02437344|Naltrexone|naltrexone|mesh-list
64780055|NCT02437344|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64780056|NCT02437344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64780057|NCT02437344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780058|NCT02437344|Sensory System Agents|sensory system agents|mesh-ancestor
64780059|NCT02437344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64852881|NCT01699360|Cyclosporine|cyclosporine|mesh-list
64852882|NCT01699360|Sirolimus|sirolimus|mesh-list
64852883|NCT01699360|Tacrolimus|tacrolimus|mesh-list
64852884|NCT01699360|Cyclosporins|cyclosporins|mesh-list
64852885|NCT01699360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64852886|NCT01699360|Immunologic Factors|immunologic factors|mesh-ancestor
64852887|NCT01699360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852888|NCT01699360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64852889|NCT01699360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852890|NCT01699360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852891|NCT01699360|Antifungal Agents|antifungal agents|mesh-ancestor
64852892|NCT01699360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64852893|NCT01699360|Dermatologic Agents|dermatologic agents|mesh-ancestor
64852894|NCT01699360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64852895|NCT01699360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64852896|NCT01699360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64852897|NCT01699360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852898|NCT01699412|Dexamethasone|dexamethasone|mesh-list
64852899|NCT01699412|Clobetasol|clobetasol|mesh-list
64852900|NCT01699412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64852901|NCT01699412|Antiemetics|antiemetics|mesh-ancestor
64852902|NCT01699412|Autonomic Agents|autonomic agents|mesh-ancestor
64852903|NCT01699412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64852904|NCT01699412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852905|NCT01699412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64852906|NCT01699412|Glucocorticoids|glucocorticoids|mesh-ancestor
64780060|NCT02440308|Bombesin|bombesin|mesh-list
64780061|NCT02440308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780062|NCT02440308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64780063|NCT02440308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780064|NCT02444988|Plasma-lyte 148|plasma-lyte 148|mesh-list
64780065|NCT02444988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64780066|NCT02444988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64780067|NCT02448654|Tolcapone|tolcapone|mesh-list
64780068|NCT02448654|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64780069|NCT02448654|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64780070|NCT02448654|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64780071|NCT02448654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780072|NCT02448654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780073|NCT02451150|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
64780074|NCT02451150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64780075|NCT02451150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64780076|NCT02451150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780077|NCT02452866|Secnidazole|secnidazole|mesh-list
64780078|NCT02452866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64852919|NCT01699438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64852920|NCT01699490|Valsartan|valsartan|mesh-list
64852921|NCT01699490|Fluoxetine|fluoxetine|mesh-list
64852922|NCT01699490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64852923|NCT01699490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64852924|NCT01699490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64852925|NCT01699490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852926|NCT01699490|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64852927|NCT01699490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64852928|NCT01699490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64852929|NCT01699490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64852930|NCT01699490|Serotonin Agents|serotonin agents|mesh-ancestor
64852931|NCT01699490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852932|NCT01699490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64852933|NCT01699490|Antidepressive Agents|antidepressive agents|mesh-ancestor
64852934|NCT01699490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64852935|NCT01699490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64852936|NCT01699490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64852937|NCT01699490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852938|NCT01699594|Mannitol|mannitol|mesh-list
64780092|NCT02462148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64780093|NCT02462148|Glucocorticoids|glucocorticoids|mesh-ancestor
64780094|NCT02462148|Hormones|hormones|mesh-ancestor
64780095|NCT02462148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64780096|NCT02462148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64780097|NCT02462148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780098|NCT02462148|Protease Inhibitors|protease inhibitors|mesh-ancestor
64780099|NCT02462148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303668|NCT02400346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303669|NCT02400346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303670|NCT02400346|Dopamine Agonists|dopamine agonists|mesh-ancestor
64332190|NCT03514368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64303671|NCT02400346|Dopamine Agents|dopamine agents|mesh-ancestor
64303672|NCT02130973|Denosumab|denosumab|mesh-list
64303673|NCT02130973|Teriparatide|teriparatide|mesh-list
64303674|NCT02130973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64332191|NCT03514368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332192|NCT03514368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332193|NCT03496766|Tipifarnib|tipifarnib|mesh-list
64332194|NCT03496766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332195|NCT03484819|Nivolumab|nivolumab|mesh-list
64332196|NCT03484819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64332197|NCT03484819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332198|NCT03484819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64332199|NCT03484819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332200|NCT03467789|Vitamin D|vitamin d|mesh-list
64332201|NCT03467789|Ergocalciferols|ergocalciferols|mesh-list
64332202|NCT03467789|Cholecalciferol|cholecalciferol|mesh-list
64852939|NCT01699594|Methacholine Chloride|methacholine chloride|mesh-list
64852940|NCT01699594|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64852941|NCT01699594|Diuretics|diuretics|mesh-ancestor
64852942|NCT01699594|Natriuretic Agents|natriuretic agents|mesh-ancestor
64852943|NCT01699594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852944|NCT01699594|Miotics|miotics|mesh-ancestor
64303675|NCT02130973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303676|NCT02130973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64391513|NCT05377619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780114|NCT02462148|Sympathomimetics|sympathomimetics|mesh-ancestor
64780115|NCT02462148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64780117|NCT02462382|Anesthetics, Local|anesthetics, local|mesh-ancestor
64780118|NCT02462382|Anesthetics|anesthetics|mesh-ancestor
64780119|NCT02462382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64780120|NCT02462382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780121|NCT02462382|Sensory System Agents|sensory system agents|mesh-ancestor
64780122|NCT02462382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64852962|NCT01699711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852963|NCT01699711|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64852964|NCT01699724|Sertraline|sertraline|mesh-list
64852965|NCT01699724|Antidepressive Agents|antidepressive agents|mesh-ancestor
64852966|NCT01699724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64852967|NCT01699724|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64852968|NCT01699724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64852969|NCT01699724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64780123|NCT02464176|Dexamethasone|dexamethasone|mesh-list
64780124|NCT02464176|Dexamethasone acetate|dexamethasone acetate|mesh-list
64780125|NCT02464176|Epinephrine|epinephrine|mesh-list
64780126|NCT02464176|Bupivacaine|bupivacaine|mesh-list
64303677|NCT02456662|Ondansetron|ondansetron|mesh-list
64303678|NCT02456662|Antiemetics|antiemetics|mesh-ancestor
64303679|NCT02456662|Autonomic Agents|autonomic agents|mesh-ancestor
64303680|NCT02456662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303681|NCT02456662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780127|NCT02464176|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64780129|NCT02464176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64780130|NCT02464176|Antiemetics|antiemetics|mesh-ancestor
64853023|NCT01700010|Paclitaxel|paclitaxel|mesh-list
64853024|NCT01700010|Lapatinib|lapatinib|mesh-list
64853025|NCT01700010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64853026|NCT01700010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853027|NCT01700010|Tubulin Modulators|tubulin modulators|mesh-ancestor
64853028|NCT01700010|Antimitotic Agents|antimitotic agents|mesh-ancestor
64853029|NCT01700010|Mitosis Modulators|mitosis modulators|mesh-ancestor
64853030|NCT01700010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853031|NCT01700010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64853032|NCT01700010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853033|NCT01700270|Fluvoxamine|fluvoxamine|mesh-list
64853034|NCT01700270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64853035|NCT01700270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64853036|NCT01700270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64853037|NCT01700270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853038|NCT01700270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64853039|NCT01700270|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64853040|NCT01700270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64853041|NCT01700270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64853042|NCT01700270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853043|NCT01700270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64853044|NCT01700270|Serotonin Agents|serotonin agents|mesh-ancestor
64332255|NCT03363763|Immunologic Factors|immunologic factors|mesh-ancestor
64332256|NCT03363763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332257|NCT03224507|Dexamethasone|dexamethasone|mesh-list
64780131|NCT02464176|Autonomic Agents|autonomic agents|mesh-ancestor
64780132|NCT02464176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780133|NCT02464176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780134|NCT02464176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64780135|NCT02464176|Glucocorticoids|glucocorticoids|mesh-ancestor
64780136|NCT02464176|Hormones|hormones|mesh-ancestor
64780137|NCT02464176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64780138|NCT02464176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64780139|NCT02464176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780140|NCT02464176|Protease Inhibitors|protease inhibitors|mesh-ancestor
64780141|NCT02464176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780142|NCT02464176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391527|NCT03199157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64780143|NCT02464176|Anesthetics, Local|anesthetics, local|mesh-ancestor
64780145|NCT02464176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64780146|NCT02464176|Sensory System Agents|sensory system agents|mesh-ancestor
64780147|NCT02464176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64780148|NCT02464176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64780149|NCT02464176|Adrenergic Agents|adrenergic agents|mesh-ancestor
64780150|NCT02464176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64780151|NCT02464176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64780152|NCT02464176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64780153|NCT02464176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64780154|NCT02464176|Respiratory System Agents|respiratory system agents|mesh-ancestor
64303682|NCT02456662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64303683|NCT02456662|Antipruritics|antipruritics|mesh-ancestor
64303684|NCT02456662|Dermatologic Agents|dermatologic agents|mesh-ancestor
64303685|NCT02456662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64303686|NCT02456662|Serotonin Agents|serotonin agents|mesh-ancestor
64303687|NCT02456662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64853046|NCT01700270|Antidepressive Agents|antidepressive agents|mesh-ancestor
64303688|NCT02456662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303689|NCT02456662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64303690|NCT02456662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64303691|NCT02456662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64303692|NCT02456662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64303693|NCT02456662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64303694|NCT03548311|Vitamin B 12|vitamin b 12|mesh-list
64303695|NCT03548311|Vitamin B Complex|vitamin b complex|mesh-ancestor
64303696|NCT03548311|Vitamins|vitamins|mesh-ancestor
64361964|NCT05001555|Analgesics|analgesics|mesh-ancestor
64780156|NCT02464176|Sympathomimetics|sympathomimetics|mesh-ancestor
64780157|NCT02464176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64780158|NCT02468700|Dexamethasone|dexamethasone|mesh-list
64780159|NCT02468700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64780160|NCT02468700|Antiemetics|antiemetics|mesh-ancestor
64780161|NCT02468700|Autonomic Agents|autonomic agents|mesh-ancestor
64780162|NCT02468700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780163|NCT02468700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780164|NCT02468700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64780165|NCT02468700|Glucocorticoids|glucocorticoids|mesh-ancestor
64780166|NCT02468700|Hormones|hormones|mesh-ancestor
64332279|NCT03224507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64332280|NCT03224507|Growth Substances|growth substances|mesh-ancestor
64332281|NCT03224507|Growth Inhibitors|growth inhibitors|mesh-ancestor
64332283|NCT03218826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332284|NCT03218826|Tubulin Modulators|tubulin modulators|mesh-ancestor
64332285|NCT03218826|Antimitotic Agents|antimitotic agents|mesh-ancestor
64332286|NCT03218826|Mitosis Modulators|mitosis modulators|mesh-ancestor
64853080|NCT01700413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64853081|NCT01700413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853082|NCT01700413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64853083|NCT01700413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64853084|NCT01700413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853085|NCT01700413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853086|NCT01700426|Vitamins|vitamins|mesh-list
64853087|NCT01700426|Vitamin E|vitamin e|mesh-list
64853088|NCT01700426|Tocopherols|tocopherols|mesh-list
64853089|NCT01700426|Tocotrienols|tocotrienols|mesh-list
64853090|NCT01700426|alpha-Tocopherol|alpha-tocopherol|mesh-list
64853091|NCT01700426|Micronutrients|micronutrients|mesh-ancestor
64853092|NCT01700426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853111|NCT01700478|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64853112|NCT01700491|Ropivacaine|ropivacaine|mesh-list
64853113|NCT01700491|Anesthetics, Local|anesthetics, local|mesh-ancestor
64853114|NCT01700491|Anesthetics|anesthetics|mesh-ancestor
64853115|NCT01700491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64853116|NCT01700491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853117|NCT01700491|Sensory System Agents|sensory system agents|mesh-ancestor
64853118|NCT01700491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64853119|NCT01700504|Gentamicins|gentamicins|mesh-list
64780167|NCT02468700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64780168|NCT02468700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64780169|NCT02468700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64391556|NCT02416999|Alkylating Agents|alkylating agents|mesh-ancestor
64780170|NCT02472522|Dexmedetomidine|dexmedetomidine|mesh-list
64780171|NCT02472522|Ropivacaine|ropivacaine|mesh-list
64780172|NCT02472522|Adrenergic Agonists|adrenergic agonists|mesh-list
64780173|NCT02472522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64780174|NCT02472522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64780175|NCT02472522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780176|NCT02472522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64853133|NCT01700790|Ritonavir|ritonavir|mesh-list
64853134|NCT01700790|Lopinavir|lopinavir|mesh-list
64853135|NCT01700790|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64853136|NCT01700790|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64853137|NCT01700790|Protease Inhibitors|protease inhibitors|mesh-ancestor
64853138|NCT01700790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853139|NCT01700790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853140|NCT01700790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64853141|NCT01700790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64853142|NCT01700790|Antiviral Agents|antiviral agents|mesh-ancestor
64853143|NCT01700790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64853144|NCT01700790|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64853145|NCT01700790|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64853146|NCT01700803|Iodine|iodine|mesh-list
64853147|NCT01700803|Cadexomer iodine|cadexomer iodine|mesh-list
64853148|NCT01700803|Povidone-Iodine|povidone-iodine|mesh-list
64853149|NCT01700803|Povidone|povidone|mesh-list
64853150|NCT01700803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64853151|NCT01700803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64853152|NCT01700803|Trace Elements|trace elements|mesh-ancestor
64853153|NCT01700803|Micronutrients|micronutrients|mesh-ancestor
64853154|NCT01700803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853155|NCT01700803|Plasma Substitutes|plasma substitutes|mesh-ancestor
64853156|NCT01700803|Blood Substitutes|blood substitutes|mesh-ancestor
64853157|NCT01700881|Vitamin E|vitamin e|mesh-list
64780177|NCT02472522|Analgesics|analgesics|mesh-ancestor
64780178|NCT02472522|Sensory System Agents|sensory system agents|mesh-ancestor
64780179|NCT02472522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780180|NCT02472522|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64780181|NCT02472522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64853188|NCT01701089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64853189|NCT01701089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64780182|NCT02472522|Adrenergic Agents|adrenergic agents|mesh-ancestor
64780183|NCT02472522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64780184|NCT02472522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780185|NCT02472522|Anesthetics, Local|anesthetics, local|mesh-ancestor
64780186|NCT02472522|Anesthetics|anesthetics|mesh-ancestor
64853190|NCT01701089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64853191|NCT01701089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64853192|NCT01701089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853193|NCT01701089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853194|NCT01701089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64853195|NCT01701089|Protective Agents|protective agents|mesh-ancestor
64391583|NCT03175705|Sensory System Agents|sensory system agents|mesh-ancestor
64391584|NCT03175705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64391585|NCT03175705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391586|NCT03175705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64391587|NCT03175705|Antimetabolites|antimetabolites|mesh-ancestor
64391588|NCT03175705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391589|NCT00301457|Anastrozole|anastrozole|mesh-list
64391590|NCT00301457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64391591|NCT00301457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64391592|NCT00301457|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64391593|NCT00301457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64391594|NCT00301457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391595|NCT00301457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391596|NCT00301457|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64780187|NCT02480166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64780189|NCT02480166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64780190|NCT02481258|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
64780191|NCT02481258|Enzyme Activators|enzyme activators|mesh-ancestor
64780192|NCT02481258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780193|NCT02484222|Fentanyl|fentanyl|mesh-list
64780194|NCT02484222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64780195|NCT02484222|Narcotics|narcotics|mesh-ancestor
64780196|NCT02484222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64780197|NCT02484222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780198|NCT02484222|Analgesics|analgesics|mesh-ancestor
64780199|NCT02484222|Sensory System Agents|sensory system agents|mesh-ancestor
64780200|NCT02484222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780201|NCT02484222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64780202|NCT02484222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64780203|NCT02484222|Anesthetics, General|anesthetics, general|mesh-ancestor
64853196|NCT01701089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853198|NCT01701180|Oxytocics|oxytocics|mesh-ancestor
64853199|NCT01701180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64853200|NCT01701180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853201|NCT01701219|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64853202|NCT01701219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64853203|NCT01701219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64853204|NCT01701232|Rituximab|rituximab|mesh-list
64853205|NCT01701232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64853206|NCT01701232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853207|NCT01701232|Immunologic Factors|immunologic factors|mesh-ancestor
64853208|NCT01701232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853209|NCT01701232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64853210|NCT01701297|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64780204|NCT02484222|Anesthetics|anesthetics|mesh-ancestor
64780205|NCT02486016|Fentanyl|fentanyl|mesh-list
64780206|NCT02486016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64780207|NCT02486016|Narcotics|narcotics|mesh-ancestor
64780208|NCT02486016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64780209|NCT02486016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780210|NCT02486016|Analgesics|analgesics|mesh-ancestor
64780211|NCT02486016|Sensory System Agents|sensory system agents|mesh-ancestor
64780212|NCT02486016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780216|NCT02486016|Anesthetics|anesthetics|mesh-ancestor
64780234|NCT02486328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780235|NCT02486328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64780236|NCT02486328|Narcotics|narcotics|mesh-ancestor
64780237|NCT02486328|Analgesics|analgesics|mesh-ancestor
64780238|NCT02486328|Sensory System Agents|sensory system agents|mesh-ancestor
64780239|NCT02486328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64853211|NCT01701297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64853212|NCT01701297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64853213|NCT01701297|Renal Agents|renal agents|mesh-ancestor
64853214|NCT01701297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64853215|NCT01701297|Antimalarials|antimalarials|mesh-ancestor
64853216|NCT01701297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64853217|NCT01701297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64853218|NCT01701323|Cytarabine|cytarabine|mesh-list
64853219|NCT01701323|Fludarabine|fludarabine|mesh-list
64853220|NCT01701323|Fludarabine phosphate|fludarabine phosphate|mesh-list
64853221|NCT01701323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853222|NCT01701323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64853223|NCT01701323|Antimetabolites|antimetabolites|mesh-ancestor
64853224|NCT01701323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853225|NCT01701323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64853226|NCT01701323|Immunologic Factors|immunologic factors|mesh-ancestor
64853227|NCT01701323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780240|NCT02491788|Suvorexant|suvorexant|mesh-list
64780241|NCT02491788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64780242|NCT02491788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64780243|NCT02491788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64780244|NCT02491788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780245|NCT02491788|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64780246|NCT02491788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64332323|NCT03105245|Thiopental|thiopental|mesh-list
64332324|NCT03105245|Anesthetics|anesthetics|mesh-list
64332325|NCT03105245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64332326|NCT03105245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332327|NCT03105245|Anticonvulsants|anticonvulsants|mesh-ancestor
64332328|NCT03105245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64332329|NCT03105245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64332330|NCT03105245|Anesthetics, General|anesthetics, general|mesh-ancestor
64332331|NCT03105245|GABA Modulators|gaba modulators|mesh-ancestor
64332332|NCT03105245|GABA Agents|gaba agents|mesh-ancestor
64332333|NCT03105245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64853263|NCT01701479|Analgesics|analgesics|mesh-ancestor
64853264|NCT01701479|Sensory System Agents|sensory system agents|mesh-ancestor
64853265|NCT01701479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64853266|NCT01701479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853267|NCT01701479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64853268|NCT01701479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64853269|NCT01701479|Antiviral Agents|antiviral agents|mesh-ancestor
64853270|NCT01701479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64853271|NCT01701479|Dermatologic Agents|dermatologic agents|mesh-ancestor
64853272|NCT01701518|Dexamethasone|dexamethasone|mesh-list
64853273|NCT01701518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64853274|NCT01701518|Antiemetics|antiemetics|mesh-ancestor
64853275|NCT01701518|Autonomic Agents|autonomic agents|mesh-ancestor
64853276|NCT01701518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64853277|NCT01701518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853278|NCT01701518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64853279|NCT01701518|Glucocorticoids|glucocorticoids|mesh-ancestor
64853280|NCT01701518|Hormones|hormones|mesh-ancestor
64853281|NCT01701518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64853283|NCT01701518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780247|NCT02491788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780248|NCT02491944|Osimertinib|osimertinib|mesh-list
64780249|NCT02491944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780250|NCT02491944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64780251|NCT02491944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391646|NCT02703259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64391647|NCT02703259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64391648|NCT02703259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64391649|NCT02703259|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64391650|NCT02703259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64853292|NCT01701739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853293|NCT01701739|Protective Agents|protective agents|mesh-ancestor
64853294|NCT01701739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853295|NCT01701778|Dexmedetomidine|dexmedetomidine|mesh-list
64853296|NCT01701778|Sevoflurane|sevoflurane|mesh-list
64853297|NCT01701778|Levobupivacaine|levobupivacaine|mesh-list
64853298|NCT01701778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64853299|NCT01701778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64853300|NCT01701778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853301|NCT01701778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64853302|NCT01701778|Analgesics|analgesics|mesh-ancestor
64853303|NCT01701778|Sensory System Agents|sensory system agents|mesh-ancestor
64853304|NCT01701778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64332334|NCT03105245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332336|NCT03092674|Nivolumab|nivolumab|mesh-list
64332337|NCT03092674|Azacitidine|azacitidine|mesh-list
64332338|NCT03092674|Decitabine|decitabine|mesh-list
64332339|NCT03092674|Midostaurin|midostaurin|mesh-list
64332340|NCT03092674|Staurosporine|staurosporine|mesh-list
64332341|NCT03092674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64332342|NCT03092674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332343|NCT03092674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64332344|NCT03092674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332345|NCT03092674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64332346|NCT03092674|Antimetabolites|antimetabolites|mesh-ancestor
64332347|NCT03092674|Antiviral Agents|antiviral agents|mesh-ancestor
64332348|NCT03092674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64295168|NCT04695704|Montelukast|montelukast|mesh-list
64391651|NCT02703259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391652|NCT02703259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391653|NCT02703259|Anticonvulsants|anticonvulsants|mesh-ancestor
64391654|NCT02703259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64391655|NCT02703259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64780252|NCT02491944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780254|NCT02492802|Antifungal Agents|antifungal agents|mesh-ancestor
64780255|NCT02492802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64853305|NCT01701778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64853306|NCT01701778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64853307|NCT01701778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64853308|NCT01701778|Adrenergic Agents|adrenergic agents|mesh-ancestor
64853309|NCT01701778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64853310|NCT01701778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853311|NCT01701778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64853312|NCT01701778|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64853313|NCT01701778|Anesthetics, General|anesthetics, general|mesh-ancestor
64853314|NCT01701778|Anesthetics|anesthetics|mesh-ancestor
64853316|NCT01701843|Cromolyn Sodium|cromolyn sodium|mesh-list
64780256|NCT02492802|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64780257|NCT02492802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64780258|NCT02492802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64303698|NCT03548311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303699|NCT01653262|Brivaracetam|brivaracetam|mesh-list
64780259|NCT02492802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64780260|NCT02492802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64780261|NCT02492802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780262|NCT02492802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780263|NCT02492802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64780264|NCT02492802|Hormone Antagonists|hormone antagonists|mesh-ancestor
64780265|NCT02492802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64780266|NCT02492802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780267|NCT02495454|Obinutuzumab|obinutuzumab|mesh-list
64853361|NCT01702038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853362|NCT01702038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64853363|NCT01702090|Ritonavir|ritonavir|mesh-list
64853364|NCT01702090|Darunavir|darunavir|mesh-list
64853365|NCT01702090|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64853366|NCT01702090|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64853367|NCT01702090|Protease Inhibitors|protease inhibitors|mesh-ancestor
64853368|NCT01702090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853369|NCT01702090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853370|NCT01702090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64853371|NCT01702090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64853372|NCT01702090|Antiviral Agents|antiviral agents|mesh-ancestor
64853373|NCT01702090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64853374|NCT01702090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64853375|NCT01702090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64332349|NCT03092674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64332350|NCT03092674|Immunologic Factors|immunologic factors|mesh-ancestor
64332351|NCT03092674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332352|NCT03092674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64332353|NCT03092674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64332354|NCT03057106|Durvalumab|durvalumab|mesh-list
64332355|NCT03057106|Tremelimumab|tremelimumab|mesh-list
64332356|NCT03057106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64332357|NCT03057106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332360|NCT03027388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64332361|NCT03027388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332362|NCT03020199|Betamethasone|betamethasone|mesh-list
64332363|NCT03020199|Calcipotriene|calcipotriene|mesh-list
64332364|NCT03020199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64780268|NCT02495454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64780269|NCT02495454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780271|NCT02500602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64780272|NCT02500602|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64780273|NCT02500602|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64780274|NCT02500602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64780275|NCT02500602|Adrenergic Agents|adrenergic agents|mesh-ancestor
64391668|NCT02411695|Brexpiprazole|brexpiprazole|mesh-list
64780276|NCT02500602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64780277|NCT02500602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780278|NCT02500602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780279|NCT02500836|Cocaine|cocaine|mesh-list
64853376|NCT01702103|Mometasone Furoate|mometasone furoate|mesh-list
64853377|NCT01702103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64853378|NCT01702103|Dermatologic Agents|dermatologic agents|mesh-ancestor
64853379|NCT01702103|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64853380|NCT01702129|Doxorubicin|doxorubicin|mesh-list
64853381|NCT01702129|Cetuximab|cetuximab|mesh-list
64853382|NCT01702129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64853383|NCT01702129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853384|NCT01702129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64853385|NCT01702129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64853386|NCT01702129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853387|NCT01702129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853389|NCT01702181|Tacrolimus|tacrolimus|mesh-list
64780280|NCT02500836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64780281|NCT02500836|Anesthetics, Local|anesthetics, local|mesh-ancestor
64780282|NCT02500836|Anesthetics|anesthetics|mesh-ancestor
64780283|NCT02500836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64780284|NCT02500836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780285|NCT02500836|Sensory System Agents|sensory system agents|mesh-ancestor
64780286|NCT02500836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303700|NCT01653262|Anticonvulsants|anticonvulsants|mesh-ancestor
64303701|NCT02455336|Fenofibrate|fenofibrate|mesh-list
64303702|NCT02455336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64303703|NCT02455336|Antimetabolites|antimetabolites|mesh-ancestor
64303704|NCT02455336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303705|NCT02455336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64303706|NCT02253121|Insulin|insulin|mesh-list
64303707|NCT02253121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64853425|NCT01702610|Temozolomide|temozolomide|mesh-list
64853427|NCT01702610|Alkylating Agents|alkylating agents|mesh-ancestor
64303708|NCT02253121|Dapagliflozin|dapagliflozin|mesh-list
64303709|NCT02253121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64853498|NCT01702857|Antacids|antacids|mesh-ancestor
64303711|NCT02253121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64303712|NCT02253121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303713|NCT03548233|BCG Vaccine|bcg vaccine|mesh-list
64303714|NCT03548233|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64303715|NCT03548233|Immunologic Factors|immunologic factors|mesh-ancestor
64303716|NCT03548233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780289|NCT02500836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64780290|NCT02500836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64780291|NCT02500836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853579|NCT01703468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64853580|NCT01703468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64853581|NCT01703468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64853582|NCT01703468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853583|NCT01703468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64853584|NCT01703468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64853585|NCT01703559|Phentolamine|phentolamine|mesh-list
64853586|NCT01703559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64853587|NCT01703559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64853588|NCT01703559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64853589|NCT01703559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64853590|NCT01703559|Adrenergic Agents|adrenergic agents|mesh-ancestor
64853591|NCT01703559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64853592|NCT01703559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853593|NCT01703559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853594|NCT01703559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64853595|NCT01703624|Glycopyrrolate|glycopyrrolate|mesh-list
64853596|NCT01703624|Bromides|bromides|mesh-list
64853597|NCT01703624|Anticonvulsants|anticonvulsants|mesh-ancestor
64853598|NCT01703624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64853599|NCT01703624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64853600|NCT01703624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64853601|NCT01703624|Cholinergic Agents|cholinergic agents|mesh-ancestor
64780292|NCT02500836|Dopamine Agents|dopamine agents|mesh-ancestor
64780293|NCT02500836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64780294|NCT02508636|Leuprolide|leuprolide|mesh-list
64780295|NCT02508636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64780296|NCT02508636|Fertility Agents|fertility agents|mesh-ancestor
64780297|NCT02508636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64780298|NCT02508636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391689|NCT02411149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64853618|NCT01703728|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64853619|NCT01703728|Fertility Agents|fertility agents|mesh-ancestor
64853620|NCT01703728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64853621|NCT01703728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853622|NCT01703754|Isophosphamide mustard|isophosphamide mustard|mesh-list
64853623|NCT01703754|Ifosfamide|ifosfamide|mesh-list
64853624|NCT01703754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64853625|NCT01703754|Alkylating Agents|alkylating agents|mesh-ancestor
64853626|NCT01703754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853627|NCT01703754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853628|NCT01703910|Gemcitabine|gemcitabine|mesh-list
64853629|NCT01703910|Paclitaxel|paclitaxel|mesh-list
64853630|NCT01703910|Etoposide|etoposide|mesh-list
64853631|NCT01703910|Vinorelbine|vinorelbine|mesh-list
64853632|NCT01703910|Docetaxel|docetaxel|mesh-list
64853633|NCT01703910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64853634|NCT01703910|Cisplatin|cisplatin|mesh-list
64853635|NCT01703910|Doxorubicin|doxorubicin|mesh-list
64853636|NCT01703910|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64853637|NCT01703910|Fluorouracil|fluorouracil|mesh-list
64853638|NCT01703910|Capecitabine|capecitabine|mesh-list
64853639|NCT01703910|Oxaliplatin|oxaliplatin|mesh-list
64853640|NCT01703910|Irinotecan|irinotecan|mesh-list
64853641|NCT01703910|Etoposide phosphate|etoposide phosphate|mesh-list
64853642|NCT01703910|Pemetrexed|pemetrexed|mesh-list
64332372|NCT03020199|Immunologic Factors|immunologic factors|mesh-ancestor
64332373|NCT03020199|Dermatologic Agents|dermatologic agents|mesh-ancestor
64853643|NCT01703910|Cetuximab|cetuximab|mesh-list
64853644|NCT01703910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64853645|NCT01703910|Sorafenib|sorafenib|mesh-list
64853646|NCT01703910|Topotecan|topotecan|mesh-list
64853647|NCT01703910|Dasatinib|dasatinib|mesh-list
64853648|NCT01703910|Mitomycins|mitomycins|mesh-list
64853649|NCT01703910|Mitomycin|mitomycin|mesh-list
64853650|NCT01703910|Raltitrexed|raltitrexed|mesh-list
64853651|NCT01703910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64853652|NCT01703910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853653|NCT01703910|Tubulin Modulators|tubulin modulators|mesh-ancestor
64391690|NCT02411149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391691|NCT02411149|Analgesics|analgesics|mesh-ancestor
64391692|NCT02411149|Sensory System Agents|sensory system agents|mesh-ancestor
64391693|NCT02411149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64391694|NCT02411149|Anesthetics, Local|anesthetics, local|mesh-ancestor
64391695|NCT02411149|Anesthetics|anesthetics|mesh-ancestor
64391696|NCT02411149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64391697|NCT02411149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64391698|NCT02411149|Adrenergic Agents|adrenergic agents|mesh-ancestor
64391699|NCT02411149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64391700|NCT02411149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780299|NCT02508636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64780300|NCT02508636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780301|NCT02513940|Ibutilide|ibutilide|mesh-list
64853654|NCT01703910|Antimitotic Agents|antimitotic agents|mesh-ancestor
64853655|NCT01703910|Mitosis Modulators|mitosis modulators|mesh-ancestor
64853656|NCT01703910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853657|NCT01703910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64853658|NCT01703910|Antimetabolites|antimetabolites|mesh-ancestor
64853659|NCT01703910|Antiviral Agents|antiviral agents|mesh-ancestor
64853660|NCT01703910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64853661|NCT01703910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853662|NCT01703910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64853663|NCT01703910|Immunologic Factors|immunologic factors|mesh-ancestor
64853664|NCT01703910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853665|NCT01703910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64853666|NCT01703910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64853667|NCT01703910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64853668|NCT01703910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64780302|NCT02513940|Testosterone|testosterone|mesh-list
64780303|NCT02513940|Progesterone|progesterone|mesh-list
64780304|NCT02513940|Androgens|androgens|mesh-ancestor
64780305|NCT02513940|Hormones|hormones|mesh-ancestor
64780306|NCT02513940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64780307|NCT02513940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780308|NCT02513940|Progestins|progestins|mesh-ancestor
64780309|NCT02513940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64780310|NCT02515890|Midazolam|midazolam|mesh-list
64780311|NCT02515890|Dexmedetomidine|dexmedetomidine|mesh-list
64780312|NCT02515890|Ketamine|ketamine|mesh-list
64853689|NCT01704092|Adrenergic Agents|adrenergic agents|mesh-ancestor
64853690|NCT01704092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64853691|NCT01704092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853692|NCT01704248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64853693|NCT01704248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64853694|NCT01704339|Capsaicin|capsaicin|mesh-list
64853695|NCT01704339|Antipruritics|antipruritics|mesh-ancestor
64853696|NCT01704339|Dermatologic Agents|dermatologic agents|mesh-ancestor
64853697|NCT01704339|Sensory System Agents|sensory system agents|mesh-ancestor
64853698|NCT01704339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64853699|NCT01704339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853700|NCT01704378|Insulin Aspart|insulin aspart|mesh-list
64853701|NCT01704378|Biphasic Insulins|biphasic insulins|mesh-list
64853702|NCT01704378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64853703|NCT01704378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853704|NCT01704417|Insulin|insulin|mesh-list
64853705|NCT01704417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64853706|NCT01704417|Insulin Glargine|insulin glargine|mesh-list
64853707|NCT01704417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64853708|NCT01704417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853709|NCT01704469|Anesthetics|anesthetics|mesh-list
64853710|NCT01704469|Anesthetics, Local|anesthetics, local|mesh-list
64853711|NCT01704469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64853712|NCT01704469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853713|NCT01704469|Sensory System Agents|sensory system agents|mesh-ancestor
64853714|NCT01704469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780313|NCT02515890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64780314|NCT02515890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64780315|NCT02515890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780316|NCT02515890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64780318|NCT02515890|Sensory System Agents|sensory system agents|mesh-ancestor
64780319|NCT02515890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780320|NCT02515890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64780321|NCT02515890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64853729|NCT01704508|Piperaquine|piperaquine|mesh-list
64853730|NCT01704508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64853731|NCT01704508|Artenimol|artenimol|mesh-list
64853732|NCT01704508|Antimalarials|antimalarials|mesh-ancestor
64853733|NCT01704508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64853734|NCT01704508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64853735|NCT01704508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64853736|NCT01704534|Ustekinumab|ustekinumab|mesh-list
64853737|NCT01704534|Dermatologic Agents|dermatologic agents|mesh-ancestor
64853738|NCT01704612|Ropivacaine|ropivacaine|mesh-list
64853739|NCT01704612|Anesthetics, Local|anesthetics, local|mesh-ancestor
64853740|NCT01704612|Anesthetics|anesthetics|mesh-ancestor
64780322|NCT02515890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64780323|NCT02515890|Adrenergic Agents|adrenergic agents|mesh-ancestor
64780324|NCT02515890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64780325|NCT02515890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780326|NCT02515890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64780327|NCT02515890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64780328|NCT02515890|Anesthetics, General|anesthetics, general|mesh-ancestor
64853797|NCT01704716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853798|NCT01704716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64853799|NCT01704716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64853800|NCT01704716|Alkylating Agents|alkylating agents|mesh-ancestor
64853801|NCT01704716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853802|NCT01704716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853803|NCT01704716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64853804|NCT01704716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64853805|NCT01704716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64853806|NCT01704716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64853807|NCT01704716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853808|NCT01704716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64853809|NCT01704716|Tubulin Modulators|tubulin modulators|mesh-ancestor
64853810|NCT01704716|Antimitotic Agents|antimitotic agents|mesh-ancestor
64780329|NCT02515890|Anesthetics|anesthetics|mesh-ancestor
64391715|NCT04413227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780330|NCT02515890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64780331|NCT02515890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64780332|NCT02515890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64780333|NCT02515890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64780334|NCT02515890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64780335|NCT02515890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64780337|NCT02515890|GABA Agents|gaba agents|mesh-ancestor
64780338|NCT02517996|Lidocaine|lidocaine|mesh-list
64780339|NCT02517996|Anesthetics, Local|anesthetics, local|mesh-ancestor
64780340|NCT02517996|Anesthetics|anesthetics|mesh-ancestor
64780341|NCT02517996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64780342|NCT02517996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853874|NCT01705249|Norethindrone|norethindrone|mesh-list
64853875|NCT01705249|Norethindrone Acetate|norethindrone acetate|mesh-list
64853876|NCT01705249|Estradiol|estradiol|mesh-list
64853877|NCT01705249|Estrogens|estrogens|mesh-ancestor
64853878|NCT01705249|Hormones|hormones|mesh-ancestor
64853879|NCT01705249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64853880|NCT01705249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853881|NCT01705249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64853882|NCT01705249|Contraceptive Agents|contraceptive agents|mesh-ancestor
64853883|NCT01705249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64853884|NCT01705249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64853885|NCT01705249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64853886|NCT01705249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64853887|NCT01705249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64853888|NCT01705314|Vitamin D|vitamin d|mesh-list
64853889|NCT01705314|Vitamins|vitamins|mesh-ancestor
64853890|NCT01705314|Micronutrients|micronutrients|mesh-ancestor
64853891|NCT01705314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853892|NCT01705314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64780343|NCT02517996|Sensory System Agents|sensory system agents|mesh-ancestor
64780344|NCT02517996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780345|NCT02517996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64780346|NCT02517996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64780347|NCT02517996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64780348|NCT02517996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64780349|NCT02517996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780350|NCT02525718|Dexamethasone|dexamethasone|mesh-list
64780351|NCT02525718|Epinephrine|epinephrine|mesh-list
64780352|NCT02525718|Bupivacaine|bupivacaine|mesh-list
64780353|NCT02525718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64780354|NCT02525718|Antiemetics|antiemetics|mesh-ancestor
64780355|NCT02525718|Autonomic Agents|autonomic agents|mesh-ancestor
64780356|NCT02525718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780357|NCT02525718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780358|NCT02525718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64780359|NCT02525718|Glucocorticoids|glucocorticoids|mesh-ancestor
64780360|NCT02525718|Hormones|hormones|mesh-ancestor
64780361|NCT02525718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64780362|NCT02525718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64332408|NCT02959944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64853936|NCT01705457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853937|NCT01705470|Furosemide|furosemide|mesh-list
64853938|NCT01705470|Diuretics|diuretics|mesh-ancestor
64853939|NCT01705470|Natriuretic Agents|natriuretic agents|mesh-ancestor
64853940|NCT01705470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853941|NCT01705470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64853942|NCT01705470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64853943|NCT01705470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853944|NCT01705483|Paclitaxel|paclitaxel|mesh-list
64853945|NCT01705483|Docetaxel|docetaxel|mesh-list
64853946|NCT01705483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64332428|NCT02890355|Leucovorin|leucovorin|mesh-list
64780363|NCT02525718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780364|NCT02525718|Anesthetics, Local|anesthetics, local|mesh-ancestor
64780365|NCT02525718|Anesthetics|anesthetics|mesh-ancestor
64780366|NCT02525718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64780367|NCT02525718|Sensory System Agents|sensory system agents|mesh-ancestor
64853953|NCT01705639|Antioxidants|antioxidants|mesh-ancestor
64780368|NCT02525718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64780369|NCT02525718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64780370|NCT02525718|Adrenergic Agents|adrenergic agents|mesh-ancestor
64780371|NCT02525718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64780372|NCT02525718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780373|NCT02525718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64362219|NCT02480335|Bosentan|bosentan|mesh-list
64780383|NCT02527512|Blood Substitutes|blood substitutes|mesh-ancestor
64780384|NCT02527512|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64780385|NCT02527512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64780386|NCT02529072|Nivolumab|nivolumab|mesh-list
64780387|NCT02529072|Vaccines|vaccines|mesh-list
64780388|NCT02529072|Immunologic Factors|immunologic factors|mesh-ancestor
64853988|NCT01705951|Nicotine|nicotine|mesh-list
64391772|NCT01619878|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64780389|NCT02529072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780390|NCT02529072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64780391|NCT02529072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780392|NCT02529072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64780393|NCT02529072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780395|NCT02530476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780396|NCT02530476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64780397|NCT02530476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780398|NCT02530476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780399|NCT02530554|Chlorhexidine|chlorhexidine|mesh-list
64854030|NCT01706367|Immunologic Factors|immunologic factors|mesh-ancestor
64854031|NCT01706367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854032|NCT01706471|Mycophenolic Acid|mycophenolic acid|mesh-list
64854033|NCT01706471|Everolimus|everolimus|mesh-list
64854034|NCT01706471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854035|NCT01706471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64854036|NCT01706471|Immunologic Factors|immunologic factors|mesh-ancestor
64854037|NCT01706471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854038|NCT01706471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64854039|NCT01706471|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64854040|NCT01706471|Antitubercular Agents|antitubercular agents|mesh-ancestor
64854041|NCT01706471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64854042|NCT01706471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64854043|NCT01706471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854044|NCT01706471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332501|NCT02723331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332502|NCT02723331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64780400|NCT02530554|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64780401|NCT02530554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64780402|NCT02530554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64780403|NCT02530554|Disinfectants|disinfectants|mesh-ancestor
64780404|NCT02530554|Dermatologic Agents|dermatologic agents|mesh-ancestor
64780405|NCT02536248|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64780406|NCT02536248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64780407|NCT02536248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780408|NCT02536248|Incretins|incretins|mesh-ancestor
64780409|NCT02536248|Hormones|hormones|mesh-ancestor
64780410|NCT02536248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64780411|NCT02536248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64780412|NCT02536248|Protease Inhibitors|protease inhibitors|mesh-ancestor
64780413|NCT02536248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780414|NCT02536248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391804|NCT04666714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64391805|NCT04666714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64391806|NCT04666714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64391807|NCT01668719|Dexamethasone|dexamethasone|mesh-list
64391808|NCT01668719|Dexamethasone acetate|dexamethasone acetate|mesh-list
64391809|NCT01668719|Lenalidomide|lenalidomide|mesh-list
64391810|NCT01668719|Bortezomib|bortezomib|mesh-list
64391811|NCT01668719|Elotuzumab|elotuzumab|mesh-list
64391812|NCT01668719|Ichthammol|ichthammol|mesh-list
64854062|NCT01706562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64854063|NCT01706562|Hormone Antagonists|hormone antagonists|mesh-ancestor
64854064|NCT01706562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64854065|NCT01706562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854066|NCT01706562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64854067|NCT01706627|Melatonin|melatonin|mesh-list
64854068|NCT01706627|Antioxidants|antioxidants|mesh-ancestor
64854069|NCT01706627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854070|NCT01706627|Protective Agents|protective agents|mesh-ancestor
64854100|NCT01707082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64854101|NCT01707082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64854102|NCT01707082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64854105|NCT01707082|GABA Modulators|gaba modulators|mesh-ancestor
64854106|NCT01707082|GABA Agents|gaba agents|mesh-ancestor
64854107|NCT01707082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64854108|NCT01707082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854109|NCT01707134|Insulin|insulin|mesh-list
64854110|NCT01707134|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64854111|NCT01707134|Insulin Aspart|insulin aspart|mesh-list
64854112|NCT01707134|Isophane Insulin, Human|isophane insulin, human|mesh-list
64854113|NCT01707134|Insulin, Isophane|insulin, isophane|mesh-list
64854114|NCT01707134|Isophane insulin, beef|isophane insulin, beef|mesh-list
64854115|NCT01707134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64391813|NCT01668719|BB 1101|bb 1101|mesh-list
64391821|NCT01668719|Hormones|hormones|mesh-ancestor
64780415|NCT02538042|Nicotine|nicotine|mesh-list
64780416|NCT02538042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64780418|NCT02538042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780419|NCT02538042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780420|NCT02538042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64780421|NCT02538042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64854142|NCT01707251|Ibuprofen|ibuprofen|mesh-list
64854143|NCT01707251|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64854144|NCT01707251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64780422|NCT02538042|Cholinergic Agents|cholinergic agents|mesh-ancestor
64780423|NCT02538042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64780424|NCT02538042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780425|NCT02538354|Riboflavin|riboflavin|mesh-list
64780426|NCT02538354|Vitamins|vitamins|mesh-ancestor
64780427|NCT02538354|Micronutrients|micronutrients|mesh-ancestor
64780428|NCT02538354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780429|NCT02538354|Vitamin B Complex|vitamin b complex|mesh-ancestor
64780430|NCT02538354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64780431|NCT02538354|Dermatologic Agents|dermatologic agents|mesh-ancestor
64780432|NCT02540226|Tranexamic Acid|tranexamic acid|mesh-list
64780433|NCT02540226|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64780434|NCT02540226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64854206|NCT01707407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64854207|NCT01707407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64854208|NCT01707407|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64854209|NCT01707407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64854210|NCT01707407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64854211|NCT01707407|Serotonin Agents|serotonin agents|mesh-ancestor
64854212|NCT01707407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64854213|NCT01707407|Antidepressive Agents|antidepressive agents|mesh-ancestor
64854214|NCT01707407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64854215|NCT01707407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64854216|NCT01707537|Vaccines|vaccines|mesh-list
64854217|NCT01707537|Immunologic Factors|immunologic factors|mesh-ancestor
64854218|NCT01707537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854220|NCT01707615|Antioxidants|antioxidants|mesh-ancestor
64854221|NCT01707615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854222|NCT01707615|Protective Agents|protective agents|mesh-ancestor
64854223|NCT01707615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854224|NCT01707615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64854225|NCT01707615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64854226|NCT01707615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64854227|NCT01707732|Enoxaparin|enoxaparin|mesh-list
64854228|NCT01707732|Anticoagulants|anticoagulants|mesh-ancestor
64854229|NCT01707732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64854230|NCT01707732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64854231|NCT01707732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854232|NCT01707745|Bevacizumab|bevacizumab|mesh-list
64622704|NCT02534038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854233|NCT01707745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64332589|NCT02455557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780435|NCT02540226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780436|NCT02540226|Hemostatics|hemostatics|mesh-ancestor
64780437|NCT02540226|Coagulants|coagulants|mesh-ancestor
64391832|NCT01668719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391833|NCT01668719|Dermatologic Agents|dermatologic agents|mesh-ancestor
64391834|NCT01261247|Panobinostat|panobinostat|mesh-list
64391835|NCT01261247|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
64391836|NCT01261247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780439|NCT02541864|Metronidazole|metronidazole|mesh-list
64780440|NCT02541864|Clarithromycin|clarithromycin|mesh-list
64780441|NCT02541864|Tetracycline|tetracycline|mesh-list
64780442|NCT02541864|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
64780443|NCT02541864|Pantoprazole|pantoprazole|mesh-list
64780444|NCT02541864|Bismuth|bismuth|mesh-list
64332590|NCT02455557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64332592|NCT02401139|Analgesics|analgesics|mesh-ancestor
64332593|NCT02401139|Sensory System Agents|sensory system agents|mesh-ancestor
64332594|NCT02401139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64332595|NCT02401139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332596|NCT02401139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64332597|NCT02401139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64332598|NCT02401139|Anesthetics, General|anesthetics, general|mesh-ancestor
64332599|NCT02401139|Anesthetics|anesthetics|mesh-ancestor
64332600|NCT02401139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64854234|NCT01707745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854235|NCT01707745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64854236|NCT01707745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64854237|NCT01707745|Growth Substances|growth substances|mesh-ancestor
64854238|NCT01707745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854239|NCT01707745|Growth Inhibitors|growth inhibitors|mesh-ancestor
64854240|NCT01707823|Aspirin|aspirin|mesh-list
64854241|NCT01707823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64854242|NCT01707823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64854243|NCT01707823|Analgesics|analgesics|mesh-ancestor
64854244|NCT01707823|Sensory System Agents|sensory system agents|mesh-ancestor
64854245|NCT01707823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64854246|NCT01707823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854247|NCT01707823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64854248|NCT01707823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64854249|NCT01707823|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64854250|NCT01707823|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64854251|NCT01707823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780445|NCT02541864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64780446|NCT02541864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64780447|NCT02541864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64780448|NCT02541864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64780449|NCT02541864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64780450|NCT02541864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780451|NCT02541864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780452|NCT02541864|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64780453|NCT02541864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64780454|NCT02541864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64780455|NCT02541864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64780456|NCT02541864|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64780457|NCT02541864|Antacids|antacids|mesh-ancestor
64780458|NCT02542410|Cabergoline|cabergoline|mesh-list
64780459|NCT02542410|Norethindrone|norethindrone|mesh-list
64780460|NCT02542410|Norethindrone Acetate|norethindrone acetate|mesh-list
64780461|NCT02542410|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64780462|NCT02542410|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64780463|NCT02542410|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64780464|NCT02542410|Contraceptive Agents|contraceptive agents|mesh-ancestor
64780465|NCT02542410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64854311|NCT01708330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64854312|NCT01708330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854313|NCT01708369|Aspirin|aspirin|mesh-list
64854314|NCT01708369|Ethanol|ethanol|mesh-list
64854330|NCT01708369|Antipyretics|antipyretics|mesh-ancestor
64854331|NCT01708369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64854332|NCT01708369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64854333|NCT01708369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64854334|NCT01708369|Antiviral Agents|antiviral agents|mesh-ancestor
64854335|NCT01708447|Lidocaine|lidocaine|mesh-list
64854336|NCT01708447|Anesthetics, Local|anesthetics, local|mesh-list
64854337|NCT01708447|Anesthetics|anesthetics|mesh-list
64854338|NCT01708447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64854339|NCT01708447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854340|NCT01708447|Sensory System Agents|sensory system agents|mesh-ancestor
64854341|NCT01708447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64854342|NCT01708447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64854343|NCT01708447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64854344|NCT01708447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64854345|NCT01708447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64854346|NCT01708447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295237|NCT02048683|Anesthetics|anesthetics|mesh-ancestor
64391854|NCT02449655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391855|NCT04254731|Methadone|methadone|mesh-list
64391856|NCT04254731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64362380|NCT02479555|Dexamethasone|dexamethasone|mesh-list
64324264|NCT05488106|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64324265|NCT05488106|Dermatologic Agents|dermatologic agents|mesh-ancestor
64780466|NCT02542410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780467|NCT02542410|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64780468|NCT02542410|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64854347|NCT01708616|Risperidone|risperidone|mesh-list
64854348|NCT01708616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64854349|NCT01708616|Serotonin Agents|serotonin agents|mesh-ancestor
64854350|NCT01708616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64854351|NCT01708616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854358|NCT01708616|Dopamine Agents|dopamine agents|mesh-ancestor
64780469|NCT02542410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64854410|NCT01708850|Protease Inhibitors|protease inhibitors|mesh-ancestor
64780470|NCT02542410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64780471|NCT02542410|Dopamine Agonists|dopamine agonists|mesh-ancestor
64780473|NCT02542410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64780474|NCT02542410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780475|NCT02544984|Azithromycin|azithromycin|mesh-list
64780476|NCT02544984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64780477|NCT02544984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64780478|NCT02547012|Amoxicillin|amoxicillin|mesh-list
64854411|NCT01708850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854412|NCT01708850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854413|NCT01708850|Anticoagulants|anticoagulants|mesh-ancestor
64854414|NCT01708876|Artesunate|artesunate|mesh-list
64332616|NCT02379416|Antimitotic Agents|antimitotic agents|mesh-ancestor
64332617|NCT02379416|Mitosis Modulators|mitosis modulators|mesh-ancestor
64332618|NCT02379416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332619|NCT02369458|Mitomycins|mitomycins|mesh-list
64332620|NCT02369458|Mitomycin|mitomycin|mesh-list
64332621|NCT02369458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64332622|NCT02369458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332623|NCT02369458|Alkylating Agents|alkylating agents|mesh-ancestor
64332624|NCT02369458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780479|NCT02547012|Levofloxacin|levofloxacin|mesh-list
64780480|NCT02547012|Ofloxacin|ofloxacin|mesh-list
64780481|NCT02547012|Tetracycline|tetracycline|mesh-list
64780482|NCT02547012|Esomeprazole|esomeprazole|mesh-list
64780483|NCT02547012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64391880|NCT01678313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64391881|NCT01678313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391882|NCT01678313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391883|NCT01678313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64391884|NCT01678313|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64391885|NCT01678313|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64391886|NCT01678313|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64391887|NCT01678313|Adrenergic Agents|adrenergic agents|mesh-ancestor
64391888|NCT01678313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64391889|NCT03197207|Camphor|camphor|mesh-list
64391890|NCT03197207|Salicylates|salicylates|mesh-list
64391891|NCT03197207|Methyl salicylate|methyl salicylate|mesh-list
64780484|NCT02547012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64780485|NCT02547012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64780486|NCT02547012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64780487|NCT02547012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64780488|NCT02547012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780489|NCT02547012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854451|NCT01709019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854452|NCT01709071|Vaccines|vaccines|mesh-list
64854453|NCT01709071|Immunologic Factors|immunologic factors|mesh-ancestor
64780491|NCT02547012|Renal Agents|renal agents|mesh-ancestor
64780492|NCT02547012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64780493|NCT02547012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64780494|NCT02547012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780495|NCT02547012|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64780496|NCT02547012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64780497|NCT02547012|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64780498|NCT02548728|Oxytocin|oxytocin|mesh-list
64780499|NCT02548728|Oxytocics|oxytocics|mesh-ancestor
64780500|NCT02548728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64780501|NCT02548728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780502|NCT02553798|Glycopyrrolate|glycopyrrolate|mesh-list
64780503|NCT02553798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64780504|NCT02553798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64780505|NCT02553798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64780506|NCT02553798|Cholinergic Agents|cholinergic agents|mesh-ancestor
64780507|NCT02553798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64780508|NCT02553798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780509|NCT02553798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780510|NCT02560038|Gemcitabine|gemcitabine|mesh-list
64391898|NCT03197207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64391899|NCT03197207|Analgesics|analgesics|mesh-ancestor
64391900|NCT03197207|Sensory System Agents|sensory system agents|mesh-ancestor
64391901|NCT03197207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780512|NCT02560038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64780514|NCT02560038|Tubulin Modulators|tubulin modulators|mesh-ancestor
64854557|NCT01709942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64854558|NCT01709955|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
64854559|NCT01709955|Cathartics|cathartics|mesh-ancestor
64854560|NCT01709955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64854561|NCT01709994|Aspirin|aspirin|mesh-list
64854562|NCT01709994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64854563|NCT01709994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64854564|NCT01709994|Analgesics|analgesics|mesh-ancestor
64854565|NCT01709994|Sensory System Agents|sensory system agents|mesh-ancestor
64854566|NCT01709994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64854567|NCT01709994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854569|NCT01709994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64780515|NCT02560038|Antimitotic Agents|antimitotic agents|mesh-ancestor
64780516|NCT02560038|Mitosis Modulators|mitosis modulators|mesh-ancestor
64780517|NCT02560038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780518|NCT02560038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64780519|NCT02560038|Antimetabolites|antimetabolites|mesh-ancestor
64780520|NCT02560038|Antiviral Agents|antiviral agents|mesh-ancestor
64780521|NCT02560038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64780522|NCT02560038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780523|NCT02560038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64854595|NCT01710072|Sensory System Agents|sensory system agents|mesh-ancestor
64854596|NCT01710072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64854597|NCT01710072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854598|NCT01710072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64854600|NCT01710072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64854601|NCT01710072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64854602|NCT01710072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854603|NCT01710072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64854604|NCT01710072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64854605|NCT01710072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854606|NCT01710072|Antipyretics|antipyretics|mesh-ancestor
64854607|NCT01710163|Aripiprazole|aripiprazole|mesh-list
64854608|NCT01710163|Antidepressive Agents|antidepressive agents|mesh-ancestor
64854609|NCT01710163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64854610|NCT01710163|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64854611|NCT01710163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64854612|NCT01710163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64854613|NCT01710163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854614|NCT01710163|Dopamine Agonists|dopamine agonists|mesh-ancestor
64854615|NCT01710163|Dopamine Agents|dopamine agents|mesh-ancestor
64854616|NCT01710163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64854617|NCT01710163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854618|NCT01710163|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64854619|NCT01710163|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64854620|NCT01710163|Serotonin Agents|serotonin agents|mesh-ancestor
64854621|NCT01710163|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64854622|NCT01710163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64780524|NCT02560038|Immunologic Factors|immunologic factors|mesh-ancestor
64780525|NCT02560038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780526|NCT02560584|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64780527|NCT02560584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64780528|NCT02560584|Dermatologic Agents|dermatologic agents|mesh-ancestor
64780529|NCT02561130|Metformin|metformin|mesh-list
64780530|NCT02561130|Insulin Glargine|insulin glargine|mesh-list
64780531|NCT02561130|Dapagliflozin|dapagliflozin|mesh-list
64780532|NCT02561130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64780533|NCT02561130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391924|NCT02449265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64391925|NCT02449265|Immunologic Factors|immunologic factors|mesh-ancestor
64391926|NCT02449265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391927|NCT02449265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64303717|NCT03568721|Acetaminophen|acetaminophen|mesh-list
64303718|NCT03568721|Ibuprofen|ibuprofen|mesh-list
64854631|NCT01710228|Prednisolone acetate|prednisolone acetate|mesh-list
64854632|NCT01710228|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64854633|NCT01710228|Prednisolone phosphate|prednisolone phosphate|mesh-list
64854634|NCT01710228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64854635|NCT01710228|Antiemetics|antiemetics|mesh-ancestor
64854636|NCT01710228|Autonomic Agents|autonomic agents|mesh-ancestor
64854637|NCT01710228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64854638|NCT01710228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854639|NCT01710228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64854640|NCT01710228|Glucocorticoids|glucocorticoids|mesh-ancestor
64854641|NCT01710228|Hormones|hormones|mesh-ancestor
64854642|NCT01710228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64854643|NCT01710228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64854644|NCT01710228|Protective Agents|protective agents|mesh-ancestor
64854645|NCT01710228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64854646|NCT01710228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854648|NCT01710384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64854649|NCT01710384|Glucocorticoids|glucocorticoids|mesh-ancestor
64854650|NCT01710384|Hormones|hormones|mesh-ancestor
64854651|NCT01710384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64854652|NCT01710384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332675|NCT02195895|Vitamins|vitamins|mesh-list
64332677|NCT02195895|Antacids|antacids|mesh-list
64303719|NCT03568721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64303720|NCT03568721|Analgesics|analgesics|mesh-ancestor
64303721|NCT03568721|Sensory System Agents|sensory system agents|mesh-ancestor
64303722|NCT03568721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303723|NCT03568721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303724|NCT03568721|Antipyretics|antipyretics|mesh-ancestor
64303725|NCT03568721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64303726|NCT03568721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64303727|NCT03568721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64303728|NCT03568721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64303729|NCT03568721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303730|NCT03568721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303731|NCT03548155|Antipsychotic Agents|antipsychotic agents|mesh-list
64303732|NCT03548155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64332692|NCT01970722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64332693|NCT01970722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332694|NCT01970722|Tubulin Modulators|tubulin modulators|mesh-ancestor
64332695|NCT01970722|Antimitotic Agents|antimitotic agents|mesh-ancestor
64332696|NCT01970722|Mitosis Modulators|mitosis modulators|mesh-ancestor
64332697|NCT01970722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332698|NCT01970722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64332700|NCT01970722|Antiviral Agents|antiviral agents|mesh-ancestor
64332701|NCT01970722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64332702|NCT01970722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64332703|NCT01970722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64332704|NCT01970722|Immunologic Factors|immunologic factors|mesh-ancestor
64854653|NCT01710384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64854654|NCT01710384|Respiratory System Agents|respiratory system agents|mesh-ancestor
64854655|NCT01710462|Domperidone|domperidone|mesh-list
64854656|NCT01710462|Pantoprazole|pantoprazole|mesh-list
64854657|NCT01710462|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64854658|NCT01710462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64854659|NCT01710462|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64854660|NCT01710462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854661|NCT01710462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854662|NCT01710462|Antiemetics|antiemetics|mesh-ancestor
64854663|NCT01710462|Autonomic Agents|autonomic agents|mesh-ancestor
64854664|NCT01710462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64854665|NCT01710462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854666|NCT01710462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64303735|NCT03548155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64391928|NCT02449265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64391929|NCT02449265|Alkylating Agents|alkylating agents|mesh-ancestor
64391930|NCT02449265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391931|NCT02449265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780534|NCT02561130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64780535|NCT02561130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780536|NCT02562066|Amifampridine|amifampridine|mesh-list
64854676|NCT01710488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64854677|NCT01710488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64854678|NCT01710488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854679|NCT01710488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854680|NCT01710488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854681|NCT01710488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64854682|NCT01710488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64854683|NCT01710540|Metformin|metformin|mesh-list
64854684|NCT01710540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64854685|NCT01710540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854686|NCT01710553|Metformin|metformin|mesh-list
64854687|NCT01710553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64854688|NCT01710553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854689|NCT01710566|Misoprostol|misoprostol|mesh-list
64854690|NCT01710566|Oxytocin|oxytocin|mesh-list
64854691|NCT01710566|Oxytocics|oxytocics|mesh-ancestor
64332706|NCT01970722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64332707|NCT01970722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64332708|NCT01970722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64332709|NCT01961375|Levonorgestrel|levonorgestrel|mesh-list
64332710|NCT01961375|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64332711|NCT01961375|Contraceptive Agents|contraceptive agents|mesh-ancestor
64332712|NCT01961375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64332713|NCT01961375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332714|NCT01961375|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64332715|NCT01961375|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64332716|NCT01961375|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64332717|NCT01953900|Cyclophosphamide|cyclophosphamide|mesh-list
64332718|NCT01953900|Fludarabine|fludarabine|mesh-list
64332719|NCT01953900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64780537|NCT02562066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64780538|NCT02562066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780539|NCT02562066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780540|NCT02562066|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64780541|NCT02562066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64780542|NCT02562066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780543|NCT02562924|Prednisone|prednisone|mesh-list
64780544|NCT02562924|Budesonide|budesonide|mesh-list
64780545|NCT02562924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64780546|NCT02562924|Glucocorticoids|glucocorticoids|mesh-ancestor
64780547|NCT02562924|Hormones|hormones|mesh-ancestor
64780548|NCT02562924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64332720|NCT01953900|Immunologic Factors|immunologic factors|mesh-ancestor
64332721|NCT01953900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332722|NCT01953900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64332723|NCT01953900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64332724|NCT01953900|Alkylating Agents|alkylating agents|mesh-ancestor
64854693|NCT01710566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854694|NCT01710566|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64854695|NCT01710566|Abortifacient Agents|abortifacient agents|mesh-ancestor
64854696|NCT01710566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64854697|NCT01710566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64854698|NCT01710592|Docetaxel|docetaxel|mesh-list
64854699|NCT01710592|Capecitabine|capecitabine|mesh-list
64854700|NCT01710592|Oxaliplatin|oxaliplatin|mesh-list
64854701|NCT01710592|Epirubicin|epirubicin|mesh-list
64854702|NCT01710592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854703|NCT01710592|Tubulin Modulators|tubulin modulators|mesh-ancestor
64854704|NCT01710592|Antimitotic Agents|antimitotic agents|mesh-ancestor
64854705|NCT01710592|Mitosis Modulators|mitosis modulators|mesh-ancestor
64854706|NCT01710592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854707|NCT01710592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64854708|NCT01710592|Antimetabolites|antimetabolites|mesh-ancestor
64780549|NCT02562924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780550|NCT02562924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64780551|NCT02562924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780552|NCT02562924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64780553|NCT02562924|Autonomic Agents|autonomic agents|mesh-ancestor
64780554|NCT02562924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780555|NCT02562924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64391944|NCT02449265|Antimitotic Agents|antimitotic agents|mesh-ancestor
64391945|NCT02449265|Mitosis Modulators|mitosis modulators|mesh-ancestor
64391946|NCT03196817|Betamethasone|betamethasone|mesh-list
64391947|NCT03196817|Betamethasone Valerate|betamethasone valerate|mesh-list
64391948|NCT03196817|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64391949|NCT03196817|Betamethasone benzoate|betamethasone benzoate|mesh-list
64391950|NCT03196817|Lidocaine|lidocaine|mesh-list
64854730|NCT01710696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64854731|NCT01710696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332725|NCT01953900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332726|NCT01953900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332727|NCT01953900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64854732|NCT01710696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64854734|NCT01710696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64854735|NCT01710696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64854736|NCT01710722|Ephedrine|ephedrine|mesh-list
64854737|NCT01710722|Pseudoephedrine|pseudoephedrine|mesh-list
64854738|NCT01710722|Caffeine|caffeine|mesh-list
64854739|NCT01710722|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64854740|NCT01710722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854741|NCT01710722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64854742|NCT01710722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854743|NCT01710722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854744|NCT01710722|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64854745|NCT01710722|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64854746|NCT01710722|Purinergic Agents|purinergic agents|mesh-ancestor
64854747|NCT01710722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64854748|NCT01710722|Sympathomimetics|sympathomimetics|mesh-ancestor
64780556|NCT02562924|Respiratory System Agents|respiratory system agents|mesh-ancestor
64780557|NCT02563860|Lovastatin|lovastatin|mesh-list
64780558|NCT02563860|L 647318|l 647318|mesh-list
64780559|NCT02563860|Dihydromevinolin|dihydromevinolin|mesh-list
64780560|NCT02563860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64780561|NCT02563860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64780562|NCT02563860|Antimetabolites|antimetabolites|mesh-ancestor
64780563|NCT02563860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780564|NCT02563860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64780565|NCT02563860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64780566|NCT02563860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780567|NCT02568852|Anesthetics|anesthetics|mesh-list
64780568|NCT02568852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64780569|NCT02568852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780570|NCT02570022|Bupivacaine|bupivacaine|mesh-list
64780571|NCT02570022|Ropivacaine|ropivacaine|mesh-list
64780572|NCT02570022|Anesthetics, Local|anesthetics, local|mesh-ancestor
64780573|NCT02570022|Anesthetics|anesthetics|mesh-ancestor
64780574|NCT02570022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64780575|NCT02570022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780576|NCT02570022|Sensory System Agents|sensory system agents|mesh-ancestor
64780577|NCT02570022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780579|NCT02572752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780580|NCT02572752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64780581|NCT02572752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780582|NCT02572752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780583|NCT02577042|Raltegravir Potassium|raltegravir potassium|mesh-list
64780584|NCT02577042|Atorvastatin|atorvastatin|mesh-list
64780585|NCT02577042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64780586|NCT02577042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64780587|NCT02577042|Antimetabolites|antimetabolites|mesh-ancestor
64303742|NCT03566303|Anticoagulants|anticoagulants|mesh-ancestor
64332728|NCT01913951|Azacitidine|azacitidine|mesh-list
64332729|NCT01913951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64332730|NCT01913951|Antimetabolites|antimetabolites|mesh-ancestor
64332731|NCT01913951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332732|NCT01913951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854749|NCT01710722|Autonomic Agents|autonomic agents|mesh-ancestor
64854750|NCT01710722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64854751|NCT01710722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64854752|NCT01710722|Adrenergic Agents|adrenergic agents|mesh-ancestor
64854753|NCT01710722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64854754|NCT01710722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64854755|NCT01710722|Respiratory System Agents|respiratory system agents|mesh-ancestor
64854756|NCT01710722|Nasal Decongestants|nasal decongestants|mesh-ancestor
64854758|NCT01710748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854759|NCT01710748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64854760|NCT01710748|Immunologic Factors|immunologic factors|mesh-ancestor
64854761|NCT01710748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854763|NCT01710761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64854764|NCT01710761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303743|NCT03566303|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64303744|NCT03566303|Antithrombins|antithrombins|mesh-ancestor
64780588|NCT02577042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780589|NCT02577042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64780590|NCT02577042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64780591|NCT02577042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780592|NCT02577042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64780593|NCT02577042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64780594|NCT02577042|Antiviral Agents|antiviral agents|mesh-ancestor
64780595|NCT02577042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64780596|NCT02577042|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64780597|NCT02577042|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64780598|NCT02582970|Bevacizumab|bevacizumab|mesh-list
64780599|NCT02582970|Fluorouracil|fluorouracil|mesh-list
64780600|NCT02582970|Oxaliplatin|oxaliplatin|mesh-list
64780601|NCT02582970|Irinotecan|irinotecan|mesh-list
64780602|NCT02582970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64780603|NCT02582970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780604|NCT02582970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64780605|NCT02582970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64780606|NCT02582970|Growth Substances|growth substances|mesh-ancestor
64780607|NCT02582970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780608|NCT02582970|Growth Inhibitors|growth inhibitors|mesh-ancestor
64780609|NCT02582970|Antimetabolites|antimetabolites|mesh-ancestor
64780610|NCT02582970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780611|NCT02582970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64780612|NCT02582970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64854768|NCT01710761|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64854769|NCT01710761|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64854770|NCT01710761|Purinergic Agents|purinergic agents|mesh-ancestor
64854771|NCT01710761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64854772|NCT01710904|Oxycodone|oxycodone|mesh-list
64854773|NCT01710904|Naloxone|naloxone|mesh-list
64854774|NCT01710904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64854775|NCT01710904|Narcotics|narcotics|mesh-ancestor
64854776|NCT01710904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64854777|NCT01710904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854778|NCT01710904|Analgesics|analgesics|mesh-ancestor
64854779|NCT01710904|Sensory System Agents|sensory system agents|mesh-ancestor
64854780|NCT01710904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64854781|NCT01710904|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64854783|NCT01710995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64780613|NCT02582970|Immunologic Factors|immunologic factors|mesh-ancestor
64780614|NCT02582970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64780615|NCT02582970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64780616|NCT02582970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780617|NCT02584608|Interferon-gamma|interferon-gamma|mesh-list
64780620|NCT02584686|Botulinum Toxins|botulinum toxins|mesh-list
64780621|NCT02584686|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64780622|NCT02584686|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64780623|NCT02584686|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64780624|NCT02584686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64780625|NCT02584686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780626|NCT02584686|Cholinergic Agents|cholinergic agents|mesh-ancestor
64780627|NCT02584686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64780628|NCT02584686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780629|NCT02584686|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64780630|NCT02584686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780631|NCT05249556|Ganaxolone|ganaxolone|mesh-list
64780632|NCT05249556|Neurosteroids|neurosteroids|mesh-ancestor
64780633|NCT05249556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64780634|NCT05249556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780635|NCT05249556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780636|NCT05249556|GABA Modulators|gaba modulators|mesh-ancestor
64780638|NCT05248152|Acetaminophen|acetaminophen|mesh-list
64780639|NCT05248152|Ibuprofen|ibuprofen|mesh-list
64780640|NCT05248152|Pregabalin|pregabalin|mesh-list
64780641|NCT05248152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64780642|NCT05248152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64392030|NCT02449187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392031|NCT02449187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64392032|NCT02449187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64392033|NCT02449187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64392034|NCT05095571|Niacinamide|niacinamide|mesh-list
64392035|NCT05095571|Niacin|niacin|mesh-list
64392036|NCT05095571|Nicotinic Acids|nicotinic acids|mesh-list
64392037|NCT05095571|Vitamin B Complex|vitamin b complex|mesh-ancestor
64392038|NCT05095571|Vitamins|vitamins|mesh-ancestor
64392039|NCT05095571|Micronutrients|micronutrients|mesh-ancestor
64392042|NCT05095571|Antimetabolites|antimetabolites|mesh-ancestor
64780644|NCT05248152|Sensory System Agents|sensory system agents|mesh-ancestor
64780645|NCT05248152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780646|NCT05248152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780647|NCT05248152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64780648|NCT05248152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64303745|NCT03566303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64303746|NCT03566303|Protease Inhibitors|protease inhibitors|mesh-ancestor
64854802|NCT01711086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64295269|NCT02048917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303747|NCT03566303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780660|NCT05248152|Antipyretics|antipyretics|mesh-ancestor
64780661|NCT05247684|Paclitaxel|paclitaxel|mesh-list
64780662|NCT05247684|Carboplatin|carboplatin|mesh-list
64780663|NCT05247684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64780664|NCT05247684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780665|NCT05247684|Tubulin Modulators|tubulin modulators|mesh-ancestor
64780666|NCT05247684|Antimitotic Agents|antimitotic agents|mesh-ancestor
64780667|NCT05247684|Mitosis Modulators|mitosis modulators|mesh-ancestor
64780668|NCT05247684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780669|NCT05184348|Acitretin|acitretin|mesh-list
64780670|NCT05184348|Keratolytic Agents|keratolytic agents|mesh-ancestor
64780671|NCT05184348|Dermatologic Agents|dermatologic agents|mesh-ancestor
64780672|NCT05132166|Sirolimus|sirolimus|mesh-list
64780673|NCT05132166|Everolimus|everolimus|mesh-list
64780674|NCT05132166|Vedolizumab|vedolizumab|mesh-list
64780675|NCT05132166|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64780676|NCT05132166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780677|NCT05132166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64780678|NCT05132166|Immunologic Factors|immunologic factors|mesh-ancestor
64780679|NCT05132166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780680|NCT05132166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64780681|NCT05132166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64780682|NCT05132166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64780683|NCT05132166|Antifungal Agents|antifungal agents|mesh-ancestor
64780684|NCT05132166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64780685|NCT04808466|Paclitaxel|paclitaxel|mesh-list
64854804|NCT01711086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64854805|NCT01711086|Adrenergic Agents|adrenergic agents|mesh-ancestor
64854806|NCT01711086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64854807|NCT01711086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854808|NCT01711112|Docetaxel|docetaxel|mesh-list
64854809|NCT01711112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854810|NCT01711112|Tubulin Modulators|tubulin modulators|mesh-ancestor
64854811|NCT01711112|Antimitotic Agents|antimitotic agents|mesh-ancestor
64854812|NCT01711112|Mitosis Modulators|mitosis modulators|mesh-ancestor
64854813|NCT01711112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854814|NCT01711125|Baclofen|baclofen|mesh-list
64780686|NCT04808466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64780687|NCT04808466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780688|NCT04808466|Tubulin Modulators|tubulin modulators|mesh-ancestor
64780689|NCT04808466|Antimitotic Agents|antimitotic agents|mesh-ancestor
64780690|NCT04808466|Mitosis Modulators|mitosis modulators|mesh-ancestor
64392077|NCT05056259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64854844|NCT01711437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64392078|NCT05056259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392079|NCT01987960|Brexpiprazole|brexpiprazole|mesh-list
64392080|NCT01987960|Serotonin Agents|serotonin agents|mesh-ancestor
64392081|NCT01987960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64392082|NCT01987960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392083|NCT01987960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392084|NCT01987960|Dopamine Agonists|dopamine agonists|mesh-ancestor
64392085|NCT01987960|Dopamine Agents|dopamine agents|mesh-ancestor
64854845|NCT01711437|Anticoagulants|anticoagulants|mesh-ancestor
64854846|NCT01711437|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64854847|NCT01711437|Chelating Agents|chelating agents|mesh-ancestor
64854848|NCT01711437|Sequestering Agents|sequestering agents|mesh-ancestor
64854849|NCT01711437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854850|NCT01711437|Antioxidants|antioxidants|mesh-ancestor
64854851|NCT01711437|Protective Agents|protective agents|mesh-ancestor
64854852|NCT01711437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854853|NCT01711437|Vitamins|vitamins|mesh-ancestor
64854854|NCT01711437|Micronutrients|micronutrients|mesh-ancestor
64854855|NCT01711437|Antifoaming Agents|antifoaming agents|mesh-ancestor
64854856|NCT01711437|Emollients|emollients|mesh-ancestor
64854857|NCT01711437|Dermatologic Agents|dermatologic agents|mesh-ancestor
64854858|NCT01711437|Cathartics|cathartics|mesh-ancestor
64854859|NCT01711437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64854860|NCT01711437|Antacids|antacids|mesh-ancestor
64392086|NCT05084027|Fludarabine|fludarabine|mesh-list
64392087|NCT05084027|Melphalan|melphalan|mesh-list
64392088|NCT05084027|Venetoclax|venetoclax|mesh-list
64780691|NCT04808466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780692|NCT03939234|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64780693|NCT03939234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64549356|NCT01421225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549374|NCT03082885|Thymalfasin|thymalfasin|mesh-list
64549375|NCT03082885|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64549376|NCT03082885|Immunologic Factors|immunologic factors|mesh-ancestor
64549377|NCT03082885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549378|NCT04382781|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64549379|NCT04382781|Immunologic Factors|immunologic factors|mesh-ancestor
64549381|NCT05688631|Antioxidants|antioxidants|mesh-list
64549382|NCT05688631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64549383|NCT05688631|Protective Agents|protective agents|mesh-ancestor
64854888|NCT01711489|Antifungal Agents|antifungal agents|mesh-ancestor
64854889|NCT01711515|Cisplatin|cisplatin|mesh-list
64854890|NCT01711515|Ipilimumab|ipilimumab|mesh-list
64854891|NCT01711515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854892|NCT01711515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64854893|NCT01711515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64854894|NCT01711515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854895|NCT01711528|Dexamethasone|dexamethasone|mesh-list
64854896|NCT01711528|Dexamethasone acetate|dexamethasone acetate|mesh-list
64854897|NCT01711528|Bortezomib|bortezomib|mesh-list
64854898|NCT01711528|Ichthammol|ichthammol|mesh-list
64854899|NCT01711528|BB 1101|bb 1101|mesh-list
64854900|NCT01711528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64854901|NCT01711528|Antiemetics|antiemetics|mesh-ancestor
64854902|NCT01711528|Autonomic Agents|autonomic agents|mesh-ancestor
64332739|NCT01867320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64332741|NCT01867320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64332742|NCT01867320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332743|NCT01709136|Sirolimus|sirolimus|mesh-list
64332744|NCT01709136|Tacrolimus|tacrolimus|mesh-list
64332745|NCT01709136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64332746|NCT01709136|Immunologic Factors|immunologic factors|mesh-ancestor
64332747|NCT01709136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332748|NCT01709136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64549384|NCT05688631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549386|NCT04348032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549387|NCT04348032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64549388|NCT04348032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64549389|NCT04348032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780694|NCT03939234|Immunologic Factors|immunologic factors|mesh-ancestor
64780695|NCT03939234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780697|NCT03907176|Ibuprofen|ibuprofen|mesh-list
64392096|NCT05084027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64392097|NCT02013622|Brexpiprazole|brexpiprazole|mesh-list
64392098|NCT02013622|Serotonin Agents|serotonin agents|mesh-ancestor
64392099|NCT02013622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64392100|NCT02013622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392101|NCT02013622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392102|NCT02013622|Dopamine Agonists|dopamine agonists|mesh-ancestor
64392103|NCT02013622|Dopamine Agents|dopamine agents|mesh-ancestor
64392104|NCT02448797|Vinorelbine|vinorelbine|mesh-list
64392107|NCT02448797|Tubulin Modulators|tubulin modulators|mesh-ancestor
64780699|NCT03907176|Analgesics|analgesics|mesh-ancestor
64780700|NCT03907176|Sensory System Agents|sensory system agents|mesh-ancestor
64780701|NCT03907176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780702|NCT03907176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780703|NCT03907176|Antipyretics|antipyretics|mesh-ancestor
64332749|NCT01709136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64332750|NCT01709136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854903|NCT01711528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64854904|NCT01711528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854905|NCT01711528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64854906|NCT01711528|Glucocorticoids|glucocorticoids|mesh-ancestor
64854907|NCT01711528|Hormones|hormones|mesh-ancestor
64854908|NCT01711528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64623384|NCT01662102|Rituximab|rituximab|mesh-list
64854909|NCT01711528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64854910|NCT01711528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854911|NCT01711528|Protease Inhibitors|protease inhibitors|mesh-ancestor
64854912|NCT01711528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854913|NCT01711528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854914|NCT01711528|Dermatologic Agents|dermatologic agents|mesh-ancestor
64854916|NCT01711567|Entecavir|entecavir|mesh-list
64854917|NCT01711567|Antiviral Agents|antiviral agents|mesh-ancestor
64854918|NCT01711567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64854919|NCT01711567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64854920|NCT01711567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64780704|NCT03907176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64780705|NCT03907176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64780706|NCT03907176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64780707|NCT03907176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64780708|NCT03907176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780709|NCT03907176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780710|NCT03675672|Misoprostol|misoprostol|mesh-list
64780711|NCT03675672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64780712|NCT03675672|Abortifacient Agents|abortifacient agents|mesh-ancestor
64780713|NCT03675672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64780714|NCT03675672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780715|NCT03675672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64780716|NCT03675672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64780717|NCT03675672|Oxytocics|oxytocics|mesh-ancestor
64780718|NCT02108496|Hyaluronic Acid|hyaluronic acid|mesh-list
64780719|NCT02108496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64780720|NCT02108496|Immunologic Factors|immunologic factors|mesh-ancestor
64780721|NCT02108496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780722|NCT02108496|Viscosupplements|viscosupplements|mesh-ancestor
64780723|NCT02108496|Protective Agents|protective agents|mesh-ancestor
64392120|NCT04438421|Immunologic Factors|immunologic factors|mesh-ancestor
64392121|NCT04438421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392122|NCT04438421|Viscosupplements|viscosupplements|mesh-ancestor
64392123|NCT04438421|Protective Agents|protective agents|mesh-ancestor
64392124|NCT05099081|Ethanolamine oleate|ethanolamine oleate|mesh-list
64392125|NCT05099081|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64324266|NCT05492318|Clarithromycin|clarithromycin|mesh-list
64324267|NCT05492318|Midazolam|midazolam|mesh-list
64324268|NCT05492318|Dabigatran|dabigatran|mesh-list
64324269|NCT05492318|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
64303749|NCT03566303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64303750|NCT03566303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64855030|NCT01712139|Irbesartan|irbesartan|mesh-list
64303751|NCT03566303|Hemostatics|hemostatics|mesh-ancestor
64362897|NCT04755634|Immunologic Factors|immunologic factors|mesh-ancestor
64780725|NCT02056236|Levetiracetam|levetiracetam|mesh-list
64780726|NCT02056236|Valproic Acid|valproic acid|mesh-list
64780727|NCT02056236|Lorazepam|lorazepam|mesh-list
64780728|NCT02056236|Thiopental|thiopental|mesh-list
64780729|NCT02056236|Anticonvulsants|anticonvulsants|mesh-list
64780730|NCT02056236|Propofol|propofol|mesh-list
64780731|NCT02056236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64780732|NCT02056236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64780733|NCT02056236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780734|NCT02056236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64780735|NCT02056236|Anesthetics, General|anesthetics, general|mesh-ancestor
64780736|NCT02056236|Anesthetics|anesthetics|mesh-ancestor
64780737|NCT02056236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64780738|NCT02056236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64780739|NCT02056236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64780740|NCT02056236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64780741|NCT02056236|GABA Modulators|gaba modulators|mesh-ancestor
64780742|NCT02056236|GABA Agents|gaba agents|mesh-ancestor
64855077|NCT01712464|Oxytocin|oxytocin|mesh-list
64855078|NCT01712464|Oxytocics|oxytocics|mesh-ancestor
64855079|NCT01712464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64855080|NCT01712464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855081|NCT01712477|Midazolam|midazolam|mesh-list
64855082|NCT01712477|Propofol|propofol|mesh-list
64855099|NCT01712568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64855100|NCT01712568|Dopamine Agonists|dopamine agonists|mesh-ancestor
64855101|NCT01712568|Dopamine Agents|dopamine agents|mesh-ancestor
64855102|NCT01712568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64855103|NCT01712568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855104|NCT01712568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855105|NCT01712646|Oxytocin|oxytocin|mesh-list
64855106|NCT01712646|Oxytocics|oxytocics|mesh-ancestor
64855107|NCT01712646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64855108|NCT01712646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855109|NCT01712828|Diphenhydramine|diphenhydramine|mesh-list
64855110|NCT01712828|Promethazine|promethazine|mesh-list
64855111|NCT01712828|Sirolimus|sirolimus|mesh-list
64855112|NCT01712828|Quinidine|quinidine|mesh-list
64780743|NCT02056236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64780744|NCT02056236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780745|NCT02056236|Nootropic Agents|nootropic agents|mesh-ancestor
64780746|NCT02056236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780747|NCT02056236|Antimanic Agents|antimanic agents|mesh-ancestor
64780748|NCT02056236|Antiemetics|antiemetics|mesh-ancestor
64780778|NCT04227366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64780779|NCT04227366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780780|NCT04227366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64780781|NCT04227366|Antimetabolites|antimetabolites|mesh-ancestor
64332751|NCT01709136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64332752|NCT01709136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855114|NCT01712828|Immunologic Factors|immunologic factors|mesh-ancestor
64855115|NCT01712828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855116|NCT01712828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64855117|NCT01712828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64855118|NCT01712828|Growth Substances|growth substances|mesh-ancestor
64855119|NCT01712828|Growth Inhibitors|growth inhibitors|mesh-ancestor
64855120|NCT01712828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855121|NCT01712828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64855122|NCT01712828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855123|NCT01712828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64855124|NCT01712828|Antifungal Agents|antifungal agents|mesh-ancestor
64855125|NCT01712828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64855126|NCT01712828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64855127|NCT01712828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64855128|NCT01712828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64855129|NCT01712828|Anesthetics, Local|anesthetics, local|mesh-ancestor
64855130|NCT01712828|Anesthetics|anesthetics|mesh-ancestor
64855131|NCT01712828|Sensory System Agents|sensory system agents|mesh-ancestor
64855132|NCT01712828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64855133|NCT01712828|Antiemetics|antiemetics|mesh-ancestor
64855134|NCT01712828|Autonomic Agents|autonomic agents|mesh-ancestor
64855135|NCT01712828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64855136|NCT01712828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64855137|NCT01712828|Histamine Antagonists|histamine antagonists|mesh-ancestor
64780782|NCT04227366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780783|NCT04227366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780784|NCT04227366|Dermatologic Agents|dermatologic agents|mesh-ancestor
64855150|NCT01712828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64855151|NCT01712828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855152|NCT01712828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64780785|NCT04227366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780786|NCT04227366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64780787|NCT04227366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64780788|NCT04227366|Immunologic Factors|immunologic factors|mesh-ancestor
64780789|NCT04227366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64780790|NCT04227366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64855153|NCT01712828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64855154|NCT01712828|Cholinergic Agents|cholinergic agents|mesh-ancestor
64855155|NCT01712828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64855156|NCT01712828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64855157|NCT01712828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64855158|NCT01712828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64855159|NCT01712828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64855160|NCT01712893|Goserelin|goserelin|mesh-list
64855161|NCT01712893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64855162|NCT01712893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855163|NCT01712919|Paclitaxel|paclitaxel|mesh-list
64780792|NCT03560466|Prednisolone|prednisolone|mesh-list
64780793|NCT03560466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64780794|NCT03560466|Glucocorticoids|glucocorticoids|mesh-ancestor
64780795|NCT03560466|Hormones|hormones|mesh-ancestor
64780796|NCT03560466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64392199|NCT03968939|Antioxidants|antioxidants|mesh-ancestor
64392200|NCT03968939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392201|NCT03968939|Protective Agents|protective agents|mesh-ancestor
64392202|NCT03968939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392203|NCT03968939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64303752|NCT03566303|Coagulants|coagulants|mesh-ancestor
64303753|NCT02140333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64303754|NCT02140333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303755|NCT02140333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64303756|NCT02140333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303757|NCT02140333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855208|NCT01713127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64855210|NCT01713153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64855211|NCT01713153|Abortifacient Agents|abortifacient agents|mesh-ancestor
64855212|NCT01713153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64855213|NCT01713153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855214|NCT01713153|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64855215|NCT01713153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64855216|NCT01713153|Oxytocics|oxytocics|mesh-ancestor
64855217|NCT01713166|Plasma-lyte 148|plasma-lyte 148|mesh-list
64855218|NCT01713166|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64855219|NCT01713166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64855220|NCT01713179|Ambroxol|ambroxol|mesh-list
64855221|NCT01713179|Expectorants|expectorants|mesh-ancestor
64855222|NCT01713179|Respiratory System Agents|respiratory system agents|mesh-ancestor
64855223|NCT01713218|Gemcitabine|gemcitabine|mesh-list
64855224|NCT01713218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64855225|NCT01713218|Antimetabolites|antimetabolites|mesh-ancestor
64855226|NCT01713218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855227|NCT01713218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855228|NCT01713218|Antiviral Agents|antiviral agents|mesh-ancestor
64855229|NCT01713218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855230|NCT01713218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855231|NCT01713218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64855232|NCT01713218|Immunologic Factors|immunologic factors|mesh-ancestor
64855233|NCT01713218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855234|NCT01713231|Vitamin D|vitamin d|mesh-list
64855235|NCT01713231|Ergocalciferols|ergocalciferols|mesh-list
64855236|NCT01713231|Cholecalciferol|cholecalciferol|mesh-list
64303758|NCT03567941|Acetaminophen|acetaminophen|mesh-list
64303759|NCT03567941|Hydrocodone|hydrocodone|mesh-list
64303760|NCT03567941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64303761|NCT03567941|Analgesics|analgesics|mesh-ancestor
64303762|NCT03567941|Sensory System Agents|sensory system agents|mesh-ancestor
64855241|NCT01713231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64855250|NCT01713361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855252|NCT01713387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64855253|NCT01713387|Antimetabolites|antimetabolites|mesh-ancestor
64303763|NCT03567941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303764|NCT03567941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303765|NCT03567941|Antipyretics|antipyretics|mesh-ancestor
64303766|NCT03567941|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64392211|NCT03968939|Autonomic Agents|autonomic agents|mesh-ancestor
64392212|NCT03968939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64392213|NCT03968939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64780797|NCT03560466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780798|NCT03560466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64780799|NCT03560466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780800|NCT03376698|Colchicine|colchicine|mesh-list
64780801|NCT03376698|Gout Suppressants|gout suppressants|mesh-ancestor
64780802|NCT03376698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64855254|NCT01713387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855255|NCT01713387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855256|NCT01713387|Antiviral Agents|antiviral agents|mesh-ancestor
64855257|NCT01713387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855258|NCT01713387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855259|NCT01713387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64855260|NCT01713387|Immunologic Factors|immunologic factors|mesh-ancestor
64855261|NCT01713387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855262|NCT01713426|Pregabalin|pregabalin|mesh-list
64855263|NCT01713426|Capsaicin|capsaicin|mesh-list
64855264|NCT01713426|Analgesics|analgesics|mesh-ancestor
64855265|NCT01713426|Sensory System Agents|sensory system agents|mesh-ancestor
64855266|NCT01713426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64855267|NCT01713426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332753|NCT01709136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64332754|NCT01709136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332755|NCT01709136|Antifungal Agents|antifungal agents|mesh-ancestor
64332756|NCT01570868|Ponatinib|ponatinib|mesh-list
64332757|NCT01570868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780803|NCT03376698|Tubulin Modulators|tubulin modulators|mesh-ancestor
64780804|NCT03376698|Antimitotic Agents|antimitotic agents|mesh-ancestor
64780805|NCT03376698|Mitosis Modulators|mitosis modulators|mesh-ancestor
64780806|NCT03376698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780807|NCT03376698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780808|NCT03295734|Losartan|losartan|mesh-list
64780809|NCT03295734|Perindopril|perindopril|mesh-list
64780810|NCT03295734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64780811|NCT03295734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64780812|NCT03295734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64780813|NCT03295734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64780814|NCT03295734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780815|NCT03295734|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64780816|NCT03295734|Protease Inhibitors|protease inhibitors|mesh-ancestor
64780817|NCT03295734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64392219|NCT03968939|Dermatologic Agents|dermatologic agents|mesh-ancestor
64392220|NCT03856619|Teriflunomide|teriflunomide|mesh-list
64392221|NCT03856619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64392222|NCT03856619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64392223|NCT03856619|Analgesics|analgesics|mesh-ancestor
64392224|NCT03856619|Sensory System Agents|sensory system agents|mesh-ancestor
64392225|NCT03856619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392226|NCT03856619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392227|NCT03856619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64392228|NCT03856619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64855268|NCT01713426|Anticonvulsants|anticonvulsants|mesh-ancestor
64855269|NCT01713426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64855270|NCT01713426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64855271|NCT01713426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855272|NCT01713426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64855273|NCT01713426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64392229|NCT03856619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64392230|NCT03856619|Immunologic Factors|immunologic factors|mesh-ancestor
64855274|NCT01713426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64855275|NCT01713426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64855276|NCT01713426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64780818|NCT03246750|Cisplatin|cisplatin|mesh-list
64780819|NCT03246750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780820|NCT02595684|Tadalafil|tadalafil|mesh-list
64780821|NCT02595684|Vasodilator Agents|vasodilator agents|mesh-ancestor
64780822|NCT02595684|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64780823|NCT02595684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64780824|NCT02595684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780825|NCT02595684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780830|NCT02604810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64780831|NCT02604810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64780832|NCT02604810|Immunoglobulin G|immunoglobulin g|mesh-list
64780833|NCT02604810|Immunologic Factors|immunologic factors|mesh-ancestor
64780834|NCT02604810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780835|NCT02607618|Vancomycin|vancomycin|mesh-list
64780836|NCT02607618|Iclaprim|iclaprim|mesh-list
64780837|NCT02607618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64855299|NCT01713738|Rituximab|rituximab|mesh-list
64855300|NCT01713738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64855301|NCT01713738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855302|NCT01713738|Immunologic Factors|immunologic factors|mesh-ancestor
64855303|NCT01713738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855304|NCT01713738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64855305|NCT01713777|Lamotrigine|lamotrigine|mesh-list
64855306|NCT01713777|Anticonvulsants|anticonvulsants|mesh-list
64855307|NCT01713777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64855308|NCT01713777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64855309|NCT01713777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855310|NCT01713777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64855311|NCT01713777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855312|NCT01713777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64855313|NCT01713777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64855314|NCT01713777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64295287|NCT02049073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64295288|NCT02049073|Antiemetics|antiemetics|mesh-ancestor
64295289|NCT02049073|Autonomic Agents|autonomic agents|mesh-ancestor
64295290|NCT02049073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64295294|NCT02049073|Hormones|hormones|mesh-ancestor
64780838|NCT02607618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64780839|NCT02607618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64780840|NCT02607618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780841|NCT02607618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780842|NCT05732064|Dexmedetomidine|dexmedetomidine|mesh-list
64780843|NCT05732064|Esketamine|esketamine|mesh-list
64780844|NCT05732064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64549505|NCT03082183|Leprostatic Agents|leprostatic agents|mesh-ancestor
64392241|NCT05099471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64392242|NCT05099471|Immunologic Factors|immunologic factors|mesh-ancestor
64780845|NCT05732064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64780846|NCT05732064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780847|NCT05732064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64332758|NCT01570868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64332759|NCT01570868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855315|NCT01713777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64855316|NCT01713777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64855317|NCT01713803|Buprenorphine|buprenorphine|mesh-list
64855318|NCT01713803|Naloxone|naloxone|mesh-list
64855319|NCT01713803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64855320|NCT01713803|Narcotics|narcotics|mesh-ancestor
64855321|NCT01713803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64855322|NCT01713803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855323|NCT01713803|Analgesics|analgesics|mesh-ancestor
64855324|NCT01713803|Sensory System Agents|sensory system agents|mesh-ancestor
64780849|NCT05732064|Sensory System Agents|sensory system agents|mesh-ancestor
64855325|NCT01713803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64855326|NCT01713803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64855327|NCT01713920|Amlodipine|amlodipine|mesh-list
64855328|NCT01713920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64855329|NCT01713920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64855334|NCT01713920|Vasodilator Agents|vasodilator agents|mesh-ancestor
64780850|NCT05732064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780851|NCT05732064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64855371|NCT01714037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855372|NCT01714037|Tubulin Modulators|tubulin modulators|mesh-ancestor
64855373|NCT01714037|Antimitotic Agents|antimitotic agents|mesh-ancestor
64855374|NCT01714037|Mitosis Modulators|mitosis modulators|mesh-ancestor
64855375|NCT01714037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64780852|NCT05732064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64780853|NCT05732064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64780854|NCT05732064|Adrenergic Agents|adrenergic agents|mesh-ancestor
64780855|NCT05732064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64780856|NCT05732064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780857|NCT05732064|Antidepressive Agents|antidepressive agents|mesh-ancestor
64780858|NCT05732064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64780859|NCT05731986|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
64780860|NCT05731986|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64780861|NCT05731986|Immunologic Factors|immunologic factors|mesh-ancestor
64780862|NCT05731986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780863|NCT05731752|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64780864|NCT05731752|Immunologic Factors|immunologic factors|mesh-ancestor
64780865|NCT05731752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780866|NCT05731596|Ubiquinone|ubiquinone|mesh-list
64780867|NCT05731596|Coenzyme Q10|coenzyme q10|mesh-list
64780868|NCT05731596|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64303767|NCT03567941|Narcotics|narcotics|mesh-ancestor
64303768|NCT03567941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64303769|NCT03567941|Antitussive Agents|antitussive agents|mesh-ancestor
64303770|NCT03567941|Respiratory System Agents|respiratory system agents|mesh-ancestor
64303771|NCT02140489|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64303772|NCT02140489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64303773|NCT02140489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64303774|NCT02140489|Antimetabolites|antimetabolites|mesh-ancestor
64303775|NCT02140489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303776|NCT02140489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64303777|NCT02140489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64303778|NCT02140489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303779|NCT03566225|Metformin|metformin|mesh-list
64780869|NCT05731596|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64780871|NCT05731596|Antimetabolites|antimetabolites|mesh-ancestor
64780872|NCT05731596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780873|NCT05731596|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64780874|NCT05731596|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64780875|NCT05731596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780876|NCT05731596|Micronutrients|micronutrients|mesh-ancestor
64855449|NCT01714206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855450|NCT01714206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64855451|NCT01714206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64855452|NCT01714297|Dalteparin|dalteparin|mesh-list
64855453|NCT01714297|Tinzaparin|tinzaparin|mesh-list
64780877|NCT05731596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780878|NCT05731596|Vitamins|vitamins|mesh-ancestor
64780879|NCT05731518|Irinotecan|irinotecan|mesh-list
64780880|NCT05731518|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64780881|NCT05731518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64780882|NCT05731518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855454|NCT01714297|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64855455|NCT01714297|Anticoagulants|anticoagulants|mesh-ancestor
64855509|NCT01714427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64855510|NCT01714427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64855511|NCT01714427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855512|NCT01714557|Tazobactam|tazobactam|mesh-list
64855513|NCT01714557|Piperacillin|piperacillin|mesh-list
64855514|NCT01714557|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64855515|NCT01714557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64855516|NCT01714557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855518|NCT01714557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780883|NCT05731518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780884|NCT05731518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780885|NCT05730738|4-Aminopyridine|4-aminopyridine|mesh-list
64780886|NCT05730738|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64780887|NCT05730738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64780888|NCT05730738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780889|NCT05730660|Quercetin|quercetin|mesh-list
64780890|NCT05730660|Antioxidants|antioxidants|mesh-ancestor
64780891|NCT05730660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780892|NCT05730660|Protective Agents|protective agents|mesh-ancestor
64780893|NCT05730660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780894|NCT05697276|Lidocaine|lidocaine|mesh-list
64780895|NCT05697276|Bupivacaine|bupivacaine|mesh-list
64780896|NCT05697276|Anesthetics, Local|anesthetics, local|mesh-ancestor
64780897|NCT05697276|Anesthetics|anesthetics|mesh-ancestor
64303780|NCT03566225|Pioglitazone|pioglitazone|mesh-list
64303781|NCT03566225|Clomiphene|clomiphene|mesh-list
64303782|NCT03566225|Enclomiphene|enclomiphene|mesh-list
64855528|NCT01714570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855530|NCT01714596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855531|NCT01714648|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64855532|NCT01714648|Luteolytic Agents|luteolytic agents|mesh-ancestor
64855533|NCT01714648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64855534|NCT01714648|Contraceptive Agents|contraceptive agents|mesh-ancestor
64855535|NCT01714648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64855536|NCT01714648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855537|NCT01714648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64855538|NCT01714648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64855539|NCT01714648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855540|NCT01714765|Everolimus|everolimus|mesh-list
64855541|NCT01714765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855542|NCT01714765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64855543|NCT01714765|Immunologic Factors|immunologic factors|mesh-ancestor
64855544|NCT01714765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855545|NCT01714817|Mycophenolic Acid|mycophenolic acid|mesh-list
64855546|NCT01714817|Prednisone|prednisone|mesh-list
64855547|NCT01714817|Abatacept|abatacept|mesh-list
64295304|NCT02049073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64295305|NCT04518345|Azacitidine|azacitidine|mesh-list
64295307|NCT04518345|Antimetabolites|antimetabolites|mesh-ancestor
64303783|NCT03566225|Zuclomiphene|zuclomiphene|mesh-list
64303784|NCT03566225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64303785|NCT03566225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303786|NCT03566225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64303787|NCT03566225|Hormone Antagonists|hormone antagonists|mesh-ancestor
64303788|NCT03566225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64303792|NCT03566225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64303793|NCT03566225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64303794|NCT02397694|Dolutegravir|dolutegravir|mesh-list
64303795|NCT02397694|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64303796|NCT02397694|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64303797|NCT02397694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303798|NCT02397694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303799|NCT02397694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64303800|NCT02397694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64780898|NCT05697276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64392301|NCT04658836|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64392302|NCT04658836|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64392303|NCT04658836|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64392304|NCT04658836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64392305|NCT04658836|Glucocorticoids|glucocorticoids|mesh-ancestor
64392307|NCT04658836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64392308|NCT04658836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392309|NCT04658836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64392310|NCT04658836|Immunologic Factors|immunologic factors|mesh-ancestor
64780899|NCT05697276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780900|NCT05697276|Sensory System Agents|sensory system agents|mesh-ancestor
64780901|NCT05697276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780902|NCT05697276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64855548|NCT01714817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64855549|NCT01714817|Glucocorticoids|glucocorticoids|mesh-ancestor
64855550|NCT01714817|Hormones|hormones|mesh-ancestor
64855551|NCT01714817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64855552|NCT01714817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855553|NCT01714817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64855554|NCT01714817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780903|NCT05697276|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64780904|NCT05697276|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64780905|NCT05697276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64780906|NCT05697276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780907|NCT05419674|Amoxicillin|amoxicillin|mesh-list
64780908|NCT05419674|Clarithromycin|clarithromycin|mesh-list
64780909|NCT05419674|Rabeprazole|rabeprazole|mesh-list
64780910|NCT05419674|Bismuth|bismuth|mesh-list
64780911|NCT05419674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64855555|NCT01714817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64855556|NCT01714817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64855557|NCT01714817|Antitubercular Agents|antitubercular agents|mesh-ancestor
64855558|NCT01714817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64855559|NCT01714817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855560|NCT01714817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855561|NCT01714817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855562|NCT01714817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64855563|NCT01714817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64855564|NCT01714817|Immunologic Factors|immunologic factors|mesh-ancestor
64780912|NCT05419674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64780913|NCT05419674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64780914|NCT05419674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64392320|NCT01677377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64392321|NCT01677377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64392322|NCT01677377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64392323|NCT01677377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64855565|NCT01714817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64855567|NCT01714843|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64855568|NCT01714843|Enzyme Activators|enzyme activators|mesh-ancestor
64855569|NCT01714843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855570|NCT01714843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64855571|NCT01714856|Ropinirole|ropinirole|mesh-list
64855572|NCT01714856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64855573|NCT01714856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64855574|NCT01714856|Dopamine Agonists|dopamine agonists|mesh-ancestor
64855575|NCT01714856|Dopamine Agents|dopamine agents|mesh-ancestor
64332760|NCT01570868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855576|NCT01714856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64855577|NCT01714856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855578|NCT01714856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855580|NCT01714895|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64855581|NCT01714895|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64392324|NCT01677377|Dopamine Agents|dopamine agents|mesh-ancestor
64855582|NCT01714895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855583|NCT01714908|Etoposide|etoposide|mesh-list
64392325|NCT05097911|Bevacizumab|bevacizumab|mesh-list
64392326|NCT05097911|Atezolizumab|atezolizumab|mesh-list
64392327|NCT05097911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64392328|NCT05097911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64392329|NCT05097911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64392330|NCT05097911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64392331|NCT05097911|Growth Substances|growth substances|mesh-ancestor
64392332|NCT05097911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392333|NCT05097911|Growth Inhibitors|growth inhibitors|mesh-ancestor
64392334|NCT05097365|Folic Acid|folic acid|mesh-list
64780915|NCT05419674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780916|NCT05419674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64780917|NCT05419674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64780919|NCT05419674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64780920|NCT05419674|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64780921|NCT05419674|Antacids|antacids|mesh-ancestor
64780922|NCT05386524|Bevacizumab|bevacizumab|mesh-list
64780923|NCT05386524|Doxorubicin|doxorubicin|mesh-list
64780924|NCT05386524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64780925|NCT05386524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64780926|NCT05386524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780927|NCT05386524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64780928|NCT05386524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64780929|NCT05386524|Growth Substances|growth substances|mesh-ancestor
64780930|NCT05386524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780931|NCT05386524|Growth Inhibitors|growth inhibitors|mesh-ancestor
64780932|NCT05386524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64855584|NCT01714908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64855585|NCT01714908|Cisplatin|cisplatin|mesh-list
64855586|NCT01714908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64855587|NCT01714908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855588|NCT01714908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64855589|NCT01714908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64855590|NCT01714908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780933|NCT05386524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64855591|NCT01714908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855592|NCT01714908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64295324|NCT04398914|Antimitotic Agents|antimitotic agents|mesh-ancestor
64295325|NCT04398914|Mitosis Modulators|mitosis modulators|mesh-ancestor
64295326|NCT04398914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295327|NCT04398914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64780934|NCT05386524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64392338|NCT05097365|Micronutrients|micronutrients|mesh-ancestor
64392339|NCT05097365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392340|NCT05097365|Hematinics|hematinics|mesh-ancestor
64303801|NCT02397694|Antiviral Agents|antiviral agents|mesh-ancestor
64303802|NCT02397694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64303803|NCT03566069|Oxytocin|oxytocin|mesh-list
64392342|NCT01964716|Vaccines|vaccines|mesh-list
64392343|NCT01964716|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64392344|NCT01964716|Immunologic Factors|immunologic factors|mesh-ancestor
64392345|NCT01964716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392346|NCT01964560|Lacosamide|lacosamide|mesh-list
64392347|NCT01964560|Anticonvulsants|anticonvulsants|mesh-ancestor
64392348|NCT01964560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64392349|NCT01964560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64780935|NCT05386524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780936|NCT05386524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780937|NCT04965714|Nivolumab|nivolumab|mesh-list
64780938|NCT04965714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64780939|NCT04965714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780940|NCT04965714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64780941|NCT04965714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855593|NCT01714960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64855594|NCT01714960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64855595|NCT01715077|Ipilimumab|ipilimumab|mesh-list
64855596|NCT01715077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64855597|NCT01715077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855598|NCT01715077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64855599|NCT01715077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855600|NCT01715090|Insulin|insulin|mesh-list
64855601|NCT01715090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64855602|NCT01715090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855603|NCT01715142|Gemcitabine|gemcitabine|mesh-list
64855604|NCT01715142|Paclitaxel|paclitaxel|mesh-list
64855605|NCT01715142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64855606|NCT01715142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64855607|NCT01715142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855608|NCT01715142|Tubulin Modulators|tubulin modulators|mesh-ancestor
64855609|NCT01715142|Antimitotic Agents|antimitotic agents|mesh-ancestor
64855610|NCT01715142|Mitosis Modulators|mitosis modulators|mesh-ancestor
64332762|NCT01565499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64332763|NCT01565499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332764|NCT01565499|Tubulin Modulators|tubulin modulators|mesh-ancestor
64332765|NCT01565499|Antimitotic Agents|antimitotic agents|mesh-ancestor
64332766|NCT01565499|Mitosis Modulators|mitosis modulators|mesh-ancestor
64780942|NCT04905654|Cromakalim|cromakalim|mesh-list
64780943|NCT04905654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64780944|NCT04905654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64780945|NCT04905654|Autonomic Agents|autonomic agents|mesh-ancestor
64780946|NCT04905654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64780947|NCT04905654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780948|NCT04905654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64780949|NCT04905654|Respiratory System Agents|respiratory system agents|mesh-ancestor
64780950|NCT04905654|Parasympatholytics|parasympatholytics|mesh-ancestor
64780951|NCT04905654|Vasodilator Agents|vasodilator agents|mesh-ancestor
64780952|NCT04787562|Imipenem|imipenem|mesh-list
64780953|NCT04787562|Cilastatin|cilastatin|mesh-list
64780954|NCT04787562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64780955|NCT04787562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64392359|NCT02659943|Alkylating Agents|alkylating agents|mesh-ancestor
64392360|NCT02659943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392361|NCT02659943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64392362|NCT02659943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64392363|NCT05083325|Oseltamivir|oseltamivir|mesh-list
64855722|NCT01715636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855723|NCT01715636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64855724|NCT01715636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64855725|NCT01715688|Lidocaine|lidocaine|mesh-list
64855726|NCT01715688|Anesthetics, Local|anesthetics, local|mesh-ancestor
64855727|NCT01715688|Anesthetics|anesthetics|mesh-ancestor
64392364|NCT05083325|Antiviral Agents|antiviral agents|mesh-ancestor
64855822|NCT01716611|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64855823|NCT01716611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392365|NCT05083325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64392366|NCT05083325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64392367|NCT05083325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392368|NCT01677299|Metformin|metformin|mesh-list
64392369|NCT01677299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64780956|NCT04787562|Protease Inhibitors|protease inhibitors|mesh-ancestor
64303810|NCT04916548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303811|NCT04916548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855824|NCT01716611|Natriuretic Agents|natriuretic agents|mesh-ancestor
64855825|NCT01716611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855826|NCT01716624|Oxybutynin|oxybutynin|mesh-list
64855827|NCT01716624|Botulinum Toxins|botulinum toxins|mesh-list
64855828|NCT01716624|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64855829|NCT01716624|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64855830|NCT01716624|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64855831|NCT01716624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64855832|NCT01716624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855833|NCT01716624|Cholinergic Agents|cholinergic agents|mesh-ancestor
64855834|NCT01716624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64855835|NCT01716624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855836|NCT01716624|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64855837|NCT01716624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64855838|NCT01716624|Parasympatholytics|parasympatholytics|mesh-ancestor
64855839|NCT01716624|Autonomic Agents|autonomic agents|mesh-ancestor
64855840|NCT01716624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64855843|NCT01716637|Etanercept|etanercept|mesh-list
64303812|NCT04916548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64303813|NCT04916548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64303814|NCT04916548|Anesthetics, General|anesthetics, general|mesh-ancestor
64780957|NCT04787562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64780958|NCT04787562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780959|NCT04780698|Immunoglobulin G|immunoglobulin g|mesh-list
64780960|NCT04780698|Immunologic Factors|immunologic factors|mesh-ancestor
64780961|NCT04780698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780962|NCT04355130|Vitamin B 12|vitamin b 12|mesh-list
64780963|NCT04355130|Hydroxocobalamin|hydroxocobalamin|mesh-list
64780964|NCT04355130|Vitamins|vitamins|mesh-ancestor
64780965|NCT04355130|Micronutrients|micronutrients|mesh-ancestor
64780966|NCT04355130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780967|NCT04355130|Vitamin B Complex|vitamin b complex|mesh-ancestor
64780968|NCT04355130|Hematinics|hematinics|mesh-ancestor
64780969|NCT04266912|Avelumab|avelumab|mesh-list
64855881|NCT01716858|Sulforaphane|sulforaphane|mesh-list
64855882|NCT01716858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64855883|NCT01716858|Protective Agents|protective agents|mesh-ancestor
64855884|NCT01716858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855923|NCT01717222|Anesthetics, Local|anesthetics, local|mesh-ancestor
64855924|NCT01717222|Anesthetics|anesthetics|mesh-ancestor
64855925|NCT01717222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64855926|NCT01717222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855927|NCT01717222|Sensory System Agents|sensory system agents|mesh-ancestor
64855928|NCT01717222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64855929|NCT01717222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64855930|NCT01717222|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64855931|NCT01717222|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64855932|NCT01717222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64855933|NCT01717222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855934|NCT01717235|Ropinirole|ropinirole|mesh-list
64855935|NCT01717235|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64780970|NCT04266912|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64780971|NCT04266912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64780972|NCT04266912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780973|NCT04266912|Immunologic Factors|immunologic factors|mesh-ancestor
64780974|NCT04266912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780975|NCT04107168|Bevacizumab|bevacizumab|mesh-list
64780976|NCT04107168|Pembrolizumab|pembrolizumab|mesh-list
64780977|NCT04107168|Nivolumab|nivolumab|mesh-list
64392379|NCT02718833|Dexamethasone|dexamethasone|mesh-list
64392380|NCT02718833|Bortezomib|bortezomib|mesh-list
64392381|NCT02718833|Pomalidomide|pomalidomide|mesh-list
64392382|NCT02718833|Elotuzumab|elotuzumab|mesh-list
64392383|NCT02718833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64392384|NCT02718833|Antiemetics|antiemetics|mesh-ancestor
64392385|NCT02718833|Autonomic Agents|autonomic agents|mesh-ancestor
64392386|NCT02718833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392387|NCT02718833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392388|NCT02718833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64780978|NCT04107168|Ipilimumab|ipilimumab|mesh-list
64780979|NCT04107168|Durvalumab|durvalumab|mesh-list
64780980|NCT04107168|Atezolizumab|atezolizumab|mesh-list
64780981|NCT04107168|Tremelimumab|tremelimumab|mesh-list
64780982|NCT04107168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64780983|NCT04107168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64780984|NCT04107168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64780985|NCT04107168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64780986|NCT04107168|Growth Substances|growth substances|mesh-ancestor
64780987|NCT04107168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780988|NCT04107168|Growth Inhibitors|growth inhibitors|mesh-ancestor
64549633|NCT00775671|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64549634|NCT00775671|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64855997|NCT01717807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64332767|NCT01565499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332769|NCT01371630|Dexamethasone|dexamethasone|mesh-list
64332770|NCT01371630|Prednisone|prednisone|mesh-list
64332771|NCT01371630|Cyclophosphamide|cyclophosphamide|mesh-list
64855998|NCT01717807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855999|NCT01717807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856000|NCT01717846|Abatacept|abatacept|mesh-list
64549635|NCT00775671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64549636|NCT05634967|Ofatumumab|ofatumumab|mesh-list
64549637|NCT05634967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549638|NCT03800745|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64549639|NCT03800745|Laxatives|laxatives|mesh-ancestor
64549641|NCT01459796|Rilonacept|rilonacept|mesh-list
64780989|NCT04107168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64780990|NCT04107168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64780992|NCT03958344|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64780993|NCT03958344|Methylprednisolone|methylprednisolone|mesh-list
64856001|NCT01717846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64856002|NCT01717846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856003|NCT01717846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856004|NCT01717846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64856005|NCT01717846|Immunologic Factors|immunologic factors|mesh-ancestor
64856006|NCT01717846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856007|NCT01717846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64856008|NCT01717911|Metformin|metformin|mesh-list
64856009|NCT01717911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64856010|NCT01717911|Isophane Insulin, Human|isophane insulin, human|mesh-list
64780994|NCT03958344|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64780995|NCT03958344|Prednisolone acetate|prednisolone acetate|mesh-list
64392400|NCT04908293|Sodium Fluoride|sodium fluoride|mesh-list
64392401|NCT04908293|Cariostatic Agents|cariostatic agents|mesh-ancestor
64392402|NCT04908293|Protective Agents|protective agents|mesh-ancestor
64392403|NCT04908293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392404|NCT04908293|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64392405|NCT04908293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64392406|NCT01964326|Atorvastatin|atorvastatin|mesh-list
64392407|NCT01964326|Calcium|calcium|mesh-list
64392408|NCT01964326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64392409|NCT01964326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64780996|NCT03958344|Triamcinolone|triamcinolone|mesh-list
64780997|NCT03958344|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64856011|NCT01717911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64856012|NCT01717911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856013|NCT01717911|Incretins|incretins|mesh-ancestor
64856014|NCT01717911|Hormones|hormones|mesh-ancestor
64856015|NCT01717911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64856016|NCT01717911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64856017|NCT01717911|Protease Inhibitors|protease inhibitors|mesh-ancestor
64780998|NCT03958344|Prednisolone phosphate|prednisolone phosphate|mesh-list
64780999|NCT03958344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64856036|NCT01717963|Sensory System Agents|sensory system agents|mesh-ancestor
64781000|NCT03958344|Glucocorticoids|glucocorticoids|mesh-ancestor
64781001|NCT03958344|Hormones|hormones|mesh-ancestor
64781002|NCT03958344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64781003|NCT03958344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781004|NCT03958344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64781005|NCT03958344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781006|NCT03958344|Antiemetics|antiemetics|mesh-ancestor
64781007|NCT03958344|Autonomic Agents|autonomic agents|mesh-ancestor
64781008|NCT03958344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64781009|NCT03958344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64781010|NCT03958344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64781012|NCT02960646|Cyclophosphamide|cyclophosphamide|mesh-list
64781057|NCT01448616|Tenofovir|tenofovir|mesh-list
64781058|NCT01448616|Antiviral Agents|antiviral agents|mesh-ancestor
64781059|NCT01448616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64781060|NCT01448616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64781061|NCT01448616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64781062|NCT01448616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781063|NCT01448616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781064|NCT01448616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64781065|NCT01448616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64781066|NCT00074412|Nevirapine|nevirapine|mesh-list
64781067|NCT00074412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64781068|NCT00074412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64781069|NCT00074412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781070|NCT00074412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781071|NCT00074412|Antiviral Agents|antiviral agents|mesh-ancestor
64781072|NCT00074412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64781073|NCT00074412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64781074|NCT00074412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64856122|NCT01718327|Sunitinib|sunitinib|mesh-list
64856123|NCT01718327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856124|NCT01718327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64856125|NCT01718327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64856126|NCT01718327|Growth Substances|growth substances|mesh-ancestor
64856127|NCT01718327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856128|NCT01718327|Growth Inhibitors|growth inhibitors|mesh-ancestor
64856129|NCT01718327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64856130|NCT01718327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856131|NCT01718327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856132|NCT01718340|Metformin|metformin|mesh-list
64856133|NCT01718340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64781075|NCT00074412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64781076|NCT00074412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64781077|NCT02618772|Midazolam|midazolam|mesh-list
64781078|NCT02618772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64781079|NCT02618772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64781080|NCT02618772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64781081|NCT02618772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392481|NCT03847181|Anticoagulants|anticoagulants|mesh-list
64856134|NCT01718340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856135|NCT01718366|Vitamin D|vitamin d|mesh-list
64781082|NCT02618772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64781083|NCT02618772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64781084|NCT02618772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64781085|NCT02618772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64781086|NCT02618772|Anesthetics, General|anesthetics, general|mesh-ancestor
64781087|NCT02618772|Anesthetics|anesthetics|mesh-ancestor
64781088|NCT02618772|GABA Modulators|gaba modulators|mesh-ancestor
64781089|NCT02618772|GABA Agents|gaba agents|mesh-ancestor
64781090|NCT02618772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64856178|NCT01718613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64856179|NCT01718613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64856180|NCT01718613|Adrenergic Agents|adrenergic agents|mesh-ancestor
64856181|NCT01718613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64856182|NCT01718613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856183|NCT01718613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856184|NCT01718613|Sympathomimetics|sympathomimetics|mesh-ancestor
64856185|NCT01718613|Autonomic Agents|autonomic agents|mesh-ancestor
64856186|NCT01718613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64856187|NCT01718613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64856188|NCT01718613|Hemostatics|hemostatics|mesh-ancestor
64856189|NCT01718613|Coagulants|coagulants|mesh-ancestor
64856190|NCT01718613|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64856191|NCT01718613|Natriuretic Agents|natriuretic agents|mesh-ancestor
64856193|NCT01718626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856194|NCT01718626|Tubulin Modulators|tubulin modulators|mesh-ancestor
64856195|NCT01718626|Antimitotic Agents|antimitotic agents|mesh-ancestor
64856214|NCT01718678|Antioxidants|antioxidants|mesh-ancestor
64856215|NCT01718678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856216|NCT01718678|Protective Agents|protective agents|mesh-ancestor
64856217|NCT01718678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856218|NCT01718678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64856219|NCT01718717|Morphine|morphine|mesh-list
64856220|NCT01718717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64856221|NCT01718717|Narcotics|narcotics|mesh-ancestor
64856222|NCT01718717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64856223|NCT01718717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856224|NCT01718717|Analgesics|analgesics|mesh-ancestor
64856225|NCT01718717|Sensory System Agents|sensory system agents|mesh-ancestor
64856226|NCT01718717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64856227|NCT01718808|Capecitabine|capecitabine|mesh-list
64856228|NCT01718808|Cetuximab|cetuximab|mesh-list
64781091|NCT02618772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781092|NCT02620878|Pancrelipase|pancrelipase|mesh-list
64781093|NCT02620878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64781094|NCT02624700|Pemetrexed|pemetrexed|mesh-list
64781095|NCT02624700|Sorafenib|sorafenib|mesh-list
64781096|NCT02624700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781097|NCT02624700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781098|NCT02624700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781099|NCT02624700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64781100|NCT02624700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64781101|NCT02624700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64781102|NCT02631954|Voriconazole|voriconazole|mesh-list
64781103|NCT02631954|Antifungal Agents|antifungal agents|mesh-ancestor
64781104|NCT02631954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64781105|NCT02631954|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64781106|NCT02631954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64856232|NCT01718808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856233|NCT01718808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64856234|NCT01718834|Vaccines|vaccines|mesh-list
64856235|NCT01718834|Immunologic Factors|immunologic factors|mesh-ancestor
64856236|NCT01718834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856237|NCT01718899|Lenalidomide|lenalidomide|mesh-list
64856238|NCT01718899|Immunologic Factors|immunologic factors|mesh-ancestor
64856239|NCT01718899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856240|NCT01718899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64856241|NCT01718899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64856242|NCT01718899|Growth Substances|growth substances|mesh-ancestor
64856243|NCT01718899|Growth Inhibitors|growth inhibitors|mesh-ancestor
64781107|NCT02631954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781108|NCT02631954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781109|NCT02631954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64781110|NCT02631954|Hormone Antagonists|hormone antagonists|mesh-ancestor
64781111|NCT02631954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64781112|NCT02631954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781113|NCT02631954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64781114|NCT02632812|Naproxen|naproxen|mesh-list
64392507|NCT02409199|Antimitotic Agents|antimitotic agents|mesh-ancestor
64856281|NCT01719042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856282|NCT01719042|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64856283|NCT01719042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64856284|NCT01719042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64856285|NCT01719042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64856286|NCT01719042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64856287|NCT01719133|Histamine|histamine|mesh-list
64856288|NCT01719133|Histamine phosphate|histamine phosphate|mesh-list
64856289|NCT01719133|Histamine Agonists|histamine agonists|mesh-ancestor
64856290|NCT01719133|Histamine Agents|histamine agents|mesh-ancestor
64856291|NCT01719133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64856294|NCT01719159|Rituximab|rituximab|mesh-list
64856319|NCT01719302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856320|NCT01719302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856321|NCT01719302|Antiviral Agents|antiviral agents|mesh-ancestor
64856322|NCT01719302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64856323|NCT01719302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856324|NCT01719302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64856325|NCT01719302|Immunologic Factors|immunologic factors|mesh-ancestor
64856326|NCT01719302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392508|NCT02409199|Mitosis Modulators|mitosis modulators|mesh-ancestor
64781116|NCT02632812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64781117|NCT02632812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64781118|NCT02632812|Analgesics|analgesics|mesh-ancestor
64781119|NCT02632812|Sensory System Agents|sensory system agents|mesh-ancestor
64781120|NCT02632812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64781121|NCT02632812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781122|NCT02632812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64781123|NCT02632812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64781124|NCT02632812|Gout Suppressants|gout suppressants|mesh-ancestor
64781125|NCT02632812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64781126|NCT02632812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781127|NCT02632812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781128|NCT02632812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64781129|NCT02632812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64781130|NCT02632812|Antioxidants|antioxidants|mesh-ancestor
64781131|NCT02632812|Protective Agents|protective agents|mesh-ancestor
64781132|NCT02634684|Amphetamine|amphetamine|mesh-list
64781133|NCT02634684|Dextroamphetamine|dextroamphetamine|mesh-list
64781134|NCT02634684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64856346|NCT01719588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856347|NCT01719588|Adrenergic Agents|adrenergic agents|mesh-ancestor
64856348|NCT01719588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64781135|NCT02634684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64549787|NCT02900976|Antibodies|antibodies|mesh-list
64781136|NCT02634684|Sympathomimetics|sympathomimetics|mesh-ancestor
64781137|NCT02634684|Autonomic Agents|autonomic agents|mesh-ancestor
64781138|NCT02634684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64781140|NCT02634684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64781141|NCT02634684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781142|NCT02634684|Adrenergic Agents|adrenergic agents|mesh-ancestor
64781143|NCT02634684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64303863|NCT03567395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303864|NCT03567395|Protective Agents|protective agents|mesh-ancestor
64303865|NCT03567395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303866|NCT03567395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64303867|NCT03565133|Quinine|quinine|mesh-list
64363438|NCT02469259|Oxytocin|oxytocin|mesh-list
64781144|NCT02634684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64856502|NCT01720537|Antimetabolites|antimetabolites|mesh-ancestor
64856504|NCT01720537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64856521|NCT01722214|Adalimumab|adalimumab|mesh-list
64856522|NCT01722214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64856523|NCT01722214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64856524|NCT01722578|N-Methylaspartate|n-methylaspartate|mesh-list
64856525|NCT01722578|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
64856526|NCT01722578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64856527|NCT01722578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64781145|NCT02634684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64781146|NCT02634684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64781147|NCT02635542|Cisatracurium|cisatracurium|mesh-list
64781148|NCT02635542|Succinylcholine|succinylcholine|mesh-list
64781154|NCT05585658|Epoetin Alfa|epoetin alfa|mesh-list
64781155|NCT05585658|Hematinics|hematinics|mesh-ancestor
64781156|NCT05533242|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
64781157|NCT05533242|Immunologic Factors|immunologic factors|mesh-ancestor
64781158|NCT05533242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781159|NCT05510856|Lacosamide|lacosamide|mesh-list
64781160|NCT05510856|Gabapentin|gabapentin|mesh-list
64781161|NCT05510856|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64781162|NCT05510856|Analgesics|analgesics|mesh-ancestor
64781163|NCT05510856|Sensory System Agents|sensory system agents|mesh-ancestor
64781164|NCT05510856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64781165|NCT05510856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781166|NCT05510856|Anticonvulsants|anticonvulsants|mesh-ancestor
64781167|NCT05510856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64781168|NCT05510856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64781169|NCT05510856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64781170|NCT05510856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64781171|NCT05510856|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64781172|NCT05510856|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64781173|NCT05510856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64781174|NCT05510856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781175|NCT05510856|Antimanic Agents|antimanic agents|mesh-ancestor
64781176|NCT05510856|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64781204|NCT05225610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64781205|NCT05225610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856592|NCT01726400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64856593|NCT01726400|Antimetabolites|antimetabolites|mesh-ancestor
64856594|NCT01726400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781206|NCT05150652|Tamoxifen|tamoxifen|mesh-list
64781207|NCT05150652|Letrozole|letrozole|mesh-list
64781208|NCT05150652|Anastrozole|anastrozole|mesh-list
64781209|NCT05150652|Exemestane|exemestane|mesh-list
64781210|NCT05150652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64549862|NCT04520217|Adrenergic Agents|adrenergic agents|mesh-ancestor
64781211|NCT05150652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64781212|NCT05150652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64781213|NCT05150652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781214|NCT05150652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781215|NCT05150652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64781216|NCT05150652|Hormone Antagonists|hormone antagonists|mesh-ancestor
64781217|NCT05150652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64856625|NCT01727427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856626|NCT01727427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64856627|NCT01727427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64856628|NCT01727427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856629|NCT01727427|Antipyretics|antipyretics|mesh-ancestor
64856630|NCT01727427|Anticoagulants|anticoagulants|mesh-ancestor
64856631|NCT01727427|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64856632|NCT01727427|Antithrombins|antithrombins|mesh-ancestor
64856633|NCT01727427|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64856634|NCT01727427|Protease Inhibitors|protease inhibitors|mesh-ancestor
64856635|NCT01727427|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64856636|NCT01727427|Hemostatics|hemostatics|mesh-ancestor
64856637|NCT01727427|Coagulants|coagulants|mesh-ancestor
64856639|NCT01727778|Immunoglobulin M|immunoglobulin m|mesh-list
64856640|NCT01727778|Immunologic Factors|immunologic factors|mesh-ancestor
64856641|NCT01727778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856642|NCT01728025|Ranolazine|ranolazine|mesh-list
64856643|NCT01728025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64856644|NCT01728025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64856645|NCT01728025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856647|NCT01728363|Rifampin|rifampin|mesh-list
64781218|NCT05150652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781219|NCT05150652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64781220|NCT05150652|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64781221|NCT05150652|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64781222|NCT05150652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64781224|NCT04511052|Antioxidants|antioxidants|mesh-ancestor
64781225|NCT04511052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781226|NCT04511052|Protective Agents|protective agents|mesh-ancestor
64392634|NCT02405689|Anesthetics, General|anesthetics, general|mesh-ancestor
64332779|NCT01371630|Immunologic Factors|immunologic factors|mesh-ancestor
64332780|NCT01371630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856659|NCT01728363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64856660|NCT01728363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64856661|NCT01728363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64856662|NCT01728363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64856663|NCT01728363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64856664|NCT01728363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64856665|NCT01728363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64856666|NCT01728363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64856668|NCT01729195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64856669|NCT01729195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64856670|NCT01729195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64856671|NCT01729195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64856672|NCT01729195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856673|NCT01729195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856674|NCT01729195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856675|NCT01729195|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64856676|NCT01729195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64332781|NCT01371630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64332782|NCT01371630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64332783|NCT01371630|Alkylating Agents|alkylating agents|mesh-ancestor
64856677|NCT01730014|Insulin Glargine|insulin glargine|mesh-list
64856678|NCT01730014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64856679|NCT01730014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295470|NCT02477007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64295471|NCT02477007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64295472|NCT02477007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64392635|NCT02405689|Anesthetics|anesthetics|mesh-ancestor
64392636|NCT02400619|Botulinum Toxins|botulinum toxins|mesh-list
64392637|NCT02400619|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64392638|NCT02400619|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64392639|NCT02400619|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64392640|NCT02400619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64392641|NCT02400619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392642|NCT02400619|Cholinergic Agents|cholinergic agents|mesh-ancestor
64392643|NCT02400619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64781228|NCT03693846|Nivolumab|nivolumab|mesh-list
64781229|NCT03693846|Ipilimumab|ipilimumab|mesh-list
64781230|NCT03693846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64781231|NCT03693846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781232|NCT03693846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64303868|NCT03565133|Antimalarials|antimalarials|mesh-ancestor
64781233|NCT03693846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781235|NCT03529890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64781236|NCT03529890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781237|NCT03529890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64781238|NCT03529890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781239|NCT03471624|Tenofovir|tenofovir|mesh-list
64781240|NCT03471624|Antiviral Agents|antiviral agents|mesh-ancestor
64781241|NCT03471624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64781242|NCT03471624|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64781243|NCT03471624|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64392658|NCT02699125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856782|NCT01731067|Caffeine|caffeine|mesh-list
64856842|NCT01731132|Trace Elements|trace elements|mesh-ancestor
64392659|NCT02699125|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64392660|NCT02699125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64392661|NCT02699125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392662|NCT02699125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64392663|NCT02699125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64392664|NCT02699125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64392665|NCT02699125|Adrenergic Agents|adrenergic agents|mesh-ancestor
64392666|NCT02699125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64392667|NCT04279535|Ascorbic Acid|ascorbic acid|mesh-list
64392668|NCT04279535|Antioxidants|antioxidants|mesh-ancestor
64392669|NCT04279535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781244|NCT03471624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781245|NCT03471624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781246|NCT03471624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64781247|NCT03471624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64781248|NCT03441048|Cytarabine|cytarabine|mesh-list
64781249|NCT03441048|Mitoxantrone|mitoxantrone|mesh-list
64781250|NCT03441048|Cladribine|cladribine|mesh-list
64781251|NCT03441048|Lintuzumab|lintuzumab|mesh-list
64781252|NCT03441048|Lenograstim|lenograstim|mesh-list
64781253|NCT03441048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64781254|NCT03441048|Antimetabolites|antimetabolites|mesh-ancestor
64781255|NCT03441048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781256|NCT03441048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781257|NCT03441048|Antiviral Agents|antiviral agents|mesh-ancestor
64781258|NCT03441048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64781259|NCT03441048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64781260|NCT03441048|Immunologic Factors|immunologic factors|mesh-ancestor
64856843|NCT01731132|Micronutrients|micronutrients|mesh-ancestor
64856844|NCT01731158|Interferon alpha-2|interferon alpha-2|mesh-list
64856845|NCT01731158|Bevacizumab|bevacizumab|mesh-list
64856846|NCT01731158|Sunitinib|sunitinib|mesh-list
64856847|NCT01731158|Everolimus|everolimus|mesh-list
64781261|NCT03441048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781262|NCT03441048|Analgesics|analgesics|mesh-ancestor
64781263|NCT03441048|Sensory System Agents|sensory system agents|mesh-ancestor
64781264|NCT03441048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64781265|NCT03441048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64781266|NCT03441048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64392672|NCT04279535|Vitamins|vitamins|mesh-ancestor
64303869|NCT03565133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64303870|NCT03565133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64303871|NCT03565133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64856886|NCT01731301|Antiviral Agents|antiviral agents|mesh-ancestor
64856887|NCT01731301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64856888|NCT01731327|Tofacitinib|tofacitinib|mesh-list
64856889|NCT01731327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64856890|NCT01731327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856891|NCT01731327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303872|NCT03565133|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64303873|NCT03565133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303874|NCT03565133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64303875|NCT03565133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303876|NCT03565133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64303877|NCT03565133|Analgesics|analgesics|mesh-ancestor
64303878|NCT03565133|Sensory System Agents|sensory system agents|mesh-ancestor
64303879|NCT05353673|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64303880|NCT05353673|Danazol|danazol|mesh-list
64392673|NCT04279535|Micronutrients|micronutrients|mesh-ancestor
64392675|NCT02400151|Vitamins|vitamins|mesh-ancestor
64392676|NCT02400151|Micronutrients|micronutrients|mesh-ancestor
64392677|NCT02400151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392678|NCT02400151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64392679|NCT02400385|Nivolumab|nivolumab|mesh-list
64392680|NCT02400385|Sunitinib|sunitinib|mesh-list
64857035|NCT01732224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64857036|NCT01732224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64857037|NCT01732250|Meropenem|meropenem|mesh-list
64857038|NCT01732250|Colistin|colistin|mesh-list
64857039|NCT01732250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64857040|NCT01732250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64392681|NCT02400385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64392682|NCT02400385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64392683|NCT02400385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64392684|NCT02400385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392685|NCT02400385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64392686|NCT02400385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64781267|NCT03441048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781268|NCT03441048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64781269|NCT03441048|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64781270|NCT02828592|Cyclophosphamide|cyclophosphamide|mesh-list
64781271|NCT02828592|Fludarabine|fludarabine|mesh-list
64781272|NCT02828592|Thymoglobulin|thymoglobulin|mesh-list
64781273|NCT02828592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64781274|NCT02828592|Immunologic Factors|immunologic factors|mesh-ancestor
64781275|NCT02828592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781276|NCT02828592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64781277|NCT02828592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64781278|NCT02828592|Alkylating Agents|alkylating agents|mesh-ancestor
64857041|NCT01732276|Gefitinib|gefitinib|mesh-list
64857042|NCT01732276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64857043|NCT01732276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64857044|NCT01732276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857045|NCT01732276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857046|NCT01732328|Vitamin D|vitamin d|mesh-list
64857047|NCT01732328|Calcium|calcium|mesh-list
64857048|NCT01732328|Vitamins|vitamins|mesh-ancestor
64857053|NCT01732367|Tenofovir|tenofovir|mesh-list
64781279|NCT02828592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857099|NCT01732861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64781280|NCT02828592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781281|NCT02828592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64781282|NCT02369406|Lamivudine|lamivudine|mesh-list
64781283|NCT02369406|Zidovudine|zidovudine|mesh-list
64781284|NCT02369406|Nevirapine|nevirapine|mesh-list
64392695|NCT03173365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64392696|NCT03173365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64392697|NCT03173365|Adrenergic Agents|adrenergic agents|mesh-ancestor
64392698|NCT03173365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64392699|NCT03173365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392700|NCT03173365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392701|NCT05100719|Mebeverine|mebeverine|mesh-list
64857100|NCT01732861|Growth Substances|growth substances|mesh-ancestor
64857101|NCT01732861|Growth Inhibitors|growth inhibitors|mesh-ancestor
64857102|NCT01732861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64857103|NCT01733017|Lycopene|lycopene|mesh-list
64857104|NCT01733017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64857105|NCT01733017|Antioxidants|antioxidants|mesh-ancestor
64857106|NCT01733017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857107|NCT01733017|Protective Agents|protective agents|mesh-ancestor
64857108|NCT01733017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857109|NCT01733017|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64857110|NCT01733017|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64332784|NCT01371630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332785|NCT01371630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332786|NCT01371630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64857111|NCT01733017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64857113|NCT01733030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64857114|NCT01733030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64857115|NCT01733030|Renal Agents|renal agents|mesh-ancestor
64857116|NCT01733030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64857117|NCT01733030|Antitubercular Agents|antitubercular agents|mesh-ancestor
64857118|NCT01733030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64857119|NCT01733030|Antimetabolites|antimetabolites|mesh-ancestor
64857120|NCT01733030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857121|NCT01733043|Dexmedetomidine|dexmedetomidine|mesh-list
64857122|NCT01733043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64392702|NCT05100719|Simethicone|simethicone|mesh-list
64392703|NCT05100719|Citric Acid|citric acid|mesh-list
64392704|NCT05100719|Sodium Citrate|sodium citrate|mesh-list
64392705|NCT05100719|Alverine|alverine|mesh-list
64392706|NCT05100719|Anticoagulants|anticoagulants|mesh-ancestor
64392707|NCT05100719|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64392708|NCT05100719|Chelating Agents|chelating agents|mesh-ancestor
64392709|NCT05100719|Sequestering Agents|sequestering agents|mesh-ancestor
64392710|NCT05100719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392711|NCT05100719|Antifoaming Agents|antifoaming agents|mesh-ancestor
64303882|NCT05353673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857123|NCT01733043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64857124|NCT01733043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857125|NCT01733043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64857126|NCT01733043|Analgesics|analgesics|mesh-ancestor
64857127|NCT01733043|Sensory System Agents|sensory system agents|mesh-ancestor
64857128|NCT01733043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857129|NCT01733043|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64857130|NCT01733043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64303883|NCT05353673|Incretins|incretins|mesh-ancestor
64303884|NCT05353673|Hormones|hormones|mesh-ancestor
64303885|NCT05353673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64303886|NCT05353673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64303887|NCT05353673|Protease Inhibitors|protease inhibitors|mesh-ancestor
64303888|NCT05353673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857197|NCT01733589|Etoposide|etoposide|mesh-list
64857198|NCT01733589|Cisplatin|cisplatin|mesh-list
64857199|NCT01733589|Endostatins|endostatins|mesh-list
64857200|NCT01733589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64857201|NCT01733589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303889|NCT05353673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363576|NCT03311581|Anesthetics|anesthetics|mesh-ancestor
64781285|NCT02369406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64781286|NCT02369406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64781287|NCT02369406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781288|NCT02369406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857202|NCT01733589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64857211|NCT01733706|Nicotine|nicotine|mesh-list
64781290|NCT02369406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64781291|NCT02369406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64781292|NCT02369406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64781293|NCT02369406|Antimetabolites|antimetabolites|mesh-ancestor
64781294|NCT02369406|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64781295|NCT02369406|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64781296|NCT02649192|Vitamin D|vitamin d|mesh-list
64781297|NCT02649192|Vitamin A|vitamin a|mesh-list
64781298|NCT02649192|Vitamins|vitamins|mesh-ancestor
64781299|NCT02649192|Micronutrients|micronutrients|mesh-ancestor
64781300|NCT02649192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781301|NCT02649192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64781302|NCT02652390|Methylprednisolone|methylprednisolone|mesh-list
64781303|NCT02652390|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64857285|NCT01734057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64857286|NCT01734096|Candesartan|candesartan|mesh-list
64857287|NCT01734096|Candesartan cilexetil|candesartan cilexetil|mesh-list
64857288|NCT01734096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64857289|NCT01734096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64857290|NCT01734096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64857291|NCT01734096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857292|NCT01734252|Argatroban|argatroban|mesh-list
64857293|NCT01734252|Antithrombins|antithrombins|mesh-ancestor
64857294|NCT01734252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64857295|NCT01734252|Protease Inhibitors|protease inhibitors|mesh-ancestor
64857296|NCT01734252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857300|NCT01734330|Nicotine|nicotine|mesh-list
64303890|NCT05353673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64303891|NCT05353673|Hormone Antagonists|hormone antagonists|mesh-ancestor
64303892|NCT05353205|HH-GV-678|hh-gv-678|mesh-list
64303893|NCT05353205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64303894|NCT05353205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303895|NCT05353205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303896|NCT03564509|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64303897|NCT03564509|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64303898|NCT03564509|Hormones|hormones|mesh-ancestor
64857358|NCT01734915|Iproplatin|iproplatin|mesh-list
64843973|NCT01666067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303899|NCT03564509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64363631|NCT02916979|Alkylating Agents|alkylating agents|mesh-ancestor
64363632|NCT02916979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64303900|NCT03564509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781305|NCT02652390|Prednisolone|prednisolone|mesh-list
64781306|NCT02652390|Prednisolone acetate|prednisolone acetate|mesh-list
64781307|NCT02652390|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64781308|NCT02652390|Prednisolone phosphate|prednisolone phosphate|mesh-list
64781309|NCT02652390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64781310|NCT02652390|Antiemetics|antiemetics|mesh-ancestor
64781311|NCT02652390|Autonomic Agents|autonomic agents|mesh-ancestor
64781312|NCT02652390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392713|NCT05100719|Dermatologic Agents|dermatologic agents|mesh-ancestor
64392719|NCT05100563|Naltrexone|naltrexone|mesh-list
64781313|NCT02652390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781314|NCT02652390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64781315|NCT02652390|Glucocorticoids|glucocorticoids|mesh-ancestor
64781316|NCT02652390|Hormones|hormones|mesh-ancestor
64781317|NCT02652390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64858089|NCT01739582|Clomiphene|clomiphene|mesh-list
64858090|NCT01739582|Zuclomiphene|zuclomiphene|mesh-list
64858091|NCT01739582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64858092|NCT01739582|Hormone Antagonists|hormone antagonists|mesh-ancestor
64858158|NCT01739985|Antipruritics|antipruritics|mesh-ancestor
64858159|NCT01739985|Dermatologic Agents|dermatologic agents|mesh-ancestor
64858160|NCT01739985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64858232|NCT01740947|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64858233|NCT01740947|Amebicides|amebicides|mesh-ancestor
64858234|NCT01740947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64858235|NCT01740947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64858304|NCT01741376|Progestins|progestins|mesh-ancestor
64858305|NCT01741376|Hormones|hormones|mesh-ancestor
64858306|NCT01741376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64781318|NCT02652390|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64781319|NCT02652390|Protective Agents|protective agents|mesh-ancestor
64781320|NCT02652390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64781321|NCT02652390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781322|NCT02653560|Potassium Citrate|potassium citrate|mesh-list
64781323|NCT02653560|Magnesium citrate|magnesium citrate|mesh-list
64781324|NCT02653560|Citric Acid|citric acid|mesh-list
64781325|NCT02653560|Sodium Citrate|sodium citrate|mesh-list
64781326|NCT02653560|Anticoagulants|anticoagulants|mesh-ancestor
64781327|NCT02653560|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64781328|NCT02653560|Chelating Agents|chelating agents|mesh-ancestor
64781329|NCT02653560|Sequestering Agents|sequestering agents|mesh-ancestor
64781330|NCT02653560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781331|NCT02653560|Diuretics|diuretics|mesh-ancestor
64781372|NCT02655354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64781373|NCT02655354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781374|NCT02655354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64858308|NCT01741389|Melatonin|melatonin|mesh-list
64781375|NCT02655354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781376|NCT02655354|Analgesics|analgesics|mesh-ancestor
64781377|NCT02655354|Sensory System Agents|sensory system agents|mesh-ancestor
64781378|NCT02655354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64781379|NCT02655354|Antidepressive Agents|antidepressive agents|mesh-ancestor
64781380|NCT02655354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64781381|NCT02655354|Dopamine Agents|dopamine agents|mesh-ancestor
64781382|NCT02655354|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64781383|NCT02655354|Serotonin Agents|serotonin agents|mesh-ancestor
64781384|NCT02655354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64781385|NCT02655354|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64781386|NCT02655354|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64781387|NCT02655354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858372|NCT01741649|Plasma Substitutes|plasma substitutes|mesh-ancestor
64858373|NCT01741649|Blood Substitutes|blood substitutes|mesh-ancestor
64858374|NCT01741753|Prednisone|prednisone|mesh-list
64858375|NCT01741753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64858376|NCT01741753|Glucocorticoids|glucocorticoids|mesh-ancestor
64858377|NCT01741753|Hormones|hormones|mesh-ancestor
64858378|NCT01741753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64858379|NCT01741753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858381|NCT01741753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781388|NCT02655354|Autonomic Agents|autonomic agents|mesh-ancestor
64781389|NCT02655354|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64781390|NCT02655354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64781393|NCT02655354|Anesthetics|anesthetics|mesh-ancestor
64781422|NCT02657928|Hormone Antagonists|hormone antagonists|mesh-ancestor
64781423|NCT02657928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64781424|NCT02657928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303901|NCT03564509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64303902|NCT02935634|Nivolumab|nivolumab|mesh-list
64303903|NCT02935634|Ipilimumab|ipilimumab|mesh-list
64303921|NCT03068234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303922|NCT05339399|Oxytocin|oxytocin|mesh-list
64303923|NCT05339399|Oxytocics|oxytocics|mesh-ancestor
64303924|NCT05339399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64303925|NCT05339399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303926|NCT04092179|Venetoclax|venetoclax|mesh-list
64303927|NCT04092179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303928|NCT05634824|Immunoglobulins|immunoglobulins|mesh-list
64781425|NCT02658240|Epinephrine|epinephrine|mesh-list
64781426|NCT02658240|Ropivacaine|ropivacaine|mesh-list
64781427|NCT02658240|Anesthetics, Local|anesthetics, local|mesh-ancestor
64781428|NCT02658240|Anesthetics|anesthetics|mesh-ancestor
64781429|NCT02658240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64781430|NCT02658240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781431|NCT02658240|Sensory System Agents|sensory system agents|mesh-ancestor
64781432|NCT02658240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64781433|NCT02658240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64781434|NCT02658240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64781435|NCT02658240|Adrenergic Agents|adrenergic agents|mesh-ancestor
64781436|NCT02658240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64781437|NCT02658240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859144|NCT01746199|Sulfamethoxazole|sulfamethoxazole|mesh-list
64781438|NCT02658240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64781439|NCT02658240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64781440|NCT02658240|Autonomic Agents|autonomic agents|mesh-ancestor
64781441|NCT02658240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64781442|NCT02658240|Respiratory System Agents|respiratory system agents|mesh-ancestor
64781443|NCT02658240|Mydriatics|mydriatics|mesh-ancestor
64781444|NCT02658240|Sympathomimetics|sympathomimetics|mesh-ancestor
64781445|NCT02658240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64781446|NCT02661126|Uprifosbuvir|uprifosbuvir|mesh-list
64781447|NCT02661126|Antiviral Agents|antiviral agents|mesh-ancestor
64781448|NCT02661126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64860008|NCT01750723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64392854|NCT05106803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64392855|NCT05106803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860603|NCT01755520|Analgesics|analgesics|mesh-ancestor
64392856|NCT05106803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392857|NCT05106803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64392858|NCT05106803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64392859|NCT05106803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64392862|NCT05106803|Renal Agents|renal agents|mesh-ancestor
64781449|NCT02661828|Antidepressive Agents|antidepressive agents|mesh-list
64781450|NCT02661828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64781451|NCT02665260|Cantharidin|cantharidin|mesh-list
64781452|NCT02665260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781453|NCT02665260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781454|NCT02665728|Laxatives|laxatives|mesh-list
64781455|NCT02665728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64861276|NCT01758978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64861277|NCT01758978|Antitussive Agents|antitussive agents|mesh-ancestor
64861278|NCT01758978|Respiratory System Agents|respiratory system agents|mesh-ancestor
64861279|NCT01759030|Rituximab|rituximab|mesh-list
64861280|NCT01759030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64861345|NCT01759589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64861346|NCT01759589|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64781456|NCT02666352|Uprifosbuvir|uprifosbuvir|mesh-list
64781457|NCT02666352|Ruzasvir|ruzasvir|mesh-list
64781458|NCT02666352|Antiviral Agents|antiviral agents|mesh-ancestor
64781459|NCT02666352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64781460|NCT02673138|Canagliflozin|canagliflozin|mesh-list
64363719|NCT05727397|Aflibercept|aflibercept|mesh-list
64781461|NCT02673138|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64781462|NCT02673138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781463|NCT02673138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64781464|NCT02673138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781466|NCT02673372|Morphine|morphine|mesh-list
64781467|NCT02673372|Analgesics|analgesics|mesh-ancestor
64781468|NCT02673372|Sensory System Agents|sensory system agents|mesh-ancestor
64781469|NCT02673372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64781470|NCT02673372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781471|NCT02673372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64862811|NCT01767272|Fexofenadine|fexofenadine|mesh-list
64862812|NCT01767272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64862813|NCT01767272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64862872|NCT01767545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64781472|NCT02673372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64781473|NCT02673372|Anesthetics, General|anesthetics, general|mesh-ancestor
64781474|NCT02673372|Anesthetics|anesthetics|mesh-ancestor
64392881|NCT02398201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64392882|NCT02398201|Antimetabolites|antimetabolites|mesh-ancestor
64392883|NCT02398201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392884|NCT02398201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64392885|NCT05106179|Propranolol|propranolol|mesh-list
64392886|NCT05106179|Atenolol|atenolol|mesh-list
64392887|NCT05106179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64392888|NCT05106179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64781475|NCT02673372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64863129|NCT01768663|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64863130|NCT01768663|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64781476|NCT02673372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64781477|NCT02673372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64781478|NCT02673372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64781479|NCT02673372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781480|NCT02673372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64781481|NCT02673372|Narcotics|narcotics|mesh-ancestor
64781482|NCT02682498|Bupivacaine|bupivacaine|mesh-list
64781483|NCT02682498|Anesthetics, Local|anesthetics, local|mesh-ancestor
64781484|NCT02682498|Anesthetics|anesthetics|mesh-ancestor
64781485|NCT02682498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64781486|NCT02682498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781487|NCT02682498|Sensory System Agents|sensory system agents|mesh-ancestor
64863183|NCT01768897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863184|NCT01768897|Antioxidants|antioxidants|mesh-ancestor
64863185|NCT01768897|Protective Agents|protective agents|mesh-ancestor
64863186|NCT01768897|Vitamin B Complex|vitamin b complex|mesh-ancestor
64863187|NCT01768897|Vitamins|vitamins|mesh-ancestor
64863188|NCT01768897|Micronutrients|micronutrients|mesh-ancestor
64863189|NCT01768988|Pregabalin|pregabalin|mesh-list
64863190|NCT01768988|Analgesics|analgesics|mesh-ancestor
64863191|NCT01768988|Sensory System Agents|sensory system agents|mesh-ancestor
64863192|NCT01768988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64863193|NCT01768988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863194|NCT01768988|Anticonvulsants|anticonvulsants|mesh-ancestor
64863195|NCT01768988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64863196|NCT01768988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64863197|NCT01768988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863198|NCT01768988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64863199|NCT01768988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64863200|NCT01768988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64863201|NCT01768988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64863202|NCT01768988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64863203|NCT01769040|Rifaximin|rifaximin|mesh-list
64863204|NCT01769040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64863205|NCT01769040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863206|NCT01769040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64863207|NCT01769066|Pemetrexed|pemetrexed|mesh-list
64863208|NCT01769066|Gefitinib|gefitinib|mesh-list
64332787|NCT01371630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64332788|NCT01371630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64332789|NCT01371630|Antiemetics|antiemetics|mesh-ancestor
64332790|NCT01371630|Autonomic Agents|autonomic agents|mesh-ancestor
64781488|NCT02682498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64781489|NCT02684136|Suvorexant|suvorexant|mesh-list
64781490|NCT02684136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64781491|NCT02684136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64781492|NCT02684136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64781493|NCT02684136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392907|NCT04670471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392908|NCT02406781|Pembrolizumab|pembrolizumab|mesh-list
64392909|NCT02406781|Cyclophosphamide|cyclophosphamide|mesh-list
64392910|NCT02406781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64392912|NCT02406781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64863209|NCT01769066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863210|NCT01769066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863211|NCT01769066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863212|NCT01769066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64863213|NCT01769066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64863214|NCT01769066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64863215|NCT01769079|Isosorbide|isosorbide|mesh-list
64863216|NCT01769079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64863217|NCT01769079|Diuretics|diuretics|mesh-ancestor
64863218|NCT01769079|Natriuretic Agents|natriuretic agents|mesh-ancestor
64863219|NCT01769079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863220|NCT01769118|Caffeine|caffeine|mesh-list
64631787|NCT01260649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64863221|NCT01769118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64863222|NCT01769118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863223|NCT01769118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64863224|NCT01769118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863225|NCT01769118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863226|NCT01769118|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64863227|NCT01769118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64863228|NCT01769118|Purinergic Agents|purinergic agents|mesh-ancestor
64863229|NCT01769118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64863230|NCT01769183|Squalamine|squalamine|mesh-list
64863231|NCT01769183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64863232|NCT01769183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64392913|NCT02406781|Immunologic Factors|immunologic factors|mesh-ancestor
64392914|NCT02406781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392915|NCT02406781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64392916|NCT02406781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64392917|NCT02406781|Alkylating Agents|alkylating agents|mesh-ancestor
64781494|NCT02684136|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64781495|NCT02684136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64781496|NCT02684136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781498|NCT02695290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781499|NCT02695290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64781500|NCT02695290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863277|NCT01769651|Methadone|methadone|mesh-list
64863278|NCT01769651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64863279|NCT01769651|Narcotics|narcotics|mesh-ancestor
64863280|NCT01769651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64863281|NCT01769651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863283|NCT01769651|Sensory System Agents|sensory system agents|mesh-ancestor
64863284|NCT01769651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64863285|NCT01769651|Antitussive Agents|antitussive agents|mesh-ancestor
64863286|NCT01769651|Respiratory System Agents|respiratory system agents|mesh-ancestor
64863287|NCT01769664|Clindamycin|clindamycin|mesh-list
64863288|NCT01769664|Clindamycin palmitate|clindamycin palmitate|mesh-list
64781501|NCT02695290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781502|NCT02695446|Minocycline|minocycline|mesh-list
64781503|NCT02695446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64781504|NCT02695446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64781505|NCT02698566|Ranibizumab|ranibizumab|mesh-list
64781506|NCT02698566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64781507|NCT02698566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64781508|NCT02698566|Growth Substances|growth substances|mesh-ancestor
64303931|NCT05634824|gamma-Globulins|gamma-globulins|mesh-list
64303932|NCT05634824|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64303933|NCT05634824|Immunologic Factors|immunologic factors|mesh-ancestor
64303935|NCT02454478|Everolimus|everolimus|mesh-list
64303936|NCT02454478|Lenvatinib|lenvatinib|mesh-list
64303937|NCT02454478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303938|NCT02454478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64303939|NCT02454478|Immunologic Factors|immunologic factors|mesh-ancestor
64863289|NCT01769664|Clindamycin phosphate|clindamycin phosphate|mesh-list
64863290|NCT01769664|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64863291|NCT01769664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64863292|NCT01769664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863293|NCT01769664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64863294|NCT01769664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863295|NCT01769664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863296|NCT01769664|Dermatologic Agents|dermatologic agents|mesh-ancestor
64863297|NCT01769677|Hydrocodone|hydrocodone|mesh-list
64863298|NCT01769677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64303940|NCT02454478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303941|NCT02454478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64303942|NCT02454478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781509|NCT02698566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781510|NCT02698566|Growth Inhibitors|growth inhibitors|mesh-ancestor
64781511|NCT02698566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781512|NCT02701062|Warfarin|warfarin|mesh-list
64781513|NCT02701062|Rivaroxaban|rivaroxaban|mesh-list
64781514|NCT02701062|Dabigatran|dabigatran|mesh-list
64781515|NCT02701062|Apixaban|apixaban|mesh-list
64863299|NCT01769677|Narcotics|narcotics|mesh-ancestor
64863300|NCT01769677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64863301|NCT01769677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332802|NCT01371630|Dermatologic Agents|dermatologic agents|mesh-ancestor
64332803|NCT01371630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64332804|NCT01371630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64332805|NCT01371630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64863302|NCT01769677|Analgesics|analgesics|mesh-ancestor
64863303|NCT01769677|Sensory System Agents|sensory system agents|mesh-ancestor
64863304|NCT01769677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64863305|NCT01769677|Antitussive Agents|antitussive agents|mesh-ancestor
64863306|NCT01769677|Respiratory System Agents|respiratory system agents|mesh-ancestor
64863307|NCT01769703|Dabigatran|dabigatran|mesh-list
64863308|NCT01769703|Antithrombins|antithrombins|mesh-ancestor
64863309|NCT01769703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64863310|NCT01769703|Protease Inhibitors|protease inhibitors|mesh-ancestor
64863311|NCT01769703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863312|NCT01769703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863313|NCT01769703|Anticoagulants|anticoagulants|mesh-ancestor
64863314|NCT01769768|Bupropion|bupropion|mesh-list
64863315|NCT01769768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64863316|NCT01769768|Antidepressive Agents|antidepressive agents|mesh-ancestor
64863317|NCT01769768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64863318|NCT01769768|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64863319|NCT01769768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64863320|NCT01769768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64863321|NCT01769768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863322|NCT01769768|Dopamine Agents|dopamine agents|mesh-ancestor
64863323|NCT01769768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64863324|NCT01769768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781516|NCT02701062|Anticoagulants|anticoagulants|mesh-list
64781517|NCT02701062|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64781518|NCT02701062|Antithrombins|antithrombins|mesh-ancestor
64781519|NCT02701062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64781520|NCT02701062|Protease Inhibitors|protease inhibitors|mesh-ancestor
64781521|NCT02701062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781523|NCT02704104|Hemostatics|hemostatics|mesh-list
64781541|NCT02709018|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64781542|NCT02709018|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64781543|NCT02709018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781544|NCT02713230|Bupivacaine|bupivacaine|mesh-list
64781545|NCT02713230|Anesthetics, Local|anesthetics, local|mesh-ancestor
64863325|NCT01769768|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64863326|NCT01769768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64863327|NCT01769768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863328|NCT01769781|Anastrozole|anastrozole|mesh-list
64863329|NCT01769781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64863330|NCT01769781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863331|NCT01769781|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64863332|NCT01769781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64863333|NCT01769781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863334|NCT01769781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863335|NCT01769781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64863336|NCT01769781|Hormone Antagonists|hormone antagonists|mesh-ancestor
64863337|NCT01769781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64863338|NCT01769781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863339|NCT01769820|Dexamethasone|dexamethasone|mesh-list
64863340|NCT01769820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64863341|NCT01769820|Antiemetics|antiemetics|mesh-ancestor
64863342|NCT01769820|Autonomic Agents|autonomic agents|mesh-ancestor
64863343|NCT01769820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64863344|NCT01769820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863345|NCT01769820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64863346|NCT01769820|Glucocorticoids|glucocorticoids|mesh-ancestor
64863348|NCT01769820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64863350|NCT01769820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863351|NCT01769833|Interferons|interferons|mesh-list
64781546|NCT02713230|Anesthetics|anesthetics|mesh-ancestor
64781547|NCT02713230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64781548|NCT02713230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781549|NCT02713230|Sensory System Agents|sensory system agents|mesh-ancestor
64781550|NCT02713230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64781551|NCT02713698|Propofol|propofol|mesh-list
64781552|NCT02713698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64781553|NCT02713698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64781554|NCT02713698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781555|NCT02713698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64781556|NCT02713698|Anesthetics, General|anesthetics, general|mesh-ancestor
64781557|NCT02713698|Anesthetics|anesthetics|mesh-ancestor
64781558|NCT02714400|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64781559|NCT02714400|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64392972|NCT02658149|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64392973|NCT02658149|Epinephrine|epinephrine|mesh-list
64392974|NCT02658149|Morphine|morphine|mesh-list
64392975|NCT02658149|Ropivacaine|ropivacaine|mesh-list
64392976|NCT02658149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64392977|NCT02658149|Narcotics|narcotics|mesh-ancestor
64392978|NCT02658149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64392979|NCT02658149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303943|NCT02454478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303944|NCT02359097|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64392981|NCT02658149|Sensory System Agents|sensory system agents|mesh-ancestor
64392982|NCT02658149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64781560|NCT02714400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64781561|NCT02714400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64781562|NCT02714400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781563|NCT02714400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64781564|NCT02714400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781565|NCT02714400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64863352|NCT01769833|Interferon-alpha|interferon-alpha|mesh-list
64863353|NCT01769833|Interferon alpha-2|interferon alpha-2|mesh-list
64863354|NCT01769833|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64863355|NCT01769833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863356|NCT01769833|Antiviral Agents|antiviral agents|mesh-ancestor
64863357|NCT01769833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863358|NCT01769833|Immunologic Factors|immunologic factors|mesh-ancestor
64863359|NCT01769833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863360|NCT01769898|Budesonide|budesonide|mesh-list
64863361|NCT01769898|Theophylline|theophylline|mesh-list
64863362|NCT01769898|Formoterol Fumarate|formoterol fumarate|mesh-list
64863363|NCT01769898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64863364|NCT01769898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64863365|NCT01769898|Autonomic Agents|autonomic agents|mesh-ancestor
64781566|NCT02714400|Antidepressive Agents|antidepressive agents|mesh-ancestor
64781567|NCT02714400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64781568|NCT02716818|Dexamethasone|dexamethasone|mesh-list
64781569|NCT02716818|Prednisone|prednisone|mesh-list
64781570|NCT02716818|Prednisolone|prednisolone|mesh-list
64781571|NCT02716818|Hydrocortisone|hydrocortisone|mesh-list
64781572|NCT02716818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64781573|NCT02716818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64781574|NCT02716818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64781575|NCT02716818|Glucocorticoids|glucocorticoids|mesh-list
64781576|NCT02716818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64781577|NCT02716818|Antiemetics|antiemetics|mesh-ancestor
64781578|NCT02716818|Autonomic Agents|autonomic agents|mesh-ancestor
64781579|NCT02716818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64863369|NCT01769898|Respiratory System Agents|respiratory system agents|mesh-ancestor
64863370|NCT01769898|Glucocorticoids|glucocorticoids|mesh-ancestor
64863371|NCT01769898|Hormones|hormones|mesh-ancestor
64863372|NCT01769898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64863373|NCT01769898|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64863374|NCT01769898|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64863375|NCT01769898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64863376|NCT01769898|Adrenergic Agents|adrenergic agents|mesh-ancestor
64863377|NCT01769898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64863378|NCT01769898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863379|NCT01769898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64863380|NCT01769898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863381|NCT01769898|Vasodilator Agents|vasodilator agents|mesh-ancestor
64863382|NCT01769898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64863383|NCT01769898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64863384|NCT01769898|Purinergic Agents|purinergic agents|mesh-ancestor
64863385|NCT01769911|Cytarabine|cytarabine|mesh-list
64863386|NCT01769911|Etoposide|etoposide|mesh-list
64863387|NCT01769911|Etoposide phosphate|etoposide phosphate|mesh-list
64863388|NCT01769911|Melphalan|melphalan|mesh-list
64863389|NCT01769911|Carmustine|carmustine|mesh-list
64863390|NCT01769911|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64863391|NCT01769911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64863392|NCT01769911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863393|NCT01769911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64863394|NCT01769911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64863395|NCT01769911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781580|NCT02716818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781581|NCT02716818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64781582|NCT02716818|Hormones|hormones|mesh-ancestor
64781583|NCT02716818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64393015|NCT04481971|Hormones|hormones|mesh-ancestor
64781585|NCT02716818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781586|NCT02719158|Ciprofloxacin|ciprofloxacin|mesh-list
64781587|NCT02719158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64781588|NCT02719158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64781589|NCT02719158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64781590|NCT02719158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64781591|NCT02719158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781592|NCT02719158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863398|NCT01769911|Antimetabolites|antimetabolites|mesh-ancestor
64863399|NCT01769911|Antiviral Agents|antiviral agents|mesh-ancestor
64863400|NCT01769911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863401|NCT01769911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64863402|NCT01769911|Immunologic Factors|immunologic factors|mesh-ancestor
64863403|NCT01769911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863404|NCT01769911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64863405|NCT01769911|Alkylating Agents|alkylating agents|mesh-ancestor
64863406|NCT01769911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64863407|NCT01769950|Choline|choline|mesh-list
64863408|NCT01769950|Lipotropic Agents|lipotropic agents|mesh-ancestor
64863409|NCT01769950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64863410|NCT01769950|Antimetabolites|antimetabolites|mesh-ancestor
64863411|NCT01769950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863412|NCT01769950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64863413|NCT01769950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64863414|NCT01769950|Nootropic Agents|nootropic agents|mesh-ancestor
64863415|NCT01770041|Acetaminophen|acetaminophen|mesh-list
64863416|NCT01770041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64863417|NCT01770041|Analgesics|analgesics|mesh-ancestor
64863418|NCT01770041|Sensory System Agents|sensory system agents|mesh-ancestor
64863419|NCT01770041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64863420|NCT01770041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863421|NCT01770041|Antipyretics|antipyretics|mesh-ancestor
64863422|NCT01770080|Peppermint oil|peppermint oil|mesh-list
64863423|NCT01770080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64863424|NCT01770080|Antiemetics|antiemetics|mesh-ancestor
64863425|NCT01770080|Autonomic Agents|autonomic agents|mesh-ancestor
64781593|NCT02719158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781594|NCT02719158|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64781595|NCT02719158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64781596|NCT02726178|Ibuprofen|ibuprofen|mesh-list
64781597|NCT02726178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64781598|NCT02726178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64781599|NCT02726178|Analgesics|analgesics|mesh-ancestor
64863433|NCT01770106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863434|NCT01770132|Gemcitabine|gemcitabine|mesh-list
64781600|NCT02726178|Sensory System Agents|sensory system agents|mesh-ancestor
64781601|NCT02726178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64863435|NCT01770132|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
64863436|NCT01770132|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
64863437|NCT01770132|Trioxsalen|trioxsalen|mesh-list
64863438|NCT01770132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64863439|NCT01770132|Antimetabolites|antimetabolites|mesh-ancestor
64863440|NCT01770132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863441|NCT01770132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863442|NCT01770132|Antiviral Agents|antiviral agents|mesh-ancestor
64863443|NCT01770132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863444|NCT01770132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863445|NCT01770132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64863446|NCT01770132|Immunologic Factors|immunologic factors|mesh-ancestor
64863447|NCT01770132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863448|NCT01770132|Dermatologic Agents|dermatologic agents|mesh-ancestor
64863467|NCT01770197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64863468|NCT01770197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781602|NCT02726178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393019|NCT04481971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393020|NCT03172741|Dronabinol|dronabinol|mesh-list
64393021|NCT03172741|Cannabidiol|cannabidiol|mesh-list
64393022|NCT03172741|Anticonvulsants|anticonvulsants|mesh-ancestor
64393023|NCT03172741|Hallucinogens|hallucinogens|mesh-ancestor
64393025|NCT03172741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64393026|NCT03172741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64393027|NCT03172741|Analgesics|analgesics|mesh-ancestor
64393028|NCT03172741|Sensory System Agents|sensory system agents|mesh-ancestor
64393029|NCT03172741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393030|NCT03172741|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64393031|NCT03172741|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64393037|NCT02702011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64781603|NCT02726178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64781604|NCT02726178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64781605|NCT02726178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64781606|NCT02726178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64843974|NCT01666067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64863485|NCT01770236|Analgesics|analgesics|mesh-ancestor
64863486|NCT01770236|Sensory System Agents|sensory system agents|mesh-ancestor
64863487|NCT01770236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64863488|NCT01770236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863489|NCT01770236|Antipyretics|antipyretics|mesh-ancestor
64863490|NCT01770301|Paclitaxel|paclitaxel|mesh-list
64863491|NCT01770301|Bevacizumab|bevacizumab|mesh-list
64863492|NCT01770301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64863493|NCT01770301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863494|NCT01770301|Tubulin Modulators|tubulin modulators|mesh-ancestor
64863495|NCT01770301|Antimitotic Agents|antimitotic agents|mesh-ancestor
64863496|NCT01770301|Mitosis Modulators|mitosis modulators|mesh-ancestor
64863497|NCT01770301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863498|NCT01770301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64863499|NCT01770301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64863500|NCT01770301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64863501|NCT01770301|Growth Substances|growth substances|mesh-ancestor
64863502|NCT01770301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295567|NCT02415400|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64295568|NCT02415400|Antithrombins|antithrombins|mesh-ancestor
64295569|NCT02415400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64295570|NCT02415400|Protease Inhibitors|protease inhibitors|mesh-ancestor
64295571|NCT02415400|Anticoagulants|anticoagulants|mesh-ancestor
64295572|NCT02415400|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64295574|NCT02415400|Coagulants|coagulants|mesh-ancestor
64295575|NCT02053675|Vasopressins|vasopressins|mesh-list
64295576|NCT02053675|Arginine Vasopressin|arginine vasopressin|mesh-list
64295577|NCT02053675|Hemostatics|hemostatics|mesh-ancestor
64781607|NCT02726178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781608|NCT02733588|Glucagon|glucagon|mesh-list
64781609|NCT02733588|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64781610|NCT02733588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64781611|NCT02733588|Hormones|hormones|mesh-ancestor
64781612|NCT02733588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64781613|NCT02733588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781614|NCT02733588|Incretins|incretins|mesh-ancestor
64781615|NCT02737332|Abiraterone Acetate|abiraterone acetate|mesh-list
64781616|NCT02737332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781617|NCT02737332|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64781618|NCT02737332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781619|NCT02737332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781620|NCT02737332|Hormone Antagonists|hormone antagonists|mesh-ancestor
64781621|NCT02737332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64332823|NCT01306942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64332824|NCT01306942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64332826|NCT01036087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64332827|NCT01036087|Cyclophosphamide|cyclophosphamide|mesh-list
64863503|NCT01770301|Growth Inhibitors|growth inhibitors|mesh-ancestor
64863504|NCT01770444|Cytarabine|cytarabine|mesh-list
64863505|NCT01770444|Thioguanine|thioguanine|mesh-list
64863506|NCT01770444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64863507|NCT01770444|Antimetabolites|antimetabolites|mesh-ancestor
64863508|NCT01770444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863509|NCT01770444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863510|NCT01770444|Antiviral Agents|antiviral agents|mesh-ancestor
64863511|NCT01770444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863512|NCT01770444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64863570|NCT01770964|Analgesics|analgesics|mesh-ancestor
64863571|NCT01770964|Sensory System Agents|sensory system agents|mesh-ancestor
64863572|NCT01770964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64863573|NCT01770964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863574|NCT01770964|Anticonvulsants|anticonvulsants|mesh-ancestor
64863575|NCT01770964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64863576|NCT01770964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64393038|NCT02702011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393039|NCT02702011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64393040|NCT02702011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393041|NCT03170713|Ibuprofen|ibuprofen|mesh-list
64393042|NCT03170713|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
64393043|NCT03170713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64393054|NCT02657369|Lenvatinib|lenvatinib|mesh-list
64781622|NCT02737332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781623|NCT02737332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64863592|NCT01771146|Folfirinox|folfirinox|mesh-list
64863593|NCT01771146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781625|NCT05444088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64781626|NCT05444088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781627|NCT05444088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64781628|NCT05444088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64781629|NCT05444088|Growth Substances|growth substances|mesh-ancestor
64781630|NCT05444088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781631|NCT05444088|Growth Inhibitors|growth inhibitors|mesh-ancestor
64781632|NCT05443932|Dapagliflozin|dapagliflozin|mesh-list
64781633|NCT05443932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64781634|NCT05443932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64781635|NCT05443932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781636|NCT05443932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64781637|NCT05443932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781638|NCT05443932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64781639|NCT05443932|Diuretics|diuretics|mesh-ancestor
64781640|NCT05443932|Natriuretic Agents|natriuretic agents|mesh-ancestor
64863594|NCT01771146|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64863595|NCT01771146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64863596|NCT01771146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632162|NCT00003694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863597|NCT01771146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863598|NCT01771185|Metformin|metformin|mesh-list
64863599|NCT01771185|Gliclazide|gliclazide|mesh-list
64863600|NCT01771185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64863601|NCT01771185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863602|NCT01771198|Simvastatin|simvastatin|mesh-list
64863603|NCT01771198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64863604|NCT01771198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64863605|NCT01771198|Antimetabolites|antimetabolites|mesh-ancestor
64863606|NCT01771198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863608|NCT01771198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64863609|NCT01771198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863610|NCT01771289|Docetaxel|docetaxel|mesh-list
64863611|NCT01771289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781641|NCT05443932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64781659|NCT05439564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64781660|NCT05439564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781661|NCT05439564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64781662|NCT05439564|Analgesics|analgesics|mesh-ancestor
64781663|NCT05439564|Sensory System Agents|sensory system agents|mesh-ancestor
64781664|NCT05439564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64781665|NCT05439564|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64781666|NCT05439564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64781667|NCT05439564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64781668|NCT05439564|Adrenergic Agents|adrenergic agents|mesh-ancestor
64781669|NCT05439564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64781670|NCT05439564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781671|NCT05439564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64781672|NCT05439564|Narcotics|narcotics|mesh-ancestor
64781674|NCT05423340|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64364097|NCT03332095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781675|NCT05423340|Autonomic Agents|autonomic agents|mesh-ancestor
64781676|NCT05423340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64781677|NCT05423340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781678|NCT05423340|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64781679|NCT05423340|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64781680|NCT05423340|Cholinergic Agents|cholinergic agents|mesh-ancestor
64781681|NCT05423340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64393091|NCT03129113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393092|NCT03129113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64303956|NCT05284214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303957|NCT05284214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64303958|NCT05284214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863621|NCT01771328|Cortisone|cortisone|mesh-list
64863622|NCT01771328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64863623|NCT01771406|Nebivolol|nebivolol|mesh-list
64863624|NCT01771406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64295596|NCT02056405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64303959|NCT05284214|Immunologic Factors|immunologic factors|mesh-ancestor
64303960|NCT05284214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303962|NCT03563963|Ropivacaine|ropivacaine|mesh-list
64303963|NCT03563963|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64364122|NCT04489459|Meropenem|meropenem|mesh-list
64393093|NCT03129113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64393094|NCT03129113|Antiviral Agents|antiviral agents|mesh-ancestor
64393095|NCT03129113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64393096|NCT03129113|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64393097|NCT05105009|Furosemide|furosemide|mesh-list
64393098|NCT05105009|Diuretics|diuretics|mesh-ancestor
64393099|NCT05105009|Natriuretic Agents|natriuretic agents|mesh-ancestor
64393104|NCT05104931|Piroxicam|piroxicam|mesh-list
64383240|NCT05515185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64383241|NCT05515185|Alkylating Agents|alkylating agents|mesh-ancestor
64383242|NCT05515185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383243|NCT05515185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383244|NCT05515185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64863625|NCT01771406|Vasodilator Agents|vasodilator agents|mesh-ancestor
64863626|NCT01771406|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64863627|NCT01771406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64863628|NCT01771406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64863629|NCT01771406|Adrenergic Agents|adrenergic agents|mesh-ancestor
64863630|NCT01771406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64863631|NCT01771406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863632|NCT01771406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863633|NCT01771432|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64863634|NCT01771432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863635|NCT01771445|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64863636|NCT01771445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64863637|NCT01771458|Tamoxifen|tamoxifen|mesh-list
64863638|NCT01771458|Trastuzumab|trastuzumab|mesh-list
64863639|NCT01771458|Everolimus|everolimus|mesh-list
64863640|NCT01771458|Sorafenib|sorafenib|mesh-list
64863641|NCT01771458|Letrozole|letrozole|mesh-list
64863642|NCT01771458|Dasatinib|dasatinib|mesh-list
64332828|NCT01036087|Carboplatin|carboplatin|mesh-list
64332829|NCT01036087|Fluorouracil|fluorouracil|mesh-list
64332830|NCT01036087|Epirubicin|epirubicin|mesh-list
64332831|NCT01036087|Panitumumab|panitumumab|mesh-list
64332832|NCT01036087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64332833|NCT01036087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863644|NCT01771458|Vemurafenib|vemurafenib|mesh-list
64863645|NCT01771458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64863646|NCT01771458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863647|NCT01771458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64383245|NCT02044822|Rituximab|rituximab|mesh-list
64383246|NCT02044822|Idelalisib|idelalisib|mesh-list
64383247|NCT02044822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64383248|NCT02044822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383249|NCT02044822|Immunologic Factors|immunologic factors|mesh-ancestor
64383250|NCT02044822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383251|NCT02044822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64383252|NCT02044822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383253|NCT02044822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383254|NCT03116555|Irinotecan|irinotecan|mesh-list
64383255|NCT03116555|Apatinib|apatinib|mesh-list
64383256|NCT03116555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64383257|NCT03116555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64863652|NCT01771458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863653|NCT01771458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64863654|NCT01771458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64863655|NCT01771458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64863656|NCT01771458|Hormone Antagonists|hormone antagonists|mesh-ancestor
64863657|NCT01771458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64863658|NCT01771458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64863659|NCT01771458|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64863660|NCT01771458|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64863661|NCT01771458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64863662|NCT05318365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64863663|NCT05318365|Laxatives|laxatives|mesh-ancestor
64863664|NCT05318365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64863665|NCT01771783|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64863666|NCT01771783|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64863667|NCT01771783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64863668|NCT01771783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863669|NCT01771783|Protease Inhibitors|protease inhibitors|mesh-ancestor
64863670|NCT01771822|Ibuprofen|ibuprofen|mesh-list
64295622|NCT02802865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863671|NCT01771822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64295623|NCT02802865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64383258|NCT03116555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383259|NCT03116555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383260|NCT03116555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383261|NCT03116555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64383262|NCT04871529|Gemcitabine|gemcitabine|mesh-list
64383263|NCT04871529|Carboplatin|carboplatin|mesh-list
64383264|NCT04871529|Avelumab|avelumab|mesh-list
64383265|NCT04871529|Immunoglobulins|immunoglobulins|mesh-list
64383266|NCT04871529|Immunoglobulin G|immunoglobulin g|mesh-list
64383267|NCT04871529|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64383268|NCT04871529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383269|NCT04871529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64383270|NCT04871529|Antimetabolites|antimetabolites|mesh-ancestor
64383271|NCT04871529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383272|NCT04871529|Antiviral Agents|antiviral agents|mesh-ancestor
64383300|NCT02411903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64383302|NCT02411903|Purinergic Agents|purinergic agents|mesh-ancestor
64863672|NCT01771822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64863673|NCT01771822|Analgesics|analgesics|mesh-ancestor
64863674|NCT01771822|Sensory System Agents|sensory system agents|mesh-ancestor
64863675|NCT01771822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64863676|NCT01771822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863677|NCT01771822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64332835|NCT01036087|Antimitotic Agents|antimitotic agents|mesh-ancestor
64332836|NCT01036087|Mitosis Modulators|mitosis modulators|mesh-ancestor
64332837|NCT01036087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332838|NCT01036087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64332839|NCT01036087|Immunologic Factors|immunologic factors|mesh-ancestor
64332840|NCT01036087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332841|NCT01036087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64332842|NCT01036087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64332843|NCT01036087|Alkylating Agents|alkylating agents|mesh-ancestor
64332844|NCT01036087|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64863678|NCT01771822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64863679|NCT01771822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64863680|NCT01771822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863681|NCT01771822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863683|NCT01771874|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
64863684|NCT01771874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64863744|NCT01772290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863745|NCT01772290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64863746|NCT01772290|Hormone Antagonists|hormone antagonists|mesh-ancestor
64863747|NCT01772290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64383303|NCT02411903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64383304|NCT02411903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383305|NCT02411825|Metformin|metformin|mesh-list
64383306|NCT02411825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64383346|NCT04987775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383347|NCT04987775|Protective Agents|protective agents|mesh-ancestor
64383348|NCT04987775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383349|NCT04987775|Antidotes|antidotes|mesh-ancestor
64383350|NCT05514015|Cyclophosphamide|cyclophosphamide|mesh-list
64383351|NCT05514015|Rituximab|rituximab|mesh-list
64383352|NCT05514015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64383353|NCT05514015|Immunologic Factors|immunologic factors|mesh-ancestor
64383354|NCT05514015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383355|NCT05514015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64383356|NCT05514015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64383357|NCT05514015|Alkylating Agents|alkylating agents|mesh-ancestor
64383358|NCT05514015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383359|NCT05514015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383360|NCT05514015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64383361|NCT05514015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64383362|NCT03174821|Insulin|insulin|mesh-list
64383363|NCT03174821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64383364|NCT03174821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64383365|NCT03174821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383367|NCT05520021|Nifedipine|nifedipine|mesh-list
64383368|NCT05520021|Analgesics|analgesics|mesh-ancestor
64383369|NCT05520021|Sensory System Agents|sensory system agents|mesh-ancestor
64383370|NCT05520021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64383371|NCT05520021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383372|NCT05520021|Anesthetics|anesthetics|mesh-ancestor
64383373|NCT05520021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64781683|NCT05340270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64781684|NCT05340270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781685|NCT05340270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781686|NCT05266404|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64781687|NCT05266404|Dapagliflozin|dapagliflozin|mesh-list
64781688|NCT05266404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64781689|NCT05266404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781690|NCT05266404|Incretins|incretins|mesh-ancestor
64863748|NCT01772290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863749|NCT01772290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64781691|NCT05266404|Hormones|hormones|mesh-ancestor
64863750|NCT01772290|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64863751|NCT01772290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64863752|NCT01772290|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64863753|NCT01772290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64863754|NCT01772290|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64863755|NCT01772381|Dexamethasone|dexamethasone|mesh-list
64863756|NCT01772381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64781692|NCT05266404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64781693|NCT05266404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64781694|NCT05266404|Protease Inhibitors|protease inhibitors|mesh-ancestor
64781695|NCT05266404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781696|NCT05266404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781697|NCT05266404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64781698|NCT05122494|Capecitabine|capecitabine|mesh-list
64781699|NCT05122494|Lapatinib|lapatinib|mesh-list
64393114|NCT05104931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393115|NCT05104931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393116|NCT02397499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64393117|NCT02397499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64393118|NCT02397499|Autonomic Agents|autonomic agents|mesh-ancestor
64393119|NCT02397499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393120|NCT02397499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393121|NCT02397499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64393122|NCT02397499|Respiratory System Agents|respiratory system agents|mesh-ancestor
64393123|NCT02397499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64393125|NCT02397499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64393126|NCT02397499|Adrenergic Agents|adrenergic agents|mesh-ancestor
64393127|NCT02397499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64393129|NCT02406703|Mepivacaine|mepivacaine|mesh-list
64781707|NCT05063604|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64781708|NCT05063604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64781709|NCT05063604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64781710|NCT05063604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863774|NCT01772420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863775|NCT01772563|Itraconazole|itraconazole|mesh-list
64863776|NCT01772563|Antifungal Agents|antifungal agents|mesh-ancestor
64863777|NCT01772563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863778|NCT01772563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64863779|NCT01772563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64863780|NCT01772563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863781|NCT01772563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863782|NCT01772563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64863783|NCT01772563|Hormone Antagonists|hormone antagonists|mesh-ancestor
64863784|NCT01772563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64863785|NCT01772563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863786|NCT01772563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64863787|NCT01772589|Pyrithione zinc|pyrithione zinc|mesh-list
64863788|NCT01772589|Keratolytic Agents|keratolytic agents|mesh-ancestor
64863789|NCT01772589|Dermatologic Agents|dermatologic agents|mesh-ancestor
64863790|NCT01772615|Ciprofloxacin|ciprofloxacin|mesh-list
64863791|NCT01772615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64332845|NCT01036087|Antimetabolites|antimetabolites|mesh-ancestor
64332846|NCT01036087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64781711|NCT05063604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64781712|NCT05063604|Serotonin Agents|serotonin agents|mesh-ancestor
64781713|NCT05063604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393130|NCT02406703|Chloroprocaine|chloroprocaine|mesh-list
64393131|NCT02406703|Anesthetics, Local|anesthetics, local|mesh-ancestor
64393132|NCT02406703|Anesthetics|anesthetics|mesh-ancestor
64393133|NCT02406703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64393134|NCT02406703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393135|NCT02406703|Sensory System Agents|sensory system agents|mesh-ancestor
64393136|NCT02406703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393137|NCT02682641|Rituximab|rituximab|mesh-list
64393138|NCT02682641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64863792|NCT01772615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863793|NCT01772615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64863794|NCT01772615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64863795|NCT01772615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863796|NCT01772615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863797|NCT01772615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863798|NCT01772615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64863799|NCT01772615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64863800|NCT01772641|Varenicline|varenicline|mesh-list
64863801|NCT01772641|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64863802|NCT01772641|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64863803|NCT01772641|Cholinergic Agents|cholinergic agents|mesh-ancestor
64863804|NCT01772641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64863805|NCT01772641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863806|NCT01772641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863807|NCT01772797|Ceritinib|ceritinib|mesh-list
64863808|NCT01772797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863809|NCT01772797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64863810|NCT01772797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863811|NCT01772797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863812|NCT01772836|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
64863813|NCT01772836|Biapenem|biapenem|mesh-list
64863814|NCT01772836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632395|NCT04329130|Lenalidomide|lenalidomide|mesh-list
64863815|NCT01772836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393139|NCT02682641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393140|NCT02682641|Immunologic Factors|immunologic factors|mesh-ancestor
64393141|NCT02682641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393142|NCT02682641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64393143|NCT05110469|Magnesium Sulfate|magnesium sulfate|mesh-list
64393144|NCT05110469|Meperidine|meperidine|mesh-list
64781714|NCT05063604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64863829|NCT01772940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781715|NCT05063604|Antidepressive Agents|antidepressive agents|mesh-ancestor
64781716|NCT05063604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64781717|NCT04978428|Cannabidiol|cannabidiol|mesh-list
64303964|NCT03563963|Anesthetics, Local|anesthetics, local|mesh-ancestor
64303965|NCT03563963|Anesthetics|anesthetics|mesh-ancestor
64303966|NCT03563963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64303967|NCT03563963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303968|NCT03563963|Sensory System Agents|sensory system agents|mesh-ancestor
64303969|NCT03563963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64863830|NCT01772940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64863831|NCT01772940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64863832|NCT01772940|Antiviral Agents|antiviral agents|mesh-ancestor
64303970|NCT03563963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64303971|NCT03563963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64781724|NCT04968054|Anesthetics, General|anesthetics, general|mesh-ancestor
64781725|NCT04968054|Anesthetics|anesthetics|mesh-ancestor
64781726|NCT04956120|Dialysis Solutions|dialysis solutions|mesh-list
64781727|NCT04956120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64781728|NCT04780464|Prednisone|prednisone|mesh-list
64781729|NCT04780464|Prednisolone|prednisolone|mesh-list
64863883|NCT01773096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64863884|NCT01773096|Laxatives|laxatives|mesh-ancestor
64863885|NCT01773096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64863886|NCT01773096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863887|NCT01773096|Sensory System Agents|sensory system agents|mesh-ancestor
64863888|NCT01773096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64632469|NCT00003994|Amifostine|amifostine|mesh-list
64863889|NCT01773096|Antacids|antacids|mesh-ancestor
64863890|NCT01773096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863891|NCT01773096|Antidiarrheals|antidiarrheals|mesh-ancestor
64781730|NCT04780464|Cyclophosphamide|cyclophosphamide|mesh-list
64550371|NCT01496612|Buspirone|buspirone|mesh-list
64781731|NCT04780464|Doxorubicin|doxorubicin|mesh-list
64781732|NCT04780464|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64781733|NCT04780464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64781734|NCT04780464|Immunologic Factors|immunologic factors|mesh-ancestor
64781735|NCT04780464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781736|NCT04780464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64781737|NCT04780464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64781738|NCT04780464|Alkylating Agents|alkylating agents|mesh-ancestor
64781739|NCT04780464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781740|NCT04780464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781741|NCT04780464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64781742|NCT04780464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64781743|NCT04780464|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64781744|NCT04780464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64863942|NCT01773616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64863943|NCT01773616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863944|NCT01773616|Immunologic Factors|immunologic factors|mesh-ancestor
64863945|NCT01773616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863946|NCT01773616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64863947|NCT01773616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64863948|NCT01773616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64863949|NCT01773616|Antitubercular Agents|antitubercular agents|mesh-ancestor
64863950|NCT01773616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64863951|NCT01773616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863952|NCT01773616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863953|NCT01773616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863954|NCT01773616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64863955|NCT01773616|Glucocorticoids|glucocorticoids|mesh-ancestor
64863956|NCT01773616|Hormones|hormones|mesh-ancestor
64863957|NCT01773616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64863958|NCT01773616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64863959|NCT01773616|Antiemetics|antiemetics|mesh-ancestor
64863960|NCT01773616|Autonomic Agents|autonomic agents|mesh-ancestor
64863961|NCT01773616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64863970|NCT01773772|Progesterone|progesterone|mesh-list
64781745|NCT04780464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781746|NCT04780464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64781747|NCT04780464|Glucocorticoids|glucocorticoids|mesh-ancestor
64781748|NCT04780464|Hormones|hormones|mesh-ancestor
64781749|NCT04780464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64303972|NCT03563963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64303973|NCT03563963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64303974|NCT03563963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863976|NCT01773798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64303975|NCT03066518|Melatonin|melatonin|mesh-list
64863977|NCT01773798|Insulin Aspart|insulin aspart|mesh-list
64863978|NCT01773798|Insulin, Long-Acting|insulin, long-acting|mesh-list
64863979|NCT01773798|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64863980|NCT01773798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64863981|NCT01773798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863982|NCT01773824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64863983|NCT01773824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863984|NCT01773837|Methylphenidate|methylphenidate|mesh-list
64863985|NCT01773837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64863986|NCT01773837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863987|NCT01773837|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64863988|NCT01773837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64863989|NCT01773837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64863990|NCT01773837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863991|NCT01773837|Dopamine Agents|dopamine agents|mesh-ancestor
64863992|NCT01773837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64863993|NCT01773876|Micafungin|micafungin|mesh-list
64863994|NCT01773876|Antifungal Agents|antifungal agents|mesh-ancestor
64303976|NCT03066518|Antioxidants|antioxidants|mesh-ancestor
64303977|NCT03066518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303978|NCT03066518|Protective Agents|protective agents|mesh-ancestor
64303979|NCT03066518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303980|NCT03066518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64303981|NCT03069248|Interferons|interferons|mesh-list
64303984|NCT03069248|Rituximab|rituximab|mesh-list
64781750|NCT04780464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64781752|NCT04495608|Antifungal Agents|antifungal agents|mesh-ancestor
64781753|NCT04495608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64781754|NCT04495608|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64781755|NCT04495608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64781756|NCT04495608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781757|NCT04495608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781758|NCT04495608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64781759|NCT04495608|Hormone Antagonists|hormone antagonists|mesh-ancestor
64781760|NCT04495608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64781761|NCT04495608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781762|NCT04495608|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64781763|NCT04495608|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64781764|NCT04356690|Etoposide|etoposide|mesh-list
64863996|NCT01774370|Dabigatran|dabigatran|mesh-list
64863997|NCT01774370|Antithrombins|antithrombins|mesh-ancestor
64863998|NCT01774370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64863999|NCT01774370|Protease Inhibitors|protease inhibitors|mesh-ancestor
64864000|NCT01774370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64864001|NCT01774370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864002|NCT01774370|Anticoagulants|anticoagulants|mesh-ancestor
64864003|NCT01774396|Lidocaine|lidocaine|mesh-list
64864004|NCT01774396|Anesthetics, Local|anesthetics, local|mesh-ancestor
64864005|NCT01774396|Anesthetics|anesthetics|mesh-ancestor
64864006|NCT01774396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64864007|NCT01774396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864008|NCT01774396|Sensory System Agents|sensory system agents|mesh-ancestor
64864009|NCT01774396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64332857|NCT00783367|Dexamethasone|dexamethasone|mesh-list
64304022|NCT05004116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64304023|NCT05004116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64304024|NCT05004116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304076|NCT05487092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304077|NCT05487092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304078|NCT05487092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64304079|NCT05487092|Hormone Antagonists|hormone antagonists|mesh-ancestor
64304081|NCT05487092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781765|NCT04356690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64781766|NCT04356690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781767|NCT04356690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64781768|NCT04356690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64781769|NCT04356690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781770|NCT04356690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864031|NCT01774474|Growth Inhibitors|growth inhibitors|mesh-ancestor
64864032|NCT01774474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64864033|NCT01774474|Antiemetics|antiemetics|mesh-ancestor
64864034|NCT01774474|Autonomic Agents|autonomic agents|mesh-ancestor
64864035|NCT01774474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64781771|NCT04238754|Cannabidiol|cannabidiol|mesh-list
64864036|NCT01774474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64864037|NCT01774474|Glucocorticoids|glucocorticoids|mesh-ancestor
64864038|NCT01774474|Hormones|hormones|mesh-ancestor
64632615|NCT00004024|Immunologic Factors|immunologic factors|mesh-ancestor
64945482|NCT05595603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64864039|NCT01774474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64864040|NCT01774474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64864041|NCT01774474|Protease Inhibitors|protease inhibitors|mesh-ancestor
64864042|NCT01774474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64864043|NCT01774474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864044|NCT01774474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64864045|NCT01774474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64864046|NCT01774474|Immunologic Factors|immunologic factors|mesh-ancestor
64864047|NCT01774474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64781772|NCT04238754|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64781773|NCT04238754|Anticonvulsants|anticonvulsants|mesh-ancestor
64393178|NCT05101109|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64393179|NCT05101109|Immunologic Factors|immunologic factors|mesh-ancestor
64393180|NCT05101109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393181|NCT05094323|Bupivacaine|bupivacaine|mesh-list
64393182|NCT05094323|Anesthetics, Local|anesthetics, local|mesh-ancestor
64393183|NCT05094323|Anesthetics|anesthetics|mesh-ancestor
64393184|NCT05094323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64781774|NCT04017468|Vancomycin|vancomycin|mesh-list
64781775|NCT04017468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64304339|NCT03893630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64864048|NCT01774474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64864049|NCT01774474|Analgesics|analgesics|mesh-ancestor
64864050|NCT01774474|Sensory System Agents|sensory system agents|mesh-ancestor
64864051|NCT01774474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64864052|NCT01774565|Insulin|insulin|mesh-list
64864053|NCT01774565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64864054|NCT01774565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64864055|NCT01774565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864056|NCT01774812|Ergocalciferols|ergocalciferols|mesh-list
64864057|NCT01774812|Vitamin D|vitamin d|mesh-list
64864058|NCT01774812|Alfacalcidol|alfacalcidol|mesh-list
64864062|NCT01774812|Vitamins|vitamins|mesh-ancestor
64864079|NCT01774864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864080|NCT01774877|Leflunomide|leflunomide|mesh-list
64864081|NCT01774877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64864082|NCT01774877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864083|NCT01774877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64864084|NCT01774877|Immunologic Factors|immunologic factors|mesh-ancestor
64864085|NCT01774877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864086|NCT01775098|Allopurinol|allopurinol|mesh-list
64864087|NCT01775098|Antimetabolites|antimetabolites|mesh-ancestor
64864088|NCT01775098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864089|NCT01775098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304340|NCT03893630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64304341|NCT03893630|Analgesics|analgesics|mesh-ancestor
64304342|NCT03893630|Sensory System Agents|sensory system agents|mesh-ancestor
64304343|NCT03893630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64304344|NCT03893630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304345|NCT03893630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64304346|NCT03893630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64304347|NCT03893630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64304348|NCT03893630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64304349|NCT03893630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304350|NCT03893630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64304351|NCT03893630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64864106|NCT01775540|Antiemetics|antiemetics|mesh-ancestor
64864107|NCT01775540|Autonomic Agents|autonomic agents|mesh-ancestor
64864108|NCT01775540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64864109|NCT01775540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864110|NCT01775540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64864111|NCT01775540|Glucocorticoids|glucocorticoids|mesh-ancestor
64864112|NCT01775540|Hormones|hormones|mesh-ancestor
64632692|NCT00003340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64864113|NCT01775540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64864114|NCT01775540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64864115|NCT01775540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64864116|NCT01775540|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64864117|NCT01775540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64864119|NCT01775579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64864120|NCT01775579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64864121|NCT01775579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864122|NCT01775579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64864123|NCT01775579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64864124|NCT01775579|Antimetabolites|antimetabolites|mesh-ancestor
64864125|NCT01775579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864126|NCT01775579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64864127|NCT01775579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64864128|NCT01775579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781776|NCT04017468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64781777|NCT03770130|Dexmedetomidine|dexmedetomidine|mesh-list
64781778|NCT03770130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64781779|NCT03770130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64781780|NCT03770130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781781|NCT03770130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64781782|NCT03770130|Analgesics|analgesics|mesh-ancestor
64781783|NCT03770130|Sensory System Agents|sensory system agents|mesh-ancestor
64781784|NCT03770130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64781785|NCT03770130|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64781786|NCT03770130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64781787|NCT03770130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64781788|NCT03770130|Adrenergic Agents|adrenergic agents|mesh-ancestor
64781789|NCT03770130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64864143|NCT01775761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864144|NCT01775761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64864145|NCT01775839|Aspirin|aspirin|mesh-list
64864146|NCT01775839|Digoxin|digoxin|mesh-list
64864147|NCT01775839|Clopidogrel|clopidogrel|mesh-list
64864148|NCT01775839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64864149|NCT01775839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64864150|NCT01775839|Analgesics|analgesics|mesh-ancestor
64864151|NCT01775839|Sensory System Agents|sensory system agents|mesh-ancestor
64332865|NCT00783367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332867|NCT00783367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64332869|NCT00783367|Autonomic Agents|autonomic agents|mesh-ancestor
64332870|NCT00783367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64332871|NCT00783367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64864152|NCT01775839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64864153|NCT01775839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864154|NCT01775839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64864155|NCT01775839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64864156|NCT01775839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64864157|NCT01775839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64864158|NCT01775839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864159|NCT01775839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64864160|NCT01775839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64864161|NCT01775839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64864162|NCT01775839|Antipyretics|antipyretics|mesh-ancestor
64864163|NCT01775839|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64781790|NCT03770130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781791|NCT03668340|Adavosertib|adavosertib|mesh-list
64781792|NCT03668340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781793|NCT03668340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781794|NCT03586284|Valganciclovir|valganciclovir|mesh-list
64781795|NCT03586284|Ganciclovir|ganciclovir|mesh-list
64781796|NCT03586284|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64781797|NCT03586284|Antiviral Agents|antiviral agents|mesh-ancestor
64781798|NCT03586284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64781799|NCT03586284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64781800|NCT03586284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393205|NCT03170323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64393206|NCT02396563|Ropivacaine|ropivacaine|mesh-list
64781801|NCT03586284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781802|NCT03567642|Etoposide|etoposide|mesh-list
64550441|NCT00819507|Fluocinonide|fluocinonide|mesh-list
64864172|NCT01775891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64864173|NCT01775891|Propafenone|propafenone|mesh-list
64864174|NCT01775891|Pilsicainide|pilsicainide|mesh-list
64864175|NCT01775891|Lidocaine|lidocaine|mesh-list
64864176|NCT01775891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64864177|NCT01775891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64864178|NCT01775891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64864179|NCT01775891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864180|NCT01775891|Anesthetics, Local|anesthetics, local|mesh-ancestor
64864181|NCT01775891|Anesthetics|anesthetics|mesh-ancestor
64864182|NCT01775891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64864183|NCT01775891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864184|NCT01775891|Sensory System Agents|sensory system agents|mesh-ancestor
64864185|NCT01775891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64864186|NCT01776047|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
64781803|NCT03567642|Osimertinib|osimertinib|mesh-list
64781804|NCT03567642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64781805|NCT03567642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781806|NCT03567642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64781807|NCT03567642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64781808|NCT03567642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781809|NCT03567642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781810|NCT03567642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64781811|NCT03190668|Cefazolin|cefazolin|mesh-list
64781812|NCT03190668|Dialysis Solutions|dialysis solutions|mesh-list
64781813|NCT03190668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64781814|NCT03190668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64781815|NCT03190668|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64781816|NCT02952534|Rucaparib|rucaparib|mesh-list
64364199|NCT03289819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429994|NCT05022329|Immunologic Factors|immunologic factors|mesh-ancestor
64781826|NCT01871766|Irinotecan|irinotecan|mesh-list
64332872|NCT00783367|Glucocorticoids|glucocorticoids|mesh-ancestor
64332873|NCT00783367|Hormones|hormones|mesh-ancestor
64332874|NCT00783367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64864187|NCT01776047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64864188|NCT01776203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64864189|NCT01776203|Medroxyprogesterone|medroxyprogesterone|mesh-list
64864190|NCT01776203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64864191|NCT01776203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64864192|NCT01776203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64864193|NCT01776203|Contraceptive Agents|contraceptive agents|mesh-ancestor
64864194|NCT01776203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64864195|NCT01776203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864196|NCT01776203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64864197|NCT01776203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64864198|NCT01776203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64864199|NCT01776203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64864200|NCT01776203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64864201|NCT01776320|Alprostadil|alprostadil|mesh-list
64864202|NCT01776320|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64781827|NCT01871766|Etoposide|etoposide|mesh-list
64781828|NCT01871766|Etoposide phosphate|etoposide phosphate|mesh-list
64781829|NCT01871766|Vincristine|vincristine|mesh-list
64781830|NCT01871766|Sorafenib|sorafenib|mesh-list
64781831|NCT01871766|Dexrazoxane|dexrazoxane|mesh-list
64781832|NCT01871766|Razoxane|razoxane|mesh-list
64781833|NCT01871766|Mitogens|mitogens|mesh-list
64781834|NCT01871766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64781835|NCT01871766|Immunologic Factors|immunologic factors|mesh-ancestor
64781836|NCT01871766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781837|NCT01871766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64781838|NCT01871766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64781839|NCT01871766|Alkylating Agents|alkylating agents|mesh-ancestor
64781840|NCT01871766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864203|NCT01776320|Vasodilator Agents|vasodilator agents|mesh-ancestor
64864204|NCT01776320|Urological Agents|urological agents|mesh-ancestor
64864205|NCT01776437|Talazoparib|talazoparib|mesh-list
64864206|NCT01776437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64864207|NCT01776437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64864208|NCT01776437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864209|NCT01776437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64864210|NCT01776515|Acetaminophen|acetaminophen|mesh-list
64864211|NCT01776515|Tramadol|tramadol|mesh-list
64864212|NCT01776515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64864213|NCT01776515|Analgesics|analgesics|mesh-ancestor
64864214|NCT01776515|Sensory System Agents|sensory system agents|mesh-ancestor
64864215|NCT01776515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64864216|NCT01776515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864217|NCT01776515|Antipyretics|antipyretics|mesh-ancestor
64864218|NCT01776515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64864219|NCT01776515|Narcotics|narcotics|mesh-ancestor
64864220|NCT01776515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64864221|NCT01776567|Everolimus|everolimus|mesh-list
64332876|NCT00783367|Protease Inhibitors|protease inhibitors|mesh-ancestor
64332877|NCT00783367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64332878|NCT00783367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332879|NCT00783367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64332880|NCT00783367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64295697|NCT02054143|Anesthetics|anesthetics|mesh-ancestor
64864222|NCT01776567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64864223|NCT01776567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64864224|NCT01776567|Immunologic Factors|immunologic factors|mesh-ancestor
64864225|NCT01776567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864226|NCT01776671|Gabapentin|gabapentin|mesh-list
64864227|NCT01776671|Analgesics|analgesics|mesh-ancestor
64864228|NCT01776671|Sensory System Agents|sensory system agents|mesh-ancestor
64864229|NCT01776671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64864230|NCT01776671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864231|NCT01776671|Anticonvulsants|anticonvulsants|mesh-ancestor
64864242|NCT01776684|Gefitinib|gefitinib|mesh-list
64781841|NCT01871766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781842|NCT01871766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64781843|NCT01871766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64781844|NCT01871766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64304404|NCT05619848|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64304405|NCT05619848|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64304406|NCT05619848|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64304407|NCT01560637|Treprostinil|treprostinil|mesh-list
64304408|NCT01560637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64304409|NCT04447352|Leucovorin|leucovorin|mesh-list
64864344|NCT01777867|Respiratory System Agents|respiratory system agents|mesh-ancestor
64864345|NCT01777867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64864346|NCT01777867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64864347|NCT01777867|Cholinergic Agents|cholinergic agents|mesh-ancestor
64864348|NCT01777867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64864349|NCT01777867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864351|NCT01777919|Temozolomide|temozolomide|mesh-list
64864352|NCT01777919|Disulfiram|disulfiram|mesh-list
64864353|NCT01777919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64864354|NCT01777919|Alkylating Agents|alkylating agents|mesh-ancestor
64864355|NCT01777919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864356|NCT01777919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64864357|NCT01777919|Trace Elements|trace elements|mesh-ancestor
64864359|NCT01777919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864360|NCT01777919|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64864361|NCT01777919|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
64864362|NCT01777919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64864363|NCT01778075|Acetaminophen|acetaminophen|mesh-list
64864364|NCT01778075|Tramadol|tramadol|mesh-list
64864365|NCT01778075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64864366|NCT01778075|Analgesics|analgesics|mesh-ancestor
64864367|NCT01778075|Sensory System Agents|sensory system agents|mesh-ancestor
64304410|NCT04447352|Docetaxel|docetaxel|mesh-list
64304411|NCT04447352|Fluorouracil|fluorouracil|mesh-list
64304412|NCT04447352|Oxaliplatin|oxaliplatin|mesh-list
64304413|NCT04447352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304414|NCT04447352|Tubulin Modulators|tubulin modulators|mesh-ancestor
64304415|NCT04447352|Antimitotic Agents|antimitotic agents|mesh-ancestor
64304416|NCT04447352|Mitosis Modulators|mitosis modulators|mesh-ancestor
64304417|NCT04447352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393259|NCT04383119|Gemcitabine|gemcitabine|mesh-list
64393260|NCT04383119|Trabectedin|trabectedin|mesh-list
64393261|NCT04383119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64393262|NCT04383119|Antimetabolites|antimetabolites|mesh-ancestor
64393263|NCT04383119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393264|NCT04383119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393265|NCT04383119|Antiviral Agents|antiviral agents|mesh-ancestor
64393266|NCT04383119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64393267|NCT04383119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393268|NCT04383119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64393269|NCT04383119|Immunologic Factors|immunologic factors|mesh-ancestor
64393270|NCT04383119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393271|NCT04383119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64393272|NCT04383119|Alkylating Agents|alkylating agents|mesh-ancestor
64393273|NCT04522739|Spironolactone|spironolactone|mesh-list
64393274|NCT04522739|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64781845|NCT01871766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64781846|NCT01871766|Growth Substances|growth substances|mesh-ancestor
64781847|NCT01871766|Growth Inhibitors|growth inhibitors|mesh-ancestor
64781848|NCT01871766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64781849|NCT01871766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64781850|NCT01871766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64781851|NCT01871766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304421|NCT04447352|Immunologic Factors|immunologic factors|mesh-ancestor
64304422|NCT04447352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304423|NCT04447352|Antidotes|antidotes|mesh-ancestor
64304424|NCT04447352|Protective Agents|protective agents|mesh-ancestor
64304425|NCT04447352|Vitamin B Complex|vitamin b complex|mesh-ancestor
64864388|NCT01778114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64864389|NCT01778192|Picosulfate sodium|picosulfate sodium|mesh-list
64864390|NCT01778192|Magnesium citrate|magnesium citrate|mesh-list
64864391|NCT01778192|Citric Acid|citric acid|mesh-list
64864392|NCT01778192|Sodium Citrate|sodium citrate|mesh-list
64364348|NCT03371069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304426|NCT04447352|Vitamins|vitamins|mesh-ancestor
64304427|NCT04447352|Micronutrients|micronutrients|mesh-ancestor
64781853|NCT01871766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64781854|NCT01871766|Tubulin Modulators|tubulin modulators|mesh-ancestor
64781855|NCT01871766|Antimitotic Agents|antimitotic agents|mesh-ancestor
64781856|NCT01871766|Mitosis Modulators|mitosis modulators|mesh-ancestor
64781857|NCT01871766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64781858|NCT01871766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64781859|NCT01871766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64781860|NCT01871766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64864468|NCT01778803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64864469|NCT01778803|Tubulin Modulators|tubulin modulators|mesh-ancestor
64864470|NCT01778803|Antimitotic Agents|antimitotic agents|mesh-ancestor
64864471|NCT01778803|Mitosis Modulators|mitosis modulators|mesh-ancestor
64864472|NCT01778803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864473|NCT01778842|Clopidogrel|clopidogrel|mesh-list
64864474|NCT01778842|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64781861|NCT01871766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64781862|NCT01871766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64781863|NCT01871766|Protective Agents|protective agents|mesh-ancestor
64781864|NCT05452434|Mirabegron|mirabegron|mesh-list
64781865|NCT05452434|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64393275|NCT04522739|Hormone Antagonists|hormone antagonists|mesh-ancestor
64393276|NCT04522739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64393277|NCT04522739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393278|NCT04522739|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64393279|NCT04522739|Diuretics|diuretics|mesh-ancestor
64393280|NCT04522739|Natriuretic Agents|natriuretic agents|mesh-ancestor
64393281|NCT04309877|Theophylline|theophylline|mesh-list
64393282|NCT04309877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64393283|NCT04309877|Autonomic Agents|autonomic agents|mesh-ancestor
64781866|NCT05452434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64781867|NCT05452434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64864515|NCT01779284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64864520|NCT01779284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64781868|NCT05452434|Adrenergic Agents|adrenergic agents|mesh-ancestor
64781869|NCT05452434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64781870|NCT05452434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781871|NCT05452434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781872|NCT05452434|Urological Agents|urological agents|mesh-ancestor
64781873|NCT05450328|Epoprostenol|epoprostenol|mesh-list
64781874|NCT05450328|Milrinone|milrinone|mesh-list
64781875|NCT05450328|Tezosentan|tezosentan|mesh-list
64781876|NCT05450328|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64781877|NCT05450328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64781878|NCT05450328|Vasodilator Agents|vasodilator agents|mesh-ancestor
64304428|NCT04157036|Ibuprofen|ibuprofen|mesh-list
64304429|NCT04157036|Methylprednisolone|methylprednisolone|mesh-list
64304430|NCT04157036|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64304431|NCT04157036|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64304432|NCT04157036|Prednisolone|prednisolone|mesh-list
64304433|NCT04157036|Prednisolone acetate|prednisolone acetate|mesh-list
64304434|NCT04157036|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64781880|NCT05450328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64864576|NCT01779492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64864577|NCT01779492|Narcotics|narcotics|mesh-ancestor
64864578|NCT01779492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64864579|NCT01779492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864580|NCT01779492|Analgesics|analgesics|mesh-ancestor
64864581|NCT01779492|Sensory System Agents|sensory system agents|mesh-ancestor
64864582|NCT01779492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64864583|NCT01779518|Interferons|interferons|mesh-list
64864584|NCT01779518|Ribavirin|ribavirin|mesh-list
64864585|NCT01779518|Sofosbuvir|sofosbuvir|mesh-list
64864586|NCT01779518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64864587|NCT01779518|Antiviral Agents|antiviral agents|mesh-ancestor
64864588|NCT01779518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64864589|NCT01779518|Antimetabolites|antimetabolites|mesh-ancestor
64864590|NCT01779518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864665|NCT01780181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64864666|NCT01780181|Antimetabolites|antimetabolites|mesh-ancestor
64864667|NCT01780181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864668|NCT01780181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64864669|NCT01780181|Antiviral Agents|antiviral agents|mesh-ancestor
64864670|NCT01780181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64864671|NCT01780181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64864672|NCT01780181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64864673|NCT01780181|Immunologic Factors|immunologic factors|mesh-ancestor
64864675|NCT01780181|Tubulin Modulators|tubulin modulators|mesh-ancestor
64781881|NCT05450328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781882|NCT05450328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781883|NCT05450328|Protective Agents|protective agents|mesh-ancestor
64781884|NCT05450328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781885|NCT05450328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64781886|NCT05448924|Hormones|hormones|mesh-list
64781887|NCT05448924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64781888|NCT05448924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781889|NCT05447676|4-Aminopyridine|4-aminopyridine|mesh-list
64393295|NCT04309877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64393296|NCT04367909|Carboplatin|carboplatin|mesh-list
64304436|NCT04157036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64304437|NCT04157036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64304438|NCT04157036|Analgesics|analgesics|mesh-ancestor
64304439|NCT04157036|Sensory System Agents|sensory system agents|mesh-ancestor
64304440|NCT04157036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64304441|NCT04157036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864731|NCT01780467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64864733|NCT01780467|Autonomic Agents|autonomic agents|mesh-ancestor
64864734|NCT01780467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64864735|NCT01780467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864736|NCT01780467|Dopamine Agents|dopamine agents|mesh-ancestor
64864737|NCT01780467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64864738|NCT01780467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864739|NCT01780467|Protective Agents|protective agents|mesh-ancestor
64864740|NCT01780519|Lorazepam|lorazepam|mesh-list
64864741|NCT01780519|Anticonvulsants|anticonvulsants|mesh-ancestor
64864742|NCT01780519|Antiemetics|antiemetics|mesh-ancestor
64864743|NCT01780519|Autonomic Agents|autonomic agents|mesh-ancestor
64864744|NCT01780519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64864745|NCT01780519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304442|NCT04157036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64304443|NCT04157036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64304444|NCT04157036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64304445|NCT04157036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304446|NCT04157036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304447|NCT04157036|Antiemetics|antiemetics|mesh-ancestor
64304448|NCT04157036|Autonomic Agents|autonomic agents|mesh-ancestor
64304449|NCT04157036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64304450|NCT04157036|Glucocorticoids|glucocorticoids|mesh-ancestor
64304451|NCT04157036|Hormones|hormones|mesh-ancestor
64393299|NCT04367909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393300|NCT04367909|Tubulin Modulators|tubulin modulators|mesh-ancestor
64393301|NCT04367909|Antimitotic Agents|antimitotic agents|mesh-ancestor
64393302|NCT04367909|Mitosis Modulators|mitosis modulators|mesh-ancestor
64393304|NCT04367909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64324270|NCT05492318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64324271|NCT05492318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64324272|NCT05492318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64324273|NCT05492318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324274|NCT05492318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64324275|NCT05492318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64324276|NCT05492318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64781890|NCT05447676|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64781891|NCT05447676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64781892|NCT05447676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864781|NCT01780610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64864782|NCT01780610|Contraceptive Agents|contraceptive agents|mesh-ancestor
64864783|NCT01780610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64864784|NCT01780610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64864785|NCT01780610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64864786|NCT01780610|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64864787|NCT01780610|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64864788|NCT01780610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64864789|NCT01780610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864790|NCT01780610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64864791|NCT01780610|Hormone Antagonists|hormone antagonists|mesh-ancestor
64332911|NCT04416451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64332912|NCT04416451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64864792|NCT01780610|Progestins|progestins|mesh-ancestor
64864793|NCT01780740|Atorvastatin|atorvastatin|mesh-list
64864794|NCT01780740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64864795|NCT01780740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64864796|NCT01780740|Antimetabolites|antimetabolites|mesh-ancestor
64864797|NCT01780740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781894|NCT05447364|Analgesics|analgesics|mesh-ancestor
64781895|NCT05447364|Sensory System Agents|sensory system agents|mesh-ancestor
64781896|NCT05447364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64781897|NCT05447364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781898|NCT05447364|Anticonvulsants|anticonvulsants|mesh-ancestor
64781899|NCT05447364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64781900|NCT05447364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64781901|NCT05447364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781902|NCT05447364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64781903|NCT05447364|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64864800|NCT01780740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64781904|NCT05447364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64781905|NCT05447364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64781906|NCT05447364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64864863|NCT01781377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64864864|NCT01781377|Dopamine Agents|dopamine agents|mesh-ancestor
64864865|NCT01781377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64781907|NCT05442684|Vaccines|vaccines|mesh-list
64781908|NCT05442684|Immunologic Factors|immunologic factors|mesh-ancestor
64864866|NCT01781377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864867|NCT01781442|Sirolimus|sirolimus|mesh-list
64864868|NCT01781442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64633444|NCT05776030|Dopamine Agents|dopamine agents|mesh-ancestor
64864869|NCT01781442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64864870|NCT01781442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64864871|NCT01781442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64864872|NCT01781442|Antifungal Agents|antifungal agents|mesh-ancestor
64864873|NCT01781442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64864874|NCT01781442|Immunologic Factors|immunologic factors|mesh-ancestor
64864875|NCT01781442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864876|NCT01781507|Cetirizine|cetirizine|mesh-list
64864877|NCT01781507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64864878|NCT01781507|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64864879|NCT01781507|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64864880|NCT01781507|Histamine Antagonists|histamine antagonists|mesh-ancestor
64864881|NCT01781507|Histamine Agents|histamine agents|mesh-ancestor
64781909|NCT05442684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781910|NCT05430750|Nitrous Oxide|nitrous oxide|mesh-list
64781911|NCT05430750|Sevoflurane|sevoflurane|mesh-list
64781912|NCT05430750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64781913|NCT05430750|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64781914|NCT05430750|Anesthetics, General|anesthetics, general|mesh-ancestor
64781915|NCT05430750|Anesthetics|anesthetics|mesh-ancestor
64781916|NCT05430750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64781917|NCT05430750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393319|NCT04196075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393321|NCT04196075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64781919|NCT05430750|Analgesics|analgesics|mesh-ancestor
64781920|NCT05430750|Sensory System Agents|sensory system agents|mesh-ancestor
64781921|NCT05430750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64781922|NCT05418036|Sotalol|sotalol|mesh-list
64781923|NCT05418036|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64864883|NCT01781507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864884|NCT01781507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864885|NCT01781663|Petrolatum|petrolatum|mesh-list
64864886|NCT01781663|Emollients|emollients|mesh-ancestor
64864887|NCT01781663|Dermatologic Agents|dermatologic agents|mesh-ancestor
64864888|NCT01781702|Celecoxib|celecoxib|mesh-list
64864889|NCT01781702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64864890|NCT01781702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64864891|NCT01781702|Analgesics|analgesics|mesh-ancestor
64864892|NCT01781702|Sensory System Agents|sensory system agents|mesh-ancestor
64864893|NCT01781702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64864894|NCT01781702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864937|NCT01782001|Micronutrients|micronutrients|mesh-ancestor
64781924|NCT05418036|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64781925|NCT05418036|Adrenergic Agents|adrenergic agents|mesh-ancestor
64781926|NCT05418036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64781927|NCT05418036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781928|NCT05418036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781929|NCT05418036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64781930|NCT05418036|Sympatholytics|sympatholytics|mesh-ancestor
64781931|NCT05418036|Autonomic Agents|autonomic agents|mesh-ancestor
64781932|NCT05418036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64781933|NCT05274048|Trastuzumab|trastuzumab|mesh-list
64864966|NCT01782404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64864967|NCT01782404|Disinfectants|disinfectants|mesh-ancestor
64864968|NCT01782508|Interferons|interferons|mesh-list
64864969|NCT01782508|Imatinib Mesylate|imatinib mesylate|mesh-list
64864970|NCT01782508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64864971|NCT01782508|Antiviral Agents|antiviral agents|mesh-ancestor
64864972|NCT01782508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64864973|NCT01782508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64864976|NCT01782560|Omeprazole|omeprazole|mesh-list
64864977|NCT01782560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64864978|NCT01782560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64864979|NCT01782560|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64864980|NCT01782560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64864981|NCT01782560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864982|NCT01782573|Chlorhexidine|chlorhexidine|mesh-list
64864983|NCT01782573|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64864984|NCT01782573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64864985|NCT01782573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64864986|NCT01782573|Disinfectants|disinfectants|mesh-ancestor
64864987|NCT01782573|Dermatologic Agents|dermatologic agents|mesh-ancestor
64864988|NCT01782599|Nicotine|nicotine|mesh-list
64864989|NCT01782599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64864990|NCT01782599|Autonomic Agents|autonomic agents|mesh-ancestor
64864991|NCT01782599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64864992|NCT01782599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864993|NCT01782599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64864994|NCT01782599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64332914|NCT04416451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332915|NCT04416451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64332916|NCT04348747|Pembrolizumab|pembrolizumab|mesh-list
64332917|NCT04348747|Vaccines|vaccines|mesh-list
64781934|NCT05274048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64781935|NCT05274048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781936|NCT05023278|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64781937|NCT05023278|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64393346|NCT03830411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64393347|NCT03300479|Urapidil|urapidil|mesh-list
64393348|NCT03300479|Clevidipine|clevidipine|mesh-list
64864995|NCT01782599|Cholinergic Agents|cholinergic agents|mesh-ancestor
64864996|NCT01782599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64864997|NCT01782599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864998|NCT01782612|Analgesics|analgesics|mesh-list
64864999|NCT01782612|Sensory System Agents|sensory system agents|mesh-ancestor
64865000|NCT01782612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865001|NCT01782612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865002|NCT01782651|Capecitabine|capecitabine|mesh-list
64865003|NCT01782651|Lapatinib|lapatinib|mesh-list
64865004|NCT01782651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64865005|NCT01782651|Antimetabolites|antimetabolites|mesh-ancestor
64865006|NCT01782651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865007|NCT01782651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865008|NCT01782651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64865009|NCT01782651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393349|NCT03300479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64393350|NCT03300479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64393351|NCT03300479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393352|NCT03300479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64393353|NCT03300479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393354|NCT03300479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64393355|NCT03300479|Vasodilator Agents|vasodilator agents|mesh-ancestor
64304452|NCT04157036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64304453|NCT04157036|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64304454|NCT04157036|Protective Agents|protective agents|mesh-ancestor
64304455|NCT04157036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64304456|NCT04157036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393357|NCT03300479|Serotonin Agents|serotonin agents|mesh-ancestor
64393358|NCT03300479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64865058|NCT01782950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64781938|NCT05023278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64781939|NCT05023278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64781940|NCT05023278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64781941|NCT05023278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64781942|NCT05023278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781943|NCT05023278|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64781944|NCT05023278|Antidepressive Agents|antidepressive agents|mesh-ancestor
64781945|NCT05023278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64781946|NCT04964466|Becaplermin|becaplermin|mesh-list
64781947|NCT04964466|Anticoagulants|anticoagulants|mesh-ancestor
64781948|NCT04964466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
64865059|NCT01782950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64865060|NCT01782950|Leprostatic Agents|leprostatic agents|mesh-ancestor
64865061|NCT01782950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64865062|NCT01782950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865063|NCT01782950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865064|NCT01782950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64865065|NCT01782950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64865066|NCT01782950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64865067|NCT01782950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64865068|NCT01782950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64865069|NCT01782950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64865070|NCT01782950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64865071|NCT01782950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64865072|NCT01782950|Antimetabolites|antimetabolites|mesh-ancestor
64865073|NCT01782950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64865074|NCT01782976|Bevacizumab|bevacizumab|mesh-list
64865075|NCT01782976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64865076|NCT01782976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865077|NCT01782976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64295748|NCT02054299|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64781949|NCT04964466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64781950|NCT04964466|Growth Substances|growth substances|mesh-ancestor
64781951|NCT04964466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781952|NCT04727424|Budesonide|budesonide|mesh-list
64865078|NCT01782976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64781953|NCT04727424|Fluvoxamine|fluvoxamine|mesh-list
64781954|NCT04727424|Fluoxetine|fluoxetine|mesh-list
64781955|NCT04727424|Maleic acid|maleic acid|mesh-list
64781956|NCT04727424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64781957|NCT04727424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64393366|NCT03540875|Propofol|propofol|mesh-list
64393367|NCT03540875|Anesthetics|anesthetics|mesh-ancestor
64393368|NCT03540875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64393369|NCT03540875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393370|NCT03540875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64393371|NCT03540875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64393372|NCT03540875|Anesthetics, General|anesthetics, general|mesh-ancestor
64393373|NCT03540875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64781958|NCT04727424|Autonomic Agents|autonomic agents|mesh-ancestor
64781959|NCT04727424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64781960|NCT04727424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781961|NCT04727424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64781962|NCT04727424|Respiratory System Agents|respiratory system agents|mesh-ancestor
64781963|NCT04727424|Glucocorticoids|glucocorticoids|mesh-ancestor
64781964|NCT04727424|Hormones|hormones|mesh-ancestor
64781965|NCT04727424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64304459|NCT03547375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64304460|NCT03547375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304461|NCT03547375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304462|NCT01353911|Interferons|interferons|mesh-list
64304463|NCT01353911|Ribavirin|ribavirin|mesh-list
64304464|NCT01353911|Interferon-alpha|interferon-alpha|mesh-list
64781967|NCT04727424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865079|NCT01782976|Growth Substances|growth substances|mesh-ancestor
64332920|NCT04348747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64332921|NCT04348747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332922|NCT03525223|Dialysis Solutions|dialysis solutions|mesh-list
64332923|NCT03525223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64332925|NCT02257697|Cyclophosphamide|cyclophosphamide|mesh-list
64332926|NCT02257697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64332927|NCT02257697|Immunologic Factors|immunologic factors|mesh-ancestor
64332928|NCT02257697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332929|NCT02257697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64332930|NCT02257697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64332931|NCT02257697|Alkylating Agents|alkylating agents|mesh-ancestor
64332932|NCT02257697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332933|NCT02257697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865081|NCT01782976|Growth Inhibitors|growth inhibitors|mesh-ancestor
64781968|NCT04727424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64781969|NCT04727424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64781970|NCT04727424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64781971|NCT04727424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64781972|NCT04727424|Serotonin Agents|serotonin agents|mesh-ancestor
64781973|NCT04727424|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64865092|NCT01783106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865093|NCT01783106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865094|NCT01783106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64781974|NCT04727424|Antidepressive Agents|antidepressive agents|mesh-ancestor
64781975|NCT04727424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64781976|NCT04727424|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64865095|NCT01783106|Respiratory System Agents|respiratory system agents|mesh-ancestor
64865096|NCT01783106|Glucocorticoids|glucocorticoids|mesh-ancestor
64865097|NCT01783106|Hormones|hormones|mesh-ancestor
64865098|NCT01783106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64865099|NCT01783106|Antimalarials|antimalarials|mesh-ancestor
64332935|NCT02257697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64332936|NCT02257697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64332937|NCT02257697|Analgesics|analgesics|mesh-ancestor
64332938|NCT02257697|Sensory System Agents|sensory system agents|mesh-ancestor
64865100|NCT01783106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64865101|NCT01783106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64865102|NCT01783106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64865103|NCT01783106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865104|NCT01783106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865105|NCT01783106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64865106|NCT01783106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64865107|NCT01783106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64865108|NCT01783106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64865109|NCT01783106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64781977|NCT04727424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64781978|NCT04727424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64781979|NCT04727424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64781980|NCT04727424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64781981|NCT04727424|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64781982|NCT04727424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64393385|NCT03536507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393386|NCT04765787|Acetaminophen|acetaminophen|mesh-list
64393387|NCT04765787|Orphenadrine|orphenadrine|mesh-list
64393388|NCT04765787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64393389|NCT04765787|Analgesics|analgesics|mesh-ancestor
64393390|NCT04765787|Sensory System Agents|sensory system agents|mesh-ancestor
64393391|NCT04765787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393392|NCT04765787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865110|NCT01783106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64865111|NCT01783106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64865112|NCT01783197|Paclitaxel|paclitaxel|mesh-list
64865113|NCT01783197|Carboplatin|carboplatin|mesh-list
64865114|NCT01783197|Pemetrexed|pemetrexed|mesh-list
64865115|NCT01783197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64865116|NCT01783197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865117|NCT01783197|Tubulin Modulators|tubulin modulators|mesh-ancestor
64332939|NCT02257697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64332940|NCT02257697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64332941|NCT02257697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64332942|NCT02257697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64332943|NCT02257697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64332944|NCT02257697|Antimalarials|antimalarials|mesh-ancestor
64865118|NCT01783197|Antimitotic Agents|antimitotic agents|mesh-ancestor
64865119|NCT01783197|Mitosis Modulators|mitosis modulators|mesh-ancestor
64865120|NCT01783197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865121|NCT01783197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865122|NCT01783197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64781984|NCT04715646|Anticonvulsants|anticonvulsants|mesh-ancestor
64781985|NCT04569942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64781986|NCT04522206|Oxycodone|oxycodone|mesh-list
64781987|NCT04522206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64865123|NCT01783197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64865124|NCT01783340|Azithromycin|azithromycin|mesh-list
64781988|NCT04522206|Narcotics|narcotics|mesh-ancestor
64781989|NCT04522206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64781990|NCT04522206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64781991|NCT04522206|Analgesics|analgesics|mesh-ancestor
64865125|NCT01783340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64865126|NCT01783340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64865127|NCT01783379|Micafungin|micafungin|mesh-list
64865128|NCT01783379|Antifungal Agents|antifungal agents|mesh-ancestor
64781992|NCT04522206|Sensory System Agents|sensory system agents|mesh-ancestor
64865129|NCT01783379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64865130|NCT01783431|Poly ICLC|poly iclc|mesh-list
64865131|NCT01783431|Interferon Inducers|interferon inducers|mesh-ancestor
64865132|NCT01783431|Immunologic Factors|immunologic factors|mesh-ancestor
64865133|NCT01783431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865134|NCT01783587|Docetaxel|docetaxel|mesh-list
64865135|NCT01783587|Afatinib|afatinib|mesh-list
64865136|NCT01783587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865137|NCT01783587|Tubulin Modulators|tubulin modulators|mesh-ancestor
64865138|NCT01783587|Antimitotic Agents|antimitotic agents|mesh-ancestor
64865139|NCT01783587|Mitosis Modulators|mitosis modulators|mesh-ancestor
64865140|NCT01783587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865141|NCT01783587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64865142|NCT01783587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865143|NCT01783717|Exenatide|exenatide|mesh-list
64865144|NCT01783717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64865145|NCT01783717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865146|NCT01783717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64865147|NCT01783717|Incretins|incretins|mesh-ancestor
64865148|NCT01783717|Hormones|hormones|mesh-ancestor
64865149|NCT01783717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64865150|NCT01783756|Capecitabine|capecitabine|mesh-list
64865151|NCT01783756|Everolimus|everolimus|mesh-list
64865152|NCT01783756|Lapatinib|lapatinib|mesh-list
64781993|NCT04522206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64781994|NCT04519944|Edoxaban|edoxaban|mesh-list
64781995|NCT04519944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64304465|NCT01353911|Interferon alpha-2|interferon alpha-2|mesh-list
64304466|NCT01353911|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64304467|NCT01353911|Grazoprevir|grazoprevir|mesh-list
64304468|NCT01353911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304469|NCT01353911|Antiviral Agents|antiviral agents|mesh-ancestor
64304470|NCT01353911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64781997|NCT04519944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64781998|NCT04519944|Protease Inhibitors|protease inhibitors|mesh-ancestor
64781999|NCT04519944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865153|NCT01783756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64865154|NCT01783756|Antimetabolites|antimetabolites|mesh-ancestor
64865155|NCT01783756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865156|NCT01783756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332949|NCT04468711|Hydrocortisone|hydrocortisone|mesh-list
64332951|NCT04468711|Micronutrients|micronutrients|mesh-ancestor
64332952|NCT04468711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332953|NCT04468711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64332954|NCT04468711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64332955|NCT02207387|Rasagiline|rasagiline|mesh-list
64332956|NCT02207387|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64332957|NCT02207387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865157|NCT01783756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64865158|NCT01783756|Immunologic Factors|immunologic factors|mesh-ancestor
64865159|NCT01783756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865160|NCT01783756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64865161|NCT01783756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865162|NCT01783834|Pemetrexed|pemetrexed|mesh-list
64865163|NCT01783834|Gefitinib|gefitinib|mesh-list
64865164|NCT01783834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865165|NCT01783834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865166|NCT01783834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865167|NCT01783834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64865168|NCT01783834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64865169|NCT01783834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64865170|NCT01783925|Aflibercept|aflibercept|mesh-list
64865171|NCT01783925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64865172|NCT01783925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64782000|NCT04519944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782001|NCT04519944|Anticoagulants|anticoagulants|mesh-ancestor
64782002|NCT04505592|Tenecteplase|tenecteplase|mesh-list
64782003|NCT04505592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64782004|NCT04505592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64782005|NCT04505592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782006|NCT04477200|Mycophenolic Acid|mycophenolic acid|mesh-list
64782007|NCT04477200|Temozolomide|temozolomide|mesh-list
64782008|NCT04477200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64782009|NCT04477200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782010|NCT04477200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64782011|NCT04477200|Antitubercular Agents|antitubercular agents|mesh-ancestor
64782012|NCT04477200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64782013|NCT04477200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64782014|NCT04477200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865173|NCT01783925|Growth Substances|growth substances|mesh-ancestor
64865174|NCT01783925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865175|NCT01783925|Growth Inhibitors|growth inhibitors|mesh-ancestor
64865176|NCT01783925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865177|NCT01783951|Cisplatin|cisplatin|mesh-list
64865178|NCT01783951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865179|NCT01783964|Cytarabine|cytarabine|mesh-list
64865180|NCT01783964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64865181|NCT01783964|Antimetabolites|antimetabolites|mesh-ancestor
64865182|NCT01783964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865183|NCT01783964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865184|NCT01783964|Antiviral Agents|antiviral agents|mesh-ancestor
64865185|NCT01783964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64865186|NCT01783964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64865187|NCT01783964|Immunologic Factors|immunologic factors|mesh-ancestor
64865188|NCT01783964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865189|NCT01783977|Vaccines|vaccines|mesh-list
64865190|NCT01783977|Immunologic Factors|immunologic factors|mesh-ancestor
64865191|NCT01783977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865196|NCT01784107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865197|NCT01784107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865198|NCT01784107|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64865201|NCT01784120|Doxorubicin|doxorubicin|mesh-list
64782015|NCT04477200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782016|NCT04477200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64332958|NCT02207387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782017|NCT04477200|Alkylating Agents|alkylating agents|mesh-ancestor
64782018|NCT04415892|Cinnamaldehyde|cinnamaldehyde|mesh-list
64782019|NCT04415892|Capsaicin|capsaicin|mesh-list
64782020|NCT04415892|Antipruritics|antipruritics|mesh-ancestor
64782021|NCT04415892|Dermatologic Agents|dermatologic agents|mesh-ancestor
64782022|NCT04415892|Sensory System Agents|sensory system agents|mesh-ancestor
64782023|NCT04415892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782024|NCT04415892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782025|NCT04415892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64782026|NCT04415892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782028|NCT04415892|Protective Agents|protective agents|mesh-ancestor
64782029|NCT04176354|Letrozole|letrozole|mesh-list
64782030|NCT04176354|Palbociclib|palbociclib|mesh-list
64782031|NCT04176354|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64782032|NCT04176354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304473|NCT01353911|Immunologic Factors|immunologic factors|mesh-ancestor
64304474|NCT01353911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304475|NCT05575297|Rifampin|rifampin|mesh-list
64304476|NCT05575297|Methotrexate|methotrexate|mesh-list
64304477|NCT05575297|Febuxostat|febuxostat|mesh-list
64332959|NCT02207387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64332960|NCT02207387|Protective Agents|protective agents|mesh-ancestor
64332961|NCT02207387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332962|NCT03528421|Cyclophosphamide|cyclophosphamide|mesh-list
64865214|NCT01784250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865215|NCT01784250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865216|NCT01784250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64865217|NCT01784250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64865218|NCT01784250|Vasodilator Agents|vasodilator agents|mesh-ancestor
64865219|NCT01784250|Analgesics|analgesics|mesh-ancestor
64865220|NCT01784250|Sensory System Agents|sensory system agents|mesh-ancestor
64865221|NCT01784250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865222|NCT01784250|Sympatholytics|sympatholytics|mesh-ancestor
64865223|NCT01784250|Autonomic Agents|autonomic agents|mesh-ancestor
64865224|NCT01784250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64865225|NCT01784250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64865226|NCT01784250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64865227|NCT01784302|Raltegravir Potassium|raltegravir potassium|mesh-list
64865228|NCT01784302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64865229|NCT01784302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64865230|NCT01784302|Antiviral Agents|antiviral agents|mesh-ancestor
64865231|NCT01784302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64865232|NCT01784302|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64865233|NCT01784302|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64304478|NCT05575297|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64304479|NCT05575297|Abortifacient Agents|abortifacient agents|mesh-ancestor
64782034|NCT04176354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782035|NCT04176354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782036|NCT04176354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64782037|NCT04176354|Hormone Antagonists|hormone antagonists|mesh-ancestor
64393441|NCT01675661|Expectorants|expectorants|mesh-ancestor
64393442|NCT01675661|Respiratory System Agents|respiratory system agents|mesh-ancestor
64393443|NCT01675661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64393444|NCT01675661|Antioxidants|antioxidants|mesh-ancestor
64782038|NCT04176354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64782039|NCT04176354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782040|NCT04176354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64782041|NCT04173780|Atropine|atropine|mesh-list
64865234|NCT01784302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865235|NCT01784302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865236|NCT01784315|Chloroquine|chloroquine|mesh-list
64865237|NCT01784315|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64865238|NCT01784315|Primaquine|primaquine|mesh-list
64865239|NCT01784315|Artemisinins|artemisinins|mesh-list
64865240|NCT01784315|Artemisinin|artemisinin|mesh-list
64865241|NCT01784315|Amebicides|amebicides|mesh-ancestor
64865242|NCT01784315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64865243|NCT01784315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64865244|NCT01784315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64865245|NCT01784315|Antimalarials|antimalarials|mesh-ancestor
64865246|NCT01784315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64865247|NCT01784315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64865248|NCT01784315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64865249|NCT01784315|Analgesics|analgesics|mesh-ancestor
64865250|NCT01784315|Sensory System Agents|sensory system agents|mesh-ancestor
64332964|NCT03528421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64332965|NCT03528421|Immunologic Factors|immunologic factors|mesh-ancestor
64332966|NCT03528421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865251|NCT01784315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865252|NCT01784315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865253|NCT01784315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64865254|NCT01784315|Filaricides|filaricides|mesh-ancestor
64865255|NCT01784315|Antinematodal Agents|antinematodal agents|mesh-ancestor
64865256|NCT01784315|Anthelmintics|anthelmintics|mesh-ancestor
64865258|NCT01784380|Clomiphene|clomiphene|mesh-list
64865259|NCT01784380|Enclomiphene|enclomiphene|mesh-list
64865260|NCT01784380|Zuclomiphene|zuclomiphene|mesh-list
64865261|NCT01784380|Menotropins|menotropins|mesh-list
64865262|NCT01784380|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
64782042|NCT04173780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64782043|NCT04173780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64782044|NCT04173780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64782045|NCT04173780|Autonomic Agents|autonomic agents|mesh-ancestor
64782046|NCT04173780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782047|NCT04173780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782048|NCT04173780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64782049|NCT04173780|Respiratory System Agents|respiratory system agents|mesh-ancestor
64782050|NCT04173780|Mydriatics|mydriatics|mesh-ancestor
64865263|NCT01784380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64865264|NCT01784380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865265|NCT01784380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64865266|NCT01784380|Hormone Antagonists|hormone antagonists|mesh-ancestor
64865267|NCT01784380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64865268|NCT01784380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64865269|NCT01784380|Fertility Agents|fertility agents|mesh-ancestor
64865270|NCT01784380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64865271|NCT01784380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64865272|NCT01784380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64865273|NCT01784380|Androgen Antagonists|androgen antagonists|mesh-ancestor
64865274|NCT01784445|Ceftazidime|ceftazidime|mesh-list
64865275|NCT01784445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64865276|NCT01784445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64865277|NCT01784536|Oritavancin|oritavancin|mesh-list
64865278|NCT01784536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64865305|NCT01784640|Pemetrexed|pemetrexed|mesh-list
64782051|NCT04173780|Parasympatholytics|parasympatholytics|mesh-ancestor
64782052|NCT04173780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64782053|NCT04173780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64782054|NCT04173780|Cholinergic Agents|cholinergic agents|mesh-ancestor
64782055|NCT04173780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64782056|NCT04173780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782057|NCT04129554|Tenofovir|tenofovir|mesh-list
64782058|NCT04129554|Entecavir|entecavir|mesh-list
64782059|NCT04129554|JNJ-56136379|jnj-56136379|mesh-list
64782060|NCT04129554|Antiviral Agents|antiviral agents|mesh-ancestor
64782061|NCT04129554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64782062|NCT04129554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64865327|NCT01784978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64865328|NCT01784978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64865329|NCT01784978|Growth Substances|growth substances|mesh-ancestor
64865331|NCT01784978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64865332|NCT01784978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865395|NCT01785290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64865396|NCT01785290|Dopamine Agents|dopamine agents|mesh-ancestor
64865397|NCT01785290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64865398|NCT01785290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865399|NCT01785290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64865400|NCT01785446|Sufentanil|sufentanil|mesh-list
64865401|NCT01785446|Dexmedetomidine|dexmedetomidine|mesh-list
64865402|NCT01785446|Dsuvia|dsuvia|mesh-list
64865403|NCT01785446|Atracurium|atracurium|mesh-list
64865404|NCT01785446|Cisatracurium|cisatracurium|mesh-list
64865405|NCT01785446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64865406|NCT01785446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64865407|NCT01785446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865408|NCT01785446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64865410|NCT01785446|Sensory System Agents|sensory system agents|mesh-ancestor
64865411|NCT01785446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865412|NCT01785446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64865413|NCT01785446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64865414|NCT01785446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64865415|NCT01785446|Adrenergic Agents|adrenergic agents|mesh-ancestor
64393468|NCT03169985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865425|NCT01785446|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64393469|NCT03169985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64393470|NCT03169985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64393471|NCT03169985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393472|NCT04161989|Progesterone|progesterone|mesh-list
64393473|NCT04161989|Progestins|progestins|mesh-ancestor
64393474|NCT04161989|Hormones|hormones|mesh-ancestor
64393475|NCT04161989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64393477|NCT01986010|Aluminum phosphate|aluminum phosphate|mesh-list
64782063|NCT04129554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64782064|NCT04129554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782065|NCT04129554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782066|NCT04129554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64782067|NCT04129554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64782068|NCT04128540|Fentanyl|fentanyl|mesh-list
64782069|NCT04128540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64782070|NCT04128540|Narcotics|narcotics|mesh-ancestor
64782071|NCT04128540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64782072|NCT04128540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782073|NCT04128540|Analgesics|analgesics|mesh-ancestor
64782074|NCT04128540|Sensory System Agents|sensory system agents|mesh-ancestor
64782075|NCT04128540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782076|NCT04128540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64304480|NCT05575297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64782077|NCT04128540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64782078|NCT04128540|Anesthetics, General|anesthetics, general|mesh-ancestor
64782079|NCT04128540|Anesthetics|anesthetics|mesh-ancestor
64782080|NCT04104438|Everolimus|everolimus|mesh-list
64782081|NCT04104438|Basiliximab|basiliximab|mesh-list
64782082|NCT04104438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865426|NCT01785446|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64865427|NCT01785446|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64865428|NCT01785446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64865429|NCT01785446|Cholinergic Agents|cholinergic agents|mesh-ancestor
64865430|NCT01785589|Adenosine|adenosine|mesh-list
64865431|NCT01785589|Analgesics|analgesics|mesh-ancestor
64865432|NCT01785589|Sensory System Agents|sensory system agents|mesh-ancestor
64865433|NCT01785589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865434|NCT01785589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865435|NCT01785589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64865437|NCT01785589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64865438|NCT01785589|Purinergic Agonists|purinergic agonists|mesh-ancestor
64865439|NCT01785589|Purinergic Agents|purinergic agents|mesh-ancestor
64865440|NCT01785589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64865442|NCT01785641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64865454|NCT01785641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865455|NCT01785641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64332973|NCT02374047|Atorvastatin|atorvastatin|mesh-list
64332974|NCT02374047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64332975|NCT02374047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64332976|NCT02374047|Antimetabolites|antimetabolites|mesh-ancestor
64865456|NCT01785641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64865457|NCT01785641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64865458|NCT01785693|Clonidine|clonidine|mesh-list
64865459|NCT01785693|Levobupivacaine|levobupivacaine|mesh-list
64865460|NCT01785693|Analgesics|analgesics|mesh-ancestor
64865461|NCT01785693|Sensory System Agents|sensory system agents|mesh-ancestor
64865462|NCT01785693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865463|NCT01785693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865464|NCT01785693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64865474|NCT01785693|Anesthetics|anesthetics|mesh-ancestor
64865519|NCT01785979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64865520|NCT01785979|Analgesics|analgesics|mesh-ancestor
64865521|NCT01785979|Sensory System Agents|sensory system agents|mesh-ancestor
64865522|NCT01785979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865523|NCT01785979|Filaricides|filaricides|mesh-ancestor
64865524|NCT01785979|Antinematodal Agents|antinematodal agents|mesh-ancestor
64865525|NCT01785979|Anthelmintics|anthelmintics|mesh-ancestor
64865526|NCT01786018|Cyclosporine|cyclosporine|mesh-list
64865527|NCT01786018|Methotrexate|methotrexate|mesh-list
64782083|NCT04104438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64782084|NCT04104438|Immunologic Factors|immunologic factors|mesh-ancestor
64393493|NCT02700841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393494|NCT04160117|Colchicine|colchicine|mesh-list
64393495|NCT04160117|Gout Suppressants|gout suppressants|mesh-ancestor
64393496|NCT04160117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64393497|NCT04160117|Tubulin Modulators|tubulin modulators|mesh-ancestor
64393498|NCT04160117|Antimitotic Agents|antimitotic agents|mesh-ancestor
64393499|NCT04160117|Mitosis Modulators|mitosis modulators|mesh-ancestor
64393500|NCT04160117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393501|NCT04160117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393502|NCT04414631|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64393513|NCT03115255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393514|NCT02009878|Tolvaptan|tolvaptan|mesh-list
64393515|NCT02009878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64782098|NCT03737604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782099|NCT03703206|Anesthetics|anesthetics|mesh-list
64782100|NCT03703206|Anesthetics, Local|anesthetics, local|mesh-list
64782101|NCT03703206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64782102|NCT03703206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782103|NCT03703206|Sensory System Agents|sensory system agents|mesh-ancestor
64782104|NCT03703206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865627|NCT01786538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865628|NCT01786538|Antidotes|antidotes|mesh-ancestor
64865629|NCT01786538|Protective Agents|protective agents|mesh-ancestor
64865630|NCT01786538|Vitamin B Complex|vitamin b complex|mesh-ancestor
64865632|NCT01786538|Micronutrients|micronutrients|mesh-ancestor
64865633|NCT01786616|Formoterol Fumarate|formoterol fumarate|mesh-list
64865634|NCT01786616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64865635|NCT01786616|Autonomic Agents|autonomic agents|mesh-ancestor
64865636|NCT01786616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865637|NCT01786616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865638|NCT01786616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64865639|NCT01786616|Respiratory System Agents|respiratory system agents|mesh-ancestor
64865640|NCT01786616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64865641|NCT01786616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64865642|NCT01786616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64865643|NCT01786616|Adrenergic Agents|adrenergic agents|mesh-ancestor
64865644|NCT01786616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64865645|NCT01786616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865646|NCT01786655|Epinephrine|epinephrine|mesh-list
64865647|NCT01786655|Bupivacaine|bupivacaine|mesh-list
64865648|NCT01786655|Neosaxitoxin|neosaxitoxin|mesh-list
64865649|NCT01786655|Anesthetics, Local|anesthetics, local|mesh-ancestor
64865650|NCT01786655|Anesthetics|anesthetics|mesh-ancestor
64865651|NCT01786655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64865652|NCT01786655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865653|NCT01786655|Sensory System Agents|sensory system agents|mesh-ancestor
64782105|NCT03689244|Selexipag|selexipag|mesh-list
64782106|NCT03689244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64865654|NCT01786655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782107|NCT03443856|Nivolumab|nivolumab|mesh-list
64782108|NCT03443856|Ipilimumab|ipilimumab|mesh-list
64782109|NCT03443856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64782110|NCT03443856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782111|NCT03443856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64364810|NCT04527055|Bismuth|bismuth|mesh-list
64782112|NCT03443856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782114|NCT03260712|Pembrolizumab|pembrolizumab|mesh-list
64782115|NCT03260712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393516|NCT02009878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865655|NCT01786655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64865656|NCT01786655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64865657|NCT01786655|Adrenergic Agents|adrenergic agents|mesh-ancestor
64865658|NCT01786655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64393517|NCT02009878|Natriuretic Agents|natriuretic agents|mesh-ancestor
64865659|NCT01786655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865660|NCT01786655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64865661|NCT01786655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64865662|NCT01786655|Autonomic Agents|autonomic agents|mesh-ancestor
64865663|NCT01786655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64865664|NCT01786655|Respiratory System Agents|respiratory system agents|mesh-ancestor
64865665|NCT01786655|Mydriatics|mydriatics|mesh-ancestor
64865666|NCT01786655|Sympathomimetics|sympathomimetics|mesh-ancestor
64865667|NCT01786655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64865668|NCT01786655|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64865669|NCT01786655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64865670|NCT01786759|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64865671|NCT01786759|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64865672|NCT01786759|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64865673|NCT01786759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64865674|NCT01787123|Cerebrolysin|cerebrolysin|mesh-list
64865675|NCT01787123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64393518|NCT02009878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393519|NCT02009722|Morphine|morphine|mesh-list
64393520|NCT02009722|Hydromorphone|hydromorphone|mesh-list
64393521|NCT02009722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64393522|NCT02009722|Narcotics|narcotics|mesh-ancestor
64393523|NCT02009722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64393524|NCT02009722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393525|NCT02009722|Analgesics|analgesics|mesh-ancestor
64393526|NCT02009722|Sensory System Agents|sensory system agents|mesh-ancestor
64393527|NCT02009722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393528|NCT02655419|Metronidazole|metronidazole|mesh-list
64393531|NCT02655419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64782122|NCT03260712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64782123|NCT03260712|Immunologic Factors|immunologic factors|mesh-ancestor
64782124|NCT03260712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782125|NCT03260712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64782126|NCT03086616|Irinotecan|irinotecan|mesh-list
64782127|NCT03086616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64782128|NCT03086616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64782129|NCT03086616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393535|NCT01962922|Immunologic Factors|immunologic factors|mesh-ancestor
64865693|NCT01787344|Cholinergic Agents|cholinergic agents|mesh-ancestor
64865694|NCT01787344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64865695|NCT01787344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865696|NCT01787344|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64865697|NCT01787344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865698|NCT01787357|Canagliflozin|canagliflozin|mesh-list
64865699|NCT01787357|Moxifloxacin|moxifloxacin|mesh-list
64865700|NCT01787357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64865701|NCT01787357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64332985|NCT02203253|Antiemetics|antiemetics|mesh-ancestor
64332986|NCT02203253|Autonomic Agents|autonomic agents|mesh-ancestor
64332987|NCT02203253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64332988|NCT02203253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332989|NCT02203253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64865702|NCT01787357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64865703|NCT01787357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64865704|NCT01787357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865705|NCT01787357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865706|NCT01787357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865707|NCT01787357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865708|NCT01787357|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64865709|NCT01787357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64865710|NCT01787396|Metformin|metformin|mesh-list
64865711|NCT01787396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64865712|NCT01787396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865713|NCT01787474|Cytarabine|cytarabine|mesh-list
64304481|NCT05575297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304482|NCT05575297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64304483|NCT05575297|Antimetabolites|antimetabolites|mesh-ancestor
64304484|NCT05575297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304485|NCT05575297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304486|NCT05575297|Dermatologic Agents|dermatologic agents|mesh-ancestor
64304487|NCT05575297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304488|NCT05575297|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64304489|NCT05575297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64304490|NCT05575297|Immunologic Factors|immunologic factors|mesh-ancestor
64304491|NCT05575297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64304492|NCT05575297|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64865714|NCT01787474|Fludarabine|fludarabine|mesh-list
64865715|NCT01787474|Fludarabine phosphate|fludarabine phosphate|mesh-list
64865716|NCT01787474|Lenograstim|lenograstim|mesh-list
64865717|NCT01787474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865718|NCT01787474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64865719|NCT01787474|Antimetabolites|antimetabolites|mesh-ancestor
64304493|NCT05575297|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64865720|NCT01787474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865721|NCT01787474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64865722|NCT01787474|Immunologic Factors|immunologic factors|mesh-ancestor
64865723|NCT01787474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865724|NCT01787474|Antiviral Agents|antiviral agents|mesh-ancestor
64865725|NCT01787474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64865726|NCT01787474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64865727|NCT01787630|Hyaluronic Acid|hyaluronic acid|mesh-list
64865728|NCT01787630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64865729|NCT01787630|Immunologic Factors|immunologic factors|mesh-ancestor
64865730|NCT01787630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865731|NCT01787630|Viscosupplements|viscosupplements|mesh-ancestor
64865732|NCT01787630|Protective Agents|protective agents|mesh-ancestor
64865733|NCT01787669|Dexamethasone|dexamethasone|mesh-list
64865734|NCT01787669|Bevacizumab|bevacizumab|mesh-list
64865744|NCT01787669|Autonomic Agents|autonomic agents|mesh-ancestor
64865745|NCT01787669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865746|NCT01787669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64393536|NCT01962922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393537|NCT01962922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64393538|NCT01962922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393539|NCT01962922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393540|NCT04198961|Analgesics, Opioid|analgesics, opioid|mesh-list
64393541|NCT04198961|Narcotics|narcotics|mesh-ancestor
64393542|NCT04198961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64393543|NCT04198961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332990|NCT02203253|Glucocorticoids|glucocorticoids|mesh-ancestor
64332991|NCT02203253|Hormones|hormones|mesh-ancestor
64865762|NCT01788176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64865763|NCT01788176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865764|NCT01788189|Lenalidomide|lenalidomide|mesh-list
64865765|NCT01788189|Immunologic Factors|immunologic factors|mesh-ancestor
64865766|NCT01788189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865767|NCT01788189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64865768|NCT01788189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64865769|NCT01788189|Growth Substances|growth substances|mesh-ancestor
64865770|NCT01788189|Growth Inhibitors|growth inhibitors|mesh-ancestor
64865771|NCT01788189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865772|NCT01788254|Talinolol|talinolol|mesh-list
64865773|NCT01788254|Torsemide|torsemide|mesh-list
64865774|NCT01788254|Midazolam|midazolam|mesh-list
64865775|NCT01788254|Codeine|codeine|mesh-list
64865776|NCT01788254|Pravastatin|pravastatin|mesh-list
64865777|NCT01788254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64865778|NCT01788254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64865779|NCT01788254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64865780|NCT01788254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865781|NCT01788254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64393544|NCT04198961|Analgesics|analgesics|mesh-ancestor
64393545|NCT04198961|Sensory System Agents|sensory system agents|mesh-ancestor
64393546|NCT04198961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393547|NCT01984684|Vancomycin|vancomycin|mesh-list
64782138|NCT03040596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782139|NCT03040596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64782140|NCT03040596|Respiratory System Agents|respiratory system agents|mesh-ancestor
64782141|NCT03040596|Dermatologic Agents|dermatologic agents|mesh-ancestor
64782142|NCT03040596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64393548|NCT01984684|Aztreonam|aztreonam|mesh-list
64393549|NCT01984684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64393550|NCT01984684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64865816|NCT01788280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64865817|NCT01788280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64865818|NCT01788280|Growth Substances|growth substances|mesh-ancestor
64865819|NCT01788280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865820|NCT01788280|Growth Inhibitors|growth inhibitors|mesh-ancestor
64865821|NCT01788332|Olaparib|olaparib|mesh-list
64865822|NCT01788332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64865823|NCT01788332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865824|NCT01788332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865825|NCT01788332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865826|NCT01788371|Lamivudine|lamivudine|mesh-list
64865827|NCT01788371|Telbivudine|telbivudine|mesh-list
64865828|NCT01788371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64393551|NCT04589663|Mometasone Furoate|mometasone furoate|mesh-list
64393552|NCT04589663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64393553|NCT04589663|Dermatologic Agents|dermatologic agents|mesh-ancestor
64393554|NCT04589663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64393555|NCT04585841|Cannabidiol|cannabidiol|mesh-list
64393556|NCT04585841|Anticonvulsants|anticonvulsants|mesh-ancestor
64393557|NCT02694523|Adalimumab|adalimumab|mesh-list
64393558|NCT02694523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64393559|NCT02694523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64393560|NCT02694523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64393561|NCT02694523|Immunologic Factors|immunologic factors|mesh-ancestor
64332995|NCT02203253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64332996|NCT02203253|Immunologic Factors|immunologic factors|mesh-ancestor
64332997|NCT02203253|Leprostatic Agents|leprostatic agents|mesh-ancestor
64332998|NCT02203253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64332999|NCT02203253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64333000|NCT02203253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64333001|NCT02203253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64333002|NCT02203253|Growth Substances|growth substances|mesh-ancestor
64333003|NCT02203253|Growth Inhibitors|growth inhibitors|mesh-ancestor
64865830|NCT01788371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865831|NCT01788371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865832|NCT01788371|Antiviral Agents|antiviral agents|mesh-ancestor
64865833|NCT01788371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64865834|NCT01788371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64865835|NCT01788371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64865836|NCT01788384|Clindamycin|clindamycin|mesh-list
64865837|NCT01788384|Clindamycin palmitate|clindamycin palmitate|mesh-list
64865838|NCT01788384|Clindamycin phosphate|clindamycin phosphate|mesh-list
64865839|NCT01788384|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64865840|NCT01788384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64865841|NCT01788384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64865842|NCT01788384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64865843|NCT01788384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865844|NCT01788384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865845|NCT01788384|Dermatologic Agents|dermatologic agents|mesh-ancestor
64364851|NCT03361709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64393562|NCT02694523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393563|NCT05038475|Antibodies|antibodies|mesh-list
64782144|NCT02952924|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64782145|NCT02952924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64782146|NCT02952924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64782147|NCT02952924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782148|NCT02952924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64782149|NCT02952924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64782150|NCT02952924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64782151|NCT02952924|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64782152|NCT02952924|Anesthetics, General|anesthetics, general|mesh-ancestor
64782153|NCT02952924|Anesthetics|anesthetics|mesh-ancestor
64782154|NCT02952924|GABA Modulators|gaba modulators|mesh-ancestor
64782155|NCT02952924|GABA Agents|gaba agents|mesh-ancestor
64782156|NCT02952924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64782157|NCT02952924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782158|NCT02905578|Ascorbic Acid|ascorbic acid|mesh-list
64782159|NCT02905578|Gemcitabine|gemcitabine|mesh-list
64782160|NCT02905578|Paclitaxel|paclitaxel|mesh-list
64782161|NCT02905578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64782162|NCT02905578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782163|NCT02905578|Tubulin Modulators|tubulin modulators|mesh-ancestor
64782164|NCT02905578|Antimitotic Agents|antimitotic agents|mesh-ancestor
64782165|NCT02905578|Mitosis Modulators|mitosis modulators|mesh-ancestor
64782166|NCT02905578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333004|NCT02203253|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64333005|NCT02203253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64333006|NCT02203253|Serotonin Agents|serotonin agents|mesh-ancestor
64333007|NCT02203253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64865846|NCT01788462|Tesamorelin|tesamorelin|mesh-list
64865847|NCT01788462|Growth Substances|growth substances|mesh-ancestor
64865848|NCT01788462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865849|NCT01788501|Cyclosporine|cyclosporine|mesh-list
64782197|NCT00677586|Liver Extracts|liver extracts|mesh-list
64782198|NCT00677586|Hematinics|hematinics|mesh-ancestor
64782200|NCT05453448|Entecavir|entecavir|mesh-list
64782201|NCT05453448|Antiviral Agents|antiviral agents|mesh-ancestor
64782202|NCT05453448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64782203|NCT05453448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64304496|NCT05575297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64304497|NCT05575297|Leprostatic Agents|leprostatic agents|mesh-ancestor
64304498|NCT05575297|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64304499|NCT05575297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64304500|NCT05575297|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64865850|NCT01788501|Methotrexate|methotrexate|mesh-list
64865851|NCT01788501|Tacrolimus|tacrolimus|mesh-list
64865852|NCT01788501|Cyclosporins|cyclosporins|mesh-list
64865853|NCT01788501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64865854|NCT01788501|Abortifacient Agents|abortifacient agents|mesh-ancestor
64865855|NCT01788501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64865856|NCT01788501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634433|NCT03377491|Gemcitabine|gemcitabine|mesh-list
64865857|NCT01788501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64304501|NCT05575297|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64304502|NCT05575297|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64304503|NCT05575297|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64304504|NCT05575297|Gout Suppressants|gout suppressants|mesh-ancestor
64304505|NCT01671488|Mitomycins|mitomycins|mesh-list
64304506|NCT01671488|Mitomycin|mitomycin|mesh-list
64304507|NCT01671488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64304508|NCT01671488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304509|NCT01671488|Alkylating Agents|alkylating agents|mesh-ancestor
64304510|NCT01671488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304511|NCT01671488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64304512|NCT01671488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782204|NCT05453448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64782205|NCT05453448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782206|NCT05453448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782207|NCT05453448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64782208|NCT05453448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64782209|NCT05453214|Fludrocortisone|fludrocortisone|mesh-list
64782210|NCT05453214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64782211|NCT05444478|Lenvatinib|lenvatinib|mesh-list
64782212|NCT05444478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782213|NCT05444478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64865859|NCT01788501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865860|NCT01788501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865861|NCT01788501|Dermatologic Agents|dermatologic agents|mesh-ancestor
64865862|NCT01788501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865863|NCT01788501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64865864|NCT01788501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64865865|NCT01788501|Immunologic Factors|immunologic factors|mesh-ancestor
64865866|NCT01788501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64865867|NCT01788501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64333008|NCT02203253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333009|NCT02207699|Moxifloxacin|moxifloxacin|mesh-list
64333010|NCT02207699|Benzonatate|benzonatate|mesh-list
64333011|NCT02207699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64333012|NCT02207699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64333013|NCT02207699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64295774|NCT02054299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64782214|NCT05444478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782215|NCT05444478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782216|NCT05354466|Neostigmine|neostigmine|mesh-list
64782217|NCT05354466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64782218|NCT05354466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782219|NCT05354466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393616|NCT01962298|Cholinergic Agents|cholinergic agents|mesh-ancestor
64393617|NCT01962298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64393618|NCT01962298|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64393619|NCT01962298|Autonomic Agents|autonomic agents|mesh-ancestor
64393620|NCT03169933|Androgens|androgens|mesh-list
64393621|NCT03169933|Hormones|hormones|mesh-ancestor
64393622|NCT03169933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64393623|NCT03169933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393624|NCT04416334|Acetaminophen|acetaminophen|mesh-list
64393625|NCT04416334|Colchicine|colchicine|mesh-list
64393626|NCT04416334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64393627|NCT04416334|Analgesics|analgesics|mesh-ancestor
64782221|NCT05354466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64304514|NCT05400889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64304515|NCT05400889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865868|NCT01788501|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64865869|NCT01788501|Antifungal Agents|antifungal agents|mesh-ancestor
64865870|NCT01788501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64865871|NCT01788540|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64865872|NCT01788540|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64865873|NCT01788540|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64865874|NCT01788540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64865875|NCT01788605|Ramosetron|ramosetron|mesh-list
64865876|NCT01788605|Antiemetics|antiemetics|mesh-ancestor
64865877|NCT01788605|Autonomic Agents|autonomic agents|mesh-ancestor
64865878|NCT01788605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64295775|NCT02054299|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64295776|NCT02054299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64295777|NCT02054299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64295778|NCT02058823|Amlodipine|amlodipine|mesh-list
64295779|NCT02058823|Valsartan|valsartan|mesh-list
64295780|NCT02058823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64295781|NCT02058823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64295782|NCT02058823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64295783|NCT02058823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295784|NCT02058823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64295785|NCT02058823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295786|NCT02058823|Vasodilator Agents|vasodilator agents|mesh-ancestor
64304516|NCT05400889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304517|NCT05395117|Digoxin|digoxin|mesh-list
64304518|NCT05395117|Midazolam|midazolam|mesh-list
64304519|NCT05395117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64304520|NCT05395117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64304521|NCT05395117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64304522|NCT05395117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64304523|NCT05395117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304524|NCT05395117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64304525|NCT05395117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64304526|NCT05395117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64304527|NCT05395117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64304528|NCT05395117|Anesthetics, General|anesthetics, general|mesh-ancestor
64304529|NCT05395117|Anesthetics|anesthetics|mesh-ancestor
64304530|NCT05395117|GABA Modulators|gaba modulators|mesh-ancestor
64304531|NCT05395117|GABA Agents|gaba agents|mesh-ancestor
64304532|NCT05395117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64304533|NCT05395117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304534|NCT05395117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64304535|NCT05395117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64304536|NCT05395117|Antimetabolites|antimetabolites|mesh-ancestor
64782223|NCT05354466|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64782224|NCT05354466|Autonomic Agents|autonomic agents|mesh-ancestor
64865879|NCT01788605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865880|NCT01788605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64865881|NCT01788605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64865882|NCT01788605|Serotonin Agents|serotonin agents|mesh-ancestor
64865883|NCT01788605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64865884|NCT01788605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865885|NCT01788670|Ethanol|ethanol|mesh-list
64865886|NCT01788670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64865887|NCT01788670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64865888|NCT01788670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64865889|NCT01788670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865890|NCT01788722|Dienogest|dienogest|mesh-list
64865891|NCT01788722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64865892|NCT01788722|Contraceptive Agents|contraceptive agents|mesh-ancestor
64333017|NCT02207699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333018|NCT02207699|Antitussive Agents|antitussive agents|mesh-ancestor
64333019|NCT02207699|Respiratory System Agents|respiratory system agents|mesh-ancestor
64333020|NCT01838187|Vorinostat|vorinostat|mesh-list
64333021|NCT01838187|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64865905|NCT01788774|Serotonin Agents|serotonin agents|mesh-ancestor
64865906|NCT01788774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64865907|NCT01788774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865908|NCT01788774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865909|NCT01788774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64865910|NCT01788774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64333022|NCT01838187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333023|NCT01838187|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64333024|NCT01838187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333026|NCT01838187|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64782225|NCT05354466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782226|NCT04978584|Prednisone|prednisone|mesh-list
64782227|NCT04978584|Cortisone|cortisone|mesh-list
64782228|NCT04978584|Cyclophosphamide|cyclophosphamide|mesh-list
64782229|NCT04978584|Rituximab|rituximab|mesh-list
64782230|NCT04978584|Doxorubicin|doxorubicin|mesh-list
64782231|NCT04978584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64782232|NCT04978584|Vincristine|vincristine|mesh-list
64782233|NCT04978584|Lenalidomide|lenalidomide|mesh-list
64782234|NCT04978584|Acalabrutinib|acalabrutinib|mesh-list
64782235|NCT04978584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64782236|NCT04978584|Antibodies|antibodies|mesh-list
64782237|NCT04978584|Immunoglobulins|immunoglobulins|mesh-list
64782238|NCT04978584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64782239|NCT04978584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64782240|NCT04978584|Immunologic Factors|immunologic factors|mesh-ancestor
64782241|NCT04978584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782242|NCT04978584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64782243|NCT04978584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64782244|NCT04978584|Alkylating Agents|alkylating agents|mesh-ancestor
64782245|NCT04978584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782246|NCT04978584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782247|NCT04978584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64782248|NCT04978584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64782249|NCT04978584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64782250|NCT04978584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64782251|NCT04978584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782252|NCT04978584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64865920|NCT01788969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64782253|NCT04978584|Glucocorticoids|glucocorticoids|mesh-ancestor
64865921|NCT01788969|Serotonin Agents|serotonin agents|mesh-ancestor
64865922|NCT01788969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865923|NCT01788969|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64865924|NCT01788969|Antidepressive Agents|antidepressive agents|mesh-ancestor
64393639|NCT02403349|Atenolol|atenolol|mesh-list
64393640|NCT02403349|Valsartan|valsartan|mesh-list
64782267|NCT04674462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393676|NCT04299113|Mocetinostat|mocetinostat|mesh-list
64393677|NCT04299113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64393678|NCT04299113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393679|NCT04299113|Tubulin Modulators|tubulin modulators|mesh-ancestor
64393680|NCT04299113|Antimitotic Agents|antimitotic agents|mesh-ancestor
64393681|NCT04299113|Mitosis Modulators|mitosis modulators|mesh-ancestor
64393682|NCT04299113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393683|NCT04299113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64782268|NCT04095624|Analgesics, Opioid|analgesics, opioid|mesh-list
64782269|NCT04095624|Narcotics|narcotics|mesh-ancestor
64782270|NCT04095624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64782271|NCT04095624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782272|NCT04095624|Analgesics|analgesics|mesh-ancestor
64782273|NCT04095624|Sensory System Agents|sensory system agents|mesh-ancestor
64782274|NCT04095624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782275|NCT03745716|Azacitidine|azacitidine|mesh-list
64782276|NCT03745716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64782277|NCT03745716|Antimetabolites|antimetabolites|mesh-ancestor
64782278|NCT03745716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782279|NCT03745716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782280|NCT03745716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782281|NCT03341676|Dexamethasone|dexamethasone|mesh-list
64782282|NCT03341676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64782283|NCT03341676|Antiemetics|antiemetics|mesh-ancestor
64865925|NCT01788969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64865926|NCT01788982|Nintedanib|nintedanib|mesh-list
64865927|NCT01788982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782284|NCT03341676|Autonomic Agents|autonomic agents|mesh-ancestor
64782285|NCT03341676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865928|NCT01788982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64634504|NCT02856594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64865929|NCT01788982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865930|NCT01788982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333037|NCT02296138|Cholinergic Agents|cholinergic agents|mesh-ancestor
64333038|NCT02296138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64333039|NCT02296138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333040|NCT02207855|Chloroprocaine|chloroprocaine|mesh-list
64295790|NCT00704535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64295791|NCT00704535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64295792|NCT00704535|Antimetabolites|antimetabolites|mesh-ancestor
64295793|NCT00704535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295794|NCT00704535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64295795|NCT02058901|Sunitinib|sunitinib|mesh-list
64295796|NCT02058901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295797|NCT02058901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64295798|NCT02058901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64782286|NCT03341676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782287|NCT03341676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64782288|NCT03341676|Glucocorticoids|glucocorticoids|mesh-ancestor
64393684|NCT04299113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393685|NCT01982812|Levetiracetam|levetiracetam|mesh-list
64393686|NCT01982812|Anticonvulsants|anticonvulsants|mesh-ancestor
64393687|NCT01982812|Nootropic Agents|nootropic agents|mesh-ancestor
64393688|NCT02007070|Pembrolizumab|pembrolizumab|mesh-list
64393689|NCT02007070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64393690|NCT02007070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393691|NCT03906617|Dexamethasone|dexamethasone|mesh-list
64393692|NCT03906617|Epinephrine|epinephrine|mesh-list
64324277|NCT05492318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64324278|NCT05492318|Anesthetics, General|anesthetics, general|mesh-ancestor
64324279|NCT05492318|Anesthetics|anesthetics|mesh-ancestor
64324280|NCT05492318|GABA Modulators|gaba modulators|mesh-ancestor
64324281|NCT05492318|GABA Agents|gaba agents|mesh-ancestor
64304538|NCT05395117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64304539|NCT05395117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304540|NCT05395117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64304541|NCT05395117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64304542|NCT05395117|Protective Agents|protective agents|mesh-ancestor
64304543|NCT05325229|Bevacizumab|bevacizumab|mesh-list
64304544|NCT05325229|Docetaxel|docetaxel|mesh-list
64304545|NCT05325229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64304546|NCT05325229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304547|NCT05325229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64304548|NCT05325229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64333041|NCT02207855|Anesthetics, Local|anesthetics, local|mesh-ancestor
64333042|NCT02207855|Anesthetics|anesthetics|mesh-ancestor
64333043|NCT02207855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64865932|NCT01789086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64865933|NCT01789086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865934|NCT01789086|Incretins|incretins|mesh-ancestor
64865935|NCT01789086|Hormones|hormones|mesh-ancestor
64865936|NCT01789086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64865937|NCT01789099|Sargramostim|sargramostim|mesh-list
64304549|NCT05325229|Growth Substances|growth substances|mesh-ancestor
64304550|NCT05325229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304551|NCT05325229|Growth Inhibitors|growth inhibitors|mesh-ancestor
64295799|NCT02058901|Growth Substances|growth substances|mesh-ancestor
64295800|NCT02058901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304552|NCT05325229|Tubulin Modulators|tubulin modulators|mesh-ancestor
64333044|NCT02207855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304553|NCT05325229|Antimitotic Agents|antimitotic agents|mesh-ancestor
64782298|NCT03121716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64304554|NCT05325229|Mitosis Modulators|mitosis modulators|mesh-ancestor
64304555|NCT05325229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304556|NCT05573581|Botulinum Toxins|botulinum toxins|mesh-list
64304557|NCT05573581|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64304558|NCT05573581|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64333045|NCT02207855|Sensory System Agents|sensory system agents|mesh-ancestor
64333046|NCT02207855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64333048|NCT01345851|Carboplatin|carboplatin|mesh-list
64333049|NCT01345851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64333050|NCT01345851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865938|NCT01789099|Immunologic Factors|immunologic factors|mesh-ancestor
64865939|NCT01789099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865940|NCT01789125|Nicotine|nicotine|mesh-list
64865941|NCT01789125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64865942|NCT01789125|Autonomic Agents|autonomic agents|mesh-ancestor
64865943|NCT01789125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865944|NCT01789125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865945|NCT01789125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64865946|NCT01789125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64865947|NCT01789125|Cholinergic Agents|cholinergic agents|mesh-ancestor
64865948|NCT01789125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64865949|NCT01789125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865950|NCT01789216|Ketorolac|ketorolac|mesh-list
64865951|NCT01789216|Meloxicam|meloxicam|mesh-list
64304559|NCT05573581|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64304560|NCT05573581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64304561|NCT05573581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304562|NCT05573581|Cholinergic Agents|cholinergic agents|mesh-ancestor
64304563|NCT05573581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64304564|NCT05573581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304565|NCT05573581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64365015|NCT03282643|Heparin|heparin|mesh-list
64782300|NCT03121716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782301|NCT03121716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782302|NCT03121716|Antiviral Agents|antiviral agents|mesh-ancestor
64782303|NCT03121716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64782304|NCT03121716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782305|NCT03121716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64782306|NCT03121716|Immunologic Factors|immunologic factors|mesh-ancestor
64782307|NCT03121716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782308|NCT02714634|Hydroxychloroquine|hydroxychloroquine|mesh-list
64782309|NCT02714634|Sulfasalazine|sulfasalazine|mesh-list
64782310|NCT02714634|Methotrexate|methotrexate|mesh-list
64865952|NCT01789216|Pregabalin|pregabalin|mesh-list
64865953|NCT01789216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64865954|NCT01789216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64865956|NCT01789216|Sensory System Agents|sensory system agents|mesh-ancestor
64865957|NCT01789216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865958|NCT01789216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782311|NCT02714634|Leflunomide|leflunomide|mesh-list
64782312|NCT02714634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64782313|NCT02714634|Abortifacient Agents|abortifacient agents|mesh-ancestor
64865959|NCT01789216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64304567|NCT01358357|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64304568|NCT01358357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64304569|NCT01358357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64304570|NCT01358357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64304571|NCT01358357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304572|NCT01358357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64304573|NCT01358357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64304574|NCT01358357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64304575|NCT01358357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64365051|NCT02458729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782315|NCT02714634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782316|NCT02714634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64782319|NCT02714634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782332|NCT02714634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64782333|NCT02714634|Analgesics|analgesics|mesh-ancestor
64782334|NCT02714634|Sensory System Agents|sensory system agents|mesh-ancestor
64782335|NCT02714634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782336|NCT02714634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64782337|NCT02714634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64782338|NCT02708394|Olanzapine|olanzapine|mesh-list
64782339|NCT02708394|Antiemetics|antiemetics|mesh-ancestor
64865960|NCT01789216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64865961|NCT01789216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64865962|NCT01789216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865963|NCT01789216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865964|NCT01789216|Anticonvulsants|anticonvulsants|mesh-ancestor
64333051|NCT01345851|Tubulin Modulators|tubulin modulators|mesh-ancestor
64333052|NCT01345851|Antimitotic Agents|antimitotic agents|mesh-ancestor
64333053|NCT01345851|Mitosis Modulators|mitosis modulators|mesh-ancestor
64333054|NCT01345851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333056|NCT03532841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64782340|NCT02708394|Autonomic Agents|autonomic agents|mesh-ancestor
64333057|NCT03532841|Narcotics|narcotics|mesh-ancestor
64782341|NCT02708394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782342|NCT02708394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782343|NCT02708394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64782344|NCT02708394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64782345|NCT02708394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64782346|NCT02708394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64782347|NCT02708394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64782348|NCT02708394|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64782349|NCT02708394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64782350|NCT02708394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64782351|NCT02708394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304576|NCT01358357|Adrenergic Agents|adrenergic agents|mesh-ancestor
64304577|NCT01358357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64304578|NCT01358357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865965|NCT01789216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64865966|NCT01789216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64865967|NCT01789216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64865968|NCT01789216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64865969|NCT01789216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64865970|NCT01789216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64865971|NCT01789216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64865972|NCT01789216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64865973|NCT01789242|Dexamethasone|dexamethasone|mesh-list
64865974|NCT01789242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64865975|NCT01789242|Antiemetics|antiemetics|mesh-ancestor
64865976|NCT01789242|Autonomic Agents|autonomic agents|mesh-ancestor
64865977|NCT01789242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865978|NCT01789242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865979|NCT01789242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64865980|NCT01789242|Glucocorticoids|glucocorticoids|mesh-ancestor
64865981|NCT01789242|Hormones|hormones|mesh-ancestor
64865982|NCT01789242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64865983|NCT01789242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64865984|NCT01789242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865985|NCT01789294|Mesalamine|mesalamine|mesh-list
64865987|NCT01789294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64304579|NCT01358357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64304580|NCT01358357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64304581|NCT01358357|Serotonin Agents|serotonin agents|mesh-ancestor
64304582|NCT01358357|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64304583|NCT01358357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64304584|NCT01358357|Dopamine Agents|dopamine agents|mesh-ancestor
64304585|NCT05573425|Tazarotene|tazarotene|mesh-list
64304586|NCT05573425|Dermatologic Agents|dermatologic agents|mesh-ancestor
64304587|NCT05573425|Keratolytic Agents|keratolytic agents|mesh-ancestor
64304588|NCT02253901|Ritonavir|ritonavir|mesh-list
64634577|NCT02112864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64866002|NCT01789385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64866003|NCT01789385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64866006|NCT01789385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64866007|NCT01789385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866008|NCT01789437|Dexamethasone|dexamethasone|mesh-list
64866009|NCT01789437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64866010|NCT01789437|Antiemetics|antiemetics|mesh-ancestor
64866011|NCT01789437|Autonomic Agents|autonomic agents|mesh-ancestor
64866012|NCT01789437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64866013|NCT01789437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866014|NCT01789437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64866015|NCT01789437|Glucocorticoids|glucocorticoids|mesh-ancestor
64866016|NCT01789437|Hormones|hormones|mesh-ancestor
64866017|NCT01789437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64866018|NCT01789437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64866019|NCT01789437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866020|NCT01789619|Tacrolimus|tacrolimus|mesh-list
64866021|NCT01789619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64866022|NCT01789619|Immunologic Factors|immunologic factors|mesh-ancestor
64866023|NCT01789619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866024|NCT01789619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64866025|NCT01789619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866026|NCT01789619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782352|NCT02708394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64782353|NCT02708394|Serotonin Agents|serotonin agents|mesh-ancestor
64782354|NCT01682616|Rituximab|rituximab|mesh-list
64782355|NCT01682616|Venetoclax|venetoclax|mesh-list
64866027|NCT01789710|Bupropion|bupropion|mesh-list
64782356|NCT01682616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64782357|NCT01682616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782358|NCT01682616|Immunologic Factors|immunologic factors|mesh-ancestor
64782359|NCT01682616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782360|NCT01682616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64393750|NCT03727139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782361|NCT00553800|Bevacizumab|bevacizumab|mesh-list
64782362|NCT00553800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64782363|NCT00553800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64782364|NCT00553800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782365|NCT00553800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64782366|NCT00553800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64782367|NCT00553800|Growth Substances|growth substances|mesh-ancestor
64782368|NCT00553800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782369|NCT00553800|Growth Inhibitors|growth inhibitors|mesh-ancestor
64782370|NCT00553800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64782371|NCT00553800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782372|NCT00553800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782373|NCT02740920|Pembrolizumab|pembrolizumab|mesh-list
64782374|NCT02740920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64782375|NCT02740920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782376|NCT02747628|Melatonin|melatonin|mesh-list
64782377|NCT02747628|Nicotine|nicotine|mesh-list
64782378|NCT02747628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64782379|NCT02747628|Autonomic Agents|autonomic agents|mesh-ancestor
64782380|NCT02747628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782381|NCT02747628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782382|NCT02747628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64866028|NCT01789710|Nicotine|nicotine|mesh-list
64866029|NCT01789710|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64333077|NCT02199431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782383|NCT02747628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64333078|NCT02199431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333079|NCT02199431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64333080|NCT02199431|Hormone Antagonists|hormone antagonists|mesh-ancestor
64333083|NCT02199431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64295801|NCT02058901|Growth Inhibitors|growth inhibitors|mesh-ancestor
64295802|NCT02058901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64295803|NCT02058901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295804|NCT02058901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295806|NCT03945591|Bortezomib|bortezomib|mesh-list
64304589|NCT02253901|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64304591|NCT02253901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64304592|NCT02253901|Protease Inhibitors|protease inhibitors|mesh-ancestor
64304593|NCT02253901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304594|NCT02253901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304595|NCT02253901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64304596|NCT02253901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64304597|NCT02253901|Antiviral Agents|antiviral agents|mesh-ancestor
64304598|NCT02253901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64304599|NCT02253901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64304600|NCT02253901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64304601|NCT02253901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64782384|NCT02747628|Cholinergic Agents|cholinergic agents|mesh-ancestor
64782385|NCT02747628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64866031|NCT01789710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64866032|NCT01789710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866033|NCT01789710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64866034|NCT01789710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64866035|NCT01789710|Cholinergic Agents|cholinergic agents|mesh-ancestor
64866036|NCT01789710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64866037|NCT01789710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866038|NCT01789710|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64866039|NCT01789710|Antidepressive Agents|antidepressive agents|mesh-ancestor
64866040|NCT01789710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64295807|NCT03945591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64295808|NCT03945591|Immunologic Factors|immunologic factors|mesh-ancestor
64782386|NCT02747628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393780|NCT05120687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64393781|NCT05120687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64393782|NCT05120687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64393783|NCT05120687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64393784|NCT05120687|Antitubercular Agents|antitubercular agents|mesh-ancestor
64393785|NCT05120687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64782388|NCT02747628|Protective Agents|protective agents|mesh-ancestor
64782389|NCT02747628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64782390|NCT02754570|Pilocarpine|pilocarpine|mesh-list
64782392|NCT02754570|Autonomic Agents|autonomic agents|mesh-ancestor
64782393|NCT02754570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782394|NCT02754570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782395|NCT02754570|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64782396|NCT02754570|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64782397|NCT02754570|Cholinergic Agents|cholinergic agents|mesh-ancestor
64782398|NCT02754570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64782399|NCT02754570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782400|NCT02765256|Promethazine|promethazine|mesh-list
64782401|NCT02765256|Diphenhydramine|diphenhydramine|mesh-list
64782402|NCT02765256|Vancomycin|vancomycin|mesh-list
64782403|NCT02765256|Ciprofloxacin|ciprofloxacin|mesh-list
64782404|NCT02765256|Neomycin|neomycin|mesh-list
64782405|NCT02765256|Fluconazole|fluconazole|mesh-list
64782406|NCT02765256|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64333084|NCT02203799|Immunologic Factors|immunologic factors|mesh-list
64333085|NCT02203799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333086|NCT03532763|Tocotrienols|tocotrienols|mesh-list
64333087|NCT03532763|Vitamin E|vitamin e|mesh-list
64333088|NCT03532763|Tocopherols|tocopherols|mesh-list
64333089|NCT03532763|Tocovid|tocovid|mesh-list
64333090|NCT03532763|Antioxidants|antioxidants|mesh-ancestor
64333091|NCT03532763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333092|NCT03532763|Protective Agents|protective agents|mesh-ancestor
64333093|NCT03532763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333094|NCT03532763|Vitamins|vitamins|mesh-ancestor
64782407|NCT02765256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64782408|NCT02765256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64333095|NCT03532763|Micronutrients|micronutrients|mesh-ancestor
64333096|NCT02208245|Ropivacaine|ropivacaine|mesh-list
64333097|NCT02208245|Anesthetics, Local|anesthetics, local|mesh-ancestor
64333098|NCT02208245|Anesthetics|anesthetics|mesh-ancestor
64333099|NCT02208245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64866041|NCT01789710|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64866042|NCT01789710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64866043|NCT01789710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64866045|NCT01789710|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64866046|NCT01789710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64866047|NCT01789710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866048|NCT01789723|Leucovorin|leucovorin|mesh-list
64866049|NCT01789723|Levoleucovorin|levoleucovorin|mesh-list
64866050|NCT01789723|Antidotes|antidotes|mesh-ancestor
64782409|NCT02765256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64304604|NCT03546283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64304605|NCT03546283|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64304606|NCT03546283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304607|NCT03546283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304608|NCT03546283|Protective Agents|protective agents|mesh-ancestor
64304609|NCT03546283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304610|NCT02831387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64304611|NCT02831387|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64304612|NCT04940546|Bevacizumab|bevacizumab|mesh-list
64304613|NCT04940546|Capecitabine|capecitabine|mesh-list
64304614|NCT04940546|Oxaliplatin|oxaliplatin|mesh-list
64304615|NCT04940546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64304616|NCT04940546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304617|NCT04940546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64782410|NCT02765256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64393807|NCT03096041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393808|NCT05121233|Diclofenac|diclofenac|mesh-list
64393809|NCT05121233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64393810|NCT05121233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64393811|NCT05121233|Analgesics|analgesics|mesh-ancestor
64393812|NCT05121233|Sensory System Agents|sensory system agents|mesh-ancestor
64393813|NCT05121233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782411|NCT02765256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782412|NCT02765256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782413|NCT02765256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782414|NCT02765256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64782415|NCT02765256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64782416|NCT02765256|Antifungal Agents|antifungal agents|mesh-ancestor
64782417|NCT02765256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64782418|NCT02765256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64782419|NCT02765256|Hormone Antagonists|hormone antagonists|mesh-ancestor
64866051|NCT01789723|Protective Agents|protective agents|mesh-ancestor
64782420|NCT02765256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64782421|NCT02765256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782422|NCT02765256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64333100|NCT02208245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333101|NCT02208245|Sensory System Agents|sensory system agents|mesh-ancestor
64782423|NCT02765256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64782424|NCT02765256|Antipruritics|antipruritics|mesh-ancestor
64782425|NCT02765256|Dermatologic Agents|dermatologic agents|mesh-ancestor
64782426|NCT02765256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64782427|NCT02765256|Histamine Antagonists|histamine antagonists|mesh-ancestor
64782428|NCT02765256|Histamine Agents|histamine agents|mesh-ancestor
64782429|NCT02765256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64782430|NCT02765256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64782431|NCT02765256|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64782432|NCT02765256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64782433|NCT02765256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64782434|NCT02765256|Anesthetics, Local|anesthetics, local|mesh-ancestor
64393827|NCT02893241|Ephedrine|ephedrine|mesh-list
64333102|NCT02208245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64333103|NCT03514901|Pembrolizumab|pembrolizumab|mesh-list
64333104|NCT03514901|Nivolumab|nivolumab|mesh-list
64333105|NCT03514901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64333106|NCT03514901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866052|NCT01789723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866053|NCT01789723|Vitamin B Complex|vitamin b complex|mesh-ancestor
64866054|NCT01789723|Vitamins|vitamins|mesh-ancestor
64866055|NCT01789723|Micronutrients|micronutrients|mesh-ancestor
64866056|NCT01789827|Interleukin-2|interleukin-2|mesh-list
64866057|NCT01789827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866058|NCT01789827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64866059|NCT01789827|Analgesics|analgesics|mesh-ancestor
64866060|NCT01789827|Sensory System Agents|sensory system agents|mesh-ancestor
64866061|NCT01789827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64866062|NCT01789827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866063|NCT01789879|Efavirenz|efavirenz|mesh-list
64866064|NCT01789879|Nevirapine|nevirapine|mesh-list
64866065|NCT01789879|Levonorgestrel|levonorgestrel|mesh-list
64333107|NCT03514901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64866066|NCT01789879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64393828|NCT02893241|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64393829|NCT02893241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393830|NCT02893241|Sympathomimetics|sympathomimetics|mesh-ancestor
64393831|NCT02893241|Autonomic Agents|autonomic agents|mesh-ancestor
64393832|NCT02893241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782435|NCT02765256|Anesthetics|anesthetics|mesh-ancestor
64782436|NCT02765256|Sensory System Agents|sensory system agents|mesh-ancestor
64782437|NCT02765256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782438|NCT02765256|Antiemetics|antiemetics|mesh-ancestor
64782439|NCT02765256|Autonomic Agents|autonomic agents|mesh-ancestor
64782440|NCT02765256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64782441|NCT02765256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64782442|NCT02765256|Laxatives|laxatives|mesh-ancestor
64782443|NCT02767128|Citric Acid|citric acid|mesh-list
64304619|NCT04940546|Growth Substances|growth substances|mesh-ancestor
64304620|NCT04940546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304621|NCT04940546|Growth Inhibitors|growth inhibitors|mesh-ancestor
64304622|NCT04940546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64304623|NCT04940546|Antimetabolites|antimetabolites|mesh-ancestor
64782479|NCT02775240|Dextromethorphan|dextromethorphan|mesh-list
64866067|NCT01789879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64866068|NCT01789879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782480|NCT02775240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64295809|NCT03945591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295810|NCT03945591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64782481|NCT02775240|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64295811|NCT03945591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64295812|NCT03945591|Alkylating Agents|alkylating agents|mesh-ancestor
64295813|NCT03945591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295814|NCT03945591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782482|NCT02775240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295815|NCT03945591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64295817|NCT01955499|Immunologic Factors|immunologic factors|mesh-ancestor
64295818|NCT01955499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295819|NCT01955499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64782483|NCT02775240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782484|NCT02775240|Protective Agents|protective agents|mesh-ancestor
64782485|NCT02775240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782486|NCT02775240|Antitussive Agents|antitussive agents|mesh-ancestor
64782487|NCT02775240|Respiratory System Agents|respiratory system agents|mesh-ancestor
64782488|NCT02775240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64782489|NCT02775240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64782490|NCT02775240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64782491|NCT02775240|Antiviral Agents|antiviral agents|mesh-ancestor
64782492|NCT02775240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64782493|NCT02777268|Hydrocortisone|hydrocortisone|mesh-list
64782495|NCT05350020|Hydrocortisone|hydrocortisone|mesh-list
64782496|NCT05350020|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64782497|NCT05350020|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64782498|NCT05350020|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64782499|NCT05350020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64782500|NCT05349474|Metformin|metformin|mesh-list
64782501|NCT05349474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64782502|NCT05349474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782503|NCT05349396|Eszopiclone|eszopiclone|mesh-list
64866069|NCT01789879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866070|NCT01789879|Antiviral Agents|antiviral agents|mesh-ancestor
64866071|NCT01789879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64866072|NCT01789879|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64866073|NCT01789879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64866074|NCT01789879|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64866075|NCT01789879|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64866076|NCT01789879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64866077|NCT01789879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64866078|NCT01789879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64866079|NCT01789879|Contraceptive Agents|contraceptive agents|mesh-ancestor
64866080|NCT01789879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64866081|NCT01789879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866082|NCT01789879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64866083|NCT01789879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64333108|NCT03514901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333110|NCT04441021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64333111|NCT04441021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64333112|NCT03533387|Ibudilast|ibudilast|mesh-list
64333113|NCT03533387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64333114|NCT03533387|Autonomic Agents|autonomic agents|mesh-ancestor
64295820|NCT01955499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64295821|NCT01955499|Growth Substances|growth substances|mesh-ancestor
64295822|NCT01955499|Growth Inhibitors|growth inhibitors|mesh-ancestor
64295823|NCT01955499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866085|NCT01789879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64866086|NCT01789879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64866087|NCT01789892|Methylprednisolone|methylprednisolone|mesh-list
64866088|NCT01789892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64866089|NCT01789892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64866091|NCT01789892|Prednisolone acetate|prednisolone acetate|mesh-list
64866092|NCT01789892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64866093|NCT01789892|Prednisolone phosphate|prednisolone phosphate|mesh-list
64866094|NCT01789892|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64866095|NCT01789892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64866096|NCT01789892|Antiemetics|antiemetics|mesh-ancestor
64866097|NCT01789892|Autonomic Agents|autonomic agents|mesh-ancestor
64866098|NCT01789892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64866099|NCT01789892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866100|NCT01789892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64782504|NCT05349396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64782505|NCT05349396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64782506|NCT05349396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782507|NCT05348148|Mometasone Furoate|mometasone furoate|mesh-list
64782508|NCT05348148|Cetirizine|cetirizine|mesh-list
64782509|NCT05348148|Phenylephrine|phenylephrine|mesh-list
64333125|NCT02324842|Canagliflozin|canagliflozin|mesh-list
64782510|NCT05348148|Oxymetazoline|oxymetazoline|mesh-list
64782511|NCT05348148|Levocetirizine|levocetirizine|mesh-list
64782512|NCT05348148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64782513|NCT05348148|Dermatologic Agents|dermatologic agents|mesh-ancestor
64333126|NCT02324842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64333127|NCT02324842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866117|NCT01790854|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64866118|NCT01790854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64866119|NCT01792063|Sevoflurane|sevoflurane|mesh-list
64866120|NCT01792063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64866121|NCT01792063|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64866122|NCT01792063|Anesthetics, General|anesthetics, general|mesh-ancestor
64866123|NCT01792063|Anesthetics|anesthetics|mesh-ancestor
64866124|NCT01792063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64866125|NCT01792063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333129|NCT02324842|Hormones|hormones|mesh-ancestor
64333130|NCT02324842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64333131|NCT02324842|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64333132|NCT02324842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782514|NCT05348148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64782515|NCT05348148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64782516|NCT05348148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64782517|NCT05348148|Histamine Antagonists|histamine antagonists|mesh-ancestor
64782518|NCT05348148|Histamine Agents|histamine agents|mesh-ancestor
64782519|NCT05348148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64782520|NCT05348148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782521|NCT05348148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782522|NCT05348148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64782523|NCT05348148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64782524|NCT05348148|Adrenergic Agents|adrenergic agents|mesh-ancestor
64782525|NCT05348148|Sympathomimetics|sympathomimetics|mesh-ancestor
64393910|NCT01980940|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
64393911|NCT01980940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64393912|NCT01980940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64782526|NCT05348148|Autonomic Agents|autonomic agents|mesh-ancestor
64782527|NCT05348148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782528|NCT05348148|Nasal Decongestants|nasal decongestants|mesh-ancestor
64866127|NCT01792570|Rilpivirine|rilpivirine|mesh-list
64866128|NCT01792570|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64866129|NCT01792570|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64866130|NCT01792570|Protease Inhibitors|protease inhibitors|mesh-ancestor
64866131|NCT01792570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866132|NCT01792570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866133|NCT01792570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64866134|NCT01792570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64866135|NCT01792570|Antiviral Agents|antiviral agents|mesh-ancestor
64866136|NCT01792570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64866137|NCT01792570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64333134|NCT02295280|Promethazine|promethazine|mesh-list
64333135|NCT02295280|Codeine|codeine|mesh-list
64333136|NCT02295280|Metoclopramide|metoclopramide|mesh-list
64333137|NCT02295280|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64333138|NCT02295280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64333139|NCT02295280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64333140|NCT02295280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333141|NCT02295280|Anesthetics, Local|anesthetics, local|mesh-ancestor
64333142|NCT02295280|Anesthetics|anesthetics|mesh-ancestor
64333143|NCT02295280|Sensory System Agents|sensory system agents|mesh-ancestor
64782529|NCT05348148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64782530|NCT05348148|Respiratory System Agents|respiratory system agents|mesh-ancestor
64304624|NCT04940546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304626|NCT03547219|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64304627|NCT03547219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64304628|NCT03547219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64304629|NCT03547219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782532|NCT05348148|Mydriatics|mydriatics|mesh-ancestor
64782533|NCT05348148|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64782534|NCT05348148|Protective Agents|protective agents|mesh-ancestor
64782535|NCT05257590|Nivolumab|nivolumab|mesh-list
64782536|NCT05257590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64782537|NCT05257590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782538|NCT05257590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64782539|NCT05257590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782540|NCT05456022|Doxorubicin|doxorubicin|mesh-list
64782541|NCT05456022|Quercetin|quercetin|mesh-list
64866138|NCT01792570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64866139|NCT01792804|Vancomycin|vancomycin|mesh-list
64866140|NCT01792804|Clindamycin|clindamycin|mesh-list
64866141|NCT01792804|Cefazolin|cefazolin|mesh-list
64866142|NCT01792804|Linezolid|linezolid|mesh-list
64866143|NCT01792804|Daptomycin|daptomycin|mesh-list
64866144|NCT01792804|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64866145|NCT01792804|Floxacillin|floxacillin|mesh-list
64866146|NCT01792804|Cloxacillin|cloxacillin|mesh-list
64866147|NCT01792804|Trimethoprim|trimethoprim|mesh-list
64866148|NCT01792804|Sulfamethoxazole|sulfamethoxazole|mesh-list
64866149|NCT01792804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64333144|NCT02295280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64333147|NCT02295280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64333148|NCT02295280|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64333149|NCT02295280|Histamine Antagonists|histamine antagonists|mesh-ancestor
64333150|NCT02295280|Histamine Agents|histamine agents|mesh-ancestor
64333151|NCT02295280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64333152|NCT02295280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782542|NCT05456022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64782543|NCT05456022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782544|NCT05456022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64782545|NCT05456022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64782546|NCT05456022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782547|NCT05456022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782548|NCT05456022|Antioxidants|antioxidants|mesh-ancestor
64782549|NCT05456022|Protective Agents|protective agents|mesh-ancestor
64782550|NCT05456022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782551|NCT05453916|Rifaximin|rifaximin|mesh-list
64782552|NCT05453916|Nitazoxanide|nitazoxanide|mesh-list
64782553|NCT05453916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64782554|NCT05453916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64782555|NCT05453916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64782556|NCT05453916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64782557|NCT05273814|Bevacizumab|bevacizumab|mesh-list
64782558|NCT05273814|Pemetrexed|pemetrexed|mesh-list
64866150|NCT01792804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64782559|NCT05273814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64866151|NCT01792804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64866152|NCT01792804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866153|NCT01792804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866154|NCT01792804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64866155|NCT01792804|Renal Agents|renal agents|mesh-ancestor
64866156|NCT01792804|Antimalarials|antimalarials|mesh-ancestor
64866157|NCT01792804|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64866158|NCT01792804|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64866159|NCT01792804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64866160|NCT01792804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64866161|NCT01792804|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64866162|NCT01792804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64866164|NCT01793038|Enclomiphene|enclomiphene|mesh-list
64866165|NCT01793038|Zuclomiphene|zuclomiphene|mesh-list
64393942|NCT04752527|Antimetabolites|antimetabolites|mesh-ancestor
64782560|NCT05273814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64782562|NCT05273814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64782563|NCT05273814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64782564|NCT05273814|Growth Substances|growth substances|mesh-ancestor
64304630|NCT03547219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64304631|NCT03547219|Serotonin Agents|serotonin agents|mesh-ancestor
64304632|NCT03547219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365424|NCT03263299|Sensory System Agents|sensory system agents|mesh-ancestor
64782566|NCT05273814|Growth Inhibitors|growth inhibitors|mesh-ancestor
64782567|NCT05273814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333153|NCT02295280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64333154|NCT02295280|Antipruritics|antipruritics|mesh-ancestor
64333155|NCT02295280|Dermatologic Agents|dermatologic agents|mesh-ancestor
64333156|NCT02295280|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64333157|NCT02295280|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64333158|NCT02295280|Dopamine Agents|dopamine agents|mesh-ancestor
64866167|NCT01793038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866168|NCT01793038|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64866169|NCT01793038|Hormone Antagonists|hormone antagonists|mesh-ancestor
64866170|NCT01793038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64866171|NCT01793038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866172|NCT01793038|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64866173|NCT01793038|Fertility Agents|fertility agents|mesh-ancestor
64866174|NCT01793038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64866175|NCT01793038|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64866176|NCT01793038|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64866177|NCT01793038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64866178|NCT01793038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866179|NCT01794182|Glyburide|glyburide|mesh-list
64866180|NCT01794182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64866181|NCT01794182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866182|NCT01794208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64782568|NCT05273814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782569|NCT05273814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64782570|NCT05273814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64782571|NCT04800510|Carbon Fiber|carbon fiber|mesh-list
64782572|NCT04800510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64782573|NCT04800510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64782575|NCT04784208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64782576|NCT04784208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782577|NCT04024878|Nivolumab|nivolumab|mesh-list
64782578|NCT04024878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64782579|NCT04024878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782580|NCT04024878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64782581|NCT04024878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782582|NCT03845010|Verapamil|verapamil|mesh-list
64782583|NCT03845010|Sotalol|sotalol|mesh-list
64782584|NCT03845010|Flecainide|flecainide|mesh-list
64782585|NCT03845010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64782586|NCT03845010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64782587|NCT03845010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64393974|NCT03169777|Growth Substances|growth substances|mesh-ancestor
64866184|NCT01794208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64866185|NCT01794208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866186|NCT01794247|Lidocaine|lidocaine|mesh-list
64866187|NCT01794247|Magnesium Sulfate|magnesium sulfate|mesh-list
64866188|NCT01794247|Fentanyl|fentanyl|mesh-list
64866189|NCT01794247|Anesthetics, Local|anesthetics, local|mesh-ancestor
64866190|NCT01794247|Anesthetics|anesthetics|mesh-ancestor
64866191|NCT01794247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64866192|NCT01794247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866193|NCT01794247|Sensory System Agents|sensory system agents|mesh-ancestor
64866194|NCT01794247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64866195|NCT01794247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64333159|NCT02295280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64333160|NCT02295280|Narcotics|narcotics|mesh-ancestor
64333161|NCT02295280|Analgesics|analgesics|mesh-ancestor
64333162|NCT02295280|Antitussive Agents|antitussive agents|mesh-ancestor
64333163|NCT02295280|Respiratory System Agents|respiratory system agents|mesh-ancestor
64333164|NCT05263505|Methotrexate|methotrexate|mesh-list
64333165|NCT05263505|Azathioprine|azathioprine|mesh-list
64333166|NCT05263505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64333167|NCT05263505|Abortifacient Agents|abortifacient agents|mesh-ancestor
64333168|NCT05263505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64333169|NCT05263505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333170|NCT05263505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64393975|NCT03169777|Growth Inhibitors|growth inhibitors|mesh-ancestor
64782588|NCT03845010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782589|NCT03845010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64782591|NCT03845010|Vasodilator Agents|vasodilator agents|mesh-ancestor
64782592|NCT03845010|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64782593|NCT03845010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64782594|NCT03845010|Adrenergic Agents|adrenergic agents|mesh-ancestor
64782595|NCT03845010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64782596|NCT03845010|Sympatholytics|sympatholytics|mesh-ancestor
64782597|NCT03845010|Autonomic Agents|autonomic agents|mesh-ancestor
64782598|NCT03845010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782599|NCT03845010|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64782600|NCT03845010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64866196|NCT01794247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64866197|NCT01794247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64866198|NCT01794247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64866199|NCT01794247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866200|NCT01794247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64866201|NCT01794247|Narcotics|narcotics|mesh-ancestor
64866202|NCT01794247|Analgesics|analgesics|mesh-ancestor
64866203|NCT01794247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64866204|NCT01794247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64866205|NCT01794247|Anesthetics, General|anesthetics, general|mesh-ancestor
64866206|NCT01794247|Anticonvulsants|anticonvulsants|mesh-ancestor
64866207|NCT01794247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64866208|NCT01794247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64866209|NCT01794247|Tocolytic Agents|tocolytic agents|mesh-ancestor
64782601|NCT03568890|Aspirin|aspirin|mesh-list
64304635|NCT03547219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64304636|NCT05188898|Hyaluronic Acid|hyaluronic acid|mesh-list
64304637|NCT05188898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64304638|NCT05188898|Immunologic Factors|immunologic factors|mesh-ancestor
64304639|NCT05188898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304640|NCT05188898|Viscosupplements|viscosupplements|mesh-ancestor
64304641|NCT05188898|Protective Agents|protective agents|mesh-ancestor
64304642|NCT04116320|Poly ICLC|poly iclc|mesh-list
64304643|NCT04116320|Interferon Inducers|interferon inducers|mesh-ancestor
64304644|NCT04116320|Immunologic Factors|immunologic factors|mesh-ancestor
64304645|NCT04116320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304646|NCT04069819|Cilostazol|cilostazol|mesh-list
64304647|NCT04069819|Citalopram|citalopram|mesh-list
64333172|NCT05263505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333173|NCT05263505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333174|NCT05263505|Dermatologic Agents|dermatologic agents|mesh-ancestor
64333175|NCT05263505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333176|NCT05263505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64333177|NCT05263505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64333178|NCT05263505|Immunologic Factors|immunologic factors|mesh-ancestor
64333179|NCT05263505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64333180|NCT05263505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64333181|NCT05488405|Mesalamine|mesalamine|mesh-list
64333182|NCT05488405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64333183|NCT05488405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64333184|NCT05488405|Analgesics|analgesics|mesh-ancestor
64333185|NCT05488405|Sensory System Agents|sensory system agents|mesh-ancestor
64333187|NCT05488405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333189|NCT05488405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64333190|NCT02204501|Midazolam|midazolam|mesh-list
64333191|NCT02204501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64866245|NCT01796132|Dopamine Agents|dopamine agents|mesh-ancestor
64866246|NCT01796132|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64866247|NCT01796132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64866248|NCT01796132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866249|NCT01796132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64866250|NCT01796132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64866251|NCT01796132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64866252|NCT01796132|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64866253|NCT01796132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64866254|NCT01796418|Beraprost|beraprost|mesh-list
64866255|NCT01796418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64333192|NCT02204501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64304648|NCT04069819|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64304649|NCT04069819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64304650|NCT04069819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64304651|NCT04069819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782602|NCT03568890|Rivaroxaban|rivaroxaban|mesh-list
64782603|NCT03568890|Apixaban|apixaban|mesh-list
64782604|NCT03568890|Edoxaban|edoxaban|mesh-list
64782605|NCT03568890|Dabigatran|dabigatran|mesh-list
64782606|NCT03568890|Clopidogrel|clopidogrel|mesh-list
64782607|NCT03568890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64782608|NCT03568890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64333193|NCT02204501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64333194|NCT02204501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333195|NCT02204501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64333196|NCT02204501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64866256|NCT01796418|Vasodilator Agents|vasodilator agents|mesh-ancestor
64866257|NCT01796522|Nifedipine|nifedipine|mesh-list
64866258|NCT01796522|Progesterone|progesterone|mesh-list
64866259|NCT01796522|Progestins|progestins|mesh-ancestor
64866260|NCT01796522|Hormones|hormones|mesh-ancestor
64866261|NCT01796522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64866262|NCT01796522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866263|NCT01796522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64866264|NCT01796522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64866265|NCT01796522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866266|NCT01796522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64866267|NCT01796522|Vasodilator Agents|vasodilator agents|mesh-ancestor
64866268|NCT01796522|Tocolytic Agents|tocolytic agents|mesh-ancestor
64866269|NCT01796522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64782609|NCT03568890|Analgesics|analgesics|mesh-ancestor
64782610|NCT03568890|Sensory System Agents|sensory system agents|mesh-ancestor
64782611|NCT03568890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782612|NCT03568890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782613|NCT03568890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64782614|NCT03568890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64782615|NCT03568890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64782616|NCT03568890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64782617|NCT03568890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782618|NCT03568890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64782619|NCT03568890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64782620|NCT03568890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782629|NCT03568890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64782630|NCT03568890|Protease Inhibitors|protease inhibitors|mesh-ancestor
64782631|NCT03568890|Anticoagulants|anticoagulants|mesh-ancestor
64782632|NCT03004248|Botulinum Toxins|botulinum toxins|mesh-list
64782633|NCT03004248|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64782634|NCT03004248|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64782635|NCT03004248|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64782636|NCT03004248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64782637|NCT03004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782638|NCT03004248|Cholinergic Agents|cholinergic agents|mesh-ancestor
64333197|NCT02204501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64333198|NCT02204501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64333199|NCT02204501|Anesthetics, General|anesthetics, general|mesh-ancestor
64333200|NCT02204501|Anesthetics|anesthetics|mesh-ancestor
64333201|NCT02204501|GABA Modulators|gaba modulators|mesh-ancestor
64333202|NCT02204501|GABA Agents|gaba agents|mesh-ancestor
64333203|NCT02204501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64866270|NCT01796730|Bambuterol|bambuterol|mesh-list
64866271|NCT01796730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64866272|NCT01796730|Autonomic Agents|autonomic agents|mesh-ancestor
64866273|NCT01796730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64866274|NCT01796730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866275|NCT01796730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64782639|NCT03004248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64782640|NCT03004248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782641|NCT03004248|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64782642|NCT03004248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782643|NCT02529930|Vaccines|vaccines|mesh-list
64782644|NCT02529930|Immunologic Factors|immunologic factors|mesh-ancestor
64782645|NCT02529930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866276|NCT01796730|Respiratory System Agents|respiratory system agents|mesh-ancestor
64866277|NCT01796808|Lidocaine|lidocaine|mesh-list
64866278|NCT01796808|Epinephrine|epinephrine|mesh-list
64866279|NCT01796808|Anesthetics, Local|anesthetics, local|mesh-list
64866280|NCT01796808|Anesthetics|anesthetics|mesh-list
64866281|NCT01796808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64866282|NCT01796808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866283|NCT01796808|Sensory System Agents|sensory system agents|mesh-ancestor
64866284|NCT01796808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64866286|NCT01796808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64866287|NCT01796808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64866288|NCT01796808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64866289|NCT01796808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866290|NCT01796808|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64866291|NCT01796808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64866292|NCT01796808|Adrenergic Agents|adrenergic agents|mesh-ancestor
64782646|NCT00039780|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
64782647|NCT00039780|Protective Agents|protective agents|mesh-ancestor
64782648|NCT00039780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782649|NCT05101746|Nitric Oxide|nitric oxide|mesh-list
64782650|NCT05101746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64394047|NCT04255277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64365527|NCT04508231|Hormones|hormones|mesh-list
64394049|NCT04255277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64333204|NCT02204501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333205|NCT02294734|Nemiralisib|nemiralisib|mesh-list
64333206|NCT02294734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64866293|NCT01796808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64866294|NCT01796808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64866295|NCT01796808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64866296|NCT01796808|Autonomic Agents|autonomic agents|mesh-ancestor
64866297|NCT01796808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64866298|NCT01796808|Respiratory System Agents|respiratory system agents|mesh-ancestor
64866299|NCT01796808|Mydriatics|mydriatics|mesh-ancestor
64866300|NCT01796808|Sympathomimetics|sympathomimetics|mesh-ancestor
64295844|NCT01217931|Bevacizumab|bevacizumab|mesh-list
64394050|NCT04255277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64394051|NCT04255277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394052|NCT04255277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394053|NCT04255277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394054|NCT04255277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64394055|NCT04255277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64394056|NCT04255277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394057|NCT04255277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64782651|NCT05101746|Autonomic Agents|autonomic agents|mesh-ancestor
64782652|NCT05101746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782653|NCT05101746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333207|NCT02294734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333208|NCT02294734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333209|NCT03533231|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64333210|NCT03533231|Metronidazole|metronidazole|mesh-list
64333211|NCT03533231|Ciprofloxacin|ciprofloxacin|mesh-list
64333212|NCT03533231|Propolis|propolis|mesh-list
64866302|NCT01797289|Fibrin fragment D|fibrin fragment d|mesh-list
64866303|NCT01797289|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64866304|NCT01797289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64866305|NCT01797289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866306|NCT01797289|Hemostatics|hemostatics|mesh-ancestor
64866307|NCT01797289|Coagulants|coagulants|mesh-ancestor
64866308|NCT01797718|Letrozole|letrozole|mesh-list
64866309|NCT01797718|Testosterone|testosterone|mesh-list
64866310|NCT01797718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866311|NCT01797718|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64866312|NCT01797718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64866313|NCT01797718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866314|NCT01797718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866315|NCT01797718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64866316|NCT01797718|Hormone Antagonists|hormone antagonists|mesh-ancestor
64866317|NCT01797718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64866318|NCT01797718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866319|NCT01797718|Androgens|androgens|mesh-ancestor
64782654|NCT05101746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64782655|NCT05101746|Respiratory System Agents|respiratory system agents|mesh-ancestor
64782656|NCT05101746|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64782657|NCT05101746|Antioxidants|antioxidants|mesh-ancestor
64782658|NCT05101746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304654|NCT04069819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304655|NCT04069819|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64304656|NCT04069819|Antidepressive Agents|antidepressive agents|mesh-ancestor
64304657|NCT04069819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64304658|NCT04069819|Autonomic Agents|autonomic agents|mesh-ancestor
64304659|NCT04069819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64304660|NCT04069819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64304661|NCT04069819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64304662|NCT04069819|Respiratory System Agents|respiratory system agents|mesh-ancestor
64304663|NCT04069819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64304664|NCT04069819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64365574|NCT02458963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304665|NCT04069819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64304666|NCT04069819|Vasodilator Agents|vasodilator agents|mesh-ancestor
64304667|NCT04069819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64866320|NCT01797718|Hormones|hormones|mesh-ancestor
64866321|NCT01797796|Capsaicin|capsaicin|mesh-list
64866322|NCT01797796|Antipruritics|antipruritics|mesh-ancestor
64866323|NCT01797796|Dermatologic Agents|dermatologic agents|mesh-ancestor
64866324|NCT01797796|Sensory System Agents|sensory system agents|mesh-ancestor
64866325|NCT01797796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64866326|NCT01797796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866327|NCT01798108|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64866328|NCT01798108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866329|NCT01798446|Axitinib|axitinib|mesh-list
64866330|NCT01798446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866331|NCT01798446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64866332|NCT01798446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866335|NCT01798680|Cholecalciferol|cholecalciferol|mesh-list
64304668|NCT04069819|Protective Agents|protective agents|mesh-ancestor
64304669|NCT04069819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64782667|NCT04763226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782668|NCT04763226|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64782669|NCT04763226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64782670|NCT04763226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782671|NCT04549428|Atezolizumab|atezolizumab|mesh-list
64782672|NCT04549428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782673|NCT04527900|Paclitaxel|paclitaxel|mesh-list
64782674|NCT04527900|Carboplatin|carboplatin|mesh-list
64782675|NCT04527900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64782676|NCT04527900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394068|NCT04435925|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64394069|NCT04435925|Narcotics|narcotics|mesh-ancestor
64394070|NCT04435925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64324283|NCT05492318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324284|NCT05492318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64324285|NCT05492318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324291|NCT05492318|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64324292|NCT05492318|Protease Inhibitors|protease inhibitors|mesh-ancestor
64324293|NCT05492318|Anticoagulants|anticoagulants|mesh-ancestor
64324294|NCT05492318|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64782678|NCT04527900|Antimitotic Agents|antimitotic agents|mesh-ancestor
64782679|NCT04527900|Mitosis Modulators|mitosis modulators|mesh-ancestor
64866356|NCT01798901|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
64866357|NCT01798901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64866358|NCT01798901|Antimetabolites|antimetabolites|mesh-ancestor
64866359|NCT01798901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866360|NCT01798901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866361|NCT01798901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866362|NCT01799863|Ketorolac|ketorolac|mesh-list
64866363|NCT01799863|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64866364|NCT01799863|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64866365|NCT01799863|Lubricant Eye Drops|lubricant eye drops|mesh-list
64866366|NCT01799863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64866367|NCT01799863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64866368|NCT01799863|Analgesics|analgesics|mesh-ancestor
64866369|NCT01799863|Sensory System Agents|sensory system agents|mesh-ancestor
64866370|NCT01799863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64866371|NCT01799863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866372|NCT01799863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64866373|NCT01799863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64866374|NCT01799863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64866375|NCT01799863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866376|NCT01799863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866377|NCT01799863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64866378|NCT01799863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64782680|NCT04527900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782681|NCT04340856|Bisacodyl|bisacodyl|mesh-list
64304670|NCT04069819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64304671|NCT04069819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304672|NCT04084496|Folfirinox|folfirinox|mesh-list
64304673|NCT04084496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304674|NCT04433156|Prednisone|prednisone|mesh-list
64304675|NCT04433156|Cyclophosphamide|cyclophosphamide|mesh-list
64304676|NCT04433156|Rituximab|rituximab|mesh-list
64304677|NCT04433156|Bortezomib|bortezomib|mesh-list
64304678|NCT04433156|Epirubicin|epirubicin|mesh-list
64304679|NCT04433156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64304680|NCT04433156|Immunologic Factors|immunologic factors|mesh-ancestor
64304681|NCT04433156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365623|NCT04507217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64365652|NCT03352895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64365653|NCT05074147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64365664|NCT03265795|Ether|ether|mesh-list
64782682|NCT04340856|Laxatives|laxatives|mesh-list
64782683|NCT04340856|Cathartics|cathartics|mesh-ancestor
64782684|NCT04340856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64782685|NCT04040790|Phenylephrine|phenylephrine|mesh-list
64333214|NCT03533231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64333215|NCT03533231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64782686|NCT04040790|Oxymetazoline|oxymetazoline|mesh-list
64782687|NCT04040790|Tropicamide|tropicamide|mesh-list
64782688|NCT04040790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64782689|NCT04040790|Mydriatics|mydriatics|mesh-ancestor
64333216|NCT03533231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64333217|NCT03533231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64333218|NCT03533231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295857|NCT05291325|Enzyme Activators|enzyme activators|mesh-ancestor
64295858|NCT05291325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295859|NCT05291325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64295861|NCT03310593|Anticonvulsants|anticonvulsants|mesh-ancestor
64295862|NCT05304338|Chlorhexidine|chlorhexidine|mesh-list
64295863|NCT05304338|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64295864|NCT05304338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64295865|NCT05304338|Disinfectants|disinfectants|mesh-ancestor
64295866|NCT03810807|Osimertinib|osimertinib|mesh-list
64295867|NCT03810807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295868|NCT03810807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64295869|NCT03810807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782690|NCT04040790|Autonomic Agents|autonomic agents|mesh-ancestor
64782691|NCT04040790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782692|NCT04040790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782693|NCT04040790|Sympathomimetics|sympathomimetics|mesh-ancestor
64782694|NCT04040790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64782695|NCT04040790|Nasal Decongestants|nasal decongestants|mesh-ancestor
64782696|NCT04040790|Respiratory System Agents|respiratory system agents|mesh-ancestor
64782697|NCT04040790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64782698|NCT04040790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64782699|NCT04040790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64782700|NCT04040790|Adrenergic Agents|adrenergic agents|mesh-ancestor
64866381|NCT01800006|Rivaroxaban|rivaroxaban|mesh-list
64866382|NCT01800006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64866383|NCT01800006|Antithrombins|antithrombins|mesh-ancestor
64866384|NCT01800006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64866385|NCT01800006|Protease Inhibitors|protease inhibitors|mesh-ancestor
64866386|NCT01800006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866387|NCT01800006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866388|NCT01800006|Anticoagulants|anticoagulants|mesh-ancestor
64866389|NCT01800019|Nicotine|nicotine|mesh-list
64866390|NCT01800019|Varenicline|varenicline|mesh-list
64866391|NCT01800019|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64866392|NCT01800019|Autonomic Agents|autonomic agents|mesh-ancestor
64866393|NCT01800019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64866394|NCT01800019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866395|NCT01800019|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64866396|NCT01800019|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64866397|NCT01800019|Cholinergic Agents|cholinergic agents|mesh-ancestor
64866398|NCT01800019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64866399|NCT01800019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866400|NCT01800097|Modafinil|modafinil|mesh-list
64333219|NCT03533231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333220|NCT03533231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333221|NCT03533231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64333222|NCT03533231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64866401|NCT01800097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64866402|NCT01800097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866403|NCT01800097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64866404|NCT01800097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64866405|NCT01800097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64782701|NCT04040790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64782702|NCT04040790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782703|NCT04040790|Protective Agents|protective agents|mesh-ancestor
64551307|NCT00874887|Moxifloxacin|moxifloxacin|mesh-list
64782704|NCT04040790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64782705|NCT04040790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64782707|NCT03797196|Mycophenolic Acid|mycophenolic acid|mesh-list
64866409|NCT01800227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64866410|NCT01800227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866411|NCT01800240|Metformin|metformin|mesh-list
64866412|NCT01800240|Pioglitazone|pioglitazone|mesh-list
64866413|NCT01800240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64866414|NCT01800240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782708|NCT03797196|Everolimus|everolimus|mesh-list
64782709|NCT03797196|Tacrolimus|tacrolimus|mesh-list
64782710|NCT03797196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64782711|NCT03797196|Immunologic Factors|immunologic factors|mesh-ancestor
64782712|NCT03797196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782713|NCT03797196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64782714|NCT03797196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782715|NCT03797196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782716|NCT03797196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782717|NCT03797196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64782718|NCT03797196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64782719|NCT03797196|Antitubercular Agents|antitubercular agents|mesh-ancestor
64782720|NCT03797196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64782721|NCT03797196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64782722|NCT03743766|Nivolumab|nivolumab|mesh-list
64782723|NCT03743766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64782724|NCT03743766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782725|NCT03743766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64782726|NCT03743766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782727|NCT03556800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64782728|NCT03556800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64782729|NCT03556800|Estradiol|estradiol|mesh-list
64782730|NCT03556800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64866416|NCT01800292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866417|NCT01800292|Vasodilator Agents|vasodilator agents|mesh-ancestor
64866418|NCT01800292|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64866419|NCT01800292|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64866420|NCT01800292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866421|NCT01800292|Urological Agents|urological agents|mesh-ancestor
64866422|NCT01800357|Aspirin|aspirin|mesh-list
64866423|NCT01800357|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
64866424|NCT01800357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64866425|NCT01800357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64866426|NCT01800357|Analgesics|analgesics|mesh-ancestor
64333223|NCT02200757|Topotecan|topotecan|mesh-list
64333224|NCT02200757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64333225|NCT02200757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64782731|NCT03556800|Estrogens|estrogens|mesh-ancestor
64782732|NCT03556800|Hormones|hormones|mesh-ancestor
64782733|NCT03556800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64782734|NCT03556800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394129|NCT02696785|Adalimumab|adalimumab|mesh-list
64394130|NCT02696785|Ixekizumab|ixekizumab|mesh-list
64394131|NCT02696785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64394132|NCT02696785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64394133|NCT02696785|Dermatologic Agents|dermatologic agents|mesh-ancestor
64394135|NCT02004262|Pancrelipase|pancrelipase|mesh-list
64324296|NCT01337635|Vitamins|vitamins|mesh-ancestor
64324297|NCT01337635|Micronutrients|micronutrients|mesh-ancestor
64324304|NCT02264041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64324305|NCT02264041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782735|NCT03556800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64782736|NCT03556800|Contraceptive Agents|contraceptive agents|mesh-ancestor
64782737|NCT03556800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64782738|NCT03556800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64782740|NCT04741620|Capsaicin|capsaicin|mesh-list
64782741|NCT04741620|Sodium Citrate|sodium citrate|mesh-list
64782742|NCT04741620|Citric Acid|citric acid|mesh-list
64782743|NCT04741620|Piperine|piperine|mesh-list
64782744|NCT04741620|Antipruritics|antipruritics|mesh-ancestor
64782745|NCT04741620|Dermatologic Agents|dermatologic agents|mesh-ancestor
64782746|NCT04741620|Sensory System Agents|sensory system agents|mesh-ancestor
64782747|NCT04741620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782748|NCT04741620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782749|NCT04741620|Anticoagulants|anticoagulants|mesh-ancestor
64782750|NCT04741620|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64782751|NCT04741620|Chelating Agents|chelating agents|mesh-ancestor
64782752|NCT04741620|Sequestering Agents|sequestering agents|mesh-ancestor
64782753|NCT04741620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866427|NCT01800357|Sensory System Agents|sensory system agents|mesh-ancestor
64866428|NCT01800357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782754|NCT04741620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64866429|NCT01800357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866430|NCT01800357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64866431|NCT01800357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64866432|NCT01800357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64365766|NCT02455609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64782755|NCT04741620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782756|NCT04741620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64866433|NCT01800357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64866434|NCT01800357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866435|NCT01800357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64866436|NCT01800357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64866437|NCT01800357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866438|NCT01800357|Antipyretics|antipyretics|mesh-ancestor
64866439|NCT01800357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64866440|NCT01800357|Immunologic Factors|immunologic factors|mesh-ancestor
64866441|NCT01800396|Caseins|caseins|mesh-list
64866442|NCT01800396|Chelating Agents|chelating agents|mesh-ancestor
64782757|NCT04741620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782758|NCT04741620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64782759|NCT04741620|Protective Agents|protective agents|mesh-ancestor
64782760|NCT02721732|Pembrolizumab|pembrolizumab|mesh-list
64782761|NCT02721732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64782762|NCT02721732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782763|NCT01785420|Trastuzumab|trastuzumab|mesh-list
64782764|NCT01785420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64782765|NCT01785420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394153|NCT02393599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64394154|NCT02393599|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64394155|NCT02393599|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64394158|NCT02393599|Dopamine Agents|dopamine agents|mesh-ancestor
64782775|NCT00800514|Amantadine|amantadine|mesh-list
64782776|NCT00800514|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64333226|NCT02200757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333227|NCT02200757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333228|NCT02200757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333229|NCT05374057|Ibuprofen|ibuprofen|mesh-list
64333230|NCT05374057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64333231|NCT05374057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64333232|NCT05374057|Analgesics|analgesics|mesh-ancestor
64333233|NCT05374057|Sensory System Agents|sensory system agents|mesh-ancestor
64333234|NCT05374057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64333235|NCT05374057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333236|NCT05374057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64782777|NCT00800514|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64782778|NCT00800514|Antiviral Agents|antiviral agents|mesh-ancestor
64333237|NCT05374057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64333238|NCT05374057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64333239|NCT05374057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333240|NCT05374057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866444|NCT01800396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866445|NCT01800422|Progesterone|progesterone|mesh-list
64866446|NCT01800422|Progestins|progestins|mesh-ancestor
64866447|NCT01800422|Hormones|hormones|mesh-ancestor
64866448|NCT01800422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64866449|NCT01800422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866450|NCT01800435|Tranexamic Acid|tranexamic acid|mesh-list
64866455|NCT01800435|Hemostatics|hemostatics|mesh-ancestor
64782779|NCT00800514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64782780|NCT00800514|Dopamine Agents|dopamine agents|mesh-ancestor
64782781|NCT00800514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64782782|NCT00800514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782783|NCT00800514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782784|NCT00800514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64782785|NCT00800514|Analgesics|analgesics|mesh-ancestor
64782786|NCT00800514|Sensory System Agents|sensory system agents|mesh-ancestor
64782787|NCT00800514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782788|NCT02780622|Oseltamivir|oseltamivir|mesh-list
64782789|NCT02780622|Warfarin|warfarin|mesh-list
64782790|NCT02780622|Anticoagulants|anticoagulants|mesh-ancestor
64782791|NCT02780622|Antiviral Agents|antiviral agents|mesh-ancestor
64782792|NCT02780622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64782793|NCT02780622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782794|NCT02780622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782795|NCT02791308|Pimecrolimus|pimecrolimus|mesh-list
64782796|NCT02791308|Tacrolimus|tacrolimus|mesh-list
64782797|NCT02791308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64782798|NCT02791308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64394186|NCT02393443|Oxytocics|oxytocics|mesh-ancestor
64394187|NCT02393443|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64394188|NCT02393443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304682|NCT04433156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64304683|NCT04433156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64866459|NCT01800487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866460|NCT01800487|Protective Agents|protective agents|mesh-ancestor
64866461|NCT01800487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866462|NCT01800526|Acetylcysteine|acetylcysteine|mesh-list
64866463|NCT01800526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64866464|NCT01800526|Antiviral Agents|antiviral agents|mesh-ancestor
64866465|NCT01800526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64866466|NCT01800526|Expectorants|expectorants|mesh-ancestor
64295875|NCT02058199|Protease Inhibitors|protease inhibitors|mesh-ancestor
64304684|NCT04433156|Alkylating Agents|alkylating agents|mesh-ancestor
64304685|NCT04433156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304686|NCT04433156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304687|NCT04433156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64304688|NCT04433156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64304689|NCT04433156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64304690|NCT04433156|Glucocorticoids|glucocorticoids|mesh-ancestor
64304692|NCT04433156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64304693|NCT04433156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64304694|NCT04433156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64365821|NCT03517969|Carboplatin|carboplatin|mesh-list
64782807|NCT02791308|Immunologic Factors|immunologic factors|mesh-ancestor
64782808|NCT02791308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64782809|NCT02791308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782810|NCT02791308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782811|NCT02796144|Metformin|metformin|mesh-list
64782812|NCT02796144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64782813|NCT02796144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782814|NCT02801370|Ciprofloxacin|ciprofloxacin|mesh-list
64782815|NCT02801370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64782816|NCT02801370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64866467|NCT01800526|Respiratory System Agents|respiratory system agents|mesh-ancestor
64866468|NCT01800526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64866469|NCT01800526|Antioxidants|antioxidants|mesh-ancestor
64866470|NCT01800526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866471|NCT01800526|Protective Agents|protective agents|mesh-ancestor
64866472|NCT01800526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866473|NCT01800526|Antidotes|antidotes|mesh-ancestor
64866474|NCT01800630|Gemcitabine|gemcitabine|mesh-list
64866475|NCT01800630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64866476|NCT01800630|Antimetabolites|antimetabolites|mesh-ancestor
64866477|NCT01800630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866478|NCT01800630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866479|NCT01800630|Antiviral Agents|antiviral agents|mesh-ancestor
64333242|NCT02208791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64333243|NCT02208791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64333244|NCT02208791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64782817|NCT02801370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64782818|NCT02801370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64782819|NCT02801370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782820|NCT02801370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782821|NCT02801370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782822|NCT02801370|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64782823|NCT02801370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64782824|NCT02813070|Flutemetamol|flutemetamol|mesh-list
64782825|NCT02813070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64866480|NCT01800630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64866481|NCT01800630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866482|NCT01800630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64866483|NCT01800630|Immunologic Factors|immunologic factors|mesh-ancestor
64394216|NCT02003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394217|NCT04649398|Nimodipine|nimodipine|mesh-list
64394218|NCT04649398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64394225|NCT02402179|Tryptophan|tryptophan|mesh-list
64782826|NCT02813070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782827|NCT02815644|Empagliflozin|empagliflozin|mesh-list
64782828|NCT02815644|Linagliptin|linagliptin|mesh-list
64782829|NCT02815644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64782830|NCT02815644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782831|NCT02815644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64782832|NCT02815644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782833|NCT02815644|Incretins|incretins|mesh-ancestor
64866484|NCT01800630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866485|NCT01800643|Busulfan|busulfan|mesh-list
64866486|NCT01800643|Alkylating Agents|alkylating agents|mesh-ancestor
64866487|NCT01800643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782834|NCT02815644|Hormones|hormones|mesh-ancestor
64866488|NCT01800643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64866489|NCT01800643|Immunologic Factors|immunologic factors|mesh-ancestor
64866490|NCT01800643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866491|NCT01800643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64866492|NCT01800643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866493|NCT01800643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64866494|NCT01800695|Temozolomide|temozolomide|mesh-list
64333245|NCT02208791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333246|NCT02208791|Antifungal Agents|antifungal agents|mesh-ancestor
64333247|NCT02208791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64333248|NCT02208791|Immunologic Factors|immunologic factors|mesh-ancestor
64333249|NCT02208791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333250|NCT05223101|Telmisartan|telmisartan|mesh-list
64866495|NCT01800695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64866496|NCT01800695|Alkylating Agents|alkylating agents|mesh-ancestor
64866497|NCT01800695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782835|NCT02815644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64782836|NCT02815644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64782837|NCT02815644|Protease Inhibitors|protease inhibitors|mesh-ancestor
64782838|NCT02815644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782839|NCT02820324|Morphine|morphine|mesh-list
64782840|NCT02820324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64782841|NCT02820324|Narcotics|narcotics|mesh-ancestor
64782842|NCT02820324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64782843|NCT02820324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782844|NCT02820324|Analgesics|analgesics|mesh-ancestor
64782845|NCT02820324|Sensory System Agents|sensory system agents|mesh-ancestor
64782846|NCT02820324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64866498|NCT01800695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782847|NCT02821338|Lamotrigine|lamotrigine|mesh-list
64782848|NCT02821338|Anticonvulsants|anticonvulsants|mesh-ancestor
64782849|NCT02821338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64782850|NCT02821338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64782851|NCT02821338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782852|NCT02821338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64782860|NCT02835846|Hormones|hormones|mesh-ancestor
64782871|NCT02844582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782873|NCT02845752|Tiotropium Bromide|tiotropium bromide|mesh-list
64782874|NCT02845752|Olodaterol|olodaterol|mesh-list
64782875|NCT02845752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64782876|NCT02845752|Autonomic Agents|autonomic agents|mesh-ancestor
64782877|NCT02845752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782878|NCT02845752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782879|NCT02845752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64782880|NCT02845752|Respiratory System Agents|respiratory system agents|mesh-ancestor
64782881|NCT02845752|Parasympatholytics|parasympatholytics|mesh-ancestor
64782882|NCT02845752|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64782883|NCT02845752|Cholinergic Agents|cholinergic agents|mesh-ancestor
64782884|NCT02845752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64782885|NCT02845752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782886|NCT02845752|Anticonvulsants|anticonvulsants|mesh-ancestor
64782887|NCT02849184|Suvorexant|suvorexant|mesh-list
64782888|NCT02849184|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64782889|NCT02849184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64782890|NCT02849184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64866500|NCT01800708|Triamcinolone|triamcinolone|mesh-list
64866501|NCT01800708|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64866502|NCT01800708|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64866503|NCT01800708|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64866504|NCT01800708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64333251|NCT05223101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64333252|NCT05223101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64333253|NCT05223101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64333254|NCT05223101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333255|NCT02852057|Timolol|timolol|mesh-list
64333256|NCT02852057|Dorzolamide|dorzolamide|mesh-list
64333257|NCT02852057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866505|NCT01800708|Glucocorticoids|glucocorticoids|mesh-ancestor
64866507|NCT01800708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64866508|NCT01800708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782891|NCT02849184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782892|NCT02849184|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64782893|NCT02849184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64782894|NCT02849184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782895|NCT02862912|Fentanyl|fentanyl|mesh-list
64782896|NCT02862912|Bupivacaine|bupivacaine|mesh-list
64394289|NCT03106363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64394290|NCT03106363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64394291|NCT03106363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64782897|NCT02862912|Chloroprocaine|chloroprocaine|mesh-list
64782898|NCT02862912|Anesthetics, Local|anesthetics, local|mesh-ancestor
64782899|NCT02862912|Anesthetics|anesthetics|mesh-ancestor
64782900|NCT02862912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64782901|NCT02862912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782902|NCT02862912|Sensory System Agents|sensory system agents|mesh-ancestor
64782903|NCT02862912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782904|NCT02862912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64782905|NCT02862912|Narcotics|narcotics|mesh-ancestor
64782906|NCT02862912|Analgesics|analgesics|mesh-ancestor
64782907|NCT02862912|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64782908|NCT02862912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64782909|NCT02862912|Anesthetics, General|anesthetics, general|mesh-ancestor
64782910|NCT02864706|Cyclosporine|cyclosporine|mesh-list
64782911|NCT02864706|Mycophenolic Acid|mycophenolic acid|mesh-list
64782912|NCT02864706|Everolimus|everolimus|mesh-list
64782913|NCT02864706|Cyclosporins|cyclosporins|mesh-list
64782914|NCT02864706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782915|NCT02864706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782916|NCT02864706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64782917|NCT02864706|Immunologic Factors|immunologic factors|mesh-ancestor
64782918|NCT02864706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782919|NCT02864706|Antifungal Agents|antifungal agents|mesh-ancestor
64866509|NCT01800708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64782920|NCT02864706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64782921|NCT02864706|Dermatologic Agents|dermatologic agents|mesh-ancestor
64782922|NCT02864706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64782923|NCT02864706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64782924|NCT02864706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782925|NCT02864706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64782926|NCT02864706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64782927|NCT02864706|Antitubercular Agents|antitubercular agents|mesh-ancestor
64324306|NCT02264041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782931|NCT02865720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64782932|NCT02865720|Immunologic Factors|immunologic factors|mesh-ancestor
64782933|NCT02865720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782934|NCT02867202|Contraceptive Agents|contraceptive agents|mesh-list
64782935|NCT02867202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64782936|NCT02867202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782937|NCT02874846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64782938|NCT02874846|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64782939|NCT02880228|Dexamethasone|dexamethasone|mesh-list
64782940|NCT02880228|Dexamethasone acetate|dexamethasone acetate|mesh-list
64782941|NCT02880228|Pembrolizumab|pembrolizumab|mesh-list
64333282|NCT03524833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333284|NCT02220647|Linagliptin|linagliptin|mesh-list
64333285|NCT02220647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64333286|NCT02220647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333291|NCT02220647|Protease Inhibitors|protease inhibitors|mesh-ancestor
64333292|NCT02220647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333293|NCT02220647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333294|NCT05426395|Vitamins|vitamins|mesh-list
64782942|NCT02880228|Lenalidomide|lenalidomide|mesh-list
64782943|NCT02880228|Ichthammol|ichthammol|mesh-list
64782944|NCT02880228|BB 1101|bb 1101|mesh-list
64333295|NCT05426395|Hydroxocobalamin|hydroxocobalamin|mesh-list
64333296|NCT05426395|Vitamin B 12|vitamin b 12|mesh-list
64333297|NCT05426395|Vitamin B Complex|vitamin b complex|mesh-list
64333298|NCT05426395|Micronutrients|micronutrients|mesh-ancestor
64866518|NCT01800799|Celecoxib|celecoxib|mesh-list
64866519|NCT01800799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64866520|NCT01800799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64866521|NCT01800799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64866522|NCT01800799|Analgesics|analgesics|mesh-ancestor
64866523|NCT01800799|Sensory System Agents|sensory system agents|mesh-ancestor
64866524|NCT01800799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64866525|NCT01800799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782945|NCT02880228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64782946|NCT02880228|Antiemetics|antiemetics|mesh-ancestor
64782947|NCT02880228|Autonomic Agents|autonomic agents|mesh-ancestor
64782948|NCT02880228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782949|NCT02880228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782950|NCT02880228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64782951|NCT02880228|Glucocorticoids|glucocorticoids|mesh-ancestor
64782952|NCT02880228|Hormones|hormones|mesh-ancestor
64782953|NCT02880228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64782954|NCT02880228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64782955|NCT02880228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64782956|NCT02880228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64394346|NCT01958476|Antitussive Agents|antitussive agents|mesh-ancestor
64333299|NCT05426395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333301|NCT03544567|Paclitaxel|paclitaxel|mesh-list
64333302|NCT03544567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64333303|NCT03544567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866526|NCT01800799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64866527|NCT01800799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64866528|NCT01800799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64866529|NCT01800799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866530|NCT01800799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866531|NCT01800825|Clindamycin|clindamycin|mesh-list
64394347|NCT01958476|Respiratory System Agents|respiratory system agents|mesh-ancestor
64394348|NCT01958476|Anticonvulsants|anticonvulsants|mesh-ancestor
64394349|NCT01958476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64366179|NCT02454751|Fentanyl|fentanyl|mesh-list
64394351|NCT01958476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64394352|NCT01958476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64782957|NCT02880228|Immunologic Factors|immunologic factors|mesh-ancestor
64782958|NCT02880228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64782959|NCT02880228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64782960|NCT02880228|Growth Substances|growth substances|mesh-ancestor
64782961|NCT02880228|Growth Inhibitors|growth inhibitors|mesh-ancestor
64782962|NCT02880228|Protease Inhibitors|protease inhibitors|mesh-ancestor
64782963|NCT02880228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64782964|NCT02880228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64782965|NCT02880228|Dermatologic Agents|dermatologic agents|mesh-ancestor
64782966|NCT02880852|Belimumab|belimumab|mesh-list
64782967|NCT02880852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64782968|NCT02880852|Immunologic Factors|immunologic factors|mesh-ancestor
64782969|NCT02880852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782970|NCT02881008|Entecavir|entecavir|mesh-list
64782971|NCT02881008|Antiviral Agents|antiviral agents|mesh-ancestor
64782972|NCT02881008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64782973|NCT02887404|Analgesics|analgesics|mesh-list
64782974|NCT02887404|Sensory System Agents|sensory system agents|mesh-ancestor
64782975|NCT02887404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782976|NCT02887404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782977|NCT02889510|Liraglutide|liraglutide|mesh-list
64782978|NCT02889510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64782979|NCT02889510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333304|NCT03544567|Tubulin Modulators|tubulin modulators|mesh-ancestor
64333305|NCT03544567|Antimitotic Agents|antimitotic agents|mesh-ancestor
64333306|NCT03544567|Mitosis Modulators|mitosis modulators|mesh-ancestor
64333307|NCT03544567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866532|NCT01800825|Clindamycin palmitate|clindamycin palmitate|mesh-list
64866533|NCT01800825|Clindamycin phosphate|clindamycin phosphate|mesh-list
64866534|NCT01800825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64866535|NCT01800825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64866536|NCT01800825|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64866537|NCT01800825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866538|NCT01800825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866539|NCT01800942|Azithromycin|azithromycin|mesh-list
64866540|NCT01800942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64866542|NCT01801046|Cytarabine|cytarabine|mesh-list
64782980|NCT02889510|Incretins|incretins|mesh-ancestor
64782981|NCT02889510|Hormones|hormones|mesh-ancestor
64782982|NCT02889510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64782983|NCT02902770|Ketorolac|ketorolac|mesh-list
64782984|NCT02902770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64782985|NCT02902770|Lidocaine|lidocaine|mesh-list
64782986|NCT02902770|Anesthetics, Local|anesthetics, local|mesh-ancestor
64394380|NCT02695537|Cannabidiol|cannabidiol|mesh-list
64782987|NCT02902770|Anesthetics|anesthetics|mesh-ancestor
64782988|NCT02902770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64782989|NCT02902770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64782990|NCT02902770|Sensory System Agents|sensory system agents|mesh-ancestor
64782991|NCT02902770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64782992|NCT02902770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64866573|NCT01801228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866574|NCT01801228|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64782993|NCT02902770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64782994|NCT02902770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64304695|NCT04433156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64304696|NCT04433156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64866575|NCT01801228|Diuretics|diuretics|mesh-ancestor
64866576|NCT01801228|Natriuretic Agents|natriuretic agents|mesh-ancestor
64866577|NCT01801228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64866578|NCT01801410|Misoprostol|misoprostol|mesh-list
64866579|NCT01801410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64866580|NCT01801410|Abortifacient Agents|abortifacient agents|mesh-ancestor
64866581|NCT01801410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64866582|NCT01801410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866583|NCT01801410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64866584|NCT01801410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64866585|NCT01801410|Oxytocics|oxytocics|mesh-ancestor
64866586|NCT01801423|Hydroxyurea|hydroxyurea|mesh-list
64866587|NCT01801423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866588|NCT01801423|Antisickling Agents|antisickling agents|mesh-ancestor
64866589|NCT01801423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295896|NCT03314025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64295897|NCT03314025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295898|NCT03314025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295899|NCT03314025|Urological Agents|urological agents|mesh-ancestor
64295900|NCT02055079|Sirolimus|sirolimus|mesh-list
64295901|NCT02055079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64295902|NCT02055079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64304697|NCT04433156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304698|NCT02831855|Methotrexate|methotrexate|mesh-list
64304699|NCT02831855|Tofacitinib|tofacitinib|mesh-list
64782997|NCT02902770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64782999|NCT02902770|Analgesics|analgesics|mesh-ancestor
64866591|NCT01801423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64866592|NCT01801644|Gemcitabine|gemcitabine|mesh-list
64866593|NCT01801644|Cisplatin|cisplatin|mesh-list
64866594|NCT01801644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866595|NCT01801644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64866596|NCT01801644|Antimetabolites|antimetabolites|mesh-ancestor
64866597|NCT01801644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866598|NCT01801644|Antiviral Agents|antiviral agents|mesh-ancestor
64635193|NCT00005578|Glucocorticoids|glucocorticoids|mesh-ancestor
64783000|NCT02902770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64783001|NCT02902770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64783002|NCT02902770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64783003|NCT02902770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64783004|NCT02907918|Trastuzumab|trastuzumab|mesh-list
64783005|NCT02907918|Letrozole|letrozole|mesh-list
64783006|NCT02907918|Palbociclib|palbociclib|mesh-list
64783007|NCT02907918|Goserelin|goserelin|mesh-list
64783008|NCT02907918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64783009|NCT02907918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64783010|NCT02907918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64783011|NCT02907918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64783012|NCT02907918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64783013|NCT02907918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783014|NCT02907918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64783015|NCT02907918|Hormone Antagonists|hormone antagonists|mesh-ancestor
64783016|NCT02907918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64783017|NCT02907918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783018|NCT02907918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64783019|NCT02907918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64394404|NCT04746989|Antioxidants|antioxidants|mesh-ancestor
64394405|NCT04746989|Protective Agents|protective agents|mesh-ancestor
64783022|NCT02908620|Benzocaine|benzocaine|mesh-list
64783023|NCT02908620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64783024|NCT02908620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783025|NCT02908620|Anesthetics, Local|anesthetics, local|mesh-ancestor
64783026|NCT02908620|Sensory System Agents|sensory system agents|mesh-ancestor
64783027|NCT02908620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783028|NCT02911818|Liraglutide|liraglutide|mesh-list
64783029|NCT02911818|Phentermine|phentermine|mesh-list
64783030|NCT02911818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64783031|NCT02911818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783032|NCT02911818|Incretins|incretins|mesh-ancestor
64783033|NCT02911818|Hormones|hormones|mesh-ancestor
64783034|NCT02911818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64783035|NCT02911818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64783036|NCT02911818|Appetite Depressants|appetite depressants|mesh-ancestor
64783037|NCT02911818|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64333313|NCT02209025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64333314|NCT02209025|Respiratory System Agents|respiratory system agents|mesh-ancestor
64333315|NCT02209025|Vasodilator Agents|vasodilator agents|mesh-ancestor
64333316|NCT02220803|Acetazolamide|acetazolamide|mesh-list
64333317|NCT02220803|Anticonvulsants|anticonvulsants|mesh-ancestor
64866599|NCT01801644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64866600|NCT01801644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866601|NCT01801644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64783038|NCT02911818|Sympathomimetics|sympathomimetics|mesh-ancestor
64866602|NCT01801644|Immunologic Factors|immunologic factors|mesh-ancestor
64866603|NCT01801644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866604|NCT01801774|Triamcinolone|triamcinolone|mesh-list
64783039|NCT02911818|Autonomic Agents|autonomic agents|mesh-ancestor
64866605|NCT01801774|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64866606|NCT01801774|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64866607|NCT01801774|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64866608|NCT01801774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64866609|NCT01801774|Glucocorticoids|glucocorticoids|mesh-ancestor
64866610|NCT01801774|Hormones|hormones|mesh-ancestor
64783040|NCT02911818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783041|NCT02911818|Adrenergic Agents|adrenergic agents|mesh-ancestor
64783042|NCT02911818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64394439|NCT04585061|Anesthetics|anesthetics|mesh-ancestor
64394440|NCT04585061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64394441|NCT04585061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394442|NCT04585061|Sensory System Agents|sensory system agents|mesh-ancestor
64394443|NCT04585061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64394444|NCT04585061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64394445|NCT04585061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64394446|NCT04585061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64394447|NCT04585061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64866611|NCT01801774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64866612|NCT01801774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866613|NCT01801774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64866614|NCT01801774|Immunologic Factors|immunologic factors|mesh-ancestor
64866615|NCT01801774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866616|NCT01801774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866617|NCT01802255|Midazolam|midazolam|mesh-list
64866618|NCT01802255|Sevoflurane|sevoflurane|mesh-list
64866619|NCT01802255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64866620|NCT01802255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64866621|NCT01802255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64866622|NCT01802255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866623|NCT01802255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64866624|NCT01802255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64866625|NCT01802255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64866626|NCT01802255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64866627|NCT01802255|Anesthetics, General|anesthetics, general|mesh-ancestor
64866628|NCT01802255|Anesthetics|anesthetics|mesh-ancestor
64866629|NCT01802255|GABA Modulators|gaba modulators|mesh-ancestor
64866630|NCT01802255|GABA Agents|gaba agents|mesh-ancestor
64866631|NCT01802255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64866632|NCT01802255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866633|NCT01802255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64783047|NCT02912364|Antimanic Agents|antimanic agents|mesh-ancestor
64783048|NCT02912364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64783049|NCT02912364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64783050|NCT02912364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783051|NCT02912364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64783052|NCT02912364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64783053|NCT02912364|Analgesics|analgesics|mesh-ancestor
64783054|NCT02912364|Sensory System Agents|sensory system agents|mesh-ancestor
64783055|NCT02912364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783056|NCT02912364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64783057|NCT02912364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64783058|NCT02912364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783059|NCT02912364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64783060|NCT02912364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64783061|NCT02912364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64783062|NCT02913924|Clonazepam|clonazepam|mesh-list
64783063|NCT02913924|Anticonvulsants|anticonvulsants|mesh-ancestor
64783064|NCT02913924|GABA Modulators|gaba modulators|mesh-ancestor
64866634|NCT01802255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64783065|NCT02913924|GABA Agents|gaba agents|mesh-ancestor
64783066|NCT02913924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64866635|NCT01802268|Sirolimus|sirolimus|mesh-list
64866636|NCT01802268|Tacrolimus|tacrolimus|mesh-list
64333320|NCT02220803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333321|NCT02220803|Diuretics|diuretics|mesh-ancestor
64333322|NCT02220803|Natriuretic Agents|natriuretic agents|mesh-ancestor
64295903|NCT02055079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64295904|NCT02055079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295905|NCT02055079|Antifungal Agents|antifungal agents|mesh-ancestor
64295906|NCT02055079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64295907|NCT02055079|Immunologic Factors|immunologic factors|mesh-ancestor
64783067|NCT02913924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295908|NCT02055079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295909|NCT02470065|Afatinib|afatinib|mesh-list
64783068|NCT02913924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295910|NCT02470065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64783069|NCT02917122|Sertraline|sertraline|mesh-list
64394463|NCT03874091|Epinephrine|epinephrine|mesh-list
64394464|NCT03874091|Racepinephrine|racepinephrine|mesh-list
64866637|NCT01802268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64866638|NCT01802268|Immunologic Factors|immunologic factors|mesh-ancestor
64866639|NCT01802268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866640|NCT01802268|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64866641|NCT01802268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866642|NCT01802268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866643|NCT01802268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64866644|NCT01802268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64866645|NCT01802268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64866646|NCT01802268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866647|NCT01802268|Antifungal Agents|antifungal agents|mesh-ancestor
64866648|NCT01802450|Dasatinib|dasatinib|mesh-list
64866649|NCT01802450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866650|NCT01802450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64866651|NCT01802450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394465|NCT03874091|Morphine|morphine|mesh-list
64394466|NCT03874091|Bupivacaine|bupivacaine|mesh-list
64783070|NCT02917122|Antidepressive Agents|antidepressive agents|mesh-ancestor
64783071|NCT02917122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64783072|NCT02917122|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64783073|NCT02917122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64783074|NCT02917122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64783075|NCT02917122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783076|NCT02917122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64783077|NCT02917122|Serotonin Agents|serotonin agents|mesh-ancestor
64783078|NCT02917122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783079|NCT02922582|Tranexamic Acid|tranexamic acid|mesh-list
64783080|NCT02922582|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64866652|NCT01802450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783081|NCT02922582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64783082|NCT02922582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866653|NCT01802476|Palbociclib|palbociclib|mesh-list
64866654|NCT01802476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866655|NCT01802476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64783083|NCT02922582|Hemostatics|hemostatics|mesh-ancestor
64783084|NCT02922582|Coagulants|coagulants|mesh-ancestor
64783085|NCT02925858|Ketamine|ketamine|mesh-list
64783086|NCT02925858|Analgesics|analgesics|mesh-ancestor
64783087|NCT02925858|Sensory System Agents|sensory system agents|mesh-ancestor
64783088|NCT02925858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783089|NCT02925858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783090|NCT02925858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64783091|NCT02925858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64783092|NCT02925858|Anesthetics, General|anesthetics, general|mesh-ancestor
64783093|NCT02925858|Anesthetics|anesthetics|mesh-ancestor
64783094|NCT02925858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64394487|NCT03874091|Mydriatics|mydriatics|mesh-ancestor
64394488|NCT03874091|Sympathomimetics|sympathomimetics|mesh-ancestor
64394489|NCT03874091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64394490|NCT01362491|Ibuprofen|ibuprofen|mesh-list
64394491|NCT01362491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64394492|NCT01362491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64394493|NCT01362491|Analgesics|analgesics|mesh-ancestor
64394494|NCT01362491|Sensory System Agents|sensory system agents|mesh-ancestor
64394495|NCT01362491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64394496|NCT01362491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866656|NCT01802476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866657|NCT01802476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866658|NCT01802489|Amiloride|amiloride|mesh-list
64866659|NCT01802489|Diuretics|diuretics|mesh-ancestor
64866660|NCT01802489|Natriuretic Agents|natriuretic agents|mesh-ancestor
64866661|NCT01802489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866662|NCT01802489|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
64866663|NCT01802489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64866664|NCT01802489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64866665|NCT01802489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866666|NCT01802489|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64866667|NCT01802489|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64304722|NCT01356407|Cathartics|cathartics|mesh-ancestor
64866668|NCT01802502|Rifampin|rifampin|mesh-list
64866669|NCT01802502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64866670|NCT01802502|Antitubercular Agents|antitubercular agents|mesh-ancestor
64866671|NCT01802502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64866672|NCT01802502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64866673|NCT01802502|Leprostatic Agents|leprostatic agents|mesh-ancestor
64866674|NCT01802502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64304723|NCT01356407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64304724|NCT05289323|Neostigmine|neostigmine|mesh-list
64394498|NCT01362491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64783095|NCT02925858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64783096|NCT02925858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64783097|NCT02925858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64783098|NCT02925858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783099|NCT02933034|Manganese|manganese|mesh-list
64783100|NCT02933034|Trace Elements|trace elements|mesh-ancestor
64783101|NCT02933034|Micronutrients|micronutrients|mesh-ancestor
64783102|NCT02933034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783103|NCT02937168|Reslizumab|reslizumab|mesh-list
64783104|NCT02937168|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64783105|NCT02937168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64783106|NCT02937168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783107|NCT02937168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64783108|NCT02937168|Respiratory System Agents|respiratory system agents|mesh-ancestor
64783109|NCT02937558|Glucagon|glucagon|mesh-list
64783110|NCT02937558|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64783111|NCT02937558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64783112|NCT02937558|Hormones|hormones|mesh-ancestor
64783113|NCT02937558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64783114|NCT02937558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783115|NCT02937558|Incretins|incretins|mesh-ancestor
64783116|NCT02938494|Tazarotene|tazarotene|mesh-list
64783117|NCT02938494|Dermatologic Agents|dermatologic agents|mesh-ancestor
64866675|NCT01802502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866676|NCT01802502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866677|NCT01802502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64866678|NCT01802502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64866679|NCT01802502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64866680|NCT01802502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64866681|NCT01802502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64866682|NCT01802502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64866683|NCT01802593|Methotrexate|methotrexate|mesh-list
64866684|NCT01802593|Mercaptopurine|mercaptopurine|mesh-list
64866685|NCT01802593|Azathioprine|azathioprine|mesh-list
64783118|NCT02938494|Keratolytic Agents|keratolytic agents|mesh-ancestor
64783119|NCT02941692|Oxytocin|oxytocin|mesh-list
64394513|NCT03560297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394514|NCT04965389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64394515|NCT04122287|Levofloxacin|levofloxacin|mesh-list
64394516|NCT04122287|Ofloxacin|ofloxacin|mesh-list
64394517|NCT04122287|Tinidazole|tinidazole|mesh-list
64394518|NCT04122287|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64394519|NCT04122287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64394520|NCT04122287|Renal Agents|renal agents|mesh-ancestor
64394521|NCT04122287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64783120|NCT02941692|Oxytocics|oxytocics|mesh-ancestor
64783121|NCT02941692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64783122|NCT02941692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783123|NCT02953860|Fulvestrant|fulvestrant|mesh-list
64783124|NCT02953860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64783125|NCT02953860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64783126|NCT02953860|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64783127|NCT02953860|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64783128|NCT02953860|Hormone Antagonists|hormone antagonists|mesh-ancestor
64783129|NCT02953860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64783130|NCT02953860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783131|NCT02956044|Metformin|metformin|mesh-list
64783132|NCT02956044|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64783133|NCT02956044|Glimepiride|glimepiride|mesh-list
64866721|NCT01802645|Oxaliplatin|oxaliplatin|mesh-list
64866722|NCT01802645|Irinotecan|irinotecan|mesh-list
64866723|NCT01802645|Levoleucovorin|levoleucovorin|mesh-list
64866724|NCT01802645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64866725|NCT01802645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866726|NCT01802645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64866727|NCT01802645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64866728|NCT01802645|Growth Substances|growth substances|mesh-ancestor
64866729|NCT01802645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866730|NCT01802645|Growth Inhibitors|growth inhibitors|mesh-ancestor
64866731|NCT01802645|Antimetabolites|antimetabolites|mesh-ancestor
64866732|NCT01802645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866733|NCT01802645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64866734|NCT01802645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64866735|NCT01802645|Immunologic Factors|immunologic factors|mesh-ancestor
64866736|NCT01802645|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64866737|NCT01802645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64866738|NCT01802645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866739|NCT01802645|Antidotes|antidotes|mesh-ancestor
64866740|NCT01802645|Protective Agents|protective agents|mesh-ancestor
64866741|NCT01802645|Vitamin B Complex|vitamin b complex|mesh-ancestor
64295911|NCT02470065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64295912|NCT02470065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295913|NCT02470065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295914|NCT03313869|Vitamin E|vitamin e|mesh-list
64295915|NCT03313869|Selenium|selenium|mesh-list
64295916|NCT03313869|Vitamins|vitamins|mesh-ancestor
64304725|NCT05289323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64304726|NCT05289323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304727|NCT05289323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304728|NCT05289323|Cholinergic Agents|cholinergic agents|mesh-ancestor
64783135|NCT02956044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64783136|NCT02956044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783137|NCT02956044|Incretins|incretins|mesh-ancestor
64783138|NCT02956044|Hormones|hormones|mesh-ancestor
64783139|NCT02956044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64783140|NCT02956044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64866742|NCT01802645|Vitamins|vitamins|mesh-ancestor
64866743|NCT01802645|Micronutrients|micronutrients|mesh-ancestor
64783141|NCT02956044|Protease Inhibitors|protease inhibitors|mesh-ancestor
64783142|NCT02956044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866744|NCT01802645|Hematinics|hematinics|mesh-ancestor
64866745|NCT01802658|Zoledronic Acid|zoledronic acid|mesh-list
64866746|NCT01802658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64866747|NCT01802658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866748|NCT01802684|Aflibercept|aflibercept|mesh-list
64866749|NCT01802684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64866750|NCT01802684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64866751|NCT01802684|Growth Substances|growth substances|mesh-ancestor
64866752|NCT01802684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866753|NCT01802684|Growth Inhibitors|growth inhibitors|mesh-ancestor
64866754|NCT01802684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333323|NCT02220803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333324|NCT04972123|Phenylephrine|phenylephrine|mesh-list
64333325|NCT04972123|Oxymetazoline|oxymetazoline|mesh-list
64333326|NCT04972123|Caffeine|caffeine|mesh-list
64333327|NCT04972123|Capsaicin|capsaicin|mesh-list
64333328|NCT04972123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64333329|NCT04972123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333330|NCT04972123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64333331|NCT04972123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866756|NCT01802814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64783143|NCT02956044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783144|NCT02956044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64783145|NCT02956044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64783146|NCT02956044|Immunologic Factors|immunologic factors|mesh-ancestor
64783147|NCT02956122|Methylprednisolone|methylprednisolone|mesh-list
64783148|NCT02956122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64394538|NCT05746351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394539|NCT05746351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64394540|NCT05746351|Analgesics|analgesics|mesh-ancestor
64866757|NCT01802814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866758|NCT01802892|Plerixafor|plerixafor|mesh-list
64866759|NCT01802892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64866760|NCT01802892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64866761|NCT01802892|Antiviral Agents|antiviral agents|mesh-ancestor
64866762|NCT01802892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64866763|NCT01802918|Ritonavir|ritonavir|mesh-list
64866764|NCT01802918|GSK-2838232|gsk-2838232|mesh-list
64866765|NCT01802918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64866766|NCT01802918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64866767|NCT01802918|Protease Inhibitors|protease inhibitors|mesh-ancestor
64866768|NCT01802918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333332|NCT04972123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333333|NCT04972123|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64333334|NCT04972123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64333335|NCT04972123|Purinergic Agents|purinergic agents|mesh-ancestor
64866770|NCT01802918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64866771|NCT01802918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64866772|NCT01802918|Antiviral Agents|antiviral agents|mesh-ancestor
64866773|NCT01802918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64866774|NCT01802918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64394541|NCT05746351|Sensory System Agents|sensory system agents|mesh-ancestor
64394542|NCT05746351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783149|NCT02956122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64783150|NCT02956122|Prednisolone|prednisolone|mesh-list
64783151|NCT02956122|Prednisolone acetate|prednisolone acetate|mesh-list
64783152|NCT02956122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64783153|NCT02956122|Prednisolone phosphate|prednisolone phosphate|mesh-list
64783154|NCT02956122|Protease Inhibitors|protease inhibitors|mesh-list
64783155|NCT02956122|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64783156|NCT02956122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64783158|NCT02956122|Autonomic Agents|autonomic agents|mesh-ancestor
64783159|NCT02956122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783160|NCT02956122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783161|NCT02956122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64783162|NCT02956122|Glucocorticoids|glucocorticoids|mesh-ancestor
64783163|NCT02956122|Hormones|hormones|mesh-ancestor
64783164|NCT02956122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64783165|NCT02956122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64866775|NCT01802918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64866776|NCT01802931|Ketoconazole|ketoconazole|mesh-list
64866777|NCT01802931|Antifungal Agents|antifungal agents|mesh-ancestor
64866778|NCT01802931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64866779|NCT01802931|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64866780|NCT01802931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64866781|NCT01802931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866782|NCT01802931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866783|NCT01802931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64866784|NCT01802931|Hormone Antagonists|hormone antagonists|mesh-ancestor
64866785|NCT01802931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64866786|NCT01802931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866787|NCT01802931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64783166|NCT02956122|Protective Agents|protective agents|mesh-ancestor
64783167|NCT02956122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64783168|NCT02956122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64783169|NCT02956122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64783170|NCT02956122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783171|NCT02956122|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64783172|NCT02956122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64783173|NCT02956746|Immunoglobulins|immunoglobulins|mesh-list
64783174|NCT02956746|Antibodies|antibodies|mesh-list
64783175|NCT02956746|gamma-Globulins|gamma-globulins|mesh-list
64783176|NCT02956746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64394569|NCT03115099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64783177|NCT02956746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64783178|NCT02956746|Immunologic Factors|immunologic factors|mesh-ancestor
64783179|NCT02956746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783180|NCT02967354|Tryptophan|tryptophan|mesh-list
64866789|NCT01802944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64866790|NCT01802944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866791|NCT01802970|Paclitaxel|paclitaxel|mesh-list
64866792|NCT01802970|Vinorelbine|vinorelbine|mesh-list
64866793|NCT01802970|Capecitabine|capecitabine|mesh-list
64866794|NCT01802970|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64866795|NCT01802970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64866796|NCT01802970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866797|NCT01802970|Tubulin Modulators|tubulin modulators|mesh-ancestor
64866798|NCT01802970|Antimitotic Agents|antimitotic agents|mesh-ancestor
64866799|NCT01802970|Mitosis Modulators|mitosis modulators|mesh-ancestor
64866800|NCT01802970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866801|NCT01802970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64866802|NCT01802970|Antimetabolites|antimetabolites|mesh-ancestor
64866803|NCT01802970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64866804|NCT01803087|Formoterol Fumarate|formoterol fumarate|mesh-list
64866805|NCT01803087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64333336|NCT04972123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64333337|NCT04972123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64333338|NCT04972123|Mydriatics|mydriatics|mesh-ancestor
64333339|NCT04972123|Autonomic Agents|autonomic agents|mesh-ancestor
64333340|NCT04972123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64333341|NCT04972123|Sympathomimetics|sympathomimetics|mesh-ancestor
64783181|NCT02967354|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
64783182|NCT02967354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64783183|NCT02967354|Antidepressive Agents|antidepressive agents|mesh-ancestor
64783184|NCT02967354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64783185|NCT02968134|Posaconazole|posaconazole|mesh-list
64783186|NCT02968134|Antifungal Agents|antifungal agents|mesh-ancestor
64783187|NCT02968134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64783188|NCT02968134|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64783189|NCT02968134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64783190|NCT02968134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64783191|NCT02968134|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64783192|NCT02968134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64783193|NCT02968134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383374|NCT05520021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64383375|NCT05520021|Anticonvulsants|anticonvulsants|mesh-ancestor
64866808|NCT01803087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866809|NCT01803087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64866810|NCT01803087|Respiratory System Agents|respiratory system agents|mesh-ancestor
64866811|NCT01803087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64866812|NCT01803087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64866813|NCT01803087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64866814|NCT01803087|Adrenergic Agents|adrenergic agents|mesh-ancestor
64866815|NCT01803087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64866816|NCT01803087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866817|NCT01803191|Ciprofloxacin|ciprofloxacin|mesh-list
64866818|NCT01803191|Fosfomycin|fosfomycin|mesh-list
64866819|NCT01803191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64866820|NCT01803191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64866821|NCT01803191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64866822|NCT01803191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64866823|NCT01803191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866824|NCT01803191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866825|NCT01803191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866826|NCT01803191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64333355|NCT02322892|Micronutrients|micronutrients|mesh-ancestor
64333356|NCT02322892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333357|NCT02322892|Vitamin B Complex|vitamin b complex|mesh-ancestor
64333358|NCT03274375|Rituximab|rituximab|mesh-list
64333359|NCT03274375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64383376|NCT05520021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64383377|NCT05520021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64383378|NCT05520021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383379|NCT05520021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64383380|NCT05520021|Tocolytic Agents|tocolytic agents|mesh-ancestor
64383381|NCT05520021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64383382|NCT05520021|Vasodilator Agents|vasodilator agents|mesh-ancestor
64783194|NCT02968134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783195|NCT02968134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64783196|NCT02968134|Hormone Antagonists|hormone antagonists|mesh-ancestor
64783197|NCT02968134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64783198|NCT02968134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783199|NCT02968368|Ferric maltol|ferric maltol|mesh-list
64783200|NCT02968368|Hematinics|hematinics|mesh-ancestor
64783201|NCT02968914|Benralizumab|benralizumab|mesh-list
64783202|NCT02968914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64783203|NCT02968914|Respiratory System Agents|respiratory system agents|mesh-ancestor
64783204|NCT02970162|Amifampridine|amifampridine|mesh-list
64783205|NCT02970162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64783206|NCT02970162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783207|NCT02970162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783208|NCT02970162|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64783209|NCT02970162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64783210|NCT02970162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783211|NCT02970552|Progesterone|progesterone|mesh-list
64783212|NCT02970552|Progestins|progestins|mesh-ancestor
64783213|NCT02970552|Hormones|hormones|mesh-ancestor
64783214|NCT02970552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64783215|NCT02970552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866837|NCT01803399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64866838|NCT01803399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866839|NCT01803399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866840|NCT01803399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866841|NCT01803438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64866842|NCT01803503|Docetaxel|docetaxel|mesh-list
64866843|NCT01803503|Sunitinib|sunitinib|mesh-list
64866844|NCT01803503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64783216|NCT02978508|Permethrin|permethrin|mesh-list
64866845|NCT01803503|Tubulin Modulators|tubulin modulators|mesh-ancestor
64866846|NCT01803503|Antimitotic Agents|antimitotic agents|mesh-ancestor
64866847|NCT01803503|Mitosis Modulators|mitosis modulators|mesh-ancestor
64866848|NCT01803503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866849|NCT01803503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64866850|NCT01803503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64333361|NCT03274375|Immunologic Factors|immunologic factors|mesh-ancestor
64333362|NCT03274375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783217|NCT02978508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64783218|NCT02978508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783219|NCT02988882|Dexamethasone|dexamethasone|mesh-list
64783220|NCT02988882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64783221|NCT02988882|Antiemetics|antiemetics|mesh-ancestor
64783222|NCT02988882|Autonomic Agents|autonomic agents|mesh-ancestor
64783223|NCT02988882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783224|NCT02988882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783225|NCT02988882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64866851|NCT01803503|Growth Substances|growth substances|mesh-ancestor
64866852|NCT01803503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866853|NCT01803503|Growth Inhibitors|growth inhibitors|mesh-ancestor
64866854|NCT01803503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64866855|NCT01803503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866857|NCT01803659|Retinol palmitate|retinol palmitate|mesh-list
64866858|NCT01803659|Carotenoids|carotenoids|mesh-list
64866859|NCT01803659|Antioxidants|antioxidants|mesh-ancestor
64866860|NCT01803659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866861|NCT01803659|Protective Agents|protective agents|mesh-ancestor
64866862|NCT01803659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866863|NCT01803659|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64866864|NCT01803659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866865|NCT01803659|Vitamins|vitamins|mesh-ancestor
64866866|NCT01803659|Micronutrients|micronutrients|mesh-ancestor
64866867|NCT01803763|Omalizumab|omalizumab|mesh-list
64866868|NCT01803763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64866869|NCT01803763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64866870|NCT01803763|Respiratory System Agents|respiratory system agents|mesh-ancestor
64866871|NCT01803828|Tadalafil|tadalafil|mesh-list
64866872|NCT01803828|Vasodilator Agents|vasodilator agents|mesh-ancestor
64866873|NCT01803828|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64866874|NCT01803828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64866875|NCT01803828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866876|NCT01803828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866877|NCT01803828|Urological Agents|urological agents|mesh-ancestor
64866878|NCT01804127|Rituximab|rituximab|mesh-list
64783226|NCT02988882|Glucocorticoids|glucocorticoids|mesh-ancestor
64783227|NCT02988882|Hormones|hormones|mesh-ancestor
64783228|NCT02988882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64551828|NCT05070468|Antiemetics|antiemetics|mesh-ancestor
64783229|NCT02988882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64783230|NCT02988882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64783231|NCT03002454|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
64783232|NCT03002454|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
64783233|NCT03002454|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64783234|NCT03002454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783235|NCT03009162|Lasmiditan|lasmiditan|mesh-list
64783236|NCT03009162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64783237|NCT03009162|Serotonin Agents|serotonin agents|mesh-ancestor
64783238|NCT03009162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64783239|NCT03009162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783240|NCT03009162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783241|NCT03009396|Clarithromycin|clarithromycin|mesh-list
64783242|NCT03009396|Rifabutin|rifabutin|mesh-list
64783243|NCT03009396|Clofazimine|clofazimine|mesh-list
64783244|NCT03009396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64783245|NCT03009396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64783246|NCT03009396|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64866892|NCT01804205|Anticonvulsants|anticonvulsants|mesh-ancestor
64866893|NCT01804205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64866894|NCT01804205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64866895|NCT01804205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866896|NCT01804205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64866897|NCT01804205|Tocolytic Agents|tocolytic agents|mesh-ancestor
64866898|NCT01804205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64866899|NCT01804218|Nadolol|nadolol|mesh-list
64866900|NCT01804218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64866901|NCT01804218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64866902|NCT01804218|Adrenergic Agents|adrenergic agents|mesh-ancestor
64866903|NCT01804218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64333363|NCT03274375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64333365|NCT03250117|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64333366|NCT03250117|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64333367|NCT03250117|Dopamine Agonists|dopamine agonists|mesh-ancestor
64333368|NCT03250117|Dopamine Agents|dopamine agents|mesh-ancestor
64333369|NCT03250117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64333370|NCT03250117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333371|NCT03250117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866904|NCT01804218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783247|NCT03009396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64783248|NCT03009396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783249|NCT03009396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64866913|NCT01804244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64783250|NCT03009396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64783252|NCT03009396|Antitubercular Agents|antitubercular agents|mesh-ancestor
64783253|NCT03009396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64783254|NCT03009396|Leprostatic Agents|leprostatic agents|mesh-ancestor
64783255|NCT03012594|Lanreotide|lanreotide|mesh-list
64783256|NCT03012594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64783257|NCT03017508|Riluzole|riluzole|mesh-list
64783258|NCT03017508|Anticonvulsants|anticonvulsants|mesh-ancestor
64783259|NCT03017508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64783260|NCT03017508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64866914|NCT01804244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866915|NCT01804244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866916|NCT01804244|Antiviral Agents|antiviral agents|mesh-ancestor
64866917|NCT01804244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64866918|NCT01804244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64866919|NCT01804244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64866920|NCT01804335|Trifarotene|trifarotene|mesh-list
64866921|NCT01804335|Dermatologic Agents|dermatologic agents|mesh-ancestor
64866922|NCT01804361|Cyclosporine|cyclosporine|mesh-list
64866923|NCT01804361|Cyclosporins|cyclosporins|mesh-list
64866924|NCT01804361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295918|NCT03313869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295920|NCT03313869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295921|NCT03313869|Protective Agents|protective agents|mesh-ancestor
64295922|NCT03313869|Trace Elements|trace elements|mesh-ancestor
64295923|NCT00705159|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64295924|NCT00705159|Tobramycin|tobramycin|mesh-list
64295925|NCT00705159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64783261|NCT03017508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64783262|NCT03017508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783263|NCT03017508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783264|NCT03017508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64783265|NCT03017508|Protective Agents|protective agents|mesh-ancestor
64783266|NCT03020004|Ritonavir|ritonavir|mesh-list
64783267|NCT03020004|Ribavirin|ribavirin|mesh-list
64783268|NCT03020004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64783269|NCT03020004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64783270|NCT03020004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64783271|NCT03020004|Protease Inhibitors|protease inhibitors|mesh-ancestor
64783272|NCT03020004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64783273|NCT03020004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783274|NCT03020004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64783275|NCT03020004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64783276|NCT03020004|Antiviral Agents|antiviral agents|mesh-ancestor
64783277|NCT03020004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64783278|NCT03020004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64394669|NCT05697055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64783279|NCT03020004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64783281|NCT03020082|Ritonavir|ritonavir|mesh-list
64783282|NCT03020082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64783283|NCT03020082|Ribavirin|ribavirin|mesh-list
64783284|NCT03020082|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64783285|NCT03020082|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64783286|NCT03020082|Protease Inhibitors|protease inhibitors|mesh-ancestor
64783287|NCT03020082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64783288|NCT03020082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866925|NCT01804361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866926|NCT01804361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64866927|NCT01804361|Immunologic Factors|immunologic factors|mesh-ancestor
64866928|NCT01804361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866929|NCT01804361|Antifungal Agents|antifungal agents|mesh-ancestor
64866930|NCT01804361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64866931|NCT01804361|Dermatologic Agents|dermatologic agents|mesh-ancestor
64866932|NCT01804361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64866933|NCT01804361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64866934|NCT01804374|Everolimus|everolimus|mesh-list
64866935|NCT01804374|Sorafenib|sorafenib|mesh-list
64866936|NCT01804374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866937|NCT01804374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64866938|NCT01804374|Immunologic Factors|immunologic factors|mesh-ancestor
64866939|NCT01804374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866940|NCT01804374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64866943|NCT01804387|Lamivudine|lamivudine|mesh-list
64783289|NCT03020082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64783290|NCT03020082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64783291|NCT03020082|Antiviral Agents|antiviral agents|mesh-ancestor
64783292|NCT03020082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64783293|NCT03020082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64783294|NCT03020082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64783295|NCT03020082|Antimetabolites|antimetabolites|mesh-ancestor
64783296|NCT03026556|Rivaroxaban|rivaroxaban|mesh-list
64783297|NCT03026556|Apixaban|apixaban|mesh-list
64783298|NCT03026556|Dabigatran|dabigatran|mesh-list
64783299|NCT03026556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64783300|NCT03026556|Antithrombins|antithrombins|mesh-ancestor
64783301|NCT03026556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64783302|NCT03026556|Protease Inhibitors|protease inhibitors|mesh-ancestor
64783303|NCT03026556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64783304|NCT03026556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783305|NCT03026556|Anticoagulants|anticoagulants|mesh-ancestor
64783307|NCT03035760|Anthelmintics|anthelmintics|mesh-ancestor
64783308|NCT03035760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64783309|NCT03035760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64783310|NCT03035760|Antinematodal Agents|antinematodal agents|mesh-ancestor
64783311|NCT03036384|Sufentanil|sufentanil|mesh-list
64394702|NCT01976806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64333375|NCT03088813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64333376|NCT03088813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333377|NCT03088813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333378|NCT03088813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333379|NCT02739997|Metronidazole|metronidazole|mesh-list
64333380|NCT02739997|Tazobactam|tazobactam|mesh-list
64333381|NCT02739997|Ceftolozane|ceftolozane|mesh-list
64333382|NCT02739997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64866946|NCT01804387|Telbivudine|telbivudine|mesh-list
64866947|NCT01804387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64394703|NCT01976806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394704|NCT01976806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64866948|NCT01804387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64866949|NCT01804387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866950|NCT01804387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866951|NCT01804387|Antiviral Agents|antiviral agents|mesh-ancestor
64866952|NCT01804387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64866953|NCT01804387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64866954|NCT01804387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64866955|NCT01804400|Montelukast|montelukast|mesh-list
64866956|NCT01804400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64866957|NCT01804400|Respiratory System Agents|respiratory system agents|mesh-ancestor
64783313|NCT03036384|Prilocaine|prilocaine|mesh-list
64783314|NCT03036384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64783315|NCT03036384|Narcotics|narcotics|mesh-ancestor
64783316|NCT03036384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64783317|NCT03036384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783318|NCT03036384|Analgesics|analgesics|mesh-ancestor
64783319|NCT03036384|Sensory System Agents|sensory system agents|mesh-ancestor
64783320|NCT03036384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783321|NCT03036384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64866968|NCT01804413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866969|NCT01804543|Ranolazine|ranolazine|mesh-list
64866970|NCT01804543|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64866971|NCT01804543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64866972|NCT01804543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866973|NCT01804595|Sunscreening Agents|sunscreening agents|mesh-list
64635567|NCT00030992|Antiemetics|antiemetics|mesh-ancestor
64866974|NCT01804595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64866975|NCT01804595|Protective Agents|protective agents|mesh-ancestor
64783322|NCT03036384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64783323|NCT03036384|Anesthetics, General|anesthetics, general|mesh-ancestor
64783324|NCT03036384|Anesthetics|anesthetics|mesh-ancestor
64866976|NCT01804595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866977|NCT01804595|Dermatologic Agents|dermatologic agents|mesh-ancestor
64866978|NCT01804712|Rituximab|rituximab|mesh-list
64866979|NCT01804712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64866980|NCT01804712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866981|NCT01804712|Immunologic Factors|immunologic factors|mesh-ancestor
64866982|NCT01804712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866983|NCT01804712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64866984|NCT01804777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64866985|NCT01804777|Amiloride|amiloride|mesh-list
64866986|NCT01804777|Diuretics|diuretics|mesh-ancestor
64866987|NCT01804777|Natriuretic Agents|natriuretic agents|mesh-ancestor
64783325|NCT03036384|Anesthetics, Local|anesthetics, local|mesh-ancestor
64783326|NCT03040362|Lasmiditan|lasmiditan|mesh-list
64783327|NCT03040362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64783328|NCT03040362|Serotonin Agents|serotonin agents|mesh-ancestor
64783329|NCT03040362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64783330|NCT03040362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783331|NCT03040362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783332|NCT03041298|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
64783333|NCT03041298|Chelating Agents|chelating agents|mesh-ancestor
64333383|NCT02739997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64333385|NCT02739997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64333386|NCT02739997|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64866988|NCT01804777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866989|NCT01804777|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
64866990|NCT01804777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64866991|NCT01804777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64866992|NCT01804777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866993|NCT01804777|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64866994|NCT01804777|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64866995|NCT01804777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64783334|NCT03041298|Sequestering Agents|sequestering agents|mesh-ancestor
64866996|NCT01804777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64866997|NCT01804985|Imatinib Mesylate|imatinib mesylate|mesh-list
64866998|NCT01804985|Dasatinib|dasatinib|mesh-list
64866999|NCT01804985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867000|NCT01804985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64867001|NCT01804985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867002|NCT01804985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867003|NCT01805115|Misoprostol|misoprostol|mesh-list
64867004|NCT01805115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64867005|NCT01805115|Abortifacient Agents|abortifacient agents|mesh-ancestor
64867006|NCT01805115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64867007|NCT01805115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867008|NCT01805115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64783335|NCT03041298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783336|NCT03044418|Propofol|propofol|mesh-list
64394731|NCT03165253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64783339|NCT03044418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783340|NCT03044418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64783341|NCT03044418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64783342|NCT03044418|Anesthetics, General|anesthetics, general|mesh-ancestor
64783343|NCT03048006|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
64783344|NCT03048006|Chelating Agents|chelating agents|mesh-ancestor
64867009|NCT01805115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64867010|NCT01805115|Oxytocics|oxytocics|mesh-ancestor
64867011|NCT01805232|Artesunate|artesunate|mesh-list
64867012|NCT01805232|Quinine|quinine|mesh-list
64867013|NCT01805232|Antimalarials|antimalarials|mesh-ancestor
64867014|NCT01805232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64867015|NCT01805232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64867016|NCT01805232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867017|NCT01805232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867018|NCT01805232|Antiviral Agents|antiviral agents|mesh-ancestor
64867019|NCT01805232|Schistosomicides|schistosomicides|mesh-ancestor
64867020|NCT01805232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64867021|NCT01805232|Anthelmintics|anthelmintics|mesh-ancestor
64867022|NCT01805232|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64867023|NCT01805232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867024|NCT01805232|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64867025|NCT01805232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64867026|NCT01805232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64867027|NCT01805232|Analgesics|analgesics|mesh-ancestor
64783345|NCT03048006|Sequestering Agents|sequestering agents|mesh-ancestor
64783346|NCT03048006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783347|NCT03051672|Pembrolizumab|pembrolizumab|mesh-list
64783348|NCT03051672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64783349|NCT03051672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64783350|NCT03057132|Protective Agents|protective agents|mesh-list
64783351|NCT03057132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783352|NCT03057366|Paclitaxel|paclitaxel|mesh-list
64783353|NCT03057366|Docetaxel|docetaxel|mesh-list
64783354|NCT03057366|Carboplatin|carboplatin|mesh-list
64783355|NCT03057366|Pevonedistat|pevonedistat|mesh-list
64867062|NCT01807767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64867063|NCT01807767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867064|NCT01807767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867065|NCT01807767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867066|NCT01807767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64867067|NCT01807767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64867068|NCT01807767|Antitubercular Agents|antitubercular agents|mesh-ancestor
64867069|NCT01807767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64867070|NCT01807767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867071|NCT01807832|Capsaicin|capsaicin|mesh-list
64867072|NCT01807832|Antipruritics|antipruritics|mesh-ancestor
64867073|NCT01807832|Dermatologic Agents|dermatologic agents|mesh-ancestor
64867074|NCT01807832|Sensory System Agents|sensory system agents|mesh-ancestor
64867077|NCT01807910|Choline|choline|mesh-list
64783356|NCT03057366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64783357|NCT03057366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64783358|NCT03057366|Tubulin Modulators|tubulin modulators|mesh-ancestor
64783359|NCT03057366|Antimitotic Agents|antimitotic agents|mesh-ancestor
64783360|NCT03057366|Mitosis Modulators|mitosis modulators|mesh-ancestor
64783361|NCT03057366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783362|NCT03057366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64783363|NCT03060486|Hybenx|hybenx|mesh-list
64783364|NCT03060486|Dental Disinfectants|dental disinfectants|mesh-ancestor
64783365|NCT03060486|Disinfectants|disinfectants|mesh-ancestor
64783366|NCT03060486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64394755|NCT01976338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64783367|NCT03061812|Dexamethasone|dexamethasone|mesh-list
64783368|NCT03061812|Topotecan|topotecan|mesh-list
64783369|NCT03061812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64783370|NCT03061812|Antiemetics|antiemetics|mesh-ancestor
64783371|NCT03061812|Autonomic Agents|autonomic agents|mesh-ancestor
64783372|NCT03061812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783373|NCT03061812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783374|NCT03061812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64867106|NCT01808131|Uricosuric Agents|uricosuric agents|mesh-ancestor
64867107|NCT01808131|Renal Agents|renal agents|mesh-ancestor
64867108|NCT01808300|Thioctic Acid|thioctic acid|mesh-list
64867109|NCT01808300|Pregabalin|pregabalin|mesh-list
64867110|NCT01808300|Analgesics|analgesics|mesh-ancestor
64333388|NCT02739997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333389|NCT04467931|Losartan|losartan|mesh-list
64333390|NCT04467931|Timolol|timolol|mesh-list
64333391|NCT04467931|Propranolol|propranolol|mesh-list
64783375|NCT03061812|Glucocorticoids|glucocorticoids|mesh-ancestor
64783376|NCT03061812|Hormones|hormones|mesh-ancestor
64333392|NCT04467931|Metoprolol|metoprolol|mesh-list
64867111|NCT01808300|Sensory System Agents|sensory system agents|mesh-ancestor
64867112|NCT01808300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64867113|NCT01808300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867114|NCT01808300|Anticonvulsants|anticonvulsants|mesh-ancestor
64867115|NCT01808300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64867116|NCT01808300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64867117|NCT01808300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867118|NCT01808300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64867119|NCT01808300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64867120|NCT01808300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64867121|NCT01808300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64867122|NCT01808300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64867123|NCT01808300|Antioxidants|antioxidants|mesh-ancestor
64867124|NCT01808300|Protective Agents|protective agents|mesh-ancestor
64867125|NCT01808300|Vitamin B Complex|vitamin b complex|mesh-ancestor
64867127|NCT01808300|Micronutrients|micronutrients|mesh-ancestor
64867128|NCT01808469|Antibodies|antibodies|mesh-list
64867129|NCT01808469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64783377|NCT03061812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64783378|NCT03061812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64783379|NCT03061812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64783380|NCT03061812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64783381|NCT03061812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64783383|NCT03061812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783384|NCT03070470|Ritonavir|ritonavir|mesh-list
64783385|NCT03070470|Lopinavir|lopinavir|mesh-list
64783386|NCT03070470|Chloroquine|chloroquine|mesh-list
64783387|NCT03070470|Verapamil|verapamil|mesh-list
64783388|NCT03070470|Dofetilide|dofetilide|mesh-list
64783389|NCT03070470|Diltiazem|diltiazem|mesh-list
64783390|NCT03070470|Ranolazine|ranolazine|mesh-list
64783391|NCT03070470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64867130|NCT01808469|Immunologic Factors|immunologic factors|mesh-ancestor
64867131|NCT01808469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783392|NCT03070470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64783393|NCT03070470|Protease Inhibitors|protease inhibitors|mesh-ancestor
64783394|NCT03070470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64783395|NCT03070470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783396|NCT03070470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64394785|NCT01999114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64394786|NCT01999114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394787|NCT01999114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783397|NCT03070470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64783398|NCT03070470|Antiviral Agents|antiviral agents|mesh-ancestor
64783399|NCT03070470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64783400|NCT03070470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64783401|NCT03070470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64783402|NCT03070470|Amebicides|amebicides|mesh-ancestor
64783403|NCT03070470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64783404|NCT03070470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64783405|NCT03070470|Antimalarials|antimalarials|mesh-ancestor
64783406|NCT03070470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64783407|NCT03070470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783408|NCT03070470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64783409|NCT03070470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64783410|NCT03070470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64783411|NCT03070470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64783412|NCT03070470|Vasodilator Agents|vasodilator agents|mesh-ancestor
64783413|NCT03070470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64783414|NCT03070470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64783415|NCT03070470|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64783416|NCT03070548|Talazoparib|talazoparib|mesh-list
64867132|NCT01808495|Mitomycins|mitomycins|mesh-list
64867133|NCT01808495|Mitomycin|mitomycin|mesh-list
64867134|NCT01808495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64867135|NCT01808495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867136|NCT01808495|Alkylating Agents|alkylating agents|mesh-ancestor
64867137|NCT01808495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867138|NCT01808495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64867139|NCT01808495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867140|NCT01808521|Acetylcysteine|acetylcysteine|mesh-list
64867141|NCT01808521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64867142|NCT01808521|Antiviral Agents|antiviral agents|mesh-ancestor
64867143|NCT01808521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867144|NCT01808521|Expectorants|expectorants|mesh-ancestor
64867145|NCT01808521|Respiratory System Agents|respiratory system agents|mesh-ancestor
64867146|NCT01808521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64867147|NCT01808521|Antioxidants|antioxidants|mesh-ancestor
64295954|NCT03313557|Adavosertib|adavosertib|mesh-list
64295955|NCT03313557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295956|NCT03313557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295957|NCT04103216|Nitazoxanide|nitazoxanide|mesh-list
64295958|NCT04103216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64295959|NCT04103216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64295960|NCT03313479|Dexmedetomidine|dexmedetomidine|mesh-list
64295965|NCT03313479|Analgesics|analgesics|mesh-ancestor
64783417|NCT03070548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64783418|NCT03070548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394814|NCT04503161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394815|NCT04503161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64394816|NCT04503161|Contraceptive Agents|contraceptive agents|mesh-ancestor
64394817|NCT04503161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64394818|NCT04503161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64394819|NCT02214407|Decitabine|decitabine|mesh-list
64394820|NCT02214407|Hydroxyurea|hydroxyurea|mesh-list
64394821|NCT02214407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64394822|NCT02214407|Antimetabolites|antimetabolites|mesh-ancestor
64394823|NCT02214407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394824|NCT02214407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394825|NCT02214407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64783419|NCT03070548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783420|NCT03070548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64783421|NCT03080142|Bupivacaine|bupivacaine|mesh-list
64783422|NCT03080142|Ropivacaine|ropivacaine|mesh-list
64783423|NCT03080142|Anesthetics, Local|anesthetics, local|mesh-ancestor
64783424|NCT03080142|Anesthetics|anesthetics|mesh-ancestor
64333393|NCT04467931|Atenolol|atenolol|mesh-list
64333394|NCT04467931|Verapamil|verapamil|mesh-list
64333395|NCT04467931|Felodipine|felodipine|mesh-list
64333396|NCT04467931|Nadolol|nadolol|mesh-list
64333397|NCT04467931|Acebutolol|acebutolol|mesh-list
64867149|NCT01808521|Protective Agents|protective agents|mesh-ancestor
64867150|NCT01808521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867151|NCT01808521|Antidotes|antidotes|mesh-ancestor
64867152|NCT01808586|Dexamethasone|dexamethasone|mesh-list
64867153|NCT01808586|Betamethasone|betamethasone|mesh-list
64867154|NCT01808586|Lidocaine|lidocaine|mesh-list
64867155|NCT01808586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64867156|NCT01808586|Antiemetics|antiemetics|mesh-ancestor
64867157|NCT01808586|Autonomic Agents|autonomic agents|mesh-ancestor
64867158|NCT01808586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64867159|NCT01808586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867160|NCT01808586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64867161|NCT01808586|Glucocorticoids|glucocorticoids|mesh-ancestor
64867162|NCT01808586|Hormones|hormones|mesh-ancestor
64867163|NCT01808586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64867164|NCT01808586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64783425|NCT03080142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64783426|NCT03080142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783427|NCT03080142|Sensory System Agents|sensory system agents|mesh-ancestor
64783428|NCT03080142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783429|NCT03088800|Ibuprofen|ibuprofen|mesh-list
64783430|NCT03088800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64783431|NCT03088800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64783432|NCT03088800|Analgesics|analgesics|mesh-ancestor
64783433|NCT03088800|Sensory System Agents|sensory system agents|mesh-ancestor
64366976|NCT02453425|Autonomic Agents|autonomic agents|mesh-ancestor
64783434|NCT03088800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783435|NCT03088800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783436|NCT03088800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64783437|NCT03088800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64783438|NCT03088800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64783439|NCT03088800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64783440|NCT03088800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783441|NCT03096444|Lidocaine|lidocaine|mesh-list
64783442|NCT03096444|Ketamine|ketamine|mesh-list
64867166|NCT01808586|Anesthetics, Local|anesthetics, local|mesh-ancestor
64867168|NCT01808586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64867169|NCT01808586|Sensory System Agents|sensory system agents|mesh-ancestor
64867170|NCT01808586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64867171|NCT01808586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64867172|NCT01808586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64867173|NCT01808586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64867174|NCT01808586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867175|NCT01808586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64867176|NCT01808586|Respiratory System Agents|respiratory system agents|mesh-ancestor
64867177|NCT01808638|Gemcitabine|gemcitabine|mesh-list
64867178|NCT01808638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64867179|NCT01808638|Antimetabolites|antimetabolites|mesh-ancestor
64867180|NCT01808638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867181|NCT01808638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867182|NCT01808638|Antiviral Agents|antiviral agents|mesh-ancestor
64333399|NCT04467931|Valsartan|valsartan|mesh-list
64333400|NCT04467931|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64333401|NCT04467931|Telmisartan|telmisartan|mesh-list
64333402|NCT04467931|Clonidine|clonidine|mesh-list
64333403|NCT04467931|Carvedilol|carvedilol|mesh-list
64333404|NCT04467931|Candesartan|candesartan|mesh-list
64333409|NCT04467931|Enalapril|enalapril|mesh-list
64783443|NCT03096444|Amitriptyline|amitriptyline|mesh-list
64783444|NCT03096444|Anesthetics, Local|anesthetics, local|mesh-ancestor
64783445|NCT03096444|Anesthetics|anesthetics|mesh-ancestor
64783446|NCT03096444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64783447|NCT03096444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783448|NCT03096444|Sensory System Agents|sensory system agents|mesh-ancestor
64783449|NCT03096444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783450|NCT03096444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64783451|NCT03096444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64783452|NCT03096444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64783453|NCT03096444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64783454|NCT03096444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783455|NCT03096444|Analgesics|analgesics|mesh-ancestor
64783456|NCT03096444|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64783457|NCT03096444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64783458|NCT03096444|Anesthetics, General|anesthetics, general|mesh-ancestor
64783459|NCT03096444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64783460|NCT03096444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64333410|NCT04467931|Enalaprilat|enalaprilat|mesh-list
64333411|NCT04467931|Lisinopril|lisinopril|mesh-list
64333412|NCT04467931|Irbesartan|irbesartan|mesh-list
64333413|NCT04467931|Eplerenone|eplerenone|mesh-list
64333414|NCT04467931|Nebivolol|nebivolol|mesh-list
64333415|NCT04467931|Chlorthalidone|chlorthalidone|mesh-list
64333416|NCT04467931|Bisoprolol|bisoprolol|mesh-list
64333417|NCT04467931|Perindopril|perindopril|mesh-list
64333418|NCT04467931|Diltiazem|diltiazem|mesh-list
64333419|NCT04467931|Minoxidil|minoxidil|mesh-list
64333420|NCT04467931|Guanfacine|guanfacine|mesh-list
64333421|NCT04467931|Prazosin|prazosin|mesh-list
64333422|NCT04467931|Doxazosin|doxazosin|mesh-list
64333423|NCT04467931|Benazepril|benazepril|mesh-list
64333424|NCT04467931|Hydralazine|hydralazine|mesh-list
64333425|NCT04467931|Labetalol|labetalol|mesh-list
64333426|NCT04467931|Captopril|captopril|mesh-list
64333427|NCT04467931|Indapamide|indapamide|mesh-list
64333428|NCT04467931|Nicardipine|nicardipine|mesh-list
64333429|NCT04467931|Quinapril|quinapril|mesh-list
64333430|NCT04467931|Metolazone|metolazone|mesh-list
64867183|NCT01808638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867184|NCT01808638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64783461|NCT03096444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64783462|NCT03096444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64783463|NCT03096444|Antidepressive Agents|antidepressive agents|mesh-ancestor
64783464|NCT03096444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64783465|NCT03096444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64783466|NCT03096444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64783467|NCT03096444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64783468|NCT03096444|Adrenergic Agents|adrenergic agents|mesh-ancestor
64783469|NCT03107754|Lidocaine|lidocaine|mesh-list
64783470|NCT03107754|Anesthetics|anesthetics|mesh-list
64783471|NCT03107754|Anesthetics, Local|anesthetics, local|mesh-ancestor
64783472|NCT03107754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64783473|NCT03107754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783474|NCT03107754|Sensory System Agents|sensory system agents|mesh-ancestor
64783475|NCT03107754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783476|NCT03107754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64783477|NCT03107754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64783478|NCT03107754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64783479|NCT03107754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64783480|NCT03107754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783481|NCT03124758|Chrysarobin|chrysarobin|mesh-list
64783482|NCT03124758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64394871|NCT03161509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64394872|NCT03161509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64783483|NCT03124758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64783484|NCT03124758|Analgesics|analgesics|mesh-ancestor
64783485|NCT03124758|Sensory System Agents|sensory system agents|mesh-ancestor
64783486|NCT03124758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783487|NCT03124758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783488|NCT03124758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64783489|NCT03124758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64367073|NCT03121547|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64367074|NCT03121547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64783490|NCT03148236|Ascorbic Acid|ascorbic acid|mesh-list
64783491|NCT03148236|Vitamins|vitamins|mesh-ancestor
64783492|NCT03148236|Micronutrients|micronutrients|mesh-ancestor
64783493|NCT03148236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333432|NCT04467931|Torsemide|torsemide|mesh-list
64333433|NCT04467931|Fosinopril|fosinopril|mesh-list
64333434|NCT04467931|Methyldopa|methyldopa|mesh-list
64333435|NCT04467931|Isradipine|isradipine|mesh-list
64333436|NCT04467931|Eprosartan|eprosartan|mesh-list
64333437|NCT04467931|Pindolol|pindolol|mesh-list
64333438|NCT04467931|Moexipril|moexipril|mesh-list
64333439|NCT04467931|Betaxolol|betaxolol|mesh-list
64333440|NCT04467931|Reserpine|reserpine|mesh-list
64333441|NCT04467931|Bendroflumethiazide|bendroflumethiazide|mesh-list
64333442|NCT04467931|Chlorothiazide|chlorothiazide|mesh-list
64333443|NCT04467931|Guanabenz|guanabenz|mesh-list
64333444|NCT04467931|Nisoldipine|nisoldipine|mesh-list
64333445|NCT04467931|Penbutolol|penbutolol|mesh-list
64783494|NCT03148236|Antioxidants|antioxidants|mesh-ancestor
64783495|NCT03148236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783496|NCT03148236|Protective Agents|protective agents|mesh-ancestor
64783497|NCT03174366|Denosumab|denosumab|mesh-list
64783498|NCT03174366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64783499|NCT03174366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783500|NCT03177798|Icatibant|icatibant|mesh-list
64783501|NCT03177798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64783502|NCT03177798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64783503|NCT03177798|Analgesics|analgesics|mesh-ancestor
64783504|NCT03177798|Sensory System Agents|sensory system agents|mesh-ancestor
64783505|NCT03177798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783506|NCT03177798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394905|NCT05129033|Antifungal Agents|antifungal agents|mesh-ancestor
64394906|NCT05129033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64394907|NCT05129033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64394908|NCT05129033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64394909|NCT05129033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394910|NCT05129033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333446|NCT04467931|Nifedipine|nifedipine|mesh-list
64333447|NCT04467931|Amiloride|amiloride|mesh-list
64333448|NCT04467931|Triamterene|triamterene|mesh-list
64333449|NCT04467931|Furosemide|furosemide|mesh-list
64333450|NCT04467931|Spironolactone|spironolactone|mesh-list
64333451|NCT04467931|Bumetanide|bumetanide|mesh-list
64867206|NCT01808911|Immunologic Factors|immunologic factors|mesh-ancestor
64867207|NCT01808911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867208|NCT01808911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64867209|NCT01808911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64867210|NCT01808911|Alkylating Agents|alkylating agents|mesh-ancestor
64867211|NCT01808911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867212|NCT01808911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867213|NCT01808911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64867214|NCT01808911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64867215|NCT01809041|Remifentanil|remifentanil|mesh-list
64867216|NCT01809041|Propofol|propofol|mesh-list
64867217|NCT01809041|Sevoflurane|sevoflurane|mesh-list
64867218|NCT01809041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64867219|NCT01809041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64867220|NCT01809041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867221|NCT01809041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64295978|NCT04079738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295979|NCT03313401|Aflibercept|aflibercept|mesh-list
64295980|NCT03313401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64295981|NCT03313401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64295982|NCT03313401|Growth Substances|growth substances|mesh-ancestor
64394911|NCT05129033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64394912|NCT05129033|Hormone Antagonists|hormone antagonists|mesh-ancestor
64394913|NCT05129033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64394914|NCT05129033|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64783507|NCT03177798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64783508|NCT03177798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64783509|NCT03177798|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
64783510|NCT03177798|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
64783511|NCT03177798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783512|NCT03177798|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64783513|NCT03177798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64783514|NCT03177798|Immunologic Factors|immunologic factors|mesh-ancestor
64783516|NCT05093790|Ticagrelor|ticagrelor|mesh-list
64783517|NCT05093790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64783518|NCT05093790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64783519|NCT05093790|Analgesics|analgesics|mesh-ancestor
64783520|NCT05093790|Sensory System Agents|sensory system agents|mesh-ancestor
64783521|NCT05093790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783522|NCT05093790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783523|NCT05093790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64783524|NCT05093790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64783525|NCT05093790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64783526|NCT05093790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64783527|NCT05093790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64552116|NCT00900237|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64552117|NCT00900237|Oxcarbazepine|oxcarbazepine|mesh-list
64783528|NCT05093790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64783529|NCT05093790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64783530|NCT05093790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64783531|NCT05093790|Antipyretics|antipyretics|mesh-ancestor
64867235|NCT01809171|Cholecalciferol|cholecalciferol|mesh-list
64867236|NCT01809171|Vitamins|vitamins|mesh-ancestor
64867237|NCT01809171|Micronutrients|micronutrients|mesh-ancestor
64867238|NCT01809171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867239|NCT01809171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64333453|NCT04467931|Terazosin|terazosin|mesh-list
64333454|NCT04467931|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
64333455|NCT04467931|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64333456|NCT04467931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64333457|NCT04467931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64333458|NCT04467931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64333459|NCT04467931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333460|NCT04467931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64333461|NCT04467931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333462|NCT04467931|Vasodilator Agents|vasodilator agents|mesh-ancestor
64333463|NCT04467931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64783532|NCT05093790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64783533|NCT05093790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64304729|NCT05289323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64304730|NCT05289323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304731|NCT05289323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64304732|NCT05289323|Autonomic Agents|autonomic agents|mesh-ancestor
64304733|NCT05289323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64304734|NCT00109837|Leucovorin|leucovorin|mesh-list
64304735|NCT00109837|Cytarabine|cytarabine|mesh-list
64783562|NCT04890366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64783563|NCT04890366|Immunologic Factors|immunologic factors|mesh-ancestor
64783564|NCT04890366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783565|NCT04601532|Sulfadiazine|sulfadiazine|mesh-list
64783566|NCT04601532|Silver Sulfadiazine|silver sulfadiazine|mesh-list
64783567|NCT04601532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64783568|NCT04601532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64783569|NCT04601532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64783570|NCT04601532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64783571|NCT04601532|Coccidiostats|coccidiostats|mesh-ancestor
64783572|NCT04601532|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64783578|NCT04263792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64783579|NCT04263792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64783580|NCT04263792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64333464|NCT04467931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64333465|NCT04467931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64867240|NCT01809171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64867241|NCT01809184|Insulin|insulin|mesh-list
64867242|NCT01809184|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64867243|NCT01809184|Insulin Glargine|insulin glargine|mesh-list
64867244|NCT01809184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64867245|NCT01809184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867246|NCT01809301|Niacin|niacin|mesh-list
64783581|NCT04263792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64783582|NCT04263792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867247|NCT01809301|Nicotinic Acids|nicotinic acids|mesh-list
64867248|NCT01809301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64867249|NCT01809301|Antimetabolites|antimetabolites|mesh-ancestor
64867250|NCT01809301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867251|NCT01809301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64867252|NCT01809301|Vasodilator Agents|vasodilator agents|mesh-ancestor
64867253|NCT01809301|Vitamin B Complex|vitamin b complex|mesh-ancestor
64867254|NCT01809301|Vitamins|vitamins|mesh-ancestor
64867255|NCT01809301|Micronutrients|micronutrients|mesh-ancestor
64867256|NCT01809301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867257|NCT01809340|Minocycline|minocycline|mesh-list
64867258|NCT01809340|Ketamine|ketamine|mesh-list
64867259|NCT01809340|Analgesics|analgesics|mesh-ancestor
64867260|NCT01809340|Sensory System Agents|sensory system agents|mesh-ancestor
64867261|NCT01809340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64867262|NCT01809340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783583|NCT04263792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64783584|NCT04263792|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64783585|NCT04263792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64394981|NCT05134337|Antitubercular Agents|antitubercular agents|mesh-ancestor
64394982|NCT05134337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64394983|NCT05134337|Leprostatic Agents|leprostatic agents|mesh-ancestor
64394984|NCT05134337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64324313|NCT02261779|Tranylcypromine|tranylcypromine|mesh-list
64324314|NCT02261779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324315|NCT02261779|Keratolytic Agents|keratolytic agents|mesh-ancestor
64324316|NCT02261779|Dermatologic Agents|dermatologic agents|mesh-ancestor
64324317|NCT02261779|Antidepressive Agents|antidepressive agents|mesh-ancestor
64324318|NCT02261779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64324319|NCT02261779|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64324320|NCT02261779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324321|NCT02261779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324322|NCT02261779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64324323|NCT02261779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64324324|NCT02261779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64333467|NCT04467931|Natriuretic Agents|natriuretic agents|mesh-ancestor
64333468|NCT04467931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64333469|NCT04467931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64867263|NCT01809340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64867264|NCT01809340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64867265|NCT01809340|Anesthetics, General|anesthetics, general|mesh-ancestor
64867266|NCT01809340|Anesthetics|anesthetics|mesh-ancestor
64867267|NCT01809340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64867268|NCT01809340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64867269|NCT01809340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64867270|NCT01809340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64324325|NCT02261779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324326|NCT05157685|Azithromycin|azithromycin|mesh-list
64324327|NCT05157685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64324328|NCT05157685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64783587|NCT03872700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64783588|NCT03872700|Narcotics|narcotics|mesh-ancestor
64783589|NCT03872700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64783590|NCT03872700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783591|NCT03872700|Analgesics|analgesics|mesh-ancestor
64783592|NCT03872700|Sensory System Agents|sensory system agents|mesh-ancestor
64783593|NCT03872700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783594|NCT03872700|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64783595|NCT03872700|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64783596|NCT03872700|Anesthetics, General|anesthetics, general|mesh-ancestor
64783597|NCT03872700|Anesthetics|anesthetics|mesh-ancestor
64783598|NCT03137160|Ixekizumab|ixekizumab|mesh-list
64783599|NCT03137160|Dermatologic Agents|dermatologic agents|mesh-ancestor
64783600|NCT02856126|Sorafenib|sorafenib|mesh-list
64783601|NCT02856126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64783602|NCT02856126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64867271|NCT01809340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867272|NCT01809340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64867273|NCT01809340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867274|NCT01809392|Decitabine|decitabine|mesh-list
64867275|NCT01809392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64867276|NCT01809392|Antimetabolites|antimetabolites|mesh-ancestor
64867277|NCT01809392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867278|NCT01809392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867279|NCT01809392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867281|NCT01809444|Prednisone|prednisone|mesh-list
64867282|NCT01809444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64867284|NCT01809444|Hormones|hormones|mesh-ancestor
64867285|NCT01809444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64867286|NCT01809444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867287|NCT01809444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64867288|NCT01809444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867289|NCT01809444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64867290|NCT01809444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867291|NCT01809444|Antimalarials|antimalarials|mesh-ancestor
64295986|NCT05278065|Nicotine|nicotine|mesh-list
64295988|NCT05278065|Autonomic Agents|autonomic agents|mesh-ancestor
64783603|NCT02856126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64783604|NCT02856126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783605|NCT04589364|Botulinum Toxins|botulinum toxins|mesh-list
64783606|NCT04589364|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64783607|NCT04589364|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64783608|NCT04589364|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64783609|NCT04589364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64783610|NCT04589364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783611|NCT04589364|Cholinergic Agents|cholinergic agents|mesh-ancestor
64783612|NCT04589364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64395005|NCT05323175|Anesthetics, Local|anesthetics, local|mesh-ancestor
64324329|NCT02556632|Curcumin|curcumin|mesh-list
64783614|NCT04589364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64783615|NCT04589364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783616|NCT04473924|Mycophenolic Acid|mycophenolic acid|mesh-list
64783617|NCT04473924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64783618|NCT04473924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64783619|NCT04473924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64783620|NCT04473924|Antitubercular Agents|antitubercular agents|mesh-ancestor
64783621|NCT04473924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64783622|NCT04473924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64783623|NCT04473924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64783624|NCT04473924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783625|NCT04426500|Bupivacaine|bupivacaine|mesh-list
64783626|NCT04426500|Anesthetics, Local|anesthetics, local|mesh-ancestor
64783627|NCT04426500|Anesthetics|anesthetics|mesh-ancestor
64783628|NCT04426500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64783629|NCT04426500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783630|NCT04426500|Sensory System Agents|sensory system agents|mesh-ancestor
64783631|NCT04426500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783632|NCT04131192|Gemcitabine|gemcitabine|mesh-list
64867292|NCT01809444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64867293|NCT01809444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64867294|NCT01809626|Zolpidem|zolpidem|mesh-list
64867295|NCT01809626|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64867296|NCT01809626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64867297|NCT01809626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64867298|NCT01809626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867299|NCT01809626|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64867300|NCT01809626|GABA Agonists|gaba agonists|mesh-ancestor
64867301|NCT01809626|GABA Agents|gaba agents|mesh-ancestor
64867302|NCT01809626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64333470|NCT04467931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64783633|NCT04131192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64783634|NCT04131192|Antimetabolites|antimetabolites|mesh-ancestor
64395032|NCT05126693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395033|NCT05133791|Annexin A5|annexin a5|mesh-list
64395034|NCT05133791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64395035|NCT05133791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395036|NCT05133635|Methylprednisolone|methylprednisolone|mesh-list
64395037|NCT05133635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64395038|NCT05133635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64395039|NCT05133635|Prednisolone|prednisolone|mesh-list
64783635|NCT04131192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783636|NCT04131192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64783637|NCT04131192|Antiviral Agents|antiviral agents|mesh-ancestor
64783638|NCT04131192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64783639|NCT04131192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64783640|NCT04131192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64783641|NCT04131192|Immunologic Factors|immunologic factors|mesh-ancestor
64783642|NCT04131192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783643|NCT03925116|Contraceptive Agents|contraceptive agents|mesh-list
64333471|NCT04467931|Adrenergic Agents|adrenergic agents|mesh-ancestor
64333472|NCT04467931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64333473|NCT04467931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64333475|NCT04467931|Autonomic Agents|autonomic agents|mesh-ancestor
64333476|NCT04467931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64333477|NCT04467931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64333478|NCT04467931|Analgesics|analgesics|mesh-ancestor
64333479|NCT04467931|Sensory System Agents|sensory system agents|mesh-ancestor
64867303|NCT01809626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867304|NCT01809743|Adenosine|adenosine|mesh-list
64867305|NCT01809743|Regadenoson|regadenoson|mesh-list
64867306|NCT01809743|Analgesics|analgesics|mesh-ancestor
64867307|NCT01809743|Sensory System Agents|sensory system agents|mesh-ancestor
64867308|NCT01809743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64867309|NCT01809743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867310|NCT01809743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64867311|NCT01809743|Vasodilator Agents|vasodilator agents|mesh-ancestor
64867312|NCT01809743|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64867313|NCT01809743|Purinergic Agonists|purinergic agonists|mesh-ancestor
64867314|NCT01809743|Purinergic Agents|purinergic agents|mesh-ancestor
64783644|NCT03925116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64783645|NCT03925116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783646|NCT03883074|Magnesium trisilicate|magnesium trisilicate|mesh-list
64783647|NCT03883074|Hyaluronic Acid|hyaluronic acid|mesh-list
64304755|NCT00109837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783648|NCT03883074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64783649|NCT03883074|Immunologic Factors|immunologic factors|mesh-ancestor
64783650|NCT03883074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783651|NCT03883074|Viscosupplements|viscosupplements|mesh-ancestor
64783652|NCT03883074|Protective Agents|protective agents|mesh-ancestor
64395054|NCT05133635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64395055|NCT05133635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395056|NCT04219969|Deoxyglucose|deoxyglucose|mesh-list
64395057|NCT04219969|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64395058|NCT04219969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64395059|NCT04219969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395060|NCT04219969|Antimetabolites|antimetabolites|mesh-ancestor
64395061|NCT04219969|Antiviral Agents|antiviral agents|mesh-ancestor
64395062|NCT04219969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867330|NCT01809886|Neostigmine|neostigmine|mesh-list
64867331|NCT01809886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64867332|NCT01809886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867334|NCT01809886|Cholinergic Agents|cholinergic agents|mesh-ancestor
64867348|NCT01810185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867349|NCT01810185|Sensory System Agents|sensory system agents|mesh-ancestor
64867350|NCT01810185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64867351|NCT01810237|Dabigatran|dabigatran|mesh-list
64635954|NCT00004690|Monolaurin|monolaurin|mesh-list
64867352|NCT01810237|Antithrombins|antithrombins|mesh-ancestor
64867353|NCT01810237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64867354|NCT01810237|Protease Inhibitors|protease inhibitors|mesh-ancestor
64867355|NCT01810237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867356|NCT01810237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867357|NCT01810237|Anticoagulants|anticoagulants|mesh-ancestor
64867358|NCT01810315|Estradiol|estradiol|mesh-list
64867359|NCT01810315|Estrogens|estrogens|mesh-ancestor
64867360|NCT01810315|Hormones|hormones|mesh-ancestor
64867361|NCT01810315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64867362|NCT01810315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867363|NCT01810354|Cefazolin|cefazolin|mesh-list
64867364|NCT01810354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64867365|NCT01810354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867366|NCT01810367|Gemcitabine|gemcitabine|mesh-list
64867367|NCT01810367|Cisplatin|cisplatin|mesh-list
64867368|NCT01810367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867370|NCT01810367|Antimetabolites|antimetabolites|mesh-ancestor
64395063|NCT05132777|Osimertinib|osimertinib|mesh-list
64395064|NCT05132777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64783654|NCT03883074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783655|NCT03883074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64783656|NCT03670836|Misoprostol|misoprostol|mesh-list
64783657|NCT03670836|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64783658|NCT03670836|Abortifacient Agents|abortifacient agents|mesh-ancestor
64783659|NCT03670836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64783660|NCT03670836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783661|NCT03670836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64783662|NCT03670836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64783663|NCT03670836|Oxytocics|oxytocics|mesh-ancestor
64783664|NCT03607656|Docetaxel|docetaxel|mesh-list
64783665|NCT03607656|Capecitabine|capecitabine|mesh-list
64783666|NCT03607656|Oxaliplatin|oxaliplatin|mesh-list
64783667|NCT03607656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64783668|NCT03607656|Tubulin Modulators|tubulin modulators|mesh-ancestor
64783669|NCT03607656|Antimitotic Agents|antimitotic agents|mesh-ancestor
64783670|NCT03607656|Mitosis Modulators|mitosis modulators|mesh-ancestor
64783671|NCT03607656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783672|NCT03607656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64783673|NCT03607656|Antimetabolites|antimetabolites|mesh-ancestor
64867374|NCT01810367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867375|NCT01810367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64867376|NCT01810367|Immunologic Factors|immunologic factors|mesh-ancestor
64867377|NCT01810367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867378|NCT01810393|Trastuzumab|trastuzumab|mesh-list
64867379|NCT01810393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64867380|NCT01810393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867381|NCT01810458|Acetaminophen|acetaminophen|mesh-list
64867382|NCT01810458|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64867383|NCT01810458|Lidocaine|lidocaine|mesh-list
64783674|NCT03409614|Cemiplimab|cemiplimab|mesh-list
64867384|NCT01810458|Fentanyl|fentanyl|mesh-list
64867385|NCT01810458|Midazolam|midazolam|mesh-list
64867386|NCT01810458|Oxycodone|oxycodone|mesh-list
64867387|NCT01810458|Lorazepam|lorazepam|mesh-list
64867388|NCT01810458|Ondansetron|ondansetron|mesh-list
64867389|NCT01810458|Liver Extracts|liver extracts|mesh-list
64867390|NCT01810458|Anesthetics, Local|anesthetics, local|mesh-ancestor
64867391|NCT01810458|Anesthetics|anesthetics|mesh-ancestor
64867392|NCT01810458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64867393|NCT01810458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867394|NCT01810458|Sensory System Agents|sensory system agents|mesh-ancestor
64867395|NCT01810458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64867396|NCT01810458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64867397|NCT01810458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64867398|NCT01810458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64783675|NCT03409614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64783676|NCT03409614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395073|NCT05422027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64395074|NCT05422027|Antiemetics|antiemetics|mesh-ancestor
64395075|NCT05422027|Autonomic Agents|autonomic agents|mesh-ancestor
64395076|NCT05422027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395077|NCT05422027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783677|NCT02651844|Mifepristone|mifepristone|mesh-list
64783678|NCT02651844|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64552273|NCT01830777|Cytarabine|cytarabine|mesh-list
64783679|NCT02651844|Abortifacient Agents|abortifacient agents|mesh-ancestor
64783680|NCT02651844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64783681|NCT02651844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783682|NCT02651844|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64783683|NCT02651844|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64783684|NCT02651844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64783685|NCT02651844|Contraceptive Agents|contraceptive agents|mesh-ancestor
64783686|NCT02651844|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64783687|NCT02651844|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64783688|NCT02651844|Hormone Antagonists|hormone antagonists|mesh-ancestor
64867399|NCT01810458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64867400|NCT01810458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867401|NCT01810458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64867402|NCT01810458|Narcotics|narcotics|mesh-ancestor
64867403|NCT01810458|Analgesics|analgesics|mesh-ancestor
64867404|NCT01810458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64867405|NCT01810458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64867406|NCT01810458|Anesthetics, General|anesthetics, general|mesh-ancestor
64867407|NCT01810458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64867408|NCT01810458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64867409|NCT01810458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64867410|NCT01810458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64867411|NCT01810458|GABA Modulators|gaba modulators|mesh-ancestor
64867412|NCT01810458|GABA Agents|gaba agents|mesh-ancestor
64867413|NCT01810458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64867415|NCT01810458|Antipyretics|antipyretics|mesh-ancestor
64783689|NCT02651844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64783690|NCT02651844|Luteolytic Agents|luteolytic agents|mesh-ancestor
64783691|NCT02651844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64783692|NCT02651844|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64783693|NCT01463670|Lenalidomide|lenalidomide|mesh-list
64783694|NCT01463670|Immunologic Factors|immunologic factors|mesh-ancestor
64783695|NCT01463670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783696|NCT01463670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64783697|NCT01463670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64395096|NCT05072821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64395097|NCT05072821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367649|NCT02497157|Leucovorin|leucovorin|mesh-list
64395098|NCT05072821|Cholinergic Agents|cholinergic agents|mesh-ancestor
64395099|NCT05072821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64395100|NCT05072821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395101|NCT05072821|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64395102|NCT05072821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395103|NCT01674725|Ribavirin|ribavirin|mesh-list
64395104|NCT01674725|Antimetabolites|antimetabolites|mesh-ancestor
64395105|NCT01674725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395106|NCT01674725|Antiviral Agents|antiviral agents|mesh-ancestor
64867439|NCT01810731|Immunologic Factors|immunologic factors|mesh-ancestor
64324330|NCT02556632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64324331|NCT02556632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64783698|NCT01463670|Growth Substances|growth substances|mesh-ancestor
64783699|NCT01463670|Growth Inhibitors|growth inhibitors|mesh-ancestor
64783700|NCT01463670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64783702|NCT00151398|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64783703|NCT00151398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867440|NCT01810731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867441|NCT01810770|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64867442|NCT01810770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867443|NCT01810796|Ranolazine|ranolazine|mesh-list
64867444|NCT01810796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64867445|NCT01810796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64867446|NCT01810796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867447|NCT01810809|Hylan|hylan|mesh-list
64867448|NCT01810809|Hyaluronic Acid|hyaluronic acid|mesh-list
64867449|NCT01810809|Viscosupplements|viscosupplements|mesh-ancestor
64867450|NCT01810809|Protective Agents|protective agents|mesh-ancestor
64333481|NCT04467931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64333482|NCT04467931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64333483|NCT04467931|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64333484|NCT04467931|Hormone Antagonists|hormone antagonists|mesh-ancestor
64333485|NCT04467931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64333486|NCT04467931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64333487|NCT04467931|Antioxidants|antioxidants|mesh-ancestor
64333488|NCT04467931|Protective Agents|protective agents|mesh-ancestor
64333489|NCT04467931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64333490|NCT04467931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64783704|NCT00151398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783705|NCT00151398|Cholinergic Agents|cholinergic agents|mesh-ancestor
64783706|NCT00151398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64783707|NCT00151398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783708|NCT00151398|Nootropic Agents|nootropic agents|mesh-ancestor
64783709|NCT03181308|Nivolumab|nivolumab|mesh-list
64783710|NCT03181308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64783711|NCT03181308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64783712|NCT03181308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64783713|NCT03181308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783714|NCT03198000|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64783715|NCT03198000|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64783716|NCT03202134|Analgesics, Opioid|analgesics, opioid|mesh-list
64395115|NCT05051293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64395116|NCT05051293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395117|NCT03161041|Bevacizumab|bevacizumab|mesh-list
64395118|NCT03161041|Oxaliplatin|oxaliplatin|mesh-list
64333491|NCT04467931|Protease Inhibitors|protease inhibitors|mesh-ancestor
64333492|NCT04467931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867451|NCT01810809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867452|NCT01810809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64867453|NCT01810809|Immunologic Factors|immunologic factors|mesh-ancestor
64867454|NCT01810848|Hyaluronic Acid|hyaluronic acid|mesh-list
64867456|NCT01810848|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64867457|NCT01810848|Immunologic Factors|immunologic factors|mesh-ancestor
64867458|NCT01810848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867459|NCT01810848|Viscosupplements|viscosupplements|mesh-ancestor
64867460|NCT01810848|Protective Agents|protective agents|mesh-ancestor
64395119|NCT03161041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64867461|NCT01810887|Ritonavir|ritonavir|mesh-list
64867462|NCT01810887|Darunavir|darunavir|mesh-list
64867463|NCT01810887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64867465|NCT01810887|Protease Inhibitors|protease inhibitors|mesh-ancestor
64395120|NCT03161041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395121|NCT03161041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64395122|NCT03161041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64395123|NCT03161041|Growth Substances|growth substances|mesh-ancestor
64395124|NCT03161041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395125|NCT03161041|Growth Inhibitors|growth inhibitors|mesh-ancestor
64395126|NCT04139317|Pembrolizumab|pembrolizumab|mesh-list
64395127|NCT04139317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64395128|NCT04139317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64783717|NCT03202134|Anesthetics|anesthetics|mesh-list
64783718|NCT03202134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64783719|NCT03202134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783720|NCT03202134|Narcotics|narcotics|mesh-ancestor
64783721|NCT03202134|Analgesics|analgesics|mesh-ancestor
64783722|NCT03202134|Sensory System Agents|sensory system agents|mesh-ancestor
64783723|NCT03202134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783724|NCT03207438|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64783725|NCT03207438|Antidepressive Agents|antidepressive agents|mesh-ancestor
64783726|NCT03207438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64783727|NCT03207438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64783728|NCT03207438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64783729|NCT03207438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64867508|NCT01811056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867509|NCT01811056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64867510|NCT01811056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64867511|NCT01811056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64783730|NCT03207438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783731|NCT03218592|Tenofovir|tenofovir|mesh-list
64783732|NCT03218592|Emtricitabine|emtricitabine|mesh-list
64783733|NCT03218592|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64783734|NCT03218592|Maraviroc|maraviroc|mesh-list
64395133|NCT03163693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64395134|NCT03163693|Analgesics|analgesics|mesh-ancestor
64395135|NCT03163693|Sensory System Agents|sensory system agents|mesh-ancestor
64395136|NCT03163693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395137|NCT03163693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64367830|NCT02496299|Hormones|hormones|mesh-ancestor
64783737|NCT03218592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64783738|NCT03218592|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64783739|NCT03218592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64783740|NCT03218592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64783741|NCT03218592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783742|NCT03218592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64783743|NCT03218592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64783744|NCT03218592|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64783745|NCT03218592|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64783746|NCT03218592|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64783747|NCT03218592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64783748|NCT03218592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64867558|NCT01811381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867559|NCT01811381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64867560|NCT01811381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64867561|NCT01811381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867562|NCT01811381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867563|NCT01811381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867564|NCT01811459|Haloperidol|haloperidol|mesh-list
64867565|NCT01811459|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64867566|NCT01811459|Haloperidol decanoate|haloperidol decanoate|mesh-list
64783749|NCT03219294|Bromides|bromides|mesh-list
64867567|NCT01811459|Antidepressive Agents|antidepressive agents|mesh-ancestor
64867568|NCT01811459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64867569|NCT01811459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64867570|NCT01811459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64867571|NCT01811459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64867572|NCT01811459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867573|NCT01811459|Antiemetics|antiemetics|mesh-ancestor
64867574|NCT01811459|Autonomic Agents|autonomic agents|mesh-ancestor
64867575|NCT01811459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783750|NCT03219294|Vecuronium Bromide|vecuronium bromide|mesh-list
64783751|NCT03219294|Anticonvulsants|anticonvulsants|mesh-ancestor
64783752|NCT03219294|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64395151|NCT05030545|Natriuretic Agents|natriuretic agents|mesh-ancestor
64395152|NCT05030545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64395153|NCT05030545|Hormones|hormones|mesh-ancestor
64395154|NCT03164161|Endorphins|endorphins|mesh-list
64395155|NCT03164161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64867577|NCT01811459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64867578|NCT01811459|Dopamine Agents|dopamine agents|mesh-ancestor
64867579|NCT01811459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64867580|NCT01811459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867581|NCT01811459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64333493|NCT04467931|Tocolytic Agents|tocolytic agents|mesh-ancestor
64395156|NCT03164161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395157|NCT03164161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395158|NCT00754949|Azithromycin|azithromycin|mesh-list
64395159|NCT00754949|Dexamethasone|dexamethasone|mesh-list
64395160|NCT00754949|Dexamethasone acetate|dexamethasone acetate|mesh-list
64395161|NCT00754949|BB 1101|bb 1101|mesh-list
64395163|NCT00754949|Antiemetics|antiemetics|mesh-ancestor
64783761|NCT03219294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783762|NCT03219840|Cetylpyridinium|cetylpyridinium|mesh-list
64783763|NCT03219840|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64783764|NCT03219840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64395170|NCT00754949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64395171|NCT00754949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64395172|NCT00754949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333494|NCT04467931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64333495|NCT04467931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64333496|NCT04467931|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64333497|NCT04467931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64867582|NCT01811615|Ethanol|ethanol|mesh-list
64867583|NCT01811615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64867584|NCT01811615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867585|NCT01811615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64867586|NCT01811615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296015|NCT05302232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64296016|NCT05302232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64296017|NCT05302232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64296018|NCT05302232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64395173|NCT00754949|Protease Inhibitors|protease inhibitors|mesh-ancestor
64395174|NCT00754949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64395175|NCT00754949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395176|NCT00754949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64395177|NCT00754949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64395178|NCT03160807|Levofloxacin|levofloxacin|mesh-list
64395179|NCT03160807|Ofloxacin|ofloxacin|mesh-list
64395180|NCT03160807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64324332|NCT02556632|Analgesics|analgesics|mesh-ancestor
64324333|NCT02556632|Sensory System Agents|sensory system agents|mesh-ancestor
64324334|NCT02556632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64324335|NCT02556632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324336|NCT02556632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64324337|NCT02556632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64783769|NCT03223272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64783770|NCT03223272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867588|NCT01811667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64867589|NCT01811667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867590|NCT01811667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64867591|NCT01811667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867592|NCT01811667|Antifungal Agents|antifungal agents|mesh-ancestor
64867593|NCT01811667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64867594|NCT01811667|Immunologic Factors|immunologic factors|mesh-ancestor
64867595|NCT01811667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867596|NCT01811810|Androgens|androgens|mesh-list
64867597|NCT01811810|Hormones|hormones|mesh-ancestor
64867598|NCT01811810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64867599|NCT01811810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333498|NCT04467931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
64333499|NCT04467931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64333500|NCT04467931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64333501|NCT04467931|Sympathomimetics|sympathomimetics|mesh-ancestor
64296019|NCT05302232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296020|NCT05302232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64783771|NCT03223272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64783772|NCT03223272|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64395181|NCT03160807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64395183|NCT03160807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64395184|NCT03160807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64395185|NCT03160807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64395186|NCT03160807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64395187|NCT03160807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395188|NCT03160807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395189|NCT03160807|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64395190|NCT03160807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64395191|NCT01674569|Ranibizumab|ranibizumab|mesh-list
64395192|NCT01674569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64395193|NCT01674569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64867600|NCT01811836|Zinc|zinc|mesh-list
64867601|NCT01811836|Trace Elements|trace elements|mesh-ancestor
64867602|NCT01811836|Micronutrients|micronutrients|mesh-ancestor
64867603|NCT01811836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867604|NCT01811849|Insulin|insulin|mesh-list
64867605|NCT01811849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64867606|NCT01811849|Insulin Lispro|insulin lispro|mesh-list
64867607|NCT01811849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64867608|NCT01811849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867609|NCT01812018|Gemcitabine|gemcitabine|mesh-list
64867610|NCT01812018|Docetaxel|docetaxel|mesh-list
64867611|NCT01812018|Endostar protein|endostar protein|mesh-list
64867612|NCT01812018|Endostatins|endostatins|mesh-list
64867613|NCT01812018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64867614|NCT01812018|Antimetabolites|antimetabolites|mesh-ancestor
64867615|NCT01812018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867616|NCT01812018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867617|NCT01812018|Antiviral Agents|antiviral agents|mesh-ancestor
64867618|NCT01812018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867619|NCT01812018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867620|NCT01812018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64867621|NCT01812018|Immunologic Factors|immunologic factors|mesh-ancestor
64867622|NCT01812018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867623|NCT01812018|Tubulin Modulators|tubulin modulators|mesh-ancestor
64395195|NCT01674569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395196|NCT01674569|Growth Inhibitors|growth inhibitors|mesh-ancestor
64395197|NCT01674569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395198|NCT03160729|Dexamethasone|dexamethasone|mesh-list
64395199|NCT03160729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64395200|NCT03160729|Antiemetics|antiemetics|mesh-ancestor
64395201|NCT03160729|Autonomic Agents|autonomic agents|mesh-ancestor
64395202|NCT03160729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395203|NCT03160729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783791|NCT03257202|Clindamycin|clindamycin|mesh-list
64783792|NCT03257202|Clindamycin palmitate|clindamycin palmitate|mesh-list
64783793|NCT03257202|Clindamycin phosphate|clindamycin phosphate|mesh-list
64783794|NCT03257202|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64783795|NCT03257202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64783796|NCT03257202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64783797|NCT03257202|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64783798|NCT03257202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64783799|NCT03257202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783800|NCT03257202|Dermatologic Agents|dermatologic agents|mesh-ancestor
64867646|NCT01812200|Rivaroxaban|rivaroxaban|mesh-list
64867647|NCT01812200|Dabigatran|dabigatran|mesh-list
64867648|NCT01812200|Phenprocoumon|phenprocoumon|mesh-list
64867649|NCT01812200|Ticagrelor|ticagrelor|mesh-list
64867650|NCT01812200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64867651|NCT01812200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64867652|NCT01812200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64867653|NCT01812200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64867654|NCT01812200|Purinergic Agents|purinergic agents|mesh-ancestor
64867655|NCT01812200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64867656|NCT01812200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867657|NCT01812200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867658|NCT01812200|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64867659|NCT01812200|Antithrombins|antithrombins|mesh-ancestor
64867660|NCT01812200|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64867661|NCT01812200|Protease Inhibitors|protease inhibitors|mesh-ancestor
64867662|NCT01812200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867663|NCT01812200|Anticoagulants|anticoagulants|mesh-ancestor
64867664|NCT01812239|Progesterone|progesterone|mesh-list
64867665|NCT01812239|Progestins|progestins|mesh-list
64333502|NCT04467931|Urological Agents|urological agents|mesh-ancestor
64333503|NCT04467931|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
64333504|NCT04467931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64783801|NCT03260790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64783802|NCT03260790|Immunologic Factors|immunologic factors|mesh-ancestor
64783803|NCT03260790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783804|NCT03278886|Naltrexone|naltrexone|mesh-list
64783805|NCT03278886|Nalmefene|nalmefene|mesh-list
64783806|NCT03278886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64783807|NCT03278886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64783808|NCT03278886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783809|NCT03278886|Sensory System Agents|sensory system agents|mesh-ancestor
64783810|NCT03278886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783811|NCT03285984|Listerine|listerine|mesh-list
64333506|NCT04467931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64333507|NCT04467931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64867667|NCT01812239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64867668|NCT01812239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867669|NCT01812330|Clopidogrel|clopidogrel|mesh-list
64867670|NCT01812330|Ticagrelor|ticagrelor|mesh-list
64867671|NCT01812330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64867672|NCT01812330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64867673|NCT01812330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64867674|NCT01812330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64783812|NCT03285984|Fluorides|fluorides|mesh-list
64783813|NCT03285984|Sodium Fluoride|sodium fluoride|mesh-list
64867675|NCT01812330|Purinergic Agents|purinergic agents|mesh-ancestor
64867676|NCT01812330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64867677|NCT01812330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867678|NCT01812330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867679|NCT01812356|Nitrous Oxide|nitrous oxide|mesh-list
64867680|NCT01812356|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64867681|NCT01812356|Anesthetics, General|anesthetics, general|mesh-ancestor
64867682|NCT01812356|Anesthetics|anesthetics|mesh-ancestor
64867683|NCT01812356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64867684|NCT01812356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783814|NCT03285984|Cariostatic Agents|cariostatic agents|mesh-ancestor
64304759|NCT00109837|Antiemetics|antiemetics|mesh-ancestor
64783815|NCT03285984|Protective Agents|protective agents|mesh-ancestor
64783816|NCT03285984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783817|NCT03285984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64783818|NCT03285984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64783819|NCT03287310|Albuterol|albuterol|mesh-list
64783820|NCT03287310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64783821|NCT03287310|Autonomic Agents|autonomic agents|mesh-ancestor
64783822|NCT03287310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783823|NCT03287310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783824|NCT03287310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64783825|NCT03287310|Respiratory System Agents|respiratory system agents|mesh-ancestor
64783826|NCT03287310|Tocolytic Agents|tocolytic agents|mesh-ancestor
64783831|NCT03287310|Adrenergic Agents|adrenergic agents|mesh-ancestor
64783832|NCT03287310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64867685|NCT01812356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64867686|NCT01812356|Analgesics|analgesics|mesh-ancestor
64867687|NCT01812356|Sensory System Agents|sensory system agents|mesh-ancestor
64867688|NCT01812356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64867689|NCT01812369|Gemcitabine|gemcitabine|mesh-list
64867690|NCT01812369|Doxorubicin|doxorubicin|mesh-list
64867691|NCT01812369|Vinblastine|vinblastine|mesh-list
64867692|NCT01812369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64867693|NCT01812369|Antimetabolites|antimetabolites|mesh-ancestor
64867694|NCT01812369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867695|NCT01812369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867696|NCT01812369|Antiviral Agents|antiviral agents|mesh-ancestor
64867709|NCT01812382|Retapamulin|retapamulin|mesh-list
64783833|NCT03287310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783834|NCT03301272|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64783835|NCT03301272|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64783836|NCT03301272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64783837|NCT03301272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64783838|NCT03301272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783839|NCT03301272|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64783840|NCT03301272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64783841|NCT03301272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783842|NCT03301272|Cholinergic Agents|cholinergic agents|mesh-ancestor
64783843|NCT03301272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64783844|NCT03315780|Dulaglutide|dulaglutide|mesh-list
64783845|NCT03315780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64783846|NCT03315780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783847|NCT03334734|Isoniazid|isoniazid|mesh-list
64783848|NCT03334734|Macozinone|macozinone|mesh-list
64783849|NCT03334734|Antitubercular Agents|antitubercular agents|mesh-ancestor
64783850|NCT03334734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64783851|NCT03334734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64395244|NCT01374217|Clarithromycin|clarithromycin|mesh-list
64395245|NCT01374217|Dexamethasone|dexamethasone|mesh-list
64395246|NCT01374217|Lenalidomide|lenalidomide|mesh-list
64395247|NCT01374217|Tadalafil|tadalafil|mesh-list
64395248|NCT01374217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64395249|NCT01374217|Antiemetics|antiemetics|mesh-ancestor
64395250|NCT01374217|Autonomic Agents|autonomic agents|mesh-ancestor
64333508|NCT04467931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64333509|NCT04467931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64333510|NCT04467931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64333511|NCT04467931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64333512|NCT03705559|Analgesics, Opioid|analgesics, opioid|mesh-list
64333513|NCT03705559|Narcotics|narcotics|mesh-ancestor
64333514|NCT03705559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64333515|NCT03705559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333516|NCT03705559|Analgesics|analgesics|mesh-ancestor
64333517|NCT03705559|Sensory System Agents|sensory system agents|mesh-ancestor
64333518|NCT03705559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64333520|NCT03522649|Fluorouracil|fluorouracil|mesh-list
64333521|NCT03522649|Irinotecan|irinotecan|mesh-list
64333522|NCT03522649|Antimetabolites|antimetabolites|mesh-ancestor
64333523|NCT03522649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395251|NCT01374217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395252|NCT01374217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395253|NCT01374217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64395254|NCT01374217|Glucocorticoids|glucocorticoids|mesh-ancestor
64395255|NCT01374217|Hormones|hormones|mesh-ancestor
64395272|NCT01374217|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64395273|NCT01374217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64395274|NCT01374217|Urological Agents|urological agents|mesh-ancestor
64783871|NCT03336450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867739|NCT01812642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867740|NCT01812642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867742|NCT01812720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64867743|NCT01812720|Antiemetics|antiemetics|mesh-ancestor
64867744|NCT01812720|Autonomic Agents|autonomic agents|mesh-ancestor
64867745|NCT01812720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64867746|NCT01812720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867747|NCT01812720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64867748|NCT01812720|Glucocorticoids|glucocorticoids|mesh-ancestor
64867749|NCT01812720|Hormones|hormones|mesh-ancestor
64867750|NCT01812720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64867751|NCT01812720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64867752|NCT01812720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867753|NCT01812889|TOL-463|tol-463|mesh-list
64867754|NCT01812889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64783873|NCT03340350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64395275|NCT04494503|Rituximab|rituximab|mesh-list
64395276|NCT04494503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64395277|NCT04494503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395278|NCT04494503|Immunologic Factors|immunologic factors|mesh-ancestor
64395279|NCT04494503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395280|NCT04494503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64395281|NCT04941937|Thalidomide|thalidomide|mesh-list
64395282|NCT04941937|Dexamethasone|dexamethasone|mesh-list
64395283|NCT04941937|Lenalidomide|lenalidomide|mesh-list
64395284|NCT04941937|Pomalidomide|pomalidomide|mesh-list
64395285|NCT04941937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64304763|NCT00109837|Glucocorticoids|glucocorticoids|mesh-ancestor
64395299|NCT04941937|Growth Substances|growth substances|mesh-ancestor
64395300|NCT04941937|Growth Inhibitors|growth inhibitors|mesh-ancestor
64395301|NCT04941937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64395302|NCT04941937|Leprostatic Agents|leprostatic agents|mesh-ancestor
64395303|NCT04941937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64395304|NCT04941937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64395305|NCT02959619|Ensartinib|ensartinib|mesh-list
64324338|NCT02556632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324339|NCT02556632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324340|NCT02556632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783943|NCT03430050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64783944|NCT03440424|Lemborexant|lemborexant|mesh-list
64783945|NCT03440424|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64867814|NCT01813162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783946|NCT03440424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64783947|NCT03440424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783948|NCT03440424|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64783949|NCT03440424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64324343|NCT05491928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324345|NCT05491928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395348|NCT04955249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64395349|NCT04955249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64395350|NCT04955249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395351|NCT04955249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64324346|NCT05491928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64324347|NCT05491928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324348|NCT05491928|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64324349|NCT05491928|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64324350|NCT05487794|Methyltestosterone|methyltestosterone|mesh-list
64324351|NCT05487794|Testosterone|testosterone|mesh-list
64324352|NCT05487794|Testosterone undecanoate|testosterone undecanoate|mesh-list
64324353|NCT05487794|Testosterone enanthate|testosterone enanthate|mesh-list
64324354|NCT05487794|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64324355|NCT05487794|Androgens|androgens|mesh-ancestor
64324357|NCT05487794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64324358|NCT05487794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324359|NCT05487794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64324360|NCT05487794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324361|NCT05487794|Anabolic Agents|anabolic agents|mesh-ancestor
64324362|NCT01515007|Ciprofloxacin|ciprofloxacin|mesh-list
64783965|NCT03448068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783967|NCT03453060|Hemostatics|hemostatics|mesh-ancestor
64783968|NCT03453060|Coagulants|coagulants|mesh-ancestor
64783969|NCT03459612|Diphenhydramine|diphenhydramine|mesh-list
64324365|NCT01515007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64867865|NCT01813552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64867866|NCT01813552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64867867|NCT01813552|Protease Inhibitors|protease inhibitors|mesh-ancestor
64867868|NCT01813552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867869|NCT01813552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867870|NCT01813552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64867871|NCT01813552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64867872|NCT01813552|Antiviral Agents|antiviral agents|mesh-ancestor
64867873|NCT01813552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867874|NCT01813552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64867875|NCT01813552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64867876|NCT01813552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64867877|NCT01813552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64867878|NCT01813552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64867879|NCT01813565|Hyaluronic Acid|hyaluronic acid|mesh-list
64867880|NCT01813565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64296034|NCT02468661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296035|NCT02468661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296036|NCT03304431|Lidocaine|lidocaine|mesh-list
64296037|NCT03304431|Anesthetics, Local|anesthetics, local|mesh-ancestor
64296038|NCT03304431|Anesthetics|anesthetics|mesh-ancestor
64324366|NCT01515007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64783987|NCT03459612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783988|NCT03459612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64783990|NCT03459612|Dermatologic Agents|dermatologic agents|mesh-ancestor
64783991|NCT03459612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64783992|NCT03459612|Serotonin Agents|serotonin agents|mesh-ancestor
64783993|NCT03463512|Racecadotril|racecadotril|mesh-list
64783994|NCT03463512|Antidiarrheals|antidiarrheals|mesh-ancestor
64783995|NCT03463512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64783996|NCT03463512|Protease Inhibitors|protease inhibitors|mesh-ancestor
64783997|NCT03463512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64783998|NCT03463512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64783999|NCT03473184|Diacetylrhein|diacetylrhein|mesh-list
64333524|NCT03522649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64784000|NCT03473184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64333525|NCT03522649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333526|NCT03522649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64333527|NCT03522649|Immunologic Factors|immunologic factors|mesh-ancestor
64333528|NCT03522649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333529|NCT03522649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64867882|NCT01813565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867883|NCT01813565|Viscosupplements|viscosupplements|mesh-ancestor
64867884|NCT01813565|Protective Agents|protective agents|mesh-ancestor
64867885|NCT01813591|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64867886|NCT01813591|Hormones|hormones|mesh-ancestor
64867887|NCT01813591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64784002|NCT03485976|Dermatologic Agents|dermatologic agents|mesh-ancestor
64867888|NCT01813591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867889|NCT01813604|Vaccines|vaccines|mesh-list
64867890|NCT01813604|Immunologic Factors|immunologic factors|mesh-ancestor
64867891|NCT01813604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784003|NCT03496974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64784004|NCT03496974|Antibodies|antibodies|mesh-list
64784005|NCT03496974|Immunoglobulins|immunoglobulins|mesh-list
64784006|NCT03496974|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64395381|NCT03114085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64395382|NCT03114085|Antimetabolites|antimetabolites|mesh-ancestor
64395383|NCT03114085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395384|NCT03114085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395385|NCT03114085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64368780|NCT03119857|Androgen Antagonists|androgen antagonists|mesh-list
64395386|NCT03114085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64395387|NCT04886453|Morphine|morphine|mesh-list
64395388|NCT04886453|Anesthetics|anesthetics|mesh-list
64395389|NCT04886453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64395390|NCT04886453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395391|NCT04886453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64395392|NCT04886453|Narcotics|narcotics|mesh-ancestor
64395393|NCT04886453|Analgesics|analgesics|mesh-ancestor
64867892|NCT01813617|Prednisone|prednisone|mesh-list
64867893|NCT01813617|Methotrexate|methotrexate|mesh-list
64867894|NCT01813617|Azathioprine|azathioprine|mesh-list
64333531|NCT03522649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333532|NCT03522649|Antidotes|antidotes|mesh-ancestor
64333533|NCT03522649|Protective Agents|protective agents|mesh-ancestor
64333534|NCT03522649|Vitamin B Complex|vitamin b complex|mesh-ancestor
64333535|NCT03522649|Vitamins|vitamins|mesh-ancestor
64333536|NCT03522649|Micronutrients|micronutrients|mesh-ancestor
64333537|NCT02366481|Vitamins|vitamins|mesh-list
64416845|NCT04312243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416846|NCT04312243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64416847|NCT04312243|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64416848|NCT04312243|Vasodilator Agents|vasodilator agents|mesh-ancestor
64416849|NCT04312243|Gasotransmitters|gasotransmitters|mesh-ancestor
64416850|NCT04312243|Protective Agents|protective agents|mesh-ancestor
64416851|NCT04841551|Deoxycholic Acid|deoxycholic acid|mesh-list
64416852|NCT04841551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64416853|NCT04841551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64395394|NCT04886453|Sensory System Agents|sensory system agents|mesh-ancestor
64395395|NCT04886453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395396|NCT05136521|Trazodone|trazodone|mesh-list
64395397|NCT05136521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64395398|NCT05136521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64784007|NCT03496974|Immunologic Factors|immunologic factors|mesh-ancestor
64784008|NCT03496974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784009|NCT03496974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784010|NCT03503292|Ondansetron|ondansetron|mesh-list
64784011|NCT03503292|Granisetron|granisetron|mesh-list
64784012|NCT03503292|Antiemetics|antiemetics|mesh-ancestor
64784013|NCT03503292|Autonomic Agents|autonomic agents|mesh-ancestor
64784014|NCT03503292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64784015|NCT03503292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784016|NCT03503292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64784017|NCT03503292|Antipruritics|antipruritics|mesh-ancestor
64784018|NCT03503292|Dermatologic Agents|dermatologic agents|mesh-ancestor
64784019|NCT03503292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64784020|NCT03503292|Serotonin Agents|serotonin agents|mesh-ancestor
64784021|NCT03503292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64784022|NCT03503292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784023|NCT03503292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64784024|NCT03503292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64395400|NCT05136521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395401|NCT05136521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64867895|NCT01813617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64867896|NCT01813617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64867897|NCT01813617|Glucocorticoids|glucocorticoids|mesh-ancestor
64867899|NCT01813617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64867900|NCT01813617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867901|NCT01813617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64867902|NCT01813617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867903|NCT01813617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64867904|NCT01813617|Abortifacient Agents|abortifacient agents|mesh-ancestor
64416854|NCT04837651|Antibodies|antibodies|mesh-list
64395402|NCT05136521|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64395403|NCT05136521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64395404|NCT05136521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64395405|NCT05136521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304778|NCT00109837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64304779|NCT00109837|Antiviral Agents|antiviral agents|mesh-ancestor
64304780|NCT00109837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64304781|NCT00109837|Antidotes|antidotes|mesh-ancestor
64304782|NCT00109837|Protective Agents|protective agents|mesh-ancestor
64304783|NCT00109837|Vitamin B Complex|vitamin b complex|mesh-ancestor
64304784|NCT00109837|Vitamins|vitamins|mesh-ancestor
64304785|NCT00109837|Micronutrients|micronutrients|mesh-ancestor
64304786|NCT00109837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64304787|NCT00109837|Tubulin Modulators|tubulin modulators|mesh-ancestor
64304788|NCT00109837|Antimitotic Agents|antimitotic agents|mesh-ancestor
64304789|NCT00109837|Mitosis Modulators|mitosis modulators|mesh-ancestor
64304790|NCT00109837|Analgesics|analgesics|mesh-ancestor
64304791|NCT00109837|Sensory System Agents|sensory system agents|mesh-ancestor
64304792|NCT00109837|Gout Suppressants|gout suppressants|mesh-ancestor
64304793|NCT00109837|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64304794|NCT00109837|Antioxidants|antioxidants|mesh-ancestor
64304796|NCT00109837|Renal Agents|renal agents|mesh-ancestor
64395422|NCT02388373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395423|NCT02388373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395424|NCT02388373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64395425|NCT02388373|Respiratory System Agents|respiratory system agents|mesh-ancestor
64784039|NCT03506724|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64784040|NCT03506724|Adrenergic Agents|adrenergic agents|mesh-ancestor
64784041|NCT03506724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64784042|NCT03506724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64784043|NCT03506724|Sympathomimetics|sympathomimetics|mesh-ancestor
64784044|NCT03506724|Autonomic Agents|autonomic agents|mesh-ancestor
64867917|NCT01813643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64867918|NCT01813643|Serotonin Agents|serotonin agents|mesh-ancestor
64867919|NCT01813643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64867920|NCT01813643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416873|NCT04837261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64416874|NCT04837261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416875|NCT04837261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416886|NCT04837261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64416887|NCT04837261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64416888|NCT04837261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64416889|NCT04792645|Memantine|memantine|mesh-list
64416890|NCT04792645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64416891|NCT04792645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64416893|NCT04792645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64416894|NCT04792645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416895|NCT04792645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416896|NCT04792645|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64416897|NCT04792645|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64416898|NCT04832035|Psychotropic Drugs|psychotropic drugs|mesh-list
64784045|NCT03506724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64784046|NCT03506724|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64784047|NCT03506724|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64784048|NCT03509766|Histamine|histamine|mesh-list
64784049|NCT03509766|Histamine Agonists|histamine agonists|mesh-ancestor
64784050|NCT03509766|Histamine Agents|histamine agents|mesh-ancestor
64395426|NCT02388373|Dermatologic Agents|dermatologic agents|mesh-ancestor
64395427|NCT02388373|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64395433|NCT02388373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395435|NCT01674647|Rivaroxaban|rivaroxaban|mesh-list
64395436|NCT01674647|Vitamins|vitamins|mesh-ancestor
64395437|NCT01674647|Micronutrients|micronutrients|mesh-ancestor
64395438|NCT01674647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395439|NCT01674647|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64395440|NCT01674647|Antithrombins|antithrombins|mesh-ancestor
64304821|NCT03897062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64304822|NCT03897062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64304823|NCT03897062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64304824|NCT03897062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304825|NCT03897062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64304826|NCT03897062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64304827|NCT03897062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304828|NCT05048264|Dexamethasone|dexamethasone|mesh-list
64304829|NCT05048264|Methylprednisolone|methylprednisolone|mesh-list
64304830|NCT05048264|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64784079|NCT03572478|Nivolumab|nivolumab|mesh-list
64784080|NCT03572478|Rucaparib|rucaparib|mesh-list
64867921|NCT01813643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784081|NCT03572478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64867922|NCT01813643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64867923|NCT01813643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64867924|NCT01813643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64867925|NCT01813643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64867926|NCT01813643|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64867927|NCT01813643|Dopamine Agents|dopamine agents|mesh-ancestor
64867928|NCT01813643|Antidepressive Agents|antidepressive agents|mesh-ancestor
64867929|NCT01813643|Dopamine Agonists|dopamine agonists|mesh-ancestor
64867930|NCT01813643|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64867931|NCT01813643|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64867932|NCT01813643|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64867933|NCT01813643|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64867934|NCT01813656|Aripiprazole|aripiprazole|mesh-list
64867935|NCT01813656|Antidepressive Agents|antidepressive agents|mesh-ancestor
64784082|NCT03572478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784083|NCT03572478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64784084|NCT03572478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784085|NCT03572478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64784086|NCT03572478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784087|NCT03574818|Gemcitabine|gemcitabine|mesh-list
64784088|NCT03574818|Necitumumab|necitumumab|mesh-list
64784089|NCT03574818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784090|NCT03574818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64304832|NCT05048264|Prednisolone|prednisolone|mesh-list
64304833|NCT05048264|Prednisolone acetate|prednisolone acetate|mesh-list
64304834|NCT05048264|Triamcinolone|triamcinolone|mesh-list
64304835|NCT05048264|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64304836|NCT05048264|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64304837|NCT05048264|Betamethasone|betamethasone|mesh-list
64304838|NCT05048264|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64304839|NCT05048264|Prednisolone phosphate|prednisolone phosphate|mesh-list
64304840|NCT05048264|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64304841|NCT05048264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64304842|NCT05048264|Antiemetics|antiemetics|mesh-ancestor
64784091|NCT03574818|Antimetabolites|antimetabolites|mesh-ancestor
64784092|NCT03574818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784093|NCT03574818|Antiviral Agents|antiviral agents|mesh-ancestor
64784094|NCT03574818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64784095|NCT03574818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784096|NCT03574818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64784097|NCT03574818|Immunologic Factors|immunologic factors|mesh-ancestor
64784098|NCT03574818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784099|NCT03574818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64333539|NCT02366481|Vitamin K 2|vitamin k 2|mesh-list
64333540|NCT02366481|Vitamin MK 7|vitamin mk 7|mesh-list
64333541|NCT02366481|Micronutrients|micronutrients|mesh-ancestor
64867940|NCT01813656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867941|NCT01813656|Dopamine Agonists|dopamine agonists|mesh-ancestor
64867942|NCT01813656|Dopamine Agents|dopamine agents|mesh-ancestor
64867943|NCT01813656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64867944|NCT01813656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867945|NCT01813656|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64867946|NCT01813656|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64784101|NCT03593538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64395460|NCT02669407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64395461|NCT02669407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395462|NCT04909853|Ritonavir|ritonavir|mesh-list
64304844|NCT05048264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64304845|NCT05048264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304846|NCT05048264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64304848|NCT05048264|Hormones|hormones|mesh-ancestor
64304862|NCT05046314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304863|NCT05046314|Tubulin Modulators|tubulin modulators|mesh-ancestor
64369092|NCT03221569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324371|NCT01515007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64395471|NCT04909853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64395472|NCT04909853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64395473|NCT04909853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64395474|NCT04637555|Valsartan|valsartan|mesh-list
64395475|NCT04637555|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64395476|NCT04637555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64304865|NCT05046314|Mitosis Modulators|mitosis modulators|mesh-ancestor
64304866|NCT05046314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304867|NCT04795661|Pembrolizumab|pembrolizumab|mesh-list
64304868|NCT04795661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64333547|NCT02366481|Coagulants|coagulants|mesh-ancestor
64333548|NCT02366247|Adefovir|adefovir|mesh-list
64333549|NCT02366247|Thymalfasin|thymalfasin|mesh-list
64333550|NCT02366247|Antiviral Agents|antiviral agents|mesh-ancestor
64333551|NCT02366247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64333552|NCT02366247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64333553|NCT02366247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64333554|NCT02366247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867956|NCT01813773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867958|NCT01813773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867959|NCT01813812|Rebamipide|rebamipide|mesh-list
64867960|NCT01813812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64867961|NCT01813812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64636548|NCT04780061|Vitamin D|vitamin d|mesh-list
64416961|NCT02429427|Celecoxib|celecoxib|mesh-list
64416964|NCT02429427|Analgesics|analgesics|mesh-ancestor
64416980|NCT02412657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64416981|NCT02412657|Glucocorticoids|glucocorticoids|mesh-ancestor
64416982|NCT02412657|Hormones|hormones|mesh-ancestor
64416983|NCT02412657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64416984|NCT02412657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64416985|NCT02412657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416986|NCT02412111|Ivacaftor|ivacaftor|mesh-list
64416990|NCT02426541|Dapagliflozin|dapagliflozin|mesh-list
64304869|NCT04795661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304870|NCT00100802|Temozolomide|temozolomide|mesh-list
64304871|NCT00100802|Lomustine|lomustine|mesh-list
64304872|NCT00100802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64304873|NCT00100802|Alkylating Agents|alkylating agents|mesh-ancestor
64369103|NCT03319043|Hormones|hormones|mesh-ancestor
64784113|NCT03610464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64784114|NCT03610464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64304881|NCT01355159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304883|NCT04703036|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64867964|NCT01813812|Protective Agents|protective agents|mesh-ancestor
64867965|NCT01813812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867966|NCT01813812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867967|NCT01813955|Papaverine|papaverine|mesh-list
64867968|NCT01813955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64867969|NCT01813955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867970|NCT01813955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867971|NCT01813955|Vasodilator Agents|vasodilator agents|mesh-ancestor
64867972|NCT01813955|Urological Agents|urological agents|mesh-ancestor
64867973|NCT01813981|Caffeine|caffeine|mesh-list
64333555|NCT02366247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333557|NCT02366247|Immunologic Factors|immunologic factors|mesh-ancestor
64333558|NCT02366247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333559|NCT02373735|Mannitol|mannitol|mesh-list
64333560|NCT02373735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64333561|NCT02373735|Diuretics|diuretics|mesh-ancestor
64333562|NCT02373735|Natriuretic Agents|natriuretic agents|mesh-ancestor
64333563|NCT02373735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304884|NCT04703036|Glycine|glycine|mesh-list
64304885|NCT04703036|Antiviral Agents|antiviral agents|mesh-ancestor
64304886|NCT04703036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64304887|NCT04703036|Expectorants|expectorants|mesh-ancestor
64304888|NCT04703036|Respiratory System Agents|respiratory system agents|mesh-ancestor
64304889|NCT04703036|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64304890|NCT04703036|Antioxidants|antioxidants|mesh-ancestor
64304891|NCT04703036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304892|NCT04703036|Protective Agents|protective agents|mesh-ancestor
64304893|NCT04703036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324378|NCT05491694|Paclitaxel|paclitaxel|mesh-list
64324379|NCT05491694|Cyclophosphamide|cyclophosphamide|mesh-list
64324380|NCT05491694|Carboplatin|carboplatin|mesh-list
64867991|NCT01814059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64324381|NCT05491694|Epirubicin|epirubicin|mesh-list
64324382|NCT05491694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64867992|NCT01814059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867993|NCT01814059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64867994|NCT01814059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867996|NCT01814059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64867997|NCT01814059|Immunologic Factors|immunologic factors|mesh-ancestor
64867998|NCT01814059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867999|NCT01814085|Citalopram|citalopram|mesh-list
64868000|NCT01814085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64868001|NCT01814085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64868002|NCT01814085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64868003|NCT01814085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868004|NCT01814085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64868005|NCT01814085|Serotonin Agents|serotonin agents|mesh-ancestor
64868006|NCT01814085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868007|NCT01814085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64868052|NCT01814189|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64416992|NCT02426541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416993|NCT02426541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64416994|NCT02426541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416995|NCT02484651|Rocuronium|rocuronium|mesh-list
64416996|NCT02484651|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64416997|NCT02484651|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64416998|NCT02484651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64416999|NCT02484651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64417000|NCT02484651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417001|NCT02410551|Fludarabine|fludarabine|mesh-list
64324383|NCT05491694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324384|NCT05491694|Tubulin Modulators|tubulin modulators|mesh-ancestor
64324385|NCT05491694|Antimitotic Agents|antimitotic agents|mesh-ancestor
64324392|NCT05491694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64324393|NCT05491694|Alkylating Agents|alkylating agents|mesh-ancestor
64784121|NCT03615534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784123|NCT03615534|Vasodilator Agents|vasodilator agents|mesh-ancestor
64304901|NCT04661852|Immunologic Factors|immunologic factors|mesh-ancestor
64304902|NCT04661852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304903|NCT04661852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64304904|NCT04661852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64304905|NCT04661852|Alkylating Agents|alkylating agents|mesh-ancestor
64868054|NCT01814189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64868055|NCT01814189|Anesthetics, Local|anesthetics, local|mesh-ancestor
64868057|NCT01814189|Sensory System Agents|sensory system agents|mesh-ancestor
64868058|NCT01814189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64868059|NCT01814189|Antiemetics|antiemetics|mesh-ancestor
64868060|NCT01814189|Autonomic Agents|autonomic agents|mesh-ancestor
64868061|NCT01814189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64868062|NCT01814319|Probenecid|probenecid|mesh-list
64333577|NCT03112551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64333578|NCT03112551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64333579|NCT03112551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333580|NCT03112551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64333581|NCT03112551|Tocolytic Agents|tocolytic agents|mesh-ancestor
64333586|NCT04466917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64333587|NCT04466917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333588|NCT04466917|Tubulin Modulators|tubulin modulators|mesh-ancestor
64333589|NCT04466917|Antimitotic Agents|antimitotic agents|mesh-ancestor
64333590|NCT04466917|Mitosis Modulators|mitosis modulators|mesh-ancestor
64333591|NCT04466917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333592|NCT04466917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64333593|NCT04466917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64333594|NCT04466917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64304906|NCT04661852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304907|NCT04661852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324395|NCT05491694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64324396|NCT05491694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64324397|NCT05491694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64784146|NCT03655080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784147|NCT03655080|Tubulin Modulators|tubulin modulators|mesh-ancestor
64784148|NCT03655080|Antimitotic Agents|antimitotic agents|mesh-ancestor
64784149|NCT03655080|Mitosis Modulators|mitosis modulators|mesh-ancestor
64784150|NCT03655080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784151|NCT03674970|Nicotine|nicotine|mesh-list
64784152|NCT03674970|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64784153|NCT03674970|Autonomic Agents|autonomic agents|mesh-ancestor
64784154|NCT03674970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395503|NCT04556357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395504|NCT04556357|Protective Agents|protective agents|mesh-ancestor
64395505|NCT04553939|Gemcitabine|gemcitabine|mesh-list
64395506|NCT04553939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64395507|NCT04553939|Antimetabolites|antimetabolites|mesh-ancestor
64395508|NCT04553939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395509|NCT04553939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395510|NCT04553939|Antiviral Agents|antiviral agents|mesh-ancestor
64395511|NCT04553939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64304909|NCT04661852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64304910|NCT04661852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64304911|NCT04661852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304912|NCT04661852|Mitosis Modulators|mitosis modulators|mesh-ancestor
64868063|NCT01814319|Uricosuric Agents|uricosuric agents|mesh-ancestor
64868064|NCT01814319|Gout Suppressants|gout suppressants|mesh-ancestor
64868065|NCT01814319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64868066|NCT01814319|Renal Agents|renal agents|mesh-ancestor
64868067|NCT01814410|Ethanol|ethanol|mesh-list
64868068|NCT01814410|Nicotine|nicotine|mesh-list
64868069|NCT01814410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64868070|NCT01814410|Autonomic Agents|autonomic agents|mesh-ancestor
64868071|NCT01814410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64868072|NCT01814410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868073|NCT01814410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64868074|NCT01814410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64868075|NCT01814410|Cholinergic Agents|cholinergic agents|mesh-ancestor
64868076|NCT01814410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64868077|NCT01814410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868078|NCT01814410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64868079|NCT01814410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64868080|NCT01814410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64868081|NCT01814423|Chloroquine|chloroquine|mesh-list
64868082|NCT01814423|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64868083|NCT01814423|Amebicides|amebicides|mesh-ancestor
64868084|NCT01814423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64304913|NCT02630186|Atezolizumab|atezolizumab|mesh-list
64304914|NCT02630186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304916|NCT00002462|Prednisone|prednisone|mesh-list
64304917|NCT00002462|Doxorubicin|doxorubicin|mesh-list
64304918|NCT00002462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64304919|NCT00002462|Bleomycin|bleomycin|mesh-list
64304920|NCT00002462|Vincristine|vincristine|mesh-list
64304921|NCT00002462|Vinblastine|vinblastine|mesh-list
64395514|NCT04553939|Immunologic Factors|immunologic factors|mesh-ancestor
64395515|NCT04553939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395516|NCT02790853|Proflavine|proflavine|mesh-list
64395517|NCT02790853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64324410|NCT05480072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324411|NCT05480072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64304922|NCT00002462|Procarbazine|procarbazine|mesh-list
64304923|NCT00002462|Mechlorethamine|mechlorethamine|mesh-list
64304924|NCT00002462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64304925|NCT00002462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868086|NCT01814423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64868087|NCT01814423|Antimalarials|antimalarials|mesh-ancestor
64868088|NCT01814423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64868089|NCT01814423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64868090|NCT01814423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64868091|NCT01814423|Analgesics|analgesics|mesh-ancestor
64868092|NCT01814423|Sensory System Agents|sensory system agents|mesh-ancestor
64868093|NCT01814423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64868094|NCT01814423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868095|NCT01814423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64868096|NCT01814423|Filaricides|filaricides|mesh-ancestor
64868097|NCT01814423|Antinematodal Agents|antinematodal agents|mesh-ancestor
64868098|NCT01814423|Anthelmintics|anthelmintics|mesh-ancestor
64868099|NCT01814449|Letrozole|letrozole|mesh-list
64868100|NCT01814449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868101|NCT01814449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64868102|NCT01814449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64868103|NCT01814449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868104|NCT01814449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868105|NCT01814449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64868106|NCT01814449|Hormone Antagonists|hormone antagonists|mesh-ancestor
64868107|NCT01814449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64868108|NCT01814449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868109|NCT01814475|Vidarabine|vidarabine|mesh-list
64868110|NCT01814475|Fludarabine|fludarabine|mesh-list
64868111|NCT01814475|Fludarabine phosphate|fludarabine phosphate|mesh-list
64868112|NCT01814475|Busulfan|busulfan|mesh-list
64868113|NCT01814475|Thiotepa|thiotepa|mesh-list
64304926|NCT00002462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64304927|NCT00002462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64304929|NCT00002462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304930|NCT00002462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64304931|NCT00002462|Glucocorticoids|glucocorticoids|mesh-ancestor
64304932|NCT00002462|Hormones|hormones|mesh-ancestor
64304933|NCT00002462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64304934|NCT00002462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304935|NCT00002462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64304936|NCT00002462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64304937|NCT00002462|Tubulin Modulators|tubulin modulators|mesh-ancestor
64304938|NCT00002462|Antimitotic Agents|antimitotic agents|mesh-ancestor
64304939|NCT00002462|Mitosis Modulators|mitosis modulators|mesh-ancestor
64304940|NCT00002462|Trace Elements|trace elements|mesh-ancestor
64304941|NCT00002462|Micronutrients|micronutrients|mesh-ancestor
64304942|NCT00002462|Alkylating Agents|alkylating agents|mesh-ancestor
64784165|NCT03704376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64395518|NCT02790853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64395519|NCT03113773|Aldesleukin|aldesleukin|mesh-list
64395520|NCT03113773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395521|NCT03113773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64304943|NCT00002462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64304944|NCT01669928|Antihypertensive Agents|antihypertensive agents|mesh-list
64304945|NCT01669928|Calcium Channel Blockers|calcium channel blockers|mesh-list
64304946|NCT01669928|Angiotensin II|angiotensin ii|mesh-list
64304947|NCT01669928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64304948|NCT01669928|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64868117|NCT01814475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868118|NCT01814475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64868119|NCT01814475|Immunologic Factors|immunologic factors|mesh-ancestor
64868120|NCT01814475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868121|NCT01814475|Antiviral Agents|antiviral agents|mesh-ancestor
64868122|NCT01814475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64868123|NCT01814475|Alkylating Agents|alkylating agents|mesh-ancestor
64868124|NCT01814475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64868125|NCT01814475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64868126|NCT01814501|Leucovorin|leucovorin|mesh-list
64868127|NCT01814501|Fluorouracil|fluorouracil|mesh-list
64868128|NCT01814501|Irinotecan|irinotecan|mesh-list
64868129|NCT01814501|Panitumumab|panitumumab|mesh-list
64868130|NCT01814501|Calcium|calcium|mesh-list
64868131|NCT01814501|Levoleucovorin|levoleucovorin|mesh-list
64868132|NCT01814501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64868134|NCT01814501|Antimetabolites|antimetabolites|mesh-ancestor
64304949|NCT01669928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64304950|NCT01669928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304951|NCT01669928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304952|NCT01669928|Protease Inhibitors|protease inhibitors|mesh-ancestor
64304953|NCT01669928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304954|NCT01669928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64304955|NCT01669928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64304960|NCT01995578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304961|NCT01995578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304963|NCT04440176|Immunologic Factors|immunologic factors|mesh-ancestor
64304964|NCT04440176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304965|NCT03595592|Paclitaxel|paclitaxel|mesh-list
64305026|NCT03062462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64305027|NCT03062462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64305028|NCT03062462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64305029|NCT03062462|Purinergic Agents|purinergic agents|mesh-ancestor
64305030|NCT03062462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64868136|NCT01814501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64868137|NCT01814501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868138|NCT01814501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64868139|NCT01814501|Immunologic Factors|immunologic factors|mesh-ancestor
64868140|NCT01814501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64868141|NCT01814501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64868142|NCT01814501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868143|NCT01814501|Antidotes|antidotes|mesh-ancestor
64868144|NCT01814501|Protective Agents|protective agents|mesh-ancestor
64868145|NCT01814501|Vitamin B Complex|vitamin b complex|mesh-ancestor
64868146|NCT01814501|Vitamins|vitamins|mesh-ancestor
64868147|NCT01814501|Micronutrients|micronutrients|mesh-ancestor
64868148|NCT01814501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64868149|NCT01814514|Timolol|timolol|mesh-list
64868150|NCT01814514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64417011|NCT02410551|Alkylating Agents|alkylating agents|mesh-ancestor
64417012|NCT02410551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64417013|NCT02410551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64417014|NCT02424591|Ketamine|ketamine|mesh-list
64417015|NCT02424591|Analgesics|analgesics|mesh-ancestor
64417016|NCT02424591|Sensory System Agents|sensory system agents|mesh-ancestor
64417017|NCT02424591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64417018|NCT02424591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417019|NCT02424591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64417020|NCT02424591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64417021|NCT02424591|Anesthetics, General|anesthetics, general|mesh-ancestor
64417022|NCT02424591|Anesthetics|anesthetics|mesh-ancestor
64784178|NCT03704376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784179|NCT03716076|Carbetocin|carbetocin|mesh-list
64395529|NCT05122169|Chlorhexidine|chlorhexidine|mesh-list
64395530|NCT05122169|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64395531|NCT05122169|Povidone-Iodine|povidone-iodine|mesh-list
64395532|NCT05122169|Povidone|povidone|mesh-list
64395533|NCT05122169|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64395534|NCT05122169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64395535|NCT05122169|Disinfectants|disinfectants|mesh-ancestor
64395536|NCT05122169|Dermatologic Agents|dermatologic agents|mesh-ancestor
64395537|NCT05122169|Trace Elements|trace elements|mesh-ancestor
64395538|NCT05122169|Micronutrients|micronutrients|mesh-ancestor
64395539|NCT05122169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395540|NCT05122169|Plasma Substitutes|plasma substitutes|mesh-ancestor
64395541|NCT05122169|Blood Substitutes|blood substitutes|mesh-ancestor
64305032|NCT03062462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305034|NCT04433078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64305035|NCT04433078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64305036|NCT04433078|Antimalarials|antimalarials|mesh-ancestor
64305037|NCT04433078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64305038|NCT04433078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64305039|NCT04458311|Abiraterone Acetate|abiraterone acetate|mesh-list
64305040|NCT04458311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305041|NCT04458311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64305042|NCT04458311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369587|NCT03075657|Risperidone|risperidone|mesh-list
64395546|NCT04359329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395548|NCT05403749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64868152|NCT01814514|Adrenergic Agents|adrenergic agents|mesh-ancestor
64395549|NCT05403749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64395550|NCT05403749|Growth Substances|growth substances|mesh-ancestor
64784202|NCT04138758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64784203|NCT04138758|Respiratory System Agents|respiratory system agents|mesh-ancestor
64784204|NCT04138758|Parasympatholytics|parasympatholytics|mesh-ancestor
64784205|NCT04138758|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64784206|NCT04138758|Cholinergic Agents|cholinergic agents|mesh-ancestor
64305043|NCT04458311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305044|NCT04458311|Hormone Antagonists|hormone antagonists|mesh-ancestor
64305045|NCT04458311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64305046|NCT04458311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305047|NCT04458311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64305049|NCT05212571|Esketamine|esketamine|mesh-list
64305050|NCT05212571|Analgesics|analgesics|mesh-ancestor
64305051|NCT05212571|Sensory System Agents|sensory system agents|mesh-ancestor
64305052|NCT05212571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64305053|NCT05212571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868192|NCT01814709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64868193|NCT01814709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64333630|NCT03523741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64868194|NCT01814709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64868195|NCT01814709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64868196|NCT01814709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64417051|NCT04822909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64417052|NCT04822909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64417053|NCT04822909|Analgesics|analgesics|mesh-ancestor
64417054|NCT04822909|Sensory System Agents|sensory system agents|mesh-ancestor
64417055|NCT04822909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64417056|NCT04822909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417057|NCT04822909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64417058|NCT04822909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64417059|NCT04822909|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64417060|NCT04822909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64417061|NCT04822909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417062|NCT04822909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305054|NCT05212571|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64305055|NCT05212571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64305056|NCT05212571|Anesthetics, General|anesthetics, general|mesh-ancestor
64305057|NCT05212571|Anesthetics|anesthetics|mesh-ancestor
64305058|NCT05212571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64305059|NCT05212571|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64305060|NCT05212571|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64305061|NCT05212571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64305062|NCT05212571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305063|NCT05212571|Antidepressive Agents|antidepressive agents|mesh-ancestor
64305064|NCT05212571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64305065|NCT04368533|Fluorides|fluorides|mesh-list
64305066|NCT04368533|Cariostatic Agents|cariostatic agents|mesh-ancestor
64305067|NCT04368533|Protective Agents|protective agents|mesh-ancestor
64305068|NCT04368533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305069|NCT04002271|Propofol|propofol|mesh-list
64305070|NCT04002271|Sevoflurane|sevoflurane|mesh-list
64395551|NCT05403749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395552|NCT05403749|Growth Inhibitors|growth inhibitors|mesh-ancestor
64868197|NCT01814709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64868198|NCT01814826|Azacitidine|azacitidine|mesh-list
64868199|NCT01814826|Pevonedistat|pevonedistat|mesh-list
64868200|NCT01814826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64868201|NCT01814826|Antimetabolites|antimetabolites|mesh-ancestor
64868202|NCT01814826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868203|NCT01814826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868204|NCT01814826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868205|NCT01814865|Prednisone|prednisone|mesh-list
64868206|NCT01814865|Anastrozole|anastrozole|mesh-list
64868207|NCT01814865|Abiraterone Acetate|abiraterone acetate|mesh-list
64868208|NCT01814865|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64868209|NCT01814865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64868210|NCT01814865|Glucocorticoids|glucocorticoids|mesh-ancestor
64868211|NCT01814865|Hormones|hormones|mesh-ancestor
64333631|NCT03523741|GABA Antagonists|gaba antagonists|mesh-ancestor
64333632|NCT03523741|GABA Agents|gaba agents|mesh-ancestor
64333633|NCT02362581|Factor VIII|factor viii|mesh-list
64333634|NCT02362581|Coagulants|coagulants|mesh-ancestor
64417063|NCT04822909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64417064|NCT04822909|Immunologic Factors|immunologic factors|mesh-ancestor
64417065|NCT04822909|Leprostatic Agents|leprostatic agents|mesh-ancestor
64417066|NCT04822909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64417067|NCT04822909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64417068|NCT04822909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64417069|NCT04822909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64417070|NCT04822909|Growth Substances|growth substances|mesh-ancestor
64417086|NCT04367935|Protective Agents|protective agents|mesh-ancestor
64417087|NCT04367935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395553|NCT05403749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395554|NCT04745351|Remdesivir|remdesivir|mesh-list
64395555|NCT04745351|Antimetabolites|antimetabolites|mesh-ancestor
64395556|NCT04745351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395557|NCT04745351|Antiviral Agents|antiviral agents|mesh-ancestor
64395558|NCT04745351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64395559|NCT04203875|Abatacept|abatacept|mesh-list
64395560|NCT04203875|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64395561|NCT04203875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395562|NCT04203875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305072|NCT04002271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64305073|NCT04002271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305074|NCT04002271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64305075|NCT04002271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64305076|NCT04002271|Anesthetics, General|anesthetics, general|mesh-ancestor
64305077|NCT04002271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64305078|NCT04002271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64305080|NCT05160805|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64305081|NCT02627144|Interferons|interferons|mesh-list
64305082|NCT02627144|Interferon-alpha|interferon-alpha|mesh-list
64305083|NCT02627144|Interferon alpha-2|interferon alpha-2|mesh-list
64305084|NCT02627144|Bevacizumab|bevacizumab|mesh-list
64305085|NCT02627144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64305086|NCT02627144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868212|NCT01814865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64868213|NCT01814865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868214|NCT01814865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64868215|NCT01814865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868216|NCT01814865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64868217|NCT01814865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868218|NCT01814865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868219|NCT01814865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64868220|NCT01814865|Hormone Antagonists|hormone antagonists|mesh-ancestor
64868221|NCT01814865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64868223|NCT01814891|Vitamins|vitamins|mesh-ancestor
64868224|NCT01814891|Micronutrients|micronutrients|mesh-ancestor
64868225|NCT01814891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868226|NCT01814904|Bile Acids and Salts|bile acids and salts|mesh-list
64417088|NCT04367935|Vasodilator Agents|vasodilator agents|mesh-ancestor
64417089|NCT04367935|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64417090|NCT04367935|Antioxidants|antioxidants|mesh-ancestor
64417091|NCT04829773|Midazolam|midazolam|mesh-list
64417092|NCT04829773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64417093|NCT04829773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64417094|NCT04829773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64417095|NCT04829773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417096|NCT04829773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64417097|NCT04829773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64305087|NCT02627144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64305088|NCT02627144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64395566|NCT04203875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64395568|NCT04491383|Vitamins|vitamins|mesh-ancestor
64395569|NCT04491383|Micronutrients|micronutrients|mesh-ancestor
64395570|NCT04491383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395571|NCT05260073|Tirbanibulin|tirbanibulin|mesh-list
64305089|NCT02627144|Growth Substances|growth substances|mesh-ancestor
64305090|NCT02627144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395575|NCT04576325|Antifungal Agents|antifungal agents|mesh-ancestor
64395576|NCT04576325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64305091|NCT02627144|Growth Inhibitors|growth inhibitors|mesh-ancestor
64305092|NCT02627144|Antiviral Agents|antiviral agents|mesh-ancestor
64305093|NCT02627144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64305094|NCT02627144|Immunologic Factors|immunologic factors|mesh-ancestor
64305095|NCT04586335|Olaparib|olaparib|mesh-list
64305096|NCT04586335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64305097|NCT04586335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305098|NCT04586335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305099|NCT04586335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305100|NCT04981886|Bimatoprost|bimatoprost|mesh-list
64305101|NCT04981886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64305102|NCT03900637|Letrozole|letrozole|mesh-list
64305103|NCT03900637|Leuprolide|leuprolide|mesh-list
64305104|NCT03900637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305105|NCT03900637|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64305106|NCT03900637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64333635|NCT03525925|Nivolumab|nivolumab|mesh-list
64333636|NCT03525925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64868227|NCT01814904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64868228|NCT01814930|Contraceptive Agents|contraceptive agents|mesh-list
64868229|NCT01814930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64868230|NCT01814930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868231|NCT01815021|Calcium, Dietary|calcium, dietary|mesh-list
64868232|NCT01815021|Calcium Carbonate|calcium carbonate|mesh-list
64868233|NCT01815021|Calcium|calcium|mesh-list
64868234|NCT01815021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64868235|NCT01815021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868237|NCT01815021|Antacids|antacids|mesh-ancestor
64305107|NCT03900637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305108|NCT03900637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305109|NCT03900637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64305110|NCT03900637|Hormone Antagonists|hormone antagonists|mesh-ancestor
64305111|NCT03900637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64305112|NCT03900637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395578|NCT04576325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64395579|NCT04576325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64395580|NCT04576325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395581|NCT04576325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64395582|NCT04576325|Hormone Antagonists|hormone antagonists|mesh-ancestor
64395583|NCT04576325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64784233|NCT04463004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64784234|NCT04399980|Mavrilimumab|mavrilimumab|mesh-list
64868253|NCT01815125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64868254|NCT01815125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417148|NCT04828525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64333637|NCT03525925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333638|NCT03525925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64333639|NCT03525925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868255|NCT01815125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64868256|NCT01815125|Antipruritics|antipruritics|mesh-ancestor
64868257|NCT01815125|Dermatologic Agents|dermatologic agents|mesh-ancestor
64868258|NCT01815125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64868259|NCT01815125|Serotonin Agents|serotonin agents|mesh-ancestor
64868260|NCT01815125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64784235|NCT04399980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64784236|NCT04335552|Azithromycin|azithromycin|mesh-list
64784237|NCT04335552|Hydroxychloroquine|hydroxychloroquine|mesh-list
64784238|NCT04335552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64784239|NCT04335552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64784240|NCT04335552|Antimalarials|antimalarials|mesh-ancestor
64784241|NCT04335552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64784242|NCT04335552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64784243|NCT04335552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784244|NCT04335552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305124|NCT05107453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305125|NCT05107453|Sensory System Agents|sensory system agents|mesh-ancestor
64305126|NCT05107453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64305127|NCT03493178|Acetylcysteine|acetylcysteine|mesh-list
64305128|NCT03493178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64305129|NCT03493178|Glycine|glycine|mesh-list
64305130|NCT03493178|Antiviral Agents|antiviral agents|mesh-ancestor
64305131|NCT03493178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64395592|NCT04520711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64395593|NCT04520711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395594|NCT03126617|Elotuzumab|elotuzumab|mesh-list
64395595|NCT03126617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395596|NCT04422743|Tramiprosate|tramiprosate|mesh-list
64868286|NCT01815268|Vaccines|vaccines|mesh-list
64395597|NCT04422743|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64395598|NCT04422743|Nootropic Agents|nootropic agents|mesh-ancestor
64395599|NCT04422743|Anticonvulsants|anticonvulsants|mesh-ancestor
64395600|NCT04422743|GABA Agonists|gaba agonists|mesh-ancestor
64784269|NCT04179474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64784270|NCT04179474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784272|NCT04175262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395609|NCT02535221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64395610|NCT02535221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64395611|NCT02535221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64395612|NCT02535221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395613|NCT02535221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64395614|NCT00000587|Epoetin Alfa|epoetin alfa|mesh-list
64395615|NCT00000587|Hematinics|hematinics|mesh-ancestor
64395616|NCT04592159|Nabiximols|nabiximols|mesh-list
64395617|NCT04592159|Analgesics|analgesics|mesh-ancestor
64395618|NCT04592159|Sensory System Agents|sensory system agents|mesh-ancestor
64395619|NCT04592159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64305132|NCT03493178|Expectorants|expectorants|mesh-ancestor
64305133|NCT03493178|Respiratory System Agents|respiratory system agents|mesh-ancestor
64305134|NCT03493178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64305135|NCT03493178|Antioxidants|antioxidants|mesh-ancestor
64395630|NCT04419389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395631|NCT04419389|Immunologic Factors|immunologic factors|mesh-ancestor
64395632|NCT04419389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395636|NCT05304845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64395637|NCT05304845|Analgesics|analgesics|mesh-ancestor
64868328|NCT01815723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868329|NCT01815892|Furosemide|furosemide|mesh-list
64868330|NCT01815892|Diuretics|diuretics|mesh-ancestor
64395638|NCT05304845|Sensory System Agents|sensory system agents|mesh-ancestor
64395639|NCT05304845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395640|NCT05304845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395641|NCT05304845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64395642|NCT05304845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64395649|NCT05304845|Antipyretics|antipyretics|mesh-ancestor
64395650|NCT05303597|Lidocaine|lidocaine|mesh-list
64395655|NCT05303597|Sensory System Agents|sensory system agents|mesh-ancestor
64395656|NCT05303597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395657|NCT05303597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64395658|NCT05303597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64395659|NCT05303597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64784342|NCT03933774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305136|NCT03493178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305137|NCT03493178|Protective Agents|protective agents|mesh-ancestor
64305138|NCT03493178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305139|NCT03493178|Antidotes|antidotes|mesh-ancestor
64305140|NCT03493178|Glycine Agents|glycine agents|mesh-ancestor
64868350|NCT01816035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868351|NCT01816035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64868352|NCT01816035|Tubulin Modulators|tubulin modulators|mesh-ancestor
64868353|NCT01816035|Antimitotic Agents|antimitotic agents|mesh-ancestor
64868354|NCT01816035|Mitosis Modulators|mitosis modulators|mesh-ancestor
64868355|NCT01816035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868356|NCT01816035|Immunologic Factors|immunologic factors|mesh-ancestor
64868358|NCT01816191|Diltiazem|diltiazem|mesh-list
64305141|NCT03493178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64305142|NCT04548440|Paclitaxel|paclitaxel|mesh-list
64305143|NCT04548440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64305144|NCT04548440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64305145|NCT04548440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305146|NCT04548440|Tubulin Modulators|tubulin modulators|mesh-ancestor
64305147|NCT04548440|Antimitotic Agents|antimitotic agents|mesh-ancestor
64305148|NCT04548440|Mitosis Modulators|mitosis modulators|mesh-ancestor
64868379|NCT01816334|Antiemetics|antiemetics|mesh-ancestor
64868380|NCT01816334|Autonomic Agents|autonomic agents|mesh-ancestor
64868381|NCT01816334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64868382|NCT01816334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868383|NCT01816334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64868384|NCT01816334|Glucocorticoids|glucocorticoids|mesh-ancestor
64868385|NCT01816334|Hormones|hormones|mesh-ancestor
64868386|NCT01816334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64868387|NCT01816334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64868388|NCT01816334|Protective Agents|protective agents|mesh-ancestor
64305149|NCT04548440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305151|NCT03742921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64784383|NCT03849690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64784384|NCT03849690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64784385|NCT03849690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64395693|NCT04328441|Immunologic Factors|immunologic factors|mesh-ancestor
64395694|NCT04328441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395695|NCT04314713|Scopolamine|scopolamine|mesh-list
64868457|NCT01816646|Renal Agents|renal agents|mesh-ancestor
64305152|NCT03742921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305153|NCT02626520|Gemcitabine|gemcitabine|mesh-list
64305154|NCT02626520|Paclitaxel|paclitaxel|mesh-list
64305155|NCT02626520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64305156|NCT02626520|Fluorouracil|fluorouracil|mesh-list
64305157|NCT02626520|Irinotecan|irinotecan|mesh-list
64305158|NCT02626520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64305159|NCT02626520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305160|NCT02626520|Tubulin Modulators|tubulin modulators|mesh-ancestor
64305161|NCT02626520|Antimitotic Agents|antimitotic agents|mesh-ancestor
64305162|NCT02626520|Mitosis Modulators|mitosis modulators|mesh-ancestor
64305163|NCT02626520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305164|NCT02626520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64305165|NCT02626520|Antimetabolites|antimetabolites|mesh-ancestor
64305166|NCT02626520|Antiviral Agents|antiviral agents|mesh-ancestor
64305167|NCT02626520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64305168|NCT02626520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305169|NCT02626520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64305170|NCT02626520|Immunologic Factors|immunologic factors|mesh-ancestor
64868556|NCT01817348|Anesthetics, Local|anesthetics, local|mesh-ancestor
64868557|NCT01817348|Anesthetics|anesthetics|mesh-ancestor
64305171|NCT02626520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305172|NCT02626520|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64305173|NCT02626520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64305174|NCT03063710|Olaparib|olaparib|mesh-list
64305175|NCT03063710|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64305176|NCT03063710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305177|NCT03063710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305178|NCT03063710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305179|NCT05084521|Famotidine|famotidine|mesh-list
64305180|NCT05084521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64305181|NCT05084521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64305182|NCT05084521|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64305183|NCT05084521|Histamine Antagonists|histamine antagonists|mesh-ancestor
64395700|NCT04314713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395701|NCT04314713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395702|NCT04314713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64395703|NCT04314713|Mydriatics|mydriatics|mesh-ancestor
64395704|NCT04314713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64395705|NCT04314713|Cholinergic Agents|cholinergic agents|mesh-ancestor
64784386|NCT03849690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784387|NCT03822078|Denosumab|denosumab|mesh-list
64784388|NCT03822078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64784389|NCT03822078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784390|NCT03806556|Tranexamic Acid|tranexamic acid|mesh-list
64784391|NCT03806556|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64784392|NCT03806556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64784393|NCT03806556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784394|NCT03806556|Hemostatics|hemostatics|mesh-ancestor
64784395|NCT03806556|Coagulants|coagulants|mesh-ancestor
64784396|NCT03812328|Enoxaparin|enoxaparin|mesh-list
64784397|NCT03812328|Anticoagulants|anticoagulants|mesh-ancestor
64305196|NCT02971891|Natriuretic Agents|natriuretic agents|mesh-ancestor
64395707|NCT04314713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395708|NCT04314713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64395709|NCT04314713|Parasympatholytics|parasympatholytics|mesh-ancestor
64395710|NCT04121507|Cyclophosphamide|cyclophosphamide|mesh-list
64395711|NCT04121507|Thiotepa|thiotepa|mesh-list
64395712|NCT04121507|Fludarabine|fludarabine|mesh-list
64395713|NCT04121507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64395714|NCT04121507|Immunologic Factors|immunologic factors|mesh-ancestor
64395715|NCT04121507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395716|NCT04121507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64784408|NCT03796260|Entrectinib|entrectinib|mesh-list
64784409|NCT03796260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64305197|NCT02971891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305198|NCT02971891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64305199|NCT02971891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64305200|NCT02971891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305201|NCT05063851|Memantine|memantine|mesh-list
64305202|NCT05063851|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64305203|NCT05063851|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64784410|NCT03796260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784411|NCT03796260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784412|NCT03796182|Metformin|metformin|mesh-list
64784413|NCT03796182|Abrocitinib|abrocitinib|mesh-list
64784414|NCT03796182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64784415|NCT03796182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784416|NCT03796182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64784417|NCT03796182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784418|NCT03796182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868714|NCT01818869|Purinergic Agents|purinergic agents|mesh-ancestor
64868715|NCT01818869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64868716|NCT01818869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868717|NCT01818908|Prednisone|prednisone|mesh-list
64868718|NCT01818908|Cyclophosphamide|cyclophosphamide|mesh-list
64868719|NCT01818908|Doxorubicin|doxorubicin|mesh-list
64868720|NCT01818908|Etoposide|etoposide|mesh-list
64868721|NCT01818908|Vincristine|vincristine|mesh-list
64868722|NCT01818908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64868723|NCT01818908|Immunologic Factors|immunologic factors|mesh-ancestor
64868724|NCT01818908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868725|NCT01818908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64868726|NCT01818908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64868727|NCT01818908|Alkylating Agents|alkylating agents|mesh-ancestor
64868728|NCT01818908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868729|NCT01818908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784419|NCT03730116|Bisoprolol|bisoprolol|mesh-list
64305204|NCT05063851|Dopamine Agents|dopamine agents|mesh-ancestor
64305205|NCT05063851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64305206|NCT05063851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305207|NCT05063851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305208|NCT05063851|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64305209|NCT05063851|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64305210|NCT04392037|Dexamethasone|dexamethasone|mesh-list
64305211|NCT04392037|Cyclophosphamide|cyclophosphamide|mesh-list
64305212|NCT04392037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64305213|NCT04392037|Immunologic Factors|immunologic factors|mesh-ancestor
64305214|NCT04392037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305215|NCT04392037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64305216|NCT04392037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64305217|NCT04392037|Alkylating Agents|alkylating agents|mesh-ancestor
64305218|NCT04392037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305219|NCT04392037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305220|NCT04392037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64305221|NCT04392037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64305222|NCT04392037|Antiemetics|antiemetics|mesh-ancestor
64305223|NCT04392037|Autonomic Agents|autonomic agents|mesh-ancestor
64305224|NCT04392037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64305225|NCT04392037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64305226|NCT04392037|Glucocorticoids|glucocorticoids|mesh-ancestor
64868731|NCT01818908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64868732|NCT01818908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64868733|NCT01818908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64868734|NCT01818908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868735|NCT01818908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64868737|NCT01818908|Hormones|hormones|mesh-ancestor
64868738|NCT01818908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64868739|NCT01818908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64868740|NCT01818908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64868741|NCT01818908|Tubulin Modulators|tubulin modulators|mesh-ancestor
64868742|NCT01818908|Antimitotic Agents|antimitotic agents|mesh-ancestor
64868743|NCT01818908|Mitosis Modulators|mitosis modulators|mesh-ancestor
64868744|NCT01818973|Bevacizumab|bevacizumab|mesh-list
64868745|NCT01818973|Capecitabine|capecitabine|mesh-list
64868746|NCT01818973|Oxaliplatin|oxaliplatin|mesh-list
64868747|NCT01818973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64868748|NCT01818973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868749|NCT01818973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64868750|NCT01818973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64417369|NCT04807543|Progestins|progestins|mesh-ancestor
64784420|NCT03730116|Perindopril|perindopril|mesh-list
64784421|NCT03730116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64784422|NCT03730116|Sympatholytics|sympatholytics|mesh-ancestor
64395728|NCT04006925|Sodium Oxybate|sodium oxybate|mesh-list
64395729|NCT04006925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64395730|NCT04006925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64395731|NCT04006925|Anesthetics, General|anesthetics, general|mesh-ancestor
64395732|NCT04006925|Anesthetics|anesthetics|mesh-ancestor
64395733|NCT04006925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64395734|NCT04006925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395735|NCT03790397|Osimertinib|osimertinib|mesh-list
64868751|NCT01818973|Growth Substances|growth substances|mesh-ancestor
64868752|NCT01818973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868753|NCT01818973|Growth Inhibitors|growth inhibitors|mesh-ancestor
64868754|NCT01818973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64868755|NCT01818973|Antimetabolites|antimetabolites|mesh-ancestor
64868756|NCT01818973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868758|NCT01819012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64868759|NCT01819012|Anesthetics, General|anesthetics, general|mesh-ancestor
64868765|NCT01819155|Vaccines|vaccines|mesh-list
64395736|NCT03790397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395737|NCT03790397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64305227|NCT04392037|Hormones|hormones|mesh-ancestor
64305228|NCT04392037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64305229|NCT04392037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64305230|NCT03359161|Furosemide|furosemide|mesh-list
64305231|NCT03359161|Diuretics|diuretics|mesh-ancestor
64305232|NCT03359161|Natriuretic Agents|natriuretic agents|mesh-ancestor
64305233|NCT03359161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305234|NCT03359161|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64305235|NCT03359161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64305236|NCT03359161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305237|NCT05030623|Tadalafil|tadalafil|mesh-list
64305238|NCT05030623|Vasodilator Agents|vasodilator agents|mesh-ancestor
64305239|NCT05030623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64305240|NCT05030623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64305241|NCT05030623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305242|NCT05030623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305244|NCT04986631|Topiramate|topiramate|mesh-list
64305245|NCT04986631|Anticonvulsants|anticonvulsants|mesh-ancestor
64305246|NCT04986631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64305247|NCT04986631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305248|NCT03277339|Paroxetine|paroxetine|mesh-list
64305249|NCT03277339|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64395747|NCT03718559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395749|NCT01228331|Cytarabine|cytarabine|mesh-list
64395750|NCT01228331|Dexamethasone|dexamethasone|mesh-list
64395751|NCT01228331|Methylprednisolone|methylprednisolone|mesh-list
64395752|NCT01228331|Cyclophosphamide|cyclophosphamide|mesh-list
64395753|NCT01228331|Doxorubicin|doxorubicin|mesh-list
64395754|NCT01228331|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64395755|NCT01228331|Methotrexate|methotrexate|mesh-list
64395756|NCT01228331|Etoposide|etoposide|mesh-list
64784441|NCT03161964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64784442|NCT03161964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784443|NCT03161964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784444|NCT03161964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64784445|NCT03161964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64784446|NCT03161964|Vasodilator Agents|vasodilator agents|mesh-ancestor
64784447|NCT03078270|Botulinum Toxins|botulinum toxins|mesh-list
64784448|NCT03078270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64395757|NCT01228331|Vincristine|vincristine|mesh-list
64395758|NCT01228331|Daunorubicin|daunorubicin|mesh-list
64395759|NCT01228331|Mercaptopurine|mercaptopurine|mesh-list
64395760|NCT01228331|Clofarabine|clofarabine|mesh-list
64395761|NCT01228331|Pegaspargase|pegaspargase|mesh-list
64868835|NCT01819610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395762|NCT01228331|Thioguanine|thioguanine|mesh-list
64395763|NCT01228331|Etoposide phosphate|etoposide phosphate|mesh-list
64395764|NCT01228331|Amsacrine|amsacrine|mesh-list
64395765|NCT01228331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64305266|NCT03145675|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64305267|NCT03145675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305268|NCT04251715|Leucovorin|leucovorin|mesh-list
64305269|NCT04251715|Dexamethasone|dexamethasone|mesh-list
64305270|NCT04251715|Dexamethasone acetate|dexamethasone acetate|mesh-list
64305271|NCT04251715|Fluorouracil|fluorouracil|mesh-list
64305272|NCT04251715|Oxaliplatin|oxaliplatin|mesh-list
64305273|NCT04251715|Irinotecan|irinotecan|mesh-list
64305293|NCT04251715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64305294|NCT04251715|Immunologic Factors|immunologic factors|mesh-ancestor
64305295|NCT04251715|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64305296|NCT04251715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64305297|NCT04251715|Antidotes|antidotes|mesh-ancestor
64305298|NCT04251715|Protective Agents|protective agents|mesh-ancestor
64305299|NCT04251715|Vitamin B Complex|vitamin b complex|mesh-ancestor
64305300|NCT04251715|Vitamins|vitamins|mesh-ancestor
64868895|NCT01819961|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64868896|NCT01819961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64868897|NCT01820026|Amoxicillin|amoxicillin|mesh-list
64868898|NCT01820026|Azithromycin|azithromycin|mesh-list
64868899|NCT01820026|Vancomycin|vancomycin|mesh-list
64868900|NCT01820026|Imipenem|imipenem|mesh-list
64868901|NCT01820026|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64868902|NCT01820026|Cefotaxime|cefotaxime|mesh-list
64868903|NCT01820026|Cefoxitin|cefoxitin|mesh-list
64868904|NCT01820026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64868905|NCT01820026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64868906|NCT01820026|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64868907|NCT01820026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868908|NCT01820026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868909|NCT01820091|Levoleucovorin|levoleucovorin|mesh-list
64868910|NCT01820091|Antidotes|antidotes|mesh-ancestor
64868911|NCT01820091|Protective Agents|protective agents|mesh-ancestor
64868912|NCT01820091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868913|NCT01820104|Lansoprazole|lansoprazole|mesh-list
64417448|NCT04805827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64417449|NCT04805827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64417450|NCT04805827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64305301|NCT04251715|Micronutrients|micronutrients|mesh-ancestor
64305302|NCT04042727|Dexmedetomidine|dexmedetomidine|mesh-list
64305303|NCT04042727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64305304|NCT04042727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64305305|NCT04042727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305306|NCT04042727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64305307|NCT04042727|Analgesics|analgesics|mesh-ancestor
64305308|NCT04042727|Sensory System Agents|sensory system agents|mesh-ancestor
64305309|NCT04042727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64305310|NCT04042727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64305311|NCT04042727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64305312|NCT04042727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64305313|NCT04042727|Adrenergic Agents|adrenergic agents|mesh-ancestor
64305314|NCT04042727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64305337|NCT04940299|Immunoglobulins|immunoglobulins|mesh-list
64305338|NCT04940299|Immunoglobulin G|immunoglobulin g|mesh-list
64305339|NCT04940299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64305340|NCT04940299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305341|NCT04940299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64305342|NCT04940299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305343|NCT04940299|Immunologic Factors|immunologic factors|mesh-ancestor
64305344|NCT04940299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305345|NCT02819297|Laxatives|laxatives|mesh-list
64305346|NCT02819297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64305347|NCT05134441|Calcium, Dietary|calcium, dietary|mesh-list
64305348|NCT05134441|Calcium|calcium|mesh-list
64305349|NCT05134441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64305350|NCT05134441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305351|NCT05134441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64868914|NCT01820104|Dexlansoprazole|dexlansoprazole|mesh-list
64868915|NCT01820104|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64868916|NCT01820104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64868917|NCT01820104|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64868918|NCT01820104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868919|NCT01820104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868920|NCT01820143|Esomeprazole|esomeprazole|mesh-list
64868921|NCT01820143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64868922|NCT01820143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64868923|NCT01820143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64868924|NCT01820143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868925|NCT01820143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868926|NCT01820299|Vitamin D|vitamin d|mesh-list
64868927|NCT01820299|Grape Seed Extract|grape seed extract|mesh-list
64868928|NCT01820299|Vitamins|vitamins|mesh-ancestor
64417526|NCT04813471|Hematinics|hematinics|mesh-ancestor
64417527|NCT04813471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64417528|NCT04813471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64417529|NCT04813471|Vasodilator Agents|vasodilator agents|mesh-ancestor
64417530|NCT04803175|Valsartan|valsartan|mesh-list
64305352|NCT03309878|Pembrolizumab|pembrolizumab|mesh-list
64305353|NCT03309878|Mogamulizumab|mogamulizumab|mesh-list
64305354|NCT03309878|Immunoglobulins|immunoglobulins|mesh-list
64305355|NCT03309878|Immunoglobulin G|immunoglobulin g|mesh-list
64305356|NCT03309878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64305357|NCT03309878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305358|NCT03309878|Immunologic Factors|immunologic factors|mesh-ancestor
64305359|NCT03309878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305360|NCT04925557|Ocrelizumab|ocrelizumab|mesh-list
64305361|NCT04925557|Siponimod|siponimod|mesh-list
64784526|NCT02744352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64784527|NCT02744352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784528|NCT02744352|Sensory System Agents|sensory system agents|mesh-ancestor
64784529|NCT02744352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64784530|NCT02587650|Ceritinib|ceritinib|mesh-list
64784531|NCT02587650|Entrectinib|entrectinib|mesh-list
64305380|NCT02821715|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64305381|NCT02821715|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64305382|NCT02821715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64305383|NCT04377932|Cyclophosphamide|cyclophosphamide|mesh-list
64305384|NCT04377932|Fludarabine|fludarabine|mesh-list
64305385|NCT04377932|Fludarabine phosphate|fludarabine phosphate|mesh-list
64305386|NCT04377932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64305387|NCT04377932|Immunologic Factors|immunologic factors|mesh-ancestor
64784532|NCT02587650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784533|NCT02587650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64395817|NCT03136445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64395818|NCT03136445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395819|NCT03136445|Hemostatics|hemostatics|mesh-ancestor
64395820|NCT03136445|Coagulants|coagulants|mesh-ancestor
64395821|NCT00887783|Vinorelbine|vinorelbine|mesh-list
64395822|NCT00887783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64395823|NCT00887783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395824|NCT00887783|Tubulin Modulators|tubulin modulators|mesh-ancestor
64395825|NCT00887783|Antimitotic Agents|antimitotic agents|mesh-ancestor
64395826|NCT00887783|Mitosis Modulators|mitosis modulators|mesh-ancestor
64305450|NCT02036489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64305451|NCT02036489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64305452|NCT02036489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64305453|NCT02036489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305454|NCT02036489|Antimetabolites|antimetabolites|mesh-ancestor
64305455|NCT02036489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64305456|NCT02036489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64869062|NCT01821027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64395827|NCT00887783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784544|NCT02514252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64784545|NCT02514252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64395829|NCT02047097|Dermatologic Agents|dermatologic agents|mesh-ancestor
64395830|NCT02047097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64395831|NCT02047097|Immunologic Factors|immunologic factors|mesh-ancestor
64395832|NCT02047097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395833|NCT01125371|Ethanol|ethanol|mesh-list
64395834|NCT01125371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64395835|NCT01125371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64395836|NCT01125371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64395837|NCT01125371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305597|NCT02048423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64305598|NCT02048423|Anesthetics, General|anesthetics, general|mesh-ancestor
64305695|NCT02048969|Protective Agents|protective agents|mesh-ancestor
64305702|NCT03561935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64324449|NCT02262481|Hormones|hormones|mesh-ancestor
64305875|NCT02052323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305876|NCT02052323|Antiviral Agents|antiviral agents|mesh-ancestor
64305877|NCT02052323|Schistosomicides|schistosomicides|mesh-ancestor
64305878|NCT02052323|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64305879|NCT02052323|Anthelmintics|anthelmintics|mesh-ancestor
64305880|NCT02056223|Acetaminophen|acetaminophen|mesh-list
64305881|NCT02056223|Ibuprofen|ibuprofen|mesh-list
64306102|NCT01333865|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64306106|NCT01333865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324450|NCT02262481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64324451|NCT02262481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324452|NCT01435369|Pidilizumab|pidilizumab|mesh-list
64784578|NCT02345460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784579|NCT02345460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64784580|NCT02345460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784581|NCT02345460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64784582|NCT02345460|Immunologic Factors|immunologic factors|mesh-ancestor
64784583|NCT02345460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64784584|NCT02345460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64784585|NCT02345460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784587|NCT02345460|Protective Agents|protective agents|mesh-ancestor
64784588|NCT02345460|Vitamin B Complex|vitamin b complex|mesh-ancestor
64306210|NCT02058485|GABA Modulators|gaba modulators|mesh-ancestor
64306211|NCT02058485|GABA Agents|gaba agents|mesh-ancestor
64306212|NCT02060279|Carotenoids|carotenoids|mesh-list
64306213|NCT02060279|Antioxidants|antioxidants|mesh-ancestor
64306214|NCT02060279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306215|NCT02060279|Protective Agents|protective agents|mesh-ancestor
64306216|NCT02060279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306217|NCT02058641|Darapladib|darapladib|mesh-list
64784589|NCT02345460|Vitamins|vitamins|mesh-ancestor
64784590|NCT02345460|Micronutrients|micronutrients|mesh-ancestor
64784591|NCT02345772|Docetaxel|docetaxel|mesh-list
64784592|NCT02345772|Trastuzumab|trastuzumab|mesh-list
64784593|NCT02345772|Fulvestrant|fulvestrant|mesh-list
64784594|NCT02345772|Pertuzumab|pertuzumab|mesh-list
64784595|NCT02345772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784596|NCT02345772|Tubulin Modulators|tubulin modulators|mesh-ancestor
64784597|NCT02345772|Antimitotic Agents|antimitotic agents|mesh-ancestor
64784598|NCT02345772|Mitosis Modulators|mitosis modulators|mesh-ancestor
64784599|NCT02345772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784600|NCT02345772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64784601|NCT02345772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64784602|NCT02345772|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64395860|NCT00416351|Antimetabolites|antimetabolites|mesh-ancestor
64869299|NCT01822509|Ipilimumab|ipilimumab|mesh-list
64395861|NCT00416351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395862|NCT00416351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395863|NCT03938831|Fentanyl|fentanyl|mesh-list
64395864|NCT03938831|Dexmedetomidine|dexmedetomidine|mesh-list
64395865|NCT03938831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64395866|NCT03938831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64395867|NCT03938831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395868|NCT03938831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64784603|NCT02345772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64784604|NCT02345772|Hormone Antagonists|hormone antagonists|mesh-ancestor
64784605|NCT02345772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64306286|NCT02061917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64306287|NCT02061917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64306288|NCT02061917|Cholinergic Agents|cholinergic agents|mesh-ancestor
64306311|NCT02422186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306312|NCT02422186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64306313|NCT02422186|Serotonin Agents|serotonin agents|mesh-ancestor
64306314|NCT02422186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306315|NCT02422186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64306316|NCT02422186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64306317|NCT02422186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64306318|NCT02422186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64306319|NCT02422186|Analgesics|analgesics|mesh-ancestor
64306320|NCT02422186|Sensory System Agents|sensory system agents|mesh-ancestor
64306321|NCT02422186|Dopamine Agents|dopamine agents|mesh-ancestor
64869341|NCT01822730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869342|NCT01822730|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64869343|NCT01822730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64869344|NCT01822730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64869345|NCT01822730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64869346|NCT01822730|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64869347|NCT01822730|Dopamine Agents|dopamine agents|mesh-ancestor
64869348|NCT01822730|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64869349|NCT01822730|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64869350|NCT01822808|Hydralazine|hydralazine|mesh-list
64333645|NCT02373579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64333646|NCT02373579|Antimetabolites|antimetabolites|mesh-ancestor
64417642|NCT04789915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64417644|NCT04789915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64417645|NCT04789915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64417646|NCT04789915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64417647|NCT04789915|Antidepressive Agents|antidepressive agents|mesh-ancestor
64306323|NCT02796677|Formoterol Fumarate|formoterol fumarate|mesh-list
64784606|NCT02345772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784607|NCT02280252|Paclitaxel|paclitaxel|mesh-list
64784608|NCT02280252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64784609|NCT02280252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784610|NCT02280252|Tubulin Modulators|tubulin modulators|mesh-ancestor
64784611|NCT02280252|Antimitotic Agents|antimitotic agents|mesh-ancestor
64784612|NCT02280252|Mitosis Modulators|mitosis modulators|mesh-ancestor
64784613|NCT02280252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784614|NCT02140788|Metformin|metformin|mesh-list
64784615|NCT02140788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64784616|NCT02140788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784617|NCT02133534|Atorvastatin|atorvastatin|mesh-list
64784618|NCT02133534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64784619|NCT02133534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64784620|NCT02133534|Antimetabolites|antimetabolites|mesh-ancestor
64784621|NCT02133534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784622|NCT02133534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64784623|NCT02133534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64306351|NCT04973462|Oseltamivir|oseltamivir|mesh-list
64306352|NCT04973462|Antiviral Agents|antiviral agents|mesh-ancestor
64306353|NCT04973462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64306354|NCT04973462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306355|NCT04973462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306356|NCT02378506|Etanercept|etanercept|mesh-list
64306357|NCT02378506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64306358|NCT02378506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64784624|NCT02133534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64395882|NCT03938831|Anesthetics, General|anesthetics, general|mesh-ancestor
64395883|NCT03938831|Anesthetics|anesthetics|mesh-ancestor
64333647|NCT02373579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869351|NCT01822808|Isosorbide|isosorbide|mesh-list
64869352|NCT01822808|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64869353|NCT01822808|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64869354|NCT01822808|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64869355|NCT01822808|Diuretics|diuretics|mesh-ancestor
64869356|NCT01822808|Natriuretic Agents|natriuretic agents|mesh-ancestor
64869357|NCT01822808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869358|NCT01822808|Vasodilator Agents|vasodilator agents|mesh-ancestor
64869359|NCT01822808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64869361|NCT01822808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64395884|NCT02592707|Dexamethasone|dexamethasone|mesh-list
64395885|NCT02592707|Ondansetron|ondansetron|mesh-list
64395886|NCT02592707|Antiemetics|antiemetics|mesh-list
64395887|NCT02592707|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
64395888|NCT02592707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64395889|NCT02592707|Autonomic Agents|autonomic agents|mesh-ancestor
64395890|NCT02592707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395891|NCT02592707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395892|NCT02592707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64395893|NCT02592707|Glucocorticoids|glucocorticoids|mesh-ancestor
64324454|NCT01435369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324455|NCT01257607|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64306401|NCT02063945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64306402|NCT02064023|Insulin|insulin|mesh-list
64306403|NCT02064023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64306404|NCT02064023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64306405|NCT02064023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306406|NCT02064725|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
64306407|NCT02064725|Interferon Inducers|interferon inducers|mesh-ancestor
64306408|NCT02064725|Immunologic Factors|immunologic factors|mesh-ancestor
64869370|NCT01822860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869371|NCT01822951|Cerebrolysin|cerebrolysin|mesh-list
64869372|NCT01822951|Donepezil|donepezil|mesh-list
64869373|NCT01822951|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64869374|NCT01822951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869376|NCT01822951|Cholinergic Agents|cholinergic agents|mesh-ancestor
64306409|NCT02064725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306410|NCT01370603|Atorvastatin|atorvastatin|mesh-list
64324456|NCT01257607|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64324458|NCT01252693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64324459|NCT01252693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324460|NCT03980509|Curcumin|curcumin|mesh-list
64324461|NCT03980509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64395919|NCT03104855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64395920|NCT03104621|Benzalkonium Compounds|benzalkonium compounds|mesh-list
64395921|NCT03104621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64395922|NCT03104621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64395923|NCT03102359|Dexmedetomidine|dexmedetomidine|mesh-list
64306460|NCT02064491|Tubulin Modulators|tubulin modulators|mesh-ancestor
64869421|NCT01823133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64869422|NCT01823133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869423|NCT01823159|Ezogabine|ezogabine|mesh-list
64869424|NCT01823159|Anticonvulsants|anticonvulsants|mesh-ancestor
64869425|NCT01823159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64869426|NCT01823159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869427|NCT01823172|Methylene Blue|methylene blue|mesh-list
64869428|NCT01823172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869429|NCT01823172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869430|NCT01823185|Clopidogrel|clopidogrel|mesh-list
64869431|NCT01823185|Ticagrelor|ticagrelor|mesh-list
64869432|NCT01823185|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64869433|NCT01823185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64869434|NCT01823185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64869435|NCT01823185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64869436|NCT01823185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64869437|NCT01823185|Purinergic Agents|purinergic agents|mesh-ancestor
64869438|NCT01823185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64869439|NCT01823185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417787|NCT04786327|Antidotes|antidotes|mesh-ancestor
64417788|NCT04786327|Protective Agents|protective agents|mesh-ancestor
64417789|NCT04786327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417791|NCT04153435|Calcium|calcium|mesh-list
64417792|NCT04153435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64417793|NCT04153435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417794|NCT01667419|Vemurafenib|vemurafenib|mesh-list
64417795|NCT01667419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417796|NCT01667419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64306461|NCT02064491|Antimitotic Agents|antimitotic agents|mesh-ancestor
64306462|NCT02064491|Mitosis Modulators|mitosis modulators|mesh-ancestor
64306463|NCT02064491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306464|NCT02064491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306465|NCT02064491|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64306466|NCT02064491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64306467|NCT02064491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64306468|NCT02064881|Metformin|metformin|mesh-list
64306469|NCT02064881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64306470|NCT02064881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306471|NCT02346370|Docetaxel|docetaxel|mesh-list
64306472|NCT02346370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64306473|NCT02346370|Tubulin Modulators|tubulin modulators|mesh-ancestor
64306474|NCT02346370|Antimitotic Agents|antimitotic agents|mesh-ancestor
64306475|NCT02346370|Mitosis Modulators|mitosis modulators|mesh-ancestor
64306477|NCT02065739|Itraconazole|itraconazole|mesh-list
64784645|NCT01980342|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64784646|NCT01980342|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64784647|NCT01980342|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64306507|NCT02793947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64306508|NCT02793947|Anesthetics, Local|anesthetics, local|mesh-ancestor
64306509|NCT02793947|Anesthetics|anesthetics|mesh-ancestor
64306672|NCT04964180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324470|NCT03980509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324471|NCT03980509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324472|NCT01486849|Riluzole|riluzole|mesh-list
64324473|NCT01486849|Anticonvulsants|anticonvulsants|mesh-ancestor
64869440|NCT01823185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869441|NCT01823393|Heparin|heparin|mesh-list
64869442|NCT01823393|Calcium heparin|calcium heparin|mesh-list
64869443|NCT01823393|Anticoagulants|anticoagulants|mesh-ancestor
64869444|NCT01823393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64869445|NCT01823393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64869446|NCT01823393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869447|NCT01823523|Clindamycin|clindamycin|mesh-list
64869448|NCT01823523|Clindamycin palmitate|clindamycin palmitate|mesh-list
64869449|NCT01823523|Clindamycin phosphate|clindamycin phosphate|mesh-list
64869450|NCT01823523|Cefazolin|cefazolin|mesh-list
64869451|NCT01823523|Cephalexin|cephalexin|mesh-list
64869452|NCT01823523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64869453|NCT01823523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64869454|NCT01823523|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64869455|NCT01823523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869456|NCT01823523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869457|NCT01823744|Micronutrients|micronutrients|mesh-list
64869458|NCT01823744|Trace Elements|trace elements|mesh-list
64869459|NCT01823744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324474|NCT01486849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64324475|NCT01486849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64324476|NCT01486849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64324477|NCT01486849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324478|NCT01486849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324479|NCT01486849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64784653|NCT01878786|Everolimus|everolimus|mesh-list
64784654|NCT01878786|Tacrolimus|tacrolimus|mesh-list
64784655|NCT01878786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64784656|NCT01878786|Immunologic Factors|immunologic factors|mesh-ancestor
64784657|NCT01878786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784658|NCT01878786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64784659|NCT01878786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784660|NCT01878786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784661|NCT01878786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784662|NCT01878786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64784663|NCT01878786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64784664|NCT01878786|Antitubercular Agents|antitubercular agents|mesh-ancestor
64784665|NCT01878786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64784666|NCT01878786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64784667|NCT01851174|Gemcitabine|gemcitabine|mesh-list
64784668|NCT01851174|Paclitaxel|paclitaxel|mesh-list
64784669|NCT01851174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64306705|NCT02625974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64306706|NCT02625974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64306707|NCT02625974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64306708|NCT02625974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64306709|NCT02067767|Lamivudine|lamivudine|mesh-list
64306710|NCT02067767|Abacavir|abacavir|mesh-list
64306711|NCT02067767|Dolutegravir|dolutegravir|mesh-list
64306712|NCT02067767|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64869461|NCT01823770|Dopamine Agonists|dopamine agonists|mesh-ancestor
64869462|NCT01823770|Dopamine Agents|dopamine agents|mesh-ancestor
64869463|NCT01823770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64869464|NCT01823770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869465|NCT01823770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869466|NCT01823809|Adenosine|adenosine|mesh-list
64869467|NCT01823809|Analgesics|analgesics|mesh-ancestor
64869468|NCT01823809|Sensory System Agents|sensory system agents|mesh-ancestor
64333649|NCT02373579|Dermatologic Agents|dermatologic agents|mesh-ancestor
64306713|NCT02067767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64306729|NCT03060044|Xhance|xhance|mesh-list
64784670|NCT01851174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784671|NCT01851174|Tubulin Modulators|tubulin modulators|mesh-ancestor
64784672|NCT01851174|Antimitotic Agents|antimitotic agents|mesh-ancestor
64784673|NCT01851174|Mitosis Modulators|mitosis modulators|mesh-ancestor
64395934|NCT03102359|Adrenergic Agents|adrenergic agents|mesh-ancestor
64395935|NCT03102359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64395936|NCT03102359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395937|NCT03104309|Levonorgestrel|levonorgestrel|mesh-list
64395938|NCT03104309|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64395939|NCT03104309|Contraceptive Agents|contraceptive agents|mesh-ancestor
64395940|NCT03104309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64395941|NCT03104309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395942|NCT03104309|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64395943|NCT03104309|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64395944|NCT03104309|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64395945|NCT03832049|Vaccines|vaccines|mesh-list
64395946|NCT03832049|Immunologic Factors|immunologic factors|mesh-ancestor
64395947|NCT03832049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395948|NCT02102477|Androgens|androgens|mesh-list
64395949|NCT02102477|Hormones|hormones|mesh-ancestor
64395956|NCT03103685|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64395957|NCT03103685|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64395958|NCT03103685|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64395960|NCT03103685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64395961|NCT03103685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869527|NCT01824264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64869528|NCT01824264|Licogliflozin|licogliflozin|mesh-list
64869529|NCT01824264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64869530|NCT01824264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869531|NCT01824264|Incretins|incretins|mesh-ancestor
64869532|NCT01824264|Hormones|hormones|mesh-ancestor
64869533|NCT01824264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64395962|NCT03103685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306732|NCT03060044|Charcoal|charcoal|mesh-list
64306733|NCT03060044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64306734|NCT03060044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64306735|NCT03060044|Autonomic Agents|autonomic agents|mesh-ancestor
64306736|NCT03060044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64306737|NCT03060044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306738|NCT03060044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64396001|NCT05103215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396002|NCT05001815|Insulin|insulin|mesh-list
64396012|NCT04771637|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64396013|NCT04771637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64396014|NCT04771637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396015|NCT04771637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64784751|NCT01608906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64784752|NCT01608906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784754|NCT01602198|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64306833|NCT02071043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306834|NCT02071043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64306835|NCT02076893|Ibuprofen|ibuprofen|mesh-list
64306836|NCT02076893|Gabapentin|gabapentin|mesh-list
64306837|NCT02076893|Tramadol|tramadol|mesh-list
64371135|NCT00705263|Antiviral Agents|antiviral agents|mesh-ancestor
64869560|NCT01824433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784755|NCT01602198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784756|NCT01602198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784757|NCT01602198|Cholinergic Agents|cholinergic agents|mesh-ancestor
64784758|NCT01602198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64784759|NCT01602198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784760|NCT01602198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64784761|NCT01602198|Protective Agents|protective agents|mesh-ancestor
64784762|NCT01545648|Denosumab|denosumab|mesh-list
64784763|NCT01545648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64306838|NCT02076893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64306839|NCT02076893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64306841|NCT02076893|Sensory System Agents|sensory system agents|mesh-ancestor
64306842|NCT02076893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64869587|NCT01824615|Growth Inhibitors|growth inhibitors|mesh-ancestor
64869588|NCT01824615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64869589|NCT01824615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869590|NCT01824615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869591|NCT01824758|Lidocaine|lidocaine|mesh-list
64869592|NCT01824758|Rocuronium|rocuronium|mesh-list
64869593|NCT01824758|Esmolol|esmolol|mesh-list
64869594|NCT01824758|Anesthetics, Local|anesthetics, local|mesh-ancestor
64869595|NCT01824758|Anesthetics|anesthetics|mesh-ancestor
64869596|NCT01824758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64869597|NCT01824758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869598|NCT01824758|Sensory System Agents|sensory system agents|mesh-ancestor
64869599|NCT01824758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64869600|NCT01824758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64869601|NCT01824758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64869602|NCT01824758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64869603|NCT01824758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64869604|NCT01824758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869605|NCT01824758|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64869606|NCT01824758|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64306843|NCT02076893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306844|NCT02076893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64306845|NCT02076893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64306846|NCT02076893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64306847|NCT02076893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306848|NCT02076893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306849|NCT02076893|Anticonvulsants|anticonvulsants|mesh-ancestor
64306850|NCT02076893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64306851|NCT02076893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64306852|NCT02076893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64306853|NCT02076893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64306854|NCT02076893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64306855|NCT02076893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64306856|NCT02076893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64306857|NCT02076893|Antimanic Agents|antimanic agents|mesh-ancestor
64869626|NCT01825031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64869627|NCT01825031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64869628|NCT01825031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64869629|NCT01825031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64869630|NCT01825031|Antiviral Agents|antiviral agents|mesh-ancestor
64869631|NCT01825031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64869632|NCT01825031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64869633|NCT01825031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869634|NCT01825031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869635|NCT01825031|Antifungal Agents|antifungal agents|mesh-ancestor
64869636|NCT01825031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64869637|NCT01825031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64869638|NCT01825031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64869639|NCT01825031|Hormone Antagonists|hormone antagonists|mesh-ancestor
64869640|NCT01825031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64869641|NCT01825031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869642|NCT01825031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64869643|NCT01825031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64869644|NCT01825031|Antitubercular Agents|antitubercular agents|mesh-ancestor
64306858|NCT02076893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64306859|NCT02076893|Narcotics|narcotics|mesh-ancestor
64306860|NCT02074163|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64306861|NCT02074163|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64306862|NCT02074163|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64306863|NCT02074163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64306864|NCT02074163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784764|NCT01545648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784765|NCT01527942|Acetaminophen|acetaminophen|mesh-list
64784766|NCT01527942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64784767|NCT01527942|Analgesics|analgesics|mesh-ancestor
64396016|NCT04771637|Analgesics|analgesics|mesh-ancestor
64396017|NCT04771637|Sensory System Agents|sensory system agents|mesh-ancestor
64396018|NCT04771637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64396019|NCT04771637|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64396020|NCT04771637|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64306875|NCT04963088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64306876|NCT04970576|Warfarin|warfarin|mesh-list
64306877|NCT04970576|Rivaroxaban|rivaroxaban|mesh-list
64306878|NCT04970576|Anticoagulants|anticoagulants|mesh-ancestor
64306879|NCT04970576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64869654|NCT01825031|Tubulin Modulators|tubulin modulators|mesh-ancestor
64869655|NCT01825031|Antimitotic Agents|antimitotic agents|mesh-ancestor
64869656|NCT01825031|Mitosis Modulators|mitosis modulators|mesh-ancestor
64306880|NCT04970576|Antithrombins|antithrombins|mesh-ancestor
64306881|NCT04970576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64306882|NCT04970576|Protease Inhibitors|protease inhibitors|mesh-ancestor
64306883|NCT04970576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306884|NCT04970576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306885|NCT02074319|Methotrexate|methotrexate|mesh-list
64306886|NCT02074319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64306888|NCT02074319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64306889|NCT02074319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306890|NCT02074319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64306891|NCT02074319|Antimetabolites|antimetabolites|mesh-ancestor
64306892|NCT02074319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306893|NCT02074319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64306894|NCT02074319|Dermatologic Agents|dermatologic agents|mesh-ancestor
64306895|NCT02074319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306896|NCT02074319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64869688|NCT01825395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64869689|NCT01825395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64869690|NCT01825395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869691|NCT01825395|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64869692|NCT01825395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64869693|NCT01825395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869694|NCT01825421|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64869695|NCT01825421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64869696|NCT01825447|Naltrexone|naltrexone|mesh-list
64869697|NCT01825447|Oxycodone|oxycodone|mesh-list
64869698|NCT01825447|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64869699|NCT01825447|Narcotics|narcotics|mesh-ancestor
64869702|NCT01825447|Analgesics|analgesics|mesh-ancestor
64306897|NCT02074319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64306898|NCT02074319|Immunologic Factors|immunologic factors|mesh-ancestor
64306899|NCT02074319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64306900|NCT02074319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64306902|NCT04975022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64306914|NCT04974944|Bevacizumab|bevacizumab|mesh-list
64306915|NCT04974944|Carboplatin|carboplatin|mesh-list
64306916|NCT04974944|Apatinib|apatinib|mesh-list
64306917|NCT04974944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64306918|NCT04974944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64306919|NCT04974944|Tubulin Modulators|tubulin modulators|mesh-ancestor
64396021|NCT04771637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64396022|NCT04771637|Adrenergic Agents|adrenergic agents|mesh-ancestor
64396023|NCT04771637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64396024|NCT04771637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396025|NCT03101735|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64396026|NCT03101735|Dermatologic Agents|dermatologic agents|mesh-ancestor
64396027|NCT03101735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64396028|NCT03101735|Immunologic Factors|immunologic factors|mesh-ancestor
64396029|NCT03101735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396030|NCT04701593|Triamcinolone|triamcinolone|mesh-list
64869721|NCT01825473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869722|NCT01825473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64869723|NCT01825473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64869724|NCT01825473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64869725|NCT01825473|GABA Modulators|gaba modulators|mesh-ancestor
64869726|NCT01825473|GABA Agents|gaba agents|mesh-ancestor
64869727|NCT01825473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64869728|NCT01825473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64869729|NCT01825473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64869730|NCT01825551|Lenograstim|lenograstim|mesh-list
64869731|NCT01825551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64869732|NCT01825551|Immunologic Factors|immunologic factors|mesh-ancestor
64869733|NCT01825551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869734|NCT01825590|Dialysis Solutions|dialysis solutions|mesh-list
64869735|NCT01825590|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64869736|NCT01825603|Gemcitabine|gemcitabine|mesh-list
64869737|NCT01825603|Cisplatin|cisplatin|mesh-list
64869738|NCT01825603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784768|NCT01527942|Sensory System Agents|sensory system agents|mesh-ancestor
64784769|NCT01527942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64306922|NCT04974944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306923|NCT04974944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64306924|NCT04974944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64306925|NCT04974944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64306926|NCT04974944|Growth Substances|growth substances|mesh-ancestor
64306927|NCT04974944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306928|NCT04974944|Growth Inhibitors|growth inhibitors|mesh-ancestor
64306929|NCT04974944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64306930|NCT04974944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306931|NCT04962386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64306932|NCT04962386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64306933|NCT04962386|Hormones|hormones|mesh-list
64306934|NCT04962386|Estradiol|estradiol|mesh-list
64306935|NCT04962386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64306936|NCT04962386|Progesterone|progesterone|mesh-list
64306937|NCT04962386|Estrogens|estrogens|mesh-list
64306938|NCT04962386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64306939|NCT04962386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306940|NCT04962386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64306941|NCT04962386|Contraceptive Agents|contraceptive agents|mesh-ancestor
64306942|NCT04962386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64306943|NCT04962386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64306944|NCT04962386|Progestins|progestins|mesh-ancestor
64306945|NCT02071355|Simeprevir|simeprevir|mesh-list
64306946|NCT02071355|Antiviral Agents|antiviral agents|mesh-ancestor
64306947|NCT02071355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64869743|NCT01825603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64869744|NCT01825603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869746|NCT01825603|Immunologic Factors|immunologic factors|mesh-ancestor
64306951|NCT02071433|Iodine|iodine|mesh-list
64784770|NCT01527942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784772|NCT01507584|Bimatoprost|bimatoprost|mesh-list
64784773|NCT01507584|Brinzolamide|brinzolamide|mesh-list
64784774|NCT01507584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64784775|NCT01507584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64784776|NCT01507584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784777|NCT01507584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784778|NCT01483872|Tigecycline|tigecycline|mesh-list
64784779|NCT01483872|Heparin|heparin|mesh-list
64784780|NCT01483872|Calcium heparin|calcium heparin|mesh-list
64306959|NCT04962308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306960|NCT02071589|Nifedipine|nifedipine|mesh-list
64306961|NCT02071589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64869781|NCT01825863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64869782|NCT01825902|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64869783|NCT01825902|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64869784|NCT01825902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869785|NCT01825928|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64869786|NCT01825928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64869787|NCT01825928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64869788|NCT01825928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64869789|NCT01825928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869790|NCT01825928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64869791|NCT01825928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64869792|NCT01825928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64869793|NCT01825928|Serotonin Agents|serotonin agents|mesh-ancestor
64333653|NCT02373579|Immunologic Factors|immunologic factors|mesh-ancestor
64333654|NCT02373579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64333655|NCT02373579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64333656|NCT02365857|Dexmedetomidine|dexmedetomidine|mesh-list
64869799|NCT01825993|Morphine|morphine|mesh-list
64306962|NCT02071589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64306963|NCT02071589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306964|NCT02071589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64306965|NCT02071589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306966|NCT02071589|Vasodilator Agents|vasodilator agents|mesh-ancestor
64306967|NCT02071589|Tocolytic Agents|tocolytic agents|mesh-ancestor
64306968|NCT02071589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64306969|NCT04970342|Alprazolam|alprazolam|mesh-list
64396032|NCT04701593|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64396033|NCT04701593|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64396034|NCT04701593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64396035|NCT04701593|Glucocorticoids|glucocorticoids|mesh-ancestor
64396036|NCT04701593|Hormones|hormones|mesh-ancestor
64396037|NCT04701593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64396038|NCT04701593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396039|NCT04701593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64396040|NCT04701593|Immunologic Factors|immunologic factors|mesh-ancestor
64307031|NCT04968392|Dexmedetomidine|dexmedetomidine|mesh-list
64307032|NCT04968392|Levobupivacaine|levobupivacaine|mesh-list
64307033|NCT04968392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64307034|NCT04968392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64307035|NCT04968392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307036|NCT04968392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64307037|NCT04968392|Analgesics|analgesics|mesh-ancestor
64307038|NCT04968392|Sensory System Agents|sensory system agents|mesh-ancestor
64307039|NCT04968392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64307040|NCT04968392|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64307041|NCT04968392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64307042|NCT04968392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64307043|NCT04968392|Adrenergic Agents|adrenergic agents|mesh-ancestor
64307044|NCT04968392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64307045|NCT04968392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307046|NCT04968392|Anesthetics, Local|anesthetics, local|mesh-ancestor
64307047|NCT04968392|Anesthetics|anesthetics|mesh-ancestor
64307048|NCT02792699|Rituximab|rituximab|mesh-list
64307049|NCT02792699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64307050|NCT02792699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307051|NCT02792699|Immunologic Factors|immunologic factors|mesh-ancestor
64307053|NCT02792699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64307138|NCT04950530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64396050|NCT04552847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396054|NCT05167331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64396055|NCT05167331|Anesthetics, General|anesthetics, general|mesh-ancestor
64396056|NCT05167331|Anesthetics|anesthetics|mesh-ancestor
64396057|NCT05167331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64396058|NCT05167331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396059|NCT05167331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64396060|NCT05167331|Analgesics|analgesics|mesh-ancestor
64784805|NCT01385280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784806|NCT01385280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784807|NCT01385280|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64784808|NCT01385280|Hormone Antagonists|hormone antagonists|mesh-ancestor
64784809|NCT01350258|Fludarabine|fludarabine|mesh-list
64784810|NCT01350258|Fludarabine phosphate|fludarabine phosphate|mesh-list
64784811|NCT01350258|Melphalan|melphalan|mesh-list
64784812|NCT01350258|Thiotepa|thiotepa|mesh-list
64784813|NCT01350258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870021|NCT01827722|Growth Inhibitors|growth inhibitors|mesh-ancestor
64870022|NCT01827735|Aldesleukin|aldesleukin|mesh-list
64870023|NCT01827735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870024|NCT01827735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64870025|NCT01827735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64870026|NCT01827735|Antiviral Agents|antiviral agents|mesh-ancestor
64870027|NCT01827735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64870029|NCT01827865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64870030|NCT01827865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64870031|NCT01827865|Analgesics|analgesics|mesh-ancestor
64870032|NCT01827865|Sensory System Agents|sensory system agents|mesh-ancestor
64870033|NCT01827865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870034|NCT01827865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870035|NCT01827865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64870036|NCT01827865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64870037|NCT01827865|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64870038|NCT01827865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64870039|NCT01827865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870040|NCT01827865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784814|NCT01350258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64784815|NCT01350258|Antimetabolites|antimetabolites|mesh-ancestor
64307201|NCT02081027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64307202|NCT02081027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307203|NCT02081027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307204|NCT02081027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64307205|NCT02081027|Protective Agents|protective agents|mesh-ancestor
64307206|NCT04947956|Apatinib|apatinib|mesh-list
64307207|NCT04947956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307208|NCT04947956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64307209|NCT04947956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307224|NCT04947566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307225|NCT04947566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64307226|NCT04947566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64307227|NCT04947566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64307228|NCT04947566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870041|NCT01827878|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64870042|NCT01827878|Lisinopril|lisinopril|mesh-list
64870043|NCT01827878|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
64870044|NCT01827878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64870045|NCT01827878|Diuretics|diuretics|mesh-ancestor
64870046|NCT01827878|Natriuretic Agents|natriuretic agents|mesh-ancestor
64870047|NCT01827878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870048|NCT01827878|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64870057|NCT01828125|Glucagon|glucagon|mesh-list
64307229|NCT04947566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307230|NCT04947566|Gout Suppressants|gout suppressants|mesh-ancestor
64307231|NCT03241875|Pregabalin|pregabalin|mesh-list
64307232|NCT03241875|Gabapentin|gabapentin|mesh-list
64307233|NCT03241875|Analgesics|analgesics|mesh-ancestor
64307234|NCT03241875|Sensory System Agents|sensory system agents|mesh-ancestor
64307235|NCT03241875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64307236|NCT03241875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307237|NCT03241875|Anticonvulsants|anticonvulsants|mesh-ancestor
64784816|NCT01350258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784817|NCT01350258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64784818|NCT01350258|Immunologic Factors|immunologic factors|mesh-ancestor
64784819|NCT01350258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784820|NCT01350258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64784821|NCT01350258|Alkylating Agents|alkylating agents|mesh-ancestor
64784822|NCT01350258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64784823|NCT01302444|Tadalafil|tadalafil|mesh-list
64784824|NCT01302444|Vasodilator Agents|vasodilator agents|mesh-ancestor
64784825|NCT01302444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64784826|NCT01302444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64784827|NCT01302444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396061|NCT05167331|Sensory System Agents|sensory system agents|mesh-ancestor
64396062|NCT05167331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64396063|NCT04509401|Vitamins|vitamins|mesh-list
64396064|NCT04509401|Vitamin B 6|vitamin b 6|mesh-list
64396065|NCT04509401|Pyridoxal|pyridoxal|mesh-list
64396066|NCT04509401|Pyridoxine|pyridoxine|mesh-list
64396067|NCT04509401|Vitamin B Complex|vitamin b complex|mesh-list
64396068|NCT04509401|Micronutrients|micronutrients|mesh-ancestor
64396069|NCT04509401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396070|NCT05155007|Cyclosporine|cyclosporine|mesh-list
64396071|NCT05155007|Cyclosporins|cyclosporins|mesh-list
64396072|NCT05155007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396073|NCT05155007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870109|NCT01828437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64870110|NCT01828437|Prednisolone phosphate|prednisolone phosphate|mesh-list
64870111|NCT01828437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64870112|NCT01828437|Glucocorticoids|glucocorticoids|mesh-ancestor
64870113|NCT01828437|Hormones|hormones|mesh-ancestor
64870114|NCT01828437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64870115|NCT01828437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870116|NCT01828437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64870117|NCT01828437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870118|NCT01828437|Antiemetics|antiemetics|mesh-ancestor
64870119|NCT01828437|Autonomic Agents|autonomic agents|mesh-ancestor
64870120|NCT01828437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870121|NCT01828437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64870122|NCT01828437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64870123|NCT01828437|Protective Agents|protective agents|mesh-ancestor
64870124|NCT01828437|Vitamin B Complex|vitamin b complex|mesh-ancestor
64870125|NCT01828437|Vitamins|vitamins|mesh-ancestor
64870127|NCT01828463|Nitisinone|nitisinone|mesh-list
64396074|NCT05155007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64396075|NCT05155007|Immunologic Factors|immunologic factors|mesh-ancestor
64324502|NCT02268409|Luspatercept|luspatercept|mesh-list
64784828|NCT01302444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784830|NCT01292070|Histamine|histamine|mesh-list
64784831|NCT01292070|Histamine Agonists|histamine agonists|mesh-ancestor
64307243|NCT03241875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64307244|NCT03241875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64307245|NCT03241875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64307246|NCT03241875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64870161|NCT01828736|Antiviral Agents|antiviral agents|mesh-ancestor
64870162|NCT01828736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64870163|NCT01828736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870164|NCT01828736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64870165|NCT01828736|Immunologic Factors|immunologic factors|mesh-ancestor
64870166|NCT01828736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870167|NCT01828736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64870169|NCT01828788|Anesthetics, Local|anesthetics, local|mesh-ancestor
64870170|NCT01828788|Anesthetics|anesthetics|mesh-ancestor
64870171|NCT01828788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64870172|NCT01828788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870173|NCT01828788|Sensory System Agents|sensory system agents|mesh-ancestor
64870175|NCT01828879|Tacrolimus|tacrolimus|mesh-list
64307247|NCT03241875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64307248|NCT03241875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64307249|NCT03241875|Antimanic Agents|antimanic agents|mesh-ancestor
64307251|NCT03058094|Abivertinib|abivertinib|mesh-list
64307252|NCT03058094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307253|NCT03058094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307254|NCT03058094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307255|NCT03058094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64307256|NCT03058094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64307257|NCT03058094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64307258|NCT04413266|Curcumin|curcumin|mesh-list
64307259|NCT04413266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64307260|NCT04413266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64784832|NCT01292070|Histamine Agents|histamine agents|mesh-ancestor
64784833|NCT01292070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64784834|NCT01292070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784835|NCT01292070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784836|NCT01284504|Celecoxib|celecoxib|mesh-list
64870214|NCT01829334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870215|NCT01829334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64870216|NCT01829334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64870217|NCT01829451|Hyaluronic Acid|hyaluronic acid|mesh-list
64870218|NCT01829451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64870219|NCT01829451|Immunologic Factors|immunologic factors|mesh-ancestor
64870220|NCT01829451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870221|NCT01829451|Viscosupplements|viscosupplements|mesh-ancestor
64870222|NCT01829451|Protective Agents|protective agents|mesh-ancestor
64870223|NCT01829529|Amoxicillin|amoxicillin|mesh-list
64870224|NCT01829529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64870225|NCT01829529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64870226|NCT01829659|Ticagrelor|ticagrelor|mesh-list
64870227|NCT01829659|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64870228|NCT01829659|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64870229|NCT01829659|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64870230|NCT01829659|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64870231|NCT01829659|Purinergic Agents|purinergic agents|mesh-ancestor
64870232|NCT01829659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64870233|NCT01829659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870234|NCT01829659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870235|NCT01829685|Entecavir|entecavir|mesh-list
64870236|NCT01829685|Adefovir|adefovir|mesh-list
64870237|NCT01829685|Antiviral Agents|antiviral agents|mesh-ancestor
64870238|NCT01829685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64418687|NCT05678257|Antidotes|antidotes|mesh-ancestor
64784837|NCT01284504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64784838|NCT01284504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64784839|NCT01284504|Analgesics|analgesics|mesh-ancestor
64307261|NCT04413266|Analgesics|analgesics|mesh-ancestor
64307262|NCT04413266|Sensory System Agents|sensory system agents|mesh-ancestor
64307263|NCT04413266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64307264|NCT04413266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307265|NCT04413266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64307266|NCT04413266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64870239|NCT01829685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64870240|NCT01829685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64870241|NCT01829685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870242|NCT01829685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870243|NCT01829698|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64870244|NCT01829698|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64870245|NCT01829698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64870246|NCT01829711|Immunotoxin HA22|immunotoxin ha22|mesh-list
64870247|NCT01829711|Protective Agents|protective agents|mesh-list
64870248|NCT01829711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870249|NCT01829711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870251|NCT01829802|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64870252|NCT01829802|Raltegravir Potassium|raltegravir potassium|mesh-list
64870253|NCT01829802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64870254|NCT01829802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64870255|NCT01829802|Protease Inhibitors|protease inhibitors|mesh-ancestor
64870256|NCT01829802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870257|NCT01829802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870258|NCT01829802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64870259|NCT01829802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64870260|NCT01829802|Antiviral Agents|antiviral agents|mesh-ancestor
64870261|NCT01829802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64870262|NCT01829802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64870263|NCT01829802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64870264|NCT01829802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64870265|NCT01829802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64870267|NCT01829841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870268|NCT01829841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64418706|NCT02579863|Lenalidomide|lenalidomide|mesh-list
64870269|NCT01829841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64307267|NCT04413266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307268|NCT04413266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307269|NCT04413266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307270|NCT04944524|Methotrexate|methotrexate|mesh-list
64307271|NCT04944524|Tofacitinib|tofacitinib|mesh-list
64307272|NCT04944524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64307273|NCT04944524|Abortifacient Agents|abortifacient agents|mesh-ancestor
64307274|NCT04944524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64307275|NCT04944524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307276|NCT04944524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64307277|NCT04944524|Antimetabolites|antimetabolites|mesh-ancestor
64307278|NCT04944524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307279|NCT04944524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307280|NCT04944524|Dermatologic Agents|dermatologic agents|mesh-ancestor
64307281|NCT04944524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307282|NCT04944524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64307283|NCT04944524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64307284|NCT04944524|Immunologic Factors|immunologic factors|mesh-ancestor
64307285|NCT04944524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64307286|NCT04944524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64307287|NCT04944524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64307288|NCT04412876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64307289|NCT04412876|Imipramine|imipramine|mesh-list
64307290|NCT04412876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64307291|NCT04412876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64784840|NCT01284504|Sensory System Agents|sensory system agents|mesh-ancestor
64784841|NCT01284504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64784842|NCT01284504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784843|NCT01284504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64870270|NCT01829841|Growth Substances|growth substances|mesh-ancestor
64870271|NCT01829841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870272|NCT01829841|Growth Inhibitors|growth inhibitors|mesh-ancestor
64870273|NCT01829841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64784844|NCT01284504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64784845|NCT01284504|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64396086|NCT01641107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396087|NCT03101423|Interleukin-2|interleukin-2|mesh-list
64396088|NCT03101423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396089|NCT03101423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64396090|NCT03101423|Analgesics|analgesics|mesh-ancestor
64396091|NCT03101423|Sensory System Agents|sensory system agents|mesh-ancestor
64396092|NCT03101423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64396093|NCT03101423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396094|NCT05073029|Vitamin D|vitamin d|mesh-list
64396095|NCT05073029|Cholecalciferol|cholecalciferol|mesh-list
64396096|NCT05073029|Vitamins|vitamins|mesh-ancestor
64396097|NCT05073029|Micronutrients|micronutrients|mesh-ancestor
64870309|NCT01830270|Mitosis Modulators|mitosis modulators|mesh-ancestor
64870310|NCT01830270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870311|NCT01830270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64870312|NCT01830270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64870313|NCT01830270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64870314|NCT01830270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870315|NCT01830530|Telmisartan|telmisartan|mesh-list
64870316|NCT01830530|Nifedipine|nifedipine|mesh-list
64870317|NCT01830530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64396098|NCT05073029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396099|NCT05073029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64396100|NCT05073029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64396101|NCT04268849|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64396102|NCT04268849|Hematinics|hematinics|mesh-ancestor
64307384|NCT02084225|Sensory System Agents|sensory system agents|mesh-ancestor
64307385|NCT02084225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64307386|NCT02084225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64307387|NCT02084225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64784861|NCT01169610|Cholinergic Agents|cholinergic agents|mesh-ancestor
64784862|NCT01169610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64784863|NCT01169610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784864|NCT01169610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784866|NCT01166724|Tacrolimus|tacrolimus|mesh-list
64784867|NCT01166724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64307467|NCT03240939|Dutasteride|dutasteride|mesh-list
64307468|NCT03240939|Vasodilator Agents|vasodilator agents|mesh-ancestor
64307469|NCT03240939|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64307470|NCT03240939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64307471|NCT03240939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307472|NCT03240939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784868|NCT01166724|Immunologic Factors|immunologic factors|mesh-ancestor
64784869|NCT01166724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784870|NCT01166724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64870361|NCT01832350|Antimalarials|antimalarials|mesh-ancestor
64784871|NCT01166724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784872|NCT01166724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784873|NCT01166724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64784874|NCT01166724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64396112|NCT02642159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64396113|NCT02642159|Antimetabolites|antimetabolites|mesh-ancestor
64396114|NCT02642159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396115|NCT02642159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64396116|NCT02642159|Vitamin B Complex|vitamin b complex|mesh-ancestor
64396117|NCT02642159|Vitamins|vitamins|mesh-ancestor
64396118|NCT02642159|Micronutrients|micronutrients|mesh-ancestor
64396119|NCT02642159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396134|NCT05072405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64396135|NCT05072405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396136|NCT03962855|Ifetroban|ifetroban|mesh-list
64784893|NCT01151904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64307533|NCT03240471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307534|NCT03240471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307535|NCT04942652|Itraconazole|itraconazole|mesh-list
64307536|NCT04942652|Esomeprazole|esomeprazole|mesh-list
64870433|NCT01836614|Lidocaine|lidocaine|mesh-list
64307537|NCT04942652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64784894|NCT01115244|Dapsone|dapsone|mesh-list
64784895|NCT01115244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64784896|NCT01115244|Antimalarials|antimalarials|mesh-ancestor
64784897|NCT01115244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64784898|NCT01115244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64784899|NCT01115244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64784900|NCT01115244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784901|NCT01115244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784902|NCT01115244|Leprostatic Agents|leprostatic agents|mesh-ancestor
64784903|NCT01115244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64784904|NCT01031550|Propofol|propofol|mesh-list
64784905|NCT01031550|Isoflurane|isoflurane|mesh-list
64784906|NCT01031550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64784907|NCT01031550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64784908|NCT01031550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784909|NCT01031550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64784910|NCT01031550|Anesthetics, General|anesthetics, general|mesh-ancestor
64307595|NCT04942496|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64307596|NCT04942496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64307597|NCT04942496|Disinfectants|disinfectants|mesh-ancestor
64307598|NCT04942496|Dermatologic Agents|dermatologic agents|mesh-ancestor
64307599|NCT04941872|FAPI-46|fapi-46|mesh-list
64784911|NCT01031550|Anesthetics|anesthetics|mesh-ancestor
64784912|NCT01031550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64784913|NCT00986310|Fluoxetine|fluoxetine|mesh-list
64784914|NCT00986310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64784915|NCT00986310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64396137|NCT03962855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64396138|NCT03101579|Folic Acid|folic acid|mesh-list
64396139|NCT03101579|Vitamin B 12|vitamin b 12|mesh-list
64396140|NCT03101579|Dexamethasone|dexamethasone|mesh-list
64396141|NCT03101579|Pemetrexed|pemetrexed|mesh-list
64396142|NCT03101579|Vitamins|vitamins|mesh-ancestor
64396143|NCT03101579|Micronutrients|micronutrients|mesh-ancestor
64396144|NCT03101579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307651|NCT05234619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64307652|NCT05234619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307653|NCT05234619|Sensory System Agents|sensory system agents|mesh-ancestor
64307654|NCT05234619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64307655|NCT05234619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64307656|NCT05234619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64307657|NCT05234619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64307658|NCT05234619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64307659|NCT05234619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307660|NCT05234619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64307661|NCT05234619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64307662|NCT05234619|Analgesics|analgesics|mesh-ancestor
64870517|NCT01837446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64870518|NCT01837446|Antipruritics|antipruritics|mesh-ancestor
64870519|NCT01837446|Dermatologic Agents|dermatologic agents|mesh-ancestor
64870520|NCT01837446|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64870521|NCT01837446|Immunologic Factors|immunologic factors|mesh-ancestor
64870522|NCT01837446|Antacids|antacids|mesh-ancestor
64870523|NCT01838850|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64396145|NCT03101579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64396146|NCT03101579|Antiemetics|antiemetics|mesh-ancestor
64396147|NCT03101579|Autonomic Agents|autonomic agents|mesh-ancestor
64396148|NCT03101579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64784916|NCT00986310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64784917|NCT00986310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784918|NCT00986310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64784919|NCT00986310|Serotonin Agents|serotonin agents|mesh-ancestor
64784920|NCT00986310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784921|NCT00986310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64784922|NCT00986310|Antidepressive Agents|antidepressive agents|mesh-ancestor
64784923|NCT00986310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64784924|NCT00986310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64784925|NCT00986310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64784926|NCT00986310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784927|NCT00907218|Varenicline|varenicline|mesh-list
64784928|NCT00907218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64784929|NCT00907218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64307699|NCT03236493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307700|NCT04921124|Teriparatide|teriparatide|mesh-list
64307701|NCT04921124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64307702|NCT04921124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307703|NCT04921124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64307704|NCT04921046|Lidocaine|lidocaine|mesh-list
64307705|NCT04921046|Midazolam|midazolam|mesh-list
64307706|NCT04921046|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64307707|NCT04921046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64307708|NCT04921046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64307709|NCT04921046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870640|NCT01841099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64870641|NCT01841112|BI 409306|bi 409306|mesh-list
64870642|NCT01841112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64870643|NCT01841112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333696|NCT03112707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64333697|NCT03112707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333698|NCT03112707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64333699|NCT03112707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64333700|NCT03112707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333701|NCT03112707|Antipyretics|antipyretics|mesh-ancestor
64870644|NCT01841112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870645|NCT01841125|Citalopram|citalopram|mesh-list
64870646|NCT01841125|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64870647|NCT01841125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64870648|NCT01841125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64639240|NCT05266274|Antibodies|antibodies|mesh-list
64870649|NCT01841125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870650|NCT01841125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64870651|NCT01841125|Serotonin Agents|serotonin agents|mesh-ancestor
64870652|NCT01841125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870653|NCT01841125|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64870654|NCT01841125|Antidepressive Agents|antidepressive agents|mesh-ancestor
64870655|NCT01841125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64870656|NCT01841164|Montelukast|montelukast|mesh-list
64307710|NCT04921046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64307728|NCT02792231|Ofatumumab|ofatumumab|mesh-list
64784930|NCT00907218|Cholinergic Agents|cholinergic agents|mesh-ancestor
64784931|NCT00907218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64784932|NCT00907218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784933|NCT00907218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784934|NCT00903396|Palonosetron|palonosetron|mesh-list
64784935|NCT00903396|Antiemetics|antiemetics|mesh-ancestor
64784936|NCT00903396|Autonomic Agents|autonomic agents|mesh-ancestor
64784937|NCT00903396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64784938|NCT00903396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396158|NCT03101579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64870663|NCT01841164|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64396159|NCT03101579|Hematinics|hematinics|mesh-ancestor
64396160|NCT03101579|Vitamin B Complex|vitamin b complex|mesh-ancestor
64396161|NCT05071781|Hormones|hormones|mesh-list
64396162|NCT05071781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64396163|NCT05071781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64396164|NCT05071781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396165|NCT03882905|Ezetimibe|ezetimibe|mesh-list
64396166|NCT03882905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64396167|NCT03882905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64396168|NCT03882905|Antimetabolites|antimetabolites|mesh-ancestor
64870746|NCT01841502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64870747|NCT01841502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870748|NCT01841515|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64870749|NCT01841515|Hemostatics|hemostatics|mesh-ancestor
64870750|NCT01841515|Coagulants|coagulants|mesh-ancestor
64870751|NCT01841515|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64870765|NCT01841684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64870767|NCT01841775|Ribavirin|ribavirin|mesh-list
64870768|NCT01841775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870769|NCT01841775|Antiviral Agents|antiviral agents|mesh-ancestor
64870770|NCT01841775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64870771|NCT01841775|Antimetabolites|antimetabolites|mesh-ancestor
64870772|NCT01841775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870773|NCT01841827|Cilostazol|cilostazol|mesh-list
64870774|NCT01841827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64870775|NCT01841827|Autonomic Agents|autonomic agents|mesh-ancestor
64870776|NCT01841827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64396170|NCT03882905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64324505|NCT02268487|Antidepressive Agents|antidepressive agents|mesh-ancestor
64324506|NCT02268487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64396188|NCT03491059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64324507|NCT02268487|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64784949|NCT00875394|Incretins|incretins|mesh-ancestor
64784950|NCT00875394|Hormones|hormones|mesh-ancestor
64784951|NCT00875394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64307741|NCT04930952|Ethanol|ethanol|mesh-list
64307742|NCT04930952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64307743|NCT04930952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64307744|NCT04930952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64307745|NCT04930952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307746|NCT04920968|Rituximab|rituximab|mesh-list
64307747|NCT04920968|Obinutuzumab|obinutuzumab|mesh-list
64307748|NCT04920968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64307749|NCT04920968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307750|NCT04920968|Immunologic Factors|immunologic factors|mesh-ancestor
64333702|NCT05262413|Lenvatinib|lenvatinib|mesh-list
64333703|NCT05262413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333704|NCT05262413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64333705|NCT05262413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333706|NCT05262413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333707|NCT02209649|Telmisartan|telmisartan|mesh-list
64333708|NCT02209649|Lacidipine|lacidipine|mesh-list
64870811|NCT01842139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64870812|NCT01842139|Laxatives|laxatives|mesh-ancestor
64870813|NCT01842139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64870814|NCT01842139|Antiviral Agents|antiviral agents|mesh-ancestor
64870815|NCT01842139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64870816|NCT01842230|Niacin|niacin|mesh-list
64870817|NCT01842230|Amlodipine|amlodipine|mesh-list
64870818|NCT01842230|Telmisartan|telmisartan|mesh-list
64870819|NCT01842230|Atorvastatin|atorvastatin|mesh-list
64870820|NCT01842230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64870821|NCT01842230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64870822|NCT01842230|Antimetabolites|antimetabolites|mesh-ancestor
64419112|NCT05533255|Z 350|z 350|mesh-list
64307751|NCT04920968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307752|NCT04920968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64307753|NCT00700401|Ribavirin|ribavirin|mesh-list
64784952|NCT00875394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64784953|NCT00875394|Protease Inhibitors|protease inhibitors|mesh-ancestor
64784954|NCT00875394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784955|NCT00875394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784957|NCT00832572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64784958|NCT00832572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64784959|NCT00832572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784960|NCT00811590|Everolimus|everolimus|mesh-list
64784961|NCT00811590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64784962|NCT00811590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64784963|NCT00811590|Immunologic Factors|immunologic factors|mesh-ancestor
64784964|NCT00811590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64784965|NCT00749658|Bupropion|bupropion|mesh-list
64784966|NCT00749658|Varenicline|varenicline|mesh-list
64784967|NCT00749658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64396189|NCT03491059|Cholinergic Agents|cholinergic agents|mesh-ancestor
64396190|NCT03491059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64396191|NCT03491059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396192|NCT02668393|Docetaxel|docetaxel|mesh-list
64396193|NCT02668393|Nintedanib|nintedanib|mesh-list
64396194|NCT02668393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396195|NCT02668393|Tubulin Modulators|tubulin modulators|mesh-ancestor
64396196|NCT02668393|Antimitotic Agents|antimitotic agents|mesh-ancestor
64307775|NCT04931108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64307776|NCT04931108|Vasodilator Agents|vasodilator agents|mesh-ancestor
64307777|NCT04920500|Cytarabine|cytarabine|mesh-list
64307778|NCT04920500|Daunorubicin|daunorubicin|mesh-list
64307779|NCT04920500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64307781|NCT04920500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307782|NCT04920500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307783|NCT04920500|Antiviral Agents|antiviral agents|mesh-ancestor
64307784|NCT04920500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64307785|NCT04920500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64307786|NCT04920500|Immunologic Factors|immunologic factors|mesh-ancestor
64307787|NCT04920500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307788|NCT04920500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64307789|NCT04920500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64870823|NCT01842230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870851|NCT01842256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64870852|NCT01842256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870853|NCT01842256|Vasodilator Agents|vasodilator agents|mesh-ancestor
64870854|NCT01842256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64870855|NCT01842256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64870856|NCT01842269|Mycophenolic Acid|mycophenolic acid|mesh-list
64870857|NCT01842269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64870858|NCT01842269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870859|NCT01842269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64870860|NCT01842269|Antitubercular Agents|antitubercular agents|mesh-ancestor
64870861|NCT01842269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64870862|NCT01842269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64307790|NCT04920500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64307791|NCT04920500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307792|NCT02084615|Aspirin|aspirin|mesh-list
64307793|NCT02084615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64307794|NCT02084615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64307795|NCT02084615|Analgesics|analgesics|mesh-ancestor
64307796|NCT02084615|Sensory System Agents|sensory system agents|mesh-ancestor
64307799|NCT02084615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64324511|NCT02268487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64324512|NCT02268487|Serotonin Agents|serotonin agents|mesh-ancestor
64784980|NCT00749658|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64784981|NCT00749658|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64784982|NCT00749658|Cholinergic Agents|cholinergic agents|mesh-ancestor
64784983|NCT00738972|Valsartan|valsartan|mesh-list
64784984|NCT00738972|Simvastatin|simvastatin|mesh-list
64784985|NCT00738972|Ezetimibe|ezetimibe|mesh-list
64784986|NCT00738972|Pravastatin|pravastatin|mesh-list
64784987|NCT00738972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64784988|NCT00738972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64307804|NCT02084615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64307805|NCT02084615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64307806|NCT02084615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307808|NCT03559751|Nicotine|nicotine|mesh-list
64870868|NCT01842321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870869|NCT01842321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870870|NCT01842321|Hormone Antagonists|hormone antagonists|mesh-ancestor
64870871|NCT01842321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64870872|NCT01842321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870873|NCT01842321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64870875|NCT01842373|Tetracaine|tetracaine|mesh-list
64639468|NCT02106494|Glucocorticoids|glucocorticoids|mesh-ancestor
64870877|NCT01842373|Anesthetics, Local|anesthetics, local|mesh-ancestor
64870878|NCT01842373|Anesthetics|anesthetics|mesh-ancestor
64870879|NCT01842373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64870880|NCT01842373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870881|NCT01842373|Sensory System Agents|sensory system agents|mesh-ancestor
64870882|NCT01842373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64307809|NCT03559751|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64307810|NCT03559751|Autonomic Agents|autonomic agents|mesh-ancestor
64307811|NCT03559751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64307812|NCT03559751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307813|NCT03559751|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64307814|NCT03559751|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64307815|NCT03559751|Cholinergic Agents|cholinergic agents|mesh-ancestor
64307816|NCT03559751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64307817|NCT03559751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307818|NCT03234699|Midazolam|midazolam|mesh-list
64307819|NCT03234699|Cenobamate|cenobamate|mesh-list
64307822|NCT03234699|Warfarin|warfarin|mesh-list
64307823|NCT03234699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64307824|NCT03234699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64307825|NCT03234699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64307826|NCT03234699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307827|NCT03234699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64307828|NCT03234699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64784990|NCT00738972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64784991|NCT00738972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64784992|NCT00738972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64784993|NCT00738972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64784994|NCT00738972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64870932|NCT01843010|Analgesics|analgesics|mesh-ancestor
64784995|NCT00738972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64784996|NCT00738972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64784997|NCT00726180|Trastuzumab|trastuzumab|mesh-list
64784998|NCT00726180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64784999|NCT00726180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396213|NCT01797523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396214|NCT01797523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396215|NCT01797523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64307838|NCT03234699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64307849|NCT03234699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64307850|NCT03234699|Anticonvulsants|anticonvulsants|mesh-ancestor
64307851|NCT03559673|Lacosamide|lacosamide|mesh-list
64307852|NCT03559673|Anticonvulsants|anticonvulsants|mesh-ancestor
64307853|NCT03559673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64870983|NCT01843179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64870984|NCT01843179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64870985|NCT01843179|Analgesics|analgesics|mesh-ancestor
64870986|NCT01843179|Sensory System Agents|sensory system agents|mesh-ancestor
64870987|NCT01843179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870988|NCT01843179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64870990|NCT01843179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64870991|NCT01843179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870992|NCT01843257|Ethanol|ethanol|mesh-list
64870993|NCT01843257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64870994|NCT01843257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64870995|NCT01843257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64870996|NCT01843257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870997|NCT01843296|Magnesium Sulfate|magnesium sulfate|mesh-list
64870998|NCT01843296|Fentanyl|fentanyl|mesh-list
64870999|NCT01843296|Bupivacaine|bupivacaine|mesh-list
64871000|NCT01843296|Anesthetics, Local|anesthetics, local|mesh-ancestor
64871001|NCT01843296|Anesthetics|anesthetics|mesh-ancestor
64871002|NCT01843296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64871003|NCT01843296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871004|NCT01843296|Sensory System Agents|sensory system agents|mesh-ancestor
64871005|NCT01843296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64871006|NCT01843296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64333709|NCT02209649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64333710|NCT02209649|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64333711|NCT02209649|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64307854|NCT03559673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64307855|NCT03559673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64307856|NCT03559673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307857|NCT03228771|Atorvastatin|atorvastatin|mesh-list
64307858|NCT03228771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64307859|NCT03228771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64307860|NCT03228771|Antimetabolites|antimetabolites|mesh-ancestor
64307861|NCT03228771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307862|NCT03228771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64871008|NCT01843296|Analgesics|analgesics|mesh-ancestor
64871009|NCT01843296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64871010|NCT01843296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64871011|NCT01843296|Anesthetics, General|anesthetics, general|mesh-ancestor
64871012|NCT01843296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64871013|NCT01843296|Anticonvulsants|anticonvulsants|mesh-ancestor
64871014|NCT01843296|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64871015|NCT01843296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64871016|NCT01843296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871017|NCT01843296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64871018|NCT01843296|Tocolytic Agents|tocolytic agents|mesh-ancestor
64871019|NCT01843296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64871020|NCT01843309|Spironolactone|spironolactone|mesh-list
64871021|NCT01843309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64871022|NCT01843309|Hormone Antagonists|hormone antagonists|mesh-ancestor
64871023|NCT01843309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64396216|NCT01797523|Immunologic Factors|immunologic factors|mesh-ancestor
64396217|NCT01797523|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64396218|NCT01797523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64396219|NCT01797523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396220|NCT01797523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396221|NCT01797523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64396234|NCT03377023|Nintedanib|nintedanib|mesh-list
64396235|NCT03377023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64396236|NCT03377023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307894|NCT03235947|Renal Agents|renal agents|mesh-ancestor
64396237|NCT03377023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64871077|NCT01843725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871078|NCT01843725|Growth Inhibitors|growth inhibitors|mesh-ancestor
64871080|NCT01843738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871082|NCT01843738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396238|NCT03377023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396239|NCT03377023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64396240|NCT03377023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396241|NCT01226563|Calcium|calcium|mesh-list
64396242|NCT01226563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64396243|NCT01226563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307974|NCT03227679|Cholinergic Agents|cholinergic agents|mesh-ancestor
64307975|NCT03227679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64307976|NCT03227679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307977|NCT03227679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64307978|NCT03227679|Antidepressive Agents|antidepressive agents|mesh-ancestor
64871148|NCT01843868|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64871149|NCT01843868|Dopamine Agents|dopamine agents|mesh-ancestor
64871150|NCT01843868|Anticonvulsants|anticonvulsants|mesh-ancestor
64871151|NCT01843868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64871152|NCT01843868|GABA Modulators|gaba modulators|mesh-ancestor
64871153|NCT01843868|GABA Agents|gaba agents|mesh-ancestor
64871154|NCT01843998|Sirolimus|sirolimus|mesh-list
64871155|NCT01843998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64871156|NCT01843998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64871157|NCT01843998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64871158|NCT01843998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871159|NCT01843998|Antifungal Agents|antifungal agents|mesh-ancestor
64871160|NCT01843998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64871161|NCT01843998|Immunologic Factors|immunologic factors|mesh-ancestor
64871162|NCT01843998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871163|NCT01844024|Misoprostol|misoprostol|mesh-list
64871164|NCT01844024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64871165|NCT01844024|Abortifacient Agents|abortifacient agents|mesh-ancestor
64871166|NCT01844024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64871167|NCT01844024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871168|NCT01844024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64871169|NCT01844024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64871170|NCT01844024|Oxytocics|oxytocics|mesh-ancestor
64871171|NCT01844063|Antiviral Agents|antiviral agents|mesh-list
64871172|NCT01844063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64871173|NCT01844141|Ethanol|ethanol|mesh-list
64871174|NCT01844141|Chlorhexidine|chlorhexidine|mesh-list
64871175|NCT01844141|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64871176|NCT01844141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64639767|NCT01650350|Naltrexone|naltrexone|mesh-list
64871177|NCT01844141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64307979|NCT03227679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64307980|NCT03227679|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64307981|NCT03227679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64307982|NCT03227679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64307983|NCT03227679|Dopamine Agents|dopamine agents|mesh-ancestor
64307984|NCT03227679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64307985|NCT03227679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64307986|NCT03227679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307987|NCT04886167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64307988|NCT04886167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64871180|NCT01844141|Disinfectants|disinfectants|mesh-ancestor
64307989|NCT04886167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64307990|NCT04886167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64307991|NCT04886167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307992|NCT04886167|Cholinergic Agents|cholinergic agents|mesh-ancestor
64307993|NCT04886167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64307994|NCT04886167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307995|NCT04886167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64307996|NCT04886167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64307997|NCT04937894|Tigecycline|tigecycline|mesh-list
64307998|NCT04937894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64307999|NCT04937894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64308010|NCT04919174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64308011|NCT04919174|Analgesics|analgesics|mesh-ancestor
64308012|NCT04919174|Sensory System Agents|sensory system agents|mesh-ancestor
64308013|NCT04919174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64308014|NCT04919174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64308015|NCT04919174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64308016|NCT04919174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64308017|NCT04919174|Adrenergic Agents|adrenergic agents|mesh-ancestor
64308018|NCT04919174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64308019|NCT04919174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871246|NCT01844674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871247|NCT01844674|Anticonvulsants|anticonvulsants|mesh-ancestor
64871248|NCT01844674|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64871249|NCT01844674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64871251|NCT01844674|Autonomic Agents|autonomic agents|mesh-ancestor
64871252|NCT01844674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64871253|NCT01844674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64871254|NCT01844674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64871255|NCT01844674|Adrenergic Agents|adrenergic agents|mesh-ancestor
64871256|NCT01844674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64871258|NCT01844791|Pentamidine|pentamidine|mesh-list
64871259|NCT01844791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64871260|NCT01844791|Antimetabolites|antimetabolites|mesh-ancestor
64871261|NCT01844791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871262|NCT01844791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871263|NCT01844791|Antiviral Agents|antiviral agents|mesh-ancestor
64871264|NCT01844791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64871265|NCT01844791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871266|NCT01844791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64871267|NCT01844791|Immunologic Factors|immunologic factors|mesh-ancestor
64871268|NCT01844791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871269|NCT01844791|Antifungal Agents|antifungal agents|mesh-ancestor
64871270|NCT01844791|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64308020|NCT04919174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64308021|NCT04919174|Narcotics|narcotics|mesh-ancestor
64308022|NCT02085239|Lidocaine|lidocaine|mesh-list
64308023|NCT02085239|Ropivacaine|ropivacaine|mesh-list
64308024|NCT02085239|Anesthetics, Local|anesthetics, local|mesh-ancestor
64785023|NCT00676026|Progesterone|progesterone|mesh-list
64871283|NCT01844947|Sorafenib|sorafenib|mesh-list
64785024|NCT00676026|Progestins|progestins|mesh-ancestor
64785025|NCT00676026|Hormones|hormones|mesh-ancestor
64785026|NCT00676026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64785027|NCT00676026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785028|NCT00676026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64785029|NCT00676026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64308070|NCT05523401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308071|NCT05523401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64308072|NCT05523401|Serotonin Agents|serotonin agents|mesh-ancestor
64308073|NCT05523401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64308074|NCT05523401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785030|NCT00676026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64785031|NCT00676026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785032|NCT00676026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64785033|NCT00676026|Serotonin Agents|serotonin agents|mesh-ancestor
64785034|NCT00676026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64785035|NCT00676026|Antidepressive Agents|antidepressive agents|mesh-ancestor
64785036|NCT00676026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64871342|NCT01845194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871343|NCT01845194|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64871344|NCT01845194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64871345|NCT01845194|Purinergic Agents|purinergic agents|mesh-ancestor
64871346|NCT01845194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64871347|NCT01845194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64871348|NCT01845194|Sympatholytics|sympatholytics|mesh-ancestor
64871349|NCT01845194|Autonomic Agents|autonomic agents|mesh-ancestor
64871350|NCT01845194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64871351|NCT01845194|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64871352|NCT01845194|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64871353|NCT01845194|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64871354|NCT01845194|Adrenergic Agents|adrenergic agents|mesh-ancestor
64871355|NCT01845194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64871356|NCT01845194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64871357|NCT01845194|Antimetabolites|antimetabolites|mesh-ancestor
64308130|NCT02452125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64308131|NCT02452125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308132|NCT02619812|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
64308133|NCT02619812|Immunoglobulins|immunoglobulins|mesh-list
64308134|NCT02619812|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64308135|NCT02619812|Antibodies|antibodies|mesh-list
64308136|NCT02619812|Immunologic Factors|immunologic factors|mesh-ancestor
64308137|NCT02619812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871382|NCT01845272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64871383|NCT01845272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64871384|NCT01845272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64871385|NCT01845272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871386|NCT01845272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64871387|NCT01845272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871388|NCT01845272|Vasodilator Agents|vasodilator agents|mesh-ancestor
64871389|NCT01845272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64871390|NCT01845272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64871391|NCT01845298|Rifampin|rifampin|mesh-list
64871392|NCT01845298|Rifamycins|rifamycins|mesh-list
64871393|NCT01845298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64871394|NCT01845298|Antitubercular Agents|antitubercular agents|mesh-ancestor
64871395|NCT01845298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64871396|NCT01845298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64871397|NCT01845298|Leprostatic Agents|leprostatic agents|mesh-ancestor
64871399|NCT01845298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64308138|NCT02619812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64308139|NCT02619812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64308140|NCT02619812|Antimetabolites|antimetabolites|mesh-ancestor
64308141|NCT02619812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308142|NCT02619812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64308143|NCT04928066|Prednisone|prednisone|mesh-list
64308144|NCT04928066|Tofacitinib|tofacitinib|mesh-list
64308145|NCT04928066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64785037|NCT00676026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64785038|NCT00676026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64785039|NCT00676026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785040|NCT00676026|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64785041|NCT00676026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64785042|NCT00676026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64871428|NCT01845493|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64871429|NCT01845493|Protective Agents|protective agents|mesh-ancestor
64871430|NCT01845493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871431|NCT01845493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871432|NCT01845532|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64871433|NCT01845532|Anesthetics, Local|anesthetics, local|mesh-ancestor
64871462|NCT01845675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64871463|NCT01845675|Growth Substances|growth substances|mesh-ancestor
64871464|NCT01845675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871465|NCT01845675|Growth Inhibitors|growth inhibitors|mesh-ancestor
64871467|NCT01845701|Lumefantrine|lumefantrine|mesh-list
64871468|NCT01845701|Artemether|artemether|mesh-list
64871469|NCT01845701|Piperaquine|piperaquine|mesh-list
64871470|NCT01845701|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64871471|NCT01845701|Amodiaquine|amodiaquine|mesh-list
64871472|NCT01845701|Artenimol|artenimol|mesh-list
64871473|NCT01845701|Antimalarials|antimalarials|mesh-ancestor
64871474|NCT01845701|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64871475|NCT01845701|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64871476|NCT01845701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64871477|NCT01845701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871478|NCT01845701|Antiviral Agents|antiviral agents|mesh-ancestor
64871479|NCT01845701|Schistosomicides|schistosomicides|mesh-ancestor
64871480|NCT01845701|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64871481|NCT01845701|Anthelmintics|anthelmintics|mesh-ancestor
64871482|NCT01845727|Amphotericin B|amphotericin b|mesh-list
64871483|NCT01845727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64871484|NCT01845727|Amebicides|amebicides|mesh-ancestor
64871485|NCT01845727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64871486|NCT01845727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64871489|NCT01845727|Antifungal Agents|antifungal agents|mesh-ancestor
64785043|NCT00676026|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64785044|NCT00676026|GABA Agonists|gaba agonists|mesh-ancestor
64785045|NCT00676026|GABA Agents|gaba agents|mesh-ancestor
64785046|NCT00656916|Fluticasone|fluticasone|mesh-list
64785047|NCT00656916|Xhance|xhance|mesh-list
64785048|NCT00656916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64785049|NCT00656916|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64785050|NCT00656916|Autonomic Agents|autonomic agents|mesh-ancestor
64396255|NCT00916747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396256|NCT00916747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64785051|NCT00656916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785052|NCT00656916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785053|NCT00656916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64785054|NCT00656916|Respiratory System Agents|respiratory system agents|mesh-ancestor
64785056|NCT00656916|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64785057|NCT00619242|Sorafenib|sorafenib|mesh-list
64785058|NCT00619242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64785059|NCT00619242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64785060|NCT00619242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785061|NCT00619242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785062|NCT00601848|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
64785063|NCT00601848|Trioxsalen|trioxsalen|mesh-list
64785064|NCT00601848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64785065|NCT00601848|Dermatologic Agents|dermatologic agents|mesh-ancestor
64785066|NCT00601848|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64785067|NCT00586716|Immunoglobulins|immunoglobulins|mesh-list
64785068|NCT00586716|Antibodies|antibodies|mesh-list
64308206|NCT02451579|Histamine Antagonists|histamine antagonists|mesh-list
64308207|NCT02451579|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
64308208|NCT02451579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64871583|NCT01846832|Interferons|interferons|mesh-list
64871584|NCT01846832|Ribavirin|ribavirin|mesh-list
64871585|NCT01846832|Interferon-alpha|interferon-alpha|mesh-list
64871586|NCT01846832|Interferon alpha-2|interferon alpha-2|mesh-list
64871587|NCT01846832|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64333716|NCT02209649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333717|NCT02361567|Acetaminophen|acetaminophen|mesh-list
64333718|NCT02361567|Oxycodone|oxycodone|mesh-list
64333719|NCT02361567|Tramadol|tramadol|mesh-list
64333720|NCT02361567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64333721|NCT02361567|Narcotics|narcotics|mesh-ancestor
64871589|NCT01846832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871590|NCT01846832|Antiviral Agents|antiviral agents|mesh-ancestor
64871591|NCT01846832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64871592|NCT01846832|Antimetabolites|antimetabolites|mesh-ancestor
64871594|NCT01846832|Immunologic Factors|immunologic factors|mesh-ancestor
64308209|NCT02451579|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64308210|NCT02451579|Histamine Agents|histamine agents|mesh-ancestor
64308211|NCT02451579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64308214|NCT04935788|Caseins|caseins|mesh-list
64785069|NCT00586716|gamma-Globulins|gamma-globulins|mesh-list
64785070|NCT00586716|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64785071|NCT00586716|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64785072|NCT00586716|Immunologic Factors|immunologic factors|mesh-ancestor
64785073|NCT00586716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871638|NCT01847235|Temozolomide|temozolomide|mesh-list
64871639|NCT01847235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64871640|NCT01847235|Alkylating Agents|alkylating agents|mesh-ancestor
64871641|NCT01847235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785074|NCT00571194|Pravastatin|pravastatin|mesh-list
64785075|NCT00571194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64785076|NCT00571194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64785077|NCT00571194|Antimetabolites|antimetabolites|mesh-ancestor
64785078|NCT00571194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785079|NCT00571194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64308243|NCT03221907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64308244|NCT03221907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64308245|NCT03221907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308246|NCT03221907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64308247|NCT03221907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64308249|NCT03221907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64308250|NCT03221907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64871726|NCT01847677|Growth Inhibitors|growth inhibitors|mesh-ancestor
64871727|NCT01847690|Hydrocortisone|hydrocortisone|mesh-list
64871728|NCT01847690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64871729|NCT01847768|Methacholine Chloride|methacholine chloride|mesh-list
64871730|NCT01847768|Dimercaprol|dimercaprol|mesh-list
64871731|NCT01847768|Chelating Agents|chelating agents|mesh-ancestor
64871732|NCT01847768|Sequestering Agents|sequestering agents|mesh-ancestor
64871733|NCT01847768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871734|NCT01847768|Miotics|miotics|mesh-ancestor
64871735|NCT01847768|Autonomic Agents|autonomic agents|mesh-ancestor
64871736|NCT01847768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64871737|NCT01847768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871738|NCT01847768|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64871739|NCT01847768|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
64871740|NCT01847768|Respiratory System Agents|respiratory system agents|mesh-ancestor
64871741|NCT01847768|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64871742|NCT01847768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64419744|NCT04843579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64419745|NCT04843579|Antiemetics|antiemetics|mesh-ancestor
64308251|NCT04934930|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64308252|NCT04934930|Obinutuzumab|obinutuzumab|mesh-list
64308253|NCT04934930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64308254|NCT04934930|Alkylating Agents|alkylating agents|mesh-ancestor
64308255|NCT04934930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308256|NCT04934930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308257|NCT04934930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64308258|NCT03107481|Acetaminophen|acetaminophen|mesh-list
64308259|NCT03107481|Hydromorphone|hydromorphone|mesh-list
64308260|NCT03107481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64785080|NCT00571194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64785081|NCT00571194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785082|NCT00570258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64785083|NCT00570258|Fulvestrant|fulvestrant|mesh-list
64396284|NCT02391805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64785084|NCT00570258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64785085|NCT00570258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64785086|NCT00570258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785087|NCT00570258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785088|NCT00570258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64785089|NCT00570258|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64785090|NCT00570258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64785091|NCT00570258|Hormone Antagonists|hormone antagonists|mesh-ancestor
64871743|NCT01847768|Cholinergic Agents|cholinergic agents|mesh-ancestor
64871744|NCT01847768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64871745|NCT01847781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64871746|NCT01847781|Immunologic Factors|immunologic factors|mesh-ancestor
64871747|NCT01847781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871749|NCT01847872|Immunologic Factors|immunologic factors|mesh-ancestor
64871750|NCT01847872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871751|NCT01847976|Doxycycline|doxycycline|mesh-list
64871752|NCT01847976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64871753|NCT01847976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64871754|NCT01847976|Antimalarials|antimalarials|mesh-ancestor
64785092|NCT00570258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64785093|NCT00570258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785094|NCT00568698|Hydroxyurea|hydroxyurea|mesh-list
64785095|NCT00568698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308333|NCT04913402|Dsuvia|dsuvia|mesh-list
64785096|NCT00568698|Antisickling Agents|antisickling agents|mesh-ancestor
64785097|NCT00568698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785098|NCT00568698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785099|NCT00568698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64785101|NCT00577356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64553681|NCT00637273|Exenatide|exenatide|mesh-list
64785103|NCT00577356|Antimitotic Agents|antimitotic agents|mesh-ancestor
64785104|NCT00577356|Mitosis Modulators|mitosis modulators|mesh-ancestor
64308377|NCT03224637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308378|NCT04912700|Vaccines|vaccines|mesh-list
64308379|NCT04912700|Immunologic Factors|immunologic factors|mesh-ancestor
64308380|NCT04912700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308381|NCT03224871|Aldesleukin|aldesleukin|mesh-list
64308382|NCT03224871|Pembrolizumab|pembrolizumab|mesh-list
64308383|NCT03224871|Nivolumab|nivolumab|mesh-list
64785105|NCT00577356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785106|NCT00569868|Bortezomib|bortezomib|mesh-list
64871793|NCT01848132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64871794|NCT01848132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64871795|NCT01848132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64871796|NCT01848132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64871797|NCT01848132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64871798|NCT01848132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871799|NCT01848132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64871800|NCT01848132|Glucocorticoids|glucocorticoids|mesh-ancestor
64871801|NCT01848132|Hormones|hormones|mesh-ancestor
64871802|NCT01848132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64871803|NCT01848132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64871804|NCT01848132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64871805|NCT01848132|Tubulin Modulators|tubulin modulators|mesh-ancestor
64871806|NCT01848132|Antimitotic Agents|antimitotic agents|mesh-ancestor
64871807|NCT01848132|Mitosis Modulators|mitosis modulators|mesh-ancestor
64419817|NCT04291885|Avelumab|avelumab|mesh-list
64871808|NCT01848197|Paclitaxel|paclitaxel|mesh-list
64333722|NCT02361567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64333723|NCT02361567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419819|NCT04291885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871809|NCT01848197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64785107|NCT00569868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64785108|NCT05599230|Ivacaftor|ivacaftor|mesh-list
64785109|NCT05599230|Elexacaftor|elexacaftor|mesh-list
64785110|NCT05599230|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64785111|NCT05599230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64785112|NCT05599230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785113|NCT05524584|Fulvestrant|fulvestrant|mesh-list
64785114|NCT05524584|Anastrozole|anastrozole|mesh-list
64785115|NCT05524584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64871891|NCT01848769|Autonomic Agents|autonomic agents|mesh-ancestor
64871892|NCT01848769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64871893|NCT01848769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871894|NCT01848769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64871895|NCT01848769|Respiratory System Agents|respiratory system agents|mesh-ancestor
64419869|NCT04712851|Pembrolizumab|pembrolizumab|mesh-list
64871896|NCT01848769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64871897|NCT01848769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64871898|NCT01848769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64871899|NCT01848769|Adrenergic Agents|adrenergic agents|mesh-ancestor
64871900|NCT01848769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64871901|NCT01848769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871902|NCT01848769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64871903|NCT01848769|Glucocorticoids|glucocorticoids|mesh-ancestor
64871904|NCT01848769|Hormones|hormones|mesh-ancestor
64871905|NCT01848769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64871906|NCT01848808|Wobenzym|wobenzym|mesh-list
64871907|NCT01848808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64871908|NCT01848808|Immunologic Factors|immunologic factors|mesh-ancestor
64871909|NCT01848808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871911|NCT01848873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64785116|NCT05524584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64785118|NCT05524584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64785121|NCT05524584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785122|NCT05524584|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64785123|NCT05524584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64785124|NCT05524584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785125|NCT05524584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308449|NCT02254525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64785126|NCT05403762|Protective Agents|protective agents|mesh-list
64308453|NCT03231813|Emollients|emollients|mesh-list
64785127|NCT05403762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785129|NCT05164614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64785130|NCT05164614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785131|NCT05164614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64785132|NCT05001048|Phenylephrine|phenylephrine|mesh-list
64785133|NCT05001048|Oxymetazoline|oxymetazoline|mesh-list
64785134|NCT05001048|Synephrine|synephrine|mesh-list
64785135|NCT05001048|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64785136|NCT05001048|Mydriatics|mydriatics|mesh-ancestor
64785137|NCT05001048|Autonomic Agents|autonomic agents|mesh-ancestor
64785138|NCT05001048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785139|NCT05001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785140|NCT05001048|Sympathomimetics|sympathomimetics|mesh-ancestor
64871935|NCT01849016|Antidotes|antidotes|mesh-ancestor
64785141|NCT05001048|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64785142|NCT05001048|Nasal Decongestants|nasal decongestants|mesh-ancestor
64785143|NCT05001048|Respiratory System Agents|respiratory system agents|mesh-ancestor
64785144|NCT05001048|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64785145|NCT05001048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64785146|NCT05001048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64785147|NCT05001048|Adrenergic Agents|adrenergic agents|mesh-ancestor
64785148|NCT05001048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64871993|NCT01849861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64871994|NCT01849861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871995|NCT01849926|Amdinocillin|amdinocillin|mesh-list
64871996|NCT01849926|Ibuprofen|ibuprofen|mesh-list
64871997|NCT01849926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64871998|NCT01849926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64871999|NCT01849926|Analgesics|analgesics|mesh-ancestor
64872000|NCT01849926|Sensory System Agents|sensory system agents|mesh-ancestor
64872001|NCT01849926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64872002|NCT01849926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872003|NCT01849926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64872004|NCT01849926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64872005|NCT01849926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64872006|NCT01849926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872007|NCT01849926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872008|NCT01849926|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64872009|NCT01849926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64640600|NCT01795430|Immunologic Factors|immunologic factors|mesh-ancestor
64872010|NCT01849926|Renal Agents|renal agents|mesh-ancestor
64872011|NCT01849926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64872012|NCT01849939|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64872013|NCT01849939|Immunologic Factors|immunologic factors|mesh-ancestor
64872014|NCT01849939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872015|NCT01850017|Dexmedetomidine|dexmedetomidine|mesh-list
64872016|NCT01850017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64872017|NCT01850017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64872018|NCT01850017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419960|NCT04697719|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64396351|NCT03105661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64396352|NCT03105661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64396353|NCT03105661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64785149|NCT05001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785150|NCT05001048|Protective Agents|protective agents|mesh-ancestor
64785151|NCT04954638|Sodium Hypochlorite|sodium hypochlorite|mesh-list
64785152|NCT04954638|Chlorine dioxide|chlorine dioxide|mesh-list
64785154|NCT04954638|Disinfectants|disinfectants|mesh-ancestor
64785155|NCT04954638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64785156|NCT04954638|Dental Disinfectants|dental disinfectants|mesh-ancestor
64785157|NCT04810572|Silymarin|silymarin|mesh-list
64785158|NCT04810572|Antioxidants|antioxidants|mesh-ancestor
64785159|NCT04810572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785160|NCT04810572|Protective Agents|protective agents|mesh-ancestor
64785161|NCT04810572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785162|NCT04575090|Simvastatin|simvastatin|mesh-list
64785163|NCT04575090|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64872019|NCT01850017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64872020|NCT01850017|Analgesics|analgesics|mesh-ancestor
64872021|NCT01850017|Sensory System Agents|sensory system agents|mesh-ancestor
64872022|NCT01850017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64872023|NCT01850017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64333724|NCT02361567|Analgesics|analgesics|mesh-ancestor
64333725|NCT02361567|Sensory System Agents|sensory system agents|mesh-ancestor
64333726|NCT02361567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64872024|NCT01850017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64872025|NCT01850017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64872026|NCT01850017|Adrenergic Agents|adrenergic agents|mesh-ancestor
64872027|NCT01850017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64872028|NCT01850017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872029|NCT01850095|Azelaic acid|azelaic acid|mesh-list
64872030|NCT01850095|Estradiol|estradiol|mesh-list
64785164|NCT04575090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64785165|NCT04575090|Antimetabolites|antimetabolites|mesh-ancestor
64785166|NCT04575090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785167|NCT04575090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64785168|NCT04575090|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64785169|NCT04575090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785170|NCT04100772|Vaccines|vaccines|mesh-list
64785171|NCT04100772|Immunologic Factors|immunologic factors|mesh-ancestor
64785172|NCT04100772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785173|NCT04043520|Estradiol|estradiol|mesh-list
64785174|NCT04043520|Estrogens|estrogens|mesh-list
64785175|NCT04043520|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64785176|NCT04043520|Hormones|hormones|mesh-ancestor
64396378|NCT04747561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396379|NCT02380417|Ropivacaine|ropivacaine|mesh-list
64872116|NCT01850680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64872117|NCT01850680|Antimetabolites|antimetabolites|mesh-ancestor
64872118|NCT01850680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872119|NCT01850680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872127|NCT01850680|Hematinics|hematinics|mesh-ancestor
64872132|NCT01850940|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64872133|NCT01850940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872134|NCT01850940|Natriuretic Agents|natriuretic agents|mesh-ancestor
64872135|NCT01850940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872136|NCT01850953|Varenicline|varenicline|mesh-list
64872137|NCT01850953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64872138|NCT01850953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64872139|NCT01850953|Cholinergic Agents|cholinergic agents|mesh-ancestor
64872143|NCT01850979|Tacrolimus|tacrolimus|mesh-list
64308597|NCT03214653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64308598|NCT03214653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64308599|NCT02450877|Azacitidine|azacitidine|mesh-list
64396383|NCT02380417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785186|NCT03472872|Sensory System Agents|sensory system agents|mesh-ancestor
64785187|NCT03472872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785188|NCT03472872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785189|NCT03472872|Antipyretics|antipyretics|mesh-ancestor
64785190|NCT03472872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64785191|NCT03472872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64308815|NCT03209037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64308816|NCT03209037|Antiviral Agents|antiviral agents|mesh-ancestor
64308818|NCT03209115|Calcium, Dietary|calcium, dietary|mesh-list
64308819|NCT03209115|Chlorhexidine|chlorhexidine|mesh-list
64308820|NCT03209115|Calcium|calcium|mesh-list
64308821|NCT03209115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64308822|NCT03209115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308823|NCT03209115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64308824|NCT03209115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64308825|NCT03209115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64308826|NCT03209115|Disinfectants|disinfectants|mesh-ancestor
64308827|NCT03209193|Sevoflurane|sevoflurane|mesh-list
64872172|NCT01851005|Narcotics|narcotics|mesh-ancestor
64872173|NCT01851005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64872174|NCT01851005|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64872175|NCT01851005|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64872176|NCT01851005|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64872177|NCT01851005|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64872178|NCT01851148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
64872179|NCT01851148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64872180|NCT01851148|Serotonin Agents|serotonin agents|mesh-ancestor
64872181|NCT01851148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64872182|NCT01851148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872183|NCT01851148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308828|NCT03209193|Desflurane|desflurane|mesh-list
64308829|NCT03209193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64308830|NCT03209193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64308831|NCT03209193|Anesthetics, General|anesthetics, general|mesh-ancestor
64308832|NCT03209193|Anesthetics|anesthetics|mesh-ancestor
64308833|NCT03209193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64308834|NCT03209193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308835|NCT02142595|Midazolam|midazolam|mesh-list
64308836|NCT02142595|Dexmedetomidine|dexmedetomidine|mesh-list
64308837|NCT02142595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64308838|NCT02142595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64308839|NCT02142595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308840|NCT02142595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64308841|NCT02142595|Analgesics|analgesics|mesh-ancestor
64308842|NCT02142595|Sensory System Agents|sensory system agents|mesh-ancestor
64308843|NCT02142595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64396408|NCT01975246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64396409|NCT01975246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64396410|NCT01975246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64396411|NCT02389933|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64396412|NCT02389933|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64872231|NCT01851473|Sensory System Agents|sensory system agents|mesh-ancestor
64872232|NCT01851473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64872233|NCT01851473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64640880|NCT05299086|Xhance|xhance|mesh-list
64872234|NCT01851473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64872235|NCT01851473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64872236|NCT01851473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64872237|NCT01851473|Dopamine Agents|dopamine agents|mesh-ancestor
64872239|NCT01851473|Antimalarials|antimalarials|mesh-ancestor
64396413|NCT02389933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396414|NCT02379715|Remifentanil|remifentanil|mesh-list
64396415|NCT02379715|Desflurane|desflurane|mesh-list
64396416|NCT02379715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64396417|NCT02379715|Narcotics|narcotics|mesh-ancestor
64396418|NCT02379715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64396419|NCT02379715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396420|NCT02379715|Analgesics|analgesics|mesh-ancestor
64785197|NCT03301038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64785198|NCT03301038|Antitubercular Agents|antitubercular agents|mesh-ancestor
64785199|NCT03301038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64785200|NCT03301038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64785201|NCT03301038|Leprostatic Agents|leprostatic agents|mesh-ancestor
64785202|NCT03301038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64785203|NCT03301038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396421|NCT02379715|Sensory System Agents|sensory system agents|mesh-ancestor
64396422|NCT02379715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64396423|NCT02379715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64396424|NCT02379715|Anesthetics, General|anesthetics, general|mesh-ancestor
64396425|NCT02379715|Anesthetics|anesthetics|mesh-ancestor
64308844|NCT02142595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64308845|NCT02142595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64308846|NCT02142595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64396426|NCT04439773|Lidocaine|lidocaine|mesh-list
64396427|NCT04439773|Anesthetics, Local|anesthetics, local|mesh-ancestor
64396428|NCT04439773|Anesthetics|anesthetics|mesh-ancestor
64396429|NCT04439773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64872286|NCT01851733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872287|NCT01851733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872288|NCT01851759|Cinepazide|cinepazide|mesh-list
64872289|NCT01851759|Vasodilator Agents|vasodilator agents|mesh-ancestor
64872290|NCT01851824|Vemurafenib|vemurafenib|mesh-list
64872291|NCT01851824|Acenocoumarol|acenocoumarol|mesh-list
64872292|NCT01851824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872293|NCT01851824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64872294|NCT01851824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872295|NCT01851824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872296|NCT01851824|Anticoagulants|anticoagulants|mesh-ancestor
64872297|NCT01851850|Opicapone|opicapone|mesh-list
64872298|NCT01851850|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64872299|NCT01851850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396430|NCT04439773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396431|NCT04439773|Sensory System Agents|sensory system agents|mesh-ancestor
64324517|NCT02265289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64324518|NCT02265289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64396454|NCT02383771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396455|NCT02383771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64396456|NCT02383771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64396457|NCT02383771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64396458|NCT02383771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64396459|NCT02383771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396460|NCT02383771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64396461|NCT02383771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64396462|NCT02383771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309349|NCT02450175|Immunologic Factors|immunologic factors|mesh-ancestor
64309350|NCT02450175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309351|NCT02450175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64333727|NCT02361567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64333728|NCT02361567|Antipyretics|antipyretics|mesh-ancestor
64333729|NCT03112785|Cimetidine|cimetidine|mesh-list
64333730|NCT03112785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64872332|NCT01851980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872333|NCT01851980|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64872334|NCT01851980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64872335|NCT01851980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872336|NCT01851993|Ondansetron|ondansetron|mesh-list
64872337|NCT01851993|Antiemetics|antiemetics|mesh-ancestor
64872338|NCT01851993|Autonomic Agents|autonomic agents|mesh-ancestor
64872339|NCT01851993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64872340|NCT01851993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872341|NCT01851993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64872342|NCT01851993|Antipruritics|antipruritics|mesh-ancestor
64872343|NCT01851993|Dermatologic Agents|dermatologic agents|mesh-ancestor
64872344|NCT01851993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64872345|NCT01851993|Serotonin Agents|serotonin agents|mesh-ancestor
64872346|NCT01851993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64872347|NCT01851993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309352|NCT02450175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64309353|NCT02450175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309354|NCT02450175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309355|NCT02450175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64309356|NCT02450175|Hormone Antagonists|hormone antagonists|mesh-ancestor
64309357|NCT02450175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64309359|NCT03202719|Immunologic Factors|immunologic factors|mesh-ancestor
64872390|NCT01852409|Growth Inhibitors|growth inhibitors|mesh-ancestor
64872391|NCT01852461|Poractant alfa|poractant alfa|mesh-list
64872392|NCT01852461|Beractant|beractant|mesh-list
64872393|NCT01852461|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
64872394|NCT01852461|Respiratory System Agents|respiratory system agents|mesh-ancestor
64872395|NCT01852539|Dexmedetomidine|dexmedetomidine|mesh-list
64872396|NCT01852539|Propofol|propofol|mesh-list
64872397|NCT01852539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64872398|NCT01852539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64872399|NCT01852539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872400|NCT01852539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64872401|NCT01852539|Anesthetics, General|anesthetics, general|mesh-ancestor
64872402|NCT01852539|Anesthetics|anesthetics|mesh-ancestor
64872403|NCT01852539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64872404|NCT01852539|Analgesics|analgesics|mesh-ancestor
64872405|NCT01852539|Sensory System Agents|sensory system agents|mesh-ancestor
64872406|NCT01852539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64872407|NCT01852539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64872408|NCT01852539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64872409|NCT01852539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64872410|NCT01852539|Adrenergic Agents|adrenergic agents|mesh-ancestor
64872411|NCT01852539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64872412|NCT01852539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872413|NCT01852565|Diltiazem|diltiazem|mesh-list
64872414|NCT01852565|Darapladib|darapladib|mesh-list
64872415|NCT01852565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64872416|NCT01852565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64872417|NCT01852565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64872418|NCT01852565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872419|NCT01852565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64309360|NCT03202719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309361|NCT03202407|Calcium|calcium|mesh-list
64309362|NCT03202407|Sevelamer|sevelamer|mesh-list
64309363|NCT03202407|Calcium acetate|calcium acetate|mesh-list
64309364|NCT03202407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64309365|NCT03202407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309366|NCT03202407|Chelating Agents|chelating agents|mesh-ancestor
64309384|NCT03196869|Cisplatin|cisplatin|mesh-list
64396487|NCT02661061|Sensory System Agents|sensory system agents|mesh-ancestor
64396488|NCT02661061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64324520|NCT02265289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64324521|NCT02265289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872420|NCT01852565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872421|NCT01852565|Vasodilator Agents|vasodilator agents|mesh-ancestor
64872422|NCT01852565|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
64872423|NCT01852565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872424|NCT01852604|Interferons|interferons|mesh-list
64872425|NCT01852604|Ritonavir|ritonavir|mesh-list
64872426|NCT01852604|Ribavirin|ribavirin|mesh-list
64872427|NCT01852604|Simeprevir|simeprevir|mesh-list
64872428|NCT01852604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872429|NCT01852604|Antiviral Agents|antiviral agents|mesh-ancestor
64872430|NCT01852604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64872431|NCT01852604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64872432|NCT01852604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64872433|NCT01852604|Protease Inhibitors|protease inhibitors|mesh-ancestor
64872434|NCT01852604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872435|NCT01852604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872436|NCT01852604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64872437|NCT01852604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64872438|NCT01852604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64872439|NCT01852604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64872440|NCT01852604|Antimetabolites|antimetabolites|mesh-ancestor
64872441|NCT01852630|Imipenem|imipenem|mesh-list
64872442|NCT01852630|Cefepime|cefepime|mesh-list
64872443|NCT01852630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64872444|NCT01852630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64872445|NCT01852786|Contraceptive Agents|contraceptive agents|mesh-list
64872446|NCT01852786|Contraceptives, Oral|contraceptives, oral|mesh-list
64420217|NCT05560945|Protective Agents|protective agents|mesh-ancestor
64420218|NCT05560945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333731|NCT03112785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64324522|NCT02265289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324523|NCT02265445|beta-Lactams|beta-lactams|mesh-list
64324524|NCT02265445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64309471|NCT03197103|Antidotes|antidotes|mesh-ancestor
64309472|NCT02144623|Valproic Acid|valproic acid|mesh-list
64396496|NCT02661061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64309549|NCT03201627|Lithium Carbonate|lithium carbonate|mesh-list
64396501|NCT02661061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64396502|NCT02661061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64396503|NCT02661061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64396504|NCT02661061|GABA Modulators|gaba modulators|mesh-ancestor
64396506|NCT02376985|Everolimus|everolimus|mesh-list
64396507|NCT02376985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396508|NCT02376985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64309723|NCT02444481|Ionophores|ionophores|mesh-ancestor
64309724|NCT02444481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64309726|NCT02444559|Ropivacaine|ropivacaine|mesh-list
64309727|NCT02444559|Anesthetics, Local|anesthetics, local|mesh-ancestor
64309728|NCT02444559|Anesthetics|anesthetics|mesh-ancestor
64309729|NCT02444559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64309730|NCT02444559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309731|NCT02444559|Sensory System Agents|sensory system agents|mesh-ancestor
64309732|NCT02444559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64309734|NCT02444559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64309735|NCT02444559|Sympatholytics|sympatholytics|mesh-ancestor
64309736|NCT02444559|Autonomic Agents|autonomic agents|mesh-ancestor
64333732|NCT03112785|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64333733|NCT03112785|Histamine Antagonists|histamine antagonists|mesh-ancestor
64333734|NCT03112785|Histamine Agents|histamine agents|mesh-ancestor
64333735|NCT03112785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64872447|NCT01852786|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64872448|NCT01852786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64872449|NCT01852786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309737|NCT02444559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64309738|NCT02444559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64309739|NCT02444559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64396517|NCT02371993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64785311|NCT00108342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64785312|NCT00108342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785313|NCT00090870|Interferons|interferons|mesh-list
64785314|NCT00090870|Interferon-alpha|interferon-alpha|mesh-list
64785315|NCT00090870|Interferon alpha-2|interferon alpha-2|mesh-list
64396518|NCT02371993|Nootropic Agents|nootropic agents|mesh-ancestor
64396519|NCT02371603|Pioglitazone|pioglitazone|mesh-list
64396520|NCT02371603|Trimethoprim|trimethoprim|mesh-list
64396521|NCT02371603|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64872488|NCT01853306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872489|NCT01853306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872490|NCT01853423|Sirolimus|sirolimus|mesh-list
64872491|NCT01853423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64872492|NCT01853423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64872493|NCT01853423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64872494|NCT01853423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872495|NCT01853423|Antifungal Agents|antifungal agents|mesh-ancestor
64396522|NCT02371603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64396523|NCT02371603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64396524|NCT02371603|Antimetabolites|antimetabolites|mesh-ancestor
64396525|NCT02371603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396526|NCT02371603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64396543|NCT04230109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396544|NCT04149145|Niraparib|niraparib|mesh-list
64396545|NCT04149145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64396546|NCT04149145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396547|NCT04149145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310071|NCT02436993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64310072|NCT02436993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64310073|NCT02436993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64310074|NCT02436993|Growth Substances|growth substances|mesh-ancestor
64872541|NCT01853800|Antithrombins|antithrombins|mesh-ancestor
64872542|NCT01853800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64872543|NCT01853800|Protease Inhibitors|protease inhibitors|mesh-ancestor
64872544|NCT01853800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872545|NCT01853800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872546|NCT01853800|Anticoagulants|anticoagulants|mesh-ancestor
64310075|NCT02436993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310076|NCT02436993|Growth Inhibitors|growth inhibitors|mesh-ancestor
64310083|NCT04893980|Aldesleukin|aldesleukin|mesh-list
64310084|NCT04893980|Interleukin-2|interleukin-2|mesh-list
64310085|NCT04893980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310086|NCT04893980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64310087|NCT04893980|Analgesics|analgesics|mesh-ancestor
64310088|NCT04893980|Sensory System Agents|sensory system agents|mesh-ancestor
64310089|NCT04893980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64310090|NCT04893980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310091|NCT04893980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64310092|NCT04893980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64310093|NCT04893980|Antiviral Agents|antiviral agents|mesh-ancestor
64310205|NCT04899674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64310206|NCT04899674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310208|NCT04907708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64310209|NCT04907708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310210|NCT04890626|Tenofovir|tenofovir|mesh-list
64310211|NCT04890626|Emtricitabine|emtricitabine|mesh-list
64310212|NCT04890626|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64310213|NCT04890626|Dexamethasone|dexamethasone|mesh-list
64396553|NCT02378389|Mitosis Modulators|mitosis modulators|mesh-ancestor
64396554|NCT02378389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396555|NCT02376595|Bromides|bromides|mesh-list
64396556|NCT02376595|Rocuronium|rocuronium|mesh-list
64396557|NCT02376595|Anticonvulsants|anticonvulsants|mesh-ancestor
64396558|NCT02376595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64396559|NCT02376595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64396560|NCT02376595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64310248|NCT03051542|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64310249|NCT03051542|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64310250|NCT03051542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310251|NCT04907474|Phenylephrine|phenylephrine|mesh-list
64396561|NCT02376595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785348|NCT00058188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785350|NCT00058188|Micronutrients|micronutrients|mesh-ancestor
64785351|NCT00058188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64785352|NCT00003726|Lepirudin|lepirudin|mesh-list
64785353|NCT00003726|Antithrombins|antithrombins|mesh-ancestor
64785354|NCT00003726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64785355|NCT00003726|Protease Inhibitors|protease inhibitors|mesh-ancestor
64785356|NCT00003726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785357|NCT00003726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785358|NCT00003726|Anticoagulants|anticoagulants|mesh-ancestor
64785359|NCT00003726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64396562|NCT02376595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396563|NCT02370745|Insulin|insulin|mesh-list
64396564|NCT02370745|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64396565|NCT02370745|Incretins|incretins|mesh-list
64396566|NCT02370745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64396567|NCT02370745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396568|NCT02370745|Hormones|hormones|mesh-ancestor
64396569|NCT02370745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64396570|NCT02376049|Betamethasone|betamethasone|mesh-list
64396571|NCT02376049|Betamethasone Valerate|betamethasone valerate|mesh-list
64310342|NCT04889768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310366|NCT04906304|Immunologic Factors|immunologic factors|mesh-ancestor
64310367|NCT04906304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310368|NCT04906304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64310369|NCT04906304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64310370|NCT04906304|Antitubercular Agents|antitubercular agents|mesh-ancestor
64310371|NCT04906304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64310372|NCT04906304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64310373|NCT04906304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310374|NCT04906304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310375|NCT04906304|Antifungal Agents|antifungal agents|mesh-ancestor
64310376|NCT04906304|Dermatologic Agents|dermatologic agents|mesh-ancestor
64872658|NCT01854502|Cariostatic Agents|cariostatic agents|mesh-ancestor
64872659|NCT01854502|Protective Agents|protective agents|mesh-ancestor
64872660|NCT01854502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872661|NCT01854515|Dexamethasone|dexamethasone|mesh-list
64872662|NCT01854515|Budesonide|budesonide|mesh-list
64872663|NCT01854515|Dexamethasone acetate|dexamethasone acetate|mesh-list
64872664|NCT01854515|BB 1101|bb 1101|mesh-list
64872665|NCT01854515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64872666|NCT01854515|Antiemetics|antiemetics|mesh-ancestor
64872667|NCT01854515|Autonomic Agents|autonomic agents|mesh-ancestor
64872668|NCT01854515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64872669|NCT01854515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872670|NCT01854515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64872671|NCT01854515|Glucocorticoids|glucocorticoids|mesh-ancestor
64872672|NCT01854515|Hormones|hormones|mesh-ancestor
64872673|NCT01854515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64872674|NCT01854515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64872675|NCT01854515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872676|NCT01854515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64872677|NCT01854515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64872678|NCT01854515|Respiratory System Agents|respiratory system agents|mesh-ancestor
64872679|NCT01854515|Protease Inhibitors|protease inhibitors|mesh-ancestor
64420461|NCT02554981|Dermatologic Agents|dermatologic agents|mesh-ancestor
64310377|NCT04906304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64310378|NCT04906304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64310379|NCT03051698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64310381|NCT03051698|Vancomycin|vancomycin|mesh-list
64310382|NCT03051698|Ciprofloxacin|ciprofloxacin|mesh-list
64310383|NCT03051698|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64310384|NCT03051698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324537|NCT04476121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324538|NCT04476121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64310400|NCT04896164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64310401|NCT04896164|Analgesics|analgesics|mesh-ancestor
64310402|NCT04896164|Sensory System Agents|sensory system agents|mesh-ancestor
64310403|NCT04896164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64310404|NCT04896164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310405|NCT04896164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64872680|NCT01854515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872682|NCT01854606|Everolimus|everolimus|mesh-list
64310406|NCT04896164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64310407|NCT04896164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310566|NCT02145559|Antifungal Agents|antifungal agents|mesh-ancestor
64310567|NCT02145559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64310568|NCT02145559|Immunologic Factors|immunologic factors|mesh-ancestor
64310569|NCT02145637|Afatinib|afatinib|mesh-list
64310570|NCT02145637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310571|NCT02145637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64310572|NCT02145637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310573|NCT02145637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310574|NCT03154580|Acetylcysteine|acetylcysteine|mesh-list
64310575|NCT03154580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64310576|NCT03154580|Antiviral Agents|antiviral agents|mesh-ancestor
64310577|NCT03154580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64310578|NCT03154580|Expectorants|expectorants|mesh-ancestor
64310579|NCT03154580|Respiratory System Agents|respiratory system agents|mesh-ancestor
64310580|NCT03154580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64310581|NCT03154580|Antioxidants|antioxidants|mesh-ancestor
64872754|NCT01855100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872755|NCT01855100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872756|NCT01855100|Anticoagulants|anticoagulants|mesh-ancestor
64872757|NCT01855139|Rivaroxaban|rivaroxaban|mesh-list
64872758|NCT01855139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64310583|NCT03154580|Protective Agents|protective agents|mesh-ancestor
64785371|NCT04422210|Carboplatin|carboplatin|mesh-list
64785372|NCT04422210|Etoposide|etoposide|mesh-list
64785373|NCT04422210|Atezolizumab|atezolizumab|mesh-list
64785374|NCT04422210|Venetoclax|venetoclax|mesh-list
64785375|NCT04422210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64785376|NCT04422210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64785377|NCT04422210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64785378|NCT04422210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64785379|NCT04422210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872818|NCT01855555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872819|NCT01855555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64872820|NCT01855555|Anesthetics, General|anesthetics, general|mesh-ancestor
64872821|NCT01855555|Anesthetics|anesthetics|mesh-ancestor
64872822|NCT01855568|Methotrexate|methotrexate|mesh-list
64872823|NCT01855568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64872824|NCT01855568|Abortifacient Agents|abortifacient agents|mesh-ancestor
64872825|NCT01855568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64872826|NCT01855568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872827|NCT01855568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64872828|NCT01855568|Antimetabolites|antimetabolites|mesh-ancestor
64872829|NCT01855568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872830|NCT01855568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872831|NCT01855568|Dermatologic Agents|dermatologic agents|mesh-ancestor
64872832|NCT01855568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872833|NCT01855568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64872834|NCT01855568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64872835|NCT01855568|Immunologic Factors|immunologic factors|mesh-ancestor
64872836|NCT01855568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64872837|NCT01855568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64872838|NCT01855581|Ketamine|ketamine|mesh-list
64872839|NCT01855581|Propofol|propofol|mesh-list
64333736|NCT03112785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333738|NCT03112785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64872840|NCT01855581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64872841|NCT01855581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64872842|NCT01855581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872844|NCT01855581|Anesthetics, General|anesthetics, general|mesh-ancestor
64872845|NCT01855581|Anesthetics|anesthetics|mesh-ancestor
64872846|NCT01855581|Analgesics|analgesics|mesh-ancestor
64872847|NCT01855581|Sensory System Agents|sensory system agents|mesh-ancestor
64420581|NCT03796195|Sensory System Agents|sensory system agents|mesh-ancestor
64785380|NCT04422210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785395|NCT00000138|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64396593|NCT02376049|Immunologic Factors|immunologic factors|mesh-ancestor
64396594|NCT02376049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64396595|NCT02376049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396596|NCT02376049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396597|NCT02376205|Bupivacaine|bupivacaine|mesh-list
64396598|NCT02376205|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64396599|NCT02376205|Anesthetics, Local|anesthetics, local|mesh-ancestor
64396600|NCT02376205|Anesthetics|anesthetics|mesh-ancestor
64872848|NCT01855581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64872849|NCT01855581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64872863|NCT01855711|Alosetron|alosetron|mesh-list
64396601|NCT02376205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64396602|NCT02376205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396603|NCT02376205|Sensory System Agents|sensory system agents|mesh-ancestor
64311033|NCT02086097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311034|NCT02086097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64311035|NCT02086097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64311036|NCT02086097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64396615|NCT02370433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64396616|NCT02370433|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64785410|NCT00000138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785411|NCT00000138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64785412|NCT00000138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64872911|NCT01856023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872912|NCT01856023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64872913|NCT01856023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872914|NCT01856023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64872915|NCT01856023|Analgesics|analgesics|mesh-ancestor
64872916|NCT01856023|Sensory System Agents|sensory system agents|mesh-ancestor
64872917|NCT01856023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641504|NCT05275374|Trametinib|trametinib|mesh-list
64872918|NCT01856023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872919|NCT01856023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64785413|NCT00000138|Protective Agents|protective agents|mesh-ancestor
64785414|NCT00000138|Antiviral Agents|antiviral agents|mesh-ancestor
64785415|NCT00000138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64785416|NCT00000174|Rivastigmine|rivastigmine|mesh-list
64785417|NCT00000174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64785418|NCT00000174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785419|NCT00000174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785420|NCT00000174|Cholinergic Agents|cholinergic agents|mesh-ancestor
64311093|NCT04385966|Anesthetics|anesthetics|mesh-ancestor
64785434|NCT00000192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64785435|NCT00000192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64785436|NCT00000192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64785437|NCT00000198|Piracetam|piracetam|mesh-list
64872980|NCT01856374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64872981|NCT01856374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64872983|NCT01856374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872984|NCT01856374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64872985|NCT01856374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64872986|NCT01856374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872987|NCT01856374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872988|NCT01856374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64333739|NCT03112785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64333740|NCT03112785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333742|NCT02361879|Ulipristal acetate|ulipristal acetate|mesh-list
64333743|NCT02361879|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64333744|NCT02361879|Fertility Agents|fertility agents|mesh-ancestor
64333745|NCT02361879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64333746|NCT02361879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333747|NCT02361879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64333748|NCT02361879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333749|NCT02361879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64333750|NCT02361879|Contraceptive Agents|contraceptive agents|mesh-ancestor
64785438|NCT00000198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64785439|NCT00000198|Protective Agents|protective agents|mesh-ancestor
64785440|NCT00000198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785441|NCT00000198|Nootropic Agents|nootropic agents|mesh-ancestor
64785442|NCT00000204|Buprenorphine|buprenorphine|mesh-list
64785443|NCT00000204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64785444|NCT00000204|Narcotics|narcotics|mesh-ancestor
64785445|NCT00000204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64785446|NCT00000204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785447|NCT00000204|Analgesics|analgesics|mesh-ancestor
64396640|NCT01946152|Lenograstim|lenograstim|mesh-list
64396641|NCT01946152|BB 1101|bb 1101|mesh-list
64396642|NCT01946152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64396643|NCT01946152|Antiemetics|antiemetics|mesh-ancestor
64396644|NCT01946152|Autonomic Agents|autonomic agents|mesh-ancestor
64311113|NCT03048110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64311114|NCT03048110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311115|NCT03048110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311116|NCT03048110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64311117|NCT03048110|Hormone Antagonists|hormone antagonists|mesh-ancestor
64311121|NCT03048110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64324544|NCT01234519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324545|NCT01234519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64872989|NCT01856374|Immunologic Factors|immunologic factors|mesh-ancestor
64872990|NCT01856374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872991|NCT01856374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64872992|NCT01856374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64872993|NCT01856374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64872994|NCT01856374|Antifungal Agents|antifungal agents|mesh-ancestor
64872995|NCT01856413|Immunoglobulins|immunoglobulins|mesh-list
64872996|NCT01856413|Immunologic Factors|immunologic factors|mesh-ancestor
64324546|NCT01234519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64396660|NCT01946152|Growth Substances|growth substances|mesh-ancestor
64396661|NCT01946152|Growth Inhibitors|growth inhibitors|mesh-ancestor
64396662|NCT01946152|Dermatologic Agents|dermatologic agents|mesh-ancestor
64396664|NCT01971346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64785467|NCT00000222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785468|NCT00000222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64873046|NCT01856946|Cholecalciferol|cholecalciferol|mesh-list
64873047|NCT01856946|Vitamins|vitamins|mesh-ancestor
64873048|NCT01856946|Micronutrients|micronutrients|mesh-ancestor
64873049|NCT01856946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873050|NCT01856946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64873051|NCT01856946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64873052|NCT01856959|Magnesium Sulfate|magnesium sulfate|mesh-list
64873053|NCT01856959|Albuterol|albuterol|mesh-list
64873054|NCT01856959|Analgesics|analgesics|mesh-ancestor
64873055|NCT01856959|Sensory System Agents|sensory system agents|mesh-ancestor
64873056|NCT01856959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64873057|NCT01856959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873058|NCT01856959|Anesthetics|anesthetics|mesh-ancestor
64873059|NCT01856959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64873060|NCT01856959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64873061|NCT01856959|Anticonvulsants|anticonvulsants|mesh-ancestor
64873062|NCT01856959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64873063|NCT01856959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64873064|NCT01856959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873065|NCT01856959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64873066|NCT01856959|Tocolytic Agents|tocolytic agents|mesh-ancestor
64785469|NCT00000228|Buprenorphine|buprenorphine|mesh-list
64785470|NCT00000228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64396665|NCT01971346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64396666|NCT01971346|Analgesics|analgesics|mesh-ancestor
64785479|NCT00000234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64785480|NCT00000234|Narcotics|narcotics|mesh-ancestor
64785481|NCT00000234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64785482|NCT00000234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785483|NCT00000234|Analgesics|analgesics|mesh-ancestor
64396677|NCT01945216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396678|NCT01945216|Incretins|incretins|mesh-ancestor
64396679|NCT01945216|Hormones|hormones|mesh-ancestor
64396680|NCT01945216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64873095|NCT01856985|Luteolytic Agents|luteolytic agents|mesh-ancestor
64873096|NCT01856985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64873097|NCT01856985|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64873098|NCT01856998|Propofol|propofol|mesh-list
64873099|NCT01856998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64873100|NCT01856998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64873101|NCT01856998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396681|NCT01945216|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64396682|NCT01945216|Protease Inhibitors|protease inhibitors|mesh-ancestor
64396683|NCT01945216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396684|NCT01945216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396685|NCT02641379|Ribavirin|ribavirin|mesh-list
64396686|NCT02641379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64396687|NCT02641379|Antimetabolites|antimetabolites|mesh-ancestor
64396688|NCT02641379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396689|NCT02641379|Antiviral Agents|antiviral agents|mesh-ancestor
64333756|NCT05262335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64333757|NCT05262335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333758|NCT05262335|Tubulin Modulators|tubulin modulators|mesh-ancestor
64333759|NCT05262335|Antimitotic Agents|antimitotic agents|mesh-ancestor
64333760|NCT05262335|Mitosis Modulators|mitosis modulators|mesh-ancestor
64333761|NCT05262335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333762|NCT05262335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64333763|NCT05262335|Antimetabolites|antimetabolites|mesh-ancestor
64333764|NCT02361645|Ketorolac|ketorolac|mesh-list
64873167|NCT01857349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64873168|NCT01857349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64873169|NCT01857349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873170|NCT01857349|Disinfectants|disinfectants|mesh-ancestor
64873171|NCT01857349|Dermatologic Agents|dermatologic agents|mesh-ancestor
64873172|NCT01857375|Insulin|insulin|mesh-list
64396690|NCT02641379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64396691|NCT02660983|Donepezil|donepezil|mesh-list
64396692|NCT02660983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64311180|NCT02082665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64311185|NCT02082665|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64396693|NCT02660983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396694|NCT02660983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396695|NCT02660983|Cholinergic Agents|cholinergic agents|mesh-ancestor
64873195|NCT01857479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64873196|NCT01857479|Amebicides|amebicides|mesh-ancestor
64873197|NCT01857479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64873198|NCT01857479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64873199|NCT01857479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64873200|NCT01857479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64873201|NCT01857479|Antifungal Agents|antifungal agents|mesh-ancestor
64873202|NCT01857544|Aflibercept|aflibercept|mesh-list
64333779|NCT02361645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333780|NCT02361645|Gout Suppressants|gout suppressants|mesh-ancestor
64333781|NCT02361645|Tocolytic Agents|tocolytic agents|mesh-ancestor
64333782|NCT02361645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64333783|NCT02361645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64873203|NCT01857544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64873204|NCT01857544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64873205|NCT01857544|Growth Substances|growth substances|mesh-ancestor
64873206|NCT01857544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873207|NCT01857544|Growth Inhibitors|growth inhibitors|mesh-ancestor
64873208|NCT01857544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873209|NCT01857596|Trazodone|trazodone|mesh-list
64873210|NCT01857596|Bupropion|bupropion|mesh-list
64873211|NCT01857596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64873212|NCT01857596|Antidepressive Agents|antidepressive agents|mesh-ancestor
64873213|NCT01857596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64873214|NCT01857596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64873215|NCT01857596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64873216|NCT01857596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64873217|NCT01857596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396696|NCT02660983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64396697|NCT02660983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396698|NCT02660983|Nootropic Agents|nootropic agents|mesh-ancestor
64396699|NCT05070221|Axitinib|axitinib|mesh-list
64396700|NCT05070221|Antibodies|antibodies|mesh-list
64396701|NCT05070221|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64785498|NCT00000246|Protective Agents|protective agents|mesh-ancestor
64785499|NCT00000246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785500|NCT00000246|GABA Modulators|gaba modulators|mesh-ancestor
64785501|NCT00000246|GABA Agents|gaba agents|mesh-ancestor
64785502|NCT00000246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64785503|NCT00000246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873225|NCT01857596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64873226|NCT01857596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64873227|NCT01857596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64873228|NCT01857596|Serotonin Agents|serotonin agents|mesh-ancestor
64873229|NCT01857609|Metformin|metformin|mesh-list
64873230|NCT01857609|Rabeprazole|rabeprazole|mesh-list
64873231|NCT01857609|Pantoprazole|pantoprazole|mesh-list
64873232|NCT01857609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64873233|NCT01857609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873234|NCT01857609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64873235|NCT01857609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64873236|NCT01857609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64873237|NCT01857609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873238|NCT01857609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873239|NCT01857726|Doxorubicin|doxorubicin|mesh-list
64873240|NCT01857726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873241|NCT01857726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64873242|NCT01857726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64873243|NCT01857726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64873244|NCT01857726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873245|NCT01857726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873246|NCT01857752|Temozolomide|temozolomide|mesh-list
64873247|NCT01857752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64873248|NCT01857752|Alkylating Agents|alkylating agents|mesh-ancestor
64873249|NCT01857752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785504|NCT00000264|Ethanol|ethanol|mesh-list
64785505|NCT00000264|Nitrous Oxide|nitrous oxide|mesh-list
64785506|NCT00000264|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64785507|NCT00000264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64785508|NCT00000264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64785509|NCT00000264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785510|NCT00000264|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64785511|NCT00000264|Anesthetics, General|anesthetics, general|mesh-ancestor
64311219|NCT02083055|Nitroglycerin|nitroglycerin|mesh-list
64311220|NCT02083055|Dexmedetomidine|dexmedetomidine|mesh-list
64311221|NCT02083055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64311222|NCT02083055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64311223|NCT02083055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311224|NCT02083055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64311225|NCT02083055|Analgesics|analgesics|mesh-ancestor
64311226|NCT02083055|Sensory System Agents|sensory system agents|mesh-ancestor
64311227|NCT02083055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64311228|NCT02083055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64311229|NCT02083055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64311230|NCT02083055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64311231|NCT02083055|Adrenergic Agents|adrenergic agents|mesh-ancestor
64311232|NCT02083055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64311233|NCT02083055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311234|NCT02083055|Vasodilator Agents|vasodilator agents|mesh-ancestor
64311235|NCT02089295|Oxycodone|oxycodone|mesh-list
64311236|NCT02089295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64311238|NCT02089295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64311239|NCT02089295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311240|NCT02089295|Analgesics|analgesics|mesh-ancestor
64396704|NCT05070221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396705|NCT05070221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64396706|NCT05070221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396707|NCT05070221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396708|NCT04404439|Topiramate|topiramate|mesh-list
64396709|NCT04404439|Verapamil|verapamil|mesh-list
64396710|NCT04404439|Paroxetine|paroxetine|mesh-list
64396711|NCT04404439|Nortriptyline|nortriptyline|mesh-list
64396712|NCT04404439|Anticonvulsants|anticonvulsants|mesh-ancestor
64396713|NCT04404439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64396714|NCT04404439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311249|NCT02370784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64311250|NCT02370784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311251|NCT02083211|Nimotuzumab|nimotuzumab|mesh-list
64311252|NCT02083211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64311253|NCT02083211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64311254|NCT01595438|Ciprofloxacin|ciprofloxacin|mesh-list
64311255|NCT01595438|Ceftazidime|ceftazidime|mesh-list
64873374|NCT01858090|Sensory System Agents|sensory system agents|mesh-ancestor
64873375|NCT01858090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64873376|NCT01858090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64873377|NCT01858090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64873378|NCT01858090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64873379|NCT01858090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64873380|NCT01858090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64873381|NCT01858090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64873382|NCT01858090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873383|NCT01858090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873384|NCT01858090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64873385|NCT01858090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64873386|NCT01858090|Autonomic Agents|autonomic agents|mesh-ancestor
64873387|NCT01858090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64873388|NCT01858090|Respiratory System Agents|respiratory system agents|mesh-ancestor
64873389|NCT01858090|Mydriatics|mydriatics|mesh-ancestor
64873390|NCT01858090|Parasympatholytics|parasympatholytics|mesh-ancestor
64873391|NCT01858090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64873392|NCT01858090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64873393|NCT01858090|Cholinergic Agents|cholinergic agents|mesh-ancestor
64873396|NCT01858090|Anesthetics, Local|anesthetics, local|mesh-ancestor
64311256|NCT01595438|Avibactam|avibactam|mesh-list
64311257|NCT01595438|Doripenem|doripenem|mesh-list
64311258|NCT01595438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64311259|NCT01595438|Trimethoprim|trimethoprim|mesh-list
64311260|NCT01595438|Sulfamethoxazole|sulfamethoxazole|mesh-list
64311265|NCT01595438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311328|NCT02339584|Brinzolamide|brinzolamide|mesh-list
64311329|NCT02339584|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64311330|NCT02339584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64311331|NCT02339584|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64311340|NCT02339506|Cosyntropin|cosyntropin|mesh-list
64396718|NCT04404439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396720|NCT04404439|Serotonin Agents|serotonin agents|mesh-ancestor
64396721|NCT04404439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64396722|NCT04404439|Antidepressive Agents|antidepressive agents|mesh-ancestor
64396723|NCT04404439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64311345|NCT02087813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64311346|NCT02087813|Protease Inhibitors|protease inhibitors|mesh-list
64311347|NCT02087813|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64311348|NCT02087813|Protein C Inhibitor|protein c inhibitor|mesh-list
64333785|NCT03522181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64333786|NCT03522181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64873405|NCT01858090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64873406|NCT01858090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64873407|NCT01858090|Dopamine Agents|dopamine agents|mesh-ancestor
64873408|NCT01858090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64873409|NCT01858090|Sympathomimetics|sympathomimetics|mesh-ancestor
64873410|NCT01858090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64873411|NCT01858090|Adrenergic Agents|adrenergic agents|mesh-ancestor
64873412|NCT01858155|Melatonin|melatonin|mesh-list
64873413|NCT01858155|Antioxidants|antioxidants|mesh-ancestor
64873414|NCT01858155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873415|NCT01858155|Protective Agents|protective agents|mesh-ancestor
64873416|NCT01858155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873417|NCT01858155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64873418|NCT01858168|Irinotecan|irinotecan|mesh-list
64873419|NCT01858168|Temozolomide|temozolomide|mesh-list
64873420|NCT01858168|Olaparib|olaparib|mesh-list
64873421|NCT01858168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64873422|NCT01858168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64873423|NCT01858168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873424|NCT01858168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873425|NCT01858168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420979|NCT05284643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873426|NCT01858168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64873427|NCT01858168|Alkylating Agents|alkylating agents|mesh-ancestor
64311350|NCT02087813|Antiemetics|antiemetics|mesh-ancestor
64311519|NCT02090153|Protective Agents|protective agents|mesh-ancestor
64311520|NCT02090153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311521|NCT02090153|Vitamin B Complex|vitamin b complex|mesh-ancestor
64311522|NCT02090153|Vitamins|vitamins|mesh-ancestor
64311523|NCT02090153|Micronutrients|micronutrients|mesh-ancestor
64311524|NCT02090153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64311525|NCT02090153|Antimetabolites|antimetabolites|mesh-ancestor
64311526|NCT02090153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311527|NCT02090153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64311528|NCT00358163|Paclitaxel|paclitaxel|mesh-list
64311529|NCT00358163|Vatalanib|vatalanib|mesh-list
64311530|NCT00358163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64311532|NCT00358163|Tubulin Modulators|tubulin modulators|mesh-ancestor
64311533|NCT00358163|Antimitotic Agents|antimitotic agents|mesh-ancestor
64311534|NCT00358163|Mitosis Modulators|mitosis modulators|mesh-ancestor
64311535|NCT00358163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311536|NCT00358163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64311537|NCT00358163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311538|NCT02096315|Murepavadin|murepavadin|mesh-list
64311539|NCT02096315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64311540|NCT02096315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64311541|NCT02337946|Calcium, Dietary|calcium, dietary|mesh-list
64311543|NCT02337946|Oxaliplatin|oxaliplatin|mesh-list
64311544|NCT02337946|Fluorouracil|fluorouracil|mesh-list
64311545|NCT02337946|Panitumumab|panitumumab|mesh-list
64311546|NCT02337946|Calcium|calcium|mesh-list
64311547|NCT02337946|Levoleucovorin|levoleucovorin|mesh-list
64311548|NCT02337946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64785528|NCT00000270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785529|NCT00000270|Dopamine Agents|dopamine agents|mesh-ancestor
64396724|NCT04404439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64311549|NCT02337946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311673|NCT02097329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311675|NCT02097329|Protective Agents|protective agents|mesh-ancestor
64311676|NCT02097329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64785534|NCT00000276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64785535|NCT00000276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64785536|NCT00000276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64785537|NCT00000276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64311962|NCT02103023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311963|NCT02103023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64311964|NCT02103023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64311965|NCT02103023|Interferon Inducers|interferon inducers|mesh-ancestor
64311966|NCT02101931|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64311967|NCT02101931|Levulinic acid|levulinic acid|mesh-list
64311968|NCT02101931|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64311969|NCT02101931|Dermatologic Agents|dermatologic agents|mesh-ancestor
64311970|NCT02101931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311971|NCT02101931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311972|NCT02106845|Digoxin|digoxin|mesh-list
64311973|NCT02106845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64311974|NCT02106845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64311975|NCT02106845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64311976|NCT02106845|Antimetabolites|antimetabolites|mesh-ancestor
64311977|NCT02106845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311978|NCT02106845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64873719|NCT01860105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64873720|NCT01860105|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64873721|NCT01860105|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64873722|NCT01860105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64873723|NCT01860105|Purinergic Agents|purinergic agents|mesh-ancestor
64873724|NCT01860105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64873725|NCT01860105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873726|NCT01860105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873727|NCT01860144|Bevacizumab|bevacizumab|mesh-list
64873728|NCT01860144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64873729|NCT01860144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873730|NCT01860144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64873731|NCT01860144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64873732|NCT01860144|Growth Substances|growth substances|mesh-ancestor
64873733|NCT01860144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873760|NCT01860300|Amoxicillin|amoxicillin|mesh-list
64873761|NCT01860300|Clavulanic Acid|clavulanic acid|mesh-list
64873762|NCT01860300|Clavulanic Acids|clavulanic acids|mesh-list
64873763|NCT01860300|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64873764|NCT01860300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64873765|NCT01860300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64338492|NCT01004081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64311979|NCT02106845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64311980|NCT02106845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311981|NCT02106845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64311982|NCT02106845|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64311983|NCT02106845|Protective Agents|protective agents|mesh-ancestor
64311984|NCT02106845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311985|NCT03554447|Pentoxifylline|pentoxifylline|mesh-list
64311986|NCT03554447|Dexetimide|dexetimide|mesh-list
64311987|NCT03554447|Citalopram|citalopram|mesh-list
64311988|NCT03554447|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64311989|NCT03554447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64373309|NCT02711137|Paclitaxel|paclitaxel|mesh-list
64785541|NCT00000276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785542|NCT00000276|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64785543|NCT00000276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64785544|NCT00000276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785545|NCT00000282|Pemoline|pemoline|mesh-list
64785546|NCT00000282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64785547|NCT00000282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396732|NCT04404439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64873780|NCT01860469|Vancomycin|vancomycin|mesh-list
64396733|NCT04404439|Adrenergic Agents|adrenergic agents|mesh-ancestor
64396734|NCT01953328|Atorvastatin|atorvastatin|mesh-list
64396735|NCT01953328|Evolocumab|evolocumab|mesh-list
64396736|NCT01953328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64312006|NCT03554447|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64312007|NCT03554447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312023|NCT02103335|Hormones|hormones|mesh-ancestor
64785555|NCT00000294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64785556|NCT00000294|Antioxidants|antioxidants|mesh-ancestor
64785557|NCT00000294|Protective Agents|protective agents|mesh-ancestor
64785558|NCT00000294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64785559|NCT00000294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64785560|NCT00000294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64785561|NCT00000294|Vasodilator Agents|vasodilator agents|mesh-ancestor
64785562|NCT00000294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64396751|NCT03100955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64396752|NCT03100955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64396753|NCT03100955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64873923|NCT01861223|Afatinib|afatinib|mesh-list
64396754|NCT03100955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396755|NCT03100955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396756|NCT03100955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64396757|NCT02377609|Tacrolimus|tacrolimus|mesh-list
64396758|NCT02377609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64324554|NCT02268565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64324555|NCT02268565|Analgesics|analgesics|mesh-ancestor
64324556|NCT02268565|Sensory System Agents|sensory system agents|mesh-ancestor
64324557|NCT02268565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64324558|NCT02268565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324559|NCT02268565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64324560|NCT02268565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64312209|NCT03554915|Analgesics|analgesics|mesh-ancestor
64312210|NCT03554915|Sensory System Agents|sensory system agents|mesh-ancestor
64312211|NCT03554915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312212|NCT03554915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785565|NCT00000306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64785566|NCT00000306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785567|NCT00000306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64785568|NCT00000306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64785569|NCT00000306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64785570|NCT00000306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785571|NCT00000306|Dopamine Agents|dopamine agents|mesh-ancestor
64785572|NCT00000306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64874372|NCT01864213|Tetracaine|tetracaine|mesh-list
64785574|NCT00000318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64785575|NCT00000318|Narcotics|narcotics|mesh-ancestor
64785576|NCT00000318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64785577|NCT00000318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312310|NCT03041948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312311|NCT03041948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64312312|NCT03041948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64312313|NCT03041948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64312314|NCT03041948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64312315|NCT03041948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64312316|NCT03041948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64312317|NCT03041948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64312318|NCT03041948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312319|NCT02104193|Simvastatin|simvastatin|mesh-list
64312320|NCT02104193|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64312321|NCT02104193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64312322|NCT02104193|Antimetabolites|antimetabolites|mesh-ancestor
64312323|NCT02104193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312324|NCT02104193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64312325|NCT02104193|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64312326|NCT02104193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312328|NCT03042182|Immunologic Factors|immunologic factors|mesh-ancestor
64312329|NCT03042182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312353|NCT04856852|Iodine|iodine|mesh-list
64785578|NCT00000318|Analgesics|analgesics|mesh-ancestor
64785579|NCT00000318|Sensory System Agents|sensory system agents|mesh-ancestor
64785580|NCT00000318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785581|NCT00000318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64785582|NCT00000330|Analgesics, Opioid|analgesics, opioid|mesh-list
64785583|NCT00000330|Narcotics|narcotics|mesh-ancestor
64785584|NCT00000330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64785585|NCT00000330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785586|NCT00000330|Analgesics|analgesics|mesh-ancestor
64312361|NCT04856852|Trace Elements|trace elements|mesh-ancestor
64312362|NCT04856852|Micronutrients|micronutrients|mesh-ancestor
64312363|NCT04856852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312364|NCT02711553|Gemcitabine|gemcitabine|mesh-list
64312365|NCT02711553|Ramucirumab|ramucirumab|mesh-list
64312366|NCT02711553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312367|NCT02711553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64312368|NCT02711553|Antimetabolites|antimetabolites|mesh-ancestor
64785587|NCT00000330|Sensory System Agents|sensory system agents|mesh-ancestor
64785588|NCT00000330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785589|NCT00000336|Selegiline|selegiline|mesh-list
64785590|NCT00000336|Antidepressive Agents|antidepressive agents|mesh-ancestor
64785591|NCT00000336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64785592|NCT00000336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64785593|NCT00000336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64785594|NCT00000336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64785595|NCT00000336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785596|NCT00000336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312463|NCT03187899|Anesthetics, Local|anesthetics, local|mesh-ancestor
64312464|NCT03187899|Anesthetics|anesthetics|mesh-ancestor
64312465|NCT03187899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64312466|NCT03187899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312467|NCT03187899|Sensory System Agents|sensory system agents|mesh-ancestor
64312468|NCT03187899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312469|NCT01648582|Metformin|metformin|mesh-list
64312470|NCT01648582|Insulin Glargine|insulin glargine|mesh-list
64312471|NCT01648582|Dulaglutide|dulaglutide|mesh-list
64312472|NCT01648582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64312473|NCT01648582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312474|NCT02440347|Anesthetics|anesthetics|mesh-list
64312475|NCT02440347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64312476|NCT02440347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312477|NCT03043820|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64312478|NCT03043820|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64312479|NCT03043820|Hormone Antagonists|hormone antagonists|mesh-ancestor
64312480|NCT03043820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64312481|NCT03043820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312482|NCT03043820|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64312483|NCT03043820|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64312484|NCT03043820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64874943|NCT01869010|Tenofovir|tenofovir|mesh-list
64312485|NCT03191097|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
64312486|NCT03191097|Antiviral Agents|antiviral agents|mesh-ancestor
64312487|NCT03191097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64312488|NCT04854668|Bevacizumab|bevacizumab|mesh-list
64312489|NCT04854668|Capecitabine|capecitabine|mesh-list
64312490|NCT04854668|Oxaliplatin|oxaliplatin|mesh-list
64312491|NCT04854668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64312492|NCT04854668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373448|NCT00189319|Flecainide|flecainide|mesh-list
64396773|NCT02369965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64396774|NCT02369965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64396775|NCT02369965|Antiviral Agents|antiviral agents|mesh-ancestor
64396776|NCT02369965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64396777|NCT02369965|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64396778|NCT02369965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64396779|NCT02369965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64312493|NCT04854668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64312494|NCT04854668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64312495|NCT04854668|Growth Substances|growth substances|mesh-ancestor
64312496|NCT04854668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312497|NCT04854668|Growth Inhibitors|growth inhibitors|mesh-ancestor
64312498|NCT04854668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64312500|NCT04854668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312502|NCT03189069|Rivaroxaban|rivaroxaban|mesh-list
64312504|NCT03189069|Apixaban|apixaban|mesh-list
64312505|NCT03189069|Anticoagulants|anticoagulants|mesh-ancestor
64312506|NCT03189069|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64312507|NCT03189069|Antithrombins|antithrombins|mesh-ancestor
64312508|NCT03189069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64312509|NCT03189069|Protease Inhibitors|protease inhibitors|mesh-ancestor
64373458|NCT00189241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373459|NCT00189241|Interferon Inducers|interferon inducers|mesh-ancestor
64312524|NCT04861142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64312525|NCT04861142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312526|NCT03117855|Capecitabine|capecitabine|mesh-list
64312527|NCT03117855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64312528|NCT03117855|Antimetabolites|antimetabolites|mesh-ancestor
64312529|NCT03117855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312530|NCT03117855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312531|NCT02607800|Sofosbuvir|sofosbuvir|mesh-list
64312532|NCT02607800|Velpatasvir|velpatasvir|mesh-list
64312533|NCT02607800|Antiviral Agents|antiviral agents|mesh-ancestor
64312534|NCT02607800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64312535|NCT02304484|Evolocumab|evolocumab|mesh-list
64312536|NCT02304484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64312538|NCT02304484|Antimetabolites|antimetabolites|mesh-ancestor
64312539|NCT02304484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312547|NCT02434029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64312548|NCT02434029|Respiratory System Agents|respiratory system agents|mesh-ancestor
64312549|NCT02434029|Glucocorticoids|glucocorticoids|mesh-ancestor
64312551|NCT02434029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64312575|NCT02708355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64312576|NCT02708355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64785622|NCT00000354|Sensory System Agents|sensory system agents|mesh-ancestor
64785623|NCT00000354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64554221|NCT03095040|Everolimus|everolimus|mesh-list
64785624|NCT00000354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64785625|NCT00000354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64339864|NCT00890591|Amlodipine|amlodipine|mesh-list
64785626|NCT00000354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64785627|NCT00000354|Adrenergic Agents|adrenergic agents|mesh-ancestor
64785628|NCT00000354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64312578|NCT02708355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312579|NCT02708355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312580|NCT04854044|TIC10 compound|tic10 compound|mesh-list
64312581|NCT04854044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312582|NCT02708277|Contraceptive Agents|contraceptive agents|mesh-list
64312583|NCT02708277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64312584|NCT02708277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312585|NCT02337478|Vincristine|vincristine|mesh-list
64312586|NCT02337478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64312587|NCT02337478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312588|NCT02337478|Tubulin Modulators|tubulin modulators|mesh-ancestor
64312591|NCT02337478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312593|NCT02434653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64312594|NCT02434653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64312595|NCT02434653|Analgesics|analgesics|mesh-ancestor
64312596|NCT02434653|Sensory System Agents|sensory system agents|mesh-ancestor
64312597|NCT02434653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312598|NCT02434653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312599|NCT02434653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64312600|NCT02434653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64312601|NCT03043196|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64312602|NCT03043196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64312603|NCT03043196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64312604|NCT03043196|Antimetabolites|antimetabolites|mesh-ancestor
64312605|NCT03043196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312606|NCT03043196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64312611|NCT03188835|Protective Agents|protective agents|mesh-ancestor
64312612|NCT03188835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312613|NCT04847024|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
64312615|NCT04847024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64312616|NCT04847024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64312617|NCT04847024|Analgesics|analgesics|mesh-ancestor
64312618|NCT04847024|Sensory System Agents|sensory system agents|mesh-ancestor
64312619|NCT04847024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64875559|NCT01872013|ASP7991|asp7991|mesh-list
64312620|NCT04847024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312621|NCT04847024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64312622|NCT04847024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64785644|NCT00000372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785645|NCT00000372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64785646|NCT00000372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64312623|NCT04847024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64312624|NCT04847024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64312625|NCT04847024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312626|NCT04847024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312627|NCT04860674|Carboplatin|carboplatin|mesh-list
64312628|NCT04860674|Etoposide|etoposide|mesh-list
64312629|NCT04860674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64875620|NCT01872494|Flurbiprofen|flurbiprofen|mesh-list
64312630|NCT04860674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312631|NCT04860674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64312632|NCT04860674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64312633|NCT04860674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64312634|NCT04860674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312635|NCT04860674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312636|NCT04853030|Insulin Aspart|insulin aspart|mesh-list
64312637|NCT04853030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64312638|NCT04853030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312639|NCT02430363|Pembrolizumab|pembrolizumab|mesh-list
64312640|NCT02430363|Dactolisib|dactolisib|mesh-list
64312641|NCT02430363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64312642|NCT02430363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312643|NCT02429973|Gemcitabine|gemcitabine|mesh-list
64396810|NCT02375503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64396811|NCT02375503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64396813|NCT00867191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64396814|NCT00867191|Cholinergic Agents|cholinergic agents|mesh-ancestor
64396815|NCT00867191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64312644|NCT02429973|Sirolimus|sirolimus|mesh-list
64312645|NCT02429973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64312646|NCT02429973|Antimetabolites|antimetabolites|mesh-ancestor
64312647|NCT02429973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312648|NCT02429973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312649|NCT02429973|Antiviral Agents|antiviral agents|mesh-ancestor
64312650|NCT02429973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64312651|NCT02429973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312652|NCT02429973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64312653|NCT02429973|Immunologic Factors|immunologic factors|mesh-ancestor
64312654|NCT02429973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312655|NCT02429973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64312656|NCT02429973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64373536|NCT02439697|Hematinics|hematinics|mesh-ancestor
64312669|NCT04846634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64312670|NCT04846634|Cisplatin|cisplatin|mesh-list
64312671|NCT04846634|Carboplatin|carboplatin|mesh-list
64312672|NCT04846634|Pemetrexed|pemetrexed|mesh-list
64312673|NCT04846634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64312674|NCT04846634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312675|NCT04846634|Tubulin Modulators|tubulin modulators|mesh-ancestor
64312676|NCT04846634|Antimitotic Agents|antimitotic agents|mesh-ancestor
64312677|NCT04846634|Mitosis Modulators|mitosis modulators|mesh-ancestor
64312678|NCT04846634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312679|NCT04846634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64312680|NCT04846634|Antimetabolites|antimetabolites|mesh-ancestor
64312681|NCT04846634|Antiviral Agents|antiviral agents|mesh-ancestor
64312682|NCT04846634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64312683|NCT04846634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312684|NCT04846634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64312685|NCT04846634|Immunologic Factors|immunologic factors|mesh-ancestor
64312686|NCT04846634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312710|NCT02429817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312712|NCT02429817|Anticoagulants|anticoagulants|mesh-ancestor
64876131|NCT01875653|Molgramostim|molgramostim|mesh-list
64312713|NCT02429817|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64312714|NCT04851548|Hyaluronic Acid|hyaluronic acid|mesh-list
64312715|NCT04851548|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64312726|NCT02706951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64312750|NCT04851392|Sensory System Agents|sensory system agents|mesh-ancestor
64312751|NCT04851392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312752|NCT04851392|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64312753|NCT04851392|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64312754|NCT04851392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64312755|NCT04851392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312756|NCT04851392|Hormones|hormones|mesh-ancestor
64312757|NCT04851392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64312758|NCT02429193|Prednisone|prednisone|mesh-list
64324572|NCT05479448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324573|NCT05479448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64876414|NCT01877889|Dapagliflozin|dapagliflozin|mesh-list
64876487|NCT01878422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876488|NCT01878422|Growth Inhibitors|growth inhibitors|mesh-ancestor
64876489|NCT01878422|Antimetabolites|antimetabolites|mesh-ancestor
64876490|NCT01878422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876491|NCT01878422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64876492|NCT01878422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64396865|NCT02375191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64396866|NCT02375191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64396867|NCT02375191|Anesthetics, General|anesthetics, general|mesh-ancestor
64396868|NCT03100877|Cyclophosphamide|cyclophosphamide|mesh-list
64785686|NCT00000444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785688|NCT00000444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64785689|NCT00000444|Cholinergic Agents|cholinergic agents|mesh-ancestor
64312791|NCT02429271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64312794|NCT02429505|Miltefosine|miltefosine|mesh-list
64785690|NCT00000444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64785691|NCT00000444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785692|NCT00000450|Naltrexone|naltrexone|mesh-list
64785693|NCT00000450|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64785694|NCT00000450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64785695|NCT00000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785696|NCT00000450|Sensory System Agents|sensory system agents|mesh-ancestor
64785697|NCT00000450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64785698|NCT00000510|Aspirin|aspirin|mesh-list
64876576|NCT01878942|Hallucinogens|hallucinogens|mesh-ancestor
64785699|NCT00000510|Dipyridamole|dipyridamole|mesh-list
64396877|NCT03100877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396878|NCT03100877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64396879|NCT03100877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64396880|NCT03100877|Alkylating Agents|alkylating agents|mesh-ancestor
64396881|NCT03100877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396882|NCT03100877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312868|NCT04840394|Pembrolizumab|pembrolizumab|mesh-list
64312869|NCT04840394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64312870|NCT04840394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312871|NCT04833218|Propranolol|propranolol|mesh-list
64312872|NCT04833218|Clonidine|clonidine|mesh-list
64312873|NCT04833218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64312874|NCT04833218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64312875|NCT04833218|Adrenergic Agents|adrenergic agents|mesh-ancestor
64312876|NCT04833218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64312877|NCT04833218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312878|NCT04833218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312879|NCT04833218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64312880|NCT04833218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64312881|NCT04833218|Vasodilator Agents|vasodilator agents|mesh-ancestor
64396883|NCT03100877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64396884|NCT03100877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64396885|NCT03100877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64396886|NCT03100877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64396887|NCT03100877|Growth Substances|growth substances|mesh-ancestor
64396888|NCT03100877|Growth Inhibitors|growth inhibitors|mesh-ancestor
64396889|NCT03100877|Mitosis Modulators|mitosis modulators|mesh-ancestor
64396890|NCT02365441|Imatinib Mesylate|imatinib mesylate|mesh-list
64785709|NCT00000510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64876904|NCT01882127|Glucocorticoids|glucocorticoids|mesh-ancestor
64785710|NCT00000510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785711|NCT00000510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64312913|NCT04843982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64785714|NCT00000510|Antipyretics|antipyretics|mesh-ancestor
64785715|NCT00000510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64396891|NCT02365441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396892|NCT02365441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64396893|NCT02365441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396894|NCT02365441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396895|NCT00794495|Cetirizine|cetirizine|mesh-list
64396896|NCT00794495|Desloratadine|desloratadine|mesh-list
64396897|NCT00794495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64324574|NCT05479448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324575|NCT02264587|Domperidone|domperidone|mesh-list
64312991|NCT03036644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312992|NCT03036644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64312993|NCT03036644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64312994|NCT03036644|Cholinergic Agents|cholinergic agents|mesh-ancestor
64312995|NCT03036644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64312996|NCT03036644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312997|NCT02424201|Ascorbic Acid|ascorbic acid|mesh-list
64312998|NCT02424201|Misoprostol|misoprostol|mesh-list
64312999|NCT02424201|Vitamins|vitamins|mesh-ancestor
64313000|NCT02424201|Micronutrients|micronutrients|mesh-ancestor
64313001|NCT02424201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313002|NCT02424201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64313003|NCT02424201|Abortifacient Agents|abortifacient agents|mesh-ancestor
64313004|NCT02424201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64313005|NCT02424201|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64313006|NCT02424201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64313035|NCT00702273|Ganirelix|ganirelix|mesh-list
64313065|NCT02424435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64313066|NCT02424435|Antiemetics|antiemetics|mesh-ancestor
64396918|NCT00763529|Autonomic Agents|autonomic agents|mesh-ancestor
64396919|NCT00763529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64396920|NCT00763529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396921|NCT00763529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64396922|NCT00763529|Respiratory System Agents|respiratory system agents|mesh-ancestor
64396923|NCT00763529|Dermatologic Agents|dermatologic agents|mesh-ancestor
64396924|NCT00763529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64396925|NCT03105505|Fusidic Acid|fusidic acid|mesh-list
64396926|NCT03105505|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64396927|NCT03105505|Permethrin|permethrin|mesh-list
64396928|NCT03105505|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64396929|NCT03105505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313094|NCT02424045|Dexamethasone|dexamethasone|mesh-list
64313095|NCT02424045|Carboplatin|carboplatin|mesh-list
64313096|NCT02424045|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64313165|NCT03038048|Growth Substances|growth substances|mesh-ancestor
64313166|NCT03038048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313167|NCT03038048|Growth Inhibitors|growth inhibitors|mesh-ancestor
64313168|NCT03038048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64785772|NCT00000660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785773|NCT00000702|Zidovudine|zidovudine|mesh-list
64877322|NCT01885013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64877323|NCT01885013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64877324|NCT01885013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877325|NCT01885091|Kinetin|kinetin|mesh-list
64877326|NCT01885091|Plant Growth Regulators|plant growth regulators|mesh-ancestor
64877327|NCT01885091|Growth Substances|growth substances|mesh-ancestor
64877328|NCT01885091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877329|NCT01885338|Acetylcysteine|acetylcysteine|mesh-list
64877330|NCT01885338|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64877331|NCT01885338|Antiviral Agents|antiviral agents|mesh-ancestor
64333787|NCT03522181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333788|NCT02373033|Folic Acid|folic acid|mesh-list
64877332|NCT01885338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64877334|NCT01885338|Respiratory System Agents|respiratory system agents|mesh-ancestor
64877336|NCT01885338|Antioxidants|antioxidants|mesh-ancestor
64785774|NCT00000702|Antimetabolites|antimetabolites|mesh-ancestor
64785775|NCT00000702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785776|NCT00000702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64785777|NCT00000702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64785778|NCT00000702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313185|NCT03181113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64313186|NCT03180957|Adalimumab|adalimumab|mesh-list
64313187|NCT03180957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64313188|NCT03180957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64313189|NCT02427165|Albuterol|albuterol|mesh-list
64313190|NCT02427165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64313191|NCT02427165|Autonomic Agents|autonomic agents|mesh-ancestor
64313192|NCT02427165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313193|NCT02427165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313194|NCT02427165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64313195|NCT02427165|Respiratory System Agents|respiratory system agents|mesh-ancestor
64313196|NCT02427165|Tocolytic Agents|tocolytic agents|mesh-ancestor
64313197|NCT02427165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64396942|NCT03105193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64396943|NCT03105193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64396944|NCT03105193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64877412|NCT01885988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64396945|NCT03105193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396946|NCT05066633|Metoprolol|metoprolol|mesh-list
64396947|NCT05066633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64396948|NCT05066633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64396949|NCT05066633|Sympatholytics|sympatholytics|mesh-ancestor
64396950|NCT05066633|Autonomic Agents|autonomic agents|mesh-ancestor
64313241|NCT03037892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64313242|NCT03037892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64313243|NCT03037892|GABA Modulators|gaba modulators|mesh-ancestor
64313244|NCT03037892|GABA Agents|gaba agents|mesh-ancestor
64313245|NCT03037892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64313246|NCT03037892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313247|NCT03183843|Warfarin|warfarin|mesh-list
64313248|NCT03183843|Dabigatran|dabigatran|mesh-list
64313249|NCT03183843|Anticoagulants|anticoagulants|mesh-ancestor
64313250|NCT03183843|Antithrombins|antithrombins|mesh-ancestor
64313251|NCT03183843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64313252|NCT03183843|Protease Inhibitors|protease inhibitors|mesh-ancestor
64313253|NCT03183843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313254|NCT03183843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313265|NCT03180879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313267|NCT03180723|Cyclosporine|cyclosporine|mesh-list
64396952|NCT05066633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396953|NCT05066633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64396954|NCT05066633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64396955|NCT05066633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64396956|NCT05066633|Adrenergic Agents|adrenergic agents|mesh-ancestor
64313290|NCT04841096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64313292|NCT04841096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313293|NCT04841096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313294|NCT02427243|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64313295|NCT02427243|Immunologic Factors|immunologic factors|mesh-ancestor
64313296|NCT02427243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313298|NCT02426697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64313299|NCT02426697|Narcotics|narcotics|mesh-ancestor
64877780|NCT01887821|Artenimol|artenimol|mesh-list
64313300|NCT02426697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64313301|NCT02426697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313309|NCT03039608|Prednisone|prednisone|mesh-list
64396958|NCT05066633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396959|NCT04439305|Dasatinib|dasatinib|mesh-list
64396960|NCT04439305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396961|NCT04439305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64785795|NCT00000714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64785796|NCT00000714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64785797|NCT00000714|Antimetabolites|antimetabolites|mesh-ancestor
64785798|NCT00000714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785799|NCT00000714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396962|NCT04439305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785800|NCT00000714|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64396963|NCT04439305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396964|NCT02368795|Indomethacin|indomethacin|mesh-list
64313340|NCT04837664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64313341|NCT01331837|Etanercept|etanercept|mesh-list
64313342|NCT01331837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64313343|NCT01331837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64313344|NCT01331837|Analgesics|analgesics|mesh-ancestor
64313345|NCT01331837|Sensory System Agents|sensory system agents|mesh-ancestor
64313346|NCT01331837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313347|NCT01331837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313370|NCT03183297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313371|NCT03183297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313372|NCT03183297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64785804|NCT00000732|Sulfamethoxazole|sulfamethoxazole|mesh-list
64785805|NCT00000732|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64785806|NCT00000732|Antimetabolites|antimetabolites|mesh-ancestor
64785807|NCT00000732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878346|NCT01896622|Ritonavir|ritonavir|mesh-list
64785808|NCT00000732|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64785809|NCT00000732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64785810|NCT00000732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64785811|NCT00000732|Antiviral Agents|antiviral agents|mesh-ancestor
64396965|NCT02368795|Isosorbide|isosorbide|mesh-list
64396966|NCT02368795|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64324579|NCT02264587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64324580|NCT02264587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313411|NCT01648348|Growth Substances|growth substances|mesh-ancestor
64313412|NCT01648348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313413|NCT01648348|Growth Inhibitors|growth inhibitors|mesh-ancestor
64313414|NCT01648348|Immunologic Factors|immunologic factors|mesh-ancestor
64313416|NCT03180255|Sodium Citrate|sodium citrate|mesh-list
64313489|NCT04792424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64313490|NCT00709371|Zonisamide|zonisamide|mesh-list
64313491|NCT00709371|Bupropion|bupropion|mesh-list
64313492|NCT00709371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64313493|NCT00709371|Antidepressive Agents|antidepressive agents|mesh-ancestor
64313494|NCT00709371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64313495|NCT00709371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64313496|NCT00709371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64878497|NCT01900327|Antiviral Agents|antiviral agents|mesh-ancestor
64313497|NCT00709371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64313498|NCT00709371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878717|NCT01901380|Caseins|caseins|mesh-list
64313499|NCT00709371|Dopamine Agents|dopamine agents|mesh-ancestor
64313500|NCT00709371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64313501|NCT00709371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313503|NCT00709371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64313504|NCT00709371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313506|NCT00709371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64313507|NCT00709371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64313508|NCT02426463|Oxycodone|oxycodone|mesh-list
64313509|NCT02426463|Propofol|propofol|mesh-list
64313510|NCT02426463|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64313511|NCT02426463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64313512|NCT02426463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878879|NCT01902446|Dermatologic Agents|dermatologic agents|mesh-ancestor
64878880|NCT01902485|Contraceptive Agents|contraceptive agents|mesh-list
64878881|NCT01902485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64878882|NCT01902485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878883|NCT01902498|Aspirin|aspirin|mesh-list
64878884|NCT01902498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64878885|NCT01902498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64878886|NCT01902498|Analgesics|analgesics|mesh-ancestor
64878887|NCT01902498|Sensory System Agents|sensory system agents|mesh-ancestor
64878888|NCT01902498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64878889|NCT01902498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878890|NCT01902498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64878891|NCT01902498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64878892|NCT01902498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64878893|NCT01902498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64343553|NCT00403169|Growth Substances|growth substances|mesh-ancestor
64878894|NCT01902498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878895|NCT01902498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64878896|NCT01902498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64878897|NCT01902498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313513|NCT02426463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64313514|NCT02426463|Anesthetics, General|anesthetics, general|mesh-ancestor
64313515|NCT02426463|Anesthetics|anesthetics|mesh-ancestor
64313516|NCT02426463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64313525|NCT02426229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313526|NCT02426229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313527|NCT02426229|Anticoagulants|anticoagulants|mesh-ancestor
64313528|NCT01648270|Buprenorphine|buprenorphine|mesh-list
64313529|NCT01648270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64313530|NCT01648270|Narcotics|narcotics|mesh-ancestor
64313531|NCT01648270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64313532|NCT01648270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313533|NCT01648270|Analgesics|analgesics|mesh-ancestor
64313534|NCT01648270|Sensory System Agents|sensory system agents|mesh-ancestor
64313535|NCT01648270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313536|NCT01648270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64313537|NCT02108795|Remifentanil|remifentanil|mesh-list
64313538|NCT02108795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64313572|NCT04836806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313573|NCT04836806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64313574|NCT04836806|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64313575|NCT04836806|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64313576|NCT04836728|Paclitaxel|paclitaxel|mesh-list
64879187|NCT01904591|Vitamin E|vitamin e|mesh-list
64313577|NCT04836728|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64313578|NCT04836728|Carboplatin|carboplatin|mesh-list
64313579|NCT04836728|Pemetrexed|pemetrexed|mesh-list
64313606|NCT02336230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64313607|NCT02336230|Antiviral Agents|antiviral agents|mesh-ancestor
64313608|NCT02336230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64313609|NCT04835948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64313610|NCT04835948|Immunologic Factors|immunologic factors|mesh-ancestor
64313611|NCT04835948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313612|NCT04835948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64313613|NCT04824404|Buprenorphine|buprenorphine|mesh-list
64313614|NCT04824404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64879364|NCT01905566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64879365|NCT01905566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64879366|NCT01905566|Purinergic Agents|purinergic agents|mesh-ancestor
64879367|NCT01905566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64313615|NCT04824404|Narcotics|narcotics|mesh-ancestor
64383428|NCT02409407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383429|NCT02409407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64383430|NCT02409407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64383431|NCT02409407|Oxytocics|oxytocics|mesh-ancestor
64383432|NCT02409407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64383433|NCT02409407|Vasodilator Agents|vasodilator agents|mesh-ancestor
64383434|NCT02409407|Urological Agents|urological agents|mesh-ancestor
64383446|NCT02409017|Insulin|insulin|mesh-list
64383477|NCT05509569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64879669|NCT01907685|Docetaxel|docetaxel|mesh-list
64383478|NCT05509569|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
64879671|NCT01907685|Tubulin Modulators|tubulin modulators|mesh-ancestor
64879782|NCT01908296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64879783|NCT01908296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64879784|NCT01908296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879785|NCT01908296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64879786|NCT01908296|Serotonin Agents|serotonin agents|mesh-ancestor
64879792|NCT01908322|Sorafenib|sorafenib|mesh-list
64879851|NCT01908660|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64879852|NCT01908660|Antiviral Agents|antiviral agents|mesh-ancestor
64383479|NCT05509569|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
64383480|NCT05509569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383481|NCT05509569|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64313623|NCT02109341|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64313624|NCT02109341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64313625|NCT02109341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313626|NCT02109341|Tubulin Modulators|tubulin modulators|mesh-ancestor
64879979|NCT01910090|Analgesics|analgesics|mesh-ancestor
64313627|NCT02109341|Antimitotic Agents|antimitotic agents|mesh-ancestor
64313628|NCT02109341|Mitosis Modulators|mitosis modulators|mesh-ancestor
64313629|NCT02109341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313630|NCT02336074|Raltegravir Potassium|raltegravir potassium|mesh-list
64313631|NCT02336074|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64313632|NCT02336074|Vorinostat|vorinostat|mesh-list
64313633|NCT02336074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313634|NCT02336074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64313635|NCT02336074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313636|NCT02336074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313637|NCT02336074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64313638|NCT02336074|Antiviral Agents|antiviral agents|mesh-ancestor
64313639|NCT02336074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64313640|NCT02336074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64313641|NCT02336074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64880069|NCT01910363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64313642|NCT04827134|Triumeq|triumeq|mesh-list
64313643|NCT04827134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64313744|NCT02114333|Immunologic Factors|immunologic factors|mesh-ancestor
64313745|NCT02114333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313746|NCT02114489|Ibandronic Acid|ibandronic acid|mesh-list
64313747|NCT02114489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64313748|NCT02114489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313750|NCT02114645|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64374072|NCT04976673|Triamcinolone|triamcinolone|mesh-list
64324600|NCT02264665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64324601|NCT02264665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313752|NCT02114645|Estradiol|estradiol|mesh-list
64313753|NCT02114645|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64313754|NCT02114645|Progesterone|progesterone|mesh-list
64313755|NCT02114645|Estrogens|estrogens|mesh-ancestor
64880286|NCT01911494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64880287|NCT01911494|Sympatholytics|sympatholytics|mesh-ancestor
64880288|NCT01911494|Autonomic Agents|autonomic agents|mesh-ancestor
64880289|NCT01911494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64880290|NCT01911494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64880291|NCT01911494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64880292|NCT01911494|Adrenergic Agents|adrenergic agents|mesh-ancestor
64880293|NCT01911494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64313756|NCT02114645|Hormones|hormones|mesh-ancestor
64313757|NCT02114645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64313758|NCT02114645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313759|NCT02114645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64313760|NCT02114645|Contraceptive Agents|contraceptive agents|mesh-ancestor
64313761|NCT02114645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64313762|NCT02114645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64313764|NCT02114645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64313765|NCT02114645|Fertility Agents|fertility agents|mesh-ancestor
64313766|NCT02114645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64313767|NCT02114645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880351|NCT01911949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880352|NCT01911949|Sensory System Agents|sensory system agents|mesh-ancestor
64880353|NCT01911949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64880354|NCT01911949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64880355|NCT01911949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64880356|NCT01911949|Adrenergic Agents|adrenergic agents|mesh-ancestor
64880357|NCT01911949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64880358|NCT01911949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880361|NCT01911949|Autonomic Agents|autonomic agents|mesh-ancestor
64313768|NCT02112695|Diprenorphine|diprenorphine|mesh-list
64313769|NCT02112695|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64313770|NCT02112695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313771|NCT02112695|Sensory System Agents|sensory system agents|mesh-ancestor
64313772|NCT02112695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313773|NCT02603432|Avelumab|avelumab|mesh-list
64313774|NCT02603432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64313775|NCT02603432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64313776|NCT02603432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313777|NCT02603432|Immunologic Factors|immunologic factors|mesh-ancestor
64313789|NCT04361162|Ipilimumab|ipilimumab|mesh-list
64313790|NCT04361162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64313791|NCT04361162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313801|NCT04823390|Sensory System Agents|sensory system agents|mesh-ancestor
64313802|NCT04823390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313803|NCT04823390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64313804|NCT04823390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64313805|NCT04823390|Anesthetics, General|anesthetics, general|mesh-ancestor
64313806|NCT04823390|Anesthetics|anesthetics|mesh-ancestor
64313807|NCT04823390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64880687|NCT01914146|Insulin|insulin|mesh-list
64313808|NCT04823390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64313809|NCT04823390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64313810|NCT04823390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64313811|NCT04823390|GABA Modulators|gaba modulators|mesh-ancestor
64313812|NCT04823390|GABA Agents|gaba agents|mesh-ancestor
64313813|NCT04823390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64313814|NCT04823390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313815|NCT04826432|Pasireotide|pasireotide|mesh-list
64313817|NCT04826432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64313818|NCT04826432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313819|NCT05618912|Petrolatum|petrolatum|mesh-list
64785857|NCT00000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785859|NCT00000804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64785860|NCT00000804|Antiviral Agents|antiviral agents|mesh-ancestor
64785861|NCT00000804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64313835|NCT03036800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313837|NCT03036800|Hormones|hormones|mesh-ancestor
64313838|NCT03036800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64313839|NCT02301988|Paclitaxel|paclitaxel|mesh-list
64313840|NCT02301988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64313841|NCT02301988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313842|NCT02301988|Tubulin Modulators|tubulin modulators|mesh-ancestor
64313843|NCT02301988|Antimitotic Agents|antimitotic agents|mesh-ancestor
64313844|NCT02301988|Mitosis Modulators|mitosis modulators|mesh-ancestor
64313845|NCT02301988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313846|NCT04326920|Sargramostim|sargramostim|mesh-list
64313847|NCT04326920|Immunologic Factors|immunologic factors|mesh-ancestor
64313848|NCT04326920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313849|NCT02112929|Xenon|xenon|mesh-list
64313850|NCT02112929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64313851|NCT02112929|Anesthetics, General|anesthetics, general|mesh-ancestor
64313852|NCT02112929|Anesthetics|anesthetics|mesh-ancestor
64313853|NCT02112929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64313854|NCT02112929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313855|NCT02119091|Moxifloxacin|moxifloxacin|mesh-list
64313856|NCT02119091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64313857|NCT02119091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64313858|NCT02119091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64313859|NCT02119091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64313860|NCT02119091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313861|NCT02119091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313862|NCT02119091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313897|NCT04822064|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64313899|NCT03553433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64313900|NCT03553433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64881091|NCT01916850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64313901|NCT03553433|Analgesics|analgesics|mesh-ancestor
64785872|NCT00000810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64785873|NCT00000810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64785875|NCT00000834|Zidovudine|zidovudine|mesh-list
64785876|NCT00000834|Methotrexate|methotrexate|mesh-list
64785877|NCT00000834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64785878|NCT00000834|Abortifacient Agents|abortifacient agents|mesh-ancestor
64785879|NCT00000834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64785880|NCT00000834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64785881|NCT00000834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64785882|NCT00000834|Antimetabolites|antimetabolites|mesh-ancestor
64313903|NCT03553433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313904|NCT03553433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313905|NCT03553433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64313906|NCT03553433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64313907|NCT03553433|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64313908|NCT03553433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64313909|NCT03553433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313918|NCT02604212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64313919|NCT02604212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313920|NCT02604212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313921|NCT02604212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64313922|NCT02604212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64313923|NCT02604212|Histamine Agents|histamine agents|mesh-ancestor
64313924|NCT02604212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64313925|NCT02604212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313927|NCT02115659|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
64313928|NCT02115659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313929|NCT02115659|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64881318|NCT01917799|Antipyretics|antipyretics|mesh-ancestor
64333789|NCT02373033|Vitamin B Complex|vitamin b complex|mesh-list
64333791|NCT02373033|Vitamins|vitamins|mesh-ancestor
64881319|NCT01917799|Anticoagulants|anticoagulants|mesh-ancestor
64881320|NCT01917890|Curcumin|curcumin|mesh-list
64881321|NCT01917890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64881322|NCT01917890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64881323|NCT01917890|Analgesics|analgesics|mesh-ancestor
64881324|NCT01917890|Sensory System Agents|sensory system agents|mesh-ancestor
64881325|NCT01917890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64881326|NCT01917890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881327|NCT01917890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64881328|NCT01917890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64881329|NCT01917890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64881330|NCT01917890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64881331|NCT01917890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313930|NCT02115659|Contraceptive Agents|contraceptive agents|mesh-ancestor
64313931|NCT02115659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64313932|NCT02115659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64313933|NCT02115659|Immunologic Factors|immunologic factors|mesh-ancestor
64313934|NCT02115659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64313935|NCT02115659|Alkylating Agents|alkylating agents|mesh-ancestor
64313938|NCT02113631|Interferons|interferons|mesh-list
64785888|NCT00000834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64785889|NCT00000834|Immunologic Factors|immunologic factors|mesh-ancestor
64785890|NCT00000834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64785891|NCT00000834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64785892|NCT00000834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64785894|NCT00000834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64785895|NCT00000834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64313944|NCT02113631|Antiviral Agents|antiviral agents|mesh-ancestor
64313945|NCT02113631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64313946|NCT02113631|Antimetabolites|antimetabolites|mesh-ancestor
64313947|NCT02113631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313948|NCT02113631|Immunologic Factors|immunologic factors|mesh-ancestor
64313949|NCT02113631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313951|NCT02123069|Phenylephrine|phenylephrine|mesh-list
64313952|NCT02123069|Oxymetazoline|oxymetazoline|mesh-list
64313953|NCT02123069|Norepinephrine|norepinephrine|mesh-list
64313954|NCT02123069|Acetylcholine|acetylcholine|mesh-list
64313955|NCT02123069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64313956|NCT02123069|Mydriatics|mydriatics|mesh-ancestor
64313957|NCT02123069|Autonomic Agents|autonomic agents|mesh-ancestor
64313958|NCT02123069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313960|NCT02123069|Sympathomimetics|sympathomimetics|mesh-ancestor
64314021|NCT03552575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314022|NCT01359644|Ribavirin|ribavirin|mesh-list
64314023|NCT01359644|Sofosbuvir|sofosbuvir|mesh-list
64314024|NCT01359644|Antimetabolites|antimetabolites|mesh-ancestor
64314025|NCT01359644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314026|NCT01359644|Antiviral Agents|antiviral agents|mesh-ancestor
64314027|NCT01359644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64314028|NCT04821206|Antirheumatic Agents|antirheumatic agents|mesh-list
64314029|NCT04821206|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
64314030|NCT04821206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64314031|NCT04821206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314032|NCT04821206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314033|NCT04806230|Mirtazapine|mirtazapine|mesh-list
64314036|NCT04806230|Sertraline|sertraline|mesh-list
64314071|NCT02603120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314072|NCT02603120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64881482|NCT01918852|Growth Substances|growth substances|mesh-ancestor
64314073|NCT02603120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64314075|NCT04815200|Nickel|nickel|mesh-list
64314076|NCT04815200|Trace Elements|trace elements|mesh-ancestor
64314077|NCT04815200|Micronutrients|micronutrients|mesh-ancestor
64314078|NCT04815200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314079|NCT04426994|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64314080|NCT04426994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314081|NCT04426994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314082|NCT04814030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64314083|NCT04814030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314084|NCT04814030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314085|NCT04412252|Tofacitinib|tofacitinib|mesh-list
64314086|NCT04412252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64314087|NCT04412252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314088|NCT04412252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314097|NCT04813874|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64314098|NCT04813874|Anesthetics, General|anesthetics, general|mesh-ancestor
64314099|NCT04813874|Anesthetics|anesthetics|mesh-ancestor
64314100|NCT04813874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64314101|NCT04813874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314102|NCT04813874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64314103|NCT04813874|Analgesics|analgesics|mesh-ancestor
64314104|NCT04813874|Sensory System Agents|sensory system agents|mesh-ancestor
64314105|NCT04813874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64314106|NCT04803500|Simvastatin|simvastatin|mesh-list
64374346|NCT04487951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314112|NCT04803500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64314114|NCT01331681|Aflibercept|aflibercept|mesh-list
64314115|NCT01331681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64314116|NCT01331681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64314117|NCT01331681|Growth Substances|growth substances|mesh-ancestor
64314118|NCT01331681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314120|NCT01331681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314121|NCT02120339|Carvedilol|carvedilol|mesh-list
64314124|NCT02120339|Adrenergic Agents|adrenergic agents|mesh-ancestor
64314125|NCT02120339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64314126|NCT02120339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314127|NCT02120339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314128|NCT02120339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64314129|NCT02120339|Antioxidants|antioxidants|mesh-ancestor
64314130|NCT02120339|Protective Agents|protective agents|mesh-ancestor
64314131|NCT02120339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64314132|NCT02120339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64374377|NCT04966845|Carbon Monoxide|carbon monoxide|mesh-list
64314155|NCT02117219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314156|NCT02117219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314157|NCT02117219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314158|NCT02117219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64314159|NCT02117453|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64881938|NCT01930604|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64314160|NCT02117453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64324618|NCT01225393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64324620|NCT01225393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324621|NCT01225393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324622|NCT01225393|Dermatologic Agents|dermatologic agents|mesh-ancestor
64324623|NCT01225393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324624|NCT01225393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64324625|NCT01225393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64324626|NCT01225393|Immunologic Factors|immunologic factors|mesh-ancestor
64324627|NCT01225393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64397073|NCT02374489|Ceritinib|ceritinib|mesh-list
64882154|NCT01931657|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64785919|NCT00000894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64785920|NCT00000894|Uricosuric Agents|uricosuric agents|mesh-ancestor
64785921|NCT00000894|Gout Suppressants|gout suppressants|mesh-ancestor
64785922|NCT00000894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64785923|NCT00000894|Renal Agents|renal agents|mesh-ancestor
64785924|NCT00000912|Efavirenz|efavirenz|mesh-list
64785925|NCT00000912|Abacavir|abacavir|mesh-list
64785926|NCT00000912|Adefovir|adefovir|mesh-list
64882344|NCT01932918|Ketorolac|ketorolac|mesh-list
64785927|NCT00000912|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64882433|NCT01933711|Rituximab|rituximab|mesh-list
64314235|NCT05617430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314236|NCT05617430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64314237|NCT05617430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64314238|NCT05617430|Immunologic Factors|immunologic factors|mesh-ancestor
64314239|NCT05617430|Antidotes|antidotes|mesh-ancestor
64314240|NCT05617430|Protective Agents|protective agents|mesh-ancestor
64314241|NCT05617430|Vitamin B Complex|vitamin b complex|mesh-ancestor
64314248|NCT02251691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64314249|NCT02251691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314250|NCT02251691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314252|NCT02595398|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64314253|NCT02595398|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64314254|NCT02595398|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64314255|NCT02595398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64314256|NCT02595398|Glucocorticoids|glucocorticoids|mesh-ancestor
64314257|NCT02595398|Hormones|hormones|mesh-ancestor
64314258|NCT02595398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64314259|NCT02595398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314260|NCT02595398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64314261|NCT02595398|Immunologic Factors|immunologic factors|mesh-ancestor
64314262|NCT02595398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314263|NCT02595398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314264|NCT02251769|Ritonavir|ritonavir|mesh-list
64314265|NCT02251769|Tipranavir|tipranavir|mesh-list
64314266|NCT02251769|Clarithromycin|clarithromycin|mesh-list
64314267|NCT02251769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64314268|NCT02251769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64314269|NCT02251769|Protease Inhibitors|protease inhibitors|mesh-ancestor
64314270|NCT02251769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383482|NCT05509569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64383483|NCT05509569|Immunologic Factors|immunologic factors|mesh-ancestor
64383484|NCT02408939|Hydrocortisone|hydrocortisone|mesh-list
64383485|NCT02408939|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64383486|NCT02408939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64383487|NCT05507697|Thioctic Acid|thioctic acid|mesh-list
64383488|NCT05507697|Antioxidants|antioxidants|mesh-ancestor
64383489|NCT05507697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383490|NCT05507697|Protective Agents|protective agents|mesh-ancestor
64383491|NCT05507697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883006|NCT01936636|Narcotics|narcotics|mesh-ancestor
64883007|NCT01936636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64883008|NCT01936636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883009|NCT01936636|Analgesics|analgesics|mesh-ancestor
64651541|NCT01549223|Misoprostol|misoprostol|mesh-list
64883011|NCT01936636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64883012|NCT01936636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64883013|NCT01936636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64883014|NCT01936636|Anesthetics, General|anesthetics, general|mesh-ancestor
64883015|NCT01936636|Anesthetics|anesthetics|mesh-ancestor
64883016|NCT01936805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64883017|NCT01936805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64883018|NCT01936805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64883019|NCT01936805|Antimetabolites|antimetabolites|mesh-ancestor
64883020|NCT01936805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883021|NCT01936805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64883022|NCT01936805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64883023|NCT01936805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64883024|NCT01936961|Antibodies|antibodies|mesh-list
64883025|NCT01936961|Immunologic Factors|immunologic factors|mesh-ancestor
64883026|NCT01936961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383536|NCT03174041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64314283|NCT02118311|Immunologic Factors|immunologic factors|mesh-ancestor
64314284|NCT02118311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314285|NCT02118311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64314286|NCT02118311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64314287|NCT02118311|Alkylating Agents|alkylating agents|mesh-ancestor
64314288|NCT02118311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314289|NCT02118311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314290|NCT02118311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64314399|NCT03551171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314400|NCT03551171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883047|NCT01937104|Sensory System Agents|sensory system agents|mesh-ancestor
64883048|NCT01937104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64883049|NCT01937104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64883050|NCT01937104|Anesthetics, General|anesthetics, general|mesh-ancestor
64883051|NCT01937104|Anesthetics|anesthetics|mesh-ancestor
64883053|NCT01937169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64883054|NCT01937169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64883055|NCT01937169|Dopamine Agents|dopamine agents|mesh-ancestor
64883056|NCT01937169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64883057|NCT01937169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883059|NCT01937182|Citalopram|citalopram|mesh-list
64314401|NCT03551171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314402|NCT02787083|Mirabegron|mirabegron|mesh-list
64314403|NCT02787083|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64314404|NCT02787083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64314405|NCT02787083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64314406|NCT02787083|Adrenergic Agents|adrenergic agents|mesh-ancestor
64314407|NCT02787083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64785940|NCT00000912|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64785942|NCT00000912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64785943|NCT00000912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64785944|NCT00000912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64785945|NCT00000912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64883089|NCT01937338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64883090|NCT01937338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883091|NCT01937442|Thalidomide|thalidomide|mesh-list
64883092|NCT01937442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64883093|NCT01937442|Immunologic Factors|immunologic factors|mesh-ancestor
64883094|NCT01937442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883095|NCT01937442|Leprostatic Agents|leprostatic agents|mesh-ancestor
64883096|NCT01937442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64883097|NCT01937442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64883110|NCT01937494|Anesthetics, Local|anesthetics, local|mesh-ancestor
64883111|NCT01937494|Anesthetics|anesthetics|mesh-ancestor
64883112|NCT01937494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64883113|NCT01937494|Sensory System Agents|sensory system agents|mesh-ancestor
64883114|NCT01937494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64883115|NCT01937611|Midazolam|midazolam|mesh-list
64883116|NCT01937611|Dexmedetomidine|dexmedetomidine|mesh-list
64883117|NCT01937611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64785946|NCT00000912|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64314433|NCT02125643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64314434|NCT02125643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314435|NCT02125643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314436|NCT02125643|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64314437|NCT02125643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64314438|NCT02125643|Purinergic Agents|purinergic agents|mesh-ancestor
64314439|NCT02125643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64314440|NCT02127437|Lanreotide|lanreotide|mesh-list
64324648|NCT01220947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314441|NCT02127437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314443|NCT05319587|Annamycin|annamycin|mesh-list
64333807|NCT03596281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64333808|NCT03596281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333809|NCT03596281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64883145|NCT01937728|Ribavirin|ribavirin|mesh-list
64883146|NCT01937728|Interferon-alpha|interferon-alpha|mesh-list
64883147|NCT01937728|Interferon alpha-2|interferon alpha-2|mesh-list
64883148|NCT01937728|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64883149|NCT01937728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883150|NCT01937728|Antiviral Agents|antiviral agents|mesh-ancestor
64883151|NCT01937728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64883152|NCT01937728|Antimetabolites|antimetabolites|mesh-ancestor
64883153|NCT01937728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883154|NCT01937728|Immunologic Factors|immunologic factors|mesh-ancestor
64883155|NCT01937728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883156|NCT01937754|Nitric Oxide|nitric oxide|mesh-list
64651688|NCT01831700|Protease Inhibitors|protease inhibitors|mesh-ancestor
64883157|NCT01937754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64883158|NCT01937754|Autonomic Agents|autonomic agents|mesh-ancestor
64883159|NCT01937754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64883160|NCT01937754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883161|NCT01937754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64883162|NCT01937754|Respiratory System Agents|respiratory system agents|mesh-ancestor
64883163|NCT01937754|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64883164|NCT01937754|Antioxidants|antioxidants|mesh-ancestor
64883165|NCT01937754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883166|NCT01937754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64883167|NCT01937754|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64347835|NCT02307695|Hormones|hormones|mesh-ancestor
64883169|NCT01937754|Gasotransmitters|gasotransmitters|mesh-ancestor
64883170|NCT01937754|Protective Agents|protective agents|mesh-ancestor
64883172|NCT01937767|Remifentanil|remifentanil|mesh-list
64883173|NCT01937767|Propofol|propofol|mesh-list
64883174|NCT01937767|Sevoflurane|sevoflurane|mesh-list
64883175|NCT01937767|Rocuronium|rocuronium|mesh-list
64883176|NCT01937767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64314444|NCT05319587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64314445|NCT05319587|Antimetabolites|antimetabolites|mesh-ancestor
64314446|NCT05319587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314447|NCT05319587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314448|NCT05319587|Antiviral Agents|antiviral agents|mesh-ancestor
64314449|NCT05319587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64314450|NCT05319587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64314451|NCT05319587|Immunologic Factors|immunologic factors|mesh-ancestor
64883194|NCT01937806|Antiviral Agents|antiviral agents|mesh-ancestor
64883195|NCT01937806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64883196|NCT01937806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64883197|NCT01937806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64883198|NCT01937806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64883199|NCT01937806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883200|NCT01937806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64883201|NCT01937806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64883202|NCT01937832|Ertapenem|ertapenem|mesh-list
64883203|NCT01937832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64333816|NCT03596281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64333817|NCT03596281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333818|NCT03596281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333819|NCT05172167|Antibodies|antibodies|mesh-list
64333820|NCT05172167|Immunologic Factors|immunologic factors|mesh-ancestor
64333821|NCT05172167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333822|NCT02359149|Endothelial Growth Factors|endothelial growth factors|mesh-list
64333823|NCT02359149|Growth Substances|growth substances|mesh-ancestor
64333824|NCT02359149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883204|NCT01937832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64883205|NCT01938092|Diazepam|diazepam|mesh-list
64883206|NCT01938092|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64883207|NCT01938092|Anticonvulsants|anticonvulsants|mesh-ancestor
64314452|NCT05319587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314453|NCT05319587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64314454|NCT02122601|Hyaluronic Acid|hyaluronic acid|mesh-list
64314455|NCT02122601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64314456|NCT02122601|Immunologic Factors|immunologic factors|mesh-ancestor
64314457|NCT02122601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314458|NCT02122601|Viscosupplements|viscosupplements|mesh-ancestor
64314459|NCT02122601|Protective Agents|protective agents|mesh-ancestor
64314460|NCT02127593|Moxifloxacin|moxifloxacin|mesh-list
64314461|NCT02127593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64314462|NCT02127593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64314463|NCT02127593|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64314464|NCT02127593|Norgestimate|norgestimate|mesh-list
64314465|NCT02127593|Norgestrel|norgestrel|mesh-list
64314472|NCT02127593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314473|NCT02127593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64314475|NCT02127593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64883281|NCT01938456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883282|NCT01938456|Tubulin Modulators|tubulin modulators|mesh-ancestor
64883283|NCT01938456|Antimitotic Agents|antimitotic agents|mesh-ancestor
64883284|NCT01938456|Mitosis Modulators|mitosis modulators|mesh-ancestor
64883285|NCT01938456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883286|NCT01938456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64883287|NCT01938456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64883288|NCT01938508|Minocycline|minocycline|mesh-list
64883289|NCT01938508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64883290|NCT01938508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64883291|NCT01938612|Durvalumab|durvalumab|mesh-list
64883292|NCT01938612|Tremelimumab|tremelimumab|mesh-list
64883293|NCT01938612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64883294|NCT01938612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883295|NCT01938729|Gemcitabine|gemcitabine|mesh-list
64883296|NCT01938729|Dexamethasone|dexamethasone|mesh-list
64883297|NCT01938729|Floxuridine|floxuridine|mesh-list
64883298|NCT01938729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64883299|NCT01938729|Antiemetics|antiemetics|mesh-ancestor
64883300|NCT01938729|Autonomic Agents|autonomic agents|mesh-ancestor
64883301|NCT01938729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64883302|NCT01938729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883303|NCT01938729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64883304|NCT01938729|Glucocorticoids|glucocorticoids|mesh-ancestor
64883305|NCT01938729|Hormones|hormones|mesh-ancestor
64883306|NCT01938729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64424051|NCT01364467|Phenylpropanolamine|phenylpropanolamine|mesh-list
64314476|NCT02127593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64314477|NCT02127593|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64314478|NCT02127593|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64314479|NCT02127593|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64314480|NCT02127593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64314481|NCT02127593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64314482|NCT02127593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64333832|NCT02221583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333833|NCT02221583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64333834|NCT02221583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883307|NCT01938729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64883308|NCT01938729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883309|NCT01938729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64883310|NCT01938729|Antimetabolites|antimetabolites|mesh-ancestor
64883311|NCT01938729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883312|NCT01938729|Antiviral Agents|antiviral agents|mesh-ancestor
64883313|NCT01938729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64883314|NCT01938729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64883315|NCT01938729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64883316|NCT01938729|Immunologic Factors|immunologic factors|mesh-ancestor
64883317|NCT01938755|Levobupivacaine|levobupivacaine|mesh-list
64883318|NCT01938755|Anesthetics, Local|anesthetics, local|mesh-ancestor
64883319|NCT01938755|Anesthetics|anesthetics|mesh-ancestor
64883320|NCT01938755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64883321|NCT01938755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424126|NCT04997317|Chelating Agents|chelating agents|mesh-ancestor
64314483|NCT02127593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64314484|NCT02127593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314485|NCT02127593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314486|NCT02127593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314488|NCT02122679|Tranexamic Acid|tranexamic acid|mesh-list
64314517|NCT04797338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64314518|NCT04797338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883322|NCT01938755|Sensory System Agents|sensory system agents|mesh-ancestor
64883323|NCT01938755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64883324|NCT01938781|Entecavir|entecavir|mesh-list
64883325|NCT01938781|Antiviral Agents|antiviral agents|mesh-ancestor
64883326|NCT01938781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64883327|NCT01938820|Entecavir|entecavir|mesh-list
64883328|NCT01938820|Antiviral Agents|antiviral agents|mesh-ancestor
64883329|NCT01938820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64883330|NCT01938859|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64883331|NCT01938859|Antidepressive Agents|antidepressive agents|mesh-ancestor
64883332|NCT01938859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64883333|NCT01938859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64314519|NCT04797338|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64314520|NCT04797338|Hormone Antagonists|hormone antagonists|mesh-ancestor
64314521|NCT04797338|Estrogens|estrogens|mesh-ancestor
64314522|NCT04797338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64314523|NCT04797338|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64314540|NCT02787863|Immunologic Factors|immunologic factors|mesh-ancestor
64314541|NCT02787863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314542|NCT04809818|Aspirin|aspirin|mesh-list
64314543|NCT04809818|Dabigatran|dabigatran|mesh-list
64314544|NCT04809818|Apixaban|apixaban|mesh-list
64314545|NCT04809818|Clopidogrel|clopidogrel|mesh-list
64314546|NCT04809818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64314547|NCT04809818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64314548|NCT04809818|Analgesics|analgesics|mesh-ancestor
64314549|NCT04809818|Sensory System Agents|sensory system agents|mesh-ancestor
64314550|NCT04809818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64314551|NCT04809818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314552|NCT04809818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64314553|NCT04809818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64314554|NCT04809818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64314555|NCT04809818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64374742|NCT04947267|Mydriatics|mydriatics|mesh-ancestor
64314570|NCT04809818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64314571|NCT04796402|Bamlanivimab|bamlanivimab|mesh-list
64314572|NCT04796402|Antiviral Agents|antiviral agents|mesh-ancestor
64314573|NCT04796402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64314574|NCT04809584|Motexafin gadolinium|motexafin gadolinium|mesh-list
64314575|NCT04809584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883374|NCT01939093|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64883375|NCT01939093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64883376|NCT01939093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64883377|NCT01939093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64883378|NCT01939093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64883379|NCT01939093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64883380|NCT01939093|Anesthetics, General|anesthetics, general|mesh-ancestor
64883381|NCT01939093|Anesthetics|anesthetics|mesh-ancestor
64883382|NCT01939093|GABA Modulators|gaba modulators|mesh-ancestor
64883383|NCT01939093|GABA Agents|gaba agents|mesh-ancestor
64883384|NCT01939093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64883385|NCT01939093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883386|NCT01939093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64314576|NCT04809584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64314577|NCT04809584|Dermatologic Agents|dermatologic agents|mesh-ancestor
64314578|NCT02126267|Chlorhexidine|chlorhexidine|mesh-list
64314579|NCT02126267|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64314582|NCT02126267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64314583|NCT02126267|Disinfectants|disinfectants|mesh-ancestor
64314584|NCT02126267|Dermatologic Agents|dermatologic agents|mesh-ancestor
64314585|NCT02126267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64314587|NCT02128061|Lenalidomide|lenalidomide|mesh-list
64314588|NCT02128061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64314589|NCT02128061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314625|NCT04808648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64314627|NCT04808648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64314628|NCT04808648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314629|NCT04808648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64374896|NCT02625909|Sofosbuvir|sofosbuvir|mesh-list
64314636|NCT04808648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64785975|NCT00000918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64785976|NCT00000918|Antimetabolites|antimetabolites|mesh-ancestor
64554594|NCT01040871|Prednisone|prednisone|mesh-list
64785977|NCT00000918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64785978|NCT00000918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64785979|NCT00000918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64883511|NCT01939691|Prednisolone phosphate|prednisolone phosphate|mesh-list
64883512|NCT01939691|Difluprednate|difluprednate|mesh-list
64883513|NCT01939691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64883514|NCT01939691|Glucocorticoids|glucocorticoids|mesh-ancestor
64883515|NCT01939691|Hormones|hormones|mesh-ancestor
64883516|NCT01939691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64883517|NCT01939691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883518|NCT01939691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64883519|NCT01939691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883520|NCT01939691|Antiemetics|antiemetics|mesh-ancestor
64883521|NCT01939691|Autonomic Agents|autonomic agents|mesh-ancestor
64883522|NCT01939691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64883523|NCT01939691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64883524|NCT01939691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64883525|NCT01939691|Protective Agents|protective agents|mesh-ancestor
64333840|NCT03514069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64333841|NCT03514069|Alkylating Agents|alkylating agents|mesh-ancestor
64424184|NCT04984993|Vasodilator Agents|vasodilator agents|mesh-ancestor
64424185|NCT04984993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64424186|NCT04984993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64785980|NCT00000918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64785981|NCT00000918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64785982|NCT00000918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64785983|NCT00000918|Antitubercular Agents|antitubercular agents|mesh-ancestor
64785984|NCT00000918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64785985|NCT00000924|Ritonavir|ritonavir|mesh-list
64314666|NCT01367249|Analgesics|analgesics|mesh-ancestor
64314667|NCT01367249|Sensory System Agents|sensory system agents|mesh-ancestor
64314668|NCT01367249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64314669|NCT01367249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314670|NCT01367249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64314671|NCT01367249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64314672|NCT02128685|Dydrogesterone|dydrogesterone|mesh-list
64314673|NCT02128685|Progestins|progestins|mesh-ancestor
64314674|NCT02128685|Hormones|hormones|mesh-ancestor
64314675|NCT02128685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64314676|NCT02128685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314677|NCT02252627|Phenylephrine|phenylephrine|mesh-list
64314678|NCT02252627|Oxymetazoline|oxymetazoline|mesh-list
64314679|NCT02252627|Ephedrine|ephedrine|mesh-list
64883526|NCT01939691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64883527|NCT01939691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64883529|NCT01939691|Sensory System Agents|sensory system agents|mesh-ancestor
64883530|NCT01939691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64883531|NCT01939730|Rituximab|rituximab|mesh-list
64883532|NCT01939730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64883533|NCT01939730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883534|NCT01939730|Immunologic Factors|immunologic factors|mesh-ancestor
64883535|NCT01939730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883536|NCT01939730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64883537|NCT01939743|Diclofenac|diclofenac|mesh-list
64883538|NCT01939743|Lidocaine|lidocaine|mesh-list
64883539|NCT01939743|Anesthetics, Local|anesthetics, local|mesh-ancestor
64883540|NCT01939743|Anesthetics|anesthetics|mesh-ancestor
64883541|NCT01939743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64652064|NCT03217838|Antimetabolites|antimetabolites|mesh-ancestor
64883542|NCT01939743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883543|NCT01939743|Sensory System Agents|sensory system agents|mesh-ancestor
64883544|NCT01939743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64883545|NCT01939743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64883546|NCT01939743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64883547|NCT01939743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64883548|NCT01939743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64883549|NCT01939743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348205|NCT02309177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64314680|NCT02252627|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64314684|NCT02252627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314686|NCT02252627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64314687|NCT02252627|Nasal Decongestants|nasal decongestants|mesh-ancestor
64314688|NCT02252627|Respiratory System Agents|respiratory system agents|mesh-ancestor
64314689|NCT02252627|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64314690|NCT02252627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64883553|NCT01939743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64883554|NCT01939743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64883555|NCT01939743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64883556|NCT01939743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64883557|NCT01939834|Insulin|insulin|mesh-list
64883558|NCT01939834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64883559|NCT01939834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883560|NCT01939886|Artesunate|artesunate|mesh-list
64883561|NCT01939886|Lumefantrine|lumefantrine|mesh-list
64883562|NCT01939886|Artemether|artemether|mesh-list
64883563|NCT01939886|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64883564|NCT01939886|Mefloquine|mefloquine|mesh-list
64883565|NCT01939886|Antimalarials|antimalarials|mesh-ancestor
64883566|NCT01939886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64883567|NCT01939886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64883568|NCT01939886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64883569|NCT01939886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883570|NCT01939886|Antiviral Agents|antiviral agents|mesh-ancestor
64883571|NCT01939886|Schistosomicides|schistosomicides|mesh-ancestor
64883572|NCT01939886|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64883573|NCT01939886|Anthelmintics|anthelmintics|mesh-ancestor
64883574|NCT01939912|Adenosine|adenosine|mesh-list
64883575|NCT01939912|Analgesics|analgesics|mesh-ancestor
64333844|NCT03500731|Rituximab|rituximab|mesh-list
64314691|NCT02252627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64314692|NCT02252627|Adrenergic Agents|adrenergic agents|mesh-ancestor
64314693|NCT02252627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64314694|NCT02252627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314695|NCT02252627|Protective Agents|protective agents|mesh-ancestor
64314696|NCT02252627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64314697|NCT02128841|Rivaroxaban|rivaroxaban|mesh-list
64314698|NCT02128841|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64314699|NCT02128841|Antithrombins|antithrombins|mesh-ancestor
64314700|NCT02128841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64314701|NCT02128841|Protease Inhibitors|protease inhibitors|mesh-ancestor
64314702|NCT02128841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64883600|NCT01940081|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64883601|NCT01940172|Conatumumab|conatumumab|mesh-list
64883602|NCT01940172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64883603|NCT01940172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883604|NCT01940224|Pregabalin|pregabalin|mesh-list
64883605|NCT01940224|Morphine|morphine|mesh-list
64883606|NCT01940224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64883607|NCT01940224|Narcotics|narcotics|mesh-ancestor
64883608|NCT01940224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64883609|NCT01940224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883610|NCT01940224|Analgesics|analgesics|mesh-ancestor
64883611|NCT01940224|Sensory System Agents|sensory system agents|mesh-ancestor
64883612|NCT01940224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64883613|NCT01940224|Anticonvulsants|anticonvulsants|mesh-ancestor
64883614|NCT01940224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64883615|NCT01940224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64883616|NCT01940224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883617|NCT01940224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64883618|NCT01940224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64883619|NCT01940224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64883620|NCT01940224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64314703|NCT02128841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314704|NCT02128841|Anticoagulants|anticoagulants|mesh-ancestor
64314705|NCT03550859|Telmisartan|telmisartan|mesh-list
64314706|NCT03550859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64314707|NCT03550859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64314708|NCT03550859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64314709|NCT03550859|Antimetabolites|antimetabolites|mesh-ancestor
64314710|NCT03550859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314711|NCT03550859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64314712|NCT03550859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64314723|NCT03550781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64314724|NCT03550781|Alkylating Agents|alkylating agents|mesh-ancestor
64314725|NCT03550781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314726|NCT03550781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314727|NCT03550781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64314728|NCT03550781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64314730|NCT03550781|Hormones|hormones|mesh-ancestor
64314731|NCT03550781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64883644|NCT01940393|Histamine Agents|histamine agents|mesh-ancestor
64883645|NCT01940393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64883646|NCT01940393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883647|NCT01940393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883648|NCT01940393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64883649|NCT01940393|Cholinergic Agents|cholinergic agents|mesh-ancestor
64883650|NCT01940419|Tranexamic Acid|tranexamic acid|mesh-list
64883651|NCT01940419|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64883652|NCT01940419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64883653|NCT01940419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883654|NCT01940419|Hemostatics|hemostatics|mesh-ancestor
64883655|NCT01940419|Coagulants|coagulants|mesh-ancestor
64883656|NCT01940536|Tranexamic Acid|tranexamic acid|mesh-list
64883657|NCT01940536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64883658|NCT01940536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64348314|NCT03506009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64333848|NCT03500731|Hydroxyurea|hydroxyurea|mesh-list
64333849|NCT03500731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64333850|NCT03500731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314732|NCT03550781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64314733|NCT02260661|Fulvestrant|fulvestrant|mesh-list
64314735|NCT02260661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314736|NCT02260661|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64314737|NCT02260661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64314738|NCT02260661|Hormone Antagonists|hormone antagonists|mesh-ancestor
64314739|NCT02260661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64314740|NCT02260661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314741|NCT02136329|Sildenafil Citrate|sildenafil citrate|mesh-list
64314742|NCT02136329|Vasodilator Agents|vasodilator agents|mesh-ancestor
64314743|NCT02136329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64314744|NCT02136329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64314745|NCT02136329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314754|NCT02129231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64314755|NCT02129231|Antimetabolites|antimetabolites|mesh-ancestor
64314756|NCT02129231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314757|NCT02129231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64314758|NCT02129231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64314759|NCT02129231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314760|NCT02129231|Antacids|antacids|mesh-ancestor
64314761|NCT02129231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64314762|NCT02136641|Fentanyl|fentanyl|mesh-list
64314763|NCT02136641|Midazolam|midazolam|mesh-list
64314764|NCT02136641|Ketamine|ketamine|mesh-list
64883673|NCT01940653|Estrogens|estrogens|mesh-ancestor
64883674|NCT01940653|Hormones|hormones|mesh-ancestor
64883675|NCT01940653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64883676|NCT01940653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883677|NCT01940653|Progestins|progestins|mesh-ancestor
64883678|NCT01940692|Tranexamic Acid|tranexamic acid|mesh-list
64883679|NCT01940692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64883680|NCT01940692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64883681|NCT01940692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883682|NCT01940692|Hemostatics|hemostatics|mesh-ancestor
64883683|NCT01940692|Coagulants|coagulants|mesh-ancestor
64883685|NCT01940718|Testosterone|testosterone|mesh-list
64314765|NCT02136641|Analgesics|analgesics|mesh-ancestor
64314766|NCT02136641|Sensory System Agents|sensory system agents|mesh-ancestor
64314767|NCT02136641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64314768|NCT02136641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314769|NCT02136641|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64314770|NCT02136641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64314771|NCT02136641|Anesthetics, General|anesthetics, general|mesh-ancestor
64314772|NCT02136641|Anesthetics|anesthetics|mesh-ancestor
64314773|NCT02136641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64314774|NCT02136641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64314782|NCT02136641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64314783|NCT02136641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64883692|NCT01940718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883693|NCT01940718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64883694|NCT01940718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883695|NCT01940718|Anabolic Agents|anabolic agents|mesh-ancestor
64883696|NCT01940796|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64883697|NCT01940796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64883698|NCT01940796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883699|NCT01940952|Donepezil|donepezil|mesh-list
64883700|NCT01940952|Udenafil|udenafil|mesh-list
64883701|NCT01940952|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64883702|NCT01940952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64883703|NCT01940952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883704|NCT01940952|Cholinergic Agents|cholinergic agents|mesh-ancestor
64883705|NCT01940952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64883706|NCT01940952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883707|NCT01940952|Nootropic Agents|nootropic agents|mesh-ancestor
64883708|NCT01940952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64883709|NCT01940952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64314784|NCT02136641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64314785|NCT02136641|GABA Modulators|gaba modulators|mesh-ancestor
64314786|NCT02136641|GABA Agents|gaba agents|mesh-ancestor
64314787|NCT03549689|Tenofovir|tenofovir|mesh-list
64314788|NCT03549689|Lamivudine|lamivudine|mesh-list
64314789|NCT03549689|Dolutegravir|dolutegravir|mesh-list
64314790|NCT03549689|Antiviral Agents|antiviral agents|mesh-ancestor
64314791|NCT03549689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64314792|NCT03549689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64314793|NCT03549689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64314794|NCT03549689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314795|NCT03549689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314796|NCT03549689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64314797|NCT03549689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64314799|NCT03549689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64314800|NCT02129621|Spironolactone|spironolactone|mesh-list
64314801|NCT02129621|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64883728|NCT01940978|Histamine Antagonists|histamine antagonists|mesh-ancestor
64883729|NCT01940978|Histamine Agents|histamine agents|mesh-ancestor
64883730|NCT01940978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64883731|NCT01940978|Serotonin Agents|serotonin agents|mesh-ancestor
64883732|NCT01940978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64333882|NCT04059445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333883|NCT04059445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64333884|NCT03395197|Talazoparib|talazoparib|mesh-list
64333885|NCT03395197|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64333886|NCT03395197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333887|NCT03395197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333888|NCT03395197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333889|NCT05092841|Naltrexone|naltrexone|mesh-list
64333890|NCT05092841|Baclofen|baclofen|mesh-list
64333891|NCT05092841|Sorbitol|sorbitol|mesh-list
64333897|NCT05092841|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64333898|NCT05092841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64333899|NCT05092841|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64883734|NCT01941004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64883735|NCT01941004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883736|NCT01941004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64883737|NCT01941004|Immunologic Factors|immunologic factors|mesh-ancestor
64883738|NCT01941004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883739|NCT01941056|Vaccines|vaccines|mesh-list
64883740|NCT01941056|Immunologic Factors|immunologic factors|mesh-ancestor
64333902|NCT05092841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64785994|NCT00000924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314802|NCT02129621|Hormone Antagonists|hormone antagonists|mesh-ancestor
64314803|NCT02129621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64314804|NCT02129621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314805|NCT02129621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64314807|NCT02129621|Natriuretic Agents|natriuretic agents|mesh-ancestor
64314808|NCT02129699|Denosumab|denosumab|mesh-list
64314809|NCT02129699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64314810|NCT02129699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314811|NCT03549923|Esmolol|esmolol|mesh-list
64314812|NCT03549923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64314813|NCT03549923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64314814|NCT03549923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64314815|NCT03549923|Adrenergic Agents|adrenergic agents|mesh-ancestor
64314816|NCT03549923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64314817|NCT03549923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314851|NCT02132897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64314852|NCT02132897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64314853|NCT02132897|Analgesics|analgesics|mesh-ancestor
64314854|NCT02132897|Sensory System Agents|sensory system agents|mesh-ancestor
64314855|NCT02132897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64883749|NCT01941134|Hormones|hormones|mesh-ancestor
64883750|NCT01941134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64883751|NCT01941134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883752|NCT01941134|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64883753|NCT01941134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64883754|NCT01941134|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64883755|NCT01941134|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64883756|NCT01941134|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64883757|NCT01941134|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64883758|NCT01941173|Leucovorin|leucovorin|mesh-list
64883759|NCT01941173|Fluorouracil|fluorouracil|mesh-list
64314856|NCT02132897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64314857|NCT02132897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64314858|NCT02132897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314868|NCT02133053|Respiratory System Agents|respiratory system agents|mesh-ancestor
64314870|NCT02137109|Immunologic Factors|immunologic factors|mesh-ancestor
64314871|NCT02137109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314872|NCT02130167|Atropine|atropine|mesh-list
64883760|NCT01941173|Irinotecan|irinotecan|mesh-list
64883761|NCT01941173|Aflibercept|aflibercept|mesh-list
64883762|NCT01941173|Calcium|calcium|mesh-list
64883763|NCT01941173|Levoleucovorin|levoleucovorin|mesh-list
64883764|NCT01941173|Endothelial Growth Factors|endothelial growth factors|mesh-list
64883765|NCT01941173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64883766|NCT01941173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883767|NCT01941173|Antimetabolites|antimetabolites|mesh-ancestor
64883768|NCT01941173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883769|NCT01941173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64883770|NCT01941173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883771|NCT01941173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64333903|NCT05092841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883772|NCT01941173|Immunologic Factors|immunologic factors|mesh-ancestor
64883773|NCT01941173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64883774|NCT01941173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64883775|NCT01941173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64883776|NCT01941173|Antidotes|antidotes|mesh-ancestor
64883777|NCT01941173|Protective Agents|protective agents|mesh-ancestor
64883778|NCT01941173|Vitamin B Complex|vitamin b complex|mesh-ancestor
64883779|NCT01941173|Vitamins|vitamins|mesh-ancestor
64883780|NCT01941173|Micronutrients|micronutrients|mesh-ancestor
64883781|NCT01941173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64883782|NCT01941173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64314873|NCT02130167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64314874|NCT02130167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64314875|NCT02130167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64314876|NCT02130167|Autonomic Agents|autonomic agents|mesh-ancestor
64314877|NCT02130167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64314878|NCT02130167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314879|NCT02130167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64314880|NCT02130167|Respiratory System Agents|respiratory system agents|mesh-ancestor
64883805|NCT01941329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64883806|NCT01941329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64883807|NCT01941329|Growth Substances|growth substances|mesh-ancestor
64883808|NCT01941329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883809|NCT01941329|Growth Inhibitors|growth inhibitors|mesh-ancestor
64883810|NCT01941329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883811|NCT01941407|Bevacizumab|bevacizumab|mesh-list
64883812|NCT01941407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64883813|NCT01941407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883814|NCT01941407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64883815|NCT01941407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64883816|NCT01941407|Growth Substances|growth substances|mesh-ancestor
64883817|NCT01941407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883818|NCT01941407|Growth Inhibitors|growth inhibitors|mesh-ancestor
64883819|NCT01941524|Poractant alfa|poractant alfa|mesh-list
64883820|NCT01941524|Beractant|beractant|mesh-list
64883821|NCT01941524|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
64883822|NCT01941524|Respiratory System Agents|respiratory system agents|mesh-ancestor
64348497|NCT05098119|Paclitaxel|paclitaxel|mesh-list
64883824|NCT01941576|Natriuretic Agents|natriuretic agents|mesh-ancestor
64883825|NCT01941576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883826|NCT01941602|Enoxaparin|enoxaparin|mesh-list
64883827|NCT01941602|Anticoagulants|anticoagulants|mesh-ancestor
64883828|NCT01941602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64314881|NCT02130167|Mydriatics|mydriatics|mesh-ancestor
64375050|NCT03241199|Imatinib Mesylate|imatinib mesylate|mesh-list
64314900|NCT03549611|Sensory System Agents|sensory system agents|mesh-ancestor
64314901|NCT03549611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64314902|NCT03549611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314903|NCT03549611|Antipyretics|antipyretics|mesh-ancestor
64314914|NCT03549611|Anticonvulsants|anticonvulsants|mesh-ancestor
64314915|NCT03549611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64883829|NCT01941602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64883830|NCT01941602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883831|NCT01941732|Sildenafil Citrate|sildenafil citrate|mesh-list
64883832|NCT01941732|Vasodilator Agents|vasodilator agents|mesh-ancestor
64883833|NCT01941732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64333904|NCT05092841|Cathartics|cathartics|mesh-ancestor
64333905|NCT05092841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64333906|NCT02224937|Melatonin|melatonin|mesh-list
64333907|NCT02224937|Antioxidants|antioxidants|mesh-ancestor
64333908|NCT02224937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883834|NCT01941732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64883835|NCT01941732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64883836|NCT01941732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883837|NCT01941732|Urological Agents|urological agents|mesh-ancestor
64883838|NCT01941758|Vaccines|vaccines|mesh-list
64883839|NCT01941758|Immunologic Factors|immunologic factors|mesh-ancestor
64883840|NCT01941758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883841|NCT01941771|Capecitabine|capecitabine|mesh-list
64883842|NCT01941771|Vinorelbine|vinorelbine|mesh-list
64883843|NCT01941771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64314916|NCT03549611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64314917|NCT03549611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64314918|NCT03549611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64314919|NCT03549611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64314920|NCT03549611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64314921|NCT03549611|Antimanic Agents|antimanic agents|mesh-ancestor
64314922|NCT02133287|Sirolimus|sirolimus|mesh-list
64314923|NCT02133287|Arsenic Trioxide|arsenic trioxide|mesh-list
64314924|NCT02133287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64883844|NCT01941771|Antimetabolites|antimetabolites|mesh-ancestor
64883845|NCT01941771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883846|NCT01941771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883847|NCT01941771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64883848|NCT01941771|Tubulin Modulators|tubulin modulators|mesh-ancestor
64883849|NCT01941771|Antimitotic Agents|antimitotic agents|mesh-ancestor
64883850|NCT01941771|Mitosis Modulators|mitosis modulators|mesh-ancestor
64883851|NCT01941810|Lactoferrin|lactoferrin|mesh-list
64883852|NCT01941810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64883854|NCT01941888|Propofol|propofol|mesh-list
64883855|NCT01941888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64883856|NCT01941888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64883857|NCT01941888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883858|NCT01941888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64883859|NCT01941888|Anesthetics, General|anesthetics, general|mesh-ancestor
64883860|NCT01941888|Anesthetics|anesthetics|mesh-ancestor
64883861|NCT01941888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64883862|NCT01941888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64883863|NCT01941888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64883865|NCT01941888|GABA Modulators|gaba modulators|mesh-ancestor
64883866|NCT01941888|GABA Agents|gaba agents|mesh-ancestor
64883867|NCT01941888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64883868|NCT01941888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883869|NCT01941901|Calcium, Dietary|calcium, dietary|mesh-list
64883870|NCT01941901|Bleomycin|bleomycin|mesh-list
64883871|NCT01941901|Calcium|calcium|mesh-list
64883872|NCT01941901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64348545|NCT03237819|Tocolytic Agents|tocolytic agents|mesh-ancestor
64333909|NCT02224937|Protective Agents|protective agents|mesh-ancestor
64333910|NCT02224937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333911|NCT02224937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64333912|NCT02290327|Pantoprazole|pantoprazole|mesh-list
64424308|NCT02515045|Hormones|hormones|mesh-ancestor
64314925|NCT02133287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64314954|NCT02137421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314955|NCT02137421|Protective Agents|protective agents|mesh-ancestor
64314956|NCT02137421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314957|NCT02137421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314958|NCT02137421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64314959|NCT02133677|Temozolomide|temozolomide|mesh-list
64314960|NCT02133677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64314961|NCT02133677|Alkylating Agents|alkylating agents|mesh-ancestor
64314962|NCT02133677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314963|NCT02133677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314964|NCT02137733|Carvedilol|carvedilol|mesh-list
64314965|NCT02137733|Bisoprolol|bisoprolol|mesh-list
64314966|NCT02137733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64314967|NCT02137733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64314980|NCT02137733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64314981|NCT02137733|Sympatholytics|sympatholytics|mesh-ancestor
64883874|NCT01941901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64883875|NCT01941901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64883876|NCT01941901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883878|NCT01941914|Calcium|calcium|mesh-list
64883879|NCT01941914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64883880|NCT01941914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883881|NCT01941914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64883882|NCT01941953|Metformin|metformin|mesh-list
64883883|NCT01941953|Fluorouracil|fluorouracil|mesh-list
64883884|NCT01941953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64883885|NCT01941953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883886|NCT01941953|Antimetabolites|antimetabolites|mesh-ancestor
64883887|NCT01941953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883888|NCT01941953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64883889|NCT01941953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333913|NCT02290327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64333914|NCT02290327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64314982|NCT02137733|Autonomic Agents|autonomic agents|mesh-ancestor
64314983|NCT02137733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64314984|NCT02137733|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64314985|NCT02133755|Bromocriptine|bromocriptine|mesh-list
64314986|NCT02133755|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64314987|NCT02133755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64314988|NCT02133755|Hormone Antagonists|hormone antagonists|mesh-ancestor
64314989|NCT02133755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64314990|NCT02133755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314991|NCT02133755|Dopamine Agonists|dopamine agonists|mesh-ancestor
64314992|NCT02133755|Dopamine Agents|dopamine agents|mesh-ancestor
64314993|NCT02133755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64314994|NCT02133755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314995|NCT02130869|Cytarabine|cytarabine|mesh-list
64333915|NCT02290327|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64883891|NCT01941953|Immunologic Factors|immunologic factors|mesh-ancestor
64883892|NCT01941966|Capecitabine|capecitabine|mesh-list
64883893|NCT01941966|Mitomycins|mitomycins|mesh-list
64883894|NCT01941966|Mitomycin|mitomycin|mesh-list
64883895|NCT01941966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64883896|NCT01941966|Antimetabolites|antimetabolites|mesh-ancestor
64883897|NCT01941966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883898|NCT01941966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883899|NCT01941966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64883900|NCT01941966|Alkylating Agents|alkylating agents|mesh-ancestor
64883901|NCT01941966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64883902|NCT01941966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64883903|NCT01941979|Leucovorin|leucovorin|mesh-list
64883904|NCT01941979|Capecitabine|capecitabine|mesh-list
64883905|NCT01941979|Oxaliplatin|oxaliplatin|mesh-list
64883906|NCT01941979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64424373|NCT02288325|Levomilnacipran|levomilnacipran|mesh-list
64424374|NCT02288325|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64424383|NCT02288325|Analgesics|analgesics|mesh-ancestor
64314996|NCT02130869|Aldesleukin|aldesleukin|mesh-list
64314997|NCT02130869|Carboplatin|carboplatin|mesh-list
64314998|NCT02130869|Etoposide|etoposide|mesh-list
64314999|NCT02130869|Etoposide phosphate|etoposide phosphate|mesh-list
64315000|NCT02130869|Melphalan|melphalan|mesh-list
64315001|NCT02130869|Busulfan|busulfan|mesh-list
64315002|NCT02130869|Interleukin-2|interleukin-2|mesh-list
64315003|NCT02130869|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64375080|NCT03239327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64315026|NCT02130869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64883907|NCT01941979|Antimetabolites|antimetabolites|mesh-ancestor
64883908|NCT01941979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883909|NCT01941979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883910|NCT01941979|Antidotes|antidotes|mesh-ancestor
64883911|NCT01941979|Protective Agents|protective agents|mesh-ancestor
64883912|NCT01941979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883913|NCT01941979|Vitamin B Complex|vitamin b complex|mesh-ancestor
64883914|NCT01941979|Vitamins|vitamins|mesh-ancestor
64883915|NCT01941979|Micronutrients|micronutrients|mesh-ancestor
64883916|NCT01942070|Everolimus|everolimus|mesh-list
64883917|NCT01942070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883918|NCT01942070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64883919|NCT01942070|Immunologic Factors|immunologic factors|mesh-ancestor
64883920|NCT01942070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883921|NCT01942109|Torsemide|torsemide|mesh-list
64883922|NCT01942109|Furosemide|furosemide|mesh-list
64883923|NCT01942109|Diuretics|diuretics|mesh-ancestor
64883924|NCT01942109|Natriuretic Agents|natriuretic agents|mesh-ancestor
64883925|NCT01942109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883926|NCT01942109|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64883927|NCT01942109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64883928|NCT01942109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883929|NCT01942109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64883930|NCT01942174|Methotrexate|methotrexate|mesh-list
64883931|NCT01942174|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64333916|NCT02290327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333917|NCT02290327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333918|NCT02372955|Dapagliflozin|dapagliflozin|mesh-list
64333919|NCT02372955|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64315027|NCT02130869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64315029|NCT02133911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64315030|NCT02133911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64315031|NCT02133911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315032|NCT02133989|Ticlopidine|ticlopidine|mesh-list
64315033|NCT02133989|Clopidogrel|clopidogrel|mesh-list
64315034|NCT02133989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64883938|NCT01942174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883939|NCT01942174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883940|NCT01942174|Dermatologic Agents|dermatologic agents|mesh-ancestor
64883941|NCT01942174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64883942|NCT01942174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64883943|NCT01942174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64883944|NCT01942174|Immunologic Factors|immunologic factors|mesh-ancestor
64883945|NCT01942174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64883946|NCT01942174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64883947|NCT01942187|Aripiprazole|aripiprazole|mesh-list
64883948|NCT01942187|Bupropion|bupropion|mesh-list
64883949|NCT01942187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64883950|NCT01942187|Antidepressive Agents|antidepressive agents|mesh-ancestor
64883951|NCT01942187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64883952|NCT01942187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64883953|NCT01942187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64883954|NCT01942187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64883955|NCT01942187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883956|NCT01942187|Dopamine Agents|dopamine agents|mesh-ancestor
64883973|NCT01942291|Niacin|niacin|mesh-list
64315035|NCT02133989|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64315036|NCT02133989|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64315037|NCT02133989|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64315038|NCT02133989|Purinergic Agents|purinergic agents|mesh-ancestor
64315039|NCT02133989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64315040|NCT02133989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786012|NCT00000936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786013|NCT00000936|Antifungal Agents|antifungal agents|mesh-ancestor
64786014|NCT00000936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786015|NCT00000936|Dermatologic Agents|dermatologic agents|mesh-ancestor
64786016|NCT00000936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64786017|NCT00000936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64786018|NCT00000942|Nevirapine|nevirapine|mesh-list
64786019|NCT00000942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786020|NCT00000942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786021|NCT00000942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786022|NCT00000942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315062|NCT02138045|Incretins|incretins|mesh-ancestor
64315063|NCT02138045|Hormones|hormones|mesh-ancestor
64883985|NCT01942304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64883986|NCT01942304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883987|NCT01942343|Droperidol|droperidol|mesh-list
64883988|NCT01942343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64883989|NCT01942343|Antiemetics|antiemetics|mesh-ancestor
64883990|NCT01942343|Autonomic Agents|autonomic agents|mesh-ancestor
64883991|NCT01942343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64883992|NCT01942343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883993|NCT01942343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64883994|NCT01942343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64883995|NCT01942343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64883996|NCT01942343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64883997|NCT01942343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64883998|NCT01942343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64883999|NCT01942343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64884000|NCT01942343|Dopamine Agents|dopamine agents|mesh-ancestor
64884001|NCT01942343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64884002|NCT01942343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884003|NCT01942369|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64348669|NCT03502421|Ketamine|ketamine|mesh-list
64333922|NCT02372955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333923|NCT02358057|Dexmedetomidine|dexmedetomidine|mesh-list
64333925|NCT02358057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64333926|NCT02358057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64315064|NCT02138045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64315065|NCT02134067|Paclitaxel|paclitaxel|mesh-list
64315066|NCT02134067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64315067|NCT02134067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315068|NCT02134067|Tubulin Modulators|tubulin modulators|mesh-ancestor
64315069|NCT02134067|Antimitotic Agents|antimitotic agents|mesh-ancestor
64315070|NCT02134067|Mitosis Modulators|mitosis modulators|mesh-ancestor
64315071|NCT02134067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315072|NCT04091126|Dexamethasone|dexamethasone|mesh-list
64315073|NCT04091126|Lenalidomide|lenalidomide|mesh-list
64315074|NCT04091126|Bortezomib|bortezomib|mesh-list
64315075|NCT04091126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64315076|NCT04091126|Antiemetics|antiemetics|mesh-ancestor
64315077|NCT04091126|Autonomic Agents|autonomic agents|mesh-ancestor
64315078|NCT04091126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315079|NCT04091126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315080|NCT04091126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64315081|NCT04091126|Glucocorticoids|glucocorticoids|mesh-ancestor
64315082|NCT04091126|Hormones|hormones|mesh-ancestor
64315083|NCT04091126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64315084|NCT04091126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64315085|NCT04091126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315086|NCT04091126|Immunologic Factors|immunologic factors|mesh-ancestor
64429997|NCT05056883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64315101|NCT03962114|Niacinamide|niacinamide|mesh-list
64315103|NCT03962114|Nicotinic Acids|nicotinic acids|mesh-list
64315104|NCT03962114|Vitamins|vitamins|mesh-ancestor
64315105|NCT03962114|Micronutrients|micronutrients|mesh-ancestor
64315106|NCT03962114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315107|NCT03962114|Vitamin B Complex|vitamin b complex|mesh-ancestor
64315108|NCT03962114|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64315109|NCT03962114|Antimetabolites|antimetabolites|mesh-ancestor
64315110|NCT03962114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315111|NCT03962114|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64884004|NCT01942369|Luteolytic Agents|luteolytic agents|mesh-ancestor
64884005|NCT01942369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64884006|NCT01942369|Contraceptive Agents|contraceptive agents|mesh-ancestor
64884007|NCT01942369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64884008|NCT01942369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884009|NCT01942369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64884010|NCT01942369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64884011|NCT01942369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64884012|NCT01942382|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64884013|NCT01942382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64884014|NCT01942382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64884015|NCT01942382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64884016|NCT01942382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884017|NCT01942382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64884018|NCT01942382|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64884019|NCT01942382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64884020|NCT01942382|Serotonin Agents|serotonin agents|mesh-ancestor
64884021|NCT01942382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64348683|NCT03502343|Gemcitabine|gemcitabine|mesh-list
64424671|NCT02495077|Hormones|hormones|mesh-ancestor
64315112|NCT03962114|Vasodilator Agents|vasodilator agents|mesh-ancestor
64375202|NCT03235973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315129|NCT02138357|Analgesics|analgesics|mesh-ancestor
64315130|NCT02138357|Sensory System Agents|sensory system agents|mesh-ancestor
64315131|NCT02138357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315132|NCT02138357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64315133|NCT03596918|Vincristine|vincristine|mesh-list
64315134|NCT03596918|Bleomycin|bleomycin|mesh-list
64315135|NCT03596918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64315136|NCT03596918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315137|NCT03596918|Tubulin Modulators|tubulin modulators|mesh-ancestor
64315138|NCT03596918|Antimitotic Agents|antimitotic agents|mesh-ancestor
64315139|NCT03596918|Mitosis Modulators|mitosis modulators|mesh-ancestor
64315140|NCT03596918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333927|NCT02358057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333928|NCT02358057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64333929|NCT02358057|Analgesics|analgesics|mesh-ancestor
64884022|NCT01942382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884023|NCT01942382|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64884024|NCT01942382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64884025|NCT01942382|Dopamine Agents|dopamine agents|mesh-ancestor
64884026|NCT01942447|Vancomycin|vancomycin|mesh-list
64884027|NCT01942447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64884028|NCT01942447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64884029|NCT01942460|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64884030|NCT01942460|Hematinics|hematinics|mesh-ancestor
64884031|NCT01942460|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64884032|NCT01942460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64884033|NCT01942551|Tadalafil|tadalafil|mesh-list
64884034|NCT01942551|Dutasteride|dutasteride|mesh-list
64884035|NCT01942551|Vasodilator Agents|vasodilator agents|mesh-ancestor
64884036|NCT01942551|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64884037|NCT01942551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64884038|NCT01942551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884039|NCT01942551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884040|NCT01942551|Urological Agents|urological agents|mesh-ancestor
64884041|NCT01942551|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64884042|NCT01942551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64884043|NCT01942551|Hormone Antagonists|hormone antagonists|mesh-ancestor
64884044|NCT01942551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64884045|NCT01942551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424736|NCT01653847|Immunologic Factors|immunologic factors|mesh-ancestor
64786025|NCT00000942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786026|NCT00000942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786027|NCT00000942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64786028|NCT00000942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64786030|NCT00000948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64786031|NCT00000948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786032|NCT00000948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786033|NCT00000948|Antiviral Agents|antiviral agents|mesh-ancestor
64315224|NCT03511118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315225|NCT03511118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64315226|NCT03511118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64315227|NCT03511118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64315228|NCT03511118|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64315229|NCT03511118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64315230|NCT03511118|Hemostatics|hemostatics|mesh-ancestor
64315231|NCT03511118|Coagulants|coagulants|mesh-ancestor
64315232|NCT03511118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64315233|NCT03511118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64315234|NCT03511118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64315235|NCT03511118|Narcotics|narcotics|mesh-ancestor
64315236|NCT03511118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64315237|NCT03511118|Analgesics|analgesics|mesh-ancestor
64315238|NCT03511118|Sensory System Agents|sensory system agents|mesh-ancestor
64315239|NCT03511118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315240|NCT03511118|Anticonvulsants|anticonvulsants|mesh-ancestor
64315241|NCT03511118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64315242|NCT03511118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64315243|NCT03511118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64884046|NCT01942577|Protective Agents|protective agents|mesh-list
64884047|NCT01942577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333930|NCT02358057|Sensory System Agents|sensory system agents|mesh-ancestor
64884048|NCT01942681|Propiverine|propiverine|mesh-list
64884049|NCT01942681|Parasympatholytics|parasympatholytics|mesh-ancestor
64884050|NCT01942681|Autonomic Agents|autonomic agents|mesh-ancestor
64884051|NCT01942681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64884052|NCT01942681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884053|NCT01942681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64884054|NCT01942681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64884055|NCT01942681|Cholinergic Agents|cholinergic agents|mesh-ancestor
64884056|NCT01942681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64884057|NCT01942681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884058|NCT01942681|Urological Agents|urological agents|mesh-ancestor
64884059|NCT01942889|Antioxidants|antioxidants|mesh-list
64884060|NCT01942889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884061|NCT01942889|Protective Agents|protective agents|mesh-ancestor
64884062|NCT01942889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884063|NCT01943019|Linagliptin|linagliptin|mesh-list
64884064|NCT01943019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64315244|NCT03511118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64315245|NCT03511118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64315253|NCT03511118|Antidepressive Agents|antidepressive agents|mesh-ancestor
64315254|NCT03511118|Autonomic Agents|autonomic agents|mesh-ancestor
64315255|NCT03511118|Antiemetics|antiemetics|mesh-ancestor
64315256|NCT03511118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64315257|NCT03511118|Antipruritics|antipruritics|mesh-ancestor
64315258|NCT03511118|Dermatologic Agents|dermatologic agents|mesh-ancestor
64315259|NCT03511118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64315260|NCT03511118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64315261|NCT03511118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64315262|NCT03511118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64375243|NCT05269030|Glucocorticoids|glucocorticoids|mesh-ancestor
64315272|NCT03511118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64315273|NCT03511118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315274|NCT03511118|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64315275|NCT03511118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64315276|NCT03511118|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64315277|NCT03511118|Renal Agents|renal agents|mesh-ancestor
64315278|NCT03511118|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64315279|NCT03511118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64315280|NCT03511118|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64315281|NCT03511118|Antisickling Agents|antisickling agents|mesh-ancestor
64315290|NCT03511118|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64315292|NCT03511118|Antiviral Agents|antiviral agents|mesh-ancestor
64315293|NCT03511118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64315294|NCT03511118|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64315295|NCT03511118|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64315296|NCT03511118|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64315298|NCT03511118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64315299|NCT03511118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64375257|NCT03057015|Antiemetics|antiemetics|mesh-ancestor
64315310|NCT02134457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315311|NCT04090190|Solifenacin Succinate|solifenacin succinate|mesh-list
64884065|NCT01943019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884066|NCT01943019|Incretins|incretins|mesh-ancestor
64884067|NCT01943019|Hormones|hormones|mesh-ancestor
64884068|NCT01943019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64884069|NCT01943019|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64884070|NCT01943019|Protease Inhibitors|protease inhibitors|mesh-ancestor
64424926|NCT02475265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315312|NCT04090190|Fesoterodine|fesoterodine|mesh-list
64315313|NCT04090190|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64315314|NCT04090190|Oxybutynin|oxybutynin|mesh-list
64315315|NCT04090190|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64315316|NCT04090190|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64315317|NCT04090190|Cholinergic Agents|cholinergic agents|mesh-ancestor
64315318|NCT04090190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64315319|NCT04090190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315320|NCT04090190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884071|NCT01943019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884072|NCT01943019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884073|NCT01943058|Megestrol|megestrol|mesh-list
64884074|NCT01943058|Megestrol Acetate|megestrol acetate|mesh-list
64884075|NCT01943058|Levonorgestrel|levonorgestrel|mesh-list
64884076|NCT01943058|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64884077|NCT01943058|Contraceptive Agents|contraceptive agents|mesh-ancestor
64884078|NCT01943058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64884079|NCT01943058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884080|NCT01943058|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64884081|NCT01943058|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64884082|NCT01943058|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64333931|NCT02358057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64333932|NCT02358057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64333933|NCT02358057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64333934|NCT02358057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64884083|NCT01943058|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64884084|NCT01943058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64884085|NCT01943058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64884086|NCT01943058|Appetite Stimulants|appetite stimulants|mesh-ancestor
64884087|NCT01943058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64884088|NCT01943136|Mupirocin|mupirocin|mesh-list
64884089|NCT01943136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64884090|NCT01943136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64884091|NCT01943136|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64884092|NCT01943136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884093|NCT01943136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884094|NCT01943188|Cyclophosphamide|cyclophosphamide|mesh-list
64884095|NCT01943188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64315321|NCT04090190|Urological Agents|urological agents|mesh-ancestor
64315322|NCT04090190|Parasympatholytics|parasympatholytics|mesh-ancestor
64315323|NCT04090190|Autonomic Agents|autonomic agents|mesh-ancestor
64315324|NCT04090190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315345|NCT02253095|Anticestodal Agents|anticestodal agents|mesh-ancestor
64315346|NCT02253095|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64315347|NCT02253095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64315348|NCT02253095|Tubulin Modulators|tubulin modulators|mesh-ancestor
64315349|NCT02253095|Antimitotic Agents|antimitotic agents|mesh-ancestor
64315350|NCT02253095|Mitosis Modulators|mitosis modulators|mesh-ancestor
64884099|NCT01943188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64884100|NCT01943188|Alkylating Agents|alkylating agents|mesh-ancestor
64884101|NCT01943188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884102|NCT01943188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64884103|NCT01943188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64348760|NCT03501251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64884104|NCT01943240|Ropivacaine|ropivacaine|mesh-list
64884105|NCT01943240|Anesthetics, Local|anesthetics, local|mesh-ancestor
64884106|NCT01943240|Anesthetics|anesthetics|mesh-ancestor
64884107|NCT01943240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64884108|NCT01943240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884109|NCT01943240|Sensory System Agents|sensory system agents|mesh-ancestor
64884110|NCT01943240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64884111|NCT01943305|Vaccines|vaccines|mesh-list
64884112|NCT01943305|Immunologic Factors|immunologic factors|mesh-ancestor
64884113|NCT01943305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884114|NCT01943409|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64884115|NCT01943409|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64884116|NCT01943409|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64884117|NCT01943409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64884118|NCT01943422|Interferons|interferons|mesh-list
64884119|NCT01943422|Interferon-alpha|interferon-alpha|mesh-list
64884120|NCT01943422|Interferon alpha-2|interferon alpha-2|mesh-list
64884121|NCT01943422|Vemurafenib|vemurafenib|mesh-list
64884122|NCT01943422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64884123|NCT01943422|Antiviral Agents|antiviral agents|mesh-ancestor
64884124|NCT01943422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64884125|NCT01943422|Immunologic Factors|immunologic factors|mesh-ancestor
64348784|NCT01634152|Tiotropium Bromide|tiotropium bromide|mesh-list
64425172|NCT05649111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425173|NCT02465515|rGLP-1 protein|rglp-1 protein|mesh-list
64425175|NCT02465515|Incretins|incretins|mesh-ancestor
64315351|NCT02253095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315352|NCT02253095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315353|NCT02253095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315354|NCT03358706|Vitamin K|vitamin k|mesh-list
64315355|NCT03358706|Midazolam|midazolam|mesh-list
64315356|NCT03358706|Dextromethorphan|dextromethorphan|mesh-list
64315357|NCT03358706|Caffeine|caffeine|mesh-list
64315358|NCT03358706|Ustekinumab|ustekinumab|mesh-list
64315359|NCT03358706|Omeprazole|omeprazole|mesh-list
64315360|NCT03358706|Warfarin|warfarin|mesh-list
64315361|NCT03358706|Vitamins|vitamins|mesh-ancestor
64315362|NCT03358706|Micronutrients|micronutrients|mesh-ancestor
64315363|NCT03358706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786044|NCT00000954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64786045|NCT00000954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397214|NCT02374567|Antiemetics|antiemetics|mesh-ancestor
64315364|NCT03358706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64315365|NCT03358706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64333938|NCT02358057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64333939|NCT02358057|Narcotics|narcotics|mesh-ancestor
64333940|NCT02358057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64333941|NCT02358057|Anesthetics, General|anesthetics, general|mesh-ancestor
64333942|NCT02358057|Anesthetics|anesthetics|mesh-ancestor
64333943|NCT02225093|Dextromethorphan|dextromethorphan|mesh-list
64333944|NCT02225093|Caffeine|caffeine|mesh-list
64884126|NCT01943422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884127|NCT01943422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64884128|NCT01943422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884129|NCT01943422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884130|NCT01943487|Verapamil|verapamil|mesh-list
64884131|NCT01943487|Tamsulosin|tamsulosin|mesh-list
64884132|NCT01943487|Solifenacin Succinate|solifenacin succinate|mesh-list
64884133|NCT01943487|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64884134|NCT01943487|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64884135|NCT01943487|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64425242|NCT02442271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64315366|NCT03358706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64315367|NCT03358706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64315368|NCT03358706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64315369|NCT03358706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64315370|NCT03358706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64315371|NCT03358706|Anesthetics, General|anesthetics, general|mesh-ancestor
64315372|NCT03358706|Anesthetics|anesthetics|mesh-ancestor
64315373|NCT03358706|GABA Modulators|gaba modulators|mesh-ancestor
64315374|NCT03358706|GABA Agents|gaba agents|mesh-ancestor
64315375|NCT03358706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64315376|NCT03358706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333945|NCT02225093|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64333946|NCT02225093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333947|NCT02225093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64333948|NCT02225093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333949|NCT02225093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333950|NCT02225093|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64333951|NCT02225093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64884136|NCT01943487|Adrenergic Agents|adrenergic agents|mesh-ancestor
64884137|NCT01943487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64884138|NCT01943487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884139|NCT01943487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884140|NCT01943487|Urological Agents|urological agents|mesh-ancestor
64884141|NCT01943487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64884142|NCT01943487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64348813|NCT02317601|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64315377|NCT03358706|Anticoagulants|anticoagulants|mesh-ancestor
64315378|NCT03358706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64315379|NCT03358706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64315380|NCT03358706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64315381|NCT03358706|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64315382|NCT03358706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64315383|NCT03358706|Purinergic Agents|purinergic agents|mesh-ancestor
64333954|NCT02225093|Antitussive Agents|antitussive agents|mesh-ancestor
64333955|NCT02225093|Respiratory System Agents|respiratory system agents|mesh-ancestor
64333956|NCT02225093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64333957|NCT02225093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64333958|NCT02212535|Plerixafor|plerixafor|mesh-list
64333959|NCT02212535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64884144|NCT01943487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64884145|NCT01943487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64884146|NCT01943487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64884147|NCT01943487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64884148|NCT01943487|Vasodilator Agents|vasodilator agents|mesh-ancestor
64884149|NCT01943526|Natalizumab|natalizumab|mesh-list
64884150|NCT01943526|Immunologic Factors|immunologic factors|mesh-ancestor
64884151|NCT01943526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884152|NCT01943617|Entecavir|entecavir|mesh-list
64884153|NCT01943617|Antiviral Agents|antiviral agents|mesh-ancestor
64884154|NCT01943617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64884155|NCT01943630|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
64884156|NCT01943630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64884157|NCT01943630|Immunologic Factors|immunologic factors|mesh-ancestor
64884158|NCT01943630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425305|NCT02463331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64315384|NCT03358706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64315385|NCT03358706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64315386|NCT03358706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64315387|NCT03358706|Dermatologic Agents|dermatologic agents|mesh-ancestor
64315388|NCT03358706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64315389|NCT03358706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64315390|NCT03358706|Hemostatics|hemostatics|mesh-ancestor
64315391|NCT03358706|Coagulants|coagulants|mesh-ancestor
64315430|NCT02531906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64884159|NCT01943630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64884160|NCT01943630|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64884161|NCT01943630|Protective Agents|protective agents|mesh-ancestor
64884162|NCT01943630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64884163|NCT01943630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64884164|NCT01943630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884165|NCT01943630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884167|NCT01943630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64884168|NCT01943760|Tramadol|tramadol|mesh-list
64884169|NCT01943760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64884170|NCT01943760|Narcotics|narcotics|mesh-ancestor
64884171|NCT01943760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64884172|NCT01943760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884173|NCT01943760|Analgesics|analgesics|mesh-ancestor
64884174|NCT01943760|Sensory System Agents|sensory system agents|mesh-ancestor
64884175|NCT01943760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64884176|NCT01943786|Cetuximab|cetuximab|mesh-list
64884177|NCT01943786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64884178|NCT01943786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64884179|NCT01943812|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64884180|NCT01943812|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64884181|NCT01943812|Estradiol|estradiol|mesh-list
64884182|NCT01943812|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64884183|NCT01943812|Progesterone|progesterone|mesh-list
64333960|NCT02212535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64333962|NCT02212535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64333963|NCT02372487|Sildenafil Citrate|sildenafil citrate|mesh-list
64333964|NCT02372487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333965|NCT02372487|Vasodilator Agents|vasodilator agents|mesh-ancestor
64884185|NCT01943812|Hormones|hormones|mesh-ancestor
64884186|NCT01943812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64425313|NCT02463331|Anthelmintics|anthelmintics|mesh-ancestor
64315431|NCT02531906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64315432|NCT02531906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64315433|NCT02531906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64315434|NCT02531906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64315435|NCT02531906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315437|NCT02531906|Antitussive Agents|antitussive agents|mesh-ancestor
64315438|NCT02531906|Respiratory System Agents|respiratory system agents|mesh-ancestor
64884187|NCT01943812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884188|NCT01943812|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64884189|NCT01943812|Contraceptive Agents|contraceptive agents|mesh-ancestor
64884190|NCT01943812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64884191|NCT01943812|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64884192|NCT01943812|Progestins|progestins|mesh-ancestor
64884193|NCT01943877|Propolis|propolis|mesh-list
64884194|NCT01943877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64884195|NCT01943942|Montelukast|montelukast|mesh-list
64884196|NCT01943942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64884197|NCT01943942|Respiratory System Agents|respiratory system agents|mesh-ancestor
64884198|NCT01943942|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64884199|NCT01943942|Hormone Antagonists|hormone antagonists|mesh-ancestor
64736780|NCT01645709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64736781|NCT01645709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736782|NCT01645709|Vasodilator Agents|vasodilator agents|mesh-ancestor
64736783|NCT00608465|Ramipril|ramipril|mesh-list
64736784|NCT00608465|Eplerenone|eplerenone|mesh-list
64736785|NCT00608465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64736786|NCT00608465|Protease Inhibitors|protease inhibitors|mesh-ancestor
64736787|NCT00608465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736788|NCT00608465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736789|NCT00608465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64425355|NCT02462473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64425356|NCT02462473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64425420|NCT02532647|Anesthetics|anesthetics|mesh-ancestor
64315439|NCT02783729|Zolpidem|zolpidem|mesh-list
64315440|NCT02783729|Lemborexant|lemborexant|mesh-list
64315441|NCT02783729|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64315442|NCT02783729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64315443|NCT02783729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64315444|NCT02783729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315445|NCT02783729|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64315446|NCT02783729|GABA Agonists|gaba agonists|mesh-ancestor
64315447|NCT02783729|GABA Agents|gaba agents|mesh-ancestor
64315448|NCT02783729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64315449|NCT02783729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315450|NCT02783729|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64315452|NCT02227940|Paclitaxel|paclitaxel|mesh-list
64315453|NCT02227940|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64315456|NCT02227940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64315457|NCT02227940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315458|NCT02227940|Tubulin Modulators|tubulin modulators|mesh-ancestor
64315459|NCT02227940|Antimitotic Agents|antimitotic agents|mesh-ancestor
64315460|NCT02227940|Mitosis Modulators|mitosis modulators|mesh-ancestor
64315461|NCT02227940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315462|NCT02227940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64315464|NCT02227940|Antiviral Agents|antiviral agents|mesh-ancestor
64315465|NCT02227940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64315466|NCT02227940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64315467|NCT02227940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64315468|NCT02227940|Immunologic Factors|immunologic factors|mesh-ancestor
64736790|NCT00608465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64736791|NCT00608465|Hormone Antagonists|hormone antagonists|mesh-ancestor
64736792|NCT00608465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64736793|NCT00608465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348878|NCT02315573|Autonomic Agents|autonomic agents|mesh-ancestor
64321463|NCT04772222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64321464|NCT04772222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321465|NCT04772222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64321466|NCT04772222|Narcotics|narcotics|mesh-ancestor
64321467|NCT02199925|gamma-Globulins|gamma-globulins|mesh-list
64321468|NCT02199925|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64321469|NCT02199925|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64321470|NCT02199925|Immunologic Factors|immunologic factors|mesh-ancestor
64321471|NCT02199925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321472|NCT03338647|Doxorubicin|doxorubicin|mesh-list
64321473|NCT03338647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64321474|NCT03338647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64321475|NCT03338647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64321476|NCT03338647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64321477|NCT03338647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425424|NCT02532647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315469|NCT02227940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315473|NCT02072486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64315475|NCT02072486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315476|NCT00988364|Simvastatin|simvastatin|mesh-list
64315477|NCT00988364|Ezetimibe|ezetimibe|mesh-list
64315478|NCT00988364|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
64315479|NCT00988364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64315480|NCT00988364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64315481|NCT00988364|Antimetabolites|antimetabolites|mesh-ancestor
64315482|NCT00988364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315483|NCT00988364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64315484|NCT00988364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64315485|NCT00988364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736795|NCT00608465|Diuretics|diuretics|mesh-ancestor
64736796|NCT00608465|Natriuretic Agents|natriuretic agents|mesh-ancestor
64736797|NCT00608777|Betamethasone|betamethasone|mesh-list
64736798|NCT00608777|Calcipotriene|calcipotriene|mesh-list
64736799|NCT00608777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64736800|NCT00608777|Glucocorticoids|glucocorticoids|mesh-ancestor
64736801|NCT00608777|Hormones|hormones|mesh-ancestor
64736802|NCT00608777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64736803|NCT00608777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736804|NCT00608777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64736805|NCT00608777|Respiratory System Agents|respiratory system agents|mesh-ancestor
64736806|NCT00608777|Dermatologic Agents|dermatologic agents|mesh-ancestor
64736807|NCT00379457|Dactinomycin|dactinomycin|mesh-list
64736808|NCT00379457|Cyclophosphamide|cyclophosphamide|mesh-list
64736809|NCT00379457|Ifosfamide|ifosfamide|mesh-list
64736810|NCT00379457|Carboplatin|carboplatin|mesh-list
64736811|NCT00379457|Doxorubicin|doxorubicin|mesh-list
64321479|NCT05500742|Selenium|selenium|mesh-list
64321480|NCT05500742|Ubiquinone|ubiquinone|mesh-list
64321481|NCT05500742|Coenzyme Q10|coenzyme q10|mesh-list
64321482|NCT05500742|Resveratrol|resveratrol|mesh-list
64321483|NCT05500742|Antioxidants|antioxidants|mesh-ancestor
64321484|NCT05500742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321485|NCT05500742|Protective Agents|protective agents|mesh-ancestor
64321486|NCT05500742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321487|NCT05500742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375401|NCT03056703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64315498|NCT05577923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64315499|NCT05577923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315500|NCT05577923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64315501|NCT05577923|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64315502|NCT05577923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64315503|NCT05577923|Hormone Antagonists|hormone antagonists|mesh-ancestor
64315504|NCT05577923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64315505|NCT05577923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315507|NCT04790708|Edotreotide|edotreotide|mesh-list
64315508|NCT04790708|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
64315509|NCT04790708|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64315510|NCT04790708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315511|NCT04790708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64375439|NCT04912011|Diuretics|diuretics|mesh-ancestor
64315532|NCT05614934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64315534|NCT02135393|Hematinics|hematinics|mesh-ancestor
64315535|NCT02135393|Vitamin B Complex|vitamin b complex|mesh-ancestor
64315536|NCT02135393|Vitamins|vitamins|mesh-ancestor
64315537|NCT02135393|Micronutrients|micronutrients|mesh-ancestor
64315538|NCT02135393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736819|NCT00379457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736820|NCT00379457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64736821|NCT00379457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64736822|NCT00379457|Alkylating Agents|alkylating agents|mesh-ancestor
64736823|NCT00379457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736824|NCT00379457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736825|NCT00379457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64736826|NCT00379457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64736827|NCT00379457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64476182|NCT00470392|Clobetasol|clobetasol|mesh-list
64736828|NCT00379457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64736829|NCT00379457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64321498|NCT02200159|Dexmedetomidine|dexmedetomidine|mesh-list
64321499|NCT02200159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64321500|NCT02200159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64321501|NCT02200159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321502|NCT02200159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64321503|NCT02200159|Analgesics|analgesics|mesh-ancestor
64315539|NCT02139761|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
64315550|NCT02139761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64315551|NCT02139761|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64315553|NCT02139761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64315554|NCT02139761|Adrenergic Agents|adrenergic agents|mesh-ancestor
64315555|NCT02139761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64315556|NCT02139761|Analgesics|analgesics|mesh-ancestor
64315557|NCT02139761|Sensory System Agents|sensory system agents|mesh-ancestor
64315558|NCT02139761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315559|NCT05614778|Zoledronic Acid|zoledronic acid|mesh-list
64315560|NCT05614778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64736834|NCT00379457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64736835|NCT00379457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64736836|NCT00379457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64736837|NCT00379457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64736838|NCT00379457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64736839|NCT01629329|Aspirin|aspirin|mesh-list
64736840|NCT01629329|Acetaminophen|acetaminophen|mesh-list
64736841|NCT01629329|Prochlorperazine|prochlorperazine|mesh-list
64736842|NCT01629329|Caffeine|caffeine|mesh-list
64736843|NCT01629329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64736844|NCT01629329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64736845|NCT01629329|Analgesics|analgesics|mesh-ancestor
64736846|NCT01629329|Sensory System Agents|sensory system agents|mesh-ancestor
64736847|NCT01629329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64736848|NCT01629329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736849|NCT01629329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64736850|NCT01629329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64321517|NCT02204527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321518|NCT02204527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64321519|NCT02204527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64736852|NCT01629329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64736853|NCT01629329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736854|NCT01629329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64315561|NCT05614778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315562|NCT05474924|Prednisolone|prednisolone|mesh-list
64315563|NCT05474924|Budesonide|budesonide|mesh-list
64315564|NCT05474924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64315565|NCT05474924|Glucocorticoids|glucocorticoids|mesh-ancestor
64315566|NCT05474924|Hormones|hormones|mesh-ancestor
64315575|NCT05474924|Respiratory System Agents|respiratory system agents|mesh-ancestor
64315576|NCT02135627|Epinephrine|epinephrine|mesh-list
64315577|NCT02135627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64315578|NCT02135627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64315579|NCT02135627|Adrenergic Agents|adrenergic agents|mesh-ancestor
64315580|NCT02135627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64736867|NCT01629329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64736868|NCT01629329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64736869|NCT01629329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64736870|NCT01629329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64736871|NCT01629329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64736872|NCT01629329|Dopamine Agents|dopamine agents|mesh-ancestor
64736873|NCT01606709|Leuprolide|leuprolide|mesh-list
64736874|NCT01606709|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64736875|NCT01606709|Fertility Agents|fertility agents|mesh-ancestor
64736876|NCT01606709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64736877|NCT01606709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736878|NCT01606709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64736879|NCT01606709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736880|NCT00423059|Bevacizumab|bevacizumab|mesh-list
64736881|NCT00423059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64736882|NCT00423059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315581|NCT02135627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315582|NCT02135627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315583|NCT02135627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64315584|NCT02135627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64315585|NCT02135627|Autonomic Agents|autonomic agents|mesh-ancestor
64315593|NCT05613140|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64315594|NCT05613140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64315595|NCT05613140|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64348979|NCT00424099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64736883|NCT00423059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64736884|NCT00423059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64736885|NCT00423059|Growth Substances|growth substances|mesh-ancestor
64736886|NCT00423059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736887|NCT00423059|Growth Inhibitors|growth inhibitors|mesh-ancestor
64736888|NCT00585611|Atorvastatin|atorvastatin|mesh-list
64736889|NCT00585611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64736890|NCT00585611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64736891|NCT00585611|Antimetabolites|antimetabolites|mesh-ancestor
64321532|NCT02209831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321533|NCT01663532|Aripiprazole|aripiprazole|mesh-list
64321534|NCT01663532|Antidepressive Agents|antidepressive agents|mesh-ancestor
64321535|NCT01663532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64321536|NCT01663532|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64321537|NCT01663532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64315596|NCT05613140|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64315597|NCT05613140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315599|NCT05613062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64315600|NCT05613062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64315601|NCT05613062|Analgesics|analgesics|mesh-ancestor
64315602|NCT05613062|Sensory System Agents|sensory system agents|mesh-ancestor
64315603|NCT05613062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315604|NCT05613062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315605|NCT05613062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64315606|NCT05613062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64315607|NCT05614622|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64315609|NCT05614622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64315610|NCT05614622|Mydriatics|mydriatics|mesh-ancestor
64786087|NCT00001044|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64786088|NCT00001044|Immunologic Factors|immunologic factors|mesh-ancestor
64736892|NCT00585611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736893|NCT00585611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64736894|NCT00585611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64736895|NCT00585611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736896|NCT00379691|Phenylephrine|phenylephrine|mesh-list
64736897|NCT00379691|Oxymetazoline|oxymetazoline|mesh-list
64736898|NCT00379691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64736899|NCT00379691|Mydriatics|mydriatics|mesh-ancestor
64736900|NCT00379691|Autonomic Agents|autonomic agents|mesh-ancestor
64736901|NCT00379691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64736902|NCT00379691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736903|NCT00379691|Sympathomimetics|sympathomimetics|mesh-ancestor
64736904|NCT00379691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64736905|NCT00379691|Nasal Decongestants|nasal decongestants|mesh-ancestor
64736906|NCT00379691|Respiratory System Agents|respiratory system agents|mesh-ancestor
64736907|NCT00379691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64736908|NCT00379691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64736909|NCT00379691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64736910|NCT00379691|Adrenergic Agents|adrenergic agents|mesh-ancestor
64736911|NCT00379691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64736912|NCT00379691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736913|NCT00379691|Protective Agents|protective agents|mesh-ancestor
64736914|NCT01685333|Epoetin Alfa|epoetin alfa|mesh-list
64736915|NCT01685333|Hematinics|hematinics|mesh-ancestor
64736916|NCT01556009|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64348988|NCT01378429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64425799|NCT01639131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786089|NCT00001044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315611|NCT05614622|Autonomic Agents|autonomic agents|mesh-ancestor
64315612|NCT05614622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315613|NCT05614622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315614|NCT05614622|Parasympatholytics|parasympatholytics|mesh-ancestor
64315615|NCT05614622|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64315616|NCT05614622|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64315617|NCT05614622|Cholinergic Agents|cholinergic agents|mesh-ancestor
64315618|NCT05614622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64315619|NCT05614622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315620|NCT03548129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64315621|NCT03548129|Fosfomycin|fosfomycin|mesh-list
64315622|NCT03548129|Anti-Infective Agents|anti-infective agents|mesh-list
64315623|NCT02140073|Domperidone|domperidone|mesh-list
64315624|NCT02140073|Omeprazole|omeprazole|mesh-list
64315625|NCT02140073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64315626|NCT02140073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64315627|NCT02140073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64315628|NCT02140073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64315629|NCT02140073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315631|NCT02140073|Autonomic Agents|autonomic agents|mesh-ancestor
64315646|NCT05474690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64315647|NCT05474690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64315648|NCT05474690|Alkylating Agents|alkylating agents|mesh-ancestor
64736917|NCT01556009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64736918|NCT01556009|Dermatologic Agents|dermatologic agents|mesh-ancestor
64736919|NCT00546455|Fenretinide|fenretinide|mesh-list
64736920|NCT00546455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736921|NCT00546455|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64736922|NCT00546455|Protective Agents|protective agents|mesh-ancestor
64736923|NCT00546455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736924|NCT00000737|Megestrol|megestrol|mesh-list
64736925|NCT00000737|Megestrol Acetate|megestrol acetate|mesh-list
64736926|NCT00000737|Dronabinol|dronabinol|mesh-list
64736927|NCT00000737|Hallucinogens|hallucinogens|mesh-ancestor
64736928|NCT00000737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736929|NCT00000737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64736930|NCT00000737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64321539|NCT01663532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321540|NCT01663532|Dopamine Agonists|dopamine agonists|mesh-ancestor
64321541|NCT01663532|Dopamine Agents|dopamine agents|mesh-ancestor
64321542|NCT01663532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64321543|NCT01663532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321544|NCT01663532|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64321545|NCT01663532|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64321546|NCT01663532|Serotonin Agents|serotonin agents|mesh-ancestor
64321547|NCT01663532|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64321548|NCT01663532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64321549|NCT01663532|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64315649|NCT05474690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315650|NCT05474690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315651|NCT05474690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64315652|NCT05474690|Tubulin Modulators|tubulin modulators|mesh-ancestor
64315653|NCT05474690|Antimitotic Agents|antimitotic agents|mesh-ancestor
64315654|NCT05474690|Mitosis Modulators|mitosis modulators|mesh-ancestor
64315655|NCT05474690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64315656|NCT05474690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64375601|NCT02121262|Dexamethasone|dexamethasone|mesh-list
64736932|NCT00000737|Sensory System Agents|sensory system agents|mesh-ancestor
64736933|NCT00000737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64736934|NCT00000737|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64736935|NCT00000737|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64736936|NCT00000737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64736937|NCT00000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736938|NCT00000737|Hormones|hormones|mesh-ancestor
64736939|NCT00000737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64736940|NCT00000737|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64736941|NCT00000737|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64736942|NCT00000737|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64736943|NCT00000737|Contraceptive Agents|contraceptive agents|mesh-ancestor
64736944|NCT00000737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64349024|NCT04936399|Nivolumab|nivolumab|mesh-list
64321551|NCT02200315|Anti-Infective Agents|anti-infective agents|mesh-list
64321552|NCT02200315|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64321554|NCT05215106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64321555|NCT05215106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64786102|NCT00001068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786103|NCT00001068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786104|NCT00001068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315682|NCT03547895|Sofosbuvir|sofosbuvir|mesh-list
64315683|NCT03547895|Furosemide|furosemide|mesh-list
64315684|NCT03547895|Spironolactone|spironolactone|mesh-list
64315685|NCT03547895|Silymarin|silymarin|mesh-list
64315686|NCT03547895|Vitamins|vitamins|mesh-ancestor
64315687|NCT03547895|Micronutrients|micronutrients|mesh-ancestor
64315688|NCT03547895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315689|NCT03547895|Antimetabolites|antimetabolites|mesh-ancestor
64315690|NCT03547895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736945|NCT00000737|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64736946|NCT00000737|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64736947|NCT00000737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64736948|NCT00000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736949|NCT00000737|Appetite Stimulants|appetite stimulants|mesh-ancestor
64736950|NCT00000737|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64736951|NCT00528437|Carboplatin|carboplatin|mesh-list
64736952|NCT00528437|Temozolomide|temozolomide|mesh-list
64736953|NCT00528437|Thiotepa|thiotepa|mesh-list
64736954|NCT00528437|Tretinoin|tretinoin|mesh-list
64736955|NCT00528437|Isotretinoin|isotretinoin|mesh-list
64736956|NCT00528437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736957|NCT00528437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64736958|NCT00528437|Alkylating Agents|alkylating agents|mesh-ancestor
64736959|NCT00528437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736960|NCT00528437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64736961|NCT00528437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64349039|NCT02319161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64425928|NCT04586985|Anesthetics|anesthetics|mesh-ancestor
64315691|NCT03547895|Antiviral Agents|antiviral agents|mesh-ancestor
64315692|NCT03547895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64315693|NCT03547895|Diuretics|diuretics|mesh-ancestor
64315694|NCT03547895|Natriuretic Agents|natriuretic agents|mesh-ancestor
64315695|NCT03547895|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64315696|NCT03547895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64315698|NCT03547895|Hormone Antagonists|hormone antagonists|mesh-ancestor
64786106|NCT00001068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786107|NCT00001068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64736963|NCT00528437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736964|NCT00528437|Keratolytic Agents|keratolytic agents|mesh-ancestor
64736965|NCT00528437|Dermatologic Agents|dermatologic agents|mesh-ancestor
64736966|NCT00000743|Zidovudine|zidovudine|mesh-list
64736967|NCT00000743|Antimetabolites|antimetabolites|mesh-ancestor
64736968|NCT00000743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736969|NCT00000743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64736970|NCT00000743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64736971|NCT00000743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736972|NCT00000743|Antiviral Agents|antiviral agents|mesh-ancestor
64736973|NCT00000743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64736974|NCT00000743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64736975|NCT00000743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64736976|NCT00506909|Oxytocin|oxytocin|mesh-list
64736977|NCT00506909|Oxytocics|oxytocics|mesh-ancestor
64736978|NCT00506909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64476331|NCT00453388|Cyclosporine|cyclosporine|mesh-list
64736979|NCT00506909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736980|NCT00500045|Niacin|niacin|mesh-list
64786108|NCT00001068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786109|NCT00001080|Lamivudine|lamivudine|mesh-list
64786110|NCT00001080|Vaccines|vaccines|mesh-list
64786111|NCT00001080|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64315719|NCT01359254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64315720|NCT01359254|Alkylating Agents|alkylating agents|mesh-ancestor
64315721|NCT01359254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64315722|NCT05575739|Antioxidants|antioxidants|mesh-list
64315723|NCT05575739|Superoxide Dismutase|superoxide dismutase|mesh-list
64315724|NCT05575739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315725|NCT05575739|Protective Agents|protective agents|mesh-ancestor
64315726|NCT05575739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737012|NCT00428207|Insulin Aspart|insulin aspart|mesh-list
64737013|NCT00428207|Insulin, Long-Acting|insulin, long-acting|mesh-list
64737014|NCT00428207|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64737015|NCT00428207|Insulin Lispro|insulin lispro|mesh-list
64737016|NCT00428207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64737017|NCT00428207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737018|NCT00000791|Zidovudine|zidovudine|mesh-list
64737019|NCT00000791|Antimetabolites|antimetabolites|mesh-ancestor
64737020|NCT00000791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737021|NCT00000791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64737022|NCT00000791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64737023|NCT00000791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737028|NCT00379847|Conivaptan|conivaptan|mesh-list
64737041|NCT00374543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64737042|NCT00374543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64737043|NCT00374543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64737044|NCT00374543|Dopamine Agents|dopamine agents|mesh-ancestor
64737045|NCT00000803|Zidovudine|zidovudine|mesh-list
64737046|NCT00000803|Didanosine|didanosine|mesh-list
64737047|NCT00000803|Delavirdine|delavirdine|mesh-list
64737048|NCT00000803|Antimetabolites|antimetabolites|mesh-ancestor
64737049|NCT00000803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737050|NCT00000803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64737051|NCT00000803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64737052|NCT00000803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737053|NCT00000803|Antiviral Agents|antiviral agents|mesh-ancestor
64737054|NCT00000803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737055|NCT00000803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64737056|NCT00000803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64737057|NCT00299195|Sulindac|sulindac|mesh-list
64737058|NCT00299195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64315727|NCT05575739|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64315728|NCT05035862|Interferons|interferons|mesh-list
64315729|NCT05035862|Interferon-gamma|interferon-gamma|mesh-list
64786112|NCT00001080|Immunologic Factors|immunologic factors|mesh-ancestor
64786113|NCT00001080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786114|NCT00001080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786115|NCT00001080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786116|NCT00001080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786117|NCT00001080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786118|NCT00001080|Antiviral Agents|antiviral agents|mesh-ancestor
64315732|NCT05035862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64315733|NCT05035862|Glucocorticoids|glucocorticoids|mesh-ancestor
64315734|NCT05035862|Hormones|hormones|mesh-ancestor
64315735|NCT05035862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64321561|NCT02204683|Growth Inhibitors|growth inhibitors|mesh-ancestor
64321562|NCT02204683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64321563|NCT02204839|Insulin|insulin|mesh-list
64737060|NCT00299195|Analgesics|analgesics|mesh-ancestor
64737061|NCT00299195|Sensory System Agents|sensory system agents|mesh-ancestor
64737062|NCT00299195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737063|NCT00299195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737064|NCT00299195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64737065|NCT00299195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64737066|NCT00299195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64737067|NCT00299195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64737068|NCT00299195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737069|NCT00299195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737070|NCT01351415|Bevacizumab|bevacizumab|mesh-list
64737071|NCT01351415|Docetaxel|docetaxel|mesh-list
64737072|NCT01351415|Pemetrexed|pemetrexed|mesh-list
64321564|NCT02204839|Insulin Glargine|insulin glargine|mesh-list
64321565|NCT02204839|Insulin Detemir|insulin detemir|mesh-list
64321566|NCT02204839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64321567|NCT02204839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425951|NCT05244057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64315736|NCT05035862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315737|NCT05035862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64315743|NCT05035862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315744|NCT05035862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64315745|NCT05035862|Respiratory System Agents|respiratory system agents|mesh-ancestor
64315747|NCT05035862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64315748|NCT05035862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64315749|NCT05035862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64737073|NCT01351415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64737074|NCT01351415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64737075|NCT01351415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64737076|NCT01351415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64737077|NCT01351415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64737079|NCT01351415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737080|NCT01351415|Growth Inhibitors|growth inhibitors|mesh-ancestor
64737081|NCT01351415|Tubulin Modulators|tubulin modulators|mesh-ancestor
64737082|NCT01351415|Antimitotic Agents|antimitotic agents|mesh-ancestor
64737083|NCT01351415|Mitosis Modulators|mitosis modulators|mesh-ancestor
64737084|NCT01351415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737085|NCT01351415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737086|NCT01351415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64349170|NCT05398393|Tenofovir|tenofovir|mesh-list
64321568|NCT02209909|Aspirin|aspirin|mesh-list
64321569|NCT02209909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64321570|NCT02209909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64321571|NCT02209909|Analgesics|analgesics|mesh-ancestor
64321572|NCT02209909|Sensory System Agents|sensory system agents|mesh-ancestor
64321573|NCT02209909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321574|NCT02209909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321575|NCT02209909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64321576|NCT02209909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64321577|NCT02209909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64425997|NCT04411329|Dexamethasone|dexamethasone|mesh-list
64425998|NCT04411329|Dexmedetomidine|dexmedetomidine|mesh-list
64425999|NCT04411329|Bupivacaine|bupivacaine|mesh-list
64426000|NCT04411329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64426001|NCT04411329|Antiemetics|antiemetics|mesh-ancestor
64315751|NCT05035862|Adrenergic Agents|adrenergic agents|mesh-ancestor
64315752|NCT05035862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64315761|NCT03549221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315762|NCT03549221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315763|NCT03549221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64315786|NCT05013632|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64315787|NCT05013632|Immunologic Factors|immunologic factors|mesh-ancestor
64315788|NCT05013632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315789|NCT05013632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64315790|NCT05013632|Antimetabolites|antimetabolites|mesh-ancestor
64315791|NCT05013632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315793|NCT05614544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64315794|NCT05614544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64315795|NCT05614544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315796|NCT05614544|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64375866|NCT04897269|Progesterone|progesterone|mesh-list
64786140|NCT00001122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786141|NCT00001122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786142|NCT00001122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786143|NCT00001122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349181|NCT05398393|Antiviral Agents|antiviral agents|mesh-ancestor
64737087|NCT01351415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64737088|NCT01351415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64737089|NCT00281879|Cytarabine|cytarabine|mesh-list
64737090|NCT00281879|Cyclosporine|cyclosporine|mesh-list
64737091|NCT00281879|Mycophenolic Acid|mycophenolic acid|mesh-list
64737092|NCT00281879|Methylprednisolone|methylprednisolone|mesh-list
64737093|NCT00281879|Cyclophosphamide|cyclophosphamide|mesh-list
64737094|NCT00281879|Melphalan|melphalan|mesh-list
64737095|NCT00281879|Busulfan|busulfan|mesh-list
64737096|NCT00281879|Carmustine|carmustine|mesh-list
64737097|NCT00281879|Methotrexate|methotrexate|mesh-list
64737098|NCT00281879|Fludarabine|fludarabine|mesh-list
64737099|NCT00281879|Fludarabine phosphate|fludarabine phosphate|mesh-list
64737100|NCT00281879|Etoposide|etoposide|mesh-list
64737101|NCT00281879|Tacrolimus|tacrolimus|mesh-list
64737102|NCT00281879|Cyclosporins|cyclosporins|mesh-list
64737103|NCT00281879|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64737104|NCT00281879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64737105|NCT00281879|Immunologic Factors|immunologic factors|mesh-ancestor
64321580|NCT02209909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64426007|NCT04411329|Hormones|hormones|mesh-ancestor
64321581|NCT02209909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64315802|NCT05185505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315803|NCT05185505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64315804|NCT05185505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64315805|NCT05185505|Growth Substances|growth substances|mesh-ancestor
64315806|NCT05185505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315807|NCT05185505|Growth Inhibitors|growth inhibitors|mesh-ancestor
64315808|NCT01667432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64315809|NCT01667432|Antiviral Agents|antiviral agents|mesh-ancestor
64321583|NCT02209909|Antipyretics|antipyretics|mesh-ancestor
64321584|NCT02209987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64321585|NCT02209987|Immunologic Factors|immunologic factors|mesh-ancestor
64321586|NCT02209987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321588|NCT02205151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64737106|NCT00281879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737107|NCT00281879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64737108|NCT00281879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64737109|NCT00281879|Alkylating Agents|alkylating agents|mesh-ancestor
64737110|NCT00281879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426207|NCT02817633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64321589|NCT02205151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64426208|NCT02817633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64315816|NCT05575271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315817|NCT05575271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315819|NCT05575271|Autonomic Agents|autonomic agents|mesh-ancestor
64315820|NCT05575271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315821|NCT05575271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64315822|NCT04750460|Teriparatide|teriparatide|mesh-list
64315823|NCT04750460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64315824|NCT04750460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315825|NCT04750460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64321590|NCT02205151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64321591|NCT02205151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737111|NCT00281879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64737112|NCT00281879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64737113|NCT00281879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64737114|NCT00281879|Abortifacient Agents|abortifacient agents|mesh-ancestor
64737115|NCT00281879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64737116|NCT00281879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64737117|NCT00281879|Antimetabolites|antimetabolites|mesh-ancestor
64737118|NCT00281879|Dermatologic Agents|dermatologic agents|mesh-ancestor
64737119|NCT00281879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737120|NCT00281879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64737121|NCT00281879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64737122|NCT00281879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64737123|NCT00281879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64737124|NCT00281879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64737125|NCT00281879|Antiviral Agents|antiviral agents|mesh-ancestor
64737126|NCT00281879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737127|NCT00281879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64737128|NCT00281879|Antifungal Agents|antifungal agents|mesh-ancestor
64349208|NCT05164627|Magnesium Sulfate|magnesium sulfate|mesh-list
64426263|NCT03905889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426264|NCT04804059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64426265|NCT02527707|Ritonavir|ritonavir|mesh-list
64426266|NCT02527707|Lonafarnib|lonafarnib|mesh-list
64426272|NCT02527707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64426326|NCT03846765|Protective Agents|protective agents|mesh-ancestor
64426327|NCT03846765|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64426328|NCT03846765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64315826|NCT05575037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64315827|NCT05575037|Immunologic Factors|immunologic factors|mesh-ancestor
64315869|NCT04787510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64315870|NCT04787510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64315871|NCT04787510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315872|NCT05424263|Calcium, Dietary|calcium, dietary|mesh-list
64786150|NCT00001122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64786151|NCT00001122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64786152|NCT00001122|Antimetabolites|antimetabolites|mesh-ancestor
64786153|NCT00001122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786154|NCT00001122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64737129|NCT00281879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64737130|NCT00281879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64737131|NCT00281879|Antitubercular Agents|antitubercular agents|mesh-ancestor
64737132|NCT00281879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64737133|NCT00281879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64737134|NCT00281879|Antiemetics|antiemetics|mesh-ancestor
64737135|NCT00281879|Autonomic Agents|autonomic agents|mesh-ancestor
64737136|NCT00281879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737137|NCT00281879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64737138|NCT00281879|Glucocorticoids|glucocorticoids|mesh-ancestor
64737139|NCT00281879|Hormones|hormones|mesh-ancestor
64737140|NCT00281879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64737141|NCT00281879|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64737142|NCT00281879|Protective Agents|protective agents|mesh-ancestor
64737143|NCT00000809|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64737144|NCT00000809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64737145|NCT00000809|Immunologic Factors|immunologic factors|mesh-ancestor
64737146|NCT00000809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737147|NCT00000809|Antacids|antacids|mesh-ancestor
64737148|NCT00000809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737150|NCT05091203|Vitamin D|vitamin d|mesh-list
64786155|NCT00001122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64786156|NCT00001122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64786157|NCT00001122|Protease Inhibitors|protease inhibitors|mesh-ancestor
64786159|NCT00001128|Paromomycin|paromomycin|mesh-list
64786160|NCT00001128|Interleukin-12|interleukin-12|mesh-list
64786161|NCT00001128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64786162|NCT00001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786163|NCT00001128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64786164|NCT00001128|Immunologic Factors|immunologic factors|mesh-ancestor
64315900|NCT05398757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315901|NCT05398757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64315904|NCT05398757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737172|NCT00205049|Vasodilator Agents|vasodilator agents|mesh-ancestor
64737173|NCT00205049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64737174|NCT00205049|Antioxidants|antioxidants|mesh-ancestor
64321592|NCT02205151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64321594|NCT02205151|Vasodilator Agents|vasodilator agents|mesh-ancestor
64321595|NCT05262985|Durvalumab|durvalumab|mesh-list
64321596|NCT05262985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64321597|NCT05262985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64321598|NCT05504720|Pembrolizumab|pembrolizumab|mesh-list
64426339|NCT02311179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64737175|NCT00000833|Ribavirin|ribavirin|mesh-list
64737176|NCT00000833|Didanosine|didanosine|mesh-list
64737177|NCT00000833|Antimetabolites|antimetabolites|mesh-ancestor
64737178|NCT00000833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737179|NCT00000833|Antiviral Agents|antiviral agents|mesh-ancestor
64737180|NCT00000833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737181|NCT00000833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64737182|NCT00000833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64737183|NCT00000833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737184|NCT00000833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64737185|NCT00000833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64737186|NCT00000839|Didanosine|didanosine|mesh-list
64737187|NCT00000839|Antimetabolites|antimetabolites|mesh-ancestor
64737188|NCT00000839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737189|NCT00000839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64737190|NCT00000839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64737191|NCT00000839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737192|NCT00000839|Antiviral Agents|antiviral agents|mesh-ancestor
64737193|NCT00000839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737194|NCT00000839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64315905|NCT05398757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64315906|NCT05398757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64315908|NCT05398757|Adrenergic Agents|adrenergic agents|mesh-ancestor
64315910|NCT04787276|Lactulose|lactulose|mesh-list
64315911|NCT04787276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64315921|NCT01564979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64315922|NCT01564979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315923|NCT01564979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64315924|NCT01564979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315925|NCT04618016|Vitamins|vitamins|mesh-list
64315926|NCT04618016|Vitamin E|vitamin e|mesh-list
64315927|NCT04618016|Tocopherols|tocopherols|mesh-list
64315928|NCT04618016|Tocotrienols|tocotrienols|mesh-list
64315929|NCT04618016|alpha-Tocopherol|alpha-tocopherol|mesh-list
64315930|NCT04618016|Micronutrients|micronutrients|mesh-ancestor
64315931|NCT04618016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315932|NCT04618016|Antioxidants|antioxidants|mesh-ancestor
64315933|NCT04618016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315934|NCT04618016|Protective Agents|protective agents|mesh-ancestor
64315935|NCT05612594|Ertugliflozin|ertugliflozin|mesh-list
64315936|NCT05612594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64315937|NCT05612594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315938|NCT05612594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64376153|NCT04886193|Protective Agents|protective agents|mesh-ancestor
64315939|NCT05612594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376158|NCT04337073|Propofol|propofol|mesh-list
64315960|NCT04429022|Oxycodone|oxycodone|mesh-list
64315961|NCT04429022|Gabapentin|gabapentin|mesh-list
64315962|NCT04429022|Hydromorphone|hydromorphone|mesh-list
64315963|NCT04429022|Ropivacaine|ropivacaine|mesh-list
64315964|NCT04429022|Anesthetics, Local|anesthetics, local|mesh-list
64315965|NCT04429022|Anesthetics|anesthetics|mesh-list
64315968|NCT04429022|Sensory System Agents|sensory system agents|mesh-ancestor
64315969|NCT04429022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315970|NCT04429022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64315971|NCT04429022|Analgesics|analgesics|mesh-ancestor
64315972|NCT04429022|Antipyretics|antipyretics|mesh-ancestor
64315973|NCT04429022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64315985|NCT04429022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64315986|NCT04429022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64315987|NCT04429022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64315988|NCT04429022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64315989|NCT04429022|Antimanic Agents|antimanic agents|mesh-ancestor
64315990|NCT02253485|Telbivudine|telbivudine|mesh-list
64315991|NCT02253485|Antiviral Agents|antiviral agents|mesh-ancestor
64315992|NCT02253485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64315993|NCT02253485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64737195|NCT00000839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64737196|NCT00133679|Sildenafil Citrate|sildenafil citrate|mesh-list
64737197|NCT00133679|Vasodilator Agents|vasodilator agents|mesh-ancestor
64737198|NCT00133679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64737199|NCT00133679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64737200|NCT00133679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737201|NCT00133679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737202|NCT00133679|Urological Agents|urological agents|mesh-ancestor
64737203|NCT00000875|Acetaminophen|acetaminophen|mesh-list
64315994|NCT02253485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64315995|NCT02253485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315996|NCT05612516|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64315997|NCT05612516|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64315998|NCT05612516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64315999|NCT05700812|Levonorgestrel|levonorgestrel|mesh-list
64316000|NCT05700812|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64316001|NCT05700812|Contraceptive Agents|contraceptive agents|mesh-ancestor
64316032|NCT05556122|Betamethasone|betamethasone|mesh-list
64316033|NCT05556122|Ropivacaine|ropivacaine|mesh-list
64316034|NCT05556122|Anesthetics, Local|anesthetics, local|mesh-ancestor
64316035|NCT05556122|Anesthetics|anesthetics|mesh-ancestor
64316036|NCT05556122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64316037|NCT05556122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316039|NCT05556122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316040|NCT05556122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64316041|NCT05556122|Glucocorticoids|glucocorticoids|mesh-ancestor
64316042|NCT05556122|Hormones|hormones|mesh-ancestor
64316046|NCT05611268|Pentoxifylline|pentoxifylline|mesh-list
64316047|NCT05611268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64316048|NCT05611268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316049|NCT05611268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316050|NCT05611268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64316052|NCT05611268|Protective Agents|protective agents|mesh-ancestor
64316053|NCT05611268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316054|NCT05611268|Vasodilator Agents|vasodilator agents|mesh-ancestor
64316055|NCT05611268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64316056|NCT05611268|Antioxidants|antioxidants|mesh-ancestor
64316057|NCT05549570|Metformin|metformin|mesh-list
64316058|NCT05549570|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64316059|NCT05549570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64316060|NCT05549570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316061|NCT05549570|Incretins|incretins|mesh-ancestor
64316062|NCT05549570|Hormones|hormones|mesh-ancestor
64737213|NCT00000875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737214|NCT00000875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737215|NCT00000875|Antipyretics|antipyretics|mesh-ancestor
64316063|NCT05549570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64316064|NCT05549570|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64316065|NCT05549570|Protease Inhibitors|protease inhibitors|mesh-ancestor
64416682|NCT01668667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786191|NCT00001428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64786192|NCT00001428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64737250|NCT04941833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737251|NCT04941833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64737252|NCT04941833|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64737253|NCT04941833|Progestins|progestins|mesh-ancestor
64737254|NCT04941833|Hormones|hormones|mesh-ancestor
64737255|NCT04941833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64737256|NCT04841369|Vaccines|vaccines|mesh-list
64737257|NCT04841369|Immunologic Factors|immunologic factors|mesh-ancestor
64737258|NCT04841369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737259|NCT00002975|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64737260|NCT00002975|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64737261|NCT00002975|Dermatologic Agents|dermatologic agents|mesh-ancestor
64321602|NCT04476992|Nitric Oxide|nitric oxide|mesh-list
64321603|NCT04476992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64321604|NCT04476992|Autonomic Agents|autonomic agents|mesh-ancestor
64321605|NCT04476992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321612|NCT04476992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64321613|NCT04476992|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64321615|NCT04476992|Gasotransmitters|gasotransmitters|mesh-ancestor
64321616|NCT04476992|Protective Agents|protective agents|mesh-ancestor
64321617|NCT02220673|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
64321618|NCT02220673|Antioxidants|antioxidants|mesh-ancestor
64321619|NCT02220673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737262|NCT00521885|Enoxaparin|enoxaparin|mesh-list
64737263|NCT00521885|Fondaparinux|fondaparinux|mesh-list
64737264|NCT00521885|Anticoagulants|anticoagulants|mesh-ancestor
64737265|NCT00521885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64737266|NCT00521885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64786193|NCT00001428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64316066|NCT05549570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316067|NCT05549570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316068|NCT05549492|Buprenorphine|buprenorphine|mesh-list
64316069|NCT05549492|Ropivacaine|ropivacaine|mesh-list
64316070|NCT05549492|Anesthetics, Local|anesthetics, local|mesh-ancestor
64316071|NCT05549492|Anesthetics|anesthetics|mesh-ancestor
64316072|NCT05549492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64316073|NCT05549492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316074|NCT05549492|Sensory System Agents|sensory system agents|mesh-ancestor
64316075|NCT05549492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316076|NCT05549492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64737279|NCT00000881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64737280|NCT00000881|Renal Agents|renal agents|mesh-ancestor
64737281|NCT00000881|Antiviral Agents|antiviral agents|mesh-ancestor
64737282|NCT00000881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737283|NCT00000881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737284|NCT00000881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737285|NCT00000887|Lamivudine|lamivudine|mesh-list
64737286|NCT00000887|Zidovudine|zidovudine|mesh-list
64737287|NCT00000887|Nelfinavir|nelfinavir|mesh-list
64737288|NCT00000887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64737289|NCT00000887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64737291|NCT00000887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737292|NCT00000887|Antiviral Agents|antiviral agents|mesh-ancestor
64737293|NCT00000887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737294|NCT00000887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64737295|NCT00000887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64737296|NCT00000887|Antimetabolites|antimetabolites|mesh-ancestor
64737297|NCT00000887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64737298|NCT00000887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64737299|NCT00000887|Protease Inhibitors|protease inhibitors|mesh-ancestor
64737300|NCT04755647|Nitric Oxide|nitric oxide|mesh-list
64737301|NCT04755647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64737302|NCT04755647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64349376|NCT02323529|Nitisinone|nitisinone|mesh-list
64321621|NCT02220673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316077|NCT05549492|Narcotics|narcotics|mesh-ancestor
64316078|NCT05549492|Analgesics|analgesics|mesh-ancestor
64316079|NCT05549492|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64316080|NCT04331132|Tolvaptan|tolvaptan|mesh-list
64316081|NCT04331132|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64316082|NCT04331132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316083|NCT04331132|Natriuretic Agents|natriuretic agents|mesh-ancestor
64316084|NCT04331132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376486|NCT04864509|Protective Agents|protective agents|mesh-ancestor
64316120|NCT04434560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64376588|NCT03226145|Bisacodyl|bisacodyl|mesh-list
64316126|NCT05700656|Antimetabolites|antimetabolites|mesh-ancestor
64316127|NCT05700656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316128|NCT05700656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316129|NCT00103285|Calcium, Dietary|calcium, dietary|mesh-list
64786198|NCT00001440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64786199|NCT00001440|Analgesics|analgesics|mesh-ancestor
64786200|NCT00001440|Sensory System Agents|sensory system agents|mesh-ancestor
64786201|NCT00001440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321623|NCT05499572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64321624|NCT05499572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64321625|NCT02220751|Doxycycline|doxycycline|mesh-list
64321626|NCT02220751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64737303|NCT04755647|Autonomic Agents|autonomic agents|mesh-ancestor
64737304|NCT04755647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737305|NCT04755647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737306|NCT04755647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64737307|NCT04755647|Respiratory System Agents|respiratory system agents|mesh-ancestor
64737308|NCT04755647|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64737309|NCT04755647|Antioxidants|antioxidants|mesh-ancestor
64737310|NCT04755647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737311|NCT04755647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64737312|NCT04755647|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64737313|NCT04755647|Vasodilator Agents|vasodilator agents|mesh-ancestor
64737314|NCT04755647|Gasotransmitters|gasotransmitters|mesh-ancestor
64737315|NCT04755647|Protective Agents|protective agents|mesh-ancestor
64737316|NCT04716725|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64737317|NCT04716725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64737318|NCT04716725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737319|NCT00000119|Heparin|heparin|mesh-list
64737320|NCT00000119|Anticoagulants|anticoagulants|mesh-ancestor
64737321|NCT00000119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64737322|NCT00000119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64737323|NCT00000119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786202|NCT00001440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786203|NCT00001446|Thalidomide|thalidomide|mesh-list
64786204|NCT00001446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64324735|NCT05478356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64324736|NCT05478356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64316132|NCT00103285|Cytarabine|cytarabine|mesh-list
64316133|NCT00103285|Dexamethasone|dexamethasone|mesh-list
64316134|NCT00103285|Dexamethasone acetate|dexamethasone acetate|mesh-list
64316135|NCT00103285|Cyclophosphamide|cyclophosphamide|mesh-list
64316136|NCT00103285|Doxorubicin|doxorubicin|mesh-list
64316137|NCT00103285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64316138|NCT00103285|Methotrexate|methotrexate|mesh-list
64737330|NCT00000923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64737331|NCT00000923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64737332|NCT00000923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737333|NCT00000923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737334|NCT00000923|Antiviral Agents|antiviral agents|mesh-ancestor
64737335|NCT00000923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737336|NCT00000923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64737337|NCT00000923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64737338|NCT00000923|Antimetabolites|antimetabolites|mesh-ancestor
64737339|NCT00000923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64737340|NCT00000923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64737341|NCT00000923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64737342|NCT00000923|Protease Inhibitors|protease inhibitors|mesh-ancestor
64737343|NCT00000161|Aspirin|aspirin|mesh-list
64737344|NCT00000161|Vitamins|vitamins|mesh-list
64737345|NCT00000161|Vitamin E|vitamin e|mesh-list
64737346|NCT00000161|Beta Carotene|beta carotene|mesh-list
64737347|NCT00000161|Carotenoids|carotenoids|mesh-list
64737348|NCT00000161|Micronutrients|micronutrients|mesh-ancestor
64737349|NCT00000161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737350|NCT00000161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64737351|NCT00000161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64737352|NCT00000161|Analgesics|analgesics|mesh-ancestor
64737353|NCT00000161|Sensory System Agents|sensory system agents|mesh-ancestor
64737354|NCT00000161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737355|NCT00000161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64316139|NCT00103285|Vincristine|vincristine|mesh-list
64316140|NCT00103285|Asparaginase|asparaginase|mesh-list
64316141|NCT00103285|Mercaptopurine|mercaptopurine|mesh-list
64316142|NCT00103285|Pegaspargase|pegaspargase|mesh-list
64316143|NCT00103285|Thioguanine|thioguanine|mesh-list
64316144|NCT00103285|BB 1101|bb 1101|mesh-list
64316145|NCT00103285|Calcium|calcium|mesh-list
64316146|NCT00103285|2-Aminopurine|2-aminopurine|mesh-list
64316147|NCT00103285|Levoleucovorin|levoleucovorin|mesh-list
64316148|NCT00103285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64316149|NCT00103285|Immunologic Factors|immunologic factors|mesh-ancestor
64316150|NCT00103285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737360|NCT00000161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64737361|NCT00000161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64737362|NCT00000161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737363|NCT00000161|Antipyretics|antipyretics|mesh-ancestor
64737364|NCT00000161|Antioxidants|antioxidants|mesh-ancestor
64737365|NCT00000161|Protective Agents|protective agents|mesh-ancestor
64737366|NCT00000161|Provitamins|provitamins|mesh-ancestor
64737368|NCT00000929|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
64737369|NCT00000929|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
64737370|NCT00000929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737371|NCT00000929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64737372|NCT00000929|Contraceptive Agents|contraceptive agents|mesh-ancestor
64737373|NCT00000929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64737374|NCT00000929|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64737375|NCT00000935|Immunoglobulins|immunoglobulins|mesh-list
64737376|NCT00000935|Antibodies|antibodies|mesh-list
64737377|NCT00000935|gamma-Globulins|gamma-globulins|mesh-list
64737378|NCT00000935|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64737379|NCT00000935|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64737380|NCT00000935|Immunologic Factors|immunologic factors|mesh-ancestor
64737381|NCT00000935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737382|NCT00000197|Propranolol|propranolol|mesh-list
64737383|NCT00000197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64737384|NCT00000197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64376632|NCT02453009|Docetaxel|docetaxel|mesh-list
64316231|NCT02160223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316232|NCT02160223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316233|NCT02160223|Cholinergic Agents|cholinergic agents|mesh-ancestor
64316234|NCT02160223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64316235|NCT02160223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316236|NCT02160223|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64316238|NCT02160223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316240|NCT04802837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64316241|NCT04802837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737403|NCT00000203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64737404|NCT00000209|Buprenorphine|buprenorphine|mesh-list
64737405|NCT00000209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64737406|NCT00000209|Narcotics|narcotics|mesh-ancestor
64737407|NCT00000209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64349486|NCT04034459|Vitamins|vitamins|mesh-ancestor
64321639|NCT02205619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321640|NCT02205619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321642|NCT05504330|Clopidogrel|clopidogrel|mesh-list
64321643|NCT05504330|Atorvastatin|atorvastatin|mesh-list
64321644|NCT05504330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64321645|NCT05504330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64321646|NCT05504330|Analgesics|analgesics|mesh-ancestor
64321647|NCT05504330|Sensory System Agents|sensory system agents|mesh-ancestor
64321648|NCT05504330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321649|NCT05504330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321650|NCT05504330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64321651|NCT05504330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64321652|NCT05504330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64321653|NCT05504330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64737408|NCT00000209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737410|NCT00000209|Sensory System Agents|sensory system agents|mesh-ancestor
64737411|NCT00000209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737412|NCT00000209|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64737413|NCT00000215|Pergolide|pergolide|mesh-list
64737414|NCT00000215|Dopamine Agonists|dopamine agonists|mesh-ancestor
64737415|NCT00000215|Dopamine Agents|dopamine agents|mesh-ancestor
64737416|NCT00000215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64737417|NCT00000215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737419|NCT00000953|Acyclovir|acyclovir|mesh-list
64316242|NCT05256797|Rivaroxaban|rivaroxaban|mesh-list
64316243|NCT05256797|Apixaban|apixaban|mesh-list
64786210|NCT00001446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64786211|NCT00001446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64786212|NCT00001446|Growth Substances|growth substances|mesh-ancestor
64316287|NCT02160301|Antimanic Agents|antimanic agents|mesh-ancestor
64316288|NCT03541759|Hydromorphone|hydromorphone|mesh-list
64316289|NCT03541759|Pirinitramide|pirinitramide|mesh-list
64316290|NCT03541759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64316291|NCT03541759|Narcotics|narcotics|mesh-ancestor
64321654|NCT05504330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321655|NCT05504330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64737424|NCT00000953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737425|NCT00000983|Zidovudine|zidovudine|mesh-list
64737426|NCT00000983|Antimetabolites|antimetabolites|mesh-ancestor
64737427|NCT00000983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737428|NCT00000983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64737429|NCT00000983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64737430|NCT00000983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737431|NCT00000983|Antiviral Agents|antiviral agents|mesh-ancestor
64737432|NCT00000983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737433|NCT00000983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64737434|NCT00000983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64737435|NCT00000227|Buprenorphine|buprenorphine|mesh-list
64737436|NCT00000227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64737437|NCT00000227|Narcotics|narcotics|mesh-ancestor
64737438|NCT00000227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64737439|NCT00000227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737440|NCT00000227|Analgesics|analgesics|mesh-ancestor
64349514|NCT02736409|Budesonide|budesonide|mesh-list
64426772|NCT02233803|Budesonide|budesonide|mesh-list
64316292|NCT03541759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64316293|NCT03541759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316294|NCT03541759|Analgesics|analgesics|mesh-ancestor
64316295|NCT03541759|Sensory System Agents|sensory system agents|mesh-ancestor
64316296|NCT03541759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316297|NCT05206955|Tadalafil|tadalafil|mesh-list
64316298|NCT05206955|Vasodilator Agents|vasodilator agents|mesh-ancestor
64316299|NCT05206955|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64316300|NCT05206955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64316301|NCT05206955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737441|NCT00000227|Sensory System Agents|sensory system agents|mesh-ancestor
64737442|NCT00000227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737444|NCT00000233|Buprenorphine|buprenorphine|mesh-list
64737445|NCT00000233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64737446|NCT00000233|Narcotics|narcotics|mesh-ancestor
64737447|NCT00000233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64737448|NCT00000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737449|NCT00000233|Analgesics|analgesics|mesh-ancestor
64737450|NCT00000233|Sensory System Agents|sensory system agents|mesh-ancestor
64737451|NCT00000233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737452|NCT00000233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64737453|NCT00000239|Buprenorphine|buprenorphine|mesh-list
64737454|NCT00000239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64737455|NCT00000239|Narcotics|narcotics|mesh-ancestor
64737456|NCT00000239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64737457|NCT00000239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737458|NCT00000239|Analgesics|analgesics|mesh-ancestor
64737459|NCT00000239|Sensory System Agents|sensory system agents|mesh-ancestor
64349532|NCT05131867|Nimodipine|nimodipine|mesh-list
64321662|NCT05504330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64321663|NCT05504330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64321664|NCT05504330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64321675|NCT02220829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321676|NCT02220829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321677|NCT02220829|Urological Agents|urological agents|mesh-ancestor
64321679|NCT02525939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64737460|NCT00000239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737461|NCT00000239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64737463|NCT00000245|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64316302|NCT05206955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316303|NCT05206955|Urological Agents|urological agents|mesh-ancestor
64316304|NCT05159453|Insulin|insulin|mesh-list
64316305|NCT05159453|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64316306|NCT05159453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64316307|NCT05159453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316308|NCT01666652|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64316309|NCT01666652|Aluminum sulfate|aluminum sulfate|mesh-list
64316328|NCT05174585|Immunologic Factors|immunologic factors|mesh-ancestor
64737468|NCT00000245|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64737469|NCT00000245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64737470|NCT00000245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64737471|NCT00000245|Adrenergic Agents|adrenergic agents|mesh-ancestor
64737472|NCT00000245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64737473|NCT00000245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737474|NCT00000263|Ethanol|ethanol|mesh-list
64737475|NCT00000263|Nitrous Oxide|nitrous oxide|mesh-list
64737476|NCT00000263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64737477|NCT00000263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737478|NCT00000263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64737479|NCT00000263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737480|NCT00000263|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64737481|NCT00000263|Anesthetics, General|anesthetics, general|mesh-ancestor
64737482|NCT00000263|Anesthetics|anesthetics|mesh-ancestor
64737483|NCT00000263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64737484|NCT00000263|Analgesics|analgesics|mesh-ancestor
64737485|NCT00000263|Sensory System Agents|sensory system agents|mesh-ancestor
64737486|NCT00000263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737487|NCT00000269|Pergolide|pergolide|mesh-list
64737488|NCT00000269|Dopamine Agonists|dopamine agonists|mesh-ancestor
64737489|NCT00000269|Dopamine Agents|dopamine agents|mesh-ancestor
64737490|NCT00000269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64316329|NCT05174585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316330|NCT05174585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316332|NCT04428086|Apatinib|apatinib|mesh-list
64316333|NCT04428086|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64316334|NCT04428086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64316335|NCT04428086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316336|NCT04428086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64316337|NCT04428086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64349572|NCT04952857|Cholecalciferol|cholecalciferol|mesh-list
64321680|NCT02525939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64321681|NCT02525939|Antimetabolites|antimetabolites|mesh-ancestor
64321682|NCT02525939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321683|NCT02525939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64321684|NCT02215213|Vitamin D|vitamin d|mesh-list
64321685|NCT02215213|Ergocalciferols|ergocalciferols|mesh-list
64321686|NCT02215213|Cholecalciferol|cholecalciferol|mesh-list
64321687|NCT02215213|Vitamins|vitamins|mesh-list
64737511|NCT00000989|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64737512|NCT00000989|Sargramostim|sargramostim|mesh-list
64737513|NCT00000989|Antimetabolites|antimetabolites|mesh-ancestor
64737514|NCT00000989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737515|NCT00000989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64737516|NCT00000989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64737517|NCT00000989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737518|NCT00000989|Antiviral Agents|antiviral agents|mesh-ancestor
64737519|NCT00000989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737520|NCT00000989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64737521|NCT00000989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64737522|NCT00000989|Immunologic Factors|immunologic factors|mesh-ancestor
64737523|NCT00000989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737524|NCT03617705|Ethanol|ethanol|mesh-list
64737525|NCT03617705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64737526|NCT03617705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737527|NCT03617705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64737528|NCT03617705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737529|NCT00000995|Zidovudine|zidovudine|mesh-list
64737530|NCT00000995|Ganciclovir|ganciclovir|mesh-list
64737531|NCT00000995|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64737532|NCT00000995|Antimetabolites|antimetabolites|mesh-ancestor
64316338|NCT04428086|Antimetabolites|antimetabolites|mesh-ancestor
64316339|NCT04428086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316340|NCT04428086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64316341|NCT04428086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64316342|NCT04428086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316343|NCT04428086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316344|NCT04428086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64316345|NCT05132231|Brodalumab|brodalumab|mesh-list
64316346|NCT05132231|Dermatologic Agents|dermatologic agents|mesh-ancestor
64316347|NCT05125055|Paclitaxel|paclitaxel|mesh-list
64316348|NCT05125055|Docetaxel|docetaxel|mesh-list
64316349|NCT05125055|Fluorouracil|fluorouracil|mesh-list
64316350|NCT05125055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64316351|NCT05125055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316352|NCT05125055|Tubulin Modulators|tubulin modulators|mesh-ancestor
64316353|NCT05125055|Antimitotic Agents|antimitotic agents|mesh-ancestor
64316354|NCT05125055|Mitosis Modulators|mitosis modulators|mesh-ancestor
64316355|NCT05125055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316356|NCT05125055|Antimetabolites|antimetabolites|mesh-ancestor
64316357|NCT05125055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64316377|NCT05610956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737608|NCT00000275|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
64737609|NCT00000275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64737610|NCT00000275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64737611|NCT00000275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64737612|NCT00000275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737616|NCT00000275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64737617|NCT00000275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737618|NCT00001061|Ganciclovir|ganciclovir|mesh-list
64737619|NCT00001061|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64737620|NCT00001061|Foscarnet|foscarnet|mesh-list
64737621|NCT00001061|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
64737622|NCT00001061|Antiviral Agents|antiviral agents|mesh-ancestor
64737623|NCT00001061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737624|NCT00001061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64737625|NCT00001061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737626|NCT00001061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737627|NCT00001061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64737628|NCT00000281|Amantadine|amantadine|mesh-list
64737629|NCT00000281|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64321689|NCT02215213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321698|NCT05564546|Respiratory System Agents|respiratory system agents|mesh-ancestor
64321700|NCT05564546|Antioxidants|antioxidants|mesh-ancestor
64321701|NCT05564546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321702|NCT05564546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64321703|NCT05564546|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64737630|NCT00000281|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64737631|NCT00000281|Antiviral Agents|antiviral agents|mesh-ancestor
64737632|NCT00000281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737633|NCT00000281|Dopamine Agents|dopamine agents|mesh-ancestor
64316378|NCT05610956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64316379|NCT05610956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316380|NCT00109733|Hormones|hormones|mesh-list
64316381|NCT00109733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64316382|NCT00109733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316383|NCT05699876|Gabapentin|gabapentin|mesh-list
64316384|NCT05699876|Melatonin|melatonin|mesh-list
64316385|NCT05699876|Analgesics|analgesics|mesh-ancestor
64316386|NCT05699876|Sensory System Agents|sensory system agents|mesh-ancestor
64316387|NCT05699876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737634|NCT00000281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64737635|NCT00000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737636|NCT00000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737637|NCT00000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64737638|NCT00000281|Analgesics|analgesics|mesh-ancestor
64737639|NCT00000281|Sensory System Agents|sensory system agents|mesh-ancestor
64737640|NCT00000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737641|NCT00001067|Lamivudine|lamivudine|mesh-list
64737642|NCT00001067|Zidovudine|zidovudine|mesh-list
64737643|NCT00001067|Stavudine|stavudine|mesh-list
64737644|NCT00001067|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64737645|NCT00001067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64737646|NCT00001067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737647|NCT00001067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737648|NCT00001067|Antiviral Agents|antiviral agents|mesh-ancestor
64737654|NCT00001079|Megestrol|megestrol|mesh-list
64316388|NCT05699876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316389|NCT05699876|Anticonvulsants|anticonvulsants|mesh-ancestor
64786216|NCT00001572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64786217|NCT00001572|Immunologic Factors|immunologic factors|mesh-ancestor
64786218|NCT00001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786220|NCT00001626|Cyclophosphamide|cyclophosphamide|mesh-list
64786221|NCT00001626|Cyclosporins|cyclosporins|mesh-list
64786222|NCT00001626|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64316404|NCT05610878|Analgesics|analgesics|mesh-ancestor
64316405|NCT05610878|Sensory System Agents|sensory system agents|mesh-ancestor
64316406|NCT05610878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316407|NCT05610878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316408|NCT05610878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64316409|NCT05610878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64316410|NCT05610878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316411|NCT05610878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316412|NCT05610878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316413|NCT02706405|Cyclophosphamide|cyclophosphamide|mesh-list
64316414|NCT02706405|Fludarabine|fludarabine|mesh-list
64316415|NCT02706405|Durvalumab|durvalumab|mesh-list
64316416|NCT02706405|Immunoglobulins|immunoglobulins|mesh-list
64316425|NCT02706405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316426|NCT02706405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316427|NCT02706405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64316428|NCT02706405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64316430|NCT02254031|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
64316442|NCT04174352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316443|NCT04174352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64316444|NCT04174352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316445|NCT04174352|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64316446|NCT04174352|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64316447|NCT04174352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64316449|NCT03545711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64321717|NCT02205775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64321718|NCT02205775|Ezetimibe|ezetimibe|mesh-list
64321719|NCT02205775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64321720|NCT02205775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64321721|NCT02205775|Antimetabolites|antimetabolites|mesh-ancestor
64321722|NCT02205775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321723|NCT02205775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64321724|NCT02205775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64737671|NCT00001079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64737672|NCT00001079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64737673|NCT00001079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64737674|NCT00001079|Appetite Stimulants|appetite stimulants|mesh-ancestor
64737675|NCT00001079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64737677|NCT00000293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64737678|NCT00000293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64737679|NCT00000293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64426945|NCT02469519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64426947|NCT02469519|Hormones|hormones|mesh-ancestor
64316450|NCT03545711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64316451|NCT03545711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316452|NCT03545711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316453|NCT03545711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316469|NCT01569659|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64316470|NCT01569659|Adrenergic Agents|adrenergic agents|mesh-ancestor
64316471|NCT01569659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64316472|NCT01569659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316474|NCT01569659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64737680|NCT00000293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737681|NCT00000293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64737682|NCT00000293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737683|NCT00000293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64737684|NCT00000293|Antidepressive Agents|antidepressive agents|mesh-ancestor
64737685|NCT00000293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64737686|NCT00000293|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64737687|NCT00000293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64737688|NCT00000293|Serotonin Agents|serotonin agents|mesh-ancestor
64737690|NCT00001091|Nelfinavir|nelfinavir|mesh-list
64737691|NCT00001091|Lamivudine|lamivudine|mesh-list
64737692|NCT00001091|Nevirapine|nevirapine|mesh-list
64737693|NCT00001091|Stavudine|stavudine|mesh-list
64737694|NCT00001091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64737695|NCT00001091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64737696|NCT00001091|Protease Inhibitors|protease inhibitors|mesh-ancestor
64737697|NCT00001091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737698|NCT00001091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737699|NCT00001091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64349773|NCT03307759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64321726|NCT02217787|PF-06372865|pf-06372865|mesh-list
64321727|NCT02217787|GABA Modulators|gaba modulators|mesh-ancestor
64321728|NCT02217787|GABA Agents|gaba agents|mesh-ancestor
64321729|NCT02217787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64321730|NCT02217787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321731|NCT02217787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321732|NCT02205931|Topiramate|topiramate|mesh-list
64321733|NCT02205931|Lamotrigine|lamotrigine|mesh-list
64321734|NCT02205931|Zonisamide|zonisamide|mesh-list
64316475|NCT01569659|Serotonin Agents|serotonin agents|mesh-ancestor
64316476|NCT01569659|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64377033|NCT02504801|Glucocorticoids|glucocorticoids|mesh-ancestor
64316483|NCT02253953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316484|NCT02253953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316485|NCT02253953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64316486|NCT02253953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64316487|NCT02253953|Antiviral Agents|antiviral agents|mesh-ancestor
64316488|NCT02253953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64316489|NCT02253953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64316491|NCT03546803|Protective Agents|protective agents|mesh-list
64316492|NCT03546803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316494|NCT02422953|Trace Elements|trace elements|mesh-list
64316495|NCT02422953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316496|NCT04053140|Penicillins|penicillins|mesh-list
64316497|NCT04053140|Penicillin G|penicillin g|mesh-list
64321737|NCT02205931|Rufinamide|rufinamide|mesh-list
64321738|NCT02205931|Levetiracetam|levetiracetam|mesh-list
64321739|NCT02205931|Valproic Acid|valproic acid|mesh-list
64737700|NCT00001091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64737701|NCT00001091|Antiviral Agents|antiviral agents|mesh-ancestor
64737702|NCT00001091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737703|NCT00001091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64737704|NCT00001091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64737705|NCT00001091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64737706|NCT00001091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64737707|NCT00001091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64321740|NCT02205931|Clonazepam|clonazepam|mesh-list
64321741|NCT02205931|Vigabatrin|vigabatrin|mesh-list
64321748|NCT02205931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321750|NCT02205931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64321751|NCT02205931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64316510|NCT03713879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316511|NCT03713879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316512|NCT03713879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64316513|NCT03713879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64316515|NCT03713879|Tocolytic Agents|tocolytic agents|mesh-ancestor
64316557|NCT03185403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316558|NCT03185403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64316559|NCT03185403|Narcotics|narcotics|mesh-ancestor
64316560|NCT03185403|Analgesics|analgesics|mesh-ancestor
64316561|NCT03185403|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64427123|NCT02217501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64321752|NCT02205931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321753|NCT02205931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64321754|NCT02205931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64321755|NCT02205931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64737708|NCT00001091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64737709|NCT00001091|Antimetabolites|antimetabolites|mesh-ancestor
64737710|NCT00000299|Buprenorphine|buprenorphine|mesh-list
64737711|NCT00000299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64737712|NCT00000299|Narcotics|narcotics|mesh-ancestor
64737713|NCT00000299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64737714|NCT00000299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737715|NCT00000299|Analgesics|analgesics|mesh-ancestor
64737716|NCT00000299|Sensory System Agents|sensory system agents|mesh-ancestor
64349793|NCT02252536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64321756|NCT02205931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64321757|NCT02205931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64321758|NCT02205931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64321759|NCT02205931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64321760|NCT02205931|GABA Agents|gaba agents|mesh-ancestor
64321761|NCT02205931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64321762|NCT02205931|Antimanic Agents|antimanic agents|mesh-ancestor
64316571|NCT04329806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316572|NCT04329806|Vasodilator Agents|vasodilator agents|mesh-ancestor
64316573|NCT03635021|Bevacizumab|bevacizumab|mesh-list
64316574|NCT03635021|Panitumumab|panitumumab|mesh-list
64316586|NCT02422485|Sensory System Agents|sensory system agents|mesh-ancestor
64316587|NCT02422485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316588|NCT02422485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316589|NCT02422485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64316590|NCT02422485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64316591|NCT05551910|Remifentanil|remifentanil|mesh-list
64316592|NCT05551910|Propofol|propofol|mesh-list
64316593|NCT05551910|Esketamine|esketamine|mesh-list
64316594|NCT05551910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64316595|NCT05551910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64321763|NCT02205931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64321765|NCT02205931|Sensory System Agents|sensory system agents|mesh-ancestor
64321766|NCT02205931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321767|NCT02205931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64737717|NCT00000299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737718|NCT00000299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64737719|NCT00000305|Dextroamphetamine|dextroamphetamine|mesh-list
64737720|NCT00000305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64737721|NCT00000305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737722|NCT00000305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64737723|NCT00000305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64737724|NCT00000305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64737725|NCT00000305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737726|NCT00000305|Dopamine Agents|dopamine agents|mesh-ancestor
64737727|NCT00000305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64737728|NCT00000311|Buprenorphine|buprenorphine|mesh-list
64737729|NCT00000311|Methadone|methadone|mesh-list
64737730|NCT00000311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64737731|NCT00000311|Narcotics|narcotics|mesh-ancestor
64737732|NCT00000311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64737733|NCT00000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737734|NCT00000311|Analgesics|analgesics|mesh-ancestor
64737735|NCT00000311|Sensory System Agents|sensory system agents|mesh-ancestor
64737736|NCT00000311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737737|NCT00000311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64737738|NCT00000311|Antitussive Agents|antitussive agents|mesh-ancestor
64737739|NCT00000311|Respiratory System Agents|respiratory system agents|mesh-ancestor
64316596|NCT05551910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316597|NCT05551910|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64316598|NCT05551910|Anesthetics, General|anesthetics, general|mesh-ancestor
64316599|NCT05551910|Anesthetics|anesthetics|mesh-ancestor
64316600|NCT05551910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64316672|NCT02422017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64316673|NCT02761915|Cyclophosphamide|cyclophosphamide|mesh-list
64316675|NCT02761915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64316676|NCT02761915|Immunologic Factors|immunologic factors|mesh-ancestor
64737741|NCT00000317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64737742|NCT00000317|Serotonin Agents|serotonin agents|mesh-ancestor
64737743|NCT00000317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64737744|NCT00000317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737745|NCT00000317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737746|NCT00000317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64737747|NCT00000317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64737748|NCT00000317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64737749|NCT00000317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64737750|NCT00000317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64737751|NCT00000317|Dopamine Agents|dopamine agents|mesh-ancestor
64737752|NCT00001115|Acyclovir|acyclovir|mesh-list
64737753|NCT00001115|Antiviral Agents|antiviral agents|mesh-ancestor
64737754|NCT00001115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737755|NCT00001757|Voriconazole|voriconazole|mesh-list
64737756|NCT00001757|Antifungal Agents|antifungal agents|mesh-ancestor
64737757|NCT00001757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737758|NCT00001757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64737759|NCT00001757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64737760|NCT00001757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737761|NCT00001757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737762|NCT00001757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64737763|NCT00001757|Hormone Antagonists|hormone antagonists|mesh-ancestor
64349825|NCT03490487|Analgesics|analgesics|mesh-ancestor
64737764|NCT00001757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64737765|NCT00001757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737766|NCT00001757|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64737768|NCT00001133|Indinavir|indinavir|mesh-list
64737769|NCT00001133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64316677|NCT02761915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316678|NCT02761915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64416683|NCT01668667|Antimanic Agents|antimanic agents|mesh-ancestor
64786254|NCT00001698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64786255|NCT00001698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786257|NCT00001698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64786258|NCT00001698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64786259|NCT00001698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316679|NCT02761915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64316680|NCT02761915|Alkylating Agents|alkylating agents|mesh-ancestor
64316681|NCT02761915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316682|NCT02761915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316684|NCT03464084|Melatonin|melatonin|mesh-list
64316685|NCT03464084|Antioxidants|antioxidants|mesh-ancestor
64316686|NCT03464084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316687|NCT03464084|Protective Agents|protective agents|mesh-ancestor
64316688|NCT03464084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316689|NCT03464084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64316690|NCT02160925|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
64316691|NCT02160925|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64383650|NCT02406911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64383651|NCT02406911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64383652|NCT02406911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64383653|NCT02406911|Purinergic Agents|purinergic agents|mesh-ancestor
64383654|NCT02406911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64737776|NCT00001133|Antiviral Agents|antiviral agents|mesh-ancestor
64737777|NCT00001133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737778|NCT00001133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64737779|NCT00001133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64737780|NCT00000329|Analgesics, Opioid|analgesics, opioid|mesh-list
64737781|NCT00000329|Narcotics|narcotics|mesh-ancestor
64349848|NCT03466567|Dermatologic Agents|dermatologic agents|mesh-ancestor
64321769|NCT02205931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64321770|NCT02205931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64321771|NCT02205931|GABA Modulators|gaba modulators|mesh-ancestor
64321772|NCT02205931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64321773|NCT02205931|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64321774|NCT02205931|GABA Agonists|gaba agonists|mesh-ancestor
64321775|NCT02205931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64321776|NCT04528004|Niacinamide|niacinamide|mesh-list
64321777|NCT04528004|Niacin|niacin|mesh-list
64737782|NCT00000329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64737784|NCT00000329|Analgesics|analgesics|mesh-ancestor
64737785|NCT00000329|Sensory System Agents|sensory system agents|mesh-ancestor
64737786|NCT00000329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737787|NCT00000335|Morphine|morphine|mesh-list
64427135|NCT01649869|Antiviral Agents|antiviral agents|mesh-ancestor
64737788|NCT00000335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64383655|NCT02406911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383656|NCT02406911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383657|NCT03172793|Telavancin|telavancin|mesh-list
64383658|NCT03172793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64383659|NCT03172793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64383660|NCT03116087|Methyltestosterone|methyltestosterone|mesh-list
64383661|NCT03116087|Testosterone|testosterone|mesh-list
64383662|NCT03116087|Testosterone undecanoate|testosterone undecanoate|mesh-list
64383663|NCT03116087|Testosterone enanthate|testosterone enanthate|mesh-list
64383664|NCT03116087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64383665|NCT03116087|Androgens|androgens|mesh-ancestor
64383666|NCT03116087|Hormones|hormones|mesh-ancestor
64383668|NCT03116087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383678|NCT02406521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64383679|NCT02406521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383680|NCT02406521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383681|NCT02406287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64383682|NCT02406287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64383683|NCT02406053|Antioxidants|antioxidants|mesh-list
64383684|NCT02406053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383685|NCT02406053|Protective Agents|protective agents|mesh-ancestor
64383686|NCT02406053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383687|NCT02064166|Insulin|insulin|mesh-list
64383688|NCT02064166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64383689|NCT02064166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383690|NCT03171623|Globalagliatin|globalagliatin|mesh-list
64316711|NCT03334682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416684|NCT03040219|Folic Acid|folic acid|mesh-list
64786264|NCT00001716|Autonomic Agents|autonomic agents|mesh-ancestor
64786265|NCT00001716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64786266|NCT00001716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737789|NCT00000335|Narcotics|narcotics|mesh-ancestor
64737790|NCT00000335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64737791|NCT00000335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737792|NCT00000335|Analgesics|analgesics|mesh-ancestor
64737793|NCT00000335|Sensory System Agents|sensory system agents|mesh-ancestor
64737794|NCT00000335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737795|NCT00000341|Buprenorphine|buprenorphine|mesh-list
64737796|NCT00000341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64737797|NCT00000341|Narcotics|narcotics|mesh-ancestor
64737798|NCT00000341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64737799|NCT00000341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737800|NCT00000341|Analgesics|analgesics|mesh-ancestor
64737801|NCT00000341|Sensory System Agents|sensory system agents|mesh-ancestor
64349871|NCT03130153|Antipyretics|antipyretics|mesh-ancestor
64427251|NCT02395627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427252|NCT02395081|Vitamin D|vitamin d|mesh-list
64786267|NCT00001716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64786268|NCT00001716|Respiratory System Agents|respiratory system agents|mesh-ancestor
64786269|NCT00001716|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64786270|NCT00001716|Antioxidants|antioxidants|mesh-ancestor
64786271|NCT00001716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786272|NCT00001716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64786273|NCT00001716|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64786274|NCT00001716|Vasodilator Agents|vasodilator agents|mesh-ancestor
64737802|NCT00000341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737803|NCT00000341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64737804|NCT00000347|Risperidone|risperidone|mesh-list
64737805|NCT00000347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64737806|NCT00000347|Serotonin Agents|serotonin agents|mesh-ancestor
64737807|NCT00000347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64737808|NCT00000347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737809|NCT00000347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737810|NCT00000347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64737811|NCT00000347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64737812|NCT00000347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64737813|NCT00000347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64737814|NCT00000347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64737815|NCT00000347|Dopamine Agents|dopamine agents|mesh-ancestor
64737816|NCT00001835|Oxaliplatin|oxaliplatin|mesh-list
64737818|NCT00001193|Melphalan|melphalan|mesh-list
64737819|NCT00001193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64737820|NCT00001193|Alkylating Agents|alkylating agents|mesh-ancestor
64737821|NCT00001193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737822|NCT00001193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64786275|NCT00001716|Gasotransmitters|gasotransmitters|mesh-ancestor
64786276|NCT00001716|Protective Agents|protective agents|mesh-ancestor
64786277|NCT00001812|Nystatin|nystatin|mesh-list
64316712|NCT03334682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64316713|NCT03334682|Diuretics|diuretics|mesh-ancestor
64316714|NCT03334682|Natriuretic Agents|natriuretic agents|mesh-ancestor
64316715|NCT02764333|Durvalumab|durvalumab|mesh-list
64316716|NCT02764333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64316717|NCT02764333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316754|NCT05546060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64316755|NCT05546060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64737839|NCT00000377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64737840|NCT00000377|Antidepressive Agents|antidepressive agents|mesh-ancestor
64737841|NCT00000377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64737842|NCT00000377|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64737843|NCT00000377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64737844|NCT00000377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64737845|NCT00000377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737846|NCT00000377|Adrenergic Agents|adrenergic agents|mesh-ancestor
64349911|NCT03490097|Sofosbuvir|sofosbuvir|mesh-list
64737847|NCT00000377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64737848|NCT00000377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737850|NCT00001865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64737851|NCT00001865|Immunologic Factors|immunologic factors|mesh-ancestor
64737852|NCT00001865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737853|NCT00000389|Fluvoxamine|fluvoxamine|mesh-list
64737854|NCT00000389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64737855|NCT00000389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64737856|NCT00000389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64737858|NCT00000389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64316756|NCT05546060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64316757|NCT05546060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316758|NCT05546060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316759|NCT02416869|Dexamethasone|dexamethasone|mesh-list
64316760|NCT02416869|Dexamethasone acetate|dexamethasone acetate|mesh-list
64316762|NCT02416869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64316763|NCT02416869|Antiemetics|antiemetics|mesh-ancestor
64316764|NCT02416869|Autonomic Agents|autonomic agents|mesh-ancestor
64316765|NCT02416869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316766|NCT02416869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316767|NCT02416869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64321794|NCT02220049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64321795|NCT01351805|Vitamin D|vitamin d|mesh-list
64321796|NCT01351805|Ergocalciferols|ergocalciferols|mesh-list
64321797|NCT01351805|Cholecalciferol|cholecalciferol|mesh-list
64321798|NCT01351805|Vitamins|vitamins|mesh-list
64321799|NCT01351805|Micronutrients|micronutrients|mesh-ancestor
64321800|NCT01351805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737876|NCT00001877|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64737877|NCT00001877|Protective Agents|protective agents|mesh-ancestor
64737878|NCT00001877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737879|NCT00001877|Vasodilator Agents|vasodilator agents|mesh-ancestor
64737880|NCT00001877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64737881|NCT00001877|Antioxidants|antioxidants|mesh-ancestor
64737882|NCT00380939|Atorvastatin|atorvastatin|mesh-list
64737883|NCT00380939|Pravastatin|pravastatin|mesh-list
64737884|NCT00380939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64737885|NCT00380939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64786290|NCT00001842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786292|NCT00001842|Glucocorticoids|glucocorticoids|mesh-ancestor
64324776|NCT01175785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64324777|NCT01175785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64324778|NCT01175785|Antitubercular Agents|antitubercular agents|mesh-ancestor
64324779|NCT01175785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64324780|NCT05478044|Ascorbic Acid|ascorbic acid|mesh-list
64324782|NCT05478044|Micronutrients|micronutrients|mesh-ancestor
64321816|NCT04356950|Hemostatics|hemostatics|mesh-ancestor
64321817|NCT04356950|Coagulants|coagulants|mesh-ancestor
64321818|NCT02425943|Mannitol|mannitol|mesh-list
64321819|NCT02425943|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64321820|NCT02425943|Diuretics|diuretics|mesh-ancestor
64321821|NCT02425943|Natriuretic Agents|natriuretic agents|mesh-ancestor
64321822|NCT02425943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321823|NCT02254187|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64321824|NCT02254187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64321825|NCT02254187|Autonomic Agents|autonomic agents|mesh-ancestor
64321826|NCT02254187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321827|NCT02254187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321828|NCT02254187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64321829|NCT02254187|Respiratory System Agents|respiratory system agents|mesh-ancestor
64321830|NCT02254187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64321831|NCT02254187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64321832|NCT02254187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64321835|NCT02254187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321837|NCT05563610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64737902|NCT00001889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737903|NCT00001889|Protective Agents|protective agents|mesh-ancestor
64737904|NCT00001901|Etanercept|etanercept|mesh-list
64737905|NCT00001901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64737906|NCT00001901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64737907|NCT00001901|Analgesics|analgesics|mesh-ancestor
64737908|NCT00001901|Sensory System Agents|sensory system agents|mesh-ancestor
64737909|NCT00001901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321838|NCT05563610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64321839|NCT05503706|Selenium|selenium|mesh-list
64321840|NCT05503706|Salicylic Acid|salicylic acid|mesh-list
64321841|NCT05503706|Salicylates|salicylates|mesh-list
64321842|NCT05503706|Selenium disulfide|selenium disulfide|mesh-list
64321843|NCT05503706|Antioxidants|antioxidants|mesh-ancestor
64324783|NCT05478044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324784|NCT05478044|Antioxidants|antioxidants|mesh-ancestor
64324785|NCT05478044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316796|NCT03540979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316797|NCT03540979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64316798|NCT03540979|Hormone Antagonists|hormone antagonists|mesh-ancestor
64316799|NCT03540979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64316800|NCT03540979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316801|NCT03540979|Progestins|progestins|mesh-ancestor
64316803|NCT02946788|Minocycline|minocycline|mesh-list
64737910|NCT00001901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737911|NCT00001901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64737913|NCT00001901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64737914|NCT00001901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64737915|NCT00001901|Immunologic Factors|immunologic factors|mesh-ancestor
64737916|NCT00000437|Naltrexone|naltrexone|mesh-list
64737917|NCT00000437|Nicotine|nicotine|mesh-list
64737918|NCT00000437|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64737919|NCT00000437|Autonomic Agents|autonomic agents|mesh-ancestor
64737920|NCT00000437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737921|NCT00000437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737922|NCT00000437|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64737923|NCT00000437|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64737924|NCT00000437|Cholinergic Agents|cholinergic agents|mesh-ancestor
64737925|NCT00000437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64737926|NCT00000437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350003|NCT04894721|Ivermectin|ivermectin|mesh-list
64321844|NCT05503706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321846|NCT05503706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316804|NCT02946788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64316805|NCT02946788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64316806|NCT02159131|Cabotegravir|cabotegravir|mesh-list
64316807|NCT02159131|Levonorgestrel|levonorgestrel|mesh-list
64316808|NCT02159131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64316809|NCT02159131|Contraceptive Agents|contraceptive agents|mesh-ancestor
64316810|NCT02159131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64786297|NCT00001842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64786298|NCT00001842|Immunologic Factors|immunologic factors|mesh-ancestor
64786299|NCT00001848|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64786300|NCT00001848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64786301|NCT00001848|Hormone Antagonists|hormone antagonists|mesh-ancestor
64786302|NCT00001848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64316849|NCT02410083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64316850|NCT02410083|Analgesics|analgesics|mesh-ancestor
64316851|NCT02410083|Sensory System Agents|sensory system agents|mesh-ancestor
64316852|NCT02410083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316853|NCT02410083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316854|NCT02410083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64316855|NCT02410083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64316870|NCT02416245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316871|NCT02416167|Dotinurad|dotinurad|mesh-list
64316872|NCT02416167|Uricosuric Agents|uricosuric agents|mesh-ancestor
64316873|NCT02416167|Gout Suppressants|gout suppressants|mesh-ancestor
64316874|NCT02416167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64316875|NCT02416167|Renal Agents|renal agents|mesh-ancestor
64316876|NCT01463072|Paclitaxel|paclitaxel|mesh-list
64737927|NCT00000437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64737928|NCT00000437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64737929|NCT00000437|Sensory System Agents|sensory system agents|mesh-ancestor
64737930|NCT00000443|Ondansetron|ondansetron|mesh-list
64737931|NCT00000443|Antiemetics|antiemetics|mesh-ancestor
64737932|NCT00000443|Autonomic Agents|autonomic agents|mesh-ancestor
64737933|NCT00000443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737934|NCT00000443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737935|NCT00000443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64737936|NCT00000443|Antipruritics|antipruritics|mesh-ancestor
64737937|NCT00000443|Dermatologic Agents|dermatologic agents|mesh-ancestor
64737938|NCT00000443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64737939|NCT00000443|Serotonin Agents|serotonin agents|mesh-ancestor
64737940|NCT00000443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64737941|NCT00000443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737942|NCT00000443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64737943|NCT00000443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64427337|NCT02422303|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64737944|NCT00000443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64737945|NCT00000443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64737946|NCT00000443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64737947|NCT00000449|Naltrexone|naltrexone|mesh-list
64737948|NCT00000449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64737949|NCT00000449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64737951|NCT00000449|Sensory System Agents|sensory system agents|mesh-ancestor
64737979|NCT00001937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64737980|NCT00001937|Hormone Antagonists|hormone antagonists|mesh-ancestor
64737981|NCT00001937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64737991|NCT00001955|Celecoxib|celecoxib|mesh-list
64316877|NCT01463072|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64316878|NCT01463072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64786311|NCT00001854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786312|NCT00001860|Octreotide|octreotide|mesh-list
64324788|NCT05472506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64324789|NCT05472506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324790|NCT05472506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64321858|NCT05503706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64321860|NCT05503706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64321861|NCT05503706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64321862|NCT02174861|Erenumab|erenumab|mesh-list
64321863|NCT02174861|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64738020|NCT00000605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64738021|NCT00000605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738022|NCT00000605|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64738023|NCT00000605|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64738024|NCT00000605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64738025|NCT00000605|Contraceptive Agents|contraceptive agents|mesh-ancestor
64738026|NCT00000605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64738027|NCT00000605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64738028|NCT00000605|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64738029|NCT00000605|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64738030|NCT00000605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64738031|NCT00000605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738032|NCT00000617|Azithromycin|azithromycin|mesh-list
64738033|NCT00000617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64738034|NCT00000617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738035|NCT00000623|Decitabine|decitabine|mesh-list
64477381|NCT04415983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738036|NCT00000623|Sildenafil Citrate|sildenafil citrate|mesh-list
64738037|NCT00000623|Deferiprone|deferiprone|mesh-list
64738038|NCT00000623|Deferoxamine|deferoxamine|mesh-list
64350136|NCT03104075|Vaccines|vaccines|mesh-list
64324791|NCT05472506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316909|NCT02162251|Nootropic Agents|nootropic agents|mesh-ancestor
64316910|NCT02164045|Fostemsavir|fostemsavir|mesh-list
64316911|NCT02164045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64316912|NCT02164045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64316913|NCT02164045|Antiviral Agents|antiviral agents|mesh-ancestor
64316914|NCT02164045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64316915|NCT02164045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64316916|NCT02164045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64316917|NCT02164045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316918|NCT02410005|Calcitriol|calcitriol|mesh-list
64738049|NCT00000623|Chelating Agents|chelating agents|mesh-ancestor
64738050|NCT00000623|Sequestering Agents|sequestering agents|mesh-ancestor
64738051|NCT00000623|Siderophores|siderophores|mesh-ancestor
64738052|NCT00001991|Atovaquone|atovaquone|mesh-list
64738053|NCT00001991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738054|NCT00001991|Antimalarials|antimalarials|mesh-ancestor
64738055|NCT00001991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64738056|NCT00001991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64738057|NCT00001991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738058|NCT00001991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738059|NCT00001997|Zidovudine|zidovudine|mesh-list
64738060|NCT00001997|Didanosine|didanosine|mesh-list
64738061|NCT00001997|Interleukin-2|interleukin-2|mesh-list
64738062|NCT00001997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738063|NCT00001997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64738064|NCT00001997|Analgesics|analgesics|mesh-ancestor
64738065|NCT00001997|Sensory System Agents|sensory system agents|mesh-ancestor
64738066|NCT00001997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64738067|NCT00001997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316919|NCT02410005|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
64316920|NCT02410005|Losartan|losartan|mesh-list
64316921|NCT02410005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64316922|NCT02410005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64316923|NCT02410005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64316924|NCT02410005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64316925|NCT02410005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316926|NCT02410005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64316927|NCT02410005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316929|NCT02410005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64316930|NCT02410005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64377501|NCT04845399|Factor VIII|factor viii|mesh-list
64377502|NCT04845399|Coagulants|coagulants|mesh-ancestor
64377503|NCT04839471|Afatinib|afatinib|mesh-list
64377508|NCT04839237|Metformin|metformin|mesh-list
64316956|NCT05545436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316958|NCT02167165|Digoxin|digoxin|mesh-list
64316959|NCT02167165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64316960|NCT02167165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64316961|NCT02167165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316962|NCT02167165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316963|NCT02167165|Protective Agents|protective agents|mesh-ancestor
64316964|NCT02167165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316965|NCT02409849|Octreotide|octreotide|mesh-list
64316966|NCT02409849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64316967|NCT02409849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64316968|NCT02409849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738095|NCT00000629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738096|NCT00000629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738099|NCT00000629|Antiviral Agents|antiviral agents|mesh-ancestor
64316969|NCT00664040|Aspirin|aspirin|mesh-list
64316981|NCT00664040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64316982|NCT00664040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64316984|NCT00664040|Antipyretics|antipyretics|mesh-ancestor
64316985|NCT02162407|Insulin|insulin|mesh-list
64316986|NCT02162407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64316987|NCT02162407|Insulin Detemir|insulin detemir|mesh-list
64316988|NCT02162407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64316990|NCT02162485|Fluticasone|fluticasone|mesh-list
64316991|NCT02162485|Xhance|xhance|mesh-list
64316992|NCT02162485|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64316993|NCT02162485|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64316994|NCT02162485|Charcoal|charcoal|mesh-list
64377572|NCT03038217|Oxaliplatin|oxaliplatin|mesh-list
64383733|NCT04591431|Maytansine|maytansine|mesh-list
64383734|NCT04591431|Talazoparib|talazoparib|mesh-list
64383735|NCT04591431|Ponatinib|ponatinib|mesh-list
64383736|NCT04591431|Tepotinib|tepotinib|mesh-list
64383737|NCT04591431|Pralsetinib|pralsetinib|mesh-list
64383738|NCT04591431|Entrectinib|entrectinib|mesh-list
64383739|NCT04591431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64383740|NCT04591431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383741|NCT04591431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64383742|NCT04591431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738123|NCT00000647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738124|NCT00000647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738125|NCT00000647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738126|NCT00000647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738127|NCT00000653|Zalcitabine|zalcitabine|mesh-list
64738128|NCT00000653|Antimetabolites|antimetabolites|mesh-ancestor
64738129|NCT00000653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738130|NCT00000653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738131|NCT00000653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738132|NCT00000653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738133|NCT00000653|Antiviral Agents|antiviral agents|mesh-ancestor
64738134|NCT00000653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64383743|NCT04591431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64383744|NCT04591431|Immunologic Factors|immunologic factors|mesh-ancestor
64383745|NCT04591431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383746|NCT04591431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64324799|NCT03649724|Leuprolide|leuprolide|mesh-list
64316995|NCT02162485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64316996|NCT02162485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64316997|NCT02162485|Autonomic Agents|autonomic agents|mesh-ancestor
64316998|NCT02162485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316999|NCT02162485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738165|NCT00002015|Antiviral Agents|antiviral agents|mesh-ancestor
64738166|NCT00002015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738167|NCT00002015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738168|NCT00002015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738169|NCT00002015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321886|NCT02220361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321887|NCT02220361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64321888|NCT02220361|Analgesics|analgesics|mesh-ancestor
64321889|NCT02220361|Sensory System Agents|sensory system agents|mesh-ancestor
64321890|NCT02220361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321891|NCT02220361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64738171|NCT00002021|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
64738172|NCT00002021|Antiviral Agents|antiviral agents|mesh-ancestor
64738173|NCT00002021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738174|NCT00002021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738175|NCT00002021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738176|NCT00002021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738177|NCT00002021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738178|NCT00002027|Diclazuril|diclazuril|mesh-list
64738179|NCT00002027|Coccidiostats|coccidiostats|mesh-ancestor
64738180|NCT00002027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64738181|NCT00002027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64738182|NCT00002027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738183|NCT00000695|Interferons|interferons|mesh-list
64738184|NCT00000695|Zidovudine|zidovudine|mesh-list
64738185|NCT00000695|Interferon-beta|interferon-beta|mesh-list
64738186|NCT00000695|Interferon beta-1b|interferon beta-1b|mesh-list
64738187|NCT00000695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738188|NCT00000695|Antiviral Agents|antiviral agents|mesh-ancestor
64738189|NCT00000695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738190|NCT00000695|Antimetabolites|antimetabolites|mesh-ancestor
64738191|NCT00000695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317000|NCT02162485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64317001|NCT02162485|Respiratory System Agents|respiratory system agents|mesh-ancestor
64317002|NCT02162485|Dermatologic Agents|dermatologic agents|mesh-ancestor
64317003|NCT02162485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64317004|NCT02162485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64317005|NCT02162485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64317006|NCT02162485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64317007|NCT02162485|Adrenergic Agents|adrenergic agents|mesh-ancestor
64317008|NCT02162485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64317009|NCT02162485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317011|NCT02162485|Hormones|hormones|mesh-ancestor
64738194|NCT00000695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738195|NCT00000695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738196|NCT00000695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738197|NCT00000695|Immunologic Factors|immunologic factors|mesh-ancestor
64738198|NCT00000695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738199|NCT00000695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64738200|NCT00000701|Zidovudine|zidovudine|mesh-list
64738201|NCT00000701|Antimetabolites|antimetabolites|mesh-ancestor
64738202|NCT00000701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738203|NCT00000701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738204|NCT00000701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738205|NCT00000701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350285|NCT03317795|Levonorgestrel|levonorgestrel|mesh-list
64321892|NCT02220361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64321893|NCT02220361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64321894|NCT02220361|Adrenergic Agents|adrenergic agents|mesh-ancestor
64321895|NCT02220361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64317012|NCT02162485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64317013|NCT02162485|Sympathomimetics|sympathomimetics|mesh-ancestor
64317014|NCT02162485|Antidotes|antidotes|mesh-ancestor
64317015|NCT02162485|Protective Agents|protective agents|mesh-ancestor
64317016|NCT02415777|Riboflavin|riboflavin|mesh-list
64317017|NCT02415777|Thiamine|thiamine|mesh-list
64317018|NCT02415777|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64317019|NCT02415777|Vitamin B Complex|vitamin b complex|mesh-ancestor
64377616|NCT04843839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64786325|NCT00001944|Mitosis Modulators|mitosis modulators|mesh-ancestor
64786326|NCT00001944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786328|NCT00001968|Amprenavir|amprenavir|mesh-list
64786329|NCT00001968|Lamivudine|lamivudine|mesh-list
64786330|NCT00001968|Abacavir|abacavir|mesh-list
64786331|NCT00001968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64786332|NCT00001968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64786333|NCT00001968|Protease Inhibitors|protease inhibitors|mesh-ancestor
64317020|NCT02415777|Vitamins|vitamins|mesh-ancestor
64738206|NCT00000701|Antiviral Agents|antiviral agents|mesh-ancestor
64738207|NCT00000701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738208|NCT00000701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738209|NCT00000701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738210|NCT00000713|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
64738211|NCT00000713|Antiviral Agents|antiviral agents|mesh-ancestor
64738212|NCT00000713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738213|NCT00000725|Interferons|interferons|mesh-list
64738214|NCT00000725|Interferon-alpha|interferon-alpha|mesh-list
64738215|NCT00000725|Interferon alpha-2|interferon alpha-2|mesh-list
64738216|NCT00000725|Zidovudine|zidovudine|mesh-list
64738217|NCT00000725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738218|NCT00000725|Antiviral Agents|antiviral agents|mesh-ancestor
64738219|NCT00000725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738220|NCT00000725|Immunologic Factors|immunologic factors|mesh-ancestor
64738221|NCT00000725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738222|NCT00000725|Antimetabolites|antimetabolites|mesh-ancestor
64738223|NCT00000725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738224|NCT00000725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64350297|NCT03317795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64321896|NCT02220361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321897|NCT05175001|Betamethasone|betamethasone|mesh-list
64317021|NCT02415777|Micronutrients|micronutrients|mesh-ancestor
64317022|NCT02415777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317023|NCT02415777|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64317024|NCT02415777|Dermatologic Agents|dermatologic agents|mesh-ancestor
64317025|NCT02415777|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64317026|NCT02415777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64317027|NCT05544968|Antibodies|antibodies|mesh-list
64317028|NCT05544968|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64317029|NCT05544968|Immunologic Factors|immunologic factors|mesh-ancestor
64738225|NCT00000725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738226|NCT00000725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738227|NCT00000725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738228|NCT00000725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738230|NCT00002033|Antimetabolites|antimetabolites|mesh-ancestor
64738231|NCT00002033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738232|NCT00002033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738233|NCT00002033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64321898|NCT05175001|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
64321899|NCT05175001|Ropivacaine|ropivacaine|mesh-list
64321900|NCT05175001|Anesthetics, Local|anesthetics, local|mesh-ancestor
64321901|NCT05175001|Anesthetics|anesthetics|mesh-ancestor
64317030|NCT05544968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317031|NCT03178539|Ketorolac|ketorolac|mesh-list
64317032|NCT03178539|Diclofenac|diclofenac|mesh-list
64317033|NCT03178539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64317034|NCT03178539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64317035|NCT03178539|Analgesics|analgesics|mesh-ancestor
64317036|NCT03178539|Sensory System Agents|sensory system agents|mesh-ancestor
64317051|NCT03174483|Respiratory System Agents|respiratory system agents|mesh-ancestor
64317052|NCT03174483|Dermatologic Agents|dermatologic agents|mesh-ancestor
64738234|NCT00002033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738235|NCT00002033|Antiviral Agents|antiviral agents|mesh-ancestor
64738236|NCT00002033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738237|NCT00002033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738238|NCT00002033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738239|NCT00002039|Foscarnet|foscarnet|mesh-list
64738240|NCT00002039|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
64738241|NCT00002039|Antiviral Agents|antiviral agents|mesh-ancestor
64738242|NCT00002039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738243|NCT00002039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738244|NCT00002039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738245|NCT00002039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738246|NCT00002039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738247|NCT00000731|Acetaminophen|acetaminophen|mesh-list
64738248|NCT00000731|Zidovudine|zidovudine|mesh-list
64738249|NCT00000731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64738250|NCT00000731|Analgesics|analgesics|mesh-ancestor
64738251|NCT00000731|Sensory System Agents|sensory system agents|mesh-ancestor
64738252|NCT00000731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64738253|NCT00000731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738254|NCT00000731|Antipyretics|antipyretics|mesh-ancestor
64738255|NCT00000731|Antimetabolites|antimetabolites|mesh-ancestor
64738256|NCT00000731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738257|NCT00000731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738258|NCT00000731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738259|NCT00000731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738260|NCT00000731|Antiviral Agents|antiviral agents|mesh-ancestor
64350323|NCT02432846|Growth Substances|growth substances|mesh-ancestor
64738261|NCT00000731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738262|NCT00000731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738263|NCT00000731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64317053|NCT03174483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64317054|NCT05699174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64317055|NCT05699174|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64317056|NCT05699174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64317057|NCT05699174|Antitubercular Agents|antitubercular agents|mesh-ancestor
64317058|NCT04320914|Ibuprofen|ibuprofen|mesh-list
64317059|NCT04320914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64317060|NCT04320914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64317061|NCT04320914|Analgesics|analgesics|mesh-ancestor
64321902|NCT05175001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64321903|NCT05175001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321904|NCT05175001|Sensory System Agents|sensory system agents|mesh-ancestor
64738267|NCT00002045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738268|NCT00002045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738270|NCT00002045|Antiviral Agents|antiviral agents|mesh-ancestor
64738271|NCT00002045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738272|NCT00002045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738273|NCT00002045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738274|NCT00002051|Thymopentin|thymopentin|mesh-list
64738275|NCT00002051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64738276|NCT00002051|Immunologic Factors|immunologic factors|mesh-ancestor
64738277|NCT00002051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738278|NCT00001499|Paclitaxel|paclitaxel|mesh-list
64738279|NCT00001499|Cisplatin|cisplatin|mesh-list
64738280|NCT00001499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64738281|NCT00001499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738282|NCT00001499|Tubulin Modulators|tubulin modulators|mesh-ancestor
64738283|NCT00001499|Antimitotic Agents|antimitotic agents|mesh-ancestor
64738284|NCT00001499|Mitosis Modulators|mitosis modulators|mesh-ancestor
64738285|NCT00001499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738286|NCT00002057|Nystatin|nystatin|mesh-list
64317062|NCT04320914|Sensory System Agents|sensory system agents|mesh-ancestor
64317063|NCT04320914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317064|NCT04320914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786345|NCT00001968|Antitubercular Agents|antitubercular agents|mesh-ancestor
64786346|NCT00001968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64786347|NCT00001998|Nystatin|nystatin|mesh-list
64786348|NCT00001998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64786349|NCT00001998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786350|NCT00001998|Antifungal Agents|antifungal agents|mesh-ancestor
64786351|NCT00001998|Ionophores|ionophores|mesh-ancestor
64786352|NCT00001998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64786353|NCT00001998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786354|NCT00002010|Fluconazole|fluconazole|mesh-list
64786355|NCT00002010|Antifungal Agents|antifungal agents|mesh-ancestor
64786356|NCT00002010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786357|NCT00002010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64786358|NCT00002010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64317065|NCT04320914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64317066|NCT04320914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64317067|NCT04320914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64317068|NCT04320914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317069|NCT04320914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317070|NCT05544812|Cetuximab|cetuximab|mesh-list
64738287|NCT00002057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64738288|NCT00002057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738290|NCT00002057|Ionophores|ionophores|mesh-ancestor
64738291|NCT00002057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64738292|NCT00002057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738293|NCT00002297|Inosine Pranobex|inosine pranobex|mesh-list
64738294|NCT00002297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64738295|NCT00002297|Immunologic Factors|immunologic factors|mesh-ancestor
64350369|NCT00805961|Alkylating Agents|alkylating agents|mesh-ancestor
64321906|NCT05175001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64321907|NCT05175001|Glucocorticoids|glucocorticoids|mesh-ancestor
64321908|NCT05175001|Hormones|hormones|mesh-ancestor
64321909|NCT05175001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64321910|NCT05175001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64321911|NCT05175001|Respiratory System Agents|respiratory system agents|mesh-ancestor
64321912|NCT00140855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64321913|NCT00140855|Ipilimumab|ipilimumab|mesh-list
64321914|NCT00140855|Antibodies|antibodies|mesh-list
64317071|NCT05544812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64317072|NCT05544812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64317073|NCT02415699|Leucovorin|leucovorin|mesh-list
64317074|NCT02415699|Fluorouracil|fluorouracil|mesh-list
64317075|NCT02415699|Oxaliplatin|oxaliplatin|mesh-list
64317076|NCT02415699|Antimetabolites|antimetabolites|mesh-ancestor
64317077|NCT02415699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317078|NCT02415699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64317079|NCT02415699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64317080|NCT02415699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64738296|NCT00002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738297|NCT00002297|Antiviral Agents|antiviral agents|mesh-ancestor
64738298|NCT00002297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738299|NCT00001535|Interleukin-2|interleukin-2|mesh-list
64738300|NCT00001535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738301|NCT00001535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64738302|NCT00001535|Analgesics|analgesics|mesh-ancestor
64738303|NCT00001535|Sensory System Agents|sensory system agents|mesh-ancestor
64738304|NCT00001535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350378|NCT02454608|Vasodilator Agents|vasodilator agents|mesh-ancestor
64321916|NCT00140855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64321917|NCT00140855|Immunologic Factors|immunologic factors|mesh-ancestor
64321918|NCT00140855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321919|NCT00140855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64321920|NCT00140855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64321921|NCT00140855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321922|NCT02399397|Fentanyl|fentanyl|mesh-list
64321923|NCT02399397|Midazolam|midazolam|mesh-list
64321924|NCT02399397|Anesthetics|anesthetics|mesh-list
64321925|NCT02399397|Propofol|propofol|mesh-list
64321926|NCT02399397|Rocuronium|rocuronium|mesh-list
64321927|NCT02399397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64321928|NCT02399397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321929|NCT02399397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64427640|NCT01889602|GABA Modulators|gaba modulators|mesh-ancestor
64317081|NCT02415699|Immunologic Factors|immunologic factors|mesh-ancestor
64317082|NCT02415699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317084|NCT02415699|Protective Agents|protective agents|mesh-ancestor
64317085|NCT02415699|Vitamin B Complex|vitamin b complex|mesh-ancestor
64317086|NCT02415699|Vitamins|vitamins|mesh-ancestor
64317087|NCT02415699|Micronutrients|micronutrients|mesh-ancestor
64317088|NCT05544656|Tolperisone|tolperisone|mesh-list
64317089|NCT05544656|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64317090|NCT05544656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317092|NCT05544656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317093|NCT02409537|Resveratrol|resveratrol|mesh-list
64317094|NCT02409537|Antioxidants|antioxidants|mesh-ancestor
64317095|NCT02409537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786359|NCT00002010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786360|NCT00002010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786361|NCT00002010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64786362|NCT00002010|Hormone Antagonists|hormone antagonists|mesh-ancestor
64786363|NCT00002010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64786386|NCT00002034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786387|NCT00002034|Antiviral Agents|antiviral agents|mesh-ancestor
64786388|NCT00002034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64321930|NCT02399397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64321931|NCT02399397|Anesthetics, General|anesthetics, general|mesh-ancestor
64321932|NCT02399397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64321933|NCT02399397|Narcotics|narcotics|mesh-ancestor
64321934|NCT02399397|Analgesics|analgesics|mesh-ancestor
64321935|NCT02399397|Sensory System Agents|sensory system agents|mesh-ancestor
64738305|NCT00001535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738307|NCT00002303|Hematinics|hematinics|mesh-ancestor
64738308|NCT00002063|Zidovudine|zidovudine|mesh-list
64738309|NCT00002063|Antimetabolites|antimetabolites|mesh-ancestor
64738310|NCT00002063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738311|NCT00002063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738312|NCT00002063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738313|NCT00002063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738314|NCT00002063|Antiviral Agents|antiviral agents|mesh-ancestor
64350388|NCT05152355|Hormones|hormones|mesh-ancestor
64786389|NCT00002034|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786390|NCT00002034|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786391|NCT00002040|Fluconazole|fluconazole|mesh-list
64786392|NCT00002040|Antifungal Agents|antifungal agents|mesh-ancestor
64786393|NCT00002040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786394|NCT00002040|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64786395|NCT00002040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64786396|NCT00002040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317098|NCT02409537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317099|NCT02409537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64738315|NCT00002063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738316|NCT00002063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738317|NCT00002063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738318|NCT00002069|Ditiocarb|ditiocarb|mesh-list
64738319|NCT00002069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64738320|NCT00002069|Immunologic Factors|immunologic factors|mesh-ancestor
64738321|NCT00002069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738322|NCT00002069|Antiviral Agents|antiviral agents|mesh-ancestor
64350401|NCT03484091|Hylan|hylan|mesh-list
64321936|NCT02399397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321937|NCT02399397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64321938|NCT02399397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64321939|NCT02399397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64321940|NCT02399397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64321941|NCT02399397|GABA Modulators|gaba modulators|mesh-ancestor
64321942|NCT02399397|GABA Agents|gaba agents|mesh-ancestor
64317100|NCT03177993|Ivermectin|ivermectin|mesh-list
64317101|NCT03177993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64317102|NCT03177993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64317103|NCT04425590|Aspirin|aspirin|mesh-list
64317104|NCT04425590|Atorvastatin|atorvastatin|mesh-list
64317105|NCT04425590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64317106|NCT04425590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64317107|NCT04425590|Analgesics|analgesics|mesh-ancestor
64317108|NCT04425590|Sensory System Agents|sensory system agents|mesh-ancestor
64738323|NCT00002069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738324|NCT00002069|Chelating Agents|chelating agents|mesh-ancestor
64738325|NCT00002069|Sequestering Agents|sequestering agents|mesh-ancestor
64738326|NCT00002069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738327|NCT00001565|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64738328|NCT00001565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738329|NCT00002309|Azithromycin|azithromycin|mesh-list
64738330|NCT00002309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64738331|NCT00002309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738332|NCT00002315|Acyclovir|acyclovir|mesh-list
64738333|NCT00002315|5-propynylarabinofuranosyluracil|5-propynylarabinofuranosyluracil|mesh-list
64350407|NCT03486353|Antimetabolites|antimetabolites|mesh-ancestor
64321945|NCT02399397|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64321946|NCT02399397|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64321947|NCT02399397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64321948|NCT02221453|Triamcinolone|triamcinolone|mesh-list
64321949|NCT02221453|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64321950|NCT02221453|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64321951|NCT02221453|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64321952|NCT02221453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64321953|NCT02221453|Glucocorticoids|glucocorticoids|mesh-ancestor
64321955|NCT02221453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64321956|NCT02221453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321957|NCT02221453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64321958|NCT02221453|Immunologic Factors|immunologic factors|mesh-ancestor
64321959|NCT02221453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64321960|NCT02221453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321961|NCT03106545|Bupivacaine|bupivacaine|mesh-list
64321962|NCT03106545|Anesthetics, Local|anesthetics, local|mesh-ancestor
64321963|NCT03106545|Anesthetics|anesthetics|mesh-ancestor
64427747|NCT02170077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317109|NCT04425590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317110|NCT04425590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317111|NCT04425590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64317112|NCT04425590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64317113|NCT04425590|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64317114|NCT04425590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64317115|NCT04425590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786398|NCT00002040|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64786399|NCT00002040|Hormone Antagonists|hormone antagonists|mesh-ancestor
64738334|NCT00002315|Antiviral Agents|antiviral agents|mesh-ancestor
64738335|NCT00002315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738336|NCT00002075|Fluconazole|fluconazole|mesh-list
64738337|NCT00002075|Amphotericin B|amphotericin b|mesh-list
64738338|NCT00002075|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64738339|NCT00002075|Flucytosine|flucytosine|mesh-list
64738340|NCT00002075|Antifungal Agents|antifungal agents|mesh-ancestor
64738341|NCT00002075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738342|NCT00002075|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64738343|NCT00002075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64738344|NCT00002075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738345|NCT00002075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786400|NCT00002040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64786401|NCT00002040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786402|NCT00002040|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64786403|NCT00002040|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64786404|NCT00002046|Zidovudine|zidovudine|mesh-list
64786405|NCT00002046|Antimetabolites|antimetabolites|mesh-ancestor
64786441|NCT00002070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317116|NCT04425590|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64317117|NCT04425590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64317118|NCT04425590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317120|NCT04425590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64317121|NCT04425590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64317122|NCT04425590|Antimetabolites|antimetabolites|mesh-ancestor
64738346|NCT00002075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64738347|NCT00002075|Hormone Antagonists|hormone antagonists|mesh-ancestor
64738348|NCT00002075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64738349|NCT00002075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738350|NCT00002075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64738351|NCT00002075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64738352|NCT00002075|Amebicides|amebicides|mesh-ancestor
64738353|NCT00002075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64738354|NCT00002075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64738355|NCT00002075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64738356|NCT00002075|Antimetabolites|antimetabolites|mesh-ancestor
64738357|NCT00001577|Melphalan|melphalan|mesh-list
64738358|NCT00001577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64738366|NCT00002081|Zidovudine|zidovudine|mesh-list
64317123|NCT04425590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64317124|NCT04425590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64317126|NCT00707889|Folic Acid|folic acid|mesh-list
64317127|NCT00707889|Bevacizumab|bevacizumab|mesh-list
64317128|NCT00707889|Fluorouracil|fluorouracil|mesh-list
64786442|NCT00002070|Antiviral Agents|antiviral agents|mesh-ancestor
64786443|NCT00002070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786444|NCT00002070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738465|NCT00002345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64738466|NCT00002345|Contraceptive Agents|contraceptive agents|mesh-ancestor
64738467|NCT00002345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64738468|NCT00002345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738469|NCT00002345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64738470|NCT00002345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64738471|NCT00002345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64738472|NCT00002345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738473|NCT00002345|Appetite Stimulants|appetite stimulants|mesh-ancestor
64738474|NCT00002345|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64738475|NCT00002111|Saquinavir|saquinavir|mesh-list
64738476|NCT00002111|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64738477|NCT00002111|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64738478|NCT00002111|Protease Inhibitors|protease inhibitors|mesh-ancestor
64738479|NCT00002111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786445|NCT00002070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786446|NCT00002070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786447|NCT00002076|Fluconazole|fluconazole|mesh-list
64786448|NCT00002076|Antifungal Agents|antifungal agents|mesh-ancestor
64786449|NCT00002076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786450|NCT00002076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64786451|NCT00002076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64738521|NCT00002123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738522|NCT00002123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738523|NCT00002123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738524|NCT00002123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738525|NCT00002123|Antiviral Agents|antiviral agents|mesh-ancestor
64738526|NCT00002123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738527|NCT00002123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738528|NCT00002123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738529|NCT00381173|Cyclophosphamide|cyclophosphamide|mesh-list
64738530|NCT00381173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64738531|NCT00381173|Immunologic Factors|immunologic factors|mesh-ancestor
64738532|NCT00381173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786452|NCT00002076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786453|NCT00002076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786454|NCT00002076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64786455|NCT00002076|Hormone Antagonists|hormone antagonists|mesh-ancestor
64317130|NCT00707889|Levoleucovorin|levoleucovorin|mesh-list
64317131|NCT00707889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64317132|NCT00707889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64317133|NCT00707889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64738576|NCT00002135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738577|NCT00002141|Abacavir|abacavir|mesh-list
64738578|NCT00002141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738579|NCT00002141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738580|NCT00002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738581|NCT00002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738582|NCT00002141|Antiviral Agents|antiviral agents|mesh-ancestor
64738583|NCT00002141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738584|NCT00002141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738585|NCT00002141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738586|NCT00002369|Lamivudine|lamivudine|mesh-list
64738587|NCT00002369|Zidovudine|zidovudine|mesh-list
64738588|NCT00002369|Stavudine|stavudine|mesh-list
64738589|NCT00002369|Indinavir|indinavir|mesh-list
64738590|NCT00002369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738591|NCT00002369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738592|NCT00002369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738593|NCT00002369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738594|NCT00002369|Antiviral Agents|antiviral agents|mesh-ancestor
64738595|NCT00002369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738596|NCT00002369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738597|NCT00002369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738598|NCT00002369|Antimetabolites|antimetabolites|mesh-ancestor
64738599|NCT00002369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64738600|NCT00002369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64738601|NCT00002369|Protease Inhibitors|protease inhibitors|mesh-ancestor
64738602|NCT00002375|Nelfinavir|nelfinavir|mesh-list
64738603|NCT00002375|Indinavir|indinavir|mesh-list
64321975|NCT02231125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64317134|NCT00707889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64317135|NCT00707889|Growth Substances|growth substances|mesh-ancestor
64317136|NCT00707889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317137|NCT00707889|Growth Inhibitors|growth inhibitors|mesh-ancestor
64317138|NCT00707889|Antimetabolites|antimetabolites|mesh-ancestor
64317139|NCT00707889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317140|NCT00707889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64383747|NCT04591431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383748|NCT04591431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64383749|NCT04591431|Tubulin Modulators|tubulin modulators|mesh-ancestor
64383751|NCT04591431|Mitosis Modulators|mitosis modulators|mesh-ancestor
64383752|NCT04591431|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64383753|NCT05506137|Pilocarpine|pilocarpine|mesh-list
64383754|NCT05506137|Miotics|miotics|mesh-ancestor
64383755|NCT05506137|Autonomic Agents|autonomic agents|mesh-ancestor
64383756|NCT05506137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64383757|NCT05506137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383758|NCT05506137|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64738612|NCT00002375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738614|NCT00002381|Stavudine|stavudine|mesh-list
64738615|NCT00002381|Nelfinavir|nelfinavir|mesh-list
64738616|NCT00002381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738617|NCT00002381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738618|NCT00002381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738619|NCT00002381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738620|NCT00002381|Antiviral Agents|antiviral agents|mesh-ancestor
64738621|NCT00002381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64383759|NCT05506137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64383760|NCT05506137|Cholinergic Agents|cholinergic agents|mesh-ancestor
64383761|NCT05506137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64383762|NCT05506137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383763|NCT04742283|Timolol|timolol|mesh-list
64383764|NCT04742283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64383765|NCT04742283|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64383766|NCT04742283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383767|NCT04742283|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64383774|NCT04289805|Letrozole|letrozole|mesh-list
64383800|NCT05505591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64738658|NCT00002393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64738659|NCT00002393|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64738660|NCT00002393|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64738661|NCT00002393|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64738668|NCT00002399|Fluconazole|fluconazole|mesh-list
64383801|NCT05505591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64383802|NCT05505591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64383803|NCT05505591|Purinergic Agents|purinergic agents|mesh-ancestor
64383804|NCT05505591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64383805|NCT05505591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383806|NCT05505591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383807|NCT05448807|Phentolamine|phentolamine|mesh-list
64383808|NCT05448807|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64383809|NCT05448807|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64383810|NCT05448807|Adrenergic Agents|adrenergic agents|mesh-ancestor
64383811|NCT05448807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64321980|NCT02396433|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64321981|NCT02396433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64321982|NCT02396433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64321983|NCT02396433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321984|NCT02231203|Tocopherols|tocopherols|mesh-list
64321985|NCT02231203|Antioxidants|antioxidants|mesh-list
64738716|NCT00002423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738717|NCT00002423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738718|NCT00002423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738719|NCT00002423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738720|NCT00002423|Antiviral Agents|antiviral agents|mesh-ancestor
64383812|NCT05448807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786456|NCT00002076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64786457|NCT00002076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786458|NCT00002076|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64786493|NCT00002112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786494|NCT00002112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64786495|NCT00002112|Hormone Antagonists|hormone antagonists|mesh-ancestor
64786496|NCT00002112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64786497|NCT00002112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738771|NCT00002447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738772|NCT00002447|Antiviral Agents|antiviral agents|mesh-ancestor
64738773|NCT00002447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738774|NCT00002447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64738775|NCT00002447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64738776|NCT00002447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738777|NCT00002447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738778|NCT00002447|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64738779|NCT00002447|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64738780|NCT00002447|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64738781|NCT00002447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64738782|NCT00002447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64738783|NCT00002453|Tenofovir|tenofovir|mesh-list
64738784|NCT00002453|Antiviral Agents|antiviral agents|mesh-ancestor
64738785|NCT00002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738786|NCT00002453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738787|NCT00002453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738788|NCT00002453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738789|NCT00002453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738790|NCT00002453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738791|NCT00002453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738792|NCT00002465|Megestrol|megestrol|mesh-list
64786498|NCT00002112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64786499|NCT00002112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64786500|NCT00002112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64786501|NCT00002112|Ionophores|ionophores|mesh-ancestor
64786502|NCT00002112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64786503|NCT00002118|Zalcitabine|zalcitabine|mesh-list
64786504|NCT00002118|Antimetabolites|antimetabolites|mesh-ancestor
64786505|NCT00002118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786506|NCT00002118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786507|NCT00002118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64317141|NCT00707889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64317142|NCT00707889|Immunologic Factors|immunologic factors|mesh-ancestor
64317144|NCT00707889|Protective Agents|protective agents|mesh-ancestor
64317145|NCT00707889|Vitamin B Complex|vitamin b complex|mesh-ancestor
64317146|NCT00707889|Vitamins|vitamins|mesh-ancestor
64317147|NCT00707889|Micronutrients|micronutrients|mesh-ancestor
64317148|NCT00707889|Hematinics|hematinics|mesh-ancestor
64317149|NCT00109031|Cyclophosphamide|cyclophosphamide|mesh-list
64317150|NCT00109031|Etoposide|etoposide|mesh-list
64738809|NCT00002471|Methylprednisolone|methylprednisolone|mesh-list
64738810|NCT00002471|Hydrocortisone|hydrocortisone|mesh-list
64738811|NCT00002471|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64738812|NCT00002471|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64738813|NCT00002471|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64738814|NCT00002471|Cyclophosphamide|cyclophosphamide|mesh-list
64738815|NCT00002471|Thiotepa|thiotepa|mesh-list
64738816|NCT00002471|Methotrexate|methotrexate|mesh-list
64738817|NCT00002471|Etoposide|etoposide|mesh-list
64738818|NCT00002471|Vincristine|vincristine|mesh-list
64738819|NCT00002471|Daunorubicin|daunorubicin|mesh-list
64738820|NCT00002471|Asparaginase|asparaginase|mesh-list
64738821|NCT00002471|Levoleucovorin|levoleucovorin|mesh-list
64738822|NCT00002471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64738823|NCT00002471|Immunologic Factors|immunologic factors|mesh-ancestor
64738825|NCT00002471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64786550|NCT00002148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786552|NCT00002148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64786554|NCT00002154|Selegiline|selegiline|mesh-list
64786555|NCT00002154|Antidepressive Agents|antidepressive agents|mesh-ancestor
64786556|NCT00002154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64786557|NCT00002154|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64786558|NCT00002154|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64786567|NCT00002154|Vitamins|vitamins|mesh-ancestor
64786617|NCT00002184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786618|NCT00002184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738887|NCT00002489|Methotrexate|methotrexate|mesh-list
64738888|NCT00002489|Etoposide|etoposide|mesh-list
64738889|NCT00002489|Vincristine|vincristine|mesh-list
64738890|NCT00002489|Levoleucovorin|levoleucovorin|mesh-list
64738891|NCT00002489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64738892|NCT00002489|Immunologic Factors|immunologic factors|mesh-ancestor
64738893|NCT00002489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738894|NCT00002489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64738895|NCT00002489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64738896|NCT00002489|Alkylating Agents|alkylating agents|mesh-ancestor
64738897|NCT00002489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738898|NCT00002489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738899|NCT00002489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64738916|NCT00002489|Vitamins|vitamins|mesh-ancestor
64786619|NCT00002184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786620|NCT00002184|Antiviral Agents|antiviral agents|mesh-ancestor
64786621|NCT00002184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786622|NCT00002184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786623|NCT00002184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786624|NCT00002184|Antimetabolites|antimetabolites|mesh-ancestor
64786625|NCT00002184|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64786626|NCT00002184|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64786627|NCT00002184|Protease Inhibitors|protease inhibitors|mesh-ancestor
64317151|NCT00109031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64317152|NCT00109031|Immunologic Factors|immunologic factors|mesh-ancestor
64317153|NCT00109031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317154|NCT00109031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64317155|NCT00109031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64317156|NCT00109031|Alkylating Agents|alkylating agents|mesh-ancestor
64317157|NCT00109031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317159|NCT00109031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64317160|NCT00109031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64317161|NCT00109031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64317162|NCT00109031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64317163|NCT00109031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738964|NCT00002159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64738965|NCT00002159|Hormone Antagonists|hormone antagonists|mesh-ancestor
64738966|NCT00002159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64738967|NCT00002159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738968|NCT00002159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64738969|NCT00002159|Amebicides|amebicides|mesh-ancestor
64738970|NCT00002159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64738971|NCT00002159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64738972|NCT00002159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64738973|NCT00002165|Nelfinavir|nelfinavir|mesh-list
64738974|NCT00002165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64738975|NCT00002165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64738976|NCT00002165|Protease Inhibitors|protease inhibitors|mesh-ancestor
64738977|NCT00002165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738978|NCT00002165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738979|NCT00002165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738980|NCT00002165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738981|NCT00002165|Antiviral Agents|antiviral agents|mesh-ancestor
64738982|NCT00002165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738983|NCT00002171|Nelfinavir|nelfinavir|mesh-list
64738984|NCT00002171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64738985|NCT00002171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64738986|NCT00002171|Protease Inhibitors|protease inhibitors|mesh-ancestor
64738987|NCT00002171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351047|NCT05162183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427863|NCT02372383|Pancrelipase|pancrelipase|mesh-list
64317164|NCT02419443|Gabapentin|gabapentin|mesh-list
64317165|NCT02419443|Analgesics|analgesics|mesh-ancestor
64317166|NCT02419443|Sensory System Agents|sensory system agents|mesh-ancestor
64317167|NCT02419443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317169|NCT02419443|Anticonvulsants|anticonvulsants|mesh-ancestor
64317170|NCT02419443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64317171|NCT02419443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64317172|NCT02419443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64317173|NCT02419443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64317174|NCT02419443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64317175|NCT02419443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64317176|NCT02419443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64786628|NCT00002184|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64738988|NCT00002171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738989|NCT00002171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738990|NCT00002171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738991|NCT00002171|Antiviral Agents|antiviral agents|mesh-ancestor
64738992|NCT00002171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738993|NCT00002177|Stavudine|stavudine|mesh-list
64738994|NCT00002177|Didanosine|didanosine|mesh-list
64738995|NCT00002177|Nelfinavir|nelfinavir|mesh-list
64738996|NCT00002177|Hydroxyurea|hydroxyurea|mesh-list
64738997|NCT00002177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738998|NCT00002177|Antisickling Agents|antisickling agents|mesh-ancestor
64738999|NCT00002177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739011|NCT00002183|Lamivudine|lamivudine|mesh-list
64786629|NCT00002184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64786631|NCT00002190|Zidovudine|zidovudine|mesh-list
64786677|NCT00002214|Capravirine|capravirine|mesh-list
64786678|NCT00002214|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786679|NCT00002214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786680|NCT00002214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317177|NCT02419443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739036|NCT00002189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739037|NCT00002195|Lamivudine|lamivudine|mesh-list
64739038|NCT00002195|Zidovudine|zidovudine|mesh-list
64739039|NCT00002195|Amprenavir|amprenavir|mesh-list
64739040|NCT00002195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64739041|NCT00002195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64739042|NCT00002195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739043|NCT00002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739044|NCT00002195|Antiviral Agents|antiviral agents|mesh-ancestor
64739045|NCT00002195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739046|NCT00002195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64317178|NCT02419443|Antimanic Agents|antimanic agents|mesh-ancestor
64317179|NCT02409147|Nystatin|nystatin|mesh-list
64317180|NCT02409147|Prednisone|prednisone|mesh-list
64317181|NCT02409147|Thymoglobulin|thymoglobulin|mesh-list
64317182|NCT02409147|Basiliximab|basiliximab|mesh-list
64317183|NCT02409147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64317184|NCT02409147|Glucocorticoids|glucocorticoids|mesh-ancestor
64317185|NCT02409147|Hormones|hormones|mesh-ancestor
64317186|NCT02409147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64317187|NCT02409147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317188|NCT02409147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64317189|NCT02409147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64317191|NCT02409147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64317192|NCT02409147|Immunologic Factors|immunologic factors|mesh-ancestor
64739095|NCT00381251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739097|NCT00002219|Adefovir|adefovir|mesh-list
64739098|NCT00002219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64739099|NCT00002219|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64739100|NCT00002219|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64739101|NCT00002219|Protease Inhibitors|protease inhibitors|mesh-ancestor
64739102|NCT00002219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739103|NCT00002219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739104|NCT00002219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64739105|NCT00002219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64739106|NCT00002219|Antiviral Agents|antiviral agents|mesh-ancestor
64739107|NCT00002219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64317193|NCT02409147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64317194|NCT02409147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64317195|NCT02409147|Antifungal Agents|antifungal agents|mesh-ancestor
64317196|NCT02409147|Ionophores|ionophores|mesh-ancestor
64317197|NCT02409147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64317198|NCT05017103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64317199|NCT05017103|Antibodies|antibodies|mesh-list
64317200|NCT05017103|Immunoglobulins|immunoglobulins|mesh-list
64317201|NCT05017103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64317202|NCT05017103|Immunologic Factors|immunologic factors|mesh-ancestor
64317203|NCT05017103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317204|NCT05017103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64786681|NCT00002214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786682|NCT00002214|Antiviral Agents|antiviral agents|mesh-ancestor
64739144|NCT00002249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64739145|NCT00002249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64739146|NCT00002255|Zidovudine|zidovudine|mesh-list
64739158|NCT00002261|Vaccines|vaccines|mesh-list
64786683|NCT00002214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786684|NCT00002214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786685|NCT00002214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786686|NCT00002220|Efavirenz|efavirenz|mesh-list
64786687|NCT00002220|Adefovir|adefovir|mesh-list
64786688|NCT00002220|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64786689|NCT00002220|Indinavir|indinavir|mesh-list
64786739|NCT00002256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786740|NCT00002256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786808|NCT00002316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786809|NCT00002316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64786810|NCT00002316|Antifungal Agents|antifungal agents|mesh-ancestor
64317207|NCT02414919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64317208|NCT02414919|Contraceptive Agents|contraceptive agents|mesh-ancestor
64321994|NCT02231281|Lamivudine|lamivudine|mesh-list
64321995|NCT02231281|Zidovudine|zidovudine|mesh-list
64321996|NCT02231281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64321997|NCT02231281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64321998|NCT02231281|Protease Inhibitors|protease inhibitors|mesh-ancestor
64739201|NCT00002285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739202|NCT00002285|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64739203|NCT00002285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64739204|NCT00002285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739205|NCT00002285|Antiviral Agents|antiviral agents|mesh-ancestor
64739206|NCT00002285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739207|NCT00002285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64739208|NCT00002285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64739209|NCT00002531|Leucovorin|leucovorin|mesh-list
64739210|NCT00002531|Cytarabine|cytarabine|mesh-list
64739211|NCT00002531|Dexamethasone|dexamethasone|mesh-list
64739212|NCT00002531|Prednisolone|prednisolone|mesh-list
64739213|NCT00002531|Cyclophosphamide|cyclophosphamide|mesh-list
64317209|NCT02414919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64317210|NCT02414919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317211|NCT02414919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64317212|NCT02414919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64317213|NCT02414919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64317214|NCT05005559|Myeloma Proteins|myeloma proteins|mesh-list
64317215|NCT05005559|Paraproteins|paraproteins|mesh-list
64317216|NCT05005559|Immunologic Factors|immunologic factors|mesh-ancestor
64317217|NCT05005559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739278|NCT00002543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64739279|NCT00002543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739280|NCT00002543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739281|NCT00002291|Pentamidine|pentamidine|mesh-list
64739282|NCT00002291|Antifungal Agents|antifungal agents|mesh-ancestor
64739283|NCT00002291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739284|NCT00002291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64739285|NCT00002291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64739286|NCT00002291|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64739287|NCT00002549|Cytarabine|cytarabine|mesh-list
64739288|NCT00002549|Cyclophosphamide|cyclophosphamide|mesh-list
64739289|NCT00002549|Busulfan|busulfan|mesh-list
64739290|NCT00002549|Etoposide|etoposide|mesh-list
64739291|NCT00002549|Daunorubicin|daunorubicin|mesh-list
64739292|NCT00002549|Mitoxantrone|mitoxantrone|mesh-list
64739293|NCT00002549|Idarubicin|idarubicin|mesh-list
64739294|NCT00002549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64739295|NCT00002549|Immunologic Factors|immunologic factors|mesh-ancestor
64739296|NCT00002549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739297|NCT00002549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64739298|NCT00002549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64739299|NCT00002549|Alkylating Agents|alkylating agents|mesh-ancestor
64739300|NCT00002549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739301|NCT00002549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739302|NCT00002549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64739303|NCT00002549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64739304|NCT00002549|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64739305|NCT00002549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64739308|NCT00002549|Antimetabolites|antimetabolites|mesh-ancestor
64317218|NCT05543954|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64317219|NCT05543954|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64317220|NCT05543954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317222|NCT02408679|Vitamins|vitamins|mesh-ancestor
64317223|NCT02408679|Micronutrients|micronutrients|mesh-ancestor
64317224|NCT02408679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317225|NCT02408679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64317226|NCT04486781|Pembrolizumab|pembrolizumab|mesh-list
64317227|NCT04486781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64317228|NCT04486781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64317229|NCT05089565|Interferons|interferons|mesh-list
64317230|NCT05089565|Interferon-gamma|interferon-gamma|mesh-list
64786813|NCT00002322|Antimetabolites|antimetabolites|mesh-ancestor
64786814|NCT00002322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786815|NCT00002322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64786816|NCT00002322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786817|NCT00002322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786818|NCT00002322|Antiviral Agents|antiviral agents|mesh-ancestor
64786819|NCT00002322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786820|NCT00002322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786821|NCT00002322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786822|NCT00002328|Azithromycin|azithromycin|mesh-list
64786823|NCT00002328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64786824|NCT00002328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786825|NCT00002334|Zidovudine|zidovudine|mesh-list
64786826|NCT00002334|Zalcitabine|zalcitabine|mesh-list
64322014|NCT02231359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322015|NCT02231359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64322016|NCT02231359|Respiratory System Agents|respiratory system agents|mesh-ancestor
64322017|NCT02780687|Afatinib|afatinib|mesh-list
64739366|NCT00002579|Hormone Antagonists|hormone antagonists|mesh-ancestor
64739367|NCT00002579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64739368|NCT00002579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64739369|NCT00002579|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64739370|NCT00002579|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64739371|NCT00002579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64739372|NCT00002585|NSC 366140|nsc 366140|mesh-list
64739373|NCT00002585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739374|NCT00002609|Cytarabine|cytarabine|mesh-list
64739375|NCT00002609|Idarubicin|idarubicin|mesh-list
64739376|NCT00002609|Lintuzumab|lintuzumab|mesh-list
64739377|NCT00002609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64739378|NCT00002609|Antimetabolites|antimetabolites|mesh-ancestor
64739379|NCT00002609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739380|NCT00002609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739381|NCT00002609|Antiviral Agents|antiviral agents|mesh-ancestor
64739382|NCT00002609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739383|NCT00002609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64739384|NCT00002609|Immunologic Factors|immunologic factors|mesh-ancestor
64786827|NCT00002334|Saquinavir|saquinavir|mesh-list
64786865|NCT00002352|Antiviral Agents|antiviral agents|mesh-ancestor
64786866|NCT00002352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786867|NCT00002352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64786868|NCT00002358|Sorivudine|sorivudine|mesh-list
64786869|NCT00002358|Antiviral Agents|antiviral agents|mesh-ancestor
64786870|NCT00002358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786871|NCT00002358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317233|NCT05089565|Immunologic Factors|immunologic factors|mesh-ancestor
64317234|NCT05089565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317235|NCT05089565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739408|NCT00002621|Antiviral Agents|antiviral agents|mesh-ancestor
64739409|NCT00002621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739410|NCT00002621|Immunologic Factors|immunologic factors|mesh-ancestor
64739411|NCT00002621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739413|NCT00002627|Cyclophosphamide|cyclophosphamide|mesh-list
64739414|NCT00002627|Carboplatin|carboplatin|mesh-list
64739415|NCT00002627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64739416|NCT00002627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739417|NCT00002627|Tubulin Modulators|tubulin modulators|mesh-ancestor
64739418|NCT00002627|Antimitotic Agents|antimitotic agents|mesh-ancestor
64739419|NCT00002627|Mitosis Modulators|mitosis modulators|mesh-ancestor
64317236|NCT05089565|Antiviral Agents|antiviral agents|mesh-ancestor
64317237|NCT05089565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64317238|NCT03174171|Everolimus|everolimus|mesh-list
64317239|NCT03174171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64786872|NCT00002358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786930|NCT00002388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64786931|NCT00002388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64786932|NCT00002394|Terbinafine|terbinafine|mesh-list
64786933|NCT00002394|Antifungal Agents|antifungal agents|mesh-ancestor
64739448|NCT00002639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739449|NCT00002639|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64739450|NCT00002639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64739451|NCT00002657|Interferons|interferons|mesh-list
64739453|NCT00002657|Interferon-alpha|interferon-alpha|mesh-list
64739454|NCT00002657|Prednisone|prednisone|mesh-list
64739455|NCT00002657|Cyclophosphamide|cyclophosphamide|mesh-list
64739456|NCT00002657|Doxorubicin|doxorubicin|mesh-list
64739457|NCT00002657|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64739458|NCT00002657|Methotrexate|methotrexate|mesh-list
64739459|NCT00002657|Etoposide|etoposide|mesh-list
64739460|NCT00002657|Vincristine|vincristine|mesh-list
64739461|NCT00002657|Bleomycin|bleomycin|mesh-list
64739462|NCT00002657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64739463|NCT00002657|Immunologic Factors|immunologic factors|mesh-ancestor
64739464|NCT00002657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739465|NCT00002657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64739466|NCT00002657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64739467|NCT00002657|Alkylating Agents|alkylating agents|mesh-ancestor
64739468|NCT00002657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739469|NCT00002657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739470|NCT00002657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64739471|NCT00002657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64739472|NCT00002657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64739473|NCT00002657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64478812|NCT01875367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739474|NCT00002657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739475|NCT00002657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64739476|NCT00002657|Glucocorticoids|glucocorticoids|mesh-ancestor
64739477|NCT00002657|Hormones|hormones|mesh-ancestor
64739494|NCT05673785|Prednisone|prednisone|mesh-list
64739495|NCT05673785|Cyclophosphamide|cyclophosphamide|mesh-list
64739496|NCT05673785|Doxorubicin|doxorubicin|mesh-list
64786934|NCT00002394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64786935|NCT00002394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64786936|NCT00002394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64786937|NCT00002400|Lamivudine|lamivudine|mesh-list
64786938|NCT00002400|Zidovudine|zidovudine|mesh-list
64786939|NCT00002400|Delavirdine|delavirdine|mesh-list
64786999|NCT00002424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64787000|NCT00002424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64317240|NCT03174171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64317241|NCT03174171|Immunologic Factors|immunologic factors|mesh-ancestor
64317242|NCT03174171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317243|NCT02414529|Vitamin D|vitamin d|mesh-list
64317244|NCT02414529|Ergocalciferols|ergocalciferols|mesh-list
64317245|NCT02414529|Cholecalciferol|cholecalciferol|mesh-list
64739500|NCT05673785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739501|NCT05673785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64739502|NCT05673785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64739503|NCT05673785|Alkylating Agents|alkylating agents|mesh-ancestor
64739504|NCT05673785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739505|NCT05673785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739506|NCT05673785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64739507|NCT05673785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64739508|NCT05673785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64739509|NCT05673785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64739510|NCT05673785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317246|NCT02414529|Vitamins|vitamins|mesh-list
64317247|NCT02414529|Micronutrients|micronutrients|mesh-ancestor
64317248|NCT02414529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317249|NCT02414529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64317250|NCT02414529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64317252|NCT02418273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64317253|NCT02418273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317254|NCT02414685|Paclitaxel|paclitaxel|mesh-list
64317255|NCT02414685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64317256|NCT02414685|Cisplatin|cisplatin|mesh-list
64787001|NCT00002424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739570|NCT00002681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739571|NCT02973113|Nivolumab|nivolumab|mesh-list
64739572|NCT02973113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64739573|NCT02973113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739574|NCT02973113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64739575|NCT02973113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739576|NCT00002687|Aldesleukin|aldesleukin|mesh-list
64739577|NCT00002687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739578|NCT00002687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64739579|NCT00002687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64739580|NCT00002687|Antiviral Agents|antiviral agents|mesh-ancestor
64739581|NCT00002687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739582|NCT00002693|Carboplatin|carboplatin|mesh-list
64739583|NCT00002693|Topotecan|topotecan|mesh-list
64739584|NCT00002693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739585|NCT00002693|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64739586|NCT00002693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64787002|NCT00002424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787003|NCT00002424|Antiviral Agents|antiviral agents|mesh-ancestor
64787004|NCT00002424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64787005|NCT00002424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64787006|NCT00002424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64787011|NCT00002430|Lamivudine|lamivudine|mesh-list
64787067|NCT00002448|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64787068|NCT00002448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64787069|NCT00002448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64787070|NCT00002448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64739618|NCT00002723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64739619|NCT05645393|Estrogens|estrogens|mesh-list
64739620|NCT05645393|Hormones|hormones|mesh-ancestor
64739621|NCT05645393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64739622|NCT05645393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739623|NCT00002735|Cobalt|cobalt|mesh-list
64739624|NCT00002735|Cisplatin|cisplatin|mesh-list
64739625|NCT00002735|Fluorouracil|fluorouracil|mesh-list
64322040|NCT02398929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322046|NCT02398929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739626|NCT00002735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739628|NCT00002735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739629|NCT00002735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64739630|NCT00002735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64739631|NCT00002735|Immunologic Factors|immunologic factors|mesh-ancestor
64739632|NCT00002735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739633|NCT00002735|Trace Elements|trace elements|mesh-ancestor
64739634|NCT00002735|Micronutrients|micronutrients|mesh-ancestor
64739636|NCT00002747|Fluorouracil|fluorouracil|mesh-list
64739637|NCT00002747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739638|NCT00002747|Antimetabolites|antimetabolites|mesh-ancestor
64739639|NCT00002747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739640|NCT00002747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64739641|NCT00002747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64739693|NCT00002771|Cytarabine|cytarabine|mesh-list
64317257|NCT02414685|Ifosfamide|ifosfamide|mesh-list
64317258|NCT02414685|Isophosphamide mustard|isophosphamide mustard|mesh-list
64317259|NCT02414685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64317260|NCT02414685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64317263|NCT02414685|Mitosis Modulators|mitosis modulators|mesh-ancestor
64317264|NCT02414685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317265|NCT02414685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64317266|NCT02414685|Alkylating Agents|alkylating agents|mesh-ancestor
64317267|NCT04425824|Rituximab|rituximab|mesh-list
64787071|NCT00002448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64739701|NCT00002771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64739702|NCT00002771|Antimetabolites|antimetabolites|mesh-ancestor
64739703|NCT00002771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739704|NCT00002771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64739705|NCT00002771|Immunologic Factors|immunologic factors|mesh-ancestor
64739706|NCT00002771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739707|NCT00002771|Alkylating Agents|alkylating agents|mesh-ancestor
64739708|NCT00002771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64739709|NCT00002771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64739710|NCT00002771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64739711|NCT00002771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64787072|NCT00002448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64787073|NCT00002448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64787074|NCT00002448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64787075|NCT00002448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64787076|NCT00002460|Tamoxifen|tamoxifen|mesh-list
64787077|NCT00002460|Goserelin|goserelin|mesh-list
64787078|NCT00002460|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64787079|NCT00002460|Hormone Antagonists|hormone antagonists|mesh-ancestor
64787080|NCT00002460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64787123|NCT00002478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787125|NCT00002490|Mitomycin|mitomycin|mesh-list
64317268|NCT04425824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64739793|NCT00382343|Antimalarials|antimalarials|mesh-ancestor
64739794|NCT00382343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64739795|NCT00382343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64739796|NCT00382343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64351855|NCT01378325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64739798|NCT00382343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739799|NCT00382343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64739800|NCT00382343|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64739801|NCT00382343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64739802|NCT00382343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64739803|NCT05749445|Ritonavir|ritonavir|mesh-list
64739804|NCT05749445|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64739805|NCT05749445|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64739806|NCT05749445|Protease Inhibitors|protease inhibitors|mesh-ancestor
64739807|NCT05749445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739808|NCT05749445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739809|NCT05749445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64739810|NCT05749445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64739811|NCT05749445|Antiviral Agents|antiviral agents|mesh-ancestor
64739812|NCT05749445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739813|NCT05749445|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64739814|NCT05749445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64739815|NCT05749367|Ropivacaine|ropivacaine|mesh-list
64739816|NCT05749367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64317269|NCT04425824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64317270|NCT04425824|Immunologic Factors|immunologic factors|mesh-ancestor
64317271|NCT04425824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317272|NCT04425824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64317273|NCT02414451|Propranolol|propranolol|mesh-list
64317274|NCT02414451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64317275|NCT02414451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64787127|NCT00002490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64787128|NCT00002490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787129|NCT00002490|Alkylating Agents|alkylating agents|mesh-ancestor
64787130|NCT00002490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787136|NCT00002496|Cobalt|cobalt|mesh-list
64787192|NCT00002514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787193|NCT00002514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787194|NCT00002514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64787195|NCT00002514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64787196|NCT00002514|Antiemetics|antiemetics|mesh-ancestor
64787197|NCT00002514|Autonomic Agents|autonomic agents|mesh-ancestor
64739828|NCT05749211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64739829|NCT05749211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787198|NCT00002514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64787199|NCT00002514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64787200|NCT00002514|Glucocorticoids|glucocorticoids|mesh-ancestor
64787201|NCT00002514|Hormones|hormones|mesh-ancestor
64787202|NCT00002514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64787203|NCT00002514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64317276|NCT02414451|Adrenergic Agents|adrenergic agents|mesh-ancestor
64739870|NCT05561387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64739871|NCT05561387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64739872|NCT05561387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739873|NCT05561387|Protease Inhibitors|protease inhibitors|mesh-ancestor
64739874|NCT05561387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739875|NCT05561387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739882|NCT05545319|Ritonavir|ritonavir|mesh-list
64317277|NCT02414451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64317278|NCT02414451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317279|NCT02414451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317280|NCT02414451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64317281|NCT02414451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64317282|NCT02414451|Vasodilator Agents|vasodilator agents|mesh-ancestor
64787204|NCT00002514|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64787206|NCT00002514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64787207|NCT00002514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64787218|NCT00002514|Antidotes|antidotes|mesh-ancestor
64787249|NCT00002532|Leucovorin|leucovorin|mesh-list
64739930|NCT05215691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64739931|NCT05215691|Narcotics|narcotics|mesh-ancestor
64739932|NCT05215691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64739933|NCT05215691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739934|NCT05215691|Analgesics|analgesics|mesh-ancestor
64739935|NCT05215691|Sensory System Agents|sensory system agents|mesh-ancestor
64739936|NCT05215691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64739937|NCT05204147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64739938|NCT05204147|Antibodies|antibodies|mesh-list
64739939|NCT05204147|Immunoglobulins|immunoglobulins|mesh-list
64739940|NCT05204147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64739941|NCT05204147|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
64739942|NCT05204147|Immunologic Factors|immunologic factors|mesh-ancestor
64739943|NCT05204147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739944|NCT05204147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739945|NCT05204147|Chelating Agents|chelating agents|mesh-ancestor
64739946|NCT05204147|Sequestering Agents|sequestering agents|mesh-ancestor
64739947|NCT05204147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322068|NCT02396043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322069|NCT02396043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64322070|NCT02396043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64322071|NCT02396043|Alkylating Agents|alkylating agents|mesh-ancestor
64322072|NCT02396043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787250|NCT00002532|Cytarabine|cytarabine|mesh-list
64787251|NCT00002532|Dexamethasone|dexamethasone|mesh-list
64787252|NCT00002532|Prednisolone|prednisolone|mesh-list
64787253|NCT00002532|Methotrexate|methotrexate|mesh-list
64317283|NCT02408289|Proanthocyanidin|proanthocyanidin|mesh-list
64317284|NCT02408289|Procyanidin|procyanidin|mesh-list
64317285|NCT02408289|Antioxidants|antioxidants|mesh-ancestor
64317286|NCT02408289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317287|NCT02408289|Protective Agents|protective agents|mesh-ancestor
64317288|NCT02408289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317289|NCT02408289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64317290|NCT02408289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64317291|NCT02408289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64317292|NCT02417883|Furosemide|furosemide|mesh-list
64317293|NCT02417883|Diuretics|diuretics|mesh-ancestor
64317294|NCT02417883|Natriuretic Agents|natriuretic agents|mesh-ancestor
64317295|NCT02417883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739953|NCT04824053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739954|NCT04824053|Trace Elements|trace elements|mesh-ancestor
64739955|NCT04824053|Micronutrients|micronutrients|mesh-ancestor
64739956|NCT04824053|Chelating Agents|chelating agents|mesh-ancestor
64739957|NCT04824053|Sequestering Agents|sequestering agents|mesh-ancestor
64739958|NCT04811339|Bismuth|bismuth|mesh-list
64739959|NCT04811339|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
64739960|NCT04811339|Antacids|antacids|mesh-ancestor
64739961|NCT04811339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739962|NCT04811339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64739963|NCT04811339|Antidiarrheals|antidiarrheals|mesh-ancestor
64739964|NCT05167409|Pembrolizumab|pembrolizumab|mesh-list
64739965|NCT05167409|Cetuximab|cetuximab|mesh-list
64739966|NCT05167409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64317296|NCT02417883|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64317297|NCT02417883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64317298|NCT02417883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317299|NCT01664624|Exenatide|exenatide|mesh-list
64317300|NCT01664624|Alogliptin|alogliptin|mesh-list
64317301|NCT01664624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64317302|NCT01664624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317317|NCT05540834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64317318|NCT05540834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317319|NCT05696132|Povidone-Iodine|povidone-iodine|mesh-list
64317320|NCT05696132|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64317321|NCT05696132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64317322|NCT02407899|Vitamin D|vitamin d|mesh-list
64317323|NCT02407899|Cholecalciferol|cholecalciferol|mesh-list
64317324|NCT02407899|Insulin|insulin|mesh-list
64739996|NCT04735367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64322087|NCT02396043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64322088|NCT02396043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64322089|NCT02396043|Antimetabolites|antimetabolites|mesh-ancestor
64322090|NCT02396043|Dermatologic Agents|dermatologic agents|mesh-ancestor
64322091|NCT02396043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64317325|NCT02407899|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64317326|NCT02407899|Metformin|metformin|mesh-list
64317327|NCT02407899|Saxagliptin|saxagliptin|mesh-list
64317329|NCT02407899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64787254|NCT00002532|Etoposide|etoposide|mesh-list
64787255|NCT00002532|Daunorubicin|daunorubicin|mesh-list
64787256|NCT00002532|Asparaginase|asparaginase|mesh-list
64787257|NCT00002532|Ifosfamide|ifosfamide|mesh-list
64787321|NCT00002550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787322|NCT00002556|Interferons|interferons|mesh-list
64787323|NCT00002556|Interferon-alpha|interferon-alpha|mesh-list
64787324|NCT00002556|Interferon alpha-2|interferon alpha-2|mesh-list
64787325|NCT00002556|Prednisone|prednisone|mesh-list
64787326|NCT00002556|Cyclophosphamide|cyclophosphamide|mesh-list
64740041|NCT05049863|Mycophenolic Acid|mycophenolic acid|mesh-list
64740042|NCT05049863|Irinotecan|irinotecan|mesh-list
64740043|NCT05049863|Allopurinol|allopurinol|mesh-list
64740044|NCT05049863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64740045|NCT05049863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64740046|NCT05049863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740047|NCT05049863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740048|NCT05049863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740049|NCT05049863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64740050|NCT05049863|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64740051|NCT05049863|Antitubercular Agents|antitubercular agents|mesh-ancestor
64740052|NCT05049863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64740053|NCT05049863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64740054|NCT05049863|Antimetabolites|antimetabolites|mesh-ancestor
64740055|NCT05049863|Gout Suppressants|gout suppressants|mesh-ancestor
64740056|NCT05049863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64740057|NCT05049863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64740058|NCT05049863|Antioxidants|antioxidants|mesh-ancestor
64740059|NCT05049863|Protective Agents|protective agents|mesh-ancestor
64740060|NCT05049863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740061|NCT05312255|Propranolol|propranolol|mesh-list
64787327|NCT00002556|Melphalan|melphalan|mesh-list
64787328|NCT00002556|Carmustine|carmustine|mesh-list
64787329|NCT00002556|Vincristine|vincristine|mesh-list
64787330|NCT00002556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64787331|NCT00002556|Immunologic Factors|immunologic factors|mesh-ancestor
64317334|NCT02407899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64317335|NCT02407899|Incretins|incretins|mesh-ancestor
64317336|NCT02407899|Hormones|hormones|mesh-ancestor
64317337|NCT02407899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64317338|NCT02407899|Protease Inhibitors|protease inhibitors|mesh-ancestor
64317339|NCT02407899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317340|NCT02407899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317341|NCT02417493|Epinephrine|epinephrine|mesh-list
64322099|NCT02396043|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64322100|NCT02396043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64740083|NCT05015621|Immunologic Factors|immunologic factors|mesh-ancestor
64740084|NCT05015621|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64740085|NCT05015621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64740086|NCT05015621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740087|NCT05015621|Antidotes|antidotes|mesh-ancestor
64740088|NCT05015621|Protective Agents|protective agents|mesh-ancestor
64740089|NCT05015621|Vitamin B Complex|vitamin b complex|mesh-ancestor
64740090|NCT05015621|Vitamins|vitamins|mesh-ancestor
64740091|NCT05015621|Micronutrients|micronutrients|mesh-ancestor
64317342|NCT02417493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64317343|NCT02417493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64317344|NCT02417493|Adrenergic Agents|adrenergic agents|mesh-ancestor
64317345|NCT02417493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64317346|NCT02417493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317347|NCT02417493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317348|NCT02417493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64378265|NCT04807413|Gasotransmitters|gasotransmitters|mesh-ancestor
64787332|NCT00002556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787386|NCT00002580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64787387|NCT00002580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64787388|NCT00002580|Alkylating Agents|alkylating agents|mesh-ancestor
64787458|NCT00002598|Dermatologic Agents|dermatologic agents|mesh-ancestor
64787459|NCT00002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64787460|NCT00002598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64787461|NCT00002598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64787462|NCT00002598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64787528|NCT00002628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740093|NCT05007509|Immunologic Factors|immunologic factors|mesh-ancestor
64740094|NCT05007509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740095|NCT05289167|Cyclophosphamide|cyclophosphamide|mesh-list
64740096|NCT05289167|Bortezomib|bortezomib|mesh-list
64740097|NCT05289167|Abatacept|abatacept|mesh-list
64740098|NCT05289167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64740099|NCT05289167|Immunologic Factors|immunologic factors|mesh-ancestor
64740100|NCT05289167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740101|NCT05289167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64740102|NCT05289167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64740103|NCT05289167|Alkylating Agents|alkylating agents|mesh-ancestor
64740104|NCT05289167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428816|NCT02187159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64428819|NCT02335411|Pembrolizumab|pembrolizumab|mesh-list
64787529|NCT00002628|Tubulin Modulators|tubulin modulators|mesh-ancestor
64787530|NCT00002628|Antimitotic Agents|antimitotic agents|mesh-ancestor
64787531|NCT00002628|Mitosis Modulators|mitosis modulators|mesh-ancestor
64317349|NCT02417493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64317350|NCT02417493|Autonomic Agents|autonomic agents|mesh-ancestor
64317351|NCT02417493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317352|NCT02417493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64317353|NCT02417493|Respiratory System Agents|respiratory system agents|mesh-ancestor
64317354|NCT02417493|Mydriatics|mydriatics|mesh-ancestor
64317355|NCT02417493|Sympathomimetics|sympathomimetics|mesh-ancestor
64317356|NCT02417493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64317357|NCT05540600|Digoxin|digoxin|mesh-list
64317358|NCT05540600|Bisoprolol|bisoprolol|mesh-list
64479485|NCT01845025|Xhance|xhance|mesh-list
64317359|NCT05540600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64317360|NCT05540600|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64317361|NCT05540600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317362|NCT05540600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317363|NCT05540600|Protective Agents|protective agents|mesh-ancestor
64317364|NCT05540600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317365|NCT05540600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64317366|NCT05540600|Sympatholytics|sympatholytics|mesh-ancestor
64322105|NCT03544073|Leuprolide|leuprolide|mesh-list
64322106|NCT03544073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64352312|NCT03463967|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64352313|NCT03463967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352314|NCT03463733|Temozolomide|temozolomide|mesh-list
64740235|NCT04328285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64740236|NCT04328285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64740237|NCT04328285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64317367|NCT05540600|Autonomic Agents|autonomic agents|mesh-ancestor
64317368|NCT05540600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317369|NCT05540600|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64317370|NCT05540600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64317371|NCT05540600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64317372|NCT05540600|Adrenergic Agents|adrenergic agents|mesh-ancestor
64317373|NCT05540600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64787532|NCT00002628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787600|NCT00002658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64787601|NCT00002658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64787602|NCT00002658|Alkylating Agents|alkylating agents|mesh-ancestor
64787603|NCT00002658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740288|NCT04481243|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64740289|NCT04481243|Immunologic Factors|immunologic factors|mesh-ancestor
64740290|NCT04481243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740291|NCT04431635|Rituximab|rituximab|mesh-list
64740292|NCT04431635|Nivolumab|nivolumab|mesh-list
64740293|NCT04431635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64740294|NCT04431635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740295|NCT04431635|Immunologic Factors|immunologic factors|mesh-ancestor
64740296|NCT04431635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740297|NCT04431635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64740298|NCT04431635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64740299|NCT04431635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740300|NCT03575195|Rifaximin|rifaximin|mesh-list
64740301|NCT03575195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64740302|NCT03575195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64740303|NCT03575195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64740304|NCT00002897|Fluorouracil|fluorouracil|mesh-list
64740305|NCT00002897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740306|NCT00002897|Antimetabolites|antimetabolites|mesh-ancestor
64740307|NCT00002897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740308|NCT00002897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64740309|NCT00002897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64740310|NCT00002897|Immunologic Factors|immunologic factors|mesh-ancestor
64740311|NCT00002897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740312|NCT00002903|Docetaxel|docetaxel|mesh-list
64740313|NCT00002903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740314|NCT00002903|Tubulin Modulators|tubulin modulators|mesh-ancestor
64740315|NCT00002903|Antimitotic Agents|antimitotic agents|mesh-ancestor
64428997|NCT05319431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64787604|NCT00002658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787672|NCT00002676|Antimitotic Agents|antimitotic agents|mesh-ancestor
64787673|NCT00002676|Mitosis Modulators|mitosis modulators|mesh-ancestor
64787674|NCT00002676|Trace Elements|trace elements|mesh-ancestor
64317374|NCT02417649|Broncho-Vaxom|broncho-vaxom|mesh-list
64317375|NCT02417649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64317376|NCT02417649|Immunologic Factors|immunologic factors|mesh-ancestor
64317377|NCT02417649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317379|NCT03265574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64317380|NCT03265574|Protease Inhibitors|protease inhibitors|mesh-ancestor
64352365|NCT05096715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64740317|NCT00002903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740318|NCT03375203|Zolpidem|zolpidem|mesh-list
64740319|NCT03375203|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64740320|NCT03375203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64740321|NCT03375203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64740322|NCT03375203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740323|NCT03375203|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64740324|NCT03375203|GABA Agonists|gaba agonists|mesh-ancestor
64740325|NCT03375203|GABA Agents|gaba agents|mesh-ancestor
64740326|NCT03375203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64740327|NCT03375203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740328|NCT00002909|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64740329|NCT00002909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740330|NCT00002915|Penclomedine|penclomedine|mesh-list
64740331|NCT00002915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740332|NCT00002921|Suramin|suramin|mesh-list
64740333|NCT00002921|Hydrocortisone|hydrocortisone|mesh-list
64740334|NCT00002921|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64740335|NCT00002921|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64740336|NCT00002921|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64740337|NCT00002921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64740338|NCT00002921|Antinematodal Agents|antinematodal agents|mesh-ancestor
64352405|NCT03522753|Hormones|hormones|mesh-ancestor
64322108|NCT03544073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64322109|NCT03544073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322110|NCT03544073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64322111|NCT03544073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322112|NCT02398383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64317381|NCT03265574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317382|NCT03265574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317383|NCT03265574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64317384|NCT03177837|Acetazolamide|acetazolamide|mesh-list
64317385|NCT03177837|Anticonvulsants|anticonvulsants|mesh-ancestor
64317386|NCT03177837|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64317387|NCT03177837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317388|NCT03177837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317389|NCT03177837|Diuretics|diuretics|mesh-ancestor
64317390|NCT03177837|Natriuretic Agents|natriuretic agents|mesh-ancestor
64317391|NCT03177837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317392|NCT02414373|Bupivacaine|bupivacaine|mesh-list
64317393|NCT02414373|Ropivacaine|ropivacaine|mesh-list
64317394|NCT02414373|Anesthetics, Local|anesthetics, local|mesh-ancestor
64317395|NCT02414373|Anesthetics|anesthetics|mesh-ancestor
64317396|NCT02414373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64317397|NCT02414373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317398|NCT02414373|Sensory System Agents|sensory system agents|mesh-ancestor
64317399|NCT02414373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317400|NCT04320290|Antiviral Agents|antiviral agents|mesh-list
64378313|NCT04805775|Desflurane|desflurane|mesh-list
64378314|NCT04805775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64787677|NCT00002682|Metronidazole|metronidazole|mesh-list
64787678|NCT00002682|Clarithromycin|clarithromycin|mesh-list
64787746|NCT00002700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64787747|NCT00002700|Antiemetics|antiemetics|mesh-ancestor
64787748|NCT00002700|Autonomic Agents|autonomic agents|mesh-ancestor
64740339|NCT00002921|Anthelmintics|anthelmintics|mesh-ancestor
64740340|NCT00002921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64740341|NCT00002921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64740342|NCT00002921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740343|NCT00002921|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64740344|NCT00002921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64740345|NCT00383045|Naltrexone|naltrexone|mesh-list
64740346|NCT00383045|Buprenorphine|buprenorphine|mesh-list
64740347|NCT00383045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64740348|NCT00383045|Narcotics|narcotics|mesh-ancestor
64787749|NCT00002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64787750|NCT00002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64787751|NCT00002700|Glucocorticoids|glucocorticoids|mesh-ancestor
64787752|NCT00002700|Hormones|hormones|mesh-ancestor
64787753|NCT00002700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64787754|NCT00002700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64787755|NCT00002700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64787756|NCT00002700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64787810|NCT00002730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64787811|NCT00002730|Alkylating Agents|alkylating agents|mesh-ancestor
64787812|NCT00002730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787813|NCT00002730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787814|NCT00002730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64787815|NCT00002730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64787879|NCT00002772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787880|NCT00002772|Tubulin Modulators|tubulin modulators|mesh-ancestor
64787881|NCT00002772|Antimitotic Agents|antimitotic agents|mesh-ancestor
64787882|NCT00002772|Mitosis Modulators|mitosis modulators|mesh-ancestor
64787883|NCT00002772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787902|NCT00002778|Sargramostim|sargramostim|mesh-list
64787946|NCT00002790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64317402|NCT03173235|Vitamin D|vitamin d|mesh-list
64317403|NCT03173235|Vitamins|vitamins|mesh-ancestor
64317404|NCT03173235|Micronutrients|micronutrients|mesh-ancestor
64317405|NCT03173235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317406|NCT03173235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64317407|NCT05697692|Heparin|heparin|mesh-list
64317408|NCT05697692|Calcium heparin|calcium heparin|mesh-list
64317409|NCT05697692|Anticoagulants|anticoagulants|mesh-ancestor
64317410|NCT05697692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64317411|NCT05697692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64317412|NCT05697692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317413|NCT02761057|Sunitinib|sunitinib|mesh-list
64322113|NCT02398383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322115|NCT03168087|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64322116|NCT03168087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64322117|NCT02781311|Finasteride|finasteride|mesh-list
64317414|NCT02761057|Crizotinib|crizotinib|mesh-list
64317415|NCT02761057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64317416|NCT02761057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64317417|NCT02761057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64317418|NCT02761057|Growth Substances|growth substances|mesh-ancestor
64317419|NCT02761057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317420|NCT02761057|Growth Inhibitors|growth inhibitors|mesh-ancestor
64317421|NCT02761057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64317422|NCT02761057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317423|NCT02761057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787947|NCT00002790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64787948|NCT00002790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64787949|NCT00002790|Antimetabolites|antimetabolites|mesh-ancestor
64945437|NCT05633615|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64787950|NCT00002790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64787951|NCT00002790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64787952|NCT00002790|Dermatologic Agents|dermatologic agents|mesh-ancestor
64788010|NCT05749614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64788011|NCT05749614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64788012|NCT05749614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64740400|NCT00002945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740401|NCT00002945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740402|NCT00002945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64740403|NCT00002945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64740404|NCT00002945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64740405|NCT00002945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64740406|NCT00002945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740407|NCT00002945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64740408|NCT00002945|Antimetabolites|antimetabolites|mesh-ancestor
64740409|NCT00002945|Antiviral Agents|antiviral agents|mesh-ancestor
64740410|NCT00002945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64740411|NCT00002945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64740412|NCT00002945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64740413|NCT00002945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64740415|NCT00002951|Hydroxyurea|hydroxyurea|mesh-list
64429308|NCT05196815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64788013|NCT05749614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64788014|NCT05749614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788015|NCT05749380|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64788016|NCT05749380|Antifungal Agents|antifungal agents|mesh-ancestor
64788017|NCT05749380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64788018|NCT05749380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64788019|NCT05749380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64788021|NCT05748990|Insulin Lispro|insulin lispro|mesh-list
64556620|NCT04368273|Antibodies|antibodies|mesh-list
64740417|NCT00002951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740418|NCT00002951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64740419|NCT00002951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740420|NCT00002951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64740421|NCT00002951|Immunologic Factors|immunologic factors|mesh-ancestor
64740422|NCT00002951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740423|NCT00002951|Antisickling Agents|antisickling agents|mesh-ancestor
64740424|NCT00002951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740425|NCT00002951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64740426|NCT03058289|Pembrolizumab|pembrolizumab|mesh-list
64740427|NCT03058289|Ipilimumab|ipilimumab|mesh-list
64740428|NCT03058289|Antibodies|antibodies|mesh-list
64740429|NCT03058289|Immunoglobulins|immunoglobulins|mesh-list
64740430|NCT03058289|Immunologic Factors|immunologic factors|mesh-ancestor
64740431|NCT03058289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740432|NCT03058289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64740433|NCT03058289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740434|NCT03058289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64740435|NCT03058289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740436|NCT00002963|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64322120|NCT02781311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322121|NCT02781311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322122|NCT02781311|Hormone Antagonists|hormone antagonists|mesh-ancestor
64740437|NCT00002963|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64740438|NCT00002963|Dermatologic Agents|dermatologic agents|mesh-ancestor
64788073|NCT05497674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788074|NCT05497674|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64788075|NCT05497674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64788076|NCT05497674|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64788143|NCT05309928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64788144|NCT05309928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64788145|NCT05309928|Uricosuric Agents|uricosuric agents|mesh-ancestor
64788146|NCT05309928|Gout Suppressants|gout suppressants|mesh-ancestor
64788147|NCT05309928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64788148|NCT05309928|Renal Agents|renal agents|mesh-ancestor
64317425|NCT02407821|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64317426|NCT02407821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64317427|NCT02407821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64317428|NCT02407821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740452|NCT00002987|Bleomycin|bleomycin|mesh-list
64740453|NCT00002987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64740454|NCT00002987|Immunologic Factors|immunologic factors|mesh-ancestor
64740455|NCT00002987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740456|NCT00002987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64740457|NCT00002987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64740458|NCT00002987|Alkylating Agents|alkylating agents|mesh-ancestor
64740459|NCT00002987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740460|NCT00002987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740461|NCT00002987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64740462|NCT00002987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64740463|NCT00002987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64740464|NCT00002987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64479790|NCT01868893|Alkylating Agents|alkylating agents|mesh-ancestor
64317429|NCT02407821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64317430|NCT02407821|Serotonin Agents|serotonin agents|mesh-ancestor
64317431|NCT02407821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317432|NCT02407821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64317433|NCT02407821|Antidepressive Agents|antidepressive agents|mesh-ancestor
64317434|NCT02407821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64317435|NCT02164357|Fibrinolytic Agents|fibrinolytic agents|mesh-list
64317436|NCT02164357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64740466|NCT00002987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64740467|NCT00002987|Tubulin Modulators|tubulin modulators|mesh-ancestor
64740468|NCT00002987|Antimitotic Agents|antimitotic agents|mesh-ancestor
64740469|NCT00002987|Mitosis Modulators|mitosis modulators|mesh-ancestor
64740470|NCT00002987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64740471|NCT00002987|Glucocorticoids|glucocorticoids|mesh-ancestor
64740473|NCT00002987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64322123|NCT02781311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64322124|NCT02781311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322125|NCT02781311|Urological Agents|urological agents|mesh-ancestor
64740474|NCT00002987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64740475|NCT02919683|Nivolumab|nivolumab|mesh-list
64740476|NCT02919683|Ipilimumab|ipilimumab|mesh-list
64740477|NCT02919683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64740478|NCT02919683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740479|NCT02919683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64740480|NCT02919683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740481|NCT03933293|Ezetimibe|ezetimibe|mesh-list
64740482|NCT03933293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64740483|NCT03933293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64740484|NCT03933293|Antimetabolites|antimetabolites|mesh-ancestor
64740485|NCT03933293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740486|NCT03933293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64740487|NCT00002993|Doxorubicin|doxorubicin|mesh-list
64740488|NCT00002993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64740489|NCT00002993|Mitomycins|mitomycins|mesh-list
64740490|NCT00002993|Mitomycin|mitomycin|mesh-list
64740491|NCT00002993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740492|NCT00002993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64317437|NCT02164357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317438|NCT02417337|Acetaminophen|acetaminophen|mesh-list
64317439|NCT02417337|Ibuprofen|ibuprofen|mesh-list
64317440|NCT02417337|Diclofenac|diclofenac|mesh-list
64788150|NCT05296278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788151|NCT05296278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64788210|NCT04836780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64788211|NCT04836780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64788212|NCT04836780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788213|NCT04800822|Cetuximab|cetuximab|mesh-list
64788214|NCT04800822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64788215|NCT04800822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740499|NCT01928082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64740500|NCT01928082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64740501|NCT01928082|Estradiol|estradiol|mesh-list
64740502|NCT01928082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64740503|NCT01928082|Estrogens|estrogens|mesh-ancestor
64740504|NCT01928082|Hormones|hormones|mesh-ancestor
64740505|NCT01928082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64740506|NCT01928082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740507|NCT01928082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64740508|NCT01928082|Contraceptive Agents|contraceptive agents|mesh-ancestor
64740509|NCT01928082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64740510|NCT01928082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64740511|NCT02908685|Risdiplam|risdiplam|mesh-list
64740512|NCT02908685|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64740513|NCT02908685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64740514|NCT02908685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740515|NCT00002999|Fluorouracil|fluorouracil|mesh-list
64740516|NCT00002999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740517|NCT00002999|Antimetabolites|antimetabolites|mesh-ancestor
64740518|NCT00002999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740519|NCT00002999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64788216|NCT04740294|Magnesium Sulfate|magnesium sulfate|mesh-list
64788217|NCT04740294|Analgesics|analgesics|mesh-ancestor
64788218|NCT04740294|Sensory System Agents|sensory system agents|mesh-ancestor
64788219|NCT04740294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64788220|NCT04740294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788221|NCT04740294|Anesthetics|anesthetics|mesh-ancestor
64788270|NCT04519164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64788271|NCT04519164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788272|NCT04519164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64788273|NCT04519164|Diuretics|diuretics|mesh-ancestor
64788274|NCT04519164|Natriuretic Agents|natriuretic agents|mesh-ancestor
64788275|NCT04519164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64788276|NCT04519164|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64740539|NCT03905603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740540|NCT00003011|Marimastat|marimastat|mesh-list
64740541|NCT00003011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740542|NCT00003011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740543|NCT00003017|Interleukin-12|interleukin-12|mesh-list
64740544|NCT00003017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64740545|NCT00003017|Immunologic Factors|immunologic factors|mesh-ancestor
64740546|NCT00003017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740547|NCT00003017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64740548|NCT00003017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64740549|NCT00003017|Growth Substances|growth substances|mesh-ancestor
64740550|NCT00003017|Growth Inhibitors|growth inhibitors|mesh-ancestor
64740551|NCT00003017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740552|NCT00003023|Vaccines|vaccines|mesh-list
64740553|NCT00003023|Antibodies|antibodies|mesh-list
64322127|NCT02144441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64322128|NCT02144441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322129|NCT02225977|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64322130|NCT02225977|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64322131|NCT02225977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322133|NCT02225977|Immunologic Factors|immunologic factors|mesh-ancestor
64322134|NCT02225977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322136|NCT02141009|Immunologic Factors|immunologic factors|mesh-ancestor
64788277|NCT04519164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64788278|NCT04519164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788279|NCT04471974|Pembrolizumab|pembrolizumab|mesh-list
64788280|NCT04471974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64788332|NCT03874338|Gout Suppressants|gout suppressants|mesh-ancestor
64788333|NCT03874338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64788334|NCT03874338|Tubulin Modulators|tubulin modulators|mesh-ancestor
64317451|NCT02417337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317452|NCT02417337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317454|NCT02167321|Leucovorin|leucovorin|mesh-list
64317455|NCT02167321|Fluorouracil|fluorouracil|mesh-list
64740558|NCT00003023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64740559|NCT03850067|Carboplatin|carboplatin|mesh-list
64740560|NCT03850067|Nivolumab|nivolumab|mesh-list
64740561|NCT03850067|Etoposide|etoposide|mesh-list
64740562|NCT03850067|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
64740563|NCT03850067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740564|NCT03850067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64740565|NCT03850067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64740566|NCT03850067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740567|NCT03850067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64740568|NCT03850067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64740569|NCT03850067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64740570|NCT03850067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740571|NCT00003029|Fluorouracil|fluorouracil|mesh-list
64352659|NCT03645603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64352660|NCT03645603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352661|NCT03645603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64352662|NCT03645603|Analgesics|analgesics|mesh-ancestor
64352663|NCT03645603|Sensory System Agents|sensory system agents|mesh-ancestor
64352664|NCT03645603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64352665|NCT03645603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64352666|NCT03645603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64740572|NCT00003029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740573|NCT00003029|Antimetabolites|antimetabolites|mesh-ancestor
64740574|NCT00003029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740575|NCT00003029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64740576|NCT00003029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64317456|NCT02167321|Oxaliplatin|oxaliplatin|mesh-list
64317457|NCT02167321|Antimetabolites|antimetabolites|mesh-ancestor
64317458|NCT02167321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317459|NCT02167321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64317460|NCT02167321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64317461|NCT02167321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64317462|NCT02167321|Immunologic Factors|immunologic factors|mesh-ancestor
64317463|NCT02167321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317464|NCT02167321|Antidotes|antidotes|mesh-ancestor
64317465|NCT02167321|Protective Agents|protective agents|mesh-ancestor
64317466|NCT02167321|Vitamin B Complex|vitamin b complex|mesh-ancestor
64317467|NCT02167321|Vitamins|vitamins|mesh-ancestor
64317468|NCT02167321|Micronutrients|micronutrients|mesh-ancestor
64378481|NCT03200561|Glucocorticoids|glucocorticoids|mesh-ancestor
64788335|NCT03874338|Antimitotic Agents|antimitotic agents|mesh-ancestor
64788336|NCT03874338|Mitosis Modulators|mitosis modulators|mesh-ancestor
64788337|NCT03874338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788401|NCT03662022|Leprostatic Agents|leprostatic agents|mesh-ancestor
64788402|NCT03662022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64788403|NCT03662022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788404|NCT03662022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788405|NCT03662022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64317470|NCT02162797|Trace Elements|trace elements|mesh-ancestor
64317471|NCT02162797|Micronutrients|micronutrients|mesh-ancestor
64317472|NCT02162797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317473|NCT02162875|Praziquantel|praziquantel|mesh-list
64317474|NCT02162875|Anthelmintics|anthelmintics|mesh-ancestor
64317475|NCT02162875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64317476|NCT02162875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64317477|NCT02167633|Pantoprazole|pantoprazole|mesh-list
64317478|NCT02167633|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64740668|NCT03713801|Metformin|metformin|mesh-list
64317479|NCT02167633|Glucocorticoids|glucocorticoids|mesh-list
64317480|NCT02167633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64317481|NCT02167633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64317482|NCT02167633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317483|NCT02167633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317484|NCT02167633|Hormones|hormones|mesh-ancestor
64317485|NCT02167633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64317486|NCT02167633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317487|NCT02413281|Buprenorphine|buprenorphine|mesh-list
64317488|NCT02413281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64317489|NCT02413281|Narcotics|narcotics|mesh-ancestor
64317490|NCT02413281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64788469|NCT02795988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788471|NCT02782104|Antidepressive Agents|antidepressive agents|mesh-ancestor
64788472|NCT02782104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64788473|NCT02743494|Nivolumab|nivolumab|mesh-list
64740779|NCT00003401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64788474|NCT02743494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64788475|NCT02743494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788476|NCT02743494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64788477|NCT02743494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788478|NCT01821690|Buspirone|buspirone|mesh-list
64317491|NCT02413281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317492|NCT02413281|Analgesics|analgesics|mesh-ancestor
64317493|NCT02413281|Sensory System Agents|sensory system agents|mesh-ancestor
64317494|NCT02413281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317495|NCT02413281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64317496|NCT02170909|Dabigatran|dabigatran|mesh-list
64317497|NCT02170909|Antithrombins|antithrombins|mesh-ancestor
64317498|NCT02170909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64740984|NCT00003449|Antimetabolites|antimetabolites|mesh-ancestor
64317499|NCT02170909|Protease Inhibitors|protease inhibitors|mesh-ancestor
64317500|NCT02170909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317501|NCT02170909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317502|NCT02170909|Anticoagulants|anticoagulants|mesh-ancestor
64317503|NCT02164825|Morphine|morphine|mesh-list
64416686|NCT03040219|Vitamin B Complex|vitamin b complex|mesh-ancestor
64788534|NCT00577200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64788535|NCT00577200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64788536|NCT00577200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64788537|NCT00577200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64788538|NCT00577200|Anesthetics, General|anesthetics, general|mesh-ancestor
64788539|NCT00577200|Anesthetics|anesthetics|mesh-ancestor
64788540|NCT00577200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64788541|NCT00577200|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64788542|NCT00577200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64317505|NCT02164825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64317506|NCT02164825|Narcotics|narcotics|mesh-ancestor
64317507|NCT02164825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64317508|NCT02164825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317509|NCT02164825|Analgesics|analgesics|mesh-ancestor
64317510|NCT02164825|Sensory System Agents|sensory system agents|mesh-ancestor
64317511|NCT02164825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317512|NCT02164825|Anesthetics, Local|anesthetics, local|mesh-ancestor
64317513|NCT02164825|Anesthetics|anesthetics|mesh-ancestor
64317514|NCT02170987|Moxifloxacin|moxifloxacin|mesh-list
64788543|NCT00577200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64788545|NCT00577200|GABA Agents|gaba agents|mesh-ancestor
64557142|NCT04140461|Amphotericin B|amphotericin b|mesh-list
64788546|NCT00577200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64788581|NCT00002802|Melphalan|melphalan|mesh-list
64788599|NCT00002802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64788600|NCT00002802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64788601|NCT00002802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64788602|NCT00002802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788668|NCT00002862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788669|NCT00002862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741169|NCT00002855|Alkylating Agents|alkylating agents|mesh-ancestor
64788670|NCT00002862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788671|NCT00002868|Interferons|interferons|mesh-list
64788672|NCT00002868|Cytarabine|cytarabine|mesh-list
64788673|NCT00002868|Interferon-alpha|interferon-alpha|mesh-list
64788674|NCT00002868|Etoposide|etoposide|mesh-list
64788675|NCT00002868|Idarubicin|idarubicin|mesh-list
64788676|NCT00002868|Busulfan|busulfan|mesh-list
64788677|NCT00002868|Hydroxyurea|hydroxyurea|mesh-list
64788678|NCT00002868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64317515|NCT02170987|Dabigatran|dabigatran|mesh-list
64317516|NCT02170987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64317517|NCT02170987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64317518|NCT02170987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64317519|NCT02170987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64322158|NCT02398539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64322159|NCT02398539|Glucocorticoids|glucocorticoids|mesh-ancestor
64322160|NCT02398539|Hormones|hormones|mesh-ancestor
64322161|NCT02398539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64322162|NCT02398539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322163|NCT02398539|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64322164|NCT02398539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64322165|NCT02144753|Psyllium|psyllium|mesh-list
64322166|NCT02144753|Calcium polycarbophil|calcium polycarbophil|mesh-list
64322169|NCT02144753|Antidiarrheals|antidiarrheals|mesh-ancestor
64322170|NCT02231905|Pramipexole|pramipexole|mesh-list
64741392|NCT00003215|Leucovorin|leucovorin|mesh-list
64317520|NCT02170987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317521|NCT02170987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317522|NCT02170987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64317523|NCT02170987|Antithrombins|antithrombins|mesh-ancestor
64317524|NCT02170987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64317525|NCT02170987|Protease Inhibitors|protease inhibitors|mesh-ancestor
64416687|NCT03040219|Vitamins|vitamins|mesh-ancestor
64788679|NCT00002868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788680|NCT00002868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64788681|NCT00002868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64788682|NCT00002868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788683|NCT00002868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741426|NCT00003215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64741427|NCT00003215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64741428|NCT00003215|Abortifacient Agents|abortifacient agents|mesh-ancestor
64741429|NCT00003215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64741430|NCT00003215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64741431|NCT00003215|Antimetabolites|antimetabolites|mesh-ancestor
64741432|NCT00003215|Dermatologic Agents|dermatologic agents|mesh-ancestor
64741433|NCT00003215|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64741434|NCT00003215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64741435|NCT00003215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64741436|NCT00003215|Antiviral Agents|antiviral agents|mesh-ancestor
64322173|NCT02231905|Protective Agents|protective agents|mesh-ancestor
64322174|NCT02231905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322175|NCT02231905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64322176|NCT02231905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64322177|NCT02231905|Dopamine Agonists|dopamine agonists|mesh-ancestor
64322178|NCT02231905|Dopamine Agents|dopamine agents|mesh-ancestor
64322179|NCT02231905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64322180|NCT02141087|Pirfenidone|pirfenidone|mesh-list
64322181|NCT02141087|Analgesics|analgesics|mesh-ancestor
64322182|NCT02141087|Sensory System Agents|sensory system agents|mesh-ancestor
64322183|NCT02141087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322184|NCT02141087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741441|NCT00003215|Vitamins|vitamins|mesh-ancestor
64788684|NCT00002868|Antiviral Agents|antiviral agents|mesh-ancestor
64788685|NCT00002868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64788686|NCT00002868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64788727|NCT00002898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64788728|NCT00002898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64788729|NCT00002898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64788730|NCT00002898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64317526|NCT02170987|Anticoagulants|anticoagulants|mesh-ancestor
64317527|NCT03176121|Oxycodone|oxycodone|mesh-list
64741452|NCT00003215|Sensory System Agents|sensory system agents|mesh-ancestor
64741453|NCT00003995|Trastuzumab|trastuzumab|mesh-list
64741455|NCT00003995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64741456|NCT00003995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741457|NCT00003995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64741458|NCT00003995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64741459|NCT00003995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322186|NCT02141087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64322187|NCT02141087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64322188|NCT02141087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64322189|NCT02141087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322190|NCT02698293|Vitamin D|vitamin d|mesh-list
64322191|NCT02698293|Ergocalciferols|ergocalciferols|mesh-list
64741460|NCT00003995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741461|NCT00004001|Prednisone|prednisone|mesh-list
64741462|NCT00004001|Docetaxel|docetaxel|mesh-list
64741463|NCT00004001|Mitoxantrone|mitoxantrone|mesh-list
64741464|NCT00004001|Estramustine|estramustine|mesh-list
64741465|NCT00004001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741466|NCT00004001|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741467|NCT00004001|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741468|NCT00004001|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741469|NCT00004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741470|NCT00004001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64741471|NCT00004001|Glucocorticoids|glucocorticoids|mesh-ancestor
64741472|NCT00004001|Hormones|hormones|mesh-ancestor
64741473|NCT00004001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64741474|NCT00004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741475|NCT00004001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64317528|NCT03176121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64317529|NCT03176121|Narcotics|narcotics|mesh-ancestor
64317530|NCT03176121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64317531|NCT03176121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317532|NCT03176121|Analgesics|analgesics|mesh-ancestor
64317533|NCT03176121|Sensory System Agents|sensory system agents|mesh-ancestor
64317534|NCT03176121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317535|NCT02261155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64317536|NCT02261155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64317537|NCT02261155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317540|NCT03176199|Narcotics|narcotics|mesh-ancestor
64317541|NCT03176199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64317542|NCT03176199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317543|NCT03176199|Analgesics|analgesics|mesh-ancestor
64317544|NCT03176199|Sensory System Agents|sensory system agents|mesh-ancestor
64788731|NCT00002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64788732|NCT00002898|Tubulin Modulators|tubulin modulators|mesh-ancestor
64788733|NCT00002898|Antimitotic Agents|antimitotic agents|mesh-ancestor
64788734|NCT00002898|Mitosis Modulators|mitosis modulators|mesh-ancestor
64788740|NCT00002904|Trabectedin|trabectedin|mesh-list
64788792|NCT00002970|Antimetabolites|antimetabolites|mesh-ancestor
64788869|NCT00003012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64788870|NCT00003012|Alkylating Agents|alkylating agents|mesh-ancestor
64741480|NCT00004001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64741481|NCT00004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741482|NCT00004001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64741483|NCT00004001|Alkylating Agents|alkylating agents|mesh-ancestor
64741484|NCT00003593|Cytarabine|cytarabine|mesh-list
64741485|NCT00003593|Hydrocortisone|hydrocortisone|mesh-list
64741486|NCT00003593|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64741487|NCT00003593|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64741488|NCT00003593|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64741489|NCT00003593|Methotrexate|methotrexate|mesh-list
64741490|NCT00003593|Thioguanine|thioguanine|mesh-list
64741491|NCT00003593|Daunorubicin|daunorubicin|mesh-list
64741492|NCT00003593|Asparaginase|asparaginase|mesh-list
64741493|NCT00003593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64741494|NCT00003593|Abortifacient Agents|abortifacient agents|mesh-ancestor
64741495|NCT00003593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64741496|NCT00003593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741497|NCT00003593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64741498|NCT00003593|Antimetabolites|antimetabolites|mesh-ancestor
64741499|NCT00003593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741500|NCT00003593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64788871|NCT00003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788886|NCT00003018|Leucovorin|leucovorin|mesh-list
64317545|NCT03176199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317546|NCT05697614|Lamotrigine|lamotrigine|mesh-list
64317547|NCT05697614|Carbamazepine|carbamazepine|mesh-list
64317548|NCT05697614|Phenytoin|phenytoin|mesh-list
64317549|NCT05697614|Oxcarbazepine|oxcarbazepine|mesh-list
64317550|NCT05697614|Valproic Acid|valproic acid|mesh-list
64317551|NCT05697614|Clobazam|clobazam|mesh-list
64317552|NCT05697614|Anticonvulsants|anticonvulsants|mesh-ancestor
64741501|NCT00003593|Dermatologic Agents|dermatologic agents|mesh-ancestor
64741502|NCT00003593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741503|NCT00003593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64741504|NCT00003593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741505|NCT00003593|Immunologic Factors|immunologic factors|mesh-ancestor
64741506|NCT00003593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64741507|NCT00003593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64741508|NCT00003593|Antiviral Agents|antiviral agents|mesh-ancestor
64741509|NCT00003593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64741510|NCT00003593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64741511|NCT00003593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64741512|NCT00003593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64741513|NCT00003593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64741515|NCT00003599|Tocopherols|tocopherols|mesh-list
64741516|NCT00003599|alpha-Tocopherol|alpha-tocopherol|mesh-list
64741517|NCT00003599|Isotretinoin|isotretinoin|mesh-list
64741518|NCT00003599|Vitamins|vitamins|mesh-ancestor
64741519|NCT00003599|Micronutrients|micronutrients|mesh-ancestor
64741520|NCT00003599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741521|NCT00003599|Antioxidants|antioxidants|mesh-ancestor
64741522|NCT00003599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317553|NCT05697614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64317554|NCT05697614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64317555|NCT05697614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317556|NCT05697614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64317557|NCT05697614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317558|NCT05697614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64317559|NCT05697614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64317560|NCT05697614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64317561|NCT05697614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64317562|NCT05697614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64741557|NCT00003617|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64741558|NCT00003617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64741559|NCT00003617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64741560|NCT00004013|Paclitaxel|paclitaxel|mesh-list
64741561|NCT00004013|Trastuzumab|trastuzumab|mesh-list
64741562|NCT00004013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64741563|NCT00004013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741564|NCT00004013|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741565|NCT00004013|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741566|NCT00004013|Mitosis Modulators|mitosis modulators|mesh-ancestor
64322193|NCT02698293|Vitamins|vitamins|mesh-list
64322194|NCT02698293|Micronutrients|micronutrients|mesh-ancestor
64322195|NCT02698293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322196|NCT02698293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64741567|NCT00004013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741568|NCT00004013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64741569|NCT00004025|Aldesleukin|aldesleukin|mesh-list
64741570|NCT00004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741571|NCT00004025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64741572|NCT00004025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64741573|NCT00004025|Antiviral Agents|antiviral agents|mesh-ancestor
64741574|NCT00004025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64741576|NCT00004037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741577|NCT00004037|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741578|NCT00004037|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741579|NCT00004037|Mitosis Modulators|mitosis modulators|mesh-ancestor
64430096|NCT02519777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317563|NCT05697614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317564|NCT05697614|GABA Agents|gaba agents|mesh-ancestor
64317565|NCT05697614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64317566|NCT05697614|Antimanic Agents|antimanic agents|mesh-ancestor
64317567|NCT05697614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64317568|NCT05697614|Analgesics|analgesics|mesh-ancestor
64317569|NCT05697614|Sensory System Agents|sensory system agents|mesh-ancestor
64788941|NCT00003060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64788942|NCT00003060|Antimetabolites|antimetabolites|mesh-ancestor
64788943|NCT00003060|Dermatologic Agents|dermatologic agents|mesh-ancestor
64788944|NCT00003060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741580|NCT00004037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64788945|NCT00003060|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64788947|NCT00003060|Antifungal Agents|antifungal agents|mesh-ancestor
64789008|NCT00003084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64789009|NCT00003090|Aldesleukin|aldesleukin|mesh-list
64789010|NCT00003090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789011|NCT00003090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64789012|NCT00003090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64789013|NCT00003090|Antiviral Agents|antiviral agents|mesh-ancestor
64789014|NCT00003090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64789015|NCT00003108|Bryostatin 1|bryostatin 1|mesh-list
64322197|NCT02698293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64322202|NCT02226289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64322203|NCT02226289|Growth Substances|growth substances|mesh-ancestor
64741679|NCT00004103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741680|NCT00004103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64741681|NCT00004103|Antimetabolites|antimetabolites|mesh-ancestor
64741682|NCT00004109|Doxorubicin|doxorubicin|mesh-list
64741683|NCT00004109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64741684|NCT00004109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64741685|NCT00004109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741686|NCT00004109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64741687|NCT00004109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64741688|NCT00004109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741689|NCT00004109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741690|NCT00003239|Interferons|interferons|mesh-list
64741691|NCT00003239|Cytarabine|cytarabine|mesh-list
64741692|NCT00003239|Interferon-alpha|interferon-alpha|mesh-list
64741693|NCT00003239|Interferon alpha-2|interferon alpha-2|mesh-list
64789016|NCT00003108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789017|NCT00003108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64557670|NCT05634174|Mirabegron|mirabegron|mesh-list
64789076|NCT00003150|Cyclophosphamide|cyclophosphamide|mesh-list
64789077|NCT00003150|Rituximab|rituximab|mesh-list
64789078|NCT00003150|Doxorubicin|doxorubicin|mesh-list
64317571|NCT05697614|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64317572|NCT05697614|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64317573|NCT05697614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64317574|NCT05697614|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64317575|NCT05697614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64317576|NCT05697614|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64317577|NCT05697614|GABA Agonists|gaba agonists|mesh-ancestor
64741694|NCT00003239|Homoharringtonine|homoharringtonine|mesh-list
64741695|NCT00003239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741696|NCT00003239|Antiviral Agents|antiviral agents|mesh-ancestor
64741697|NCT00003239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64741698|NCT00003239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64741699|NCT00003239|Antimetabolites|antimetabolites|mesh-ancestor
64741700|NCT00003239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741701|NCT00003239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741702|NCT00003239|Immunologic Factors|immunologic factors|mesh-ancestor
64741703|NCT00003239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741704|NCT00003239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64741705|NCT00003239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64741706|NCT00003239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741707|NCT00004115|Antibodies|antibodies|mesh-list
64741708|NCT00004115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64741709|NCT00004115|Immunologic Factors|immunologic factors|mesh-ancestor
64741710|NCT00004115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741711|NCT00003245|Irinotecan|irinotecan|mesh-list
64741712|NCT00003245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64741713|NCT00003245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64741714|NCT00003245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741715|NCT00003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353738|NCT02424344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64430273|NCT02507375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64430274|NCT02507375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322204|NCT02226289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317579|NCT02171221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64317580|NCT02171221|Antimetabolites|antimetabolites|mesh-ancestor
64378625|NCT03232307|Dexamethasone|dexamethasone|mesh-list
64789079|NCT00003150|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64789080|NCT00003150|Vincristine|vincristine|mesh-list
64789081|NCT00003150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789082|NCT00003150|Immunologic Factors|immunologic factors|mesh-ancestor
64789083|NCT00003150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789084|NCT00003150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64322205|NCT02226289|Growth Inhibitors|growth inhibitors|mesh-ancestor
64322206|NCT04480593|Propolis|propolis|mesh-list
64322207|NCT04480593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64322208|NCT05079217|Vaccines|vaccines|mesh-list
64322210|NCT05079217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322211|NCT02141321|Alprostadil|alprostadil|mesh-list
64789085|NCT00003150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64789139|NCT00003204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789140|NCT00003204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64789141|NCT00003204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64789142|NCT00003204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64317581|NCT02171221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317582|NCT02171221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64317583|NCT02413515|Nifedipine|nifedipine|mesh-list
64317584|NCT02413515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64317585|NCT02413515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64741766|NCT00004145|Fludarabine phosphate|fludarabine phosphate|mesh-list
64741767|NCT00004145|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64741768|NCT00004145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741769|NCT00004145|Immunologic Factors|immunologic factors|mesh-ancestor
64741770|NCT00004145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741771|NCT00004145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64741772|NCT00004145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64741773|NCT00004145|Alkylating Agents|alkylating agents|mesh-ancestor
64741774|NCT00004145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741775|NCT00004145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741776|NCT00004145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64741777|NCT00004145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64741799|NCT00003269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741800|NCT00003269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64741801|NCT00003269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64741802|NCT00003269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64741803|NCT00003269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64741804|NCT00003269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741805|NCT00003269|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64317586|NCT02413515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317587|NCT02413515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64317588|NCT02413515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317589|NCT02413515|Vasodilator Agents|vasodilator agents|mesh-ancestor
64317590|NCT02413515|Tocolytic Agents|tocolytic agents|mesh-ancestor
64317591|NCT02413515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64317592|NCT03194906|Memantine|memantine|mesh-list
64317593|NCT03194906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64317594|NCT03194906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64317595|NCT03194906|Dopamine Agents|dopamine agents|mesh-ancestor
64317596|NCT03194906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64317597|NCT03194906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317598|NCT03194906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317599|NCT03194906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64317600|NCT03194906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64317601|NCT03171987|Flurbiprofen|flurbiprofen|mesh-list
64317602|NCT03171987|Lidocaine|lidocaine|mesh-list
64378710|NCT02593773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64789145|NCT00003204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64789146|NCT00003204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64789147|NCT00003204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64789148|NCT00003204|Antimetabolites|antimetabolites|mesh-ancestor
64789149|NCT00003204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64789150|NCT00003204|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789151|NCT00003204|Antimitotic Agents|antimitotic agents|mesh-ancestor
64789152|NCT00003204|Mitosis Modulators|mitosis modulators|mesh-ancestor
64317603|NCT03171987|Anesthetics, Local|anesthetics, local|mesh-ancestor
64317604|NCT03171987|Anesthetics|anesthetics|mesh-ancestor
64317605|NCT03171987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64317606|NCT03171987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317607|NCT03171987|Sensory System Agents|sensory system agents|mesh-ancestor
64317608|NCT03171987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317609|NCT03171987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64741831|NCT00003287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741832|NCT00003287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741833|NCT00003287|Immunologic Factors|immunologic factors|mesh-ancestor
64741834|NCT00003287|Antidotes|antidotes|mesh-ancestor
64741835|NCT00003287|Protective Agents|protective agents|mesh-ancestor
64741836|NCT00003287|Vitamin B Complex|vitamin b complex|mesh-ancestor
64741837|NCT00003287|Vitamins|vitamins|mesh-ancestor
64741838|NCT00003287|Micronutrients|micronutrients|mesh-ancestor
64741839|NCT00004187|Capecitabine|capecitabine|mesh-list
64741840|NCT00004187|Oxaliplatin|oxaliplatin|mesh-list
64741841|NCT00004187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64322219|NCT02141321|Oxytocics|oxytocics|mesh-ancestor
64322220|NCT02141321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64322221|NCT02141321|Vasodilator Agents|vasodilator agents|mesh-ancestor
64322222|NCT02141321|Urological Agents|urological agents|mesh-ancestor
64322223|NCT03965078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64322224|NCT03965078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64322225|NCT03965078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64430376|NCT04207619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322226|NCT02141477|Decitabine|decitabine|mesh-list
64322227|NCT02141477|Homoharringtonine|homoharringtonine|mesh-list
64317610|NCT03171987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64317611|NCT03171987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64317612|NCT03171987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64317613|NCT03171987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317614|NCT03171987|Analgesics|analgesics|mesh-ancestor
64789201|NCT00003252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789203|NCT00003264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789204|NCT00003264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64789206|NCT00003264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789207|NCT00003264|Antiviral Agents|antiviral agents|mesh-ancestor
64789208|NCT00003264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64789209|NCT00003264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789210|NCT00003264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789211|NCT00003264|Immunologic Factors|immunologic factors|mesh-ancestor
64789212|NCT00003264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789213|NCT00003276|Irinotecan|irinotecan|mesh-list
64789214|NCT00003276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64789260|NCT00003336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64789262|NCT00003336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789263|NCT00003336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789264|NCT00003336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64789265|NCT00003336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64789266|NCT00003336|Antiemetics|antiemetics|mesh-ancestor
64789267|NCT00003336|Autonomic Agents|autonomic agents|mesh-ancestor
64317616|NCT03171987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64317617|NCT03171987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64317618|NCT03171987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64317619|NCT03171987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64317620|NCT03171987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317621|NCT05540288|Nalmefene|nalmefene|mesh-list
64317622|NCT05540288|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64317623|NCT05540288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317624|NCT05540288|Sensory System Agents|sensory system agents|mesh-ancestor
64317625|NCT05540288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317626|NCT03172065|Dexmedetomidine|dexmedetomidine|mesh-list
64317627|NCT03172065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64317628|NCT03172065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64317629|NCT03172065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317630|NCT03172065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64789268|NCT00003336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64789269|NCT00003336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64789270|NCT00003336|Glucocorticoids|glucocorticoids|mesh-ancestor
64789272|NCT00003336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64789273|NCT00003336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64789275|NCT00003342|Gemcitabine|gemcitabine|mesh-list
64789319|NCT00003378|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789320|NCT00003378|Antimitotic Agents|antimitotic agents|mesh-ancestor
64789321|NCT00003378|Mitosis Modulators|mitosis modulators|mesh-ancestor
64789322|NCT00003378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789323|NCT00003378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64789324|NCT00003378|Antimetabolites|antimetabolites|mesh-ancestor
64789325|NCT00003378|Antiviral Agents|antiviral agents|mesh-ancestor
64789326|NCT00003378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64789327|NCT00003378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789328|NCT00003378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789329|NCT00003378|Immunologic Factors|immunologic factors|mesh-ancestor
64789330|NCT00003378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789331|NCT00003390|Irofulven|irofulven|mesh-list
64789332|NCT00003390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64317632|NCT03172065|Sensory System Agents|sensory system agents|mesh-ancestor
64317633|NCT03172065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317634|NCT03172065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64317635|NCT03172065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64317636|NCT03172065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64317637|NCT03172065|Adrenergic Agents|adrenergic agents|mesh-ancestor
64317638|NCT03172065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64317639|NCT03172065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317640|NCT02171299|Ropivacaine|ropivacaine|mesh-list
64317641|NCT02171299|Anesthetics, Local|anesthetics, local|mesh-list
64789333|NCT00003390|Alkylating Agents|alkylating agents|mesh-ancestor
64789334|NCT00003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741899|NCT00004205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64741900|NCT00004205|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64741901|NCT00004205|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64322268|NCT02397603|Anesthetics|anesthetics|mesh-ancestor
64322269|NCT02397603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64322270|NCT02397603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741902|NCT00004205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64741903|NCT00003305|Leucovorin|leucovorin|mesh-list
64481203|NCT00700336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741904|NCT00003305|Calcium|calcium|mesh-list
64741906|NCT00003305|Aminopterin|aminopterin|mesh-list
64789335|NCT00003390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789336|NCT00003396|Cyclophosphamide|cyclophosphamide|mesh-list
64789376|NCT00003402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64789377|NCT00003402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64789378|NCT00003402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789380|NCT00003408|Interferon-alpha|interferon-alpha|mesh-list
64789381|NCT00003408|Aldesleukin|aldesleukin|mesh-list
64789382|NCT00003408|Sargramostim|sargramostim|mesh-list
64789383|NCT00003408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64317643|NCT02171299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64317645|NCT02171299|Sensory System Agents|sensory system agents|mesh-ancestor
64317646|NCT02171299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317647|NCT03171831|Mycophenolic Acid|mycophenolic acid|mesh-list
64317648|NCT03171831|Cyclophosphamide|cyclophosphamide|mesh-list
64317649|NCT03171831|Busulfan|busulfan|mesh-list
64741933|NCT00003311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64741934|NCT00003311|Antiemetics|antiemetics|mesh-ancestor
64741935|NCT00003311|Autonomic Agents|autonomic agents|mesh-ancestor
64741936|NCT00003311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64741937|NCT00003311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64741938|NCT00003311|Glucocorticoids|glucocorticoids|mesh-ancestor
64741939|NCT00003311|Hormones|hormones|mesh-ancestor
64741945|NCT00003311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317650|NCT03171831|Methotrexate|methotrexate|mesh-list
64317651|NCT03171831|Fludarabine|fludarabine|mesh-list
64317652|NCT03171831|Tacrolimus|tacrolimus|mesh-list
64317653|NCT03171831|Thymoglobulin|thymoglobulin|mesh-list
64317654|NCT03171831|Basiliximab|basiliximab|mesh-list
64317655|NCT03171831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64317656|NCT03171831|Immunologic Factors|immunologic factors|mesh-ancestor
64317657|NCT03171831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317658|NCT03171831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64317659|NCT03171831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64378910|NCT04791345|Glucocorticoids|glucocorticoids|mesh-ancestor
64789384|NCT00003408|Antiviral Agents|antiviral agents|mesh-ancestor
64789385|NCT00003408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64789386|NCT00003408|Immunologic Factors|immunologic factors|mesh-ancestor
64741976|NCT00004217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64741977|NCT00004217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741978|NCT00004217|Immunologic Factors|immunologic factors|mesh-ancestor
64741979|NCT00004217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741980|NCT00004217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64741981|NCT00004217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64789387|NCT00003408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789388|NCT00003408|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64789389|NCT00003408|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64789390|NCT00003414|Interferons|interferons|mesh-list
64789391|NCT00003414|Aldesleukin|aldesleukin|mesh-list
64789392|NCT00003414|Interferon-gamma|interferon-gamma|mesh-list
64789393|NCT00003414|Cyclosporine|cyclosporine|mesh-list
64789394|NCT00003414|Cyclophosphamide|cyclophosphamide|mesh-list
64789395|NCT00003414|Busulfan|busulfan|mesh-list
64789436|NCT00003462|Immunologic Factors|immunologic factors|mesh-ancestor
64789437|NCT00003462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789438|NCT00003462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64789439|NCT00003462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789440|NCT00003462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64789441|NCT00003528|Raltitrexed|raltitrexed|mesh-list
64742187|NCT00004403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64742188|NCT00004403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64742189|NCT00004403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64742190|NCT00004403|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64789442|NCT00003528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64789443|NCT00003528|Antimetabolites|antimetabolites|mesh-ancestor
64317661|NCT03171831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317662|NCT03171831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64317663|NCT03171831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64317664|NCT03171831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64317665|NCT03171831|Abortifacient Agents|abortifacient agents|mesh-ancestor
64317666|NCT03171831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64317667|NCT03171831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64317668|NCT03171831|Antimetabolites|antimetabolites|mesh-ancestor
64317669|NCT03171831|Dermatologic Agents|dermatologic agents|mesh-ancestor
64317670|NCT03171831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322306|NCT04616924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64322307|NCT04616924|Antitubercular Agents|antitubercular agents|mesh-ancestor
64322308|NCT04616924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64322309|NCT04616924|Leprostatic Agents|leprostatic agents|mesh-ancestor
64322310|NCT02226913|Lidocaine|lidocaine|mesh-list
64322311|NCT02226913|Epinephrine|epinephrine|mesh-list
64322315|NCT02226913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322316|NCT02226913|Sensory System Agents|sensory system agents|mesh-ancestor
64322317|NCT02226913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64742262|NCT00004925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742263|NCT00004925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742264|NCT00004925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64742265|NCT00004931|Leucovorin|leucovorin|mesh-list
64317671|NCT03171831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64742296|NCT00004985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64742421|NCT00004697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64317672|NCT03171831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64317673|NCT03171831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64317674|NCT03171831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64317675|NCT03171831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64317676|NCT03171831|Antitubercular Agents|antitubercular agents|mesh-ancestor
64317677|NCT03171831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64317678|NCT03171831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64317679|NCT02171455|Dabigatran|dabigatran|mesh-list
64317680|NCT02171455|Antithrombins|antithrombins|mesh-ancestor
64317681|NCT02171455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64317682|NCT02171455|Protease Inhibitors|protease inhibitors|mesh-ancestor
64317683|NCT02171455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378937|NCT03231215|Autonomic Agents|autonomic agents|mesh-ancestor
64789444|NCT00003528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789445|NCT00003528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789501|NCT00003558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64789502|NCT00003558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64789503|NCT00003558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789505|NCT00003558|Protective Agents|protective agents|mesh-ancestor
64789506|NCT00003558|Vitamin B Complex|vitamin b complex|mesh-ancestor
64789507|NCT00003558|Vitamins|vitamins|mesh-ancestor
64789508|NCT00003558|Micronutrients|micronutrients|mesh-ancestor
64789509|NCT00003564|Procarbazine|procarbazine|mesh-list
64789510|NCT00003564|Isotretinoin|isotretinoin|mesh-list
64789511|NCT00003564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789512|NCT00003564|Dermatologic Agents|dermatologic agents|mesh-ancestor
64317684|NCT02171455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317685|NCT02171455|Anticoagulants|anticoagulants|mesh-ancestor
64317687|NCT02171533|Dabigatran|dabigatran|mesh-list
64317688|NCT02171533|Antithrombins|antithrombins|mesh-ancestor
64317689|NCT02171533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64317690|NCT02171533|Protease Inhibitors|protease inhibitors|mesh-ancestor
64317691|NCT02171533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317692|NCT02171533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322357|NCT02226991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64322361|NCT02226991|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64322362|NCT02226991|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64322363|NCT02226991|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64322364|NCT04616534|Gemcitabine|gemcitabine|mesh-list
64322365|NCT04616534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64742755|NCT00005627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742756|NCT00005627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64742759|NCT00005639|Azacitidine|azacitidine|mesh-list
64317693|NCT02171533|Anticoagulants|anticoagulants|mesh-ancestor
64317694|NCT02171533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64317695|NCT02171533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64317696|NCT02171533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64317697|NCT02171533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64317698|NCT02171533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317699|NCT02171533|Vasodilator Agents|vasodilator agents|mesh-ancestor
64317700|NCT04482543|Methotrexate|methotrexate|mesh-list
64317701|NCT04482543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64317702|NCT04482543|Abortifacient Agents|abortifacient agents|mesh-ancestor
64317703|NCT04482543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64317704|NCT04482543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317705|NCT04482543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64742936|NCT00003701|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64742937|NCT00003701|Methotrexate|methotrexate|mesh-list
64742938|NCT00003701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64742939|NCT00003701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742940|NCT00003701|Tubulin Modulators|tubulin modulators|mesh-ancestor
64742941|NCT00003701|Antimitotic Agents|antimitotic agents|mesh-ancestor
64322391|NCT00705783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64742942|NCT00003701|Mitosis Modulators|mitosis modulators|mesh-ancestor
64742943|NCT00003701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742944|NCT00003701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64742945|NCT00003701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64742946|NCT00003701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64742947|NCT00003701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742948|NCT00003701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64742949|NCT00003701|Abortifacient Agents|abortifacient agents|mesh-ancestor
64742950|NCT00003701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64742951|NCT00003701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742952|NCT00003701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64742953|NCT00003701|Antimetabolites|antimetabolites|mesh-ancestor
64742954|NCT00003701|Dermatologic Agents|dermatologic agents|mesh-ancestor
64742955|NCT00003701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64742956|NCT00003701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64742957|NCT00003701|Immunologic Factors|immunologic factors|mesh-ancestor
64742958|NCT00003701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64742959|NCT00003701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64742961|NCT00003707|Tipifarnib|tipifarnib|mesh-list
64742962|NCT00003707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64742963|NCT00003707|Antimetabolites|antimetabolites|mesh-ancestor
64742965|NCT00003707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64317706|NCT04482543|Antimetabolites|antimetabolites|mesh-ancestor
64317707|NCT04482543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317709|NCT04482543|Dermatologic Agents|dermatologic agents|mesh-ancestor
64317710|NCT04482543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317711|NCT04482543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64317712|NCT04482543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64317713|NCT04482543|Immunologic Factors|immunologic factors|mesh-ancestor
64789513|NCT00003576|Fluorouracil|fluorouracil|mesh-list
64789514|NCT00003576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789515|NCT00003576|Antimetabolites|antimetabolites|mesh-ancestor
64355255|NCT03416231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430987|NCT02096835|Hormones|hormones|mesh-ancestor
64743432|NCT01917006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64789516|NCT00003576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789517|NCT00003576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64789518|NCT00003576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789519|NCT00003576|Immunologic Factors|immunologic factors|mesh-ancestor
64789562|NCT00003606|Etoposide|etoposide|mesh-list
64789563|NCT00003606|Epirubicin|epirubicin|mesh-list
64789564|NCT00003606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64789565|NCT00003606|Immunologic Factors|immunologic factors|mesh-ancestor
64743537|NCT01911780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64743538|NCT01911780|Diuretics|diuretics|mesh-ancestor
64743539|NCT01911780|Natriuretic Agents|natriuretic agents|mesh-ancestor
64743540|NCT01911780|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64743541|NCT01911546|Everolimus|everolimus|mesh-list
64743542|NCT01911546|Tacrolimus|tacrolimus|mesh-list
64743543|NCT01911546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64743544|NCT01911546|Immunologic Factors|immunologic factors|mesh-ancestor
64322393|NCT00705783|Serotonin Agents|serotonin agents|mesh-ancestor
64322394|NCT00705783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64322395|NCT00705783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64322396|NCT00705783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64322397|NCT00705783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64789566|NCT00003606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789567|NCT00003606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64789568|NCT00003606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64789569|NCT00003606|Alkylating Agents|alkylating agents|mesh-ancestor
64789570|NCT00003606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789571|NCT00003606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789572|NCT00003606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64789573|NCT00003606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64789574|NCT00003606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64317714|NCT04482543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64317715|NCT04482543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64317716|NCT04728230|Carboplatin|carboplatin|mesh-list
64317717|NCT04728230|Etoposide|etoposide|mesh-list
64317718|NCT04728230|Etoposide phosphate|etoposide phosphate|mesh-list
64317719|NCT04728230|Durvalumab|durvalumab|mesh-list
64317720|NCT04728230|Olaparib|olaparib|mesh-list
64317721|NCT04728230|Podophyllotoxin|podophyllotoxin|mesh-list
64317722|NCT04728230|Immunoglobulins|immunoglobulins|mesh-list
64317723|NCT04728230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64317724|NCT04728230|Immunoglobulin G|immunoglobulin g|mesh-list
64317725|NCT04728230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64317726|NCT04728230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64743741|NCT04414800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64743742|NCT04414800|Anesthetics, General|anesthetics, general|mesh-ancestor
64743743|NCT04414800|Anesthetics|anesthetics|mesh-ancestor
64743744|NCT04414800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64743745|NCT04414800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64743746|NCT04414800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64743747|NCT04414800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64743748|NCT04414800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743749|NCT04414800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64743750|NCT04414800|Narcotics|narcotics|mesh-ancestor
64317727|NCT04728230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64317730|NCT04728230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317731|NCT04728230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64789575|NCT00003606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64789576|NCT00003606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64789577|NCT00003606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64789578|NCT00003612|Paclitaxel|paclitaxel|mesh-list
64789579|NCT00003612|Carboplatin|carboplatin|mesh-list
64789580|NCT00003612|Trastuzumab|trastuzumab|mesh-list
64789615|NCT00003666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64789617|NCT00003666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743795|NCT01873950|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64743796|NCT01873950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64743797|NCT01873950|Adrenergic Agents|adrenergic agents|mesh-ancestor
64743798|NCT01873950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64743799|NCT01873950|Antimalarials|antimalarials|mesh-ancestor
64743800|NCT01873950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64743801|NCT01873950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64743802|NCT01873950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64743803|NCT01873950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743804|NCT01873950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64743805|NCT01873950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64743806|NCT01873950|Cholinergic Agents|cholinergic agents|mesh-ancestor
64743807|NCT01873950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64743808|NCT01873950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64743809|NCT01873950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64743810|NCT01873950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64743813|NCT01896726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64789618|NCT00003666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789619|NCT00003678|Tamoxifen|tamoxifen|mesh-list
64789683|NCT00003720|Semaxinib|semaxinib|mesh-list
64789684|NCT00003720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64789685|NCT00003720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64789686|NCT00003720|Growth Substances|growth substances|mesh-ancestor
64789687|NCT00003720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789753|NCT00003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789754|NCT00003798|Motexafin gadolinium|motexafin gadolinium|mesh-list
64789755|NCT00003798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743831|NCT01856322|Sulindac|sulindac|mesh-list
64743832|NCT01856322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64743833|NCT01856322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64743834|NCT01856322|Analgesics|analgesics|mesh-ancestor
64743835|NCT01856322|Sensory System Agents|sensory system agents|mesh-ancestor
64743836|NCT01856322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64743837|NCT01856322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743838|NCT01856322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64743839|NCT01856322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64743840|NCT01856322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743841|NCT01856322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64743842|NCT01856322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743843|NCT01856322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743844|NCT01871532|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64743846|NCT01871532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64743847|NCT01871532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743848|NCT01855074|Risperidone|risperidone|mesh-list
64743849|NCT01855074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64789756|NCT00003798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64789758|NCT00003804|Dactinomycin|dactinomycin|mesh-list
64789825|NCT00003846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64789826|NCT00003846|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789827|NCT00003846|Antimitotic Agents|antimitotic agents|mesh-ancestor
64789828|NCT00003846|Mitosis Modulators|mitosis modulators|mesh-ancestor
64789829|NCT00003852|Paclitaxel|paclitaxel|mesh-list
64789830|NCT00003852|Etoposide|etoposide|mesh-list
64789831|NCT00003852|Cyclophosphamide|cyclophosphamide|mesh-list
64317732|NCT04728230|Immunologic Factors|immunologic factors|mesh-ancestor
64317733|NCT04728230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743876|NCT01894776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64743877|NCT01894776|Antitubercular Agents|antitubercular agents|mesh-ancestor
64743878|NCT01854918|Evolocumab|evolocumab|mesh-list
64743879|NCT01854918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64743880|NCT01854918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64743881|NCT01854918|Antimetabolites|antimetabolites|mesh-ancestor
64743882|NCT01854918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743883|NCT01854918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64743884|NCT01894152|Everolimus|everolimus|mesh-list
64743885|NCT01894152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743886|NCT01894152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64743887|NCT01894152|Immunologic Factors|immunologic factors|mesh-ancestor
64743888|NCT01894152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743889|NCT01854528|Interferons|interferons|mesh-list
64317734|NCT04728230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64317735|NCT04728230|Keratolytic Agents|keratolytic agents|mesh-ancestor
64317736|NCT04728230|Dermatologic Agents|dermatologic agents|mesh-ancestor
64317737|NCT04728230|Tubulin Modulators|tubulin modulators|mesh-ancestor
64317738|NCT04728230|Antimitotic Agents|antimitotic agents|mesh-ancestor
64317739|NCT04728230|Mitosis Modulators|mitosis modulators|mesh-ancestor
64317740|NCT02406183|Ipilimumab|ipilimumab|mesh-list
64317741|NCT02406183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64317742|NCT02406183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744018|NCT01867710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744019|NCT01867710|Hormone Antagonists|hormone antagonists|mesh-ancestor
64744020|NCT01867710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64744022|NCT01832766|Hallucinogens|hallucinogens|mesh-ancestor
64744023|NCT01832766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744024|NCT01832766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64744025|NCT01832766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64744026|NCT01832766|Analgesics|analgesics|mesh-ancestor
64322416|NCT03543683|Analgesics|analgesics|mesh-ancestor
64322417|NCT03543683|Sensory System Agents|sensory system agents|mesh-ancestor
64322418|NCT03543683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322419|NCT03543683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322420|NCT03543683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64744027|NCT01832766|Sensory System Agents|sensory system agents|mesh-ancestor
64744028|NCT01832766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64744029|NCT01832766|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64744030|NCT01832766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64744031|NCT01832766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64744032|NCT01832766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317743|NCT02406183|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64317744|NCT02406183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317745|NCT04723472|Cefuroxime|cefuroxime|mesh-list
64789832|NCT00003852|Carboplatin|carboplatin|mesh-list
64789833|NCT00003852|Epirubicin|epirubicin|mesh-list
64789834|NCT00003852|Ifosfamide|ifosfamide|mesh-list
64789835|NCT00003852|Thiotepa|thiotepa|mesh-list
64789836|NCT00003852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64789891|NCT00003870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64789892|NCT00003876|Carmustine|carmustine|mesh-list
64789893|NCT00003876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64744034|NCT01832766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64744035|NCT01832532|Liraglutide|liraglutide|mesh-list
64744036|NCT01832532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64744037|NCT01832532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744038|NCT01832532|Incretins|incretins|mesh-ancestor
64789894|NCT00003876|Alkylating Agents|alkylating agents|mesh-ancestor
64789895|NCT00003876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789896|NCT00003876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789897|NCT00003888|Docetaxel|docetaxel|mesh-list
64789898|NCT00003888|Fluorouracil|fluorouracil|mesh-list
64789899|NCT00003888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789900|NCT00003888|Tubulin Modulators|tubulin modulators|mesh-ancestor
64789901|NCT00003888|Antimitotic Agents|antimitotic agents|mesh-ancestor
64744150|NCT01844700|Ziprasidone|ziprasidone|mesh-list
64744151|NCT01844700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64744152|NCT01844700|Serotonin Agents|serotonin agents|mesh-ancestor
64744153|NCT01844700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64744154|NCT01844700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744155|NCT01844700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744156|NCT01844700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64744157|NCT01844700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64744158|NCT01844700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64744159|NCT01844700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64744160|NCT01844700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64744161|NCT01844700|Dopamine Agents|dopamine agents|mesh-ancestor
64744162|NCT01844700|Antidepressive Agents|antidepressive agents|mesh-ancestor
64744163|NCT01844700|Dopamine Agonists|dopamine agonists|mesh-ancestor
64744164|NCT01844700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64744166|NCT01844700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64744167|NCT01844700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64744168|NCT01827384|Carboplatin|carboplatin|mesh-list
64744169|NCT01827384|Everolimus|everolimus|mesh-list
64744170|NCT01827384|Temozolomide|temozolomide|mesh-list
64744171|NCT01827384|Trametinib|trametinib|mesh-list
64789902|NCT00003888|Mitosis Modulators|mitosis modulators|mesh-ancestor
64789904|NCT00003888|Antimetabolites|antimetabolites|mesh-ancestor
64789953|NCT00003924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64789954|NCT00003924|Antiviral Agents|antiviral agents|mesh-ancestor
64789955|NCT00003924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64317746|NCT04723472|Cefuroxime axetil|cefuroxime axetil|mesh-list
64317747|NCT04723472|Bismuth|bismuth|mesh-list
64317748|NCT04723472|Antacids|antacids|mesh-ancestor
64317749|NCT04723472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317750|NCT04723472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64317751|NCT04723472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64317752|NCT04723472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64317753|NCT02412813|Cobalt|cobalt|mesh-list
64317754|NCT02412813|Trace Elements|trace elements|mesh-ancestor
64744196|NCT01844076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64744197|NCT01844076|Antinematodal Agents|antinematodal agents|mesh-ancestor
64744198|NCT01844076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744199|NCT01826448|Vemurafenib|vemurafenib|mesh-list
64744200|NCT01826448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744201|NCT01826448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64317755|NCT02412813|Micronutrients|micronutrients|mesh-ancestor
64317756|NCT02412813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317757|NCT03116295|Opicapone|opicapone|mesh-list
64317758|NCT03116295|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64317759|NCT03116295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317760|NCT03116295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317761|NCT03116295|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64317762|NCT03116295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64317763|NCT02405715|Oxytocin|oxytocin|mesh-list
64317764|NCT02405715|Oxytocics|oxytocics|mesh-ancestor
64744286|NCT01797432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64789956|NCT00003924|Immunologic Factors|immunologic factors|mesh-ancestor
64789957|NCT00003924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64789958|NCT00003930|Gemcitabine|gemcitabine|mesh-list
64789959|NCT00003930|Paclitaxel|paclitaxel|mesh-list
64790023|NCT00003960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64790024|NCT00003960|Glucocorticoids|glucocorticoids|mesh-ancestor
64790025|NCT00003960|Hormones|hormones|mesh-ancestor
64790027|NCT00003960|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64790095|NCT00004032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64790096|NCT00004050|Interleukin-2|interleukin-2|mesh-list
64790097|NCT00004050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744367|NCT04580472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64744368|NCT04580472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744369|NCT04580472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744370|NCT01611558|Ipilimumab|ipilimumab|mesh-list
64744371|NCT01611558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64744372|NCT01611558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744373|NCT01611558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64744374|NCT01611558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744375|NCT01818726|Deferasirox|deferasirox|mesh-list
64744376|NCT01818726|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64744377|NCT01818726|Chelating Agents|chelating agents|mesh-ancestor
64790098|NCT00004050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64790099|NCT00004050|Analgesics|analgesics|mesh-ancestor
64790100|NCT00004050|Sensory System Agents|sensory system agents|mesh-ancestor
64790166|NCT00004086|Antiviral Agents|antiviral agents|mesh-ancestor
64790167|NCT00004086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64790168|NCT00004086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64790169|NCT00004086|Immunologic Factors|immunologic factors|mesh-ancestor
64790170|NCT00004086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790171|NCT00004086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64317766|NCT02405715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317768|NCT02412423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64322449|NCT02396979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322453|NCT02145767|Progestins|progestins|mesh-ancestor
64322454|NCT02145767|Hormones|hormones|mesh-ancestor
64322455|NCT02145767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64322456|NCT02145767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322457|NCT02031523|Analgesics|analgesics|mesh-list
64322458|NCT02031523|Sensory System Agents|sensory system agents|mesh-ancestor
64322459|NCT02031523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322460|NCT02031523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322461|NCT02397213|Cyclosporine|cyclosporine|mesh-list
64322462|NCT02397213|Cyclosporins|cyclosporins|mesh-list
64744434|NCT01792830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64744435|NCT01792830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744436|NCT01792518|Linagliptin|linagliptin|mesh-list
64744437|NCT01792518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64744438|NCT01792518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744439|NCT01792518|Incretins|incretins|mesh-ancestor
64317769|NCT02412423|Immunologic Factors|immunologic factors|mesh-ancestor
64317770|NCT02412423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317771|NCT02412423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64317772|NCT02412423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64317773|NCT02412423|Alkylating Agents|alkylating agents|mesh-ancestor
64317774|NCT02412423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317775|NCT02412423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64317776|NCT02412423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64317777|NCT02412345|Alprostadil|alprostadil|mesh-list
64317778|NCT02412345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64317779|NCT02412345|Vasodilator Agents|vasodilator agents|mesh-ancestor
64744451|NCT04414566|Gemcitabine|gemcitabine|mesh-list
64744452|NCT04414566|Cisplatin|cisplatin|mesh-list
64744453|NCT04414566|Docetaxel|docetaxel|mesh-list
64744454|NCT04414566|Fluorouracil|fluorouracil|mesh-list
64744455|NCT04414566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744456|NCT04414566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64744470|NCT04592016|Diclofenac|diclofenac|mesh-list
64317780|NCT02412345|Urological Agents|urological agents|mesh-ancestor
64317781|NCT05679050|Folfirinox|folfirinox|mesh-list
64790172|NCT00004086|Alkylating Agents|alkylating agents|mesh-ancestor
64790173|NCT00004086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64790174|NCT00004104|Interferons|interferons|mesh-list
64790233|NCT00004128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64790234|NCT00004152|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64790235|NCT00004152|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64790236|NCT00004152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790238|NCT00004158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64790239|NCT00004158|Alkylating Agents|alkylating agents|mesh-ancestor
64790240|NCT00004158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790241|NCT00004158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322490|NCT02149433|Prednisone|prednisone|mesh-list
64322491|NCT02149433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64322492|NCT02149433|Glucocorticoids|glucocorticoids|mesh-ancestor
64322493|NCT02149433|Hormones|hormones|mesh-ancestor
64322495|NCT02149433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790242|NCT00004158|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64790243|NCT00004158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64790244|NCT00004158|Immunologic Factors|immunologic factors|mesh-ancestor
64790245|NCT00004158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790246|NCT00004164|Leucovorin|leucovorin|mesh-list
64790247|NCT00004164|Docetaxel|docetaxel|mesh-list
64790248|NCT00004164|Fluorouracil|fluorouracil|mesh-list
64790295|NCT00004188|Alkylating Agents|alkylating agents|mesh-ancestor
64790296|NCT00004188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744536|NCT01816074|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64744537|NCT01816074|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64744538|NCT01816074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744539|NCT01816074|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64744540|NCT01816074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64744541|NCT01816074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64744542|NCT01816074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744543|NCT01816074|Dopamine Agents|dopamine agents|mesh-ancestor
64744544|NCT01816074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64744545|NCT04586166|Imidacloprid|imidacloprid|mesh-list
64744546|NCT04586166|Cholinergic Agents|cholinergic agents|mesh-ancestor
64744547|NCT04586166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64744548|NCT04586166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744549|NCT04586166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744558|NCT01789320|Hormones|hormones|mesh-ancestor
64790297|NCT00004188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790298|NCT00004188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64790367|NCT00004218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790368|NCT00004218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64790371|NCT00004218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64790440|NCT00004254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790441|NCT00004254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790442|NCT00004254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64790443|NCT00004254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790511|NCT00004368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790512|NCT00004368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790513|NCT00004380|Methocarbamol|methocarbamol|mesh-list
64790514|NCT00004380|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64790515|NCT00004380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790516|NCT00004380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64744661|NCT01811706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744662|NCT01811238|Oxycodone|oxycodone|mesh-list
64744663|NCT01811238|Naloxone|naloxone|mesh-list
64744664|NCT01811238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64744669|NCT01811238|Sensory System Agents|sensory system agents|mesh-ancestor
64744670|NCT01811238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64744671|NCT01811238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64744672|NCT01769508|Fluorouracil|fluorouracil|mesh-list
64744673|NCT01769508|Oxaliplatin|oxaliplatin|mesh-list
64744674|NCT01769508|Lapatinib|lapatinib|mesh-list
64744675|NCT01769508|Antimetabolites|antimetabolites|mesh-ancestor
64744676|NCT01769508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744678|NCT01769508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790517|NCT00004380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64790518|NCT00004398|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
64790519|NCT00004398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790520|NCT00004398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790521|NCT00004404|Clotrimazole|clotrimazole|mesh-list
64790523|NCT00004404|Hydroxyurea|hydroxyurea|mesh-list
64317782|NCT05679050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64317783|NCT02412267|Carboplatin|carboplatin|mesh-list
64317784|NCT02412267|Etoposide|etoposide|mesh-list
64317785|NCT02412267|Ifosfamide|ifosfamide|mesh-list
64317786|NCT02412267|Ofatumumab|ofatumumab|mesh-list
64317787|NCT02412267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64317788|NCT02412267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64317789|NCT02412267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64317790|NCT02412267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64317791|NCT02412267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317792|NCT02412267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317793|NCT02412267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64379108|NCT03229889|Adrenergic Agents|adrenergic agents|mesh-ancestor
64790525|NCT00004404|Antisickling Agents|antisickling agents|mesh-ancestor
64790526|NCT00004404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744767|NCT01809132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64744768|NCT01809132|Prednisolone|prednisolone|mesh-list
64744769|NCT01809132|Prednisolone acetate|prednisolone acetate|mesh-list
64744770|NCT01809132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64744771|NCT01809132|Pentoxifylline|pentoxifylline|mesh-list
64744772|NCT01809132|Zinc Sulfate|zinc sulfate|mesh-list
64744773|NCT01809132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64744774|NCT01809132|Prednisolone phosphate|prednisolone phosphate|mesh-list
64744775|NCT01809132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64744776|NCT01809132|Antiemetics|antiemetics|mesh-ancestor
64744777|NCT01809132|Autonomic Agents|autonomic agents|mesh-ancestor
64322563|NCT03167385|Apatinib|apatinib|mesh-list
64790527|NCT00004404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790530|NCT00004404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64790565|NCT00004440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64790566|NCT00004440|Analgesics|analgesics|mesh-ancestor
64790567|NCT00004440|Sensory System Agents|sensory system agents|mesh-ancestor
64790568|NCT00004440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64790569|NCT00004440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317794|NCT02412267|Alkylating Agents|alkylating agents|mesh-ancestor
64317795|NCT03172455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64317796|NCT03172455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64322591|NCT02228473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322592|NCT02228473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64322593|NCT02228473|Respiratory System Agents|respiratory system agents|mesh-ancestor
64322594|NCT02228473|Mydriatics|mydriatics|mesh-ancestor
64322595|NCT02228473|Parasympatholytics|parasympatholytics|mesh-ancestor
64322596|NCT02228473|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64322597|NCT02228473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64322598|NCT02228473|Cholinergic Agents|cholinergic agents|mesh-ancestor
64322599|NCT02228473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64322600|NCT02228473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322601|NCT02394015|Doxorubicin|doxorubicin|mesh-list
64322602|NCT02394015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64322603|NCT02394015|Trabectedin|trabectedin|mesh-list
64322604|NCT02394015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64744791|NCT01809132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64744792|NCT01809132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744793|NCT01809132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744794|NCT01809132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64744795|NCT01809132|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64744796|NCT01809132|Vasodilator Agents|vasodilator agents|mesh-ancestor
64744797|NCT01809132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64744798|NCT01809132|Antioxidants|antioxidants|mesh-ancestor
64744799|NCT01809132|Astringents|astringents|mesh-ancestor
64744800|NCT01809132|Dermatologic Agents|dermatologic agents|mesh-ancestor
64744801|NCT01766778|Metformin|metformin|mesh-list
64744802|NCT01766778|Vildagliptin|vildagliptin|mesh-list
64744803|NCT01766778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64322609|NCT02394015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322610|NCT02394015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64322611|NCT02394015|Alkylating Agents|alkylating agents|mesh-ancestor
64431298|NCT01613326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64317797|NCT03172455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64317798|NCT03172455|Protease Inhibitors|protease inhibitors|mesh-ancestor
64317799|NCT03172455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317800|NCT03172455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317801|NCT03171597|Vasodilator Agents|vasodilator agents|mesh-list
64317802|NCT03171597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64317803|NCT03171597|Lipid Regulating Agents|lipid regulating agents|mesh-list
64790571|NCT00004440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64322613|NCT02394093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64322614|NCT02394093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64322615|NCT02394093|Analgesics|analgesics|mesh-ancestor
64322616|NCT02394093|Sensory System Agents|sensory system agents|mesh-ancestor
64322617|NCT02394093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322618|NCT02394093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322619|NCT02394093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64322620|NCT02394093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64322621|NCT02394093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64322622|NCT02394093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64322623|NCT02394093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322624|NCT02394093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64790572|NCT00004440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64790573|NCT00004440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790574|NCT00004440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790575|NCT00004446|Fluoxetine|fluoxetine|mesh-list
64790576|NCT00004446|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64790577|NCT00004446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64790578|NCT00004446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64790579|NCT00004446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790580|NCT00004446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64790581|NCT00004446|Serotonin Agents|serotonin agents|mesh-ancestor
64790620|NCT00004482|Antiemetics|antiemetics|mesh-ancestor
64790621|NCT00004482|Autonomic Agents|autonomic agents|mesh-ancestor
64790622|NCT00004482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64790623|NCT00004482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64790624|NCT00004482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64790625|NCT00004482|Protective Agents|protective agents|mesh-ancestor
64790626|NCT00004488|Cholecalciferol|cholecalciferol|mesh-list
64790627|NCT00004488|Vitamin D|vitamin d|mesh-list
64790628|NCT00004488|Alendronate|alendronate|mesh-list
64790629|NCT00004488|Calcium Carbonate|calcium carbonate|mesh-list
64790630|NCT00004488|Calcium|calcium|mesh-list
64790631|NCT00004488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64790632|NCT00004488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317805|NCT05698394|Antidepressive Agents|antidepressive agents|mesh-ancestor
64317806|NCT05698394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64317807|NCT05539118|Interferons|interferons|mesh-list
64317808|NCT05539118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790634|NCT00004488|Micronutrients|micronutrients|mesh-ancestor
64790635|NCT00004488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64790636|NCT00004488|Antacids|antacids|mesh-ancestor
64744872|NCT01780974|Thioctic Acid|thioctic acid|mesh-list
64744873|NCT01780974|Antioxidants|antioxidants|mesh-ancestor
64322635|NCT02146391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64322636|NCT02146391|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64322637|NCT02146391|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64322638|NCT04225273|Lidocaine|lidocaine|mesh-list
64322639|NCT04225273|Anesthetics, Local|anesthetics, local|mesh-ancestor
64322640|NCT04225273|Anesthetics|anesthetics|mesh-ancestor
64322641|NCT04225273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64790637|NCT00004488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790680|NCT00004650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64790681|NCT00004650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64790682|NCT00004650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64790683|NCT00004650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64790684|NCT00004650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64790749|NCT00004740|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64317809|NCT05539118|Antiviral Agents|antiviral agents|mesh-ancestor
64317810|NCT05539118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64317811|NCT02405793|Meloxicam|meloxicam|mesh-list
64317812|NCT02405793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64317813|NCT02405793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64317814|NCT02405793|Analgesics|analgesics|mesh-ancestor
64317815|NCT02405793|Sensory System Agents|sensory system agents|mesh-ancestor
64317816|NCT02405793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317817|NCT02405793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317818|NCT02405793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64317819|NCT02405793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64317820|NCT02405793|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64317821|NCT02405793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64317822|NCT02405793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744933|NCT04562532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64744934|NCT04562532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64744935|NCT04562532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744936|NCT04562532|Antifungal Agents|antifungal agents|mesh-ancestor
64744937|NCT04562532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64744938|NCT04562532|Immunologic Factors|immunologic factors|mesh-ancestor
64744939|NCT04562532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744940|NCT01778010|Cocaine|cocaine|mesh-list
64744941|NCT01778010|Modafinil|modafinil|mesh-list
64744942|NCT01778010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64744943|NCT01778010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744944|NCT01778010|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64744945|NCT01778010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64744946|NCT01778010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64744947|NCT01778010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744948|NCT01778010|Anesthetics, Local|anesthetics, local|mesh-ancestor
64356971|NCT03388697|Insulin|insulin|mesh-list
64322644|NCT04225273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322645|NCT04225273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64322646|NCT04225273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64322647|NCT04225273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64744949|NCT01778010|Anesthetics|anesthetics|mesh-ancestor
64744950|NCT01778010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64317823|NCT02405793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317824|NCT05695664|Ibuprofen|ibuprofen|mesh-list
64317825|NCT05695664|Ketorolac|ketorolac|mesh-list
64317827|NCT05695664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64317829|NCT05695664|Sensory System Agents|sensory system agents|mesh-ancestor
64317830|NCT05695664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317831|NCT05695664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317832|NCT05695664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64317833|NCT05695664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64317834|NCT05695664|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64317835|NCT05695664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790750|NCT00004740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64790751|NCT00004740|Antimetabolites|antimetabolites|mesh-ancestor
64790752|NCT00004740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64790753|NCT00004740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64790754|NCT00004758|Pyridoxine|pyridoxine|mesh-list
64790755|NCT00004758|Carbamazepine|carbamazepine|mesh-list
64790756|NCT00004758|Valproic Acid|valproic acid|mesh-list
64790757|NCT00004758|Nitrazepam|nitrazepam|mesh-list
64744955|NCT01778010|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64744956|NCT01778010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64744957|NCT01778010|Dopamine Agents|dopamine agents|mesh-ancestor
64744958|NCT01778010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64744959|NCT01777854|Omeprazole|omeprazole|mesh-list
64744960|NCT01777854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64744961|NCT01777854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64744962|NCT01777854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64744963|NCT01777854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744964|NCT01777854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744965|NCT01777620|Botulinum Toxins|botulinum toxins|mesh-list
64744966|NCT01777620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64744967|NCT01777620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64744968|NCT01777620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64744969|NCT01777620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64744970|NCT01777620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744971|NCT01777620|Cholinergic Agents|cholinergic agents|mesh-ancestor
64744972|NCT01777620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64744973|NCT01777620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744974|NCT01777620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64744975|NCT01777620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64744976|NCT01777542|Insulin|insulin|mesh-list
64744977|NCT01777542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64744978|NCT01777542|Mitogens|mitogens|mesh-list
64744979|NCT01777542|Mecasermin|mecasermin|mesh-list
64431408|NCT02316847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64790758|NCT00004758|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64790759|NCT00004758|Anticonvulsants|anticonvulsants|mesh-ancestor
64790815|NCT00004842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64790816|NCT00004854|Carvedilol|carvedilol|mesh-list
64790817|NCT00004854|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64790818|NCT00004854|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64790886|NCT00004878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64790887|NCT00004884|Gemcitabine|gemcitabine|mesh-list
64790888|NCT00004884|Docetaxel|docetaxel|mesh-list
64790889|NCT00004884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64790890|NCT00004884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64790891|NCT00004884|Antimetabolites|antimetabolites|mesh-ancestor
64790892|NCT00004884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744980|NCT01777542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64744981|NCT01777542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744982|NCT01777542|Mitosis Modulators|mitosis modulators|mesh-ancestor
64744983|NCT01777542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744984|NCT01777542|Growth Substances|growth substances|mesh-ancestor
64744985|NCT01777152|Prednisone|prednisone|mesh-list
64744986|NCT01777152|Cyclophosphamide|cyclophosphamide|mesh-list
64744987|NCT01777152|Doxorubicin|doxorubicin|mesh-list
64744988|NCT01777152|Vincristine|vincristine|mesh-list
64744989|NCT01777152|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64744990|NCT01777152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64744991|NCT01777152|Immunologic Factors|immunologic factors|mesh-ancestor
64744992|NCT01777152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745013|NCT01775124|Ranibizumab|ranibizumab|mesh-list
64317837|NCT02412189|Norepinephrine|norepinephrine|mesh-list
64317838|NCT02412189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64317840|NCT02412189|Adrenergic Agents|adrenergic agents|mesh-ancestor
64317841|NCT02412189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64317842|NCT02412189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317843|NCT02412189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317844|NCT02412189|Sympathomimetics|sympathomimetics|mesh-ancestor
64317845|NCT02412189|Autonomic Agents|autonomic agents|mesh-ancestor
64790893|NCT00004884|Antiviral Agents|antiviral agents|mesh-ancestor
64790953|NCT00004998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64790954|NCT00004998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64790955|NCT00004998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64790957|NCT00004998|Antiviral Agents|antiviral agents|mesh-ancestor
64322660|NCT02146547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64322661|NCT02146547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745016|NCT01775124|Growth Substances|growth substances|mesh-ancestor
64745017|NCT01775124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745018|NCT01775124|Growth Inhibitors|growth inhibitors|mesh-ancestor
64745019|NCT01775124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64745020|NCT01733316|Cysteamine|cysteamine|mesh-list
64745021|NCT01733316|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
64745022|NCT01733316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745023|NCT01732926|Rituximab|rituximab|mesh-list
64745024|NCT01732926|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64745025|NCT01732926|Idelalisib|idelalisib|mesh-list
64745026|NCT01732926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64745027|NCT01732926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64745028|NCT01732926|Immunologic Factors|immunologic factors|mesh-ancestor
64745029|NCT01732926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745030|NCT01732926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64745031|NCT01732926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64745032|NCT01732926|Alkylating Agents|alkylating agents|mesh-ancestor
64745033|NCT01732926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745034|NCT01732926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745035|NCT01732770|Zoledronic Acid|zoledronic acid|mesh-list
64745036|NCT01732770|Denosumab|denosumab|mesh-list
64745037|NCT01732770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64745038|NCT01732770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431486|NCT02059239|Carmustine|carmustine|mesh-list
64791022|NCT00005094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64791023|NCT00005094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64791024|NCT00005094|Analgesics|analgesics|mesh-ancestor
64791025|NCT00005094|Sensory System Agents|sensory system agents|mesh-ancestor
64791026|NCT00005094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64791027|NCT00005094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791028|NCT00005094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64791029|NCT00005094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64791088|NCT00005580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322662|NCT02146547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64745039|NCT01774968|Insulin|insulin|mesh-list
64745040|NCT01774968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64745041|NCT01774968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745042|NCT01732536|Mometasone Furoate|mometasone furoate|mesh-list
64745043|NCT01732536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64745044|NCT01732536|Dermatologic Agents|dermatologic agents|mesh-ancestor
64745045|NCT01732536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64745046|NCT01755702|Acetaminophen|acetaminophen|mesh-list
64745047|NCT01755702|Ibuprofen|ibuprofen|mesh-list
64745048|NCT01755702|Caffeine|caffeine|mesh-list
64745049|NCT01755702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64745050|NCT01755702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64745051|NCT01755702|Analgesics|analgesics|mesh-ancestor
64745052|NCT01755702|Sensory System Agents|sensory system agents|mesh-ancestor
64745053|NCT01755702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64745054|NCT01755702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322663|NCT02146547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64322665|NCT02146547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64322666|NCT02146547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64322667|NCT02146547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64322668|NCT02146547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64322669|NCT02142881|Antihypertensive Agents|antihypertensive agents|mesh-list
64322670|NCT02146703|Gemcitabine|gemcitabine|mesh-list
64322671|NCT02146703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64322672|NCT02146703|Antimetabolites|antimetabolites|mesh-ancestor
64745055|NCT01755702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64745056|NCT01755702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64791089|NCT00005580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64791090|NCT00005580|Immunologic Factors|immunologic factors|mesh-ancestor
64791091|NCT00005580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791093|NCT00005586|Leucovorin|leucovorin|mesh-list
64791159|NCT00005622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791160|NCT00005622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64791161|NCT00005634|Vorinostat|vorinostat|mesh-list
64791162|NCT00005634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791163|NCT00005634|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64791164|NCT00005634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745066|NCT01755702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64745067|NCT01732458|Ondansetron|ondansetron|mesh-list
64745068|NCT01732458|Aprepitant|aprepitant|mesh-list
64745069|NCT01732458|Fosaprepitant|fosaprepitant|mesh-list
64745070|NCT01732458|Antiemetics|antiemetics|mesh-ancestor
64745087|NCT01708902|Metformin|metformin|mesh-list
64317846|NCT02412189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317847|NCT02412189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64317848|NCT03172299|Aflibercept|aflibercept|mesh-list
64317849|NCT03172299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64317850|NCT03172299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64317851|NCT03172299|Growth Substances|growth substances|mesh-ancestor
64317852|NCT03172299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322714|NCT04163185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64322715|NCT04163185|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64322716|NCT04163185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64322717|NCT04163185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322718|NCT04163185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322719|NCT04163185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64322721|NCT04163185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64322722|NCT02149901|Pseudoephedrine|pseudoephedrine|mesh-list
64322724|NCT02149901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64745090|NCT01708902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745092|NCT01708902|Hormones|hormones|mesh-ancestor
64745093|NCT01708902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64745094|NCT01708902|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64745095|NCT01708902|Protease Inhibitors|protease inhibitors|mesh-ancestor
64745096|NCT01708902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745097|NCT01708902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745098|NCT01755546|Buprenorphine|buprenorphine|mesh-list
64745099|NCT01755546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64745100|NCT01755546|Narcotics|narcotics|mesh-ancestor
64745101|NCT01755546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64745102|NCT01755546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745103|NCT01755546|Analgesics|analgesics|mesh-ancestor
64745104|NCT01755546|Sensory System Agents|sensory system agents|mesh-ancestor
64745105|NCT01755546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64745106|NCT01755546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64745107|NCT04413864|Dexmedetomidine|dexmedetomidine|mesh-list
64745108|NCT04413864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64745109|NCT04413864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64745110|NCT04413864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317853|NCT03172299|Growth Inhibitors|growth inhibitors|mesh-ancestor
64317854|NCT03172299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64317855|NCT02411955|Nicotinic Acids|nicotinic acids|mesh-list
64317856|NCT02411955|Tazarotene|tazarotene|mesh-list
64317857|NCT02411955|Dermatologic Agents|dermatologic agents|mesh-ancestor
64317858|NCT02411955|Keratolytic Agents|keratolytic agents|mesh-ancestor
64317859|NCT02411955|Vitamin B Complex|vitamin b complex|mesh-ancestor
64317860|NCT02411955|Vitamins|vitamins|mesh-ancestor
64317861|NCT02411955|Micronutrients|micronutrients|mesh-ancestor
64745116|NCT04413864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64745117|NCT04413864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64745118|NCT04413864|Adrenergic Agents|adrenergic agents|mesh-ancestor
64745119|NCT04413864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64745120|NCT04413864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745122|NCT01755234|Sevoflurane|sevoflurane|mesh-list
64745123|NCT01755234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64745124|NCT01755234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64745125|NCT01755234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745126|NCT01755234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64791165|NCT00005634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791166|NCT00005640|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
64791167|NCT00005640|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64791168|NCT00005640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791169|NCT00005646|Paclitaxel|paclitaxel|mesh-list
64791170|NCT00005646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64791171|NCT00005646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791172|NCT00005646|Tubulin Modulators|tubulin modulators|mesh-ancestor
64322730|NCT02149901|Nasal Decongestants|nasal decongestants|mesh-ancestor
64322731|NCT02149901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64322732|NCT02149901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64745169|NCT01605396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64745170|NCT01605396|Hormone Antagonists|hormone antagonists|mesh-ancestor
64745171|NCT01605396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64745172|NCT01605396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745174|NCT01730118|Mitosis Modulators|mitosis modulators|mesh-ancestor
64745175|NCT01730118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745176|NCT01730040|Atorvastatin|atorvastatin|mesh-list
64745177|NCT01730040|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64745178|NCT01730040|Ezetimibe|ezetimibe|mesh-list
64745179|NCT01730040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64745180|NCT01730040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64745181|NCT01730040|Antimetabolites|antimetabolites|mesh-ancestor
64745182|NCT01730040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357207|NCT03385967|Analgesics|analgesics|mesh-ancestor
64791219|NCT00005802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64791220|NCT00005802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64791221|NCT00005802|Immunologic Factors|immunologic factors|mesh-ancestor
64791222|NCT00005802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64791223|NCT00005802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64791224|NCT00005802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64791225|NCT00005802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64791226|NCT00005802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64791286|NCT00355602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64791287|NCT00355602|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64791288|NCT00355602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791289|NCT00355602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791309|NCT00356226|Clonidine|clonidine|mesh-list
64791356|NCT00356928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791357|NCT00356928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791358|NCT00356928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64791359|NCT00357084|Prednisone|prednisone|mesh-list
64745233|NCT01729728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64745234|NCT01729728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64357254|NCT02732015|Dermatologic Agents|dermatologic agents|mesh-ancestor
64322752|NCT04440267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322753|NCT04440267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64322754|NCT04440267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64322756|NCT04440267|Autonomic Agents|autonomic agents|mesh-ancestor
64322757|NCT04440267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322758|NCT04440267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64322759|NCT04440267|Glucocorticoids|glucocorticoids|mesh-ancestor
64322760|NCT04440267|Hormones|hormones|mesh-ancestor
64745235|NCT01729728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745236|NCT01729728|Adrenergic Agents|adrenergic agents|mesh-ancestor
64745237|NCT01729728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64745238|NCT01728324|Ribavirin|ribavirin|mesh-list
64745239|NCT01728324|Antimetabolites|antimetabolites|mesh-ancestor
64745240|NCT01728324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745241|NCT01728324|Antiviral Agents|antiviral agents|mesh-ancestor
64745242|NCT01728324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64745243|NCT01728246|Acetaminophen|acetaminophen|mesh-list
64791360|NCT00357084|Methylprednisolone|methylprednisolone|mesh-list
64791361|NCT00357084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64791362|NCT00357084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64791363|NCT00357084|Prednisolone|prednisolone|mesh-list
64791364|NCT00357084|Prednisolone acetate|prednisolone acetate|mesh-list
64791365|NCT00357084|Methotrexate|methotrexate|mesh-list
64791366|NCT00357084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64791367|NCT00357084|Prednisolone phosphate|prednisolone phosphate|mesh-list
64791418|NCT00357318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64322780|NCT02043847|Lenograstim|lenograstim|mesh-list
64322781|NCT02043847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64322782|NCT02043847|Immunologic Factors|immunologic factors|mesh-ancestor
64322783|NCT02043847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322784|NCT02043847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64322785|NCT02043847|Alkylating Agents|alkylating agents|mesh-ancestor
64322786|NCT02043847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322787|NCT02043847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322788|NCT02043847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64745250|NCT01728246|Antipyretics|antipyretics|mesh-ancestor
64745251|NCT01728246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64745252|NCT01728246|Narcotics|narcotics|mesh-ancestor
64745253|NCT01728246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64745254|NCT04414020|Progesterone|progesterone|mesh-list
64745255|NCT04414020|Progestins|progestins|mesh-ancestor
64745256|NCT04414020|Hormones|hormones|mesh-ancestor
64745257|NCT04414020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64745258|NCT04414020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745259|NCT01705236|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64745260|NCT01705236|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64745261|NCT01705236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745262|NCT01705236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64745263|NCT01705236|Immunologic Factors|immunologic factors|mesh-ancestor
64745264|NCT01705236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745265|NCT01751802|Ecopipam|ecopipam|mesh-list
64745266|NCT01751802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64745267|NCT01751802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64745268|NCT01751802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64745269|NCT01751802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745270|NCT01751802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64791419|NCT00357318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64791420|NCT00357318|Growth Substances|growth substances|mesh-ancestor
64791421|NCT00357318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791422|NCT00357318|Growth Inhibitors|growth inhibitors|mesh-ancestor
64791423|NCT00357318|Immunologic Factors|immunologic factors|mesh-ancestor
64791424|NCT00357318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64791425|NCT00357318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791485|NCT00358020|Growth Substances|growth substances|mesh-ancestor
64791486|NCT00358020|Growth Inhibitors|growth inhibitors|mesh-ancestor
64745271|NCT01751802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64745272|NCT01751802|Dopamine Agents|dopamine agents|mesh-ancestor
64745273|NCT01751802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64745274|NCT01751802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745275|NCT01703286|Glimepiride|glimepiride|mesh-list
64745276|NCT01703286|Linagliptin|linagliptin|mesh-list
64745277|NCT01703286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64745278|NCT01703286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64745279|NCT01703286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745280|NCT01703286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64745281|NCT01703286|Immunologic Factors|immunologic factors|mesh-ancestor
64745282|NCT01703286|Incretins|incretins|mesh-ancestor
64745283|NCT01703286|Hormones|hormones|mesh-ancestor
64745284|NCT01703286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64745285|NCT01703286|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64745286|NCT01703286|Protease Inhibitors|protease inhibitors|mesh-ancestor
64745287|NCT01703286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745288|NCT01703286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791487|NCT00358176|Risedronic Acid|risedronic acid|mesh-list
64791488|NCT00358176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64791489|NCT00358176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64791490|NCT00358176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791491|NCT00358176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64791492|NCT00358176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791493|NCT00358176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64791550|NCT00359658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64357339|NCT02732119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64322789|NCT02043847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64322792|NCT02146937|Androgen Antagonists|androgen antagonists|mesh-ancestor
64322793|NCT02146937|Hormone Antagonists|hormone antagonists|mesh-ancestor
64322794|NCT02146937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64322795|NCT02146937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322796|NCT02146937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322797|NCT02146937|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64322798|NCT02146937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64322799|NCT02146937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322800|NCT02146937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745319|NCT01725126|Hormones|hormones|mesh-ancestor
64791551|NCT00359658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64791552|NCT00359658|Glucocorticoids|glucocorticoids|mesh-ancestor
64317883|NCT02412033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64317884|NCT02412033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317885|NCT02412033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64317886|NCT02412033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64317888|NCT02401971|Thalidomide|thalidomide|mesh-list
64317889|NCT02401971|Irinotecan|irinotecan|mesh-list
64745453|NCT01700946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64745454|NCT01700946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64745455|NCT01700946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64745456|NCT01700946|Abortifacient Agents|abortifacient agents|mesh-ancestor
64745457|NCT01700946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64745458|NCT01700946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64745459|NCT01700946|Antimetabolites|antimetabolites|mesh-ancestor
64745460|NCT01700946|Dermatologic Agents|dermatologic agents|mesh-ancestor
64745461|NCT01700946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745462|NCT01700946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64745463|NCT01700946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64745464|NCT01700946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64745465|NCT01700946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64745466|NCT01700946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64317890|NCT02401971|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64317891|NCT02401971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64317892|NCT02401971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317893|NCT02401971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317894|NCT02401971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64317895|NCT02401971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64317896|NCT02401971|Immunologic Factors|immunologic factors|mesh-ancestor
64317897|NCT02401971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317898|NCT02401971|Leprostatic Agents|leprostatic agents|mesh-ancestor
64317899|NCT02401971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64317900|NCT02401971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64317901|NCT02401971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64317902|NCT02401971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64379413|NCT04331691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64379414|NCT04331691|Hormone Antagonists|hormone antagonists|mesh-ancestor
64745507|NCT01748292|Growth Substances|growth substances|mesh-ancestor
64745508|NCT01748292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745509|NCT01748292|Growth Inhibitors|growth inhibitors|mesh-ancestor
64745510|NCT01748292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64745511|NCT01720602|Letrozole|letrozole|mesh-list
64745512|NCT01720602|Anastrozole|anastrozole|mesh-list
64745513|NCT01720602|Vorinostat|vorinostat|mesh-list
64745514|NCT01720602|Exemestane|exemestane|mesh-list
64745515|NCT01720602|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64745516|NCT01720602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64745517|NCT01720602|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64745518|NCT01720602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64791554|NCT00359658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64791555|NCT00359658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64791556|NCT00359658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791558|NCT00359814|Cyclosporins|cyclosporins|mesh-list
64791559|NCT00359814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791560|NCT00359814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791561|NCT00359814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64791562|NCT00359814|Immunologic Factors|immunologic factors|mesh-ancestor
64791563|NCT00359814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791564|NCT00359814|Antifungal Agents|antifungal agents|mesh-ancestor
64791565|NCT00359814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64791566|NCT00359814|Dermatologic Agents|dermatologic agents|mesh-ancestor
64791567|NCT00359814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64745541|NCT01746732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64745542|NCT01746732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64745543|NCT01746732|Contraceptive Agents|contraceptive agents|mesh-ancestor
64745544|NCT01746732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64745545|NCT01746732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745546|NCT01746732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64745547|NCT01746732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64745548|NCT01746732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64745549|NCT01720524|Sildenafil Citrate|sildenafil citrate|mesh-list
64745550|NCT01720524|Vasodilator Agents|vasodilator agents|mesh-ancestor
64745551|NCT01720524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64745552|NCT01720524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64322823|NCT02229175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322824|NCT02229175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64322825|NCT02229175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64322826|NCT02229175|Growth Substances|growth substances|mesh-ancestor
64322827|NCT02229175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322828|NCT02229175|Growth Inhibitors|growth inhibitors|mesh-ancestor
64322829|NCT05744739|Azacitidine|azacitidine|mesh-list
64322830|NCT05744739|Venetoclax|venetoclax|mesh-list
64322831|NCT05744739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64791568|NCT00359814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64317903|NCT02401971|Growth Substances|growth substances|mesh-ancestor
64317904|NCT02401971|Growth Inhibitors|growth inhibitors|mesh-ancestor
64317905|NCT00701883|Atorvastatin|atorvastatin|mesh-list
64317906|NCT00701883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64317907|NCT00701883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64317908|NCT00701883|Antimetabolites|antimetabolites|mesh-ancestor
64317909|NCT00701883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322852|NCT04104685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322853|NCT04104685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64322854|NCT04104685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64322855|NCT04104685|Dermatologic Agents|dermatologic agents|mesh-ancestor
64745666|NCT01696032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64745667|NCT01696032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64745668|NCT01696032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64745669|NCT01695954|Ritonavir|ritonavir|mesh-list
64745670|NCT01695954|Darunavir|darunavir|mesh-list
64745671|NCT01695954|Efavirenz|efavirenz|mesh-list
64745672|NCT01695954|Pitavastatin|pitavastatin|mesh-list
64745673|NCT01695954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64745674|NCT01695954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64745675|NCT01695954|Protease Inhibitors|protease inhibitors|mesh-ancestor
64745676|NCT01695954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745677|NCT01695954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745678|NCT01695954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64745679|NCT01695954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64745680|NCT01695954|Antiviral Agents|antiviral agents|mesh-ancestor
64745681|NCT01695954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64745682|NCT01695954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64745683|NCT01695954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64745684|NCT01695954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64745685|NCT01695954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64745686|NCT01695954|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64745687|NCT01695954|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64745688|NCT01695954|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64745689|NCT01695954|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64745690|NCT01695954|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64317910|NCT00701883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64317911|NCT00701883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64317912|NCT00701883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317913|NCT05678738|Antioxidants|antioxidants|mesh-list
64317914|NCT05678738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317915|NCT05678738|Protective Agents|protective agents|mesh-ancestor
64317916|NCT05678738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317917|NCT03175653|Oxycodone|oxycodone|mesh-list
64745691|NCT01695954|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64745692|NCT01695954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64745693|NCT01695954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64745694|NCT01695954|Antimetabolites|antimetabolites|mesh-ancestor
64745695|NCT01695954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64745697|NCT01694706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64745698|NCT01694706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64745699|NCT01694706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64745700|NCT01694706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745701|NCT01694706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745702|NCT01715298|Glycopyrrolate|glycopyrrolate|mesh-list
64745703|NCT01715298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64745704|NCT01715298|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64745705|NCT01715298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64745706|NCT01715298|Cholinergic Agents|cholinergic agents|mesh-ancestor
64745707|NCT01715298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64745708|NCT01715298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745709|NCT01715298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745710|NCT01739400|Macitentan|macitentan|mesh-list
64745711|NCT01739400|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64745716|NCT01712178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64317918|NCT03175653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64791569|NCT00359892|Obatoclax|obatoclax|mesh-list
64791570|NCT00359892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791571|NCT00359892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791572|NCT00359970|Azithromycin|azithromycin|mesh-list
64791573|NCT00359970|Loperamide|loperamide|mesh-list
64791574|NCT00359970|Antidiarrheals|antidiarrheals|mesh-list
64791575|NCT00359970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64791576|NCT00359970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64791577|NCT00359970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64791578|NCT00360048|Oxytocin|oxytocin|mesh-list
64745736|NCT01737840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745737|NCT01737840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745738|NCT01737840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64745739|NCT01737840|Histamine Antagonists|histamine antagonists|mesh-ancestor
64745743|NCT01711866|Rotigotine|rotigotine|mesh-list
64745760|NCT01682460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64745761|NCT01709838|Deferasirox|deferasirox|mesh-list
64745762|NCT01709838|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64745763|NCT01709838|Chelating Agents|chelating agents|mesh-ancestor
64745764|NCT01709838|Sequestering Agents|sequestering agents|mesh-ancestor
64745765|NCT01709838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745766|NCT01688466|Pomalidomide|pomalidomide|mesh-list
64745767|NCT01688466|Immunologic Factors|immunologic factors|mesh-ancestor
64745768|NCT01688466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745769|NCT01688466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64745770|NCT01688466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64745771|NCT01688466|Growth Substances|growth substances|mesh-ancestor
64745772|NCT01688466|Growth Inhibitors|growth inhibitors|mesh-ancestor
64745773|NCT01688466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357797|NCT02766335|Durvalumab|durvalumab|mesh-list
64322857|NCT02147249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64322858|NCT02392845|Docetaxel|docetaxel|mesh-list
64322859|NCT02392845|Epirubicin|epirubicin|mesh-list
64322860|NCT02392845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322861|NCT02392845|Tubulin Modulators|tubulin modulators|mesh-ancestor
64322862|NCT02392845|Antimitotic Agents|antimitotic agents|mesh-ancestor
64322863|NCT02392845|Mitosis Modulators|mitosis modulators|mesh-ancestor
64322865|NCT02392845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64322866|NCT02392845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64322867|NCT02392845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64745774|NCT01682148|Botulinum Toxins|botulinum toxins|mesh-list
64791579|NCT00360048|Oxytocics|oxytocics|mesh-ancestor
64317919|NCT03175653|Narcotics|narcotics|mesh-ancestor
64317920|NCT03175653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64317921|NCT03175653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317922|NCT03175653|Analgesics|analgesics|mesh-ancestor
64317923|NCT03175653|Sensory System Agents|sensory system agents|mesh-ancestor
64317924|NCT03175653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317925|NCT02401737|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64317926|NCT02401737|Antiviral Agents|antiviral agents|mesh-ancestor
64317927|NCT02401737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64317928|NCT03175341|Ascorbic Acid|ascorbic acid|mesh-list
64317929|NCT03175341|Vitamins|vitamins|mesh-ancestor
64745779|NCT01682148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745780|NCT01682148|Cholinergic Agents|cholinergic agents|mesh-ancestor
64745781|NCT01682148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64745782|NCT01682148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745783|NCT01682148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64745784|NCT01682148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322869|NCT04093765|Antimalarials|antimalarials|mesh-list
64322870|NCT04093765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64322871|NCT04093765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64322872|NCT04093765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64322873|NCT03166605|Simethicone|simethicone|mesh-list
64322874|NCT03166605|Antifoaming Agents|antifoaming agents|mesh-ancestor
64322875|NCT03166605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322876|NCT03166605|Emollients|emollients|mesh-ancestor
64322877|NCT03166605|Dermatologic Agents|dermatologic agents|mesh-ancestor
64322878|NCT03699956|Carboplatin|carboplatin|mesh-list
64322879|NCT03699956|Etoposide|etoposide|mesh-list
64322880|NCT03699956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322881|NCT03699956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64322882|NCT03699956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64322883|NCT03699956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64322884|NCT03699956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322885|NCT03699956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745786|NCT01681992|Immunologic Factors|immunologic factors|mesh-ancestor
64317930|NCT03175341|Micronutrients|micronutrients|mesh-ancestor
64317931|NCT03175341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317932|NCT03175341|Antioxidants|antioxidants|mesh-ancestor
64317933|NCT03175341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317934|NCT03175341|Protective Agents|protective agents|mesh-ancestor
64317935|NCT05538026|Mesalamine|mesalamine|mesh-list
64317936|NCT05538026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64745801|NCT01681212|Alkylating Agents|alkylating agents|mesh-ancestor
64745802|NCT01687296|Fluticasone|fluticasone|mesh-list
64745803|NCT01687296|Xhance|xhance|mesh-list
64745804|NCT01687296|Prednisone|prednisone|mesh-list
64745805|NCT01687296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64745806|NCT01687296|Albuterol|albuterol|mesh-list
64745807|NCT01687296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64745808|NCT01687296|Glucocorticoids|glucocorticoids|mesh-ancestor
64322887|NCT03166527|Antibodies|antibodies|mesh-list
64322888|NCT03166527|gamma-Globulins|gamma-globulins|mesh-list
64322889|NCT03166527|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64322890|NCT03166527|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64322891|NCT03166527|Immunologic Factors|immunologic factors|mesh-ancestor
64322892|NCT03166527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322893|NCT02695719|Lubiprostone|lubiprostone|mesh-list
64745809|NCT01687296|Hormones|hormones|mesh-ancestor
64745810|NCT01687296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64745811|NCT01687296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317937|NCT05538026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64317938|NCT05538026|Analgesics|analgesics|mesh-ancestor
64317939|NCT05538026|Sensory System Agents|sensory system agents|mesh-ancestor
64317940|NCT05538026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317941|NCT05538026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317942|NCT05538026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64379451|NCT05304273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64317943|NCT05538026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64317945|NCT02401425|Misoprostol|misoprostol|mesh-list
64379486|NCT05610969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64322918|NCT05497934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322919|NCT02229721|Oxytocin|oxytocin|mesh-list
64322920|NCT02229721|Oxytocics|oxytocics|mesh-ancestor
64791580|NCT00360048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64791581|NCT00360048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791593|NCT00360750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64791594|NCT00360750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64791595|NCT00360750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791596|NCT00360750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791597|NCT00360750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64791598|NCT00360750|Antimetabolites|antimetabolites|mesh-ancestor
64791599|NCT00360750|Antiviral Agents|antiviral agents|mesh-ancestor
64791600|NCT00360750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64745854|NCT01568112|Antipyretics|antipyretics|mesh-ancestor
64791601|NCT00360750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64791602|NCT00360750|Immunologic Factors|immunologic factors|mesh-ancestor
64791603|NCT00360750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791604|NCT00360750|Tubulin Modulators|tubulin modulators|mesh-ancestor
64791605|NCT00360750|Antimitotic Agents|antimitotic agents|mesh-ancestor
64791606|NCT00360750|Mitosis Modulators|mitosis modulators|mesh-ancestor
64791607|NCT00360984|Insulin|insulin|mesh-list
64791608|NCT00360984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64791609|NCT00360984|Insulin Glargine|insulin glargine|mesh-list
64791610|NCT00360984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64791611|NCT00360984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791612|NCT00361452|Epinephrine|epinephrine|mesh-list
64791613|NCT00361452|Albuterol|albuterol|mesh-list
64791614|NCT00361452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64317946|NCT02401425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64317947|NCT02401425|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64317948|NCT02401425|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64317949|NCT02401425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745907|NCT01603602|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64745908|NCT01603602|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64745909|NCT01603602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64745910|NCT01603602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745911|NCT01603602|Cholinergic Agents|cholinergic agents|mesh-ancestor
64745912|NCT01603602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64745913|NCT01603602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745914|NCT01603602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64745915|NCT01603602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64745916|NCT01684878|Gemcitabine|gemcitabine|mesh-list
64745917|NCT01684878|Paclitaxel|paclitaxel|mesh-list
64745918|NCT01684878|Topotecan|topotecan|mesh-list
64745919|NCT01684878|Pertuzumab|pertuzumab|mesh-list
64745920|NCT01684878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64745921|NCT01684878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64745922|NCT01684878|Tubulin Modulators|tubulin modulators|mesh-ancestor
64745923|NCT01684878|Antimitotic Agents|antimitotic agents|mesh-ancestor
64745924|NCT01684878|Mitosis Modulators|mitosis modulators|mesh-ancestor
64745926|NCT01684878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64317950|NCT02401425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317951|NCT02401425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64317952|NCT02401425|Hormone Antagonists|hormone antagonists|mesh-ancestor
64317953|NCT02401425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64317954|NCT02401425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317955|NCT02401425|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64317956|NCT02401425|Abortifacient Agents|abortifacient agents|mesh-ancestor
64379547|NCT05555667|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64745946|NCT01592292|Etanercept|etanercept|mesh-list
64745947|NCT01592292|Rituximab|rituximab|mesh-list
64745948|NCT01592292|Infliximab|infliximab|mesh-list
64745949|NCT01592292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64745950|NCT01592292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64745951|NCT01592292|Immunologic Factors|immunologic factors|mesh-ancestor
64745952|NCT01592292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745953|NCT01592292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64745954|NCT01592292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64745955|NCT01592292|Dermatologic Agents|dermatologic agents|mesh-ancestor
64379549|NCT05555667|Anesthetics|anesthetics|mesh-ancestor
64379550|NCT04425993|Indomethacin|indomethacin|mesh-list
64379551|NCT04425993|Isosorbide|isosorbide|mesh-list
64791615|NCT00361452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64791646|NCT00361920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791647|NCT00361920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64791648|NCT00361920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791649|NCT00361998|Nitrofurantoin|nitrofurantoin|mesh-list
64791650|NCT00361998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64791651|NCT00361998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64791652|NCT00361998|Renal Agents|renal agents|mesh-ancestor
64745991|NCT01543152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745992|NCT01543152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64745993|NCT01543152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64745994|NCT01565148|Ranibizumab|ranibizumab|mesh-list
64745995|NCT01565148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64745996|NCT01565148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64745997|NCT01565148|Growth Substances|growth substances|mesh-ancestor
64745998|NCT01565148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745999|NCT01565148|Growth Inhibitors|growth inhibitors|mesh-ancestor
64746000|NCT01565148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746002|NCT04410354|Antimetabolites|antimetabolites|mesh-ancestor
64746003|NCT04410354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746004|NCT04410354|Antiviral Agents|antiviral agents|mesh-ancestor
64746005|NCT04410354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64746006|NCT01564758|Linezolid|linezolid|mesh-list
64746007|NCT01564758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64746008|NCT01564758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64746009|NCT01564758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64746010|NCT01564758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746011|NCT01564758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746012|NCT01589094|Gemcitabine|gemcitabine|mesh-list
64791653|NCT00361998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64791654|NCT00362310|Indinavir|indinavir|mesh-list
64791655|NCT00362310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64791656|NCT00362310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64791657|NCT00362310|Protease Inhibitors|protease inhibitors|mesh-ancestor
64791710|NCT00363090|Tubulin Modulators|tubulin modulators|mesh-ancestor
64791711|NCT00363090|Antimitotic Agents|antimitotic agents|mesh-ancestor
64791712|NCT00363090|Mitosis Modulators|mitosis modulators|mesh-ancestor
64791713|NCT00363090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64791714|NCT00363792|Nitroglycerin|nitroglycerin|mesh-list
64791715|NCT00363792|Vasodilator Agents|vasodilator agents|mesh-ancestor
64791716|NCT00363948|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64791717|NCT00363948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64791718|NCT00363948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791776|NCT00365586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64317957|NCT02401425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64317958|NCT02401425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64317959|NCT02401425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64317960|NCT02401425|Oxytocics|oxytocics|mesh-ancestor
64322979|NCT02229955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322980|NCT02229955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322981|NCT02229955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64322982|NCT02229955|Immunologic Factors|immunologic factors|mesh-ancestor
64322983|NCT02229955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322984|NCT02229955|Antifungal Agents|antifungal agents|mesh-ancestor
64322985|NCT02229955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64322986|NCT02229955|Dermatologic Agents|dermatologic agents|mesh-ancestor
64322987|NCT02229955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64322988|NCT02229955|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64317961|NCT05537948|Pitavastatin|pitavastatin|mesh-list
64317962|NCT05537948|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64317963|NCT05537948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64317964|NCT05537948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64317965|NCT05537948|Antimetabolites|antimetabolites|mesh-ancestor
64317966|NCT05537948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317967|NCT05537948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317968|NCT05537948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64317969|NCT02759185|Dronabinol|dronabinol|mesh-list
64317970|NCT02759185|Cannabidiol|cannabidiol|mesh-list
64317971|NCT02759185|Anticonvulsants|anticonvulsants|mesh-ancestor
64317972|NCT02759185|Hallucinogens|hallucinogens|mesh-ancestor
64323012|NCT05740371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323013|NCT05740371|Anticoagulants|anticoagulants|mesh-ancestor
64323014|NCT05740371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64323015|NCT02223949|Alprostadil|alprostadil|mesh-list
64323016|NCT02223949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64323017|NCT02223949|Vasodilator Agents|vasodilator agents|mesh-ancestor
64323018|NCT02223949|Urological Agents|urological agents|mesh-ancestor
64323019|NCT03915067|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64323020|NCT03915067|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64323021|NCT03915067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64323022|NCT03915067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64323023|NCT03915067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323024|NCT03915067|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64323025|NCT03915067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64746049|NCT01539642|Anesthetics|anesthetics|mesh-ancestor
64317973|NCT02759185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317974|NCT02759185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64791778|NCT00365586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791779|NCT00365742|Simvastatin|simvastatin|mesh-list
64791780|NCT00365742|Red yeast rice|red yeast rice|mesh-list
64791781|NCT00365742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64791782|NCT00365742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64791783|NCT00365742|Antimetabolites|antimetabolites|mesh-ancestor
64323031|NCT02691507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64323032|NCT02259361|4-Aminopyridine|4-aminopyridine|mesh-list
64323033|NCT02259361|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64323034|NCT02259361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64746073|NCT01562028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64746074|NCT01562028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64746075|NCT01562028|Growth Substances|growth substances|mesh-ancestor
64746076|NCT01562028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746077|NCT01562028|Growth Inhibitors|growth inhibitors|mesh-ancestor
64746079|NCT01562028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791784|NCT00365742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791785|NCT00365742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64791786|NCT00365742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64791787|NCT00365742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791788|NCT00365820|Tegaserod|tegaserod|mesh-list
64791789|NCT00365820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64791790|NCT00365820|Serotonin Agents|serotonin agents|mesh-ancestor
64317975|NCT02759185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64317976|NCT02759185|Analgesics|analgesics|mesh-ancestor
64317977|NCT02759185|Sensory System Agents|sensory system agents|mesh-ancestor
64317978|NCT02759185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317979|NCT02759185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64317980|NCT02759185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64317981|NCT02759185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64317982|NCT02759185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317983|NCT02759185|Hormones|hormones|mesh-ancestor
64317984|NCT02759185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64317985|NCT02401269|Aspirin|aspirin|mesh-list
64791791|NCT00365820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64791792|NCT00365820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791793|NCT00365820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791794|NCT00365898|Hydromorphone|hydromorphone|mesh-list
64791805|NCT00366834|Casopitant|casopitant|mesh-list
64791831|NCT00366834|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64791832|NCT00367068|Baclofen|baclofen|mesh-list
64791833|NCT00367068|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64791834|NCT00367068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746122|NCT01585272|Protective Agents|protective agents|mesh-ancestor
64746123|NCT01585194|Nivolumab|nivolumab|mesh-list
64746124|NCT01585194|Ipilimumab|ipilimumab|mesh-list
64746144|NCT01585038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64746145|NCT01585038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64746146|NCT01585038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64746147|NCT01559844|Ribavirin|ribavirin|mesh-list
64746148|NCT01559844|Sofosbuvir|sofosbuvir|mesh-list
64746149|NCT01559844|Antimetabolites|antimetabolites|mesh-ancestor
64746150|NCT01559844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746151|NCT01559844|Antiviral Agents|antiviral agents|mesh-ancestor
64746152|NCT01559844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64746153|NCT01584648|Trametinib|trametinib|mesh-list
64746154|NCT01584648|Dabrafenib|dabrafenib|mesh-list
64746155|NCT01584648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64791835|NCT00367068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64791836|NCT00367068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317986|NCT02401269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64317987|NCT02401269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64317988|NCT02401269|Analgesics|analgesics|mesh-ancestor
64317989|NCT02401269|Sensory System Agents|sensory system agents|mesh-ancestor
64317990|NCT02401269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317991|NCT02401269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317992|NCT02401269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64317993|NCT02401269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64317994|NCT02401269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64317995|NCT02401269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64317996|NCT02401269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317997|NCT02401269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64746175|NCT01583166|Anesthetics, Local|anesthetics, local|mesh-ancestor
64746176|NCT01583166|Anesthetics|anesthetics|mesh-ancestor
64746177|NCT01583166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64746178|NCT01583166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746179|NCT01583166|Sensory System Agents|sensory system agents|mesh-ancestor
64746180|NCT01583166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64746181|NCT01583166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64746182|NCT01583166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64746183|NCT01583166|Adrenergic Agents|adrenergic agents|mesh-ancestor
64746184|NCT01583166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64746185|NCT01583166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514963|NCT04776850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64746186|NCT01583166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64746188|NCT01583166|Autonomic Agents|autonomic agents|mesh-ancestor
64317998|NCT02401269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64379743|NCT05553717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64791837|NCT00367068|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64791838|NCT00367068|GABA Agonists|gaba agonists|mesh-ancestor
64791840|NCT00367068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64791842|NCT00367302|Buprenorphine|buprenorphine|mesh-list
64791894|NCT00368238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64791895|NCT00368238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64791896|NCT00368238|Purinergic Agents|purinergic agents|mesh-ancestor
64746213|NCT01582308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746214|NCT01582308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746215|NCT01558674|Torsemide|torsemide|mesh-list
64746216|NCT01558674|Furosemide|furosemide|mesh-list
64746217|NCT01558674|Diuretics|diuretics|mesh-ancestor
64323049|NCT03542357|Salmon calcitonin|salmon calcitonin|mesh-list
64323050|NCT03542357|Sumatriptan|sumatriptan|mesh-list
64323051|NCT03542357|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
64323052|NCT03542357|Katacalcin|katacalcin|mesh-list
64323053|NCT03542357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64323054|NCT03542357|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64323055|NCT03542357|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64323056|NCT03542357|Serotonin Agents|serotonin agents|mesh-ancestor
64323057|NCT03542357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64323058|NCT03542357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746218|NCT01558674|Natriuretic Agents|natriuretic agents|mesh-ancestor
64746219|NCT01558674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746220|NCT01558674|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64746221|NCT01558674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64746222|NCT01558674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746223|NCT01558674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64746224|NCT01535040|Memantine|memantine|mesh-list
64746225|NCT01535040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64746226|NCT01535040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64746233|NCT01534962|Ranolazine|ranolazine|mesh-list
64791897|NCT00368238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64791898|NCT00368238|Hematinics|hematinics|mesh-ancestor
64791899|NCT00368394|Insulin glulisine|insulin glulisine|mesh-list
64791900|NCT00368394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64791901|NCT00368394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64791902|NCT00368706|Solifenacin Succinate|solifenacin succinate|mesh-list
64791903|NCT00368706|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64791904|NCT00368706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64791905|NCT00368706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64791906|NCT00368706|Cholinergic Agents|cholinergic agents|mesh-ancestor
64746241|NCT01582152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64746242|NCT01582152|Growth Substances|growth substances|mesh-ancestor
64746243|NCT01582152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746244|NCT01582152|Growth Inhibitors|growth inhibitors|mesh-ancestor
64746245|NCT01557504|Metformin|metformin|mesh-list
64323059|NCT03542357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323060|NCT03542357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64323061|NCT03542357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64323062|NCT03542357|Vasodilator Agents|vasodilator agents|mesh-ancestor
64323064|NCT04811001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323065|NCT04811001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64323066|NCT04811001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746246|NCT01557504|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64746247|NCT01557504|Hormones|hormones|mesh-list
64746248|NCT01557504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64746249|NCT01557504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746250|NCT01557504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64746251|NCT01557504|Incretins|incretins|mesh-ancestor
64746252|NCT01557504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64746253|NCT01557504|Protease Inhibitors|protease inhibitors|mesh-ancestor
64746254|NCT01557504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746255|NCT01557504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746256|NCT01580670|Infliximab|infliximab|mesh-list
64746257|NCT01580670|Dermatologic Agents|dermatologic agents|mesh-ancestor
64746258|NCT01580670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64746259|NCT01580670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64746260|NCT01534260|Bortezomib|bortezomib|mesh-list
64746261|NCT01534260|Sorafenib|sorafenib|mesh-list
64791907|NCT00368706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64791908|NCT00368706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791954|NCT00369954|Carboplatin|carboplatin|mesh-list
64791955|NCT00369954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318000|NCT02401269|Antipyretics|antipyretics|mesh-ancestor
64318001|NCT04480827|Cholic Acids|cholic acids|mesh-list
64318002|NCT04480827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64318003|NCT02582684|Lamivudine|lamivudine|mesh-list
64318004|NCT02582684|Dolutegravir|dolutegravir|mesh-list
64318005|NCT02582684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64746262|NCT01534260|Vorinostat|vorinostat|mesh-list
64746263|NCT01534260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746264|NCT01534260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64746265|NCT01534260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746266|NCT01534260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746267|NCT01534260|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64746268|NCT01534182|Interferons|interferons|mesh-list
64746269|NCT01534182|Interferon-beta|interferon-beta|mesh-list
64746270|NCT01534182|Glatiramer Acetate|glatiramer acetate|mesh-list
64746271|NCT01534182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64746272|NCT01534182|(T,G)-A-L|(t,g)-a-l|mesh-list
64746273|NCT01534182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746274|NCT01534182|Antiviral Agents|antiviral agents|mesh-ancestor
64746275|NCT01534182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64746276|NCT01534182|Immunologic Factors|immunologic factors|mesh-ancestor
64746322|NCT01577160|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64746323|NCT01577160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64746324|NCT01577160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64746325|NCT01577160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746326|NCT01577160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64746327|NCT01577160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64318006|NCT02582684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64318007|NCT02582684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318008|NCT02582684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318010|NCT02582684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64318011|NCT02582684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64318012|NCT02582684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64318013|NCT02582684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64318014|NCT02582684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64318015|NCT02411877|Clotrimazole|clotrimazole|mesh-list
64318016|NCT02411877|Miconazole|miconazole|mesh-list
64379753|NCT05553093|Insulin|insulin|mesh-list
64791956|NCT00369954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64791957|NCT00369954|Antimetabolites|antimetabolites|mesh-ancestor
64791958|NCT00369954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64791959|NCT00369954|Antiviral Agents|antiviral agents|mesh-ancestor
64791960|NCT00369954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64791961|NCT00369954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64791962|NCT00369954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64791966|NCT00370188|Anticonvulsants|anticonvulsants|mesh-ancestor
64792019|NCT00370656|Adrenergic Agents|adrenergic agents|mesh-ancestor
64792021|NCT00370734|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64792022|NCT00370734|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64792023|NCT00370734|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64792024|NCT00370734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64792025|NCT00370734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792026|NCT00370734|Cholinergic Agents|cholinergic agents|mesh-ancestor
64318017|NCT02411877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64318018|NCT02411877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64318019|NCT02411877|Antifungal Agents|antifungal agents|mesh-ancestor
64318020|NCT02411877|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64318021|NCT02411877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64318022|NCT02411877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318023|NCT02411877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323071|NCT02150993|Lamivudine|lamivudine|mesh-list
64323072|NCT02150993|Zidovudine|zidovudine|mesh-list
64323073|NCT02150993|Emtricitabine|emtricitabine|mesh-list
64323074|NCT02150993|Raltegravir Potassium|raltegravir potassium|mesh-list
64318024|NCT02411877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64318025|NCT02411877|Hormone Antagonists|hormone antagonists|mesh-ancestor
64318026|NCT02411877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64318027|NCT02411877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318028|NCT02411877|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64318029|NCT02411877|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64318030|NCT04903119|Trametinib|trametinib|mesh-list
64318031|NCT04903119|Dabrafenib|dabrafenib|mesh-list
64318032|NCT04903119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792027|NCT00370734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64792028|NCT00370734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792029|NCT00370734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64792035|NCT00371124|Atropine|atropine|mesh-list
64792084|NCT00372294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64792085|NCT00372294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792086|NCT00372294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64792087|NCT00372294|Glucocorticoids|glucocorticoids|mesh-ancestor
64792088|NCT00372294|Hormones|hormones|mesh-ancestor
64792089|NCT00372294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64792090|NCT00372294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64792091|NCT00372294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792092|NCT00372294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64792093|NCT00372294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64792094|NCT00372294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64792095|NCT00372294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792096|NCT00372294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792109|NCT00372762|Furosemide|furosemide|mesh-list
64792141|NCT00373620|Tubulin Modulators|tubulin modulators|mesh-ancestor
64792142|NCT00373620|Antimitotic Agents|antimitotic agents|mesh-ancestor
64792143|NCT00373620|Mitosis Modulators|mitosis modulators|mesh-ancestor
64792144|NCT00373620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792145|NCT00373776|Miltefosine|miltefosine|mesh-list
64318033|NCT04903119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64318034|NCT04903119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318035|NCT04903119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318037|NCT03169569|Coagulants|coagulants|mesh-ancestor
64318038|NCT02585960|Factor VIII|factor viii|mesh-list
64318039|NCT02585960|BAX 855|bax 855|mesh-list
64318040|NCT02585960|Coagulants|coagulants|mesh-ancestor
64318041|NCT03169413|Adenosine|adenosine|mesh-list
64318042|NCT03169413|Analgesics|analgesics|mesh-ancestor
64318043|NCT03169413|Sensory System Agents|sensory system agents|mesh-ancestor
64318044|NCT03169413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318045|NCT03169413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792146|NCT00373776|Antifungal Agents|antifungal agents|mesh-ancestor
64792147|NCT00373776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64792151|NCT00374478|Scopolamine|scopolamine|mesh-list
64792208|NCT00376818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64792209|NCT00376818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792210|NCT00377052|Gemcitabine|gemcitabine|mesh-list
64792211|NCT00377052|Bortezomib|bortezomib|mesh-list
64792222|NCT00377442|Simvastatin|simvastatin|mesh-list
64792277|NCT00378144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64792278|NCT00378144|Respiratory System Agents|respiratory system agents|mesh-ancestor
64792279|NCT00378144|Nasal Decongestants|nasal decongestants|mesh-ancestor
64792280|NCT00378144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64792281|NCT00378144|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64792282|NCT00378144|Sympathomimetics|sympathomimetics|mesh-ancestor
64792283|NCT00378144|Adrenergic Agents|adrenergic agents|mesh-ancestor
64792284|NCT00378144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64792285|NCT00378144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792287|NCT00378456|Leucovorin|leucovorin|mesh-list
64792288|NCT00378456|Folic Acid|folic acid|mesh-list
64792289|NCT00378456|Vitamin A|vitamin a|mesh-list
64792290|NCT00378456|Zinc|zinc|mesh-list
64318046|NCT03169413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64318047|NCT03169413|Vasodilator Agents|vasodilator agents|mesh-ancestor
64318048|NCT03169413|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64318049|NCT03169413|Purinergic Agonists|purinergic agonists|mesh-ancestor
64318050|NCT03169413|Purinergic Agents|purinergic agents|mesh-ancestor
64318051|NCT03169413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64318052|NCT03169413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318053|NCT03169335|Paclitaxel|paclitaxel|mesh-list
64318054|NCT03169335|Bevacizumab|bevacizumab|mesh-list
64318055|NCT03169335|Carboplatin|carboplatin|mesh-list
64318056|NCT03169335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64318057|NCT03169335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318058|NCT03169335|Tubulin Modulators|tubulin modulators|mesh-ancestor
64318059|NCT03169335|Antimitotic Agents|antimitotic agents|mesh-ancestor
64318060|NCT03169335|Mitosis Modulators|mitosis modulators|mesh-ancestor
64318061|NCT03169335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318062|NCT03169335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64318063|NCT03169335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64318064|NCT03169335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64379824|NCT02109562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64379826|NCT02109562|Dopamine Agents|dopamine agents|mesh-ancestor
64792292|NCT00378456|Retinol palmitate|retinol palmitate|mesh-list
64792293|NCT00378456|Levoleucovorin|levoleucovorin|mesh-list
64792294|NCT00378456|Antioxidants|antioxidants|mesh-list
64792295|NCT00378456|Micronutrients|micronutrients|mesh-ancestor
64792296|NCT00378456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792297|NCT00378456|Trace Elements|trace elements|mesh-ancestor
64792298|NCT00378456|Antidotes|antidotes|mesh-ancestor
64792299|NCT00378456|Protective Agents|protective agents|mesh-ancestor
64792300|NCT00378456|Vitamin B Complex|vitamin b complex|mesh-ancestor
64792301|NCT00378456|Hematinics|hematinics|mesh-ancestor
64746530|NCT01524198|Glucocorticoids|glucocorticoids|mesh-ancestor
64746531|NCT01524198|Hormones|hormones|mesh-ancestor
64746532|NCT01524198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64746533|NCT01523886|Rocuronium|rocuronium|mesh-list
64746534|NCT01523886|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64746535|NCT01523886|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64746536|NCT01523886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64746537|NCT01523886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64432295|NCT02404220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792302|NCT00378456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792303|NCT00378456|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64792304|NCT00378456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792305|NCT00378612|Sirolimus|sirolimus|mesh-list
64792306|NCT00378612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64792307|NCT00378612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64792308|NCT00378612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64792309|NCT00378612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792310|NCT00378612|Antifungal Agents|antifungal agents|mesh-ancestor
64792311|NCT00378612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64792321|NCT00378768|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64792322|NCT00378768|Immunologic Factors|immunologic factors|mesh-ancestor
64792323|NCT00378768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792324|NCT00378768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64792325|NCT00379158|Micronutrients|micronutrients|mesh-list
64792326|NCT00379158|Trace Elements|trace elements|mesh-list
64792327|NCT00379158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792328|NCT00379626|Hormones|hormones|mesh-list
64792329|NCT00379626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64318066|NCT03169335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318067|NCT03169335|Growth Inhibitors|growth inhibitors|mesh-ancestor
64318068|NCT03106623|Solifenacin Succinate|solifenacin succinate|mesh-list
64318070|NCT03106623|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64318071|NCT03106623|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64318072|NCT03106623|Cholinergic Agents|cholinergic agents|mesh-ancestor
64318073|NCT03106623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64318074|NCT03106623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318075|NCT03106623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318076|NCT03106623|Urological Agents|urological agents|mesh-ancestor
64318077|NCT03106623|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64318078|NCT03106623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64318079|NCT03106623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64746538|NCT01523886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746539|NCT01546038|Cytarabine|cytarabine|mesh-list
64746540|NCT01546038|Decitabine|decitabine|mesh-list
64746541|NCT01546038|Daunorubicin|daunorubicin|mesh-list
64746542|NCT01546038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64746543|NCT01546038|Antimetabolites|antimetabolites|mesh-ancestor
64746544|NCT01546038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746545|NCT01546038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746546|NCT01546038|Antiviral Agents|antiviral agents|mesh-ancestor
64746547|NCT01546038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64746548|NCT01546038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64746549|NCT01546038|Immunologic Factors|immunologic factors|mesh-ancestor
64746550|NCT01546038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746551|NCT01546038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64746552|NCT01546038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64746553|NCT01546038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64746554|NCT01546038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746555|NCT01571232|Dexamethasone|dexamethasone|mesh-list
64746556|NCT01571232|Bevacizumab|bevacizumab|mesh-list
64432369|NCT02349295|Ixekizumab|ixekizumab|mesh-list
64318080|NCT03106623|Adrenergic Agents|adrenergic agents|mesh-ancestor
64318081|NCT02411175|Ethanol|ethanol|mesh-list
64318082|NCT02411175|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64318083|NCT02411175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64318084|NCT02411175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64318085|NCT02411175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792330|NCT00379626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792331|NCT00380406|Leuprolide|leuprolide|mesh-list
64792332|NCT00380406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64560899|NCT01114503|Prednisolone acetate|prednisolone acetate|mesh-list
64792333|NCT00380406|Fertility Agents|fertility agents|mesh-ancestor
64792338|NCT00380484|Budesonide|budesonide|mesh-list
64792379|NCT00381030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64792380|NCT00381030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64792381|NCT00381030|Vasodilator Agents|vasodilator agents|mesh-ancestor
64792382|NCT00381030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64792383|NCT00381030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64792384|NCT00381264|Nabilone|nabilone|mesh-list
64792385|NCT00381264|Antiemetics|antiemetics|mesh-ancestor
64318088|NCT02411331|Ethanol|ethanol|mesh-list
64318089|NCT02411331|Enoxaparin|enoxaparin|mesh-list
64318090|NCT02411331|Anticoagulants|anticoagulants|mesh-ancestor
64318091|NCT02411331|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64318092|NCT02411331|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64318093|NCT02411331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318094|NCT02411331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64318095|NCT02411331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64318096|NCT02411331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64318097|NCT02411331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318098|NCT00100789|Gemcitabine|gemcitabine|mesh-list
64318099|NCT00100789|Paclitaxel|paclitaxel|mesh-list
64792386|NCT00381264|Autonomic Agents|autonomic agents|mesh-ancestor
64792387|NCT00381264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64792444|NCT00383214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792446|NCT00383370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64792447|NCT00383370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64746559|NCT01571232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64746560|NCT01571232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64746561|NCT01571232|Growth Substances|growth substances|mesh-ancestor
64792448|NCT00383370|Growth Substances|growth substances|mesh-ancestor
64792449|NCT00383370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792450|NCT00383370|Growth Inhibitors|growth inhibitors|mesh-ancestor
64792451|NCT00383370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792452|NCT00383526|Vaccines|vaccines|mesh-list
64792453|NCT00383526|Immunologic Factors|immunologic factors|mesh-ancestor
64318101|NCT00100789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318102|NCT00100789|Tubulin Modulators|tubulin modulators|mesh-ancestor
64318103|NCT00100789|Antimitotic Agents|antimitotic agents|mesh-ancestor
64318104|NCT00100789|Mitosis Modulators|mitosis modulators|mesh-ancestor
64318105|NCT00100789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318106|NCT00100789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64318107|NCT00100789|Antimetabolites|antimetabolites|mesh-ancestor
64318108|NCT00100789|Antiviral Agents|antiviral agents|mesh-ancestor
64318109|NCT00100789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64318110|NCT00100789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318111|NCT00100789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64318112|NCT00100789|Immunologic Factors|immunologic factors|mesh-ancestor
64318113|NCT00100789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318116|NCT02410863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318117|NCT02410863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64318118|NCT02410863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318119|NCT02410863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379925|NCT02141854|Dermatologic Agents|dermatologic agents|mesh-ancestor
64792454|NCT00383526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792455|NCT00383682|Mexiletine|mexiletine|mesh-list
64792505|NCT00384540|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64792506|NCT00384540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64792507|NCT00384540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64792508|NCT00384540|Adrenergic Agents|adrenergic agents|mesh-ancestor
64792509|NCT00384540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64792510|NCT00384540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792511|NCT00384540|Protective Agents|protective agents|mesh-ancestor
64792574|NCT00386178|Protective Agents|protective agents|mesh-ancestor
64746595|NCT01522404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746596|NCT01522404|Adrenergic Agents|adrenergic agents|mesh-ancestor
64746597|NCT01522404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64746598|NCT01522404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746599|NCT03911466|Buprenorphine|buprenorphine|mesh-list
64746600|NCT03911466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64746601|NCT03911466|Narcotics|narcotics|mesh-ancestor
64746602|NCT03911466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64358620|NCT03357055|Ketamine|ketamine|mesh-list
64792575|NCT00421824|Capecitabine|capecitabine|mesh-list
64792576|NCT00421824|Oxaliplatin|oxaliplatin|mesh-list
64318120|NCT05678192|Hormones|hormones|mesh-list
64318121|NCT05678192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64318122|NCT05678192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318123|NCT00708123|Listerine|listerine|mesh-list
64318124|NCT00708123|Fluorides|fluorides|mesh-list
64318125|NCT00708123|Sodium Fluoride|sodium fluoride|mesh-list
64318126|NCT00708123|Cariostatic Agents|cariostatic agents|mesh-ancestor
64318127|NCT00708123|Protective Agents|protective agents|mesh-ancestor
64318128|NCT00708123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318129|NCT00708123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64318130|NCT00708123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64318131|NCT05678114|Inositol|inositol|mesh-list
64318132|NCT05678114|Vitamin B Complex|vitamin b complex|mesh-ancestor
64318133|NCT05678114|Vitamins|vitamins|mesh-ancestor
64318134|NCT05678114|Micronutrients|micronutrients|mesh-ancestor
64318135|NCT05678114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318136|NCT05678036|Analgesics, Opioid|analgesics, opioid|mesh-list
64318137|NCT05678036|Narcotics|narcotics|mesh-ancestor
64318138|NCT05678036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64318139|NCT05678036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318141|NCT05678036|Sensory System Agents|sensory system agents|mesh-ancestor
64318142|NCT05678036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318143|NCT05537090|Midazolam|midazolam|mesh-list
64318153|NCT05537090|Anesthetics|anesthetics|mesh-ancestor
64792577|NCT00421824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64792578|NCT00421824|Antimetabolites|antimetabolites|mesh-ancestor
64792579|NCT00421824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792580|NCT00421824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792582|NCT00421980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64792641|NCT00422682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792642|NCT00422682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64792643|NCT00422682|Alkylating Agents|alkylating agents|mesh-ancestor
64792644|NCT00422682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64792645|NCT00422682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64792646|NCT00422682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64792648|NCT00422994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64792649|NCT00422994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64792650|NCT00422994|Dopamine Agonists|dopamine agonists|mesh-ancestor
64792651|NCT00422994|Dopamine Agents|dopamine agents|mesh-ancestor
64792706|NCT01799460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64792707|NCT02999724|Gabapentin|gabapentin|mesh-list
64318163|NCT02400879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64318164|NCT02400879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318165|NCT02400879|Analgesics|analgesics|mesh-ancestor
64318166|NCT02400879|Sensory System Agents|sensory system agents|mesh-ancestor
64318167|NCT02400879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318168|NCT02400879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64318169|NCT02400879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64318170|NCT02400879|Anesthetics, General|anesthetics, general|mesh-ancestor
64318171|NCT02400879|Anesthetics|anesthetics|mesh-ancestor
64318172|NCT02400879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64318173|NCT02400879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64318174|NCT04133480|Cannabidiol|cannabidiol|mesh-list
64318175|NCT04133480|Anticonvulsants|anticonvulsants|mesh-ancestor
64318176|NCT02400645|Ketorolac|ketorolac|mesh-list
64318177|NCT02400645|Bupivacaine|bupivacaine|mesh-list
64318178|NCT02400645|Anesthetics, Local|anesthetics, local|mesh-ancestor
64318179|NCT02400645|Anesthetics|anesthetics|mesh-ancestor
64318180|NCT02400645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64318181|NCT02400645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318182|NCT02400645|Sensory System Agents|sensory system agents|mesh-ancestor
64318183|NCT02400645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64792708|NCT02999724|Analgesics|analgesics|mesh-ancestor
64792709|NCT02999724|Sensory System Agents|sensory system agents|mesh-ancestor
64561270|NCT01135329|Mycophenolic Acid|mycophenolic acid|mesh-list
64792710|NCT02999724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64792711|NCT02999724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792712|NCT02999724|Anticonvulsants|anticonvulsants|mesh-ancestor
64792769|NCT02996058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792770|NCT02996058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64792771|NCT02996058|Analgesics|analgesics|mesh-ancestor
64792772|NCT02996058|Sensory System Agents|sensory system agents|mesh-ancestor
64792780|NCT02995512|Colchicine|colchicine|mesh-list
64792841|NCT02992548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64792842|NCT02992392|Dextrans|dextrans|mesh-list
64792843|NCT02992392|Anticoagulants|anticoagulants|mesh-ancestor
64792844|NCT02992392|Plasma Substitutes|plasma substitutes|mesh-ancestor
64792845|NCT02992392|Blood Substitutes|blood substitutes|mesh-ancestor
64792846|NCT02991768|Budesonide|budesonide|mesh-list
64792847|NCT02991768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64792848|NCT02991768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64792849|NCT02991768|Autonomic Agents|autonomic agents|mesh-ancestor
64792850|NCT02991768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318184|NCT02400645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64318185|NCT02400645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64318186|NCT02400645|Analgesics|analgesics|mesh-ancestor
64318187|NCT02400645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64318188|NCT02400645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64323095|NCT02690727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318189|NCT02400645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64318190|NCT02400645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318191|NCT02400645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318192|NCT02165215|Etrolizumab|etrolizumab|mesh-list
64318193|NCT02165215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64318194|NCT02165215|Immunologic Factors|immunologic factors|mesh-ancestor
64318195|NCT02165215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318196|NCT02400801|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64318197|NCT02400801|Dienogest|dienogest|mesh-list
64318198|NCT02400801|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64318199|NCT02400801|Luteolytic Agents|luteolytic agents|mesh-ancestor
64318200|NCT02400801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64318201|NCT02400801|Contraceptive Agents|contraceptive agents|mesh-ancestor
64318202|NCT02400801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64318203|NCT02400801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318204|NCT02400801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64318205|NCT02400801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64318206|NCT02400801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64792851|NCT02991768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792854|NCT02991768|Glucocorticoids|glucocorticoids|mesh-ancestor
64792907|NCT02990364|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64792908|NCT02990364|Anesthetics|anesthetics|mesh-list
64792909|NCT02990364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64792910|NCT02990364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792911|NCT02990364|Sensory System Agents|sensory system agents|mesh-ancestor
64792912|NCT02990364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64792913|NCT02990364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64792914|NCT02990364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64792915|NCT02990364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64792916|NCT02990364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64318207|NCT02400801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64318208|NCT02400801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64318210|NCT02400801|Hormones|hormones|mesh-ancestor
64318211|NCT02400801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64318212|NCT02400801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64318213|NCT02400801|Hormone Antagonists|hormone antagonists|mesh-ancestor
64318214|NCT02168569|Artesunate|artesunate|mesh-list
64318215|NCT02168569|Lumefantrine|lumefantrine|mesh-list
64318216|NCT02168569|Artemether|artemether|mesh-list
64318217|NCT02168569|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64318218|NCT02168569|Amodiaquine|amodiaquine|mesh-list
64318219|NCT02168569|Antimalarials|antimalarials|mesh-ancestor
64318220|NCT02168569|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64318221|NCT02168569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64318222|NCT02168569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64318223|NCT02168569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318224|NCT02168569|Antiviral Agents|antiviral agents|mesh-ancestor
64416714|NCT04852315|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64380112|NCT05546853|Leucovorin|leucovorin|mesh-list
64383813|NCT05448807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383814|NCT05448807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64383815|NCT01662999|Dapagliflozin|dapagliflozin|mesh-list
64383816|NCT01662999|Saxagliptin|saxagliptin|mesh-list
64383817|NCT01662999|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64383818|NCT01662999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383819|NCT01662999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64746642|NCT04714710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64746643|NCT04714710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746644|NCT04714710|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64746645|NCT04714710|Diuretics|diuretics|mesh-ancestor
64383820|NCT01662999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383821|NCT01662999|Incretins|incretins|mesh-ancestor
64383823|NCT01662999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64383824|NCT01662999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64383825|NCT01662999|Protease Inhibitors|protease inhibitors|mesh-ancestor
64383845|NCT02063854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64383846|NCT02063854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383847|NCT02063854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64383848|NCT02063698|Auranofin|auranofin|mesh-list
64383849|NCT02063698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64383850|NCT04701333|Cabergoline|cabergoline|mesh-list
64383851|NCT04701333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64383852|NCT04701333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64383853|NCT04701333|Dopamine Agonists|dopamine agonists|mesh-ancestor
64383854|NCT04701333|Dopamine Agents|dopamine agents|mesh-ancestor
64383855|NCT04701333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64792917|NCT02990364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792968|NCT01271088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64792969|NCT01271088|Protective Agents|protective agents|mesh-ancestor
64792970|NCT01271088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64792971|NCT01271088|Antidotes|antidotes|mesh-ancestor
64792972|NCT01271166|Leucovorin|leucovorin|mesh-list
64792973|NCT01271166|Bevacizumab|bevacizumab|mesh-list
64792974|NCT01271166|Fluorouracil|fluorouracil|mesh-list
64792975|NCT01271166|Oxaliplatin|oxaliplatin|mesh-list
64793035|NCT01273506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793036|NCT01273506|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64793037|NCT01273506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64793038|NCT01273506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64793039|NCT01273506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793040|NCT01273506|Adrenergic Agents|adrenergic agents|mesh-ancestor
64793041|NCT01273506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64793042|NCT01273662|Axitinib|axitinib|mesh-list
64793043|NCT01273662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793044|NCT01273662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64793045|NCT01273662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64793047|NCT01273974|Vaccines|vaccines|mesh-list
64793097|NCT01279434|Tocopherols|tocopherols|mesh-list
64793098|NCT01279434|Tocotrienols|tocotrienols|mesh-list
64793099|NCT01279434|alpha-Tocopherol|alpha-tocopherol|mesh-list
64793100|NCT01279434|Micronutrients|micronutrients|mesh-ancestor
64793101|NCT01279434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793102|NCT01279434|Antioxidants|antioxidants|mesh-ancestor
64793103|NCT01279434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318225|NCT02168569|Schistosomicides|schistosomicides|mesh-ancestor
64746649|NCT01520922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64746650|NCT01520922|Alkylating Agents|alkylating agents|mesh-ancestor
64746651|NCT01520922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746652|NCT01520922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746653|NCT01517412|Metformin|metformin|mesh-list
64746654|NCT01517412|Lixisenatide|lixisenatide|mesh-list
64746655|NCT01517412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64432944|NCT04854889|Decitabine|decitabine|mesh-list
64318226|NCT02168569|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64318227|NCT02168569|Anthelmintics|anthelmintics|mesh-ancestor
64318228|NCT02400255|Crenolanib|crenolanib|mesh-list
64318229|NCT02400255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318230|NCT02171689|Afatinib|afatinib|mesh-list
64318232|NCT02171689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64318233|NCT02171689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318234|NCT02171689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318235|NCT02171767|Afatinib|afatinib|mesh-list
64318236|NCT02171767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318237|NCT02171767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64318238|NCT02171767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318239|NCT02171767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318240|NCT02400021|Progesterone|progesterone|mesh-list
64318241|NCT02400021|Progestins|progestins|mesh-ancestor
64318242|NCT02400021|Hormones|hormones|mesh-ancestor
64318243|NCT02400021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64380115|NCT05546853|Calcium|calcium|mesh-list
64793104|NCT01279434|Protective Agents|protective agents|mesh-ancestor
64793105|NCT01279512|Metformin|metformin|mesh-list
64793106|NCT01279512|Acarbose|acarbose|mesh-list
64793107|NCT01279512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64793161|NCT01275222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64793162|NCT01275222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64793163|NCT01275222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793165|NCT01275144|Anticonvulsants|anticonvulsants|mesh-ancestor
64793166|NCT01275144|Antiemetics|antiemetics|mesh-ancestor
64793231|NCT01270152|Micronutrients|micronutrients|mesh-ancestor
64793233|NCT01274988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64793234|NCT01274988|Narcotics|narcotics|mesh-ancestor
64793235|NCT01274988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64793236|NCT01274988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793300|NCT00247962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64793301|NCT00247962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64793302|NCT00247962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64793303|NCT00247962|Immunologic Factors|immunologic factors|mesh-ancestor
64793304|NCT00247962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64793371|NCT03804840|Dronabinol|dronabinol|mesh-list
64793372|NCT03804840|Hallucinogens|hallucinogens|mesh-ancestor
64793373|NCT03804840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793374|NCT03804840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64793375|NCT03804840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64793376|NCT03804840|Analgesics|analgesics|mesh-ancestor
64793377|NCT03804840|Sensory System Agents|sensory system agents|mesh-ancestor
64793378|NCT03804840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793379|NCT03804840|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64793380|NCT03804840|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64793381|NCT03804840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64793382|NCT03804840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793383|NCT03804840|Hormones|hormones|mesh-ancestor
64793385|NCT03804372|Tenofovir|tenofovir|mesh-list
64746661|NCT01489956|Immunologic Factors|immunologic factors|mesh-ancestor
64746662|NCT01489956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746663|NCT01516008|Tapentadol|tapentadol|mesh-list
64746664|NCT01516008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64746665|NCT01516008|Narcotics|narcotics|mesh-ancestor
64746666|NCT01516008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64746667|NCT01516008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746668|NCT01516008|Analgesics|analgesics|mesh-ancestor
64746669|NCT01516008|Sensory System Agents|sensory system agents|mesh-ancestor
64746670|NCT01516008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793430|NCT03800550|Antitubercular Agents|antitubercular agents|mesh-ancestor
64793431|NCT03808818|Nicotine|nicotine|mesh-list
64793432|NCT03808818|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64793433|NCT03808818|Autonomic Agents|autonomic agents|mesh-ancestor
64793434|NCT03808818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318246|NCT05677490|Leucovorin|leucovorin|mesh-list
64318247|NCT05677490|Tetrahydrofolates|tetrahydrofolates|mesh-list
64318248|NCT05677490|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
64318249|NCT05677490|Fluorouracil|fluorouracil|mesh-list
64793435|NCT03808818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793436|NCT03808818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64793437|NCT03808818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64793444|NCT05742750|Apatinib|apatinib|mesh-list
64793497|NCT03467256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64793498|NCT03467256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64793499|NCT03467256|Alkylating Agents|alkylating agents|mesh-ancestor
64793500|NCT03467256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793501|NCT03467256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793502|NCT03467256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64793503|NCT03467256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64793504|NCT03467256|Antiemetics|antiemetics|mesh-ancestor
64793505|NCT03467256|Autonomic Agents|autonomic agents|mesh-ancestor
64793506|NCT03467256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793507|NCT03467256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64793508|NCT03467256|Glucocorticoids|glucocorticoids|mesh-ancestor
64793509|NCT03467256|Hormones|hormones|mesh-ancestor
64793511|NCT03467256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64793561|NCT02017704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793562|NCT02017704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64318250|NCT05677490|Oxaliplatin|oxaliplatin|mesh-list
64318251|NCT05677490|Nivolumab|nivolumab|mesh-list
64318252|NCT05677490|Irinotecan|irinotecan|mesh-list
64318253|NCT05677490|Calcium|calcium|mesh-list
64318254|NCT05677490|Levoleucovorin|levoleucovorin|mesh-list
64318255|NCT05677490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64318256|NCT05677490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318257|NCT05677490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64318258|NCT05677490|Antimetabolites|antimetabolites|mesh-ancestor
64380255|NCT02586207|Cisplatin|cisplatin|mesh-list
64793563|NCT02017704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793564|NCT02017704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64793630|NCT03215940|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64793631|NCT03215940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64793632|NCT03215940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793634|NCT03215940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64793635|NCT03219528|Rifaximin|rifaximin|mesh-list
64793636|NCT03219528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64793637|NCT03219528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64793638|NCT03219528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64793639|NCT03219762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64793640|NCT03219762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793641|NCT03218514|Dalteparin|dalteparin|mesh-list
64793642|NCT03218514|Tinzaparin|tinzaparin|mesh-list
64793643|NCT03218514|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64793644|NCT03218514|Anticoagulants|anticoagulants|mesh-ancestor
64746671|NCT01516008|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64746672|NCT01516008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64746673|NCT01516008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64433190|NCT02032173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433191|NCT02032173|Growth Inhibitors|growth inhibitors|mesh-ancestor
64433193|NCT02461589|Liraglutide|liraglutide|mesh-list
64433250|NCT02419469|Dermatologic Agents|dermatologic agents|mesh-ancestor
64793645|NCT03218514|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64318259|NCT05677490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318260|NCT05677490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64318261|NCT05677490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318262|NCT05677490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64318263|NCT05677490|Immunologic Factors|immunologic factors|mesh-ancestor
64318264|NCT05677490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64318265|NCT05677490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64318266|NCT05677490|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64318267|NCT05677490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64318268|NCT05677490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318269|NCT05677490|Antidotes|antidotes|mesh-ancestor
64318270|NCT05677490|Protective Agents|protective agents|mesh-ancestor
64318271|NCT05677490|Vitamin B Complex|vitamin b complex|mesh-ancestor
64318272|NCT05677490|Vitamins|vitamins|mesh-ancestor
64318273|NCT05677490|Micronutrients|micronutrients|mesh-ancestor
64318274|NCT02165449|Ketamine|ketamine|mesh-list
64318275|NCT02165449|Analgesics|analgesics|mesh-ancestor
64318276|NCT02165449|Sensory System Agents|sensory system agents|mesh-ancestor
64318277|NCT02165449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318282|NCT02165449|Anesthetics|anesthetics|mesh-ancestor
64793647|NCT03218514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793648|NCT03218124|Remifentanil|remifentanil|mesh-list
64793649|NCT03218124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64793650|NCT03218124|Narcotics|narcotics|mesh-ancestor
64793683|NCT03216876|Analgesics|analgesics|mesh-ancestor
64793684|NCT03216876|Sensory System Agents|sensory system agents|mesh-ancestor
64793685|NCT03216876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793686|NCT03216876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793687|NCT03216876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64562247|NCT03011463|Parasympatholytics|parasympatholytics|mesh-ancestor
64793688|NCT03216876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64793689|NCT03216642|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64793690|NCT03216642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64793692|NCT03216408|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64793693|NCT03216408|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64793697|NCT03216408|Cholinergic Agents|cholinergic agents|mesh-ancestor
64793744|NCT03212820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64746674|NCT01516008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746675|NCT01516008|Adrenergic Agents|adrenergic agents|mesh-ancestor
64793745|NCT03212820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793746|NCT03212820|Sympathomimetics|sympathomimetics|mesh-ancestor
64793747|NCT03212820|Autonomic Agents|autonomic agents|mesh-ancestor
64793748|NCT03212820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64793749|NCT03212820|Dopamine Agents|dopamine agents|mesh-ancestor
64793750|NCT03212820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64318297|NCT05535998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64318298|NCT05535998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318299|NCT05535998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318301|NCT05531942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64318302|NCT05531942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64318304|NCT05531942|Sensory System Agents|sensory system agents|mesh-ancestor
64318305|NCT05531942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318306|NCT05531942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793752|NCT03212820|Adrenergic Agents|adrenergic agents|mesh-ancestor
64793807|NCT03210246|Contraceptive Agents|contraceptive agents|mesh-ancestor
64793808|NCT03210246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64793809|NCT03210246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793810|NCT03210246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64793877|NCT01834014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64793878|NCT01834014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64793879|NCT01834014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64793880|NCT01834014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64793881|NCT01834014|Growth Substances|growth substances|mesh-ancestor
64793882|NCT01834014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64793883|NCT01834014|Growth Inhibitors|growth inhibitors|mesh-ancestor
64793884|NCT01834014|Antimetabolites|antimetabolites|mesh-ancestor
64793943|NCT01838460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64793944|NCT01838460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64793945|NCT01838460|Respiratory System Agents|respiratory system agents|mesh-ancestor
64793946|NCT01838538|Paclitaxel|paclitaxel|mesh-list
64793947|NCT01838538|Bevacizumab|bevacizumab|mesh-list
64794014|NCT01839630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794015|NCT01839630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794016|NCT01839864|Chrysarobin|chrysarobin|mesh-list
64794017|NCT01839864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64794018|NCT01839864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64794019|NCT01839864|Analgesics|analgesics|mesh-ancestor
64794020|NCT01839864|Sensory System Agents|sensory system agents|mesh-ancestor
64794084|NCT01720056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64794085|NCT01720056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64794086|NCT01720056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64318307|NCT05531942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64318308|NCT05531942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64318309|NCT05531942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64318310|NCT05531942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64318311|NCT05531942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318312|NCT05531942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64318313|NCT05531942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64318314|NCT05531942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318315|NCT05531942|Antipyretics|antipyretics|mesh-ancestor
64318316|NCT03540199|Antibodies|antibodies|mesh-list
64318317|NCT03540199|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64318318|NCT03540199|Immunologic Factors|immunologic factors|mesh-ancestor
64318319|NCT03540199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318320|NCT05677334|Insulin|insulin|mesh-list
64318321|NCT05677334|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64794087|NCT01720056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64794088|NCT01720056|Vasodilator Agents|vasodilator agents|mesh-ancestor
64794090|NCT01720212|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64323132|NCT04057131|Immunologic Factors|immunologic factors|mesh-ancestor
64323133|NCT03542279|Glucocorticoids|glucocorticoids|mesh-list
64323134|NCT03542279|Hormones|hormones|mesh-ancestor
64323135|NCT03542279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64323136|NCT03542279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323137|NCT02230735|Epinephrine|epinephrine|mesh-list
64433454|NCT04681833|Vaccines|vaccines|mesh-list
64794091|NCT01720212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64794092|NCT01720212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64794149|NCT01723800|Carboplatin|carboplatin|mesh-list
64794150|NCT01723800|Pemetrexed|pemetrexed|mesh-list
64794151|NCT01723800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794152|NCT01723800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64794153|NCT01723800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794154|NCT01723800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64794155|NCT01723800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64794156|NCT01724190|Vitamin D|vitamin d|mesh-list
64794157|NCT01724190|Cholecalciferol|cholecalciferol|mesh-list
64794214|NCT01725048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794215|NCT01725048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64794216|NCT01725048|Antidepressive Agents|antidepressive agents|mesh-ancestor
64794217|NCT01725048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64794218|NCT01725048|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64794219|NCT01725048|Histamine Antagonists|histamine antagonists|mesh-ancestor
64794282|NCT01726920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64794283|NCT01726920|Analgesics|analgesics|mesh-ancestor
64794284|NCT01726920|Sensory System Agents|sensory system agents|mesh-ancestor
64318322|NCT05677334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64318323|NCT05677334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318324|NCT02165917|Hyaluronic Acid|hyaluronic acid|mesh-list
64318325|NCT02165917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64318326|NCT02165917|Immunologic Factors|immunologic factors|mesh-ancestor
64318327|NCT02165917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318328|NCT02165917|Viscosupplements|viscosupplements|mesh-ancestor
64318329|NCT02165917|Protective Agents|protective agents|mesh-ancestor
64318331|NCT02168881|Dinoprostone|dinoprostone|mesh-list
64318332|NCT02168881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64318333|NCT02168881|Abortifacient Agents|abortifacient agents|mesh-ancestor
64318334|NCT02168881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64318335|NCT02168881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318336|NCT02168881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64318337|NCT02168881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64318338|NCT02168881|Oxytocics|oxytocics|mesh-ancestor
64318339|NCT02168959|Bupivacaine|bupivacaine|mesh-list
64318340|NCT02168959|Anesthetics, Local|anesthetics, local|mesh-ancestor
64318341|NCT02168959|Anesthetics|anesthetics|mesh-ancestor
64794285|NCT01726920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794286|NCT01726920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794287|NCT01726920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64794288|NCT01726920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64794289|NCT01726920|Gout Suppressants|gout suppressants|mesh-ancestor
64794352|NCT01720836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794354|NCT01724658|Testosterone|testosterone|mesh-list
64794355|NCT01724658|Testosterone undecanoate|testosterone undecanoate|mesh-list
64794356|NCT01724658|Testosterone enanthate|testosterone enanthate|mesh-list
64794357|NCT01724658|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64746691|NCT01514448|Immunologic Factors|immunologic factors|mesh-ancestor
64746692|NCT01514448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746693|NCT01514370|Interferons|interferons|mesh-list
64746694|NCT01514370|Interferon-beta|interferon-beta|mesh-list
64746695|NCT01514370|Interferon beta-1a|interferon beta-1a|mesh-list
64746696|NCT01514370|Curcumin|curcumin|mesh-list
64746697|NCT01514370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64794358|NCT01724658|Androgens|androgens|mesh-ancestor
64318342|NCT02168959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64318343|NCT02168959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318344|NCT02168959|Sensory System Agents|sensory system agents|mesh-ancestor
64318345|NCT02168959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318347|NCT05696678|Ropivacaine|ropivacaine|mesh-list
64318348|NCT05696678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64318349|NCT05696678|Narcotics|narcotics|mesh-ancestor
64318350|NCT05696678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64318351|NCT05696678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318352|NCT05696678|Analgesics|analgesics|mesh-ancestor
64318353|NCT05696678|Sensory System Agents|sensory system agents|mesh-ancestor
64318354|NCT05696678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318355|NCT05696678|Anesthetics, Local|anesthetics, local|mesh-ancestor
64318356|NCT05696678|Anesthetics|anesthetics|mesh-ancestor
64318357|NCT05450822|Lamotrigine|lamotrigine|mesh-list
64318358|NCT05450822|Levetiracetam|levetiracetam|mesh-list
64318359|NCT05450822|Anticonvulsants|anticonvulsants|mesh-list
64318360|NCT05450822|Nootropic Agents|nootropic agents|mesh-ancestor
64318361|NCT05450822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64318362|NCT05450822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64318363|NCT05450822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380503|NCT03526887|Pembrolizumab|pembrolizumab|mesh-list
64794359|NCT01724658|Hormones|hormones|mesh-ancestor
64794361|NCT01724658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794415|NCT01048788|Natriuretic Agents|natriuretic agents|mesh-ancestor
64794416|NCT01048788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794417|NCT01046682|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
64794418|NCT01046682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64794419|NCT01046682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64794420|NCT01046682|Analgesics|analgesics|mesh-ancestor
64794421|NCT01046682|Sensory System Agents|sensory system agents|mesh-ancestor
64794422|NCT01046682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794423|NCT01046682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794480|NCT03407196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64794481|NCT03407196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794482|NCT03407196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64794483|NCT03407196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794546|NCT03402204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794547|NCT03402204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64794548|NCT03402204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64794549|NCT03402204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64794616|NCT03400254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64794617|NCT03400020|Ascorbic Acid|ascorbic acid|mesh-list
64794618|NCT03400020|Vitamins|vitamins|mesh-ancestor
64794619|NCT03400020|Micronutrients|micronutrients|mesh-ancestor
64794620|NCT03400020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794621|NCT03400020|Antioxidants|antioxidants|mesh-ancestor
64794623|NCT03400020|Protective Agents|protective agents|mesh-ancestor
64794685|NCT02242032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64794686|NCT02242266|Tiotropium Bromide|tiotropium bromide|mesh-list
64318364|NCT05450822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64318366|NCT05450822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64318367|NCT05450822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64746698|NCT01514370|Antiviral Agents|antiviral agents|mesh-ancestor
64746702|NCT01514370|Analgesics|analgesics|mesh-ancestor
64318368|NCT05450822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64318369|NCT05450822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64318370|NCT05450822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64318371|NCT02172157|Olodaterol|olodaterol|mesh-list
64318372|NCT02172157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64318373|NCT02172157|Autonomic Agents|autonomic agents|mesh-ancestor
64794687|NCT02242266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64794688|NCT02242266|Autonomic Agents|autonomic agents|mesh-ancestor
64794689|NCT02242266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794690|NCT02242266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794754|NCT02243436|Antimetabolites|antimetabolites|mesh-ancestor
64794755|NCT02243436|Antiviral Agents|antiviral agents|mesh-ancestor
64794756|NCT02243436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64794757|NCT02243436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64794758|NCT02243436|Immunologic Factors|immunologic factors|mesh-ancestor
64794759|NCT02243436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794760|NCT02243436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64794761|NCT02243436|Antiemetics|antiemetics|mesh-ancestor
64794762|NCT02243436|Autonomic Agents|autonomic agents|mesh-ancestor
64794763|NCT02243436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64794816|NCT02245464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64794817|NCT02245464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794818|NCT02246244|Citalopram|citalopram|mesh-list
64794819|NCT02246244|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64794820|NCT02246244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64794821|NCT02246244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64794824|NCT02246244|Serotonin Agents|serotonin agents|mesh-ancestor
64794885|NCT02248428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64794886|NCT02248428|Immunologic Factors|immunologic factors|mesh-ancestor
64794887|NCT02248428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64794888|NCT02248428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64794889|NCT02248428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64318403|NCT02757625|Dexmedetomidine|dexmedetomidine|mesh-list
64318405|NCT02757625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64318406|NCT02757625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318408|NCT02757625|Analgesics|analgesics|mesh-ancestor
64318409|NCT02757625|Sensory System Agents|sensory system agents|mesh-ancestor
64318410|NCT02757625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318411|NCT02757625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64318412|NCT02757625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64318413|NCT02757625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64746717|NCT01519674|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64746718|NCT01519674|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64746719|NCT01519674|Biphasic Insulins|biphasic insulins|mesh-list
64746720|NCT01519674|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64746721|NCT01519674|Insulin, Isophane|insulin, isophane|mesh-list
64746722|NCT01519674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64746723|NCT01519674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746724|NCT01519674|Incretins|incretins|mesh-ancestor
64746726|NCT01519674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64433978|NCT01612702|Glucocorticoids|glucocorticoids|mesh-ancestor
64318414|NCT02757625|Adrenergic Agents|adrenergic agents|mesh-ancestor
64318415|NCT02757625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64318416|NCT02757625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794890|NCT02248428|Alkylating Agents|alkylating agents|mesh-ancestor
64794891|NCT02248428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64794952|NCT02249130|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64563528|NCT00630331|Vaccines|vaccines|mesh-list
64794953|NCT02249130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64794954|NCT02249130|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64794955|NCT02249130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64795019|NCT02245308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64795020|NCT02245308|Cholinergic Agents|cholinergic agents|mesh-ancestor
64318417|NCT05691920|Fentanyl|fentanyl|mesh-list
64318418|NCT05691920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64318419|NCT05691920|Narcotics|narcotics|mesh-ancestor
64318420|NCT05691920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64318421|NCT05691920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318422|NCT05691920|Analgesics|analgesics|mesh-ancestor
64318423|NCT05691920|Sensory System Agents|sensory system agents|mesh-ancestor
64318424|NCT05691920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318425|NCT05691920|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64318426|NCT05691920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64318427|NCT05691920|Anesthetics, General|anesthetics, general|mesh-ancestor
64318428|NCT05691920|Anesthetics|anesthetics|mesh-ancestor
64318429|NCT05696366|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
64318430|NCT05696366|Volagidemab|volagidemab|mesh-list
64318431|NCT05696366|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64318432|NCT05696366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318433|NCT05696366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64318434|NCT05696366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318435|NCT02169583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64318439|NCT05613842|Bombesin|bombesin|mesh-list
64318440|NCT05613842|Trace Elements|trace elements|mesh-ancestor
64318441|NCT05613842|Micronutrients|micronutrients|mesh-ancestor
64318442|NCT05613842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318443|NCT05613842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64318444|NCT05613842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318445|NCT02172391|Tiotropium Bromide|tiotropium bromide|mesh-list
64318446|NCT02172391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64795021|NCT02245308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64795022|NCT02245308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746727|NCT01519674|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64746728|NCT01519674|Protease Inhibitors|protease inhibitors|mesh-ancestor
64746729|NCT01519674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746730|NCT01519674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746731|NCT01519518|Heparin|heparin|mesh-list
64323138|NCT02230735|Racepinephrine|racepinephrine|mesh-list
64323139|NCT02230735|Epinephryl borate|epinephryl borate|mesh-list
64323140|NCT02230735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64323141|NCT02230735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64323142|NCT02230735|Adrenergic Agents|adrenergic agents|mesh-ancestor
64323143|NCT02230735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64323144|NCT02230735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323148|NCT02230735|Autonomic Agents|autonomic agents|mesh-ancestor
64795023|NCT02245308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64795024|NCT02245308|Antidepressive Agents|antidepressive agents|mesh-ancestor
64795025|NCT02245308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64795082|NCT00558636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64795083|NCT00558636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795084|NCT00558558|Flurandrenolone|flurandrenolone|mesh-list
64795085|NCT00558558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64795086|NCT00558558|Glucocorticoids|glucocorticoids|mesh-ancestor
64795087|NCT00558558|Hormones|hormones|mesh-ancestor
64795088|NCT00558558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64795089|NCT00558558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795149|NCT00552240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795150|NCT00552240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795151|NCT00552240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64795152|NCT00552240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64795153|NCT00552240|Antiviral Agents|antiviral agents|mesh-ancestor
64795154|NCT00552240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64795217|NCT00556374|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64795218|NCT00556374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64795219|NCT00556374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795220|NCT00556374|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64795221|NCT00556374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795286|NCT03839160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64795287|NCT03839160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795288|NCT03839160|Analgesics|analgesics|mesh-ancestor
64795289|NCT03839160|Sensory System Agents|sensory system agents|mesh-ancestor
64795290|NCT03839160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64795291|NCT03838926|Trichostatin A|trichostatin a|mesh-list
64795292|NCT03838926|Antifungal Agents|antifungal agents|mesh-ancestor
64795293|NCT03838926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64795294|NCT03838926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64318453|NCT02172391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64318454|NCT02172391|Cholinergic Agents|cholinergic agents|mesh-ancestor
64318455|NCT02172391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64746732|NCT01519518|Calcium heparin|calcium heparin|mesh-list
64746733|NCT01519518|Bivalirudin|bivalirudin|mesh-list
64746734|NCT01519518|Anticoagulants|anticoagulants|mesh-ancestor
64746735|NCT01519518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64746736|NCT01519518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64746737|NCT01519518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746738|NCT01519518|Antithrombins|antithrombins|mesh-ancestor
64746739|NCT01519518|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64746740|NCT01519518|Protease Inhibitors|protease inhibitors|mesh-ancestor
64746741|NCT01519518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746742|NCT01518972|Prazosin|prazosin|mesh-list
64746743|NCT01518972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64746744|NCT01518972|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64746745|NCT01518972|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64746746|NCT01518972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64746747|NCT01518972|Adrenergic Agents|adrenergic agents|mesh-ancestor
64746748|NCT01518972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64746751|NCT01513590|Insulin|insulin|mesh-list
64318456|NCT02172391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318457|NCT00109681|Iloprost|iloprost|mesh-list
64318458|NCT00109681|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64318459|NCT00109681|Vasodilator Agents|vasodilator agents|mesh-ancestor
64318460|NCT02172469|Bromides|bromides|mesh-list
64318461|NCT02172469|Tiotropium Bromide|tiotropium bromide|mesh-list
64318462|NCT02172469|Ipratropium|ipratropium|mesh-list
64318463|NCT02172469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64318464|NCT02172469|Autonomic Agents|autonomic agents|mesh-ancestor
64318465|NCT02172469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318466|NCT02172469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318467|NCT02172469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64380640|NCT03192527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795295|NCT03838926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795296|NCT03838926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795297|NCT03838926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64795299|NCT03834012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64795300|NCT03834012|Glucocorticoids|glucocorticoids|mesh-ancestor
64795347|NCT05444556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64795348|NCT05444556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64795349|NCT05444556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64795350|NCT05444556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64795351|NCT05444556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64795352|NCT05444556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64795353|NCT05444556|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64795354|NCT05444556|Protective Agents|protective agents|mesh-ancestor
64795355|NCT05444556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795409|NCT05768854|Diphosphonates|diphosphonates|mesh-list
64795410|NCT05768854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64795411|NCT05768854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795412|NCT05768542|Metoprolol|metoprolol|mesh-list
64795413|NCT05768542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64795414|NCT05768542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64795478|NCT05768191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64795479|NCT05768191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795480|NCT05768126|Rivastigmine|rivastigmine|mesh-list
64795481|NCT05768126|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64795482|NCT05768126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746754|NCT01513590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746755|NCT04672512|Prednisone|prednisone|mesh-list
64746756|NCT04672512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64746757|NCT04672512|Glucocorticoids|glucocorticoids|mesh-ancestor
64746758|NCT04672512|Hormones|hormones|mesh-ancestor
64746759|NCT04672512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64746762|NCT04672512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64795549|NCT05767749|Autonomic Agents|autonomic agents|mesh-ancestor
64795550|NCT05767749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64795551|NCT05767749|Respiratory System Agents|respiratory system agents|mesh-ancestor
64795552|NCT05767749|Mydriatics|mydriatics|mesh-ancestor
64795553|NCT05767749|Sympathomimetics|sympathomimetics|mesh-ancestor
64795554|NCT05767749|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64795621|NCT05767346|Autonomic Agents|autonomic agents|mesh-ancestor
64318468|NCT02172469|Respiratory System Agents|respiratory system agents|mesh-ancestor
64318470|NCT02172469|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64318471|NCT02172469|Cholinergic Agents|cholinergic agents|mesh-ancestor
64318472|NCT02172469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64318473|NCT02172469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318474|NCT02172469|Anticonvulsants|anticonvulsants|mesh-ancestor
64318475|NCT02172547|Tiotropium Bromide|tiotropium bromide|mesh-list
64318476|NCT02172547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64795622|NCT05767346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64795623|NCT05767346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795624|NCT05767346|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64795691|NCT05751343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64795692|NCT05751343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64795693|NCT05751343|Growth Substances|growth substances|mesh-ancestor
64795694|NCT05751343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795695|NCT05751343|Growth Inhibitors|growth inhibitors|mesh-ancestor
64795696|NCT05702853|Cyclophosphamide|cyclophosphamide|mesh-list
64795697|NCT05702853|Fludarabine|fludarabine|mesh-list
64795698|NCT05702853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64795699|NCT05702853|Immunologic Factors|immunologic factors|mesh-ancestor
64795700|NCT05702853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795701|NCT05702853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64795702|NCT05702853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64795703|NCT05702853|Alkylating Agents|alkylating agents|mesh-ancestor
64795704|NCT05702853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795705|NCT05702853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64795706|NCT05702853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64795707|NCT05678348|Pyrimethamine|pyrimethamine|mesh-list
64795708|NCT05678348|Antimalarials|antimalarials|mesh-ancestor
64318477|NCT02172547|Autonomic Agents|autonomic agents|mesh-ancestor
64318478|NCT02172547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318479|NCT02172547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746777|NCT01463982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746778|NCT01463982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64318480|NCT02172547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64318481|NCT02172547|Respiratory System Agents|respiratory system agents|mesh-ancestor
64318482|NCT02172547|Parasympatholytics|parasympatholytics|mesh-ancestor
64318483|NCT02172547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64318484|NCT02172547|Cholinergic Agents|cholinergic agents|mesh-ancestor
64318485|NCT02172547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64318486|NCT02172547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318487|NCT02174887|Gemcitabine|gemcitabine|mesh-list
64318488|NCT02174887|Paclitaxel|paclitaxel|mesh-list
64318489|NCT02174887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64318490|NCT02174887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318491|NCT02174887|Tubulin Modulators|tubulin modulators|mesh-ancestor
64318492|NCT02174887|Antimitotic Agents|antimitotic agents|mesh-ancestor
64318493|NCT02174887|Mitosis Modulators|mitosis modulators|mesh-ancestor
64318494|NCT02174887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318495|NCT02174887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64318496|NCT02174887|Antimetabolites|antimetabolites|mesh-ancestor
64795748|NCT05631028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64795749|NCT05631028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64795750|NCT05631028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64795751|NCT05631028|Adrenergic Agents|adrenergic agents|mesh-ancestor
64795752|NCT05631028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64795753|NCT05631028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795754|NCT05630976|Isavuconazole|isavuconazole|mesh-list
64795755|NCT05630976|Antifungal Agents|antifungal agents|mesh-ancestor
64795757|NCT05621616|Mirabegron|mirabegron|mesh-list
64318509|NCT05142319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318510|NCT02169973|JNJ-42165279|jnj-42165279|mesh-list
64318511|NCT02169973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318512|NCT02169973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318513|NCT05576792|Ranibizumab|ranibizumab|mesh-list
64318514|NCT05576792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64318515|NCT05576792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64318516|NCT05576792|Growth Substances|growth substances|mesh-ancestor
64318517|NCT05576792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318518|NCT05576792|Growth Inhibitors|growth inhibitors|mesh-ancestor
64746810|NCT01509846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746811|NCT01462344|Fluticasone|fluticasone|mesh-list
64746812|NCT01462344|Xhance|xhance|mesh-list
64746813|NCT01462344|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64746814|NCT01462344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64746815|NCT01462344|Autonomic Agents|autonomic agents|mesh-ancestor
64746816|NCT01462344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358843|NCT05124951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434667|NCT04898075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434668|NCT01621191|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64434670|NCT01621191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64434727|NCT01624233|Ixekizumab|ixekizumab|mesh-list
64434728|NCT01624233|Dermatologic Agents|dermatologic agents|mesh-ancestor
64434729|NCT01993017|Bupropion|bupropion|mesh-list
64434730|NCT01993017|Sertraline|sertraline|mesh-list
64434731|NCT01993017|Antidepressive Agents|antidepressive agents|mesh-list
64318519|NCT05576792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318520|NCT04298528|Dronabinol|dronabinol|mesh-list
64318521|NCT04298528|Hallucinogens|hallucinogens|mesh-ancestor
64318522|NCT04298528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318523|NCT04298528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64318524|NCT04298528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64318525|NCT04298528|Analgesics|analgesics|mesh-ancestor
64318526|NCT04298528|Sensory System Agents|sensory system agents|mesh-ancestor
64318527|NCT04298528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318528|NCT04298528|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64318529|NCT04298528|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64318530|NCT04298528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64318531|NCT04298528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318532|NCT04298528|Hormones|hormones|mesh-ancestor
64380940|NCT03192059|Micronutrients|micronutrients|mesh-ancestor
64795816|NCT05602636|Anesthetics|anesthetics|mesh-ancestor
64795817|NCT05602636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64795818|NCT05602636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795819|NCT05602636|Sensory System Agents|sensory system agents|mesh-ancestor
64795820|NCT05602636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64795821|NCT05602636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64795822|NCT05602636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64795823|NCT05602636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64795824|NCT05602636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64795825|NCT05602636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64795826|NCT05602636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64795877|NCT05486026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64795878|NCT05486026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64795879|NCT05486026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795880|NCT05486026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64795881|NCT05486026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795882|NCT05486026|Analgesics|analgesics|mesh-ancestor
64795883|NCT05486026|Sensory System Agents|sensory system agents|mesh-ancestor
64795945|NCT05342844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64795946|NCT05342844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795947|NCT05337540|Hylan|hylan|mesh-list
64795948|NCT05337540|Viscosupplements|viscosupplements|mesh-ancestor
64795949|NCT05337540|Protective Agents|protective agents|mesh-ancestor
64795950|NCT05337540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64795951|NCT05334472|Ofatumumab|ofatumumab|mesh-list
64795952|NCT05334472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64795953|NCT05332067|Omalizumab|omalizumab|mesh-list
64795954|NCT05332067|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64795955|NCT05332067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64795956|NCT05332067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64318533|NCT04298528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64318535|NCT00100711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318536|NCT00100711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64318537|NCT00100711|Dermatologic Agents|dermatologic agents|mesh-ancestor
64318538|NCT02581202|Ritonavir|ritonavir|mesh-list
64318539|NCT02581202|Lopinavir|lopinavir|mesh-list
64318540|NCT02581202|Lamivudine|lamivudine|mesh-list
64318541|NCT02581202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64318542|NCT02581202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64318543|NCT02581202|Protease Inhibitors|protease inhibitors|mesh-ancestor
64323151|NCT02230735|Respiratory System Agents|respiratory system agents|mesh-ancestor
64323153|NCT02230735|Sympathomimetics|sympathomimetics|mesh-ancestor
64323154|NCT02230735|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64323155|NCT02258581|Tenofovir|tenofovir|mesh-list
64323156|NCT02258581|Vesatolimod|vesatolimod|mesh-list
64318544|NCT02581202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318545|NCT02581202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64795957|NCT05332067|Respiratory System Agents|respiratory system agents|mesh-ancestor
64795958|NCT05332067|Immunologic Factors|immunologic factors|mesh-ancestor
64795959|NCT05332067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796005|NCT05257083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64796006|NCT05257083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64796007|NCT05257083|Alkylating Agents|alkylating agents|mesh-ancestor
64796008|NCT05257083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796009|NCT05257083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796010|NCT05257083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64796011|NCT05257083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64796012|NCT05257083|Antiemetics|antiemetics|mesh-ancestor
64796013|NCT05257083|Autonomic Agents|autonomic agents|mesh-ancestor
64796072|NCT05156710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64796073|NCT05156710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796075|NCT05156710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796076|NCT05156710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64796077|NCT05156710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64796078|NCT05156710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64796079|NCT05156710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796080|NCT05156710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796138|NCT05037812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64796139|NCT05037812|Adrenergic Agents|adrenergic agents|mesh-ancestor
64796140|NCT05037812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64796141|NCT05037812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796142|NCT05037812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64796143|NCT05037812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64796144|NCT05037812|Autonomic Agents|autonomic agents|mesh-ancestor
64796145|NCT05037812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64796146|NCT05037812|Respiratory System Agents|respiratory system agents|mesh-ancestor
64796147|NCT05037812|Mydriatics|mydriatics|mesh-ancestor
64796148|NCT05037812|Sympathomimetics|sympathomimetics|mesh-ancestor
64796149|NCT05037812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64796150|NCT05037812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64796151|NCT05037812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64796201|NCT04907253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323168|NCT05746377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64323169|NCT05746377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323170|NCT05746377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64323171|NCT05746377|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64323172|NCT05746377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64796202|NCT04907253|Protective Agents|protective agents|mesh-ancestor
64318546|NCT02581202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64318547|NCT02581202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64318548|NCT02581202|Antiviral Agents|antiviral agents|mesh-ancestor
64318549|NCT02581202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64318550|NCT02581202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64318551|NCT02581202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64318552|NCT02581202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64318553|NCT02581202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64318554|NCT02758171|Empagliflozin|empagliflozin|mesh-list
64318555|NCT02758171|Linagliptin|linagliptin|mesh-list
64318556|NCT02758171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64318557|NCT02758171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796203|NCT04907253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796204|NCT04905979|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64796205|NCT04905979|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64796206|NCT04905979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64796212|NCT04854512|Metformin|metformin|mesh-list
64796267|NCT04677959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64796268|NCT04677959|Autonomic Agents|autonomic agents|mesh-ancestor
64796269|NCT04677959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64796283|NCT04671043|Caffeine|caffeine|mesh-list
64796339|NCT04570293|Anesthetics, Local|anesthetics, local|mesh-ancestor
64796341|NCT04570293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64796342|NCT04570293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796343|NCT04570293|Sensory System Agents|sensory system agents|mesh-ancestor
64796344|NCT04570293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64796345|NCT04570293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64796347|NCT04570293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64323174|NCT05746377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64323175|NCT05746377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323176|NCT03165825|Dexamethasone|dexamethasone|mesh-list
64323177|NCT03165825|Betamethasone|betamethasone|mesh-list
64435337|NCT04887506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64435338|NCT04887506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435339|NCT04887506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64435340|NCT04887506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435341|NCT04887506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435342|NCT04887506|Hormone Antagonists|hormone antagonists|mesh-ancestor
64435343|NCT04887506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64435344|NCT02336165|Bevacizumab|bevacizumab|mesh-list
64435345|NCT02336165|Durvalumab|durvalumab|mesh-list
64435346|NCT02336165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64435347|NCT02336165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435348|NCT02336165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64435363|NCT02319044|Durvalumab|durvalumab|mesh-list
64435397|NCT02281760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435398|NCT02281760|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64796404|NCT04512105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796405|NCT04512105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796406|NCT04512105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64796407|NCT04505254|Obinutuzumab|obinutuzumab|mesh-list
64796408|NCT04505254|Acalabrutinib|acalabrutinib|mesh-list
64796409|NCT04505254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64796410|NCT04505254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796411|NCT04504318|Enoxaparin|enoxaparin|mesh-list
64796412|NCT04504318|Apixaban|apixaban|mesh-list
64796413|NCT04504318|Anticoagulants|anticoagulants|mesh-ancestor
64796414|NCT04504318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64796415|NCT04504318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64796416|NCT04504318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796417|NCT04504318|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64796418|NCT04504318|Antithrombins|antithrombins|mesh-ancestor
64796419|NCT04504318|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64796420|NCT04504318|Protease Inhibitors|protease inhibitors|mesh-ancestor
64796421|NCT04504318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796422|NCT04501120|Azacitidine|azacitidine|mesh-list
64796423|NCT04501120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64796424|NCT04501120|Antimetabolites|antimetabolites|mesh-ancestor
64796425|NCT04501120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796426|NCT04501120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796427|NCT04501120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796428|NCT04497142|Levetiracetam|levetiracetam|mesh-list
64796455|NCT04477317|Sensory System Agents|sensory system agents|mesh-ancestor
64796457|NCT04469959|Carbidopa|carbidopa|mesh-list
64796458|NCT04469959|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64318571|NCT00101101|Vincristine|vincristine|mesh-list
64318572|NCT00101101|Interleukin-2|interleukin-2|mesh-list
64318573|NCT00101101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64318574|NCT00101101|Immunologic Factors|immunologic factors|mesh-ancestor
64318575|NCT00101101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318576|NCT00101101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64318577|NCT00101101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64318578|NCT00101101|Alkylating Agents|alkylating agents|mesh-ancestor
64318579|NCT00101101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318580|NCT00101101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796460|NCT04469959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64796461|NCT04469959|Dopamine Agents|dopamine agents|mesh-ancestor
64796462|NCT04469959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64796463|NCT04469959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796464|NCT04469959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796465|NCT04469959|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64796466|NCT04469959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796520|NCT04291521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64796521|NCT04291521|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64796522|NCT04291521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64796523|NCT04291521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64796524|NCT04291521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64796525|NCT04291521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796527|NCT04288427|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64796528|NCT04288427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64796536|NCT04280601|Vitamins|vitamins|mesh-ancestor
64796585|NCT04131309|Autonomic Agents|autonomic agents|mesh-ancestor
64318581|NCT00101101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64318582|NCT00101101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64318583|NCT00101101|Antiemetics|antiemetics|mesh-ancestor
64318584|NCT00101101|Autonomic Agents|autonomic agents|mesh-ancestor
64318585|NCT00101101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318586|NCT00101101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64318587|NCT00101101|Glucocorticoids|glucocorticoids|mesh-ancestor
64318588|NCT00101101|Hormones|hormones|mesh-ancestor
64318589|NCT00101101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64318590|NCT00101101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64318591|NCT00101101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64318592|NCT00101101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64318593|NCT00101101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64318594|NCT00101101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318595|NCT00101101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64318596|NCT00101101|Tubulin Modulators|tubulin modulators|mesh-ancestor
64796586|NCT04131309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64796587|NCT04131309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796658|NCT04039464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796659|NCT04039464|Urological Agents|urological agents|mesh-ancestor
64796660|NCT04039464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64796661|NCT04039464|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64796662|NCT04035031|Dapagliflozin|dapagliflozin|mesh-list
64796729|NCT03786783|Etoposide phosphate|etoposide phosphate|mesh-list
64796730|NCT03786783|Daunorubicin|daunorubicin|mesh-list
64796731|NCT03786783|Topotecan|topotecan|mesh-list
64796732|NCT03786783|Tretinoin|tretinoin|mesh-list
64796733|NCT03786783|Podophyllotoxin|podophyllotoxin|mesh-list
64796734|NCT03786783|Dinutuximab|dinutuximab|mesh-list
64796735|NCT03786783|Dexrazoxane|dexrazoxane|mesh-list
64796801|NCT03639935|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64796802|NCT03639935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796803|NCT03635333|Nicotine|nicotine|mesh-list
64796804|NCT03635333|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64796805|NCT03635333|Autonomic Agents|autonomic agents|mesh-ancestor
64318597|NCT00101101|Antimitotic Agents|antimitotic agents|mesh-ancestor
64318598|NCT00101101|Mitosis Modulators|mitosis modulators|mesh-ancestor
64318599|NCT00101101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64318601|NCT00101101|Sensory System Agents|sensory system agents|mesh-ancestor
64318602|NCT00101101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64318603|NCT00101101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64318604|NCT00101101|Antiviral Agents|antiviral agents|mesh-ancestor
64318605|NCT00101101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64318606|NCT02172781|Tiotropium Bromide|tiotropium bromide|mesh-list
64318607|NCT02172781|Ipratropium|ipratropium|mesh-list
64318608|NCT02172781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64318609|NCT02172781|Autonomic Agents|autonomic agents|mesh-ancestor
64318610|NCT02172781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318611|NCT02172781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318612|NCT02172781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64381177|NCT02435537|Morphine|morphine|mesh-list
64796806|NCT03635333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64796807|NCT03635333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796808|NCT03635333|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64796809|NCT03635333|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64796810|NCT03635333|Cholinergic Agents|cholinergic agents|mesh-ancestor
64796811|NCT03635333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64323182|NCT03165825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323183|NCT03165825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64323184|NCT03165825|Glucocorticoids|glucocorticoids|mesh-ancestor
64323185|NCT03165825|Hormones|hormones|mesh-ancestor
64323186|NCT03165825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64323187|NCT03165825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64323188|NCT03165825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323189|NCT03165825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64323190|NCT03165825|Respiratory System Agents|respiratory system agents|mesh-ancestor
64323191|NCT03167853|Antibodies|antibodies|mesh-list
64323192|NCT03167853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64323193|NCT03167853|Immunologic Factors|immunologic factors|mesh-ancestor
64323194|NCT03167853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746900|NCT01480674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64796866|NCT03273413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64796867|NCT03273413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64796868|NCT03273413|Antimetabolites|antimetabolites|mesh-ancestor
64796869|NCT03273413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64796870|NCT03273413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64796871|NCT03273413|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64796872|NCT03273413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64796934|NCT02983578|Immunologic Factors|immunologic factors|mesh-ancestor
64796935|NCT02983578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796937|NCT02932826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64318613|NCT02172781|Respiratory System Agents|respiratory system agents|mesh-ancestor
64318615|NCT02172781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64318616|NCT02172781|Cholinergic Agents|cholinergic agents|mesh-ancestor
64318617|NCT02172781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64318618|NCT02172781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318619|NCT02173093|Aldesleukin|aldesleukin|mesh-list
64318620|NCT02173093|Interleukin-2|interleukin-2|mesh-list
64318621|NCT02173093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318622|NCT02173093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64318623|NCT02173093|Analgesics|analgesics|mesh-ancestor
64318624|NCT02173093|Sensory System Agents|sensory system agents|mesh-ancestor
64318625|NCT02173093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318626|NCT02173093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318627|NCT02173093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64318628|NCT02173093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64318629|NCT02173093|Antiviral Agents|antiviral agents|mesh-ancestor
64318630|NCT02173093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64318631|NCT01465100|Liver Extracts|liver extracts|mesh-list
64318632|NCT01465100|Hematinics|hematinics|mesh-ancestor
64318633|NCT05142085|Mineral Oil|mineral oil|mesh-list
64318634|NCT05142085|Emollients|emollients|mesh-ancestor
64381212|NCT02435459|Calcium|calcium|mesh-list
64796940|NCT02860000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64796941|NCT02860000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796942|NCT02860000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64796943|NCT02860000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64796944|NCT02860000|Hormone Antagonists|hormone antagonists|mesh-ancestor
64796945|NCT02860000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64796946|NCT02860000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64796947|NCT02846623|Atezolizumab|atezolizumab|mesh-list
64796948|NCT02846623|Venetoclax|venetoclax|mesh-list
64796949|NCT02846623|Obinutuzumab|obinutuzumab|mesh-list
64796950|NCT02846623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64746911|NCT01506726|Sensory System Agents|sensory system agents|mesh-ancestor
64746912|NCT01506726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64746913|NCT01506726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746914|NCT01506726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64746915|NCT01506726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64796951|NCT02846623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64796952|NCT02846623|Immunologic Factors|immunologic factors|mesh-ancestor
64796995|NCT02817360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64318636|NCT00103831|Taxane|taxane|mesh-list
64318637|NCT00103831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318638|NCT03538483|Bupivacaine|bupivacaine|mesh-list
64318639|NCT03538483|Anesthetics, Local|anesthetics, local|mesh-ancestor
64318640|NCT03538483|Anesthetics|anesthetics|mesh-ancestor
64318641|NCT03538483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64318642|NCT03538483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318643|NCT03538483|Sensory System Agents|sensory system agents|mesh-ancestor
64318644|NCT03538483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318645|NCT05033054|Dapagliflozin|dapagliflozin|mesh-list
64318646|NCT05033054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64318647|NCT05033054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318648|NCT05033054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64318649|NCT05033054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318650|NCT02175355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64318651|NCT02175355|Telmisartan|telmisartan|mesh-list
64318652|NCT02175355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64318653|NCT02175355|Diuretics|diuretics|mesh-ancestor
64318654|NCT02175355|Natriuretic Agents|natriuretic agents|mesh-ancestor
64318655|NCT02175355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318656|NCT02175355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64318657|NCT02175355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64318658|NCT02175355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318659|NCT02175355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64318660|NCT02175355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64796996|NCT02817360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64796997|NCT02817360|Vasodilator Agents|vasodilator agents|mesh-ancestor
64796998|NCT02817360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64796999|NCT02817360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64797000|NCT02817360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64797001|NCT02817360|Protease Inhibitors|protease inhibitors|mesh-ancestor
64797002|NCT02817360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797003|NCT02817360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64797004|NCT02817360|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64797005|NCT02817360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64797006|NCT02817360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64797007|NCT02817360|Sympatholytics|sympatholytics|mesh-ancestor
64797008|NCT02817360|Autonomic Agents|autonomic agents|mesh-ancestor
64797009|NCT02817360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64797010|NCT02817360|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64797011|NCT02817360|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
64797013|NCT02811133|Vitamin B Complex|vitamin b complex|mesh-ancestor
64797014|NCT02811133|Vitamins|vitamins|mesh-ancestor
64797015|NCT02811133|Micronutrients|micronutrients|mesh-ancestor
64797016|NCT02811133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797017|NCT02743806|Vedolizumab|vedolizumab|mesh-list
64318682|NCT02170597|Protease Inhibitors|protease inhibitors|mesh-ancestor
64318683|NCT02170597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318684|NCT02170597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318685|NCT02170597|Anticoagulants|anticoagulants|mesh-ancestor
64318687|NCT02170675|Dabigatran|dabigatran|mesh-list
64318688|NCT02170675|Antithrombins|antithrombins|mesh-ancestor
64746933|NCT01505634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746934|NCT01505634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746935|NCT01505634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746936|NCT01505634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64746937|NCT01505634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64746938|NCT01505634|Protease Inhibitors|protease inhibitors|mesh-ancestor
64318689|NCT02170675|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64318690|NCT02170675|Protease Inhibitors|protease inhibitors|mesh-ancestor
64318694|NCT02170675|Antifungal Agents|antifungal agents|mesh-ancestor
64318695|NCT02170675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64318696|NCT02170675|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64797018|NCT02743806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64797019|NCT02717624|Acalabrutinib|acalabrutinib|mesh-list
64797020|NCT02717624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797021|NCT02689778|Pirfenidone|pirfenidone|mesh-list
64797022|NCT02689778|Analgesics|analgesics|mesh-ancestor
64797023|NCT02689778|Sensory System Agents|sensory system agents|mesh-ancestor
64797024|NCT02689778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64797037|NCT02678377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64797038|NCT02678377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318697|NCT02170675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64318698|NCT02170675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64318699|NCT02170675|Hormone Antagonists|hormone antagonists|mesh-ancestor
64318700|NCT02170675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64318701|NCT02170675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318702|NCT02170675|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64318704|NCT04154150|Analgesics|analgesics|mesh-ancestor
64318705|NCT04154150|Sensory System Agents|sensory system agents|mesh-ancestor
64318706|NCT04154150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318707|NCT04154150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318708|NCT04154150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64318709|NCT04154150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64318710|NCT04154150|Anesthetics, General|anesthetics, general|mesh-ancestor
64318711|NCT04154150|Anesthetics|anesthetics|mesh-ancestor
64318712|NCT04154150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64318713|NCT04154150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64318714|NCT04154150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64318715|NCT04154150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64797039|NCT02678377|Cholinergic Agents|cholinergic agents|mesh-ancestor
64797040|NCT02678377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64797041|NCT02659384|Aspirin|aspirin|mesh-list
64797042|NCT02659384|Bevacizumab|bevacizumab|mesh-list
64797043|NCT02659384|Atezolizumab|atezolizumab|mesh-list
64797044|NCT02659384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64797045|NCT02659384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797046|NCT02659384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64797047|NCT02659384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64797048|NCT02659384|Growth Substances|growth substances|mesh-ancestor
64797049|NCT02659384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797050|NCT02659384|Growth Inhibitors|growth inhibitors|mesh-ancestor
64797051|NCT02659384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64797052|NCT02659384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64797053|NCT02659384|Analgesics|analgesics|mesh-ancestor
64797054|NCT02659384|Sensory System Agents|sensory system agents|mesh-ancestor
64797055|NCT02659384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64797056|NCT02659384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64797057|NCT02659384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64797058|NCT02659384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64797059|NCT02659384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64797060|NCT02659384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797061|NCT02659384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64797062|NCT02659384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64797065|NCT02659306|Metformin|metformin|mesh-list
64797084|NCT02579161|Fluoroquinolones|fluoroquinolones|mesh-list
64746947|NCT01480596|Belimumab|belimumab|mesh-list
64797085|NCT02579161|Lincosamides|lincosamides|mesh-list
64797086|NCT02579161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64797087|NCT02579161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64797088|NCT02579161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64797089|NCT02579161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64318716|NCT04154150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318717|NCT00521846|Cimetidine|cimetidine|mesh-list
64318718|NCT00521846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64318719|NCT00521846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64318720|NCT00521846|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64318721|NCT00521846|Histamine Antagonists|histamine antagonists|mesh-ancestor
64318722|NCT00521846|Histamine Agents|histamine agents|mesh-ancestor
64318723|NCT00521846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64318724|NCT00521846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318725|NCT00521846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318726|NCT00521846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64318727|NCT00521846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64318728|NCT00521846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318729|NCT02170831|Dabigatran|dabigatran|mesh-list
64318730|NCT02170831|Antithrombins|antithrombins|mesh-ancestor
64381265|NCT03188471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64381270|NCT03188471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64797091|NCT02579161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797092|NCT02579161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797093|NCT02579161|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64797146|NCT02192398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64797147|NCT02192398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64797148|NCT02192398|Adrenergic Agents|adrenergic agents|mesh-ancestor
64797149|NCT02192398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64797150|NCT02192398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797151|NCT02192398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797152|NCT02157324|Acalabrutinib|acalabrutinib|mesh-list
64797153|NCT02157324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797213|NCT01969578|Contraceptive Agents|contraceptive agents|mesh-ancestor
64797214|NCT01969578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64797215|NCT01969578|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64797216|NCT01969578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64565787|NCT05783817|Adrenergic Agents|adrenergic agents|mesh-ancestor
64797217|NCT01850303|Gemcitabine|gemcitabine|mesh-list
64797218|NCT01850303|Pemetrexed|pemetrexed|mesh-list
64797219|NCT01850303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64797220|NCT01850303|Antimetabolites|antimetabolites|mesh-ancestor
64797221|NCT01850303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746959|NCT01459614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64746960|NCT01459614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746961|NCT01459614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64746962|NCT01459614|Immunologic Factors|immunologic factors|mesh-ancestor
64746963|NCT01459614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323195|NCT05704647|Nivolumab|nivolumab|mesh-list
64436519|NCT04572256|Hormone Antagonists|hormone antagonists|mesh-ancestor
64797222|NCT01850303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797223|NCT01850303|Antiviral Agents|antiviral agents|mesh-ancestor
64797224|NCT01850303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64797225|NCT01850303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797226|NCT01850303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64797227|NCT01850303|Immunologic Factors|immunologic factors|mesh-ancestor
64797270|NCT01681264|Sensory System Agents|sensory system agents|mesh-ancestor
64797271|NCT01681264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64797272|NCT01681264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64797273|NCT01681264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64797274|NCT01681264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64318731|NCT02170831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64797276|NCT01681264|Adrenergic Agents|adrenergic agents|mesh-ancestor
64797277|NCT01681264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64797278|NCT01681264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797279|NCT01654276|Febuxostat|febuxostat|mesh-list
64797280|NCT01654276|Gout Suppressants|gout suppressants|mesh-ancestor
64797285|NCT00590122|Levodopa|levodopa|mesh-list
64797332|NCT00295893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64797333|NCT00295893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64797334|NCT00295893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64797336|NCT00295893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64797337|NCT00110591|Leronlimab|leronlimab|mesh-list
64797338|NCT00110591|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64797339|NCT00110591|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64797340|NCT00110591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797341|NCT00110591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64797342|NCT00110591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64797343|NCT00110591|Antiviral Agents|antiviral agents|mesh-ancestor
64797398|NCT01384448|Autonomic Agents|autonomic agents|mesh-ancestor
64797399|NCT01384448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64797400|NCT01384448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318732|NCT02170831|Protease Inhibitors|protease inhibitors|mesh-ancestor
64318733|NCT02170831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318734|NCT02170831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318735|NCT02170831|Anticoagulants|anticoagulants|mesh-ancestor
64318736|NCT02175589|Colchicine|colchicine|mesh-list
64318737|NCT02175589|Gout Suppressants|gout suppressants|mesh-ancestor
64318738|NCT02175589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64318739|NCT02175589|Tubulin Modulators|tubulin modulators|mesh-ancestor
64318740|NCT02175589|Antimitotic Agents|antimitotic agents|mesh-ancestor
64318741|NCT02175589|Mitosis Modulators|mitosis modulators|mesh-ancestor
64318742|NCT02175589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318743|NCT02175589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318745|NCT05438186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64318746|NCT05438186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381297|NCT05524857|Decitabine|decitabine|mesh-list
64797401|NCT01384448|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64797402|NCT01384448|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64797403|NCT01384448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64797404|NCT01384448|Adrenergic Agents|adrenergic agents|mesh-ancestor
64797405|NCT01384448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64797406|NCT01384448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797407|NCT01384448|Protective Agents|protective agents|mesh-ancestor
64797408|NCT01384578|Vitamins|vitamins|mesh-list
64797409|NCT01384578|Vitamin E|vitamin e|mesh-list
64797453|NCT01384812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797455|NCT01384864|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64797456|NCT01384864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64797457|NCT01384903|Antithrombins|antithrombins|mesh-list
64797458|NCT01384903|Antithrombin III|antithrombin iii|mesh-list
64797459|NCT01384903|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64318749|NCT05438186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64318750|NCT02178397|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64318751|NCT02178397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318752|NCT02178397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64318753|NCT02178397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318754|NCT02178397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318755|NCT02173639|Metformin|metformin|mesh-list
64318756|NCT02173639|Linagliptin|linagliptin|mesh-list
64318757|NCT02173639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64318758|NCT02173639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318759|NCT02173639|Incretins|incretins|mesh-ancestor
64318760|NCT02173639|Hormones|hormones|mesh-ancestor
64318761|NCT02173639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64318762|NCT02173639|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64318763|NCT02173639|Protease Inhibitors|protease inhibitors|mesh-ancestor
64318764|NCT02173639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318765|NCT02173639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318766|NCT02173717|Rifampin|rifampin|mesh-list
64318767|NCT02173717|Dabigatran|dabigatran|mesh-list
64318768|NCT02173717|Antithrombins|antithrombins|mesh-ancestor
64318769|NCT02173717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64318770|NCT02173717|Protease Inhibitors|protease inhibitors|mesh-ancestor
64318771|NCT02173717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318772|NCT02173717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318774|NCT02173717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64318775|NCT02173717|Antitubercular Agents|antitubercular agents|mesh-ancestor
64318776|NCT02173717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64318777|NCT02173717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64797460|NCT01384903|Protease Inhibitors|protease inhibitors|mesh-ancestor
64797461|NCT01384903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797462|NCT01384903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797463|NCT01384903|Anticoagulants|anticoagulants|mesh-ancestor
64797464|NCT01384994|Folic Acid|folic acid|mesh-list
64797465|NCT01384994|Vitamin B Complex|vitamin b complex|mesh-list
64797466|NCT01384994|Oxaliplatin|oxaliplatin|mesh-list
64797467|NCT01384994|Fluorouracil|fluorouracil|mesh-list
64318778|NCT02173717|Leprostatic Agents|leprostatic agents|mesh-ancestor
64797468|NCT01384994|Panitumumab|panitumumab|mesh-list
64797469|NCT01384994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797470|NCT01384994|Antimetabolites|antimetabolites|mesh-ancestor
64318779|NCT02173717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64318780|NCT02173717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64318781|NCT02173717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64318782|NCT02173717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64318783|NCT02173717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64318784|NCT02173717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64318785|NCT02173717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64318786|NCT04516447|Gemcitabine|gemcitabine|mesh-list
64318787|NCT04516447|Paclitaxel|paclitaxel|mesh-list
64318788|NCT04516447|Carboplatin|carboplatin|mesh-list
64318789|NCT04516447|Doxorubicin|doxorubicin|mesh-list
64318790|NCT04516447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64318791|NCT04516447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64318792|NCT04516447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318793|NCT04516447|Tubulin Modulators|tubulin modulators|mesh-ancestor
64318794|NCT04516447|Antimitotic Agents|antimitotic agents|mesh-ancestor
64318795|NCT04516447|Mitosis Modulators|mitosis modulators|mesh-ancestor
64318796|NCT04516447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318797|NCT04516447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64318802|NCT04516447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64318803|NCT04516447|Immunologic Factors|immunologic factors|mesh-ancestor
64318804|NCT04516447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318805|NCT04516447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64318806|NCT04516447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64318807|NCT04516447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64318808|NCT04067648|Sufentanil|sufentanil|mesh-list
64318809|NCT04067648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64318810|NCT04067648|Narcotics|narcotics|mesh-ancestor
64318811|NCT04067648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64318812|NCT04067648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797471|NCT01384994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797472|NCT01384994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64797473|NCT01384994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64797474|NCT01384994|Immunologic Factors|immunologic factors|mesh-ancestor
64797475|NCT01384994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797476|NCT01384994|Hematinics|hematinics|mesh-ancestor
64797477|NCT01384994|Vitamins|vitamins|mesh-ancestor
64797478|NCT01384994|Micronutrients|micronutrients|mesh-ancestor
64797479|NCT01384994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64797480|NCT01385020|Gemfibrozil|gemfibrozil|mesh-list
64797481|NCT01385020|Red yeast rice|red yeast rice|mesh-list
64318815|NCT04067648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318816|NCT04067648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64318817|NCT04067648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64318818|NCT04067648|Anesthetics, General|anesthetics, general|mesh-ancestor
64318819|NCT04067648|Anesthetics|anesthetics|mesh-ancestor
64318821|NCT02173795|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
64318822|NCT02173795|Ipratropium|ipratropium|mesh-list
64797482|NCT01385020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64797483|NCT01385020|Antimetabolites|antimetabolites|mesh-ancestor
64797484|NCT01385020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797485|NCT01385020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64797497|NCT01385228|Antimitotic Agents|antimitotic agents|mesh-ancestor
64797498|NCT01385228|Mitosis Modulators|mitosis modulators|mesh-ancestor
64797499|NCT01385228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797500|NCT01385228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64797501|NCT01385228|Glucocorticoids|glucocorticoids|mesh-ancestor
64797502|NCT01385228|Hormones|hormones|mesh-ancestor
64797503|NCT01385228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64318823|NCT02173795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64318824|NCT02173795|Autonomic Agents|autonomic agents|mesh-ancestor
64318825|NCT02173795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318826|NCT02173795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318827|NCT02173795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64318828|NCT02173795|Respiratory System Agents|respiratory system agents|mesh-ancestor
64318829|NCT02173795|Sympathomimetics|sympathomimetics|mesh-ancestor
64318830|NCT02173795|Tocolytic Agents|tocolytic agents|mesh-ancestor
64318831|NCT02173795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64318832|NCT02173795|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64318833|NCT02173795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64318834|NCT02173795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64318835|NCT02173795|Adrenergic Agents|adrenergic agents|mesh-ancestor
64318836|NCT02173795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64318837|NCT02173795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318838|NCT02173795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64318839|NCT02173795|Cholinergic Agents|cholinergic agents|mesh-ancestor
64318840|NCT02175901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64381337|NCT05192889|Abortifacient Agents|abortifacient agents|mesh-ancestor
64797504|NCT01385228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797505|NCT01385228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64797506|NCT01385345|Vitamin D|vitamin d|mesh-list
64797507|NCT01385345|Cholecalciferol|cholecalciferol|mesh-list
64797508|NCT01385345|Vitamins|vitamins|mesh-ancestor
64797509|NCT01385345|Micronutrients|micronutrients|mesh-ancestor
64797510|NCT01385345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797511|NCT01385345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64797512|NCT01385345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64797513|NCT01385527|Triamcinolone|triamcinolone|mesh-list
64797514|NCT01385527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64797515|NCT01385527|Glucocorticoids|glucocorticoids|mesh-ancestor
64797516|NCT01385527|Hormones|hormones|mesh-ancestor
64797518|NCT01385527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797551|NCT01385891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64797552|NCT01385891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797553|NCT01385891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64797554|NCT01385891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64318841|NCT02175901|Amoxicillin|amoxicillin|mesh-list
64318842|NCT02175901|Metronidazole|metronidazole|mesh-list
64318843|NCT02175901|Clarithromycin|clarithromycin|mesh-list
64318844|NCT02175901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64318845|NCT02175901|Potassium Citrate|potassium citrate|mesh-list
64318846|NCT02175901|Lansoprazole|lansoprazole|mesh-list
64318847|NCT02175901|Bismuth|bismuth|mesh-list
64318848|NCT02175901|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64318849|NCT02175901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318850|NCT02175901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64318851|NCT02175901|Antitubercular Agents|antitubercular agents|mesh-ancestor
64318852|NCT02175901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64318853|NCT02175901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64318854|NCT02175901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64318855|NCT02175901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318856|NCT02175901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64318857|NCT02175901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64318858|NCT02175901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64318859|NCT02175901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64318860|NCT02175901|Antacids|antacids|mesh-ancestor
64318861|NCT02175901|Diuretics|diuretics|mesh-ancestor
64318862|NCT02175901|Natriuretic Agents|natriuretic agents|mesh-ancestor
64318863|NCT02175901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318864|NCT02175901|Expectorants|expectorants|mesh-ancestor
64318865|NCT02175901|Respiratory System Agents|respiratory system agents|mesh-ancestor
64318866|NCT05534750|Linezolid|linezolid|mesh-list
64318867|NCT05534750|Tedizolid|tedizolid|mesh-list
64318868|NCT05534750|Tedizolid phosphate|tedizolid phosphate|mesh-list
64318869|NCT05534750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64797555|NCT01385891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64797556|NCT01385891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797557|NCT01385891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64797558|NCT01385891|Antimetabolites|antimetabolites|mesh-ancestor
64797559|NCT01385956|Gemcitabine|gemcitabine|mesh-list
64797560|NCT01385956|Pasireotide|pasireotide|mesh-list
64797615|NCT01386229|Analgesics|analgesics|mesh-ancestor
64797616|NCT01386229|Sensory System Agents|sensory system agents|mesh-ancestor
64797617|NCT01386229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64797618|NCT01386229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797619|NCT01386229|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64797620|NCT01386229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64797621|NCT01386229|Anesthetics, General|anesthetics, general|mesh-ancestor
64797683|NCT01386502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797684|NCT01386567|Methyltestosterone|methyltestosterone|mesh-list
64797686|NCT01386567|Sodium Citrate|sodium citrate|mesh-list
64797687|NCT01386567|Enclomiphene|enclomiphene|mesh-list
64797688|NCT01386567|Clomiphene|clomiphene|mesh-list
64797689|NCT01386567|Zuclomiphene|zuclomiphene|mesh-list
64797690|NCT01386567|Testosterone|testosterone|mesh-list
64797691|NCT01386567|Testosterone undecanoate|testosterone undecanoate|mesh-list
64797692|NCT01386567|Testosterone enanthate|testosterone enanthate|mesh-list
64797693|NCT01386567|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64797694|NCT01386567|Anticoagulants|anticoagulants|mesh-ancestor
64797695|NCT01386567|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64797696|NCT01386567|Chelating Agents|chelating agents|mesh-ancestor
64797697|NCT01386567|Sequestering Agents|sequestering agents|mesh-ancestor
64797698|NCT01386567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797700|NCT01386567|Hormones|hormones|mesh-ancestor
64797742|NCT01386593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64797743|NCT01386593|Antidepressive Agents|antidepressive agents|mesh-ancestor
64797744|NCT01386593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64797745|NCT01386593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64566318|NCT04812548|Antimetabolites|antimetabolites|mesh-ancestor
64797746|NCT01386593|Antifungal Agents|antifungal agents|mesh-ancestor
64797747|NCT01386593|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64797748|NCT01386593|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64797749|NCT01386593|Hormone Antagonists|hormone antagonists|mesh-ancestor
64797750|NCT01386593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64797802|NCT01386996|Budesonide|budesonide|mesh-list
64797803|NCT01386996|Formoterol Fumarate|formoterol fumarate|mesh-list
64318949|NCT04620746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64318950|NCT02253875|Ritonavir|ritonavir|mesh-list
64318951|NCT02253875|Tipranavir|tipranavir|mesh-list
64318952|NCT02253875|Omeprazole|omeprazole|mesh-list
64318953|NCT02253875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64318954|NCT02253875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64318955|NCT02253875|Protease Inhibitors|protease inhibitors|mesh-ancestor
64318956|NCT02253875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318957|NCT02253875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318958|NCT02253875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64318959|NCT02253875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64318960|NCT02253875|Antiviral Agents|antiviral agents|mesh-ancestor
64318961|NCT02253875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64318962|NCT02253875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64318963|NCT02253875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64318964|NCT02253875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64318965|NCT02253875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64318966|NCT02253875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64318968|NCT05534672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64318969|NCT05534672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64318970|NCT05534672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64318971|NCT05534672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318972|NCT05534672|Antifungal Agents|antifungal agents|mesh-ancestor
64318973|NCT05534672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64318974|NCT05534672|Immunologic Factors|immunologic factors|mesh-ancestor
64318975|NCT05534672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318976|NCT03819140|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
64318977|NCT03819140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64797804|NCT01386996|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64797805|NCT01386996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64797806|NCT01386996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64797807|NCT01386996|Autonomic Agents|autonomic agents|mesh-ancestor
64797808|NCT01386996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64797809|NCT01386996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797810|NCT01386996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64797811|NCT01386996|Respiratory System Agents|respiratory system agents|mesh-ancestor
64797812|NCT01386996|Glucocorticoids|glucocorticoids|mesh-ancestor
64797813|NCT01386996|Hormones|hormones|mesh-ancestor
64797814|NCT01386996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64797815|NCT01386996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64797816|NCT01386996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64797817|NCT01386996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64797818|NCT01386996|Adrenergic Agents|adrenergic agents|mesh-ancestor
64797819|NCT01386996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64797821|NCT01387048|Adapalene|adapalene|mesh-list
64797840|NCT01387191|Tezosentan|tezosentan|mesh-list
64797858|NCT01387295|Antimetabolites|antimetabolites|mesh-ancestor
64797859|NCT01387295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797860|NCT01387295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797861|NCT01387295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64797862|NCT01387373|Capecitabine|capecitabine|mesh-list
64797863|NCT01387373|Oxaliplatin|oxaliplatin|mesh-list
64797864|NCT01387373|Trastuzumab|trastuzumab|mesh-list
64797865|NCT01387373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64318978|NCT03819140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318979|NCT04597268|Midazolam|midazolam|mesh-list
64318980|NCT04597268|Dexmedetomidine|dexmedetomidine|mesh-list
64318981|NCT04597268|Ketamine|ketamine|mesh-list
64318982|NCT04597268|Propofol|propofol|mesh-list
64318983|NCT04597268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64318984|NCT04597268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64318985|NCT04597268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318986|NCT04597268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64318987|NCT04597268|Anesthetics, General|anesthetics, general|mesh-ancestor
64318988|NCT04597268|Anesthetics|anesthetics|mesh-ancestor
64318989|NCT04597268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64318990|NCT04597268|Analgesics|analgesics|mesh-ancestor
64318995|NCT04597268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64318996|NCT04597268|Adrenergic Agents|adrenergic agents|mesh-ancestor
64318997|NCT04597268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64318998|NCT04597268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318999|NCT04597268|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64319000|NCT04597268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64319001|NCT04597268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64319002|NCT04597268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64319003|NCT04597268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64319004|NCT04597268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64319005|NCT04597268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64797866|NCT01387373|Antimetabolites|antimetabolites|mesh-ancestor
64797867|NCT01387373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797868|NCT01387373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64797869|NCT01387373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64797918|NCT01388036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797919|NCT01388036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797921|NCT01388049|Immunologic Factors|immunologic factors|mesh-ancestor
64797922|NCT01388049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797923|NCT01388062|Antibodies|antibodies|mesh-list
64797924|NCT01388062|Immunologic Factors|immunologic factors|mesh-ancestor
64797925|NCT01388062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64797926|NCT01388075|Rifampin|rifampin|mesh-list
64797927|NCT01388075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64797928|NCT01388075|Antitubercular Agents|antitubercular agents|mesh-ancestor
64747206|NCT01496976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64747207|NCT01475838|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64747208|NCT01475838|Antiviral Agents|antiviral agents|mesh-ancestor
64747209|NCT01475838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64747210|NCT01475838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64747211|NCT01475838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64747212|NCT01451814|Nicotine|nicotine|mesh-list
64747213|NCT01451814|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64747214|NCT01451814|Autonomic Agents|autonomic agents|mesh-ancestor
64747215|NCT01451814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64747216|NCT01451814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747217|NCT01451814|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64797972|NCT01388270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797973|NCT01388322|Enoxaparin|enoxaparin|mesh-list
64797974|NCT01388322|Anticoagulants|anticoagulants|mesh-ancestor
64797975|NCT01388322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64797976|NCT01388322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64797977|NCT01388322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64797978|NCT01388387|Tacrolimus|tacrolimus|mesh-list
64319007|NCT04597268|GABA Agents|gaba agents|mesh-ancestor
64319008|NCT04976543|Nadroparin|nadroparin|mesh-list
64319009|NCT04976543|Warfarin|warfarin|mesh-list
64319010|NCT04976543|Calcium|calcium|mesh-list
64319011|NCT04976543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64319012|NCT04976543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319013|NCT04976543|Anticoagulants|anticoagulants|mesh-ancestor
64319014|NCT04976543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64319015|NCT04976543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64319016|NCT04976543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319017|NCT04310930|Azithromycin|azithromycin|mesh-list
64319018|NCT04310930|Moxifloxacin|moxifloxacin|mesh-list
64319019|NCT04310930|Clarithromycin|clarithromycin|mesh-list
64319020|NCT04310930|Doxycycline|doxycycline|mesh-list
64319021|NCT04310930|Linezolid|linezolid|mesh-list
64319022|NCT04310930|Imipenem|imipenem|mesh-list
64319023|NCT04310930|Amikacin|amikacin|mesh-list
64319024|NCT04310930|Ethambutol|ethambutol|mesh-list
64319026|NCT04310930|Tigecycline|tigecycline|mesh-list
64319027|NCT04310930|Bedaquiline|bedaquiline|mesh-list
64319028|NCT04310930|Clofazimine|clofazimine|mesh-list
64319029|NCT04310930|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64319030|NCT04310930|Cefoxitin|cefoxitin|mesh-list
64319031|NCT04310930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64319032|NCT04310930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64797979|NCT01388387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64798040|NCT01388595|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64798041|NCT01388595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64798042|NCT01388595|Adrenergic Agents|adrenergic agents|mesh-ancestor
64798043|NCT01388595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64798044|NCT01388595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798045|NCT01388621|Gemcitabine|gemcitabine|mesh-list
64798046|NCT01388621|Carboplatin|carboplatin|mesh-list
64319033|NCT04310930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64319034|NCT04310930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64319035|NCT04310930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319036|NCT04310930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319037|NCT04310930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319038|NCT04310930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64319039|NCT04310930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64319040|NCT04310930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64319041|NCT04310930|Antimalarials|antimalarials|mesh-ancestor
64319042|NCT04310930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64319043|NCT04310930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64319044|NCT04310930|Antitubercular Agents|antitubercular agents|mesh-ancestor
64319045|NCT04310930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64319046|NCT04310930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64319047|NCT04310930|Leprostatic Agents|leprostatic agents|mesh-ancestor
64319048|NCT04310930|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64319049|NCT04310930|Renal Agents|renal agents|mesh-ancestor
64319050|NCT05533892|Lenvatinib|lenvatinib|mesh-list
64319051|NCT05533892|Cell Wall Skeleton|cell wall skeleton|mesh-list
64319052|NCT05533892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319053|NCT05533892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64319054|NCT05533892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319055|NCT05533892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319056|NCT05533892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64319057|NCT05533892|Immunologic Factors|immunologic factors|mesh-ancestor
64319059|NCT02924441|Lidocaine|lidocaine|mesh-list
64319060|NCT02924441|Anesthetics, Local|anesthetics, local|mesh-ancestor
64319061|NCT02924441|Anesthetics|anesthetics|mesh-ancestor
64319062|NCT02924441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64319063|NCT02924441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319064|NCT02924441|Sensory System Agents|sensory system agents|mesh-ancestor
64798047|NCT01388621|Doxorubicin|doxorubicin|mesh-list
64798048|NCT01388621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64798049|NCT01388621|Panitumumab|panitumumab|mesh-list
64798050|NCT01388621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798051|NCT01388621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64798052|NCT01388621|Antimetabolites|antimetabolites|mesh-ancestor
64798053|NCT01388621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798100|NCT01388855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64798101|NCT01388959|Rituximab|rituximab|mesh-list
64798102|NCT01388959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64798103|NCT01388959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798104|NCT01388959|Immunologic Factors|immunologic factors|mesh-ancestor
64798105|NCT01388959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798106|NCT01388959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64319068|NCT02924441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64319069|NCT02924441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64319070|NCT02924441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319072|NCT04526288|Daunorubicin|daunorubicin|mesh-list
64319073|NCT04526288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64319074|NCT04526288|Antimetabolites|antimetabolites|mesh-ancestor
64319075|NCT04526288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319076|NCT04526288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319077|NCT04526288|Antiviral Agents|antiviral agents|mesh-ancestor
64319078|NCT04526288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64319079|NCT04526288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64319080|NCT04526288|Immunologic Factors|immunologic factors|mesh-ancestor
64319081|NCT04526288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319082|NCT04526288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64319083|NCT04526288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64319084|NCT04526288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64319085|NCT04526288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319086|NCT05631626|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
64319087|NCT05631626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64319088|NCT05631626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319089|NCT05631626|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64319090|NCT05631626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64319091|NCT05631626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64319092|NCT05631626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319093|NCT05631626|Dopamine Agents|dopamine agents|mesh-ancestor
64319094|NCT05631626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64798167|NCT01389414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798168|NCT01389414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798169|NCT01389414|Antiviral Agents|antiviral agents|mesh-ancestor
64798170|NCT01389414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64798171|NCT01389414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798172|NCT01389414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64798173|NCT01389414|Immunologic Factors|immunologic factors|mesh-ancestor
64798174|NCT01389414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798175|NCT01389414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64798176|NCT01389427|Sirolimus|sirolimus|mesh-list
64798177|NCT01389427|Prednisone|prednisone|mesh-list
64798178|NCT01389427|Doxorubicin|doxorubicin|mesh-list
64798179|NCT01389427|Cyclophosphamide|cyclophosphamide|mesh-list
64798230|NCT01389544|Methadone|methadone|mesh-list
64798231|NCT01389544|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64798233|NCT01389544|Protease Inhibitors|protease inhibitors|mesh-ancestor
64798301|NCT01389791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798302|NCT01389791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64798304|NCT01389791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64798305|NCT01389791|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64798306|NCT01389791|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64798307|NCT01389791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64798308|NCT01389908|Olanzapine|olanzapine|mesh-list
64798309|NCT01389908|Antiemetics|antiemetics|mesh-ancestor
64798310|NCT01389908|Autonomic Agents|autonomic agents|mesh-ancestor
64798311|NCT01389908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64798312|NCT01389908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798313|NCT01389908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64798361|NCT01390324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798362|NCT01390324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64798363|NCT01390324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64319096|NCT00109967|Rituximab|rituximab|mesh-list
64319097|NCT00109967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64319098|NCT00109967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319099|NCT00109967|Immunologic Factors|immunologic factors|mesh-ancestor
64798364|NCT01390324|Gout Suppressants|gout suppressants|mesh-ancestor
64798365|NCT01390324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64798366|NCT01390324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798367|NCT01390324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798368|NCT01390324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64798428|NCT01390766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64798429|NCT01390766|Immunologic Factors|immunologic factors|mesh-ancestor
64798430|NCT01390766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798431|NCT01390766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64798432|NCT01390792|Zanamivir|zanamivir|mesh-list
64798433|NCT01390792|Antiviral Agents|antiviral agents|mesh-ancestor
64798434|NCT01390792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64798435|NCT01390792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798436|NCT01390792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798437|NCT01390805|Valacyclovir|valacyclovir|mesh-list
64798438|NCT01390805|Antiviral Agents|antiviral agents|mesh-ancestor
64798439|NCT01390805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64798440|NCT01390883|PENTA|penta|mesh-list
64798441|NCT01390883|Fondaparinux|fondaparinux|mesh-list
64798442|NCT01390883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64319100|NCT00109967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319101|NCT00109967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64319102|NCT00109967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64516185|NCT02069704|Antidotes|antidotes|mesh-ancestor
64319103|NCT00109967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64319104|NCT00109967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64319105|NCT00109967|Antifungal Agents|antifungal agents|mesh-ancestor
64319106|NCT00109967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64319107|NCT02579096|Allopurinol|allopurinol|mesh-list
64319108|NCT02579096|Febuxostat|febuxostat|mesh-list
64319109|NCT02579096|Antimetabolites|antimetabolites|mesh-ancestor
64319110|NCT02579096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319111|NCT02579096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319112|NCT02579096|Gout Suppressants|gout suppressants|mesh-ancestor
64319113|NCT02579096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64319114|NCT02579096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64319115|NCT02579096|Antioxidants|antioxidants|mesh-ancestor
64798443|NCT01390883|Antithrombins|antithrombins|mesh-ancestor
64798448|NCT01390883|Anticoagulants|anticoagulants|mesh-ancestor
64798487|NCT01390961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798488|NCT01390961|Nasal Decongestants|nasal decongestants|mesh-ancestor
64798489|NCT01390961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64798490|NCT01390961|Respiratory System Agents|respiratory system agents|mesh-ancestor
64798491|NCT01390961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64798492|NCT01390961|Histamine Antagonists|histamine antagonists|mesh-ancestor
64798493|NCT01390961|Histamine Agents|histamine agents|mesh-ancestor
64798494|NCT01390961|Antipruritics|antipruritics|mesh-ancestor
64798495|NCT01390961|Dermatologic Agents|dermatologic agents|mesh-ancestor
64798496|NCT01390961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64798497|NCT01391052|Norethindrone|norethindrone|mesh-list
64798498|NCT01391052|Norethindrone Acetate|norethindrone acetate|mesh-list
64798499|NCT01391052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64798500|NCT01391052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64798501|NCT01391052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64798507|NCT01391104|Sildenafil Citrate|sildenafil citrate|mesh-list
64798545|NCT01391377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64798546|NCT01391377|Antimetabolites|antimetabolites|mesh-ancestor
64798547|NCT01391377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798548|NCT01391377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64798549|NCT01391377|Vasodilator Agents|vasodilator agents|mesh-ancestor
64798550|NCT01391377|Vitamin B Complex|vitamin b complex|mesh-ancestor
64798551|NCT01391377|Vitamins|vitamins|mesh-ancestor
64798552|NCT01391377|Micronutrients|micronutrients|mesh-ancestor
64798553|NCT01391377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798554|NCT01391390|Melatonin|melatonin|mesh-list
64798610|NCT01391845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64798612|NCT01392014|Piperaquine|piperaquine|mesh-list
64798613|NCT01392014|Artenimol|artenimol|mesh-list
64798614|NCT01392014|Artemisinins|artemisinins|mesh-list
64798615|NCT01392014|Antimalarials|antimalarials|mesh-ancestor
64798616|NCT01392014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64319141|NCT02578706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319142|NCT02578706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64319143|NCT02578706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64319144|NCT02578706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319145|NCT02578706|Antipyretics|antipyretics|mesh-ancestor
64319146|NCT02578706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64319147|NCT02578706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64319148|NCT02578706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64319149|NCT02578706|Purinergic Agents|purinergic agents|mesh-ancestor
64319150|NCT02578706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64319205|NCT04464980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64319206|NCT04464980|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64319207|NCT02741531|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64319208|NCT03365882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64319209|NCT03365882|Trastuzumab|trastuzumab|mesh-list
64798618|NCT01392014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64798619|NCT01392079|Alemtuzumab|alemtuzumab|mesh-list
64798676|NCT01392430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798677|NCT01392430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64798678|NCT01392430|Hormone Antagonists|hormone antagonists|mesh-ancestor
64798679|NCT01392430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64798680|NCT01392430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798681|NCT01392430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64798682|NCT01392430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64798683|NCT01392430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64798684|NCT01392430|Antimalarials|antimalarials|mesh-ancestor
64798685|NCT01392430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64798686|NCT01392430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64798687|NCT01392430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64798688|NCT01392430|Leprostatic Agents|leprostatic agents|mesh-ancestor
64798690|NCT01392430|Renal Agents|renal agents|mesh-ancestor
64798733|NCT01392755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64798734|NCT01392755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64798735|NCT01392755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64798736|NCT01392755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64798737|NCT01392755|Histamine Antagonists|histamine antagonists|mesh-ancestor
64798739|NCT01392755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64798740|NCT01392755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798741|NCT01392768|Levetiracetam|levetiracetam|mesh-list
64798742|NCT01392768|Anticonvulsants|anticonvulsants|mesh-ancestor
64798743|NCT01392768|Nootropic Agents|nootropic agents|mesh-ancestor
64798744|NCT01392794|Ramosetron|ramosetron|mesh-list
64798745|NCT01392794|Antiemetics|antiemetics|mesh-ancestor
64798746|NCT01392794|Autonomic Agents|autonomic agents|mesh-ancestor
64798747|NCT01392794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64747584|NCT01442064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747585|NCT01442064|Growth Inhibitors|growth inhibitors|mesh-ancestor
64747586|NCT01442064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747587|NCT01441596|Vinorelbine|vinorelbine|mesh-list
64747588|NCT01441596|Afatinib|afatinib|mesh-list
64747589|NCT01441596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64747590|NCT01441596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747591|NCT01441596|Tubulin Modulators|tubulin modulators|mesh-ancestor
64798748|NCT01392794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798749|NCT01392794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64798750|NCT01392794|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64798751|NCT01392794|Serotonin Agents|serotonin agents|mesh-ancestor
64798789|NCT01392898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798790|NCT01392898|Incretins|incretins|mesh-ancestor
64798791|NCT01392898|Hormones|hormones|mesh-ancestor
64798792|NCT01392898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64798793|NCT01392911|Rifampin|rifampin|mesh-list
64798794|NCT01392911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64798795|NCT01392911|Antitubercular Agents|antitubercular agents|mesh-ancestor
64319223|NCT03365882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319224|NCT03365882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64319225|NCT03054896|Venetoclax|venetoclax|mesh-list
64798796|NCT01392911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64798797|NCT01392911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64798854|NCT01393288|Dermatologic Agents|dermatologic agents|mesh-ancestor
64798855|NCT01393288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64798856|NCT01393288|Serotonin Agents|serotonin agents|mesh-ancestor
64798857|NCT01393288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64798858|NCT01393288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798859|NCT01393288|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64798860|NCT01393288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64798861|NCT01393288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64798862|NCT01393288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64319250|NCT05532878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319251|NCT05532878|Anticoagulants|anticoagulants|mesh-ancestor
64319252|NCT05498792|Nivolumab|nivolumab|mesh-list
64319253|NCT05498792|Ipilimumab|ipilimumab|mesh-list
64319254|NCT05498792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64319255|NCT05498792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319256|NCT05498792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64319257|NCT05498792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319259|NCT02576678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64319260|NCT02576678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64319261|NCT02576678|Analgesics|analgesics|mesh-ancestor
64319262|NCT02576678|Sensory System Agents|sensory system agents|mesh-ancestor
64319263|NCT02576678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64319264|NCT02576678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798863|NCT01393288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64798865|NCT01393288|Anticonvulsants|anticonvulsants|mesh-ancestor
64798918|NCT01393756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64798919|NCT01393756|Growth Substances|growth substances|mesh-ancestor
64798920|NCT01393756|Growth Inhibitors|growth inhibitors|mesh-ancestor
64798921|NCT01393756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798922|NCT01393769|Melphalan|melphalan|mesh-list
64798923|NCT01393769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64798924|NCT01393769|Alkylating Agents|alkylating agents|mesh-ancestor
64747663|NCT01467492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747664|NCT01466790|Ribavirin|ribavirin|mesh-list
64747665|NCT01466790|Sofosbuvir|sofosbuvir|mesh-list
64798925|NCT01393769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319265|NCT02576678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64319266|NCT02576678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64319267|NCT02576678|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64319268|NCT02576678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64319269|NCT02576678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319270|NCT02576678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319271|NCT05532332|Fluoxetine|fluoxetine|mesh-list
64319272|NCT05532332|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64319273|NCT05532332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64319274|NCT05532332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64319275|NCT05532332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319276|NCT05532332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64319277|NCT05532332|Serotonin Agents|serotonin agents|mesh-ancestor
64319278|NCT05532332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319279|NCT05532332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64319280|NCT05532332|Antidepressive Agents|antidepressive agents|mesh-ancestor
64319281|NCT05532332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64319282|NCT05532332|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64319283|NCT05532332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64319284|NCT05532332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798926|NCT01393769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64798927|NCT01393769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64798928|NCT01393769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64798929|NCT01393769|Immunologic Factors|immunologic factors|mesh-ancestor
64798930|NCT01393769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64798931|NCT01393782|Angiotensin II|angiotensin ii|mesh-list
64798932|NCT01393782|Giapreza|giapreza|mesh-list
64798933|NCT01393782|Angiotensinogen|angiotensinogen|mesh-list
64798934|NCT01393782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64798935|NCT01393782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64798936|NCT01393782|Protease Inhibitors|protease inhibitors|mesh-ancestor
64798937|NCT01393782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798974|NCT01394133|Protease Inhibitors|protease inhibitors|mesh-ancestor
64798975|NCT01394133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64798976|NCT01394133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64798977|NCT01394133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64798978|NCT01394133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64798979|NCT01394133|Antiviral Agents|antiviral agents|mesh-ancestor
64798980|NCT01394133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64798981|NCT01394133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64319299|NCT05532254|Aripiprazole|aripiprazole|mesh-list
64319300|NCT05532254|Antidepressive Agents|antidepressive agents|mesh-ancestor
64319301|NCT05532254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64319302|NCT05532254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64319303|NCT05532254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64323215|NCT03114813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64747679|NCT01418352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747680|NCT01418352|Dopamine Agonists|dopamine agonists|mesh-ancestor
64747681|NCT01418352|Dopamine Agents|dopamine agents|mesh-ancestor
64747682|NCT01418352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64747683|NCT01418352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747684|NCT01418352|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64747685|NCT01418352|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64747687|NCT01418352|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64747688|NCT01418352|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64319304|NCT05532254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64319305|NCT05532254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319306|NCT05532254|Dopamine Agonists|dopamine agonists|mesh-ancestor
64319307|NCT05532254|Dopamine Agents|dopamine agents|mesh-ancestor
64319308|NCT05532254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64319309|NCT05532254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319310|NCT05532254|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64798982|NCT01394133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64798983|NCT01394133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64798984|NCT01394133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64798985|NCT01394224|Levetiracetam|levetiracetam|mesh-list
64799034|NCT01394419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64799035|NCT01394419|Antiviral Agents|antiviral agents|mesh-ancestor
64799036|NCT01394419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64799037|NCT01394419|Expectorants|expectorants|mesh-ancestor
64799038|NCT01394419|Respiratory System Agents|respiratory system agents|mesh-ancestor
64799039|NCT01394419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64799040|NCT01394419|Antioxidants|antioxidants|mesh-ancestor
64799042|NCT01394419|Protective Agents|protective agents|mesh-ancestor
64319311|NCT05532254|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64319312|NCT05532254|Serotonin Agents|serotonin agents|mesh-ancestor
64319313|NCT05532254|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64319314|NCT05532254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64319315|NCT05532254|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64319316|NCT05532254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64319318|NCT05471648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64410302|NCT04799639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799103|NCT01394731|Meperidine|meperidine|mesh-list
64799104|NCT01394731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64799105|NCT01394731|Analgesics|analgesics|mesh-ancestor
64799106|NCT01394731|Sensory System Agents|sensory system agents|mesh-ancestor
64799107|NCT01394731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64799108|NCT01394731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799109|NCT01394731|Antipyretics|antipyretics|mesh-ancestor
64799167|NCT01394848|Immunologic Factors|immunologic factors|mesh-ancestor
64799168|NCT01394848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799169|NCT01394848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64799170|NCT01394848|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64799171|NCT01394848|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64799172|NCT01394848|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64799173|NCT01394848|Purinergic Agents|purinergic agents|mesh-ancestor
64799174|NCT01394848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64799175|NCT01394887|Metformin|metformin|mesh-list
64799176|NCT01394887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64319319|NCT05471648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319320|NCT05467748|Pembrolizumab|pembrolizumab|mesh-list
64319321|NCT05467748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64319322|NCT05467748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319323|NCT00108745|Paclitaxel|paclitaxel|mesh-list
64319324|NCT00108745|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64319325|NCT00108745|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
64319326|NCT00108745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64319327|NCT00108745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319328|NCT00108745|Tubulin Modulators|tubulin modulators|mesh-ancestor
64319329|NCT00108745|Antimitotic Agents|antimitotic agents|mesh-ancestor
64319330|NCT00108745|Mitosis Modulators|mitosis modulators|mesh-ancestor
64799178|NCT01394913|Etanercept|etanercept|mesh-list
64799179|NCT01394913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64799180|NCT01394913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64799181|NCT01394913|Analgesics|analgesics|mesh-ancestor
64799182|NCT01394913|Sensory System Agents|sensory system agents|mesh-ancestor
64799183|NCT01394913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64799184|NCT01394913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799185|NCT01394913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64799186|NCT01394913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64799187|NCT01394913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64799218|NCT01395147|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64799219|NCT01395147|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64799220|NCT01395199|Amlodipine|amlodipine|mesh-list
64799221|NCT01395199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64799222|NCT01395199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64799223|NCT01395199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64799224|NCT01395199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799225|NCT01395199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64799226|NCT01395199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799283|NCT01395485|Dermatologic Agents|dermatologic agents|mesh-ancestor
64799284|NCT01395589|Vitamin D|vitamin d|mesh-list
64799285|NCT01395589|Vitamins|vitamins|mesh-ancestor
64799286|NCT01395589|Micronutrients|micronutrients|mesh-ancestor
64799287|NCT01395589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799288|NCT01395589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64799289|NCT01395602|Cabergoline|cabergoline|mesh-list
64799290|NCT01395602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64319331|NCT00108745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319332|NCT05532020|Diazoxide|diazoxide|mesh-list
64319333|NCT05532020|Choline|choline|mesh-list
64319334|NCT05532020|Lipotropic Agents|lipotropic agents|mesh-ancestor
64319335|NCT05532020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64319336|NCT05532020|Antimetabolites|antimetabolites|mesh-ancestor
64319337|NCT05532020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319338|NCT05532020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64319339|NCT05532020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64319340|NCT05532020|Nootropic Agents|nootropic agents|mesh-ancestor
64319341|NCT05532020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64799291|NCT01395602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64799292|NCT01395602|Dopamine Agonists|dopamine agonists|mesh-ancestor
64799348|NCT01395849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64799349|NCT01395849|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64799350|NCT01395849|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64799351|NCT01395849|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64799352|NCT01395849|Adrenergic Agents|adrenergic agents|mesh-ancestor
64799353|NCT01395849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64799354|NCT01395849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799355|NCT01395849|Glucocorticoids|glucocorticoids|mesh-ancestor
64799356|NCT01395849|Hormones|hormones|mesh-ancestor
64799413|NCT01395927|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64799414|NCT01395927|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64799415|NCT01395927|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64799416|NCT01395927|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64799417|NCT01395927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64799418|NCT01395927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64799482|NCT01396668|Capecitabine|capecitabine|mesh-list
64799483|NCT01396668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323220|NCT03114813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64799484|NCT01396668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64319343|NCT02098343|Carboplatin|carboplatin|mesh-list
64319344|NCT02098343|Doxorubicin|doxorubicin|mesh-list
64319345|NCT02098343|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64319346|NCT02098343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319347|NCT02098343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64319348|NCT02098343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64319349|NCT02098343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64319350|NCT02098343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319351|NCT02098343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319353|NCT02581982|Pembrolizumab|pembrolizumab|mesh-list
64799485|NCT01396668|Antimetabolites|antimetabolites|mesh-ancestor
64799486|NCT01396668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799487|NCT01396668|Antiviral Agents|antiviral agents|mesh-ancestor
64799488|NCT01396668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64799489|NCT01396668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799490|NCT01396668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64799491|NCT01396668|Immunologic Factors|immunologic factors|mesh-ancestor
64799546|NCT01397006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319355|NCT02581982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64319356|NCT02581982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319357|NCT02581982|Tubulin Modulators|tubulin modulators|mesh-ancestor
64319358|NCT02581982|Antimitotic Agents|antimitotic agents|mesh-ancestor
64319359|NCT02581982|Mitosis Modulators|mitosis modulators|mesh-ancestor
64319360|NCT02581982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319361|NCT02581982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64319362|NCT02176369|Vinorelbine|vinorelbine|mesh-list
64319363|NCT02176369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64319364|NCT02176369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319365|NCT02176369|Tubulin Modulators|tubulin modulators|mesh-ancestor
64319366|NCT02176369|Antimitotic Agents|antimitotic agents|mesh-ancestor
64319367|NCT02176369|Mitosis Modulators|mitosis modulators|mesh-ancestor
64319368|NCT02176369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319369|NCT02716805|Melphalan|melphalan|mesh-list
64319370|NCT02716805|Durvalumab|durvalumab|mesh-list
64319371|NCT02716805|Tremelimumab|tremelimumab|mesh-list
64319372|NCT02716805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64319373|NCT02716805|Alkylating Agents|alkylating agents|mesh-ancestor
64319374|NCT02716805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799548|NCT01397006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64799549|NCT01397006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64799550|NCT01397006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64799551|NCT01397006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64799552|NCT01397019|Leucovorin|leucovorin|mesh-list
64799553|NCT01397019|Oxaliplatin|oxaliplatin|mesh-list
64799554|NCT01397019|Irinotecan|irinotecan|mesh-list
64799555|NCT01397019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799556|NCT01397019|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64799557|NCT01397019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64799611|NCT05268835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64799612|NCT05268835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64799613|NCT05268835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319375|NCT02716805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319376|NCT02716805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64319377|NCT02716805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64319378|NCT02716805|Immunologic Factors|immunologic factors|mesh-ancestor
64319379|NCT02716805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319380|NCT02716805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64319381|NCT02174263|Immunoglobulins|immunoglobulins|mesh-list
64319382|NCT02174263|Immunoglobulin G|immunoglobulin g|mesh-list
64319383|NCT02174263|Immunologic Factors|immunologic factors|mesh-ancestor
64319384|NCT02174263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319385|NCT04152473|Proglumide|proglumide|mesh-list
64319386|NCT04152473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64319387|NCT04152473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64319388|NCT04099355|Dronabinol|dronabinol|mesh-list
64319389|NCT04099355|Hallucinogens|hallucinogens|mesh-ancestor
64319390|NCT04099355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319391|NCT04099355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64747782|NCT01412424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747783|NCT01433250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64747784|NCT01433250|Immunologic Factors|immunologic factors|mesh-ancestor
64747785|NCT01433250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747786|NCT01432938|Dulaglutide|dulaglutide|mesh-list
64747787|NCT01432938|Warfarin|warfarin|mesh-list
64747788|NCT01432938|Anticoagulants|anticoagulants|mesh-ancestor
64747789|NCT01432938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64747790|NCT01432938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747791|NCT01392300|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64747792|NCT01392300|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64747793|NCT01392300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64323273|NCT03165123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64323280|NCT03165123|Hormones|hormones|mesh-ancestor
64319392|NCT04099355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64319393|NCT04099355|Analgesics|analgesics|mesh-ancestor
64319394|NCT04099355|Sensory System Agents|sensory system agents|mesh-ancestor
64319395|NCT04099355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64799614|NCT05268835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799616|NCT05268718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64799617|NCT05268718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64799676|NCT04975269|Diuretics|diuretics|mesh-ancestor
64799677|NCT04975269|Natriuretic Agents|natriuretic agents|mesh-ancestor
64799678|NCT04975269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799679|NCT04965870|Trifluridine|trifluridine|mesh-list
64799680|NCT04965870|Antimetabolites|antimetabolites|mesh-ancestor
64799681|NCT04965870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799682|NCT04965870|Antiviral Agents|antiviral agents|mesh-ancestor
64799683|NCT04965870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64799684|NCT04925986|Pembrolizumab|pembrolizumab|mesh-list
64799685|NCT04925986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64799686|NCT04925986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799687|NCT04695054|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64799688|NCT04695054|Anesthetics, Local|anesthetics, local|mesh-ancestor
64799689|NCT04695054|Anesthetics|anesthetics|mesh-ancestor
64799690|NCT04695054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64799691|NCT04695054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799692|NCT04695054|Sensory System Agents|sensory system agents|mesh-ancestor
64799693|NCT04695054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64799694|NCT04695054|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64319396|NCT04099355|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64319397|NCT04099355|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64319398|NCT04099355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64319399|NCT04099355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319401|NCT04099355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64319402|NCT02174575|Sevoflurane|sevoflurane|mesh-list
64319403|NCT02174575|Desflurane|desflurane|mesh-list
64319404|NCT02174575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64319405|NCT02174575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64319406|NCT02174575|Anesthetics, General|anesthetics, general|mesh-ancestor
64319407|NCT02174575|Anesthetics|anesthetics|mesh-ancestor
64799731|NCT04415333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64799732|NCT04415333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799733|NCT04415333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799734|NCT04093596|Cyclophosphamide|cyclophosphamide|mesh-list
64799735|NCT04093596|Fludarabine|fludarabine|mesh-list
64799736|NCT04093596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64799737|NCT04093596|Immunologic Factors|immunologic factors|mesh-ancestor
64799739|NCT04093596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64799796|NCT03107611|Dermatologic Agents|dermatologic agents|mesh-ancestor
64799797|NCT03107611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64799798|NCT03107611|Immunologic Factors|immunologic factors|mesh-ancestor
64799799|NCT03107611|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64799800|NCT03107611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799801|NCT03107611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799802|NCT03040726|Palonosetron|palonosetron|mesh-list
64799803|NCT03040726|Antiemetics|antiemetics|mesh-ancestor
64799804|NCT03040726|Autonomic Agents|autonomic agents|mesh-ancestor
64799805|NCT03040726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64799806|NCT03040726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799807|NCT03040726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64799808|NCT03040726|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64799809|NCT03040726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64799855|NCT00667329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799856|NCT00667329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319409|NCT02174575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319411|NCT03751397|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64319412|NCT03751397|Protease Inhibitors|protease inhibitors|mesh-ancestor
64319413|NCT03751397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319414|NCT03751397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319415|NCT02176681|Vildagliptin|vildagliptin|mesh-list
64319416|NCT02176681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64319417|NCT02176681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319418|NCT02176681|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64382157|NCT02422121|RNS60|rns60|mesh-list
64799857|NCT00667329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64799858|NCT00667329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64799859|NCT00492167|Antibodies|antibodies|mesh-list
64799860|NCT00492167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64799861|NCT00492167|Immunologic Factors|immunologic factors|mesh-ancestor
64799862|NCT00492167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799863|NCT05274438|Imatinib Mesylate|imatinib mesylate|mesh-list
64799864|NCT05274438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799919|NCT05273944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64799920|NCT05273944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64799922|NCT05273944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799923|NCT05273528|Vaccines|vaccines|mesh-list
64799924|NCT05273528|Immunologic Factors|immunologic factors|mesh-ancestor
64799925|NCT05273528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799926|NCT05273398|Diazepam|diazepam|mesh-list
64747857|NCT01390584|Antimitotic Agents|antimitotic agents|mesh-ancestor
64747858|NCT01390584|Mitosis Modulators|mitosis modulators|mesh-ancestor
64359898|NCT05135013|Estradiol|estradiol|mesh-list
64323285|NCT03165123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64323287|NCT01131169|Fludarabine|fludarabine|mesh-list
64323288|NCT01131169|Fludarabine phosphate|fludarabine phosphate|mesh-list
64323289|NCT01131169|Melphalan|melphalan|mesh-list
64323290|NCT01131169|Busulfan|busulfan|mesh-list
64323291|NCT01131169|Lenograstim|lenograstim|mesh-list
64323292|NCT01131169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64799927|NCT05273398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64319420|NCT02176681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319421|NCT02176681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319422|NCT02179099|Botulinum Toxins|botulinum toxins|mesh-list
64319423|NCT02179099|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64319424|NCT02179099|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64319425|NCT02179099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64799928|NCT05273398|Anticonvulsants|anticonvulsants|mesh-ancestor
64799929|NCT05273398|Antiemetics|antiemetics|mesh-ancestor
64799930|NCT05273398|Autonomic Agents|autonomic agents|mesh-ancestor
64799931|NCT05273398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64799932|NCT05273398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64799933|NCT05273398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64799934|NCT05273398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64799935|NCT05273398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64799979|NCT05271448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64799980|NCT05271448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64799981|NCT05271448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64799982|NCT05271448|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64319445|NCT02576990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64319446|NCT02576990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319447|NCT03538171|Exemestane|exemestane|mesh-list
64319448|NCT03538171|Entinostat|entinostat|mesh-list
64799983|NCT05271448|Protease Inhibitors|protease inhibitors|mesh-ancestor
64799984|NCT05271448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64799985|NCT05271370|Leronlimab|leronlimab|mesh-list
64799986|NCT05271370|HIV Antibodies|hiv antibodies|mesh-list
64799987|NCT05271370|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64799988|NCT05271370|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64799989|NCT05271370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747859|NCT01390584|Keratolytic Agents|keratolytic agents|mesh-ancestor
64747860|NCT01390584|Dermatologic Agents|dermatologic agents|mesh-ancestor
64747862|NCT01408914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64747863|NCT01408914|Antitubercular Agents|antitubercular agents|mesh-ancestor
64747864|NCT01408914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64747865|NCT01408914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64747866|NCT01408914|Leprostatic Agents|leprostatic agents|mesh-ancestor
64747867|NCT01408914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64747868|NCT01408914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440898|NCT01745380|Sympathomimetics|sympathomimetics|mesh-ancestor
64799990|NCT05271370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64800042|NCT05271058|Protease Inhibitors|protease inhibitors|mesh-ancestor
64800043|NCT05271058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800044|NCT05271058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319450|NCT03538171|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64319451|NCT03538171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64319452|NCT03538171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319453|NCT03538171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319454|NCT03538171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64319455|NCT03538171|Hormone Antagonists|hormone antagonists|mesh-ancestor
64319456|NCT03538171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64319457|NCT03538171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319458|NCT03538171|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64319459|NCT05312216|Durvalumab|durvalumab|mesh-list
64319460|NCT05312216|Lenvatinib|lenvatinib|mesh-list
64319461|NCT05312216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64319462|NCT05312216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319463|NCT05312216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64319464|NCT05312216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382287|NCT02140060|Travoprost|travoprost|mesh-list
64800045|NCT05271058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64800046|NCT05271058|Immunologic Factors|immunologic factors|mesh-ancestor
64800047|NCT05271045|Vitamin D|vitamin d|mesh-list
64800048|NCT05271045|Vitamin A|vitamin a|mesh-list
64800049|NCT05271045|Vitamins|vitamins|mesh-ancestor
64800050|NCT05271045|Micronutrients|micronutrients|mesh-ancestor
64747872|NCT01408914|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64747873|NCT01408914|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64747874|NCT01408914|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64747875|NCT01408914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64747876|NCT04044222|Carboplatin|carboplatin|mesh-list
64747877|NCT04044222|Etoposide|etoposide|mesh-list
64747878|NCT04044222|Etoposide phosphate|etoposide phosphate|mesh-list
64747879|NCT04044222|Ifosfamide|ifosfamide|mesh-list
64359916|NCT05135013|Progestins|progestins|mesh-ancestor
64323298|NCT01131169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323299|NCT01131169|Antiviral Agents|antiviral agents|mesh-ancestor
64323300|NCT01131169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64323301|NCT01131169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64747880|NCT04044222|Isophosphamide mustard|isophosphamide mustard|mesh-list
64747881|NCT04044222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747882|NCT04044222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64747883|NCT04044222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64747884|NCT04044222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64747885|NCT04044222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747886|NCT04044222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747887|NCT04044222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64747888|NCT04044222|Alkylating Agents|alkylating agents|mesh-ancestor
64747889|NCT01390428|Grazoprevir|grazoprevir|mesh-list
64441092|NCT02269670|Tamoxifen|tamoxifen|mesh-list
64800051|NCT05271045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800052|NCT05271045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64800053|NCT05270967|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64800054|NCT05270967|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64800055|NCT05270967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800056|NCT05270434|Dipyrone|dipyrone|mesh-list
64319465|NCT05312216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319466|NCT02256319|Dexmedetomidine|dexmedetomidine|mesh-list
64319467|NCT02256319|Propofol|propofol|mesh-list
64319468|NCT02256319|Imidazole|imidazole|mesh-list
64319469|NCT02256319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64319470|NCT02256319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64319471|NCT02256319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319472|NCT02256319|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64319473|NCT02256319|Anesthetics, General|anesthetics, general|mesh-ancestor
64319474|NCT02256319|Anesthetics|anesthetics|mesh-ancestor
64319475|NCT02256319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64319476|NCT02256319|Analgesics|analgesics|mesh-ancestor
64319477|NCT02256319|Sensory System Agents|sensory system agents|mesh-ancestor
64319478|NCT02256319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800057|NCT05270434|Meperidine|meperidine|mesh-list
64800102|NCT05253846|Irinotecan|irinotecan|mesh-list
64800103|NCT05253846|Antimetabolites|antimetabolites|mesh-ancestor
64800104|NCT05253846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800105|NCT05253846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64800106|NCT05253846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800107|NCT05253846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64800108|NCT05253846|Immunologic Factors|immunologic factors|mesh-ancestor
64800170|NCT05209841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800184|NCT05173142|Gemcitabine|gemcitabine|mesh-list
64800185|NCT05173142|Docetaxel|docetaxel|mesh-list
64800186|NCT05173142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800187|NCT05173142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64800188|NCT05173142|Antimetabolites|antimetabolites|mesh-ancestor
64800189|NCT05173142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800190|NCT05173142|Antiviral Agents|antiviral agents|mesh-ancestor
64800191|NCT05173142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64800192|NCT05173142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800199|NCT05166746|Clindamycin|clindamycin|mesh-list
64800234|NCT05142267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800235|NCT05142267|Analgesics|analgesics|mesh-ancestor
64800236|NCT05142267|Sensory System Agents|sensory system agents|mesh-ancestor
64800237|NCT05142267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800238|NCT05142267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64800239|NCT05138029|Dexamethasone|dexamethasone|mesh-list
64800240|NCT05138029|Dexamethasone acetate|dexamethasone acetate|mesh-list
64800241|NCT05138029|Ranibizumab|ranibizumab|mesh-list
64800242|NCT05138029|BB 1101|bb 1101|mesh-list
64319480|NCT02256319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64319481|NCT02256319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64319482|NCT02256319|Adrenergic Agents|adrenergic agents|mesh-ancestor
64319483|NCT02256319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64319484|NCT02256319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319485|NCT02256319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319486|NCT04510285|Pembrolizumab|pembrolizumab|mesh-list
64319487|NCT04510285|Trastuzumab|trastuzumab|mesh-list
64800243|NCT05138029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64800301|NCT05067439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64800302|NCT05067439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64800303|NCT05067439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64800304|NCT05067439|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64800305|NCT05067439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64800306|NCT05067439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64800307|NCT05067439|Antiviral Agents|antiviral agents|mesh-ancestor
64800308|NCT05067439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64319493|NCT05450432|Sensory System Agents|sensory system agents|mesh-ancestor
64319494|NCT05450432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64319495|NCT05450432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319496|NCT05450432|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64319497|NCT05450432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64319498|NCT05450432|Anesthetics, General|anesthetics, general|mesh-ancestor
64319500|NCT05450432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64319501|NCT05450432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64800309|NCT05067439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64800310|NCT05067439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64800311|NCT05067439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64800312|NCT05067439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64747911|NCT01405950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64800313|NCT05067439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64800362|NCT05045313|Probenecid|probenecid|mesh-list
64800363|NCT05045313|Digoxin|digoxin|mesh-list
64800364|NCT05045313|Warfarin|warfarin|mesh-list
64800365|NCT05045313|Anticoagulants|anticoagulants|mesh-ancestor
64319502|NCT05450432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64319503|NCT05450432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64319504|NCT05450432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319505|NCT05450432|Antidepressive Agents|antidepressive agents|mesh-ancestor
64319507|NCT02179255|Hormones|hormones|mesh-list
64319508|NCT02179255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64319509|NCT02179255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64319510|NCT02179255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319512|NCT02182063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319513|NCT02182063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64319515|NCT02182063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319516|NCT02182141|Nintedanib|nintedanib|mesh-list
64382342|NCT02139280|Alkylating Agents|alkylating agents|mesh-ancestor
64319517|NCT02182141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800367|NCT05045313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64800368|NCT05045313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800369|NCT05045313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800370|NCT05045313|Protective Agents|protective agents|mesh-ancestor
64800371|NCT05045313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800430|NCT04801641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800431|NCT04801641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800434|NCT04801641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64800436|NCT04801641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64800502|NCT04530006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64800503|NCT04530006|Antiviral Agents|antiviral agents|mesh-ancestor
64800504|NCT04530006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64800505|NCT04530006|Dopamine Agents|dopamine agents|mesh-ancestor
64800506|NCT04530006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64569115|NCT02352337|Folfirinox|folfirinox|mesh-list
64319518|NCT02182141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64319519|NCT02182141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319520|NCT02182141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319521|NCT02182219|Nintedanib|nintedanib|mesh-list
64319522|NCT02182219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319523|NCT02182219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64319524|NCT02182219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319525|NCT02182219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319526|NCT05303480|Mechlorethamine|mechlorethamine|mesh-list
64319527|NCT05303480|Alkylating Agents|alkylating agents|mesh-ancestor
64319528|NCT05303480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319529|NCT05303480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64319530|NCT05303480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319531|NCT02182375|Raltegravir Potassium|raltegravir potassium|mesh-list
64319533|NCT02182375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64319534|NCT02182375|Antiviral Agents|antiviral agents|mesh-ancestor
64319535|NCT02182375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64319536|NCT02182375|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64319537|NCT02182375|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64319538|NCT02182375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319539|NCT02182375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319540|NCT02179567|Bevacizumab|bevacizumab|mesh-list
64319541|NCT02179567|Docetaxel|docetaxel|mesh-list
64800508|NCT04530006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800509|NCT04530006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64800511|NCT04530006|Sensory System Agents|sensory system agents|mesh-ancestor
64800512|NCT04530006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800513|NCT04496245|Broncho-Vaxom|broncho-vaxom|mesh-list
64800514|NCT04496245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64800515|NCT04496245|Immunologic Factors|immunologic factors|mesh-ancestor
64800516|NCT04496245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800517|NCT04476745|Vitamin D|vitamin d|mesh-list
64800561|NCT04324021|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64800563|NCT04302168|Choline|choline|mesh-list
64800564|NCT04302168|Lipotropic Agents|lipotropic agents|mesh-ancestor
64800565|NCT04302168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64800566|NCT04302168|Antimetabolites|antimetabolites|mesh-ancestor
64800567|NCT04302168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800568|NCT04302168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64800569|NCT04302168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64800570|NCT04302168|Nootropic Agents|nootropic agents|mesh-ancestor
64800571|NCT04301271|Simvastatin|simvastatin|mesh-list
64319542|NCT02179567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64319543|NCT02179567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319544|NCT02179567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64319545|NCT02179567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64319546|NCT02179567|Growth Substances|growth substances|mesh-ancestor
64319547|NCT02179567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382388|NCT04735354|Valsartan|valsartan|mesh-list
64800572|NCT04301271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64800573|NCT04301271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64800574|NCT04301271|Antimetabolites|antimetabolites|mesh-ancestor
64800575|NCT04301271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64800576|NCT04301271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64800577|NCT04301271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64800578|NCT04301271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64800579|NCT04245644|Aspirin|aspirin|mesh-list
64800580|NCT04245644|Metformin|metformin|mesh-list
64800617|NCT04095104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800618|NCT04095104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64800619|NCT04095104|Appetite Depressants|appetite depressants|mesh-ancestor
64800620|NCT04095104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64800621|NCT04095104|Sympathomimetics|sympathomimetics|mesh-ancestor
64748015|NCT01402284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64800622|NCT04095104|Autonomic Agents|autonomic agents|mesh-ancestor
64800687|NCT03867682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64800688|NCT03867682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800689|NCT03867682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64800690|NCT03867682|Diuretics|diuretics|mesh-ancestor
64800691|NCT03867682|Natriuretic Agents|natriuretic agents|mesh-ancestor
64800692|NCT03867682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64800693|NCT03858621|Fentanyl|fentanyl|mesh-list
64800694|NCT03858621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64800695|NCT03858621|Narcotics|narcotics|mesh-ancestor
64319548|NCT02179567|Growth Inhibitors|growth inhibitors|mesh-ancestor
64319549|NCT02179567|Tubulin Modulators|tubulin modulators|mesh-ancestor
64319550|NCT02179567|Antimitotic Agents|antimitotic agents|mesh-ancestor
64319551|NCT02179567|Mitosis Modulators|mitosis modulators|mesh-ancestor
64319552|NCT02179567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319554|NCT02182453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64319555|NCT02182453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319556|NCT02182453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64319557|NCT02182453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319558|NCT02182531|Pseudoephedrine|pseudoephedrine|mesh-list
64319559|NCT02182531|Ephedrine|ephedrine|mesh-list
64319560|NCT02182531|Epinastine|epinastine|mesh-list
64319561|NCT02182531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64319562|NCT02182531|Autonomic Agents|autonomic agents|mesh-ancestor
64319563|NCT02182531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64319564|NCT02182531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319565|NCT02182531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64382389|NCT04735354|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64800696|NCT03858621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64800697|NCT03858621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800698|NCT03858621|Analgesics|analgesics|mesh-ancestor
64800699|NCT03858621|Sensory System Agents|sensory system agents|mesh-ancestor
64800700|NCT03858621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64800701|NCT03858621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64800702|NCT03858621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64800703|NCT03858621|Anesthetics, General|anesthetics, general|mesh-ancestor
64800704|NCT03858621|Anesthetics|anesthetics|mesh-ancestor
64800706|NCT03845270|Trastuzumab|trastuzumab|mesh-list
64800707|NCT03845270|Pertuzumab|pertuzumab|mesh-list
64800708|NCT03845270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800709|NCT03845270|Tubulin Modulators|tubulin modulators|mesh-ancestor
64800714|NCT03777462|Gemcitabine|gemcitabine|mesh-list
64800740|NCT03758170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64319566|NCT02182531|Respiratory System Agents|respiratory system agents|mesh-ancestor
64319569|NCT02182531|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64319570|NCT02182531|Sympathomimetics|sympathomimetics|mesh-ancestor
64319571|NCT02182531|Adrenergic Agents|adrenergic agents|mesh-ancestor
64319572|NCT02182531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64319573|NCT02182531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319574|NCT02182531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64319575|NCT02182531|Histamine Antagonists|histamine antagonists|mesh-ancestor
64319576|NCT02182531|Histamine Agents|histamine agents|mesh-ancestor
64319577|NCT01990352|Doxorubicin|doxorubicin|mesh-list
64319578|NCT01990352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64319579|NCT01990352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64319580|NCT01990352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319581|NCT01990352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64319582|NCT01990352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64800741|NCT03758170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64800742|NCT03758170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800743|NCT03733119|TIC10 compound|tic10 compound|mesh-list
64800744|NCT03733119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800745|NCT03716921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64800746|NCT03716921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64800747|NCT03716921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64800748|NCT03716921|Antitubercular Agents|antitubercular agents|mesh-ancestor
64800749|NCT03705962|Tobramycin|tobramycin|mesh-list
64800750|NCT03705962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64800751|NCT03705962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64800752|NCT03705338|Propofol|propofol|mesh-list
64800753|NCT03705338|Anesthetics|anesthetics|mesh-list
64800754|NCT03705338|Anesthetics, General|anesthetics, general|mesh-list
64800755|NCT03705338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64800759|NCT03704285|Propofol|propofol|mesh-list
64800800|NCT03659799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64800801|NCT03659799|Insulin Aspart|insulin aspart|mesh-list
64800802|NCT03659799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64319583|NCT01990352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319584|NCT01990352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319585|NCT02177305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64319586|NCT02177305|Tiotropium Bromide|tiotropium bromide|mesh-list
64319587|NCT02177305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64319589|NCT02177305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64319590|NCT02177305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319591|NCT02177305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64319592|NCT02177305|Respiratory System Agents|respiratory system agents|mesh-ancestor
64319593|NCT02177305|Parasympatholytics|parasympatholytics|mesh-ancestor
64319594|NCT02177305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64319595|NCT02177305|Cholinergic Agents|cholinergic agents|mesh-ancestor
64319596|NCT02177305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64319597|NCT02177305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319598|NCT02182765|Nevirapine|nevirapine|mesh-list
64319599|NCT02182765|Abacavir|abacavir|mesh-list
64319600|NCT02182765|Amprenavir|amprenavir|mesh-list
64319601|NCT02182765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64319602|NCT02182765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64800804|NCT03620903|Rituximab|rituximab|mesh-list
64800805|NCT03620903|Bortezomib|bortezomib|mesh-list
64800807|NCT03620903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64800870|NCT03360214|Ropivacaine|ropivacaine|mesh-list
64800871|NCT03360214|Anesthetics, Local|anesthetics, local|mesh-ancestor
64800872|NCT03360214|Anesthetics|anesthetics|mesh-ancestor
64800873|NCT03360214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64800874|NCT03360214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64800875|NCT03360214|Sensory System Agents|sensory system agents|mesh-ancestor
64800938|NCT03276533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64800939|NCT03276533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64748137|NCT01387542|Serotonin Agents|serotonin agents|mesh-ancestor
64800940|NCT03276533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64800941|NCT03276533|Adrenergic Agents|adrenergic agents|mesh-ancestor
64800942|NCT03276533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64800944|NCT03254394|Anesthetics, Local|anesthetics, local|mesh-ancestor
64800945|NCT03254394|Anesthetics|anesthetics|mesh-ancestor
64800946|NCT03254394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64800955|NCT03203876|Nivolumab|nivolumab|mesh-list
64801004|NCT03071601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801005|NCT03071601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64801006|NCT03071601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64801011|NCT03071601|Autonomic Agents|autonomic agents|mesh-ancestor
64801076|NCT03012672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64801077|NCT03012672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801078|NCT03011775|Aspirin|aspirin|mesh-list
64801079|NCT03011775|Pioglitazone|pioglitazone|mesh-list
64319603|NCT02182765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319604|NCT02182765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319605|NCT02182765|Antiviral Agents|antiviral agents|mesh-ancestor
64319606|NCT02182765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64319607|NCT02182765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64319608|NCT02182765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64319609|NCT02182765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64319610|NCT02182765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64801080|NCT03011775|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64801082|NCT03011775|Bisoprolol|bisoprolol|mesh-list
64801083|NCT03011775|Isosorbide|isosorbide|mesh-list
64801084|NCT03011775|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64801085|NCT03011775|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64801086|NCT03011775|Vasodilator Agents|vasodilator agents|mesh-list
64801087|NCT03011775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64801088|NCT03011775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64801091|NCT03011775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64801139|NCT02924480|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64319611|NCT02182765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64319612|NCT02182765|Antitubercular Agents|antitubercular agents|mesh-ancestor
64319613|NCT02182765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64319614|NCT02182765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64319615|NCT02182765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64319617|NCT02179645|Celecoxib|celecoxib|mesh-list
64319618|NCT02179645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64319619|NCT02179645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64319620|NCT02179645|Analgesics|analgesics|mesh-ancestor
64319621|NCT02179645|Sensory System Agents|sensory system agents|mesh-ancestor
64319622|NCT02179645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64801140|NCT02924480|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64801141|NCT02924480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64801142|NCT02924480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801144|NCT02924064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64801145|NCT02924064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801146|NCT02889900|Olaparib|olaparib|mesh-list
64801147|NCT02889900|Cediranib|cediranib|mesh-list
64801161|NCT02873819|Sargramostim|sargramostim|mesh-list
64319623|NCT02179645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319624|NCT02179645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64319626|NCT02179645|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64319627|NCT02179645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64319628|NCT02179645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319629|NCT02179645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801205|NCT02729701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64801206|NCT02729701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801207|NCT02729701|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64801208|NCT02729701|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64801209|NCT02729701|Hormone Antagonists|hormone antagonists|mesh-ancestor
64801210|NCT02729701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64801211|NCT02719314|Methylprednisolone|methylprednisolone|mesh-list
64801212|NCT02719314|Glucocorticoids|glucocorticoids|mesh-list
64801213|NCT02719314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64801214|NCT02719314|Antiemetics|antiemetics|mesh-ancestor
64801215|NCT02719314|Autonomic Agents|autonomic agents|mesh-ancestor
64801216|NCT02719314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64801217|NCT02719314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801218|NCT02719314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64801219|NCT02719314|Hormones|hormones|mesh-ancestor
64801220|NCT02719314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64801221|NCT02719314|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64801222|NCT02719314|Protective Agents|protective agents|mesh-ancestor
64801261|NCT02684253|Nivolumab|nivolumab|mesh-list
64801262|NCT02684253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64801263|NCT02684253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64801264|NCT02684253|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64382530|NCT02099110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64319630|NCT03537157|Rifaximin|rifaximin|mesh-list
64319631|NCT03537157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64319632|NCT03537157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64319633|NCT03537157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64319635|NCT01606202|Analgesics|analgesics|mesh-ancestor
64319636|NCT01606202|Sensory System Agents|sensory system agents|mesh-ancestor
64382538|NCT02098876|Everolimus|everolimus|mesh-list
64801265|NCT02684253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801266|NCT02666794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64801267|NCT02666794|Sufentanil|sufentanil|mesh-list
64801268|NCT02666794|Morphine|morphine|mesh-list
64801330|NCT02636322|Tubulin Modulators|tubulin modulators|mesh-ancestor
64801331|NCT02636322|Antimitotic Agents|antimitotic agents|mesh-ancestor
64801332|NCT02636322|Mitosis Modulators|mitosis modulators|mesh-ancestor
64801333|NCT02636322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64801334|NCT02636322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64801335|NCT02636322|Growth Substances|growth substances|mesh-ancestor
64801336|NCT02636322|Growth Inhibitors|growth inhibitors|mesh-ancestor
64801337|NCT02636322|Keratolytic Agents|keratolytic agents|mesh-ancestor
64801338|NCT02636322|Dermatologic Agents|dermatologic agents|mesh-ancestor
64801340|NCT02619552|Budesonide|budesonide|mesh-list
64801341|NCT02619552|Adalimumab|adalimumab|mesh-list
64801342|NCT02619552|Infliximab|infliximab|mesh-list
64801398|NCT02575963|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64801399|NCT02575963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64801400|NCT02575963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64801405|NCT02539225|Paclitaxel|paclitaxel|mesh-list
64801471|NCT02293109|Vincristine|vincristine|mesh-list
64801472|NCT02293109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64801473|NCT02293109|Prednisolone phosphate|prednisolone phosphate|mesh-list
64801474|NCT02293109|Levoleucovorin|levoleucovorin|mesh-list
64801475|NCT02293109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64801476|NCT02293109|Immunologic Factors|immunologic factors|mesh-ancestor
64801477|NCT02293109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801478|NCT02293109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64801538|NCT01982448|Tubulin Modulators|tubulin modulators|mesh-ancestor
64801539|NCT01982448|Antimitotic Agents|antimitotic agents|mesh-ancestor
64382552|NCT02571777|Fluticasone|fluticasone|mesh-list
64801541|NCT01982448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801543|NCT01951469|Gefitinib|gefitinib|mesh-list
64801606|NCT01595620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64801608|NCT01595620|Sensory System Agents|sensory system agents|mesh-ancestor
64801609|NCT01595620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64801610|NCT01595620|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64801611|NCT01595620|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64801612|NCT01595620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64801613|NCT01595620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801614|NCT01595620|Hormones|hormones|mesh-ancestor
64801615|NCT01595620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64801616|NCT01595620|Antipruritics|antipruritics|mesh-ancestor
64801617|NCT01595620|Dermatologic Agents|dermatologic agents|mesh-ancestor
64801618|NCT01591629|Dronabinol|dronabinol|mesh-list
64801619|NCT01591629|Naloxone|naloxone|mesh-list
64801620|NCT01591629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64801621|NCT01591629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801665|NCT01360593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64801666|NCT01360593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801667|NCT01360593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64801668|NCT01360593|Immunologic Factors|immunologic factors|mesh-ancestor
64801669|NCT01360593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801671|NCT01354977|Antioxidants|antioxidants|mesh-ancestor
64319637|NCT01606202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64319638|NCT01606202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319640|NCT05529290|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
64319642|NCT05529290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64319643|NCT05529290|Analgesics|analgesics|mesh-ancestor
64319644|NCT05529290|Sensory System Agents|sensory system agents|mesh-ancestor
64319645|NCT05529290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64382647|NCT03180125|Anesthetics, Local|anesthetics, local|mesh-ancestor
64384022|NCT02560389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64384023|NCT02560389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384024|NCT02560389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384025|NCT02564211|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64384026|NCT02564211|Ipragliflozin|ipragliflozin|mesh-list
64384027|NCT02564211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64384028|NCT02564211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384029|NCT02564211|Incretins|incretins|mesh-ancestor
64384074|NCT05500677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384075|NCT05500677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64384077|NCT05500677|Analgesics|analgesics|mesh-ancestor
64384078|NCT05500677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64384079|NCT05500677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64384080|NCT05500677|Anesthetics, General|anesthetics, general|mesh-ancestor
64384082|NCT04511013|Ipilimumab|ipilimumab|mesh-list
64384094|NCT02093026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384096|NCT02093026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64384097|NCT02093026|Abortifacient Agents|abortifacient agents|mesh-ancestor
64384098|NCT02093026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64384099|NCT02093026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64384100|NCT02093026|Antimetabolites|antimetabolites|mesh-ancestor
64384101|NCT02093026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384102|NCT02093026|Dermatologic Agents|dermatologic agents|mesh-ancestor
64384103|NCT02093026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384104|NCT02093026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64384105|NCT02093026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64384106|NCT02093026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64384107|NCT02093026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64384108|NCT02093026|Antiemetics|antiemetics|mesh-ancestor
64384109|NCT02093026|Autonomic Agents|autonomic agents|mesh-ancestor
64801672|NCT01354977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64801673|NCT01354977|Protective Agents|protective agents|mesh-ancestor
64801674|NCT01354977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801675|NCT01354977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64801677|NCT01334606|Insulin|insulin|mesh-list
64801727|NCT00678730|Dronabinol|dronabinol|mesh-list
64801728|NCT00678730|Hallucinogens|hallucinogens|mesh-ancestor
64801729|NCT00678730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801730|NCT00678730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64801731|NCT00678730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64801739|NCT00678730|Hormones|hormones|mesh-ancestor
64801795|NCT00290251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801796|NCT00290251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64801797|NCT00066963|Fluorides|fluorides|mesh-list
64801798|NCT00066963|Fluorides, Topical|fluorides, topical|mesh-list
64801799|NCT00066963|Cariostatic Agents|cariostatic agents|mesh-ancestor
64801800|NCT00066963|Protective Agents|protective agents|mesh-ancestor
64801801|NCT00066963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801864|NCT01398046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64801865|NCT01398046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64801866|NCT01398046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64801867|NCT01398046|Lipotropic Agents|lipotropic agents|mesh-ancestor
64801868|NCT01398046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64801869|NCT01398046|Antimetabolites|antimetabolites|mesh-ancestor
64801870|NCT01398046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64801871|NCT01398072|Azithromycin|azithromycin|mesh-list
64801872|NCT01398072|Moxifloxacin|moxifloxacin|mesh-list
64801873|NCT01398072|Doxycycline|doxycycline|mesh-list
64801874|NCT01398072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64801930|NCT01398267|Protective Agents|protective agents|mesh-ancestor
64382652|NCT03180125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64319646|NCT05529290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319648|NCT05529290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64319649|NCT05529290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64319650|NCT05529290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64319651|NCT05529290|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64319652|NCT05529290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319653|NCT05529290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319654|NCT05528588|Furosemide|furosemide|mesh-list
64319656|NCT05528588|Natriuretic Agents|natriuretic agents|mesh-ancestor
64319657|NCT05528588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319658|NCT05528588|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64801931|NCT01398267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64801932|NCT01398293|Ritonavir|ritonavir|mesh-list
64801933|NCT01398293|Moxifloxacin|moxifloxacin|mesh-list
64801934|NCT01398293|Lactams|lactams|mesh-list
64801935|NCT01398293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64801936|NCT01398293|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64801937|NCT01398293|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64801996|NCT01398618|Rifampin|rifampin|mesh-list
64801997|NCT01398618|Isoniazid|isoniazid|mesh-list
64801998|NCT01398618|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64801999|NCT01398618|Antitubercular Agents|antitubercular agents|mesh-ancestor
64802000|NCT01398618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64802001|NCT01398618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64802002|NCT01398618|Leprostatic Agents|leprostatic agents|mesh-ancestor
64802065|NCT01399346|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64802066|NCT01399346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64802067|NCT01399346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802068|NCT01399450|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64319659|NCT05528588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64319660|NCT05528588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319662|NCT03536611|Dabigatran|dabigatran|mesh-list
64319663|NCT03536611|Anticoagulants|anticoagulants|mesh-ancestor
64319664|NCT03536611|Antithrombins|antithrombins|mesh-ancestor
64319665|NCT03536611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64319666|NCT03536611|Protease Inhibitors|protease inhibitors|mesh-ancestor
64319667|NCT03536611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319668|NCT03536611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802069|NCT01399450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64802070|NCT01399450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64748197|NCT01384734|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64802071|NCT01399450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64802133|NCT01400100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64802134|NCT01400100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64802135|NCT01400100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64802136|NCT01400100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802203|NCT01400633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64319669|NCT02630459|Erenumab|erenumab|mesh-list
64319670|NCT02630459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64319671|NCT02630459|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64319672|NCT02630459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319673|NCT02630459|Analgesics|analgesics|mesh-ancestor
64319674|NCT02630459|Sensory System Agents|sensory system agents|mesh-ancestor
64319675|NCT02630459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64382737|NCT02422823|Sympathomimetics|sympathomimetics|mesh-ancestor
64802205|NCT01400633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802206|NCT01400633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802207|NCT01400633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802208|NCT01400646|Vitamins|vitamins|mesh-list
64802209|NCT01400646|Vitamin K|vitamin k|mesh-list
64802210|NCT01400646|Warfarin|warfarin|mesh-list
64802211|NCT01400646|Rivaroxaban|rivaroxaban|mesh-list
64802212|NCT01400646|Micronutrients|micronutrients|mesh-ancestor
64802213|NCT01400646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802223|NCT01400646|Hemostatics|hemostatics|mesh-ancestor
64802267|NCT01400750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802268|NCT01400750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64802269|NCT01400750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64802271|NCT01400789|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
64802272|NCT01400789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64802273|NCT01400789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802274|NCT01400802|Insulin Lispro|insulin lispro|mesh-list
64802275|NCT01400802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64802276|NCT01400802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802277|NCT01400828|Desloratadine|desloratadine|mesh-list
64802278|NCT01400828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64802279|NCT01400828|Cholinergic Agents|cholinergic agents|mesh-ancestor
64802280|NCT01400828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64802281|NCT01400828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802287|NCT01400867|Vancomycin|vancomycin|mesh-list
64802326|NCT01401075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64802327|NCT01401179|Clarithromycin|clarithromycin|mesh-list
64802329|NCT01401179|Erythromycin|erythromycin|mesh-list
64416715|NCT04852315|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64382745|NCT02422589|Warfarin|warfarin|mesh-list
64802330|NCT01401179|Erythromycin Estolate|erythromycin estolate|mesh-list
64748307|NCT01382940|Antipyretics|antipyretics|mesh-ancestor
64802331|NCT01401179|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64802332|NCT01401179|Erythromycin stearate|erythromycin stearate|mesh-list
64802333|NCT01401179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64802334|NCT01401179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64802335|NCT01401179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64802336|NCT01401179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802337|NCT01401179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802338|NCT01401179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64802339|NCT01401179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64319676|NCT02630459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319677|NCT02630459|Immunologic Factors|immunologic factors|mesh-ancestor
64319678|NCT02183077|Meloxicam|meloxicam|mesh-list
64319679|NCT02183077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64319680|NCT02183077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64319681|NCT02183077|Analgesics|analgesics|mesh-ancestor
64319682|NCT02183077|Sensory System Agents|sensory system agents|mesh-ancestor
64802387|NCT01401803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64802388|NCT01401803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802390|NCT01401933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64802391|NCT01401933|Antitubercular Agents|antitubercular agents|mesh-ancestor
64802392|NCT01401933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64802393|NCT01401933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64802394|NCT01401933|Leprostatic Agents|leprostatic agents|mesh-ancestor
64802395|NCT01401933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64802396|NCT01401933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319684|NCT02183077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319685|NCT02183077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64319686|NCT02183077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64319687|NCT02183077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64319688|NCT02183077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64319689|NCT02183077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748337|NCT01395888|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64748338|NCT01395888|Parasympatholytics|parasympatholytics|mesh-ancestor
64319690|NCT02183077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319691|NCT02183155|Indomethacin|indomethacin|mesh-list
64319692|NCT02183155|Meloxicam|meloxicam|mesh-list
64319693|NCT02183155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64319694|NCT02183155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64319695|NCT02183155|Analgesics|analgesics|mesh-ancestor
64802397|NCT01401933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802398|NCT01401933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64802399|NCT01401933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64570999|NCT02053909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64802400|NCT01401933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64802401|NCT01401933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64802402|NCT01401933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64802403|NCT01401933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64802404|NCT01402024|Aprepitant|aprepitant|mesh-list
64802405|NCT01402024|Antiemetics|antiemetics|mesh-ancestor
64802413|NCT01402076|Rosiglitazone|rosiglitazone|mesh-list
64802438|NCT01402089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64802439|NCT01402089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64802440|NCT01402089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64319696|NCT02183155|Sensory System Agents|sensory system agents|mesh-ancestor
64319697|NCT02183155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64319698|NCT02183155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319699|NCT02183155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64319700|NCT02183155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64319701|NCT02183155|Gout Suppressants|gout suppressants|mesh-ancestor
64319702|NCT02183155|Tocolytic Agents|tocolytic agents|mesh-ancestor
64319703|NCT02183155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64319704|NCT02183155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64319705|NCT02183155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319706|NCT02183155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319707|NCT02183155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64802441|NCT01402089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64802442|NCT01402089|Anesthetics, General|anesthetics, general|mesh-ancestor
64802444|NCT01402089|GABA Modulators|gaba modulators|mesh-ancestor
64802445|NCT01402089|GABA Agents|gaba agents|mesh-ancestor
64802446|NCT01402089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64748409|NCT01380990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748410|NCT01380990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64748411|NCT01380990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748412|NCT01380990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64802447|NCT01402089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802448|NCT01402089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802449|NCT01402089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64802450|NCT01402089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802451|NCT01402089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64802452|NCT01402089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64802497|NCT01402336|Luteolytic Agents|luteolytic agents|mesh-ancestor
64802498|NCT01402336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64802499|NCT01402336|Contraceptive Agents|contraceptive agents|mesh-ancestor
64802500|NCT01402336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64802501|NCT01402336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64802502|NCT01402336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64802503|NCT01402336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802504|NCT01402336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64802506|NCT01402336|Hormone Antagonists|hormone antagonists|mesh-ancestor
64802507|NCT01402479|Ramipril|ramipril|mesh-list
64802508|NCT01402479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64802509|NCT01402479|Protease Inhibitors|protease inhibitors|mesh-ancestor
64319708|NCT02177461|Telmisartan|telmisartan|mesh-list
64319709|NCT02177461|Clonidine|clonidine|mesh-list
64319710|NCT02177461|Enalapril|enalapril|mesh-list
64319711|NCT02177461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64319712|NCT02177461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64319713|NCT02177461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64319714|NCT02177461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319715|NCT02177461|Analgesics|analgesics|mesh-ancestor
64319716|NCT02177461|Sensory System Agents|sensory system agents|mesh-ancestor
64319717|NCT02177461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64319718|NCT02177461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319719|NCT02177461|Sympatholytics|sympatholytics|mesh-ancestor
64319720|NCT02177461|Autonomic Agents|autonomic agents|mesh-ancestor
64319721|NCT02177461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64319722|NCT02177461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64319723|NCT02177461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64319724|NCT02177461|Adrenergic Agents|adrenergic agents|mesh-ancestor
64319725|NCT02177461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64319726|NCT02177461|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64319727|NCT02177461|Protease Inhibitors|protease inhibitors|mesh-ancestor
64319728|NCT02177461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382842|NCT04482881|Abortifacient Agents|abortifacient agents|mesh-ancestor
64802511|NCT01402479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802512|NCT01402479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64802513|NCT01402583|Ribavirin|ribavirin|mesh-list
64802514|NCT01402583|Antimetabolites|antimetabolites|mesh-ancestor
64802515|NCT01402583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802516|NCT01402583|Antiviral Agents|antiviral agents|mesh-ancestor
64802517|NCT01402583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64802518|NCT01402596|Midazolam|midazolam|mesh-list
64802519|NCT01402596|Chloral Hydrate|chloral hydrate|mesh-list
64802524|NCT01402596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64802548|NCT01402674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64802549|NCT01402674|Adrenergic Agents|adrenergic agents|mesh-ancestor
64802550|NCT01402674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64319729|NCT03545243|Pantoprazole|pantoprazole|mesh-list
64319730|NCT03545243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64319731|NCT03545243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64319732|NCT03545243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64319733|NCT03545243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319734|NCT03545243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319735|NCT02183311|Linagliptin|linagliptin|mesh-list
64319736|NCT02183311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64319737|NCT02183311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319738|NCT02183311|Incretins|incretins|mesh-ancestor
64319739|NCT02183311|Hormones|hormones|mesh-ancestor
64319740|NCT02183311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64319741|NCT02183311|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64319742|NCT02183311|Protease Inhibitors|protease inhibitors|mesh-ancestor
64319743|NCT02183311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319744|NCT02183311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802551|NCT01402674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802553|NCT01402843|Pitavastatin|pitavastatin|mesh-list
64802618|NCT01403363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64802619|NCT01403363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64802620|NCT01403363|Anesthetics, General|anesthetics, general|mesh-ancestor
64802621|NCT01403363|Anesthetics|anesthetics|mesh-ancestor
64802622|NCT01403389|Eculizumab|eculizumab|mesh-list
64802623|NCT01403389|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64802690|NCT01403545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64802691|NCT01403545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802692|NCT01403545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64802693|NCT01403545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64802694|NCT01403545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802695|NCT01403545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64802696|NCT01403545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571313|NCT03047538|Amlodipine|amlodipine|mesh-list
64802698|NCT01403662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64802699|NCT01403662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64802752|NCT01404013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64319745|NCT05518526|Annamycin|annamycin|mesh-list
64319746|NCT05518526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64319747|NCT05518526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319748|NCT01464593|Doxorubicin|doxorubicin|mesh-list
64319749|NCT01464593|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64319750|NCT01464593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64319751|NCT01464593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319752|NCT01464593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64319753|NCT01464593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64319754|NCT01464593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748512|NCT03997266|Ampicillin|ampicillin|mesh-list
64319755|NCT01464593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319756|NCT02183389|Linagliptin|linagliptin|mesh-list
64319757|NCT02183389|Warfarin|warfarin|mesh-list
64802753|NCT01404013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802754|NCT01404104|Sirolimus|sirolimus|mesh-list
64802755|NCT01404104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64802756|NCT01404104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64802826|NCT01404312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64802827|NCT01404312|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64802828|NCT01404312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64802829|NCT01404312|Antimetabolites|antimetabolites|mesh-ancestor
64802830|NCT01404312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319758|NCT02183389|Anticoagulants|anticoagulants|mesh-ancestor
64319759|NCT02183389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64319760|NCT02183389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319761|NCT02183389|Incretins|incretins|mesh-ancestor
64319762|NCT02183389|Hormones|hormones|mesh-ancestor
64319763|NCT02183389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64319764|NCT02183389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64319765|NCT02183389|Protease Inhibitors|protease inhibitors|mesh-ancestor
64319766|NCT02183389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319767|NCT02183389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319768|NCT02177539|Phenylephrine|phenylephrine|mesh-list
64319769|NCT02177539|Oxymetazoline|oxymetazoline|mesh-list
64319770|NCT02177539|Tropicamide|tropicamide|mesh-list
64319771|NCT02177539|Cyclopentolate|cyclopentolate|mesh-list
64319772|NCT02177539|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64319773|NCT02177539|Mydriatics|mydriatics|mesh-ancestor
64319774|NCT02177539|Autonomic Agents|autonomic agents|mesh-ancestor
64319775|NCT02177539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64319776|NCT02177539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319777|NCT02177539|Sympathomimetics|sympathomimetics|mesh-ancestor
64319778|NCT02177539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64319779|NCT02177539|Nasal Decongestants|nasal decongestants|mesh-ancestor
64319780|NCT02177539|Respiratory System Agents|respiratory system agents|mesh-ancestor
64319781|NCT02177539|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64319782|NCT02177539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64319784|NCT02177539|Adrenergic Agents|adrenergic agents|mesh-ancestor
64319785|NCT02177539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64802831|NCT01404312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64802832|NCT01404312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64802833|NCT01404312|Leprostatic Agents|leprostatic agents|mesh-ancestor
64802892|NCT01404468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64802893|NCT01404468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64802894|NCT01404468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64802895|NCT01404468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64802896|NCT01404507|Abciximab|abciximab|mesh-list
64802897|NCT01404507|Anticoagulants|anticoagulants|mesh-ancestor
64319786|NCT02177539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319788|NCT02177539|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64748547|NCT04407312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748557|NCT04407312|Antipyretics|antipyretics|mesh-ancestor
64319789|NCT02177539|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64319790|NCT02177539|Cholinergic Agents|cholinergic agents|mesh-ancestor
64319791|NCT02177539|Parasympatholytics|parasympatholytics|mesh-ancestor
64319792|NCT05528198|Montelukast|montelukast|mesh-list
64319793|NCT05528198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64319794|NCT05528198|Respiratory System Agents|respiratory system agents|mesh-ancestor
64319796|NCT05528198|Hormone Antagonists|hormone antagonists|mesh-ancestor
64802898|NCT01404507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64802899|NCT01404598|Naproxen|naproxen|mesh-list
64802900|NCT01404598|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
64802956|NCT01404702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802957|NCT01404702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64802958|NCT01404702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64802959|NCT01404702|Antiviral Agents|antiviral agents|mesh-ancestor
64802960|NCT01404702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64319797|NCT05528198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64319798|NCT05528198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319799|NCT05528198|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64319800|NCT05528198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64319801|NCT05528198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319802|NCT05527808|Carboplatin|carboplatin|mesh-list
64319803|NCT05527808|Pemetrexed|pemetrexed|mesh-list
64319804|NCT05527808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319805|NCT05527808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319806|NCT05527808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319807|NCT05527808|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64319808|NCT05527808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64319810|NCT04141904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64319811|NCT04141904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319812|NCT04141904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319813|NCT05523986|Vitamin D|vitamin d|mesh-list
64319814|NCT05523986|Vitamins|vitamins|mesh-ancestor
64319815|NCT05523986|Micronutrients|micronutrients|mesh-ancestor
64319816|NCT05523986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319817|NCT05523986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64319818|NCT01361711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64319819|NCT01361711|Alemtuzumab|alemtuzumab|mesh-list
64319820|NCT01361711|Ofatumumab|ofatumumab|mesh-list
64319821|NCT01361711|Antibodies|antibodies|mesh-list
64802961|NCT01404702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64802962|NCT01404715|Metformin|metformin|mesh-list
64802963|NCT01404715|Imatinib Mesylate|imatinib mesylate|mesh-list
64802964|NCT01404715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64802965|NCT01404715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64802966|NCT01404715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64802967|NCT01404715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64802968|NCT01404715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803018|NCT01404871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64748569|NCT04407312|Protective Agents|protective agents|mesh-ancestor
64803019|NCT01404871|Antidepressive Agents|antidepressive agents|mesh-ancestor
64803020|NCT01404871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64803089|NCT01405157|Protective Agents|protective agents|mesh-ancestor
64803090|NCT01405157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64319822|NCT01361711|Immunoglobulins|immunoglobulins|mesh-list
64319823|NCT01361711|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64319824|NCT01361711|Immunologic Factors|immunologic factors|mesh-ancestor
64319825|NCT01361711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319826|NCT01361711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319827|NCT05527418|Dasatinib|dasatinib|mesh-list
64319828|NCT05527418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319829|NCT05527418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64319830|NCT05527418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319831|NCT05527418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319832|NCT04614974|Famotidine|famotidine|mesh-list
64319833|NCT04614974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64382915|NCT02415179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64382917|NCT02415023|Paclitaxel|paclitaxel|mesh-list
64803091|NCT01405157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803092|NCT01405170|Methylprednisolone|methylprednisolone|mesh-list
64803093|NCT01405170|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64803094|NCT01405170|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64803095|NCT01405170|Prednisolone|prednisolone|mesh-list
64803096|NCT01405170|Prednisolone acetate|prednisolone acetate|mesh-list
64803106|NCT01405170|Hormones|hormones|mesh-ancestor
64803158|NCT01405482|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64319834|NCT04614974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64319835|NCT04614974|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64319836|NCT04614974|Histamine Antagonists|histamine antagonists|mesh-ancestor
64319837|NCT04614974|Histamine Agents|histamine agents|mesh-ancestor
64748596|NCT04347486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748597|NCT04347486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748598|NCT04347486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64748599|NCT04347486|Respiratory System Agents|respiratory system agents|mesh-ancestor
64748600|NCT04347486|Mydriatics|mydriatics|mesh-ancestor
64748601|NCT04347486|Parasympatholytics|parasympatholytics|mesh-ancestor
64748602|NCT04347486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64444161|NCT02236988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64748603|NCT04347486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64748604|NCT04347486|Cholinergic Agents|cholinergic agents|mesh-ancestor
64748605|NCT04347486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64319838|NCT04614974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64748610|NCT03598608|Pembrolizumab|pembrolizumab|mesh-list
64319839|NCT04614974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382958|NCT02414555|Protective Agents|protective agents|mesh-ancestor
64382962|NCT02046070|Dexamethasone|dexamethasone|mesh-list
64803159|NCT01405482|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64803160|NCT01405482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64803161|NCT01405482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803163|NCT01405482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64803164|NCT01405482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803165|NCT01405482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64803166|NCT01405482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64803167|NCT01405521|Vaccines|vaccines|mesh-list
64803168|NCT01405521|Immunologic Factors|immunologic factors|mesh-ancestor
64319840|NCT04614974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319841|NCT05517746|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64319842|NCT05527340|Dexamethasone|dexamethasone|mesh-list
64319843|NCT05527340|Daratumumab|daratumumab|mesh-list
64319844|NCT05527340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64803169|NCT01405521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803170|NCT01405573|Sorafenib|sorafenib|mesh-list
64803175|NCT01405612|Midazolam|midazolam|mesh-list
64803216|NCT01405989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803217|NCT01405989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64803218|NCT01405989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64803219|NCT01405989|Antithrombins|antithrombins|mesh-ancestor
64803220|NCT01405989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64319847|NCT05527340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64319848|NCT05527340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319849|NCT05527340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64319850|NCT05527340|Glucocorticoids|glucocorticoids|mesh-ancestor
64319851|NCT05527340|Hormones|hormones|mesh-ancestor
64319852|NCT05527340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64319853|NCT05527340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64319854|NCT05527340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319855|NCT05527106|Ascorbic Acid|ascorbic acid|mesh-list
64416716|NCT04852315|Purinergic Agents|purinergic agents|mesh-ancestor
64803221|NCT01405989|Protease Inhibitors|protease inhibitors|mesh-ancestor
64803223|NCT01406002|Rifampin|rifampin|mesh-list
64748621|NCT04407234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64803284|NCT01406171|GABA Modulators|gaba modulators|mesh-ancestor
64803285|NCT01406171|GABA Agents|gaba agents|mesh-ancestor
64803286|NCT01406171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64803287|NCT01406171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803288|NCT01406171|Antifungal Agents|antifungal agents|mesh-ancestor
64803289|NCT01406171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64803290|NCT01406262|Moxifloxacin|moxifloxacin|mesh-list
64803291|NCT01406262|rGLP-1 protein|rglp-1 protein|mesh-list
64803292|NCT01406262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64803293|NCT01406262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64803294|NCT01406262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64803300|NCT01406262|Incretins|incretins|mesh-ancestor
64803348|NCT01406470|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64803349|NCT01406470|Immunoglobulin G|immunoglobulin g|mesh-list
64803350|NCT01406470|Immunologic Factors|immunologic factors|mesh-ancestor
64803351|NCT01406470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803352|NCT01406496|Insulin|insulin|mesh-list
64803353|NCT01406496|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64319856|NCT05527106|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64319857|NCT05527106|Vitamins|vitamins|mesh-ancestor
64319858|NCT05527106|Micronutrients|micronutrients|mesh-ancestor
64319859|NCT05527106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319860|NCT05527106|Antioxidants|antioxidants|mesh-ancestor
64319861|NCT05527106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319862|NCT05527106|Protective Agents|protective agents|mesh-ancestor
64319863|NCT05527106|Nootropic Agents|nootropic agents|mesh-ancestor
64803420|NCT01407211|Vitamin A|vitamin a|mesh-list
64803421|NCT01407211|Vitamins|vitamins|mesh-ancestor
64803422|NCT01407211|Micronutrients|micronutrients|mesh-ancestor
64803423|NCT01407211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803424|NCT01407237|Angiotensin II|angiotensin ii|mesh-list
64803425|NCT01407237|Giapreza|giapreza|mesh-list
64803426|NCT01407237|Angiotensinogen|angiotensinogen|mesh-list
64803427|NCT01407237|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64748679|NCT03024840|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64748680|NCT05631678|Itraconazole|itraconazole|mesh-list
64748681|NCT05631678|Rifampin|rifampin|mesh-list
64748682|NCT05631678|Antifungal Agents|antifungal agents|mesh-ancestor
64748683|NCT05631678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64748684|NCT05631678|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64748685|NCT05631678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64748686|NCT05631678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748687|NCT05631678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748688|NCT05631678|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64748689|NCT05631678|Hormone Antagonists|hormone antagonists|mesh-ancestor
64748690|NCT05631678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64748691|NCT05631678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748704|NCT03599778|Apatinib|apatinib|mesh-list
64803428|NCT01407237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64803432|NCT01407289|Insulin|insulin|mesh-list
64803487|NCT01407848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803489|NCT01407887|Amodiaquine|amodiaquine|mesh-list
64803490|NCT01407887|Methylene Blue|methylene blue|mesh-list
64803491|NCT01407887|Antimalarials|antimalarials|mesh-ancestor
64803492|NCT01407887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64803493|NCT01407887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64803494|NCT01407887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64803495|NCT01407887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803496|NCT01407887|Antiviral Agents|antiviral agents|mesh-ancestor
64803497|NCT01407887|Schistosomicides|schistosomicides|mesh-ancestor
64803499|NCT01407887|Anthelmintics|anthelmintics|mesh-ancestor
64803551|NCT01408173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64319864|NCT05526794|Analgesics|analgesics|mesh-list
64319865|NCT05526794|Sensory System Agents|sensory system agents|mesh-ancestor
64319866|NCT05526794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64319867|NCT05526794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319868|NCT05522894|Paclitaxel|paclitaxel|mesh-list
64319869|NCT05522894|Cisplatin|cisplatin|mesh-list
64803553|NCT01408186|Famotidine|famotidine|mesh-list
64803554|NCT01408186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64803555|NCT01408186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64803556|NCT01408186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64803620|NCT01408589|Adrenergic Agents|adrenergic agents|mesh-ancestor
64803621|NCT01408589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64803622|NCT01408589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803623|NCT01408680|Ubiquinone|ubiquinone|mesh-list
64803624|NCT01408680|Coenzyme Q10|coenzyme q10|mesh-list
64319870|NCT05522894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64319872|NCT05522894|Tubulin Modulators|tubulin modulators|mesh-ancestor
64319873|NCT05522894|Antimitotic Agents|antimitotic agents|mesh-ancestor
64319874|NCT05522894|Mitosis Modulators|mitosis modulators|mesh-ancestor
64319875|NCT05522894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319876|NCT05522816|Tirbanibulin|tirbanibulin|mesh-list
64319877|NCT05522816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383127|NCT02413541|Polymyxins|polymyxins|mesh-list
64803625|NCT01408680|Micronutrients|micronutrients|mesh-ancestor
64803626|NCT01408680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748709|NCT04008264|Scopolamine|scopolamine|mesh-list
64748712|NCT04008264|Antiemetics|antiemetics|mesh-ancestor
64748757|NCT03594396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64748758|NCT03594396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748759|NCT03594396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748760|NCT03594240|Folic Acid|folic acid|mesh-list
64748761|NCT03594240|Vitamin B Complex|vitamin b complex|mesh-list
64748762|NCT03594240|Vitamins|vitamins|mesh-ancestor
64748763|NCT03594240|Micronutrients|micronutrients|mesh-ancestor
64748764|NCT03594240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748765|NCT03594240|Hematinics|hematinics|mesh-ancestor
64748766|NCT03976362|Paclitaxel|paclitaxel|mesh-list
64748767|NCT03976362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64748768|NCT03976362|Carboplatin|carboplatin|mesh-list
64803627|NCT01408680|Vitamins|vitamins|mesh-ancestor
64803628|NCT01408797|Bortezomib|bortezomib|mesh-list
64803688|NCT01408979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803690|NCT01408979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64803691|NCT01408979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64803692|NCT01408979|Anticonvulsants|anticonvulsants|mesh-ancestor
64803693|NCT01408979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64748769|NCT03976362|Pembrolizumab|pembrolizumab|mesh-list
64748770|NCT03976362|Olaparib|olaparib|mesh-list
64803694|NCT01408979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64803695|NCT01408979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803696|NCT01408979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64803697|NCT01408979|Tocolytic Agents|tocolytic agents|mesh-ancestor
64803698|NCT01408979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64803699|NCT01409005|Gemcitabine|gemcitabine|mesh-list
64803701|NCT01409005|Antimetabolites|antimetabolites|mesh-ancestor
64803748|NCT01409174|Sensory System Agents|sensory system agents|mesh-ancestor
64803749|NCT01409174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64803750|NCT01409174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64803751|NCT01409174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64803752|NCT01409187|Interferons|interferons|mesh-list
64803753|NCT01409187|Interferon-alpha|interferon-alpha|mesh-list
64803754|NCT01409187|Interferon alpha-2|interferon alpha-2|mesh-list
64572347|NCT01419795|Rituximab|rituximab|mesh-list
64803817|NCT01409603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64803819|NCT01409603|Gout Suppressants|gout suppressants|mesh-ancestor
64803820|NCT01409603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64803821|NCT01409603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803822|NCT01409603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803823|NCT01409603|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64803886|NCT01409772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64803887|NCT01409772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64803888|NCT01409772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64803889|NCT01409772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803891|NCT01410162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64803892|NCT01410162|Immunologic Factors|immunologic factors|mesh-ancestor
64803893|NCT01410162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803894|NCT01410162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64803952|NCT01410747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803953|NCT01410747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803954|NCT01410916|Eculizumab|eculizumab|mesh-list
64803955|NCT01410916|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64319878|NCT05522816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319879|NCT02573870|Fluticasone|fluticasone|mesh-list
64319880|NCT02573870|Xhance|xhance|mesh-list
64319881|NCT02573870|Albuterol|albuterol|mesh-list
64319882|NCT02573870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64319883|NCT02573870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64319884|NCT02573870|Autonomic Agents|autonomic agents|mesh-ancestor
64803956|NCT01410916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64803957|NCT01410916|Immunologic Factors|immunologic factors|mesh-ancestor
64803958|NCT01410916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803959|NCT01410968|Poly ICLC|poly iclc|mesh-list
64803960|NCT01410968|Interferon Inducers|interferon inducers|mesh-ancestor
64803961|NCT01410968|Immunologic Factors|immunologic factors|mesh-ancestor
64803962|NCT01410968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64803963|NCT01411072|Gemcitabine|gemcitabine|mesh-list
64803964|NCT01411072|Fluorouracil|fluorouracil|mesh-list
64803965|NCT01411072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64319885|NCT02573870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64319886|NCT02573870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319887|NCT02573870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64319888|NCT02573870|Respiratory System Agents|respiratory system agents|mesh-ancestor
64319889|NCT02573870|Dermatologic Agents|dermatologic agents|mesh-ancestor
64319890|NCT02573870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64319891|NCT02573870|Tocolytic Agents|tocolytic agents|mesh-ancestor
64319892|NCT02573870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64319893|NCT02573870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64319894|NCT02573870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64383179|NCT02412059|Prednisolone|prednisolone|mesh-list
64803966|NCT01411072|Antimetabolites|antimetabolites|mesh-ancestor
64803967|NCT01411072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64803968|NCT01411072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64803969|NCT01411072|Antiviral Agents|antiviral agents|mesh-ancestor
64803970|NCT01411072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64803971|NCT01411072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64803972|NCT01411072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64803975|NCT01411098|Etoposide|etoposide|mesh-list
64804006|NCT01411124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804007|NCT01411124|Antimanic Agents|antimanic agents|mesh-ancestor
64804008|NCT01411124|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64804009|NCT01411124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64748809|NCT00217464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748810|NCT03597282|Nivolumab|nivolumab|mesh-list
64748811|NCT03597282|Ipilimumab|ipilimumab|mesh-list
64804010|NCT01411124|Anesthetics, Local|anesthetics, local|mesh-ancestor
64804011|NCT01411124|Anesthetics|anesthetics|mesh-ancestor
64804012|NCT01411124|Antiemetics|antiemetics|mesh-ancestor
64804013|NCT01411124|Autonomic Agents|autonomic agents|mesh-ancestor
64804014|NCT01411124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64804015|NCT01411124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64804016|NCT01411124|Histamine Antagonists|histamine antagonists|mesh-ancestor
64804017|NCT01411124|Histamine Agents|histamine agents|mesh-ancestor
64319895|NCT02573870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64319896|NCT02573870|Adrenergic Agents|adrenergic agents|mesh-ancestor
64319897|NCT02573870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64319898|NCT02573870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383188|NCT02412059|Hormones|hormones|mesh-ancestor
64804018|NCT01411124|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64804019|NCT01411124|Antipruritics|antipruritics|mesh-ancestor
64804020|NCT01411124|Dermatologic Agents|dermatologic agents|mesh-ancestor
64804022|NCT01411176|Antipruritics|antipruritics|mesh-ancestor
64804023|NCT01411176|Dermatologic Agents|dermatologic agents|mesh-ancestor
64804024|NCT01411189|Menthol|menthol|mesh-list
64804025|NCT01411189|Antipruritics|antipruritics|mesh-ancestor
64804026|NCT01411189|Dermatologic Agents|dermatologic agents|mesh-ancestor
64804027|NCT01411202|Doxycycline|doxycycline|mesh-list
64804028|NCT01411202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64804058|NCT01411410|Antimitotic Agents|antimitotic agents|mesh-ancestor
64804059|NCT01411410|Mitosis Modulators|mitosis modulators|mesh-ancestor
64319899|NCT05149898|Cannabidiol|cannabidiol|mesh-list
64319900|NCT05149898|Anticonvulsants|anticonvulsants|mesh-ancestor
64319901|NCT05148026|Heparin|heparin|mesh-list
64319902|NCT05148026|Calcium heparin|calcium heparin|mesh-list
64319903|NCT05148026|Dialysis Solutions|dialysis solutions|mesh-list
64748877|NCT03981744|Ustekinumab|ustekinumab|mesh-list
64748878|NCT03981744|Dermatologic Agents|dermatologic agents|mesh-ancestor
64748879|NCT03591900|Insulin|insulin|mesh-list
64748880|NCT03591900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64748881|NCT03591900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748882|NCT03591744|Dexamethasone|dexamethasone|mesh-list
64748883|NCT03591744|Dexamethasone acetate|dexamethasone acetate|mesh-list
64748884|NCT03591744|Doxorubicin|doxorubicin|mesh-list
64748885|NCT03591744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64748886|NCT03591744|Lenalidomide|lenalidomide|mesh-list
64748887|NCT03591744|Bortezomib|bortezomib|mesh-list
64748888|NCT03591744|Daratumumab|daratumumab|mesh-list
64748889|NCT03591744|Ichthammol|ichthammol|mesh-list
64748890|NCT03591744|BB 1101|bb 1101|mesh-list
64748891|NCT03591744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64748892|NCT03591744|Antiemetics|antiemetics|mesh-ancestor
64748893|NCT03591744|Autonomic Agents|autonomic agents|mesh-ancestor
64748894|NCT03591744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748895|NCT03591744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748896|NCT03591744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64748897|NCT03591744|Glucocorticoids|glucocorticoids|mesh-ancestor
64748898|NCT03591744|Hormones|hormones|mesh-ancestor
64319904|NCT05148026|Anticoagulants|anticoagulants|mesh-ancestor
64319905|NCT05148026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64383395|NCT02410031|Hormones|hormones|mesh-ancestor
64748899|NCT03591744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64748900|NCT03591744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64804060|NCT01411410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804061|NCT01411423|Sorafenib|sorafenib|mesh-list
64804062|NCT01411423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804128|NCT01411969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64804129|NCT01411969|Nasal Decongestants|nasal decongestants|mesh-ancestor
64804130|NCT01411969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64804131|NCT01411969|Respiratory System Agents|respiratory system agents|mesh-ancestor
64804132|NCT01411969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64804133|NCT01411969|Mydriatics|mydriatics|mesh-ancestor
64804134|NCT01411969|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64804135|NCT01411969|Protective Agents|protective agents|mesh-ancestor
64804136|NCT01412008|Botulinum Toxins|botulinum toxins|mesh-list
64804137|NCT01412008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64804138|NCT01412008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64804139|NCT01412008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804140|NCT01412008|Cholinergic Agents|cholinergic agents|mesh-ancestor
64804141|NCT01412008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64804142|NCT01412008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804143|NCT01412073|Misoprostol|misoprostol|mesh-list
64804144|NCT01412073|Oxytocin|oxytocin|mesh-list
64804145|NCT01412073|Oxytocics|oxytocics|mesh-ancestor
64804183|NCT01412437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64804184|NCT01412437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319906|NCT05148026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64319907|NCT05148026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319908|NCT05148026|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64319909|NCT05522270|Mitogens|mitogens|mesh-list
64416717|NCT04852315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64383406|NCT05513625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64804185|NCT01412437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64804186|NCT01412437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804187|NCT01412437|Vasodilator Agents|vasodilator agents|mesh-ancestor
64804188|NCT01412515|Everolimus|everolimus|mesh-list
64804189|NCT01412515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804252|NCT01413022|Antimetabolites|antimetabolites|mesh-ancestor
64748902|NCT03591744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64748903|NCT03591744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64748904|NCT03591744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64748905|NCT03591744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748906|NCT03591744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748907|NCT03591744|Immunologic Factors|immunologic factors|mesh-ancestor
64748908|NCT03591744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64748909|NCT03591744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64748910|NCT03591744|Growth Substances|growth substances|mesh-ancestor
64748911|NCT03591744|Growth Inhibitors|growth inhibitors|mesh-ancestor
64748912|NCT03591744|Protease Inhibitors|protease inhibitors|mesh-ancestor
64748913|NCT03591744|Dermatologic Agents|dermatologic agents|mesh-ancestor
64748915|NCT04196946|Alfentanil|alfentanil|mesh-list
64748916|NCT04196946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64748917|NCT04196946|Narcotics|narcotics|mesh-ancestor
64748918|NCT04196946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64748920|NCT04196946|Analgesics|analgesics|mesh-ancestor
64804253|NCT01413022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804254|NCT01413022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64804255|NCT01413022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319910|NCT05522270|Mitosis Modulators|mitosis modulators|mesh-ancestor
64319911|NCT05522270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319912|NCT05522192|Venetoclax|venetoclax|mesh-list
64319913|NCT05522192|Mitoxantrone|mitoxantrone|mesh-list
64319914|NCT05522192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804256|NCT01413022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64804257|NCT01413022|Immunologic Factors|immunologic factors|mesh-ancestor
64804258|NCT01413022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804259|NCT01413022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64804260|NCT01413022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64804317|NCT01413490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804318|NCT01413490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804319|NCT01413581|Bile Acids and Salts|bile acids and salts|mesh-list
64319915|NCT05522192|Analgesics|analgesics|mesh-ancestor
64319916|NCT05522192|Sensory System Agents|sensory system agents|mesh-ancestor
64319917|NCT05522192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64319918|NCT05522192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319919|NCT05522192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64319920|NCT05522192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64319921|NCT05522192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319922|NCT05522192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319923|NCT05522036|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
64319924|NCT05522036|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64319925|NCT05522036|Dermatologic Agents|dermatologic agents|mesh-ancestor
64319926|NCT05515874|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64319927|NCT05515874|Hematinics|hematinics|mesh-ancestor
64319928|NCT05515874|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64319929|NCT05515874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64319930|NCT05525234|Thalidomide|thalidomide|mesh-list
64383458|NCT02408705|Liraglutide|liraglutide|mesh-list
64804320|NCT01413581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64804321|NCT01413620|Vitamins|vitamins|mesh-list
64804322|NCT01413620|Vitamin E|vitamin e|mesh-list
64804323|NCT01413620|Tocopherols|tocopherols|mesh-list
64804324|NCT01413620|Tocotrienols|tocotrienols|mesh-list
64804325|NCT01413620|alpha-Tocopherol|alpha-tocopherol|mesh-list
64804326|NCT01413620|Micronutrients|micronutrients|mesh-ancestor
64804327|NCT01413620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804328|NCT01413620|Antioxidants|antioxidants|mesh-ancestor
64804329|NCT01413620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804330|NCT01413620|Protective Agents|protective agents|mesh-ancestor
64804331|NCT01413711|Vigabatrin|vigabatrin|mesh-list
64804332|NCT01413711|Anticonvulsants|anticonvulsants|mesh-ancestor
64804333|NCT01413711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804334|NCT01413711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804335|NCT01413711|GABA Agents|gaba agents|mesh-ancestor
64804336|NCT01413711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64804337|NCT01413711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319931|NCT05525234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64319932|NCT05525234|Immunologic Factors|immunologic factors|mesh-ancestor
64319933|NCT05525234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748956|NCT04196010|Antiviral Agents|antiviral agents|mesh-ancestor
64748957|NCT04196010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64319934|NCT05525234|Leprostatic Agents|leprostatic agents|mesh-ancestor
64319935|NCT05525234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64319936|NCT05525234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64319937|NCT05525234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64319938|NCT05525234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64319939|NCT05525234|Growth Substances|growth substances|mesh-ancestor
64319940|NCT05525234|Growth Inhibitors|growth inhibitors|mesh-ancestor
64804338|NCT01413763|Imiquimod|imiquimod|mesh-list
64804339|NCT01413763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64804340|NCT01413763|Immunologic Factors|immunologic factors|mesh-ancestor
64804341|NCT01413763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804342|NCT01413763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804343|NCT01413763|Interferon Inducers|interferon inducers|mesh-ancestor
64804344|NCT01413854|Diclofenac|diclofenac|mesh-list
64804345|NCT01413854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64804346|NCT01413854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64804347|NCT01413854|Analgesics|analgesics|mesh-ancestor
64804348|NCT01413854|Sensory System Agents|sensory system agents|mesh-ancestor
64319941|NCT05525234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319942|NCT02574260|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
64319943|NCT02574260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64804349|NCT01413854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64804360|NCT01414140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804361|NCT01414140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64804362|NCT01414140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64804363|NCT01414140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64804365|NCT01414231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64804366|NCT01414231|Antimetabolites|antimetabolites|mesh-ancestor
64319944|NCT02574260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319945|NCT04300790|Metformin|metformin|mesh-list
64319948|NCT04300790|Exemestane|exemestane|mesh-list
64319949|NCT04300790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64319950|NCT04300790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319951|NCT04300790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319952|NCT04300790|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64319953|NCT04300790|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64319954|NCT04300790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319955|NCT04300790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319956|NCT04300790|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64749014|NCT04195074|Antiviral Agents|antiviral agents|mesh-ancestor
64749015|NCT04195074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64319957|NCT04300790|Hormone Antagonists|hormone antagonists|mesh-ancestor
64749016|NCT04195074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64319958|NCT04300790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64319959|NCT04300790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64319960|NCT04300790|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64319961|NCT04295330|Lidocaine|lidocaine|mesh-list
64319962|NCT04295330|Anesthetics, Local|anesthetics, local|mesh-ancestor
64319964|NCT04295330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64319965|NCT04295330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319966|NCT04295330|Sensory System Agents|sensory system agents|mesh-ancestor
64319967|NCT04295330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64319968|NCT04295330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64319969|NCT04295330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64319970|NCT04295330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64319971|NCT04295330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64804367|NCT01414231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804368|NCT01414231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804369|NCT01414231|Antiviral Agents|antiviral agents|mesh-ancestor
64804370|NCT01414231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64804371|NCT01414231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64804372|NCT01414231|Immunologic Factors|immunologic factors|mesh-ancestor
64804373|NCT01414231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804374|NCT01414465|Orlistat|orlistat|mesh-list
64319972|NCT04295330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319973|NCT05525156|Aspirin|aspirin|mesh-list
64319974|NCT05525156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64319975|NCT05525156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64319976|NCT05525156|Analgesics|analgesics|mesh-ancestor
64804375|NCT01414465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804417|NCT01414816|Interferon-beta|interferon-beta|mesh-list
64804418|NCT01414816|Interferon beta-1b|interferon beta-1b|mesh-list
64804419|NCT01414816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804420|NCT01414816|Antiviral Agents|antiviral agents|mesh-ancestor
64804421|NCT01414816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64804422|NCT01414816|Immunologic Factors|immunologic factors|mesh-ancestor
64804423|NCT01414816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804424|NCT01414816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64804425|NCT01414842|Dialysis Solutions|dialysis solutions|mesh-list
64804426|NCT01414842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64804427|NCT01414868|Montelukast|montelukast|mesh-list
64804428|NCT01414868|Leukotriene Antagonists|leukotriene antagonists|mesh-list
64804429|NCT01414868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64804430|NCT01414868|Respiratory System Agents|respiratory system agents|mesh-ancestor
64319977|NCT05525156|Sensory System Agents|sensory system agents|mesh-ancestor
64319978|NCT05525156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64319979|NCT05525156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319980|NCT05525156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64319981|NCT05525156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64749072|NCT04193982|Protective Agents|protective agents|mesh-ancestor
64749073|NCT04028778|Gefitinib|gefitinib|mesh-list
64749074|NCT04028778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749075|NCT04028778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64749076|NCT04028778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749077|NCT04028778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749078|NCT04028856|Interferons|interferons|mesh-list
64749079|NCT04028856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749080|NCT04028856|Antiviral Agents|antiviral agents|mesh-ancestor
64749081|NCT04028856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64749082|NCT03594474|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64319982|NCT05525156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64416718|NCT03038425|Ropivacaine|ropivacaine|mesh-list
64804431|NCT01414868|Hormone Antagonists|hormone antagonists|mesh-ancestor
64804432|NCT01414868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64804433|NCT01414868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804474|NCT01415128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64804475|NCT01415128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64804476|NCT01415128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64804477|NCT01415128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64804478|NCT01415128|Adrenergic Agents|adrenergic agents|mesh-ancestor
64804479|NCT01415128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64804480|NCT01415141|Ribavirin|ribavirin|mesh-list
64804481|NCT01415141|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64804482|NCT01415141|Antimetabolites|antimetabolites|mesh-ancestor
64804483|NCT01415141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804484|NCT01415141|Antiviral Agents|antiviral agents|mesh-ancestor
64804485|NCT01415141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64804486|NCT01415284|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
64804487|NCT01415284|Plasma Substitutes|plasma substitutes|mesh-ancestor
64804488|NCT01415284|Blood Substitutes|blood substitutes|mesh-ancestor
64804533|NCT01415557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804534|NCT01415596|Albuterol|albuterol|mesh-list
64804535|NCT01415596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64804536|NCT01415596|Autonomic Agents|autonomic agents|mesh-ancestor
64804537|NCT01415596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64804538|NCT01415596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804539|NCT01415596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64804604|NCT01415765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64749086|NCT04193592|Pirfenidone|pirfenidone|mesh-list
64749087|NCT04193592|Analgesics|analgesics|mesh-ancestor
64749088|NCT04193592|Sensory System Agents|sensory system agents|mesh-ancestor
64749089|NCT04193592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749090|NCT04193592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749091|NCT04193592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64749105|NCT03933384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64749106|NCT04028466|Omeprazole|omeprazole|mesh-list
64749107|NCT04028466|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64749108|NCT04028466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64749109|NCT04028466|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64319984|NCT05525156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319985|NCT05525156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64319986|NCT05525156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64319987|NCT05525156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319988|NCT05525156|Antipyretics|antipyretics|mesh-ancestor
64319989|NCT05512364|Tamoxifen|tamoxifen|mesh-list
64319990|NCT05512364|Letrozole|letrozole|mesh-list
64319991|NCT05512364|Anastrozole|anastrozole|mesh-list
64319992|NCT05512364|Exemestane|exemestane|mesh-list
64319993|NCT05512364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319994|NCT05512364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64319995|NCT05512364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64319997|NCT05512364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319998|NCT05512364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64319999|NCT05512364|Hormone Antagonists|hormone antagonists|mesh-ancestor
64804605|NCT01415765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64804606|NCT01415765|Tubulin Modulators|tubulin modulators|mesh-ancestor
64804621|NCT01415895|Clonidine|clonidine|mesh-list
64804675|NCT01416207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804677|NCT01416220|Paroxetine|paroxetine|mesh-list
64804678|NCT01416220|Antidepressive Agents|antidepressive agents|mesh-ancestor
64804679|NCT01416220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64804680|NCT01416220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804681|NCT01416220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804742|NCT01416701|Cholecalciferol|cholecalciferol|mesh-list
64804743|NCT01416701|Vitamins|vitamins|mesh-list
64804744|NCT01416701|Micronutrients|micronutrients|mesh-ancestor
64320000|NCT05512364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64320001|NCT05512364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320002|NCT05512364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64320003|NCT05512364|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64320004|NCT05512364|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64320005|NCT05512364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64320007|NCT04424641|Immunoglobulins|immunoglobulins|mesh-list
64320008|NCT04424641|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64320009|NCT04424641|Immunoglobulin G|immunoglobulin g|mesh-list
64320010|NCT04424641|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64320011|NCT04424641|Immunologic Factors|immunologic factors|mesh-ancestor
64320012|NCT04424641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804745|NCT01416701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804746|NCT01416701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64804747|NCT01416701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64804748|NCT01416870|Bicalutamide|bicalutamide|mesh-list
64804749|NCT01416870|Androgen Antagonists|androgen antagonists|mesh-ancestor
64804750|NCT01416870|Hormone Antagonists|hormone antagonists|mesh-ancestor
64804807|NCT01417065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64804808|NCT01417065|Immunologic Factors|immunologic factors|mesh-ancestor
64804809|NCT01417065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804810|NCT01417169|Micafungin|micafungin|mesh-list
64804811|NCT01417169|Antifungal Agents|antifungal agents|mesh-ancestor
64749167|NCT04192656|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64749168|NCT04192656|Prednisolone phosphate|prednisolone phosphate|mesh-list
64749169|NCT04192656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64749176|NCT04192656|Hormones|hormones|mesh-ancestor
64804812|NCT01417169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64804813|NCT01417273|Vitamin A|vitamin a|mesh-list
64804814|NCT01417273|Vitamins|vitamins|mesh-ancestor
64804815|NCT01417273|Micronutrients|micronutrients|mesh-ancestor
64804816|NCT01417273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804876|NCT01417494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64804877|NCT01417494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804878|NCT01417494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64749188|NCT04191954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804879|NCT01417494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64804880|NCT01417494|Growth Substances|growth substances|mesh-ancestor
64749189|NCT04191954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64749190|NCT04191954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804881|NCT01417494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804882|NCT01417494|Growth Inhibitors|growth inhibitors|mesh-ancestor
64804883|NCT01417494|Antimetabolites|antimetabolites|mesh-ancestor
64804884|NCT01417494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804885|NCT01417494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64804886|NCT01417494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64804887|NCT01417494|Immunologic Factors|immunologic factors|mesh-ancestor
64804889|NCT01417494|Protective Agents|protective agents|mesh-ancestor
64804890|NCT01417494|Vitamin B Complex|vitamin b complex|mesh-ancestor
64804891|NCT01417494|Vitamins|vitamins|mesh-ancestor
64804892|NCT01417494|Micronutrients|micronutrients|mesh-ancestor
64804893|NCT01417572|Lidocaine|lidocaine|mesh-list
64804894|NCT01417572|Anesthetics, Local|anesthetics, local|mesh-ancestor
64749191|NCT04191954|Vasodilator Agents|vasodilator agents|mesh-ancestor
64749192|NCT04191954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64749193|NCT04191954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749194|NCT04192032|Nicotine|nicotine|mesh-list
64749195|NCT04192032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64749201|NCT04192032|Cholinergic Agents|cholinergic agents|mesh-ancestor
64749202|NCT04192032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64749203|NCT04192032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749204|NCT03023982|Morphine|morphine|mesh-list
64749205|NCT03023982|Bupivacaine|bupivacaine|mesh-list
64749206|NCT03023982|Anesthetics, Local|anesthetics, local|mesh-ancestor
64749207|NCT03023982|Anesthetics|anesthetics|mesh-ancestor
64749208|NCT03023982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64749209|NCT03023982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749210|NCT03023982|Sensory System Agents|sensory system agents|mesh-ancestor
64749211|NCT03023982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749212|NCT03023982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64804895|NCT01417572|Anesthetics|anesthetics|mesh-ancestor
64804896|NCT01417572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64749213|NCT03023982|Narcotics|narcotics|mesh-ancestor
64804897|NCT01417572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320013|NCT05512130|Empagliflozin|empagliflozin|mesh-list
64320014|NCT05512130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64320015|NCT05512130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320016|NCT05512130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64320017|NCT05512130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320064|NCT02183467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320065|NCT02183467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320066|NCT02183467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64320067|NCT02183467|Incretins|incretins|mesh-ancestor
64320068|NCT02183467|Hormones|hormones|mesh-ancestor
64804900|NCT01417572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64804901|NCT01417572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64804902|NCT01417572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64804903|NCT01417572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64804904|NCT01417572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804906|NCT01417689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64804907|NCT01417754|Toremifene|toremifene|mesh-list
64804908|NCT01417754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64804909|NCT01417754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804910|NCT01417754|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64804911|NCT01417754|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64804912|NCT01417754|Hormone Antagonists|hormone antagonists|mesh-ancestor
64804913|NCT01417754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64804914|NCT01417754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64804915|NCT01417754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64804916|NCT01417767|Decitabine|decitabine|mesh-list
64804917|NCT01417767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64804918|NCT01417767|Antimetabolites|antimetabolites|mesh-ancestor
64804919|NCT01417767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804920|NCT01417767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64804921|NCT01417767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804976|NCT01418118|Protective Agents|protective agents|mesh-ancestor
64320089|NCT05075876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64320090|NCT05075876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320091|NCT05075876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64416719|NCT03038425|Anesthetics, Local|anesthetics, local|mesh-ancestor
64804979|NCT01418118|Dopamine Agents|dopamine agents|mesh-ancestor
64804981|NCT01418131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
64804982|NCT01418131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64804983|NCT01418131|Immunologic Factors|immunologic factors|mesh-ancestor
64804984|NCT01418131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749272|NCT04198662|Mydriatics|mydriatics|mesh-ancestor
64804985|NCT01418131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64804986|NCT01418131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64804987|NCT01418144|Ropivacaine|ropivacaine|mesh-list
64804989|NCT01418144|Anesthetics|anesthetics|mesh-ancestor
64805040|NCT01418417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805041|NCT01418430|Daclizumab|daclizumab|mesh-list
64805042|NCT01418430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64805043|NCT01418430|Immunologic Factors|immunologic factors|mesh-ancestor
64805044|NCT01418430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805045|NCT01418443|Pantoprazole|pantoprazole|mesh-list
64805046|NCT01418443|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64805105|NCT01418625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64805106|NCT01418625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805107|NCT01418625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64805108|NCT01418625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805109|NCT01418625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64805110|NCT01418625|Antidepressive Agents|antidepressive agents|mesh-ancestor
64805111|NCT01418625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64805112|NCT01418651|Milnacipran|milnacipran|mesh-list
64805113|NCT01418651|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64805114|NCT01418651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64805115|NCT01418651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64805116|NCT01418651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805117|NCT01418651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64805118|NCT01418651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805119|NCT01418651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64320092|NCT05075876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64320093|NCT05075876|Serotonin Agents|serotonin agents|mesh-ancestor
64320094|NCT05075876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64320095|NCT05075876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320097|NCT02180737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64320098|NCT02180737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64320099|NCT02180737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320100|NCT02180737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64320101|NCT02180737|Analgesics|analgesics|mesh-ancestor
64749322|NCT03929640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64749323|NCT03929640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749324|NCT03929640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749325|NCT04021992|Gemcitabine|gemcitabine|mesh-list
64749326|NCT04021992|Rituximab|rituximab|mesh-list
64749327|NCT04021992|Doxorubicin|doxorubicin|mesh-list
64749373|NCT04020588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64749374|NCT04020588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749375|NCT04020588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749376|NCT04020588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64749377|NCT04020588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64749378|NCT04145856|Simethicone|simethicone|mesh-list
64749379|NCT04145856|Alverine|alverine|mesh-list
64749380|NCT04145856|Antifoaming Agents|antifoaming agents|mesh-ancestor
64749381|NCT04145856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320102|NCT02180737|Sensory System Agents|sensory system agents|mesh-ancestor
64805120|NCT01418651|Analgesics|analgesics|mesh-ancestor
64805121|NCT01418651|Sensory System Agents|sensory system agents|mesh-ancestor
64805159|NCT01419119|Vitamins|vitamins|mesh-ancestor
64805160|NCT01419119|Micronutrients|micronutrients|mesh-ancestor
64805161|NCT01419119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64805162|NCT01419132|Furosemide|furosemide|mesh-list
64805163|NCT01419132|Diuretics|diuretics|mesh-list
64805164|NCT01419132|Natriuretic Agents|natriuretic agents|mesh-ancestor
64805165|NCT01419132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805166|NCT01419132|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64805169|NCT01419262|Vitamin D|vitamin d|mesh-list
64805225|NCT01419405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64805227|NCT01419405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64805228|NCT01419405|Narcotics|narcotics|mesh-ancestor
64805229|NCT01419457|Favipiravir|favipiravir|mesh-list
64805230|NCT01419457|Antiviral Agents|antiviral agents|mesh-ancestor
64805231|NCT01419457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64805232|NCT01419548|Paclitaxel|paclitaxel|mesh-list
64805233|NCT01419548|Carboplatin|carboplatin|mesh-list
64805294|NCT01420159|Anesthetics, General|anesthetics, general|mesh-ancestor
64805295|NCT01420159|Anesthetics|anesthetics|mesh-ancestor
64805296|NCT01420159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64805297|NCT01420159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805299|NCT01420302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64805324|NCT01420406|Vitamin A|vitamin a|mesh-list
64805362|NCT01420575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64805363|NCT01420575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64805364|NCT01420575|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64805365|NCT01420575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64805366|NCT01420575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64805367|NCT01420575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805368|NCT01420575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64320103|NCT02180737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64320104|NCT02180737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64320105|NCT02180737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64320106|NCT02180737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64383789|NCT05508009|Immunologic Factors|immunologic factors|mesh-ancestor
64805372|NCT01420666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64805373|NCT01420666|Analgesics|analgesics|mesh-ancestor
64805374|NCT01420666|Sensory System Agents|sensory system agents|mesh-ancestor
64805375|NCT01420666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64805376|NCT01420666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805377|NCT01420666|Antipyretics|antipyretics|mesh-ancestor
64805378|NCT01420666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64805379|NCT01420666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64749386|NCT04145856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749387|NCT04145856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749388|NCT04140786|Gentamicins|gentamicins|mesh-list
64805417|NCT01420913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749389|NCT04140786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64805419|NCT01420913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64805420|NCT01420913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64805421|NCT01420913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64805422|NCT01420913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64805423|NCT01421043|Triazolam|triazolam|mesh-list
64805424|NCT01421043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64805425|NCT01421043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64805426|NCT01421043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64805427|NCT01421043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64805428|NCT01421043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805429|NCT01421043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64805430|NCT01421043|GABA Modulators|gaba modulators|mesh-ancestor
64805431|NCT01421043|GABA Agents|gaba agents|mesh-ancestor
64805432|NCT01421043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64805433|NCT01421043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805475|NCT01421173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64805476|NCT01421173|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64805477|NCT01421173|Protease Inhibitors|protease inhibitors|mesh-ancestor
64805478|NCT01421212|Immunoglobulins|immunoglobulins|mesh-list
64805479|NCT01421212|Antibodies|antibodies|mesh-list
64805480|NCT01421212|gamma-Globulins|gamma-globulins|mesh-list
64805481|NCT01421212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64805482|NCT01421212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64805483|NCT01421212|Immunoglobulin G|immunoglobulin g|mesh-list
64574085|NCT02099591|Naloxegol|naloxegol|mesh-list
64805484|NCT01421212|Immunologic Factors|immunologic factors|mesh-ancestor
64805485|NCT01421212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805487|NCT01421368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64805488|NCT01421368|Contraceptive Agents|contraceptive agents|mesh-list
64805489|NCT01421368|Medroxyprogesterone|medroxyprogesterone|mesh-list
64805490|NCT01421368|Contraceptives, Oral|contraceptives, oral|mesh-list
64805491|NCT01421368|Antiviral Agents|antiviral agents|mesh-ancestor
64805492|NCT01421368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64749436|NCT04144920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749437|NCT04144920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749438|NCT04144920|Sympathomimetics|sympathomimetics|mesh-ancestor
64749439|NCT04144920|Autonomic Agents|autonomic agents|mesh-ancestor
64749440|NCT04144920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749441|NCT04144920|Nasal Decongestants|nasal decongestants|mesh-ancestor
64749442|NCT04144920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64749443|NCT04144920|Respiratory System Agents|respiratory system agents|mesh-ancestor
64749444|NCT04026282|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64749445|NCT04026282|Hormones|hormones|mesh-ancestor
64749446|NCT04026282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64749448|NCT04144218|Lacosamide|lacosamide|mesh-list
64805493|NCT01421368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64805530|NCT01421706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64805531|NCT01421706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64805532|NCT01421706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64805533|NCT01421706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805534|NCT01421706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64805535|NCT01421706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64805536|NCT01421706|Antidepressive Agents|antidepressive agents|mesh-ancestor
64805537|NCT01421706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64805538|NCT01421706|Appetite Depressants|appetite depressants|mesh-ancestor
64805539|NCT01421706|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64805540|NCT01421771|Antihypertensive Agents|antihypertensive agents|mesh-list
64805542|NCT01421901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64805543|NCT01421901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64805544|NCT01421914|Bupivacaine|bupivacaine|mesh-list
64805545|NCT01421914|Anesthetics, Local|anesthetics, local|mesh-ancestor
64805546|NCT01421914|Anesthetics|anesthetics|mesh-ancestor
64805547|NCT01421914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64805548|NCT01421914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805549|NCT01421914|Sensory System Agents|sensory system agents|mesh-ancestor
64805550|NCT01421914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64805551|NCT01421927|Lenalidomide|lenalidomide|mesh-list
64805552|NCT01421927|Immunologic Factors|immunologic factors|mesh-ancestor
64805553|NCT01421927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805559|NCT01421940|Udenafil|udenafil|mesh-list
64805579|NCT01421992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64805580|NCT01421992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805581|NCT01421992|Dopamine Agents|dopamine agents|mesh-ancestor
64805582|NCT01421992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64805583|NCT01422018|Bevacizumab|bevacizumab|mesh-list
64805584|NCT01422018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64805585|NCT01422018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64805591|NCT01422096|Leuprolide|leuprolide|mesh-list
64805646|NCT01422317|alpha-Tocopherol|alpha-tocopherol|mesh-list
64805647|NCT01422317|Antioxidants|antioxidants|mesh-ancestor
64805648|NCT01422317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805649|NCT01422317|Protective Agents|protective agents|mesh-ancestor
64805650|NCT01422317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320108|NCT02180737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64320109|NCT02180737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320110|NCT05520944|Chlorpheniramine|chlorpheniramine|mesh-list
64320111|NCT05520944|Antipruritics|antipruritics|mesh-ancestor
64320112|NCT05520944|Dermatologic Agents|dermatologic agents|mesh-ancestor
64749495|NCT05587608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64749496|NCT05587608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749497|NCT02703714|Pembrolizumab|pembrolizumab|mesh-list
64320113|NCT05520944|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64320114|NCT05520944|Histamine Antagonists|histamine antagonists|mesh-ancestor
64320115|NCT05520944|Histamine Agents|histamine agents|mesh-ancestor
64320116|NCT05520944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64805651|NCT01422317|Vitamins|vitamins|mesh-ancestor
64805652|NCT01422317|Micronutrients|micronutrients|mesh-ancestor
64805653|NCT01422330|Etravirine|etravirine|mesh-list
64805654|NCT01422330|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64805655|NCT01422330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64805711|NCT01422616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64805712|NCT01422616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64805713|NCT01422616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64805714|NCT01422616|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64805715|NCT01422616|Protective Agents|protective agents|mesh-ancestor
64805716|NCT01422616|Sympathomimetics|sympathomimetics|mesh-ancestor
64805717|NCT01422616|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64805718|NCT01422616|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64805719|NCT01422616|Vasodilator Agents|vasodilator agents|mesh-ancestor
64805720|NCT01422616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64805721|NCT01422616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64805722|NCT01422616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64805723|NCT01422616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64805724|NCT01422616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64805725|NCT01422616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64805726|NCT01422616|Serotonin Agents|serotonin agents|mesh-ancestor
64805727|NCT01422616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64805728|NCT01422616|Protease Inhibitors|protease inhibitors|mesh-ancestor
64805729|NCT01422616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805730|NCT01422707|Hydrocortisone|hydrocortisone|mesh-list
64749529|NCT03916068|Vitamin E|vitamin e|mesh-list
64749530|NCT03916068|Pentoxifylline|pentoxifylline|mesh-list
64749531|NCT03916068|Vitamins|vitamins|mesh-ancestor
64749532|NCT03916068|Micronutrients|micronutrients|mesh-ancestor
64749533|NCT03916068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805731|NCT01422707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64805732|NCT01422733|Dexamethasone|dexamethasone|mesh-list
64805733|NCT01422733|Hydrocortisone|hydrocortisone|mesh-list
64805734|NCT01422733|Cosyntropin|cosyntropin|mesh-list
64805735|NCT01422733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64805736|NCT01422733|Antiemetics|antiemetics|mesh-ancestor
64805737|NCT01422733|Autonomic Agents|autonomic agents|mesh-ancestor
64805738|NCT01422733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64805739|NCT01422733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805740|NCT01422733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64805741|NCT01422733|Glucocorticoids|glucocorticoids|mesh-ancestor
64805742|NCT01422733|Hormones|hormones|mesh-ancestor
64805746|NCT01422785|Clindamycin|clindamycin|mesh-list
64805754|NCT01422785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805755|NCT01422785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805756|NCT01422785|Dermatologic Agents|dermatologic agents|mesh-ancestor
64805757|NCT01422785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64805758|NCT01422785|Keratolytic Agents|keratolytic agents|mesh-ancestor
64805759|NCT01422954|Chloroquine|chloroquine|mesh-list
64805761|NCT01422954|Proguanil|proguanil|mesh-list
64805762|NCT01422954|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
64805763|NCT01422954|Amebicides|amebicides|mesh-ancestor
64320117|NCT05520944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320118|NCT05520944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320119|NCT05520944|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64320120|NCT02183623|Linagliptin|linagliptin|mesh-list
64320121|NCT02183623|Simvastatin|simvastatin|mesh-list
64320122|NCT02183623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64320123|NCT02183623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64320124|NCT02183623|Antimetabolites|antimetabolites|mesh-ancestor
64320125|NCT02183623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320126|NCT02183623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64384006|NCT01625338|Sofosbuvir|sofosbuvir|mesh-list
64805765|NCT01422954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64805766|NCT01422954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64805767|NCT01422954|Antimalarials|antimalarials|mesh-ancestor
64805768|NCT01422954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64805769|NCT01422954|Antimetabolites|antimetabolites|mesh-ancestor
64805770|NCT01422954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805771|NCT01423019|Synephrine|synephrine|mesh-list
64805772|NCT01423019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64805773|NCT01423019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64805774|NCT01423019|Adrenergic Agents|adrenergic agents|mesh-ancestor
64805775|NCT01423019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64805776|NCT01423019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805777|NCT01423019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805778|NCT01423019|Sympathomimetics|sympathomimetics|mesh-ancestor
64805779|NCT01423019|Autonomic Agents|autonomic agents|mesh-ancestor
64805803|NCT01423175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64805804|NCT01423240|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64805805|NCT01423240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64805806|NCT01423240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64805807|NCT01423240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64805808|NCT01423240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805809|NCT01423240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64805810|NCT01423240|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64805811|NCT01423240|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64805812|NCT01423240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64805813|NCT01423240|Adrenergic Agents|adrenergic agents|mesh-ancestor
64805814|NCT01423240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64805815|NCT01423240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749660|NCT03021330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64749661|NCT03021330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64749662|NCT03021330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64749663|NCT03021330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749664|NCT04140006|Alendronate|alendronate|mesh-list
64749665|NCT04140006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64805816|NCT01423240|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64805817|NCT01423240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64805818|NCT01423240|Serotonin Agents|serotonin agents|mesh-ancestor
64805819|NCT01423240|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64805820|NCT01423240|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64805821|NCT01423240|Dopamine Agents|dopamine agents|mesh-ancestor
64805822|NCT01423292|Bupivacaine|bupivacaine|mesh-list
64805823|NCT01423292|Anesthetics, Local|anesthetics, local|mesh-ancestor
64805824|NCT01423292|Anesthetics|anesthetics|mesh-ancestor
64805825|NCT01423292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64805826|NCT01423292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805827|NCT01423292|Sensory System Agents|sensory system agents|mesh-ancestor
64805828|NCT01423292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64805829|NCT01423305|Budesonide|budesonide|mesh-list
64805840|NCT01423305|Hormones|hormones|mesh-ancestor
64805847|NCT01423305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805848|NCT01423370|Tadalafil|tadalafil|mesh-list
64805849|NCT01423370|Vasodilator Agents|vasodilator agents|mesh-ancestor
64805850|NCT01423370|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64805851|NCT01423370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64805852|NCT01423370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805853|NCT01423370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805854|NCT01423370|Urological Agents|urological agents|mesh-ancestor
64805855|NCT01423435|Beraprost|beraprost|mesh-list
64805856|NCT01423435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64805857|NCT01423435|Vasodilator Agents|vasodilator agents|mesh-ancestor
64805858|NCT01423487|Metformin|metformin|mesh-list
64805859|NCT01423487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64805860|NCT01423487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320127|NCT02183623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64320128|NCT02183623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320129|NCT02183623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64324804|NCT03649724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64324805|NCT03649724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324806|NCT01358695|Botulinum Toxins|botulinum toxins|mesh-list
64324807|NCT01358695|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64324808|NCT01358695|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64324809|NCT01358695|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64324810|NCT01358695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64324811|NCT01358695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324812|NCT01358695|Cholinergic Agents|cholinergic agents|mesh-ancestor
64324813|NCT01358695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64324814|NCT01358695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805871|NCT01423500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64805872|NCT01423500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64805873|NCT01423500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64805875|NCT01423500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64805876|NCT01423500|Alkylating Agents|alkylating agents|mesh-ancestor
64805877|NCT01423500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64805878|NCT01423539|Rituximab|rituximab|mesh-list
64805879|NCT01423539|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64805880|NCT01423539|Navitoclax|navitoclax|mesh-list
64805881|NCT01423539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64805882|NCT01423539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64805883|NCT01423539|Immunologic Factors|immunologic factors|mesh-ancestor
64805884|NCT01423539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805885|NCT01423539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64805886|NCT01423539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64320130|NCT02183623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320131|NCT02183623|Incretins|incretins|mesh-ancestor
64320132|NCT02183623|Hormones|hormones|mesh-ancestor
64320133|NCT02183623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64320134|NCT02183623|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64320135|NCT02183623|Protease Inhibitors|protease inhibitors|mesh-ancestor
64320136|NCT02183701|Losartan|losartan|mesh-list
64320137|NCT02183701|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64320138|NCT02183701|Telmisartan|telmisartan|mesh-list
64320139|NCT02183701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64320140|NCT02183701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64805887|NCT01423539|Alkylating Agents|alkylating agents|mesh-ancestor
64805888|NCT01423539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805889|NCT01423591|Infliximab|infliximab|mesh-list
64805890|NCT01423591|Dermatologic Agents|dermatologic agents|mesh-ancestor
64805891|NCT01423591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64805892|NCT01423591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64805893|NCT01423695|Paclitaxel|paclitaxel|mesh-list
64805894|NCT01423695|Trastuzumab|trastuzumab|mesh-list
64805895|NCT01423695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64805896|NCT01423695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64805897|NCT01423695|Tubulin Modulators|tubulin modulators|mesh-ancestor
64805898|NCT01423695|Antimitotic Agents|antimitotic agents|mesh-ancestor
64805899|NCT01423695|Mitosis Modulators|mitosis modulators|mesh-ancestor
64805900|NCT01423695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805901|NCT01423695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64805902|NCT01423708|Everolimus|everolimus|mesh-list
64805907|NCT01423747|Fludarabine|fludarabine|mesh-list
64805913|NCT01423747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805914|NCT01423747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64805915|NCT01423747|Immunologic Factors|immunologic factors|mesh-ancestor
64805916|NCT01423747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805917|NCT01423747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64805918|NCT01423747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64805919|NCT01423747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64805920|NCT01423747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64805921|NCT01423747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64749753|NCT03580980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805922|NCT01423747|Alkylating Agents|alkylating agents|mesh-ancestor
64805923|NCT01423747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64805924|NCT01423838|Solifenacin Succinate|solifenacin succinate|mesh-list
64805925|NCT01423838|Oxybutynin|oxybutynin|mesh-list
64805926|NCT01423838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64805927|NCT01423838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64805928|NCT01423838|Cholinergic Agents|cholinergic agents|mesh-ancestor
64805929|NCT01423838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64805930|NCT01423838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805931|NCT01423838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574538|NCT01458561|Thrombin|thrombin|mesh-list
64805932|NCT01423838|Urological Agents|urological agents|mesh-ancestor
64805933|NCT01423838|Parasympatholytics|parasympatholytics|mesh-ancestor
64805934|NCT01423838|Autonomic Agents|autonomic agents|mesh-ancestor
64805935|NCT01423838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64805936|NCT01423864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64805937|NCT01423864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64805938|NCT01423864|Methylprednisolone|methylprednisolone|mesh-list
64805939|NCT01423864|Prednisolone|prednisolone|mesh-list
64805940|NCT01423864|Prednisolone acetate|prednisolone acetate|mesh-list
64805956|NCT01423864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64805957|NCT01423955|Epoetin Alfa|epoetin alfa|mesh-list
64805958|NCT01423955|Hematinics|hematinics|mesh-ancestor
64805959|NCT01424046|Insulin Glargine|insulin glargine|mesh-list
64805960|NCT01424046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64805961|NCT01424046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805963|NCT01424111|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64805964|NCT01424111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64805965|NCT01424111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64805966|NCT01424111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64805967|NCT01424111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64805968|NCT01424111|Serotonin Agents|serotonin agents|mesh-ancestor
64805969|NCT01424111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64805970|NCT01424111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64805971|NCT01424111|Antidepressive Agents|antidepressive agents|mesh-ancestor
64805972|NCT01424111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64805973|NCT01424124|Montelukast|montelukast|mesh-list
64806011|NCT01424319|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64806012|NCT01424319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806014|NCT01424332|Salicylic Acid|salicylic acid|mesh-list
64806015|NCT01424332|Salicylates|salicylates|mesh-list
64806016|NCT01424332|Darexaban|darexaban|mesh-list
64749816|NCT03580590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749817|NCT03580590|Hemostatics|hemostatics|mesh-ancestor
64749818|NCT03580590|Coagulants|coagulants|mesh-ancestor
64749819|NCT03580590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64749820|NCT03580590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64749821|NCT03580590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64749822|NCT03580590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64749823|NCT03580590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749824|NCT03580590|Vasodilator Agents|vasodilator agents|mesh-ancestor
64749825|NCT03891576|Niraparib|niraparib|mesh-list
64749826|NCT03891576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64806017|NCT01424332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64806018|NCT01424332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64806019|NCT01424332|Analgesics|analgesics|mesh-ancestor
64806020|NCT01424332|Sensory System Agents|sensory system agents|mesh-ancestor
64806021|NCT01424332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806022|NCT01424332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806023|NCT01424332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64806024|NCT01424332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64806025|NCT01424332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64806026|NCT01424332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64806027|NCT01424332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806028|NCT01424332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64806029|NCT01424332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64806030|NCT01424332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806031|NCT01424332|Antipyretics|antipyretics|mesh-ancestor
64806032|NCT01424332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64806033|NCT01424332|Antifungal Agents|antifungal agents|mesh-ancestor
64806034|NCT01424332|Keratolytic Agents|keratolytic agents|mesh-ancestor
64806035|NCT01424332|Dermatologic Agents|dermatologic agents|mesh-ancestor
64806044|NCT01424384|Citalopram|citalopram|mesh-list
64806060|NCT01424449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64806061|NCT01424449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806062|NCT01424449|Dopamine Agonists|dopamine agonists|mesh-ancestor
64806063|NCT01424449|Dopamine Agents|dopamine agents|mesh-ancestor
64806064|NCT01424449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64806065|NCT01424449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806066|NCT01424449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64806067|NCT01424449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64806068|NCT01424449|Serotonin Agents|serotonin agents|mesh-ancestor
64386215|NCT02085460|Antioxidants|antioxidants|mesh-ancestor
64386216|NCT02085460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386217|NCT02085460|Protective Agents|protective agents|mesh-ancestor
64386218|NCT02085460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386219|NCT02085460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386220|NCT03164291|Rifabutin|rifabutin|mesh-list
64386221|NCT03164291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64386222|NCT03164291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64386223|NCT03164291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64386224|NCT03164291|Antitubercular Agents|antitubercular agents|mesh-ancestor
64386225|NCT02084134|Dexamethasone|dexamethasone|mesh-list
64386246|NCT01374269|Acetaminophen|acetaminophen|mesh-list
64806073|NCT01424618|Leuprolide|leuprolide|mesh-list
64806125|NCT01424826|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64806126|NCT01424826|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64806127|NCT01424826|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64806128|NCT01424839|Cisplatin|cisplatin|mesh-list
64806129|NCT01424839|Carboplatin|carboplatin|mesh-list
64806130|NCT01424839|Etoposide|etoposide|mesh-list
64806131|NCT01424839|Etoposide phosphate|etoposide phosphate|mesh-list
64806132|NCT01424839|Ifosfamide|ifosfamide|mesh-list
64806133|NCT01424839|Isophosphamide mustard|isophosphamide mustard|mesh-list
64806134|NCT01424839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806135|NCT01424839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64806136|NCT01424839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64806137|NCT01424839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64806138|NCT01424839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806139|NCT01424839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806140|NCT01424839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64806141|NCT01424839|Alkylating Agents|alkylating agents|mesh-ancestor
64806142|NCT01424891|Simvastatin|simvastatin|mesh-list
64806143|NCT01424891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64806144|NCT01424891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64806145|NCT01424891|Antimetabolites|antimetabolites|mesh-ancestor
64749966|NCT03155646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749967|NCT03155646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64749968|NCT03155646|Sympatholytics|sympatholytics|mesh-ancestor
64749969|NCT03155646|Autonomic Agents|autonomic agents|mesh-ancestor
64749970|NCT03155646|Anesthetics, Local|anesthetics, local|mesh-ancestor
64749971|NCT03155646|Anesthetics|anesthetics|mesh-ancestor
64749972|NCT03584178|Budesonide|budesonide|mesh-list
64749973|NCT03584178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64749974|NCT03584178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64806146|NCT01424891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806147|NCT01424891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64749975|NCT03584178|Autonomic Agents|autonomic agents|mesh-ancestor
64806177|NCT01425099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64806178|NCT01425125|Tolvaptan|tolvaptan|mesh-list
64806179|NCT01425125|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64806180|NCT01425125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806181|NCT01425125|Natriuretic Agents|natriuretic agents|mesh-ancestor
64806182|NCT01425125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806183|NCT01425164|Carvedilol|carvedilol|mesh-list
64806184|NCT01425164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64806185|NCT01425164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64806186|NCT01425164|Adrenergic Agents|adrenergic agents|mesh-ancestor
64806187|NCT01425164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64806188|NCT01425164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806189|NCT01425164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806190|NCT01425164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64806191|NCT01425164|Antioxidants|antioxidants|mesh-ancestor
64806192|NCT01425164|Protective Agents|protective agents|mesh-ancestor
64806193|NCT01425164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64806194|NCT01425164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64806195|NCT01425164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64806196|NCT01425164|Vasodilator Agents|vasodilator agents|mesh-ancestor
64806197|NCT01425164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64806198|NCT01425164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64806199|NCT01425216|Sorafenib|sorafenib|mesh-list
64806200|NCT01425216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750021|NCT03583242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64750022|NCT03583242|Growth Substances|growth substances|mesh-ancestor
64750023|NCT03583242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750024|NCT03583242|Growth Inhibitors|growth inhibitors|mesh-ancestor
64750025|NCT03583242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750027|NCT05701488|Tremelimumab|tremelimumab|mesh-list
64750028|NCT05701488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64750029|NCT05701488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750030|NCT02728050|Cytarabine|cytarabine|mesh-list
64750031|NCT02728050|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
64806201|NCT01425216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64806202|NCT01425216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806203|NCT01425216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806204|NCT01425242|Amlodipine|amlodipine|mesh-list
64806205|NCT01425242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64806206|NCT01425242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64806212|NCT01425320|Dapsone|dapsone|mesh-list
64806218|NCT01425320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806219|NCT01425320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806220|NCT01425320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64806221|NCT01425320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64806222|NCT01425320|Dermatologic Agents|dermatologic agents|mesh-ancestor
64806223|NCT01425320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64806224|NCT01425320|Antimalarials|antimalarials|mesh-ancestor
64806225|NCT01425320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64806226|NCT01425320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64806227|NCT01425320|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64806228|NCT01425320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64574839|NCT00784823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64806229|NCT01425320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806230|NCT01425320|Leprostatic Agents|leprostatic agents|mesh-ancestor
64806231|NCT01425320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64806232|NCT01425398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64806233|NCT01425398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64806234|NCT01425398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64806235|NCT01425398|Antimetabolites|antimetabolites|mesh-ancestor
64806236|NCT01425398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806237|NCT01425398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64806238|NCT01425398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64806267|NCT01425476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64806268|NCT01425476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64806269|NCT01425476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64806270|NCT01425476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806271|NCT01425476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750124|NCT03158142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64806272|NCT01425567|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
64806273|NCT01425567|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64806274|NCT01425567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64750125|NCT03158142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64750126|NCT03158142|Autonomic Agents|autonomic agents|mesh-ancestor
64750127|NCT03158142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64750128|NCT03158142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806276|NCT01425580|Liraglutide|liraglutide|mesh-list
64806277|NCT01425580|Glimepiride|glimepiride|mesh-list
64806278|NCT01425580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64806279|NCT01425580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806280|NCT01425580|Incretins|incretins|mesh-ancestor
64806281|NCT01425580|Hormones|hormones|mesh-ancestor
64806282|NCT01425580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64806283|NCT01425580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64806284|NCT01425580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64806285|NCT01425580|Immunologic Factors|immunologic factors|mesh-ancestor
64806286|NCT01425619|Lidocaine|lidocaine|mesh-list
64806287|NCT01425619|Prilocaine|prilocaine|mesh-list
64806288|NCT01425619|Anesthetics, Local|anesthetics, local|mesh-ancestor
64806289|NCT01425619|Anesthetics|anesthetics|mesh-ancestor
64806290|NCT01425619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64806291|NCT01425619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806292|NCT01425619|Sensory System Agents|sensory system agents|mesh-ancestor
64806293|NCT01425619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806294|NCT01425619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64806295|NCT01425619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64806296|NCT01425619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64806309|NCT01425658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64806310|NCT01425658|Anesthetics, General|anesthetics, general|mesh-ancestor
64806312|NCT01425658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64806313|NCT01425658|Sympatholytics|sympatholytics|mesh-ancestor
64806314|NCT01425658|Autonomic Agents|autonomic agents|mesh-ancestor
64806315|NCT01425658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64806316|NCT01425658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64806378|NCT05386186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64806379|NCT05386186|Immunologic Factors|immunologic factors|mesh-ancestor
64574992|NCT01454102|Nivolumab|nivolumab|mesh-list
64806381|NCT05386160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64386260|NCT01374269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806382|NCT05386160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64806383|NCT05386160|Growth Substances|growth substances|mesh-ancestor
64806384|NCT05386160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806385|NCT05386160|Growth Inhibitors|growth inhibitors|mesh-ancestor
64806386|NCT05386160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806387|NCT05386121|Fentanyl|fentanyl|mesh-list
64806388|NCT05386121|Meperidine|meperidine|mesh-list
64806389|NCT05386121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64806390|NCT05386121|Narcotics|narcotics|mesh-ancestor
64806391|NCT05386121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64806392|NCT05386121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806393|NCT05386121|Analgesics|analgesics|mesh-ancestor
64806394|NCT05386121|Sensory System Agents|sensory system agents|mesh-ancestor
64806395|NCT05386121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806396|NCT05386121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64806397|NCT05386121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64806398|NCT05386121|Anesthetics, General|anesthetics, general|mesh-ancestor
64806399|NCT05386121|Anesthetics|anesthetics|mesh-ancestor
64806400|NCT05386056|Pembrolizumab|pembrolizumab|mesh-list
64806403|NCT05385900|Oxaliplatin|oxaliplatin|mesh-list
64806430|NCT05385744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806431|NCT05385744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806432|NCT05385744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64806433|NCT05385744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64806434|NCT05385744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64806435|NCT05385744|Immunologic Factors|immunologic factors|mesh-ancestor
64806437|NCT05385185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806438|NCT05385185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64806439|NCT05385185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64806440|NCT05385185|Growth Substances|growth substances|mesh-ancestor
64806441|NCT05385185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806442|NCT05385185|Growth Inhibitors|growth inhibitors|mesh-ancestor
64806444|NCT05385094|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64806445|NCT05385094|Protease Inhibitors|protease inhibitors|mesh-ancestor
64806446|NCT05385094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806486|NCT05375708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806487|NCT05375708|Growth Inhibitors|growth inhibitors|mesh-ancestor
64806488|NCT05308979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64806489|NCT05308979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64806490|NCT05308979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64806491|NCT05308979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806492|NCT05308979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806493|NCT05308979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64806494|NCT05308979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64806495|NCT05308979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750269|NCT01673724|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64750270|NCT01673724|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64750271|NCT01673724|Dopamine Agonists|dopamine agonists|mesh-ancestor
64750272|NCT01673724|Dopamine Agents|dopamine agents|mesh-ancestor
64750273|NCT01673724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64750274|NCT01673724|Hormone Antagonists|hormone antagonists|mesh-ancestor
64750275|NCT01673724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64750276|NCT04765098|Tamoxifen|tamoxifen|mesh-list
64750277|NCT04765098|Etoposide|etoposide|mesh-list
64806496|NCT05308979|Cholinergic Agents|cholinergic agents|mesh-ancestor
64750283|NCT04765098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750284|NCT04765098|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64750285|NCT04765098|Hormone Antagonists|hormone antagonists|mesh-ancestor
64750286|NCT04765098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64806497|NCT05308979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64806498|NCT05210439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64806499|NCT05210439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64806500|NCT05210439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64806501|NCT05210439|Antitubercular Agents|antitubercular agents|mesh-ancestor
64806502|NCT05176379|Fluconazole|fluconazole|mesh-list
64806503|NCT05176379|Antifungal Agents|antifungal agents|mesh-ancestor
64806504|NCT05176379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64806505|NCT05176379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64806506|NCT05176379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64806507|NCT05176379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806508|NCT05176379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806535|NCT04850378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64806536|NCT04850378|Protease Inhibitors|protease inhibitors|mesh-ancestor
64806537|NCT04850378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806538|NCT04850378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806539|NCT04850378|Anticoagulants|anticoagulants|mesh-ancestor
64806540|NCT04850378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64806541|NCT04850378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64806542|NCT04809103|Cisplatin|cisplatin|mesh-list
64806543|NCT04809103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806544|NCT04804371|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64806545|NCT04804371|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64806546|NCT04804371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806547|NCT04765371|Dexamethasone|dexamethasone|mesh-list
64806548|NCT04765371|Dexamethasone acetate|dexamethasone acetate|mesh-list
64806549|NCT04765371|Prednisolone|prednisolone|mesh-list
64806550|NCT04765371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64806551|NCT04765371|Methylprednisolone|methylprednisolone|mesh-list
64806552|NCT04765371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64806553|NCT04765371|Prednisolone acetate|prednisolone acetate|mesh-list
64806554|NCT04765371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64806555|NCT04765371|Prednisolone phosphate|prednisolone phosphate|mesh-list
64806556|NCT04765371|BB 1101|bb 1101|mesh-list
64806557|NCT04765371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64806558|NCT04765371|Antiemetics|antiemetics|mesh-ancestor
64806559|NCT04765371|Autonomic Agents|autonomic agents|mesh-ancestor
64806586|NCT04729517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64806587|NCT04729517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64750315|NCT01674270|Hormone Antagonists|hormone antagonists|mesh-ancestor
64806588|NCT04729517|Histamine Antagonists|histamine antagonists|mesh-ancestor
64806589|NCT04729517|Histamine Agents|histamine agents|mesh-ancestor
64806590|NCT04729517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64806591|NCT04698525|Valproic Acid|valproic acid|mesh-list
64806592|NCT04698525|Memantine|memantine|mesh-list
64806593|NCT04698525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64806594|NCT04698525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64806595|NCT04698525|Dopamine Agents|dopamine agents|mesh-ancestor
64806596|NCT04698525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64806597|NCT04698525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750322|NCT01674504|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64806598|NCT04698525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806599|NCT04698525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64806600|NCT04698525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64806601|NCT04698525|Anticonvulsants|anticonvulsants|mesh-ancestor
64806602|NCT04698525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806603|NCT04698525|GABA Agents|gaba agents|mesh-ancestor
64806604|NCT04698525|Antimanic Agents|antimanic agents|mesh-ancestor
64806605|NCT04698525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64806642|NCT04560556|Immunologic Factors|immunologic factors|mesh-ancestor
64806643|NCT04560556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806644|NCT04425902|Flurbiprofen|flurbiprofen|mesh-list
64806645|NCT04425902|Metoprolol|metoprolol|mesh-list
64806646|NCT04425902|Digoxin|digoxin|mesh-list
64806647|NCT04425902|Midazolam|midazolam|mesh-list
64806648|NCT04425902|Caffeine|caffeine|mesh-list
64806649|NCT04425902|Omeprazole|omeprazole|mesh-list
64806650|NCT04425902|Pravastatin|pravastatin|mesh-list
64806651|NCT04425902|Montelukast|montelukast|mesh-list
64806652|NCT04425902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64806653|NCT04425902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64806654|NCT04425902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64806655|NCT04425902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806656|NCT04425902|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64386376|NCT04722887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64386377|NCT04722887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806657|NCT04425902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64806658|NCT04425902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64806659|NCT04425902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64806660|NCT04425902|Anesthetics, General|anesthetics, general|mesh-ancestor
64806661|NCT04425902|Anesthetics|anesthetics|mesh-ancestor
64806662|NCT04425902|GABA Modulators|gaba modulators|mesh-ancestor
64806663|NCT04425902|GABA Agents|gaba agents|mesh-ancestor
64806664|NCT04425902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64806665|NCT04425902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806696|NCT04425902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64806697|NCT04425902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64806698|NCT04425902|Analgesics|analgesics|mesh-ancestor
64806699|NCT04425902|Sensory System Agents|sensory system agents|mesh-ancestor
64806700|NCT04425902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64806701|NCT04425902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64806702|NCT04425902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64806703|NCT04425902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64750323|NCT01674504|Hormone Antagonists|hormone antagonists|mesh-ancestor
64750324|NCT01674504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64750325|NCT01674504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750326|NCT01674504|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64750327|NCT01674504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64750328|NCT01674504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750329|NCT05353062|Epinephrine|epinephrine|mesh-list
64750330|NCT05353062|Hemostatics|hemostatics|mesh-list
64750331|NCT05353062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64750332|NCT05353062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64750333|NCT05353062|Adrenergic Agents|adrenergic agents|mesh-ancestor
64750334|NCT05353062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64444568|NCT02247440|Ribavirin|ribavirin|mesh-list
64806704|NCT04425902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64806705|NCT04421677|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64806706|NCT04421677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806707|NCT04370093|Pioglitazone|pioglitazone|mesh-list
64806708|NCT04370093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64806709|NCT04370093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806710|NCT04311762|Cisplatin|cisplatin|mesh-list
64806711|NCT04311762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806712|NCT04203472|Budesonide|budesonide|mesh-list
64806713|NCT04203472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64806714|NCT04203472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64806715|NCT04203472|Autonomic Agents|autonomic agents|mesh-ancestor
64806716|NCT04203472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806717|NCT04203472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806718|NCT04203472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64806719|NCT04203472|Respiratory System Agents|respiratory system agents|mesh-ancestor
64806720|NCT04203472|Glucocorticoids|glucocorticoids|mesh-ancestor
64806721|NCT04203472|Hormones|hormones|mesh-ancestor
64806723|NCT04166071|Naltrexone|naltrexone|mesh-list
64806743|NCT03996265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64806744|NCT03996265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806746|NCT03996265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64806747|NCT03996265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806748|NCT03996265|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64386476|NCT04205903|Paclitaxel|paclitaxel|mesh-list
64806749|NCT03996265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64806750|NCT03996265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806751|NCT03945084|Niraparib|niraparib|mesh-list
64806752|NCT03945084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64806753|NCT03945084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806754|NCT03945084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806755|NCT03945084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806757|NCT03882463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64806758|NCT03882463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806759|NCT03861481|Rozanolixizumab|rozanolixizumab|mesh-list
64806760|NCT03861481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64806761|NCT03861481|Immunologic Factors|immunologic factors|mesh-ancestor
64806762|NCT03861481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806763|NCT03821649|Naloxone|naloxone|mesh-list
64806764|NCT03821649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64806765|NCT03821649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806766|NCT03821649|Sensory System Agents|sensory system agents|mesh-ancestor
64806767|NCT03821649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806768|NCT03811262|Levobupivacaine|levobupivacaine|mesh-list
64806769|NCT03811262|Anesthetics, Local|anesthetics, local|mesh-ancestor
64806770|NCT03811262|Anesthetics|anesthetics|mesh-ancestor
64386510|NCT01430351|Alkylating Agents|alkylating agents|mesh-ancestor
64386562|NCT04479527|Apatinib|apatinib|mesh-list
64750335|NCT05353062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750336|NCT05353062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750337|NCT05353062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64750338|NCT05353062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64750339|NCT05353062|Autonomic Agents|autonomic agents|mesh-ancestor
64750340|NCT05353062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64750361|NCT03152370|Protective Agents|protective agents|mesh-ancestor
64750362|NCT03152370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750363|NCT03152370|Vitamin B Complex|vitamin b complex|mesh-ancestor
64386563|NCT04479527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386568|NCT02391077|Chlorhexidine|chlorhexidine|mesh-list
64750364|NCT03152370|Vitamins|vitamins|mesh-ancestor
64806780|NCT03771612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806781|NCT03771612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806782|NCT03771612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64806783|NCT03771612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64806784|NCT03771612|Gout Suppressants|gout suppressants|mesh-ancestor
64806785|NCT03771612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64806786|NCT03771612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806787|NCT03771612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806788|NCT03759028|Acetaminophen|acetaminophen|mesh-list
64806789|NCT03759028|Ibuprofen|ibuprofen|mesh-list
64806790|NCT03759028|Oxycodone|oxycodone|mesh-list
64806791|NCT03759028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64806792|NCT03759028|Analgesics|analgesics|mesh-ancestor
64806793|NCT03759028|Sensory System Agents|sensory system agents|mesh-ancestor
64806794|NCT03759028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806795|NCT03759028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806829|NCT03713424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64806830|NCT03713424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64806831|NCT03713424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806832|NCT03713424|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64806833|NCT03708198|Bupivacaine|bupivacaine|mesh-list
64806834|NCT03708198|Anesthetics, Local|anesthetics, local|mesh-ancestor
64806835|NCT03708198|Anesthetics|anesthetics|mesh-ancestor
64806836|NCT03708198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64806837|NCT03708198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806838|NCT03708198|Sensory System Agents|sensory system agents|mesh-ancestor
64806839|NCT03708198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806840|NCT03559426|Antipsychotic Agents|antipsychotic agents|mesh-list
64806841|NCT03559426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64806842|NCT03559426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64806843|NCT03559426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806844|NCT03559426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64386614|NCT03806309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386623|NCT03806309|Antidotes|antidotes|mesh-ancestor
64806845|NCT03512405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64806846|NCT03512405|Pembrolizumab|pembrolizumab|mesh-list
64806847|NCT03512405|Blinatumomab|blinatumomab|mesh-list
64806884|NCT02786875|Vitamins|vitamins|mesh-list
64806885|NCT02786875|Micronutrients|micronutrients|mesh-ancestor
64806886|NCT02786875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806887|NCT02786875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64806888|NCT02786875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64750432|NCT04747080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64750433|NCT04747080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64750434|NCT04747080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750435|NCT04747080|Protease Inhibitors|protease inhibitors|mesh-ancestor
64750436|NCT04747080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750437|NCT04747080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750438|NCT04747080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64750439|NCT04747080|Immunologic Factors|immunologic factors|mesh-ancestor
64750440|NCT04747080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64750441|NCT01675362|Selenium|selenium|mesh-list
64806889|NCT02767882|Dexamethasone|dexamethasone|mesh-list
64806890|NCT02767882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64806891|NCT02767882|Antiemetics|antiemetics|mesh-ancestor
64806892|NCT02767882|Autonomic Agents|autonomic agents|mesh-ancestor
64806893|NCT02767882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64806894|NCT02767882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806895|NCT02767882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64806896|NCT02767882|Glucocorticoids|glucocorticoids|mesh-ancestor
64806897|NCT02767882|Hormones|hormones|mesh-ancestor
64806898|NCT02767882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64806945|NCT02246257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64806946|NCT02197221|Bortezomib|bortezomib|mesh-list
64806947|NCT02197221|Melphalan|melphalan|mesh-list
64806948|NCT02197221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64806949|NCT02197221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64806950|NCT02197221|Alkylating Agents|alkylating agents|mesh-ancestor
64806951|NCT02197221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64806952|NCT02197221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64806953|NCT02197221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64806954|NCT02197221|Immunologic Factors|immunologic factors|mesh-ancestor
64806955|NCT02197221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64806956|NCT02094794|Cyclophosphamide|cyclophosphamide|mesh-list
64807009|NCT01231906|Dexrazoxane|dexrazoxane|mesh-list
64807010|NCT01231906|Razoxane|razoxane|mesh-list
64807011|NCT01231906|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
64807012|NCT01231906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64807013|NCT01231906|Immunologic Factors|immunologic factors|mesh-ancestor
64807014|NCT01231906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807015|NCT01231906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64807016|NCT01231906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64807017|NCT01231906|Alkylating Agents|alkylating agents|mesh-ancestor
64807018|NCT01231906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807019|NCT01231906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807020|NCT01231906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64807021|NCT01231906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64807022|NCT01231906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64807023|NCT01231906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64807024|NCT01231906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807025|NCT01231906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64807026|NCT01231906|Tubulin Modulators|tubulin modulators|mesh-ancestor
64807027|NCT01231906|Antimitotic Agents|antimitotic agents|mesh-ancestor
64807028|NCT01231906|Mitosis Modulators|mitosis modulators|mesh-ancestor
64807029|NCT01231906|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64807030|NCT01231906|Keratolytic Agents|keratolytic agents|mesh-ancestor
64807060|NCT01425840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64750454|NCT01675362|Protective Agents|protective agents|mesh-ancestor
64807061|NCT01425840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807062|NCT01425840|Sensory System Agents|sensory system agents|mesh-ancestor
64807063|NCT01425840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807064|NCT01425840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64807065|NCT01425840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64807066|NCT01425840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64807067|NCT01425840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64807068|NCT01425840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807069|NCT01425996|Camptothecin|camptothecin|mesh-list
64807070|NCT01425996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64807071|NCT01425996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807072|NCT01425996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64807073|NCT01425996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64807074|NCT01425996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807075|NCT01425996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807076|NCT01426022|Ethanol|ethanol|mesh-list
64807077|NCT01426022|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64807078|NCT01426022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64807092|NCT01426087|Hormones|hormones|mesh-ancestor
64807110|NCT01426165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64807111|NCT01426165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807112|NCT01426165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64807113|NCT01426165|Tocolytic Agents|tocolytic agents|mesh-ancestor
64807114|NCT01426165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64807115|NCT01426256|Vitamin D|vitamin d|mesh-list
64807116|NCT01426256|Cholecalciferol|cholecalciferol|mesh-list
64807117|NCT01426256|Vitamins|vitamins|mesh-ancestor
64807118|NCT01426256|Micronutrients|micronutrients|mesh-ancestor
64807119|NCT01426256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807120|NCT01426256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64807121|NCT01426256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64807122|NCT01426334|Cyclosporine|cyclosporine|mesh-list
64807123|NCT01426334|Dasatinib|dasatinib|mesh-list
64807124|NCT01426334|Cyclosporins|cyclosporins|mesh-list
64807125|NCT01426334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807126|NCT01426334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807127|NCT01426334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64807128|NCT01426334|Immunologic Factors|immunologic factors|mesh-ancestor
64807129|NCT01426334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807130|NCT01426334|Antifungal Agents|antifungal agents|mesh-ancestor
64807131|NCT01426334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64807132|NCT01426334|Dermatologic Agents|dermatologic agents|mesh-ancestor
64807133|NCT01426334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64807134|NCT01426334|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64807135|NCT01426334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807136|NCT01426334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64807160|NCT01426633|Gemcitabine|gemcitabine|mesh-list
64807161|NCT01426633|Trabectedin|trabectedin|mesh-list
64807162|NCT01426633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64807163|NCT01426633|Antimetabolites|antimetabolites|mesh-ancestor
64807164|NCT01426633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750494|NCT03875664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64750495|NCT03875664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750496|NCT03875664|Sensory System Agents|sensory system agents|mesh-ancestor
64750497|NCT03875664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64750498|NCT01670136|Sildenafil Citrate|sildenafil citrate|mesh-list
64750499|NCT01670136|Vasodilator Agents|vasodilator agents|mesh-ancestor
64750500|NCT01670136|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64750501|NCT01670136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64807165|NCT01426633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807166|NCT01426633|Antiviral Agents|antiviral agents|mesh-ancestor
64807167|NCT01426633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64807168|NCT01426633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807169|NCT01426633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64807170|NCT01426633|Immunologic Factors|immunologic factors|mesh-ancestor
64807171|NCT01426633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807172|NCT01426633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64807173|NCT01426633|Alkylating Agents|alkylating agents|mesh-ancestor
64807174|NCT01426646|Cisplatin|cisplatin|mesh-list
64807175|NCT01426646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807176|NCT01426737|Vildagliptin|vildagliptin|mesh-list
64807177|NCT01426737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64807218|NCT01426906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64807219|NCT01426906|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64807220|NCT01426906|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64807221|NCT01426906|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64807222|NCT01426906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64807223|NCT01426906|Antifungal Agents|antifungal agents|mesh-ancestor
64750523|NCT03873480|Anesthetics|anesthetics|mesh-ancestor
64807224|NCT01426906|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64807225|NCT01426906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64807226|NCT01426906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64807227|NCT01426906|Hormone Antagonists|hormone antagonists|mesh-ancestor
64807228|NCT01426906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64807229|NCT01426906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807230|NCT01426906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64807231|NCT01426971|Ibuprofen|ibuprofen|mesh-list
64807232|NCT01426971|Caffeine|caffeine|mesh-list
64807233|NCT01426971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64807234|NCT01426971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64807235|NCT01426971|Analgesics|analgesics|mesh-ancestor
64807236|NCT01426971|Sensory System Agents|sensory system agents|mesh-ancestor
64807237|NCT01426971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64418414|NCT02586805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64418415|NCT02586805|Immunologic Factors|immunologic factors|mesh-ancestor
64418416|NCT02586805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750569|NCT01677390|Everolimus|everolimus|mesh-list
64807268|NCT01427114|Alkylating Agents|alkylating agents|mesh-ancestor
64750570|NCT01677390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807269|NCT01427114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750571|NCT01677390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64750572|NCT01677390|Immunologic Factors|immunologic factors|mesh-ancestor
64750573|NCT01677390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750574|NCT03749460|Nivolumab|nivolumab|mesh-list
64750575|NCT03749460|Ipilimumab|ipilimumab|mesh-list
64750580|NCT03749070|Silymarin|silymarin|mesh-list
64807270|NCT01427114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807271|NCT01427114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64807272|NCT01427114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64807331|NCT01427335|Calcium, Dietary|calcium, dietary|mesh-list
64807332|NCT01427335|Calcium|calcium|mesh-list
64807333|NCT01427335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64807334|NCT01427335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807335|NCT01427335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64807336|NCT01427387|Linaclotide|linaclotide|mesh-list
64807337|NCT01427387|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64807338|NCT01427387|Enzyme Activators|enzyme activators|mesh-ancestor
64807339|NCT01427387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807340|NCT01427387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64807341|NCT01427400|Botulinum Toxins|botulinum toxins|mesh-list
64807342|NCT01427400|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64807343|NCT01427400|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64807344|NCT01427400|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64807345|NCT01427400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64807346|NCT01427400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807347|NCT01427400|Cholinergic Agents|cholinergic agents|mesh-ancestor
64807348|NCT01427400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64750654|NCT03652974|GABA Antagonists|gaba antagonists|mesh-ancestor
64750655|NCT03652974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64750656|NCT03652974|Dopamine Agents|dopamine agents|mesh-ancestor
64750657|NCT03652974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64750658|NCT03652974|Antidepressive Agents|antidepressive agents|mesh-ancestor
64750659|NCT03649152|Proxigermanium|proxigermanium|mesh-list
64750660|NCT03649152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750664|NCT03646188|Doxorubicin|doxorubicin|mesh-list
64807349|NCT01427400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807350|NCT01427400|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64807351|NCT01427400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807352|NCT01427478|Afatinib|afatinib|mesh-list
64807353|NCT01427478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807354|NCT01427478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64807355|NCT01427478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807356|NCT01427478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807357|NCT01427491|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64807376|NCT01427686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64807377|NCT01427686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807378|NCT01427686|Protective Agents|protective agents|mesh-ancestor
64807379|NCT01427686|Dopamine Agents|dopamine agents|mesh-ancestor
64807380|NCT01427699|Antibodies|antibodies|mesh-list
64807381|NCT01427699|Immunologic Factors|immunologic factors|mesh-ancestor
64386781|NCT04714372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64807382|NCT01427699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807383|NCT01427842|Vancomycin|vancomycin|mesh-list
64807384|NCT01427842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64807385|NCT01427842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64807386|NCT01427868|Maleic acid|maleic acid|mesh-list
64807387|NCT01427868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807388|NCT01427868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807389|NCT01427946|Everolimus|everolimus|mesh-list
64807390|NCT01427946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807391|NCT01427946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64807392|NCT01427946|Immunologic Factors|immunologic factors|mesh-ancestor
64807393|NCT01427946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807394|NCT01427985|Atropine|atropine|mesh-list
64807395|NCT01427985|Fentanyl|fentanyl|mesh-list
64807396|NCT01427985|Mivacurium|mivacurium|mesh-list
64807397|NCT01427985|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64807398|NCT01427985|Narcotics|narcotics|mesh-ancestor
64807399|NCT01427985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64807400|NCT01427985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576050|NCT00078559|Acetaminophen|acetaminophen|mesh-list
64807428|NCT01428037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64751163|NCT03524820|Cetuximab|cetuximab|mesh-list
64807429|NCT01428037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64807430|NCT01428037|Oxytocics|oxytocics|mesh-ancestor
64807431|NCT01428050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64807432|NCT01428154|Darbepoetin alfa|darbepoetin alfa|mesh-list
64807433|NCT01428154|Hematinics|hematinics|mesh-ancestor
64807434|NCT01428180|Ibuprofen|ibuprofen|mesh-list
64807435|NCT01428180|Indomethacin|indomethacin|mesh-list
64807436|NCT01428180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64807437|NCT01428180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64807438|NCT01428180|Analgesics|analgesics|mesh-ancestor
64807439|NCT01428180|Sensory System Agents|sensory system agents|mesh-ancestor
64807440|NCT01428180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807441|NCT01428180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807442|NCT01428180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64807443|NCT01428180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64807444|NCT01428180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64807445|NCT01428180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807446|NCT01428180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807447|NCT01428180|Gout Suppressants|gout suppressants|mesh-ancestor
64807448|NCT01428180|Tocolytic Agents|tocolytic agents|mesh-ancestor
64807449|NCT01428180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64807450|NCT01428284|Canagliflozin|canagliflozin|mesh-list
64807451|NCT01428284|Probenecid|probenecid|mesh-list
64807452|NCT01428284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64751273|NCT00089778|Mitogens|mitogens|mesh-list
64807453|NCT01428284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807454|NCT01428284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64807455|NCT01428284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807456|NCT01428284|Uricosuric Agents|uricosuric agents|mesh-ancestor
64807457|NCT01428284|Gout Suppressants|gout suppressants|mesh-ancestor
64807459|NCT01428284|Renal Agents|renal agents|mesh-ancestor
64807471|NCT01428388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64807472|NCT01428388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64807473|NCT01428388|Growth Substances|growth substances|mesh-ancestor
64807474|NCT01428388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807475|NCT01428388|Growth Inhibitors|growth inhibitors|mesh-ancestor
64807476|NCT01428414|Paclitaxel|paclitaxel|mesh-list
64807477|NCT01428414|Carboplatin|carboplatin|mesh-list
64807478|NCT01428414|Trastuzumab|trastuzumab|mesh-list
64807479|NCT01428414|Epirubicin|epirubicin|mesh-list
64807480|NCT01428414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64807481|NCT01428414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807491|NCT01428427|Gemcitabine|gemcitabine|mesh-list
64807537|NCT01428531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807538|NCT01428531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807539|NCT01428531|Anticoagulants|anticoagulants|mesh-ancestor
64807540|NCT01428531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64807541|NCT01428531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64751609|NCT01679574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64751612|NCT01679652|Nebivolol|nebivolol|mesh-list
64751650|NCT03080766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751651|NCT03080766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751652|NCT03080766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751653|NCT03088722|Contraceptive Agents|contraceptive agents|mesh-list
64751654|NCT03088722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64751655|NCT03088722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751656|NCT03088644|(18)F-JNJ-64413739|(18)f-jnj-64413739|mesh-list
64751657|NCT03088644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64751658|NCT03088644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751659|NCT03088254|Amlodipine|amlodipine|mesh-list
64751660|NCT03088254|Telmisartan|telmisartan|mesh-list
64751661|NCT03088254|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64751662|NCT03088254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64807542|NCT01428544|PENTA|penta|mesh-list
64751663|NCT03088254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64807543|NCT01428544|Fondaparinux|fondaparinux|mesh-list
64807544|NCT01428544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64807545|NCT01428544|Antithrombins|antithrombins|mesh-ancestor
64807546|NCT01428544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64807547|NCT01428544|Protease Inhibitors|protease inhibitors|mesh-ancestor
64807548|NCT01428544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807549|NCT01428544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807550|NCT01428544|Anticoagulants|anticoagulants|mesh-ancestor
64807551|NCT01428544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64807552|NCT01428544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64807553|NCT01428622|Olodaterol|olodaterol|mesh-list
64807554|NCT01428622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64807555|NCT01428622|Autonomic Agents|autonomic agents|mesh-ancestor
64807556|NCT01428622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807557|NCT01428622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807558|NCT01428622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64807559|NCT01428622|Respiratory System Agents|respiratory system agents|mesh-ancestor
64807560|NCT01428817|Carbetocin|carbetocin|mesh-list
64807561|NCT01428817|Oxytocin|oxytocin|mesh-list
64807562|NCT01428817|Oxytocics|oxytocics|mesh-ancestor
64807563|NCT01428817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64807564|NCT01428817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807565|NCT01428908|Vaccines|vaccines|mesh-list
64807566|NCT01428908|Immunologic Factors|immunologic factors|mesh-ancestor
64807567|NCT01428908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807568|NCT01428986|Maraviroc|maraviroc|mesh-list
64807569|NCT01428986|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64751767|NCT05667324|Hormones|hormones|mesh-ancestor
64807570|NCT01428986|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64807571|NCT01428986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807572|NCT01428986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64807575|NCT01428986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64807576|NCT01428986|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64807577|NCT01429025|Rituximab|rituximab|mesh-list
64807578|NCT01429025|Lenalidomide|lenalidomide|mesh-list
64807579|NCT01429025|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64576209|NCT00182767|Doxorubicin|doxorubicin|mesh-list
64386865|NCT02382029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64807584|NCT01429025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64807585|NCT01429025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64807586|NCT01429025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64807587|NCT01429025|Growth Substances|growth substances|mesh-ancestor
64807588|NCT01429025|Growth Inhibitors|growth inhibitors|mesh-ancestor
64807589|NCT01429025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64807590|NCT01429025|Alkylating Agents|alkylating agents|mesh-ancestor
64807591|NCT01429025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807592|NCT01429090|Methantheline|methantheline|mesh-list
64807593|NCT01429090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64807594|NCT01429090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64807595|NCT01429090|Cholinergic Agents|cholinergic agents|mesh-ancestor
64807596|NCT01429090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64807597|NCT01429090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807599|NCT01429129|Nicotine|nicotine|mesh-list
64807624|NCT01429337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807625|NCT01429402|Botulinum Toxins|botulinum toxins|mesh-list
64807626|NCT01429402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64807627|NCT01429402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64807628|NCT01429402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64807629|NCT01429402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64807630|NCT01429402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807631|NCT01429402|Cholinergic Agents|cholinergic agents|mesh-ancestor
64807632|NCT01429402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64807633|NCT01429402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807634|NCT01429402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64807635|NCT01429402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807636|NCT01429415|Magnesium Sulfate|magnesium sulfate|mesh-list
64807637|NCT01429415|Analgesics|analgesics|mesh-ancestor
64807638|NCT01429415|Sensory System Agents|sensory system agents|mesh-ancestor
64807639|NCT01429415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807640|NCT01429415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807641|NCT01429415|Anesthetics|anesthetics|mesh-ancestor
64807642|NCT01429415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64807643|NCT01429415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64807644|NCT01429415|Anticonvulsants|anticonvulsants|mesh-ancestor
64807645|NCT01429415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64807646|NCT01429415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64807647|NCT01429415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807648|NCT01429415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64807649|NCT01429415|Tocolytic Agents|tocolytic agents|mesh-ancestor
64807650|NCT01429415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64807652|NCT01429545|Vasotocin|vasotocin|mesh-list
64807653|NCT01429545|Atosiban|atosiban|mesh-list
64807654|NCT01429545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64807655|NCT01429545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64807656|NCT01429545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386915|NCT02385071|Simeprevir|simeprevir|mesh-list
64386916|NCT02385071|Antiviral Agents|antiviral agents|mesh-ancestor
64386917|NCT02385071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64386918|NCT02385071|Protease Inhibitors|protease inhibitors|mesh-ancestor
64807660|NCT01429545|Tocolytic Agents|tocolytic agents|mesh-ancestor
64807661|NCT01429545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64807662|NCT01429545|Hormone Antagonists|hormone antagonists|mesh-ancestor
64807663|NCT01429545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64807664|NCT01429545|Oxytocics|oxytocics|mesh-ancestor
64807665|NCT01429545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64807666|NCT01429571|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64807667|NCT01429571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64807668|NCT01429610|Cytarabine|cytarabine|mesh-list
64807669|NCT01429610|Rituximab|rituximab|mesh-list
64807670|NCT01429610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64807671|NCT01429610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64807672|NCT01429610|Immunologic Factors|immunologic factors|mesh-ancestor
64807673|NCT01429610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807674|NCT01429610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64807675|NCT01429610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64807676|NCT01429610|Antimetabolites|antimetabolites|mesh-ancestor
64807677|NCT01429610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807678|NCT01429610|Antiviral Agents|antiviral agents|mesh-ancestor
64807679|NCT01429610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64807680|NCT01429610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64807681|NCT01429675|Ibandronic Acid|ibandronic acid|mesh-list
64807682|NCT01429675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64807683|NCT01429675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807684|NCT01429701|Gentamicins|gentamicins|mesh-list
64807685|NCT01429701|Polymyxins|polymyxins|mesh-list
64807686|NCT01429701|Polymyxin B|polymyxin b|mesh-list
64807687|NCT01429701|Prednisolone|prednisolone|mesh-list
64807688|NCT01429701|Betamethasone|betamethasone|mesh-list
64807689|NCT01429701|Benzocaine|benzocaine|mesh-list
64807699|NCT01429701|Respiratory System Agents|respiratory system agents|mesh-ancestor
64807701|NCT01429701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64807702|NCT01429701|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64807703|NCT01429701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807704|NCT01429701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807705|NCT01429701|Anesthetics, Local|anesthetics, local|mesh-ancestor
64807706|NCT01429701|Anesthetics|anesthetics|mesh-ancestor
64807707|NCT01429701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64807708|NCT01429701|Sensory System Agents|sensory system agents|mesh-ancestor
64807709|NCT01429714|Oxymetazoline|oxymetazoline|mesh-list
64807710|NCT01429714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64807711|NCT01429714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64807712|NCT01429714|Adrenergic Agents|adrenergic agents|mesh-ancestor
64807713|NCT01429714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64807714|NCT01429714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807715|NCT01429714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807716|NCT01429714|Sympathomimetics|sympathomimetics|mesh-ancestor
64807717|NCT01429714|Autonomic Agents|autonomic agents|mesh-ancestor
64807718|NCT01429714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807719|NCT01429714|Nasal Decongestants|nasal decongestants|mesh-ancestor
64807720|NCT01429714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64807721|NCT01429714|Respiratory System Agents|respiratory system agents|mesh-ancestor
64807722|NCT01429818|Metformin|metformin|mesh-list
64807723|NCT01429818|Glimepiride|glimepiride|mesh-list
64807724|NCT01429818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64807725|NCT01429818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807726|NCT01429818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64751920|NCT05686434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64807727|NCT01429818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64807728|NCT01429818|Immunologic Factors|immunologic factors|mesh-ancestor
64807743|NCT01429831|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64807744|NCT01429831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64807745|NCT01429831|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64807746|NCT01429831|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64807747|NCT01429844|Cyclosporine|cyclosporine|mesh-list
64807748|NCT01429844|Tacrolimus|tacrolimus|mesh-list
64386973|NCT02380625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64807749|NCT01429844|Cyclosporins|cyclosporins|mesh-list
64807750|NCT01429844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64807751|NCT01429844|Immunologic Factors|immunologic factors|mesh-ancestor
64807752|NCT01429844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807753|NCT01429844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64807754|NCT01429844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64807755|NCT01429844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807756|NCT01429844|Antifungal Agents|antifungal agents|mesh-ancestor
64807757|NCT01429844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64807758|NCT01429844|Dermatologic Agents|dermatologic agents|mesh-ancestor
64807759|NCT01429844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64807801|NCT01430065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807802|NCT01430065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64807803|NCT01430065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576431|NCT01538745|Anesthetics|anesthetics|mesh-ancestor
64807804|NCT01430065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807805|NCT01430078|Niacinamide|niacinamide|mesh-list
64807871|NCT01430910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64807872|NCT01430923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64807873|NCT01430923|Latanoprost|latanoprost|mesh-list
64807874|NCT01430923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64807877|NCT01431053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64807878|NCT01431053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64807879|NCT01431053|Analgesics|analgesics|mesh-ancestor
64807880|NCT01431053|Sensory System Agents|sensory system agents|mesh-ancestor
64807881|NCT01431053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807882|NCT01431053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807891|NCT01431053|Antipyretics|antipyretics|mesh-ancestor
64807936|NCT01431326|Labetalol|labetalol|mesh-list
64807937|NCT01431326|Nifedipine|nifedipine|mesh-list
64807938|NCT01431326|Spironolactone|spironolactone|mesh-list
64807939|NCT01431326|Pentobarbital|pentobarbital|mesh-list
64807940|NCT01431326|Oxycodone|oxycodone|mesh-list
64807941|NCT01431326|Alfentanil|alfentanil|mesh-list
64807942|NCT01431326|Haloperidol|haloperidol|mesh-list
64807943|NCT01431326|Zolpidem|zolpidem|mesh-list
64807944|NCT01431326|Ziprasidone|ziprasidone|mesh-list
64807945|NCT01431326|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64807946|NCT01431326|Clozapine|clozapine|mesh-list
64807947|NCT01431326|Molindone|molindone|mesh-list
64807948|NCT01431326|Warfarin|warfarin|mesh-list
64807949|NCT01431326|Tranexamic Acid|tranexamic acid|mesh-list
64807950|NCT01431326|Aminocaproic Acid|aminocaproic acid|mesh-list
64807951|NCT01431326|Rocuronium|rocuronium|mesh-list
64807952|NCT01431326|Vecuronium Bromide|vecuronium bromide|mesh-list
64807953|NCT01431326|Sevelamer|sevelamer|mesh-list
64807954|NCT01431326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64807955|NCT01431326|Antiemetics|antiemetics|mesh-ancestor
64807956|NCT01431326|Autonomic Agents|autonomic agents|mesh-ancestor
64807957|NCT01431326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64807958|NCT01431326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64807959|NCT01431326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64807994|NCT01431326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64387039|NCT02661815|Tubulin Modulators|tubulin modulators|mesh-ancestor
64807996|NCT01431326|Tocolytic Agents|tocolytic agents|mesh-ancestor
64807997|NCT01431326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64807998|NCT01431326|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64807999|NCT01431326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64808000|NCT01431326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64808001|NCT01431326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64808002|NCT01431326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64808003|NCT01431326|Dopamine Agents|dopamine agents|mesh-ancestor
64808004|NCT01431326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808005|NCT01431326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64808006|NCT01431326|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64808007|NCT01431326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64808008|NCT01431326|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64808009|NCT01431326|GABA Agonists|gaba agonists|mesh-ancestor
64808010|NCT01431326|GABA Agents|gaba agents|mesh-ancestor
64808011|NCT01431326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64808012|NCT01431326|Serotonin Agents|serotonin agents|mesh-ancestor
64808013|NCT01431326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64808014|NCT01431326|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64808015|NCT01431326|Chelating Agents|chelating agents|mesh-ancestor
64808016|NCT01431326|Sequestering Agents|sequestering agents|mesh-ancestor
64808017|NCT01431326|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64808018|NCT01431326|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64808019|NCT01431326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64808020|NCT01431326|Adrenergic Agents|adrenergic agents|mesh-ancestor
64808021|NCT01431326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64808022|NCT01431326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64808023|NCT01431326|GABA Antagonists|gaba antagonists|mesh-ancestor
64808025|NCT01431326|Sympathomimetics|sympathomimetics|mesh-ancestor
64808039|NCT01431352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64808040|NCT01431352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64808041|NCT01431352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808042|NCT01431352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64808043|NCT01431352|Hormone Antagonists|hormone antagonists|mesh-ancestor
64808044|NCT01431352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64808045|NCT01431352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808046|NCT01431404|Etanercept|etanercept|mesh-list
64808047|NCT01431404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64808049|NCT01431404|Analgesics|analgesics|mesh-ancestor
64808103|NCT01431612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64808104|NCT01431612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808105|NCT01431612|Sympathomimetics|sympathomimetics|mesh-ancestor
64387084|NCT04688021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387085|NCT04688021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64387162|NCT02378441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64387163|NCT02378441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387164|NCT02378441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64387165|NCT02378441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64387166|NCT02378441|Antimetabolites|antimetabolites|mesh-ancestor
64387167|NCT02378441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387168|NCT02378441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64387169|NCT02378441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64387170|NCT02378441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387171|NCT04072445|Trifluridine|trifluridine|mesh-list
64387172|NCT04072445|Irinotecan|irinotecan|mesh-list
64808106|NCT01431612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64808107|NCT01431612|Nasal Decongestants|nasal decongestants|mesh-ancestor
64808108|NCT01431612|Respiratory System Agents|respiratory system agents|mesh-ancestor
64808109|NCT01431612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64808110|NCT01431612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64808111|NCT01431612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64808112|NCT01431612|Adrenergic Agents|adrenergic agents|mesh-ancestor
64808113|NCT01431612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808114|NCT01431612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808115|NCT01431612|Protective Agents|protective agents|mesh-ancestor
64808116|NCT01431612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64808117|NCT01431612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64808118|NCT01431612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64808119|NCT01431690|Warfarin|warfarin|mesh-list
64808120|NCT01431690|Anticoagulants|anticoagulants|mesh-list
64808121|NCT01431729|Propolis|propolis|mesh-list
64808122|NCT01431729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64808123|NCT01431742|Buprenorphine|buprenorphine|mesh-list
64808124|NCT01431742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64808125|NCT01431742|Narcotics|narcotics|mesh-ancestor
64808126|NCT01431742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64808127|NCT01431742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808128|NCT01431742|Analgesics|analgesics|mesh-ancestor
64808129|NCT01431742|Sensory System Agents|sensory system agents|mesh-ancestor
64808152|NCT01431924|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64808153|NCT01431924|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64808154|NCT01431924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64808155|NCT01431924|Adrenergic Agents|adrenergic agents|mesh-ancestor
64808156|NCT01431924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808157|NCT01431924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808158|NCT01432028|Drospirenone|drospirenone|mesh-list
64808159|NCT01432028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64808160|NCT01432028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64808161|NCT01432028|Estradiol|estradiol|mesh-list
64808162|NCT01432028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64808163|NCT01432028|Progesterone|progesterone|mesh-list
64808164|NCT01432028|Estrogens|estrogens|mesh-ancestor
64808165|NCT01432028|Hormones|hormones|mesh-ancestor
64808166|NCT01432028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64808167|NCT01432028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808168|NCT01432028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64387178|NCT04072445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64808169|NCT01432028|Contraceptive Agents|contraceptive agents|mesh-ancestor
64808170|NCT01432028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64808171|NCT01432028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64752150|NCT03292926|Protease Inhibitors|protease inhibitors|mesh-ancestor
64752151|NCT03292926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752152|NCT03292926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752153|NCT03292926|Anesthetics, Local|anesthetics, local|mesh-ancestor
64752154|NCT03292926|Anesthetics|anesthetics|mesh-ancestor
64752155|NCT03292926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64752156|NCT03292926|Sensory System Agents|sensory system agents|mesh-ancestor
64752157|NCT04400136|Lansoprazole|lansoprazole|mesh-list
64752158|NCT04400136|Dexlansoprazole|dexlansoprazole|mesh-list
64752159|NCT04400136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64752160|NCT04400136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64808173|NCT01432028|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64808174|NCT01432028|Hormone Antagonists|hormone antagonists|mesh-ancestor
64808175|NCT01432028|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64808176|NCT01432028|Diuretics|diuretics|mesh-ancestor
64808177|NCT01432028|Natriuretic Agents|natriuretic agents|mesh-ancestor
64808178|NCT01432080|Azithromycin|azithromycin|mesh-list
64808179|NCT01432080|Prednisone|prednisone|mesh-list
64808180|NCT01432080|Budesonide|budesonide|mesh-list
64808181|NCT01432080|Formoterol Fumarate|formoterol fumarate|mesh-list
64808182|NCT01432080|Montelukast|montelukast|mesh-list
64808184|NCT01432080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64808193|NCT01432080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64808194|NCT01432080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64808195|NCT01432080|Respiratory System Agents|respiratory system agents|mesh-ancestor
64808196|NCT01432080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64808197|NCT01432080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64808198|NCT01432080|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64808199|NCT01432080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64808200|NCT01432080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64808201|NCT01432080|Adrenergic Agents|adrenergic agents|mesh-ancestor
64808202|NCT01432080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808203|NCT01432080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808204|NCT01432080|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64808205|NCT01432080|Hormone Antagonists|hormone antagonists|mesh-ancestor
64808206|NCT01432080|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64808207|NCT01432080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64808208|NCT01432106|Valsartan|valsartan|mesh-list
64808209|NCT01432106|Ramipril|ramipril|mesh-list
64808210|NCT01432106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64808211|NCT01432106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64808212|NCT01432106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64808213|NCT01432106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808214|NCT01432106|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64808217|NCT01432119|Cetuximab|cetuximab|mesh-list
64808242|NCT01432249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64808243|NCT01432249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64808244|NCT01432249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64808245|NCT01432249|Immunologic Factors|immunologic factors|mesh-ancestor
64808246|NCT01432470|Oxytocin|oxytocin|mesh-list
64808247|NCT01432470|Oxytocics|oxytocics|mesh-ancestor
64808248|NCT01432470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64808249|NCT01432470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808250|NCT01432483|Denileukin diftitox|denileukin diftitox|mesh-list
64808251|NCT01432483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64808252|NCT01432496|Ropivacaine|ropivacaine|mesh-list
64808253|NCT01432496|Anesthetics, Local|anesthetics, local|mesh-ancestor
64808254|NCT01432496|Anesthetics|anesthetics|mesh-ancestor
64808255|NCT01432496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64808256|NCT01432496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808257|NCT01432496|Sensory System Agents|sensory system agents|mesh-ancestor
64808258|NCT01432496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64808259|NCT01432522|Epinephrine|epinephrine|mesh-list
64808272|NCT01432522|Mydriatics|mydriatics|mesh-ancestor
64752484|NCT03818802|Niacin|niacin|mesh-list
64808297|NCT01432665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808298|NCT01432665|Urological Agents|urological agents|mesh-ancestor
64808299|NCT01432704|Cholecalciferol|cholecalciferol|mesh-list
64808300|NCT01432704|Vitamin D|vitamin d|mesh-list
64808301|NCT01432704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64808302|NCT01432704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808303|NCT01432704|Vitamins|vitamins|mesh-ancestor
64808304|NCT01432704|Micronutrients|micronutrients|mesh-ancestor
64808305|NCT01432704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64808306|NCT01432717|Luspatercept|luspatercept|mesh-list
64808307|NCT01432717|Hematinics|hematinics|mesh-ancestor
64808308|NCT01432782|Botulinum Toxins|botulinum toxins|mesh-list
64808309|NCT01432782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64808310|NCT01432782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64808311|NCT01432782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64808312|NCT01432782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64808313|NCT01432782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808314|NCT01432782|Cholinergic Agents|cholinergic agents|mesh-ancestor
64808315|NCT01432782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808316|NCT01432782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808317|NCT01432782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64808318|NCT01432782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64752573|NCT03193866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64752574|NCT01064466|Etoposide|etoposide|mesh-list
64752575|NCT01064466|Etoposide phosphate|etoposide phosphate|mesh-list
64752576|NCT01064466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64752577|NCT01064466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64808319|NCT01432821|Apomorphine|apomorphine|mesh-list
64808320|NCT01432821|Emetics|emetics|mesh-ancestor
64808321|NCT01432821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808322|NCT01432821|Autonomic Agents|autonomic agents|mesh-ancestor
64808323|NCT01432821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64808324|NCT01432821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64808325|NCT01432821|Dopamine Agonists|dopamine agonists|mesh-ancestor
64808326|NCT01432821|Dopamine Agents|dopamine agents|mesh-ancestor
64808327|NCT01432821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808328|NCT01432821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808329|NCT01432873|Selenium|selenium|mesh-list
64808330|NCT01432873|Antioxidants|antioxidants|mesh-ancestor
64808331|NCT01432873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808332|NCT01432873|Protective Agents|protective agents|mesh-ancestor
64419446|NCT04903899|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64808333|NCT01432873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808334|NCT01432873|Trace Elements|trace elements|mesh-ancestor
64808335|NCT01432873|Micronutrients|micronutrients|mesh-ancestor
64752636|NCT03165942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752637|NCT03163992|Pembrolizumab|pembrolizumab|mesh-list
64752638|NCT03163992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64752639|NCT03163992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752640|NCT04397328|Hydroxychloroquine|hydroxychloroquine|mesh-list
64752641|NCT04397328|Antimalarials|antimalarials|mesh-ancestor
64752642|NCT04397328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64752643|NCT04397328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64752644|NCT04397328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64752645|NCT04397328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752646|NCT04397328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808336|NCT01432977|Acetaminophen|acetaminophen|mesh-list
64808337|NCT01432977|Droperidol|droperidol|mesh-list
64752647|NCT04397328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64808338|NCT01432977|Ondansetron|ondansetron|mesh-list
64808339|NCT01432977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64576960|NCT04788654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64808340|NCT01432977|Analgesics|analgesics|mesh-ancestor
64808341|NCT01432977|Sensory System Agents|sensory system agents|mesh-ancestor
64808342|NCT01432977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64808343|NCT01432977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808398|NCT01433627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808399|NCT01433627|Anticoagulants|anticoagulants|mesh-ancestor
64808400|NCT01433627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64808401|NCT01433627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64808402|NCT01433666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
64808403|NCT01433666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64808404|NCT01433666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64808405|NCT01433666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808406|NCT01433705|Regadenoson|regadenoson|mesh-list
64808407|NCT01433705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808408|NCT01433705|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64808409|NCT01433705|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64808410|NCT01433705|Purinergic Agonists|purinergic agonists|mesh-ancestor
64808411|NCT01433705|Purinergic Agents|purinergic agents|mesh-ancestor
64808412|NCT01433705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808413|NCT01433705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808414|NCT01433757|Ampicillin|ampicillin|mesh-list
64577065|NCT04784988|BAX 855|bax 855|mesh-list
64808415|NCT01433757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64808416|NCT01433757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64808417|NCT01433770|Alefacept|alefacept|mesh-list
64808418|NCT01433770|Dermatologic Agents|dermatologic agents|mesh-ancestor
64808419|NCT01433770|Immunologic Factors|immunologic factors|mesh-ancestor
64808420|NCT01433770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808421|NCT01433887|Ribavirin|ribavirin|mesh-list
64808422|NCT01433887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64808423|NCT01433887|Antimetabolites|antimetabolites|mesh-ancestor
64808447|NCT01434017|Hormones|hormones|mesh-ancestor
64752826|NCT02914158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64752827|NCT02914158|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64752828|NCT02914158|Fertility Agents|fertility agents|mesh-ancestor
64752829|NCT02914158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64752830|NCT02914158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64752831|NCT02914158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752832|NCT02914158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752833|NCT03136146|Dexamethasone|dexamethasone|mesh-list
64808448|NCT01434017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64808449|NCT01434017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64808450|NCT01434017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64808451|NCT01434017|Protease Inhibitors|protease inhibitors|mesh-ancestor
64808452|NCT01434017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64808453|NCT01434017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808454|NCT01434017|Antipruritics|antipruritics|mesh-ancestor
64753008|NCT00636636|Gabapentin|gabapentin|mesh-list
64808455|NCT01434017|Dermatologic Agents|dermatologic agents|mesh-ancestor
64808456|NCT01434017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64808457|NCT01434017|Serotonin Agents|serotonin agents|mesh-ancestor
64808458|NCT01434017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808459|NCT01434017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64808460|NCT01434017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64808461|NCT01434017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64808506|NCT01434147|Bevacizumab|bevacizumab|mesh-list
64808507|NCT01434147|Capecitabine|capecitabine|mesh-list
64808508|NCT01434147|Oxaliplatin|oxaliplatin|mesh-list
64808509|NCT01434147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64808510|NCT01434147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64808511|NCT01434147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64808512|NCT01434147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64808513|NCT01434147|Growth Substances|growth substances|mesh-ancestor
64808514|NCT01434147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808515|NCT01434147|Growth Inhibitors|growth inhibitors|mesh-ancestor
64808516|NCT01434147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64808519|NCT01434160|Levonorgestrel|levonorgestrel|mesh-list
64808570|NCT01434212|Immunologic Factors|immunologic factors|mesh-ancestor
64808571|NCT01434212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808572|NCT01434225|Bumetanide|bumetanide|mesh-list
64808573|NCT01434225|Diuretics|diuretics|mesh-ancestor
64808574|NCT01434225|Natriuretic Agents|natriuretic agents|mesh-ancestor
64808575|NCT01434225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808576|NCT01434225|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64808577|NCT01434225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64387289|NCT02372357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64808578|NCT01434225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808579|NCT01434251|Antihypertensive Agents|antihypertensive agents|mesh-list
64808580|NCT01434277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64808581|NCT01434277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64808582|NCT01434303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64808583|NCT01434303|Trastuzumab|trastuzumab|mesh-list
64808584|NCT01434303|Lapatinib|lapatinib|mesh-list
64808585|NCT01434303|Entinostat|entinostat|mesh-list
64808586|NCT01434303|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
64808587|NCT01434303|Antibodies|antibodies|mesh-list
64808588|NCT01434303|Immunoglobulins|immunoglobulins|mesh-list
64808589|NCT01434303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64753169|NCT01921218|Dermatologic Agents|dermatologic agents|mesh-ancestor
64753170|NCT01921218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64753171|NCT01921218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64753172|NCT01921218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64753173|NCT01921218|Antitubercular Agents|antitubercular agents|mesh-ancestor
64753174|NCT01921218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64753175|NCT01921218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64753176|NCT03129828|Bortezomib|bortezomib|mesh-list
64753177|NCT03129828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753178|NCT01922076|Adavosertib|adavosertib|mesh-list
64753179|NCT01922076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753180|NCT01922076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753181|NCT00633750|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64753182|NCT00633750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753207|NCT00988260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64753208|NCT00988260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808590|NCT01434303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
64808591|NCT01434303|Immunologic Factors|immunologic factors|mesh-ancestor
64808592|NCT01434303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808593|NCT01434303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64808594|NCT01434303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64808595|NCT01434303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64808596|NCT01434303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808597|NCT01434381|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64808598|NCT01434381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64808599|NCT01434381|Immunologic Factors|immunologic factors|mesh-ancestor
64808600|NCT01434381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808601|NCT01434381|Antacids|antacids|mesh-ancestor
64808602|NCT01434381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808603|NCT01434381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64808610|NCT01434459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808611|NCT01434459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64808612|NCT01434459|Antiviral Agents|antiviral agents|mesh-ancestor
64808613|NCT01434459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64808614|NCT01434459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64808615|NCT01434459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64808616|NCT01434459|Immunologic Factors|immunologic factors|mesh-ancestor
64808617|NCT01434459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808618|NCT01434849|Timolol|timolol|mesh-list
64808619|NCT01434849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808620|NCT01434849|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64808621|NCT01434849|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64808622|NCT01434849|Adrenergic Agents|adrenergic agents|mesh-ancestor
64808623|NCT01434849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808624|NCT01434849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808625|NCT01434849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64808626|NCT01434849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64808627|NCT01434862|Pramlintide|pramlintide|mesh-list
64387326|NCT02373449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808628|NCT01434862|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
64808629|NCT01434862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64808630|NCT01434862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808631|NCT01434862|Appetite Depressants|appetite depressants|mesh-ancestor
64808632|NCT01434862|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64808660|NCT01435083|Hemostatics|hemostatics|mesh-ancestor
64808661|NCT01435083|Coagulants|coagulants|mesh-ancestor
64808662|NCT01435083|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64808663|NCT01435083|Natriuretic Agents|natriuretic agents|mesh-ancestor
64808664|NCT01435083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808665|NCT01435161|Telmisartan|telmisartan|mesh-list
64808666|NCT01435161|Antihypertensive Agents|antihypertensive agents|mesh-list
64808667|NCT01435161|Nifedipine|nifedipine|mesh-list
64808668|NCT01435161|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64808669|NCT01435161|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64808670|NCT01435161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808671|NCT01435161|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64808672|NCT01435161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64808673|NCT01435161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64808674|NCT01435161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808675|NCT01435161|Vasodilator Agents|vasodilator agents|mesh-ancestor
64808676|NCT01435161|Tocolytic Agents|tocolytic agents|mesh-ancestor
64808677|NCT01435161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64808678|NCT01435200|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64808679|NCT01435200|Hematinics|hematinics|mesh-ancestor
64808680|NCT01435213|Insulin|insulin|mesh-list
64808681|NCT01435213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64808682|NCT01435213|Ketamine|ketamine|mesh-list
64808683|NCT01435213|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64808684|NCT01435213|Atipamezole|atipamezole|mesh-list
64753321|NCT01920204|Midostaurin|midostaurin|mesh-list
64808685|NCT01435213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64808687|NCT01435213|Analgesics|analgesics|mesh-ancestor
64808709|NCT01435291|Tacrolimus|tacrolimus|mesh-list
64808710|NCT01435291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64808711|NCT01435291|Immunologic Factors|immunologic factors|mesh-ancestor
64808712|NCT01435291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808713|NCT01435291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64808714|NCT01435291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64808715|NCT01435291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808716|NCT01435343|Cytarabine|cytarabine|mesh-list
64577337|NCT05087381|Fluvoxamine|fluvoxamine|mesh-list
64808718|NCT01435343|Fludarabine|fludarabine|mesh-list
64808719|NCT01435343|Idarubicin|idarubicin|mesh-list
64808720|NCT01435343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64808721|NCT01435343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64808722|NCT01435343|Antimetabolites|antimetabolites|mesh-ancestor
64808723|NCT01435343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808724|NCT01435343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64808725|NCT01435343|Immunologic Factors|immunologic factors|mesh-ancestor
64808726|NCT01435343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808727|NCT01435343|Antiviral Agents|antiviral agents|mesh-ancestor
64808728|NCT01435343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64808729|NCT01435343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64808730|NCT01435343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64808731|NCT01435343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64808732|NCT01435343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64808758|NCT01435486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808759|NCT01435499|Cyclophosphamide|cyclophosphamide|mesh-list
64808760|NCT01435499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64387355|NCT03959891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64387356|NCT03959891|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64808761|NCT01435499|Immunologic Factors|immunologic factors|mesh-ancestor
64808762|NCT01435499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808763|NCT01435499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64808764|NCT01435499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64808765|NCT01435499|Alkylating Agents|alkylating agents|mesh-ancestor
64753354|NCT01925898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64753355|NCT01925898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64753360|NCT01925898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64808766|NCT01435499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808767|NCT01435499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64808768|NCT01435499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64808769|NCT01435707|Triamcinolone|triamcinolone|mesh-list
64808770|NCT01435707|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64808771|NCT01435707|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64808772|NCT01435707|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64808773|NCT01435707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64808774|NCT01435707|Glucocorticoids|glucocorticoids|mesh-ancestor
64808814|NCT01435941|Analgesics|analgesics|mesh-ancestor
64808815|NCT01435941|Sensory System Agents|sensory system agents|mesh-ancestor
64808816|NCT01435941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64808817|NCT01435941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808818|NCT01435941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64808819|NCT01435954|Doxazosin|doxazosin|mesh-list
64808820|NCT01435954|Tamsulosin|tamsulosin|mesh-list
64808821|NCT01435954|Finasteride|finasteride|mesh-list
64808822|NCT01435954|Silodosin|silodosin|mesh-list
64808823|NCT01435954|Terazosin|terazosin|mesh-list
64808824|NCT01435954|Alfuzosin|alfuzosin|mesh-list
64808825|NCT01435954|Dutasteride|dutasteride|mesh-list
64808826|NCT01435954|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64808827|NCT01435954|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64808828|NCT01435954|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64808829|NCT01435954|Adrenergic Agents|adrenergic agents|mesh-ancestor
64808874|NCT01436513|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64808875|NCT01436513|Estrogens|estrogens|mesh-ancestor
64808876|NCT01436513|Hormones|hormones|mesh-ancestor
64808877|NCT01436513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64808878|NCT01436513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808879|NCT01436539|Adefovir|adefovir|mesh-list
64808880|NCT01436539|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64808881|NCT01436539|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
64808882|NCT01436539|Antiviral Agents|antiviral agents|mesh-ancestor
64808883|NCT01436539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64808884|NCT01436539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64808885|NCT01436539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64808886|NCT01436539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64808887|NCT01436539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808888|NCT01436539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64808889|NCT01436539|Antimetabolites|antimetabolites|mesh-ancestor
64808890|NCT01436539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64387407|NCT02372591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64387408|NCT02372591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387409|NCT02372591|Analgesics|analgesics|mesh-ancestor
64387410|NCT02372591|Sensory System Agents|sensory system agents|mesh-ancestor
64387411|NCT02372591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64808891|NCT01436578|Posaconazole|posaconazole|mesh-list
64808892|NCT01436578|Antifungal Agents|antifungal agents|mesh-ancestor
64808893|NCT01436578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64808894|NCT01436578|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64808895|NCT01436578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64808896|NCT01436578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64808897|NCT01436578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64808898|NCT01436578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64808899|NCT01436578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64808900|NCT01436578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808901|NCT01436578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64808902|NCT01436578|Hormone Antagonists|hormone antagonists|mesh-ancestor
64808905|NCT01436825|Factor VIII|factor viii|mesh-list
64753504|NCT03087708|Sensory System Agents|sensory system agents|mesh-ancestor
64808918|NCT01436916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64808919|NCT01436916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808920|NCT01436916|Vitamins|vitamins|mesh-ancestor
64808921|NCT01436916|Micronutrients|micronutrients|mesh-ancestor
64808922|NCT01436916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64808923|NCT01436929|Silymarin|silymarin|mesh-list
64808924|NCT01436929|Antioxidants|antioxidants|mesh-ancestor
64808925|NCT01436929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808926|NCT01436929|Protective Agents|protective agents|mesh-ancestor
64808927|NCT01436929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808928|NCT01436994|Propylthiouracil|propylthiouracil|mesh-list
64808929|NCT01436994|Carbimazole|carbimazole|mesh-list
64808930|NCT01436994|Antimetabolites|antimetabolites|mesh-ancestor
64808931|NCT01436994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808977|NCT01437306|Lofexidine|lofexidine|mesh-list
64808978|NCT01437306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64808979|NCT01437306|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64808980|NCT01437306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64808981|NCT01437306|Sensory System Agents|sensory system agents|mesh-ancestor
64808982|NCT01437306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64753586|NCT03423342|Vitamin B Complex|vitamin b complex|mesh-ancestor
64808983|NCT01437306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64808984|NCT01437306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64808985|NCT01437306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64808986|NCT01437306|Adrenergic Agents|adrenergic agents|mesh-ancestor
64808987|NCT01437306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64808988|NCT01437306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808989|NCT01437371|Ramipril|ramipril|mesh-list
64808990|NCT01437371|Enalapril|enalapril|mesh-list
64808991|NCT01437371|Lisinopril|lisinopril|mesh-list
64808992|NCT01437371|Captopril|captopril|mesh-list
64808993|NCT01437371|Trandolapril|trandolapril|mesh-list
64808994|NCT01437371|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64808995|NCT01437371|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64808996|NCT01437371|Protease Inhibitors|protease inhibitors|mesh-ancestor
64387432|NCT02369939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387433|NCT02369939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64808997|NCT01437371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64808998|NCT01437371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64808999|NCT01437371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64809000|NCT01437371|Protective Agents|protective agents|mesh-ancestor
64809001|NCT01437371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809002|NCT01437462|Propofol|propofol|mesh-list
64753671|NCT05605002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809003|NCT01437462|Sevoflurane|sevoflurane|mesh-list
64809004|NCT01437462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64809005|NCT01437462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64809006|NCT01437462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809007|NCT01437462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64809008|NCT01437462|Anesthetics, General|anesthetics, general|mesh-ancestor
64809009|NCT01437462|Anesthetics|anesthetics|mesh-ancestor
64809010|NCT01437462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64809011|NCT01437462|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64809012|NCT01437566|Fulvestrant|fulvestrant|mesh-list
64809016|NCT01437566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64809017|NCT01437566|Hormone Antagonists|hormone antagonists|mesh-ancestor
64809018|NCT01437566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64809019|NCT01437566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809020|NCT01437579|Botulinum Toxins|botulinum toxins|mesh-list
64809021|NCT01437579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64809022|NCT01437579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64809023|NCT01437579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809024|NCT01437579|Cholinergic Agents|cholinergic agents|mesh-ancestor
64809025|NCT01437579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64809026|NCT01437579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809028|NCT01437592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64809029|NCT01437592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809030|NCT01437618|Bevacizumab|bevacizumab|mesh-list
64809031|NCT01437618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64809032|NCT01437618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809033|NCT01437618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64809034|NCT01437618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64809035|NCT01437618|Growth Substances|growth substances|mesh-ancestor
64809036|NCT01437618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809037|NCT01437618|Growth Inhibitors|growth inhibitors|mesh-ancestor
64753672|NCT03238248|Azacitidine|azacitidine|mesh-list
64753673|NCT03238248|Pevonedistat|pevonedistat|mesh-list
64809038|NCT01437644|Botulinum Toxins|botulinum toxins|mesh-list
64809039|NCT01437644|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64809040|NCT01437644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64809041|NCT01437644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809042|NCT01437644|Cholinergic Agents|cholinergic agents|mesh-ancestor
64387464|NCT02369081|Bisoprolol|bisoprolol|mesh-list
64809043|NCT01437644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64809044|NCT01437644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809045|NCT01437670|Solifenacin Succinate|solifenacin succinate|mesh-list
64809057|NCT01437696|Micronutrients|micronutrients|mesh-ancestor
64809058|NCT01437696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809059|NCT01437696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64809060|NCT01437696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64809062|NCT01437748|Tiotropium Bromide|tiotropium bromide|mesh-list
64809063|NCT01437748|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64809064|NCT01437748|Autonomic Agents|autonomic agents|mesh-ancestor
64809065|NCT01437748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64809066|NCT01437748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809067|NCT01437748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64809068|NCT01437748|Respiratory System Agents|respiratory system agents|mesh-ancestor
64809069|NCT01437748|Parasympatholytics|parasympatholytics|mesh-ancestor
64809070|NCT01437748|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64753690|NCT04124094|Charcoal|charcoal|mesh-list
64753691|NCT04124094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64753693|NCT04124094|Autonomic Agents|autonomic agents|mesh-ancestor
64809071|NCT01437748|Cholinergic Agents|cholinergic agents|mesh-ancestor
64809072|NCT01437748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64809073|NCT01437748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809074|NCT01437748|Anticonvulsants|anticonvulsants|mesh-ancestor
64809076|NCT01437800|Glimepiride|glimepiride|mesh-list
64809077|NCT01437800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64809078|NCT01437800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809079|NCT01437800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64809080|NCT01437800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64809081|NCT01437800|Immunologic Factors|immunologic factors|mesh-ancestor
64809082|NCT01437813|Metformin|metformin|mesh-list
64809083|NCT01437813|Glimepiride|glimepiride|mesh-list
64809084|NCT01437813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64809085|NCT01437813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809086|NCT01437813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64809087|NCT01437813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64577720|NCT00347412|Paclitaxel|paclitaxel|mesh-list
64809088|NCT01437813|Immunologic Factors|immunologic factors|mesh-ancestor
64809089|NCT01437826|Selenium|selenium|mesh-list
64809090|NCT01437826|Antioxidants|antioxidants|mesh-list
64809091|NCT01437826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809096|NCT01437839|Apixaban|apixaban|mesh-list
64809097|NCT01437839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64809098|NCT01437839|Antithrombins|antithrombins|mesh-ancestor
64809099|NCT01437839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64809100|NCT01437839|Protease Inhibitors|protease inhibitors|mesh-ancestor
64809101|NCT01437839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809102|NCT01437839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809103|NCT01437839|Anticoagulants|anticoagulants|mesh-ancestor
64809107|NCT01437982|Methylprednisolone|methylprednisolone|mesh-list
64809108|NCT01437982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64809109|NCT01437982|Prednisolone acetate|prednisolone acetate|mesh-list
64809110|NCT01437982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64809111|NCT01437982|Prednisolone phosphate|prednisolone phosphate|mesh-list
64809112|NCT01437982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64809113|NCT01437982|Glucocorticoids|glucocorticoids|mesh-ancestor
64809115|NCT01437982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64809116|NCT01437982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809117|NCT01437982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64809118|NCT01437982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809119|NCT01437982|Antiemetics|antiemetics|mesh-ancestor
64809120|NCT01437982|Autonomic Agents|autonomic agents|mesh-ancestor
64809121|NCT01437982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64809122|NCT01437982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64809123|NCT01437982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64809124|NCT01437982|Protective Agents|protective agents|mesh-ancestor
64809125|NCT01437982|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64809126|NCT01438021|Methotrexate|methotrexate|mesh-list
64809127|NCT01438021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64809128|NCT01438021|Abortifacient Agents|abortifacient agents|mesh-ancestor
64809129|NCT01438021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64809130|NCT01438021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420242|NCT05495893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64809131|NCT01438021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64809132|NCT01438021|Antimetabolites|antimetabolites|mesh-ancestor
64809133|NCT01438021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809134|NCT01438021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809135|NCT01438021|Dermatologic Agents|dermatologic agents|mesh-ancestor
64809136|NCT01438021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809137|NCT01438021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64809138|NCT01438021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64809139|NCT01438021|Immunologic Factors|immunologic factors|mesh-ancestor
64809140|NCT01438021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64809141|NCT01438021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64809142|NCT01438086|Mecasermin|mecasermin|mesh-list
64809195|NCT05525013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64809196|NCT05525013|Antimetabolites|antimetabolites|mesh-ancestor
64809197|NCT05525013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809198|NCT05525013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64809199|NCT05525013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64809200|NCT05525013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809201|NCT05465174|Nivolumab|nivolumab|mesh-list
64809202|NCT05465174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64809203|NCT05465174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809204|NCT05465174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64809205|NCT05465174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809206|NCT05418088|Cyclophosphamide|cyclophosphamide|mesh-list
64809256|NCT05343507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64809257|NCT05343507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64809258|NCT05343507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64387541|NCT02367755|Lorazepam|lorazepam|mesh-list
64809259|NCT05343507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809260|NCT05295927|Prednisone|prednisone|mesh-list
64809261|NCT05295927|Prednisolone|prednisolone|mesh-list
64809262|NCT05295927|Abiraterone Acetate|abiraterone acetate|mesh-list
64809263|NCT05295927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64809264|NCT05295927|Glucocorticoids|glucocorticoids|mesh-ancestor
64809265|NCT05295927|Hormones|hormones|mesh-ancestor
64809266|NCT05295927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64809267|NCT05295927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809268|NCT05295927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64809269|NCT05295927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809270|NCT05295927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64809271|NCT05295927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809272|NCT05295927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809273|NCT05295927|Hormone Antagonists|hormone antagonists|mesh-ancestor
64809274|NCT05295927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64809275|NCT05213832|Isoflurane|isoflurane|mesh-list
64809307|NCT05164146|Anesthetics, General|anesthetics, general|mesh-ancestor
64809308|NCT05164146|Anesthetics|anesthetics|mesh-ancestor
64809309|NCT05153070|Cyclosporine|cyclosporine|mesh-list
64809310|NCT05153070|Cyclosporins|cyclosporins|mesh-list
64809311|NCT05153070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809312|NCT05153070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809313|NCT05153070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64809314|NCT05153070|Immunologic Factors|immunologic factors|mesh-ancestor
64809315|NCT05153070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809316|NCT05153070|Antifungal Agents|antifungal agents|mesh-ancestor
64809317|NCT05153070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64809318|NCT05153070|Dermatologic Agents|dermatologic agents|mesh-ancestor
64809319|NCT05153070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64809320|NCT05153070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64809321|NCT05111431|Dexmedetomidine|dexmedetomidine|mesh-list
64809322|NCT05111431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64809323|NCT05111431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64809324|NCT05111431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809325|NCT05111431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64809326|NCT05111431|Analgesics|analgesics|mesh-ancestor
64809327|NCT05111431|Sensory System Agents|sensory system agents|mesh-ancestor
64387560|NCT02367755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809328|NCT05111431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64809329|NCT05111431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64809330|NCT05111431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64809331|NCT05111431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64809332|NCT05111431|Adrenergic Agents|adrenergic agents|mesh-ancestor
64809333|NCT05111431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64809334|NCT05111431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809350|NCT04956939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64753934|NCT04127058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753935|NCT04127058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64753939|NCT03012360|Ciprofloxacin|ciprofloxacin|mesh-list
64753940|NCT03012360|Ceftriaxone|ceftriaxone|mesh-list
64809351|NCT04956939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809352|NCT04956939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809354|NCT04955470|Ketamine|ketamine|mesh-list
64809355|NCT04955470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64809356|NCT04955470|Analgesics|analgesics|mesh-ancestor
64809357|NCT04955470|Sensory System Agents|sensory system agents|mesh-ancestor
64809358|NCT04955470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64809359|NCT04955470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809360|NCT04955470|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64809361|NCT04955470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64809412|NCT04922567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64809413|NCT04922567|Tubulin Modulators|tubulin modulators|mesh-ancestor
64809414|NCT04922567|Antimitotic Agents|antimitotic agents|mesh-ancestor
64809415|NCT04922567|Mitosis Modulators|mitosis modulators|mesh-ancestor
64809416|NCT04922567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64809417|NCT04922567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64809418|NCT04922567|Growth Substances|growth substances|mesh-ancestor
64753977|NCT04758936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809419|NCT04922567|Growth Inhibitors|growth inhibitors|mesh-ancestor
64809420|NCT04906278|Oxytocin|oxytocin|mesh-list
64809421|NCT04906278|Oxytocics|oxytocics|mesh-ancestor
64809422|NCT04906278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64809423|NCT04906278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809424|NCT04850222|Fluoxetine|fluoxetine|mesh-list
64809425|NCT04850222|Calcium|calcium|mesh-list
64809426|NCT04850222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64809427|NCT04850222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809428|NCT04850222|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64809429|NCT04850222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64809430|NCT04850222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64387601|NCT03344159|Hormone Antagonists|hormone antagonists|mesh-ancestor
64809431|NCT04850222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809432|NCT04850222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64809433|NCT04850222|Serotonin Agents|serotonin agents|mesh-ancestor
64809434|NCT04850222|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64809435|NCT04850222|Antidepressive Agents|antidepressive agents|mesh-ancestor
64809436|NCT04850222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64809437|NCT04850222|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64809438|NCT04850222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64809459|NCT04800692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64809460|NCT04800692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753978|NCT04758936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64753979|NCT04758936|Sympatholytics|sympatholytics|mesh-ancestor
64753980|NCT04758936|Autonomic Agents|autonomic agents|mesh-ancestor
64753981|NCT04126044|Bevacizumab|bevacizumab|mesh-list
64809461|NCT04800692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64809462|NCT04800692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809465|NCT04787848|Methylnaltrexone|methylnaltrexone|mesh-list
64809466|NCT04787848|Anticonvulsants|anticonvulsants|mesh-ancestor
64809467|NCT04787848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64809469|NCT04787848|Sensory System Agents|sensory system agents|mesh-ancestor
64809525|NCT04636632|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64809526|NCT04636632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64809527|NCT04636632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809528|NCT04597372|Tamsulosin|tamsulosin|mesh-list
64809529|NCT04597372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64809530|NCT04597372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64809531|NCT04597372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64809532|NCT04597372|Adrenergic Agents|adrenergic agents|mesh-ancestor
64809533|NCT04597372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64809534|NCT04597372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809535|NCT04597372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809536|NCT04597372|Urological Agents|urological agents|mesh-ancestor
64809537|NCT04588688|Mifepristone|mifepristone|mesh-list
64809538|NCT04588688|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64809539|NCT04588688|Abortifacient Agents|abortifacient agents|mesh-ancestor
64809540|NCT04588688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64809541|NCT04588688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809542|NCT04588688|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64387658|NCT02367053|Glucagon|glucagon|mesh-list
64809547|NCT04588688|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64809548|NCT04588688|Hormone Antagonists|hormone antagonists|mesh-ancestor
64809560|NCT04502602|Niraparib|niraparib|mesh-list
64809571|NCT04375202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809572|NCT04375202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809573|NCT04345744|Chlorhexidine|chlorhexidine|mesh-list
64809574|NCT04345744|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64809575|NCT04345744|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64809576|NCT04345744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64809577|NCT04345744|Disinfectants|disinfectants|mesh-ancestor
64809640|NCT03980171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64809641|NCT03980171|Growth Substances|growth substances|mesh-ancestor
64809642|NCT03980171|Growth Inhibitors|growth inhibitors|mesh-ancestor
64809643|NCT03980171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809644|NCT03980171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64809646|NCT03979365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64809647|NCT03979365|Immunologic Factors|immunologic factors|mesh-ancestor
64809648|NCT03979365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809649|NCT03979365|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64809650|NCT03979365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809651|NCT03979365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809652|NCT03901339|Gemcitabine|gemcitabine|mesh-list
64809653|NCT03901339|Capecitabine|capecitabine|mesh-list
64809654|NCT03901339|Vinorelbine|vinorelbine|mesh-list
64809655|NCT03901339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64809656|NCT03901339|Antimetabolites|antimetabolites|mesh-ancestor
64809657|NCT03901339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809658|NCT03901339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809659|NCT03901339|Antiviral Agents|antiviral agents|mesh-ancestor
64809660|NCT03901339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64809661|NCT03901339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754058|NCT02972424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754060|NCT05608590|Ethiodized Oil|ethiodized oil|mesh-list
64809662|NCT03901339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64809663|NCT03901339|Immunologic Factors|immunologic factors|mesh-ancestor
64809664|NCT03901339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809665|NCT03901339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64809666|NCT03901339|Tubulin Modulators|tubulin modulators|mesh-ancestor
64809667|NCT03901339|Antimitotic Agents|antimitotic agents|mesh-ancestor
64809668|NCT03901339|Mitosis Modulators|mitosis modulators|mesh-ancestor
64809669|NCT03860077|Nicotine|nicotine|mesh-list
64809670|NCT03860077|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64809671|NCT03860077|Autonomic Agents|autonomic agents|mesh-ancestor
64387697|NCT02366585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64809678|NCT03860077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809680|NCT03697512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64809681|NCT03697512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809682|NCT03697512|Immunologic Factors|immunologic factors|mesh-ancestor
64809683|NCT03697512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809684|NCT03697512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64809685|NCT03671746|Ketorolac|ketorolac|mesh-list
64809686|NCT03671746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64809687|NCT03671746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64754151|NCT02983734|Antitubercular Agents|antitubercular agents|mesh-ancestor
64754152|NCT02983734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64809729|NCT03495960|Antimetabolites|antimetabolites|mesh-ancestor
64809730|NCT03495960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809731|NCT03495960|Dermatologic Agents|dermatologic agents|mesh-ancestor
64809732|NCT03495960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809733|NCT03495960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64809734|NCT03495960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64809735|NCT03495960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64809736|NCT03495960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64809737|NCT03495960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64809738|NCT03495960|Growth Substances|growth substances|mesh-ancestor
64809739|NCT03495960|Growth Inhibitors|growth inhibitors|mesh-ancestor
64809740|NCT03495960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64809742|NCT03416127|Metformin|metformin|mesh-list
64420935|NCT02304705|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64387723|NCT02362529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64387724|NCT02362529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64809789|NCT03227731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809791|NCT03227731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64809793|NCT03200015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64809794|NCT03200015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809795|NCT03193281|Imatinib Mesylate|imatinib mesylate|mesh-list
64809796|NCT03193281|Dasatinib|dasatinib|mesh-list
64809797|NCT03193281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809798|NCT03193281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64809799|NCT03193281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809800|NCT03193281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809801|NCT03149640|Amikacin|amikacin|mesh-list
64754319|NCT04391868|Sequestering Agents|sequestering agents|mesh-ancestor
64754360|NCT01450176|Histamine Agents|histamine agents|mesh-ancestor
64809802|NCT03149640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64809803|NCT03149640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64809804|NCT03098355|Interleukin-2|interleukin-2|mesh-list
64809805|NCT03098355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809806|NCT03098355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64809807|NCT03098355|Analgesics|analgesics|mesh-ancestor
64809808|NCT03098355|Sensory System Agents|sensory system agents|mesh-ancestor
64809809|NCT03098355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64809810|NCT03098355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809811|NCT02986334|Naproxen|naproxen|mesh-list
64809812|NCT02986334|Omeprazole|omeprazole|mesh-list
64809813|NCT02986334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64809814|NCT02986334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64809815|NCT02986334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64809816|NCT02986334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64809835|NCT02655315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809836|NCT02572843|Durvalumab|durvalumab|mesh-list
64809837|NCT02572843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64809838|NCT02572843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64809839|NCT02436733|Pemetrexed|pemetrexed|mesh-list
64809840|NCT02436733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754413|NCT02947386|Nivolumab|nivolumab|mesh-list
64809841|NCT02436733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578471|NCT01946373|Antimetabolites|antimetabolites|mesh-ancestor
64809843|NCT02436733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64809901|NCT01877837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64809902|NCT01877837|Immunologic Factors|immunologic factors|mesh-ancestor
64809903|NCT01877837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809904|NCT01877837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64809905|NCT01877837|Alkylating Agents|alkylating agents|mesh-ancestor
64809906|NCT01877837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64809907|NCT01877837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64809908|NCT01781468|Modafinil|modafinil|mesh-list
64809909|NCT01781468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64809910|NCT01781468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754560|NCT03823248|Vitamin B Complex|vitamin b complex|mesh-list
64754561|NCT03823248|Hematinics|hematinics|mesh-ancestor
64754562|NCT03823248|Vitamins|vitamins|mesh-ancestor
64809911|NCT01781468|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64809912|NCT01781468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64809913|NCT01781468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64809914|NCT01781468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578543|NCT02234427|Analgesics|analgesics|mesh-ancestor
64809915|NCT01624142|Evolocumab|evolocumab|mesh-list
64809916|NCT01624142|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64809917|NCT01624142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64809918|NCT01624142|Antimetabolites|antimetabolites|mesh-ancestor
64809919|NCT01624142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64809920|NCT01624142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64809921|NCT01375764|Ezetimibe|ezetimibe|mesh-list
64809922|NCT01375764|Evolocumab|evolocumab|mesh-list
64809923|NCT01375764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64809924|NCT01375764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64809925|NCT01375764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64809926|NCT01375764|Antimetabolites|antimetabolites|mesh-ancestor
64809931|NCT00523341|Denosumab|denosumab|mesh-list
64809945|NCT00330759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64809946|NCT00330759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64809947|NCT00113763|Panitumumab|panitumumab|mesh-list
64809948|NCT00113763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64810015|NCT01438580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810016|NCT01438580|Antipyretics|antipyretics|mesh-ancestor
64810017|NCT01438580|Anticoagulants|anticoagulants|mesh-ancestor
64810018|NCT01438632|Insulin|insulin|mesh-list
64810019|NCT01438632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64810020|NCT01438632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810021|NCT01438723|Metformin|metformin|mesh-list
64810022|NCT01438723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64810023|NCT01438723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810024|NCT01438736|Etonogestrel|etonogestrel|mesh-list
64810025|NCT01438736|Desogestrel|desogestrel|mesh-list
64810026|NCT01438736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64810027|NCT01438736|Contraceptive Agents|contraceptive agents|mesh-ancestor
64810028|NCT01438736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64810029|NCT01438736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810030|NCT01438736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64810031|NCT01438736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64810032|NCT01438736|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64754620|NCT01890408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64810033|NCT01438736|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64810034|NCT01438736|Progestins|progestins|mesh-ancestor
64810035|NCT01438736|Hormones|hormones|mesh-ancestor
64754621|NCT04849650|Amisulpride|amisulpride|mesh-list
64810036|NCT01438736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64810071|NCT01438944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64754622|NCT04849650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64810072|NCT01438944|Cholinergic Agents|cholinergic agents|mesh-ancestor
64387864|NCT03112577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64810073|NCT01438944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64810074|NCT01438944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810075|NCT01439100|Oxycodone|oxycodone|mesh-list
64810076|NCT01439100|Naloxone|naloxone|mesh-list
64810077|NCT01439100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64810078|NCT01439100|Narcotics|narcotics|mesh-ancestor
64810079|NCT01439100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64810080|NCT01439100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810081|NCT01439100|Analgesics|analgesics|mesh-ancestor
64810082|NCT01439100|Sensory System Agents|sensory system agents|mesh-ancestor
64810083|NCT01439100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64810084|NCT01439100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64810085|NCT01439152|Maytansine|maytansine|mesh-list
64810086|NCT01439152|Immunoconjugates|immunoconjugates|mesh-list
64810131|NCT01439399|Anesthetics, Local|anesthetics, local|mesh-ancestor
64810132|NCT01439399|Anesthetics|anesthetics|mesh-ancestor
64810133|NCT01439399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64810134|NCT01439399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810135|NCT01439399|Sensory System Agents|sensory system agents|mesh-ancestor
64810136|NCT01439399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64810137|NCT01439399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64810138|NCT01439399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64810139|NCT01439399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64810140|NCT01439399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64578765|NCT01931033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810192|NCT01440088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810193|NCT01440114|Fentanyl|fentanyl|mesh-list
64810194|NCT01440114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64810195|NCT01440114|Narcotics|narcotics|mesh-ancestor
64810196|NCT01440114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64810197|NCT01440114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810198|NCT01440114|Analgesics|analgesics|mesh-ancestor
64810199|NCT01440114|Sensory System Agents|sensory system agents|mesh-ancestor
64810200|NCT01440114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64810201|NCT01440114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64754659|NCT01891500|Protective Agents|protective agents|mesh-ancestor
64754660|NCT02439450|Pembrolizumab|pembrolizumab|mesh-list
64754661|NCT02439450|Nivolumab|nivolumab|mesh-list
64754662|NCT02439450|Pemetrexed|pemetrexed|mesh-list
64810202|NCT01440114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64810203|NCT01440114|Anesthetics, General|anesthetics, general|mesh-ancestor
64810204|NCT01440114|Anesthetics|anesthetics|mesh-ancestor
64810256|NCT01440582|Glucocorticoids|glucocorticoids|mesh-ancestor
64810257|NCT01440582|Hormones|hormones|mesh-ancestor
64810258|NCT01440582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64810259|NCT01440582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64810260|NCT01440582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810261|NCT01440582|Immunologic Factors|immunologic factors|mesh-ancestor
64810262|NCT01440582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64810263|NCT01440582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64810323|NCT01440829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810324|NCT01440829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810325|NCT01440842|Insulin|insulin|mesh-list
64810326|NCT01440842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64810327|NCT01440842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64810328|NCT01440842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810329|NCT01440933|Magnesium Sulfate|magnesium sulfate|mesh-list
64810330|NCT01440933|Analgesics|analgesics|mesh-ancestor
64810331|NCT01440933|Sensory System Agents|sensory system agents|mesh-ancestor
64810332|NCT01440933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64810333|NCT01440933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810334|NCT01440933|Anesthetics|anesthetics|mesh-ancestor
64810335|NCT01440933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64810336|NCT01440933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64810337|NCT01440933|Anticonvulsants|anticonvulsants|mesh-ancestor
64810338|NCT01440933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64810339|NCT01440933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64810340|NCT01440933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810341|NCT01440933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64810342|NCT01440933|Tocolytic Agents|tocolytic agents|mesh-ancestor
64810343|NCT01440933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64810344|NCT01440985|Nicotine|nicotine|mesh-list
64810345|NCT01440985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64810354|NCT01440998|Paclitaxel|paclitaxel|mesh-list
64810372|NCT01441193|Immunologic Factors|immunologic factors|mesh-ancestor
64810373|NCT01441193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810374|NCT01441206|Rifampin|rifampin|mesh-list
64810375|NCT01441206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64810376|NCT01441206|Antitubercular Agents|antitubercular agents|mesh-ancestor
64754737|NCT02344290|Pitavastatin|pitavastatin|mesh-list
64810377|NCT01441206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64810378|NCT01441206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64810379|NCT01441206|Leprostatic Agents|leprostatic agents|mesh-ancestor
64810380|NCT01441206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64810381|NCT01441206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810382|NCT01441206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810383|NCT01441206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64810384|NCT01441206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64810385|NCT01441206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64810386|NCT01441206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64810387|NCT01441206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64810388|NCT01441206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64810389|NCT01441232|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64810390|NCT01441232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
64810391|NCT01441232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64810392|NCT01441232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810393|NCT01441232|Incretins|incretins|mesh-ancestor
64810394|NCT01441232|Hormones|hormones|mesh-ancestor
64810395|NCT01441232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64810396|NCT01441232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64810397|NCT01441232|Protease Inhibitors|protease inhibitors|mesh-ancestor
64810398|NCT01441232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387920|NCT02358161|Gemcitabine|gemcitabine|mesh-list
64810399|NCT01441232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810400|NCT01441232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64810401|NCT01441284|Pramipexole|pramipexole|mesh-list
64810409|NCT01441284|Dopamine Agents|dopamine agents|mesh-ancestor
64810410|NCT01441284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64810412|NCT01441297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810413|NCT01441297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64810414|NCT01441297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810415|NCT01441297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810416|NCT01441388|Bevacizumab|bevacizumab|mesh-list
64810417|NCT01441388|Sunitinib|sunitinib|mesh-list
64810418|NCT01441388|Sorafenib|sorafenib|mesh-list
64810419|NCT01441388|Axitinib|axitinib|mesh-list
64810420|NCT01441388|Crizotinib|crizotinib|mesh-list
64810421|NCT01441388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64810422|NCT01441388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810423|NCT01441388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64810424|NCT01441388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64810425|NCT01441388|Growth Substances|growth substances|mesh-ancestor
64810426|NCT01441388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810427|NCT01441388|Growth Inhibitors|growth inhibitors|mesh-ancestor
64810428|NCT01441388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64810429|NCT01441388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810430|NCT01441388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810431|NCT01441427|Lenograstim|lenograstim|mesh-list
64810432|NCT01441427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64810433|NCT01441427|Immunologic Factors|immunologic factors|mesh-ancestor
64810434|NCT01441427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810435|NCT01441505|Midazolam|midazolam|mesh-list
64810436|NCT01441505|Ketamine|ketamine|mesh-list
64810437|NCT01441505|Analgesics|analgesics|mesh-ancestor
64810438|NCT01441505|Sensory System Agents|sensory system agents|mesh-ancestor
64579072|NCT00476190|Cyclophosphamide|cyclophosphamide|mesh-list
64810456|NCT01441505|GABA Agents|gaba agents|mesh-ancestor
64810457|NCT01441531|Gabapentin|gabapentin|mesh-list
64810458|NCT01441531|Analgesics|analgesics|mesh-ancestor
64810459|NCT01441531|Sensory System Agents|sensory system agents|mesh-ancestor
64810460|NCT01441531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64810461|NCT01441531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810462|NCT01441531|Anticonvulsants|anticonvulsants|mesh-ancestor
64810463|NCT01441531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64810464|NCT01441531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64810465|NCT01441531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64810466|NCT01441531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64810467|NCT01441531|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64810468|NCT01441531|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64810469|NCT01441531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64810470|NCT01441531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810471|NCT01441531|Antimanic Agents|antimanic agents|mesh-ancestor
64810472|NCT01441557|Amifampridine|amifampridine|mesh-list
64810473|NCT01441557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64810474|NCT01441557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64810475|NCT01441557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810476|NCT01441557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64810477|NCT01441557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64810478|NCT01441557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810479|NCT01441700|Anesthetics|anesthetics|mesh-list
64810480|NCT01441700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64810481|NCT01441700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810482|NCT01441804|Ribavirin|ribavirin|mesh-list
64810483|NCT01441804|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64754838|NCT01458600|Propranolol|propranolol|mesh-list
64810484|NCT01441804|Interferon-alpha|interferon-alpha|mesh-list
64754839|NCT01458600|Metoprolol|metoprolol|mesh-list
64810485|NCT01441804|Antimetabolites|antimetabolites|mesh-ancestor
64810486|NCT01441804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810487|NCT01441804|Antiviral Agents|antiviral agents|mesh-ancestor
64810488|NCT01441804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64810496|NCT01441869|Hormones|hormones|mesh-ancestor
64810497|NCT01441869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64810517|NCT01441986|Amantadine|amantadine|mesh-list
64810567|NCT01442428|Antiemetics|antiemetics|mesh-ancestor
64810568|NCT01442428|Autonomic Agents|autonomic agents|mesh-ancestor
64810569|NCT01442428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64810570|NCT01442428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810571|NCT01442428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64810572|NCT01442428|Glucocorticoids|glucocorticoids|mesh-ancestor
64810573|NCT01442428|Hormones|hormones|mesh-ancestor
64810574|NCT01442428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64810575|NCT01442428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64810576|NCT01442428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810577|NCT01442428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64810578|NCT01442428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64810579|NCT01442428|Antimetabolites|antimetabolites|mesh-ancestor
64810580|NCT01442428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810581|NCT01442428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64810582|NCT01442428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64579210|NCT00110461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64810623|NCT01442558|Sensory System Agents|sensory system agents|mesh-ancestor
64810624|NCT01442558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64810625|NCT01442571|Hyaluronic Acid|hyaluronic acid|mesh-list
64810626|NCT01442571|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64810627|NCT01442571|Immunologic Factors|immunologic factors|mesh-ancestor
64810628|NCT01442571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810629|NCT01442571|Viscosupplements|viscosupplements|mesh-ancestor
64810630|NCT01442571|Protective Agents|protective agents|mesh-ancestor
64810631|NCT01442610|Rasagiline|rasagiline|mesh-list
64810632|NCT01442610|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64810633|NCT01442610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810634|NCT01442610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810635|NCT01442610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64810636|NCT01442610|Protective Agents|protective agents|mesh-ancestor
64810637|NCT01442610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810638|NCT01442662|Gemcitabine|gemcitabine|mesh-list
64810639|NCT01442662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64810640|NCT01442662|Antimetabolites|antimetabolites|mesh-ancestor
64810641|NCT01442662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754886|NCT02730546|Fluorouracil|fluorouracil|mesh-list
64810642|NCT01442662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810643|NCT01442662|Antiviral Agents|antiviral agents|mesh-ancestor
64810644|NCT01442662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64810645|NCT01442662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810646|NCT01442662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64810649|NCT01442701|Triclosan|triclosan|mesh-list
64810673|NCT01442766|Nootropic Agents|nootropic agents|mesh-ancestor
64810674|NCT01442818|Hydromorphone|hydromorphone|mesh-list
64810675|NCT01442818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64810676|NCT01442818|Narcotics|narcotics|mesh-ancestor
64810677|NCT01442818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64810678|NCT01442818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810679|NCT01442818|Analgesics|analgesics|mesh-ancestor
64810680|NCT01442818|Sensory System Agents|sensory system agents|mesh-ancestor
64810681|NCT01442818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64810682|NCT01442870|Metformin|metformin|mesh-list
64810683|NCT01442870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64810684|NCT01442870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810685|NCT01442909|Docetaxel|docetaxel|mesh-list
64810686|NCT01442909|Pemetrexed|pemetrexed|mesh-list
64810695|NCT01442935|Leucovorin|leucovorin|mesh-list
64579364|NCT01439204|Abatacept|abatacept|mesh-list
64810738|NCT01442974|Immunologic Factors|immunologic factors|mesh-ancestor
64810739|NCT01442974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810741|NCT01442987|Atorvastatin|atorvastatin|mesh-list
64810742|NCT01442987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64810743|NCT01442987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64810744|NCT01442987|Antimetabolites|antimetabolites|mesh-ancestor
64810745|NCT01442987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810746|NCT01442987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64810747|NCT01442987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64810748|NCT01442987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810749|NCT01442987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64755063|NCT02666742|Rivaroxaban|rivaroxaban|mesh-list
64755064|NCT02666742|Edoxaban|edoxaban|mesh-list
64810750|NCT01442987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64810751|NCT01442987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64810753|NCT01443065|Folic Acid|folic acid|mesh-list
64810754|NCT01443065|Oxaliplatin|oxaliplatin|mesh-list
64810755|NCT01443065|Panitumumab|panitumumab|mesh-list
64810756|NCT01443065|Fluorouracil|fluorouracil|mesh-list
64810757|NCT01443065|Rilotumumab|rilotumumab|mesh-list
64810758|NCT01443065|Levoleucovorin|levoleucovorin|mesh-list
64810759|NCT01443065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810760|NCT01443065|Antidotes|antidotes|mesh-ancestor
64810761|NCT01443065|Protective Agents|protective agents|mesh-ancestor
64810762|NCT01443065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810763|NCT01443065|Vitamin B Complex|vitamin b complex|mesh-ancestor
64810764|NCT01443065|Vitamins|vitamins|mesh-ancestor
64810765|NCT01443065|Micronutrients|micronutrients|mesh-ancestor
64810766|NCT01443065|Hematinics|hematinics|mesh-ancestor
64810767|NCT01443065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64810768|NCT01443065|Antimetabolites|antimetabolites|mesh-ancestor
64810773|NCT01443104|Sirolimus|sirolimus|mesh-list
64810785|NCT01443117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810786|NCT01443169|Pregabalin|pregabalin|mesh-list
64810787|NCT01443169|Analgesics|analgesics|mesh-ancestor
64810788|NCT01443169|Sensory System Agents|sensory system agents|mesh-ancestor
64810789|NCT01443169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64810790|NCT01443169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810791|NCT01443169|Anticonvulsants|anticonvulsants|mesh-ancestor
64810792|NCT01443169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64810793|NCT01443169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64810796|NCT01443169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64810849|NCT01443520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64810850|NCT01443520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64810851|NCT01443520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64810852|NCT01443520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810853|NCT01443520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64810854|NCT01443520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810855|NCT01443520|Analgesics|analgesics|mesh-ancestor
64810856|NCT01443520|Sensory System Agents|sensory system agents|mesh-ancestor
64810857|NCT01443520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64388057|NCT02357069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64810858|NCT01443520|Antidepressive Agents|antidepressive agents|mesh-ancestor
64810859|NCT01443520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64810860|NCT01443520|Dopamine Agents|dopamine agents|mesh-ancestor
64810861|NCT01443520|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64810862|NCT01443572|Anesthetics|anesthetics|mesh-list
64810863|NCT01443572|Sevoflurane|sevoflurane|mesh-list
64810864|NCT01443572|Desflurane|desflurane|mesh-list
64810865|NCT01443572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64810866|NCT01443572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810867|NCT01443572|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64810868|NCT01443572|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64810869|NCT01443572|Anesthetics, General|anesthetics, general|mesh-ancestor
64810870|NCT01443624|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64810871|NCT01443624|Hematinics|hematinics|mesh-ancestor
64810872|NCT01443676|Bevacizumab|bevacizumab|mesh-list
64810899|NCT01443897|Vitamins|vitamins|mesh-list
64810900|NCT01443897|Micronutrients|micronutrients|mesh-ancestor
64810901|NCT01443897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810902|NCT01443897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64810903|NCT01443897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64810904|NCT01443988|Travoprost|travoprost|mesh-list
64810905|NCT01443988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64810906|NCT01444001|Vaccines|vaccines|mesh-list
64810907|NCT01444001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64810908|NCT01444001|Immunologic Factors|immunologic factors|mesh-ancestor
64810909|NCT01444001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810910|NCT01444118|Cyclophosphamide|cyclophosphamide|mesh-list
64810911|NCT01444118|Vaccines|vaccines|mesh-list
64810912|NCT01444118|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64810913|NCT01444118|Immunologic Factors|immunologic factors|mesh-ancestor
64810914|NCT01444118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810915|NCT01444118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64810916|NCT01444118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64810917|NCT01444118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64810918|NCT01444118|Alkylating Agents|alkylating agents|mesh-ancestor
64755213|NCT01451736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64810919|NCT01444118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64810920|NCT01444118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810921|NCT01444118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64810922|NCT01444118|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64810923|NCT01444131|Nicotine|nicotine|mesh-list
64388094|NCT02356835|Gasotransmitters|gasotransmitters|mesh-ancestor
64810924|NCT01444131|Varenicline|varenicline|mesh-list
64810926|NCT01444131|Autonomic Agents|autonomic agents|mesh-ancestor
64810947|NCT01444248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810948|NCT01444248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64810949|NCT01444248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64810950|NCT01444248|Immunologic Factors|immunologic factors|mesh-ancestor
64810951|NCT01444339|Vaccines|vaccines|mesh-list
64810952|NCT01444339|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64810953|NCT01444339|Immunologic Factors|immunologic factors|mesh-ancestor
64755263|NCT02983422|Respiratory System Agents|respiratory system agents|mesh-ancestor
64755264|NCT02983422|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64810954|NCT01444339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810955|NCT01444352|Vaccines|vaccines|mesh-list
64755266|NCT02983422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64810956|NCT01444352|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64810957|NCT01444352|Immunologic Factors|immunologic factors|mesh-ancestor
64810958|NCT01444352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64810959|NCT01444469|Azithromycin|azithromycin|mesh-list
64810960|NCT01444469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64810961|NCT01444469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64810962|NCT01444521|Irinotecan|irinotecan|mesh-list
64810963|NCT01444521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64810964|NCT01444521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64810965|NCT01444521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64810990|NCT01444612|PENTA|penta|mesh-list
64811003|NCT01444677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64811004|NCT01444677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64811005|NCT01444677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811006|NCT01444677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811007|NCT01444677|Antiviral Agents|antiviral agents|mesh-ancestor
64811008|NCT01444703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64811009|NCT01444807|Sorafenib|sorafenib|mesh-list
64811010|NCT01444807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811011|NCT01444807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64811012|NCT01444807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811013|NCT01444807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811064|NCT01445106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811065|NCT01445106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811066|NCT01445106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64811067|NCT01445106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64811134|NCT01445392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811135|NCT01445392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64811136|NCT01445392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64811137|NCT01445392|Immunologic Factors|immunologic factors|mesh-ancestor
64811138|NCT01445392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811139|NCT01445405|Cetuximab|cetuximab|mesh-list
64811140|NCT01445405|Bortezomib|bortezomib|mesh-list
64811141|NCT01445405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811142|NCT01445405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64811143|NCT01445418|Carboplatin|carboplatin|mesh-list
64811144|NCT01445418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811145|NCT01445431|Mineral Oil|mineral oil|mesh-list
64811146|NCT01445431|Emollients|emollients|mesh-ancestor
64811147|NCT01445431|Dermatologic Agents|dermatologic agents|mesh-ancestor
64811148|NCT01445522|Cyclophosphamide|cyclophosphamide|mesh-list
64811150|NCT01445522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64811151|NCT01445522|Immunologic Factors|immunologic factors|mesh-ancestor
64811152|NCT01445522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811161|NCT01445561|Interleukin-2|interleukin-2|mesh-list
64811190|NCT01445743|Vaccines|vaccines|mesh-list
64811191|NCT01445743|Immunologic Factors|immunologic factors|mesh-ancestor
64811192|NCT01445743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811193|NCT01445756|Lidocaine|lidocaine|mesh-list
64811194|NCT01445756|Anesthetics, Local|anesthetics, local|mesh-ancestor
64811195|NCT01445756|Anesthetics|anesthetics|mesh-ancestor
64811196|NCT01445756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64811197|NCT01445756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811198|NCT01445756|Sensory System Agents|sensory system agents|mesh-ancestor
64811199|NCT01445756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64811200|NCT01445756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64811201|NCT01445756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64811202|NCT01445756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64811203|NCT01445756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64811204|NCT01445756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811205|NCT01445860|Simvastatin|simvastatin|mesh-list
64811206|NCT01445860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64811247|NCT01446120|Isophane Insulin, Human|isophane insulin, human|mesh-list
64811248|NCT01446120|Isophane insulin, beef|isophane insulin, beef|mesh-list
64811249|NCT01446120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64811250|NCT01446120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811251|NCT01446211|Gusperimus|gusperimus|mesh-list
64811252|NCT01446211|Cyclophosphamide|cyclophosphamide|mesh-list
64811253|NCT01446211|Methotrexate|methotrexate|mesh-list
64811254|NCT01446211|Azathioprine|azathioprine|mesh-list
64811255|NCT01446211|Glucocorticoids|glucocorticoids|mesh-list
64811256|NCT01446211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64811257|NCT01446211|Immunologic Factors|immunologic factors|mesh-ancestor
64811269|NCT01446211|Antimetabolites|antimetabolites|mesh-ancestor
64755503|NCT02456532|GABA Agonists|gaba agonists|mesh-ancestor
64811311|NCT01446328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64811312|NCT01446328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64811314|NCT01446328|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64811315|NCT01446445|Valganciclovir|valganciclovir|mesh-list
64811316|NCT01446445|Ganciclovir|ganciclovir|mesh-list
64811317|NCT01446445|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64811318|NCT01446445|Antiviral Agents|antiviral agents|mesh-ancestor
64811319|NCT01446445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64811320|NCT01446445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64811321|NCT01446445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811323|NCT01446458|Folfirinox|folfirinox|mesh-list
64811374|NCT01446731|Docetaxel|docetaxel|mesh-list
64811375|NCT01446731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811376|NCT01446731|Tubulin Modulators|tubulin modulators|mesh-ancestor
64811377|NCT01446731|Antimitotic Agents|antimitotic agents|mesh-ancestor
64811378|NCT01446731|Mitosis Modulators|mitosis modulators|mesh-ancestor
64811379|NCT01446731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811380|NCT01446783|Mecasermin|mecasermin|mesh-list
64811381|NCT01446783|Growth Substances|growth substances|mesh-ancestor
64811382|NCT01446783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811383|NCT01446900|Rituximab|rituximab|mesh-list
64811384|NCT01446900|Cladribine|cladribine|mesh-list
64811385|NCT01446900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64811386|NCT01446900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811387|NCT01446900|Immunologic Factors|immunologic factors|mesh-ancestor
64811388|NCT01446900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811389|NCT01446900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64811390|NCT01446900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64811391|NCT01446926|Vaccines|vaccines|mesh-list
64811392|NCT01446926|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64811393|NCT01446926|Immunologic Factors|immunologic factors|mesh-ancestor
64811394|NCT01446926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811395|NCT01446952|Vitamin E|vitamin e|mesh-list
64811396|NCT01446952|Tocopherols|tocopherols|mesh-list
64811427|NCT01447069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64811428|NCT01447069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811429|NCT01447095|Epoprostenol|epoprostenol|mesh-list
64811430|NCT01447095|Tezosentan|tezosentan|mesh-list
64811431|NCT01447095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64811432|NCT01447095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64811433|NCT01447095|Vasodilator Agents|vasodilator agents|mesh-ancestor
64811434|NCT01447160|Cortisone|cortisone|mesh-list
64388200|NCT02355197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388201|NCT02355197|Antioxidants|antioxidants|mesh-ancestor
64388202|NCT02355197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388203|NCT02355197|Protective Agents|protective agents|mesh-ancestor
64388216|NCT02355119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64388217|NCT02355119|Immunologic Factors|immunologic factors|mesh-ancestor
64388218|NCT02355119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388220|NCT03149939|Gout Suppressants|gout suppressants|mesh-ancestor
64755603|NCT02104986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64388221|NCT03149939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64388222|NCT03149783|Ropivacaine|ropivacaine|mesh-list
64388223|NCT03149783|Anesthetics, Local|anesthetics, local|mesh-ancestor
64388224|NCT03149783|Anesthetics|anesthetics|mesh-ancestor
64811494|NCT01447589|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64811495|NCT01447589|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64811496|NCT01447589|Protease Inhibitors|protease inhibitors|mesh-ancestor
64811497|NCT01447589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811498|NCT01447589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811499|NCT01447589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64811500|NCT01447589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64811501|NCT01447589|Antiviral Agents|antiviral agents|mesh-ancestor
64811502|NCT01447589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64811504|NCT01447654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64811505|NCT01447654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64811506|NCT01447654|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64811507|NCT01447654|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64811508|NCT01447654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811510|NCT01447797|Atorvastatin|atorvastatin|mesh-list
64811511|NCT01447797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64811550|NCT01448070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811552|NCT01448096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64811553|NCT01448096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811554|NCT01448096|Immunologic Factors|immunologic factors|mesh-ancestor
64811555|NCT01448096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811556|NCT01448096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64811557|NCT01448109|Hydrocortisone|hydrocortisone|mesh-list
64811558|NCT01448109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64811559|NCT01448109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64811614|NCT01448395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811615|NCT01448395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64811616|NCT01448395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64811617|NCT01448434|Plasma-lyte 148|plasma-lyte 148|mesh-list
64811618|NCT01448434|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64811619|NCT01448434|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64811621|NCT01448499|Amisulpride|amisulpride|mesh-list
64811622|NCT01448499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64811623|NCT01448499|Serotonin Agents|serotonin agents|mesh-ancestor
64811624|NCT01448499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64811625|NCT01448499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811632|NCT01448499|GABA Agents|gaba agents|mesh-ancestor
64811677|NCT01448746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64811678|NCT01448746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64811679|NCT01448746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811681|NCT01448772|Hallucinogens|hallucinogens|mesh-ancestor
64811682|NCT01448772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811683|NCT01448772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64811684|NCT01448772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64811685|NCT01448772|Analgesics|analgesics|mesh-ancestor
64811687|NCT01448772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64811688|NCT01448772|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64811689|NCT01448772|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64811690|NCT01448772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64811691|NCT01448772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811692|NCT01448772|Hormones|hormones|mesh-ancestor
64811693|NCT01448772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64811694|NCT01448798|Thrombin|thrombin|mesh-list
64811695|NCT01448798|Hemostatics|hemostatics|mesh-list
64811696|NCT01448798|Coagulants|coagulants|mesh-ancestor
64811697|NCT01448837|Timolol|timolol|mesh-list
64811698|NCT01448837|Bimatoprost|bimatoprost|mesh-list
64811699|NCT01448837|Latanoprost|latanoprost|mesh-list
64811700|NCT01448837|Cloprostenol|cloprostenol|mesh-list
64811701|NCT01448837|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64755727|NCT01896336|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64811702|NCT01448837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64811703|NCT01448837|Adrenergic Agents|adrenergic agents|mesh-ancestor
64811704|NCT01448837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64811705|NCT01448837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811706|NCT01448837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811707|NCT01448837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64811708|NCT01448837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64811709|NCT01448837|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64811710|NCT01448837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64811716|NCT01448993|Azithromycin|azithromycin|mesh-list
64811717|NCT01448993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64811718|NCT01448993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64811719|NCT01449045|Lumefantrine|lumefantrine|mesh-list
64811720|NCT01449045|Artemether|artemether|mesh-list
64811721|NCT01449045|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64811722|NCT01449045|Antimalarials|antimalarials|mesh-ancestor
64811723|NCT01449045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64811724|NCT01449045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64811725|NCT01449045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64811726|NCT01449110|Resveratrol|resveratrol|mesh-list
64811737|NCT01449123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811738|NCT01449136|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64811739|NCT01449136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64811740|NCT01449188|Moxifloxacin|moxifloxacin|mesh-list
64811741|NCT01449188|Ondansetron|ondansetron|mesh-list
64811742|NCT01449188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64811743|NCT01449188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64811744|NCT01449188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64811745|NCT01449188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64811746|NCT01449188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811747|NCT01449188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811762|NCT01449188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64811763|NCT01449188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64811764|NCT01449253|Bosentan|bosentan|mesh-list
64811765|NCT01449253|Sildenafil Citrate|sildenafil citrate|mesh-list
64811766|NCT01449253|Vasodilator Agents|vasodilator agents|mesh-ancestor
64811767|NCT01449253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64811768|NCT01449253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64811769|NCT01449253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811770|NCT01449253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811771|NCT01449253|Urological Agents|urological agents|mesh-ancestor
64811772|NCT01449253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64811773|NCT01449253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64811774|NCT01449344|Cytarabine|cytarabine|mesh-list
64811775|NCT01449344|Dexamethasone|dexamethasone|mesh-list
64811776|NCT01449344|Dexamethasone acetate|dexamethasone acetate|mesh-list
64811777|NCT01449344|Rituximab|rituximab|mesh-list
64811778|NCT01449344|Bortezomib|bortezomib|mesh-list
64811779|NCT01449344|BB 1101|bb 1101|mesh-list
64811780|NCT01449344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64811781|NCT01449344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811782|NCT01449344|Immunologic Factors|immunologic factors|mesh-ancestor
64811783|NCT01449344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811784|NCT01449344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64811785|NCT01449344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64811786|NCT01449344|Antiemetics|antiemetics|mesh-ancestor
64811787|NCT01449344|Autonomic Agents|autonomic agents|mesh-ancestor
64755895|NCT01253070|Cytarabine|cytarabine|mesh-list
64811788|NCT01449344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64811789|NCT01449344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64324816|NCT01358695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64324818|NCT02266303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64324819|NCT02266303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324820|NCT02551874|Metformin|metformin|mesh-list
64324821|NCT02551874|Insulin Glargine|insulin glargine|mesh-list
64324822|NCT02551874|Dapagliflozin|dapagliflozin|mesh-list
64324823|NCT02551874|Saxagliptin|saxagliptin|mesh-list
64324824|NCT02551874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64811805|NCT01449435|Methacholine Chloride|methacholine chloride|mesh-list
64811806|NCT01449435|Miotics|miotics|mesh-ancestor
64811807|NCT01449435|Autonomic Agents|autonomic agents|mesh-ancestor
64811808|NCT01449435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64811809|NCT01449435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811810|NCT01449435|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64811811|NCT01449435|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
64811812|NCT01449435|Respiratory System Agents|respiratory system agents|mesh-ancestor
64811813|NCT01449435|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64811814|NCT01449435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64811815|NCT01449435|Cholinergic Agents|cholinergic agents|mesh-ancestor
64811816|NCT01449435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64811817|NCT01449435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811818|NCT01449448|Triamcinolone|triamcinolone|mesh-list
64811819|NCT01449448|Ketorolac|ketorolac|mesh-list
64811820|NCT01449448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64811821|NCT01449448|Glucocorticoids|glucocorticoids|mesh-ancestor
64811822|NCT01449448|Hormones|hormones|mesh-ancestor
64811823|NCT01449448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64811824|NCT01449448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811825|NCT01449448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811826|NCT01449448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811827|NCT01449448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64811828|NCT01449448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64811829|NCT01449448|Analgesics|analgesics|mesh-ancestor
64811830|NCT01449448|Sensory System Agents|sensory system agents|mesh-ancestor
64811831|NCT01449448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64811832|NCT01449448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64811833|NCT01449448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64811834|NCT01449552|Tranexamic Acid|tranexamic acid|mesh-list
64811835|NCT01449552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64811836|NCT01449552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64811837|NCT01449552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64811852|NCT01449578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64811853|NCT01449578|Dopamine Agonists|dopamine agonists|mesh-ancestor
64811854|NCT01449578|Dopamine Agents|dopamine agents|mesh-ancestor
64811855|NCT01449578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64811857|NCT01449617|Clopidogrel|clopidogrel|mesh-list
64811858|NCT01449617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64811859|NCT01449617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64811860|NCT01449617|Analgesics|analgesics|mesh-ancestor
64811861|NCT01449617|Sensory System Agents|sensory system agents|mesh-ancestor
64755935|NCT01212822|Vitamins|vitamins|mesh-ancestor
64811862|NCT01449617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64811863|NCT01449617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811864|NCT01449617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64811865|NCT01449617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64811866|NCT01449617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64811867|NCT01449617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64811871|NCT01449617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64811919|NCT01450163|Pregabalin|pregabalin|mesh-list
64811920|NCT01450163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64811921|NCT01450163|Analgesics|analgesics|mesh-ancestor
64811922|NCT01450163|Sensory System Agents|sensory system agents|mesh-ancestor
64811925|NCT01450163|Anticonvulsants|anticonvulsants|mesh-ancestor
64811989|NCT01452256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64811990|NCT01452256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811991|NCT01452256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64811992|NCT01452256|Anesthetics, General|anesthetics, general|mesh-ancestor
64811994|NCT01452256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64811995|NCT01452373|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64811996|NCT01452373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64811997|NCT01452373|Immunologic Factors|immunologic factors|mesh-ancestor
64811998|NCT01452373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64811999|NCT01452607|Ebselen|ebselen|mesh-list
64812000|NCT01452607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64812001|NCT01452607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64812002|NCT01452607|Analgesics|analgesics|mesh-ancestor
64812003|NCT01452607|Sensory System Agents|sensory system agents|mesh-ancestor
64812004|NCT01452607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64812006|NCT01452607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64812048|NCT01455636|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64812049|NCT01455636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812050|NCT01455636|Disinfectants|disinfectants|mesh-ancestor
64812051|NCT01456078|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64812052|NCT01456078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64812053|NCT01456078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812054|NCT01456507|Naltrexone|naltrexone|mesh-list
64812055|NCT01456507|Oxycodone|oxycodone|mesh-list
64812056|NCT01456507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64812057|NCT01456507|Narcotics|narcotics|mesh-ancestor
64812058|NCT01456507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64756072|NCT05320692|Estrogens|estrogens|mesh-ancestor
64812059|NCT01456507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812060|NCT01456507|Analgesics|analgesics|mesh-ancestor
64812061|NCT01456507|Sensory System Agents|sensory system agents|mesh-ancestor
64812062|NCT01456507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64812063|NCT01456507|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64812064|NCT01456507|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64812106|NCT01458808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64812107|NCT01459445|Metformin|metformin|mesh-list
64812108|NCT01459445|Drospirenone|drospirenone|mesh-list
64812109|NCT01459445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64812110|NCT01459445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64812111|NCT01459445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812112|NCT01459445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64812113|NCT01459445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64812114|NCT01459445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64812115|NCT01459445|Contraceptive Agents|contraceptive agents|mesh-ancestor
64812116|NCT01459445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64812117|NCT01459445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64812118|NCT01459445|Estrogens|estrogens|mesh-ancestor
64812119|NCT01459445|Hormones|hormones|mesh-ancestor
64812120|NCT01459445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64812122|NCT01459445|Hormone Antagonists|hormone antagonists|mesh-ancestor
64812163|NCT01460212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64812165|NCT01460355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64812166|NCT01460355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64812167|NCT01460355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64812168|NCT01460355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64812169|NCT01460355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812230|NCT01460667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64812231|NCT01460667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812232|NCT01460667|Antipyretics|antipyretics|mesh-ancestor
64812233|NCT01460693|Imatinib Mesylate|imatinib mesylate|mesh-list
64812234|NCT01460693|Dasatinib|dasatinib|mesh-list
64812235|NCT01460693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812236|NCT01460693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64812237|NCT01460693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812238|NCT01460693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812239|NCT01460706|Edotreotide|edotreotide|mesh-list
64812240|NCT01460706|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64812241|NCT01460706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812242|NCT01460797|Metformin|metformin|mesh-list
64812243|NCT01460797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64812244|NCT01460797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812245|NCT01460836|Tobramycin|tobramycin|mesh-list
64812246|NCT01460836|Aztreonam|aztreonam|mesh-list
64812247|NCT01460836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64812248|NCT01460836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812249|NCT01460888|Olaparib|olaparib|mesh-list
64812250|NCT01460888|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64812251|NCT01460888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812285|NCT01461174|Nootropic Agents|nootropic agents|mesh-ancestor
64812286|NCT01461174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64812287|NCT01461174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64812288|NCT01461174|Dopamine Agents|dopamine agents|mesh-ancestor
64812289|NCT01461174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64812358|NCT01462422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64812360|NCT01462474|Cisplatin|cisplatin|mesh-list
64812361|NCT01462474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812362|NCT01462487|Zanamivir|zanamivir|mesh-list
64812363|NCT01462487|Antiviral Agents|antiviral agents|mesh-ancestor
64812364|NCT01462487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812365|NCT01462487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812366|NCT01462487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812367|NCT01462500|Miltefosine|miltefosine|mesh-list
64812368|NCT01462500|Antifungal Agents|antifungal agents|mesh-ancestor
64812369|NCT01462500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64812370|NCT01462500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812371|NCT01462500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64812372|NCT01462500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64812373|NCT01462617|Nemiralisib|nemiralisib|mesh-list
64812415|NCT01463163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64812416|NCT01463163|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64812417|NCT01463163|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64812418|NCT01463163|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64812419|NCT01463163|Purinergic Agents|purinergic agents|mesh-ancestor
64812420|NCT01463163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64812421|NCT01463163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812422|NCT01463163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812423|NCT01463215|Ambroxol|ambroxol|mesh-list
64812479|NCT01463605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812481|NCT01463735|Vitamins|vitamins|mesh-ancestor
64812482|NCT01463735|Micronutrients|micronutrients|mesh-ancestor
64812483|NCT01463735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812484|NCT01463735|Antioxidants|antioxidants|mesh-ancestor
64812485|NCT01463735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812486|NCT01463735|Protective Agents|protective agents|mesh-ancestor
64812487|NCT01463774|Metformin|metformin|mesh-list
64812488|NCT01463774|Canagliflozin|canagliflozin|mesh-list
64812489|NCT01463774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64812490|NCT01463774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812491|NCT01463774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64812493|NCT01463813|Vitamin D|vitamin d|mesh-list
64812543|NCT01464060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812544|NCT01464060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64812545|NCT01464060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64812547|NCT01464099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64812548|NCT01464099|Insulin Aspart|insulin aspart|mesh-list
64812549|NCT01464099|Insulin, Long-Acting|insulin, long-acting|mesh-list
64812551|NCT01464099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64812552|NCT01464099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812608|NCT01464476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64812609|NCT01464476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812610|NCT01464476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64812611|NCT01464476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756405|NCT00060528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64812613|NCT01464489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64812614|NCT01464489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64812615|NCT01464489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64812616|NCT01464489|Autonomic Agents|autonomic agents|mesh-ancestor
64812617|NCT01464489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64812618|NCT01464489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812619|NCT01464489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64812620|NCT01464489|Respiratory System Agents|respiratory system agents|mesh-ancestor
64812621|NCT01464489|Mydriatics|mydriatics|mesh-ancestor
64812622|NCT01464489|Parasympatholytics|parasympatholytics|mesh-ancestor
64812623|NCT01464489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64812624|NCT01464489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64812625|NCT01464489|Cholinergic Agents|cholinergic agents|mesh-ancestor
64812626|NCT01464489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64812627|NCT01464489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812660|NCT01466829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64812662|NCT01466829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64812663|NCT01466855|Topotecan|topotecan|mesh-list
64812664|NCT01466855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64812665|NCT01466855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64812666|NCT01466855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812667|NCT01466855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812668|NCT01466855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812669|NCT01466959|Acetic Acid|acetic acid|mesh-list
64812670|NCT01466959|Retinol acetate|retinol acetate|mesh-list
64812671|NCT01466959|Citric Acid|citric acid|mesh-list
64812672|NCT01466959|Dialysis Solutions|dialysis solutions|mesh-list
64812673|NCT01466959|Anticoagulants|anticoagulants|mesh-ancestor
64812723|NCT01467141|Insulin, Isophane|insulin, isophane|mesh-list
64812724|NCT01467141|Isophane insulin, beef|isophane insulin, beef|mesh-list
64812725|NCT01467141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64812726|NCT01467141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812727|NCT01467219|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64812728|NCT01467219|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64812729|NCT01467219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812730|NCT01467232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64812731|NCT01467258|Amantadine|amantadine|mesh-list
64812732|NCT01467258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64812791|NCT01467518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64812792|NCT01467518|Analgesics|analgesics|mesh-ancestor
64812793|NCT01467518|Sensory System Agents|sensory system agents|mesh-ancestor
64812794|NCT01467518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64812795|NCT01467518|Antitussive Agents|antitussive agents|mesh-ancestor
64812796|NCT01467518|Respiratory System Agents|respiratory system agents|mesh-ancestor
64812797|NCT01467518|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64812798|NCT01467518|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64812858|NCT01467986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812859|NCT01467986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388368|NCT03149159|Ipilimumab|ipilimumab|mesh-list
64388369|NCT03149159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64812860|NCT01467986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64812861|NCT01467986|Alkylating Agents|alkylating agents|mesh-ancestor
64812862|NCT01467986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64812927|NCT01468272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64812928|NCT01468272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812929|NCT01468272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64812930|NCT01468272|Glucocorticoids|glucocorticoids|mesh-ancestor
64812993|NCT01468610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64812994|NCT01468688|Imatinib Mesylate|imatinib mesylate|mesh-list
64812995|NCT01468688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64812996|NCT01468688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64812997|NCT01468688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64812998|NCT01468688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64812999|NCT01468714|Ketoconazole|ketoconazole|mesh-list
64813000|NCT01468714|Antifungal Agents|antifungal agents|mesh-ancestor
64813001|NCT01468714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64581622|NCT05663658|Morphine|morphine|mesh-list
64813002|NCT01468714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64813003|NCT01468714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64813056|NCT01469338|Hormones|hormones|mesh-ancestor
64813057|NCT01469338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64813058|NCT01469338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813059|NCT01469338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64813060|NCT01469338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813061|NCT01469338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64813062|NCT01469351|Liraglutide|liraglutide|mesh-list
64813063|NCT01469351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64813064|NCT01469351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813065|NCT01469351|Incretins|incretins|mesh-ancestor
64813066|NCT01469351|Hormones|hormones|mesh-ancestor
64813067|NCT01469351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64813068|NCT01469416|Clopidogrel|clopidogrel|mesh-list
64813069|NCT01469416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64813070|NCT01469416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64813071|NCT01469416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64813072|NCT01469416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64813073|NCT01469416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64813074|NCT01469416|Purinergic Agents|purinergic agents|mesh-ancestor
64813075|NCT01469416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64581698|NCT05669742|Serotonin Agents|serotonin agents|mesh-ancestor
64813076|NCT01469416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813077|NCT01469416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813078|NCT01469416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64813079|NCT01469416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64813080|NCT01469416|Antimetabolites|antimetabolites|mesh-ancestor
64813099|NCT01469507|Viscosupplements|viscosupplements|mesh-ancestor
64813100|NCT01469507|Protective Agents|protective agents|mesh-ancestor
64813101|NCT01469520|Lamivudine|lamivudine|mesh-list
64813102|NCT01469520|Zidovudine|zidovudine|mesh-list
64813103|NCT01469520|Nevirapine|nevirapine|mesh-list
64813104|NCT01469520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64813105|NCT01469520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64813106|NCT01469520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813107|NCT01469520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813108|NCT01469520|Antiviral Agents|antiviral agents|mesh-ancestor
64813109|NCT01469520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64813110|NCT01469520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64813111|NCT01469520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64813112|NCT01469520|Antimetabolites|antimetabolites|mesh-ancestor
64813113|NCT01469520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64813114|NCT01469520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64813115|NCT01469559|Insulin|insulin|mesh-list
64813116|NCT01469559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64813117|NCT01469559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813118|NCT01469572|Everolimus|everolimus|mesh-list
64388370|NCT03149159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813139|NCT01469598|Antimitotic Agents|antimitotic agents|mesh-ancestor
64813140|NCT01469598|Mitosis Modulators|mitosis modulators|mesh-ancestor
64813141|NCT01469624|Pentoxifylline|pentoxifylline|mesh-list
64813142|NCT01469624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64813143|NCT01469624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813144|NCT01469624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813145|NCT01469624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64813146|NCT01469624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64813147|NCT01469624|Protective Agents|protective agents|mesh-ancestor
64813148|NCT01469624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813149|NCT01469624|Vasodilator Agents|vasodilator agents|mesh-ancestor
64813150|NCT01469624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64813151|NCT01469624|Antioxidants|antioxidants|mesh-ancestor
64813180|NCT01469975|Antidotes|antidotes|mesh-ancestor
64813181|NCT01469975|Protective Agents|protective agents|mesh-ancestor
64813182|NCT01469975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813183|NCT01469975|Chelating Agents|chelating agents|mesh-ancestor
64813184|NCT01469975|Sequestering Agents|sequestering agents|mesh-ancestor
64813185|NCT01469975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813186|NCT01469975|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64813187|NCT01469975|Anticoagulants|anticoagulants|mesh-ancestor
64813188|NCT01469975|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64813189|NCT01469988|Testosterone|testosterone|mesh-list
64813191|NCT01469988|Hormones|hormones|mesh-ancestor
64813244|NCT01470157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813245|NCT01470157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64813246|NCT01470157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64813247|NCT01470157|Anesthetics, General|anesthetics, general|mesh-ancestor
64813248|NCT01470157|Anesthetics|anesthetics|mesh-ancestor
64813249|NCT01470157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64813250|NCT01470157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64813251|NCT01470157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64813252|NCT01470157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64813253|NCT01470157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813254|NCT01470209|Everolimus|everolimus|mesh-list
64813255|NCT01470209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813256|NCT01470209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64813257|NCT01470209|Immunologic Factors|immunologic factors|mesh-ancestor
64756775|NCT00254592|Growth Substances|growth substances|mesh-ancestor
64813258|NCT01470209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813259|NCT01470326|Bazedoxifene|bazedoxifene|mesh-list
64813260|NCT01470326|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64813261|NCT01470326|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64813262|NCT01470326|Hormone Antagonists|hormone antagonists|mesh-ancestor
64813263|NCT01470326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64813273|NCT01470339|Analgesics|analgesics|mesh-ancestor
64813293|NCT01470443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813295|NCT01470456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64813296|NCT01470456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813297|NCT01470456|Immunologic Factors|immunologic factors|mesh-ancestor
64813298|NCT01470456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813299|NCT01470456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64813300|NCT01470495|Sorafenib|sorafenib|mesh-list
64813305|NCT01470690|Omeprazole|omeprazole|mesh-list
64813361|NCT01471132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813362|NCT01471132|Tubulin Modulators|tubulin modulators|mesh-ancestor
64813363|NCT01471132|Antimitotic Agents|antimitotic agents|mesh-ancestor
64813364|NCT01471132|Mitosis Modulators|mitosis modulators|mesh-ancestor
64813365|NCT01471132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813366|NCT01471145|Naltrexone|naltrexone|mesh-list
64813367|NCT01471145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64813368|NCT01471145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64813369|NCT01471145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813370|NCT01471145|Sensory System Agents|sensory system agents|mesh-ancestor
64813371|NCT01471145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64813372|NCT01471158|Timolol|timolol|mesh-list
64813373|NCT01471158|Dorzolamide|dorzolamide|mesh-list
64813374|NCT01471158|Maleic acid|maleic acid|mesh-list
64813376|NCT01471158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813377|NCT01471158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813378|NCT01471158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64388392|NCT03154385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388393|NCT03154385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64388394|NCT03154385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64388395|NCT03112187|Iron|iron|mesh-list
64388396|NCT03112187|Trace Elements|trace elements|mesh-ancestor
64388397|NCT03112187|Micronutrients|micronutrients|mesh-ancestor
64388398|NCT03112187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388399|NCT03147677|Alfacalcidol|alfacalcidol|mesh-list
64756911|NCT00265200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64756912|NCT00265200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813380|NCT01471158|Adrenergic Agents|adrenergic agents|mesh-ancestor
64813381|NCT01471158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64813418|NCT01471535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64813419|NCT01471535|Immunologic Factors|immunologic factors|mesh-ancestor
64813420|NCT01471535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813421|NCT01471613|Lithium Carbonate|lithium carbonate|mesh-list
64813422|NCT01471613|Antidepressive Agents|antidepressive agents|mesh-ancestor
64813423|NCT01471613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64813424|NCT01471613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813425|NCT01471613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813426|NCT01471613|Antimanic Agents|antimanic agents|mesh-ancestor
64813427|NCT01471613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64813428|NCT01471613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64813481|NCT01471847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813482|NCT01471886|Ketorolac|ketorolac|mesh-list
64813483|NCT01471886|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64813484|NCT01471886|Naproxen|naproxen|mesh-list
64813485|NCT01471886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64813486|NCT01471886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64813487|NCT01471886|Analgesics|analgesics|mesh-ancestor
64813488|NCT01471886|Sensory System Agents|sensory system agents|mesh-ancestor
64813489|NCT01471886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64813490|NCT01471886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813491|NCT01471886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64813492|NCT01471886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64813543|NCT01472016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813545|NCT01472029|Docetaxel|docetaxel|mesh-list
64813546|NCT01472029|Oxaliplatin|oxaliplatin|mesh-list
64813547|NCT01472029|Trastuzumab|trastuzumab|mesh-list
64813548|NCT01472029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813549|NCT01472029|Tubulin Modulators|tubulin modulators|mesh-ancestor
64813550|NCT01472029|Antimitotic Agents|antimitotic agents|mesh-ancestor
64813551|NCT01472029|Mitosis Modulators|mitosis modulators|mesh-ancestor
64813552|NCT01472029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813553|NCT01472029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64813554|NCT01472029|Antidotes|antidotes|mesh-ancestor
64813555|NCT01472029|Protective Agents|protective agents|mesh-ancestor
64813557|NCT01472029|Vitamin B Complex|vitamin b complex|mesh-ancestor
64813607|NCT01472640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813608|NCT01472640|Incretins|incretins|mesh-ancestor
64813609|NCT01472640|Hormones|hormones|mesh-ancestor
64813610|NCT01472640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64813611|NCT01472653|Cetuximab|cetuximab|mesh-list
64813612|NCT01472653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813613|NCT01472653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64813614|NCT01472666|Caseins|caseins|mesh-list
64813615|NCT01472666|Chelating Agents|chelating agents|mesh-ancestor
64813616|NCT01472666|Sequestering Agents|sequestering agents|mesh-ancestor
64813617|NCT01472666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813618|NCT01472731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64813619|NCT01472731|Immunologic Factors|immunologic factors|mesh-ancestor
64813620|NCT01472731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813621|NCT01472770|Gemcitabine|gemcitabine|mesh-list
64813622|NCT01472770|Capecitabine|capecitabine|mesh-list
64813623|NCT01472770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64813664|NCT01473043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813665|NCT01473043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813666|NCT01473069|Ketoconazole|ketoconazole|mesh-list
64813667|NCT01473069|Antifungal Agents|antifungal agents|mesh-ancestor
64813668|NCT01473069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64813669|NCT01473069|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64813670|NCT01473069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64813729|NCT01473303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813731|NCT01473303|Immunologic Factors|immunologic factors|mesh-ancestor
64813732|NCT01473303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64813733|NCT01473303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64813734|NCT01473303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64813735|NCT01473303|Antidotes|antidotes|mesh-ancestor
64813736|NCT01473303|Protective Agents|protective agents|mesh-ancestor
64757100|NCT00201864|Exemestane|exemestane|mesh-list
64813737|NCT01473303|Vitamin B Complex|vitamin b complex|mesh-ancestor
64813738|NCT01473303|Vitamins|vitamins|mesh-ancestor
64813739|NCT01473303|Micronutrients|micronutrients|mesh-ancestor
64813740|NCT01473316|Ketoconazole|ketoconazole|mesh-list
64813792|NCT01473914|Protective Agents|protective agents|mesh-ancestor
64813793|NCT01474174|Vaccines|vaccines|mesh-list
64813794|NCT01474174|Immunologic Factors|immunologic factors|mesh-ancestor
64813795|NCT01474174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813796|NCT01474187|Capecitabine|capecitabine|mesh-list
64813797|NCT01474187|Irinotecan|irinotecan|mesh-list
64813798|NCT01474187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64813799|NCT01474187|Antimetabolites|antimetabolites|mesh-ancestor
64813800|NCT01474187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813801|NCT01474187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813802|NCT01474187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64813858|NCT01474499|Antidiarrheals|antidiarrheals|mesh-ancestor
64813859|NCT01474642|Capecitabine|capecitabine|mesh-list
64813860|NCT01474642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64813861|NCT01474642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64813862|NCT01474642|Antimetabolites|antimetabolites|mesh-ancestor
64757201|NCT00282282|Sirolimus|sirolimus|mesh-list
64813863|NCT01474642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813864|NCT01474902|Enoxaparin|enoxaparin|mesh-list
64813865|NCT01474902|Anticoagulants|anticoagulants|mesh-ancestor
64813866|NCT01474902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64813867|NCT01474902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64813868|NCT01474902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64813869|NCT01474967|Metformin|metformin|mesh-list
64813870|NCT01474967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64813871|NCT01474967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813872|NCT01475019|Orlistat|orlistat|mesh-list
64813873|NCT01475019|Sibutramine|sibutramine|mesh-list
64813919|NCT01475318|Hormone Antagonists|hormone antagonists|mesh-ancestor
64813920|NCT01475318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64813921|NCT01475318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813922|NCT01475318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64813990|NCT01475760|Coagulants|coagulants|mesh-ancestor
64813992|NCT01475877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64813993|NCT01475877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64813994|NCT01475877|Analgesics|analgesics|mesh-ancestor
64813995|NCT01475877|Sensory System Agents|sensory system agents|mesh-ancestor
64813996|NCT01475877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64813997|NCT01475877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64813998|NCT01475877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64813999|NCT01475877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64814000|NCT01475890|Vitamin D|vitamin d|mesh-list
64814001|NCT01475890|Cholecalciferol|cholecalciferol|mesh-list
64814002|NCT01475890|Vitamins|vitamins|mesh-ancestor
64814003|NCT01475890|Micronutrients|micronutrients|mesh-ancestor
64814004|NCT01475890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814006|NCT01475890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64814007|NCT01476007|Vitamins|vitamins|mesh-list
64814052|NCT01476280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814053|NCT01476280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814054|NCT01476280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64814055|NCT01476280|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64814056|NCT01476280|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64814057|NCT01476280|Serotonin Agents|serotonin agents|mesh-ancestor
64814120|NCT01476683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369464|NCT03205033|Melatonin|melatonin|mesh-list
64814121|NCT01476683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814122|NCT01476774|Buprenorphine|buprenorphine|mesh-list
64814123|NCT01476774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64814124|NCT01476774|Narcotics|narcotics|mesh-ancestor
64814125|NCT01476774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64814126|NCT01476774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814127|NCT01476774|Analgesics|analgesics|mesh-ancestor
64814128|NCT01476774|Sensory System Agents|sensory system agents|mesh-ancestor
64814129|NCT01476774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814130|NCT01476774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64814131|NCT01476787|Rituximab|rituximab|mesh-list
64814132|NCT01476787|Lenalidomide|lenalidomide|mesh-list
64814133|NCT01476787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64814134|NCT01476787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64814135|NCT01476787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814177|NCT01477021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64814178|NCT01477021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64814179|NCT01477021|Alkylating Agents|alkylating agents|mesh-ancestor
64814180|NCT01477021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814181|NCT01477021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814182|NCT01477021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64814183|NCT01477034|Vitamin D|vitamin d|mesh-list
64814184|NCT01477034|Ergocalciferols|ergocalciferols|mesh-list
64814185|NCT01477034|Cholecalciferol|cholecalciferol|mesh-list
64814186|NCT01477034|Vitamins|vitamins|mesh-list
64814187|NCT01477034|Micronutrients|micronutrients|mesh-ancestor
64814188|NCT01477034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814189|NCT01477034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64388407|NCT03147677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388409|NCT03147677|Micronutrients|micronutrients|mesh-ancestor
64388410|NCT03148535|Lithium Carbonate|lithium carbonate|mesh-list
64388411|NCT03148535|Antidepressive Agents|antidepressive agents|mesh-list
64388412|NCT03148535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64388413|NCT03148535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388414|NCT03148535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388415|NCT03148535|Antimanic Agents|antimanic agents|mesh-ancestor
64388416|NCT03148535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64388417|NCT03148535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64388418|NCT03148535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814192|NCT01477060|Lapatinib|lapatinib|mesh-list
64814193|NCT01477060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64814194|NCT01477060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814195|NCT01477060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814196|NCT01477060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64814197|NCT01477060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814232|NCT01477242|Autonomic Agents|autonomic agents|mesh-ancestor
64814233|NCT01477242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64757684|NCT00127218|Antimetabolites|antimetabolites|mesh-ancestor
64757688|NCT00127218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814234|NCT01477242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814235|NCT01477242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64814236|NCT01477242|Antipruritics|antipruritics|mesh-ancestor
64814237|NCT01477242|Dermatologic Agents|dermatologic agents|mesh-ancestor
64814298|NCT01477606|Antimetabolites|antimetabolites|mesh-ancestor
64814299|NCT01477606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814300|NCT01477606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64814301|NCT01477606|Antiviral Agents|antiviral agents|mesh-ancestor
64814302|NCT01477606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64814303|NCT01477606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64814304|NCT01477606|Immunologic Factors|immunologic factors|mesh-ancestor
64814305|NCT01477606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814306|NCT01477606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64814307|NCT01477606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64814363|NCT01477931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64814364|NCT01477931|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64814365|NCT01477931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64814366|NCT01477931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64814367|NCT01477931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814368|NCT01477931|Dopamine Agents|dopamine agents|mesh-ancestor
64814369|NCT01477931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64814370|NCT01477931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814371|NCT01477931|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64814372|NCT01477931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64814373|NCT01477931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814374|NCT01477983|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64814375|NCT01477983|Flecainide|flecainide|mesh-list
64814376|NCT01477983|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64814377|NCT01477983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64814378|NCT01477983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64814380|NCT01478022|Ibuprofen|ibuprofen|mesh-list
64814418|NCT01478165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64814419|NCT01478165|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64814420|NCT01478165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64814421|NCT01478165|Serotonin Agents|serotonin agents|mesh-ancestor
64814422|NCT01478165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64814423|NCT01478165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814424|NCT01478230|Nicotine|nicotine|mesh-list
64814426|NCT01478230|Autonomic Agents|autonomic agents|mesh-ancestor
64814427|NCT01478230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814428|NCT01478230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814429|NCT01478230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64814430|NCT01478230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64814480|NCT01478490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64814481|NCT01478490|Urological Agents|urological agents|mesh-ancestor
64814483|NCT01478503|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64814484|NCT01478503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64814485|NCT01478503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64814486|NCT01478503|Adrenergic Agents|adrenergic agents|mesh-ancestor
64814487|NCT01478503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64814489|NCT01478503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814547|NCT01478685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814549|NCT01478724|Chelating Agents|chelating agents|mesh-ancestor
64814550|NCT01478724|Sequestering Agents|sequestering agents|mesh-ancestor
64814551|NCT01478724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814552|NCT01478737|Dexamethasone|dexamethasone|mesh-list
64814553|NCT01478737|Dexamethasone acetate|dexamethasone acetate|mesh-list
64814554|NCT01478737|BB 1101|bb 1101|mesh-list
64814555|NCT01478737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64814556|NCT01478737|Antiemetics|antiemetics|mesh-ancestor
64814557|NCT01478737|Autonomic Agents|autonomic agents|mesh-ancestor
64814558|NCT01478737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814559|NCT01478737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814560|NCT01478737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64814561|NCT01478737|Glucocorticoids|glucocorticoids|mesh-ancestor
64814562|NCT01478737|Hormones|hormones|mesh-ancestor
64814563|NCT01478737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64814564|NCT01478737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64814565|NCT01478737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758116|NCT00351000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64758117|NCT00351000|Serotonin Agents|serotonin agents|mesh-ancestor
64758118|NCT00351000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64814566|NCT01478737|Protease Inhibitors|protease inhibitors|mesh-ancestor
64814567|NCT01478737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814569|NCT01478997|Acetaminophen|acetaminophen|mesh-list
64814602|NCT01479088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814603|NCT01479088|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64814604|NCT01479088|Hormone Antagonists|hormone antagonists|mesh-ancestor
64814605|NCT01479088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64814606|NCT01479114|Lenograstim|lenograstim|mesh-list
64814607|NCT01479114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64814608|NCT01479114|Immunologic Factors|immunologic factors|mesh-ancestor
64814609|NCT01479114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814610|NCT01479179|Trastuzumab|trastuzumab|mesh-list
64814669|NCT01479634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64814671|NCT01479634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814672|NCT01479634|Antiviral Agents|antiviral agents|mesh-ancestor
64814673|NCT01479634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64814674|NCT01479634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64814675|NCT01479634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64814676|NCT01479634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64814677|NCT01479634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64814678|NCT01479634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64814679|NCT01479634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64814681|NCT01479751|Ketamine|ketamine|mesh-list
64814682|NCT01479751|Rocuronium|rocuronium|mesh-list
64814683|NCT01479751|Analgesics|analgesics|mesh-ancestor
64814684|NCT01479751|Sensory System Agents|sensory system agents|mesh-ancestor
64814685|NCT01479751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64814686|NCT01479751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814688|NCT01479751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64814724|NCT01479920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64814725|NCT01479920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64814726|NCT01479920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814727|NCT01479920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64814728|NCT01479920|Serotonin Agents|serotonin agents|mesh-ancestor
64758185|NCT02982798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758189|NCT03709914|Fosfomycin|fosfomycin|mesh-list
64814729|NCT01479920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814730|NCT01479920|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64814731|NCT01479920|Antidepressive Agents|antidepressive agents|mesh-ancestor
64583349|NCT00282971|Insulin|insulin|mesh-list
64814732|NCT01479920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64814733|NCT01479920|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64814734|NCT01479920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64814735|NCT01479920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814779|NCT01480323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814780|NCT01480323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64814781|NCT01480323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64814782|NCT01480323|Antiviral Agents|antiviral agents|mesh-ancestor
64814783|NCT01480323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64814784|NCT01480336|Amiodarone|amiodarone|mesh-list
64814785|NCT01480336|Ranolazine|ranolazine|mesh-list
64814786|NCT01480336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64814787|NCT01480336|Vasodilator Agents|vasodilator agents|mesh-ancestor
64814788|NCT01480336|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64814789|NCT01480336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64814790|NCT01480336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758344|NCT03983226|Antimetabolites|antimetabolites|mesh-ancestor
64814791|NCT01480336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64814792|NCT01480336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64814793|NCT01480336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64814794|NCT01480336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814795|NCT01480336|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64814796|NCT01480336|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64814797|NCT01480336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64814798|NCT01480492|Telbivudine|telbivudine|mesh-list
64814799|NCT01480492|Antiviral Agents|antiviral agents|mesh-ancestor
64814807|NCT01480531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814808|NCT01480531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64324826|NCT02551874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64324827|NCT02551874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324828|NCT02551874|Incretins|incretins|mesh-ancestor
64324829|NCT02551874|Hormones|hormones|mesh-ancestor
64324830|NCT02551874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64324831|NCT02551874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64324832|NCT02551874|Protease Inhibitors|protease inhibitors|mesh-ancestor
64814809|NCT01480531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814810|NCT01480609|Ezogabine|ezogabine|mesh-list
64814811|NCT01480609|Anticonvulsants|anticonvulsants|mesh-ancestor
64814812|NCT01480609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64814813|NCT01480609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814814|NCT01480687|Ciprofibrate|ciprofibrate|mesh-list
64814815|NCT01480687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64814816|NCT01480687|Antimetabolites|antimetabolites|mesh-ancestor
64814817|NCT01480687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814818|NCT01480687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64814819|NCT01480713|Raltegravir Potassium|raltegravir potassium|mesh-list
64814820|NCT01480713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64814821|NCT01480713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64814822|NCT01480713|Antiviral Agents|antiviral agents|mesh-ancestor
64814823|NCT01480713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64814824|NCT01480713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64814825|NCT01480713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64814826|NCT01480713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64814827|NCT01480713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64814828|NCT01480752|Lornoxicam|lornoxicam|mesh-list
64814829|NCT01480752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64814861|NCT01480778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64814862|NCT01480778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64814863|NCT01480778|Contraceptive Agents|contraceptive agents|mesh-ancestor
64814864|NCT01480778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64814865|NCT01480778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64814866|NCT01480778|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64388436|NCT02349113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64388437|NCT04183205|Sertraline|sertraline|mesh-list
64388438|NCT04183205|Antidepressive Agents|antidepressive agents|mesh-ancestor
64388439|NCT04183205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64388440|NCT04183205|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64388441|NCT04183205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64388442|NCT04183205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64416782|NCT04842487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64758529|NCT00319644|Dimercaprol|dimercaprol|mesh-list
64814867|NCT01480778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64814868|NCT01480778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64814869|NCT01480778|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
64814870|NCT01480778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64814871|NCT01480778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64814923|NCT01481194|Hormones|hormones|mesh-ancestor
64814924|NCT01481194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64814925|NCT01481194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64814926|NCT01481194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64814934|NCT01481233|Colchicine|colchicine|mesh-list
64814992|NCT01481519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64814993|NCT01481519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64814994|NCT01481532|Histamine Antagonists|histamine antagonists|mesh-list
64814995|NCT01481532|Histamine Agents|histamine agents|mesh-ancestor
64814996|NCT01481532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64814998|NCT01481532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815063|NCT01481870|Sorafenib|sorafenib|mesh-list
64815064|NCT01481870|Sunitinib|sunitinib|mesh-list
64815065|NCT01481870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815066|NCT01481870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64815067|NCT01481870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815068|NCT01481870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815069|NCT01481870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64815070|NCT01481870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64815071|NCT01481870|Growth Substances|growth substances|mesh-ancestor
64815072|NCT01481870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815073|NCT01481870|Growth Inhibitors|growth inhibitors|mesh-ancestor
64815074|NCT01481883|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64758795|NCT00381810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64815075|NCT01481883|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64815076|NCT01481883|Hormone Antagonists|hormone antagonists|mesh-ancestor
64815082|NCT01482052|Vaccines|vaccines|mesh-list
64815122|NCT01482299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815123|NCT01482338|Drospirenone|drospirenone|mesh-list
64815124|NCT01482338|Desogestrel|desogestrel|mesh-list
64815125|NCT01482338|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64815126|NCT01482338|Hormone Antagonists|hormone antagonists|mesh-ancestor
64815127|NCT01482338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64815128|NCT01482338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815129|NCT01482338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64815187|NCT01482728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64815188|NCT01482728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815189|NCT01482728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815190|NCT01482754|Rituximab|rituximab|mesh-list
64815191|NCT01482754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64815192|NCT01482754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815193|NCT01482754|Immunologic Factors|immunologic factors|mesh-ancestor
64815194|NCT01482754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815195|NCT01482754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64815196|NCT01482897|Prednisolone|prednisolone|mesh-list
64815197|NCT01482897|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64388443|NCT04183205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815199|NCT01482897|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64815248|NCT01483248|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64815249|NCT01483248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64815250|NCT01483274|Vaccines|vaccines|mesh-list
64815251|NCT01483274|Immunologic Factors|immunologic factors|mesh-ancestor
64815252|NCT01483274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815253|NCT01483300|Cisplatin|cisplatin|mesh-list
64815254|NCT01483300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815255|NCT01483365|Progesterone|progesterone|mesh-list
64815256|NCT01483365|Progestins|progestins|mesh-ancestor
64815257|NCT01483365|Hormones|hormones|mesh-ancestor
64815258|NCT01483365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64815259|NCT01483365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815260|NCT01483508|Proanthocyanidin|proanthocyanidin|mesh-list
64815261|NCT01483508|Procyanidin|procyanidin|mesh-list
64815262|NCT01483508|Antioxidants|antioxidants|mesh-ancestor
64815263|NCT01483508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815264|NCT01483508|Protective Agents|protective agents|mesh-ancestor
64815265|NCT01483508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815266|NCT01483508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64815267|NCT01483508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64815268|NCT01483508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64815269|NCT01483638|Axitinib|axitinib|mesh-list
64815270|NCT01483638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815271|NCT01483638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64815272|NCT01483638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815300|NCT01484015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64815301|NCT01484080|Paclitaxel|paclitaxel|mesh-list
64815302|NCT01484080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64758870|NCT00382590|Immunologic Factors|immunologic factors|mesh-ancestor
64815303|NCT01484080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64815304|NCT01484080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815305|NCT01484080|Tubulin Modulators|tubulin modulators|mesh-ancestor
64815306|NCT01484080|Antimitotic Agents|antimitotic agents|mesh-ancestor
64815307|NCT01484080|Mitosis Modulators|mitosis modulators|mesh-ancestor
64815365|NCT01484613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64815366|NCT01484613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815367|NCT01484613|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64815368|NCT01484613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64815369|NCT01484613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64758911|NCT00408564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758912|NCT00408564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64815370|NCT01484717|Nicotine|nicotine|mesh-list
64815371|NCT01484717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64815372|NCT01484717|Autonomic Agents|autonomic agents|mesh-ancestor
64815380|NCT01484756|Micronutrients|micronutrients|mesh-list
64815432|NCT01485185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64815433|NCT01485185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815434|NCT01485185|Anticonvulsants|anticonvulsants|mesh-ancestor
64815435|NCT01485185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64815436|NCT01485185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64815437|NCT01485185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64815438|NCT01485185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64815439|NCT01485185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64815440|NCT01485185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64815441|NCT01485185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64815442|NCT01485185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815443|NCT01485185|Antimanic Agents|antimanic agents|mesh-ancestor
64815444|NCT01485185|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64815445|NCT01485185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815446|NCT01485185|Cholinergic Agents|cholinergic agents|mesh-ancestor
64815447|NCT01485185|Nootropic Agents|nootropic agents|mesh-ancestor
64815448|NCT01485198|Acetaminophen|acetaminophen|mesh-list
64815494|NCT01485445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64815495|NCT01485445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64815496|NCT01485445|Autonomic Agents|autonomic agents|mesh-ancestor
64758997|NCT00410904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815497|NCT01485445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64815498|NCT01485445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815499|NCT01485445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64815500|NCT01485445|Respiratory System Agents|respiratory system agents|mesh-ancestor
64815501|NCT01485445|Dermatologic Agents|dermatologic agents|mesh-ancestor
64815502|NCT01485445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64815503|NCT01485562|Misoprostol|misoprostol|mesh-list
64815504|NCT01485562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64815505|NCT01485562|Abortifacient Agents|abortifacient agents|mesh-ancestor
64815506|NCT01485562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64815507|NCT01485562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815508|NCT01485562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64815509|NCT01485562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64815510|NCT01485562|Oxytocics|oxytocics|mesh-ancestor
64815511|NCT01485653|Mepivacaine|mepivacaine|mesh-list
64815512|NCT01485653|Anesthetics, Local|anesthetics, local|mesh-ancestor
64815513|NCT01485653|Anesthetics|anesthetics|mesh-ancestor
64815514|NCT01485653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64815515|NCT01485653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815516|NCT01485653|Sensory System Agents|sensory system agents|mesh-ancestor
64815517|NCT01485653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64815518|NCT01485679|Deoxyglucose|deoxyglucose|mesh-list
64815519|NCT01485679|Antimetabolites|antimetabolites|mesh-ancestor
64815520|NCT01485679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815521|NCT01485679|Antiviral Agents|antiviral agents|mesh-ancestor
64815522|NCT01485679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64815523|NCT01485692|Promethazine|promethazine|mesh-list
64815524|NCT01485692|Diphenhydramine|diphenhydramine|mesh-list
64815525|NCT01485692|Midazolam|midazolam|mesh-list
64815526|NCT01485692|Haloperidol|haloperidol|mesh-list
64815527|NCT01485692|Olanzapine|olanzapine|mesh-list
64815528|NCT01485692|Haloperidol decanoate|haloperidol decanoate|mesh-list
64815529|NCT01485692|Ziprasidone|ziprasidone|mesh-list
64815530|NCT01485692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64815531|NCT01485692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64815532|NCT01485692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64815533|NCT01485692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815534|NCT01485692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64815535|NCT01485692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64815536|NCT01485692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64815537|NCT01485692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64815540|NCT01485692|GABA Modulators|gaba modulators|mesh-ancestor
64815541|NCT01485692|GABA Agents|gaba agents|mesh-ancestor
64815542|NCT01485692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64815543|NCT01485692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815544|NCT01485692|Antiemetics|antiemetics|mesh-ancestor
64815568|NCT01485718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64815569|NCT01485731|Nelfinavir|nelfinavir|mesh-list
64815570|NCT01485731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64815571|NCT01485731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64815572|NCT01485731|Protease Inhibitors|protease inhibitors|mesh-ancestor
64815573|NCT01485731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815574|NCT01485731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815575|NCT01485731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64815637|NCT01485926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64815638|NCT01485926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64815639|NCT01485926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815641|NCT01485939|Anesthetics, Local|anesthetics, local|mesh-ancestor
64815642|NCT01485939|Anesthetics|anesthetics|mesh-ancestor
64815643|NCT01485939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64815644|NCT01485939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815652|NCT01485978|Ramipril|ramipril|mesh-list
64815703|NCT01486433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64815704|NCT01486433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64815705|NCT01486433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815706|NCT01486433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64815707|NCT01486433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64815708|NCT01486433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759178|NCT03531918|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
64815710|NCT01486433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64815711|NCT01486433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64815712|NCT01486433|Antimetabolites|antimetabolites|mesh-ancestor
64815713|NCT01486433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64815714|NCT01486433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64815715|NCT01486459|Lithium Carbonate|lithium carbonate|mesh-list
64815716|NCT01486459|Antidepressive Agents|antidepressive agents|mesh-ancestor
64815717|NCT01486459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64815718|NCT01486459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815719|NCT01486459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759221|NCT01957956|Temozolomide|temozolomide|mesh-list
64815720|NCT01486459|Antimanic Agents|antimanic agents|mesh-ancestor
64815721|NCT01486459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64815722|NCT01486459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64815723|NCT01486459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815724|NCT01486485|Nafamostat|nafamostat|mesh-list
64815725|NCT01486485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64815726|NCT01486485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64815727|NCT01486485|Analgesics|analgesics|mesh-ancestor
64815728|NCT01486485|Sensory System Agents|sensory system agents|mesh-ancestor
64815729|NCT01486485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64815730|NCT01486485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815731|NCT01486485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64815732|NCT01486485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64815733|NCT01486485|Anticoagulants|anticoagulants|mesh-ancestor
64815744|NCT01486550|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
64815745|NCT01486550|Plasma Substitutes|plasma substitutes|mesh-ancestor
64815746|NCT01486550|Blood Substitutes|blood substitutes|mesh-ancestor
64815747|NCT01486563|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
64815753|NCT01486602|Paclitaxel|paclitaxel|mesh-list
64815814|NCT01486940|Isophane insulin, beef|isophane insulin, beef|mesh-list
64815815|NCT01486940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64815816|NCT01486940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815817|NCT01486953|Sevoflurane|sevoflurane|mesh-list
64815819|NCT01486953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64815820|NCT01486953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64815821|NCT01486953|Anesthetics, General|anesthetics, general|mesh-ancestor
64815822|NCT01486953|Anesthetics|anesthetics|mesh-ancestor
64815823|NCT01486953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64815824|NCT01486953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815825|NCT01486979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64815826|NCT01486979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64815827|NCT01486979|Estradiol|estradiol|mesh-list
64815828|NCT01486979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64815829|NCT01486979|Estrogens|estrogens|mesh-ancestor
64815830|NCT01486979|Hormones|hormones|mesh-ancestor
64815834|NCT01486979|Contraceptive Agents|contraceptive agents|mesh-ancestor
64815873|NCT01487278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64759300|NCT04270656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64759301|NCT04270656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815874|NCT01487278|Oxytocics|oxytocics|mesh-ancestor
64815875|NCT01487304|Hormones|hormones|mesh-list
64815876|NCT01487304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64815877|NCT01487304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815878|NCT01487317|Rivastigmine|rivastigmine|mesh-list
64815879|NCT01487317|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64815880|NCT01487317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815881|NCT01487317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815882|NCT01487317|Cholinergic Agents|cholinergic agents|mesh-ancestor
64815883|NCT01487317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64815884|NCT01487317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815885|NCT01487317|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64815887|NCT01487369|Insulin Aspart|insulin aspart|mesh-list
64815933|NCT01487629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815934|NCT01487629|Growth Inhibitors|growth inhibitors|mesh-ancestor
64815935|NCT01487785|Gemcitabine|gemcitabine|mesh-list
64815936|NCT01487785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64815937|NCT01487785|Antimetabolites|antimetabolites|mesh-ancestor
64815938|NCT01487785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64815939|NCT01487785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64815940|NCT01487785|Antiviral Agents|antiviral agents|mesh-ancestor
64815941|NCT01487785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64815942|NCT01487785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64815943|NCT01487785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64815944|NCT01487785|Immunologic Factors|immunologic factors|mesh-ancestor
64759651|NCT00439296|Hormones|hormones|mesh-ancestor
64815945|NCT01487785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64815997|NCT01488253|Tacrolimus|tacrolimus|mesh-list
64815998|NCT01488253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64815999|NCT01488253|Immunologic Factors|immunologic factors|mesh-ancestor
64816000|NCT01488253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388458|NCT02348177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64388459|NCT02348177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64388460|NCT02348177|Antiviral Agents|antiviral agents|mesh-ancestor
64388461|NCT02348177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64388462|NCT02348177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64388463|NCT02348177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64816002|NCT01488253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816003|NCT01488253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816004|NCT01488253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64816005|NCT01488253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64816006|NCT01488253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64816007|NCT01488253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816008|NCT01488253|Antifungal Agents|antifungal agents|mesh-ancestor
64816009|NCT01488266|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64816011|NCT01488266|Aripiprazole|aripiprazole|mesh-list
64816012|NCT01488266|Mirtazapine|mirtazapine|mesh-list
64816013|NCT01488266|Citalopram|citalopram|mesh-list
64816014|NCT01488266|Bupropion|bupropion|mesh-list
64816015|NCT01488266|Fluoxetine|fluoxetine|mesh-list
64816016|NCT01488266|Paroxetine|paroxetine|mesh-list
64816053|NCT01488266|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64816054|NCT01488266|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64816055|NCT01488266|Adrenergic Agents|adrenergic agents|mesh-ancestor
64816056|NCT01488266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64816057|NCT01488266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64816058|NCT01488305|Micronutrients|micronutrients|mesh-list
64816059|NCT01488305|Trace Elements|trace elements|mesh-list
64816060|NCT01488305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816061|NCT01488344|Nintedanib|nintedanib|mesh-list
64816062|NCT01488344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816063|NCT01488344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64816064|NCT01488344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816119|NCT01488656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759860|NCT00509496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64816120|NCT01488656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64816121|NCT01488656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816122|NCT01488656|Protective Agents|protective agents|mesh-ancestor
64816123|NCT01488734|Vitamin D|vitamin d|mesh-list
64816124|NCT01488734|Ergocalciferols|ergocalciferols|mesh-list
64816125|NCT01488734|Cholecalciferol|cholecalciferol|mesh-list
64816126|NCT01488734|Vitamins|vitamins|mesh-list
64816127|NCT01488734|Micronutrients|micronutrients|mesh-ancestor
64816128|NCT01488734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816129|NCT01488734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64816130|NCT01488734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64816131|NCT01488773|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64816132|NCT01488773|Montelukast|montelukast|mesh-list
64816133|NCT01488773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64816134|NCT01488773|Autonomic Agents|autonomic agents|mesh-ancestor
64816135|NCT01488773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64816136|NCT01488773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816137|NCT01488773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64816138|NCT01488773|Respiratory System Agents|respiratory system agents|mesh-ancestor
64816139|NCT01488773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64816140|NCT01488773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64816141|NCT01488773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64816150|NCT01488838|Cisplatin|cisplatin|mesh-list
64816168|NCT01489059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64816169|NCT01489059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816170|NCT01489059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64760129|NCT03158376|Antimanic Agents|antimanic agents|mesh-ancestor
64816171|NCT01489059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816172|NCT01489072|Remifentanil|remifentanil|mesh-list
64816173|NCT01489072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64816174|NCT01489072|Narcotics|narcotics|mesh-ancestor
64816175|NCT01489072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64816176|NCT01489072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816177|NCT01489072|Analgesics|analgesics|mesh-ancestor
64816178|NCT01489072|Sensory System Agents|sensory system agents|mesh-ancestor
64816179|NCT01489072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64816180|NCT01489124|Imipenem|imipenem|mesh-list
64816181|NCT01489124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64816182|NCT01489124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64816183|NCT01489137|Remifentanil|remifentanil|mesh-list
64816184|NCT01489137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64816185|NCT01489137|Narcotics|narcotics|mesh-ancestor
64816186|NCT01489137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64816187|NCT01489137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816188|NCT01489137|Analgesics|analgesics|mesh-ancestor
64816189|NCT01489137|Sensory System Agents|sensory system agents|mesh-ancestor
64816190|NCT01489137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64816191|NCT01489202|Cobalt|cobalt|mesh-list
64816192|NCT01489202|Chromium|chromium|mesh-list
64816193|NCT01489202|Everolimus|everolimus|mesh-list
64816194|NCT01489202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816195|NCT01489202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64816196|NCT01489202|Immunologic Factors|immunologic factors|mesh-ancestor
64816197|NCT01489202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816198|NCT01489202|Trace Elements|trace elements|mesh-ancestor
64816213|NCT01489319|Sensory System Agents|sensory system agents|mesh-ancestor
64816214|NCT01489319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64816215|NCT01489319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760487|NCT01797666|Pioglitazone|pioglitazone|mesh-list
64816216|NCT01489319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64816217|NCT01489319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64816218|NCT01489319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64816219|NCT01489319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816220|NCT01489319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816221|NCT01489371|Doxorubicin|doxorubicin|mesh-list
64816222|NCT01489371|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64816223|NCT01489371|Interleukin-12|interleukin-12|mesh-list
64816228|NCT01489371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816277|NCT01489631|Anesthetics, Local|anesthetics, local|mesh-ancestor
64816278|NCT01489631|Anesthetics|anesthetics|mesh-ancestor
64816279|NCT01489631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64816280|NCT01489631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816281|NCT01489631|Sensory System Agents|sensory system agents|mesh-ancestor
64816282|NCT01489631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64816283|NCT01489631|Analgesics|analgesics|mesh-ancestor
64816284|NCT01489631|Anticonvulsants|anticonvulsants|mesh-ancestor
64816285|NCT01489631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64816286|NCT01489631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64816287|NCT01489631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64816288|NCT01489631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64816289|NCT01489631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64816290|NCT01489631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64816291|NCT01489631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816292|NCT01489631|Antimanic Agents|antimanic agents|mesh-ancestor
64816293|NCT01489631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64816294|NCT01489631|Narcotics|narcotics|mesh-ancestor
64816295|NCT01489631|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64816296|NCT01489631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64816297|NCT01489631|Anesthetics, General|anesthetics, general|mesh-ancestor
64816299|NCT01489644|Repaglinide|repaglinide|mesh-list
64816300|NCT01489644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64816302|NCT01489683|Lidocaine|lidocaine|mesh-list
64816324|NCT01489696|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64816325|NCT01489696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64816326|NCT01489696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64816327|NCT01489709|Solifenacin Succinate|solifenacin succinate|mesh-list
64816328|NCT01489709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64816329|NCT01489709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64816330|NCT01489709|Cholinergic Agents|cholinergic agents|mesh-ancestor
64816331|NCT01489709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64816332|NCT01489709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816333|NCT01489709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816334|NCT01489709|Urological Agents|urological agents|mesh-ancestor
64816335|NCT01489852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64816336|NCT01489852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64816337|NCT01489852|Estradiol|estradiol|mesh-list
64760877|NCT00614484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64816338|NCT01489852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64816339|NCT01489852|Estrogens|estrogens|mesh-ancestor
64816340|NCT01489852|Hormones|hormones|mesh-ancestor
64816341|NCT01489852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64816342|NCT01489852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816343|NCT01489852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64816344|NCT01489852|Contraceptive Agents|contraceptive agents|mesh-ancestor
64816345|NCT01489852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64816346|NCT01489852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64816347|NCT01489865|Fluorouracil|fluorouracil|mesh-list
64816348|NCT01489865|Veliparib|veliparib|mesh-list
64816349|NCT01489865|Antimetabolites|antimetabolites|mesh-ancestor
64816371|NCT01489917|Anticoagulants|anticoagulants|mesh-ancestor
64816372|NCT01489917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64816373|NCT01489917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64816374|NCT01489917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816375|NCT01489917|Coagulants|coagulants|mesh-ancestor
64816376|NCT01489943|Pioglitazone|pioglitazone|mesh-list
64816377|NCT01489943|Midazolam|midazolam|mesh-list
64816378|NCT01489943|Omeprazole|omeprazole|mesh-list
64816379|NCT01489943|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64816380|NCT01489943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64816381|NCT01489943|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64816382|NCT01489943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64816383|NCT01489943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816384|NCT01489943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64816385|NCT01489943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64816386|NCT01489943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64816387|NCT01489943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64816388|NCT01489943|Anesthetics, General|anesthetics, general|mesh-ancestor
64816389|NCT01489943|Anesthetics|anesthetics|mesh-ancestor
64816390|NCT01489943|GABA Modulators|gaba modulators|mesh-ancestor
64761237|NCT05765825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761239|NCT05765747|Celecoxib|celecoxib|mesh-list
64816391|NCT01489943|GABA Agents|gaba agents|mesh-ancestor
64816392|NCT01489943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64816393|NCT01489943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816394|NCT01489943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64816423|NCT01490047|Doxorubicin|doxorubicin|mesh-list
64816424|NCT01490047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64816425|NCT01490047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64816426|NCT01490047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816427|NCT01490047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64816428|NCT01490047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64816429|NCT01490047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816491|NCT01490268|Analgesics|analgesics|mesh-ancestor
64816492|NCT01490268|Sensory System Agents|sensory system agents|mesh-ancestor
64816493|NCT01490268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64816494|NCT01490268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64816495|NCT01490268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64816496|NCT01490268|Anesthetics, General|anesthetics, general|mesh-ancestor
64816497|NCT01490268|Anesthetics|anesthetics|mesh-ancestor
64816498|NCT01490333|Vitamin D|vitamin d|mesh-list
64816499|NCT01490333|Cholecalciferol|cholecalciferol|mesh-list
64816500|NCT01490333|Vitamins|vitamins|mesh-ancestor
64816501|NCT01490333|Micronutrients|micronutrients|mesh-ancestor
64761479|NCT05705258|Growth Inhibitors|growth inhibitors|mesh-ancestor
64816502|NCT01490333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816503|NCT01490333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64816504|NCT01490333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64816505|NCT01490346|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64816506|NCT01490346|Antiviral Agents|antiviral agents|mesh-ancestor
64816507|NCT01490346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64816508|NCT01490398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64816509|NCT01490398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64816510|NCT01490398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64816511|NCT01490398|Antimetabolites|antimetabolites|mesh-ancestor
64816512|NCT01490398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816513|NCT01490398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64816514|NCT01490398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64816515|NCT01490398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816516|NCT01490411|Immunologic Factors|immunologic factors|mesh-list
64816519|NCT01490437|Pemetrexed|pemetrexed|mesh-list
64816539|NCT01490476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816541|NCT01490567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64816542|NCT01490567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816543|NCT01490567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816544|NCT01490567|Cholinergic Agents|cholinergic agents|mesh-ancestor
64816545|NCT01490567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64816546|NCT01490567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816547|NCT01490567|Nootropic Agents|nootropic agents|mesh-ancestor
64816548|NCT01490658|Metformin|metformin|mesh-list
64816606|NCT01490996|Analgesics|analgesics|mesh-ancestor
64761959|NCT04778267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816607|NCT01490996|Sensory System Agents|sensory system agents|mesh-ancestor
64816608|NCT01490996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64816609|NCT01490996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816610|NCT01490996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64816611|NCT01490996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64816612|NCT01490996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64816613|NCT01491009|Midazolam|midazolam|mesh-list
64816614|NCT01491009|Remifentanil|remifentanil|mesh-list
64816615|NCT01491009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64816616|NCT01491009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64816617|NCT01491009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64816618|NCT01491009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816619|NCT01491009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64816620|NCT01491009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64816621|NCT01491009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64816622|NCT01491009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64816623|NCT01491009|Anesthetics, General|anesthetics, general|mesh-ancestor
64816624|NCT01491009|Anesthetics|anesthetics|mesh-ancestor
64816625|NCT01491009|GABA Modulators|gaba modulators|mesh-ancestor
64816662|NCT01491139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816663|NCT01491191|Palmidrol|palmidrol|mesh-list
64816664|NCT01491191|Analgesics|analgesics|mesh-ancestor
64816665|NCT01491191|Sensory System Agents|sensory system agents|mesh-ancestor
64816666|NCT01491191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64816667|NCT01491191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816668|NCT01491191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64816669|NCT01491191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64816670|NCT01491191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64816671|NCT01491191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64816672|NCT01491191|Antiviral Agents|antiviral agents|mesh-ancestor
64816673|NCT01491191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64816674|NCT01491191|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64816675|NCT01491191|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64762510|NCT03538691|Dexetimide|dexetimide|mesh-list
64762511|NCT03538691|Citalopram|citalopram|mesh-list
64816677|NCT01491191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816679|NCT01491191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64816680|NCT01491204|Paclitaxel|paclitaxel|mesh-list
64816715|NCT01491321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64816716|NCT01491321|Analgesics|analgesics|mesh-ancestor
64816717|NCT01491321|Sensory System Agents|sensory system agents|mesh-ancestor
64816718|NCT01491321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64816719|NCT01491321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816720|NCT01491321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64816721|NCT01491321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64816722|NCT01491438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64816723|NCT01491438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64816724|NCT01491438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64816725|NCT01491438|Antitubercular Agents|antitubercular agents|mesh-ancestor
64816726|NCT01491503|Cetirizine|cetirizine|mesh-list
64816727|NCT01491503|Montelukast|montelukast|mesh-list
64816728|NCT01491503|Levocetirizine|levocetirizine|mesh-list
64816729|NCT01491503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64816730|NCT01491503|Respiratory System Agents|respiratory system agents|mesh-ancestor
64816731|NCT01491503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64762642|NCT03188705|Aspirin|aspirin|mesh-list
64816732|NCT01491503|Hormone Antagonists|hormone antagonists|mesh-ancestor
64816733|NCT01491503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64816734|NCT01491503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816735|NCT01491503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64816736|NCT01491503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64816737|NCT01491503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816738|NCT01491503|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64816739|NCT01491503|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64816740|NCT01491503|Histamine Antagonists|histamine antagonists|mesh-ancestor
64816741|NCT01491503|Histamine Agents|histamine agents|mesh-ancestor
64816742|NCT01491503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64816743|NCT01491503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64816760|NCT01492153|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64816761|NCT01492153|Isophane Insulin, Human|isophane insulin, human|mesh-list
64816762|NCT01492153|Insulin, Isophane|insulin, isophane|mesh-list
64816763|NCT01492153|Isophane insulin, beef|isophane insulin, beef|mesh-list
64762749|NCT02616965|Romidepsin|romidepsin|mesh-list
64816764|NCT01492153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64816765|NCT01492153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816766|NCT01492166|Insulin|insulin|mesh-list
64816767|NCT01492166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64816768|NCT01492166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64816769|NCT01492166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557413|NCT05581979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557414|NCT05331144|Losartan|losartan|mesh-list
64557465|NCT03076203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557466|NCT03076203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557468|NCT02943057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64557469|NCT02943057|Antiviral Agents|antiviral agents|mesh-ancestor
64816820|NCT01492608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64816821|NCT01492608|Tocolytic Agents|tocolytic agents|mesh-ancestor
64816822|NCT01492608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64816831|NCT01492621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64816891|NCT01493050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816892|NCT01493050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64816893|NCT01493050|Chelating Agents|chelating agents|mesh-ancestor
64816894|NCT01493050|Sequestering Agents|sequestering agents|mesh-ancestor
64816895|NCT01493102|Vasopressins|vasopressins|mesh-list
64816896|NCT01493102|Arginine Vasopressin|arginine vasopressin|mesh-list
64816897|NCT01493102|Norepinephrine|norepinephrine|mesh-list
64816898|NCT01493102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64763019|NCT01285817|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64763020|NCT01285817|Abortifacient Agents|abortifacient agents|mesh-ancestor
64763021|NCT01285817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64763022|NCT01285817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64763023|NCT01285817|Antimetabolites|antimetabolites|mesh-ancestor
64763024|NCT01285817|Dermatologic Agents|dermatologic agents|mesh-ancestor
64763025|NCT01285817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374806|NCT03249311|Milnacipran|milnacipran|mesh-list
64816899|NCT01493102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64816900|NCT01493102|Adrenergic Agents|adrenergic agents|mesh-ancestor
64816901|NCT01493102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64816902|NCT01493102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816903|NCT01493102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816904|NCT01493102|Sympathomimetics|sympathomimetics|mesh-ancestor
64816905|NCT01493102|Autonomic Agents|autonomic agents|mesh-ancestor
64816906|NCT01493102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64816907|NCT01493102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64816948|NCT01493310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64816949|NCT01493310|Luteolytic Agents|luteolytic agents|mesh-ancestor
64816950|NCT01493310|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64816951|NCT01493310|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64816952|NCT01493336|Capecitabine|capecitabine|mesh-list
64816953|NCT01493336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64816954|NCT01493336|Antimetabolites|antimetabolites|mesh-ancestor
64816955|NCT01493336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64816956|NCT01493336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64816957|NCT01493388|Insulin|insulin|mesh-list
64816958|NCT01493388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64816959|NCT01493388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64816960|NCT01493440|Atosiban|atosiban|mesh-list
64763061|NCT01250496|Protective Agents|protective agents|mesh-ancestor
64763062|NCT01105975|Atorvastatin|atorvastatin|mesh-list
64763063|NCT01105975|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64816961|NCT01493440|Hormone Antagonists|hormone antagonists|mesh-ancestor
64816963|NCT01493440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817008|NCT01493843|Antimitotic Agents|antimitotic agents|mesh-ancestor
64817009|NCT01493843|Mitosis Modulators|mitosis modulators|mesh-ancestor
64817010|NCT01493843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817011|NCT01493843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64817012|NCT01493843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64817013|NCT01493843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64817014|NCT01493843|Growth Substances|growth substances|mesh-ancestor
64817015|NCT01493843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817016|NCT01493843|Growth Inhibitors|growth inhibitors|mesh-ancestor
64817017|NCT01493856|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64817018|NCT01493856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64817019|NCT01493856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64817020|NCT01493856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64817021|NCT01493856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817022|NCT01493973|Epoetin Alfa|epoetin alfa|mesh-list
64817023|NCT01493973|Hematinics|hematinics|mesh-ancestor
64817024|NCT01493986|Ropivacaine|ropivacaine|mesh-list
64817025|NCT01493986|Anesthetics, Local|anesthetics, local|mesh-ancestor
64817026|NCT01493986|Anesthetics|anesthetics|mesh-ancestor
64817060|NCT01494155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64817061|NCT01494155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64817062|NCT01494155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763218|NCT04378608|Antimetabolites|antimetabolites|mesh-ancestor
64817063|NCT01494155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64817064|NCT01494259|Epinephrine|epinephrine|mesh-list
64817065|NCT01494259|Bupivacaine|bupivacaine|mesh-list
64817066|NCT01494259|Anesthetics, Local|anesthetics, local|mesh-ancestor
64817067|NCT01494259|Anesthetics|anesthetics|mesh-ancestor
64817068|NCT01494259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64585695|NCT02988921|Paclitaxel|paclitaxel|mesh-list
64817127|NCT01494402|Sensory System Agents|sensory system agents|mesh-ancestor
64817128|NCT01494402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64817129|NCT01494402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817130|NCT01494402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64817197|NCT01494727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64817198|NCT01494740|Vaccines|vaccines|mesh-list
64817199|NCT01494740|Immunologic Factors|immunologic factors|mesh-ancestor
64817200|NCT01494740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817201|NCT01494805|Ranibizumab|ranibizumab|mesh-list
64817202|NCT01494805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64817203|NCT01494805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64817204|NCT01494805|Growth Substances|growth substances|mesh-ancestor
64817205|NCT01494805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817206|NCT01494805|Growth Inhibitors|growth inhibitors|mesh-ancestor
64817207|NCT01494805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817208|NCT01494857|Adalimumab|adalimumab|mesh-list
64817261|NCT01495156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64817262|NCT01495156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64817263|NCT01495156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817264|NCT01495169|Iloperidone|iloperidone|mesh-list
64817265|NCT01495169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64817266|NCT01495169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64817267|NCT01495169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64817268|NCT01495169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817269|NCT01495169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64817271|NCT01495195|Donepezil|donepezil|mesh-list
64817272|NCT01495195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64817273|NCT01495195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817274|NCT01495195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817275|NCT01495195|Cholinergic Agents|cholinergic agents|mesh-ancestor
64817276|NCT01495195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64817277|NCT01495195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817278|NCT01495195|Nootropic Agents|nootropic agents|mesh-ancestor
64817279|NCT01495195|Antidepressive Agents|antidepressive agents|mesh-ancestor
64817280|NCT01495195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64817281|NCT01495195|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64817282|NCT01495195|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64817283|NCT01495195|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64817284|NCT01495195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64817285|NCT01495195|Protective Agents|protective agents|mesh-ancestor
64817286|NCT01495208|Aflibercept|aflibercept|mesh-list
64817287|NCT01495208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64817288|NCT01495208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64817289|NCT01495208|Growth Substances|growth substances|mesh-ancestor
64817290|NCT01495208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817291|NCT01495208|Growth Inhibitors|growth inhibitors|mesh-ancestor
64817292|NCT01495208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817293|NCT01495260|Vitamin E|vitamin e|mesh-list
64817294|NCT01495260|Thioctic Acid|thioctic acid|mesh-list
64817295|NCT01495260|Acetylcysteine|acetylcysteine|mesh-list
64817300|NCT01495260|Antiviral Agents|antiviral agents|mesh-ancestor
64817301|NCT01495260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64817302|NCT01495260|Expectorants|expectorants|mesh-ancestor
64817303|NCT01495260|Respiratory System Agents|respiratory system agents|mesh-ancestor
64817304|NCT01495260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64817305|NCT01495260|Antioxidants|antioxidants|mesh-ancestor
64817306|NCT01495260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817369|NCT01495624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64817370|NCT01495624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64817371|NCT01495624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817372|NCT01495624|Protease Inhibitors|protease inhibitors|mesh-ancestor
64557483|NCT02555007|Vinorelbine|vinorelbine|mesh-list
64817373|NCT01495624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817374|NCT01495624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817375|NCT01495624|Anesthetics, Local|anesthetics, local|mesh-ancestor
64817376|NCT01495624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64817377|NCT01495624|Sensory System Agents|sensory system agents|mesh-ancestor
64817379|NCT01495715|Antioxidants|antioxidants|mesh-ancestor
64817429|NCT01495962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64817430|NCT01495962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817431|NCT01495962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64817432|NCT01495962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64817433|NCT01496105|Lidocaine|lidocaine|mesh-list
64817434|NCT01496105|Anesthetics, Local|anesthetics, local|mesh-ancestor
64817435|NCT01496105|Anesthetics|anesthetics|mesh-ancestor
64817436|NCT01496105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64817497|NCT01496443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64817498|NCT01496443|Immunologic Factors|immunologic factors|mesh-ancestor
64817499|NCT01496521|Aspirin|aspirin|mesh-list
64817500|NCT01496521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64817501|NCT01496521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64817502|NCT01496521|Analgesics|analgesics|mesh-ancestor
64817557|NCT01496911|Histamine Antagonists|histamine antagonists|mesh-ancestor
64817558|NCT01496911|Histamine Agents|histamine agents|mesh-ancestor
64817559|NCT01496911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64817560|NCT01496911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817561|NCT01496911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817562|NCT01496911|Antipruritics|antipruritics|mesh-ancestor
64817563|NCT01496911|Dermatologic Agents|dermatologic agents|mesh-ancestor
64817564|NCT01496989|Interleukin-12|interleukin-12|mesh-list
64817565|NCT01496989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64817566|NCT01496989|Immunologic Factors|immunologic factors|mesh-ancestor
64817567|NCT01496989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817568|NCT01496989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64817569|NCT01496989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64817570|NCT01496989|Growth Substances|growth substances|mesh-ancestor
64817571|NCT01496989|Growth Inhibitors|growth inhibitors|mesh-ancestor
64817572|NCT01496989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817574|NCT01497002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64817575|NCT01497002|Antimetabolites|antimetabolites|mesh-ancestor
64817576|NCT01497002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817612|NCT01497093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64817613|NCT01497093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64817614|NCT01497132|Vitamin D|vitamin d|mesh-list
64817615|NCT01497132|Cholecalciferol|cholecalciferol|mesh-list
64817616|NCT01497132|Vitamins|vitamins|mesh-ancestor
64817617|NCT01497132|Micronutrients|micronutrients|mesh-ancestor
64817618|NCT01497132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817619|NCT01497132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64817620|NCT01497132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64817621|NCT01497145|Darbepoetin alfa|darbepoetin alfa|mesh-list
64817622|NCT01497145|Hematinics|hematinics|mesh-ancestor
64817623|NCT01497288|Fentanyl|fentanyl|mesh-list
64817624|NCT01497288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64817625|NCT01497288|Narcotics|narcotics|mesh-ancestor
64817626|NCT01497288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64817627|NCT01497288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817628|NCT01497288|Analgesics|analgesics|mesh-ancestor
64763492|NCT04361370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817629|NCT01497288|Sensory System Agents|sensory system agents|mesh-ancestor
64817630|NCT01497288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64817631|NCT01497288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64817632|NCT01497288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64817633|NCT01497288|Anesthetics, General|anesthetics, general|mesh-ancestor
64817634|NCT01497288|Anesthetics|anesthetics|mesh-ancestor
64817635|NCT01497327|Sofosbuvir|sofosbuvir|mesh-list
64817636|NCT01497327|Antiviral Agents|antiviral agents|mesh-ancestor
64817665|NCT01497483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817666|NCT01497483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64817667|NCT01497483|Immunologic Factors|immunologic factors|mesh-ancestor
64817668|NCT01497483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817669|NCT01497483|Antifungal Agents|antifungal agents|mesh-ancestor
64586285|NCT00322439|Etanercept|etanercept|mesh-list
64817670|NCT01497483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64817671|NCT01497483|Dermatologic Agents|dermatologic agents|mesh-ancestor
64817672|NCT01497483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64817673|NCT01497483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64817731|NCT01497626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817732|NCT01497652|Rasagiline|rasagiline|mesh-list
64817733|NCT01497652|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64817734|NCT01497652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64817735|NCT01497652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817736|NCT01497652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64817737|NCT01497652|Protective Agents|protective agents|mesh-ancestor
64763554|NCT04358016|Somatostatin|somatostatin|mesh-list
64817738|NCT01497652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817739|NCT01497717|Adalimumab|adalimumab|mesh-list
64817795|NCT01498380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817796|NCT01498380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64817797|NCT01498380|Analgesics|analgesics|mesh-ancestor
64817798|NCT01498380|Sensory System Agents|sensory system agents|mesh-ancestor
64817799|NCT01498380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64817800|NCT01498380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64817801|NCT01498380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64817802|NCT01498380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64817803|NCT01498380|Adrenergic Agents|adrenergic agents|mesh-ancestor
64817804|NCT01498380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64817805|NCT01498380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817807|NCT01498406|Ergocalciferols|ergocalciferols|mesh-list
64817808|NCT01498406|Cholecalciferol|cholecalciferol|mesh-list
64817809|NCT01498406|Vitamins|vitamins|mesh-list
64817810|NCT01498406|Micronutrients|micronutrients|mesh-ancestor
64817852|NCT01498809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64817853|NCT01498809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64817854|NCT01498809|Adrenergic Agents|adrenergic agents|mesh-ancestor
64817855|NCT01498809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64817856|NCT01498809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64817857|NCT01498835|Sunitinib|sunitinib|mesh-list
64817858|NCT01498835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64817859|NCT01498835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64817867|NCT01498861|Dolutegravir|dolutegravir|mesh-list
64763676|NCT04353336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763677|NCT04353336|Amebicides|amebicides|mesh-ancestor
64763678|NCT04353336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64817916|NCT01499069|Urological Agents|urological agents|mesh-ancestor
64817917|NCT01499069|Parasympatholytics|parasympatholytics|mesh-ancestor
64817918|NCT01499069|Autonomic Agents|autonomic agents|mesh-ancestor
64817919|NCT01499069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64817920|NCT01499108|Liraglutide|liraglutide|mesh-list
64817921|NCT01499108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64817922|NCT01499108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817923|NCT01499108|Incretins|incretins|mesh-ancestor
64817926|NCT01499121|Sunitinib|sunitinib|mesh-list
64817983|NCT01499602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64817984|NCT01499602|Contraceptive Agents|contraceptive agents|mesh-ancestor
64817985|NCT01499602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64817986|NCT01499602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64817987|NCT01499602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64817988|NCT01499602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64817989|NCT01499602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64817990|NCT01499602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64817991|NCT01499641|Methylprednisolone|methylprednisolone|mesh-list
64817992|NCT01499641|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64817993|NCT01499641|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64817994|NCT01499641|Prednisolone|prednisolone|mesh-list
64817995|NCT01499641|Prednisolone acetate|prednisolone acetate|mesh-list
64817996|NCT01499641|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64817997|NCT01499641|Prednisolone phosphate|prednisolone phosphate|mesh-list
64817998|NCT01499641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64817999|NCT01499641|Antiemetics|antiemetics|mesh-ancestor
64818000|NCT01499641|Autonomic Agents|autonomic agents|mesh-ancestor
64818001|NCT01499641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64763781|NCT04349592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64818002|NCT01499641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818003|NCT01499641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64818004|NCT01499641|Glucocorticoids|glucocorticoids|mesh-ancestor
64818005|NCT01499641|Hormones|hormones|mesh-ancestor
64818006|NCT01499641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64818008|NCT01499641|Protective Agents|protective agents|mesh-ancestor
64818009|NCT01499641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64818010|NCT01499641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818011|NCT01499693|Pantoprazole|pantoprazole|mesh-list
64818012|NCT01499693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64818017|NCT01499758|Atorvastatin|atorvastatin|mesh-list
64818026|NCT01499771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64818027|NCT01499771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64818028|NCT01499771|Antimetabolites|antimetabolites|mesh-ancestor
64818029|NCT01499771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818030|NCT01499771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64818031|NCT01499771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64818032|NCT01499771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818033|NCT01499875|Penicillin V|penicillin v|mesh-list
64818034|NCT01499875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64818035|NCT01499875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64818093|NCT01500161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64818094|NCT01500161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64818095|NCT01500161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64818096|NCT01500161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818097|NCT01500161|Antiviral Agents|antiviral agents|mesh-ancestor
64818098|NCT01500161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64818099|NCT01500161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64818100|NCT01500161|Alkylating Agents|alkylating agents|mesh-ancestor
64818101|NCT01500161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64818102|NCT01500408|Interferons|interferons|mesh-list
64818103|NCT01500408|Interferon-beta|interferon-beta|mesh-list
64818104|NCT01500408|Interferon beta-1a|interferon beta-1a|mesh-list
64818105|NCT01500408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818106|NCT01500408|Antiviral Agents|antiviral agents|mesh-ancestor
64818107|NCT01500408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64818108|NCT01500408|Immunologic Factors|immunologic factors|mesh-ancestor
64818109|NCT01500408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818110|NCT01500408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64818111|NCT01500473|Desogestrel|desogestrel|mesh-list
64818148|NCT01500590|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64818150|NCT01500590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818151|NCT01500590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818152|NCT01500590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64818153|NCT01500590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64818154|NCT01500590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64818155|NCT01500785|Vitamin B 12|vitamin b 12|mesh-list
64818156|NCT01500785|Hydroxocobalamin|hydroxocobalamin|mesh-list
64763940|NCT04340388|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64818157|NCT01500785|Simendan|simendan|mesh-list
64763941|NCT04340388|Antiviral Agents|antiviral agents|mesh-ancestor
64818158|NCT01500785|Vitamins|vitamins|mesh-ancestor
64818159|NCT01500785|Micronutrients|micronutrients|mesh-ancestor
64818160|NCT01500785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818161|NCT01500785|Vitamin B Complex|vitamin b complex|mesh-ancestor
64818162|NCT01500785|Hematinics|hematinics|mesh-ancestor
64818163|NCT01500785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64818164|NCT01500785|Vasodilator Agents|vasodilator agents|mesh-ancestor
64818165|NCT01500785|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64818166|NCT01500785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64818167|NCT01500785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818168|NCT01500785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818199|NCT01500837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64818200|NCT01500837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64818201|NCT01500837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64818202|NCT01500837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64818203|NCT01500850|Insulin|insulin|mesh-list
64818204|NCT01500850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64818205|NCT01500850|Insulin Glargine|insulin glargine|mesh-list
64818206|NCT01500850|Insulin glulisine|insulin glulisine|mesh-list
64818268|NCT01501123|Haloperidol decanoate|haloperidol decanoate|mesh-list
64818269|NCT01501123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64818270|NCT01501123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64818271|NCT01501123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64818272|NCT01501123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818273|NCT01501123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64818274|NCT01501123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64818275|NCT01501123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64818276|NCT01501123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64818277|NCT01501123|Anesthetics, General|anesthetics, general|mesh-ancestor
64818278|NCT01501123|Anesthetics|anesthetics|mesh-ancestor
64818279|NCT01501123|GABA Modulators|gaba modulators|mesh-ancestor
64818280|NCT01501123|GABA Agents|gaba agents|mesh-ancestor
64818281|NCT01501123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64818335|NCT01501149|Autonomic Agents|autonomic agents|mesh-ancestor
64818336|NCT01501149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64818337|NCT01501149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818338|NCT01501149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64818339|NCT01501149|Glucocorticoids|glucocorticoids|mesh-ancestor
64764014|NCT04336488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64764015|NCT04336488|Immunologic Factors|immunologic factors|mesh-ancestor
64764016|NCT04336488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764017|NCT04336488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764018|NCT04336488|Protease Inhibitors|protease inhibitors|mesh-ancestor
64764019|NCT04335786|Valsartan|valsartan|mesh-list
64764024|NCT04335006|Paclitaxel|paclitaxel|mesh-list
64818340|NCT01501149|Hormones|hormones|mesh-ancestor
64818341|NCT01501149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64818342|NCT01501149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64818343|NCT01501149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818344|NCT01501149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64818345|NCT01501149|Antimetabolites|antimetabolites|mesh-ancestor
64818346|NCT01501149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818347|NCT01501149|Antiviral Agents|antiviral agents|mesh-ancestor
64818348|NCT01501149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64818349|NCT01501149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818350|NCT01501149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64818351|NCT01501149|Immunologic Factors|immunologic factors|mesh-ancestor
64818352|NCT01501149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64818353|NCT01501149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64818354|NCT01501149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64818355|NCT01501214|Atosiban|atosiban|mesh-list
64818356|NCT01501214|Hormone Antagonists|hormone antagonists|mesh-ancestor
64818357|NCT01501214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64818358|NCT01501214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818359|NCT01501214|Tocolytic Agents|tocolytic agents|mesh-ancestor
64818360|NCT01501214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64818361|NCT01501253|Amlodipine|amlodipine|mesh-list
64764044|NCT04334928|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64818379|NCT01501370|Autonomic Agents|autonomic agents|mesh-ancestor
64818380|NCT01501370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64818381|NCT01501370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818382|NCT01501370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64818383|NCT01501370|Glucocorticoids|glucocorticoids|mesh-ancestor
64818384|NCT01501370|Hormones|hormones|mesh-ancestor
64818385|NCT01501370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64818386|NCT01501370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64818387|NCT01501370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818388|NCT01501370|Protease Inhibitors|protease inhibitors|mesh-ancestor
64818389|NCT01501370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818390|NCT01501370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818391|NCT01501370|Immunologic Factors|immunologic factors|mesh-ancestor
64818397|NCT01501396|Megestrol|megestrol|mesh-list
64818438|NCT01501435|Antimetabolites|antimetabolites|mesh-ancestor
64818439|NCT01501435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818440|NCT01501435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64818441|NCT01501448|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64818442|NCT01501448|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64818443|NCT01501448|Levonorgestrel|levonorgestrel|mesh-list
64818444|NCT01501448|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64818445|NCT01501448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64818446|NCT01501448|Estradiol|estradiol|mesh-list
64764153|NCT00704106|Entecavir|entecavir|mesh-list
64818447|NCT01501448|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64818448|NCT01501448|Estrogens|estrogens|mesh-ancestor
64818449|NCT01501448|Hormones|hormones|mesh-ancestor
64818450|NCT01501448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64818451|NCT01501448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818452|NCT01501448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64818453|NCT01501448|Contraceptive Agents|contraceptive agents|mesh-ancestor
64818454|NCT01501448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64818455|NCT01501448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64818456|NCT01501448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64818457|NCT01501448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64818458|NCT01501448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64818459|NCT01501448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64818460|NCT01501487|Paclitaxel|paclitaxel|mesh-list
64818461|NCT01501487|Docetaxel|docetaxel|mesh-list
64818462|NCT01501487|Trastuzumab|trastuzumab|mesh-list
64818463|NCT01501487|Pertuzumab|pertuzumab|mesh-list
64818464|NCT01501487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64818465|NCT01501487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818466|NCT01501487|Tubulin Modulators|tubulin modulators|mesh-ancestor
64818483|NCT01501591|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64818484|NCT01501591|Histamine Antagonists|histamine antagonists|mesh-ancestor
64818485|NCT01501591|Histamine Agents|histamine agents|mesh-ancestor
64818486|NCT01501591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64818487|NCT01501591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818488|NCT01501591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818489|NCT01501669|Capecitabine|capecitabine|mesh-list
64818491|NCT01501669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64818492|NCT01501669|Antimetabolites|antimetabolites|mesh-ancestor
64818493|NCT01501669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818494|NCT01501669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818495|NCT01501669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64818496|NCT01501669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64818497|NCT01501669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818498|NCT01501695|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
64818499|NCT01501695|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64764230|NCT03035214|Antiemetics|antiemetics|mesh-ancestor
64764231|NCT03035214|Autonomic Agents|autonomic agents|mesh-ancestor
64764232|NCT03035214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764233|NCT03035214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818500|NCT01501695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64818501|NCT01501695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64818502|NCT01501695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818503|NCT01501695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64818535|NCT01501747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818536|NCT01501747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64818537|NCT01501747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64818538|NCT01501747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64818539|NCT01501747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818540|NCT01501747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818542|NCT01501747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64818543|NCT01501747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64818544|NCT01501747|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64818545|NCT01501747|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64818597|NCT01501890|Contraceptive Agents|contraceptive agents|mesh-ancestor
64818598|NCT01501890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64818599|NCT01501890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64818600|NCT01501890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64818602|NCT01501916|Cholecalciferol|cholecalciferol|mesh-list
64818603|NCT01501916|Vitamins|vitamins|mesh-ancestor
64818604|NCT01501916|Micronutrients|micronutrients|mesh-ancestor
64818605|NCT01501916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818606|NCT01501916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64818607|NCT01501916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64818608|NCT01501942|Glycine|glycine|mesh-list
64818609|NCT01501942|Glycine Agents|glycine agents|mesh-ancestor
64818610|NCT01501942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64818611|NCT01501942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818612|NCT01501942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818613|NCT01501968|Ascorbic Acid|ascorbic acid|mesh-list
64818614|NCT01501968|Colistin|colistin|mesh-list
64818615|NCT01501968|Vitamins|vitamins|mesh-ancestor
64818616|NCT01501968|Micronutrients|micronutrients|mesh-ancestor
64818617|NCT01501968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818618|NCT01501968|Antioxidants|antioxidants|mesh-ancestor
64818619|NCT01501968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818620|NCT01501968|Protective Agents|protective agents|mesh-ancestor
64818621|NCT01501968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64818622|NCT01501968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64818624|NCT01502020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64818625|NCT01502020|Immunologic Factors|immunologic factors|mesh-ancestor
64818626|NCT01502020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818627|NCT01502020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764394|NCT03017430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64764395|NCT03017430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64818628|NCT01502020|Interferon Inducers|interferon inducers|mesh-ancestor
64818629|NCT01502046|Dronabinol|dronabinol|mesh-list
64818630|NCT01502046|Cannabidiol|cannabidiol|mesh-list
64818631|NCT01502046|Anticonvulsants|anticonvulsants|mesh-ancestor
64818638|NCT01502046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64818639|NCT01502046|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64818640|NCT01502046|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64818641|NCT01502046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64818642|NCT01502046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818643|NCT01502046|Hormones|hormones|mesh-ancestor
64818644|NCT01502046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64818645|NCT01502202|Pemetrexed|pemetrexed|mesh-list
64818646|NCT01502202|Gefitinib|gefitinib|mesh-list
64818647|NCT01502202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818648|NCT01502202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818649|NCT01502202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818650|NCT01502202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64818651|NCT01502202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64818652|NCT01502202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64818653|NCT01502241|Temozolomide|temozolomide|mesh-list
64818654|NCT01502241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64818694|NCT01502774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818696|NCT01502774|Immunologic Factors|immunologic factors|mesh-ancestor
64818697|NCT01502774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818698|NCT01502774|Antifungal Agents|antifungal agents|mesh-ancestor
64818699|NCT01502774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64818700|NCT01502774|Dermatologic Agents|dermatologic agents|mesh-ancestor
64818701|NCT01502774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64818702|NCT01502774|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64818703|NCT01502800|Beta-lapachone|beta-lapachone|mesh-list
64818704|NCT01502800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64818705|NCT01502800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64818706|NCT01502800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64818707|NCT01502800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818708|NCT01502800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818709|NCT01502800|Antiviral Agents|antiviral agents|mesh-ancestor
64818710|NCT01502878|Cefpodoxime|cefpodoxime|mesh-list
64818711|NCT01502878|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
64818714|NCT01502904|Sirolimus|sirolimus|mesh-list
64818750|NCT01503060|Anesthetics, Local|anesthetics, local|mesh-ancestor
64818751|NCT01503060|Anesthetics|anesthetics|mesh-ancestor
64818752|NCT01503060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64818753|NCT01503060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818754|NCT01503060|Sensory System Agents|sensory system agents|mesh-ancestor
64818755|NCT01503060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64818756|NCT01503060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64818757|NCT01503060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64818758|NCT01503060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64818761|NCT01503216|Vitamin D|vitamin d|mesh-list
64818816|NCT01503385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64818817|NCT01503385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64818818|NCT01503385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818819|NCT01503385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818820|NCT01503398|Olanzapine|olanzapine|mesh-list
64818821|NCT01503398|Antiemetics|antiemetics|mesh-ancestor
64818822|NCT01503398|Autonomic Agents|autonomic agents|mesh-ancestor
64818823|NCT01503398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764517|NCT03010098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64818824|NCT01503398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818825|NCT01503398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64818836|NCT01503424|Olanzapine|olanzapine|mesh-list
64818879|NCT01503450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64818880|NCT01503450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64818881|NCT01503450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818883|NCT01503450|Serotonin Agents|serotonin agents|mesh-ancestor
64818884|NCT01503502|Imatinib Mesylate|imatinib mesylate|mesh-list
64818886|NCT01503502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64818887|NCT01503502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64818888|NCT01503502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64818889|NCT01503502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818890|NCT01503580|Solifenacin Succinate|solifenacin succinate|mesh-list
64818891|NCT01503580|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64818892|NCT01503580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64818893|NCT01503580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64818894|NCT01503580|Cholinergic Agents|cholinergic agents|mesh-ancestor
64818895|NCT01503580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64818898|NCT01503580|Urological Agents|urological agents|mesh-ancestor
64818934|NCT01503736|Ferric Compounds|ferric compounds|mesh-list
64818935|NCT01503736|Anticoagulants|anticoagulants|mesh-ancestor
64818936|NCT01503736|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64818937|NCT01503736|Chelating Agents|chelating agents|mesh-ancestor
64818938|NCT01503736|Sequestering Agents|sequestering agents|mesh-ancestor
64818939|NCT01503736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64818940|NCT01503736|Hematinics|hematinics|mesh-ancestor
64818942|NCT01503788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64818943|NCT01503788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64818944|NCT01503788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64818945|NCT01503788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64818952|NCT01503788|GABA Modulators|gaba modulators|mesh-ancestor
64818997|NCT01503905|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64818998|NCT01503905|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64818999|NCT01503905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64819001|NCT01503918|Acyclovir|acyclovir|mesh-list
64819002|NCT01503918|Valganciclovir|valganciclovir|mesh-list
64819003|NCT01503918|Ganciclovir|ganciclovir|mesh-list
64819064|NCT01504178|Analgesics|analgesics|mesh-ancestor
64819065|NCT01504178|Sensory System Agents|sensory system agents|mesh-ancestor
64819066|NCT01504178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64819067|NCT01504178|Antidepressive Agents|antidepressive agents|mesh-ancestor
64819068|NCT01504178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64819069|NCT01504178|Dopamine Agents|dopamine agents|mesh-ancestor
64819070|NCT01504178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64819071|NCT01504178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64819073|NCT01504178|Autonomic Agents|autonomic agents|mesh-ancestor
64819074|NCT01504178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64819075|NCT01504178|Dopamine Agonists|dopamine agonists|mesh-ancestor
64819076|NCT01504256|Leucovorin|leucovorin|mesh-list
64819077|NCT01504256|Docetaxel|docetaxel|mesh-list
64819078|NCT01504256|Fluorouracil|fluorouracil|mesh-list
64819079|NCT01504256|Oxaliplatin|oxaliplatin|mesh-list
64819080|NCT01504256|Catumaxomab|catumaxomab|mesh-list
64819081|NCT01504256|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64819096|NCT01504256|Vitamins|vitamins|mesh-ancestor
64819126|NCT01504386|Anesthetics|anesthetics|mesh-ancestor
64819127|NCT01504386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64819128|NCT01504386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819129|NCT01504386|Sensory System Agents|sensory system agents|mesh-ancestor
64819130|NCT01504386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64819131|NCT01504490|Bexarotene|bexarotene|mesh-list
64819132|NCT01504490|Efatutazone|efatutazone|mesh-list
64819133|NCT01504490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819134|NCT01504503|Donepezil|donepezil|mesh-list
64819135|NCT01504503|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64819136|NCT01504503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64819137|NCT01504503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819138|NCT01504503|Cholinergic Agents|cholinergic agents|mesh-ancestor
64819139|NCT01504503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64764639|NCT03005340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64819140|NCT01504503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819141|NCT01504503|Nootropic Agents|nootropic agents|mesh-ancestor
64819142|NCT01504516|Donepezil|donepezil|mesh-list
64819143|NCT01504516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64819144|NCT01504516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64819145|NCT01504516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819146|NCT01504516|Cholinergic Agents|cholinergic agents|mesh-ancestor
64819149|NCT01504516|Nootropic Agents|nootropic agents|mesh-ancestor
64819179|NCT01504724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64819180|NCT01504724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819181|NCT01504724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64819182|NCT01504724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64819183|NCT01504724|Growth Substances|growth substances|mesh-ancestor
64819248|NCT01505088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64819249|NCT01505088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819250|NCT01505088|Anticoagulants|anticoagulants|mesh-ancestor
64819251|NCT01505088|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64819252|NCT01505088|Chelating Agents|chelating agents|mesh-ancestor
64819253|NCT01505088|Sequestering Agents|sequestering agents|mesh-ancestor
64819254|NCT01505088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819255|NCT01505088|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64819256|NCT01505088|Protective Agents|protective agents|mesh-ancestor
64819257|NCT01505088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64819314|NCT01505283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64819315|NCT01505283|Anesthetics, General|anesthetics, general|mesh-ancestor
64819316|NCT01505296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64819317|NCT01505413|Gemcitabine|gemcitabine|mesh-list
64819318|NCT01505413|Oxaliplatin|oxaliplatin|mesh-list
64819319|NCT01505413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64764678|NCT03002844|Gefitinib|gefitinib|mesh-list
64764679|NCT03002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764680|NCT03002844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64764681|NCT03002844|Antimetabolites|antimetabolites|mesh-ancestor
64764682|NCT03002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764683|NCT03002844|Antiviral Agents|antiviral agents|mesh-ancestor
64764684|NCT03002844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64764685|NCT03002844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764686|NCT03002844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64819320|NCT01505413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64819321|NCT01505413|Antimetabolites|antimetabolites|mesh-ancestor
64819323|NCT01505413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819379|NCT01505790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64819380|NCT01505790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819381|NCT01505790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819382|NCT01505855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64819383|NCT01505855|Immunologic Factors|immunologic factors|mesh-ancestor
64819384|NCT01505855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819385|NCT01505894|BI 409306|bi 409306|mesh-list
64819386|NCT01505894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64819387|NCT01505894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64819388|NCT01505894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819389|NCT01505920|Lidocaine|lidocaine|mesh-list
64819390|NCT01505920|Anesthetics, Local|anesthetics, local|mesh-ancestor
64819391|NCT01505920|Anesthetics|anesthetics|mesh-ancestor
64819392|NCT01505920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64764742|NCT02989272|Magnesium Sulfate|magnesium sulfate|mesh-list
64764743|NCT02989272|Analgesics|analgesics|mesh-ancestor
64819436|NCT01506024|Autonomic Agents|autonomic agents|mesh-ancestor
64764744|NCT02989272|Sensory System Agents|sensory system agents|mesh-ancestor
64764745|NCT02989272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764746|NCT02989272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764747|NCT02989272|Anesthetics|anesthetics|mesh-ancestor
64764748|NCT02989272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64819437|NCT01506024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64819438|NCT01506024|Nootropic Agents|nootropic agents|mesh-ancestor
64819439|NCT01506037|Desloratadine|desloratadine|mesh-list
64819440|NCT01506037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64819441|NCT01506037|Cholinergic Agents|cholinergic agents|mesh-ancestor
64819442|NCT01506037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64819443|NCT01506037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819444|NCT01506037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819445|NCT01506037|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64819446|NCT01506037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64819447|NCT01506037|Histamine Antagonists|histamine antagonists|mesh-ancestor
64819448|NCT01506037|Histamine Agents|histamine agents|mesh-ancestor
64819449|NCT01506050|Desloratadine|desloratadine|mesh-list
64819450|NCT01506050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64819495|NCT01506167|Growth Inhibitors|growth inhibitors|mesh-ancestor
64819496|NCT01506167|Antimetabolites|antimetabolites|mesh-ancestor
64819497|NCT01506167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819498|NCT01506167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64819504|NCT01506167|Antidotes|antidotes|mesh-ancestor
64819567|NCT01506544|Hydroxyurea|hydroxyurea|mesh-list
64819568|NCT01506544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819569|NCT01506544|Antisickling Agents|antisickling agents|mesh-ancestor
64819570|NCT01506544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64819571|NCT01506544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819572|NCT01506544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64819573|NCT01506557|Cholecalciferol|cholecalciferol|mesh-list
64819574|NCT01506557|Vitamin D|vitamin d|mesh-list
64819575|NCT01506557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64819576|NCT01506557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819577|NCT01506557|Vitamins|vitamins|mesh-ancestor
64819578|NCT01506557|Micronutrients|micronutrients|mesh-ancestor
64819579|NCT01506557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64819580|NCT01506570|Vaccines|vaccines|mesh-list
64819581|NCT01506570|Immunologic Factors|immunologic factors|mesh-ancestor
64819625|NCT01506752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64819626|NCT01506752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819627|NCT01506752|Cholinergic Agents|cholinergic agents|mesh-ancestor
64819628|NCT01506752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64819629|NCT01506752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819630|NCT01506752|Nootropic Agents|nootropic agents|mesh-ancestor
64819631|NCT01506765|Acetylcysteine|acetylcysteine|mesh-list
64819632|NCT01506765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64819633|NCT01506765|Antiviral Agents|antiviral agents|mesh-ancestor
64819634|NCT01506765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64819635|NCT01506765|Expectorants|expectorants|mesh-ancestor
64819636|NCT01506765|Respiratory System Agents|respiratory system agents|mesh-ancestor
64819637|NCT01506765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64819638|NCT01506765|Antioxidants|antioxidants|mesh-ancestor
64819639|NCT01506765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819640|NCT01506765|Protective Agents|protective agents|mesh-ancestor
64819641|NCT01506765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819642|NCT01506765|Antidotes|antidotes|mesh-ancestor
64819644|NCT01506791|Ephedrine|ephedrine|mesh-list
64764901|NCT02974920|Aspirin|aspirin|mesh-list
64819682|NCT01506804|Protective Agents|protective agents|mesh-ancestor
64819683|NCT01506804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64819684|NCT01506804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819685|NCT01506895|Darapladib|darapladib|mesh-list
64819686|NCT01506895|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
64819687|NCT01506895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64819688|NCT01506895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819689|NCT01506921|Ketamine|ketamine|mesh-list
64819690|NCT01506921|Esketamine|esketamine|mesh-list
64819691|NCT01506921|Analgesics|analgesics|mesh-ancestor
64819692|NCT01506921|Sensory System Agents|sensory system agents|mesh-ancestor
64819693|NCT01506921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64819694|NCT01506921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588308|NCT00490009|Hemostatics|hemostatics|mesh-ancestor
64819695|NCT01506921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64819696|NCT01506921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64819697|NCT01506921|Anesthetics, General|anesthetics, general|mesh-ancestor
64819698|NCT01506921|Anesthetics|anesthetics|mesh-ancestor
64819699|NCT01506921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64819700|NCT01506921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64764963|NCT02641782|Interleukin-2|interleukin-2|mesh-list
64819701|NCT01506921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64819702|NCT01506921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64819703|NCT01506921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819704|NCT01506921|Antidepressive Agents|antidepressive agents|mesh-ancestor
64819705|NCT01506921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64819706|NCT01507064|Sorafenib|sorafenib|mesh-list
64819707|NCT01507064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819729|NCT01507194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64765077|NCT04739202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64819730|NCT01507194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819731|NCT01507194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64819732|NCT01507194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64819733|NCT01507194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64819734|NCT01507194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64819735|NCT01507194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64819736|NCT01507194|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64765184|NCT00580398|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64765185|NCT00580398|Cholinergic Agents|cholinergic agents|mesh-ancestor
64765186|NCT00580398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64765187|NCT00580398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765188|NCT00580398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765189|NCT00582660|Celecoxib|celecoxib|mesh-list
64765190|NCT00582660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64765191|NCT00582660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64819737|NCT01507272|Liraglutide|liraglutide|mesh-list
64819738|NCT01507272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64819739|NCT01507272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819740|NCT01507272|Incretins|incretins|mesh-ancestor
64819741|NCT01507272|Hormones|hormones|mesh-ancestor
64819742|NCT01507272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64819744|NCT01507285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64819788|NCT01507428|Carboplatin|carboplatin|mesh-list
64819789|NCT01507428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64819790|NCT01507428|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64819791|NCT01507428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64819792|NCT01507428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64819793|NCT01507428|Tubulin Modulators|tubulin modulators|mesh-ancestor
64819794|NCT01507428|Antimitotic Agents|antimitotic agents|mesh-ancestor
64819795|NCT01507428|Mitosis Modulators|mitosis modulators|mesh-ancestor
64819796|NCT01507428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819797|NCT01507428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64819798|NCT01507428|Antimetabolites|antimetabolites|mesh-ancestor
64819799|NCT01507428|Antiviral Agents|antiviral agents|mesh-ancestor
64819849|NCT01507597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64819850|NCT01507597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64819851|NCT01507597|Hormones|hormones|mesh-ancestor
64819852|NCT01507597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64819853|NCT01507597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819854|NCT01507597|Incretins|incretins|mesh-ancestor
64819855|NCT01507701|Clonidine|clonidine|mesh-list
64819856|NCT01507701|Analgesics|analgesics|mesh-ancestor
64819857|NCT01507701|Sensory System Agents|sensory system agents|mesh-ancestor
64819858|NCT01507701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64819859|NCT01507701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819860|NCT01507701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64819861|NCT01507701|Sympatholytics|sympatholytics|mesh-ancestor
64819862|NCT01507701|Autonomic Agents|autonomic agents|mesh-ancestor
64819863|NCT01507701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64819864|NCT01507701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64819865|NCT01507701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64819866|NCT01507701|Adrenergic Agents|adrenergic agents|mesh-ancestor
64819867|NCT01507701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64765242|NCT03527472|Memantine|memantine|mesh-list
64765266|NCT01740648|Trametinib|trametinib|mesh-list
64819868|NCT01507701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819869|NCT01507727|Tolvaptan|tolvaptan|mesh-list
64819870|NCT01507727|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64819872|NCT01507727|Natriuretic Agents|natriuretic agents|mesh-ancestor
64819899|NCT01507792|Histamine Antagonists|histamine antagonists|mesh-ancestor
64819900|NCT01507792|Histamine Agents|histamine agents|mesh-ancestor
64819901|NCT01507792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64819902|NCT01507792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819903|NCT01507792|Histamine Agonists|histamine agonists|mesh-ancestor
64819904|NCT01507857|Vaccines|vaccines|mesh-list
64819905|NCT01507857|Immunologic Factors|immunologic factors|mesh-ancestor
64819906|NCT01507857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819907|NCT01507922|Fenoverine|fenoverine|mesh-list
64819969|NCT01508182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64819970|NCT01508182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64819971|NCT01508182|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64819972|NCT01508182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64819973|NCT01508195|Metformin|metformin|mesh-list
64819974|NCT01508195|Canagliflozin|canagliflozin|mesh-list
64819975|NCT01508195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64819976|NCT01508195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820035|NCT01508468|Adrenergic Agents|adrenergic agents|mesh-ancestor
64820036|NCT01508468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64820037|NCT01508468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820038|NCT01508468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64820039|NCT01508468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64820040|NCT01508468|Protease Inhibitors|protease inhibitors|mesh-ancestor
64820041|NCT01508468|Hormone Antagonists|hormone antagonists|mesh-ancestor
64820042|NCT01508468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64820100|NCT01508845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64820101|NCT01508845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64820103|NCT01508858|Levonorgestrel|levonorgestrel|mesh-list
64820104|NCT01508858|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64820105|NCT01508858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64820106|NCT01508858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820107|NCT01508858|Incretins|incretins|mesh-ancestor
64820108|NCT01508858|Hormones|hormones|mesh-ancestor
64820109|NCT01508858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64820110|NCT01508858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64820111|NCT01508858|Contraceptive Agents|contraceptive agents|mesh-ancestor
64820112|NCT01508858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64765307|NCT00393354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64820113|NCT01508858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64820114|NCT01508858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64820115|NCT01508858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64820116|NCT01508858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64820117|NCT01508858|Estrogens|estrogens|mesh-ancestor
64820118|NCT01508884|Imiquimod|imiquimod|mesh-list
64820119|NCT01508884|Vaccines|vaccines|mesh-list
64820120|NCT01508884|Immunologic Factors|immunologic factors|mesh-ancestor
64820121|NCT01508884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820122|NCT01508884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64820123|NCT01508884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820124|NCT01508884|Interferon Inducers|interferon inducers|mesh-ancestor
64820125|NCT01508897|Liraglutide|liraglutide|mesh-list
64820129|NCT01508897|Hormones|hormones|mesh-ancestor
64820148|NCT01509001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64820149|NCT01509001|Immunologic Factors|immunologic factors|mesh-ancestor
64820150|NCT01509131|Bisacodyl|bisacodyl|mesh-list
64820151|NCT01509131|Cathartics|cathartics|mesh-ancestor
64820152|NCT01509131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64820153|NCT01509131|Laxatives|laxatives|mesh-ancestor
64820154|NCT01509144|Vaccines|vaccines|mesh-list
64820155|NCT01509144|Immunologic Factors|immunologic factors|mesh-ancestor
64820156|NCT01509144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820157|NCT01509209|Pseudoephedrine|pseudoephedrine|mesh-list
64820158|NCT01509209|Ephedrine|ephedrine|mesh-list
64820159|NCT01509209|Levocetirizine|levocetirizine|mesh-list
64820214|NCT01509365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820215|NCT01509365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820216|NCT01509391|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
64820217|NCT01509391|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64820218|NCT01509391|Immunologic Factors|immunologic factors|mesh-ancestor
64820219|NCT01509391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820220|NCT01509469|Caseins|caseins|mesh-list
64820221|NCT01509469|Chelating Agents|chelating agents|mesh-ancestor
64820222|NCT01509469|Sequestering Agents|sequestering agents|mesh-ancestor
64820224|NCT01509521|Phenylephrine|phenylephrine|mesh-list
64820280|NCT01509911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820282|NCT01509976|Triclocarban|triclocarban|mesh-list
64820283|NCT01509976|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64820284|NCT01509976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64820285|NCT01509976|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64820286|NCT01509976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64820287|NCT01509976|Antimetabolites|antimetabolites|mesh-ancestor
64820288|NCT01509976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820289|NCT01509976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64820290|NCT01510015|Risperidone|risperidone|mesh-list
64820291|NCT01510015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64820292|NCT01510015|Serotonin Agents|serotonin agents|mesh-ancestor
64820293|NCT01510015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64820341|NCT01510509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820342|NCT01510522|Metformin|metformin|mesh-list
64820343|NCT01510522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64820344|NCT01510522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820345|NCT01510548|Adalimumab|adalimumab|mesh-list
64820346|NCT01510548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64820347|NCT01510548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64820348|NCT01510561|Gemcitabine|gemcitabine|mesh-list
64820410|NCT01510860|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64820412|NCT01510977|Bisacodyl|bisacodyl|mesh-list
64820413|NCT01510977|Cathartics|cathartics|mesh-ancestor
64820414|NCT01510977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64820415|NCT01510977|Laxatives|laxatives|mesh-ancestor
64820416|NCT01510990|Gefitinib|gefitinib|mesh-list
64820417|NCT01510990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820418|NCT01510990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64820479|NCT01511172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64820480|NCT01511172|Immunologic Factors|immunologic factors|mesh-ancestor
64820481|NCT01511185|Liraglutide|liraglutide|mesh-list
64820482|NCT01511185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64820483|NCT01511185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820484|NCT01511185|Incretins|incretins|mesh-ancestor
64820485|NCT01511185|Hormones|hormones|mesh-ancestor
64820486|NCT01511185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64820487|NCT01511198|Metformin|metformin|mesh-list
64820488|NCT01511198|Liraglutide|liraglutide|mesh-list
64820489|NCT01511198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64820490|NCT01511198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820491|NCT01511198|Incretins|incretins|mesh-ancestor
64820492|NCT01511198|Hormones|hormones|mesh-ancestor
64820493|NCT01511198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64820494|NCT01511211|Dexamethasone|dexamethasone|mesh-list
64820495|NCT01511211|Ropivacaine|ropivacaine|mesh-list
64820496|NCT01511211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64820497|NCT01511211|Antiemetics|antiemetics|mesh-ancestor
64820498|NCT01511211|Autonomic Agents|autonomic agents|mesh-ancestor
64820499|NCT01511211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64820535|NCT01511263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64820536|NCT01511263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64820537|NCT01511263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64820538|NCT01511263|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64820539|NCT01511263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64820540|NCT01511263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64820541|NCT01511289|Imatinib Mesylate|imatinib mesylate|mesh-list
64820542|NCT01511289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820543|NCT01511289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64820544|NCT01511289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64820545|NCT01511289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820546|NCT01511302|Budesonide|budesonide|mesh-list
64820547|NCT01511302|RNS60|rns60|mesh-list
64820548|NCT01511302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64820549|NCT01511302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64820550|NCT01511302|Autonomic Agents|autonomic agents|mesh-ancestor
64820551|NCT01511302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64820552|NCT01511302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820553|NCT01511302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64820554|NCT01511302|Respiratory System Agents|respiratory system agents|mesh-ancestor
64820555|NCT01511302|Glucocorticoids|glucocorticoids|mesh-ancestor
64820556|NCT01511302|Hormones|hormones|mesh-ancestor
64820557|NCT01511302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64820559|NCT01511302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64820583|NCT01511471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64820584|NCT01511471|Purinergic Agents|purinergic agents|mesh-ancestor
64820585|NCT01511471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64820586|NCT01511471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820587|NCT01511471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820588|NCT01511562|Cytarabine|cytarabine|mesh-list
64820589|NCT01511562|Etoposide|etoposide|mesh-list
64820590|NCT01511562|Thiotepa|thiotepa|mesh-list
64820591|NCT01511562|Carmustine|carmustine|mesh-list
64820592|NCT01511562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64820593|NCT01511562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820594|NCT01511562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64820595|NCT01511562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64820597|NCT01511562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820598|NCT01511562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64820643|NCT01511718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64820644|NCT01511718|Antipruritics|antipruritics|mesh-ancestor
64820645|NCT01511718|Dermatologic Agents|dermatologic agents|mesh-ancestor
64820646|NCT01511718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64820647|NCT01511718|Serotonin Agents|serotonin agents|mesh-ancestor
64820648|NCT01511718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64820649|NCT01511718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820650|NCT01511718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64820651|NCT01511718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64820652|NCT01511718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64820653|NCT01511718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64820654|NCT01511718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64820655|NCT01511731|Famotidine|famotidine|mesh-list
64820656|NCT01511731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64820657|NCT01511731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64820658|NCT01511731|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64820659|NCT01511731|Histamine Antagonists|histamine antagonists|mesh-ancestor
64820690|NCT01511822|Inositol|inositol|mesh-list
64820698|NCT01511822|Estrogens|estrogens|mesh-ancestor
64820699|NCT01511822|Hormones|hormones|mesh-ancestor
64820700|NCT01511822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64820701|NCT01511822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765554|NCT00638820|Alemtuzumab|alemtuzumab|mesh-list
64765571|NCT00641862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765573|NCT00641862|Hematinics|hematinics|mesh-ancestor
64820702|NCT01511822|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64820703|NCT01511822|Contraceptive Agents|contraceptive agents|mesh-ancestor
64820704|NCT01511822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64820705|NCT01511822|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64820706|NCT01511822|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64820707|NCT01511822|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64820708|NCT01511822|Vitamin B Complex|vitamin b complex|mesh-ancestor
64820709|NCT01511822|Vitamins|vitamins|mesh-ancestor
64820710|NCT01511822|Micronutrients|micronutrients|mesh-ancestor
64820711|NCT01511822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64820712|NCT01511822|Hormone Antagonists|hormone antagonists|mesh-ancestor
64820713|NCT01511822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64820714|NCT01511822|Diuretics|diuretics|mesh-ancestor
64820715|NCT01511822|Natriuretic Agents|natriuretic agents|mesh-ancestor
64820716|NCT01511835|Folic Acid|folic acid|mesh-list
64820717|NCT01511835|Vitamin B Complex|vitamin b complex|mesh-list
64820753|NCT01511991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64820754|NCT01511991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820756|NCT01512004|Propiverine|propiverine|mesh-list
64820757|NCT01512004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64820758|NCT01512004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64820759|NCT01512004|Cholinergic Agents|cholinergic agents|mesh-ancestor
64820760|NCT01512004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64820761|NCT01512004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820762|NCT01512004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820763|NCT01512004|Urological Agents|urological agents|mesh-ancestor
64820764|NCT01512004|Parasympatholytics|parasympatholytics|mesh-ancestor
64820765|NCT01512004|Autonomic Agents|autonomic agents|mesh-ancestor
64820766|NCT01512004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64820767|NCT01512017|Petrolatum|petrolatum|mesh-list
64820768|NCT01512017|Emollients|emollients|mesh-ancestor
64820769|NCT01512017|Dermatologic Agents|dermatologic agents|mesh-ancestor
64820770|NCT01512147|Dexmedetomidine|dexmedetomidine|mesh-list
64820771|NCT01512147|Propofol|propofol|mesh-list
64820772|NCT01512147|Isoflurane|isoflurane|mesh-list
64820809|NCT01512199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820810|NCT01512199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64820811|NCT01512199|Immunologic Factors|immunologic factors|mesh-ancestor
64820812|NCT01512199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820813|NCT01512355|Dexmedetomidine|dexmedetomidine|mesh-list
64820814|NCT01512355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64820815|NCT01512355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64820816|NCT01512355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820817|NCT01512355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64820818|NCT01512355|Analgesics|analgesics|mesh-ancestor
64820819|NCT01512355|Sensory System Agents|sensory system agents|mesh-ancestor
64820820|NCT01512355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64820821|NCT01512355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64820822|NCT01512355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64820823|NCT01512355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64820824|NCT01512355|Adrenergic Agents|adrenergic agents|mesh-ancestor
64820825|NCT01512355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64820826|NCT01512355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820827|NCT01512459|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64765628|NCT00660504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765629|NCT00660504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64765630|NCT00660504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64765631|NCT00660504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64765632|NCT00660504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765633|NCT00660504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820828|NCT01512459|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64820829|NCT01512459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64820830|NCT01512459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64820831|NCT01512459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820832|NCT01512459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64820833|NCT01512459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820834|NCT01512459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64820850|NCT01512511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64820851|NCT01512511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820852|NCT01512511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64820853|NCT01512511|Analgesics|analgesics|mesh-ancestor
64820854|NCT01512511|Sensory System Agents|sensory system agents|mesh-ancestor
64820855|NCT01512511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64820856|NCT01512537|Vitamin D|vitamin d|mesh-list
64820857|NCT01512537|Ergocalciferols|ergocalciferols|mesh-list
64820858|NCT01512537|Cholecalciferol|cholecalciferol|mesh-list
64820916|NCT01513044|Mycophenolic Acid|mycophenolic acid|mesh-list
64820917|NCT01513044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64820918|NCT01513044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820919|NCT01513044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64820920|NCT01513044|Antitubercular Agents|antitubercular agents|mesh-ancestor
64820921|NCT01513044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64820922|NCT01513044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64820923|NCT01513044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64820924|NCT01513044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820925|NCT01513057|Mycophenolic Acid|mycophenolic acid|mesh-list
64820926|NCT01513057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64820927|NCT01513057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820928|NCT01513057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64820929|NCT01513057|Antitubercular Agents|antitubercular agents|mesh-ancestor
64820930|NCT01513057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64820931|NCT01513057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64820932|NCT01513057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64820933|NCT01513057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820934|NCT01513070|Aspirin|aspirin|mesh-list
64820935|NCT01513070|Isosorbide|isosorbide|mesh-list
64820936|NCT01513070|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64820937|NCT01513070|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64820969|NCT01513174|Gefitinib|gefitinib|mesh-list
64820970|NCT01513174|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64820971|NCT01513174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945446|NCT05633615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64820972|NCT01513174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820973|NCT01513174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64820974|NCT01513174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64820975|NCT01513200|Heparin|heparin|mesh-list
64820976|NCT01513200|Calcium heparin|calcium heparin|mesh-list
64820977|NCT01513200|Anticoagulants|anticoagulants|mesh-ancestor
64820978|NCT01513200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64820979|NCT01513200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64820980|NCT01513200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64820981|NCT01513499|Oxytocin|oxytocin|mesh-list
64820982|NCT01513499|Oxytocics|oxytocics|mesh-ancestor
64820983|NCT01513499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64820984|NCT01513499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820985|NCT01513525|Liraglutide|liraglutide|mesh-list
64820986|NCT01513525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64820987|NCT01513525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64820988|NCT01513525|Incretins|incretins|mesh-ancestor
64820989|NCT01513525|Hormones|hormones|mesh-ancestor
64821021|NCT01513668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64821022|NCT01513668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821023|NCT01513668|Antipyretics|antipyretics|mesh-ancestor
64821024|NCT01513681|Lamotrigine|lamotrigine|mesh-list
64821025|NCT01513681|Anticonvulsants|anticonvulsants|mesh-ancestor
64821026|NCT01513681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64821027|NCT01513681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64821028|NCT01513681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821029|NCT01513681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64821030|NCT01513681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821031|NCT01513681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64821032|NCT01513681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64821033|NCT01513681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64821034|NCT01513681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64821035|NCT01513681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64821036|NCT01513720|Lamotrigine|lamotrigine|mesh-list
64821037|NCT01513720|Anticonvulsants|anticonvulsants|mesh-ancestor
64821038|NCT01513720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64821039|NCT01513720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64821040|NCT01513720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821053|NCT01513772|Analgesics|analgesics|mesh-ancestor
64821072|NCT01513863|Metronidazole|metronidazole|mesh-list
64821073|NCT01513863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64821074|NCT01513863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64821075|NCT01513863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64821076|NCT01513863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64821077|NCT01513941|Interferons|interferons|mesh-list
64821078|NCT01513941|Ribavirin|ribavirin|mesh-list
64821079|NCT01513941|Interferon-alpha|interferon-alpha|mesh-list
64821080|NCT01513941|Interferon alpha-2|interferon alpha-2|mesh-list
64821081|NCT01513941|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64821082|NCT01513941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821083|NCT01513941|Antiviral Agents|antiviral agents|mesh-ancestor
64821084|NCT01513941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64821085|NCT01513941|Antimetabolites|antimetabolites|mesh-ancestor
64821086|NCT01513941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821087|NCT01513941|Immunologic Factors|immunologic factors|mesh-ancestor
64821088|NCT01513941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821089|NCT01514019|Acebutolol|acebutolol|mesh-list
64821090|NCT01514019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64821091|NCT01514019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64821092|NCT01514019|Sympathomimetics|sympathomimetics|mesh-ancestor
64821093|NCT01514019|Autonomic Agents|autonomic agents|mesh-ancestor
64821094|NCT01514019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64821095|NCT01514019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821096|NCT01514019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64821097|NCT01514019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64821098|NCT01514019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64821099|NCT01514019|Adrenergic Agents|adrenergic agents|mesh-ancestor
64821100|NCT01514019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64821101|NCT01514019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821102|NCT01514110|Paclitaxel|paclitaxel|mesh-list
64821116|NCT01514123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821117|NCT01514123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64821118|NCT01514123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64821119|NCT01514123|Growth Substances|growth substances|mesh-ancestor
64821120|NCT01514123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821121|NCT01514123|Growth Inhibitors|growth inhibitors|mesh-ancestor
64821122|NCT01514175|Ibuprofen|ibuprofen|mesh-list
64821123|NCT01514175|Ketorolac|ketorolac|mesh-list
64821124|NCT01514175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64821125|NCT01514175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64821126|NCT01514175|Analgesics|analgesics|mesh-ancestor
64821127|NCT01514175|Sensory System Agents|sensory system agents|mesh-ancestor
64821128|NCT01514175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64821129|NCT01514175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821130|NCT01514175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64821131|NCT01514175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64821132|NCT01514175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64821133|NCT01514175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821134|NCT01514175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821135|NCT01514188|Doxorubicin|doxorubicin|mesh-list
64821136|NCT01514188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64821137|NCT01514188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821138|NCT01514188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64821139|NCT01514188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64821140|NCT01514188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821141|NCT01514188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821142|NCT01514227|Aspirin|aspirin|mesh-list
64821143|NCT01514227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64821144|NCT01514227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64821145|NCT01514227|Analgesics|analgesics|mesh-ancestor
64821146|NCT01514227|Sensory System Agents|sensory system agents|mesh-ancestor
64821149|NCT01514227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64821157|NCT01514227|Antipyretics|antipyretics|mesh-ancestor
64821158|NCT01514266|Curcumin|curcumin|mesh-list
64821159|NCT01514266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64821160|NCT01514266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64821161|NCT01514266|Analgesics|analgesics|mesh-ancestor
64821162|NCT01514266|Sensory System Agents|sensory system agents|mesh-ancestor
64821163|NCT01514266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64821164|NCT01514266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821165|NCT01514266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64821166|NCT01514266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64821167|NCT01514266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821168|NCT01514266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821169|NCT01514266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821170|NCT01514409|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
64821171|NCT01514409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64821172|NCT01514409|Antidepressive Agents|antidepressive agents|mesh-ancestor
64821173|NCT01514409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64821174|NCT01514487|Liraglutide|liraglutide|mesh-list
64821175|NCT01514487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64821176|NCT01514487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821177|NCT01514487|Incretins|incretins|mesh-ancestor
64821178|NCT01514487|Hormones|hormones|mesh-ancestor
64821179|NCT01514487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64821180|NCT01514695|Fentanyl|fentanyl|mesh-list
64765992|NCT00711828|Glucocorticoids|glucocorticoids|mesh-ancestor
64821181|NCT01514695|Midazolam|midazolam|mesh-list
64821182|NCT01514695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64821183|NCT01514695|Narcotics|narcotics|mesh-ancestor
64821184|NCT01514695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64821185|NCT01514695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821186|NCT01514695|Analgesics|analgesics|mesh-ancestor
64821203|NCT01514721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821204|NCT01514721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64821205|NCT01514721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64821206|NCT01514721|Adrenergic Agents|adrenergic agents|mesh-ancestor
64821207|NCT01514721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64821208|NCT01514721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416783|NCT04842487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64821209|NCT01514721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64821210|NCT01514721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64821211|NCT01514812|Digoxin|digoxin|mesh-list
64821212|NCT01514812|Darexaban|darexaban|mesh-list
64821213|NCT01514812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64821214|NCT01514812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64821215|NCT01514812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821216|NCT01514812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821217|NCT01514812|Protective Agents|protective agents|mesh-ancestor
64821218|NCT01514812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821260|NCT01514929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821261|NCT01514929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821262|NCT01514942|Folic Acid|folic acid|mesh-list
64821263|NCT01514942|Vitamin B Complex|vitamin b complex|mesh-list
64821264|NCT01514942|Hydroxocobalamin|hydroxocobalamin|mesh-list
64821265|NCT01514942|Vitamin B 12|vitamin b 12|mesh-list
64821266|NCT01514942|Inositol|inositol|mesh-list
64821267|NCT01514942|Manganese|manganese|mesh-list
64821268|NCT01514942|Hematinics|hematinics|mesh-ancestor
64821269|NCT01514942|Vitamins|vitamins|mesh-ancestor
64821270|NCT01514942|Micronutrients|micronutrients|mesh-ancestor
64821271|NCT01514942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821272|NCT01514942|Trace Elements|trace elements|mesh-ancestor
64821273|NCT01514968|Cyclosporine|cyclosporine|mesh-list
64821274|NCT01514968|Ritonavir|ritonavir|mesh-list
64821275|NCT01514968|Cyclosporins|cyclosporins|mesh-list
64821276|NCT01514968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821277|NCT01514968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821278|NCT01514968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64821279|NCT01514968|Immunologic Factors|immunologic factors|mesh-ancestor
64821280|NCT01514968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821281|NCT01514968|Antifungal Agents|antifungal agents|mesh-ancestor
64821282|NCT01514968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64821283|NCT01514968|Dermatologic Agents|dermatologic agents|mesh-ancestor
64821284|NCT01514968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64821285|NCT01514968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64821286|NCT01514968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64821287|NCT01514968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64821288|NCT01514968|Protease Inhibitors|protease inhibitors|mesh-ancestor
64821289|NCT01514968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64821310|NCT01515228|Immunologic Factors|immunologic factors|mesh-ancestor
64821311|NCT01515228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821312|NCT01515228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64766013|NCT00716742|Bimatoprost|bimatoprost|mesh-list
64821313|NCT01515228|Autonomic Agents|autonomic agents|mesh-ancestor
64821314|NCT01515228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64821315|NCT01515228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64821316|NCT01515228|Respiratory System Agents|respiratory system agents|mesh-ancestor
64821317|NCT01515228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64821318|NCT01515228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64821319|NCT01515228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64821320|NCT01515228|Vasodilator Agents|vasodilator agents|mesh-ancestor
64821321|NCT01515228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64821322|NCT01515228|Protective Agents|protective agents|mesh-ancestor
64821323|NCT01515228|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64821324|NCT01515228|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64821325|NCT01515228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821326|NCT01515371|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64821327|NCT01515371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64821328|NCT01515371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64821329|NCT01515371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821330|NCT01515371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64821331|NCT01515371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64821332|NCT01515371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821333|NCT01515371|Cholinergic Agents|cholinergic agents|mesh-ancestor
64821334|NCT01515371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64821335|NCT01515397|Polygeline|polygeline|mesh-list
64821336|NCT01515397|Plasma Substitutes|plasma substitutes|mesh-ancestor
64821337|NCT01515397|Blood Substitutes|blood substitutes|mesh-ancestor
64821338|NCT01515553|Liraglutide|liraglutide|mesh-list
64821339|NCT01515553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64821356|NCT01515683|Anesthetics|anesthetics|mesh-list
64821357|NCT01515683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64821358|NCT01515683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821359|NCT01515774|Pramipexole|pramipexole|mesh-list
64821360|NCT01515774|Antioxidants|antioxidants|mesh-ancestor
64821361|NCT01515774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821362|NCT01515774|Protective Agents|protective agents|mesh-ancestor
64821363|NCT01515774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821364|NCT01515774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64821365|NCT01515774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64821366|NCT01515774|Dopamine Agonists|dopamine agonists|mesh-ancestor
64821367|NCT01515774|Dopamine Agents|dopamine agents|mesh-ancestor
64821368|NCT01515774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64821369|NCT01515813|Tenofovir|tenofovir|mesh-list
64821370|NCT01515813|Emtricitabine|emtricitabine|mesh-list
64821371|NCT01515813|Efavirenz|efavirenz|mesh-list
64821372|NCT01515813|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64821373|NCT01515813|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64821374|NCT01515813|Pravastatin|pravastatin|mesh-list
64821375|NCT01515813|Antiviral Agents|antiviral agents|mesh-ancestor
64821381|NCT01515813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64821399|NCT01515826|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64821400|NCT01515826|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64821401|NCT01515826|BB 1101|bb 1101|mesh-list
64766055|NCT00720330|Lidocaine|lidocaine|mesh-list
64766056|NCT00720330|Ketamine|ketamine|mesh-list
64821402|NCT01515826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64821403|NCT01515826|Antiemetics|antiemetics|mesh-ancestor
64821404|NCT01515826|Autonomic Agents|autonomic agents|mesh-ancestor
64821405|NCT01515826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64821406|NCT01515826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821407|NCT01515826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64821408|NCT01515826|Glucocorticoids|glucocorticoids|mesh-ancestor
64821409|NCT01515826|Hormones|hormones|mesh-ancestor
64821410|NCT01515826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64821411|NCT01515826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64821412|NCT01515826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821413|NCT01515826|Protease Inhibitors|protease inhibitors|mesh-ancestor
64821414|NCT01515826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821415|NCT01515826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821416|NCT01515826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64821417|NCT01515826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64821418|NCT01515826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64821419|NCT01515826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64821420|NCT01515826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64821421|NCT01515826|Contraceptive Agents|contraceptive agents|mesh-ancestor
64821422|NCT01515826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64821423|NCT01515826|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64821424|NCT01515826|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64821425|NCT01515826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64388514|NCT04478357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388515|NCT04478357|Urological Agents|urological agents|mesh-ancestor
64388517|NCT04478513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64821433|NCT01515839|Protective Agents|protective agents|mesh-ancestor
64821434|NCT01515839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821435|NCT01515839|Vitamin B Complex|vitamin b complex|mesh-ancestor
64821437|NCT01515839|Micronutrients|micronutrients|mesh-ancestor
64821438|NCT01515839|Nootropic Agents|nootropic agents|mesh-ancestor
64821439|NCT01515839|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64821487|NCT01516255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64821489|NCT01516255|Hormones|hormones|mesh-ancestor
64821490|NCT01516255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64821491|NCT01516372|Moxifloxacin|moxifloxacin|mesh-list
64821492|NCT01516372|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64821493|NCT01516372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64821494|NCT01516372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64821495|NCT01516372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64821496|NCT01516372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64821497|NCT01516372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945447|NCT05619627|Dexmedetomidine|dexmedetomidine|mesh-list
64821498|NCT01516372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821499|NCT01516372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821500|NCT01516372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64821501|NCT01516372|Contraceptive Agents|contraceptive agents|mesh-ancestor
64821502|NCT01516372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64821503|NCT01516372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821504|NCT01516372|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64821541|NCT01516567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64821542|NCT01516567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64821543|NCT01516567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64821544|NCT01516567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64821545|NCT01516567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821546|NCT01516567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64821547|NCT01516567|Tubulin Modulators|tubulin modulators|mesh-ancestor
64821548|NCT01516567|Antimitotic Agents|antimitotic agents|mesh-ancestor
64821549|NCT01516567|Mitosis Modulators|mitosis modulators|mesh-ancestor
64821550|NCT01516580|Cytarabine|cytarabine|mesh-list
64821551|NCT01516580|Cyclophosphamide|cyclophosphamide|mesh-list
64821552|NCT01516580|Rituximab|rituximab|mesh-list
64821553|NCT01516580|Doxorubicin|doxorubicin|mesh-list
64821554|NCT01516580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64821555|NCT01516580|Methotrexate|methotrexate|mesh-list
64821556|NCT01516580|Vincristine|vincristine|mesh-list
64821557|NCT01516580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64821558|NCT01516580|Immunologic Factors|immunologic factors|mesh-ancestor
64821559|NCT01516580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821560|NCT01516580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64821561|NCT01516580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64821562|NCT01516580|Alkylating Agents|alkylating agents|mesh-ancestor
64821564|NCT01516580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821595|NCT01516723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64388518|NCT04478513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64388519|NCT04478513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64821596|NCT01516723|Antifungal Agents|antifungal agents|mesh-ancestor
64821597|NCT01516762|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64821598|NCT01516762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821599|NCT01516814|Heparin|heparin|mesh-list
64821600|NCT01516814|Calcium heparin|calcium heparin|mesh-list
64821601|NCT01516814|Warfarin|warfarin|mesh-list
64821602|NCT01516814|Rivaroxaban|rivaroxaban|mesh-list
64821603|NCT01516814|Anticoagulants|anticoagulants|mesh-ancestor
64821604|NCT01516814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64821605|NCT01516814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64821660|NCT01517022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64821661|NCT01517022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821662|NCT01517022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64821663|NCT01517022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64821664|NCT01517022|Cholinergic Agents|cholinergic agents|mesh-ancestor
64821665|NCT01517022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64821666|NCT01517022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821729|NCT01517399|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64821730|NCT01517399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64821731|NCT01517399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821732|NCT01517399|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64821733|NCT01517399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64821734|NCT01517399|Purinergic Agents|purinergic agents|mesh-ancestor
64821735|NCT01517399|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64821736|NCT01517399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64821737|NCT01517399|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64821738|NCT01517399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64821739|NCT01517399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64821740|NCT01517399|Protective Agents|protective agents|mesh-ancestor
64821741|NCT01517399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64821742|NCT01517399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64821743|NCT01517399|Hemostatics|hemostatics|mesh-ancestor
64821744|NCT01517399|Coagulants|coagulants|mesh-ancestor
64821745|NCT01517490|Insulin|insulin|mesh-list
64821746|NCT01517490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64821747|NCT01517490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64766236|NCT00741468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64766237|NCT00741468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64821748|NCT01517490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821749|NCT01517555|Acetaminophen|acetaminophen|mesh-list
64821750|NCT01517555|Liraglutide|liraglutide|mesh-list
64821751|NCT01517555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64821752|NCT01517555|Analgesics|analgesics|mesh-ancestor
64821753|NCT01517555|Sensory System Agents|sensory system agents|mesh-ancestor
64821754|NCT01517555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64821755|NCT01517555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821756|NCT01517555|Antipyretics|antipyretics|mesh-ancestor
64821757|NCT01517555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64821777|NCT01517724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821778|NCT01517815|Tazobactam|tazobactam|mesh-list
64821779|NCT01517815|Piperacillin|piperacillin|mesh-list
64821780|NCT01517815|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64821781|NCT01517815|Doripenem|doripenem|mesh-list
64821782|NCT01517815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64821783|NCT01517815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64821784|NCT01517815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64821785|NCT01517815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821786|NCT01517815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821787|NCT01517828|Midazolam|midazolam|mesh-list
64821788|NCT01517828|Ketamine|ketamine|mesh-list
64821789|NCT01517828|Analgesics|analgesics|mesh-ancestor
64821790|NCT01517828|Sensory System Agents|sensory system agents|mesh-ancestor
64821791|NCT01517828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64821792|NCT01517828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821793|NCT01517828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64821794|NCT01517828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64821795|NCT01517828|Anesthetics, General|anesthetics, general|mesh-ancestor
64821796|NCT01517828|Anesthetics|anesthetics|mesh-ancestor
64821797|NCT01517828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64821831|NCT01517997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64821832|NCT01517997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821833|NCT01517997|Tubulin Modulators|tubulin modulators|mesh-ancestor
64821834|NCT01517997|Antimitotic Agents|antimitotic agents|mesh-ancestor
64821835|NCT01517997|Mitosis Modulators|mitosis modulators|mesh-ancestor
64821836|NCT01517997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821838|NCT01518062|Hormones|hormones|mesh-ancestor
64821839|NCT01518062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64821840|NCT01518062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821841|NCT01518101|Metformin|metformin|mesh-list
64821842|NCT01518101|Liraglutide|liraglutide|mesh-list
64821843|NCT01518101|Vildagliptin|vildagliptin|mesh-list
64821844|NCT01518101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64821845|NCT01518101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821846|NCT01518101|Incretins|incretins|mesh-ancestor
64821847|NCT01518101|Hormones|hormones|mesh-ancestor
64821849|NCT01518101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64821889|NCT01518231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64821890|NCT01518231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64821891|NCT01518231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64821892|NCT01518231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821893|NCT01518231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64821894|NCT01518231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64821895|NCT01518231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821897|NCT01518231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64821898|NCT01518231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64821899|NCT01518231|Antimetabolites|antimetabolites|mesh-ancestor
64821900|NCT01518231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64821901|NCT01518231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64821902|NCT01518231|Anticoagulants|anticoagulants|mesh-ancestor
64821903|NCT01518231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64821904|NCT01518231|Antioxidants|antioxidants|mesh-ancestor
64821905|NCT01518231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64821906|NCT01518231|Protective Agents|protective agents|mesh-ancestor
64821907|NCT01518413|Irinotecan|irinotecan|mesh-list
64821908|NCT01518413|Sorafenib|sorafenib|mesh-list
64821909|NCT01518413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64821910|NCT01518413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64821911|NCT01518413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821913|NCT01518413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64821941|NCT01518569|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64821942|NCT01518569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64821943|NCT01518569|Protease Inhibitors|protease inhibitors|mesh-ancestor
64821944|NCT01518569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64821945|NCT01518569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821947|NCT01518595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64821948|NCT01518595|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64821949|NCT01518595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821950|NCT01518608|Alfentanil|alfentanil|mesh-list
64821951|NCT01518608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64821952|NCT01518608|Narcotics|narcotics|mesh-ancestor
64821953|NCT01518608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64821954|NCT01518608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64821955|NCT01518608|Analgesics|analgesics|mesh-ancestor
64821956|NCT01518608|Sensory System Agents|sensory system agents|mesh-ancestor
64821957|NCT01518608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64821958|NCT01518608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64821959|NCT01518608|Anesthetics, General|anesthetics, general|mesh-ancestor
64821960|NCT01518608|Anesthetics|anesthetics|mesh-ancestor
64821961|NCT01518621|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64821994|NCT01518855|Nifedipine|nifedipine|mesh-list
64821995|NCT01518855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64821996|NCT01518855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64821997|NCT01518855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64821998|NCT01518855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64821999|NCT01518855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64822000|NCT01518855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822001|NCT01518855|Vasodilator Agents|vasodilator agents|mesh-ancestor
64822002|NCT01518855|Tocolytic Agents|tocolytic agents|mesh-ancestor
64822004|NCT01518933|Silybin|silybin|mesh-list
64822057|NCT01519128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64766362|NCT00758784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64766363|NCT00758784|Analgesics|analgesics|mesh-ancestor
64822058|NCT01519128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64822060|NCT01519154|Propofol|propofol|mesh-list
64822061|NCT01519154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64822062|NCT01519154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64822063|NCT01519154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822064|NCT01519154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64822065|NCT01519154|Anesthetics, General|anesthetics, general|mesh-ancestor
64822066|NCT01519154|Anesthetics|anesthetics|mesh-ancestor
64822067|NCT01519154|Analgesics|analgesics|mesh-ancestor
64822068|NCT01519154|Sensory System Agents|sensory system agents|mesh-ancestor
64822069|NCT01519154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64822070|NCT01519154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64822071|NCT01519154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64822072|NCT01519154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64822073|NCT01519154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64822074|NCT01519154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822075|NCT01519297|Irbesartan|irbesartan|mesh-list
64822076|NCT01519297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64822077|NCT01519297|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64822078|NCT01519297|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64822079|NCT01519297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822080|NCT01519310|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64822081|NCT01519310|Metronidazole|metronidazole|mesh-list
64822082|NCT01519310|Ciprofloxacin|ciprofloxacin|mesh-list
64822083|NCT01519310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64822104|NCT01519336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64822105|NCT01519336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64822106|NCT01519401|Drospirenone|drospirenone|mesh-list
64822107|NCT01519401|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64822108|NCT01519401|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64822110|NCT01519401|Estradiol|estradiol|mesh-list
64822111|NCT01519401|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64822112|NCT01519401|Estrogens|estrogens|mesh-ancestor
64822113|NCT01519401|Hormones|hormones|mesh-ancestor
64822114|NCT01519401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64822115|NCT01519401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822116|NCT01519401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64822169|NCT01519856|Dopamine Agents|dopamine agents|mesh-ancestor
64822170|NCT01519856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64822171|NCT01519856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822172|NCT01519856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822173|NCT01519986|Vitamin D|vitamin d|mesh-list
64766428|NCT00762450|Triclosan|triclosan|mesh-list
64822174|NCT01519986|Cholecalciferol|cholecalciferol|mesh-list
64822175|NCT01519986|Vitamins|vitamins|mesh-ancestor
64822176|NCT01519986|Micronutrients|micronutrients|mesh-ancestor
64822177|NCT01519986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822178|NCT01519986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64822179|NCT01519986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64822180|NCT01520012|Esomeprazole|esomeprazole|mesh-list
64822181|NCT01520012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64822182|NCT01520012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64822183|NCT01520012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64822184|NCT01520012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822185|NCT01520012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822186|NCT01520025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64822187|NCT01520025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64822188|NCT01520025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766472|NCT00766116|Gemtuzumab|gemtuzumab|mesh-list
64822189|NCT01520077|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
64822190|NCT01520077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64822191|NCT01520077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64822192|NCT01520077|Antimetabolites|antimetabolites|mesh-ancestor
64822193|NCT01520077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822194|NCT01520077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64822195|NCT01520103|Everolimus|everolimus|mesh-list
64822196|NCT01520103|Vinorelbine|vinorelbine|mesh-list
64822197|NCT01520103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822198|NCT01520103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64822199|NCT01520103|Immunologic Factors|immunologic factors|mesh-ancestor
64822211|NCT01520116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822212|NCT01520116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822213|NCT01520116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64822214|NCT01520116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64822215|NCT01520181|Lactams|lactams|mesh-list
64822216|NCT01520181|beta-Lactams|beta-lactams|mesh-list
64822217|NCT01520181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64822218|NCT01520181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64822219|NCT01520285|Felodipine|felodipine|mesh-list
64822220|NCT01520285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64822221|NCT01520285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64822222|NCT01520285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64822223|NCT01520285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64822224|NCT01520285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822225|NCT01520285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64822226|NCT01520285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822227|NCT01520285|Vasodilator Agents|vasodilator agents|mesh-ancestor
64822228|NCT01520298|Acetaminophen|acetaminophen|mesh-list
64822229|NCT01520298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64822230|NCT01520298|Analgesics|analgesics|mesh-ancestor
64822231|NCT01520298|Sensory System Agents|sensory system agents|mesh-ancestor
64822253|NCT01520389|Irinotecan|irinotecan|mesh-list
64822264|NCT01520415|Anesthetics, Local|anesthetics, local|mesh-ancestor
64822265|NCT01520415|Anesthetics|anesthetics|mesh-ancestor
64822266|NCT01520415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64822267|NCT01520415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822268|NCT01520415|Sensory System Agents|sensory system agents|mesh-ancestor
64822269|NCT01520415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64822270|NCT01520415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64822271|NCT01520415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64822272|NCT01520415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64822273|NCT01520415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64822274|NCT01520415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822275|NCT01520441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64822276|NCT01520441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64822277|NCT01520441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64822278|NCT01520441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822279|NCT01520441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64822316|NCT01520766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64822317|NCT01520766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64822318|NCT01520766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64822385|NCT01521377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64822386|NCT01521377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64822387|NCT01521377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64822388|NCT01521377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822389|NCT01521377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822390|NCT01521377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822391|NCT01521377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64822392|NCT01521377|Contraceptive Agents|contraceptive agents|mesh-ancestor
64822393|NCT01521377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64822394|NCT01521377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822395|NCT01521377|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64822396|NCT01521377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64822397|NCT01521377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64822398|NCT01521455|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64822399|NCT01521455|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64822400|NCT01521455|Autonomic Agents|autonomic agents|mesh-ancestor
64822401|NCT01521455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64822402|NCT01521455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822403|NCT01521455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64822404|NCT01521455|Respiratory System Agents|respiratory system agents|mesh-ancestor
64822405|NCT01521455|Glucocorticoids|glucocorticoids|mesh-ancestor
64822406|NCT01521455|Hormones|hormones|mesh-ancestor
64822407|NCT01521455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64822409|NCT01521481|Anesthetics|anesthetics|mesh-list
64822410|NCT01521481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64822411|NCT01521481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822412|NCT01521520|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64822413|NCT01521520|Hematinics|hematinics|mesh-ancestor
64822414|NCT01521520|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64822415|NCT01521520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64822416|NCT01521572|Albuterol|albuterol|mesh-list
64822425|NCT01521572|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64822426|NCT01521572|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64822427|NCT01521572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64822428|NCT01521572|Adrenergic Agents|adrenergic agents|mesh-ancestor
64822429|NCT01521572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64822430|NCT01521572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822432|NCT01521624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64822433|NCT01521624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822434|NCT01521689|Rituximab|rituximab|mesh-list
64822435|NCT01521689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64822436|NCT01521689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822437|NCT01521689|Immunologic Factors|immunologic factors|mesh-ancestor
64822438|NCT01521689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822439|NCT01521689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64822484|NCT01521975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64822485|NCT01521975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64822486|NCT01521975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64822487|NCT01521975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822488|NCT01521975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822489|NCT01522040|Magnesium Sulfate|magnesium sulfate|mesh-list
64822490|NCT01522040|Analgesics|analgesics|mesh-ancestor
64822491|NCT01522040|Sensory System Agents|sensory system agents|mesh-ancestor
64822492|NCT01522040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64822493|NCT01522040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822494|NCT01522040|Anesthetics|anesthetics|mesh-ancestor
64822495|NCT01522040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64822496|NCT01522040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64822497|NCT01522040|Anticonvulsants|anticonvulsants|mesh-ancestor
64822498|NCT01522040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64822499|NCT01522040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64822504|NCT01522092|Citalopram|citalopram|mesh-list
64822540|NCT01522378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822541|NCT01522378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822542|NCT01522378|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64822543|NCT01522534|Morphine|morphine|mesh-list
64822544|NCT01522534|Mepivacaine|mepivacaine|mesh-list
64766598|NCT00788892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822545|NCT01522534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64822546|NCT01522534|Narcotics|narcotics|mesh-ancestor
64822547|NCT01522534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64822548|NCT01522534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822549|NCT01522534|Analgesics|analgesics|mesh-ancestor
64822550|NCT01522534|Sensory System Agents|sensory system agents|mesh-ancestor
64945448|NCT05619627|Anesthetics|anesthetics|mesh-list
64822551|NCT01522534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64822552|NCT01522534|Anesthetics, Local|anesthetics, local|mesh-ancestor
64822553|NCT01522534|Anesthetics|anesthetics|mesh-ancestor
64822554|NCT01522547|Pomalidomide|pomalidomide|mesh-list
64822555|NCT01522547|Immunologic Factors|immunologic factors|mesh-ancestor
64822556|NCT01522547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822557|NCT01522547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64822598|NCT01522729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64822599|NCT01522729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64822600|NCT01522729|Anesthetics, General|anesthetics, general|mesh-ancestor
64822601|NCT01522729|Anesthetics|anesthetics|mesh-ancestor
64822603|NCT01522820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64822604|NCT01522820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64822605|NCT01522820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64822606|NCT01522820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822607|NCT01522820|Antifungal Agents|antifungal agents|mesh-ancestor
64822608|NCT01522820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64822665|NCT01523002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64822666|NCT01523002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64822667|NCT01523002|Adrenergic Agents|adrenergic agents|mesh-ancestor
64822668|NCT01523002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64822669|NCT01523002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822670|NCT01523002|Antimalarials|antimalarials|mesh-ancestor
64822671|NCT01523002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64822672|NCT01523002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64822673|NCT01523002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64822674|NCT01523002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822675|NCT01523002|Antiviral Agents|antiviral agents|mesh-ancestor
64822676|NCT01523002|Schistosomicides|schistosomicides|mesh-ancestor
64822677|NCT01523002|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64822678|NCT01523002|Anthelmintics|anthelmintics|mesh-ancestor
64822679|NCT01523015|Docetaxel|docetaxel|mesh-list
64822680|NCT01523015|Fluorouracil|fluorouracil|mesh-list
64822681|NCT01523015|Oxaliplatin|oxaliplatin|mesh-list
64822724|NCT01523093|Autonomic Agents|autonomic agents|mesh-ancestor
64822725|NCT01523093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64822726|NCT01523093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766698|NCT00796302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64822727|NCT01523093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64822728|NCT01523093|Antipruritics|antipruritics|mesh-ancestor
64822729|NCT01523093|Dermatologic Agents|dermatologic agents|mesh-ancestor
64822730|NCT01523093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64822731|NCT01523093|Serotonin Agents|serotonin agents|mesh-ancestor
64822732|NCT01523093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64822733|NCT01523093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822734|NCT01523093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64822735|NCT01523093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64822736|NCT01523093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64822737|NCT01523093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64822738|NCT01523093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64822739|NCT01523119|Ondansetron|ondansetron|mesh-list
64822740|NCT01523119|Antiemetics|antiemetics|mesh-ancestor
64822741|NCT01523119|Autonomic Agents|autonomic agents|mesh-ancestor
64766740|NCT00801138|Autonomic Agents|autonomic agents|mesh-ancestor
64766741|NCT00801138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64766742|NCT00801138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766743|NCT00801138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64766744|NCT00801138|Glucocorticoids|glucocorticoids|mesh-ancestor
64822742|NCT01523119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64822743|NCT01523119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822744|NCT01523119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64822745|NCT01523119|Antipruritics|antipruritics|mesh-ancestor
64822777|NCT01523314|Growth Substances|growth substances|mesh-ancestor
64822778|NCT01523314|Growth Inhibitors|growth inhibitors|mesh-ancestor
64822779|NCT01523314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64822780|NCT01523327|Uric Acid|uric acid|mesh-list
64822781|NCT01523327|Antioxidants|antioxidants|mesh-ancestor
64822782|NCT01523327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822783|NCT01523327|Protective Agents|protective agents|mesh-ancestor
64766862|NCT00808470|Carotenoids|carotenoids|mesh-list
64766863|NCT00808470|Vitamins|vitamins|mesh-ancestor
64766864|NCT00808470|Micronutrients|micronutrients|mesh-ancestor
64822784|NCT01523327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822786|NCT01523379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64822787|NCT01523379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64822788|NCT01523379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822789|NCT01523379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822790|NCT01523379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64822841|NCT01523574|Micronutrients|micronutrients|mesh-ancestor
64822842|NCT01523574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822843|NCT01523574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64822844|NCT01523574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64822845|NCT01523574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822846|NCT01523574|Analgesics|analgesics|mesh-ancestor
64822847|NCT01523574|Sensory System Agents|sensory system agents|mesh-ancestor
64766941|NCT05131152|Immunologic Factors|immunologic factors|mesh-ancestor
64766942|NCT05131152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822848|NCT01523574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64822849|NCT01523574|Anesthetics|anesthetics|mesh-ancestor
64388535|NCT02342093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64388536|NCT02342093|Hormone Antagonists|hormone antagonists|mesh-ancestor
64822851|NCT01523574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64822852|NCT01523574|Anticonvulsants|anticonvulsants|mesh-ancestor
64822853|NCT01523574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64822854|NCT01523574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64822855|NCT01523574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64822856|NCT01523574|Tocolytic Agents|tocolytic agents|mesh-ancestor
64822857|NCT01523574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64822858|NCT01523574|Antioxidants|antioxidants|mesh-ancestor
64822859|NCT01523574|Protective Agents|protective agents|mesh-ancestor
64822861|NCT01523639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64822862|NCT01523639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822863|NCT01523678|Paclitaxel|paclitaxel|mesh-list
64822864|NCT01523678|Carboplatin|carboplatin|mesh-list
64822865|NCT01523678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64822866|NCT01523678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822867|NCT01523678|Tubulin Modulators|tubulin modulators|mesh-ancestor
64822868|NCT01523678|Antimitotic Agents|antimitotic agents|mesh-ancestor
64822869|NCT01523678|Mitosis Modulators|mitosis modulators|mesh-ancestor
64822886|NCT01523860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64822887|NCT01523860|Alkylating Agents|alkylating agents|mesh-ancestor
64822888|NCT01523860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767082|NCT00830076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64822889|NCT01523860|Analgesics|analgesics|mesh-ancestor
64822890|NCT01523860|Sensory System Agents|sensory system agents|mesh-ancestor
64822891|NCT01523860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64822892|NCT01523860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64822893|NCT01523860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64822894|NCT01523860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64822895|NCT01524068|Rituximab|rituximab|mesh-list
64822896|NCT01524068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64822897|NCT01524068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64822898|NCT01524068|Immunologic Factors|immunologic factors|mesh-ancestor
64822899|NCT01524068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822905|NCT01524081|Cefuroxime|cefuroxime|mesh-list
64822945|NCT01524237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64822946|NCT01524237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64822947|NCT01524237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64822948|NCT01524237|Anesthetics, General|anesthetics, general|mesh-ancestor
64822949|NCT01524237|Anesthetics|anesthetics|mesh-ancestor
64822950|NCT01524237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64822951|NCT01524237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64822952|NCT01524237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64823010|NCT01524575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64823011|NCT01524575|Antimetabolites|antimetabolites|mesh-ancestor
64823012|NCT01524575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823013|NCT01524575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823014|NCT01524575|Antiviral Agents|antiviral agents|mesh-ancestor
64823015|NCT01524575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64823016|NCT01524575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64823017|NCT01524575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64823018|NCT01524575|Immunologic Factors|immunologic factors|mesh-ancestor
64823019|NCT01524575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823020|NCT01524601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64823021|NCT01524601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64823071|NCT01524744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823072|NCT01524744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64823073|NCT01524744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64823074|NCT01524744|Dermatologic Agents|dermatologic agents|mesh-ancestor
64823075|NCT01524744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64823076|NCT01524744|Immunologic Factors|immunologic factors|mesh-ancestor
64823140|NCT01525290|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64823141|NCT01525290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64823142|NCT01525290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64823143|NCT01525290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823144|NCT01525394|Moxifloxacin|moxifloxacin|mesh-list
64823211|NCT01525914|Dutasteride|dutasteride|mesh-list
64823212|NCT01525914|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64823213|NCT01525914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64823214|NCT01525914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64823215|NCT01525914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823216|NCT01525914|Hormone Antagonists|hormone antagonists|mesh-ancestor
64823217|NCT01525914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64823218|NCT01525914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823219|NCT01526005|Nicotine|nicotine|mesh-list
64823220|NCT01526005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64823221|NCT01526005|Autonomic Agents|autonomic agents|mesh-ancestor
64823222|NCT01526005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64823223|NCT01526005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823224|NCT01526005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64823225|NCT01526005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64823229|NCT01526070|Aflibercept|aflibercept|mesh-list
64823270|NCT01526122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64823271|NCT01526122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823272|NCT01526122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64823273|NCT01526122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64823274|NCT01526122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64823275|NCT01526122|Antipyretics|antipyretics|mesh-ancestor
64823276|NCT01526122|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64823277|NCT01526122|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64823278|NCT01526122|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64823279|NCT01526122|Purinergic Agents|purinergic agents|mesh-ancestor
64823280|NCT01526122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64823281|NCT01526161|Fluticasone|fluticasone|mesh-list
64823282|NCT01526161|Xhance|xhance|mesh-list
64823283|NCT01526161|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64823284|NCT01526161|Montelukast|montelukast|mesh-list
64823285|NCT01526161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64823286|NCT01526161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64823287|NCT01526161|Autonomic Agents|autonomic agents|mesh-ancestor
64823288|NCT01526161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64823289|NCT01526161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823290|NCT01526161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64823291|NCT01526161|Respiratory System Agents|respiratory system agents|mesh-ancestor
64823292|NCT01526161|Dermatologic Agents|dermatologic agents|mesh-ancestor
64823293|NCT01526161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64823294|NCT01526161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64823295|NCT01526161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64823296|NCT01526161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64823297|NCT01526161|Adrenergic Agents|adrenergic agents|mesh-ancestor
64823298|NCT01526161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64823299|NCT01526161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823300|NCT01526161|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64767239|NCT00849810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64767240|NCT00849810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823301|NCT01526161|Hormone Antagonists|hormone antagonists|mesh-ancestor
64823305|NCT01526174|Golimumab|golimumab|mesh-list
64823309|NCT01526174|Immunologic Factors|immunologic factors|mesh-ancestor
64823310|NCT01526174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823312|NCT01526278|Calcitriol|calcitriol|mesh-list
64823313|NCT01526278|Maxmarvil|maxmarvil|mesh-list
64823314|NCT01526278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64823315|NCT01526278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823316|NCT01526278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64823317|NCT01526278|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64823318|NCT01526278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64823319|NCT01526278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823320|NCT01526278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64823321|NCT01526278|Vitamins|vitamins|mesh-ancestor
64823322|NCT01526278|Micronutrients|micronutrients|mesh-ancestor
64823323|NCT01526317|Metformin|metformin|mesh-list
64823324|NCT01526317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64823325|NCT01526317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64823328|NCT01526317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64823329|NCT01526317|Antimetabolites|antimetabolites|mesh-ancestor
64823330|NCT01526317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823331|NCT01526317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64823360|NCT01526460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64823361|NCT01526460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64823362|NCT01526499|Cyclophosphamide|cyclophosphamide|mesh-list
64823363|NCT01526499|Docetaxel|docetaxel|mesh-list
64823364|NCT01526499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64823365|NCT01526499|Immunologic Factors|immunologic factors|mesh-ancestor
64823366|NCT01526499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823367|NCT01526499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64823368|NCT01526499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64823427|NCT01526694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823428|NCT01526694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64823429|NCT01526694|Glucocorticoids|glucocorticoids|mesh-ancestor
64823430|NCT01526694|Hormones|hormones|mesh-ancestor
64823431|NCT01526694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64823432|NCT01526694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64823433|NCT01526694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823434|NCT01526694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64823435|NCT01526694|Alkylating Agents|alkylating agents|mesh-ancestor
64823436|NCT01526694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823437|NCT01526694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64767284|NCT00868452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767285|NCT00868452|Antimanic Agents|antimanic agents|mesh-ancestor
64767286|NCT00868452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64823438|NCT01526694|Immunologic Factors|immunologic factors|mesh-ancestor
64823439|NCT01526694|Leprostatic Agents|leprostatic agents|mesh-ancestor
64823440|NCT01526694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64823441|NCT01526694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64823442|NCT01526694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64823443|NCT01526694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64823444|NCT01526694|Growth Substances|growth substances|mesh-ancestor
64823445|NCT01526694|Growth Inhibitors|growth inhibitors|mesh-ancestor
64823446|NCT01526837|Bevacizumab|bevacizumab|mesh-list
64823447|NCT01526837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64823448|NCT01526837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64823449|NCT01526837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64823450|NCT01526837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64823451|NCT01526837|Growth Substances|growth substances|mesh-ancestor
64823452|NCT01526837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823453|NCT01526837|Growth Inhibitors|growth inhibitors|mesh-ancestor
64823454|NCT01526850|Cyclosporine|cyclosporine|mesh-list
64823455|NCT01526850|Cyclosporins|cyclosporins|mesh-list
64823456|NCT01526850|Glucocorticoids|glucocorticoids|mesh-list
64823458|NCT01526850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823459|NCT01526850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64823466|NCT01526850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64823467|NCT01526850|Hormones|hormones|mesh-ancestor
64823468|NCT01526850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64823469|NCT01526876|Clevidipine|clevidipine|mesh-list
64823470|NCT01526876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64823471|NCT01526876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64823472|NCT01526876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823473|NCT01526876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64823474|NCT01526876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767346|NCT00875550|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64823528|NCT01527032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64823529|NCT01527032|Growth Substances|growth substances|mesh-ancestor
64823530|NCT01527032|Growth Inhibitors|growth inhibitors|mesh-ancestor
64823531|NCT01527097|Atorvastatin|atorvastatin|mesh-list
64823534|NCT01527097|Antimetabolites|antimetabolites|mesh-ancestor
64823535|NCT01527097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823536|NCT01527097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64823537|NCT01527097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64823538|NCT01527097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64823540|NCT01527279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64823589|NCT01527422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64823590|NCT01527422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64823591|NCT01527422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64823593|NCT01527422|Antimitotic Agents|antimitotic agents|mesh-ancestor
64823594|NCT01527422|Mitosis Modulators|mitosis modulators|mesh-ancestor
64823595|NCT01527448|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64823596|NCT01527448|Antidepressive Agents|antidepressive agents|mesh-ancestor
64823597|NCT01527448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64823598|NCT01527448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64823599|NCT01527448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64823600|NCT01527448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64823601|NCT01527448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823602|NCT01527474|Citalopram|citalopram|mesh-list
64823603|NCT01527474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64823604|NCT01527474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64823605|NCT01527474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64823607|NCT01527474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64823644|NCT01527669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823645|NCT01527669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64823646|NCT01527669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64823647|NCT01527669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64823648|NCT01527734|Tetrodotoxin|tetrodotoxin|mesh-list
64823649|NCT01527734|Anesthetics, Local|anesthetics, local|mesh-ancestor
64823650|NCT01527734|Anesthetics|anesthetics|mesh-ancestor
64823667|NCT01527864|Paclitaxel|paclitaxel|mesh-list
64823710|NCT01527968|Tranexamic Acid|tranexamic acid|mesh-list
64823711|NCT01527968|Aminocaproic Acid|aminocaproic acid|mesh-list
64823712|NCT01527968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64823713|NCT01527968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64823782|NCT01528540|Sensory System Agents|sensory system agents|mesh-ancestor
64823783|NCT01528540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64823784|NCT01528540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823785|NCT01528540|Anticonvulsants|anticonvulsants|mesh-ancestor
64823786|NCT01528540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64823787|NCT01528540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64823788|NCT01528540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823790|NCT01528540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64823850|NCT01528852|Disinfectants|disinfectants|mesh-ancestor
64823851|NCT01528852|Dermatologic Agents|dermatologic agents|mesh-ancestor
64823852|NCT01528865|Tenofovir|tenofovir|mesh-list
64823853|NCT01528865|Lamivudine|lamivudine|mesh-list
64823854|NCT01528865|Antiviral Agents|antiviral agents|mesh-ancestor
64823855|NCT01528865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64823856|NCT01528865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64823857|NCT01528865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64823858|NCT01528865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64823859|NCT01528865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823860|NCT01528865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64823861|NCT01528865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64823862|NCT01528930|Amikacin|amikacin|mesh-list
64823863|NCT01528930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64823914|NCT01529164|Vitamin B Complex|vitamin b complex|mesh-ancestor
64823916|NCT01529164|Micronutrients|micronutrients|mesh-ancestor
64823917|NCT01529164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64823918|NCT01529164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64823919|NCT01529164|Growth Substances|growth substances|mesh-ancestor
64823920|NCT01529164|Growth Inhibitors|growth inhibitors|mesh-ancestor
64823922|NCT01529177|Citric Acid|citric acid|mesh-list
64823923|NCT01529177|Sodium Citrate|sodium citrate|mesh-list
64823924|NCT01529177|Clomiphene|clomiphene|mesh-list
64823925|NCT01529177|Enclomiphene|enclomiphene|mesh-list
64823926|NCT01529177|Zuclomiphene|zuclomiphene|mesh-list
64823927|NCT01529177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64823928|NCT01529177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64823929|NCT01529177|Anticoagulants|anticoagulants|mesh-ancestor
64823930|NCT01529177|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64767447|NCT00889200|Eszopiclone|eszopiclone|mesh-list
64767448|NCT00889200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64767450|NCT00889200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767466|NCT00894504|Carboplatin|carboplatin|mesh-list
64767467|NCT00894504|Panitumumab|panitumumab|mesh-list
64767468|NCT00894504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767469|NCT00894504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64823931|NCT01529177|Chelating Agents|chelating agents|mesh-ancestor
64823932|NCT01529177|Sequestering Agents|sequestering agents|mesh-ancestor
64823933|NCT01529177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823934|NCT01529177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64823935|NCT01529177|Hormone Antagonists|hormone antagonists|mesh-ancestor
64823936|NCT01529177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64823969|NCT01529229|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64823970|NCT01529229|Cholinergic Agents|cholinergic agents|mesh-ancestor
64823971|NCT01529229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64823972|NCT01529229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64823973|NCT01529229|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64823974|NCT01529229|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64823975|NCT01529229|Histamine Antagonists|histamine antagonists|mesh-ancestor
64823976|NCT01529229|Histamine Agents|histamine agents|mesh-ancestor
64823977|NCT01529242|Prednisolone|prednisolone|mesh-list
64823978|NCT01529242|Betamethasone|betamethasone|mesh-list
64823979|NCT01529242|Desloratadine|desloratadine|mesh-list
64823980|NCT01529242|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
64823981|NCT01529242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64823983|NCT01529242|Hormones|hormones|mesh-ancestor
64824029|NCT01529320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64824030|NCT01529320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824031|NCT01529437|Immunologic Factors|immunologic factors|mesh-list
64824032|NCT01529437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824033|NCT01529476|Levofloxacin|levofloxacin|mesh-list
64824034|NCT01529476|Ofloxacin|ofloxacin|mesh-list
64824096|NCT01529892|Autonomic Agents|autonomic agents|mesh-ancestor
64824097|NCT01529892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824098|NCT01529892|Dopamine Agents|dopamine agents|mesh-ancestor
64824099|NCT01529892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64824100|NCT01529892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824101|NCT01529892|Adrenergic Agents|adrenergic agents|mesh-ancestor
64824102|NCT01529892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64824103|NCT01529892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64824104|NCT01529892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64824105|NCT01529892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64824106|NCT01530022|Lacosamide|lacosamide|mesh-list
64824107|NCT01530022|Carbamazepine|carbamazepine|mesh-list
64767494|NCT00898560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64767495|NCT00898560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64767496|NCT00898560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64767497|NCT00898560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767498|NCT00899574|Imiquimod|imiquimod|mesh-list
64767499|NCT00899574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64824108|NCT01530022|Anticonvulsants|anticonvulsants|mesh-ancestor
64824109|NCT01530022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64824110|NCT01530022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64824111|NCT01530022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64824112|NCT01530022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824113|NCT01530022|Antimanic Agents|antimanic agents|mesh-ancestor
64824114|NCT01530022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64824115|NCT01530022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64824116|NCT01530022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824117|NCT01530022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64824119|NCT01530022|Analgesics|analgesics|mesh-ancestor
64824145|NCT01530217|Ibuprofen|ibuprofen|mesh-list
64824146|NCT01530217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64824147|NCT01530217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64824148|NCT01530217|Analgesics|analgesics|mesh-ancestor
64824149|NCT01530217|Sensory System Agents|sensory system agents|mesh-ancestor
64824150|NCT01530217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824152|NCT01530217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64824153|NCT01530217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64824154|NCT01530217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64824155|NCT01530217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824156|NCT01530217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824157|NCT01530230|Oxytocin|oxytocin|mesh-list
64824158|NCT01530230|Oxytocics|oxytocics|mesh-ancestor
64824161|NCT01530295|Docetaxel|docetaxel|mesh-list
64824206|NCT01530490|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64824207|NCT01530490|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64824208|NCT01530490|Dopamine Agonists|dopamine agonists|mesh-ancestor
64824209|NCT01530490|Dopamine Agents|dopamine agents|mesh-ancestor
64824210|NCT01530490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64824211|NCT01530490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824212|NCT01530490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824213|NCT01530503|Capecitabine|capecitabine|mesh-list
64824214|NCT01530503|Mitomycins|mitomycins|mesh-list
64824215|NCT01530503|Mitomycin|mitomycin|mesh-list
64824272|NCT01530711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64824273|NCT01530711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64824274|NCT01530737|Antithrombins|antithrombins|mesh-list
64824275|NCT01530737|Antithrombin III|antithrombin iii|mesh-list
64824276|NCT01530737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64824277|NCT01530737|Protease Inhibitors|protease inhibitors|mesh-ancestor
64824278|NCT01530737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824279|NCT01530737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824280|NCT01530737|Anticoagulants|anticoagulants|mesh-ancestor
64592902|NCT01674686|Sarpogrelate|sarpogrelate|mesh-list
64824281|NCT01530763|Amoxicillin|amoxicillin|mesh-list
64824299|NCT01530984|Ipilimumab|ipilimumab|mesh-list
64824336|NCT01531166|Interferon alpha-2|interferon alpha-2|mesh-list
64824337|NCT01531166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64824338|NCT01531166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824339|NCT01531166|Antiviral Agents|antiviral agents|mesh-ancestor
64824340|NCT01531166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824341|NCT01531166|Immunologic Factors|immunologic factors|mesh-ancestor
64824342|NCT01531166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824343|NCT01531192|Nystatin|nystatin|mesh-list
64824344|NCT01531192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64824405|NCT01531595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824406|NCT01531595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64824407|NCT01531595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64824408|NCT01531595|Growth Substances|growth substances|mesh-ancestor
64824409|NCT01531595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824410|NCT01531595|Growth Inhibitors|growth inhibitors|mesh-ancestor
64824411|NCT01531595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64824412|NCT01531595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64824413|NCT01531595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824414|NCT01531595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824415|NCT01531647|Ritonavir|ritonavir|mesh-list
64824416|NCT01531647|Raltegravir Potassium|raltegravir potassium|mesh-list
64824467|NCT01531790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64824468|NCT01531790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64824469|NCT01531790|Growth Substances|growth substances|mesh-ancestor
64824470|NCT01531790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824471|NCT01531790|Growth Inhibitors|growth inhibitors|mesh-ancestor
64824538|NCT01532518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64824539|NCT01532518|Autonomic Agents|autonomic agents|mesh-ancestor
64824540|NCT01532518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824541|NCT01532518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824542|NCT01532518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64824543|NCT01532518|Respiratory System Agents|respiratory system agents|mesh-ancestor
64824544|NCT01532544|Heparin|heparin|mesh-list
64824545|NCT01532544|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64824546|NCT01532544|Tinzaparin|tinzaparin|mesh-list
64824547|NCT01532544|Dalteparin|dalteparin|mesh-list
64767544|NCT00904488|Furosemide|furosemide|mesh-list
64824548|NCT01532544|Eptifibatide|eptifibatide|mesh-list
64767545|NCT00904488|Diuretics|diuretics|mesh-ancestor
64824549|NCT01532544|Anticoagulants|anticoagulants|mesh-ancestor
64824551|NCT01532544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64824552|NCT01532544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824553|NCT01532544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64824554|NCT01532674|Anti-Infective Agents|anti-infective agents|mesh-list
64824555|NCT01532674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64824556|NCT01532726|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64824557|NCT01532726|Anticonvulsants|anticonvulsants|mesh-ancestor
64824558|NCT01532726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64824559|NCT01532726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64824592|NCT01532856|Alkylating Agents|alkylating agents|mesh-ancestor
64824593|NCT01532856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824594|NCT01532856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824595|NCT01532856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64824596|NCT01532856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64824597|NCT01532856|Antiemetics|antiemetics|mesh-ancestor
64824598|NCT01532856|Autonomic Agents|autonomic agents|mesh-ancestor
64824599|NCT01532856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824660|NCT01533155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64824661|NCT01533155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64824662|NCT01533155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64824663|NCT01533155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64824664|NCT01533220|Pheniramine|pheniramine|mesh-list
64824665|NCT01533220|Naphazoline|naphazoline|mesh-list
64824666|NCT01533220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824667|NCT01533220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64824668|NCT01533220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64824669|NCT01533220|Adrenergic Agents|adrenergic agents|mesh-ancestor
64824670|NCT01533220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64824671|NCT01533220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824672|NCT01533220|Nasal Decongestants|nasal decongestants|mesh-ancestor
64824673|NCT01533220|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64824674|NCT01533220|Respiratory System Agents|respiratory system agents|mesh-ancestor
64824675|NCT01533220|Antipruritics|antipruritics|mesh-ancestor
64824676|NCT01533220|Dermatologic Agents|dermatologic agents|mesh-ancestor
64824677|NCT01533220|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64824678|NCT01533220|Histamine Antagonists|histamine antagonists|mesh-ancestor
64824681|NCT01533272|Tenofovir|tenofovir|mesh-list
64824715|NCT01533376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824716|NCT01533376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824717|NCT01533376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64824718|NCT01533376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64824719|NCT01533376|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64824720|NCT01533376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64824721|NCT01533389|Silodosin|silodosin|mesh-list
64824722|NCT01533389|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64824723|NCT01533389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64824724|NCT01533389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64824725|NCT01533389|Adrenergic Agents|adrenergic agents|mesh-ancestor
64824780|NCT01533662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64824781|NCT01533662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64824782|NCT01533662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64824783|NCT01533662|Adrenergic Agents|adrenergic agents|mesh-ancestor
64824784|NCT01533662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64824785|NCT01533662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824786|NCT01533662|Protective Agents|protective agents|mesh-ancestor
64824787|NCT01533675|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64824788|NCT01533675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64824789|NCT01533675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64824790|NCT01533740|Leucovorin|leucovorin|mesh-list
64824791|NCT01533740|Folic Acid|folic acid|mesh-list
64824792|NCT01533740|Bevacizumab|bevacizumab|mesh-list
64824793|NCT01533740|Fluorouracil|fluorouracil|mesh-list
64824794|NCT01533740|Irinotecan|irinotecan|mesh-list
64824795|NCT01533740|Levoleucovorin|levoleucovorin|mesh-list
64824796|NCT01533740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64824797|NCT01533740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824839|NCT01533870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824841|NCT01534026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64824842|NCT01534026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64824843|NCT01534026|Analgesics|analgesics|mesh-ancestor
64824844|NCT01534026|Sensory System Agents|sensory system agents|mesh-ancestor
64824845|NCT01534026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824846|NCT01534026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824847|NCT01534026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64824848|NCT01534026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64824849|NCT01534026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64824850|NCT01534026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64824851|NCT01534026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824852|NCT01534026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64824853|NCT01534026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64824854|NCT01534026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824855|NCT01534026|Antipyretics|antipyretics|mesh-ancestor
64824856|NCT01534169|Dexamethasone|dexamethasone|mesh-list
64824857|NCT01534169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64824858|NCT01534169|Antiemetics|antiemetics|mesh-ancestor
64824859|NCT01534169|Autonomic Agents|autonomic agents|mesh-ancestor
64824860|NCT01534169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824861|NCT01534169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824864|NCT01534169|Hormones|hormones|mesh-ancestor
64824890|NCT01534442|Respiratory System Agents|respiratory system agents|mesh-ancestor
64824891|NCT01534442|Mydriatics|mydriatics|mesh-ancestor
64557487|NCT02555007|Antimitotic Agents|antimitotic agents|mesh-ancestor
64824892|NCT01534442|Parasympatholytics|parasympatholytics|mesh-ancestor
64824893|NCT01534442|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64824894|NCT01534442|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64824895|NCT01534442|Cholinergic Agents|cholinergic agents|mesh-ancestor
64824896|NCT01534442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64824897|NCT01534442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824899|NCT01534455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824900|NCT01534455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64824901|NCT01534455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824902|NCT01534455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824903|NCT01534494|Psilocybin|psilocybin|mesh-list
64824904|NCT01534494|Hallucinogens|hallucinogens|mesh-ancestor
64824905|NCT01534494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824906|NCT01534494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64824907|NCT01534546|Capecitabine|capecitabine|mesh-list
64824908|NCT01534546|Oxaliplatin|oxaliplatin|mesh-list
64824909|NCT01534546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64824910|NCT01534546|Antimetabolites|antimetabolites|mesh-ancestor
64824911|NCT01534546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64824912|NCT01534546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824913|NCT01534585|Paclitaxel|paclitaxel|mesh-list
64824914|NCT01534585|Mitogens|mitogens|mesh-list
64824915|NCT01534585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64824916|NCT01534585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64824917|NCT01534585|Tubulin Modulators|tubulin modulators|mesh-ancestor
64824918|NCT01534585|Antimitotic Agents|antimitotic agents|mesh-ancestor
64824919|NCT01534585|Mitosis Modulators|mitosis modulators|mesh-ancestor
64824934|NCT01534702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64824935|NCT01534702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64824936|NCT01534702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64824937|NCT01534754|Mesalamine|mesalamine|mesh-list
64824938|NCT01534754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64824939|NCT01534754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64824940|NCT01534754|Analgesics|analgesics|mesh-ancestor
64824941|NCT01534754|Sensory System Agents|sensory system agents|mesh-ancestor
64824942|NCT01534754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64824943|NCT01534754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64824946|NCT01534806|Ketorolac|ketorolac|mesh-list
64824998|NCT01535079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64824999|NCT01535079|Analgesics|analgesics|mesh-ancestor
64825000|NCT01535079|Sensory System Agents|sensory system agents|mesh-ancestor
64825002|NCT01535079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825004|NCT01535079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64825005|NCT01535079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64825006|NCT01535079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825007|NCT01535079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825009|NCT01535092|Protective Agents|protective agents|mesh-ancestor
64767724|NCT00928200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767725|NCT00928200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64767726|NCT00928200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64767727|NCT00928200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64767728|NCT00928200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64767729|NCT00928200|Abortifacient Agents|abortifacient agents|mesh-ancestor
64767730|NCT00928200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64430250|NCT04978649|Amlodipine|amlodipine|mesh-list
64825010|NCT01535092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825012|NCT01535092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825056|NCT01535469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825057|NCT01535469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825058|NCT01535469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64825059|NCT01535469|Hormone Antagonists|hormone antagonists|mesh-ancestor
64825060|NCT01535469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64825061|NCT01535469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825062|NCT01535469|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64825063|NCT01535469|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64825064|NCT01535495|Propranolol|propranolol|mesh-list
64825065|NCT01535495|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64825066|NCT01535495|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64825067|NCT01535495|Adrenergic Agents|adrenergic agents|mesh-ancestor
64825068|NCT01535495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64825069|NCT01535495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825070|NCT01535495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825071|NCT01535495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64825072|NCT01535495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64825074|NCT01535547|Isavuconazole|isavuconazole|mesh-list
64825109|NCT01535781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64825110|NCT01535781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64825111|NCT01535781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825113|NCT01535781|Coagulants|coagulants|mesh-ancestor
64825114|NCT01535820|Ortho Evra|ortho evra|mesh-list
64825115|NCT01535820|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64825179|NCT01536158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64825180|NCT01536158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64825181|NCT01536158|Analgesics|analgesics|mesh-ancestor
64825182|NCT01536158|Sensory System Agents|sensory system agents|mesh-ancestor
64825183|NCT01536158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64825184|NCT01536158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825185|NCT01536158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64825186|NCT01536158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64825187|NCT01536158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64825188|NCT01536158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825189|NCT01536158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825190|NCT01536158|Antipyretics|antipyretics|mesh-ancestor
64825191|NCT01536223|Cisplatin|cisplatin|mesh-list
64825192|NCT01536223|Docetaxel|docetaxel|mesh-list
64825193|NCT01536223|Fluorouracil|fluorouracil|mesh-list
64825239|NCT01536314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64825240|NCT01536314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64825241|NCT01536353|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
64825242|NCT01536353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64825244|NCT01536431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64825245|NCT01536431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64825246|NCT01536431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825247|NCT01536470|Norepinephrine|norepinephrine|mesh-list
64825248|NCT01536470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64825249|NCT01536470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64825250|NCT01536470|Adrenergic Agents|adrenergic agents|mesh-ancestor
64430312|NCT02047227|Hormones|hormones|mesh-ancestor
64825251|NCT01536470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64825252|NCT01536470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825253|NCT01536470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825254|NCT01536470|Sympathomimetics|sympathomimetics|mesh-ancestor
64825255|NCT01536470|Autonomic Agents|autonomic agents|mesh-ancestor
64825256|NCT01536470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64825257|NCT01536470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64825258|NCT01536600|Insulin Aspart|insulin aspart|mesh-list
64825259|NCT01536600|Biphasic Insulins|biphasic insulins|mesh-list
64825260|NCT01536600|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64825261|NCT01536600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64825264|NCT01536613|Biphasic Insulins|biphasic insulins|mesh-list
64825288|NCT01536665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64825289|NCT01536691|Ondansetron|ondansetron|mesh-list
64825290|NCT01536691|Aprepitant|aprepitant|mesh-list
64825291|NCT01536691|Fosaprepitant|fosaprepitant|mesh-list
64825292|NCT01536691|Ramosetron|ramosetron|mesh-list
64825293|NCT01536691|Antiemetics|antiemetics|mesh-ancestor
64825294|NCT01536691|Autonomic Agents|autonomic agents|mesh-ancestor
64825295|NCT01536691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64825296|NCT01536691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825297|NCT01536691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64825298|NCT01536691|Antipruritics|antipruritics|mesh-ancestor
64825299|NCT01536691|Dermatologic Agents|dermatologic agents|mesh-ancestor
64825300|NCT01536691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64825301|NCT01536691|Serotonin Agents|serotonin agents|mesh-ancestor
64825302|NCT01536691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64825303|NCT01536691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825304|NCT01536691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64825305|NCT01536691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64825306|NCT01536691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64825307|NCT01536691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64825308|NCT01536691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64825309|NCT01536691|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64825310|NCT01536717|Carticaine|carticaine|mesh-list
64825311|NCT01536717|Anesthetics, Local|anesthetics, local|mesh-ancestor
64825312|NCT01536717|Anesthetics|anesthetics|mesh-ancestor
64825313|NCT01536717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64825314|NCT01536717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825315|NCT01536717|Sensory System Agents|sensory system agents|mesh-ancestor
64825316|NCT01536717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64825317|NCT01536743|Palbociclib|palbociclib|mesh-list
64825318|NCT01536743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825319|NCT01536743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64825320|NCT01536743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825321|NCT01536743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825322|NCT01536873|Dolutegravir|dolutegravir|mesh-list
64825328|NCT01536873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64825330|NCT01536873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64825331|NCT01537055|Amoxicillin|amoxicillin|mesh-list
64825332|NCT01537055|Levofloxacin|levofloxacin|mesh-list
64825333|NCT01537055|Ofloxacin|ofloxacin|mesh-list
64825334|NCT01537055|Lansoprazole|lansoprazole|mesh-list
64825335|NCT01537055|Dexlansoprazole|dexlansoprazole|mesh-list
64825336|NCT01537055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64825337|NCT01537055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64323367|NCT03724825|Testosterone|testosterone|mesh-list
64323368|NCT03724825|Androgens|androgens|mesh-ancestor
64323369|NCT03724825|Hormones|hormones|mesh-ancestor
64767739|NCT00928200|Antiviral Agents|antiviral agents|mesh-ancestor
64767740|NCT00928200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64767741|NCT00928200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64825338|NCT01537055|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64825339|NCT01537055|Renal Agents|renal agents|mesh-ancestor
64825340|NCT01537055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64825341|NCT01537055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64825342|NCT01537055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825344|NCT01537055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825388|NCT01537250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64825389|NCT01537354|Poractant alfa|poractant alfa|mesh-list
64825390|NCT01537354|Beractant|beractant|mesh-list
64825391|NCT01537354|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
64825392|NCT01537354|Respiratory System Agents|respiratory system agents|mesh-ancestor
64825393|NCT01537380|Cefazolin|cefazolin|mesh-list
64825394|NCT01537380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64825395|NCT01537380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64825397|NCT01537471|Dimenhydrinate|dimenhydrinate|mesh-list
64825398|NCT01537471|Antiemetics|antiemetics|mesh-ancestor
64825399|NCT01537471|Autonomic Agents|autonomic agents|mesh-ancestor
64825400|NCT01537471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64825401|NCT01537471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825402|NCT01537471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64825403|NCT01537471|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64825404|NCT01537471|Histamine Antagonists|histamine antagonists|mesh-ancestor
64825405|NCT01537471|Histamine Agents|histamine agents|mesh-ancestor
64825406|NCT01537471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64825407|NCT01537471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825408|NCT01537471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64825409|NCT01537575|Immunoglobulins|immunoglobulins|mesh-list
64825410|NCT01537575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64825411|NCT01537575|Antibodies|antibodies|mesh-list
64825412|NCT01537575|gamma-Globulins|gamma-globulins|mesh-list
64825413|NCT01537575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64825414|NCT01537575|Immunologic Factors|immunologic factors|mesh-ancestor
64825415|NCT01537575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825437|NCT01537770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64825438|NCT01537770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64825439|NCT01537770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64825440|NCT01537770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825441|NCT01537809|Vitamin D|vitamin d|mesh-list
64825442|NCT01537809|Ergocalciferols|ergocalciferols|mesh-list
64825443|NCT01537809|Cholecalciferol|cholecalciferol|mesh-list
64825444|NCT01537809|Vitamins|vitamins|mesh-list
64825445|NCT01537809|Micronutrients|micronutrients|mesh-ancestor
64825446|NCT01537809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825447|NCT01537809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64825448|NCT01537809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64825449|NCT01537861|Thalidomide|thalidomide|mesh-list
64825450|NCT01537861|Dexamethasone|dexamethasone|mesh-list
64825451|NCT01537861|Cyclophosphamide|cyclophosphamide|mesh-list
64825452|NCT01537861|Lenalidomide|lenalidomide|mesh-list
64825453|NCT01537861|Bortezomib|bortezomib|mesh-list
64825454|NCT01537861|Pomalidomide|pomalidomide|mesh-list
64825455|NCT01537861|Lenograstim|lenograstim|mesh-list
64825456|NCT01537861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64825457|NCT01537861|Immunologic Factors|immunologic factors|mesh-ancestor
64825458|NCT01537861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825459|NCT01537861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64825460|NCT01537861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64825461|NCT01537861|Alkylating Agents|alkylating agents|mesh-ancestor
64825462|NCT01537861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825463|NCT01537861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825464|NCT01537861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64825465|NCT01537861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64825466|NCT01537861|Antiemetics|antiemetics|mesh-ancestor
64825467|NCT01537861|Autonomic Agents|autonomic agents|mesh-ancestor
64825481|NCT01537861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64825483|NCT01538095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64825484|NCT01538095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64825485|NCT01538095|Growth Substances|growth substances|mesh-ancestor
64825486|NCT01538095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767831|NCT00943800|Immunologic Factors|immunologic factors|mesh-ancestor
64767832|NCT00943800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767833|NCT00943800|Antiviral Agents|antiviral agents|mesh-ancestor
64767834|NCT00943800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64767838|NCT00943878|Vaccines|vaccines|mesh-list
64825487|NCT01538095|Growth Inhibitors|growth inhibitors|mesh-ancestor
64825488|NCT01538095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825489|NCT01538108|Paclitaxel|paclitaxel|mesh-list
64825490|NCT01538108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64825547|NCT01538446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64825548|NCT01538446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64825549|NCT01538446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64825550|NCT01538446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64825551|NCT01538446|Purinergic Agents|purinergic agents|mesh-ancestor
64825552|NCT01538446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64825553|NCT01538446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825554|NCT01538446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825555|NCT01538459|Dexamethasone|dexamethasone|mesh-list
64825556|NCT01538459|Bupivacaine|bupivacaine|mesh-list
64825557|NCT01538459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64825610|NCT01538641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825612|NCT01538641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64825613|NCT01538641|Antimetabolites|antimetabolites|mesh-ancestor
64825614|NCT01538641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825615|NCT01538641|Antiviral Agents|antiviral agents|mesh-ancestor
64825616|NCT01538641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64825617|NCT01538641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825618|NCT01538641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64825619|NCT01538667|Ciprofloxacin|ciprofloxacin|mesh-list
64825620|NCT01538667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64825621|NCT01538667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64825622|NCT01538667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64825623|NCT01538667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64825624|NCT01538667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825625|NCT01538667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825629|NCT01538693|Cyproheptadine|cyproheptadine|mesh-list
64825668|NCT01538797|Histamine Antagonists|histamine antagonists|mesh-ancestor
64825669|NCT01538797|Histamine Agents|histamine agents|mesh-ancestor
64825670|NCT01538797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64825672|NCT01538797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825741|NCT01539044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64825742|NCT01539044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825743|NCT01539044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64825744|NCT01539044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825745|NCT01539044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64825747|NCT01539174|Cyclophosphamide|cyclophosphamide|mesh-list
64825748|NCT01539174|Rituximab|rituximab|mesh-list
64825749|NCT01539174|Doxorubicin|doxorubicin|mesh-list
64825750|NCT01539174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64825751|NCT01539174|Vincristine|vincristine|mesh-list
64825752|NCT01539174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64825753|NCT01539174|Immunologic Factors|immunologic factors|mesh-ancestor
64825754|NCT01539174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825755|NCT01539174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64825756|NCT01539174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64825757|NCT01539174|Alkylating Agents|alkylating agents|mesh-ancestor
64825758|NCT01539174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825759|NCT01539174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825760|NCT01539174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64825761|NCT01539174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64825762|NCT01539174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64825763|NCT01539174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64825764|NCT01539174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64825765|NCT01539174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825766|NCT01539174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64825788|NCT01539330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64825789|NCT01539330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945450|NCT05619627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64825790|NCT01539330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825791|NCT01539330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64825792|NCT01539330|Hormone Antagonists|hormone antagonists|mesh-ancestor
64825793|NCT01539330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64825794|NCT01539330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825795|NCT01539330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64825796|NCT01539343|Anti-Infective Agents|anti-infective agents|mesh-list
64825797|NCT01539343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64825798|NCT01539408|Misoprostol|misoprostol|mesh-list
64825799|NCT01539408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64825800|NCT01539408|Abortifacient Agents|abortifacient agents|mesh-ancestor
64825801|NCT01539408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64825844|NCT01539603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825845|NCT01539616|Fenofibrate|fenofibrate|mesh-list
64825846|NCT01539616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64825847|NCT01539616|Antimetabolites|antimetabolites|mesh-ancestor
64825848|NCT01539616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825849|NCT01539616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64825850|NCT01539655|Omeprazole|omeprazole|mesh-list
64825911|NCT01539902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64825912|NCT01539902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64825913|NCT01539902|Alkylating Agents|alkylating agents|mesh-ancestor
64767899|NCT00957684|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64825914|NCT01539902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825915|NCT01539902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825916|NCT01539902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64825917|NCT01540032|Salicylates|salicylates|mesh-list
64825918|NCT01540032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64825919|NCT01540032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64825920|NCT01540032|Analgesics|analgesics|mesh-ancestor
64825921|NCT01540032|Sensory System Agents|sensory system agents|mesh-ancestor
64825922|NCT01540032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64825923|NCT01540032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825924|NCT01540032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64825925|NCT01540032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64825926|NCT01540032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64825927|NCT01540032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825928|NCT01540032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64825929|NCT01540084|Propofol|propofol|mesh-list
64825930|NCT01540084|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64825931|NCT01540084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64825932|NCT01540084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64825933|NCT01540084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64825934|NCT01540084|Anesthetics, General|anesthetics, general|mesh-ancestor
64825935|NCT01540084|Anesthetics|anesthetics|mesh-ancestor
64825936|NCT01540110|Cyclophosphamide|cyclophosphamide|mesh-list
64825937|NCT01540110|Docetaxel|docetaxel|mesh-list
64594560|NCT00596167|Vancomycin|vancomycin|mesh-list
64825938|NCT01540110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64825955|NCT01540240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64825956|NCT01540240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64825957|NCT01540240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64825958|NCT01540240|Antiviral Agents|antiviral agents|mesh-ancestor
64825959|NCT01540240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64825960|NCT01540240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64825961|NCT01540240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64825962|NCT01540435|Bevacizumab|bevacizumab|mesh-list
64825963|NCT01540435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64825964|NCT01540435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64825965|NCT01540435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64826015|NCT01540721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826016|NCT01540721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826017|NCT01540721|Antipyretics|antipyretics|mesh-ancestor
64826018|NCT01540734|Acetaminophen|acetaminophen|mesh-list
64826019|NCT01540734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64826020|NCT01540734|Analgesics|analgesics|mesh-ancestor
64826088|NCT01540877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64826089|NCT01540877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826090|NCT01540877|Sensory System Agents|sensory system agents|mesh-ancestor
64826091|NCT01540877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826093|NCT01540877|Dermatologic Agents|dermatologic agents|mesh-ancestor
64826094|NCT01540877|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64826095|NCT01541059|Ropivacaine|ropivacaine|mesh-list
64826096|NCT01541059|Anesthetics, Local|anesthetics, local|mesh-ancestor
64826097|NCT01541059|Anesthetics|anesthetics|mesh-ancestor
64826154|NCT01541189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826156|NCT01541267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64826157|NCT01541267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64826158|NCT01541267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64826159|NCT01541267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826160|NCT01541280|Azacitidine|azacitidine|mesh-list
64826161|NCT01541280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64826162|NCT01541280|Antimetabolites|antimetabolites|mesh-ancestor
64826163|NCT01541280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826164|NCT01541280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388565|NCT02341079|Bupivacaine|bupivacaine|mesh-list
64826215|NCT01541475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826217|NCT01541475|Serotonin Agents|serotonin agents|mesh-ancestor
64826218|NCT01541475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826219|NCT01541475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64826220|NCT01541475|Antidepressive Agents|antidepressive agents|mesh-ancestor
64826221|NCT01541475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64826222|NCT01541475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64826223|NCT01541475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64826224|NCT01541475|Parasympatholytics|parasympatholytics|mesh-ancestor
64826225|NCT01541475|Autonomic Agents|autonomic agents|mesh-ancestor
64826226|NCT01541475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826227|NCT01541475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64826275|NCT01541943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64826277|NCT01541956|Vildagliptin|vildagliptin|mesh-list
64826278|NCT01541956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64826279|NCT01541956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826280|NCT01541956|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64826281|NCT01541956|Protease Inhibitors|protease inhibitors|mesh-ancestor
64826282|NCT01541956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826283|NCT01541956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768008|NCT00983346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64826284|NCT01542047|Carboplatin|carboplatin|mesh-list
64826285|NCT01542047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64826286|NCT01542060|Insulin Aspart|insulin aspart|mesh-list
64826287|NCT01542060|Biphasic Insulins|biphasic insulins|mesh-list
64826288|NCT01542060|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64826289|NCT01542060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64826290|NCT01542060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826291|NCT01542099|Remifentanil|remifentanil|mesh-list
64826292|NCT01542099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64826293|NCT01542099|Narcotics|narcotics|mesh-ancestor
64826294|NCT01542099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64826300|NCT01542138|Niacin|niacin|mesh-list
64826331|NCT01542242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64826332|NCT01542268|Pentoxifylline|pentoxifylline|mesh-list
64826333|NCT01542268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64826334|NCT01542268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826335|NCT01542268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826336|NCT01542268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64826337|NCT01542268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64826338|NCT01542268|Protective Agents|protective agents|mesh-ancestor
64826339|NCT01542268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826340|NCT01542268|Vasodilator Agents|vasodilator agents|mesh-ancestor
64826341|NCT01542268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64826342|NCT01542268|Antioxidants|antioxidants|mesh-ancestor
64826343|NCT01542294|Oxaliplatin|oxaliplatin|mesh-list
64826344|NCT01542294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64826345|NCT01542424|Insulin|insulin|mesh-list
64826346|NCT01542424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64826347|NCT01542424|Insulin Aspart|insulin aspart|mesh-list
64826348|NCT01542424|Insulin Detemir|insulin detemir|mesh-list
64826353|NCT01542437|Afatinib|afatinib|mesh-list
64826387|NCT01542697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64826388|NCT01542697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64826389|NCT01542697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826390|NCT01542697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64826391|NCT01542697|Tocolytic Agents|tocolytic agents|mesh-ancestor
64826392|NCT01542697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64826395|NCT01542710|Travoprost|travoprost|mesh-list
64826396|NCT01542710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64826397|NCT01542710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64826398|NCT01542710|Adrenergic Agents|adrenergic agents|mesh-ancestor
64826399|NCT01542710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64826400|NCT01542710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388566|NCT02341079|Anesthetics, Local|anesthetics, local|mesh-ancestor
64388567|NCT02341079|Anesthetics|anesthetics|mesh-ancestor
64826401|NCT01542710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826404|NCT01542723|Nadroparin|nadroparin|mesh-list
64826447|NCT01543139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826448|NCT01543139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826450|NCT01543139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64826451|NCT01543139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826452|NCT01543139|Antimanic Agents|antimanic agents|mesh-ancestor
64826453|NCT01543139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64826454|NCT01543139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64826455|NCT01543139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64826456|NCT01543165|Ketorolac|ketorolac|mesh-list
64826457|NCT01543165|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64826458|NCT01543165|Morphine|morphine|mesh-list
64826459|NCT01543165|Analgesics|analgesics|mesh-list
64826460|NCT01543165|Nefopam|nefopam|mesh-list
64826461|NCT01543165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64826462|NCT01543165|Narcotics|narcotics|mesh-ancestor
64826463|NCT01543165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64826464|NCT01543165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826465|NCT01543165|Sensory System Agents|sensory system agents|mesh-ancestor
64826466|NCT01543165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826467|NCT01543165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64826468|NCT01543165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64826469|NCT01543165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64826470|NCT01543165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64826498|NCT01543399|Androgen Antagonists|androgen antagonists|mesh-ancestor
64826499|NCT01543399|Hormone Antagonists|hormone antagonists|mesh-ancestor
64826500|NCT01543399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64826501|NCT01543399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826502|NCT01543399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64826503|NCT01543399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64826504|NCT01543399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64826505|NCT01543399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64826506|NCT01543399|Anabolic Agents|anabolic agents|mesh-ancestor
64826507|NCT01543399|Hormones|hormones|mesh-ancestor
64826508|NCT01543464|Temozolomide|temozolomide|mesh-list
64768153|NCT01001052|Tubulin Modulators|tubulin modulators|mesh-ancestor
64768154|NCT01001052|Antimitotic Agents|antimitotic agents|mesh-ancestor
64768155|NCT01001052|Mitosis Modulators|mitosis modulators|mesh-ancestor
64768156|NCT01001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768157|NCT01001052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64826509|NCT01543464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64826510|NCT01543464|Alkylating Agents|alkylating agents|mesh-ancestor
64826511|NCT01543464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826512|NCT01543464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64826513|NCT01543555|Atorvastatin|atorvastatin|mesh-list
64826515|NCT01543555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64437762|NCT04915612|Daunorubicin|daunorubicin|mesh-list
64437763|NCT04915612|Gemtuzumab|gemtuzumab|mesh-list
64826553|NCT01543932|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64826554|NCT01543932|Purinergic Agents|purinergic agents|mesh-ancestor
64826555|NCT01543932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64826556|NCT01543932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826557|NCT01543932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826558|NCT01543945|Dexamethasone|dexamethasone|mesh-list
64826559|NCT01543945|Dexamethasone acetate|dexamethasone acetate|mesh-list
64826560|NCT01543945|Ondansetron|ondansetron|mesh-list
64826561|NCT01543945|Antiemetics|antiemetics|mesh-list
64826562|NCT01543945|Dimenhydrinate|dimenhydrinate|mesh-list
64826563|NCT01543945|BB 1101|bb 1101|mesh-list
64826564|NCT01543945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64826565|NCT01543945|Autonomic Agents|autonomic agents|mesh-ancestor
64826611|NCT01544140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826612|NCT01544192|Tocopherols|tocopherols|mesh-list
64826613|NCT01544192|Vitamin E|vitamin e|mesh-list
64826614|NCT01544192|Tocotrienols|tocotrienols|mesh-list
64826615|NCT01544192|alpha-Tocopherol|alpha-tocopherol|mesh-list
64826616|NCT01544192|Antioxidants|antioxidants|mesh-list
64826617|NCT01544192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826618|NCT01544192|Protective Agents|protective agents|mesh-ancestor
64826619|NCT01544192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826620|NCT01544192|Vitamins|vitamins|mesh-ancestor
64826621|NCT01544192|Micronutrients|micronutrients|mesh-ancestor
64826622|NCT01544283|Triamcinolone|triamcinolone|mesh-list
64826623|NCT01544283|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64826624|NCT01544283|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64826625|NCT01544283|Lidocaine|lidocaine|mesh-list
64826626|NCT01544283|Tetracaine|tetracaine|mesh-list
64826627|NCT01544283|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64826628|NCT01544283|Anesthetics, Local|anesthetics, local|mesh-ancestor
64826629|NCT01544283|Anesthetics|anesthetics|mesh-ancestor
64768161|NCT01001442|Tubulin Modulators|tubulin modulators|mesh-ancestor
64768162|NCT01001442|Antimitotic Agents|antimitotic agents|mesh-ancestor
64768163|NCT01001442|Mitosis Modulators|mitosis modulators|mesh-ancestor
64768164|NCT01001442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768165|NCT01003080|Hemostatics|hemostatics|mesh-list
64768166|NCT01003080|Coagulants|coagulants|mesh-ancestor
64826670|NCT01544517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64826671|NCT01544517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64826672|NCT01544517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826673|NCT01544517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826674|NCT01544517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64826675|NCT01544517|Renal Agents|renal agents|mesh-ancestor
64826676|NCT01544517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64826677|NCT01544517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64826678|NCT01544517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64826679|NCT01544517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64826680|NCT01544517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64826685|NCT01544634|Beclomethasone|beclomethasone|mesh-list
64437933|NCT04650854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826731|NCT01544751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826733|NCT01544751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64826734|NCT01544751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826735|NCT01544829|Theobromine|theobromine|mesh-list
64826736|NCT01544829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64826737|NCT01544829|Autonomic Agents|autonomic agents|mesh-ancestor
64826738|NCT01544829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826739|NCT01544829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826794|NCT01544959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826795|NCT01544959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64826796|NCT01544972|Acetaminophen|acetaminophen|mesh-list
64826797|NCT01544972|Ibuprofen|ibuprofen|mesh-list
64826798|NCT01544972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64826799|NCT01544972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64826800|NCT01544972|Analgesics|analgesics|mesh-ancestor
64826801|NCT01544972|Sensory System Agents|sensory system agents|mesh-ancestor
64826802|NCT01544972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64826803|NCT01544972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826804|NCT01544972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64826805|NCT01544972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64826806|NCT01544972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64826807|NCT01544972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826854|NCT01545479|Protease Inhibitors|protease inhibitors|mesh-ancestor
64826855|NCT01545479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826856|NCT01545479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826857|NCT01545479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64826858|NCT01545635|Thrombin|thrombin|mesh-list
64826859|NCT01545635|Hemostatics|hemostatics|mesh-ancestor
64826860|NCT01545635|Coagulants|coagulants|mesh-ancestor
64826861|NCT01545778|Oxycodone|oxycodone|mesh-list
64826862|NCT01545778|Tapentadol|tapentadol|mesh-list
64826863|NCT01545778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64826864|NCT01545778|Narcotics|narcotics|mesh-ancestor
64768189|NCT01005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768190|NCT01005576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64768191|NCT01005576|Alkylating Agents|alkylating agents|mesh-ancestor
64826865|NCT01545778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64826866|NCT01545778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826867|NCT01545778|Analgesics|analgesics|mesh-ancestor
64826916|NCT01546090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64826917|NCT01546090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64826918|NCT01546090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64826919|NCT01546090|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64826920|NCT01546090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64826921|NCT01546090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64826926|NCT01546103|Vitamin D|vitamin d|mesh-list
64826987|NCT01546896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826988|NCT01546896|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64826990|NCT01546935|Oseltamivir|oseltamivir|mesh-list
64826991|NCT01546935|Antiviral Agents|antiviral agents|mesh-ancestor
64826992|NCT01546935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64826993|NCT01546935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64826994|NCT01546935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64826995|NCT01546961|Chloroquine|chloroquine|mesh-list
64826996|NCT01546961|Amebicides|amebicides|mesh-ancestor
64826997|NCT01546961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64826998|NCT01546961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64826999|NCT01546961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64827000|NCT01546961|Antimalarials|antimalarials|mesh-ancestor
64827001|NCT01546961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64827002|NCT01547091|Antirheumatic Agents|antirheumatic agents|mesh-list
64827003|NCT01547104|Glimepiride|glimepiride|mesh-list
64827004|NCT01547104|Linagliptin|linagliptin|mesh-list
64827005|NCT01547104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64827006|NCT01547104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64827043|NCT01547143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64827044|NCT01547143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64827045|NCT01547169|Insulin|insulin|mesh-list
64827046|NCT01547169|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64827047|NCT01547169|Insulin Detemir|insulin detemir|mesh-list
64827048|NCT01547169|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64827049|NCT01547169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827050|NCT01547221|Clotrimazole|clotrimazole|mesh-list
64827051|NCT01547221|Miconazole|miconazole|mesh-list
64827052|NCT01547221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64827053|NCT01547221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64827054|NCT01547221|Antifungal Agents|antifungal agents|mesh-ancestor
64827055|NCT01547221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64827056|NCT01547221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64827057|NCT01547221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827058|NCT01547221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827059|NCT01547221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64768212|NCT01005888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64768213|NCT01007994|Propranolol|propranolol|mesh-list
64768215|NCT01007994|Isradipine|isradipine|mesh-list
64768216|NCT01007994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64768217|NCT01007994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64768218|NCT01007994|Adrenergic Agents|adrenergic agents|mesh-ancestor
64768219|NCT01007994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64768220|NCT01007994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768221|NCT01007994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430813|NCT01901848|Bupropion|bupropion|mesh-list
64430814|NCT01901848|Nicotine|nicotine|mesh-list
64430815|NCT01901848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64430816|NCT01901848|Autonomic Agents|autonomic agents|mesh-ancestor
64827060|NCT01547221|Hormone Antagonists|hormone antagonists|mesh-ancestor
64827061|NCT01547221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64827062|NCT01547221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827063|NCT01547221|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64827064|NCT01547221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64827065|NCT01547312|Interferons|interferons|mesh-list
64827066|NCT01547312|Ribavirin|ribavirin|mesh-list
64827067|NCT01547312|Grazoprevir|grazoprevir|mesh-list
64827068|NCT01547312|Liver Extracts|liver extracts|mesh-list
64827069|NCT01547312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827070|NCT01547312|Antiviral Agents|antiviral agents|mesh-ancestor
64827071|NCT01547312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64827072|NCT01547312|Antimetabolites|antimetabolites|mesh-ancestor
64827073|NCT01547312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827074|NCT01547312|Hematinics|hematinics|mesh-ancestor
64827087|NCT01547377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827088|NCT01547377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64827089|NCT01547377|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64827090|NCT01547377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827091|NCT01547377|Trace Elements|trace elements|mesh-ancestor
64827092|NCT01547377|Micronutrients|micronutrients|mesh-ancestor
64827093|NCT01547377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827094|NCT01547377|Antioxidants|antioxidants|mesh-ancestor
64827095|NCT01547377|Protective Agents|protective agents|mesh-ancestor
64827096|NCT01547416|Fentanyl|fentanyl|mesh-list
64827097|NCT01547416|Ropivacaine|ropivacaine|mesh-list
64827098|NCT01547416|Anesthetics, Local|anesthetics, local|mesh-ancestor
64827099|NCT01547416|Anesthetics|anesthetics|mesh-ancestor
64827100|NCT01547416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64827101|NCT01547416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827102|NCT01547416|Sensory System Agents|sensory system agents|mesh-ancestor
64827103|NCT01547416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827104|NCT01547416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64827105|NCT01547416|Narcotics|narcotics|mesh-ancestor
64827106|NCT01547416|Analgesics|analgesics|mesh-ancestor
64827107|NCT01547416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64827108|NCT01547416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64416784|NCT04842487|Alkylating Agents|alkylating agents|mesh-ancestor
64827109|NCT01547416|Anesthetics, General|anesthetics, general|mesh-ancestor
64768222|NCT01007994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64768223|NCT01007994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64768224|NCT01007994|Vasodilator Agents|vasodilator agents|mesh-ancestor
64827110|NCT01547455|Atorvastatin|atorvastatin|mesh-list
64827112|NCT01547455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64827137|NCT01548001|Methotrexate|methotrexate|mesh-list
64768226|NCT01007994|Protease Inhibitors|protease inhibitors|mesh-ancestor
64827138|NCT01548001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64827139|NCT01548001|Abortifacient Agents|abortifacient agents|mesh-ancestor
64827140|NCT01548001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64827141|NCT01548001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827142|NCT01548001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64827143|NCT01548001|Antimetabolites|antimetabolites|mesh-ancestor
64827144|NCT01548001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827145|NCT01548001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827146|NCT01548001|Dermatologic Agents|dermatologic agents|mesh-ancestor
64827147|NCT01548001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827150|NCT01548001|Immunologic Factors|immunologic factors|mesh-ancestor
64438399|NCT03915964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64438400|NCT03915964|Immunologic Factors|immunologic factors|mesh-ancestor
64438412|NCT03907423|Metformin|metformin|mesh-list
64438413|NCT03907423|Glimepiride|glimepiride|mesh-list
64438414|NCT03907423|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64438415|NCT03907423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64438416|NCT03907423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827200|NCT01548170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64827201|NCT01548170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827202|NCT01548170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827203|NCT01548170|Antifungal Agents|antifungal agents|mesh-ancestor
64827254|NCT01548482|Trebananib|trebananib|mesh-list
64827255|NCT01548482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64827256|NCT01548482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64827257|NCT01548482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64438529|NCT03672539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64438530|NCT03672539|Antimetabolites|antimetabolites|mesh-ancestor
64438531|NCT03672539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438532|NCT03672539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438533|NCT03672539|Antiviral Agents|antiviral agents|mesh-ancestor
64438534|NCT03672539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64438535|NCT03672539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64438536|NCT03672539|Immunologic Factors|immunologic factors|mesh-ancestor
64827327|NCT01548872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64827328|NCT01548911|Gemtuzumab|gemtuzumab|mesh-list
64827329|NCT01548911|Calicheamicins|calicheamicins|mesh-list
64827330|NCT01548911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64827331|NCT01548911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827332|NCT01548911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64827333|NCT01548924|Paclitaxel|paclitaxel|mesh-list
64827340|NCT01548950|Bosentan|bosentan|mesh-list
64827378|NCT01549171|Vasodilator Agents|vasodilator agents|mesh-ancestor
64827379|NCT01549236|Benzonidazole|benzonidazole|mesh-list
64827380|NCT01549236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64827381|NCT01549236|Immunologic Factors|immunologic factors|mesh-ancestor
64827382|NCT01549236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827383|NCT01549236|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64827384|NCT01549236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64827385|NCT01549236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64827386|NCT01549236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64827387|NCT01549301|Lenograstim|lenograstim|mesh-list
64827388|NCT01549301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64827389|NCT01549301|Immunologic Factors|immunologic factors|mesh-ancestor
64827390|NCT01549301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827392|NCT01549418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64827393|NCT01549418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64827394|NCT01549418|Analgesics|analgesics|mesh-ancestor
64827395|NCT01549418|Sensory System Agents|sensory system agents|mesh-ancestor
64827396|NCT01549418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827434|NCT01549548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64827436|NCT01549548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827437|NCT01549574|Crizotinib|crizotinib|mesh-list
64827438|NCT01549574|Esomeprazole|esomeprazole|mesh-list
64596042|NCT01918761|Pemetrexed|pemetrexed|mesh-list
64827439|NCT01549574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64827440|NCT01549574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64827441|NCT01549574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64827443|NCT01549574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827444|NCT01549574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827445|NCT01549574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64827447|NCT01549600|Cathartics|cathartics|mesh-ancestor
64827448|NCT01549600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64827449|NCT01549691|Alprazolam|alprazolam|mesh-list
64827450|NCT01549691|Zopiclone|zopiclone|mesh-list
64827451|NCT01549691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64827491|NCT01549795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827492|NCT01549795|Hematinics|hematinics|mesh-ancestor
64827494|NCT01549847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64827495|NCT01549847|Protective Agents|protective agents|mesh-ancestor
64827496|NCT01549847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827563|NCT01550354|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64827564|NCT01550354|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64827565|NCT01550354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827566|NCT01550354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64827567|NCT01550354|Narcotics|narcotics|mesh-ancestor
64827568|NCT01550354|Analgesics|analgesics|mesh-ancestor
64827569|NCT01550354|Sensory System Agents|sensory system agents|mesh-ancestor
64827570|NCT01550419|Atorvastatin|atorvastatin|mesh-list
64827571|NCT01550419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64827572|NCT01550419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64827573|NCT01550419|Antimetabolites|antimetabolites|mesh-ancestor
64827574|NCT01550419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827575|NCT01550419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64827576|NCT01550419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64827577|NCT01550419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64827578|NCT01550445|Prednisolone|prednisolone|mesh-list
64827579|NCT01550445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64827580|NCT01550445|Glucocorticoids|glucocorticoids|mesh-ancestor
64827581|NCT01550445|Hormones|hormones|mesh-ancestor
64827582|NCT01550445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64827583|NCT01550445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827584|NCT01550445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64827585|NCT01550445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827586|NCT01550458|Mibefradil|mibefradil|mesh-list
64827587|NCT01550458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64827588|NCT01550458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64596186|NCT01925469|Anesthetics|anesthetics|mesh-ancestor
64827589|NCT01550458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64827590|NCT01550458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827591|NCT01550458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64827592|NCT01550458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827593|NCT01550458|Vasodilator Agents|vasodilator agents|mesh-ancestor
64827594|NCT01550458|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64827595|NCT01550458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64827601|NCT01550640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827602|NCT01550640|Analgesics|analgesics|mesh-ancestor
64827603|NCT01550640|Sensory System Agents|sensory system agents|mesh-ancestor
64827604|NCT01550640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827605|NCT01550653|Liraglutide|liraglutide|mesh-list
64827606|NCT01550653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64827607|NCT01550653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827608|NCT01550653|Incretins|incretins|mesh-ancestor
64827609|NCT01550653|Hormones|hormones|mesh-ancestor
64388568|NCT02341079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64388569|NCT02341079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388570|NCT02341079|Sensory System Agents|sensory system agents|mesh-ancestor
64388571|NCT02341079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64388573|NCT02346539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64388574|NCT02346539|Autonomic Agents|autonomic agents|mesh-ancestor
64388575|NCT02346539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827610|NCT01550653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64827664|NCT01551225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64827665|NCT01551225|Antidepressive Agents|antidepressive agents|mesh-ancestor
64827666|NCT01551225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64827668|NCT01551290|Dermatologic Agents|dermatologic agents|mesh-ancestor
64827669|NCT01551290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64827670|NCT01551290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64827671|NCT01551329|Ketamine|ketamine|mesh-list
64827672|NCT01551329|Analgesics|analgesics|mesh-ancestor
64827673|NCT01551329|Sensory System Agents|sensory system agents|mesh-ancestor
64827674|NCT01551329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827675|NCT01551329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827676|NCT01551329|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64827677|NCT01551329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64827678|NCT01551329|Anesthetics, General|anesthetics, general|mesh-ancestor
64827724|NCT01551485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64827725|NCT01551485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827726|NCT01551511|Dronabinol|dronabinol|mesh-list
64827727|NCT01551511|Hallucinogens|hallucinogens|mesh-ancestor
64827728|NCT01551511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827729|NCT01551511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64827730|NCT01551511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64827731|NCT01551511|Analgesics|analgesics|mesh-ancestor
64827732|NCT01551511|Sensory System Agents|sensory system agents|mesh-ancestor
64827733|NCT01551511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827734|NCT01551511|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64827735|NCT01551511|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64827736|NCT01551511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64827737|NCT01551511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827738|NCT01551511|Hormones|hormones|mesh-ancestor
64827739|NCT01551511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64827740|NCT01551589|Docetaxel|docetaxel|mesh-list
64827741|NCT01551589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827742|NCT01551589|Tubulin Modulators|tubulin modulators|mesh-ancestor
64827743|NCT01551589|Antimitotic Agents|antimitotic agents|mesh-ancestor
64827744|NCT01551589|Mitosis Modulators|mitosis modulators|mesh-ancestor
64827745|NCT01551589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827746|NCT01551615|Metformin|metformin|mesh-list
64827747|NCT01551615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64827748|NCT01551615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827749|NCT01551628|BCT-100|bct-100|mesh-list
64827750|NCT01551628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827751|NCT01551641|Thalidomide|thalidomide|mesh-list
64827752|NCT01551641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64827753|NCT01551641|Immunologic Factors|immunologic factors|mesh-ancestor
64827768|NCT01551680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768395|NCT02406222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768396|NCT02406222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827769|NCT01551680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827770|NCT01551680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827771|NCT01551719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64827772|NCT01551719|Vancomycin|vancomycin|mesh-list
64827773|NCT01551719|Linezolid|linezolid|mesh-list
64827774|NCT01551719|Daptomycin|daptomycin|mesh-list
64388576|NCT02346539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388577|NCT02346539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64388578|NCT02346539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64388579|NCT02346539|Cholinergic Agents|cholinergic agents|mesh-ancestor
64388580|NCT02346539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64827839|NCT01552122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64827840|NCT01552122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64827842|NCT01552122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827910|NCT01552837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827912|NCT01552850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64827913|NCT01552850|Narcotics|narcotics|mesh-ancestor
64827914|NCT01552850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64827915|NCT01552850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827916|NCT01552850|Analgesics|analgesics|mesh-ancestor
64827917|NCT01552850|Sensory System Agents|sensory system agents|mesh-ancestor
64827918|NCT01552850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64827919|NCT01552863|Oxycodone|oxycodone|mesh-list
64827920|NCT01552863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64827921|NCT01552863|Narcotics|narcotics|mesh-ancestor
64827922|NCT01552863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64827923|NCT01552863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827924|NCT01552863|Analgesics|analgesics|mesh-ancestor
64827972|NCT01553357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64827973|NCT01553357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64827974|NCT01553357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64827975|NCT01553357|Immunologic Factors|immunologic factors|mesh-ancestor
64827976|NCT01553357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64827977|NCT01553357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64827978|NCT01553357|Growth Substances|growth substances|mesh-ancestor
64827979|NCT01553357|Growth Inhibitors|growth inhibitors|mesh-ancestor
64827980|NCT01553435|Dextromethorphan|dextromethorphan|mesh-list
64827981|NCT01553435|Antitussive Agents|antitussive agents|mesh-ancestor
64827982|NCT01553435|Respiratory System Agents|respiratory system agents|mesh-ancestor
64827983|NCT01553435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64827984|NCT01553435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64827985|NCT01553435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64827986|NCT01553435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64827987|NCT01553435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64827988|NCT01553500|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
64827989|NCT01553500|Cathartics|cathartics|mesh-ancestor
64828026|NCT01553903|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64828027|NCT01553903|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64828028|NCT01553903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64828029|NCT01553942|Pemetrexed|pemetrexed|mesh-list
64828030|NCT01553942|Afatinib|afatinib|mesh-list
64828031|NCT01553942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828032|NCT01553942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828033|NCT01553942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828034|NCT01553942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64828035|NCT01553942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64828036|NCT01553942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64828037|NCT01553981|Tadalafil|tadalafil|mesh-list
64828038|NCT01553981|Vasodilator Agents|vasodilator agents|mesh-ancestor
64828039|NCT01553981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64828040|NCT01553981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64828041|NCT01553981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828042|NCT01553981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596630|NCT05445921|Anesthetics|anesthetics|mesh-ancestor
64828043|NCT01553981|Urological Agents|urological agents|mesh-ancestor
64828044|NCT01554059|Bevacizumab|bevacizumab|mesh-list
64828045|NCT01554059|Oxaliplatin|oxaliplatin|mesh-list
64768453|NCT01028820|Serotonin Agents|serotonin agents|mesh-ancestor
64828048|NCT01554059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64828049|NCT01554059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64828050|NCT01554059|Growth Substances|growth substances|mesh-ancestor
64828052|NCT01554059|Growth Inhibitors|growth inhibitors|mesh-ancestor
64828074|NCT01554540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64828075|NCT01554592|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
64828076|NCT01554592|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64828077|NCT01554592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64828078|NCT01554592|Antimetabolites|antimetabolites|mesh-ancestor
64828079|NCT01554592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828080|NCT01554592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828081|NCT01554592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64828083|NCT01554631|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64828084|NCT01554631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828085|NCT01554631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828086|NCT01554631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64828087|NCT01554631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828088|NCT01554657|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64828134|NCT01554852|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64828137|NCT01554930|Immunoglobulins|immunoglobulins|mesh-list
64828138|NCT01554930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64828139|NCT01554930|Antiemetics|antiemetics|mesh-ancestor
64828140|NCT01554930|Autonomic Agents|autonomic agents|mesh-ancestor
64828141|NCT01554930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64828142|NCT01554930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828143|NCT01554930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64828144|NCT01554930|Glucocorticoids|glucocorticoids|mesh-ancestor
64828145|NCT01554930|Hormones|hormones|mesh-ancestor
64828146|NCT01554930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64828194|NCT01555112|Antiviral Agents|antiviral agents|mesh-ancestor
64828195|NCT01555112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64828196|NCT01555190|Folic Acid|folic acid|mesh-list
64828197|NCT01555190|Inositol|inositol|mesh-list
64828198|NCT01555190|Hematinics|hematinics|mesh-ancestor
64828199|NCT01555190|Vitamin B Complex|vitamin b complex|mesh-ancestor
64828200|NCT01555190|Vitamins|vitamins|mesh-ancestor
64828201|NCT01555190|Micronutrients|micronutrients|mesh-ancestor
64768458|NCT01029054|Dexamethasone|dexamethasone|mesh-list
64768459|NCT01029054|Dexamethasone acetate|dexamethasone acetate|mesh-list
64828202|NCT01555190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828203|NCT01555216|Ropivacaine|ropivacaine|mesh-list
64828204|NCT01555216|Anesthetics, Local|anesthetics, local|mesh-ancestor
64828205|NCT01555216|Anesthetics|anesthetics|mesh-ancestor
64828206|NCT01555216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64828259|NCT01555710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64828260|NCT01555710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64828261|NCT01555710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64828285|NCT01555879|Abatacept|abatacept|mesh-list
64828330|NCT01556321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64828331|NCT01556321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828332|NCT01556321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64828333|NCT01556321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828334|NCT01556321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828335|NCT01556321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64828336|NCT01556321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64828337|NCT01556321|Purinergic Agents|purinergic agents|mesh-ancestor
64828338|NCT01556321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64828339|NCT01556334|Azithromycin|azithromycin|mesh-list
64828340|NCT01556334|Erythromycin|erythromycin|mesh-list
64828341|NCT01556334|Erythromycin Estolate|erythromycin estolate|mesh-list
64828342|NCT01556334|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64828343|NCT01556334|Erythromycin stearate|erythromycin stearate|mesh-list
64828344|NCT01556334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64828345|NCT01556334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64828350|NCT01556477|Lenalidomide|lenalidomide|mesh-list
64828388|NCT01556698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64828390|NCT01556698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64828391|NCT01556698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828392|NCT01556698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64828393|NCT01556698|Respiratory System Agents|respiratory system agents|mesh-ancestor
64828394|NCT01556698|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64828395|NCT01556698|Antioxidants|antioxidants|mesh-ancestor
64828396|NCT01556698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828397|NCT01556698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64828398|NCT01556698|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64828399|NCT01556698|Vasodilator Agents|vasodilator agents|mesh-ancestor
64828400|NCT01556698|Gasotransmitters|gasotransmitters|mesh-ancestor
64828401|NCT01556698|Protective Agents|protective agents|mesh-ancestor
64828402|NCT01556737|Genistein|genistein|mesh-list
64828403|NCT01556737|Daidzein|daidzein|mesh-list
64828404|NCT01556737|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64828405|NCT01556737|Protective Agents|protective agents|mesh-ancestor
64828444|NCT01557127|Sorafenib|sorafenib|mesh-list
64828445|NCT01557127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828446|NCT01557127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64828447|NCT01557127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828448|NCT01557127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828449|NCT01557140|Carvedilol|carvedilol|mesh-list
64768511|NCT05306028|Metformin|metformin|mesh-list
64828450|NCT01557140|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64828451|NCT01557140|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64828509|NCT01557335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64828510|NCT01557335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64828511|NCT01557335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828512|NCT01557335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64828513|NCT01557335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64828577|NCT01557764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64828578|NCT01557764|Immunologic Factors|immunologic factors|mesh-ancestor
64828579|NCT01557764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828580|NCT01557764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64828581|NCT01557764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828582|NCT01557764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64828644|NCT01558193|Analgesics|analgesics|mesh-ancestor
64828645|NCT01558193|Sensory System Agents|sensory system agents|mesh-ancestor
64828646|NCT01558193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64828647|NCT01558193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64828648|NCT01558193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64828649|NCT01558193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64828650|NCT01558193|Antimetabolites|antimetabolites|mesh-ancestor
64828651|NCT01558193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828652|NCT01558193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64828653|NCT01558193|Dermatologic Agents|dermatologic agents|mesh-ancestor
64828654|NCT01558245|Kallikreins|kallikreins|mesh-list
64828655|NCT01558245|Coagulants|coagulants|mesh-ancestor
64828709|NCT01558713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64828710|NCT01558713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64828711|NCT01558713|Narcotics|narcotics|mesh-ancestor
64828712|NCT01558713|Analgesics|analgesics|mesh-ancestor
64828713|NCT01558713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64828714|NCT01558713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64828715|NCT01558713|Anesthetics, General|anesthetics, general|mesh-ancestor
64828716|NCT01558830|Ranolazine|ranolazine|mesh-list
64828717|NCT01558830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64597302|NCT04270669|RC28-E protein|rc28-e protein|mesh-list
64828720|NCT01558869|Capecitabine|capecitabine|mesh-list
64828773|NCT01559142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64828774|NCT01559142|Immunologic Factors|immunologic factors|mesh-ancestor
64828775|NCT01559142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828776|NCT01559272|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64828777|NCT01559272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64828842|NCT01559584|Hormones|hormones|mesh-ancestor
64828843|NCT01559584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64828844|NCT01559584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828845|NCT01559584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64828846|NCT01559584|Immunologic Factors|immunologic factors|mesh-ancestor
64828847|NCT01559584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64828848|NCT01559584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828849|NCT01559727|Prednisone|prednisone|mesh-list
64828850|NCT01559727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64828851|NCT01559727|Glucocorticoids|glucocorticoids|mesh-ancestor
64828852|NCT01559727|Hormones|hormones|mesh-ancestor
64828853|NCT01559727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64828854|NCT01559727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828855|NCT01559727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64828856|NCT01559727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828857|NCT01559740|Bupivacaine|bupivacaine|mesh-list
64828858|NCT01559740|Anesthetics, Local|anesthetics, local|mesh-ancestor
64828859|NCT01559740|Anesthetics|anesthetics|mesh-ancestor
64828860|NCT01559740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64828861|NCT01559740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828862|NCT01559740|Sensory System Agents|sensory system agents|mesh-ancestor
64828863|NCT01559740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64828864|NCT01559753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64828865|NCT01559753|Amoxicillin|amoxicillin|mesh-list
64828866|NCT01559753|Ceftriaxone|ceftriaxone|mesh-list
64828867|NCT01559753|Tobramycin|tobramycin|mesh-list
64828868|NCT01559753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64828869|NCT01559753|Clavulanic Acids|clavulanic acids|mesh-list
64828870|NCT01559753|Clavulanic Acid|clavulanic acid|mesh-list
64828871|NCT01559753|Cefotaxime|cefotaxime|mesh-list
64828872|NCT01559753|Cefoxitin|cefoxitin|mesh-list
64828873|NCT01559753|Netilmicin|netilmicin|mesh-list
64828885|NCT01559974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64828886|NCT01560117|Rituximab|rituximab|mesh-list
64828887|NCT01560117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64828888|NCT01560117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828889|NCT01560117|Immunologic Factors|immunologic factors|mesh-ancestor
64828890|NCT01560117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64828891|NCT01560117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64828892|NCT05570669|Simethicone|simethicone|mesh-list
64828893|NCT05570669|Sodium sulfate|sodium sulfate|mesh-list
64828894|NCT05570669|Antifoaming Agents|antifoaming agents|mesh-ancestor
64828895|NCT05570669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828896|NCT05570669|Emollients|emollients|mesh-ancestor
64828897|NCT05570669|Dermatologic Agents|dermatologic agents|mesh-ancestor
64828898|NCT05570669|Cathartics|cathartics|mesh-ancestor
64828899|NCT05570669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64828900|NCT05570409|Mycophenolic Acid|mycophenolic acid|mesh-list
64828901|NCT05570409|Prednisolone|prednisolone|mesh-list
64828902|NCT05570409|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64828903|NCT05570409|Methylprednisolone|methylprednisolone|mesh-list
64828904|NCT05570409|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64828905|NCT05570409|Prednisolone acetate|prednisolone acetate|mesh-list
64828906|NCT05570409|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64828907|NCT05570409|Prednisolone phosphate|prednisolone phosphate|mesh-list
64828908|NCT05570409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64828909|NCT05570409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64828910|NCT05570409|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64828911|NCT05570409|Antitubercular Agents|antitubercular agents|mesh-ancestor
64828912|NCT05570409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64828913|NCT05570409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64768574|NCT01043640|Busulfan|busulfan|mesh-list
64828915|NCT05570409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828917|NCT05570409|Glucocorticoids|glucocorticoids|mesh-ancestor
64828918|NCT05570409|Hormones|hormones|mesh-ancestor
64828919|NCT05570409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64828926|NCT05570409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64828927|NCT05570409|Protective Agents|protective agents|mesh-ancestor
64828928|NCT05570383|Antacids|antacids|mesh-list
64828929|NCT05570383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64828930|NCT05570383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64828931|NCT05570110|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
64828932|NCT05570110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64828933|NCT05570084|Tamsulosin|tamsulosin|mesh-list
64828934|NCT05570084|Silodosin|silodosin|mesh-list
64828935|NCT05570084|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64828936|NCT05570084|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64828937|NCT05570084|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64828938|NCT05570084|Adrenergic Agents|adrenergic agents|mesh-ancestor
64828983|NCT05569031|Antidepressive Agents|antidepressive agents|mesh-ancestor
64828984|NCT05569031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64828985|NCT05569031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64828986|NCT05569031|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64829054|NCT05391555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64829055|NCT05391555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829056|NCT05391555|Analgesics|analgesics|mesh-ancestor
64829057|NCT05391555|Sensory System Agents|sensory system agents|mesh-ancestor
64829058|NCT05391555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829059|NCT05388773|Carboplatin|carboplatin|mesh-list
64829060|NCT05388773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829061|NCT05388656|Estradiol|estradiol|mesh-list
64829062|NCT05388656|Progesterone|progesterone|mesh-list
64829063|NCT05388656|Estrogens|estrogens|mesh-ancestor
64829064|NCT05388656|Hormones|hormones|mesh-ancestor
64829065|NCT05388656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64829066|NCT05388656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829067|NCT05388656|Progestins|progestins|mesh-ancestor
64597680|NCT03298802|Diuretics|diuretics|mesh-ancestor
64829094|NCT05372393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64829095|NCT05372393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829096|NCT05229965|Acetaminophen|acetaminophen|mesh-list
64829113|NCT05229965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829114|NCT05229965|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64829115|NCT05229965|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64829116|NCT05229965|Purinergic Agents|purinergic agents|mesh-ancestor
64829118|NCT05219604|Diphenhydramine|diphenhydramine|mesh-list
64829182|NCT04787731|Anesthetics|anesthetics|mesh-list
64829183|NCT04787731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64829184|NCT04787731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829185|NCT04787731|Sensory System Agents|sensory system agents|mesh-ancestor
64829186|NCT04787731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829187|NCT04787731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64829188|NCT04787731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64829249|NCT04410406|Albendazole|albendazole|mesh-list
64829250|NCT04410406|Moxidectin|moxidectin|mesh-list
64829251|NCT04410406|Diethylcarbamazine|diethylcarbamazine|mesh-list
64829252|NCT04410406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829253|NCT04410406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64829254|NCT04410406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64829255|NCT04410406|Anthelmintics|anthelmintics|mesh-ancestor
64829256|NCT04410406|Anticestodal Agents|anticestodal agents|mesh-ancestor
64829257|NCT04410406|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64829258|NCT04410406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64768629|NCT01050582|Risperidone|risperidone|mesh-list
64829259|NCT04410406|Tubulin Modulators|tubulin modulators|mesh-ancestor
64829260|NCT04410406|Antimitotic Agents|antimitotic agents|mesh-ancestor
64829261|NCT04410406|Mitosis Modulators|mitosis modulators|mesh-ancestor
64829262|NCT04410406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829263|NCT04410406|Antinematodal Agents|antinematodal agents|mesh-ancestor
64829264|NCT04410406|Filaricides|filaricides|mesh-ancestor
64829265|NCT04410406|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64829309|NCT04182672|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64829310|NCT04182672|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64829311|NCT04182672|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64829312|NCT04182672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64829313|NCT04182672|Glucocorticoids|glucocorticoids|mesh-ancestor
64829314|NCT04182672|Hormones|hormones|mesh-ancestor
64829315|NCT04182672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64829316|NCT04182672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829317|NCT04182672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64829318|NCT04182672|Immunologic Factors|immunologic factors|mesh-ancestor
64829319|NCT04182672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829320|NCT04182672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829321|NCT04101227|Ondansetron|ondansetron|mesh-list
64829322|NCT04101227|Antiemetics|antiemetics|mesh-ancestor
64829323|NCT04101227|Autonomic Agents|autonomic agents|mesh-ancestor
64829324|NCT04101227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829325|NCT04101227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829326|NCT04101227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64829327|NCT04101227|Antipruritics|antipruritics|mesh-ancestor
64829341|NCT04047004|Doxorubicin|doxorubicin|mesh-list
64829363|NCT03813121|Sensory System Agents|sensory system agents|mesh-ancestor
64829364|NCT03813121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829365|NCT03813121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829366|NCT03813121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64829367|NCT03813121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64829368|NCT03813121|Anesthetics, General|anesthetics, general|mesh-ancestor
64829369|NCT03813121|Anesthetics|anesthetics|mesh-ancestor
64829370|NCT03813121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64829371|NCT03813121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64829427|NCT03471507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64829428|NCT03471507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64829429|NCT03471507|Analgesics|analgesics|mesh-ancestor
64829430|NCT03471507|Sensory System Agents|sensory system agents|mesh-ancestor
64829431|NCT03471507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829432|NCT03471507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829493|NCT03104400|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64829494|NCT03104400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64829495|NCT03104400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768636|NCT01050582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64768638|NCT01050582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64829496|NCT03104400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829564|NCT02658487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64829565|NCT02658487|Antimetabolites|antimetabolites|mesh-ancestor
64829566|NCT02658487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829567|NCT02658487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829568|NCT02658487|Antiviral Agents|antiviral agents|mesh-ancestor
64829569|NCT02658487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64829570|NCT02658487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64829571|NCT02658487|Immunologic Factors|immunologic factors|mesh-ancestor
64829572|NCT02658487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829573|NCT02583282|Doxycycline|doxycycline|mesh-list
64829574|NCT02583282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64829575|NCT02583282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64829576|NCT02583282|Antimalarials|antimalarials|mesh-ancestor
64829577|NCT02583282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64829578|NCT02583282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64829579|NCT02553941|Azacitidine|azacitidine|mesh-list
64829580|NCT02553941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64829587|NCT02546492|beta-Endorphin|beta-endorphin|mesh-list
64829619|NCT02179749|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64829620|NCT02065609|Trastuzumab|trastuzumab|mesh-list
64829621|NCT02065609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64829622|NCT02065609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829623|NCT01992861|Deoxyglucose|deoxyglucose|mesh-list
64829624|NCT01992861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64829625|NCT01992861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64829626|NCT01992861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829627|NCT01992861|Antimetabolites|antimetabolites|mesh-ancestor
64829628|NCT01992861|Antiviral Agents|antiviral agents|mesh-ancestor
64829629|NCT01992861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64829630|NCT00700882|Dasatinib|dasatinib|mesh-list
64829631|NCT00700882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829632|NCT00700882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64829633|NCT00700882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829634|NCT00700882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829678|NCT01564238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64829679|NCT01564576|Bromides|bromides|mesh-list
64829680|NCT01564576|Rocuronium|rocuronium|mesh-list
64768682|NCT05822440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768683|NCT05822440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64768684|NCT05822440|Hormone Antagonists|hormone antagonists|mesh-ancestor
64768685|NCT05822440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64768688|NCT05822362|Cannabidiol|cannabidiol|mesh-list
64829681|NCT01564576|Anticonvulsants|anticonvulsants|mesh-ancestor
64829682|NCT01564576|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64829683|NCT01564576|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64829684|NCT01564576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64829685|NCT01564576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64829686|NCT01564576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829687|NCT01564823|Metronidazole|metronidazole|mesh-list
64829688|NCT01564823|Adalimumab|adalimumab|mesh-list
64829689|NCT01564823|Azathioprine|azathioprine|mesh-list
64829690|NCT01564823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64829691|NCT01564823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64829692|NCT01564823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64829693|NCT01564823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64829737|NCT01566760|Urological Agents|urological agents|mesh-ancestor
64829738|NCT01566890|Regadenoson|regadenoson|mesh-list
64829739|NCT01566890|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64829740|NCT01566890|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64829741|NCT01566890|Purinergic Agonists|purinergic agonists|mesh-ancestor
64829746|NCT01567072|Ibuprofen|ibuprofen|mesh-list
64829803|NCT01569685|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64829804|NCT01569685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64829805|NCT01569685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64829806|NCT01569685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829807|NCT01569685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64829808|NCT01569685|Serotonin Agents|serotonin agents|mesh-ancestor
64829809|NCT01569685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829810|NCT01569685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64829868|NCT01570569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64829869|NCT01570569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64829870|NCT01570569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64829871|NCT01570569|Antitussive Agents|antitussive agents|mesh-ancestor
64829872|NCT01570569|Respiratory System Agents|respiratory system agents|mesh-ancestor
64829873|NCT01570569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64829874|NCT01570569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64829875|NCT01570582|Gemcitabine|gemcitabine|mesh-list
64829876|NCT01570582|Paclitaxel|paclitaxel|mesh-list
64829877|NCT01570582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64829878|NCT01570582|Carboplatin|carboplatin|mesh-list
64829879|NCT01570582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64829880|NCT01570582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64829881|NCT01570582|Tubulin Modulators|tubulin modulators|mesh-ancestor
64829882|NCT01570582|Antimitotic Agents|antimitotic agents|mesh-ancestor
64829883|NCT01570582|Mitosis Modulators|mitosis modulators|mesh-ancestor
64829884|NCT01570582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829885|NCT01570582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64829886|NCT01570582|Antimetabolites|antimetabolites|mesh-ancestor
64829887|NCT01570582|Antiviral Agents|antiviral agents|mesh-ancestor
64829888|NCT01570582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64829889|NCT01570582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768707|NCT05822063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64829919|NCT01570790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768708|NCT05822063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64768709|NCT05822063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64829920|NCT01570790|Tubulin Modulators|tubulin modulators|mesh-ancestor
64829921|NCT01570790|Antimitotic Agents|antimitotic agents|mesh-ancestor
64829922|NCT01570790|Mitosis Modulators|mitosis modulators|mesh-ancestor
64829924|NCT01570894|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64829925|NCT01570894|Antidepressive Agents|antidepressive agents|mesh-ancestor
64829926|NCT01570894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64829927|NCT01570894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64829928|NCT01570894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64829929|NCT01570894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64829930|NCT01570894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829931|NCT01570907|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64829932|NCT01570907|Antidepressive Agents|antidepressive agents|mesh-ancestor
64829933|NCT01570907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64829934|NCT01570907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64829935|NCT01570907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64829936|NCT01570907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64829937|NCT01570907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64829938|NCT01570959|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64829974|NCT01571037|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64829975|NCT01571037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64829976|NCT01571037|Vasodilator Agents|vasodilator agents|mesh-ancestor
64829977|NCT01571037|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64829978|NCT01571037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64829979|NCT01571037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64829980|NCT01571037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64829981|NCT01571037|Protective Agents|protective agents|mesh-ancestor
64829982|NCT01571037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598569|NCT00657917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64829983|NCT01571050|Calcium Carbonate|calcium carbonate|mesh-list
64830037|NCT01571414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64830038|NCT01571414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64830039|NCT01571414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64830040|NCT01571414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64830041|NCT01571414|Antitubercular Agents|antitubercular agents|mesh-ancestor
64830042|NCT01571414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64830043|NCT01571414|Leprostatic Agents|leprostatic agents|mesh-ancestor
64830044|NCT01571414|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64830047|NCT01571570|Simeprevir|simeprevir|mesh-list
64830103|NCT01571804|Anticonvulsants|anticonvulsants|mesh-ancestor
64768785|NCT05821478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768786|NCT05821478|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64768800|NCT05821361|Bevacizumab|bevacizumab|mesh-list
64830104|NCT01571804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64830105|NCT01571804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64830106|NCT01571804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830107|NCT01571804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64830108|NCT01571804|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64830109|NCT01571804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64830110|NCT01571804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64830111|NCT01571804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64830112|NCT01571856|Zinc Sulfate|zinc sulfate|mesh-list
64830113|NCT01571856|Astringents|astringents|mesh-ancestor
64830114|NCT01571856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830115|NCT01571856|Dermatologic Agents|dermatologic agents|mesh-ancestor
64830165|NCT01572090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830166|NCT01572116|Lidocaine|lidocaine|mesh-list
64830167|NCT01572116|Epinephrine|epinephrine|mesh-list
64830168|NCT01572116|Racepinephrine|racepinephrine|mesh-list
64830169|NCT01572116|Sufentanil|sufentanil|mesh-list
64830170|NCT01572116|Epinephryl borate|epinephryl borate|mesh-list
64830171|NCT01572116|Anesthetics, Local|anesthetics, local|mesh-ancestor
64830172|NCT01572116|Anesthetics|anesthetics|mesh-ancestor
64830173|NCT01572116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64830233|NCT01572285|Hormones|hormones|mesh-ancestor
64830234|NCT01572285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64830235|NCT01572285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64830236|NCT01572285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64830237|NCT01572285|Protease Inhibitors|protease inhibitors|mesh-ancestor
64830238|NCT01572285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830239|NCT01572285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830298|NCT01572454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64830299|NCT01572454|Narcotics|narcotics|mesh-ancestor
64830300|NCT01572545|Zoledronic Acid|zoledronic acid|mesh-list
64830301|NCT01572545|Denosumab|denosumab|mesh-list
64830302|NCT01572545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64830303|NCT01572545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830368|NCT01572805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830369|NCT01572805|Protective Agents|protective agents|mesh-ancestor
64830370|NCT01572805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830371|NCT01572805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64830372|NCT01572831|Tin Fluorides|tin fluorides|mesh-list
64830373|NCT01572831|Cariostatic Agents|cariostatic agents|mesh-ancestor
64830374|NCT01572831|Protective Agents|protective agents|mesh-ancestor
64830375|NCT01572831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830376|NCT01572857|Immunoglobulins|immunoglobulins|mesh-list
64830377|NCT01572857|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64830378|NCT01572857|Antibodies|antibodies|mesh-list
64830379|NCT01572857|Immunologic Factors|immunologic factors|mesh-ancestor
64830380|NCT01572857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830381|NCT01572961|Aspirin|aspirin|mesh-list
64830382|NCT01572961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64830383|NCT01572961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64830384|NCT01572961|Analgesics|analgesics|mesh-ancestor
64830385|NCT01572961|Sensory System Agents|sensory system agents|mesh-ancestor
64830386|NCT01572961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64830387|NCT01572961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830388|NCT01572961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64830389|NCT01572961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64830390|NCT01572961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64830397|NCT01573013|Iron|iron|mesh-list
64830419|NCT01573338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64830420|NCT01573338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64830421|NCT01573338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64830422|NCT01573338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830423|NCT01573338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830425|NCT01573377|Cyproterone Acetate|cyproterone acetate|mesh-list
64830426|NCT01573377|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64830427|NCT01573377|Cyproterone|cyproterone|mesh-list
64830428|NCT01573377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64830429|NCT01573377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830430|NCT01573377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64830431|NCT01573377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64830432|NCT01573377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64830433|NCT01573377|Contraceptive Agents|contraceptive agents|mesh-ancestor
64830434|NCT01573377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64830475|NCT01573715|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64830476|NCT01573715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64830477|NCT01573715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64830547|NCT01574313|Niacin|niacin|mesh-list
64830548|NCT01574313|Diphenidol|diphenidol|mesh-list
64830549|NCT01574313|Antioxidants|antioxidants|mesh-ancestor
64830550|NCT01574313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830551|NCT01574313|Protective Agents|protective agents|mesh-ancestor
64830552|NCT01574313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830553|NCT01574313|Vitamins|vitamins|mesh-ancestor
64830554|NCT01574313|Micronutrients|micronutrients|mesh-ancestor
64830555|NCT01574313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64830556|NCT01574313|Antimetabolites|antimetabolites|mesh-ancestor
64830557|NCT01574313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64830558|NCT01574313|Vasodilator Agents|vasodilator agents|mesh-ancestor
64830559|NCT01574313|Vitamin B Complex|vitamin b complex|mesh-ancestor
64830560|NCT01574313|Antiemetics|antiemetics|mesh-ancestor
64830561|NCT01574313|Autonomic Agents|autonomic agents|mesh-ancestor
64830562|NCT01574313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64830563|NCT01574313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64830564|NCT01574508|Insulin|insulin|mesh-list
64830565|NCT01574508|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64830606|NCT01575405|Glycerol|glycerol|mesh-list
64830607|NCT01575405|Antiviral Agents|antiviral agents|mesh-ancestor
64830608|NCT01575405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64830609|NCT01575405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64830610|NCT01575405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64830611|NCT01575405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830612|NCT01575405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830613|NCT01575405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64830614|NCT01575405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64830615|NCT01575405|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64830616|NCT01575405|Protective Agents|protective agents|mesh-ancestor
64830617|NCT01575405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830618|NCT01575418|Tenofovir|tenofovir|mesh-list
64830619|NCT01575418|Glycerol|glycerol|mesh-list
64830620|NCT01575418|Antiviral Agents|antiviral agents|mesh-ancestor
64830621|NCT01575418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64830622|NCT01575418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64768865|NCT05821088|Growth Substances|growth substances|mesh-ancestor
64830623|NCT01575418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64830624|NCT01575418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830625|NCT01575418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830626|NCT01575418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64830627|NCT01575418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64830628|NCT01575418|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64830629|NCT01575418|Protective Agents|protective agents|mesh-ancestor
64830630|NCT01575418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830631|NCT01575483|Saxagliptin|saxagliptin|mesh-list
64830632|NCT01575483|Incretins|incretins|mesh-ancestor
64830654|NCT01575626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64830655|NCT01575626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830656|NCT01575639|Prednisolone|prednisolone|mesh-list
64830657|NCT01575639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64830658|NCT01575639|Glucocorticoids|glucocorticoids|mesh-ancestor
64599242|NCT01973205|Aspirin|aspirin|mesh-list
64830659|NCT01575639|Hormones|hormones|mesh-ancestor
64830660|NCT01575639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64830661|NCT01575639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830662|NCT01575639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64830663|NCT01575639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64830664|NCT01575652|Lisinopril|lisinopril|mesh-list
64830665|NCT01575652|Perindopril|perindopril|mesh-list
64830666|NCT01575652|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64830667|NCT01575652|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64830668|NCT01575652|Protease Inhibitors|protease inhibitors|mesh-ancestor
64830669|NCT01575652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830670|NCT01575652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64830671|NCT01575652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64830672|NCT01575652|Protective Agents|protective agents|mesh-ancestor
64830673|NCT01575652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830674|NCT01575678|Melatonin|melatonin|mesh-list
64830675|NCT01575678|Antioxidants|antioxidants|mesh-ancestor
64830677|NCT01575678|Protective Agents|protective agents|mesh-ancestor
64830704|NCT01576029|Docetaxel|docetaxel|mesh-list
64830705|NCT01576029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64830706|NCT01576029|Tubulin Modulators|tubulin modulators|mesh-ancestor
64830707|NCT01576029|Antimitotic Agents|antimitotic agents|mesh-ancestor
64830708|NCT01576029|Mitosis Modulators|mitosis modulators|mesh-ancestor
64830709|NCT01576029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830710|NCT01576094|Simendan|simendan|mesh-list
64830711|NCT01576094|Milrinone|milrinone|mesh-list
64830712|NCT01576094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64830713|NCT01576094|Vasodilator Agents|vasodilator agents|mesh-ancestor
64830714|NCT01576094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64830715|NCT01576094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64830716|NCT01576094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830721|NCT01576185|Sorafenib|sorafenib|mesh-list
64830763|NCT01576458|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64830764|NCT01576458|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64830765|NCT01576458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64830766|NCT01576627|Zinc|zinc|mesh-list
64388611|NCT02345993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64388613|NCT02345993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64388614|NCT02345993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830770|NCT01576627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830771|NCT01576627|Dermatologic Agents|dermatologic agents|mesh-ancestor
64830772|NCT01576627|Sunscreening Agents|sunscreening agents|mesh-ancestor
64830773|NCT01576627|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64830774|NCT01576627|Protective Agents|protective agents|mesh-ancestor
64830775|NCT01576640|Bupropion|bupropion|mesh-list
64830776|NCT01576640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64830777|NCT01576640|Antidepressive Agents|antidepressive agents|mesh-ancestor
64768876|NCT05821075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64830778|NCT01576640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64830779|NCT01576640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64830822|NCT01576731|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64830824|NCT01576770|Tetracaine|tetracaine|mesh-list
64830825|NCT01576770|Ethyl Chloride|ethyl chloride|mesh-list
64830826|NCT01576770|Anesthetics, Local|anesthetics, local|mesh-ancestor
64830827|NCT01576770|Anesthetics|anesthetics|mesh-ancestor
64830828|NCT01576770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64830829|NCT01576770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830891|NCT01577342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64830892|NCT01577342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830893|NCT01577342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830894|NCT01577342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64830895|NCT01577368|Tazobactam|tazobactam|mesh-list
64830896|NCT01577368|Piperacillin|piperacillin|mesh-list
64830897|NCT01577368|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64830898|NCT01577368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64830899|NCT01577368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64830900|NCT01577368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64830901|NCT01577368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830902|NCT01577368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830903|NCT01577407|Nefopam|nefopam|mesh-list
64830904|NCT01577407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64830905|NCT01577407|Analgesics|analgesics|mesh-ancestor
64830906|NCT01577407|Sensory System Agents|sensory system agents|mesh-ancestor
64830907|NCT01577407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64830908|NCT01577407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830909|NCT01577459|Tedizolid|tedizolid|mesh-list
64830910|NCT01577459|Tedizolid phosphate|tedizolid phosphate|mesh-list
64830911|NCT01577459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64830945|NCT01577862|Colistin|colistin|mesh-list
64830946|NCT01577862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64830947|NCT01577862|Antitubercular Agents|antitubercular agents|mesh-ancestor
64830948|NCT01577862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64830949|NCT01577862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64830950|NCT01577862|Leprostatic Agents|leprostatic agents|mesh-ancestor
64830951|NCT01577862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64830952|NCT01577862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64830953|NCT01577862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830954|NCT01577862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64830955|NCT01577862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64830956|NCT01577862|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64830957|NCT01577862|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64830958|NCT01577862|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64830959|NCT01577862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64830960|NCT01577914|Carvedilol|carvedilol|mesh-list
64830961|NCT01577914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64830962|NCT01577914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64830963|NCT01577914|Adrenergic Agents|adrenergic agents|mesh-ancestor
64830964|NCT01577914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64830965|NCT01577914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64830966|NCT01577914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830967|NCT01577914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64830968|NCT01577914|Antioxidants|antioxidants|mesh-ancestor
64830969|NCT01577914|Protective Agents|protective agents|mesh-ancestor
64830970|NCT01577914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64830971|NCT01577914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64830989|NCT01577992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830991|NCT01578057|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64830992|NCT01578057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64830993|NCT01578057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64830994|NCT01578057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64830995|NCT01578070|Salicylic Acid|salicylic acid|mesh-list
64830996|NCT01578070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64830997|NCT01578070|Antifungal Agents|antifungal agents|mesh-ancestor
64830998|NCT01578070|Keratolytic Agents|keratolytic agents|mesh-ancestor
64830999|NCT01578070|Dermatologic Agents|dermatologic agents|mesh-ancestor
64831000|NCT01578109|Sorafenib|sorafenib|mesh-list
64831051|NCT01578252|Antipruritics|antipruritics|mesh-ancestor
64831052|NCT01578252|Dermatologic Agents|dermatologic agents|mesh-ancestor
64831053|NCT01578252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64831054|NCT01578252|Serotonin Agents|serotonin agents|mesh-ancestor
64831055|NCT01578252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64831057|NCT01578252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64831123|NCT01578434|Calcium|calcium|mesh-list
64831124|NCT01578434|Micronutrients|micronutrients|mesh-ancestor
64831125|NCT01578434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831126|NCT01578434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64831127|NCT01578434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64831128|NCT01578434|Antacids|antacids|mesh-ancestor
64831129|NCT01578434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831130|NCT01578434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64831131|NCT01578447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64831132|NCT01578447|Medroxyprogesterone|medroxyprogesterone|mesh-list
64831133|NCT01578447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64831134|NCT01578447|Contraceptive Agents|contraceptive agents|mesh-ancestor
64831135|NCT01578447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64831136|NCT01578447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831137|NCT01578447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64831138|NCT01578447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64388624|NCT02345993|Glucocorticoids|glucocorticoids|mesh-ancestor
64388626|NCT02345993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64831183|NCT01578629|Tocotrienols|tocotrienols|mesh-list
64831184|NCT01578629|Vitamins|vitamins|mesh-ancestor
64831185|NCT01578629|Micronutrients|micronutrients|mesh-ancestor
64831186|NCT01578629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831187|NCT01578629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64831188|NCT01578629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64831189|NCT01578629|Analgesics|analgesics|mesh-ancestor
64831190|NCT01578629|Sensory System Agents|sensory system agents|mesh-ancestor
64831191|NCT01578629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64831192|NCT01578629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64831193|NCT01578629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64831194|NCT01578629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64831195|NCT01578629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64831196|NCT01578629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831197|NCT01578629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64831238|NCT01579019|Ritonavir|ritonavir|mesh-list
64831239|NCT01579019|Ribavirin|ribavirin|mesh-list
64831240|NCT01579019|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64831241|NCT01579019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64831242|NCT01579019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64831243|NCT01579019|Protease Inhibitors|protease inhibitors|mesh-ancestor
64831244|NCT01579019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831245|NCT01579019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831246|NCT01579019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64831247|NCT01579019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64831248|NCT01579019|Antiviral Agents|antiviral agents|mesh-ancestor
64831249|NCT01579019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64831250|NCT01579019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64831251|NCT01579019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64831252|NCT01579019|Antimetabolites|antimetabolites|mesh-ancestor
64831253|NCT01579058|Bisoprolol|bisoprolol|mesh-list
64831300|NCT01579227|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64431715|NCT02058147|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64431716|NCT02058147|Metformin|metformin|mesh-list
64431717|NCT02058147|Insulin Glargine|insulin glargine|mesh-list
64831301|NCT01579227|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64831302|NCT01579227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64831303|NCT01579227|Antioxidants|antioxidants|mesh-ancestor
64831304|NCT01579227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831305|NCT01579227|Protective Agents|protective agents|mesh-ancestor
64831307|NCT01579227|Micronutrients|micronutrients|mesh-ancestor
64831308|NCT01579279|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64831309|NCT01579279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64831310|NCT01579279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64388633|NCT02345681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388634|NCT02340611|Olaparib|olaparib|mesh-list
64831311|NCT01579279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64831312|NCT01579279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831360|NCT01579539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64831362|NCT01579539|Autonomic Agents|autonomic agents|mesh-ancestor
64831363|NCT01579539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64831364|NCT01579539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831365|NCT01579539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64831366|NCT01579539|Glucocorticoids|glucocorticoids|mesh-ancestor
64831367|NCT01579539|Hormones|hormones|mesh-ancestor
64831368|NCT01579539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64831369|NCT01579539|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64831370|NCT01579539|Protective Agents|protective agents|mesh-ancestor
64831371|NCT01579539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64831372|NCT01579539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831373|NCT01579539|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64831374|NCT01579539|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64831375|NCT01579539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831416|NCT01579838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831417|NCT01579864|Rocuronium|rocuronium|mesh-list
64831418|NCT01579864|Succinylcholine|succinylcholine|mesh-list
64831419|NCT01579864|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64831420|NCT01579864|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64831421|NCT01579864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64831422|NCT01579864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64831423|NCT01579864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831424|NCT01579864|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
64831425|NCT01579890|Diclofenac|diclofenac|mesh-list
64831428|NCT01579890|Analgesics|analgesics|mesh-ancestor
64831478|NCT01582321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831479|NCT01582438|Sildenafil Citrate|sildenafil citrate|mesh-list
64831481|NCT01582438|Sodium Citrate|sodium citrate|mesh-list
64831482|NCT01582438|Anticoagulants|anticoagulants|mesh-ancestor
64831483|NCT01582438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64831484|NCT01582438|Chelating Agents|chelating agents|mesh-ancestor
64831485|NCT01582438|Sequestering Agents|sequestering agents|mesh-ancestor
64831486|NCT01582438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831487|NCT01582438|Vasodilator Agents|vasodilator agents|mesh-ancestor
64831488|NCT01582438|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64831489|NCT01582438|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64831490|NCT01582438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64831491|NCT01582438|Urological Agents|urological agents|mesh-ancestor
64831493|NCT01582711|Rifapentine|rifapentine|mesh-list
64831494|NCT01582711|Antitubercular Agents|antitubercular agents|mesh-ancestor
64831495|NCT01582711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64768926|NCT05820763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64768927|NCT05820763|Glucocorticoids|glucocorticoids|mesh-ancestor
64768928|NCT05820763|Hormones|hormones|mesh-ancestor
64768930|NCT05820763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64831496|NCT01582711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64831497|NCT01582711|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64831498|NCT01582711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64831499|NCT01582711|Antimetabolites|antimetabolites|mesh-ancestor
64831500|NCT01582711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831501|NCT01582711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64831502|NCT01582711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64831503|NCT01582711|Leprostatic Agents|leprostatic agents|mesh-ancestor
64831504|NCT01583062|Amoxicillin|amoxicillin|mesh-list
64831528|NCT01583972|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64831530|NCT01584362|Oxfendazole|oxfendazole|mesh-list
64831531|NCT01584362|Anthelmintics|anthelmintics|mesh-ancestor
64831532|NCT01584362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64831533|NCT01584362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64831535|NCT01584921|Epoetin Alfa|epoetin alfa|mesh-list
64831600|NCT01588171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64831601|NCT01588171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831602|NCT01588873|Desogestrel|desogestrel|mesh-list
64831603|NCT01588873|NuvaRing|nuvaring|mesh-list
64831604|NCT01588873|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64831605|NCT01588873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64831606|NCT01588873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64831607|NCT01588873|Contraceptive Agents|contraceptive agents|mesh-ancestor
64831608|NCT01588873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64831609|NCT01588873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831610|NCT01588873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64831611|NCT01588873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64831612|NCT01588873|Progestins|progestins|mesh-ancestor
64831613|NCT01588873|Hormones|hormones|mesh-ancestor
64831614|NCT01588873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64831615|NCT01589367|Metformin|metformin|mesh-list
64831616|NCT01589367|Letrozole|letrozole|mesh-list
64831617|NCT01589367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64831618|NCT01589367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831619|NCT01589367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831620|NCT01589367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64831653|NCT01589861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831654|NCT01590173|Prednisolone|prednisolone|mesh-list
64831655|NCT01590173|Heparin|heparin|mesh-list
64831656|NCT01590173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64831657|NCT01590173|Glucocorticoids|glucocorticoids|mesh-ancestor
64831658|NCT01590173|Hormones|hormones|mesh-ancestor
64831659|NCT01590173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64831660|NCT01590173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831661|NCT01590173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64831662|NCT01590173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64831663|NCT01590173|Anticoagulants|anticoagulants|mesh-ancestor
64831664|NCT01590173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64831665|NCT01590173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64831666|NCT01590173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831667|NCT01590199|Everolimus|everolimus|mesh-list
64388636|NCT02340611|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64388637|NCT02340611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388638|NCT02340611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388639|NCT02340611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388640|NCT02340611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64388641|NCT03145649|Insulin|insulin|mesh-list
64388642|NCT03145649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64388643|NCT03145649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388644|NCT02345213|Donepezil|donepezil|mesh-list
64388645|NCT02345213|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64388646|NCT02345213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388647|NCT02345213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388648|NCT02345213|Cholinergic Agents|cholinergic agents|mesh-ancestor
64831670|NCT01590199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64831671|NCT01590199|Immunologic Factors|immunologic factors|mesh-ancestor
64831672|NCT01590199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831673|NCT01590199|Hormones|hormones|mesh-ancestor
64831674|NCT01590199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64831675|NCT01590225|Ribavirin|ribavirin|mesh-list
64831702|NCT01590537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64831703|NCT01590537|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64831704|NCT01590537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64831705|NCT01590537|Trace Elements|trace elements|mesh-ancestor
64831706|NCT01590537|Micronutrients|micronutrients|mesh-ancestor
64831707|NCT01590641|Vesatolimod|vesatolimod|mesh-list
64831708|NCT01590641|Antiviral Agents|antiviral agents|mesh-ancestor
64831709|NCT01590641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64831710|NCT01590654|Vesatolimod|vesatolimod|mesh-list
64831711|NCT01590654|Antiviral Agents|antiviral agents|mesh-ancestor
64831712|NCT01590654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64831713|NCT01590693|Botulinum Toxins|botulinum toxins|mesh-list
64831714|NCT01590693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64831715|NCT01590693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64831716|NCT01590693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64831765|NCT01590849|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64831766|NCT01590901|Probucol|probucol|mesh-list
64831767|NCT01590901|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64831768|NCT01590901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64831769|NCT01590901|Antimetabolites|antimetabolites|mesh-ancestor
64831770|NCT01590901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64831771|NCT01590901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64831772|NCT01590901|Antioxidants|antioxidants|mesh-ancestor
64388649|NCT02345213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64388650|NCT02345213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388652|NCT02339753|Carboplatin|carboplatin|mesh-list
64388653|NCT02339753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388654|NCT02339441|Mycophenolic Acid|mycophenolic acid|mesh-list
64388655|NCT02339441|Cyclophosphamide|cyclophosphamide|mesh-list
64388656|NCT02339441|Methotrexate|methotrexate|mesh-list
64388657|NCT02339441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64388658|NCT02339441|Immunologic Factors|immunologic factors|mesh-ancestor
64388659|NCT02339441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388660|NCT02339441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64388661|NCT02339441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64388662|NCT02339441|Alkylating Agents|alkylating agents|mesh-ancestor
64831773|NCT01590901|Protective Agents|protective agents|mesh-ancestor
64831774|NCT01590901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831775|NCT01590966|Certolizumab Pegol|certolizumab pegol|mesh-list
64831829|NCT01591135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64831830|NCT01591135|Immunologic Factors|immunologic factors|mesh-ancestor
64831831|NCT01591135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831832|NCT01591148|Propofol|propofol|mesh-list
64831833|NCT01591148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64831834|NCT01591148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64831835|NCT01591148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831836|NCT01591148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64831837|NCT01591148|Anesthetics, General|anesthetics, general|mesh-ancestor
64831838|NCT01591148|Anesthetics|anesthetics|mesh-ancestor
64831839|NCT01591226|Mannitol|mannitol|mesh-list
64831840|NCT01591226|Caffeine|caffeine|mesh-list
64831841|NCT01591226|Citric Acid|citric acid|mesh-list
64831842|NCT01591226|Sodium Citrate|sodium citrate|mesh-list
64831892|NCT01591850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64831893|NCT01591850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64768959|NCT05817903|Axitinib|axitinib|mesh-list
64831894|NCT01591850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64831895|NCT01591850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64831896|NCT01591850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64831897|NCT01591850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64831898|NCT01591850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64831899|NCT01591850|Antifungal Agents|antifungal agents|mesh-ancestor
64831900|NCT01591850|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64831901|NCT01591850|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64831902|NCT01591850|Hormone Antagonists|hormone antagonists|mesh-ancestor
64831903|NCT01591850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64831904|NCT01591850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64831905|NCT01591889|Tinidazole|tinidazole|mesh-list
64831906|NCT01591889|Alkylating Agents|alkylating agents|mesh-ancestor
64831949|NCT01592032|Anti-Infective Agents|anti-infective agents|mesh-list
64831950|NCT01592032|Heparin|heparin|mesh-list
64831951|NCT01592032|Calcium heparin|calcium heparin|mesh-list
64831959|NCT01592136|Ponatinib|ponatinib|mesh-list
64832021|NCT01592253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64832022|NCT01592253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64832023|NCT01592253|Antifungal Agents|antifungal agents|mesh-ancestor
64832024|NCT01592253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64832025|NCT01592253|Immunologic Factors|immunologic factors|mesh-ancestor
64832026|NCT01592253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832027|NCT01592279|Liraglutide|liraglutide|mesh-list
64388663|NCT02339441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388664|NCT02339441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388665|NCT02339441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64832029|NCT01592279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832088|NCT01592981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64832089|NCT01592981|Alkylating Agents|alkylating agents|mesh-ancestor
64832091|NCT01592981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64832161|NCT01593293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64832162|NCT01593293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832163|NCT01593293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832164|NCT01593293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64832165|NCT01593293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64832167|NCT01593306|Cisplatin|cisplatin|mesh-list
64832168|NCT01593306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64832169|NCT01593306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64832170|NCT01593306|Tubulin Modulators|tubulin modulators|mesh-ancestor
64832171|NCT01593306|Antimitotic Agents|antimitotic agents|mesh-ancestor
64832172|NCT01593306|Mitosis Modulators|mitosis modulators|mesh-ancestor
64832173|NCT01593306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832174|NCT01593319|Ropivacaine|ropivacaine|mesh-list
64832175|NCT01593319|Anesthetics, Local|anesthetics, local|mesh-ancestor
64832176|NCT01593319|Anesthetics|anesthetics|mesh-ancestor
64832177|NCT01593319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64832178|NCT01593319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832179|NCT01593319|Sensory System Agents|sensory system agents|mesh-ancestor
64832180|NCT01593319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64388667|NCT02339441|Abortifacient Agents|abortifacient agents|mesh-ancestor
64388668|NCT02339441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64388669|NCT02339441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64388670|NCT02339441|Antimetabolites|antimetabolites|mesh-ancestor
64388671|NCT02339441|Dermatologic Agents|dermatologic agents|mesh-ancestor
64388672|NCT02339441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388673|NCT02339441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64388674|NCT02339441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64388675|NCT02339441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64832216|NCT01593410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64832217|NCT01593410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64832219|NCT01593410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64832220|NCT01593410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64832221|NCT01593410|Growth Substances|growth substances|mesh-ancestor
64832222|NCT01593410|Growth Inhibitors|growth inhibitors|mesh-ancestor
64832223|NCT01593501|Vitamin D|vitamin d|mesh-list
64832224|NCT01593501|Cholecalciferol|cholecalciferol|mesh-list
64832225|NCT01593501|Vitamins|vitamins|mesh-ancestor
64832226|NCT01593501|Micronutrients|micronutrients|mesh-ancestor
64832227|NCT01593501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832228|NCT01593501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64832229|NCT01593501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64832230|NCT01593514|Lactitol|lactitol|mesh-list
64600818|NCT01274039|Acetazolamide|acetazolamide|mesh-list
64832231|NCT01593514|Vaccines|vaccines|mesh-list
64832232|NCT01593514|Immunologic Factors|immunologic factors|mesh-ancestor
64832233|NCT01593514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832234|NCT01593514|Cathartics|cathartics|mesh-ancestor
64832235|NCT01593514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64832236|NCT01593566|Bupivacaine|bupivacaine|mesh-list
64832237|NCT01593566|Anesthetics, Local|anesthetics, local|mesh-ancestor
64388681|NCT02344823|Vasodilator Agents|vasodilator agents|mesh-ancestor
64388682|NCT02344823|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64388683|NCT02344823|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64388684|NCT02344823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388685|NCT02344823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388686|NCT02344823|Urological Agents|urological agents|mesh-ancestor
64388687|NCT03145961|Pembrolizumab|pembrolizumab|mesh-list
64388688|NCT03145961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64388689|NCT03145961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388690|NCT02339207|Adafosbuvir|adafosbuvir|mesh-list
64832261|NCT01593644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64832262|NCT01593644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832263|NCT01593644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64832264|NCT01593644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832265|NCT01593644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64832266|NCT01593774|Melatonin|melatonin|mesh-list
64832267|NCT01593774|Antioxidants|antioxidants|mesh-ancestor
64832268|NCT01593774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832269|NCT01593774|Protective Agents|protective agents|mesh-ancestor
64832270|NCT01593774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832271|NCT01593774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64832272|NCT01593826|Budesonide|budesonide|mesh-list
64832273|NCT01593826|Formoterol Fumarate|formoterol fumarate|mesh-list
64832274|NCT01593826|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64832275|NCT01593826|Charcoal|charcoal|mesh-list
64832276|NCT01593826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64388698|NCT02344511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64388699|NCT02344511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64388701|NCT02344589|Anesthetics, Local|anesthetics, local|mesh-ancestor
64388702|NCT02344589|Anesthetics|anesthetics|mesh-ancestor
64388703|NCT02344589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64388704|NCT02344589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388705|NCT02344589|Sensory System Agents|sensory system agents|mesh-ancestor
64388706|NCT02344589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64388707|NCT02344589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64832280|NCT01593826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832281|NCT01593826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64832282|NCT01593826|Respiratory System Agents|respiratory system agents|mesh-ancestor
64832283|NCT01593826|Glucocorticoids|glucocorticoids|mesh-ancestor
64832284|NCT01593826|Hormones|hormones|mesh-ancestor
64832285|NCT01593826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64600886|NCT00762853|Antimetabolites|antimetabolites|mesh-ancestor
64832308|NCT01593995|Mitosis Modulators|mitosis modulators|mesh-ancestor
64832309|NCT01593995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832311|NCT01594047|Methadone|methadone|mesh-list
64832312|NCT01594047|Analgesics|analgesics|mesh-ancestor
64832313|NCT01594047|Sensory System Agents|sensory system agents|mesh-ancestor
64832314|NCT01594047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832315|NCT01594047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388722|NCT02337881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64388723|NCT02337881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388724|NCT02337881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388725|NCT02337881|Urological Agents|urological agents|mesh-ancestor
64388726|NCT02337257|Vitamin D|vitamin d|mesh-list
64388727|NCT02337257|Cholecalciferol|cholecalciferol|mesh-list
64388728|NCT02337257|Vitamins|vitamins|mesh-ancestor
64388729|NCT02337257|Micronutrients|micronutrients|mesh-ancestor
64768984|NCT05816746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388730|NCT02337257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388731|NCT02337257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64388732|NCT02337257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64388733|NCT02337413|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64388734|NCT02337413|Laxatives|laxatives|mesh-ancestor
64388735|NCT02337413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64388736|NCT04850495|Prednisone|prednisone|mesh-list
64388737|NCT04850495|Cortisone|cortisone|mesh-list
64388738|NCT04850495|Cyclophosphamide|cyclophosphamide|mesh-list
64388739|NCT04850495|Rituximab|rituximab|mesh-list
64388740|NCT04850495|Doxorubicin|doxorubicin|mesh-list
64388741|NCT04850495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64388742|NCT04850495|Vincristine|vincristine|mesh-list
64388743|NCT04850495|Zanubrutinib|zanubrutinib|mesh-list
64388744|NCT04850495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64388745|NCT04850495|Antibodies|antibodies|mesh-list
64388746|NCT04850495|Immunoglobulins|immunoglobulins|mesh-list
64388747|NCT04850495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64388748|NCT04850495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64388749|NCT04850495|Immunologic Factors|immunologic factors|mesh-ancestor
64832316|NCT01594047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64832317|NCT01594047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64832318|NCT01594047|Anesthetics, General|anesthetics, general|mesh-ancestor
64832319|NCT01594047|Anesthetics|anesthetics|mesh-ancestor
64832320|NCT01594047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64832321|NCT01594047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64832322|NCT01594047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64832323|NCT01594047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64832324|NCT01594047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832325|NCT01594047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64832326|NCT01594047|Narcotics|narcotics|mesh-ancestor
64832327|NCT01594047|Antitussive Agents|antitussive agents|mesh-ancestor
64832361|NCT01594177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64832362|NCT01594177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64832363|NCT01594177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64832364|NCT01594177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64832365|NCT01594177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832366|NCT01594177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64832367|NCT01594229|Rituximab|rituximab|mesh-list
64832368|NCT01594229|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64832369|NCT01594229|Venetoclax|venetoclax|mesh-list
64832370|NCT01594229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64832371|NCT01594229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64832372|NCT01594229|Immunologic Factors|immunologic factors|mesh-ancestor
64832373|NCT01594229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832374|NCT01594229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64832375|NCT01594229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64832376|NCT01594229|Alkylating Agents|alkylating agents|mesh-ancestor
64832377|NCT01594229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832378|NCT01594242|Bortezomib|bortezomib|mesh-list
64832379|NCT01594242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64832380|NCT01594255|Moxifloxacin|moxifloxacin|mesh-list
64832381|NCT01594255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64832382|NCT01594255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64832383|NCT01594255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64832384|NCT01594255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64832385|NCT01594255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768986|NCT05814991|Vasodilator Agents|vasodilator agents|mesh-ancestor
64768987|NCT05809180|Rituximab|rituximab|mesh-list
64768988|NCT05809180|Pomalidomide|pomalidomide|mesh-list
64768989|NCT05809180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64768990|NCT05809180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64832386|NCT01594255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832387|NCT01594255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64832388|NCT01594268|Everolimus|everolimus|mesh-list
64832389|NCT01594268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64832390|NCT01594268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64832391|NCT01594268|Immunologic Factors|immunologic factors|mesh-ancestor
64832392|NCT01594268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832393|NCT01594346|Vitamin E|vitamin e|mesh-list
64832403|NCT01594489|Aminophylline|aminophylline|mesh-list
64832404|NCT01594489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64832405|NCT01594489|Autonomic Agents|autonomic agents|mesh-ancestor
64832406|NCT01594489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832407|NCT01594489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832408|NCT01594489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64832409|NCT01594489|Respiratory System Agents|respiratory system agents|mesh-ancestor
64832410|NCT01594489|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64832411|NCT01594489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64832412|NCT01594489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832413|NCT01594489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388752|NCT04850495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64388754|NCT04850495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388755|NCT04850495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388756|NCT04850495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64388757|NCT04850495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64832414|NCT01594489|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64832416|NCT01594489|Purinergic Agents|purinergic agents|mesh-ancestor
64832417|NCT01594489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64832418|NCT01594489|Protective Agents|protective agents|mesh-ancestor
64832419|NCT01594502|Dutasteride|dutasteride|mesh-list
64832459|NCT01594866|Serotonin Agents|serotonin agents|mesh-ancestor
64832460|NCT01594866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832461|NCT01594866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64832462|NCT01594866|Antidepressive Agents|antidepressive agents|mesh-ancestor
64832463|NCT01594866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64832464|NCT01594866|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64832465|NCT01594866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64832466|NCT01594866|Parasympatholytics|parasympatholytics|mesh-ancestor
64832467|NCT01594866|Autonomic Agents|autonomic agents|mesh-ancestor
64832468|NCT01594866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832469|NCT01594866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64832470|NCT01594866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64832471|NCT01594866|Cholinergic Agents|cholinergic agents|mesh-ancestor
64832472|NCT01594879|Levonorgestrel|levonorgestrel|mesh-list
64832521|NCT01595152|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64832522|NCT01595152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64832523|NCT01595152|Cholinergic Agents|cholinergic agents|mesh-ancestor
64832524|NCT01595152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64832525|NCT01595152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832526|NCT01595152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832527|NCT01595152|Urological Agents|urological agents|mesh-ancestor
64832528|NCT01595334|Cetrorelix|cetrorelix|mesh-list
64832529|NCT01595334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64832530|NCT01595334|Fertility Agents|fertility agents|mesh-ancestor
64832531|NCT01595334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64832532|NCT01595334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832533|NCT01595334|Hormone Antagonists|hormone antagonists|mesh-ancestor
64832534|NCT01595334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64832536|NCT01595399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64768996|NCT05809180|Growth Substances|growth substances|mesh-ancestor
64832537|NCT01595399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64832538|NCT01595399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64832539|NCT01595399|Autonomic Agents|autonomic agents|mesh-ancestor
64832540|NCT01595399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832541|NCT01595399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832542|NCT01595399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64832572|NCT01595633|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64832573|NCT01595685|Entecavir|entecavir|mesh-list
64832574|NCT01595685|Telbivudine|telbivudine|mesh-list
64832575|NCT01595685|Antiviral Agents|antiviral agents|mesh-ancestor
64832576|NCT01595685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64832577|NCT01595685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64832578|NCT01595685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832579|NCT01595685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832580|NCT01595724|Dienogest|dienogest|mesh-list
64832581|NCT01595724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64832582|NCT01595724|Contraceptive Agents|contraceptive agents|mesh-ancestor
64832583|NCT01595724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64832584|NCT01595724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832593|NCT01595737|Simendan|simendan|mesh-list
64388758|NCT04850495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64388759|NCT04850495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64388760|NCT04850495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388761|NCT04850495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64388762|NCT04850495|Glucocorticoids|glucocorticoids|mesh-ancestor
64388763|NCT04850495|Hormones|hormones|mesh-ancestor
64388764|NCT04850495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64388765|NCT04850495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64832633|NCT01595867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64832634|NCT01595867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832635|NCT01595867|Analgesics|analgesics|mesh-ancestor
64832636|NCT01595867|Sensory System Agents|sensory system agents|mesh-ancestor
64832640|NCT01595880|Metformin|metformin|mesh-list
64832706|NCT01596140|Immunologic Factors|immunologic factors|mesh-ancestor
64832707|NCT01596140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832708|NCT01596140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832778|NCT01596426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64832779|NCT01596426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832780|NCT01596517|Ribavirin|ribavirin|mesh-list
64832781|NCT01596517|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64832782|NCT01596517|Interferon-alpha|interferon-alpha|mesh-list
64832783|NCT01596517|Antimetabolites|antimetabolites|mesh-ancestor
64832784|NCT01596517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832785|NCT01596517|Antiviral Agents|antiviral agents|mesh-ancestor
64832786|NCT01596517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64832787|NCT01596517|Immunologic Factors|immunologic factors|mesh-ancestor
64832788|NCT01596517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832789|NCT01596556|Nicotine|nicotine|mesh-list
64832790|NCT01596556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64832841|NCT01596660|Sensory System Agents|sensory system agents|mesh-ancestor
64832842|NCT01596660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832843|NCT01596673|Hydrocodone|hydrocodone|mesh-list
64832844|NCT01596673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64832845|NCT01596673|Narcotics|narcotics|mesh-ancestor
64388940|NCT02442739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64389071|NCT02039531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389072|NCT02039531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64389073|NCT02039531|Immunologic Factors|immunologic factors|mesh-ancestor
64389074|NCT02039531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389075|NCT02039531|Viscosupplements|viscosupplements|mesh-ancestor
64389076|NCT02039531|Protective Agents|protective agents|mesh-ancestor
64389077|NCT02331251|Gemcitabine|gemcitabine|mesh-list
64389078|NCT02331251|Paclitaxel|paclitaxel|mesh-list
64389079|NCT02331251|Vinorelbine|vinorelbine|mesh-list
64389080|NCT02331251|Docetaxel|docetaxel|mesh-list
64389081|NCT02331251|Doxorubicin|doxorubicin|mesh-list
64389082|NCT02331251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64389083|NCT02331251|Pembrolizumab|pembrolizumab|mesh-list
64389179|NCT03187795|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64389180|NCT03187795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64389181|NCT03187795|Cholinergic Agents|cholinergic agents|mesh-ancestor
64832873|NCT01596764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64832875|NCT01596764|Analgesics|analgesics|mesh-ancestor
64832876|NCT01596764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64832877|NCT01596764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64832878|NCT01596777|Sulfasalazine|sulfasalazine|mesh-list
64832879|NCT01596777|Naltrexone|naltrexone|mesh-list
64832880|NCT01596777|Methylnaltrexone|methylnaltrexone|mesh-list
64832881|NCT01596777|Loperamide|loperamide|mesh-list
64832882|NCT01596777|Antidiarrheals|antidiarrheals|mesh-list
64832883|NCT01596777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64832884|NCT01596777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64832885|NCT01596777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64389183|NCT02435563|Ticagrelor|ticagrelor|mesh-list
64832886|NCT01596777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64832888|NCT01596777|Sensory System Agents|sensory system agents|mesh-ancestor
64832889|NCT01596777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832890|NCT01596777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832891|NCT01596777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64832892|NCT01596777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64832893|NCT01596777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64832894|NCT01596777|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64832895|NCT01596803|Ascorbic Acid|ascorbic acid|mesh-list
64832896|NCT01596803|Vitamin E|vitamin e|mesh-list
64832897|NCT01596803|alpha-Tocopherol|alpha-tocopherol|mesh-list
64832898|NCT01596803|Tocopherols|tocopherols|mesh-list
64832899|NCT01596803|Antioxidants|antioxidants|mesh-list
64832900|NCT01596803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832901|NCT01596803|Protective Agents|protective agents|mesh-ancestor
64832902|NCT01596803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832903|NCT01596803|Vitamins|vitamins|mesh-ancestor
64832904|NCT01596803|Micronutrients|micronutrients|mesh-ancestor
64832905|NCT01596855|Epoetin Alfa|epoetin alfa|mesh-list
64832915|NCT01596868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64601491|NCT00786643|Leucovorin|leucovorin|mesh-list
64832916|NCT01596868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64832917|NCT01596868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64832918|NCT01596868|Immunologic Factors|immunologic factors|mesh-ancestor
64832919|NCT01596868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832920|NCT01596868|Tubulin Modulators|tubulin modulators|mesh-ancestor
64832921|NCT01596868|Antimitotic Agents|antimitotic agents|mesh-ancestor
64832922|NCT01596868|Mitosis Modulators|mitosis modulators|mesh-ancestor
64832923|NCT01596894|Azithromycin|azithromycin|mesh-list
64832924|NCT01596894|Metronidazole|metronidazole|mesh-list
64832925|NCT01596894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64832926|NCT01596894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64832927|NCT01596894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64832928|NCT01596894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64832929|NCT01596907|Ephedrine|ephedrine|mesh-list
64832930|NCT01596907|Pseudoephedrine|pseudoephedrine|mesh-list
64832931|NCT01596907|Caffeine|caffeine|mesh-list
64832932|NCT01596907|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64832933|NCT01596907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64832934|NCT01596907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64832935|NCT01596907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389383|NCT02328443|Hormone Antagonists|hormone antagonists|mesh-ancestor
64389437|NCT02327663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64324838|NCT03646604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832943|NCT01596907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64832944|NCT01596907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64832945|NCT01596907|Adrenergic Agents|adrenergic agents|mesh-ancestor
64832946|NCT01596907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64832947|NCT01596907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64832948|NCT01596907|Respiratory System Agents|respiratory system agents|mesh-ancestor
64832949|NCT01596907|Nasal Decongestants|nasal decongestants|mesh-ancestor
64832951|NCT01596998|Racepinephrine|racepinephrine|mesh-list
64832952|NCT01596998|Levobupivacaine|levobupivacaine|mesh-list
64832953|NCT01596998|Epinephryl borate|epinephryl borate|mesh-list
64832954|NCT01596998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64832955|NCT01596998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64769010|NCT05796570|Antimetabolites|antimetabolites|mesh-ancestor
64832956|NCT01596998|Adrenergic Agents|adrenergic agents|mesh-ancestor
64832957|NCT01596998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64832958|NCT01596998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64832984|NCT01597167|Anticonvulsants|anticonvulsants|mesh-ancestor
64832985|NCT01597167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64832986|NCT01597167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64832987|NCT01597167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389689|NCT04996199|Oxcarbazepine|oxcarbazepine|mesh-list
64389690|NCT04996199|Anticonvulsants|anticonvulsants|mesh-ancestor
64389691|NCT04996199|Antimanic Agents|antimanic agents|mesh-ancestor
64389692|NCT04996199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64389740|NCT04984733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64389741|NCT04984733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64389772|NCT03185143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64833012|NCT01597310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833013|NCT01597310|Protective Agents|protective agents|mesh-ancestor
64833014|NCT01597310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833015|NCT01597310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64833016|NCT01597310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64833017|NCT01597310|Dopamine Agonists|dopamine agonists|mesh-ancestor
64833018|NCT01597310|Dopamine Agents|dopamine agents|mesh-ancestor
64833019|NCT01597310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64833020|NCT01597336|Plasminogen|plasminogen|mesh-list
64833021|NCT01597336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64833022|NCT01597336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64833023|NCT01597336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64833024|NCT01597336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833025|NCT01597427|Clonidine|clonidine|mesh-list
64833026|NCT01597427|Analgesics|analgesics|mesh-ancestor
64389905|NCT03190681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64389906|NCT03190681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64389907|NCT03190681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64389908|NCT03190681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389909|NCT03190681|Dopamine Agents|dopamine agents|mesh-ancestor
64389910|NCT03190681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64389911|NCT03186001|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64389931|NCT02431975|Lopinavir|lopinavir|mesh-list
64389932|NCT02431975|Lamivudine|lamivudine|mesh-list
64389933|NCT02431975|Zidovudine|zidovudine|mesh-list
64389934|NCT02431975|Nevirapine|nevirapine|mesh-list
64389935|NCT02431975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64389936|NCT02431975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64389937|NCT02431975|Protease Inhibitors|protease inhibitors|mesh-ancestor
64389938|NCT02431975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389947|NCT02431975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64389949|NCT02431975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64389950|NCT02431975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64389951|NCT03143465|Calcitonin|calcitonin|mesh-list
64389952|NCT03143465|Salmon calcitonin|salmon calcitonin|mesh-list
64833029|NCT01597427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833030|NCT01597427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64833031|NCT01597427|Sympatholytics|sympatholytics|mesh-ancestor
64833032|NCT01597427|Autonomic Agents|autonomic agents|mesh-ancestor
64390123|NCT01994590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64390124|NCT01994590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390125|NCT01994590|Hormone Antagonists|hormone antagonists|mesh-ancestor
64390126|NCT01994590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64390127|NCT05387603|Capecitabine|capecitabine|mesh-list
64390137|NCT03182413|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64390138|NCT03182413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64390139|NCT03182413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64390140|NCT03182413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390142|NCT03182257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64390143|NCT03182257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64390144|NCT03182257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390146|NCT03183739|Analgesics|analgesics|mesh-ancestor
64390183|NCT02421289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64390184|NCT02421289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64390185|NCT02421289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64833045|NCT01597518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833046|NCT01597518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64390234|NCT03511391|Nivolumab|nivolumab|mesh-list
64390235|NCT03511391|Atezolizumab|atezolizumab|mesh-list
64390236|NCT03511391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64390237|NCT03511391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64390239|NCT03511391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390240|NCT05081765|Olaparib|olaparib|mesh-list
64390241|NCT05081765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64390242|NCT05081765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64390243|NCT05081765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390244|NCT05081765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324862|NCT03347708|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64324863|NCT03347708|Hyaluronic Acid|hyaluronic acid|mesh-list
64390657|NCT01993186|Protective Agents|protective agents|mesh-ancestor
64390658|NCT01993186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390659|NCT03181243|Anesthetics|anesthetics|mesh-list
64390660|NCT03181243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64833106|NCT01597726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64833107|NCT01597726|Oxytocics|oxytocics|mesh-ancestor
64833108|NCT01597765|Vitamins|vitamins|mesh-list
64833109|NCT01597765|Vitamin E|vitamin e|mesh-list
64833110|NCT01597765|Tocopherols|tocopherols|mesh-list
64833111|NCT01597765|Tocotrienols|tocotrienols|mesh-list
64324866|NCT03347708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390753|NCT01828697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64390754|NCT01828697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390755|NCT02415985|Lopinavir|lopinavir|mesh-list
64390756|NCT02415985|Rifabutin|rifabutin|mesh-list
64390757|NCT02415985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64390758|NCT02415985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64390789|NCT04631393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64390791|NCT03180775|Glycine Agents|glycine agents|mesh-ancestor
64390792|NCT03180775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64390793|NCT03180775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390795|NCT03137927|Vaccines|vaccines|mesh-list
64833139|NCT01597817|Coagulants|coagulants|mesh-ancestor
64390908|NCT02414503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64390909|NCT02414503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833147|NCT01597895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64833148|NCT01597895|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64833149|NCT01597934|Tenofovir|tenofovir|mesh-list
64833150|NCT01597934|Entecavir|entecavir|mesh-list
64833151|NCT01597934|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64833152|NCT01597934|Adefovir|adefovir|mesh-list
64833153|NCT01597934|Lamivudine|lamivudine|mesh-list
64833154|NCT01597934|Telbivudine|telbivudine|mesh-list
64833155|NCT01597934|Antiviral Agents|antiviral agents|mesh-ancestor
64833156|NCT01597934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64833157|NCT01597934|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64833158|NCT01597934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64833159|NCT01597934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833160|NCT01597934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833161|NCT01597934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64324874|NCT01159249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324875|NCT01159249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390976|NCT05085587|Xhance|xhance|mesh-list
64390977|NCT05085587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64390978|NCT05085587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64390979|NCT05085587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64390980|NCT05085587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64390981|NCT05085587|Autonomic Agents|autonomic agents|mesh-ancestor
64390982|NCT05085587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64390983|NCT05085587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390984|NCT05085587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64390985|NCT05085587|Respiratory System Agents|respiratory system agents|mesh-ancestor
64390986|NCT05085587|Dermatologic Agents|dermatologic agents|mesh-ancestor
64390987|NCT05085587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64390988|NCT05085587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64390989|NCT05085587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64390990|NCT05085587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64390991|NCT05085587|Adrenergic Agents|adrenergic agents|mesh-ancestor
64390992|NCT05085587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64391008|NCT05088707|Misoprostol|misoprostol|mesh-list
64391009|NCT05088707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64391010|NCT05088707|Abortifacient Agents|abortifacient agents|mesh-ancestor
64391051|NCT04850651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64324883|NCT01345045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324884|NCT01345045|Anticonvulsants|anticonvulsants|mesh-ancestor
64833177|NCT01597986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64833178|NCT01597986|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64833179|NCT01597986|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64833180|NCT01597986|Antifungal Agents|antifungal agents|mesh-ancestor
64833181|NCT01597986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64833182|NCT01597986|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64833183|NCT01598012|Mefenamic Acid|mefenamic acid|mesh-list
64833184|NCT01598012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64833185|NCT01598012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64833186|NCT01598012|Analgesics|analgesics|mesh-ancestor
64833187|NCT01598012|Sensory System Agents|sensory system agents|mesh-ancestor
64833188|NCT01598012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64833189|NCT01598012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833190|NCT01598012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64833191|NCT01598012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64833192|NCT01598012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64833193|NCT01598012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444373|NCT01586806|Anesthetics|anesthetics|mesh-ancestor
64324885|NCT01345045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64324886|NCT01345045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64324887|NCT01345045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324888|NCT01345045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64324889|NCT01345045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64324890|NCT01345045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64324891|NCT01345045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64324892|NCT01345045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64391142|NCT04643249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64391143|NCT04643249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64391144|NCT02414425|Botulinum Toxins|botulinum toxins|mesh-list
64391145|NCT02414425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64391146|NCT02414425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64391147|NCT02414425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64391148|NCT02414425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64391149|NCT02414425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391150|NCT02414425|Cholinergic Agents|cholinergic agents|mesh-ancestor
64391151|NCT02414425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64391152|NCT02414425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769053|NCT05704036|Estradiol|estradiol|mesh-list
64391153|NCT02414425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64391154|NCT02414425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64391155|NCT03116893|Itraconazole|itraconazole|mesh-list
64391156|NCT03116893|Rifampin|rifampin|mesh-list
64391157|NCT03116893|Antifungal Agents|antifungal agents|mesh-ancestor
64391158|NCT03116893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64833198|NCT01598051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64833199|NCT01598051|Protease Inhibitors|protease inhibitors|mesh-ancestor
64833200|NCT01598051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833201|NCT01598051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833202|NCT01598051|Anticoagulants|anticoagulants|mesh-ancestor
64833203|NCT01598168|Rivaroxaban|rivaroxaban|mesh-list
64833204|NCT01598168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64833205|NCT01598168|Antithrombins|antithrombins|mesh-ancestor
64833206|NCT01598168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64833207|NCT01598168|Protease Inhibitors|protease inhibitors|mesh-ancestor
64833208|NCT01598168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833209|NCT01598168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833210|NCT01598168|Anticoagulants|anticoagulants|mesh-ancestor
64391178|NCT03116893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64391180|NCT05737511|Gabapentin|gabapentin|mesh-list
64391181|NCT05737511|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64391182|NCT05737511|Milnacipran|milnacipran|mesh-list
64391183|NCT05737511|Levetiracetam|levetiracetam|mesh-list
64391184|NCT05737511|Lorazepam|lorazepam|mesh-list
64833227|NCT01598337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64833228|NCT01598337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64833229|NCT01598337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64833230|NCT01598337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64391247|NCT05737511|GABA Agents|gaba agents|mesh-ancestor
64391248|NCT05737511|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64391249|NCT05737511|Histamine Antagonists|histamine antagonists|mesh-ancestor
64833252|NCT01598363|Protective Agents|protective agents|mesh-ancestor
64833253|NCT01598363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833254|NCT01598402|Amoxicillin|amoxicillin|mesh-list
64833255|NCT01598402|Clavulanic Acids|clavulanic acids|mesh-list
64833256|NCT01598402|Clavulanic Acid|clavulanic acid|mesh-list
64833257|NCT01598402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64833258|NCT01598402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64833259|NCT01598402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833260|NCT01598402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833261|NCT01598402|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64833262|NCT01598441|Iloprost|iloprost|mesh-list
64833263|NCT01598441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64833264|NCT01598441|Vasodilator Agents|vasodilator agents|mesh-ancestor
64444440|NCT02143141|Analgesics|analgesics|mesh-ancestor
64391305|NCT05735639|Enoxaparin|enoxaparin|mesh-list
64833291|NCT01598584|Antidepressive Agents|antidepressive agents|mesh-ancestor
64833293|NCT01598584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64833294|NCT01598584|Histamine Antagonists|histamine antagonists|mesh-ancestor
64601813|NCT03800953|Avelumab|avelumab|mesh-list
64833295|NCT01598584|Histamine Agents|histamine agents|mesh-ancestor
64833296|NCT01598584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64833297|NCT01598584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64833298|NCT01598584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64833299|NCT01598584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64833300|NCT01598584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64833301|NCT01598584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64324921|NCT05625919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64391404|NCT02417467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64391405|NCT02417467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391406|NCT02417467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64391407|NCT02417467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64391408|NCT02417467|Cholinergic Agents|cholinergic agents|mesh-ancestor
64391409|NCT02417467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64391411|NCT02417389|Alendronate|alendronate|mesh-list
64833315|NCT01598649|Diuretics|diuretics|mesh-ancestor
64833316|NCT01598649|Natriuretic Agents|natriuretic agents|mesh-ancestor
64833317|NCT01598649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833318|NCT01598649|Chelating Agents|chelating agents|mesh-ancestor
64833319|NCT01598649|Sequestering Agents|sequestering agents|mesh-ancestor
64833320|NCT01598649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833321|NCT01598675|Methamphetamine|methamphetamine|mesh-list
64769063|NCT05696782|Durvalumab|durvalumab|mesh-list
64833322|NCT01598675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64833323|NCT01598675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391458|NCT02417077|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64391459|NCT02417077|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64391460|NCT02417077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64391461|NCT02417077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64391462|NCT02417077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391463|NCT02417077|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64391464|NCT02417077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64391465|NCT02417077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391466|NCT02417077|Cholinergic Agents|cholinergic agents|mesh-ancestor
64391467|NCT02417077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64391468|NCT03179527|Vasodilator Agents|vasodilator agents|mesh-list
64391522|NCT03199157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833340|NCT01598883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64391551|NCT02416999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64391552|NCT02416999|Growth Substances|growth substances|mesh-ancestor
64391553|NCT02416999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391554|NCT02416999|Growth Inhibitors|growth inhibitors|mesh-ancestor
64391555|NCT02416999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64391576|NCT01679405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391577|NCT01679405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64391578|NCT03175705|Interleukin-2|interleukin-2|mesh-list
64391579|NCT03175705|Tegafur|tegafur|mesh-list
64391580|NCT03175705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64391581|NCT03175705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64391582|NCT03175705|Analgesics|analgesics|mesh-ancestor
64391600|NCT03177109|Fluorides|fluorides|mesh-list
64391601|NCT03177109|Fluorides, Topical|fluorides, topical|mesh-list
64391611|NCT02421913|Ketamine|ketamine|mesh-list
64391709|NCT04413227|Docetaxel|docetaxel|mesh-list
64391710|NCT04413227|Endostatins|endostatins|mesh-list
64391711|NCT04413227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64391712|NCT04413227|Tubulin Modulators|tubulin modulators|mesh-ancestor
64391713|NCT04413227|Antimitotic Agents|antimitotic agents|mesh-ancestor
64391714|NCT04413227|Mitosis Modulators|mitosis modulators|mesh-ancestor
64391726|NCT02410135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64391727|NCT02410135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391728|NCT02410135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391729|NCT02410135|Urological Agents|urological agents|mesh-ancestor
64391730|NCT02410759|Carbetocin|carbetocin|mesh-list
64391731|NCT02410759|Ergonovine|ergonovine|mesh-list
64391732|NCT02410759|Oxytocics|oxytocics|mesh-ancestor
64391862|NCT04254731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64391863|NCT04254731|Antitussive Agents|antitussive agents|mesh-ancestor
64391864|NCT04254731|Respiratory System Agents|respiratory system agents|mesh-ancestor
64391866|NCT01603277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64391867|NCT01603277|Immunologic Factors|immunologic factors|mesh-ancestor
64391868|NCT01603277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391869|NCT01678313|Celecoxib|celecoxib|mesh-list
64391870|NCT01678313|Doxazosin|doxazosin|mesh-list
64391920|NCT02449265|Prednisone|prednisone|mesh-list
64324924|NCT05625919|Antifungal Agents|antifungal agents|mesh-ancestor
64324925|NCT05625919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64324926|NCT05625919|Immunologic Factors|immunologic factors|mesh-ancestor
64324927|NCT05625919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324928|NCT02682927|Fenfluramine|fenfluramine|mesh-list
64324929|NCT02682927|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64324930|NCT02682927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64391964|NCT03196817|Glucocorticoids|glucocorticoids|mesh-ancestor
64391965|NCT03196817|Hormones|hormones|mesh-ancestor
64391966|NCT03196817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64391990|NCT03593759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64391991|NCT03593759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64391992|NCT03593759|Immunologic Factors|immunologic factors|mesh-ancestor
64391993|NCT03593759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64391994|NCT03593759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64391995|NCT03564821|Ivosidenib|ivosidenib|mesh-list
64391996|NCT03564821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64391997|NCT03564821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391998|NCT03564821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391999|NCT02014402|Thrombin|thrombin|mesh-list
64392000|NCT02014402|Hemostatics|hemostatics|mesh-ancestor
64392001|NCT02014402|Coagulants|coagulants|mesh-ancestor
64392002|NCT01988662|Ranibizumab|ranibizumab|mesh-list
64324932|NCT02682927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324933|NCT02682927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64324934|NCT02682927|Serotonin Agents|serotonin agents|mesh-ancestor
64324935|NCT02682927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324936|NCT02266537|Doxazosin|doxazosin|mesh-list
64324937|NCT02266537|Tamsulosin|tamsulosin|mesh-list
64324938|NCT02266537|Alfuzosin|alfuzosin|mesh-list
64324939|NCT02266537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64324940|NCT02266537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64392113|NCT04438421|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64392114|NCT04438421|Hyaluronic Acid|hyaluronic acid|mesh-list
64392115|NCT04438421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64392116|NCT04438421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64392117|NCT04438421|Disinfectants|disinfectants|mesh-ancestor
64392118|NCT04438421|Dermatologic Agents|dermatologic agents|mesh-ancestor
64392119|NCT04438421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64392126|NCT05099081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64392127|NCT04438577|Lidocaine|lidocaine|mesh-list
64392128|NCT04438577|Anesthetics, Local|anesthetics, local|mesh-ancestor
64392129|NCT04438577|Anesthetics|anesthetics|mesh-ancestor
64392130|NCT04438577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64392131|NCT04438577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392132|NCT04438577|Sensory System Agents|sensory system agents|mesh-ancestor
64392133|NCT04438577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392134|NCT04438577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64392135|NCT04438577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64392136|NCT04438577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64392137|NCT04438577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64392138|NCT04438577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392140|NCT05087615|Metoclopramide|metoclopramide|mesh-list
64392141|NCT05087615|Granisetron|granisetron|mesh-list
64392142|NCT05087615|Antiemetics|antiemetics|mesh-ancestor
64392143|NCT05087615|Autonomic Agents|autonomic agents|mesh-ancestor
64392144|NCT05087615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392145|NCT05087615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392146|NCT05087615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64392147|NCT05087615|Antipruritics|antipruritics|mesh-ancestor
64392149|NCT05087615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64769116|NCT05665465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64833341|NCT01598883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833342|NCT01598883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64392150|NCT05087615|Serotonin Agents|serotonin agents|mesh-ancestor
64392151|NCT05087615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64392152|NCT05087615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392153|NCT05087615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64392154|NCT05087615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64392155|NCT05087615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64392156|NCT05087615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64392157|NCT05087615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64392158|NCT05087615|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64392159|NCT05087615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64392160|NCT05087615|Dopamine Agents|dopamine agents|mesh-ancestor
64392163|NCT01987102|Levoleucovorin|levoleucovorin|mesh-list
64392164|NCT01987102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64392165|NCT01987102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392166|NCT01987102|Antidotes|antidotes|mesh-ancestor
64392167|NCT01987102|Protective Agents|protective agents|mesh-ancestor
64833343|NCT01598883|Protease Inhibitors|protease inhibitors|mesh-ancestor
64833344|NCT01598883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833345|NCT01598948|Mipomersen|mipomersen|mesh-list
64833346|NCT01598948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64833347|NCT01598948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64833348|NCT01598948|Antimetabolites|antimetabolites|mesh-ancestor
64833349|NCT01598948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833350|NCT01598948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64833351|NCT01599000|Lumefantrine|lumefantrine|mesh-list
64833352|NCT01599000|Artemether|artemether|mesh-list
64392278|NCT02012296|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64392279|NCT02012296|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64392280|NCT02012296|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64392281|NCT02012296|Contraceptive Agents|contraceptive agents|mesh-ancestor
64392282|NCT02012296|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64392283|NCT02012296|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64392284|NCT02012296|Hormone Antagonists|hormone antagonists|mesh-ancestor
64392285|NCT02012296|Luteolytic Agents|luteolytic agents|mesh-ancestor
64392286|NCT02012296|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64392287|NCT02012296|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64392289|NCT02012218|Serotonin Agents|serotonin agents|mesh-ancestor
64392290|NCT02012218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64392291|NCT02012218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392292|NCT02012218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392293|NCT02012218|Dopamine Agonists|dopamine agonists|mesh-ancestor
64392294|NCT02012218|Dopamine Agents|dopamine agents|mesh-ancestor
64392295|NCT04177498|ON 01910|on 01910|mesh-list
64392296|NCT04177498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64392297|NCT04177498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64392298|NCT04177498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64392502|NCT03477851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392504|NCT02409199|Apatinib|apatinib|mesh-list
64392505|NCT02409199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64392506|NCT02409199|Tubulin Modulators|tubulin modulators|mesh-ancestor
64392511|NCT02409199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64392512|NCT03115489|Ketamine|ketamine|mesh-list
64392513|NCT03115489|Propofol|propofol|mesh-list
64392518|NCT03115489|Anesthetics, General|anesthetics, general|mesh-ancestor
64833355|NCT01599000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64833356|NCT01599000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64833357|NCT01599000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64392574|NCT03116269|Protective Agents|protective agents|mesh-ancestor
64392577|NCT03174067|Clonidine|clonidine|mesh-list
64392582|NCT03174067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392583|NCT03174067|Analgesics|analgesics|mesh-ancestor
64392584|NCT03174067|Sensory System Agents|sensory system agents|mesh-ancestor
64392585|NCT03174067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392586|NCT03174067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64392587|NCT03174067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64392588|NCT03174067|Sympatholytics|sympatholytics|mesh-ancestor
64392589|NCT03174067|Autonomic Agents|autonomic agents|mesh-ancestor
64392590|NCT03174067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64392591|NCT03174067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64392592|NCT03174067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64392593|NCT03174067|Adrenergic Agents|adrenergic agents|mesh-ancestor
64392594|NCT03174067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64392595|NCT03174067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392597|NCT02408185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64392598|NCT02408185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64392599|NCT02408419|Bupivacaine|bupivacaine|mesh-list
64392600|NCT02408419|Anesthetics, Local|anesthetics, local|mesh-ancestor
64392601|NCT02408419|Anesthetics|anesthetics|mesh-ancestor
64392602|NCT02408419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64392603|NCT02408419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392604|NCT02408419|Sensory System Agents|sensory system agents|mesh-ancestor
64392606|NCT00708097|Fluorides|fluorides|mesh-list
64392650|NCT05083949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392903|NCT04670471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64392906|NCT04670471|Sensory System Agents|sensory system agents|mesh-ancestor
64392927|NCT02398123|Anesthetics|anesthetics|mesh-ancestor
64392928|NCT02398123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64392929|NCT02398123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392930|NCT02398123|Sensory System Agents|sensory system agents|mesh-ancestor
64392931|NCT02398123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392932|NCT04486625|Aztreonam|aztreonam|mesh-list
64392933|NCT04486625|Avibactam|avibactam|mesh-list
64392934|NCT04486625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64392935|NCT04486625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64392936|NCT04486625|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64392937|NCT04486625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64392938|NCT04486625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392939|NCT02404363|Clopidogrel|clopidogrel|mesh-list
64392940|NCT02404363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64392941|NCT02404363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64392942|NCT02404363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64392943|NCT02404363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64392944|NCT02404363|Purinergic Agents|purinergic agents|mesh-ancestor
64392945|NCT02404363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64392947|NCT02404363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324953|NCT02269735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324954|NCT05625373|Vancomycin|vancomycin|mesh-list
64324955|NCT05625373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64324956|NCT05625373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64393056|NCT02657369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64393057|NCT02657369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393058|NCT02657369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393059|NCT02397421|Dapagliflozin|dapagliflozin|mesh-list
64393060|NCT02397421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64393061|NCT02397421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393062|NCT02397421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64393063|NCT02397421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393064|NCT04952779|Insulin|insulin|mesh-list
64393065|NCT04952779|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64393066|NCT04952779|Liraglutide|liraglutide|mesh-list
64393067|NCT04952779|Insulin, Long-Acting|insulin, long-acting|mesh-list
64393068|NCT04952779|Xultophy|xultophy|mesh-list
64393069|NCT04952779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64393070|NCT04952779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393071|NCT04952779|Incretins|incretins|mesh-ancestor
64393072|NCT04952779|Hormones|hormones|mesh-ancestor
64393073|NCT04952779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64393074|NCT04832009|Ascorbic Acid|ascorbic acid|mesh-list
64393075|NCT04832009|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64393076|NCT04832009|Antioxidants|antioxidants|mesh-ancestor
64393077|NCT04832009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393078|NCT04832009|Protective Agents|protective agents|mesh-ancestor
64393155|NCT05110469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833360|NCT01599013|Vinblastine|vinblastine|mesh-list
64833361|NCT01599013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833362|NCT01599013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64833363|NCT01599013|Antimetabolites|antimetabolites|mesh-ancestor
64833364|NCT01599013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833365|NCT01599013|Antiviral Agents|antiviral agents|mesh-ancestor
64833366|NCT01599013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64833367|NCT01599013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393225|NCT05108597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64393226|NCT05108597|Abortifacient Agents|abortifacient agents|mesh-ancestor
64393227|NCT05108597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64393228|NCT05108597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393229|NCT05108597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64393230|NCT05108597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64393231|NCT05108597|Oxytocics|oxytocics|mesh-ancestor
64393232|NCT02396329|Chlorhexidine|chlorhexidine|mesh-list
64393237|NCT02396329|Disinfectants|disinfectants|mesh-ancestor
64393238|NCT02396329|Plasma Substitutes|plasma substitutes|mesh-ancestor
64393239|NCT02396329|Blood Substitutes|blood substitutes|mesh-ancestor
64393240|NCT03168139|Pembrolizumab|pembrolizumab|mesh-list
64393241|NCT03168139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64393242|NCT03168139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393244|NCT02395783|Antioxidants|antioxidants|mesh-ancestor
64393245|NCT02395783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393246|NCT02395783|Protective Agents|protective agents|mesh-ancestor
64393247|NCT02395783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393248|NCT02395783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64393249|NCT04555343|Tranexamic Acid|tranexamic acid|mesh-list
64393250|NCT04555343|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64393251|NCT04555343|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64393252|NCT04555343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393253|NCT04555343|Hemostatics|hemostatics|mesh-ancestor
64769209|NCT05580003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64769210|NCT05580003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64769211|NCT05580003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64769212|NCT05580003|Anesthetics, General|anesthetics, general|mesh-ancestor
64393254|NCT04555343|Coagulants|coagulants|mesh-ancestor
64393255|NCT04528667|Abivertinib|abivertinib|mesh-list
64393256|NCT04528667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393257|NCT04528667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833372|NCT01599013|Tubulin Modulators|tubulin modulators|mesh-ancestor
64833373|NCT01599013|Antimitotic Agents|antimitotic agents|mesh-ancestor
64833374|NCT01599013|Mitosis Modulators|mitosis modulators|mesh-ancestor
64393303|NCT04367909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393305|NCT04058873|Levonorgestrel|levonorgestrel|mesh-list
64393306|NCT04058873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64393307|NCT04058873|Contraceptive Agents|contraceptive agents|mesh-ancestor
64393308|NCT04058873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64393309|NCT04058873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393310|NCT04058873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64393311|NCT04058873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64393312|NCT04058873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64393313|NCT04196075|Andrographolide|andrographolide|mesh-list
64393314|NCT04196075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64393315|NCT04196075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64393316|NCT04196075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64393317|NCT04196075|Analgesics|analgesics|mesh-ancestor
64393318|NCT04196075|Sensory System Agents|sensory system agents|mesh-ancestor
64393333|NCT03863483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393335|NCT03863483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64393336|NCT03863483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64393337|NCT03830411|Docetaxel|docetaxel|mesh-list
64393338|NCT03830411|Pemetrexed|pemetrexed|mesh-list
64393339|NCT03830411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393340|NCT03830411|Tubulin Modulators|tubulin modulators|mesh-ancestor
64393341|NCT03830411|Antimitotic Agents|antimitotic agents|mesh-ancestor
64393342|NCT03830411|Mitosis Modulators|mitosis modulators|mesh-ancestor
64393343|NCT03830411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393344|NCT03830411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393345|NCT03830411|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64393364|NCT03012425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64393365|NCT03540875|Remifentanil|remifentanil|mesh-list
64294269|NCT03562585|Immunologic Factors|immunologic factors|mesh-ancestor
64393436|NCT04305899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393437|NCT01675661|Acetylcysteine|acetylcysteine|mesh-list
64393438|NCT01675661|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64393439|NCT01675661|Antiviral Agents|antiviral agents|mesh-ancestor
64393440|NCT01675661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64393486|NCT02700841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64393487|NCT02700841|Alkylating Agents|alkylating agents|mesh-ancestor
64393488|NCT02700841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393489|NCT02700841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393490|NCT02700841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64393491|NCT02700841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64393492|NCT02700841|Immunologic Factors|immunologic factors|mesh-ancestor
64393564|NCT05038475|Immunologic Factors|immunologic factors|mesh-ancestor
64393565|NCT05038475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393566|NCT02009332|Gemcitabine|gemcitabine|mesh-list
64393567|NCT02009332|Sirolimus|sirolimus|mesh-list
64769241|NCT05543629|Taxane|taxane|mesh-list
64769242|NCT05543629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64769243|NCT05543629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769244|NCT05543629|Tubulin Modulators|tubulin modulators|mesh-ancestor
64393568|NCT02009332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64393570|NCT02009332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393571|NCT02009332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393572|NCT02009332|Antiviral Agents|antiviral agents|mesh-ancestor
64393573|NCT02009332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64393574|NCT02009332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393575|NCT02009332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64393576|NCT02009332|Immunologic Factors|immunologic factors|mesh-ancestor
64393577|NCT02009332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393578|NCT02009332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64393579|NCT02009332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64393580|NCT02009332|Antifungal Agents|antifungal agents|mesh-ancestor
64393581|NCT04518293|Amlodipine|amlodipine|mesh-list
64393582|NCT04518293|Telmisartan|telmisartan|mesh-list
64393583|NCT04518293|Indapamide|indapamide|mesh-list
64833378|NCT01599078|Tubulin Modulators|tubulin modulators|mesh-ancestor
64833379|NCT01599078|Antimitotic Agents|antimitotic agents|mesh-ancestor
64393584|NCT04518293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64393585|NCT04518293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64393586|NCT04518293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64393589|NCT04518293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393634|NCT04416334|Tubulin Modulators|tubulin modulators|mesh-ancestor
64393635|NCT04416334|Antimitotic Agents|antimitotic agents|mesh-ancestor
64393636|NCT04416334|Mitosis Modulators|mitosis modulators|mesh-ancestor
64393637|NCT04416334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393638|NCT04416334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393647|NCT02403349|Autonomic Agents|autonomic agents|mesh-ancestor
64393648|NCT02403349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393649|NCT02403349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393650|NCT02403349|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64393651|NCT02403349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64393652|NCT02403349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64393653|NCT02403349|Adrenergic Agents|adrenergic agents|mesh-ancestor
64393654|NCT02403349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64393655|NCT04735822|Belumosudil|belumosudil|mesh-list
64393656|NCT04735822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64393657|NCT04735822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393658|NCT04735822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393659|NCT01984138|Estradiol|estradiol|mesh-list
64393660|NCT01984138|Estrogens|estrogens|mesh-ancestor
64393661|NCT01984138|Hormones|hormones|mesh-ancestor
64393662|NCT01984138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64833380|NCT01599078|Mitosis Modulators|mitosis modulators|mesh-ancestor
64833381|NCT01599078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833382|NCT01599117|Udenafil|udenafil|mesh-list
64833383|NCT01599117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64833384|NCT01599117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64833385|NCT01599117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833386|NCT01599117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833387|NCT01599130|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64833388|NCT01599130|Entecavir|entecavir|mesh-list
64833389|NCT01599130|Antiviral Agents|antiviral agents|mesh-ancestor
64833390|NCT01599130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64833391|NCT01599273|Triamcinolone|triamcinolone|mesh-list
64833392|NCT01599273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64833393|NCT01599273|Glucocorticoids|glucocorticoids|mesh-ancestor
64833394|NCT01599273|Hormones|hormones|mesh-ancestor
64833395|NCT01599273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64833396|NCT01599273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833397|NCT01599312|Cobalt|cobalt|mesh-list
64393705|NCT03906617|Anesthetics, Local|anesthetics, local|mesh-ancestor
64393706|NCT03906617|Anesthetics|anesthetics|mesh-ancestor
64393707|NCT03906617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64393708|NCT03906617|Sensory System Agents|sensory system agents|mesh-ancestor
64393709|NCT03906617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64393710|NCT03906617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64393711|NCT03906617|Adrenergic Agents|adrenergic agents|mesh-ancestor
64393712|NCT03906617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64393713|NCT03906617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393714|NCT03906617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64393715|NCT03906617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64393716|NCT03906617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64393717|NCT03906617|Respiratory System Agents|respiratory system agents|mesh-ancestor
64393718|NCT03906617|Mydriatics|mydriatics|mesh-ancestor
64393719|NCT03906617|Sympathomimetics|sympathomimetics|mesh-ancestor
64393720|NCT03906617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64393721|NCT04655482|Aflibercept|aflibercept|mesh-list
64393722|NCT04655482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64393723|NCT04655482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64393724|NCT04655482|Growth Substances|growth substances|mesh-ancestor
64393725|NCT04655482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393726|NCT04655482|Growth Inhibitors|growth inhibitors|mesh-ancestor
64393728|NCT04515797|Antiviral Agents|antiviral agents|mesh-list
64393773|NCT05120687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64393775|NCT05120687|Dermatologic Agents|dermatologic agents|mesh-ancestor
64393776|NCT05120687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393777|NCT05120687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64393778|NCT05120687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64393796|NCT04224545|Colchicine|colchicine|mesh-list
64393875|NCT02403037|BB 1101|bb 1101|mesh-list
64393876|NCT02403037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64393877|NCT02403037|Autonomic Agents|autonomic agents|mesh-ancestor
64393878|NCT02403037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393879|NCT02403037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393880|NCT02403037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64393881|NCT02403037|Glucocorticoids|glucocorticoids|mesh-ancestor
64393883|NCT02403037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64393884|NCT02403037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64394010|NCT02402725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64394011|NCT02402725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394013|NCT02402725|Glucocorticoids|glucocorticoids|mesh-ancestor
64394014|NCT02402725|Hormones|hormones|mesh-ancestor
64394015|NCT02402725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64394018|NCT02402725|Protease Inhibitors|protease inhibitors|mesh-ancestor
64394084|NCT04649476|Antimitotic Agents|antimitotic agents|mesh-ancestor
64394085|NCT04649476|Mitosis Modulators|mitosis modulators|mesh-ancestor
64394086|NCT04649476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394087|NCT04649476|Antimetabolites|antimetabolites|mesh-ancestor
64394088|NCT04649476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64394089|NCT04649476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64394090|NCT04649476|Immunologic Factors|immunologic factors|mesh-ancestor
64394091|NCT04649476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394093|NCT05117957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394094|NCT05117957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64394095|NCT05117957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394116|NCT03343301|Bemarituzumab|bemarituzumab|mesh-list
64394119|NCT04507919|Dabrafenib|dabrafenib|mesh-list
64833400|NCT01599312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833401|NCT01599338|Liraglutide|liraglutide|mesh-list
64833402|NCT01599338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64833403|NCT01599338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833404|NCT01599338|Incretins|incretins|mesh-ancestor
64833406|NCT01599338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64833407|NCT01599364|Ritonavir|ritonavir|mesh-list
64833408|NCT01599364|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64394152|NCT02393599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64394159|NCT02393599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64394160|NCT02402491|Aspirin|aspirin|mesh-list
64394161|NCT02402491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
64394162|NCT02402491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64394163|NCT02402491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64394164|NCT02402491|Analgesics|analgesics|mesh-ancestor
64394165|NCT02402491|Sensory System Agents|sensory system agents|mesh-ancestor
64394166|NCT02402491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64394167|NCT02402491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394168|NCT02402491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64394169|NCT02402491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64394170|NCT02402491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64394171|NCT02402491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64394172|NCT02402491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394173|NCT02402491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64394174|NCT02402491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64394175|NCT02402491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394177|NCT02402491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64394178|NCT02402491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64394179|NCT02402491|Purinergic Agents|purinergic agents|mesh-ancestor
64833414|NCT01599364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833415|NCT01599364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64833416|NCT01599364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64833417|NCT01599364|Antiviral Agents|antiviral agents|mesh-ancestor
64833418|NCT01599364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64444590|NCT05381597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394210|NCT02003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394211|NCT02003638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64394212|NCT02003638|Vasodilator Agents|vasodilator agents|mesh-ancestor
64394213|NCT02003638|Vitamin B Complex|vitamin b complex|mesh-ancestor
64394214|NCT02003638|Vitamins|vitamins|mesh-ancestor
64394215|NCT02003638|Micronutrients|micronutrients|mesh-ancestor
64394219|NCT04649398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64394220|NCT04649398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64394221|NCT04649398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394223|NCT04649398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394309|NCT03106519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394353|NCT01958476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394354|NCT01958476|GABA Modulators|gaba modulators|mesh-ancestor
64394355|NCT01958476|GABA Agents|gaba agents|mesh-ancestor
64394356|NCT01958476|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64394357|NCT01958476|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64394358|NCT01958476|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64394359|NCT04809181|Azacitidine|azacitidine|mesh-list
64394360|NCT04809181|Venetoclax|venetoclax|mesh-list
64394361|NCT04809181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64394475|NCT03874091|Narcotics|narcotics|mesh-ancestor
64394476|NCT03874091|Analgesics|analgesics|mesh-ancestor
64394477|NCT03874091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64394478|NCT03874091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64394479|NCT03874091|Adrenergic Agents|adrenergic agents|mesh-ancestor
64394480|NCT03874091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64394481|NCT03874091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394482|NCT03874091|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64394483|NCT03874091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64394484|NCT03874091|Autonomic Agents|autonomic agents|mesh-ancestor
64394485|NCT03874091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64394486|NCT03874091|Respiratory System Agents|respiratory system agents|mesh-ancestor
64394499|NCT01362491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64394500|NCT01362491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394501|NCT01362491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394502|NCT03560297|Nitrazepam|nitrazepam|mesh-list
64394503|NCT03560297|Anticonvulsants|anticonvulsants|mesh-ancestor
64394505|NCT03560297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64394506|NCT03560297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394507|NCT03560297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64394508|NCT03560297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64394509|NCT03560297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64769270|NCT05500599|Narcotics|narcotics|mesh-ancestor
64769287|NCT05500599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769288|NCT05498116|Montelukast|montelukast|mesh-list
64394510|NCT03560297|GABA Modulators|gaba modulators|mesh-ancestor
64394511|NCT03560297|GABA Agents|gaba agents|mesh-ancestor
64394512|NCT03560297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64394529|NCT04122287|Alkylating Agents|alkylating agents|mesh-ancestor
64394530|NCT04122287|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64394531|NCT04122287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64833419|NCT01599364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64833420|NCT01599364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64833421|NCT01599364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64833422|NCT01599364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64833424|NCT01599377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64833425|NCT01599377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833426|NCT01599377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833427|NCT05691088|Acetaminophen|acetaminophen|mesh-list
64833428|NCT05691088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64833429|NCT05691088|Analgesics|analgesics|mesh-ancestor
64394676|NCT05697055|Antiviral Agents|antiviral agents|mesh-ancestor
64394677|NCT05697055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64394680|NCT03162367|Sulfadiazine|sulfadiazine|mesh-list
64833430|NCT05691088|Sensory System Agents|sensory system agents|mesh-ancestor
64833431|NCT05691088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64833432|NCT05691088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833433|NCT05691088|Antipyretics|antipyretics|mesh-ancestor
64833434|NCT05691010|Paclitaxel|paclitaxel|mesh-list
64833435|NCT05691010|Carboplatin|carboplatin|mesh-list
64833436|NCT05691010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64833437|NCT05691010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394773|NCT04657939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64394774|NCT04657939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394775|NCT04657939|Incretins|incretins|mesh-ancestor
64394776|NCT04657939|Hormones|hormones|mesh-ancestor
64394777|NCT04657939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64394778|NCT01999114|Moxifloxacin|moxifloxacin|mesh-list
64394779|NCT01999114|Naltrexone|naltrexone|mesh-list
64394780|NCT01999114|Buprenorphine|buprenorphine|mesh-list
64394781|NCT01999114|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64394782|NCT01999114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64833442|NCT05690802|Palonosetron|palonosetron|mesh-list
64833443|NCT05690802|Antiemetics|antiemetics|mesh-ancestor
64833444|NCT05690802|Autonomic Agents|autonomic agents|mesh-ancestor
64833445|NCT05690802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64833446|NCT05690802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833447|NCT05690802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64833448|NCT05690802|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64394869|NCT03161509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64394870|NCT03161509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64394953|NCT02207465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64394954|NCT02207465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394955|NCT02207465|Tubulin Modulators|tubulin modulators|mesh-ancestor
64394956|NCT02207465|Antimitotic Agents|antimitotic agents|mesh-ancestor
64394957|NCT02207465|Mitosis Modulators|mitosis modulators|mesh-ancestor
64394958|NCT02207465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394960|NCT00719225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64394961|NCT00719225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394962|NCT00719225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394963|NCT00719225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64394964|NCT00719225|Immunologic Factors|immunologic factors|mesh-ancestor
64394965|NCT00719225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394966|NCT00719225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64394967|NCT05134337|Itraconazole|itraconazole|mesh-list
64394968|NCT05134337|Rifampin|rifampin|mesh-list
64394969|NCT05134337|Antifungal Agents|antifungal agents|mesh-ancestor
64394970|NCT05134337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64394971|NCT05134337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64394972|NCT05134337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64769295|NCT05498116|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64394973|NCT05134337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833451|NCT05690802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64833452|NCT05690802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833453|NCT05690321|Opium|opium|mesh-list
64833454|NCT05690321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64833455|NCT05690321|Narcotics|narcotics|mesh-ancestor
64833456|NCT05690321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64833457|NCT05690321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833458|NCT05690321|Analgesics|analgesics|mesh-ancestor
64833459|NCT05690321|Sensory System Agents|sensory system agents|mesh-ancestor
64833460|NCT05690321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64394986|NCT05134337|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64833461|NCT05690321|Antidiarrheals|antidiarrheals|mesh-ancestor
64833462|NCT05690321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64394987|NCT05134337|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64394988|NCT05134337|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64394989|NCT05134337|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64394990|NCT05134337|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64394991|NCT04499495|Aminosalicylic Acid|aminosalicylic acid|mesh-list
64394992|NCT04499495|Mesalamine|mesalamine|mesh-list
64394993|NCT04499495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64394994|NCT04499495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64394995|NCT04499495|Analgesics|analgesics|mesh-ancestor
64394996|NCT04499495|Sensory System Agents|sensory system agents|mesh-ancestor
64394997|NCT04499495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64394998|NCT04499495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394999|NCT04499495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64395000|NCT04499495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64395001|NCT04499495|Antitubercular Agents|antitubercular agents|mesh-ancestor
64395002|NCT04499495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64395003|NCT04499495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64395004|NCT05323175|Ropivacaine|ropivacaine|mesh-list
64395006|NCT05323175|Anesthetics|anesthetics|mesh-ancestor
64395007|NCT05323175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64395008|NCT05323175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395009|NCT05323175|Sensory System Agents|sensory system agents|mesh-ancestor
64395047|NCT05133635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395048|NCT05133635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64395049|NCT05133635|Glucocorticoids|glucocorticoids|mesh-ancestor
64395050|NCT05133635|Hormones|hormones|mesh-ancestor
64395051|NCT05133635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64395052|NCT05133635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64395053|NCT05133635|Protective Agents|protective agents|mesh-ancestor
64395107|NCT01674725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64395108|NCT05404061|Hormones|hormones|mesh-list
64395109|NCT05404061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64395110|NCT05404061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395111|NCT05051293|Testosterone|testosterone|mesh-list
64395112|NCT05051293|Estrogens|estrogens|mesh-list
64395113|NCT05051293|Androgens|androgens|mesh-ancestor
64395214|NCT05131841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64395215|NCT05131841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395216|NCT05131841|Tubulin Modulators|tubulin modulators|mesh-ancestor
64395217|NCT05131841|Antimitotic Agents|antimitotic agents|mesh-ancestor
64395218|NCT05131841|Mitosis Modulators|mitosis modulators|mesh-ancestor
64395219|NCT05131841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395220|NCT03163849|Sofosbuvir|sofosbuvir|mesh-list
64395221|NCT03163849|Antiviral Agents|antiviral agents|mesh-ancestor
64395222|NCT03163849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64395223|NCT03163381|Apatinib|apatinib|mesh-list
64395224|NCT03163381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395225|NCT03163381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64395226|NCT03163381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833472|NCT05690282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833473|NCT05690282|Sensory System Agents|sensory system agents|mesh-ancestor
64833474|NCT05690282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64833475|NCT05690282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64395227|NCT03163381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395228|NCT05131295|Dapsone|dapsone|mesh-list
64395229|NCT05131295|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64395230|NCT05131295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64395231|NCT05131295|Antimalarials|antimalarials|mesh-ancestor
64395232|NCT05131295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64395233|NCT05131295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64395234|NCT05131295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64395235|NCT05131295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64395236|NCT05131295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395237|NCT05131295|Leprostatic Agents|leprostatic agents|mesh-ancestor
64395238|NCT05131295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64395242|NCT05131295|Antacids|antacids|mesh-ancestor
64395265|NCT01374217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64395266|NCT01374217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64833478|NCT05690282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64833479|NCT05690282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64833480|NCT05690282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64833481|NCT05690282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64833482|NCT05690282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833483|NCT05690282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395306|NCT02959619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395307|NCT02959619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64294300|NCT03023462|Ondansetron|ondansetron|mesh-list
64833485|NCT05690282|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64833486|NCT05690282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64833487|NCT05690282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64833488|NCT05690282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64833489|NCT05690282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64833490|NCT05690282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64833491|NCT05690282|Antimanic Agents|antimanic agents|mesh-ancestor
64324978|NCT01336465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64324979|NCT01336465|Immunologic Factors|immunologic factors|mesh-ancestor
64324980|NCT01336465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395323|NCT04877275|Doxorubicin|doxorubicin|mesh-list
64395324|NCT04877275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64395325|NCT04877275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64395326|NCT04877275|Immunologic Factors|immunologic factors|mesh-ancestor
64395327|NCT04877275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395328|NCT04877275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64769412|NCT05292755|Laxatives|laxatives|mesh-ancestor
64294302|NCT03023462|Anesthetics, Local|anesthetics, local|mesh-ancestor
64324981|NCT03315026|Siltuximab|siltuximab|mesh-list
64324982|NCT03315026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324983|NCT02769065|Donepezil|donepezil|mesh-list
64324984|NCT02769065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64324985|NCT02769065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324986|NCT02769065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324987|NCT02769065|Cholinergic Agents|cholinergic agents|mesh-ancestor
64324988|NCT02769065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64324989|NCT02769065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324990|NCT02769065|Nootropic Agents|nootropic agents|mesh-ancestor
64324991|NCT02540954|Aflibercept|aflibercept|mesh-list
64395329|NCT04877275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64395330|NCT04877275|Alkylating Agents|alkylating agents|mesh-ancestor
64395331|NCT04877275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395332|NCT04877275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395333|NCT04877275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64395334|NCT04877275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64395335|NCT04877275|Antiemetics|antiemetics|mesh-ancestor
64395336|NCT04877275|Autonomic Agents|autonomic agents|mesh-ancestor
64395337|NCT04877275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395338|NCT04877275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64395339|NCT04877275|Glucocorticoids|glucocorticoids|mesh-ancestor
64395340|NCT04877275|Hormones|hormones|mesh-ancestor
64395341|NCT04877275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64395342|NCT04877275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64395343|NCT04877275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64395344|NCT04877275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64324992|NCT02540954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64324993|NCT02540954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64324994|NCT02540954|Growth Substances|growth substances|mesh-ancestor
64833493|NCT05690191|Lenalidomide|lenalidomide|mesh-list
64833494|NCT05690191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64833495|NCT05690191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833496|NCT05690191|Immunologic Factors|immunologic factors|mesh-ancestor
64833497|NCT05690191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833498|NCT05690191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64833499|NCT05690191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64833500|NCT05690191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64833501|NCT05690191|Growth Substances|growth substances|mesh-ancestor
64833502|NCT05690191|Growth Inhibitors|growth inhibitors|mesh-ancestor
64833503|NCT05689996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64833504|NCT05689996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64833505|NCT05689983|Budesonide|budesonide|mesh-list
64395360|NCT04955249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395362|NCT05676463|Methyltestosterone|methyltestosterone|mesh-list
64395363|NCT05676463|Hormones|hormones|mesh-list
64395364|NCT05676463|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64395365|NCT05676463|Androgens|androgens|mesh-list
64395366|NCT05676463|Androgen Antagonists|androgen antagonists|mesh-list
64395367|NCT05676463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64395368|NCT05676463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395369|NCT05676463|Antioxidants|antioxidants|mesh-ancestor
64395370|NCT05676463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395371|NCT05676463|Protective Agents|protective agents|mesh-ancestor
64395372|NCT05676463|Vitamins|vitamins|mesh-ancestor
64395373|NCT05676463|Micronutrients|micronutrients|mesh-ancestor
64395374|NCT05676463|Estrogens|estrogens|mesh-ancestor
64395375|NCT05676463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64395376|NCT05676463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395377|NCT05676463|Anabolic Agents|anabolic agents|mesh-ancestor
64395378|NCT05676463|Hormone Antagonists|hormone antagonists|mesh-ancestor
64395379|NCT03114085|Capecitabine|capecitabine|mesh-list
64395380|NCT03114085|Apatinib|apatinib|mesh-list
64395408|NCT05136521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64833507|NCT05689983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64833508|NCT05689983|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64833509|NCT05689983|Autonomic Agents|autonomic agents|mesh-ancestor
64833510|NCT05689983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64833511|NCT05689983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833512|NCT05689983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64833513|NCT05689983|Respiratory System Agents|respiratory system agents|mesh-ancestor
64833514|NCT05689983|Glucocorticoids|glucocorticoids|mesh-ancestor
64395409|NCT05136521|Antidepressive Agents|antidepressive agents|mesh-ancestor
64395410|NCT05343013|Trifluridine|trifluridine|mesh-list
64395411|NCT05343013|Antimetabolites|antimetabolites|mesh-ancestor
64395412|NCT05343013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395413|NCT05343013|Antiviral Agents|antiviral agents|mesh-ancestor
64395414|NCT05343013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64395415|NCT02388373|Fluticasone|fluticasone|mesh-list
64395416|NCT02388373|Xhance|xhance|mesh-list
64833519|NCT05689983|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64833520|NCT05689983|Adrenergic Agents|adrenergic agents|mesh-ancestor
64833521|NCT05689983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64833522|NCT05689983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833523|NCT05689957|Rocuronium|rocuronium|mesh-list
64833524|NCT05689957|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64833525|NCT05689957|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64833526|NCT05689957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64833527|NCT05689957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64833528|NCT05689957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833529|NCT05689671|Paclitaxel|paclitaxel|mesh-list
64833530|NCT05689671|Carboplatin|carboplatin|mesh-list
64833531|NCT05689671|Pembrolizumab|pembrolizumab|mesh-list
64833532|NCT05689671|Pemetrexed|pemetrexed|mesh-list
64833533|NCT05689671|Atezolizumab|atezolizumab|mesh-list
64833534|NCT05689671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64833535|NCT05689671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833536|NCT05689671|Tubulin Modulators|tubulin modulators|mesh-ancestor
64833537|NCT05689671|Antimitotic Agents|antimitotic agents|mesh-ancestor
64833538|NCT05689671|Mitosis Modulators|mitosis modulators|mesh-ancestor
64833539|NCT05689671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833540|NCT05689671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64833541|NCT05689671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833542|NCT05689671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64833543|NCT05689671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64833544|NCT05689632|Vitamin D|vitamin d|mesh-list
64833560|NCT05689463|Immunologic Factors|immunologic factors|mesh-ancestor
64833561|NCT05689463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833562|NCT05689242|Dexmedetomidine|dexmedetomidine|mesh-list
64833563|NCT05689242|Nalbuphine|nalbuphine|mesh-list
64833564|NCT05689242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64833565|NCT05689242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64395522|NCT03113773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64395523|NCT03113773|Antiviral Agents|antiviral agents|mesh-ancestor
64395524|NCT03113773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64395525|NCT04874831|Avelumab|avelumab|mesh-list
64395526|NCT04874831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64395527|NCT04874831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395528|NCT05122169|Iodine|iodine|mesh-list
64833566|NCT05689242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833567|NCT05689242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64833568|NCT05689242|Analgesics|analgesics|mesh-ancestor
64833569|NCT05689242|Sensory System Agents|sensory system agents|mesh-ancestor
64833570|NCT05689242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64833571|NCT05689242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64833572|NCT05689242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64833573|NCT05689242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64833574|NCT05689242|Adrenergic Agents|adrenergic agents|mesh-ancestor
64833575|NCT05689242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64395572|NCT05260073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64395573|NCT05260073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384110|NCT02093026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64384111|NCT02093026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64384112|NCT02093026|Glucocorticoids|glucocorticoids|mesh-ancestor
64384113|NCT02093026|Hormones|hormones|mesh-ancestor
64384120|NCT02093026|Micronutrients|micronutrients|mesh-ancestor
64384121|NCT04697602|Colchicine|colchicine|mesh-list
64384122|NCT04697602|Febuxostat|febuxostat|mesh-list
64384123|NCT04697602|Gout Suppressants|gout suppressants|mesh-ancestor
64384124|NCT04697602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64384125|NCT04697602|Tubulin Modulators|tubulin modulators|mesh-ancestor
64384127|NCT04697602|Mitosis Modulators|mitosis modulators|mesh-ancestor
64384128|NCT04697602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384129|NCT04697602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384130|NCT02059174|Insulin Aspart|insulin aspart|mesh-list
64384131|NCT02059174|MK-1293|mk-1293|mesh-list
64384132|NCT02059174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64384133|NCT02059174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384134|NCT02059174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64384135|NCT02059174|Antimetabolites|antimetabolites|mesh-ancestor
64384136|NCT02059174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384137|NCT02059174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64384168|NCT02040766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64384170|NCT02040532|Analgesics|analgesics|mesh-ancestor
64384171|NCT02040532|Sensory System Agents|sensory system agents|mesh-ancestor
64384172|NCT02040532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64384173|NCT02040532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384174|NCT02040532|Anticonvulsants|anticonvulsants|mesh-ancestor
64384175|NCT02040532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64384176|NCT02040532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64384177|NCT02040532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64384178|NCT02040532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64384179|NCT02040532|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64384180|NCT02040532|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64384181|NCT02040532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64384182|NCT02040532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384183|NCT02040532|Antimanic Agents|antimanic agents|mesh-ancestor
64384184|NCT02039908|Methylphenidate|methylphenidate|mesh-list
64384185|NCT02039908|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64384186|NCT02039908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384187|NCT02039908|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64384188|NCT02039908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64384189|NCT02039908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64384190|NCT02039908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384191|NCT02039908|Dopamine Agents|dopamine agents|mesh-ancestor
64384192|NCT02039908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64384193|NCT04417348|Tretinoin|tretinoin|mesh-list
64384194|NCT04417348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384195|NCT04417348|Keratolytic Agents|keratolytic agents|mesh-ancestor
64384196|NCT04417348|Dermatologic Agents|dermatologic agents|mesh-ancestor
64384197|NCT02058940|Exenatide|exenatide|mesh-list
64384198|NCT02058940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64384199|NCT02058940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384200|NCT02058940|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64384201|NCT02058940|Incretins|incretins|mesh-ancestor
64384203|NCT02058940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64384204|NCT02058628|Clindamycin|clindamycin|mesh-list
64384205|NCT02058628|Clindamycin palmitate|clindamycin palmitate|mesh-list
64833577|NCT05689242|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64833578|NCT05689242|Narcotics|narcotics|mesh-ancestor
64833579|NCT05689229|Colistin|colistin|mesh-list
64833580|NCT05689229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64833581|NCT05689229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64833582|NCT05688046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64833583|NCT05688046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
64833584|NCT05688046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833585|NCT05688046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833586|NCT05688046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64833587|NCT05688046|Growth Substances|growth substances|mesh-ancestor
64833588|NCT05688046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833589|NCT05688046|Growth Inhibitors|growth inhibitors|mesh-ancestor
64833590|NCT05646563|Eculizumab|eculizumab|mesh-list
64833591|NCT05646563|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64395601|NCT04422743|GABA Agents|gaba agents|mesh-ancestor
64294333|NCT01371565|Mifepristone|mifepristone|mesh-list
64833594|NCT05646563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833595|NCT05618132|Acetylcholine|acetylcholine|mesh-list
64833596|NCT05618132|Vasodilator Agents|vasodilator agents|mesh-ancestor
64833597|NCT05618132|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64833598|NCT05618132|Cholinergic Agents|cholinergic agents|mesh-ancestor
64833599|NCT05618132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64833600|NCT05618132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833601|NCT05618132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833603|NCT05610072|Hydromorphone|hydromorphone|mesh-list
64833604|NCT05610072|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64833605|NCT05610072|Antiviral Agents|antiviral agents|mesh-ancestor
64833606|NCT05610072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64833607|NCT05610072|Expectorants|expectorants|mesh-ancestor
64833608|NCT05610072|Respiratory System Agents|respiratory system agents|mesh-ancestor
64833609|NCT05610072|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64833610|NCT05610072|Antioxidants|antioxidants|mesh-ancestor
64833611|NCT05610072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833612|NCT05610072|Protective Agents|protective agents|mesh-ancestor
64395717|NCT04121507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64395718|NCT04121507|Alkylating Agents|alkylating agents|mesh-ancestor
64395719|NCT04121507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395720|NCT04121507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64395721|NCT04121507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64395722|NCT04719221|Evolocumab|evolocumab|mesh-list
64395723|NCT04719221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64395724|NCT04719221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64395725|NCT04719221|Antimetabolites|antimetabolites|mesh-ancestor
64395726|NCT04719221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395727|NCT04719221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64833614|NCT05610072|Antidotes|antidotes|mesh-ancestor
64833615|NCT05610072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64833616|NCT05610072|Narcotics|narcotics|mesh-ancestor
64833617|NCT05610072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64444779|NCT02169830|Topiramate|topiramate|mesh-list
64324997|NCT02540954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324998|NCT05265975|Rituximab|rituximab|mesh-list
64324999|NCT05265975|Lenalidomide|lenalidomide|mesh-list
64325000|NCT05265975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64325001|NCT05265975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325002|NCT05265975|Immunologic Factors|immunologic factors|mesh-ancestor
64384206|NCT02058628|Clindamycin phosphate|clindamycin phosphate|mesh-list
64384207|NCT02058628|Azelaic acid|azelaic acid|mesh-list
64384208|NCT02058628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64384209|NCT02058628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64384210|NCT02058628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64384211|NCT02058628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384212|NCT02058628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384213|NCT02058628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384214|NCT02058628|Dermatologic Agents|dermatologic agents|mesh-ancestor
64384215|NCT02058160|Insulin|insulin|mesh-list
64384216|NCT02058160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64384217|NCT02058160|Metformin|metformin|mesh-list
64384218|NCT02058160|Insulin Glargine|insulin glargine|mesh-list
64384219|NCT02058160|Lixisenatide|lixisenatide|mesh-list
64384220|NCT02058160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64384221|NCT02058160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384254|NCT02056288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64384255|NCT02056288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64384256|NCT02056288|Anesthetics, General|anesthetics, general|mesh-ancestor
64384257|NCT03115697|Rifaximin|rifaximin|mesh-list
64384258|NCT03115697|Lactulose|lactulose|mesh-list
64384259|NCT03115697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64384260|NCT03115697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64384261|NCT03115697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64384262|NCT03115775|Vitamin D|vitamin d|mesh-list
64384263|NCT03115775|Ergocalciferols|ergocalciferols|mesh-list
64384264|NCT03115775|Cholecalciferol|cholecalciferol|mesh-list
64384265|NCT03115775|Vitamins|vitamins|mesh-list
64384266|NCT03115775|Micronutrients|micronutrients|mesh-ancestor
64384267|NCT03115775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384268|NCT03115775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64384269|NCT03115775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64384270|NCT02404259|Ritonavir|ritonavir|mesh-list
64384271|NCT02404259|Lopinavir|lopinavir|mesh-list
64384272|NCT02404259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64384273|NCT02404259|Tenofovir|tenofovir|mesh-list
64384274|NCT02404259|Efavirenz|efavirenz|mesh-list
64384275|NCT02404259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64384276|NCT02404259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64384277|NCT02404259|Protease Inhibitors|protease inhibitors|mesh-ancestor
64384278|NCT02404259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384279|NCT02404259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384298|NCT03169751|Caffeine|caffeine|mesh-list
64384303|NCT03169751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384304|NCT03169751|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64384305|NCT03169751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64384306|NCT03169751|Purinergic Agents|purinergic agents|mesh-ancestor
64384307|NCT03169751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64384308|NCT02403713|Fluticasone|fluticasone|mesh-list
64384309|NCT02403713|Xhance|xhance|mesh-list
64384310|NCT02403713|Formoterol Fumarate|formoterol fumarate|mesh-list
64384311|NCT02403713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64384312|NCT02403713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64384313|NCT02403713|Autonomic Agents|autonomic agents|mesh-ancestor
64384314|NCT02403713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64384315|NCT02403713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384316|NCT02403713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64384317|NCT02403713|Respiratory System Agents|respiratory system agents|mesh-ancestor
64769583|NCT05063552|Endothelial Growth Factors|endothelial growth factors|mesh-list
64384318|NCT02403713|Dermatologic Agents|dermatologic agents|mesh-ancestor
64384319|NCT02403713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64384320|NCT02403713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64384321|NCT02403713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64384322|NCT02403713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64384323|NCT02403713|Adrenergic Agents|adrenergic agents|mesh-ancestor
64833626|NCT05553808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395844|NCT03189641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395845|NCT03189641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395846|NCT03189641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64395847|NCT03189641|Respiratory System Agents|respiratory system agents|mesh-ancestor
64395848|NCT03189641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64395849|NCT03189641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64395850|NCT03189641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395851|NCT03189641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64833627|NCT05540184|Allopurinol|allopurinol|mesh-list
64833628|NCT05540184|Trimetazidine|trimetazidine|mesh-list
64833629|NCT05540184|Antimetabolites|antimetabolites|mesh-ancestor
64833630|NCT05540184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833631|NCT05540184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833632|NCT05540184|Gout Suppressants|gout suppressants|mesh-ancestor
64833633|NCT05540184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64833634|NCT05540184|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64833635|NCT05540184|Antioxidants|antioxidants|mesh-ancestor
64833636|NCT05540184|Protective Agents|protective agents|mesh-ancestor
64395877|NCT03938831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395878|NCT03938831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64395879|NCT03938831|Narcotics|narcotics|mesh-ancestor
64395880|NCT03938831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64395881|NCT03938831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64395898|NCT02592707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395900|NCT02592707|Dermatologic Agents|dermatologic agents|mesh-ancestor
64395901|NCT02592707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64395902|NCT02592707|Serotonin Agents|serotonin agents|mesh-ancestor
64395903|NCT02592707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64395904|NCT02592707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64395905|NCT02592707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64395924|NCT03102359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64395925|NCT03102359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64395926|NCT03102359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395927|NCT03102359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64395928|NCT03102359|Analgesics|analgesics|mesh-ancestor
64395929|NCT03102359|Sensory System Agents|sensory system agents|mesh-ancestor
64395930|NCT03102359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64833647|NCT05473195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64833648|NCT05473195|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64833649|NCT05473195|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64833650|NCT05473195|Antimetabolites|antimetabolites|mesh-ancestor
64833651|NCT05473195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833652|NCT05473195|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64396076|NCT05155007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396077|NCT05155007|Antifungal Agents|antifungal agents|mesh-ancestor
64396078|NCT05155007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64396079|NCT05155007|Dermatologic Agents|dermatologic agents|mesh-ancestor
64396080|NCT05155007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64396081|NCT05155007|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64396083|NCT01641107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396084|NCT01641107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64396085|NCT01641107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833653|NCT05442216|Azacitidine|azacitidine|mesh-list
64833654|NCT05442216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64833655|NCT05442216|Antimetabolites|antimetabolites|mesh-ancestor
64833656|NCT05442216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833657|NCT05442216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833658|NCT05442216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833659|NCT05422053|Insulin|insulin|mesh-list
64833660|NCT05422053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64833661|NCT05422053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833662|NCT05419505|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
64833663|NCT05419505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64396156|NCT03101579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396157|NCT03101579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64396172|NCT02669017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64396173|NCT02669017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396174|NCT04479865|Donepezil|donepezil|mesh-list
64396175|NCT04479865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64396176|NCT04479865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396177|NCT04479865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396178|NCT04479865|Cholinergic Agents|cholinergic agents|mesh-ancestor
64396179|NCT04479865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64396199|NCT02668393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64396200|NCT02668393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833674|NCT05414240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64833676|NCT05414240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833677|NCT05414240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64833678|NCT05414240|Vasodilator Agents|vasodilator agents|mesh-ancestor
64833679|NCT05400122|Cyclophosphamide|cyclophosphamide|mesh-list
64833680|NCT05400122|Fludarabine|fludarabine|mesh-list
64833681|NCT05400122|Fludarabine phosphate|fludarabine phosphate|mesh-list
64833682|NCT05400122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64833683|NCT05400122|Immunologic Factors|immunologic factors|mesh-ancestor
64833684|NCT05400122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396201|NCT05251129|Atorvastatin|atorvastatin|mesh-list
64396202|NCT05251129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64396203|NCT05251129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64396204|NCT05251129|Antimetabolites|antimetabolites|mesh-ancestor
64396205|NCT05251129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396206|NCT05251129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64396266|NCT02391883|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64396267|NCT02391883|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64396268|NCT02391883|Purinergic Agents|purinergic agents|mesh-ancestor
64396269|NCT02391883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64396270|NCT02391883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396271|NCT02391883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396272|NCT02382523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64396273|NCT02382523|Hormones|hormones|mesh-ancestor
64396274|NCT02382523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64396275|NCT02382523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396276|NCT02391805|Tenofovir|tenofovir|mesh-list
64396277|NCT02391805|Entecavir|entecavir|mesh-list
64396278|NCT02391805|Antiviral Agents|antiviral agents|mesh-ancestor
64396279|NCT02391805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64396280|NCT02391805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64396281|NCT02391805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64396282|NCT02391805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833685|NCT05400122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64833686|NCT05400122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64833687|NCT05400122|Alkylating Agents|alkylating agents|mesh-ancestor
64833688|NCT05400122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833689|NCT05400122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833690|NCT05400122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64833691|NCT05400122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64833692|NCT05400122|Antimetabolites|antimetabolites|mesh-ancestor
64833693|NCT05344911|Remifentanil|remifentanil|mesh-list
64833695|NCT05344911|Propofol|propofol|mesh-list
64833696|NCT05344911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64833697|NCT05344911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64833698|NCT05344911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833699|NCT05344911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64833700|NCT05344911|Anesthetics, General|anesthetics, general|mesh-ancestor
64833701|NCT05344911|Anesthetics|anesthetics|mesh-ancestor
64833702|NCT05344911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64396305|NCT02386111|Growth Substances|growth substances|mesh-ancestor
64833706|NCT05344911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64833707|NCT05344417|Iodine|iodine|mesh-list
64833708|NCT05344417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64833709|NCT05344417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64444859|NCT04766450|Antioxidants|antioxidants|mesh-ancestor
64833710|NCT05344417|Trace Elements|trace elements|mesh-ancestor
64833711|NCT05344417|Micronutrients|micronutrients|mesh-ancestor
64833712|NCT05344417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396384|NCT02380417|Sensory System Agents|sensory system agents|mesh-ancestor
64396385|NCT02380417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64396387|NCT02390089|Antipruritics|antipruritics|mesh-ancestor
64396388|NCT02390089|Dermatologic Agents|dermatologic agents|mesh-ancestor
64396389|NCT02390089|Sensory System Agents|sensory system agents|mesh-ancestor
64396390|NCT02390089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64396391|NCT02390089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396392|NCT02379793|Mineral Oil|mineral oil|mesh-list
64396393|NCT02379793|Emollients|emollients|mesh-ancestor
64396394|NCT02379793|Dermatologic Agents|dermatologic agents|mesh-ancestor
64396395|NCT01975246|Amlodipine|amlodipine|mesh-list
64396396|NCT01975246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64396397|NCT01975246|Telmisartan|telmisartan|mesh-list
64396398|NCT01975246|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
64396399|NCT01975246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64396400|NCT01975246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64396401|NCT01975246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64396402|NCT01975246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396403|NCT01975246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64396404|NCT01975246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396405|NCT01975246|Vasodilator Agents|vasodilator agents|mesh-ancestor
64396406|NCT01975246|Diuretics|diuretics|mesh-ancestor
64833713|NCT05338021|Vancomycin|vancomycin|mesh-list
64833714|NCT05338021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64833715|NCT05338021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64833716|NCT05338008|Vancomycin|vancomycin|mesh-list
64833717|NCT05338008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64833718|NCT05338008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64833719|NCT05281328|Octreotide|octreotide|mesh-list
64833720|NCT05281328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64833721|NCT05281328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64833727|NCT05267626|Antiviral Agents|antiviral agents|mesh-ancestor
64769708|NCT04900792|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64769709|NCT04900792|Vitamins|vitamins|mesh-ancestor
64833728|NCT05267626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64833730|NCT05265208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64833731|NCT05265208|Antimetabolites|antimetabolites|mesh-ancestor
64833732|NCT05265208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833733|NCT05265208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396585|NCT02376049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64396587|NCT02376049|Analgesics|analgesics|mesh-ancestor
64396588|NCT02376049|Sensory System Agents|sensory system agents|mesh-ancestor
64396589|NCT02376049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64396590|NCT02376049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64396591|NCT02376049|Dermatologic Agents|dermatologic agents|mesh-ancestor
64396592|NCT02376049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64396638|NCT01946152|Pomalidomide|pomalidomide|mesh-list
64396655|NCT01946152|Protease Inhibitors|protease inhibitors|mesh-ancestor
64325024|NCT02151305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64325025|NCT02151305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325026|NCT02151305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64325028|NCT02151305|Anesthetics|anesthetics|mesh-ancestor
64325029|NCT02151305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64325030|NCT02151305|Narcotics|narcotics|mesh-ancestor
64325034|NCT02151305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64325036|NCT03164421|Acetylcysteine|acetylcysteine|mesh-list
64396729|NCT04404439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64396730|NCT04404439|Vasodilator Agents|vasodilator agents|mesh-ancestor
64396731|NCT04404439|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64396742|NCT01953328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64396744|NCT01953328|Immunologic Factors|immunologic factors|mesh-ancestor
64396745|NCT01953328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396746|NCT03100955|Cisplatin|cisplatin|mesh-list
64396747|NCT03100955|Etoposide|etoposide|mesh-list
64396748|NCT03100955|Etoposide phosphate|etoposide phosphate|mesh-list
64396749|NCT03100955|Apatinib|apatinib|mesh-list
64396750|NCT03100955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833737|NCT05251376|Narcotics|narcotics|mesh-ancestor
64833738|NCT05251376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64833739|NCT05251376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833740|NCT05251376|Analgesics|analgesics|mesh-ancestor
64833741|NCT05251376|Sensory System Agents|sensory system agents|mesh-ancestor
64833742|NCT05251376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64833743|NCT05251376|Antitussive Agents|antitussive agents|mesh-ancestor
64833744|NCT05251376|Respiratory System Agents|respiratory system agents|mesh-ancestor
64833745|NCT05221398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64833746|NCT05221398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833747|NCT05221398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833748|NCT05191797|Atezolizumab|atezolizumab|mesh-list
64833749|NCT05191797|Immunoglobulins|immunoglobulins|mesh-list
64396759|NCT02377609|Immunologic Factors|immunologic factors|mesh-ancestor
64396760|NCT02377609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396761|NCT02377609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64396762|NCT02377609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396763|NCT02377609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396764|NCT02369965|Ritonavir|ritonavir|mesh-list
64396765|NCT02369965|Lopinavir|lopinavir|mesh-list
64833750|NCT05191797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64833751|NCT05191797|Immunoglobulin G|immunoglobulin g|mesh-list
64833752|NCT05191797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833753|NCT05191797|Immunologic Factors|immunologic factors|mesh-ancestor
64833754|NCT05191797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833755|NCT05191446|Ethanol|ethanol|mesh-list
64833756|NCT05191446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64833757|NCT05191446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64833758|NCT05191446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64833759|NCT05191446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833760|NCT05189483|Paclitaxel|paclitaxel|mesh-list
64833761|NCT05189483|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64833762|NCT05189483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64833763|NCT05189483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833764|NCT05189483|Tubulin Modulators|tubulin modulators|mesh-ancestor
64396769|NCT02369965|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64396770|NCT02369965|Protease Inhibitors|protease inhibitors|mesh-ancestor
64396771|NCT02369965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833771|NCT05177055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64833772|NCT05177055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833773|NCT05177055|Sympathomimetics|sympathomimetics|mesh-ancestor
64833774|NCT05177055|Autonomic Agents|autonomic agents|mesh-ancestor
64833775|NCT05177055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64833778|NCT05177055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833780|NCT05177055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64833781|NCT05177055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64833782|NCT05177055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64833783|NCT05177055|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64833784|NCT05156281|Teriflunomide|teriflunomide|mesh-list
64833785|NCT05156281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64833786|NCT05156281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64833787|NCT05156281|Analgesics|analgesics|mesh-ancestor
64833788|NCT05156281|Sensory System Agents|sensory system agents|mesh-ancestor
64833789|NCT05156281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64833790|NCT05156281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833791|NCT05156281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64833792|NCT05156281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64396967|NCT02368795|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64396968|NCT02368795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64396969|NCT02368795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64396970|NCT02368795|Analgesics|analgesics|mesh-ancestor
64396971|NCT02368795|Sensory System Agents|sensory system agents|mesh-ancestor
64396972|NCT02368795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64833799|NCT05121974|Ceftriaxone|ceftriaxone|mesh-list
64833800|NCT05121974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64833801|NCT05121974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64833802|NCT05106192|Triamcinolone|triamcinolone|mesh-list
64833803|NCT05106192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64833804|NCT05106192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64833805|NCT05106192|Mechlorethamine|mechlorethamine|mesh-list
64833806|NCT05106192|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64833807|NCT05106192|Bexarotene|bexarotene|mesh-list
64833808|NCT05106192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64444980|NCT04824131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64325039|NCT03164421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64325040|NCT03164421|Expectorants|expectorants|mesh-ancestor
64325041|NCT03164421|Respiratory System Agents|respiratory system agents|mesh-ancestor
64325042|NCT03164421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64325043|NCT03164421|Antioxidants|antioxidants|mesh-ancestor
64833814|NCT05106192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64833815|NCT05106192|Immunologic Factors|immunologic factors|mesh-ancestor
64833816|NCT05106192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833817|NCT05106192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833818|NCT05106192|Alkylating Agents|alkylating agents|mesh-ancestor
64444995|NCT02166476|Renal Agents|renal agents|mesh-ancestor
64325051|NCT05476952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64325058|NCT02658812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64325059|NCT02658812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325060|NCT02628704|Dexamethasone|dexamethasone|mesh-list
64325061|NCT02628704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64325062|NCT02628704|Antiemetics|antiemetics|mesh-ancestor
64325063|NCT02628704|Autonomic Agents|autonomic agents|mesh-ancestor
64325064|NCT02628704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64325065|NCT02628704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325066|NCT02628704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64325067|NCT02628704|Glucocorticoids|glucocorticoids|mesh-ancestor
64325068|NCT02628704|Hormones|hormones|mesh-ancestor
64325069|NCT02628704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64833820|NCT05106192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833821|NCT05070247|Pembrolizumab|pembrolizumab|mesh-list
64833822|NCT05070247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64833823|NCT05070247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833824|NCT05065866|Azacitidine|azacitidine|mesh-list
64833825|NCT05065866|Cc-486|cc-486|mesh-list
64833826|NCT05065866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64833827|NCT05065866|Antimetabolites|antimetabolites|mesh-ancestor
64833828|NCT05065866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833829|NCT05065866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833830|NCT05065866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833831|NCT05064878|Fenfluramine|fenfluramine|mesh-list
64833832|NCT05064878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64833833|NCT05064878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64833834|NCT05064878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64833835|NCT05064878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833836|NCT05064878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64833837|NCT05064878|Serotonin Agents|serotonin agents|mesh-ancestor
64833838|NCT05064878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325073|NCT02152475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64325075|NCT02152475|Analgesics|analgesics|mesh-ancestor
64325080|NCT02152475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64325081|NCT02152475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325082|NCT02152475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64325083|NCT02152475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833847|NCT04950426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64833848|NCT04950426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64833849|NCT04950426|Adrenergic Agents|adrenergic agents|mesh-ancestor
64833850|NCT04950426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64833851|NCT04950426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833852|NCT04950426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833853|NCT04950426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64833854|NCT04950426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64833855|NCT04950426|Vasodilator Agents|vasodilator agents|mesh-ancestor
64833856|NCT04938609|Pembrolizumab|pembrolizumab|mesh-list
64833857|NCT04938609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64833858|NCT04938609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833859|NCT04896320|Tucatinib|tucatinib|mesh-list
64833860|NCT04896320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833861|NCT04896320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64833862|NCT04896320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833875|NCT04812457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64833876|NCT04808505|Miglustat|miglustat|mesh-list
64833877|NCT04808505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833878|NCT04808505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833879|NCT04808505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64833880|NCT04808505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64833883|NCT04808505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64833884|NCT04808505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64397389|NCT05047055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64325097|NCT02576912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64833894|NCT04789616|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64769802|NCT04830878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64769803|NCT04830878|Immunologic Factors|immunologic factors|mesh-ancestor
64769804|NCT04830878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64769805|NCT04830878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64833898|NCT04785300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64833899|NCT04785300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833900|NCT04785300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833901|NCT04785300|Antioxidants|antioxidants|mesh-ancestor
64833902|NCT04785300|Protective Agents|protective agents|mesh-ancestor
64833903|NCT04785300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602411|NCT00814177|Warfarin|warfarin|mesh-list
64833904|NCT04753216|Bevacizumab|bevacizumab|mesh-list
64833905|NCT04753216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64833906|NCT04753216|Irinotecan|irinotecan|mesh-list
64833907|NCT04753216|Endothelial Growth Factors|endothelial growth factors|mesh-list
64833908|NCT04753216|Antibodies|antibodies|mesh-list
64833909|NCT04753216|Immunoglobulins|immunoglobulins|mesh-list
64833910|NCT04753216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64833911|NCT04753216|Immunoglobulin G|immunoglobulin g|mesh-list
64833912|NCT04753216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833913|NCT04753216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64833914|NCT04753216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64833915|NCT04753216|Growth Substances|growth substances|mesh-ancestor
64833920|NCT04753216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64833924|NCT04742634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64833925|NCT04742634|Antimetabolites|antimetabolites|mesh-ancestor
64833926|NCT04742634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833927|NCT04742634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833928|NCT04742634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833929|NCT04734990|Azacitidine|azacitidine|mesh-list
64833930|NCT04734990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64833931|NCT04734990|Antimetabolites|antimetabolites|mesh-ancestor
64833932|NCT04734990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64833933|NCT04734990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833934|NCT04734990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64833935|NCT04714619|Letrozole|letrozole|mesh-list
64833936|NCT04714619|Anastrozole|anastrozole|mesh-list
64833937|NCT04714619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64833938|NCT04714619|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64833939|NCT04714619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64833940|NCT04714619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445105|NCT05398913|Hormones|hormones|mesh-ancestor
64325100|NCT02576912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64325101|NCT02576912|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64325102|NCT02576912|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64399670|NCT05004545|Anesthetics|anesthetics|mesh-ancestor
64833943|NCT04714619|Hormone Antagonists|hormone antagonists|mesh-ancestor
64833944|NCT04714619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64833945|NCT04714619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833946|NCT04714619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64400206|NCT02328079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64400207|NCT02328079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64833971|NCT04643574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769819|NCT04812366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64445151|NCT04721015|Docetaxel|docetaxel|mesh-list
64401631|NCT03066557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64833974|NCT04643574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64833975|NCT04643574|Analgesics|analgesics|mesh-ancestor
64402701|NCT02747407|Vaccines|vaccines|mesh-list
64325115|NCT02152709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325116|NCT03164109|Moxifloxacin|moxifloxacin|mesh-list
64408206|NCT05053009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64408216|NCT03094663|Cefazolin|cefazolin|mesh-list
64834009|NCT04464174|Gemcitabine|gemcitabine|mesh-list
64834010|NCT04464174|Carboplatin|carboplatin|mesh-list
64834011|NCT04464174|Capecitabine|capecitabine|mesh-list
64834012|NCT04464174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834013|NCT04464174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64834014|NCT04464174|Antimetabolites|antimetabolites|mesh-ancestor
64834015|NCT04464174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834016|NCT04464174|Antiviral Agents|antiviral agents|mesh-ancestor
64834017|NCT04464174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64409168|NCT05260359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409236|NCT05325645|Brexpiprazole|brexpiprazole|mesh-list
64834022|NCT04463498|Methamphetamine|methamphetamine|mesh-list
64834023|NCT04463498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64834024|NCT04463498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834025|NCT04463498|Sympathomimetics|sympathomimetics|mesh-ancestor
64409628|NCT02597855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64409633|NCT04987567|Antioxidants|antioxidants|mesh-list
64834033|NCT04463498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64834035|NCT04463498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64834042|NCT04456296|Hormones|hormones|mesh-ancestor
64834043|NCT04456296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64834044|NCT04456296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834045|NCT04456296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64834046|NCT04456296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325149|NCT03970304|Vaccines|vaccines|mesh-list
64325150|NCT03970304|Immunologic Factors|immunologic factors|mesh-ancestor
64325151|NCT03970304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325152|NCT01037179|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64325153|NCT01037179|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64325154|NCT01037179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64834122|NCT04002115|Fludarabine|fludarabine|mesh-list
64834123|NCT04002115|Clofarabine|clofarabine|mesh-list
64834124|NCT04002115|Tacrolimus|tacrolimus|mesh-list
64834125|NCT04002115|Lenograstim|lenograstim|mesh-list
64834126|NCT04002115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64602637|NCT03839485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64834127|NCT04002115|Immunologic Factors|immunologic factors|mesh-ancestor
64834128|NCT04002115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834129|NCT04002115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64834130|NCT04002115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64834131|NCT04002115|Alkylating Agents|alkylating agents|mesh-ancestor
64834132|NCT04002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834133|NCT04002115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834134|NCT04002115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64834135|NCT04002115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64834136|NCT04002115|Antimetabolites|antimetabolites|mesh-ancestor
64834137|NCT04002115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64834138|NCT04002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834139|NCT04002115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64325155|NCT01037179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64325156|NCT01037179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64325157|NCT01037179|Analgesics|analgesics|mesh-ancestor
64325158|NCT01037179|Sensory System Agents|sensory system agents|mesh-ancestor
64834147|NCT03987503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64834148|NCT03978598|Etonogestrel|etonogestrel|mesh-list
64834149|NCT03978598|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64834150|NCT03978598|Contraceptive Agents|contraceptive agents|mesh-ancestor
64834151|NCT03978598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64416041|NCT02570711|Gemcitabine|gemcitabine|mesh-list
64834191|NCT03871153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834192|NCT03871153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64834240|NCT03462251|Growth Substances|growth substances|mesh-ancestor
64834241|NCT03462251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834242|NCT03462251|Growth Inhibitors|growth inhibitors|mesh-ancestor
64834284|NCT03418038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64834290|NCT03418038|Antimetabolites|antimetabolites|mesh-ancestor
64834291|NCT03418038|Antiviral Agents|antiviral agents|mesh-ancestor
64834292|NCT03418038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64834293|NCT03418038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64834294|NCT03418038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64834295|NCT03418038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64834296|NCT03418038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64834297|NCT03418038|Antioxidants|antioxidants|mesh-ancestor
64834298|NCT03418038|Protective Agents|protective agents|mesh-ancestor
64834299|NCT03418038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64834300|NCT03418038|Alkylating Agents|alkylating agents|mesh-ancestor
64834301|NCT03418038|Keratolytic Agents|keratolytic agents|mesh-ancestor
64834302|NCT03418038|Dermatologic Agents|dermatologic agents|mesh-ancestor
64834303|NCT03418038|Tubulin Modulators|tubulin modulators|mesh-ancestor
64834304|NCT03418038|Antimitotic Agents|antimitotic agents|mesh-ancestor
64834305|NCT03418038|Mitosis Modulators|mitosis modulators|mesh-ancestor
64834310|NCT03409718|Histamine Antagonists|histamine antagonists|mesh-ancestor
64834311|NCT03409718|Histamine Agents|histamine agents|mesh-ancestor
64834312|NCT03409718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64834313|NCT03409718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834314|NCT03409718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834315|NCT03409718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64834316|NCT03409718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64834317|NCT03409718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834319|NCT03404778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64834320|NCT03404778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64834321|NCT03404778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64834322|NCT03404778|Histamine Antagonists|histamine antagonists|mesh-ancestor
64424140|NCT01364389|Prednisone|prednisone|mesh-list
64834335|NCT03340766|Pembrolizumab|pembrolizumab|mesh-list
64834336|NCT03340766|Blinatumomab|blinatumomab|mesh-list
64769914|NCT04685616|Dacarbazine|dacarbazine|mesh-list
64834337|NCT03340766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64834338|NCT03340766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834339|NCT03317457|Doxorubicin|doxorubicin|mesh-list
64834340|NCT03317457|Durvalumab|durvalumab|mesh-list
64834341|NCT03317457|Tremelimumab|tremelimumab|mesh-list
64834342|NCT03317457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64834343|NCT03317457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834344|NCT03317457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64834345|NCT03317457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64834346|NCT03317457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64834347|NCT03317457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834348|NCT03317457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64834349|NCT03294954|Cyclophosphamide|cyclophosphamide|mesh-list
64834350|NCT03294954|Fludarabine|fludarabine|mesh-list
64834351|NCT03294954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64834352|NCT03294954|Immunologic Factors|immunologic factors|mesh-ancestor
64834353|NCT03294954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424166|NCT04203901|Immunologic Factors|immunologic factors|mesh-ancestor
64834388|NCT05705492|Antiemetics|antiemetics|mesh-ancestor
64834389|NCT05705492|Autonomic Agents|autonomic agents|mesh-ancestor
64834390|NCT05705492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64834391|NCT05705492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834392|NCT05705492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64834393|NCT05705492|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64834394|NCT05705492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64834395|NCT05705492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64834396|NCT05705492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64834397|NCT05705492|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64834398|NCT05705492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64325223|NCT02270281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64325224|NCT02270281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64325225|NCT02270281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64325226|NCT02270281|Adrenergic Agents|adrenergic agents|mesh-ancestor
64325227|NCT02270281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64834399|NCT05705492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64834400|NCT05705492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834401|NCT05705492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64834402|NCT05705492|Serotonin Agents|serotonin agents|mesh-ancestor
64834403|NCT05705466|Pembrolizumab|pembrolizumab|mesh-list
64834404|NCT05705466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64834405|NCT05705466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834406|NCT05705388|Liraglutide|liraglutide|mesh-list
64834407|NCT05705388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64834408|NCT05705388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834409|NCT05705388|Incretins|incretins|mesh-ancestor
64834410|NCT05705388|Hormones|hormones|mesh-ancestor
64834411|NCT05705388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64834412|NCT05705336|Tranexamic Acid|tranexamic acid|mesh-list
64834413|NCT05705336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64834414|NCT05705336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64834415|NCT05705336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834416|NCT05705336|Hemostatics|hemostatics|mesh-ancestor
64834417|NCT05705336|Coagulants|coagulants|mesh-ancestor
64834418|NCT05705037|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
64834419|NCT05705037|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64834420|NCT05705037|Serotonin Agents|serotonin agents|mesh-ancestor
64834421|NCT05705037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64834422|NCT05705037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445594|NCT04113616|Cytarabine|cytarabine|mesh-list
64325228|NCT02270281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424369|NCT04979065|Micronutrients|micronutrients|mesh-ancestor
64834438|NCT05704595|Diuretics|diuretics|mesh-list
64834439|NCT05704595|Natriuretic Agents|natriuretic agents|mesh-ancestor
64424456|NCT02501629|Respiratory System Agents|respiratory system agents|mesh-ancestor
64834510|NCT05702190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64834511|NCT05702190|Narcotics|narcotics|mesh-ancestor
64834512|NCT05702190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64834513|NCT05702190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834514|NCT05702190|Analgesics|analgesics|mesh-ancestor
64834515|NCT05702190|Sensory System Agents|sensory system agents|mesh-ancestor
64834516|NCT05702190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64834517|NCT05702190|Antidiarrheals|antidiarrheals|mesh-ancestor
64834518|NCT05702190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64834519|NCT05702190|Antitussive Agents|antitussive agents|mesh-ancestor
64834520|NCT05702190|Respiratory System Agents|respiratory system agents|mesh-ancestor
64834521|NCT05701124|Ranibizumab|ranibizumab|mesh-list
64834522|NCT05701124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64445679|NCT04801589|Dexmedetomidine|dexmedetomidine|mesh-list
64325270|NCT05476172|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64325271|NCT05476172|Hormone Antagonists|hormone antagonists|mesh-ancestor
64325272|NCT05476172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64325273|NCT05476172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64325274|NCT05476172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325275|NCT02765165|Lomustine|lomustine|mesh-list
64325276|NCT02765165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64325277|NCT02765165|Alkylating Agents|alkylating agents|mesh-ancestor
64325278|NCT02765165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325279|NCT02765165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325280|NCT02156843|Pyridoxamine|pyridoxamine|mesh-list
64834566|NCT05641246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64834567|NCT05641246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834583|NCT05584709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325294|NCT02675907|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64325295|NCT02675907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64325296|NCT02675907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64325297|NCT02675907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834654|NCT04911621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325324|NCT02156999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64325326|NCT05014581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64325328|NCT05014581|Adrenergic Agents|adrenergic agents|mesh-ancestor
64834704|NCT04551885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64834705|NCT04551885|Immunologic Factors|immunologic factors|mesh-ancestor
64834706|NCT04551885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834707|NCT04551885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64834708|NCT04551885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64834709|NCT04551885|Alkylating Agents|alkylating agents|mesh-ancestor
64834710|NCT04551885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834711|NCT04551885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834712|NCT04551885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64834714|NCT04551885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64834715|NCT04551885|Antiviral Agents|antiviral agents|mesh-ancestor
64834716|NCT04551885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64425962|NCT04830735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834728|NCT04484532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834729|NCT04427709|Oxytocin|oxytocin|mesh-list
64834730|NCT04427709|Oxytocics|oxytocics|mesh-ancestor
64834731|NCT04427709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64834732|NCT04427709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834733|NCT04402073|Vincristine|vincristine|mesh-list
64834734|NCT04402073|Lomustine|lomustine|mesh-list
64834735|NCT04402073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834736|NCT04402073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64834737|NCT04402073|Tubulin Modulators|tubulin modulators|mesh-ancestor
64834761|NCT04231877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64834762|NCT04231877|Etoposide|etoposide|mesh-list
64834763|NCT04231877|Daunorubicin|daunorubicin|mesh-list
64834764|NCT04231877|Podophyllotoxin|podophyllotoxin|mesh-list
64834765|NCT04231877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64834766|NCT04231877|Antibodies|antibodies|mesh-list
64834767|NCT04231877|Immunoglobulins|immunoglobulins|mesh-list
64834768|NCT04231877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64834769|NCT04231877|Lenograstim|lenograstim|mesh-list
64834770|NCT04231877|Immunoconjugates|immunoconjugates|mesh-list
64325356|NCT02159651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64325357|NCT02159651|Immunologic Factors|immunologic factors|mesh-ancestor
64325358|NCT02159651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325359|NCT02159651|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64325360|NCT02159651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426180|NCT01636947|Dopamine Agents|dopamine agents|mesh-ancestor
64426182|NCT03052725|Reslizumab|reslizumab|mesh-list
64834797|NCT04199728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64834798|NCT04199728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834799|NCT04199728|Incretins|incretins|mesh-ancestor
64834800|NCT04199728|Hormones|hormones|mesh-ancestor
64834801|NCT04199728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64834802|NCT04166435|Temozolomide|temozolomide|mesh-list
64834803|NCT04166435|Olaparib|olaparib|mesh-list
64834804|NCT04166435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64834805|NCT04166435|Alkylating Agents|alkylating agents|mesh-ancestor
64445934|NCT04691375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834819|NCT04162015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64834820|NCT04077515|Sirolimus|sirolimus|mesh-list
64834821|NCT04077515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64834831|NCT04037527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64834833|NCT04037527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834834|NCT04037527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834835|NCT04037527|Antiviral Agents|antiviral agents|mesh-ancestor
64834836|NCT04037527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64426433|NCT04784247|Pembrolizumab|pembrolizumab|mesh-list
64834842|NCT04037527|Antimitotic Agents|antimitotic agents|mesh-ancestor
64325376|NCT02157311|Emtricitabine|emtricitabine|mesh-list
64325377|NCT02157311|Efavirenz|efavirenz|mesh-list
64325378|NCT02157311|Lopinavir|lopinavir|mesh-list
64325379|NCT02157311|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64325380|NCT02157311|Darunavir|darunavir|mesh-list
64325381|NCT02157311|Abacavir|abacavir|mesh-list
64325382|NCT02157311|Rilpivirine|rilpivirine|mesh-list
64325383|NCT02157311|Etravirine|etravirine|mesh-list
64325384|NCT02157311|Antiviral Agents|antiviral agents|mesh-ancestor
64426527|NCT03560349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64426528|NCT03560349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64834850|NCT04009044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64834851|NCT04009044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834852|NCT04009044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64834853|NCT04009044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64834854|NCT04009044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64834855|NCT03999515|Abiraterone Acetate|abiraterone acetate|mesh-list
64834856|NCT03999515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834857|NCT03999515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64325389|NCT02157311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325390|NCT02157311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64325391|NCT02157311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64325392|NCT02157311|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64426737|NCT02207907|Protective Agents|protective agents|mesh-ancestor
64834861|NCT03999515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64834862|NCT03999515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834863|NCT03999515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64834864|NCT03980769|Fludarabine|fludarabine|mesh-list
64834865|NCT03980769|Fludarabine phosphate|fludarabine phosphate|mesh-list
64325402|NCT04784039|Fibrin fragment D|fibrin fragment d|mesh-list
64325403|NCT04784039|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64426977|NCT02224599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64834889|NCT03921008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64834890|NCT03921008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834891|NCT03921008|Tubulin Modulators|tubulin modulators|mesh-ancestor
64834892|NCT03921008|Antimitotic Agents|antimitotic agents|mesh-ancestor
64834893|NCT03921008|Mitosis Modulators|mitosis modulators|mesh-ancestor
64834894|NCT03921008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834895|NCT03919773|Immunoglobulins|immunoglobulins|mesh-list
64834896|NCT03919773|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64427389|NCT01649791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64325416|NCT02157467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325418|NCT02157467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64325419|NCT02157467|Contraceptive Agents|contraceptive agents|mesh-ancestor
64325420|NCT02157467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64834899|NCT03919773|Immunologic Factors|immunologic factors|mesh-ancestor
64834900|NCT03919773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834901|NCT03841110|Aldesleukin|aldesleukin|mesh-list
64834902|NCT03841110|Cyclophosphamide|cyclophosphamide|mesh-list
64834903|NCT03841110|Pembrolizumab|pembrolizumab|mesh-list
64834904|NCT03841110|Nivolumab|nivolumab|mesh-list
64834905|NCT03841110|Fludarabine|fludarabine|mesh-list
64834906|NCT03841110|Atezolizumab|atezolizumab|mesh-list
64834907|NCT03841110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64834908|NCT03841110|Immunologic Factors|immunologic factors|mesh-ancestor
64834909|NCT03841110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834910|NCT03841110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64834911|NCT03841110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64834912|NCT03841110|Alkylating Agents|alkylating agents|mesh-ancestor
64834913|NCT03841110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836097|NCT01611077|Amlodipine|amlodipine|mesh-list
64325430|NCT01374087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64325431|NCT01374087|Contraceptive Agents|contraceptive agents|mesh-ancestor
64325432|NCT01374087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64427583|NCT04886323|Hormone Antagonists|hormone antagonists|mesh-ancestor
64834922|NCT03810313|Aflibercept|aflibercept|mesh-list
64834923|NCT03810313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64427723|NCT02339155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64427724|NCT02339155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64427725|NCT02339155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64427728|NCT02339155|Anesthetics|anesthetics|mesh-ancestor
64834924|NCT03810313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64834925|NCT03810313|Growth Substances|growth substances|mesh-ancestor
64834926|NCT03810313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834927|NCT03810313|Growth Inhibitors|growth inhibitors|mesh-ancestor
64427822|NCT02134977|Leuprolide|leuprolide|mesh-list
64834930|NCT03802630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64834931|NCT03802630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64834932|NCT03802630|Growth Substances|growth substances|mesh-ancestor
64325434|NCT01374087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64325435|NCT01374087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64325436|NCT01374087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325438|NCT00152971|Dabigatran|dabigatran|mesh-list
64325439|NCT00152971|Anticoagulants|anticoagulants|mesh-ancestor
64325440|NCT00152971|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64834936|NCT03785691|Ondansetron|ondansetron|mesh-list
64834937|NCT03785691|Mirtazapine|mirtazapine|mesh-list
64834938|NCT03785691|Antiemetics|antiemetics|mesh-ancestor
64834939|NCT03785691|Autonomic Agents|autonomic agents|mesh-ancestor
64834940|NCT03785691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64834941|NCT03785691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834942|NCT03785691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64834943|NCT03785691|Antipruritics|antipruritics|mesh-ancestor
64834944|NCT03785691|Dermatologic Agents|dermatologic agents|mesh-ancestor
64834945|NCT03785691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64769949|NCT04669678|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64834946|NCT03785691|Serotonin Agents|serotonin agents|mesh-ancestor
64834947|NCT03785691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64834948|NCT03785691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769950|NCT04669678|Medroxyprogesterone|medroxyprogesterone|mesh-list
64834949|NCT03785691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64769951|NCT04669678|Etonogestrel|etonogestrel|mesh-list
64834950|NCT03785691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64769953|NCT04669678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64428012|NCT02164929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64428059|NCT01888432|Everolimus|everolimus|mesh-list
64834954|NCT03785691|Antidepressive Agents|antidepressive agents|mesh-ancestor
64834955|NCT03785691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64834956|NCT03785691|Histamine Antagonists|histamine antagonists|mesh-ancestor
64428198|NCT02131155|Afatinib|afatinib|mesh-list
64834966|NCT03780829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64834967|NCT03780829|Renal Agents|renal agents|mesh-ancestor
64834968|NCT03780829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64834969|NCT03780829|Antitubercular Agents|antitubercular agents|mesh-ancestor
64834970|NCT03780829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64834971|NCT03780829|Antimetabolites|antimetabolites|mesh-ancestor
64834972|NCT03780829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64834973|NCT03736863|Apatinib|apatinib|mesh-list
64834974|NCT03736863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64834975|NCT03736863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64834985|NCT03703492|Estradiol|estradiol|mesh-list
64834986|NCT03703492|Estrogens|estrogens|mesh-ancestor
64834987|NCT03703492|Hormones|hormones|mesh-ancestor
64834988|NCT03703492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64834989|NCT03703492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834990|NCT03624127|Apremilast|apremilast|mesh-list
64834991|NCT03624127|BMS-986165|bms-986165|mesh-list
64446115|NCT01572844|Antitubercular Agents|antitubercular agents|mesh-ancestor
64428512|NCT01912222|Ixazomib|ixazomib|mesh-list
64428585|NCT02525861|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64428586|NCT02525861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428587|NCT02525861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325453|NCT04675827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64325454|NCT04675827|Tubulin Modulators|tubulin modulators|mesh-ancestor
64325455|NCT04675827|Antimitotic Agents|antimitotic agents|mesh-ancestor
64834994|NCT03624127|Analgesics|analgesics|mesh-ancestor
64834995|NCT03624127|Sensory System Agents|sensory system agents|mesh-ancestor
64834996|NCT03624127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64834997|NCT03624127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64834998|NCT03624127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64834999|NCT03624127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64835000|NCT03624127|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64835001|NCT03624127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64835002|NCT03624127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835003|NCT03624127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835016|NCT03597568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64835017|NCT03499899|Carboplatin|carboplatin|mesh-list
64835018|NCT03499899|Spartalizumab|spartalizumab|mesh-list
64835019|NCT03499899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835020|NCT03499899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64835021|NCT03499899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835022|NCT03481634|Aflibercept|aflibercept|mesh-list
64835023|NCT03481634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64835024|NCT03481634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64835025|NCT03481634|Growth Substances|growth substances|mesh-ancestor
64769971|NCT04652661|Analgesics|analgesics|mesh-ancestor
64835026|NCT03481634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835027|NCT03481634|Growth Inhibitors|growth inhibitors|mesh-ancestor
64835028|NCT03481634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835029|NCT03476642|Epinephrine|epinephrine|mesh-list
64835030|NCT03476642|Ropivacaine|ropivacaine|mesh-list
64835031|NCT03476642|Anesthetics, Local|anesthetics, local|mesh-ancestor
64835032|NCT03476642|Anesthetics|anesthetics|mesh-ancestor
64446142|NCT01533688|Bisacodyl|bisacodyl|mesh-list
64325460|NCT02538614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325461|NCT02538614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64325462|NCT02538614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325463|NCT02538614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64325464|NCT03504644|Vincristine|vincristine|mesh-list
64325465|NCT03504644|Venetoclax|venetoclax|mesh-list
64325466|NCT03504644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64325467|NCT03504644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429089|NCT05218889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64835034|NCT03476642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835035|NCT03476642|Sensory System Agents|sensory system agents|mesh-ancestor
64835043|NCT03476642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64835058|NCT03430700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64835060|NCT03291028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64446180|NCT02217566|Hormone Antagonists|hormone antagonists|mesh-ancestor
64835069|NCT03289910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835070|NCT03289910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835071|NCT03289910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64835073|NCT03245151|Lenvatinib|lenvatinib|mesh-list
64835074|NCT03245151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835075|NCT03245151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64835082|NCT03171025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64835083|NCT03171025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835084|NCT03171025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64325485|NCT03126968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325486|NCT03126968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325487|NCT03126968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64325490|NCT03126968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64325492|NCT03126968|Respiratory System Agents|respiratory system agents|mesh-ancestor
64325493|NCT03126968|Mydriatics|mydriatics|mesh-ancestor
64325494|NCT03126968|Sympathomimetics|sympathomimetics|mesh-ancestor
64325495|NCT03126968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64325496|NCT02266849|Loperamide|loperamide|mesh-list
64325497|NCT02266849|Antidiarrheals|antidiarrheals|mesh-list
64325498|NCT02266849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64325499|NCT01309945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64835085|NCT03171025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835086|NCT03149003|Bevacizumab|bevacizumab|mesh-list
64835087|NCT03149003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64835088|NCT03149003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835089|NCT03149003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64835090|NCT03149003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64835091|NCT03149003|Growth Substances|growth substances|mesh-ancestor
64835092|NCT03149003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835093|NCT03149003|Growth Inhibitors|growth inhibitors|mesh-ancestor
64835094|NCT03148275|Trametinib|trametinib|mesh-list
64835095|NCT03148275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835096|NCT03148275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64835097|NCT03148275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835098|NCT03148275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835099|NCT03106454|Ferrous fumarate|ferrous fumarate|mesh-list
64835100|NCT03106454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64835101|NCT03106454|Norethindrone|norethindrone|mesh-list
64835102|NCT03106454|Norethindrone Acetate|norethindrone acetate|mesh-list
64835103|NCT03106454|Estradiol|estradiol|mesh-list
64325503|NCT01309945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835151|NCT02938442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64835152|NCT02938442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835195|NCT02606045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64835196|NCT02606045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64835197|NCT02606045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835198|NCT02606045|Hemostatics|hemostatics|mesh-ancestor
64835199|NCT02606045|Coagulants|coagulants|mesh-ancestor
64835200|NCT02420821|Bevacizumab|bevacizumab|mesh-list
64835202|NCT02420821|Atezolizumab|atezolizumab|mesh-list
64835203|NCT02420821|Antibodies|antibodies|mesh-list
64835204|NCT02420821|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64446315|NCT02156492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835227|NCT02229084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64835228|NCT02229084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835229|NCT02229084|Tubulin Modulators|tubulin modulators|mesh-ancestor
64835230|NCT02229084|Antimitotic Agents|antimitotic agents|mesh-ancestor
64835231|NCT02229084|Mitosis Modulators|mitosis modulators|mesh-ancestor
64835232|NCT02229084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835234|NCT02229084|Immunologic Factors|immunologic factors|mesh-ancestor
64835235|NCT02229084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835236|NCT02229084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64835237|NCT02229084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64835238|NCT02229084|Alkylating Agents|alkylating agents|mesh-ancestor
64835239|NCT02229084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64835240|NCT02229084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64835241|NCT02229084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64835242|NCT02229084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64835243|NCT02229084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835244|NCT02229084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64835245|NCT02188121|Losartan|losartan|mesh-list
64835246|NCT02188121|Simvastatin|simvastatin|mesh-list
64835247|NCT02188121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64835248|NCT02188121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64835250|NCT02188121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835252|NCT02188121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64835253|NCT02188121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835254|NCT02188121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64835255|NCT02188121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64835256|NCT02188121|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64835257|NCT02188121|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64835258|NCT02066181|Sorafenib|sorafenib|mesh-list
64835259|NCT02066181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835260|NCT02066181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64835261|NCT02066181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835262|NCT02066181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835263|NCT02059265|Dasatinib|dasatinib|mesh-list
64835264|NCT02059265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325518|NCT02153567|Serotonin Agents|serotonin agents|mesh-ancestor
64325519|NCT02153567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325520|NCT02153567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64586564|NCT01512407|Ethiodized Oil|ethiodized oil|mesh-list
64325522|NCT02153567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64586630|NCT01423916|Moxifloxacin|moxifloxacin|mesh-list
64325533|NCT01303783|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64325534|NCT01303783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64835344|NCT01746173|Plerixafor|plerixafor|mesh-list
64835345|NCT01746173|Prednisone|prednisone|mesh-list
64835346|NCT01746173|Cyclophosphamide|cyclophosphamide|mesh-list
64835347|NCT01746173|Melphalan|melphalan|mesh-list
64835348|NCT01746173|Busulfan|busulfan|mesh-list
64835349|NCT01746173|Doxorubicin|doxorubicin|mesh-list
64835350|NCT01746173|Etoposide|etoposide|mesh-list
64835351|NCT01746173|Etoposide phosphate|etoposide phosphate|mesh-list
64835352|NCT01746173|Vincristine|vincristine|mesh-list
64835353|NCT01746173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64835354|NCT01746173|Immunologic Factors|immunologic factors|mesh-ancestor
64835355|NCT01746173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835356|NCT01746173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64835357|NCT01746173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64835358|NCT01746173|Alkylating Agents|alkylating agents|mesh-ancestor
64770017|NCT04573751|Sympathomimetics|sympathomimetics|mesh-ancestor
64835359|NCT01746173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835360|NCT01746173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835361|NCT01746173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64586986|NCT00383747|Cholinergic Agents|cholinergic agents|mesh-ancestor
64835366|NCT01746173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835367|NCT01746173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64835368|NCT01746173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64835369|NCT01746173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64835370|NCT01746173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64835371|NCT01746173|Glucocorticoids|glucocorticoids|mesh-ancestor
64835373|NCT01746173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64835374|NCT01746173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64835375|NCT01746173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64835376|NCT01746173|Tubulin Modulators|tubulin modulators|mesh-ancestor
64835377|NCT01746173|Antimitotic Agents|antimitotic agents|mesh-ancestor
64835378|NCT01746173|Mitosis Modulators|mitosis modulators|mesh-ancestor
64835379|NCT01746173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64835380|NCT01746173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64835381|NCT01694004|Benzocaine|benzocaine|mesh-list
64835382|NCT01694004|Anesthetics, Local|anesthetics, local|mesh-ancestor
64835383|NCT01694004|Anesthetics|anesthetics|mesh-ancestor
64835398|NCT01545843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64835399|NCT01545843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64587162|NCT00528541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64835401|NCT01545843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835402|NCT00843791|Pioglitazone|pioglitazone|mesh-list
64835403|NCT00843791|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
64835404|NCT00843791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64835405|NCT00843791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835406|NCT03187769|Olanzapine|olanzapine|mesh-list
64835407|NCT03187769|Antiemetics|antiemetics|mesh-ancestor
64835408|NCT03187769|Autonomic Agents|autonomic agents|mesh-ancestor
64835409|NCT03187769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64835410|NCT03187769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835411|NCT03187769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64835412|NCT03187769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64835413|NCT03187769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64835414|NCT03187769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64835415|NCT03187769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64835416|NCT03187769|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64835417|NCT03187769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64835418|NCT03187769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64835419|NCT03187769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835421|NCT03187769|Serotonin Agents|serotonin agents|mesh-ancestor
64835423|NCT03161353|Carboplatin|carboplatin|mesh-list
64835424|NCT03161353|Docetaxel|docetaxel|mesh-list
64835425|NCT03161353|Trastuzumab|trastuzumab|mesh-list
64835426|NCT03161353|Letrozole|letrozole|mesh-list
64835427|NCT03161353|Pertuzumab|pertuzumab|mesh-list
64835428|NCT03161353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835429|NCT03161353|Tubulin Modulators|tubulin modulators|mesh-ancestor
64835430|NCT03161353|Antimitotic Agents|antimitotic agents|mesh-ancestor
64835431|NCT03161353|Mitosis Modulators|mitosis modulators|mesh-ancestor
64835432|NCT03161353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835444|NCT03161353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64835445|NCT03136731|Antibodies|antibodies|mesh-list
64835446|NCT03136731|Immunologic Factors|immunologic factors|mesh-ancestor
64835447|NCT03136731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835448|NCT03134196|Valacyclovir|valacyclovir|mesh-list
64835449|NCT03134196|Antiviral Agents|antiviral agents|mesh-ancestor
64835450|NCT03134196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64835451|NCT02956382|Venetoclax|venetoclax|mesh-list
64835452|NCT02956382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835453|NCT02939573|Dapsone|dapsone|mesh-list
64835454|NCT02939573|Colchicine|colchicine|mesh-list
64835455|NCT02939573|Azathioprine|azathioprine|mesh-list
64835456|NCT02939573|Gout Suppressants|gout suppressants|mesh-ancestor
64835457|NCT02939573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64835458|NCT02939573|Tubulin Modulators|tubulin modulators|mesh-ancestor
64835459|NCT02939573|Antimitotic Agents|antimitotic agents|mesh-ancestor
64835460|NCT02939573|Mitosis Modulators|mitosis modulators|mesh-ancestor
64835468|NCT02939573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64835469|NCT02939573|Antimalarials|antimalarials|mesh-ancestor
64835470|NCT02939573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64835471|NCT02939573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64835472|NCT02939573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64835473|NCT02939573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835474|NCT02939573|Leprostatic Agents|leprostatic agents|mesh-ancestor
64835475|NCT02939573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64835476|NCT02891603|Sirolimus|sirolimus|mesh-list
64835477|NCT02891603|Tacrolimus|tacrolimus|mesh-list
64835478|NCT02891603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64835479|NCT02891603|Immunologic Factors|immunologic factors|mesh-ancestor
64835480|NCT02891603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835481|NCT02891603|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64835482|NCT02891603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446589|NCT01553188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64587552|NCT02078882|Abatacept|abatacept|mesh-list
64587951|NCT00433745|Vaccines|vaccines|mesh-list
64835485|NCT02891603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64835486|NCT02891603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64835487|NCT02891603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835488|NCT02891603|Antifungal Agents|antifungal agents|mesh-ancestor
64835490|NCT02876107|Carboplatin|carboplatin|mesh-list
64835491|NCT02876107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64835492|NCT02876107|Panitumumab|panitumumab|mesh-list
64835493|NCT02876107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64835494|NCT02876107|Antibodies|antibodies|mesh-list
64835495|NCT02876107|Immunoglobulins|immunoglobulins|mesh-list
64835496|NCT02876107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64835497|NCT02876107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64588144|NCT00537511|Etoposide|etoposide|mesh-list
64835498|NCT02876107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835499|NCT02876107|Tubulin Modulators|tubulin modulators|mesh-ancestor
64835500|NCT02876107|Antimitotic Agents|antimitotic agents|mesh-ancestor
64835501|NCT02876107|Mitosis Modulators|mitosis modulators|mesh-ancestor
64835502|NCT02876107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835503|NCT02876107|Immunologic Factors|immunologic factors|mesh-ancestor
64835504|NCT02876107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835505|NCT02855229|Methylphenidate|methylphenidate|mesh-list
64835506|NCT02855229|Modafinil|modafinil|mesh-list
64835507|NCT02855229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64835508|NCT02855229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835509|NCT02855229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64835512|NCT02855229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835513|NCT02855229|Dopamine Agents|dopamine agents|mesh-ancestor
64835514|NCT02855229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64835515|NCT02855229|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64835516|NCT02855229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64835517|NCT02855229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64835518|NCT02829931|Bevacizumab|bevacizumab|mesh-list
64835519|NCT02829931|Nivolumab|nivolumab|mesh-list
64835529|NCT02829931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835531|NCT02815566|Emtricitabine|emtricitabine|mesh-list
64835532|NCT02815566|Antiviral Agents|antiviral agents|mesh-ancestor
64835533|NCT02815566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64835534|NCT02815566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64325561|NCT02153879|Vitamin B Complex|vitamin b complex|mesh-ancestor
64325563|NCT02153879|Micronutrients|micronutrients|mesh-ancestor
64325564|NCT02153879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325565|NCT01373931|Moxifloxacin|moxifloxacin|mesh-list
64325566|NCT01373931|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64325567|NCT01373931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64325568|NCT01373931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64588761|NCT00506155|Antimetabolites|antimetabolites|mesh-ancestor
64835548|NCT02727803|Busulfan|busulfan|mesh-list
64835549|NCT02727803|Mechlorethamine|mechlorethamine|mesh-list
64835550|NCT02727803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64835553|NCT02727803|Fludarabine phosphate|fludarabine phosphate|mesh-list
64835555|NCT02727803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64835556|NCT02727803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64835557|NCT02727803|Antibodies|antibodies|mesh-list
64325572|NCT01373931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325573|NCT01373931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325574|NCT01373931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64835564|NCT02727803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64835565|NCT02727803|Alkylating Agents|alkylating agents|mesh-ancestor
64835566|NCT02727803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835567|NCT02727803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835568|NCT02727803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64835569|NCT02727803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64835570|NCT02727803|Antimetabolites|antimetabolites|mesh-ancestor
64835572|NCT02702492|Nivolumab|nivolumab|mesh-list
64835573|NCT02702492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64835574|NCT02702492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835575|NCT02702492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64589905|NCT00478361|Antimetabolites|antimetabolites|mesh-ancestor
64836102|NCT01611077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64835579|NCT02702492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64835580|NCT02702492|Vasodilator Agents|vasodilator agents|mesh-ancestor
64835581|NCT02702492|Vitamin B Complex|vitamin b complex|mesh-ancestor
64835583|NCT02702492|Micronutrients|micronutrients|mesh-ancestor
64835584|NCT02702492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835585|NCT02652455|Aldesleukin|aldesleukin|mesh-list
64835586|NCT02652455|Cyclophosphamide|cyclophosphamide|mesh-list
64835587|NCT02652455|Nivolumab|nivolumab|mesh-list
64835588|NCT02652455|Fludarabine|fludarabine|mesh-list
64835589|NCT02652455|Interleukin-2|interleukin-2|mesh-list
64835590|NCT02652455|Antibodies|antibodies|mesh-list
64835591|NCT02652455|Immunoglobulins|immunoglobulins|mesh-list
64835592|NCT02652455|Antibodies, Blocking|antibodies, blocking|mesh-list
64835593|NCT02652455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64835594|NCT02652455|Immunologic Factors|immunologic factors|mesh-ancestor
64835595|NCT02652455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836103|NCT01611077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64590448|NCT03805477|Nintedanib|nintedanib|mesh-list
64835596|NCT02652455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64835597|NCT02652455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64835598|NCT02652455|Alkylating Agents|alkylating agents|mesh-ancestor
64835599|NCT02652455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835600|NCT02652455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835601|NCT02652455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64835602|NCT02652455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64835603|NCT02652455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64591086|NCT02125721|Penicillamine|penicillamine|mesh-list
64835604|NCT02652455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64835605|NCT02652455|Analgesics|analgesics|mesh-ancestor
64835606|NCT02652455|Sensory System Agents|sensory system agents|mesh-ancestor
64835607|NCT02652455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64835608|NCT02652455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64835609|NCT02652455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64835610|NCT02652455|Antiviral Agents|antiviral agents|mesh-ancestor
64835611|NCT02652455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64835612|NCT02578680|Folic Acid|folic acid|mesh-list
64835613|NCT02578680|Vitamin B 12|vitamin b 12|mesh-list
64325584|NCT02160743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325585|NCT02160743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64835624|NCT02578680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64835625|NCT02578680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64770086|NCT04373707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64835626|NCT02578680|Glucocorticoids|glucocorticoids|mesh-ancestor
64835627|NCT02578680|Hormones|hormones|mesh-ancestor
64836104|NCT01611077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64835628|NCT02578680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64835630|NCT02578680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835631|NCT02578680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64835632|NCT02578680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835633|NCT02578680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835634|NCT02578680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64835635|NCT02578680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64591774|NCT00509249|Growth Substances|growth substances|mesh-ancestor
64835639|NCT02520791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64835640|NCT02520791|Immunologic Factors|immunologic factors|mesh-ancestor
64592114|NCT00584857|Paclitaxel|paclitaxel|mesh-list
64835641|NCT02520791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835642|NCT02491983|Letrozole|letrozole|mesh-list
64835643|NCT02491983|Fulvestrant|fulvestrant|mesh-list
64835644|NCT02491983|Palbociclib|palbociclib|mesh-list
64835645|NCT02491983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835646|NCT02491983|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64835647|NCT02491983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64592554|NCT05621759|Abatacept|abatacept|mesh-list
64835651|NCT02491983|Hormone Antagonists|hormone antagonists|mesh-ancestor
64835652|NCT02491983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64835653|NCT02491983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835654|NCT02491983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64835655|NCT02491983|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64593038|NCT04763876|Ketorolac|ketorolac|mesh-list
64835663|NCT02467478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64835664|NCT02467478|Protease Inhibitors|protease inhibitors|mesh-ancestor
64835665|NCT02467478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835666|NCT02467478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835667|NCT02466243|Lenabasum|lenabasum|mesh-list
64835668|NCT02466243|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64835669|NCT02466243|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64835670|NCT02466243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64593272|NCT03025269|Immunologic Factors|immunologic factors|mesh-ancestor
64835671|NCT02466243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835672|NCT02466243|Hormones|hormones|mesh-ancestor
64835673|NCT02466243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64835674|NCT02466243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835675|NCT02321098|Amorolfine|amorolfine|mesh-list
64835676|NCT02321098|Antifungal Agents|antifungal agents|mesh-ancestor
64835677|NCT02321098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64835678|NCT02213926|Acalabrutinib|acalabrutinib|mesh-list
64835679|NCT02213926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835680|NCT02185417|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64835681|NCT02185417|Chlorthalidone|chlorthalidone|mesh-list
64835682|NCT02185417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64835683|NCT02185417|Diuretics|diuretics|mesh-ancestor
64835684|NCT02185417|Natriuretic Agents|natriuretic agents|mesh-ancestor
64835685|NCT02185417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593338|NCT03864926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64835691|NCT02158234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835692|NCT02158234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446776|NCT01919229|Letrozole|letrozole|mesh-list
64835693|NCT02019641|beta-Aminoethyl Isothiourea|beta-aminoethyl isothiourea|mesh-list
64835694|NCT02019641|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64835695|NCT02019641|Protective Agents|protective agents|mesh-ancestor
64835696|NCT02019641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835697|NCT01966731|Hydroxyurea|hydroxyurea|mesh-list
64835698|NCT01966731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835699|NCT01966731|Antisickling Agents|antisickling agents|mesh-ancestor
64835700|NCT01966731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835701|NCT01966731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770095|NCT04345718|Sensory System Agents|sensory system agents|mesh-ancestor
64770098|NCT04332068|Ivermectin|ivermectin|mesh-list
64835706|NCT01953926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835707|NCT01953926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64835708|NCT01953926|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64835709|NCT01953926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64835710|NCT01953926|Hormone Antagonists|hormone antagonists|mesh-ancestor
64835711|NCT01953926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64835712|NCT01953926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835713|NCT01859026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64835714|NCT01859026|Mitogens|mitogens|mesh-list
64835715|NCT01859026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835716|NCT01859026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64835717|NCT01859026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604213|NCT00810719|Antiviral Agents|antiviral agents|mesh-ancestor
64835718|NCT01859026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835719|NCT01859026|Mitosis Modulators|mitosis modulators|mesh-ancestor
64835720|NCT01843374|Tremelimumab|tremelimumab|mesh-list
64835721|NCT01843374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835722|NCT01657591|Vemurafenib|vemurafenib|mesh-list
64835723|NCT01657591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835724|NCT01657591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64835725|NCT01657591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446814|NCT01510756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64835730|NCT01599468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835731|NCT01599468|Hemostatics|hemostatics|mesh-ancestor
64835732|NCT01599468|Coagulants|coagulants|mesh-ancestor
64835734|NCT01599572|Trace Elements|trace elements|mesh-ancestor
64835735|NCT01599572|Micronutrients|micronutrients|mesh-ancestor
64835736|NCT01599572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835737|NCT01599598|Imidacloprid|imidacloprid|mesh-list
64835738|NCT01599598|Cholinergic Agents|cholinergic agents|mesh-ancestor
64835739|NCT01599598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64835740|NCT01599598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835741|NCT01599598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835742|NCT01599702|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
64835743|NCT01599702|Hematinics|hematinics|mesh-ancestor
64835751|NCT01599819|Coagulants|coagulants|mesh-ancestor
64835752|NCT01599858|Omeprazole|omeprazole|mesh-list
64835766|NCT01599871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835767|NCT01599871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835768|NCT01599871|Vasodilator Agents|vasodilator agents|mesh-ancestor
64835769|NCT01599871|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64835770|NCT01599871|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64835771|NCT01599871|Purinergic Agents|purinergic agents|mesh-ancestor
64835772|NCT01599871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64835773|NCT01599884|Acetylcysteine|acetylcysteine|mesh-list
64835774|NCT01599884|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64835775|NCT01599884|Antiviral Agents|antiviral agents|mesh-ancestor
64835776|NCT01599884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64835777|NCT01599884|Expectorants|expectorants|mesh-ancestor
64835778|NCT01599884|Respiratory System Agents|respiratory system agents|mesh-ancestor
64835779|NCT01599884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64835780|NCT01599884|Antioxidants|antioxidants|mesh-ancestor
64594886|NCT05245721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64835791|NCT01599962|Cinacalcet|cinacalcet|mesh-list
64835792|NCT01599962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64604291|NCT00801827|Fallypride|fallypride|mesh-list
64446899|NCT03870022|Gasotransmitters|gasotransmitters|mesh-ancestor
64595443|NCT00726739|Immunologic Factors|immunologic factors|mesh-ancestor
64835801|NCT01599975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64835803|NCT01599975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835805|NCT01599975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64835806|NCT01599988|Caseins|caseins|mesh-list
64835807|NCT01599988|Chelating Agents|chelating agents|mesh-ancestor
64835808|NCT01599988|Sequestering Agents|sequestering agents|mesh-ancestor
64835809|NCT01599988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835810|NCT01600430|Vitamin D|vitamin d|mesh-list
64835811|NCT01600430|Ergocalciferols|ergocalciferols|mesh-list
64835812|NCT01600430|Cholecalciferol|cholecalciferol|mesh-list
64835813|NCT01600430|Vitamins|vitamins|mesh-list
64835814|NCT01600430|Micronutrients|micronutrients|mesh-ancestor
64835828|NCT01601028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64835830|NCT01601028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835831|NCT01601028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64835832|NCT01602029|Ondansetron|ondansetron|mesh-list
64835834|NCT01602029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64835835|NCT01602029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64835836|NCT01602029|Antimetabolites|antimetabolites|mesh-ancestor
64835837|NCT01602029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835838|NCT01602029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64835839|NCT01602029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64835840|NCT01602029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835841|NCT01602029|Antiemetics|antiemetics|mesh-ancestor
64325636|NCT03541265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325637|NCT03541265|Sensory System Agents|sensory system agents|mesh-ancestor
64325638|NCT03541265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64325639|NCT02547038|Amoxicillin|amoxicillin|mesh-list
64325640|NCT02547038|Metronidazole|metronidazole|mesh-list
64325641|NCT02547038|Clarithromycin|clarithromycin|mesh-list
64325642|NCT02547038|Tetracycline|tetracycline|mesh-list
64835842|NCT01602029|Autonomic Agents|autonomic agents|mesh-ancestor
64835843|NCT01602029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64835844|NCT01602029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835845|NCT01602029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64835846|NCT01602029|Antipruritics|antipruritics|mesh-ancestor
64835847|NCT01602029|Dermatologic Agents|dermatologic agents|mesh-ancestor
64835848|NCT01602029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64835849|NCT01602029|Serotonin Agents|serotonin agents|mesh-ancestor
64835850|NCT01602029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64835851|NCT01602029|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64835852|NCT01602029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64835857|NCT01602874|Clarithromycin|clarithromycin|mesh-list
64835858|NCT01602874|Ceftriaxone|ceftriaxone|mesh-list
64835859|NCT01602874|Tigecycline|tigecycline|mesh-list
64325643|NCT02547038|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
64325644|NCT02547038|Pantoprazole|pantoprazole|mesh-list
64325645|NCT02547038|Bismuth|bismuth|mesh-list
64325646|NCT02547038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64325647|NCT02547038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64325648|NCT02547038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64325649|NCT02547038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64325650|NCT02547038|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64325651|NCT02547038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64325652|NCT02547038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325653|NCT02547038|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64325654|NCT02547038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64325656|NCT02547038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64835860|NCT01602874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64835861|NCT01602874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64835862|NCT01602874|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64835863|NCT01602874|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64596724|NCT03432650|Dexamethasone|dexamethasone|mesh-list
64835864|NCT01602874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64835865|NCT01602874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835866|NCT01602874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835867|NCT01602874|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64835868|NCT01602874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64835869|NCT01602887|Palbociclib|palbociclib|mesh-list
64835870|NCT01602887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835871|NCT01602887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64325664|NCT04984317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64835886|NCT01604213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64835887|NCT01604213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835888|NCT01604213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64835889|NCT01604213|Protease Inhibitors|protease inhibitors|mesh-ancestor
64835890|NCT01604213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64597355|NCT00674765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64597356|NCT00674765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64835891|NCT01604213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835892|NCT01605240|Acetaminophen|acetaminophen|mesh-list
64446993|NCT01898091|Ascorbic Acid|ascorbic acid|mesh-list
64446994|NCT01898091|Glycerol|glycerol|mesh-list
64446995|NCT01898091|Antioxidants|antioxidants|mesh-ancestor
64446996|NCT01898091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446997|NCT01898091|Protective Agents|protective agents|mesh-ancestor
64597426|NCT05539053|Acetylcysteine|acetylcysteine|mesh-list
64835898|NCT01605240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64835899|NCT01605240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835900|NCT01605240|Antipyretics|antipyretics|mesh-ancestor
64835901|NCT01605240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64325673|NCT02764697|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64325674|NCT02764697|Hormones|hormones|mesh-ancestor
64597550|NCT00632489|Capecitabine|capecitabine|mesh-list
64447012|NCT01888497|Analgesics|analgesics|mesh-ancestor
64325681|NCT04822337|Autonomic Agents|autonomic agents|mesh-ancestor
64325682|NCT04822337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64325683|NCT04822337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835926|NCT01606072|Hemostatics|hemostatics|mesh-ancestor
64835927|NCT01606072|Coagulants|coagulants|mesh-ancestor
64835928|NCT01606072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64835929|NCT01606072|Natriuretic Agents|natriuretic agents|mesh-ancestor
64835930|NCT01606072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835931|NCT01606722|Ritonavir|ritonavir|mesh-list
64835932|NCT01606722|Darunavir|darunavir|mesh-list
64835933|NCT01606722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64835934|NCT01606722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64835935|NCT01606722|Protease Inhibitors|protease inhibitors|mesh-ancestor
64835936|NCT01606722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64835937|NCT01606722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835938|NCT01606722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64835939|NCT01606722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64835940|NCT01606722|Antiviral Agents|antiviral agents|mesh-ancestor
64835941|NCT01606722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64835942|NCT01606722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64835943|NCT01606722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64597852|NCT02980497|Cariostatic Agents|cariostatic agents|mesh-ancestor
64325688|NCT04822337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64325689|NCT04822337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64835946|NCT01607983|Autonomic Agents|autonomic agents|mesh-ancestor
64598270|NCT00646763|Mitosis Modulators|mitosis modulators|mesh-ancestor
64835947|NCT01607983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64835948|NCT01607983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835950|NCT01607983|Respiratory System Agents|respiratory system agents|mesh-ancestor
64835951|NCT01607983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64835952|NCT01607983|Antioxidants|antioxidants|mesh-ancestor
64835953|NCT01607983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598342|NCT03231722|Antidotes|antidotes|mesh-ancestor
64835954|NCT01607983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64835955|NCT01607983|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64835956|NCT01607983|Vasodilator Agents|vasodilator agents|mesh-ancestor
64598406|NCT00653861|Anesthetics, Local|anesthetics, local|mesh-ancestor
64835959|NCT01608217|Acetaminophen|acetaminophen|mesh-list
64835960|NCT01608217|Dronabinol|dronabinol|mesh-list
64835961|NCT01608217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64835962|NCT01608217|Analgesics|analgesics|mesh-ancestor
64835963|NCT01608217|Sensory System Agents|sensory system agents|mesh-ancestor
64835964|NCT01608217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64835965|NCT01608217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835966|NCT01608217|Antipyretics|antipyretics|mesh-ancestor
64835967|NCT01608217|Hallucinogens|hallucinogens|mesh-ancestor
64598814|NCT00551447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64835968|NCT01608217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64770140|NCT04249037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770164|NCT04190550|Cytarabine|cytarabine|mesh-list
64835969|NCT01608217|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64835970|NCT01608217|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64835971|NCT01608217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64835972|NCT01608217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64835973|NCT01608217|Hormones|hormones|mesh-ancestor
64835974|NCT01608217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64325697|NCT02266927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64325698|NCT02266927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64325699|NCT02266927|Autonomic Agents|autonomic agents|mesh-ancestor
64835981|NCT01608854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64835982|NCT01608880|Nitroglycerin|nitroglycerin|mesh-list
64835983|NCT01608880|Vasodilator Agents|vasodilator agents|mesh-ancestor
64835984|NCT01608958|Oxytocin|oxytocin|mesh-list
64835985|NCT01608958|Oxytocics|oxytocics|mesh-ancestor
64835986|NCT01608958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64599302|NCT02999087|Cetuximab|cetuximab|mesh-list
64835987|NCT01608958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835988|NCT01609153|Olanzapine|olanzapine|mesh-list
64835989|NCT01609153|Amisulpride|amisulpride|mesh-list
64835991|NCT01609153|Autonomic Agents|autonomic agents|mesh-ancestor
64835992|NCT01609153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64835993|NCT01609153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64835994|NCT01609153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64835995|NCT01609153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64835996|NCT01609153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64835997|NCT01609153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64835998|NCT01609153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64835999|NCT01609153|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64836000|NCT01609153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64836001|NCT01609153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64836002|NCT01609153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836003|NCT01609153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64836004|NCT01609153|Serotonin Agents|serotonin agents|mesh-ancestor
64836005|NCT01609153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64836006|NCT01609153|Dopamine Agents|dopamine agents|mesh-ancestor
64836007|NCT01609153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64599679|NCT04183868|Empagliflozin|empagliflozin|mesh-list
64836008|NCT01609153|Antidepressive Agents|antidepressive agents|mesh-ancestor
64836010|NCT01610141|Anticoagulants|anticoagulants|mesh-ancestor
64836011|NCT01610310|Interferon-beta|interferon-beta|mesh-list
64836012|NCT01610310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836013|NCT01610310|Antiviral Agents|antiviral agents|mesh-ancestor
64836014|NCT01610310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64836015|NCT01610310|Immunologic Factors|immunologic factors|mesh-ancestor
64836016|NCT01610310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836017|NCT01610362|Immunoglobulins|immunoglobulins|mesh-list
64836018|NCT01610362|Antibodies|antibodies|mesh-list
64836019|NCT01610362|gamma-Globulins|gamma-globulins|mesh-list
64604526|NCT04436458|Niclosamide|niclosamide|mesh-list
64836020|NCT01610362|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64836021|NCT01610362|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64836022|NCT01610362|Immunoglobulin G|immunoglobulin g|mesh-list
64836023|NCT01610362|Immunologic Factors|immunologic factors|mesh-ancestor
64836024|NCT01610362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836025|NCT01610401|Metformin|metformin|mesh-list
64836026|NCT01610401|Caffeine|caffeine|mesh-list
64836028|NCT01610401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836029|NCT01610401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64836030|NCT01610401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64836031|NCT01610401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600471|NCT02674958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64836032|NCT01610401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600692|NCT00736229|Incretins|incretins|mesh-ancestor
64836033|NCT01610401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64600769|NCT02994173|Ketamine|ketamine|mesh-list
64836034|NCT01610401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64836035|NCT01610401|Purinergic Agents|purinergic agents|mesh-ancestor
64836036|NCT01610401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64836037|NCT01610765|Antiviral Agents|antiviral agents|mesh-list
64836038|NCT01610765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64836039|NCT01610778|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64836040|NCT01610778|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64601050|NCT00782821|Rituximab|rituximab|mesh-list
64836042|NCT01610869|Nintedanib|nintedanib|mesh-list
64836043|NCT01610869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64836044|NCT01610869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64836045|NCT01610869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64836046|NCT01610869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836047|NCT01610921|Adenosine|adenosine|mesh-list
64836048|NCT01610921|Analgesics|analgesics|mesh-ancestor
64601122|NCT00784225|Trace Elements|trace elements|mesh-ancestor
64601186|NCT01272635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64601709|NCT00772915|Antiemetics|antiemetics|mesh-ancestor
64836050|NCT01610921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64836051|NCT01610921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836052|NCT01610921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64836053|NCT01610921|Vasodilator Agents|vasodilator agents|mesh-ancestor
64836054|NCT01610921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64836055|NCT01610921|Purinergic Agonists|purinergic agonists|mesh-ancestor
64836056|NCT01610921|Purinergic Agents|purinergic agents|mesh-ancestor
64836057|NCT01610921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64836058|NCT01610921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64836059|NCT01610934|Liraglutide|liraglutide|mesh-list
64836060|NCT01610934|Glimepiride|glimepiride|mesh-list
64836061|NCT01610934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64836062|NCT01610934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836063|NCT01610934|Incretins|incretins|mesh-ancestor
64836064|NCT01610934|Hormones|hormones|mesh-ancestor
64836065|NCT01610934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64447158|NCT02140645|Incretins|incretins|mesh-ancestor
64602814|NCT02069847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602945|NCT00823303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64603098|NCT02351115|Alprazolam|alprazolam|mesh-list
64603470|NCT02038179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603630|NCT00771875|Analgesics|analgesics|mesh-ancestor
64836081|NCT01610947|Sensory System Agents|sensory system agents|mesh-ancestor
64836082|NCT01610947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64836083|NCT01610947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64836084|NCT01610947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64836085|NCT01610947|Immunologic Factors|immunologic factors|mesh-ancestor
64447177|NCT01485172|Ropinirole|ropinirole|mesh-list
64836090|NCT01610999|Antiviral Agents|antiviral agents|mesh-ancestor
64836091|NCT01610999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64836092|NCT01611038|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
64836093|NCT01611038|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64836094|NCT01611038|Protective Agents|protective agents|mesh-ancestor
64836095|NCT01611038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447195|NCT04742491|Emtricitabine|emtricitabine|mesh-list
64325712|NCT05445362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64325713|NCT01020565|Entecavir|entecavir|mesh-list
64604225|NCT03761277|Analgesics|analgesics|mesh-ancestor
64733703|NCT00005641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64733704|NCT00005641|Antidotes|antidotes|mesh-ancestor
64733705|NCT00005641|Protective Agents|protective agents|mesh-ancestor
64733706|NCT00005641|Vitamin B Complex|vitamin b complex|mesh-ancestor
64733707|NCT00005641|Vitamins|vitamins|mesh-ancestor
64733708|NCT00005641|Micronutrients|micronutrients|mesh-ancestor
64733709|NCT00005641|Antifungal Agents|antifungal agents|mesh-ancestor
64733710|NCT00005641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64733711|NCT00005641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64733715|NCT00005641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64733716|NCT00005641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64733717|NCT00005641|Glucocorticoids|glucocorticoids|mesh-ancestor
64733718|NCT00005641|Hormones|hormones|mesh-ancestor
64770177|NCT04190550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64770178|NCT04190550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64770182|NCT04164082|Antimetabolites|antimetabolites|mesh-ancestor
64770183|NCT04164082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770184|NCT04164082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770185|NCT04164082|Antiviral Agents|antiviral agents|mesh-ancestor
64770186|NCT04164082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64770187|NCT04164082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604439|NCT00807209|Narcotics|narcotics|mesh-ancestor
64733723|NCT00005647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64733724|NCT00005647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733725|NCT00005647|Tubulin Modulators|tubulin modulators|mesh-ancestor
64733726|NCT00005647|Antimitotic Agents|antimitotic agents|mesh-ancestor
64733727|NCT00005647|Mitosis Modulators|mitosis modulators|mesh-ancestor
64733728|NCT00005647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733729|NCT00005647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64733733|NCT00005647|Growth Inhibitors|growth inhibitors|mesh-ancestor
64733734|NCT00005647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64733735|NCT00005647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733736|NCT00005665|Interferons|interferons|mesh-list
64733737|NCT00005665|Interferon-alpha|interferon-alpha|mesh-list
64733738|NCT00005665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733739|NCT00005665|Antiviral Agents|antiviral agents|mesh-ancestor
64733740|NCT00005665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64733741|NCT00005665|Immunologic Factors|immunologic factors|mesh-ancestor
64733742|NCT00005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733743|NCT00004669|Hydrocortisone|hydrocortisone|mesh-list
64605158|NCT04991350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64733748|NCT00385411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733749|NCT00385411|GABA Agents|gaba agents|mesh-ancestor
64733750|NCT00385411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64733751|NCT00385411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733752|NCT00385411|Antimanic Agents|antimanic agents|mesh-ancestor
64733753|NCT00385411|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64733754|NCT00385411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64430836|NCT01901614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430837|NCT02499575|Bupivacaine|bupivacaine|mesh-list
64430838|NCT02499575|Ropivacaine|ropivacaine|mesh-list
64430839|NCT02499575|Anesthetics, Local|anesthetics, local|mesh-ancestor
64430840|NCT02499575|Anesthetics|anesthetics|mesh-ancestor
64430841|NCT02499575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64430842|NCT02499575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430844|NCT02499575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64430845|NCT02065791|Canagliflozin|canagliflozin|mesh-list
64430846|NCT02065791|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64430847|NCT02065791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430848|NCT02065791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64733755|NCT00385411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64733756|NCT00004699|Mitogens|mitogens|mesh-list
64733757|NCT00004699|Mitosis Modulators|mitosis modulators|mesh-ancestor
64733758|NCT00004699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733762|NCT00004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733763|NCT00004705|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
64733764|NCT00004705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64733765|NCT00004705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64733766|NCT00004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733767|NCT00004705|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64733768|NCT00004705|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64733769|NCT00004747|Immunoglobulins|immunoglobulins|mesh-list
64605621|NCT00866749|Antimetabolites|antimetabolites|mesh-ancestor
64733778|NCT00004759|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64733779|NCT00004759|Prednisolone|prednisolone|mesh-list
64733780|NCT00004759|Prednisolone acetate|prednisolone acetate|mesh-list
64733781|NCT00004759|Tirilazad|tirilazad|mesh-list
64733782|NCT00004759|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64733783|NCT00004759|Prednisolone phosphate|prednisolone phosphate|mesh-list
64733784|NCT00004759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64733785|NCT00004759|Antiemetics|antiemetics|mesh-ancestor
64733786|NCT00004759|Autonomic Agents|autonomic agents|mesh-ancestor
64733843|NCT00385645|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64733844|NCT00385645|Zidovudine|zidovudine|mesh-list
64733845|NCT00385645|Lamivudine|lamivudine|mesh-list
64733860|NCT00385957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64733861|NCT00385957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733862|NCT00385957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733863|NCT00385957|Antiviral Agents|antiviral agents|mesh-ancestor
64733864|NCT00385957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64733865|NCT00385957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64733866|NCT00385957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64770188|NCT04164082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64733867|NCT00005773|Nitric Oxide|nitric oxide|mesh-list
64606049|NCT03376477|Lenalidomide|lenalidomide|mesh-list
64320976|NCT05509244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64320978|NCT05509244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64733871|NCT00005773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733872|NCT00005773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64733884|NCT00005779|Immunologic Factors|immunologic factors|mesh-ancestor
64733885|NCT00005779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733886|NCT00005779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64733887|NCT00005779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64733899|NCT00005791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733900|NCT00005791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64733901|NCT00005791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64733902|NCT00005791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733903|NCT00005797|Cyclophosphamide|cyclophosphamide|mesh-list
64733905|NCT00005797|Etoposide|etoposide|mesh-list
64733906|NCT00005797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64733907|NCT00005797|Immunologic Factors|immunologic factors|mesh-ancestor
64733908|NCT00005797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733910|NCT00005797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64733911|NCT00005797|Alkylating Agents|alkylating agents|mesh-ancestor
64733912|NCT00005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733913|NCT00005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64733914|NCT00005797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64733915|NCT00005797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64733916|NCT00005797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64733917|NCT00005797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64733918|NCT00005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64733919|NCT00005815|Thalidomide|thalidomide|mesh-list
64733923|NCT00005815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733925|NCT00005815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64733926|NCT00005815|Immunologic Factors|immunologic factors|mesh-ancestor
64733927|NCT00005815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733928|NCT00005815|Leprostatic Agents|leprostatic agents|mesh-ancestor
64733929|NCT00005815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64733930|NCT00005815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64733931|NCT00005815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64606820|NCT02485834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64733932|NCT00005815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64733939|NCT02151786|Dexlansoprazole|dexlansoprazole|mesh-list
64733940|NCT02151786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64733941|NCT02151786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64606949|NCT01836289|Cyclophosphamide|cyclophosphamide|mesh-list
64606950|NCT01836289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64606951|NCT01836289|Immunologic Factors|immunologic factors|mesh-ancestor
64606970|NCT01839643|Meloxicam|meloxicam|mesh-list
64320987|NCT02030977|Antioxidants|antioxidants|mesh-ancestor
64320988|NCT02030977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64733957|NCT02131272|Insulin|insulin|mesh-list
64733958|NCT02131272|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64733959|NCT02131272|Insulin Detemir|insulin detemir|mesh-list
64733960|NCT02131272|Isophane Insulin, Human|isophane insulin, human|mesh-list
64733961|NCT02131272|Insulin, Isophane|insulin, isophane|mesh-list
64733962|NCT02131272|Isophane insulin, beef|isophane insulin, beef|mesh-list
64733963|NCT02131272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64733964|NCT02131272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64733965|NCT02130882|Benralizumab|benralizumab|mesh-list
64733966|NCT02130882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64734038|NCT04735770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734039|NCT04735770|Anesthetics, Local|anesthetics, local|mesh-ancestor
64734040|NCT04735770|Sensory System Agents|sensory system agents|mesh-ancestor
64734041|NCT04735770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64734042|NCT02146248|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64734043|NCT02146248|Contraceptive Agents|contraceptive agents|mesh-list
64734044|NCT02146248|Medroxyprogesterone|medroxyprogesterone|mesh-list
64734045|NCT02146248|Contraceptives, Oral|contraceptives, oral|mesh-list
64734046|NCT02146248|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64734047|NCT02146248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64734048|NCT02146248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734049|NCT02146248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64734050|NCT02146248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64734051|NCT02146248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64734052|NCT02146248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64734053|NCT02146248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64734054|NCT02146248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64734055|NCT02146248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734057|NCT02124564|Anticonvulsants|anticonvulsants|mesh-ancestor
64734058|NCT02124564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64734059|NCT02124564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64734060|NCT02124564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64734061|NCT02124564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734062|NCT02100696|Etrolizumab|etrolizumab|mesh-list
64734063|NCT02100696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64734064|NCT02100696|Immunologic Factors|immunologic factors|mesh-ancestor
64734065|NCT02100696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734066|NCT02123472|Cephalexin|cephalexin|mesh-list
64734067|NCT02123472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64734068|NCT02123472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64607701|NCT02939872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320998|NCT02194855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64320999|NCT02194855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321000|NCT03534661|Teduglutide|teduglutide|mesh-list
64321001|NCT03534661|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
64321002|NCT03534661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64321003|NCT03534661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321004|NCT03534661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64321005|NCT03534661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64321006|NCT03534661|Protective Agents|protective agents|mesh-ancestor
64321007|NCT03534661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321008|NCT02031211|Etanercept|etanercept|mesh-list
64321009|NCT02031211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64321010|NCT02031211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64321011|NCT02031211|Analgesics|analgesics|mesh-ancestor
64321012|NCT02031211|Sensory System Agents|sensory system agents|mesh-ancestor
64321013|NCT02031211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321014|NCT02031211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734090|NCT02100228|Vitamins|vitamins|mesh-ancestor
64734091|NCT02100228|Micronutrients|micronutrients|mesh-ancestor
64734092|NCT02100228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734093|NCT02100228|Anticoagulants|anticoagulants|mesh-ancestor
64607734|NCT01727557|Anesthetics|anesthetics|mesh-list
64321018|NCT02031211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64321019|NCT02031211|Immunologic Factors|immunologic factors|mesh-ancestor
64734111|NCT02099682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64734112|NCT02099682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64734113|NCT02099682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64734114|NCT02099682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734115|NCT02099682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734117|NCT02098746|Glimepiride|glimepiride|mesh-list
64734118|NCT02098746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64734119|NCT02098746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734120|NCT02098746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64734121|NCT02098746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64734122|NCT02098746|Immunologic Factors|immunologic factors|mesh-ancestor
64734123|NCT02122770|Itraconazole|itraconazole|mesh-list
64734124|NCT02122770|Fluconazole|fluconazole|mesh-list
64734125|NCT02122770|Paclitaxel|paclitaxel|mesh-list
64734126|NCT02122770|Docetaxel|docetaxel|mesh-list
64734127|NCT02122770|Carboplatin|carboplatin|mesh-list
64734128|NCT02122770|Pevonedistat|pevonedistat|mesh-list
64734129|NCT02122770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64734130|NCT02122770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734131|NCT02122770|Tubulin Modulators|tubulin modulators|mesh-ancestor
64734132|NCT02122770|Antimitotic Agents|antimitotic agents|mesh-ancestor
64734161|NCT02121756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64734162|NCT02121756|Vasodilator Agents|vasodilator agents|mesh-ancestor
64734163|NCT02141490|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64734164|NCT02141490|Hematinics|hematinics|mesh-ancestor
64734165|NCT02141490|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64734166|NCT02141490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64734167|NCT02097108|Raltegravir Potassium|raltegravir potassium|mesh-list
64734168|NCT02097108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64734169|NCT02097108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64734170|NCT02097108|Antiviral Agents|antiviral agents|mesh-ancestor
64734171|NCT02097108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64734172|NCT02097108|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64734173|NCT02097108|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64734174|NCT02097108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734177|NCT02096952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64734178|NCT02096952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734179|NCT02096952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64734180|NCT02096952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64734219|NCT02119416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734220|NCT02119416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64734221|NCT02119416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734222|NCT02119416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734223|NCT02119416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64734224|NCT02119416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64770271|NCT04014283|Antioxidants|antioxidants|mesh-ancestor
64770272|NCT04014283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770273|NCT04014283|Protective Agents|protective agents|mesh-ancestor
64770274|NCT04014283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770275|NCT04014283|Trace Elements|trace elements|mesh-ancestor
64770276|NCT04014283|Micronutrients|micronutrients|mesh-ancestor
64770277|NCT04013542|Nivolumab|nivolumab|mesh-list
64770278|NCT04013542|Ipilimumab|ipilimumab|mesh-list
64770279|NCT04013542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64770280|NCT04013542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770281|NCT04013542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64734225|NCT02119416|Purinergic Agents|purinergic agents|mesh-ancestor
64734226|NCT02119416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64734227|NCT02140164|Minocycline|minocycline|mesh-list
64734228|NCT02140164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64734229|NCT02140164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64734230|NCT02119260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64734231|NCT02119104|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64734232|NCT02119104|Immunologic Factors|immunologic factors|mesh-ancestor
64734233|NCT02119104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734263|NCT02095158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64734264|NCT02095158|Respiratory System Agents|respiratory system agents|mesh-ancestor
64734265|NCT02095158|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64734266|NCT02095158|Mydriatics|mydriatics|mesh-ancestor
64734275|NCT02138916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64734276|NCT02138916|Respiratory System Agents|respiratory system agents|mesh-ancestor
64734277|NCT02118012|Ribavirin|ribavirin|mesh-list
64734278|NCT02118012|Antimetabolites|antimetabolites|mesh-ancestor
64431926|NCT01622673|TEMPO|tempo|mesh-list
64321046|NCT03533803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64321047|NCT03533803|Analgesics|analgesics|mesh-ancestor
64321048|NCT03533803|Sensory System Agents|sensory system agents|mesh-ancestor
64321060|NCT02198209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64321061|NCT02198209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321063|NCT02198209|Hormones|hormones|mesh-ancestor
64321064|NCT02198209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64321065|NCT02031055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64321067|NCT02195557|Viscosupplements|viscosupplements|mesh-ancestor
64321068|NCT02195557|Protective Agents|protective agents|mesh-ancestor
64734315|NCT02091414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64734316|NCT02091414|Dermatologic Agents|dermatologic agents|mesh-ancestor
64734317|NCT02091414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64734318|NCT02091414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64734319|NCT02091414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64734320|NCT02091414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734321|NCT02091414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64734322|NCT02091414|Antitubercular Agents|antitubercular agents|mesh-ancestor
64734323|NCT02091414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64734324|NCT04731558|Enoxaparin|enoxaparin|mesh-list
64734325|NCT04731558|Dalteparin|dalteparin|mesh-list
64734326|NCT04731558|Tinzaparin|tinzaparin|mesh-list
64734327|NCT04731558|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64734328|NCT04731558|Anticoagulants|anticoagulants|mesh-ancestor
64734329|NCT04731558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64734330|NCT04731558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64770288|NCT04000529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770289|NCT04000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770290|NCT03994601|Nivolumab|nivolumab|mesh-list
64770291|NCT03994601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64770292|NCT03994601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770293|NCT03994601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64770294|NCT03994601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734331|NCT04731558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734332|NCT02116530|Dexamethasone|dexamethasone|mesh-list
64734374|NCT02116530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64734375|NCT02116530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64734376|NCT02116530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64734377|NCT02116530|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64734379|NCT02072226|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64734380|NCT02072226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64734381|NCT02072226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64734382|NCT02072226|Analgesics|analgesics|mesh-ancestor
64734383|NCT02072226|Sensory System Agents|sensory system agents|mesh-ancestor
64734384|NCT02072226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64734385|NCT02072226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734386|NCT02072226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64734387|NCT02072226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64734388|NCT02072226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64734389|NCT02072226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64734390|NCT02072226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734391|NCT02072226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64734392|NCT02072226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64734393|NCT02072226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734394|NCT02072226|Antipyretics|antipyretics|mesh-ancestor
64734395|NCT04730856|Tinzaparin|tinzaparin|mesh-list
64734396|NCT04730856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64734397|NCT04730856|Dalteparin|dalteparin|mesh-list
64734398|NCT04730856|Anticoagulants|anticoagulants|mesh-ancestor
64734399|NCT04730856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64734400|NCT04730856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64734401|NCT04730856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734402|NCT02114892|Resveratrol|resveratrol|mesh-list
64734403|NCT02114892|Antioxidants|antioxidants|mesh-ancestor
64734404|NCT02114892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734405|NCT02114892|Protective Agents|protective agents|mesh-ancestor
64734409|NCT02070744|Ivacaftor|ivacaftor|mesh-list
64734414|NCT04741698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64734429|NCT02111850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64734430|NCT02111850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64734431|NCT02111850|Alkylating Agents|alkylating agents|mesh-ancestor
64734432|NCT02111850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734433|NCT02111850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734434|NCT02111850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64734435|NCT02111850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64734436|NCT02111850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64734437|NCT02111850|Antiviral Agents|antiviral agents|mesh-ancestor
64734438|NCT02111850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64473776|NCT00237718|Vitamin E|vitamin e|mesh-list
64473781|NCT00237718|Vitamins|vitamins|mesh-ancestor
64734439|NCT02085252|Bicalutamide|bicalutamide|mesh-list
64734440|NCT02085252|Leuprolide|leuprolide|mesh-list
64734454|NCT02084238|Sensory System Agents|sensory system agents|mesh-ancestor
64608173|NCT02740114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734466|NCT02084082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64770324|NCT03901482|Dopamine Agonists|dopamine agonists|mesh-ancestor
64770325|NCT03901482|Dopamine Agents|dopamine agents|mesh-ancestor
64770326|NCT03901482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64770327|NCT03901482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608519|NCT04659616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64734489|NCT02109744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64734491|NCT02109744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734492|NCT02109744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734495|NCT04185402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64734496|NCT04185402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64734497|NCT04728360|Ustekinumab|ustekinumab|mesh-list
64734498|NCT04728360|Dermatologic Agents|dermatologic agents|mesh-ancestor
64734499|NCT02066298|Mometasone Furoate|mometasone furoate|mesh-list
64734500|NCT02066298|Tiotropium Bromide|tiotropium bromide|mesh-list
64734501|NCT02066298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64734502|NCT02066298|Autonomic Agents|autonomic agents|mesh-ancestor
64321101|NCT02196805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321102|NCT02198443|Ritonavir|ritonavir|mesh-list
64609409|NCT03020303|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64734520|NCT02082912|Antitubercular Agents|antitubercular agents|mesh-ancestor
64609647|NCT03213977|Cyclophosphamide|cyclophosphamide|mesh-list
64609749|NCT01832285|Fluvoxamine|fluvoxamine|mesh-list
64734592|NCT02064894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64734593|NCT02064894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64734594|NCT02064894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64734595|NCT02064894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609964|NCT02240641|Natriuretic Agents|natriuretic agents|mesh-ancestor
64734596|NCT02064894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610040|NCT03218657|Hormones|hormones|mesh-ancestor
64734597|NCT02064816|Interferon beta-1a|interferon beta-1a|mesh-list
64734598|NCT02064816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64734603|NCT02064816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64335763|NCT04771923|Mydriatics|mydriatics|mesh-ancestor
64734606|NCT01624194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64610442|NCT03833947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64734607|NCT01624194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734608|NCT02079636|Gemcitabine|gemcitabine|mesh-list
64734609|NCT02079636|Pembrolizumab|pembrolizumab|mesh-list
64734610|NCT02079636|Pemetrexed|pemetrexed|mesh-list
64734611|NCT02079636|Ramucirumab|ramucirumab|mesh-list
64734612|NCT02079636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64734613|NCT02079636|Antimetabolites|antimetabolites|mesh-ancestor
64734614|NCT02079636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734615|NCT02079636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734616|NCT02079636|Antiviral Agents|antiviral agents|mesh-ancestor
64770357|NCT03834519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64734617|NCT02079636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64734618|NCT02079636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734619|NCT02079636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64321132|NCT03533179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64734621|NCT02079636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734622|NCT02079636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64734623|NCT02079636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64734624|NCT02079636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64734625|NCT02047110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64610693|NCT03402295|Hormones|hormones|mesh-ancestor
64734626|NCT02047110|Immunologic Factors|immunologic factors|mesh-ancestor
64734627|NCT02047110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770363|NCT03810105|Durvalumab|durvalumab|mesh-list
64770364|NCT03810105|Olaparib|olaparib|mesh-list
64734628|NCT02045862|Solifenacin Succinate|solifenacin succinate|mesh-list
64321133|NCT03533179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64321134|NCT03533179|Adrenergic Agents|adrenergic agents|mesh-ancestor
64321141|NCT05261971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64734630|NCT02045862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64734631|NCT02045862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64734632|NCT02045862|Cholinergic Agents|cholinergic agents|mesh-ancestor
64734633|NCT02045862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64734634|NCT02045862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734635|NCT02045862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734636|NCT02045862|Urological Agents|urological agents|mesh-ancestor
64734637|NCT02045862|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64734638|NCT02045862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64734639|NCT02045862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64734640|NCT02045862|Adrenergic Agents|adrenergic agents|mesh-ancestor
64734641|NCT04182984|Mycophenolic Acid|mycophenolic acid|mesh-list
64734642|NCT04182984|Prednisone|prednisone|mesh-list
64734643|NCT04182984|Azathioprine|azathioprine|mesh-list
64734644|NCT04182984|Bromides|bromides|mesh-list
64734645|NCT04182984|Tacrolimus|tacrolimus|mesh-list
64734646|NCT04182984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64734647|NCT04182984|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
64734648|NCT04182984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64734649|NCT04182984|Glucocorticoids|glucocorticoids|mesh-ancestor
64734650|NCT04182984|Hormones|hormones|mesh-ancestor
64734651|NCT04182984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64734652|NCT04182984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734653|NCT04182984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64734654|NCT04182984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734655|NCT04182984|Immunologic Factors|immunologic factors|mesh-ancestor
64734664|NCT04182984|Anticonvulsants|anticonvulsants|mesh-ancestor
64611319|NCT02909140|Mydriatics|mydriatics|mesh-ancestor
64734665|NCT04182984|Antimetabolites|antimetabolites|mesh-ancestor
64474000|NCT02100748|Narcotics|narcotics|mesh-ancestor
64734666|NCT04182984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64734667|NCT04182984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64734668|NCT04182984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64734669|NCT04182984|Cholinergic Agents|cholinergic agents|mesh-ancestor
64734670|NCT04182984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64734672|NCT02044302|Narcotics|narcotics|mesh-list
64734673|NCT02044302|Analgesics|analgesics|mesh-list
64734674|NCT02044302|Bupivacaine|bupivacaine|mesh-list
64734675|NCT02044302|Botulinum Toxins|botulinum toxins|mesh-list
64734676|NCT02044302|Anesthetics, Local|anesthetics, local|mesh-ancestor
64734677|NCT02044302|Anesthetics|anesthetics|mesh-ancestor
64734678|NCT02044302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64734679|NCT02044302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734681|NCT02044302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64734682|NCT02044302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64734683|NCT02044302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64734684|NCT02044302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64734685|NCT02044302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611452|NCT03197194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64611524|NCT03403439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64611525|NCT03403439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611526|NCT03403439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64611527|NCT04346797|Eculizumab|eculizumab|mesh-list
64611528|NCT04346797|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64734696|NCT02062944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734697|NCT02062632|Doxepin|doxepin|mesh-list
64734698|NCT02062632|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64734699|NCT02062632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64734703|NCT02062632|Antidepressive Agents|antidepressive agents|mesh-ancestor
64734704|NCT02062632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64734705|NCT02062632|Histamine Antagonists|histamine antagonists|mesh-ancestor
64734706|NCT02062632|Histamine Agents|histamine agents|mesh-ancestor
64734707|NCT02062632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64734708|NCT02062632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734709|NCT02043366|Flurbiprofen|flurbiprofen|mesh-list
64734710|NCT02043366|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
64734711|NCT02043366|Sufentanil|sufentanil|mesh-list
64734712|NCT02043366|Remifentanil|remifentanil|mesh-list
64734713|NCT02043366|Butorphanol|butorphanol|mesh-list
64734714|NCT02043366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64611951|NCT02935738|Prednisolone|prednisolone|mesh-list
64612579|NCT05685225|Antipyretics|antipyretics|mesh-ancestor
64734719|NCT02043366|Sensory System Agents|sensory system agents|mesh-ancestor
64734720|NCT02043366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64734721|NCT02043366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64734722|NCT02043366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64734723|NCT02043366|Anesthetics, General|anesthetics, general|mesh-ancestor
64734724|NCT02043366|Anesthetics|anesthetics|mesh-ancestor
64734725|NCT02043366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64612731|NCT00929981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64612732|NCT00929981|Protective Agents|protective agents|mesh-ancestor
64612733|NCT00929981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64612734|NCT00929981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734726|NCT02043366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64734727|NCT02043366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64734728|NCT02043366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64734729|NCT02043366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64734730|NCT02043366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734731|NCT02043366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734732|NCT02043366|Antitussive Agents|antitussive agents|mesh-ancestor
64734733|NCT02043366|Respiratory System Agents|respiratory system agents|mesh-ancestor
64734734|NCT02043366|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64612781|NCT04358497|Ibuprofen|ibuprofen|mesh-list
64612782|NCT04358497|Polidocanol|polidocanol|mesh-list
64612783|NCT04358497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64612785|NCT04358497|Analgesics|analgesics|mesh-ancestor
64321152|NCT05261971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321154|NCT02201563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64321155|NCT02201563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64321156|NCT02206477|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
64321161|NCT02206477|Antioxidants|antioxidants|mesh-ancestor
64612920|NCT04364321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64734741|NCT02060370|Growth Inhibitors|growth inhibitors|mesh-ancestor
64734742|NCT02060370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64734743|NCT02060370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734744|NCT02060370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734745|NCT01622088|Pramipexole|pramipexole|mesh-list
64613358|NCT05593341|Sensory System Agents|sensory system agents|mesh-ancestor
64613415|NCT00932477|Lubricant Eye Drops|lubricant eye drops|mesh-list
64734759|NCT02021292|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64734761|NCT02043132|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
64734762|NCT02043132|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64613743|NCT04360031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734763|NCT02043132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734765|NCT02043132|Coagulants|coagulants|mesh-ancestor
64734766|NCT02059434|Tiotropium Bromide|tiotropium bromide|mesh-list
64734771|NCT02059434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321174|NCT02206555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613962|NCT00936377|Analgesics|analgesics|mesh-ancestor
64614026|NCT02982395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734778|NCT02059434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734779|NCT02059434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64734780|NCT02059434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64321176|NCT02206555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64321177|NCT02206711|BMS-955176|bms-955176|mesh-list
64321178|NCT02206711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64321179|NCT02206711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64770386|NCT03732352|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64614418|NCT00987415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339828|NCT03778671|Narcotics|narcotics|mesh-ancestor
64614433|NCT04771156|Ketorolac|ketorolac|mesh-list
64734788|NCT04722354|Plant Growth Regulators|plant growth regulators|mesh-ancestor
64734789|NCT04722354|Growth Substances|growth substances|mesh-ancestor
64734790|NCT04722354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734791|NCT02020512|Bimatoprost|bimatoprost|mesh-list
64734792|NCT02020512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64734793|NCT02019420|Linezolid|linezolid|mesh-list
64734794|NCT02019420|Tedizolid|tedizolid|mesh-list
64734795|NCT02019420|Tedizolid phosphate|tedizolid phosphate|mesh-list
64734796|NCT02019420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64734797|NCT02019420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64614810|NCT03018301|Anesthetics|anesthetics|mesh-ancestor
64734804|NCT02058966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64734805|NCT02058966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64734806|NCT02058966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734807|NCT02058966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734808|NCT02058966|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64734809|NCT02058966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734810|NCT02058966|Sympathomimetics|sympathomimetics|mesh-ancestor
64734811|NCT02058966|Autonomic Agents|autonomic agents|mesh-ancestor
64734812|NCT02058966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64734813|NCT02058966|Dopamine Agents|dopamine agents|mesh-ancestor
64734814|NCT02058966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64734815|NCT02058966|Adrenergic Agents|adrenergic agents|mesh-ancestor
64734816|NCT02058966|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64734818|NCT02058966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64734819|NCT02058966|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64734820|NCT02017860|Everolimus|everolimus|mesh-list
64734821|NCT02017860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734822|NCT02017860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64734823|NCT02017860|Immunologic Factors|immunologic factors|mesh-ancestor
64734829|NCT02040870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734830|NCT04720716|Sorafenib|sorafenib|mesh-list
64734831|NCT04720716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734834|NCT04720716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734836|NCT02039778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64734837|NCT02039778|Alkylating Agents|alkylating agents|mesh-ancestor
64734838|NCT02039778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734839|NCT02039778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734840|NCT02015676|Paclitaxel|paclitaxel|mesh-list
64734841|NCT02015676|Trastuzumab|trastuzumab|mesh-list
64734842|NCT02015676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64734843|NCT02015676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734847|NCT02015676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734848|NCT02015676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64734849|NCT02058108|Telbivudine|telbivudine|mesh-list
64734850|NCT02058108|Antiviral Agents|antiviral agents|mesh-ancestor
64734851|NCT02058108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64734852|NCT02058108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64734853|NCT02058108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734854|NCT02058108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734855|NCT04678362|Avelumab|avelumab|mesh-list
64734856|NCT04678362|Talazoparib|talazoparib|mesh-list
64734857|NCT04678362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64734858|NCT04678362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734859|NCT04678362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64734860|NCT04678362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734861|NCT04678362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734862|NCT04678050|Dexmedetomidine|dexmedetomidine|mesh-list
64734863|NCT04678050|Ketamine|ketamine|mesh-list
64734864|NCT04678050|Propofol|propofol|mesh-list
64734865|NCT04678050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64615124|NCT00421863|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64734867|NCT04678050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734868|NCT04678050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64734869|NCT04678050|Anesthetics, General|anesthetics, general|mesh-ancestor
64734871|NCT04678050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64734872|NCT04678050|Analgesics|analgesics|mesh-ancestor
64734873|NCT04678050|Sensory System Agents|sensory system agents|mesh-ancestor
64734874|NCT04678050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64734875|NCT04678050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64615198|NCT04342221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64734876|NCT04678050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64615439|NCT00362271|Aripiprazole|aripiprazole|mesh-list
64734897|NCT02014740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64734899|NCT02014584|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64734900|NCT02014584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64734901|NCT02014584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734902|NCT02014584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734903|NCT02014584|Hormone Antagonists|hormone antagonists|mesh-ancestor
64734904|NCT02014584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64734905|NCT02014584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734906|NCT02037984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64734907|NCT02037984|Immunologic Factors|immunologic factors|mesh-ancestor
64321191|NCT02206789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616107|NCT03445390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64616108|NCT03445390|Analgesics|analgesics|mesh-ancestor
64734919|NCT02057250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734920|NCT02057250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64616454|NCT01924910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64616456|NCT04395638|Ergocalciferols|ergocalciferols|mesh-list
64616457|NCT04395638|Cholecalciferol|cholecalciferol|mesh-list
64616458|NCT04395638|Vitamins|vitamins|mesh-list
64616459|NCT04395638|Micronutrients|micronutrients|mesh-ancestor
64734921|NCT02057250|Antimetabolites|antimetabolites|mesh-ancestor
64734922|NCT02057250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734923|NCT02057250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734924|NCT02057250|Dermatologic Agents|dermatologic agents|mesh-ancestor
64734925|NCT02057250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734926|NCT02057250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64734927|NCT02057250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64734928|NCT02057250|Immunologic Factors|immunologic factors|mesh-ancestor
64734929|NCT02057250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64734930|NCT02057250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64734931|NCT02057250|Antimalarials|antimalarials|mesh-ancestor
64734932|NCT02057250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64734933|NCT02057250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64734934|NCT02057250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64734935|NCT02057250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64616580|NCT02226159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64734936|NCT02057250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64734937|NCT02057250|Analgesics|analgesics|mesh-ancestor
64734938|NCT02057250|Sensory System Agents|sensory system agents|mesh-ancestor
64734939|NCT02057250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64734940|NCT02057250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64616643|NCT02129751|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64734948|NCT02036502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64734949|NCT02036502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616717|NCT01341405|Celecoxib|celecoxib|mesh-list
64734952|NCT02036502|Hormones|hormones|mesh-ancestor
64734953|NCT02036502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64770402|NCT03725436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770416|NCT03636451|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64770417|NCT03636451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64770420|NCT03636451|Hemostatics|hemostatics|mesh-ancestor
64734954|NCT02036502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64734955|NCT02036502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64321214|NCT03892369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64616983|NCT03503578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64734960|NCT02036502|Growth Substances|growth substances|mesh-ancestor
64734961|NCT02036502|Growth Inhibitors|growth inhibitors|mesh-ancestor
64734962|NCT02056626|Carvedilol|carvedilol|mesh-list
64734963|NCT02056626|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64734964|NCT02056626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64734965|NCT02056626|Adrenergic Agents|adrenergic agents|mesh-ancestor
64734966|NCT02056626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64734967|NCT02056626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734968|NCT02056626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734969|NCT02056626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64734970|NCT02056626|Antioxidants|antioxidants|mesh-ancestor
64734971|NCT02056626|Protective Agents|protective agents|mesh-ancestor
64734972|NCT02056626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64734973|NCT02056626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64734974|NCT02056626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64734975|NCT02056626|Vasodilator Agents|vasodilator agents|mesh-ancestor
64617442|NCT00947765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64321219|NCT02206867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64321220|NCT02206867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64321222|NCT02751931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64321223|NCT02751931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64321224|NCT02751931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64321225|NCT02751931|Adrenergic Agents|adrenergic agents|mesh-ancestor
64321226|NCT02751931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64321227|NCT02751931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617666|NCT02516241|Tremelimumab|tremelimumab|mesh-list
64617724|NCT03031535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64321228|NCT02751931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321229|NCT02751931|Urological Agents|urological agents|mesh-ancestor
64321230|NCT05261581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64321232|NCT05261581|Sensory System Agents|sensory system agents|mesh-ancestor
64321233|NCT05261581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64734976|NCT02056626|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64734977|NCT02056626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64617881|NCT03162731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617882|NCT03030911|Fentanyl|fentanyl|mesh-list
64617883|NCT03030911|Midazolam|midazolam|mesh-list
64734978|NCT02056392|Moxifloxacin|moxifloxacin|mesh-list
64734979|NCT02056392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64734980|NCT02056392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64734981|NCT02056392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64734982|NCT02056392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64734983|NCT02056392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734984|NCT02056392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734985|NCT02056392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734986|NCT02034552|Prednisone|prednisone|mesh-list
64734987|NCT02034552|Abiraterone Acetate|abiraterone acetate|mesh-list
64617950|NCT02245451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64734988|NCT02034552|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64734989|NCT02034552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64734990|NCT02034552|Glucocorticoids|glucocorticoids|mesh-ancestor
64734991|NCT02034552|Hormones|hormones|mesh-ancestor
64734992|NCT02034552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64734993|NCT02034552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64734994|NCT02034552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64734995|NCT02034552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64734996|NCT02034552|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64734997|NCT02034552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64734998|NCT02034552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64734999|NCT02034552|Hormone Antagonists|hormone antagonists|mesh-ancestor
64735000|NCT02034552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64735001|NCT02011386|Golimumab|golimumab|mesh-list
64735002|NCT02011386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64735003|NCT02011386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64735004|NCT02011386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64735005|NCT02011386|Immunologic Factors|immunologic factors|mesh-ancestor
64735006|NCT02011386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618030|NCT03030677|Lidocaine|lidocaine|mesh-list
64618031|NCT03030677|Anesthetics, Local|anesthetics, local|mesh-ancestor
64735012|NCT02034162|Anthelmintics|anthelmintics|mesh-ancestor
64735013|NCT02034162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64735014|NCT02034162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64735015|NCT02034162|Tubulin Modulators|tubulin modulators|mesh-ancestor
64735016|NCT02034162|Antimitotic Agents|antimitotic agents|mesh-ancestor
64735017|NCT02034162|Mitosis Modulators|mitosis modulators|mesh-ancestor
64735018|NCT02034162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735019|NCT02034162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735020|NCT02034162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735021|NCT02034006|Ranibizumab|ranibizumab|mesh-list
64618141|NCT03035045|Acetaminophen|acetaminophen|mesh-list
64735022|NCT02034006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64735023|NCT02034006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64735024|NCT02034006|Growth Substances|growth substances|mesh-ancestor
64735025|NCT02034006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735026|NCT02034006|Growth Inhibitors|growth inhibitors|mesh-ancestor
64735027|NCT02034006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735028|NCT04675788|Ibutilide|ibutilide|mesh-list
64735029|NCT04675788|Testosterone|testosterone|mesh-list
64735030|NCT04675788|Progesterone|progesterone|mesh-list
64735108|NCT02006706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64735110|NCT02006706|Autonomic Agents|autonomic agents|mesh-ancestor
64735111|NCT02006706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64735112|NCT02006706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64735113|NCT02006706|Glucocorticoids|glucocorticoids|mesh-ancestor
64474462|NCT00332644|Bupropion|bupropion|mesh-list
64735114|NCT02006706|Hormones|hormones|mesh-ancestor
64735115|NCT02006706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64735116|NCT02006706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64735117|NCT02006706|Protective Agents|protective agents|mesh-ancestor
64735118|NCT02006706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64735119|NCT02049138|Upadacitinib|upadacitinib|mesh-list
64735120|NCT02049138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64321236|NCT02199223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64321237|NCT02199223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64321238|NCT02207335|Gemcitabine|gemcitabine|mesh-list
64321239|NCT02207335|Carboplatin|carboplatin|mesh-list
64321240|NCT02207335|Capecitabine|capecitabine|mesh-list
64321241|NCT02207335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64321242|NCT02207335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64321243|NCT02207335|Antimetabolites|antimetabolites|mesh-ancestor
64321244|NCT02207335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321245|NCT02207335|Antiviral Agents|antiviral agents|mesh-ancestor
64321246|NCT02207335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64735159|NCT02029638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64735160|NCT02029638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64735161|NCT02029638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64735162|NCT02029638|Analgesics|analgesics|mesh-ancestor
64735163|NCT02029638|Sensory System Agents|sensory system agents|mesh-ancestor
64735164|NCT02029638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64735165|NCT02029638|Antipyretics|antipyretics|mesh-ancestor
64735166|NCT02029638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64735167|NCT02029638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64735168|NCT02029638|Antitubercular Agents|antitubercular agents|mesh-ancestor
64735169|NCT02029638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64735170|NCT02029638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64735171|NCT02029638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735172|NCT02029638|Antiemetics|antiemetics|mesh-ancestor
64735173|NCT02029638|Autonomic Agents|autonomic agents|mesh-ancestor
64735174|NCT02029638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64321260|NCT04058197|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64321261|NCT04058197|Chelating Agents|chelating agents|mesh-ancestor
64321262|NCT04058197|Sequestering Agents|sequestering agents|mesh-ancestor
64321263|NCT04058197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321264|NCT02202967|Misoprostol|misoprostol|mesh-list
64321265|NCT02202967|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64321266|NCT02202967|Abortifacient Agents|abortifacient agents|mesh-ancestor
64321267|NCT02202967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64735175|NCT02029638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64735176|NCT02029638|Protective Agents|protective agents|mesh-ancestor
64735177|NCT02029638|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64735178|NCT02029638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64735179|NCT02029638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64735180|NCT02029638|Anesthetics, Local|anesthetics, local|mesh-ancestor
64735181|NCT02029638|Anesthetics|anesthetics|mesh-ancestor
64735182|NCT02029638|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64735183|NCT02029638|Histamine Antagonists|histamine antagonists|mesh-ancestor
64735184|NCT02029638|Histamine Agents|histamine agents|mesh-ancestor
64735185|NCT02029638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64735186|NCT02029638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64735187|NCT02029638|Antipruritics|antipruritics|mesh-ancestor
64735188|NCT02029638|Dermatologic Agents|dermatologic agents|mesh-ancestor
64735268|NCT01990560|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64735270|NCT01990560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64735271|NCT01990560|Luteolytic Agents|luteolytic agents|mesh-ancestor
64735272|NCT01990560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64735273|NCT01990560|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64735274|NCT01999218|Metformin|metformin|mesh-list
64735275|NCT01999218|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64735276|NCT01999218|Glimepiride|glimepiride|mesh-list
64735277|NCT01999218|Ertugliflozin|ertugliflozin|mesh-list
64770624|NCT02621489|Incretins|incretins|mesh-ancestor
64735278|NCT01999218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64618315|NCT02982161|Narcotics|narcotics|mesh-ancestor
64618317|NCT05506488|Dasatinib|dasatinib|mesh-list
64735293|NCT01967628|Vitamins|vitamins|mesh-ancestor
64735294|NCT01967628|Micronutrients|micronutrients|mesh-ancestor
64735295|NCT01967628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735296|NCT01967628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64735297|NCT01967628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64735298|NCT01998906|Paclitaxel|paclitaxel|mesh-list
64735299|NCT01998906|Doxorubicin|doxorubicin|mesh-list
64735300|NCT01998906|Trastuzumab|trastuzumab|mesh-list
64735301|NCT01998906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64735302|NCT01998906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735303|NCT01998906|Tubulin Modulators|tubulin modulators|mesh-ancestor
64735304|NCT01998906|Antimitotic Agents|antimitotic agents|mesh-ancestor
64735305|NCT01998906|Mitosis Modulators|mitosis modulators|mesh-ancestor
64735306|NCT01998906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735307|NCT01998906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64618320|NCT05506488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64735313|NCT01967550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64735314|NCT01967550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64735315|NCT01967550|Analgesics|analgesics|mesh-ancestor
64735316|NCT01967550|Sensory System Agents|sensory system agents|mesh-ancestor
64735317|NCT01967550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64735318|NCT01967550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735319|NCT01967550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64735320|NCT01967550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64735321|NCT01967550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64735322|NCT01967550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735323|NCT01967550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735324|NCT01989546|Talazoparib|talazoparib|mesh-list
64735325|NCT01989546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64735326|NCT01989546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735327|NCT01989546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735328|NCT01989546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735329|NCT01989468|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64735330|NCT01989468|Immunologic Factors|immunologic factors|mesh-ancestor
64735331|NCT01989468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735332|NCT01989156|Menthol|menthol|mesh-list
64735333|NCT01989156|Antipruritics|antipruritics|mesh-ancestor
64735334|NCT01989156|Dermatologic Agents|dermatologic agents|mesh-ancestor
64735335|NCT01965834|Fenofibrate|fenofibrate|mesh-list
64735336|NCT01965834|Fenofibric acid|fenofibric acid|mesh-list
64735337|NCT01965834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64735338|NCT01965834|Antimetabolites|antimetabolites|mesh-ancestor
64735339|NCT01965834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735340|NCT01965834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64735351|NCT01964898|Nicotine|nicotine|mesh-list
64735354|NCT01964898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64735355|NCT01964898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735356|NCT01964898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64735357|NCT01964898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64735358|NCT01964898|Cholinergic Agents|cholinergic agents|mesh-ancestor
64735359|NCT01964898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64770640|NCT02512718|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64770641|NCT02512718|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64735360|NCT01964898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735361|NCT01964352|Tiotropium Bromide|tiotropium bromide|mesh-list
64735362|NCT01964352|Olodaterol|olodaterol|mesh-list
64735363|NCT01964352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64735364|NCT01964352|Autonomic Agents|autonomic agents|mesh-ancestor
64735365|NCT01964352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64735366|NCT01964352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735367|NCT01964352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64735368|NCT01964352|Respiratory System Agents|respiratory system agents|mesh-ancestor
64735369|NCT01964352|Parasympatholytics|parasympatholytics|mesh-ancestor
64735370|NCT01964352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64735371|NCT01964352|Cholinergic Agents|cholinergic agents|mesh-ancestor
64735372|NCT01964352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64735373|NCT01964352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735374|NCT01946412|Ivacaftor|ivacaftor|mesh-list
64735375|NCT01946412|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64735376|NCT01946412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64735377|NCT01946412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735378|NCT01945866|Dexamethasone|dexamethasone|mesh-list
64735379|NCT01945866|Ranibizumab|ranibizumab|mesh-list
64618326|NCT00942149|Daptomycin|daptomycin|mesh-list
64735398|NCT01986114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64735399|NCT01986114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735400|NCT01986114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64735401|NCT01986114|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64735402|NCT01986114|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64735403|NCT01986114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64735404|NCT01986114|Adrenergic Agents|adrenergic agents|mesh-ancestor
64735405|NCT01986114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64434566|NCT02420717|Hormones|hormones|mesh-ancestor
64321292|NCT02208427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321294|NCT02208427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64321296|NCT05508620|Sirolimus|sirolimus|mesh-list
64321297|NCT05508620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64321298|NCT05508620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64321299|NCT05508620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64321300|NCT05508620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64321301|NCT05508620|Antifungal Agents|antifungal agents|mesh-ancestor
64321302|NCT05508620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64321303|NCT05508620|Immunologic Factors|immunologic factors|mesh-ancestor
64770686|NCT01856478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770695|NCT01845688|Losartan|losartan|mesh-list
64321304|NCT05508620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321305|NCT03803605|Vorinostat|vorinostat|mesh-list
64321306|NCT03803605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64321307|NCT03803605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64735406|NCT01986114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735407|NCT01986114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64735408|NCT01986114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64735409|NCT01986114|Serotonin Agents|serotonin agents|mesh-ancestor
64735410|NCT01986114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64735411|NCT01986114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64735425|NCT04658160|Imidacloprid|imidacloprid|mesh-list
64735426|NCT04658160|Cholinergic Agents|cholinergic agents|mesh-ancestor
64735427|NCT04658160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64735428|NCT04658160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735429|NCT04658160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321309|NCT03803605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321310|NCT02208505|Dexmedetomidine|dexmedetomidine|mesh-list
64321311|NCT02208505|Remifentanil|remifentanil|mesh-list
64321312|NCT02208505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64321313|NCT02208505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64321314|NCT02208505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321315|NCT02208505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64735430|NCT01963728|Insulin|insulin|mesh-list
64735431|NCT01963728|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64735432|NCT01963728|Insulin Glargine|insulin glargine|mesh-list
64735433|NCT01963728|Insulin, Isophane|insulin, isophane|mesh-list
64735434|NCT01963728|Isophane Insulin, Human|isophane insulin, human|mesh-list
64735435|NCT01963728|Isophane insulin, beef|isophane insulin, beef|mesh-list
64735436|NCT01963728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64735437|NCT01963728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735438|NCT01962948|Paclitaxel|paclitaxel|mesh-list
64735439|NCT01962948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64735440|NCT01962948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735441|NCT01962948|Tubulin Modulators|tubulin modulators|mesh-ancestor
64735442|NCT01962948|Antimitotic Agents|antimitotic agents|mesh-ancestor
64735443|NCT01962948|Mitosis Modulators|mitosis modulators|mesh-ancestor
64735444|NCT01962948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735445|NCT01985334|Glycopyrrolate|glycopyrrolate|mesh-list
64735446|NCT01985334|Bromides|bromides|mesh-list
64735447|NCT01985334|Anticonvulsants|anticonvulsants|mesh-ancestor
64735448|NCT01985334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735449|NCT01985334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64735450|NCT01985334|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64770735|NCT01154920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64735451|NCT01985334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64735452|NCT01985334|Cholinergic Agents|cholinergic agents|mesh-ancestor
64735453|NCT01985334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64735454|NCT01985334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735455|NCT01944774|Moxifloxacin|moxifloxacin|mesh-list
64735481|NCT01942590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64735483|NCT01942590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64735484|NCT01942590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64735485|NCT01942590|Respiratory System Agents|respiratory system agents|mesh-ancestor
64735486|NCT01942590|Sympathomimetics|sympathomimetics|mesh-ancestor
64735487|NCT01984242|Bevacizumab|bevacizumab|mesh-list
64735488|NCT01984242|Sunitinib|sunitinib|mesh-list
64735489|NCT01984242|Atezolizumab|atezolizumab|mesh-list
64735490|NCT01984242|Antibodies|antibodies|mesh-list
64735491|NCT01984242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64735492|NCT01984242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64735493|NCT01984242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735494|NCT01984242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64735495|NCT01984242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64735496|NCT01984242|Growth Substances|growth substances|mesh-ancestor
64735497|NCT01984242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735498|NCT01984242|Growth Inhibitors|growth inhibitors|mesh-ancestor
64735499|NCT01984242|Immunologic Factors|immunologic factors|mesh-ancestor
64735500|NCT01984242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64735501|NCT01984242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735502|NCT01984242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735504|NCT01960842|Carbidopa|carbidopa|mesh-list
64735505|NCT01960842|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64735506|NCT01960842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64735507|NCT01960842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64735508|NCT01960842|Dopamine Agents|dopamine agents|mesh-ancestor
64735509|NCT01960842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64735528|NCT01984164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735529|NCT01983774|Esomeprazole|esomeprazole|mesh-list
64735530|NCT01983774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64735531|NCT01983774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64735532|NCT01983774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64735533|NCT01983774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735534|NCT01983774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735535|NCT01982682|Mycophenolic Acid|mycophenolic acid|mesh-list
64735536|NCT01982682|Cyclophosphamide|cyclophosphamide|mesh-list
64735537|NCT01982682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64735538|NCT01982682|Immunologic Factors|immunologic factors|mesh-ancestor
64735539|NCT01982682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735540|NCT01982682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64735541|NCT01982682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64735542|NCT01982682|Alkylating Agents|alkylating agents|mesh-ancestor
64735543|NCT01982682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735544|NCT01982682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735545|NCT01982682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64735546|NCT01982682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64735547|NCT01982682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64321317|NCT02208505|Sensory System Agents|sensory system agents|mesh-ancestor
64770781|NCT00716066|Dermatologic Agents|dermatologic agents|mesh-ancestor
64770782|NCT00716066|Tubulin Modulators|tubulin modulators|mesh-ancestor
64770783|NCT00716066|Antimitotic Agents|antimitotic agents|mesh-ancestor
64321318|NCT02208505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321319|NCT02208505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64618344|NCT03022253|Analgesics|analgesics|mesh-ancestor
64735552|NCT01940484|Epoetin Alfa|epoetin alfa|mesh-list
64735553|NCT01940484|Hematinics|hematinics|mesh-ancestor
64735554|NCT01960296|Clopidogrel|clopidogrel|mesh-list
64735555|NCT01960296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64735556|NCT01960296|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64735557|NCT01960296|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64735558|NCT01960296|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64735559|NCT01960296|Purinergic Agents|purinergic agents|mesh-ancestor
64735560|NCT01960296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64735561|NCT01960296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735562|NCT01960296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735563|NCT04653246|Dexamethasone|dexamethasone|mesh-list
64735564|NCT04653246|Lenalidomide|lenalidomide|mesh-list
64735565|NCT04653246|Bortezomib|bortezomib|mesh-list
64735566|NCT04653246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64735567|NCT04653246|Antiemetics|antiemetics|mesh-ancestor
64735568|NCT04653246|Autonomic Agents|autonomic agents|mesh-ancestor
64735569|NCT04653246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64735570|NCT04653246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735571|NCT04653246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64735572|NCT04653246|Glucocorticoids|glucocorticoids|mesh-ancestor
64735573|NCT04653246|Hormones|hormones|mesh-ancestor
64735574|NCT04653246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64735575|NCT04653246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64735576|NCT04653246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735577|NCT04653246|Immunologic Factors|immunologic factors|mesh-ancestor
64735578|NCT04653246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64735579|NCT04653246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64735580|NCT04653246|Growth Substances|growth substances|mesh-ancestor
64735581|NCT04653246|Growth Inhibitors|growth inhibitors|mesh-ancestor
64735582|NCT01939314|Bupivacaine|bupivacaine|mesh-list
64735583|NCT01939314|Anesthetics, Local|anesthetics, local|mesh-ancestor
64735584|NCT01939314|Anesthetics|anesthetics|mesh-ancestor
64735585|NCT01939314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64735586|NCT01939314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735587|NCT01939314|Sensory System Agents|sensory system agents|mesh-ancestor
64735588|NCT01939314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64735589|NCT01939158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64735590|NCT01939158|Immunologic Factors|immunologic factors|mesh-ancestor
64618348|NCT03022253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64321340|NCT02208583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64321341|NCT02208583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321343|NCT02208583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64321345|NCT02208583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64321346|NCT02208583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64321347|NCT05501288|Pholcodine|pholcodine|mesh-list
64321348|NCT05501288|Analgesics|analgesics|mesh-ancestor
64321349|NCT05501288|Sensory System Agents|sensory system agents|mesh-ancestor
64321350|NCT05501288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321351|NCT05501288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321352|NCT05501288|Antitussive Agents|antitussive agents|mesh-ancestor
64770809|NCT01054404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770810|NCT01054404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64321353|NCT05501288|Respiratory System Agents|respiratory system agents|mesh-ancestor
64321354|NCT04738292|Fulvestrant|fulvestrant|mesh-list
64321355|NCT04738292|Onapristone|onapristone|mesh-list
64321356|NCT04738292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64321357|NCT04738292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64321358|NCT04738292|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64321359|NCT04738292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64321360|NCT04738292|Hormone Antagonists|hormone antagonists|mesh-ancestor
64321361|NCT04738292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64321362|NCT04738292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321363|NCT04738292|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64735631|NCT04652700|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64735632|NCT04652700|Antiviral Agents|antiviral agents|mesh-ancestor
64735633|NCT04652700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64735634|NCT04652700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64735635|NCT04652700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64735636|NCT04652700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735637|NCT04652700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735638|NCT04652700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64735639|NCT04652700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64735640|NCT01960140|Simvastatin|simvastatin|mesh-list
64735641|NCT01960140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64735642|NCT01960140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64735643|NCT01960140|Antimetabolites|antimetabolites|mesh-ancestor
64735644|NCT01960140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735645|NCT01960140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64735646|NCT01960140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64735647|NCT01960140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735648|NCT01959672|Calcium, Dietary|calcium, dietary|mesh-list
64735649|NCT01959672|Leucovorin|leucovorin|mesh-list
64735650|NCT01959672|Folic Acid|folic acid|mesh-list
64735651|NCT01959672|Gemcitabine|gemcitabine|mesh-list
64735652|NCT01959672|Nelfinavir|nelfinavir|mesh-list
64735653|NCT01959672|Fluorouracil|fluorouracil|mesh-list
64735654|NCT01959672|Oregovomab|oregovomab|mesh-list
64735655|NCT01959672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64735656|NCT01959672|Antibodies|antibodies|mesh-list
64735657|NCT01959672|Immunoglobulins|immunoglobulins|mesh-list
64735658|NCT01959672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64735659|NCT01959672|Calcium|calcium|mesh-list
64735660|NCT01959672|Levoleucovorin|levoleucovorin|mesh-list
64735679|NCT01959672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64735680|NCT01959672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64735681|NCT01959672|Protease Inhibitors|protease inhibitors|mesh-ancestor
64735683|NCT01959672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64735684|NCT01980888|Rituximab|rituximab|mesh-list
64735685|NCT01980888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64735686|NCT01980888|Idelalisib|idelalisib|mesh-list
64735687|NCT01980888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64735688|NCT01980888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735689|NCT01980888|Immunologic Factors|immunologic factors|mesh-ancestor
64735690|NCT01980888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735691|NCT01980888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64321364|NCT04738292|Fertility Agents|fertility agents|mesh-ancestor
64321365|NCT04738292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64735716|NCT01937364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64735717|NCT01937364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735718|NCT01979952|Nintedanib|nintedanib|mesh-list
64735719|NCT01979952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64735720|NCT01979952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64735721|NCT01979952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735722|NCT01979952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735732|NCT01936974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735733|NCT01936974|Growth Inhibitors|growth inhibitors|mesh-ancestor
64735734|NCT01936974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64735735|NCT01936974|Antimetabolites|antimetabolites|mesh-ancestor
64735736|NCT01936974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735737|NCT01936974|Antiviral Agents|antiviral agents|mesh-ancestor
64735738|NCT01936974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64735739|NCT01936974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64735740|NCT01936974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64735741|NCT01936974|Immunologic Factors|immunologic factors|mesh-ancestor
64735742|NCT01959516|Glycopyrrolate|glycopyrrolate|mesh-list
64735743|NCT01959516|Tiotropium Bromide|tiotropium bromide|mesh-list
64735744|NCT01959516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64735745|NCT01959516|Autonomic Agents|autonomic agents|mesh-ancestor
64735746|NCT01959516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64735747|NCT01959516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735748|NCT01959516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64735749|NCT01959516|Respiratory System Agents|respiratory system agents|mesh-ancestor
64735750|NCT01959516|Parasympatholytics|parasympatholytics|mesh-ancestor
64735751|NCT01959516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64735752|NCT01959516|Cholinergic Agents|cholinergic agents|mesh-ancestor
64735753|NCT01959516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64735754|NCT01959516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735755|NCT01959516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64735757|NCT01979016|Emollients|emollients|mesh-list
64735782|NCT04411212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735783|NCT01620138|Cabergoline|cabergoline|mesh-list
64735784|NCT01620138|Pasireotide|pasireotide|mesh-list
64735785|NCT01620138|Hormones|hormones|mesh-ancestor
64735786|NCT01620138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64770918|NCT01094106|Ropivacaine|ropivacaine|mesh-list
64735787|NCT01620138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735788|NCT01620138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64735789|NCT01620138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64735790|NCT01620138|Dopamine Agonists|dopamine agonists|mesh-ancestor
64735791|NCT01620138|Dopamine Agents|dopamine agents|mesh-ancestor
64735792|NCT01620138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64735793|NCT01620138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735794|NCT01932996|Nicotine|nicotine|mesh-list
64735795|NCT01932996|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64735796|NCT01932996|Autonomic Agents|autonomic agents|mesh-ancestor
64735797|NCT01932996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64735798|NCT01932996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735799|NCT01932996|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64735800|NCT01932996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64735801|NCT01932996|Cholinergic Agents|cholinergic agents|mesh-ancestor
64735802|NCT01932996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64735803|NCT01932996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64735804|NCT01932762|Ribavirin|ribavirin|mesh-list
64321377|NCT05508152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64321378|NCT05508152|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64321379|NCT05508152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64321380|NCT05508152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321382|NCT03532711|Fluorouracil|fluorouracil|mesh-list
64321383|NCT03532711|Capecitabine|capecitabine|mesh-list
64321384|NCT03532711|Oxaliplatin|oxaliplatin|mesh-list
64321385|NCT03532711|Irinotecan|irinotecan|mesh-list
64321386|NCT03532711|Levoleucovorin|levoleucovorin|mesh-list
64321387|NCT03532711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321388|NCT03532711|Antimetabolites|antimetabolites|mesh-ancestor
64321389|NCT03532711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618398|NCT01039207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64297950|NCT02443402|Insulin Glargine|insulin glargine|mesh-list
64735896|NCT01975272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735898|NCT03965039|Fluorides|fluorides|mesh-list
64735899|NCT03965039|Tin Fluorides|tin fluorides|mesh-list
64735900|NCT03965039|Fluorophosphate|fluorophosphate|mesh-list
64735901|NCT03965039|Cariostatic Agents|cariostatic agents|mesh-ancestor
64735902|NCT03965039|Protective Agents|protective agents|mesh-ancestor
64735903|NCT03965039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735904|NCT03961295|Vedolizumab|vedolizumab|mesh-list
64735905|NCT03961295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64735906|NCT03935399|Oxytocin|oxytocin|mesh-list
64735907|NCT03935399|Oxytocics|oxytocics|mesh-ancestor
64735908|NCT03935399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64735909|NCT03935399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735910|NCT03571607|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64735911|NCT03571607|Immunologic Factors|immunologic factors|mesh-ancestor
64735912|NCT03571607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64735913|NCT03993119|Anticoagulants|anticoagulants|mesh-list
64770963|NCT01096680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64770964|NCT01096680|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64770965|NCT01096680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64770966|NCT01096680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64770967|NCT01096992|Rituximab|rituximab|mesh-list
64770968|NCT01096992|Fludarabine|fludarabine|mesh-list
64770969|NCT01096992|Fludarabine phosphate|fludarabine phosphate|mesh-list
64770970|NCT01096992|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64770971|NCT01096992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64770972|NCT01096992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770973|NCT01096992|Immunologic Factors|immunologic factors|mesh-ancestor
64770974|NCT01096992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435955|NCT01732822|Ticagrelor|ticagrelor|mesh-list
64735914|NCT03910439|Avelumab|avelumab|mesh-list
64735915|NCT03910439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64736032|NCT00378443|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64736034|NCT00378443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736035|NCT00378443|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64736036|NCT00378443|Protease Inhibitors|protease inhibitors|mesh-ancestor
64736037|NCT00378443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736038|NCT01340573|Interferons|interferons|mesh-list
64736039|NCT01340573|Ribavirin|ribavirin|mesh-list
64736040|NCT01340573|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64736041|NCT01340573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736042|NCT01340573|Antiviral Agents|antiviral agents|mesh-ancestor
64736043|NCT01340573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64736044|NCT01340573|Antimetabolites|antimetabolites|mesh-ancestor
64736045|NCT01340573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736046|NCT01340885|Rivastigmine|rivastigmine|mesh-list
64736047|NCT01340885|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64736048|NCT01340885|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64736049|NCT01340885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64736050|NCT01340885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64321451|NCT04772222|Morphine|morphine|mesh-list
64321452|NCT04772222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64321453|NCT04772222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64736079|NCT03855059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736080|NCT03855059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736081|NCT01301963|Plerixafor|plerixafor|mesh-list
64736082|NCT01301963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64736083|NCT01301963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64736084|NCT01301963|Antiviral Agents|antiviral agents|mesh-ancestor
64736085|NCT01301963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64736086|NCT01262339|Botulinum Toxins|botulinum toxins|mesh-list
64736087|NCT01262339|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64475427|NCT00408460|Paclitaxel|paclitaxel|mesh-list
64736088|NCT01262339|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64736089|NCT01262339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64736090|NCT01262339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736091|NCT01262339|Cholinergic Agents|cholinergic agents|mesh-ancestor
64736092|NCT01262339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64736093|NCT01262339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736094|NCT01262339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64736095|NCT01262339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64736097|NCT02708849|Ketamine|ketamine|mesh-list
64736098|NCT02708849|Analgesics|analgesics|mesh-ancestor
64736099|NCT02708849|Sensory System Agents|sensory system agents|mesh-ancestor
64736100|NCT02708849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64736101|NCT02708849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736102|NCT02708849|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64736103|NCT02708849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64736104|NCT02708849|Anesthetics, General|anesthetics, general|mesh-ancestor
64736105|NCT02708849|Anesthetics|anesthetics|mesh-ancestor
64736106|NCT02708849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64736107|NCT02708849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64736108|NCT02708849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64736109|NCT02708849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64736110|NCT02708849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736111|NCT02708849|Anticonvulsants|anticonvulsants|mesh-ancestor
64736112|NCT02708849|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64736113|NCT02708849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64736114|NCT02708849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64736115|NCT02708849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64736116|NCT02708849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64736117|NCT02708849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64736118|NCT02708849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64736119|NCT01222871|Triamcinolone|triamcinolone|mesh-list
64736120|NCT01222871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64435968|NCT02004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64736121|NCT01222871|Glucocorticoids|glucocorticoids|mesh-ancestor
64736122|NCT01222871|Hormones|hormones|mesh-ancestor
64736779|NCT01645709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321456|NCT04772222|Analgesics|analgesics|mesh-ancestor
64321457|NCT04772222|Sensory System Agents|sensory system agents|mesh-ancestor
64321458|NCT04772222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321459|NCT04772222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64736136|NCT01219673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64736137|NCT01219673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736138|NCT01219673|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64736139|NCT01219673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64736140|NCT01219673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736141|NCT01219673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64736142|NCT01219673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64736143|NCT01219673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64736144|NCT01219673|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64736145|NCT01219673|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64736146|NCT01219673|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64736147|NCT01216631|Methylprednisolone|methylprednisolone|mesh-list
64736148|NCT01216631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64736149|NCT01216631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64401054|NCT02936843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64401055|NCT02936843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64401057|NCT02936843|Sensory System Agents|sensory system agents|mesh-ancestor
64401058|NCT02936843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401059|NCT02936843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401060|NCT02936843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64401061|NCT02936843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64401062|NCT03285763|Atezolizumab|atezolizumab|mesh-list
64401063|NCT03285763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401087|NCT04705727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401088|NCT04705727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64401089|NCT04705727|Respiratory System Agents|respiratory system agents|mesh-ancestor
64401090|NCT04705727|Glucocorticoids|glucocorticoids|mesh-ancestor
64401092|NCT04705727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64736151|NCT01216631|Prednisolone acetate|prednisolone acetate|mesh-list
64736152|NCT01216631|Infliximab|infliximab|mesh-list
64736153|NCT01216631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64736154|NCT01216631|Prednisolone phosphate|prednisolone phosphate|mesh-list
64736155|NCT01216631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64736156|NCT01216631|Antiemetics|antiemetics|mesh-ancestor
64736157|NCT01216631|Autonomic Agents|autonomic agents|mesh-ancestor
64736158|NCT01216631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64736159|NCT01216631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736160|NCT01216631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64736162|NCT01216631|Hormones|hormones|mesh-ancestor
64401093|NCT04705727|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64401094|NCT04705727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64401095|NCT04705727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64401096|NCT04705727|Adrenergic Agents|adrenergic agents|mesh-ancestor
64401097|NCT04705727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64401098|NCT04705727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382424|NCT02069392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64382425|NCT02069392|Autonomic Agents|autonomic agents|mesh-ancestor
64382426|NCT02069392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64382427|NCT02069392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382428|NCT02069392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64382429|NCT02069392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64382430|NCT02069392|Cholinergic Agents|cholinergic agents|mesh-ancestor
64382431|NCT02069392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64382432|NCT02069392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382443|NCT05522361|Risdiplam|risdiplam|mesh-list
64401099|NCT04705727|Sympathomimetics|sympathomimetics|mesh-ancestor
64401100|NCT04705727|Tocolytic Agents|tocolytic agents|mesh-ancestor
64401101|NCT04705727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64401102|NCT03114865|Dexamethasone|dexamethasone|mesh-list
64401103|NCT03114865|Blinatumomab|blinatumomab|mesh-list
64401104|NCT03114865|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64401105|NCT03114865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64401106|NCT03114865|Antiemetics|antiemetics|mesh-ancestor
64401107|NCT03114865|Autonomic Agents|autonomic agents|mesh-ancestor
64401108|NCT03114865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401109|NCT03114865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401110|NCT03114865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64401111|NCT03114865|Glucocorticoids|glucocorticoids|mesh-ancestor
64401112|NCT03114865|Hormones|hormones|mesh-ancestor
64401113|NCT03114865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64401114|NCT03114865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64401115|NCT03114865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401116|NCT03114865|Immunologic Factors|immunologic factors|mesh-ancestor
64401117|NCT03085771|Deferoxamine|deferoxamine|mesh-list
64401118|NCT03085771|Siderophores|siderophores|mesh-ancestor
64401119|NCT03085771|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64401120|NCT03085771|Chelating Agents|chelating agents|mesh-ancestor
64401121|NCT03085771|Sequestering Agents|sequestering agents|mesh-ancestor
64401122|NCT03085771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401123|NCT05619965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64401124|NCT05619965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64401125|NCT05619965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401157|NCT03110653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401158|NCT03110653|Analgesics|analgesics|mesh-ancestor
64401159|NCT03110653|Sensory System Agents|sensory system agents|mesh-ancestor
64401160|NCT03110653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401161|NCT05392387|Antiviral Agents|antiviral agents|mesh-list
64401162|NCT05392387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64401163|NCT02037529|Paclitaxel|paclitaxel|mesh-list
64401164|NCT02037529|Halichondrin B|halichondrin b|mesh-list
64401165|NCT02037529|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64401166|NCT02037529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64401167|NCT02037529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401168|NCT02037529|Tubulin Modulators|tubulin modulators|mesh-ancestor
64401169|NCT02037529|Antimitotic Agents|antimitotic agents|mesh-ancestor
64401170|NCT02037529|Mitosis Modulators|mitosis modulators|mesh-ancestor
64401171|NCT02037529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401172|NCT04450199|Vitamin D|vitamin d|mesh-list
64401173|NCT04450199|Ergocalciferols|ergocalciferols|mesh-list
64736163|NCT01216631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64736164|NCT01216631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64736165|NCT01216631|Protective Agents|protective agents|mesh-ancestor
64618508|NCT05313958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770975|NCT01096992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64736166|NCT01216631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64736167|NCT01216631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736168|NCT01216631|Dermatologic Agents|dermatologic agents|mesh-ancestor
64736169|NCT01216631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64736170|NCT02693717|Pemetrexed|pemetrexed|mesh-list
64736171|NCT02693717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736172|NCT02693717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736173|NCT02693717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736174|NCT02693717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64736175|NCT02693717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64736176|NCT03860753|Pioglitazone|pioglitazone|mesh-list
64736177|NCT03860753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64736178|NCT03860753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736179|NCT02687165|Cycloserine|cycloserine|mesh-list
64736180|NCT02687165|Milnacipran|milnacipran|mesh-list
64736181|NCT02687165|Levomilnacipran|levomilnacipran|mesh-list
64736182|NCT02687165|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64736183|NCT02687165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64736184|NCT02687165|Renal Agents|renal agents|mesh-ancestor
64736185|NCT02687165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64736186|NCT02687165|Antitubercular Agents|antitubercular agents|mesh-ancestor
64736187|NCT02687165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64736188|NCT02687165|Antimetabolites|antimetabolites|mesh-ancestor
64401174|NCT04450199|Cholecalciferol|cholecalciferol|mesh-list
64401175|NCT04450199|Vitamins|vitamins|mesh-list
64401176|NCT04450199|Micronutrients|micronutrients|mesh-ancestor
64401177|NCT04450199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401240|NCT03067103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64401241|NCT03067103|Narcotics|narcotics|mesh-ancestor
64401242|NCT05492123|Cisplatin|cisplatin|mesh-list
64401243|NCT05492123|Nivolumab|nivolumab|mesh-list
64401244|NCT05492123|Ipilimumab|ipilimumab|mesh-list
64401245|NCT05492123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401246|NCT05492123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64401247|NCT05492123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64401248|NCT05492123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401249|NCT01398319|Ethanol|ethanol|mesh-list
64401250|NCT01398319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64401251|NCT01398319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64401252|NCT01398319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64401253|NCT01398319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401254|NCT01305889|Sertraline|sertraline|mesh-list
64401255|NCT01305889|Antidepressive Agents|antidepressive agents|mesh-ancestor
64401265|NCT05392075|Immunologic Factors|immunologic factors|mesh-ancestor
64401266|NCT05392075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401267|NCT03604289|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
64401268|NCT03604289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64736189|NCT02687165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736190|NCT02687165|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64736191|NCT02687165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64736192|NCT02687165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64736193|NCT02687165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64736194|NCT02687165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736195|NCT02687165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64736197|NCT02687165|Sensory System Agents|sensory system agents|mesh-ancestor
64736198|NCT02687165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64736199|NCT02687165|Antidepressive Agents|antidepressive agents|mesh-ancestor
64736200|NCT02687165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64736201|NCT01169753|Modafinil|modafinil|mesh-list
64736202|NCT01169753|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64736203|NCT01169753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736204|NCT01169753|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64736205|NCT01169753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64736206|NCT01169753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64736207|NCT01169753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736208|NCT02654639|Bevacizumab|bevacizumab|mesh-list
64736209|NCT02654639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64736210|NCT02654639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736211|NCT02654639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64401269|NCT03604289|Vasodilator Agents|vasodilator agents|mesh-ancestor
64401270|NCT00223171|Androgens|androgens|mesh-list
64401271|NCT00223171|Hormones|hormones|mesh-ancestor
64401272|NCT00223171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64401273|NCT00223171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401274|NCT03138031|Ethanol|ethanol|mesh-list
64401275|NCT03138031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64401276|NCT03138031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64401277|NCT03138031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64401278|NCT03138031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401279|NCT02735057|Paclitaxel|paclitaxel|mesh-list
64401280|NCT02735057|Carboplatin|carboplatin|mesh-list
64401281|NCT02735057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64401291|NCT04439357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64401292|NCT04439357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401293|NCT04439357|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64401294|NCT04439357|Protective Agents|protective agents|mesh-ancestor
64401295|NCT04439357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401296|NCT04439357|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64401297|NCT04439357|Antioxidants|antioxidants|mesh-ancestor
64401298|NCT05431283|Tofacitinib|tofacitinib|mesh-list
64401299|NCT05431283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64401300|NCT05431283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64401301|NCT05431283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401302|NCT03208985|Ulipristal acetate|ulipristal acetate|mesh-list
64736212|NCT02654639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64736213|NCT02654639|Growth Substances|growth substances|mesh-ancestor
64736214|NCT02654639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736215|NCT02654639|Growth Inhibitors|growth inhibitors|mesh-ancestor
64736216|NCT02634827|Decitabine|decitabine|mesh-list
64736217|NCT02634827|Midostaurin|midostaurin|mesh-list
64736218|NCT02634827|Staurosporine|staurosporine|mesh-list
64736219|NCT02634827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64736220|NCT02634827|Antimetabolites|antimetabolites|mesh-ancestor
64736221|NCT02634827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736222|NCT02634827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736223|NCT02634827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736224|NCT02634827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64736225|NCT02506985|Warfarin|warfarin|mesh-list
64736226|NCT02506985|Rivaroxaban|rivaroxaban|mesh-list
64736227|NCT02506985|Anticoagulants|anticoagulants|mesh-ancestor
64736228|NCT02506985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64736229|NCT02506985|Antithrombins|antithrombins|mesh-ancestor
64736230|NCT02506985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64736231|NCT02506985|Protease Inhibitors|protease inhibitors|mesh-ancestor
64736232|NCT02506985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736233|NCT02506985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736234|NCT01150409|Hydrocortisone|hydrocortisone|mesh-list
64736235|NCT01150409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64736236|NCT01133639|Ketorolac|ketorolac|mesh-list
64736237|NCT01133639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64771184|NCT01120704|Autonomic Agents|autonomic agents|mesh-ancestor
64736238|NCT01133639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64736239|NCT01133639|Analgesics|analgesics|mesh-ancestor
64736240|NCT01133639|Sensory System Agents|sensory system agents|mesh-ancestor
64736241|NCT01133639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401321|NCT04764097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401322|NCT02902757|Deoxyglucose|deoxyglucose|mesh-list
64401323|NCT02902757|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64401324|NCT02902757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64401325|NCT02902757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401326|NCT02902757|Antimetabolites|antimetabolites|mesh-ancestor
64401327|NCT02902757|Antiviral Agents|antiviral agents|mesh-ancestor
64401328|NCT02902757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64401329|NCT05391451|Anesthetics|anesthetics|mesh-list
64401330|NCT05391451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64401331|NCT05391451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401332|NCT03110341|Epoetin Alfa|epoetin alfa|mesh-list
64618518|NCT01006655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64401333|NCT03110341|Hematinics|hematinics|mesh-ancestor
64401334|NCT04648189|Cetuximab|cetuximab|mesh-list
64401335|NCT04648189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64736242|NCT01133639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736244|NCT01133639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64736245|NCT01133639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64736246|NCT01133639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736247|NCT01133639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736248|NCT00378911|Sunitinib|sunitinib|mesh-list
64736249|NCT00378911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736250|NCT00378911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64736251|NCT00378911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64736252|NCT00378911|Growth Substances|growth substances|mesh-ancestor
64736253|NCT00378911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736254|NCT00378911|Growth Inhibitors|growth inhibitors|mesh-ancestor
64736255|NCT00378911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64736256|NCT00378911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736257|NCT00378911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736258|NCT03822377|Ticagrelor|ticagrelor|mesh-list
64736259|NCT03822377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64736260|NCT03822377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64736261|NCT03822377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64736262|NCT03822377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64736263|NCT03822377|Purinergic Agents|purinergic agents|mesh-ancestor
64736264|NCT03822377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64736265|NCT03822377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736266|NCT03822377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401336|NCT04648189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401337|NCT04537897|Midazolam|midazolam|mesh-list
64401338|NCT04537897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64401339|NCT04537897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64401340|NCT04537897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64401341|NCT04537897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401342|NCT04537897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64401343|NCT04537897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64401344|NCT04537897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64401345|NCT04537897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64401346|NCT04537897|Anesthetics, General|anesthetics, general|mesh-ancestor
64401363|NCT05090449|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64401364|NCT05090449|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64401365|NCT05090449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401366|NCT05090449|Diuretics|diuretics|mesh-ancestor
64771272|NCT03697356|Hormones|hormones|mesh-ancestor
64401367|NCT05090449|Natriuretic Agents|natriuretic agents|mesh-ancestor
64401368|NCT05090449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401369|NCT05090449|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64401370|NCT05090449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64401371|NCT05090137|Diuretics|diuretics|mesh-list
64401372|NCT05090137|Natriuretic Agents|natriuretic agents|mesh-ancestor
64736268|NCT02501759|Antidotes|antidotes|mesh-ancestor
64736269|NCT02501759|Protective Agents|protective agents|mesh-ancestor
64736270|NCT02501759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736271|NCT02501759|Chelating Agents|chelating agents|mesh-ancestor
64736272|NCT02501759|Sequestering Agents|sequestering agents|mesh-ancestor
64736273|NCT02501759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736274|NCT02501759|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64736275|NCT02499887|Prednisone|prednisone|mesh-list
64736276|NCT02499887|Albuterol|albuterol|mesh-list
64736277|NCT02499887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64736278|NCT02499887|Glucocorticoids|glucocorticoids|mesh-ancestor
64736279|NCT02499887|Hormones|hormones|mesh-ancestor
64736280|NCT02499887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64736281|NCT02499887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736282|NCT02499887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64401373|NCT05090137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401398|NCT04271189|Hormones|hormones|mesh-ancestor
64401399|NCT04271189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64401400|NCT04271189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64401401|NCT04271189|Protease Inhibitors|protease inhibitors|mesh-ancestor
64401402|NCT04271189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618525|NCT03633526|Ivacaftor|ivacaftor|mesh-list
64401403|NCT04271189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401404|NCT05730413|Bisoprolol|bisoprolol|mesh-list
64401405|NCT05730413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64401406|NCT05730413|Sympatholytics|sympatholytics|mesh-ancestor
64401411|NCT05730413|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64401412|NCT05730413|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64401413|NCT05730413|Adrenergic Agents|adrenergic agents|mesh-ancestor
64401414|NCT05730413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64401415|NCT05730413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401416|NCT04206059|Dexmedetomidine|dexmedetomidine|mesh-list
64401417|NCT04206059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64401418|NCT04206059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64401419|NCT04206059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401420|NCT04206059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64401421|NCT04206059|Analgesics|analgesics|mesh-ancestor
64401422|NCT04206059|Sensory System Agents|sensory system agents|mesh-ancestor
64401423|NCT04206059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401424|NCT04206059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64401425|NCT04206059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64401426|NCT04206059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64401427|NCT04206059|Adrenergic Agents|adrenergic agents|mesh-ancestor
64401428|NCT04206059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64401429|NCT04206059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401457|NCT04118387|Natriuretic Agents|natriuretic agents|mesh-ancestor
64401458|NCT04118387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64401459|NCT04118387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64771274|NCT03697356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64771275|NCT03697356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64401460|NCT04118387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64401461|NCT04118387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64401462|NCT04118387|Serotonin Agents|serotonin agents|mesh-ancestor
64401463|NCT03066635|Botulinum Toxins|botulinum toxins|mesh-list
64401464|NCT03066635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64401465|NCT03066635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64401466|NCT03066635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64401467|NCT03066635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64401468|NCT03066635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401469|NCT03066635|Cholinergic Agents|cholinergic agents|mesh-ancestor
64736283|NCT02499887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736284|NCT02499887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64736285|NCT02499887|Autonomic Agents|autonomic agents|mesh-ancestor
64736286|NCT02499887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64736287|NCT02499887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64736288|NCT02499887|Respiratory System Agents|respiratory system agents|mesh-ancestor
64736289|NCT02499887|Tocolytic Agents|tocolytic agents|mesh-ancestor
64736290|NCT02499887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64736291|NCT02499887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64401470|NCT03066635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64401471|NCT03066635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401472|NCT03066635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64401473|NCT03066635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401474|NCT03136237|Cyclosporine|cyclosporine|mesh-list
64401475|NCT03136237|Digoxin|digoxin|mesh-list
64401476|NCT03136237|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64401480|NCT03136237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401481|NCT03136237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64401494|NCT03136237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64401495|NCT03136237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64401496|NCT03136237|Protective Agents|protective agents|mesh-ancestor
64401497|NCT04001309|Anti-Infective Agents|anti-infective agents|mesh-list
64401498|NCT04001309|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64401499|NCT04021381|Magnesium citrate|magnesium citrate|mesh-list
64401500|NCT04021381|Cathartics|cathartics|mesh-ancestor
64401501|NCT04021381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64401502|NCT03066791|Curcumin|curcumin|mesh-list
64401503|NCT03066791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64401504|NCT03066791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64401505|NCT03066791|Analgesics|analgesics|mesh-ancestor
64618530|NCT01007591|Hydrocortisone|hydrocortisone|mesh-list
64401506|NCT03066791|Sensory System Agents|sensory system agents|mesh-ancestor
64401507|NCT03066791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401508|NCT03066791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401509|NCT03066791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64401510|NCT03066791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64401511|NCT03066791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401512|NCT03066791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64401513|NCT03066791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401514|NCT05729555|Diphenhydramine|diphenhydramine|mesh-list
64401515|NCT05729555|Promethazine|promethazine|mesh-list
64401516|NCT05729555|Ibuprofen|ibuprofen|mesh-list
64401517|NCT05729555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64401518|NCT05729555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64401519|NCT05729555|Analgesics|analgesics|mesh-ancestor
64401520|NCT05729555|Sensory System Agents|sensory system agents|mesh-ancestor
64771287|NCT02410512|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64771288|NCT02410512|Immunologic Factors|immunologic factors|mesh-ancestor
64771289|NCT02410512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771290|NCT02410512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401521|NCT05729555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401522|NCT05729555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401523|NCT05729555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64401524|NCT05729555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64401525|NCT05729555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64401526|NCT05729555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64401527|NCT05729555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401528|NCT05729555|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64401529|NCT05729555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64401530|NCT05729555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64401531|NCT05729555|Anesthetics, Local|anesthetics, local|mesh-ancestor
64401532|NCT05729555|Anesthetics|anesthetics|mesh-ancestor
64401533|NCT05729555|Antiemetics|antiemetics|mesh-ancestor
64401534|NCT05729555|Autonomic Agents|autonomic agents|mesh-ancestor
64401535|NCT05729555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64401536|NCT05729555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64401537|NCT05729555|Histamine Antagonists|histamine antagonists|mesh-ancestor
64401538|NCT05729555|Histamine Agents|histamine agents|mesh-ancestor
64401539|NCT05729555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64401540|NCT05729555|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64736292|NCT02499887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64736293|NCT02499887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64736294|NCT02499887|Adrenergic Agents|adrenergic agents|mesh-ancestor
64736295|NCT02499887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64736296|NCT02499887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736297|NCT02504099|Ritonavir|ritonavir|mesh-list
64736298|NCT02504099|Ribavirin|ribavirin|mesh-list
64736299|NCT02504099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64736300|NCT02504099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64401541|NCT05729555|Antipruritics|antipruritics|mesh-ancestor
64401542|NCT05729555|Dermatologic Agents|dermatologic agents|mesh-ancestor
64401543|NCT01603459|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64401544|NCT01603459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64401545|NCT01603459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401546|NCT01603459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401560|NCT03136003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401562|NCT03777215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64401563|NCT03777215|Vasodilator Agents|vasodilator agents|mesh-ancestor
64401564|NCT04945213|Biperiden|biperiden|mesh-list
64401565|NCT04945213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64401566|NCT04945213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64401567|NCT04945213|Parasympatholytics|parasympatholytics|mesh-ancestor
64401568|NCT04945213|Autonomic Agents|autonomic agents|mesh-ancestor
64401569|NCT04945213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401570|NCT04945213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401571|NCT04945213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64401572|NCT04945213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64401573|NCT04945213|Cholinergic Agents|cholinergic agents|mesh-ancestor
64401574|NCT04945213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64401575|NCT04945213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401576|NCT05410847|Paclitaxel|paclitaxel|mesh-list
64401577|NCT05410847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64401578|NCT05410847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401579|NCT05410847|Tubulin Modulators|tubulin modulators|mesh-ancestor
64401580|NCT05410847|Antimitotic Agents|antimitotic agents|mesh-ancestor
64401581|NCT05410847|Mitosis Modulators|mitosis modulators|mesh-ancestor
64401582|NCT05410847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771322|NCT01129206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771323|NCT01129206|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64401583|NCT04750291|Botulinum Toxins|botulinum toxins|mesh-list
64401584|NCT04750291|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64401585|NCT04750291|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64401586|NCT04750291|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64401587|NCT04750291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64401588|NCT04750291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401589|NCT04750291|Cholinergic Agents|cholinergic agents|mesh-ancestor
64401590|NCT04750291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64401591|NCT04750291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401592|NCT04750291|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64401593|NCT04750291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401594|NCT03726749|Prednisone|prednisone|mesh-list
64401595|NCT03726749|Glucocorticoids|glucocorticoids|mesh-list
64401596|NCT03726749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64401597|NCT03726749|Hormones|hormones|mesh-ancestor
64401598|NCT03726749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64401599|NCT03726749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401600|NCT03726749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64401601|NCT03726749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401602|NCT03136705|Niacinamide|niacinamide|mesh-list
64401603|NCT03136705|Niacin|niacin|mesh-list
64401604|NCT03136705|Nicotinic Acids|nicotinic acids|mesh-list
64401605|NCT03136705|Vitamin B Complex|vitamin b complex|mesh-ancestor
64401606|NCT03136705|Vitamins|vitamins|mesh-ancestor
64401607|NCT03136705|Micronutrients|micronutrients|mesh-ancestor
64401608|NCT03136705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401609|NCT03136705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64401610|NCT03136705|Antimetabolites|antimetabolites|mesh-ancestor
64736301|NCT02504099|Protease Inhibitors|protease inhibitors|mesh-ancestor
64736302|NCT02504099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736303|NCT02504099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736304|NCT02504099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64736305|NCT02504099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64736306|NCT02504099|Antiviral Agents|antiviral agents|mesh-ancestor
64736307|NCT02504099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64475651|NCT00424840|Growth Inhibitors|growth inhibitors|mesh-ancestor
64736308|NCT02504099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64736309|NCT02504099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64736310|NCT02504099|Antimetabolites|antimetabolites|mesh-ancestor
64736311|NCT02450591|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64736312|NCT02450591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736313|NCT02450591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64736314|NCT02450591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736315|NCT02450591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736317|NCT01094561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64771374|NCT01136226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64736318|NCT01094561|Hormones|hormones|mesh-ancestor
64736319|NCT01094561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64736320|NCT01094561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736321|NCT01074437|Prednisolone|prednisolone|mesh-list
64736322|NCT01074437|Propranolol|propranolol|mesh-list
64736323|NCT01074437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64618542|NCT01008059|Alfentanil|alfentanil|mesh-list
64736324|NCT01074437|Glucocorticoids|glucocorticoids|mesh-ancestor
64771375|NCT01136226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771376|NCT01136226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64771377|NCT01136226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401611|NCT03136705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401612|NCT03136705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64401613|NCT03136705|Vasodilator Agents|vasodilator agents|mesh-ancestor
64401614|NCT04540861|Siponimod|siponimod|mesh-list
64401615|NCT04540861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64401652|NCT05737693|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64401653|NCT05737693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64401654|NCT05737693|Anesthetics, General|anesthetics, general|mesh-ancestor
64401655|NCT05737693|Anesthetics|anesthetics|mesh-ancestor
64401656|NCT05737693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64401657|NCT05737693|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64401658|NCT05737693|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64401659|NCT05737693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64401660|NCT05737693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401661|NCT05737693|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64401662|NCT05737693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64401663|NCT05737693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64401664|NCT05737693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64401665|NCT05737693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64401666|NCT05737693|GABA Modulators|gaba modulators|mesh-ancestor
64401667|NCT05737693|GABA Agents|gaba agents|mesh-ancestor
64401668|NCT05728619|Temozolomide|temozolomide|mesh-list
64401669|NCT05728619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64401670|NCT05728619|Alkylating Agents|alkylating agents|mesh-ancestor
64736326|NCT01074437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64736327|NCT01074437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736328|NCT01074437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64736329|NCT01074437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736330|NCT01074437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64736331|NCT01074437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64736332|NCT01074437|Adrenergic Agents|adrenergic agents|mesh-ancestor
64736333|NCT01074437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64736334|NCT01074437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736335|NCT01074437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64736336|NCT01074437|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64736337|NCT01074437|Vasodilator Agents|vasodilator agents|mesh-ancestor
64736338|NCT03807245|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64736339|NCT03807245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64736340|NCT03807245|Immunologic Factors|immunologic factors|mesh-ancestor
64736341|NCT03807245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736342|NCT03807245|Antacids|antacids|mesh-ancestor
64736343|NCT03807245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736344|NCT03807245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64736345|NCT03796013|Entrectinib|entrectinib|mesh-list
64401671|NCT05728619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401672|NCT05728619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401673|NCT05737303|Paclitaxel|paclitaxel|mesh-list
64401674|NCT05737303|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64401675|NCT05737303|Carboplatin|carboplatin|mesh-list
64401676|NCT05737303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64401677|NCT05737303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401697|NCT05188313|Tubulin Modulators|tubulin modulators|mesh-ancestor
64401698|NCT05188313|Antimitotic Agents|antimitotic agents|mesh-ancestor
64401699|NCT05188313|Mitosis Modulators|mitosis modulators|mesh-ancestor
64401700|NCT05188313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771424|NCT01144494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64771425|NCT01144494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64401701|NCT05188313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64401763|NCT05736757|Plasminogen|plasminogen|mesh-list
64401764|NCT05736757|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64401765|NCT05736757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64401836|NCT02631551|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64401837|NCT02631551|Histamine Antagonists|histamine antagonists|mesh-ancestor
64401838|NCT02631551|Histamine Agents|histamine agents|mesh-ancestor
64401839|NCT02631551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64401840|NCT02631551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401841|NCT05091151|Dexmedetomidine|dexmedetomidine|mesh-list
64401842|NCT05091151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64401843|NCT05091151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64401844|NCT05091151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401845|NCT05091151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64401846|NCT05091151|Analgesics|analgesics|mesh-ancestor
64401847|NCT05091151|Sensory System Agents|sensory system agents|mesh-ancestor
64401848|NCT05091151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401885|NCT01700569|Alkylating Agents|alkylating agents|mesh-ancestor
64401886|NCT01700569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401887|NCT01700569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401888|NCT01700569|Antidotes|antidotes|mesh-ancestor
64736346|NCT03796013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64736347|NCT03796013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736348|NCT03796013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736349|NCT03793751|Dexmedetomidine|dexmedetomidine|mesh-list
64736350|NCT03793751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64736351|NCT03793751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64736352|NCT03793751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736353|NCT03793751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64736354|NCT03793751|Analgesics|analgesics|mesh-ancestor
64436332|NCT02308163|Etanercept|etanercept|mesh-list
64401889|NCT01700569|Protective Agents|protective agents|mesh-ancestor
64401890|NCT01700569|Vitamin B Complex|vitamin b complex|mesh-ancestor
64401891|NCT01700569|Vitamins|vitamins|mesh-ancestor
64401892|NCT01700569|Micronutrients|micronutrients|mesh-ancestor
64401893|NCT01700569|Hematinics|hematinics|mesh-ancestor
64401894|NCT05090761|Magnesium Sulfate|magnesium sulfate|mesh-list
64401895|NCT05090761|Buprenorphine|buprenorphine|mesh-list
64401896|NCT05090761|Bupivacaine|bupivacaine|mesh-list
64401897|NCT05090761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64401898|NCT05090761|Anesthetics, Local|anesthetics, local|mesh-ancestor
64401899|NCT05090761|Anesthetics|anesthetics|mesh-ancestor
64401900|NCT05090761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64401901|NCT05090761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401902|NCT05090761|Sensory System Agents|sensory system agents|mesh-ancestor
64401903|NCT05090761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401904|NCT05090761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64401905|NCT05090761|Narcotics|narcotics|mesh-ancestor
64401906|NCT05090761|Analgesics|analgesics|mesh-ancestor
64401907|NCT05090761|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64401947|NCT04533841|Misoprostol|misoprostol|mesh-list
64401976|NCT04012931|Rilpivirine|rilpivirine|mesh-list
64401977|NCT04012931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64401978|NCT04012931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64401979|NCT04012931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64401980|NCT04012931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401981|NCT04012931|Antiviral Agents|antiviral agents|mesh-ancestor
64401982|NCT04012931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64401983|NCT04012931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64401984|NCT04012931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64401985|NCT03063359|Fentanyl|fentanyl|mesh-list
64401986|NCT03063359|Morphine|morphine|mesh-list
64401987|NCT03063359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64401988|NCT03063359|Narcotics|narcotics|mesh-ancestor
64401989|NCT03063359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64401990|NCT03063359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401991|NCT03063359|Analgesics|analgesics|mesh-ancestor
64401992|NCT03063359|Sensory System Agents|sensory system agents|mesh-ancestor
64401993|NCT03063359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64402035|NCT04901299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402036|NCT05067985|Anesthetics|anesthetics|mesh-list
64402037|NCT05067985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64402038|NCT05067985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402039|NCT04262869|Paclitaxel|paclitaxel|mesh-list
64736355|NCT03793751|Sensory System Agents|sensory system agents|mesh-ancestor
64736356|NCT03793751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618570|NCT04467424|Sensory System Agents|sensory system agents|mesh-ancestor
64736359|NCT03793751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64736360|NCT03793751|Adrenergic Agents|adrenergic agents|mesh-ancestor
64736361|NCT03793751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64736362|NCT03793751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736363|NCT02351063|Angiotensin II|angiotensin ii|mesh-list
64736364|NCT02351063|Diuretics|diuretics|mesh-list
64736365|NCT02351063|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64402040|NCT04262869|Carboplatin|carboplatin|mesh-list
64402041|NCT04262869|Pemetrexed|pemetrexed|mesh-list
64402042|NCT04262869|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64402058|NCT04262869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402060|NCT05092165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402061|NCT05092165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402062|NCT03062813|Entecavir|entecavir|mesh-list
64402063|NCT03062813|Tacrolimus|tacrolimus|mesh-list
64402064|NCT03062813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64402069|NCT03062813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402070|NCT03062813|Antiviral Agents|antiviral agents|mesh-ancestor
64402071|NCT03062813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64402072|NCT04893161|Belimumab|belimumab|mesh-list
64402073|NCT04893161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64402074|NCT04893161|Immunologic Factors|immunologic factors|mesh-ancestor
64402075|NCT04893161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402076|NCT04884035|Prednisone|prednisone|mesh-list
64402077|NCT04884035|Prednisolone|prednisolone|mesh-list
64402078|NCT04884035|Cyclophosphamide|cyclophosphamide|mesh-list
64402080|NCT04884035|Doxorubicin|doxorubicin|mesh-list
64402081|NCT04884035|Vincristine|vincristine|mesh-list
64771497|NCT01163214|Ropivacaine|ropivacaine|mesh-list
64771498|NCT01163214|Anesthetics, Local|anesthetics, local|mesh-ancestor
64402082|NCT04884035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64402083|NCT04884035|Immunologic Factors|immunologic factors|mesh-ancestor
64402084|NCT04884035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402085|NCT04884035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64402086|NCT04884035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64402087|NCT04884035|Alkylating Agents|alkylating agents|mesh-ancestor
64402088|NCT04884035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402089|NCT04884035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402090|NCT04884035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64402091|NCT04884035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64402092|NCT04884035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64402093|NCT04884035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64402094|NCT04884035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64402095|NCT04884035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402096|NCT04884035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64402097|NCT04884035|Glucocorticoids|glucocorticoids|mesh-ancestor
64402098|NCT04884035|Hormones|hormones|mesh-ancestor
64402099|NCT04884035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64402100|NCT04884035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64402101|NCT04884035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64402102|NCT04884035|Tubulin Modulators|tubulin modulators|mesh-ancestor
64402103|NCT04884035|Antimitotic Agents|antimitotic agents|mesh-ancestor
64402104|NCT04884035|Mitosis Modulators|mitosis modulators|mesh-ancestor
64402105|NCT04582981|Raltitrexed|raltitrexed|mesh-list
64402148|NCT01117441|Mercaptopurine|mercaptopurine|mesh-list
64402149|NCT01117441|Thioguanine|thioguanine|mesh-list
64402150|NCT01117441|Pegaspargase|pegaspargase|mesh-list
64402152|NCT01117441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64402153|NCT01117441|Immunologic Factors|immunologic factors|mesh-ancestor
64402154|NCT01117441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736366|NCT02351063|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
64736367|NCT02351063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64736368|NCT02351063|Natriuretic Agents|natriuretic agents|mesh-ancestor
64736369|NCT02351063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736370|NCT02351063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736371|NCT02351063|Protease Inhibitors|protease inhibitors|mesh-ancestor
64736372|NCT02351063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736373|NCT02351063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64736374|NCT02351063|Hormone Antagonists|hormone antagonists|mesh-ancestor
64736375|NCT02351063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64736376|NCT02351063|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64736377|NCT01016561|Cisplatin|cisplatin|mesh-list
64736378|NCT01016561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736379|NCT01009931|Dexamethasone|dexamethasone|mesh-list
64736380|NCT01009931|Dexamethasone acetate|dexamethasone acetate|mesh-list
64736381|NCT01009931|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
64736382|NCT01009931|Choline|choline|mesh-list
64736383|NCT01009931|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64736384|NCT01009931|BB 1101|bb 1101|mesh-list
64736385|NCT01009931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64736386|NCT01009931|Antiemetics|antiemetics|mesh-ancestor
64736387|NCT01009931|Autonomic Agents|autonomic agents|mesh-ancestor
64736388|NCT01009931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64771525|NCT01168674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64736389|NCT01009931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736390|NCT01009931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64736391|NCT01009931|Glucocorticoids|glucocorticoids|mesh-ancestor
64736392|NCT01009931|Hormones|hormones|mesh-ancestor
64402155|NCT01117441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64402156|NCT01117441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64402157|NCT01117441|Alkylating Agents|alkylating agents|mesh-ancestor
64402158|NCT01117441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402177|NCT01117441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64402178|NCT01117441|Antimetabolites|antimetabolites|mesh-ancestor
64402179|NCT01117441|Dermatologic Agents|dermatologic agents|mesh-ancestor
64402180|NCT01117441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64402181|NCT01117441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64402182|NCT01117441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64402183|NCT01117441|Antiviral Agents|antiviral agents|mesh-ancestor
64402184|NCT01117441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64402185|NCT01117441|Tubulin Modulators|tubulin modulators|mesh-ancestor
64402186|NCT01117441|Antimitotic Agents|antimitotic agents|mesh-ancestor
64402187|NCT01117441|Mitosis Modulators|mitosis modulators|mesh-ancestor
64402188|NCT01101451|Cisplatin|cisplatin|mesh-list
64402189|NCT01101451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402190|NCT03656627|Nivolumab|nivolumab|mesh-list
64402191|NCT03656627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64402192|NCT03656627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736393|NCT01009931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64736394|NCT01009931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64736395|NCT01009931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736397|NCT01009931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736398|NCT01009931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736399|NCT01009931|Lipotropic Agents|lipotropic agents|mesh-ancestor
64736400|NCT01009931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64736401|NCT01009931|Antimetabolites|antimetabolites|mesh-ancestor
64736402|NCT01009931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64736403|NCT01009931|Nootropic Agents|nootropic agents|mesh-ancestor
64736404|NCT01009931|Analgesics|analgesics|mesh-ancestor
64736405|NCT01009931|Sensory System Agents|sensory system agents|mesh-ancestor
64736406|NCT01009931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64736407|NCT01009931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64736408|NCT01009931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64736409|NCT03792191|Fentanyl|fentanyl|mesh-list
64736410|NCT03792191|Bupivacaine|bupivacaine|mesh-list
64736411|NCT03792191|Anesthetics, Local|anesthetics, local|mesh-ancestor
64736412|NCT03792191|Anesthetics|anesthetics|mesh-ancestor
64736413|NCT03792191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64736414|NCT03792191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736415|NCT03792191|Sensory System Agents|sensory system agents|mesh-ancestor
64736416|NCT03792191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64402193|NCT03656627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64402194|NCT03656627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402195|NCT04759703|Pramipexole|pramipexole|mesh-list
64402196|NCT04759703|Antioxidants|antioxidants|mesh-ancestor
64402197|NCT04759703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402198|NCT04759703|Protective Agents|protective agents|mesh-ancestor
64402199|NCT04759703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402200|NCT04759703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64402201|NCT04759703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64402202|NCT04759703|Dopamine Agonists|dopamine agonists|mesh-ancestor
64402203|NCT04759703|Dopamine Agents|dopamine agents|mesh-ancestor
64402204|NCT04759703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64402205|NCT05026801|Azithromycin|azithromycin|mesh-list
64402211|NCT05026801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64402212|NCT05026801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402213|NCT05026801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402214|NCT05026801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64402215|NCT05073575|Hyaluronic Acid|hyaluronic acid|mesh-list
64402216|NCT05073575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64402235|NCT03511625|Glucocorticoids|glucocorticoids|mesh-ancestor
64402237|NCT03511625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64402238|NCT03511625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64402239|NCT03511625|Protective Agents|protective agents|mesh-ancestor
64402240|NCT03511625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64402241|NCT03511625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402242|NCT03493061|Oxaliplatin|oxaliplatin|mesh-list
64736417|NCT03792191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64736418|NCT03792191|Narcotics|narcotics|mesh-ancestor
64736419|NCT03792191|Analgesics|analgesics|mesh-ancestor
64736420|NCT03792191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64736421|NCT03792191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64736422|NCT03792191|Anesthetics, General|anesthetics, general|mesh-ancestor
64736423|NCT00986999|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64736424|NCT00986999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64736425|NCT00986999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64736426|NCT00986999|Antimetabolites|antimetabolites|mesh-ancestor
64736427|NCT00986999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736428|NCT00986999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64736429|NCT00986999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64736430|NCT00986999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736431|NCT00983645|Cyclosporine|cyclosporine|mesh-list
64771599|NCT01177098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64736432|NCT00983645|Tacrolimus|tacrolimus|mesh-list
64736433|NCT00983645|Cyclosporins|cyclosporins|mesh-list
64736434|NCT00983645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64736435|NCT00983645|Immunologic Factors|immunologic factors|mesh-ancestor
64402243|NCT03493061|Irinotecan|irinotecan|mesh-list
64402244|NCT03493061|Floxuridine|floxuridine|mesh-list
64402245|NCT03493061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402246|NCT03493061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64402247|NCT03493061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64402248|NCT03493061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402249|NCT03493061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402250|NCT03493061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64402251|NCT03493061|Antimetabolites|antimetabolites|mesh-ancestor
64402252|NCT03809533|Sofosbuvir|sofosbuvir|mesh-list
64402253|NCT03809533|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64402254|NCT03809533|Velpatasvir|velpatasvir|mesh-list
64402255|NCT03809533|Antiviral Agents|antiviral agents|mesh-ancestor
64402256|NCT03809533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64402257|NCT04523935|Topiramate|topiramate|mesh-list
64402258|NCT04523935|Lamotrigine|lamotrigine|mesh-list
64402259|NCT04523935|Diazepam|diazepam|mesh-list
64402260|NCT04523935|Gabapentin|gabapentin|mesh-list
64402261|NCT04523935|Amitriptyline|amitriptyline|mesh-list
64402262|NCT04523935|Anticonvulsants|anticonvulsants|mesh-list
64402263|NCT04523935|Clonazepam|clonazepam|mesh-list
64402264|NCT04523935|Trihexyphenidyl|trihexyphenidyl|mesh-list
64402265|NCT04523935|Baclofen|baclofen|mesh-list
64402266|NCT04523935|Tetrabenazine|tetrabenazine|mesh-list
64402267|NCT04523935|Analgesics|analgesics|mesh-ancestor
64402268|NCT04523935|Sensory System Agents|sensory system agents|mesh-ancestor
64402269|NCT04523935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64402270|NCT04523935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402271|NCT04523935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64402272|NCT04523935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64402273|NCT04523935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64402274|NCT04523935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64402275|NCT04523935|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64402276|NCT04523935|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64402277|NCT04523935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64402324|NCT02630693|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64402325|NCT02630693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64402326|NCT02630693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402327|NCT02630693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402328|NCT02630693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64402329|NCT01938430|Sofosbuvir|sofosbuvir|mesh-list
64736437|NCT00983645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64736438|NCT00983645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736439|NCT00983645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736440|NCT00983645|Antifungal Agents|antifungal agents|mesh-ancestor
64736441|NCT00983645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64736442|NCT00983645|Dermatologic Agents|dermatologic agents|mesh-ancestor
64736443|NCT00983645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64736444|NCT00978419|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64736445|NCT00978419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64736446|NCT00978419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64736447|NCT00978419|Antimetabolites|antimetabolites|mesh-ancestor
64402330|NCT01938430|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64323381|NCT04227704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64323382|NCT04227704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64436903|NCT05813249|Protective Agents|protective agents|mesh-ancestor
64402331|NCT01938430|Ledipasvir|ledipasvir|mesh-list
64402332|NCT01938430|Antiviral Agents|antiviral agents|mesh-ancestor
64402333|NCT01938430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64402334|NCT04625530|Tranexamic Acid|tranexamic acid|mesh-list
64402335|NCT04625530|Ferric Compounds|ferric compounds|mesh-list
64402378|NCT01916824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64402379|NCT01916824|Adrenergic Agents|adrenergic agents|mesh-ancestor
64402380|NCT01916824|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64402381|NCT01916824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64402382|NCT01916824|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64402417|NCT02229149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64402418|NCT04642469|Durvalumab|durvalumab|mesh-list
64402419|NCT04642469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64402420|NCT04642469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402421|NCT04440371|Betamethasone|betamethasone|mesh-list
64402422|NCT04440371|Calcipotriene|calcipotriene|mesh-list
64402423|NCT04440371|Tacrolimus|tacrolimus|mesh-list
64402424|NCT04440371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64402425|NCT04440371|Immunologic Factors|immunologic factors|mesh-ancestor
64402426|NCT04440371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402427|NCT04440371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64402428|NCT04440371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402429|NCT04440371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402430|NCT04440371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64402431|NCT04440371|Glucocorticoids|glucocorticoids|mesh-ancestor
64402432|NCT04440371|Hormones|hormones|mesh-ancestor
64402433|NCT04440371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64402471|NCT03118037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64771624|NCT01184898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64771625|NCT01184898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64771626|NCT01184898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64771642|NCT01188876|Folic Acid|folic acid|mesh-list
64402472|NCT03118037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402517|NCT02875223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64402518|NCT02875223|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64402519|NCT02875223|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64402520|NCT02875223|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64402521|NCT02875223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64402522|NCT02875223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402524|NCT02621021|Cyclophosphamide|cyclophosphamide|mesh-list
64402554|NCT03062423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64402555|NCT00790933|Vedolizumab|vedolizumab|mesh-list
64402556|NCT00790933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64402557|NCT04981457|Misoprostol|misoprostol|mesh-list
64402558|NCT04981457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64402559|NCT04981457|Abortifacient Agents|abortifacient agents|mesh-ancestor
64402560|NCT04981457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64402561|NCT04981457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402562|NCT04981457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64736448|NCT00978419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736449|NCT00978419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64736450|NCT00978419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64736451|NCT00978419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736452|NCT00957827|Cephalexin|cephalexin|mesh-list
64736453|NCT00957827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64618585|NCT03016715|Sirolimus|sirolimus|mesh-list
64736455|NCT00962429|Thioctic Acid|thioctic acid|mesh-list
64736456|NCT00962429|Antioxidants|antioxidants|mesh-ancestor
64402563|NCT04981457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64402564|NCT04981457|Oxytocics|oxytocics|mesh-ancestor
64402565|NCT01676701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64402566|NCT01676701|Immunologic Factors|immunologic factors|mesh-ancestor
64402567|NCT01676701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402568|NCT04981379|Hydroxychloroquine|hydroxychloroquine|mesh-list
64402569|NCT04981379|Favipiravir|favipiravir|mesh-list
64402570|NCT04981379|Antimalarials|antimalarials|mesh-ancestor
64402571|NCT04981379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64402572|NCT04981379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64402573|NCT04981379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64402574|NCT04981379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402575|NCT04981379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402576|NCT04981379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64402577|NCT04981379|Antiviral Agents|antiviral agents|mesh-ancestor
64402578|NCT04389775|Glucagon|glucagon|mesh-list
64402579|NCT04389775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64402580|NCT04389775|Incretins|incretins|mesh-ancestor
64402581|NCT04389775|Hormones|hormones|mesh-ancestor
64402582|NCT04389775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64402583|NCT04389775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402584|NCT04389775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64771738|NCT01210560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771739|NCT01211730|Insulin|insulin|mesh-list
64771740|NCT01211730|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64771741|NCT01211730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64771742|NCT01211730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771743|NCT01212900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
64771750|NCT01215318|Silicon|silicon|mesh-list
64402585|NCT03062501|Hydroxyurea|hydroxyurea|mesh-list
64402586|NCT03062501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402607|NCT02102789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402620|NCT02926651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402621|NCT02926651|Hemostatics|hemostatics|mesh-ancestor
64402622|NCT02926651|Coagulants|coagulants|mesh-ancestor
64402623|NCT04305145|Prednisone|prednisone|mesh-list
64402624|NCT04305145|Methylprednisolone|methylprednisolone|mesh-list
64402625|NCT04305145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64402626|NCT04305145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64402627|NCT04305145|Prednisolone|prednisolone|mesh-list
64402628|NCT04305145|Prednisolone acetate|prednisolone acetate|mesh-list
64402629|NCT04305145|Infliximab|infliximab|mesh-list
64402630|NCT04305145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64402631|NCT04305145|Prednisolone phosphate|prednisolone phosphate|mesh-list
64402632|NCT04305145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64402633|NCT04305145|Glucocorticoids|glucocorticoids|mesh-ancestor
64402634|NCT04305145|Hormones|hormones|mesh-ancestor
64402635|NCT04305145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64402636|NCT04305145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402637|NCT04305145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64402638|NCT04305145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402639|NCT04305145|Antiemetics|antiemetics|mesh-ancestor
64402640|NCT04305145|Autonomic Agents|autonomic agents|mesh-ancestor
64402641|NCT04305145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64402642|NCT04305145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64402643|NCT04305145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64402644|NCT04305145|Protective Agents|protective agents|mesh-ancestor
64402645|NCT04305145|Dermatologic Agents|dermatologic agents|mesh-ancestor
64402646|NCT04305145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64402647|NCT01670279|Brexpiprazole|brexpiprazole|mesh-list
64402648|NCT01670279|Serotonin Agents|serotonin agents|mesh-ancestor
64402649|NCT01670279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64402650|NCT01670279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736457|NCT00962429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736458|NCT00962429|Protective Agents|protective agents|mesh-ancestor
64736459|NCT00962429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736460|NCT00962429|Vitamin B Complex|vitamin b complex|mesh-ancestor
64736462|NCT00962429|Micronutrients|micronutrients|mesh-ancestor
64736463|NCT00949403|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
64736464|NCT00949403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736465|NCT00920309|Sirolimus|sirolimus|mesh-list
64429989|NCT05024747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771756|NCT01215786|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64771757|NCT01215786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64771758|NCT01215786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64771759|NCT01215786|Adrenergic Agents|adrenergic agents|mesh-ancestor
64771760|NCT01215786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64771761|NCT01215786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771762|NCT01215786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437030|NCT05765812|Temozolomide|temozolomide|mesh-list
64437031|NCT05765812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64736466|NCT00920309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64736467|NCT00920309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64736468|NCT00920309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64736469|NCT00920309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736470|NCT00920309|Antifungal Agents|antifungal agents|mesh-ancestor
64736471|NCT00920309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64736472|NCT00920309|Immunologic Factors|immunologic factors|mesh-ancestor
64736473|NCT00920309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736474|NCT02075411|Bupivacaine|bupivacaine|mesh-list
64402651|NCT01670279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402652|NCT01670279|Dopamine Agonists|dopamine agonists|mesh-ancestor
64402666|NCT03063983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402667|NCT03063983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64402668|NCT03063983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64402669|NCT03063983|Alkylating Agents|alkylating agents|mesh-ancestor
64402670|NCT03063983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402671|NCT03063983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402672|NCT03063983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64402673|NCT03063983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64402674|NCT03063983|Abortifacient Agents|abortifacient agents|mesh-ancestor
64402707|NCT01870193|Antiviral Agents|antiviral agents|mesh-ancestor
64402708|NCT01870193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64402709|NCT01870193|Expectorants|expectorants|mesh-ancestor
64402710|NCT01870193|Respiratory System Agents|respiratory system agents|mesh-ancestor
64402711|NCT01870193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64402712|NCT01870193|Antioxidants|antioxidants|mesh-ancestor
64402713|NCT01870193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402714|NCT01870193|Protective Agents|protective agents|mesh-ancestor
64402715|NCT01870193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402740|NCT01402271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402741|NCT03063671|Dexmedetomidine|dexmedetomidine|mesh-list
64402742|NCT03063671|Ketamine|ketamine|mesh-list
64402743|NCT03063671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64402744|NCT03063671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64402745|NCT03063671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402746|NCT03063671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64402747|NCT03063671|Analgesics|analgesics|mesh-ancestor
64402748|NCT03063671|Sensory System Agents|sensory system agents|mesh-ancestor
64402749|NCT03063671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64402750|NCT03063671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64402751|NCT03063671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64402752|NCT03063671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64402753|NCT03063671|Adrenergic Agents|adrenergic agents|mesh-ancestor
64402754|NCT03063671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64402755|NCT03063671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402756|NCT03063671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64736476|NCT02075411|Anesthetics|anesthetics|mesh-ancestor
64736477|NCT02075411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64736478|NCT02075411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736479|NCT02075411|Sensory System Agents|sensory system agents|mesh-ancestor
64736480|NCT02075411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64736481|NCT03753113|Minoxidil|minoxidil|mesh-list
64736482|NCT03753113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64736483|NCT03753113|Vasodilator Agents|vasodilator agents|mesh-ancestor
64736484|NCT02075021|Paclitaxel|paclitaxel|mesh-list
64736485|NCT02075021|Lenalidomide|lenalidomide|mesh-list
64736486|NCT02075021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64736487|NCT02075021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736488|NCT02075021|Tubulin Modulators|tubulin modulators|mesh-ancestor
64771763|NCT01215786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64771764|NCT01215786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64771766|NCT01216410|Oxymetazoline|oxymetazoline|mesh-list
64771767|NCT01216410|Ondansetron|ondansetron|mesh-list
64771768|NCT01216410|Metoclopramide|metoclopramide|mesh-list
64437099|NCT05732883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64437102|NCT05731492|Macitentan|macitentan|mesh-list
64736489|NCT02075021|Antimitotic Agents|antimitotic agents|mesh-ancestor
64736490|NCT02075021|Mitosis Modulators|mitosis modulators|mesh-ancestor
64736491|NCT02075021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736492|NCT02075021|Immunologic Factors|immunologic factors|mesh-ancestor
64736493|NCT02075021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736494|NCT02075021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64736495|NCT02075021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64736496|NCT02075021|Growth Substances|growth substances|mesh-ancestor
64736497|NCT02075021|Growth Inhibitors|growth inhibitors|mesh-ancestor
64402757|NCT03063671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64402758|NCT03063671|Anesthetics, General|anesthetics, general|mesh-ancestor
64402759|NCT03063671|Anesthetics|anesthetics|mesh-ancestor
64402760|NCT03063671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64402761|NCT03063671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64402762|NCT03063827|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64402763|NCT03063827|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64402764|NCT03063827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64402765|NCT03063827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64402766|NCT03063827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402793|NCT03079999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402794|NCT03079999|Antipyretics|antipyretics|mesh-ancestor
64402795|NCT04973969|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64402796|NCT04973969|Luteolytic Agents|luteolytic agents|mesh-ancestor
64402797|NCT04973969|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64402798|NCT04973969|Contraceptive Agents|contraceptive agents|mesh-ancestor
64402799|NCT04973969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64402800|NCT04973969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402801|NCT04973969|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64402802|NCT04973969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64402803|NCT04973969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402804|NCT02958709|Rifampin|rifampin|mesh-list
64402805|NCT02958709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64402806|NCT02958709|Antitubercular Agents|antitubercular agents|mesh-ancestor
64402807|NCT02958709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64736498|NCT02057237|Mitotane|mitotane|mesh-list
64736499|NCT02057237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64736500|NCT02057237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736501|NCT00378677|Cyclosporine|cyclosporine|mesh-list
64736502|NCT00378677|Cyclosporins|cyclosporins|mesh-list
64736503|NCT00378677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736504|NCT00378677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736505|NCT00378677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64402808|NCT02958709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64402809|NCT02958709|Leprostatic Agents|leprostatic agents|mesh-ancestor
64402810|NCT02958709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64402811|NCT02958709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402812|NCT02958709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402813|NCT02958709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64402814|NCT02958709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64402815|NCT02958709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64402816|NCT02958709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64402817|NCT02958709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64402818|NCT02958709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64402819|NCT04979663|Gemcitabine|gemcitabine|mesh-list
64402820|NCT04979663|Oxaliplatin|oxaliplatin|mesh-list
64402821|NCT04979663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64402822|NCT04979663|Antimetabolites|antimetabolites|mesh-ancestor
64402823|NCT04979663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402824|NCT04979663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402825|NCT04979663|Antiviral Agents|antiviral agents|mesh-ancestor
64437153|NCT05688735|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64437154|NCT05688735|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64437155|NCT05688735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64402826|NCT04979663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64402827|NCT04979663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402837|NCT04979585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402838|NCT05103397|Prednisolone|prednisolone|mesh-list
64402839|NCT05103397|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64402840|NCT05103397|Methylprednisolone|methylprednisolone|mesh-list
64402842|NCT05103397|Prednisolone acetate|prednisolone acetate|mesh-list
64402843|NCT05103397|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64402844|NCT05103397|Prednisolone phosphate|prednisolone phosphate|mesh-list
64402845|NCT05103397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64402846|NCT05103397|Glucocorticoids|glucocorticoids|mesh-ancestor
64402847|NCT05103397|Hormones|hormones|mesh-ancestor
64402848|NCT05103397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64402876|NCT04342169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64402877|NCT04342169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64402878|NCT04342169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64402879|NCT04342169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402880|NCT04342169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402881|NCT04342169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64402883|NCT04979273|Racepinephrine|racepinephrine|mesh-list
64618592|NCT03016715|Immunologic Factors|immunologic factors|mesh-ancestor
64402887|NCT04979273|Adrenergic Agents|adrenergic agents|mesh-ancestor
64402888|NCT04979273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64402889|NCT04979273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402890|NCT04979273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402891|NCT04979273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64402892|NCT04979273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64402893|NCT04979273|Autonomic Agents|autonomic agents|mesh-ancestor
64402944|NCT03063515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402946|NCT04973579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64402947|NCT04973579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402948|NCT04834063|Selenium|selenium|mesh-list
64402949|NCT04834063|Antioxidants|antioxidants|mesh-ancestor
64402961|NCT04794205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736506|NCT00378677|Immunologic Factors|immunologic factors|mesh-ancestor
64736507|NCT00378677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736508|NCT00378677|Antifungal Agents|antifungal agents|mesh-ancestor
64736509|NCT00378677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64736510|NCT00378677|Dermatologic Agents|dermatologic agents|mesh-ancestor
64736511|NCT00378677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64736512|NCT00378677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64736513|NCT00850421|Botulinum Toxins|botulinum toxins|mesh-list
64736514|NCT00850421|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64736515|NCT00850421|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64736516|NCT00850421|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64323383|NCT04227704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64736517|NCT00850421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64736518|NCT00850421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736519|NCT00850421|Cholinergic Agents|cholinergic agents|mesh-ancestor
64736520|NCT00850421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64736521|NCT00850421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736522|NCT00850421|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64736523|NCT00850421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64736524|NCT02017379|Erythromycin|erythromycin|mesh-list
64736525|NCT02017379|Erythromycin Estolate|erythromycin estolate|mesh-list
64323384|NCT04227704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64323385|NCT04227704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323386|NCT03720613|Naloxegol|naloxegol|mesh-list
64323387|NCT03720613|Lubiprostone|lubiprostone|mesh-list
64323388|NCT03720613|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64323389|NCT03720613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64323390|NCT03720613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736526|NCT02017379|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64736527|NCT02017379|Erythromycin stearate|erythromycin stearate|mesh-list
64736528|NCT02017379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64736529|NCT02017379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64402962|NCT04794205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64402963|NCT04794205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64402964|NCT04973033|Tofacitinib|tofacitinib|mesh-list
64402965|NCT04973033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64402966|NCT04973033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402967|NCT04973033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402968|NCT03061565|Epoetin Alfa|epoetin alfa|mesh-list
64402990|NCT05107921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64402991|NCT05107921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64402992|NCT05107921|Analgesics|analgesics|mesh-ancestor
64402993|NCT05107921|Sensory System Agents|sensory system agents|mesh-ancestor
64402994|NCT05107921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64402995|NCT05107921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402996|NCT05107921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64402997|NCT05107921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64402998|NCT01669811|Esomeprazole|esomeprazole|mesh-list
64402999|NCT01669811|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64403000|NCT01669811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64403001|NCT01669811|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64403002|NCT01669811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403003|NCT01669811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403004|NCT05164081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64618600|NCT00377104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403006|NCT05164081|Clindamycin palmitate|clindamycin palmitate|mesh-list
64403007|NCT05164081|Clindamycin phosphate|clindamycin phosphate|mesh-list
64403008|NCT05164081|Gentamicins|gentamicins|mesh-list
64736530|NCT02017379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64736531|NCT02017379|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64736532|NCT02017379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736533|NCT02017379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736534|NCT01997567|Ropivacaine|ropivacaine|mesh-list
64736535|NCT01997567|Anesthetics, Local|anesthetics, local|mesh-ancestor
64736536|NCT01997567|Anesthetics|anesthetics|mesh-ancestor
64736537|NCT01997567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64736538|NCT01997567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736539|NCT01997567|Sensory System Agents|sensory system agents|mesh-ancestor
64736540|NCT01997567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64736542|NCT00825227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64736543|NCT00825227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736544|NCT00825227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64403009|NCT05164081|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64403010|NCT05164081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64403011|NCT05164081|Antitubercular Agents|antitubercular agents|mesh-ancestor
64403012|NCT05164081|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64403013|NCT05164081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403014|NCT05164081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403031|NCT04437017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64403032|NCT04437017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64403033|NCT04437017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403034|NCT04437017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64403035|NCT04437017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64403036|NCT04437017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64403037|NCT04437017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64403038|NCT04437017|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64323391|NCT03720613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64323392|NCT03720613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437225|NCT05552222|Dexamethasone|dexamethasone|mesh-list
64437226|NCT05552222|Lenalidomide|lenalidomide|mesh-list
64437227|NCT05552222|Daratumumab|daratumumab|mesh-list
64437228|NCT05552222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64437229|NCT05552222|Antiemetics|antiemetics|mesh-ancestor
64437244|NCT05552196|Carbamazepine|carbamazepine|mesh-list
64403059|NCT05107063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64403060|NCT05107063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64403061|NCT05107063|Antimetabolites|antimetabolites|mesh-ancestor
64403062|NCT05107063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403063|NCT05107063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64403064|NCT05107063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64403065|NCT05107063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403066|NCT04977401|Glycerol|glycerol|mesh-list
64403067|NCT04977401|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64403068|NCT04977401|Protective Agents|protective agents|mesh-ancestor
64403069|NCT04977401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403070|NCT05106751|Hyaluronic Acid|hyaluronic acid|mesh-list
64403071|NCT05106751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64618609|NCT01010399|Fosamprenavir|fosamprenavir|mesh-list
64618610|NCT01010399|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64403072|NCT05106751|Immunologic Factors|immunologic factors|mesh-ancestor
64403073|NCT05106751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403085|NCT04530877|Dermatologic Agents|dermatologic agents|mesh-ancestor
64403086|NCT04530877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64403087|NCT04530877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64403088|NCT04971239|Methotrexate|methotrexate|mesh-list
64403089|NCT04971239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64403090|NCT04971239|Abortifacient Agents|abortifacient agents|mesh-ancestor
64403091|NCT04971239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64403092|NCT04971239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403093|NCT04971239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64403094|NCT04971239|Antimetabolites|antimetabolites|mesh-ancestor
64403095|NCT04971239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403096|NCT04971239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403097|NCT04971239|Dermatologic Agents|dermatologic agents|mesh-ancestor
64736545|NCT00825227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64736546|NCT00825227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64736547|NCT00825227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736549|NCT01978535|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64736550|NCT01978535|Trace Elements|trace elements|mesh-ancestor
64736551|NCT01978535|Micronutrients|micronutrients|mesh-ancestor
64736552|NCT01978535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437064|NCT05750459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64437065|NCT05750459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437066|NCT05750459|Antiviral Agents|antiviral agents|mesh-ancestor
64437067|NCT05750459|Schistosomicides|schistosomicides|mesh-ancestor
64437068|NCT05750459|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64437070|NCT05749393|Heparin|heparin|mesh-list
64403098|NCT04971239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403099|NCT04971239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64403100|NCT04971239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64403101|NCT04971239|Immunologic Factors|immunologic factors|mesh-ancestor
64403102|NCT04971239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64403128|NCT04271293|Anticoagulants|anticoagulants|mesh-ancestor
64403129|NCT03059849|Adalimumab|adalimumab|mesh-list
64403130|NCT03059849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64403131|NCT03059849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64403132|NCT04970069|Analgesics|analgesics|mesh-list
64403133|NCT04970069|Sensory System Agents|sensory system agents|mesh-ancestor
64403134|NCT04970069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403135|NCT04970069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403136|NCT04970303|Methylphenidate|methylphenidate|mesh-list
64403137|NCT04970303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64403138|NCT04970303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403139|NCT04970303|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64403151|NCT04432259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64403152|NCT04432259|Glucocorticoids|glucocorticoids|mesh-ancestor
64403154|NCT04432259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64403155|NCT04432259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64403156|NCT04432259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403157|NCT04964219|Ketamine|ketamine|mesh-list
64771769|NCT01216410|Antiemetics|antiemetics|mesh-ancestor
64771770|NCT01216410|Autonomic Agents|autonomic agents|mesh-ancestor
64403158|NCT04964219|Esketamine|esketamine|mesh-list
64403159|NCT04964219|Analgesics|analgesics|mesh-ancestor
64403160|NCT04964219|Sensory System Agents|sensory system agents|mesh-ancestor
64403161|NCT04964219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403162|NCT04964219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403163|NCT04964219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64403190|NCT04968509|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64736554|NCT00808769|Omeprazole|omeprazole|mesh-list
64736555|NCT00808769|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
64736556|NCT00808769|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64736557|NCT00808769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64736558|NCT00808769|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64736559|NCT00808769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736560|NCT00808769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736561|NCT00379067|Tamsulosin|tamsulosin|mesh-list
64736562|NCT00379067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64736563|NCT00379067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64736564|NCT00379067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64736565|NCT00379067|Adrenergic Agents|adrenergic agents|mesh-ancestor
64736566|NCT00379067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64736567|NCT00379067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736568|NCT00379067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736569|NCT00379067|Urological Agents|urological agents|mesh-ancestor
64736570|NCT00378287|Rabeprazole|rabeprazole|mesh-list
64736571|NCT00378287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64736572|NCT00378287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64736573|NCT00378287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64736574|NCT00378287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736575|NCT00378287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736576|NCT01938833|Paclitaxel|paclitaxel|mesh-list
64736577|NCT01938833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64771771|NCT01216410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64771772|NCT01216410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771773|NCT01216410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64771774|NCT01216410|Antipruritics|antipruritics|mesh-ancestor
64771775|NCT01216410|Dermatologic Agents|dermatologic agents|mesh-ancestor
64771776|NCT01216410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64736578|NCT01938833|Romidepsin|romidepsin|mesh-list
64736579|NCT01938833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64736580|NCT01938833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736581|NCT01938833|Tubulin Modulators|tubulin modulators|mesh-ancestor
64736582|NCT01938833|Antimitotic Agents|antimitotic agents|mesh-ancestor
64736583|NCT01938833|Mitosis Modulators|mitosis modulators|mesh-ancestor
64403191|NCT04968509|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64403192|NCT04968509|Antimetabolites|antimetabolites|mesh-ancestor
64403193|NCT04968509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403194|NCT04968509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403195|NCT04968509|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64403196|NCT04962425|Trastuzumab|trastuzumab|mesh-list
64403197|NCT04962425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64403198|NCT04962425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403199|NCT03060707|Bromides|bromides|mesh-list
64403200|NCT03060707|Rocuronium|rocuronium|mesh-list
64403201|NCT03060707|Anticonvulsants|anticonvulsants|mesh-ancestor
64403215|NCT04967417|Mitosis Modulators|mitosis modulators|mesh-ancestor
64736584|NCT01938833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736585|NCT01938833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64736586|NCT01893359|Riboflavin|riboflavin|mesh-list
64736587|NCT01893359|Dextrans|dextrans|mesh-list
64736588|NCT01893359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64736589|NCT01893359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64736590|NCT01893359|Vitamin B Complex|vitamin b complex|mesh-ancestor
64736591|NCT01893359|Vitamins|vitamins|mesh-ancestor
64736592|NCT01893359|Micronutrients|micronutrients|mesh-ancestor
64736593|NCT01893359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736594|NCT01893359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64736595|NCT01893359|Dermatologic Agents|dermatologic agents|mesh-ancestor
64736596|NCT01893359|Anticoagulants|anticoagulants|mesh-ancestor
64736597|NCT01893359|Plasma Substitutes|plasma substitutes|mesh-ancestor
64736598|NCT01893359|Blood Substitutes|blood substitutes|mesh-ancestor
64736599|NCT00795665|Bevacizumab|bevacizumab|mesh-list
64736600|NCT00795665|Carmustine|carmustine|mesh-list
64736601|NCT00795665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64736602|NCT00795665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736603|NCT00795665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64736604|NCT00795665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64736605|NCT00795665|Growth Substances|growth substances|mesh-ancestor
64736606|NCT00795665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736607|NCT00795665|Growth Inhibitors|growth inhibitors|mesh-ancestor
64403216|NCT04967417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403217|NCT04967417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64403218|NCT04967417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403219|NCT04967417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64403251|NCT02555293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64403252|NCT05104255|Anesthetics|anesthetics|mesh-list
64771802|NCT01218048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64771803|NCT01218984|Naltrexone|naltrexone|mesh-list
64771804|NCT01218984|Hydromorphone|hydromorphone|mesh-list
64771805|NCT01218984|Naloxone|naloxone|mesh-list
64403253|NCT05104255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64618638|NCT01041781|Pemetrexed|pemetrexed|mesh-list
64403254|NCT05104255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403256|NCT03293017|Baclofen|baclofen|mesh-list
64403257|NCT03293017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64403258|NCT03293017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403259|NCT03293017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64403260|NCT03293017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403261|NCT03293017|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64403262|NCT03293017|GABA Agonists|gaba agonists|mesh-ancestor
64403263|NCT03293017|GABA Agents|gaba agents|mesh-ancestor
64403271|NCT03293017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64403272|NCT03293017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64403273|NCT03293017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64403274|NCT03293017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64736608|NCT00795665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64736609|NCT00795665|Alkylating Agents|alkylating agents|mesh-ancestor
64736610|NCT00795665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736611|NCT00791843|Hormones|hormones|mesh-list
64736612|NCT00791843|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
64736613|NCT00791843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64736614|NCT00791843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736615|NCT01836809|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64736616|NCT01836809|Natriuretic Agents|natriuretic agents|mesh-ancestor
64736617|NCT01836809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736618|NCT00780455|Interferons|interferons|mesh-list
64736619|NCT00780455|Interferon-beta|interferon-beta|mesh-list
64736620|NCT00780455|Interferon beta-1b|interferon beta-1b|mesh-list
64736621|NCT00780455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736622|NCT00780455|Antiviral Agents|antiviral agents|mesh-ancestor
64736623|NCT00780455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64736624|NCT00780455|Immunologic Factors|immunologic factors|mesh-ancestor
64736625|NCT00780455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736626|NCT00780455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64736627|NCT00755261|Bevacizumab|bevacizumab|mesh-list
64736628|NCT00755261|Doxorubicin|doxorubicin|mesh-list
64736629|NCT00755261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64736630|NCT00755261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736631|NCT00755261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64736632|NCT00755261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64736633|NCT00755261|Growth Substances|growth substances|mesh-ancestor
64736654|NCT00746603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736655|NCT04713527|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64736656|NCT04713527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64736657|NCT00716807|Nalbuphine|nalbuphine|mesh-list
64736658|NCT00716807|Naloxone|naloxone|mesh-list
64736659|NCT00716807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64736660|NCT00716807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736661|NCT00716807|Sensory System Agents|sensory system agents|mesh-ancestor
64736662|NCT00716807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64736663|NCT00716807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64736664|NCT00716807|Narcotics|narcotics|mesh-ancestor
64736665|NCT00716807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64736666|NCT00716807|Analgesics|analgesics|mesh-ancestor
64736667|NCT03426137|Ketorolac|ketorolac|mesh-list
64736668|NCT03426137|Oxycodone|oxycodone|mesh-list
64736669|NCT03426137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64771826|NCT01222260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64771827|NCT01222260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64771828|NCT01222260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64736670|NCT03426137|Narcotics|narcotics|mesh-ancestor
64403305|NCT02749513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64403306|NCT02749513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403307|NCT02749513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403308|NCT02749513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64403309|NCT02749513|Hormone Antagonists|hormone antagonists|mesh-ancestor
64403310|NCT02749513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64403311|NCT02749513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403312|NCT02749513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64403313|NCT02684227|Paclitaxel|paclitaxel|mesh-list
64403314|NCT02684227|Carboplatin|carboplatin|mesh-list
64618641|NCT01041781|Antimetabolites|antimetabolites|mesh-ancestor
64403315|NCT02684227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64403316|NCT02684227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64403317|NCT02684227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403318|NCT02684227|Tubulin Modulators|tubulin modulators|mesh-ancestor
64403319|NCT02684227|Antimitotic Agents|antimitotic agents|mesh-ancestor
64403320|NCT02684227|Mitosis Modulators|mitosis modulators|mesh-ancestor
64403347|NCT05105347|Hormones|hormones|mesh-ancestor
64403348|NCT05105347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64403349|NCT05105347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403350|NCT05105347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64403351|NCT05105347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403352|NCT05105347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64403353|NCT05110651|Hydroxychloroquine|hydroxychloroquine|mesh-list
64403354|NCT05110651|Antimalarials|antimalarials|mesh-ancestor
64403355|NCT05110651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64403356|NCT05110651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64403357|NCT05110651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64403358|NCT05110651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403359|NCT05110651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403360|NCT05110651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64403361|NCT03060785|Tenofovir|tenofovir|mesh-list
64403362|NCT03060785|Emtricitabine|emtricitabine|mesh-list
64403363|NCT03060785|Antiviral Agents|antiviral agents|mesh-ancestor
64403364|NCT03060785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64403365|NCT03060785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64403366|NCT03060785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64403367|NCT03060785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403368|NCT03060785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403369|NCT03060785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64403370|NCT03060785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64403371|NCT04952207|Sofosbuvir|sofosbuvir|mesh-list
64736671|NCT03426137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64736672|NCT03426137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736674|NCT03426137|Sensory System Agents|sensory system agents|mesh-ancestor
64736675|NCT03426137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64736676|NCT03426137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64736677|NCT03426137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64736678|NCT03426137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64736679|NCT03426137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64476051|NCT00465088|Niacin|niacin|mesh-list
64736680|NCT03426137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64736681|NCT03426137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736682|NCT03426137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736683|NCT01760993|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64736684|NCT01760993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64736685|NCT01760993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771830|NCT01222260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771831|NCT01222572|Etoposide|etoposide|mesh-list
64771832|NCT01222572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64771833|NCT01222572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64771834|NCT01222572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64771835|NCT01222572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64736686|NCT01760993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64736687|NCT01760993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64736688|NCT01760993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64736689|NCT01760993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403372|NCT04952207|Antiviral Agents|antiviral agents|mesh-list
64403373|NCT04952207|Grazoprevir|grazoprevir|mesh-list
64403374|NCT04952207|Ledipasvir|ledipasvir|mesh-list
64403375|NCT04952207|Velpatasvir|velpatasvir|mesh-list
64403376|NCT04952207|Asunaprevir|asunaprevir|mesh-list
64403377|NCT04952207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64403378|NCT04952207|Protease Inhibitors|protease inhibitors|mesh-ancestor
64403446|NCT05104333|Vaccines|vaccines|mesh-list
64403462|NCT03059615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403463|NCT03059615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403464|NCT04951505|Cefepime|cefepime|mesh-list
64403465|NCT04951505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64403466|NCT04951505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64403467|NCT04951349|Petrolatum|petrolatum|mesh-list
64403468|NCT04951349|Emollients|emollients|mesh-ancestor
64403469|NCT04951349|Dermatologic Agents|dermatologic agents|mesh-ancestor
64403499|NCT04950569|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64403500|NCT04950569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64403501|NCT04950569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403502|NCT04950569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403503|NCT04950569|Protective Agents|protective agents|mesh-ancestor
64403504|NCT04950569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403505|NCT04944641|Anticonvulsants|anticonvulsants|mesh-list
64403507|NCT04944173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64403508|NCT04944173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403518|NCT01675765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64403520|NCT01675765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403521|NCT01675765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403522|NCT01675765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64403523|NCT01675765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736690|NCT01760993|Dopamine Agents|dopamine agents|mesh-ancestor
64736691|NCT01760993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64736692|NCT00669461|Lubiprostone|lubiprostone|mesh-list
64736693|NCT00669461|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64771838|NCT01222884|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64771839|NCT01222884|Hematinics|hematinics|mesh-ancestor
64771840|NCT01223352|Bosentan|bosentan|mesh-list
64771841|NCT01223352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64403524|NCT01675765|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64403538|NCT04285255|Fentanyl|fentanyl|mesh-list
64403539|NCT04285255|Dexmedetomidine|dexmedetomidine|mesh-list
64403540|NCT04285255|Ketamine|ketamine|mesh-list
64403541|NCT04285255|Anesthetics, Local|anesthetics, local|mesh-ancestor
64403542|NCT04285255|Anesthetics|anesthetics|mesh-ancestor
64403543|NCT04285255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64403544|NCT04285255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403545|NCT04285255|Sensory System Agents|sensory system agents|mesh-ancestor
64403546|NCT04285255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403547|NCT04285255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64403548|NCT04285255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64403549|NCT04285255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64403550|NCT04285255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64403551|NCT04285255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403552|NCT04285255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64403553|NCT04285255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64403554|NCT04285255|Analgesics|analgesics|mesh-ancestor
64403555|NCT04285255|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64403556|NCT04285255|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64403557|NCT04285255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64403558|NCT04285255|Adrenergic Agents|adrenergic agents|mesh-ancestor
64403559|NCT04285255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64403560|NCT04285255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64403561|NCT04285255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64403562|NCT04285255|Anesthetics, General|anesthetics, general|mesh-ancestor
64403563|NCT04285255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64403564|NCT04285255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64403565|NCT04285255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64403566|NCT04285255|Narcotics|narcotics|mesh-ancestor
64403567|NCT04285255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64403569|NCT04121299|Carvedilol|carvedilol|mesh-list
64403570|NCT04121299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64403571|NCT04121299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64403572|NCT04121299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64403573|NCT04121299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403574|NCT04121299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64403587|NCT04942769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403588|NCT04942769|Protective Agents|protective agents|mesh-ancestor
64403589|NCT04942769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403590|NCT04942769|Trace Elements|trace elements|mesh-ancestor
64403591|NCT04942769|Micronutrients|micronutrients|mesh-ancestor
64403592|NCT04942301|Endostar protein|endostar protein|mesh-list
64403593|NCT04942301|Endostatins|endostatins|mesh-list
64403594|NCT04942301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64403595|NCT04942301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64403596|NCT04942301|Growth Substances|growth substances|mesh-ancestor
64403597|NCT04942301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403598|NCT04942301|Growth Inhibitors|growth inhibitors|mesh-ancestor
64403609|NCT03540901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64403610|NCT03540901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618653|NCT01041781|Analgesics|analgesics|mesh-ancestor
64403613|NCT03540901|Natriuretic Agents|natriuretic agents|mesh-ancestor
64403614|NCT03540901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403615|NCT03517735|Remifentanil|remifentanil|mesh-list
64403616|NCT03517735|Propofol|propofol|mesh-list
64403617|NCT03517735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64403618|NCT03517735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64403619|NCT03517735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403620|NCT03517735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64403621|NCT03517735|Anesthetics, General|anesthetics, general|mesh-ancestor
64403622|NCT03517735|Anesthetics|anesthetics|mesh-ancestor
64736694|NCT00669461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64736695|NCT00669461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736696|NCT00673595|Varenicline|varenicline|mesh-list
64736697|NCT00673595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64736698|NCT00673595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64736699|NCT00673595|Cholinergic Agents|cholinergic agents|mesh-ancestor
64736700|NCT00673595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64736701|NCT00673595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736702|NCT00673595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403623|NCT03517735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64403624|NCT03517735|Narcotics|narcotics|mesh-ancestor
64403625|NCT03517735|Analgesics|analgesics|mesh-ancestor
64403626|NCT03517735|Sensory System Agents|sensory system agents|mesh-ancestor
64403627|NCT03517735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403628|NCT04941131|Chlorhexidine|chlorhexidine|mesh-list
64403629|NCT04941131|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64403630|NCT04941131|Povidone-Iodine|povidone-iodine|mesh-list
64403631|NCT04941131|Povidone|povidone|mesh-list
64403632|NCT04941131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64403633|NCT04941131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64403634|NCT04941131|Disinfectants|disinfectants|mesh-ancestor
64403635|NCT04941131|Dermatologic Agents|dermatologic agents|mesh-ancestor
64403636|NCT04941131|Plasma Substitutes|plasma substitutes|mesh-ancestor
64403637|NCT04941131|Blood Substitutes|blood substitutes|mesh-ancestor
64403638|NCT03400501|Insulin|insulin|mesh-list
64403639|NCT03400501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64403640|NCT03400501|Insulin Glargine|insulin glargine|mesh-list
64403649|NCT04940273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64403650|NCT04940273|Narcotics|narcotics|mesh-ancestor
64403651|NCT04940273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64403652|NCT04940273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403653|NCT04940273|Analgesics|analgesics|mesh-ancestor
64403654|NCT04940273|Sensory System Agents|sensory system agents|mesh-ancestor
64403655|NCT04940273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403657|NCT04948385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64403658|NCT04948385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64771867|NCT01226706|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64771868|NCT01226706|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64771869|NCT01226706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64403659|NCT04948385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403660|NCT04948385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64403661|NCT04948385|Anesthetics, General|anesthetics, general|mesh-ancestor
64771870|NCT01226706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771871|NCT01226706|Cholinergic Agents|cholinergic agents|mesh-ancestor
64771872|NCT01226706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64771873|NCT01226706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771874|NCT01226706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64771876|NCT01231230|Fluticasone|fluticasone|mesh-list
64403662|NCT04948385|Anesthetics|anesthetics|mesh-ancestor
64403663|NCT03057821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64403664|NCT03057821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64403665|NCT03057821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64403666|NCT04948151|Sildenafil Citrate|sildenafil citrate|mesh-list
64403667|NCT04948151|Vasodilator Agents|vasodilator agents|mesh-ancestor
64403668|NCT04948151|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64403669|NCT04948151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64403670|NCT04948151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403671|NCT04948151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403672|NCT04948151|Urological Agents|urological agents|mesh-ancestor
64403673|NCT02633293|Treprostinil|treprostinil|mesh-list
64403674|NCT02633293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64403675|NCT04938713|Ketamine|ketamine|mesh-list
64618656|NCT01041781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64403705|NCT04946825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403706|NCT04946825|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64403707|NCT04946825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64403708|NCT04946825|Cholinergic Agents|cholinergic agents|mesh-ancestor
64403709|NCT04946825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64403718|NCT03572413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403720|NCT04956419|Antifungal Agents|antifungal agents|mesh-ancestor
64403721|NCT04956419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64403722|NCT04956419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64403723|NCT04956419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64736703|NCT03248141|Factor VIII|factor viii|mesh-list
64736704|NCT03248141|Coagulants|coagulants|mesh-ancestor
64736705|NCT00378365|Arsenic Trioxide|arsenic trioxide|mesh-list
64736706|NCT00378365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736707|NCT05313425|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64736708|NCT05313425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64736709|NCT01754987|Ascorbic Acid|ascorbic acid|mesh-list
64736710|NCT01754987|Sorafenib|sorafenib|mesh-list
64736711|NCT01754987|Vitamins|vitamins|mesh-ancestor
64736712|NCT01754987|Micronutrients|micronutrients|mesh-ancestor
64736713|NCT01754987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736714|NCT01754987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736715|NCT01754987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64736716|NCT01754987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736717|NCT01754987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736718|NCT01754987|Antioxidants|antioxidants|mesh-ancestor
64736719|NCT01754987|Protective Agents|protective agents|mesh-ancestor
64736720|NCT05600309|Pembrolizumab|pembrolizumab|mesh-list
64736721|NCT05600309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64403724|NCT04956419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403725|NCT04956419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403726|NCT04956419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64403727|NCT04956419|Hormone Antagonists|hormone antagonists|mesh-ancestor
64771878|NCT01231230|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64771879|NCT01231230|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64771880|NCT01231230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64771881|NCT01231230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64771882|NCT01231230|Autonomic Agents|autonomic agents|mesh-ancestor
64771883|NCT01231230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64771884|NCT01231230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771885|NCT01231230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64771886|NCT01231230|Respiratory System Agents|respiratory system agents|mesh-ancestor
64771887|NCT01231230|Dermatologic Agents|dermatologic agents|mesh-ancestor
64403728|NCT04956419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64403754|NCT03100045|Antiviral Agents|antiviral agents|mesh-ancestor
64403755|NCT03100045|Schistosomicides|schistosomicides|mesh-ancestor
64403756|NCT03100045|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64403757|NCT03100045|Anthelmintics|anthelmintics|mesh-ancestor
64403759|NCT04946123|Antioxidants|antioxidants|mesh-ancestor
64403760|NCT04946123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403761|NCT04946123|Protective Agents|protective agents|mesh-ancestor
64403762|NCT04946123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403763|NCT04946123|Trace Elements|trace elements|mesh-ancestor
64403764|NCT04946123|Micronutrients|micronutrients|mesh-ancestor
64403765|NCT04945577|Vitamin D|vitamin d|mesh-list
64403766|NCT04945577|Vitamins|vitamins|mesh-ancestor
64403767|NCT04945577|Micronutrients|micronutrients|mesh-ancestor
64403768|NCT04945577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403769|NCT04945577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64403770|NCT04936841|Pembrolizumab|pembrolizumab|mesh-list
64403771|NCT04936841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64403772|NCT04936841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403773|NCT02623829|Botulinum Toxins|botulinum toxins|mesh-list
64403774|NCT02623829|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64403775|NCT02623829|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64403785|NCT02655679|Anesthetics, General|anesthetics, general|mesh-ancestor
64403855|NCT04526197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64403856|NCT04526197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64403857|NCT04526197|Nootropic Agents|nootropic agents|mesh-ancestor
64403858|NCT04526197|Chelating Agents|chelating agents|mesh-ancestor
64403859|NCT04526197|Sequestering Agents|sequestering agents|mesh-ancestor
64403860|NCT04526197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64403861|NCT04526197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64403862|NCT04526197|Growth Substances|growth substances|mesh-ancestor
64403863|NCT04526197|Growth Inhibitors|growth inhibitors|mesh-ancestor
64403864|NCT04526197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403865|NCT04933019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64736722|NCT05600309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736723|NCT05600231|Listerine|listerine|mesh-list
64736724|NCT05600231|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
64736725|NCT05600231|Sodium Fluoride|sodium fluoride|mesh-list
64736726|NCT05600231|Cariostatic Agents|cariostatic agents|mesh-ancestor
64736727|NCT05600231|Protective Agents|protective agents|mesh-ancestor
64736728|NCT05600231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736729|NCT05600231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64736730|NCT00652457|Memantine|memantine|mesh-list
64403866|NCT04933019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64403868|NCT05060965|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64403869|NCT05060965|Autonomic Agents|autonomic agents|mesh-ancestor
64403870|NCT05060965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403871|NCT05060965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403872|NCT05060965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64403873|NCT05060965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64403874|NCT05060965|Cholinergic Agents|cholinergic agents|mesh-ancestor
64403875|NCT05060965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64403876|NCT05060965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403877|NCT04935515|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64403878|NCT04935515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64403879|NCT04935515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64403880|NCT04935515|Anticoagulants|anticoagulants|mesh-list
64403881|NCT04935515|Coagulants|coagulants|mesh-list
64403882|NCT04935515|Histamine Antagonists|histamine antagonists|mesh-list
64403883|NCT04935515|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
64403884|NCT04935515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64771895|NCT01231230|Glucocorticoids|glucocorticoids|mesh-ancestor
64403885|NCT04935515|Antitubercular Agents|antitubercular agents|mesh-ancestor
64403886|NCT04935515|Histamine Agents|histamine agents|mesh-ancestor
64403887|NCT04935515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64403888|NCT04935515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403889|NCT04935515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403928|NCT04516993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64403929|NCT04516993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64403930|NCT04516993|Analgesics|analgesics|mesh-ancestor
64403931|NCT04516993|Sensory System Agents|sensory system agents|mesh-ancestor
64403932|NCT04516993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403957|NCT05015335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403958|NCT05015335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64403959|NCT05015335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64403960|NCT05015335|Immunologic Factors|immunologic factors|mesh-ancestor
64403961|NCT05015335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64403962|NCT05015335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64403963|NCT05015335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64403964|NCT03056261|Anesthetics|anesthetics|mesh-list
64403965|NCT03056261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64403966|NCT03056261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403967|NCT03533257|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
64403968|NCT03533257|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64403969|NCT03533257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403970|NCT03533257|Antiviral Agents|antiviral agents|mesh-ancestor
64403971|NCT03533257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64403972|NCT03533257|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64403973|NCT03533257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64403974|NCT04574479|Morphine|morphine|mesh-list
64403975|NCT04574479|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64403976|NCT04574479|Narcotics|narcotics|mesh-ancestor
64403987|NCT04931225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403988|NCT04931225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403990|NCT04516057|Nabilone|nabilone|mesh-list
64403991|NCT04516057|Antiemetics|antiemetics|mesh-ancestor
64403992|NCT04516057|Autonomic Agents|autonomic agents|mesh-ancestor
64403993|NCT04516057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403994|NCT04516057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404024|NCT01966263|Epinephryl borate|epinephryl borate|mesh-list
64404025|NCT01966263|Anesthetics, Local|anesthetics, local|mesh-ancestor
64404026|NCT01966263|Anesthetics|anesthetics|mesh-ancestor
64736731|NCT00652457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64736732|NCT00652457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64736733|NCT00652457|Dopamine Agents|dopamine agents|mesh-ancestor
64736734|NCT00652457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64736735|NCT00652457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736736|NCT00652457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736737|NCT00652457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64736738|NCT00652457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64323423|NCT03659929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64323424|NCT03659929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64323425|NCT03659929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64323426|NCT02811679|Blinatumomab|blinatumomab|mesh-list
64736739|NCT00625703|Linezolid|linezolid|mesh-list
64736740|NCT00625703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64736741|NCT00625703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64736742|NCT00625703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64736743|NCT00625703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736744|NCT00625703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404027|NCT01966263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64404028|NCT01966263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404029|NCT01966263|Sensory System Agents|sensory system agents|mesh-ancestor
64404030|NCT01966263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404031|NCT01966263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64404032|NCT01966263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64404033|NCT01966263|Adrenergic Agents|adrenergic agents|mesh-ancestor
64404034|NCT01966263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64404035|NCT01966263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404036|NCT01966263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64404037|NCT01966263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64404038|NCT01966263|Autonomic Agents|autonomic agents|mesh-ancestor
64404039|NCT01966263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64404040|NCT01966263|Respiratory System Agents|respiratory system agents|mesh-ancestor
64404055|NCT04423107|Analgesics|analgesics|mesh-ancestor
64404056|NCT04423107|Sensory System Agents|sensory system agents|mesh-ancestor
64404057|NCT04423107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404058|NCT04423107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404059|NCT04423107|Antipyretics|antipyretics|mesh-ancestor
64404060|NCT04423107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64404061|NCT04423107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64404096|NCT04930211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64404097|NCT04930211|Antiemetics|antiemetics|mesh-ancestor
64404098|NCT04930211|Autonomic Agents|autonomic agents|mesh-ancestor
64404099|NCT04930211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404100|NCT04930211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404101|NCT04930211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64404131|NCT04912271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404132|NCT04912271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64404133|NCT04912271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64404134|NCT04912271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404135|NCT04912271|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64404136|NCT04912271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64404138|NCT02807779|Dexamethasone|dexamethasone|mesh-list
64404139|NCT02807779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64404140|NCT02807779|Antiemetics|antiemetics|mesh-ancestor
64404141|NCT02807779|Autonomic Agents|autonomic agents|mesh-ancestor
64404142|NCT02807779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404143|NCT02807779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404144|NCT02807779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64404145|NCT02807779|Glucocorticoids|glucocorticoids|mesh-ancestor
64404146|NCT02807779|Hormones|hormones|mesh-ancestor
64404147|NCT02807779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64514753|NCT05586711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64514754|NCT05586711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514755|NCT05317858|Pembrolizumab|pembrolizumab|mesh-list
64514756|NCT05317858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64514757|NCT05317858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514758|NCT01724489|Hormones|hormones|mesh-list
64514759|NCT01724489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64514760|NCT01724489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514761|NCT01996293|Lamotrigine|lamotrigine|mesh-list
64514762|NCT01996293|Anticonvulsants|anticonvulsants|mesh-ancestor
64514763|NCT01996293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64514764|NCT01996293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64514765|NCT01996293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514766|NCT01996293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64514767|NCT01996293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514768|NCT01996293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64404152|NCT04912193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64404153|NCT04912193|Protease Inhibitors|protease inhibitors|mesh-ancestor
64404154|NCT04912193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404155|NCT04912193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404156|NCT04912193|Anticoagulants|anticoagulants|mesh-ancestor
64404157|NCT02680561|Fluticasone|fluticasone|mesh-list
64404159|NCT02680561|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64404184|NCT05025163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404186|NCT02592031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64404187|NCT02592031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404189|NCT04784299|Anesthetics, Local|anesthetics, local|mesh-ancestor
64404190|NCT04784299|Anesthetics|anesthetics|mesh-ancestor
64404191|NCT04784299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64404192|NCT04784299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404193|NCT04784299|Sensory System Agents|sensory system agents|mesh-ancestor
64404194|NCT04784299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404195|NCT04784299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64514779|NCT05304364|Sensory System Agents|sensory system agents|mesh-ancestor
64514780|NCT05304364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64514781|NCT05022004|Brinzolamide|brinzolamide|mesh-list
64514782|NCT05022004|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64514783|NCT05022004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514784|NCT05022004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514785|NCT01724177|Lenalidomide|lenalidomide|mesh-list
64514786|NCT01724177|Immunologic Factors|immunologic factors|mesh-ancestor
64514787|NCT01724177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514788|NCT01724177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64514789|NCT01724177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64514790|NCT01724177|Growth Substances|growth substances|mesh-ancestor
64514791|NCT01724177|Growth Inhibitors|growth inhibitors|mesh-ancestor
64514792|NCT01724177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404196|NCT04784299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64404197|NCT04784299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64404198|NCT04784299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64404199|NCT04784299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404200|NCT02333149|Melatonin|melatonin|mesh-list
64404201|NCT02333149|Antioxidants|antioxidants|mesh-ancestor
64404202|NCT02333149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404203|NCT02333149|Protective Agents|protective agents|mesh-ancestor
64404204|NCT02333149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404205|NCT02333149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64404206|NCT02144857|Cyclosporine|cyclosporine|mesh-list
64404207|NCT02144857|Etanercept|etanercept|mesh-list
64404208|NCT02144857|Apremilast|apremilast|mesh-list
64404209|NCT02144857|Ustekinumab|ustekinumab|mesh-list
64404210|NCT02144857|Cyclosporins|cyclosporins|mesh-list
64404211|NCT02144857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514793|NCT01991457|Fludarabine|fludarabine|mesh-list
64514794|NCT01991457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514795|NCT02117817|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64514796|NCT02117817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514797|NCT05529784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64514798|NCT05529784|Immunologic Factors|immunologic factors|mesh-ancestor
64514799|NCT05529784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514800|NCT05524246|Pravastatin|pravastatin|mesh-list
64514801|NCT05524246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64514802|NCT05524246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64514803|NCT05524246|Antimetabolites|antimetabolites|mesh-ancestor
64514804|NCT05524246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514805|NCT05524246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64514806|NCT05524246|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64514807|NCT05524246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514808|NCT02685735|Gabapentin|gabapentin|mesh-list
64514809|NCT02685735|Analgesics|analgesics|mesh-ancestor
64514810|NCT02685735|Sensory System Agents|sensory system agents|mesh-ancestor
64514811|NCT02685735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64514812|NCT02685735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514813|NCT02685735|Anticonvulsants|anticonvulsants|mesh-ancestor
64514814|NCT02685735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64514815|NCT02685735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64514816|NCT02685735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64514817|NCT02685735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64772104|NCT01275300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64514818|NCT02685735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64514819|NCT02685735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64404212|NCT02144857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404213|NCT02144857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64404214|NCT02144857|Immunologic Factors|immunologic factors|mesh-ancestor
64404215|NCT02144857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404216|NCT02144857|Antifungal Agents|antifungal agents|mesh-ancestor
64404217|NCT02144857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64404218|NCT02144857|Dermatologic Agents|dermatologic agents|mesh-ancestor
64404219|NCT02144857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64404220|NCT02144857|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64404221|NCT02144857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64404222|NCT02144857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64404223|NCT02144857|Analgesics|analgesics|mesh-ancestor
64404224|NCT02144857|Sensory System Agents|sensory system agents|mesh-ancestor
64404225|NCT02144857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404226|NCT02144857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64404227|NCT02144857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64404228|NCT02144857|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64404229|NCT02144857|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64404230|NCT05117983|Antidepressive Agents|antidepressive agents|mesh-list
64514820|NCT02685735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64514821|NCT02685735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514822|NCT02685735|Antimanic Agents|antimanic agents|mesh-ancestor
64514824|NCT02074839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514825|NCT02074839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514826|NCT02074839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514827|NCT01530009|Amoxicillin|amoxicillin|mesh-list
64437809|NCT04853446|BB 1101|bb 1101|mesh-list
64404231|NCT05117983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64404279|NCT04513639|Antiemetics|antiemetics|mesh-ancestor
64404280|NCT04513639|Autonomic Agents|autonomic agents|mesh-ancestor
64404290|NCT04513639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404291|NCT04513639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404292|NCT04513639|Immunologic Factors|immunologic factors|mesh-ancestor
64404293|NCT04675333|Carboplatin|carboplatin|mesh-list
64404294|NCT04675333|Pembrolizumab|pembrolizumab|mesh-list
64404295|NCT04675333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404296|NCT04675333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64404304|NCT05229991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64404305|NCT05229991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64404306|NCT05229991|Antiviral Agents|antiviral agents|mesh-ancestor
64404307|NCT05229991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64404308|NCT05229991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64404309|NCT05229991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64404310|NCT05229913|Esketamine|esketamine|mesh-list
64404311|NCT05229913|Antidepressive Agents|antidepressive agents|mesh-ancestor
64404324|NCT04375735|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64404325|NCT04375735|Respiratory System Agents|respiratory system agents|mesh-ancestor
64404326|NCT01362439|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64404327|NCT01362439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64404328|NCT01362439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64404329|NCT01362439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64404330|NCT01362439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404331|NCT01362439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64404332|NCT01362439|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64404333|NCT01362439|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64404334|NCT01362439|Serotonin Agents|serotonin agents|mesh-ancestor
64404335|NCT01362439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64404336|NCT01362439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404337|NCT01362439|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64404338|NCT01362439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64404339|NCT01362439|Dopamine Agents|dopamine agents|mesh-ancestor
64404340|NCT05228743|Paclitaxel|paclitaxel|mesh-list
64404341|NCT05228743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64772140|NCT01280058|Tubulin Modulators|tubulin modulators|mesh-ancestor
64404342|NCT05228743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404343|NCT05228743|Tubulin Modulators|tubulin modulators|mesh-ancestor
64404344|NCT05228743|Antimitotic Agents|antimitotic agents|mesh-ancestor
64404345|NCT05228743|Mitosis Modulators|mitosis modulators|mesh-ancestor
64404346|NCT05228743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404347|NCT03321019|Capsaicin|capsaicin|mesh-list
64404348|NCT03321019|Antipruritics|antipruritics|mesh-ancestor
64404349|NCT03321019|Dermatologic Agents|dermatologic agents|mesh-ancestor
64404350|NCT03321019|Sensory System Agents|sensory system agents|mesh-ancestor
64514830|NCT05238142|Insulin|insulin|mesh-list
64514831|NCT05238142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64514832|NCT05238142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514833|NCT04915144|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
64514834|NCT04915144|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64514835|NCT04915144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514836|NCT01724021|Prednisone|prednisone|mesh-list
64514837|NCT01724021|Prednisolone|prednisolone|mesh-list
64514838|NCT01724021|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64514839|NCT01724021|Methylprednisolone|methylprednisolone|mesh-list
64514840|NCT01724021|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64514841|NCT01724021|Prednisolone acetate|prednisolone acetate|mesh-list
64404388|NCT03906721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64404389|NCT03906721|Narcotics|narcotics|mesh-ancestor
64618685|NCT00953849|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64404390|NCT03906721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64404398|NCT04529863|Abatacept|abatacept|mesh-list
64404399|NCT04529863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64404416|NCT03688633|Candesartan|candesartan|mesh-list
64404417|NCT03688633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64404418|NCT03688633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64404419|NCT03688633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64404420|NCT03688633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404421|NCT03963895|Thrombin|thrombin|mesh-list
64404422|NCT03963895|Hemostatics|hemostatics|mesh-ancestor
64404423|NCT03963895|Coagulants|coagulants|mesh-ancestor
64404424|NCT03662815|Molgramostim|molgramostim|mesh-list
64404425|NCT03662815|Sargramostim|sargramostim|mesh-list
64404426|NCT03662815|Immunologic Factors|immunologic factors|mesh-ancestor
64514842|NCT01724021|Cyclophosphamide|cyclophosphamide|mesh-list
64514843|NCT01724021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64514845|NCT01724021|Vincristine|vincristine|mesh-list
64514846|NCT01724021|Doxorubicin|doxorubicin|mesh-list
64514847|NCT01724021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64514848|NCT01724021|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64514849|NCT01724021|Prednisolone phosphate|prednisolone phosphate|mesh-list
64514850|NCT01724021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64514851|NCT01724021|Immunologic Factors|immunologic factors|mesh-ancestor
64514852|NCT01724021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514853|NCT01724021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64514854|NCT01724021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64514855|NCT01724021|Alkylating Agents|alkylating agents|mesh-ancestor
64736745|NCT00616577|Ropivacaine|ropivacaine|mesh-list
64404427|NCT03662815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404428|NCT03662815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404429|NCT03490903|Fentanyl|fentanyl|mesh-list
64772148|NCT01280604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64772149|NCT01282242|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64772150|NCT01282242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64772151|NCT01282242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64772152|NCT01282242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772153|NCT01285050|Tenofovir|tenofovir|mesh-list
64772154|NCT01285050|Emtricitabine|emtricitabine|mesh-list
64772155|NCT01285050|Raltegravir Potassium|raltegravir potassium|mesh-list
64772156|NCT01285050|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64438208|NCT04218240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64404431|NCT03490903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64404432|NCT03490903|Narcotics|narcotics|mesh-ancestor
64404433|NCT03490903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64404434|NCT03490903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404435|NCT03490903|Analgesics|analgesics|mesh-ancestor
64404436|NCT03490903|Sensory System Agents|sensory system agents|mesh-ancestor
64404437|NCT03490903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404438|NCT03490903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64404444|NCT03490903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64404445|NCT03490903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64404446|NCT03490903|GABA Modulators|gaba modulators|mesh-ancestor
64404447|NCT03490903|GABA Agents|gaba agents|mesh-ancestor
64404448|NCT03490903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64404449|NCT03490903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404450|NCT04169191|Sildenafil Citrate|sildenafil citrate|mesh-list
64438022|NCT04458545|Heroin|heroin|mesh-list
64404451|NCT04169191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404452|NCT04169191|Vasodilator Agents|vasodilator agents|mesh-ancestor
64404453|NCT04169191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64404454|NCT04169191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64618696|NCT04425850|Ivermectin|ivermectin|mesh-list
64404456|NCT04169191|Urological Agents|urological agents|mesh-ancestor
64404496|NCT04023253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64404497|NCT04023253|Cholinergic Agents|cholinergic agents|mesh-ancestor
64404498|NCT04023253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64404499|NCT04023253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404500|NCT04023253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404501|NCT04023253|Urological Agents|urological agents|mesh-ancestor
64404502|NCT04023253|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64404503|NCT04023253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64404551|NCT03554707|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64404552|NCT03554707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64404553|NCT03554707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404554|NCT03554707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404555|NCT03554707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64404556|NCT03554707|Alkylating Agents|alkylating agents|mesh-ancestor
64404557|NCT04264663|Furazolidone|furazolidone|mesh-list
64404558|NCT04264663|Tinidazole|tinidazole|mesh-list
64404559|NCT04264663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64404560|NCT04264663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64404582|NCT04563559|Glucocorticoids|glucocorticoids|mesh-ancestor
64404584|NCT04563559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64404585|NCT04563559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404586|NCT04563559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64404587|NCT04563559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404588|NCT04563559|Antiemetics|antiemetics|mesh-ancestor
64404589|NCT04563559|Autonomic Agents|autonomic agents|mesh-ancestor
64404590|NCT04563559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404591|NCT04563559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64404592|NCT04563559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64404593|NCT04563559|Protective Agents|protective agents|mesh-ancestor
64404594|NCT02124187|Nicotine|nicotine|mesh-list
64404595|NCT02124187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64404596|NCT02124187|Autonomic Agents|autonomic agents|mesh-ancestor
64404597|NCT02124187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404598|NCT02124187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404599|NCT02124187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64404600|NCT02124187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64404601|NCT02124187|Cholinergic Agents|cholinergic agents|mesh-ancestor
64404602|NCT02124187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64404603|NCT02124187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404604|NCT02002819|Levetiracetam|levetiracetam|mesh-list
64404605|NCT02002819|Anticonvulsants|anticonvulsants|mesh-ancestor
64404606|NCT02002819|Nootropic Agents|nootropic agents|mesh-ancestor
64514863|NCT01724021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64514864|NCT01724021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64514865|NCT01724021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64772180|NCT01287078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772181|NCT01287078|Antifungal Agents|antifungal agents|mesh-ancestor
64772182|NCT01287078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64772183|NCT01287078|Dermatologic Agents|dermatologic agents|mesh-ancestor
64772184|NCT01287078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64772185|NCT01287078|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64772187|NCT01291056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64772188|NCT01291056|Hormone Antagonists|hormone antagonists|mesh-ancestor
64772189|NCT01291056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64772190|NCT01291056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772191|NCT01291056|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64772192|NCT01291056|Fertility Agents|fertility agents|mesh-ancestor
64772193|NCT01291056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64772194|NCT01291056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64772195|NCT01291056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64514866|NCT01724021|Tubulin Modulators|tubulin modulators|mesh-ancestor
64514867|NCT01724021|Antimitotic Agents|antimitotic agents|mesh-ancestor
64514868|NCT01724021|Mitosis Modulators|mitosis modulators|mesh-ancestor
64514869|NCT01724021|Antiemetics|antiemetics|mesh-ancestor
64404607|NCT01597193|Fulvestrant|fulvestrant|mesh-list
64404608|NCT01597193|Anastrozole|anastrozole|mesh-list
64404610|NCT01597193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64404611|NCT01597193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404612|NCT01597193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64404613|NCT01597193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64404614|NCT01597193|Hormone Antagonists|hormone antagonists|mesh-ancestor
64404615|NCT01597193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64404616|NCT01597193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404617|NCT01597193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64404618|NCT01597193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64618699|NCT03639766|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64404619|NCT01597193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404620|NCT01597193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404621|NCT04930133|Afatinib|afatinib|mesh-list
64404622|NCT04930133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404623|NCT04930133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64404624|NCT04930133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404625|NCT04930133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404626|NCT03057041|Fentanyl|fentanyl|mesh-list
64404627|NCT03057041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64404628|NCT03057041|Narcotics|narcotics|mesh-ancestor
64404629|NCT03057041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64404630|NCT03057041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404631|NCT03057041|Analgesics|analgesics|mesh-ancestor
64404632|NCT03057041|Sensory System Agents|sensory system agents|mesh-ancestor
64404658|NCT05123053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64404659|NCT05123053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404660|NCT03889795|Metformin|metformin|mesh-list
64404661|NCT03889795|Digoxin|digoxin|mesh-list
64404662|NCT03889795|Simvastatin|simvastatin|mesh-list
64404663|NCT03889795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64404664|NCT03889795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404665|NCT03889795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64404666|NCT03889795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64404667|NCT03889795|Antimetabolites|antimetabolites|mesh-ancestor
64404668|NCT03889795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404669|NCT03889795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64404670|NCT03889795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64772232|NCT01295112|Glucocorticoids|glucocorticoids|mesh-ancestor
64772233|NCT01295112|Hormones|hormones|mesh-ancestor
64772234|NCT01295112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64772235|NCT01295112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64404671|NCT03889795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404672|NCT03889795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64404673|NCT03889795|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64404674|NCT03889795|Protective Agents|protective agents|mesh-ancestor
64404675|NCT02622113|Canagliflozin|canagliflozin|mesh-list
64404676|NCT02622113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64404677|NCT02622113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404678|NCT02622113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64404679|NCT02622113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404680|NCT03872791|Paclitaxel|paclitaxel|mesh-list
64404681|NCT03872791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64404682|NCT03872791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404683|NCT03872791|Tubulin Modulators|tubulin modulators|mesh-ancestor
64404684|NCT03872791|Antimitotic Agents|antimitotic agents|mesh-ancestor
64404685|NCT03872791|Mitosis Modulators|mitosis modulators|mesh-ancestor
64404686|NCT03872791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404687|NCT04430777|Tranexamic Acid|tranexamic acid|mesh-list
64404688|NCT04430777|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64404689|NCT04430777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64514870|NCT01724021|Autonomic Agents|autonomic agents|mesh-ancestor
64514871|NCT01724021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64514872|NCT01724021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64514873|NCT01724021|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64514874|NCT01724021|Protective Agents|protective agents|mesh-ancestor
64514875|NCT01724021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64404690|NCT04430777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404691|NCT04430777|Hemostatics|hemostatics|mesh-ancestor
64404692|NCT04430777|Coagulants|coagulants|mesh-ancestor
64404694|NCT04910477|Dexmedetomidine|dexmedetomidine|mesh-list
64404695|NCT04910477|Neostigmine|neostigmine|mesh-list
64404701|NCT04910477|Sensory System Agents|sensory system agents|mesh-ancestor
64404702|NCT04910477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404703|NCT04910477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64404704|NCT04910477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64404706|NCT04910477|Adrenergic Agents|adrenergic agents|mesh-ancestor
64404707|NCT04910477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64772256|NCT01304082|Sensory System Agents|sensory system agents|mesh-ancestor
64772263|NCT01304238|PENTA|penta|mesh-list
64772264|NCT01304238|Lepirudin|lepirudin|mesh-list
64772265|NCT01304238|Danaparoid|danaparoid|mesh-list
64772266|NCT01304238|Fondaparinux|fondaparinux|mesh-list
64772267|NCT01304238|Argatroban|argatroban|mesh-list
64772268|NCT01304238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64772269|NCT01304238|Antithrombins|antithrombins|mesh-ancestor
64772270|NCT01304238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64772271|NCT01304238|Protease Inhibitors|protease inhibitors|mesh-ancestor
64772272|NCT01304238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772273|NCT01304238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772274|NCT01304238|Anticoagulants|anticoagulants|mesh-ancestor
64404708|NCT04910477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404709|NCT04910477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64404710|NCT04910477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64404711|NCT04910477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64404712|NCT04910477|Autonomic Agents|autonomic agents|mesh-ancestor
64404735|NCT04929509|Listerine|listerine|mesh-list
64404736|NCT04929509|Fluorides|fluorides|mesh-list
64404737|NCT04929509|Sodium Fluoride|sodium fluoride|mesh-list
64404738|NCT04929509|Fluorides, Topical|fluorides, topical|mesh-list
64404739|NCT04929509|Cariostatic Agents|cariostatic agents|mesh-ancestor
64404740|NCT04929509|Protective Agents|protective agents|mesh-ancestor
64404741|NCT04929509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404742|NCT04929509|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64404743|NCT04929509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64404744|NCT03054467|Amlodipine|amlodipine|mesh-list
64404745|NCT03054467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64404746|NCT03054467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64404747|NCT03054467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64404748|NCT03054467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404749|NCT03054467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64404750|NCT03054467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404751|NCT03054467|Vasodilator Agents|vasodilator agents|mesh-ancestor
64404752|NCT04910165|Ropivacaine|ropivacaine|mesh-list
64404753|NCT04910165|Anesthetics, Local|anesthetics, local|mesh-ancestor
64404754|NCT04910165|Anesthetics|anesthetics|mesh-ancestor
64404755|NCT04910165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64404756|NCT04910165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404757|NCT04910165|Sensory System Agents|sensory system agents|mesh-ancestor
64323431|NCT04721977|Trastuzumab|trastuzumab|mesh-list
64323432|NCT04721977|Tucatinib|tucatinib|mesh-list
64772291|NCT01308060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64772292|NCT01308060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772293|NCT01308060|Cholinergic Agents|cholinergic agents|mesh-ancestor
64772294|NCT01308060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64772295|NCT01308060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772296|NCT01308060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64772297|NCT01308060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772298|NCT01308294|Vaccines|vaccines|mesh-list
64772299|NCT01308294|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64404758|NCT04910165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404759|NCT02730325|Immunoglobulins|immunoglobulins|mesh-list
64404760|NCT02730325|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64404761|NCT02730325|Antibodies|antibodies|mesh-list
64404762|NCT02730325|Immunologic Factors|immunologic factors|mesh-ancestor
64404763|NCT02730325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404870|NCT03520231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404872|NCT03520231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64404873|NCT03520231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404913|NCT03055793|Formoterol Fumarate|formoterol fumarate|mesh-list
64404914|NCT03055793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64404915|NCT03055793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64772358|NCT01312818|Antimetabolites|antimetabolites|mesh-ancestor
64772359|NCT01312818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772360|NCT01312818|Dermatologic Agents|dermatologic agents|mesh-ancestor
64772361|NCT01312818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772362|NCT01312818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64772363|NCT01312818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64772364|NCT01312818|Immunologic Factors|immunologic factors|mesh-ancestor
64404917|NCT03055793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404918|NCT03055793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404919|NCT03055793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64404947|NCT04925141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404951|NCT02651155|Lubiprostone|lubiprostone|mesh-list
64404952|NCT02651155|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64404953|NCT02651155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64404954|NCT02651155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404955|NCT04925063|Metformin|metformin|mesh-list
64404956|NCT04925063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64514876|NCT01724021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64514877|NCT01724021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64514879|NCT05197504|Bevacizumab|bevacizumab|mesh-list
64514880|NCT05197504|Atezolizumab|atezolizumab|mesh-list
64514881|NCT05197504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64514882|NCT05197504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514883|NCT05197504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64514884|NCT05197504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64514885|NCT05197504|Growth Substances|growth substances|mesh-ancestor
64514886|NCT05197504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514887|NCT05197504|Growth Inhibitors|growth inhibitors|mesh-ancestor
64514888|NCT02293096|Metoprolol|metoprolol|mesh-list
64514889|NCT02293096|Dextromethorphan|dextromethorphan|mesh-list
64514890|NCT02293096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64514891|NCT02293096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64514892|NCT02293096|Sympatholytics|sympatholytics|mesh-ancestor
64514893|NCT02293096|Autonomic Agents|autonomic agents|mesh-ancestor
64514894|NCT02293096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404957|NCT04925063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404958|NCT04909151|Methamphetamine|methamphetamine|mesh-list
64404959|NCT04909151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64404960|NCT04909151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404961|NCT04909151|Sympathomimetics|sympathomimetics|mesh-ancestor
64404965|NCT04909151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64404966|NCT04909151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404967|NCT04909151|Adrenergic Agents|adrenergic agents|mesh-ancestor
64404968|NCT04909151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64404969|NCT04909151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64405004|NCT04917497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64405005|NCT04917497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405006|NCT04917497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405046|NCT04907747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405047|NCT04907747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405049|NCT04907747|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64405050|NCT04907747|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64405052|NCT04907747|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64405053|NCT04907747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64405054|NCT04907747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64405055|NCT04907747|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64405056|NCT03052673|Fentanyl|fentanyl|mesh-list
64405057|NCT03052673|Ketamine|ketamine|mesh-list
64405058|NCT03052673|Analgesics|analgesics|mesh-ancestor
64405059|NCT03052673|Sensory System Agents|sensory system agents|mesh-ancestor
64405060|NCT03052673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64405061|NCT03052673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405062|NCT03052673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64405063|NCT03052673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64405104|NCT04430933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64514896|NCT02293096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64514897|NCT02293096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64514898|NCT02293096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64772426|NCT01318356|Antimalarials|antimalarials|mesh-ancestor
64514899|NCT02293096|Adrenergic Agents|adrenergic agents|mesh-ancestor
64514900|NCT02293096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64514901|NCT02293096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514902|NCT02293096|Antitussive Agents|antitussive agents|mesh-ancestor
64514903|NCT02293096|Respiratory System Agents|respiratory system agents|mesh-ancestor
64514904|NCT02293096|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64514905|NCT02293096|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64514906|NCT05192200|Interferons|interferons|mesh-list
64514907|NCT05192200|Interferon-beta|interferon-beta|mesh-list
64514908|NCT05192200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514909|NCT05192200|Antiviral Agents|antiviral agents|mesh-ancestor
64514910|NCT05192200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64514911|NCT05192200|Immunologic Factors|immunologic factors|mesh-ancestor
64514912|NCT05192200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514913|NCT01722071|Oxytocin|oxytocin|mesh-list
64514914|NCT01722071|Oxytocics|oxytocics|mesh-ancestor
64514915|NCT01722071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64405105|NCT04430933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405106|NCT04430933|Tubulin Modulators|tubulin modulators|mesh-ancestor
64405107|NCT04430933|Antimitotic Agents|antimitotic agents|mesh-ancestor
64405108|NCT04430933|Mitosis Modulators|mitosis modulators|mesh-ancestor
64405109|NCT04430933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405110|NCT04430933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405139|NCT02619617|Pasireotide|pasireotide|mesh-list
64405140|NCT02619617|Hormones|hormones|mesh-ancestor
64405141|NCT02619617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64405142|NCT02619617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405143|NCT04012957|Darbepoetin alfa|darbepoetin alfa|mesh-list
64405144|NCT04012957|Hematinics|hematinics|mesh-ancestor
64405145|NCT04906031|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
64618721|NCT03644212|Vitamins|vitamins|mesh-list
64405147|NCT04906031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64405148|NCT04906031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64405149|NCT04906031|Schistosomicides|schistosomicides|mesh-ancestor
64405150|NCT04906031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64405151|NCT04906031|Anthelmintics|anthelmintics|mesh-ancestor
64405152|NCT05125627|Progesterone|progesterone|mesh-list
64405153|NCT05125627|Progestins|progestins|mesh-ancestor
64405154|NCT05125627|Hormones|hormones|mesh-ancestor
64405155|NCT05125627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64405191|NCT04905953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405192|NCT04905953|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64405193|NCT04905953|Autonomic Agents|autonomic agents|mesh-ancestor
64405194|NCT04905953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64405195|NCT04916093|Metformin|metformin|mesh-list
64405196|NCT04916093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64405197|NCT04916093|Vildagliptin|vildagliptin|mesh-list
64405198|NCT04916093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64514916|NCT01722071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514918|NCT04223752|Ceftolozane|ceftolozane|mesh-list
64514919|NCT04223752|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
64514920|NCT04223752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64514921|NCT04223752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64514922|NCT04223752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64514923|NCT04223752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514924|NCT04223752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514925|NCT04223752|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64514926|NCT04223752|Renal Agents|renal agents|mesh-ancestor
64514927|NCT04187404|Nivolumab|nivolumab|mesh-list
64514928|NCT04187404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64514929|NCT04187404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514930|NCT04187404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64736747|NCT00616577|Anesthetics|anesthetics|mesh-ancestor
64405199|NCT04916093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405200|NCT04916093|Incretins|incretins|mesh-ancestor
64405201|NCT04916093|Hormones|hormones|mesh-ancestor
64405202|NCT04916093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64405203|NCT04916093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64405204|NCT04916093|Protease Inhibitors|protease inhibitors|mesh-ancestor
64405205|NCT04916093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405206|NCT04916093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405207|NCT05130619|Ethanol|ethanol|mesh-list
64405208|NCT05130619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64405209|NCT05130619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64405250|NCT04966507|Listerine|listerine|mesh-list
64405251|NCT04966507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
64405252|NCT04966507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64405253|NCT04949113|Nivolumab|nivolumab|mesh-list
64405254|NCT04949113|Ipilimumab|ipilimumab|mesh-list
64405255|NCT04949113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64405256|NCT04949113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405257|NCT04949113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64405258|NCT04949113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405260|NCT05057845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405261|NCT05057845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64405262|NCT05057845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405263|NCT05057845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405303|NCT04901117|Tetracycline|tetracycline|mesh-list
64405304|NCT04901117|Potassium Citrate|potassium citrate|mesh-list
64405305|NCT04901117|Bismuth|bismuth|mesh-list
64405306|NCT04901117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405307|NCT04901117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64405308|NCT04901117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64405309|NCT04901117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64618729|NCT03906448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405311|NCT04901117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64405312|NCT04901117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405313|NCT04901117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64405314|NCT04901117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64405316|NCT04901117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64405333|NCT04576663|Oxymetazoline|oxymetazoline|mesh-list
64405334|NCT04576663|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64405335|NCT04576663|Mydriatics|mydriatics|mesh-ancestor
64405336|NCT04576663|Autonomic Agents|autonomic agents|mesh-ancestor
64405337|NCT04576663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64514932|NCT04155580|Decitabine|decitabine|mesh-list
64514933|NCT04155580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64514934|NCT04155580|Antimetabolites|antimetabolites|mesh-ancestor
64514935|NCT04155580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514936|NCT04155580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514937|NCT04155580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514938|NCT01721759|Nivolumab|nivolumab|mesh-list
64514939|NCT01721759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64514940|NCT01721759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514941|NCT01721759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64514942|NCT01721759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514943|NCT04776850|Mycophenolic Acid|mycophenolic acid|mesh-list
64514944|NCT04776850|Dexamethasone|dexamethasone|mesh-list
64514945|NCT04776850|Dexamethasone acetate|dexamethasone acetate|mesh-list
64514946|NCT04776850|Cyclophosphamide|cyclophosphamide|mesh-list
64514947|NCT04776850|Busulfan|busulfan|mesh-list
64405338|NCT04576663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405339|NCT04576663|Sympathomimetics|sympathomimetics|mesh-ancestor
64405340|NCT04576663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64405341|NCT04576663|Nasal Decongestants|nasal decongestants|mesh-ancestor
64405342|NCT04576663|Respiratory System Agents|respiratory system agents|mesh-ancestor
64405343|NCT04576663|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64405344|NCT04576663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64405345|NCT04576663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64405346|NCT04576663|Adrenergic Agents|adrenergic agents|mesh-ancestor
64405347|NCT04576663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64772498|NCT01330134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64772499|NCT01330134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64772501|NCT01330290|Rotigotine|rotigotine|mesh-list
64772515|NCT01331694|Bromides|bromides|mesh-list
64405348|NCT04576663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405349|NCT04576663|Protective Agents|protective agents|mesh-ancestor
64405350|NCT05281549|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64405351|NCT05281549|Tenecteplase|tenecteplase|mesh-list
64405352|NCT05281549|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64405353|NCT05281549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64405354|NCT05281549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405355|NCT04400695|Paclitaxel|paclitaxel|mesh-list
64405356|NCT04400695|Vinorelbine|vinorelbine|mesh-list
64405357|NCT04400695|Docetaxel|docetaxel|mesh-list
64405358|NCT04400695|Capecitabine|capecitabine|mesh-list
64405365|NCT04400695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64405366|NCT04400695|Antimetabolites|antimetabolites|mesh-ancestor
64405367|NCT05205499|Sirolimus|sirolimus|mesh-list
64405368|NCT05205499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64405369|NCT05205499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64405370|NCT05205499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64405371|NCT05205499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405372|NCT05205499|Antifungal Agents|antifungal agents|mesh-ancestor
64405373|NCT05205499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64772617|NCT01339260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64772618|NCT01339260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64772619|NCT01339260|Serotonin Agents|serotonin agents|mesh-ancestor
64772620|NCT01339260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64772621|NCT01339260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772622|NCT01340586|Apixaban|apixaban|mesh-list
64772623|NCT01340586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64772624|NCT01340586|Antithrombins|antithrombins|mesh-ancestor
64384076|NCT05500677|Narcotics|narcotics|mesh-ancestor
64323444|NCT02232607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323445|NCT02232607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64323446|NCT02232607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323448|NCT02232685|Lipotropic Agents|lipotropic agents|mesh-ancestor
64323449|NCT02232685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64323450|NCT02232685|Antimetabolites|antimetabolites|mesh-ancestor
64405374|NCT05205499|Immunologic Factors|immunologic factors|mesh-ancestor
64405375|NCT05205499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405376|NCT05191225|Rituximab|rituximab|mesh-list
64405377|NCT05191225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64405378|NCT05191225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405379|NCT05191225|Immunologic Factors|immunologic factors|mesh-ancestor
64405380|NCT05191225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405381|NCT05191225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64405382|NCT03909217|Dexetimide|dexetimide|mesh-list
64405414|NCT04913987|Cimetidine|cimetidine|mesh-list
64405415|NCT04913987|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64514949|NCT04776850|Fludarabine|fludarabine|mesh-list
64514950|NCT04776850|Fludarabine phosphate|fludarabine phosphate|mesh-list
64514951|NCT04776850|Bortezomib|bortezomib|mesh-list
64514952|NCT04776850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64514953|NCT04776850|Tacrolimus|tacrolimus|mesh-list
64514960|NCT04776850|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64514961|NCT04776850|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64514962|NCT04776850|BB 1101|bb 1101|mesh-list
64514964|NCT04776850|Immunologic Factors|immunologic factors|mesh-ancestor
64514965|NCT04776850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514966|NCT04776850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64514967|NCT04776850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64514968|NCT04776850|Alkylating Agents|alkylating agents|mesh-ancestor
64405416|NCT04913987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64405417|NCT04913987|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64405418|NCT04913987|Histamine Antagonists|histamine antagonists|mesh-ancestor
64405419|NCT04913987|Histamine Agents|histamine agents|mesh-ancestor
64405420|NCT04913987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64405421|NCT04913987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405422|NCT04913987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405452|NCT04900571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64405454|NCT04891211|Vitamins|vitamins|mesh-ancestor
64405455|NCT04891211|Micronutrients|micronutrients|mesh-ancestor
64405456|NCT04891211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405457|NCT04891211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64405458|NCT04817189|Dexamethasone|dexamethasone|mesh-list
64405459|NCT04817189|Ondansetron|ondansetron|mesh-list
64405460|NCT04817189|Palonosetron|palonosetron|mesh-list
64405461|NCT04817189|Granisetron|granisetron|mesh-list
64405462|NCT04817189|Tropisetron|tropisetron|mesh-list
64405463|NCT04817189|Dolasetron|dolasetron|mesh-list
64405464|NCT04817189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64405465|NCT04817189|Antiemetics|antiemetics|mesh-ancestor
64405466|NCT04817189|Autonomic Agents|autonomic agents|mesh-ancestor
64405467|NCT04817189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64405468|NCT04817189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405469|NCT04817189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64405470|NCT04817189|Glucocorticoids|glucocorticoids|mesh-ancestor
64405471|NCT04817189|Hormones|hormones|mesh-ancestor
64405472|NCT04817189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64405473|NCT04817189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64405474|NCT04817189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405475|NCT04817189|Antipruritics|antipruritics|mesh-ancestor
64405476|NCT04817189|Dermatologic Agents|dermatologic agents|mesh-ancestor
64405477|NCT04817189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64405478|NCT04817189|Serotonin Agents|serotonin agents|mesh-ancestor
64405479|NCT04817189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64405480|NCT04817189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514969|NCT04776850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64514970|NCT04776850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64514971|NCT04776850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64514972|NCT04776850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64514973|NCT04776850|Antiemetics|antiemetics|mesh-ancestor
64514974|NCT04776850|Autonomic Agents|autonomic agents|mesh-ancestor
64514975|NCT04776850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64514976|NCT04776850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64772641|NCT01347060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64772642|NCT01347060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64772643|NCT01347060|Autonomic Agents|autonomic agents|mesh-ancestor
64772644|NCT01347060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772646|NCT01347060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64514977|NCT04776850|Glucocorticoids|glucocorticoids|mesh-ancestor
64514978|NCT04776850|Hormones|hormones|mesh-ancestor
64514979|NCT04776850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64405481|NCT04817189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64405482|NCT04817189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64618744|NCT03889444|Dexamethasone|dexamethasone|mesh-list
64405483|NCT04817189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64405485|NCT04817189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64405528|NCT04884503|GABA Agents|gaba agents|mesh-ancestor
64405529|NCT04884503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64405530|NCT04884503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405531|NCT04884503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405532|NCT04889651|Abiraterone Acetate|abiraterone acetate|mesh-list
64405533|NCT04889651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405534|NCT04889651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64405535|NCT04889651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405574|NCT04898387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64405575|NCT04898387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64405576|NCT04888403|Paclitaxel|paclitaxel|mesh-list
64405577|NCT04888403|Nedaplatin|nedaplatin|mesh-list
64405578|NCT04888403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64405579|NCT04888403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405580|NCT04888403|Tubulin Modulators|tubulin modulators|mesh-ancestor
64405581|NCT04888403|Antimitotic Agents|antimitotic agents|mesh-ancestor
64405582|NCT04888403|Mitosis Modulators|mitosis modulators|mesh-ancestor
64405583|NCT04888403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405584|NCT03050177|Gefitinib|gefitinib|mesh-list
64405602|NCT04887311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405603|NCT04887311|Protective Agents|protective agents|mesh-ancestor
64405604|NCT04887311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405605|NCT04887311|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64405606|NCT04887311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405607|NCT04887311|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64405608|NCT04887311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64405609|NCT03051503|Fentanyl|fentanyl|mesh-list
64405610|NCT03051503|Morphine|morphine|mesh-list
64405611|NCT03051503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64405612|NCT03051503|Narcotics|narcotics|mesh-ancestor
64405613|NCT03051503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64405614|NCT03051503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405615|NCT03051503|Analgesics|analgesics|mesh-ancestor
64405616|NCT03051503|Sensory System Agents|sensory system agents|mesh-ancestor
64772727|NCT01363128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772728|NCT01363128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64772729|NCT01363128|Glucocorticoids|glucocorticoids|mesh-ancestor
64772730|NCT01363128|Hormones|hormones|mesh-ancestor
64772731|NCT01363128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64772732|NCT01363128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64772735|NCT01363128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64514980|NCT04776850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64514981|NCT04776850|Protease Inhibitors|protease inhibitors|mesh-ancestor
64514982|NCT04776850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64514983|NCT04776850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64514984|NCT04776850|Antimetabolites|antimetabolites|mesh-ancestor
64514985|NCT04776850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64514986|NCT04776850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64514987|NCT04776850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64514988|NCT04776850|Antitubercular Agents|antitubercular agents|mesh-ancestor
64514989|NCT04776850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64514990|NCT04776850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64514991|NCT04766086|Vaccines|vaccines|mesh-list
64514992|NCT04766086|Immunologic Factors|immunologic factors|mesh-ancestor
64514993|NCT04766086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514994|NCT05137054|Lenalidomide|lenalidomide|mesh-list
64514995|NCT05137054|Pomalidomide|pomalidomide|mesh-list
64514996|NCT05137054|Bortezomib|bortezomib|mesh-list
64514997|NCT05137054|Daratumumab|daratumumab|mesh-list
64514998|NCT05137054|Immunologic Factors|immunologic factors|mesh-ancestor
64514999|NCT05137054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515000|NCT05137054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64515001|NCT05137054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64405617|NCT03051503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64405618|NCT03051503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64405619|NCT03051503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64405620|NCT03051503|Anesthetics, General|anesthetics, general|mesh-ancestor
64405621|NCT03051503|Anesthetics|anesthetics|mesh-ancestor
64405622|NCT04896125|Bimatoprost|bimatoprost|mesh-list
64405623|NCT04896125|Latanoprost|latanoprost|mesh-list
64405624|NCT04896125|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64405625|NCT04896125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64405632|NCT04895657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64405633|NCT04895657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405634|NCT04895657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405635|NCT04895423|Cyclosporine|cyclosporine|mesh-list
64405636|NCT04895423|Mycophenolic Acid|mycophenolic acid|mesh-list
64405637|NCT04895423|Methotrexate|methotrexate|mesh-list
64405638|NCT04895423|Cyclosporins|cyclosporins|mesh-list
64405639|NCT04895423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64405640|NCT04895423|Abortifacient Agents|abortifacient agents|mesh-ancestor
64405641|NCT04895423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64405642|NCT04895423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405643|NCT04895423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64405644|NCT04895423|Antimetabolites|antimetabolites|mesh-ancestor
64405645|NCT04895423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405646|NCT04895423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405647|NCT04895423|Dermatologic Agents|dermatologic agents|mesh-ancestor
64405648|NCT04895423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405666|NCT04882163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64405667|NCT04882163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405668|NCT04882163|Immunologic Factors|immunologic factors|mesh-ancestor
64405669|NCT04882163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405670|NCT04882163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64405671|NCT04882163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64515002|NCT05137054|Growth Substances|growth substances|mesh-ancestor
64515003|NCT05137054|Growth Inhibitors|growth inhibitors|mesh-ancestor
64772756|NCT01365624|Analgesics|analgesics|mesh-ancestor
64515004|NCT05137054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515005|NCT04132648|Curcumin|curcumin|mesh-list
64515006|NCT04132648|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64515007|NCT04132648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64515008|NCT04132648|Analgesics|analgesics|mesh-ancestor
64515009|NCT04132648|Sensory System Agents|sensory system agents|mesh-ancestor
64515010|NCT04132648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64515011|NCT04132648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515012|NCT04132648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64515014|NCT04132648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515015|NCT04132648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515016|NCT04132648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515017|NCT02331940|Tiotropium Bromide|tiotropium bromide|mesh-list
64515018|NCT02331940|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64515019|NCT02331940|Autonomic Agents|autonomic agents|mesh-ancestor
64515020|NCT02331940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64515021|NCT02331940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515022|NCT02331940|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64515023|NCT02331940|Respiratory System Agents|respiratory system agents|mesh-ancestor
64515024|NCT02331940|Parasympatholytics|parasympatholytics|mesh-ancestor
64515025|NCT02331940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64515026|NCT02331940|Cholinergic Agents|cholinergic agents|mesh-ancestor
64515027|NCT02331940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64515028|NCT02331940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515029|NCT04095208|Nivolumab|nivolumab|mesh-list
64515030|NCT04095208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64515031|NCT04095208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515032|NCT04095208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64405672|NCT04882163|Antiemetics|antiemetics|mesh-ancestor
64405673|NCT04882163|Autonomic Agents|autonomic agents|mesh-ancestor
64405674|NCT04882163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64405675|NCT04882163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64405676|NCT04882163|Glucocorticoids|glucocorticoids|mesh-ancestor
64405677|NCT04882163|Hormones|hormones|mesh-ancestor
64405678|NCT04882163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64405679|NCT04882163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64405680|NCT04882163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64405681|NCT04882163|Antimetabolites|antimetabolites|mesh-ancestor
64405682|NCT04882163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405683|NCT04882163|Antiviral Agents|antiviral agents|mesh-ancestor
64405684|NCT04882163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64515033|NCT04095208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515034|NCT05117554|Midazolam|midazolam|mesh-list
64515035|NCT05117554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64515036|NCT05117554|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64515037|NCT05117554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64515038|NCT05117554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515039|NCT05117554|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64515040|NCT05117554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64515041|NCT05117554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64515042|NCT05117554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64515043|NCT05117554|Anesthetics, General|anesthetics, general|mesh-ancestor
64515044|NCT05117554|Anesthetics|anesthetics|mesh-ancestor
64772838|NCT01390818|Elafin|elafin|mesh-list
64515045|NCT05117554|GABA Modulators|gaba modulators|mesh-ancestor
64515046|NCT05117554|GABA Agents|gaba agents|mesh-ancestor
64515047|NCT05117554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64515048|NCT05117554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515049|NCT04093570|Decitabine|decitabine|mesh-list
64515050|NCT04093570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64515051|NCT04093570|Antimetabolites|antimetabolites|mesh-ancestor
64515052|NCT04093570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515053|NCT04093570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515054|NCT04093570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405685|NCT04882163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405686|NCT04882163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64405687|NCT04882163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64405688|NCT04882163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64405689|NCT04882163|Growth Substances|growth substances|mesh-ancestor
64405690|NCT04882163|Growth Inhibitors|growth inhibitors|mesh-ancestor
64405691|NCT04882163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64405692|NCT04882163|Alkylating Agents|alkylating agents|mesh-ancestor
64405693|NCT04885751|Rebamipide|rebamipide|mesh-list
64405694|NCT04885751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64405699|NCT04885751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405701|NCT03049163|Proxymetacaine|proxymetacaine|mesh-list
64405702|NCT03049163|Propoxycaine|propoxycaine|mesh-list
64405703|NCT03049163|Anesthetics|anesthetics|mesh-ancestor
64405704|NCT03049163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64405705|NCT03049163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405706|NCT03049163|Anesthetics, Local|anesthetics, local|mesh-ancestor
64405707|NCT03049163|Sensory System Agents|sensory system agents|mesh-ancestor
64405708|NCT03049163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64405709|NCT04881851|Folic Acid|folic acid|mesh-list
64405710|NCT04881851|Thioctic Acid|thioctic acid|mesh-list
64405711|NCT04881851|Inositol|inositol|mesh-list
64405712|NCT04881851|Hematinics|hematinics|mesh-ancestor
64405713|NCT04881851|Vitamin B Complex|vitamin b complex|mesh-ancestor
64405748|NCT03046979|Apatinib|apatinib|mesh-list
64405749|NCT03046979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405750|NCT03046979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64405751|NCT03046979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405787|NCT04879511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405788|NCT04361825|Durvalumab|durvalumab|mesh-list
64405789|NCT04361825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64772846|NCT01390818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64405790|NCT04361825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405791|NCT03046901|Vancomycin|vancomycin|mesh-list
64515056|NCT04034056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64515057|NCT04034056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515058|NCT04708054|Fludarabine|fludarabine|mesh-list
64515059|NCT04708054|Fludarabine phosphate|fludarabine phosphate|mesh-list
64515060|NCT04708054|Busulfan|busulfan|mesh-list
64515061|NCT04708054|Venetoclax|venetoclax|mesh-list
64515062|NCT04708054|Thiotepa|thiotepa|mesh-list
64515063|NCT04708054|Cladribine|cladribine|mesh-list
64515064|NCT04708054|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
64405794|NCT04423055|Contraceptive Agents|contraceptive agents|mesh-list
64405795|NCT04423055|Etonogestrel|etonogestrel|mesh-list
64405796|NCT04423055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64405797|NCT04423055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405798|NCT04423055|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64405799|NCT04423055|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64405822|NCT04870541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405824|NCT04870541|Antipruritics|antipruritics|mesh-ancestor
64405825|NCT04870541|Dermatologic Agents|dermatologic agents|mesh-ancestor
64405826|NCT04870541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64405827|NCT04870541|Serotonin Agents|serotonin agents|mesh-ancestor
64405828|NCT04870541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64405829|NCT04870541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405830|NCT04870541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64405831|NCT04870541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64405832|NCT04870541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64405833|NCT04870541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64405841|NCT04870073|Natriuretic Agents|natriuretic agents|mesh-ancestor
64405842|NCT04870073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405843|NCT02616029|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64405844|NCT02616029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64405845|NCT02616029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64405846|NCT02616029|Antiviral Agents|antiviral agents|mesh-ancestor
64405847|NCT02616029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64405848|NCT04878497|Warfarin|warfarin|mesh-list
64405849|NCT04878497|Rivaroxaban|rivaroxaban|mesh-list
64405850|NCT04878497|Dabigatran|dabigatran|mesh-list
64405851|NCT04878497|Apixaban|apixaban|mesh-list
64405852|NCT04878497|Edoxaban|edoxaban|mesh-list
64405853|NCT04878497|Anticoagulants|anticoagulants|mesh-ancestor
64405854|NCT04878497|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64405855|NCT04878497|Antithrombins|antithrombins|mesh-ancestor
64405856|NCT04878497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64405857|NCT04878497|Protease Inhibitors|protease inhibitors|mesh-ancestor
64405858|NCT04878497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405859|NCT04878497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405860|NCT03257033|Gemcitabine|gemcitabine|mesh-list
64405861|NCT03257033|Paclitaxel|paclitaxel|mesh-list
64405877|NCT03250169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64405878|NCT03250169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405879|NCT02614859|Metformin|metformin|mesh-list
64405880|NCT02614859|Bicalutamide|bicalutamide|mesh-list
64405881|NCT02614859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64405882|NCT02614859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405883|NCT02614859|Androgen Antagonists|androgen antagonists|mesh-ancestor
64405884|NCT02614859|Hormone Antagonists|hormone antagonists|mesh-ancestor
64405885|NCT02614859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64405886|NCT02614859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405887|NCT01495637|Sargramostim|sargramostim|mesh-list
64405888|NCT01495637|Immunologic Factors|immunologic factors|mesh-ancestor
64405889|NCT01495637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405890|NCT04876859|Anesthetics|anesthetics|mesh-list
64405891|NCT04876859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64405892|NCT04876859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405893|NCT04876313|Paclitaxel|paclitaxel|mesh-list
64405894|NCT04876313|Nivolumab|nivolumab|mesh-list
64515066|NCT04708054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64515067|NCT04708054|Antimetabolites|antimetabolites|mesh-ancestor
64515068|NCT04708054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515069|NCT04708054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64515070|NCT04708054|Immunologic Factors|immunologic factors|mesh-ancestor
64515071|NCT04708054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515072|NCT04708054|Alkylating Agents|alkylating agents|mesh-ancestor
64405895|NCT04876313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64405896|NCT04876313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405897|NCT04876313|Tubulin Modulators|tubulin modulators|mesh-ancestor
64405898|NCT04876313|Antimitotic Agents|antimitotic agents|mesh-ancestor
64405899|NCT04876313|Mitosis Modulators|mitosis modulators|mesh-ancestor
64405900|NCT04876313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405901|NCT04876313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64405902|NCT04876313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64405914|NCT03049085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405915|NCT03049085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64405916|NCT03049085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64405918|NCT03049085|Antipyretics|antipyretics|mesh-ancestor
64405919|NCT04875611|Nivolumab|nivolumab|mesh-list
64405920|NCT04875611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64405921|NCT04875611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405922|NCT04875611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64405923|NCT04875611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405924|NCT04386317|Terazosin|terazosin|mesh-list
64405925|NCT04386317|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64405926|NCT04386317|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64405927|NCT04386317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64405928|NCT04386317|Adrenergic Agents|adrenergic agents|mesh-ancestor
64405929|NCT04386317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64405957|NCT04874675|Sensory System Agents|sensory system agents|mesh-ancestor
64405958|NCT04874675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64405959|NCT04874675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405961|NCT04874675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64405962|NCT04874675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64405963|NCT04874675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64405964|NCT04874675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64405965|NCT04874675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405966|NCT04874675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405975|NCT04868513|Cariostatic Agents|cariostatic agents|mesh-ancestor
64405976|NCT04868513|Protective Agents|protective agents|mesh-ancestor
64405977|NCT04868513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405978|NCT04868513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64405979|NCT04868513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64405980|NCT04868513|Disinfectants|disinfectants|mesh-ancestor
64405981|NCT04868513|Dermatologic Agents|dermatologic agents|mesh-ancestor
64405982|NCT03047837|Aspirin|aspirin|mesh-list
64405983|NCT03047837|Metformin|metformin|mesh-list
64406001|NCT05256173|Antioxidants|antioxidants|mesh-ancestor
64406002|NCT05256173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406003|NCT05256173|Protective Agents|protective agents|mesh-ancestor
64406004|NCT05256173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406005|NCT05256173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64406006|NCT02648347|Darbepoetin alfa|darbepoetin alfa|mesh-list
64406007|NCT02648347|Hematinics|hematinics|mesh-ancestor
64406008|NCT02614703|Acetic Acid|acetic acid|mesh-list
64406009|NCT02614703|Retinol acetate|retinol acetate|mesh-list
64406010|NCT02614703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64406011|NCT02614703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64515073|NCT04708054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64515074|NCT04708054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64515075|NCT02292082|Cefazolin|cefazolin|mesh-list
64515076|NCT02292082|Dexamethasone|dexamethasone|mesh-list
64515077|NCT02292082|Methylprednisolone|methylprednisolone|mesh-list
64515078|NCT02292082|Midazolam|midazolam|mesh-list
64515079|NCT02292082|Morphine|morphine|mesh-list
64515080|NCT02292082|Bupivacaine|bupivacaine|mesh-list
64515081|NCT02292082|Propofol|propofol|mesh-list
64515082|NCT02292082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64515083|NCT02292082|Antiemetics|antiemetics|mesh-ancestor
64515084|NCT02292082|Autonomic Agents|autonomic agents|mesh-ancestor
64515085|NCT02292082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64515086|NCT02292082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515087|NCT02292082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64515088|NCT02292082|Glucocorticoids|glucocorticoids|mesh-ancestor
64515089|NCT02292082|Hormones|hormones|mesh-ancestor
64515090|NCT02292082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64515091|NCT02292082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64515092|NCT02292082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515093|NCT02292082|Anesthetics, Local|anesthetics, local|mesh-ancestor
64515094|NCT02292082|Anesthetics|anesthetics|mesh-ancestor
64515095|NCT02292082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64515096|NCT02292082|Sensory System Agents|sensory system agents|mesh-ancestor
64515097|NCT02292082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64515098|NCT02292082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64515099|NCT02292082|Anesthetics, General|anesthetics, general|mesh-ancestor
64515100|NCT02292082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64515101|NCT02292082|Narcotics|narcotics|mesh-ancestor
64515102|NCT02292082|Analgesics|analgesics|mesh-ancestor
64515103|NCT02292082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64515104|NCT02292082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64515105|NCT02292082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64515106|NCT02292082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64515107|NCT02292082|GABA Modulators|gaba modulators|mesh-ancestor
64772942|NCT01404936|Tubulin Modulators|tubulin modulators|mesh-ancestor
64772943|NCT01404936|Antimitotic Agents|antimitotic agents|mesh-ancestor
64772944|NCT01404936|Mitosis Modulators|mitosis modulators|mesh-ancestor
64772945|NCT01410084|Vitamin D|vitamin d|mesh-list
64772946|NCT01410084|Cholecalciferol|cholecalciferol|mesh-list
64772947|NCT01410084|Vitamins|vitamins|mesh-list
64772948|NCT01410084|Vitamin E|vitamin e|mesh-list
64772949|NCT01410084|Micronutrients|micronutrients|mesh-ancestor
64772950|NCT01410084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515108|NCT02292082|GABA Agents|gaba agents|mesh-ancestor
64406012|NCT02614703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64406013|NCT02614703|Immunologic Factors|immunologic factors|mesh-ancestor
64406014|NCT02614703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406015|NCT02614703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64406016|NCT02614703|Protective Agents|protective agents|mesh-ancestor
64406017|NCT02614703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406018|NCT01669343|Letrozole|letrozole|mesh-list
64406019|NCT01669343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406020|NCT01669343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64515109|NCT02292082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64515110|NCT02292082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515111|NCT02292082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64515112|NCT02292082|Protective Agents|protective agents|mesh-ancestor
64515113|NCT02292082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64515114|NCT02292082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64515115|NCT05072704|Sufentanil|sufentanil|mesh-list
64515116|NCT05072704|Dexmedetomidine|dexmedetomidine|mesh-list
64515117|NCT05072704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64515118|NCT05072704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64515119|NCT05072704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515120|NCT05072704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64515121|NCT05072704|Analgesics|analgesics|mesh-ancestor
64515122|NCT05072704|Sensory System Agents|sensory system agents|mesh-ancestor
64515123|NCT05072704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64515124|NCT05072704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64515125|NCT05072704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64772973|NCT01413750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515126|NCT05072704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64515127|NCT05072704|Adrenergic Agents|adrenergic agents|mesh-ancestor
64515128|NCT05072704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64515129|NCT05072704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406021|NCT01669343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64406022|NCT01669343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406023|NCT01669343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406024|NCT01669343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64406025|NCT01669343|Hormone Antagonists|hormone antagonists|mesh-ancestor
64406026|NCT01669343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64406027|NCT01669343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406028|NCT04874597|Ocrelizumab|ocrelizumab|mesh-list
64406029|NCT04874597|Immunologic Factors|immunologic factors|mesh-ancestor
64406030|NCT04874597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406031|NCT04383743|Cisplatin|cisplatin|mesh-list
64406032|NCT04383743|Doxorubicin|doxorubicin|mesh-list
64406033|NCT04383743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64406034|NCT04383743|Pembrolizumab|pembrolizumab|mesh-list
64406035|NCT04383743|Methotrexate|methotrexate|mesh-list
64406036|NCT04383743|Daunorubicin|daunorubicin|mesh-list
64406044|NCT04383743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406045|NCT04383743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64406046|NCT04383743|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64406048|NCT04383743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64406067|NCT03126643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406069|NCT04617067|Paclitaxel|paclitaxel|mesh-list
64406070|NCT04617067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64406071|NCT04617067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406072|NCT04617067|Tubulin Modulators|tubulin modulators|mesh-ancestor
64406073|NCT04617067|Antimitotic Agents|antimitotic agents|mesh-ancestor
64406074|NCT04617067|Mitosis Modulators|mitosis modulators|mesh-ancestor
64406075|NCT04617067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406076|NCT04617067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64406077|NCT04617067|Antimetabolites|antimetabolites|mesh-ancestor
64515130|NCT05072704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64515131|NCT05072704|Narcotics|narcotics|mesh-ancestor
64515132|NCT05072704|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64515133|NCT05072704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64515134|NCT05072704|Anesthetics, General|anesthetics, general|mesh-ancestor
64773009|NCT01429272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773013|NCT01429272|Antipyretics|antipyretics|mesh-ancestor
64515135|NCT05072704|Anesthetics|anesthetics|mesh-ancestor
64515136|NCT03969004|Cemiplimab|cemiplimab|mesh-list
64515137|NCT03969004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64515138|NCT03969004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515139|NCT04678336|Cyclophosphamide|cyclophosphamide|mesh-list
64515140|NCT04678336|Fludarabine|fludarabine|mesh-list
64515141|NCT04678336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64515142|NCT04678336|Immunologic Factors|immunologic factors|mesh-ancestor
64515143|NCT04678336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406078|NCT04617067|Antiviral Agents|antiviral agents|mesh-ancestor
64406079|NCT04617067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64406080|NCT04617067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406081|NCT04617067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64406082|NCT04617067|Immunologic Factors|immunologic factors|mesh-ancestor
64406083|NCT04617067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406084|NCT01594931|Artesunate|artesunate|mesh-list
64406085|NCT01594931|Pyronaridine|pyronaridine|mesh-list
64406087|NCT01594931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64406088|NCT01594931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64406089|NCT01594931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64406090|NCT01594931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406091|NCT01594931|Antiviral Agents|antiviral agents|mesh-ancestor
64406092|NCT01594931|Schistosomicides|schistosomicides|mesh-ancestor
64406093|NCT01594931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64406094|NCT01594931|Anthelmintics|anthelmintics|mesh-ancestor
64406095|NCT03045185|Metronidazole|metronidazole|mesh-list
64406096|NCT03045185|Ciprofloxacin|ciprofloxacin|mesh-list
64406097|NCT03045185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64406098|NCT03045185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64406099|NCT03045185|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64406100|NCT03045185|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64406101|NCT03045185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64406102|NCT03045185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64406103|NCT03045185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406104|NCT03045185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406123|NCT04341467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64406124|NCT04341467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64406125|NCT04341467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64406126|NCT04341467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64406127|NCT04341467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406128|NCT04341467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64406129|NCT04341467|Serotonin Agents|serotonin agents|mesh-ancestor
64406130|NCT04341467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64406131|NCT04341467|Dopamine Agents|dopamine agents|mesh-ancestor
64406132|NCT04341467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64406133|NCT04341467|Antidepressive Agents|antidepressive agents|mesh-ancestor
64406134|NCT04872881|Fentanyl|fentanyl|mesh-list
64406135|NCT04872881|Propofol|propofol|mesh-list
64406137|NCT04872881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64406138|NCT04872881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64406139|NCT04872881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406140|NCT04872881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64406141|NCT04872881|Anesthetics, General|anesthetics, general|mesh-ancestor
64406142|NCT04872881|Anesthetics|anesthetics|mesh-ancestor
64406143|NCT04872881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64406144|NCT04872881|Narcotics|narcotics|mesh-ancestor
64406145|NCT04872881|Analgesics|analgesics|mesh-ancestor
64406146|NCT04872881|Sensory System Agents|sensory system agents|mesh-ancestor
64406147|NCT04872881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64323496|NCT02262637|Telmisartan|telmisartan|mesh-list
64515145|NCT04678336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64515146|NCT04678336|Alkylating Agents|alkylating agents|mesh-ancestor
64515147|NCT04678336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515148|NCT04678336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515149|NCT04678336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64515150|NCT03195478|Nivolumab|nivolumab|mesh-list
64515151|NCT03195478|Ipilimumab|ipilimumab|mesh-list
64406148|NCT04872881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64406149|NCT04872881|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64406150|NCT04872881|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64406151|NCT04872881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64406152|NCT03044873|BMS-986165|bms-986165|mesh-list
64406153|NCT03044873|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64406154|NCT03044873|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64406155|NCT03044873|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64406156|NCT03044873|Antimetabolites|antimetabolites|mesh-ancestor
64406157|NCT03044873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406158|NCT03044873|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64406159|NCT03044873|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64406160|NCT03044873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406161|NCT03044873|Dermatologic Agents|dermatologic agents|mesh-ancestor
64406162|NCT03044873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64406164|NCT03044795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64406165|NCT03044795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406166|NCT03044795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406167|NCT03044795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406168|NCT04341155|Dexamethasone|dexamethasone|mesh-list
64406169|NCT04341155|Dexamethasone acetate|dexamethasone acetate|mesh-list
64406170|NCT04341155|BB 1101|bb 1101|mesh-list
64406171|NCT04341155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64406172|NCT04341155|Antiemetics|antiemetics|mesh-ancestor
64406173|NCT04341155|Autonomic Agents|autonomic agents|mesh-ancestor
64406174|NCT04341155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64406205|NCT04865653|Hallucinogens|hallucinogens|mesh-ancestor
64406206|NCT04865653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406207|NCT04865653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64406208|NCT04865653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64406209|NCT04865653|Serotonin Agents|serotonin agents|mesh-ancestor
64406210|NCT04865653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64406211|NCT04865653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406212|NCT04865653|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64406213|NCT05305183|Alendronate|alendronate|mesh-list
64406214|NCT05305183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64406215|NCT05305183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406216|NCT01668797|Brexpiprazole|brexpiprazole|mesh-list
64406217|NCT01668797|Serotonin Agents|serotonin agents|mesh-ancestor
64406218|NCT01668797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64406219|NCT01668797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406220|NCT01668797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406221|NCT01668797|Dopamine Agonists|dopamine agonists|mesh-ancestor
64406222|NCT01668797|Dopamine Agents|dopamine agents|mesh-ancestor
64406223|NCT05304559|Ketamine|ketamine|mesh-list
64406224|NCT05304559|Esketamine|esketamine|mesh-list
64406225|NCT05304559|Analgesics|analgesics|mesh-ancestor
64406226|NCT05304559|Sensory System Agents|sensory system agents|mesh-ancestor
64406227|NCT05304559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64406228|NCT05304559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406229|NCT05304559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64406230|NCT05304559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64406231|NCT05304559|Anesthetics, General|anesthetics, general|mesh-ancestor
64406232|NCT05304559|Anesthetics|anesthetics|mesh-ancestor
64515152|NCT03195478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64515153|NCT03195478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515154|NCT03195478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64515155|NCT03195478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515157|NCT04607122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64515158|NCT04607122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64515159|NCT04607122|Adrenergic Agents|adrenergic agents|mesh-ancestor
64515160|NCT04607122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64515161|NCT04607122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515162|NCT04607122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64714084|NCT03053401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515163|NCT04607122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64515164|NCT03099382|Docetaxel|docetaxel|mesh-list
64515165|NCT03099382|Irinotecan|irinotecan|mesh-list
64515166|NCT03099382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515167|NCT03099382|Tubulin Modulators|tubulin modulators|mesh-ancestor
64515168|NCT03099382|Antimitotic Agents|antimitotic agents|mesh-ancestor
64515169|NCT03099382|Mitosis Modulators|mitosis modulators|mesh-ancestor
64515170|NCT03099382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515171|NCT03099382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64515172|NCT03099382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64515173|NCT03099382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773100|NCT01457430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773101|NCT01457430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773102|NCT01457430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64773103|NCT01457430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64773104|NCT01457430|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
64773105|NCT01457430|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
64773106|NCT01457430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773107|NCT01457430|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64773108|NCT01457430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64773109|NCT01457430|Immunologic Factors|immunologic factors|mesh-ancestor
64773110|NCT01458990|Omeprazole|omeprazole|mesh-list
64773111|NCT01458990|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64773112|NCT01458990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64515174|NCT04590664|Verteporfin|verteporfin|mesh-list
64515175|NCT04590664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64515176|NCT04590664|Dermatologic Agents|dermatologic agents|mesh-ancestor
64515177|NCT03818776|Durvalumab|durvalumab|mesh-list
64515178|NCT03818776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64515179|NCT03818776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515180|NCT04494412|Zanamivir|zanamivir|mesh-list
64515181|NCT04494412|Antiviral Agents|antiviral agents|mesh-ancestor
64515182|NCT04494412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64515186|NCT03583528|Edotreotide|edotreotide|mesh-list
64515203|NCT03578146|Protease Inhibitors|protease inhibitors|mesh-ancestor
64515204|NCT03578146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515205|NCT03578146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515206|NCT03578146|Anticoagulants|anticoagulants|mesh-ancestor
64515207|NCT04355832|Glucagon|glucagon|mesh-list
64515208|NCT04355832|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64515209|NCT04355832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64515210|NCT04355832|Hormones|hormones|mesh-ancestor
64406233|NCT05304559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64406312|NCT04682743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64406314|NCT04682743|Sensory System Agents|sensory system agents|mesh-ancestor
64406315|NCT04682743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64406316|NCT04682743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406317|NCT04682743|Antipyretics|antipyretics|mesh-ancestor
64406318|NCT04682743|Antiemetics|antiemetics|mesh-ancestor
64406319|NCT04682743|Autonomic Agents|autonomic agents|mesh-ancestor
64406320|NCT04682743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64406321|NCT04682743|Antipruritics|antipruritics|mesh-ancestor
64406322|NCT04682743|Dermatologic Agents|dermatologic agents|mesh-ancestor
64406323|NCT04682743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64406324|NCT04682743|Serotonin Agents|serotonin agents|mesh-ancestor
64406325|NCT04682743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64406326|NCT04682743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406327|NCT04682743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64406328|NCT04682743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64406410|NCT00136435|Hydrocortisone|hydrocortisone|mesh-list
64406411|NCT00136435|Doxorubicin|doxorubicin|mesh-list
64406412|NCT00136435|Methotrexate|methotrexate|mesh-list
64406413|NCT00136435|Vincristine|vincristine|mesh-list
64406414|NCT00136435|Asparaginase|asparaginase|mesh-list
64406415|NCT00136435|Mercaptopurine|mercaptopurine|mesh-list
64406416|NCT00136435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64406417|NCT00136435|Antiemetics|antiemetics|mesh-ancestor
64515211|NCT04355832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64515214|NCT02518594|Progesterone|progesterone|mesh-list
64515215|NCT02518594|Progestins|progestins|mesh-ancestor
64515216|NCT02518594|Hormones|hormones|mesh-ancestor
64515217|NCT02518594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64515218|NCT02518594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515219|NCT01516593|Cytarabine|cytarabine|mesh-list
64406418|NCT00136435|Autonomic Agents|autonomic agents|mesh-ancestor
64406419|NCT00136435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64406420|NCT00136435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406421|NCT00136435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64406422|NCT00136435|Glucocorticoids|glucocorticoids|mesh-ancestor
64406423|NCT00136435|Hormones|hormones|mesh-ancestor
64406424|NCT00136435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64406425|NCT00136435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64406426|NCT00136435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406427|NCT00136435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64406428|NCT00136435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64406429|NCT00136435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64406469|NCT03044561|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64406470|NCT03044561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64406471|NCT03044561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406472|NCT03044561|Urological Agents|urological agents|mesh-ancestor
64406473|NCT02455141|Cyclophosphamide|cyclophosphamide|mesh-list
64406474|NCT02455141|Carboplatin|carboplatin|mesh-list
64406475|NCT02455141|Epirubicin|epirubicin|mesh-list
64406476|NCT02455141|Taxane|taxane|mesh-list
64406477|NCT02455141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64406478|NCT02455141|Immunologic Factors|immunologic factors|mesh-ancestor
64406479|NCT02455141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406480|NCT02455141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64406481|NCT02455141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64406482|NCT02455141|Alkylating Agents|alkylating agents|mesh-ancestor
64406483|NCT02455141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406484|NCT02455141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406485|NCT02455141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64406486|NCT02455141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64406487|NCT02455141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64406488|NCT02455141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64406489|NCT02455141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773164|NCT01468584|Antimetabolites|antimetabolites|mesh-ancestor
64406490|NCT03044639|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
64406491|NCT03044639|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64406492|NCT03044639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64406493|NCT02439385|Curcumin|curcumin|mesh-list
64406494|NCT02439385|Bevacizumab|bevacizumab|mesh-list
64406521|NCT03104959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406524|NCT03044171|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64406525|NCT03044171|Fluorides|fluorides|mesh-list
64406526|NCT03044171|Sodium Fluoride|sodium fluoride|mesh-list
64406527|NCT03044171|Cariostatic Agents|cariostatic agents|mesh-ancestor
64406528|NCT03044171|Protective Agents|protective agents|mesh-ancestor
64406529|NCT03044171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406530|NCT03044171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64406531|NCT03044171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64406532|NCT03998839|Pyrimethamine|pyrimethamine|mesh-list
64406533|NCT03998839|Sulfadoxine|sulfadoxine|mesh-list
64406534|NCT03998839|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64406535|NCT03998839|Antimalarials|antimalarials|mesh-ancestor
64406536|NCT03998839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64773287|NCT01508832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406537|NCT03998839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64406538|NCT03998839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64406539|NCT03998839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64406540|NCT03998839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515221|NCT01516593|Antimetabolites|antimetabolites|mesh-ancestor
64515222|NCT01516593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515223|NCT01516593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515224|NCT01516593|Antiviral Agents|antiviral agents|mesh-ancestor
64515225|NCT01516593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64515226|NCT01516593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64515227|NCT01516593|Immunologic Factors|immunologic factors|mesh-ancestor
64515228|NCT01516593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515229|NCT04273932|Lithium Carbonate|lithium carbonate|mesh-list
64406541|NCT03998839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406542|NCT03998839|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64406543|NCT03998839|Renal Agents|renal agents|mesh-ancestor
64406544|NCT04856969|Dapagliflozin|dapagliflozin|mesh-list
64406545|NCT04856969|Olmesartan|olmesartan|mesh-list
64406546|NCT04856969|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64773360|NCT01520454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64773361|NCT01520454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64773362|NCT01520454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64773363|NCT01520688|Fluticasone|fluticasone|mesh-list
64773364|NCT01520688|Xhance|xhance|mesh-list
64773365|NCT01520688|Budesonide|budesonide|mesh-list
64773366|NCT01520688|Beclomethasone|beclomethasone|mesh-list
64773367|NCT01520688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64773368|NCT01520688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64773369|NCT01520688|Autonomic Agents|autonomic agents|mesh-ancestor
64773370|NCT01520688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773371|NCT01520688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773372|NCT01520688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64773373|NCT01520688|Respiratory System Agents|respiratory system agents|mesh-ancestor
64773374|NCT01520688|Dermatologic Agents|dermatologic agents|mesh-ancestor
64773375|NCT01520688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64773376|NCT01520688|Glucocorticoids|glucocorticoids|mesh-ancestor
64773377|NCT01520688|Hormones|hormones|mesh-ancestor
64773378|NCT01520688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64323509|NCT03301051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323510|NCT02606305|Bevacizumab|bevacizumab|mesh-list
64323511|NCT02606305|Pembrolizumab|pembrolizumab|mesh-list
64323512|NCT02606305|Carboplatin|carboplatin|mesh-list
64323513|NCT02606305|Doxorubicin|doxorubicin|mesh-list
64773379|NCT01521546|Eplerenone|eplerenone|mesh-list
64773380|NCT01521546|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64773381|NCT01521546|Hormone Antagonists|hormone antagonists|mesh-ancestor
64773385|NCT01521546|Diuretics|diuretics|mesh-ancestor
64406547|NCT04856969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406548|NCT04856969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64406549|NCT04856969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406550|NCT04856969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64406551|NCT04856969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64406552|NCT04856969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64406553|NCT04108039|Cetrorelix|cetrorelix|mesh-list
64406554|NCT04108039|Progesterone|progesterone|mesh-list
64406555|NCT04108039|Ganirelix|ganirelix|mesh-list
64406556|NCT04108039|Progestins|progestins|mesh-ancestor
64406557|NCT04108039|Hormones|hormones|mesh-ancestor
64406558|NCT04108039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64406559|NCT04108039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406560|NCT04108039|Hormone Antagonists|hormone antagonists|mesh-ancestor
64406600|NCT01371981|Podophyllotoxin|podophyllotoxin|mesh-list
64406601|NCT01371981|Daunorubicin|daunorubicin|mesh-list
64406602|NCT01371981|Mitoxantrone|mitoxantrone|mesh-list
64406603|NCT01371981|Etoposide phosphate|etoposide phosphate|mesh-list
64406604|NCT01371981|Bortezomib|bortezomib|mesh-list
64406605|NCT01371981|Sorafenib|sorafenib|mesh-list
64406606|NCT01371981|Asparaginase|asparaginase|mesh-list
64406607|NCT01371981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64406608|NCT01371981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406609|NCT01371981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64406610|NCT01371981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64406611|NCT01371981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406635|NCT02845453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64406636|NCT02845453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406637|NCT01799629|Glycerol|glycerol|mesh-list
64773546|NCT01556724|Anesthetics|anesthetics|mesh-ancestor
64773547|NCT01556724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64773548|NCT01556724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773549|NCT01556724|Sensory System Agents|sensory system agents|mesh-ancestor
64773550|NCT01556724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773551|NCT01558128|Amiodarone|amiodarone|mesh-list
64542208|NCT05366101|Valsartan|valsartan|mesh-list
64773552|NCT01558128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64773553|NCT01558128|Vasodilator Agents|vasodilator agents|mesh-ancestor
64773554|NCT01558128|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64773555|NCT01558128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64773556|NCT01558128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773557|NCT01558128|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64773558|NCT01558128|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64773559|NCT01558128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64406638|NCT01799629|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64406639|NCT01799629|Protective Agents|protective agents|mesh-ancestor
64406640|NCT01799629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406641|NCT01597375|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64406642|NCT01597375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64406643|NCT03044093|Misoprostol|misoprostol|mesh-list
64406644|NCT03044093|Mifepristone|mifepristone|mesh-list
64406645|NCT03044093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64406646|NCT03044093|Abortifacient Agents|abortifacient agents|mesh-ancestor
64406652|NCT03044093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64406653|NCT03044093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64406654|NCT03044093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64406655|NCT03044093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64406656|NCT03044093|Contraceptive Agents|contraceptive agents|mesh-ancestor
64406657|NCT03044093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64406658|NCT03044093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64406659|NCT03044093|Hormone Antagonists|hormone antagonists|mesh-ancestor
64618833|NCT01106833|Immunologic Factors|immunologic factors|mesh-ancestor
64406660|NCT03044093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64406661|NCT03044093|Luteolytic Agents|luteolytic agents|mesh-ancestor
64515230|NCT04273932|Antidepressive Agents|antidepressive agents|mesh-ancestor
64515231|NCT04273932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64515232|NCT04273932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323514|NCT02606305|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64323515|NCT02606305|Maytansine|maytansine|mesh-list
64323516|NCT02606305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64515233|NCT04273932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515234|NCT04273932|Antimanic Agents|antimanic agents|mesh-ancestor
64515235|NCT04273932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64515236|NCT04273932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64515237|NCT04273932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515239|NCT02042391|Prednisone|prednisone|mesh-list
64515240|NCT02042391|Cyclophosphamide|cyclophosphamide|mesh-list
64515241|NCT02042391|Rituximab|rituximab|mesh-list
64515242|NCT02042391|Oxaliplatin|oxaliplatin|mesh-list
64515243|NCT02042391|Doxorubicin|doxorubicin|mesh-list
64515244|NCT02042391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64515245|NCT02042391|Vincristine|vincristine|mesh-list
64515246|NCT02042391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64515247|NCT02042391|Immunologic Factors|immunologic factors|mesh-ancestor
64406662|NCT03044093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64406663|NCT03044093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64406664|NCT01553071|Fenretinide|fenretinide|mesh-list
64406665|NCT01553071|Safingol|safingol|mesh-list
64406699|NCT04380545|Immunologic Factors|immunologic factors|mesh-ancestor
64406700|NCT04380545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406701|NCT04380545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64773760|NCT05360784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64773761|NCT05360784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773762|NCT05360784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773763|NCT05672784|Acetaminophen|acetaminophen|mesh-list
64773764|NCT05672784|Meloxicam|meloxicam|mesh-list
64773765|NCT05672784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64773766|NCT05672784|Analgesics|analgesics|mesh-ancestor
64385196|NCT05482113|Bupivacaine|bupivacaine|mesh-list
64406702|NCT04380545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64406703|NCT04380545|Antiviral Agents|antiviral agents|mesh-ancestor
64406704|NCT04380545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64406705|NCT03041207|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64406706|NCT03041207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64406707|NCT03101995|Gemcitabine|gemcitabine|mesh-list
64406751|NCT05430841|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64406767|NCT04847921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64406768|NCT04847687|Methylprednisolone|methylprednisolone|mesh-list
64406769|NCT04847687|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64406770|NCT04847687|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64406772|NCT04847687|Prednisolone acetate|prednisolone acetate|mesh-list
64406773|NCT04847687|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64406774|NCT04847687|Prednisolone phosphate|prednisolone phosphate|mesh-list
64773807|NCT05672394|Sympathomimetics|sympathomimetics|mesh-ancestor
64773808|NCT05672394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64773809|NCT05607342|SR 142801|sr 142801|mesh-list
64773810|NCT05607342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64773811|NCT05607342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64773812|NCT05607342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64773813|NCT05607342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773814|NCT05607342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64773815|NCT05379972|Pembrolizumab|pembrolizumab|mesh-list
64773816|NCT05379972|Olaparib|olaparib|mesh-list
64773817|NCT05379972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64773818|NCT05379972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773819|NCT05379972|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64773820|NCT05379972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773821|NCT05379972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773822|NCT05326464|Tofacitinib|tofacitinib|mesh-list
64773823|NCT05326464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64773824|NCT05326464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773834|NCT04518228|Ritonavir|ritonavir|mesh-list
64406775|NCT04847687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64406776|NCT04847687|Antiemetics|antiemetics|mesh-ancestor
64406777|NCT04847687|Autonomic Agents|autonomic agents|mesh-ancestor
64406778|NCT04847687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64406779|NCT04847687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406780|NCT04847687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64406781|NCT04847687|Glucocorticoids|glucocorticoids|mesh-ancestor
64406782|NCT04847687|Hormones|hormones|mesh-ancestor
64406783|NCT04847687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64406784|NCT04847687|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64406785|NCT04847687|Protective Agents|protective agents|mesh-ancestor
64406786|NCT04847687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64406787|NCT04847687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406793|NCT03103867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64406794|NCT03103867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406795|NCT04847375|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64406796|NCT04847375|Respiratory System Agents|respiratory system agents|mesh-ancestor
64406797|NCT04737343|Azathioprine|azathioprine|mesh-list
64773851|NCT04518228|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64773852|NCT04518228|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64773853|NCT04518228|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64773854|NCT04518228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64773855|NCT04518228|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64773856|NCT04518228|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64773858|NCT03729258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64773859|NCT03729258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64773860|NCT03729258|Antiviral Agents|antiviral agents|mesh-ancestor
64773861|NCT03729258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64773862|NCT03729258|Dopamine Agents|dopamine agents|mesh-ancestor
64773863|NCT03729258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64773871|NCT03355170|Lansoprazole|lansoprazole|mesh-list
64406798|NCT04737343|Leflunomide|leflunomide|mesh-list
64406799|NCT04737343|Antimetabolites|antimetabolites|mesh-ancestor
64406800|NCT04737343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406801|NCT04737343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64406802|NCT04737343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515248|NCT02042391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515249|NCT02042391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64515250|NCT02042391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64515251|NCT02042391|Alkylating Agents|alkylating agents|mesh-ancestor
64515252|NCT02042391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773904|NCT00221598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64773905|NCT05120076|Dexamethasone|dexamethasone|mesh-list
64773906|NCT05120076|Dexamethasone acetate|dexamethasone acetate|mesh-list
64773907|NCT05120076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64773908|NCT05120076|Antiemetics|antiemetics|mesh-ancestor
64773909|NCT05120076|Autonomic Agents|autonomic agents|mesh-ancestor
64773910|NCT05120076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773911|NCT05120076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773912|NCT05120076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64773913|NCT05120076|Glucocorticoids|glucocorticoids|mesh-ancestor
64773914|NCT05120076|Hormones|hormones|mesh-ancestor
64773915|NCT05120076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64773916|NCT05120076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64773917|NCT05120076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773918|NCT05094804|Docetaxel|docetaxel|mesh-list
64773919|NCT05094804|Cemiplimab|cemiplimab|mesh-list
64515253|NCT02042391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515254|NCT02042391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64618842|NCT00957359|Niacin|niacin|mesh-list
64515255|NCT02042391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64515256|NCT02042391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64515257|NCT02042391|Glucocorticoids|glucocorticoids|mesh-ancestor
64515258|NCT02042391|Hormones|hormones|mesh-ancestor
64515259|NCT02042391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64515260|NCT02042391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64515261|NCT02042391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64406803|NCT04737343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64406804|NCT04737343|Immunologic Factors|immunologic factors|mesh-ancestor
64406805|NCT04737343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406806|NCT04737343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64406807|NCT04737343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406808|NCT05579769|Cyclosporine|cyclosporine|mesh-list
64406809|NCT05579769|Cyclophosphamide|cyclophosphamide|mesh-list
64406811|NCT05579769|Thiotepa|thiotepa|mesh-list
64406812|NCT05579769|Methotrexate|methotrexate|mesh-list
64406813|NCT05579769|Fludarabine|fludarabine|mesh-list
64406814|NCT05579769|Cyclosporins|cyclosporins|mesh-list
64406815|NCT05579769|Thymoglobulin|thymoglobulin|mesh-list
64406816|NCT05579769|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64406817|NCT05579769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64406818|NCT05579769|Immunologic Factors|immunologic factors|mesh-ancestor
64406819|NCT05579769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406845|NCT05430217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64406846|NCT05430217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64406847|NCT05430217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64406848|NCT05430217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406849|NCT05430217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64406850|NCT05430217|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64406852|NCT05430217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64406853|NCT05430217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406854|NCT03103555|Cyclophosphamide|cyclophosphamide|mesh-list
64406855|NCT03103555|Bortezomib|bortezomib|mesh-list
64406856|NCT03103555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64406857|NCT03103555|Immunologic Factors|immunologic factors|mesh-ancestor
64406858|NCT03103555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406859|NCT03103555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64406860|NCT03103555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64406880|NCT04846673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64406881|NCT04846673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64406882|NCT04846673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64406883|NCT04846673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64406884|NCT04846673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64406885|NCT04846673|Antioxidants|antioxidants|mesh-ancestor
64406886|NCT04846673|Protective Agents|protective agents|mesh-ancestor
64406902|NCT04498273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406904|NCT04498273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64406905|NCT04498273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406906|NCT04498273|Antipyretics|antipyretics|mesh-ancestor
64406907|NCT04498273|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64406908|NCT04498273|Antithrombins|antithrombins|mesh-ancestor
64406909|NCT04498273|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64406910|NCT04498273|Protease Inhibitors|protease inhibitors|mesh-ancestor
64515262|NCT02042391|Antimetabolites|antimetabolites|mesh-ancestor
64515263|NCT02042391|Antiviral Agents|antiviral agents|mesh-ancestor
64515264|NCT02042391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64385662|NCT02548455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64515265|NCT02042391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64515266|NCT02042391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64515267|NCT02042391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64515268|NCT02042391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515269|NCT02042391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64515270|NCT02042391|Tubulin Modulators|tubulin modulators|mesh-ancestor
64515271|NCT02042391|Antimitotic Agents|antimitotic agents|mesh-ancestor
64515272|NCT02042391|Mitosis Modulators|mitosis modulators|mesh-ancestor
64515273|NCT02461836|Gemcitabine|gemcitabine|mesh-list
64515274|NCT02461836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64515275|NCT02461836|Antimetabolites|antimetabolites|mesh-ancestor
64774228|NCT01640340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64774229|NCT01640340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64774230|NCT01640340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774232|NCT01640340|Dermatologic Agents|dermatologic agents|mesh-ancestor
64774233|NCT01640340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64774234|NCT01640340|Serotonin Agents|serotonin agents|mesh-ancestor
64515276|NCT02461836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515277|NCT02461836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406912|NCT01660971|Gemcitabine|gemcitabine|mesh-list
64406913|NCT01660971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64406914|NCT01660971|Dasatinib|dasatinib|mesh-list
64406915|NCT01660971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64406916|NCT01660971|Antimetabolites|antimetabolites|mesh-ancestor
64406925|NCT01660971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64406926|NCT04853615|Empagliflozin|empagliflozin|mesh-list
64774315|NCT01652040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64774316|NCT01652040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774317|NCT01652040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64774320|NCT01652976|Leucovorin|leucovorin|mesh-list
64406927|NCT04853615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64406928|NCT04853615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406929|NCT04853615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64406930|NCT04853615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406931|NCT05573607|Chromium|chromium|mesh-list
64406932|NCT05573607|Trace Elements|trace elements|mesh-ancestor
64406933|NCT05573607|Micronutrients|micronutrients|mesh-ancestor
64406934|NCT05573607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406935|NCT04435483|Acalabrutinib|acalabrutinib|mesh-list
64406936|NCT04435483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406937|NCT04862117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64406938|NCT04862117|Cholinergic Agents|cholinergic agents|mesh-list
64406939|NCT04862117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64406940|NCT04862117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406941|NCT04862117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774434|NCT01692756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64774435|NCT01692756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64774436|NCT01692756|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64774437|NCT01692756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64774438|NCT01692756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64774439|NCT01692756|Glucocorticoids|glucocorticoids|mesh-ancestor
64774440|NCT01692756|Hormones|hormones|mesh-ancestor
64774441|NCT01692756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64774442|NCT01692756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774443|NCT01692756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64774444|NCT01692756|Immunologic Factors|immunologic factors|mesh-ancestor
64774445|NCT01692756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64543161|NCT04766359|Paclitaxel|paclitaxel|mesh-list
64774446|NCT01692756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774447|NCT01695330|Bortezomib|bortezomib|mesh-list
64774448|NCT01695330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774449|NCT01701102|Fentanyl|fentanyl|mesh-list
64774450|NCT01701102|Mepivacaine|mepivacaine|mesh-list
64406942|NCT03040817|Esomeprazole|esomeprazole|mesh-list
64406943|NCT03040817|Mosapride|mosapride|mesh-list
64406944|NCT03040817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406945|NCT03040817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64406946|NCT03040817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64406947|NCT03040817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64406948|NCT03040817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406949|NCT03040817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64406950|NCT03040817|Serotonin Agents|serotonin agents|mesh-ancestor
64406951|NCT03040817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64406952|NCT03040817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406953|NCT04853069|Estradiol|estradiol|mesh-list
64406954|NCT04853069|Estrogens|estrogens|mesh-ancestor
64407000|NCT05395065|Listerine|listerine|mesh-list
64407001|NCT05395065|Fluorides|fluorides|mesh-list
64407002|NCT05395065|Sodium Fluoride|sodium fluoride|mesh-list
64407003|NCT05395065|Fluorides, Topical|fluorides, topical|mesh-list
64515279|NCT02461836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64515280|NCT02461836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515281|NCT02461836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64515282|NCT02461836|Immunologic Factors|immunologic factors|mesh-ancestor
64515283|NCT02461836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515284|NCT02034981|Crizotinib|crizotinib|mesh-list
64515285|NCT02034981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515286|NCT02034981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64515287|NCT02034981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515288|NCT02034981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515289|NCT01986946|Hydromorphone|hydromorphone|mesh-list
64515290|NCT01986946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64515291|NCT01986946|Narcotics|narcotics|mesh-ancestor
64515292|NCT01986946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64515293|NCT01986946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515294|NCT01986946|Analgesics|analgesics|mesh-ancestor
64515295|NCT01986946|Sensory System Agents|sensory system agents|mesh-ancestor
64515296|NCT01986946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64515297|NCT01504815|Cisplatin|cisplatin|mesh-list
64515298|NCT01504815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515299|NCT01921335|Trastuzumab|trastuzumab|mesh-list
64407004|NCT05395065|Cariostatic Agents|cariostatic agents|mesh-ancestor
64407005|NCT05395065|Protective Agents|protective agents|mesh-ancestor
64407006|NCT05395065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407007|NCT05395065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64407008|NCT05395065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64407009|NCT02710669|Propafenone|propafenone|mesh-list
64407019|NCT05392959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407020|NCT04851977|Vaccines|vaccines|mesh-list
64407021|NCT04851977|Immunologic Factors|immunologic factors|mesh-ancestor
64407022|NCT04851977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323538|NCT01662986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64323539|NCT01662986|Respiratory System Agents|respiratory system agents|mesh-ancestor
64323540|NCT01662986|Parasympatholytics|parasympatholytics|mesh-ancestor
64323541|NCT01662986|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64323542|NCT01662986|Cholinergic Agents|cholinergic agents|mesh-ancestor
64774485|NCT01706952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64774486|NCT01706952|Respiratory System Agents|respiratory system agents|mesh-ancestor
64774487|NCT01706952|Mydriatics|mydriatics|mesh-ancestor
64774488|NCT01706952|Sympathomimetics|sympathomimetics|mesh-ancestor
64774498|NCT01707420|Gabapentin|gabapentin|mesh-list
64407023|NCT05370495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64407024|NCT05370495|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64407025|NCT05370417|Fluorides|fluorides|mesh-list
64407026|NCT05370417|Cariostatic Agents|cariostatic agents|mesh-ancestor
64407027|NCT05370417|Protective Agents|protective agents|mesh-ancestor
64407028|NCT05370417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407029|NCT05369793|Thioctic Acid|thioctic acid|mesh-list
64407030|NCT05369793|Antioxidants|antioxidants|mesh-ancestor
64407031|NCT05369793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407032|NCT05369793|Protective Agents|protective agents|mesh-ancestor
64774503|NCT01707420|Anticonvulsants|anticonvulsants|mesh-ancestor
64407033|NCT05369793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407034|NCT05369793|Vitamin B Complex|vitamin b complex|mesh-ancestor
64407035|NCT05369793|Vitamins|vitamins|mesh-ancestor
64407036|NCT05369793|Micronutrients|micronutrients|mesh-ancestor
64407037|NCT04844333|Anesthetics|anesthetics|mesh-list
64407038|NCT04844333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64407039|NCT04844333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407040|NCT04423185|Atezolizumab|atezolizumab|mesh-list
64407041|NCT04423185|Imatinib Mesylate|imatinib mesylate|mesh-list
64407042|NCT04423185|Palbociclib|palbociclib|mesh-list
64407043|NCT04423185|Niraparib|niraparib|mesh-list
64407044|NCT04423185|Vemurafenib|vemurafenib|mesh-list
64407045|NCT04423185|Crizotinib|crizotinib|mesh-list
64407046|NCT04423185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515300|NCT01921335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64515301|NCT01921335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515302|NCT02427724|Lidocaine|lidocaine|mesh-list
64515303|NCT02427724|Tetracaine|tetracaine|mesh-list
64515304|NCT02427724|Prilocaine|prilocaine|mesh-list
64515305|NCT02427724|Anesthetics, Local|anesthetics, local|mesh-list
64515306|NCT02427724|Anesthetics|anesthetics|mesh-list
64515307|NCT02427724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64515308|NCT02427724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515309|NCT02427724|Sensory System Agents|sensory system agents|mesh-ancestor
64515310|NCT02427724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64515311|NCT02427724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64515312|NCT02427724|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64515313|NCT02427724|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64515314|NCT02427724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64515315|NCT02427724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515316|NCT02337634|Silymarin|silymarin|mesh-list
64515317|NCT02337634|Antioxidants|antioxidants|mesh-ancestor
64515318|NCT02337634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515319|NCT02337634|Protective Agents|protective agents|mesh-ancestor
64515320|NCT02337634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515321|NCT01908777|Cytarabine|cytarabine|mesh-list
64515322|NCT01908777|Etoposide|etoposide|mesh-list
64515323|NCT01908777|Melphalan|melphalan|mesh-list
64515324|NCT01908777|Carmustine|carmustine|mesh-list
64407047|NCT04423185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64407048|NCT04423185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407057|NCT05414877|Autonomic Agents|autonomic agents|mesh-ancestor
64407058|NCT05414877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407059|NCT05414877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407060|NCT05414877|Sympathomimetics|sympathomimetics|mesh-ancestor
64407061|NCT05414877|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64407062|NCT05414877|Nasal Decongestants|nasal decongestants|mesh-ancestor
64407063|NCT05414877|Respiratory System Agents|respiratory system agents|mesh-ancestor
64407064|NCT05414877|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64407065|NCT05414877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64407066|NCT05414877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64407067|NCT05414877|Adrenergic Agents|adrenergic agents|mesh-ancestor
64407068|NCT05414877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64407069|NCT05414877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407070|NCT05414877|Protective Agents|protective agents|mesh-ancestor
64407071|NCT05414877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64407072|NCT04850885|Dexamethasone|dexamethasone|mesh-list
64407073|NCT04850885|Lidocaine|lidocaine|mesh-list
64407074|NCT04850885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64407075|NCT04850885|Antiemetics|antiemetics|mesh-ancestor
64407076|NCT04850885|Autonomic Agents|autonomic agents|mesh-ancestor
64407077|NCT04850885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407078|NCT04850885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407079|NCT04850885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64407080|NCT04850885|Glucocorticoids|glucocorticoids|mesh-ancestor
64515325|NCT01908777|Romidepsin|romidepsin|mesh-list
64515326|NCT01908777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64515327|NCT01908777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774648|NCT04068948|Meperidine|meperidine|mesh-list
64774667|NCT04068948|Sensory System Agents|sensory system agents|mesh-ancestor
64774668|NCT04068948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64515328|NCT01908777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64515329|NCT01908777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64515330|NCT01908777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515331|NCT01908777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515332|NCT01908777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64407081|NCT04850885|Hormones|hormones|mesh-ancestor
64407082|NCT04850885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64407107|NCT04850417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407109|NCT04850417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64407110|NCT04850417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407111|NCT04850417|Antipyretics|antipyretics|mesh-ancestor
64407112|NCT04850417|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64407113|NCT04850417|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64407114|NCT04850417|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64407130|NCT04850261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64407131|NCT04850261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407132|NCT04843553|Niacinamide|niacinamide|mesh-list
64407134|NCT04843553|Nicotinic Acids|nicotinic acids|mesh-list
64407135|NCT04843553|Vitamins|vitamins|mesh-ancestor
64407136|NCT04843553|Micronutrients|micronutrients|mesh-ancestor
64407137|NCT04843553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407138|NCT04843553|Vitamin B Complex|vitamin b complex|mesh-ancestor
64407139|NCT04843553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64407140|NCT04843553|Antimetabolites|antimetabolites|mesh-ancestor
64407141|NCT04843553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407142|NCT04843553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64407143|NCT04843553|Vasodilator Agents|vasodilator agents|mesh-ancestor
64407144|NCT02684461|Paclitaxel|paclitaxel|mesh-list
64407145|NCT02684461|Pembrolizumab|pembrolizumab|mesh-list
64407167|NCT05373199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407168|NCT03039101|Montelukast|montelukast|mesh-list
64407169|NCT03039101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64407170|NCT03039101|Respiratory System Agents|respiratory system agents|mesh-ancestor
64407171|NCT03039101|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64407172|NCT03039101|Hormone Antagonists|hormone antagonists|mesh-ancestor
64407173|NCT03039101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64407174|NCT03039101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407175|NCT03039101|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64407186|NCT03103399|Benserazide|benserazide|mesh-list
64407187|NCT03103399|Dopa Decarboxylase|dopa decarboxylase|mesh-list
64407188|NCT03103399|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
64407189|NCT03103399|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64407190|NCT03103399|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64407191|NCT03103399|Dopamine Agents|dopamine agents|mesh-ancestor
64407192|NCT03103399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64407193|NCT03103399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407194|NCT03103399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407195|NCT03103399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407196|NCT03103399|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64407197|NCT05357833|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64407198|NCT05357833|Hematinics|hematinics|mesh-ancestor
64407199|NCT05357833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64407200|NCT05357833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64407201|NCT03043157|Rocuronium|rocuronium|mesh-list
64407202|NCT03043157|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64407203|NCT03043157|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64407204|NCT03043157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64407205|NCT03043157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407212|NCT05332795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330261|NCT02376075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64330280|NCT03532087|Denosumab|denosumab|mesh-list
64407214|NCT04370483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515333|NCT01908777|Antimetabolites|antimetabolites|mesh-ancestor
64515334|NCT01908777|Antiviral Agents|antiviral agents|mesh-ancestor
64515335|NCT01908777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64515336|NCT01908777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64515337|NCT01908777|Immunologic Factors|immunologic factors|mesh-ancestor
64515338|NCT01908777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515339|NCT01908777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64515340|NCT01908777|Alkylating Agents|alkylating agents|mesh-ancestor
64515341|NCT01908777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64515342|NCT01908777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64515343|NCT03437200|Nivolumab|nivolumab|mesh-list
64515344|NCT03437200|Ipilimumab|ipilimumab|mesh-list
64515345|NCT03437200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64515346|NCT03437200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64407215|NCT04370483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407216|NCT04370483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64407217|NCT04370483|Immunologic Factors|immunologic factors|mesh-ancestor
64407218|NCT04370483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407219|NCT04861103|Enoxaparin|enoxaparin|mesh-list
64407220|NCT04861103|Anticoagulants|anticoagulants|mesh-ancestor
64407221|NCT04861103|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64407222|NCT04861103|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64407223|NCT04861103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407225|NCT03042923|Lactulose|lactulose|mesh-list
64407226|NCT03042923|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64332105|NCT03816332|Hormones|hormones|mesh-ancestor
64407227|NCT03042923|Diuretics|diuretics|mesh-ancestor
64407228|NCT03042923|Natriuretic Agents|natriuretic agents|mesh-ancestor
64407229|NCT03042923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332109|NCT03816332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64407230|NCT03042923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64407231|NCT04429295|Vaccines|vaccines|mesh-list
64407232|NCT04429295|Immunologic Factors|immunologic factors|mesh-ancestor
64407233|NCT04429295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407234|NCT05258851|Ceftazidime|ceftazidime|mesh-list
64407235|NCT05258851|Colistin|colistin|mesh-list
64407236|NCT05258851|Avibactam|avibactam|mesh-list
64407237|NCT05258851|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
64407238|NCT05258851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64407239|NCT05258851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64407240|NCT05258851|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64407241|NCT05258851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407250|NCT03043001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64407252|NCT04843007|Pemetrexed|pemetrexed|mesh-list
64407253|NCT04843007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64407254|NCT04843007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407255|NCT04843007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407256|NCT04843007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64407257|NCT04843007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64407258|NCT04840745|Leuprolide|leuprolide|mesh-list
64407259|NCT04840745|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64407260|NCT04840745|Fertility Agents|fertility agents|mesh-ancestor
64407261|NCT04840745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64407262|NCT04840745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407263|NCT04840745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64407264|NCT04840745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64407265|NCT05072899|Hyaluronic Acid|hyaluronic acid|mesh-list
64407303|NCT04884139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64407304|NCT04884139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407305|NCT04884139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407306|NCT04884139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64515347|NCT03437200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64515348|NCT03437200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515349|NCT01903473|Sirolimus|sirolimus|mesh-list
64515350|NCT01903473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64515351|NCT01903473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64515352|NCT01903473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64515353|NCT01903473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515354|NCT01903473|Antifungal Agents|antifungal agents|mesh-ancestor
64515355|NCT01903473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64515356|NCT01903473|Immunologic Factors|immunologic factors|mesh-ancestor
64515357|NCT01903473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515358|NCT02715726|Atorvastatin|atorvastatin|mesh-list
64515359|NCT02715726|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64407307|NCT04884139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64407308|NCT04884139|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64407309|NCT04884139|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64337492|NCT02236169|Cholinergic Agents|cholinergic agents|mesh-ancestor
64337495|NCT02236169|Anesthetics|anesthetics|mesh-ancestor
64407339|NCT04880785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407341|NCT04880785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64407342|NCT04880785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64407343|NCT04880785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64407344|NCT04880785|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64407345|NCT04880785|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64407346|NCT02514031|Gemcitabine|gemcitabine|mesh-list
64407347|NCT02514031|Beta-lapachone|beta-lapachone|mesh-list
64407348|NCT02514031|Paclitaxel|paclitaxel|mesh-list
64407349|NCT02514031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64407350|NCT02514031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64407351|NCT02514031|Tubulin Modulators|tubulin modulators|mesh-ancestor
64407352|NCT02514031|Antimitotic Agents|antimitotic agents|mesh-ancestor
64407353|NCT02514031|Mitosis Modulators|mitosis modulators|mesh-ancestor
64407354|NCT02514031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407355|NCT02514031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64407356|NCT02514031|Antimetabolites|antimetabolites|mesh-ancestor
64407357|NCT02514031|Antiviral Agents|antiviral agents|mesh-ancestor
64407358|NCT02514031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64407359|NCT02514031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338090|NCT02267057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64338091|NCT02267057|Analgesics|analgesics|mesh-ancestor
64338092|NCT02267057|Sensory System Agents|sensory system agents|mesh-ancestor
64338093|NCT02267057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64338094|NCT02267057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338095|NCT02267057|Antipyretics|antipyretics|mesh-ancestor
64338096|NCT02267057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64338097|NCT02267057|Narcotics|narcotics|mesh-ancestor
64338098|NCT02267057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64338099|NCT02267057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64338100|NCT05260541|Pramoxine|pramoxine|mesh-list
64338101|NCT05260541|Anesthetics, Local|anesthetics, local|mesh-ancestor
64338102|NCT05260541|Anesthetics|anesthetics|mesh-ancestor
64338158|NCT05174507|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64338159|NCT05174507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338160|NCT05174507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64338161|NCT05174507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338162|NCT05174507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64338163|NCT01480154|Hydroxychloroquine|hydroxychloroquine|mesh-list
64338164|NCT01480154|Antimalarials|antimalarials|mesh-ancestor
64338165|NCT01480154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64338166|NCT01480154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64407360|NCT02514031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64407361|NCT02514031|Immunologic Factors|immunologic factors|mesh-ancestor
64407362|NCT02514031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407363|NCT02514031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64407364|NCT02514031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64407365|NCT04793815|Pembrolizumab|pembrolizumab|mesh-list
64407366|NCT04793815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64407367|NCT04793815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64407368|NCT04622917|Methylprednisolone|methylprednisolone|mesh-list
64407369|NCT04622917|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64407370|NCT04622917|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64407379|NCT04622917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407380|NCT04622917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64407382|NCT04622917|Hormones|hormones|mesh-ancestor
64407383|NCT04622917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64407384|NCT04622917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64407385|NCT04622917|Protective Agents|protective agents|mesh-ancestor
64407386|NCT04622917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64407387|NCT04622917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64407388|NCT03038477|Durvalumab|durvalumab|mesh-list
64407389|NCT03038477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64407390|NCT03038477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64407391|NCT03038243|Vaccines|vaccines|mesh-list
64407418|NCT03042377|Calcium, Dietary|calcium, dietary|mesh-list
64407419|NCT03042377|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64407420|NCT03042377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64515360|NCT02715726|Simvastatin|simvastatin|mesh-list
64515361|NCT02715726|Ezetimibe|ezetimibe|mesh-list
64515362|NCT02715726|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64515363|NCT02715726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64515364|NCT02715726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64515365|NCT02715726|Antimetabolites|antimetabolites|mesh-ancestor
64515366|NCT02715726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515367|NCT02715726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64515368|NCT02715726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64515369|NCT02715726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515370|NCT02715726|Immunologic Factors|immunologic factors|mesh-ancestor
64515371|NCT02715726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515372|NCT01893567|Clobetasol|clobetasol|mesh-list
64515373|NCT01893567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64515374|NCT01893567|Glucocorticoids|glucocorticoids|mesh-ancestor
64515375|NCT01893567|Hormones|hormones|mesh-ancestor
64515376|NCT01893567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64515377|NCT01893567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515378|NCT01485861|Prednisone|prednisone|mesh-list
64515379|NCT01485861|Prednisolone|prednisolone|mesh-list
64515380|NCT01485861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64515381|NCT01485861|Glucocorticoids|glucocorticoids|mesh-ancestor
64515382|NCT01485861|Hormones|hormones|mesh-ancestor
64515383|NCT01485861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64515384|NCT01485861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515385|NCT01485861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64515386|NCT01485861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515387|NCT04847466|Pembrolizumab|pembrolizumab|mesh-list
64515388|NCT04847466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64515389|NCT04847466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515390|NCT04249596|Tianeptine|tianeptine|mesh-list
64515391|NCT04249596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64407422|NCT03042377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64407423|NCT03042377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407424|NCT03042377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64407425|NCT03042377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64407426|NCT03042377|Antitubercular Agents|antitubercular agents|mesh-ancestor
64407427|NCT04859777|Pembrolizumab|pembrolizumab|mesh-list
64407428|NCT04859777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64407429|NCT04859777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64407430|NCT05562609|Tranexamic Acid|tranexamic acid|mesh-list
64407431|NCT05562609|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64515392|NCT04249596|Antidepressive Agents|antidepressive agents|mesh-ancestor
64515394|NCT01476501|Vitamin D|vitamin d|mesh-list
64515395|NCT01476501|Cholecalciferol|cholecalciferol|mesh-list
64515396|NCT01476501|Vitamins|vitamins|mesh-ancestor
64515397|NCT01476501|Micronutrients|micronutrients|mesh-ancestor
64515398|NCT01476501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515399|NCT01476501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64515400|NCT01476501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64515401|NCT03426124|Fibrinolytic Agents|fibrinolytic agents|mesh-list
64515402|NCT03426124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64515403|NCT03426124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515404|NCT02464020|Vancomycin|vancomycin|mesh-list
64515405|NCT02464020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64515406|NCT02464020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64515407|NCT04756089|Oxytocin|oxytocin|mesh-list
64515408|NCT04756089|Oxytocics|oxytocics|mesh-ancestor
64515409|NCT04756089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64407432|NCT05562609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64407433|NCT05562609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407434|NCT05562609|Hemostatics|hemostatics|mesh-ancestor
64407435|NCT05562609|Coagulants|coagulants|mesh-ancestor
64407436|NCT05071339|Ganirelix|ganirelix|mesh-list
64407437|NCT05071339|Hormone Antagonists|hormone antagonists|mesh-ancestor
64407456|NCT03039491|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64407457|NCT03039491|Immunologic Factors|immunologic factors|mesh-ancestor
64407458|NCT03039491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407459|NCT03037775|Nicotine|nicotine|mesh-list
64407460|NCT03037775|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64407461|NCT03037775|Autonomic Agents|autonomic agents|mesh-ancestor
64407462|NCT03037775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407463|NCT03037775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407464|NCT03037775|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64407465|NCT03037775|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64407466|NCT03037775|Cholinergic Agents|cholinergic agents|mesh-ancestor
64407467|NCT03037775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64407468|NCT03037775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407469|NCT03039257|Vitamin A|vitamin a|mesh-list
64407470|NCT03039257|Vitamins|vitamins|mesh-ancestor
64407471|NCT03039257|Micronutrients|micronutrients|mesh-ancestor
64407472|NCT03039257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407473|NCT03038009|Pantoprazole|pantoprazole|mesh-list
64407474|NCT03038009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64439813|NCT01269463|Methylphenidate|methylphenidate|mesh-list
64407475|NCT03038009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64407476|NCT03038009|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64407477|NCT03038009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407481|NCT03466801|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64407482|NCT03466801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64407484|NCT03466801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64407485|NCT03466801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407486|NCT03466801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64407487|NCT03466801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515410|NCT04756089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515411|NCT03397888|Betrixaban|betrixaban|mesh-list
64515412|NCT03397888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64515413|NCT03397888|Antithrombins|antithrombins|mesh-ancestor
64515414|NCT03397888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64515415|NCT03397888|Protease Inhibitors|protease inhibitors|mesh-ancestor
64515416|NCT03397888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515417|NCT03397888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515418|NCT03397888|Anticoagulants|anticoagulants|mesh-ancestor
64515419|NCT01886859|Lenalidomide|lenalidomide|mesh-list
64515420|NCT01886859|Immunologic Factors|immunologic factors|mesh-ancestor
64515421|NCT01886859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515422|NCT01886859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64515423|NCT01886859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64515424|NCT01886859|Growth Substances|growth substances|mesh-ancestor
64515425|NCT01886859|Growth Inhibitors|growth inhibitors|mesh-ancestor
64515426|NCT01886859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515428|NCT01989910|Raltegravir Potassium|raltegravir potassium|mesh-list
64515429|NCT01989910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64515430|NCT01989910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64407488|NCT03466801|Immunologic Factors|immunologic factors|mesh-ancestor
64407489|NCT05069779|Diazepam|diazepam|mesh-list
64407490|NCT05069779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64407491|NCT05069779|Anticonvulsants|anticonvulsants|mesh-ancestor
64407492|NCT05069779|Antiemetics|antiemetics|mesh-ancestor
64407493|NCT05069779|Autonomic Agents|autonomic agents|mesh-ancestor
64407494|NCT05069779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407495|NCT05069779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407496|NCT05069779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64407497|NCT05069779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64407498|NCT05069779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64407499|NCT05069779|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64407538|NCT02643355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64407539|NCT02643355|Adrenergic Agents|adrenergic agents|mesh-ancestor
64407561|NCT03036605|Sensory System Agents|sensory system agents|mesh-ancestor
64407562|NCT03098875|Remifentanil|remifentanil|mesh-list
64407563|NCT03098875|Propofol|propofol|mesh-list
64407564|NCT03098875|Sevoflurane|sevoflurane|mesh-list
64407565|NCT03098875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64407566|NCT03098875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64407567|NCT03098875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407568|NCT03098875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64407569|NCT03098875|Anesthetics, General|anesthetics, general|mesh-ancestor
64407570|NCT03098875|Anesthetics|anesthetics|mesh-ancestor
64407571|NCT03098875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64407572|NCT03098875|Narcotics|narcotics|mesh-ancestor
64407573|NCT03098875|Analgesics|analgesics|mesh-ancestor
64407574|NCT03098875|Sensory System Agents|sensory system agents|mesh-ancestor
64407575|NCT03098875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407576|NCT03098875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64407602|NCT03101137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64407603|NCT03101137|Glucocorticoids|glucocorticoids|mesh-ancestor
64407604|NCT03101137|Hormones|hormones|mesh-ancestor
64515431|NCT01989910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515432|NCT01989910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515433|NCT01989910|Antiviral Agents|antiviral agents|mesh-ancestor
64515434|NCT01989910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64515435|NCT01989910|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64515436|NCT01989910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64515437|NCT01989910|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64515438|NCT01989910|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64515439|NCT01989910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64515440|NCT01989910|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64515441|NCT01989910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64515442|NCT01989910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64515443|NCT01989910|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64515444|NCT01989910|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64515445|NCT02464722|Epinephrine|epinephrine|mesh-list
64407605|NCT03101137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64407606|NCT03101137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64407607|NCT03101137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64407646|NCT03098407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407647|NCT03098407|Analgesics|analgesics|mesh-ancestor
64407648|NCT03098407|Sensory System Agents|sensory system agents|mesh-ancestor
64407649|NCT03098407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407650|NCT03098407|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64407651|NCT03098407|Antitussive Agents|antitussive agents|mesh-ancestor
64407652|NCT03098407|Respiratory System Agents|respiratory system agents|mesh-ancestor
64407653|NCT04836143|Mitogens|mitogens|mesh-list
64407654|NCT04836143|Endothelial Growth Factors|endothelial growth factors|mesh-list
64407655|NCT04836143|Mitosis Modulators|mitosis modulators|mesh-ancestor
64407656|NCT04836143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407657|NCT04836143|Growth Substances|growth substances|mesh-ancestor
64407658|NCT04836143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407659|NCT05068453|Antibodies|antibodies|mesh-list
64407660|NCT05068453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64407661|NCT05068453|Immunologic Factors|immunologic factors|mesh-ancestor
64407662|NCT05068453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407663|NCT00751075|Mometasone Furoate|mometasone furoate|mesh-list
64407664|NCT00751075|Amoxicillin|amoxicillin|mesh-list
64407665|NCT00751075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64407666|NCT00751075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64407667|NCT00751075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64407708|NCT00552097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64407709|NCT00552097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64407710|NCT00552097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407711|NCT00396175|Finasteride|finasteride|mesh-list
64407712|NCT00396175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407713|NCT00396175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407714|NCT00396175|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64407715|NCT00396175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64407716|NCT00396175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407717|NCT00396175|Hormone Antagonists|hormone antagonists|mesh-ancestor
64407718|NCT00396175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64407719|NCT00396175|Urological Agents|urological agents|mesh-ancestor
64407720|NCT02603393|Fluticasone|fluticasone|mesh-list
64407721|NCT02603393|Tiotropium Bromide|tiotropium bromide|mesh-list
64407722|NCT02603393|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64407762|NCT01659567|Antimetabolites|antimetabolites|mesh-ancestor
64515446|NCT02464722|Dexmedetomidine|dexmedetomidine|mesh-list
64515447|NCT02464722|Remifentanil|remifentanil|mesh-list
64515448|NCT02464722|Propofol|propofol|mesh-list
64515449|NCT02464722|Rocuronium|rocuronium|mesh-list
64515450|NCT02464722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64515451|NCT02464722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64515452|NCT02464722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515453|NCT02464722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64515454|NCT02464722|Anesthetics, General|anesthetics, general|mesh-ancestor
64515455|NCT02464722|Anesthetics|anesthetics|mesh-ancestor
64515456|NCT02464722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64515457|NCT02464722|Analgesics|analgesics|mesh-ancestor
64515458|NCT02464722|Sensory System Agents|sensory system agents|mesh-ancestor
64515459|NCT02464722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64515460|NCT02464722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64618892|NCT00958919|Endorphins|endorphins|mesh-list
64515461|NCT02464722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64515462|NCT02464722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64515463|NCT02464722|Adrenergic Agents|adrenergic agents|mesh-ancestor
64515464|NCT02464722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64515465|NCT02464722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515466|NCT02464722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64515468|NCT02464722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64515469|NCT02464722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64515470|NCT02464722|Autonomic Agents|autonomic agents|mesh-ancestor
64515471|NCT02464722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64515472|NCT02464722|Respiratory System Agents|respiratory system agents|mesh-ancestor
64515473|NCT02464722|Mydriatics|mydriatics|mesh-ancestor
64407763|NCT01659567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407764|NCT01659567|Immunologic Factors|immunologic factors|mesh-ancestor
64407765|NCT01659567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407782|NCT03100435|Carbon Fiber|carbon fiber|mesh-list
64407783|NCT03100435|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64407784|NCT03100435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64407785|NCT03036995|Apremilast|apremilast|mesh-list
64407786|NCT03036995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64407787|NCT03036995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64407788|NCT03036995|Analgesics|analgesics|mesh-ancestor
64407789|NCT03036995|Sensory System Agents|sensory system agents|mesh-ancestor
64407790|NCT03036995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407791|NCT03036995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407792|NCT03036995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64407793|NCT03036995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64407794|NCT03036995|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64407795|NCT03036995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64407796|NCT03036995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515474|NCT02464722|Sympathomimetics|sympathomimetics|mesh-ancestor
64515475|NCT02464722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64515476|NCT02464722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64515477|NCT02464722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64515478|NCT02464722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64515479|NCT01991548|Insulin|insulin|mesh-list
64515480|NCT01991548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64515481|NCT01991548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515482|NCT03298854|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
64515483|NCT03298854|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64515484|NCT03298854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515485|NCT01878669|Acetylcysteine|acetylcysteine|mesh-list
64515486|NCT01878669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64515487|NCT01878669|Antiviral Agents|antiviral agents|mesh-ancestor
64515488|NCT01878669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64515489|NCT01878669|Expectorants|expectorants|mesh-ancestor
64515490|NCT01878669|Respiratory System Agents|respiratory system agents|mesh-ancestor
64515491|NCT01878669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64515492|NCT01878669|Antioxidants|antioxidants|mesh-ancestor
64515493|NCT01878669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515494|NCT01878669|Protective Agents|protective agents|mesh-ancestor
64515495|NCT01878669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515497|NCT02461914|Warfarin|warfarin|mesh-list
64515498|NCT02461914|Anticoagulants|anticoagulants|mesh-ancestor
64515499|NCT01991860|Amisulpride|amisulpride|mesh-list
64515500|NCT01991860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64515501|NCT01991860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64515502|NCT01991860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64515503|NCT01991860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515504|NCT01991860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64515505|NCT01991860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64515506|NCT01991860|Dopamine Agents|dopamine agents|mesh-ancestor
64515507|NCT01991860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64515508|NCT01991860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515509|NCT01991860|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64294830|NCT04495088|Antidotes|antidotes|mesh-ancestor
64294929|NCT04435652|Antimitotic Agents|antimitotic agents|mesh-ancestor
64294930|NCT04435652|Mitosis Modulators|mitosis modulators|mesh-ancestor
64294931|NCT04435652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294932|NCT02473887|Ondansetron|ondansetron|mesh-list
64294933|NCT02473887|Antiemetics|antiemetics|mesh-ancestor
64294934|NCT02473887|Autonomic Agents|autonomic agents|mesh-ancestor
64294935|NCT02473887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64294936|NCT02473887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294937|NCT02473887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64294938|NCT02473887|Antipruritics|antipruritics|mesh-ancestor
64294939|NCT02473887|Dermatologic Agents|dermatologic agents|mesh-ancestor
64294940|NCT02473887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64294941|NCT02473887|Serotonin Agents|serotonin agents|mesh-ancestor
64294942|NCT02473887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64294944|NCT02473887|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64407797|NCT03036995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407798|NCT05066035|Neostigmine|neostigmine|mesh-list
64407799|NCT05066035|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64515510|NCT01991860|Antidepressive Agents|antidepressive agents|mesh-ancestor
64515512|NCT01873131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515513|NCT01873131|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64515514|NCT01873131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64515515|NCT01873131|Adrenergic Agents|adrenergic agents|mesh-ancestor
64515516|NCT01873131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64515517|NCT01873131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515518|NCT01873131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64295410|NCT02049541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64515519|NCT01873131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64515520|NCT02463552|Naproxen|naproxen|mesh-list
64515521|NCT02463552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64515522|NCT02463552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64515523|NCT02463552|Analgesics|analgesics|mesh-ancestor
64515524|NCT02463552|Sensory System Agents|sensory system agents|mesh-ancestor
64515525|NCT02463552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64515526|NCT02463552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515527|NCT02463552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64515528|NCT02463552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64515529|NCT02463552|Gout Suppressants|gout suppressants|mesh-ancestor
64515530|NCT02463552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64515531|NCT02463552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515532|NCT02463552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515533|NCT01992016|Ranolazine|ranolazine|mesh-list
64515534|NCT01992016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64515535|NCT01992016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64297068|NCT01554410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64297069|NCT01554410|Antimetabolites|antimetabolites|mesh-ancestor
64515536|NCT01992016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515537|NCT01871571|Leucovorin|leucovorin|mesh-list
64515538|NCT01871571|Bevacizumab|bevacizumab|mesh-list
64515539|NCT01871571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64515540|NCT01871571|Fluorouracil|fluorouracil|mesh-list
64407800|NCT05066035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407801|NCT05066035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407802|NCT05066035|Cholinergic Agents|cholinergic agents|mesh-ancestor
64407803|NCT05066035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64407804|NCT05066035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407805|NCT05066035|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64298282|NCT01369849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407806|NCT05066035|Autonomic Agents|autonomic agents|mesh-ancestor
64298283|NCT01369849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64407807|NCT05066035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407809|NCT04822649|Analgesics|analgesics|mesh-ancestor
64407810|NCT04822649|Sensory System Agents|sensory system agents|mesh-ancestor
64515541|NCT01871571|Oxaliplatin|oxaliplatin|mesh-list
64515542|NCT01871571|Antibodies|antibodies|mesh-list
64515543|NCT01871571|Immunoglobulins|immunoglobulins|mesh-list
64515544|NCT01871571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64515545|NCT01871571|Levoleucovorin|levoleucovorin|mesh-list
64515546|NCT01871571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515547|NCT01871571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64300491|NCT02111317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64300500|NCT03553615|Ivermectin|ivermectin|mesh-list
64515548|NCT01871571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64515549|NCT01871571|Growth Substances|growth substances|mesh-ancestor
64515550|NCT01871571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515551|NCT01871571|Growth Inhibitors|growth inhibitors|mesh-ancestor
64515552|NCT01871571|Immunologic Factors|immunologic factors|mesh-ancestor
64515553|NCT01871571|Antimetabolites|antimetabolites|mesh-ancestor
64515554|NCT01871571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515555|NCT01871571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64515556|NCT01871571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64515557|NCT01871571|Antidotes|antidotes|mesh-ancestor
64515558|NCT01871571|Protective Agents|protective agents|mesh-ancestor
64515559|NCT01871571|Vitamin B Complex|vitamin b complex|mesh-ancestor
64515560|NCT01871571|Vitamins|vitamins|mesh-ancestor
64515561|NCT01871571|Micronutrients|micronutrients|mesh-ancestor
64515562|NCT02461368|Triamcinolone|triamcinolone|mesh-list
64515563|NCT02461368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64515564|NCT02461368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64515565|NCT02461368|Lidocaine|lidocaine|mesh-list
64515566|NCT02461368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64515567|NCT02461368|Anesthetics, Local|anesthetics, local|mesh-ancestor
64515568|NCT02461368|Anesthetics|anesthetics|mesh-ancestor
64300835|NCT03094442|Glucocorticoids|glucocorticoids|mesh-ancestor
64515569|NCT02461368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64515570|NCT02461368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515571|NCT02461368|Sensory System Agents|sensory system agents|mesh-ancestor
64515572|NCT02461368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407811|NCT04822649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618896|NCT00958919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407812|NCT04822649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407813|NCT04822649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64407814|NCT04822649|Vasodilator Agents|vasodilator agents|mesh-ancestor
64407815|NCT04822649|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64407816|NCT04822649|Purinergic Agonists|purinergic agonists|mesh-ancestor
64407817|NCT04822649|Purinergic Agents|purinergic agents|mesh-ancestor
64407818|NCT04822649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64303454|NCT02138383|Tubulin Modulators|tubulin modulators|mesh-ancestor
64407819|NCT04822649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407820|NCT04822415|Mepivacaine|mepivacaine|mesh-list
64407822|NCT04822415|Anesthetics, Local|anesthetics, local|mesh-ancestor
64407823|NCT04822415|Anesthetics|anesthetics|mesh-ancestor
64407865|NCT05063071|Antiviral Agents|antiviral agents|mesh-ancestor
64515573|NCT02461368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64515574|NCT02461368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64515575|NCT02461368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64515576|NCT02461368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64515577|NCT02461368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515578|NCT02461368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64515581|NCT02461368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64515582|NCT02461368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64515583|NCT02461368|Immunologic Factors|immunologic factors|mesh-ancestor
64515584|NCT02461368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515585|NCT01422759|Spironolactone|spironolactone|mesh-list
64304010|NCT05017610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64515586|NCT01422759|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64515587|NCT01422759|Hormone Antagonists|hormone antagonists|mesh-ancestor
64515588|NCT01422759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64515589|NCT01422759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515590|NCT01422759|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64515591|NCT01422759|Diuretics|diuretics|mesh-ancestor
64515592|NCT01422759|Natriuretic Agents|natriuretic agents|mesh-ancestor
64515593|NCT01992172|Sunscreening Agents|sunscreening agents|mesh-list
64515594|NCT01992172|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64515595|NCT01992172|Protective Agents|protective agents|mesh-ancestor
64515596|NCT01992172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407866|NCT05063071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64407877|NCT05062681|Prednisolone|prednisolone|mesh-list
64407878|NCT05062681|Prednisolone acetate|prednisolone acetate|mesh-list
64407879|NCT05062681|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64407880|NCT05062681|Prednisolone phosphate|prednisolone phosphate|mesh-list
64407881|NCT05062681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64407882|NCT05062681|Antiemetics|antiemetics|mesh-ancestor
64407883|NCT05062681|Autonomic Agents|autonomic agents|mesh-ancestor
64304127|NCT05728424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64407884|NCT05062681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407885|NCT05062681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407886|NCT05062681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64407887|NCT05062681|Glucocorticoids|glucocorticoids|mesh-ancestor
64407889|NCT05062681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64407890|NCT05062681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64407891|NCT05062681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64407892|NCT05062681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64407893|NCT05062681|Protective Agents|protective agents|mesh-ancestor
64407894|NCT05056519|Vaccines|vaccines|mesh-list
64407895|NCT05056519|Immunologic Factors|immunologic factors|mesh-ancestor
64407896|NCT05056519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407897|NCT05045443|Curcumin|curcumin|mesh-list
64407903|NCT05045443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407904|NCT05045443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64407905|NCT05045443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64407906|NCT05045443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515597|NCT01992172|Dermatologic Agents|dermatologic agents|mesh-ancestor
64515598|NCT03296982|Enoxaparin|enoxaparin|mesh-list
64515599|NCT03296982|Edoxaban|edoxaban|mesh-list
64515600|NCT03296982|Anticoagulants|anticoagulants|mesh-ancestor
64515601|NCT03296982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64515602|NCT03296982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64304246|NCT05376878|Copper|copper|mesh-list
64304247|NCT05376878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64304248|NCT05376878|Trastuzumab|trastuzumab|mesh-list
64304299|NCT02394340|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64304300|NCT02394340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304301|NCT02394340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304302|NCT02394340|Antifungal Agents|antifungal agents|mesh-ancestor
64304303|NCT02394340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64304305|NCT01672736|Dexamethasone acetate|dexamethasone acetate|mesh-list
64304306|NCT01672736|Bortezomib|bortezomib|mesh-list
64304307|NCT01672736|BB 1101|bb 1101|mesh-list
64304308|NCT01672736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64304309|NCT01672736|Antiemetics|antiemetics|mesh-ancestor
64304310|NCT01672736|Autonomic Agents|autonomic agents|mesh-ancestor
64304311|NCT01672736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64304312|NCT01672736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304313|NCT01672736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64304314|NCT01672736|Glucocorticoids|glucocorticoids|mesh-ancestor
64304315|NCT01672736|Hormones|hormones|mesh-ancestor
64304316|NCT01672736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64304317|NCT01672736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64304318|NCT01672736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515603|NCT03296982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515604|NCT03296982|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64515605|NCT03296982|Antithrombins|antithrombins|mesh-ancestor
64515606|NCT03296982|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64618898|NCT00958919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515607|NCT03296982|Protease Inhibitors|protease inhibitors|mesh-ancestor
64515608|NCT03296982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515609|NCT01895829|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64515611|NCT01895829|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64515612|NCT01895829|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64515613|NCT03298698|Prednisone|prednisone|mesh-list
64515614|NCT03298698|Prednisolone|prednisolone|mesh-list
64515615|NCT03298698|Rituximab|rituximab|mesh-list
64515616|NCT03298698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64515617|NCT03298698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515618|NCT03298698|Immunologic Factors|immunologic factors|mesh-ancestor
64515619|NCT03298698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304320|NCT01672736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304321|NCT01672736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304322|NCT03065660|Mifepristone|mifepristone|mesh-list
64304323|NCT03065660|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64515620|NCT03298698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64515621|NCT03298698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64515623|NCT03298698|Hormones|hormones|mesh-ancestor
64515624|NCT03298698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64515625|NCT03298698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64515626|NCT03389620|Dexamethasone|dexamethasone|mesh-list
64515627|NCT03389620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64515628|NCT03389620|Antiemetics|antiemetics|mesh-ancestor
64305017|NCT02259959|Respiratory System Agents|respiratory system agents|mesh-ancestor
64305024|NCT03062462|Ticagrelor|ticagrelor|mesh-list
64515629|NCT03389620|Autonomic Agents|autonomic agents|mesh-ancestor
64515630|NCT03389620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407907|NCT05045443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407908|NCT05045443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407909|NCT05045053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64407910|NCT05045053|Lifitegrast|lifitegrast|mesh-list
64407911|NCT05045053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64407912|NCT05055895|Cholinergic Antagonists|cholinergic antagonists|mesh-list
64407913|NCT05055895|Cholinergic Agents|cholinergic agents|mesh-ancestor
64407914|NCT05055895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64407915|NCT05055895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407916|NCT05055895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515631|NCT03389620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515632|NCT03389620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64515633|NCT03389620|Glucocorticoids|glucocorticoids|mesh-ancestor
64305729|NCT02806973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305730|NCT02049203|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
64305731|NCT02049203|Enzyme Activators|enzyme activators|mesh-ancestor
64305732|NCT02049203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305734|NCT02037737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64586292|NCT00322439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64305735|NCT02037737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305736|NCT02037737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305937|NCT02054975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64305938|NCT02055131|Aspirin|aspirin|mesh-list
64305939|NCT02055131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64305940|NCT02055131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64305941|NCT02055131|Analgesics|analgesics|mesh-ancestor
64515634|NCT03389620|Hormones|hormones|mesh-ancestor
64515635|NCT03389620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64515636|NCT03389620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64515637|NCT03389620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515638|NCT02463942|Doxycycline|doxycycline|mesh-list
64515639|NCT02463942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64515640|NCT02463942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64515641|NCT02463942|Antimalarials|antimalarials|mesh-ancestor
64515642|NCT02463942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64515643|NCT02463942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64515644|NCT03298542|Golimumab|golimumab|mesh-list
64515645|NCT03298542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64306175|NCT02060201|Incretins|incretins|mesh-ancestor
64306176|NCT02060201|Hormones|hormones|mesh-ancestor
64306177|NCT02060201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64306178|NCT02060201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64306179|NCT02060201|Protease Inhibitors|protease inhibitors|mesh-ancestor
64515646|NCT03298542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64515647|NCT03298542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64515648|NCT03298542|Immunologic Factors|immunologic factors|mesh-ancestor
64515649|NCT03298542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515651|NCT03296670|Alprostadil|alprostadil|mesh-list
64515652|NCT03296670|Vasodilator Agents|vasodilator agents|mesh-ancestor
64515653|NCT03296670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64515654|NCT03296670|Urological Agents|urological agents|mesh-ancestor
64515655|NCT03298464|Pioglitazone|pioglitazone|mesh-list
64515656|NCT03298464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64515657|NCT03298464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407917|NCT05060809|Vitamin K|vitamin k|mesh-list
64407918|NCT05060809|Vitamin K 1|vitamin k 1|mesh-list
64407919|NCT05060809|Vitamins|vitamins|mesh-ancestor
64407920|NCT05060809|Micronutrients|micronutrients|mesh-ancestor
64407921|NCT05060809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407922|NCT05060809|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64407923|NCT05060809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64407924|NCT05060809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407925|NCT05060809|Hemostatics|hemostatics|mesh-ancestor
64407926|NCT05060809|Coagulants|coagulants|mesh-ancestor
64407927|NCT05060419|Meropenem|meropenem|mesh-list
64407928|NCT05060419|Tazobactam|tazobactam|mesh-list
64407929|NCT05060419|Piperacillin|piperacillin|mesh-list
64306553|NCT01370525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306554|NCT02065349|ASP8477|asp8477|mesh-list
64306612|NCT02072213|Tamsulosin|tamsulosin|mesh-list
64306613|NCT02072213|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64306614|NCT02072213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64306615|NCT02072213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64306616|NCT02072213|Adrenergic Agents|adrenergic agents|mesh-ancestor
64407930|NCT05060419|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64407931|NCT05060419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64407932|NCT05060419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64407933|NCT05060419|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64407934|NCT05060419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407935|NCT05060419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407978|NCT04834427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64407979|NCT04834427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64407980|NCT04834427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407981|NCT04834427|Antidepressive Agents|antidepressive agents|mesh-ancestor
64407982|NCT04834427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64407983|NCT05035849|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64515658|NCT04491084|Antibodies|antibodies|mesh-list
64515659|NCT04491084|Flt3 ligand protein|flt3 ligand protein|mesh-list
64515660|NCT04491084|Immunologic Factors|immunologic factors|mesh-ancestor
64515661|NCT04491084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515662|NCT04491084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64515663|NCT04491084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64515664|NCT04491084|Protective Agents|protective agents|mesh-ancestor
64515665|NCT01852071|Busulfan|busulfan|mesh-list
64515666|NCT01852071|Alkylating Agents|alkylating agents|mesh-ancestor
64515667|NCT01852071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515668|NCT01852071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64515669|NCT01852071|Immunologic Factors|immunologic factors|mesh-ancestor
64515670|NCT01852071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515671|NCT01852071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64307574|NCT04933292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515672|NCT01852071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515673|NCT01852071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64515674|NCT04084548|Lidocaine|lidocaine|mesh-list
64515675|NCT04084548|Ketamine|ketamine|mesh-list
64515676|NCT04084548|Anesthetics, Local|anesthetics, local|mesh-ancestor
64515677|NCT04084548|Anesthetics|anesthetics|mesh-ancestor
64407984|NCT05035849|Acarbose|acarbose|mesh-list
64407985|NCT05035849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64407986|NCT05035849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408012|NCT05035381|Growth Inhibitors|growth inhibitors|mesh-ancestor
64408013|NCT05035381|Antimetabolites|antimetabolites|mesh-ancestor
64408014|NCT05035381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408015|NCT05035381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64408016|NCT05035381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64408017|NCT05035381|Immunologic Factors|immunologic factors|mesh-ancestor
64408018|NCT05035381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64408019|NCT05035381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64308361|NCT03232125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64308362|NCT03232125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408020|NCT05035381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64408021|NCT05035381|Antidotes|antidotes|mesh-ancestor
64408022|NCT05035381|Protective Agents|protective agents|mesh-ancestor
64408023|NCT05035381|Vitamin B Complex|vitamin b complex|mesh-ancestor
64408024|NCT05035381|Vitamins|vitamins|mesh-ancestor
64408025|NCT05035381|Micronutrients|micronutrients|mesh-ancestor
64408026|NCT04821323|Indomethacin|indomethacin|mesh-list
64408027|NCT04821323|Mannitol|mannitol|mesh-list
64408028|NCT04821323|Lactulose|lactulose|mesh-list
64408029|NCT04821323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64408030|NCT04821323|Diuretics|diuretics|mesh-ancestor
64408063|NCT05035147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64408064|NCT05035147|Antimetabolites|antimetabolites|mesh-ancestor
64408065|NCT05035147|Antiviral Agents|antiviral agents|mesh-ancestor
64408066|NCT05035147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64408067|NCT05035147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64408068|NCT05035147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64408094|NCT04816253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64408095|NCT04816253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64408096|NCT04816253|Prednisolone|prednisolone|mesh-list
64408097|NCT04816253|Prednisolone acetate|prednisolone acetate|mesh-list
64408116|NCT04816253|Viscosupplements|viscosupplements|mesh-ancestor
64408117|NCT04816097|Dexamethasone|dexamethasone|mesh-list
64408118|NCT04816097|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64408119|NCT04816097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64408120|NCT04816097|Antiemetics|antiemetics|mesh-ancestor
64408121|NCT04816097|Autonomic Agents|autonomic agents|mesh-ancestor
64515678|NCT04084548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64515679|NCT04084548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308620|NCT03231033|Pioglitazone|pioglitazone|mesh-list
64515681|NCT04084548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64515682|NCT04084548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64515683|NCT04084548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64515684|NCT04084548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64515685|NCT04084548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64515686|NCT04084548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515687|NCT04084548|Analgesics|analgesics|mesh-ancestor
64515688|NCT04084548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64515689|NCT04084548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64515690|NCT04084548|Anesthetics, General|anesthetics, general|mesh-ancestor
64515691|NCT04084548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64308765|NCT03207165|Milrinone|milrinone|mesh-list
64308766|NCT03207165|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-list
64308767|NCT03207165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64308768|NCT03207165|Sympathomimetics|sympathomimetics|mesh-ancestor
64308769|NCT03207165|Autonomic Agents|autonomic agents|mesh-ancestor
64308770|NCT03207165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64308778|NCT03207165|Protective Agents|protective agents|mesh-ancestor
64308783|NCT02142205|Natalizumab|natalizumab|mesh-list
64515692|NCT04084548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64515693|NCT04084548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64515694|NCT02059642|Metadoxine|metadoxine|mesh-list
64515695|NCT02059642|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64515696|NCT03296358|Dexamethasone|dexamethasone|mesh-list
64515697|NCT03296358|Prednisolone|prednisolone|mesh-list
64515698|NCT03296358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64515699|NCT03296358|Antiemetics|antiemetics|mesh-ancestor
64515700|NCT03296358|Autonomic Agents|autonomic agents|mesh-ancestor
64515701|NCT03296358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64515702|NCT03296358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309015|NCT02449941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64515703|NCT03296358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64515704|NCT03296358|Glucocorticoids|glucocorticoids|mesh-ancestor
64515705|NCT03296358|Hormones|hormones|mesh-ancestor
64515706|NCT03296358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64408122|NCT04816097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64408123|NCT04816097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408124|NCT04816097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64408125|NCT04816097|Glucocorticoids|glucocorticoids|mesh-ancestor
64408127|NCT04816097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64408128|NCT04816097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64408130|NCT02600351|Sofosbuvir|sofosbuvir|mesh-list
64408131|NCT02600351|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64408132|NCT02600351|Ledipasvir|ledipasvir|mesh-list
64408133|NCT02600351|Antiviral Agents|antiviral agents|mesh-ancestor
64309385|NCT03196869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408134|NCT02600351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64408135|NCT04829435|Rasburicase|rasburicase|mesh-list
64408136|NCT04829435|Gout Suppressants|gout suppressants|mesh-ancestor
64515707|NCT03296358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64515708|NCT03296358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515709|NCT04756323|Vaccines|vaccines|mesh-list
64515710|NCT04756323|Immunologic Factors|immunologic factors|mesh-ancestor
64515711|NCT04756323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515712|NCT00469755|Nicotinic Acids|nicotinic acids|mesh-list
64515713|NCT00469755|Adapalene|adapalene|mesh-list
64515714|NCT00469755|Tazarotene|tazarotene|mesh-list
64309614|NCT03192579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64515715|NCT00469755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64515716|NCT00469755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64515717|NCT00469755|Analgesics|analgesics|mesh-ancestor
64515718|NCT00469755|Sensory System Agents|sensory system agents|mesh-ancestor
64515719|NCT00469755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64515720|NCT00469755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515721|NCT00469755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64515722|NCT00469755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64515723|NCT00469755|Dermatologic Agents|dermatologic agents|mesh-ancestor
64515724|NCT00469755|Keratolytic Agents|keratolytic agents|mesh-ancestor
64515725|NCT00469755|Vitamin B Complex|vitamin b complex|mesh-ancestor
64515726|NCT00469755|Vitamins|vitamins|mesh-ancestor
64515727|NCT00469755|Micronutrients|micronutrients|mesh-ancestor
64515728|NCT00453531|Acetylcholine|acetylcholine|mesh-list
64515729|NCT00453531|Vasodilator Agents|vasodilator agents|mesh-ancestor
64515730|NCT00453531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64515731|NCT00453531|Cholinergic Agents|cholinergic agents|mesh-ancestor
64515732|NCT00453531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64515733|NCT00453531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515734|NCT00453531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515735|NCT03295968|Ibuprofen|ibuprofen|mesh-list
64515736|NCT03295968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64515737|NCT03295968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64515738|NCT03295968|Analgesics|analgesics|mesh-ancestor
64515739|NCT03295968|Sensory System Agents|sensory system agents|mesh-ancestor
64408137|NCT04829435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64408138|NCT05042635|Ixekizumab|ixekizumab|mesh-list
64408139|NCT05042635|Dermatologic Agents|dermatologic agents|mesh-ancestor
64408231|NCT03094663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64408233|NCT03094663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408234|NCT03094663|Protease Inhibitors|protease inhibitors|mesh-ancestor
64408235|NCT03094663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64408237|NCT03094663|Anesthetics, Local|anesthetics, local|mesh-ancestor
64408238|NCT03094663|Anesthetics|anesthetics|mesh-ancestor
64515740|NCT03295968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64515741|NCT03295968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515742|NCT03295968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64515743|NCT03295968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64515744|NCT03295968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64515745|NCT03295968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515746|NCT03295968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515747|NCT03298074|Etoposide|etoposide|mesh-list
64515748|NCT03298074|Apatinib|apatinib|mesh-list
64515749|NCT03298074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64515750|NCT03298074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515751|NCT03298074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64515752|NCT03298074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64515753|NCT03298074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515754|NCT03298074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515755|NCT03298074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64515756|NCT01992874|Niacinamide|niacinamide|mesh-list
64515757|NCT01992874|Vitamin B Complex|vitamin b complex|mesh-ancestor
64515758|NCT01992874|Vitamins|vitamins|mesh-ancestor
64310552|NCT04881110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64515759|NCT01992874|Micronutrients|micronutrients|mesh-ancestor
64515760|NCT01992874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515761|NCT04755543|Fluorouracil|fluorouracil|mesh-list
64515762|NCT04755543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515763|NCT04755543|Antimetabolites|antimetabolites|mesh-ancestor
64515764|NCT04755543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515765|NCT04755543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64515766|NCT04755543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64515767|NCT04755543|Immunologic Factors|immunologic factors|mesh-ancestor
64310874|NCT05005273|Ipilimumab|ipilimumab|mesh-list
64515768|NCT04755543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515769|NCT01993108|Naltrexone|naltrexone|mesh-list
64515770|NCT01993108|Methylphenidate|methylphenidate|mesh-list
64515771|NCT01993108|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64408239|NCT03094663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64408240|NCT03094663|Sensory System Agents|sensory system agents|mesh-ancestor
64408241|NCT03094663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64408242|NCT03094663|Protective Agents|protective agents|mesh-ancestor
64311204|NCT03047954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64311205|NCT03047954|Immunologic Factors|immunologic factors|mesh-ancestor
64311206|NCT03047954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311301|NCT02087579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64311302|NCT02087579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64311303|NCT02087579|Serotonin Agents|serotonin agents|mesh-ancestor
64311304|NCT02087579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64311305|NCT02087579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311398|NCT03046238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64515772|NCT01993108|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64515773|NCT01993108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515774|NCT01993108|Sensory System Agents|sensory system agents|mesh-ancestor
64515775|NCT01993108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64515776|NCT01993108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64515777|NCT01993108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64515778|NCT01993108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64515779|NCT01993108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64515780|NCT01993108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515781|NCT01993108|Dopamine Agents|dopamine agents|mesh-ancestor
64515782|NCT01993108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64334656|NCT02295709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64334657|NCT02295709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334658|NCT02295709|Protease Inhibitors|protease inhibitors|mesh-ancestor
64334659|NCT02295709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334660|NCT02295709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334661|NCT02354937|Cabotegravir|cabotegravir|mesh-list
64334662|NCT02354937|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64334663|NCT02354937|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64334664|NCT02354937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334665|NCT02354937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334666|NCT02354937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64515784|NCT02307526|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
64515785|NCT02307526|Anticonvulsants|anticonvulsants|mesh-ancestor
64515786|NCT02307526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64515787|NCT02307526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515788|NCT02307526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515789|NCT02307526|Cholinergic Agents|cholinergic agents|mesh-ancestor
64515790|NCT02307526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64515791|NCT02307526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515792|NCT01371201|Sunitinib|sunitinib|mesh-list
64408270|NCT04814381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408271|NCT04814381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64408272|NCT04814381|Anticonvulsants|anticonvulsants|mesh-ancestor
64408273|NCT04814381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64618902|NCT04323592|Prednisolone|prednisolone|mesh-list
64408277|NCT04814381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64408279|NCT04819217|Antidotes|antidotes|mesh-ancestor
64408280|NCT04819217|Protective Agents|protective agents|mesh-ancestor
64408281|NCT04819217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408282|NCT05052619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64312091|NCT02109965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64312092|NCT02109965|Anesthetics, General|anesthetics, general|mesh-ancestor
64312093|NCT02109965|Anesthetics|anesthetics|mesh-ancestor
64312094|NCT02109965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64312095|NCT02109965|Analgesics|analgesics|mesh-ancestor
64312096|NCT02109965|Sensory System Agents|sensory system agents|mesh-ancestor
64312097|NCT02109965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312099|NCT02109965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64408297|NCT05032261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64408299|NCT05032261|Adrenergic Agents|adrenergic agents|mesh-ancestor
64408300|NCT05032261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64408301|NCT05032261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408302|NCT05032261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408303|NCT05032261|Sympathomimetics|sympathomimetics|mesh-ancestor
64408304|NCT05032261|Autonomic Agents|autonomic agents|mesh-ancestor
64408305|NCT05032261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64408306|NCT05032261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64408308|NCT05619341|Cathartics|cathartics|mesh-ancestor
64408309|NCT05619341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64408310|NCT05051137|Hydroxychloroquine|hydroxychloroquine|mesh-list
64408311|NCT05051137|Sulfasalazine|sulfasalazine|mesh-list
64312278|NCT03041948|Ondansetron|ondansetron|mesh-list
64312279|NCT03041948|Propofol|propofol|mesh-list
64312280|NCT03041948|Sevoflurane|sevoflurane|mesh-list
64312281|NCT03041948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64312282|NCT03041948|Antiemetics|antiemetics|mesh-ancestor
64312283|NCT03041948|Autonomic Agents|autonomic agents|mesh-ancestor
64312339|NCT02611778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64312340|NCT02611778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64312341|NCT02611778|Growth Substances|growth substances|mesh-ancestor
64312342|NCT02611778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312343|NCT02611778|Growth Inhibitors|growth inhibitors|mesh-ancestor
64312344|NCT02611778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312345|NCT04867226|Colchicine|colchicine|mesh-list
64312346|NCT04867226|Gout Suppressants|gout suppressants|mesh-ancestor
64312347|NCT04867226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64312348|NCT04867226|Tubulin Modulators|tubulin modulators|mesh-ancestor
64312349|NCT04867226|Antimitotic Agents|antimitotic agents|mesh-ancestor
64312350|NCT04867226|Mitosis Modulators|mitosis modulators|mesh-ancestor
64408312|NCT05051137|Infliximab|infliximab|mesh-list
64408313|NCT05051137|Antimalarials|antimalarials|mesh-ancestor
64408322|NCT05051137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64408323|NCT05051137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64515793|NCT01371201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515794|NCT01371201|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64515795|NCT01371201|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64515796|NCT01371201|Growth Substances|growth substances|mesh-ancestor
64515797|NCT01371201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515798|NCT01371201|Growth Inhibitors|growth inhibitors|mesh-ancestor
64515799|NCT01371201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64515800|NCT01371201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515801|NCT01371201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334667|NCT02354937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64334668|NCT02354937|Antiviral Agents|antiviral agents|mesh-ancestor
64334669|NCT02354937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64334670|NCT02295787|Ketamine|ketamine|mesh-list
64312781|NCT04859738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64312782|NCT04859738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64312812|NCT02425137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312814|NCT02425137|Antiviral Agents|antiviral agents|mesh-ancestor
64312815|NCT02425137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64312822|NCT04841018|BB 1101|bb 1101|mesh-list
64515802|NCT00436527|Metronidazole|metronidazole|mesh-list
64515803|NCT00436527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64515804|NCT00436527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64515805|NCT00436527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64515806|NCT00436527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64515807|NCT02307916|Mitogens|mitogens|mesh-list
64515808|NCT02307916|Mitosis Modulators|mitosis modulators|mesh-ancestor
64515809|NCT02307916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515810|NCT00419367|Vorinostat|vorinostat|mesh-list
64515811|NCT00419367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313263|NCT03180879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64313264|NCT03180879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64313348|NCT01331837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64313349|NCT01331837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64313350|NCT01331837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64313351|NCT01331837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64313352|NCT01331837|Immunologic Factors|immunologic factors|mesh-ancestor
64313353|NCT02706483|Plecanatide|plecanatide|mesh-list
64313354|NCT02706483|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64313355|NCT02706483|Enzyme Activators|enzyme activators|mesh-ancestor
64313356|NCT02706483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313357|NCT02706483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64515812|NCT00419367|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64515813|NCT00419367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515814|NCT00419367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515815|NCT01994746|Glucagon|glucagon|mesh-list
64515816|NCT01994746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64515817|NCT01994746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64515818|NCT01994746|Hormones|hormones|mesh-ancestor
64408324|NCT05051137|Analgesics|analgesics|mesh-ancestor
64618906|NCT04323592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64515823|NCT04034238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64515824|NCT04034238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515825|NCT04034238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515827|NCT00291525|Anticoagulants|anticoagulants|mesh-ancestor
64515828|NCT01337349|Pentoxifylline|pentoxifylline|mesh-list
64408326|NCT05051137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64408327|NCT05051137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408328|NCT05051137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64408329|NCT05038969|Esomeprazole|esomeprazole|mesh-list
64408330|NCT05038969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64408331|NCT05038969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64408332|NCT05038969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64408347|NCT05038111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64408348|NCT05038111|Adrenergic Agents|adrenergic agents|mesh-ancestor
64408349|NCT05038111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64408350|NCT05038111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408351|NCT05030077|Gemcitabine|gemcitabine|mesh-list
64408352|NCT05030077|Carboplatin|carboplatin|mesh-list
64314492|NCT02122679|Hemostatics|hemostatics|mesh-ancestor
64408353|NCT05030077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408354|NCT05030077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64408355|NCT05030077|Antimetabolites|antimetabolites|mesh-ancestor
64408356|NCT05030077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408357|NCT05030077|Antiviral Agents|antiviral agents|mesh-ancestor
64408358|NCT05030077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64408359|NCT05030077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64408360|NCT05030077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64408361|NCT05030077|Immunologic Factors|immunologic factors|mesh-ancestor
64408362|NCT05030077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408364|NCT05029453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408365|NCT05029453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64408366|NCT05029453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64408367|NCT05029453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408369|NCT02640157|Antiviral Agents|antiviral agents|mesh-ancestor
64408412|NCT05028907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386896|NCT02381717|Narcotics|narcotics|mesh-ancestor
64408413|NCT05028907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64408414|NCT05028907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64408415|NCT05028907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64408416|NCT05028907|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64408417|NCT05028907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64408418|NCT05028907|Sympathomimetics|sympathomimetics|mesh-ancestor
64408419|NCT05028907|Nasal Decongestants|nasal decongestants|mesh-ancestor
64408420|NCT05028907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64408421|NCT05028907|Respiratory System Agents|respiratory system agents|mesh-ancestor
64408422|NCT05050357|Norethindrone|norethindrone|mesh-list
64408423|NCT05050357|Norethindrone Acetate|norethindrone acetate|mesh-list
64408424|NCT05050357|Progestins|progestins|mesh-list
64408425|NCT05050357|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64515829|NCT01337349|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64515830|NCT01337349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618908|NCT04323592|Autonomic Agents|autonomic agents|mesh-ancestor
64515835|NCT01337349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515836|NCT01337349|Vasodilator Agents|vasodilator agents|mesh-ancestor
64515837|NCT01337349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64515838|NCT01337349|Antioxidants|antioxidants|mesh-ancestor
64515839|NCT01999348|Timolol|timolol|mesh-list
64515840|NCT01999348|Bimatoprost|bimatoprost|mesh-list
64515841|NCT01999348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64515842|NCT01999348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64515844|NCT01999348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64440339|NCT02238379|Oxytocin|oxytocin|mesh-list
64408426|NCT05050357|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64408427|NCT05050357|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64408428|NCT05050357|Contraceptive Agents|contraceptive agents|mesh-ancestor
64408429|NCT05050357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64408430|NCT05050357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408431|NCT05050357|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64408432|NCT05050357|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64408433|NCT05050357|Hormones|hormones|mesh-ancestor
64408434|NCT05050357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64408435|NCT05028049|Sufentanil|sufentanil|mesh-list
64388240|NCT02354807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64408436|NCT05028049|Remifentanil|remifentanil|mesh-list
64408484|NCT03094507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64408485|NCT03094507|Antiviral Agents|antiviral agents|mesh-ancestor
64408486|NCT03094507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64408487|NCT03094507|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64408488|NCT03094507|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64408489|NCT03094507|Protease Inhibitors|protease inhibitors|mesh-ancestor
64408490|NCT03094507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64408491|NCT03094507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64408492|NCT02528253|Tramadol|tramadol|mesh-list
64408493|NCT02528253|Tanezumab|tanezumab|mesh-list
64408524|NCT05047393|Vitamin D|vitamin d|mesh-list
64408525|NCT05047393|Vitamins|vitamins|mesh-ancestor
64408526|NCT05047393|Micronutrients|micronutrients|mesh-ancestor
64408527|NCT05047393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408528|NCT05047393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64408529|NCT05017987|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64408530|NCT05017987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408531|NCT05017987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64390605|NCT02423083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64390606|NCT02423083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64408532|NCT05017987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64408533|NCT05017987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64408534|NCT05021887|Fluticasone|fluticasone|mesh-list
64408535|NCT05021887|Xhance|xhance|mesh-list
64408536|NCT05021887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64408537|NCT05021887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64408538|NCT05021887|Autonomic Agents|autonomic agents|mesh-ancestor
64408539|NCT05021887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64408540|NCT05021887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408541|NCT05021887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64515845|NCT01999348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515846|NCT01999348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515847|NCT01999348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64515848|NCT01999348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64515849|NCT00280761|Fluorouracil|fluorouracil|mesh-list
64515850|NCT00280761|Capecitabine|capecitabine|mesh-list
64515851|NCT00280761|Antimetabolites|antimetabolites|mesh-ancestor
64515852|NCT00280761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515853|NCT00280761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64515854|NCT00280761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408591|NCT03079453|Glucocorticoids|glucocorticoids|mesh-ancestor
64408593|NCT03079453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64408594|NCT03079453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64408595|NCT03079453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408596|NCT04294459|Acetaminophen|acetaminophen|mesh-list
64408597|NCT04294459|Diphenhydramine|diphenhydramine|mesh-list
64408598|NCT04294459|Promethazine|promethazine|mesh-list
64408599|NCT04294459|Methylprednisolone|methylprednisolone|mesh-list
64408600|NCT04294459|Ranitidine|ranitidine|mesh-list
64408615|NCT04294459|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64408616|NCT04294459|Protective Agents|protective agents|mesh-ancestor
64408617|NCT04294459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64408618|NCT04294459|Respiratory System Agents|respiratory system agents|mesh-ancestor
64408619|NCT04294459|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64408620|NCT04294459|Hormone Antagonists|hormone antagonists|mesh-ancestor
64408621|NCT04294459|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64515863|NCT02463318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515864|NCT02463318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64515865|NCT02463318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64515866|NCT02463318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64515868|NCT01436968|Antiviral Agents|antiviral agents|mesh-ancestor
64515869|NCT01436968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64515870|NCT02462772|Cabotegravir|cabotegravir|mesh-list
64515871|NCT02462772|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64515872|NCT02462772|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64515873|NCT02462772|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64515874|NCT02462772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64515875|NCT02462772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64391633|NCT02416765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391634|NCT02416765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64391635|NCT02416765|Hormones|hormones|mesh-ancestor
64391636|NCT02416765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64391637|NCT02703259|Acetaminophen|acetaminophen|mesh-list
64391638|NCT02703259|Celecoxib|celecoxib|mesh-list
64391639|NCT02703259|Gabapentin|gabapentin|mesh-list
64391640|NCT02703259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64391641|NCT02703259|Analgesics|analgesics|mesh-ancestor
64344290|NCT05428150|Pirfenidone|pirfenidone|mesh-list
64515877|NCT02462772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515878|NCT02462772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515879|NCT02462772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64515880|NCT02462772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64515881|NCT02462772|Antiviral Agents|antiviral agents|mesh-ancestor
64515882|NCT02462772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64515883|NCT02716194|Factor VIII|factor viii|mesh-list
64515884|NCT02716194|Coagulants|coagulants|mesh-ancestor
64408622|NCT04294459|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64408623|NCT04294459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408624|NCT04294459|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64408625|NCT04294459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64408626|NCT04294459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64408627|NCT04294459|Anesthetics, Local|anesthetics, local|mesh-ancestor
64408628|NCT04294459|Anesthetics|anesthetics|mesh-ancestor
64408661|NCT05008861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408662|NCT05008861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64408663|NCT05008861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408665|NCT05360277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64408666|NCT05360277|Antimetabolites|antimetabolites|mesh-ancestor
64408667|NCT05360277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408668|NCT05360277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408669|NCT03091699|Nicotine|nicotine|mesh-list
64408670|NCT03091699|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64408671|NCT03091699|Autonomic Agents|autonomic agents|mesh-ancestor
64408692|NCT04253457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64408693|NCT04253457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408694|NCT05380947|Rabeprazole|rabeprazole|mesh-list
64408695|NCT05380947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64408696|NCT05380947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64408697|NCT05380947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64392444|NCT05101811|Vitamin D|vitamin d|mesh-list
64392445|NCT05101811|Ergocalciferols|ergocalciferols|mesh-list
64392446|NCT05101811|Cholecalciferol|cholecalciferol|mesh-list
64392447|NCT05101811|Vitamins|vitamins|mesh-list
64392448|NCT05101811|Micronutrients|micronutrients|mesh-ancestor
64392449|NCT05101811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392452|NCT04088123|Ticagrelor|ticagrelor|mesh-list
64408698|NCT05380947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64408699|NCT05380947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408700|NCT02525133|Bupivacaine|bupivacaine|mesh-list
64408701|NCT02525133|Anesthetics, Local|anesthetics, local|mesh-ancestor
64408702|NCT02525133|Anesthetics|anesthetics|mesh-ancestor
64515887|NCT02461056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64515888|NCT02461056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64515889|NCT02461056|Analgesics|analgesics|mesh-ancestor
64515890|NCT02461056|Sensory System Agents|sensory system agents|mesh-ancestor
64515891|NCT02461056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64515892|NCT02461056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515893|NCT02461056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64515894|NCT02461056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64515895|NCT02461056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64515896|NCT02461056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515897|NCT02461056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515898|NCT02461056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64515899|NCT02461056|Narcotics|narcotics|mesh-ancestor
64515900|NCT02461056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64408703|NCT02525133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64408704|NCT02525133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408705|NCT02525133|Sensory System Agents|sensory system agents|mesh-ancestor
64408706|NCT02525133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64408707|NCT05602311|Anesthetics|anesthetics|mesh-list
64408708|NCT05602311|Anesthetics, General|anesthetics, general|mesh-list
64408709|NCT05602311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64408710|NCT05602311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408711|NCT05016349|Tamoxifen|tamoxifen|mesh-list
64408749|NCT05380635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64408750|NCT05380635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408751|NCT05380635|Antiviral Agents|antiviral agents|mesh-ancestor
64408752|NCT05380635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64408753|NCT05380635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64408754|NCT05380635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408755|NCT05380635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64408756|NCT05380635|Immunologic Factors|immunologic factors|mesh-ancestor
64408757|NCT05380635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408758|NCT05538819|Glimepiride|glimepiride|mesh-list
64408759|NCT05538819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64408760|NCT05538819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64408761|NCT05538819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392609|NCT00708097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392610|NCT02400775|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
64392611|NCT02400775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64392612|NCT02400775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64392613|NCT02400775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392614|NCT02405689|Dexmedetomidine|dexmedetomidine|mesh-list
64392615|NCT02405689|Remifentanil|remifentanil|mesh-list
64408762|NCT05538819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64408763|NCT05538819|Immunologic Factors|immunologic factors|mesh-ancestor
64408764|NCT03079219|Dexamethasone|dexamethasone|mesh-list
64408765|NCT03079219|Dexamethasone acetate|dexamethasone acetate|mesh-list
64408766|NCT03079219|Ondansetron|ondansetron|mesh-list
64408767|NCT03079219|Olanzapine|olanzapine|mesh-list
64408768|NCT03079219|Aprepitant|aprepitant|mesh-list
64408769|NCT03079219|Fosaprepitant|fosaprepitant|mesh-list
64408770|NCT03079219|BB 1101|bb 1101|mesh-list
64408771|NCT03079219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64408772|NCT03079219|Antiemetics|antiemetics|mesh-ancestor
64408773|NCT03079219|Autonomic Agents|autonomic agents|mesh-ancestor
64408790|NCT03079219|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64408791|NCT03079219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64408798|NCT03079219|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64408800|NCT03078829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64408801|NCT03078829|Fertility Agents|fertility agents|mesh-ancestor
64408802|NCT03078829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64408803|NCT03078829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408804|NCT03078829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64408805|NCT03078829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515902|NCT01173172|Trace Elements|trace elements|mesh-ancestor
64515903|NCT01173172|Micronutrients|micronutrients|mesh-ancestor
64392633|NCT02405689|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64392759|NCT04719065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64392760|NCT04719065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515904|NCT01173172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515905|NCT00003270|Cyclosporine|cyclosporine|mesh-list
64515906|NCT00003270|Methylprednisolone|methylprednisolone|mesh-list
64515907|NCT00003270|Cyclophosphamide|cyclophosphamide|mesh-list
64515908|NCT00003270|Busulfan|busulfan|mesh-list
64515909|NCT00003270|Cyclosporins|cyclosporins|mesh-list
64515910|NCT00003270|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64515911|NCT00003270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64515912|NCT00003270|Immunologic Factors|immunologic factors|mesh-ancestor
64515913|NCT00003270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515914|NCT00003270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64515915|NCT00003270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64515916|NCT00003270|Alkylating Agents|alkylating agents|mesh-ancestor
64408807|NCT05008237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408808|NCT05008237|Tubulin Modulators|tubulin modulators|mesh-ancestor
64408809|NCT05008237|Antimitotic Agents|antimitotic agents|mesh-ancestor
64408810|NCT05008237|Mitosis Modulators|mitosis modulators|mesh-ancestor
64408811|NCT05008237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408812|NCT05014711|Fentanyl|fentanyl|mesh-list
64408813|NCT05014711|Remifentanil|remifentanil|mesh-list
64408814|NCT05014711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64408815|NCT05014711|Narcotics|narcotics|mesh-ancestor
64408816|NCT05014711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64408817|NCT05014711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408818|NCT05014711|Analgesics|analgesics|mesh-ancestor
64408819|NCT05014711|Sensory System Agents|sensory system agents|mesh-ancestor
64408820|NCT05014711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64408821|NCT05014711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64408822|NCT05014711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64408823|NCT05014711|Anesthetics, General|anesthetics, general|mesh-ancestor
64408824|NCT05014711|Anesthetics|anesthetics|mesh-ancestor
64408825|NCT05018923|Metronidazole|metronidazole|mesh-list
64408826|NCT05018923|Doxycycline|doxycycline|mesh-list
64408827|NCT05018923|Tetracycline|tetracycline|mesh-list
64408828|NCT05018923|Potassium Citrate|potassium citrate|mesh-list
64408829|NCT05018923|Rabeprazole|rabeprazole|mesh-list
64408830|NCT05018923|Bismuth|bismuth|mesh-list
64408831|NCT05018923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408832|NCT05018923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64408833|NCT05018923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64408834|NCT05018923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64408835|NCT05018923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64408836|NCT05018923|Antimalarials|antimalarials|mesh-ancestor
64618949|NCT03655444|Nivolumab|nivolumab|mesh-list
64408837|NCT05018923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64408838|NCT05018923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64408852|NCT03086473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408853|NCT03086473|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64408854|NCT03086473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64408855|NCT03086473|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64408856|NCT03086473|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64408857|NCT03086473|Purinergic Agents|purinergic agents|mesh-ancestor
64408858|NCT03086473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64408860|NCT03086005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64408877|NCT05001529|Immunologic Factors|immunologic factors|mesh-ancestor
64408878|NCT05001529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408880|NCT05001061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64408881|NCT05001061|Abortifacient Agents|abortifacient agents|mesh-ancestor
64515917|NCT00003270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515918|NCT00003270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64515919|NCT00003270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64515920|NCT00003270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515921|NCT00003270|Antifungal Agents|antifungal agents|mesh-ancestor
64515922|NCT00003270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64515923|NCT00003270|Dermatologic Agents|dermatologic agents|mesh-ancestor
64515924|NCT00003270|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64515925|NCT00003270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64515927|NCT00003270|Autonomic Agents|autonomic agents|mesh-ancestor
64515928|NCT00003270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64408882|NCT05001061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64408883|NCT05001061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408884|NCT05001061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64408885|NCT05001061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64408886|NCT05001061|Oxytocics|oxytocics|mesh-ancestor
64408887|NCT05531955|Pirfenidone|pirfenidone|mesh-list
64408888|NCT05531955|Analgesics|analgesics|mesh-ancestor
64408889|NCT05531955|Sensory System Agents|sensory system agents|mesh-ancestor
64408890|NCT05531955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64408891|NCT05531955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408892|NCT05531955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64408893|NCT05531955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64408894|NCT05531955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64408895|NCT05531955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64408896|NCT05531955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408898|NCT05339529|Thymalfasin|thymalfasin|mesh-list
64408899|NCT05339529|Glycine Agents|glycine agents|mesh-ancestor
64408900|NCT05339529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64408901|NCT05339529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408902|NCT05339529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408903|NCT05339529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64408904|NCT05339529|Immunologic Factors|immunologic factors|mesh-ancestor
64408905|NCT05006911|Bromfenac|bromfenac|mesh-list
64408906|NCT05006911|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64408907|NCT05006911|Phenylephrine|phenylephrine|mesh-list
64408908|NCT05006911|Oxymetazoline|oxymetazoline|mesh-list
64392956|NCT02404519|Vitamins|vitamins|mesh-ancestor
64392957|NCT02404519|Micronutrients|micronutrients|mesh-ancestor
64392958|NCT02404519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392959|NCT03173131|Analgesics, Opioid|analgesics, opioid|mesh-list
64392960|NCT03173131|Narcotics|narcotics|mesh-ancestor
64392961|NCT03173131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64392962|NCT03173131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392963|NCT03173131|Analgesics|analgesics|mesh-ancestor
64392964|NCT03173131|Sensory System Agents|sensory system agents|mesh-ancestor
64392965|NCT03173131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393598|NCT01984294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64393599|NCT01984294|Antimetabolites|antimetabolites|mesh-ancestor
64393600|NCT01984294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408909|NCT05006911|Hyaluronic Acid|hyaluronic acid|mesh-list
64408910|NCT05006911|Pilocarpine|pilocarpine|mesh-list
64408911|NCT05006911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64408912|NCT05006911|Immunologic Factors|immunologic factors|mesh-ancestor
64408942|NCT05339295|Levofloxacin|levofloxacin|mesh-list
64408943|NCT05339295|Ofloxacin|ofloxacin|mesh-list
64408944|NCT05339295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64408945|NCT05339295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64408946|NCT05339295|Renal Agents|renal agents|mesh-ancestor
64408947|NCT05339295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64408948|NCT05339295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64408949|NCT05339295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64408950|NCT05339295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64408951|NCT05339295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408952|NCT05339295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618951|NCT03655444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408956|NCT02637037|Dapagliflozin|dapagliflozin|mesh-list
64408957|NCT02637037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64408958|NCT02637037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408959|NCT02637037|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64515929|NCT00003270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64515930|NCT00003270|Glucocorticoids|glucocorticoids|mesh-ancestor
64515931|NCT00003270|Hormones|hormones|mesh-ancestor
64515932|NCT00003270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64515933|NCT00003270|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64515934|NCT00003270|Protective Agents|protective agents|mesh-ancestor
64515935|NCT02005354|Nitrous Oxide|nitrous oxide|mesh-list
64515936|NCT02005354|Anesthetics|anesthetics|mesh-list
64515937|NCT02005354|Anesthetics, Local|anesthetics, local|mesh-list
64515938|NCT02005354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64515939|NCT02005354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515940|NCT02005354|Sensory System Agents|sensory system agents|mesh-ancestor
64515941|NCT02005354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64515942|NCT02005354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64515943|NCT02005354|Anesthetics, General|anesthetics, general|mesh-ancestor
64515944|NCT02005354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64515945|NCT02005354|Analgesics|analgesics|mesh-ancestor
64515946|NCT03290820|Aspirin|aspirin|mesh-list
64515947|NCT03290820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64515949|NCT03290820|Analgesics|analgesics|mesh-ancestor
64515950|NCT03290820|Sensory System Agents|sensory system agents|mesh-ancestor
64515951|NCT03290820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393740|NCT01981954|Solifenacin Succinate|solifenacin succinate|mesh-list
64393741|NCT01981954|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64393742|NCT01981954|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64393743|NCT01981954|Cholinergic Agents|cholinergic agents|mesh-ancestor
64393744|NCT01981954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64393745|NCT01981954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393746|NCT01981954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393747|NCT01981954|Urological Agents|urological agents|mesh-ancestor
64393749|NCT03727139|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64394037|NCT05228483|Dermatologic Agents|dermatologic agents|mesh-ancestor
64515952|NCT03290820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515953|NCT03290820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64515954|NCT03290820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64515955|NCT03290820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64515956|NCT03290820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64515957|NCT03290820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408960|NCT02637037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408961|NCT05307081|Lubricant Eye Drops|lubricant eye drops|mesh-list
64408962|NCT05307081|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64408963|NCT05307081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64408964|NCT05306535|Salicylic Acid|salicylic acid|mesh-list
64408965|NCT05306535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64408966|NCT05306535|Antifungal Agents|antifungal agents|mesh-ancestor
64515959|NCT03290820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64515960|NCT03290820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64515961|NCT03290820|Antipyretics|antipyretics|mesh-ancestor
64515962|NCT03295110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64515963|NCT03773484|Analgesics, Opioid|analgesics, opioid|mesh-list
64515964|NCT03773484|Narcotics|narcotics|mesh-ancestor
64515965|NCT03773484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64515966|NCT03773484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515967|NCT03773484|Analgesics|analgesics|mesh-ancestor
64515968|NCT03773484|Sensory System Agents|sensory system agents|mesh-ancestor
64515969|NCT03773484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64515970|NCT03283410|Propofol|propofol|mesh-list
64515971|NCT03283410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64515972|NCT03283410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64515973|NCT03283410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515974|NCT03283410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64515975|NCT03283410|Anesthetics, General|anesthetics, general|mesh-ancestor
64408968|NCT05306535|Dermatologic Agents|dermatologic agents|mesh-ancestor
64408969|NCT02637895|Vortioxetine|vortioxetine|mesh-list
64408970|NCT02637895|Antidepressive Agents|antidepressive agents|mesh-ancestor
64409013|NCT05007223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64409014|NCT05007223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64409016|NCT05007223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64409017|NCT05007223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64409018|NCT05000281|Ibuprofen|ibuprofen|mesh-list
64409019|NCT05000281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64409020|NCT05000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64409021|NCT05000281|Analgesics|analgesics|mesh-ancestor
64409022|NCT05000281|Sensory System Agents|sensory system agents|mesh-ancestor
64409023|NCT05000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409024|NCT05000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409025|NCT05000281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64409026|NCT05000281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64409027|NCT05000281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64409028|NCT05000281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409029|NCT05000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409034|NCT03081949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409036|NCT03081949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409037|NCT03081949|Trace Elements|trace elements|mesh-ancestor
64409051|NCT05347173|Adrenergic Agents|adrenergic agents|mesh-ancestor
64409052|NCT05347173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64409053|NCT05347173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409054|NCT05347173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64409056|NCT05006287|Warfarin|warfarin|mesh-list
64409057|NCT05006287|Rivaroxaban|rivaroxaban|mesh-list
64409058|NCT05006287|Dabigatran|dabigatran|mesh-list
64515976|NCT03283410|Anesthetics|anesthetics|mesh-ancestor
64515977|NCT04318704|Ifenprodil|ifenprodil|mesh-list
64515978|NCT04318704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64515979|NCT04318704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64515980|NCT04318704|Adrenergic Agents|adrenergic agents|mesh-ancestor
64515981|NCT04318704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64397615|NCT01951378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64515982|NCT04318704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64515983|NCT04318704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515984|NCT04318704|Vasodilator Agents|vasodilator agents|mesh-ancestor
64515985|NCT04318704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64515986|NCT04318704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64515987|NCT03283176|Folic Acid|folic acid|mesh-list
64515988|NCT03283176|Vitamin B 12|vitamin b 12|mesh-list
64515989|NCT03283176|Hydroxocobalamin|hydroxocobalamin|mesh-list
64515990|NCT03283176|Vitamins|vitamins|mesh-ancestor
64515991|NCT03283176|Micronutrients|micronutrients|mesh-ancestor
64515992|NCT03283176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515993|NCT03283176|Hematinics|hematinics|mesh-ancestor
64515994|NCT03283176|Vitamin B Complex|vitamin b complex|mesh-ancestor
64515995|NCT03290430|Nicotine|nicotine|mesh-list
64515996|NCT03290430|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64409059|NCT05006287|Apixaban|apixaban|mesh-list
64409060|NCT05006287|Anticoagulants|anticoagulants|mesh-list
64409061|NCT05006287|Edoxaban|edoxaban|mesh-list
64409062|NCT05006287|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64409063|NCT05006287|Antithrombins|antithrombins|mesh-ancestor
64409064|NCT05006287|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64409065|NCT05006287|Protease Inhibitors|protease inhibitors|mesh-ancestor
64409066|NCT05006287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397698|NCT02366299|Sensory System Agents|sensory system agents|mesh-ancestor
64397699|NCT02366299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64397700|NCT02366299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64397702|NCT02366299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64397722|NCT05041985|Anesthetics, General|anesthetics, general|mesh-ancestor
64397723|NCT05041985|Anesthetics|anesthetics|mesh-ancestor
64397724|NCT05041985|GABA Modulators|gaba modulators|mesh-ancestor
64397725|NCT05041985|GABA Agents|gaba agents|mesh-ancestor
64397726|NCT05041985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64409067|NCT05006287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409068|NCT05013151|Castor Oil|castor oil|mesh-list
64409069|NCT05013151|Cathartics|cathartics|mesh-ancestor
64409070|NCT05013151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64409071|NCT05006209|Calcium|calcium|mesh-list
64409072|NCT05006209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64409076|NCT05335629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409097|NCT05554965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64409098|NCT05554965|Anesthetics, General|anesthetics, general|mesh-ancestor
64409099|NCT05554965|Anesthetics|anesthetics|mesh-ancestor
64409112|NCT05554419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409113|NCT05554419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397765|NCT05052515|Lipotropic Agents|lipotropic agents|mesh-ancestor
64409114|NCT05554419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64515997|NCT03290430|Autonomic Agents|autonomic agents|mesh-ancestor
64515998|NCT03290430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64515999|NCT03290430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516000|NCT03290430|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64516001|NCT03290430|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64516002|NCT03290430|Cholinergic Agents|cholinergic agents|mesh-ancestor
64516003|NCT03290430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64516004|NCT03290430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516005|NCT03294798|Interferons|interferons|mesh-list
64516006|NCT03294798|Interferon-alpha|interferon-alpha|mesh-list
64516007|NCT03294798|Interferon alpha-2|interferon alpha-2|mesh-list
64516008|NCT03294798|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64516009|NCT03294798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516010|NCT03294798|Antiviral Agents|antiviral agents|mesh-ancestor
64516011|NCT03294798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64516012|NCT03294798|Immunologic Factors|immunologic factors|mesh-ancestor
64409115|NCT05554419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64409116|NCT05554419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64409117|NCT05554341|Paclitaxel|paclitaxel|mesh-list
64409118|NCT05554341|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64409119|NCT05554341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64409120|NCT05554341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409121|NCT05554341|Tubulin Modulators|tubulin modulators|mesh-ancestor
64409122|NCT05554341|Antimitotic Agents|antimitotic agents|mesh-ancestor
64409123|NCT05554341|Mitosis Modulators|mitosis modulators|mesh-ancestor
64409124|NCT05554341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409125|NCT05529147|Antihypertensive Agents|antihypertensive agents|mesh-list
64409126|NCT05505825|Chiauranib|chiauranib|mesh-list
64409127|NCT05505825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64397899|NCT01968694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64409128|NCT05505825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64409129|NCT05505825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409130|NCT05505825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409131|NCT05268003|Venetoclax|venetoclax|mesh-list
64409132|NCT05268003|Ponatinib|ponatinib|mesh-list
64409133|NCT05268003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409134|NCT05268003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64409135|NCT05268003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409136|NCT05268003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409137|NCT05331573|Apomorphine|apomorphine|mesh-list
64409138|NCT05331573|Emetics|emetics|mesh-ancestor
64516016|NCT04488744|Autonomic Agents|autonomic agents|mesh-ancestor
64516017|NCT04488744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516018|NCT04488744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516019|NCT04488744|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64516020|NCT04488744|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64516021|NCT04488744|Cholinergic Agents|cholinergic agents|mesh-ancestor
64516022|NCT04488744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64516023|NCT04488744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516025|NCT02005666|Clindamycin palmitate|clindamycin palmitate|mesh-list
64516026|NCT02005666|Clindamycin phosphate|clindamycin phosphate|mesh-list
64516027|NCT02005666|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64516028|NCT02005666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64516029|NCT02005666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64516030|NCT02005666|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64516031|NCT02005666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409139|NCT05331573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409140|NCT05331573|Autonomic Agents|autonomic agents|mesh-ancestor
64409141|NCT05331573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409142|NCT05331573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64409143|NCT05331573|Dopamine Agonists|dopamine agonists|mesh-ancestor
64409144|NCT05331573|Dopamine Agents|dopamine agents|mesh-ancestor
64409145|NCT05331573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64409146|NCT05331573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409147|NCT05262855|FAPI-46|fapi-46|mesh-list
64409148|NCT05262855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64409149|NCT05262855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409150|NCT05262777|Lidocaine|lidocaine|mesh-list
64409151|NCT05262777|Anesthetics, Local|anesthetics, local|mesh-ancestor
64397996|NCT05049473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64398048|NCT03160261|Hormones|hormones|mesh-ancestor
64409152|NCT05262777|Anesthetics|anesthetics|mesh-ancestor
64409153|NCT05262777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64409154|NCT05262777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409155|NCT05262777|Sensory System Agents|sensory system agents|mesh-ancestor
64409156|NCT05262777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409157|NCT05262777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64409158|NCT05262777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64409159|NCT05262777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64398062|NCT02361619|Clarithromycin|clarithromycin|mesh-list
64409160|NCT05262777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64409161|NCT05262777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409162|NCT05260359|Ethanol|ethanol|mesh-list
64409171|NCT05260359|Dermatologic Agents|dermatologic agents|mesh-ancestor
64409172|NCT05260359|Emollients|emollients|mesh-ancestor
64409173|NCT05331027|Sevoflurane|sevoflurane|mesh-list
64409174|NCT05331027|Desflurane|desflurane|mesh-list
64409175|NCT05331027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64409176|NCT05331027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64409177|NCT05331027|Anesthetics, General|anesthetics, general|mesh-ancestor
64409178|NCT05331027|Anesthetics|anesthetics|mesh-ancestor
64409179|NCT05331027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64409180|NCT05331027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409181|NCT05329155|Heparin|heparin|mesh-list
64516032|NCT02005666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516033|NCT02005666|Dermatologic Agents|dermatologic agents|mesh-ancestor
64516034|NCT03283020|Naltrexone|naltrexone|mesh-list
64516035|NCT03283020|Remifentanil|remifentanil|mesh-list
64516036|NCT03283020|Methylnaltrexone|methylnaltrexone|mesh-list
64516037|NCT03283020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64516038|NCT03283020|Narcotics|narcotics|mesh-ancestor
64516039|NCT03283020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64516040|NCT03283020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516041|NCT03283020|Analgesics|analgesics|mesh-ancestor
64516042|NCT03283020|Sensory System Agents|sensory system agents|mesh-ancestor
64516043|NCT03283020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516044|NCT03283020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64516045|NCT03283020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64516047|NCT00494182|Carboplatin|carboplatin|mesh-list
64516048|NCT00494182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64516049|NCT00494182|Sorafenib|sorafenib|mesh-list
64516050|NCT00494182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64516051|NCT00494182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516052|NCT00494182|Tubulin Modulators|tubulin modulators|mesh-ancestor
64516053|NCT00494182|Antimitotic Agents|antimitotic agents|mesh-ancestor
64409182|NCT05329155|Calcium heparin|calcium heparin|mesh-list
64409183|NCT05329155|Anticoagulants|anticoagulants|mesh-ancestor
64409213|NCT02522325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409214|NCT02522325|Dopamine Agents|dopamine agents|mesh-ancestor
64398154|NCT05047991|Antimitotic Agents|antimitotic agents|mesh-ancestor
64409215|NCT02522325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64409216|NCT02522325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64409217|NCT05326347|Brexpiprazole|brexpiprazole|mesh-list
64409218|NCT05326347|Serotonin Agents|serotonin agents|mesh-ancestor
64409219|NCT05326347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64409220|NCT05326347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409221|NCT05326347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409222|NCT05326347|Dopamine Agonists|dopamine agonists|mesh-ancestor
64409223|NCT05326347|Dopamine Agents|dopamine agents|mesh-ancestor
64409224|NCT01659021|Ofatumumab|ofatumumab|mesh-list
64409225|NCT01659021|Idelalisib|idelalisib|mesh-list
64409226|NCT01659021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409277|NCT02524665|Antifungal Agents|antifungal agents|mesh-ancestor
64409278|NCT02524665|Keratolytic Agents|keratolytic agents|mesh-ancestor
64409296|NCT04998253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409297|NCT04998253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64409298|NCT04998253|Anesthetics, General|anesthetics, general|mesh-ancestor
64409300|NCT04998253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64516054|NCT00494182|Mitosis Modulators|mitosis modulators|mesh-ancestor
64516055|NCT00494182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516056|NCT00494182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64516057|NCT00494182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64516058|NCT02006056|Ondansetron|ondansetron|mesh-list
64516059|NCT02006056|Antiemetics|antiemetics|mesh-ancestor
64516060|NCT02006056|Autonomic Agents|autonomic agents|mesh-ancestor
64409301|NCT04998253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64409302|NCT05616923|Trametinib|trametinib|mesh-list
64409303|NCT05616923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409304|NCT05616923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64409305|NCT05616923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409306|NCT05616923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409307|NCT02638129|Naltrexone|naltrexone|mesh-list
64409308|NCT02638129|Bupropion|bupropion|mesh-list
64409309|NCT02638129|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64409310|NCT02638129|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64409311|NCT02638129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398211|NCT02357407|Renal Agents|renal agents|mesh-ancestor
64409312|NCT02638129|Sensory System Agents|sensory system agents|mesh-ancestor
64409313|NCT02638129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409314|NCT02638129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64409315|NCT02638129|Antidepressive Agents|antidepressive agents|mesh-ancestor
64409316|NCT02638129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64409317|NCT02638129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64409318|NCT02638129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64409319|NCT02638129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64409320|NCT02638129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409321|NCT02638129|Dopamine Agents|dopamine agents|mesh-ancestor
64409322|NCT02638129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64409323|NCT02638129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64618967|NCT03866434|Anagrelide|anagrelide|mesh-list
64409324|NCT02638129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64618968|NCT03866434|Omeprazole|omeprazole|mesh-list
64618969|NCT03866434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64409325|NCT02638129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409327|NCT02524275|Capecitabine|capecitabine|mesh-list
64409328|NCT02524275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409329|NCT02524275|Tubulin Modulators|tubulin modulators|mesh-ancestor
64409330|NCT02524275|Antimitotic Agents|antimitotic agents|mesh-ancestor
64409331|NCT02524275|Mitosis Modulators|mitosis modulators|mesh-ancestor
64398299|NCT03149653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64409332|NCT02524275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409333|NCT02524275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64409334|NCT02524275|Antimetabolites|antimetabolites|mesh-ancestor
64409335|NCT03079687|Olaparib|olaparib|mesh-list
64409336|NCT03079687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64409337|NCT03079687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409338|NCT03079687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409339|NCT03079687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409340|NCT04997707|Propofol|propofol|mesh-list
64409341|NCT04997707|Sevoflurane|sevoflurane|mesh-list
64409342|NCT04997707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64409343|NCT04997707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64409344|NCT04997707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409388|NCT04433533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64409390|NCT04433533|Antimetabolites|antimetabolites|mesh-ancestor
64409391|NCT04433533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409392|NCT04433533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64409393|NCT04433533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64409394|NCT04433533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409430|NCT03077503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64409431|NCT03077503|Narcotics|narcotics|mesh-ancestor
64409432|NCT03077503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64409433|NCT03077503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64409434|NCT03077503|Anesthetics, General|anesthetics, general|mesh-ancestor
64409435|NCT03077503|Anesthetics|anesthetics|mesh-ancestor
64409436|NCT05246085|Hydrocortisone|hydrocortisone|mesh-list
64516061|NCT02006056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516062|NCT02006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516064|NCT02006056|Antipruritics|antipruritics|mesh-ancestor
64516065|NCT02006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
64516066|NCT02006056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64516067|NCT02006056|Serotonin Agents|serotonin agents|mesh-ancestor
64516068|NCT02006056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64516069|NCT02006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516070|NCT02006056|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64516071|NCT02006056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64516072|NCT02006056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64516073|NCT02006056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64516074|NCT02006056|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64516075|NCT03290196|Bupivacaine|bupivacaine|mesh-list
64516076|NCT03290196|Anesthetics, Local|anesthetics, local|mesh-ancestor
64516077|NCT03290196|Anesthetics|anesthetics|mesh-ancestor
64398413|NCT02350543|Antipyretics|antipyretics|mesh-ancestor
64398414|NCT05023577|Metronidazole|metronidazole|mesh-list
64398415|NCT05023577|Clarithromycin|clarithromycin|mesh-list
64398416|NCT05023577|Levofloxacin|levofloxacin|mesh-list
64398417|NCT05023577|Ofloxacin|ofloxacin|mesh-list
64398418|NCT05023577|Potassium Citrate|potassium citrate|mesh-list
64516078|NCT03290196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64516079|NCT03290196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516080|NCT03290196|Sensory System Agents|sensory system agents|mesh-ancestor
64516081|NCT03290196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516083|NCT02006836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64516084|NCT02006836|Metformin|metformin|mesh-list
64516085|NCT02006836|Insulin Aspart|insulin aspart|mesh-list
64516086|NCT02006836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64516087|NCT02006836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516088|NCT02068846|Ciprofloxacin|ciprofloxacin|mesh-list
64516089|NCT02068846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64409469|NCT03073057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64409470|NCT03073057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409472|NCT03073057|Protective Agents|protective agents|mesh-ancestor
64409473|NCT03073369|Ergocalciferols|ergocalciferols|mesh-list
64409474|NCT03073369|Vitamin D|vitamin d|mesh-list
64409510|NCT04362839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409511|NCT04362839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64409512|NCT04362839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409513|NCT04360889|Tocopherols|tocopherols|mesh-list
64409514|NCT04360889|Vitamin E|vitamin e|mesh-list
64409515|NCT04360889|Tocotrienols|tocotrienols|mesh-list
64409516|NCT04360889|alpha-Tocopherol|alpha-tocopherol|mesh-list
64409517|NCT04360889|Antioxidants|antioxidants|mesh-ancestor
64409518|NCT04360889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409519|NCT04360889|Protective Agents|protective agents|mesh-ancestor
64409520|NCT04360889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409521|NCT04360889|Vitamins|vitamins|mesh-ancestor
64409522|NCT04360889|Micronutrients|micronutrients|mesh-ancestor
64409523|NCT03072589|Regadenoson|regadenoson|mesh-list
64516090|NCT02068846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64516091|NCT02068846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64516092|NCT02068846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64516093|NCT02068846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64516094|NCT02068846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516095|NCT02068846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516096|NCT02068846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64516097|NCT02068846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64516098|NCT03289728|Dobutamine|dobutamine|mesh-list
64516099|NCT03289728|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64516100|NCT03289728|Sympathomimetics|sympathomimetics|mesh-ancestor
64516101|NCT03289728|Autonomic Agents|autonomic agents|mesh-ancestor
64516102|NCT03289728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516103|NCT03289728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516104|NCT03289728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64516105|NCT03289728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64516106|NCT03289728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64516107|NCT03289728|Adrenergic Agents|adrenergic agents|mesh-ancestor
64516108|NCT03289728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64516109|NCT03289728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516110|NCT03289728|Protective Agents|protective agents|mesh-ancestor
64516111|NCT03294486|Flucytosine|flucytosine|mesh-list
64516112|NCT03294486|Antifungal Agents|antifungal agents|mesh-ancestor
64516113|NCT03294486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64516114|NCT03294486|Antimetabolites|antimetabolites|mesh-ancestor
64409524|NCT03072589|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64409525|NCT03072589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64409526|NCT03072589|Purinergic Agonists|purinergic agonists|mesh-ancestor
64409527|NCT03072589|Purinergic Agents|purinergic agents|mesh-ancestor
64409528|NCT03072589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64409529|NCT03072589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409530|NCT03072589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409531|NCT04994743|Cortisone|cortisone|mesh-list
64409532|NCT04994743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64409533|NCT04994353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64409572|NCT03072511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409573|NCT03072511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64409574|NCT03072511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64409575|NCT03072511|Cholinergic Agents|cholinergic agents|mesh-ancestor
64409576|NCT03072511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64409577|NCT03072511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409579|NCT03072121|Metoprolol|metoprolol|mesh-list
64409580|NCT03072121|Isosorbide|isosorbide|mesh-list
64409581|NCT03072121|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64409582|NCT03072121|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64409613|NCT03072121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64516115|NCT03294486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516118|NCT03294252|Fluorouracil|fluorouracil|mesh-list
64516119|NCT03294252|Oxaliplatin|oxaliplatin|mesh-list
64516120|NCT03294252|Levoleucovorin|levoleucovorin|mesh-list
64516121|NCT03294252|Antimetabolites|antimetabolites|mesh-ancestor
64516122|NCT03294252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516123|NCT03294252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64516124|NCT03294252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516125|NCT03294252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64516126|NCT03294252|Immunologic Factors|immunologic factors|mesh-ancestor
64618983|NCT00962039|Serotonin Agents|serotonin agents|mesh-ancestor
64516127|NCT03294252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516128|NCT03294252|Antidotes|antidotes|mesh-ancestor
64516129|NCT03294252|Protective Agents|protective agents|mesh-ancestor
64516130|NCT03294252|Vitamin B Complex|vitamin b complex|mesh-ancestor
64516132|NCT03294252|Micronutrients|micronutrients|mesh-ancestor
64516133|NCT03294252|Hematinics|hematinics|mesh-ancestor
64516134|NCT03294174|Ropivacaine|ropivacaine|mesh-list
64516135|NCT03294174|Anesthetics, Local|anesthetics, local|mesh-ancestor
64516136|NCT03294174|Anesthetics|anesthetics|mesh-ancestor
64409614|NCT03072121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64409615|NCT03072121|Sympatholytics|sympatholytics|mesh-ancestor
64409616|NCT03072121|Autonomic Agents|autonomic agents|mesh-ancestor
64409617|NCT03072121|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64409618|NCT03072121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64409635|NCT04987567|Protective Agents|protective agents|mesh-ancestor
64409668|NCT04806425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64409669|NCT04806425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64409670|NCT03071731|Bromides|bromides|mesh-list
64409671|NCT03071731|Ipratropium|ipratropium|mesh-list
64409672|NCT03071731|Bronchodilator Agents|bronchodilator agents|mesh-list
64409673|NCT03071731|Anticonvulsants|anticonvulsants|mesh-ancestor
64409674|NCT03071731|Autonomic Agents|autonomic agents|mesh-ancestor
64409675|NCT03071731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409676|NCT03071731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409677|NCT03071731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64409678|NCT03071731|Respiratory System Agents|respiratory system agents|mesh-ancestor
64409679|NCT03071731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64409715|NCT04798391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409716|NCT04798391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409717|NCT04798391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64409718|NCT04798391|Glucocorticoids|glucocorticoids|mesh-ancestor
64409719|NCT04798391|Hormones|hormones|mesh-ancestor
64409720|NCT04798391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64409721|NCT04798391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64409722|NCT04798391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409723|NCT03071497|Protoporphyrin IX|protoporphyrin ix|mesh-list
64409724|NCT03071497|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
64516137|NCT03294174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64516138|NCT03294174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516139|NCT03294174|Sensory System Agents|sensory system agents|mesh-ancestor
64398582|NCT02349919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64398583|NCT02349919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64516140|NCT03294174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516141|NCT03289338|Zoledronic Acid|zoledronic acid|mesh-list
64516142|NCT03289338|Methylprednisolone|methylprednisolone|mesh-list
64516143|NCT03289338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64516144|NCT03289338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64516146|NCT03289338|Prednisolone acetate|prednisolone acetate|mesh-list
64516147|NCT03289338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64516148|NCT03289338|Prednisolone phosphate|prednisolone phosphate|mesh-list
64516149|NCT03289338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64516151|NCT03289338|Autonomic Agents|autonomic agents|mesh-ancestor
64516152|NCT03289338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516153|NCT03289338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516154|NCT03289338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64516155|NCT03289338|Glucocorticoids|glucocorticoids|mesh-ancestor
64516156|NCT03289338|Hormones|hormones|mesh-ancestor
64516157|NCT03289338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64516158|NCT03289338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64516159|NCT03289338|Protective Agents|protective agents|mesh-ancestor
64516160|NCT03289338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64516161|NCT03289338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516162|NCT03289338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64516163|NCT02069704|Leucovorin|leucovorin|mesh-list
64516164|NCT02069704|Folic Acid|folic acid|mesh-list
64516167|NCT02069704|Oxaliplatin|oxaliplatin|mesh-list
64516169|NCT02069704|Levoleucovorin|levoleucovorin|mesh-list
64516170|NCT02069704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64516171|NCT02069704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516172|NCT02069704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64516173|NCT02069704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64516174|NCT02069704|Growth Substances|growth substances|mesh-ancestor
64409725|NCT03071497|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64516176|NCT02069704|Growth Inhibitors|growth inhibitors|mesh-ancestor
64516177|NCT02069704|Antimetabolites|antimetabolites|mesh-ancestor
64516178|NCT02069704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516179|NCT02069704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64516180|NCT02069704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64516181|NCT02069704|Immunologic Factors|immunologic factors|mesh-ancestor
64516182|NCT02069704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64516183|NCT02069704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64398611|NCT02349841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398614|NCT02354053|Triumeq|triumeq|mesh-list
64516184|NCT02069704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64516186|NCT02069704|Protective Agents|protective agents|mesh-ancestor
64516187|NCT02069704|Vitamin B Complex|vitamin b complex|mesh-ancestor
64516188|NCT02069704|Vitamins|vitamins|mesh-ancestor
64516189|NCT02069704|Micronutrients|micronutrients|mesh-ancestor
64516190|NCT02069704|Hematinics|hematinics|mesh-ancestor
64409726|NCT03071497|Dermatologic Agents|dermatologic agents|mesh-ancestor
64409727|NCT03071497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409728|NCT03071497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409729|NCT05616455|Nitroglycerin|nitroglycerin|mesh-list
64409730|NCT05616455|Vasodilator Agents|vasodilator agents|mesh-ancestor
64409731|NCT04986319|Vitamin D|vitamin d|mesh-list
64409732|NCT04986319|Vitamins|vitamins|mesh-ancestor
64409733|NCT04986319|Micronutrients|micronutrients|mesh-ancestor
64409734|NCT04986319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409777|NCT04989127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409778|NCT04989127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409779|NCT04982809|Dexamethasone|dexamethasone|mesh-list
64409780|NCT04982809|Prednisolone|prednisolone|mesh-list
64409781|NCT04982809|Betamethasone|betamethasone|mesh-list
64409782|NCT04982809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64409783|NCT04982809|Antiemetics|antiemetics|mesh-ancestor
64409784|NCT04982809|Autonomic Agents|autonomic agents|mesh-ancestor
64409785|NCT04982809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409786|NCT04982809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409820|NCT05279703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409821|NCT05279703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64409822|NCT05279703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64409823|NCT05279703|Autonomic Agents|autonomic agents|mesh-ancestor
64409824|NCT05279703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409825|NCT05279703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64409826|NCT05279703|Respiratory System Agents|respiratory system agents|mesh-ancestor
64409827|NCT05279703|Mydriatics|mydriatics|mesh-ancestor
64409828|NCT05279703|Sympathomimetics|sympathomimetics|mesh-ancestor
64409829|NCT05279703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64409830|NCT05392933|Lidocaine|lidocaine|mesh-list
64409831|NCT05392933|Anesthetics, Local|anesthetics, local|mesh-ancestor
64409832|NCT05392933|Anesthetics|anesthetics|mesh-ancestor
64409833|NCT05392933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64409834|NCT05392933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409835|NCT05392933|Sensory System Agents|sensory system agents|mesh-ancestor
64409836|NCT05392933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409837|NCT05392933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64409838|NCT05392933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64409839|NCT05392933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64409840|NCT05392933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64409841|NCT05392933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409842|NCT04796675|Cyclophosphamide|cyclophosphamide|mesh-list
64409843|NCT04796675|Fludarabine|fludarabine|mesh-list
64409924|NCT04240821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64409925|NCT04240821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409926|NCT04240821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516192|NCT02314546|Midazolam|midazolam|mesh-list
64516193|NCT02314546|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64516194|NCT02314546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64516195|NCT02314546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64516196|NCT02314546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516197|NCT02314546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64516198|NCT02314546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64516199|NCT02314546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64516200|NCT02314546|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64516201|NCT02314546|Anesthetics, General|anesthetics, general|mesh-ancestor
64516202|NCT02314546|Anesthetics|anesthetics|mesh-ancestor
64516203|NCT02314546|GABA Modulators|gaba modulators|mesh-ancestor
64516204|NCT02314546|GABA Agents|gaba agents|mesh-ancestor
64516205|NCT02314546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64516206|NCT02314546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516207|NCT02314546|Anesthetics, Local|anesthetics, local|mesh-ancestor
64409927|NCT04240821|Vasodilator Agents|vasodilator agents|mesh-ancestor
64409928|NCT04240821|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64409948|NCT05221749|Cariostatic Agents|cariostatic agents|mesh-ancestor
64409949|NCT05221749|Protective Agents|protective agents|mesh-ancestor
64409950|NCT05221749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409951|NCT04426721|Hyaluronic Acid|hyaluronic acid|mesh-list
64409952|NCT04426721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64409953|NCT04426721|Immunologic Factors|immunologic factors|mesh-ancestor
64409998|NCT04988191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410075|NCT05209425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64410076|NCT05209425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64410078|NCT04793243|Cholecalciferol|cholecalciferol|mesh-list
64410079|NCT04793243|Vitamins|vitamins|mesh-ancestor
64410080|NCT04793243|Micronutrients|micronutrients|mesh-ancestor
64410081|NCT04793243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410082|NCT04793243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64410083|NCT04793243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64410084|NCT04793399|Atezolizumab|atezolizumab|mesh-list
64410113|NCT05157711|Hemostatics|hemostatics|mesh-ancestor
64410114|NCT05157711|Coagulants|coagulants|mesh-ancestor
64410115|NCT05105997|Dexamethasone|dexamethasone|mesh-list
64410116|NCT05105997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64410117|NCT05105997|Antiemetics|antiemetics|mesh-ancestor
64410118|NCT05105997|Autonomic Agents|autonomic agents|mesh-ancestor
64410137|NCT03424525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64410138|NCT03424525|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64410139|NCT03424525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64410141|NCT05104983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64410142|NCT05104983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64410143|NCT05104983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64410144|NCT05104983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410145|NCT05104983|Antifungal Agents|antifungal agents|mesh-ancestor
64410146|NCT05104983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64410147|NCT05104983|Immunologic Factors|immunologic factors|mesh-ancestor
64410148|NCT05104983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410149|NCT04801511|Ascorbic Acid|ascorbic acid|mesh-list
64410150|NCT04801511|Vitamins|vitamins|mesh-ancestor
64398664|NCT02347891|Belimumab|belimumab|mesh-list
64398665|NCT02347891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64398666|NCT02347891|Immunologic Factors|immunologic factors|mesh-ancestor
64398667|NCT02347891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398668|NCT03147157|Tacrolimus|tacrolimus|mesh-list
64398669|NCT03147157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64398670|NCT03147157|Immunologic Factors|immunologic factors|mesh-ancestor
64398671|NCT03147157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398672|NCT03147157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64398673|NCT03147157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398679|NCT03091595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64410152|NCT04801511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410153|NCT04801511|Antioxidants|antioxidants|mesh-ancestor
64410192|NCT05471609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516209|NCT02314546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516210|NCT02314546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64516211|NCT02314546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64516212|NCT02314546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64516213|NCT02314546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64516214|NCT03289260|Imiquimod|imiquimod|mesh-list
64516215|NCT03289260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64516216|NCT03289260|Immunologic Factors|immunologic factors|mesh-ancestor
64516217|NCT03289260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516218|NCT03289260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516219|NCT03289260|Interferon Inducers|interferon inducers|mesh-ancestor
64410193|NCT05471609|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64410194|NCT05471609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410195|NCT05370729|Acetylcysteine|acetylcysteine|mesh-list
64410196|NCT05370729|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64410197|NCT05370729|Antiviral Agents|antiviral agents|mesh-ancestor
64410200|NCT05370729|Respiratory System Agents|respiratory system agents|mesh-ancestor
64410201|NCT05370729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64410202|NCT05370729|Antioxidants|antioxidants|mesh-ancestor
64410203|NCT05370729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410204|NCT05370729|Protective Agents|protective agents|mesh-ancestor
64410205|NCT05370729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410206|NCT05370729|Antidotes|antidotes|mesh-ancestor
64410207|NCT05471531|Vaccines|vaccines|mesh-list
64410208|NCT05471531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64410209|NCT05471531|Immunologic Factors|immunologic factors|mesh-ancestor
64410210|NCT05471531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410211|NCT05204667|Acetaminophen|acetaminophen|mesh-list
64410212|NCT05204667|Aspirin|aspirin|mesh-list
64410213|NCT05204667|Methocarbamol|methocarbamol|mesh-list
64410214|NCT05204667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64410215|NCT05204667|Analgesics|analgesics|mesh-ancestor
64410216|NCT05204667|Sensory System Agents|sensory system agents|mesh-ancestor
64410252|NCT04340141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410253|NCT04340141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64410254|NCT04340141|Immunologic Factors|immunologic factors|mesh-ancestor
64410255|NCT04340141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64410284|NCT05201313|Anesthetics|anesthetics|mesh-ancestor
64410285|NCT05201313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64410286|NCT05201313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410287|NCT05201313|Sensory System Agents|sensory system agents|mesh-ancestor
64410288|NCT05201313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410289|NCT05201313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64410290|NCT05201313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64410291|NCT05201313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64410292|NCT05201313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64410293|NCT05201313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410294|NCT05201001|Carboplatin|carboplatin|mesh-list
64410295|NCT05201001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410296|NCT04799639|Paclitaxel|paclitaxel|mesh-list
64410297|NCT04799639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64410298|NCT04799639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410299|NCT04799639|Tubulin Modulators|tubulin modulators|mesh-ancestor
64410300|NCT04799639|Antimitotic Agents|antimitotic agents|mesh-ancestor
64410301|NCT04799639|Mitosis Modulators|mitosis modulators|mesh-ancestor
64410317|NCT04798703|Paclitaxel|paclitaxel|mesh-list
64410353|NCT05194293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410354|NCT04848857|Colchicine|colchicine|mesh-list
64516223|NCT03289182|Immunologic Factors|immunologic factors|mesh-ancestor
64516224|NCT03289182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516225|NCT03289182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64516226|NCT03289026|Aripiprazole|aripiprazole|mesh-list
64472326|NCT03559192|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64516227|NCT03289026|Antidepressive Agents|antidepressive agents|mesh-ancestor
64516228|NCT03289026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64516229|NCT03289026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64516230|NCT03289026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64516231|NCT03289026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64516232|NCT03289026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516233|NCT03289026|Dopamine Agonists|dopamine agonists|mesh-ancestor
64516234|NCT03289026|Dopamine Agents|dopamine agents|mesh-ancestor
64410421|NCT05089461|Sensory System Agents|sensory system agents|mesh-ancestor
64410422|NCT05089461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410423|NCT05089461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410434|NCT05730439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410435|NCT05730439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64410509|NCT05597839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64410510|NCT05597839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410511|NCT05597839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64410512|NCT05597839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410518|NCT05151263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64410519|NCT05151263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64410520|NCT05151263|Analgesics|analgesics|mesh-ancestor
64410521|NCT05151263|Sensory System Agents|sensory system agents|mesh-ancestor
64516235|NCT03289026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64516236|NCT03289026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516237|NCT03289026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64516238|NCT03289026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64516239|NCT03289026|Serotonin Agents|serotonin agents|mesh-ancestor
64516240|NCT03289026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64516241|NCT03289026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64516242|NCT03289026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64516243|NCT03289026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64516245|NCT02460510|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64516246|NCT02460510|Diuretics|diuretics|mesh-ancestor
64516247|NCT02460510|Natriuretic Agents|natriuretic agents|mesh-ancestor
64516248|NCT02460510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410592|NCT05555641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410593|NCT05555641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64410594|NCT05555641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64410596|NCT05555641|Sensory System Agents|sensory system agents|mesh-ancestor
64410597|NCT05555641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410598|NCT05555641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410599|NCT05555641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64410600|NCT05555641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64410601|NCT05555641|Protease Inhibitors|protease inhibitors|mesh-ancestor
64410602|NCT05555641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410603|NCT05555641|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64410604|NCT05555641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64410605|NCT05555641|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64410606|NCT05555641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64410607|NCT05555641|Immunologic Factors|immunologic factors|mesh-ancestor
64410608|NCT05115513|Dronabinol|dronabinol|mesh-list
64410609|NCT05115513|Hallucinogens|hallucinogens|mesh-ancestor
64410630|NCT05613335|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64619007|NCT03018665|Exenatide|exenatide|mesh-list
64410769|NCT04222023|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64410770|NCT04222023|Immunologic Factors|immunologic factors|mesh-ancestor
64410771|NCT04222023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410810|NCT05728333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64410811|NCT05728333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410812|NCT05728333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64410855|NCT03065569|Sensory System Agents|sensory system agents|mesh-ancestor
64410856|NCT03065569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410857|NCT05723419|Anesthetics|anesthetics|mesh-list
64410858|NCT05723419|Anesthetics, Local|anesthetics, local|mesh-list
64410859|NCT05723419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64410860|NCT05723419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410861|NCT05723419|Sensory System Agents|sensory system agents|mesh-ancestor
64410916|NCT05036577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64410917|NCT05036577|Antiemetics|antiemetics|mesh-ancestor
64410918|NCT05036577|Autonomic Agents|autonomic agents|mesh-ancestor
64516254|NCT02334436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516255|NCT02334436|Cholinergic Agents|cholinergic agents|mesh-ancestor
64516256|NCT02334436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64516257|NCT02334436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516258|NCT02334436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64516259|NCT02334436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516260|NCT03288870|Docetaxel|docetaxel|mesh-list
64516261|NCT03288870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516262|NCT03288870|Tubulin Modulators|tubulin modulators|mesh-ancestor
64441420|NCT01644890|Paclitaxel|paclitaxel|mesh-list
64410919|NCT05036577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410920|NCT05036577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64410921|NCT05036577|Glucocorticoids|glucocorticoids|mesh-ancestor
64410923|NCT05036577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64410924|NCT05036577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64410961|NCT05031975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64410962|NCT05031975|Alkylating Agents|alkylating agents|mesh-ancestor
64410963|NCT02632747|Empagliflozin|empagliflozin|mesh-list
64410964|NCT02632747|Ramipril|ramipril|mesh-list
64410998|NCT04216797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64411041|NCT05060913|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64411042|NCT05060913|Anesthetics, Local|anesthetics, local|mesh-ancestor
64411043|NCT05060913|Anesthetics|anesthetics|mesh-ancestor
64411044|NCT05060913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64411045|NCT05060913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411046|NCT05060913|Sensory System Agents|sensory system agents|mesh-ancestor
64411047|NCT05060913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619023|NCT03012763|Antipyretics|antipyretics|mesh-ancestor
64411048|NCT05060913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64586298|NCT01795027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64411087|NCT05022147|Dopamine Agonists|dopamine agonists|mesh-list
64411088|NCT05022147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64411089|NCT05022147|Sympathomimetics|sympathomimetics|mesh-ancestor
64411090|NCT05022147|Autonomic Agents|autonomic agents|mesh-ancestor
64411091|NCT05022147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411092|NCT05022147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411093|NCT05022147|Dopamine Agents|dopamine agents|mesh-ancestor
64411094|NCT05022147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64411095|NCT05022147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411096|NCT05022147|Protective Agents|protective agents|mesh-ancestor
64411097|NCT03775629|Tramadol|tramadol|mesh-list
64411098|NCT03775629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64411099|NCT03775629|Narcotics|narcotics|mesh-ancestor
64411100|NCT03775629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64411101|NCT03775629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411102|NCT03775629|Analgesics|analgesics|mesh-ancestor
64411103|NCT03775629|Sensory System Agents|sensory system agents|mesh-ancestor
64411104|NCT03775629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516263|NCT03288870|Antimitotic Agents|antimitotic agents|mesh-ancestor
64516264|NCT03288870|Mitosis Modulators|mitosis modulators|mesh-ancestor
64516265|NCT03288870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516266|NCT03282474|Sofosbuvir|sofosbuvir|mesh-list
64516267|NCT03282474|Antiviral Agents|antiviral agents|mesh-ancestor
64411151|NCT03763305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64411152|NCT03763305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411153|NCT03763305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64411154|NCT03763305|Anesthetics, General|anesthetics, general|mesh-ancestor
64411155|NCT03763305|Anesthetics|anesthetics|mesh-ancestor
64411156|NCT03763305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64411187|NCT01670539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64411201|NCT02252887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411202|NCT02252887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64411204|NCT04431895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64411205|NCT04431895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64411206|NCT04431895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411208|NCT03064633|Dexamethasone acetate|dexamethasone acetate|mesh-list
64411209|NCT03064633|Dexmedetomidine|dexmedetomidine|mesh-list
64411210|NCT03064633|Bupivacaine|bupivacaine|mesh-list
64411211|NCT03064633|BB 1101|bb 1101|mesh-list
64411247|NCT04877821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64411248|NCT04877821|Tubulin Modulators|tubulin modulators|mesh-ancestor
64398806|NCT03112135|Sympathomimetics|sympathomimetics|mesh-ancestor
64411249|NCT04877821|Antimitotic Agents|antimitotic agents|mesh-ancestor
64411250|NCT04877821|Mitosis Modulators|mitosis modulators|mesh-ancestor
64411251|NCT04877821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411302|NCT01697527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64411304|NCT01697527|Sensory System Agents|sensory system agents|mesh-ancestor
64411305|NCT01697527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411307|NCT01697527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64411350|NCT05008809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64411351|NCT05008809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64411352|NCT05008809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64411353|NCT05008809|Antidotes|antidotes|mesh-ancestor
64411354|NCT05008809|Protective Agents|protective agents|mesh-ancestor
64411355|NCT05008809|Vitamin B Complex|vitamin b complex|mesh-ancestor
64411356|NCT05008809|Vitamins|vitamins|mesh-ancestor
64411357|NCT05008809|Micronutrients|micronutrients|mesh-ancestor
64411395|NCT02519595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411397|NCT04278755|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64411398|NCT04278755|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
64411399|NCT04278755|Estradiol|estradiol|mesh-list
64411400|NCT04278755|Estrogens|estrogens|mesh-ancestor
64411401|NCT04278755|Hormones|hormones|mesh-ancestor
64411402|NCT04278755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64411403|NCT04278755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411404|NCT04278755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64411405|NCT04278755|Contraceptive Agents|contraceptive agents|mesh-ancestor
64411406|NCT04278755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64411407|NCT04278755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64411410|NCT04278755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64411411|NCT04278755|Hormone Antagonists|hormone antagonists|mesh-ancestor
64411412|NCT04278755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64411413|NCT04278755|Diuretics|diuretics|mesh-ancestor
64411414|NCT04278755|Natriuretic Agents|natriuretic agents|mesh-ancestor
64411415|NCT04277975|Analgesics, Opioid|analgesics, opioid|mesh-list
64411442|NCT00660673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64411454|NCT05612711|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64411455|NCT05612711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64411456|NCT05612711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411457|NCT05612711|Hormones|hormones|mesh-ancestor
64411458|NCT05612711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64411459|NCT04807309|Danazol|danazol|mesh-list
64411460|NCT04807309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64516268|NCT03282474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64516270|NCT02460354|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64516271|NCT02460354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516272|NCT02008942|Aspirin|aspirin|mesh-list
64516273|NCT02008942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64516274|NCT02008942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64516275|NCT02008942|Analgesics|analgesics|mesh-ancestor
64516276|NCT02008942|Sensory System Agents|sensory system agents|mesh-ancestor
64516277|NCT02008942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411461|NCT04807309|Hormone Antagonists|hormone antagonists|mesh-ancestor
64411462|NCT04807309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64411463|NCT04807309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411464|NCT04744649|Fluorouracil|fluorouracil|mesh-list
64411465|NCT04744649|Antimetabolites|antimetabolites|mesh-ancestor
64411466|NCT04744649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411467|NCT04744649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64411468|NCT04744649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398829|NCT03090971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398830|NCT03090971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64398831|NCT03090971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64398835|NCT03146689|Ibuprofen|ibuprofen|mesh-list
64411469|NCT04744649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64411505|NCT02630563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411506|NCT02630563|Antifungal Agents|antifungal agents|mesh-ancestor
64411507|NCT02630563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64411508|NCT02630563|Dermatologic Agents|dermatologic agents|mesh-ancestor
64411524|NCT05555147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411525|NCT02587247|Antibodies|antibodies|mesh-list
64411563|NCT02078141|Deoxyglucose|deoxyglucose|mesh-list
64411599|NCT05554211|Coagulants|coagulants|mesh-ancestor
64411600|NCT05554055|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64411601|NCT05554055|Dalteparin|dalteparin|mesh-list
64411602|NCT05554055|Anticoagulants|anticoagulants|mesh-ancestor
64411603|NCT05554055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64411604|NCT05554055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64411605|NCT05554055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411607|NCT05700617|Milrinone|milrinone|mesh-list
64411608|NCT05700617|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64411609|NCT05700617|Sympathomimetics|sympathomimetics|mesh-ancestor
64411610|NCT05700617|Autonomic Agents|autonomic agents|mesh-ancestor
64411611|NCT05700617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411612|NCT05700617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411613|NCT05700617|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64411614|NCT05700617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64411615|NCT05700617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64411616|NCT05700617|Adrenergic Agents|adrenergic agents|mesh-ancestor
64411617|NCT05700617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64411618|NCT05700617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411619|NCT05700617|Protective Agents|protective agents|mesh-ancestor
64411620|NCT05700617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64411621|NCT05700617|Vasodilator Agents|vasodilator agents|mesh-ancestor
64411622|NCT05700617|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64411662|NCT02629159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64411663|NCT02629159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64411664|NCT02629159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411665|NCT05548985|Midodrine|midodrine|mesh-list
64411666|NCT05548985|Metoclopramide|metoclopramide|mesh-list
64411695|NCT04981951|Analgesics|analgesics|mesh-ancestor
64411696|NCT04981951|Sensory System Agents|sensory system agents|mesh-ancestor
64411697|NCT04981951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411698|NCT04981951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64411699|NCT04981951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64411700|NCT04981951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64411701|NCT04981951|Adrenergic Agents|adrenergic agents|mesh-ancestor
64411702|NCT04981951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64411703|NCT04981951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516279|NCT02008942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64516280|NCT02008942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64516281|NCT02008942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64516282|NCT02008942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64516283|NCT02008942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516284|NCT02008942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64516285|NCT02008942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64516286|NCT02008942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64411704|NCT05548361|Chlorhexidine|chlorhexidine|mesh-list
64411705|NCT05548361|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64411706|NCT05548361|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64411724|NCT05552807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334673|NCT02295787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334674|NCT02295787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334675|NCT02295787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64334676|NCT02295787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64334677|NCT02295787|Anesthetics, General|anesthetics, general|mesh-ancestor
64411726|NCT05552729|Ergocalciferols|ergocalciferols|mesh-list
64411727|NCT05552729|Cholecalciferol|cholecalciferol|mesh-list
64411753|NCT05699993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64411754|NCT05699993|Hormone Antagonists|hormone antagonists|mesh-ancestor
64411755|NCT05699993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64411756|NCT05699993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411757|NCT05699993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64411758|NCT05699993|Antitussive Agents|antitussive agents|mesh-ancestor
64411759|NCT05699993|Respiratory System Agents|respiratory system agents|mesh-ancestor
64411760|NCT05699993|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64411761|NCT05699993|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64411762|NCT05699993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64411765|NCT05552651|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64411786|NCT05547659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411787|NCT05547659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411788|NCT05547659|Antipyretics|antipyretics|mesh-ancestor
64411789|NCT05547659|Anticonvulsants|anticonvulsants|mesh-ancestor
64411790|NCT05547659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64411791|NCT05547659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64411792|NCT05547659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411817|NCT05546879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64411818|NCT05546879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64411819|NCT05546879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64411820|NCT05546879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64411828|NCT05541185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64411829|NCT05541185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411830|NCT05541185|Sensory System Agents|sensory system agents|mesh-ancestor
64411831|NCT05541185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411832|NCT05541185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64411833|NCT05541185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64411834|NCT05541185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64411835|NCT05541185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64411836|NCT05541185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619040|NCT03012607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64411858|NCT05541107|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64411859|NCT05541107|Amebicides|amebicides|mesh-ancestor
64411908|NCT05698511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411910|NCT02629861|Calcitonin|calcitonin|mesh-list
64398841|NCT03146689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64398842|NCT03146689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398843|NCT03146689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64398844|NCT03146689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64398845|NCT03146689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64398846|NCT03146689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398847|NCT03146689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411911|NCT02629861|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
64411912|NCT02629861|Katacalcin|katacalcin|mesh-list
64411913|NCT02629861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64411914|NCT02629861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411915|NCT02629861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64411916|NCT02629861|Vasodilator Agents|vasodilator agents|mesh-ancestor
64411917|NCT02513823|Vitamin D|vitamin d|mesh-list
64411918|NCT02513823|Cholecalciferol|cholecalciferol|mesh-list
64411919|NCT02513823|Vitamins|vitamins|mesh-ancestor
64411964|NCT03063073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64411965|NCT03063073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64411966|NCT03063073|Analgesics|analgesics|mesh-ancestor
64411997|NCT04428307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64411998|NCT05535725|Vancomycin|vancomycin|mesh-list
64411999|NCT05535725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64412000|NCT05535725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64412001|NCT05544695|Hyaluronic Acid|hyaluronic acid|mesh-list
64412002|NCT05544695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64412003|NCT05544695|Immunologic Factors|immunologic factors|mesh-ancestor
64412004|NCT05544695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412005|NCT05544695|Viscosupplements|viscosupplements|mesh-ancestor
64412006|NCT05544695|Protective Agents|protective agents|mesh-ancestor
64412007|NCT05535569|Paclitaxel|paclitaxel|mesh-list
64412008|NCT05535569|Nivolumab|nivolumab|mesh-list
64412009|NCT05535569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64412010|NCT05535569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412016|NCT05535569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64412017|NCT03822871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64412051|NCT03813199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64412052|NCT03813199|Antimetabolites|antimetabolites|mesh-ancestor
64412053|NCT03813199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412054|NCT03813199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412055|NCT03813199|Dermatologic Agents|dermatologic agents|mesh-ancestor
64412056|NCT03813199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412099|NCT04979923|Anesthetics, Local|anesthetics, local|mesh-ancestor
64412100|NCT04979923|Anesthetics|anesthetics|mesh-ancestor
64412101|NCT04979923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64412102|NCT04979923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412103|NCT04979923|Sensory System Agents|sensory system agents|mesh-ancestor
64412104|NCT04979923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64412105|NCT04979923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64619045|NCT03012607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64412170|NCT03980483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64412172|NCT03611881|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64412173|NCT03611881|Autonomic Agents|autonomic agents|mesh-ancestor
64412174|NCT03611881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64412175|NCT03611881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412176|NCT03611881|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64412177|NCT03611881|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64516292|NCT03288636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64516293|NCT03288636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516294|NCT03288636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64516295|NCT03288636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64516296|NCT03288636|Antiviral Agents|antiviral agents|mesh-ancestor
64516297|NCT03288636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64516298|NCT03288636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64714085|NCT03053401|Sensory System Agents|sensory system agents|mesh-ancestor
64472412|NCT03410030|Vitamins|vitamins|mesh-ancestor
64516299|NCT03288636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64516300|NCT03293472|Bupivacaine|bupivacaine|mesh-list
64516301|NCT03293472|Ropivacaine|ropivacaine|mesh-list
64516302|NCT03293472|Anesthetics, Local|anesthetics, local|mesh-ancestor
64516303|NCT03293472|Anesthetics|anesthetics|mesh-ancestor
64516304|NCT03293472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64516305|NCT03293472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516306|NCT03293472|Sensory System Agents|sensory system agents|mesh-ancestor
64516307|NCT03293472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516308|NCT02071810|Opicapone|opicapone|mesh-list
64412178|NCT03611881|Cholinergic Agents|cholinergic agents|mesh-ancestor
64412179|NCT03611881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64412180|NCT03611881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412181|NCT03063775|Fibrin Foam|fibrin foam|mesh-list
64412182|NCT03063775|Hemostatics|hemostatics|mesh-ancestor
64412183|NCT03063775|Coagulants|coagulants|mesh-ancestor
64412184|NCT03063541|Aspirin|aspirin|mesh-list
64412185|NCT03063541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64412186|NCT03063541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64412187|NCT03063541|Analgesics|analgesics|mesh-ancestor
64412188|NCT03063541|Sensory System Agents|sensory system agents|mesh-ancestor
64412189|NCT03063541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64412190|NCT03063541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412191|NCT03063541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64412235|NCT04977661|Micronutrients|micronutrients|mesh-ancestor
64412236|NCT04977661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412237|NCT04977661|Antioxidants|antioxidants|mesh-ancestor
64412238|NCT04977661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412239|NCT04977661|Protective Agents|protective agents|mesh-ancestor
64412240|NCT04977661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64412241|NCT04977661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412242|NCT04977661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64412289|NCT03239899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64412324|NCT02474355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412325|NCT02474355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64412326|NCT02474355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412327|NCT02474355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412328|NCT02474199|Acetaminophen|acetaminophen|mesh-list
64412329|NCT02474199|Diphenhydramine|diphenhydramine|mesh-list
64412330|NCT02474199|Promethazine|promethazine|mesh-list
64412331|NCT02474199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64412332|NCT02474199|Analgesics|analgesics|mesh-ancestor
64412426|NCT03117751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516309|NCT02071810|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64516310|NCT02071810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64619051|NCT01048879|Antiviral Agents|antiviral agents|mesh-ancestor
64412428|NCT03117751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64412429|NCT03117751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64412430|NCT03117751|Antiemetics|antiemetics|mesh-ancestor
64412431|NCT03117751|Autonomic Agents|autonomic agents|mesh-ancestor
64412432|NCT03117751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64412433|NCT03117751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64412434|NCT03117751|Glucocorticoids|glucocorticoids|mesh-ancestor
64412435|NCT03117751|Hormones|hormones|mesh-ancestor
64412436|NCT03117751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64398897|NCT02347033|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64412437|NCT03117751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64412438|NCT03117751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64412479|NCT03063307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412481|NCT04874935|Dexlansoprazole|dexlansoprazole|mesh-list
64412482|NCT04874935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64412483|NCT04874935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64412484|NCT04874935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64412485|NCT04874935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412486|NCT04874935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412487|NCT02961361|Dexmedetomidine|dexmedetomidine|mesh-list
64412488|NCT02961361|Ropivacaine|ropivacaine|mesh-list
64412489|NCT02961361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64412490|NCT02961361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64412491|NCT02961361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412523|NCT02426281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412524|NCT02426281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64412525|NCT02426281|Immunologic Factors|immunologic factors|mesh-ancestor
64412526|NCT02426281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412528|NCT02448537|Doxorubicin|doxorubicin|mesh-list
64412533|NCT02448537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412534|NCT02448537|Antiviral Agents|antiviral agents|mesh-ancestor
64412535|NCT02448537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64412536|NCT02448537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412537|NCT02448537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64412575|NCT02448225|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64412616|NCT05536271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64412617|NCT05536271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412618|NCT05536271|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64412655|NCT05697185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64412656|NCT05697185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64412657|NCT05697185|Antimetabolites|antimetabolites|mesh-ancestor
64412658|NCT05697185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412700|NCT05591417|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64412701|NCT05591417|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64412702|NCT05591417|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64412703|NCT05591417|Adrenergic Agents|adrenergic agents|mesh-ancestor
64412753|NCT05678621|Clavulanic Acids|clavulanic acids|mesh-list
64412754|NCT05678621|Clavulanic Acid|clavulanic acid|mesh-list
64412755|NCT05678621|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64412756|NCT05678621|Trimethoprim|trimethoprim|mesh-list
64412757|NCT05678621|Sulfamethoxazole|sulfamethoxazole|mesh-list
64412758|NCT05678621|Immunoglobulins|immunoglobulins|mesh-list
64412759|NCT05678621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64412760|NCT05678621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64412761|NCT05678621|Immunologic Factors|immunologic factors|mesh-ancestor
64412762|NCT05678621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412806|NCT05182073|Daratumumab|daratumumab|mesh-list
64516315|NCT02715258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64516316|NCT02715258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516317|NCT01959490|Paclitaxel|paclitaxel|mesh-list
64412807|NCT05182073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64412808|NCT05182073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64398917|NCT03146377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398918|NCT02346955|Pembrolizumab|pembrolizumab|mesh-list
64398919|NCT02346955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64412809|NCT05182073|Immunologic Factors|immunologic factors|mesh-ancestor
64412810|NCT05182073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412811|NCT05182073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64412812|NCT05182073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64412813|NCT05182073|Alkylating Agents|alkylating agents|mesh-ancestor
64412814|NCT05182073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412840|NCT04150939|Immunologic Factors|immunologic factors|mesh-list
64412841|NCT04150939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412842|NCT05041907|Ritonavir|ritonavir|mesh-list
64412843|NCT05041907|Ivermectin|ivermectin|mesh-list
64412844|NCT05041907|Nitazoxanide|nitazoxanide|mesh-list
64412845|NCT05041907|Remdesivir|remdesivir|mesh-list
64412846|NCT05041907|Favipiravir|favipiravir|mesh-list
64412847|NCT05041907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64412848|NCT05041907|Fluoxetine|fluoxetine|mesh-list
64412849|NCT05041907|Antibodies|antibodies|mesh-list
64412850|NCT05041907|Immunoglobulins|immunoglobulins|mesh-list
64412851|NCT05041907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64412852|NCT05041907|Immunologic Factors|immunologic factors|mesh-ancestor
64412853|NCT05041907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412854|NCT05041907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412855|NCT05041907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64412861|NCT05041907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64412862|NCT05041907|Antiviral Agents|antiviral agents|mesh-ancestor
64412863|NCT05041907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64412864|NCT05041907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64412865|NCT05041907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64412866|NCT05041907|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64412867|NCT05041907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64412884|NCT05674253|Analgesics|analgesics|mesh-ancestor
64412885|NCT05674253|Sensory System Agents|sensory system agents|mesh-ancestor
64412886|NCT05674253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64412887|NCT05674253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64412888|NCT05674253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64412889|NCT05674253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64412890|NCT05674253|Adrenergic Agents|adrenergic agents|mesh-ancestor
64412891|NCT05674253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64412892|NCT05674253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412893|NCT05674253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64412895|NCT02500641|Colchicine|colchicine|mesh-list
64412896|NCT02500641|Allopurinol|allopurinol|mesh-list
64412897|NCT02500641|Febuxostat|febuxostat|mesh-list
64412898|NCT02500641|Omeprazole|omeprazole|mesh-list
64412899|NCT02500641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64412900|NCT02500641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64412901|NCT02500641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64412902|NCT02500641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412903|NCT02500641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412904|NCT02500641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64412905|NCT02500641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64412906|NCT02500641|Analgesics|analgesics|mesh-ancestor
64412907|NCT02500641|Sensory System Agents|sensory system agents|mesh-ancestor
64412908|NCT02500641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64412909|NCT02500641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412910|NCT02500641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64412911|NCT02500641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64412912|NCT02500641|Gout Suppressants|gout suppressants|mesh-ancestor
64398936|NCT03090503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412913|NCT02500641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64412914|NCT02500641|Tubulin Modulators|tubulin modulators|mesh-ancestor
64412915|NCT02500641|Antimitotic Agents|antimitotic agents|mesh-ancestor
64412916|NCT02500641|Mitosis Modulators|mitosis modulators|mesh-ancestor
64412917|NCT02500641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412918|NCT02500641|Antimetabolites|antimetabolites|mesh-ancestor
64412919|NCT02500641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64412920|NCT02500641|Antioxidants|antioxidants|mesh-ancestor
64412921|NCT02500641|Protective Agents|protective agents|mesh-ancestor
64412922|NCT04973293|Bevacizumab|bevacizumab|mesh-list
64516319|NCT01959490|Cyclophosphamide|cyclophosphamide|mesh-list
64516320|NCT01959490|Bevacizumab|bevacizumab|mesh-list
64516321|NCT01959490|Carboplatin|carboplatin|mesh-list
64516322|NCT01959490|Doxorubicin|doxorubicin|mesh-list
64516323|NCT01959490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64516324|NCT01959490|Trastuzumab|trastuzumab|mesh-list
64516325|NCT01959490|Pertuzumab|pertuzumab|mesh-list
64516326|NCT01959490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64516327|NCT01959490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516328|NCT01959490|Tubulin Modulators|tubulin modulators|mesh-ancestor
64516329|NCT01959490|Antimitotic Agents|antimitotic agents|mesh-ancestor
64516330|NCT01959490|Mitosis Modulators|mitosis modulators|mesh-ancestor
64736749|NCT00616577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412923|NCT04973293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64412931|NCT04962451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64412964|NCT04972045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412966|NCT04972045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412967|NCT05614115|Empagliflozin|empagliflozin|mesh-list
64412968|NCT05614115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64412969|NCT05614115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412970|NCT05614115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64412971|NCT05614115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413010|NCT04970719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413011|NCT04970719|Antimetabolites|antimetabolites|mesh-ancestor
64413012|NCT04970719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413013|NCT04970719|Antiviral Agents|antiviral agents|mesh-ancestor
64413014|NCT04970719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64413015|NCT04970719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64413016|NCT04970719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64413017|NCT02466399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64413018|NCT02466399|Latanoprost|latanoprost|mesh-list
64413019|NCT02466399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64413020|NCT03059251|Obinutuzumab|obinutuzumab|mesh-list
64413021|NCT03059251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64413022|NCT03059251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413023|NCT04970251|Aflibercept|aflibercept|mesh-list
64413024|NCT04970251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64413025|NCT04970251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64413026|NCT04970251|Growth Substances|growth substances|mesh-ancestor
64413027|NCT04970251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413068|NCT02464059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64413069|NCT02464059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64413070|NCT02463357|Metformin|metformin|mesh-list
64413071|NCT02463357|Nifedipine|nifedipine|mesh-list
64413072|NCT02463357|Methazolamide|methazolamide|mesh-list
64413073|NCT02463357|Quercetin|quercetin|mesh-list
64413074|NCT02463357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64413075|NCT02463357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413076|NCT02463357|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64413077|NCT02463357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64413111|NCT04959721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413112|NCT04959721|Sensory System Agents|sensory system agents|mesh-ancestor
64413113|NCT04959721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413114|NCT04959721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64413115|NCT04959721|Glucocorticoids|glucocorticoids|mesh-ancestor
64413146|NCT05575427|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64413147|NCT05575427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64413149|NCT05575427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64413150|NCT05575427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64413151|NCT04959253|Psilocybin|psilocybin|mesh-list
64413152|NCT04959253|Hallucinogens|hallucinogens|mesh-ancestor
64516331|NCT01959490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516332|NCT01959490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64516333|NCT01959490|Immunologic Factors|immunologic factors|mesh-ancestor
64516334|NCT01959490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516335|NCT01959490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64516336|NCT01959490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64516337|NCT01959490|Alkylating Agents|alkylating agents|mesh-ancestor
64516338|NCT01959490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64516339|NCT01959490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64516340|NCT01959490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64516341|NCT01959490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64516342|NCT01959490|Growth Substances|growth substances|mesh-ancestor
64516343|NCT01959490|Growth Inhibitors|growth inhibitors|mesh-ancestor
64516344|NCT01959490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64516345|NCT01959490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64516346|NCT01959490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64516347|NCT01959490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64516349|NCT03288402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64516350|NCT03288402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516351|NCT03288402|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64516352|NCT03288402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64516353|NCT03288402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413153|NCT04959253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413154|NCT04959253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64413155|NCT02499159|Bupivacaine|bupivacaine|mesh-list
64413156|NCT02499159|Anesthetics, Local|anesthetics, local|mesh-ancestor
64413157|NCT02499159|Anesthetics|anesthetics|mesh-ancestor
64413158|NCT02499159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64413159|NCT02499159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413160|NCT02499159|Sensory System Agents|sensory system agents|mesh-ancestor
64413161|NCT02499159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413162|NCT01664039|Bimatoprost|bimatoprost|mesh-list
64413163|NCT01664039|Travoprost|travoprost|mesh-list
64413164|NCT01664039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64413165|NCT01664039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64413166|NCT01664039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64413167|NCT05645705|Listerine|listerine|mesh-list
64413168|NCT05645705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
64413169|NCT05645705|Sodium Fluoride|sodium fluoride|mesh-list
64413170|NCT05645705|Cariostatic Agents|cariostatic agents|mesh-ancestor
64413205|NCT03058939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64413206|NCT03058939|Hormone Antagonists|hormone antagonists|mesh-ancestor
64413207|NCT03058939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64413208|NCT03058939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398979|NCT03090269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64413209|NCT03058939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64413210|NCT03058939|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64413211|NCT03058939|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64413212|NCT03058939|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64516354|NCT03288402|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64516355|NCT03288402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64516357|NCT03288402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64516358|NCT02341144|Ropivacaine|ropivacaine|mesh-list
64516359|NCT02341144|Anesthetics, Local|anesthetics, local|mesh-ancestor
64516360|NCT02341144|Anesthetics|anesthetics|mesh-ancestor
64516361|NCT02341144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64516362|NCT02341144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516363|NCT02341144|Sensory System Agents|sensory system agents|mesh-ancestor
64516364|NCT02341144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516365|NCT02011516|Baclofen|baclofen|mesh-list
64516366|NCT02011516|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64516367|NCT02011516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516368|NCT02011516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64516369|NCT02011516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413213|NCT03058471|Methotrexate|methotrexate|mesh-list
64413214|NCT03058471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64413215|NCT03058471|Abortifacient Agents|abortifacient agents|mesh-ancestor
64413216|NCT03058471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64413217|NCT03058471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413218|NCT03058471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64413219|NCT03058471|Antimetabolites|antimetabolites|mesh-ancestor
64413220|NCT03058471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413221|NCT03058471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413222|NCT03058471|Dermatologic Agents|dermatologic agents|mesh-ancestor
64413223|NCT03058471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64413256|NCT04177433|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64413257|NCT04177433|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64619080|NCT03112993|Autonomic Agents|autonomic agents|mesh-ancestor
64413267|NCT04177433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64413268|NCT04177433|Glucocorticoids|glucocorticoids|mesh-ancestor
64413269|NCT04177433|Hormones|hormones|mesh-ancestor
64413299|NCT04950205|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64413301|NCT04950205|Anesthetics|anesthetics|mesh-ancestor
64413302|NCT04950205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64413303|NCT04950205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413304|NCT02625259|Lansoprazole|lansoprazole|mesh-list
64413305|NCT02625259|Dexlansoprazole|dexlansoprazole|mesh-list
64413306|NCT02625259|Serabelisib|serabelisib|mesh-list
64413307|NCT02625259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64413308|NCT02625259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64413309|NCT02625259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64398990|NCT03090035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413310|NCT02625259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64413311|NCT02625259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413312|NCT02577107|Ranibizumab|ranibizumab|mesh-list
64413359|NCT04950049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413360|NCT05587673|Methylprednisolone|methylprednisolone|mesh-list
64413412|NCT04948567|Sensory System Agents|sensory system agents|mesh-ancestor
64413413|NCT04948567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413414|NCT04948567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413449|NCT04964869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64413450|NCT04964869|Respiratory System Agents|respiratory system agents|mesh-ancestor
64516370|NCT02011516|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64516372|NCT02011516|GABA Agents|gaba agents|mesh-ancestor
64714086|NCT03053401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516373|NCT02011516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64516374|NCT02011516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516375|NCT04349410|Interferons|interferons|mesh-list
64516376|NCT04349410|Interferon-alpha|interferon-alpha|mesh-list
64516377|NCT04349410|Interferon alpha-2|interferon alpha-2|mesh-list
64516378|NCT04349410|Remdesivir|remdesivir|mesh-list
64516379|NCT04349410|Azithromycin|azithromycin|mesh-list
64516380|NCT04349410|Hydroxychloroquine|hydroxychloroquine|mesh-list
64413466|NCT04946929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64413467|NCT04946929|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64413473|NCT03058237|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
64413474|NCT03058237|Baclofen|baclofen|mesh-list
64413475|NCT03058237|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64413476|NCT03058237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413477|NCT03058237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64413478|NCT03058237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413479|NCT03058237|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64413480|NCT03058237|GABA Agonists|gaba agonists|mesh-ancestor
64413481|NCT03058237|GABA Agents|gaba agents|mesh-ancestor
64413482|NCT03058237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64413483|NCT03058237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413484|NCT04947241|Gemcitabine|gemcitabine|mesh-list
64413485|NCT04947241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64413486|NCT04947241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413487|NCT04947241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64413488|NCT04947241|Antimetabolites|antimetabolites|mesh-ancestor
64413489|NCT04947241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413490|NCT04947241|Antiviral Agents|antiviral agents|mesh-ancestor
64413491|NCT04947241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64413492|NCT04947241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64413493|NCT04947241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64413494|NCT04947241|Immunologic Factors|immunologic factors|mesh-ancestor
64413495|NCT04947241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413496|NCT04410991|Teriflunomide|teriflunomide|mesh-list
64413497|NCT04410991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64413498|NCT04410991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64413499|NCT04410991|Analgesics|analgesics|mesh-ancestor
64413500|NCT04410991|Sensory System Agents|sensory system agents|mesh-ancestor
64413501|NCT04410991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413502|NCT04410991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413503|NCT04410991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64413504|NCT04410991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64413505|NCT04410991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64413506|NCT04410991|Immunologic Factors|immunologic factors|mesh-ancestor
64399042|NCT02337127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64413507|NCT04933279|Iodine|iodine|mesh-list
64413508|NCT04933279|Cadexomer iodine|cadexomer iodine|mesh-list
64413509|NCT04933279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64413510|NCT04933279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64413511|NCT04933279|Trace Elements|trace elements|mesh-ancestor
64413512|NCT04933279|Micronutrients|micronutrients|mesh-ancestor
64413545|NCT04946383|Dasatinib|dasatinib|mesh-list
64413546|NCT04946383|Quercetin|quercetin|mesh-list
64413547|NCT04946383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413548|NCT04946383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64413549|NCT04946383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64413550|NCT04946383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413551|NCT04946383|Antioxidants|antioxidants|mesh-ancestor
64413552|NCT04946383|Protective Agents|protective agents|mesh-ancestor
64413553|NCT04946383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413554|NCT04943653|Paclitaxel|paclitaxel|mesh-list
64516381|NCT04349410|Doxycycline|doxycycline|mesh-list
64516382|NCT04349410|Clindamycin|clindamycin|mesh-list
64516383|NCT04349410|Clindamycin palmitate|clindamycin palmitate|mesh-list
64516384|NCT04349410|Clindamycin phosphate|clindamycin phosphate|mesh-list
64516385|NCT04349410|Primaquine|primaquine|mesh-list
64516386|NCT04349410|Methylprednisolone|methylprednisolone|mesh-list
64516387|NCT04349410|Losartan|losartan|mesh-list
64516388|NCT04349410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516389|NCT04349410|Antiviral Agents|antiviral agents|mesh-ancestor
64516390|NCT04349410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64516391|NCT04349410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64516392|NCT04349410|Antiemetics|antiemetics|mesh-ancestor
64516393|NCT04349410|Autonomic Agents|autonomic agents|mesh-ancestor
64516394|NCT04349410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516395|NCT04349410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516396|NCT04349410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64516397|NCT04349410|Glucocorticoids|glucocorticoids|mesh-ancestor
64516398|NCT04349410|Hormones|hormones|mesh-ancestor
64516399|NCT04349410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64516400|NCT04349410|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64516401|NCT04349410|Protective Agents|protective agents|mesh-ancestor
64516402|NCT04349410|Immunologic Factors|immunologic factors|mesh-ancestor
64516403|NCT04349410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64516404|NCT04349410|Antimalarials|antimalarials|mesh-ancestor
64516405|NCT04349410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64516406|NCT04349410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64516407|NCT04349410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64516408|NCT04349410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516409|NCT04349410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64516410|NCT04349410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64516411|NCT04349410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64413555|NCT04943653|Capecitabine|capecitabine|mesh-list
64413556|NCT04943653|Oxaliplatin|oxaliplatin|mesh-list
64413557|NCT04943653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64413558|NCT04943653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413559|NCT04943653|Tubulin Modulators|tubulin modulators|mesh-ancestor
64413560|NCT04943653|Antimitotic Agents|antimitotic agents|mesh-ancestor
64413561|NCT04943653|Mitosis Modulators|mitosis modulators|mesh-ancestor
64413562|NCT04943653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413563|NCT04943653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64413564|NCT04943653|Antimetabolites|antimetabolites|mesh-ancestor
64413566|NCT04943029|Carboplatin|carboplatin|mesh-list
64413581|NCT03660059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64413582|NCT03660059|Immunologic Factors|immunologic factors|mesh-ancestor
64413583|NCT03660059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516412|NCT04349410|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64399085|NCT03945643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64399086|NCT03945643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399087|NCT03945643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399088|NCT03945643|Urological Agents|urological agents|mesh-ancestor
64516413|NCT04349410|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64516414|NCT04349410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64516416|NCT03287388|Rocuronium|rocuronium|mesh-list
64516417|NCT03287388|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64516418|NCT03287388|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64516419|NCT03287388|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64516420|NCT03287388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619082|NCT03670030|Sirolimus|sirolimus|mesh-list
64516421|NCT03287388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516422|NCT03293004|Vitamins|vitamins|mesh-list
64516423|NCT03293004|Ascorbic Acid|ascorbic acid|mesh-list
64516424|NCT03293004|Micronutrients|micronutrients|mesh-ancestor
64516425|NCT03293004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516426|NCT03293004|Antioxidants|antioxidants|mesh-ancestor
64516427|NCT03293004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516428|NCT03293004|Protective Agents|protective agents|mesh-ancestor
64516429|NCT03292848|Brexpiprazole|brexpiprazole|mesh-list
64516430|NCT03292848|Serotonin Agents|serotonin agents|mesh-ancestor
64516431|NCT03292848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64413584|NCT04946227|Paclitaxel|paclitaxel|mesh-list
64413585|NCT04946227|Pembrolizumab|pembrolizumab|mesh-list
64413586|NCT04946227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64413587|NCT04946227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413588|NCT04946227|Tubulin Modulators|tubulin modulators|mesh-ancestor
64413589|NCT04946227|Antimitotic Agents|antimitotic agents|mesh-ancestor
64413590|NCT04946227|Mitosis Modulators|mitosis modulators|mesh-ancestor
64413591|NCT04946227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413592|NCT04946227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64413593|NCT04932187|Capecitabine|capecitabine|mesh-list
64413594|NCT04932187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64413595|NCT04932187|Antimetabolites|antimetabolites|mesh-ancestor
64413596|NCT04932187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413597|NCT04932187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413598|NCT04945681|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64413599|NCT04945681|Immunologic Factors|immunologic factors|mesh-ancestor
64413600|NCT04945681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413601|NCT03597347|Molgramostim|molgramostim|mesh-list
64413602|NCT03597347|Sargramostim|sargramostim|mesh-list
64413603|NCT03597347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413604|NCT03597347|Immunologic Factors|immunologic factors|mesh-ancestor
64413605|NCT03597347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413606|NCT04930627|Empagliflozin|empagliflozin|mesh-list
64413607|NCT04930627|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64413608|NCT04930627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413609|NCT04930627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64413610|NCT04930627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413611|NCT03057769|Indomethacin|indomethacin|mesh-list
64413612|NCT03057769|Epinephrine|epinephrine|mesh-list
64413665|NCT04406389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64413666|NCT04406389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413667|NCT04406389|Antithrombins|antithrombins|mesh-ancestor
64413668|NCT04406389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64413669|NCT04406389|Protease Inhibitors|protease inhibitors|mesh-ancestor
64413670|NCT04406389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64516432|NCT03292848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516433|NCT03292848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516434|NCT03292848|Dopamine Agonists|dopamine agonists|mesh-ancestor
64516435|NCT03292848|Dopamine Agents|dopamine agents|mesh-ancestor
64516436|NCT03282162|Oxytocin|oxytocin|mesh-list
64516437|NCT03282162|Oxytocics|oxytocics|mesh-ancestor
64516438|NCT03282162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64516439|NCT03282162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516440|NCT03287076|Exenatide|exenatide|mesh-list
64516441|NCT03287076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64516442|NCT03287076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516443|NCT03287076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64516444|NCT03287076|Incretins|incretins|mesh-ancestor
64516445|NCT03287076|Hormones|hormones|mesh-ancestor
64516446|NCT03287076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64516447|NCT02460276|Rituximab|rituximab|mesh-list
64516448|NCT02460276|Lenalidomide|lenalidomide|mesh-list
64516449|NCT02460276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64516450|NCT02460276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516451|NCT02460276|Immunologic Factors|immunologic factors|mesh-ancestor
64472556|NCT03138720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64516452|NCT02460276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516453|NCT02460276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64516454|NCT02460276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64516455|NCT02460276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64516457|NCT02460276|Growth Inhibitors|growth inhibitors|mesh-ancestor
64413671|NCT04406389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64413672|NCT04921657|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64413673|NCT04921657|Simvastatin|simvastatin|mesh-list
64413674|NCT04921657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64413675|NCT04921657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64413681|NCT04930471|Metformin|metformin|mesh-list
64413682|NCT04930471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64413683|NCT04930471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413684|NCT04418401|Antibodies|antibodies|mesh-list
64413685|NCT04418401|Immunologic Factors|immunologic factors|mesh-ancestor
64413686|NCT04418401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413687|NCT04940689|Lidocaine|lidocaine|mesh-list
64413688|NCT04940689|Dexmedetomidine|dexmedetomidine|mesh-list
64413716|NCT05530811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413717|NCT05530811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413718|NCT05530811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64413719|NCT05530811|Glucocorticoids|glucocorticoids|mesh-ancestor
64413720|NCT05530811|Hormones|hormones|mesh-ancestor
64413721|NCT05530811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64413722|NCT05530811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64413723|NCT05530811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413724|NCT05530811|Anesthetics, Local|anesthetics, local|mesh-ancestor
64413725|NCT05530811|Anesthetics|anesthetics|mesh-ancestor
64516458|NCT02460432|Paclitaxel|paclitaxel|mesh-list
64516459|NCT02460432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64399094|NCT02039323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64399110|NCT03078725|Metformin|metformin|mesh-list
64516460|NCT02460432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516461|NCT02460432|Tubulin Modulators|tubulin modulators|mesh-ancestor
64516462|NCT02460432|Antimitotic Agents|antimitotic agents|mesh-ancestor
64516463|NCT02460432|Mitosis Modulators|mitosis modulators|mesh-ancestor
64516464|NCT02460432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516465|NCT03282006|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
64516466|NCT03282006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64516467|NCT03282006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64516468|NCT03282006|Renal Agents|renal agents|mesh-ancestor
64516469|NCT03282006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64516470|NCT03281928|Potassium Citrate|potassium citrate|mesh-list
64516471|NCT03281928|Diuretics|diuretics|mesh-ancestor
64516472|NCT03281928|Natriuretic Agents|natriuretic agents|mesh-ancestor
64516473|NCT03281928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516474|NCT03281928|Expectorants|expectorants|mesh-ancestor
64516475|NCT03281928|Respiratory System Agents|respiratory system agents|mesh-ancestor
64516476|NCT03286764|Peppermint oil|peppermint oil|mesh-list
64516477|NCT03286764|Antiemetics|antiemetics|mesh-ancestor
64516478|NCT03286764|Autonomic Agents|autonomic agents|mesh-ancestor
64516479|NCT03286764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516480|NCT03286764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516481|NCT03286764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64516482|NCT03286764|Parasympatholytics|parasympatholytics|mesh-ancestor
64516483|NCT03281694|Nicotine|nicotine|mesh-list
64516484|NCT03281694|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64516485|NCT03281694|Autonomic Agents|autonomic agents|mesh-ancestor
64516486|NCT03281694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516487|NCT03281694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516488|NCT03281694|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64516489|NCT03281694|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64516490|NCT03281694|Cholinergic Agents|cholinergic agents|mesh-ancestor
64516491|NCT03281694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64516492|NCT03281694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413726|NCT05530811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64413727|NCT05530811|Sensory System Agents|sensory system agents|mesh-ancestor
64413728|NCT04940845|Denosumab|denosumab|mesh-list
64413729|NCT04940845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64516493|NCT03286452|Anti-Infective Agents|anti-infective agents|mesh-list
64516494|NCT03286452|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64619092|NCT02955355|Immunologic Factors|immunologic factors|mesh-ancestor
64516495|NCT03291054|Pembrolizumab|pembrolizumab|mesh-list
64516496|NCT03291054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64516497|NCT03291054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516499|NCT03286296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64516500|NCT03286296|Immunologic Factors|immunologic factors|mesh-ancestor
64516501|NCT03286296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516502|NCT03285906|Apatinib|apatinib|mesh-list
64516503|NCT03285906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516504|NCT03285906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64516505|NCT03285906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64516506|NCT03285906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516507|NCT01895205|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
64516508|NCT01895205|Hematinics|hematinics|mesh-ancestor
64516509|NCT01748175|Triamcinolone|triamcinolone|mesh-list
64516510|NCT01748175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64516511|NCT01748175|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64516512|NCT01748175|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64516513|NCT01748175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64516514|NCT01748175|Glucocorticoids|glucocorticoids|mesh-ancestor
64516515|NCT01748175|Hormones|hormones|mesh-ancestor
64516516|NCT01748175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64516517|NCT01748175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516518|NCT01748175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64516519|NCT01748175|Immunologic Factors|immunologic factors|mesh-ancestor
64516520|NCT01748175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64516521|NCT01748175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516522|NCT04755387|Ticagrelor|ticagrelor|mesh-list
64516523|NCT04755387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64399113|NCT03078725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413730|NCT04940845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413731|NCT04921111|Aluminum phosphate|aluminum phosphate|mesh-list
64413732|NCT04921111|Vaccines|vaccines|mesh-list
64413733|NCT04921111|Immunologic Factors|immunologic factors|mesh-ancestor
64413734|NCT04921111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413735|NCT04921111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64413736|NCT04921111|Antacids|antacids|mesh-ancestor
64413769|NCT05411237|Tubulin Modulators|tubulin modulators|mesh-ancestor
64413770|NCT05411237|Antimitotic Agents|antimitotic agents|mesh-ancestor
64413771|NCT05411237|Mitosis Modulators|mitosis modulators|mesh-ancestor
64413772|NCT05411237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413773|NCT05411237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64714087|NCT03054103|Midazolam|midazolam|mesh-list
64714088|NCT03054103|Ketamine|ketamine|mesh-list
64516525|NCT04755387|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64516526|NCT04755387|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64516527|NCT04755387|Purinergic Agents|purinergic agents|mesh-ancestor
64516528|NCT04755387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64516529|NCT04755387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516530|NCT04755387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516531|NCT04046328|Cholestyramine Resin|cholestyramine resin|mesh-list
64516532|NCT04046328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64516533|NCT04046328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64516534|NCT04046328|Antimetabolites|antimetabolites|mesh-ancestor
64516535|NCT04046328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516536|NCT04046328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64516537|NCT03285360|Fluorides|fluorides|mesh-list
64516538|NCT03285360|Fluorides, Topical|fluorides, topical|mesh-list
64442385|NCT01363700|Epinastine|epinastine|mesh-list
64413774|NCT05411237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64413775|NCT05411237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64413776|NCT05411237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64413777|NCT04940143|Botulinum Toxins|botulinum toxins|mesh-list
64413778|NCT04940143|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64413779|NCT04940143|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64413780|NCT04940143|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64413781|NCT04940143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64413782|NCT04940143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413783|NCT04940143|Cholinergic Agents|cholinergic agents|mesh-ancestor
64413784|NCT04940143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64413785|NCT04940143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413786|NCT04940143|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64413831|NCT03055663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64413834|NCT03055663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64413835|NCT03055663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64413836|NCT03055663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64413837|NCT03055663|Anesthetics, General|anesthetics, general|mesh-ancestor
64413870|NCT04938037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64413871|NCT04938037|Protective Agents|protective agents|mesh-ancestor
64413872|NCT04938037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64413873|NCT04938037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413875|NCT04937569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64413876|NCT04937569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64413877|NCT04937101|Chlorpheniramine|chlorpheniramine|mesh-list
64413884|NCT04937101|Sensory System Agents|sensory system agents|mesh-ancestor
64413885|NCT04937101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413886|NCT04937101|Antitussive Agents|antitussive agents|mesh-ancestor
64413918|NCT03055741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64413919|NCT03055741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413920|NCT03055741|Cholinergic Agents|cholinergic agents|mesh-ancestor
64413921|NCT03055741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64516539|NCT03285360|Cariostatic Agents|cariostatic agents|mesh-ancestor
64516540|NCT03285360|Protective Agents|protective agents|mesh-ancestor
64516541|NCT03285360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516542|NCT00160173|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64516543|NCT00160173|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64413922|NCT03055741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413923|NCT03055741|Nootropic Agents|nootropic agents|mesh-ancestor
64413924|NCT04927039|Iloprost|iloprost|mesh-list
64413925|NCT04927039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64413926|NCT04927039|Vasodilator Agents|vasodilator agents|mesh-ancestor
64413970|NCT04917757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64413972|NCT04917757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413973|NCT04916899|Rifampin|rifampin|mesh-list
64413974|NCT04916899|Isoniazid|isoniazid|mesh-list
64413975|NCT04916899|Pyrazinamide|pyrazinamide|mesh-list
64413976|NCT04916899|Ethambutol|ethambutol|mesh-list
64414005|NCT04916509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64414007|NCT04916509|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64414008|NCT04916509|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64414009|NCT04916509|Hormone Antagonists|hormone antagonists|mesh-ancestor
64414010|NCT04916509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64414011|NCT04916509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414012|NCT04916509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64414013|NCT04916509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414023|NCT04916353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64414024|NCT04916353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414025|NCT04916353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64414026|NCT04916353|Immunologic Factors|immunologic factors|mesh-ancestor
64414027|NCT04916353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414108|NCT02497287|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64414109|NCT02497287|Sertraline|sertraline|mesh-list
64414110|NCT02497287|Antidepressive Agents|antidepressive agents|mesh-list
64414111|NCT02497287|Esketamine|esketamine|mesh-list
64414112|NCT02497287|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64414113|NCT02497287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64414114|NCT02497287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64414115|NCT02497287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414116|NCT02497287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64414117|NCT02497287|Serotonin Agents|serotonin agents|mesh-ancestor
64414118|NCT02497287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414119|NCT02497287|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64414120|NCT02497287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64414121|NCT02497287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414122|NCT02497287|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64414123|NCT02497287|Analgesics|analgesics|mesh-ancestor
64414161|NCT02496039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64414162|NCT02496039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64414163|NCT02496039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64414189|NCT02495883|Adrenergic Agents|adrenergic agents|mesh-ancestor
64414190|NCT02495883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64414191|NCT02495883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414192|NCT02495883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414193|NCT02495883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64414194|NCT02495883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64414195|NCT02495883|Vasodilator Agents|vasodilator agents|mesh-ancestor
64399161|NCT02341729|Ticagrelor|ticagrelor|mesh-list
64414196|NCT02495883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64414197|NCT02495883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64414198|NCT02495883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64414199|NCT04910347|Nivolumab|nivolumab|mesh-list
64414200|NCT04910347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64414201|NCT04910347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414202|NCT04910347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64414203|NCT04910347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414204|NCT02439957|Valganciclovir|valganciclovir|mesh-list
64414205|NCT02439957|Brincidofovir|brincidofovir|mesh-list
64414206|NCT02439957|Antiviral Agents|antiviral agents|mesh-ancestor
64414207|NCT02439957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64516546|NCT00160173|Estrogens|estrogens|mesh-ancestor
64516547|NCT00160173|Hormones|hormones|mesh-ancestor
64516548|NCT00160173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64516549|NCT00160173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516550|NCT00160173|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64516551|NCT00160173|Contraceptive Agents|contraceptive agents|mesh-ancestor
64516552|NCT00160173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64516553|NCT00160173|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64516554|NCT00136695|Anastrozole|anastrozole|mesh-list
64516555|NCT00136695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64516556|NCT00136695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516558|NCT00136695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64516559|NCT00136695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414208|NCT02457195|Granisetron|granisetron|mesh-list
64414209|NCT02457195|Antiemetics|antiemetics|mesh-ancestor
64414210|NCT02457195|Autonomic Agents|autonomic agents|mesh-ancestor
64414211|NCT02457195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414212|NCT02457195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414213|NCT02457195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64414256|NCT03053869|Diazepam|diazepam|mesh-list
64414257|NCT03053869|Lorazepam|lorazepam|mesh-list
64414258|NCT03053869|Alprazolam|alprazolam|mesh-list
64414259|NCT03053869|Anticonvulsants|anticonvulsants|mesh-ancestor
64414260|NCT03053869|Antiemetics|antiemetics|mesh-ancestor
64414261|NCT03053869|Autonomic Agents|autonomic agents|mesh-ancestor
64414306|NCT02493855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414307|NCT02493855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64414308|NCT02493855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64414309|NCT02493855|Antiviral Agents|antiviral agents|mesh-ancestor
64414310|NCT02493855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64414311|NCT02493855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64414312|NCT02493855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64414313|NCT02493855|Antimetabolites|antimetabolites|mesh-ancestor
64399168|NCT02341729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414314|NCT04892563|Morphine|morphine|mesh-list
64414315|NCT04892563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64414316|NCT04892563|Narcotics|narcotics|mesh-ancestor
64414317|NCT04892563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64414318|NCT04892563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414319|NCT04892563|Analgesics|analgesics|mesh-ancestor
64414320|NCT04892563|Sensory System Agents|sensory system agents|mesh-ancestor
64414321|NCT04892563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414322|NCT04909255|Solifenacin Succinate|solifenacin succinate|mesh-list
64414323|NCT04909255|Mirabegron|mirabegron|mesh-list
64414364|NCT04901923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64414365|NCT04901923|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64414366|NCT04901923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64414367|NCT04901923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414368|NCT04901923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414369|NCT04901923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64414370|NCT04901923|Hormone Antagonists|hormone antagonists|mesh-ancestor
64414438|NCT04906915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64414439|NCT04906915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64414473|NCT04900129|Antidotes|antidotes|mesh-ancestor
64414474|NCT02616601|Fluorouracil|fluorouracil|mesh-list
64414480|NCT02616601|Immunologic Factors|immunologic factors|mesh-ancestor
64414481|NCT02616601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414482|NCT02492997|Glycerol|glycerol|mesh-list
64414483|NCT02492997|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64414484|NCT02492997|Protective Agents|protective agents|mesh-ancestor
64516560|NCT00136695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516561|NCT00136695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64516562|NCT00136695|Hormone Antagonists|hormone antagonists|mesh-ancestor
64516563|NCT00136695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64516564|NCT00136695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516565|NCT04782375|Antiviral Agents|antiviral agents|mesh-list
64516566|NCT04782375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64516567|NCT02459574|Amiodarone|amiodarone|mesh-list
64516568|NCT02459574|Sotalol|sotalol|mesh-list
64516569|NCT02459574|Flecainide|flecainide|mesh-list
64516570|NCT02459574|Propafenone|propafenone|mesh-list
64516571|NCT02459574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64516572|NCT02459574|Calcium Channel Blockers|calcium channel blockers|mesh-list
64414485|NCT02492997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414486|NCT04393207|Dexamethasone|dexamethasone|mesh-list
64414487|NCT04393207|Dexamethasone acetate|dexamethasone acetate|mesh-list
64414526|NCT04814875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64414570|NCT04397107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64414571|NCT02453841|Phenylephrine|phenylephrine|mesh-list
64414572|NCT02453841|Oxymetazoline|oxymetazoline|mesh-list
64414573|NCT02453841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64414574|NCT02453841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64414575|NCT02453841|Adrenergic Agents|adrenergic agents|mesh-ancestor
64414576|NCT02453841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64414577|NCT02453841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414607|NCT04888663|Antimitotic Agents|antimitotic agents|mesh-ancestor
64414608|NCT04888663|Mitosis Modulators|mitosis modulators|mesh-ancestor
64414609|NCT04888663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414610|NCT04888663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64414611|NCT02453685|Insulin|insulin|mesh-list
64414612|NCT02453685|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64414624|NCT03051841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64414625|NCT03051841|Antiemetics|antiemetics|mesh-ancestor
64414626|NCT03051841|Autonomic Agents|autonomic agents|mesh-ancestor
64414627|NCT03051841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414628|NCT03051841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414629|NCT03051841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64414630|NCT03051841|Glucocorticoids|glucocorticoids|mesh-ancestor
64414631|NCT03051841|Hormones|hormones|mesh-ancestor
64414632|NCT03051841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64414633|NCT03051841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64414669|NCT04888741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64414670|NCT04888741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64414671|NCT04888741|Alkylating Agents|alkylating agents|mesh-ancestor
64414672|NCT04888741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414673|NCT04888741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414712|NCT04898725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64414713|NCT04898725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64414714|NCT04887961|Trabectedin|trabectedin|mesh-list
64414715|NCT04887961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64414716|NCT04887961|Alkylating Agents|alkylating agents|mesh-ancestor
64414717|NCT04887961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414757|NCT02433483|Abortifacient Agents|abortifacient agents|mesh-ancestor
64414758|NCT02433483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64414759|NCT02433483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414760|NCT02433483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64414761|NCT02433483|Antimetabolites|antimetabolites|mesh-ancestor
64516576|NCT02459574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64516577|NCT02459574|Adrenergic Agents|adrenergic agents|mesh-ancestor
64516578|NCT02459574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64516579|NCT02459574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516580|NCT02459574|Vasodilator Agents|vasodilator agents|mesh-ancestor
64516581|NCT02459574|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64414762|NCT02433483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414763|NCT02433483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414764|NCT02433483|Dermatologic Agents|dermatologic agents|mesh-ancestor
64414765|NCT02433483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414766|NCT02433483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64414767|NCT02433483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64557639|NCT03067896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557668|NCT03067740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557671|NCT05634174|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64557672|NCT05634174|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64557673|NCT05634174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64557674|NCT05634174|Adrenergic Agents|adrenergic agents|mesh-ancestor
64557675|NCT05634174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64557676|NCT05634174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557677|NCT05634174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557678|NCT05634174|Urological Agents|urological agents|mesh-ancestor
64557679|NCT03027843|Hormones|hormones|mesh-list
64557680|NCT03027843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64557681|NCT03027843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557682|NCT03068832|Poly I-C|poly i-c|mesh-list
64557683|NCT03068832|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64557684|NCT03068832|Poly ICLC|poly iclc|mesh-list
64557685|NCT03068832|Interferon Inducers|interferon inducers|mesh-ancestor
64557686|NCT03068832|Immunologic Factors|immunologic factors|mesh-ancestor
64557720|NCT03033537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64557721|NCT03033537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557722|NCT03033537|Vasodilator Agents|vasodilator agents|mesh-ancestor
64557724|NCT01670435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64557725|NCT01670435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64557726|NCT01670435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64557727|NCT01670435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64557759|NCT01670669|Serotonin Agents|serotonin agents|mesh-ancestor
64557760|NCT01670669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64557761|NCT01670669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557762|NCT01670669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557763|NCT00946023|Mycophenolic Acid|mycophenolic acid|mesh-list
64557764|NCT00946023|Cyclophosphamide|cyclophosphamide|mesh-list
64557766|NCT00946023|Fludarabine|fludarabine|mesh-list
64557767|NCT00946023|Tacrolimus|tacrolimus|mesh-list
64619119|NCT05314270|Copper|copper|mesh-list
64557793|NCT01672151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557795|NCT05729646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557796|NCT01672229|Bortezomib|bortezomib|mesh-list
64557797|NCT01672229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557798|NCT01672307|Minoxidil|minoxidil|mesh-list
64557799|NCT01672307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64557800|NCT01672307|Vasodilator Agents|vasodilator agents|mesh-ancestor
64557801|NCT03067194|Celecoxib|celecoxib|mesh-list
64557802|NCT03067194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64557803|NCT03067194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64557804|NCT03067194|Analgesics|analgesics|mesh-ancestor
64557805|NCT03067194|Sensory System Agents|sensory system agents|mesh-ancestor
64516582|NCT02459574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64516583|NCT02459574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64516584|NCT02459574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64516585|NCT02459574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64516586|NCT02459574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64516587|NCT02459574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64516588|NCT02459574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64516589|NCT02459574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64516590|NCT02459574|Sympatholytics|sympatholytics|mesh-ancestor
64516591|NCT02459574|Autonomic Agents|autonomic agents|mesh-ancestor
64516592|NCT02459574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516593|NCT02459574|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64516594|NCT04389567|Famotidine|famotidine|mesh-list
64399301|NCT04688203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64399302|NCT04688203|Anticonvulsants|anticonvulsants|mesh-ancestor
64516595|NCT04389567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64516596|NCT04389567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64516597|NCT04389567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64516598|NCT04389567|Histamine Antagonists|histamine antagonists|mesh-ancestor
64516599|NCT04389567|Histamine Agents|histamine agents|mesh-ancestor
64516600|NCT04389567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64516601|NCT04389567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516602|NCT04389567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516603|NCT04168866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64516604|NCT04168866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64516605|NCT03280212|Tranexamic Acid|tranexamic acid|mesh-list
64516606|NCT03280212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64516607|NCT03280212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64557806|NCT03067194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64557807|NCT03067194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557808|NCT03067194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64557809|NCT03067194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64557810|NCT03067194|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64557811|NCT03067194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64557812|NCT03067194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557813|NCT03067194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557814|NCT05629494|Ibuprofen|ibuprofen|mesh-list
64557815|NCT05629494|Naproxen|naproxen|mesh-list
64557915|NCT00953121|Irinotecan|irinotecan|mesh-list
64557916|NCT00953121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64557917|NCT00953121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557918|NCT00953121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64557919|NCT00953121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64557920|NCT00953121|Growth Substances|growth substances|mesh-ancestor
64557921|NCT00953121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557922|NCT00953121|Growth Inhibitors|growth inhibitors|mesh-ancestor
64557954|NCT00953199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64557956|NCT00953199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64516608|NCT03280212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516609|NCT03280212|Hemostatics|hemostatics|mesh-ancestor
64516610|NCT03280212|Coagulants|coagulants|mesh-ancestor
64516611|NCT03536520|Acetazolamide|acetazolamide|mesh-list
64516612|NCT03536520|Anticonvulsants|anticonvulsants|mesh-ancestor
64516613|NCT03536520|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64442794|NCT04192136|Niacin|niacin|mesh-list
64557957|NCT00953199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64557960|NCT03033147|Amoxicillin|amoxicillin|mesh-list
64557961|NCT03033147|Clavulanic Acid|clavulanic acid|mesh-list
64557962|NCT03033147|Clavulanic Acids|clavulanic acids|mesh-list
64557995|NCT04764851|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64557996|NCT04764851|Dopamine Agents|dopamine agents|mesh-ancestor
64557997|NCT04764851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64557998|NCT04764851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557999|NCT00956085|Memantine|memantine|mesh-list
64558000|NCT00956085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64558029|NCT01676363|Diflunisal|diflunisal|mesh-list
64558030|NCT01676363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64558031|NCT01676363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64558032|NCT01676363|Analgesics|analgesics|mesh-ancestor
64558033|NCT01676363|Sensory System Agents|sensory system agents|mesh-ancestor
64558034|NCT01676363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64558035|NCT01676363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558036|NCT01676363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64558037|NCT01676363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64558038|NCT01676363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64558039|NCT01676363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558040|NCT01676363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558041|NCT00956709|Ropivacaine|ropivacaine|mesh-list
64558042|NCT00956709|Levobupivacaine|levobupivacaine|mesh-list
64558072|NCT00958035|Bimatoprost|bimatoprost|mesh-list
64558073|NCT00958035|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64558074|NCT00958035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64558075|NCT01011075|Paclitaxel|paclitaxel|mesh-list
64558076|NCT01011075|Imatinib Mesylate|imatinib mesylate|mesh-list
64558077|NCT01011075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64558078|NCT01011075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558079|NCT01011075|Tubulin Modulators|tubulin modulators|mesh-ancestor
64558080|NCT01011075|Antimitotic Agents|antimitotic agents|mesh-ancestor
64558081|NCT01011075|Mitosis Modulators|mitosis modulators|mesh-ancestor
64558118|NCT04055753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64558119|NCT04055753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64558121|NCT04055753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558122|NCT03871361|Abatacept|abatacept|mesh-list
64558151|NCT03016611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64558153|NCT03016611|Purinergic Agents|purinergic agents|mesh-ancestor
64558154|NCT03016611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64558155|NCT03016611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558156|NCT03016611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558158|NCT00961233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64558159|NCT00961233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64558160|NCT00961233|Autonomic Agents|autonomic agents|mesh-ancestor
64558161|NCT00961233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64558162|NCT00961233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558163|NCT00961233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64558164|NCT00961233|Respiratory System Agents|respiratory system agents|mesh-ancestor
64558231|NCT02631876|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64558232|NCT02631876|Topotecan|topotecan|mesh-list
64558233|NCT02631876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64558234|NCT02631876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558235|NCT02631876|Tubulin Modulators|tubulin modulators|mesh-ancestor
64558236|NCT02631876|Antimitotic Agents|antimitotic agents|mesh-ancestor
64558237|NCT02631876|Mitosis Modulators|mitosis modulators|mesh-ancestor
64516614|NCT03536520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64516615|NCT03536520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516616|NCT03536520|Diuretics|diuretics|mesh-ancestor
64516617|NCT03536520|Natriuretic Agents|natriuretic agents|mesh-ancestor
64516618|NCT03536520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516619|NCT01673217|Doxorubicin|doxorubicin|mesh-list
64516620|NCT01673217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64516622|NCT01673217|Azacitidine|azacitidine|mesh-list
64516623|NCT01673217|Vaccines|vaccines|mesh-list
64399355|NCT02336347|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64399356|NCT02336347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64399357|NCT02336347|Cholinergic Agents|cholinergic agents|mesh-ancestor
64399358|NCT02336347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64399359|NCT02336347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64399360|NCT02336347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64399361|NCT02336347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64399362|NCT02336347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64399363|NCT02341027|Contraceptive Agents|contraceptive agents|mesh-list
64399364|NCT02341027|Levonorgestrel|levonorgestrel|mesh-list
64399365|NCT02341027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64399366|NCT02341027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334678|NCT02295787|Anesthetics|anesthetics|mesh-ancestor
64558238|NCT02631876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558239|NCT02631876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64558240|NCT02631876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64558241|NCT02631876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64558242|NCT02631876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558243|NCT02631876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64558244|NCT03156179|Calcium|calcium|mesh-list
64558282|NCT01676597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64558320|NCT03867617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558350|NCT04879992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558351|NCT04879992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64558352|NCT04879992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64558353|NCT04879992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64558354|NCT04879992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64558355|NCT04879992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64558356|NCT04879992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64558357|NCT04879992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64558358|NCT04879992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558359|NCT04879992|Antacids|antacids|mesh-ancestor
64558360|NCT04879992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64558361|NCT04879992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64558362|NCT04879992|Antitubercular Agents|antitubercular agents|mesh-ancestor
64558363|NCT04879992|Diuretics|diuretics|mesh-ancestor
64558394|NCT05573568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558395|NCT05573568|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64558396|NCT03858491|Cobicistat|cobicistat|mesh-list
64558397|NCT03858491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64558398|NCT03858491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64558399|NCT03858491|Antiviral Agents|antiviral agents|mesh-ancestor
64558400|NCT03858491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64558401|NCT03858491|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64558402|NCT03858491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64558403|NCT03858491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558404|NCT03858491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558405|NCT01672788|Metformin|metformin|mesh-list
64558406|NCT01672788|Empagliflozin|empagliflozin|mesh-list
64558407|NCT01672788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64558408|NCT01672788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558423|NCT02705963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64558424|NCT02705963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64558426|NCT02705963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64558427|NCT02705963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558428|NCT02705963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558429|NCT02705963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64558430|NCT02705963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64558431|NCT03914742|Temozolomide|temozolomide|mesh-list
64336799|NCT02330757|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64399369|NCT02341027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64399370|NCT02341027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64558432|NCT03914742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64558433|NCT03914742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64558434|NCT03914742|Alkylating Agents|alkylating agents|mesh-ancestor
64558435|NCT03914742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558436|NCT03914742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558437|NCT03914742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558438|NCT03065868|Clarithromycin|clarithromycin|mesh-list
64558439|NCT03065868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64516624|NCT01673217|Sargramostim|sargramostim|mesh-list
64516625|NCT01673217|Freund's Adjuvant|freund's adjuvant|mesh-list
64516626|NCT01673217|Immunologic Factors|immunologic factors|mesh-ancestor
64516627|NCT01673217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516628|NCT01673217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64516629|NCT01673217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516630|NCT01673217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64516631|NCT01673217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64619162|NCT01924819|Antimetabolites|antimetabolites|mesh-ancestor
64516633|NCT01673217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516634|NCT01673217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64558440|NCT03065868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64558441|NCT03065868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64558442|NCT03065868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558443|NCT03065868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558444|NCT03065868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64558445|NCT03065868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64558446|NCT03844061|Mycophenolic Acid|mycophenolic acid|mesh-list
64558447|NCT03844061|Rituximab|rituximab|mesh-list
64558448|NCT03844061|Belimumab|belimumab|mesh-list
64558449|NCT03844061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64558450|NCT03844061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558451|NCT03844061|Immunologic Factors|immunologic factors|mesh-ancestor
64558452|NCT03844061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558453|NCT03844061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64558454|NCT03844061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64558455|NCT03844061|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64558456|NCT03844061|Antitubercular Agents|antitubercular agents|mesh-ancestor
64558458|NCT03844061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64558459|NCT03844061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558460|NCT03844061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558461|NCT03844061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64558462|NCT03840239|Capecitabine|capecitabine|mesh-list
64558463|NCT03840239|Oxaliplatin|oxaliplatin|mesh-list
64399395|NCT05253781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64399396|NCT05253781|Analgesics|analgesics|mesh-ancestor
64399408|NCT05253781|Antipyretics|antipyretics|mesh-ancestor
64399409|NCT02340325|Kynurenic Acid|kynurenic acid|mesh-list
64399410|NCT02340325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64399411|NCT02340325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64399412|NCT02340325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64399415|NCT02340247|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64558464|NCT03840239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64558465|NCT03840239|Antimetabolites|antimetabolites|mesh-ancestor
64558490|NCT03824483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64558491|NCT03824483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64558492|NCT03824483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558493|NCT03824483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558495|NCT03814109|Indapamide|indapamide|mesh-list
64558496|NCT03814109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64558497|NCT03814109|Diuretics|diuretics|mesh-ancestor
64558498|NCT03814109|Natriuretic Agents|natriuretic agents|mesh-ancestor
64558499|NCT03814109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558500|NCT03814109|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64558501|NCT03814109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64558502|NCT03814109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558503|NCT03814109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64558504|NCT03814109|Antimetabolites|antimetabolites|mesh-ancestor
64558505|NCT03814109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64558506|NCT03814109|Vasodilator Agents|vasodilator agents|mesh-ancestor
64558507|NCT03814109|Vitamin B Complex|vitamin b complex|mesh-ancestor
64558508|NCT03814109|Vitamins|vitamins|mesh-ancestor
64558509|NCT03814109|Micronutrients|micronutrients|mesh-ancestor
64558510|NCT01016769|Sirolimus|sirolimus|mesh-list
64558511|NCT01016769|Paclitaxel|paclitaxel|mesh-list
64558512|NCT01016769|Carboplatin|carboplatin|mesh-list
64558513|NCT01016769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64558514|NCT01016769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558515|NCT01016769|Tubulin Modulators|tubulin modulators|mesh-ancestor
64558552|NCT00964431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64516636|NCT01673217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64516637|NCT03475134|Cyclophosphamide|cyclophosphamide|mesh-list
64516638|NCT03475134|Nivolumab|nivolumab|mesh-list
64516639|NCT03475134|Fludarabine|fludarabine|mesh-list
64516640|NCT03475134|Interleukin-2|interleukin-2|mesh-list
64516641|NCT03475134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64516642|NCT03475134|Immunologic Factors|immunologic factors|mesh-ancestor
64516643|NCT03475134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516644|NCT03475134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64516645|NCT03475134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64516646|NCT03475134|Alkylating Agents|alkylating agents|mesh-ancestor
64736750|NCT00616577|Sensory System Agents|sensory system agents|mesh-ancestor
64558553|NCT00964431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558554|NCT00964431|Gout Suppressants|gout suppressants|mesh-ancestor
64558555|NCT00964431|Tocolytic Agents|tocolytic agents|mesh-ancestor
64558589|NCT01017237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64558590|NCT01017237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64558591|NCT01017237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64558592|NCT01017237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64558593|NCT01017237|GABA Modulators|gaba modulators|mesh-ancestor
64558594|NCT01017237|GABA Agents|gaba agents|mesh-ancestor
64558595|NCT04442412|Vitamin D|vitamin d|mesh-list
64558596|NCT04442412|Cholecalciferol|cholecalciferol|mesh-list
64558597|NCT04442412|Vitamins|vitamins|mesh-ancestor
64558598|NCT04442412|Micronutrients|micronutrients|mesh-ancestor
64558635|NCT00971295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64558636|NCT00971295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558637|NCT00971295|Anticonvulsants|anticonvulsants|mesh-ancestor
64558638|NCT00971295|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64558639|NCT00971295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64558675|NCT02246049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558676|NCT02246049|Growth Inhibitors|growth inhibitors|mesh-ancestor
64558677|NCT02246049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64558678|NCT02246049|Antimetabolites|antimetabolites|mesh-ancestor
64558679|NCT02246049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558712|NCT05694858|Sensory System Agents|sensory system agents|mesh-ancestor
64558713|NCT05694858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64558714|NCT05694858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64558715|NCT05694858|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64558716|NCT05694858|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64558717|NCT05694858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64558718|NCT05694858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558720|NCT02159859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64558721|NCT02159859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64558722|NCT00974493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64558723|NCT00974493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64558752|NCT03769025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64558753|NCT03769025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558754|NCT03769025|Analgesics|analgesics|mesh-ancestor
64558755|NCT03769025|Sensory System Agents|sensory system agents|mesh-ancestor
64558756|NCT03769025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64558757|NCT03769025|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64558758|NCT01672710|Niacin|niacin|mesh-list
64558759|NCT01672710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64558760|NCT01672710|Antimetabolites|antimetabolites|mesh-ancestor
64558761|NCT01672710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558762|NCT01672710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64558763|NCT01672710|Vasodilator Agents|vasodilator agents|mesh-ancestor
64558764|NCT01672710|Vitamin B Complex|vitamin b complex|mesh-ancestor
64558765|NCT01672710|Vitamins|vitamins|mesh-ancestor
64558766|NCT01672710|Micronutrients|micronutrients|mesh-ancestor
64558767|NCT01672710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516647|NCT03475134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516648|NCT03475134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516649|NCT03475134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64516650|NCT03475134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64516651|NCT03475134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64516652|NCT03475134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64516653|NCT03475134|Analgesics|analgesics|mesh-ancestor
64516654|NCT03475134|Sensory System Agents|sensory system agents|mesh-ancestor
64516655|NCT03475134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516656|NCT01668849|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64516658|NCT01668849|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64516659|NCT01668849|Narcotics|narcotics|mesh-ancestor
64516660|NCT01668849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64516661|NCT01668849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516662|NCT01668849|Analgesics|analgesics|mesh-ancestor
64516663|NCT01668849|Sensory System Agents|sensory system agents|mesh-ancestor
64399479|NCT03077555|Contraceptive Agents|contraceptive agents|mesh-ancestor
64399480|NCT03077555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64399481|NCT03077555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64399482|NCT03077555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64399483|NCT03077555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64399484|NCT02335255|Naftifine|naftifine|mesh-list
64399485|NCT02335255|Antifungal Agents|antifungal agents|mesh-ancestor
64399486|NCT02335255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64399487|NCT05012033|Prednisolone|prednisolone|mesh-list
64399488|NCT05012033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64516664|NCT01668849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516665|NCT01668849|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64516666|NCT01668849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64619170|NCT01924819|Vitamins|vitamins|mesh-ancestor
64619171|NCT01924819|Micronutrients|micronutrients|mesh-ancestor
64516667|NCT01668849|Anesthetics, General|anesthetics, general|mesh-ancestor
64558769|NCT03766763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558770|NCT04790448|Irinotecan|irinotecan|mesh-list
64558771|NCT04790448|Camptothecin|camptothecin|mesh-list
64558772|NCT04790448|Cetuximab|cetuximab|mesh-list
64558773|NCT04790448|Vemurafenib|vemurafenib|mesh-list
64558801|NCT05319756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64558802|NCT05319756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558804|NCT05319756|Sensory System Agents|sensory system agents|mesh-ancestor
64558805|NCT05319756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64558806|NCT05319756|Anticonvulsants|anticonvulsants|mesh-ancestor
64558807|NCT05319756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64558808|NCT05319756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64558809|NCT05319756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64558810|NCT05319756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64558811|NCT05319756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64558812|NCT05319756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64558813|NCT05319756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558814|NCT05319756|Antimanic Agents|antimanic agents|mesh-ancestor
64558815|NCT00976521|Abciximab|abciximab|mesh-list
64558816|NCT00976521|Anticoagulants|anticoagulants|mesh-ancestor
64558817|NCT00976521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64558818|NCT04410588|Fentanyl|fentanyl|mesh-list
64558819|NCT04410588|Levobupivacaine|levobupivacaine|mesh-list
64558820|NCT04410588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64558849|NCT01273259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64558850|NCT01273259|Immunologic Factors|immunologic factors|mesh-ancestor
64558851|NCT01273259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558852|NCT04717362|Methyltestosterone|methyltestosterone|mesh-list
64558853|NCT04717362|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64558854|NCT04717362|Testosterone|testosterone|mesh-list
64558855|NCT04717362|Testosterone undecanoate|testosterone undecanoate|mesh-list
64558856|NCT04717362|Testosterone enanthate|testosterone enanthate|mesh-list
64516668|NCT01668849|Anesthetics|anesthetics|mesh-ancestor
64516669|NCT01668849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64516670|NCT01668849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64516671|NCT01668849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64516672|NCT01668849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64516673|NCT01252719|Vancomycin|vancomycin|mesh-list
64516674|NCT01252719|Oritavancin|oritavancin|mesh-list
64516675|NCT01252719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64516676|NCT01252719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64516678|NCT01230411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64516679|NCT01230411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64516680|NCT01230411|Analgesics|analgesics|mesh-ancestor
64516681|NCT01230411|Sensory System Agents|sensory system agents|mesh-ancestor
64558857|NCT04717362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64558858|NCT04717362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558859|NCT04717362|Anabolic Agents|anabolic agents|mesh-ancestor
64558860|NCT04717362|Hormones|hormones|mesh-ancestor
64558861|NCT04717362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64558862|NCT04717362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558863|NCT04717362|Androgens|androgens|mesh-ancestor
64558864|NCT03739619|Gemcitabine|gemcitabine|mesh-list
64558865|NCT03739619|Nivolumab|nivolumab|mesh-list
64558866|NCT03739619|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64558922|NCT02630472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558923|NCT02630472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64558924|NCT02630472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64558925|NCT02630472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64558926|NCT02630472|Analgesics|analgesics|mesh-ancestor
64558927|NCT02630472|Sensory System Agents|sensory system agents|mesh-ancestor
64558928|NCT03729011|Propofol|propofol|mesh-list
64558929|NCT03729011|Sevoflurane|sevoflurane|mesh-list
64558930|NCT03729011|Desflurane|desflurane|mesh-list
64558931|NCT03729011|Isoflurane|isoflurane|mesh-list
64558932|NCT03729011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64558933|NCT03729011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64558934|NCT03729011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558935|NCT03729011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64558936|NCT03729011|Anesthetics, General|anesthetics, general|mesh-ancestor
64558937|NCT03729011|Anesthetics|anesthetics|mesh-ancestor
64558938|NCT03729011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64558939|NCT03729011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64558972|NCT00977769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558974|NCT03725501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64558975|NCT03725501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64558976|NCT03725501|Growth Substances|growth substances|mesh-ancestor
64558977|NCT03725501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558978|NCT03725501|Growth Inhibitors|growth inhibitors|mesh-ancestor
64558979|NCT03725501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558980|NCT00979017|Bevacizumab|bevacizumab|mesh-list
64558982|NCT00979017|Temozolomide|temozolomide|mesh-list
64558983|NCT00979017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64559018|NCT03720431|Pembrolizumab|pembrolizumab|mesh-list
64559084|NCT03710603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559085|NCT03710603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64399490|NCT05012033|Hormones|hormones|mesh-ancestor
64559086|NCT03710603|Glucocorticoids|glucocorticoids|mesh-ancestor
64559087|NCT03710603|Hormones|hormones|mesh-ancestor
64559088|NCT03710603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64559089|NCT03710603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64399491|NCT05012033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64399492|NCT05012033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399495|NCT03895099|Desogestrel|desogestrel|mesh-list
64559125|NCT03707951|Antidotes|antidotes|mesh-ancestor
64559126|NCT04763057|Calcium|calcium|mesh-list
64559150|NCT03692663|Immunologic Factors|immunologic factors|mesh-ancestor
64559151|NCT03692663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559152|NCT03692663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64516682|NCT01230411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516683|NCT01230411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516684|NCT01230411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64516685|NCT01230411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64516686|NCT01230411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64516687|NCT01230411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64516688|NCT01230411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559153|NCT03692663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64559154|NCT03692663|Alkylating Agents|alkylating agents|mesh-ancestor
64559155|NCT03692663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559156|NCT03692663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559157|NCT03692663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64559158|NCT02084069|Atorvastatin|atorvastatin|mesh-list
64559159|NCT02084069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64559160|NCT02084069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64559161|NCT02084069|Antimetabolites|antimetabolites|mesh-ancestor
64559162|NCT02084069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559163|NCT02084069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64559164|NCT02084069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64559165|NCT02084069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64559166|NCT04439292|Trametinib|trametinib|mesh-list
64559167|NCT04439292|Dabrafenib|dabrafenib|mesh-list
64559168|NCT04439292|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
64559169|NCT04439292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559170|NCT04439292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64559171|NCT04439292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64559172|NCT04439292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559173|NCT04439292|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64559174|NCT04439292|Protective Agents|protective agents|mesh-ancestor
64559175|NCT04439292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619185|NCT01126255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64619189|NCT04198948|Gliclazide|gliclazide|mesh-list
64559176|NCT04439292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64559177|NCT04439292|Antioxidants|antioxidants|mesh-ancestor
64559178|NCT03685331|Olaparib|olaparib|mesh-list
64559282|NCT04762745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559283|NCT04762745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64559284|NCT04762745|Glucocorticoids|glucocorticoids|mesh-ancestor
64559285|NCT04762745|Hormones|hormones|mesh-ancestor
64559286|NCT04762745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64559287|NCT04762745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64559288|NCT04762745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559289|NCT04762745|Protease Inhibitors|protease inhibitors|mesh-ancestor
64559290|NCT04762745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64559291|NCT04762745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559292|NCT04762745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64559293|NCT04762745|Alkylating Agents|alkylating agents|mesh-ancestor
64559294|NCT04762745|Immunologic Factors|immunologic factors|mesh-ancestor
64559295|NCT04762745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64559319|NCT03667703|Histamine Antagonists|histamine antagonists|mesh-ancestor
64559320|NCT03667703|Histamine Agents|histamine agents|mesh-ancestor
64559321|NCT03667703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64559322|NCT03667703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559323|NCT03667703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559324|NCT05074056|Ketorolac|ketorolac|mesh-list
64559325|NCT05074056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64559326|NCT05074056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64559327|NCT05074056|Analgesics|analgesics|mesh-ancestor
64559328|NCT05074056|Sensory System Agents|sensory system agents|mesh-ancestor
64559329|NCT05074056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559330|NCT05074056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559331|NCT05074056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64559332|NCT05074056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64559333|NCT05074056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64559334|NCT05074056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64559335|NCT05074056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559336|NCT05061420|Pembrolizumab|pembrolizumab|mesh-list
64516689|NCT03283800|Copper|copper|mesh-list
64516690|NCT03283800|Trace Elements|trace elements|mesh-ancestor
64516691|NCT03283800|Micronutrients|micronutrients|mesh-ancestor
64516692|NCT03283800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516693|NCT01962688|Diuretics|diuretics|mesh-list
64516694|NCT01962688|Natriuretic Agents|natriuretic agents|mesh-ancestor
64516695|NCT01962688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516696|NCT03274596|Vitamin E|vitamin e|mesh-list
64516697|NCT03274596|Vitamins|vitamins|mesh-ancestor
64516698|NCT03274596|Micronutrients|micronutrients|mesh-ancestor
64516699|NCT03274596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516700|NCT03274596|Antioxidants|antioxidants|mesh-ancestor
64516701|NCT03274596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516702|NCT03274596|Protective Agents|protective agents|mesh-ancestor
64516703|NCT01963078|Oxytocin|oxytocin|mesh-list
64516704|NCT01963078|Oxytocics|oxytocics|mesh-ancestor
64516705|NCT01963078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64516706|NCT01963078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516707|NCT03269760|Zolpidem|zolpidem|mesh-list
64516708|NCT03269760|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64516709|NCT03269760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64516710|NCT03269760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64516711|NCT03269760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516712|NCT03269760|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64516713|NCT03269760|GABA Agonists|gaba agonists|mesh-ancestor
64559337|NCT05061420|Cetuximab|cetuximab|mesh-list
64559338|NCT05061420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64559339|NCT05061420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559340|NCT03965130|Glucagon|glucagon|mesh-list
64559341|NCT03965130|Hormones|hormones|mesh-ancestor
64559342|NCT03965130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64619203|NCT01169467|Analgesics|analgesics|mesh-ancestor
64559343|NCT03965130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619204|NCT01169467|Sensory System Agents|sensory system agents|mesh-ancestor
64559344|NCT03965130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64559345|NCT03656549|Pemetrexed|pemetrexed|mesh-list
64559346|NCT03656549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559347|NCT03656549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64559382|NCT04762511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559383|NCT04762901|Paclitaxel|paclitaxel|mesh-list
64559384|NCT04762901|Cyclophosphamide|cyclophosphamide|mesh-list
64559385|NCT04762901|Carboplatin|carboplatin|mesh-list
64559386|NCT04762901|Doxorubicin|doxorubicin|mesh-list
64559387|NCT04762901|Niraparib|niraparib|mesh-list
64559388|NCT04762901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64559416|NCT04491942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64559417|NCT04491942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64559418|NCT04491942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64559419|NCT04491942|Immunologic Factors|immunologic factors|mesh-ancestor
64559420|NCT04491942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559421|NCT03018171|Clonidine|clonidine|mesh-list
64559422|NCT03018171|Sufentanil|sufentanil|mesh-list
64559423|NCT03018171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64559424|NCT03018171|Narcotics|narcotics|mesh-ancestor
64559425|NCT03018171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64559426|NCT03018171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559427|NCT03018171|Analgesics|analgesics|mesh-ancestor
64516715|NCT03269760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64516716|NCT03269760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516717|NCT03269916|Hormones|hormones|mesh-list
64516718|NCT03269916|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64516719|NCT03269916|Estrogens|estrogens|mesh-list
64516721|NCT03269916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516784|NCT01966978|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64516785|NCT01966978|Liraglutide|liraglutide|mesh-list
64516786|NCT01966978|Insulin Detemir|insulin detemir|mesh-list
64516787|NCT01966978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64516788|NCT01966978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516789|NCT01966978|Incretins|incretins|mesh-ancestor
64516790|NCT01966978|Hormones|hormones|mesh-ancestor
64516791|NCT01966978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64516792|NCT03269214|Phenytoin|phenytoin|mesh-list
64516793|NCT03269214|Anticonvulsants|anticonvulsants|mesh-ancestor
64516794|NCT03269214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64516795|NCT03269214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64516796|NCT03269214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64736751|NCT00616577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559428|NCT03018171|Sensory System Agents|sensory system agents|mesh-ancestor
64559429|NCT03018171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559430|NCT03018171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64559431|NCT03018171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64559432|NCT03018171|Anesthetics, General|anesthetics, general|mesh-ancestor
64559433|NCT03018171|Anesthetics|anesthetics|mesh-ancestor
64559434|NCT03018171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64559435|NCT03018171|Sympatholytics|sympatholytics|mesh-ancestor
64559436|NCT03018171|Autonomic Agents|autonomic agents|mesh-ancestor
64559437|NCT03018171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64559466|NCT00989157|Dopamine Agents|dopamine agents|mesh-ancestor
64559467|NCT00990561|Clobetasol|clobetasol|mesh-list
64559468|NCT00990561|Halobetasol|halobetasol|mesh-list
64559469|NCT00990561|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64559470|NCT00990561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64559471|NCT00990561|Glucocorticoids|glucocorticoids|mesh-ancestor
64559472|NCT00990561|Hormones|hormones|mesh-ancestor
64559473|NCT00990561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64559474|NCT00990561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559475|NCT03018015|Ibuprofen|ibuprofen|mesh-list
64559476|NCT03018015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64559477|NCT03018015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64559478|NCT03018015|Analgesics|analgesics|mesh-ancestor
64559479|NCT03018015|Sensory System Agents|sensory system agents|mesh-ancestor
64559480|NCT03018015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559512|NCT00004547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64559513|NCT00004547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559514|NCT00004547|Tubulin Modulators|tubulin modulators|mesh-ancestor
64559515|NCT00004547|Antimitotic Agents|antimitotic agents|mesh-ancestor
64559516|NCT00004547|Mitosis Modulators|mitosis modulators|mesh-ancestor
64559517|NCT00004547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559519|NCT00005669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64559520|NCT00005669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559548|NCT02089997|Risedronic Acid|risedronic acid|mesh-list
64559549|NCT02089997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64559550|NCT02089997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64559551|NCT02089997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559580|NCT02628600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64559581|NCT02628600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64559583|NCT00006101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559584|NCT00006101|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64559585|NCT00006101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64559587|NCT00006101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64559588|NCT00006101|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64559589|NCT00006101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64516797|NCT03269214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516798|NCT03269214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64516799|NCT03269214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64516800|NCT03269058|Dapagliflozin|dapagliflozin|mesh-list
64516801|NCT03269058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64516802|NCT03269058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516803|NCT03269058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64516804|NCT03269058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516805|NCT05074602|Fluconazole|fluconazole|mesh-list
64516806|NCT05074602|Antifungal Agents|antifungal agents|mesh-ancestor
64516807|NCT05074602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64516808|NCT05074602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64516809|NCT05074602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64516810|NCT05074602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64516811|NCT05074602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516812|NCT05074602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64516813|NCT05074602|Hormone Antagonists|hormone antagonists|mesh-ancestor
64736752|NCT00616343|Zonisamide|zonisamide|mesh-list
64736753|NCT00616343|Anticonvulsants|anticonvulsants|mesh-ancestor
64559590|NCT00006101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559591|NCT05576207|Micronutrients|micronutrients|mesh-list
64559592|NCT05576207|Trace Elements|trace elements|mesh-list
64559593|NCT05576207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559594|NCT04294134|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
64559595|NCT04294134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64559596|NCT04294134|Serotonin Agents|serotonin agents|mesh-ancestor
64559597|NCT04294134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64586300|NCT00365261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64559623|NCT00991029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64559624|NCT00991029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559625|NCT00991029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559626|NCT00991809|Diphenhydramine|diphenhydramine|mesh-list
64559627|NCT00991809|Promethazine|promethazine|mesh-list
64559628|NCT00991809|Alfentanil|alfentanil|mesh-list
64559629|NCT00991809|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64559630|NCT00991809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64559631|NCT00991809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64559632|NCT00991809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559633|NCT00991809|Anesthetics, Local|anesthetics, local|mesh-ancestor
64559634|NCT00991809|Anesthetics|anesthetics|mesh-ancestor
64559635|NCT00991809|Sensory System Agents|sensory system agents|mesh-ancestor
64559636|NCT00991809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559637|NCT00991809|Antiemetics|antiemetics|mesh-ancestor
64559638|NCT00991809|Autonomic Agents|autonomic agents|mesh-ancestor
64619221|NCT04822363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64559639|NCT00991809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64559640|NCT00991809|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64559641|NCT00991809|Histamine Antagonists|histamine antagonists|mesh-ancestor
64559642|NCT00991809|Histamine Agents|histamine agents|mesh-ancestor
64559643|NCT00991809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64559644|NCT00991809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559681|NCT04436250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64559682|NCT04436250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64516814|NCT05074602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64516815|NCT05074602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516816|NCT05074602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64516817|NCT05074602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64516818|NCT02457312|Letrozole|letrozole|mesh-list
64516819|NCT02457312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516820|NCT02457312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64516821|NCT02457312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64516822|NCT02457312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64516823|NCT02457312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516824|NCT02457312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64516825|NCT02457312|Hormone Antagonists|hormone antagonists|mesh-ancestor
64516826|NCT02457312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64516827|NCT02457312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516828|NCT03268902|Niacinamide|niacinamide|mesh-list
64516829|NCT03268902|Niacin|niacin|mesh-list
64516830|NCT03268902|Nicotinic Acids|nicotinic acids|mesh-list
64516831|NCT03268902|Azithromycin|azithromycin|mesh-list
64516832|NCT03268902|Nitazoxanide|nitazoxanide|mesh-list
64516833|NCT03268902|Vitamins|vitamins|mesh-ancestor
64516834|NCT03268902|Micronutrients|micronutrients|mesh-ancestor
64516835|NCT03268902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516836|NCT03268902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64516837|NCT03268902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64559683|NCT04436250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64559684|NCT04436250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64559718|NCT04374903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64559719|NCT04374903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64559720|NCT04374903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559721|NCT04374903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64559722|NCT03063060|Vitamin D|vitamin d|mesh-list
64559723|NCT03063060|Calcium|calcium|mesh-list
64559724|NCT03063060|Vitamins|vitamins|mesh-ancestor
64559725|NCT03063060|Micronutrients|micronutrients|mesh-ancestor
64559726|NCT03063060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559727|NCT03063060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64559728|NCT03063060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64559768|NCT00997113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64559769|NCT00997113|Narcotics|narcotics|mesh-ancestor
64559800|NCT04981704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64559801|NCT02163837|Rifaximin|rifaximin|mesh-list
64559802|NCT02163837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64559803|NCT02163837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64559804|NCT02163837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64559805|NCT04974060|Remifentanil|remifentanil|mesh-list
64559806|NCT04974060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64559807|NCT04974060|Narcotics|narcotics|mesh-ancestor
64559808|NCT04974060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64559809|NCT04974060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559810|NCT04974060|Analgesics|analgesics|mesh-ancestor
64399623|NCT02331823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64399624|NCT02331823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399625|NCT02331823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442897|NCT01691794|Protease Inhibitors|protease inhibitors|mesh-ancestor
64559839|NCT04973904|Growth Substances|growth substances|mesh-ancestor
64516838|NCT03268902|Vitamin B Complex|vitamin b complex|mesh-ancestor
64516839|NCT03268902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64516840|NCT03268902|Antimetabolites|antimetabolites|mesh-ancestor
64516841|NCT03268902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516842|NCT03268902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64516843|NCT03268902|Vasodilator Agents|vasodilator agents|mesh-ancestor
64516844|NCT03268902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64516845|NCT02458716|Leuprolide|leuprolide|mesh-list
64516846|NCT02458716|Bicalutamide|bicalutamide|mesh-list
64516847|NCT02458716|Androgens|androgens|mesh-list
64516848|NCT02458716|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
64516849|NCT02458716|Hormones|hormones|mesh-ancestor
64619226|NCT04822363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64516850|NCT02458716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64516851|NCT02458716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516852|NCT02458716|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64516853|NCT02458716|Fertility Agents|fertility agents|mesh-ancestor
64516854|NCT02458716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64516855|NCT02458716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64516856|NCT02458716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516857|NCT02458716|Androgen Antagonists|androgen antagonists|mesh-ancestor
64516858|NCT02458716|Hormone Antagonists|hormone antagonists|mesh-ancestor
64516859|NCT03268278|Lidocaine|lidocaine|mesh-list
64516860|NCT03268278|Epinephrine|epinephrine|mesh-list
64516861|NCT03268278|Buprenorphine|buprenorphine|mesh-list
64516862|NCT03268278|Anesthetics, Local|anesthetics, local|mesh-list
64559840|NCT04973904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559841|NCT04973904|Growth Inhibitors|growth inhibitors|mesh-ancestor
64559843|NCT00998049|Lenograstim|lenograstim|mesh-list
64559844|NCT00998049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64559845|NCT00998049|Immunologic Factors|immunologic factors|mesh-ancestor
64559846|NCT00998049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559847|NCT00998049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64559848|NCT00998049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64559849|NCT00998049|Antiviral Agents|antiviral agents|mesh-ancestor
64559850|NCT00998049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64559851|NCT00998205|Atropine|atropine|mesh-list
64559852|NCT00998205|Dobutamine|dobutamine|mesh-list
64559853|NCT00998205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64559854|NCT00998205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64559855|NCT00998205|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64559887|NCT01023477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64559888|NCT01023477|Antimalarials|antimalarials|mesh-ancestor
64559889|NCT01023477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64559890|NCT01023477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64559891|NCT01023477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64559892|NCT01023477|Analgesics|analgesics|mesh-ancestor
64559893|NCT01023477|Sensory System Agents|sensory system agents|mesh-ancestor
64559894|NCT01023477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559895|NCT01023477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559896|NCT01023477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64559897|NCT01023477|Filaricides|filaricides|mesh-ancestor
64559962|NCT01025427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64559964|NCT01025427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516863|NCT03268278|Anesthetics|anesthetics|mesh-list
64399626|NCT02331823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399628|NCT02331823|Antitubercular Agents|antitubercular agents|mesh-ancestor
64516864|NCT03268278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64516865|NCT03268278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516866|NCT03268278|Sensory System Agents|sensory system agents|mesh-ancestor
64516867|NCT03268278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516868|NCT03268278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64516869|NCT03268278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64516870|NCT03268278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64516871|NCT03268278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64516872|NCT03268278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516873|NCT03268278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64559965|NCT01025427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64559966|NCT01025427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64559967|NCT01025427|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64559968|NCT01025427|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64559969|NCT02162433|Dexmedetomidine|dexmedetomidine|mesh-list
64559970|NCT02162433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64559971|NCT02162433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64559972|NCT02162433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559973|NCT02162433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64559974|NCT02162433|Analgesics|analgesics|mesh-ancestor
64560005|NCT01004991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64560006|NCT01004991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64560007|NCT01004991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560008|NCT01004991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64560009|NCT01004991|Glucocorticoids|glucocorticoids|mesh-ancestor
64560011|NCT01004991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64560012|NCT01004991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64560013|NCT01004991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64560014|NCT01004991|Tubulin Modulators|tubulin modulators|mesh-ancestor
64560015|NCT01004991|Antimitotic Agents|antimitotic agents|mesh-ancestor
64560046|NCT01030653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64560047|NCT01030653|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64560048|NCT01030653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64560049|NCT01030653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560050|NCT01030653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560051|NCT01030653|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64560052|NCT01030653|Hormone Antagonists|hormone antagonists|mesh-ancestor
64560053|NCT01030653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64560054|NCT01030653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560055|NCT01030653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64560056|NCT01031043|Bethanechol|bethanechol|mesh-list
64560057|NCT01031043|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64560058|NCT01031043|Autonomic Agents|autonomic agents|mesh-ancestor
64560093|NCT04358133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560094|NCT04291209|Acetylcysteine|acetylcysteine|mesh-list
64560095|NCT04291209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64560096|NCT04291209|Antiviral Agents|antiviral agents|mesh-ancestor
64560097|NCT04291209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64560098|NCT04291209|Expectorants|expectorants|mesh-ancestor
64560131|NCT01053507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64560132|NCT01053507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64560133|NCT01053507|Gout Suppressants|gout suppressants|mesh-ancestor
64560134|NCT01053507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64334685|NCT04530383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64334686|NCT04530383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334688|NCT04464967|Cetuximab|cetuximab|mesh-list
64443010|NCT04787744|Prednisone|prednisone|mesh-list
64443011|NCT04787744|Methylprednisolone|methylprednisolone|mesh-list
64560135|NCT01053507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560136|NCT01053507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560137|NCT01053507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64560138|NCT01053507|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64516874|NCT03268278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64516875|NCT03268278|Adrenergic Agents|adrenergic agents|mesh-ancestor
64516876|NCT03268278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64516877|NCT03268278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64516878|NCT03268278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64516879|NCT03268278|Autonomic Agents|autonomic agents|mesh-ancestor
64516880|NCT03268278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64560139|NCT01053507|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64560174|NCT01055223|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
64560175|NCT01055223|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64560176|NCT01055223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64560177|NCT01055223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560178|NCT01055223|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64560198|NCT01360554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64560199|NCT01360554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560200|NCT01360554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560202|NCT01055769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64560203|NCT01055769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64560204|NCT01055769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64560205|NCT01055769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560206|NCT01055769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560207|NCT01057017|Panitumumab|panitumumab|mesh-list
64560208|NCT01057017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64560209|NCT01057017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560210|NCT04972032|Estrogens|estrogens|mesh-list
64560211|NCT04972032|Hyaluronic Acid|hyaluronic acid|mesh-list
64560212|NCT04972032|Hormones|hormones|mesh-ancestor
64560213|NCT04972032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64399645|NCT03077009|Viscosupplements|viscosupplements|mesh-ancestor
64399646|NCT03077009|Protective Agents|protective agents|mesh-ancestor
64399647|NCT04477525|Bupivacaine|bupivacaine|mesh-list
64399648|NCT04477525|Anesthetics, Local|anesthetics, local|mesh-ancestor
64399649|NCT04477525|Anesthetics|anesthetics|mesh-ancestor
64399650|NCT04477525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64399651|NCT04477525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399652|NCT04477525|Sensory System Agents|sensory system agents|mesh-ancestor
64399653|NCT04477525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399654|NCT03079973|Calcipotriene|calcipotriene|mesh-list
64399655|NCT03079973|Dermatologic Agents|dermatologic agents|mesh-ancestor
64399656|NCT03861871|Fenfluramine|fenfluramine|mesh-list
64399657|NCT03861871|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64399658|NCT03861871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64560214|NCT04972032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560215|NCT04972032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64560216|NCT04972032|Immunologic Factors|immunologic factors|mesh-ancestor
64560217|NCT04972032|Viscosupplements|viscosupplements|mesh-ancestor
64619234|NCT01170247|Ketamine|ketamine|mesh-list
64560220|NCT04432662|Hematinics|hematinics|mesh-ancestor
64560221|NCT02918370|Aripiprazole|aripiprazole|mesh-list
64560222|NCT02918370|Antidepressive Agents|antidepressive agents|mesh-ancestor
64560223|NCT02918370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64560224|NCT02918370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64560225|NCT02918370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64560226|NCT02918370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64560227|NCT02918370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560228|NCT02918370|Dopamine Agonists|dopamine agonists|mesh-ancestor
64560229|NCT02918370|Dopamine Agents|dopamine agents|mesh-ancestor
64560230|NCT02918370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64560231|NCT02918370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560232|NCT02918370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64560233|NCT02918370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64560234|NCT02918370|Serotonin Agents|serotonin agents|mesh-ancestor
64560235|NCT02918370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64560236|NCT02918370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64560237|NCT02918370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64560238|NCT02918370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64560271|NCT05593731|Protective Agents|protective agents|mesh-ancestor
64560272|NCT05593731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560273|NCT05593731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64560274|NCT01062009|Zinc Sulfate|zinc sulfate|mesh-list
64560275|NCT01062009|Astringents|astringents|mesh-ancestor
64560276|NCT01062009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560277|NCT01062009|Dermatologic Agents|dermatologic agents|mesh-ancestor
64560278|NCT01062165|Caspofungin|caspofungin|mesh-list
64560307|NCT01068873|Maraviroc|maraviroc|mesh-list
64560308|NCT01068873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64560309|NCT01068873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64560310|NCT01068873|Protease Inhibitors|protease inhibitors|mesh-ancestor
64560311|NCT01068873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64516881|NCT03268278|Respiratory System Agents|respiratory system agents|mesh-ancestor
64516882|NCT03268278|Mydriatics|mydriatics|mesh-ancestor
64516883|NCT03268278|Sympathomimetics|sympathomimetics|mesh-ancestor
64516884|NCT03268278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64516885|NCT03268278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64516886|NCT03268278|Narcotics|narcotics|mesh-ancestor
64560312|NCT01068873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560313|NCT01068873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64560314|NCT01068873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64560315|NCT01068873|Antiviral Agents|antiviral agents|mesh-ancestor
64560316|NCT01068873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64560317|NCT01068873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64560318|NCT01068873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64560319|NCT01068873|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64560320|NCT01068873|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64560321|NCT01068873|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64560322|NCT01072773|Dexamethasone|dexamethasone|mesh-list
64560323|NCT01072773|Cyclophosphamide|cyclophosphamide|mesh-list
64560324|NCT01072773|Bortezomib|bortezomib|mesh-list
64399688|NCT05003765|Buprenorphine|buprenorphine|mesh-list
64560356|NCT01076283|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64560357|NCT01076283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560358|NCT01076283|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64560360|NCT01076283|GABA Agents|gaba agents|mesh-ancestor
64560361|NCT01076283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64560362|NCT01076283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560363|NCT01076283|Antipruritics|antipruritics|mesh-ancestor
64560364|NCT01076283|Dermatologic Agents|dermatologic agents|mesh-ancestor
64560399|NCT05539911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64560400|NCT05539911|Narcotics|narcotics|mesh-ancestor
64560401|NCT05539911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64560402|NCT05539911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560403|NCT05539911|Analgesics|analgesics|mesh-ancestor
64560404|NCT05539911|Sensory System Agents|sensory system agents|mesh-ancestor
64560436|NCT03484299|Gemcitabine|gemcitabine|mesh-list
64560437|NCT03484299|Folfirinox|folfirinox|mesh-list
64560438|NCT03484299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64560439|NCT03484299|Antimetabolites|antimetabolites|mesh-ancestor
64560440|NCT03484299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560441|NCT03484299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560442|NCT03484299|Antiviral Agents|antiviral agents|mesh-ancestor
64560443|NCT03484299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64560444|NCT03484299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560445|NCT03484299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64560446|NCT03484299|Immunologic Factors|immunologic factors|mesh-ancestor
64560460|NCT04970238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560462|NCT04970238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560463|NCT02169453|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64560464|NCT02169453|Opicapone|opicapone|mesh-list
64560465|NCT02169453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64560466|NCT02169453|Immunologic Factors|immunologic factors|mesh-ancestor
64560467|NCT02169453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560468|NCT02169453|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64560469|NCT02169453|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64560470|NCT02169453|Dopamine Agonists|dopamine agonists|mesh-ancestor
64560471|NCT02169453|Dopamine Agents|dopamine agents|mesh-ancestor
64560472|NCT02169453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64560473|NCT02169453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560474|NCT02169453|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64560475|NCT02169453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560476|NCT01822314|Paclitaxel|paclitaxel|mesh-list
64560477|NCT01822314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64560478|NCT01822314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64560479|NCT01822314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560480|NCT01822314|Tubulin Modulators|tubulin modulators|mesh-ancestor
64560481|NCT01822314|Antimitotic Agents|antimitotic agents|mesh-ancestor
64560482|NCT01822314|Mitosis Modulators|mitosis modulators|mesh-ancestor
64560483|NCT01822314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560484|NCT01765296|Celecoxib|celecoxib|mesh-list
64516887|NCT03268278|Analgesics|analgesics|mesh-ancestor
64516888|NCT03268278|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64516889|NCT05045586|Hyaluronic Acid|hyaluronic acid|mesh-list
64516890|NCT05045586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64516891|NCT05045586|Immunologic Factors|immunologic factors|mesh-ancestor
64516892|NCT05045586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516893|NCT05045586|Viscosupplements|viscosupplements|mesh-ancestor
64516894|NCT05045586|Protective Agents|protective agents|mesh-ancestor
64516895|NCT03263520|Nandrolone Decanoate|nandrolone decanoate|mesh-list
64516896|NCT03263520|Dexamethasone|dexamethasone|mesh-list
64516897|NCT03263520|Dexamethasone acetate|dexamethasone acetate|mesh-list
64516898|NCT03263520|Nandrolone|nandrolone|mesh-list
64516899|NCT03263520|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
64516900|NCT03263520|BB 1101|bb 1101|mesh-list
64560485|NCT01765296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64560486|NCT01765296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64560487|NCT01765296|Analgesics|analgesics|mesh-ancestor
64560488|NCT01765296|Sensory System Agents|sensory system agents|mesh-ancestor
64560489|NCT01765296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560490|NCT01765296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560491|NCT01765296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64560492|NCT01765296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64560493|NCT01765296|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64560494|NCT01765296|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64560495|NCT01765296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560496|NCT01765296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560497|NCT01081041|Carboplatin|carboplatin|mesh-list
64560498|NCT01081041|Fluorouracil|fluorouracil|mesh-list
64560499|NCT01081041|Cetuximab|cetuximab|mesh-list
64560500|NCT01081041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560501|NCT01081041|Antimetabolites|antimetabolites|mesh-ancestor
64619249|NCT01126099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64560535|NCT02089685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64560536|NCT02089685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560537|NCT02089685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64560538|NCT02089685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560539|NCT01088295|Telmisartan|telmisartan|mesh-list
64560540|NCT01088295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64560574|NCT04730531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560575|NCT04730531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64560576|NCT04730531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64560577|NCT04730531|Adrenergic Agents|adrenergic agents|mesh-ancestor
64560578|NCT04730531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64560603|NCT05307003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560604|NCT05307003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64560605|NCT05307003|Serotonin Agents|serotonin agents|mesh-ancestor
64560606|NCT05307003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64560607|NCT03586661|Niraparib|niraparib|mesh-list
64560608|NCT03586661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64560609|NCT03586661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560610|NCT03586661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560611|NCT03586661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560612|NCT03153917|Hydrocortisone|hydrocortisone|mesh-list
64560613|NCT03153917|Melatonin|melatonin|mesh-list
64560614|NCT03153917|Antioxidants|antioxidants|mesh-ancestor
64560615|NCT03153917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560616|NCT03153917|Protective Agents|protective agents|mesh-ancestor
64560617|NCT03153917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560618|NCT03153917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64560619|NCT03153917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64560620|NCT05496335|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64560621|NCT05496335|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64560622|NCT05496335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516901|NCT03263520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64516902|NCT03263520|Antiemetics|antiemetics|mesh-ancestor
64516903|NCT03263520|Autonomic Agents|autonomic agents|mesh-ancestor
64516904|NCT03263520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516905|NCT03263520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516906|NCT03263520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64516907|NCT03263520|Glucocorticoids|glucocorticoids|mesh-ancestor
64516908|NCT03263520|Hormones|hormones|mesh-ancestor
64516909|NCT03263520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64516910|NCT03263520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64443815|NCT02238626|Ibudilast|ibudilast|mesh-list
64560623|NCT05496335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560624|NCT05496335|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64560672|NCT02085161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64560673|NCT02085161|Respiratory System Agents|respiratory system agents|mesh-ancestor
64560675|NCT02085161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64560676|NCT02085161|Cholinergic Agents|cholinergic agents|mesh-ancestor
64560677|NCT02085161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64560678|NCT02085161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560680|NCT01034553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560681|NCT01035333|Orlistat|orlistat|mesh-list
64560682|NCT01035333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560683|NCT01035333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560684|NCT01035333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64560685|NCT01035333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64560686|NCT05073549|Anti-Infective Agents|anti-infective agents|mesh-list
64560687|NCT05073549|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64560688|NCT03152981|Remifentanil|remifentanil|mesh-list
64560689|NCT03152981|Propofol|propofol|mesh-list
64560690|NCT03152981|Desflurane|desflurane|mesh-list
64560691|NCT03152981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64560692|NCT03152981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64399796|NCT03111511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64560693|NCT03152981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560694|NCT03152981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64560695|NCT03152981|Anesthetics, General|anesthetics, general|mesh-ancestor
64560696|NCT03152981|Anesthetics|anesthetics|mesh-ancestor
64560697|NCT03152981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64560698|NCT03152981|Narcotics|narcotics|mesh-ancestor
64560699|NCT03152981|Analgesics|analgesics|mesh-ancestor
64560700|NCT03152981|Sensory System Agents|sensory system agents|mesh-ancestor
64619257|NCT01170715|Etanercept|etanercept|mesh-list
64560703|NCT03576755|Spironolactone|spironolactone|mesh-list
64560704|NCT03576755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64560705|NCT03576755|Hormone Antagonists|hormone antagonists|mesh-ancestor
64560706|NCT03576755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64560707|NCT03576755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560708|NCT03576755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64560709|NCT03576755|Diuretics|diuretics|mesh-ancestor
64560710|NCT03576755|Natriuretic Agents|natriuretic agents|mesh-ancestor
64560711|NCT05384015|Carboplatin|carboplatin|mesh-list
64560712|NCT05384015|Pembrolizumab|pembrolizumab|mesh-list
64560713|NCT05384015|Etoposide|etoposide|mesh-list
64560741|NCT03568643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64560742|NCT03568643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64560744|NCT01100931|Carboplatin|carboplatin|mesh-list
64560745|NCT01100931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64560746|NCT01100931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560747|NCT01100931|Tubulin Modulators|tubulin modulators|mesh-ancestor
64560748|NCT01100931|Antimitotic Agents|antimitotic agents|mesh-ancestor
64560749|NCT01100931|Mitosis Modulators|mitosis modulators|mesh-ancestor
64560750|NCT01100931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560752|NCT01101867|Insulin, Long-Acting|insulin, long-acting|mesh-list
64516912|NCT03263520|Protease Inhibitors|protease inhibitors|mesh-ancestor
64516913|NCT03263520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64516914|NCT03263520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516915|NCT03263520|Androgens|androgens|mesh-ancestor
64516916|NCT03263520|Anabolic Agents|anabolic agents|mesh-ancestor
64516917|NCT03263520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64516918|NCT02456844|Leucovorin|leucovorin|mesh-list
64516919|NCT02456844|Flurbiprofen|flurbiprofen|mesh-list
64516920|NCT02456844|Methotrexate|methotrexate|mesh-list
64516921|NCT02456844|Digoxin|digoxin|mesh-list
64516922|NCT02456844|Midazolam|midazolam|mesh-list
64516923|NCT02456844|Pravastatin|pravastatin|mesh-list
64516924|NCT02456844|Montelukast|montelukast|mesh-list
64516925|NCT02456844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64516926|NCT02456844|Abortifacient Agents|abortifacient agents|mesh-ancestor
64516927|NCT02456844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64516928|NCT02456844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516929|NCT02456844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64516930|NCT02456844|Antimetabolites|antimetabolites|mesh-ancestor
64516931|NCT02456844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516932|NCT02456844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516934|NCT02456844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64516935|NCT02456844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64560753|NCT01101867|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64560754|NCT01101867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64560755|NCT01101867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560756|NCT04999449|Scopolamine|scopolamine|mesh-list
64560757|NCT04999449|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64560758|NCT04999449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64560759|NCT04999449|Antiemetics|antiemetics|mesh-ancestor
64560760|NCT04999449|Autonomic Agents|autonomic agents|mesh-ancestor
64399877|NCT02326051|Enoxaparin|enoxaparin|mesh-list
64399878|NCT02326051|Enoxaparin sodium|enoxaparin sodium|mesh-list
64399879|NCT02326051|Anticoagulants|anticoagulants|mesh-ancestor
64399880|NCT02326051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64560783|NCT02246595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64560784|NCT02246595|Immunologic Factors|immunologic factors|mesh-ancestor
64560785|NCT02246595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399881|NCT02326051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64560786|NCT01106859|Zolpidem|zolpidem|mesh-list
64560787|NCT01106859|Zopiclone|zopiclone|mesh-list
64560788|NCT01106859|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64560789|NCT01106859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64560790|NCT01106859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64560791|NCT01106859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560793|NCT01106859|GABA Agonists|gaba agonists|mesh-ancestor
64560794|NCT01106859|GABA Agents|gaba agents|mesh-ancestor
64560795|NCT01106859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64560796|NCT01106859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560797|NCT01042509|Rituximab|rituximab|mesh-list
64560798|NCT01042509|Alemtuzumab|alemtuzumab|mesh-list
64560799|NCT01042509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64560800|NCT01042509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516936|NCT02456844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64516937|NCT02456844|Immunologic Factors|immunologic factors|mesh-ancestor
64516938|NCT02456844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64516939|NCT02456844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64516940|NCT02456844|Antidotes|antidotes|mesh-ancestor
64516941|NCT02456844|Protective Agents|protective agents|mesh-ancestor
64516942|NCT02456844|Vitamin B Complex|vitamin b complex|mesh-ancestor
64516943|NCT02456844|Vitamins|vitamins|mesh-ancestor
64516944|NCT02456844|Micronutrients|micronutrients|mesh-ancestor
64516945|NCT02456844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64560801|NCT01042509|Immunologic Factors|immunologic factors|mesh-ancestor
64560802|NCT01042509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560803|NCT01042509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64560804|NCT04814355|Celecoxib|celecoxib|mesh-list
64560805|NCT04814355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64560806|NCT04814355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64560807|NCT04814355|Analgesics|analgesics|mesh-ancestor
64560808|NCT04814355|Sensory System Agents|sensory system agents|mesh-ancestor
64560809|NCT04814355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560810|NCT04814355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560811|NCT04814355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64560841|NCT01110135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64560842|NCT01110135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560843|NCT01110135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64560844|NCT01110135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64560845|NCT01110135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64560846|NCT01110135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560847|NCT01110135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560848|NCT01110135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64560849|NCT01110135|Alkylating Agents|alkylating agents|mesh-ancestor
64560850|NCT01112241|Albuterol|albuterol|mesh-list
64560851|NCT01112241|Tiotropium Bromide|tiotropium bromide|mesh-list
64560852|NCT01112241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64560853|NCT01112241|Autonomic Agents|autonomic agents|mesh-ancestor
64560854|NCT01112241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560855|NCT01112241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560856|NCT01112241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64560857|NCT01112241|Respiratory System Agents|respiratory system agents|mesh-ancestor
64399886|NCT05076955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64560858|NCT01112241|Parasympatholytics|parasympatholytics|mesh-ancestor
64560859|NCT01112241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64560896|NCT01114503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64560897|NCT01114503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64560898|NCT01114503|Prednisolone|prednisolone|mesh-list
64560967|NCT01114971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64560969|NCT01044693|Nebivolol|nebivolol|mesh-list
64560970|NCT01044693|Sildenafil Citrate|sildenafil citrate|mesh-list
64560971|NCT01044693|Vasodilator Agents|vasodilator agents|mesh-ancestor
64560972|NCT01044693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64560973|NCT01044693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64560974|NCT01044693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560975|NCT01044693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560976|NCT01044693|Urological Agents|urological agents|mesh-ancestor
64561013|NCT01044771|Tenofovir|tenofovir|mesh-list
64561014|NCT01044771|Raltegravir Potassium|raltegravir potassium|mesh-list
64561015|NCT01044771|Antiviral Agents|antiviral agents|mesh-ancestor
64561030|NCT01115673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561031|NCT01115673|Antipyretics|antipyretics|mesh-ancestor
64619270|NCT03809182|Dexmedetomidine|dexmedetomidine|mesh-list
64561032|NCT01116921|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64561033|NCT01116921|Respiratory System Agents|respiratory system agents|mesh-ancestor
64561035|NCT04582383|Spironolactone|spironolactone|mesh-list
64561036|NCT04582383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64561037|NCT04582383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64561038|NCT04582383|Antimalarials|antimalarials|mesh-ancestor
64561039|NCT04582383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64516946|NCT02456844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64516947|NCT02456844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64516948|NCT02456844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64516949|NCT02456844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64516950|NCT02456844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64516951|NCT02456844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64516952|NCT02456844|Anesthetics, General|anesthetics, general|mesh-ancestor
64516953|NCT02456844|Anesthetics|anesthetics|mesh-ancestor
64516954|NCT02456844|GABA Modulators|gaba modulators|mesh-ancestor
64516955|NCT02456844|GABA Agents|gaba agents|mesh-ancestor
64516956|NCT02456844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64516957|NCT02456844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64516958|NCT02456844|Respiratory System Agents|respiratory system agents|mesh-ancestor
64516959|NCT02456844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64516960|NCT02456844|Hormone Antagonists|hormone antagonists|mesh-ancestor
64516961|NCT02456844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64516962|NCT02456844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64516963|NCT02456844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64516964|NCT02456844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64516965|NCT02456844|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64516966|NCT02456844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64516967|NCT02456844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64516968|NCT02456844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64516969|NCT02456844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64516970|NCT02456844|Analgesics|analgesics|mesh-ancestor
64561040|NCT04582383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64561041|NCT04582383|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64561042|NCT04582383|Hormone Antagonists|hormone antagonists|mesh-ancestor
64561043|NCT04582383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64399911|NCT02330419|Naltrexone|naltrexone|mesh-list
64561044|NCT04582383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561045|NCT04582383|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64561046|NCT04582383|Diuretics|diuretics|mesh-ancestor
64561047|NCT04582383|Natriuretic Agents|natriuretic agents|mesh-ancestor
64561048|NCT01118091|Aldesleukin|aldesleukin|mesh-list
64561049|NCT01118091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561051|NCT01118091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64561053|NCT01118091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64561054|NCT01045551|Apremilast|apremilast|mesh-list
64561055|NCT01045551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64561056|NCT01045551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64561057|NCT01045551|Analgesics|analgesics|mesh-ancestor
64561058|NCT01045551|Sensory System Agents|sensory system agents|mesh-ancestor
64561059|NCT01045551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64561060|NCT01045551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561061|NCT01045551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64561062|NCT01045551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64561063|NCT01045551|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64561064|NCT01045551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64561065|NCT01045551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64516972|NCT02456844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64516973|NCT02456844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64516974|NCT02456844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64516975|NCT02456844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64516976|NCT02456844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64516977|NCT03263208|Cyclophosphamide|cyclophosphamide|mesh-list
64516978|NCT03263208|Fludarabine|fludarabine|mesh-list
64516979|NCT03263208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64516980|NCT03263208|Immunologic Factors|immunologic factors|mesh-ancestor
64561066|NCT01045551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561069|NCT01047189|Clindamycin phosphate|clindamycin phosphate|mesh-list
64561070|NCT01047189|Tretinoin|tretinoin|mesh-list
64561071|NCT01047189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64561072|NCT01047189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64561073|NCT01047189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64561074|NCT01047189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561075|NCT01047189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561076|NCT01047189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561077|NCT01047189|Keratolytic Agents|keratolytic agents|mesh-ancestor
64561104|NCT01162551|Dermatologic Agents|dermatologic agents|mesh-ancestor
64561105|NCT01162551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561106|NCT01162551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64561107|NCT01162551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64561108|NCT01162551|Immunologic Factors|immunologic factors|mesh-ancestor
64561109|NCT01162551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64561110|NCT01162551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64561111|NCT01162551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64561112|NCT01162551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64561113|NCT01162551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64561114|NCT01162551|Antifungal Agents|antifungal agents|mesh-ancestor
64561116|NCT01163097|Anticoagulants|anticoagulants|mesh-ancestor
64561117|NCT01163097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64561118|NCT01163097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64561119|NCT01163097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561120|NCT03013101|Antibodies|antibodies|mesh-list
64561121|NCT03013101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64561122|NCT03013101|Immunologic Factors|immunologic factors|mesh-ancestor
64561123|NCT03013101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561158|NCT01170117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64561159|NCT01170117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561160|NCT01170117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64561161|NCT01170117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64561162|NCT01170117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64561163|NCT01170117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64399932|NCT03142165|Anesthetics|anesthetics|mesh-ancestor
64561194|NCT01176591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64561195|NCT01176591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64561196|NCT01176591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64561197|NCT01176591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561198|NCT01176981|Methotrexate|methotrexate|mesh-list
64561199|NCT01176981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64561200|NCT01176981|Abortifacient Agents|abortifacient agents|mesh-ancestor
64561201|NCT01176981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64561202|NCT01176981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561223|NCT01181349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64561224|NCT01181349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561225|NCT01126671|Vitamin D|vitamin d|mesh-list
64561226|NCT01126671|Vitamins|vitamins|mesh-ancestor
64561227|NCT01126671|Micronutrients|micronutrients|mesh-ancestor
64561228|NCT01126671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516981|NCT03263208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64516982|NCT03263208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64516983|NCT03263208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64516984|NCT03263208|Alkylating Agents|alkylating agents|mesh-ancestor
64516985|NCT03263208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64516986|NCT03263208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64516987|NCT03263208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64516988|NCT04630002|Ritonavir|ritonavir|mesh-list
64516989|NCT04630002|Darunavir|darunavir|mesh-list
64516990|NCT04630002|Etravirine|etravirine|mesh-list
64516991|NCT04630002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64516992|NCT04630002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64516993|NCT04630002|Protease Inhibitors|protease inhibitors|mesh-ancestor
64561229|NCT01126671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64561230|NCT01182675|Plerixafor|plerixafor|mesh-list
64561231|NCT01182675|Alemtuzumab|alemtuzumab|mesh-list
64561232|NCT01182675|Lenograstim|lenograstim|mesh-list
64561233|NCT01182675|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64561234|NCT01182675|Immunologic Factors|immunologic factors|mesh-ancestor
64399953|NCT02330029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561235|NCT01182675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561236|NCT01182675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64561237|NCT01182675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561238|NCT01182675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64561239|NCT01182675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64561240|NCT01182675|Antiviral Agents|antiviral agents|mesh-ancestor
64561241|NCT01182675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64561242|NCT01129245|Celecoxib|celecoxib|mesh-list
64561243|NCT01129245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64561244|NCT01129245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64561245|NCT01129245|Analgesics|analgesics|mesh-ancestor
64561246|NCT01129245|Sensory System Agents|sensory system agents|mesh-ancestor
64561247|NCT01129245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64561248|NCT01129245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561249|NCT01129245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64561250|NCT01129245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64561251|NCT01129245|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64561252|NCT01129245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64561253|NCT01129245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561254|NCT01129245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561255|NCT01183533|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64561256|NCT01183533|Plasminogen|plasminogen|mesh-list
64561282|NCT01135329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561283|NCT01135329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64561284|NCT01135329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64561285|NCT01135329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561286|NCT01135329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64561287|NCT01135329|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64561288|NCT01135329|Antitubercular Agents|antitubercular agents|mesh-ancestor
64561289|NCT01135329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64561290|NCT01135329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64561292|NCT03012009|Epinephrine|epinephrine|mesh-list
64561293|NCT03012009|Racepinephrine|racepinephrine|mesh-list
64561294|NCT03012009|Anesthetics, Local|anesthetics, local|mesh-list
64561295|NCT03012009|Anesthetics|anesthetics|mesh-list
64561296|NCT03012009|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
64561297|NCT03012009|Epinephryl borate|epinephryl borate|mesh-list
64561298|NCT03012009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64561299|NCT03012009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561300|NCT03012009|Sensory System Agents|sensory system agents|mesh-ancestor
64561301|NCT03012009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64561302|NCT03012009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64561303|NCT03012009|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64561304|NCT03012009|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64516994|NCT04630002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64516995|NCT04630002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400023|NCT05002361|Hormones|hormones|mesh-ancestor
64516996|NCT04630002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64516997|NCT04630002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64516998|NCT04630002|Antiviral Agents|antiviral agents|mesh-ancestor
64516999|NCT04630002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64517000|NCT04630002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64517001|NCT04630002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64517002|NCT04630002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64517003|NCT04630002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64517004|NCT03259542|Itraconazole|itraconazole|mesh-list
64517005|NCT03259542|Mifepristone|mifepristone|mesh-list
64517006|NCT03259542|Antifungal Agents|antifungal agents|mesh-ancestor
64517007|NCT03259542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64517008|NCT03259542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64517009|NCT03259542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64517010|NCT03259542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517011|NCT03259542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517012|NCT03259542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64517013|NCT03259542|Hormone Antagonists|hormone antagonists|mesh-ancestor
64517014|NCT03259542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64619297|NCT03805672|Enoxaparin|enoxaparin|mesh-list
64517015|NCT03259542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517016|NCT03259542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64517017|NCT03259542|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64517018|NCT03259542|Abortifacient Agents|abortifacient agents|mesh-ancestor
64517019|NCT03259542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64517020|NCT03259542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64561305|NCT03012009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64561306|NCT03012009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561343|NCT03563729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64561344|NCT03563729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561346|NCT03563729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561347|NCT03563729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64561379|NCT02081183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561381|NCT02080403|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64561382|NCT02080403|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64561383|NCT02080403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64561384|NCT02080403|Disinfectants|disinfectants|mesh-ancestor
64561385|NCT02080403|Dermatologic Agents|dermatologic agents|mesh-ancestor
64561386|NCT02079077|Aspirin|aspirin|mesh-list
64561387|NCT02079077|Hydroxychloroquine|hydroxychloroquine|mesh-list
64517021|NCT03259542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64517022|NCT03259542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64517023|NCT03259542|Contraceptive Agents|contraceptive agents|mesh-ancestor
64517024|NCT03259542|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64517025|NCT03259542|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64517026|NCT03259542|Luteolytic Agents|luteolytic agents|mesh-ancestor
64517027|NCT03259542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64517028|NCT03259542|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64517030|NCT03267654|Gefitinib|gefitinib|mesh-list
64517031|NCT03267654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64517032|NCT03267654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64517033|NCT03267654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517034|NCT03267654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517035|NCT03263052|Tacrolimus|tacrolimus|mesh-list
64561388|NCT02079077|Antimalarials|antimalarials|mesh-ancestor
64561389|NCT02079077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64561390|NCT02079077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64561391|NCT02079077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64561419|NCT01191255|Sequestering Agents|sequestering agents|mesh-ancestor
64561420|NCT01191255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561422|NCT02078219|Verinurad|verinurad|mesh-list
64561423|NCT02078219|Antimetabolites|antimetabolites|mesh-ancestor
64561424|NCT02078219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561425|NCT02078219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561426|NCT02078219|Gout Suppressants|gout suppressants|mesh-ancestor
64561427|NCT02078219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64561428|NCT02078219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64561429|NCT02078219|Antioxidants|antioxidants|mesh-ancestor
64561430|NCT02078219|Protective Agents|protective agents|mesh-ancestor
64561431|NCT02078219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561432|NCT03536039|Prednisone|prednisone|mesh-list
64561433|NCT03536039|Cyclophosphamide|cyclophosphamide|mesh-list
64561434|NCT03536039|Rituximab|rituximab|mesh-list
64561435|NCT03536039|Doxorubicin|doxorubicin|mesh-list
64561436|NCT03536039|Vincristine|vincristine|mesh-list
64561437|NCT03536039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64561438|NCT03536039|Immunologic Factors|immunologic factors|mesh-ancestor
64561439|NCT03536039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561440|NCT03536039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64561455|NCT03536039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64561456|NCT03536039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64561457|NCT03536039|Tubulin Modulators|tubulin modulators|mesh-ancestor
64561458|NCT03536039|Antimitotic Agents|antimitotic agents|mesh-ancestor
64561459|NCT03536039|Mitosis Modulators|mitosis modulators|mesh-ancestor
64561461|NCT02075255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64561462|NCT02075255|Respiratory System Agents|respiratory system agents|mesh-ancestor
64561463|NCT03532217|Nivolumab|nivolumab|mesh-list
64561464|NCT03532217|Ipilimumab|ipilimumab|mesh-list
64561465|NCT03532217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64561466|NCT03532217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561467|NCT03532217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64561468|NCT03532217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561469|NCT03529487|Phenylephrine|phenylephrine|mesh-list
64561470|NCT03529487|Oxymetazoline|oxymetazoline|mesh-list
64561471|NCT03529487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64561472|NCT03529487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64561473|NCT03529487|Adrenergic Agents|adrenergic agents|mesh-ancestor
64561474|NCT03529487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64561475|NCT03529487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517036|NCT03263052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64400105|NCT03111121|Neostigmine|neostigmine|mesh-list
64400106|NCT03111121|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64517037|NCT03263052|Immunologic Factors|immunologic factors|mesh-ancestor
64517038|NCT03263052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517039|NCT03263052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64517040|NCT03263052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517041|NCT03263052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517042|NCT03259152|Denosumab|denosumab|mesh-list
64517043|NCT03259152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64517044|NCT03259152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517045|NCT02456142|Morphine|morphine|mesh-list
64517046|NCT02456142|Bupivacaine|bupivacaine|mesh-list
64517047|NCT02456142|Anesthetics, Local|anesthetics, local|mesh-ancestor
64517048|NCT02456142|Anesthetics|anesthetics|mesh-ancestor
64517049|NCT02456142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64517050|NCT02456142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517051|NCT02456142|Sensory System Agents|sensory system agents|mesh-ancestor
64517052|NCT02456142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64517053|NCT02456142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64517054|NCT02456142|Narcotics|narcotics|mesh-ancestor
64517055|NCT02456142|Analgesics|analgesics|mesh-ancestor
64517056|NCT03262740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64517057|NCT03262740|Norethindrone|norethindrone|mesh-list
64517058|NCT03262740|Norethindrone Acetate|norethindrone acetate|mesh-list
64561476|NCT03529487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561477|NCT03529487|Sympathomimetics|sympathomimetics|mesh-ancestor
64561478|NCT03529487|Autonomic Agents|autonomic agents|mesh-ancestor
64561479|NCT03529487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64561480|NCT03529487|Nasal Decongestants|nasal decongestants|mesh-ancestor
64561481|NCT03529487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64561482|NCT03529487|Respiratory System Agents|respiratory system agents|mesh-ancestor
64561483|NCT03529487|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64561484|NCT03529487|Mydriatics|mydriatics|mesh-ancestor
64561485|NCT03529487|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64561486|NCT03529487|Protective Agents|protective agents|mesh-ancestor
64561487|NCT03527927|Muscarinic Antagonists|muscarinic antagonists|mesh-list
64561488|NCT03527927|Cholinergic Agents|cholinergic agents|mesh-ancestor
64561489|NCT03527927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64561490|NCT03527927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561491|NCT03527927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561492|NCT03527927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64561493|NCT03527147|Rituximab|rituximab|mesh-list
64561494|NCT03527147|Magrolimab|magrolimab|mesh-list
64561496|NCT03527147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64561497|NCT03527147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561499|NCT03527147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561500|NCT03527147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64561525|NCT01191723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561526|NCT01193049|Prednisone|prednisone|mesh-list
64561527|NCT01193049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64561528|NCT01193049|Glucocorticoids|glucocorticoids|mesh-ancestor
64561529|NCT01193049|Hormones|hormones|mesh-ancestor
64561530|NCT01193049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64561531|NCT01193049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517059|NCT03262740|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
64517060|NCT03262740|Estradiol|estradiol|mesh-list
64517061|NCT03262740|Branebrutinib|branebrutinib|mesh-list
64517062|NCT03262740|Estrogens|estrogens|mesh-ancestor
64400167|NCT04996979|Anesthetics, Local|anesthetics, local|mesh-ancestor
64400168|NCT04996979|Anesthetics|anesthetics|mesh-ancestor
64400169|NCT04996979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64517063|NCT03262740|Hormones|hormones|mesh-ancestor
64400170|NCT04996979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400171|NCT04996979|Sensory System Agents|sensory system agents|mesh-ancestor
64517064|NCT03262740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64517065|NCT03262740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517066|NCT03262740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64517067|NCT03262740|Contraceptive Agents|contraceptive agents|mesh-ancestor
64517068|NCT03262740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64561532|NCT01193049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64561533|NCT01193049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561534|NCT01679951|Methotrexate|methotrexate|mesh-list
64561535|NCT01679951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64561536|NCT01679951|Abortifacient Agents|abortifacient agents|mesh-ancestor
64561537|NCT01679951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64561538|NCT01679951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561539|NCT01679951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64561540|NCT01679951|Antimetabolites|antimetabolites|mesh-ancestor
64561541|NCT01679951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561542|NCT01679951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561543|NCT01679951|Dermatologic Agents|dermatologic agents|mesh-ancestor
64561544|NCT01679951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561545|NCT01679951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64561546|NCT01679951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64561547|NCT01679951|Immunologic Factors|immunologic factors|mesh-ancestor
64561548|NCT01679951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64561581|NCT01194453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64561582|NCT01194453|Immunologic Factors|immunologic factors|mesh-ancestor
64561583|NCT01194453|Hematinics|hematinics|mesh-ancestor
64561584|NCT01194453|Vitamin B Complex|vitamin b complex|mesh-ancestor
64561585|NCT03507413|Metformin|metformin|mesh-list
64561586|NCT03507413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64561587|NCT03507413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561588|NCT01195467|Tenofovir|tenofovir|mesh-list
64561589|NCT01195467|Emtricitabine|emtricitabine|mesh-list
64561590|NCT01195467|Efavirenz|efavirenz|mesh-list
64561591|NCT01195467|Raltegravir Potassium|raltegravir potassium|mesh-list
64561592|NCT01195467|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64561593|NCT01195467|Antiviral Agents|antiviral agents|mesh-ancestor
64561624|NCT02405585|Gemcitabine|gemcitabine|mesh-list
64561625|NCT02405585|Fluorouracil|fluorouracil|mesh-list
64561626|NCT02405585|Oxaliplatin|oxaliplatin|mesh-list
64561628|NCT02405585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64561629|NCT02405585|Antimetabolites|antimetabolites|mesh-ancestor
64561630|NCT02405585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561631|NCT02405585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561632|NCT02405585|Antiviral Agents|antiviral agents|mesh-ancestor
64561633|NCT02405585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64561634|NCT02405585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561635|NCT02405585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64561636|NCT02405585|Immunologic Factors|immunologic factors|mesh-ancestor
64561669|NCT00089843|Anabolic Agents|anabolic agents|mesh-ancestor
64561670|NCT00089843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64561671|NCT00089843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64561672|NCT00089843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561673|NCT00089843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64561674|NCT00089843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64561675|NCT03485417|Aripiprazole|aripiprazole|mesh-list
64561676|NCT03485417|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64561677|NCT03485417|Antidepressive Agents|antidepressive agents|mesh-ancestor
64561678|NCT03485417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64517069|NCT03262740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64400179|NCT03145285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64400182|NCT04997291|Dexrazoxane|dexrazoxane|mesh-list
64517070|NCT03262740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64619308|NCT03802864|Sensory System Agents|sensory system agents|mesh-ancestor
64517071|NCT03262740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64517072|NCT03262740|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64561679|NCT03485417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64561680|NCT03485417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64561711|NCT01678001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64561712|NCT01678001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64561713|NCT01678001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561714|NCT01678001|Cholinergic Agents|cholinergic agents|mesh-ancestor
64561715|NCT01678001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64561716|NCT03482297|Midodrine|midodrine|mesh-list
64414771|NCT02433483|Antiviral Agents|antiviral agents|mesh-ancestor
64561758|NCT01678079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64561760|NCT01678235|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64561761|NCT01678235|Insulin Aspart|insulin aspart|mesh-list
64561791|NCT02185131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561792|NCT02185131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64561793|NCT02185131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64561794|NCT02185131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64561795|NCT02185131|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64561796|NCT02185131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64561797|NCT02185131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64561798|NCT02185131|Adrenergic Agents|adrenergic agents|mesh-ancestor
64561799|NCT02185131|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64561800|NCT02185131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64561802|NCT02185131|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64561803|NCT00085709|Cytarabine|cytarabine|mesh-list
64561804|NCT00085709|Daunorubicin|daunorubicin|mesh-list
64561805|NCT00085709|Gemtuzumab|gemtuzumab|mesh-list
64561837|NCT00085631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561838|NCT01141491|Vaccines|vaccines|mesh-list
64561839|NCT01141491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
64561840|NCT01141491|Immunologic Factors|immunologic factors|mesh-ancestor
64561841|NCT01141491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561842|NCT01141569|R04929097|r04929097|mesh-list
64561843|NCT01141569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561844|NCT01141569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561845|NCT01141725|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64561846|NCT01141725|Idarubicin|idarubicin|mesh-list
64561847|NCT01141725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64561848|NCT01141725|Alkylating Agents|alkylating agents|mesh-ancestor
64561864|NCT01202721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64561865|NCT01202721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561866|NCT01202721|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64561867|NCT01202721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64561868|NCT01202721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64561869|NCT01202721|Adrenergic Agents|adrenergic agents|mesh-ancestor
64561870|NCT01202721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64561872|NCT00084617|Oxaliplatin|oxaliplatin|mesh-list
64561873|NCT00084617|Irinotecan|irinotecan|mesh-list
64561874|NCT00084617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64561875|NCT00084617|Antimetabolites|antimetabolites|mesh-ancestor
64561876|NCT00084617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561877|NCT00084617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561878|NCT00084617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64561879|NCT00084617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64561880|NCT00084617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561881|NCT04270175|Dexamethasone|dexamethasone|mesh-list
64561882|NCT04270175|Daratumumab|daratumumab|mesh-list
64517073|NCT03262740|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64517074|NCT03262740|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
64517075|NCT03262740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64517076|NCT03262740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517077|NCT03262740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517078|NCT03266562|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64453120|NCT02098109|Plerixafor|plerixafor|mesh-list
64561883|NCT04270175|Pomalidomide|pomalidomide|mesh-list
64561884|NCT04270175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64561887|NCT04270175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64561888|NCT04270175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561889|NCT04270175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64561890|NCT04270175|Glucocorticoids|glucocorticoids|mesh-ancestor
64561891|NCT04270175|Hormones|hormones|mesh-ancestor
64561892|NCT04270175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64561893|NCT04270175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64561894|NCT04270175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561895|NCT04270175|Immunologic Factors|immunologic factors|mesh-ancestor
64561896|NCT04270175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64561897|NCT04270175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64561898|NCT04270175|Growth Substances|growth substances|mesh-ancestor
64561899|NCT04270175|Growth Inhibitors|growth inhibitors|mesh-ancestor
64561900|NCT01203189|Ketoconazole|ketoconazole|mesh-list
64561901|NCT01203189|Antifungal Agents|antifungal agents|mesh-ancestor
64561902|NCT01203189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64561903|NCT01203189|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64561939|NCT01206387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64561968|NCT01679795|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64561969|NCT01679795|Anabolic Agents|anabolic agents|mesh-ancestor
64561970|NCT01679795|Hormones|hormones|mesh-ancestor
64561971|NCT01206465|Fluorouracil|fluorouracil|mesh-list
64561972|NCT01206465|Antimetabolites|antimetabolites|mesh-ancestor
64561973|NCT01206465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561974|NCT01206465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64561975|NCT01206465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561976|NCT01206465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64561977|NCT01206465|Immunologic Factors|immunologic factors|mesh-ancestor
64561978|NCT01206465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561979|NCT01207401|Lidocaine|lidocaine|mesh-list
64561980|NCT01207401|Anesthetics, Local|anesthetics, local|mesh-ancestor
64561981|NCT01207401|Anesthetics|anesthetics|mesh-ancestor
64562013|NCT03086681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562014|NCT03086681|Growth Inhibitors|growth inhibitors|mesh-ancestor
64562015|NCT03086759|Triamcinolone|triamcinolone|mesh-list
64562016|NCT03086759|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64562017|NCT03086759|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64562018|NCT03086759|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64562019|NCT03086759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64562020|NCT03086759|Glucocorticoids|glucocorticoids|mesh-ancestor
64562021|NCT03086759|Hormones|hormones|mesh-ancestor
64562022|NCT03086759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64562023|NCT03086759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562056|NCT03084809|Vitamins|vitamins|mesh-ancestor
64562057|NCT03084809|Micronutrients|micronutrients|mesh-ancestor
64562058|NCT03084809|Antimetabolites|antimetabolites|mesh-ancestor
64562059|NCT03084809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562060|NCT03084809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64562061|NCT03084809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64562062|NCT03084809|Immunologic Factors|immunologic factors|mesh-ancestor
64400290|NCT03074435|Ivermectin|ivermectin|mesh-list
64400291|NCT03074435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64400292|NCT03074435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64562063|NCT01144143|Methylprednisolone|methylprednisolone|mesh-list
64562064|NCT01144143|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64517079|NCT03266562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64517080|NCT03266562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517081|NCT03258684|Thiamine|thiamine|mesh-list
64517082|NCT03258684|Hydrocortisone|hydrocortisone|mesh-list
64517083|NCT03258684|Vitamins|vitamins|mesh-ancestor
64517084|NCT03258684|Micronutrients|micronutrients|mesh-ancestor
64517085|NCT03258684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517086|NCT03258684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64517087|NCT03258684|Vitamin B Complex|vitamin b complex|mesh-ancestor
64517088|NCT03266250|Anesthetics|anesthetics|mesh-list
64517089|NCT03266250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64517090|NCT03266250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517091|NCT03258372|Rifampin|rifampin|mesh-list
64517092|NCT03258372|Mifepristone|mifepristone|mesh-list
64562065|NCT01144143|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64562097|NCT01212471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64562098|NCT01212471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562099|NCT01212471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64562100|NCT01212471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64562102|NCT03084419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64562103|NCT03084419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562104|NCT03084419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562105|NCT03084419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64562106|NCT03084419|Immunologic Factors|immunologic factors|mesh-ancestor
64562107|NCT03084419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562108|NCT03084419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64562109|NCT03084029|Oxytocin|oxytocin|mesh-list
64562110|NCT03084029|Oxytocics|oxytocics|mesh-ancestor
64562143|NCT00083915|Melphalan|melphalan|mesh-list
64562144|NCT00083915|Cisplatin|cisplatin|mesh-list
64562145|NCT00083915|Doxorubicin|doxorubicin|mesh-list
64562146|NCT00083915|Etoposide|etoposide|mesh-list
64562147|NCT00083915|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64562148|NCT00083915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64562149|NCT00083915|Immunologic Factors|immunologic factors|mesh-ancestor
64562150|NCT00083915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562151|NCT00083915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64562152|NCT00083915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64562153|NCT00083915|Alkylating Agents|alkylating agents|mesh-ancestor
64562154|NCT00083915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562155|NCT00083915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562190|NCT01144455|Phosphoramide Mustards|phosphoramide mustards|mesh-list
64562191|NCT01144455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64400302|NCT03072329|Anesthetics, Local|anesthetics, local|mesh-ancestor
64562192|NCT01144455|Antimetabolites|antimetabolites|mesh-ancestor
64562193|NCT01144455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562218|NCT03080363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562219|NCT01145001|Nicotine|nicotine|mesh-list
64562220|NCT01145001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64562221|NCT01145001|Autonomic Agents|autonomic agents|mesh-ancestor
64562222|NCT01145001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64562223|NCT01145001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562224|NCT01145001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64562225|NCT01145001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64562226|NCT01145001|Cholinergic Agents|cholinergic agents|mesh-ancestor
64562227|NCT01145001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64562228|NCT01145001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562229|NCT03011463|Clarithromycin|clarithromycin|mesh-list
64562230|NCT03011463|Ranitidine|ranitidine|mesh-list
64517094|NCT03258372|Antitubercular Agents|antitubercular agents|mesh-ancestor
64517095|NCT03258372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64517096|NCT03258372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64517097|NCT03258372|Leprostatic Agents|leprostatic agents|mesh-ancestor
64517098|NCT03258372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64562231|NCT03011463|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
64562233|NCT03011463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64562234|NCT03011463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64562235|NCT03011463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64562236|NCT03011463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562237|NCT03011463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562238|NCT03011463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64562239|NCT03011463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64562240|NCT03011463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64562241|NCT03011463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64562242|NCT03011463|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64562276|NCT01215123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562277|NCT01215123|Growth Inhibitors|growth inhibitors|mesh-ancestor
64562278|NCT05312645|Diclofenac|diclofenac|mesh-list
64562279|NCT05312645|Petrolatum|petrolatum|mesh-list
64562280|NCT05312645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64562281|NCT05312645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64562282|NCT05312645|Analgesics|analgesics|mesh-ancestor
64562283|NCT05312645|Sensory System Agents|sensory system agents|mesh-ancestor
64562284|NCT05312645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64562285|NCT05312645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562319|NCT05685407|Caffeine|caffeine|mesh-list
64562320|NCT05685407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64562321|NCT05685407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562322|NCT05685407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64562323|NCT05685407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562324|NCT05685407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562325|NCT05685407|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64562326|NCT05685407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64562327|NCT05685407|Purinergic Agents|purinergic agents|mesh-ancestor
64562328|NCT05685407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64562329|NCT04761029|Tramadol|tramadol|mesh-list
64400415|NCT03494569|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64400424|NCT03071549|Salicylic Acid|salicylic acid|mesh-list
64562363|NCT05687669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562364|NCT05687669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562365|NCT05687669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64562366|NCT05687669|Vasodilator Agents|vasodilator agents|mesh-ancestor
64562379|NCT04400747|Vitamin D|vitamin d|mesh-list
64562380|NCT04400747|Cholecalciferol|cholecalciferol|mesh-list
64562381|NCT04400747|Vitamins|vitamins|mesh-ancestor
64562382|NCT04400747|Micronutrients|micronutrients|mesh-ancestor
64562383|NCT04400747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562407|NCT01216761|Iodine|iodine|mesh-list
64562408|NCT01216761|Chlorhexidine|chlorhexidine|mesh-list
64562409|NCT01216761|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64562410|NCT01216761|Cadexomer iodine|cadexomer iodine|mesh-list
64562411|NCT01216761|Povidone-Iodine|povidone-iodine|mesh-list
64562412|NCT01216761|Povidone|povidone|mesh-list
64562413|NCT01216761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64562414|NCT01216761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64562415|NCT01216761|Disinfectants|disinfectants|mesh-ancestor
64562416|NCT01216761|Dermatologic Agents|dermatologic agents|mesh-ancestor
64562417|NCT01216761|Trace Elements|trace elements|mesh-ancestor
64562418|NCT01216761|Micronutrients|micronutrients|mesh-ancestor
64562419|NCT01216761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562420|NCT01216761|Plasma Substitutes|plasma substitutes|mesh-ancestor
64562421|NCT01216761|Blood Substitutes|blood substitutes|mesh-ancestor
64562422|NCT04279379|Decitabine|decitabine|mesh-list
64562423|NCT04279379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64562424|NCT04279379|Antimetabolites|antimetabolites|mesh-ancestor
64562425|NCT04279379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517099|NCT03258372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64517100|NCT03258372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64517101|NCT03258372|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64619336|NCT03797872|Immunologic Factors|immunologic factors|mesh-ancestor
64619340|NCT03797872|Antiemetics|antiemetics|mesh-ancestor
64517103|NCT03258372|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64517104|NCT03258372|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64517105|NCT03258372|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64517106|NCT03258372|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64517107|NCT03258372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64517108|NCT03258372|Abortifacient Agents|abortifacient agents|mesh-ancestor
64517109|NCT03258372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64562426|NCT04279379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562427|NCT04279379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562428|NCT05685719|Itraconazole|itraconazole|mesh-list
64562429|NCT05685719|Rifampin|rifampin|mesh-list
64562430|NCT05685719|Antifungal Agents|antifungal agents|mesh-ancestor
64562431|NCT05685719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64562432|NCT05685719|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64562433|NCT05685719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64562463|NCT01218399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64562464|NCT01218399|Autonomic Agents|autonomic agents|mesh-ancestor
64562465|NCT01218399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64562466|NCT01218399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562467|NCT01218399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64562468|NCT01218399|Respiratory System Agents|respiratory system agents|mesh-ancestor
64562469|NCT01218399|Glucocorticoids|glucocorticoids|mesh-ancestor
64562471|NCT01218399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64562472|NCT01219881|Sevoflurane|sevoflurane|mesh-list
64562505|NCT05375747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64562506|NCT05375747|Anesthetics, General|anesthetics, general|mesh-ancestor
64562507|NCT05375747|Anesthetics|anesthetics|mesh-ancestor
64562508|NCT01221207|Calpastatin|calpastatin|mesh-list
64562509|NCT01221207|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64562510|NCT01221207|Protease Inhibitors|protease inhibitors|mesh-ancestor
64562511|NCT01221207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562512|NCT01221207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562513|NCT03296813|Torsemide|torsemide|mesh-list
64562543|NCT04400045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562544|NCT01222689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64562545|NCT01222689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562546|NCT01222689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64562547|NCT01222689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562548|NCT01222689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562549|NCT01153581|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64562550|NCT01153581|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64562551|NCT01153581|Estradiol|estradiol|mesh-list
64562552|NCT01153581|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64562553|NCT01153581|Progesterone|progesterone|mesh-list
64562554|NCT01153581|Ganirelix|ganirelix|mesh-list
64562555|NCT01153581|Estrogens|estrogens|mesh-ancestor
64562556|NCT01153581|Hormones|hormones|mesh-ancestor
64562557|NCT01153581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64562558|NCT01153581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562592|NCT01225263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562593|NCT01225263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64562594|NCT01225263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64562595|NCT01225263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64562597|NCT01225263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562598|NCT01225263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64517110|NCT03258372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64517111|NCT03258372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64517112|NCT03258372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64517113|NCT03258372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64517114|NCT03258372|Contraceptive Agents|contraceptive agents|mesh-ancestor
64619355|NCT01127581|Dinoprostone|dinoprostone|mesh-list
64884816|NCT03714880|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64884817|NCT03714880|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64884819|NCT03623633|Alendronate|alendronate|mesh-list
64884820|NCT03623633|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64884821|NCT03623633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64884822|NCT03623633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884823|NCT03623633|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64884824|NCT03623633|Hormone Antagonists|hormone antagonists|mesh-ancestor
64884825|NCT03623633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64884826|NCT03623633|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64884827|NCT03623633|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64884828|NCT03619850|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64400503|NCT03139747|Immunologic Factors|immunologic factors|mesh-ancestor
64884829|NCT03619850|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64884830|NCT03619850|Hematinics|hematinics|mesh-ancestor
64884831|NCT03619850|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64884832|NCT03619850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64884833|NCT03559686|Certolizumab Pegol|certolizumab pegol|mesh-list
64884834|NCT03559686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64884835|NCT03559686|Immunologic Factors|immunologic factors|mesh-ancestor
64884836|NCT03559686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884837|NCT03559686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64884838|NCT03559660|Certolizumab Pegol|certolizumab pegol|mesh-list
64884839|NCT03559660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64884840|NCT03559660|Immunologic Factors|immunologic factors|mesh-ancestor
64884841|NCT03559660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884842|NCT03559660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64884843|NCT03532516|Brivaracetam|brivaracetam|mesh-list
64884844|NCT03532516|Anticonvulsants|anticonvulsants|mesh-ancestor
64884845|NCT03333005|Antifungal Agents|antifungal agents|mesh-list
64884846|NCT03333005|Clotrimazole|clotrimazole|mesh-list
64884847|NCT03333005|Miconazole|miconazole|mesh-list
64884848|NCT03333005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64884852|NCT03333005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884853|NCT03333005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884854|NCT03333005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64884855|NCT03333005|Hormone Antagonists|hormone antagonists|mesh-ancestor
64884856|NCT03333005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64884857|NCT03333005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884858|NCT03333005|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64884859|NCT03333005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64884860|NCT03148366|Levofloxacin|levofloxacin|mesh-list
64884861|NCT03148366|Ofloxacin|ofloxacin|mesh-list
64884862|NCT03148366|Bismuth|bismuth|mesh-list
64884863|NCT03148366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64884864|NCT03148366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64884865|NCT03148366|Renal Agents|renal agents|mesh-ancestor
64884866|NCT03148366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64884912|NCT02862548|Antiviral Agents|antiviral agents|mesh-list
64884913|NCT02862548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64884914|NCT02818738|Levamisole|levamisole|mesh-list
64884915|NCT02818738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64884916|NCT02818738|Immunologic Factors|immunologic factors|mesh-ancestor
64884917|NCT02818738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884918|NCT02818738|Antinematodal Agents|antinematodal agents|mesh-ancestor
64884919|NCT02818738|Anthelmintics|anthelmintics|mesh-ancestor
64884920|NCT02818738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64884921|NCT02818738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64884922|NCT02818738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64884923|NCT02335099|Ticagrelor|ticagrelor|mesh-list
64884924|NCT02335099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64884925|NCT02335099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64884926|NCT02335099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64884927|NCT02335099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64884928|NCT02335099|Purinergic Agents|purinergic agents|mesh-ancestor
64884929|NCT02335099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64884930|NCT02335099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884931|NCT02335099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884932|NCT02330562|Bevacizumab|bevacizumab|mesh-list
64884933|NCT02330562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64884934|NCT02330562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64884960|NCT00504712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64884961|NCT00504712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884962|NCT05413200|Isotretinoin|isotretinoin|mesh-list
64884963|NCT05413200|Dermatologic Agents|dermatologic agents|mesh-ancestor
64884964|NCT05413096|Propolis|propolis|mesh-list
64884965|NCT05413096|Diclofenac|diclofenac|mesh-list
64884966|NCT05413096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64884968|NCT05413096|Analgesics|analgesics|mesh-ancestor
64400581|NCT03070847|Hemostatics|hemostatics|mesh-ancestor
64400582|NCT03070847|Coagulants|coagulants|mesh-ancestor
64334509|NCT00503035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334510|NCT02227745|Dorzolamide|dorzolamide|mesh-list
64334511|NCT02227745|Hyaluronic Acid|hyaluronic acid|mesh-list
64334512|NCT02227745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64334513|NCT02227745|Immunologic Factors|immunologic factors|mesh-ancestor
64884971|NCT05413096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371030|NCT02470559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334514|NCT02227745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334516|NCT02227745|Protective Agents|protective agents|mesh-ancestor
64334517|NCT02227745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64884985|NCT05412589|Apatinib|apatinib|mesh-list
64884986|NCT05412589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64884987|NCT05412589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64884988|NCT05412589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884989|NCT05412589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884990|NCT05412576|Lidocaine|lidocaine|mesh-list
64884991|NCT05412576|Anesthetics, Local|anesthetics, local|mesh-ancestor
64884992|NCT05412576|Anesthetics|anesthetics|mesh-ancestor
64884993|NCT05412576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64884994|NCT05412576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884995|NCT05412576|Sensory System Agents|sensory system agents|mesh-ancestor
64884996|NCT05412576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64884997|NCT05412576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64884998|NCT05412576|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64884999|NCT05412576|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64885000|NCT05412576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64885001|NCT05412576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371039|NCT02473211|Sofosbuvir|sofosbuvir|mesh-list
64885012|NCT05412394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885013|NCT05412394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64885014|NCT05412394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885015|NCT05412147|Vitamins|vitamins|mesh-list
64885016|NCT05412147|Micronutrients|micronutrients|mesh-ancestor
64885017|NCT05412147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885018|NCT05411900|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64885019|NCT05411900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64885020|NCT05411900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64885021|NCT05411900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885022|NCT05411900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64885023|NCT05411900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64885024|NCT05411900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371040|NCT02473211|Antiviral Agents|antiviral agents|mesh-ancestor
64885031|NCT05411887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64885032|NCT05411887|Antimetabolites|antimetabolites|mesh-ancestor
64885033|NCT05411887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885034|NCT05411887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64885035|NCT05411887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64885036|NCT05411887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885037|NCT05411887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64885038|NCT05411887|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64885039|NCT05411887|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64885040|NCT05411757|Bevacizumab|bevacizumab|mesh-list
64885041|NCT05411757|Lenvatinib|lenvatinib|mesh-list
64885042|NCT05411757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64885043|NCT05411757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885044|NCT05411757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64885045|NCT05411757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64885046|NCT05411757|Growth Substances|growth substances|mesh-ancestor
64885047|NCT05411757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885048|NCT05411757|Growth Inhibitors|growth inhibitors|mesh-ancestor
64885049|NCT05411757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64885050|NCT05411757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885051|NCT05411757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334522|NCT03517033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64334523|NCT03517033|Vasodilator Agents|vasodilator agents|mesh-ancestor
64885069|NCT05411679|Olaparib|olaparib|mesh-list
64885070|NCT05411679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64885071|NCT05411679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885072|NCT05411679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885073|NCT05411679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885074|NCT05411666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64885075|NCT05411276|Maleic acid|maleic acid|mesh-list
64885076|NCT05411276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885077|NCT05411276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885078|NCT05396781|Proflavine|proflavine|mesh-list
64885079|NCT05396781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64885080|NCT05396781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64885081|NCT05384951|Vitamin D|vitamin d|mesh-list
64885082|NCT05384951|Cholecalciferol|cholecalciferol|mesh-list
64885083|NCT05384951|Vitamins|vitamins|mesh-ancestor
64885084|NCT05384951|Micronutrients|micronutrients|mesh-ancestor
64885085|NCT05384951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885086|NCT05384951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64885087|NCT05384951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64885100|NCT05303038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64885102|NCT05303038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64885103|NCT05303038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64885104|NCT05303038|Growth Substances|growth substances|mesh-ancestor
64885105|NCT05303038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885106|NCT05303038|Growth Inhibitors|growth inhibitors|mesh-ancestor
64885107|NCT05275894|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64885108|NCT05275894|Metronidazole|metronidazole|mesh-list
64885109|NCT05275894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64885110|NCT05275894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64885111|NCT05275894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64885112|NCT05167760|Apraclonidine|apraclonidine|mesh-list
64885113|NCT05167760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64885114|NCT05167760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64885115|NCT05167760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64885116|NCT05167760|Adrenergic Agents|adrenergic agents|mesh-ancestor
64885117|NCT05167760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64885118|NCT05167760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885119|NCT05167760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885120|NCT05077800|Losartan|losartan|mesh-list
64885121|NCT05077800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64334695|NCT02228369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885122|NCT05077800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64885123|NCT05077800|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64885125|NCT05077800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885126|NCT05062902|Botulinum Toxins|botulinum toxins|mesh-list
64885127|NCT05062902|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64885128|NCT05062902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64371052|NCT03652961|Immunologic Factors|immunologic factors|mesh-ancestor
64334525|NCT03517033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64334527|NCT03517033|Adrenergic Agents|adrenergic agents|mesh-ancestor
64334528|NCT03517033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64334529|NCT03517033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334530|NCT03517033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334531|NCT03516955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64334532|NCT03516955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64334533|NCT03516955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64334534|NCT03516955|Antimetabolites|antimetabolites|mesh-ancestor
64885144|NCT04917055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64885146|NCT04917055|Autonomic Agents|autonomic agents|mesh-ancestor
64885147|NCT04917055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64885148|NCT04917055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885149|NCT04917055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64885150|NCT04917055|Glucocorticoids|glucocorticoids|mesh-ancestor
64885151|NCT04917055|Hormones|hormones|mesh-ancestor
64885152|NCT04917055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64885153|NCT04917055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64885154|NCT04917055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885155|NCT04917055|Anesthetics, Local|anesthetics, local|mesh-ancestor
64885156|NCT04917055|Anesthetics|anesthetics|mesh-ancestor
64885157|NCT04917055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64885158|NCT04917055|Sensory System Agents|sensory system agents|mesh-ancestor
64885159|NCT04917055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64885160|NCT04917055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64885161|NCT04917055|Adrenergic Agents|adrenergic agents|mesh-ancestor
64885162|NCT04917055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64885163|NCT04917055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885164|NCT04917055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64885165|NCT04917055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64885166|NCT04917055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64885167|NCT04917055|Respiratory System Agents|respiratory system agents|mesh-ancestor
64885168|NCT04917055|Mydriatics|mydriatics|mesh-ancestor
64885169|NCT04917055|Sympathomimetics|sympathomimetics|mesh-ancestor
64885170|NCT04917055|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64885184|NCT04777006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885185|NCT04777006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64885186|NCT04777006|Serotonin Agents|serotonin agents|mesh-ancestor
64653718|NCT02248571|Antimetabolites|antimetabolites|mesh-ancestor
64885187|NCT04777006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885188|NCT04777006|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64885189|NCT04777006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64885190|NCT04777006|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64885191|NCT04777006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64885192|NCT04777006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885193|NCT04777006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64885194|NCT04777006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64885195|NCT04777006|Analgesics|analgesics|mesh-ancestor
64885196|NCT04777006|Sensory System Agents|sensory system agents|mesh-ancestor
64885197|NCT04777006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64885198|NCT04777006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64885199|NCT04777006|Adrenergic Agents|adrenergic agents|mesh-ancestor
64885200|NCT04755244|Azacitidine|azacitidine|mesh-list
64885201|NCT04755244|Venetoclax|venetoclax|mesh-list
64885202|NCT04755244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64885203|NCT04755244|Antimetabolites|antimetabolites|mesh-ancestor
64885204|NCT04755244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885205|NCT04755244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885206|NCT04755244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885207|NCT04733534|Dasatinib|dasatinib|mesh-list
64885208|NCT04733534|Quercetin|quercetin|mesh-list
64885209|NCT04733534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885210|NCT04733534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64885219|NCT04725864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64885220|NCT04725864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885222|NCT04721821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64885223|NCT04721821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885224|NCT04721821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885225|NCT04721353|Prazosin|prazosin|mesh-list
64885226|NCT04721353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64885227|NCT04721353|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64885228|NCT04721353|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64885229|NCT04721353|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64885230|NCT04721353|Adrenergic Agents|adrenergic agents|mesh-ancestor
64885231|NCT04721353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64885232|NCT04721353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885233|NCT04721353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885234|NCT04655391|Decitabine|decitabine|mesh-list
64885235|NCT04655391|Venetoclax|venetoclax|mesh-list
64885236|NCT04655391|Ivosidenib|ivosidenib|mesh-list
64885237|NCT04655391|Maleic acid|maleic acid|mesh-list
64885238|NCT04655391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64371054|NCT03652961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64885249|NCT04609098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64885251|NCT04605614|Pembrolizumab|pembrolizumab|mesh-list
64885252|NCT04605614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64885253|NCT04605614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885254|NCT04605614|Trace Elements|trace elements|mesh-ancestor
64885255|NCT04605614|Micronutrients|micronutrients|mesh-ancestor
64885256|NCT04605614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885257|NCT04493333|Calcium polycarbophil|calcium polycarbophil|mesh-list
64885258|NCT04493333|Psyllium|psyllium|mesh-list
64885259|NCT04493333|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64885260|NCT04493333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64334535|NCT03516955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334536|NCT03516955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64334537|NCT03516955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64334538|NCT03516955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334539|NCT02259179|Naltrexone|naltrexone|mesh-list
64334540|NCT02259179|Bupropion|bupropion|mesh-list
64334541|NCT02259179|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64334542|NCT02259179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64334543|NCT02259179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334544|NCT02259179|Sensory System Agents|sensory system agents|mesh-ancestor
64334545|NCT02259179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334546|NCT02259179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64334547|NCT02259179|Antidepressive Agents|antidepressive agents|mesh-ancestor
64334548|NCT02259179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64334549|NCT02259179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64334550|NCT02259179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64334551|NCT02259179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64371093|NCT00705341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64885270|NCT04475016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64400674|NCT04753957|Progesterone|progesterone|mesh-list
64885271|NCT04475016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885272|NCT04475016|Tubulin Modulators|tubulin modulators|mesh-ancestor
64885273|NCT04475016|Antimitotic Agents|antimitotic agents|mesh-ancestor
64885274|NCT04475016|Mitosis Modulators|mitosis modulators|mesh-ancestor
64885275|NCT04475016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885276|NCT04475016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64885277|NCT04475016|Alkylating Agents|alkylating agents|mesh-ancestor
64885278|NCT04475016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64885280|NCT04321551|Methyltestosterone|methyltestosterone|mesh-list
64885281|NCT04321551|Testosterone|testosterone|mesh-list
64885282|NCT04321551|Testosterone undecanoate|testosterone undecanoate|mesh-list
64885283|NCT04321551|Testosterone enanthate|testosterone enanthate|mesh-list
64334552|NCT02259179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334553|NCT02259179|Dopamine Agents|dopamine agents|mesh-ancestor
64334554|NCT02259179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64334555|NCT02259179|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64334556|NCT02259179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64885287|NCT04321551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64885288|NCT04321551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885289|NCT04321551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885290|NCT04321551|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64885291|NCT04321551|Hormone Antagonists|hormone antagonists|mesh-ancestor
64885292|NCT04321551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64885293|NCT04321551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885294|NCT04321551|Androgens|androgens|mesh-ancestor
64885304|NCT04302324|Autonomic Agents|autonomic agents|mesh-ancestor
64885305|NCT04302324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64885307|NCT04302324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64885308|NCT04302324|Glucocorticoids|glucocorticoids|mesh-ancestor
64885310|NCT04302324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64885311|NCT04302324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64885312|NCT04302324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885313|NCT04302324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64885314|NCT04302324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64885315|NCT04302324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64885316|NCT04302324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885317|NCT04302324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885318|NCT04302324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64885319|NCT04302324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64885320|NCT04302324|Immunologic Factors|immunologic factors|mesh-ancestor
64885321|NCT04302324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64885322|NCT04302324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64371130|NCT03193931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64885329|NCT04074460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64885330|NCT04074460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64885331|NCT04074460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885332|NCT04074460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64885333|NCT04074460|Anesthetics, General|anesthetics, general|mesh-ancestor
64400736|NCT05083429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400737|NCT05083429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885334|NCT04074460|Anesthetics|anesthetics|mesh-ancestor
64885335|NCT04074460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64885336|NCT04074460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64885338|NCT03993327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64885339|NCT03993327|Antibodies|antibodies|mesh-list
64885340|NCT03993327|Immunoglobulins|immunoglobulins|mesh-list
64653866|NCT04283669|Crizotinib|crizotinib|mesh-list
64885342|NCT03993327|Immunologic Factors|immunologic factors|mesh-ancestor
64885343|NCT03993327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885344|NCT03993327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334576|NCT02295475|Anticoagulants|anticoagulants|mesh-ancestor
64334577|NCT02295475|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64885369|NCT03637764|Atezolizumab|atezolizumab|mesh-list
64885370|NCT03637764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885371|NCT03581370|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
64885372|NCT03581370|Cephalosporins|cephalosporins|mesh-list
64885373|NCT03581370|Penicillanic Acid|penicillanic acid|mesh-list
64885374|NCT03581370|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64885375|NCT03581370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64885400|NCT03485534|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64885403|NCT03427736|Ketamine|ketamine|mesh-list
64885404|NCT03427736|Morphine|morphine|mesh-list
64885405|NCT03427736|Oxycodone|oxycodone|mesh-list
64885406|NCT03427736|Hydromorphone|hydromorphone|mesh-list
64885407|NCT03427736|Analgesics|analgesics|mesh-ancestor
64885408|NCT03427736|Sensory System Agents|sensory system agents|mesh-ancestor
64885409|NCT03427736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64885410|NCT03427736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885411|NCT03427736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64885412|NCT03427736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64885413|NCT03427736|Anesthetics, General|anesthetics, general|mesh-ancestor
64653945|NCT04934748|Protective Agents|protective agents|mesh-ancestor
64885414|NCT03427736|Anesthetics|anesthetics|mesh-ancestor
64885415|NCT03427736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64885416|NCT03427736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64885417|NCT03427736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64885418|NCT03427736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64885419|NCT03427736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885420|NCT03427736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64885421|NCT03427736|Narcotics|narcotics|mesh-ancestor
64885422|NCT03427736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64885423|NCT03427736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64885437|NCT03115567|Glucocorticoids|glucocorticoids|mesh-ancestor
64885438|NCT03115567|Hormones|hormones|mesh-ancestor
64885439|NCT03115567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64400798|NCT04572217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400799|NCT05635955|Propofol|propofol|mesh-list
64400800|NCT05635955|Esketamine|esketamine|mesh-list
64400801|NCT05635955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64400802|NCT05635955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64400803|NCT05635955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400804|NCT05635955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64400805|NCT05635955|Anesthetics, General|anesthetics, general|mesh-ancestor
64400812|NCT04452461|Oxaliplatin|oxaliplatin|mesh-list
64400813|NCT04452461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64400814|NCT04452461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400815|NCT04452461|Tubulin Modulators|tubulin modulators|mesh-ancestor
64400816|NCT04452461|Antimitotic Agents|antimitotic agents|mesh-ancestor
64885440|NCT03115567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885441|NCT03091881|Granisetron|granisetron|mesh-list
64885442|NCT03091881|Antiemetics|antiemetics|mesh-ancestor
64885443|NCT03091881|Autonomic Agents|autonomic agents|mesh-ancestor
64885444|NCT03091881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64885445|NCT03091881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885446|NCT03091881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64885447|NCT03091881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64885448|NCT03091881|Serotonin Agents|serotonin agents|mesh-ancestor
64885449|NCT03091881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64885450|NCT03091881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885451|NCT03032406|Hydroxychloroquine|hydroxychloroquine|mesh-list
64885452|NCT03032406|Everolimus|everolimus|mesh-list
64885453|NCT03032406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885470|NCT02897063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64885471|NCT02897063|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64885472|NCT02897063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64885473|NCT02897063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64885474|NCT02897063|Adrenergic Agents|adrenergic agents|mesh-ancestor
64885475|NCT02897063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64885476|NCT02897063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885477|NCT02897063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64885478|NCT02897063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64885479|NCT02864368|Temozolomide|temozolomide|mesh-list
64885480|NCT02864368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64885481|NCT02864368|Alkylating Agents|alkylating agents|mesh-ancestor
64885482|NCT02864368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885483|NCT02864368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885484|NCT02856698|Midazolam|midazolam|mesh-list
64885485|NCT02856698|Morphine|morphine|mesh-list
64885486|NCT02856698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64885487|NCT02856698|Narcotics|narcotics|mesh-ancestor
64885488|NCT02856698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64885489|NCT02856698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885490|NCT02856698|Analgesics|analgesics|mesh-ancestor
64885491|NCT02856698|Sensory System Agents|sensory system agents|mesh-ancestor
64885492|NCT02856698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64885493|NCT02856698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64885494|NCT02856698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64885495|NCT02856698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64885496|NCT02856698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64885497|NCT02856698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64885498|NCT02856698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64400851|NCT03019003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400852|NCT03019003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885499|NCT02856698|Anesthetics, General|anesthetics, general|mesh-ancestor
64885500|NCT02856698|Anesthetics|anesthetics|mesh-ancestor
64885501|NCT02856698|GABA Modulators|gaba modulators|mesh-ancestor
64885502|NCT02856698|GABA Agents|gaba agents|mesh-ancestor
64371221|NCT03309059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885525|NCT02625610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64885526|NCT02625610|Immunologic Factors|immunologic factors|mesh-ancestor
64885527|NCT02625610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885528|NCT02625610|Antidotes|antidotes|mesh-ancestor
64885529|NCT02625610|Protective Agents|protective agents|mesh-ancestor
64885530|NCT02625610|Vitamin B Complex|vitamin b complex|mesh-ancestor
64885531|NCT02625610|Vitamins|vitamins|mesh-ancestor
64334584|NCT02227901|Tipifarnib|tipifarnib|mesh-list
64334585|NCT02227901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64334586|NCT02227901|Alkylating Agents|alkylating agents|mesh-ancestor
64334587|NCT02227901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334588|NCT02227901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334589|NCT03146793|Sodium thiosulfate|sodium thiosulfate|mesh-list
64334590|NCT03146793|Antidotes|antidotes|mesh-ancestor
64885532|NCT02625610|Micronutrients|micronutrients|mesh-ancestor
64885533|NCT02625610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64371264|NCT03312413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64885551|NCT02257346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885552|NCT02257346|Sensory System Agents|sensory system agents|mesh-ancestor
64885553|NCT02257346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64885554|NCT02257346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64885555|NCT02257346|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64885556|NCT02257346|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64885557|NCT02257346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64885558|NCT02257346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885559|NCT02192359|Irinotecan|irinotecan|mesh-list
64885560|NCT02192359|Camptothecin|camptothecin|mesh-list
64885561|NCT02192359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64885562|NCT02192359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64885563|NCT02192359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885564|NCT02192359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885565|NCT02192359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654093|NCT04134845|Dantrolene|dantrolene|mesh-list
64885566|NCT02192359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64885567|NCT02167477|Pyrithione zinc|pyrithione zinc|mesh-list
64885568|NCT02167477|Keratolytic Agents|keratolytic agents|mesh-ancestor
64885569|NCT02167477|Dermatologic Agents|dermatologic agents|mesh-ancestor
64885570|NCT01618357|Veliparib|veliparib|mesh-list
64885571|NCT01618357|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64885572|NCT01618357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885573|NCT01618357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885574|NCT01618357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885575|NCT01530373|Clonidine|clonidine|mesh-list
64885576|NCT01530373|Solifenacin Succinate|solifenacin succinate|mesh-list
64885577|NCT01530373|Analgesics|analgesics|mesh-ancestor
64885578|NCT01530373|Sensory System Agents|sensory system agents|mesh-ancestor
64885579|NCT01530373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64885580|NCT01530373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885581|NCT01530373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64885589|NCT01530373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885591|NCT01530373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64885592|NCT01530373|Cholinergic Agents|cholinergic agents|mesh-ancestor
64885593|NCT01530373|Urological Agents|urological agents|mesh-ancestor
64885594|NCT01442246|Leuprolide|leuprolide|mesh-list
64885595|NCT01442246|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64885609|NCT00572169|Thalidomide|thalidomide|mesh-list
64885610|NCT00572169|Dexamethasone|dexamethasone|mesh-list
64885611|NCT00572169|Cyclophosphamide|cyclophosphamide|mesh-list
64885612|NCT00572169|Cisplatin|cisplatin|mesh-list
64885613|NCT00572169|Doxorubicin|doxorubicin|mesh-list
64400899|NCT05635253|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64400900|NCT05635253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64400901|NCT05635253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64885614|NCT00572169|Etoposide|etoposide|mesh-list
64885615|NCT00572169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64885616|NCT00572169|Bortezomib|bortezomib|mesh-list
64885617|NCT00572169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64885618|NCT00572169|Immunologic Factors|immunologic factors|mesh-ancestor
64885619|NCT00572169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885620|NCT00572169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64885621|NCT00572169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64885622|NCT00572169|Alkylating Agents|alkylating agents|mesh-ancestor
64885623|NCT00572169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885624|NCT00572169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885625|NCT00572169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64885626|NCT00572169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64885627|NCT00572169|Antiemetics|antiemetics|mesh-ancestor
64334594|NCT03146793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334595|NCT03146793|Antitubercular Agents|antitubercular agents|mesh-ancestor
64334596|NCT03146793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64334597|NCT03146793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64885628|NCT00572169|Autonomic Agents|autonomic agents|mesh-ancestor
64885629|NCT00572169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64885630|NCT00572169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64885631|NCT00572169|Glucocorticoids|glucocorticoids|mesh-ancestor
64885632|NCT00572169|Hormones|hormones|mesh-ancestor
64885633|NCT00572169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64885634|NCT00572169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64885635|NCT00572169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64885636|NCT00572169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64885637|NCT00572169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64885638|NCT00572169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885639|NCT00572169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64885688|NCT05414292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885689|NCT05414292|Antifungal Agents|antifungal agents|mesh-ancestor
64885690|NCT05414292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64885691|NCT05414292|Immunologic Factors|immunologic factors|mesh-ancestor
64885692|NCT05414292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885693|NCT05414149|Ranibizumab|ranibizumab|mesh-list
64885694|NCT05414149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64885695|NCT05414149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64885696|NCT05414149|Growth Substances|growth substances|mesh-ancestor
64885697|NCT05414149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885698|NCT05414149|Growth Inhibitors|growth inhibitors|mesh-ancestor
64885699|NCT05414149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885700|NCT05413902|Acetaminophen|acetaminophen|mesh-list
64885701|NCT05413902|Methylprednisolone|methylprednisolone|mesh-list
64885702|NCT05413902|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64885704|NCT05413902|Epinephrine|epinephrine|mesh-list
64885705|NCT05413902|Morphine|morphine|mesh-list
64885706|NCT05413902|Narcotics|narcotics|mesh-list
64885707|NCT05413902|Gabapentin|gabapentin|mesh-list
64885708|NCT05413902|Orphenadrine|orphenadrine|mesh-list
64885709|NCT05413902|Bupivacaine|bupivacaine|mesh-list
64885710|NCT05413902|Anesthetics, Local|anesthetics, local|mesh-ancestor
64885711|NCT05413902|Anesthetics|anesthetics|mesh-ancestor
64885712|NCT05413902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64885713|NCT05413902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885714|NCT05413902|Sensory System Agents|sensory system agents|mesh-ancestor
64885717|NCT05413902|Analgesics|analgesics|mesh-ancestor
64400908|NCT04133311|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64885737|NCT05413902|Respiratory System Agents|respiratory system agents|mesh-ancestor
64885738|NCT05413902|Mydriatics|mydriatics|mesh-ancestor
64885739|NCT05413902|Sympathomimetics|sympathomimetics|mesh-ancestor
64885740|NCT05413902|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64885741|NCT05413902|Anticonvulsants|anticonvulsants|mesh-ancestor
64885742|NCT05413902|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64885743|NCT05413902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64885744|NCT05413902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64885745|NCT05413902|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64885746|NCT05413902|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64885747|NCT05413902|Antimanic Agents|antimanic agents|mesh-ancestor
64885803|NCT05352178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64885804|NCT05352178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885805|NCT05352178|Antioxidants|antioxidants|mesh-ancestor
64885806|NCT05352178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885807|NCT05352178|Protective Agents|protective agents|mesh-ancestor
64885808|NCT05352178|Vitamins|vitamins|mesh-ancestor
64885809|NCT05352178|Micronutrients|micronutrients|mesh-ancestor
64885810|NCT05352178|Estrogens|estrogens|mesh-ancestor
64885811|NCT05352178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64885812|NCT05352178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885813|NCT05352178|Anabolic Agents|anabolic agents|mesh-ancestor
64885814|NCT05328141|Ascorbic Acid|ascorbic acid|mesh-list
64885815|NCT05328141|Antioxidants|antioxidants|mesh-ancestor
64885816|NCT05328141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885817|NCT05328141|Protective Agents|protective agents|mesh-ancestor
64885818|NCT05328141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885819|NCT05328141|Vitamins|vitamins|mesh-ancestor
64885820|NCT05328141|Micronutrients|micronutrients|mesh-ancestor
64885821|NCT05310916|Dapagliflozin|dapagliflozin|mesh-list
64885822|NCT05310916|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64885823|NCT05310916|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64885824|NCT05310916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885825|NCT05310916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885826|NCT05251493|Iron|iron|mesh-list
64885827|NCT05251493|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64885828|NCT05251493|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
64885852|NCT05150236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885853|NCT05150236|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64885854|NCT05150236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885855|NCT05150236|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64885856|NCT05111821|Deferiprone|deferiprone|mesh-list
64885863|NCT05105282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64885864|NCT05105282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885865|NCT05105282|Sensory System Agents|sensory system agents|mesh-ancestor
64885911|NCT04757662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64885912|NCT04757662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885913|NCT04757662|Urological Agents|urological agents|mesh-ancestor
64885914|NCT04742010|Zoledronic Acid|zoledronic acid|mesh-list
64885915|NCT04742010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64885916|NCT04742010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885918|NCT04641234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64400947|NCT05087797|Vitamins|vitamins|mesh-ancestor
64400948|NCT05087797|Micronutrients|micronutrients|mesh-ancestor
64400959|NCT03867799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64885919|NCT04641234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64885920|NCT04641234|Growth Substances|growth substances|mesh-ancestor
64885921|NCT04641234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885922|NCT04641234|Growth Inhibitors|growth inhibitors|mesh-ancestor
64885923|NCT04641234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885924|NCT04636034|Anesthetics|anesthetics|mesh-list
64885925|NCT04636034|Anesthetics, Local|anesthetics, local|mesh-list
64885926|NCT04636034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64885927|NCT04636034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64885928|NCT04636034|Sensory System Agents|sensory system agents|mesh-ancestor
64885967|NCT04131504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64885968|NCT04070352|Fidaxomicin|fidaxomicin|mesh-list
64885969|NCT04070352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64885970|NCT04070352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64885971|NCT04065152|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
64885972|NCT04065152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64885973|NCT04065152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885974|NCT03962998|Lactulose|lactulose|mesh-list
64885975|NCT03962998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64885976|NCT03926143|Maytansine|maytansine|mesh-list
64885977|NCT03926143|Tubulin Modulators|tubulin modulators|mesh-list
64885978|NCT03926143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64885979|NCT03926143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64885980|NCT03926143|Antimitotic Agents|antimitotic agents|mesh-ancestor
64885981|NCT03926143|Mitosis Modulators|mitosis modulators|mesh-ancestor
64885982|NCT03926143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64885983|NCT03891667|Disulfiram|disulfiram|mesh-list
64885984|NCT03891667|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64885985|NCT03891667|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
64886026|NCT03626922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64886027|NCT03626922|Antiemetics|antiemetics|mesh-ancestor
64886028|NCT03626922|Autonomic Agents|autonomic agents|mesh-ancestor
64886029|NCT03626922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64886030|NCT03626922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64886031|NCT03626922|Glucocorticoids|glucocorticoids|mesh-ancestor
64886032|NCT03626922|Hormones|hormones|mesh-ancestor
64886033|NCT03626922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64886034|NCT03626922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64886035|NCT03626922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886036|NCT03626922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64886037|NCT03626922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886038|NCT03626922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886039|NCT03626922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64886040|NCT03626922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64886041|NCT03626922|Hematinics|hematinics|mesh-ancestor
64886042|NCT03626922|Vitamin B Complex|vitamin b complex|mesh-ancestor
64886043|NCT03600818|Prednisone|prednisone|mesh-list
64886044|NCT03600818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64886045|NCT03600818|Glucocorticoids|glucocorticoids|mesh-ancestor
64886046|NCT03600818|Hormones|hormones|mesh-ancestor
64371346|NCT02468999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64371348|NCT03311321|Vitamin K|vitamin k|mesh-list
64886050|NCT03600818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886051|NCT03578276|Gatifloxacin|gatifloxacin|mesh-list
64400977|NCT04873297|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64886052|NCT03578276|Prednisolone|prednisolone|mesh-list
64886072|NCT03578276|Protective Agents|protective agents|mesh-ancestor
64886073|NCT03578276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64886074|NCT03578276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64886075|NCT03578276|Analgesics|analgesics|mesh-ancestor
64400979|NCT04873297|Dopamine Agents|dopamine agents|mesh-ancestor
64886076|NCT03578276|Sensory System Agents|sensory system agents|mesh-ancestor
64886077|NCT03578276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64886078|NCT03578276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64886079|NCT03578276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64886080|NCT03578276|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64886081|NCT03578276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64886082|NCT03578276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64886083|NCT03578276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64886084|NCT03578276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886085|NCT03578276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886086|NCT03534804|Pembrolizumab|pembrolizumab|mesh-list
64886087|NCT03534804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64886088|NCT03534804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886089|NCT03532477|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64654631|NCT00932438|Leucovorin|leucovorin|mesh-list
64886125|NCT03052933|Gemcitabine|gemcitabine|mesh-list
64886126|NCT03052933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64886127|NCT03052933|Antimetabolites|antimetabolites|mesh-ancestor
64886128|NCT03052933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886129|NCT03052933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886130|NCT03052933|Antiviral Agents|antiviral agents|mesh-ancestor
64886131|NCT03052933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64886132|NCT03052933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886133|NCT03052933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64886134|NCT03052933|Immunologic Factors|immunologic factors|mesh-ancestor
64886135|NCT03052933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886188|NCT02238496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886189|NCT02220426|Xenon|xenon|mesh-list
64886190|NCT02220426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64886191|NCT02220426|Anesthetics, General|anesthetics, general|mesh-ancestor
64886192|NCT02220426|Anesthetics|anesthetics|mesh-ancestor
64886193|NCT02220426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64886194|NCT02220426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886195|NCT02034110|Trametinib|trametinib|mesh-list
64886196|NCT02034110|Dabrafenib|dabrafenib|mesh-list
64886197|NCT02034110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886198|NCT02034110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64886199|NCT02034110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886200|NCT02034110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886201|NCT01968213|Rucaparib|rucaparib|mesh-list
64886202|NCT01968213|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64886247|NCT01079780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886248|NCT01079780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886249|NCT01079780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64886250|NCT00075946|Rituximab|rituximab|mesh-list
64886251|NCT00075946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64886252|NCT00075946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886253|NCT00075946|Immunologic Factors|immunologic factors|mesh-ancestor
64886254|NCT00075946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400995|NCT03138499|Nivolumab|nivolumab|mesh-list
64401001|NCT04858711|Lidocaine|lidocaine|mesh-list
64886255|NCT00075946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64886256|NCT00003641|Interferons|interferons|mesh-list
64886257|NCT00003641|Interferon-alpha|interferon-alpha|mesh-list
64886258|NCT00003641|Interferon alpha-2|interferon alpha-2|mesh-list
64886259|NCT00003641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886260|NCT00003641|Antiviral Agents|antiviral agents|mesh-ancestor
64886261|NCT00003641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64886262|NCT00003641|Immunologic Factors|immunologic factors|mesh-ancestor
64886263|NCT00003641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886306|NCT01946009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886307|NCT01946009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886308|NCT01946035|Doxazosin|doxazosin|mesh-list
64886309|NCT01946035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64886310|NCT01946035|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64886311|NCT01946035|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64886312|NCT01946035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64886313|NCT01946035|Adrenergic Agents|adrenergic agents|mesh-ancestor
64886314|NCT01946035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64886315|NCT01946035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886316|NCT01946035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886318|NCT01946061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886319|NCT01946256|Amoxicillin|amoxicillin|mesh-list
64886320|NCT01946256|Erythromycin|erythromycin|mesh-list
64886321|NCT01946256|Erythromycin Estolate|erythromycin estolate|mesh-list
64886322|NCT01946256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64886323|NCT01946256|Erythromycin stearate|erythromycin stearate|mesh-list
64886324|NCT01946256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64886325|NCT01946256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64886326|NCT01946256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64886327|NCT01946256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64886328|NCT01946256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886329|NCT01946256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886330|NCT01946295|Famotidine|famotidine|mesh-list
64886331|NCT01946295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64886332|NCT01946295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64886333|NCT01946295|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64886334|NCT01946295|Histamine Antagonists|histamine antagonists|mesh-ancestor
64886350|NCT01946386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64886351|NCT01946386|Respiratory System Agents|respiratory system agents|mesh-ancestor
64886352|NCT01946399|Dexamethasone|dexamethasone|mesh-list
64886353|NCT01946399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64886354|NCT01946399|Antiemetics|antiemetics|mesh-ancestor
64886355|NCT01946399|Autonomic Agents|autonomic agents|mesh-ancestor
64886356|NCT01946399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401083|NCT04705727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64401084|NCT04705727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64401085|NCT04705727|Autonomic Agents|autonomic agents|mesh-ancestor
64401091|NCT04705727|Hormones|hormones|mesh-ancestor
64886357|NCT01946399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886358|NCT01946399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64886359|NCT01946399|Glucocorticoids|glucocorticoids|mesh-ancestor
64886360|NCT01946399|Hormones|hormones|mesh-ancestor
64886361|NCT01946399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64886362|NCT01946399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64886363|NCT01946399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886364|NCT01946555|Fentanyl|fentanyl|mesh-list
64886365|NCT01946555|Morphine|morphine|mesh-list
64886366|NCT01946555|Oxycodone|oxycodone|mesh-list
64886367|NCT01946555|Buprenorphine|buprenorphine|mesh-list
64886368|NCT01946555|Methadone|methadone|mesh-list
64886369|NCT01946555|Hydromorphone|hydromorphone|mesh-list
64886370|NCT01946555|Tapentadol|tapentadol|mesh-list
64886371|NCT01946555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64886372|NCT01946555|Narcotics|narcotics|mesh-ancestor
64886374|NCT01946555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886404|NCT01946607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64886405|NCT01946607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886406|NCT01946607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64886407|NCT01946607|Serotonin Agents|serotonin agents|mesh-ancestor
64886408|NCT01946607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886409|NCT01946607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64886410|NCT01946607|Antidepressive Agents|antidepressive agents|mesh-ancestor
64886411|NCT01946607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64886412|NCT01946620|Formoterol Fumarate|formoterol fumarate|mesh-list
64886413|NCT01946620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64886465|NCT01947062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64401153|NCT03110653|Remifentanil|remifentanil|mesh-list
64401154|NCT03110653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64401155|NCT03110653|Narcotics|narcotics|mesh-ancestor
64401156|NCT03110653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64401178|NCT04450199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64401179|NCT04450199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64401180|NCT01884259|Docetaxel|docetaxel|mesh-list
64401181|NCT01884259|Fluorouracil|fluorouracil|mesh-list
64401182|NCT01884259|Cetuximab|cetuximab|mesh-list
64401183|NCT01884259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401184|NCT01884259|Tubulin Modulators|tubulin modulators|mesh-ancestor
64401185|NCT01884259|Antimitotic Agents|antimitotic agents|mesh-ancestor
64401186|NCT01884259|Mitosis Modulators|mitosis modulators|mesh-ancestor
64401187|NCT01884259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401188|NCT01884259|Antimetabolites|antimetabolites|mesh-ancestor
64886466|NCT01947062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64886467|NCT01947062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64886468|NCT01947062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886470|NCT01947114|Remifentanil|remifentanil|mesh-list
64886471|NCT01947114|Propofol|propofol|mesh-list
64886472|NCT01947114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64886473|NCT01947114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64886474|NCT01947114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886475|NCT01947114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64886476|NCT01947114|Anesthetics, General|anesthetics, general|mesh-ancestor
64886477|NCT01947114|Anesthetics|anesthetics|mesh-ancestor
64886478|NCT01947114|Analgesics|analgesics|mesh-ancestor
64886479|NCT01947114|Sensory System Agents|sensory system agents|mesh-ancestor
64886480|NCT01947114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64886481|NCT01947114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64886520|NCT01947608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886521|NCT01947608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886523|NCT01947660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64886524|NCT01947660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886525|NCT01947699|Glyburide|glyburide|mesh-list
64886526|NCT01947699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64886527|NCT01947699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886528|NCT01947777|Rifampin|rifampin|mesh-list
64886529|NCT01947777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64886530|NCT01947777|Antitubercular Agents|antitubercular agents|mesh-ancestor
64886531|NCT01947777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64886532|NCT01947777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64886533|NCT01947777|Leprostatic Agents|leprostatic agents|mesh-ancestor
64886534|NCT01947777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64886535|NCT01947777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886536|NCT01947777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886537|NCT01947777|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64886538|NCT01947777|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64886539|NCT01947777|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64886540|NCT01947777|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64886541|NCT01947777|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64886542|NCT01947777|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64886543|NCT01947790|Metformin|metformin|mesh-list
64886544|NCT01947790|Pioglitazone|pioglitazone|mesh-list
64886545|NCT01947790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64655072|NCT02228681|Contraceptive Agents|contraceptive agents|mesh-ancestor
64886546|NCT01947790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886547|NCT01947803|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64401205|NCT04508621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64886548|NCT01947803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64886549|NCT01947803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64401206|NCT04508621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401207|NCT04508621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64886550|NCT01947803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64886556|NCT01947803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64886557|NCT01947803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886558|NCT01947803|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64886559|NCT01947803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64886560|NCT01947803|Dopamine Agents|dopamine agents|mesh-ancestor
64886561|NCT01947920|Tramadol|tramadol|mesh-list
64886562|NCT01947920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64886563|NCT01947920|Narcotics|narcotics|mesh-ancestor
64886564|NCT01947920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64886565|NCT01947920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886566|NCT01947920|Analgesics|analgesics|mesh-ancestor
64886567|NCT01947920|Sensory System Agents|sensory system agents|mesh-ancestor
64886568|NCT01947920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64886569|NCT01947933|Mirikizumab|mirikizumab|mesh-list
64886570|NCT01947933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64886571|NCT01947933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64886572|NCT01947933|Analgesics|analgesics|mesh-ancestor
64886573|NCT01947933|Sensory System Agents|sensory system agents|mesh-ancestor
64886574|NCT01947933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64886575|NCT01947933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886612|NCT01948011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886613|NCT01948024|Asenapine|asenapine|mesh-list
64886614|NCT01948024|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64886615|NCT01948024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64886616|NCT01948024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64886617|NCT01948024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886618|NCT01948024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64886619|NCT01948115|Nitrous Oxide|nitrous oxide|mesh-list
64886621|NCT01948115|Anesthetics, General|anesthetics, general|mesh-ancestor
64886622|NCT01948115|Anesthetics|anesthetics|mesh-ancestor
64886623|NCT01948115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64886624|NCT01948115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886625|NCT01948115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64886626|NCT01948115|Analgesics|analgesics|mesh-ancestor
64886627|NCT01948115|Sensory System Agents|sensory system agents|mesh-ancestor
64886628|NCT01948115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64886629|NCT01948128|Vitamin D|vitamin d|mesh-list
64886630|NCT01948128|Ergocalciferols|ergocalciferols|mesh-list
64886631|NCT01948128|Cholecalciferol|cholecalciferol|mesh-list
64886667|NCT01948336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64886668|NCT01948336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64886669|NCT01948336|Adrenergic Agents|adrenergic agents|mesh-ancestor
64886670|NCT01948336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64886671|NCT01948336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886672|NCT01948336|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64886673|NCT01948336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64886674|NCT01948336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64886675|NCT01948362|Sulforaphane|sulforaphane|mesh-list
64886731|NCT01948895|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64886732|NCT01948895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64886733|NCT01948895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64886734|NCT01948895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64401238|NCT03067103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64401239|NCT03067103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401256|NCT01305889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64401257|NCT01305889|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64401258|NCT01305889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64401259|NCT01305889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64886735|NCT01948895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886736|NCT01948895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64886737|NCT01948895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886738|NCT01948895|Antidepressive Agents|antidepressive agents|mesh-ancestor
64886739|NCT01948895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64886740|NCT01948921|Meperidine|meperidine|mesh-list
64886741|NCT01948921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64886742|NCT01948921|Narcotics|narcotics|mesh-ancestor
64886743|NCT01948921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64886744|NCT01948921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886745|NCT01948921|Analgesics|analgesics|mesh-ancestor
64886791|NCT01949129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64886792|NCT01949129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64886793|NCT01949129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64886794|NCT01949129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886796|NCT01949168|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64886797|NCT01949168|Antimetabolites|antimetabolites|mesh-ancestor
64886798|NCT01949168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886799|NCT01949168|Antiviral Agents|antiviral agents|mesh-ancestor
64886800|NCT01949168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64886801|NCT01949233|Doxycycline|doxycycline|mesh-list
64886802|NCT01949233|Irbesartan|irbesartan|mesh-list
64886803|NCT01949233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64886804|NCT01949233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64886805|NCT01949233|Antimalarials|antimalarials|mesh-ancestor
64886806|NCT01949233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64886807|NCT01949233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64886808|NCT01949233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64886809|NCT01949233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64886847|NCT01949571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64655373|NCT01658657|Metoprolol|metoprolol|mesh-list
64886848|NCT01949571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64886849|NCT01949571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64886850|NCT01949571|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64886851|NCT01949571|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64886852|NCT01949571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64886853|NCT01949571|Adrenergic Agents|adrenergic agents|mesh-ancestor
64886854|NCT01949571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64886855|NCT01949571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64886856|NCT01949571|Serotonin Agents|serotonin agents|mesh-ancestor
64886857|NCT01949571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64886858|NCT01949675|Vaccines|vaccines|mesh-list
64886859|NCT01949675|Immunologic Factors|immunologic factors|mesh-ancestor
64886860|NCT01949675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886861|NCT01949766|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64886862|NCT01949766|Glycerol|glycerol|mesh-list
64886863|NCT01949766|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64886903|NCT01949818|Mitosis Modulators|mitosis modulators|mesh-ancestor
64886904|NCT01949857|Vaccines|vaccines|mesh-list
64886907|NCT01949909|Aluminum sulfate|aluminum sulfate|mesh-list
64886908|NCT01949909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64886909|NCT01949909|Immunologic Factors|immunologic factors|mesh-ancestor
64886910|NCT01949909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886911|NCT01949935|Mupirocin|mupirocin|mesh-list
64886912|NCT01949935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64886913|NCT01949935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64886914|NCT01949935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64886915|NCT01949935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886916|NCT01949935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886917|NCT01949948|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64886918|NCT01949948|Tenecteplase|tenecteplase|mesh-list
64886919|NCT01949948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64886920|NCT01949948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64886921|NCT01949948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886922|NCT01950000|Fentanyl|fentanyl|mesh-list
64886923|NCT01950000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64886924|NCT01950000|Narcotics|narcotics|mesh-ancestor
64886925|NCT01950000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64886926|NCT01950000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886927|NCT01950000|Analgesics|analgesics|mesh-ancestor
64886928|NCT01950000|Sensory System Agents|sensory system agents|mesh-ancestor
64886929|NCT01950000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64886930|NCT01950000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64886931|NCT01950000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64886932|NCT01950000|Anesthetics, General|anesthetics, general|mesh-ancestor
64886933|NCT01950000|Anesthetics|anesthetics|mesh-ancestor
64886934|NCT01950182|Tamoxifen|tamoxifen|mesh-list
64886935|NCT01950182|Gemcitabine|gemcitabine|mesh-list
64886936|NCT01950182|Capecitabine|capecitabine|mesh-list
64886937|NCT01950182|Trastuzumab|trastuzumab|mesh-list
64886938|NCT01950182|Vinorelbine|vinorelbine|mesh-list
64886944|NCT01950182|Antiviral Agents|antiviral agents|mesh-ancestor
64886945|NCT01950182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64886946|NCT01950182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64886947|NCT01950182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64886948|NCT01950182|Immunologic Factors|immunologic factors|mesh-ancestor
64886949|NCT01950182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886950|NCT01950182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64886951|NCT01950182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64886952|NCT01950182|Tubulin Modulators|tubulin modulators|mesh-ancestor
64886953|NCT01950182|Antimitotic Agents|antimitotic agents|mesh-ancestor
64886954|NCT01950182|Mitosis Modulators|mitosis modulators|mesh-ancestor
64886955|NCT01950182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64886956|NCT01950182|Hormone Antagonists|hormone antagonists|mesh-ancestor
64886957|NCT01950182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64886958|NCT01950182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64886959|NCT01950182|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64886960|NCT01950182|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64886961|NCT01950182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64886962|NCT01950182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64886963|NCT01950195|Ipilimumab|ipilimumab|mesh-list
64886964|NCT01950195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64886965|NCT01950195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64886966|NCT01950195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64886967|NCT01950195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64886968|NCT01950416|Clopidogrel|clopidogrel|mesh-list
64886969|NCT01950416|Ticagrelor|ticagrelor|mesh-list
64886970|NCT01950416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64886971|NCT01950416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64886986|NCT01950494|Disinfectants|disinfectants|mesh-ancestor
64886987|NCT01950507|Fluconazole|fluconazole|mesh-list
64886988|NCT01950507|Voriconazole|voriconazole|mesh-list
64886989|NCT01950507|Micafungin|micafungin|mesh-list
64886990|NCT01950507|Budesonide|budesonide|mesh-list
64886991|NCT01950507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64886992|NCT01950507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64886993|NCT01950507|Autonomic Agents|autonomic agents|mesh-ancestor
64886994|NCT01950507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64886995|NCT01950507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64886996|NCT01950507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64886998|NCT01950507|Glucocorticoids|glucocorticoids|mesh-ancestor
64887055|NCT01950923|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64887056|NCT01950923|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64887057|NCT01950923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887058|NCT01950923|Urological Agents|urological agents|mesh-ancestor
64887116|NCT01951404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887118|NCT01951430|Cephalosporins|cephalosporins|mesh-list
64887119|NCT01951430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64887120|NCT01951430|Itraconazole|itraconazole|mesh-list
64887121|NCT01951430|Fluconazole|fluconazole|mesh-list
64887122|NCT01951430|Posaconazole|posaconazole|mesh-list
64887123|NCT01951430|Antifungal Agents|antifungal agents|mesh-list
64887124|NCT01951430|Clotrimazole|clotrimazole|mesh-list
64887125|NCT01951430|Miconazole|miconazole|mesh-list
64887126|NCT01951430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64887127|NCT01951430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64401449|NCT04118387|GABA Agonists|gaba agonists|mesh-ancestor
64887128|NCT01951430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64887129|NCT01951430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887130|NCT01951430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887131|NCT01951430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64887132|NCT01951430|Hormone Antagonists|hormone antagonists|mesh-ancestor
64887133|NCT01951430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64887134|NCT01951430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887135|NCT01951430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64887168|NCT01951508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64887169|NCT01951508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64887170|NCT01951508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64887171|NCT01951508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64887172|NCT01951560|Valproic Acid|valproic acid|mesh-list
64887173|NCT01951560|Anticonvulsants|anticonvulsants|mesh-ancestor
64887174|NCT01951560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887175|NCT01951560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887176|NCT01951560|GABA Agents|gaba agents|mesh-ancestor
64887177|NCT01951560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64887178|NCT01951560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887179|NCT01951560|Antimanic Agents|antimanic agents|mesh-ancestor
64887227|NCT01951898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64887228|NCT01951898|Respiratory System Agents|respiratory system agents|mesh-ancestor
64887229|NCT01951898|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64887230|NCT01951898|Hormone Antagonists|hormone antagonists|mesh-ancestor
64887231|NCT01951898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64887236|NCT01951911|Ketamine|ketamine|mesh-list
64655822|NCT03033836|Dolutegravir|dolutegravir|mesh-list
64887293|NCT01952652|Codeine|codeine|mesh-list
64887294|NCT01952652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64887295|NCT01952652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64887296|NCT01952652|Analgesics|analgesics|mesh-ancestor
64887297|NCT01952652|Sensory System Agents|sensory system agents|mesh-ancestor
64887298|NCT01952652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64887299|NCT01952652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887300|NCT01952652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64887301|NCT01952652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64887302|NCT01952652|Gout Suppressants|gout suppressants|mesh-ancestor
64887303|NCT01952652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64887304|NCT01952652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887305|NCT01952652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887306|NCT01952652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64887307|NCT01952652|Narcotics|narcotics|mesh-ancestor
64887308|NCT01952652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64887309|NCT01952652|Antitussive Agents|antitussive agents|mesh-ancestor
64887310|NCT01952652|Respiratory System Agents|respiratory system agents|mesh-ancestor
64887311|NCT01952756|Cilostazol|cilostazol|mesh-list
64887312|NCT01952756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64887313|NCT01952756|Autonomic Agents|autonomic agents|mesh-ancestor
64887319|NCT01952756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64887320|NCT01952756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887321|NCT01952756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64887322|NCT01952756|Vasodilator Agents|vasodilator agents|mesh-ancestor
64887335|NCT01952886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401559|NCT03136003|Natriuretic Agents|natriuretic agents|mesh-ancestor
64401561|NCT03777215|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
64401618|NCT04540861|Immunologic Factors|immunologic factors|mesh-ancestor
64887336|NCT01952886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887337|NCT01952886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64887338|NCT01952886|Antipruritics|antipruritics|mesh-ancestor
64887339|NCT01952886|Dermatologic Agents|dermatologic agents|mesh-ancestor
64887340|NCT01952886|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64887341|NCT01952886|Serotonin Agents|serotonin agents|mesh-ancestor
64887342|NCT01952886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64887343|NCT01952886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887344|NCT01952886|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64887345|NCT01952886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64887346|NCT01952886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64887347|NCT01952886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64887348|NCT01952886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64887349|NCT01952951|Fluorouracil|fluorouracil|mesh-list
64887350|NCT01952951|Capecitabine|capecitabine|mesh-list
64887351|NCT01952951|Oxaliplatin|oxaliplatin|mesh-list
64887352|NCT01952951|Antimetabolites|antimetabolites|mesh-ancestor
64887353|NCT01952951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887392|NCT01953419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64887393|NCT01953419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64887395|NCT01953445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64887396|NCT01953445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887397|NCT01953445|Tubulin Modulators|tubulin modulators|mesh-ancestor
64887398|NCT01953445|Antimitotic Agents|antimitotic agents|mesh-ancestor
64887399|NCT01953445|Mitosis Modulators|mitosis modulators|mesh-ancestor
64887400|NCT01953445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887401|NCT01953536|Folic Acid|folic acid|mesh-list
64887402|NCT01953536|Paclitaxel|paclitaxel|mesh-list
64887403|NCT01953536|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64887404|NCT01953536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64887405|NCT01953536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887406|NCT01953536|Tubulin Modulators|tubulin modulators|mesh-ancestor
64887407|NCT01953536|Antimitotic Agents|antimitotic agents|mesh-ancestor
64887408|NCT01953536|Mitosis Modulators|mitosis modulators|mesh-ancestor
64887409|NCT01953536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887410|NCT01953536|Hematinics|hematinics|mesh-ancestor
64887411|NCT01953536|Vitamin B Complex|vitamin b complex|mesh-ancestor
64887446|NCT01953744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887447|NCT01953744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64887448|NCT01953744|Hormone Antagonists|hormone antagonists|mesh-ancestor
64887449|NCT01953744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64887450|NCT01953744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887451|NCT01953744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64887452|NCT01953744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64887453|NCT01953744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64887454|NCT01953744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64887455|NCT01953757|Vitamins|vitamins|mesh-list
64887456|NCT01953757|Hydroxocobalamin|hydroxocobalamin|mesh-list
64887457|NCT01953757|Vitamin B 12|vitamin b 12|mesh-list
64887458|NCT01953757|Vitamin B Complex|vitamin b complex|mesh-list
64887459|NCT01953757|Micronutrients|micronutrients|mesh-ancestor
64887460|NCT01953757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887461|NCT01953757|Hematinics|hematinics|mesh-ancestor
64887462|NCT01953770|Cytarabine|cytarabine|mesh-list
64887463|NCT01953770|Prednisone|prednisone|mesh-list
64887464|NCT01953770|Methotrexate|methotrexate|mesh-list
64887465|NCT01953770|Daunorubicin|daunorubicin|mesh-list
64887466|NCT01953770|Asparaginase|asparaginase|mesh-list
64887467|NCT01953770|Pegaspargase|pegaspargase|mesh-list
64887471|NCT01953770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64401650|NCT05737693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401651|NCT05737693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401716|NCT02514655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64401718|NCT03066011|Posaconazole|posaconazole|mesh-list
64401719|NCT03066011|Isavuconazole|isavuconazole|mesh-list
64887472|NCT01953770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887473|NCT01953770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64887474|NCT01953770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887475|NCT01953770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64887476|NCT01953770|Abortifacient Agents|abortifacient agents|mesh-ancestor
64887477|NCT01953770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64887488|NCT01953770|Antiviral Agents|antiviral agents|mesh-ancestor
64887489|NCT01953770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64887490|NCT01953770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64887491|NCT01953770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64887492|NCT01953770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64887493|NCT01953796|Clomiphene|clomiphene|mesh-list
64887494|NCT01953796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64887495|NCT01953796|Hormone Antagonists|hormone antagonists|mesh-ancestor
64887496|NCT01953796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64887497|NCT01953796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887498|NCT01953796|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64887499|NCT01953796|Fertility Agents|fertility agents|mesh-ancestor
64887500|NCT01953796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64887501|NCT01953796|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64887502|NCT01953796|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64887503|NCT01953835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64887504|NCT01953835|Simvastatin|simvastatin|mesh-list
64887505|NCT01953835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64887506|NCT01953835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64887507|NCT01953835|Antimetabolites|antimetabolites|mesh-ancestor
64887512|NCT01953848|Tamsulosin|tamsulosin|mesh-list
64887539|NCT01953952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887540|NCT01953978|Acetaminophen|acetaminophen|mesh-list
64887541|NCT01953978|Dexamethasone|dexamethasone|mesh-list
64887542|NCT01953978|Ibuprofen|ibuprofen|mesh-list
64887543|NCT01953978|Morphine|morphine|mesh-list
64887544|NCT01953978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64887545|NCT01953978|Antiemetics|antiemetics|mesh-ancestor
64887546|NCT01953978|Autonomic Agents|autonomic agents|mesh-ancestor
64887547|NCT01953978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64887548|NCT01953978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887549|NCT01953978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64887550|NCT01953978|Glucocorticoids|glucocorticoids|mesh-ancestor
64887551|NCT01953978|Hormones|hormones|mesh-ancestor
64887552|NCT01953978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64887553|NCT01953978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64887554|NCT01953978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887555|NCT01953978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64887596|NCT01954043|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64887597|NCT01954043|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64887598|NCT01954043|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64887599|NCT01954043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64887600|NCT01954043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887601|NCT01954043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64887602|NCT01954108|Hyaluronic Acid|hyaluronic acid|mesh-list
64401723|NCT03066011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64401724|NCT03066011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887603|NCT01954108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64887606|NCT01954108|Viscosupplements|viscosupplements|mesh-ancestor
64887664|NCT01954784|Antimetabolites|antimetabolites|mesh-ancestor
64887665|NCT01954784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887666|NCT01954784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64887667|NCT01954784|Immunologic Factors|immunologic factors|mesh-ancestor
64887668|NCT01954784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887669|NCT01954784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64887670|NCT01954784|Antifungal Agents|antifungal agents|mesh-ancestor
64887671|NCT01954784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64887672|NCT01954784|Dermatologic Agents|dermatologic agents|mesh-ancestor
64887673|NCT01954784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64887674|NCT01954784|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64887675|NCT01954784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64887727|NCT01955135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64887728|NCT01955135|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64887729|NCT01955135|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64887732|NCT01955135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887734|NCT01955135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64887735|NCT01955174|Botulinum Toxins|botulinum toxins|mesh-list
64887736|NCT01955174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64887737|NCT01955174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64887738|NCT01955174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887739|NCT01955174|Cholinergic Agents|cholinergic agents|mesh-ancestor
64887740|NCT01955174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64887741|NCT01955174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887784|NCT01955200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887785|NCT01955200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887786|NCT01955200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64887787|NCT01955200|Autonomic Agents|autonomic agents|mesh-ancestor
64401767|NCT05736757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401768|NCT04483739|Dexamethasone|dexamethasone|mesh-list
64401769|NCT04483739|Dexamethasone acetate|dexamethasone acetate|mesh-list
64401770|NCT04483739|Lenalidomide|lenalidomide|mesh-list
64401771|NCT04483739|BB 1101|bb 1101|mesh-list
64401772|NCT04483739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64401773|NCT04483739|Antiemetics|antiemetics|mesh-ancestor
64401774|NCT04483739|Autonomic Agents|autonomic agents|mesh-ancestor
64887788|NCT01955200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64887789|NCT01955200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64887790|NCT01955200|Respiratory System Agents|respiratory system agents|mesh-ancestor
64887791|NCT01955200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64887792|NCT01955200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64887793|NCT01955200|Vasodilator Agents|vasodilator agents|mesh-ancestor
64887794|NCT01955200|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64887795|NCT01955200|Protective Agents|protective agents|mesh-ancestor
64887796|NCT01955200|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64887844|NCT01955642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64887845|NCT01955642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887846|NCT01955642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887848|NCT01955655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64887849|NCT01955655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887850|NCT01955655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64887851|NCT01955655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64887852|NCT01955655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64887853|NCT01955655|GABA Agonists|gaba agonists|mesh-ancestor
64887854|NCT01955655|GABA Agents|gaba agents|mesh-ancestor
64887905|NCT01955824|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64887906|NCT01955824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64887907|NCT01955824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887909|NCT01955967|Anesthetics, Local|anesthetics, local|mesh-ancestor
64887910|NCT01955967|Anesthetics|anesthetics|mesh-ancestor
64887911|NCT01955967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64887920|NCT01956006|Milrinone|milrinone|mesh-list
64887970|NCT01956604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887971|NCT01956604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64887972|NCT01956604|Sympatholytics|sympatholytics|mesh-ancestor
64887973|NCT01956604|Autonomic Agents|autonomic agents|mesh-ancestor
64887974|NCT01956604|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64887975|NCT01956604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64887976|NCT01956604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64887977|NCT01956604|Adrenergic Agents|adrenergic agents|mesh-ancestor
64887978|NCT01956604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64887979|NCT01956604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64887980|NCT01956695|Rituximab|rituximab|mesh-list
64887981|NCT01956695|Lenalidomide|lenalidomide|mesh-list
64887982|NCT01956695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64887983|NCT01956695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64887984|NCT01956695|Immunologic Factors|immunologic factors|mesh-ancestor
64887985|NCT01956695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64887986|NCT01956695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64887987|NCT01956695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64887989|NCT01956695|Growth Substances|growth substances|mesh-ancestor
64888026|NCT01956981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888027|NCT01956981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64888028|NCT01956981|Analgesics|analgesics|mesh-ancestor
64888029|NCT01956981|Sensory System Agents|sensory system agents|mesh-ancestor
64401811|NCT04821869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64888030|NCT01956981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64888031|NCT01956981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64888032|NCT01956981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64888033|NCT01956981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64888037|NCT01956981|Anesthetics|anesthetics|mesh-ancestor
64888038|NCT01956981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64888039|NCT01956981|Anticonvulsants|anticonvulsants|mesh-ancestor
64888040|NCT01956981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64888041|NCT01956981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64888042|NCT01956981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64888043|NCT01956981|Tocolytic Agents|tocolytic agents|mesh-ancestor
64888044|NCT01956981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64888045|NCT01957007|Docetaxel|docetaxel|mesh-list
64888046|NCT01957007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888047|NCT01957007|Tubulin Modulators|tubulin modulators|mesh-ancestor
64888048|NCT01957007|Antimitotic Agents|antimitotic agents|mesh-ancestor
64888049|NCT01957007|Mitosis Modulators|mitosis modulators|mesh-ancestor
64888050|NCT01957007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888051|NCT01957046|Laxatives|laxatives|mesh-list
64888073|NCT01957293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64888074|NCT01957293|Respiratory System Agents|respiratory system agents|mesh-ancestor
64888075|NCT01957293|Tocolytic Agents|tocolytic agents|mesh-ancestor
64888076|NCT01957293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64888077|NCT01957293|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64888078|NCT01957293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64888079|NCT01957293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64888080|NCT01957293|Adrenergic Agents|adrenergic agents|mesh-ancestor
64888081|NCT01957293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888082|NCT01957293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888083|NCT01957319|Vitamin E|vitamin e|mesh-list
64888084|NCT01957319|Silybin|silybin|mesh-list
64888085|NCT01957319|Vitamins|vitamins|mesh-ancestor
64888086|NCT01957319|Micronutrients|micronutrients|mesh-ancestor
64888087|NCT01957319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888088|NCT01957319|Antioxidants|antioxidants|mesh-ancestor
64888089|NCT01957319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888090|NCT01957319|Protective Agents|protective agents|mesh-ancestor
64888091|NCT01957319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64888092|NCT01957319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888093|NCT01957436|Docetaxel|docetaxel|mesh-list
64888094|NCT01957436|Abiraterone Acetate|abiraterone acetate|mesh-list
64888095|NCT01957436|Androgens|androgens|mesh-list
64888096|NCT01957436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888097|NCT01957436|Tubulin Modulators|tubulin modulators|mesh-ancestor
64888098|NCT01957436|Antimitotic Agents|antimitotic agents|mesh-ancestor
64888099|NCT01957436|Mitosis Modulators|mitosis modulators|mesh-ancestor
64888100|NCT01957436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888119|NCT01957449|Sympatholytics|sympatholytics|mesh-ancestor
64888120|NCT01957449|Autonomic Agents|autonomic agents|mesh-ancestor
64888121|NCT01957449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64888122|NCT01957449|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64888123|NCT01957540|Ticagrelor|ticagrelor|mesh-list
64888124|NCT01957540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64888125|NCT01957540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64888128|NCT01957540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64888187|NCT01958138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64888188|NCT01958216|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64401834|NCT02631551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64401835|NCT02631551|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64401849|NCT05091151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64888189|NCT01958216|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64888190|NCT01958216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64888191|NCT01958216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64888193|NCT01958372|Pemetrexed|pemetrexed|mesh-list
64888194|NCT01958372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888195|NCT01958372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64888196|NCT01958372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64888197|NCT01958372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64888198|NCT01958372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64888199|NCT01958372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888200|NCT01958372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64888201|NCT01958372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64888202|NCT01958580|Gemcitabine|gemcitabine|mesh-list
64888203|NCT01958580|Docetaxel|docetaxel|mesh-list
64888204|NCT01958580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64371359|NCT02468297|Ibuprofen|ibuprofen|mesh-list
64888206|NCT01958580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888208|NCT01958580|Antiviral Agents|antiviral agents|mesh-ancestor
64888239|NCT01958814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888240|NCT01958814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64888241|NCT01958814|Respiratory System Agents|respiratory system agents|mesh-ancestor
64888242|NCT01958814|Tocolytic Agents|tocolytic agents|mesh-ancestor
64888243|NCT01958814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64888244|NCT01958814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64888245|NCT01958814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64888246|NCT01958814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64888247|NCT01958814|Adrenergic Agents|adrenergic agents|mesh-ancestor
64888248|NCT01958814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888249|NCT01958814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888250|NCT01958866|Acetaminophen|acetaminophen|mesh-list
64888251|NCT01958866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64888252|NCT01958866|Analgesics|analgesics|mesh-ancestor
64888253|NCT01958866|Sensory System Agents|sensory system agents|mesh-ancestor
64888254|NCT01958866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64888255|NCT01958866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888256|NCT01958866|Antipyretics|antipyretics|mesh-ancestor
64888257|NCT01958905|Lumefantrine|lumefantrine|mesh-list
64888258|NCT01958905|Artemether|artemether|mesh-list
64888259|NCT01958905|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64888260|NCT01958905|Antimalarials|antimalarials|mesh-ancestor
64888261|NCT01958905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64888262|NCT01958905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64888263|NCT01958905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64888264|NCT01958944|Nitric Oxide|nitric oxide|mesh-list
64888265|NCT01958944|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64888266|NCT01958944|Autonomic Agents|autonomic agents|mesh-ancestor
64888267|NCT01958944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64888285|NCT01958996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888286|NCT01959022|Doxazosin|doxazosin|mesh-list
64888287|NCT01959022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64888288|NCT01959022|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64888289|NCT01959022|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64888290|NCT01959022|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64888291|NCT01959022|Adrenergic Agents|adrenergic agents|mesh-ancestor
64401872|NCT04447235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64401874|NCT04447235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64888292|NCT01959022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888293|NCT01959022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888294|NCT01959022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888295|NCT01959061|Oxaliplatin|oxaliplatin|mesh-list
64888296|NCT01959061|Ethiodized Oil|ethiodized oil|mesh-list
64888297|NCT01959061|Raltitrexed|raltitrexed|mesh-list
64888298|NCT01959061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888299|NCT01959061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64888300|NCT01959061|Antimetabolites|antimetabolites|mesh-ancestor
64888301|NCT01959061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888302|NCT01959061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64888303|NCT01959061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64888304|NCT01959074|Aceclofenac|aceclofenac|mesh-list
64888305|NCT01959074|Naftopidil|naftopidil|mesh-list
64888306|NCT01959074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64888307|NCT01959074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64888308|NCT01959074|Analgesics|analgesics|mesh-ancestor
64888309|NCT01959074|Sensory System Agents|sensory system agents|mesh-ancestor
64888333|NCT01959191|Clopidogrel|clopidogrel|mesh-list
64888334|NCT01959191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64888335|NCT01959191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64888336|NCT01959191|Analgesics|analgesics|mesh-ancestor
64888337|NCT01959191|Sensory System Agents|sensory system agents|mesh-ancestor
64888338|NCT01959191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64888339|NCT01959191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888340|NCT01959191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64888341|NCT01959191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64888342|NCT01959191|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64888343|NCT01959191|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64888344|NCT01959191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888345|NCT01959191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64888346|NCT01959191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64888347|NCT01959191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64888354|NCT01959386|Trastuzumab|trastuzumab|mesh-list
64888355|NCT01959386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64888356|NCT01959386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888357|NCT01959399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64888358|NCT01959399|Peficitinib|peficitinib|mesh-list
64888359|NCT01959399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64888378|NCT01959451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64888379|NCT01959451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64888380|NCT01959451|Purinergic Agents|purinergic agents|mesh-ancestor
64888381|NCT01959451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888382|NCT01959451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888383|NCT01959451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888384|NCT01959477|Cyclophosphamide|cyclophosphamide|mesh-list
64888386|NCT01959477|Etoposide|etoposide|mesh-list
64888387|NCT01959477|Etoposide phosphate|etoposide phosphate|mesh-list
64888388|NCT01959477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64888389|NCT01959477|Immunologic Factors|immunologic factors|mesh-ancestor
64888390|NCT01959477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888391|NCT01959477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64888392|NCT01959477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64888393|NCT01959477|Alkylating Agents|alkylating agents|mesh-ancestor
64888394|NCT01959477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888395|NCT01959477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888396|NCT01959477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64888397|NCT01959477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64888398|NCT01959477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64888399|NCT01959477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64888400|NCT01959477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64888401|NCT01959828|Nitric Oxide|nitric oxide|mesh-list
64888402|NCT01959828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64888403|NCT01959828|Autonomic Agents|autonomic agents|mesh-ancestor
64888404|NCT01959828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64888405|NCT01959828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888424|NCT01960049|Anesthetics|anesthetics|mesh-ancestor
64888425|NCT01960049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64888426|NCT01960049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888427|NCT01960049|Sensory System Agents|sensory system agents|mesh-ancestor
64888428|NCT01960049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64888429|NCT01960153|Tadalafil|tadalafil|mesh-list
64888430|NCT01960153|Vasodilator Agents|vasodilator agents|mesh-ancestor
64888431|NCT01960153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64888432|NCT01960153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64888433|NCT01960153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64888434|NCT01960153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888435|NCT01960153|Urological Agents|urological agents|mesh-ancestor
64888436|NCT01960179|Lixisenatide|lixisenatide|mesh-list
64888437|NCT01960179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64888482|NCT01960543|Narcotics|narcotics|mesh-ancestor
64888483|NCT01960543|Analgesics|analgesics|mesh-ancestor
64888484|NCT01960543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64888485|NCT01960543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64888486|NCT01960543|Anesthetics, General|anesthetics, general|mesh-ancestor
64888487|NCT01960569|Hirudins|hirudins|mesh-list
64888488|NCT01960569|Antithrombins|antithrombins|mesh-ancestor
64888489|NCT01960569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64888490|NCT01960569|Protease Inhibitors|protease inhibitors|mesh-ancestor
64888491|NCT01960569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64888492|NCT01960569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888493|NCT01960569|Anticoagulants|anticoagulants|mesh-ancestor
64888494|NCT01960569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64888495|NCT01960569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64371361|NCT02468297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64371362|NCT02468297|Analgesics|analgesics|mesh-ancestor
64888497|NCT01960595|Bupivacaine|bupivacaine|mesh-list
64888498|NCT01960595|Anesthetics, Local|anesthetics, local|mesh-ancestor
64888499|NCT01960595|Anesthetics|anesthetics|mesh-ancestor
64888500|NCT01960595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64888501|NCT01960595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888502|NCT01960595|Sensory System Agents|sensory system agents|mesh-ancestor
64888503|NCT01960595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64888504|NCT01960595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64888505|NCT01960595|Narcotics|narcotics|mesh-ancestor
64888506|NCT01960595|Analgesics|analgesics|mesh-ancestor
64888507|NCT01960595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64888508|NCT01960595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64888509|NCT01960595|Anesthetics, General|anesthetics, general|mesh-ancestor
64888510|NCT01960647|Paclitaxel|paclitaxel|mesh-list
64888511|NCT01960647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64888528|NCT01961154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64888529|NCT01961154|Autonomic Agents|autonomic agents|mesh-ancestor
64888530|NCT01961154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64888531|NCT01961154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888532|NCT01961154|Glucocorticoids|glucocorticoids|mesh-ancestor
64888533|NCT01961154|Hormones|hormones|mesh-ancestor
64888534|NCT01961154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64888535|NCT01961154|Sympathomimetics|sympathomimetics|mesh-ancestor
64888536|NCT01961180|Citalopram|citalopram|mesh-list
64888537|NCT01961180|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64888538|NCT01961180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64888539|NCT01961180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64888540|NCT01961180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888541|NCT01961180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888542|NCT01961180|Serotonin Agents|serotonin agents|mesh-ancestor
64888543|NCT01961180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888544|NCT01961180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64888545|NCT01961180|Antidepressive Agents|antidepressive agents|mesh-ancestor
64888546|NCT01961180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64888547|NCT01961193|Silicon|silicon|mesh-list
64888548|NCT01961193|Trace Elements|trace elements|mesh-ancestor
64888549|NCT01961193|Micronutrients|micronutrients|mesh-ancestor
64888550|NCT01961193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888551|NCT01961219|Anesthetics|anesthetics|mesh-list
64888552|NCT01961219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64888553|NCT01961219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888576|NCT01961453|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64888577|NCT01961453|Diuretics|diuretics|mesh-ancestor
64888578|NCT01961453|Natriuretic Agents|natriuretic agents|mesh-ancestor
64888579|NCT01961453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888580|NCT01961453|Vasodilator Agents|vasodilator agents|mesh-ancestor
64888581|NCT01961453|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64888582|NCT01961453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888583|NCT01961635|Cimetidine|cimetidine|mesh-list
64888584|NCT01961635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64888585|NCT01961635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64401994|NCT03063359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64401995|NCT03063359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64888639|NCT01961843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888640|NCT01961843|Hormone Antagonists|hormone antagonists|mesh-ancestor
64888641|NCT01961843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64888642|NCT01961856|Clopidogrel|clopidogrel|mesh-list
64888643|NCT01961856|Ticagrelor|ticagrelor|mesh-list
64888710|NCT01962571|Epoetin Alfa|epoetin alfa|mesh-list
64888711|NCT01962571|Hematinics|hematinics|mesh-ancestor
64888712|NCT01962831|Dinoprostone|dinoprostone|mesh-list
64888713|NCT01962831|Oxytocics|oxytocics|mesh-ancestor
64557489|NCT02555007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557491|NCT03898037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64557492|NCT03898037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557495|NCT03897881|Pembrolizumab|pembrolizumab|mesh-list
64557496|NCT03897881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64557497|NCT03897881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557498|NCT04982874|Furosemide|furosemide|mesh-list
64557499|NCT04982874|Diuretics|diuretics|mesh-ancestor
64557500|NCT04982874|Natriuretic Agents|natriuretic agents|mesh-ancestor
64557501|NCT04982874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557502|NCT04982874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64557503|NCT04982874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64557504|NCT04982874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557505|NCT03584711|Panitumumab|panitumumab|mesh-list
64557510|NCT05301192|Vasodilator Agents|vasodilator agents|mesh-ancestor
64557511|NCT03897491|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64557512|NCT03897491|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64557513|NCT03897491|Dermatologic Agents|dermatologic agents|mesh-ancestor
64557514|NCT03068208|Methylene Blue|methylene blue|mesh-list
64557515|NCT03068208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557516|NCT03068208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557517|NCT03067974|Ketamine|ketamine|mesh-list
64557533|NCT05104866|Vinorelbine|vinorelbine|mesh-list
64557534|NCT05104866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64557535|NCT05104866|Antimetabolites|antimetabolites|mesh-ancestor
64557536|NCT05104866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557537|NCT05104866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557538|NCT05104866|Antiviral Agents|antiviral agents|mesh-ancestor
64557539|NCT05104866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64557540|NCT05104866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557541|NCT05104866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64557542|NCT05104866|Immunologic Factors|immunologic factors|mesh-ancestor
64557543|NCT05104866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557544|NCT05104866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64557545|NCT05104866|Tubulin Modulators|tubulin modulators|mesh-ancestor
64557546|NCT05104866|Antimitotic Agents|antimitotic agents|mesh-ancestor
64557547|NCT05104866|Mitosis Modulators|mitosis modulators|mesh-ancestor
64888744|NCT01963299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64888745|NCT01963299|Adrenergic Agents|adrenergic agents|mesh-ancestor
64888746|NCT01963299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64402028|NCT04901299|Fulvestrant|fulvestrant|mesh-list
64888747|NCT01963299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888748|NCT01963325|Paclitaxel|paclitaxel|mesh-list
64888749|NCT01963325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64888750|NCT01963325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64888751|NCT01963325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888752|NCT01963325|Tubulin Modulators|tubulin modulators|mesh-ancestor
64888809|NCT01963702|Antimetabolites|antimetabolites|mesh-ancestor
64888810|NCT01963702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888811|NCT01963702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888812|NCT01963702|Tubulin Modulators|tubulin modulators|mesh-ancestor
64888813|NCT01963702|Antimitotic Agents|antimitotic agents|mesh-ancestor
64888814|NCT01963702|Mitosis Modulators|mitosis modulators|mesh-ancestor
64888815|NCT01963741|Histamine|histamine|mesh-list
64888816|NCT01963741|Histamine Agonists|histamine agonists|mesh-ancestor
64888817|NCT01963741|Histamine Agents|histamine agents|mesh-ancestor
64888818|NCT01963741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64888819|NCT01963741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888820|NCT01963741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888821|NCT01963754|Epinephrine|epinephrine|mesh-list
64888822|NCT01963754|Racepinephrine|racepinephrine|mesh-list
64888823|NCT01963754|Anesthetics|anesthetics|mesh-list
64888824|NCT01963754|Carticaine|carticaine|mesh-list
64888825|NCT01963754|Epinephryl borate|epinephryl borate|mesh-list
64888826|NCT01963754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64888827|NCT01963754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888828|NCT01963754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64888829|NCT01963754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64888830|NCT01963754|Adrenergic Agents|adrenergic agents|mesh-ancestor
64888862|NCT01963910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888863|NCT01963962|Copper|copper|mesh-list
64888864|NCT01963962|Levonorgestrel|levonorgestrel|mesh-list
64888865|NCT01963962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64888866|NCT01963962|Contraceptive Agents|contraceptive agents|mesh-ancestor
64888867|NCT01963962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64888868|NCT01963962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64888869|NCT01963962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64888870|NCT01963962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64888871|NCT01963962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64888872|NCT01963962|Trace Elements|trace elements|mesh-ancestor
64888873|NCT01963962|Micronutrients|micronutrients|mesh-ancestor
64888874|NCT01964001|Vitamins|vitamins|mesh-list
64888875|NCT01964001|Coenzyme Q10|coenzyme q10|mesh-list
64888876|NCT01964001|Vitamin B 6|vitamin b 6|mesh-list
64888879|NCT01964001|Vitamin B Complex|vitamin b complex|mesh-list
64888881|NCT01964001|Micronutrients|micronutrients|mesh-ancestor
64888920|NCT01964079|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64888921|NCT01964157|Ceritinib|ceritinib|mesh-list
64888922|NCT01964157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64888923|NCT01964157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64888924|NCT01964157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64888925|NCT01964157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888926|NCT01964170|Goserelin|goserelin|mesh-list
64888927|NCT01964170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64888988|NCT01964365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64888989|NCT01964365|Antimetabolites|antimetabolites|mesh-ancestor
64402106|NCT04582981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64402107|NCT04582981|Antimetabolites|antimetabolites|mesh-ancestor
64888990|NCT01964365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64888991|NCT01964365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64888993|NCT01964391|Docetaxel|docetaxel|mesh-list
64888994|NCT01964391|Cyclophosphamide|cyclophosphamide|mesh-list
64888995|NCT01964391|Carboplatin|carboplatin|mesh-list
64888996|NCT01964391|Doxorubicin|doxorubicin|mesh-list
64888997|NCT01964391|Trastuzumab|trastuzumab|mesh-list
64888998|NCT01964391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64888999|NCT01964391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889000|NCT01964391|Tubulin Modulators|tubulin modulators|mesh-ancestor
64889001|NCT01964391|Antimitotic Agents|antimitotic agents|mesh-ancestor
64889002|NCT01964391|Mitosis Modulators|mitosis modulators|mesh-ancestor
64889003|NCT01964391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889004|NCT01964391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64889005|NCT01964391|Immunologic Factors|immunologic factors|mesh-ancestor
64889006|NCT01964391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889007|NCT01964391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64889008|NCT01964391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64889009|NCT01964391|Alkylating Agents|alkylating agents|mesh-ancestor
64889010|NCT01964391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64889011|NCT01964391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64889012|NCT01964391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64889013|NCT01964391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64557555|NCT04405193|Antiviral Agents|antiviral agents|mesh-ancestor
64889014|NCT01964391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889015|NCT01964391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64889016|NCT01964404|Dronabinol|dronabinol|mesh-list
64889017|NCT01964404|Hallucinogens|hallucinogens|mesh-ancestor
64889018|NCT01964404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889019|NCT01964404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64889020|NCT01964404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64889022|NCT01964404|Sensory System Agents|sensory system agents|mesh-ancestor
64889023|NCT01964404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334598|NCT03146793|Chelating Agents|chelating agents|mesh-ancestor
64334599|NCT03146793|Sequestering Agents|sequestering agents|mesh-ancestor
64889024|NCT01964404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64889025|NCT01964404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64889026|NCT01964404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64889027|NCT01964404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889028|NCT01964404|Hormones|hormones|mesh-ancestor
64889029|NCT01964404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64889030|NCT01964534|Gemcitabine|gemcitabine|mesh-list
64889031|NCT01964534|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64889032|NCT01964534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64889033|NCT01964534|Antimetabolites|antimetabolites|mesh-ancestor
64889034|NCT01964534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889035|NCT01964534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889036|NCT01964534|Antiviral Agents|antiviral agents|mesh-ancestor
64889037|NCT01964534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64889038|NCT01964534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889039|NCT01964534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64889040|NCT01964534|Immunologic Factors|immunologic factors|mesh-ancestor
64889080|NCT01964651|JNJ-42165279|jnj-42165279|mesh-list
64889081|NCT01964651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889082|NCT01964651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402126|NCT04531579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64889083|NCT01964781|Epinephrine|epinephrine|mesh-list
64889084|NCT01964781|Racepinephrine|racepinephrine|mesh-list
64889085|NCT01964781|Bupivacaine|bupivacaine|mesh-list
64889086|NCT01964781|Tranexamic Acid|tranexamic acid|mesh-list
64889087|NCT01964781|Epinephryl borate|epinephryl borate|mesh-list
64889089|NCT01964781|Anesthetics|anesthetics|mesh-ancestor
64889091|NCT01964781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889145|NCT01965080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889146|NCT01965080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889147|NCT01965080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64889148|NCT01965080|Hormone Antagonists|hormone antagonists|mesh-ancestor
64889212|NCT01965405|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64889213|NCT01965405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64889214|NCT01965405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889216|NCT01965522|Ergocalciferols|ergocalciferols|mesh-list
64889217|NCT01965522|Cholecalciferol|cholecalciferol|mesh-list
64889218|NCT01965522|Vitamins|vitamins|mesh-list
64889219|NCT01965522|Melatonin|melatonin|mesh-list
64889220|NCT01965522|Micronutrients|micronutrients|mesh-ancestor
64889221|NCT01965522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889222|NCT01965522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64889223|NCT01965522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64889224|NCT01965522|Antioxidants|antioxidants|mesh-ancestor
64889225|NCT01965522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889228|NCT01965587|Levonorgestrel|levonorgestrel|mesh-list
64889271|NCT01966133|Doxorubicin|doxorubicin|mesh-list
64889272|NCT01966133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64889273|NCT01966133|Ethiodized Oil|ethiodized oil|mesh-list
64889274|NCT01966133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64889275|NCT01966133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889276|NCT01966133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64889277|NCT01966133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64889278|NCT01966133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889279|NCT01966133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889280|NCT01966172|Acetaminophen|acetaminophen|mesh-list
64889282|NCT01966172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64889283|NCT01966172|Morphine|morphine|mesh-list
64889284|NCT01966172|Gabapentin|gabapentin|mesh-list
64889285|NCT01966172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64889332|NCT01966341|Parasympatholytics|parasympatholytics|mesh-list
64889333|NCT01966341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64889334|NCT01966341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64889335|NCT01966341|Autonomic Agents|autonomic agents|mesh-ancestor
64889336|NCT01966341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889337|NCT01966341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889338|NCT01966484|Succinylcholine|succinylcholine|mesh-list
64889340|NCT01966484|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
64889341|NCT01966484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64889342|NCT01966484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64889343|NCT01966484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889344|NCT01966484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889345|NCT01966484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64889346|NCT01966575|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64889347|NCT01966575|Medroxyprogesterone|medroxyprogesterone|mesh-list
64889348|NCT01966575|Progestins|progestins|mesh-list
64889349|NCT01966575|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64889350|NCT01966575|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64889351|NCT01966575|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64889352|NCT01966575|Contraceptive Agents|contraceptive agents|mesh-ancestor
64889353|NCT01966575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64402166|NCT01117441|Glucocorticoids|glucocorticoids|mesh-ancestor
64889354|NCT01966575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889355|NCT01966575|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64889356|NCT01966575|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64889357|NCT01966575|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64889360|NCT01966575|Hormones|hormones|mesh-ancestor
64889379|NCT01966692|Dermatologic Agents|dermatologic agents|mesh-ancestor
64889380|NCT01966692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64889381|NCT01966783|Budesonide|budesonide|mesh-list
64889382|NCT01966783|Mesalamine|mesalamine|mesh-list
64889383|NCT01966783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64889384|NCT01966783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64889385|NCT01966783|Autonomic Agents|autonomic agents|mesh-ancestor
64889386|NCT01966783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889387|NCT01966783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889388|NCT01966783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64889389|NCT01966783|Respiratory System Agents|respiratory system agents|mesh-ancestor
64889443|NCT01967199|Antimitotic Agents|antimitotic agents|mesh-ancestor
64889444|NCT01967199|Mitosis Modulators|mitosis modulators|mesh-ancestor
64889456|NCT01967264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64889457|NCT01967264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64889458|NCT01967264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889459|NCT01967368|Vaccines|vaccines|mesh-list
64889460|NCT01967368|Immunologic Factors|immunologic factors|mesh-ancestor
64889461|NCT01967368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889462|NCT01967381|Methamphetamine|methamphetamine|mesh-list
64889463|NCT01967381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64889464|NCT01967381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889465|NCT01967381|Sympathomimetics|sympathomimetics|mesh-ancestor
64889493|NCT01967472|Antiviral Agents|antiviral agents|mesh-ancestor
64889494|NCT01967472|Schistosomicides|schistosomicides|mesh-ancestor
64889495|NCT01967472|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64889496|NCT01967472|Anthelmintics|anthelmintics|mesh-ancestor
64889497|NCT01967498|Montelukast|montelukast|mesh-list
64889498|NCT01967498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64889499|NCT01967498|Respiratory System Agents|respiratory system agents|mesh-ancestor
64889500|NCT01967498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64889501|NCT01967498|Hormone Antagonists|hormone antagonists|mesh-ancestor
64889502|NCT01967498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64889503|NCT01967498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889504|NCT01967498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64889505|NCT01967498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64889506|NCT01967498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889507|NCT01967524|Ropivacaine|ropivacaine|mesh-list
64889508|NCT01967524|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64889509|NCT01967524|Botulinum Toxins|botulinum toxins|mesh-list
64889510|NCT01967524|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64889511|NCT01967524|Anesthetics, Local|anesthetics, local|mesh-ancestor
64889512|NCT01967524|Anesthetics|anesthetics|mesh-ancestor
64889513|NCT01967524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64889514|NCT01967524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889515|NCT01967524|Sensory System Agents|sensory system agents|mesh-ancestor
64889516|NCT01967524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889517|NCT01967524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64889518|NCT01967524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64889519|NCT01967524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889520|NCT01967524|Cholinergic Agents|cholinergic agents|mesh-ancestor
64889524|NCT01967758|Amoxicillin|amoxicillin|mesh-list
64889536|NCT01967758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889537|NCT01967758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64557556|NCT04405193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64889538|NCT01967758|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64889539|NCT01967758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64889540|NCT01967758|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64889541|NCT01967823|Aldesleukin|aldesleukin|mesh-list
64889542|NCT01967823|Cyclophosphamide|cyclophosphamide|mesh-list
64889543|NCT01967823|Fludarabine|fludarabine|mesh-list
64889544|NCT01967823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64889545|NCT01967823|Immunologic Factors|immunologic factors|mesh-ancestor
64889589|NCT01967979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64889590|NCT01967979|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64889591|NCT01968005|Etodolac|etodolac|mesh-list
64889592|NCT01968005|Lidocaine|lidocaine|mesh-list
64889593|NCT01968005|Anesthetics, Local|anesthetics, local|mesh-ancestor
64889594|NCT01968005|Anesthetics|anesthetics|mesh-ancestor
64889595|NCT01968005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64889596|NCT01968005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889597|NCT01968005|Sensory System Agents|sensory system agents|mesh-ancestor
64889598|NCT01968005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889599|NCT01968005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64889600|NCT01968005|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64889601|NCT01968005|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64889602|NCT01968005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64889603|NCT01968005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889748|NCT01969019|Prednisolone|prednisolone|mesh-list
64889749|NCT01969019|Prednisolone acetate|prednisolone acetate|mesh-list
64889750|NCT01969019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64889751|NCT01969019|Prednisolone phosphate|prednisolone phosphate|mesh-list
64889752|NCT01969019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64889753|NCT01969019|Glucocorticoids|glucocorticoids|mesh-ancestor
64889755|NCT01969019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64889756|NCT01969019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64889757|NCT01969019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64889758|NCT01969019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889759|NCT01969019|Antiemetics|antiemetics|mesh-ancestor
64889760|NCT01969019|Autonomic Agents|autonomic agents|mesh-ancestor
64658306|NCT05296460|Dapsone|dapsone|mesh-list
64889761|NCT01969019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64889762|NCT01969019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64889763|NCT01969019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64889764|NCT01969019|Protective Agents|protective agents|mesh-ancestor
64371422|NCT03303677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64371423|NCT03303677|Autonomic Agents|autonomic agents|mesh-ancestor
64371424|NCT03303677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371425|NCT03303677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371426|NCT03303677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64889945|NCT01970059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64889948|NCT01970059|Vasodilator Agents|vasodilator agents|mesh-ancestor
64889996|NCT01970553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64889997|NCT01970553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64889998|NCT01970553|Antiviral Agents|antiviral agents|mesh-ancestor
64889999|NCT01970553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64890000|NCT01970553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890001|NCT01970553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64890002|NCT01970553|Immunologic Factors|immunologic factors|mesh-ancestor
64402229|NCT03511625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64402230|NCT03511625|Antiemetics|antiemetics|mesh-ancestor
64402231|NCT03511625|Autonomic Agents|autonomic agents|mesh-ancestor
64890003|NCT01970553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890062|NCT01971268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64890063|NCT01971268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64890064|NCT01971268|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64890065|NCT01971268|Histamine Antagonists|histamine antagonists|mesh-ancestor
64890066|NCT01971268|Histamine Agents|histamine agents|mesh-ancestor
64890067|NCT01971268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64371428|NCT03303677|Glucocorticoids|glucocorticoids|mesh-ancestor
64371429|NCT03303677|Hormones|hormones|mesh-ancestor
64371431|NCT03303677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64890119|NCT01971515|Trastuzumab|trastuzumab|mesh-list
64890120|NCT01971515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64890121|NCT01971515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890122|NCT01971515|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64890123|NCT01971515|Hormone Antagonists|hormone antagonists|mesh-ancestor
64890124|NCT01971515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64890125|NCT01971515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890126|NCT01971515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64890127|NCT01971515|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64890128|NCT01971515|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64890129|NCT01971515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64890130|NCT01971606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64890131|NCT01971606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64890132|NCT01971606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64890133|NCT01971606|Antimetabolites|antimetabolites|mesh-ancestor
64890134|NCT01971606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890135|NCT01971606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64658685|NCT02499081|Ixazomib|ixazomib|mesh-list
64890136|NCT01971606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64890137|NCT01971606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890138|NCT01971632|Oxycodone|oxycodone|mesh-list
64890168|NCT01971658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64890169|NCT01971658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64890170|NCT01971658|Leprostatic Agents|leprostatic agents|mesh-ancestor
64890171|NCT01971658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64890172|NCT01971658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64890173|NCT01971658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64890174|NCT01971658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64890175|NCT01971658|Growth Substances|growth substances|mesh-ancestor
64890176|NCT01971658|Growth Inhibitors|growth inhibitors|mesh-ancestor
64890177|NCT01971684|Mycophenolic Acid|mycophenolic acid|mesh-list
64890178|NCT01971684|Sirolimus|sirolimus|mesh-list
64890179|NCT01971684|Mercaptopurine|mercaptopurine|mesh-list
64890231|NCT01972230|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64890232|NCT01972230|Anesthetics, General|anesthetics, general|mesh-ancestor
64890233|NCT01972230|Anesthetics|anesthetics|mesh-ancestor
64890234|NCT01972230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64890235|NCT01972230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64890236|NCT01972269|Lidocaine|lidocaine|mesh-list
64890237|NCT01972269|Fentanyl|fentanyl|mesh-list
64890238|NCT01972269|Bupivacaine|bupivacaine|mesh-list
64890298|NCT01972763|Growth Inhibitors|growth inhibitors|mesh-ancestor
64371437|NCT03303677|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64371438|NCT03303677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64371439|NCT03303677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64890357|NCT01973114|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64402311|NCT02630693|Tamoxifen|tamoxifen|mesh-list
64402312|NCT02630693|Fulvestrant|fulvestrant|mesh-list
64402313|NCT02630693|Palbociclib|palbociclib|mesh-list
64890359|NCT01973140|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64890417|NCT01973660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64890418|NCT01973660|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64890419|NCT01973660|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64890420|NCT01973660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64890421|NCT01973660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64890423|NCT01973751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64890424|NCT01973751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64890425|NCT01973751|Autonomic Agents|autonomic agents|mesh-ancestor
64890426|NCT01973751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64890427|NCT01973751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890428|NCT01973751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64890429|NCT01973751|Respiratory System Agents|respiratory system agents|mesh-ancestor
64890430|NCT01973751|Glucocorticoids|glucocorticoids|mesh-ancestor
64890431|NCT01973751|Hormones|hormones|mesh-ancestor
64890432|NCT01973751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64890433|NCT01973790|Z 338|z 338|mesh-list
64890434|NCT01973790|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64658986|NCT01154192|Dexamethasone|dexamethasone|mesh-list
64890435|NCT01973790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890436|NCT01973790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371445|NCT03303677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64890540|NCT01974336|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64890541|NCT01974336|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64890542|NCT01974336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64890544|NCT01974375|Micafungin|micafungin|mesh-list
64890545|NCT01974375|Antifungal Agents|antifungal agents|mesh-ancestor
64890546|NCT01974375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64890547|NCT01974375|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64890583|NCT01974648|Anesthetics|anesthetics|mesh-ancestor
64890584|NCT01974648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64890585|NCT01974648|Narcotics|narcotics|mesh-ancestor
64890586|NCT01974648|Analgesics|analgesics|mesh-ancestor
64659127|NCT03010670|Oxytocin|oxytocin|mesh-list
64890587|NCT01974648|Sensory System Agents|sensory system agents|mesh-ancestor
64890588|NCT01974648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64447216|NCT01502644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64447217|NCT01502644|Narcotics|narcotics|mesh-ancestor
64890661|NCT01975363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64890662|NCT01975363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64890663|NCT01975363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890664|NCT01975363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890665|NCT01975363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890666|NCT01975441|Ivermectin|ivermectin|mesh-list
64890667|NCT01975441|Albendazole|albendazole|mesh-list
64890668|NCT01975441|Diethylcarbamazine|diethylcarbamazine|mesh-list
64890669|NCT01975441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64890670|NCT01975441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64890671|NCT01975441|Anthelmintics|anthelmintics|mesh-ancestor
64890672|NCT01975441|Anticestodal Agents|anticestodal agents|mesh-ancestor
64890673|NCT01975441|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64890674|NCT01975441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64890675|NCT01975441|Tubulin Modulators|tubulin modulators|mesh-ancestor
64890676|NCT01975441|Antimitotic Agents|antimitotic agents|mesh-ancestor
64402349|NCT01916824|Sertraline|sertraline|mesh-list
64890677|NCT01975441|Mitosis Modulators|mitosis modulators|mesh-ancestor
64890680|NCT01975441|Filaricides|filaricides|mesh-ancestor
64890689|NCT01975454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64890690|NCT01975480|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64890691|NCT01975480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64890692|NCT01975480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64890693|NCT01975480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64890694|NCT01975480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890695|NCT01975480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64447241|NCT01462318|Anesthetics|anesthetics|mesh-ancestor
64890872|NCT01976936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64890873|NCT01976936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890875|NCT01977118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64890876|NCT01977118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64890877|NCT01977118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890878|NCT01977209|Gossypol|gossypol|mesh-list
64890879|NCT01977209|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64371456|NCT02468063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371458|NCT02468063|Sympathomimetics|sympathomimetics|mesh-ancestor
64890889|NCT01977300|Valproic Acid|valproic acid|mesh-list
64890890|NCT01977300|Olanzapine|olanzapine|mesh-list
64890892|NCT01977300|Lithium Carbonate|lithium carbonate|mesh-list
64890893|NCT01977300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64890894|NCT01977300|Serotonin Agents|serotonin agents|mesh-ancestor
64890895|NCT01977300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64890896|NCT01977300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890897|NCT01977300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890898|NCT01977300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64890899|NCT01977300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64890900|NCT01977300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64890901|NCT01977300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64890902|NCT01977300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64890903|NCT01977300|Dopamine Agents|dopamine agents|mesh-ancestor
64890904|NCT01977300|Antiemetics|antiemetics|mesh-ancestor
64890905|NCT01977300|Autonomic Agents|autonomic agents|mesh-ancestor
64890906|NCT01977300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64890907|NCT01977300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64890908|NCT01977300|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64890948|NCT01977430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890949|NCT01977430|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64890950|NCT01977430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64890951|NCT01977430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890952|NCT01977430|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64890953|NCT01977443|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64890954|NCT01977443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64890955|NCT01977859|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64890956|NCT01977859|Natriuretic Agents|natriuretic agents|mesh-ancestor
64890957|NCT01977859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890958|NCT01977989|Vancomycin|vancomycin|mesh-list
64890959|NCT01977989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64890960|NCT01977989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64890961|NCT01978015|Timolol|timolol|mesh-list
64890962|NCT01978015|Bimatoprost|bimatoprost|mesh-list
64890963|NCT01978015|Travoprost|travoprost|mesh-list
64890964|NCT01978015|Dextrans|dextrans|mesh-list
64890965|NCT01978015|Latanoprost|latanoprost|mesh-list
64890966|NCT01978015|Maleic acid|maleic acid|mesh-list
64890967|NCT01978015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64890968|NCT01978015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64890969|NCT01978015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64890970|NCT01978015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64890971|NCT01978015|Adrenergic Agents|adrenergic agents|mesh-ancestor
64890972|NCT01978015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64890973|NCT01978015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64890974|NCT01978015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64890975|NCT01978015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64402364|NCT01916824|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64402365|NCT01916824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64890976|NCT01978015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64890977|NCT01978015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64890978|NCT01978015|Anticoagulants|anticoagulants|mesh-ancestor
64890979|NCT01978015|Plasma Substitutes|plasma substitutes|mesh-ancestor
64890980|NCT01978015|Blood Substitutes|blood substitutes|mesh-ancestor
64890981|NCT01978041|Fluorides|fluorides|mesh-list
64890989|NCT01978301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64890990|NCT01978301|Glucocorticoids|glucocorticoids|mesh-ancestor
64890991|NCT01978301|Hormones|hormones|mesh-ancestor
64890992|NCT01978301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64447301|NCT02132312|Phenylephrine|phenylephrine|mesh-list
64891061|NCT01978678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64891115|NCT01979341|Luteolytic Agents|luteolytic agents|mesh-ancestor
64891116|NCT01979341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64891117|NCT01979341|Contraceptive Agents|contraceptive agents|mesh-ancestor
64891121|NCT01979341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891186|NCT01979679|Serotonin Agents|serotonin agents|mesh-ancestor
64891187|NCT01979679|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64891188|NCT01979679|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64891189|NCT01979679|Dopamine Agents|dopamine agents|mesh-ancestor
64891191|NCT01979965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64891192|NCT01979965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64891193|NCT01979965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891194|NCT01980004|Potassium Citrate|potassium citrate|mesh-list
64891195|NCT01980004|Diuretics|diuretics|mesh-ancestor
64891196|NCT01980004|Natriuretic Agents|natriuretic agents|mesh-ancestor
64891197|NCT01980004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891198|NCT01980004|Expectorants|expectorants|mesh-ancestor
64891199|NCT01980004|Respiratory System Agents|respiratory system agents|mesh-ancestor
64891249|NCT01980407|Protective Agents|protective agents|mesh-ancestor
64891250|NCT01980407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891251|NCT01980407|Vitamin B Complex|vitamin b complex|mesh-ancestor
64891253|NCT01980407|Micronutrients|micronutrients|mesh-ancestor
64891254|NCT01980472|Paclitaxel|paclitaxel|mesh-list
64891255|NCT01980472|Bevacizumab|bevacizumab|mesh-list
64891256|NCT01980472|Carboplatin|carboplatin|mesh-list
64891257|NCT01980472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64891258|NCT01980472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891259|NCT01980472|Tubulin Modulators|tubulin modulators|mesh-ancestor
64891260|NCT01980472|Antimitotic Agents|antimitotic agents|mesh-ancestor
64891261|NCT01980472|Mitosis Modulators|mitosis modulators|mesh-ancestor
64891262|NCT01980472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891263|NCT01980472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64891264|NCT01980472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64659797|NCT01229462|Timolol|timolol|mesh-list
64891265|NCT01980472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64891266|NCT01980472|Growth Substances|growth substances|mesh-ancestor
64891267|NCT01980472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891313|NCT01980745|Analgesics|analgesics|mesh-ancestor
64891314|NCT01980745|Sensory System Agents|sensory system agents|mesh-ancestor
64891315|NCT01980745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64891316|NCT01980745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891317|NCT01980745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64891318|NCT01980745|Filaricides|filaricides|mesh-ancestor
64891356|NCT01981278|Adrenergic Agents|adrenergic agents|mesh-ancestor
64891357|NCT01981278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64891358|NCT01981291|Anesthetics|anesthetics|mesh-list
64891359|NCT01981291|Mepivacaine|mepivacaine|mesh-list
64891360|NCT01981291|Anesthetics, Local|anesthetics, local|mesh-list
64891361|NCT01981291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64891362|NCT01981291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891363|NCT01981291|Sensory System Agents|sensory system agents|mesh-ancestor
64891364|NCT01981291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64891365|NCT01981330|Hyaluronic Acid|hyaluronic acid|mesh-list
64891366|NCT01981330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64891367|NCT01981330|Immunologic Factors|immunologic factors|mesh-ancestor
64891368|NCT01981330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891369|NCT01981330|Viscosupplements|viscosupplements|mesh-ancestor
64891417|NCT01981707|Nootropic Agents|nootropic agents|mesh-ancestor
64891418|NCT01981746|Ropivacaine|ropivacaine|mesh-list
64891419|NCT01981746|Anesthetics, Local|anesthetics, local|mesh-ancestor
64891421|NCT01981746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64891422|NCT01981746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891423|NCT01981746|Sensory System Agents|sensory system agents|mesh-ancestor
64891424|NCT01981746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64891425|NCT01981811|Aripiprazole|aripiprazole|mesh-list
64891426|NCT01981811|Antidepressive Agents|antidepressive agents|mesh-ancestor
64891427|NCT01981811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64891428|NCT01981811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64891429|NCT01981811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64891430|NCT01981811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64891431|NCT01981811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891433|NCT01981811|Dopamine Agents|dopamine agents|mesh-ancestor
64891478|NCT01982201|Gout Suppressants|gout suppressants|mesh-ancestor
64891479|NCT01982201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64891480|NCT01982201|Uricosuric Agents|uricosuric agents|mesh-ancestor
64891481|NCT01982201|Renal Agents|renal agents|mesh-ancestor
64891482|NCT01982396|Lamivudine|lamivudine|mesh-list
64891483|NCT01982396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64891484|NCT01982396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64891485|NCT01982396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64891582|NCT01983124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891583|NCT01983124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64891584|NCT01983124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64891585|NCT01983124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891586|NCT01983137|Oxycodone|oxycodone|mesh-list
64891587|NCT01983137|Naloxone|naloxone|mesh-list
64891588|NCT01983137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64891589|NCT01983137|Narcotics|narcotics|mesh-ancestor
64891590|NCT01983137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64891592|NCT01983137|Analgesics|analgesics|mesh-ancestor
64891631|NCT01983514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64891632|NCT01983514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891633|NCT01983527|Methylprednisolone|methylprednisolone|mesh-list
64891634|NCT01983527|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64891635|NCT01983527|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64891636|NCT01983527|Prednisolone|prednisolone|mesh-list
64891637|NCT01983527|Prednisolone acetate|prednisolone acetate|mesh-list
64891638|NCT01983527|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64402402|NCT01618708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402403|NCT02229149|Paclitaxel|paclitaxel|mesh-list
64402405|NCT02229149|Docetaxel|docetaxel|mesh-list
64891639|NCT01983527|Prednisolone phosphate|prednisolone phosphate|mesh-list
64891640|NCT01983527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64891641|NCT01983527|Antiemetics|antiemetics|mesh-ancestor
64891642|NCT01983527|Autonomic Agents|autonomic agents|mesh-ancestor
64891643|NCT01983527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64891644|NCT01983527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891645|NCT01983527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64891646|NCT01983527|Glucocorticoids|glucocorticoids|mesh-ancestor
64891647|NCT01983527|Hormones|hormones|mesh-ancestor
64891648|NCT01983527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64891649|NCT01983527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64891650|NCT01983527|Protective Agents|protective agents|mesh-ancestor
64891651|NCT01983527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64891652|NCT01983527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64891653|NCT01983540|Vaccines|vaccines|mesh-list
64891654|NCT01983540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64891655|NCT01983540|Immunologic Factors|immunologic factors|mesh-ancestor
64891656|NCT01983540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891682|NCT01983761|Fludarabine phosphate|fludarabine phosphate|mesh-list
64891683|NCT01983761|Melphalan|melphalan|mesh-list
64371470|NCT03303209|Analgesics|analgesics|mesh-ancestor
64371471|NCT03303209|Sensory System Agents|sensory system agents|mesh-ancestor
64891684|NCT01983761|Busulfan|busulfan|mesh-list
64891685|NCT01983761|Clofarabine|clofarabine|mesh-list
64891686|NCT01983761|Tacrolimus|tacrolimus|mesh-list
64891878|NCT01984931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64891879|NCT01984931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64891882|NCT01984931|Anticonvulsants|anticonvulsants|mesh-ancestor
64891883|NCT01984931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64891884|NCT01984931|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64891885|NCT01984931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64891886|NCT01985061|Busulfan|busulfan|mesh-list
64891887|NCT01985061|Alkylating Agents|alkylating agents|mesh-ancestor
64891888|NCT01985061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64891889|NCT01985061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64891890|NCT01985061|Immunologic Factors|immunologic factors|mesh-ancestor
64891891|NCT01985061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64891892|NCT01985061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64891893|NCT01985061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371478|NCT03303053|Hormones|hormones|mesh-ancestor
64371511|NCT03302585|Ergocalciferols|ergocalciferols|mesh-list
64447376|NCT02147132|Varenicline|varenicline|mesh-list
64371512|NCT03302585|Cholecalciferol|cholecalciferol|mesh-list
64371513|NCT03302585|Vitamins|vitamins|mesh-list
64371514|NCT03302585|Micronutrients|micronutrients|mesh-ancestor
64892059|NCT01985893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64892060|NCT01985893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64892061|NCT01985893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64892062|NCT01985893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64892063|NCT01985893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892065|NCT01986036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64892174|NCT01986582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64402445|NCT01750073|Immunoglobulins|immunoglobulins|mesh-list
64892175|NCT01986582|Protective Agents|protective agents|mesh-ancestor
64892176|NCT01986608|Lacosamide|lacosamide|mesh-list
64892177|NCT01986608|Anticonvulsants|anticonvulsants|mesh-ancestor
64892182|NCT01986660|Ibuprofen|ibuprofen|mesh-list
64892230|NCT01986894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64892680|NCT01990781|Dexamethasone acetate|dexamethasone acetate|mesh-list
64892681|NCT01990781|Lidocaine|lidocaine|mesh-list
64892682|NCT01990781|BB 1101|bb 1101|mesh-list
64892683|NCT01990781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64892684|NCT01990781|Antiemetics|antiemetics|mesh-ancestor
64892685|NCT01990781|Autonomic Agents|autonomic agents|mesh-ancestor
64892686|NCT01990781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64892687|NCT01990781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892688|NCT01990781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64892689|NCT01990781|Glucocorticoids|glucocorticoids|mesh-ancestor
64892690|NCT01990781|Hormones|hormones|mesh-ancestor
64892691|NCT01990781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64892692|NCT01990781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64892693|NCT01990781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64892694|NCT01990781|Protease Inhibitors|protease inhibitors|mesh-ancestor
64892695|NCT01990781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64892696|NCT01990781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892697|NCT01990781|Anesthetics, Local|anesthetics, local|mesh-ancestor
64892698|NCT01990781|Anesthetics|anesthetics|mesh-ancestor
64892699|NCT01990781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64892725|NCT01990937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64892726|NCT01990937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64892727|NCT01990937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64892728|NCT01990937|Anesthetics, General|anesthetics, general|mesh-ancestor
64892729|NCT01990937|Anesthetics|anesthetics|mesh-ancestor
64892730|NCT01990937|GABA Modulators|gaba modulators|mesh-ancestor
64892731|NCT01990937|GABA Agents|gaba agents|mesh-ancestor
64892732|NCT01990937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64892733|NCT01990937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892916|NCT01992211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64892918|NCT01992211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64892919|NCT01992211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64892920|NCT01992263|Vitamin D|vitamin d|mesh-list
64892921|NCT01992263|Ergocalciferols|ergocalciferols|mesh-list
64892922|NCT01992263|Cholecalciferol|cholecalciferol|mesh-list
64892923|NCT01992263|Vitamins|vitamins|mesh-list
64892924|NCT01992263|Micronutrients|micronutrients|mesh-ancestor
64892925|NCT01992263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64892926|NCT01992263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64892927|NCT01992263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64892928|NCT01992328|Immunoglobulins|immunoglobulins|mesh-list
64892929|NCT01992328|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64893093|NCT01993537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64893094|NCT01993589|Acetaminophen|acetaminophen|mesh-list
64893095|NCT01993589|Analgesics|analgesics|mesh-list
64893096|NCT01993589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64893097|NCT01993589|Sensory System Agents|sensory system agents|mesh-ancestor
64893098|NCT01993589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893099|NCT01993589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893100|NCT01993589|Antipyretics|antipyretics|mesh-ancestor
64893101|NCT01993680|Fludrocortisone|fludrocortisone|mesh-list
64893102|NCT01993680|Bromides|bromides|mesh-list
64893103|NCT01993680|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
64402466|NCT03118037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64893104|NCT01993680|Anticonvulsants|anticonvulsants|mesh-ancestor
64893105|NCT01993680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64893106|NCT01993680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64893107|NCT01993680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893108|NCT01993680|Cholinergic Agents|cholinergic agents|mesh-ancestor
64893109|NCT01993680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64893110|NCT01993680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893111|NCT01993680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64893112|NCT01993771|Anesthetics|anesthetics|mesh-list
64893113|NCT01993771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64893131|NCT01994031|Paclitaxel|paclitaxel|mesh-list
64371703|NCT02467517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64371704|NCT02467517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64371705|NCT02467517|Tocolytic Agents|tocolytic agents|mesh-ancestor
64371706|NCT02467517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64371707|NCT02467673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64371708|NCT02467673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64371710|NCT02467673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64893152|NCT01994265|Anticoagulants|anticoagulants|mesh-ancestor
64893153|NCT01994265|Antithrombins|antithrombins|mesh-ancestor
64893154|NCT01994265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64893155|NCT01994265|Protease Inhibitors|protease inhibitors|mesh-ancestor
64893156|NCT01994265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64893157|NCT01994265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893158|NCT01994330|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64893160|NCT01994330|Coagulants|coagulants|mesh-ancestor
64893161|NCT01994330|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64893162|NCT01994330|Natriuretic Agents|natriuretic agents|mesh-ancestor
64893163|NCT01994330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893164|NCT01994356|Contraceptive Agents|contraceptive agents|mesh-list
64893167|NCT01994460|Linezolid|linezolid|mesh-list
64893172|NCT01994460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64893173|NCT01994460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893174|NCT01994460|Antitubercular Agents|antitubercular agents|mesh-ancestor
64893175|NCT01994642|Ciprofloxacin|ciprofloxacin|mesh-list
64893176|NCT01994642|Dexamethasone|dexamethasone|mesh-list
64893177|NCT01994642|Dexamethasone acetate|dexamethasone acetate|mesh-list
64893178|NCT01994642|BB 1101|bb 1101|mesh-list
64893179|NCT01994642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64893180|NCT01994642|Antiemetics|antiemetics|mesh-ancestor
64893181|NCT01994642|Autonomic Agents|autonomic agents|mesh-ancestor
64893182|NCT01994642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893183|NCT01994642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893184|NCT01994642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64893185|NCT01994642|Glucocorticoids|glucocorticoids|mesh-ancestor
64893186|NCT01994642|Hormones|hormones|mesh-ancestor
64893187|NCT01994642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64893188|NCT01994642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64371741|NCT05725031|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64371742|NCT05725031|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64371746|NCT05725031|Sympathomimetics|sympathomimetics|mesh-ancestor
64893282|NCT01995019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64893283|NCT01995019|Antiemetics|antiemetics|mesh-ancestor
64893284|NCT01995019|Autonomic Agents|autonomic agents|mesh-ancestor
64893285|NCT01995019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893286|NCT01995019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893337|NCT01995292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893338|NCT01995292|Sensory System Agents|sensory system agents|mesh-ancestor
64893339|NCT01995292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893340|NCT01995331|Cyclosporine|cyclosporine|mesh-list
64893341|NCT01995331|Cyclophosphamide|cyclophosphamide|mesh-list
64893342|NCT01995331|Cyclosporins|cyclosporins|mesh-list
64893343|NCT01995331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64893729|NCT01997801|Analgesics|analgesics|mesh-ancestor
64893730|NCT01997801|Sensory System Agents|sensory system agents|mesh-ancestor
64893731|NCT01997801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893732|NCT01997801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402503|NCT02875223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64893733|NCT01997801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64893734|NCT01997801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64893735|NCT01997801|Anesthetics, General|anesthetics, general|mesh-ancestor
64893736|NCT01997801|Anesthetics|anesthetics|mesh-ancestor
64893737|NCT01997801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64371926|NCT02466347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371927|NCT02466347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64371928|NCT02466347|Respiratory System Agents|respiratory system agents|mesh-ancestor
64371929|NCT02466347|Dermatologic Agents|dermatologic agents|mesh-ancestor
64371930|NCT02466347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64371962|NCT03067701|Carbon Monoxide|carbon monoxide|mesh-list
64893770|NCT01998126|Ipilimumab|ipilimumab|mesh-list
64893771|NCT01998126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64893772|NCT01998126|Crizotinib|crizotinib|mesh-list
64893773|NCT01998126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64893774|NCT01998126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64893775|NCT01998126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64893776|NCT01998126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893777|NCT01998126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64893778|NCT01998126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64893779|NCT01998165|Remifentanil|remifentanil|mesh-list
64893780|NCT01998165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64893781|NCT01998165|Narcotics|narcotics|mesh-ancestor
64893782|NCT01998165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64893783|NCT01998165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893784|NCT01998165|Analgesics|analgesics|mesh-ancestor
64893785|NCT01998165|Sensory System Agents|sensory system agents|mesh-ancestor
64893786|NCT01998165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893787|NCT01998217|Flurbiprofen|flurbiprofen|mesh-list
64893821|NCT01998347|Antimitotic Agents|antimitotic agents|mesh-ancestor
64893822|NCT01998347|Mitosis Modulators|mitosis modulators|mesh-ancestor
64893823|NCT01998347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893824|NCT01998347|Antimetabolites|antimetabolites|mesh-ancestor
64893825|NCT01998347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64402523|NCT02621021|Aldesleukin|aldesleukin|mesh-list
64893826|NCT01998347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64893827|NCT01998347|Immunologic Factors|immunologic factors|mesh-ancestor
64893828|NCT01998347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893829|NCT01998386|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64893830|NCT01998386|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64372005|NCT05546411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64372007|NCT05542589|Anticonvulsants|anticonvulsants|mesh-ancestor
64447764|NCT01631825|Rotigotine|rotigotine|mesh-list
64893934|NCT01999153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64893936|NCT01999270|Irinotecan|irinotecan|mesh-list
64893937|NCT01999270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64893938|NCT01999270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64893939|NCT01999270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64893940|NCT01999270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64893941|NCT01999270|Growth Substances|growth substances|mesh-ancestor
64893942|NCT01999270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64893943|NCT01999270|Growth Inhibitors|growth inhibitors|mesh-ancestor
64893944|NCT01999270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64893945|NCT01999270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64893946|NCT01999270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64893947|NCT01999270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64893948|NCT01999309|Simvastatin|simvastatin|mesh-list
64893949|NCT01999309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64893990|NCT01999686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64372038|NCT03069027|Mydriatics|mydriatics|mesh-ancestor
64894049|NCT02000206|Anesthetics|anesthetics|mesh-ancestor
64894050|NCT02000206|Analgesics|analgesics|mesh-ancestor
64894051|NCT02000206|Sensory System Agents|sensory system agents|mesh-ancestor
64894052|NCT02000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894053|NCT02000206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64894054|NCT02000206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64894055|NCT02000206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64894056|NCT02000206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64894057|NCT02000206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894103|NCT02000674|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64894104|NCT02000674|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64894105|NCT02000674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64894106|NCT02000674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64894107|NCT02000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894108|NCT02000674|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
64894170|NCT02001168|Pemetrexed|pemetrexed|mesh-list
64894171|NCT02001168|Cisplatin|cisplatin|mesh-list
64894172|NCT02001168|Endostatins|endostatins|mesh-list
64894173|NCT02001168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372053|NCT02720081|Hormone Antagonists|hormone antagonists|mesh-ancestor
64372054|NCT02720081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64894221|NCT02001298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64894222|NCT02001298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894223|NCT02001298|Analgesics|analgesics|mesh-ancestor
64894224|NCT02001298|Sensory System Agents|sensory system agents|mesh-ancestor
64894225|NCT02001298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64402599|NCT02102789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64402601|NCT02102789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64894226|NCT02001298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64894227|NCT02001298|Vasodilator Agents|vasodilator agents|mesh-ancestor
64894228|NCT02001298|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64894229|NCT02001298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894230|NCT02001311|Chlorhexidine|chlorhexidine|mesh-list
64894231|NCT02001311|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64894232|NCT02001311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64894233|NCT02001311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64894234|NCT02001311|Disinfectants|disinfectants|mesh-ancestor
64894235|NCT02001311|Dermatologic Agents|dermatologic agents|mesh-ancestor
64894236|NCT02001363|Liraglutide|liraglutide|mesh-list
64894237|NCT02001363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64894238|NCT02001363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894239|NCT02001363|Incretins|incretins|mesh-ancestor
64894274|NCT02001584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894275|NCT02001584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894276|NCT02001584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64894277|NCT02001584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64894495|NCT02002442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64372092|NCT05634525|Adagrasib|adagrasib|mesh-list
64894610|NCT02003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64894612|NCT02003001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64894613|NCT02003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894614|NCT02003209|Carboplatin|carboplatin|mesh-list
64894615|NCT02003209|Docetaxel|docetaxel|mesh-list
64894616|NCT02003209|Trastuzumab|trastuzumab|mesh-list
64894617|NCT02003209|Pertuzumab|pertuzumab|mesh-list
64894618|NCT02003209|Goserelin|goserelin|mesh-list
64894667|NCT02003768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64894668|NCT02003768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64894669|NCT02003768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64894672|NCT02003768|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64894673|NCT02003885|Desflurane|desflurane|mesh-list
64372144|NCT04562597|Acetylcysteine|acetylcysteine|mesh-list
64894958|NCT02005757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895009|NCT02006173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895010|NCT02006173|Sensory System Agents|sensory system agents|mesh-ancestor
64895011|NCT02006173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895012|NCT02006173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64895013|NCT02006173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64895014|NCT02006173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64895015|NCT02006173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64895016|NCT02006173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895018|NCT02006225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64895019|NCT02006225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64895020|NCT02006225|Antiviral Agents|antiviral agents|mesh-ancestor
64895021|NCT02006225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64895022|NCT02006277|Crizotinib|crizotinib|mesh-list
64895023|NCT02006277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64895024|NCT02006277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895025|NCT02006277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64895050|NCT02006589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64895051|NCT02006589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64895052|NCT02006589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64895053|NCT02006589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895054|NCT02006602|Candesartan|candesartan|mesh-list
64895055|NCT02006602|Candesartan cilexetil|candesartan cilexetil|mesh-list
64895056|NCT02006602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64372225|NCT04969991|Varespladib methyl|varespladib methyl|mesh-list
64372226|NCT04969991|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
64372227|NCT04969991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372228|NCT04969991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895122|NCT02007174|Growth Substances|growth substances|mesh-ancestor
64895123|NCT02007174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895124|NCT02007174|Growth Inhibitors|growth inhibitors|mesh-ancestor
64895126|NCT02007330|Anesthetics, Local|anesthetics, local|mesh-ancestor
64895127|NCT02007330|Anesthetics|anesthetics|mesh-ancestor
64895128|NCT02007330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64895129|NCT02007330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895130|NCT02007330|Sensory System Agents|sensory system agents|mesh-ancestor
64895131|NCT02007330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895149|NCT02007447|Oxytocin|oxytocin|mesh-list
64895150|NCT02007447|Oxytocics|oxytocics|mesh-ancestor
64895151|NCT02007447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64895152|NCT02007447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895153|NCT02007603|Amoxicillin|amoxicillin|mesh-list
64895154|NCT02007603|Clavulanic Acids|clavulanic acids|mesh-list
64372234|NCT04424225|Vitamins|vitamins|mesh-ancestor
64372235|NCT04424225|Micronutrients|micronutrients|mesh-ancestor
64372236|NCT04424225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895200|NCT02007850|Anesthetics, Local|anesthetics, local|mesh-ancestor
64895201|NCT02007850|Anesthetics|anesthetics|mesh-ancestor
64895202|NCT02007850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64895204|NCT02007850|Sensory System Agents|sensory system agents|mesh-ancestor
64895258|NCT02008019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64895259|NCT02008019|Immunologic Factors|immunologic factors|mesh-ancestor
64402869|NCT05101291|Anesthetics|anesthetics|mesh-ancestor
64402870|NCT05101291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64895260|NCT02008019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895262|NCT02008123|Anticonvulsants|anticonvulsants|mesh-ancestor
64895263|NCT02008123|GABA Modulators|gaba modulators|mesh-ancestor
64895264|NCT02008123|GABA Agents|gaba agents|mesh-ancestor
64895265|NCT02008123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64895266|NCT02008123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895267|NCT02008123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895268|NCT02008136|Botulinum Toxins|botulinum toxins|mesh-list
64372241|NCT04424225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64895269|NCT02008136|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64895270|NCT02008136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64895383|NCT02008968|Protective Agents|protective agents|mesh-ancestor
64895384|NCT02008968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895385|NCT02008981|Aspirin|aspirin|mesh-list
64895386|NCT02008981|Turmeric extract|turmeric extract|mesh-list
64895387|NCT02008981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64895388|NCT02008981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64895389|NCT02008981|Analgesics|analgesics|mesh-ancestor
64895390|NCT02008981|Sensory System Agents|sensory system agents|mesh-ancestor
64895391|NCT02008981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895392|NCT02008981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895508|NCT05778227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895509|NCT05778227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64895510|NCT05778097|Androgens|androgens|mesh-list
64895511|NCT05778097|Hormones|hormones|mesh-ancestor
64895512|NCT05778097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64895513|NCT05778097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895514|NCT05778084|Empagliflozin|empagliflozin|mesh-list
64895515|NCT05778084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64895516|NCT05778084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895517|NCT05778084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64895538|NCT05777733|Respiratory System Agents|respiratory system agents|mesh-ancestor
64895539|NCT05777733|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64895540|NCT05777707|Paclitaxel|paclitaxel|mesh-list
64895541|NCT05777707|Carboplatin|carboplatin|mesh-list
64895542|NCT05777707|Nedaplatin|nedaplatin|mesh-list
64895543|NCT05777707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64895580|NCT05777369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64895581|NCT05777369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64895582|NCT05777369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64895584|NCT05777278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895585|NCT05777278|Tubulin Modulators|tubulin modulators|mesh-ancestor
64895586|NCT05777278|Antimitotic Agents|antimitotic agents|mesh-ancestor
64895587|NCT05777278|Mitosis Modulators|mitosis modulators|mesh-ancestor
64895588|NCT05777278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895589|NCT05777122|Lidocaine|lidocaine|mesh-list
64895590|NCT05777122|Anesthetics, Local|anesthetics, local|mesh-ancestor
64895591|NCT05777122|Anesthetics|anesthetics|mesh-ancestor
64895592|NCT05777122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64895593|NCT05777122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372249|NCT05581719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372285|NCT02465645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895600|NCT05777122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895602|NCT05777109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64402935|NCT05099575|Oxytocics|oxytocics|mesh-ancestor
64895603|NCT05777109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895604|NCT05753306|Cisplatin|cisplatin|mesh-list
64895605|NCT05753306|Docetaxel|docetaxel|mesh-list
64895606|NCT05753306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895607|NCT05753306|Tubulin Modulators|tubulin modulators|mesh-ancestor
64895608|NCT05753306|Antimitotic Agents|antimitotic agents|mesh-ancestor
64895609|NCT05753306|Mitosis Modulators|mitosis modulators|mesh-ancestor
64895610|NCT05753306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895611|NCT05741086|Atorvastatin|atorvastatin|mesh-list
64895619|NCT05741086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64895624|NCT05717140|Nivolumab|nivolumab|mesh-list
64895625|NCT05717140|Sargramostim|sargramostim|mesh-list
64895626|NCT05717140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64895627|NCT05717140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895628|NCT05717140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64895629|NCT05717140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895630|NCT05717140|Immunologic Factors|immunologic factors|mesh-ancestor
64895631|NCT05717140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895632|NCT05708950|Pembrolizumab|pembrolizumab|mesh-list
64895633|NCT05708950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64895634|NCT05708950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64895635|NCT05707273|Cyclophosphamide|cyclophosphamide|mesh-list
64895636|NCT05707273|Fludarabine|fludarabine|mesh-list
64895637|NCT05707273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64895638|NCT05707273|Immunologic Factors|immunologic factors|mesh-ancestor
64895639|NCT05707273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895640|NCT05707273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64895641|NCT05707273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64664164|NCT02683707|Lidocaine|lidocaine|mesh-list
64895673|NCT05624151|Adrenergic Agents|adrenergic agents|mesh-ancestor
64895674|NCT05624151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64895675|NCT05624151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895676|NCT05624151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64895677|NCT05624151|Anticonvulsants|anticonvulsants|mesh-ancestor
64895678|NCT05624151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64895679|NCT05624151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64895680|NCT05624151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64895742|NCT05548270|Autonomic Agents|autonomic agents|mesh-ancestor
64895743|NCT05548270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64895744|NCT05548270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895745|NCT05548270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64895746|NCT05548270|Mydriatics|mydriatics|mesh-ancestor
64895747|NCT05548270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64895748|NCT05548270|Cholinergic Agents|cholinergic agents|mesh-ancestor
64895749|NCT05548270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64895807|NCT05410158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895808|NCT05291403|Erythromycin|erythromycin|mesh-list
64402979|NCT02660281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64895809|NCT05291403|Erythromycin Estolate|erythromycin estolate|mesh-list
64895810|NCT05291403|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64895811|NCT05291403|Erythromycin stearate|erythromycin stearate|mesh-list
64895812|NCT05291403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64895813|NCT05291403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64895814|NCT05291403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64895815|NCT05291403|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64895816|NCT05291403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64895817|NCT05291403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895818|NCT05279690|Colchicine|colchicine|mesh-list
64448104|NCT05131555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64895913|NCT05085873|GABA Modulators|gaba modulators|mesh-ancestor
64895914|NCT05085873|GABA Agents|gaba agents|mesh-ancestor
64372292|NCT02465645|Vasodilator Agents|vasodilator agents|mesh-ancestor
64895971|NCT04782830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64895972|NCT04782830|Adrenergic Agents|adrenergic agents|mesh-ancestor
64895973|NCT04782830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64895974|NCT04782830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896029|NCT04558281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64896030|NCT04558281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896031|NCT04558281|Sensory System Agents|sensory system agents|mesh-ancestor
64896032|NCT04558281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64896034|NCT04495855|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64896035|NCT04495855|Contraceptive Agents|contraceptive agents|mesh-ancestor
64896036|NCT04495855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64896037|NCT04495855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896038|NCT04495855|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64896039|NCT04495855|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64896040|NCT04495855|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64896041|NCT04495855|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64896042|NCT04495855|Hormone Antagonists|hormone antagonists|mesh-ancestor
64896043|NCT04495855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64896044|NCT04495855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64896045|NCT04495855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896046|NCT04461587|Pirfenidone|pirfenidone|mesh-list
64896047|NCT04461587|Analgesics|analgesics|mesh-ancestor
64896048|NCT04461587|Sensory System Agents|sensory system agents|mesh-ancestor
64896049|NCT04461587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64896052|NCT04461587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64896078|NCT04278833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64896079|NCT04278833|Respiratory System Agents|respiratory system agents|mesh-ancestor
64896080|NCT04226690|Dronabinol|dronabinol|mesh-list
64896081|NCT04226690|Hallucinogens|hallucinogens|mesh-ancestor
64896082|NCT04226690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896083|NCT04226690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64896084|NCT04226690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64896085|NCT04226690|Analgesics|analgesics|mesh-ancestor
64896086|NCT04226690|Sensory System Agents|sensory system agents|mesh-ancestor
64896087|NCT04226690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403055|NCT03061253|Cholinergic Agents|cholinergic agents|mesh-ancestor
64403056|NCT03061253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64403058|NCT05107063|Pravastatin|pravastatin|mesh-list
64896088|NCT04226690|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64896089|NCT04226690|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64896090|NCT04226690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64896091|NCT04226690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896093|NCT04226690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64896094|NCT04225065|Chlorhexidine|chlorhexidine|mesh-list
64896095|NCT04225065|Povidone-Iodine|povidone-iodine|mesh-list
64896096|NCT04225065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64896097|NCT04225065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64896098|NCT04225065|Disinfectants|disinfectants|mesh-ancestor
64896099|NCT04221087|Dexamethasone|dexamethasone|mesh-list
64896100|NCT04221087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64896101|NCT04221087|Antiemetics|antiemetics|mesh-ancestor
64896102|NCT04221087|Autonomic Agents|autonomic agents|mesh-ancestor
64896173|NCT04057898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896174|NCT04057898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64896175|NCT04057898|Vasodilator Agents|vasodilator agents|mesh-ancestor
64896176|NCT04050280|Cytarabine|cytarabine|mesh-list
64896177|NCT04050280|Cladribine|cladribine|mesh-list
64896178|NCT04050280|Gemtuzumab|gemtuzumab|mesh-list
64896179|NCT04050280|Lenograstim|lenograstim|mesh-list
64896180|NCT04050280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64896232|NCT03994731|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64896233|NCT03994731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64896234|NCT03994731|Histamine Antagonists|histamine antagonists|mesh-ancestor
64896235|NCT03994731|Histamine Agents|histamine agents|mesh-ancestor
64896237|NCT03984357|Gemcitabine|gemcitabine|mesh-list
64896279|NCT03824522|Coagulants|coagulants|mesh-ancestor
64896280|NCT03812991|Calcitonin|calcitonin|mesh-list
64896281|NCT03812991|Salmon calcitonin|salmon calcitonin|mesh-list
64896282|NCT03812991|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
64896283|NCT03812991|Katacalcin|katacalcin|mesh-list
64896284|NCT03812991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64896285|NCT03812991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896286|NCT03812991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64896406|NCT03325972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896407|NCT03325972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64896409|NCT03325972|Sensory System Agents|sensory system agents|mesh-ancestor
64896410|NCT03325972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64896411|NCT03325972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64403121|NCT04271293|Edoxaban|edoxaban|mesh-list
64403122|NCT04271293|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64896412|NCT03325972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64896413|NCT03325972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64896414|NCT03325972|Adrenergic Agents|adrenergic agents|mesh-ancestor
64896415|NCT03325972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64896416|NCT03325972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896417|NCT03319745|Pembrolizumab|pembrolizumab|mesh-list
64372324|NCT01918397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64372325|NCT01918397|Renal Agents|renal agents|mesh-ancestor
64372326|NCT01918397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64896467|NCT02726711|Trimethaphan|trimethaphan|mesh-list
64896489|NCT02725060|Sympathomimetics|sympathomimetics|mesh-ancestor
64896490|NCT02725060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64896491|NCT02725060|Nasal Decongestants|nasal decongestants|mesh-ancestor
64372333|NCT01918397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64372334|NCT02463929|Diphenhydramine|diphenhydramine|mesh-list
64448270|NCT01881789|Hormones|hormones|mesh-ancestor
64896515|NCT02649998|Diuretics|diuretics|mesh-ancestor
64896516|NCT02649998|Natriuretic Agents|natriuretic agents|mesh-ancestor
64896517|NCT02649998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896518|NCT02649998|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64896519|NCT02649998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64896524|NCT02595944|Nivolumab|nivolumab|mesh-list
64896531|NCT02503358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64896532|NCT02503358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896533|NCT02503358|Tubulin Modulators|tubulin modulators|mesh-ancestor
64896534|NCT02503358|Antimitotic Agents|antimitotic agents|mesh-ancestor
64896535|NCT02503358|Mitosis Modulators|mitosis modulators|mesh-ancestor
64896536|NCT02503358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896599|NCT02157883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64896600|NCT02157883|Hormone Antagonists|hormone antagonists|mesh-ancestor
64896601|NCT02157883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64896602|NCT02157883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896603|NCT02157883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64896604|NCT02157883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896605|NCT02157883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64896606|NCT02087826|Metformin|metformin|mesh-list
64896607|NCT02087826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64896608|NCT02087826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896609|NCT02048813|Cyclophosphamide|cyclophosphamide|mesh-list
64896610|NCT02048813|Rituximab|rituximab|mesh-list
64896611|NCT02048813|Fludarabine|fludarabine|mesh-list
64896612|NCT02048813|Fludarabine phosphate|fludarabine phosphate|mesh-list
64896613|NCT02048813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64896614|NCT02048813|Antibodies|antibodies|mesh-list
64896615|NCT02048813|Immunoglobulins|immunoglobulins|mesh-list
64896654|NCT01933932|Tubulin Modulators|tubulin modulators|mesh-ancestor
64896655|NCT01933932|Antimitotic Agents|antimitotic agents|mesh-ancestor
64896656|NCT01933932|Mitosis Modulators|mitosis modulators|mesh-ancestor
64896657|NCT01933932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896659|NCT01898494|Carboplatin|carboplatin|mesh-list
64896660|NCT01898494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896661|NCT01748448|Vitamin D|vitamin d|mesh-list
64896662|NCT01748448|Cholecalciferol|cholecalciferol|mesh-list
64896663|NCT01748448|Vitamins|vitamins|mesh-ancestor
64896664|NCT01748448|Micronutrients|micronutrients|mesh-ancestor
64896702|NCT01163357|Melphalan|melphalan|mesh-list
64896703|NCT01163357|Tacrolimus|tacrolimus|mesh-list
64896704|NCT01163357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403220|NCT04967417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64896705|NCT01163357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64896706|NCT01163357|Antimetabolites|antimetabolites|mesh-ancestor
64896707|NCT01163357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896708|NCT01163357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64896709|NCT01163357|Immunologic Factors|immunologic factors|mesh-ancestor
64896710|NCT01163357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896711|NCT01163357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64896712|NCT01163357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64896713|NCT01163357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64896714|NCT01163357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64896715|NCT01163357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64896716|NCT01163357|Antifungal Agents|antifungal agents|mesh-ancestor
64896717|NCT01163357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64896718|NCT01163357|Alkylating Agents|alkylating agents|mesh-ancestor
64896719|NCT01163357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64896720|NCT00978458|Temozolomide|temozolomide|mesh-list
64372349|NCT02463929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64372350|NCT02463929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64372395|NCT02462915|Fentanyl|fentanyl|mesh-list
64896767|NCT00600496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64896768|NCT00600496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64896769|NCT00600496|Antifungal Agents|antifungal agents|mesh-ancestor
64896770|NCT00600496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64896771|NCT00600496|Immunologic Factors|immunologic factors|mesh-ancestor
64896772|NCT00600496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896773|NCT00600496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64896774|NCT00600496|Alkylating Agents|alkylating agents|mesh-ancestor
64896775|NCT00538031|Celecoxib|celecoxib|mesh-list
64896776|NCT00538031|Cyclophosphamide|cyclophosphamide|mesh-list
64896805|NCT00203996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896806|NCT00203996|Hormones|hormones|mesh-ancestor
64896807|NCT00203996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64896808|NCT00099437|Fulvestrant|fulvestrant|mesh-list
64896809|NCT00099437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64896810|NCT00099437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64896811|NCT00099437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64896812|NCT00099437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64896813|NCT00099437|Hormone Antagonists|hormone antagonists|mesh-ancestor
64896814|NCT00099437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64896815|NCT00099437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403239|NCT02615119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896816|NCT02009280|Anesthetics|anesthetics|mesh-list
64896817|NCT02009280|Propofol|propofol|mesh-list
64896818|NCT02009280|Sevoflurane|sevoflurane|mesh-list
64896819|NCT02009280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64896865|NCT02009488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896866|NCT02009514|Dialysis Solutions|dialysis solutions|mesh-list
64896867|NCT02009514|Hemodialysis Solutions|hemodialysis solutions|mesh-list
64896868|NCT02009514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64896869|NCT02009540|Botulinum Toxins|botulinum toxins|mesh-list
64896870|NCT02009540|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64896871|NCT02009540|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64896872|NCT02009540|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64896873|NCT02009540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64896874|NCT02009540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64896875|NCT02009540|Cholinergic Agents|cholinergic agents|mesh-ancestor
64896876|NCT02009540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64896877|NCT02009540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64896878|NCT02009540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64897089|NCT02011750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64897090|NCT02011750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64897091|NCT02011750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64897092|NCT02011828|Ergocalciferols|ergocalciferols|mesh-list
64897093|NCT02011828|Vitamin D|vitamin d|mesh-list
64897094|NCT02011828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64897095|NCT02011828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897135|NCT02011958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64897136|NCT02011958|Antifungal Agents|antifungal agents|mesh-ancestor
64897137|NCT02011958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897138|NCT02012036|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64897139|NCT02012036|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64897140|NCT02012036|Dermatologic Agents|dermatologic agents|mesh-ancestor
64897141|NCT02012049|Risperidone|risperidone|mesh-list
64897142|NCT02012049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64897143|NCT02012049|Serotonin Agents|serotonin agents|mesh-ancestor
64897144|NCT02012049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64897145|NCT02012049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897146|NCT02012049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897147|NCT02012049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64897148|NCT02012049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64897150|NCT02012049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64897151|NCT02012049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64897152|NCT02012049|Dopamine Agents|dopamine agents|mesh-ancestor
64897153|NCT02012062|Nimotuzumab|nimotuzumab|mesh-list
64897154|NCT02012062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403323|NCT05110339|Ropivacaine|ropivacaine|mesh-list
64897155|NCT02012062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64897156|NCT02012075|Metoprolol|metoprolol|mesh-list
64897157|NCT02012075|Carvedilol|carvedilol|mesh-list
64897158|NCT02012075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64897159|NCT02012075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64897160|NCT02012075|Sympatholytics|sympatholytics|mesh-ancestor
64897161|NCT02012075|Autonomic Agents|autonomic agents|mesh-ancestor
64897162|NCT02012075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64897163|NCT02012075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897164|NCT02012075|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64897165|NCT02012075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64897170|NCT02012075|Antioxidants|antioxidants|mesh-ancestor
64897181|NCT02012088|Doxorubicin|doxorubicin|mesh-list
64897182|NCT02012088|Vincristine|vincristine|mesh-list
64897183|NCT02012088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64897184|NCT02012088|Immunologic Factors|immunologic factors|mesh-ancestor
64897185|NCT02012088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897186|NCT02012088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64448373|NCT02117479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64448374|NCT02117479|Antimetabolites|antimetabolites|mesh-ancestor
64448375|NCT02117479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897187|NCT02012088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64897380|NCT02013154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897381|NCT02013154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64897382|NCT02013219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64897383|NCT02013219|Atezolizumab|atezolizumab|mesh-list
64897384|NCT02013219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897421|NCT02013362|Micronutrients|micronutrients|mesh-ancestor
64897422|NCT02013362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897423|NCT02013362|Hematinics|hematinics|mesh-ancestor
64897424|NCT02013362|Vitamin B Complex|vitamin b complex|mesh-ancestor
64897425|NCT02013453|Paclitaxel|paclitaxel|mesh-list
64897426|NCT02013453|Carboplatin|carboplatin|mesh-list
64897427|NCT02013453|Fluorouracil|fluorouracil|mesh-list
64897428|NCT02013453|Pemetrexed|pemetrexed|mesh-list
64897429|NCT02013453|Omeprazole|omeprazole|mesh-list
64897430|NCT02013453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64897432|NCT02013453|Tubulin Modulators|tubulin modulators|mesh-ancestor
64403386|NCT04632589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897487|NCT02013986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64897488|NCT02013986|Anesthetics, General|anesthetics, general|mesh-ancestor
64897489|NCT02013986|Anesthetics|anesthetics|mesh-ancestor
64897490|NCT02013986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64897491|NCT02013986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64897492|NCT02013986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64897493|NCT02013986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64897494|NCT02013986|GABA Modulators|gaba modulators|mesh-ancestor
64897495|NCT02013986|GABA Agents|gaba agents|mesh-ancestor
64897496|NCT02013986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64897506|NCT02014103|Tacrolimus|tacrolimus|mesh-list
64897552|NCT02014506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897553|NCT02014506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64897554|NCT02014506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64897555|NCT02014506|Alkylating Agents|alkylating agents|mesh-ancestor
64897556|NCT02014506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897557|NCT02014506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897558|NCT02014506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64897559|NCT02014532|Montelukast|montelukast|mesh-list
64897560|NCT02014532|Leukotriene Antagonists|leukotriene antagonists|mesh-list
64897561|NCT02014532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64897562|NCT02014532|Respiratory System Agents|respiratory system agents|mesh-ancestor
64897563|NCT02014532|Hormone Antagonists|hormone antagonists|mesh-ancestor
64897564|NCT02014532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64897565|NCT02014532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897566|NCT02014532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64897567|NCT02014532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64897568|NCT02014532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897569|NCT02014545|Lucanthone|lucanthone|mesh-list
64897570|NCT02014545|Schistosomicides|schistosomicides|mesh-ancestor
64897571|NCT02014545|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64897572|NCT02014545|Anthelmintics|anthelmintics|mesh-ancestor
64897573|NCT02014545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64897574|NCT02014545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64897575|NCT02014558|Voriconazole|voriconazole|mesh-list
64897576|NCT02014558|Cephalexin|cephalexin|mesh-list
64897577|NCT02014558|Midazolam|midazolam|mesh-list
64897578|NCT02014558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64897579|NCT02014558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64897580|NCT02014558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64897581|NCT02014558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897582|NCT02014558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64897583|NCT02014558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64897667|NCT02015182|Anesthetics|anesthetics|mesh-ancestor
64897668|NCT02015182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64897681|NCT02015299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897682|NCT02015299|Incretins|incretins|mesh-ancestor
64897684|NCT02015299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64897685|NCT02015299|Protease Inhibitors|protease inhibitors|mesh-ancestor
64897686|NCT02015299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897687|NCT02015299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897688|NCT02015312|Silicon|silicon|mesh-list
64897689|NCT02015312|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
64897690|NCT02015312|Mannitol|mannitol|mesh-list
64897691|NCT02015312|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64897747|NCT02015650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897748|NCT02015650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64403483|NCT03059303|Antiviral Agents|antiviral agents|mesh-ancestor
64403484|NCT03059303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64403485|NCT03059303|Protease Inhibitors|protease inhibitors|mesh-ancestor
64897749|NCT02015650|Immunologic Factors|immunologic factors|mesh-ancestor
64666257|NCT04958811|Bevacizumab|bevacizumab|mesh-list
64897750|NCT02015650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897751|NCT02015650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64897752|NCT02015650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64897756|NCT02015728|Etoposide|etoposide|mesh-list
64897814|NCT02016209|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64897815|NCT02016209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64897816|NCT02016209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897817|NCT02016209|Tubulin Modulators|tubulin modulators|mesh-ancestor
64897818|NCT02016209|Antimitotic Agents|antimitotic agents|mesh-ancestor
64897819|NCT02016209|Mitosis Modulators|mitosis modulators|mesh-ancestor
64897820|NCT02016209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897821|NCT02016261|Fluvoxamine|fluvoxamine|mesh-list
64897822|NCT02016261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64897823|NCT02016261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64897824|NCT02016261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64897825|NCT02016261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897875|NCT02016391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64372525|NCT02462369|Protease Inhibitors|protease inhibitors|mesh-ancestor
64897897|NCT02016443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64897899|NCT02016443|Anticonvulsants|anticonvulsants|mesh-ancestor
64897928|NCT02016664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64897929|NCT02016664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897930|NCT02016664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64897931|NCT02016664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64897932|NCT02016664|Anesthetics, General|anesthetics, general|mesh-ancestor
64897933|NCT02016664|Anesthetics|anesthetics|mesh-ancestor
64897934|NCT02016664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64897935|NCT02016664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64897936|NCT02016664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64897937|NCT02016664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64897938|NCT02016664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897939|NCT02016703|Erythritol|erythritol|mesh-list
64897940|NCT02016703|Vasodilator Agents|vasodilator agents|mesh-ancestor
64897941|NCT02016729|Trametinib|trametinib|mesh-list
64897942|NCT02016729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64897943|NCT02016729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64897944|NCT02016729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897945|NCT02016729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897946|NCT02016807|Sucralfate|sucralfate|mesh-list
64897947|NCT02016807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64897948|NCT02016807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64897949|NCT02016820|Omeprazole|omeprazole|mesh-list
64897950|NCT02016820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64897951|NCT02016820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64897952|NCT02016820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64897953|NCT02016820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64897954|NCT02016820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403525|NCT01675765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64897955|NCT02016846|Liraglutide|liraglutide|mesh-list
64897956|NCT02016846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64897957|NCT02016846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897958|NCT02016846|Incretins|incretins|mesh-ancestor
64897959|NCT02016846|Hormones|hormones|mesh-ancestor
64897960|NCT02016846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64897981|NCT02016976|Narcotics|narcotics|mesh-ancestor
64897982|NCT02017119|Lactulose|lactulose|mesh-list
64897983|NCT02017119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64897984|NCT02017197|Warfarin|warfarin|mesh-list
64897985|NCT02017197|Anticoagulants|anticoagulants|mesh-ancestor
64897986|NCT02017314|Morphine|morphine|mesh-list
64897987|NCT02017314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64897988|NCT02017314|Narcotics|narcotics|mesh-ancestor
64897989|NCT02017314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64897990|NCT02017314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64897991|NCT02017314|Analgesics|analgesics|mesh-ancestor
64897992|NCT02017314|Sensory System Agents|sensory system agents|mesh-ancestor
64897993|NCT02017314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64897994|NCT02017340|Nilvadipine|nilvadipine|mesh-list
64897995|NCT02017340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64897996|NCT02017340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64897997|NCT02017340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64897998|NCT02017340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64897999|NCT02017340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64898000|NCT02017340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898001|NCT02017392|Lidocaine|lidocaine|mesh-list
64898002|NCT02017392|Anesthetics, Local|anesthetics, local|mesh-ancestor
64898011|NCT02017392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64898012|NCT02017392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898013|NCT02017405|Immunoglobulins|immunoglobulins|mesh-list
64898014|NCT02017405|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64898015|NCT02017405|Antibodies|antibodies|mesh-list
64898016|NCT02017405|Immunologic Factors|immunologic factors|mesh-ancestor
64898017|NCT02017405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898018|NCT02017457|Azacitidine|azacitidine|mesh-list
64898019|NCT02017457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64898020|NCT02017457|Antimetabolites|antimetabolites|mesh-ancestor
64898021|NCT02017457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898022|NCT02017457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898023|NCT02017457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64898024|NCT02017561|Metformin|metformin|mesh-list
64898025|NCT02017561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64898026|NCT02017561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898027|NCT02017600|Fluorouracil|fluorouracil|mesh-list
64898028|NCT02017600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898029|NCT02017600|Antimetabolites|antimetabolites|mesh-ancestor
64898030|NCT02017600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898031|NCT02017600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64898032|NCT02017600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64403680|NCT04938713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898033|NCT02017600|Immunologic Factors|immunologic factors|mesh-ancestor
64898034|NCT02017600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898035|NCT02017613|Tenalisib|tenalisib|mesh-list
64898036|NCT02017613|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
64898037|NCT02017613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64898038|NCT02017613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898039|NCT02017639|Simvastatin|simvastatin|mesh-list
64898040|NCT02017639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64898041|NCT02017639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64898042|NCT02017639|Antimetabolites|antimetabolites|mesh-ancestor
64898126|NCT02018250|Sensory System Agents|sensory system agents|mesh-ancestor
64898127|NCT02018250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898128|NCT02018276|Lidocaine|lidocaine|mesh-list
64898129|NCT02018276|Anesthetics, Local|anesthetics, local|mesh-ancestor
64898130|NCT02018276|Anesthetics|anesthetics|mesh-ancestor
64898169|NCT02018523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64898170|NCT02018523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64898172|NCT02018523|Growth Inhibitors|growth inhibitors|mesh-ancestor
64898173|NCT02018523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898174|NCT02018536|Simeprevir|simeprevir|mesh-list
64898175|NCT02018536|Antiviral Agents|antiviral agents|mesh-ancestor
64898176|NCT02018536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64898177|NCT02018536|Protease Inhibitors|protease inhibitors|mesh-ancestor
64898178|NCT02018536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64898179|NCT02018536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898180|NCT02018588|Tryptophan|tryptophan|mesh-list
64898181|NCT02018588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64372601|NCT03922139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898226|NCT02018796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64898227|NCT02018796|Contraceptive Agents|contraceptive agents|mesh-ancestor
64898228|NCT02018796|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64898229|NCT02018796|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64898230|NCT02018796|Hormone Antagonists|hormone antagonists|mesh-ancestor
64898231|NCT02018796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64898232|NCT02018796|Luteolytic Agents|luteolytic agents|mesh-ancestor
64898233|NCT02018796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64898234|NCT02018796|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64898235|NCT02018874|Gemcitabine|gemcitabine|mesh-list
64898236|NCT02018874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64898274|NCT02019056|Pyridoxine|pyridoxine|mesh-list
64898275|NCT02019056|Metadoxine|metadoxine|mesh-list
64666779|NCT02914119|Cisatracurium|cisatracurium|mesh-list
64898276|NCT02019056|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64898277|NCT02019056|Vitamin B Complex|vitamin b complex|mesh-ancestor
64898278|NCT02019056|Vitamins|vitamins|mesh-ancestor
64898279|NCT02019056|Micronutrients|micronutrients|mesh-ancestor
64898280|NCT02019056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898281|NCT02019095|Dimercaprol|dimercaprol|mesh-list
64898282|NCT02019095|Chelating Agents|chelating agents|mesh-ancestor
64898283|NCT02019095|Sequestering Agents|sequestering agents|mesh-ancestor
64403704|NCT04946825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403729|NCT04956419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898284|NCT02019095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898285|NCT02019160|Silver Nitrate|silver nitrate|mesh-list
64898286|NCT02019160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64898287|NCT02019160|Fluorides|fluorides|mesh-list
64898288|NCT02019160|Sodium Fluoride|sodium fluoride|mesh-list
64898289|NCT02019160|Cariostatic Agents|cariostatic agents|mesh-ancestor
64898290|NCT02019160|Protective Agents|protective agents|mesh-ancestor
64898291|NCT02019160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898292|NCT02019160|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64898293|NCT02019160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64898294|NCT02019186|Vitamins|vitamins|mesh-list
64898295|NCT02019186|Vitamin E|vitamin e|mesh-list
64898296|NCT02019186|Micronutrients|micronutrients|mesh-ancestor
64372613|NCT02760329|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64898297|NCT02019186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898438|NCT02020122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898439|NCT02020122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64898449|NCT02020161|Methotrexate|methotrexate|mesh-list
64898483|NCT02020213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64898484|NCT02020213|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64898485|NCT02020213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64898486|NCT02020213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64898487|NCT02020213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898488|NCT02020213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64898489|NCT02020213|Hormone Antagonists|hormone antagonists|mesh-ancestor
64898490|NCT02020213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64372706|NCT03719313|Immunologic Factors|immunologic factors|mesh-ancestor
64372707|NCT03719313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898526|NCT02020603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898528|NCT02020603|Respiratory System Agents|respiratory system agents|mesh-ancestor
64898529|NCT02020603|Mydriatics|mydriatics|mesh-ancestor
64898530|NCT02020603|Sympathomimetics|sympathomimetics|mesh-ancestor
64898531|NCT02020603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64898532|NCT02020603|Coagulants|coagulants|mesh-ancestor
64898533|NCT02020629|Lixisenatide|lixisenatide|mesh-list
64898534|NCT02020629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64898535|NCT02020629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898537|NCT02020681|Cariostatic Agents|cariostatic agents|mesh-ancestor
64898538|NCT02020681|Protective Agents|protective agents|mesh-ancestor
64898539|NCT02020681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898540|NCT02020980|Botulinum Toxins|botulinum toxins|mesh-list
64898541|NCT02020980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64898542|NCT02020980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64898543|NCT02020980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64898544|NCT02020980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64898545|NCT02020980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898546|NCT02020980|Cholinergic Agents|cholinergic agents|mesh-ancestor
64898547|NCT02020980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64898548|NCT02020980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898549|NCT02020980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64898550|NCT02020980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898572|NCT02021123|Antifungal Agents|antifungal agents|mesh-ancestor
64898573|NCT02021123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64898574|NCT02021201|Risperidone|risperidone|mesh-list
64898575|NCT02021201|Sertindole|sertindole|mesh-list
64898576|NCT02021201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64403752|NCT03100045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64403753|NCT03100045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403758|NCT04946123|Selenium|selenium|mesh-list
64403787|NCT02655679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64403788|NCT02655679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403789|NCT04936295|Fulvestrant|fulvestrant|mesh-list
64403790|NCT04936295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64898577|NCT02021201|Serotonin Agents|serotonin agents|mesh-ancestor
64898613|NCT02021240|Anesthetics, General|anesthetics, general|mesh-ancestor
64898614|NCT02021240|Anesthetics|anesthetics|mesh-ancestor
64898615|NCT02021240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64898616|NCT02021240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64898617|NCT02021240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64898618|NCT02021240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64898619|NCT02021240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898620|NCT02021409|Darbepoetin alfa|darbepoetin alfa|mesh-list
64898621|NCT02021409|Hematinics|hematinics|mesh-ancestor
64898622|NCT02021422|Fluorouracil|fluorouracil|mesh-list
64898623|NCT02021422|Oxaliplatin|oxaliplatin|mesh-list
64898624|NCT02021422|Irinotecan|irinotecan|mesh-list
64898625|NCT02021422|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64898626|NCT02021422|Antimetabolites|antimetabolites|mesh-ancestor
64898627|NCT02021422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898628|NCT02021422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64898629|NCT02021422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64898670|NCT02021851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898671|NCT02021851|Antipruritics|antipruritics|mesh-ancestor
64898672|NCT02021851|Dermatologic Agents|dermatologic agents|mesh-ancestor
64898673|NCT02021851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64898674|NCT02021851|Serotonin Agents|serotonin agents|mesh-ancestor
64403795|NCT04936295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64403796|NCT04936295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403797|NCT05114239|Timolol|timolol|mesh-list
64403798|NCT05114239|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64403799|NCT05114239|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64403800|NCT05114239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64403801|NCT05114239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64403802|NCT05114239|Adrenergic Agents|adrenergic agents|mesh-ancestor
64403803|NCT05114239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64403804|NCT05114239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403805|NCT05114239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403806|NCT05114239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64403807|NCT05114239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64403823|NCT04418999|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64403824|NCT04418999|Dexamethasone|dexamethasone|mesh-list
64403825|NCT04418999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64403826|NCT04418999|Antiemetics|antiemetics|mesh-ancestor
64403827|NCT04418999|Autonomic Agents|autonomic agents|mesh-ancestor
64403828|NCT04418999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403829|NCT04418999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403830|NCT04418999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64403831|NCT04418999|Glucocorticoids|glucocorticoids|mesh-ancestor
64898675|NCT02021851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64898676|NCT02021851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64898677|NCT02021851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64898678|NCT02021851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64898679|NCT02021851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64898680|NCT02021851|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64898681|NCT02021851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64898682|NCT02021864|Vitamin D|vitamin d|mesh-list
64898787|NCT02022527|Salicylic Acid|salicylic acid|mesh-list
64898788|NCT02022527|Salicylates|salicylates|mesh-list
64898789|NCT02022527|Warfarin|warfarin|mesh-list
64372751|NCT03502785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372754|NCT03305445|Nivolumab|nivolumab|mesh-list
64898798|NCT02022527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64898799|NCT02022527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64898800|NCT02022527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898831|NCT02022722|Glucocorticoids|glucocorticoids|mesh-ancestor
64898832|NCT02022722|Hormones|hormones|mesh-ancestor
64898833|NCT02022722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64898834|NCT02022722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64898835|NCT02022722|Immunologic Factors|immunologic factors|mesh-ancestor
64898836|NCT02022722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64898837|NCT02022722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898838|NCT02022761|Laninamivir|laninamivir|mesh-list
64898839|NCT02022761|Antiviral Agents|antiviral agents|mesh-ancestor
64898840|NCT02022761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64898841|NCT02022852|Capecitabine|capecitabine|mesh-list
64898842|NCT02022852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64898846|NCT02022917|Bevacizumab|bevacizumab|mesh-list
64898892|NCT02023086|Tropicamide|tropicamide|mesh-list
64898893|NCT02023086|Mydriatics|mydriatics|mesh-list
64898894|NCT02023086|Autonomic Agents|autonomic agents|mesh-ancestor
64898895|NCT02023086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898896|NCT02023086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898897|NCT02023086|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64898898|NCT02023086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64898903|NCT02023164|Promethazine|promethazine|mesh-list
64898962|NCT02023554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64898963|NCT02023554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64898964|NCT02023554|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64898965|NCT02023554|Respiratory System Agents|respiratory system agents|mesh-ancestor
64898966|NCT02023554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64898967|NCT02023554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64898968|NCT02023554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64898969|NCT02023554|Vasodilator Agents|vasodilator agents|mesh-ancestor
64898970|NCT02023554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64898971|NCT02023554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64898972|NCT02023554|Purinergic Agents|purinergic agents|mesh-ancestor
64898973|NCT02023554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64898974|NCT02023567|Serotonin|serotonin|mesh-list
64898983|NCT02023684|Lidocaine|lidocaine|mesh-list
64899020|NCT02023853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64899021|NCT02023853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64899022|NCT02023853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64899023|NCT02023853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64899024|NCT02023853|Vasodilator Agents|vasodilator agents|mesh-ancestor
64899025|NCT02023892|Atorvastatin|atorvastatin|mesh-list
64899026|NCT02023892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64899027|NCT02023892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64899028|NCT02023892|Antimetabolites|antimetabolites|mesh-ancestor
64899029|NCT02023892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899030|NCT02023892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64899031|NCT02023892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64899032|NCT02023892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899033|NCT02023931|Sulforaphane|sulforaphane|mesh-list
64899034|NCT02023931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64899035|NCT02023931|Protective Agents|protective agents|mesh-ancestor
64899036|NCT02023931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899037|NCT02023931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899077|NCT02024217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64899078|NCT02024217|Antimetabolites|antimetabolites|mesh-ancestor
64448616|NCT01499134|Vasodilator Agents|vasodilator agents|mesh-ancestor
64899089|NCT02024256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64899090|NCT02024256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64899091|NCT02024256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899092|NCT02024256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64899093|NCT02024256|Tocolytic Agents|tocolytic agents|mesh-ancestor
64899094|NCT02024256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64899095|NCT02024295|Choline|choline|mesh-list
64899097|NCT02024295|Lipotropic Agents|lipotropic agents|mesh-ancestor
64899129|NCT02024425|Antioxidants|antioxidants|mesh-list
64899130|NCT02024425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899131|NCT02024425|Protective Agents|protective agents|mesh-ancestor
64899132|NCT02024425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899133|NCT02024555|Azithromycin|azithromycin|mesh-list
64899134|NCT02024555|Levofloxacin|levofloxacin|mesh-list
64899136|NCT02024555|Rifampin|rifampin|mesh-list
64899137|NCT02024555|Ethambutol|ethambutol|mesh-list
64899138|NCT02024555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64899139|NCT02024555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64899140|NCT02024555|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64899141|NCT02024555|Renal Agents|renal agents|mesh-ancestor
64899142|NCT02024555|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64899143|NCT02024555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64899144|NCT02024555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899145|NCT02024555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899146|NCT02024555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899147|NCT02024555|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64899148|NCT02024555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64899149|NCT02024555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64899150|NCT02024555|Antitubercular Agents|antitubercular agents|mesh-ancestor
64899151|NCT02024555|Leprostatic Agents|leprostatic agents|mesh-ancestor
64899152|NCT02024555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64899153|NCT02024555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64899154|NCT02024555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64899155|NCT02024555|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64899156|NCT02024555|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64403893|NCT04376281|Adrenergic Agents|adrenergic agents|mesh-ancestor
64403894|NCT04376281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64403897|NCT04376281|Sympathomimetics|sympathomimetics|mesh-ancestor
64899157|NCT02024555|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64899158|NCT02024555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64899159|NCT02024568|Pregabalin|pregabalin|mesh-list
64899160|NCT02024568|Analgesics|analgesics|mesh-ancestor
64899171|NCT02024568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64899173|NCT02024594|Nitrous Oxide|nitrous oxide|mesh-list
64899174|NCT02024594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64899175|NCT02024594|Anesthetics, General|anesthetics, general|mesh-ancestor
64899176|NCT02024594|Anesthetics|anesthetics|mesh-ancestor
64899177|NCT02024594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64899178|NCT02024594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899179|NCT02024594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64899180|NCT02024594|Analgesics|analgesics|mesh-ancestor
64899181|NCT02024594|Sensory System Agents|sensory system agents|mesh-ancestor
64899182|NCT02024594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64899183|NCT02024633|Gemcitabine|gemcitabine|mesh-list
64899184|NCT02024633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64899185|NCT02024633|Antimetabolites|antimetabolites|mesh-ancestor
64899278|NCT02025192|Trastuzumab|trastuzumab|mesh-list
64899279|NCT02025192|Tucatinib|tucatinib|mesh-list
64899280|NCT02025192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64899281|NCT02025192|Antimetabolites|antimetabolites|mesh-ancestor
64899282|NCT02025192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899283|NCT02025192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899284|NCT02025192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64899285|NCT02025192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64899286|NCT02025192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899287|NCT02025218|Gefitinib|gefitinib|mesh-list
64899288|NCT02025218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899289|NCT02025218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64899290|NCT02025218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899291|NCT02025218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899292|NCT02025348|Metoprolol|metoprolol|mesh-list
64899293|NCT02025348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64899294|NCT02025348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64899295|NCT02025348|Sympatholytics|sympatholytics|mesh-ancestor
64899296|NCT02025348|Autonomic Agents|autonomic agents|mesh-ancestor
64899297|NCT02025348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64372792|NCT03742193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372793|NCT03108287|Amoxicillin|amoxicillin|mesh-list
64899333|NCT02025465|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64899334|NCT02025465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64899335|NCT02025465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64899337|NCT02025465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64899339|NCT02025465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64899368|NCT02025712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64899369|NCT02025712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899370|NCT02025712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899371|NCT02025712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64899372|NCT02025712|Hormone Antagonists|hormone antagonists|mesh-ancestor
64899373|NCT02025712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64899374|NCT02025803|Capecitabine|capecitabine|mesh-list
64899375|NCT02025803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64899376|NCT02025803|Antimetabolites|antimetabolites|mesh-ancestor
64899454|NCT02026219|Purinergic Agents|purinergic agents|mesh-ancestor
64899455|NCT02026219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64899456|NCT02026219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899457|NCT02026219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899458|NCT02026310|Metformin|metformin|mesh-list
64899459|NCT02026310|Glimepiride|glimepiride|mesh-list
64899473|NCT02026479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899474|NCT02026479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64899475|NCT02026479|Glucocorticoids|glucocorticoids|mesh-ancestor
64899476|NCT02026479|Hormones|hormones|mesh-ancestor
64899477|NCT02026479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64899478|NCT02026479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64668025|NCT01907321|Capsaicin|capsaicin|mesh-list
64899479|NCT02026479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899480|NCT02026479|Protease Inhibitors|protease inhibitors|mesh-ancestor
64899592|NCT02027103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64899593|NCT02027103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899594|NCT02027220|Dexamethasone|dexamethasone|mesh-list
64899595|NCT02027220|Cyclophosphamide|cyclophosphamide|mesh-list
64899596|NCT02027220|Bortezomib|bortezomib|mesh-list
64899597|NCT02027220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64899598|NCT02027220|Immunologic Factors|immunologic factors|mesh-ancestor
64899599|NCT02027220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899600|NCT02027220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64899601|NCT02027220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64899602|NCT02027220|Alkylating Agents|alkylating agents|mesh-ancestor
64899603|NCT02027220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899604|NCT02027220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899621|NCT02027298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899622|NCT02027298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64899623|NCT02027324|Chlorhexidine|chlorhexidine|mesh-list
64899624|NCT02027324|Povidone-Iodine|povidone-iodine|mesh-list
64899625|NCT02027324|Povidone|povidone|mesh-list
64899626|NCT02027324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64899627|NCT02027324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64899628|NCT02027324|Disinfectants|disinfectants|mesh-ancestor
64899629|NCT02027324|Plasma Substitutes|plasma substitutes|mesh-ancestor
64668145|NCT02987465|Adrenergic Agents|adrenergic agents|mesh-ancestor
64899630|NCT02027324|Blood Substitutes|blood substitutes|mesh-ancestor
64899631|NCT02027337|Cyproterone Acetate|cyproterone acetate|mesh-list
64403949|NCT05015335|Abortifacient Agents|abortifacient agents|mesh-ancestor
64403950|NCT05015335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64403951|NCT05015335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403952|NCT05015335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64403953|NCT05015335|Antimetabolites|antimetabolites|mesh-ancestor
64403954|NCT05015335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899632|NCT02027337|Drospirenone|drospirenone|mesh-list
64899684|NCT02027493|Immunologic Factors|immunologic factors|mesh-ancestor
64899685|NCT02027493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899686|NCT02027532|Vancomycin|vancomycin|mesh-list
64899687|NCT02027532|Cefazolin|cefazolin|mesh-list
64899688|NCT02027532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64899689|NCT02027532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64899690|NCT02027675|Micronutrients|micronutrients|mesh-list
64899691|NCT02027675|Trace Elements|trace elements|mesh-list
64899692|NCT02027675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899693|NCT02027753|Metformin|metformin|mesh-list
64899694|NCT02027753|Insulin Glargine|insulin glargine|mesh-list
64372894|NCT01670877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64372895|NCT01670877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64372896|NCT01670877|Hormone Antagonists|hormone antagonists|mesh-ancestor
64372914|NCT00701129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64372915|NCT00701129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64899704|NCT02027792|Analgesics|analgesics|mesh-ancestor
64899705|NCT02027792|Sensory System Agents|sensory system agents|mesh-ancestor
64899706|NCT02027792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64899707|NCT02027792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899708|NCT02027792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64899709|NCT02027792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64899710|NCT02027792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64899711|NCT02027792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899712|NCT02027792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899713|NCT02027870|Sirolimus|sirolimus|mesh-list
64899714|NCT02027870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64899715|NCT02027870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64899729|NCT02027961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64899730|NCT02027961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899731|NCT02027961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64899732|NCT02027961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899733|NCT02027961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899734|NCT02027987|Valproic Acid|valproic acid|mesh-list
64899735|NCT02027987|Anticonvulsants|anticonvulsants|mesh-ancestor
64899736|NCT02027987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899737|NCT02027987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899738|NCT02027987|GABA Agents|gaba agents|mesh-ancestor
64899739|NCT02027987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64899740|NCT02027987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899741|NCT02027987|Antimanic Agents|antimanic agents|mesh-ancestor
64899742|NCT02027987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64404011|NCT04954339|Growth Substances|growth substances|mesh-ancestor
64899743|NCT02027987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64899744|NCT02027987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64899745|NCT02028026|Citalopram|citalopram|mesh-list
64899746|NCT02028026|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
64899747|NCT02028026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64899748|NCT02028026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64899749|NCT02028026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64899750|NCT02028026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899751|NCT02028026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64899752|NCT02028026|Serotonin Agents|serotonin agents|mesh-ancestor
64899753|NCT02028026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899754|NCT02028026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64899755|NCT02028026|Antidepressive Agents|antidepressive agents|mesh-ancestor
64899756|NCT02028026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64899757|NCT02028026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64899758|NCT02028026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64899759|NCT02028078|Insulin|insulin|mesh-list
64899760|NCT02028078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64899761|NCT02028078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64899765|NCT02028234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64899766|NCT02028234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64899767|NCT02028234|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64899768|NCT02028234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899769|NCT02028234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899771|NCT02028260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64899772|NCT02028260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899773|NCT02028260|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64899774|NCT02028260|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64899783|NCT02028403|BMS-936559|bms-936559|mesh-list
64899784|NCT02028403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64899785|NCT02028403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64899786|NCT02028403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899787|NCT02028403|Immunologic Factors|immunologic factors|mesh-ancestor
64899788|NCT02028403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899789|NCT02028416|Thymoglobulin|thymoglobulin|mesh-list
64899790|NCT02028416|Immunologic Factors|immunologic factors|mesh-ancestor
64899791|NCT02028416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899792|NCT02028416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64899793|NCT02028429|Sildenafil Citrate|sildenafil citrate|mesh-list
64899794|NCT02028429|Vasodilator Agents|vasodilator agents|mesh-ancestor
64899808|NCT02028507|Exemestane|exemestane|mesh-list
64899810|NCT02028507|Antimetabolites|antimetabolites|mesh-ancestor
64899811|NCT02028507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899812|NCT02028507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64899813|NCT02028507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64899814|NCT02028507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64899815|NCT02028507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64899816|NCT02028507|Hormone Antagonists|hormone antagonists|mesh-ancestor
64899817|NCT02028507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64899818|NCT02028507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899819|NCT02028507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64899820|NCT02028507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899821|NCT02028507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64899822|NCT02028507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64899823|NCT02028533|Oxytocin|oxytocin|mesh-list
64899824|NCT02028533|Oxytocics|oxytocics|mesh-ancestor
64899825|NCT02028533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64899826|NCT02028533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899827|NCT02028598|Sildenafil Citrate|sildenafil citrate|mesh-list
64899828|NCT02028598|Clomipramine|clomipramine|mesh-list
64404091|NCT05406999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404092|NCT05406999|Hormone Antagonists|hormone antagonists|mesh-ancestor
64899829|NCT02028598|Citric Acid|citric acid|mesh-list
64899864|NCT02028689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64899865|NCT02028689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899866|NCT02028689|Gout Suppressants|gout suppressants|mesh-ancestor
64899867|NCT02028689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64899868|NCT02028689|Uricosuric Agents|uricosuric agents|mesh-ancestor
64899869|NCT02028689|Renal Agents|renal agents|mesh-ancestor
64899870|NCT02028819|Dolutegravir|dolutegravir|mesh-list
64899871|NCT02028819|Ibalizumab|ibalizumab|mesh-list
64899872|NCT02028819|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64899873|NCT02028819|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64899874|NCT02028819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899875|NCT02028819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899876|NCT02028819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64899877|NCT02028819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64899878|NCT02028819|Antiviral Agents|antiviral agents|mesh-ancestor
64899879|NCT02028819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64899880|NCT02028910|Ondansetron|ondansetron|mesh-list
64899881|NCT02028910|Antiemetics|antiemetics|mesh-ancestor
64899882|NCT02028910|Autonomic Agents|autonomic agents|mesh-ancestor
64899883|NCT02028910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64899884|NCT02028910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899885|NCT02028910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64899886|NCT02028910|Antipruritics|antipruritics|mesh-ancestor
64899918|NCT02029118|Aspirin|aspirin|mesh-list
64899919|NCT02029118|Metoprolol|metoprolol|mesh-list
64899920|NCT02029118|Ramipril|ramipril|mesh-list
64899921|NCT02029118|Atorvastatin|atorvastatin|mesh-list
64899922|NCT02029118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64899923|NCT02029118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64448758|NCT02252081|Metformin|metformin|mesh-list
64899937|NCT02029118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64899938|NCT02029118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64899939|NCT02029118|Antimetabolites|antimetabolites|mesh-ancestor
64899940|NCT02029118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64899941|NCT02029118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64899942|NCT02029118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64899943|NCT02029118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64899944|NCT02029118|Sympatholytics|sympatholytics|mesh-ancestor
64899953|NCT02029313|Montelukast|montelukast|mesh-list
64899962|NCT02029313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899964|NCT02029378|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64899966|NCT02029378|Immunologic Factors|immunologic factors|mesh-ancestor
64899967|NCT02029378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899968|NCT02029456|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64899969|NCT02029456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64899970|NCT02029456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64899971|NCT02029456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899972|NCT02029482|Ponesimod|ponesimod|mesh-list
64899973|NCT02029482|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64899974|NCT02029482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899975|NCT02029482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64899976|NCT02029482|Immunologic Factors|immunologic factors|mesh-ancestor
64404115|NCT04930211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899977|NCT02029482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64899978|NCT02029534|Atorvastatin|atorvastatin|mesh-list
64899979|NCT02029534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64899980|NCT02029534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64899981|NCT02029534|Antimetabolites|antimetabolites|mesh-ancestor
64899982|NCT02029534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64899983|NCT02029534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64899984|NCT02029534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64899985|NCT02029534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64899986|NCT02029573|Temozolomide|temozolomide|mesh-list
64900008|NCT02029599|Abortifacient Agents|abortifacient agents|mesh-ancestor
64900009|NCT02029599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64900010|NCT02029599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900011|NCT02029599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64900012|NCT02029599|Antimetabolites|antimetabolites|mesh-ancestor
64900013|NCT02029599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900014|NCT02029599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900015|NCT02029599|Dermatologic Agents|dermatologic agents|mesh-ancestor
64900016|NCT02029599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900017|NCT02029599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64900018|NCT02029599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64900074|NCT02029950|Idarubicin|idarubicin|mesh-list
64900075|NCT02029950|Etoposide phosphate|etoposide phosphate|mesh-list
64900076|NCT02029950|Pomalidomide|pomalidomide|mesh-list
64448776|NCT01623596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64900084|NCT02029950|Antimetabolites|antimetabolites|mesh-ancestor
64900085|NCT02029950|Antiviral Agents|antiviral agents|mesh-ancestor
64900086|NCT02029950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64900087|NCT02029950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64900088|NCT02029950|Immunologic Factors|immunologic factors|mesh-ancestor
64900089|NCT02029950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900090|NCT02029950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64900091|NCT02029950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64900092|NCT02029950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64900093|NCT02029950|Growth Substances|growth substances|mesh-ancestor
64900094|NCT02029950|Growth Inhibitors|growth inhibitors|mesh-ancestor
64900095|NCT02029950|Keratolytic Agents|keratolytic agents|mesh-ancestor
64900096|NCT02029950|Dermatologic Agents|dermatologic agents|mesh-ancestor
64900097|NCT02029950|Tubulin Modulators|tubulin modulators|mesh-ancestor
64404166|NCT02680561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64404167|NCT02680561|Respiratory System Agents|respiratory system agents|mesh-ancestor
64900098|NCT02029950|Antimitotic Agents|antimitotic agents|mesh-ancestor
64900099|NCT02029950|Mitosis Modulators|mitosis modulators|mesh-ancestor
64900122|NCT02031692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64900123|NCT02031692|Vitamins|vitamins|mesh-ancestor
64900124|NCT02031692|Micronutrients|micronutrients|mesh-ancestor
64900125|NCT02031692|Antacids|antacids|mesh-ancestor
64900126|NCT02031692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900127|NCT02031692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64900128|NCT02031991|Bevacizumab|bevacizumab|mesh-list
64900129|NCT02031991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64900130|NCT02031991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900131|NCT02031991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64900132|NCT02031991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64900133|NCT02031991|Growth Substances|growth substances|mesh-ancestor
64900134|NCT02031991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900135|NCT02031991|Growth Inhibitors|growth inhibitors|mesh-ancestor
64900136|NCT02032043|Ivermectin|ivermectin|mesh-list
64900137|NCT02032043|Albendazole|albendazole|mesh-list
64900138|NCT02032043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64900139|NCT02032043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64900140|NCT02032043|Anthelmintics|anthelmintics|mesh-ancestor
64900141|NCT02032043|Anticestodal Agents|anticestodal agents|mesh-ancestor
64900142|NCT02032043|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64900143|NCT02032043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64900144|NCT02032043|Tubulin Modulators|tubulin modulators|mesh-ancestor
64900145|NCT02032043|Antimitotic Agents|antimitotic agents|mesh-ancestor
64900146|NCT02032043|Mitosis Modulators|mitosis modulators|mesh-ancestor
64900147|NCT02032043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900148|NCT02032043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900149|NCT02032134|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
64900164|NCT02033356|Sensory System Agents|sensory system agents|mesh-ancestor
64900165|NCT02033356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64900166|NCT02033356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64900167|NCT02033356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64900168|NCT02033356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64900169|NCT02033356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64900170|NCT02033356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900171|NCT02033733|Cisatracurium|cisatracurium|mesh-list
64900173|NCT02033733|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
64900174|NCT02033733|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64900175|NCT02033733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64900176|NCT02033733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900177|NCT02033733|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64900178|NCT02033733|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64900179|NCT02033733|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64448794|NCT02093390|Atorvastatin|atorvastatin|mesh-list
64900275|NCT02040142|Mitomycin|mitomycin|mesh-list
64900277|NCT02040142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900307|NCT02040311|Topiramate|topiramate|mesh-list
64900308|NCT02040311|Anticonvulsants|anticonvulsants|mesh-ancestor
64900309|NCT02040311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64900310|NCT02040311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372928|NCT03296189|Glucocorticoids|glucocorticoids|mesh-ancestor
64372929|NCT03296189|Hormones|hormones|mesh-ancestor
64372930|NCT03296189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64900311|NCT02040350|Pralidoxime|pralidoxime|mesh-list
64900334|NCT02040415|Autonomic Agents|autonomic agents|mesh-ancestor
64900335|NCT02040415|Vasodilator Agents|vasodilator agents|mesh-ancestor
64900336|NCT02040441|Spironolactone|spironolactone|mesh-list
64900337|NCT02040441|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64404271|NCT05076097|Growth Substances|growth substances|mesh-ancestor
64900348|NCT02040454|Antimitotic Agents|antimitotic agents|mesh-ancestor
64900349|NCT02040454|Mitosis Modulators|mitosis modulators|mesh-ancestor
64900350|NCT02040454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900352|NCT02040571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64900353|NCT02040571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900354|NCT02040597|Beclomethasone|beclomethasone|mesh-list
64900355|NCT02040597|Glycopyrrolate|glycopyrrolate|mesh-list
64900356|NCT02040597|Formoterol Fumarate|formoterol fumarate|mesh-list
64900357|NCT02040597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64900358|NCT02040597|Autonomic Agents|autonomic agents|mesh-ancestor
64900359|NCT02040597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64900360|NCT02040597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900361|NCT02040597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64900362|NCT02040597|Respiratory System Agents|respiratory system agents|mesh-ancestor
64900363|NCT02040597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64900364|NCT02040597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64900365|NCT02040597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64900366|NCT02040597|Adrenergic Agents|adrenergic agents|mesh-ancestor
64900367|NCT02040597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64900368|NCT02040597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900369|NCT02040597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64372937|NCT03296189|Protease Inhibitors|protease inhibitors|mesh-ancestor
64372938|NCT03296189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372939|NCT03296189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900400|NCT02040662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900401|NCT02040662|Analgesics|analgesics|mesh-ancestor
64900402|NCT02040662|Sensory System Agents|sensory system agents|mesh-ancestor
64900403|NCT02040662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64900404|NCT02040818|Acetylcysteine|acetylcysteine|mesh-list
64900405|NCT02040818|Tigecycline|tigecycline|mesh-list
64900406|NCT02040818|Heparin|heparin|mesh-list
64900407|NCT02040818|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64900408|NCT02040818|Anticoagulants|anticoagulants|mesh-ancestor
64900409|NCT02040818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64900410|NCT02040818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64404287|NCT04513639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64900411|NCT02040818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900412|NCT02040818|Antiviral Agents|antiviral agents|mesh-ancestor
64900413|NCT02040818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64900414|NCT02040818|Expectorants|expectorants|mesh-ancestor
64900415|NCT02040818|Respiratory System Agents|respiratory system agents|mesh-ancestor
64900416|NCT02040818|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64900417|NCT02040818|Antioxidants|antioxidants|mesh-ancestor
64900418|NCT02040818|Protective Agents|protective agents|mesh-ancestor
64900419|NCT02040818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900420|NCT02040818|Antidotes|antidotes|mesh-ancestor
64900421|NCT02040818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64900422|NCT02040818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64900423|NCT02040818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900424|NCT02040831|Vaccines|vaccines|mesh-list
64900425|NCT02040831|Immunologic Factors|immunologic factors|mesh-ancestor
64372948|NCT03295955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900426|NCT02040831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900427|NCT02040883|Olanzapine|olanzapine|mesh-list
64900476|NCT02041117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64900477|NCT02041117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64900478|NCT02041117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64900479|NCT02041117|Antimetabolites|antimetabolites|mesh-ancestor
64900480|NCT02041117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900481|NCT02041117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64900482|NCT02041117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64900483|NCT02041117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900485|NCT02041143|Chelating Agents|chelating agents|mesh-ancestor
64900486|NCT02041143|Sequestering Agents|sequestering agents|mesh-ancestor
64900487|NCT02041143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900488|NCT02041273|Palbociclib|palbociclib|mesh-list
64900489|NCT02041273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900490|NCT02041273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64900491|NCT02041273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900492|NCT02041273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900493|NCT02041338|Paclitaxel|paclitaxel|mesh-list
64900494|NCT02041338|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64372974|NCT01670721|Vitamin B Complex|vitamin b complex|mesh-ancestor
64900554|NCT02041650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64900572|NCT02042170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64900573|NCT02042170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900575|NCT02042196|Estradiol|estradiol|mesh-list
64900576|NCT02042196|Estrogens|estrogens|mesh-ancestor
64900577|NCT02042196|Hormones|hormones|mesh-ancestor
64900578|NCT02042196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64900579|NCT02042196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900580|NCT02042196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64900581|NCT02042196|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64900582|NCT02042196|Fertility Agents|fertility agents|mesh-ancestor
64900583|NCT02042196|Hormone Antagonists|hormone antagonists|mesh-ancestor
64900584|NCT02042222|Hydroxyurea|hydroxyurea|mesh-list
64900585|NCT02042222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900586|NCT02042222|Antisickling Agents|antisickling agents|mesh-ancestor
64900587|NCT02042222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900588|NCT02042222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900589|NCT02042222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64900590|NCT02042482|Ubiquinone|ubiquinone|mesh-list
64900591|NCT02042482|Coenzyme Q10|coenzyme q10|mesh-list
64404404|NCT04529863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404405|NCT04529863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64372984|NCT04491695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900687|NCT02043171|Vitamin D|vitamin d|mesh-list
64900688|NCT02043171|Ergocalciferols|ergocalciferols|mesh-list
64900689|NCT02043171|Cholecalciferol|cholecalciferol|mesh-list
64900690|NCT02043171|Vitamins|vitamins|mesh-list
64900691|NCT02043171|Micronutrients|micronutrients|mesh-ancestor
64900692|NCT02043171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372997|NCT04489121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64900747|NCT02043730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900748|NCT02043730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64900749|NCT02043730|Immunologic Factors|immunologic factors|mesh-ancestor
64900750|NCT02043730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900751|NCT02043756|Mitoxantrone|mitoxantrone|mesh-list
64900752|NCT02043756|Analgesics|analgesics|mesh-ancestor
64900753|NCT02043756|Sensory System Agents|sensory system agents|mesh-ancestor
64900754|NCT02043756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64900755|NCT02043756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900756|NCT02043756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900773|NCT02043912|Haloperidol decanoate|haloperidol decanoate|mesh-list
64900774|NCT02043912|Antiemetics|antiemetics|mesh-ancestor
64900775|NCT02043912|Autonomic Agents|autonomic agents|mesh-ancestor
64900776|NCT02043912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64900777|NCT02043912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900778|NCT02043912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64900779|NCT02043912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64900780|NCT02043912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64900781|NCT02043912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64900782|NCT02043912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64900783|NCT02043912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64900784|NCT02043912|Dopamine Agents|dopamine agents|mesh-ancestor
64900785|NCT02043912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64900786|NCT02043912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900787|NCT02043912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64900788|NCT02043977|Propofol|propofol|mesh-list
64900789|NCT02043977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64900843|NCT02044250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900844|NCT02044250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64900845|NCT02044250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64900846|NCT02044250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64900847|NCT02044250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64373006|NCT04982211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373007|NCT04982211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373008|NCT04982211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64373009|NCT04982211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64373010|NCT04982211|Vasodilator Agents|vasodilator agents|mesh-ancestor
64900888|NCT02044627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64404495|NCT04023253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64404504|NCT04023253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64404505|NCT04023253|Adrenergic Agents|adrenergic agents|mesh-ancestor
64900889|NCT02044627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64900890|NCT02044653|Darbepoetin alfa|darbepoetin alfa|mesh-list
64900891|NCT02044653|Hematinics|hematinics|mesh-ancestor
64900892|NCT02044809|Cannabidiol|cannabidiol|mesh-list
64900893|NCT02044809|Anticonvulsants|anticonvulsants|mesh-ancestor
64900894|NCT02044952|Mesalamine|mesalamine|mesh-list
64900895|NCT02044952|Triptolide|triptolide|mesh-list
64900896|NCT02044952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64900899|NCT02044952|Sensory System Agents|sensory system agents|mesh-ancestor
64900900|NCT02044952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64900901|NCT02044952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373042|NCT03290495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64900966|NCT02045069|Ivermectin|ivermectin|mesh-list
64900991|NCT02045589|Antimetabolites|antimetabolites|mesh-ancestor
64900992|NCT02045589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64900993|NCT02045589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64900994|NCT02045589|Antiviral Agents|antiviral agents|mesh-ancestor
64900995|NCT02045589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64900996|NCT02045589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64900997|NCT02045589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64900998|NCT02045589|Immunologic Factors|immunologic factors|mesh-ancestor
64900999|NCT02045589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901000|NCT02045602|Gemcitabine|gemcitabine|mesh-list
64901001|NCT02045602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64901002|NCT02045602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64901003|NCT02045602|Antimetabolites|antimetabolites|mesh-ancestor
64901004|NCT02045602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901005|NCT02045602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901006|NCT02045602|Antiviral Agents|antiviral agents|mesh-ancestor
64901007|NCT02045602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64901008|NCT02045602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901009|NCT02045602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64901046|NCT02045849|Hormone Antagonists|hormone antagonists|mesh-ancestor
64901047|NCT02045849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64901048|NCT02045849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901049|NCT02045849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64901051|NCT02045914|Ionophores|ionophores|mesh-list
64901052|NCT02045914|Ionomycin|ionomycin|mesh-list
64901053|NCT02045914|Calcium Ionophores|calcium ionophores|mesh-list
64901054|NCT02045914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64901055|NCT02045914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901056|NCT02045914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64901057|NCT02045914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901059|NCT02045940|Anabolic Agents|anabolic agents|mesh-ancestor
64901060|NCT02045940|Hormones|hormones|mesh-ancestor
64901061|NCT02045940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64901062|NCT02045940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901063|NCT02045953|Albuterol|albuterol|mesh-list
64373106|NCT04429347|Adrenergic Agents|adrenergic agents|mesh-ancestor
64449050|NCT02216123|Primaquine|primaquine|mesh-list
64901240|NCT02046629|Antimetabolites|antimetabolites|mesh-ancestor
64901241|NCT02046629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901242|NCT02046629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64901243|NCT02046668|Spironolactone|spironolactone|mesh-list
64901244|NCT02046668|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64901245|NCT02046668|Hormone Antagonists|hormone antagonists|mesh-ancestor
64901246|NCT02046668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64901247|NCT02046668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901248|NCT02046668|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64901249|NCT02046668|Diuretics|diuretics|mesh-ancestor
64901250|NCT02046668|Natriuretic Agents|natriuretic agents|mesh-ancestor
64901251|NCT02046720|Propofol|propofol|mesh-list
64901252|NCT02046720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64901253|NCT02046720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64901254|NCT02046720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901255|NCT02046720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64901256|NCT02046720|Anesthetics, General|anesthetics, general|mesh-ancestor
64901257|NCT02046720|Anesthetics|anesthetics|mesh-ancestor
64901258|NCT02046733|Nivolumab|nivolumab|mesh-list
64901259|NCT02046733|Ipilimumab|ipilimumab|mesh-list
64901260|NCT02046733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64901261|NCT02046733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901262|NCT02046733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64901263|NCT02046733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901265|NCT02046850|Rifampin|rifampin|mesh-list
64901285|NCT02046915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901286|NCT02046915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64901287|NCT02046915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64901288|NCT02046915|Alkylating Agents|alkylating agents|mesh-ancestor
64373132|NCT02983071|Hormone Antagonists|hormone antagonists|mesh-ancestor
64404650|NCT04911413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404651|NCT04911413|Hemostatics|hemostatics|mesh-ancestor
64404652|NCT04911413|Coagulants|coagulants|mesh-ancestor
64373133|NCT02983071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64901310|NCT02047006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901311|NCT02047006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901312|NCT02047006|Anticoagulants|anticoagulants|mesh-ancestor
64901314|NCT02047019|Candesartan cilexetil|candesartan cilexetil|mesh-list
64901315|NCT02047019|Nifedipine|nifedipine|mesh-list
64901327|NCT02047136|Histamine|histamine|mesh-list
64901328|NCT02047136|Histamine Agonists|histamine agonists|mesh-ancestor
64901329|NCT02047136|Histamine Agents|histamine agents|mesh-ancestor
64901330|NCT02047136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64901331|NCT02047136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901332|NCT02047136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901333|NCT02047149|Zileuton|zileuton|mesh-list
64901334|NCT02047149|Dasatinib|dasatinib|mesh-list
64901335|NCT02047149|Hydroxyurea|hydroxyurea|mesh-list
64901336|NCT02047149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901337|NCT02047149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64901338|NCT02047149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901339|NCT02047149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901340|NCT02047149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64901341|NCT02047149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64901342|NCT02047149|Analgesics|analgesics|mesh-ancestor
64901343|NCT02047149|Sensory System Agents|sensory system agents|mesh-ancestor
64901344|NCT02047149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64901345|NCT02047149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901346|NCT02047149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64901347|NCT02047149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64901348|NCT02047149|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64901349|NCT02047149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64901350|NCT02047149|Hormone Antagonists|hormone antagonists|mesh-ancestor
64373143|NCT03294395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373144|NCT04980105|Methylprednisolone|methylprednisolone|mesh-list
64901394|NCT02047292|Tacrine|tacrine|mesh-list
64901395|NCT02047292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64901405|NCT00005823|Cytarabine|cytarabine|mesh-list
64901429|NCT00005823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64901430|NCT00005823|Antisickling Agents|antisickling agents|mesh-ancestor
64901431|NCT00005823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64901432|NCT00005823|Keratolytic Agents|keratolytic agents|mesh-ancestor
64901433|NCT00005823|Dermatologic Agents|dermatologic agents|mesh-ancestor
64901435|NCT00005826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901436|NCT00005826|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64901437|NCT00005826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64404816|NCT04909931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64404817|NCT04918589|Tranexamic Acid|tranexamic acid|mesh-list
64901438|NCT00005826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404818|NCT04918589|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64404831|NCT04928651|Analgesics|analgesics|mesh-ancestor
64404832|NCT04928651|Sensory System Agents|sensory system agents|mesh-ancestor
64404833|NCT04928651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64901439|NCT00005826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901440|NCT00005829|Gemcitabine|gemcitabine|mesh-list
64901441|NCT00005829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64901442|NCT00005829|Antimetabolites|antimetabolites|mesh-ancestor
64901443|NCT00005829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901444|NCT00005829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901445|NCT00005829|Antiviral Agents|antiviral agents|mesh-ancestor
64901446|NCT00005829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64373145|NCT04980105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64373146|NCT04980105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64373147|NCT04980105|Prednisolone|prednisolone|mesh-list
64373148|NCT04980105|Prednisolone acetate|prednisolone acetate|mesh-list
64373149|NCT04980105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64373150|NCT04980105|Prednisolone phosphate|prednisolone phosphate|mesh-list
64373151|NCT04980105|Hyaluronic Acid|hyaluronic acid|mesh-list
64373152|NCT04980105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64449127|NCT02167451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64449128|NCT02167451|Antiviral Agents|antiviral agents|mesh-ancestor
64449129|NCT02167451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449131|NCT02167139|Adalimumab|adalimumab|mesh-list
64901547|NCT00005865|Tubulin Modulators|tubulin modulators|mesh-ancestor
64901548|NCT00005865|Antimitotic Agents|antimitotic agents|mesh-ancestor
64901549|NCT00005865|Mitosis Modulators|mitosis modulators|mesh-ancestor
64901573|NCT00005874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901574|NCT00005874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901575|NCT00005877|Rubitecan|rubitecan|mesh-list
64901576|NCT00005877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901577|NCT00005877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64901578|NCT00005877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64901579|NCT00005877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901580|NCT00005877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901581|NCT00005880|Budesonide|budesonide|mesh-list
64901582|NCT00005880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64901583|NCT00005880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64901584|NCT00005880|Autonomic Agents|autonomic agents|mesh-ancestor
64901585|NCT00005880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64901586|NCT00005880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64901587|NCT00005880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64901588|NCT00005880|Respiratory System Agents|respiratory system agents|mesh-ancestor
64901589|NCT00005880|Glucocorticoids|glucocorticoids|mesh-ancestor
64901590|NCT00005880|Hormones|hormones|mesh-ancestor
64901593|NCT00005883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901626|NCT00005892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64901627|NCT00005898|Cyclosporine|cyclosporine|mesh-list
64901628|NCT00005898|Methylprednisolone|methylprednisolone|mesh-list
64901629|NCT00005898|Cyclophosphamide|cyclophosphamide|mesh-list
64373174|NCT03294161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64373176|NCT03289871|Amorolfine|amorolfine|mesh-list
64901732|NCT00005940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64901733|NCT00005940|Alkylating Agents|alkylating agents|mesh-ancestor
64901734|NCT00005940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901735|NCT00005940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901736|NCT00005940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64901737|NCT00005940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64901738|NCT00005940|Abortifacient Agents|abortifacient agents|mesh-ancestor
64901739|NCT00005940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64901782|NCT00005949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64901783|NCT00005949|Antiviral Agents|antiviral agents|mesh-ancestor
64901784|NCT00005949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64901785|NCT00005952|Temozolomide|temozolomide|mesh-list
64901786|NCT00005952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64901787|NCT00005952|Alkylating Agents|alkylating agents|mesh-ancestor
64901788|NCT00005952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901789|NCT00005952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901790|NCT00005955|Temozolomide|temozolomide|mesh-list
64901791|NCT00005955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64901792|NCT00005955|Alkylating Agents|alkylating agents|mesh-ancestor
64901793|NCT00005955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901794|NCT00005955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901795|NCT00005958|Gemcitabine|gemcitabine|mesh-list
64901796|NCT00005958|Docetaxel|docetaxel|mesh-list
64901797|NCT00005958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64901814|NCT00005961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64901815|NCT00005961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901816|NCT00005961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901817|NCT00005964|Prednisone|prednisone|mesh-list
64901818|NCT00005964|Cyclophosphamide|cyclophosphamide|mesh-list
64404855|NCT04909619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64404859|NCT03520231|Vitamin D|vitamin d|mesh-list
64901819|NCT00005964|Doxorubicin|doxorubicin|mesh-list
64901820|NCT00005964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64901871|NCT00005970|Alkylating Agents|alkylating agents|mesh-ancestor
64901872|NCT00005970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64901873|NCT00005970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64901874|NCT00005970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64901875|NCT00005970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64901876|NCT00005970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901877|NCT00005970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64901878|NCT00005970|Hormone Antagonists|hormone antagonists|mesh-ancestor
64901879|NCT00005970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64901880|NCT00005970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64901881|NCT00005970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64901882|NCT00005970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64901883|NCT00005970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64901884|NCT00005970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64901922|NCT00005985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64901923|NCT00005985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64901924|NCT00005985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64901925|NCT00005985|Antiemetics|antiemetics|mesh-ancestor
64901926|NCT00005985|Autonomic Agents|autonomic agents|mesh-ancestor
64901927|NCT00005985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64901928|NCT00005985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64901929|NCT00005985|Glucocorticoids|glucocorticoids|mesh-ancestor
64901930|NCT00005985|Hormones|hormones|mesh-ancestor
64901931|NCT00005985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64901932|NCT00005985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64901933|NCT00005985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64901934|NCT00005985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64901935|NCT00005985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64901936|NCT00005985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64901937|NCT00005985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64901938|NCT00005985|Antimetabolites|antimetabolites|mesh-ancestor
64901939|NCT00005985|Antiviral Agents|antiviral agents|mesh-ancestor
64901940|NCT00005985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64901983|NCT00005988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64901984|NCT00005988|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64901985|NCT00005991|Gemcitabine|gemcitabine|mesh-list
64901986|NCT00005991|Doxorubicin|doxorubicin|mesh-list
64901987|NCT00005991|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64901988|NCT00005991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64901989|NCT00005991|Antimetabolites|antimetabolites|mesh-ancestor
64901991|NCT00005991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902028|NCT00006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902029|NCT00006003|Growth Inhibitors|growth inhibitors|mesh-ancestor
64902030|NCT00006003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902031|NCT00006003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64902033|NCT00006003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902034|NCT00006006|Interferons|interferons|mesh-list
64902035|NCT00006006|Interferon-alpha|interferon-alpha|mesh-list
64902036|NCT00006006|Thalidomide|thalidomide|mesh-list
64902037|NCT00006006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902038|NCT00006006|Antiviral Agents|antiviral agents|mesh-ancestor
64902039|NCT00006006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902040|NCT00006006|Immunologic Factors|immunologic factors|mesh-ancestor
64902041|NCT00006006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902042|NCT00006006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64902043|NCT00006006|Leprostatic Agents|leprostatic agents|mesh-ancestor
64902044|NCT00006006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64902045|NCT00006006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64902046|NCT00006006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64902047|NCT00006006|Growth Substances|growth substances|mesh-ancestor
64902048|NCT00006006|Growth Inhibitors|growth inhibitors|mesh-ancestor
64902049|NCT00006009|Visilizumab|visilizumab|mesh-list
64902050|NCT00006009|Immunologic Factors|immunologic factors|mesh-ancestor
64902052|NCT00006012|Paclitaxel|paclitaxel|mesh-list
64902083|NCT00006015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64902085|NCT00006015|Protective Agents|protective agents|mesh-ancestor
64902086|NCT00006015|Vitamin B Complex|vitamin b complex|mesh-ancestor
64902087|NCT00006015|Vitamins|vitamins|mesh-ancestor
64902088|NCT00006015|Micronutrients|micronutrients|mesh-ancestor
64902089|NCT00006018|Paclitaxel|paclitaxel|mesh-list
64902090|NCT00006018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64902091|NCT00006018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902113|NCT00006027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64902114|NCT00006027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902115|NCT00006027|Tubulin Modulators|tubulin modulators|mesh-ancestor
64902116|NCT00006027|Antimitotic Agents|antimitotic agents|mesh-ancestor
64902117|NCT00006027|Mitosis Modulators|mitosis modulators|mesh-ancestor
64902118|NCT00006027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902121|NCT00386646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64902122|NCT00386685|Trastuzumab|trastuzumab|mesh-list
64902123|NCT00386685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64902124|NCT00386685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902126|NCT00006030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64902127|NCT00006030|Hormone Antagonists|hormone antagonists|mesh-ancestor
64902128|NCT00006030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64902129|NCT00006030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902130|NCT00006030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64902131|NCT00006030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902132|NCT00006030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64902133|NCT00006030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64902134|NCT00006030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64902135|NCT00006033|Methotrexate|methotrexate|mesh-list
64902136|NCT00006033|Interleukin-2|interleukin-2|mesh-list
64902137|NCT00006033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64902138|NCT00006033|Abortifacient Agents|abortifacient agents|mesh-ancestor
64902139|NCT00006033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64373306|NCT03062631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64404939|NCT04909775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373307|NCT03062631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373310|NCT02711137|Azacitidine|azacitidine|mesh-list
64373311|NCT02711137|Rucaparib|rucaparib|mesh-list
64373312|NCT02711137|INCB057643|incb057643|mesh-list
64373313|NCT02711137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64373314|NCT02711137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64449249|NCT02100475|Insulin|insulin|mesh-list
64902177|NCT00006042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902178|NCT00006042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64902179|NCT00006042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64902180|NCT00006042|Antimetabolites|antimetabolites|mesh-ancestor
64902181|NCT00006042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64902182|NCT00006042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902183|NCT00006042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64902184|NCT00006042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64902185|NCT00006042|Antitubercular Agents|antitubercular agents|mesh-ancestor
64902186|NCT00006042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64902187|NCT00006042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902189|NCT05680974|Immunologic Factors|immunologic factors|mesh-ancestor
64902190|NCT05680974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902191|NCT05680857|Ubiquinone|ubiquinone|mesh-list
64902192|NCT05680857|Coenzyme Q10|coenzyme q10|mesh-list
64902193|NCT05680857|Micronutrients|micronutrients|mesh-ancestor
64902209|NCT05680662|Protective Agents|protective agents|mesh-ancestor
64902210|NCT05680545|Sevoflurane|sevoflurane|mesh-list
64902211|NCT05680545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64902212|NCT05680545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64902213|NCT05680545|Anesthetics, General|anesthetics, general|mesh-ancestor
64373333|NCT04970667|Flupenthixol|flupenthixol|mesh-list
64902227|NCT00386802|Clotrimazole|clotrimazole|mesh-list
64902228|NCT00386802|Miconazole|miconazole|mesh-list
64902229|NCT00386802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902230|NCT00386802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64902231|NCT00386802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64902232|NCT00386802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64902233|NCT00386802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902234|NCT00386802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902235|NCT00386802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64902236|NCT00386802|Hormone Antagonists|hormone antagonists|mesh-ancestor
64902238|NCT00386802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902252|NCT05679453|Etodolac|etodolac|mesh-list
64902253|NCT05679453|Lornoxicam|lornoxicam|mesh-list
64902254|NCT05679453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64902255|NCT05679453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64902256|NCT05679453|Analgesics|analgesics|mesh-ancestor
64902257|NCT05679453|Sensory System Agents|sensory system agents|mesh-ancestor
64902258|NCT05679453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64902259|NCT05679453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902260|NCT05679453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64902261|NCT05679453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64902262|NCT05679453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64902263|NCT05679453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64902264|NCT05679453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902265|NCT05679453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902266|NCT05679375|Ketamine|ketamine|mesh-list
64902267|NCT05679375|Analgesics|analgesics|mesh-ancestor
64902268|NCT05679375|Sensory System Agents|sensory system agents|mesh-ancestor
64902269|NCT05679375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64902270|NCT05679375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902271|NCT05679375|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64902272|NCT05679375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64902273|NCT05679375|Anesthetics, General|anesthetics, general|mesh-ancestor
64902274|NCT05679375|Anesthetics|anesthetics|mesh-ancestor
64902275|NCT05679375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64902276|NCT05679375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64902277|NCT05679375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64902299|NCT05675163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902300|NCT05675163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64902301|NCT05675163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64902302|NCT05675163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902303|NCT05675163|Hemostatics|hemostatics|mesh-ancestor
64902304|NCT05675163|Coagulants|coagulants|mesh-ancestor
64902305|NCT05626725|Insulin|insulin|mesh-list
64902306|NCT05626725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64902307|NCT05626725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902308|NCT05605509|Gemcitabine|gemcitabine|mesh-list
64902309|NCT05605509|Trastuzumab|trastuzumab|mesh-list
64449266|NCT04075240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902350|NCT00386997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64902351|NCT00386997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902352|NCT00386997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64902353|NCT00386997|Antifungal Agents|antifungal agents|mesh-ancestor
64902354|NCT03940131|Panitumumab|panitumumab|mesh-list
64902355|NCT03940131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64902356|NCT03940131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902357|NCT05309187|Pembrolizumab|pembrolizumab|mesh-list
64902358|NCT05309187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64902359|NCT05309187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902360|NCT05160597|Edetic Acid|edetic acid|mesh-list
64902361|NCT05160597|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64902362|NCT05160597|Chelating Agents|chelating agents|mesh-ancestor
64902363|NCT05160597|Sequestering Agents|sequestering agents|mesh-ancestor
64902364|NCT05160597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902365|NCT05160597|Anticoagulants|anticoagulants|mesh-ancestor
64902366|NCT05160597|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64902367|NCT05160597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64902368|NCT00387309|Methylnaltrexone|methylnaltrexone|mesh-list
64902369|NCT00387309|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64902370|NCT00387309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902371|NCT00387309|Sensory System Agents|sensory system agents|mesh-ancestor
64902372|NCT00387309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64902373|NCT04921722|Sirolimus|sirolimus|mesh-list
64902374|NCT04921722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64902401|NCT04833387|Antibodies|antibodies|mesh-list
64902402|NCT04833387|Immunologic Factors|immunologic factors|mesh-ancestor
64902403|NCT04833387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902404|NCT04803084|TEMPO|tempo|mesh-list
64902405|NCT04803084|Antioxidants|antioxidants|mesh-ancestor
64902406|NCT04803084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902407|NCT04803084|Protective Agents|protective agents|mesh-ancestor
64670932|NCT01996943|Ethanol|ethanol|mesh-list
64902408|NCT04803084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902409|NCT04793685|Prazosin|prazosin|mesh-list
64902410|NCT04793685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64902411|NCT04793685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64902412|NCT04793685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64902413|NCT04793685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64902414|NCT04793685|Adrenergic Agents|adrenergic agents|mesh-ancestor
64902415|NCT04793685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64902416|NCT04793685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902417|NCT04793685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902418|NCT04787991|Gemcitabine|gemcitabine|mesh-list
64902419|NCT04787991|Hydroxychloroquine|hydroxychloroquine|mesh-list
64902420|NCT04787991|Paclitaxel|paclitaxel|mesh-list
64902421|NCT04787991|Nivolumab|nivolumab|mesh-list
64902422|NCT04787991|Ipilimumab|ipilimumab|mesh-list
64902423|NCT04787991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64373346|NCT03288233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902465|NCT04360473|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64902466|NCT04360473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64902467|NCT04360473|Anesthetics, General|anesthetics, general|mesh-ancestor
64902470|NCT04360473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64902493|NCT04175613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64902494|NCT04175613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64902495|NCT04175613|Analgesics|analgesics|mesh-ancestor
64902496|NCT04175613|Sensory System Agents|sensory system agents|mesh-ancestor
64902497|NCT04175613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64902498|NCT04175613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902499|NCT04175613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64902500|NCT04175613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64373352|NCT03288077|Antidepressive Agents|antidepressive agents|mesh-ancestor
64373353|NCT03288077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64373354|NCT00777127|Diclofenac|diclofenac|mesh-list
64373355|NCT00777127|Imiquimod|imiquimod|mesh-list
64902607|NCT03002259|Antiemetics|antiemetics|mesh-ancestor
64902608|NCT03002259|Autonomic Agents|autonomic agents|mesh-ancestor
64373371|NCT00761371|Imiquimod|imiquimod|mesh-list
64373372|NCT00761371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64902668|NCT02593110|Telmisartan|telmisartan|mesh-list
64902669|NCT02593110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64902670|NCT02593110|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64902671|NCT02593110|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64902672|NCT02593110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902673|NCT02373813|Folic Acid|folic acid|mesh-list
64902674|NCT02373813|Etanercept|etanercept|mesh-list
64902675|NCT02373813|Methotrexate|methotrexate|mesh-list
64902676|NCT02373813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64902677|NCT02373813|Abortifacient Agents|abortifacient agents|mesh-ancestor
64902678|NCT02373813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64902679|NCT02373813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902680|NCT02373813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64902681|NCT02373813|Antimetabolites|antimetabolites|mesh-ancestor
64902682|NCT02373813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902683|NCT02373813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902684|NCT02373813|Dermatologic Agents|dermatologic agents|mesh-ancestor
64902685|NCT02373813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902686|NCT02373813|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64902687|NCT02373813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64902688|NCT02373813|Immunologic Factors|immunologic factors|mesh-ancestor
64902689|NCT02373813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64902690|NCT02373813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64902691|NCT02373813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64902692|NCT02373813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64902693|NCT02373813|Analgesics|analgesics|mesh-ancestor
64373426|NCT02448901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373427|NCT02448901|Anticoagulants|anticoagulants|mesh-ancestor
64373428|NCT03291353|Pembrolizumab|pembrolizumab|mesh-list
64373430|NCT03291353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902723|NCT01756248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64902724|NCT01756248|Growth Substances|growth substances|mesh-ancestor
64902725|NCT01756248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902726|NCT01756248|Growth Inhibitors|growth inhibitors|mesh-ancestor
64902727|NCT01756248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902728|NCT00006045|Cytarabine|cytarabine|mesh-list
64902729|NCT00006045|Etoposide|etoposide|mesh-list
64902730|NCT00006045|Mitoxantrone|mitoxantrone|mesh-list
64902731|NCT00006045|Lintuzumab|lintuzumab|mesh-list
64902732|NCT00006045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64902733|NCT00006045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902751|NCT00006048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902752|NCT00006048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64902753|NCT00006048|Antimetabolites|antimetabolites|mesh-ancestor
64902754|NCT00006048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902755|NCT00006048|Antiviral Agents|antiviral agents|mesh-ancestor
64902756|NCT00006048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902757|NCT00006048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64902758|NCT00006048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64902759|NCT00006048|Immunologic Factors|immunologic factors|mesh-ancestor
64902760|NCT00006048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902761|NCT00006048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64902762|NCT00006051|Fluorouracil|fluorouracil|mesh-list
64902763|NCT00006051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902764|NCT00006051|Antimetabolites|antimetabolites|mesh-ancestor
64902765|NCT00006051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64902766|NCT00006051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64902767|NCT00006051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64902768|NCT00006051|Immunologic Factors|immunologic factors|mesh-ancestor
64902769|NCT00006051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902770|NCT00006054|Cyclosporine|cyclosporine|mesh-list
64902771|NCT00006054|Prednisone|prednisone|mesh-list
64902772|NCT00006054|Methylprednisolone|methylprednisolone|mesh-list
64902773|NCT00006054|Cyclophosphamide|cyclophosphamide|mesh-list
64902774|NCT00006054|Busulfan|busulfan|mesh-list
64902775|NCT00006054|Methotrexate|methotrexate|mesh-list
64902776|NCT00006054|Etoposide|etoposide|mesh-list
64902777|NCT00006054|Cyclosporins|cyclosporins|mesh-list
64902778|NCT00006054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64405000|NCT04917497|Simendan|simendan|mesh-list
64373434|NCT02460341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64373441|NCT02460341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64902828|NCT00006072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64902835|NCT00006078|Lycopene|lycopene|mesh-list
64902840|NCT00006078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64902841|NCT00006078|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64902842|NCT00006078|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64902843|NCT00006078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902844|NCT00006081|Paclitaxel|paclitaxel|mesh-list
64902845|NCT00006081|Bryostatin 1|bryostatin 1|mesh-list
64902846|NCT00006081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64902847|NCT00006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64902848|NCT00006081|Tubulin Modulators|tubulin modulators|mesh-ancestor
64373451|NCT00189319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64373454|NCT00189241|Imiquimod|imiquimod|mesh-list
64902946|NCT00006126|Cyclophosphamide|cyclophosphamide|mesh-list
64902947|NCT00006126|Busulfan|busulfan|mesh-list
64902948|NCT00006126|Fludarabine|fludarabine|mesh-list
64902987|NCT00006144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64902988|NCT00006144|Antiviral Agents|antiviral agents|mesh-ancestor
64902989|NCT00006144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64902990|NCT00006144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64902991|NCT00006144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64902992|NCT00006144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64902993|NCT00006144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64902994|NCT00006144|Antimetabolites|antimetabolites|mesh-ancestor
64902995|NCT00006168|Methotrexate|methotrexate|mesh-list
64373474|NCT03286673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64373475|NCT03286673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373477|NCT03286673|Antacids|antacids|mesh-ancestor
64903265|NCT00006270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64903266|NCT00006270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903267|NCT00006270|Antimetabolites|antimetabolites|mesh-ancestor
64903268|NCT00006270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903269|NCT00006270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903270|NCT00006276|Paclitaxel|paclitaxel|mesh-list
64903271|NCT00006276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64903272|NCT00006276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903273|NCT00006276|Tubulin Modulators|tubulin modulators|mesh-ancestor
64903303|NCT00006294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903304|NCT00006294|Vasodilator Agents|vasodilator agents|mesh-ancestor
64903305|NCT00006294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64903306|NCT00006294|Protease Inhibitors|protease inhibitors|mesh-ancestor
64557559|NCT04405193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64903307|NCT00006294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903308|NCT00006294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64903309|NCT00006294|Protective Agents|protective agents|mesh-ancestor
64903310|NCT00006294|Diuretics|diuretics|mesh-ancestor
64903311|NCT00006294|Natriuretic Agents|natriuretic agents|mesh-ancestor
64903312|NCT00006294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64903313|NCT00006294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64903314|NCT00006294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64903315|NCT00006294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64903316|NCT00006294|Adrenergic Agents|adrenergic agents|mesh-ancestor
64903317|NCT00006294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64903318|NCT00005818|Irinotecan|irinotecan|mesh-list
64903319|NCT00005818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64903320|NCT00005818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64903321|NCT00005818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903322|NCT00005818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903323|NCT00005818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903324|NCT00006324|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64903325|NCT00006324|Levonorgestrel|levonorgestrel|mesh-list
64373543|NCT03284645|Efavirenz|efavirenz|mesh-list
64903354|NCT00005824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903355|NCT00005824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64903356|NCT00005827|Genistein|genistein|mesh-list
64903357|NCT00005827|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64903358|NCT00005827|Protective Agents|protective agents|mesh-ancestor
64903359|NCT00005827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903360|NCT00005827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405007|NCT04917497|Protective Agents|protective agents|mesh-ancestor
64903361|NCT00005827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64903362|NCT00005827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903363|NCT00005827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903364|NCT00005827|Phytoestrogens|phytoestrogens|mesh-ancestor
64903366|NCT00005827|Estrogens|estrogens|mesh-ancestor
64903386|NCT00006330|Protective Agents|protective agents|mesh-ancestor
64903387|NCT00006330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903388|NCT00005839|Capecitabine|capecitabine|mesh-list
64903389|NCT00005839|Oxaliplatin|oxaliplatin|mesh-list
64903390|NCT00005839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64903391|NCT00005839|Antimetabolites|antimetabolites|mesh-ancestor
64903392|NCT00005839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903393|NCT00005839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903394|NCT00005842|Trastuzumab|trastuzumab|mesh-list
64903396|NCT00005842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64903397|NCT00005842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903398|NCT00005845|Tipifarnib|tipifarnib|mesh-list
64903399|NCT00005845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903400|NCT00005848|Tipifarnib|tipifarnib|mesh-list
64373544|NCT03284645|Abacavir|abacavir|mesh-list
64373545|NCT03284645|Antiviral Agents|antiviral agents|mesh-ancestor
64903444|NCT00005854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64903445|NCT00005854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64903446|NCT00005854|Antifungal Agents|antifungal agents|mesh-ancestor
64903447|NCT00005854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64903448|NCT00005854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64903449|NCT00005857|Docetaxel|docetaxel|mesh-list
64903450|NCT00005857|Trastuzumab|trastuzumab|mesh-list
64903451|NCT00005857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903452|NCT00005857|Tubulin Modulators|tubulin modulators|mesh-ancestor
64903453|NCT00005857|Antimitotic Agents|antimitotic agents|mesh-ancestor
64903454|NCT00005857|Mitosis Modulators|mitosis modulators|mesh-ancestor
64903455|NCT00005857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903457|NCT00005860|Leucovorin|leucovorin|mesh-list
64903491|NCT00005863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64903492|NCT00005863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64903493|NCT00005863|Keratolytic Agents|keratolytic agents|mesh-ancestor
64903494|NCT00005863|Dermatologic Agents|dermatologic agents|mesh-ancestor
64903495|NCT00005866|Cyclosporine|cyclosporine|mesh-list
64903496|NCT00005866|Cyclophosphamide|cyclophosphamide|mesh-list
64903497|NCT00005866|Busulfan|busulfan|mesh-list
64903498|NCT00005866|Methotrexate|methotrexate|mesh-list
64903499|NCT00005866|Cyclosporins|cyclosporins|mesh-list
64903500|NCT00005866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64903501|NCT00005866|Immunologic Factors|immunologic factors|mesh-ancestor
64903502|NCT00005866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903503|NCT00005866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64903504|NCT00005866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64903505|NCT00005866|Alkylating Agents|alkylating agents|mesh-ancestor
64903506|NCT00005866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903507|NCT00005866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903508|NCT00005866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64903509|NCT00005866|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64373591|NCT03193957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64373592|NCT03193957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903556|NCT00005878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64903557|NCT00005878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64903558|NCT00005878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903559|NCT00005878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903560|NCT00005884|Eflornithine|eflornithine|mesh-list
64903561|NCT00005884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903562|NCT00005884|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64903563|NCT00005884|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64903564|NCT00005884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64903565|NCT00005884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64903566|NCT00005884|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64903567|NCT00005884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903568|NCT00005884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903587|NCT00006339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903589|NCT00006339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64903590|NCT00006339|Antimetabolites|antimetabolites|mesh-ancestor
64903591|NCT00006339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64903592|NCT00005890|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64903593|NCT00005890|Hormones|hormones|mesh-ancestor
64903594|NCT00005890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64903595|NCT00005890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903596|NCT00005893|Cyclophosphamide|cyclophosphamide|mesh-list
64903597|NCT00005893|Busulfan|busulfan|mesh-list
64903598|NCT00005893|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64903599|NCT00005893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64903600|NCT00005893|Immunologic Factors|immunologic factors|mesh-ancestor
64903601|NCT00005893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903602|NCT00005893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64903603|NCT00005893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64903604|NCT00005893|Alkylating Agents|alkylating agents|mesh-ancestor
64903605|NCT00005893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373602|NCT03281681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903653|NCT00005926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903654|NCT00005926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903655|NCT00005926|Antiviral Agents|antiviral agents|mesh-ancestor
64903656|NCT00005926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64903771|NCT00005959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64903772|NCT00005959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64903773|NCT00005959|Alkylating Agents|alkylating agents|mesh-ancestor
64903774|NCT00005959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903775|NCT00005959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903776|NCT00005959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64903777|NCT00005959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64903778|NCT00005959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64903779|NCT00005959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64903780|NCT00005959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64903781|NCT00005959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903782|NCT00005959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64903783|NCT00005959|Glucocorticoids|glucocorticoids|mesh-ancestor
64903785|NCT00005959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64903786|NCT00005959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64903787|NCT00005959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64903788|NCT00005959|Tubulin Modulators|tubulin modulators|mesh-ancestor
64903840|NCT00387777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64903841|NCT00005971|Alvocidib|alvocidib|mesh-list
64903842|NCT00005971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903843|NCT00005971|Growth Inhibitors|growth inhibitors|mesh-ancestor
64373638|NCT03270839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64373639|NCT03270839|Histamine Antagonists|histamine antagonists|mesh-ancestor
64373640|NCT03270839|Histamine Agents|histamine agents|mesh-ancestor
64903886|NCT00005977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64903899|NCT00005977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64903901|NCT00005977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64903902|NCT00005977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64903903|NCT00005977|Antidotes|antidotes|mesh-ancestor
64903904|NCT00005977|Protective Agents|protective agents|mesh-ancestor
64903905|NCT00005977|Vitamin B Complex|vitamin b complex|mesh-ancestor
64903906|NCT00005977|Vitamins|vitamins|mesh-ancestor
64903944|NCT00005998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64903945|NCT00005998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64903946|NCT00005998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64903947|NCT00005998|Alkylating Agents|alkylating agents|mesh-ancestor
64903948|NCT00005998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64903949|NCT00005998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64903950|NCT00005998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64405027|NCT03933007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64903951|NCT00005998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64903952|NCT00005998|Antiemetics|antiemetics|mesh-ancestor
64903953|NCT00005998|Autonomic Agents|autonomic agents|mesh-ancestor
64903954|NCT00005998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64903955|NCT00005998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64903956|NCT00005998|Glucocorticoids|glucocorticoids|mesh-ancestor
64903957|NCT00005998|Hormones|hormones|mesh-ancestor
64903958|NCT00005998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64903959|NCT00005998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64903960|NCT00005998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64903961|NCT00005998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64903962|NCT00005998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64903963|NCT00005998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64903964|NCT00005998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64903965|NCT00005998|Antimetabolites|antimetabolites|mesh-ancestor
64903966|NCT00005998|Antiviral Agents|antiviral agents|mesh-ancestor
64903967|NCT00005998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904003|NCT00006004|Antiviral Agents|antiviral agents|mesh-ancestor
64904004|NCT00006004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904005|NCT00006004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904006|NCT00006004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64904007|NCT00006004|Immunologic Factors|immunologic factors|mesh-ancestor
64904008|NCT00006004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904009|NCT00006007|Gemcitabine|gemcitabine|mesh-list
64904011|NCT00006007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64904012|NCT00006007|Antimetabolites|antimetabolites|mesh-ancestor
64904013|NCT00006007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904014|NCT00006007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904015|NCT00006007|Antiviral Agents|antiviral agents|mesh-ancestor
64904016|NCT00006007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904017|NCT00006007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904018|NCT00006007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64904019|NCT00006007|Immunologic Factors|immunologic factors|mesh-ancestor
64904020|NCT00006007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904025|NCT00006010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64904026|NCT00006010|Antimetabolites|antimetabolites|mesh-ancestor
64904027|NCT00006010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904028|NCT00006010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904029|NCT00006010|Antiviral Agents|antiviral agents|mesh-ancestor
64904030|NCT00006010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904031|NCT00006010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904032|NCT00006010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64904033|NCT00006010|Immunologic Factors|immunologic factors|mesh-ancestor
64904034|NCT00006010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904105|NCT00386659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64904106|NCT00386659|Protease Inhibitors|protease inhibitors|mesh-ancestor
64904107|NCT00386659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904108|NCT00386659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904130|NCT00006028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904131|NCT00006028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64904132|NCT00006028|Immunologic Factors|immunologic factors|mesh-ancestor
64904133|NCT00006028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904134|NCT00387933|Imatinib Mesylate|imatinib mesylate|mesh-list
64904135|NCT00387933|Hydroxyurea|hydroxyurea|mesh-list
64904136|NCT00387933|Vatalanib|vatalanib|mesh-list
64904137|NCT00387933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904138|NCT00387933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64904139|NCT00387933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904140|NCT00387933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904141|NCT00387933|Antisickling Agents|antisickling agents|mesh-ancestor
64373655|NCT02458625|Iron|iron|mesh-list
64904160|NCT00006037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904161|NCT00006037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64904162|NCT00006037|Immunologic Factors|immunologic factors|mesh-ancestor
64904166|NCT00006037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904171|NCT00006040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904172|NCT00006040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64904173|NCT00006040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405040|NCT04907747|Bismuth|bismuth|mesh-list
64904174|NCT00006040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64904175|NCT00006040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64904176|NCT00006040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904177|NCT00006040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904178|NCT00006363|Cytarabine|cytarabine|mesh-list
64904179|NCT00006363|Aldesleukin|aldesleukin|mesh-list
64904180|NCT00006363|Etoposide|etoposide|mesh-list
64904181|NCT00006363|Daunorubicin|daunorubicin|mesh-list
64904182|NCT00006363|Etoposide phosphate|etoposide phosphate|mesh-list
64904183|NCT00006363|Busulfan|busulfan|mesh-list
64904184|NCT00006363|Interleukin-2|interleukin-2|mesh-list
64904185|NCT00006363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64904186|NCT00006363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904187|NCT00006363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64904188|NCT00006363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64904189|NCT00006363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904190|NCT00006363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904191|NCT00006363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64904192|NCT00006363|Antimetabolites|antimetabolites|mesh-ancestor
64904193|NCT00006363|Antiviral Agents|antiviral agents|mesh-ancestor
64904194|NCT00006363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904195|NCT00006363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64904196|NCT00006363|Immunologic Factors|immunologic factors|mesh-ancestor
64904197|NCT00006363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904198|NCT00006363|Alkylating Agents|alkylating agents|mesh-ancestor
64904199|NCT00006363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64904200|NCT00006363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64904201|NCT00006363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64904208|NCT05680870|Omeprazole|omeprazole|mesh-list
64904214|NCT00006366|Fluorouracil|fluorouracil|mesh-list
64904215|NCT00006366|Irinotecan|irinotecan|mesh-list
64904216|NCT00006366|Antimetabolites|antimetabolites|mesh-ancestor
64373664|NCT04970043|Pemetrexed|pemetrexed|mesh-list
64904324|NCT05678296|Analgesics|analgesics|mesh-list
64904325|NCT05678296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904326|NCT05678296|Sensory System Agents|sensory system agents|mesh-ancestor
64904327|NCT05678296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64904328|NCT05678296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904373|NCT03996148|Adrenergic Agents|adrenergic agents|mesh-ancestor
64904374|NCT03996148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64904375|NCT03996148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904376|NCT03996148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64904377|NCT03996148|Narcotics|narcotics|mesh-ancestor
64904378|NCT03996148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64904379|NCT00006399|Donepezil|donepezil|mesh-list
64904380|NCT00006399|Progesterone|progesterone|mesh-list
64904381|NCT00006399|Estrogens|estrogens|mesh-list
64904382|NCT00006399|Progestins|progestins|mesh-ancestor
64904383|NCT00006399|Hormones|hormones|mesh-ancestor
64904384|NCT00006399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64904385|NCT00006399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904386|NCT00006399|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64904387|NCT00006399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904388|NCT00006399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904389|NCT00006399|Cholinergic Agents|cholinergic agents|mesh-ancestor
64904390|NCT00006399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64904391|NCT00006399|Nootropic Agents|nootropic agents|mesh-ancestor
64904392|NCT05660200|Iron|iron|mesh-list
64904393|NCT05660200|Trace Elements|trace elements|mesh-ancestor
64904435|NCT05546320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904436|NCT05546320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64904437|NCT05546320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64904438|NCT05546320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64904439|NCT05546320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64904440|NCT05546320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904441|NCT05546320|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64904442|NCT05546320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64904443|NCT05546320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904444|NCT05546320|Antipyretics|antipyretics|mesh-ancestor
64904445|NCT05546320|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64904446|NCT05546320|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64904447|NCT05546320|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64904448|NCT05546320|Purinergic Agents|purinergic agents|mesh-ancestor
64405064|NCT03052673|Anesthetics, General|anesthetics, general|mesh-ancestor
64904449|NCT05546320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64904450|NCT05546320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64904451|NCT05546320|Antithrombins|antithrombins|mesh-ancestor
64904452|NCT05546320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64904453|NCT05546320|Protease Inhibitors|protease inhibitors|mesh-ancestor
64904454|NCT05546320|Anticoagulants|anticoagulants|mesh-ancestor
64904455|NCT05546320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64904465|NCT05535595|Protease Inhibitors|protease inhibitors|mesh-ancestor
64904466|NCT05535595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904467|NCT05535595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904468|NCT05535595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64904469|NCT05470816|Tranexamic Acid|tranexamic acid|mesh-list
64904470|NCT05470816|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64904471|NCT05470816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64904472|NCT05470816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904473|NCT05470816|Hemostatics|hemostatics|mesh-ancestor
64904474|NCT05470816|Coagulants|coagulants|mesh-ancestor
64904475|NCT05431543|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64904476|NCT05431543|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64904477|NCT05431543|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64904479|NCT05431543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64904480|NCT05431543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64904481|NCT05431543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64904482|NCT05431543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64904483|NCT05431543|Adrenergic Agents|adrenergic agents|mesh-ancestor
64904484|NCT05431543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64904485|NCT05431543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904486|NCT05431543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904487|NCT05431543|Miotics|miotics|mesh-ancestor
64904488|NCT05431543|Autonomic Agents|autonomic agents|mesh-ancestor
64904489|NCT05431543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64904567|NCT05147233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904568|NCT03926845|Thiamidol|thiamidol|mesh-list
64904569|NCT03926845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904570|NCT03926845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904571|NCT00006450|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64904572|NCT00006450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904573|NCT00006453|Gemcitabine|gemcitabine|mesh-list
64904606|NCT00006459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64904607|NCT00006459|Immunologic Factors|immunologic factors|mesh-ancestor
64904608|NCT00006459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904609|NCT00387400|Everolimus|everolimus|mesh-list
64904610|NCT00387400|Temozolomide|temozolomide|mesh-list
64904611|NCT00387400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904612|NCT00387400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64904613|NCT00387400|Immunologic Factors|immunologic factors|mesh-ancestor
64904614|NCT00387400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904615|NCT00387400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64904616|NCT00387400|Alkylating Agents|alkylating agents|mesh-ancestor
64904617|NCT00387400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904618|NCT00388011|Morphine|morphine|mesh-list
64904619|NCT00388011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64904620|NCT00388011|Narcotics|narcotics|mesh-ancestor
64904621|NCT00388011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64904622|NCT00388011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904623|NCT00388011|Analgesics|analgesics|mesh-ancestor
64904624|NCT00388011|Sensory System Agents|sensory system agents|mesh-ancestor
64904625|NCT00388011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64904626|NCT00388089|Bortezomib|bortezomib|mesh-list
64904660|NCT04640545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904661|NCT04640545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904662|NCT00006465|Capecitabine|capecitabine|mesh-list
64904663|NCT00006465|Oxaliplatin|oxaliplatin|mesh-list
64904664|NCT00006465|Irinotecan|irinotecan|mesh-list
64904665|NCT00006465|Camptothecin|camptothecin|mesh-list
64904666|NCT00006465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64904667|NCT00006465|Antimetabolites|antimetabolites|mesh-ancestor
64904668|NCT00006465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904669|NCT00006465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904670|NCT00006465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64904671|NCT00006465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64904672|NCT00006465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405069|NCT03052673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64904673|NCT00006465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64904674|NCT04575181|Insulin|insulin|mesh-list
64904675|NCT04575181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64904676|NCT04575181|Insulin Glargine|insulin glargine|mesh-list
64373754|NCT03988205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64904743|NCT04191187|Immunologic Factors|immunologic factors|mesh-ancestor
64904746|NCT04191187|Alkylating Agents|alkylating agents|mesh-ancestor
64904769|NCT03765229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904770|NCT03624517|Octreotide|octreotide|mesh-list
64904771|NCT03624517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64904772|NCT03624517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64904773|NCT03624517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904774|NCT03600883|Midazolam|midazolam|mesh-list
64904775|NCT03600883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64904776|NCT03600883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64904777|NCT03600883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64904778|NCT03600883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904779|NCT03600883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64904780|NCT03600883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64904781|NCT03600883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64904782|NCT03600883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64904783|NCT03600883|Anesthetics, General|anesthetics, general|mesh-ancestor
64904784|NCT03600883|Anesthetics|anesthetics|mesh-ancestor
64904785|NCT03600883|GABA Modulators|gaba modulators|mesh-ancestor
64904786|NCT03600883|GABA Agents|gaba agents|mesh-ancestor
64904787|NCT03600883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64904788|NCT03600883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904789|NCT00423397|Interferons|interferons|mesh-list
64904790|NCT00423397|Interferon-alpha|interferon-alpha|mesh-list
64904791|NCT00423397|Interferon alpha-2|interferon alpha-2|mesh-list
64904792|NCT00423397|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64373793|NCT03278483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64373795|NCT03278483|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64904889|NCT02425501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904891|NCT02409238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64904892|NCT02409238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904893|NCT00006480|Aldesleukin|aldesleukin|mesh-list
64904894|NCT00006480|Ganciclovir|ganciclovir|mesh-list
64904895|NCT00006480|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64904896|NCT00006480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904897|NCT00006480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64904898|NCT00006480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64904916|NCT03606213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64904917|NCT00006519|Capravirine|capravirine|mesh-list
64904918|NCT00006519|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64904919|NCT00006519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64904920|NCT00006519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904921|NCT00006519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904922|NCT00006519|Antiviral Agents|antiviral agents|mesh-ancestor
64904923|NCT00006519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64904924|NCT00006519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64904925|NCT00006519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64904927|NCT00006591|Amprenavir|amprenavir|mesh-list
64904928|NCT00006591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64904929|NCT00006591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64904930|NCT00006591|Protease Inhibitors|protease inhibitors|mesh-ancestor
64904931|NCT00006591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64904932|NCT00006591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64904974|NCT00006669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64904975|NCT00006669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64904976|NCT00006669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64904977|NCT00006669|Tubulin Modulators|tubulin modulators|mesh-ancestor
64904978|NCT00006669|Antimitotic Agents|antimitotic agents|mesh-ancestor
64904979|NCT00006669|Mitosis Modulators|mitosis modulators|mesh-ancestor
64405071|NCT03052673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64904981|NCT00006708|Carboplatin|carboplatin|mesh-list
64904982|NCT00006708|Etoposide|etoposide|mesh-list
64904983|NCT00006708|Ifosfamide|ifosfamide|mesh-list
64904984|NCT00006708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64904985|NCT00006708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64904986|NCT00006708|Immunologic Factors|immunologic factors|mesh-ancestor
64373881|NCT03267329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64373883|NCT03267329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64905017|NCT00006747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64905018|NCT00006747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64905019|NCT00006747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64905020|NCT00006747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64905021|NCT00006747|Antiviral Agents|antiviral agents|mesh-ancestor
64905022|NCT00006747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64905023|NCT00006747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64905024|NCT00006747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64905025|NCT00006747|Alkylating Agents|alkylating agents|mesh-ancestor
64905026|NCT00006747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64905027|NCT00006786|Leucovorin|leucovorin|mesh-list
64905028|NCT00006786|Bevacizumab|bevacizumab|mesh-list
64905029|NCT00006786|Fluorouracil|fluorouracil|mesh-list
64905030|NCT00006786|Irinotecan|irinotecan|mesh-list
64905031|NCT00006786|Calcium|calcium|mesh-list
64905032|NCT00006786|Levoleucovorin|levoleucovorin|mesh-list
64905033|NCT00006786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64905034|NCT00006786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905035|NCT00006786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64905036|NCT00006786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64905073|NCT00006942|Immunologic Factors|immunologic factors|mesh-ancestor
64905074|NCT00006942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905075|NCT00006981|Immunotoxins|immunotoxins|mesh-list
64905076|NCT00006981|Immunologic Factors|immunologic factors|mesh-ancestor
64905077|NCT00006981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905078|NCT00007059|Mycophenolic Acid|mycophenolic acid|mesh-list
64905079|NCT00007059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64905080|NCT00007059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905081|NCT00007059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64905082|NCT00007059|Antitubercular Agents|antitubercular agents|mesh-ancestor
64905117|NCT00006043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64905118|NCT00006043|Alkylating Agents|alkylating agents|mesh-ancestor
64905119|NCT00006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905120|NCT00006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905121|NCT00006049|Paclitaxel|paclitaxel|mesh-list
64373927|NCT05065775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64373928|NCT05065775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64373967|NCT02458079|Pentoxifylline|pentoxifylline|mesh-list
64373968|NCT02458079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64905208|NCT00006094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64905209|NCT00006094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905210|NCT00006094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64905211|NCT00006094|Immunologic Factors|immunologic factors|mesh-ancestor
64905212|NCT00006094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905213|NCT00006100|Aldesleukin|aldesleukin|mesh-list
64905214|NCT00006100|Fludarabine|fludarabine|mesh-list
64905215|NCT00006100|Fludarabine phosphate|fludarabine phosphate|mesh-list
64905216|NCT00006100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905217|NCT00006100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64905218|NCT00006100|Antimetabolites|antimetabolites|mesh-ancestor
64905219|NCT00006100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905220|NCT00006100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64905221|NCT00006100|Immunologic Factors|immunologic factors|mesh-ancestor
64905222|NCT00006100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905244|NCT00006103|Protective Agents|protective agents|mesh-ancestor
64905245|NCT00006103|Vitamin B Complex|vitamin b complex|mesh-ancestor
64905247|NCT00006103|Micronutrients|micronutrients|mesh-ancestor
64905248|NCT00006106|Fluorouracil|fluorouracil|mesh-list
64405081|NCT05030857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905249|NCT00006106|Dl1520|dl1520|mesh-list
64905250|NCT00006106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905251|NCT00006106|Antimetabolites|antimetabolites|mesh-ancestor
64905252|NCT00006106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905253|NCT00006106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64905254|NCT00006106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64905255|NCT00006106|Immunologic Factors|immunologic factors|mesh-ancestor
64905308|NCT00006118|Mitosis Modulators|mitosis modulators|mesh-ancestor
64374013|NCT03259607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374014|NCT03259607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374015|NCT03259607|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64905309|NCT00006118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905310|NCT00006118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64905311|NCT00006118|Antimetabolites|antimetabolites|mesh-ancestor
64905399|NCT00006157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905400|NCT00006157|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64905401|NCT00006157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64905402|NCT00006157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64905403|NCT00006157|Adrenergic Agents|adrenergic agents|mesh-ancestor
64905404|NCT00006157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64905405|NCT00006157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905406|NCT00006190|Lamivudine|lamivudine|mesh-list
64905407|NCT00006190|Efavirenz|efavirenz|mesh-list
64905408|NCT00006190|Stavudine|stavudine|mesh-list
64905409|NCT00006190|Nelfinavir|nelfinavir|mesh-list
64905419|NCT00006190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64905420|NCT00006190|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64905421|NCT00006190|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64905422|NCT00006190|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64905423|NCT00006190|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64905424|NCT00006190|Antimetabolites|antimetabolites|mesh-ancestor
64905425|NCT00006190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64905426|NCT00006190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64905427|NCT00006190|Protease Inhibitors|protease inhibitors|mesh-ancestor
64905428|NCT00006196|Vitamin D|vitamin d|mesh-list
64905429|NCT00006196|Vitamins|vitamins|mesh-ancestor
64905430|NCT00006196|Micronutrients|micronutrients|mesh-ancestor
64905431|NCT00006196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905432|NCT00006196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64905433|NCT00006199|Topotecan|topotecan|mesh-list
64905434|NCT00006199|Tipifarnib|tipifarnib|mesh-list
64905435|NCT00006199|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64374155|NCT03262727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64374156|NCT03262727|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64374157|NCT03262727|Dermatologic Agents|dermatologic agents|mesh-ancestor
64450090|NCT02155985|Antipyretics|antipyretics|mesh-ancestor
64905531|NCT00006229|Mitosis Modulators|mitosis modulators|mesh-ancestor
64905532|NCT00006229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905533|NCT00006232|Dexamethasone|dexamethasone|mesh-list
64905534|NCT00006232|Doxorubicin|doxorubicin|mesh-list
64905535|NCT00006232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64905536|NCT00006232|Vincristine|vincristine|mesh-list
64905537|NCT00006232|Idarubicin|idarubicin|mesh-list
64905539|NCT00006232|Antiemetics|antiemetics|mesh-ancestor
64374175|NCT03062163|Thioctic Acid|thioctic acid|mesh-list
64905702|NCT00007683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64905703|NCT00007683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905704|NCT00007683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64905705|NCT00007683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64905706|NCT00007683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64905707|NCT00007683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64905708|NCT00007683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905709|NCT00007683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64374287|NCT03060603|Epoetin Alfa|epoetin alfa|mesh-list
64905748|NCT00006343|Antiviral Agents|antiviral agents|mesh-ancestor
64905749|NCT00006343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64905750|NCT00006343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64905751|NCT00006343|Antimetabolites|antimetabolites|mesh-ancestor
64905752|NCT00006343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405096|NCT04916951|Amoxicillin|amoxicillin|mesh-list
64905753|NCT00006343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64905754|NCT00006343|Immunologic Factors|immunologic factors|mesh-ancestor
64905755|NCT00006343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905775|NCT00006349|Micronutrients|micronutrients|mesh-ancestor
64905776|NCT00006349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905777|NCT00006349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64905778|NCT00006349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374311|NCT04967469|Calcitriol|calcitriol|mesh-list
64374312|NCT04967469|Alfacalcidol|alfacalcidol|mesh-list
64374313|NCT04967469|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
64374314|NCT04967469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64374315|NCT04967469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905844|NCT00007917|Alvocidib|alvocidib|mesh-list
64905857|NCT00007917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64905858|NCT00006367|Cytarabine|cytarabine|mesh-list
64905859|NCT00006367|Busulfan|busulfan|mesh-list
64905860|NCT00006367|Idarubicin|idarubicin|mesh-list
64905861|NCT00006367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64905862|NCT00006367|Antimetabolites|antimetabolites|mesh-ancestor
64905863|NCT00006367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64905864|NCT00006367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64905865|NCT00006367|Antiviral Agents|antiviral agents|mesh-ancestor
64905866|NCT00006367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64905867|NCT00006367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64905868|NCT00006367|Immunologic Factors|immunologic factors|mesh-ancestor
64905869|NCT00006367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64905870|NCT00006367|Alkylating Agents|alkylating agents|mesh-ancestor
64905871|NCT00006367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64905872|NCT00006367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64905873|NCT00006367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64905874|NCT00006367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64905875|NCT00006367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64905876|NCT00006367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64905877|NCT00006370|Edotreotide|edotreotide|mesh-list
64905961|NCT00008034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64905962|NCT00008034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64374373|NCT04963257|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64374374|NCT04963257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64906029|NCT00006427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64906030|NCT00006427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906031|NCT00006427|Adrenergic Agents|adrenergic agents|mesh-ancestor
64906032|NCT00006427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64906033|NCT00008151|Cyclosporine|cyclosporine|mesh-list
64906034|NCT00008151|Mycophenolic Acid|mycophenolic acid|mesh-list
64906035|NCT00008151|Methotrexate|methotrexate|mesh-list
64906059|NCT00008151|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64906060|NCT00008151|Antitubercular Agents|antitubercular agents|mesh-ancestor
64906061|NCT00008151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64906062|NCT00008151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64906063|NCT00006448|Methadone|methadone|mesh-list
64906064|NCT00006448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64374429|NCT03252665|Alprostadil|alprostadil|mesh-list
64906082|NCT00008190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64906084|NCT00008190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906085|NCT00008190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906086|NCT00008190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64906087|NCT00008190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64906106|NCT00006451|Alkylating Agents|alkylating agents|mesh-ancestor
64906107|NCT00006451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906108|NCT00006451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906109|NCT00006451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64906110|NCT00006451|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64906111|NCT00006451|Abortifacient Agents|abortifacient agents|mesh-ancestor
64906112|NCT00006451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64906113|NCT00006451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64906114|NCT00006451|Antimetabolites|antimetabolites|mesh-ancestor
64906115|NCT00006451|Dermatologic Agents|dermatologic agents|mesh-ancestor
64906116|NCT00006451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906117|NCT00006451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64906118|NCT00006451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64906119|NCT00006451|Antifungal Agents|antifungal agents|mesh-ancestor
64906120|NCT00006451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64906121|NCT00006451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64906122|NCT00006451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64906123|NCT00006451|Antiemetics|antiemetics|mesh-ancestor
64906124|NCT00006451|Autonomic Agents|autonomic agents|mesh-ancestor
64906125|NCT00006451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64906126|NCT00006451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64906127|NCT00006451|Glucocorticoids|glucocorticoids|mesh-ancestor
64906128|NCT00006451|Hormones|hormones|mesh-ancestor
64906129|NCT00006451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64906130|NCT00006451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64906131|NCT00006451|Protective Agents|protective agents|mesh-ancestor
64906132|NCT00006454|Paclitaxel|paclitaxel|mesh-list
64906133|NCT00006454|Carboplatin|carboplatin|mesh-list
64906134|NCT00006454|Topotecan|topotecan|mesh-list
64906135|NCT00006454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64906136|NCT00006454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906149|NCT00008229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906150|NCT00008229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906151|NCT00008229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64374513|NCT04964583|Antimalarials|antimalarials|mesh-ancestor
64374514|NCT04964583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64906164|NCT00006457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64906165|NCT00006457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64906167|NCT00006457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906168|NCT00008268|Melphalan|melphalan|mesh-list
64906169|NCT00008268|Immunologic Factors|immunologic factors|mesh-ancestor
64906170|NCT00008268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906171|NCT00008268|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64906172|NCT00008268|Alkylating Agents|alkylating agents|mesh-ancestor
64906173|NCT00008268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906174|NCT00008268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906175|NCT00008268|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64906176|NCT00008268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64906177|NCT00006463|Trabectedin|trabectedin|mesh-list
64906178|NCT00006463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64906192|NCT00008307|Antimetabolites|antimetabolites|mesh-ancestor
64906193|NCT00008307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906194|NCT00008307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64906195|NCT00008307|Immunologic Factors|immunologic factors|mesh-ancestor
64906196|NCT00008307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906197|NCT00008307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906198|NCT00008307|Antifungal Agents|antifungal agents|mesh-ancestor
64906199|NCT00008307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64906200|NCT00008307|Dermatologic Agents|dermatologic agents|mesh-ancestor
64906201|NCT00008307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64906202|NCT00008307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64906203|NCT00008307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64906204|NCT00008307|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64906205|NCT00008307|Antitubercular Agents|antitubercular agents|mesh-ancestor
64906206|NCT00008307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64906207|NCT00008307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64906209|NCT00008307|Autonomic Agents|autonomic agents|mesh-ancestor
64906210|NCT00008307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64906211|NCT00008307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64906212|NCT00008307|Glucocorticoids|glucocorticoids|mesh-ancestor
64906213|NCT00008307|Hormones|hormones|mesh-ancestor
64906214|NCT00008307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64906215|NCT00008307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64906216|NCT00008307|Protective Agents|protective agents|mesh-ancestor
64906217|NCT00008307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64906218|NCT00008307|Alkylating Agents|alkylating agents|mesh-ancestor
64906219|NCT00008307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64906220|NCT00006469|Paclitaxel|paclitaxel|mesh-list
64906221|NCT00006469|Carboplatin|carboplatin|mesh-list
64405119|NCT04906655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906222|NCT00006469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64906223|NCT00006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906224|NCT00006469|Tubulin Modulators|tubulin modulators|mesh-ancestor
64906233|NCT00006472|Tubulin Modulators|tubulin modulators|mesh-ancestor
64906234|NCT00006472|Antimitotic Agents|antimitotic agents|mesh-ancestor
64906235|NCT00006472|Mitosis Modulators|mitosis modulators|mesh-ancestor
64906236|NCT00006472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906237|NCT00006472|Antimetabolites|antimetabolites|mesh-ancestor
64906244|NCT00006475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64906247|NCT00008424|Irinotecan|irinotecan|mesh-list
64906295|NCT00006682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64906296|NCT00008697|Arsenic Trioxide|arsenic trioxide|mesh-list
64906297|NCT00008697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906298|NCT00006760|Vinorelbine|vinorelbine|mesh-list
64906299|NCT00006760|Ifosfamide|ifosfamide|mesh-list
64906300|NCT00006760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64906301|NCT00006760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906302|NCT00006760|Tubulin Modulators|tubulin modulators|mesh-ancestor
64906303|NCT00006760|Antimitotic Agents|antimitotic agents|mesh-ancestor
64906304|NCT00006760|Mitosis Modulators|mitosis modulators|mesh-ancestor
64906305|NCT00006760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906306|NCT00006760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64906307|NCT00006760|Alkylating Agents|alkylating agents|mesh-ancestor
64906308|NCT00008736|Metoclopramide|metoclopramide|mesh-list
64906309|NCT00008736|Antiemetics|antiemetics|mesh-ancestor
64906310|NCT00008736|Autonomic Agents|autonomic agents|mesh-ancestor
64906311|NCT00008736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64906312|NCT00008736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906313|NCT00008736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64906314|NCT00008736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64906315|NCT00008736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64906316|NCT00008736|Dopamine Agents|dopamine agents|mesh-ancestor
64906317|NCT00008736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64906318|NCT00008736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906319|NCT00006799|Megestrol|megestrol|mesh-list
64906320|NCT00006799|Megestrol Acetate|megestrol acetate|mesh-list
64906321|NCT00006799|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64906322|NCT00006799|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64906323|NCT00006799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64906324|NCT00006799|Contraceptive Agents|contraceptive agents|mesh-ancestor
64906325|NCT00006799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64906326|NCT00006799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906331|NCT00006799|Appetite Stimulants|appetite stimulants|mesh-ancestor
64906335|NCT00006877|Alkylating Agents|alkylating agents|mesh-ancestor
64906336|NCT00006877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906337|NCT00006877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906338|NCT00007033|Magnesium Sulfate|magnesium sulfate|mesh-list
64906340|NCT00007033|Sensory System Agents|sensory system agents|mesh-ancestor
64906341|NCT00007033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64906342|NCT00007033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906343|NCT00007033|Anesthetics|anesthetics|mesh-ancestor
64906344|NCT00007033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64906345|NCT00007033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64906346|NCT00007033|Anticonvulsants|anticonvulsants|mesh-ancestor
64906347|NCT00007033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64906348|NCT00007033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64906349|NCT00007033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906350|NCT00007033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64906351|NCT00007033|Tocolytic Agents|tocolytic agents|mesh-ancestor
64906352|NCT00007033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64906353|NCT00388401|Alvimopan|alvimopan|mesh-list
64906354|NCT00388401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64906355|NCT00007189|Celecoxib|celecoxib|mesh-list
64906356|NCT00007189|Naproxen|naproxen|mesh-list
64906357|NCT00007189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64906358|NCT00007189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64906359|NCT00007189|Analgesics|analgesics|mesh-ancestor
64906360|NCT00007189|Sensory System Agents|sensory system agents|mesh-ancestor
64906361|NCT00007189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64906362|NCT00007189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906363|NCT00007189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64906389|NCT00007423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64906390|NCT00007423|Immunologic Factors|immunologic factors|mesh-ancestor
64906391|NCT00007423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906392|NCT00007423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64906393|NCT00007423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906394|NCT00007423|Antiviral Agents|antiviral agents|mesh-ancestor
64906395|NCT00007423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64906396|NCT00007423|Interferon Inducers|interferon inducers|mesh-ancestor
64906397|NCT00007423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64906398|NCT00007423|Protective Agents|protective agents|mesh-ancestor
64906399|NCT00007735|Doxycycline|doxycycline|mesh-list
64906400|NCT00007735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64906401|NCT00007735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64906402|NCT00007735|Antimalarials|antimalarials|mesh-ancestor
64906403|NCT00007735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64906404|NCT00007735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64906405|NCT00007774|Haloperidol|haloperidol|mesh-list
64906406|NCT00007774|Olanzapine|olanzapine|mesh-list
64906408|NCT00007774|Antiemetics|antiemetics|mesh-ancestor
64906420|NCT00007774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906421|NCT00007774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64906422|NCT00007774|Serotonin Agents|serotonin agents|mesh-ancestor
64906423|NCT00007774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64906424|NCT00007774|Dopamine Agents|dopamine agents|mesh-ancestor
64906425|NCT00007774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64906426|NCT00007813|Cyclophosphamide|cyclophosphamide|mesh-list
64906427|NCT00007813|Carboplatin|carboplatin|mesh-list
64906429|NCT00007813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64906430|NCT00007813|Immunologic Factors|immunologic factors|mesh-ancestor
64906431|NCT00007813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906432|NCT00007813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64906433|NCT00007813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64906434|NCT00007813|Alkylating Agents|alkylating agents|mesh-ancestor
64906435|NCT00007813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906436|NCT00007813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906437|NCT00007813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64906478|NCT00007969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906480|NCT00008008|Thiotepa|thiotepa|mesh-list
64906481|NCT00008008|Sargramostim|sargramostim|mesh-list
64906482|NCT00008008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64374602|NCT04950933|Anticonvulsants|anticonvulsants|mesh-ancestor
64906490|NCT00008008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64906492|NCT00008047|Fluorouracil|fluorouracil|mesh-list
64906493|NCT00008047|Hydroxyurea|hydroxyurea|mesh-list
64906494|NCT00008047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64906495|NCT00008047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906496|NCT00008047|Tubulin Modulators|tubulin modulators|mesh-ancestor
64906497|NCT00008047|Antimitotic Agents|antimitotic agents|mesh-ancestor
64906498|NCT00008047|Mitosis Modulators|mitosis modulators|mesh-ancestor
64906499|NCT00008047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906500|NCT00008047|Antimetabolites|antimetabolites|mesh-ancestor
64906501|NCT00008047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64906502|NCT00008047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64906503|NCT00008047|Immunologic Factors|immunologic factors|mesh-ancestor
64906504|NCT00008047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906505|NCT00008047|Antisickling Agents|antisickling agents|mesh-ancestor
64405128|NCT02609815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64906506|NCT00008047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906507|NCT00008047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64906509|NCT00008086|Carboplatin|carboplatin|mesh-list
64906510|NCT00008086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906511|NCT00008086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64906512|NCT00008086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906513|NCT00008086|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64906514|NCT00008086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64906515|NCT00008086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906516|NCT00008086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64906517|NCT00008086|Vitamins|vitamins|mesh-ancestor
64906518|NCT00008086|Micronutrients|micronutrients|mesh-ancestor
64906519|NCT00008086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64906520|NCT00008125|Gemcitabine|gemcitabine|mesh-list
64906521|NCT00008125|Carboplatin|carboplatin|mesh-list
64906522|NCT00008125|Docetaxel|docetaxel|mesh-list
64906523|NCT00008125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906524|NCT00008125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64906525|NCT00008125|Antimetabolites|antimetabolites|mesh-ancestor
64906526|NCT00008125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906527|NCT00008125|Antiviral Agents|antiviral agents|mesh-ancestor
64906528|NCT00008125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64906529|NCT00008125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906530|NCT00008125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64906531|NCT00008125|Immunologic Factors|immunologic factors|mesh-ancestor
64906532|NCT00008125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906533|NCT00008125|Tubulin Modulators|tubulin modulators|mesh-ancestor
64906534|NCT00008125|Antimitotic Agents|antimitotic agents|mesh-ancestor
64906541|NCT00008203|Thiotepa|thiotepa|mesh-list
64906573|NCT00008242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64906574|NCT00008242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64906575|NCT00008242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906576|NCT00008242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64906577|NCT00008242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64906578|NCT00008242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64906579|NCT00008242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906580|NCT00008242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906581|NCT00008242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64906582|NCT00008242|Immunologic Factors|immunologic factors|mesh-ancestor
64906583|NCT00008242|Leprostatic Agents|leprostatic agents|mesh-ancestor
64906584|NCT00008242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64906585|NCT00008242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64374612|NCT04961307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906622|NCT00008476|Capsaicin|capsaicin|mesh-list
64906623|NCT00008476|Antipruritics|antipruritics|mesh-ancestor
64906624|NCT00008476|Dermatologic Agents|dermatologic agents|mesh-ancestor
64906625|NCT00008476|Sensory System Agents|sensory system agents|mesh-ancestor
64906626|NCT00008476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64906627|NCT00008476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906628|NCT00008515|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
64906629|NCT00008515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64906630|NCT00008515|Glucocorticoids|glucocorticoids|mesh-ancestor
64906631|NCT00008515|Hormones|hormones|mesh-ancestor
64906632|NCT00008515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64906633|NCT00008515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906634|NCT00008554|Lamivudine|lamivudine|mesh-list
64906635|NCT00008554|Abacavir|abacavir|mesh-list
64906636|NCT00008554|Nelfinavir|nelfinavir|mesh-list
64906637|NCT00008554|Fosamprenavir|fosamprenavir|mesh-list
64906638|NCT00008554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64906639|NCT00008554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64906640|NCT00008554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906641|NCT00008554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906642|NCT00008554|Antiviral Agents|antiviral agents|mesh-ancestor
64906643|NCT00008554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64906644|NCT00008554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64906645|NCT00008554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64906646|NCT00008554|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64906647|NCT00008554|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64906648|NCT00008554|Protease Inhibitors|protease inhibitors|mesh-ancestor
64906649|NCT05636566|Dexmedetomidine|dexmedetomidine|mesh-list
64906650|NCT05636566|Propofol|propofol|mesh-list
64906651|NCT05636566|Sevoflurane|sevoflurane|mesh-list
64906652|NCT05636566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64906653|NCT05636566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64906654|NCT05636566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906655|NCT05636566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64906656|NCT05636566|Anesthetics, General|anesthetics, general|mesh-ancestor
64906661|NCT05636566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64906662|NCT05636566|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64906664|NCT05636566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64906665|NCT05636566|Adrenergic Agents|adrenergic agents|mesh-ancestor
64906666|NCT05636566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64906667|NCT05636566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906668|NCT05636566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64906669|NCT05636566|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64906670|NCT05637034|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64906671|NCT05637034|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64906672|NCT05637034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906673|NCT05637073|Dienogest|dienogest|mesh-list
64374618|NCT03058263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64906698|NCT05637216|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64906699|NCT05637216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906700|NCT05638087|Dexamethasone|dexamethasone|mesh-list
64906701|NCT05638087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64906702|NCT05638087|Antiemetics|antiemetics|mesh-ancestor
64906703|NCT05638087|Autonomic Agents|autonomic agents|mesh-ancestor
64906704|NCT05638087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64906705|NCT05638087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906706|NCT05638087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64906707|NCT05638087|Glucocorticoids|glucocorticoids|mesh-ancestor
64906708|NCT05638087|Hormones|hormones|mesh-ancestor
64906709|NCT05638087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64906710|NCT05638087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64906711|NCT05638087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906712|NCT05638633|Vitamins|vitamins|mesh-list
64906713|NCT05638633|Vitamin B Complex|vitamin b complex|mesh-list
64906714|NCT05638633|Prednisolone|prednisolone|mesh-list
64906715|NCT05638633|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64906716|NCT05638633|Methylprednisolone|methylprednisolone|mesh-list
64906717|NCT05638633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64906718|NCT05638633|Prednisolone acetate|prednisolone acetate|mesh-list
64906719|NCT05638633|Corticosterone|corticosterone|mesh-list
64374642|NCT03059277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906792|NCT00000115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906793|NCT00000136|Ganciclovir|ganciclovir|mesh-list
64906794|NCT00000136|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64906795|NCT00000136|Foscarnet|foscarnet|mesh-list
64906796|NCT00000136|Antiviral Agents|antiviral agents|mesh-ancestor
64906797|NCT00000136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64906798|NCT00000136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64906799|NCT00000136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906800|NCT00000136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906801|NCT00000136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64906802|NCT00000139|Acyclovir|acyclovir|mesh-list
64906803|NCT00000139|Antiviral Agents|antiviral agents|mesh-ancestor
64906804|NCT00000139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64374668|NCT04941417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64374670|NCT04941417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64906871|NCT00000187|Serotonin Agents|serotonin agents|mesh-ancestor
64906872|NCT00000187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64906873|NCT00000187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906901|NCT00000220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64906903|NCT00000220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64906904|NCT00000220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64906905|NCT00000220|Analgesics|analgesics|mesh-ancestor
64906906|NCT00000220|Sensory System Agents|sensory system agents|mesh-ancestor
64906907|NCT00000220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64906908|NCT00000220|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64906909|NCT00000256|Nitrous Oxide|nitrous oxide|mesh-list
64906911|NCT00000256|Anesthetics, General|anesthetics, general|mesh-ancestor
64374711|NCT04947423|Cholinergic Agents|cholinergic agents|mesh-ancestor
64374712|NCT04947423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64405175|NCT04903847|Antiviral Agents|antiviral agents|mesh-ancestor
64405176|NCT04903847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64374713|NCT04947423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374714|NCT04947423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64374715|NCT03250481|Oxycodone|oxycodone|mesh-list
64374716|NCT03250481|Propofol|propofol|mesh-list
64374717|NCT03250481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64906962|NCT00000463|Antimetabolites|antimetabolites|mesh-ancestor
64906963|NCT00000463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64906964|NCT00000463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64906965|NCT00000463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64906966|NCT00000463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64906967|NCT00000466|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64906968|NCT00000466|Medroxyprogesterone|medroxyprogesterone|mesh-list
64906969|NCT00000466|Progesterone|progesterone|mesh-list
64906970|NCT00000466|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64906971|NCT00000466|Estrogens|estrogens|mesh-list
64906972|NCT00000466|Progestins|progestins|mesh-ancestor
64906973|NCT00000466|Hormones|hormones|mesh-ancestor
64374734|NCT04947267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907022|NCT00388882|Albuterol|albuterol|mesh-list
64374788|NCT04947189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64374789|NCT04947189|Antiemetics|antiemetics|mesh-ancestor
64907208|NCT00000556|Sympatholytics|sympatholytics|mesh-ancestor
64907209|NCT00000556|Autonomic Agents|autonomic agents|mesh-ancestor
64907210|NCT00000556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64907211|NCT00000556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64907212|NCT00000556|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64907213|NCT00000556|Antimalarials|antimalarials|mesh-ancestor
64907214|NCT00000556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64907215|NCT00000556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64907216|NCT00000556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907217|NCT00000556|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64907218|NCT00000556|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64907219|NCT00000556|Cholinergic Agents|cholinergic agents|mesh-ancestor
64907220|NCT00000559|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64907221|NCT00000559|Medroxyprogesterone|medroxyprogesterone|mesh-list
64374907|NCT03246581|Tiotropium Bromide|tiotropium bromide|mesh-list
64907263|NCT00000601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64907265|NCT00000601|Progestins|progestins|mesh-ancestor
64907266|NCT00000625|Zidovudine|zidovudine|mesh-list
64907267|NCT00000625|Didanosine|didanosine|mesh-list
64907291|NCT00000640|Clindamycin phosphate|clindamycin phosphate|mesh-list
64907292|NCT00000640|Dapsone|dapsone|mesh-list
64907293|NCT00000640|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64907294|NCT00000640|Primaquine|primaquine|mesh-list
64907295|NCT00000640|Trimethoprim|trimethoprim|mesh-list
64907296|NCT00000640|Sulfamethoxazole|sulfamethoxazole|mesh-list
64907297|NCT00000640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64907298|NCT00000640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907299|NCT00000640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64907300|NCT00000640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907301|NCT00000640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907302|NCT00000640|Antimalarials|antimalarials|mesh-ancestor
64907303|NCT00000640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64907304|NCT00000640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64907305|NCT00000640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64907306|NCT00000640|Renal Agents|renal agents|mesh-ancestor
64907307|NCT00000640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64907308|NCT00000640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64907309|NCT00000640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64907317|NCT00000643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907318|NCT00000643|Antidotes|antidotes|mesh-ancestor
64907319|NCT00000643|Protective Agents|protective agents|mesh-ancestor
64907320|NCT00000643|Vitamin B Complex|vitamin b complex|mesh-ancestor
64907321|NCT00000643|Vitamins|vitamins|mesh-ancestor
64907322|NCT00000643|Micronutrients|micronutrients|mesh-ancestor
64907323|NCT00000643|Antimalarials|antimalarials|mesh-ancestor
64907324|NCT00000643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64907326|NCT00000643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907327|NCT00000643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64907328|NCT00000643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907329|NCT00000643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907330|NCT00000646|Pentoxifylline|pentoxifylline|mesh-list
64374917|NCT03246581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64374919|NCT03246113|Temozolomide|temozolomide|mesh-list
64907386|NCT00000679|Antimetabolites|antimetabolites|mesh-ancestor
64907387|NCT00000679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907388|NCT00000679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64907389|NCT00000679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907390|NCT00000679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907391|NCT00000679|Antiviral Agents|antiviral agents|mesh-ancestor
64907392|NCT00000679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907403|NCT00000682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907404|NCT00000682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64907405|NCT00000682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907406|NCT00000688|Ganciclovir|ganciclovir|mesh-list
64907407|NCT00000688|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64907408|NCT00000688|Antiviral Agents|antiviral agents|mesh-ancestor
64907409|NCT00000688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907410|NCT00000688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907411|NCT00000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907412|NCT00000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907413|NCT00000712|Zidovudine|zidovudine|mesh-list
64907414|NCT00000712|Acyclovir|acyclovir|mesh-list
64907415|NCT00000712|Antimetabolites|antimetabolites|mesh-ancestor
64374986|NCT02623959|Anesthetics, General|anesthetics, general|mesh-ancestor
64374987|NCT02623959|Anesthetics|anesthetics|mesh-ancestor
64374988|NCT02623959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64374990|NCT02623959|Antimalarials|antimalarials|mesh-ancestor
64907453|NCT00000718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907454|NCT00000739|Dapsone|dapsone|mesh-list
64907455|NCT00000739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907456|NCT00000739|Antimalarials|antimalarials|mesh-ancestor
64907457|NCT00000739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64907458|NCT00000739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64907459|NCT00000739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64907460|NCT00000739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907461|NCT00000739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907462|NCT00000739|Leprostatic Agents|leprostatic agents|mesh-ancestor
64907463|NCT00000739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64907464|NCT00000742|Zidovudine|zidovudine|mesh-list
64907465|NCT00000742|Didanosine|didanosine|mesh-list
64907502|NCT00000751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907503|NCT00000751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907504|NCT00000751|Antiviral Agents|antiviral agents|mesh-ancestor
64907505|NCT00000751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907506|NCT00000751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64375030|NCT04931355|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64375031|NCT04931355|Fertility Agents|fertility agents|mesh-ancestor
64375032|NCT04931355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64375033|NCT04931355|Hormone Antagonists|hormone antagonists|mesh-ancestor
64375034|NCT04931121|Viscosupplements|viscosupplements|mesh-list
64375035|NCT04931121|Protective Agents|protective agents|mesh-ancestor
64907587|NCT00000799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375067|NCT02453867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375068|NCT02453867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375069|NCT03057561|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
64375070|NCT03057561|Chelating Agents|chelating agents|mesh-ancestor
64907607|NCT00000820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907608|NCT00000820|Antiviral Agents|antiviral agents|mesh-ancestor
64907609|NCT00000820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907610|NCT00000826|Clarithromycin|clarithromycin|mesh-list
64907612|NCT00000826|Rifabutin|rifabutin|mesh-list
64907613|NCT00000826|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64907614|NCT00000826|Fluconazole|fluconazole|mesh-list
64907615|NCT00000826|Trimethoprim|trimethoprim|mesh-list
64907616|NCT00000826|Sulfamethoxazole|sulfamethoxazole|mesh-list
64907617|NCT00000826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64907618|NCT00000826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907619|NCT00000826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64907621|NCT00000826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907622|NCT00000826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64907623|NCT00000826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64907624|NCT00000826|Antifungal Agents|antifungal agents|mesh-ancestor
64676065|NCT05722301|Testosterone|testosterone|mesh-list
64907625|NCT00000826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64907626|NCT00000826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64907627|NCT00000826|Hormone Antagonists|hormone antagonists|mesh-ancestor
64405182|NCT04903847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907628|NCT00000826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64907629|NCT00000826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64907630|NCT00000826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64907683|NCT00000892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907771|NCT00000919|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64907772|NCT00000919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64676209|NCT00501345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64907774|NCT00000919|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64907775|NCT00000919|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64907776|NCT00000919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64907777|NCT00000919|Antisickling Agents|antisickling agents|mesh-ancestor
64907778|NCT00000919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64907779|NCT00000919|Antitubercular Agents|antitubercular agents|mesh-ancestor
64907805|NCT00000922|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64907806|NCT00000922|Protease Inhibitors|protease inhibitors|mesh-ancestor
64907807|NCT00000940|Ritonavir|ritonavir|mesh-list
64907808|NCT00000940|Amprenavir|amprenavir|mesh-list
64907809|NCT00000940|Lamivudine|lamivudine|mesh-list
64907810|NCT00000940|Abacavir|abacavir|mesh-list
64907811|NCT00000940|Stavudine|stavudine|mesh-list
64907812|NCT00000940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64907813|NCT00000940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64907814|NCT00000940|Protease Inhibitors|protease inhibitors|mesh-ancestor
64907815|NCT00000940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907816|NCT00000940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64907817|NCT00000940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64907818|NCT00000940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907819|NCT00000940|Antiviral Agents|antiviral agents|mesh-ancestor
64907820|NCT00000940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907821|NCT00000940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64907822|NCT00000940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64375103|NCT03238703|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64375104|NCT03238703|Chelating Agents|chelating agents|mesh-ancestor
64375105|NCT03238703|Sequestering Agents|sequestering agents|mesh-ancestor
64375106|NCT03238703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375107|NCT03238703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375115|NCT03238703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64375116|NCT03238703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64375117|NCT03238703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64375118|NCT03238703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64375120|NCT03238625|Anesthetics, Local|anesthetics, local|mesh-ancestor
64375121|NCT03238625|Anesthetics|anesthetics|mesh-ancestor
64907902|NCT00001003|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64907903|NCT00001003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907904|NCT00001003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907905|NCT00001003|Antiviral Agents|antiviral agents|mesh-ancestor
64907906|NCT00001003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907907|NCT00001003|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64907908|NCT00001003|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64907909|NCT00001003|Antifungal Agents|antifungal agents|mesh-ancestor
64907910|NCT00001003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64907911|NCT00001003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64907912|NCT00001003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64907913|NCT00001030|Clarithromycin|clarithromycin|mesh-list
64907914|NCT00001030|Rifabutin|rifabutin|mesh-list
64907915|NCT00001030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64907916|NCT00001030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64907917|NCT00001030|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64907918|NCT00001030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64907951|NCT00001033|Antitubercular Agents|antitubercular agents|mesh-ancestor
64907952|NCT00001033|Leprostatic Agents|leprostatic agents|mesh-ancestor
64907953|NCT00001033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64907954|NCT00001033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64907955|NCT00001033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64907956|NCT00001033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64907957|NCT00001033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64907958|NCT00001033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64907959|NCT00001033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64907960|NCT00001033|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64907961|NCT00001033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64907962|NCT00001033|Antimetabolites|antimetabolites|mesh-ancestor
64907963|NCT00001033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64907964|NCT00001033|Vitamin B Complex|vitamin b complex|mesh-ancestor
64907965|NCT00001033|Vitamins|vitamins|mesh-ancestor
64375156|NCT04485845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375157|NCT04485845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64375158|NCT04485845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64908056|NCT00001084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908057|NCT00001084|Antiviral Agents|antiviral agents|mesh-ancestor
64908058|NCT00001084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64908059|NCT00001084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64908060|NCT00001084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64908061|NCT00001084|Antimetabolites|antimetabolites|mesh-ancestor
64908062|NCT00001084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64908063|NCT00001084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64375164|NCT00700427|Adrenergic Agents|adrenergic agents|mesh-ancestor
64375165|NCT00700427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64375166|NCT00700427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908129|NCT00001114|Didanosine|didanosine|mesh-list
64908130|NCT00001114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908131|NCT00001114|Antiviral Agents|antiviral agents|mesh-ancestor
64908132|NCT00001114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64908133|NCT00001114|Immunologic Factors|immunologic factors|mesh-ancestor
64908134|NCT00001114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908135|NCT00001114|Antimetabolites|antimetabolites|mesh-ancestor
64908136|NCT00001114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908137|NCT00001114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64908138|NCT00001114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64908139|NCT00001114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908140|NCT00001114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64908141|NCT00001114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64908142|NCT00001165|Doxorubicin|doxorubicin|mesh-list
64908159|NCT00001180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64908160|NCT00001180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908161|NCT00389272|Acetaminophen|acetaminophen|mesh-list
64908162|NCT00389272|Ibuprofen|ibuprofen|mesh-list
64405212|NCT03512119|Ivacaftor|ivacaftor|mesh-list
64405216|NCT02642809|Pembrolizumab|pembrolizumab|mesh-list
64908163|NCT00389272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64908164|NCT00389272|Analgesics|analgesics|mesh-ancestor
64908165|NCT00389272|Sensory System Agents|sensory system agents|mesh-ancestor
64908166|NCT00389272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64908167|NCT00389272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908168|NCT00389272|Antipyretics|antipyretics|mesh-ancestor
64375204|NCT03235973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64375205|NCT03235973|Immunologic Factors|immunologic factors|mesh-ancestor
64375206|NCT03235973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375207|NCT03235973|Alkylating Agents|alkylating agents|mesh-ancestor
64375208|NCT03235973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64908224|NCT00001303|Protective Agents|protective agents|mesh-ancestor
64908225|NCT00000120|Erythromycin|erythromycin|mesh-list
64908226|NCT00000120|Erythromycin Estolate|erythromycin estolate|mesh-list
64908227|NCT00000120|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64908228|NCT00000120|Erythromycin stearate|erythromycin stearate|mesh-list
64908229|NCT00000120|Silver Nitrate|silver nitrate|mesh-list
64908230|NCT00000120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64908231|NCT00000120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64908232|NCT00000120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64908233|NCT00000120|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64908234|NCT00000120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908235|NCT00000120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908236|NCT00000120|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64375213|NCT02453087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908324|NCT00001567|Antiviral Agents|antiviral agents|mesh-ancestor
64908325|NCT00001567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64908326|NCT00001576|Leucovorin|leucovorin|mesh-list
64908327|NCT00001576|Melphalan|melphalan|mesh-list
64908328|NCT00001576|Floxuridine|floxuridine|mesh-list
64908333|NCT00001576|Vitamins|vitamins|mesh-ancestor
64908335|NCT00001576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64908336|NCT00001576|Alkylating Agents|alkylating agents|mesh-ancestor
64908337|NCT00001576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908598|NCT00000369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908613|NCT03295747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64908614|NCT03295747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375444|NCT04918719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64375445|NCT04918719|Expectorants|expectorants|mesh-ancestor
64375446|NCT04918719|Respiratory System Agents|respiratory system agents|mesh-ancestor
64375447|NCT04918719|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64375449|NCT04918719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375450|NCT04918719|Protective Agents|protective agents|mesh-ancestor
64375451|NCT04918719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375452|NCT04918719|Antidotes|antidotes|mesh-ancestor
64375453|NCT03056391|Acetaminophen|acetaminophen|mesh-list
64908643|NCT05631925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908644|NCT05631925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64908645|NCT05631925|Anesthetics, General|anesthetics, general|mesh-ancestor
64908647|NCT05629468|Azithromycin|azithromycin|mesh-list
64908648|NCT05629468|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64908649|NCT05629468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64908650|NCT05629468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64908651|NCT05629468|Dermatologic Agents|dermatologic agents|mesh-ancestor
64908652|NCT00000378|Sertraline|sertraline|mesh-list
64908653|NCT00000378|Nortriptyline|nortriptyline|mesh-list
64908654|NCT00000378|Antidepressive Agents|antidepressive agents|mesh-ancestor
64908655|NCT00000378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64908656|NCT00000378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64908700|NCT05619172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64908701|NCT05619172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908702|NCT00389701|Dexamethasone|dexamethasone|mesh-list
64908703|NCT00389701|Bortezomib|bortezomib|mesh-list
64908704|NCT00389701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64908705|NCT00389701|Antiemetics|antiemetics|mesh-ancestor
64908706|NCT00389701|Autonomic Agents|autonomic agents|mesh-ancestor
64908707|NCT00389701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64908708|NCT00389701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908709|NCT00389701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64908710|NCT00389701|Glucocorticoids|glucocorticoids|mesh-ancestor
64908711|NCT00389701|Hormones|hormones|mesh-ancestor
64405270|NCT04901663|Amoxicillin|amoxicillin|mesh-list
64908712|NCT00389701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64908713|NCT00389701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64908714|NCT00389701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908715|NCT00000420|Norinyl|norinyl|mesh-list
64908716|NCT00000420|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64908717|NCT00000420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64908718|NCT00000420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64908719|NCT00000420|Contraceptive Agents|contraceptive agents|mesh-ancestor
64908720|NCT00000420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64908768|NCT05448820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64908769|NCT05448820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64908770|NCT05448820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375495|NCT04918953|Protective Agents|protective agents|mesh-ancestor
64375496|NCT04918953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64908814|NCT02972320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64908815|NCT02972320|Alkylating Agents|alkylating agents|mesh-ancestor
64908816|NCT02972320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908817|NCT02972320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908818|NCT00000480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64908819|NCT05349838|Dolutegravir|dolutegravir|mesh-list
64908820|NCT05349838|Rilpivirine|rilpivirine|mesh-list
64908821|NCT05349838|Protease Inhibitors|protease inhibitors|mesh-list
64908822|NCT05349838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64908823|NCT05349838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64375503|NCT02123134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64375504|NCT03054207|Clopidogrel|clopidogrel|mesh-list
64451250|NCT02053753|Denosumab|denosumab|mesh-list
64908862|NCT05223673|Antimetabolites|antimetabolites|mesh-ancestor
64908863|NCT05223673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908864|NCT05223673|Antiviral Agents|antiviral agents|mesh-ancestor
64908865|NCT05223673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64908866|NCT00000492|Propranolol|propranolol|mesh-list
64908867|NCT00000492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64908868|NCT00000492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64908869|NCT00000492|Adrenergic Agents|adrenergic agents|mesh-ancestor
64908870|NCT00000492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64908871|NCT00000492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908904|NCT00389935|Growth Inhibitors|growth inhibitors|mesh-ancestor
64908905|NCT00389935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64908907|NCT05116930|Neostigmine|neostigmine|mesh-list
64908908|NCT05116930|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64908909|NCT05116930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64908910|NCT05116930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64908911|NCT05116930|Autonomic Agents|autonomic agents|mesh-ancestor
64908912|NCT05116930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64908913|NCT05116930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908914|NCT05116930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64908915|NCT05116930|Respiratory System Agents|respiratory system agents|mesh-ancestor
64908916|NCT05116930|Mydriatics|mydriatics|mesh-ancestor
64908917|NCT05116930|Parasympatholytics|parasympatholytics|mesh-ancestor
64908918|NCT05116930|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64908919|NCT05116930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64908920|NCT05116930|Cholinergic Agents|cholinergic agents|mesh-ancestor
64908921|NCT05116930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64908922|NCT05116930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908923|NCT05116930|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64908924|NCT05116930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64908925|NCT05116930|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64908938|NCT05049616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64908939|NCT05049616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64908940|NCT05049616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908941|NCT05049616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64908942|NCT05049616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908943|NCT05049616|Vasodilator Agents|vasodilator agents|mesh-ancestor
64908944|NCT05049616|Tocolytic Agents|tocolytic agents|mesh-ancestor
64375536|NCT03055767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64908985|NCT03126799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908986|NCT03126799|Growth Inhibitors|growth inhibitors|mesh-ancestor
64908987|NCT03126799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64908988|NCT03126799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405273|NCT04901663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64908989|NCT03126799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64908990|NCT00000525|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64908991|NCT00000525|Chlorthalidone|chlorthalidone|mesh-list
64908992|NCT00000525|Triamterene|triamterene|mesh-list
64908993|NCT00000525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64908994|NCT00000525|Diuretics|diuretics|mesh-ancestor
64908995|NCT00000525|Natriuretic Agents|natriuretic agents|mesh-ancestor
64908996|NCT00000525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64908997|NCT00000525|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64908998|NCT00000525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64908999|NCT00000525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909000|NCT00000525|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64909001|NCT00000525|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64909002|NCT00000525|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64909003|NCT05020483|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
64909004|NCT05020483|Coagulants|coagulants|mesh-ancestor
64909005|NCT05019430|Cocaine|cocaine|mesh-list
64909032|NCT00000531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64909033|NCT00000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909034|NCT00000531|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64909035|NCT00000531|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64909036|NCT00000531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64909037|NCT00000531|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64375545|NCT02157376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909078|NCT04888858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909079|NCT04888858|Sensory System Agents|sensory system agents|mesh-ancestor
64909080|NCT04888858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64909081|NCT04888858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64909082|NCT04888858|Narcotics|narcotics|mesh-ancestor
64909083|NCT04888858|Analgesics|analgesics|mesh-ancestor
64909084|NCT04888858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64909085|NCT04888858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64909086|NCT04888858|Anesthetics, General|anesthetics, general|mesh-ancestor
64909087|NCT04870957|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64909088|NCT04870957|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64909089|NCT04870957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64909090|NCT04870957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64909091|NCT04870957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909092|NCT04870957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64909093|NCT04870957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909094|NCT04870957|Analgesics|analgesics|mesh-ancestor
64909095|NCT04870957|Sensory System Agents|sensory system agents|mesh-ancestor
64909096|NCT04870957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64909097|NCT04870957|Antidepressive Agents|antidepressive agents|mesh-ancestor
64909098|NCT04870957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64909099|NCT04870957|Dopamine Agents|dopamine agents|mesh-ancestor
64909100|NCT00000558|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64909101|NCT00000558|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64375549|NCT02157376|Histamine Agents|histamine agents|mesh-ancestor
64451542|NCT01846299|Growth Substances|growth substances|mesh-ancestor
64375557|NCT02157298|Dapagliflozin|dapagliflozin|mesh-list
64375558|NCT02157298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64375587|NCT04903275|Fluorides, Topical|fluorides, topical|mesh-list
64375588|NCT04903275|Cariostatic Agents|cariostatic agents|mesh-ancestor
64375589|NCT04903275|Protective Agents|protective agents|mesh-ancestor
64375590|NCT04903275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375738|NCT03051945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64375740|NCT03051945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64375741|NCT03051945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375742|NCT04899765|Vaccines|vaccines|mesh-list
64375743|NCT04899765|BCG Vaccine|bcg vaccine|mesh-list
64909343|NCT00389025|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64909344|NCT00389025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64909345|NCT00389025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64909364|NCT00390247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64909365|NCT00390247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909366|NCT00390247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64405276|NCT04901663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64375784|NCT04898907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64375785|NCT04898907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64375786|NCT04898907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64375787|NCT04898907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64375788|NCT04898907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375790|NCT04898907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909438|NCT00390403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64375856|NCT04897737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64375857|NCT04897737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64909494|NCT00000696|Zidovudine|zidovudine|mesh-list
64909495|NCT00000696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909496|NCT00000696|Antiviral Agents|antiviral agents|mesh-ancestor
64909497|NCT00000696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909498|NCT00000696|Immunologic Factors|immunologic factors|mesh-ancestor
64909499|NCT00000696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909500|NCT00000696|Antimetabolites|antimetabolites|mesh-ancestor
64909501|NCT00000696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677942|NCT00002103|Vitamins|vitamins|mesh-ancestor
64909502|NCT00000696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64909503|NCT00000696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64909504|NCT00000696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909505|NCT00000696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64909513|NCT00000705|Antiviral Agents|antiviral agents|mesh-ancestor
64909514|NCT00000705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909515|NCT00000705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64909516|NCT00000705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64909517|NCT00000708|Fluconazole|fluconazole|mesh-list
64909518|NCT00000708|Amphotericin B|amphotericin b|mesh-list
64909519|NCT00000708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64909520|NCT00000708|Flucytosine|flucytosine|mesh-list
64909521|NCT00000708|Antifungal Agents|antifungal agents|mesh-ancestor
64909522|NCT00000708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909523|NCT00000708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64909524|NCT00000708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64909525|NCT00000708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909526|NCT00000708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375863|NCT04148781|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64375901|NCT04906317|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64375902|NCT04906317|Anesthetics, General|anesthetics, general|mesh-ancestor
64375903|NCT04906317|Anesthetics|anesthetics|mesh-ancestor
64909686|NCT04020172|Dobutamine|dobutamine|mesh-list
64909687|NCT04020172|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64909688|NCT04020172|Sympathomimetics|sympathomimetics|mesh-ancestor
64909689|NCT04020172|Autonomic Agents|autonomic agents|mesh-ancestor
64909690|NCT04020172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64909691|NCT04020172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909692|NCT04020172|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64909693|NCT04020172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64909694|NCT04020172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64909695|NCT04020172|Adrenergic Agents|adrenergic agents|mesh-ancestor
64909696|NCT04020172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64909697|NCT04020172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909698|NCT04020172|Protective Agents|protective agents|mesh-ancestor
64909699|NCT00000747|Nevirapine|nevirapine|mesh-list
64909700|NCT00000747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64909701|NCT00000747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64909702|NCT00000747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909703|NCT00000747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909704|NCT00000747|Antiviral Agents|antiviral agents|mesh-ancestor
64909705|NCT00000747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64909706|NCT00000747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64909716|NCT00000753|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64375955|NCT02616783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64909751|NCT00000768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909752|NCT00000768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909753|NCT00000789|Zidovudine|zidovudine|mesh-list
64909755|NCT00000789|Antimetabolites|antimetabolites|mesh-ancestor
64909756|NCT00000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909757|NCT00000789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64375965|NCT04890561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64375966|NCT04890561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375967|NCT04894617|Amantadine|amantadine|mesh-list
64375968|NCT04894617|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64909844|NCT00000822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64909845|NCT00000822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64909847|NCT00000822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64909848|NCT00000822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909849|NCT00000822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64909850|NCT00000822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64909851|NCT00000822|Antiviral Agents|antiviral agents|mesh-ancestor
64909852|NCT00000822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64376056|NCT04882683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64376057|NCT04882683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376058|NCT04882683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64376059|NCT04882683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376061|NCT04882683|Antimetabolites|antimetabolites|mesh-ancestor
64909887|NCT03646123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64909888|NCT03646123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64909889|NCT03646123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64909890|NCT03646123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64909891|NCT03646123|Alkylating Agents|alkylating agents|mesh-ancestor
64909892|NCT03646123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64909893|NCT03646123|Tubulin Modulators|tubulin modulators|mesh-ancestor
64909894|NCT03646123|Antimitotic Agents|antimitotic agents|mesh-ancestor
64909895|NCT03646123|Mitosis Modulators|mitosis modulators|mesh-ancestor
64909896|NCT03576547|Dexamethasone|dexamethasone|mesh-list
64909897|NCT03576547|Dexamethasone acetate|dexamethasone acetate|mesh-list
64909898|NCT03576547|Rituximab|rituximab|mesh-list
64909899|NCT03576547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64909900|NCT03576547|Venetoclax|venetoclax|mesh-list
64909901|NCT03576547|Ponatinib|ponatinib|mesh-list
64909902|NCT03576547|Antibodies|antibodies|mesh-list
64909903|NCT03576547|Immunoglobulins|immunoglobulins|mesh-list
64909904|NCT03576547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64909905|NCT03576547|BB 1101|bb 1101|mesh-list
64909906|NCT03576547|Immunologic Factors|immunologic factors|mesh-ancestor
64909907|NCT03576547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64909908|NCT03576547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64909909|NCT03576547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64909910|NCT03576547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64909911|NCT03576547|Antiemetics|antiemetics|mesh-ancestor
64909912|NCT03576547|Autonomic Agents|autonomic agents|mesh-ancestor
64909913|NCT03576547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64909914|NCT03576547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64909915|NCT03576547|Glucocorticoids|glucocorticoids|mesh-ancestor
64909916|NCT03576547|Hormones|hormones|mesh-ancestor
64909917|NCT03576547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64909918|NCT03576547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64376082|NCT04753372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376083|NCT04753372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405283|NCT05134519|Trastuzumab|trastuzumab|mesh-list
64376094|NCT05154123|Antimetabolites|antimetabolites|mesh-ancestor
64376096|NCT05154123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64910009|NCT00390676|Antimetabolites|antimetabolites|mesh-ancestor
64910010|NCT00000870|Lamivudine|lamivudine|mesh-list
64910011|NCT00000870|Zidovudine|zidovudine|mesh-list
64910012|NCT00000870|Didanosine|didanosine|mesh-list
64910013|NCT00000870|Stavudine|stavudine|mesh-list
64910018|NCT00000870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910019|NCT00000870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910020|NCT00000870|Antiviral Agents|antiviral agents|mesh-ancestor
64910021|NCT00000870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910022|NCT00000870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64910023|NCT00000870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64910024|NCT00000870|Antimetabolites|antimetabolites|mesh-ancestor
64910025|NCT00000870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910026|NCT00000870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64910027|NCT00000870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64910028|NCT00000870|Protease Inhibitors|protease inhibitors|mesh-ancestor
64910029|NCT00390832|Epoetin Alfa|epoetin alfa|mesh-list
64910030|NCT00390832|Hematinics|hematinics|mesh-ancestor
64910032|NCT00390871|Dexmedetomidine|dexmedetomidine|mesh-list
64910033|NCT00390871|Propofol|propofol|mesh-list
64910034|NCT00390871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64910035|NCT00390871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64910036|NCT00390871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910038|NCT00390871|Anesthetics, General|anesthetics, general|mesh-ancestor
64910039|NCT00390871|Anesthetics|anesthetics|mesh-ancestor
64910040|NCT00390871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64910041|NCT00390871|Analgesics|analgesics|mesh-ancestor
64910107|NCT00000891|Protease Inhibitors|protease inhibitors|mesh-ancestor
64910108|NCT00000891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910109|NCT00000891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336781|NCT02313337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64910111|NCT00000891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64910113|NCT00000891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910114|NCT00000891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64376102|NCT04880811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910115|NCT00000891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64910177|NCT02681302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405331|NCT03051269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64910178|NCT02681302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64910179|NCT02681302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910180|NCT00000951|Fluconazole|fluconazole|mesh-list
64910265|NCT02419495|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64910266|NCT00000966|Leucovorin|leucovorin|mesh-list
64910267|NCT00000966|Azithromycin|azithromycin|mesh-list
64910268|NCT00000966|Pyrimethamine|pyrimethamine|mesh-list
64910269|NCT00000966|Calcium|calcium|mesh-list
64910270|NCT00000966|Levoleucovorin|levoleucovorin|mesh-list
64910271|NCT00000966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64910272|NCT00000966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910273|NCT00000966|Antidotes|antidotes|mesh-ancestor
64910274|NCT00000966|Protective Agents|protective agents|mesh-ancestor
64910275|NCT00000966|Vitamin B Complex|vitamin b complex|mesh-ancestor
64910276|NCT00000966|Vitamins|vitamins|mesh-ancestor
64376152|NCT04886193|Antidotes|antidotes|mesh-ancestor
64910356|NCT00001005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910357|NCT00001005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64910358|NCT00001005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64910359|NCT00001005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910360|NCT00001005|Antiviral Agents|antiviral agents|mesh-ancestor
64910361|NCT00001005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910362|NCT00001005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64910363|NCT00001005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64910364|NCT00001005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910365|NCT00391105|Remifentanil|remifentanil|mesh-list
64910366|NCT00391105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64910367|NCT00391105|Narcotics|narcotics|mesh-ancestor
64910368|NCT00391105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64910369|NCT00391105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910370|NCT00391105|Analgesics|analgesics|mesh-ancestor
64910371|NCT00391105|Sensory System Agents|sensory system agents|mesh-ancestor
64910372|NCT00391105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64405425|NCT04913987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910373|NCT00391144|Triamcinolone|triamcinolone|mesh-list
64910374|NCT00391144|Bevacizumab|bevacizumab|mesh-list
64910375|NCT00391144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64910376|NCT00391144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910377|NCT00391144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64910378|NCT00391144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64910379|NCT00391144|Growth Substances|growth substances|mesh-ancestor
64910380|NCT00391144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910394|NCT00005822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910395|NCT00005822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64910396|NCT00005822|Hormone Antagonists|hormone antagonists|mesh-ancestor
64910397|NCT00005822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64910398|NCT00005822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910399|NCT00005822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64910400|NCT00005822|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64910401|NCT00005822|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64910402|NCT00005822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64910403|NCT00391261|Metformin|metformin|mesh-list
64910404|NCT00391261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64376284|NCT05256147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376285|NCT05255913|Fluorides|fluorides|mesh-list
64678951|NCT00002505|Interferons|interferons|mesh-list
64910495|NCT00005831|Trastuzumab|trastuzumab|mesh-list
64910496|NCT00005831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64910497|NCT00005831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910498|NCT00005831|Tubulin Modulators|tubulin modulators|mesh-ancestor
64910499|NCT00005831|Antimitotic Agents|antimitotic agents|mesh-ancestor
64910500|NCT00005831|Mitosis Modulators|mitosis modulators|mesh-ancestor
64910501|NCT00005831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910502|NCT00005831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64910503|NCT00005831|Antimetabolites|antimetabolites|mesh-ancestor
64910504|NCT00005831|Antiviral Agents|antiviral agents|mesh-ancestor
64910505|NCT00005831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64376324|NCT04146207|Glucocorticoids|glucocorticoids|mesh-ancestor
64376326|NCT04146207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64376327|NCT04146207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376363|NCT02119156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64910586|NCT00005849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910587|NCT00005849|Tubulin Modulators|tubulin modulators|mesh-ancestor
64910588|NCT00005849|Antimitotic Agents|antimitotic agents|mesh-ancestor
64910589|NCT00005849|Mitosis Modulators|mitosis modulators|mesh-ancestor
64910590|NCT00005849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910591|NCT00005849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64910592|NCT00005849|Immunologic Factors|immunologic factors|mesh-ancestor
64910593|NCT00005849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910594|NCT00001047|Clarithromycin|clarithromycin|mesh-list
64910595|NCT00001047|Ethambutol|ethambutol|mesh-list
64910596|NCT00001047|Rifabutin|rifabutin|mesh-list
64910597|NCT00001047|Clofazimine|clofazimine|mesh-list
64910598|NCT00001047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64910599|NCT00001047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910600|NCT00001047|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64910611|NCT00005852|Cyclophosphamide|cyclophosphamide|mesh-list
64910612|NCT00005852|Cyclosporins|cyclosporins|mesh-list
64910613|NCT00005852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64910614|NCT00005852|Muromonab-CD3|muromonab-cd3|mesh-list
64910615|NCT00005852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64910616|NCT00005852|Immunologic Factors|immunologic factors|mesh-ancestor
64910617|NCT00005852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910618|NCT00005852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64910619|NCT00005852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64910620|NCT00005852|Alkylating Agents|alkylating agents|mesh-ancestor
64910621|NCT00005852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910622|NCT00005852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376477|NCT03228797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376478|NCT03044379|Dapivirine|dapivirine|mesh-list
64376479|NCT03044379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64376480|NCT03044379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64376481|NCT03044379|Antiviral Agents|antiviral agents|mesh-ancestor
64376482|NCT03044379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64376483|NCT04864509|Melatonin|melatonin|mesh-list
64910753|NCT00005867|Cyclophosphamide|cyclophosphamide|mesh-list
64910754|NCT00005867|Doxorubicin|doxorubicin|mesh-list
64405558|NCT04888715|Analgesics|analgesics|mesh-ancestor
64376537|NCT02452307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376539|NCT02452307|Interferon Inducers|interferon inducers|mesh-ancestor
64376540|NCT02452307|Heparin Antagonists|heparin antagonists|mesh-ancestor
64376541|NCT02452307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376570|NCT01594749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64376571|NCT01594749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64910809|NCT00017407|Tubulin Modulators|tubulin modulators|mesh-ancestor
64910810|NCT00017407|Antimitotic Agents|antimitotic agents|mesh-ancestor
64910811|NCT00017407|Mitosis Modulators|mitosis modulators|mesh-ancestor
64910812|NCT00017407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910813|NCT00008866|Didanosine|didanosine|mesh-list
64910814|NCT00008866|Hydroxyurea|hydroxyurea|mesh-list
64910815|NCT00008866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910820|NCT00008866|Antimetabolites|antimetabolites|mesh-ancestor
64910845|NCT00001119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910846|NCT00001119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64910847|NCT00001119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64910848|NCT00001119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64910849|NCT00001119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64910850|NCT00001119|Antimetabolites|antimetabolites|mesh-ancestor
64910851|NCT00001119|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64910852|NCT00001119|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64910853|NCT00001119|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64910854|NCT00001119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64910855|NCT00001119|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64910856|NCT00001119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64910857|NCT00001119|Antitubercular Agents|antitubercular agents|mesh-ancestor
64910858|NCT00001119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64910859|NCT00009061|Ritonavir|ritonavir|mesh-list
64910860|NCT00009061|Nelfinavir|nelfinavir|mesh-list
64910905|NCT00009217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64910906|NCT00009217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64910907|NCT00009217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64910908|NCT00009217|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64910909|NCT00009217|Dopamine Agents|dopamine agents|mesh-ancestor
64910910|NCT00009217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64910911|NCT00009217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910912|NCT00009217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64910913|NCT00005876|Rubitecan|rubitecan|mesh-list
64910941|NCT00009763|Immunoglobulins|immunoglobulins|mesh-list
64910942|NCT00009763|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64910943|NCT00009763|Cyclosporins|cyclosporins|mesh-list
64910944|NCT00009763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64910945|NCT00009763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64910946|NCT00009763|Tubulin Modulators|tubulin modulators|mesh-ancestor
64910947|NCT00009763|Antimitotic Agents|antimitotic agents|mesh-ancestor
64910948|NCT00009763|Mitosis Modulators|mitosis modulators|mesh-ancestor
64910949|NCT00009763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64910950|NCT00009763|Immunologic Factors|immunologic factors|mesh-ancestor
64910951|NCT00009763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64910952|NCT00009763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64910953|NCT00009763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64910954|NCT00009763|Antifungal Agents|antifungal agents|mesh-ancestor
64910955|NCT00009763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64910956|NCT00009763|Dermatologic Agents|dermatologic agents|mesh-ancestor
64910957|NCT00009763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64910998|NCT00009880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64910999|NCT00009880|Immunologic Factors|immunologic factors|mesh-ancestor
64911000|NCT00009880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911001|NCT00009919|Semaxinib|semaxinib|mesh-list
64911002|NCT00009919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64405722|NCT04871633|Dexamethasone|dexamethasone|mesh-list
64405732|NCT04871633|Hormones|hormones|mesh-ancestor
64376583|NCT01594749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64911045|NCT00009997|Hormone Antagonists|hormone antagonists|mesh-ancestor
64911046|NCT00009997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64911047|NCT00009997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64911048|NCT00009997|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64911049|NCT00009997|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64911050|NCT00009997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64911051|NCT00010036|Carboplatin|carboplatin|mesh-list
64911052|NCT00010036|Irinotecan|irinotecan|mesh-list
64911053|NCT00010036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911054|NCT00010036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64911055|NCT00010036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64911217|NCT00011362|Hormones|hormones|mesh-ancestor
64911218|NCT00011362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64911219|NCT00011362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64911220|NCT00011362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911221|NCT00011362|Protease Inhibitors|protease inhibitors|mesh-ancestor
64911222|NCT00011362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911223|NCT00011362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911249|NCT00011479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64911250|NCT00011479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911251|NCT00011479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911252|NCT00011479|Antiviral Agents|antiviral agents|mesh-ancestor
64911253|NCT00011479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911254|NCT00011479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64911255|NCT00011479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64911256|NCT00011635|Silymarin|silymarin|mesh-list
64911257|NCT00011635|Antioxidants|antioxidants|mesh-ancestor
64911258|NCT00011635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911259|NCT00011635|Protective Agents|protective agents|mesh-ancestor
64911260|NCT00011635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911261|NCT00001221|Hormones|hormones|mesh-list
64911262|NCT00001221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64911263|NCT00001221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911264|NCT00391417|Estradiol|estradiol|mesh-list
64911265|NCT00391417|Estrogens|estrogens|mesh-ancestor
64911266|NCT00391417|Hormones|hormones|mesh-ancestor
64911267|NCT00391417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64911268|NCT00391417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911269|NCT00011908|Epratuzumab|epratuzumab|mesh-list
64911270|NCT00011908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64911271|NCT00011908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911272|NCT00012025|Fulvestrant|fulvestrant|mesh-list
64911273|NCT00012025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64911274|NCT00012025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911275|NCT00012025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64911276|NCT00012025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64911277|NCT00012025|Hormone Antagonists|hormone antagonists|mesh-ancestor
64911286|NCT00005942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911287|NCT00012103|Dimercaprol|dimercaprol|mesh-list
64911288|NCT00012103|Chelating Agents|chelating agents|mesh-ancestor
64911289|NCT00012103|Sequestering Agents|sequestering agents|mesh-ancestor
64911290|NCT00012103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911291|NCT00001251|Mafosfamide|mafosfamide|mesh-list
64911292|NCT00001251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64911293|NCT00001251|Immunologic Factors|immunologic factors|mesh-ancestor
64911294|NCT00001251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911295|NCT00001251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911296|NCT00012142|Sirolimus|sirolimus|mesh-list
64911297|NCT00012142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64911298|NCT00012142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911299|NCT00012142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64911300|NCT00012142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911301|NCT00012142|Antifungal Agents|antifungal agents|mesh-ancestor
64376778|NCT03045471|Hormones|hormones|mesh-ancestor
64911460|NCT00001287|Immunologic Factors|immunologic factors|mesh-ancestor
64911461|NCT00001287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911462|NCT00005954|Temozolomide|temozolomide|mesh-list
64911463|NCT00005954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64911464|NCT00005954|Alkylating Agents|alkylating agents|mesh-ancestor
64911465|NCT00005954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911466|NCT00005954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911467|NCT00005960|Cyclophosphamide|cyclophosphamide|mesh-list
64911468|NCT00005960|Docetaxel|docetaxel|mesh-list
64911469|NCT00005960|Doxorubicin|doxorubicin|mesh-list
64911470|NCT00005960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64911471|NCT00005960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64911472|NCT00005960|Immunologic Factors|immunologic factors|mesh-ancestor
64679914|NCT05627635|Antimetabolites|antimetabolites|mesh-ancestor
64376910|NCT03043989|Tubulin Modulators|tubulin modulators|mesh-ancestor
64376911|NCT03043989|Antimitotic Agents|antimitotic agents|mesh-ancestor
64911494|NCT00013585|Selegiline|selegiline|mesh-list
64376912|NCT03043989|Mitosis Modulators|mitosis modulators|mesh-ancestor
64911526|NCT00005966|Interferon-alpha|interferon-alpha|mesh-list
64911527|NCT00005966|Thalidomide|thalidomide|mesh-list
64911540|NCT00005969|Tretinoin|tretinoin|mesh-list
64911548|NCT00014014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64911549|NCT00014014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911550|NCT00014014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911551|NCT00014014|Antiviral Agents|antiviral agents|mesh-ancestor
64679989|NCT05481528|Moxifloxacin|moxifloxacin|mesh-list
64911552|NCT00014014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911553|NCT00014014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64911554|NCT00014014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64911555|NCT00014014|Antimetabolites|antimetabolites|mesh-ancestor
64911556|NCT00014092|Interferons|interferons|mesh-list
64911557|NCT00014092|Interferon-alpha|interferon-alpha|mesh-list
64911558|NCT00014092|Aldesleukin|aldesleukin|mesh-list
64911559|NCT00014092|Temozolomide|temozolomide|mesh-list
64911560|NCT00014092|Sargramostim|sargramostim|mesh-list
64911561|NCT00014092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911562|NCT00014092|Antiviral Agents|antiviral agents|mesh-ancestor
64911563|NCT00014092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911564|NCT00014092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64911565|NCT00014092|Alkylating Agents|alkylating agents|mesh-ancestor
64911566|NCT00014092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911567|NCT00014092|Immunologic Factors|immunologic factors|mesh-ancestor
64911568|NCT00014092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911569|NCT00014092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64911612|NCT00014248|Analgesics|analgesics|mesh-ancestor
64911613|NCT00014248|Sensory System Agents|sensory system agents|mesh-ancestor
64911614|NCT00014248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64911615|NCT00014248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911616|NCT00014248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64911617|NCT00014248|Vasodilator Agents|vasodilator agents|mesh-ancestor
64405738|NCT04871633|Protective Agents|protective agents|mesh-ancestor
64405741|NCT04871633|Antimetabolites|antimetabolites|mesh-ancestor
64911618|NCT00014248|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64911641|NCT00014287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911642|NCT00014287|Antiviral Agents|antiviral agents|mesh-ancestor
64911643|NCT00014287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64911644|NCT00014287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911645|NCT00014287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64911646|NCT00014287|Immunologic Factors|immunologic factors|mesh-ancestor
64911647|NCT00014287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911648|NCT02971930|Factor VIII|factor viii|mesh-list
64911649|NCT02971930|Coagulants|coagulants|mesh-ancestor
64911650|NCT00005978|Carboplatin|carboplatin|mesh-list
64911651|NCT00005978|Etoposide|etoposide|mesh-list
64911652|NCT00005978|Melphalan|melphalan|mesh-list
64911653|NCT00005978|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64911654|NCT00005978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911655|NCT00005978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64911656|NCT00005978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64911657|NCT00005978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64911658|NCT00005978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377038|NCT02504333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64377039|NCT02504333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64911703|NCT00014638|Hormone Antagonists|hormone antagonists|mesh-ancestor
64911704|NCT00014638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64911705|NCT00014638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911706|NCT00001341|Raltitrexed|raltitrexed|mesh-list
64911707|NCT00001341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64911708|NCT00001341|Antimetabolites|antimetabolites|mesh-ancestor
64911709|NCT00001341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911710|NCT00001341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911711|NCT00001341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64911712|NCT00001341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911713|NCT00014677|Interleukin-4|interleukin-4|mesh-list
64911714|NCT00014677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64911715|NCT00014677|Immunologic Factors|immunologic factors|mesh-ancestor
64911716|NCT00014677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911717|NCT00014677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911718|NCT00014677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64911719|NCT00391534|Oxcarbazepine|oxcarbazepine|mesh-list
64911728|NCT00005984|Interferon-alpha|interferon-alpha|mesh-list
64911729|NCT00005984|Cyclophosphamide|cyclophosphamide|mesh-list
64911730|NCT00005984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64911731|NCT00005984|Immunologic Factors|immunologic factors|mesh-ancestor
64911732|NCT00005984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377073|NCT03213743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377074|NCT03213743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64911767|NCT00005987|Antiemetics|antiemetics|mesh-ancestor
64911768|NCT00005987|Autonomic Agents|autonomic agents|mesh-ancestor
64911769|NCT00005987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64911770|NCT00005987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64911771|NCT00005987|Glucocorticoids|glucocorticoids|mesh-ancestor
64911772|NCT00005987|Hormones|hormones|mesh-ancestor
64911773|NCT00005987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64911774|NCT00005987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64911775|NCT00005987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64911776|NCT00005987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64911777|NCT00005987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64911778|NCT00005987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911779|NCT00005987|Antiviral Agents|antiviral agents|mesh-ancestor
64377085|NCT03212495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377086|NCT03212495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64911817|NCT00014989|Sensory System Agents|sensory system agents|mesh-ancestor
64911818|NCT00014989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64911819|NCT00014989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911820|NCT00014989|Anesthetics|anesthetics|mesh-ancestor
64911821|NCT00014989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64911822|NCT00014989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64911823|NCT00014989|Anticonvulsants|anticonvulsants|mesh-ancestor
64911824|NCT00014989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64911825|NCT00014989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64405778|NCT04550195|Histamine Agents|histamine agents|mesh-ancestor
64911826|NCT00014989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911827|NCT00014989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64911828|NCT00014989|Tocolytic Agents|tocolytic agents|mesh-ancestor
64911829|NCT00014989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64911830|NCT00005993|Aldesleukin|aldesleukin|mesh-list
64377128|NCT04496921|Hemostatics|hemostatics|mesh-ancestor
64911884|NCT00015223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911885|NCT00015223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64911890|NCT00015223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64911892|NCT00015301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64911893|NCT00015301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911894|NCT00015301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64911895|NCT00015301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64911985|NCT00015964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911986|NCT00015964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64911987|NCT00015964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64911988|NCT00015964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64911989|NCT01630213|Vitamin D|vitamin d|mesh-list
64911990|NCT01630213|Ergocalciferols|ergocalciferols|mesh-list
64911991|NCT01630213|Cholecalciferol|cholecalciferol|mesh-list
64911992|NCT01630213|Vitamins|vitamins|mesh-list
64911993|NCT01630213|Micronutrients|micronutrients|mesh-ancestor
64911994|NCT01630213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64911995|NCT01630213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64911996|NCT01630213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64911997|NCT00006008|Arsenic Trioxide|arsenic trioxide|mesh-list
64911998|NCT00006008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64911999|NCT00016042|Interferons|interferons|mesh-list
64912000|NCT00016042|Interferon-alpha|interferon-alpha|mesh-list
64912001|NCT00016042|Fluorouracil|fluorouracil|mesh-list
64912002|NCT00016042|Sargramostim|sargramostim|mesh-list
64912003|NCT00016042|Antimetabolites|antimetabolites|mesh-ancestor
64912004|NCT00016042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912005|NCT00016042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64912006|NCT00016042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912007|NCT00016042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64912008|NCT00016042|Immunologic Factors|immunologic factors|mesh-ancestor
64912024|NCT00016159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64912099|NCT00016315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912101|NCT00006014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64912102|NCT00006014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64912103|NCT00006014|Growth Substances|growth substances|mesh-ancestor
64377180|NCT04872231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64377181|NCT04872231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377182|NCT04872231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912177|NCT00016861|Irinotecan|irinotecan|mesh-list
64912178|NCT00016861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64912179|NCT00016861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64912180|NCT00016861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405783|NCT04525391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64405784|NCT04525391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912181|NCT00016861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912182|NCT00016861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912183|NCT00016900|Paclitaxel|paclitaxel|mesh-list
64912184|NCT00016900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64912185|NCT00016900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912186|NCT00016900|Tubulin Modulators|tubulin modulators|mesh-ancestor
64912187|NCT00016900|Antimitotic Agents|antimitotic agents|mesh-ancestor
64912188|NCT00016900|Mitosis Modulators|mitosis modulators|mesh-ancestor
64912189|NCT00016900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912190|NCT00016939|Alvocidib|alvocidib|mesh-list
64912191|NCT00016939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912192|NCT00016939|Growth Inhibitors|growth inhibitors|mesh-ancestor
64912193|NCT00016939|Growth Substances|growth substances|mesh-ancestor
64912199|NCT00386672|Vitamin D|vitamin d|mesh-list
64912210|NCT00016978|Oxaliplatin|oxaliplatin|mesh-list
64912211|NCT00016978|Calcium|calcium|mesh-list
64912212|NCT00016978|Levoleucovorin|levoleucovorin|mesh-list
64912213|NCT00016978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64912256|NCT00006029|Gemcitabine|gemcitabine|mesh-list
64912257|NCT00006029|Doxorubicin|doxorubicin|mesh-list
64912258|NCT00006029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64912259|NCT00006029|Vinorelbine|vinorelbine|mesh-list
64912260|NCT00006029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64912261|NCT00006029|Antimetabolites|antimetabolites|mesh-ancestor
64912262|NCT00006029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912263|NCT00006029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912264|NCT00006029|Antiviral Agents|antiviral agents|mesh-ancestor
64912265|NCT00006029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64912266|NCT00006029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912267|NCT00006029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64912268|NCT00006029|Immunologic Factors|immunologic factors|mesh-ancestor
64912269|NCT00006029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912270|NCT00006029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64912271|NCT00006029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64912272|NCT00006029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64912273|NCT00006029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64912274|NCT00006029|Tubulin Modulators|tubulin modulators|mesh-ancestor
64912275|NCT00006029|Antimitotic Agents|antimitotic agents|mesh-ancestor
64912276|NCT00006029|Mitosis Modulators|mitosis modulators|mesh-ancestor
64912277|NCT00371059|Memantine|memantine|mesh-list
64912278|NCT00371059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64912279|NCT00371059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64912280|NCT00371059|Dopamine Agents|dopamine agents|mesh-ancestor
64912281|NCT00371059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64912372|NCT00006038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912373|NCT00006038|Tubulin Modulators|tubulin modulators|mesh-ancestor
64912374|NCT00006038|Antimitotic Agents|antimitotic agents|mesh-ancestor
64912375|NCT00006038|Mitosis Modulators|mitosis modulators|mesh-ancestor
64912376|NCT00006038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912377|NCT00006038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64912378|NCT00006038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912379|NCT00006038|Antimetabolites|antimetabolites|mesh-ancestor
64912380|NCT00006038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64912381|NCT00006038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64405821|NCT04870541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64405823|NCT04870541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64912382|NCT00006038|Immunologic Factors|immunologic factors|mesh-ancestor
64912384|NCT00006038|Protective Agents|protective agents|mesh-ancestor
64912385|NCT00006038|Vitamin B Complex|vitamin b complex|mesh-ancestor
64912386|NCT00006038|Vitamins|vitamins|mesh-ancestor
64912387|NCT00006038|Micronutrients|micronutrients|mesh-ancestor
64912388|NCT00017290|Prednisone|prednisone|mesh-list
64912389|NCT00017290|Cyclophosphamide|cyclophosphamide|mesh-list
64912390|NCT00017290|Vincristine|vincristine|mesh-list
64912391|NCT00017290|Immunoglobulins|immunoglobulins|mesh-list
64912392|NCT00017290|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64912393|NCT00017290|Antibodies|antibodies|mesh-list
64912394|NCT00017290|Sargramostim|sargramostim|mesh-list
64912395|NCT00017290|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
64912396|NCT00017290|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
64912397|NCT00017290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64912398|NCT00017290|Immunologic Factors|immunologic factors|mesh-ancestor
64912399|NCT00017290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912400|NCT00017290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64912401|NCT00017290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64912402|NCT00017290|Alkylating Agents|alkylating agents|mesh-ancestor
64912404|NCT00017290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912405|NCT00017290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64912406|NCT00017290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64912407|NCT00017290|Glucocorticoids|glucocorticoids|mesh-ancestor
64912409|NCT00017290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64912410|NCT00017290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64912514|NCT00017719|Nelfinavir|nelfinavir|mesh-list
64912515|NCT00017719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64912516|NCT00017719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64912517|NCT00017719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912518|NCT00017719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377277|NCT04849533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64912712|NCT05576194|Taurolidine|taurolidine|mesh-list
64912713|NCT05576194|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64912714|NCT05576194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64912715|NCT05576194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377398|NCT04377087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377399|NCT04377087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912776|NCT00001656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64912777|NCT00001656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912778|NCT00001656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64912780|NCT00001656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64912781|NCT00001656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64912782|NCT00001656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64912783|NCT00001656|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64377415|NCT04859361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64912841|NCT00389415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912912|NCT00001725|Dextromethorphan|dextromethorphan|mesh-list
64912913|NCT00001725|Antitussive Agents|antitussive agents|mesh-ancestor
64912914|NCT00001725|Respiratory System Agents|respiratory system agents|mesh-ancestor
64912915|NCT00001725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64912916|NCT00001725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64912917|NCT00001725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64912918|NCT00001725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912919|NCT00001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912920|NCT05311618|Pembrolizumab|pembrolizumab|mesh-list
64912921|NCT05311618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64377460|NCT03206723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64912965|NCT00392275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64912966|NCT00392275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64912967|NCT00392275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64912968|NCT00392275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64912969|NCT00392275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64912970|NCT00392275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64912971|NCT00392275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64912972|NCT00392275|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64377487|NCT03206177|Mitosis Modulators|mitosis modulators|mesh-ancestor
64377489|NCT04839549|Fluorometholone|fluorometholone|mesh-list
64405933|NCT05256953|Anesthetics|anesthetics|mesh-list
64913000|NCT05171179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64913002|NCT05171179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64913003|NCT05171179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913004|NCT05156905|Docetaxel|docetaxel|mesh-list
64913005|NCT05156905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913006|NCT05156905|Tubulin Modulators|tubulin modulators|mesh-ancestor
64913007|NCT05156905|Antimitotic Agents|antimitotic agents|mesh-ancestor
64913008|NCT05156905|Mitosis Modulators|mitosis modulators|mesh-ancestor
64913009|NCT05156905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913010|NCT00001758|Efavirenz|efavirenz|mesh-list
64913011|NCT00001758|Abacavir|abacavir|mesh-list
64913012|NCT00001758|Amprenavir|amprenavir|mesh-list
64913022|NCT00001758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64913023|NCT00001758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64913024|NCT00001758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64405937|NCT05256719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64405939|NCT05256719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913025|NCT00001758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64913026|NCT00001758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64913027|NCT00001758|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64913028|NCT00001758|Antitubercular Agents|antitubercular agents|mesh-ancestor
64913029|NCT00001758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64913030|NCT00001758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64913031|NCT00001758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64913032|NCT00001758|Protease Inhibitors|protease inhibitors|mesh-ancestor
64913033|NCT00001764|Mycophenolic Acid|mycophenolic acid|mesh-list
64913034|NCT00001764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64913035|NCT00001764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377504|NCT04839471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377509|NCT04839237|Liraglutide|liraglutide|mesh-list
64913081|NCT05591651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913082|NCT05591651|Viscosupplements|viscosupplements|mesh-ancestor
64913083|NCT05591651|Protective Agents|protective agents|mesh-ancestor
64913085|NCT04905121|Hallucinogens|hallucinogens|mesh-ancestor
64913086|NCT04905121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377516|NCT04844775|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64377517|NCT04844775|Immunologic Factors|immunologic factors|mesh-ancestor
64913115|NCT05641623|3-(3-(methylsulfonyl)phenyl)-1-propylpiperidine|3-(3-(methylsulfonyl)phenyl)-1-propylpiperidine|mesh-list
64913116|NCT05641623|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64913117|NCT05641623|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64913118|NCT05641623|Dopamine Agents|dopamine agents|mesh-ancestor
64913119|NCT05641623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64913120|NCT05641623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913121|NCT05641623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913122|NCT05573360|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64913123|NCT05573360|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64913124|NCT04796779|Ferrous fumarate|ferrous fumarate|mesh-list
64913125|NCT04796779|Trace Elements|trace elements|mesh-ancestor
64913126|NCT04796779|Micronutrients|micronutrients|mesh-ancestor
64913127|NCT04796779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913128|NCT05641506|Niraparib|niraparib|mesh-list
64913129|NCT05641506|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64913130|NCT05641506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913131|NCT05641506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913132|NCT05641506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913152|NCT05641467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64913153|NCT05641467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64913155|NCT04734730|Cortisone|cortisone|mesh-list
64913156|NCT04734730|Leuprolide|leuprolide|mesh-list
64913157|NCT04734730|Goserelin|goserelin|mesh-list
64913158|NCT04734730|Abiraterone Acetate|abiraterone acetate|mesh-list
64913159|NCT04734730|Bicalutamide|bicalutamide|mesh-list
64913160|NCT04734730|Talazoparib|talazoparib|mesh-list
64913161|NCT04734730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64913162|NCT04734730|Glucocorticoids|glucocorticoids|mesh-ancestor
64913163|NCT04734730|Hormones|hormones|mesh-ancestor
64377525|NCT03038607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377526|NCT03038607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64377527|NCT03038607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64377528|NCT03038607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64377529|NCT03038607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64377530|NCT03038607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377555|NCT03040401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64377556|NCT03040401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913204|NCT04604782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64913205|NCT04604782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913206|NCT04604782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406114|NCT04341467|Amisulpride|amisulpride|mesh-list
64406115|NCT04341467|Antiemetics|antiemetics|mesh-ancestor
64406116|NCT04341467|Autonomic Agents|autonomic agents|mesh-ancestor
64406117|NCT04341467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64406118|NCT04341467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406119|NCT04341467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64913208|NCT00386867|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64913209|NCT00386867|Abortifacient Agents|abortifacient agents|mesh-ancestor
64377567|NCT03038295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377568|NCT03038295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64453365|NCT02096003|Morphine|morphine|mesh-list
64913243|NCT00392431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64377575|NCT03038217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377576|NCT03038217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377577|NCT02609607|Bisacodyl|bisacodyl|mesh-list
64913305|NCT04733326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64913307|NCT04733326|Sensory System Agents|sensory system agents|mesh-ancestor
64913308|NCT04733326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64913330|NCT03959566|Midazolam|midazolam|mesh-list
64913331|NCT03959566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64913332|NCT03959566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64913333|NCT03959566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64913334|NCT03959566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913335|NCT03959566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64913336|NCT03959566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64913337|NCT03959566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64913338|NCT03959566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64913339|NCT03959566|Anesthetics, General|anesthetics, general|mesh-ancestor
64377619|NCT04838145|Antimetabolites|antimetabolites|mesh-ancestor
64377620|NCT04838145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377621|NCT04838145|Antiviral Agents|antiviral agents|mesh-ancestor
64377622|NCT04838145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377623|NCT04855383|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64377624|NCT04855383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64453418|NCT02023112|Ribavirin|ribavirin|mesh-list
64913393|NCT05640726|Vitamin B Complex|vitamin b complex|mesh-ancestor
64913395|NCT05640726|Micronutrients|micronutrients|mesh-ancestor
64913396|NCT03959176|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64913397|NCT03959176|Phenylephrine|phenylephrine|mesh-list
64377653|NCT04843449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913445|NCT05411861|Sensory System Agents|sensory system agents|mesh-ancestor
64913448|NCT03958513|Bupivacaine|bupivacaine|mesh-list
64913476|NCT03958123|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64913477|NCT03958123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64913478|NCT03958123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64913480|NCT03933865|Hydromorphone|hydromorphone|mesh-list
64913481|NCT03933865|Analgesics|analgesics|mesh-ancestor
64913482|NCT03933865|Sensory System Agents|sensory system agents|mesh-ancestor
64913483|NCT03933865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64913484|NCT03933865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913485|NCT03933865|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64913486|NCT03933865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64913487|NCT03933865|Anesthetics, General|anesthetics, general|mesh-ancestor
64377662|NCT04843449|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64377663|NCT04843449|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64913488|NCT03933865|Anesthetics|anesthetics|mesh-ancestor
64913521|NCT05206175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913523|NCT05206175|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64913524|NCT05206175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64913525|NCT05206175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64913526|NCT05206175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64913527|NCT00392899|Tegafur|tegafur|mesh-list
64913528|NCT00392899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64913529|NCT00392899|Antimetabolites|antimetabolites|mesh-ancestor
64913530|NCT00392899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913531|NCT00392899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913532|NCT05638893|Metformin|metformin|mesh-list
64913533|NCT05638893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64913534|NCT05638893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913535|NCT00392938|Docetaxel|docetaxel|mesh-list
64913536|NCT00392938|Androgen Antagonists|androgen antagonists|mesh-list
64913537|NCT00392938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406185|NCT04865705|Paclitaxel|paclitaxel|mesh-list
64913538|NCT00392938|Tubulin Modulators|tubulin modulators|mesh-ancestor
64913539|NCT00392938|Antimitotic Agents|antimitotic agents|mesh-ancestor
64377740|NCT03040791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64377741|NCT03040791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913578|NCT03508726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913579|NCT03508726|Antioxidants|antioxidants|mesh-ancestor
64913581|NCT03508726|Protective Agents|protective agents|mesh-ancestor
64913606|NCT05634564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913607|NCT05634564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64913608|NCT05634564|Antimetabolites|antimetabolites|mesh-ancestor
64913609|NCT05634564|Antiviral Agents|antiviral agents|mesh-ancestor
64913610|NCT05634564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64913611|NCT05634564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913651|NCT03151876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913652|NCT03151876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64913653|NCT03151876|Immunologic Factors|immunologic factors|mesh-ancestor
64913654|NCT03151876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913655|NCT03151876|Alkylating Agents|alkylating agents|mesh-ancestor
64913656|NCT03151876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64913657|NCT03151876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64913659|NCT03151720|Antipruritics|antipruritics|mesh-ancestor
64913660|NCT03151720|Dermatologic Agents|dermatologic agents|mesh-ancestor
64913661|NCT03151720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64913662|NCT03151720|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64913663|NCT03151720|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64913664|NCT03151720|Histamine Antagonists|histamine antagonists|mesh-ancestor
64913665|NCT03151720|Histamine Agents|histamine agents|mesh-ancestor
64913666|NCT03151720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64913667|NCT03151720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913668|NCT03151720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377817|NCT03038919|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64377819|NCT03038919|Hormones|hormones|mesh-ancestor
64913797|NCT03906539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64913798|NCT03906539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64913799|NCT03906539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913801|NCT00389688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913802|NCT00389688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913859|NCT02972125|Lacosamide|lacosamide|mesh-list
64913860|NCT02972125|Anticonvulsants|anticonvulsants|mesh-ancestor
64913861|NCT02972125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64913862|NCT02972125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64913863|NCT02972125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64913864|NCT02972125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913865|NCT05597553|Pemetrexed|pemetrexed|mesh-list
64913866|NCT05597553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913867|NCT05597553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913868|NCT05597553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913869|NCT05597553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64913870|NCT05597553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64913871|NCT03086044|Sofosbuvir|sofosbuvir|mesh-list
64913872|NCT03086044|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64913873|NCT03086044|Velpatasvir|velpatasvir|mesh-list
64913874|NCT03086044|Antiviral Agents|antiviral agents|mesh-ancestor
64913875|NCT03086044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64913894|NCT02633098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64913895|NCT02633098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64913896|NCT02633098|Antiviral Agents|antiviral agents|mesh-ancestor
64913897|NCT02633098|Schistosomicides|schistosomicides|mesh-ancestor
64913898|NCT02633098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64913899|NCT02633098|Anthelmintics|anthelmintics|mesh-ancestor
64913900|NCT00393289|Calcium|calcium|mesh-list
64913901|NCT00393289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64913902|NCT00393289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913903|NCT02285179|Tamoxifen|tamoxifen|mesh-list
64913904|NCT02285179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64913905|NCT02285179|Hormone Antagonists|hormone antagonists|mesh-ancestor
64913906|NCT02285179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64913907|NCT02285179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913908|NCT02285179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64913909|NCT02285179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377915|NCT04850235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64377916|NCT04850235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377917|NCT04850235|Tubulin Modulators|tubulin modulators|mesh-ancestor
64377918|NCT04850235|Antimitotic Agents|antimitotic agents|mesh-ancestor
64913946|NCT02122081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64913947|NCT02122081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64913948|NCT02122081|Antimetabolites|antimetabolites|mesh-ancestor
64913949|NCT02122081|Dermatologic Agents|dermatologic agents|mesh-ancestor
64913950|NCT02122081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913951|NCT02122081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64913952|NCT02122081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64913953|NCT02122081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64913954|NCT02020720|Fluorides|fluorides|mesh-list
64913955|NCT02020720|Cariostatic Agents|cariostatic agents|mesh-ancestor
64913956|NCT02020720|Protective Agents|protective agents|mesh-ancestor
64913957|NCT02020720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913958|NCT04708886|Alendronate|alendronate|mesh-list
64913959|NCT04708886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64913960|NCT04708886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64913961|NCT00393328|Ritonavir|ritonavir|mesh-list
64913962|NCT00393328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64913963|NCT00393328|Aripiprazole|aripiprazole|mesh-list
64913964|NCT00393328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64913965|NCT00393328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64913966|NCT00393328|Protease Inhibitors|protease inhibitors|mesh-ancestor
64913967|NCT00393328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64913968|NCT00393328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64913969|NCT00393328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64913970|NCT00393328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64913971|NCT00393328|Antiviral Agents|antiviral agents|mesh-ancestor
64913972|NCT00393328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64913973|NCT00393328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64913986|NCT00393328|Serotonin Agents|serotonin agents|mesh-ancestor
64913987|NCT00393328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64913988|NCT00393328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64913989|NCT00393328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64913990|NCT00393328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64913991|NCT05530551|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64913992|NCT05530551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64913993|NCT01807429|Midazolam|midazolam|mesh-list
64913994|NCT01807429|Ketamine|ketamine|mesh-list
64913995|NCT01807429|Morphine|morphine|mesh-list
64913996|NCT01807429|Analgesics|analgesics|mesh-ancestor
64913997|NCT01807429|Sensory System Agents|sensory system agents|mesh-ancestor
64913998|NCT01807429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64913999|NCT01807429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914000|NCT01807429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64914001|NCT01807429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64914002|NCT01807429|Anesthetics, General|anesthetics, general|mesh-ancestor
64914003|NCT01807429|Anesthetics|anesthetics|mesh-ancestor
64914004|NCT01807429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64406203|NCT04865653|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
64406204|NCT04865653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64914005|NCT01807429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64914006|NCT01807429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64914007|NCT01807429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64914008|NCT01807429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377954|NCT03036111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377955|NCT04830579|Etoricoxib|etoricoxib|mesh-list
64914032|NCT01349803|Formoterol Fumarate|formoterol fumarate|mesh-list
64914033|NCT01349803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64914034|NCT01349803|Autonomic Agents|autonomic agents|mesh-ancestor
64914035|NCT01349803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64914036|NCT01349803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914037|NCT01349803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64914038|NCT01349803|Respiratory System Agents|respiratory system agents|mesh-ancestor
64914039|NCT01349803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64914040|NCT01349803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64914041|NCT01349803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64914042|NCT01349803|Adrenergic Agents|adrenergic agents|mesh-ancestor
64914043|NCT01349803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64914044|NCT01349803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914045|NCT01807000|Prucalopride|prucalopride|mesh-list
64914046|NCT01807000|Laxatives|laxatives|mesh-ancestor
64914047|NCT01807000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64914048|NCT01807000|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64914049|NCT01807000|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64914050|NCT01807000|Serotonin Agents|serotonin agents|mesh-ancestor
64914051|NCT01807000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64914052|NCT01807000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914053|NCT01807000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914054|NCT01806805|Zonisamide|zonisamide|mesh-list
64914055|NCT01806805|Anticonvulsants|anticonvulsants|mesh-ancestor
64914056|NCT01806805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64914057|NCT01806805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64914058|NCT01806805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914060|NCT01806805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914065|NCT00387413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64914066|NCT00387413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914068|NCT00387413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914069|NCT00387413|Analgesics|analgesics|mesh-ancestor
64914070|NCT00387413|Sensory System Agents|sensory system agents|mesh-ancestor
64914071|NCT00387413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64914072|NCT00387413|Antidepressive Agents|antidepressive agents|mesh-ancestor
64914073|NCT00387413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64914074|NCT00387413|Dopamine Agents|dopamine agents|mesh-ancestor
64914075|NCT00387413|Vitamin B Complex|vitamin b complex|mesh-ancestor
64914076|NCT00387413|Vitamins|vitamins|mesh-ancestor
64914077|NCT00387413|Micronutrients|micronutrients|mesh-ancestor
64914078|NCT01806610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64914079|NCT01806610|Immunologic Factors|immunologic factors|mesh-ancestor
64406258|NCT04732195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64406259|NCT04732195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406260|NCT04858841|Levetiracetam|levetiracetam|mesh-list
64406263|NCT04858529|Carboplatin|carboplatin|mesh-list
64914080|NCT01806610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377984|NCT02600559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64377985|NCT02600559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914087|NCT05517291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914088|NCT01806571|Cytarabine|cytarabine|mesh-list
64914089|NCT01806571|Daunorubicin|daunorubicin|mesh-list
64914090|NCT01806571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64914091|NCT01806571|Antimetabolites|antimetabolites|mesh-ancestor
64914092|NCT01806571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914093|NCT01806571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914094|NCT01806571|Antiviral Agents|antiviral agents|mesh-ancestor
64914095|NCT01806571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64914103|NCT04590248|Adavosertib|adavosertib|mesh-list
64914107|NCT01806454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64914108|NCT01806454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914109|NCT01806415|Imidazole|imidazole|mesh-list
64914110|NCT01806415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914111|NCT01806415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914112|NCT01806376|Maleic acid|maleic acid|mesh-list
64914113|NCT01806376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914114|NCT01806376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914115|NCT01806337|Alemtuzumab|alemtuzumab|mesh-list
64914116|NCT01806337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64914117|NCT01806337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914118|NCT01806259|Ketorolac|ketorolac|mesh-list
64914119|NCT01806259|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64914120|NCT01806259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64914121|NCT01806259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64914122|NCT01806259|Analgesics|analgesics|mesh-ancestor
64914123|NCT01806259|Sensory System Agents|sensory system agents|mesh-ancestor
64914124|NCT01806259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64914125|NCT01806259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914126|NCT01806259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64914127|NCT01806259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64914128|NCT01806259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64914129|NCT01806259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914130|NCT01806259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914131|NCT05482542|Cyclophosphamide|cyclophosphamide|mesh-list
64914132|NCT05482542|Rituximab|rituximab|mesh-list
64914133|NCT05482542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64914134|NCT05482542|Immunologic Factors|immunologic factors|mesh-ancestor
64914135|NCT05482542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914150|NCT00393562|Methylphenidate|methylphenidate|mesh-list
64914151|NCT00393562|Modafinil|modafinil|mesh-list
64914152|NCT00393562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64914153|NCT00393562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914154|NCT00393562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64914155|NCT00393562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64914156|NCT00393562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64914157|NCT00393562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914158|NCT00393562|Dopamine Agents|dopamine agents|mesh-ancestor
64914159|NCT00393562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64914160|NCT00393562|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64914161|NCT00393562|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64914162|NCT00393562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64914163|NCT01806103|Anti-Infective Agents|anti-infective agents|mesh-list
64914164|NCT01806103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64914165|NCT04551131|Dexamethasone|dexamethasone|mesh-list
64914166|NCT04551131|Etoposide|etoposide|mesh-list
64914167|NCT04551131|Etoposide phosphate|etoposide phosphate|mesh-list
64914168|NCT04551131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64914169|NCT04551131|Antiemetics|antiemetics|mesh-ancestor
64914170|NCT04551131|Autonomic Agents|autonomic agents|mesh-ancestor
64914171|NCT04551131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64914172|NCT04551131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914173|NCT04551131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64914215|NCT04474223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64914216|NCT04474223|Antiemetics|antiemetics|mesh-ancestor
64914217|NCT04474223|Autonomic Agents|autonomic agents|mesh-ancestor
64914218|NCT04474223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64914219|NCT04474223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914220|NCT04474223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64914221|NCT04474223|Glucocorticoids|glucocorticoids|mesh-ancestor
64914222|NCT04474223|Hormones|hormones|mesh-ancestor
64914226|NCT01466530|Misoprostol|misoprostol|mesh-list
64914245|NCT01466452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914246|NCT01466452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64914247|NCT01466452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64914248|NCT01466452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914249|NCT01466452|Antipyretics|antipyretics|mesh-ancestor
64914250|NCT01466374|Antibodies|antibodies|mesh-list
64914251|NCT01466374|Immunoglobulins|immunoglobulins|mesh-list
64914252|NCT01466374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64914253|NCT01466374|Immunologic Factors|immunologic factors|mesh-ancestor
64914254|NCT01466374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914255|NCT01466257|Cetuximab|cetuximab|mesh-list
64914256|NCT01466257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914257|NCT01466257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64914258|NCT04390763|Gemcitabine|gemcitabine|mesh-list
64914259|NCT04390763|Paclitaxel|paclitaxel|mesh-list
64914260|NCT04390763|Spartalizumab|spartalizumab|mesh-list
64914261|NCT04390763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64914262|NCT04390763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914263|NCT04390763|Tubulin Modulators|tubulin modulators|mesh-ancestor
64914264|NCT04390763|Antimitotic Agents|antimitotic agents|mesh-ancestor
64914265|NCT04390763|Mitosis Modulators|mitosis modulators|mesh-ancestor
64914266|NCT04390763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914267|NCT04390763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64914268|NCT04390763|Antimetabolites|antimetabolites|mesh-ancestor
64914269|NCT04390763|Antiviral Agents|antiviral agents|mesh-ancestor
64914270|NCT04390763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64914271|NCT04390763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914272|NCT04390763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64914273|NCT04390763|Immunologic Factors|immunologic factors|mesh-ancestor
64377992|NCT04821843|Paclitaxel|paclitaxel|mesh-list
64914298|NCT01465906|Tiotropium Bromide|tiotropium bromide|mesh-list
64914300|NCT01465906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64914301|NCT01465906|Autonomic Agents|autonomic agents|mesh-ancestor
64914302|NCT01465906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64914303|NCT01465906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914304|NCT01465906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64914305|NCT01465906|Respiratory System Agents|respiratory system agents|mesh-ancestor
64914306|NCT01465906|Parasympatholytics|parasympatholytics|mesh-ancestor
64914307|NCT01465906|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64914308|NCT01465906|Cholinergic Agents|cholinergic agents|mesh-ancestor
64914309|NCT01465906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64914310|NCT01465906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914311|NCT01465906|Anticonvulsants|anticonvulsants|mesh-ancestor
64914312|NCT01465906|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64914313|NCT01465906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64406287|NCT05302999|Antimanic Agents|antimanic agents|mesh-ancestor
64406288|NCT03919435|Trimethoprim|trimethoprim|mesh-list
64406289|NCT03919435|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64914314|NCT01465906|Adrenergic Agents|adrenergic agents|mesh-ancestor
64914315|NCT01465867|Selenium|selenium|mesh-list
64914316|NCT01465867|Antioxidants|antioxidants|mesh-ancestor
64914329|NCT01465828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64914330|NCT01465828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914331|NCT01465828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914332|NCT01465438|Adalimumab|adalimumab|mesh-list
64914333|NCT01465438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64914334|NCT01465438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64914335|NCT01465399|Mitogens|mitogens|mesh-list
64914336|NCT01465399|Mitosis Modulators|mitosis modulators|mesh-ancestor
64914337|NCT01465399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914338|NCT05393505|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64914339|NCT05393505|Amoxicillin|amoxicillin|mesh-list
64914340|NCT05393505|Levofloxacin|levofloxacin|mesh-list
64914341|NCT05393505|Ofloxacin|ofloxacin|mesh-list
64914342|NCT05393505|Meropenem|meropenem|mesh-list
64914343|NCT05393505|Clavulanic Acid|clavulanic acid|mesh-list
64914344|NCT05393505|Clavulanic Acids|clavulanic acids|mesh-list
64914345|NCT05393505|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64914386|NCT01465009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64914387|NCT01465009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914388|NCT01465009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64914389|NCT01465009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64914390|NCT01465009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914391|NCT01465009|Antipyretics|antipyretics|mesh-ancestor
64914392|NCT00389766|Topotecan|topotecan|mesh-list
64914393|NCT00389766|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64914394|NCT00389766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64914395|NCT00389766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64914396|NCT00389766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914397|NCT00389766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914398|NCT00389766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914399|NCT00389766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64914400|NCT01464697|Progesterone|progesterone|mesh-list
64914401|NCT01464697|Progestins|progestins|mesh-ancestor
64914402|NCT01464697|Hormones|hormones|mesh-ancestor
64914403|NCT01464697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64914404|NCT01464697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914420|NCT04083950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64914421|NCT04083950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64914422|NCT04083950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64914423|NCT04083950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64377993|NCT04821843|Nimotuzumab|nimotuzumab|mesh-list
64377994|NCT04821843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64377995|NCT04821843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377996|NCT04821843|Tubulin Modulators|tubulin modulators|mesh-ancestor
64914479|NCT04078568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64914481|NCT04078568|Immunologic Factors|immunologic factors|mesh-ancestor
64914482|NCT01057069|Paclitaxel|paclitaxel|mesh-list
64914483|NCT01057069|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64914485|NCT01057069|Carboplatin|carboplatin|mesh-list
64914486|NCT01057069|Doxorubicin|doxorubicin|mesh-list
64914487|NCT01057069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64914488|NCT01057069|Thiotepa|thiotepa|mesh-list
64914490|NCT01057069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64914538|NCT05327127|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64914539|NCT05327127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914540|NCT05327127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64914541|NCT05327127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914542|NCT00847483|Bimatoprost|bimatoprost|mesh-list
64406331|NCT04682743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64914543|NCT00847483|Travoprost|travoprost|mesh-list
64914544|NCT00847483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64914545|NCT00847483|Latanoprost|latanoprost|mesh-list
64914546|NCT00847483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64914547|NCT00847483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64914548|NCT04034927|Olaparib|olaparib|mesh-list
64914549|NCT04034927|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64914550|NCT04034927|Tremelimumab|tremelimumab|mesh-list
64914551|NCT04034927|Ipilimumab|ipilimumab|mesh-list
64914552|NCT04034927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64914553|NCT04034927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64914554|NCT04034927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64914555|NCT04034927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683014|NCT00000477|Antimetabolites|antimetabolites|mesh-ancestor
64914556|NCT04034927|Immunologic Factors|immunologic factors|mesh-ancestor
64914557|NCT04034927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64914558|NCT04034927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64914559|NCT04034927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64378002|NCT04829487|Ergocalciferols|ergocalciferols|mesh-list
64914560|NCT00847366|Tamoxifen|tamoxifen|mesh-list
64914586|NCT05321160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64378003|NCT04829487|Vitamins|vitamins|mesh-ancestor
64914817|NCT03521570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64378907|NCT04791345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64378908|NCT04791345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378911|NCT04791345|Hormones|hormones|mesh-ancestor
64378928|NCT03674853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64914878|NCT00276757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378951|NCT03230825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64378952|NCT03230825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915016|NCT00394186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915017|NCT00394186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915068|NCT00275548|Ribavirin|ribavirin|mesh-list
64915069|NCT00275548|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64915070|NCT00275548|Antimetabolites|antimetabolites|mesh-ancestor
64379387|NCT05612451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64379388|NCT02151682|Morphine|morphine|mesh-list
64379389|NCT02151682|Tapentadol|tapentadol|mesh-list
64379448|NCT05304273|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64379449|NCT05304273|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64379450|NCT05304273|Luteolytic Agents|luteolytic agents|mesh-ancestor
64915329|NCT04712357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64915330|NCT04712357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380150|NCT05592327|Sequestering Agents|sequestering agents|mesh-ancestor
64380151|NCT05592327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380152|NCT05592171|Chlorotrianisene|chlorotrianisene|mesh-list
64380153|NCT05592171|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64380156|NCT05592171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64380157|NCT05592171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915772|NCT00085345|Arsenic Trioxide|arsenic trioxide|mesh-list
64915773|NCT00085345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64915774|NCT00085345|Alkylating Agents|alkylating agents|mesh-ancestor
64915775|NCT00085345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915776|NCT00085345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915777|NCT00085345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64915778|NCT00085345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64406348|NCT04636333|Vaccines|vaccines|mesh-list
64915779|NCT00085345|Immunologic Factors|immunologic factors|mesh-ancestor
64915780|NCT00085345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915781|NCT00085345|Antioxidants|antioxidants|mesh-ancestor
64915782|NCT00085345|Protective Agents|protective agents|mesh-ancestor
64915783|NCT00085345|Vitamins|vitamins|mesh-ancestor
64915784|NCT00085345|Micronutrients|micronutrients|mesh-ancestor
64915785|NCT00085384|Interferons|interferons|mesh-list
64915786|NCT00085384|Interferon-alpha|interferon-alpha|mesh-list
64915787|NCT00085384|Interferon alpha-2|interferon alpha-2|mesh-list
64915788|NCT00085384|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64915789|NCT00085384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915790|NCT00085384|Antiviral Agents|antiviral agents|mesh-ancestor
64381334|NCT05192889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64381335|NCT05192889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64381336|NCT05192889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64381338|NCT05192889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64381339|NCT05192889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64381340|NCT05192889|Antimetabolites|antimetabolites|mesh-ancestor
64381341|NCT05192889|Dermatologic Agents|dermatologic agents|mesh-ancestor
64381343|NCT05192889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64381344|NCT05192889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64381345|NCT05192889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64381370|NCT03187691|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64381371|NCT03187691|Amebicides|amebicides|mesh-ancestor
64381372|NCT03187691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64915829|NCT00006083|Anticoagulants|anticoagulants|mesh-ancestor
64915830|NCT00006083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64915831|NCT00006083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64915832|NCT00006083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64915833|NCT00085579|Aldesleukin|aldesleukin|mesh-list
64915834|NCT00085579|Sargramostim|sargramostim|mesh-list
64915835|NCT00085579|Immunologic Factors|immunologic factors|mesh-ancestor
64915836|NCT00085579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64915837|NCT00085579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915838|NCT00085579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64915839|NCT00085579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64915840|NCT00085579|Antiviral Agents|antiviral agents|mesh-ancestor
64915841|NCT00085579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64915843|NCT00085696|Bortezomib|bortezomib|mesh-list
64915844|NCT00085696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64915845|NCT00085696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64915846|NCT00085696|Immunologic Factors|immunologic factors|mesh-ancestor
64381386|NCT02433899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381387|NCT02433899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64381388|NCT02433899|Glucocorticoids|glucocorticoids|mesh-ancestor
64381389|NCT02433899|Hormones|hormones|mesh-ancestor
64381390|NCT02433899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64381391|NCT02433899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64381393|NCT02433899|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64381394|NCT02433899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64406391|NCT02996305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64381395|NCT02433899|Disinfectants|disinfectants|mesh-ancestor
64381396|NCT02433899|Dermatologic Agents|dermatologic agents|mesh-ancestor
64381397|NCT02433899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64381399|NCT02433899|Adrenergic Agents|adrenergic agents|mesh-ancestor
64381427|NCT03187457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64381428|NCT03187223|Melphalan|melphalan|mesh-list
64381429|NCT03187223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64381430|NCT03187223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64381431|NCT03187223|Alkylating Agents|alkylating agents|mesh-ancestor
64406393|NCT04866485|Pembrolizumab|pembrolizumab|mesh-list
64381432|NCT03187223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381433|NCT03187223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381434|NCT03187223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64381435|NCT03187223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64381436|NCT03187223|Immunologic Factors|immunologic factors|mesh-ancestor
64381437|NCT03187223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381438|NCT05532111|Cyclophosphamide|cyclophosphamide|mesh-list
64381439|NCT05532111|Rituximab|rituximab|mesh-list
64381440|NCT05532111|Tacrolimus|tacrolimus|mesh-list
64381441|NCT05532111|Glucocorticoids|glucocorticoids|mesh-list
64381442|NCT05532111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64381443|NCT05532111|Immunologic Factors|immunologic factors|mesh-ancestor
64381444|NCT05532111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916131|NCT00006122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64916133|NCT00006122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64916134|NCT00006122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64916135|NCT00006122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916136|NCT00006122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916137|NCT00006122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64916138|NCT00006122|Antimetabolites|antimetabolites|mesh-ancestor
64916139|NCT00006122|Antiviral Agents|antiviral agents|mesh-ancestor
64916140|NCT00006122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64916141|NCT00006122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64916142|NCT00006122|Immunologic Factors|immunologic factors|mesh-ancestor
64916143|NCT00006122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916144|NCT00006122|Analgesics|analgesics|mesh-ancestor
64916145|NCT00006122|Sensory System Agents|sensory system agents|mesh-ancestor
64916146|NCT00006122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64916147|NCT00006122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64916148|NCT00006122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64916149|NCT00087802|Gemcitabine|gemcitabine|mesh-list
64916150|NCT00087802|Paclitaxel|paclitaxel|mesh-list
64916151|NCT00087802|Carboplatin|carboplatin|mesh-list
64916152|NCT00087802|Oxaliplatin|oxaliplatin|mesh-list
64916153|NCT00087802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64916154|NCT00087802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916155|NCT00087802|Tubulin Modulators|tubulin modulators|mesh-ancestor
64916156|NCT00087802|Antimitotic Agents|antimitotic agents|mesh-ancestor
64916157|NCT00087802|Mitosis Modulators|mitosis modulators|mesh-ancestor
64916186|NCT00087880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64916187|NCT00087880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64916188|NCT00087880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64916189|NCT00087880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916191|NCT00087880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64916192|NCT00087880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916193|NCT00087880|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64916194|NCT00087880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64916195|NCT00087880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916196|NCT00088036|Olanzapine|olanzapine|mesh-list
64916220|NCT00088075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64916221|NCT00088075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64916222|NCT00088075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64916223|NCT00088075|Dopamine Agents|dopamine agents|mesh-ancestor
64916224|NCT00088114|Paclitaxel|paclitaxel|mesh-list
64916225|NCT00088114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64916226|NCT00088114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916227|NCT00088114|Tubulin Modulators|tubulin modulators|mesh-ancestor
64916228|NCT00088114|Antimitotic Agents|antimitotic agents|mesh-ancestor
64916229|NCT00088114|Mitosis Modulators|mitosis modulators|mesh-ancestor
64916230|NCT00088114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916231|NCT00006131|Valacyclovir|valacyclovir|mesh-list
64916232|NCT00006131|Antiviral Agents|antiviral agents|mesh-ancestor
64916233|NCT00006131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64916234|NCT00088231|Imatinib Mesylate|imatinib mesylate|mesh-list
64916235|NCT00088231|Vatalanib|vatalanib|mesh-list
64916236|NCT00088231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916237|NCT00088231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64916238|NCT00088231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916239|NCT00088231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916240|NCT00088270|Leucovorin|leucovorin|mesh-list
64916241|NCT00088270|Fluorouracil|fluorouracil|mesh-list
64406407|NCT00136435|Cytarabine|cytarabine|mesh-list
64406408|NCT00136435|Dexamethasone|dexamethasone|mesh-list
64916242|NCT00088270|Antimetabolites|antimetabolites|mesh-ancestor
64916243|NCT00088270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382051|NCT02426177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64382052|NCT02426177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64382053|NCT02426177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382054|NCT02426177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64382055|NCT02426177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382056|NCT02426177|Vasodilator Agents|vasodilator agents|mesh-ancestor
64382057|NCT02426177|Tocolytic Agents|tocolytic agents|mesh-ancestor
64382058|NCT02426177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64916278|NCT00006137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64916279|NCT00006137|Protease Inhibitors|protease inhibitors|mesh-ancestor
64916280|NCT00006137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916281|NCT00006137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916282|NCT00006137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64916283|NCT00088543|Thymoglobulin|thymoglobulin|mesh-list
64916284|NCT00088543|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64916285|NCT00088543|Immunologic Factors|immunologic factors|mesh-ancestor
64916286|NCT00088543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916287|NCT00088543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64916288|NCT00088582|Octreotide|octreotide|mesh-list
64916289|NCT00088582|Pasireotide|pasireotide|mesh-list
64916290|NCT00088582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64916291|NCT00088582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64916292|NCT00088582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916293|NCT00088582|Hormones|hormones|mesh-ancestor
64916297|NCT00088816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916309|NCT04688736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916310|NCT04688736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64916311|NCT00088855|Doxorubicin|doxorubicin|mesh-list
64916312|NCT00088855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64916313|NCT00088855|Bortezomib|bortezomib|mesh-list
64916314|NCT00088855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64916315|NCT00088855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916316|NCT00088855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64916317|NCT00088855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64916318|NCT00088855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916319|NCT00088855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916320|NCT00088894|Gemcitabine|gemcitabine|mesh-list
64382059|NCT02426177|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64382060|NCT02426177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64382061|NCT02426177|Adrenergic Agents|adrenergic agents|mesh-ancestor
64382062|NCT02426177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64916361|NCT00088933|Vaccines|vaccines|mesh-list
64916362|NCT00088933|Sargramostim|sargramostim|mesh-list
64916363|NCT00088933|Immunologic Factors|immunologic factors|mesh-ancestor
64916364|NCT00088933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406436|NCT00136435|Antimetabolites|antimetabolites|mesh-ancestor
64916365|NCT00088933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916366|NCT00088933|Tubulin Modulators|tubulin modulators|mesh-ancestor
64382066|NCT02426177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64916414|NCT00089167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916415|NCT00089167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64916416|NCT00089167|Glucocorticoids|glucocorticoids|mesh-ancestor
64916418|NCT00089167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64916419|NCT00089167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64916420|NCT00089167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916421|NCT00089167|Immunologic Factors|immunologic factors|mesh-ancestor
64916422|NCT00089167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64916423|NCT00089167|Alkylating Agents|alkylating agents|mesh-ancestor
64916424|NCT00089167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916425|NCT00089167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64916426|NCT00089167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64916427|NCT00089167|Leprostatic Agents|leprostatic agents|mesh-ancestor
64916428|NCT00089167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64916429|NCT00089167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64916430|NCT00089167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64916431|NCT00089167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64916432|NCT00089167|Growth Substances|growth substances|mesh-ancestor
64916433|NCT00089167|Growth Inhibitors|growth inhibitors|mesh-ancestor
64916434|NCT00089206|Sargramostim|sargramostim|mesh-list
64916443|NCT00400231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64916444|NCT00400231|Antimetabolites|antimetabolites|mesh-ancestor
64916445|NCT00400231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684898|NCT00002949|Paclitaxel|paclitaxel|mesh-list
64916446|NCT00400231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64916447|NCT00006158|Testosterone|testosterone|mesh-list
64916448|NCT00006158|Androgens|androgens|mesh-ancestor
64916449|NCT00006158|Hormones|hormones|mesh-ancestor
64916450|NCT00006158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64916451|NCT00006158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916452|NCT00423826|Cytarabine|cytarabine|mesh-list
64916453|NCT00423826|Mycophenolic Acid|mycophenolic acid|mesh-list
64916454|NCT00423826|Fludarabine|fludarabine|mesh-list
64916455|NCT00423826|Fludarabine phosphate|fludarabine phosphate|mesh-list
64916456|NCT00423826|Busulfan|busulfan|mesh-list
64916457|NCT00423826|Tacrolimus|tacrolimus|mesh-list
64916458|NCT00423826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916459|NCT00423826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64916460|NCT00423826|Antimetabolites|antimetabolites|mesh-ancestor
64916461|NCT00423826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916462|NCT00423826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64916463|NCT00423826|Immunologic Factors|immunologic factors|mesh-ancestor
64916509|NCT02965261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64916510|NCT02965261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64916511|NCT02965261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916512|NCT00390156|Cyclophosphamide|cyclophosphamide|mesh-list
64916513|NCT00390156|Bevacizumab|bevacizumab|mesh-list
64916514|NCT00390156|Imatinib Mesylate|imatinib mesylate|mesh-list
64916515|NCT00390156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64916516|NCT00390156|Immunologic Factors|immunologic factors|mesh-ancestor
64916518|NCT00390156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64916534|NCT00089401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916535|NCT00089401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916536|NCT00089401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64916537|NCT00089401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64916538|NCT00089401|Immunologic Factors|immunologic factors|mesh-ancestor
64916539|NCT00089401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916540|NCT00089440|Aripiprazole|aripiprazole|mesh-list
64916541|NCT00089440|Antidepressive Agents|antidepressive agents|mesh-ancestor
64916542|NCT00089440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64916580|NCT00089869|Olanzapine|olanzapine|mesh-list
64916581|NCT00089869|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64916582|NCT00089869|Antiemetics|antiemetics|mesh-ancestor
64916583|NCT00089869|Autonomic Agents|autonomic agents|mesh-ancestor
64916584|NCT00089869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64916585|NCT00089869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916586|NCT00089869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64916587|NCT00089869|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64916588|NCT00089869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64916589|NCT00089869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64916590|NCT00089869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64916591|NCT00089869|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64916592|NCT00089869|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64916593|NCT00089869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64916594|NCT00089869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916595|NCT00089869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64916596|NCT00089869|Serotonin Agents|serotonin agents|mesh-ancestor
64916597|NCT00089869|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64916598|NCT00089869|Adrenergic Agents|adrenergic agents|mesh-ancestor
64916599|NCT00006167|Oxandrolone|oxandrolone|mesh-list
64916600|NCT00006167|Androgens|androgens|mesh-ancestor
64916601|NCT00006167|Hormones|hormones|mesh-ancestor
64916602|NCT00006167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64916603|NCT00006167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916604|NCT00006167|Anabolic Agents|anabolic agents|mesh-ancestor
64916605|NCT00089947|Thymoglobulin|thymoglobulin|mesh-list
64916606|NCT00089947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64916626|NCT04633902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64916627|NCT04633902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916628|NCT04633902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64916629|NCT04633902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916630|NCT04633902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916632|NCT00090727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916634|NCT00006185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64916779|NCT00091741|Immunologic Factors|immunologic factors|mesh-ancestor
64916780|NCT00091858|Darbepoetin alfa|darbepoetin alfa|mesh-list
64916781|NCT00091858|Hematinics|hematinics|mesh-ancestor
64916782|NCT00390195|Everolimus|everolimus|mesh-list
64916783|NCT00390195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916784|NCT00390195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64916785|NCT00390195|Immunologic Factors|immunologic factors|mesh-ancestor
64406566|NCT03981211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64916786|NCT00390195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382155|NCT02422277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382158|NCT02422121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64382159|NCT02422121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64382160|NCT02422121|Analgesics|analgesics|mesh-ancestor
64916807|NCT00091936|Antiviral Agents|antiviral agents|mesh-ancestor
64916808|NCT00091936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64916809|NCT00091936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64916810|NCT00091936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64916811|NCT00091936|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64916818|NCT02972346|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64916819|NCT02972346|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64916821|NCT02972346|Hormones|hormones|mesh-ancestor
64916822|NCT02972346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64916823|NCT02972346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916824|NCT02972346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64916825|NCT02972346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916826|NCT00092170|Clavulanic Acid|clavulanic acid|mesh-list
64916827|NCT00092170|Clavulanic Acids|clavulanic acids|mesh-list
64916828|NCT00092170|Ertapenem|ertapenem|mesh-list
64916829|NCT00092170|Ticarcillin|ticarcillin|mesh-list
64916830|NCT00092170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64916831|NCT00092170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916832|NCT00092170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916833|NCT00092170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64916834|NCT00092170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64916835|NCT00006215|Docetaxel|docetaxel|mesh-list
64916836|NCT00006215|Vinorelbine|vinorelbine|mesh-list
64916837|NCT00006215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64916838|NCT00006215|Tubulin Modulators|tubulin modulators|mesh-ancestor
64916839|NCT00006215|Antimitotic Agents|antimitotic agents|mesh-ancestor
64916840|NCT00006215|Mitosis Modulators|mitosis modulators|mesh-ancestor
64382162|NCT02422121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64382163|NCT02422121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382165|NCT02422121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64916873|NCT00092365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64916874|NCT00092365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64916876|NCT00092365|Sensory System Agents|sensory system agents|mesh-ancestor
64916877|NCT00092365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64916878|NCT00092365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916879|NCT00092365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64916880|NCT00092365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64406612|NCT01371981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406613|NCT01371981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64916881|NCT00092365|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64916882|NCT00092365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64916883|NCT00092365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64916884|NCT00092365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916885|NCT00092404|Vaccines|vaccines|mesh-list
64916886|NCT00092404|Immunologic Factors|immunologic factors|mesh-ancestor
64916887|NCT00092404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64916888|NCT04728880|Remdesivir|remdesivir|mesh-list
64916889|NCT04728880|Antimetabolites|antimetabolites|mesh-ancestor
64916904|NCT00093067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64916905|NCT00093184|Anticoagulants|anticoagulants|mesh-list
64916906|NCT00093184|Bivalirudin|bivalirudin|mesh-list
64382268|NCT02423915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64382269|NCT02423915|Antimetabolites|antimetabolites|mesh-ancestor
64382270|NCT02423915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64382271|NCT02423915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64382272|NCT02423915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64382273|NCT02423915|Antitubercular Agents|antitubercular agents|mesh-ancestor
64916953|NCT00093301|Adrenergic Agents|adrenergic agents|mesh-ancestor
64916954|NCT00093301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64382279|NCT02423837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64382290|NCT02140060|Brinzolamide|brinzolamide|mesh-list
64916996|NCT00400348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64916999|NCT00006233|Fludarabine|fludarabine|mesh-list
64917000|NCT00006233|Fludarabine phosphate|fludarabine phosphate|mesh-list
64917001|NCT00006233|Cyclosporins|cyclosporins|mesh-list
64917002|NCT00006233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917003|NCT00006233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64917004|NCT00006233|Antimetabolites|antimetabolites|mesh-ancestor
64917005|NCT00006233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917006|NCT00006233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64917007|NCT00006233|Immunologic Factors|immunologic factors|mesh-ancestor
64917008|NCT00006233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917009|NCT00006233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917010|NCT00006233|Antifungal Agents|antifungal agents|mesh-ancestor
64917011|NCT00006233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917012|NCT00006233|Dermatologic Agents|dermatologic agents|mesh-ancestor
64917013|NCT00006233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64917014|NCT00006233|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64917015|NCT00006233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64917016|NCT00006233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64917017|NCT00006233|Antitubercular Agents|antitubercular agents|mesh-ancestor
64917018|NCT00006233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64917019|NCT02964715|Empagliflozin|empagliflozin|mesh-list
64917022|NCT02964715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64917037|NCT00093925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64917038|NCT00093925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917039|NCT00093925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64917040|NCT00093925|Vasodilator Agents|vasodilator agents|mesh-ancestor
64917081|NCT00094315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64917082|NCT00094315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917083|NCT00094315|Sensory System Agents|sensory system agents|mesh-ancestor
64917084|NCT00094315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64917085|NCT00094315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64917086|NCT00094315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64917087|NCT00094315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64917088|NCT00094315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64917089|NCT00094315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917090|NCT00094315|Dopamine Agents|dopamine agents|mesh-ancestor
64917091|NCT00094315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64917092|NCT00094432|Aripiprazole|aripiprazole|mesh-list
64917093|NCT00094432|Antidepressive Agents|antidepressive agents|mesh-ancestor
64917137|NCT00094549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917138|NCT00094549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64917139|NCT00094549|Serotonin Agents|serotonin agents|mesh-ancestor
64406673|NCT01506973|Hydroxychloroquine|hydroxychloroquine|mesh-list
64917140|NCT00094549|Anticonvulsants|anticonvulsants|mesh-ancestor
64917141|NCT00094549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917142|NCT00094549|GABA Agents|gaba agents|mesh-ancestor
64917143|NCT00094549|Antimanic Agents|antimanic agents|mesh-ancestor
64917144|NCT00094627|Gaboxadol|gaboxadol|mesh-list
64917145|NCT00094627|Analgesics|analgesics|mesh-ancestor
64917146|NCT00094627|Sensory System Agents|sensory system agents|mesh-ancestor
64917147|NCT00094627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64917148|NCT00094627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917149|NCT00094627|Anticonvulsants|anticonvulsants|mesh-ancestor
64917150|NCT00094627|GABA Agonists|gaba agonists|mesh-ancestor
64917151|NCT00094627|GABA Agents|gaba agents|mesh-ancestor
64917152|NCT00094627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64917153|NCT00094627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917154|NCT00094666|Gaboxadol|gaboxadol|mesh-list
64917155|NCT00094666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64917156|NCT00094666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917157|NCT00094666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917158|NCT00094666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64917159|NCT00094666|Analgesics|analgesics|mesh-ancestor
64917160|NCT00094666|Sensory System Agents|sensory system agents|mesh-ancestor
64917161|NCT00094666|Anticonvulsants|anticonvulsants|mesh-ancestor
64917162|NCT00094666|GABA Agonists|gaba agonists|mesh-ancestor
64917163|NCT00094666|GABA Agents|gaba agents|mesh-ancestor
64917164|NCT00006251|Cyclosporine|cyclosporine|mesh-list
64917165|NCT00006251|Mycophenolic Acid|mycophenolic acid|mesh-list
64917166|NCT00006251|Fludarabine|fludarabine|mesh-list
64917167|NCT00006251|Fludarabine phosphate|fludarabine phosphate|mesh-list
64917168|NCT00006251|Cyclosporins|cyclosporins|mesh-list
64382302|NCT02421029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64382303|NCT02421029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917195|NCT00094978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64917196|NCT00095134|Risperidone|risperidone|mesh-list
64917197|NCT00095134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64917204|NCT00095134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64917205|NCT00095134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64917206|NCT00095134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64917207|NCT00095134|Dopamine Agents|dopamine agents|mesh-ancestor
64917208|NCT00006257|Paclitaxel|paclitaxel|mesh-list
64917209|NCT00006257|Semaxinib|semaxinib|mesh-list
64917210|NCT00006257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64917211|NCT00006257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917212|NCT00006257|Tubulin Modulators|tubulin modulators|mesh-ancestor
64917213|NCT00006257|Antimitotic Agents|antimitotic agents|mesh-ancestor
64917214|NCT00006257|Mitosis Modulators|mitosis modulators|mesh-ancestor
64917215|NCT00006257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917216|NCT00006257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64917217|NCT00006257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64917218|NCT00006257|Growth Substances|growth substances|mesh-ancestor
64917219|NCT00006257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917220|NCT00006257|Growth Inhibitors|growth inhibitors|mesh-ancestor
64917221|NCT00006257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64917222|NCT00006257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917223|NCT00095251|Dexmedetomidine|dexmedetomidine|mesh-list
64917224|NCT00095251|Lorazepam|lorazepam|mesh-list
64917238|NCT00095251|Anticonvulsants|anticonvulsants|mesh-ancestor
64917239|NCT00095251|Antiemetics|antiemetics|mesh-ancestor
64917242|NCT00095251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64917243|NCT00095251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64917244|NCT00095251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64917245|NCT00095251|GABA Modulators|gaba modulators|mesh-ancestor
64917246|NCT00095251|GABA Agents|gaba agents|mesh-ancestor
64917247|NCT00006260|Etoposide|etoposide|mesh-list
64917248|NCT00006260|Ifosfamide|ifosfamide|mesh-list
64917249|NCT00006260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917250|NCT00006260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64917251|NCT00006260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64917252|NCT00006260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64917253|NCT00006260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917254|NCT00006260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917255|NCT00006260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64406685|NCT01506973|Antimalarials|antimalarials|mesh-ancestor
64917256|NCT00006260|Alkylating Agents|alkylating agents|mesh-ancestor
64917257|NCT00095329|Sirolimus|sirolimus|mesh-list
64917258|NCT00095329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64917259|NCT00095329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917260|NCT00095329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64917261|NCT00095329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917262|NCT00095329|Antifungal Agents|antifungal agents|mesh-ancestor
64917263|NCT00095329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64917264|NCT00095329|Immunologic Factors|immunologic factors|mesh-ancestor
64917265|NCT00095329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917266|NCT00095368|Amoxicillin|amoxicillin|mesh-list
64917267|NCT00095368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64917268|NCT00095368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917269|NCT00095446|Insulin Aspart|insulin aspart|mesh-list
64917270|NCT00095446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64917271|NCT00095446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917272|NCT00006263|Carboplatin|carboplatin|mesh-list
64917287|NCT00095524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64917288|NCT00095524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917289|NCT00095524|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64917290|NCT00095524|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64917291|NCT00095524|Serotonin Agents|serotonin agents|mesh-ancestor
64917292|NCT00095524|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64917293|NCT00095524|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64917294|NCT00095524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64917295|NCT00095524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64917297|NCT04492566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64917298|NCT00095641|Capecitabine|capecitabine|mesh-list
64917299|NCT00095641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64917300|NCT00095641|Antimetabolites|antimetabolites|mesh-ancestor
64917301|NCT00095641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382346|NCT02072434|Enoxaparin|enoxaparin|mesh-list
64917444|NCT00096304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917445|NCT00096304|Tubulin Modulators|tubulin modulators|mesh-ancestor
64917446|NCT00096304|Antimitotic Agents|antimitotic agents|mesh-ancestor
64917447|NCT00096304|Mitosis Modulators|mitosis modulators|mesh-ancestor
64917448|NCT00096304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917449|NCT00096304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64917450|NCT00096304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64917467|NCT00096616|Respiratory System Agents|respiratory system agents|mesh-ancestor
64917469|NCT00096616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64917470|NCT00096616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64917471|NCT00096616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64917472|NCT00096616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64917473|NCT00096616|Adrenergic Agents|adrenergic agents|mesh-ancestor
64917474|NCT00096616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64917475|NCT00096616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917476|NCT00096655|Infliximab|infliximab|mesh-list
64917477|NCT00096655|Dermatologic Agents|dermatologic agents|mesh-ancestor
64917478|NCT00096655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64917479|NCT00096655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64917480|NCT00096694|Levonorgestrel|levonorgestrel|mesh-list
64917481|NCT00096694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64917482|NCT00096694|Contraceptive Agents|contraceptive agents|mesh-ancestor
64917483|NCT00096694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64917484|NCT00096694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917485|NCT00096694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64917486|NCT00096694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64382380|NCT02139046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382381|NCT02139046|Tubulin Modulators|tubulin modulators|mesh-ancestor
64406688|NCT01506973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64406689|NCT04380545|Interferons|interferons|mesh-list
64382382|NCT02139046|Antimitotic Agents|antimitotic agents|mesh-ancestor
64917542|NCT00097045|Interferon omega 1|interferon omega 1|mesh-list
64917557|NCT04310709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382390|NCT04735354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64917579|NCT00390273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64917580|NCT00390273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917581|NCT00097318|Interferons|interferons|mesh-list
64917582|NCT00097318|Interferon-beta|interferon-beta|mesh-list
64917583|NCT00097318|Interferon beta-1a|interferon beta-1a|mesh-list
64917584|NCT00097318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917585|NCT00097318|Antiviral Agents|antiviral agents|mesh-ancestor
64917606|NCT00006326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917607|NCT00006326|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64917608|NCT00006326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64917609|NCT00006326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64917610|NCT00006326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64917612|NCT00390312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64917613|NCT00390312|Narcotics|narcotics|mesh-ancestor
64917614|NCT00390312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64917615|NCT00390312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917616|NCT00390312|Analgesics|analgesics|mesh-ancestor
64917617|NCT00390312|Sensory System Agents|sensory system agents|mesh-ancestor
64917618|NCT00390312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64917619|NCT00400387|Riboflavin|riboflavin|mesh-list
64917620|NCT00400387|Thiamine|thiamine|mesh-list
64917621|NCT00400387|Pyridoxine|pyridoxine|mesh-list
64917622|NCT00400387|Vitamin B 12|vitamin b 12|mesh-list
64917623|NCT00400387|Folic Acid|folic acid|mesh-list
64917624|NCT00400387|Vitamin B Complex|vitamin b complex|mesh-list
64917625|NCT00400387|Tocopherols|tocopherols|mesh-list
64917626|NCT00400387|Vitamin E|vitamin e|mesh-list
64917627|NCT00400387|Tocotrienols|tocotrienols|mesh-list
64917628|NCT00400387|alpha-Tocopherol|alpha-tocopherol|mesh-list
64917629|NCT00400387|Heparin|heparin|mesh-list
64917630|NCT00400387|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64917631|NCT00400387|Tinzaparin|tinzaparin|mesh-list
64382403|NCT02100670|Menthol|menthol|mesh-list
64382404|NCT02100670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64917632|NCT00400387|Dalteparin|dalteparin|mesh-list
64917633|NCT00400387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917672|NCT00097903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917673|NCT00097942|Memantine|memantine|mesh-list
64917674|NCT00097942|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64917675|NCT00097942|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64917676|NCT00097942|Dopamine Agents|dopamine agents|mesh-ancestor
64406729|NCT00484471|Aripiprazole|aripiprazole|mesh-list
64917677|NCT00097942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64917678|NCT00097942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917679|NCT00097942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917680|NCT00097942|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64917681|NCT00097942|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64917682|NCT04294836|Curcumin|curcumin|mesh-list
64917693|NCT04294836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917694|NCT00098137|Olmesartan|olmesartan|mesh-list
64917695|NCT00098137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64917696|NCT00098137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64917697|NCT00098137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64917698|NCT00098137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917699|NCT00098488|Rituximab|rituximab|mesh-list
64917700|NCT00098488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64917701|NCT00098488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917794|NCT02888067|Anticonvulsants|anticonvulsants|mesh-ancestor
64917795|NCT02888067|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64917796|NCT02888067|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64917797|NCT02888067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64917798|NCT02888067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64917799|NCT02888067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917800|NCT00006350|Mycophenolic Acid|mycophenolic acid|mesh-list
64917801|NCT00006350|Tacrolimus|tacrolimus|mesh-list
64917802|NCT00006350|Daclizumab|daclizumab|mesh-list
64917803|NCT00006350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64917804|NCT00006350|Immunologic Factors|immunologic factors|mesh-ancestor
64917805|NCT00006350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917806|NCT00006350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64917807|NCT00006350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917808|NCT00006350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917809|NCT00006350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64917810|NCT00006350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917811|NCT00006350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64406749|NCT00484471|GABA Agents|gaba agents|mesh-ancestor
64406750|NCT00484471|Antimanic Agents|antimanic agents|mesh-ancestor
64917828|NCT00006353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64917829|NCT00006353|Alkylating Agents|alkylating agents|mesh-ancestor
64917830|NCT00006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917831|NCT00006353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917832|NCT00400738|Ritonavir|ritonavir|mesh-list
64917833|NCT00400738|Lopinavir|lopinavir|mesh-list
64917834|NCT00400738|Saquinavir|saquinavir|mesh-list
64917835|NCT00400738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64917836|NCT00400738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64917837|NCT00400738|Protease Inhibitors|protease inhibitors|mesh-ancestor
64382467|NCT05525481|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64917887|NCT00099775|Antifungal Agents|antifungal agents|mesh-ancestor
64917888|NCT00099775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64917889|NCT00099775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917890|NCT00099775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917939|NCT04071756|Dermatologic Agents|dermatologic agents|mesh-ancestor
64917940|NCT04071756|Keratolytic Agents|keratolytic agents|mesh-ancestor
64917941|NCT00006368|Edotreotide|edotreotide|mesh-list
64917942|NCT00006368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64917943|NCT00006368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917944|NCT00100477|Etoposide|etoposide|mesh-list
64917945|NCT00100477|Mitoxantrone|mitoxantrone|mesh-list
64917946|NCT00100477|Topotecan|topotecan|mesh-list
64917947|NCT00100477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64917948|NCT00100477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64917949|NCT00100477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64917950|NCT00100477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64917951|NCT00100477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64917952|NCT00100477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64917953|NCT00100477|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64917954|NCT00100477|Analgesics|analgesics|mesh-ancestor
64917955|NCT00100477|Sensory System Agents|sensory system agents|mesh-ancestor
64917956|NCT00100477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64917957|NCT00100477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917958|NCT00100555|Zoledronic Acid|zoledronic acid|mesh-list
64917959|NCT00100555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64917960|NCT00100555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64917961|NCT00006371|Ketoconazole|ketoconazole|mesh-list
64917962|NCT00006371|Hydrocortisone|hydrocortisone|mesh-list
64917963|NCT00006371|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64382500|NCT05517213|Alkylating Agents|alkylating agents|mesh-ancestor
64918061|NCT00006380|Immunologic Factors|immunologic factors|mesh-ancestor
64918075|NCT00100906|Antiviral Agents|antiviral agents|mesh-ancestor
64918076|NCT00100906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64918077|NCT00100906|Keratolytic Agents|keratolytic agents|mesh-ancestor
64918078|NCT00100906|Dermatologic Agents|dermatologic agents|mesh-ancestor
64918079|NCT00100945|Gefitinib|gefitinib|mesh-list
64918080|NCT00100945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918081|NCT00100945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64918082|NCT00100945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382533|NCT02099110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382534|NCT02099110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64382535|NCT02099110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64382536|NCT02099110|Immunologic Factors|immunologic factors|mesh-ancestor
64382537|NCT02099110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64382539|NCT02098876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918122|NCT00006386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918123|NCT00006386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918124|NCT00101140|Fludarabine|fludarabine|mesh-list
64918125|NCT00101140|Fludarabine phosphate|fludarabine phosphate|mesh-list
64918126|NCT00101140|Thiotepa|thiotepa|mesh-list
64918127|NCT00101140|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64918128|NCT00101140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918129|NCT00101140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64918130|NCT00101140|Antimetabolites|antimetabolites|mesh-ancestor
64918131|NCT00101140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918132|NCT00101140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64918133|NCT00101140|Immunologic Factors|immunologic factors|mesh-ancestor
64918134|NCT00101140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918135|NCT00101140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64918136|NCT00101140|Alkylating Agents|alkylating agents|mesh-ancestor
64918137|NCT00101140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64918138|NCT00101179|Azacitidine|azacitidine|mesh-list
64406842|NCT02609399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918139|NCT00101179|Entinostat|entinostat|mesh-list
64918140|NCT00101179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
64918141|NCT00101179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64918151|NCT00400777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64918152|NCT00400777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918153|NCT00400777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64918154|NCT00400777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918156|NCT00400777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64918157|NCT00400777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64918158|NCT00400777|Diuretics|diuretics|mesh-ancestor
64918159|NCT00400777|Natriuretic Agents|natriuretic agents|mesh-ancestor
64918160|NCT00400777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64918161|NCT00400816|Temozolomide|temozolomide|mesh-list
64918162|NCT00400816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64918163|NCT00400816|Alkylating Agents|alkylating agents|mesh-ancestor
64918164|NCT00400816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918165|NCT00400816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918166|NCT00400855|Fluticasone|fluticasone|mesh-list
64918167|NCT00400855|Xhance|xhance|mesh-list
64918168|NCT00400855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64918169|NCT00400855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64918170|NCT00400855|Autonomic Agents|autonomic agents|mesh-ancestor
64918171|NCT00400855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64918172|NCT00400855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686636|NCT02267083|Doxorubicin|doxorubicin|mesh-list
64918173|NCT00400855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64382547|NCT01624090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382548|NCT01624090|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64382549|NCT01624090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918288|NCT00101764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918290|NCT00101803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64918291|NCT00101803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918292|NCT00101803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64918293|NCT00101803|Protease Inhibitors|protease inhibitors|mesh-ancestor
64918294|NCT00101803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382555|NCT02571777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64918363|NCT00102622|Tubulin Modulators|tubulin modulators|mesh-ancestor
64918364|NCT00102622|Antimitotic Agents|antimitotic agents|mesh-ancestor
64918365|NCT00102622|Mitosis Modulators|mitosis modulators|mesh-ancestor
64918366|NCT00102622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918367|NCT00006428|Amitriptyline|amitriptyline|mesh-list
64918368|NCT00006428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64918369|NCT00006428|Antidepressive Agents|antidepressive agents|mesh-ancestor
64918388|NCT00102700|Antimetabolites|antimetabolites|mesh-ancestor
64918389|NCT00102700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918390|NCT00102700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918391|NCT00102700|Antiviral Agents|antiviral agents|mesh-ancestor
64918392|NCT00102700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64918393|NCT00102700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918394|NCT00102700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64382571|NCT05511831|Dermatologic Agents|dermatologic agents|mesh-ancestor
64382572|NCT05511831|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64382573|NCT05511831|Histamine Antagonists|histamine antagonists|mesh-ancestor
64918413|NCT00102778|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64918414|NCT00102778|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64918416|NCT00101998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64918417|NCT00102856|Pramipexole|pramipexole|mesh-list
64918418|NCT00102856|Rivastigmine|rivastigmine|mesh-list
64918431|NCT00102856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64918432|NCT00102934|Enfuvirtide|enfuvirtide|mesh-list
64918433|NCT00102934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64918434|NCT00102934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64406843|NCT02609399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918435|NCT00102934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918436|NCT00102934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64918437|NCT00102934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64918438|NCT00102934|Antiviral Agents|antiviral agents|mesh-ancestor
64918439|NCT00102934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64918440|NCT00006443|Lamivudine|lamivudine|mesh-list
64918441|NCT00006443|Stavudine|stavudine|mesh-list
64918442|NCT00006443|Nelfinavir|nelfinavir|mesh-list
64918443|NCT00006443|Indinavir|indinavir|mesh-list
64918444|NCT00006443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64918445|NCT00006443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64918446|NCT00006443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918447|NCT00006443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918448|NCT00006443|Antiviral Agents|antiviral agents|mesh-ancestor
64918449|NCT00006443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64918450|NCT00006443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64918451|NCT00006443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64918452|NCT00006443|Antimetabolites|antimetabolites|mesh-ancestor
64918453|NCT00006443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64918454|NCT00006443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64918455|NCT00006443|Protease Inhibitors|protease inhibitors|mesh-ancestor
64918456|NCT00102973|Carboplatin|carboplatin|mesh-list
64918457|NCT00102973|Doxorubicin|doxorubicin|mesh-list
64918458|NCT00102973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64918480|NCT00103168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64918481|NCT00103168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918482|NCT00103168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918483|NCT02697474|Vaccines|vaccines|mesh-list
64918484|NCT02697474|Immunologic Factors|immunologic factors|mesh-ancestor
64918538|NCT00103792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918539|NCT00103792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64918540|NCT00103792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64918541|NCT00103792|Alkylating Agents|alkylating agents|mesh-ancestor
64918542|NCT00103792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918587|NCT03879408|Respiratory System Agents|respiratory system agents|mesh-ancestor
64918588|NCT00104182|Insulin|insulin|mesh-list
64918589|NCT00104182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64918590|NCT00104182|Insulin Detemir|insulin detemir|mesh-list
64918591|NCT00104182|Isophane Insulin, Human|isophane insulin, human|mesh-list
64918592|NCT00104182|Insulin, Isophane|insulin, isophane|mesh-list
64918593|NCT00104182|Isophane insulin, beef|isophane insulin, beef|mesh-list
64918594|NCT00104182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64918595|NCT00104182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918596|NCT00104260|Verapamil|verapamil|mesh-list
64918597|NCT00104260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64918598|NCT00104260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64918618|NCT00104689|Antimetabolites|antimetabolites|mesh-ancestor
64918619|NCT00104689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382651|NCT03180125|Sensory System Agents|sensory system agents|mesh-ancestor
64918642|NCT00104767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64918643|NCT00104767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64918645|NCT00104767|Sensory System Agents|sensory system agents|mesh-ancestor
64918646|NCT00104767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64918647|NCT00104767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918648|NCT00104767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64918649|NCT00104767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64918650|NCT00104767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64918651|NCT00104767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64918652|NCT00104767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918653|NCT00104767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918655|NCT02972268|Solifenacin Succinate|solifenacin succinate|mesh-list
64918656|NCT02972268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64918657|NCT02972268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64918658|NCT02972268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64918659|NCT02972268|Adrenergic Agents|adrenergic agents|mesh-ancestor
64918660|NCT02972268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64382681|NCT03180281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382682|NCT03180281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64382683|NCT03180281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64382684|NCT03180281|Immunologic Factors|immunologic factors|mesh-ancestor
64382685|NCT03116945|Gallium citrate|gallium citrate|mesh-list
64382686|NCT03116945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382687|NCT03116945|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64382688|NCT03117023|Dexmedetomidine|dexmedetomidine|mesh-list
64382689|NCT03117023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64382690|NCT03117023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64918679|NCT00401128|Antimetabolites|antimetabolites|mesh-ancestor
64918680|NCT00401128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918681|NCT00401128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918682|NCT00401128|Antiviral Agents|antiviral agents|mesh-ancestor
64918683|NCT00401128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64918696|NCT00401167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918697|NCT00401167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64918698|NCT00401167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64918699|NCT00006464|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
64918700|NCT00006464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918701|NCT00006464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64918702|NCT00006464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918703|NCT00006464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918704|NCT00104845|Vaccines|vaccines|mesh-list
64918705|NCT00104845|Immunologic Factors|immunologic factors|mesh-ancestor
64918706|NCT00104845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918707|NCT00104923|Fenretinide|fenretinide|mesh-list
64918708|NCT00104923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918709|NCT00104923|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64918710|NCT00104923|Protective Agents|protective agents|mesh-ancestor
64918711|NCT00104923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918712|NCT00104962|Lenalidomide|lenalidomide|mesh-list
64918713|NCT00104962|Immunologic Factors|immunologic factors|mesh-ancestor
64918714|NCT00104962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918715|NCT00104962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64918716|NCT00104962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64918717|NCT00104962|Growth Substances|growth substances|mesh-ancestor
64918718|NCT00104962|Growth Inhibitors|growth inhibitors|mesh-ancestor
64918747|NCT00105352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918748|NCT03862950|Metformin|metformin|mesh-list
64918749|NCT03862950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64918750|NCT03862950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918751|NCT00105547|Flurbiprofen|flurbiprofen|mesh-list
64918752|NCT00105547|Analgesics|analgesics|mesh-ancestor
64918753|NCT00105547|Sensory System Agents|sensory system agents|mesh-ancestor
64918754|NCT00105547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64918817|NCT00106054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64382699|NCT03117023|Adrenergic Agents|adrenergic agents|mesh-ancestor
64382700|NCT03117023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64382701|NCT03117023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918856|NCT00106288|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64918857|NCT00106288|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64918858|NCT00106288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64918859|NCT00106288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64918860|NCT00106288|Antifungal Agents|antifungal agents|mesh-ancestor
64918861|NCT00006482|Gemcitabine|gemcitabine|mesh-list
64918862|NCT00006482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918863|NCT00006482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64918864|NCT00006482|Antimetabolites|antimetabolites|mesh-ancestor
64918865|NCT00006482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918866|NCT00006482|Antiviral Agents|antiviral agents|mesh-ancestor
64918867|NCT00006482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64918868|NCT00006482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918869|NCT00006482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64918870|NCT00006482|Immunologic Factors|immunologic factors|mesh-ancestor
64918871|NCT00006482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918872|NCT03809988|Letrozole|letrozole|mesh-list
64918873|NCT03809988|Fulvestrant|fulvestrant|mesh-list
64918874|NCT03809988|Palbociclib|palbociclib|mesh-list
64918875|NCT03809988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918876|NCT03809988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64918877|NCT03809988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64918878|NCT03809988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406901|NCT04498273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64918882|NCT03809988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64918883|NCT03809988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918884|NCT03809988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64382706|NCT02097238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64918909|NCT00006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64918910|NCT00006485|Growth Inhibitors|growth inhibitors|mesh-ancestor
64918911|NCT00006485|Growth Substances|growth substances|mesh-ancestor
64918912|NCT00006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918923|NCT00106522|Dermatologic Agents|dermatologic agents|mesh-ancestor
64918924|NCT00106522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64918925|NCT00106522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64918926|NCT00106522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64918927|NCT00106522|Immunologic Factors|immunologic factors|mesh-ancestor
64918928|NCT00106522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64918929|NCT00106522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64918930|NCT00106561|Irbesartan|irbesartan|mesh-list
64918931|NCT00106561|Spironolactone|spironolactone|mesh-list
64918932|NCT00106561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64918933|NCT00106561|Hormone Antagonists|hormone antagonists|mesh-ancestor
64918934|NCT00106561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64918935|NCT00106561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918936|NCT00106561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64918937|NCT00106561|Diuretics|diuretics|mesh-ancestor
64918938|NCT00106561|Natriuretic Agents|natriuretic agents|mesh-ancestor
64918939|NCT00106561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64918940|NCT00106561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64918941|NCT00106561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64382749|NCT02422589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382750|NCT02422589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64382751|NCT02422589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64382752|NCT02422589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64918977|NCT00401362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64918978|NCT00401362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64918979|NCT00401362|Sensory System Agents|sensory system agents|mesh-ancestor
64918980|NCT00401362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64918981|NCT00401362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64918982|NCT00106834|Infliximab|infliximab|mesh-list
64918983|NCT00106834|Dermatologic Agents|dermatologic agents|mesh-ancestor
64918984|NCT00106834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64918985|NCT00106834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64918986|NCT03746106|Thiamine|thiamine|mesh-list
64382777|NCT02416739|Micronutrients|micronutrients|mesh-ancestor
64382778|NCT02416739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382779|NCT02416739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64382780|NCT02416739|Antimetabolites|antimetabolites|mesh-ancestor
64382781|NCT02416739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919068|NCT00107458|Anticonvulsants|anticonvulsants|mesh-ancestor
64919069|NCT00107458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919070|NCT00107458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919071|NCT00107458|GABA Agents|gaba agents|mesh-ancestor
64382788|NCT02416583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382789|NCT02416427|Atorvastatin|atorvastatin|mesh-list
64382790|NCT02416427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64382791|NCT02416427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64382792|NCT02416427|Antimetabolites|antimetabolites|mesh-ancestor
64382793|NCT02416427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382794|NCT02416427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64382795|NCT02416427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64382796|NCT02416427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382797|NCT02416271|Vitamin D|vitamin d|mesh-list
64382798|NCT02416271|Alendronate|alendronate|mesh-list
64382799|NCT02416271|Teriparatide|teriparatide|mesh-list
64382800|NCT02416271|Calcium|calcium|mesh-list
64382801|NCT02416271|Vitamins|vitamins|mesh-ancestor
64382802|NCT02416271|Micronutrients|micronutrients|mesh-ancestor
64382803|NCT02416271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919117|NCT04712396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919119|NCT04712396|Hormone Antagonists|hormone antagonists|mesh-ancestor
64919120|NCT04712396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64919121|NCT04712396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919122|NCT04712396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64919123|NCT00107770|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64919124|NCT00107770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919125|NCT00107809|Modafinil|modafinil|mesh-list
64919126|NCT00107809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64919127|NCT00107809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919128|NCT00107809|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64919129|NCT00107809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64919130|NCT00107809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64919131|NCT00107809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919132|NCT00006656|Ethanol|ethanol|mesh-list
64919133|NCT00006656|Carmustine|carmustine|mesh-list
64919134|NCT00006656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64919135|NCT00006656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919136|NCT00006656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64919137|NCT00006656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919138|NCT00006656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64919139|NCT00006656|Alkylating Agents|alkylating agents|mesh-ancestor
64919140|NCT00006656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919141|NCT00006656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919142|NCT03667482|Cetuximab|cetuximab|mesh-list
64919143|NCT03667482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64382804|NCT02416271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64919172|NCT00006695|Alkylating Agents|alkylating agents|mesh-ancestor
64919173|NCT00006695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64919174|NCT00006695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64919198|NCT00006734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64919199|NCT00006734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919200|NCT00006734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64919201|NCT00006734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64919202|NCT00006734|Tubulin Modulators|tubulin modulators|mesh-ancestor
64919203|NCT00006734|Antimitotic Agents|antimitotic agents|mesh-ancestor
64919204|NCT00006734|Mitosis Modulators|mitosis modulators|mesh-ancestor
64919205|NCT00108238|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64919206|NCT00108238|Estradiol|estradiol|mesh-list
64919207|NCT00108238|Progesterone|progesterone|mesh-list
64919208|NCT00108238|Estrogens|estrogens|mesh-ancestor
64919209|NCT00108238|Hormones|hormones|mesh-ancestor
64919210|NCT00108238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64919211|NCT00108238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919212|NCT00108238|Progestins|progestins|mesh-ancestor
64919213|NCT00108238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64919214|NCT00108238|Hormone Antagonists|hormone antagonists|mesh-ancestor
64919215|NCT00108238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64919216|NCT00108238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64919217|NCT00108238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64919218|NCT03625323|Pembrolizumab|pembrolizumab|mesh-list
64919219|NCT03625323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64919220|NCT03625323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919221|NCT00108316|Fluoxetine|fluoxetine|mesh-list
64919222|NCT00108316|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64919223|NCT00108316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64919226|NCT00108316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64919263|NCT00108667|Levodopa|levodopa|mesh-list
64919264|NCT00108667|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64919265|NCT00108667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64919266|NCT00108667|Dopamine Agents|dopamine agents|mesh-ancestor
64919267|NCT00108667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64919268|NCT00108667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919269|NCT00108667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919270|NCT00006773|Bortezomib|bortezomib|mesh-list
64919271|NCT00006773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919272|NCT00108706|Candesartan|candesartan|mesh-list
64919273|NCT00108706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64919274|NCT00108706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64919275|NCT00108706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64919276|NCT00108706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919277|NCT03619551|Busulfan|busulfan|mesh-list
64919278|NCT03619551|Alkylating Agents|alkylating agents|mesh-ancestor
64919281|NCT03619551|Immunologic Factors|immunologic factors|mesh-ancestor
64919282|NCT03619551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919283|NCT03619551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64919284|NCT03619551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919285|NCT03619551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64919286|NCT00006812|Capecitabine|capecitabine|mesh-list
64919287|NCT00006812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64919288|NCT00006812|Antimetabolites|antimetabolites|mesh-ancestor
64919289|NCT00006812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919290|NCT00006812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919291|NCT00006890|Thalidomide|thalidomide|mesh-list
64919292|NCT00006890|Prednisone|prednisone|mesh-list
64919293|NCT00006890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64919294|NCT00006890|Glucocorticoids|glucocorticoids|mesh-ancestor
64919295|NCT00006890|Hormones|hormones|mesh-ancestor
64919296|NCT00006890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64919297|NCT00006890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919298|NCT00006890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64919299|NCT00006890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919300|NCT00006890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64382811|NCT02416115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64382812|NCT02416115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919358|NCT00006929|Antimitotic Agents|antimitotic agents|mesh-ancestor
64919367|NCT00006968|Cyclosporine|cyclosporine|mesh-list
64919368|NCT00006968|Pentostatin|pentostatin|mesh-list
64919369|NCT00006968|Cyclosporins|cyclosporins|mesh-list
64919370|NCT00006968|Immunologic Factors|immunologic factors|mesh-ancestor
64919371|NCT00006968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919372|NCT00006968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382840|NCT04482881|Misoprostol|misoprostol|mesh-list
64919391|NCT03595917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64919392|NCT03595917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919394|NCT00109408|Methotrexate|methotrexate|mesh-list
64919413|NCT00109564|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64919414|NCT00109564|Cholinergic Agents|cholinergic agents|mesh-ancestor
64919415|NCT00109564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64919416|NCT00109564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919417|NCT00109564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919419|NCT00109603|Antiviral Agents|antiviral agents|mesh-ancestor
64919420|NCT00109603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919421|NCT00109603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64919422|NCT00109603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64919423|NCT00109603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919424|NCT00109603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919425|NCT00109603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64919426|NCT00109603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64919427|NCT00109798|Temozolomide|temozolomide|mesh-list
64919428|NCT00109798|Topotecan|topotecan|mesh-list
64919429|NCT00109798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64919430|NCT00109798|Alkylating Agents|alkylating agents|mesh-ancestor
64919431|NCT00109798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919432|NCT00109798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919433|NCT00109798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64919434|NCT00109798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64919435|NCT00109798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919436|NCT00109954|Cisplatin|cisplatin|mesh-list
64919437|NCT00109954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919438|NCT00109993|Methylprednisolone|methylprednisolone|mesh-list
64919439|NCT00109993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64919440|NCT00109993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64919441|NCT00109993|Prednisolone|prednisolone|mesh-list
64919442|NCT00109993|Prednisolone acetate|prednisolone acetate|mesh-list
64919444|NCT00109993|Tacrolimus|tacrolimus|mesh-list
64919457|NCT00109993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64919458|NCT00109993|Glucocorticoids|glucocorticoids|mesh-ancestor
64919459|NCT00109993|Hormones|hormones|mesh-ancestor
64382860|NCT03176693|Adrenergic Agents|adrenergic agents|mesh-ancestor
64406965|NCT05416125|Dopamine Agents|dopamine agents|mesh-ancestor
64382861|NCT03176693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64919502|NCT00007202|Protease Inhibitors|protease inhibitors|mesh-ancestor
64919503|NCT00007202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919504|NCT00007202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919505|NCT00007202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64382892|NCT02415257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919558|NCT00110734|Lidocaine|lidocaine|mesh-list
64919559|NCT00110734|Tetracaine|tetracaine|mesh-list
64919560|NCT00110734|Anesthetics, Local|anesthetics, local|mesh-ancestor
64919561|NCT00110734|Anesthetics|anesthetics|mesh-ancestor
64919562|NCT00110734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64919563|NCT00110734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919564|NCT00110734|Sensory System Agents|sensory system agents|mesh-ancestor
64919565|NCT00110734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64919566|NCT00110734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64919567|NCT00110734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64919568|NCT00110734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64919569|NCT00110734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64919570|NCT00110734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919571|NCT00110773|Lidocaine|lidocaine|mesh-list
64919572|NCT00110773|Tetracaine|tetracaine|mesh-list
64919573|NCT00110773|Anesthetics, Local|anesthetics, local|mesh-ancestor
64919574|NCT00110773|Anesthetics|anesthetics|mesh-ancestor
64919575|NCT00110773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64919576|NCT00110773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382903|NCT02415179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64919653|NCT00111163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64919655|NCT00111280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64919656|NCT00111280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64919657|NCT00111280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919658|NCT00111280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919659|NCT00111280|Antiviral Agents|antiviral agents|mesh-ancestor
64919660|NCT00111280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919661|NCT00111319|Bortezomib|bortezomib|mesh-list
64919662|NCT00111319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919663|NCT00111397|Interferons|interferons|mesh-list
64919664|NCT00111397|Interferon-gamma|interferon-gamma|mesh-list
64919665|NCT00111397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919666|NCT00111397|Antiviral Agents|antiviral agents|mesh-ancestor
64919667|NCT00111397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919668|NCT00111436|Etanercept|etanercept|mesh-list
64919669|NCT00111436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64919670|NCT00111436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64919671|NCT00111436|Analgesics|analgesics|mesh-ancestor
64919672|NCT00111436|Sensory System Agents|sensory system agents|mesh-ancestor
64919673|NCT00111436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64919674|NCT00111436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919675|NCT00111436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64919676|NCT00111436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64919677|NCT00111436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64919698|NCT00111748|Autonomic Agents|autonomic agents|mesh-ancestor
64919699|NCT00111748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64919700|NCT00111748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919701|NCT00111748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64919702|NCT00111748|Glucocorticoids|glucocorticoids|mesh-ancestor
64919703|NCT00111748|Hormones|hormones|mesh-ancestor
64919704|NCT00111748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64919705|NCT00111748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64919706|NCT00111748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919707|NCT00111748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64919708|NCT00111748|Immunologic Factors|immunologic factors|mesh-ancestor
64919770|NCT00112021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919772|NCT00007358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64919773|NCT00007358|Antiemetics|antiemetics|mesh-ancestor
64919774|NCT00007358|Autonomic Agents|autonomic agents|mesh-ancestor
64919775|NCT00007358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64919806|NCT00007436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919807|NCT00007436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64406975|NCT05244811|Hormones|hormones|mesh-ancestor
64919808|NCT00007436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64919809|NCT00007436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64919810|NCT00007436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919811|NCT00007436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64919812|NCT00007436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64919813|NCT00112216|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64919814|NCT00112216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64919815|NCT00112216|Immunologic Factors|immunologic factors|mesh-ancestor
64919816|NCT00112216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919817|NCT00112372|Sirolimus|sirolimus|mesh-list
64919818|NCT00112372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64919819|NCT00112372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64919820|NCT00112372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64919821|NCT00112372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64919822|NCT00112372|Antifungal Agents|antifungal agents|mesh-ancestor
64919823|NCT00112372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64919824|NCT00112372|Immunologic Factors|immunologic factors|mesh-ancestor
64688286|NCT01866943|Hemostatics|hemostatics|mesh-ancestor
64919825|NCT00112372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919858|NCT00112567|Fludarabine|fludarabine|mesh-list
64919859|NCT00112567|Fludarabine phosphate|fludarabine phosphate|mesh-list
64382951|NCT02414555|Respiratory System Agents|respiratory system agents|mesh-ancestor
64919967|NCT00112879|Growth Substances|growth substances|mesh-ancestor
64919968|NCT00112879|Growth Inhibitors|growth inhibitors|mesh-ancestor
64919969|NCT00112879|Antioxidants|antioxidants|mesh-ancestor
64919970|NCT00112879|Protective Agents|protective agents|mesh-ancestor
64919971|NCT00112879|Vitamins|vitamins|mesh-ancestor
64919972|NCT00112879|Micronutrients|micronutrients|mesh-ancestor
64919973|NCT00112996|Thioctic Acid|thioctic acid|mesh-list
64919974|NCT00112996|Antioxidants|antioxidants|mesh-ancestor
64919975|NCT00112996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64919976|NCT00112996|Protective Agents|protective agents|mesh-ancestor
64919977|NCT00112996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64919979|NCT00112996|Vitamins|vitamins|mesh-ancestor
64919980|NCT00112996|Micronutrients|micronutrients|mesh-ancestor
64919981|NCT00113074|Nicotine|nicotine|mesh-list
64919982|NCT00113074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64919983|NCT00113074|Autonomic Agents|autonomic agents|mesh-ancestor
64919984|NCT00113074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64919986|NCT00113074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64920004|NCT00007787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64920005|NCT00007787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920006|NCT00007787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920007|NCT00007787|Antifungal Agents|antifungal agents|mesh-ancestor
64920008|NCT00007787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64920009|NCT00007787|Dermatologic Agents|dermatologic agents|mesh-ancestor
64920010|NCT00007787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64382999|NCT01663857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920101|NCT03272295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64920103|NCT00007904|Paclitaxel|paclitaxel|mesh-list
64920104|NCT00007904|Cyclophosphamide|cyclophosphamide|mesh-list
64920105|NCT00007904|Doxorubicin|doxorubicin|mesh-list
64920106|NCT00007904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64920107|NCT00007904|Lenograstim|lenograstim|mesh-list
64920108|NCT00007904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64920109|NCT00007904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920110|NCT00007904|Tubulin Modulators|tubulin modulators|mesh-ancestor
64920111|NCT00007904|Antimitotic Agents|antimitotic agents|mesh-ancestor
64920112|NCT00007904|Mitosis Modulators|mitosis modulators|mesh-ancestor
64920113|NCT00007904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920114|NCT00007904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64920115|NCT00007904|Immunologic Factors|immunologic factors|mesh-ancestor
64920116|NCT00007904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920117|NCT00007904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64920118|NCT00007904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64920119|NCT00007904|Alkylating Agents|alkylating agents|mesh-ancestor
64920120|NCT00007904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64920121|NCT00007904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64920122|NCT00007904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64920123|NCT00007904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64920124|NCT00007904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920125|NCT00007904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64920126|NCT00007904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64920127|NCT00007904|Hormone Antagonists|hormone antagonists|mesh-ancestor
64920128|NCT00007904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64920144|NCT00007943|Antimetabolites|antimetabolites|mesh-ancestor
64920145|NCT00007943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920146|NCT00007943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920147|NCT00007943|Antiviral Agents|antiviral agents|mesh-ancestor
64920148|NCT00007943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64920149|NCT00007943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920150|NCT00007943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64920151|NCT00007943|Immunologic Factors|immunologic factors|mesh-ancestor
64920152|NCT00007943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920153|NCT00113971|Epratuzumab|epratuzumab|mesh-list
64920154|NCT00113971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64920155|NCT00113971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920156|NCT00114010|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64920157|NCT00114010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64383042|NCT04887831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64383043|NCT04887831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383044|NCT04887831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64383045|NCT04887831|Immunologic Factors|immunologic factors|mesh-ancestor
64383046|NCT04887831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383106|NCT03176537|Hormones|hormones|mesh-ancestor
64383107|NCT03176537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64383108|NCT03176537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920267|NCT00008021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64920268|NCT00008021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64920269|NCT03079440|Capecitabine|capecitabine|mesh-list
64920270|NCT03079440|Temozolomide|temozolomide|mesh-list
64920272|NCT03079440|Antimetabolites|antimetabolites|mesh-ancestor
64920285|NCT00008060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920347|NCT00008177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64920348|NCT00008177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64920349|NCT00008177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64920350|NCT00008177|Antitubercular Agents|antitubercular agents|mesh-ancestor
64920351|NCT00008177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64920352|NCT00008177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64920353|NCT00008177|Trace Elements|trace elements|mesh-ancestor
64920354|NCT00008177|Micronutrients|micronutrients|mesh-ancestor
64920355|NCT03007407|Durvalumab|durvalumab|mesh-list
64383129|NCT02413541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64920356|NCT03007407|Tremelimumab|tremelimumab|mesh-list
64920357|NCT03007407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64383131|NCT02045836|Vaccines|vaccines|mesh-list
64920433|NCT00115492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64920434|NCT00115492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64920435|NCT00115492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64920531|NCT00115687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64920532|NCT00115687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920534|NCT00115726|Diuretics|diuretics|mesh-ancestor
64920535|NCT00115726|Natriuretic Agents|natriuretic agents|mesh-ancestor
64920536|NCT00115726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920537|NCT00115726|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64920538|NCT00115726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64920539|NCT00115726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920540|NCT00401869|Epoetin Alfa|epoetin alfa|mesh-list
64920541|NCT00401869|Hematinics|hematinics|mesh-ancestor
64920542|NCT00008333|Vinorelbine|vinorelbine|mesh-list
64920589|NCT00008450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64920590|NCT00008450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64920591|NCT00008450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920592|NCT00008450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64920593|NCT00008450|Antitubercular Agents|antitubercular agents|mesh-ancestor
64920594|NCT00008450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64920595|NCT00008489|Didanosine|didanosine|mesh-list
64920596|NCT00008489|Antimetabolites|antimetabolites|mesh-ancestor
64920605|NCT00116350|Misoprostol|misoprostol|mesh-list
64920620|NCT00116389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64920621|NCT00116389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920622|NCT00116389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64406983|NCT05564403|Calcium|calcium|mesh-list
64920623|NCT00116389|Immunologic Factors|immunologic factors|mesh-ancestor
64920624|NCT00116389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920625|NCT00116467|Vaccines|vaccines|mesh-list
64920626|NCT00116467|Immunologic Factors|immunologic factors|mesh-ancestor
64920627|NCT00116467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920628|NCT00008528|Enfuvirtide|enfuvirtide|mesh-list
64920629|NCT00008528|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64920630|NCT00008528|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64920631|NCT00008528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920632|NCT00008528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64920633|NCT00008528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64920634|NCT00008528|Antiviral Agents|antiviral agents|mesh-ancestor
64920635|NCT00008528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64920636|NCT00116506|Bevacizumab|bevacizumab|mesh-list
64920637|NCT00116506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64920638|NCT00116506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64920639|NCT00116506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920640|NCT00116506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64920641|NCT00116506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64920642|NCT00116506|Growth Substances|growth substances|mesh-ancestor
64920643|NCT00116506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920644|NCT00116506|Growth Inhibitors|growth inhibitors|mesh-ancestor
64920727|NCT00388388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64920728|NCT00388388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64920729|NCT00388388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920730|NCT00388388|Diuretics|diuretics|mesh-ancestor
64920731|NCT00388388|Natriuretic Agents|natriuretic agents|mesh-ancestor
64920732|NCT00388388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920733|NCT00388388|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64920734|NCT00388388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64920735|NCT00117013|Topotecan|topotecan|mesh-list
64920736|NCT00117013|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64920737|NCT00117013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64920738|NCT00117013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920739|NCT00117013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920740|NCT00117013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920741|NCT02743455|Vaccines|vaccines|mesh-list
64920742|NCT02743455|Immunologic Factors|immunologic factors|mesh-ancestor
64920743|NCT02743455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920744|NCT00117052|Cinacalcet|cinacalcet|mesh-list
64920745|NCT00117052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64920746|NCT00117052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920747|NCT00117052|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64920748|NCT00117052|Hormone Antagonists|hormone antagonists|mesh-ancestor
64920749|NCT00117052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64920750|NCT00117091|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64920760|NCT00117208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64920761|NCT00117208|Diuretics|diuretics|mesh-ancestor
64920762|NCT00117208|Natriuretic Agents|natriuretic agents|mesh-ancestor
64920763|NCT00117208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920764|NCT00117247|Darbepoetin alfa|darbepoetin alfa|mesh-list
64920765|NCT00117247|Hematinics|hematinics|mesh-ancestor
64920766|NCT00388427|Cetuximab|cetuximab|mesh-list
64920767|NCT00388427|Dasatinib|dasatinib|mesh-list
64920768|NCT00388427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64920769|NCT00388427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920770|NCT00388427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64920771|NCT00388427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920772|NCT00388427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920773|NCT05442463|Angiotensin II|angiotensin ii|mesh-list
64920774|NCT05442463|Giapreza|giapreza|mesh-list
64920775|NCT05442463|Angiotensinogen|angiotensinogen|mesh-list
64920776|NCT05442463|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64920777|NCT05442463|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64920778|NCT05442463|Protease Inhibitors|protease inhibitors|mesh-ancestor
64920779|NCT05442463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920780|NCT05442463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920781|NCT00117364|Sacchachitin|sacchachitin|mesh-list
64920782|NCT00117364|Antioxidants|antioxidants|mesh-ancestor
64920783|NCT00117364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920784|NCT00117364|Protective Agents|protective agents|mesh-ancestor
64920785|NCT00117364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920835|NCT00117832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64920836|NCT00117832|Autonomic Agents|autonomic agents|mesh-ancestor
64920837|NCT00117832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64920838|NCT00117832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920839|NCT00117832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64920840|NCT00117832|Respiratory System Agents|respiratory system agents|mesh-ancestor
64920841|NCT00117832|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64920842|NCT00117832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64920843|NCT00117832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920847|NCT00117832|Histamine Antagonists|histamine antagonists|mesh-ancestor
64920848|NCT00117832|Histamine Agents|histamine agents|mesh-ancestor
64920849|NCT00117832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64920851|NCT05636111|Bevacizumab|bevacizumab|mesh-list
64920852|NCT05636111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64920853|NCT05636111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920854|NCT05636111|Tubulin Modulators|tubulin modulators|mesh-ancestor
64920855|NCT05636111|Antimitotic Agents|antimitotic agents|mesh-ancestor
64920856|NCT05636111|Mitosis Modulators|mitosis modulators|mesh-ancestor
64920857|NCT05636111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920858|NCT05636111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64920859|NCT05636111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64920860|NCT05636111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64920861|NCT05636111|Growth Substances|growth substances|mesh-ancestor
64920862|NCT05636111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920863|NCT05636111|Growth Inhibitors|growth inhibitors|mesh-ancestor
64920906|NCT00118183|Immunologic Factors|immunologic factors|mesh-ancestor
64920907|NCT00118183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920908|NCT00118183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920909|NCT00118183|Tubulin Modulators|tubulin modulators|mesh-ancestor
64920910|NCT00118183|Antimitotic Agents|antimitotic agents|mesh-ancestor
64920911|NCT00118183|Mitosis Modulators|mitosis modulators|mesh-ancestor
64920912|NCT00118183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920913|NCT00390975|Tegaserod|tegaserod|mesh-list
64920914|NCT00390975|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64920915|NCT00390975|Serotonin Agents|serotonin agents|mesh-ancestor
64920916|NCT00390975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64920917|NCT00390975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64920918|NCT00390975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920919|NCT00118222|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
64920920|NCT00118222|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
64920921|NCT00118222|Ether|ether|mesh-list
64920922|NCT00118222|Trioxsalen|trioxsalen|mesh-list
64920923|NCT00118222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920938|NCT00118261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64920939|NCT00118261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64920940|NCT00118261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64920941|NCT00118261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64920942|NCT00118261|Growth Substances|growth substances|mesh-ancestor
64920943|NCT00118261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383448|NCT02409017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383449|NCT00702689|Imatinib Mesylate|imatinib mesylate|mesh-list
64920994|NCT00118690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64920995|NCT00118690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64920996|NCT00118690|Autonomic Agents|autonomic agents|mesh-ancestor
64920997|NCT00118690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64920998|NCT00118690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64920999|NCT00118690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64921000|NCT00118690|Respiratory System Agents|respiratory system agents|mesh-ancestor
64921001|NCT00118690|Dermatologic Agents|dermatologic agents|mesh-ancestor
64921002|NCT00118690|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64921003|NCT00118690|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64921004|NCT00118690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64921005|NCT00118690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64921006|NCT00118690|Adrenergic Agents|adrenergic agents|mesh-ancestor
64407015|NCT05392959|Dapagliflozin|dapagliflozin|mesh-list
64921007|NCT00118690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64921008|NCT00118690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921009|NCT00402142|Vaccines|vaccines|mesh-list
64921010|NCT00402142|Immunologic Factors|immunologic factors|mesh-ancestor
64921011|NCT00402142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921012|NCT00118768|Interferons|interferons|mesh-list
64921013|NCT00118768|Interferon-alpha|interferon-alpha|mesh-list
64921014|NCT00118768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921015|NCT00118768|Antiviral Agents|antiviral agents|mesh-ancestor
64921016|NCT00118768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921037|NCT02706873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64921038|NCT00118807|Artesunate|artesunate|mesh-list
64921039|NCT00118807|Chloroquine|chloroquine|mesh-list
64921040|NCT00118807|Pyrimethamine|pyrimethamine|mesh-list
64921041|NCT00118807|Sulfadoxine|sulfadoxine|mesh-list
64921042|NCT00118807|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64921044|NCT00118807|Antimalarials|antimalarials|mesh-ancestor
64921045|NCT00118807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64921046|NCT00118807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64921047|NCT00118807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921048|NCT00118807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921049|NCT00118807|Antiviral Agents|antiviral agents|mesh-ancestor
64921050|NCT00118807|Schistosomicides|schistosomicides|mesh-ancestor
64383456|NCT02065570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64921100|NCT00119314|Antiviral Agents|antiviral agents|mesh-ancestor
64921101|NCT00119314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921102|NCT00119314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921103|NCT00119314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64921104|NCT00119314|Immunologic Factors|immunologic factors|mesh-ancestor
64921105|NCT00119314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921106|NCT00119314|Tubulin Modulators|tubulin modulators|mesh-ancestor
64921107|NCT00119314|Antimitotic Agents|antimitotic agents|mesh-ancestor
64921108|NCT00119314|Mitosis Modulators|mitosis modulators|mesh-ancestor
64921109|NCT00119431|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64921127|NCT00119704|Cholinergic Agents|cholinergic agents|mesh-ancestor
64921128|NCT00119704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64921129|NCT00119704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921130|NCT00119704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64921131|NCT00119704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64921132|NCT02621151|Gemcitabine|gemcitabine|mesh-list
64921133|NCT02621151|Pembrolizumab|pembrolizumab|mesh-list
64921134|NCT02621151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64921135|NCT02621151|Antimetabolites|antimetabolites|mesh-ancestor
64921136|NCT02621151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921137|NCT02621151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921138|NCT02621151|Antiviral Agents|antiviral agents|mesh-ancestor
64921139|NCT02621151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921140|NCT02621151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921141|NCT02621151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64921142|NCT02621151|Immunologic Factors|immunologic factors|mesh-ancestor
64921143|NCT02621151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921144|NCT02621151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64921180|NCT00402181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921181|NCT00402181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64921182|NCT00402181|Glucocorticoids|glucocorticoids|mesh-ancestor
64921184|NCT00402181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64921185|NCT00402181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64921186|NCT00402181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921187|NCT04727437|Heparin|heparin|mesh-list
64407084|NCT04850885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64407085|NCT04850885|Anesthetics, Local|anesthetics, local|mesh-ancestor
64921188|NCT04727437|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64921189|NCT04727437|Tinzaparin|tinzaparin|mesh-list
64921190|NCT04727437|Dalteparin|dalteparin|mesh-list
64921191|NCT04727437|Warfarin|warfarin|mesh-list
64921192|NCT04727437|Anticoagulants|anticoagulants|mesh-list
64921193|NCT04727437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64921194|NCT04727437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64921195|NCT04727437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921197|NCT02454933|Osimertinib|osimertinib|mesh-list
64921198|NCT02454933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64921199|NCT02454933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64921200|NCT02454933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64921201|NCT02454933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921202|NCT02454933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921203|NCT00120367|Tenofovir|tenofovir|mesh-list
64921204|NCT00120367|Emtricitabine|emtricitabine|mesh-list
64921205|NCT00120367|Enfuvirtide|enfuvirtide|mesh-list
64921206|NCT00120367|Antiviral Agents|antiviral agents|mesh-ancestor
64921207|NCT00120367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64383459|NCT02408705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64921237|NCT00120601|Acamprosate|acamprosate|mesh-list
64921238|NCT00120601|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64921239|NCT00120601|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64921240|NCT00120601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921241|NCT00120601|Sensory System Agents|sensory system agents|mesh-ancestor
64921242|NCT00120601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64921243|NCT05637164|Norepinephrine|norepinephrine|mesh-list
64921244|NCT05637164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64921245|NCT05637164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64921246|NCT05637164|Adrenergic Agents|adrenergic agents|mesh-ancestor
64921247|NCT05637164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64921248|NCT05637164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921249|NCT05637164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921250|NCT05637164|Sympathomimetics|sympathomimetics|mesh-ancestor
64921251|NCT05637164|Autonomic Agents|autonomic agents|mesh-ancestor
64921252|NCT05637164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64921253|NCT05637164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64921254|NCT00120640|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
64921260|NCT00120640|Progestins|progestins|mesh-ancestor
64921262|NCT00120679|Epoetin Alfa|epoetin alfa|mesh-list
64921263|NCT00120679|Darbepoetin alfa|darbepoetin alfa|mesh-list
64921264|NCT00120679|Hematinics|hematinics|mesh-ancestor
64921265|NCT00120718|Fasudil|fasudil|mesh-list
64921266|NCT00120718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64383460|NCT02408705|Analgesics|analgesics|mesh-ancestor
64383461|NCT02408705|Sensory System Agents|sensory system agents|mesh-ancestor
64383462|NCT02408705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64383463|NCT02408705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383464|NCT02408705|Antipyretics|antipyretics|mesh-ancestor
64383465|NCT02408705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64921311|NCT00121147|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64921312|NCT00121147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64921313|NCT00121147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64921314|NCT00121147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64921315|NCT00121147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64921316|NCT00121147|Adrenergic Agents|adrenergic agents|mesh-ancestor
64921317|NCT00121147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64921318|NCT00121147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383474|NCT05509569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689903|NCT00370097|Xhance|xhance|mesh-list
64921420|NCT04705948|Anesthetics|anesthetics|mesh-ancestor
64921441|NCT00121888|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64921442|NCT00121888|Antidepressive Agents|antidepressive agents|mesh-ancestor
64921443|NCT00121888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64921444|NCT00121888|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64921445|NCT00121888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64921446|NCT00121888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921447|NCT00121966|Insulin|insulin|mesh-list
64921613|NCT00819780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64921614|NCT00819780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64921615|NCT00819780|Growth Substances|growth substances|mesh-ancestor
64921616|NCT00819780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921617|NCT00819780|Growth Inhibitors|growth inhibitors|mesh-ancestor
64921618|NCT00128908|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64921619|NCT00128908|Antiviral Agents|antiviral agents|mesh-ancestor
64921620|NCT00128908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921621|NCT00128791|Nitroprusside|nitroprusside|mesh-list
64921622|NCT00128791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64921623|NCT00128791|Vasodilator Agents|vasodilator agents|mesh-ancestor
64921624|NCT00128791|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64921625|NCT00128791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921626|NCT00128752|Beta Carotene|beta carotene|mesh-list
64921627|NCT00128752|Carotenoids|carotenoids|mesh-list
64921628|NCT00128752|Antioxidants|antioxidants|mesh-ancestor
64921629|NCT00128752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921630|NCT00128752|Protective Agents|protective agents|mesh-ancestor
64921631|NCT00128752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921632|NCT00128752|Provitamins|provitamins|mesh-ancestor
64921634|NCT00128752|Micronutrients|micronutrients|mesh-ancestor
64921635|NCT05638295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64921636|NCT05638295|Panitumumab|panitumumab|mesh-list
64921637|NCT05638295|Antibodies|antibodies|mesh-list
64921638|NCT05638295|Immunoglobulins|immunoglobulins|mesh-list
64921639|NCT05638295|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64921640|NCT05638295|Immunologic Factors|immunologic factors|mesh-ancestor
64921669|NCT05638763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921670|NCT05638763|Antifungal Agents|antifungal agents|mesh-ancestor
64921671|NCT05638763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921672|NCT05638763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64921673|NCT05638763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64921674|NCT05638763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64921675|NCT05638763|Hormone Antagonists|hormone antagonists|mesh-ancestor
64921676|NCT05638763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64921693|NCT00128557|Vitamins|vitamins|mesh-ancestor
64921694|NCT00128557|Micronutrients|micronutrients|mesh-ancestor
64921695|NCT00128557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921696|NCT00128518|Perindopril|perindopril|mesh-list
64921697|NCT00128518|Indapamide|indapamide|mesh-list
64921698|NCT00128518|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64921699|NCT00128518|Protease Inhibitors|protease inhibitors|mesh-ancestor
64921700|NCT00128518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921701|NCT00128518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921702|NCT00128518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64921703|NCT00128518|Diuretics|diuretics|mesh-ancestor
64921704|NCT00128518|Natriuretic Agents|natriuretic agents|mesh-ancestor
64921705|NCT00128518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921706|NCT00128518|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64921707|NCT00128518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64921708|NCT00009204|Perphenazine|perphenazine|mesh-list
64921709|NCT00009204|Citalopram|citalopram|mesh-list
64921710|NCT00009204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64921711|NCT00009204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64921712|NCT00009204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64921748|NCT00009555|Androgens|androgens|mesh-ancestor
64921749|NCT00009555|Hormones|hormones|mesh-ancestor
64383512|NCT03116321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64383514|NCT03174041|Itraconazole|itraconazole|mesh-list
64921796|NCT00128323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64921797|NCT00128323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921798|NCT00128323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64921799|NCT00009672|Morphine|morphine|mesh-list
64921800|NCT00009672|Nortriptyline|nortriptyline|mesh-list
64921801|NCT00009672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64921802|NCT00009672|Narcotics|narcotics|mesh-ancestor
64921803|NCT00009672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64921804|NCT00009672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921805|NCT00009672|Analgesics|analgesics|mesh-ancestor
64921806|NCT00009672|Sensory System Agents|sensory system agents|mesh-ancestor
64921807|NCT00009672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64383524|NCT03174041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64383525|NCT03174041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64921835|NCT00018733|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64921837|NCT00018733|Adrenergic Agents|adrenergic agents|mesh-ancestor
64921838|NCT00018850|Haloperidol|haloperidol|mesh-list
64921839|NCT00018850|Ondansetron|ondansetron|mesh-list
64921840|NCT00018850|Haloperidol decanoate|haloperidol decanoate|mesh-list
64921841|NCT00018850|Nicotine|nicotine|mesh-list
64921842|NCT00018850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64921843|NCT00018850|Autonomic Agents|autonomic agents|mesh-ancestor
64921844|NCT00018850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64921845|NCT00018850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64921846|NCT00018850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64921847|NCT00018850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64921848|NCT00018850|Cholinergic Agents|cholinergic agents|mesh-ancestor
64921849|NCT00018850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64921850|NCT00018850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64921851|NCT00018850|Antiemetics|antiemetics|mesh-ancestor
64921852|NCT00018850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64921853|NCT00018850|Antipruritics|antipruritics|mesh-ancestor
64921854|NCT00018850|Dermatologic Agents|dermatologic agents|mesh-ancestor
64921855|NCT00018850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64921856|NCT00018850|Serotonin Agents|serotonin agents|mesh-ancestor
64383667|NCT03116087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64383671|NCT03116087|Anabolic Agents|anabolic agents|mesh-ancestor
64921969|NCT00019474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64921971|NCT00019474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64921972|NCT00019474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64921973|NCT00019513|Leucovorin|leucovorin|mesh-list
64922081|NCT00020176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64922082|NCT00020176|Immunologic Factors|immunologic factors|mesh-ancestor
64922083|NCT00020176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922084|NCT00020176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64922085|NCT00020176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64922086|NCT00020176|Alkylating Agents|alkylating agents|mesh-ancestor
64922087|NCT00020176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922088|NCT00020176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922089|NCT00020176|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64922090|NCT00020176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64922108|NCT00020254|Androgen Antagonists|androgen antagonists|mesh-ancestor
64922109|NCT00020254|Hormone Antagonists|hormone antagonists|mesh-ancestor
64922110|NCT00020254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64922111|NCT00009984|Thalidomide|thalidomide|mesh-list
64922112|NCT00009984|Fludarabine|fludarabine|mesh-list
64922113|NCT00009984|Fludarabine phosphate|fludarabine phosphate|mesh-list
64922114|NCT00009984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922115|NCT00009984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64922116|NCT00009984|Antimetabolites|antimetabolites|mesh-ancestor
64922117|NCT00009984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922118|NCT00009984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64922119|NCT00009984|Immunologic Factors|immunologic factors|mesh-ancestor
64922120|NCT00009984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383776|NCT04289805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64383777|NCT04289805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64922176|NCT00020488|Irinotecan|irinotecan|mesh-list
64922177|NCT00020488|Calcium|calcium|mesh-list
64922178|NCT00020488|Levoleucovorin|levoleucovorin|mesh-list
64922179|NCT00020488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64922180|NCT00020488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383798|NCT05505591|Cangrelor|cangrelor|mesh-list
64922181|NCT00020488|Antimetabolites|antimetabolites|mesh-ancestor
64922230|NCT00010062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922231|NCT00010062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64922246|NCT00020644|Antiviral Agents|antiviral agents|mesh-ancestor
64922247|NCT00020644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64922248|NCT00020644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922249|NCT00020644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64922250|NCT00020644|Immunologic Factors|immunologic factors|mesh-ancestor
64922251|NCT00020644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922252|NCT00020761|Paclitaxel|paclitaxel|mesh-list
64922254|NCT00020761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64922255|NCT00020761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922256|NCT00020761|Tubulin Modulators|tubulin modulators|mesh-ancestor
64922257|NCT00020761|Antimitotic Agents|antimitotic agents|mesh-ancestor
64922258|NCT00020761|Mitosis Modulators|mitosis modulators|mesh-ancestor
64922259|NCT00020761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922260|NCT00020761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64922261|NCT00020761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64922290|NCT00010140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64922292|NCT00010140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64922293|NCT00010140|Hormone Antagonists|hormone antagonists|mesh-ancestor
64922294|NCT00010140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64922295|NCT00010140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922296|NCT00010140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64922297|NCT00010140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64922298|NCT00010140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64922299|NCT00010140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64922301|NCT00020878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64922302|NCT00020878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64922303|NCT00020878|Analgesics|analgesics|mesh-ancestor
64922304|NCT00020878|Sensory System Agents|sensory system agents|mesh-ancestor
64922305|NCT00020878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64922306|NCT00020878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922307|NCT00020878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64922308|NCT00020878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64922309|NCT00020878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64922310|NCT00020878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64922311|NCT00020878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922312|NCT00020878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922313|NCT00020917|Leucovorin|leucovorin|mesh-list
64922335|NCT00020917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64922337|NCT00021034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64922338|NCT00021034|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64922339|NCT00021034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922340|NCT00010179|Lurtotecan|lurtotecan|mesh-list
64922341|NCT00010179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922342|NCT00021073|Leucovorin|leucovorin|mesh-list
64922343|NCT00021073|Fluorouracil|fluorouracil|mesh-list
64922344|NCT00021073|Irinotecan|irinotecan|mesh-list
64922345|NCT00021073|Alvocidib|alvocidib|mesh-list
64922346|NCT00021073|Calcium|calcium|mesh-list
64922347|NCT00021073|Levoleucovorin|levoleucovorin|mesh-list
64922348|NCT00021073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64922349|NCT00021073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922350|NCT00021073|Antimetabolites|antimetabolites|mesh-ancestor
64383842|NCT02063854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64383843|NCT02063854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64922389|NCT00021307|Carboplatin|carboplatin|mesh-list
64922390|NCT00021307|Temozolomide|temozolomide|mesh-list
64922391|NCT00021307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922392|NCT00021307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64922393|NCT00021307|Alkylating Agents|alkylating agents|mesh-ancestor
64922394|NCT00021307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922395|NCT00021346|Gemcitabine|gemcitabine|mesh-list
64922396|NCT00021346|Carboplatin|carboplatin|mesh-list
64922397|NCT00021346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922398|NCT00021346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64922399|NCT00021346|Antimetabolites|antimetabolites|mesh-ancestor
64922400|NCT00021346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922401|NCT00021346|Antiviral Agents|antiviral agents|mesh-ancestor
64922402|NCT00021346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64407154|NCT03040193|Anesthetics, Local|anesthetics, local|mesh-ancestor
64407155|NCT03040193|Anesthetics|anesthetics|mesh-ancestor
64407158|NCT03040193|Sensory System Agents|sensory system agents|mesh-ancestor
64922403|NCT00021346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922449|NCT00000134|Ganciclovir|ganciclovir|mesh-list
64922450|NCT00000134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64922451|NCT00000134|Foscarnet|foscarnet|mesh-list
64922452|NCT00000134|Antiviral Agents|antiviral agents|mesh-ancestor
64922453|NCT00000134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64922454|NCT00000134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64922465|NCT00010413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922466|NCT00010413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922467|NCT00010413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64922469|NCT00010452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922470|NCT00394693|Interferons|interferons|mesh-list
64922471|NCT00394693|Interferon-gamma|interferon-gamma|mesh-list
64922472|NCT00394693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922473|NCT00394693|Antiviral Agents|antiviral agents|mesh-ancestor
64383844|NCT02063854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383904|NCT02565147|Anticoagulants|anticoagulants|mesh-ancestor
64383905|NCT02565147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64383906|NCT02565147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64922516|NCT00022048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922517|NCT00022048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64922518|NCT00022048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64922519|NCT00022048|Growth Substances|growth substances|mesh-ancestor
64922520|NCT00022048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922521|NCT00022048|Growth Inhibitors|growth inhibitors|mesh-ancestor
64922522|NCT00022087|Vitamin D|vitamin d|mesh-list
64922523|NCT00022087|Cholecalciferol|cholecalciferol|mesh-list
64922524|NCT00022087|Zoledronic Acid|zoledronic acid|mesh-list
64922546|NCT00388700|Antidotes|antidotes|mesh-ancestor
64922547|NCT00388700|Protective Agents|protective agents|mesh-ancestor
64922548|NCT00388700|Vitamin B Complex|vitamin b complex|mesh-ancestor
64922549|NCT00388700|Vitamins|vitamins|mesh-ancestor
64922550|NCT00388700|Micronutrients|micronutrients|mesh-ancestor
64922551|NCT00022126|Cytarabine|cytarabine|mesh-list
64922552|NCT00022126|Cyclosporine|cyclosporine|mesh-list
64690998|NCT04669171|Rituximab|rituximab|mesh-list
64922553|NCT00022126|Dexamethasone|dexamethasone|mesh-list
64922554|NCT00022126|Methylprednisolone|methylprednisolone|mesh-list
64922555|NCT00022126|Cyclophosphamide|cyclophosphamide|mesh-list
64922556|NCT00022126|Doxorubicin|doxorubicin|mesh-list
64922557|NCT00022126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64922558|NCT00022126|Methotrexate|methotrexate|mesh-list
64922559|NCT00022126|Vincristine|vincristine|mesh-list
64922560|NCT00022126|Daunorubicin|daunorubicin|mesh-list
64922561|NCT00022126|Asparaginase|asparaginase|mesh-list
64922562|NCT00022126|Mercaptopurine|mercaptopurine|mesh-list
64922563|NCT00022126|Pegaspargase|pegaspargase|mesh-list
64922564|NCT00022126|Thioguanine|thioguanine|mesh-list
64922565|NCT00022126|Cyclosporins|cyclosporins|mesh-list
64922566|NCT00022126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64922567|NCT00022126|Immunologic Factors|immunologic factors|mesh-ancestor
64922568|NCT00022126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922569|NCT00022126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64922570|NCT00022126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64922571|NCT00022126|Alkylating Agents|alkylating agents|mesh-ancestor
64922572|NCT00022126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922573|NCT00022126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922574|NCT00022126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64922575|NCT00022126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64922576|NCT00022126|Antiemetics|antiemetics|mesh-ancestor
64922577|NCT00022126|Autonomic Agents|autonomic agents|mesh-ancestor
64922579|NCT00022126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64922585|NCT00022126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64922586|NCT00022126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64922614|NCT00022204|Pentoxifylline|pentoxifylline|mesh-list
64922615|NCT00022204|Vitamins|vitamins|mesh-ancestor
64922616|NCT00022204|Micronutrients|micronutrients|mesh-ancestor
64922617|NCT00022204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922618|NCT00022204|Antioxidants|antioxidants|mesh-ancestor
64922619|NCT00022204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922620|NCT00022204|Protective Agents|protective agents|mesh-ancestor
64922621|NCT00022204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64922622|NCT00022204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922623|NCT00022204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64922624|NCT00022204|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64922625|NCT00022204|Vasodilator Agents|vasodilator agents|mesh-ancestor
64922626|NCT00022204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64922627|NCT00388739|Prednisolone|prednisolone|mesh-list
64922628|NCT00388739|Budesonide|budesonide|mesh-list
64922629|NCT00388739|Albuterol|albuterol|mesh-list
64922630|NCT00388739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64922631|NCT00388739|Glucocorticoids|glucocorticoids|mesh-ancestor
64922632|NCT00388739|Hormones|hormones|mesh-ancestor
64922633|NCT00388739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64922634|NCT00388739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922669|NCT00022399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922671|NCT00000143|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64922672|NCT00000143|Cidofovir|cidofovir|mesh-list
64922673|NCT00000143|Antiviral Agents|antiviral agents|mesh-ancestor
64922674|NCT00000143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64922675|NCT00000143|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64922676|NCT00000143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922677|NCT00000143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922678|NCT00022438|Aldesleukin|aldesleukin|mesh-list
64922679|NCT00022438|Freund's Adjuvant|freund's adjuvant|mesh-list
64922680|NCT00022438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922681|NCT00022438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64922682|NCT00022438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64922683|NCT00022438|Antiviral Agents|antiviral agents|mesh-ancestor
64922684|NCT00022438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64922685|NCT00022438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64922686|NCT00022438|Immunologic Factors|immunologic factors|mesh-ancestor
64922728|NCT00010725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922729|NCT00022594|Lurtotecan|lurtotecan|mesh-list
64922730|NCT00022594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64922731|NCT00000149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64922732|NCT00000149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64922737|NCT00022711|Temozolomide|temozolomide|mesh-list
64922746|NCT00010842|Micronutrients|micronutrients|mesh-ancestor
64922747|NCT00010842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384002|NCT05504265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64922808|NCT00022945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64922809|NCT00022945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64922810|NCT00022945|Tubulin Modulators|tubulin modulators|mesh-ancestor
64922811|NCT00022945|Antimitotic Agents|antimitotic agents|mesh-ancestor
64922812|NCT00022945|Mitosis Modulators|mitosis modulators|mesh-ancestor
64922813|NCT00023218|Ritonavir|ritonavir|mesh-list
64922814|NCT00023218|Lopinavir|lopinavir|mesh-list
64922815|NCT00023218|Efavirenz|efavirenz|mesh-list
64922816|NCT00023218|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64922817|NCT00023218|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64922818|NCT00023218|Protease Inhibitors|protease inhibitors|mesh-ancestor
64922819|NCT00023218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922828|NCT00023218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64922829|NCT00023218|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64922830|NCT00023218|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64922831|NCT00023218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64922832|NCT00023218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64922833|NCT00023218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64922834|NCT00394966|Rolapitant|rolapitant|mesh-list
64922835|NCT00394966|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64922836|NCT00394966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64407207|NCT05339113|FAPI-46|fapi-46|mesh-list
64407208|NCT05339113|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64922837|NCT00394966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922838|NCT00394966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922839|NCT00000170|Atropine|atropine|mesh-list
64922840|NCT00000170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64922841|NCT00000170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64922842|NCT00000170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64922843|NCT00000170|Autonomic Agents|autonomic agents|mesh-ancestor
64922844|NCT00000170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64922845|NCT00000170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64922846|NCT00000170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64922847|NCT00000170|Respiratory System Agents|respiratory system agents|mesh-ancestor
64922848|NCT00000170|Mydriatics|mydriatics|mesh-ancestor
64922849|NCT00000170|Parasympatholytics|parasympatholytics|mesh-ancestor
64922850|NCT00000170|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64922851|NCT00000170|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64922852|NCT00000170|Cholinergic Agents|cholinergic agents|mesh-ancestor
64922853|NCT00000170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64922854|NCT00000170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64922855|NCT02024607|Leucovorin|leucovorin|mesh-list
64922856|NCT02024607|Bevacizumab|bevacizumab|mesh-list
64922872|NCT02024607|Immunologic Factors|immunologic factors|mesh-ancestor
64922873|NCT02024607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64922874|NCT02024607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64922875|NCT02024607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64922876|NCT02024607|Antidotes|antidotes|mesh-ancestor
64922966|NCT00023530|Hormones|hormones|mesh-ancestor
64922967|NCT00023530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64923012|NCT00000179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64923013|NCT00000179|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64923014|NCT00000179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64923015|NCT00000179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64923016|NCT00000179|Serotonin Agents|serotonin agents|mesh-ancestor
64923017|NCT00000179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64923018|NCT00000179|Antidepressive Agents|antidepressive agents|mesh-ancestor
64923061|NCT00000221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64923062|NCT00000221|Narcotics|narcotics|mesh-ancestor
64923063|NCT00000221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64923064|NCT00000221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923065|NCT00000221|Analgesics|analgesics|mesh-ancestor
64923066|NCT00000221|Sensory System Agents|sensory system agents|mesh-ancestor
64923067|NCT00000221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64923068|NCT00000221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64923069|NCT00023881|Bortezomib|bortezomib|mesh-list
64923070|NCT00023881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384054|NCT04465383|Propofol|propofol|mesh-list
64923115|NCT00023959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64923117|NCT00023998|Doxorubicin|doxorubicin|mesh-list
64923118|NCT00023998|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64923119|NCT00023998|Methotrexate|methotrexate|mesh-list
64923120|NCT00023998|Trastuzumab|trastuzumab|mesh-list
64923121|NCT00023998|Etoposide|etoposide|mesh-list
64923122|NCT00023998|Etoposide phosphate|etoposide phosphate|mesh-list
64923123|NCT00023998|Ifosfamide|ifosfamide|mesh-list
64384062|NCT05500677|Fentanyl|fentanyl|mesh-list
64384063|NCT05500677|Tramadol|tramadol|mesh-list
64407270|NCT05072899|Protective Agents|protective agents|mesh-ancestor
64923144|NCT00023998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64923145|NCT00023998|Antidotes|antidotes|mesh-ancestor
64923146|NCT00023998|Protective Agents|protective agents|mesh-ancestor
64923147|NCT00023998|Vitamin B Complex|vitamin b complex|mesh-ancestor
64923148|NCT00023998|Vitamins|vitamins|mesh-ancestor
64923149|NCT00023998|Micronutrients|micronutrients|mesh-ancestor
64923150|NCT00023998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64923151|NCT00023998|Alkylating Agents|alkylating agents|mesh-ancestor
64923152|NCT00024115|Antibodies|antibodies|mesh-list
64923153|NCT00024115|Immunotoxins|immunotoxins|mesh-list
64923154|NCT00024115|Immunologic Factors|immunologic factors|mesh-list
64923155|NCT00024115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923156|NCT00024154|Trastuzumab|trastuzumab|mesh-list
64923157|NCT00024154|Gefitinib|gefitinib|mesh-list
64923158|NCT00024154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64923159|NCT00024154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923160|NCT00024154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64923161|NCT00024154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923162|NCT00024154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923163|NCT00011076|Pirfenidone|pirfenidone|mesh-list
64923164|NCT00011076|Analgesics|analgesics|mesh-ancestor
64923165|NCT00011076|Sensory System Agents|sensory system agents|mesh-ancestor
64923166|NCT00011076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64923193|NCT00024193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923194|NCT00024193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64923195|NCT00024193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64923196|NCT00024193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64923197|NCT00024193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64923198|NCT00024193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923199|NCT00024193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64923200|NCT00024193|Tubulin Modulators|tubulin modulators|mesh-ancestor
64923201|NCT00024193|Antimitotic Agents|antimitotic agents|mesh-ancestor
64923202|NCT00024193|Mitosis Modulators|mitosis modulators|mesh-ancestor
64923204|NCT00024232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64923205|NCT00024232|Immunologic Factors|immunologic factors|mesh-ancestor
64923206|NCT00024232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923243|NCT00024310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64923244|NCT00024310|Antimetabolites|antimetabolites|mesh-ancestor
64923245|NCT00024310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64923246|NCT00024310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923247|NCT00024349|Fluorouracil|fluorouracil|mesh-list
64923248|NCT00024349|Mitomycins|mitomycins|mesh-list
64923249|NCT00024349|Mitomycin|mitomycin|mesh-list
64923250|NCT00024349|Antimetabolites|antimetabolites|mesh-ancestor
64923251|NCT00024349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923252|NCT00024349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64923253|NCT00024349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923254|NCT00024349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64923255|NCT00024349|Immunologic Factors|immunologic factors|mesh-ancestor
64923256|NCT00024349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923257|NCT00024349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64923258|NCT00024349|Alkylating Agents|alkylating agents|mesh-ancestor
64923259|NCT00024349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64923260|NCT00024349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923261|NCT00000251|Isoflurane|isoflurane|mesh-list
64923262|NCT00000251|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64923263|NCT00000251|Anesthetics, General|anesthetics, general|mesh-ancestor
64923264|NCT00000251|Anesthetics|anesthetics|mesh-ancestor
64923265|NCT00000251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64923266|NCT00000251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923267|NCT00024388|Paclitaxel|paclitaxel|mesh-list
64923268|NCT00024388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64923284|NCT00024427|Immunologic Factors|immunologic factors|mesh-ancestor
64923285|NCT00024427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923286|NCT00000257|Nitrous Oxide|nitrous oxide|mesh-list
64923287|NCT00000257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64923288|NCT00000257|Anesthetics, General|anesthetics, general|mesh-ancestor
64923289|NCT00000257|Anesthetics|anesthetics|mesh-ancestor
64923290|NCT00000257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64923291|NCT00000257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923368|NCT00025168|Irinotecan|irinotecan|mesh-list
64923369|NCT00025168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64923370|NCT00025168|Antimetabolites|antimetabolites|mesh-ancestor
64923371|NCT00025168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923372|NCT00025168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923373|NCT00025168|Antiviral Agents|antiviral agents|mesh-ancestor
64923374|NCT00025168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64923375|NCT00025168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923376|NCT00025168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64923377|NCT00025168|Immunologic Factors|immunologic factors|mesh-ancestor
64923378|NCT00025168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923379|NCT00025168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64923380|NCT00025168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64923381|NCT00025207|Gefitinib|gefitinib|mesh-list
64923382|NCT00025207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384152|NCT02040766|Autonomic Agents|autonomic agents|mesh-ancestor
64923395|NCT00025285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64923396|NCT00025285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64923397|NCT00025285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923398|NCT00025285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923411|NCT00025324|Carboplatin|carboplatin|mesh-list
64923412|NCT00025324|Etoposide|etoposide|mesh-list
64923413|NCT00025324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64923414|NCT00025324|Immunologic Factors|immunologic factors|mesh-ancestor
64923415|NCT00025324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923416|NCT00025324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64923417|NCT00025324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64923418|NCT00025324|Alkylating Agents|alkylating agents|mesh-ancestor
64923419|NCT00025324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923420|NCT00025324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923421|NCT00025324|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64923422|NCT00025324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64923423|NCT00025324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64923424|NCT00025324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64923425|NCT00025324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923426|NCT00025363|Cyclophosphamide|cyclophosphamide|mesh-list
64923427|NCT00025363|Ifosfamide|ifosfamide|mesh-list
64923428|NCT00025363|Doxorubicin|doxorubicin|mesh-list
64923429|NCT00025363|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64923430|NCT00025363|Irinotecan|irinotecan|mesh-list
64923431|NCT00025363|Etoposide|etoposide|mesh-list
64923432|NCT00025363|Vincristine|vincristine|mesh-list
64923433|NCT00025363|Etoposide phosphate|etoposide phosphate|mesh-list
64923434|NCT00025363|Tirapazamine|tirapazamine|mesh-list
64923435|NCT00025363|Sargramostim|sargramostim|mesh-list
64923436|NCT00025363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64923437|NCT00025363|Immunologic Factors|immunologic factors|mesh-ancestor
64923438|NCT00025363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923439|NCT00025363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64923440|NCT00025363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64923441|NCT00025363|Alkylating Agents|alkylating agents|mesh-ancestor
64923442|NCT00025363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923443|NCT00025363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923444|NCT00025363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64923445|NCT00025363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64923446|NCT00025363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64407299|NCT04884139|Dolutegravir|dolutegravir|mesh-list
64407300|NCT04884139|Antiviral Agents|antiviral agents|mesh-ancestor
64407301|NCT04884139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64923447|NCT00025363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64923450|NCT00025363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64923451|NCT00025363|Tubulin Modulators|tubulin modulators|mesh-ancestor
64923452|NCT00025363|Antimitotic Agents|antimitotic agents|mesh-ancestor
64923453|NCT00025363|Mitosis Modulators|mitosis modulators|mesh-ancestor
64923454|NCT00025402|Interferons|interferons|mesh-list
64923455|NCT00025402|Cytarabine|cytarabine|mesh-list
64923456|NCT00025402|Interferon-alpha|interferon-alpha|mesh-list
64923457|NCT00025402|Cyclophosphamide|cyclophosphamide|mesh-list
64923458|NCT00025402|Busulfan|busulfan|mesh-list
64923459|NCT00025402|Etoposide|etoposide|mesh-list
64923460|NCT00025402|Idarubicin|idarubicin|mesh-list
64923589|NCT00025597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923590|NCT00025597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64923591|NCT00025597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64384238|NCT02087176|Adavosertib|adavosertib|mesh-list
64923629|NCT00025636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64923630|NCT00025636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64923632|NCT00025636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64923633|NCT00025636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64923634|NCT00025636|Antimetabolites|antimetabolites|mesh-ancestor
64923635|NCT00025636|Dermatologic Agents|dermatologic agents|mesh-ancestor
64923636|NCT00025636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923637|NCT00025636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64923638|NCT00025636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64923639|NCT00025636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64923640|NCT00025636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64923641|NCT00025636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64923642|NCT00025636|Antiviral Agents|antiviral agents|mesh-ancestor
64923643|NCT00025636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64923644|NCT00025636|Tubulin Modulators|tubulin modulators|mesh-ancestor
64923645|NCT00025636|Antimitotic Agents|antimitotic agents|mesh-ancestor
64923646|NCT00025636|Mitosis Modulators|mitosis modulators|mesh-ancestor
64923647|NCT00025675|Gefitinib|gefitinib|mesh-list
64923648|NCT00025675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923649|NCT00025675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64923650|NCT00025675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923651|NCT00025675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923652|NCT00025753|Rosiglitazone|rosiglitazone|mesh-list
64923653|NCT00025753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64923667|NCT00000419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64923668|NCT00000419|Contraceptive Agents|contraceptive agents|mesh-ancestor
64923669|NCT00000419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64384249|NCT02056288|Sensory System Agents|sensory system agents|mesh-ancestor
64923678|NCT00026104|Gemcitabine|gemcitabine|mesh-list
64923679|NCT00026104|Paclitaxel|paclitaxel|mesh-list
64923680|NCT00026104|Tipifarnib|tipifarnib|mesh-list
64923681|NCT00026104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64923682|NCT00026104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923683|NCT00026104|Tubulin Modulators|tubulin modulators|mesh-ancestor
64923684|NCT00026104|Antimitotic Agents|antimitotic agents|mesh-ancestor
64923685|NCT00026104|Mitosis Modulators|mitosis modulators|mesh-ancestor
64923686|NCT00026104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923687|NCT00026104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64923688|NCT00026104|Antimetabolites|antimetabolites|mesh-ancestor
64923689|NCT00026104|Antiviral Agents|antiviral agents|mesh-ancestor
64923719|NCT00026182|Growth Substances|growth substances|mesh-ancestor
64923720|NCT00026182|Growth Inhibitors|growth inhibitors|mesh-ancestor
64923722|NCT00026260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64923723|NCT00026260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64923724|NCT00026260|Growth Substances|growth substances|mesh-ancestor
64923725|NCT00026260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923726|NCT00026260|Growth Inhibitors|growth inhibitors|mesh-ancestor
64923727|NCT00026260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923728|NCT00026260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64923729|NCT00026260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923730|NCT00026260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923731|NCT00026299|Oxaliplatin|oxaliplatin|mesh-list
64923732|NCT00026299|Gefitinib|gefitinib|mesh-list
64923733|NCT00026299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923734|NCT00026299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64923735|NCT00026299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923736|NCT00026299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923737|NCT00026338|Gemcitabine|gemcitabine|mesh-list
64923738|NCT00026338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64923739|NCT00026338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64923740|NCT00026338|Antimetabolites|antimetabolites|mesh-ancestor
64923741|NCT00026338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923742|NCT00026338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923750|NCT00026377|Leuprolide|leuprolide|mesh-list
64923769|NCT00026377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64923770|NCT00026377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923771|NCT00026416|Interferons|interferons|mesh-list
64923772|NCT00026416|Interferon-alpha|interferon-alpha|mesh-list
64923773|NCT00026416|Thalidomide|thalidomide|mesh-list
64923774|NCT00026416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64923775|NCT00026416|Antiviral Agents|antiviral agents|mesh-ancestor
64923776|NCT00026416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64923777|NCT00026416|Immunologic Factors|immunologic factors|mesh-ancestor
64923778|NCT00026416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923779|NCT00026416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64923780|NCT00026416|Leprostatic Agents|leprostatic agents|mesh-ancestor
64923781|NCT00026416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64923782|NCT00026416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64923783|NCT00026416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64923784|NCT00026416|Growth Substances|growth substances|mesh-ancestor
64923785|NCT00026416|Growth Inhibitors|growth inhibitors|mesh-ancestor
64923786|NCT00026533|Thalidomide|thalidomide|mesh-list
64923787|NCT00026533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64923788|NCT00026533|Immunologic Factors|immunologic factors|mesh-ancestor
64923789|NCT00026533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923825|NCT00027079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64923826|NCT00027079|Antipruritics|antipruritics|mesh-ancestor
64923850|NCT00000428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64923851|NCT00000428|Antidepressive Agents|antidepressive agents|mesh-ancestor
64923852|NCT00000428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64923853|NCT00000428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64923854|NCT00000428|Analgesics|analgesics|mesh-ancestor
64923855|NCT00000428|Sensory System Agents|sensory system agents|mesh-ancestor
64923864|NCT00027391|Albuterol|albuterol|mesh-list
64923868|NCT00027391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64923869|NCT00027391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64923871|NCT00027391|Respiratory System Agents|respiratory system agents|mesh-ancestor
64923872|NCT00027391|Tocolytic Agents|tocolytic agents|mesh-ancestor
64923873|NCT00027391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64923874|NCT00027391|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64923875|NCT00027391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64923876|NCT00027391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64923877|NCT00027391|Adrenergic Agents|adrenergic agents|mesh-ancestor
64923878|NCT00027391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64923879|NCT00027391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64923880|NCT00027391|Androgens|androgens|mesh-ancestor
64923881|NCT00027391|Hormones|hormones|mesh-ancestor
64923882|NCT00027391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64923883|NCT00027391|Anabolic Agents|anabolic agents|mesh-ancestor
64923885|NCT00000461|Pravastatin|pravastatin|mesh-list
64923886|NCT00000461|Gemfibrozil|gemfibrozil|mesh-list
64923887|NCT00000461|Cholestyramine Resin|cholestyramine resin|mesh-list
64923888|NCT00000461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64923889|NCT00000461|Antimetabolites|antimetabolites|mesh-ancestor
64923890|NCT00000461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384284|NCT02404259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64923973|NCT00000464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64923974|NCT00000464|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64923975|NCT00000464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64923976|NCT00000464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407399|NCT03038321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64407400|NCT03038321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64407401|NCT03038321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64923977|NCT00000464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64923978|NCT00000464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64923979|NCT00000464|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64384292|NCT02404259|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64924035|NCT00027703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924036|NCT00027703|Growth Inhibitors|growth inhibitors|mesh-ancestor
64924037|NCT00027703|Immunologic Factors|immunologic factors|mesh-ancestor
64924038|NCT00027703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64924039|NCT00027703|Antimetabolites|antimetabolites|mesh-ancestor
64924041|NCT00027703|Antiviral Agents|antiviral agents|mesh-ancestor
64924068|NCT00027820|Cyclosporins|cyclosporins|mesh-list
64924069|NCT00027820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924070|NCT00027820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64924071|NCT00027820|Antimetabolites|antimetabolites|mesh-ancestor
64924072|NCT00027820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924073|NCT00027820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64924074|NCT00027820|Immunologic Factors|immunologic factors|mesh-ancestor
64924096|NCT00027859|Docetaxel|docetaxel|mesh-list
64924097|NCT00027859|Estramustine|estramustine|mesh-list
64924098|NCT00027859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924111|NCT00027859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64924112|NCT00027859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924113|NCT00027859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64924114|NCT00027859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64924115|NCT00027859|Alkylating Agents|alkylating agents|mesh-ancestor
64924116|NCT00027859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64924117|NCT00027898|Carboplatin|carboplatin|mesh-list
64924118|NCT00027898|Etoposide|etoposide|mesh-list
64924119|NCT00027898|Etoposide phosphate|etoposide phosphate|mesh-list
64924120|NCT00027898|Bortezomib|bortezomib|mesh-list
64924121|NCT00027898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924122|NCT00027898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64924123|NCT00027898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64924124|NCT00027898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64924125|NCT00027898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924126|NCT00027898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924127|NCT00027937|Aldesleukin|aldesleukin|mesh-list
64924128|NCT00027937|Paclitaxel|paclitaxel|mesh-list
64924129|NCT00027937|Cyclophosphamide|cyclophosphamide|mesh-list
64924130|NCT00027937|Melphalan|melphalan|mesh-list
64924131|NCT00027937|Busulfan|busulfan|mesh-list
64924132|NCT00027937|Thiotepa|thiotepa|mesh-list
64924133|NCT00027937|Sargramostim|sargramostim|mesh-list
64924134|NCT00027937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64924135|NCT00027937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924136|NCT00027937|Tubulin Modulators|tubulin modulators|mesh-ancestor
64924137|NCT00027937|Antimitotic Agents|antimitotic agents|mesh-ancestor
64692575|NCT01977781|Hormones|hormones|mesh-ancestor
64924162|NCT00012051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924163|NCT00012051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64924164|NCT00012051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64924165|NCT00012051|Antiemetics|antiemetics|mesh-ancestor
64924166|NCT00012051|Autonomic Agents|autonomic agents|mesh-ancestor
64924189|NCT00012051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64924191|NCT00012051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64924192|NCT00027976|Celecoxib|celecoxib|mesh-list
64924201|NCT00027976|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64924202|NCT00027976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64924203|NCT00027976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924204|NCT00027976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924205|NCT00000479|Aspirin|aspirin|mesh-list
64924206|NCT00000479|Vitamin E|vitamin e|mesh-list
64924207|NCT00000479|Vitamins|vitamins|mesh-ancestor
64924208|NCT00000479|Micronutrients|micronutrients|mesh-ancestor
64924209|NCT00000479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924210|NCT00000479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64924211|NCT00000479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64924212|NCT00000479|Analgesics|analgesics|mesh-ancestor
64924213|NCT00000479|Sensory System Agents|sensory system agents|mesh-ancestor
64924214|NCT00000479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64924215|NCT00000479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64924216|NCT00000479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64924217|NCT00000479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64924218|NCT00000479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64924219|NCT00000479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924220|NCT00000479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64924221|NCT00000479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64924222|NCT00000479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924223|NCT00000479|Antipyretics|antipyretics|mesh-ancestor
64384372|NCT04481789|Vasodilator Agents|vasodilator agents|mesh-ancestor
64924277|NCT00395551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924278|NCT00395551|Growth Inhibitors|growth inhibitors|mesh-ancestor
64924279|NCT00395551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924280|NCT00012129|Annamycin|annamycin|mesh-list
64924281|NCT00012129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64924283|NCT00028288|Daclizumab|daclizumab|mesh-list
64924289|NCT00012168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924291|NCT00000482|Clofibrate|clofibrate|mesh-list
64924292|NCT00000482|Estrogens|estrogens|mesh-list
64924293|NCT00000482|Hormones|hormones|mesh-ancestor
64924294|NCT00000482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64384382|NCT04481789|Antioxidants|antioxidants|mesh-ancestor
64384383|NCT04481789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64924373|NCT00012207|Antiviral Agents|antiviral agents|mesh-ancestor
64924374|NCT00012207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64924375|NCT00028483|Docetaxel|docetaxel|mesh-list
64924376|NCT00028483|Doxorubicin|doxorubicin|mesh-list
64924377|NCT00028483|Immunoconjugates|immunoconjugates|mesh-list
64924378|NCT00028483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924379|NCT00028483|Tubulin Modulators|tubulin modulators|mesh-ancestor
64924380|NCT00028483|Antimitotic Agents|antimitotic agents|mesh-ancestor
64924381|NCT00028483|Mitosis Modulators|mitosis modulators|mesh-ancestor
64924382|NCT00028483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924383|NCT00028483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64924384|NCT00028483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64924385|NCT00028483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64924386|NCT00028483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384514|NCT02400281|Fludarabine|fludarabine|mesh-list
64384515|NCT02400281|Fludarabine phosphate|fludarabine phosphate|mesh-list
64924400|NCT00028561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924401|NCT00028600|Cyclophosphamide|cyclophosphamide|mesh-list
64924402|NCT00028600|Melphalan|melphalan|mesh-list
64924403|NCT00028600|Methotrexate|methotrexate|mesh-list
64924404|NCT00028600|Fludarabine|fludarabine|mesh-list
64924405|NCT00028600|Fludarabine phosphate|fludarabine phosphate|mesh-list
64924414|NCT00028600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924415|NCT00028600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64924416|NCT00028600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64924417|NCT00028600|Abortifacient Agents|abortifacient agents|mesh-ancestor
64924418|NCT00028600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64924419|NCT00028600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64924420|NCT00028600|Antimetabolites|antimetabolites|mesh-ancestor
64924421|NCT00028600|Dermatologic Agents|dermatologic agents|mesh-ancestor
64924422|NCT00028600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924423|NCT00028600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64924424|NCT00028600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64924425|NCT00028600|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64924426|NCT00388778|Doxycycline|doxycycline|mesh-list
64924427|NCT00388778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64924428|NCT00388778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64924429|NCT00388778|Antimalarials|antimalarials|mesh-ancestor
64924430|NCT00388778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64924431|NCT00388778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64924432|NCT00028678|Dalteparin|dalteparin|mesh-list
64924433|NCT00028678|Tinzaparin|tinzaparin|mesh-list
64924434|NCT00028678|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64924435|NCT00028678|Anticoagulants|anticoagulants|mesh-ancestor
64924436|NCT00028678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64924437|NCT00028678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64924438|NCT00028678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924439|NCT00012246|Sargramostim|sargramostim|mesh-list
64924440|NCT00012246|Freund's Adjuvant|freund's adjuvant|mesh-list
64924463|NCT00028717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924464|NCT00028717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64407408|NCT03038321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64924465|NCT00028717|Glucocorticoids|glucocorticoids|mesh-ancestor
64924467|NCT00028717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64924468|NCT00028717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64924469|NCT00028717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64924470|NCT00028717|Tubulin Modulators|tubulin modulators|mesh-ancestor
64924471|NCT00028717|Antimitotic Agents|antimitotic agents|mesh-ancestor
64924472|NCT00028717|Mitosis Modulators|mitosis modulators|mesh-ancestor
64924473|NCT00028756|Gemcitabine|gemcitabine|mesh-list
64924474|NCT00028756|Doxorubicin|doxorubicin|mesh-list
64924475|NCT00028756|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64924476|NCT00028756|Methotrexate|methotrexate|mesh-list
64924477|NCT00028756|Vinblastine|vinblastine|mesh-list
64924478|NCT00028756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924479|NCT00028756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64924480|NCT00028756|Antimetabolites|antimetabolites|mesh-ancestor
64924481|NCT00028756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924482|NCT00028756|Antiviral Agents|antiviral agents|mesh-ancestor
64924483|NCT00028756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64692949|NCT02058511|Anesthetics|anesthetics|mesh-list
64924529|NCT00012363|Immunologic Factors|immunologic factors|mesh-ancestor
64924530|NCT00012363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924531|NCT00012363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64924532|NCT00012363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64924533|NCT00388895|Imatinib Mesylate|imatinib mesylate|mesh-list
64924556|NCT00028834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924557|NCT00028834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64924558|NCT00028873|Paclitaxel|paclitaxel|mesh-list
64924559|NCT00028873|Docetaxel|docetaxel|mesh-list
64924560|NCT00028873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64924561|NCT00028873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924562|NCT00028873|Tubulin Modulators|tubulin modulators|mesh-ancestor
64924563|NCT00028873|Antimitotic Agents|antimitotic agents|mesh-ancestor
64924564|NCT00028873|Mitosis Modulators|mitosis modulators|mesh-ancestor
64924565|NCT00028873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924566|NCT00028912|Carboplatin|carboplatin|mesh-list
64924567|NCT00028912|Bortezomib|bortezomib|mesh-list
64924568|NCT00028912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924569|NCT00028951|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64924570|NCT00028951|Hemostatics|hemostatics|mesh-ancestor
64924619|NCT00000491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64924620|NCT00000491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924622|NCT00000491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64924623|NCT00000491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64924624|NCT00000491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64407415|NCT02531373|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64924625|NCT00000491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924626|NCT00000491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64924627|NCT00000491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64924628|NCT00000491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924629|NCT00000491|Antipyretics|antipyretics|mesh-ancestor
64924630|NCT00029380|Cyclosporine|cyclosporine|mesh-list
64924631|NCT00029380|Mycophenolic Acid|mycophenolic acid|mesh-list
64924632|NCT00029380|Cyclophosphamide|cyclophosphamide|mesh-list
64924633|NCT00029380|Busulfan|busulfan|mesh-list
64924634|NCT00029380|Cyclosporins|cyclosporins|mesh-list
64924635|NCT00029380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64924650|NCT00029380|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64924651|NCT00029380|Antitubercular Agents|antitubercular agents|mesh-ancestor
64924652|NCT00029380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64924653|NCT00029458|Clozapine|clozapine|mesh-list
64924654|NCT00029458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64924655|NCT00029458|Serotonin Agents|serotonin agents|mesh-ancestor
64924656|NCT00029458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64924657|NCT00029458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924658|NCT00029458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924659|NCT00029458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64924700|NCT00012519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924701|NCT00012519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924702|NCT00012519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64924703|NCT00012519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64924704|NCT00012519|Antiviral Agents|antiviral agents|mesh-ancestor
64924705|NCT00012519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64924706|NCT00012519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64924707|NCT00012519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64924708|NCT00029614|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64924709|NCT00029614|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64924710|NCT00029614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64924711|NCT00029614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64384537|NCT02400281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64924719|NCT00029770|Codeine|codeine|mesh-list
64924720|NCT00029770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64924735|NCT00012558|Risperidone|risperidone|mesh-list
64924736|NCT00012558|Tranylcypromine|tranylcypromine|mesh-list
64924737|NCT00012558|Bupropion|bupropion|mesh-list
64924738|NCT00012558|Paroxetine|paroxetine|mesh-list
64924739|NCT00012558|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64924740|NCT00012558|Serotonin Agents|serotonin agents|mesh-ancestor
64924741|NCT00012558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64924742|NCT00012558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924743|NCT00012558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924744|NCT00012558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64924745|NCT00012558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64924746|NCT00012558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64924747|NCT00012558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64924748|NCT00012558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64924749|NCT00012558|Dopamine Agents|dopamine agents|mesh-ancestor
64924750|NCT00012558|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64924751|NCT00012558|Antidepressive Agents|antidepressive agents|mesh-ancestor
64693173|NCT03028025|Hemostatics|hemostatics|mesh-list
64924752|NCT00012558|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64924753|NCT00012558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64924754|NCT00012558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64924755|NCT00012558|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64924756|NCT00012558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64924757|NCT00012558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924758|NCT00012558|Antimanic Agents|antimanic agents|mesh-ancestor
64924759|NCT00012558|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64924760|NCT00012558|Anticonvulsants|anticonvulsants|mesh-ancestor
64924761|NCT00012558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64924781|NCT00000500|Analgesics|analgesics|mesh-ancestor
64924782|NCT00000500|Sensory System Agents|sensory system agents|mesh-ancestor
64924783|NCT00000500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64924784|NCT00000500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924785|NCT00000500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64924786|NCT00000500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64924787|NCT00000500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64924788|NCT00000500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64924789|NCT00000500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924790|NCT00000500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64924791|NCT00000500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64924792|NCT00000500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924793|NCT00000500|Antipyretics|antipyretics|mesh-ancestor
64924794|NCT00000500|Antioxidants|antioxidants|mesh-ancestor
64924795|NCT00000500|Protective Agents|protective agents|mesh-ancestor
64924796|NCT00395902|Cinacalcet|cinacalcet|mesh-list
64924797|NCT00395902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64924798|NCT00395902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924799|NCT00395902|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64924800|NCT00395902|Hormone Antagonists|hormone antagonists|mesh-ancestor
64924801|NCT00395902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64924802|NCT00029848|Rimonabant|rimonabant|mesh-list
64924803|NCT00029848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64924804|NCT00029848|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
64924805|NCT00029848|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64924806|NCT00029848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64924807|NCT00029848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924808|NCT00029848|Hormones|hormones|mesh-ancestor
64924809|NCT00029848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64924828|NCT00030004|GABA Modulators|gaba modulators|mesh-ancestor
64924829|NCT00030004|GABA Agents|gaba agents|mesh-ancestor
64924830|NCT00030004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64924831|NCT00030004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924832|NCT00030082|Melphalan|melphalan|mesh-list
64924833|NCT00030082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64924834|NCT00030082|Alkylating Agents|alkylating agents|mesh-ancestor
64924835|NCT00030082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924836|NCT00030082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924837|NCT00030082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64924838|NCT00030082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64924839|NCT00030082|Immunologic Factors|immunologic factors|mesh-ancestor
64924840|NCT00030082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924841|NCT00000518|Quinidine|quinidine|mesh-list
64924842|NCT00000518|Sotalol|sotalol|mesh-list
64924869|NCT00000518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64924870|NCT00000518|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64924871|NCT00000518|Antidepressive Agents|antidepressive agents|mesh-ancestor
64924872|NCT00000518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64924873|NCT00000518|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64924874|NCT00000518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64924875|NCT00030121|Cardiodilatin|cardiodilatin|mesh-list
64924876|NCT00030121|Vasodilator Agents|vasodilator agents|mesh-ancestor
64924878|NCT00030238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64924879|NCT00030238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924880|NCT00030355|Homoharringtonine|homoharringtonine|mesh-list
64924881|NCT00030355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64924882|NCT00030355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924883|NCT00030355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64924884|NCT00030355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924885|NCT00030355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924886|NCT00030394|Imatinib Mesylate|imatinib mesylate|mesh-list
64924887|NCT00030394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924888|NCT00030394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64924889|NCT00030394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924890|NCT00030394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924891|NCT00395941|Pioglitazone|pioglitazone|mesh-list
64924892|NCT00395941|Acitretin|acitretin|mesh-list
64924893|NCT00395941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64924894|NCT00395941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924895|NCT00395941|Keratolytic Agents|keratolytic agents|mesh-ancestor
64924896|NCT00395941|Dermatologic Agents|dermatologic agents|mesh-ancestor
64924897|NCT00030433|Gemcitabine|gemcitabine|mesh-list
64924898|NCT00030433|Irinotecan|irinotecan|mesh-list
64924899|NCT00030433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64924900|NCT00030433|Antimetabolites|antimetabolites|mesh-ancestor
64924901|NCT00030433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384608|NCT02400047|Ketoprofen|ketoprofen|mesh-list
64924917|NCT00030472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924918|NCT00030472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924919|NCT00000527|Aspirin|aspirin|mesh-list
64924920|NCT00000527|Dipyridamole|dipyridamole|mesh-list
64924921|NCT00000527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64924922|NCT00000527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64924923|NCT00000527|Analgesics|analgesics|mesh-ancestor
64924924|NCT00000527|Sensory System Agents|sensory system agents|mesh-ancestor
64924925|NCT00000527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64924926|NCT00000527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924927|NCT00000527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64924928|NCT00000527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64924929|NCT00000527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64924930|NCT00000527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64924931|NCT00000527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924932|NCT00000527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64924933|NCT00000527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64924934|NCT00000527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924935|NCT00000527|Antipyretics|antipyretics|mesh-ancestor
64924936|NCT00000527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64924937|NCT00000527|Vasodilator Agents|vasodilator agents|mesh-ancestor
64924938|NCT00030511|Fluorouracil|fluorouracil|mesh-list
64924939|NCT00030511|Antimetabolites|antimetabolites|mesh-ancestor
64924940|NCT00030511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924941|NCT00030511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64924949|NCT00030550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924950|NCT00030550|Leprostatic Agents|leprostatic agents|mesh-ancestor
64924951|NCT00030550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64924952|NCT00030550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64924953|NCT00030550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64924954|NCT00030550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64924955|NCT00030550|Growth Substances|growth substances|mesh-ancestor
64924956|NCT00030550|Growth Inhibitors|growth inhibitors|mesh-ancestor
64924957|NCT00030550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924958|NCT00030589|Bexarotene|bexarotene|mesh-list
64924959|NCT00030589|Methoxsalen|methoxsalen|mesh-list
64407540|NCT03036605|Dexamethasone|dexamethasone|mesh-list
64407541|NCT03036605|Dexamethasone acetate|dexamethasone acetate|mesh-list
64407542|NCT03036605|Bupivacaine|bupivacaine|mesh-list
64407544|NCT03036605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64407545|NCT03036605|Antiemetics|antiemetics|mesh-ancestor
64407546|NCT03036605|Autonomic Agents|autonomic agents|mesh-ancestor
64407550|NCT03036605|Glucocorticoids|glucocorticoids|mesh-ancestor
64924960|NCT00030589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924961|NCT00030589|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64924962|NCT00030589|Dermatologic Agents|dermatologic agents|mesh-ancestor
64924963|NCT00000530|Nifedipine|nifedipine|mesh-list
64924964|NCT00000530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64924965|NCT00000530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64924966|NCT00000530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924967|NCT00000530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64924968|NCT00000530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64924969|NCT00000530|Vasodilator Agents|vasodilator agents|mesh-ancestor
64924970|NCT00000530|Tocolytic Agents|tocolytic agents|mesh-ancestor
64924971|NCT00000530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64924972|NCT00030667|Imatinib Mesylate|imatinib mesylate|mesh-list
64924973|NCT00030667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924974|NCT00030667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64924975|NCT00030667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64693400|NCT02044796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64924976|NCT00030667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64924977|NCT00030745|Gemcitabine|gemcitabine|mesh-list
64924988|NCT00030784|Doxorubicin|doxorubicin|mesh-list
64924991|NCT00030784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64924992|NCT00030784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64924993|NCT00030784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64925039|NCT00031018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925040|NCT00031018|Nootropic Agents|nootropic agents|mesh-ancestor
64925041|NCT00031018|Antiviral Agents|antiviral agents|mesh-ancestor
64925042|NCT00031018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64925043|NCT00031018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925044|NCT00031057|Riboflavin|riboflavin|mesh-list
64925045|NCT00031057|Thiamine|thiamine|mesh-list
64925046|NCT00031057|Vitamin B Complex|vitamin b complex|mesh-ancestor
64925047|NCT00031057|Vitamins|vitamins|mesh-ancestor
64925048|NCT00031057|Micronutrients|micronutrients|mesh-ancestor
64925049|NCT00031057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925050|NCT00031057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64925051|NCT00031057|Dermatologic Agents|dermatologic agents|mesh-ancestor
64925052|NCT00000554|Dobutamine|dobutamine|mesh-list
64925053|NCT00000554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64925054|NCT00000554|Sympathomimetics|sympathomimetics|mesh-ancestor
64925055|NCT00000554|Autonomic Agents|autonomic agents|mesh-ancestor
64925056|NCT00000554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64925057|NCT00000554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925058|NCT00000554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64925059|NCT00000554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64925060|NCT00000554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64925061|NCT00000554|Adrenergic Agents|adrenergic agents|mesh-ancestor
64925062|NCT00000554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64925063|NCT00000554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925094|NCT00396058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925095|NCT00396058|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64925096|NCT00396058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64925097|NCT00396058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64925098|NCT00396058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925100|NCT00396058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64925101|NCT00396214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64407560|NCT03036605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64925102|NCT00396214|Antidepressive Agents|antidepressive agents|mesh-ancestor
64925103|NCT00396214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64925104|NCT00396214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64925105|NCT00396214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64925106|NCT00396214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64925108|NCT00000563|Dexamethasone|dexamethasone|mesh-list
64925132|NCT00031642|Rituximab|rituximab|mesh-list
64925133|NCT00031642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64925134|NCT00031642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925135|NCT00031642|Immunologic Factors|immunologic factors|mesh-ancestor
64925136|NCT00031642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925137|NCT00031642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64925138|NCT00031681|Irinotecan|irinotecan|mesh-list
64925139|NCT00031681|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
64925140|NCT00031681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64925141|NCT00031681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64925142|NCT00031681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925143|NCT00031681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925144|NCT00031681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925145|NCT00031681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64925146|NCT00031720|Tamoxifen|tamoxifen|mesh-list
64925147|NCT00031720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64925148|NCT00031720|Hormone Antagonists|hormone antagonists|mesh-ancestor
64925149|NCT00031720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64925150|NCT00031720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925151|NCT00031720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64925152|NCT00031720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925153|NCT00031720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64925154|NCT00031720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64925155|NCT00031720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64925156|NCT00000569|Triamcinolone|triamcinolone|mesh-list
64925157|NCT00000569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64925158|NCT00000569|Glucocorticoids|glucocorticoids|mesh-ancestor
64925159|NCT00000569|Hormones|hormones|mesh-ancestor
64925185|NCT01791816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925186|NCT01791816|Protective Agents|protective agents|mesh-ancestor
64925187|NCT01791816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925188|NCT00031798|Methylphenidate|methylphenidate|mesh-list
64925189|NCT00031798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64925190|NCT00031798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407638|NCT00783133|Histamine Antagonists|histamine antagonists|mesh-ancestor
64407642|NCT03098407|Methadone|methadone|mesh-list
64925191|NCT00031798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64925192|NCT00031798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64925193|NCT00031798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64925194|NCT00031798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925195|NCT00031798|Dopamine Agents|dopamine agents|mesh-ancestor
64925196|NCT00031798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64925197|NCT00031837|Gemcitabine|gemcitabine|mesh-list
64925199|NCT00031837|Tinzaparin|tinzaparin|mesh-list
64925200|NCT00031837|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64925201|NCT00031837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64925202|NCT00031837|Antimetabolites|antimetabolites|mesh-ancestor
64693615|NCT02996591|Midazolam|midazolam|mesh-list
64925203|NCT00031837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925204|NCT00031837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925205|NCT00031837|Antiviral Agents|antiviral agents|mesh-ancestor
64925216|NCT00031876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64925217|NCT00031876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925218|NCT00031876|Tubulin Modulators|tubulin modulators|mesh-ancestor
64925219|NCT00031876|Antimitotic Agents|antimitotic agents|mesh-ancestor
64925220|NCT00031876|Mitosis Modulators|mitosis modulators|mesh-ancestor
64925221|NCT00031876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925222|NCT00031876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64925223|NCT00031876|Antimetabolites|antimetabolites|mesh-ancestor
64925224|NCT00031915|Imatinib Mesylate|imatinib mesylate|mesh-list
64925225|NCT00031915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925226|NCT00031915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64925227|NCT00031915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925228|NCT00031915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925229|NCT00031954|Gemcitabine|gemcitabine|mesh-list
64925230|NCT00031954|Paclitaxel|paclitaxel|mesh-list
64925231|NCT00031954|Carboplatin|carboplatin|mesh-list
64925232|NCT00031954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64925233|NCT00031954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925234|NCT00031954|Tubulin Modulators|tubulin modulators|mesh-ancestor
64925235|NCT00031954|Antimitotic Agents|antimitotic agents|mesh-ancestor
64925236|NCT00031954|Mitosis Modulators|mitosis modulators|mesh-ancestor
64925237|NCT00031954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925238|NCT00031954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64925239|NCT00031954|Antimetabolites|antimetabolites|mesh-ancestor
64925240|NCT00031954|Antiviral Agents|antiviral agents|mesh-ancestor
64925241|NCT00031954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64925242|NCT00031954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925276|NCT00032110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64925277|NCT00032110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925278|NCT00032110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925280|NCT00032149|Cyclophosphamide|cyclophosphamide|mesh-list
64925281|NCT00032149|Etoposide|etoposide|mesh-list
64925282|NCT00032149|Vincristine|vincristine|mesh-list
64925283|NCT00032149|Mitoxantrone|mitoxantrone|mesh-list
64925284|NCT00032149|Bleomycin|bleomycin|mesh-list
64925285|NCT00032149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64925286|NCT00032149|Immunologic Factors|immunologic factors|mesh-ancestor
64925287|NCT00032149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925288|NCT00032149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64925289|NCT00032149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64925290|NCT00032149|Alkylating Agents|alkylating agents|mesh-ancestor
64925309|NCT00032149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64925310|NCT00032188|Aldesleukin|aldesleukin|mesh-list
64925311|NCT00032188|Interleukin-2|interleukin-2|mesh-list
64925312|NCT00032188|Bryostatin 1|bryostatin 1|mesh-list
64925313|NCT00032188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925314|NCT00032188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64925315|NCT00032188|Analgesics|analgesics|mesh-ancestor
64925316|NCT00032188|Sensory System Agents|sensory system agents|mesh-ancestor
64925317|NCT00032188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64925318|NCT00032188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925319|NCT00032188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64407706|NCT00552097|Antimetabolites|antimetabolites|mesh-ancestor
64407725|NCT02603393|Autonomic Agents|autonomic agents|mesh-ancestor
64925320|NCT00032188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64925321|NCT00032188|Antiviral Agents|antiviral agents|mesh-ancestor
64925322|NCT00032188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64925323|NCT00032188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64925324|NCT00032188|Immunologic Factors|immunologic factors|mesh-ancestor
64925325|NCT00032305|Visilizumab|visilizumab|mesh-list
64925326|NCT00032305|Immunologic Factors|immunologic factors|mesh-ancestor
64925327|NCT00032305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925328|NCT00000596|Dapsone|dapsone|mesh-list
64925329|NCT00000596|Prednisone|prednisone|mesh-list
64925330|NCT00000596|Cyclophosphamide|cyclophosphamide|mesh-list
64925331|NCT00000596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64925332|NCT00000596|Immunologic Factors|immunologic factors|mesh-ancestor
64925333|NCT00000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925334|NCT00000596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64925335|NCT00000596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64925336|NCT00000596|Alkylating Agents|alkylating agents|mesh-ancestor
64925337|NCT00000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925338|NCT00000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925339|NCT00000596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64925340|NCT00000596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64925341|NCT00000596|Glucocorticoids|glucocorticoids|mesh-ancestor
64925369|NCT00000602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925370|NCT00000602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64925372|NCT00032734|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64925373|NCT00032734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925374|NCT00032734|Natriuretic Agents|natriuretic agents|mesh-ancestor
64925405|NCT00032929|Antidepressive Agents|antidepressive agents|mesh-ancestor
64925406|NCT00032929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64925407|NCT00032929|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64925408|NCT00032929|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64925409|NCT00032929|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64925410|NCT00032929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925411|NCT00032929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925474|NCT00033241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64925475|NCT00033241|Antimetabolites|antimetabolites|mesh-ancestor
64925476|NCT00033241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925477|NCT00033241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925478|NCT00033241|Antiviral Agents|antiviral agents|mesh-ancestor
64925479|NCT00033241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64925480|NCT00033241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925481|NCT00033241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64925482|NCT00033241|Immunologic Factors|immunologic factors|mesh-ancestor
64925483|NCT00033241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925484|NCT00033241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64925485|NCT00000620|Insulin|insulin|mesh-list
64925486|NCT00000620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64925487|NCT00000620|Metformin|metformin|mesh-list
64925488|NCT00000620|Insulin Glargine|insulin glargine|mesh-list
64925489|NCT00000620|Pioglitazone|pioglitazone|mesh-list
64925490|NCT00000620|Insulin Aspart|insulin aspart|mesh-list
64925491|NCT00000620|Glimepiride|glimepiride|mesh-list
64925492|NCT00000620|Rosiglitazone|rosiglitazone|mesh-list
64925493|NCT00000620|Insulin Detemir|insulin detemir|mesh-list
64925494|NCT00000620|Acarbose|acarbose|mesh-list
64925495|NCT00000620|Repaglinide|repaglinide|mesh-list
64925496|NCT00000620|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64925497|NCT00000620|Metoprolol|metoprolol|mesh-list
64925498|NCT00000620|Felodipine|felodipine|mesh-list
64925499|NCT00000620|Amlodipine|amlodipine|mesh-list
64925500|NCT00000620|Valsartan|valsartan|mesh-list
64925530|NCT00000620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925531|NCT00000620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64925532|NCT00000620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64925533|NCT00000620|Diuretics|diuretics|mesh-ancestor
64925534|NCT00000620|Natriuretic Agents|natriuretic agents|mesh-ancestor
64925535|NCT00000620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64925536|NCT00000620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64925636|NCT00000635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64925637|NCT00000635|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64925639|NCT00033553|Paclitaxel|paclitaxel|mesh-list
64925640|NCT00033553|Carboplatin|carboplatin|mesh-list
64925641|NCT00033553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64925642|NCT00033553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925643|NCT00033553|Tubulin Modulators|tubulin modulators|mesh-ancestor
64925644|NCT00033553|Antimitotic Agents|antimitotic agents|mesh-ancestor
64925645|NCT00033553|Mitosis Modulators|mitosis modulators|mesh-ancestor
64925646|NCT00033553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925647|NCT00033553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64925648|NCT00033553|Antimetabolites|antimetabolites|mesh-ancestor
64925649|NCT00033553|Antiviral Agents|antiviral agents|mesh-ancestor
64925650|NCT00033553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64925651|NCT00033553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925652|NCT00033553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64925653|NCT00033553|Immunologic Factors|immunologic factors|mesh-ancestor
64925654|NCT00033553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925655|NCT00033592|Bupropion|bupropion|mesh-list
64925656|NCT00033592|Nicotine|nicotine|mesh-list
64925657|NCT00033592|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64925674|NCT00033592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64925675|NCT00033592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925676|NCT00013689|Pyrimethamine|pyrimethamine|mesh-list
64925677|NCT00013689|Sulfadoxine|sulfadoxine|mesh-list
64925678|NCT00013689|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64925679|NCT00013689|Antimalarials|antimalarials|mesh-ancestor
64925680|NCT00013689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64925681|NCT00013689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64925682|NCT00013689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64925683|NCT00013689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64925684|NCT00013689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925685|NCT00013689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925686|NCT00013689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64925687|NCT00013689|Renal Agents|renal agents|mesh-ancestor
64925688|NCT00033709|Thalidomide|thalidomide|mesh-list
64925689|NCT00033709|Temozolomide|temozolomide|mesh-list
64925690|NCT00033709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64925691|NCT00033709|Alkylating Agents|alkylating agents|mesh-ancestor
64925692|NCT00033709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925693|NCT00033709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925694|NCT00033709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64925695|NCT00033709|Immunologic Factors|immunologic factors|mesh-ancestor
64925696|NCT00033709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925697|NCT00033709|Leprostatic Agents|leprostatic agents|mesh-ancestor
64925698|NCT00033709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64925699|NCT00033709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64925700|NCT00033709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64925701|NCT00033709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64925705|NCT00033748|Antibodies|antibodies|mesh-list
64925721|NCT00000641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925722|NCT00000641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925809|NCT00389129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925810|NCT00389129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64925811|NCT00389129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64925812|NCT00389129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64925813|NCT00389129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64925814|NCT00389129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925816|NCT00389129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64925828|NCT00000665|Antiviral Agents|antiviral agents|mesh-ancestor
64925829|NCT00000665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64925830|NCT00000665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64925831|NCT00000665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925832|NCT00000665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925833|NCT00000665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64925834|NCT00034372|Oregovomab|oregovomab|mesh-list
64925835|NCT00034372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64384654|NCT02399657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64925896|NCT00034489|Gemcitabine|gemcitabine|mesh-list
64925897|NCT00034489|Pemetrexed|pemetrexed|mesh-list
64407732|NCT02603393|Parasympatholytics|parasympatholytics|mesh-ancestor
64407733|NCT02603393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64925898|NCT00034489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64925899|NCT00034489|Antimetabolites|antimetabolites|mesh-ancestor
64925900|NCT00034489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925901|NCT00034489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925902|NCT00034489|Antiviral Agents|antiviral agents|mesh-ancestor
64925903|NCT00034489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64925904|NCT00034489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925905|NCT00034489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64925906|NCT00034489|Immunologic Factors|immunologic factors|mesh-ancestor
64925907|NCT00034489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925908|NCT00034489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64925909|NCT00034489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64925912|NCT00396487|Irinotecan|irinotecan|mesh-list
64925919|NCT00396487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925920|NCT00396487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64925921|NCT00396487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64925922|NCT00396487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925923|NCT00000674|Leucovorin|leucovorin|mesh-list
64925924|NCT00000674|Clindamycin|clindamycin|mesh-list
64925925|NCT00000674|Clindamycin palmitate|clindamycin palmitate|mesh-list
64925926|NCT00000674|Clindamycin phosphate|clindamycin phosphate|mesh-list
64925927|NCT00000674|Pyrimethamine|pyrimethamine|mesh-list
64925928|NCT00000674|Calcium|calcium|mesh-list
64925929|NCT00000674|Levoleucovorin|levoleucovorin|mesh-list
64925930|NCT00000674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64925931|NCT00000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925932|NCT00000674|Antidotes|antidotes|mesh-ancestor
64925933|NCT00000674|Protective Agents|protective agents|mesh-ancestor
64925934|NCT00000674|Vitamin B Complex|vitamin b complex|mesh-ancestor
64925935|NCT00000674|Vitamins|vitamins|mesh-ancestor
64925936|NCT00000674|Micronutrients|micronutrients|mesh-ancestor
64925937|NCT00000674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64925938|NCT00000674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64925939|NCT00000674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64925940|NCT00000674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925941|NCT00000674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925942|NCT00000674|Antimalarials|antimalarials|mesh-ancestor
64925973|NCT00034528|Immunologic Factors|immunologic factors|mesh-ancestor
64925974|NCT00034528|Alkylating Agents|alkylating agents|mesh-ancestor
64925975|NCT00034528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64925976|NCT00034528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64925977|NCT00000677|Sch 39304|sch 39304|mesh-list
64925978|NCT00000677|Antifungal Agents|antifungal agents|mesh-ancestor
64925979|NCT00000677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64925980|NCT04711642|Hyaluronic Acid|hyaluronic acid|mesh-list
64925981|NCT04711642|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64925982|NCT04711642|Immunologic Factors|immunologic factors|mesh-ancestor
64925983|NCT04711642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407739|NCT02603393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64925984|NCT04711642|Viscosupplements|viscosupplements|mesh-ancestor
64925985|NCT04711642|Protective Agents|protective agents|mesh-ancestor
64925986|NCT00034606|Gemcitabine|gemcitabine|mesh-list
64925987|NCT00034606|Pemetrexed|pemetrexed|mesh-list
64925988|NCT00034606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64925989|NCT00034606|Antimetabolites|antimetabolites|mesh-ancestor
64925990|NCT00034606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64925991|NCT00034606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64925992|NCT00034606|Antiviral Agents|antiviral agents|mesh-ancestor
64925993|NCT00034606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64925994|NCT00034606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64925995|NCT00034606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64925996|NCT00034606|Immunologic Factors|immunologic factors|mesh-ancestor
64925997|NCT00034606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64925998|NCT00034606|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64925999|NCT00034606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64926000|NCT00034645|Posaconazole|posaconazole|mesh-list
64926001|NCT00034645|Antifungal Agents|antifungal agents|mesh-ancestor
64926002|NCT00034645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926003|NCT00034645|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64926017|NCT00014118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926018|NCT00014118|Tubulin Modulators|tubulin modulators|mesh-ancestor
64926019|NCT00014118|Antimitotic Agents|antimitotic agents|mesh-ancestor
64926020|NCT00014118|Mitosis Modulators|mitosis modulators|mesh-ancestor
64384667|NCT03177317|Dexamethasone|dexamethasone|mesh-list
64926027|NCT00034762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926028|NCT00034762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64926029|NCT00034762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64926030|NCT00034762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64926031|NCT00034762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64926032|NCT00034762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64926033|NCT00034762|Dopamine Agents|dopamine agents|mesh-ancestor
64926035|NCT00000686|Antimetabolites|antimetabolites|mesh-ancestor
64926036|NCT00000686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926037|NCT00000686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64926038|NCT00000686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64926071|NCT00034840|Telmisartan|telmisartan|mesh-list
64926072|NCT00034840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64926073|NCT00034840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64926074|NCT00034840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64926075|NCT00034840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926076|NCT00000689|Leucovorin|leucovorin|mesh-list
64926077|NCT00000689|Cytarabine|cytarabine|mesh-list
64926078|NCT00000689|Dexamethasone|dexamethasone|mesh-list
64926079|NCT00000689|Cyclophosphamide|cyclophosphamide|mesh-list
64926080|NCT00000689|Doxorubicin|doxorubicin|mesh-list
64926081|NCT00000689|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64926082|NCT00000689|Methotrexate|methotrexate|mesh-list
64926083|NCT00000689|Vincristine|vincristine|mesh-list
64926084|NCT00000689|Bleomycin|bleomycin|mesh-list
64926085|NCT00000689|Sargramostim|sargramostim|mesh-list
64926086|NCT00000689|Levoleucovorin|levoleucovorin|mesh-list
64926087|NCT00000689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64926088|NCT00000689|Immunologic Factors|immunologic factors|mesh-ancestor
64926089|NCT00000689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926090|NCT00000689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64926097|NCT00000689|Antiemetics|antiemetics|mesh-ancestor
64926127|NCT00000689|Mitosis Modulators|mitosis modulators|mesh-ancestor
64926128|NCT00034879|Gefitinib|gefitinib|mesh-list
64926129|NCT00034879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926130|NCT00034879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64926131|NCT00034879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926132|NCT00034879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926133|NCT00000707|Pentamidine|pentamidine|mesh-list
64926134|NCT00000707|Antifungal Agents|antifungal agents|mesh-ancestor
64926135|NCT00000707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926136|NCT00000707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64926137|NCT00000707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64926138|NCT00000707|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64926139|NCT00014235|Cyclosporine|cyclosporine|mesh-list
64926140|NCT00014235|Mycophenolic Acid|mycophenolic acid|mesh-list
64407777|NCT05363631|Trace Elements|trace elements|mesh-ancestor
64926141|NCT00014235|Fludarabine|fludarabine|mesh-list
64926142|NCT00014235|Fludarabine phosphate|fludarabine phosphate|mesh-list
64926143|NCT00014235|Cyclosporins|cyclosporins|mesh-list
64926144|NCT00014235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926145|NCT00014235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64926146|NCT00014235|Antimetabolites|antimetabolites|mesh-ancestor
64926147|NCT00014235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926148|NCT00014235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64926149|NCT00014235|Immunologic Factors|immunologic factors|mesh-ancestor
64926150|NCT00014235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926151|NCT00014235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926152|NCT00014235|Antifungal Agents|antifungal agents|mesh-ancestor
64926153|NCT00014235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926154|NCT00014235|Dermatologic Agents|dermatologic agents|mesh-ancestor
64926155|NCT00014235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64926156|NCT00014235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64384669|NCT03177317|Antiemetics|antiemetics|mesh-ancestor
64384670|NCT03177317|Autonomic Agents|autonomic agents|mesh-ancestor
64926185|NCT00014274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926186|NCT00014274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64926187|NCT00014274|Antimetabolites|antimetabolites|mesh-ancestor
64926188|NCT00014274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926222|NCT00000719|Antimetabolites|antimetabolites|mesh-ancestor
64926223|NCT00000719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926224|NCT00000719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64926225|NCT00000719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64926226|NCT00000719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926227|NCT00000719|Antiviral Agents|antiviral agents|mesh-ancestor
64926228|NCT00000719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926229|NCT00000719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64926230|NCT00000719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64926231|NCT00014313|Etoposide|etoposide|mesh-list
64926232|NCT00014313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926233|NCT00014313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64926234|NCT00014313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64926235|NCT00014313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64926236|NCT00014313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926237|NCT00014313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926238|NCT00035074|Methotrexate|methotrexate|mesh-list
64926239|NCT00035074|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64926240|NCT00035074|Abortifacient Agents|abortifacient agents|mesh-ancestor
64926241|NCT00035074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64694692|NCT04298606|Vaccines|vaccines|mesh-list
64926274|NCT00035152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926275|NCT00014352|Ketoconazole|ketoconazole|mesh-list
64926276|NCT00014352|Docetaxel|docetaxel|mesh-list
64926277|NCT00014352|Doxorubicin|doxorubicin|mesh-list
64926278|NCT00014352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64926279|NCT00014352|Estramustine|estramustine|mesh-list
64926280|NCT00014352|Warfarin|warfarin|mesh-list
64926281|NCT00014352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926282|NCT00014352|Tubulin Modulators|tubulin modulators|mesh-ancestor
64926299|NCT00014352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64926300|NCT00014352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64926301|NCT00014352|Alkylating Agents|alkylating agents|mesh-ancestor
64926302|NCT00014352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64407825|NCT04822415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926317|NCT00035230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926318|NCT00035269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64926319|NCT00035269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926320|NCT00014391|Ribavirin|ribavirin|mesh-list
64926321|NCT00014391|Palivizumab|palivizumab|mesh-list
64407826|NCT04822415|Sensory System Agents|sensory system agents|mesh-ancestor
64926322|NCT00014391|Antimetabolites|antimetabolites|mesh-ancestor
64926323|NCT00014391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926324|NCT00014391|Antiviral Agents|antiviral agents|mesh-ancestor
64926325|NCT00014391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926326|NCT00035308|Abetimus|abetimus|mesh-list
64926327|NCT00035308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64926328|NCT00035308|Immunologic Factors|immunologic factors|mesh-ancestor
64926329|NCT00035308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926330|NCT00035347|Azithromycin|azithromycin|mesh-list
64926331|NCT00035347|Levofloxacin|levofloxacin|mesh-list
64926332|NCT00035347|Ofloxacin|ofloxacin|mesh-list
64926333|NCT00035347|Ceftriaxone|ceftriaxone|mesh-list
64926334|NCT00035347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64926335|NCT00035347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926336|NCT00035347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64926337|NCT00035347|Renal Agents|renal agents|mesh-ancestor
64926338|NCT00035347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64926339|NCT00035347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64926341|NCT00035347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926342|NCT00035347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926343|NCT00035347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64926344|NCT00035347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64926345|NCT00014430|Trastuzumab|trastuzumab|mesh-list
64926346|NCT00014430|Vinorelbine|vinorelbine|mesh-list
64926348|NCT00014430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926364|NCT00000752|Phenylpropanolamine|phenylpropanolamine|mesh-list
64926366|NCT00000752|Ephedrine|ephedrine|mesh-list
64926367|NCT00000752|Guaifenesin|guaifenesin|mesh-list
64926368|NCT00000752|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
64926369|NCT00000752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64926370|NCT00000752|Glucocorticoids|glucocorticoids|mesh-ancestor
64926371|NCT00000752|Hormones|hormones|mesh-ancestor
64384711|NCT02416817|Thrombin|thrombin|mesh-list
64926374|NCT00000752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64926375|NCT00000752|Respiratory System Agents|respiratory system agents|mesh-ancestor
64926376|NCT00000752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64926377|NCT00000752|Autonomic Agents|autonomic agents|mesh-ancestor
64926378|NCT00000752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64926379|NCT00000752|Nasal Decongestants|nasal decongestants|mesh-ancestor
64926380|NCT00000752|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64926381|NCT00000752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64926382|NCT00000752|Sympathomimetics|sympathomimetics|mesh-ancestor
64926383|NCT00000752|Adrenergic Agents|adrenergic agents|mesh-ancestor
64926384|NCT00000752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64926385|NCT00000752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926386|NCT00000752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64926387|NCT00000752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926388|NCT00000752|Expectorants|expectorants|mesh-ancestor
64926393|NCT00035464|Azimilide|azimilide|mesh-list
64926412|NCT00014469|Dermatologic Agents|dermatologic agents|mesh-ancestor
64926413|NCT00014469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926414|NCT00014469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64926415|NCT00014469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64926416|NCT00014469|Immunologic Factors|immunologic factors|mesh-ancestor
64926417|NCT00014469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64926418|NCT00014469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64926419|NCT00014469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64926420|NCT00014469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64926421|NCT00014469|Alkylating Agents|alkylating agents|mesh-ancestor
64926422|NCT00014469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64926423|NCT00000755|Zidovudine|zidovudine|mesh-list
64926424|NCT00000755|Antimetabolites|antimetabolites|mesh-ancestor
64926425|NCT00000755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926426|NCT00000755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64926427|NCT00000755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64926428|NCT00000755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926429|NCT00000755|Antiviral Agents|antiviral agents|mesh-ancestor
64926430|NCT00000755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926431|NCT00000755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64926432|NCT00000755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64926433|NCT00014508|Cyclosporine|cyclosporine|mesh-list
64926434|NCT00014508|Cyclophosphamide|cyclophosphamide|mesh-list
64926435|NCT00014508|Melphalan|melphalan|mesh-list
64926436|NCT00014508|Fludarabine|fludarabine|mesh-list
64926437|NCT00014508|Fludarabine phosphate|fludarabine phosphate|mesh-list
64926438|NCT00014508|Cyclosporins|cyclosporins|mesh-list
64926439|NCT00014508|Sargramostim|sargramostim|mesh-list
64926440|NCT00014508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64926441|NCT00014508|Immunologic Factors|immunologic factors|mesh-ancestor
64926442|NCT00014508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926443|NCT00014508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64926444|NCT00014508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64926445|NCT00014508|Alkylating Agents|alkylating agents|mesh-ancestor
64926454|NCT00014508|Dermatologic Agents|dermatologic agents|mesh-ancestor
64926455|NCT00014508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64926456|NCT00035581|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
64926458|NCT00035581|Antiviral Agents|antiviral agents|mesh-ancestor
64926459|NCT00035581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926460|NCT00035581|Interferon Inducers|interferon inducers|mesh-ancestor
64926461|NCT00035581|Immunologic Factors|immunologic factors|mesh-ancestor
64926462|NCT00035581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926463|NCT00000758|Fluorouracil|fluorouracil|mesh-list
64926464|NCT00000758|Antimetabolites|antimetabolites|mesh-ancestor
64926465|NCT00000758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926466|NCT00000758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64926467|NCT00000758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926468|NCT00000758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64926515|NCT04732390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926516|NCT04732390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64926517|NCT04732390|Tocolytic Agents|tocolytic agents|mesh-ancestor
64926518|NCT04732390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64926519|NCT00035854|Linezolid|linezolid|mesh-list
64926520|NCT00035854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64384721|NCT02399189|Abortifacient Agents|abortifacient agents|mesh-ancestor
64926543|NCT00035971|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64926559|NCT02971345|Trace Elements|trace elements|mesh-ancestor
64926560|NCT02971345|Micronutrients|micronutrients|mesh-ancestor
64926561|NCT02971345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926562|NCT02971345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64926563|NCT02971345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926564|NCT02971345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64694980|NCT03038672|Immunologic Factors|immunologic factors|mesh-ancestor
64926565|NCT02971345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64926566|NCT02971345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926567|NCT02971345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926568|NCT00036088|Olanzapine|olanzapine|mesh-list
64926569|NCT00036088|Antiemetics|antiemetics|mesh-ancestor
64926570|NCT00036088|Autonomic Agents|autonomic agents|mesh-ancestor
64926571|NCT00036088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64926572|NCT00036088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926573|NCT00036088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64926574|NCT00036088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64926575|NCT00036088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64926576|NCT00036088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64926577|NCT00036088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64926578|NCT00036088|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64926579|NCT00036088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64926580|NCT00036088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64926581|NCT00036088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926582|NCT00036088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64926583|NCT00036088|Serotonin Agents|serotonin agents|mesh-ancestor
64926584|NCT00036127|Aripiprazole|aripiprazole|mesh-list
64926585|NCT00036127|Antidepressive Agents|antidepressive agents|mesh-ancestor
64926603|NCT00000788|Methadone|methadone|mesh-list
64926604|NCT00000788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64926623|NCT00000788|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64926625|NCT00036166|Antifungal Agents|antifungal agents|mesh-ancestor
64926626|NCT00036166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926627|NCT00000794|Leucovorin|leucovorin|mesh-list
64926628|NCT00000794|Clarithromycin|clarithromycin|mesh-list
64926629|NCT00000794|Sulfadiazine|sulfadiazine|mesh-list
64926630|NCT00000794|Pyrimethamine|pyrimethamine|mesh-list
64926631|NCT00000794|Atovaquone|atovaquone|mesh-list
64926632|NCT00000794|Calcium|calcium|mesh-list
64926639|NCT00000794|Vitamins|vitamins|mesh-ancestor
64926647|NCT00000794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64926648|NCT00000794|Antimalarials|antimalarials|mesh-ancestor
64407845|NCT03037073|Analgesics|analgesics|mesh-ancestor
64926649|NCT00000794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64926650|NCT00000794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64926651|NCT00000794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64926652|NCT00000794|Coccidiostats|coccidiostats|mesh-ancestor
64926653|NCT00036244|Secretin|secretin|mesh-list
64926654|NCT00036244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64926655|NCT00036244|Hormones|hormones|mesh-ancestor
64926656|NCT00036244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64926657|NCT00036244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926658|NCT00036283|Celecoxib|celecoxib|mesh-list
64926659|NCT00036283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64926660|NCT00036283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64926661|NCT00036283|Analgesics|analgesics|mesh-ancestor
64926662|NCT00036283|Sensory System Agents|sensory system agents|mesh-ancestor
64926663|NCT00036283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64926664|NCT00036283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926665|NCT00036283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64926666|NCT00036283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64926667|NCT00036283|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64926668|NCT00036283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64926669|NCT00036283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926670|NCT00036283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926695|NCT00036361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926696|NCT00036361|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64926697|NCT00036361|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64926698|NCT00036361|Serotonin Agents|serotonin agents|mesh-ancestor
64926699|NCT00036361|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64926700|NCT00036361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64926701|NCT00036361|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64926702|NCT00036361|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64926703|NCT00036400|Epoetin Alfa|epoetin alfa|mesh-list
64926704|NCT00036400|Hematinics|hematinics|mesh-ancestor
64926706|NCT00036439|Dermatologic Agents|dermatologic agents|mesh-ancestor
64926707|NCT00036439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64926708|NCT00036439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64926709|NCT00000821|Aldesleukin|aldesleukin|mesh-list
64926710|NCT00000821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926711|NCT00000821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64926712|NCT00000821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64695130|NCT00358280|Bupivacaine|bupivacaine|mesh-list
64926713|NCT00000821|Antiviral Agents|antiviral agents|mesh-ancestor
64926714|NCT00000821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926715|NCT00036556|Atrasentan|atrasentan|mesh-list
64926716|NCT00036556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926718|NCT00036556|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64926728|NCT00036634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926729|NCT00036634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926730|NCT00036634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64926731|NCT00036634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64926732|NCT00000851|Didanosine|didanosine|mesh-list
64926733|NCT00000851|Stavudine|stavudine|mesh-list
64926734|NCT00000851|Antimetabolites|antimetabolites|mesh-ancestor
64926735|NCT00000851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926736|NCT00000851|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64926737|NCT00000851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64926738|NCT00000851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926739|NCT00000851|Antiviral Agents|antiviral agents|mesh-ancestor
64926740|NCT00000851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64926741|NCT00000851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64926742|NCT00000851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64926758|NCT00036790|Dermatologic Agents|dermatologic agents|mesh-ancestor
64926759|NCT00000857|Interleukin-12|interleukin-12|mesh-list
64926770|NCT00036868|Methotrexate|methotrexate|mesh-list
64926771|NCT00036868|Trastuzumab|trastuzumab|mesh-list
64926772|NCT00036868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64926773|NCT00036868|Immunologic Factors|immunologic factors|mesh-ancestor
64926774|NCT00036868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926775|NCT00036868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64926776|NCT00036868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64926777|NCT00036868|Alkylating Agents|alkylating agents|mesh-ancestor
64926778|NCT00036868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926779|NCT00036868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926780|NCT00036868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64926781|NCT00036868|Antimetabolites|antimetabolites|mesh-ancestor
64926782|NCT00036868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64926783|NCT00036868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64926784|NCT00036868|Abortifacient Agents|abortifacient agents|mesh-ancestor
64926785|NCT00036868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64926786|NCT00036868|Dermatologic Agents|dermatologic agents|mesh-ancestor
64926787|NCT00036868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926788|NCT00036868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64926789|NCT00036868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64926790|NCT00036868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64926791|NCT00036946|Aflibercept|aflibercept|mesh-list
64926792|NCT00036946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64926793|NCT00036946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64926794|NCT00036946|Growth Substances|growth substances|mesh-ancestor
64926795|NCT00036946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926796|NCT00036946|Growth Inhibitors|growth inhibitors|mesh-ancestor
64926797|NCT00036946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64926798|NCT00036985|Cyclophosphamide|cyclophosphamide|mesh-list
64926799|NCT00036985|Doxorubicin|doxorubicin|mesh-list
64926813|NCT00036985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64926814|NCT00037063|Ascorbic Acid|ascorbic acid|mesh-list
64926815|NCT00037063|Vitamin E|vitamin e|mesh-list
64926816|NCT00037063|Riboflavin|riboflavin|mesh-list
64926817|NCT00037063|Thiamine|thiamine|mesh-list
64926818|NCT00037063|Vitamins|vitamins|mesh-ancestor
64926819|NCT00037063|Micronutrients|micronutrients|mesh-ancestor
64926820|NCT00037063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64926821|NCT00037063|Antioxidants|antioxidants|mesh-ancestor
64926822|NCT00037063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64926823|NCT00037063|Protective Agents|protective agents|mesh-ancestor
64926824|NCT00037063|Vitamin B Complex|vitamin b complex|mesh-ancestor
64926825|NCT00037063|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64926826|NCT00037063|Dermatologic Agents|dermatologic agents|mesh-ancestor
64927005|NCT00038077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64927007|NCT00038077|Autonomic Agents|autonomic agents|mesh-ancestor
64927013|NCT00038077|Adrenergic Agents|adrenergic agents|mesh-ancestor
64927029|NCT00038194|Tubulin Modulators|tubulin modulators|mesh-ancestor
64927030|NCT00038194|Antimitotic Agents|antimitotic agents|mesh-ancestor
64927031|NCT00038194|Mitosis Modulators|mitosis modulators|mesh-ancestor
64927032|NCT00038194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927033|NCT00038194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64927034|NCT00038194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927036|NCT00038233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64927037|NCT00038233|Immunologic Factors|immunologic factors|mesh-ancestor
64927038|NCT00038233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407853|NCT04831541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407855|NCT04470973|Cefuroxime|cefuroxime|mesh-list
64927039|NCT00038233|Leprostatic Agents|leprostatic agents|mesh-ancestor
64927040|NCT00038233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64927041|NCT00038233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927042|NCT00038233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64927043|NCT00038233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64927044|NCT00038233|Growth Substances|growth substances|mesh-ancestor
64927045|NCT00038233|Growth Inhibitors|growth inhibitors|mesh-ancestor
64927046|NCT00038233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927047|NCT00000926|Nonoxynol|nonoxynol|mesh-list
64927048|NCT00000926|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
64927049|NCT00000926|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
64927050|NCT00000926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927051|NCT00000926|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64927052|NCT00000926|Contraceptive Agents|contraceptive agents|mesh-ancestor
64927053|NCT00000926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64927054|NCT00000926|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64927055|NCT00038272|Mycophenolic Acid|mycophenolic acid|mesh-list
64927056|NCT00038272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64927057|NCT00038272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927058|NCT00038272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64927059|NCT00038272|Antitubercular Agents|antitubercular agents|mesh-ancestor
64927060|NCT00038272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64927071|NCT00000941|Nelfinavir|nelfinavir|mesh-list
64927072|NCT00000941|Saquinavir|saquinavir|mesh-list
64927073|NCT00000941|Atorvastatin|atorvastatin|mesh-list
64927074|NCT00000941|Simvastatin|simvastatin|mesh-list
64927075|NCT00000941|Pravastatin|pravastatin|mesh-list
64927076|NCT00000941|Calcium|calcium|mesh-list
64927077|NCT00000941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64927078|NCT00000941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927079|NCT00000941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64927080|NCT00000941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64927081|NCT00000941|Antimetabolites|antimetabolites|mesh-ancestor
64927082|NCT00000941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927083|NCT00000941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64927084|NCT00000941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64927085|NCT00000941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927086|NCT00000941|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64927087|NCT00000941|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64927088|NCT00000941|Protease Inhibitors|protease inhibitors|mesh-ancestor
64927089|NCT00000941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64927090|NCT00000941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64927091|NCT00000941|Antiviral Agents|antiviral agents|mesh-ancestor
64927092|NCT00000941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927093|NCT00000941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64927094|NCT00000941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64927096|NCT00014937|Lopinavir|lopinavir|mesh-list
64927097|NCT00014937|Lamivudine|lamivudine|mesh-list
64927098|NCT00014937|Zidovudine|zidovudine|mesh-list
64927099|NCT00014937|Didanosine|didanosine|mesh-list
64927100|NCT00014937|Stavudine|stavudine|mesh-list
64384934|NCT05493969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64927127|NCT00000959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927128|NCT00000959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64927129|NCT00000959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64927130|NCT00000959|Antimetabolites|antimetabolites|mesh-ancestor
64927131|NCT00000959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927132|NCT00000959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64927133|NCT00000959|Vitamin B Complex|vitamin b complex|mesh-ancestor
64927134|NCT00000959|Vitamins|vitamins|mesh-ancestor
64927135|NCT00000959|Micronutrients|micronutrients|mesh-ancestor
64927136|NCT00000959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927137|NCT00396604|Maleic acid|maleic acid|mesh-list
64927138|NCT00396604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927139|NCT00396604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927140|NCT00000962|Nevirapine|nevirapine|mesh-list
64927141|NCT00000962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64407941|NCT03097003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407942|NCT03097003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927142|NCT00000962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64927143|NCT00000962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927145|NCT00000962|Antiviral Agents|antiviral agents|mesh-ancestor
64927164|NCT00396721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64927165|NCT00396721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64695580|NCT05723276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64927166|NCT00396721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64927167|NCT00396721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927168|NCT00396721|Antifungal Agents|antifungal agents|mesh-ancestor
64927169|NCT00396721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64927170|NCT00396721|Immunologic Factors|immunologic factors|mesh-ancestor
64927171|NCT00396721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927172|NCT00396721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64927173|NCT00396721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64927175|NCT00396721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927176|NCT00396721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927177|NCT00396721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64927178|NCT00396721|Protease Inhibitors|protease inhibitors|mesh-ancestor
64927180|NCT00000965|Antimetabolites|antimetabolites|mesh-ancestor
64927181|NCT00000965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927182|NCT00000965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64927183|NCT00000965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64927184|NCT00000965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927185|NCT00000965|Antiviral Agents|antiviral agents|mesh-ancestor
64927186|NCT00000965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927187|NCT00000965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64927188|NCT00000965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64927189|NCT00015054|Methylphenidate|methylphenidate|mesh-list
64927190|NCT00015054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64927191|NCT00015054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927192|NCT00015054|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64927193|NCT00015054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64927194|NCT00015054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64927195|NCT00015054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927202|NCT00015132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64927203|NCT00015132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64927204|NCT00015132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927205|NCT00015132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64927206|NCT00015132|Serotonin Agents|serotonin agents|mesh-ancestor
64927223|NCT00000971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64407948|NCT03097003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407949|NCT02605967|Spartalizumab|spartalizumab|mesh-list
64407950|NCT02605967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64407951|NCT02605967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407952|NCT02605967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927225|NCT00015171|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64927226|NCT00015171|Naloxone|naloxone|mesh-list
64927227|NCT00015171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64927228|NCT00015171|Narcotics|narcotics|mesh-ancestor
64927229|NCT00015171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64927230|NCT00015171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927231|NCT00015171|Analgesics|analgesics|mesh-ancestor
64927232|NCT00015171|Sensory System Agents|sensory system agents|mesh-ancestor
64927243|NCT00015210|Antidepressive Agents|antidepressive agents|mesh-ancestor
64927244|NCT00015210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64927245|NCT00015210|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64927246|NCT00015210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64927247|NCT00015210|Serotonin Agents|serotonin agents|mesh-ancestor
64927249|NCT00000986|Aldesleukin|aldesleukin|mesh-list
64927250|NCT00000986|Antimetabolites|antimetabolites|mesh-ancestor
64927251|NCT00000986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927252|NCT00000986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64927253|NCT00000986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64927254|NCT00000986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927255|NCT00000986|Antiviral Agents|antiviral agents|mesh-ancestor
64927256|NCT00000986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927257|NCT00000986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64927258|NCT00000986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64927259|NCT00000986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927260|NCT00015249|Amantadine|amantadine|mesh-list
64927261|NCT00015249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64927262|NCT00015249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64927263|NCT00015249|Antiviral Agents|antiviral agents|mesh-ancestor
64927264|NCT00015249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927265|NCT00015249|Dopamine Agents|dopamine agents|mesh-ancestor
64927266|NCT00015249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64927267|NCT00015249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927268|NCT00015249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927269|NCT00015249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64927270|NCT00015249|Analgesics|analgesics|mesh-ancestor
64927271|NCT00015249|Sensory System Agents|sensory system agents|mesh-ancestor
64927291|NCT00015288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927293|NCT00015288|Sensory System Agents|sensory system agents|mesh-ancestor
64927294|NCT00015288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64384941|NCT05493657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64927309|NCT00000998|Protective Agents|protective agents|mesh-ancestor
64927310|NCT00000998|Vitamin B Complex|vitamin b complex|mesh-ancestor
64927312|NCT00000998|Micronutrients|micronutrients|mesh-ancestor
64927313|NCT00000998|Antifungal Agents|antifungal agents|mesh-ancestor
64927314|NCT00000998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927315|NCT00000998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64927317|NCT00000998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927341|NCT05076877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64927342|NCT05076877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64927343|NCT05076877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64927344|NCT05076877|Anesthetics, General|anesthetics, general|mesh-ancestor
64927345|NCT05076877|Anesthetics|anesthetics|mesh-ancestor
64927346|NCT05076877|GABA Modulators|gaba modulators|mesh-ancestor
64927347|NCT05076877|GABA Agents|gaba agents|mesh-ancestor
64927348|NCT05076877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64927349|NCT05076877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927350|NCT05076877|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64927351|NCT05076877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64407996|NCT04428437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927352|NCT05076877|Antimetabolites|antimetabolites|mesh-ancestor
64927353|NCT05076877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64927354|NCT05076877|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64927355|NCT05076877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927356|NCT05076877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64927357|NCT00001004|Interferons|interferons|mesh-list
64927358|NCT00001004|Interferon-gamma|interferon-gamma|mesh-list
64927359|NCT00001004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927360|NCT00001004|Antiviral Agents|antiviral agents|mesh-ancestor
64927361|NCT00001004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927362|NCT00396760|Tranexamic Acid|tranexamic acid|mesh-list
64927363|NCT00396760|Aprotinin|aprotinin|mesh-list
64927364|NCT00396760|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64927365|NCT00396760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64927366|NCT00396760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927391|NCT00396799|Hormone Antagonists|hormone antagonists|mesh-ancestor
64927392|NCT00396799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64927394|NCT01786434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64927395|NCT01786434|Narcotics|narcotics|mesh-ancestor
64927396|NCT01786434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64927397|NCT01786434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927398|NCT01786434|Analgesics|analgesics|mesh-ancestor
64927399|NCT01786434|Sensory System Agents|sensory system agents|mesh-ancestor
64927400|NCT01786434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64927401|NCT01786434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64927402|NCT01786434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64927403|NCT01786434|Anesthetics, General|anesthetics, general|mesh-ancestor
64927404|NCT01786434|Anesthetics|anesthetics|mesh-ancestor
64927405|NCT00001010|Zidovudine|zidovudine|mesh-list
64927406|NCT00001010|Acyclovir|acyclovir|mesh-list
64927407|NCT00001010|Antimetabolites|antimetabolites|mesh-ancestor
64384975|NCT05492565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927584|NCT00001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927622|NCT02970916|Aflibercept|aflibercept|mesh-list
64927623|NCT02970916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64927624|NCT02970916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64927625|NCT02970916|Growth Substances|growth substances|mesh-ancestor
64927626|NCT02970916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927627|NCT02970916|Growth Inhibitors|growth inhibitors|mesh-ancestor
64927628|NCT02970916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927629|NCT00016068|Valganciclovir|valganciclovir|mesh-list
64927630|NCT00016068|Ganciclovir|ganciclovir|mesh-list
64927631|NCT00016068|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64927632|NCT00016068|Antiviral Agents|antiviral agents|mesh-ancestor
64927633|NCT00016068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927634|NCT00016068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64927635|NCT00016068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927636|NCT00016068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927637|NCT00016107|Bevacizumab|bevacizumab|mesh-list
64927638|NCT00016107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64927640|NCT00016107|Estramustine|estramustine|mesh-list
64927641|NCT00016107|Antibodies|antibodies|mesh-list
64927642|NCT00016107|Immunoglobulins|immunoglobulins|mesh-list
64927643|NCT00016107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64927644|NCT00016107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927645|NCT00016107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64927646|NCT00016107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64927647|NCT00016107|Growth Substances|growth substances|mesh-ancestor
64927648|NCT00016107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927649|NCT00016107|Growth Inhibitors|growth inhibitors|mesh-ancestor
64927658|NCT00001118|Enfuvirtide|enfuvirtide|mesh-list
64927681|NCT00001151|Micronutrients|micronutrients|mesh-ancestor
64927682|NCT00001151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927683|NCT00001151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64927684|NCT00001151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64927685|NCT00001151|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64927686|NCT00001151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64927687|NCT00001151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927688|NCT00001151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64927689|NCT00016224|Thalidomide|thalidomide|mesh-list
64927712|NCT00016302|Doxorubicin|doxorubicin|mesh-list
64927713|NCT00016302|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64408040|NCT04821323|Gout Suppressants|gout suppressants|mesh-ancestor
64927714|NCT00016302|Methotrexate|methotrexate|mesh-list
64927715|NCT00016302|Vincristine|vincristine|mesh-list
64927716|NCT00016302|Daunorubicin|daunorubicin|mesh-list
64927717|NCT00016302|Asparaginase|asparaginase|mesh-list
64927718|NCT00016302|Mercaptopurine|mercaptopurine|mesh-list
64927719|NCT00016302|Pegaspargase|pegaspargase|mesh-list
64927720|NCT00016302|Thioguanine|thioguanine|mesh-list
64927721|NCT00016302|Levoleucovorin|levoleucovorin|mesh-list
64927722|NCT00016302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64927723|NCT00016302|Immunologic Factors|immunologic factors|mesh-ancestor
64927724|NCT00016302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927725|NCT00016302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64927726|NCT00016302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64927727|NCT00016302|Alkylating Agents|alkylating agents|mesh-ancestor
64927728|NCT00016302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927729|NCT00016302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927730|NCT00016302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64927731|NCT00016302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64927732|NCT00016302|Antiemetics|antiemetics|mesh-ancestor
64927733|NCT00016302|Autonomic Agents|autonomic agents|mesh-ancestor
64927734|NCT00016302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64927735|NCT00016302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64927736|NCT00016302|Glucocorticoids|glucocorticoids|mesh-ancestor
64927737|NCT00016302|Hormones|hormones|mesh-ancestor
64927738|NCT00016302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64927739|NCT00016302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64927740|NCT00016302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64927741|NCT00016302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64927748|NCT00016302|Antimetabolites|antimetabolites|mesh-ancestor
64927759|NCT00016302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64927769|NCT00016341|Paclitaxel|paclitaxel|mesh-list
64927770|NCT00016341|Doxorubicin|doxorubicin|mesh-list
64927771|NCT00016341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64927772|NCT00016341|Megestrol|megestrol|mesh-list
64927773|NCT00016341|Megestrol Acetate|megestrol acetate|mesh-list
64927774|NCT00016341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64927775|NCT00016341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927776|NCT00016341|Tubulin Modulators|tubulin modulators|mesh-ancestor
64927777|NCT00016341|Antimitotic Agents|antimitotic agents|mesh-ancestor
64927778|NCT00016341|Mitosis Modulators|mitosis modulators|mesh-ancestor
64927779|NCT00016341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927780|NCT00016341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64927781|NCT00016341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64927782|NCT00016341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64927783|NCT00016341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927809|NCT00016380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64927810|NCT00016380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927811|NCT00016380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64927812|NCT00016380|Glucocorticoids|glucocorticoids|mesh-ancestor
64927813|NCT00016380|Hormones|hormones|mesh-ancestor
64927814|NCT00016380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64927815|NCT00016380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64927816|NCT00016380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927817|NCT00016380|Antipruritics|antipruritics|mesh-ancestor
64927818|NCT00016380|Dermatologic Agents|dermatologic agents|mesh-ancestor
64927819|NCT00016380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64927820|NCT00016380|Serotonin Agents|serotonin agents|mesh-ancestor
64927821|NCT00016380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64927822|NCT00016380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927823|NCT00016380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64927824|NCT00016380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64927825|NCT00016380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64927826|NCT00016380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64927827|NCT00016380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64927828|NCT00001190|Deslorelin|deslorelin|mesh-list
64927829|NCT00001190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927830|NCT00001190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927831|NCT00001202|Testolactone|testolactone|mesh-list
64927833|NCT00001202|Deslorelin|deslorelin|mesh-list
64927859|NCT00016458|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64408045|NCT04821323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927931|NCT02347111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64927932|NCT00001262|Copper|copper|mesh-list
64927933|NCT00001262|Trace Elements|trace elements|mesh-ancestor
64927934|NCT00001262|Micronutrients|micronutrients|mesh-ancestor
64927935|NCT00001262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927936|NCT00001280|Itraconazole|itraconazole|mesh-list
64927937|NCT00001280|Antifungal Agents|antifungal agents|mesh-ancestor
64927938|NCT00001280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927939|NCT00001280|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64927940|NCT00001280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64927941|NCT00001280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927942|NCT00001280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927943|NCT00001280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64927944|NCT00001280|Hormone Antagonists|hormone antagonists|mesh-ancestor
64927945|NCT00001280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64927946|NCT00001280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927947|NCT00001280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64927948|NCT00016887|Interferons|interferons|mesh-list
64927958|NCT00016887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927959|NCT00016887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64927960|NCT00016887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64927961|NCT00016887|Alkylating Agents|alkylating agents|mesh-ancestor
64927962|NCT00016887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927963|NCT00016887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64927972|NCT00016887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64927973|NCT00016887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64927974|NCT00016887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64927975|NCT00016887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64927976|NCT00016887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64927977|NCT00016887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927978|NCT00016887|Antiviral Agents|antiviral agents|mesh-ancestor
64927979|NCT00016887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64927980|NCT00016887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64927981|NCT00016887|Antimetabolites|antimetabolites|mesh-ancestor
64927982|NCT00038389|Rofecoxib|rofecoxib|mesh-list
64927983|NCT00038389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64927984|NCT00038389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64927985|NCT00038389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64927986|NCT00038389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64927987|NCT00038389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64927988|NCT00038389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64927989|NCT00038389|Analgesics|analgesics|mesh-ancestor
64927990|NCT00038389|Sensory System Agents|sensory system agents|mesh-ancestor
64927991|NCT00038389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64927992|NCT00038389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64927993|NCT00038389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64927994|NCT00038389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64927995|NCT00038506|Tenofovir|tenofovir|mesh-list
64927996|NCT00038506|Lamivudine|lamivudine|mesh-list
64927997|NCT00038506|Zidovudine|zidovudine|mesh-list
64927998|NCT00038506|Abacavir|abacavir|mesh-list
64928019|NCT00038545|Antimitotic Agents|antimitotic agents|mesh-ancestor
64928020|NCT00038545|Mitosis Modulators|mitosis modulators|mesh-ancestor
64928021|NCT00038545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928022|NCT00038545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64928023|NCT00038545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64928024|NCT00038545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928025|NCT00038584|Lonafarnib|lonafarnib|mesh-list
64928026|NCT00038584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928027|NCT00038584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928028|NCT00038623|Rituximab|rituximab|mesh-list
64928029|NCT00038623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64928030|NCT00038623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928031|NCT00038623|Immunologic Factors|immunologic factors|mesh-ancestor
64928032|NCT00038623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928033|NCT00038623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64928034|NCT00038662|Atrasentan|atrasentan|mesh-list
64928035|NCT00038662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928036|NCT00038662|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64928037|NCT00038662|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64408050|NCT05035069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928038|NCT00038662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928039|NCT00038701|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
64928040|NCT00038701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64928041|NCT00038701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928042|NCT00038701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64928080|NCT00017082|Oxaliplatin|oxaliplatin|mesh-list
64928081|NCT00017082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928082|NCT00039091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64928083|NCT00039091|Ipilimumab|ipilimumab|mesh-list
64928084|NCT00039091|Antibodies|antibodies|mesh-list
64928085|NCT00039091|Immunoglobulins|immunoglobulins|mesh-list
64928086|NCT00039091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64928087|NCT00039091|Immunologic Factors|immunologic factors|mesh-ancestor
64928088|NCT00039091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928089|NCT00039091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928090|NCT00039091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64928091|NCT00039091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928092|NCT00039169|IDN 5109|idn 5109|mesh-list
64928102|NCT00001304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64928103|NCT00001304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64928104|NCT00001304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64385051|NCT05489601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64385053|NCT05489601|Analgesics|analgesics|mesh-ancestor
64928153|NCT00039403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928154|NCT00039403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64928156|NCT00039442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64928157|NCT00039442|Antimetabolites|antimetabolites|mesh-ancestor
64928158|NCT00039442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928159|NCT00039442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928160|NCT00039481|Cyclophosphamide|cyclophosphamide|mesh-list
64928161|NCT00039481|Doxorubicin|doxorubicin|mesh-list
64928162|NCT00039481|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64928163|NCT00039481|Dexrazoxane|dexrazoxane|mesh-list
64928164|NCT00039481|Razoxane|razoxane|mesh-list
64928165|NCT00039481|Oblimersen|oblimersen|mesh-list
64928166|NCT00039481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64928167|NCT00039481|Immunologic Factors|immunologic factors|mesh-ancestor
64928168|NCT00039481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928169|NCT00039481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64385070|NCT05483439|Trastuzumab|trastuzumab|mesh-list
64385071|NCT05483439|Epirubicin|epirubicin|mesh-list
64385072|NCT05483439|Pertuzumab|pertuzumab|mesh-list
64928211|NCT00039520|Tubulin Modulators|tubulin modulators|mesh-ancestor
64928212|NCT00039520|Antimitotic Agents|antimitotic agents|mesh-ancestor
64928213|NCT00039520|Mitosis Modulators|mitosis modulators|mesh-ancestor
64928214|NCT00039520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928215|NCT00039520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64928216|NCT00039520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64928217|NCT00039520|Analgesics|analgesics|mesh-ancestor
64928218|NCT00039520|Sensory System Agents|sensory system agents|mesh-ancestor
64928295|NCT00001343|Anabolic Agents|anabolic agents|mesh-ancestor
64928296|NCT00040066|Cocaine|cocaine|mesh-list
64928297|NCT00040066|Anesthetics, Local|anesthetics, local|mesh-ancestor
64928298|NCT00040066|Anesthetics|anesthetics|mesh-ancestor
64928299|NCT00040066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64696716|NCT04926233|Bromides|bromides|mesh-list
64928300|NCT00040066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928311|NCT00040105|Tipifarnib|tipifarnib|mesh-list
64928320|NCT00040144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928321|NCT00040144|Antiviral Agents|antiviral agents|mesh-ancestor
64928322|NCT00040144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64928323|NCT00040144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64928324|NCT00040144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64928325|NCT00040183|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64928326|NCT00040183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928327|NCT00040183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64928328|NCT00040183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928329|NCT00040183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928330|NCT00040261|Memantine|memantine|mesh-list
64928331|NCT00040261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64928332|NCT00040261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64928333|NCT00040261|Dopamine Agents|dopamine agents|mesh-ancestor
64928334|NCT00040261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64928335|NCT00040261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928336|NCT00040261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928337|NCT00040261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64928338|NCT00040261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64928339|NCT00040300|Racivir|racivir|mesh-list
64928384|NCT00040690|Cyclophosphamide|cyclophosphamide|mesh-list
64928385|NCT00040690|Ifosfamide|ifosfamide|mesh-list
64928386|NCT00040690|Doxorubicin|doxorubicin|mesh-list
64928387|NCT00040690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64928388|NCT00040690|Methotrexate|methotrexate|mesh-list
64928389|NCT00040690|Etoposide|etoposide|mesh-list
64928390|NCT00040690|Vincristine|vincristine|mesh-list
64928391|NCT00040690|Levoleucovorin|levoleucovorin|mesh-list
64928392|NCT00040690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64928393|NCT00040690|Immunologic Factors|immunologic factors|mesh-ancestor
64928394|NCT00040690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928395|NCT00040690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64928396|NCT00040690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64928397|NCT00040690|Alkylating Agents|alkylating agents|mesh-ancestor
64928425|NCT00040768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928426|NCT00040807|Docetaxel|docetaxel|mesh-list
64928427|NCT00040807|Irinotecan|irinotecan|mesh-list
64928428|NCT00040807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928429|NCT00040807|Tubulin Modulators|tubulin modulators|mesh-ancestor
64928430|NCT00040807|Antimitotic Agents|antimitotic agents|mesh-ancestor
64928431|NCT00040807|Mitosis Modulators|mitosis modulators|mesh-ancestor
64928432|NCT00040807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928433|NCT00040807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64928434|NCT00040807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64928435|NCT00040807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928436|NCT00017238|KRN 5500|krn 5500|mesh-list
64928437|NCT00017238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928438|NCT00017238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64928439|NCT00017238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928440|NCT00017238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928441|NCT00040885|Docetaxel|docetaxel|mesh-list
64928442|NCT00040885|Infliximab|infliximab|mesh-list
64928443|NCT00040885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928444|NCT00040885|Tubulin Modulators|tubulin modulators|mesh-ancestor
64928445|NCT00040885|Antimitotic Agents|antimitotic agents|mesh-ancestor
64928446|NCT00040885|Mitosis Modulators|mitosis modulators|mesh-ancestor
64928447|NCT00040885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928448|NCT00040885|Dermatologic Agents|dermatologic agents|mesh-ancestor
64928449|NCT00040885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64928450|NCT00040885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64928451|NCT00001421|Methimazole|methimazole|mesh-list
64696874|NCT04932434|Psilocybin|psilocybin|mesh-list
64928452|NCT00001421|Antithyroid Agents|antithyroid agents|mesh-ancestor
64928471|NCT00041236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64928472|NCT00041236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64928473|NCT00041236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928487|NCT00017316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928488|NCT00041275|Megestrol|megestrol|mesh-list
64928489|NCT00041275|Megestrol Acetate|megestrol acetate|mesh-list
64928490|NCT00041275|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64928491|NCT00041275|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64928492|NCT00041275|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64928493|NCT00041275|Contraceptive Agents|contraceptive agents|mesh-ancestor
64928494|NCT00041275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64928495|NCT00041275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928496|NCT00041275|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64928497|NCT00041275|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64928498|NCT00041275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64928499|NCT00041275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928516|NCT00041314|Protective Agents|protective agents|mesh-ancestor
64928517|NCT00041314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64928518|NCT00041314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64928519|NCT00041314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64928520|NCT00041314|Analgesics|analgesics|mesh-ancestor
64928521|NCT00041314|Sensory System Agents|sensory system agents|mesh-ancestor
64408051|NCT05035069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64928522|NCT00041314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64928523|NCT00041314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64928524|NCT00041314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64928525|NCT00017355|Lenograstim|lenograstim|mesh-list
64928526|NCT00017355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64928527|NCT00017355|Immunologic Factors|immunologic factors|mesh-ancestor
64928528|NCT00017355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928529|NCT00397072|Sagopilone|sagopilone|mesh-list
64928530|NCT00397072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928531|NCT00017394|Bevacizumab|bevacizumab|mesh-list
64928532|NCT00017394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64928533|NCT00017394|Vinorelbine|vinorelbine|mesh-list
64928534|NCT00017394|Antibodies|antibodies|mesh-list
64928535|NCT00017394|Immunoglobulins|immunoglobulins|mesh-list
64928536|NCT00017394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64928537|NCT00017394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928538|NCT00017394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64928539|NCT00017394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64928540|NCT00017394|Growth Substances|growth substances|mesh-ancestor
64928541|NCT00017394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928542|NCT00017394|Growth Inhibitors|growth inhibitors|mesh-ancestor
64928543|NCT00017394|Immunologic Factors|immunologic factors|mesh-ancestor
64928544|NCT00017394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64928545|NCT00017394|Tubulin Modulators|tubulin modulators|mesh-ancestor
64928559|NCT00001436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64385326|NCT02394197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64385327|NCT02394197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64385328|NCT02394197|Analgesics|analgesics|mesh-ancestor
64385329|NCT02394197|Sensory System Agents|sensory system agents|mesh-ancestor
64385330|NCT02394197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64928621|NCT00042016|Decitabine|decitabine|mesh-list
64928622|NCT00042016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64928623|NCT00042016|Antimetabolites|antimetabolites|mesh-ancestor
64928624|NCT00042016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928625|NCT00042016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928626|NCT00042016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928627|NCT00017550|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64928628|NCT00017550|Immunologic Factors|immunologic factors|mesh-ancestor
64928629|NCT00017550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928630|NCT00017550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64928631|NCT00001457|Lamivudine|lamivudine|mesh-list
64928657|NCT00001475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64928658|NCT00001475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64928659|NCT00001475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64928660|NCT00001475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64928661|NCT00001475|Growth Substances|growth substances|mesh-ancestor
64928662|NCT00001475|Growth Inhibitors|growth inhibitors|mesh-ancestor
64928663|NCT00001475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928664|NCT00042328|Valacyclovir|valacyclovir|mesh-list
64928665|NCT00042328|Antiviral Agents|antiviral agents|mesh-ancestor
64928666|NCT00042328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64928667|NCT00042367|Mafosfamide|mafosfamide|mesh-list
64928668|NCT00042367|Cyclophosphamide|cyclophosphamide|mesh-list
64928669|NCT00042367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64928670|NCT00042367|Immunologic Factors|immunologic factors|mesh-ancestor
64928671|NCT00042367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928672|NCT00042367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928673|NCT00042367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64928674|NCT00042367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64928675|NCT00042367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64928676|NCT00042367|Alkylating Agents|alkylating agents|mesh-ancestor
64697090|NCT04714073|Hormone Antagonists|hormone antagonists|mesh-ancestor
64928677|NCT00042367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928678|NCT00042367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64928679|NCT02970643|Olanzapine|olanzapine|mesh-list
64928680|NCT02970643|Palonosetron|palonosetron|mesh-list
64928681|NCT02970643|Antiemetics|antiemetics|mesh-ancestor
64928682|NCT02970643|Autonomic Agents|autonomic agents|mesh-ancestor
64928683|NCT02970643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64928684|NCT02970643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928685|NCT02970643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64928686|NCT02970643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64928703|NCT00017628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64928705|NCT00017628|Prednisolone acetate|prednisolone acetate|mesh-list
64928706|NCT00017628|Cyclophosphamide|cyclophosphamide|mesh-list
64928707|NCT00017628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64928708|NCT00017628|Prednisolone phosphate|prednisolone phosphate|mesh-list
64928709|NCT00017628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64928710|NCT00017628|Immunologic Factors|immunologic factors|mesh-ancestor
64928711|NCT00017628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928712|NCT00017628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64928713|NCT00017628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64928714|NCT00017628|Alkylating Agents|alkylating agents|mesh-ancestor
64928715|NCT00017628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928716|NCT00017628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928717|NCT00017628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64928718|NCT00017628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64928719|NCT00017628|Antiemetics|antiemetics|mesh-ancestor
64928720|NCT00017628|Autonomic Agents|autonomic agents|mesh-ancestor
64928721|NCT00017628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64928722|NCT00017628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64928723|NCT00017628|Glucocorticoids|glucocorticoids|mesh-ancestor
64928724|NCT00017628|Hormones|hormones|mesh-ancestor
64928725|NCT00017628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64928726|NCT00017628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64928727|NCT00017628|Protective Agents|protective agents|mesh-ancestor
64928728|NCT00017628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64928736|NCT00042562|Analgesics|analgesics|mesh-ancestor
64928739|NCT00042562|Antidepressive Agents|antidepressive agents|mesh-ancestor
64928740|NCT00042562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64928805|NCT00017784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64928806|NCT00042874|Leucovorin|leucovorin|mesh-list
64928807|NCT00042874|Fluorouracil|fluorouracil|mesh-list
64928808|NCT00042874|Irinotecan|irinotecan|mesh-list
64928809|NCT00042874|Alvocidib|alvocidib|mesh-list
64928810|NCT00042874|Calcium|calcium|mesh-list
64928811|NCT00042874|Levoleucovorin|levoleucovorin|mesh-list
64928812|NCT00042874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64928813|NCT00042874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928814|NCT00042874|Antimetabolites|antimetabolites|mesh-ancestor
64928815|NCT00042874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928852|NCT00043069|Antacids|antacids|mesh-ancestor
64928853|NCT00043069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928854|NCT00043069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64928855|NCT00043069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64928856|NCT00043069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64928857|NCT00043069|Hormone Antagonists|hormone antagonists|mesh-ancestor
64928858|NCT00043147|Prednisone|prednisone|mesh-list
64928859|NCT00043147|Methylprednisolone|methylprednisolone|mesh-list
64928860|NCT00043147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64928861|NCT00043147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64928862|NCT00043147|Prednisolone|prednisolone|mesh-list
64928863|NCT00043147|Prednisolone acetate|prednisolone acetate|mesh-list
64928864|NCT00043147|Beclomethasone|beclomethasone|mesh-list
64928865|NCT00043147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64928866|NCT00043147|Prednisolone phosphate|prednisolone phosphate|mesh-list
64928867|NCT00043147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64928868|NCT00043147|Glucocorticoids|glucocorticoids|mesh-ancestor
64928893|NCT00043264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928894|NCT00043264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928895|NCT00043264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64928896|NCT00043264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64928897|NCT00043264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64928898|NCT00043264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64928899|NCT00043264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64928900|NCT00043264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64928901|NCT00043303|Interferons|interferons|mesh-list
64928902|NCT00043303|Interferon-gamma|interferon-gamma|mesh-list
64928903|NCT00043303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64928905|NCT00043303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64928906|NCT00017940|Mitogens|mitogens|mesh-list
64928907|NCT00017940|Mitosis Modulators|mitosis modulators|mesh-ancestor
64928908|NCT00017940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928909|NCT02970604|Aspirin|aspirin|mesh-list
64928910|NCT02970604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64928911|NCT02970604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64928912|NCT02970604|Analgesics|analgesics|mesh-ancestor
64928913|NCT02970604|Sensory System Agents|sensory system agents|mesh-ancestor
64928914|NCT02970604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64928915|NCT02970604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64928916|NCT02970604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64928917|NCT02970604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64928918|NCT02970604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64928919|NCT02970604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64928920|NCT02970604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64928921|NCT02970604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64928922|NCT02970604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64928923|NCT02970604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928924|NCT02970604|Antipyretics|antipyretics|mesh-ancestor
64928935|NCT00043381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64928936|NCT00001568|Deoxyglucose|deoxyglucose|mesh-list
64928937|NCT00001568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64928938|NCT00001568|Antimetabolites|antimetabolites|mesh-ancestor
64928939|NCT00001568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929053|NCT00018018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64929076|NCT00043966|Antiviral Agents|antiviral agents|mesh-ancestor
64929077|NCT00043966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64929078|NCT00043966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64929079|NCT00043966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64929080|NCT00043966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64929081|NCT00043966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64929082|NCT00001598|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64929083|NCT00001598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64929084|NCT00001598|Immunologic Factors|immunologic factors|mesh-ancestor
64929085|NCT00001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929086|NCT04731727|Riboflavin|riboflavin|mesh-list
64929087|NCT04731727|Vitamin B Complex|vitamin b complex|mesh-ancestor
64929088|NCT04731727|Vitamins|vitamins|mesh-ancestor
64929089|NCT04731727|Micronutrients|micronutrients|mesh-ancestor
64929090|NCT04731727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929091|NCT04731727|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64929092|NCT04731727|Dermatologic Agents|dermatologic agents|mesh-ancestor
64929093|NCT00044278|Lamotrigine|lamotrigine|mesh-list
64929094|NCT00044278|Anticonvulsants|anticonvulsants|mesh-ancestor
64929128|NCT00044473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64929129|NCT00044473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64929130|NCT00044473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929131|NCT00044473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929132|NCT00044473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929133|NCT00044473|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64929134|NCT00044473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64929136|NCT00044551|IDN 5109|idn 5109|mesh-list
64929137|NCT00044551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929138|NCT00018135|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64929139|NCT00018135|Calcium|calcium|mesh-list
64929140|NCT00018135|Sevelamer|sevelamer|mesh-list
64929141|NCT00018135|Calcium acetate|calcium acetate|mesh-list
64929142|NCT00018135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64929143|NCT00018135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929144|NCT00018135|Chelating Agents|chelating agents|mesh-ancestor
64929145|NCT00018135|Sequestering Agents|sequestering agents|mesh-ancestor
64929186|NCT00397501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64929187|NCT00397501|Antidotes|antidotes|mesh-ancestor
64929188|NCT00397501|Protective Agents|protective agents|mesh-ancestor
64929189|NCT00397501|Antioxidants|antioxidants|mesh-ancestor
64929190|NCT00397501|Antitubercular Agents|antitubercular agents|mesh-ancestor
64929191|NCT00397501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64929192|NCT00397501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64929193|NCT00397501|Chelating Agents|chelating agents|mesh-ancestor
64929194|NCT00397501|Sequestering Agents|sequestering agents|mesh-ancestor
64929195|NCT00018174|Fluoxetine|fluoxetine|mesh-list
64929196|NCT00018174|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64929197|NCT00018174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64929198|NCT00018174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64929199|NCT00018174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929200|NCT00018174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64929201|NCT00018174|Serotonin Agents|serotonin agents|mesh-ancestor
64929202|NCT00018174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929203|NCT00018174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64929204|NCT00018174|Antidepressive Agents|antidepressive agents|mesh-ancestor
64929205|NCT00018174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64929206|NCT00018174|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64929207|NCT00018174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64929208|NCT00018174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929260|NCT00044824|Histamine Agents|histamine agents|mesh-ancestor
64929261|NCT00044824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64929262|NCT00044824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929263|NCT00044824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929265|NCT00018213|Nicotine|nicotine|mesh-list
64929282|NCT00044902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64929283|NCT00044902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929284|NCT00045136|Melphalan|melphalan|mesh-list
64929285|NCT00045136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64929286|NCT00045136|Alkylating Agents|alkylating agents|mesh-ancestor
64929287|NCT00045136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929288|NCT00045136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929289|NCT00045136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64929290|NCT00045136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64929291|NCT00045136|Immunologic Factors|immunologic factors|mesh-ancestor
64929292|NCT00045136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929293|NCT00001649|Valacyclovir|valacyclovir|mesh-list
64929294|NCT00001649|Antiviral Agents|antiviral agents|mesh-ancestor
64929295|NCT00001649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64929296|NCT00018291|Gabapentin|gabapentin|mesh-list
64929297|NCT00018291|Risperidone|risperidone|mesh-list
64929298|NCT00018291|Analgesics|analgesics|mesh-ancestor
64385481|NCT03166397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64929343|NCT02970682|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64929344|NCT02970682|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64929345|NCT02970682|Hormone Antagonists|hormone antagonists|mesh-ancestor
64929346|NCT02970682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64929347|NCT02970682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929348|NCT02970682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64929349|NCT02970682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929350|NCT02970682|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64929351|NCT02970682|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64929352|NCT02970682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64929353|NCT02970682|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64929354|NCT02970682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64929355|NCT02970682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929356|NCT02970682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929358|NCT00045448|Alvocidib|alvocidib|mesh-list
64929359|NCT00045448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929360|NCT00045448|Tubulin Modulators|tubulin modulators|mesh-ancestor
64929361|NCT00045448|Antimitotic Agents|antimitotic agents|mesh-ancestor
64929362|NCT00045448|Mitosis Modulators|mitosis modulators|mesh-ancestor
64929378|NCT00045604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929379|NCT00045604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64929380|NCT00045604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64929381|NCT00045604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929382|NCT00045604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929383|NCT00045604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64929384|NCT00045682|Paclitaxel|paclitaxel|mesh-list
64929385|NCT00045682|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64929386|NCT00045682|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
64929387|NCT00045682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64929388|NCT00045682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929389|NCT00045682|Tubulin Modulators|tubulin modulators|mesh-ancestor
64929390|NCT00045682|Antimitotic Agents|antimitotic agents|mesh-ancestor
64929391|NCT00045682|Mitosis Modulators|mitosis modulators|mesh-ancestor
64929392|NCT00045682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929393|NCT00045721|Carmustine|carmustine|mesh-list
64929394|NCT00045721|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64929395|NCT00045721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64929396|NCT00045721|Alkylating Agents|alkylating agents|mesh-ancestor
64945543|NCT05452772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64945544|NCT05452772|Vasodilator Agents|vasodilator agents|mesh-ancestor
64945545|NCT05452772|Vitamin B Complex|vitamin b complex|mesh-ancestor
64945546|NCT05452772|Vitamins|vitamins|mesh-ancestor
64945547|NCT05452772|Micronutrients|micronutrients|mesh-ancestor
64945548|NCT05452772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945549|NCT05452772|Hallucinogens|hallucinogens|mesh-ancestor
64945550|NCT05452772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64929509|NCT00045955|Fexofenadine|fexofenadine|mesh-list
64929510|NCT00045955|Montelukast|montelukast|mesh-list
64929511|NCT00045955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64929512|NCT00045955|Respiratory System Agents|respiratory system agents|mesh-ancestor
64929513|NCT00045955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64929514|NCT00045955|Hormone Antagonists|hormone antagonists|mesh-ancestor
64929515|NCT00045955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64929516|NCT00045955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929601|NCT00397657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385523|NCT05475873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929645|NCT00046384|Serotonin Agents|serotonin agents|mesh-ancestor
64929646|NCT00046384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64929647|NCT00046384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64929648|NCT00046384|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64929649|NCT00046384|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64929650|NCT00046423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64929651|NCT00046423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929654|NCT04258410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929655|NCT04258410|Protective Agents|protective agents|mesh-ancestor
64929656|NCT04258410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929657|NCT00046462|Metformin|metformin|mesh-list
64698138|NCT04031885|Paclitaxel|paclitaxel|mesh-list
64929658|NCT00046462|Insulin Glargine|insulin glargine|mesh-list
64929659|NCT00046462|Glyburide|glyburide|mesh-list
64408193|NCT04814303|Analgesics|analgesics|mesh-ancestor
64929660|NCT00046462|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
64929661|NCT00046462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64929662|NCT00046462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929866|NCT00047710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64929867|NCT00047710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929868|NCT00047710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64929869|NCT00047710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64929870|NCT00047710|Growth Substances|growth substances|mesh-ancestor
64929871|NCT00047710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929872|NCT00047710|Growth Inhibitors|growth inhibitors|mesh-ancestor
64929873|NCT00047710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64929874|NCT00047710|Antimetabolites|antimetabolites|mesh-ancestor
64929875|NCT00047710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929876|NCT00047749|Ziconotide|ziconotide|mesh-list
64929877|NCT00047749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64929878|NCT00047749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64698377|NCT03504410|Cytarabine|cytarabine|mesh-list
64929913|NCT00048373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64929914|NCT00048373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64929915|NCT00048373|Analgesics|analgesics|mesh-ancestor
64929916|NCT00048373|Sensory System Agents|sensory system agents|mesh-ancestor
64929917|NCT00048373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64929918|NCT00048373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929919|NCT00048373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64929920|NCT00048373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64929921|NCT00048373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64929922|NCT00048373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64929923|NCT00048373|Immunologic Factors|immunologic factors|mesh-ancestor
64929924|NCT05641337|Insulin|insulin|mesh-list
64929925|NCT05641337|Metformin|metformin|mesh-list
64929926|NCT05641337|Insulin Aspart|insulin aspart|mesh-list
64929927|NCT05641337|Linagliptin|linagliptin|mesh-list
64929928|NCT05641337|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64929929|NCT05641337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64929930|NCT05641337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929931|NCT05641337|Incretins|incretins|mesh-ancestor
64929932|NCT05641337|Hormones|hormones|mesh-ancestor
64929933|NCT05641337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64929934|NCT05641337|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64929935|NCT05641337|Protease Inhibitors|protease inhibitors|mesh-ancestor
64929936|NCT05641337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64929937|NCT05641337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929938|NCT00048412|Fludarabine|fludarabine|mesh-list
64929939|NCT00048412|Alemtuzumab|alemtuzumab|mesh-list
64929940|NCT00048412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929941|NCT00048412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64929942|NCT02970526|Oxaliplatin|oxaliplatin|mesh-list
64929943|NCT02970526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64929944|NCT00048607|Aprepitant|aprepitant|mesh-list
64929961|NCT00048607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64929962|NCT00048607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64929963|NCT00048607|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64929964|NCT00048646|Progesterone|progesterone|mesh-list
64929965|NCT00048646|Progestins|progestins|mesh-ancestor
64929966|NCT00048646|Hormones|hormones|mesh-ancestor
64929967|NCT00048646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64929968|NCT00048646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929969|NCT00048763|Cilostazol|cilostazol|mesh-list
64929970|NCT00048763|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64929971|NCT00048763|Autonomic Agents|autonomic agents|mesh-ancestor
64929972|NCT00048763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64929973|NCT00048763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64929974|NCT00048763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64929975|NCT00048763|Respiratory System Agents|respiratory system agents|mesh-ancestor
64929976|NCT00048763|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64929977|NCT00048763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64929978|NCT00048763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64929979|NCT00048763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64929980|NCT00048763|Vasodilator Agents|vasodilator agents|mesh-ancestor
64929981|NCT00048763|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64929993|NCT00048802|Risperidone|risperidone|mesh-list
64929994|NCT00048802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64929995|NCT00048802|Ziprasidone|ziprasidone|mesh-list
64929996|NCT00048802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64929997|NCT00048802|Serotonin Agents|serotonin agents|mesh-ancestor
64929998|NCT00048802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64929999|NCT00048802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930000|NCT00048802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930001|NCT00048802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64930002|NCT00048802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64930003|NCT00048802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64930004|NCT00048802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64930005|NCT00048802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64930006|NCT00048802|Dopamine Agents|dopamine agents|mesh-ancestor
64930007|NCT00048802|Antiemetics|antiemetics|mesh-ancestor
64930008|NCT00048802|Autonomic Agents|autonomic agents|mesh-ancestor
64930053|NCT00049114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64930054|NCT00049114|Immunologic Factors|immunologic factors|mesh-ancestor
64930055|NCT00049114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930056|NCT00049114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64930057|NCT00049114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64930058|NCT00049114|Alkylating Agents|alkylating agents|mesh-ancestor
64930059|NCT00049114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930060|NCT00049114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930061|NCT00049114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64930062|NCT00049114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64930063|NCT00049114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64930200|NCT00049972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930201|NCT00049972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64930202|NCT00049972|Antidepressive Agents|antidepressive agents|mesh-ancestor
64930203|NCT00049972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64930204|NCT00049972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64930205|NCT00049972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64930206|NCT00049972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930207|NCT00389636|Becaplermin|becaplermin|mesh-list
64930217|NCT00050206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930218|NCT00050206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64930219|NCT00050206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64930220|NCT00050206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64930221|NCT00050206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64930222|NCT00050206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64930223|NCT00050206|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64930224|NCT00050206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64930225|NCT00050206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64930226|NCT00050206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930242|NCT00050362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64930243|NCT00050362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64930244|NCT00050362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64930245|NCT00050362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930246|NCT00050362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930247|NCT00050362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64408232|NCT03094663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64408243|NCT03094663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64930248|NCT00050362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64930249|NCT00050362|Analgesics|analgesics|mesh-ancestor
64930250|NCT00050362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64930251|NCT00050362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64930252|NCT00050401|Vancomycin|vancomycin|mesh-list
64930253|NCT00050401|Tobramycin|tobramycin|mesh-list
64930254|NCT00050401|Meropenem|meropenem|mesh-list
64930255|NCT00050401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64930256|NCT00050401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64930257|NCT05640362|Benzydamine|benzydamine|mesh-list
64930258|NCT05640362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64930259|NCT00050440|Dexamethasone|dexamethasone|mesh-list
64930260|NCT00050440|Trabectedin|trabectedin|mesh-list
64930261|NCT00050440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64930262|NCT00050440|Antiemetics|antiemetics|mesh-ancestor
64930263|NCT00050440|Autonomic Agents|autonomic agents|mesh-ancestor
64930264|NCT00050440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64930265|NCT00050440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930266|NCT00050440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64930267|NCT00050440|Glucocorticoids|glucocorticoids|mesh-ancestor
64930268|NCT00050440|Hormones|hormones|mesh-ancestor
64930269|NCT00050440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64930270|NCT00050440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64930271|NCT00050440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930273|NCT00050440|Alkylating Agents|alkylating agents|mesh-ancestor
64930286|NCT00050479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930287|NCT00050479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930288|NCT00050596|Docetaxel|docetaxel|mesh-list
64930289|NCT00050596|Ipilimumab|ipilimumab|mesh-list
64930290|NCT00050596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930291|NCT00050596|Tubulin Modulators|tubulin modulators|mesh-ancestor
64930292|NCT00050596|Antimitotic Agents|antimitotic agents|mesh-ancestor
64930293|NCT00050596|Mitosis Modulators|mitosis modulators|mesh-ancestor
64930294|NCT00050596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930295|NCT00050596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64930296|NCT00050596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64930297|NCT00050635|Octreotide|octreotide|mesh-list
64930298|NCT00050635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64930299|NCT00050635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64930300|NCT00050635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930301|NCT00050674|Lenograstim|lenograstim|mesh-list
64930302|NCT00050674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64930358|NCT05639777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64930359|NCT05639777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64930360|NCT05639777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930372|NCT00051298|Antiemetics|antiemetics|mesh-ancestor
64930373|NCT00051298|Autonomic Agents|autonomic agents|mesh-ancestor
64930374|NCT00051298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64930375|NCT00051298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930376|NCT00051298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64930377|NCT00051298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64930378|NCT00051298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64930379|NCT00051298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64930380|NCT00051298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64930381|NCT00051298|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64930382|NCT00051298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64930383|NCT00051298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64930384|NCT00051298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930385|NCT00051298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64930386|NCT00051298|Serotonin Agents|serotonin agents|mesh-ancestor
64930387|NCT00398008|Naltrexone|naltrexone|mesh-list
64930388|NCT00398008|Buprenorphine|buprenorphine|mesh-list
64930389|NCT00398008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64930390|NCT00398008|Narcotics|narcotics|mesh-ancestor
64930391|NCT00398008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64930392|NCT00398008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930393|NCT00398008|Analgesics|analgesics|mesh-ancestor
64930394|NCT00398008|Sensory System Agents|sensory system agents|mesh-ancestor
64930395|NCT00398008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64930396|NCT00398008|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64930397|NCT00398008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64930398|NCT05636189|Anesthetics|anesthetics|mesh-list
64930399|NCT05636189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64930400|NCT05636189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930401|NCT00051493|Carboplatin|carboplatin|mesh-list
64930402|NCT00051493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930403|NCT00051532|Seocalcitol|seocalcitol|mesh-list
64930404|NCT00051532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930415|NCT05573958|Rivaroxaban|rivaroxaban|mesh-list
64930416|NCT05573958|Clopidogrel|clopidogrel|mesh-list
64930417|NCT05573958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64930418|NCT05573958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64930419|NCT05573958|Analgesics|analgesics|mesh-ancestor
64930420|NCT05573958|Sensory System Agents|sensory system agents|mesh-ancestor
64930421|NCT05573958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64930422|NCT05573958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930423|NCT05573958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64930424|NCT05573958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64930425|NCT05573958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64930426|NCT05573958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64930427|NCT05573958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930428|NCT05573958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64930465|NCT00052039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64930466|NCT00052039|Antimetabolites|antimetabolites|mesh-ancestor
64930467|NCT00052039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930468|NCT00052039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64930469|NCT00052039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64930470|NCT00052039|Immunologic Factors|immunologic factors|mesh-ancestor
64930471|NCT00052039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930472|NCT00052039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64930473|NCT00052117|Capravirine|capravirine|mesh-list
64930474|NCT00052117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64930514|NCT00052351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930515|NCT00052351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64930517|NCT00052351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64930518|NCT00052351|Alkylating Agents|alkylating agents|mesh-ancestor
64930519|NCT00052351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64930520|NCT00052351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64930521|NCT00052351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64930522|NCT00052351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64930523|NCT00052351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930524|NCT00052351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64930525|NCT00052351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64930526|NCT00052351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64930527|NCT00052351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64385720|NCT02540265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64930538|NCT00052390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64930539|NCT00052390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64930562|NCT00052507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930564|NCT00052585|Fluorouracil|fluorouracil|mesh-list
64930565|NCT00052585|Irinotecan|irinotecan|mesh-list
64930566|NCT00052585|Gefitinib|gefitinib|mesh-list
64930567|NCT00052585|Calcium|calcium|mesh-list
64930568|NCT00052585|Levoleucovorin|levoleucovorin|mesh-list
64930569|NCT00052585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64930570|NCT00052585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930571|NCT00052585|Antimetabolites|antimetabolites|mesh-ancestor
64930572|NCT00052585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930573|NCT00052585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64930574|NCT00052585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930575|NCT00052585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64930576|NCT00052585|Immunologic Factors|immunologic factors|mesh-ancestor
64930577|NCT00052585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64930578|NCT00052585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64930579|NCT00052585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930580|NCT00052585|Antidotes|antidotes|mesh-ancestor
64930581|NCT00052585|Protective Agents|protective agents|mesh-ancestor
64930582|NCT00052585|Vitamin B Complex|vitamin b complex|mesh-ancestor
64930583|NCT00052585|Vitamins|vitamins|mesh-ancestor
64930584|NCT00052585|Micronutrients|micronutrients|mesh-ancestor
64408269|NCT04814381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64930616|NCT00052936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64930617|NCT00052936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64930618|NCT00052936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64930619|NCT00052936|Tubulin Modulators|tubulin modulators|mesh-ancestor
64930620|NCT00052936|Antimitotic Agents|antimitotic agents|mesh-ancestor
64930621|NCT00052936|Mitosis Modulators|mitosis modulators|mesh-ancestor
64930622|NCT00053092|Cyclophosphamide|cyclophosphamide|mesh-list
64930624|NCT00053092|Fludarabine|fludarabine|mesh-list
64930625|NCT00053092|Fludarabine phosphate|fludarabine phosphate|mesh-list
64930626|NCT00053092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64930627|NCT00053092|Immunologic Factors|immunologic factors|mesh-ancestor
64930628|NCT00053092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930629|NCT00053092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64930630|NCT00053092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64930631|NCT00053092|Alkylating Agents|alkylating agents|mesh-ancestor
64930632|NCT00053092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930633|NCT00053092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930634|NCT00053092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64930635|NCT00053092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64699176|NCT05649085|Cobalt|cobalt|mesh-list
64930636|NCT00053092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64930637|NCT00053092|Antimetabolites|antimetabolites|mesh-ancestor
64930638|NCT00053131|Cytarabine|cytarabine|mesh-list
64930639|NCT00053131|Mitoxantrone|mitoxantrone|mesh-list
64930640|NCT00053131|Sargramostim|sargramostim|mesh-list
64930641|NCT00053131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64930642|NCT00053131|Antimetabolites|antimetabolites|mesh-ancestor
64930643|NCT00053131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930644|NCT00053131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930645|NCT00053131|Antiviral Agents|antiviral agents|mesh-ancestor
64930646|NCT00053131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64930647|NCT00053131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64930733|NCT00053716|Alprostadil|alprostadil|mesh-list
64930734|NCT00053716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64930735|NCT00053716|Vasodilator Agents|vasodilator agents|mesh-ancestor
64930736|NCT00053716|Urological Agents|urological agents|mesh-ancestor
64930737|NCT05626478|Moxifloxacin|moxifloxacin|mesh-list
64930738|NCT05626478|Dexamethasone|dexamethasone|mesh-list
64930739|NCT05626478|Prednisolone|prednisolone|mesh-list
64930755|NCT05626478|Hormones|hormones|mesh-ancestor
64930766|NCT05626478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64930767|NCT02970175|Terlipressin|terlipressin|mesh-list
64385727|NCT02684357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930785|NCT00053872|Alkylating Agents|alkylating agents|mesh-ancestor
64930786|NCT05624918|Gemcitabine|gemcitabine|mesh-list
64930787|NCT05624918|Paclitaxel|paclitaxel|mesh-list
64930788|NCT05624918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64930789|NCT05624918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930790|NCT05624918|Tubulin Modulators|tubulin modulators|mesh-ancestor
64930791|NCT05624918|Antimitotic Agents|antimitotic agents|mesh-ancestor
64930792|NCT05624918|Mitosis Modulators|mitosis modulators|mesh-ancestor
64930793|NCT05624918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930794|NCT05624918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64930795|NCT05624918|Antimetabolites|antimetabolites|mesh-ancestor
64930812|NCT00053911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64930813|NCT00053911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64930814|NCT00053911|Alkylating Agents|alkylating agents|mesh-ancestor
64930815|NCT00053911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930816|NCT00053911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930817|NCT00053911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64930818|NCT00053911|Tubulin Modulators|tubulin modulators|mesh-ancestor
64930819|NCT00053911|Antimitotic Agents|antimitotic agents|mesh-ancestor
64930820|NCT00053911|Mitosis Modulators|mitosis modulators|mesh-ancestor
64930821|NCT00053911|Antimetabolites|antimetabolites|mesh-ancestor
64930822|NCT00053911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64930823|NCT00053911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64930824|NCT00053911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64930825|NCT00053911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64408278|NCT04819217|Charcoal|charcoal|mesh-list
64408284|NCT05052619|Sulperazone|sulperazone|mesh-list
64408285|NCT05052619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64408286|NCT05052619|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64930826|NCT00053911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930827|NCT00053911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64930828|NCT00053911|Hormone Antagonists|hormone antagonists|mesh-ancestor
64930829|NCT00053911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64930830|NCT00053911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64930831|NCT00053911|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64930832|NCT00053911|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64930833|NCT00053911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64930834|NCT00053911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64930835|NCT00053911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64930836|NCT00053950|NSC 366140|nsc 366140|mesh-list
64930859|NCT00054184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930860|NCT00054340|Cyclosporine|cyclosporine|mesh-list
64930861|NCT00054340|Cyclophosphamide|cyclophosphamide|mesh-list
64930862|NCT00054340|Busulfan|busulfan|mesh-list
64930906|NCT05560230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64930907|NCT05560230|Sympatholytics|sympatholytics|mesh-ancestor
64930908|NCT05560230|Autonomic Agents|autonomic agents|mesh-ancestor
64930909|NCT05560230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64930910|NCT05560230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64930911|NCT05560230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64930912|NCT05560230|Adrenergic Agents|adrenergic agents|mesh-ancestor
64930913|NCT05560230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64930914|NCT05560230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930915|NCT00054457|Docetaxel|docetaxel|mesh-list
64930916|NCT00054457|Capecitabine|capecitabine|mesh-list
64930917|NCT00054457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930918|NCT00054457|Tubulin Modulators|tubulin modulators|mesh-ancestor
64930919|NCT00054457|Antimitotic Agents|antimitotic agents|mesh-ancestor
64930920|NCT00054457|Mitosis Modulators|mitosis modulators|mesh-ancestor
64930921|NCT00054457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930922|NCT00054457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64930923|NCT00054457|Antimetabolites|antimetabolites|mesh-ancestor
64930924|NCT00054496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64930925|NCT00054496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64930926|NCT00054496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64930927|NCT00054496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64930959|NCT02970097|Midazolam|midazolam|mesh-list
64930960|NCT02970097|Ropivacaine|ropivacaine|mesh-list
64930961|NCT02970097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64930962|NCT02970097|Narcotics|narcotics|mesh-ancestor
64930963|NCT02970097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64930964|NCT02970097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930965|NCT02970097|Analgesics|analgesics|mesh-ancestor
64930966|NCT02970097|Sensory System Agents|sensory system agents|mesh-ancestor
64930967|NCT02970097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64930968|NCT02970097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64930969|NCT02970097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64930970|NCT02970097|Anesthetics, General|anesthetics, general|mesh-ancestor
64930971|NCT02970097|Anesthetics|anesthetics|mesh-ancestor
64930972|NCT02970097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64930973|NCT02970097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64930974|NCT02970097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64930975|NCT02970097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64930976|NCT02970097|GABA Modulators|gaba modulators|mesh-ancestor
64930977|NCT02970097|GABA Agents|gaba agents|mesh-ancestor
64930978|NCT02970097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64930979|NCT02970097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930980|NCT02970097|Anesthetics, Local|anesthetics, local|mesh-ancestor
64930981|NCT00398281|Dutasteride|dutasteride|mesh-list
64930989|NCT00055042|Vitamin E|vitamin e|mesh-list
64930990|NCT00055042|Vitamins|vitamins|mesh-ancestor
64930991|NCT00055042|Micronutrients|micronutrients|mesh-ancestor
64930992|NCT00055042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64930993|NCT00055042|Antioxidants|antioxidants|mesh-ancestor
64930994|NCT00055042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64930995|NCT00055042|Protective Agents|protective agents|mesh-ancestor
64930996|NCT00055120|Ritonavir|ritonavir|mesh-list
64930997|NCT00055120|Lopinavir|lopinavir|mesh-list
64930998|NCT00055120|Tenofovir|tenofovir|mesh-list
64930999|NCT00055120|Emtricitabine|emtricitabine|mesh-list
64931000|NCT00055120|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64931001|NCT00055120|Stavudine|stavudine|mesh-list
64931002|NCT00055120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64931060|NCT00055432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931062|NCT00055432|Antiviral Agents|antiviral agents|mesh-ancestor
64931063|NCT00055432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931064|NCT00055432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931074|NCT00055549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64931075|NCT00055549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64931076|NCT00055549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64931077|NCT00055549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931078|NCT00055549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931080|NCT00055549|Antiemetics|antiemetics|mesh-ancestor
64931081|NCT00055549|Autonomic Agents|autonomic agents|mesh-ancestor
64931082|NCT00055549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64931083|NCT00055549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64931084|NCT00055549|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64931085|NCT00055549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64931086|NCT00055549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64931087|NCT00055549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64931088|NCT00055549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64931089|NCT00055549|GABA Modulators|gaba modulators|mesh-ancestor
64931090|NCT00055549|GABA Agents|gaba agents|mesh-ancestor
64931091|NCT00055666|Beclomethasone|beclomethasone|mesh-list
64931092|NCT00055666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64931093|NCT00055666|Glucocorticoids|glucocorticoids|mesh-ancestor
64931094|NCT00055666|Hormones|hormones|mesh-ancestor
64931095|NCT00055666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64931096|NCT00055666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931097|NCT00055666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64931098|NCT00055666|Respiratory System Agents|respiratory system agents|mesh-ancestor
64931099|NCT00055822|Leucovorin|leucovorin|mesh-list
64931100|NCT00055822|Fluorouracil|fluorouracil|mesh-list
64931101|NCT00055822|Oxaliplatin|oxaliplatin|mesh-list
64931102|NCT00055822|Oblimersen|oblimersen|mesh-list
64931103|NCT00055822|Calcium|calcium|mesh-list
64931104|NCT00055822|Levoleucovorin|levoleucovorin|mesh-list
64931105|NCT00055822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64931118|NCT00055861|Bevacizumab|bevacizumab|mesh-list
64931119|NCT00055861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64931120|NCT00055861|Docetaxel|docetaxel|mesh-list
64931121|NCT00055861|Antibodies|antibodies|mesh-list
64931122|NCT00055861|Immunoglobulins|immunoglobulins|mesh-list
64931123|NCT00055861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64931124|NCT00055861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931125|NCT00055861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64931126|NCT00055861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64931127|NCT00055861|Growth Substances|growth substances|mesh-ancestor
64931128|NCT00055861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931129|NCT00055861|Growth Inhibitors|growth inhibitors|mesh-ancestor
64931130|NCT00055861|Immunologic Factors|immunologic factors|mesh-ancestor
64931131|NCT00055861|Tubulin Modulators|tubulin modulators|mesh-ancestor
64931132|NCT00055861|Antimitotic Agents|antimitotic agents|mesh-ancestor
64931133|NCT00055861|Mitosis Modulators|mitosis modulators|mesh-ancestor
64931134|NCT00055861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931135|NCT00392106|Amiodarone|amiodarone|mesh-list
64931136|NCT00392106|Flecainide|flecainide|mesh-list
64931137|NCT00392106|Propafenone|propafenone|mesh-list
64931138|NCT00392106|Dofetilide|dofetilide|mesh-list
64931139|NCT00392106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64931166|NCT00055978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64931167|NCT00055978|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64931168|NCT00055978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64931169|NCT00055978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931170|NCT00055978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931172|NCT00056056|Methoxsalen|methoxsalen|mesh-list
64931173|NCT00056056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931174|NCT00056056|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64931175|NCT00056056|Dermatologic Agents|dermatologic agents|mesh-ancestor
64931176|NCT00056095|Cyclosporine|cyclosporine|mesh-list
64931177|NCT00056095|Cyclophosphamide|cyclophosphamide|mesh-list
64931178|NCT00056095|Fludarabine|fludarabine|mesh-list
64931179|NCT00056095|Fludarabine phosphate|fludarabine phosphate|mesh-list
64931180|NCT00056095|Cyclosporins|cyclosporins|mesh-list
64931181|NCT00056095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64931182|NCT00056095|Immunologic Factors|immunologic factors|mesh-ancestor
64931183|NCT00056095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931184|NCT00056095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64931185|NCT00056095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64931186|NCT00056095|Alkylating Agents|alkylating agents|mesh-ancestor
64931187|NCT00056095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931188|NCT00056095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931189|NCT00056095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64931190|NCT00056095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64931191|NCT00056095|Antimetabolites|antimetabolites|mesh-ancestor
64931192|NCT00056095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931193|NCT00056095|Antifungal Agents|antifungal agents|mesh-ancestor
64931197|NCT00056329|Vitamin E|vitamin e|mesh-list
64931205|NCT00056368|Fluconazole|fluconazole|mesh-list
64931206|NCT00056368|Anidulafungin|anidulafungin|mesh-list
64931207|NCT00056368|Antifungal Agents|antifungal agents|mesh-ancestor
64931208|NCT00056368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931209|NCT00056368|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64931210|NCT00056368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64931211|NCT00056368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931212|NCT00056368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931213|NCT00056368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64931214|NCT00056368|Hormone Antagonists|hormone antagonists|mesh-ancestor
64931215|NCT00056368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64931216|NCT00056368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931217|NCT00056368|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64931218|NCT00056368|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64931219|NCT00056446|Vatalanib|vatalanib|mesh-list
64931220|NCT00056446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64931221|NCT00056446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385840|NCT02420613|Vorinostat|vorinostat|mesh-list
64931357|NCT00057421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931359|NCT00057616|Immunologic Factors|immunologic factors|mesh-ancestor
64931360|NCT00057616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931361|NCT00057616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64931362|NCT00057616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64931363|NCT00057616|Growth Substances|growth substances|mesh-ancestor
64931364|NCT00057616|Growth Inhibitors|growth inhibitors|mesh-ancestor
64931365|NCT00057616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931366|NCT02969746|Charcoal|charcoal|mesh-list
64931367|NCT02969746|Antidotes|antidotes|mesh-ancestor
64931368|NCT02969746|Protective Agents|protective agents|mesh-ancestor
64931369|NCT02969746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931370|NCT00057850|Cisplatin|cisplatin|mesh-list
64931371|NCT00057850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931372|NCT00057889|Ipilimumab|ipilimumab|mesh-list
64931373|NCT00057889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64931374|NCT00057889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931375|NCT00057889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64931376|NCT00057889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931377|NCT00057928|Gemcitabine|gemcitabine|mesh-list
64931378|NCT00057928|Paclitaxel|paclitaxel|mesh-list
64931379|NCT00057928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64931380|NCT00057928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931381|NCT00057928|Tubulin Modulators|tubulin modulators|mesh-ancestor
64931382|NCT00057928|Antimitotic Agents|antimitotic agents|mesh-ancestor
64931383|NCT00057928|Mitosis Modulators|mitosis modulators|mesh-ancestor
64931384|NCT00057928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699869|NCT00362245|Amikacin|amikacin|mesh-list
64931403|NCT00058006|Sensory System Agents|sensory system agents|mesh-ancestor
64931404|NCT00058006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64931405|NCT00058006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931406|NCT00058006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64931407|NCT00058006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64931408|NCT00058006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64931409|NCT00058006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64408333|NCT05038969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64408334|NCT05038969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408335|NCT05038657|Atezolizumab|atezolizumab|mesh-list
64931410|NCT00058006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931411|NCT00058006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931412|NCT00058045|Aldesleukin|aldesleukin|mesh-list
64931413|NCT00058045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931414|NCT00058045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64931415|NCT00058045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64931416|NCT00058045|Antiviral Agents|antiviral agents|mesh-ancestor
64931417|NCT00058045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931419|NCT00058084|Mitoxantrone|mitoxantrone|mesh-list
64931420|NCT00058084|Epothilone B|epothilone b|mesh-list
64931421|NCT00058084|Epothilones|epothilones|mesh-list
64931422|NCT00058084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64931423|NCT00058084|Glucocorticoids|glucocorticoids|mesh-ancestor
64931424|NCT00058084|Hormones|hormones|mesh-ancestor
64931425|NCT00058084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64931426|NCT00058084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931427|NCT00058084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64931428|NCT00058084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931429|NCT00058084|Analgesics|analgesics|mesh-ancestor
64931430|NCT00058084|Sensory System Agents|sensory system agents|mesh-ancestor
64931431|NCT00058084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64931450|NCT00058201|Gemcitabine|gemcitabine|mesh-list
64931452|NCT00058201|Calcium|calcium|mesh-list
64931453|NCT00058201|Levoleucovorin|levoleucovorin|mesh-list
64931454|NCT00058201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64931455|NCT00058201|Antimetabolites|antimetabolites|mesh-ancestor
64931456|NCT00058201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931457|NCT00058201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931458|NCT00058201|Antiviral Agents|antiviral agents|mesh-ancestor
64931459|NCT00058201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931460|NCT00058201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931461|NCT00058201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64931462|NCT00058201|Immunologic Factors|immunologic factors|mesh-ancestor
64931463|NCT00058201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931464|NCT00058201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64699948|NCT00003273|Leucovorin|leucovorin|mesh-list
64931466|NCT00058201|Protective Agents|protective agents|mesh-ancestor
64931467|NCT00058201|Vitamin B Complex|vitamin b complex|mesh-ancestor
64931468|NCT00058201|Vitamins|vitamins|mesh-ancestor
64931469|NCT00058201|Micronutrients|micronutrients|mesh-ancestor
64931470|NCT00058279|Aldesleukin|aldesleukin|mesh-list
64931471|NCT00058279|Ipilimumab|ipilimumab|mesh-list
64931472|NCT00058279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64931473|NCT00058279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931474|NCT00058279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64931475|NCT00058279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931476|NCT00058279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64931477|NCT00058279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64931478|NCT00058279|Antiviral Agents|antiviral agents|mesh-ancestor
64931479|NCT00058279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931480|NCT00058318|Gemcitabine|gemcitabine|mesh-list
64931481|NCT00058318|Capecitabine|capecitabine|mesh-list
64931482|NCT00058318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64931483|NCT00058318|Antimetabolites|antimetabolites|mesh-ancestor
64931484|NCT00058318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931486|NCT00058318|Antiviral Agents|antiviral agents|mesh-ancestor
64931491|NCT00058318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931492|NCT00058357|Lidocaine|lidocaine|mesh-list
64931493|NCT00058357|Anesthetics, Local|anesthetics, local|mesh-ancestor
64931494|NCT00058357|Anesthetics|anesthetics|mesh-ancestor
64931495|NCT00058357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64931496|NCT00058357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931497|NCT00058357|Sensory System Agents|sensory system agents|mesh-ancestor
64931498|NCT00058357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64931499|NCT00058357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64931500|NCT00058357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64931501|NCT00058357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64931502|NCT00058357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64931503|NCT00058357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931504|NCT00058435|Abagovomab|abagovomab|mesh-list
64931505|NCT00058435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64408336|NCT05038657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931506|NCT00058435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931507|NCT00058474|Fluorouracil|fluorouracil|mesh-list
64931508|NCT00058474|Capecitabine|capecitabine|mesh-list
64931509|NCT00058474|Oxaliplatin|oxaliplatin|mesh-list
64931510|NCT00058474|Antimetabolites|antimetabolites|mesh-ancestor
64931511|NCT00058474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931512|NCT00058474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64931513|NCT00058474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931514|NCT00058474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64931515|NCT00058474|Immunologic Factors|immunologic factors|mesh-ancestor
64931516|NCT00058474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931517|NCT00392262|Amlodipine|amlodipine|mesh-list
64931518|NCT00392262|Valsartan|valsartan|mesh-list
64931519|NCT00392262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64931520|NCT00392262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64931525|NCT00392262|Vasodilator Agents|vasodilator agents|mesh-ancestor
64931531|NCT00058747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931532|NCT00058747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931533|NCT00058903|Sertraline|sertraline|mesh-list
64931534|NCT00058903|Antidepressive Agents|antidepressive agents|mesh-ancestor
64931535|NCT00058903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64931536|NCT00058903|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64931537|NCT00058903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64931538|NCT00058903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64931539|NCT00058903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931585|NCT00059722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64931586|NCT00059722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931587|NCT00059722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931588|NCT05359133|Tetrodotoxin|tetrodotoxin|mesh-list
64931589|NCT05359133|Anesthetics, Local|anesthetics, local|mesh-ancestor
64931590|NCT05359133|Anesthetics|anesthetics|mesh-ancestor
64931591|NCT05359133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64931592|NCT05359133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931593|NCT05359133|Sensory System Agents|sensory system agents|mesh-ancestor
64931594|NCT05359133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64931595|NCT05359133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64931596|NCT05359133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64931597|NCT05359133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931598|NCT02969239|Phenylephrine|phenylephrine|mesh-list
64931599|NCT02969239|Oxymetazoline|oxymetazoline|mesh-list
64408340|NCT05038111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931600|NCT02969239|Norepinephrine|norepinephrine|mesh-list
64931601|NCT02969239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64931602|NCT02969239|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64931603|NCT02969239|Mydriatics|mydriatics|mesh-ancestor
64931604|NCT02969239|Autonomic Agents|autonomic agents|mesh-ancestor
64931605|NCT02969239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64931606|NCT02969239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931607|NCT02969239|Sympathomimetics|sympathomimetics|mesh-ancestor
64931608|NCT02969239|Nasal Decongestants|nasal decongestants|mesh-ancestor
64931609|NCT02969239|Respiratory System Agents|respiratory system agents|mesh-ancestor
64931610|NCT02969239|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64931611|NCT02969239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64931625|NCT00059800|Micronutrients|micronutrients|mesh-ancestor
64931626|NCT00059800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931627|NCT03216083|Tranexamic Acid|tranexamic acid|mesh-list
64931628|NCT03216083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64931629|NCT03216083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64931630|NCT03216083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931631|NCT03216083|Hemostatics|hemostatics|mesh-ancestor
64931632|NCT03216083|Coagulants|coagulants|mesh-ancestor
64931633|NCT00059878|Interferons|interferons|mesh-list
64931634|NCT00059878|Interferon-gamma|interferon-gamma|mesh-list
64931635|NCT00059878|Voriconazole|voriconazole|mesh-list
64931636|NCT00059878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931637|NCT00059878|Antiviral Agents|antiviral agents|mesh-ancestor
64931638|NCT00059878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931639|NCT00059878|Antifungal Agents|antifungal agents|mesh-ancestor
64931648|NCT00059878|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64931649|NCT00059917|Camptothecin|camptothecin|mesh-list
64931650|NCT00059917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64931651|NCT00059917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931652|NCT00059917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64931657|NCT00060112|Oblimersen|oblimersen|mesh-list
64931669|NCT00060307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931670|NCT00060307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64931671|NCT00060307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931672|NCT00060307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931673|NCT02968927|Vitamin D|vitamin d|mesh-list
64931674|NCT02968927|Cholecalciferol|cholecalciferol|mesh-list
64931675|NCT02968927|Rifabutin|rifabutin|mesh-list
64931676|NCT02968927|Everolimus|everolimus|mesh-list
64931677|NCT02968927|Auranofin|auranofin|mesh-list
64931678|NCT02968927|CC-11050|cc-11050|mesh-list
64931679|NCT02968927|Vitamins|vitamins|mesh-ancestor
64931680|NCT02968927|Micronutrients|micronutrients|mesh-ancestor
64931681|NCT02968927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931682|NCT02968927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64931683|NCT02968927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931684|NCT02968927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64931685|NCT02968927|Immunologic Factors|immunologic factors|mesh-ancestor
64931686|NCT02968927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64931687|NCT02968927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64931688|NCT02968927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931689|NCT02968927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64931690|NCT02968927|Antitubercular Agents|antitubercular agents|mesh-ancestor
64931691|NCT02968927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64931692|NCT02968927|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64931693|NCT02968927|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64931694|NCT02968927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931695|NCT02968927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931696|NCT00398515|Sirolimus|sirolimus|mesh-list
64931697|NCT00398515|Lenalidomide|lenalidomide|mesh-list
64931698|NCT00398515|Immunologic Factors|immunologic factors|mesh-ancestor
64931699|NCT00398515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931700|NCT00398515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64931701|NCT00398515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64931702|NCT00398515|Growth Substances|growth substances|mesh-ancestor
64931711|NCT05105685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64931712|NCT05105685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931713|NCT05325164|Morphine|morphine|mesh-list
64931714|NCT05325164|Methadone|methadone|mesh-list
64931715|NCT05325164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64931716|NCT05325164|Narcotics|narcotics|mesh-ancestor
64931717|NCT05325164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64931718|NCT05325164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931719|NCT05325164|Analgesics|analgesics|mesh-ancestor
64931720|NCT05325164|Sensory System Agents|sensory system agents|mesh-ancestor
64931721|NCT05325164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64931722|NCT05325164|Antitussive Agents|antitussive agents|mesh-ancestor
64931723|NCT05325164|Respiratory System Agents|respiratory system agents|mesh-ancestor
64931724|NCT00060385|Prednisone|prednisone|mesh-list
64931725|NCT00060385|Cyclophosphamide|cyclophosphamide|mesh-list
64931726|NCT00060385|Doxorubicin|doxorubicin|mesh-list
64931727|NCT00060385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64931728|NCT00060385|Etoposide|etoposide|mesh-list
64931770|NCT00060502|Infliximab|infliximab|mesh-list
64931771|NCT00060502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64931809|NCT02968498|Sympathomimetics|sympathomimetics|mesh-ancestor
64931810|NCT02968498|Autonomic Agents|autonomic agents|mesh-ancestor
64931811|NCT02968498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64931812|NCT02968498|Dopamine Agents|dopamine agents|mesh-ancestor
64931813|NCT02968498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64931814|NCT02968498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931815|NCT02968498|Adrenergic Agents|adrenergic agents|mesh-ancestor
64931816|NCT02968498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64931817|NCT02968498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64931818|NCT02968498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64931819|NCT02968498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64931820|NCT00060931|Metoprolol|metoprolol|mesh-list
64931821|NCT00060931|Carvedilol|carvedilol|mesh-list
64931822|NCT00060931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64931824|NCT00060931|Sympatholytics|sympatholytics|mesh-ancestor
64931834|NCT00060931|Antioxidants|antioxidants|mesh-ancestor
64931835|NCT00060931|Protective Agents|protective agents|mesh-ancestor
64931855|NCT00061087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64931856|NCT00061087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64931857|NCT00061087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931858|NCT00061243|Vaccines|vaccines|mesh-list
64931859|NCT00061243|Immunologic Factors|immunologic factors|mesh-ancestor
64931860|NCT00061243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931861|NCT04711564|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64931865|NCT00061321|Nevirapine|nevirapine|mesh-list
64931875|NCT00061321|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64931877|NCT00061360|Sirolimus|sirolimus|mesh-list
64931878|NCT00061360|Cyclosporins|cyclosporins|mesh-list
64931879|NCT00061360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931880|NCT00061360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931881|NCT00061360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64931882|NCT00061360|Immunologic Factors|immunologic factors|mesh-ancestor
64931883|NCT00061360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931884|NCT00061360|Antifungal Agents|antifungal agents|mesh-ancestor
64931885|NCT00061360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931886|NCT00061360|Dermatologic Agents|dermatologic agents|mesh-ancestor
64931887|NCT00061360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64931888|NCT00061360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64931889|NCT00061360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64931890|NCT00061360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64931891|NCT00061360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931892|NCT00061438|Meropenem|meropenem|mesh-list
64931893|NCT00061438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64931894|NCT00061438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931895|NCT00061477|Gemcitabine|gemcitabine|mesh-list
64931896|NCT00061477|Pemetrexed|pemetrexed|mesh-list
64931897|NCT00061477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64931898|NCT00061477|Antimetabolites|antimetabolites|mesh-ancestor
64931899|NCT00061477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931900|NCT00061477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64931901|NCT00061477|Antiviral Agents|antiviral agents|mesh-ancestor
64931902|NCT00061477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64931930|NCT04997304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64931931|NCT04997304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931932|NCT04997304|Tocolytic Agents|tocolytic agents|mesh-ancestor
64931933|NCT04997304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64931934|NCT00061516|Brinzolamide|brinzolamide|mesh-list
64931935|NCT00061516|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64931936|NCT00061516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931937|NCT00061516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931938|NCT00061594|Ranibizumab|ranibizumab|mesh-list
64931939|NCT00061594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64931972|NCT00061867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931973|NCT00061906|Celecoxib|celecoxib|mesh-list
64931974|NCT00061906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64931975|NCT00061906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64931976|NCT00061906|Analgesics|analgesics|mesh-ancestor
64931977|NCT00061906|Sensory System Agents|sensory system agents|mesh-ancestor
64931978|NCT00061906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64931979|NCT00061906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931980|NCT00061906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64931981|NCT00061906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64931982|NCT00061906|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64931983|NCT00061906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64931984|NCT00061906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64931985|NCT00061906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64931986|NCT05219825|Psychotropic Drugs|psychotropic drugs|mesh-list
64931987|NCT00398554|Prednisone|prednisone|mesh-list
64931988|NCT00398554|Cyclophosphamide|cyclophosphamide|mesh-list
64931989|NCT00398554|Doxorubicin|doxorubicin|mesh-list
64931990|NCT00398554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64931991|NCT00398554|Etoposide|etoposide|mesh-list
64931992|NCT00398554|Vincristine|vincristine|mesh-list
64931993|NCT00398554|Vinblastine|vinblastine|mesh-list
64931994|NCT00398554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64931995|NCT00398554|Immunologic Factors|immunologic factors|mesh-ancestor
64931996|NCT00398554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64931997|NCT00398554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64931998|NCT00398554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64931999|NCT00398554|Alkylating Agents|alkylating agents|mesh-ancestor
64932000|NCT00398554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932001|NCT00398554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932016|NCT04917900|Paclitaxel|paclitaxel|mesh-list
64932017|NCT04917900|Trastuzumab|trastuzumab|mesh-list
64932018|NCT04917900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64932019|NCT04917900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64932020|NCT04917900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932021|NCT04917900|Tubulin Modulators|tubulin modulators|mesh-ancestor
64932073|NCT00062062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64932075|NCT00392340|Doxorubicin|doxorubicin|mesh-list
64932076|NCT00392340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64932077|NCT00392340|Vincristine|vincristine|mesh-list
64932078|NCT00392340|Topotecan|topotecan|mesh-list
64932079|NCT00392340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64932080|NCT00392340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932081|NCT00392340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64932082|NCT00392340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64932083|NCT00392340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932084|NCT00392340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932248|NCT00063895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932249|NCT00063895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932251|NCT00064012|Bortezomib|bortezomib|mesh-list
64932252|NCT00064012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932253|NCT00064012|Tubulin Modulators|tubulin modulators|mesh-ancestor
64932254|NCT00064012|Antimitotic Agents|antimitotic agents|mesh-ancestor
64385878|NCT02957097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64932267|NCT00064051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932288|NCT02967172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64932289|NCT02967172|Respiratory System Agents|respiratory system agents|mesh-ancestor
64932290|NCT02967172|Mydriatics|mydriatics|mesh-ancestor
64932291|NCT02967172|Sympathomimetics|sympathomimetics|mesh-ancestor
64932292|NCT02967172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64932293|NCT00064090|Cytarabine|cytarabine|mesh-list
64932294|NCT00064090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64932295|NCT00064090|Antimetabolites|antimetabolites|mesh-ancestor
64932296|NCT00064090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932297|NCT00064090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932298|NCT00064090|Antiviral Agents|antiviral agents|mesh-ancestor
64932299|NCT00064090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64932300|NCT00064090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64932301|NCT00064090|Immunologic Factors|immunologic factors|mesh-ancestor
64932302|NCT00064090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932303|NCT05141357|Pembrolizumab|pembrolizumab|mesh-list
64932304|NCT05141357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64932305|NCT05141357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932306|NCT00064129|Ipilimumab|ipilimumab|mesh-list
64932307|NCT00064129|Sargramostim|sargramostim|mesh-list
64932308|NCT00064129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64932309|NCT00064129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932310|NCT00064129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64932311|NCT00064129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932312|NCT00064129|Immunologic Factors|immunologic factors|mesh-ancestor
64932313|NCT00064129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932314|NCT00064207|Gemcitabine|gemcitabine|mesh-list
64932315|NCT00064207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64932316|NCT00064207|Antimetabolites|antimetabolites|mesh-ancestor
64932335|NCT00064285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64932336|NCT00064285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932337|NCT00064285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932338|NCT00064285|Growth Inhibitors|growth inhibitors|mesh-ancestor
64932339|NCT00064285|Growth Substances|growth substances|mesh-ancestor
64932340|NCT00064285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932341|NCT00392418|Micronutrients|micronutrients|mesh-list
64932342|NCT00392418|Trace Elements|trace elements|mesh-list
64932343|NCT00392418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932344|NCT05126147|Hydroxychloroquine|hydroxychloroquine|mesh-list
64932345|NCT05126147|Antimalarials|antimalarials|mesh-ancestor
64932346|NCT05126147|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64932347|NCT05126147|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64932348|NCT05126147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64932349|NCT05126147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932350|NCT05126147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932351|NCT05126147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64932352|NCT00064402|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64932353|NCT00064402|Formoterol Fumarate|formoterol fumarate|mesh-list
64932354|NCT00064402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64932405|NCT00398827|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64932406|NCT00398827|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64932407|NCT00398827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64932408|NCT00398827|Adrenergic Agents|adrenergic agents|mesh-ancestor
64932414|NCT00065455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932415|NCT00065533|Pemetrexed|pemetrexed|mesh-list
64932416|NCT00065533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932417|NCT00065533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932418|NCT00065533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932419|NCT00065533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64932420|NCT00065533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64932421|NCT04488081|Cyproheptadine|cyproheptadine|mesh-list
64932422|NCT04488081|Cyclosporine|cyclosporine|mesh-list
64932423|NCT04488081|Remdesivir|remdesivir|mesh-list
64932424|NCT04488081|Cenicriviroc|cenicriviroc|mesh-list
64932425|NCT04488081|Dexamethasone|dexamethasone|mesh-list
64932426|NCT04488081|Celecoxib|celecoxib|mesh-list
64932427|NCT04488081|Apremilast|apremilast|mesh-list
64932428|NCT04488081|Icatibant|icatibant|mesh-list
64932429|NCT04488081|Imatinib Mesylate|imatinib mesylate|mesh-list
64932430|NCT04488081|Famotidine|famotidine|mesh-list
64932431|NCT04488081|Cyclosporins|cyclosporins|mesh-list
64932432|NCT04488081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64932433|NCT04488081|Antiemetics|antiemetics|mesh-ancestor
64932434|NCT04488081|Autonomic Agents|autonomic agents|mesh-ancestor
64932435|NCT04488081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64932436|NCT04488081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932437|NCT04488081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64932438|NCT04488081|Glucocorticoids|glucocorticoids|mesh-ancestor
64932439|NCT04488081|Hormones|hormones|mesh-ancestor
64932440|NCT04488081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64932441|NCT04488081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64932442|NCT04488081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932443|NCT04488081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932463|NCT04488081|Histamine Antagonists|histamine antagonists|mesh-ancestor
64932465|NCT04488081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64932466|NCT04488081|Antimetabolites|antimetabolites|mesh-ancestor
64932467|NCT04488081|Antiviral Agents|antiviral agents|mesh-ancestor
64932468|NCT04488081|Antipruritics|antipruritics|mesh-ancestor
64932469|NCT04488081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64932470|NCT04488081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64932471|NCT04488081|Serotonin Agents|serotonin agents|mesh-ancestor
64932472|NCT04488081|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64932473|NCT04488081|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
64932474|NCT04488081|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
64932475|NCT04488081|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64932476|NCT04488081|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64932477|NCT04488081|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64932478|NCT04488081|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64932479|NCT00065767|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64932480|NCT00065767|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64932481|NCT00065767|Hormone Antagonists|hormone antagonists|mesh-ancestor
64932482|NCT00065767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64932483|NCT00065767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932484|NCT00065767|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64932485|NCT00065767|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64932486|NCT00065767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64932487|NCT00065884|Valproic Acid|valproic acid|mesh-list
64932488|NCT00065884|Anticonvulsants|anticonvulsants|mesh-ancestor
64932489|NCT00065884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932490|NCT00065884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932525|NCT00066157|Hormones|hormones|mesh-ancestor
64932526|NCT00066157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64932527|NCT00066157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932528|NCT00066157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64932529|NCT00066157|Contraceptive Agents|contraceptive agents|mesh-ancestor
64932530|NCT00066157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64932531|NCT00066157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64932532|NCT00066157|Progestins|progestins|mesh-ancestor
64932533|NCT00066157|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64932534|NCT00066157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64408496|NCT02528253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64408497|NCT02528253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408498|NCT02528253|Analgesics|analgesics|mesh-ancestor
64408499|NCT02528253|Sensory System Agents|sensory system agents|mesh-ancestor
64932535|NCT00066157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64932536|NCT00066157|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64932537|NCT00066157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64932538|NCT00066157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932539|NCT00066196|Dacarbazine|dacarbazine|mesh-list
64932540|NCT00066196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64932541|NCT00066196|Alkylating Agents|alkylating agents|mesh-ancestor
64932542|NCT00066196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932544|NCT00066274|Leucovorin|leucovorin|mesh-list
64932545|NCT00066274|Fluorouracil|fluorouracil|mesh-list
64932546|NCT00066274|Oxaliplatin|oxaliplatin|mesh-list
64932547|NCT00066274|Irinotecan|irinotecan|mesh-list
64932548|NCT00066274|Calcium|calcium|mesh-list
64932549|NCT00066274|Levoleucovorin|levoleucovorin|mesh-list
64932550|NCT00066274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64932551|NCT00066274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932552|NCT00066274|Antimetabolites|antimetabolites|mesh-ancestor
64932553|NCT00066274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932554|NCT00066274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64932555|NCT00066274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932556|NCT00066274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64932557|NCT00066274|Immunologic Factors|immunologic factors|mesh-ancestor
64932558|NCT00066274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64932559|NCT00066274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64932560|NCT00066274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932561|NCT00066274|Antidotes|antidotes|mesh-ancestor
64932562|NCT00066274|Protective Agents|protective agents|mesh-ancestor
64932563|NCT00066274|Vitamin B Complex|vitamin b complex|mesh-ancestor
64932564|NCT00066274|Vitamins|vitamins|mesh-ancestor
64932565|NCT00066274|Micronutrients|micronutrients|mesh-ancestor
64932566|NCT04401150|Ascorbic Acid|ascorbic acid|mesh-list
64932567|NCT04401150|Vitamins|vitamins|mesh-ancestor
64932568|NCT04401150|Micronutrients|micronutrients|mesh-ancestor
64932666|NCT00067093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64932667|NCT00067093|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64932669|NCT00067093|Coagulants|coagulants|mesh-ancestor
64932670|NCT00067093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64932671|NCT00067093|Antithrombins|antithrombins|mesh-ancestor
64932672|NCT00067093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64932673|NCT00067093|Protease Inhibitors|protease inhibitors|mesh-ancestor
64932674|NCT00067093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932676|NCT05041127|Cetuximab|cetuximab|mesh-list
64932678|NCT05041127|Immunoglobulins|immunoglobulins|mesh-list
64932679|NCT05041127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64932680|NCT05041127|Immunologic Factors|immunologic factors|mesh-ancestor
64932681|NCT05041127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932682|NCT05041127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932683|NCT00398905|Enoxaparin|enoxaparin|mesh-list
64408548|NCT05021731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64408549|NCT05021731|Antitubercular Agents|antitubercular agents|mesh-ancestor
64408550|NCT05021731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64408551|NCT05021731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64932684|NCT00398905|Rivaroxaban|rivaroxaban|mesh-list
64932685|NCT00398905|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64932686|NCT00398905|Antithrombins|antithrombins|mesh-ancestor
64932687|NCT00398905|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64932688|NCT00398905|Protease Inhibitors|protease inhibitors|mesh-ancestor
64932790|NCT04074096|Pembrolizumab|pembrolizumab|mesh-list
64932791|NCT04074096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64932792|NCT04074096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932793|NCT00067951|Metformin|metformin|mesh-list
64932794|NCT00067951|Rosiglitazone|rosiglitazone|mesh-list
64932816|NCT00068068|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64932818|NCT00068302|Sirolimus|sirolimus|mesh-list
64932819|NCT00068302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64932820|NCT00068302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64932821|NCT00068302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64932822|NCT00068302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64932823|NCT00068302|Antifungal Agents|antifungal agents|mesh-ancestor
64932824|NCT00068302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64386114|NCT02055820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932888|NCT00069355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932890|NCT00069355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64932891|NCT00069355|Vasodilator Agents|vasodilator agents|mesh-ancestor
64932892|NCT04963712|Thymalfasin|thymalfasin|mesh-list
64932893|NCT04963712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64932894|NCT04963712|Immunologic Factors|immunologic factors|mesh-ancestor
64932895|NCT04963712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64932896|NCT00069550|Dextromethorphan|dextromethorphan|mesh-list
64932897|NCT00069550|Donepezil|donepezil|mesh-list
64932898|NCT00069550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64932899|NCT00069550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64932901|NCT00069550|Cholinergic Agents|cholinergic agents|mesh-ancestor
64932917|NCT00069706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64932918|NCT00069706|Latanoprost|latanoprost|mesh-list
64932919|NCT00069706|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64932920|NCT00069901|Paclitaxel|paclitaxel|mesh-list
64932921|NCT00069901|Carboplatin|carboplatin|mesh-list
64932922|NCT00069901|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
64932923|NCT00069901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64932924|NCT00069901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386121|NCT02055820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64386122|NCT02055820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64386123|NCT02055820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64933070|NCT00070486|Antiviral Agents|antiviral agents|mesh-ancestor
64933071|NCT00070486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64933072|NCT00070486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933073|NCT00070486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64933074|NCT00070486|Immunologic Factors|immunologic factors|mesh-ancestor
64933075|NCT00070486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933076|NCT00070486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64933077|NCT00070486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64933078|NCT00070486|Analgesics|analgesics|mesh-ancestor
64933079|NCT00070486|Sensory System Agents|sensory system agents|mesh-ancestor
64933080|NCT00070486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64933081|NCT00070486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64933082|NCT00070486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64933083|NCT00070486|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64933084|NCT00070486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64933085|NCT00070486|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64933086|NCT00070486|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64933087|NCT00070486|Hormone Antagonists|hormone antagonists|mesh-ancestor
64933088|NCT00070486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64933089|NCT00070525|Tipifarnib|tipifarnib|mesh-list
64933090|NCT00070525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933096|NCT00070759|Daclizumab|daclizumab|mesh-list
64408601|NCT04294459|Montelukast|montelukast|mesh-list
64933114|NCT00071188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933115|NCT00071227|Triamcinolone|triamcinolone|mesh-list
64933116|NCT00071227|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64933117|NCT00071227|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64933118|NCT00071227|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64933119|NCT00071227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64933120|NCT00071227|Glucocorticoids|glucocorticoids|mesh-ancestor
64933121|NCT00071227|Hormones|hormones|mesh-ancestor
64933122|NCT00071227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64933123|NCT00071227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933124|NCT00071227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64933125|NCT00071227|Immunologic Factors|immunologic factors|mesh-ancestor
64933331|NCT00072319|Paclitaxel|paclitaxel|mesh-list
64933332|NCT00072319|Cyclophosphamide|cyclophosphamide|mesh-list
64933333|NCT00072319|Epirubicin|epirubicin|mesh-list
64933334|NCT00072319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64933335|NCT00072319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933336|NCT00072319|Tubulin Modulators|tubulin modulators|mesh-ancestor
64933337|NCT00072319|Antimitotic Agents|antimitotic agents|mesh-ancestor
64933338|NCT00072319|Mitosis Modulators|mitosis modulators|mesh-ancestor
64933339|NCT00072319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933340|NCT00072319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64933341|NCT00072319|Immunologic Factors|immunologic factors|mesh-ancestor
64933342|NCT00072319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933343|NCT00072319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64933344|NCT00072319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64933346|NCT00072319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64933347|NCT00072319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64933348|NCT00072319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64933420|NCT04840589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933421|NCT04840589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64933422|NCT04840589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933423|NCT00072631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64933424|NCT00072631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933425|NCT00072631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64933426|NCT00072631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933427|NCT00072631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933428|NCT00072670|Trabectedin|trabectedin|mesh-list
64933429|NCT00072670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64933430|NCT00072670|Alkylating Agents|alkylating agents|mesh-ancestor
64933447|NCT00072748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933448|NCT00072748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64933449|NCT00072748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933450|NCT00072748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933452|NCT00072787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933453|NCT00072826|Acetylcholine|acetylcholine|mesh-list
64933454|NCT00072826|Oxypurinol|oxypurinol|mesh-list
64933455|NCT00072826|Vasodilator Agents|vasodilator agents|mesh-ancestor
64933456|NCT00072826|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64933457|NCT00072826|Cholinergic Agents|cholinergic agents|mesh-ancestor
64933458|NCT00072826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64933459|NCT00072826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933460|NCT00072826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933461|NCT00072826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933462|NCT00072865|Carboplatin|carboplatin|mesh-list
64933463|NCT00072865|Pemetrexed|pemetrexed|mesh-list
64933464|NCT00072865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933465|NCT00072865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933466|NCT00072865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933467|NCT00072865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64933468|NCT00072865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64933469|NCT00072904|Repaglinide|repaglinide|mesh-list
64933470|NCT00072904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64933471|NCT00072904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933498|NCT03959124|Cholinergic Agents|cholinergic agents|mesh-ancestor
64933499|NCT03959124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64933500|NCT03959124|Protective Agents|protective agents|mesh-ancestor
64933501|NCT02966236|Tranexamic Acid|tranexamic acid|mesh-list
64933502|NCT02966236|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64933503|NCT02966236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64933504|NCT02966236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933505|NCT02966236|Hemostatics|hemostatics|mesh-ancestor
64933506|NCT02966236|Coagulants|coagulants|mesh-ancestor
64933507|NCT04827953|Gemcitabine|gemcitabine|mesh-list
64933509|NCT04827953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64933510|NCT04827953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933511|NCT04827953|Tubulin Modulators|tubulin modulators|mesh-ancestor
64933512|NCT04827953|Antimitotic Agents|antimitotic agents|mesh-ancestor
64933513|NCT04827953|Mitosis Modulators|mitosis modulators|mesh-ancestor
64933514|NCT04827953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933515|NCT04827953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64933607|NCT00073879|Alkylating Agents|alkylating agents|mesh-ancestor
64933608|NCT00073879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933609|NCT00073879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933610|NCT00073879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64933612|NCT00073879|Antimetabolites|antimetabolites|mesh-ancestor
64933641|NCT00074191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64933642|NCT00074191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64933643|NCT00074191|Antimetabolites|antimetabolites|mesh-ancestor
64933644|NCT00074191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933645|NCT00074191|Dermatologic Agents|dermatologic agents|mesh-ancestor
64933646|NCT00074191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933647|NCT00074191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64933648|NCT00074191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64933649|NCT00074191|Immunologic Factors|immunologic factors|mesh-ancestor
64933650|NCT00074191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64933745|NCT00075010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64933746|NCT00075010|Antimetabolites|antimetabolites|mesh-ancestor
64933747|NCT00075010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933748|NCT00075010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933749|NCT00075010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933750|NCT00075010|Anticonvulsants|anticonvulsants|mesh-ancestor
64933751|NCT00075010|GABA Agents|gaba agents|mesh-ancestor
64933752|NCT00075010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64933753|NCT00075010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933754|NCT00075010|Antimanic Agents|antimanic agents|mesh-ancestor
64933755|NCT00075010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64933756|NCT00075010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64933782|NCT00075517|Docetaxel|docetaxel|mesh-list
64933783|NCT00075517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64933784|NCT00075517|Antimetabolites|antimetabolites|mesh-ancestor
64933785|NCT00075517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933786|NCT00075517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933787|NCT00075517|Antiviral Agents|antiviral agents|mesh-ancestor
64933788|NCT00075517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64933789|NCT00075517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933790|NCT00075517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64933791|NCT00075517|Immunologic Factors|immunologic factors|mesh-ancestor
64933792|NCT00075517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933793|NCT00075517|Tubulin Modulators|tubulin modulators|mesh-ancestor
64933849|NCT00075673|Sensory System Agents|sensory system agents|mesh-ancestor
64933850|NCT00075673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64933851|NCT00075673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933852|NCT00075673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64933853|NCT00075673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64933854|NCT00075673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64933855|NCT00075673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64933856|NCT00075673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64933857|NCT00075673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933858|NCT00075673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64933898|NCT00075907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933899|NCT00075907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64933900|NCT00075907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64933901|NCT00075907|Antiviral Agents|antiviral agents|mesh-ancestor
64933902|NCT00075907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64933903|NCT00075907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64933904|NCT00075907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64933905|NCT00075907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64933906|NCT00075907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64933907|NCT00075907|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64933908|NCT00075907|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64933909|NCT00075907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64933910|NCT00075907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64933911|NCT00075907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64933913|NCT03958383|Ipilimumab|ipilimumab|mesh-list
64933914|NCT03958383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64933915|NCT03958383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933916|NCT03958383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64933917|NCT03958383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933918|NCT00076414|Acetylcholine|acetylcholine|mesh-list
64933919|NCT00076414|Vasodilator Agents|vasodilator agents|mesh-ancestor
64933920|NCT00076414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64933921|NCT00076414|Cholinergic Agents|cholinergic agents|mesh-ancestor
64933946|NCT00399295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64933947|NCT00399295|Analgesics|analgesics|mesh-ancestor
64933948|NCT00399334|Antipsychotic Agents|antipsychotic agents|mesh-list
64933949|NCT00399334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64933950|NCT00399334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64933951|NCT00399334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933952|NCT00399334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64933953|NCT00076492|Coenzyme Q10|coenzyme q10|mesh-list
64933954|NCT00076492|Vitamins|vitamins|mesh-ancestor
64933955|NCT00076492|Micronutrients|micronutrients|mesh-ancestor
64933956|NCT00076492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933957|NCT00076531|Leuprolide|leuprolide|mesh-list
64933958|NCT00076531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64933959|NCT00076531|Fertility Agents|fertility agents|mesh-ancestor
64933960|NCT00076531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64933961|NCT00076531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64933962|NCT00076531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64933976|NCT00077077|Capecitabine|capecitabine|mesh-list
64933981|NCT00077116|Cytarabine|cytarabine|mesh-list
64933990|NCT00077116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64933991|NCT00077116|Alkylating Agents|alkylating agents|mesh-ancestor
64933992|NCT00077116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64933993|NCT00077116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64933994|NCT00077116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64933995|NCT00077116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64933996|NCT00077116|Antimetabolites|antimetabolites|mesh-ancestor
64933997|NCT00077116|Antiviral Agents|antiviral agents|mesh-ancestor
64933998|NCT00077116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64933999|NCT00077116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64934000|NCT00077116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64934001|NCT00077116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64934002|NCT00077116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934003|NCT00077116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64934004|NCT03951207|Amlodipine|amlodipine|mesh-list
64934005|NCT03951207|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
64934006|NCT03951207|Atorvastatin|atorvastatin|mesh-list
64934020|NCT00077194|Romidepsin|romidepsin|mesh-list
64934047|NCT02958631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64934048|NCT02958631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64934049|NCT02958631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934050|NCT00077311|Docetaxel|docetaxel|mesh-list
64934051|NCT00077311|Darbepoetin alfa|darbepoetin alfa|mesh-list
64934052|NCT00077311|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
64934053|NCT00077311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934054|NCT00077311|Tubulin Modulators|tubulin modulators|mesh-ancestor
64934055|NCT00077311|Antimitotic Agents|antimitotic agents|mesh-ancestor
64934056|NCT00077311|Mitosis Modulators|mitosis modulators|mesh-ancestor
64934057|NCT00077311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934058|NCT00077311|Hematinics|hematinics|mesh-ancestor
64934059|NCT00077311|Protective Agents|protective agents|mesh-ancestor
64934060|NCT00077311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934061|NCT00077350|Gemcitabine|gemcitabine|mesh-list
64934062|NCT00077350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64934063|NCT00077350|Antimetabolites|antimetabolites|mesh-ancestor
64934064|NCT00077350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934065|NCT00077350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934066|NCT00077350|Antiviral Agents|antiviral agents|mesh-ancestor
64934067|NCT00077350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64934068|NCT00077350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934069|NCT00077350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64934070|NCT00077350|Immunologic Factors|immunologic factors|mesh-ancestor
64934071|NCT00077350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934072|NCT00077389|Carboplatin|carboplatin|mesh-list
64934073|NCT00077389|Doxorubicin|doxorubicin|mesh-list
64934074|NCT00077389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64934104|NCT00077584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934105|NCT00077779|Adalimumab|adalimumab|mesh-list
64934106|NCT00077779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64934107|NCT00077779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64934108|NCT00077818|Enoxaparin|enoxaparin|mesh-list
64934109|NCT00077818|Enoxaparin sodium|enoxaparin sodium|mesh-list
64408972|NCT02637895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64408973|NCT02637895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64408974|NCT02637895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64408975|NCT02637895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408976|NCT02637895|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64408977|NCT02637895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64408978|NCT02637895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64408979|NCT02637895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408980|NCT02637895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64408981|NCT02637895|Serotonin Agents|serotonin agents|mesh-ancestor
64408982|NCT02637895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64408983|NCT02637895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64409004|NCT05509647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409005|NCT05305911|Dapagliflozin|dapagliflozin|mesh-list
64409006|NCT05305911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64409007|NCT05305911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934110|NCT00077818|Anticoagulants|anticoagulants|mesh-ancestor
64934111|NCT00077818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64934112|NCT00077818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64934113|NCT00077818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934114|NCT03766581|Aspirin|aspirin|mesh-list
64934115|NCT03766581|Clopidogrel|clopidogrel|mesh-list
64934116|NCT03766581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64934117|NCT03766581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64934118|NCT03766581|Analgesics|analgesics|mesh-ancestor
64934119|NCT03766581|Sensory System Agents|sensory system agents|mesh-ancestor
64934120|NCT03766581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64934121|NCT03766581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934122|NCT03766581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64934123|NCT03766581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64934124|NCT03766581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64934129|NCT03766581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934134|NCT03766581|Purinergic Agents|purinergic agents|mesh-ancestor
64934135|NCT03766581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64934136|NCT00078130|Buprenorphine|buprenorphine|mesh-list
64934137|NCT00078130|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64934138|NCT00078130|Naloxone|naloxone|mesh-list
64934139|NCT00078130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64934140|NCT00078130|Narcotics|narcotics|mesh-ancestor
64934141|NCT00078130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64934142|NCT00078130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934143|NCT00078130|Analgesics|analgesics|mesh-ancestor
64934144|NCT00078130|Sensory System Agents|sensory system agents|mesh-ancestor
64934145|NCT00078130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64934146|NCT00078130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64934147|NCT00399451|Polidocanol|polidocanol|mesh-list
64934148|NCT00399451|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64934149|NCT00399451|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64934150|NCT04711213|Dexamethasone|dexamethasone|mesh-list
64934151|NCT04711213|Dexamethasone acetate|dexamethasone acetate|mesh-list
64934152|NCT04711213|BB 1101|bb 1101|mesh-list
64934153|NCT04711213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64934154|NCT04711213|Antiemetics|antiemetics|mesh-ancestor
64934155|NCT04711213|Autonomic Agents|autonomic agents|mesh-ancestor
64409184|NCT05329155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64409185|NCT05329155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64409186|NCT05329155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409187|NCT05294835|Ketamine|ketamine|mesh-list
64409188|NCT05294835|Analgesics|analgesics|mesh-ancestor
64409189|NCT05294835|Sensory System Agents|sensory system agents|mesh-ancestor
64409190|NCT05294835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409191|NCT05294835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409192|NCT05294835|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64409195|NCT05294835|Anesthetics|anesthetics|mesh-ancestor
64934156|NCT04711213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64934157|NCT04711213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934158|NCT04711213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64934159|NCT04711213|Glucocorticoids|glucocorticoids|mesh-ancestor
64934160|NCT04711213|Hormones|hormones|mesh-ancestor
64934161|NCT04711213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64934162|NCT04711213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64934163|NCT04711213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934164|NCT04711213|Protease Inhibitors|protease inhibitors|mesh-ancestor
64934165|NCT04711213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934166|NCT04711213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934204|NCT00078793|Sensory System Agents|sensory system agents|mesh-ancestor
64934205|NCT00078793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64934206|NCT00078793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934207|NCT00078793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64934212|NCT00078832|Anastrozole|anastrozole|mesh-list
64934215|NCT00078832|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64934216|NCT00078832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64409212|NCT02522325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64409244|NCT04925167|Calcium heparin|calcium heparin|mesh-list
64934217|NCT00078832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934218|NCT00078832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934236|NCT00078910|Sulindac sulfone|sulindac sulfone|mesh-list
64934237|NCT00078910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934238|NCT00078910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64934239|NCT00078910|Protective Agents|protective agents|mesh-ancestor
64934240|NCT00078910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934241|NCT00078910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64934242|NCT00078910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934243|NCT00078910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934244|NCT00078910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64934245|NCT00078910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64409351|NCT05010499|Levobupivacaine|levobupivacaine|mesh-list
64934246|NCT00078910|Analgesics|analgesics|mesh-ancestor
64934247|NCT00078910|Sensory System Agents|sensory system agents|mesh-ancestor
64934249|NCT00078910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64934252|NCT00078988|Etoposide|etoposide|mesh-list
64934253|NCT00078988|Thiotepa|thiotepa|mesh-list
64934254|NCT00078988|Isotretinoin|isotretinoin|mesh-list
64934255|NCT00078988|Lenograstim|lenograstim|mesh-list
64934256|NCT00078988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934257|NCT00078988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64934258|NCT00078988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64934259|NCT00078988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64409441|NCT04136067|Insulin Glargine|insulin glargine|mesh-list
64409442|NCT04136067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64409443|NCT04136067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409444|NCT05282901|Pembrolizumab|pembrolizumab|mesh-list
64409445|NCT05282901|Lenvatinib|lenvatinib|mesh-list
64409446|NCT05282901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64934260|NCT00078988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934261|NCT00078988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934262|NCT00078988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64934263|NCT00078988|Immunologic Factors|immunologic factors|mesh-ancestor
64934264|NCT00078988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934265|NCT00078988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64934266|NCT00078988|Alkylating Agents|alkylating agents|mesh-ancestor
64934267|NCT00078988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64934268|NCT00078988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64934269|NCT00078988|Dermatologic Agents|dermatologic agents|mesh-ancestor
64934270|NCT00079027|Doxorubicin|doxorubicin|mesh-list
64934271|NCT00079027|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64934272|NCT00079027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64934273|NCT00079027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934274|NCT00079027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64934275|NCT00079027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64934276|NCT00079027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934277|NCT00079027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934278|NCT03655002|Cyclophosphamide|cyclophosphamide|mesh-list
64934279|NCT03655002|Nivolumab|nivolumab|mesh-list
64934280|NCT03655002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64934321|NCT00079105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64934323|NCT00079105|Sensory System Agents|sensory system agents|mesh-ancestor
64702812|NCT03257215|Cholecalciferol|cholecalciferol|mesh-list
64934324|NCT00079105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64934325|NCT04472429|Paclitaxel|paclitaxel|mesh-list
64934342|NCT00079144|Cyclophosphamide|cyclophosphamide|mesh-list
64934343|NCT00079144|Fludarabine|fludarabine|mesh-list
64934344|NCT00079144|Fludarabine phosphate|fludarabine phosphate|mesh-list
64934345|NCT00079144|Freund's Adjuvant|freund's adjuvant|mesh-list
64934346|NCT00079144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64934347|NCT00079144|Immunologic Factors|immunologic factors|mesh-ancestor
64934348|NCT00079144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934349|NCT00079144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64934350|NCT00079144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64934351|NCT00079144|Alkylating Agents|alkylating agents|mesh-ancestor
64934352|NCT00079144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934353|NCT00079144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934404|NCT00079261|Tubulin Modulators|tubulin modulators|mesh-ancestor
64934405|NCT00079261|Antimitotic Agents|antimitotic agents|mesh-ancestor
64409638|NCT03072199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64409639|NCT03072199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409640|NCT03072199|Immunologic Factors|immunologic factors|mesh-ancestor
64409641|NCT03072199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409642|NCT03072199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64409643|NCT04806737|Teriflunomide|teriflunomide|mesh-list
64409654|NCT04991155|Zamicastat|zamicastat|mesh-list
64934406|NCT00079261|Mitosis Modulators|mitosis modulators|mesh-ancestor
64934407|NCT00079300|Imiquimod|imiquimod|mesh-list
64934408|NCT00079300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64934409|NCT00079300|Immunologic Factors|immunologic factors|mesh-ancestor
64934426|NCT00079378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64934427|NCT00079378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64934428|NCT00079378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64934429|NCT00079456|Sirolimus|sirolimus|mesh-list
64934430|NCT00079456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64934431|NCT00079456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64934438|NCT04467086|Propranolol|propranolol|mesh-list
64934452|NCT00079612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934453|NCT03526107|Theobromine|theobromine|mesh-list
64934454|NCT03526107|Caffeine|caffeine|mesh-list
64934455|NCT03526107|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64934456|NCT03526107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934457|NCT03526107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64934458|NCT03526107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934459|NCT03526107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934460|NCT03526107|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64934461|NCT03526107|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64934462|NCT03526107|Purinergic Agents|purinergic agents|mesh-ancestor
64934463|NCT03526107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64934464|NCT03526107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64934465|NCT03526107|Autonomic Agents|autonomic agents|mesh-ancestor
64934466|NCT03526107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64934467|NCT03526107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64934468|NCT03526107|Respiratory System Agents|respiratory system agents|mesh-ancestor
64934469|NCT03526107|Vasodilator Agents|vasodilator agents|mesh-ancestor
64934470|NCT00079768|Alemtuzumab|alemtuzumab|mesh-list
64934471|NCT00079768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64409854|NCT05635357|Anastrozole|anastrozole|mesh-list
64934472|NCT00079768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934473|NCT00079807|Thioctic Acid|thioctic acid|mesh-list
64934474|NCT00079807|Antioxidants|antioxidants|mesh-ancestor
64934475|NCT00079807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934500|NCT00079963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934501|NCT00079963|Antioxidants|antioxidants|mesh-ancestor
64934502|NCT00079963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934503|NCT00079963|Protective Agents|protective agents|mesh-ancestor
64934504|NCT00392886|Cyclophosphamide|cyclophosphamide|mesh-list
64934505|NCT00392886|Temozolomide|temozolomide|mesh-list
64934506|NCT00392886|Thiotepa|thiotepa|mesh-list
64934507|NCT00392886|Carboplatin|carboplatin|mesh-list
64934508|NCT00392886|Methotrexate|methotrexate|mesh-list
64934509|NCT00392886|Etoposide|etoposide|mesh-list
64934510|NCT00392886|Vincristine|vincristine|mesh-list
64934511|NCT00392886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64934512|NCT00392886|Immunologic Factors|immunologic factors|mesh-ancestor
64934516|NCT00392886|Alkylating Agents|alkylating agents|mesh-ancestor
64934517|NCT00392886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934518|NCT00392886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934519|NCT00392886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64934520|NCT00392886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64934521|NCT00392886|Abortifacient Agents|abortifacient agents|mesh-ancestor
64934522|NCT00392886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64934523|NCT00392886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64934524|NCT00392886|Antimetabolites|antimetabolites|mesh-ancestor
64934525|NCT00392886|Dermatologic Agents|dermatologic agents|mesh-ancestor
64934526|NCT00392886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934527|NCT00392886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64934528|NCT00392886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64934529|NCT00392886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64934530|NCT00392886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64934531|NCT00392886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64934543|NCT00080080|Mitosis Modulators|mitosis modulators|mesh-ancestor
64934544|NCT00080080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934545|NCT00080158|Mirtazapine|mirtazapine|mesh-list
64410012|NCT03070405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64410013|NCT03070405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64410014|NCT03070405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410015|NCT03070405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410016|NCT03070405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64410017|NCT03070405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64410018|NCT03070405|Antitubercular Agents|antitubercular agents|mesh-ancestor
64934546|NCT00080158|Citalopram|citalopram|mesh-list
64934547|NCT00080158|Bupropion|bupropion|mesh-list
64934548|NCT00080158|Fluoxetine|fluoxetine|mesh-list
64934549|NCT00080158|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64934550|NCT00080158|Sertraline|sertraline|mesh-list
64934551|NCT00080158|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64934552|NCT00080158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64934553|NCT00080158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64934554|NCT00080158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934555|NCT00080158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64934556|NCT00080158|Serotonin Agents|serotonin agents|mesh-ancestor
64934557|NCT00080158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934558|NCT00080158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64934559|NCT00080158|Antidepressive Agents|antidepressive agents|mesh-ancestor
64934560|NCT00080158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64934561|NCT00080158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64934596|NCT00080275|Vitamins|vitamins|mesh-ancestor
64934597|NCT00080275|Micronutrients|micronutrients|mesh-ancestor
64410097|NCT05157711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64934598|NCT00080275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934599|NCT00393003|Anesthetics|anesthetics|mesh-list
64934600|NCT00393003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64934601|NCT00393003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934602|NCT00080314|Aripiprazole|aripiprazole|mesh-list
64934603|NCT00080314|Antidepressive Agents|antidepressive agents|mesh-ancestor
64934604|NCT00080314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64934605|NCT00080314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64934606|NCT00080314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64934607|NCT00080314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64934608|NCT00080314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934609|NCT00080314|Dopamine Agonists|dopamine agonists|mesh-ancestor
64934610|NCT00080314|Dopamine Agents|dopamine agents|mesh-ancestor
64934611|NCT00080314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64934612|NCT00080314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410232|NCT04801199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64410233|NCT04801199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410234|NCT04801199|Incretins|incretins|mesh-ancestor
64410235|NCT04801199|Hormones|hormones|mesh-ancestor
64410243|NCT04340141|Oxaliplatin|oxaliplatin|mesh-list
64410244|NCT04340141|Irinotecan|irinotecan|mesh-list
64410245|NCT04340141|Calcium|calcium|mesh-list
64934613|NCT00080314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64934614|NCT00080314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64934615|NCT00080314|Serotonin Agents|serotonin agents|mesh-ancestor
64934616|NCT00080314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64934617|NCT00080314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64934618|NCT00080314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64934619|NCT00080314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64934620|NCT00080353|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64934621|NCT00080353|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64934622|NCT00080353|Immunologic Factors|immunologic factors|mesh-ancestor
64934623|NCT00080353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703114|NCT02454283|Vanoxerine|vanoxerine|mesh-list
64934624|NCT00080431|Daclizumab|daclizumab|mesh-list
64934625|NCT00080431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64934634|NCT03506373|Ixazomib|ixazomib|mesh-list
64934638|NCT03506373|Protease Inhibitors|protease inhibitors|mesh-ancestor
64934712|NCT00080860|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
64934713|NCT00080860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64934714|NCT00080860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934715|NCT00080977|Aldesleukin|aldesleukin|mesh-list
64934716|NCT00080977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934717|NCT00080977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64934718|NCT00080977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64934719|NCT00080977|Antiviral Agents|antiviral agents|mesh-ancestor
64934720|NCT00080977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64934721|NCT00081055|Cyclosporine|cyclosporine|mesh-list
64410451|NCT04805515|Autonomic Agents|autonomic agents|mesh-ancestor
64410452|NCT04805515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410453|NCT04805515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410454|NCT04805515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64410455|NCT04805515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64410456|NCT04805515|Cholinergic Agents|cholinergic agents|mesh-ancestor
64410457|NCT04805515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64410458|NCT04805515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410459|NCT05195177|Anesthetics|anesthetics|mesh-list
64934722|NCT00081055|Cyclophosphamide|cyclophosphamide|mesh-list
64934723|NCT00081055|Busulfan|busulfan|mesh-list
64934724|NCT00081055|Methotrexate|methotrexate|mesh-list
64934725|NCT00081055|Cyclosporins|cyclosporins|mesh-list
64934726|NCT00081055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64934727|NCT00081055|Immunologic Factors|immunologic factors|mesh-ancestor
64934728|NCT00081055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934729|NCT00081055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64934730|NCT00081055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64934738|NCT00081055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64934739|NCT00081055|Antimetabolites|antimetabolites|mesh-ancestor
64934740|NCT00081055|Dermatologic Agents|dermatologic agents|mesh-ancestor
64934794|NCT00081757|Leprostatic Agents|leprostatic agents|mesh-ancestor
64934795|NCT00081757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64934796|NCT00081757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64934797|NCT00081757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64934798|NCT00081757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64934799|NCT00081757|Growth Substances|growth substances|mesh-ancestor
64934800|NCT00081757|Growth Inhibitors|growth inhibitors|mesh-ancestor
64410537|NCT03066427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410538|NCT03066427|Growth Inhibitors|growth inhibitors|mesh-ancestor
64934801|NCT00081757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934802|NCT00081796|Capecitabine|capecitabine|mesh-list
64934803|NCT00081796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64934804|NCT00081796|Antimetabolites|antimetabolites|mesh-ancestor
64934805|NCT00081796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934806|NCT00081796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934807|NCT03152175|Propranolol|propranolol|mesh-list
64934808|NCT03152175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64934809|NCT03152175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64934810|NCT03152175|Adrenergic Agents|adrenergic agents|mesh-ancestor
64934811|NCT03152175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64934812|NCT03152175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934813|NCT03152175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934814|NCT03152175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64934815|NCT03152175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64934816|NCT03152175|Vasodilator Agents|vasodilator agents|mesh-ancestor
64934817|NCT00399685|Efavirenz|efavirenz|mesh-list
64934818|NCT00399685|Moxifloxacin|moxifloxacin|mesh-list
64934819|NCT00399685|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64934820|NCT00399685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64934821|NCT00399685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64934822|NCT00399685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410619|NCT05115513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410620|NCT05115513|Hormones|hormones|mesh-ancestor
64410626|NCT01672801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410627|NCT01672801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64410629|NCT01672801|Vasodilator Agents|vasodilator agents|mesh-ancestor
64410631|NCT05613335|Hemostatics|hemostatics|mesh-ancestor
64410632|NCT05613335|Coagulants|coagulants|mesh-ancestor
64410633|NCT05078463|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64410634|NCT05078463|Terephthalic acid|terephthalic acid|mesh-list
64410635|NCT05078463|Anesthetics, Local|anesthetics, local|mesh-ancestor
64410636|NCT05078463|Anesthetics|anesthetics|mesh-ancestor
64410637|NCT05078463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64410638|NCT05078463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410639|NCT05078463|Sensory System Agents|sensory system agents|mesh-ancestor
64410640|NCT05078463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410641|NCT05078463|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64410642|NCT05078463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64410643|NCT05078463|Antioxidants|antioxidants|mesh-ancestor
64410644|NCT05078463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410645|NCT05078463|Protective Agents|protective agents|mesh-ancestor
64410646|NCT05170113|Caffeine|caffeine|mesh-list
64934823|NCT00399685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934833|NCT00399685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64934834|NCT00399685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64934835|NCT00399685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934836|NCT00399685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64934837|NCT00399685|Contraceptive Agents|contraceptive agents|mesh-ancestor
64934838|NCT00399685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64934854|NCT00081874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934855|NCT03152097|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
64934856|NCT03152097|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64934880|NCT00082576|Azithromycin|azithromycin|mesh-list
64934881|NCT00082576|Chloroquine|chloroquine|mesh-list
64934882|NCT00082576|Mefloquine|mefloquine|mesh-list
64934883|NCT00082576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64934884|NCT00082576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64934885|NCT00082576|Amebicides|amebicides|mesh-ancestor
64934886|NCT00082576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64934887|NCT00082576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64934888|NCT00082576|Antimalarials|antimalarials|mesh-ancestor
64934889|NCT00082576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64934890|NCT00082927|Ibandronic Acid|ibandronic acid|mesh-list
64934891|NCT00082927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64934892|NCT00082927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934893|NCT00082966|Bortezomib|bortezomib|mesh-list
64934894|NCT00082966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934895|NCT00083005|Thalidomide|thalidomide|mesh-list
64934896|NCT00083005|Docetaxel|docetaxel|mesh-list
64934897|NCT00083005|Estramustine|estramustine|mesh-list
64934898|NCT00083005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934899|NCT00083005|Tubulin Modulators|tubulin modulators|mesh-ancestor
64934900|NCT00083005|Antimitotic Agents|antimitotic agents|mesh-ancestor
64934901|NCT00083005|Mitosis Modulators|mitosis modulators|mesh-ancestor
64934902|NCT00083005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934903|NCT00083005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64934904|NCT00083005|Immunologic Factors|immunologic factors|mesh-ancestor
64934905|NCT00083005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64934906|NCT00083005|Leprostatic Agents|leprostatic agents|mesh-ancestor
64934907|NCT00083005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64934908|NCT00083005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64934909|NCT00083005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64934910|NCT00083005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64934911|NCT00083005|Growth Substances|growth substances|mesh-ancestor
64934912|NCT00083005|Growth Inhibitors|growth inhibitors|mesh-ancestor
64934913|NCT00083005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64410655|NCT05170113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64410656|NCT05169957|Nivolumab|nivolumab|mesh-list
64410657|NCT05169957|Ipilimumab|ipilimumab|mesh-list
64410662|NCT05611463|Docetaxel|docetaxel|mesh-list
64934916|NCT00083083|Paclitaxel|paclitaxel|mesh-list
64934923|NCT00083083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64934924|NCT00083083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64934925|NCT00083083|Tubulin Modulators|tubulin modulators|mesh-ancestor
64934926|NCT00083083|Antimitotic Agents|antimitotic agents|mesh-ancestor
64934927|NCT00083083|Mitosis Modulators|mitosis modulators|mesh-ancestor
64934928|NCT00083083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64934929|NCT00083083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64934930|NCT00083083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64934931|NCT00083083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64934932|NCT00083083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64935077|NCT04733508|Incretins|incretins|mesh-ancestor
64935078|NCT04733508|Hormones|hormones|mesh-ancestor
64935079|NCT04733508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64935080|NCT05567536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64935081|NCT00135304|Vitamin D|vitamin d|mesh-list
64410684|NCT05611307|Hormones|hormones|mesh-list
64410685|NCT05611307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64410686|NCT05611307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410697|NCT02631577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64410699|NCT01667081|Antiviral Agents|antiviral agents|mesh-ancestor
64410700|NCT01667081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64410702|NCT03067753|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64410703|NCT03067753|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64410704|NCT03067753|Prednisolone|prednisolone|mesh-list
64410705|NCT03067753|Prednisolone acetate|prednisolone acetate|mesh-list
64410706|NCT03067753|Hormones|hormones|mesh-list
64410707|NCT03067753|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64410708|NCT03067753|Prednisolone phosphate|prednisolone phosphate|mesh-list
64410709|NCT03067753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64410710|NCT03067753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410711|NCT03067753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64410712|NCT03067753|Antiemetics|antiemetics|mesh-ancestor
64410713|NCT03067753|Autonomic Agents|autonomic agents|mesh-ancestor
64410714|NCT03067753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410715|NCT03067753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64935119|NCT00135499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64935120|NCT00135499|Tubulin Modulators|tubulin modulators|mesh-ancestor
64935121|NCT00135499|Antimitotic Agents|antimitotic agents|mesh-ancestor
64935122|NCT00135499|Mitosis Modulators|mitosis modulators|mesh-ancestor
64935123|NCT03151434|Hydromorphone|hydromorphone|mesh-list
64935124|NCT03151434|Bupivacaine|bupivacaine|mesh-list
64935125|NCT03151434|Anesthetics, Local|anesthetics, local|mesh-ancestor
64935126|NCT03151434|Anesthetics|anesthetics|mesh-ancestor
64935127|NCT03151434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64935128|NCT03151434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935129|NCT03151434|Sensory System Agents|sensory system agents|mesh-ancestor
64935130|NCT03151434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64935131|NCT03151434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64935132|NCT03151434|Narcotics|narcotics|mesh-ancestor
64935133|NCT03151434|Analgesics|analgesics|mesh-ancestor
64935171|NCT00135928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935172|NCT00135967|Mycophenolic Acid|mycophenolic acid|mesh-list
64935173|NCT00135967|Prednisone|prednisone|mesh-list
64935183|NCT00135967|Hormones|hormones|mesh-ancestor
64935184|NCT00135967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64935185|NCT00135967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935186|NCT00135967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64935187|NCT00135967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410743|NCT03067597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935188|NCT00135967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64410744|NCT02518971|Tamsulosin|tamsulosin|mesh-list
64410772|NCT03066115|Ascorbic Acid|ascorbic acid|mesh-list
64410773|NCT03066115|Ketorolac|ketorolac|mesh-list
64410774|NCT03066115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64935189|NCT00135967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64935190|NCT00135967|Antitubercular Agents|antitubercular agents|mesh-ancestor
64935191|NCT00135967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64935192|NCT00135967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64935193|NCT00135967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935195|NCT00135967|Antiemetics|antiemetics|mesh-ancestor
64935221|NCT00136396|Immunologic Factors|immunologic factors|mesh-ancestor
64935222|NCT00136396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935223|NCT00136396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64935224|NCT00136474|Amifostine|amifostine|mesh-list
64935225|NCT00136474|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64935226|NCT00136474|Protective Agents|protective agents|mesh-ancestor
64935227|NCT00136474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935229|NCT00136552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64935230|NCT00136552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935231|NCT00136552|Immunologic Factors|immunologic factors|mesh-ancestor
64935232|NCT00136552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935233|NCT00136552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64935234|NCT00136591|Bortezomib|bortezomib|mesh-list
64935235|NCT00136591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935236|NCT03151161|Carboplatin|carboplatin|mesh-list
64935237|NCT03151161|Pemetrexed|pemetrexed|mesh-list
64935238|NCT03151161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935239|NCT03151161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935240|NCT03151161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935241|NCT03151161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64935242|NCT03151161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64935252|NCT03991130|Nivolumab|nivolumab|mesh-list
64935271|NCT00136747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935272|NCT00136747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64935273|NCT00136747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64935274|NCT00136747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64935275|NCT00136747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64935276|NCT00136786|Memantine|memantine|mesh-list
64935277|NCT00136786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64935278|NCT00136786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64935279|NCT00136786|Dopamine Agents|dopamine agents|mesh-ancestor
64935280|NCT00136786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64935281|NCT00136786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935282|NCT00136786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935283|NCT00136786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64935284|NCT00136786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64935285|NCT00136825|Acetylcysteine|acetylcysteine|mesh-list
64935286|NCT00136825|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64935287|NCT00136825|Antiviral Agents|antiviral agents|mesh-ancestor
64935288|NCT00136825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64935289|NCT00136825|Expectorants|expectorants|mesh-ancestor
64935290|NCT00136825|Respiratory System Agents|respiratory system agents|mesh-ancestor
64935291|NCT00136825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64935292|NCT00136825|Antioxidants|antioxidants|mesh-ancestor
64935293|NCT00136825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935375|NCT03151044|Epirubicin|epirubicin|mesh-list
64935376|NCT03151044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64935377|NCT03151044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935378|NCT03151044|Immunologic Factors|immunologic factors|mesh-ancestor
64935417|NCT00137566|Analgesics|analgesics|mesh-ancestor
64935418|NCT00137566|Sensory System Agents|sensory system agents|mesh-ancestor
64935419|NCT00137566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64935420|NCT00137566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935421|NCT00137566|Antipyretics|antipyretics|mesh-ancestor
64935422|NCT00137605|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64935423|NCT00137605|Immunologic Factors|immunologic factors|mesh-ancestor
64935424|NCT00137605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935425|NCT00137761|Docetaxel|docetaxel|mesh-list
64935426|NCT00137761|Gefitinib|gefitinib|mesh-list
64935427|NCT00137761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935428|NCT00137761|Tubulin Modulators|tubulin modulators|mesh-ancestor
64935429|NCT00137761|Antimitotic Agents|antimitotic agents|mesh-ancestor
64935430|NCT00137761|Mitosis Modulators|mitosis modulators|mesh-ancestor
64935431|NCT00137761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935432|NCT00137761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64935433|NCT00137761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935434|NCT00137800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64935435|NCT00137800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935436|NCT00137800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64935437|NCT00137800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935438|NCT00137800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935439|NCT02858921|Pembrolizumab|pembrolizumab|mesh-list
64935440|NCT02858921|Trametinib|trametinib|mesh-list
64410905|NCT04443673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64935441|NCT02858921|Dabrafenib|dabrafenib|mesh-list
64935442|NCT02858921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64935443|NCT02858921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935444|NCT02858921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64935445|NCT02858921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935446|NCT02858921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935447|NCT00137995|Cytarabine|cytarabine|mesh-list
64935448|NCT00137995|Dexamethasone|dexamethasone|mesh-list
64935449|NCT00137995|Rituximab|rituximab|mesh-list
64935459|NCT00137995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64935460|NCT00137995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64935461|NCT00137995|Antiemetics|antiemetics|mesh-ancestor
64935462|NCT00137995|Autonomic Agents|autonomic agents|mesh-ancestor
64935463|NCT00137995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410955|NCT05031975|Temozolomide|temozolomide|mesh-list
64410956|NCT05031975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64410957|NCT05031975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64410958|NCT05031975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935464|NCT00137995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64935465|NCT00137995|Glucocorticoids|glucocorticoids|mesh-ancestor
64935466|NCT00137995|Hormones|hormones|mesh-ancestor
64935467|NCT00137995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64935468|NCT00137995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64935469|NCT00137995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64935470|NCT00137995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64935480|NCT00137995|Alkylating Agents|alkylating agents|mesh-ancestor
64935481|NCT00137995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64935482|NCT03150888|Antihypertensive Agents|antihypertensive agents|mesh-list
64935483|NCT00138112|Vancomycin|vancomycin|mesh-list
64935484|NCT00138112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64411030|NCT04421547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411031|NCT03066817|Ergocalciferols|ergocalciferols|mesh-list
64411032|NCT03066817|Vitamin D|vitamin d|mesh-list
64411033|NCT03066817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64411034|NCT03066817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411035|NCT03066817|Vitamins|vitamins|mesh-ancestor
64411036|NCT03066817|Micronutrients|micronutrients|mesh-ancestor
64935485|NCT00138112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64935486|NCT00138229|Aldesleukin|aldesleukin|mesh-list
64935487|NCT00138229|Cyclophosphamide|cyclophosphamide|mesh-list
64935488|NCT00138229|Fludarabine|fludarabine|mesh-list
64935489|NCT00138229|Fludarabine phosphate|fludarabine phosphate|mesh-list
64935490|NCT00138229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64935491|NCT00138229|Immunologic Factors|immunologic factors|mesh-ancestor
64935492|NCT00138229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935493|NCT00138229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64935494|NCT00138229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64411123|NCT05019885|Sensory System Agents|sensory system agents|mesh-ancestor
64935496|NCT00138229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935497|NCT00138229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935498|NCT00138229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64935499|NCT00138229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64935500|NCT00138229|Antimetabolites|antimetabolites|mesh-ancestor
64935501|NCT00138229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64935502|NCT00138229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64935503|NCT00138229|Antiviral Agents|antiviral agents|mesh-ancestor
64935504|NCT00138229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64935505|NCT00404131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64935506|NCT00404131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64935507|NCT02826161|Paclitaxel|paclitaxel|mesh-list
64935508|NCT02826161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64935509|NCT02826161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935510|NCT02826161|Tubulin Modulators|tubulin modulators|mesh-ancestor
64935511|NCT02826161|Antimitotic Agents|antimitotic agents|mesh-ancestor
64935512|NCT02826161|Mitosis Modulators|mitosis modulators|mesh-ancestor
64935513|NCT02826161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935514|NCT03150810|Temozolomide|temozolomide|mesh-list
64935515|NCT03150810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64935519|NCT00138541|Vildagliptin|vildagliptin|mesh-list
64935547|NCT03150771|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64935548|NCT03150771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64935549|NCT03150771|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64935550|NCT03150771|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64935551|NCT00138619|Vildagliptin|vildagliptin|mesh-list
64935552|NCT00138619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64935553|NCT00138619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935554|NCT00138619|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64935555|NCT00138619|Protease Inhibitors|protease inhibitors|mesh-ancestor
64935556|NCT00138619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935557|NCT00138619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935558|NCT00138736|Lectins|lectins|mesh-list
64935559|NCT00138736|Agglutinins|agglutinins|mesh-ancestor
64935560|NCT00138736|Immunologic Factors|immunologic factors|mesh-ancestor
64935561|NCT00138736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935562|NCT00138736|Coagulants|coagulants|mesh-ancestor
64935563|NCT03150732|Nalbuphine|nalbuphine|mesh-list
64935606|NCT00138970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64935607|NCT00138970|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64935608|NCT00138970|Antitubercular Agents|antitubercular agents|mesh-ancestor
64935663|NCT00139243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935664|NCT00139243|Antimetabolites|antimetabolites|mesh-ancestor
64935665|NCT00139243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935666|NCT00139243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64935667|NCT00139243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64935668|NCT00139243|Immunologic Factors|immunologic factors|mesh-ancestor
64935669|NCT00139243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935701|NCT00139516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64935702|NCT00139516|Autonomic Agents|autonomic agents|mesh-ancestor
64935703|NCT00139516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64935704|NCT00139516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935705|NCT00139516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64935706|NCT00139516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64935707|NCT00139516|Cholinergic Agents|cholinergic agents|mesh-ancestor
64935708|NCT00139516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64935709|NCT00139516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935710|NCT00139555|Amlodipine|amlodipine|mesh-list
64935711|NCT00139555|Benazepril|benazepril|mesh-list
64935712|NCT00139555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64935713|NCT00139555|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64935714|NCT00139555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64935715|NCT00139555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935716|NCT00139555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64935717|NCT00139555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935718|NCT00139555|Vasodilator Agents|vasodilator agents|mesh-ancestor
64935719|NCT00139555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64935720|NCT00139555|Protease Inhibitors|protease inhibitors|mesh-ancestor
64935754|NCT00139711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935755|NCT00139711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64935756|NCT00139711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64411277|NCT04840615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64411279|NCT05011383|Testosterone|testosterone|mesh-list
64935757|NCT00139711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935759|NCT03837977|Folic Acid|folic acid|mesh-list
64935760|NCT03837977|Docetaxel|docetaxel|mesh-list
64935761|NCT03837977|Fluorouracil|fluorouracil|mesh-list
64935762|NCT03837977|Irinotecan|irinotecan|mesh-list
64935763|NCT03837977|Levoleucovorin|levoleucovorin|mesh-list
64935764|NCT03837977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935765|NCT03837977|Tubulin Modulators|tubulin modulators|mesh-ancestor
64935766|NCT03837977|Antimitotic Agents|antimitotic agents|mesh-ancestor
64935767|NCT03837977|Mitosis Modulators|mitosis modulators|mesh-ancestor
64935768|NCT03837977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935769|NCT03837977|Antimetabolites|antimetabolites|mesh-ancestor
64935770|NCT03837977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64935771|NCT03837977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64935772|NCT03837977|Immunologic Factors|immunologic factors|mesh-ancestor
64935773|NCT03837977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935774|NCT03837977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64935775|NCT03837977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64935776|NCT03837977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935780|NCT03837977|Vitamins|vitamins|mesh-ancestor
64935808|NCT00139867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64935809|NCT00139867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64935810|NCT00139867|Dopamine Agonists|dopamine agonists|mesh-ancestor
64935811|NCT00139867|Dopamine Agents|dopamine agents|mesh-ancestor
64935812|NCT00139867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64935813|NCT00139867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935814|NCT03150459|Rifaximin|rifaximin|mesh-list
64935815|NCT03150459|Simvastatin|simvastatin|mesh-list
64935874|NCT00140452|Thalidomide|thalidomide|mesh-list
64935875|NCT00140452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64935876|NCT00140452|Immunologic Factors|immunologic factors|mesh-ancestor
64935877|NCT00140452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64935878|NCT00140452|Leprostatic Agents|leprostatic agents|mesh-ancestor
64935879|NCT00140452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64935880|NCT00140452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64935881|NCT00140452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64935882|NCT00140452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64935883|NCT00140452|Growth Substances|growth substances|mesh-ancestor
64935884|NCT00140452|Growth Inhibitors|growth inhibitors|mesh-ancestor
64935885|NCT00140452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935886|NCT00140530|Sirolimus|sirolimus|mesh-list
64935956|NCT00140920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64935957|NCT00140920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64935958|NCT00140920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64935959|NCT00140920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64935961|NCT03136497|Venetoclax|venetoclax|mesh-list
64935962|NCT03136497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64935963|NCT03136497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64935964|NCT03136497|Immunologic Factors|immunologic factors|mesh-ancestor
64936028|NCT00141310|Urological Agents|urological agents|mesh-ancestor
64936030|NCT00141388|Analgesics|analgesics|mesh-ancestor
64936031|NCT00141388|Sensory System Agents|sensory system agents|mesh-ancestor
64936032|NCT00141388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64936033|NCT00141388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936034|NCT00141388|Anticonvulsants|anticonvulsants|mesh-ancestor
64936035|NCT00141388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64411347|NCT05008809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64936036|NCT00141388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64936037|NCT00141388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936038|NCT00141388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64936039|NCT00141388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64936040|NCT00141388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64936041|NCT00141388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64936042|NCT00141388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64936047|NCT00404404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936048|NCT00404404|Tubulin Modulators|tubulin modulators|mesh-ancestor
64936049|NCT00404404|Antimitotic Agents|antimitotic agents|mesh-ancestor
64936050|NCT00404404|Mitosis Modulators|mitosis modulators|mesh-ancestor
64936051|NCT00404404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936052|NCT00404404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64936053|NCT00404404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64936054|NCT00404404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64936055|NCT00404404|Growth Substances|growth substances|mesh-ancestor
64936056|NCT00404404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936057|NCT00404404|Growth Inhibitors|growth inhibitors|mesh-ancestor
64936058|NCT00404482|Cyclosporine|cyclosporine|mesh-list
64936059|NCT00404482|Cyclosporins|cyclosporins|mesh-list
64936060|NCT00404482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936061|NCT00404482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936062|NCT00404482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64936102|NCT00141544|Testosterone enanthate|testosterone enanthate|mesh-list
64936103|NCT00141544|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64936151|NCT00142051|Antioxidants|antioxidants|mesh-ancestor
64936152|NCT00142051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936153|NCT00142051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64936154|NCT00142051|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64936190|NCT00142246|Antimalarials|antimalarials|mesh-ancestor
64936191|NCT00142246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64936192|NCT00142246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64936193|NCT00142246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64936194|NCT00142324|Donepezil|donepezil|mesh-list
64936195|NCT00142324|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64936196|NCT00142324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936197|NCT00142324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936198|NCT00142324|Cholinergic Agents|cholinergic agents|mesh-ancestor
64936199|NCT00142324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64936200|NCT00142324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936201|NCT00142324|Nootropic Agents|nootropic agents|mesh-ancestor
64936202|NCT00142402|Modafinil|modafinil|mesh-list
64936203|NCT00142402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64936204|NCT00142402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936205|NCT00142402|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64936206|NCT00142402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64936207|NCT00142402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64936208|NCT00142402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936209|NCT00142480|Bevacizumab|bevacizumab|mesh-list
64936210|NCT00142480|Capecitabine|capecitabine|mesh-list
64936211|NCT00142480|Oxaliplatin|oxaliplatin|mesh-list
64936212|NCT00142480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64411377|NCT04373603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64936213|NCT00142480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936214|NCT00142480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64936237|NCT02781792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936238|NCT02781792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936240|NCT00142870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64936241|NCT00142870|Antidepressive Agents|antidepressive agents|mesh-ancestor
64936252|NCT00142870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936253|NCT00142948|Naltrexone|naltrexone|mesh-list
64936254|NCT00142948|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64936255|NCT00142948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64936264|NCT02780427|Analgesics|analgesics|mesh-ancestor
64936288|NCT00143026|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64936289|NCT00143026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936290|NCT00143026|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64936291|NCT00404599|Simvastatin|simvastatin|mesh-list
64936292|NCT00404599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64936293|NCT00404599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64936294|NCT00404599|Antimetabolites|antimetabolites|mesh-ancestor
64936295|NCT00404599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936296|NCT00404599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64936297|NCT00404599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64936298|NCT00404599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936300|NCT00143065|Alemtuzumab|alemtuzumab|mesh-list
64936301|NCT00143065|Fludarabine|fludarabine|mesh-list
64936348|NCT00143299|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64936349|NCT00143299|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64936350|NCT00143299|Cholinergic Agents|cholinergic agents|mesh-ancestor
64936351|NCT00143299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64936352|NCT00143299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936353|NCT00143299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936354|NCT00143338|Insulin|insulin|mesh-list
64936355|NCT00143338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64936356|NCT00143338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936357|NCT00143377|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64936358|NCT00143377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64936359|NCT00143377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64936360|NCT00143377|Cholinergic Agents|cholinergic agents|mesh-ancestor
64936361|NCT00143377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64936362|NCT00143377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936364|NCT00143377|Urological Agents|urological agents|mesh-ancestor
64936406|NCT00143689|Lamivudine|lamivudine|mesh-list
64936407|NCT00143689|Zidovudine|zidovudine|mesh-list
64936408|NCT00143689|Nevirapine|nevirapine|mesh-list
64936409|NCT00143689|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64936410|NCT00143689|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64936411|NCT00143689|Protease Inhibitors|protease inhibitors|mesh-ancestor
64936412|NCT00143689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936413|NCT00143689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936414|NCT00143689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64936415|NCT00143689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64936416|NCT00143689|Antiviral Agents|antiviral agents|mesh-ancestor
64936417|NCT00143689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64936418|NCT00143689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64936419|NCT00143689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64411535|NCT02555111|Anticoagulants|anticoagulants|mesh-ancestor
64411536|NCT02521415|Acetaminophen|acetaminophen|mesh-list
64936420|NCT00143689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64704917|NCT00367172|Antiviral Agents|antiviral agents|mesh-ancestor
64936421|NCT00143689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64936422|NCT00143689|Antimetabolites|antimetabolites|mesh-ancestor
64936437|NCT00143806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936448|NCT00390728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64936449|NCT00390728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936450|NCT00144040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64936451|NCT00144040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64936452|NCT00144040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64936453|NCT00144040|Antitubercular Agents|antitubercular agents|mesh-ancestor
64936456|NCT00144118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64936457|NCT00144118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64936458|NCT00144118|Anesthetics, General|anesthetics, general|mesh-ancestor
64936459|NCT00144118|Anesthetics|anesthetics|mesh-ancestor
64936460|NCT00144118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64936461|NCT00144118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936462|NCT00144157|Zidovudine|zidovudine|mesh-list
64936463|NCT00144157|Nevirapine|nevirapine|mesh-list
64411582|NCT02588339|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64936464|NCT00144157|Antimetabolites|antimetabolites|mesh-ancestor
64936465|NCT00144157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936466|NCT00144157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64936468|NCT00144157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936500|NCT00144352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64936501|NCT00144352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936502|NCT00144352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936503|NCT00144352|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64936504|NCT00144352|Renal Agents|renal agents|mesh-ancestor
64936505|NCT00144430|Pentostatin|pentostatin|mesh-list
64936506|NCT00144430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936507|NCT00144430|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
64936508|NCT00144430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64411677|NCT05548985|Sympathomimetics|sympathomimetics|mesh-ancestor
64936509|NCT00144430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936510|NCT00144469|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64936511|NCT00144469|Antiviral Agents|antiviral agents|mesh-ancestor
64936512|NCT00144469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64936514|NCT00404716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64936515|NCT00404716|Autonomic Agents|autonomic agents|mesh-ancestor
64936516|NCT00404716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64936517|NCT00404716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936518|NCT00404716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64936519|NCT00404716|Respiratory System Agents|respiratory system agents|mesh-ancestor
64936520|NCT00404716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64936521|NCT00404716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64936522|NCT00404716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936523|NCT00404716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64936524|NCT00404716|Vasodilator Agents|vasodilator agents|mesh-ancestor
64936525|NCT00404716|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64936568|NCT03191786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936569|NCT03191786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64936589|NCT00404833|Prednisolone phosphate|prednisolone phosphate|mesh-list
64936590|NCT00404833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64936591|NCT00404833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64411807|NCT05541419|Autonomic Agents|autonomic agents|mesh-ancestor
64411808|NCT05541419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411809|NCT05541419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411810|NCT05541419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64411811|NCT05541419|Respiratory System Agents|respiratory system agents|mesh-ancestor
64411812|NCT05541419|Glucocorticoids|glucocorticoids|mesh-ancestor
64411813|NCT05541419|Hormones|hormones|mesh-ancestor
64411814|NCT05541419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64411815|NCT05546879|Bevacizumab|bevacizumab|mesh-list
64411816|NCT05546879|Atezolizumab|atezolizumab|mesh-list
64411837|NCT05541185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64411838|NCT05541185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64342692|NCT02281643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64936592|NCT00404833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64936593|NCT00404833|Antitubercular Agents|antitubercular agents|mesh-ancestor
64936697|NCT01807494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64936698|NCT01807494|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64936699|NCT01807494|Histamine Antagonists|histamine antagonists|mesh-ancestor
64936700|NCT01807494|Histamine Agents|histamine agents|mesh-ancestor
64936701|NCT01807494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64936702|NCT01807494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936703|NCT01807494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936704|NCT01807494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64936705|NCT01807494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64936706|NCT01807494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936707|NCT03096782|Mycophenolic Acid|mycophenolic acid|mesh-list
64411847|NCT02518113|Antiemetics|antiemetics|mesh-ancestor
64411848|NCT02518113|Autonomic Agents|autonomic agents|mesh-ancestor
64411849|NCT02518113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411850|NCT02518113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411851|NCT02518113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64411852|NCT02518113|Glucocorticoids|glucocorticoids|mesh-ancestor
64411853|NCT02518113|Hormones|hormones|mesh-ancestor
64411855|NCT02518113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64411860|NCT05541107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64411861|NCT05541107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64411862|NCT05541107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64411863|NCT05541107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64411864|NCT05541107|Antifungal Agents|antifungal agents|mesh-ancestor
64411865|NCT03062839|Melatonin|melatonin|mesh-list
64411866|NCT03062839|Antioxidants|antioxidants|mesh-ancestor
64411867|NCT03062839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411868|NCT03062839|Protective Agents|protective agents|mesh-ancestor
64411869|NCT03062839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936708|NCT03096782|Cyclophosphamide|cyclophosphamide|mesh-list
64936709|NCT03096782|Melphalan|melphalan|mesh-list
64936710|NCT03096782|Busulfan|busulfan|mesh-list
64936711|NCT03096782|Mechlorethamine|mechlorethamine|mesh-list
64936712|NCT03096782|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64936713|NCT03096782|Rituximab|rituximab|mesh-list
64936714|NCT03096782|Fludarabine|fludarabine|mesh-list
64936715|NCT03096782|Clofarabine|clofarabine|mesh-list
64936716|NCT03096782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64936717|NCT03096782|Tacrolimus|tacrolimus|mesh-list
64936718|NCT03096782|Thymoglobulin|thymoglobulin|mesh-list
64936719|NCT03096782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64936720|NCT03096782|Antibodies|antibodies|mesh-list
64936721|NCT03096782|Immunoglobulins|immunoglobulins|mesh-list
64936722|NCT03096782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64936723|NCT03096782|Lenograstim|lenograstim|mesh-list
64936724|NCT03096782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64936725|NCT03096782|Immunologic Factors|immunologic factors|mesh-ancestor
64936726|NCT03096782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936728|NCT03096782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64936729|NCT03096782|Alkylating Agents|alkylating agents|mesh-ancestor
64411925|NCT05545475|Enoxaparin|enoxaparin|mesh-list
64936730|NCT03096782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936731|NCT03096782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936732|NCT03096782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64936733|NCT03096782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64936734|NCT03096782|Antimetabolites|antimetabolites|mesh-ancestor
64936735|NCT03096782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64936736|NCT03096782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64936737|NCT03096782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936738|NCT03096782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64936739|NCT03096782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64936740|NCT03096782|Antitubercular Agents|antitubercular agents|mesh-ancestor
64936741|NCT03096782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64936742|NCT03096782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64936743|NCT01807455|Lidocaine|lidocaine|mesh-list
64936744|NCT01807455|Anesthetics, Local|anesthetics, local|mesh-ancestor
64936745|NCT01807455|Anesthetics|anesthetics|mesh-ancestor
64936748|NCT01807455|Sensory System Agents|sensory system agents|mesh-ancestor
64936780|NCT05586724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64936781|NCT05586724|Contraceptive Agents|contraceptive agents|mesh-ancestor
64936782|NCT05586724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64936783|NCT05586724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64936784|NCT05586724|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64936785|NCT03092453|Cyclophosphamide|cyclophosphamide|mesh-list
64936786|NCT03092453|Pembrolizumab|pembrolizumab|mesh-list
64936787|NCT03092453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64936788|NCT03092453|Immunologic Factors|immunologic factors|mesh-ancestor
64411995|NCT04428307|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64936856|NCT03087071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936858|NCT05461807|Apixaban|apixaban|mesh-list
64936859|NCT05461807|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64936860|NCT05461807|Antithrombins|antithrombins|mesh-ancestor
64936861|NCT05461807|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64936862|NCT05461807|Protease Inhibitors|protease inhibitors|mesh-ancestor
64936863|NCT05461807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936865|NCT05461807|Anticoagulants|anticoagulants|mesh-ancestor
64936870|NCT03079427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64936871|NCT03079427|Antimetabolites|antimetabolites|mesh-ancestor
64936872|NCT03079427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936873|NCT03079427|Antiviral Agents|antiviral agents|mesh-ancestor
64412071|NCT03064243|Apatinib|apatinib|mesh-list
64936874|NCT03079427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64936875|NCT03079427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936876|NCT03079427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64936877|NCT03079427|Immunologic Factors|immunologic factors|mesh-ancestor
64936878|NCT03079427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936879|NCT00390923|Selegiline|selegiline|mesh-list
64936880|NCT00390923|Nicotine|nicotine|mesh-list
64936881|NCT00390923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64936882|NCT00390923|Autonomic Agents|autonomic agents|mesh-ancestor
64936883|NCT00390923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64936884|NCT00390923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936885|NCT00390923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64936886|NCT00390923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64412156|NCT03980483|Abortifacient Agents|abortifacient agents|mesh-ancestor
64936887|NCT00390923|Cholinergic Agents|cholinergic agents|mesh-ancestor
64936888|NCT00390923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64936889|NCT00390923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936890|NCT00390923|Antidepressive Agents|antidepressive agents|mesh-ancestor
64936891|NCT00390923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64936892|NCT00390923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64936893|NCT00390923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64936894|NCT00390923|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64936895|NCT00390923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936896|NCT00390923|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64936897|NCT00390923|Protective Agents|protective agents|mesh-ancestor
64936898|NCT00425425|Fluorouracil|fluorouracil|mesh-list
64936899|NCT00425425|Oxaliplatin|oxaliplatin|mesh-list
64936900|NCT00425425|Cetuximab|cetuximab|mesh-list
64936901|NCT00425425|Antimetabolites|antimetabolites|mesh-ancestor
64936902|NCT00425425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936903|NCT00425425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64936904|NCT00425425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936910|NCT01806948|Antiemetics|antiemetics|mesh-ancestor
64936911|NCT01806948|Autonomic Agents|autonomic agents|mesh-ancestor
64936912|NCT01806948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64936913|NCT01806948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936914|NCT01806948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64412259|NCT04977427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936915|NCT01806948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64936916|NCT01806948|Serotonin Agents|serotonin agents|mesh-ancestor
64936917|NCT01806948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64936918|NCT01806948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936923|NCT05374525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64936925|NCT05374525|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64936926|NCT05374525|Antiviral Agents|antiviral agents|mesh-ancestor
64936927|NCT05374525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64936928|NCT02958163|Doxorubicin|doxorubicin|mesh-list
64936929|NCT02958163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64936930|NCT02958163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64936931|NCT02958163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64936932|NCT02958163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64936933|NCT02958163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64936935|NCT00424138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64936960|NCT05227456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64936961|NCT05227456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936962|NCT05227456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64936963|NCT05227456|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64936964|NCT05227456|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64936965|NCT05227456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64936966|NCT05227456|Progestins|progestins|mesh-ancestor
64936967|NCT05227456|Hormones|hormones|mesh-ancestor
64936968|NCT05227456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64936969|NCT02901041|Zonisamide|zonisamide|mesh-list
64936970|NCT02901041|Anticonvulsants|anticonvulsants|mesh-ancestor
64936971|NCT02901041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64936972|NCT02901041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64936973|NCT02901041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412321|NCT03862157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412322|NCT03862157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412323|NCT02474355|Osimertinib|osimertinib|mesh-list
64412334|NCT02474199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64412335|NCT02474199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412336|NCT02474199|Antipyretics|antipyretics|mesh-ancestor
64412337|NCT02474199|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64412366|NCT02506881|Hematinics|hematinics|mesh-ancestor
64936974|NCT02901041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64936975|NCT02901041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936976|NCT01806753|Midazolam|midazolam|mesh-list
64936977|NCT01806753|Propofol|propofol|mesh-list
64936978|NCT01806753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64936979|NCT01806753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64936980|NCT01806753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64936981|NCT01806753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64936982|NCT01806753|Anesthetics, General|anesthetics, general|mesh-ancestor
64936983|NCT01806753|Anesthetics|anesthetics|mesh-ancestor
64936984|NCT01806753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64936985|NCT01806753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64937005|NCT05175430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64937007|NCT05175430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937008|NCT05175430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64937009|NCT05175430|Serotonin Agents|serotonin agents|mesh-ancestor
64937010|NCT05175430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937011|NCT05175430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64937012|NCT05175430|Antidepressive Agents|antidepressive agents|mesh-ancestor
64937013|NCT05175430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64937014|NCT05175430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64937015|NCT05175430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64937016|NCT05175430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937017|NCT05175430|Hallucinogens|hallucinogens|mesh-ancestor
64937018|NCT05175430|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64412389|NCT02448771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64937019|NCT05175430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64937020|NCT01806675|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64705524|NCT05731843|Ruzasvir|ruzasvir|mesh-list
64937021|NCT01806675|Glycine|glycine|mesh-list
64937022|NCT01806675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64937059|NCT05065567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64937060|NCT02739035|Dexamethasone|dexamethasone|mesh-list
64937061|NCT02739035|Celecoxib|celecoxib|mesh-list
64937062|NCT02739035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64937063|NCT02739035|Antiemetics|antiemetics|mesh-ancestor
64937064|NCT02739035|Autonomic Agents|autonomic agents|mesh-ancestor
64937065|NCT02739035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64937066|NCT02739035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937067|NCT02739035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64937068|NCT02739035|Glucocorticoids|glucocorticoids|mesh-ancestor
64937069|NCT02739035|Hormones|hormones|mesh-ancestor
64937126|NCT01806363|Natriuretic Agents|natriuretic agents|mesh-ancestor
64937127|NCT01806363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937128|NCT01806363|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64937130|NCT04846855|Anesthetics|anesthetics|mesh-list
64937155|NCT02964403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937197|NCT00405301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64937198|NCT00405301|Antitubercular Agents|antitubercular agents|mesh-ancestor
64937199|NCT00405301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64937200|NCT00405301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64937201|NCT00405301|Leprostatic Agents|leprostatic agents|mesh-ancestor
64937202|NCT00405301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64937203|NCT00405301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412565|NCT02448381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412566|NCT02448381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64937204|NCT00405301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937254|NCT02593175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64937255|NCT02593175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937256|NCT02593175|Tubulin Modulators|tubulin modulators|mesh-ancestor
64937257|NCT02593175|Antimitotic Agents|antimitotic agents|mesh-ancestor
64937258|NCT02593175|Mitosis Modulators|mitosis modulators|mesh-ancestor
64937260|NCT02593175|Immunologic Factors|immunologic factors|mesh-ancestor
64937290|NCT04341181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937309|NCT02316002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937311|NCT01805895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64937312|NCT01805895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64937313|NCT01805856|Cefazolin|cefazolin|mesh-list
64937314|NCT01805856|Piperacillin|piperacillin|mesh-list
64937315|NCT01805856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64937316|NCT01805856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64937317|NCT04234048|Fenretinide|fenretinide|mesh-list
64937318|NCT04234048|Retinamide|retinamide|mesh-list
64937319|NCT04234048|Tretinoin|tretinoin|mesh-list
64937320|NCT04234048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937321|NCT04234048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64937322|NCT04234048|Protective Agents|protective agents|mesh-ancestor
64412636|NCT05536193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64937323|NCT04234048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937326|NCT01805817|Copper|copper|mesh-list
64937333|NCT01805817|Hormones|hormones|mesh-ancestor
64937334|NCT01805817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64937335|NCT01805817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937336|NCT01805817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64937337|NCT01805817|Contraceptive Agents|contraceptive agents|mesh-ancestor
64937338|NCT01805817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64937339|NCT01805817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64937340|NCT01805817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64937341|NCT01805817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64937342|NCT01805817|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64937343|NCT01805817|Trace Elements|trace elements|mesh-ancestor
64937344|NCT01805817|Micronutrients|micronutrients|mesh-ancestor
64937345|NCT01805817|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64937346|NCT01805817|Hormone Antagonists|hormone antagonists|mesh-ancestor
64937347|NCT01805817|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64937348|NCT01805817|Diuretics|diuretics|mesh-ancestor
64937349|NCT01805817|Natriuretic Agents|natriuretic agents|mesh-ancestor
64937350|NCT04206046|Anesthetics|anesthetics|mesh-list
64937351|NCT04206046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64937352|NCT04206046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937387|NCT03969823|Osimertinib|osimertinib|mesh-list
64937388|NCT03969823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937389|NCT03969823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64937457|NCT01902173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64937458|NCT01902173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937459|NCT01902173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937460|NCT01902173|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64937461|NCT01902173|Protective Agents|protective agents|mesh-ancestor
64937463|NCT01902173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64937500|NCT01878617|Pemetrexed|pemetrexed|mesh-list
64937501|NCT01878617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64937502|NCT01878617|Immunologic Factors|immunologic factors|mesh-ancestor
64937503|NCT01878617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412787|NCT05697029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64937504|NCT01878617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64937505|NCT01878617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64937506|NCT01878617|Alkylating Agents|alkylating agents|mesh-ancestor
64937507|NCT01878617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937508|NCT01878617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937509|NCT01878617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64937660|NCT01466361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64937661|NCT01466361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937662|NCT00001832|Cyclophosphamide|cyclophosphamide|mesh-list
64937663|NCT00001832|Fludarabine|fludarabine|mesh-list
64937664|NCT00001832|Interleukin-2|interleukin-2|mesh-list
64937665|NCT00001832|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64937666|NCT00001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64937667|NCT00001832|Immunologic Factors|immunologic factors|mesh-ancestor
64937668|NCT00001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937709|NCT01466088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937711|NCT00009230|Celecoxib|celecoxib|mesh-list
64937712|NCT00009230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64937713|NCT00009230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64937714|NCT00009230|Analgesics|analgesics|mesh-ancestor
64937715|NCT00009230|Sensory System Agents|sensory system agents|mesh-ancestor
64937716|NCT00009230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64937717|NCT00009230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937718|NCT00009230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64937719|NCT00009230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64937720|NCT00009230|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64937721|NCT00009230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64937722|NCT00009230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937723|NCT00009230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937724|NCT00009581|Acetylcholine|acetylcholine|mesh-list
64937725|NCT00009581|Vasodilator Agents|vasodilator agents|mesh-ancestor
64937726|NCT00009581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64412940|NCT04953871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64937727|NCT00009581|Cholinergic Agents|cholinergic agents|mesh-ancestor
64937728|NCT00009581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64937729|NCT00009581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937730|NCT00009581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937731|NCT00009620|Phenobarbital|phenobarbital|mesh-list
64937732|NCT00009620|Anticonvulsants|anticonvulsants|mesh-ancestor
64937733|NCT00009620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64937734|NCT00009620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64937735|NCT00009620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937736|NCT00009620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64937737|NCT00009620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64937744|NCT00009620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64937745|NCT00009659|Ulipristal acetate|ulipristal acetate|mesh-list
64937746|NCT00009659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64937747|NCT00009659|Contraceptive Agents|contraceptive agents|mesh-ancestor
64937748|NCT00009659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64937749|NCT00009659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937750|NCT00009659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64937751|NCT00009698|Aldesleukin|aldesleukin|mesh-list
64937752|NCT00009698|Interleukin-2|interleukin-2|mesh-list
64937753|NCT00009698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937754|NCT00009698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64937755|NCT00009698|Analgesics|analgesics|mesh-ancestor
64937756|NCT00009698|Sensory System Agents|sensory system agents|mesh-ancestor
64937757|NCT00009698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64937758|NCT00009698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937759|NCT00009698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64937760|NCT00009698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64937761|NCT00009698|Antiviral Agents|antiviral agents|mesh-ancestor
64937762|NCT00009698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64937764|NCT01465893|Ergocalciferols|ergocalciferols|mesh-list
64937765|NCT01465893|Cholecalciferol|cholecalciferol|mesh-list
64937766|NCT01465893|Vitamins|vitamins|mesh-list
64937800|NCT00009815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64937802|NCT00009815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64937803|NCT00009815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64937804|NCT00009815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937805|NCT00009815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937806|NCT00009815|Antidotes|antidotes|mesh-ancestor
64937807|NCT00009815|Protective Agents|protective agents|mesh-ancestor
64937808|NCT00009815|Vitamin B Complex|vitamin b complex|mesh-ancestor
64937817|NCT01465815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937818|NCT00009854|Ethanol|ethanol|mesh-list
64937819|NCT00009854|Carmustine|carmustine|mesh-list
64937820|NCT00009854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64937821|NCT00009854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64937822|NCT00009854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64937823|NCT00009854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937824|NCT00009854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64937825|NCT00009854|Alkylating Agents|alkylating agents|mesh-ancestor
64937826|NCT00009854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937848|NCT00009893|Micronutrients|micronutrients|mesh-ancestor
64937849|NCT00009932|Paclitaxel|paclitaxel|mesh-list
64706357|NCT00367874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64937850|NCT00009932|Fenretinide|fenretinide|mesh-list
64937851|NCT00009932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64937852|NCT00009932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937853|NCT00009932|Tubulin Modulators|tubulin modulators|mesh-ancestor
64937854|NCT00009932|Antimitotic Agents|antimitotic agents|mesh-ancestor
64937855|NCT00009932|Mitosis Modulators|mitosis modulators|mesh-ancestor
64937856|NCT00009932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413078|NCT02463357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937857|NCT00009932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64937858|NCT00009932|Protective Agents|protective agents|mesh-ancestor
64937859|NCT00009932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937860|NCT00009971|Fenretinide|fenretinide|mesh-list
64937861|NCT00009971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937862|NCT00009971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64937863|NCT00009971|Protective Agents|protective agents|mesh-ancestor
64937864|NCT00009971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937865|NCT00010010|Exemestane|exemestane|mesh-list
64937866|NCT00010010|Goserelin|goserelin|mesh-list
64937867|NCT00010010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937868|NCT00010010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64937869|NCT00010010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64937870|NCT00010010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937871|NCT00010010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937872|NCT00010010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64937873|NCT00010010|Hormone Antagonists|hormone antagonists|mesh-ancestor
64937874|NCT00010010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64937875|NCT00010010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937876|NCT00010010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64937889|NCT00010088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937890|NCT00010088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937891|NCT00010088|Antiviral Agents|antiviral agents|mesh-ancestor
64937892|NCT00010088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64937893|NCT00010088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937894|NCT00010088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64937895|NCT00010088|Immunologic Factors|immunologic factors|mesh-ancestor
64937896|NCT00010088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937897|NCT00010088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64937898|NCT00010088|Antidotes|antidotes|mesh-ancestor
64937899|NCT00010088|Protective Agents|protective agents|mesh-ancestor
64937900|NCT00010088|Vitamin B Complex|vitamin b complex|mesh-ancestor
64413135|NCT05575427|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64937901|NCT00010088|Vitamins|vitamins|mesh-ancestor
64937902|NCT00010088|Micronutrients|micronutrients|mesh-ancestor
64937903|NCT01465503|Heparin|heparin|mesh-list
64937904|NCT01465503|Calcium heparin|calcium heparin|mesh-list
64937905|NCT01465503|Hirudins|hirudins|mesh-list
64937906|NCT01465503|Bivalirudin|bivalirudin|mesh-list
64937907|NCT01465503|Anticoagulants|anticoagulants|mesh-ancestor
64937956|NCT00010283|Beclomethasone|beclomethasone|mesh-list
64937957|NCT00010283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64937958|NCT00010283|Glucocorticoids|glucocorticoids|mesh-ancestor
64937959|NCT00010283|Hormones|hormones|mesh-ancestor
64937960|NCT00010283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64937961|NCT00010283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937962|NCT00010283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64937963|NCT00010283|Respiratory System Agents|respiratory system agents|mesh-ancestor
64937964|NCT00010322|Toremifene|toremifene|mesh-list
64937965|NCT00010322|Atamestane|atamestane|mesh-list
64937966|NCT00010322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64937967|NCT00010322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64937968|NCT00010322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64937969|NCT00010322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64937970|NCT00010322|Hormone Antagonists|hormone antagonists|mesh-ancestor
64937971|NCT00010322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64937972|NCT00010322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937973|NCT00010322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64937974|NCT00010322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937975|NCT00010322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64937976|NCT00010361|Cyclosporine|cyclosporine|mesh-list
64937977|NCT00010361|Mycophenolic Acid|mycophenolic acid|mesh-list
64937978|NCT00010361|Fludarabine|fludarabine|mesh-list
64937979|NCT00010361|Cyclosporins|cyclosporins|mesh-list
64937981|NCT00010361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413227|NCT03058471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64937982|NCT00010361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64937983|NCT00010361|Immunologic Factors|immunologic factors|mesh-ancestor
64937984|NCT00010361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64937985|NCT00010361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64937986|NCT00010361|Antifungal Agents|antifungal agents|mesh-ancestor
64937987|NCT00010361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64937988|NCT00010361|Dermatologic Agents|dermatologic agents|mesh-ancestor
64937989|NCT00010361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64937990|NCT00010361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64937991|NCT00010361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64937992|NCT00010361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64937993|NCT00010361|Antitubercular Agents|antitubercular agents|mesh-ancestor
64937994|NCT00010361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64937995|NCT00010400|Cyclophosphamide|cyclophosphamide|mesh-list
64937996|NCT00010400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64937997|NCT00010400|Immunologic Factors|immunologic factors|mesh-ancestor
64937998|NCT00010400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413283|NCT05546957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64706508|NCT04739774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64413284|NCT05546957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64937999|NCT00010400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64938000|NCT00010400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64938001|NCT00010400|Alkylating Agents|alkylating agents|mesh-ancestor
64938229|NCT00012116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64938231|NCT00012116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938232|NCT00012116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938233|NCT00847119|Bevacizumab|bevacizumab|mesh-list
64938234|NCT00847119|Capecitabine|capecitabine|mesh-list
64938235|NCT00847119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64938236|NCT00847119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938237|NCT00847119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64938238|NCT00847119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64938239|NCT00847119|Growth Substances|growth substances|mesh-ancestor
64938240|NCT00847119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938241|NCT00847119|Growth Inhibitors|growth inhibitors|mesh-ancestor
64938242|NCT00847119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64938243|NCT00847119|Antimetabolites|antimetabolites|mesh-ancestor
64413367|NCT05587673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64413368|NCT05587673|Antiemetics|antiemetics|mesh-ancestor
64938244|NCT00847119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938245|NCT00847080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64938246|NCT00847080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64938247|NCT00847080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938248|NCT00847080|Incretins|incretins|mesh-ancestor
64938249|NCT00847080|Hormones|hormones|mesh-ancestor
64938250|NCT00847080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64938251|NCT00847080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64938252|NCT00847080|Protease Inhibitors|protease inhibitors|mesh-ancestor
64413443|NCT04964869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413444|NCT04964869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413445|NCT04964869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64413446|NCT04964869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64413447|NCT04964869|Autonomic Agents|autonomic agents|mesh-ancestor
64413448|NCT04964869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413468|NCT04946929|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64413469|NCT04946929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64413470|NCT04946929|Purinergic Agents|purinergic agents|mesh-ancestor
64413471|NCT04946929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64413472|NCT04946929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938253|NCT00847080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938254|NCT00847080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938255|NCT00012194|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
64938383|NCT00846690|Anesthetics, Local|anesthetics, local|mesh-ancestor
64938384|NCT00846690|Anesthetics|anesthetics|mesh-ancestor
64938385|NCT00846690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64938386|NCT00846690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938414|NCT00846651|Sympathomimetics|sympathomimetics|mesh-ancestor
64938415|NCT00846651|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64938416|NCT00846651|Nasal Decongestants|nasal decongestants|mesh-ancestor
64938417|NCT00846651|Respiratory System Agents|respiratory system agents|mesh-ancestor
64938418|NCT00846651|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64938419|NCT00846651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64938420|NCT00846651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64938421|NCT00846651|Adrenergic Agents|adrenergic agents|mesh-ancestor
64938452|NCT00394056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64938453|NCT00394056|Serotonin Agents|serotonin agents|mesh-ancestor
64938454|NCT00394056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938455|NCT00394056|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64938456|NCT00394056|Antidepressive Agents|antidepressive agents|mesh-ancestor
64938457|NCT00394056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64938458|NCT00394056|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64938459|NCT00394056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64938460|NCT00394056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938461|NCT00394056|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64938462|NCT00846339|Bupropion|bupropion|mesh-list
64938585|NCT00276978|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64938586|NCT00276978|Serotonin Agents|serotonin agents|mesh-ancestor
64938587|NCT00276978|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64938588|NCT00276978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64938632|NCT00276705|Alkylating Agents|alkylating agents|mesh-ancestor
64938633|NCT00276705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938634|NCT00276705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938669|NCT00014144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938670|NCT00014144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64938671|NCT00014144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938672|NCT00014144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938675|NCT00276588|Carboplatin|carboplatin|mesh-list
64938676|NCT00276588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64938677|NCT00276588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64938678|NCT00276588|Tubulin Modulators|tubulin modulators|mesh-ancestor
64938679|NCT00276588|Antimitotic Agents|antimitotic agents|mesh-ancestor
64938680|NCT00276588|Mitosis Modulators|mitosis modulators|mesh-ancestor
64938681|NCT00276588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938682|NCT00276588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64938683|NCT00276588|Antimetabolites|antimetabolites|mesh-ancestor
64938684|NCT00276588|Antiviral Agents|antiviral agents|mesh-ancestor
64938685|NCT00276588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64938686|NCT00276588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64938687|NCT00276588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64938783|NCT00014573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64938784|NCT00014573|Immunologic Factors|immunologic factors|mesh-ancestor
64938785|NCT00014573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938786|NCT00014573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64938787|NCT00014573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64938788|NCT00014573|Alkylating Agents|alkylating agents|mesh-ancestor
64938789|NCT00014573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64938790|NCT00014573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64938791|NCT00014573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64938792|NCT00014573|Antiviral Agents|antiviral agents|mesh-ancestor
64938793|NCT00014573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64938794|NCT00276315|Botulinum Toxins|botulinum toxins|mesh-list
64938795|NCT00276315|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64938796|NCT00276315|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64938797|NCT00276315|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64938798|NCT00276315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64938799|NCT00276315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938800|NCT00276315|Cholinergic Agents|cholinergic agents|mesh-ancestor
64938801|NCT00276315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64938802|NCT00276315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938805|NCT00276276|Topotecan|topotecan|mesh-list
64938833|NCT00276081|Analgesics|analgesics|mesh-ancestor
64938834|NCT00276081|Sensory System Agents|sensory system agents|mesh-ancestor
64938835|NCT00276081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64938836|NCT00276081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64938837|NCT00276081|Anticonvulsants|anticonvulsants|mesh-ancestor
64938838|NCT00276081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64938839|NCT00276081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64938840|NCT00276081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64938841|NCT00276081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64938957|NCT00015548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64938958|NCT00015548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939064|NCT00015821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64939065|NCT00015821|Growth Substances|growth substances|mesh-ancestor
64939066|NCT00015821|Growth Inhibitors|growth inhibitors|mesh-ancestor
64939067|NCT00015821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939070|NCT00275184|Autonomic Agents|autonomic agents|mesh-ancestor
64939071|NCT00275184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64939072|NCT00275184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939073|NCT00275184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64939074|NCT00275184|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64939075|NCT00275184|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64939076|NCT00275184|Dopamine Agents|dopamine agents|mesh-ancestor
64939077|NCT00275184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64939078|NCT00275184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939079|NCT00015860|Prednisone|prednisone|mesh-list
64939080|NCT00015860|Vincristine|vincristine|mesh-list
64939081|NCT00015860|Imatinib Mesylate|imatinib mesylate|mesh-list
64939082|NCT00015860|Daunorubicin|daunorubicin|mesh-list
64939083|NCT00015860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64939084|NCT00015860|Glucocorticoids|glucocorticoids|mesh-ancestor
64939138|NCT00275106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939139|NCT00275106|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64939140|NCT00275106|Abortifacient Agents|abortifacient agents|mesh-ancestor
64939143|NCT00275106|Antimetabolites|antimetabolites|mesh-ancestor
64939154|NCT00275106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64939156|NCT00275106|Antimitotic Agents|antimitotic agents|mesh-ancestor
64939157|NCT00275106|Mitosis Modulators|mitosis modulators|mesh-ancestor
64413993|NCT04916899|Antimetabolites|antimetabolites|mesh-ancestor
64413994|NCT04916899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64413995|NCT04916821|Propolis|propolis|mesh-list
64413996|NCT04916821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64939158|NCT00015938|Docetaxel|docetaxel|mesh-list
64939159|NCT00015938|Vinorelbine|vinorelbine|mesh-list
64939214|NCT01678586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64939215|NCT01678586|Histamine Antagonists|histamine antagonists|mesh-ancestor
64939216|NCT01678586|Histamine Agents|histamine agents|mesh-ancestor
64939217|NCT01678586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64939218|NCT00274950|Carboplatin|carboplatin|mesh-list
64939219|NCT00274950|Etoposide|etoposide|mesh-list
64939220|NCT00274950|Ifosfamide|ifosfamide|mesh-list
64939221|NCT00274950|Bleomycin|bleomycin|mesh-list
64939222|NCT00274950|Vinblastine|vinblastine|mesh-list
64939223|NCT00274950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939224|NCT00274950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64939225|NCT00274950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64939226|NCT00274950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64939227|NCT00274950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939228|NCT00274950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414080|NCT04915807|Ramucirumab|ramucirumab|mesh-list
64414095|NCT01360021|Autonomic Agents|autonomic agents|mesh-ancestor
64939229|NCT00274950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64939230|NCT00274950|Alkylating Agents|alkylating agents|mesh-ancestor
64939231|NCT00274950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64939232|NCT00274950|Tubulin Modulators|tubulin modulators|mesh-ancestor
64939233|NCT00274950|Antimitotic Agents|antimitotic agents|mesh-ancestor
64939234|NCT00274950|Mitosis Modulators|mitosis modulators|mesh-ancestor
64939235|NCT00016016|Cytarabine|cytarabine|mesh-list
64939236|NCT00016016|Mitoxantrone|mitoxantrone|mesh-list
64939237|NCT00016016|Alvocidib|alvocidib|mesh-list
64939238|NCT00016016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64939239|NCT00016016|Antimetabolites|antimetabolites|mesh-ancestor
64939241|NCT00016016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939254|NCT00016016|Growth Substances|growth substances|mesh-ancestor
64939255|NCT00016016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64939257|NCT00130455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64939258|NCT00130455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64939259|NCT00130455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64939260|NCT00130455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939261|NCT00130455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64939262|NCT00130455|Serotonin Agents|serotonin agents|mesh-ancestor
64939263|NCT00130455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939264|NCT00130455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64939265|NCT00130455|Antidepressive Agents|antidepressive agents|mesh-ancestor
64939518|NCT00016601|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64939519|NCT00016601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64939520|NCT00016601|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64939521|NCT00016601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64939522|NCT00016601|Contraceptive Agents|contraceptive agents|mesh-ancestor
64939523|NCT00016601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64939524|NCT00016601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939525|NCT00016601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64939526|NCT00016601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64939527|NCT00016601|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64939528|NCT00016601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64939529|NCT00016601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939531|NCT00957086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64939532|NCT00957086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939533|NCT00129519|Imiquimod|imiquimod|mesh-list
64939534|NCT00129519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64939535|NCT00129519|Immunologic Factors|immunologic factors|mesh-ancestor
64939631|NCT00017108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939668|NCT00129168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939669|NCT00129168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939670|NCT00129168|Antiviral Agents|antiviral agents|mesh-ancestor
64939671|NCT00129168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64939672|NCT00129168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64939673|NCT00129168|Immunologic Factors|immunologic factors|mesh-ancestor
64414249|NCT01653327|Anesthetics, General|anesthetics, general|mesh-ancestor
64414251|NCT01653327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64939674|NCT00129168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939675|NCT00129168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64939676|NCT00129168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64939677|NCT00129168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64939678|NCT00129168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939679|NCT00129090|Rituximab|rituximab|mesh-list
64939733|NCT00128934|Estrogens|estrogens|mesh-ancestor
64939734|NCT00128934|Hormones|hormones|mesh-ancestor
64939735|NCT00128934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64939736|NCT00128934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939737|NCT00128934|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64939738|NCT00128934|Contraceptive Agents|contraceptive agents|mesh-ancestor
64939739|NCT00128934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64939740|NCT00128934|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64939741|NCT00128934|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64939742|NCT00128934|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64939743|NCT00128934|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64939744|NCT00017264|Atrasentan|atrasentan|mesh-list
64939745|NCT00017264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414345|NCT04891861|Antithrombins|antithrombins|mesh-ancestor
64414346|NCT04891861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64414353|NCT03053167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64414354|NCT03053167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64414356|NCT03053167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414357|NCT03053167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414358|NCT03053167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64414359|NCT03053167|Antimetabolites|antimetabolites|mesh-ancestor
64414360|NCT03053167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64414361|NCT04901923|Itraconazole|itraconazole|mesh-list
64414362|NCT04901923|Acalabrutinib|acalabrutinib|mesh-list
64414363|NCT04901923|Antifungal Agents|antifungal agents|mesh-ancestor
64414371|NCT04901923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64414372|NCT04901923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414373|NCT04901923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64414374|NCT04901923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414376|NCT03050905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64414377|NCT03050905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64939746|NCT00017264|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64939747|NCT00017264|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64939748|NCT00017264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939749|NCT00128895|Azathioprine|azathioprine|mesh-list
64939750|NCT00128895|Antimetabolites|antimetabolites|mesh-ancestor
64939751|NCT00128895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939752|NCT00128895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64939753|NCT00128895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939754|NCT00128895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64939755|NCT00128895|Immunologic Factors|immunologic factors|mesh-ancestor
64939756|NCT00128895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64939797|NCT00017381|Alkylating Agents|alkylating agents|mesh-ancestor
64939798|NCT00017381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939799|NCT00017381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939820|NCT00017498|Gemcitabine|gemcitabine|mesh-list
64939821|NCT00017498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64939822|NCT00017498|Antimetabolites|antimetabolites|mesh-ancestor
64939823|NCT00017498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64939824|NCT00017498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64939825|NCT00017498|Antiviral Agents|antiviral agents|mesh-ancestor
64939826|NCT00017498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64939827|NCT00017498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64939828|NCT00017498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64939829|NCT00017498|Immunologic Factors|immunologic factors|mesh-ancestor
64336800|NCT02330757|Clomiphene|clomiphene|mesh-list
64414395|NCT03050827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64414396|NCT03050827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414397|NCT03050827|Urological Agents|urological agents|mesh-ancestor
64414398|NCT02438787|Golimumab|golimumab|mesh-list
64414399|NCT02438787|Ustekinumab|ustekinumab|mesh-list
64414400|NCT02438787|Dermatologic Agents|dermatologic agents|mesh-ancestor
64940305|NCT00020046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64940306|NCT00020046|Immunologic Factors|immunologic factors|mesh-ancestor
64940307|NCT00020046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940308|NCT00020046|Leprostatic Agents|leprostatic agents|mesh-ancestor
64940309|NCT00020046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64940310|NCT00020046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64940311|NCT00020046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64940312|NCT00020046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64940313|NCT00020046|Growth Substances|growth substances|mesh-ancestor
64940314|NCT00020046|Growth Inhibitors|growth inhibitors|mesh-ancestor
64940315|NCT00020124|Doxorubicin|doxorubicin|mesh-list
64940316|NCT00020124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64940317|NCT00020124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64940318|NCT00020124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940319|NCT00020124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64940320|NCT00020124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64940321|NCT00020124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414451|NCT04900129|Menthol|menthol|mesh-list
64940322|NCT00020124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940323|NCT00020202|Romidepsin|romidepsin|mesh-list
64940324|NCT00020202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64940325|NCT00020202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940328|NCT05576675|Hydromorphone|hydromorphone|mesh-list
64940329|NCT05576675|Nalbuphine|nalbuphine|mesh-list
64940330|NCT05576675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64940331|NCT05576675|Narcotics|narcotics|mesh-ancestor
64940347|NCT00020358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64940348|NCT00020358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64940349|NCT00020358|Immunologic Factors|immunologic factors|mesh-ancestor
64940350|NCT00020358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940351|NCT00020397|Aldesleukin|aldesleukin|mesh-list
64414525|NCT04814875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940352|NCT00020397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940353|NCT00020397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64940354|NCT00020397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64940355|NCT00020397|Antiviral Agents|antiviral agents|mesh-ancestor
64940356|NCT00020397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64940357|NCT00020475|Interleukin-2|interleukin-2|mesh-list
64940358|NCT00020475|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64940359|NCT00020475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940360|NCT00020475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64940361|NCT00020475|Analgesics|analgesics|mesh-ancestor
64940362|NCT00020475|Sensory System Agents|sensory system agents|mesh-ancestor
64414635|NCT03051841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414637|NCT03051841|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64940363|NCT00020475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64940364|NCT00020475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940365|NCT00020475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64940366|NCT00020475|Immunologic Factors|immunologic factors|mesh-ancestor
64940367|NCT05576480|Capecitabine|capecitabine|mesh-list
64940368|NCT05576480|Oxaliplatin|oxaliplatin|mesh-list
64940369|NCT05576480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64940370|NCT05576480|Antimetabolites|antimetabolites|mesh-ancestor
64940371|NCT05576480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940372|NCT05576480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940373|NCT00020631|Pirfenidone|pirfenidone|mesh-list
64940374|NCT00020631|Analgesics|analgesics|mesh-ancestor
64940375|NCT00020631|Sensory System Agents|sensory system agents|mesh-ancestor
64940376|NCT00020631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64940377|NCT00020631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940399|NCT00020709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940400|NCT00020709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64940401|NCT00020709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64940402|NCT00020709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64940403|NCT00020709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64940404|NCT00020709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64940407|NCT00020748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64940408|NCT00020748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64940409|NCT00020748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64940410|NCT00020748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940411|NCT00020748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940412|NCT00020748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64940413|NCT00020748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64940440|NCT00020943|Cyclophosphamide|cyclophosphamide|mesh-list
64940441|NCT00020943|Carmustine|carmustine|mesh-list
64940442|NCT00020943|Rituximab|rituximab|mesh-list
64940443|NCT00020943|Doxorubicin|doxorubicin|mesh-list
64414719|NCT04887649|Morphine|morphine|mesh-list
64940444|NCT00020943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64940445|NCT00020943|Methotrexate|methotrexate|mesh-list
64940446|NCT00020943|Etoposide|etoposide|mesh-list
64940447|NCT00020943|Vincristine|vincristine|mesh-list
64940505|NCT00021060|Immunologic Factors|immunologic factors|mesh-ancestor
64940506|NCT00021099|Epothilones|epothilones|mesh-list
64940507|NCT00021099|Epothilone B|epothilone b|mesh-list
64940508|NCT00021099|Tubulin Modulators|tubulin modulators|mesh-ancestor
64940509|NCT00021099|Antimitotic Agents|antimitotic agents|mesh-ancestor
64940510|NCT00021099|Mitosis Modulators|mitosis modulators|mesh-ancestor
64940511|NCT00021099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940512|NCT00021099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940513|NCT05574257|Propofol|propofol|mesh-list
64940514|NCT05574257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64940515|NCT05574257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64940516|NCT05574257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940517|NCT05574257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64940518|NCT05574257|Anesthetics, General|anesthetics, general|mesh-ancestor
64557653|NCT03067740|Bupivacaine|bupivacaine|mesh-list
64557654|NCT03067740|Anesthetics, Local|anesthetics, local|mesh-ancestor
64557655|NCT03067740|Anesthetics|anesthetics|mesh-ancestor
64557662|NCT03067740|Analgesics|analgesics|mesh-ancestor
64940519|NCT05574257|Anesthetics|anesthetics|mesh-ancestor
64940520|NCT05574218|Glycine|glycine|mesh-list
64940521|NCT05574218|Glycine Agents|glycine agents|mesh-ancestor
64940522|NCT05574218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64940523|NCT05574218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940524|NCT05574218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940525|NCT00021138|Nicotine|nicotine|mesh-list
64940526|NCT00021138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64940527|NCT00021138|Autonomic Agents|autonomic agents|mesh-ancestor
64940530|NCT00021138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64940555|NCT05574179|Anesthetics, General|anesthetics, general|mesh-ancestor
64940556|NCT05574179|Anesthetics|anesthetics|mesh-ancestor
64940557|NCT05574179|GABA Modulators|gaba modulators|mesh-ancestor
64940563|NCT00021294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64940564|NCT00021294|Glucocorticoids|glucocorticoids|mesh-ancestor
64940565|NCT00021294|Hormones|hormones|mesh-ancestor
64940566|NCT00021294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64940567|NCT00021294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940568|NCT00021294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64940569|NCT00021294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940570|NCT00021294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940571|NCT00021294|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64940572|NCT00021294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64940573|NCT00021294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64940574|NCT00021294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64940575|NCT00021294|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64940576|NCT00021333|Paclitaxel|paclitaxel|mesh-list
64940577|NCT00021333|Cisplatin|cisplatin|mesh-list
64940578|NCT00021333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64940607|NCT00021450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940609|NCT00021489|Abacavir|abacavir|mesh-list
64940610|NCT00021489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64940611|NCT00021489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940612|NCT00021489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64940613|NCT00021489|Antitubercular Agents|antitubercular agents|mesh-ancestor
64940614|NCT00021489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64940615|NCT00021489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64940616|NCT00021489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64940617|NCT00021489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940618|NCT00021489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64940619|NCT00021489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64940620|NCT00021489|Antiviral Agents|antiviral agents|mesh-ancestor
64940621|NCT00021489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64940622|NCT00021489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64940623|NCT00021528|Mirtazapine|mirtazapine|mesh-list
64940624|NCT00021528|Buspirone|buspirone|mesh-list
64940625|NCT00021528|Tranylcypromine|tranylcypromine|mesh-list
64940626|NCT00021528|Sertraline|sertraline|mesh-list
64940627|NCT00021528|Citalopram|citalopram|mesh-list
64940628|NCT00021528|Nortriptyline|nortriptyline|mesh-list
64709125|NCT02747186|Lidocaine|lidocaine|mesh-list
64940629|NCT00021528|Antidepressive Agents|antidepressive agents|mesh-ancestor
64940630|NCT00021528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64940631|NCT00021528|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64940632|NCT00021528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64940633|NCT00021528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64940653|NCT00021528|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64940654|NCT00021528|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64940655|NCT00021528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64557792|NCT01672151|Immunologic Factors|immunologic factors|mesh-ancestor
64557816|NCT05629494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64940656|NCT00021528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64940657|NCT00021567|Interferons|interferons|mesh-list
64940658|NCT00021567|Interferon-gamma|interferon-gamma|mesh-list
64940659|NCT00021567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940660|NCT00021567|Antiviral Agents|antiviral agents|mesh-ancestor
64940661|NCT00021567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64940662|NCT00021645|Vitamin E|vitamin e|mesh-list
64940663|NCT00021645|Vitamins|vitamins|mesh-ancestor
64940664|NCT00021645|Micronutrients|micronutrients|mesh-ancestor
64940665|NCT00021645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940666|NCT00021645|Antioxidants|antioxidants|mesh-ancestor
64940667|NCT00021645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940668|NCT00021645|Protective Agents|protective agents|mesh-ancestor
64940669|NCT05573204|Vitamin E|vitamin e|mesh-list
64940670|NCT05573204|Vitamins|vitamins|mesh-ancestor
64940671|NCT05573204|Micronutrients|micronutrients|mesh-ancestor
64557853|NCT01673087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64940672|NCT05573204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940673|NCT05573204|Antioxidants|antioxidants|mesh-ancestor
64940674|NCT05573204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940675|NCT05573204|Protective Agents|protective agents|mesh-ancestor
64940676|NCT00021996|Valdecoxib|valdecoxib|mesh-list
64557854|NCT01673087|Antiemetics|antiemetics|mesh-ancestor
64557855|NCT01673087|Autonomic Agents|autonomic agents|mesh-ancestor
64557856|NCT01673087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64557857|NCT01673087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557858|NCT01673087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64557859|NCT01673087|Glucocorticoids|glucocorticoids|mesh-ancestor
64557860|NCT01673087|Hormones|hormones|mesh-ancestor
64940677|NCT00021996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64940678|NCT00021996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64940709|NCT00022152|Mitosis Modulators|mitosis modulators|mesh-ancestor
64940710|NCT00022152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940711|NCT00022191|Gemcitabine|gemcitabine|mesh-list
64940712|NCT00022191|Paclitaxel|paclitaxel|mesh-list
64940713|NCT00022191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64940714|NCT00022191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940715|NCT00022191|Tubulin Modulators|tubulin modulators|mesh-ancestor
64940716|NCT00022191|Antimitotic Agents|antimitotic agents|mesh-ancestor
64940717|NCT00022191|Mitosis Modulators|mitosis modulators|mesh-ancestor
64940718|NCT00022191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940719|NCT00022191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64940720|NCT00022191|Antimetabolites|antimetabolites|mesh-ancestor
64940721|NCT00022191|Antiviral Agents|antiviral agents|mesh-ancestor
64940722|NCT00022191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64940723|NCT00022191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64940724|NCT00022191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64940725|NCT00022191|Immunologic Factors|immunologic factors|mesh-ancestor
64940726|NCT00022191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940727|NCT00022230|Aldesleukin|aldesleukin|mesh-list
64940728|NCT00022230|Paclitaxel|paclitaxel|mesh-list
64940739|NCT00022230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64940740|NCT00022230|Immunologic Factors|immunologic factors|mesh-ancestor
64940741|NCT00022230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64940742|NCT00022230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64940743|NCT00022230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64940744|NCT00022230|Alkylating Agents|alkylating agents|mesh-ancestor
64940745|NCT00022230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64940746|NCT00022230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64940747|NCT00022230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64940748|NCT00022230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64940749|NCT00022230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64940750|NCT00022230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64940751|NCT00022230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64940752|NCT00022230|Antiviral Agents|antiviral agents|mesh-ancestor
64940753|NCT00022230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64940754|NCT00022308|Irinotecan|irinotecan|mesh-list
64940755|NCT00022308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940797|NCT00022581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64940798|NCT05551871|Simvastatin|simvastatin|mesh-list
64940799|NCT05551871|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64940800|NCT05551871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64940801|NCT05551871|Antimetabolites|antimetabolites|mesh-ancestor
64940802|NCT05551871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64940803|NCT05551871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64940804|NCT05551871|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64940805|NCT05551871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64940806|NCT00022620|Paclitaxel|paclitaxel|mesh-list
64940821|NCT00022737|Vincristine|vincristine|mesh-list
64940822|NCT00022737|Etoposide phosphate|etoposide phosphate|mesh-list
64940823|NCT00022737|Imatinib Mesylate|imatinib mesylate|mesh-list
64940824|NCT00022737|Daunorubicin|daunorubicin|mesh-list
64940825|NCT00022737|Asparaginase|asparaginase|mesh-list
64940826|NCT00022737|Mercaptopurine|mercaptopurine|mesh-list
64940827|NCT00022737|Pegaspargase|pegaspargase|mesh-list
64940828|NCT00022737|Cyclosporins|cyclosporins|mesh-list
64940961|NCT00023244|Trimethoprim|trimethoprim|mesh-list
64940970|NCT00023244|Glucocorticoids|glucocorticoids|mesh-ancestor
64940971|NCT00023244|Hormones|hormones|mesh-ancestor
64941019|NCT00023400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64941020|NCT00023400|Protease Inhibitors|protease inhibitors|mesh-ancestor
64941021|NCT00023400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941022|NCT00023400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941024|NCT00023400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64941025|NCT00023400|Antiviral Agents|antiviral agents|mesh-ancestor
64941026|NCT00023400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64941027|NCT00023400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64941028|NCT00023400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64941029|NCT00023400|Antitubercular Agents|antitubercular agents|mesh-ancestor
64941030|NCT05359172|Tranexamic Acid|tranexamic acid|mesh-list
64941031|NCT05359172|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64941032|NCT05359172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64557947|NCT03017391|Serotonin Agents|serotonin agents|mesh-ancestor
64941033|NCT05359172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941034|NCT05359172|Hemostatics|hemostatics|mesh-ancestor
64941035|NCT05359172|Coagulants|coagulants|mesh-ancestor
64941036|NCT00023634|Sargramostim|sargramostim|mesh-list
64941037|NCT00023634|Immunologic Factors|immunologic factors|mesh-ancestor
64941038|NCT00023634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941039|NCT00023751|Leucovorin|leucovorin|mesh-list
64941040|NCT00023751|Fluorouracil|fluorouracil|mesh-list
64941074|NCT02971982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64941128|NCT00023868|Micronutrients|micronutrients|mesh-ancestor
64941129|NCT00023868|Alkylating Agents|alkylating agents|mesh-ancestor
64941130|NCT00023868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64941131|NCT00023907|Paclitaxel|paclitaxel|mesh-list
64941132|NCT00023907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64941133|NCT00023907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941134|NCT00023907|Tubulin Modulators|tubulin modulators|mesh-ancestor
64941135|NCT00023907|Antimitotic Agents|antimitotic agents|mesh-ancestor
64941136|NCT00023907|Mitosis Modulators|mitosis modulators|mesh-ancestor
64941137|NCT00023907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941138|NCT00023946|Epothilones|epothilones|mesh-list
64941139|NCT00023946|Epothilone B|epothilone b|mesh-list
64941140|NCT00023946|Tubulin Modulators|tubulin modulators|mesh-ancestor
64941141|NCT00023946|Antimitotic Agents|antimitotic agents|mesh-ancestor
64941142|NCT00023946|Mitosis Modulators|mitosis modulators|mesh-ancestor
64941143|NCT00023946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941144|NCT00023946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941145|NCT05268185|Vaccines|vaccines|mesh-list
64941146|NCT05268185|Immunologic Factors|immunologic factors|mesh-ancestor
64941147|NCT05268185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941148|NCT00024063|Orantinib|orantinib|mesh-list
64557990|NCT04764851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64557991|NCT04764851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64558009|NCT01005459|Tetracaine|tetracaine|mesh-list
64941149|NCT00024063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64941150|NCT00024063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941151|NCT00024063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941193|NCT00024414|Antimitotic Agents|antimitotic agents|mesh-ancestor
64941194|NCT00024414|Mitosis Modulators|mitosis modulators|mesh-ancestor
64941195|NCT00024414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941197|NCT00024453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64941198|NCT00024453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64941217|NCT00024531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64941218|NCT00024531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64941219|NCT00024531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941220|NCT05080049|Epoetin Alfa|epoetin alfa|mesh-list
64941221|NCT05080049|Hematinics|hematinics|mesh-ancestor
64941222|NCT00024687|Immunotoxins|immunotoxins|mesh-list
64941223|NCT00024687|Immunologic Factors|immunologic factors|mesh-ancestor
64941224|NCT00024687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941225|NCT05072444|QPX7728|qpx7728|mesh-list
64941226|NCT05072444|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64941227|NCT05072444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941228|NCT05072444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941229|NCT05072444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64558056|NCT00957333|Anesthetics, General|anesthetics, general|mesh-ancestor
64941230|NCT05072444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64941231|NCT00025038|Cytarabine|cytarabine|mesh-list
64941232|NCT00025038|Cyclophosphamide|cyclophosphamide|mesh-list
64941233|NCT00025038|Fludarabine|fludarabine|mesh-list
64941234|NCT00025038|Fludarabine phosphate|fludarabine phosphate|mesh-list
64941235|NCT00025038|Tipifarnib|tipifarnib|mesh-list
64941236|NCT00025038|Isotretinoin|isotretinoin|mesh-list
64941237|NCT00025038|Thymoglobulin|thymoglobulin|mesh-list
64941281|NCT00025077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941282|NCT00025077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64941283|NCT00025077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64941284|NCT00025077|Alkylating Agents|alkylating agents|mesh-ancestor
64941285|NCT00025077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941286|NCT00025077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558117|NCT04055753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558120|NCT04055753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558123|NCT03871361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64941287|NCT00025077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64941288|NCT05051891|Prednisone|prednisone|mesh-list
64941330|NCT00025272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941331|NCT00025272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64941332|NCT00025272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64941333|NCT00025272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64941334|NCT00025272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941335|NCT00025272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941336|NCT00025272|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64941337|NCT05023382|Teduglutide|teduglutide|mesh-list
64941338|NCT05023382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64941339|NCT05023382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64941340|NCT05023382|Protective Agents|protective agents|mesh-ancestor
64558193|NCT01015443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64558194|NCT01015443|Immunologic Factors|immunologic factors|mesh-ancestor
64558195|NCT01015443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941341|NCT05023382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941342|NCT00025311|Topotecan|topotecan|mesh-list
64941343|NCT00025311|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64941344|NCT00025311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64941345|NCT00025311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941346|NCT00025311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941347|NCT00025311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941348|NCT00025350|Gefitinib|gefitinib|mesh-list
64941349|NCT00025350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941353|NCT00025389|Paclitaxel|paclitaxel|mesh-list
64941383|NCT00025428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64941384|NCT00025428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64941385|NCT00025428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64941386|NCT00025428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941387|NCT00025428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64941388|NCT00025428|Tubulin Modulators|tubulin modulators|mesh-ancestor
64941389|NCT00025428|Antimitotic Agents|antimitotic agents|mesh-ancestor
64941390|NCT00025428|Mitosis Modulators|mitosis modulators|mesh-ancestor
64941391|NCT00025467|Thalidomide|thalidomide|mesh-list
64941392|NCT00025467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64941393|NCT00025467|Immunologic Factors|immunologic factors|mesh-ancestor
64941394|NCT00025467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941395|NCT00025467|Leprostatic Agents|leprostatic agents|mesh-ancestor
64941396|NCT00025467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64941397|NCT00025467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64941398|NCT00025467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64941399|NCT00025467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64941400|NCT00025467|Growth Substances|growth substances|mesh-ancestor
64941401|NCT00025467|Growth Inhibitors|growth inhibitors|mesh-ancestor
64558272|NCT04765085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64941402|NCT00025467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941403|NCT04964414|Budesonide|budesonide|mesh-list
64941404|NCT04964414|Glucocorticoids|glucocorticoids|mesh-list
64941405|NCT04964414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64941406|NCT04964414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64941407|NCT04964414|Autonomic Agents|autonomic agents|mesh-ancestor
64941436|NCT00025623|Cyclophosphamide|cyclophosphamide|mesh-list
64941437|NCT00025623|Carboplatin|carboplatin|mesh-list
64941438|NCT00025623|Doxorubicin|doxorubicin|mesh-list
64941439|NCT00025623|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64558321|NCT05491278|Remifentanil|remifentanil|mesh-list
64558322|NCT05491278|Propofol|propofol|mesh-list
64558323|NCT05491278|Fospropofol|fospropofol|mesh-list
64558324|NCT05491278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64558325|NCT05491278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64558346|NCT04879992|Rifabutin|rifabutin|mesh-list
64941440|NCT00025623|Etoposide|etoposide|mesh-list
64941441|NCT00025623|Vincristine|vincristine|mesh-list
64941442|NCT00025623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64941443|NCT00025623|Immunologic Factors|immunologic factors|mesh-ancestor
64941444|NCT00025623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941445|NCT00025623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64941446|NCT00025623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64941447|NCT00025623|Alkylating Agents|alkylating agents|mesh-ancestor
64941448|NCT00025623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941449|NCT00025623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941450|NCT00025623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64941451|NCT00025623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64941452|NCT00025623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64941453|NCT00025623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64941454|NCT00025623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941455|NCT00025623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64941456|NCT00025623|Tubulin Modulators|tubulin modulators|mesh-ancestor
64941457|NCT00025623|Antimitotic Agents|antimitotic agents|mesh-ancestor
64941478|NCT00025779|Methylphenidate|methylphenidate|mesh-list
64941479|NCT00025779|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64941480|NCT00025779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941481|NCT00025779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64941482|NCT00025779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64941483|NCT00025779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64941484|NCT00025779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941485|NCT00025779|Dopamine Agents|dopamine agents|mesh-ancestor
64558414|NCT02705963|Norethindrone Acetate|norethindrone acetate|mesh-list
64941486|NCT00025779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64941487|NCT00025779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64941488|NCT00025779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64941489|NCT00025779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64941490|NCT00025779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64941491|NCT00025779|Adrenergic Agents|adrenergic agents|mesh-ancestor
64941492|NCT04876079|Insulin|insulin|mesh-list
64941493|NCT04876079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64941494|NCT04876079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941495|NCT00026052|Riluzole|riluzole|mesh-list
64941534|NCT00026286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64941535|NCT00026286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941536|NCT00026286|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64941537|NCT00026286|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64941538|NCT00026286|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64941539|NCT00026286|Contraceptive Agents|contraceptive agents|mesh-ancestor
64941540|NCT00026286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64710025|NCT02785159|Tazarotene|tazarotene|mesh-list
64941541|NCT00026286|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64941542|NCT00026286|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64941543|NCT00026286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64941544|NCT00026286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64941545|NCT00026286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941547|NCT00026364|Fluorouracil|fluorouracil|mesh-list
64941548|NCT00026364|Irinotecan|irinotecan|mesh-list
64941549|NCT00026364|Gefitinib|gefitinib|mesh-list
64941550|NCT00026364|Calcium|calcium|mesh-list
64941551|NCT00026364|Levoleucovorin|levoleucovorin|mesh-list
64941552|NCT00026364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64941565|NCT00026364|Vitamin B Complex|vitamin b complex|mesh-ancestor
64941566|NCT00026364|Vitamins|vitamins|mesh-ancestor
64558529|NCT03807479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558530|NCT03807479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941567|NCT00026364|Micronutrients|micronutrients|mesh-ancestor
64941569|NCT00026403|Gemcitabine|gemcitabine|mesh-list
64941573|NCT00026403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558536|NCT00964353|Warfarin|warfarin|mesh-list
64941574|NCT00026403|Antiviral Agents|antiviral agents|mesh-ancestor
64941575|NCT00026403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64941576|NCT00026403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941577|NCT00026403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64941578|NCT00026403|Immunologic Factors|immunologic factors|mesh-ancestor
64941579|NCT00026403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941580|NCT00026442|Capecitabine|capecitabine|mesh-list
64941581|NCT00026442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64941582|NCT00026442|Antimetabolites|antimetabolites|mesh-ancestor
64941583|NCT00026442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941584|NCT00026442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941585|NCT04726280|Ropivacaine|ropivacaine|mesh-list
64941586|NCT04726280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64941587|NCT04726280|Anesthetics, Local|anesthetics, local|mesh-ancestor
64941588|NCT04726280|Anesthetics|anesthetics|mesh-ancestor
64941589|NCT04726280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64941590|NCT04726280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941591|NCT04726280|Sensory System Agents|sensory system agents|mesh-ancestor
64941592|NCT04726280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64941593|NCT00026520|Interferons|interferons|mesh-list
64941594|NCT00026520|Interferon-alpha|interferon-alpha|mesh-list
64941595|NCT00026520|Thalidomide|thalidomide|mesh-list
64941596|NCT00026520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941597|NCT00026520|Antiviral Agents|antiviral agents|mesh-ancestor
64941598|NCT00026520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64941622|NCT04610684|Atezolizumab|atezolizumab|mesh-list
64941623|NCT04610684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941624|NCT04610684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64941625|NCT04610684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64941626|NCT04610684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64941627|NCT04610684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558586|NCT01017237|Anesthetics|anesthetics|mesh-ancestor
64941628|NCT04610684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941629|NCT00027066|Aspirin|aspirin|mesh-list
64941630|NCT00027066|Warfarin|warfarin|mesh-list
64941631|NCT00027066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64941632|NCT00027066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64941633|NCT00027066|Analgesics|analgesics|mesh-ancestor
64941634|NCT00027066|Sensory System Agents|sensory system agents|mesh-ancestor
64941635|NCT00027066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64941636|NCT00027066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941637|NCT00027066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64941638|NCT00027066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64941639|NCT00027066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64941640|NCT00027066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64941641|NCT00027066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941642|NCT00027066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64941681|NCT04206488|Digoxin|digoxin|mesh-list
64941682|NCT04206488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64941683|NCT04206488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64941684|NCT04206488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941685|NCT04206488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941719|NCT00027573|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64941720|NCT00027573|Abortifacient Agents|abortifacient agents|mesh-ancestor
64941721|NCT00027573|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64941722|NCT00027573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64941723|NCT00027573|Antimetabolites|antimetabolites|mesh-ancestor
64941724|NCT00027573|Dermatologic Agents|dermatologic agents|mesh-ancestor
64941725|NCT00027573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64941726|NCT00027573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64941727|NCT00027573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64941728|NCT00027573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64941729|NCT00027612|Irinotecan|irinotecan|mesh-list
64941730|NCT00027612|Carmustine|carmustine|mesh-list
64941731|NCT00027612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64941783|NCT00027885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558631|NCT00970203|Hormones|hormones|mesh-ancestor
64941785|NCT00027885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64941786|NCT00027885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64941787|NCT00027885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64941788|NCT00027885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64941789|NCT00027885|Growth Substances|growth substances|mesh-ancestor
64941790|NCT00027885|Growth Inhibitors|growth inhibitors|mesh-ancestor
64941791|NCT00027885|Tubulin Modulators|tubulin modulators|mesh-ancestor
64941896|NCT00392561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941897|NCT00392561|Protective Agents|protective agents|mesh-ancestor
64941898|NCT00392561|Trace Elements|trace elements|mesh-ancestor
64941899|NCT00028275|Interferons|interferons|mesh-list
64941900|NCT00028275|Interferon-gamma|interferon-gamma|mesh-list
64941901|NCT00028275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941902|NCT00028275|Antiviral Agents|antiviral agents|mesh-ancestor
64941903|NCT00028275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64941905|NCT03959969|Oxycodone|oxycodone|mesh-list
64941906|NCT03959969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64941907|NCT03959969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64941908|NCT03959969|Analgesics|analgesics|mesh-ancestor
64941909|NCT03959969|Sensory System Agents|sensory system agents|mesh-ancestor
64941910|NCT03959969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64941911|NCT03959969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64941927|NCT00028314|Protease Inhibitors|protease inhibitors|mesh-ancestor
64941928|NCT00028314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558686|NCT02246049|Antidotes|antidotes|mesh-ancestor
64941929|NCT00028314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941930|NCT00028314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64941931|NCT00028314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64941932|NCT00028314|Antiviral Agents|antiviral agents|mesh-ancestor
64941933|NCT00028314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64941934|NCT00028314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64941935|NCT00028314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64941936|NCT00028314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64941937|NCT00028314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64941938|NCT00028314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64941939|NCT00028314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64941940|NCT00028353|Toremifene|toremifene|mesh-list
64941941|NCT00028353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64941977|NCT00028587|Bortezomib|bortezomib|mesh-list
64941978|NCT00028587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64941979|NCT00028587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64941980|NCT00028587|Tubulin Modulators|tubulin modulators|mesh-ancestor
64941981|NCT00028587|Antimitotic Agents|antimitotic agents|mesh-ancestor
64941982|NCT00028587|Mitosis Modulators|mitosis modulators|mesh-ancestor
64941983|NCT00028587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64941984|NCT04733196|Chlorhexidine|chlorhexidine|mesh-list
64941985|NCT04733196|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64941986|NCT04733196|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64941987|NCT04733196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64941988|NCT04733196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64941989|NCT04733196|Disinfectants|disinfectants|mesh-ancestor
64941990|NCT04733196|Dermatologic Agents|dermatologic agents|mesh-ancestor
64941991|NCT00028665|Cyclophosphamide|cyclophosphamide|mesh-list
64941992|NCT00028665|Carmustine|carmustine|mesh-list
64941993|NCT00028665|Rituximab|rituximab|mesh-list
64942019|NCT00028743|Paclitaxel|paclitaxel|mesh-list
64942020|NCT00028743|Carboplatin|carboplatin|mesh-list
64942021|NCT00028743|Topotecan|topotecan|mesh-list
64942022|NCT00028743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64942023|NCT00028743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942024|NCT00028743|Tubulin Modulators|tubulin modulators|mesh-ancestor
64296054|NCT03309735|Progesterone|progesterone|mesh-list
64296055|NCT03309735|Dydrogesterone|dydrogesterone|mesh-list
64296056|NCT03309735|Progestins|progestins|mesh-ancestor
64296057|NCT03309735|Hormones|hormones|mesh-ancestor
64942085|NCT00028899|Gemtuzumab|gemtuzumab|mesh-list
64942086|NCT00028899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64942087|NCT00028899|Antimetabolites|antimetabolites|mesh-ancestor
64942088|NCT00028899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942128|NCT03959150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942129|NCT03959150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942130|NCT00029328|Etanercept|etanercept|mesh-list
64942131|NCT00029328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64942132|NCT00029328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64942133|NCT00029328|Analgesics|analgesics|mesh-ancestor
64942134|NCT00029328|Sensory System Agents|sensory system agents|mesh-ancestor
64942135|NCT00029328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64942136|NCT00029328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558848|NCT01273259|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64942137|NCT00029328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64558867|NCT03739619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64558868|NCT03739619|Antimetabolites|antimetabolites|mesh-ancestor
64558869|NCT03739619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558870|NCT03739619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558871|NCT03739619|Antiviral Agents|antiviral agents|mesh-ancestor
64558872|NCT03739619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64558873|NCT03739619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942138|NCT00029328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64942139|NCT00029328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64942188|NCT00029835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942189|NCT00029835|Hormones|hormones|mesh-ancestor
64942190|NCT00029835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64942191|NCT00029835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942192|NCT00395772|Vitamin K|vitamin k|mesh-list
64942193|NCT00395772|Heparin|heparin|mesh-list
64942230|NCT00030069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942236|NCT00030069|Vitamins|vitamins|mesh-ancestor
64942273|NCT00030420|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64942274|NCT00030420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64942275|NCT00030420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942276|NCT00030459|Vinorelbine|vinorelbine|mesh-list
64942278|NCT00030459|Mitomycin|mitomycin|mesh-list
64942279|NCT00030459|Vinblastine|vinblastine|mesh-list
64558893|NCT03738917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64558894|NCT03738917|Autonomic Agents|autonomic agents|mesh-ancestor
64558895|NCT03738917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64558896|NCT03738917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64558897|NCT03738917|Cholinergic Agents|cholinergic agents|mesh-ancestor
64558898|NCT00976599|Methotrexate|methotrexate|mesh-list
64558899|NCT00976599|Tofacitinib|tofacitinib|mesh-list
64558900|NCT00976599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64558901|NCT00976599|Abortifacient Agents|abortifacient agents|mesh-ancestor
64558902|NCT00976599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64558903|NCT00976599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558905|NCT00976599|Antimetabolites|antimetabolites|mesh-ancestor
64942280|NCT00030459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942281|NCT00030459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64942282|NCT00030459|Tubulin Modulators|tubulin modulators|mesh-ancestor
64942283|NCT00030459|Antimitotic Agents|antimitotic agents|mesh-ancestor
64942284|NCT00030459|Mitosis Modulators|mitosis modulators|mesh-ancestor
64942285|NCT00030459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942286|NCT00030459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64942287|NCT00030459|Alkylating Agents|alkylating agents|mesh-ancestor
64942288|NCT00030459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64942289|NCT00030459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942290|NCT00030498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64942329|NCT00030654|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64942330|NCT00030654|Bicalutamide|bicalutamide|mesh-list
64942331|NCT00030654|Flutamide|flutamide|mesh-list
64942332|NCT00030654|Estramustine|estramustine|mesh-list
64942333|NCT00030654|Hormones|hormones|mesh-list
64942334|NCT00030654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64942335|NCT00030654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942336|NCT00030654|Tubulin Modulators|tubulin modulators|mesh-ancestor
64942337|NCT00030654|Antimitotic Agents|antimitotic agents|mesh-ancestor
64942345|NCT00030654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942347|NCT00030654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64942348|NCT00030654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64942349|NCT00030654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64942350|NCT00030654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64942351|NCT00030654|Hormone Antagonists|hormone antagonists|mesh-ancestor
64558962|NCT03727061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64558968|NCT00977769|Oxytocin|oxytocin|mesh-list
64942352|NCT00030654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64942353|NCT00030654|Androgen Antagonists|androgen antagonists|mesh-ancestor
64942354|NCT00030654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64942355|NCT00030654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64942356|NCT00030654|Alkylating Agents|alkylating agents|mesh-ancestor
64942357|NCT03852407|Cyclophosphamide|cyclophosphamide|mesh-list
64942358|NCT03852407|Melphalan|melphalan|mesh-list
64942373|NCT00030693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942374|NCT00030693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64942375|NCT00030693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64942376|NCT00030693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64942377|NCT00030693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64942378|NCT03823274|Aspirin|aspirin|mesh-list
64942379|NCT03823274|Clopidogrel|clopidogrel|mesh-list
64942380|NCT03823274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64942381|NCT03823274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64942382|NCT03823274|Analgesics|analgesics|mesh-ancestor
64942383|NCT03823274|Sensory System Agents|sensory system agents|mesh-ancestor
64942384|NCT03823274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64942385|NCT03823274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942386|NCT03823274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64942387|NCT03823274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64942388|NCT03823274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64942389|NCT03823274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64942390|NCT03823274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942391|NCT03823274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64559021|NCT05386953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64559022|NCT05176548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64559023|NCT05176548|Myeloma Proteins|myeloma proteins|mesh-list
64559024|NCT05176548|Paraproteins|paraproteins|mesh-list
64559025|NCT05176548|Immunologic Factors|immunologic factors|mesh-ancestor
64559026|NCT05176548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559027|NCT03719105|Dexamethasone|dexamethasone|mesh-list
64559028|NCT03719105|Prednisone|prednisone|mesh-list
64559029|NCT03719105|Cyclophosphamide|cyclophosphamide|mesh-list
64559030|NCT03719105|Ifosfamide|ifosfamide|mesh-list
64559031|NCT03719105|Doxorubicin|doxorubicin|mesh-list
64559032|NCT03719105|Methotrexate|methotrexate|mesh-list
64559033|NCT03719105|Etoposide|etoposide|mesh-list
64559034|NCT03719105|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64559035|NCT03719105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64559036|NCT03719105|Immunologic Factors|immunologic factors|mesh-ancestor
64559037|NCT03719105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559038|NCT03719105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64559039|NCT03719105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64942392|NCT03823274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64942393|NCT03823274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942394|NCT03823274|Antipyretics|antipyretics|mesh-ancestor
64942395|NCT03823274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64942396|NCT03823274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64942397|NCT03823274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64942398|NCT03823274|Purinergic Agents|purinergic agents|mesh-ancestor
64942399|NCT03823274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64942400|NCT00030732|Gemcitabine|gemcitabine|mesh-list
64942401|NCT00030732|Capecitabine|capecitabine|mesh-list
64942402|NCT00030732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64942403|NCT00030732|Antimetabolites|antimetabolites|mesh-ancestor
64942404|NCT00030732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942405|NCT00030732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942406|NCT00030732|Antiviral Agents|antiviral agents|mesh-ancestor
64942407|NCT00030732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64942411|NCT00030732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942412|NCT00030810|Docetaxel|docetaxel|mesh-list
64942413|NCT00030810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942414|NCT00030810|Tubulin Modulators|tubulin modulators|mesh-ancestor
64559053|NCT03719105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64942415|NCT00030810|Antimitotic Agents|antimitotic agents|mesh-ancestor
64942416|NCT00030810|Mitosis Modulators|mitosis modulators|mesh-ancestor
64942417|NCT00030810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942418|NCT00030849|Interferons|interferons|mesh-list
64942419|NCT00030849|Interferon-alpha|interferon-alpha|mesh-list
64942463|NCT03715205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64942464|NCT03715205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942465|NCT00031044|Enfuvirtide|enfuvirtide|mesh-list
64942466|NCT00031044|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64942467|NCT00031044|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64942468|NCT00031044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942469|NCT00031044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64942470|NCT00031044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64942471|NCT00031044|Antiviral Agents|antiviral agents|mesh-ancestor
64942472|NCT00031044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64942473|NCT03698006|Ropivacaine|ropivacaine|mesh-list
64942474|NCT03698006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64942475|NCT03698006|Anesthetics, Local|anesthetics, local|mesh-ancestor
64942476|NCT03698006|Anesthetics|anesthetics|mesh-ancestor
64942477|NCT03698006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64942478|NCT03698006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942479|NCT03698006|Sensory System Agents|sensory system agents|mesh-ancestor
64942480|NCT03698006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64942481|NCT00031083|Interferons|interferons|mesh-list
64942482|NCT00031083|Interferon-beta|interferon-beta|mesh-list
64942483|NCT00031083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942484|NCT00031083|Antiviral Agents|antiviral agents|mesh-ancestor
64942485|NCT00031083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64942486|NCT00031083|Immunologic Factors|immunologic factors|mesh-ancestor
64942487|NCT00031083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942488|NCT03559985|Acetaminophen|acetaminophen|mesh-list
64942489|NCT03559985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64942509|NCT04711863|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64942510|NCT04711863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64942511|NCT04711863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942512|NCT04711863|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64942513|NCT00392912|Methyltestosterone|methyltestosterone|mesh-list
64942514|NCT00392912|Testosterone|testosterone|mesh-list
64942515|NCT00392912|Testosterone undecanoate|testosterone undecanoate|mesh-list
64942516|NCT00392912|Testosterone enanthate|testosterone enanthate|mesh-list
64942517|NCT00392912|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64942518|NCT00392912|Androgens|androgens|mesh-ancestor
64942519|NCT00392912|Hormones|hormones|mesh-ancestor
64942520|NCT00392912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64559115|NCT03707951|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64942521|NCT00392912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942522|NCT00392912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64942523|NCT00392912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942524|NCT00392912|Anabolic Agents|anabolic agents|mesh-ancestor
64711003|NCT05784753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942525|NCT04712058|Tenofovir|tenofovir|mesh-list
64942526|NCT04712058|Emtricitabine|emtricitabine|mesh-list
64942537|NCT00393107|Rituximab|rituximab|mesh-list
64942563|NCT04711668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64942564|NCT04711668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64942565|NCT04711668|Anesthetics, General|anesthetics, general|mesh-ancestor
64942566|NCT04711668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64942691|NCT00031707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64942693|NCT00031746|Chelating Agents|chelating agents|mesh-ancestor
64942694|NCT00031746|Sequestering Agents|sequestering agents|mesh-ancestor
64942695|NCT00031746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559147|NCT03692663|Cyclophosphamide|cyclophosphamide|mesh-list
64559148|NCT03692663|Fludarabine|fludarabine|mesh-list
64559149|NCT03692663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64559179|NCT03685331|Fulvestrant|fulvestrant|mesh-list
64942696|NCT00031785|Megestrol|megestrol|mesh-list
64942697|NCT00031785|Megestrol Acetate|megestrol acetate|mesh-list
64942698|NCT00031785|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64942699|NCT00031785|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64942700|NCT00031785|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64942741|NCT00031824|Dermatologic Agents|dermatologic agents|mesh-ancestor
64942742|NCT00031824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64942804|NCT03151499|Rifampin|rifampin|mesh-list
64942805|NCT03151499|BI 409306|bi 409306|mesh-list
64942807|NCT03151499|Antitubercular Agents|antitubercular agents|mesh-ancestor
64942862|NCT00032097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64942863|NCT00032097|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64942864|NCT00032097|Dermatologic Agents|dermatologic agents|mesh-ancestor
64942865|NCT03151382|Tandospirone|tandospirone|mesh-list
64942866|NCT03151382|Donepezil|donepezil|mesh-list
64942867|NCT03151382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942868|NCT03151382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64942869|NCT03151382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942870|NCT03151382|Cholinergic Agents|cholinergic agents|mesh-ancestor
64942871|NCT03151382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64942872|NCT03151382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64942873|NCT03151382|Nootropic Agents|nootropic agents|mesh-ancestor
64942874|NCT03151382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64942875|NCT03151382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64942876|NCT03151382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64942877|NCT03151382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64942878|NCT03151382|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64942879|NCT03151382|Serotonin Agents|serotonin agents|mesh-ancestor
64942880|NCT00032136|Tamoxifen|tamoxifen|mesh-list
64942881|NCT00032136|Exemestane|exemestane|mesh-list
64942882|NCT00032136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64942883|NCT00032136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64942915|NCT04712279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64942916|NCT04712279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64942917|NCT04712279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64942918|NCT04712279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64942919|NCT04712279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943135|NCT00033696|Topotecan|topotecan|mesh-list
64943136|NCT00033696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64943152|NCT00033735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64943153|NCT00033735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943154|NCT00033735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64943155|NCT00033735|Immunologic Factors|immunologic factors|mesh-ancestor
64943156|NCT00033735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943157|NCT00033735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64559241|NCT03675737|Pembrolizumab|pembrolizumab|mesh-list
64559242|NCT03675737|Fluorouracil|fluorouracil|mesh-list
64559243|NCT03675737|Capecitabine|capecitabine|mesh-list
64559244|NCT03675737|Oxaliplatin|oxaliplatin|mesh-list
64559245|NCT03675737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559246|NCT03675737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64559247|NCT03675737|Antimetabolites|antimetabolites|mesh-ancestor
64559249|NCT03675737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64943158|NCT00033735|Alkylating Agents|alkylating agents|mesh-ancestor
64943160|NCT00033813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64943161|NCT00033813|Histamine Antagonists|histamine antagonists|mesh-ancestor
64943218|NCT00034086|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64943219|NCT00034086|Immunologic Factors|immunologic factors|mesh-ancestor
64943220|NCT00034086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943221|NCT00034086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64943222|NCT00034086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64943223|NCT00034086|Protease Inhibitors|protease inhibitors|mesh-ancestor
64943224|NCT00034086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943225|NCT00034086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943227|NCT00034086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64943228|NCT00034086|Antiviral Agents|antiviral agents|mesh-ancestor
64943229|NCT00034086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64943279|NCT01807286|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64943280|NCT01807286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64943281|NCT01807286|Immunologic Factors|immunologic factors|mesh-ancestor
64943282|NCT01807286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64943283|NCT01807286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64943284|NCT01807286|Growth Substances|growth substances|mesh-ancestor
64943285|NCT01807286|Growth Inhibitors|growth inhibitors|mesh-ancestor
64943286|NCT00034359|Lamivudine|lamivudine|mesh-list
64943287|NCT00034359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64943288|NCT00034359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64943289|NCT00034359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64943290|NCT00034359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943291|NCT00034359|Antiviral Agents|antiviral agents|mesh-ancestor
64943292|NCT00034359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64943337|NCT01806857|Respiratory System Agents|respiratory system agents|mesh-ancestor
64943338|NCT01806857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64943465|NCT00393497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64943466|NCT00393497|Growth Substances|growth substances|mesh-ancestor
64943467|NCT00393497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943468|NCT00393497|Growth Inhibitors|growth inhibitors|mesh-ancestor
64943470|NCT00035100|Epothilone B|epothilone b|mesh-list
64943471|NCT00035100|Tubulin Modulators|tubulin modulators|mesh-ancestor
64943472|NCT00035100|Antimitotic Agents|antimitotic agents|mesh-ancestor
64943473|NCT00035100|Mitosis Modulators|mitosis modulators|mesh-ancestor
64943474|NCT00035100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943475|NCT00035100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64943527|NCT00035451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943528|NCT00035451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943529|NCT00035451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64943530|NCT00035451|Sympatholytics|sympatholytics|mesh-ancestor
64943531|NCT00035451|Autonomic Agents|autonomic agents|mesh-ancestor
64943532|NCT00035451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64943533|NCT00035451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64943534|NCT00035451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64943535|NCT00035451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64943536|NCT01805999|Psyllium|psyllium|mesh-list
64943537|NCT01805999|Calcium polycarbophil|calcium polycarbophil|mesh-list
64943538|NCT01805999|Cathartics|cathartics|mesh-ancestor
64943539|NCT01805999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64943540|NCT01805999|Antidiarrheals|antidiarrheals|mesh-ancestor
64943590|NCT01805726|Sensory System Agents|sensory system agents|mesh-ancestor
64943591|NCT01805726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64943592|NCT01805726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64943593|NCT01805726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64943594|NCT01805726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64943595|NCT01805726|Adrenergic Agents|adrenergic agents|mesh-ancestor
64943596|NCT01805726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64943597|NCT01805726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943598|NCT01805726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64943599|NCT01805726|Narcotics|narcotics|mesh-ancestor
64943600|NCT01805726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64943651|NCT01805570|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64943652|NCT01805570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64943653|NCT01805570|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64943654|NCT01805570|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64943806|NCT01465919|Mirtazapine|mirtazapine|mesh-list
64943807|NCT01465919|Antidepressive Agents|antidepressive agents|mesh-ancestor
64943808|NCT01465919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64943809|NCT01465919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64943810|NCT01465919|Histamine Antagonists|histamine antagonists|mesh-ancestor
64943811|NCT01465919|Histamine Agents|histamine agents|mesh-ancestor
64943812|NCT01465919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64943813|NCT01465919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64943814|NCT01465919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64943815|NCT01465919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64943816|NCT01465919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64943871|NCT00037050|Vancomycin|vancomycin|mesh-list
64943872|NCT00037050|Linezolid|linezolid|mesh-list
64943873|NCT00037050|Oxacillin|oxacillin|mesh-list
64943874|NCT00037050|Dicloxacillin|dicloxacillin|mesh-list
64944070|NCT00038259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64944071|NCT00038259|Antiviral Agents|antiviral agents|mesh-ancestor
64944072|NCT00038259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64944074|NCT00847418|Antidepressive Agents|antidepressive agents|mesh-ancestor
64944075|NCT00847418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64944076|NCT05433597|Cisplatin|cisplatin|mesh-list
64944077|NCT05433597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944078|NCT05433480|Fulvestrant|fulvestrant|mesh-list
64944111|NCT00396669|Dopamine Agents|dopamine agents|mesh-ancestor
64944112|NCT00396669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64944113|NCT00396669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559504|NCT03609593|Immunologic Factors|immunologic factors|mesh-ancestor
64944114|NCT00396669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64559505|NCT03609593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559506|NCT03609593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64944115|NCT00396669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64944116|NCT00396669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944117|NCT00846989|Latanoprost|latanoprost|mesh-list
64944134|NCT00396747|Antimetabolites|antimetabolites|mesh-ancestor
64944166|NCT00846950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64944167|NCT00846950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64944168|NCT00846950|GABA Modulators|gaba modulators|mesh-ancestor
64944170|NCT00846950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64944171|NCT00846950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944172|NCT00846950|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64944173|NCT00846950|Histamine Antagonists|histamine antagonists|mesh-ancestor
64944174|NCT00846950|Histamine Agents|histamine agents|mesh-ancestor
64944227|NCT00846716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64944228|NCT00846716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944229|NCT05432427|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64944230|NCT05432427|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64944231|NCT05432427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944232|NCT00846677|Vitamin D|vitamin d|mesh-list
64944233|NCT00846677|Ergocalciferols|ergocalciferols|mesh-list
64944234|NCT00846677|Cholecalciferol|cholecalciferol|mesh-list
64944236|NCT00846677|Micronutrients|micronutrients|mesh-ancestor
64944237|NCT00846677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944238|NCT00846677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64944239|NCT00846677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64944240|NCT00846482|Oxaliplatin|oxaliplatin|mesh-list
64944241|NCT00846482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944242|NCT05428683|Moxifloxacin|moxifloxacin|mesh-list
64944243|NCT05428683|Triamcinolone|triamcinolone|mesh-list
64944244|NCT05428683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64944245|NCT05428683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64944253|NCT05428683|Glucocorticoids|glucocorticoids|mesh-ancestor
64944285|NCT00846326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64944286|NCT00846326|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64944287|NCT00846326|Mydriatics|mydriatics|mesh-ancestor
64944288|NCT00846326|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64944289|NCT00846326|Protective Agents|protective agents|mesh-ancestor
64944290|NCT05330013|Dapagliflozin|dapagliflozin|mesh-list
64944291|NCT05330013|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64944292|NCT05330013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944293|NCT05330013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64944294|NCT05330013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944351|NCT00276965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64944352|NCT00276965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64944353|NCT00276965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64944354|NCT00276965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944355|NCT00276965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64944356|NCT00276965|Serotonin Agents|serotonin agents|mesh-ancestor
64944357|NCT00276965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944358|NCT00276965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944416|NCT00276809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64944417|NCT00276809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64944418|NCT00276809|Glucocorticoids|glucocorticoids|mesh-ancestor
64944420|NCT00276809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64559692|NCT00929253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64944421|NCT00276809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64944422|NCT00276809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64944423|NCT00276809|Antimetabolites|antimetabolites|mesh-ancestor
64944424|NCT00276809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64944425|NCT00276809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64944426|NCT00276809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64944427|NCT00276809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944428|NCT00276809|Antiviral Agents|antiviral agents|mesh-ancestor
64944429|NCT00276809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64944430|NCT00276809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64944431|NCT00276770|Fluorides|fluorides|mesh-list
64944432|NCT00276770|Cariostatic Agents|cariostatic agents|mesh-ancestor
64944433|NCT00276770|Protective Agents|protective agents|mesh-ancestor
64944434|NCT00276770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944435|NCT00276731|Cyclophosphamide|cyclophosphamide|mesh-list
64944436|NCT00276731|Carboplatin|carboplatin|mesh-list
64944437|NCT00276731|Etoposide|etoposide|mesh-list
64944438|NCT00276731|Vincristine|vincristine|mesh-list
64944439|NCT00276731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64944440|NCT00276731|Immunologic Factors|immunologic factors|mesh-ancestor
64944441|NCT00276731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944442|NCT00276731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64559761|NCT00997113|Propofol|propofol|mesh-list
64944443|NCT00276731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64944444|NCT00276731|Alkylating Agents|alkylating agents|mesh-ancestor
64944446|NCT00276731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944453|NCT00276731|Antimitotic Agents|antimitotic agents|mesh-ancestor
64944454|NCT00276731|Mitosis Modulators|mitosis modulators|mesh-ancestor
64944455|NCT00276692|Irinotecan|irinotecan|mesh-list
64944456|NCT00276692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64944457|NCT00276692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64944458|NCT00276692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944459|NCT00276692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944460|NCT00276692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944461|NCT00276575|Bevacizumab|bevacizumab|mesh-list
64944462|NCT00276575|Everolimus|everolimus|mesh-list
64944464|NCT00276575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64944465|NCT00276575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944516|NCT00276107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64944517|NCT00276107|Immunologic Factors|immunologic factors|mesh-ancestor
64944518|NCT00276107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944519|NCT04201665|Oxytocin|oxytocin|mesh-list
64944520|NCT04201665|Carbetocin|carbetocin|mesh-list
64944521|NCT04201665|Oxytocics|oxytocics|mesh-ancestor
64944522|NCT04201665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64944523|NCT04201665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944524|NCT00276068|Lidocaine|lidocaine|mesh-list
64944525|NCT00276068|Desipramine|desipramine|mesh-list
64944526|NCT00276068|Anesthetics, Local|anesthetics, local|mesh-ancestor
64944527|NCT00276068|Anesthetics|anesthetics|mesh-ancestor
64559827|NCT01021761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559828|NCT04973904|Paclitaxel|paclitaxel|mesh-list
64944528|NCT00276068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64944529|NCT00276068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944577|NCT04149210|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64944578|NCT00275951|Cetuximab|cetuximab|mesh-list
64944579|NCT00275951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64944710|NCT00275210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944711|NCT00041535|Miglustat|miglustat|mesh-list
64944712|NCT00041535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64944714|NCT00041535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64944766|NCT03430596|Cholinergic Agents|cholinergic agents|mesh-ancestor
64944767|NCT00275054|Cyclophosphamide|cyclophosphamide|mesh-list
64944768|NCT00275054|Rituximab|rituximab|mesh-list
64944769|NCT00275054|Fludarabine|fludarabine|mesh-list
64944770|NCT00275054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64944771|NCT00275054|Immunologic Factors|immunologic factors|mesh-ancestor
64944772|NCT00275054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944773|NCT00275054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64944774|NCT00275054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64559902|NCT01023711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559903|NCT01001403|Nafamostat|nafamostat|mesh-list
64559904|NCT01001403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64559905|NCT01001403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64559906|NCT01001403|Analgesics|analgesics|mesh-ancestor
64944775|NCT00275054|Alkylating Agents|alkylating agents|mesh-ancestor
64944777|NCT00275054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944832|NCT00274976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64944833|NCT00274976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944834|NCT00130403|Risedronic Acid|risedronic acid|mesh-list
64944835|NCT00130403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64944836|NCT00130403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64944837|NCT00130403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944962|NCT00129233|Amlodipine|amlodipine|mesh-list
64944963|NCT00129233|Valsartan|valsartan|mesh-list
64944964|NCT00129233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64944965|NCT00129233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64944966|NCT00129233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64944967|NCT00129233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944968|NCT00129233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64944969|NCT00129233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64944970|NCT00129233|Vasodilator Agents|vasodilator agents|mesh-ancestor
64944971|NCT00129233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64944972|NCT00129233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64944973|NCT00129155|Treosulfan|treosulfan|mesh-list
64944974|NCT00129155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64944975|NCT00129155|Alkylating Agents|alkylating agents|mesh-ancestor
64944976|NCT00129155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64944977|NCT00129155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64944978|NCT00712881|Cyclophosphamide|cyclophosphamide|mesh-list
64944979|NCT00712881|Docetaxel|docetaxel|mesh-list
64944980|NCT00712881|Doxorubicin|doxorubicin|mesh-list
64944981|NCT00712881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64945005|NCT00042003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945007|NCT00129038|Dipyridamole|dipyridamole|mesh-list
64945008|NCT00129038|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
64945009|NCT00129038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64945010|NCT00129038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64945011|NCT00129038|Analgesics|analgesics|mesh-ancestor
64945012|NCT00129038|Sensory System Agents|sensory system agents|mesh-ancestor
64945013|NCT00129038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64945014|NCT00129038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945015|NCT00129038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64945016|NCT00129038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64945130|NCT00038532|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64945131|NCT00038532|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64945132|NCT00038532|Protease Inhibitors|protease inhibitors|mesh-ancestor
64945133|NCT00038532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945134|NCT00038532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945136|NCT00038532|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64945137|NCT00038532|Antiviral Agents|antiviral agents|mesh-ancestor
64945138|NCT00038532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64945139|NCT00038532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64945140|NCT00038532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64945141|NCT00038532|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64945142|NCT00038532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64945143|NCT00038532|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64945144|NCT00038532|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64945145|NCT00038532|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64945146|NCT00038532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64945147|NCT00038532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64945148|NCT00038532|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64945149|NCT00038532|Antitubercular Agents|antitubercular agents|mesh-ancestor
64945150|NCT00038532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64945151|NCT00038571|Bortezomib|bortezomib|mesh-list
64945176|NCT05770323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945177|NCT05770102|Atezolizumab|atezolizumab|mesh-list
64945178|NCT05770102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945179|NCT05769881|Anesthetics|anesthetics|mesh-list
64945180|NCT05769881|Anesthetics, Local|anesthetics, local|mesh-list
64945181|NCT05769881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64945182|NCT05769881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945183|NCT05769881|Sensory System Agents|sensory system agents|mesh-ancestor
64945184|NCT05769881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64945185|NCT05769855|Ropivacaine|ropivacaine|mesh-list
64945186|NCT05769855|Anesthetics, Local|anesthetics, local|mesh-ancestor
64945187|NCT05769855|Anesthetics|anesthetics|mesh-ancestor
64945188|NCT05769855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64945296|NCT05762146|Antimetabolites|antimetabolites|mesh-ancestor
64945355|NCT05706727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560010|NCT01004991|Hormones|hormones|mesh-ancestor
64560019|NCT03115047|Meperidine|meperidine|mesh-list
64945356|NCT05706727|Protective Agents|protective agents|mesh-ancestor
64945357|NCT05697783|Fentanyl|fentanyl|mesh-list
64945358|NCT05697783|Methadone|methadone|mesh-list
64945359|NCT05697783|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64557561|NCT04405193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557562|NCT04405193|Protective Agents|protective agents|mesh-ancestor
64557563|NCT04405193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557624|NCT03067896|Bupivacaine|bupivacaine|mesh-list
64557625|NCT03067896|Anesthetics, Local|anesthetics, local|mesh-ancestor
64557626|NCT03067896|Anesthetics|anesthetics|mesh-ancestor
64557627|NCT03067896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64560045|NCT01030653|Antifungal Agents|antifungal agents|mesh-ancestor
64560059|NCT01031043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560061|NCT01031043|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64557628|NCT03067896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453654|NCT01438060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64453708|NCT01959139|Leucovorin|leucovorin|mesh-list
64453709|NCT01959139|Fluorouracil|fluorouracil|mesh-list
64453710|NCT01959139|Oxaliplatin|oxaliplatin|mesh-list
64453711|NCT01959139|Irinotecan|irinotecan|mesh-list
64453712|NCT01959139|Levoleucovorin|levoleucovorin|mesh-list
64453713|NCT01959139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453714|NCT01959139|Antimetabolites|antimetabolites|mesh-ancestor
64453715|NCT01959139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453716|NCT01959139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64453717|NCT01959139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453718|NCT01959139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64453719|NCT01959139|Immunologic Factors|immunologic factors|mesh-ancestor
64453720|NCT01959139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64560128|NCT01053507|Sensory System Agents|sensory system agents|mesh-ancestor
64453792|NCT04666129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453793|NCT04666129|Tubulin Modulators|tubulin modulators|mesh-ancestor
64453794|NCT04666129|Antimitotic Agents|antimitotic agents|mesh-ancestor
64453795|NCT04666129|Mitosis Modulators|mitosis modulators|mesh-ancestor
64453796|NCT04666129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453797|NCT04666129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64453798|NCT04666129|Glucocorticoids|glucocorticoids|mesh-ancestor
64453799|NCT04666129|Hormones|hormones|mesh-ancestor
64453803|NCT04666129|Antiemetics|antiemetics|mesh-ancestor
64453818|NCT01965704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453819|NCT01965704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64453820|NCT01965704|Antipruritics|antipruritics|mesh-ancestor
64453821|NCT01965704|Dermatologic Agents|dermatologic agents|mesh-ancestor
64453889|NCT04659278|Peppermint oil|peppermint oil|mesh-list
64453890|NCT04659278|Antiemetics|antiemetics|mesh-ancestor
64453891|NCT04659278|Autonomic Agents|autonomic agents|mesh-ancestor
64453892|NCT04659278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64453893|NCT04659278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453894|NCT04659278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64453895|NCT04659278|Parasympatholytics|parasympatholytics|mesh-ancestor
64453896|NCT04659044|Rituximab|rituximab|mesh-list
64453897|NCT04659044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64453898|NCT04659044|Venetoclax|venetoclax|mesh-list
64453899|NCT04659044|Antibodies|antibodies|mesh-list
64453900|NCT04659044|Immunoglobulins|immunoglobulins|mesh-list
64453901|NCT04659044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64453902|NCT04659044|Immunoconjugates|immunoconjugates|mesh-list
64453953|NCT01998919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453954|NCT01998919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64453956|NCT01998919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453957|NCT01998919|Antiviral Agents|antiviral agents|mesh-ancestor
64453960|NCT01998919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64453961|NCT01998919|Immunologic Factors|immunologic factors|mesh-ancestor
64453962|NCT01998919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453963|NCT01998919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64454016|NCT01970540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64454017|NCT01970540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64454018|NCT01970540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64454019|NCT01970540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64454020|NCT01970540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454021|NCT01970540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454022|NCT01996826|Bevacizumab|bevacizumab|mesh-list
64454023|NCT01996826|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64454025|NCT01996826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64454080|NCT01968980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64454081|NCT01968434|Carbocysteine|carbocysteine|mesh-list
64454082|NCT01968434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64454083|NCT01968434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64454084|NCT01968434|Expectorants|expectorants|mesh-ancestor
64454085|NCT01968434|Respiratory System Agents|respiratory system agents|mesh-ancestor
64454086|NCT01946438|Vaccines|vaccines|mesh-list
64454087|NCT01946438|Immunologic Factors|immunologic factors|mesh-ancestor
64454089|NCT01618214|Insulin Aspart|insulin aspart|mesh-list
64454147|NCT04624178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64454148|NCT04624178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454149|NCT04624178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64454151|NCT01943552|Bromides|bromides|mesh-list
64454152|NCT01943552|Ipratropium|ipratropium|mesh-list
64454153|NCT01943552|Anticonvulsants|anticonvulsants|mesh-ancestor
64454154|NCT01943552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64454155|NCT01943552|Autonomic Agents|autonomic agents|mesh-ancestor
64454156|NCT01943552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64454157|NCT01943552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454158|NCT01943552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64454159|NCT01943552|Respiratory System Agents|respiratory system agents|mesh-ancestor
64454160|NCT01943552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64454161|NCT01943552|Cholinergic Agents|cholinergic agents|mesh-ancestor
64454162|NCT01943552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64454163|NCT01943552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454164|NCT01915940|Timolol|timolol|mesh-list
64454165|NCT01915940|Bimatoprost|bimatoprost|mesh-list
64454166|NCT01915940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64454167|NCT01915940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64454168|NCT01915940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64454169|NCT01915940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64454170|NCT01915940|Adrenergic Agents|adrenergic agents|mesh-ancestor
64454171|NCT01915940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64454172|NCT01915940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454173|NCT01915940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454174|NCT01915940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64454175|NCT01915940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64454176|NCT01914926|Metoprolol|metoprolol|mesh-list
64454177|NCT01914926|Diltiazem|diltiazem|mesh-list
64454178|NCT01914926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64454179|NCT01914926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64454180|NCT01914926|Sympatholytics|sympatholytics|mesh-ancestor
64454186|NCT01914926|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64454188|NCT01914926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64454189|NCT01914926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454190|NCT01914926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64454191|NCT01914926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64454192|NCT01914926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64454193|NCT01914926|Vasodilator Agents|vasodilator agents|mesh-ancestor
64454194|NCT05119166|Niacinamide|niacinamide|mesh-list
64454195|NCT05119166|Niacin|niacin|mesh-list
64454196|NCT05119166|Nicotinic Acids|nicotinic acids|mesh-list
64454197|NCT05119166|Azithromycin|azithromycin|mesh-list
64454198|NCT05119166|Vitamins|vitamins|mesh-ancestor
64454199|NCT05119166|Micronutrients|micronutrients|mesh-ancestor
64454200|NCT05119166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454245|NCT02029235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454247|NCT02029235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64454248|NCT02029235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64454256|NCT02029235|Antitussive Agents|antitussive agents|mesh-ancestor
64454305|NCT01938716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64454307|NCT01938716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454308|NCT01938716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64454309|NCT01938716|Antiviral Agents|antiviral agents|mesh-ancestor
64454310|NCT01938716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64454311|NCT01938716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454312|NCT01938716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64454313|NCT01938716|Immunologic Factors|immunologic factors|mesh-ancestor
64454314|NCT01938716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454315|NCT01937390|Bromides|bromides|mesh-list
64454316|NCT01937390|Tiotropium Bromide|tiotropium bromide|mesh-list
64454317|NCT01937390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64454318|NCT01937390|Autonomic Agents|autonomic agents|mesh-ancestor
64560248|NCT04152564|Bupivacaine|bupivacaine|mesh-list
64454319|NCT01937390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64454320|NCT01937390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454321|NCT01937390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64454322|NCT01937390|Respiratory System Agents|respiratory system agents|mesh-ancestor
64454323|NCT01937390|Parasympatholytics|parasympatholytics|mesh-ancestor
64454324|NCT01937390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64454325|NCT01937390|Cholinergic Agents|cholinergic agents|mesh-ancestor
64454326|NCT01937390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64454327|NCT01937390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454328|NCT01937390|Anticonvulsants|anticonvulsants|mesh-ancestor
64454329|NCT02015663|Tobramycin|tobramycin|mesh-list
64454332|NCT02028767|Metformin|metformin|mesh-list
64454354|NCT04683965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454355|NCT04683965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64454356|NCT04683965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64454358|NCT02015195|Acetic Acid|acetic acid|mesh-list
64454359|NCT02015195|Retinol acetate|retinol acetate|mesh-list
64454360|NCT02015195|Lidocaine|lidocaine|mesh-list
64454361|NCT02015195|Anesthetics, Local|anesthetics, local|mesh-ancestor
64454362|NCT02015195|Anesthetics|anesthetics|mesh-ancestor
64454421|NCT02024867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64454422|NCT02024867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64454423|NCT02023697|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64454424|NCT02023697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64454426|NCT01951417|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64454427|NCT01951417|Dermatologic Agents|dermatologic agents|mesh-ancestor
64454428|NCT01951417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64454429|NCT01951417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64454430|NCT01951417|Analgesics|analgesics|mesh-ancestor
64454431|NCT01951417|Sensory System Agents|sensory system agents|mesh-ancestor
64454432|NCT01951417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64454433|NCT01951417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454434|NCT01951417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64454435|NCT01951417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64454436|NCT02023151|Omalizumab|omalizumab|mesh-list
64454437|NCT02023151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64454438|NCT02023151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64454439|NCT02023151|Respiratory System Agents|respiratory system agents|mesh-ancestor
64454440|NCT04667585|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64454441|NCT04667585|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64454442|NCT04667585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454443|NCT01979185|Simvastatin|simvastatin|mesh-list
64454444|NCT01979185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64454445|NCT01979185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64454446|NCT01979185|Antimetabolites|antimetabolites|mesh-ancestor
64454471|NCT01959698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64454586|NCT01951105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454587|NCT01951105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454588|NCT01951105|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64454589|NCT01951105|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64454590|NCT01951105|Dopamine Agents|dopamine agents|mesh-ancestor
64454591|NCT01951105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64560367|NCT01076283|Histamine Antagonists|histamine antagonists|mesh-ancestor
64454592|NCT01951105|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64454593|NCT01951105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64454594|NCT01951105|Immunologic Factors|immunologic factors|mesh-ancestor
64454595|NCT01951105|Dopamine Agonists|dopamine agonists|mesh-ancestor
64454596|NCT01958918|Ranibizumab|ranibizumab|mesh-list
64454597|NCT01958918|Aflibercept|aflibercept|mesh-list
64454639|NCT01909466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454641|NCT01909466|Dopamine Agents|dopamine agents|mesh-ancestor
64454642|NCT01909466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64454643|NCT01909466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454644|NCT01909466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64454645|NCT01909466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64454646|NCT01909466|Serotonin Agents|serotonin agents|mesh-ancestor
64454647|NCT01909466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64454648|NCT01909466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64454649|NCT01909466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64454650|NCT01909466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64454651|NCT01977625|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64560415|NCT03589833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64560416|NCT03589833|Antimetabolites|antimetabolites|mesh-ancestor
64454654|NCT01977625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64454680|NCT04667039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64454681|NCT04667039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64454682|NCT04667039|Growth Substances|growth substances|mesh-ancestor
64454683|NCT04667039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454684|NCT04667039|Growth Inhibitors|growth inhibitors|mesh-ancestor
64454685|NCT04667039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64454686|NCT01993823|Clotrimazole|clotrimazole|mesh-list
64454688|NCT01993823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64454689|NCT01993823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64454690|NCT01993823|Antifungal Agents|antifungal agents|mesh-ancestor
64454691|NCT01993823|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64454692|NCT01993823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64454693|NCT01993823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454694|NCT01993823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454695|NCT01993823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64454696|NCT01993823|Hormone Antagonists|hormone antagonists|mesh-ancestor
64454697|NCT01993823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64454698|NCT01993823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454699|NCT01993823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64454700|NCT01993823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64454701|NCT01993667|Acetazolamide|acetazolamide|mesh-list
64454702|NCT01993667|Anticonvulsants|anticonvulsants|mesh-ancestor
64454703|NCT01993667|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64454704|NCT01993667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64454705|NCT01993667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454706|NCT01993667|Diuretics|diuretics|mesh-ancestor
64454707|NCT01993667|Natriuretic Agents|natriuretic agents|mesh-ancestor
64454722|NCT01933880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454723|NCT01933880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64560595|NCT05307003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64454724|NCT01933880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64454725|NCT01933880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64454726|NCT01933880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454727|NCT01933880|Dopamine Agents|dopamine agents|mesh-ancestor
64454728|NCT01933880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64454729|NCT02008877|Sirolimus|sirolimus|mesh-list
64454730|NCT02008877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64454731|NCT02008877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64454849|NCT01929044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454850|NCT01929044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64454851|NCT01929044|Parasympatholytics|parasympatholytics|mesh-ancestor
64454852|NCT01929044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64454853|NCT01929044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64454904|NCT01441102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64454905|NCT01441102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64454906|NCT01441102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64454907|NCT04069156|Aspirin|aspirin|mesh-list
64454908|NCT04069156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64454909|NCT04069156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64454910|NCT04069156|Analgesics|analgesics|mesh-ancestor
64454911|NCT04069156|Sensory System Agents|sensory system agents|mesh-ancestor
64560596|NCT05307003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64560597|NCT05307003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64454912|NCT04069156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64454913|NCT04069156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455037|NCT01417078|Anesthetics, General|anesthetics, general|mesh-ancestor
64455039|NCT01417078|GABA Modulators|gaba modulators|mesh-ancestor
64455040|NCT01417078|GABA Agents|gaba agents|mesh-ancestor
64455041|NCT01417078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64455042|NCT01417078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455043|NCT01464424|Bimatoprost|bimatoprost|mesh-list
64455044|NCT01464424|Travoprost|travoprost|mesh-list
64455045|NCT01464424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64455046|NCT01464424|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64455047|NCT01464424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64455048|NCT01902134|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
64455049|NCT01902134|Tramadol|tramadol|mesh-list
64455050|NCT01902134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64455085|NCT01415518|Ipratropium|ipratropium|mesh-list
64455086|NCT01415518|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64455087|NCT01415518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64455088|NCT01415518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64455089|NCT01415518|Autonomic Agents|autonomic agents|mesh-ancestor
64455090|NCT01415518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64455091|NCT01415518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455092|NCT01415518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64455093|NCT01415518|Respiratory System Agents|respiratory system agents|mesh-ancestor
64455094|NCT01415518|Glucocorticoids|glucocorticoids|mesh-ancestor
64455095|NCT01415518|Hormones|hormones|mesh-ancestor
64455119|NCT04767178|Acetaminophen|acetaminophen|mesh-list
64455146|NCT01432600|Antiemetics|antiemetics|mesh-ancestor
64455147|NCT01432600|Autonomic Agents|autonomic agents|mesh-ancestor
64455208|NCT01413958|Respiratory System Agents|respiratory system agents|mesh-ancestor
64560642|NCT01097343|Purinergic Agents|purinergic agents|mesh-ancestor
64560643|NCT01097343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64560644|NCT01097343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560645|NCT01097343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560646|NCT03580187|Morphine|morphine|mesh-list
64560647|NCT03580187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64560648|NCT03580187|Narcotics|narcotics|mesh-ancestor
64455209|NCT01413958|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64455210|NCT01413958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64455211|NCT01413958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64455212|NCT01413958|Adrenergic Agents|adrenergic agents|mesh-ancestor
64455213|NCT01413958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64455214|NCT01413958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455215|NCT01413958|Protective Agents|protective agents|mesh-ancestor
64455216|NCT01413958|Antipruritics|antipruritics|mesh-ancestor
64455217|NCT01413958|Dermatologic Agents|dermatologic agents|mesh-ancestor
64455218|NCT01413958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64455219|NCT01413958|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64455268|NCT01767519|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64455269|NCT01767519|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64455270|NCT01767519|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64455271|NCT01767519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64455272|NCT01767519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455273|NCT01767519|Cholinergic Agents|cholinergic agents|mesh-ancestor
64455274|NCT01767519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64455275|NCT01767519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455276|NCT01767519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64455277|NCT01767519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64455332|NCT01793883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64455333|NCT01793883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455334|NCT01793883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455335|NCT01953692|Pembrolizumab|pembrolizumab|mesh-list
64455336|NCT01953692|Lenalidomide|lenalidomide|mesh-list
64455337|NCT01953692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64455338|NCT01953692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455339|NCT01953692|Immunologic Factors|immunologic factors|mesh-ancestor
64455340|NCT01953692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455341|NCT01953692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64455342|NCT01953692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64455394|NCT01900730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64455396|NCT01952834|Vancomycin|vancomycin|mesh-list
64455397|NCT01952834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64455398|NCT01952834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64455399|NCT01952054|Denosumab|denosumab|mesh-list
64455400|NCT01952054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64455401|NCT01952054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455402|NCT01925768|Apremilast|apremilast|mesh-list
64455403|NCT01925768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64455404|NCT01925768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64455405|NCT01925768|Analgesics|analgesics|mesh-ancestor
64455406|NCT01925768|Sensory System Agents|sensory system agents|mesh-ancestor
64455407|NCT01925768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64455408|NCT01925768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455409|NCT01925768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64455410|NCT01925768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64945368|NCT05697783|Anesthetics, General|anesthetics, general|mesh-ancestor
64455411|NCT01925768|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64455412|NCT01925768|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64455413|NCT01925768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455414|NCT01925768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455442|NCT01411774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64455444|NCT01411774|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64455445|NCT01411774|Antitubercular Agents|antitubercular agents|mesh-ancestor
64455446|NCT01411774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64455447|NCT01411774|Antimetabolites|antimetabolites|mesh-ancestor
64455448|NCT01411774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455449|NCT01410604|Metformin|metformin|mesh-list
64455450|NCT01410604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64455451|NCT01410604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455452|NCT01410448|Cyclosporine|cyclosporine|mesh-list
64455453|NCT01410448|Mycophenolic Acid|mycophenolic acid|mesh-list
64455454|NCT01410448|Everolimus|everolimus|mesh-list
64455455|NCT01410448|Cyclosporins|cyclosporins|mesh-list
64560888|NCT02174913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64560889|NCT02174913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64560890|NCT02174913|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64560891|NCT02174913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64560892|NCT02174913|Cholinergic Agents|cholinergic agents|mesh-ancestor
64560895|NCT01114503|Methylprednisolone|methylprednisolone|mesh-list
64455456|NCT01410448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455457|NCT01410448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455458|NCT01410448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64455459|NCT01410448|Immunologic Factors|immunologic factors|mesh-ancestor
64455460|NCT01410448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455461|NCT01410448|Antifungal Agents|antifungal agents|mesh-ancestor
64455462|NCT01410448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64455463|NCT01410448|Dermatologic Agents|dermatologic agents|mesh-ancestor
64455464|NCT01410448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64455465|NCT01410448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64455466|NCT01410448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455467|NCT01410448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64560968|NCT01044693|Metoprolol|metoprolol|mesh-list
64455492|NCT01976845|Anesthetics, General|anesthetics, general|mesh-ancestor
64455493|NCT01976845|Anesthetics|anesthetics|mesh-ancestor
64455494|NCT01976845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64455495|NCT01976845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64455496|NCT01976845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64455497|NCT01976845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64455498|NCT01976845|GABA Modulators|gaba modulators|mesh-ancestor
64455499|NCT01976845|GABA Agents|gaba agents|mesh-ancestor
64455500|NCT01976845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64561023|NCT01044771|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64455501|NCT01976845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455502|NCT01989689|Etanercept|etanercept|mesh-list
64455503|NCT01989689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64455552|NCT03842722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64455553|NCT03842722|Dermatologic Agents|dermatologic agents|mesh-ancestor
64455555|NCT01429792|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64455556|NCT01429792|Antimetabolites|antimetabolites|mesh-ancestor
64561157|NCT01170117|Autonomic Agents|autonomic agents|mesh-ancestor
64455557|NCT01429792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455558|NCT01429792|Antiviral Agents|antiviral agents|mesh-ancestor
64455559|NCT01429792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64455561|NCT01940887|Aflibercept|aflibercept|mesh-list
64455562|NCT01940887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64455563|NCT01940887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455564|NCT01940887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64455569|NCT01925612|Prednisone|prednisone|mesh-list
64455615|NCT01408888|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64455617|NCT01408888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455618|NCT01408888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455619|NCT01918033|Desloratadine|desloratadine|mesh-list
64455620|NCT01918033|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64455621|NCT01918033|Cholinergic Agents|cholinergic agents|mesh-ancestor
64455623|NCT01918033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455624|NCT01918033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455625|NCT01918033|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64455626|NCT01918033|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64455627|NCT01918033|Histamine Antagonists|histamine antagonists|mesh-ancestor
64455629|NCT01408732|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
64455630|NCT01408732|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64455631|NCT01408732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64455632|NCT01390402|Aldesleukin|aldesleukin|mesh-list
64455633|NCT01390402|Methotrexate|methotrexate|mesh-list
64455634|NCT01390402|Fludarabine phosphate|fludarabine phosphate|mesh-list
64455635|NCT01390402|Fludarabine|fludarabine|mesh-list
64455636|NCT01390402|Busulfan|busulfan|mesh-list
64455637|NCT01390402|Interleukin-2|interleukin-2|mesh-list
64455638|NCT01390402|Tacrolimus|tacrolimus|mesh-list
64455639|NCT01390402|Thymoglobulin|thymoglobulin|mesh-list
64455640|NCT01390402|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64455840|NCT02003573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64455841|NCT02003573|Antimetabolites|antimetabolites|mesh-ancestor
64455842|NCT02003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561275|NCT01135329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64455843|NCT02003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561276|NCT01135329|Immunologic Factors|immunologic factors|mesh-ancestor
64455844|NCT02003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64455845|NCT01789281|Everolimus|everolimus|mesh-list
64455846|NCT01789281|Octreotide|octreotide|mesh-list
64455847|NCT01789281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64455848|NCT01789281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64455849|NCT01789281|Immunologic Factors|immunologic factors|mesh-ancestor
64455850|NCT01789281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455851|NCT01789281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64561336|NCT03565835|Hormone Antagonists|hormone antagonists|mesh-ancestor
64455852|NCT01789281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64455881|NCT01617187|Antiemetics|antiemetics|mesh-ancestor
64455882|NCT01617187|Autonomic Agents|autonomic agents|mesh-ancestor
64455883|NCT01617187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64455884|NCT01617187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455885|NCT01617187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64455886|NCT01617187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64455887|NCT01617187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64455888|NCT01617187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64455889|NCT01617187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64455890|NCT01617187|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64455891|NCT01617187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64455892|NCT01617187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64455893|NCT01617187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455894|NCT01617187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64455895|NCT01617187|Serotonin Agents|serotonin agents|mesh-ancestor
64455896|NCT01759407|Epinephrine|epinephrine|mesh-list
64455897|NCT01759407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64455898|NCT01759407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64455899|NCT01759407|Adrenergic Agents|adrenergic agents|mesh-ancestor
64455900|NCT01759407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64455901|NCT01759407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455932|NCT01787097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64455933|NCT01787097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64455934|NCT01787097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64455935|NCT01787097|Adrenergic Agents|adrenergic agents|mesh-ancestor
64455936|NCT01787097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64455937|NCT01787097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455938|NCT01757691|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64455939|NCT01757691|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64455940|NCT01757691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64455941|NCT01757691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64455942|NCT01757691|Immunologic Factors|immunologic factors|mesh-ancestor
64455943|NCT01757691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455944|NCT01786707|Metformin|metformin|mesh-list
64455945|NCT01786707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64455946|NCT01786707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64455947|NCT01786551|Eplerenone|eplerenone|mesh-list
64455948|NCT01786551|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64455949|NCT01786551|Hormone Antagonists|hormone antagonists|mesh-ancestor
64456104|NCT01427920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456106|NCT01427608|Sertraline|sertraline|mesh-list
64456107|NCT01427608|Antiemetics|antiemetics|mesh-ancestor
64456108|NCT01427608|Autonomic Agents|autonomic agents|mesh-ancestor
64456109|NCT01427608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456110|NCT01427608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456111|NCT01427608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64456112|NCT01427608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64456113|NCT01427608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64456114|NCT01427608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64456161|NCT04173416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64561850|NCT01141725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561854|NCT01141725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64456162|NCT04173416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456163|NCT04173416|Analgesics|analgesics|mesh-ancestor
64456164|NCT04173416|Sensory System Agents|sensory system agents|mesh-ancestor
64456165|NCT04173416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456167|NCT01896128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64456168|NCT01896128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456169|NCT01896128|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64456170|NCT01896128|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64456171|NCT01896128|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64456172|NCT01896128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456173|NCT01949870|Gemcitabine|gemcitabine|mesh-list
64456174|NCT01949870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456175|NCT01949870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64456176|NCT01949870|Antimetabolites|antimetabolites|mesh-ancestor
64456177|NCT01949870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456178|NCT01949870|Antiviral Agents|antiviral agents|mesh-ancestor
64456179|NCT01949870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64456180|NCT01949870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64456181|NCT01949870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64456182|NCT01949870|Immunologic Factors|immunologic factors|mesh-ancestor
64456183|NCT01949870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456184|NCT01922258|Brexpiprazole|brexpiprazole|mesh-list
64456185|NCT01922258|Serotonin Agents|serotonin agents|mesh-ancestor
64561960|NCT01679795|Tibolone|tibolone|mesh-list
64456186|NCT01922258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64456187|NCT01922258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456188|NCT01922258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456189|NCT01922258|Dopamine Agonists|dopamine agonists|mesh-ancestor
64456190|NCT01922258|Dopamine Agents|dopamine agents|mesh-ancestor
64456191|NCT01406938|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64456192|NCT01406938|Immunologic Factors|immunologic factors|mesh-ancestor
64456194|NCT01405924|Dexamethasone|dexamethasone|mesh-list
64456201|NCT01405924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456202|NCT01405924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64562028|NCT03086291|Simvastatin|simvastatin|mesh-list
64562029|NCT03086291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64562040|NCT01209195|Paclitaxel|paclitaxel|mesh-list
64456203|NCT01405924|Glucocorticoids|glucocorticoids|mesh-ancestor
64456204|NCT01405924|Hormones|hormones|mesh-ancestor
64456205|NCT01405924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64456206|NCT01405924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64456207|NCT01405924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456208|NCT01405924|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64456209|NCT01405924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64456210|NCT01405924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456211|NCT01426438|Aspirin|aspirin|mesh-list
64456213|NCT01426438|Fenofibrate|fenofibrate|mesh-list
64456214|NCT01426438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64456215|NCT01426438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64456216|NCT01426438|Analgesics|analgesics|mesh-ancestor
64456217|NCT01426438|Sensory System Agents|sensory system agents|mesh-ancestor
64456218|NCT01426438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456219|NCT01426438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456220|NCT01426438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64456221|NCT01426438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64456222|NCT01426438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64456223|NCT01426438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64456253|NCT01922102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64456254|NCT01922102|Growth Substances|growth substances|mesh-ancestor
64456255|NCT01922102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456256|NCT01922102|Growth Inhibitors|growth inhibitors|mesh-ancestor
64456257|NCT01922102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456258|NCT01922102|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64456259|NCT01922102|Dermatologic Agents|dermatologic agents|mesh-ancestor
64456260|NCT01405768|Lidocaine|lidocaine|mesh-list
64456261|NCT01405768|Anesthetics, Local|anesthetics, local|mesh-ancestor
64456262|NCT01405768|Anesthetics|anesthetics|mesh-ancestor
64456306|NCT01896050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64456307|NCT01896050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64456308|NCT01896050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64456309|NCT01896050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456310|NCT01896050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64456311|NCT01896050|Hormone Antagonists|hormone antagonists|mesh-ancestor
64456312|NCT01896050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64456313|NCT01896050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456314|NCT01896050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64456315|NCT01896050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64456342|NCT01753401|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64562169|NCT00083915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562178|NCT04401839|Oxytocin|oxytocin|mesh-list
64456343|NCT01753401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64456344|NCT01753401|Glucocorticoids|glucocorticoids|mesh-ancestor
64456345|NCT01753401|Hormones|hormones|mesh-ancestor
64456346|NCT01753401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64456347|NCT01753401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456348|NCT01753401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64456393|NCT01780935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456394|NCT01422538|Mannitol|mannitol|mesh-list
64456395|NCT01422538|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64456396|NCT01422538|Diuretics|diuretics|mesh-ancestor
64456397|NCT01422538|Natriuretic Agents|natriuretic agents|mesh-ancestor
64456398|NCT01422538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456399|NCT04026256|Denosumab|denosumab|mesh-list
64456400|NCT04026256|Teriparatide|teriparatide|mesh-list
64456401|NCT04026256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64456402|NCT04026256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456403|NCT04026256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64456404|NCT01422382|Diltiazem|diltiazem|mesh-list
64456405|NCT01422382|Pitavastatin|pitavastatin|mesh-list
64456457|NCT01422304|Respiratory System Agents|respiratory system agents|mesh-ancestor
64456458|NCT01422304|Mydriatics|mydriatics|mesh-ancestor
64456459|NCT01422304|Parasympatholytics|parasympatholytics|mesh-ancestor
64456460|NCT01422304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64456461|NCT01422304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64456462|NCT01422304|Cholinergic Agents|cholinergic agents|mesh-ancestor
64456463|NCT01422304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64945369|NCT05697783|Anesthetics|anesthetics|mesh-ancestor
64456464|NCT01422304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456465|NCT01422304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64456466|NCT01422304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64456467|NCT01422304|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64456469|NCT01387516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64456470|NCT01387516|Autonomic Agents|autonomic agents|mesh-ancestor
64456471|NCT01387516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456536|NCT01780389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456537|NCT01780389|Antidepressive Agents|antidepressive agents|mesh-ancestor
64456538|NCT01780389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64456539|NCT01778985|Estrogens|estrogens|mesh-list
64456540|NCT01778985|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64456541|NCT01778985|Hormones|hormones|mesh-ancestor
64456542|NCT01778985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64456543|NCT01778985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456544|NCT01865084|Tadalafil|tadalafil|mesh-list
64456545|NCT01865084|Vasodilator Agents|vasodilator agents|mesh-ancestor
64456551|NCT01399372|Cytarabine|cytarabine|mesh-list
64456553|NCT01399372|Methotrexate|methotrexate|mesh-list
64456554|NCT01399372|Vincristine|vincristine|mesh-list
64456555|NCT01399372|Procarbazine|procarbazine|mesh-list
64456556|NCT01399372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64456557|NCT01399372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456558|NCT01399372|Immunologic Factors|immunologic factors|mesh-ancestor
64456559|NCT01399372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456560|NCT01399372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64456561|NCT01399372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64456562|NCT01399372|Abortifacient Agents|abortifacient agents|mesh-ancestor
64456563|NCT01399372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64456564|NCT01399372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64456565|NCT01399372|Antimetabolites|antimetabolites|mesh-ancestor
64456567|NCT01399372|Dermatologic Agents|dermatologic agents|mesh-ancestor
64456568|NCT01399372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64456569|NCT01399372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64456570|NCT01399372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64456571|NCT01399372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64456572|NCT01399372|Antiviral Agents|antiviral agents|mesh-ancestor
64456573|NCT01399372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64456574|NCT01399372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64456604|NCT03025282|Hormones|hormones|mesh-ancestor
64456605|NCT03025282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64456606|NCT03025282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456607|NCT03025282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64456608|NCT03025282|Respiratory System Agents|respiratory system agents|mesh-ancestor
64456609|NCT01778049|Empagliflozin|empagliflozin|mesh-list
64456610|NCT01778049|Linagliptin|linagliptin|mesh-list
64456611|NCT01778049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64945370|NCT05697783|Antitussive Agents|antitussive agents|mesh-ancestor
64456612|NCT01778049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456614|NCT01778049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456615|NCT01778049|Incretins|incretins|mesh-ancestor
64456616|NCT01778049|Hormones|hormones|mesh-ancestor
64456617|NCT01778049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64456618|NCT01778049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64456619|NCT01778049|Protease Inhibitors|protease inhibitors|mesh-ancestor
64456620|NCT01778049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64456621|NCT01777581|Milnacipran|milnacipran|mesh-list
64456622|NCT01777581|Levomilnacipran|levomilnacipran|mesh-list
64456623|NCT01777581|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64456624|NCT01777581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64456625|NCT01777581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64456654|NCT01890122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456655|NCT01397890|Budesonide|budesonide|mesh-list
64456656|NCT01397890|Formoterol Fumarate|formoterol fumarate|mesh-list
64456657|NCT01397890|Tiotropium Bromide|tiotropium bromide|mesh-list
64456658|NCT01397890|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64456659|NCT01397890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64456660|NCT01397890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64456661|NCT01397890|Autonomic Agents|autonomic agents|mesh-ancestor
64456662|NCT01397890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456663|NCT01397890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456664|NCT01397890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64456665|NCT01397890|Respiratory System Agents|respiratory system agents|mesh-ancestor
64456666|NCT01397890|Glucocorticoids|glucocorticoids|mesh-ancestor
64484479|NCT04658927|Hormones|hormones|mesh-ancestor
64456668|NCT01397890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64456669|NCT01397890|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64456670|NCT01397890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64456671|NCT01397890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64456672|NCT01397890|Adrenergic Agents|adrenergic agents|mesh-ancestor
64456673|NCT01397890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64562605|NCT04278287|Tubulin Modulators|tubulin modulators|mesh-ancestor
64456674|NCT01397890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456675|NCT01397890|Parasympatholytics|parasympatholytics|mesh-ancestor
64456676|NCT01397890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64456677|NCT01397890|Cholinergic Agents|cholinergic agents|mesh-ancestor
64456678|NCT01777269|Tamsulosin|tamsulosin|mesh-list
64456679|NCT01777269|Dutasteride|dutasteride|mesh-list
64456680|NCT01777269|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64456681|NCT01777269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64456682|NCT01777269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64562658|NCT04989413|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64562659|NCT04989413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64562660|NCT04989413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456683|NCT01777269|Adrenergic Agents|adrenergic agents|mesh-ancestor
64456684|NCT01777269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64456685|NCT01777269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456693|NCT04024696|Abexinostat|abexinostat|mesh-list
64456694|NCT04024696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64456695|NCT04024696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64456696|NCT04024696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562795|NCT04399187|Eusol|eusol|mesh-list
64456698|NCT01777191|Dermatologic Agents|dermatologic agents|mesh-ancestor
64456699|NCT01775787|Menthol|menthol|mesh-list
64456700|NCT01775787|Nicotine|nicotine|mesh-list
64456701|NCT01775787|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64456746|NCT01774929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64456747|NCT01774929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456748|NCT01774929|Analgesics|analgesics|mesh-ancestor
64456749|NCT01774929|Sensory System Agents|sensory system agents|mesh-ancestor
64456750|NCT01774929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456751|NCT01774929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64456752|NCT01774929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64456753|NCT01774929|Anesthetics, General|anesthetics, general|mesh-ancestor
64456754|NCT01774929|Anesthetics|anesthetics|mesh-ancestor
64456755|NCT01774305|Dexmedetomidine|dexmedetomidine|mesh-list
64456756|NCT01774305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64456757|NCT01774305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64456758|NCT01774305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456759|NCT01774305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64456760|NCT01774305|Analgesics|analgesics|mesh-ancestor
64456761|NCT01774305|Sensory System Agents|sensory system agents|mesh-ancestor
64456762|NCT01774305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456763|NCT01774305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64456764|NCT01774305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64562827|NCT04399343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64562828|NCT04399343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456765|NCT01774305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64456766|NCT01774305|Adrenergic Agents|adrenergic agents|mesh-ancestor
64456767|NCT01774305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64456769|NCT01397422|Amantadine|amantadine|mesh-list
64456788|NCT01863680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64456789|NCT01863680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456790|NCT01863680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64456791|NCT01747629|Albuterol|albuterol|mesh-list
64456792|NCT01747629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64456803|NCT01747629|Adrenergic Agents|adrenergic agents|mesh-ancestor
64456804|NCT01747629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64456805|NCT01747629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456806|NCT01863368|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64456807|NCT01863368|Lubricant Eye Drops|lubricant eye drops|mesh-list
64456808|NCT01863368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64456809|NCT01886690|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64456810|NCT01886690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64456811|NCT01886690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64456813|NCT01886690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64456814|NCT04590404|Nicotine|nicotine|mesh-list
64456815|NCT04590404|Varenicline|varenicline|mesh-list
64456816|NCT04590404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64456817|NCT04590404|Autonomic Agents|autonomic agents|mesh-ancestor
64456818|NCT04590404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64456831|NCT01885208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64456832|NCT01859702|Moxifloxacin|moxifloxacin|mesh-list
64456833|NCT01859702|Dexamethasone|dexamethasone|mesh-list
64456834|NCT01859702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64456835|NCT01859702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64456837|NCT01859702|Autonomic Agents|autonomic agents|mesh-ancestor
64456838|NCT01859702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563087|NCT04248335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64456839|NCT01859702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64456840|NCT01859702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64456841|NCT01859702|Glucocorticoids|glucocorticoids|mesh-ancestor
64456842|NCT01859702|Hormones|hormones|mesh-ancestor
64456843|NCT01859702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64456844|NCT01859702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64456845|NCT01859702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456846|NCT01859702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64456847|NCT01859702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64456848|NCT01859702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64456849|NCT01859702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64456850|NCT01859702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64456851|NCT01859702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563168|NCT01286805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64456852|NCT01859702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456853|NCT01747551|Leucovorin|leucovorin|mesh-list
64456854|NCT01747551|Fluorouracil|fluorouracil|mesh-list
64456855|NCT01747551|Oxaliplatin|oxaliplatin|mesh-list
64456867|NCT01747551|Vitamins|vitamins|mesh-ancestor
64456882|NCT01746225|Mitosis Modulators|mitosis modulators|mesh-ancestor
64456883|NCT01746225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456884|NCT01858766|Ribavirin|ribavirin|mesh-list
64456885|NCT01858766|Antiviral Agents|antiviral agents|mesh-ancestor
64456886|NCT01858766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64456887|NCT01858766|Antimetabolites|antimetabolites|mesh-ancestor
64456888|NCT01858766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456889|NCT01745367|Paclitaxel|paclitaxel|mesh-list
64456890|NCT01745367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64456891|NCT01745367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456892|NCT01745367|Tubulin Modulators|tubulin modulators|mesh-ancestor
64456893|NCT01745367|Antimitotic Agents|antimitotic agents|mesh-ancestor
64456894|NCT01745367|Mitosis Modulators|mitosis modulators|mesh-ancestor
64456938|NCT05368012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64456941|NCT05368012|Anesthetics, Local|anesthetics, local|mesh-ancestor
64456985|NCT04565301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64456986|NCT04565301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64456987|NCT04565301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64456988|NCT04565301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64456989|NCT04565301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64456990|NCT04565301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64456991|NCT04565301|Cholinergic Agents|cholinergic agents|mesh-ancestor
64456992|NCT04565301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64456993|NCT04565301|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64456994|NCT01743027|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64456995|NCT01743027|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64456996|NCT01743027|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64457002|NCT01743027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457003|NCT01743027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64457004|NCT01743027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64457005|NCT01743027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64457006|NCT01743027|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64457007|NCT01743027|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64457008|NCT01743027|Histamine Antagonists|histamine antagonists|mesh-ancestor
64457010|NCT01743027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64457012|NCT01380730|Evolocumab|evolocumab|mesh-list
64457032|NCT01380184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64457033|NCT01380184|Immunologic Factors|immunologic factors|mesh-ancestor
64457034|NCT01380184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563236|NCT03924635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64457035|NCT01395316|Alemtuzumab|alemtuzumab|mesh-list
64457036|NCT01395316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64457037|NCT01395316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457038|NCT04331938|Anesthetics|anesthetics|mesh-list
64457039|NCT04331938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64457040|NCT04331938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457041|NCT01731951|Imetelstat|imetelstat|mesh-list
64457042|NCT01731951|Motesanib diphosphate|motesanib diphosphate|mesh-list
64457043|NCT01731951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457044|NCT01731951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457045|NCT01731951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64457046|NCT01741545|Interferons|interferons|mesh-list
64457047|NCT01741545|Ribavirin|ribavirin|mesh-list
64457048|NCT01741545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457049|NCT01741545|Antiviral Agents|antiviral agents|mesh-ancestor
64457050|NCT01741545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64457088|NCT01834274|Hormones|hormones|mesh-ancestor
64457089|NCT01834274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64457090|NCT01834274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64457091|NCT01834274|Protease Inhibitors|protease inhibitors|mesh-ancestor
64457092|NCT01834274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457093|NCT01834274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457094|NCT01739595|Enclomiphene|enclomiphene|mesh-list
64457095|NCT01739595|Clomiphene|clomiphene|mesh-list
64457096|NCT01739595|Zuclomiphene|zuclomiphene|mesh-list
64457097|NCT01739595|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64457098|NCT01739595|Hormone Antagonists|hormone antagonists|mesh-ancestor
64457099|NCT01739595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64457100|NCT01739595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457101|NCT01739595|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64563272|NCT01289457|Antiviral Agents|antiviral agents|mesh-ancestor
64457102|NCT01739595|Fertility Agents|fertility agents|mesh-ancestor
64457103|NCT01739595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64457104|NCT01739595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64457105|NCT01739595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64457106|NCT01738971|Progestins|progestins|mesh-list
64457107|NCT01738971|Hormones|hormones|mesh-ancestor
64457108|NCT01738971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64457109|NCT01738971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457110|NCT01738503|Buprenorphine|buprenorphine|mesh-list
64457111|NCT01738503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64457112|NCT01738503|Narcotics|narcotics|mesh-ancestor
64457113|NCT01738503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64457115|NCT01738503|Analgesics|analgesics|mesh-ancestor
64457132|NCT01605825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457134|NCT01726335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64457135|NCT01726335|Serotonin Agents|serotonin agents|mesh-ancestor
64457136|NCT01726335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64457137|NCT01726335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457138|NCT01726335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457139|NCT01726335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64457140|NCT01726335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64457141|NCT01726335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64457142|NCT01726335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64457154|NCT01726023|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
64457155|NCT01726023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64457156|NCT01726023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64457157|NCT01726023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64457158|NCT01726023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64457159|NCT01726023|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64457160|NCT01726023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457161|NCT01726023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457162|NCT01877187|Ethiodized Oil|ethiodized oil|mesh-list
64457163|NCT01877187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457177|NCT04613960|Analgesics|analgesics|mesh-ancestor
64457178|NCT04613960|Sensory System Agents|sensory system agents|mesh-ancestor
64457179|NCT04613960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64457180|NCT04613960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457181|NCT04613960|Anesthetics|anesthetics|mesh-ancestor
64563328|NCT03613727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563329|NCT03613727|Antioxidants|antioxidants|mesh-ancestor
64563330|NCT03613727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457182|NCT04613960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64457183|NCT04613960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64457184|NCT04613960|Anticonvulsants|anticonvulsants|mesh-ancestor
64457185|NCT04613960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64457186|NCT04613960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64457187|NCT04613960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457188|NCT04613960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64457189|NCT04613960|Tocolytic Agents|tocolytic agents|mesh-ancestor
64457190|NCT04613960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64457191|NCT03361436|Halichondrin B|halichondrin b|mesh-list
64457192|NCT03361436|Tubulin Modulators|tubulin modulators|mesh-ancestor
64457193|NCT03361436|Antimitotic Agents|antimitotic agents|mesh-ancestor
64457194|NCT03361436|Mitosis Modulators|mitosis modulators|mesh-ancestor
64457195|NCT03361436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457196|NCT03361436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457198|NCT04599140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64457202|NCT01857206|Vaccines|vaccines|mesh-list
64457228|NCT01876251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457229|NCT01875237|Methylprednisolone|methylprednisolone|mesh-list
64457230|NCT01875237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64457231|NCT01875237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64457232|NCT01875237|Prednisolone|prednisolone|mesh-list
64457233|NCT01875237|Prednisolone acetate|prednisolone acetate|mesh-list
64457234|NCT01875237|Methotrexate|methotrexate|mesh-list
64457235|NCT01875237|Fludarabine phosphate|fludarabine phosphate|mesh-list
64457236|NCT01875237|Fludarabine|fludarabine|mesh-list
64457237|NCT01875237|Melphalan|melphalan|mesh-list
64457238|NCT01875237|Alemtuzumab|alemtuzumab|mesh-list
64457239|NCT01875237|Tacrolimus|tacrolimus|mesh-list
64457240|NCT01875237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64457241|NCT01875237|Prednisolone phosphate|prednisolone phosphate|mesh-list
64457242|NCT01875237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64457243|NCT01875237|Abortifacient Agents|abortifacient agents|mesh-ancestor
64457244|NCT01875237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64457245|NCT01875237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457246|NCT01875237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64457247|NCT01875237|Antimetabolites|antimetabolites|mesh-ancestor
64457248|NCT01875237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563419|NCT00630877|Aspirin|aspirin|mesh-list
64457249|NCT01875237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457250|NCT01875237|Dermatologic Agents|dermatologic agents|mesh-ancestor
64457251|NCT01875237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457284|NCT01722045|Growth Inhibitors|growth inhibitors|mesh-ancestor
64457285|NCT01722045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457286|NCT01721109|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64457287|NCT01721109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64457288|NCT01721109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64457322|NCT01881230|Tubulin Modulators|tubulin modulators|mesh-ancestor
64457323|NCT01881230|Antimitotic Agents|antimitotic agents|mesh-ancestor
64457324|NCT01881230|Mitosis Modulators|mitosis modulators|mesh-ancestor
64457325|NCT01881230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457326|NCT01881230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64457327|NCT01881230|Antimetabolites|antimetabolites|mesh-ancestor
64457328|NCT01881230|Antiviral Agents|antiviral agents|mesh-ancestor
64457329|NCT01881230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64457330|NCT01881230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457331|NCT01881230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64457332|NCT01881230|Immunologic Factors|immunologic factors|mesh-ancestor
64457333|NCT01881230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457334|NCT01856114|Fentanyl|fentanyl|mesh-list
64457335|NCT01856114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64457336|NCT01856114|Narcotics|narcotics|mesh-ancestor
64457337|NCT01856114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64457338|NCT01856114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457339|NCT01856114|Analgesics|analgesics|mesh-ancestor
64457340|NCT01856114|Sensory System Agents|sensory system agents|mesh-ancestor
64513621|NCT01457001|Vitamin D|vitamin d|mesh-list
64513622|NCT01457001|Vitamins|vitamins|mesh-ancestor
64457341|NCT01856114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64457376|NCT01854710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64457377|NCT01854710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64457378|NCT01854710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64563425|NCT00630877|Analgesics|analgesics|mesh-ancestor
64457379|NCT01854710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64457380|NCT01854710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64457381|NCT01854710|Dopamine Agents|dopamine agents|mesh-ancestor
64457382|NCT01854710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64457383|NCT01828034|Gemcitabine|gemcitabine|mesh-list
64457384|NCT01828034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457385|NCT01828034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64457405|NCT01853696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64457419|NCT01719861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64457420|NCT01719861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457421|NCT01719861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457430|NCT01719783|Vaccines|vaccines|mesh-list
64457459|NCT01719003|Empagliflozin|empagliflozin|mesh-list
64457460|NCT01719003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64457461|NCT01719003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457462|NCT01719003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64457463|NCT01719003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457464|NCT01853228|Cytarabine|cytarabine|mesh-list
64457465|NCT01853228|Decitabine|decitabine|mesh-list
64457466|NCT01853228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64457467|NCT01853228|Antimetabolites|antimetabolites|mesh-ancestor
64457468|NCT01853228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457469|NCT01853228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457470|NCT01853228|Antiviral Agents|antiviral agents|mesh-ancestor
64457471|NCT01853228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64457472|NCT01853228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64457473|NCT01853228|Immunologic Factors|immunologic factors|mesh-ancestor
64457474|NCT01853228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457475|NCT01853228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457476|NCT01705587|Teriparatide|teriparatide|mesh-list
64457477|NCT01705587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64457478|NCT01705587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563506|NCT03174197|Temozolomide|temozolomide|mesh-list
64457509|NCT01853072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64457510|NCT01717287|Raltegravir Potassium|raltegravir potassium|mesh-list
64457511|NCT01717287|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64457512|NCT01717287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64457513|NCT01717287|Antiviral Agents|antiviral agents|mesh-ancestor
64457514|NCT01717287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64457515|NCT01717287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64457516|NCT01717287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64457517|NCT01717287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380698|NCT02600897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64457520|NCT04605393|Cannabidiol|cannabidiol|mesh-list
64457521|NCT04605393|Anticonvulsants|anticonvulsants|mesh-ancestor
64457522|NCT04605393|Hallucinogens|hallucinogens|mesh-ancestor
64457523|NCT04605393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457524|NCT04605393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64457525|NCT04605393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64457526|NCT04605393|Analgesics|analgesics|mesh-ancestor
64457527|NCT04605393|Sensory System Agents|sensory system agents|mesh-ancestor
64457528|NCT04605393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64457529|NCT04605393|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64457530|NCT04605393|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64457531|NCT04605393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64457532|NCT04605393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457533|NCT04605393|Hormones|hormones|mesh-ancestor
64457534|NCT04605393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64457535|NCT01827254|Sunitinib|sunitinib|mesh-list
64457536|NCT01827254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457537|NCT01827254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64457539|NCT01827254|Growth Substances|growth substances|mesh-ancestor
64457553|NCT04609592|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64457554|NCT04609592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457555|NCT04609592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64457556|NCT01876082|Methotrexate|methotrexate|mesh-list
64457557|NCT01876082|Vinblastine|vinblastine|mesh-list
64457558|NCT01876082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64457559|NCT01876082|Abortifacient Agents|abortifacient agents|mesh-ancestor
64457560|NCT01876082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64457561|NCT01876082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457562|NCT01876082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64457563|NCT01876082|Antimetabolites|antimetabolites|mesh-ancestor
64457564|NCT01876082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457565|NCT01876082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457566|NCT01876082|Dermatologic Agents|dermatologic agents|mesh-ancestor
64457567|NCT01876082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457568|NCT01876082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64457569|NCT01876082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64457570|NCT01876082|Immunologic Factors|immunologic factors|mesh-ancestor
64457571|NCT01876082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64457574|NCT01876082|Tubulin Modulators|tubulin modulators|mesh-ancestor
64457606|NCT04594772|Gemcitabine|gemcitabine|mesh-list
64457607|NCT04594772|Paclitaxel|paclitaxel|mesh-list
64457608|NCT04594772|Fluorouracil|fluorouracil|mesh-list
64457609|NCT04594772|Oxaliplatin|oxaliplatin|mesh-list
64457610|NCT04594772|Irinotecan|irinotecan|mesh-list
64457611|NCT04594772|Folfirinox|folfirinox|mesh-list
64457612|NCT04594772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64457613|NCT04594772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457614|NCT04594772|Tubulin Modulators|tubulin modulators|mesh-ancestor
64457615|NCT04594772|Antimitotic Agents|antimitotic agents|mesh-ancestor
64457616|NCT04594772|Mitosis Modulators|mitosis modulators|mesh-ancestor
64457617|NCT04594772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457618|NCT04594772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64457619|NCT04594772|Antimetabolites|antimetabolites|mesh-ancestor
64457620|NCT04594772|Antiviral Agents|antiviral agents|mesh-ancestor
64457621|NCT04594772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64457622|NCT04594772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457623|NCT04594772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64457624|NCT04594772|Immunologic Factors|immunologic factors|mesh-ancestor
64457625|NCT04594772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457626|NCT04594772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64457627|NCT04594772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64457628|NCT01393990|Tamoxifen|tamoxifen|mesh-list
64457629|NCT01393990|Midazolam|midazolam|mesh-list
64457630|NCT01393990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64457631|NCT01393990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64457632|NCT01393990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64563590|NCT00630799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64457633|NCT01393990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457634|NCT01393990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64457635|NCT01393990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64457636|NCT01393990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64457637|NCT01393990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64457638|NCT01393990|Anesthetics, General|anesthetics, general|mesh-ancestor
64457657|NCT00210184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64457658|NCT00210184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457659|NCT00210184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64457661|NCT00210184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457662|NCT00210184|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64457663|NCT00210184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64457664|NCT00210184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457665|NCT00210184|Antidotes|antidotes|mesh-ancestor
64457666|NCT00210184|Protective Agents|protective agents|mesh-ancestor
64457667|NCT00210184|Vitamin B Complex|vitamin b complex|mesh-ancestor
64457668|NCT00210184|Vitamins|vitamins|mesh-ancestor
64457669|NCT00210184|Micronutrients|micronutrients|mesh-ancestor
64457670|NCT05364190|Empagliflozin|empagliflozin|mesh-list
64457708|NCT03593434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64457709|NCT03593434|Anesthetics, General|anesthetics, general|mesh-ancestor
64457710|NCT03593434|Anesthetics|anesthetics|mesh-ancestor
64457711|NCT03593434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64457712|NCT03593434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457714|NCT03792958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64457715|NCT03792958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457716|NCT03792958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457717|NCT03789604|Antibodies|antibodies|mesh-list
64457718|NCT03789604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64457719|NCT03789604|Immunologic Factors|immunologic factors|mesh-ancestor
64457720|NCT03789604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457721|NCT03598426|Dexamethasone|dexamethasone|mesh-list
64457722|NCT03598426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64563633|NCT00667121|Antidepressive Agents|antidepressive agents|mesh-ancestor
64457723|NCT03598426|Antiemetics|antiemetics|mesh-ancestor
64457724|NCT03598426|Autonomic Agents|autonomic agents|mesh-ancestor
64563634|NCT00667121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64457725|NCT03598426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64457728|NCT03598426|Glucocorticoids|glucocorticoids|mesh-ancestor
64457765|NCT03599284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457767|NCT04006522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457768|NCT03024814|Acetaminophen|acetaminophen|mesh-list
64457769|NCT03024814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64457770|NCT03024814|Analgesics|analgesics|mesh-ancestor
64457771|NCT03024814|Sensory System Agents|sensory system agents|mesh-ancestor
64457772|NCT03024814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64457773|NCT03024814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457774|NCT03024814|Antipyretics|antipyretics|mesh-ancestor
64457775|NCT01852058|Botulinum Toxins|botulinum toxins|mesh-list
64457776|NCT01852058|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64457777|NCT01852058|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64457778|NCT01852058|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64457779|NCT01852058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64457780|NCT01852058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457781|NCT01852058|Cholinergic Agents|cholinergic agents|mesh-ancestor
64457782|NCT01852058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64457783|NCT01852058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457784|NCT01852058|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64457785|NCT01852058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64457786|NCT03024502|Clotrimazole|clotrimazole|mesh-list
64457787|NCT03024502|Miconazole|miconazole|mesh-list
64457788|NCT03024502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64457816|NCT03024580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457817|NCT03024580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64457818|NCT03024580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64457819|NCT03024580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64457820|NCT03024580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64457821|NCT03024580|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64457822|NCT03024580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64457823|NCT03024580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64457828|NCT03024580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64457829|NCT03024580|Appetite Stimulants|appetite stimulants|mesh-ancestor
64457830|NCT03024580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64457831|NCT01851590|Terbinafine|terbinafine|mesh-list
64457832|NCT01851590|Amorolfine|amorolfine|mesh-list
64457833|NCT01851590|Antifungal Agents|antifungal agents|mesh-ancestor
64457834|NCT01851590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64457835|NCT01851590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563706|NCT03080441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457836|NCT01851590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457837|NCT03598816|Durvalumab|durvalumab|mesh-list
64457838|NCT03598816|Tremelimumab|tremelimumab|mesh-list
64457839|NCT03598816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64457840|NCT03598816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457841|NCT05633758|Metolazone|metolazone|mesh-list
64457842|NCT05633758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64457843|NCT05633758|Diuretics|diuretics|mesh-ancestor
64457844|NCT05633758|Natriuretic Agents|natriuretic agents|mesh-ancestor
64457845|NCT05633758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457846|NCT05633758|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64457855|NCT03978442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64457856|NCT03978442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457858|NCT03978442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64457859|NCT03978442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457860|NCT03978442|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64457861|NCT03978442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64457862|NCT03978442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457863|NCT03598738|Esomeprazole|esomeprazole|mesh-list
64457864|NCT03598738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64457865|NCT03598738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64457866|NCT03598738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64457867|NCT03598738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64457868|NCT03598738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457870|NCT03594214|Vitamins|vitamins|mesh-ancestor
64457871|NCT03594214|Micronutrients|micronutrients|mesh-ancestor
64457872|NCT03594214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457873|NCT03594214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64457874|NCT04003948|Ibogaine|ibogaine|mesh-list
64457875|NCT04003948|Hallucinogens|hallucinogens|mesh-ancestor
64457876|NCT04003948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457877|NCT04003948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64457878|NCT04003948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64457908|NCT03976258|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64457909|NCT03976258|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64457910|NCT03976258|Antitussive Agents|antitussive agents|mesh-ancestor
64457911|NCT03976258|Respiratory System Agents|respiratory system agents|mesh-ancestor
64457913|NCT03598192|Dsuvia|dsuvia|mesh-list
64563755|NCT01921231|Prilocaine|prilocaine|mesh-list
64457914|NCT03598192|Ropivacaine|ropivacaine|mesh-list
64457915|NCT03598192|Anesthetics, Local|anesthetics, local|mesh-ancestor
64457916|NCT03598192|Anesthetics|anesthetics|mesh-ancestor
64457917|NCT03598192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64457918|NCT03598192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457919|NCT03598192|Sensory System Agents|sensory system agents|mesh-ancestor
64457920|NCT03598192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64457921|NCT03598192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64457922|NCT03598192|Narcotics|narcotics|mesh-ancestor
64457923|NCT03598192|Analgesics|analgesics|mesh-ancestor
64457924|NCT03598192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64457925|NCT03598192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64457926|NCT03598192|Anesthetics, General|anesthetics, general|mesh-ancestor
64457927|NCT04003246|Durvalumab|durvalumab|mesh-list
64457928|NCT04003246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64457929|NCT04003246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64457930|NCT04003246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457962|NCT00216736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64457963|NCT00216736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457964|NCT00216736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64457965|NCT00216736|Glucocorticoids|glucocorticoids|mesh-ancestor
64457966|NCT00216736|Hormones|hormones|mesh-ancestor
64457975|NCT01850030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64457976|NCT00215644|Capecitabine|capecitabine|mesh-list
64457977|NCT00215644|Epirubicin|epirubicin|mesh-list
64457978|NCT00215644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64457979|NCT00215644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64457980|NCT00215644|Antimetabolites|antimetabolites|mesh-ancestor
64457981|NCT00215644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64457982|NCT00215644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64457983|NCT00215644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64458014|NCT01704261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458015|NCT01704261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64458016|NCT01704261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64458017|NCT01704261|Immunologic Factors|immunologic factors|mesh-ancestor
64563788|NCT01926379|Isoniazid|isoniazid|mesh-list
64458019|NCT00212758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64458020|NCT00212758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458022|NCT01824290|Vasodilator Agents|vasodilator agents|mesh-ancestor
64458023|NCT01824290|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64458024|NCT01824290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64458025|NCT01824290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458026|NCT01824290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458027|NCT01824290|Urological Agents|urological agents|mesh-ancestor
64458028|NCT03592342|Clobetasol|clobetasol|mesh-list
64458029|NCT03592342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64458030|NCT03592342|Glucocorticoids|glucocorticoids|mesh-ancestor
64458031|NCT03592342|Hormones|hormones|mesh-ancestor
64458032|NCT03592342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64458033|NCT03592342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458034|NCT01715415|Ribavirin|ribavirin|mesh-list
64458035|NCT01715415|Antimetabolites|antimetabolites|mesh-ancestor
64458036|NCT01715415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458037|NCT01715415|Antiviral Agents|antiviral agents|mesh-ancestor
64458038|NCT01715415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64458039|NCT00211510|Insulin|insulin|mesh-list
64458040|NCT00211510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64458041|NCT00211510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458042|NCT04198636|Denosumab|denosumab|mesh-list
64458043|NCT04198636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64458059|NCT01869699|Acetaminophen|acetaminophen|mesh-list
64458060|NCT01869699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64458061|NCT01869699|Analgesics|analgesics|mesh-ancestor
64458062|NCT01869699|Sensory System Agents|sensory system agents|mesh-ancestor
64458063|NCT01869699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458064|NCT01869699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458065|NCT01869699|Antipyretics|antipyretics|mesh-ancestor
64458066|NCT03981796|Paclitaxel|paclitaxel|mesh-list
64458067|NCT03981796|Carboplatin|carboplatin|mesh-list
64458068|NCT03981796|Niraparib|niraparib|mesh-list
64458069|NCT03981796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64458070|NCT03981796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458071|NCT03981796|Tubulin Modulators|tubulin modulators|mesh-ancestor
64458072|NCT03981796|Antimitotic Agents|antimitotic agents|mesh-ancestor
64458073|NCT03981796|Mitosis Modulators|mitosis modulators|mesh-ancestor
64458074|NCT03981796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458075|NCT03981796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64458076|NCT03981796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458117|NCT04191382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458118|NCT04191382|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64458119|NCT04191382|Hormone Antagonists|hormone antagonists|mesh-ancestor
64458134|NCT04196998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64458135|NCT04196998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458136|NCT04196998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458138|NCT04196998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64458139|NCT04196452|Ipilimumab|ipilimumab|mesh-list
64458140|NCT04196452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64458141|NCT04196452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458142|NCT04196452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64458143|NCT04196452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458144|NCT03956056|Poly I-C|poly i-c|mesh-list
64458145|NCT03956056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64458146|NCT03956056|Poly ICLC|poly iclc|mesh-list
64458147|NCT03956056|Interferon Inducers|interferon inducers|mesh-ancestor
64458148|NCT03956056|Immunologic Factors|immunologic factors|mesh-ancestor
64458149|NCT03956056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458150|NCT03956056|Laxatives|laxatives|mesh-ancestor
64458156|NCT03967054|Ivermectin|ivermectin|mesh-list
64458157|NCT03967054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64458158|NCT03967054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64458159|NCT01702311|Insulin Aspart|insulin aspart|mesh-list
64458160|NCT01702311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64458161|NCT01702311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458162|NCT04196608|Tazobactam|tazobactam|mesh-list
64458163|NCT04196608|Imipenem|imipenem|mesh-list
64458164|NCT04196608|Ceftolozane|ceftolozane|mesh-list
64458165|NCT04196608|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
64458166|NCT04196608|Relebactam|relebactam|mesh-list
64458167|NCT04196608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64458168|NCT04196608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64458169|NCT04196608|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64458170|NCT04196608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458171|NCT04196608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458172|NCT04196608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64458217|NCT04021108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64458218|NCT04021108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458219|NCT03594058|Solabegron|solabegron|mesh-list
64458220|NCT03594058|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64563892|NCT05607901|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64563893|NCT05607901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563894|NCT05607901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563895|NCT05607901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64563896|NCT05604859|Methylprednisolone|methylprednisolone|mesh-list
64563897|NCT05604859|Heparin|heparin|mesh-list
64563898|NCT05604859|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64334727|NCT02232035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64334728|NCT02232035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64563899|NCT05604859|Tinzaparin|tinzaparin|mesh-list
64563900|NCT05604859|Dalteparin|dalteparin|mesh-list
64563901|NCT05604859|Immunoglobulins|immunoglobulins|mesh-list
64563902|NCT05604859|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64458221|NCT03594058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64458222|NCT03594058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64458223|NCT03594058|Adrenergic Agents|adrenergic agents|mesh-ancestor
64458224|NCT03594058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64458225|NCT03594058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458226|NCT03594058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458227|NCT03970954|Interleukin-2|interleukin-2|mesh-list
64458228|NCT03970954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458229|NCT03970954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64458240|NCT03970720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64458241|NCT03970720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64458243|NCT03970720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64458249|NCT04194658|Letrozole|letrozole|mesh-list
64458261|NCT04028518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64458262|NCT04028518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64458263|NCT04028518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458265|NCT04194034|Antifungal Agents|antifungal agents|mesh-ancestor
64458266|NCT04194034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64458267|NCT04194034|Antimetabolites|antimetabolites|mesh-ancestor
64458268|NCT04194034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458269|NCT04747678|Ivermectin|ivermectin|mesh-list
64458270|NCT04747678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64458271|NCT04747678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64458272|NCT04027972|Glycopyrrolate|glycopyrrolate|mesh-list
64458273|NCT04027972|Neostigmine|neostigmine|mesh-list
64458274|NCT04027972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64458275|NCT04027972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458276|NCT04027972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458277|NCT04027972|Cholinergic Agents|cholinergic agents|mesh-ancestor
64458278|NCT04027972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64458279|NCT04027972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458280|NCT04027972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64458281|NCT04027972|Autonomic Agents|autonomic agents|mesh-ancestor
64458282|NCT04027972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458283|NCT04027972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64458284|NCT04027972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64458312|NCT04406506|Erythromycin Estolate|erythromycin estolate|mesh-list
64458313|NCT04406506|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64458314|NCT04406506|Erythromycin stearate|erythromycin stearate|mesh-list
64458315|NCT04406506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64458316|NCT04406506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64458317|NCT04406506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64458318|NCT04406506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64458319|NCT04406506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458320|NCT04406506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563903|NCT05604859|gamma-Globulins|gamma-globulins|mesh-list
64563904|NCT05604859|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64458321|NCT03828292|Dexamethasone|dexamethasone|mesh-list
64458322|NCT03828292|Bortezomib|bortezomib|mesh-list
64458323|NCT03828292|Pomalidomide|pomalidomide|mesh-list
64458324|NCT03828292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64458325|NCT03828292|Antiemetics|antiemetics|mesh-ancestor
64458326|NCT03828292|Autonomic Agents|autonomic agents|mesh-ancestor
64458327|NCT03828292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458328|NCT03828292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458329|NCT03828292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64458330|NCT03828292|Glucocorticoids|glucocorticoids|mesh-ancestor
64458331|NCT03828292|Hormones|hormones|mesh-ancestor
64458333|NCT03828292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64458366|NCT04026022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64458367|NCT04026022|Anesthetics, General|anesthetics, general|mesh-ancestor
64458368|NCT04026022|Anesthetics|anesthetics|mesh-ancestor
64458369|NCT04020406|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64458370|NCT04020406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64458372|NCT04020328|Leflunomide|leflunomide|mesh-list
64458373|NCT04020328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64458376|NCT04020328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64458378|NCT04020328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64458379|NCT04020328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458380|NCT04020328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458381|NCT04020328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458382|NCT04020328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64458383|NCT04020328|Immunologic Factors|immunologic factors|mesh-ancestor
64458384|NCT04020094|Atezolizumab|atezolizumab|mesh-list
64458385|NCT04020094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458386|NCT02080468|Norgestimate|norgestimate|mesh-list
64458387|NCT02080468|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64458388|NCT02080468|Contraceptive Agents|contraceptive agents|mesh-ancestor
64458389|NCT02080468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64458390|NCT02080468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458391|NCT02080468|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64458392|NCT02080468|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64458393|NCT02080468|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64458396|NCT04020016|Narcotics|narcotics|mesh-ancestor
64458415|NCT04029610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64458416|NCT04029610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458417|NCT04029610|Sensory System Agents|sensory system agents|mesh-ancestor
64458418|NCT04029610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458419|NCT04029610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64458420|NCT04029610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64458421|NCT04029610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64458422|NCT04029610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64458423|NCT04029610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458424|NCT04029610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64458425|NCT04029610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64458426|NCT04029610|Adrenergic Agents|adrenergic agents|mesh-ancestor
64458427|NCT04029610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64458428|NCT04029610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64458429|NCT04029610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64458430|NCT04029610|Autonomic Agents|autonomic agents|mesh-ancestor
64458431|NCT04029610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64458442|NCT04026880|Hormones|hormones|mesh-ancestor
64458470|NCT04026958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64458471|NCT04026958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64458473|NCT04020718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64458474|NCT04020718|Autonomic Agents|autonomic agents|mesh-ancestor
64458475|NCT04020718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458476|NCT04020718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458477|NCT04020718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64458478|NCT04020718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64563931|NCT03133325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64563933|NCT00638963|Temozolomide|temozolomide|mesh-list
64458479|NCT04020718|Cholinergic Agents|cholinergic agents|mesh-ancestor
64458480|NCT04020718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64458481|NCT04020718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458482|NCT04027348|Dexamethasone|dexamethasone|mesh-list
64458483|NCT04027348|Octreotide|octreotide|mesh-list
64458484|NCT04027348|Metoclopramide|metoclopramide|mesh-list
64458485|NCT04027348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64458486|NCT04027348|Antiemetics|antiemetics|mesh-ancestor
64458487|NCT04027348|Autonomic Agents|autonomic agents|mesh-ancestor
64458488|NCT04027348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458489|NCT04027348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458490|NCT04027348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64458491|NCT04027348|Glucocorticoids|glucocorticoids|mesh-ancestor
64458492|NCT04027348|Hormones|hormones|mesh-ancestor
64458493|NCT04027348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64458494|NCT04027348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64458495|NCT04027348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458496|NCT04027348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64458497|NCT04027348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64458498|NCT04027348|Dopamine Agents|dopamine agents|mesh-ancestor
64458499|NCT04027348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64458500|NCT04027348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458511|NCT04195204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458576|NCT04147390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64458577|NCT02708680|Atezolizumab|atezolizumab|mesh-list
64458578|NCT02708680|Entinostat|entinostat|mesh-list
64458579|NCT02708680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458580|NCT02708680|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64458581|NCT02708680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458582|NCT02708680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458583|NCT03932656|Psychotropic Drugs|psychotropic drugs|mesh-list
64458584|NCT03931642|Blinatumomab|blinatumomab|mesh-list
64458585|NCT03931642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458586|NCT04021420|Nivolumab|nivolumab|mesh-list
64458587|NCT04021420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64458588|NCT04021420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563948|NCT00638027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64563949|NCT00638027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563950|NCT00638027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563953|NCT03342911|Paclitaxel|paclitaxel|mesh-list
64458589|NCT04021420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64458590|NCT04021420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458591|NCT04144582|Docetaxel|docetaxel|mesh-list
64458592|NCT04144582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458593|NCT04144582|Tubulin Modulators|tubulin modulators|mesh-ancestor
64458594|NCT04144582|Antimitotic Agents|antimitotic agents|mesh-ancestor
64458595|NCT04144582|Mitosis Modulators|mitosis modulators|mesh-ancestor
64458596|NCT04144582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458619|NCT01871558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64458620|NCT01871558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458621|NCT01871558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64458622|NCT01871558|Protease Inhibitors|protease inhibitors|mesh-ancestor
64458623|NCT01871558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458624|NCT01871558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458625|NCT01711359|Folic Acid|folic acid|mesh-list
64458626|NCT01711359|Methotrexate|methotrexate|mesh-list
64458627|NCT01711359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64458628|NCT01711359|Abortifacient Agents|abortifacient agents|mesh-ancestor
64458629|NCT01711359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64458630|NCT01711359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458631|NCT01711359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64458632|NCT01711359|Antimetabolites|antimetabolites|mesh-ancestor
64458633|NCT01711359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458639|NCT01711359|Immunologic Factors|immunologic factors|mesh-ancestor
64458673|NCT04146532|Aspirin|aspirin|mesh-list
64458674|NCT04146532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64458675|NCT04146532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64458676|NCT04146532|Analgesics|analgesics|mesh-ancestor
64458677|NCT04146532|Sensory System Agents|sensory system agents|mesh-ancestor
64458678|NCT04146532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458679|NCT04146532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458680|NCT04146532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64458681|NCT04146532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64458682|NCT04146532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64458683|NCT04146532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64458684|NCT04146532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458685|NCT04146532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64458686|NCT04146532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64458687|NCT04146532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563998|NCT04124497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64563999|NCT04124497|Glucocorticoids|glucocorticoids|mesh-ancestor
64564000|NCT04124497|Hormones|hormones|mesh-ancestor
64564001|NCT04124497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64458688|NCT04146532|Antipyretics|antipyretics|mesh-ancestor
64458689|NCT03929224|Bacitracin|bacitracin|mesh-list
64458690|NCT03929224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64458729|NCT04145518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458730|NCT03021772|Dexamethasone|dexamethasone|mesh-list
64458731|NCT03021772|Neostigmine|neostigmine|mesh-list
64458732|NCT03021772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64458733|NCT03021772|Antiemetics|antiemetics|mesh-ancestor
64458734|NCT03021772|Autonomic Agents|autonomic agents|mesh-ancestor
64458735|NCT03021772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458736|NCT03021772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458737|NCT03021772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64458738|NCT03021772|Glucocorticoids|glucocorticoids|mesh-ancestor
64458739|NCT03021772|Hormones|hormones|mesh-ancestor
64458740|NCT03021772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64458741|NCT03021772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64458742|NCT03021772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458743|NCT03021772|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64458744|NCT03021772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458745|NCT03021772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458746|NCT03021772|Cholinergic Agents|cholinergic agents|mesh-ancestor
64458747|NCT03021772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64458748|NCT03021772|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64458749|NCT04149262|Insulin Aspart|insulin aspart|mesh-list
64458750|NCT04149262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64458751|NCT04149262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458752|NCT05581420|Ferrous fumarate|ferrous fumarate|mesh-list
64458753|NCT05581420|Trace Elements|trace elements|mesh-ancestor
64458754|NCT05581420|Micronutrients|micronutrients|mesh-ancestor
64458755|NCT05581420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458756|NCT03904498|Tolcapone|tolcapone|mesh-list
64458757|NCT03904498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64458758|NCT03904498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64458759|NCT03904498|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64458760|NCT03904498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458761|NCT03904498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458762|NCT04405960|Alfacalcidol|alfacalcidol|mesh-list
64458763|NCT04405960|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
64458764|NCT04405960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64458767|NCT04405960|Micronutrients|micronutrients|mesh-ancestor
64458768|NCT03945604|Apatinib|apatinib|mesh-list
64458769|NCT03945604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458770|NCT03945604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64458771|NCT03945604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64513625|NCT01457001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64513626|NCT02846883|Plasma-lyte 148|plasma-lyte 148|mesh-list
64458772|NCT03945604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458774|NCT03944434|Goserelin|goserelin|mesh-list
64458775|NCT03944434|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64458776|NCT03944434|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64458777|NCT03944434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64458778|NCT03944434|Fertility Agents|fertility agents|mesh-ancestor
64458780|NCT03944434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458781|NCT03944434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64458782|NCT03944434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458783|NCT03944434|Luteolytic Agents|luteolytic agents|mesh-ancestor
64458822|NCT05589766|Antimetabolites|antimetabolites|mesh-ancestor
64458823|NCT05589766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458824|NCT05589766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64458825|NCT05589766|Vasodilator Agents|vasodilator agents|mesh-ancestor
64458826|NCT05586100|Cetuximab|cetuximab|mesh-list
64458827|NCT05586100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64458828|NCT05586100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458829|NCT05585086|Peppermint oil|peppermint oil|mesh-list
64458830|NCT05585086|Antiemetics|antiemetics|mesh-ancestor
64458831|NCT05585086|Autonomic Agents|autonomic agents|mesh-ancestor
64458832|NCT05585086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458833|NCT05585086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458834|NCT05585086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64458835|NCT05585086|Parasympatholytics|parasympatholytics|mesh-ancestor
64458836|NCT01710501|Interferons|interferons|mesh-list
64458837|NCT01710501|Ribavirin|ribavirin|mesh-list
64458838|NCT01710501|Interferon-alpha|interferon-alpha|mesh-list
64458839|NCT01710501|Interferon alpha-2|interferon alpha-2|mesh-list
64458840|NCT01710501|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64458841|NCT01710501|Grazoprevir|grazoprevir|mesh-list
64458842|NCT01710501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458843|NCT01710501|Antiviral Agents|antiviral agents|mesh-ancestor
64458844|NCT01710501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64458845|NCT01710501|Antimetabolites|antimetabolites|mesh-ancestor
64458875|NCT04143880|Progestins|progestins|mesh-ancestor
64458876|NCT04143880|Hormones|hormones|mesh-ancestor
64458877|NCT04143880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64458878|NCT04143880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458879|NCT04144192|Lidocaine|lidocaine|mesh-list
64458880|NCT04144192|Anesthetics, Local|anesthetics, local|mesh-ancestor
64458881|NCT04144192|Anesthetics|anesthetics|mesh-ancestor
64458882|NCT04144192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64458883|NCT04144192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458884|NCT04144192|Sensory System Agents|sensory system agents|mesh-ancestor
64458885|NCT04144192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458886|NCT04144192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64458887|NCT04144192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64458888|NCT04144192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64458889|NCT04144192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64458891|NCT01710345|Sufentanil|sufentanil|mesh-list
64458933|NCT01710033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458935|NCT01822496|Etoposide|etoposide|mesh-list
64458936|NCT01822496|Podophyllotoxin|podophyllotoxin|mesh-list
64458937|NCT01822496|Cisplatin|cisplatin|mesh-list
64458938|NCT01822496|Carboplatin|carboplatin|mesh-list
64458939|NCT01822496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64945373|NCT05686408|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64458940|NCT01822496|Etoposide phosphate|etoposide phosphate|mesh-list
64458941|NCT01822496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64458942|NCT01822496|Crizotinib|crizotinib|mesh-list
64458943|NCT01822496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64564066|NCT04129255|Somatostatin|somatostatin|mesh-list
64458944|NCT01822496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64458945|NCT01822496|Tubulin Modulators|tubulin modulators|mesh-ancestor
64458946|NCT01822496|Antimitotic Agents|antimitotic agents|mesh-ancestor
64458947|NCT01822496|Mitosis Modulators|mitosis modulators|mesh-ancestor
64458948|NCT01822496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458949|NCT01822496|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64458950|NCT01822496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64458951|NCT01822496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64458952|NCT01822496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64458953|NCT01822496|Keratolytic Agents|keratolytic agents|mesh-ancestor
64458985|NCT01821560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64458986|NCT03896230|Ketamine|ketamine|mesh-list
64458987|NCT03896230|Analgesics|analgesics|mesh-ancestor
64458988|NCT03896230|Sensory System Agents|sensory system agents|mesh-ancestor
64458989|NCT03896230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64458990|NCT03896230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64458991|NCT03896230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64458992|NCT03896230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64458993|NCT03896230|Anesthetics, General|anesthetics, general|mesh-ancestor
64458996|NCT03896230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64458997|NCT03896230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64513628|NCT02846883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64458998|NCT03896230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64458999|NCT03896230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459000|NCT05580328|Hematoporphyrins|hematoporphyrins|mesh-list
64459001|NCT05580328|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64459002|NCT05580328|Dermatologic Agents|dermatologic agents|mesh-ancestor
64459003|NCT03588676|Melatonin|melatonin|mesh-list
64459004|NCT03588676|Antioxidants|antioxidants|mesh-ancestor
64459005|NCT03588676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459006|NCT03588676|Protective Agents|protective agents|mesh-ancestor
64459007|NCT03588676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459008|NCT03588676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64459013|NCT01709721|Hydromorphone|hydromorphone|mesh-list
64459030|NCT01866657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64459031|NCT01866657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64459032|NCT01866657|Anesthetics, General|anesthetics, general|mesh-ancestor
64459033|NCT01866657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64459034|NCT01866657|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64459035|NCT01866657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64459036|NCT01866657|Mydriatics|mydriatics|mesh-ancestor
64459037|NCT01866657|Autonomic Agents|autonomic agents|mesh-ancestor
64459038|NCT01866657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459039|NCT01866657|Sympathomimetics|sympathomimetics|mesh-ancestor
64459040|NCT01866657|Nasal Decongestants|nasal decongestants|mesh-ancestor
64459041|NCT01866657|Respiratory System Agents|respiratory system agents|mesh-ancestor
64459042|NCT01866657|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64459043|NCT01866657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64459044|NCT01866657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64459045|NCT01866657|Adrenergic Agents|adrenergic agents|mesh-ancestor
64459046|NCT01866657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64459047|NCT01866657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459048|NCT01866657|Protective Agents|protective agents|mesh-ancestor
64459049|NCT01866657|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64459050|NCT01866657|Dopamine Agents|dopamine agents|mesh-ancestor
64459051|NCT03584152|Acetaminophen|acetaminophen|mesh-list
64459052|NCT03584152|Ibuprofen|ibuprofen|mesh-list
64459053|NCT03584152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64459054|NCT03584152|Analgesics|analgesics|mesh-ancestor
64459055|NCT03584152|Sensory System Agents|sensory system agents|mesh-ancestor
64459056|NCT03584152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459057|NCT03584152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459058|NCT03584152|Antipyretics|antipyretics|mesh-ancestor
64459059|NCT03584152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64459060|NCT03584152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64459061|NCT03584152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64459074|NCT03587194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64459075|NCT03587194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64459076|NCT03587194|Analgesics|analgesics|mesh-ancestor
64459077|NCT03587194|Sensory System Agents|sensory system agents|mesh-ancestor
64459078|NCT03587194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459079|NCT03587194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459080|NCT03587194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64459081|NCT03587194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64459082|NCT03587194|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64459083|NCT03587194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64459084|NCT03587194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64459085|NCT03587194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564163|NCT03015259|Glucocorticoids|glucocorticoids|mesh-ancestor
64459086|NCT01699815|Acetaminophen|acetaminophen|mesh-list
64444809|NCT04530149|Acetaminophen|acetaminophen|mesh-list
64945375|NCT05686408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64459087|NCT01699815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64459088|NCT01699815|Analgesics|analgesics|mesh-ancestor
64459089|NCT01699815|Sensory System Agents|sensory system agents|mesh-ancestor
64459090|NCT01699815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459091|NCT01699815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459124|NCT03020368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459125|NCT03891706|Interleukin-2|interleukin-2|mesh-list
64459129|NCT03891706|Sensory System Agents|sensory system agents|mesh-ancestor
64459130|NCT03891706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459131|NCT03891706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459132|NCT03581422|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64459133|NCT03581422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64459134|NCT03581422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459135|NCT05702944|Phenoxybenzamine|phenoxybenzamine|mesh-list
64459136|NCT05702944|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64459137|NCT05702944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64459138|NCT05702944|Adrenergic Agents|adrenergic agents|mesh-ancestor
64459139|NCT05702944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64459140|NCT05702944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459141|NCT05702944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459142|NCT05702944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64459143|NCT05702944|Vasodilator Agents|vasodilator agents|mesh-ancestor
64459144|NCT03580876|Azathioprine|azathioprine|mesh-list
64459145|NCT03580876|Antimetabolites|antimetabolites|mesh-ancestor
64459146|NCT03580876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459147|NCT03580876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64459148|NCT03580876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459149|NCT03580876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64459150|NCT03580876|Immunologic Factors|immunologic factors|mesh-ancestor
64459151|NCT03580876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459152|NCT03580876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64459153|NCT03586024|Pembrolizumab|pembrolizumab|mesh-list
64459154|NCT03586024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64459155|NCT03586024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459161|NCT03585556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64459162|NCT03585556|Growth Substances|growth substances|mesh-ancestor
64459163|NCT03585556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459164|NCT03585556|Growth Inhibitors|growth inhibitors|mesh-ancestor
64459165|NCT03585556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64459166|NCT03585556|Glucocorticoids|glucocorticoids|mesh-ancestor
64459168|NCT03585556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64459231|NCT03584854|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
64459232|NCT03584854|Methylergonovine|methylergonovine|mesh-list
64459233|NCT03584854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64459234|NCT03584854|Abortifacient Agents|abortifacient agents|mesh-ancestor
64459235|NCT03584854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64459236|NCT03584854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459237|NCT03584854|Oxytocics|oxytocics|mesh-ancestor
64459238|NCT03584698|Evening primrose oil|evening primrose oil|mesh-list
64459239|NCT03584698|Misoprostol|misoprostol|mesh-list
64459240|NCT03584698|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64459241|NCT03584698|Abortifacient Agents|abortifacient agents|mesh-ancestor
64459242|NCT03584698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64459243|NCT03584698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459244|NCT03584698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64459245|NCT03584698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64459246|NCT03584698|Oxytocics|oxytocics|mesh-ancestor
64459247|NCT03584698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64564209|NCT03292861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64459289|NCT03020056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459290|NCT03020056|Protective Agents|protective agents|mesh-ancestor
64459291|NCT03020056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459294|NCT03026062|Tremelimumab|tremelimumab|mesh-list
64459295|NCT03026062|Immunoglobulins|immunoglobulins|mesh-list
64459296|NCT03026062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64459297|NCT03026062|Immunoglobulin G|immunoglobulin g|mesh-list
64459298|NCT03026062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64459299|NCT03026062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459300|NCT03026062|Immunologic Factors|immunologic factors|mesh-ancestor
64459301|NCT03026062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459302|NCT03026062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64459303|NCT03026062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459304|NCT03584074|Celecoxib|celecoxib|mesh-list
64459305|NCT03584074|Pregabalin|pregabalin|mesh-list
64459306|NCT03584074|Analgesics|analgesics|mesh-ancestor
64459314|NCT03584074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64459315|NCT03584074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64459316|NCT03584074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64459317|NCT03584074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64459318|NCT03584074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64459319|NCT03584074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64459320|NCT03584074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64459321|NCT03584074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64459327|NCT03583138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64459328|NCT03583138|Narcotics|narcotics|mesh-ancestor
64459329|NCT03583138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64459330|NCT03583138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459331|NCT03583138|Analgesics|analgesics|mesh-ancestor
64459332|NCT03583138|Sensory System Agents|sensory system agents|mesh-ancestor
64459333|NCT03583138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459334|NCT03583138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64459335|NCT03153514|Obinutuzumab|obinutuzumab|mesh-list
64459336|NCT03153514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64459337|NCT03153514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459338|NCT03020602|Ubiquinone|ubiquinone|mesh-list
64459339|NCT03020602|Coenzyme Q10|coenzyme q10|mesh-list
64459340|NCT03020602|Micronutrients|micronutrients|mesh-ancestor
64459341|NCT03020602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459342|NCT03020602|Vitamins|vitamins|mesh-ancestor
64459343|NCT01567527|Aripiprazole|aripiprazole|mesh-list
64459344|NCT01567527|Antidepressive Agents|antidepressive agents|mesh-ancestor
64459345|NCT01567527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64459346|NCT01567527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64459347|NCT01567527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64459348|NCT01567527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64459349|NCT01567527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459350|NCT01567527|Dopamine Agonists|dopamine agonists|mesh-ancestor
64459351|NCT01567527|Dopamine Agents|dopamine agents|mesh-ancestor
64459352|NCT01567527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64459353|NCT01567527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459354|NCT01567527|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64459355|NCT01567527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64459356|NCT01567527|Serotonin Agents|serotonin agents|mesh-ancestor
64459357|NCT01567527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64459371|NCT03159598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459372|NCT03159598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64459373|NCT03159598|Anesthetics, General|anesthetics, general|mesh-ancestor
64459374|NCT03159598|Anesthetics|anesthetics|mesh-ancestor
64459375|NCT03159598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64459376|NCT03159598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459378|NCT01818752|Bortezomib|bortezomib|mesh-list
64459379|NCT01818752|Melphalan|melphalan|mesh-list
64459380|NCT01818752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64459381|NCT01818752|Glucocorticoids|glucocorticoids|mesh-ancestor
64459382|NCT01818752|Hormones|hormones|mesh-ancestor
64459383|NCT01818752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64459384|NCT01818752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459385|NCT01818752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64459386|NCT01818752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459387|NCT01818752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64459388|NCT01818752|Alkylating Agents|alkylating agents|mesh-ancestor
64459389|NCT01818752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459393|NCT03582280|Calcium Carbonate|calcium carbonate|mesh-list
64459394|NCT03582280|Calcium|calcium|mesh-list
64459395|NCT03582280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64459421|NCT01362608|Triamcinolone|triamcinolone|mesh-list
64564270|NCT04274413|Adrenergic Agents|adrenergic agents|mesh-list
64459422|NCT01362608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64459423|NCT01362608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64459424|NCT01362608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64459425|NCT01362608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64459426|NCT01362608|Glucocorticoids|glucocorticoids|mesh-ancestor
64459427|NCT01362608|Hormones|hormones|mesh-ancestor
64459428|NCT01362608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64459429|NCT01362608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459430|NCT01362608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64459431|NCT01362608|Immunologic Factors|immunologic factors|mesh-ancestor
64459432|NCT01362608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64459433|NCT01362608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459434|NCT03581968|Pancrelipase|pancrelipase|mesh-list
64459435|NCT03581968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64459436|NCT03158584|Morphine|morphine|mesh-list
64459437|NCT03158584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64459438|NCT03158584|Narcotics|narcotics|mesh-ancestor
64459439|NCT03158584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64459440|NCT03158584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459470|NCT04140448|Growth Inhibitors|growth inhibitors|mesh-ancestor
64459471|NCT04140448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459472|NCT03156322|Fentanyl|fentanyl|mesh-list
64459473|NCT03156322|Bupivacaine|bupivacaine|mesh-list
64459474|NCT03156322|Anesthetics, Local|anesthetics, local|mesh-ancestor
64459475|NCT03156322|Anesthetics|anesthetics|mesh-ancestor
64459476|NCT03156322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64459477|NCT03156322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459478|NCT03156322|Sensory System Agents|sensory system agents|mesh-ancestor
64459479|NCT03156322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459480|NCT03156322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64459481|NCT03156322|Narcotics|narcotics|mesh-ancestor
64459482|NCT03156322|Analgesics|analgesics|mesh-ancestor
64459483|NCT03156322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64459484|NCT03156322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64459485|NCT03156322|Anesthetics, General|anesthetics, general|mesh-ancestor
64459486|NCT03156088|Neurotransmitter Agents|neurotransmitter agents|mesh-list
64459487|NCT03156088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459488|NCT03156088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459489|NCT04140058|Ondansetron|ondansetron|mesh-list
64459490|NCT04140058|Antiemetics|antiemetics|mesh-ancestor
64459491|NCT04140058|Autonomic Agents|autonomic agents|mesh-ancestor
64459492|NCT04140058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459493|NCT04140058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459494|NCT04140058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64459495|NCT04140058|Antipruritics|antipruritics|mesh-ancestor
64459496|NCT04140058|Dermatologic Agents|dermatologic agents|mesh-ancestor
64459497|NCT04140058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64459498|NCT04140058|Serotonin Agents|serotonin agents|mesh-ancestor
64459499|NCT04140058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64459500|NCT04140058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459501|NCT04140058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64459502|NCT04140058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64564357|NCT03830827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64564359|NCT03830827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64459513|NCT04146298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64459514|NCT04146298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64459515|NCT04146298|Alkylating Agents|alkylating agents|mesh-ancestor
64459516|NCT04146298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459517|NCT04146298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459518|NCT04146298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64459519|NCT02899078|Nivolumab|nivolumab|mesh-list
64459520|NCT02899078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64459521|NCT02899078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459522|NCT02899078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64459523|NCT02899078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459524|NCT01670890|Cisplatin|cisplatin|mesh-list
64459525|NCT01670890|Temozolomide|temozolomide|mesh-list
64459526|NCT01670890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459529|NCT01670890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459531|NCT04551196|Ibuprofen|ibuprofen|mesh-list
64459532|NCT04551196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64459533|NCT04551196|Analgesics|analgesics|mesh-ancestor
64459534|NCT04551196|Sensory System Agents|sensory system agents|mesh-ancestor
64459537|NCT04551196|Antipyretics|antipyretics|mesh-ancestor
64459564|NCT04297618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64459565|NCT03154918|Gemcitabine|gemcitabine|mesh-list
64459566|NCT03154918|Dexamethasone|dexamethasone|mesh-list
64459567|NCT03154918|Etoposide|etoposide|mesh-list
64459568|NCT03154918|Ifosfamide|ifosfamide|mesh-list
64459569|NCT03154918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64459570|NCT03154918|Antiemetics|antiemetics|mesh-ancestor
64459571|NCT03154918|Autonomic Agents|autonomic agents|mesh-ancestor
64459572|NCT03154918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459573|NCT03154918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459574|NCT03154918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64459575|NCT03154918|Glucocorticoids|glucocorticoids|mesh-ancestor
64459576|NCT03154918|Hormones|hormones|mesh-ancestor
64459577|NCT03154918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64459578|NCT03154918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64564400|NCT03822091|Sympathomimetics|sympathomimetics|mesh-ancestor
64459579|NCT03154918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459580|NCT03154918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64459581|NCT03154918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459582|NCT03154918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64459583|NCT03154918|Antimetabolites|antimetabolites|mesh-ancestor
64459584|NCT03154918|Antiviral Agents|antiviral agents|mesh-ancestor
64459585|NCT03154918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64459586|NCT03154918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64459587|NCT03154918|Immunologic Factors|immunologic factors|mesh-ancestor
64459588|NCT03154918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64459589|NCT03154918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64459590|NCT03154918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64459591|NCT03154918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64459592|NCT03154918|Alkylating Agents|alkylating agents|mesh-ancestor
64459593|NCT01671904|Rituximab|rituximab|mesh-list
64459607|NCT01671982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64459608|NCT01671982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64459609|NCT01671982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64459610|NCT01671982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64459611|NCT01671982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459612|NCT01671982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64459613|NCT01671982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64459614|NCT04040452|Ketorolac|ketorolac|mesh-list
64459615|NCT04040452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64459616|NCT04040452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64459617|NCT04040452|Analgesics|analgesics|mesh-ancestor
64459618|NCT04040452|Sensory System Agents|sensory system agents|mesh-ancestor
64459619|NCT04040452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459620|NCT04040452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459621|NCT04040452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64459622|NCT04040452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64459623|NCT04040452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64459624|NCT04040452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64564440|NCT03064867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64459625|NCT04040452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459626|NCT04027894|Rifamycins|rifamycins|mesh-list
64459627|NCT04027894|Rifamycin SV|rifamycin sv|mesh-list
64459628|NCT04027894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64459660|NCT03154294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64459661|NCT03154606|Calcium|calcium|mesh-list
64459662|NCT03154606|Caseins|caseins|mesh-list
64459663|NCT03154606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64459664|NCT03154606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459665|NCT03154606|Chelating Agents|chelating agents|mesh-ancestor
64459666|NCT03154606|Sequestering Agents|sequestering agents|mesh-ancestor
64459667|NCT03154606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459668|NCT03806452|Hydroxyurea|hydroxyurea|mesh-list
64459669|NCT03806452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459670|NCT03806452|Antisickling Agents|antisickling agents|mesh-ancestor
64459671|NCT03806452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64459682|NCT01672450|Sensory System Agents|sensory system agents|mesh-ancestor
64459683|NCT01672450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459709|NCT04964050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64459710|NCT04964050|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64459711|NCT04964050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64459712|NCT04964050|Diuretics|diuretics|mesh-ancestor
64459713|NCT04964050|Natriuretic Agents|natriuretic agents|mesh-ancestor
64459714|NCT04964050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459715|NCT02386774|Benoxinate|benoxinate|mesh-list
64459716|NCT02386774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64459717|NCT02386774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64459718|NCT02386774|Anesthetics, Local|anesthetics, local|mesh-ancestor
64459719|NCT02386774|Anesthetics|anesthetics|mesh-ancestor
64459724|NCT03526900|Atezolizumab|atezolizumab|mesh-list
64459772|NCT03025594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459773|NCT03025594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64459774|NCT03025594|Respiratory System Agents|respiratory system agents|mesh-ancestor
64459775|NCT03025594|Mydriatics|mydriatics|mesh-ancestor
64459776|NCT03025594|Sympathomimetics|sympathomimetics|mesh-ancestor
64459777|NCT03025594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64459778|NCT03025594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64459779|NCT03025594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64459780|NCT03025594|Analgesics|analgesics|mesh-ancestor
64459781|NCT03025594|Sensory System Agents|sensory system agents|mesh-ancestor
64459782|NCT03025594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64459783|NCT03025594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64459784|NCT03025594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64459808|NCT01673542|Lidocaine|lidocaine|mesh-list
64459818|NCT01673542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64459819|NCT01673542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64459820|NCT01673542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64459821|NCT01673542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459822|NCT01673542|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64459824|NCT04804540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64459825|NCT01610492|Belimumab|belimumab|mesh-list
64459826|NCT01610492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64459827|NCT01610492|Immunologic Factors|immunologic factors|mesh-ancestor
64459884|NCT01592409|Hormones|hormones|mesh-ancestor
64564503|NCT04120519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64564504|NCT04120519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64459885|NCT01592409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64459886|NCT02081638|Aspirin|aspirin|mesh-list
64459887|NCT02081638|Atorvastatin|atorvastatin|mesh-list
64459888|NCT02081638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64459889|NCT02081638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64459890|NCT02081638|Analgesics|analgesics|mesh-ancestor
64459891|NCT02081638|Sensory System Agents|sensory system agents|mesh-ancestor
64459892|NCT02081638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459893|NCT02081638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459894|NCT02081638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64459895|NCT02081638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64459896|NCT02081638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64459897|NCT02081638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64459901|NCT02081638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64459903|NCT02081638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64459904|NCT02081638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64459905|NCT02081638|Antimetabolites|antimetabolites|mesh-ancestor
64459906|NCT02081638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64459907|NCT02081638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64459908|NCT04603508|Calcium, Dietary|calcium, dietary|mesh-list
64459909|NCT04603508|Empagliflozin|empagliflozin|mesh-list
64459910|NCT04603508|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64459911|NCT04603508|Calcium|calcium|mesh-list
64459912|NCT04603508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64459913|NCT04603508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459914|NCT04603508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64459915|NCT04603508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64459926|NCT01674166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64459927|NCT01674166|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64459928|NCT01674166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64459929|NCT01674166|Serotonin Agents|serotonin agents|mesh-ancestor
64459930|NCT01674166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64459931|NCT01674166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459932|NCT01674166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459933|NCT02235688|Gemcitabine|gemcitabine|mesh-list
64459934|NCT02235688|Doxorubicin|doxorubicin|mesh-list
64459935|NCT02235688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64459936|NCT02235688|Antimetabolites|antimetabolites|mesh-ancestor
64459937|NCT02235688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459938|NCT02235688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459939|NCT02235688|Antiviral Agents|antiviral agents|mesh-ancestor
64459940|NCT02235688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64459941|NCT02235688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64459942|NCT02235688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64459943|NCT02235688|Immunologic Factors|immunologic factors|mesh-ancestor
64459944|NCT02235688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459945|NCT02235688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64459946|NCT02235688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64459947|NCT02235688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64459948|NCT03152578|Capsaicin|capsaicin|mesh-list
64459949|NCT03152578|Antipruritics|antipruritics|mesh-ancestor
64459950|NCT03152578|Dermatologic Agents|dermatologic agents|mesh-ancestor
64564531|NCT00630539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64564532|NCT00634829|Albuterol|albuterol|mesh-list
64459951|NCT03152578|Sensory System Agents|sensory system agents|mesh-ancestor
64459952|NCT03152578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459953|NCT03152578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459954|NCT01065532|Paclitaxel|paclitaxel|mesh-list
64459955|NCT01065532|Everolimus|everolimus|mesh-list
64459956|NCT01065532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64459957|NCT01065532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64459958|NCT01065532|Tubulin Modulators|tubulin modulators|mesh-ancestor
64459964|NCT01065532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459965|NCT04764916|Bupivacaine|bupivacaine|mesh-list
64459966|NCT04764916|Anesthetics, Local|anesthetics, local|mesh-ancestor
64459967|NCT04764916|Anesthetics|anesthetics|mesh-ancestor
64459968|NCT04764916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64459969|NCT04764916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459970|NCT04764916|Sensory System Agents|sensory system agents|mesh-ancestor
64459971|NCT04764916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64459972|NCT01674868|Fluoxetine|fluoxetine|mesh-list
64459973|NCT01674868|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64459974|NCT01674868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64459975|NCT01674868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64459976|NCT01674868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64459977|NCT01674868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64459978|NCT01674868|Serotonin Agents|serotonin agents|mesh-ancestor
64459979|NCT01674868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64459981|NCT01674868|Antidepressive Agents|antidepressive agents|mesh-ancestor
64460021|NCT01675648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460022|NCT01675648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64460023|NCT01675648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64460026|NCT01675648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64460027|NCT01675648|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64460028|NCT01675648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64460029|NCT01675648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64460030|NCT01675648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64460031|NCT01675648|Anesthetics, General|anesthetics, general|mesh-ancestor
64460032|NCT01675648|Anesthetics|anesthetics|mesh-ancestor
64460033|NCT01675648|GABA Modulators|gaba modulators|mesh-ancestor
64460034|NCT01675648|GABA Agents|gaba agents|mesh-ancestor
64460035|NCT01675648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64460036|NCT01675648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460037|NCT01675648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64460038|NCT01675648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64460039|NCT01675648|Sensory System Agents|sensory system agents|mesh-ancestor
64460040|NCT01675648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64460041|NCT01675648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64460042|NCT01675648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64460043|NCT01675648|Adrenergic Agents|adrenergic agents|mesh-ancestor
64460044|NCT01675648|Analgesics|analgesics|mesh-ancestor
64460045|NCT01675648|Sympatholytics|sympatholytics|mesh-ancestor
64460046|NCT03871348|Cemiplimab|cemiplimab|mesh-list
64460047|NCT03871348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64460049|NCT01566435|Paclitaxel|paclitaxel|mesh-list
64460069|NCT01675804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460070|NCT01675804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64460071|NCT01675804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64460072|NCT01675804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64460073|NCT01675804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460075|NCT01675804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64460076|NCT01696695|Capecitabine|capecitabine|mesh-list
64460077|NCT01696695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64460078|NCT01696695|Antimetabolites|antimetabolites|mesh-ancestor
64460079|NCT01696695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460080|NCT01696695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460081|NCT05261386|Betadex|betadex|mesh-list
64460082|NCT05261386|Sequestering Agents|sequestering agents|mesh-ancestor
64460083|NCT05261386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460084|NCT03899805|Pembrolizumab|pembrolizumab|mesh-list
64564552|NCT00634517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64564553|NCT00634517|Respiratory System Agents|respiratory system agents|mesh-ancestor
64564554|NCT00634517|Tocolytic Agents|tocolytic agents|mesh-ancestor
64460085|NCT03899805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64460086|NCT03899805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460087|NCT04768023|Vitamin D|vitamin d|mesh-list
64460088|NCT04768023|Vitamins|vitamins|mesh-ancestor
64460122|NCT01565889|Protease Inhibitors|protease inhibitors|mesh-ancestor
64460123|NCT01565889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460124|NCT01565889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460125|NCT01565889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64460126|NCT01565889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64460127|NCT01565889|Antiviral Agents|antiviral agents|mesh-ancestor
64460128|NCT01565889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64460129|NCT01565889|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64460130|NCT01565889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64460131|NCT01565889|Antimetabolites|antimetabolites|mesh-ancestor
64460132|NCT01696071|Tiotropium Bromide|tiotropium bromide|mesh-list
64460133|NCT01696071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64460134|NCT01696071|Autonomic Agents|autonomic agents|mesh-ancestor
64460135|NCT01696071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64460136|NCT01696071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460137|NCT01696071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64460138|NCT01696071|Respiratory System Agents|respiratory system agents|mesh-ancestor
64460139|NCT01696071|Parasympatholytics|parasympatholytics|mesh-ancestor
64460140|NCT01696071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64460141|NCT01696071|Cholinergic Agents|cholinergic agents|mesh-ancestor
64460142|NCT01696071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64460143|NCT01696071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460145|NCT01591863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64460174|NCT03654040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64460175|NCT03654040|Alkylating Agents|alkylating agents|mesh-ancestor
64460176|NCT03654040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460177|NCT03654040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460178|NCT03654040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64460180|NCT03844048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460181|NCT03833440|Docetaxel|docetaxel|mesh-list
64460182|NCT03833440|Durvalumab|durvalumab|mesh-list
64460183|NCT03833440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460184|NCT03833440|Tubulin Modulators|tubulin modulators|mesh-ancestor
64460185|NCT03833440|Antimitotic Agents|antimitotic agents|mesh-ancestor
64460186|NCT03833440|Mitosis Modulators|mitosis modulators|mesh-ancestor
64460187|NCT03833440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460188|NCT03833440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64460189|NCT01677442|Anesthetics|anesthetics|mesh-list
64460190|NCT01677442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64460191|NCT01677442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460192|NCT01695135|Prednisone|prednisone|mesh-list
64460193|NCT01695135|Abiraterone Acetate|abiraterone acetate|mesh-list
64460196|NCT01695135|Hormones|hormones|mesh-ancestor
64460228|NCT03735316|Vitamin B 12|vitamin b 12|mesh-list
64460229|NCT03735316|Hydroxocobalamin|hydroxocobalamin|mesh-list
64460230|NCT03735316|Vitamins|vitamins|mesh-ancestor
64460231|NCT03735316|Micronutrients|micronutrients|mesh-ancestor
64460232|NCT03735316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460233|NCT03735316|Vitamin B Complex|vitamin b complex|mesh-ancestor
64460234|NCT03735316|Hematinics|hematinics|mesh-ancestor
64460235|NCT01694433|Vitamin D|vitamin d|mesh-list
64460236|NCT01694433|Calcitriol|calcitriol|mesh-list
64460237|NCT01694433|Calcipotriene|calcipotriene|mesh-list
64460238|NCT01694433|Vitamins|vitamins|mesh-ancestor
64460239|NCT01694433|Micronutrients|micronutrients|mesh-ancestor
64460240|NCT01694433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460241|NCT01694433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64460242|NCT01694433|Dermatologic Agents|dermatologic agents|mesh-ancestor
64460243|NCT01694433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64460244|NCT01694433|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64460245|NCT01694433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64460246|NCT01694433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460247|NCT01694433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64460248|NCT01693185|Midazolam|midazolam|mesh-list
64460249|NCT01693185|Meperidine|meperidine|mesh-list
64460250|NCT01693185|Remifentanil|remifentanil|mesh-list
64460251|NCT01693185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64460252|NCT01693185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64460253|NCT01693185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64460254|NCT01693185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460255|NCT01693185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64460256|NCT01693185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64460257|NCT01693185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64460260|NCT01693185|Anesthetics|anesthetics|mesh-ancestor
64460277|NCT03825796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64564624|NCT02921893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64564625|NCT01920503|Doxorubicin|doxorubicin|mesh-list
64564627|NCT01920503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460278|NCT03825796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64460279|NCT03825796|Immunologic Factors|immunologic factors|mesh-ancestor
64460280|NCT03825796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460281|NCT03825796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64460282|NCT03825796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64460283|NCT03825796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64460284|NCT03825796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460285|NCT03824938|Aspirin|aspirin|mesh-list
64460286|NCT03824938|Acetaminophen|acetaminophen|mesh-list
64460287|NCT03824938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64460288|NCT03824938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64460289|NCT03824938|Analgesics|analgesics|mesh-ancestor
64460290|NCT03824938|Sensory System Agents|sensory system agents|mesh-ancestor
64460291|NCT03824938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64460292|NCT03824938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460293|NCT03824938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64460294|NCT03824938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64460295|NCT03824938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64460296|NCT03824938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64460297|NCT03824938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460298|NCT03824938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64460299|NCT03824938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64460300|NCT03824938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460302|NCT03630640|Nivolumab|nivolumab|mesh-list
64460303|NCT03630640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64460324|NCT03814954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64460325|NCT03814954|Autonomic Agents|autonomic agents|mesh-ancestor
64460326|NCT03814954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64460327|NCT03814954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64460333|NCT03814954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64460334|NCT03814954|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64460336|NCT03813160|Lenabasum|lenabasum|mesh-list
64460337|NCT03813160|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64460338|NCT03813160|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64460339|NCT03813160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64460340|NCT03813160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460341|NCT03813160|Hormones|hormones|mesh-ancestor
64460342|NCT03813160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64460343|NCT03813160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460344|NCT03813160|Hallucinogens|hallucinogens|mesh-ancestor
64460345|NCT03813160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64460346|NCT03813160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64564659|NCT03829891|Insulin Glargine|insulin glargine|mesh-list
64564660|NCT03829891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64564661|NCT03829891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564662|NCT03115151|Fentanyl|fentanyl|mesh-list
64564663|NCT03115151|Hydromorphone|hydromorphone|mesh-list
64564664|NCT03115151|Bupivacaine|bupivacaine|mesh-list
64564665|NCT03115151|Anesthetics, Local|anesthetics, local|mesh-ancestor
64460347|NCT03813160|Analgesics|analgesics|mesh-ancestor
64460349|NCT03813160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64460376|NCT03806530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460377|NCT03806530|Antimanic Agents|antimanic agents|mesh-ancestor
64460378|NCT03806530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64460379|NCT03806530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64460380|NCT03806530|Dopamine Agonists|dopamine agonists|mesh-ancestor
64460381|NCT03806530|Dopamine Agents|dopamine agents|mesh-ancestor
64460382|NCT00003820|Rituximab|rituximab|mesh-list
64460383|NCT00003820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64460384|NCT00003820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460385|NCT00003820|Immunologic Factors|immunologic factors|mesh-ancestor
64460386|NCT00003820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460387|NCT00003820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64460388|NCT01693029|Epoetin Alfa|epoetin alfa|mesh-list
64460389|NCT01693029|Hematinics|hematinics|mesh-ancestor
64460390|NCT01589445|Metformin|metformin|mesh-list
64460391|NCT01589445|Pioglitazone|pioglitazone|mesh-list
64460392|NCT01589445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64460393|NCT01589445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460394|NCT00003910|Prednisone|prednisone|mesh-list
64460433|NCT00004054|Estramustine|estramustine|mesh-list
64460434|NCT00004054|Warfarin|warfarin|mesh-list
64460435|NCT00004054|Hormones|hormones|mesh-list
64460436|NCT00004054|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64460437|NCT00004054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64460438|NCT00004054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460439|NCT00004054|Tubulin Modulators|tubulin modulators|mesh-ancestor
64460440|NCT00004054|Antimitotic Agents|antimitotic agents|mesh-ancestor
64460441|NCT00004054|Mitosis Modulators|mitosis modulators|mesh-ancestor
64557635|NCT03067896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64460442|NCT00004054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460443|NCT00004054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64460444|NCT00004054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64460445|NCT00004054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460446|NCT00004054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64460447|NCT00004054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460448|NCT00004054|Anticoagulants|anticoagulants|mesh-ancestor
64460449|NCT00004054|Androgen Antagonists|androgen antagonists|mesh-ancestor
64460450|NCT00004054|Hormone Antagonists|hormone antagonists|mesh-ancestor
64460451|NCT00004054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64564687|NCT04120753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64564691|NCT04120753|Vasodilator Agents|vasodilator agents|mesh-ancestor
64460452|NCT00004054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64460453|NCT00004054|Alkylating Agents|alkylating agents|mesh-ancestor
64460454|NCT01587885|Omeprazole|omeprazole|mesh-list
64460455|NCT01587885|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64460456|NCT01587885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64460457|NCT01587885|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64460458|NCT01587885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460459|NCT01587885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460460|NCT03802240|Pemetrexed|pemetrexed|mesh-list
64460461|NCT03802240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460462|NCT03802240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460483|NCT04763434|Antiemetics|antiemetics|mesh-ancestor
64460484|NCT04763434|Autonomic Agents|autonomic agents|mesh-ancestor
64460485|NCT04763434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64460486|NCT04763434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460487|NCT04763434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64460488|NCT04763434|Glucocorticoids|glucocorticoids|mesh-ancestor
64460490|NCT04763434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64460491|NCT04763434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64460492|NCT04763434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460493|NCT04763434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64460494|NCT04763434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64460495|NCT04763434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64460496|NCT04763434|Analgesics|analgesics|mesh-ancestor
64460497|NCT04763434|Sensory System Agents|sensory system agents|mesh-ancestor
64460498|NCT04763434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64460499|NCT04763434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64460500|NCT04763434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64460501|NCT04763434|Adrenergic Agents|adrenergic agents|mesh-ancestor
64460502|NCT04763434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64460503|NCT04763434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460504|NCT04763434|Anesthetics, Local|anesthetics, local|mesh-ancestor
64460505|NCT04763434|Anesthetics|anesthetics|mesh-ancestor
64460509|NCT03606538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64460510|NCT03606538|Serotonin Agents|serotonin agents|mesh-ancestor
64460511|NCT03606538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64460512|NCT03606538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460513|NCT03606538|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64557636|NCT03067896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64460514|NCT03606538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64460515|NCT03606538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64460516|NCT03606538|Adrenergic Agents|adrenergic agents|mesh-ancestor
64460517|NCT04762966|Metformin|metformin|mesh-list
64460518|NCT04762966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64460519|NCT04762966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460520|NCT03602560|Seladelpar|seladelpar|mesh-list
64460521|NCT03602560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64460522|NCT03602560|Antimetabolites|antimetabolites|mesh-ancestor
64460523|NCT03602560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460524|NCT03602560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64460525|NCT03797326|Pembrolizumab|pembrolizumab|mesh-list
64460526|NCT03797326|Lenvatinib|lenvatinib|mesh-list
64460527|NCT03797326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64460563|NCT04112043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64460564|NCT04112043|Vasodilator Agents|vasodilator agents|mesh-ancestor
64460565|NCT01561755|Immunoglobulins|immunoglobulins|mesh-list
64460566|NCT01561755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64460567|NCT01561755|Antibodies|antibodies|mesh-list
64460568|NCT01561755|gamma-Globulins|gamma-globulins|mesh-list
64460626|NCT03682978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460627|NCT03682978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64460628|NCT03682978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64460629|NCT03682978|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64460630|NCT03682978|GABA Agonists|gaba agonists|mesh-ancestor
64460631|NCT03682978|GABA Agents|gaba agents|mesh-ancestor
64460632|NCT03682978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64460633|NCT03682978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460634|NCT03676192|Bevacizumab|bevacizumab|mesh-list
64460636|NCT03676192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460654|NCT03580408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64460655|NCT03580408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460656|NCT03580408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64460657|NCT03580408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460658|NCT03775096|Carvedilol|carvedilol|mesh-list
64460659|NCT03775096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64460660|NCT03775096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64460661|NCT03775096|Adrenergic Agents|adrenergic agents|mesh-ancestor
64460662|NCT03775096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64460663|NCT03775096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460664|NCT03775096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460665|NCT03775096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64460666|NCT03775096|Antioxidants|antioxidants|mesh-ancestor
64460667|NCT03775096|Protective Agents|protective agents|mesh-ancestor
64460668|NCT03775096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64460669|NCT03775096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64460670|NCT03775096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64460671|NCT03775096|Vasodilator Agents|vasodilator agents|mesh-ancestor
64460674|NCT03774394|Clopidogrel|clopidogrel|mesh-list
64460705|NCT03766750|Protease Inhibitors|protease inhibitors|mesh-ancestor
64460706|NCT03766750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460707|NCT04762810|Cyclophosphamide|cyclophosphamide|mesh-list
64460708|NCT04762810|Glucocorticoids|glucocorticoids|mesh-list
64460709|NCT04762810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64460710|NCT04762810|Immunologic Factors|immunologic factors|mesh-ancestor
64460711|NCT04762810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460712|NCT04762810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64460713|NCT04762810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64460714|NCT04762810|Alkylating Agents|alkylating agents|mesh-ancestor
64460715|NCT04762810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460716|NCT04762810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460717|NCT04762810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64460718|NCT04762810|Hormones|hormones|mesh-ancestor
64460719|NCT04762810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64460720|NCT03674242|Gemcitabine|gemcitabine|mesh-list
64460721|NCT03674242|Carboplatin|carboplatin|mesh-list
64460722|NCT03674242|Asparaginase|asparaginase|mesh-list
64460723|NCT03674242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460724|NCT03674242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64460725|NCT03674242|Antimetabolites|antimetabolites|mesh-ancestor
64460726|NCT03674242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460727|NCT03674242|Antiviral Agents|antiviral agents|mesh-ancestor
64460728|NCT03674242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64460729|NCT03674242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460730|NCT03674242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64460731|NCT03674242|Immunologic Factors|immunologic factors|mesh-ancestor
64460732|NCT03674242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460793|NCT03570814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64460794|NCT03570814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64460859|NCT03662074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460861|NCT03662074|Antiviral Agents|antiviral agents|mesh-ancestor
64460862|NCT03662074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64460863|NCT03662074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460864|NCT03662074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64460865|NCT03662074|Immunologic Factors|immunologic factors|mesh-ancestor
64460866|NCT03662074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460867|NCT03662074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64460868|NCT03662074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64460869|NCT03559348|Leucovorin|leucovorin|mesh-list
64460899|NCT01559259|Analgesics|analgesics|mesh-ancestor
64564818|NCT03823339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460900|NCT01559259|Sensory System Agents|sensory system agents|mesh-ancestor
64460901|NCT01559259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64460902|NCT01559259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460903|NCT01559259|Antipyretics|antipyretics|mesh-ancestor
64460904|NCT01559259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64460905|NCT01559259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64460906|NCT01559259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64460907|NCT01559259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64460908|NCT01559259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460909|NCT01559259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460910|NCT03088306|Acetaminophen|acetaminophen|mesh-list
64460911|NCT03088306|Fentanyl|fentanyl|mesh-list
64460912|NCT03088306|Ketamine|ketamine|mesh-list
64460913|NCT03088306|Gabapentin|gabapentin|mesh-list
64460914|NCT03088306|Hydromorphone|hydromorphone|mesh-list
64460915|NCT03088306|Anesthetics|anesthetics|mesh-ancestor
64460916|NCT03088306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64460917|NCT03088306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460918|NCT03088306|Analgesics|analgesics|mesh-ancestor
64460919|NCT03088306|Sensory System Agents|sensory system agents|mesh-ancestor
64460920|NCT03088306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64460921|NCT03088306|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64460936|NCT03088306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64460937|NCT03088306|Antimanic Agents|antimanic agents|mesh-ancestor
64460938|NCT01672762|Ipragliflozin|ipragliflozin|mesh-list
64460939|NCT01672762|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64460940|NCT01672762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460941|NCT01672762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64460942|NCT01672762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460943|NCT03088384|Ketamine|ketamine|mesh-list
64460944|NCT03088384|Analgesics|analgesics|mesh-ancestor
64460945|NCT03088384|Sensory System Agents|sensory system agents|mesh-ancestor
64460946|NCT03088384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64460947|NCT03088384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64460948|NCT03088384|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64460949|NCT03088384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64460950|NCT03088384|Anesthetics, General|anesthetics, general|mesh-ancestor
64460951|NCT03088384|Anesthetics|anesthetics|mesh-ancestor
64460952|NCT03088384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64460953|NCT03088384|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64460954|NCT03088384|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64460955|NCT03088384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64460956|NCT03088384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460989|NCT01670500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64460990|NCT01670500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64460991|NCT01670500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64564880|NCT01922999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64460992|NCT01670500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64460993|NCT01670500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64460994|NCT01670500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64460995|NCT01670500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64460997|NCT01678612|Trace Elements|trace elements|mesh-ancestor
64461152|NCT01688739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461153|NCT01688739|Analgesics|analgesics|mesh-ancestor
64461154|NCT01688739|Sensory System Agents|sensory system agents|mesh-ancestor
64461155|NCT01688739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64461156|NCT01688739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461157|NCT00084838|Calcium, Dietary|calcium, dietary|mesh-list
64461158|NCT00084838|Leucovorin|leucovorin|mesh-list
64461159|NCT00084838|Cytarabine|cytarabine|mesh-list
64461160|NCT00084838|Dactinomycin|dactinomycin|mesh-list
64461161|NCT00084838|Hydrocortisone|hydrocortisone|mesh-list
64461162|NCT00084838|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64461163|NCT00084838|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64461164|NCT00084838|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64461165|NCT00084838|Cyclophosphamide|cyclophosphamide|mesh-list
64461166|NCT00084838|Temozolomide|temozolomide|mesh-list
64461196|NCT00084838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64461198|NCT00084838|Dermatologic Agents|dermatologic agents|mesh-ancestor
64461199|NCT00084838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64461200|NCT00084838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64461201|NCT00084838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64461202|NCT00084838|Antiviral Agents|antiviral agents|mesh-ancestor
64461203|NCT00084838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64461204|NCT00084838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64461205|NCT00084838|Antidotes|antidotes|mesh-ancestor
64461206|NCT00084838|Protective Agents|protective agents|mesh-ancestor
64461207|NCT00084838|Vitamin B Complex|vitamin b complex|mesh-ancestor
64461208|NCT00084838|Vitamins|vitamins|mesh-ancestor
64461209|NCT00084838|Micronutrients|micronutrients|mesh-ancestor
64461246|NCT01556997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64461247|NCT01556997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64461248|NCT01556997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64461249|NCT01556997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461250|NCT01556997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64513632|NCT01457469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64461251|NCT01556997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461252|NCT01556997|Vasodilator Agents|vasodilator agents|mesh-ancestor
64461253|NCT01556997|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64461254|NCT01556997|Protease Inhibitors|protease inhibitors|mesh-ancestor
64461255|NCT01556997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461257|NCT00082888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461258|NCT03409588|Riociguat|riociguat|mesh-list
64461259|NCT03409588|Enzyme Activators|enzyme activators|mesh-ancestor
64461260|NCT03409588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461261|NCT03085186|Crizotinib|crizotinib|mesh-list
64461262|NCT03085186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461263|NCT03085186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64461264|NCT03085186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461265|NCT03085186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461266|NCT03084952|Meglumine Antimoniate|meglumine antimoniate|mesh-list
64461267|NCT03084952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64564924|NCT01270659|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64564925|NCT01270659|Fentanyl|fentanyl|mesh-list
64564927|NCT01270659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64564928|NCT01270659|Narcotics|narcotics|mesh-ancestor
64461268|NCT03084952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64461363|NCT03435718|Antinematodal Agents|antinematodal agents|mesh-ancestor
64461365|NCT01678690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64461366|NCT01678690|Antimetabolites|antimetabolites|mesh-ancestor
64461367|NCT01678690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461368|NCT01678690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461369|NCT01678690|Antiviral Agents|antiviral agents|mesh-ancestor
64461370|NCT01678690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64461371|NCT01678690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461372|NCT01678690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64461373|NCT01678690|Immunologic Factors|immunologic factors|mesh-ancestor
64461374|NCT01678690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461375|NCT01679080|Zoledronic Acid|zoledronic acid|mesh-list
64461376|NCT01679080|Teriparatide|teriparatide|mesh-list
64461377|NCT01679080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64461378|NCT01679080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461379|NCT01679080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64461380|NCT03083782|Cyclosporine|cyclosporine|mesh-list
64461381|NCT03083782|Apixaban|apixaban|mesh-list
64461382|NCT03083782|Tacrolimus|tacrolimus|mesh-list
64461383|NCT03083782|Cyclosporins|cyclosporins|mesh-list
64461384|NCT03083782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64461385|NCT03083782|Immunologic Factors|immunologic factors|mesh-ancestor
64461386|NCT03083782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461387|NCT03083782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64461388|NCT03083782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461389|NCT03083782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461390|NCT03083782|Antifungal Agents|antifungal agents|mesh-ancestor
64461391|NCT03083782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64461392|NCT03083782|Dermatologic Agents|dermatologic agents|mesh-ancestor
64461393|NCT03083782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64336782|NCT02313337|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64461394|NCT03083782|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64461395|NCT03083782|Antithrombins|antithrombins|mesh-ancestor
64461396|NCT03083782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64461397|NCT03083782|Protease Inhibitors|protease inhibitors|mesh-ancestor
64461398|NCT03083782|Anticoagulants|anticoagulants|mesh-ancestor
64461399|NCT03083704|Enoxaparin|enoxaparin|mesh-list
64461400|NCT03083704|Rivaroxaban|rivaroxaban|mesh-list
64461401|NCT03083704|Apixaban|apixaban|mesh-list
64461402|NCT03083704|Edoxaban|edoxaban|mesh-list
64461403|NCT03083704|Enoxaparin sodium|enoxaparin sodium|mesh-list
64461404|NCT03083704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64461405|NCT03083704|Antithrombins|antithrombins|mesh-ancestor
64461406|NCT03083704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64461407|NCT03083704|Protease Inhibitors|protease inhibitors|mesh-ancestor
64461409|NCT03083704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461410|NCT03083704|Anticoagulants|anticoagulants|mesh-ancestor
64461411|NCT03083704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64461615|NCT03366298|Sympathomimetics|sympathomimetics|mesh-ancestor
64564940|NCT01270659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64564941|NCT01270659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64564942|NCT01270659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64564943|NCT01271907|Aldesleukin|aldesleukin|mesh-list
64564944|NCT01271907|Cyclophosphamide|cyclophosphamide|mesh-list
64564945|NCT01271907|Fludarabine|fludarabine|mesh-list
64564946|NCT01271907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64461616|NCT03366298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64461617|NCT05688436|Interferons|interferons|mesh-list
64461751|NCT01931059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64461752|NCT01931059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461753|NCT01931059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461754|NCT01931059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64461755|NCT01931059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64461756|NCT01931059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64461757|NCT01931059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64461758|NCT01931059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64461759|NCT01931059|Dopamine Agents|dopamine agents|mesh-ancestor
64461761|NCT01841762|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64461762|NCT01841762|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64461764|NCT01841762|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64461806|NCT01970371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461834|NCT04621435|Trace Elements|trace elements|mesh-ancestor
64461835|NCT04621435|Micronutrients|micronutrients|mesh-ancestor
64461836|NCT04621435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461837|NCT04171700|Rucaparib|rucaparib|mesh-list
64461838|NCT04171700|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64461891|NCT03274258|Ipilimumab|ipilimumab|mesh-list
64461892|NCT03274258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64461893|NCT03274258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461894|NCT03274258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64461895|NCT03274258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461896|NCT05084638|Ofatumumab|ofatumumab|mesh-list
64461897|NCT05084638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461898|NCT01839188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64461899|NCT01839188|Immunologic Factors|immunologic factors|mesh-ancestor
64461925|NCT03279250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64461926|NCT03279250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64461927|NCT03279250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461928|NCT03279250|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64461929|NCT03279250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461930|NCT03279250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461931|NCT03279250|Hormone Antagonists|hormone antagonists|mesh-ancestor
64461932|NCT03279250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64461933|NCT01838642|Ponatinib|ponatinib|mesh-list
64461934|NCT01838642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461935|NCT01838642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64461936|NCT01838642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461937|NCT01838642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461938|NCT05181046|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64461939|NCT05181046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64461940|NCT01813058|Tranexamic Acid|tranexamic acid|mesh-list
64461941|NCT01813058|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64461942|NCT01813058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64461943|NCT01813058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461944|NCT01813058|Hemostatics|hemostatics|mesh-ancestor
64461945|NCT01813058|Coagulants|coagulants|mesh-ancestor
64461946|NCT05491330|Ritonavir|ritonavir|mesh-list
64461947|NCT05491330|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64461948|NCT05491330|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64461949|NCT05491330|Protease Inhibitors|protease inhibitors|mesh-ancestor
64461950|NCT05491330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64461951|NCT05491330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64461952|NCT05491330|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64461953|NCT05491330|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64461954|NCT05491330|Antiviral Agents|antiviral agents|mesh-ancestor
64461955|NCT05491330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64461956|NCT05491330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64461957|NCT05491330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64461958|NCT04601402|Avelumab|avelumab|mesh-list
64336783|NCT02313337|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64461959|NCT04601402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64461960|NCT04601402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64461961|NCT01811732|Vancomycin|vancomycin|mesh-list
64461962|NCT01811732|Aztreonam|aztreonam|mesh-list
64461963|NCT01811732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64461964|NCT01811732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64461965|NCT05139004|Fludarabine|fludarabine|mesh-list
64461966|NCT05139004|Fludarabine phosphate|fludarabine phosphate|mesh-list
64461967|NCT05139004|Melphalan|melphalan|mesh-list
64461968|NCT05139004|Mechlorethamine|mechlorethamine|mesh-list
64461969|NCT05139004|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64461970|NCT05139004|Basiliximab|basiliximab|mesh-list
64461971|NCT05139004|Mitogens|mitogens|mesh-list
64462012|NCT04885972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462013|NCT04885972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64462014|NCT04885972|Immunologic Factors|immunologic factors|mesh-ancestor
64462015|NCT04885972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565037|NCT01302483|Lidocaine|lidocaine|mesh-list
64462016|NCT04885972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462017|NCT04039750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64462019|NCT04039750|Gentamicins|gentamicins|mesh-list
64462020|NCT04039750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64462021|NCT04039750|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64462022|NCT04039750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462023|NCT04039750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462024|NCT03236428|Daratumumab|daratumumab|mesh-list
64462025|NCT03236428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462026|NCT03985540|Methamphetamine|methamphetamine|mesh-list
64462027|NCT03985540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64462028|NCT03985540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462029|NCT03985540|Sympathomimetics|sympathomimetics|mesh-ancestor
64462030|NCT03985540|Autonomic Agents|autonomic agents|mesh-ancestor
64462031|NCT03985540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462066|NCT03943498|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64462067|NCT03943498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462068|NCT03943498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64462069|NCT03943498|Immunologic Factors|immunologic factors|mesh-ancestor
64462070|NCT03943498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462072|NCT05185024|Trace Elements|trace elements|mesh-ancestor
64462073|NCT05185024|Micronutrients|micronutrients|mesh-ancestor
64462074|NCT05185024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462075|NCT04591210|Angiotensin II|angiotensin ii|mesh-list
64462077|NCT04591210|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64462078|NCT04591210|Angiotensinogen|angiotensinogen|mesh-list
64462079|NCT04591210|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64462080|NCT04591210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64513633|NCT01457469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462081|NCT04591210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462082|NCT04591210|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64462084|NCT04591210|Protease Inhibitors|protease inhibitors|mesh-ancestor
64462085|NCT01808690|Metformin|metformin|mesh-list
64462086|NCT01808690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64462087|NCT01808690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462088|NCT04583618|Vaccines|vaccines|mesh-list
64462089|NCT04583618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64462090|NCT04583618|Immunologic Factors|immunologic factors|mesh-ancestor
64462091|NCT04583618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462092|NCT04413734|Gemcitabine|gemcitabine|mesh-list
64462093|NCT04413734|Cisplatin|cisplatin|mesh-list
64462094|NCT04413734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462110|NCT03229798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462111|NCT03229798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462112|NCT04805944|Dolutegravir|dolutegravir|mesh-list
64462204|NCT04746430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462205|NCT04746430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64462207|NCT04746430|Hormones|hormones|mesh-ancestor
64462208|NCT04746430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64462209|NCT04746430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64462210|NCT04746430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462211|NCT03781414|Tacrolimus|tacrolimus|mesh-list
64462212|NCT03781414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64462213|NCT03781414|Immunologic Factors|immunologic factors|mesh-ancestor
64462214|NCT03781414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462215|NCT03781414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64462216|NCT03781414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462217|NCT03781414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462218|NCT03642028|Suvorexant|suvorexant|mesh-list
64462219|NCT03642028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64462220|NCT03642028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64462221|NCT03642028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64462226|NCT04407442|Dexamethasone|dexamethasone|mesh-list
64462241|NCT04407442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64462242|NCT04407442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462243|NCT04407442|Protease Inhibitors|protease inhibitors|mesh-ancestor
64462244|NCT04407442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462245|NCT04407442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462246|NCT04407442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64462247|NCT04407442|Antimetabolites|antimetabolites|mesh-ancestor
64462248|NCT04407442|Dermatologic Agents|dermatologic agents|mesh-ancestor
64462249|NCT04402138|Acalabrutinib|acalabrutinib|mesh-list
64462250|NCT04402138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462251|NCT03197662|Oxytocin|oxytocin|mesh-list
64462252|NCT03197662|Oxytocics|oxytocics|mesh-ancestor
64462253|NCT03197662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64462254|NCT03197662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462255|NCT03194542|Luspatercept|luspatercept|mesh-list
64462256|NCT03194542|Hematinics|hematinics|mesh-ancestor
64462257|NCT03247582|Edoxaban|edoxaban|mesh-list
64462258|NCT03247582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64462259|NCT03247582|Antithrombins|antithrombins|mesh-ancestor
64462260|NCT03247582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64462261|NCT03247582|Protease Inhibitors|protease inhibitors|mesh-ancestor
64462262|NCT03247582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462263|NCT03247582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462264|NCT03247582|Anticoagulants|anticoagulants|mesh-ancestor
64462265|NCT01808612|Fluoxetine|fluoxetine|mesh-list
64462266|NCT01808612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64462267|NCT01808612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64462268|NCT01808612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64462269|NCT01808612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462270|NCT01808612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64462271|NCT01808612|Serotonin Agents|serotonin agents|mesh-ancestor
64462272|NCT01808612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462273|NCT01808612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64462274|NCT01808612|Antidepressive Agents|antidepressive agents|mesh-ancestor
64462281|NCT01908829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64462282|NCT01908829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64462284|NCT01908829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64462285|NCT01908829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462286|NCT01908829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462327|NCT03621904|Antineoplastic Agents|antineoplastic agents|mesh-list
64462328|NCT03621904|Progesterone|progesterone|mesh-list
64462329|NCT03621904|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64462330|NCT03621904|Progestins|progestins|mesh-ancestor
64462332|NCT03621904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64462333|NCT03621904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462334|NCT03621904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64462335|NCT03621904|Hormone Antagonists|hormone antagonists|mesh-ancestor
64462336|NCT03621904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64462337|NCT03621904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64462338|NCT03621904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64462339|NCT03621904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64462340|NCT03621904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462341|NCT03621904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462342|NCT03588754|Propranolol|propranolol|mesh-list
64462343|NCT03588754|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64462344|NCT03588754|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64462345|NCT03588754|Adrenergic Agents|adrenergic agents|mesh-ancestor
64462346|NCT03588754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64462347|NCT03588754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462348|NCT03588754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462349|NCT03588754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64462350|NCT03588754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64462352|NCT01808144|Febuxostat|febuxostat|mesh-list
64462376|NCT03568708|Hormones|hormones|mesh-ancestor
64462377|NCT03568708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64462378|NCT03568708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462379|NCT03568708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64462422|NCT01770392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462423|NCT01770392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462424|NCT01770392|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64462425|NCT01770392|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64462426|NCT01770392|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64462427|NCT01770392|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64462428|NCT01770392|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64462555|NCT01892722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462556|NCT01892722|Antiviral Agents|antiviral agents|mesh-ancestor
64462557|NCT01892722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64462558|NCT01892722|Immunologic Factors|immunologic factors|mesh-ancestor
64462559|NCT01892722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462560|NCT01892722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64462604|NCT01801280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64462625|NCT01807520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64462626|NCT01807520|Immunologic Factors|immunologic factors|mesh-ancestor
64462627|NCT01807520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462628|NCT01555125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64462629|NCT01555125|Immunologic Factors|immunologic factors|mesh-ancestor
64462630|NCT01555125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462631|NCT01768286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64462632|NCT01768286|Ledipasvir|ledipasvir|mesh-list
64462633|NCT01768286|Antiviral Agents|antiviral agents|mesh-ancestor
64462634|NCT01768286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64462635|NCT01800968|Liraglutide|liraglutide|mesh-list
64462636|NCT01800968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64462637|NCT01800968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462638|NCT01800968|Incretins|incretins|mesh-ancestor
64462639|NCT01800968|Hormones|hormones|mesh-ancestor
64462640|NCT01800968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64462641|NCT01687257|Sofosbuvir|sofosbuvir|mesh-list
64462642|NCT01687257|Antiviral Agents|antiviral agents|mesh-ancestor
64462643|NCT01687257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64462644|NCT01806740|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
64462645|NCT01806740|Chelating Agents|chelating agents|mesh-ancestor
64462832|NCT02511106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64462833|NCT02511106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462834|NCT02511106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462835|NCT03180034|Vaccines|vaccines|mesh-list
64462836|NCT03180034|Immunologic Factors|immunologic factors|mesh-ancestor
64462837|NCT03180034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462838|NCT03141424|Fluticasone|fluticasone|mesh-list
64462839|NCT03141424|Mometasone Furoate|mometasone furoate|mesh-list
64462840|NCT03141424|Ciclesonide|ciclesonide|mesh-list
64462841|NCT03141424|Budesonide|budesonide|mesh-list
64462842|NCT03141424|Beclomethasone|beclomethasone|mesh-list
64462843|NCT03141424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64462878|NCT04276480|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64462879|NCT04276480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64462880|NCT04276480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64462881|NCT04276480|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64462882|NCT04276480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462883|NCT04276480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462884|NCT05245708|Oxytocin|oxytocin|mesh-list
64462885|NCT05245708|Oxytocics|oxytocics|mesh-ancestor
64462886|NCT05245708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64462887|NCT05245708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462888|NCT01922596|Ropivacaine|ropivacaine|mesh-list
64462889|NCT01922596|Anesthetics, Local|anesthetics, local|mesh-ancestor
64462890|NCT01922596|Anesthetics|anesthetics|mesh-ancestor
64462891|NCT01922596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64462892|NCT01922596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462893|NCT01922596|Sensory System Agents|sensory system agents|mesh-ancestor
64462894|NCT01922596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462895|NCT01573767|Fluticasone|fluticasone|mesh-list
64462896|NCT01573767|Xhance|xhance|mesh-list
64462897|NCT01573767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64462898|NCT01573767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64462899|NCT01573767|Autonomic Agents|autonomic agents|mesh-ancestor
64462900|NCT01573767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462901|NCT01573767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462928|NCT01551303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64565237|NCT01924325|Anticoagulants|anticoagulants|mesh-ancestor
64565250|NCT01924481|Autonomic Agents|autonomic agents|mesh-ancestor
64462929|NCT01551303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462930|NCT01685073|Zolpidem|zolpidem|mesh-list
64462931|NCT01685073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64462932|NCT01685073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64462950|NCT01572675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64462951|NCT01572675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462952|NCT01572675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64462953|NCT01572675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64462954|NCT01572675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64462955|NCT01572675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64462956|NCT01572675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462957|NCT01572675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462959|NCT01550289|Immunologic Factors|immunologic factors|mesh-ancestor
64462969|NCT01684215|Letrozole|letrozole|mesh-list
64462970|NCT01684215|Palbociclib|palbociclib|mesh-list
64462971|NCT01684215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64462972|NCT01684215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64462973|NCT01684215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64462974|NCT01684215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64462975|NCT01684215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64462976|NCT01684215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64462977|NCT01684215|Hormone Antagonists|hormone antagonists|mesh-ancestor
64462978|NCT01684215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64462979|NCT01684215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64462980|NCT01684215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64462982|NCT01908205|Oxytocics|oxytocics|mesh-ancestor
64462983|NCT01908205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64462984|NCT01908205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463029|NCT01548573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64463030|NCT01548573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64463031|NCT01548573|Antiemetics|antiemetics|mesh-ancestor
64463032|NCT01548573|Autonomic Agents|autonomic agents|mesh-ancestor
64463033|NCT01548573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64463034|NCT01548573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64463035|NCT01548573|Glucocorticoids|glucocorticoids|mesh-ancestor
64463036|NCT01548573|Hormones|hormones|mesh-ancestor
64463037|NCT01548573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64463038|NCT01548573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64463039|NCT01548573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64463040|NCT01548573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64463041|NCT01548573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64463042|NCT01548573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64463090|NCT01517295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64565308|NCT01926821|Sizofiran|sizofiran|mesh-list
64463091|NCT01517295|Narcotics|narcotics|mesh-ancestor
64463092|NCT01517295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64463093|NCT01517295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463094|NCT01517295|Analgesics|analgesics|mesh-ancestor
64463095|NCT01517295|Sensory System Agents|sensory system agents|mesh-ancestor
64463096|NCT01517295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64463097|NCT01517295|Antitussive Agents|antitussive agents|mesh-ancestor
64463098|NCT01517295|Respiratory System Agents|respiratory system agents|mesh-ancestor
64463099|NCT01548417|Mifepristone|mifepristone|mesh-list
64463100|NCT01548417|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64463101|NCT01548417|Abortifacient Agents|abortifacient agents|mesh-ancestor
64463102|NCT01548417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64463103|NCT01548417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463104|NCT01548417|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64463105|NCT01548417|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64463106|NCT01548417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64463123|NCT01546857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64463124|NCT01546857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64463125|NCT01546857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64463126|NCT01546857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64463127|NCT01546857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64463128|NCT01546857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463129|NCT01546857|Antimanic Agents|antimanic agents|mesh-ancestor
64463130|NCT01516749|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64463131|NCT01516749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64463132|NCT01515423|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64463180|NCT00635050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64463181|NCT00635050|Alkylating Agents|alkylating agents|mesh-ancestor
64463182|NCT00635050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64463183|NCT00635050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64463184|NCT00635050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64463185|NCT00635050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64463186|NCT00635050|Growth Substances|growth substances|mesh-ancestor
64463187|NCT00635050|Growth Inhibitors|growth inhibitors|mesh-ancestor
64463216|NCT00634504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64463218|NCT00634504|Protective Agents|protective agents|mesh-ancestor
64463219|NCT00634504|Vitamin B Complex|vitamin b complex|mesh-ancestor
64463220|NCT00634504|Vitamins|vitamins|mesh-ancestor
64463221|NCT00634504|Micronutrients|micronutrients|mesh-ancestor
64463222|NCT03101254|Vemurafenib|vemurafenib|mesh-list
64463223|NCT03101254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463282|NCT01924078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64565322|NCT04395365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64463285|NCT00630994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64463286|NCT00630994|Antimetabolites|antimetabolites|mesh-ancestor
64463287|NCT00630994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463288|NCT00630994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463289|NCT00630994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64463290|NCT03126214|Warfarin|warfarin|mesh-list
64463291|NCT03126214|Anticoagulants|anticoagulants|mesh-list
64463292|NCT01924234|Morphine|morphine|mesh-list
64463293|NCT01924234|Remifentanil|remifentanil|mesh-list
64463318|NCT01924468|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64463319|NCT01924468|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64463320|NCT01924468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64463321|NCT01924468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463322|NCT01924468|Dopamine Agents|dopamine agents|mesh-ancestor
64463323|NCT01924468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64463369|NCT01925092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64463370|NCT01925092|Abortifacient Agents|abortifacient agents|mesh-ancestor
64463371|NCT01925092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64463372|NCT01925092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463373|NCT01925092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64463374|NCT01925092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64463375|NCT01925092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64463376|NCT01925092|Contraceptive Agents|contraceptive agents|mesh-ancestor
64463377|NCT01925092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64463378|NCT01925092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64463379|NCT01925092|Hormone Antagonists|hormone antagonists|mesh-ancestor
64463380|NCT01925092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64463381|NCT01925092|Luteolytic Agents|luteolytic agents|mesh-ancestor
64463382|NCT01925092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64463383|NCT01925092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64463384|NCT01905943|Cyclophosphamide|cyclophosphamide|mesh-list
64463385|NCT01905943|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64463386|NCT01905943|Chlorambucil|chlorambucil|mesh-list
64463387|NCT01905943|Fludarabine|fludarabine|mesh-list
64463388|NCT01905943|Obinutuzumab|obinutuzumab|mesh-list
64463389|NCT01905943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64463390|NCT01905943|Immunologic Factors|immunologic factors|mesh-ancestor
64463391|NCT01905943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463392|NCT01905943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64463393|NCT01905943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64463410|NCT01929031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64463411|NCT01929031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463412|NCT01929031|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64463413|NCT01929031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64463414|NCT01929031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64463461|NCT01928719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64463462|NCT01928719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463463|NCT00986674|Paclitaxel|paclitaxel|mesh-list
64463464|NCT00986674|Carboplatin|carboplatin|mesh-list
64463465|NCT00986674|Cetuximab|cetuximab|mesh-list
64463466|NCT00986674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64463467|NCT00986674|Antibodies|antibodies|mesh-list
64463468|NCT00986674|Immunoglobulins|immunoglobulins|mesh-list
64463469|NCT00986674|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64463470|NCT00986674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64463471|NCT00986674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463472|NCT00986674|Tubulin Modulators|tubulin modulators|mesh-ancestor
64463473|NCT00986674|Antimitotic Agents|antimitotic agents|mesh-ancestor
64463474|NCT00986674|Mitosis Modulators|mitosis modulators|mesh-ancestor
64463475|NCT00986674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463476|NCT00986674|Immunologic Factors|immunologic factors|mesh-ancestor
64463477|NCT00986674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463478|NCT00986440|Efatutazone|efatutazone|mesh-list
64463479|NCT00986440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463480|NCT03118492|Mycophenolic Acid|mycophenolic acid|mesh-list
64463481|NCT03118492|Cyclophosphamide|cyclophosphamide|mesh-list
64463482|NCT03118492|Melphalan|melphalan|mesh-list
64463483|NCT03118492|Mechlorethamine|mechlorethamine|mesh-list
64463484|NCT03118492|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64463485|NCT03118492|Fludarabine|fludarabine|mesh-list
64463486|NCT03118492|Tacrolimus|tacrolimus|mesh-list
64463487|NCT03118492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64463488|NCT03118492|Immunologic Factors|immunologic factors|mesh-ancestor
64463489|NCT03118492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463490|NCT03118492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64463491|NCT03118492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64463501|NCT03118492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64463502|NCT03118492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64463515|NCT01904149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64463516|NCT04629547|Suvorexant|suvorexant|mesh-list
64463517|NCT04629547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64463518|NCT04629547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64463519|NCT04629547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64463520|NCT04629547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463521|NCT04629547|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64463523|NCT04629547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463552|NCT00985504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463553|NCT00985504|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64463554|NCT00985504|Antidepressive Agents|antidepressive agents|mesh-ancestor
64463555|NCT00985504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64463556|NCT00985504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64463557|NCT00985504|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64463558|NCT00985504|Analgesics|analgesics|mesh-ancestor
64463559|NCT00985504|Sensory System Agents|sensory system agents|mesh-ancestor
64463560|NCT00985504|Dopamine Agents|dopamine agents|mesh-ancestor
64463561|NCT01921192|Folic Acid|folic acid|mesh-list
64463562|NCT01921192|Hematinics|hematinics|mesh-ancestor
64463563|NCT01921192|Vitamin B Complex|vitamin b complex|mesh-ancestor
64463564|NCT01921192|Vitamins|vitamins|mesh-ancestor
64463565|NCT01921192|Micronutrients|micronutrients|mesh-ancestor
64463566|NCT01921192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463567|NCT04275388|Interferons|interferons|mesh-list
64463568|NCT04275388|Ritonavir|ritonavir|mesh-list
64463569|NCT04275388|Lopinavir|lopinavir|mesh-list
64463570|NCT04275388|Interferon-alpha|interferon-alpha|mesh-list
64463571|NCT04275388|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
64463572|NCT04275388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463573|NCT04275388|Antiviral Agents|antiviral agents|mesh-ancestor
64463574|NCT04275388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64463575|NCT04275388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64463603|NCT00985192|Everolimus|everolimus|mesh-list
64463604|NCT00985192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463605|NCT00985192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64463606|NCT00985192|Immunologic Factors|immunologic factors|mesh-ancestor
64463607|NCT00985192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463608|NCT03390010|Misoprostol|misoprostol|mesh-list
64463609|NCT03390010|Carboprost|carboprost|mesh-list
64463610|NCT03390010|Oxytocin|oxytocin|mesh-list
64463611|NCT03390010|Methylergonovine|methylergonovine|mesh-list
64463612|NCT03390010|Carboprost tromethamine|carboprost tromethamine|mesh-list
64463613|NCT03390010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64463614|NCT03390010|Abortifacient Agents|abortifacient agents|mesh-ancestor
64463615|NCT03390010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64463616|NCT03390010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463617|NCT03390010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64463618|NCT03390010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64463619|NCT03390010|Oxytocics|oxytocics|mesh-ancestor
64463620|NCT00984568|Aminosalicylic Acid|aminosalicylic acid|mesh-list
64463621|NCT00984568|Prednisolone|prednisolone|mesh-list
64463622|NCT00984568|Mesalamine|mesalamine|mesh-list
64463623|NCT00984568|Azathioprine|azathioprine|mesh-list
64463624|NCT00984568|Infliximab|infliximab|mesh-list
64463625|NCT00984568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64463626|NCT00984568|Glucocorticoids|glucocorticoids|mesh-ancestor
64463632|NCT00984568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64463633|NCT00984568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64513637|NCT01457469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64463650|NCT02984176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463651|NCT02984176|Emollients|emollients|mesh-ancestor
64463652|NCT02984176|Dermatologic Agents|dermatologic agents|mesh-ancestor
64463653|NCT01921738|Azithromycin|azithromycin|mesh-list
64463654|NCT01921738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64463655|NCT01921738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64463656|NCT01921816|Dialysis Solutions|dialysis solutions|mesh-list
64463657|NCT01921816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64463658|NCT00984256|Atovaquone|atovaquone|mesh-list
64463659|NCT00984256|Proguanil|proguanil|mesh-list
64463660|NCT00984256|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
64463661|NCT00984256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64463662|NCT00984256|Antimalarials|antimalarials|mesh-ancestor
64463663|NCT00984256|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64463664|NCT00984256|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64463665|NCT00984256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64463666|NCT00984256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463667|NCT00984256|Antimetabolites|antimetabolites|mesh-ancestor
64463668|NCT00984022|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64463669|NCT00984022|Laxatives|laxatives|mesh-ancestor
64463670|NCT00984022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64463672|NCT01890265|Nintedanib|nintedanib|mesh-list
64463673|NCT01890265|Immunoglobulins|immunoglobulins|mesh-list
64463674|NCT01890265|Antibodies|antibodies|mesh-list
64463683|NCT01890265|Analgesics|analgesics|mesh-ancestor
64463701|NCT01926652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64463702|NCT03110926|Leucovorin|leucovorin|mesh-list
64463703|NCT03110926|Paclitaxel|paclitaxel|mesh-list
64463704|NCT03110926|Carboplatin|carboplatin|mesh-list
64463705|NCT03110926|Oxaliplatin|oxaliplatin|mesh-list
64463706|NCT03110926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64463707|NCT03110926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64463708|NCT03110926|Tubulin Modulators|tubulin modulators|mesh-ancestor
64463709|NCT03110926|Antimitotic Agents|antimitotic agents|mesh-ancestor
64463710|NCT03110926|Mitosis Modulators|mitosis modulators|mesh-ancestor
64463711|NCT03110926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463712|NCT03110926|Antidotes|antidotes|mesh-ancestor
64463713|NCT03110926|Protective Agents|protective agents|mesh-ancestor
64463714|NCT03110926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463715|NCT03110926|Vitamin B Complex|vitamin b complex|mesh-ancestor
64463716|NCT03110926|Vitamins|vitamins|mesh-ancestor
64463717|NCT03110926|Micronutrients|micronutrients|mesh-ancestor
64463718|NCT01928329|Exenatide|exenatide|mesh-list
64463719|NCT01928329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64463720|NCT01928329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463721|NCT01928329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64463722|NCT01928329|Incretins|incretins|mesh-ancestor
64463723|NCT01928329|Hormones|hormones|mesh-ancestor
64463724|NCT01928329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64463725|NCT01890109|Erenumab|erenumab|mesh-list
64463726|NCT01890109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64463727|NCT01890109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463728|NCT01890109|Analgesics|analgesics|mesh-ancestor
64463750|NCT03088540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64463751|NCT03088540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64463753|NCT03088540|Antiviral Agents|antiviral agents|mesh-ancestor
64463754|NCT03088540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64463755|NCT03088540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64463756|NCT03088540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64463757|NCT03088540|Immunologic Factors|immunologic factors|mesh-ancestor
64463758|NCT03088540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64463759|NCT03088540|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64463760|NCT03088540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64463824|NCT05601466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64464008|NCT03036904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64464010|NCT03036904|Hormones|hormones|mesh-ancestor
64464011|NCT03036904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64464048|NCT03828058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64464049|NCT03828058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464050|NCT03828058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464051|NCT01513551|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64464052|NCT01513551|Immunologic Factors|immunologic factors|mesh-ancestor
64464053|NCT01513551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464054|NCT03827122|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64464055|NCT03827122|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64464056|NCT03827122|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64464057|NCT03827122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64464058|NCT03827122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464059|NCT03827122|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64464155|NCT03825016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64464156|NCT03825016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64464157|NCT03825016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464158|NCT03825016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64464159|NCT03825016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64464160|NCT03825016|Analgesics|analgesics|mesh-ancestor
64464161|NCT03825016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64464162|NCT03825016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64464163|NCT03825016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64464164|NCT03825016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464165|NCT03043924|Cyproterone Acetate|cyproterone acetate|mesh-list
64464166|NCT03043924|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64464167|NCT03043924|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64464168|NCT03043924|Levonorgestrel|levonorgestrel|mesh-list
64464169|NCT03043924|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64464170|NCT03043924|Estradiol|estradiol|mesh-list
64464171|NCT03043924|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64464172|NCT03043924|Cyproterone|cyproterone|mesh-list
64464173|NCT03043924|Estrogens|estrogens|mesh-ancestor
64464174|NCT03043924|Hormones|hormones|mesh-ancestor
64464175|NCT03043924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64464184|NCT03043924|Androgen Antagonists|androgen antagonists|mesh-ancestor
64464185|NCT03043924|Hormone Antagonists|hormone antagonists|mesh-ancestor
64464186|NCT03043924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464187|NCT03043924|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64464190|NCT03824314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64464191|NCT03824314|Narcotics|narcotics|mesh-ancestor
64464192|NCT03824314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64464193|NCT03824314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464194|NCT03824314|Analgesics|analgesics|mesh-ancestor
64464195|NCT03824314|Sensory System Agents|sensory system agents|mesh-ancestor
64464196|NCT03824314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64464197|NCT03824314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64464198|NCT03824314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64464199|NCT03824314|Anesthetics, General|anesthetics, general|mesh-ancestor
64464200|NCT03824314|Anesthetics|anesthetics|mesh-ancestor
64464201|NCT03824314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64464202|NCT03824314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64464203|NCT03824314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64464204|NCT03824314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64464205|NCT03824314|GABA Modulators|gaba modulators|mesh-ancestor
64464206|NCT03824314|GABA Agents|gaba agents|mesh-ancestor
64464207|NCT03824314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64464208|NCT03824314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464209|NCT03824002|Insulin|insulin|mesh-list
64464210|NCT03824002|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64464211|NCT03824002|Metformin|metformin|mesh-list
64464323|NCT04273282|Protective Agents|protective agents|mesh-ancestor
64464324|NCT04273282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64464325|NCT04273282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64464326|NCT04273282|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64464327|NCT04273282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64464328|NCT04273282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464329|NCT04273282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464331|NCT01454440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64464332|NCT01454518|Anesthetics|anesthetics|mesh-list
64464333|NCT01454518|Anesthetics, Local|anesthetics, local|mesh-list
64464346|NCT01455142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464347|NCT01455532|Gemcitabine|gemcitabine|mesh-list
64464348|NCT01455532|Carboplatin|carboplatin|mesh-list
64464349|NCT01455532|Doxorubicin|doxorubicin|mesh-list
64464350|NCT01455532|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64464351|NCT01455532|Iniparib|iniparib|mesh-list
64464352|NCT01455532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464353|NCT01455532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64464354|NCT01455532|Antimetabolites|antimetabolites|mesh-ancestor
64464355|NCT01455532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464362|NCT01455532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64464363|NCT01455532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64464364|NCT01455532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64464365|NCT01455532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64464366|NCT01455922|Glimepiride|glimepiride|mesh-list
64464367|NCT01455922|Exenatide|exenatide|mesh-list
64464368|NCT01455922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64464369|NCT01455922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64565574|NCT04122755|Narcotics|narcotics|mesh-ancestor
64464370|NCT01455922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464371|NCT01455922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64464372|NCT01455922|Immunologic Factors|immunologic factors|mesh-ancestor
64464373|NCT01455922|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64464374|NCT01455922|Incretins|incretins|mesh-ancestor
64464375|NCT01455922|Hormones|hormones|mesh-ancestor
64464376|NCT01455922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64464377|NCT01456234|Oseltamivir|oseltamivir|mesh-list
64464378|NCT01456234|Antiviral Agents|antiviral agents|mesh-ancestor
64464379|NCT01456234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64464380|NCT01456234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464381|NCT01456234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464382|NCT01456312|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64464383|NCT01456312|Entecavir|entecavir|mesh-list
64464384|NCT01456312|Antiviral Agents|antiviral agents|mesh-ancestor
64464385|NCT01456312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64464386|NCT02542696|Apomorphine|apomorphine|mesh-list
64464387|NCT02542696|Emetics|emetics|mesh-ancestor
64464412|NCT01456546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64464413|NCT01456546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64464414|NCT01456546|Antimetabolites|antimetabolites|mesh-ancestor
64464415|NCT01456624|Megestrol Acetate|megestrol acetate|mesh-list
64464416|NCT01456624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64464417|NCT01456624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464418|NCT01456624|Appetite Stimulants|appetite stimulants|mesh-ancestor
64464419|NCT01456624|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64464420|NCT01456624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464421|NCT01457716|Budesonide|budesonide|mesh-list
64464422|NCT01457716|Formoterol Fumarate|formoterol fumarate|mesh-list
64464423|NCT01457716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64464424|NCT01457716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64464425|NCT01457716|Autonomic Agents|autonomic agents|mesh-ancestor
64464426|NCT01457716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64464427|NCT01457716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464428|NCT01457716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64464429|NCT01457716|Respiratory System Agents|respiratory system agents|mesh-ancestor
64464430|NCT01457716|Glucocorticoids|glucocorticoids|mesh-ancestor
64464544|NCT01892332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64464545|NCT01892332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64464566|NCT01892644|Sequestering Agents|sequestering agents|mesh-ancestor
64464567|NCT01892644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464568|NCT01925989|Insulin Glargine|insulin glargine|mesh-list
64464569|NCT01925989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64464570|NCT01925989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464571|NCT01901419|Nitroglycerin|nitroglycerin|mesh-list
64464572|NCT01901419|Vasodilator Agents|vasodilator agents|mesh-ancestor
64464573|NCT02798536|Paclitaxel|paclitaxel|mesh-list
64464574|NCT02798536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64464575|NCT02798536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565601|NCT04129697|Protective Agents|protective agents|mesh-ancestor
64565602|NCT04128137|Fludrocortisone|fludrocortisone|mesh-list
64464576|NCT02798536|Tubulin Modulators|tubulin modulators|mesh-ancestor
64464577|NCT02798536|Antimitotic Agents|antimitotic agents|mesh-ancestor
64464578|NCT02798536|Mitosis Modulators|mitosis modulators|mesh-ancestor
64464579|NCT02798536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464580|NCT04758286|Anesthetics|anesthetics|mesh-list
64464581|NCT04758286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64464582|NCT04758286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945385|NCT05672225|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64464583|NCT01615939|Bupivacaine|bupivacaine|mesh-list
64464584|NCT01615939|Ropivacaine|ropivacaine|mesh-list
64464585|NCT01615939|Anesthetics, Local|anesthetics, local|mesh-ancestor
64464586|NCT01615939|Anesthetics|anesthetics|mesh-ancestor
64464587|NCT01615939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64464588|NCT01615939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464589|NCT01615939|Sensory System Agents|sensory system agents|mesh-ancestor
64464613|NCT01893424|Nabiximols|nabiximols|mesh-list
64464614|NCT01893424|Cannabidiol|cannabidiol|mesh-list
64464615|NCT01893424|Piperine|piperine|mesh-list
64464616|NCT01893424|Anticonvulsants|anticonvulsants|mesh-ancestor
64464617|NCT01893424|Hallucinogens|hallucinogens|mesh-ancestor
64464618|NCT01893424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464629|NCT01893424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64464630|NCT01893424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64464632|NCT02788708|Paclitaxel|paclitaxel|mesh-list
64464633|NCT02788708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64464634|NCT02788708|Lenvatinib|lenvatinib|mesh-list
64464635|NCT02788708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64464636|NCT02788708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464637|NCT02788708|Tubulin Modulators|tubulin modulators|mesh-ancestor
64464638|NCT02788708|Antimitotic Agents|antimitotic agents|mesh-ancestor
64464639|NCT02788708|Mitosis Modulators|mitosis modulators|mesh-ancestor
64464662|NCT02773732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464663|NCT02773732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64464664|NCT02773732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64464665|NCT02773732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64565642|NCT05793359|Prednisolone phosphate|prednisolone phosphate|mesh-list
64565643|NCT05793359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64565644|NCT05793359|Antiemetics|antiemetics|mesh-ancestor
64565645|NCT05793359|Autonomic Agents|autonomic agents|mesh-ancestor
64565646|NCT05793359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565647|NCT05793359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565648|NCT05793359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64565649|NCT05793359|Glucocorticoids|glucocorticoids|mesh-ancestor
64565650|NCT05793359|Hormones|hormones|mesh-ancestor
64464666|NCT02773732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64464668|NCT02769520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64464669|NCT02769520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464671|NCT02762266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464672|NCT02735122|Acetaminophen|acetaminophen|mesh-list
64464673|NCT02735122|Ibuprofen|ibuprofen|mesh-list
64464674|NCT02735122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64464675|NCT02735122|Analgesics|analgesics|mesh-ancestor
64464676|NCT02735122|Sensory System Agents|sensory system agents|mesh-ancestor
64464677|NCT02735122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64464678|NCT02735122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464679|NCT02735122|Antipyretics|antipyretics|mesh-ancestor
64464680|NCT02735122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64464681|NCT02735122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64464682|NCT02735122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64464683|NCT02735122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64464684|NCT02735122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64464685|NCT02735122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464686|NCT02720068|Leucovorin|leucovorin|mesh-list
64464687|NCT02720068|Pembrolizumab|pembrolizumab|mesh-list
64464688|NCT02720068|Fluorouracil|fluorouracil|mesh-list
64464689|NCT02720068|Oxaliplatin|oxaliplatin|mesh-list
64464690|NCT02720068|Irinotecan|irinotecan|mesh-list
64464691|NCT02720068|Lenvatinib|lenvatinib|mesh-list
64464692|NCT02720068|Calcium|calcium|mesh-list
64464709|NCT02720068|Vitamins|vitamins|mesh-ancestor
64464710|NCT02720068|Micronutrients|micronutrients|mesh-ancestor
64464711|NCT02720068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64464712|NCT02718118|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64464714|NCT02718118|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64464715|NCT02718118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64464716|NCT02718118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464717|NCT02718118|Cholinergic Agents|cholinergic agents|mesh-ancestor
64464718|NCT02718118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64464719|NCT02718118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464720|NCT02718118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64464721|NCT02718118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64464722|NCT02717962|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
64464723|NCT02717962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64464783|NCT02684032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64565722|NCT05792410|Fulvestrant|fulvestrant|mesh-list
64565723|NCT05792410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64464784|NCT02684032|Hormone Antagonists|hormone antagonists|mesh-ancestor
64464785|NCT02684032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64464822|NCT02707588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464823|NCT02707588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64464824|NCT02707588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464825|NCT05602480|Vaccines|vaccines|mesh-list
64464826|NCT05602480|Immunologic Factors|immunologic factors|mesh-ancestor
64464827|NCT05602480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464828|NCT05600296|Levobupivacaine|levobupivacaine|mesh-list
64464829|NCT05600296|Anesthetics, Local|anesthetics, local|mesh-ancestor
64464830|NCT05600296|Anesthetics|anesthetics|mesh-ancestor
64464831|NCT05600296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64464832|NCT05600296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464833|NCT05600296|Sensory System Agents|sensory system agents|mesh-ancestor
64464834|NCT05600296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64464835|NCT05604586|Acetylcysteine|acetylcysteine|mesh-list
64464836|NCT05604586|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64464837|NCT05604586|Antiviral Agents|antiviral agents|mesh-ancestor
64464838|NCT05604586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64464839|NCT05604586|Expectorants|expectorants|mesh-ancestor
64464845|NCT05604586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464846|NCT05604586|Antidotes|antidotes|mesh-ancestor
64464847|NCT03349450|Cyclophosphamide|cyclophosphamide|mesh-list
64464848|NCT03349450|Pembrolizumab|pembrolizumab|mesh-list
64464849|NCT03349450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64464850|NCT03349450|Immunologic Factors|immunologic factors|mesh-ancestor
64464851|NCT03349450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464852|NCT03349450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64464853|NCT03349450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64464854|NCT03349450|Alkylating Agents|alkylating agents|mesh-ancestor
64464855|NCT03349450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64464856|NCT03349450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64464857|NCT03349450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64464858|NCT03349450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64464859|NCT05604118|Aspirin|aspirin|mesh-list
64464860|NCT05604118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64464861|NCT05604118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64464862|NCT05604118|Analgesics|analgesics|mesh-ancestor
64464863|NCT05604118|Sensory System Agents|sensory system agents|mesh-ancestor
64464864|NCT05604118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64464865|NCT05604118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64464866|NCT05604118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64464867|NCT05604118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64464943|NCT04127500|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64464944|NCT04127500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64464945|NCT04127500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64464946|NCT04127500|Adrenergic Agents|adrenergic agents|mesh-ancestor
64464947|NCT04127500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64464949|NCT03017326|Gemcitabine|gemcitabine|mesh-list
64464972|NCT03017326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64464973|NCT03017326|Tubulin Modulators|tubulin modulators|mesh-ancestor
64464974|NCT03017326|Antimitotic Agents|antimitotic agents|mesh-ancestor
64464975|NCT03017326|Mitosis Modulators|mitosis modulators|mesh-ancestor
64464976|NCT03017326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64464978|NCT03012880|Dexamethasone acetate|dexamethasone acetate|mesh-list
64464979|NCT03012880|Lenalidomide|lenalidomide|mesh-list
64464980|NCT03012880|Daratumumab|daratumumab|mesh-list
64464981|NCT03012880|Ixazomib|ixazomib|mesh-list
64464982|NCT03012880|Ichthammol|ichthammol|mesh-list
64464983|NCT03012880|BB 1101|bb 1101|mesh-list
64464984|NCT03012880|Glycine|glycine|mesh-list
64464985|NCT03012880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64464986|NCT03012880|Antiemetics|antiemetics|mesh-ancestor
64464987|NCT03012880|Autonomic Agents|autonomic agents|mesh-ancestor
64464988|NCT03012880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64465050|NCT03007732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465051|NCT03007732|Hormone Antagonists|hormone antagonists|mesh-ancestor
64465052|NCT03007732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64465053|NCT03007732|Antioxidants|antioxidants|mesh-ancestor
64465054|NCT03007732|Protective Agents|protective agents|mesh-ancestor
64465055|NCT03007732|Vitamins|vitamins|mesh-ancestor
64465056|NCT03007732|Micronutrients|micronutrients|mesh-ancestor
64465069|NCT03007420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64465070|NCT03007420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465071|NCT04125706|Metronidazole|metronidazole|mesh-list
64465072|NCT04125706|Minocycline|minocycline|mesh-list
64465073|NCT04125706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64465074|NCT04125706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64465075|NCT04125706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64465076|NCT04125706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64465077|NCT03005782|Cemiplimab|cemiplimab|mesh-list
64465176|NCT04121416|Oxycodone|oxycodone|mesh-list
64465177|NCT04121416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64465178|NCT04121416|Narcotics|narcotics|mesh-ancestor
64465179|NCT04121416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64465180|NCT04121416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465181|NCT04121416|Analgesics|analgesics|mesh-ancestor
64465182|NCT04121416|Sensory System Agents|sensory system agents|mesh-ancestor
64465183|NCT04121416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64465184|NCT04121416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64465185|NCT04121416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64465186|NCT04121416|Anesthetics, General|anesthetics, general|mesh-ancestor
64713969|NCT02834624|Calfactant|calfactant|mesh-list
64465188|NCT04121338|Bupivacaine|bupivacaine|mesh-list
64465189|NCT04121338|Anesthetics, Local|anesthetics, local|mesh-ancestor
64465190|NCT04121338|Anesthetics|anesthetics|mesh-ancestor
64465191|NCT04121338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64465192|NCT04121338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465193|NCT04121338|Sensory System Agents|sensory system agents|mesh-ancestor
64465194|NCT04121338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64465195|NCT01896193|Sofosbuvir|sofosbuvir|mesh-list
64465196|NCT01896193|Antiviral Agents|antiviral agents|mesh-ancestor
64465197|NCT01896193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64465198|NCT01922011|Vancomycin|vancomycin|mesh-list
64465199|NCT01922011|Daptomycin|daptomycin|mesh-list
64465200|NCT01922011|Nafcillin|nafcillin|mesh-list
64465201|NCT01922011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64465202|NCT01922011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64465203|NCT04127968|Vitamin A|vitamin a|mesh-list
64465204|NCT04127968|Vitamins|vitamins|mesh-ancestor
64465205|NCT04127968|Micronutrients|micronutrients|mesh-ancestor
64465206|NCT04127968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465216|NCT01921387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64465217|NCT01921387|Immunologic Factors|immunologic factors|mesh-ancestor
64465218|NCT01921387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465219|NCT01921387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64465220|NCT01921387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465221|NCT01921387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64465222|NCT01921387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64465223|NCT01921387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465224|NCT01921387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465225|NCT01921387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64465226|NCT01921387|Antimetabolites|antimetabolites|mesh-ancestor
64465227|NCT01921387|Antiviral Agents|antiviral agents|mesh-ancestor
64465228|NCT01921387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64465229|NCT01921387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64465230|NCT01921387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64465231|NCT01921387|Alkylating Agents|alkylating agents|mesh-ancestor
64465232|NCT01921387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64465233|NCT01921387|Keratolytic Agents|keratolytic agents|mesh-ancestor
64465234|NCT01921387|Dermatologic Agents|dermatologic agents|mesh-ancestor
64465235|NCT01921387|Tubulin Modulators|tubulin modulators|mesh-ancestor
64465236|NCT01921387|Antimitotic Agents|antimitotic agents|mesh-ancestor
64465237|NCT01921387|Mitosis Modulators|mitosis modulators|mesh-ancestor
64465238|NCT04129996|Paclitaxel|paclitaxel|mesh-list
64465239|NCT04129996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64465240|NCT04129996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465241|NCT04129996|Tubulin Modulators|tubulin modulators|mesh-ancestor
64465242|NCT04129996|Antimitotic Agents|antimitotic agents|mesh-ancestor
64465262|NCT04124614|Brexpiprazole|brexpiprazole|mesh-list
64465263|NCT04124614|Antidepressive Agents|antidepressive agents|mesh-ancestor
64465320|NCT03829696|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64465321|NCT03829696|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64465322|NCT03829696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64465323|NCT03829696|Contraceptive Agents|contraceptive agents|mesh-ancestor
64465324|NCT03829696|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64465325|NCT03829696|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64465326|NCT03829696|Hormone Antagonists|hormone antagonists|mesh-ancestor
64465327|NCT03829696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64465328|NCT03829696|Luteolytic Agents|luteolytic agents|mesh-ancestor
64465329|NCT03829696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64465330|NCT03829696|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64565828|NCT05708638|Anesthetics|anesthetics|mesh-list
64465331|NCT03829774|Acetaminophen|acetaminophen|mesh-list
64465332|NCT03829774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64465333|NCT03829774|Analgesics|analgesics|mesh-ancestor
64465334|NCT03829774|Sensory System Agents|sensory system agents|mesh-ancestor
64465335|NCT03829774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64465336|NCT03829774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465337|NCT03829774|Antipyretics|antipyretics|mesh-ancestor
64465338|NCT02977780|Temozolomide|temozolomide|mesh-list
64465339|NCT02977780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64465358|NCT02965768|Naltrexone|naltrexone|mesh-list
64465359|NCT02965768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64465360|NCT02965768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64465361|NCT02965768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465362|NCT02965768|Sensory System Agents|sensory system agents|mesh-ancestor
64465363|NCT02965768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64465364|NCT01895101|Tranexamic Acid|tranexamic acid|mesh-list
64465365|NCT01895101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64465366|NCT01895101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64465367|NCT01895101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465368|NCT01895101|Hemostatics|hemostatics|mesh-ancestor
64465369|NCT01895101|Coagulants|coagulants|mesh-ancestor
64465370|NCT03828682|Mycophenolic Acid|mycophenolic acid|mesh-list
64465371|NCT03828682|Prednisone|prednisone|mesh-list
64465372|NCT03828682|Methylprednisolone|methylprednisolone|mesh-list
64465373|NCT03828682|Tacrolimus|tacrolimus|mesh-list
64465374|NCT03828682|Thymoglobulin|thymoglobulin|mesh-list
64465375|NCT03828682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64465376|NCT03828682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64465377|NCT03828682|Glucocorticoids|glucocorticoids|mesh-ancestor
64465405|NCT03483649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465406|NCT03483649|Growth Inhibitors|growth inhibitors|mesh-ancestor
64465408|NCT03822520|Celecoxib|celecoxib|mesh-list
64465409|NCT03822520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64565877|NCT05656235|Pembrolizumab|pembrolizumab|mesh-list
64465410|NCT03822520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64465411|NCT03822520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64465412|NCT03822520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64465413|NCT03822520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465414|NCT03822520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465415|NCT03822520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465416|NCT03822520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713970|NCT02834624|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
64465417|NCT03822520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64465418|NCT03822520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64465419|NCT03822520|Analgesics|analgesics|mesh-ancestor
64465420|NCT03822520|Sensory System Agents|sensory system agents|mesh-ancestor
64465421|NCT03822520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64465422|NCT03822520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64465423|NCT03822520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64465424|NCT03822520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64465425|NCT03822520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64465426|NCT01894477|Fludarabine|fludarabine|mesh-list
64465427|NCT01894477|Fludarabine phosphate|fludarabine phosphate|mesh-list
64465457|NCT03820180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64465458|NCT03820180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64465459|NCT03820180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64465460|NCT03820180|Autonomic Agents|autonomic agents|mesh-ancestor
64465461|NCT03820180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64465462|NCT03820180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465463|NCT03820180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64465464|NCT03820180|Respiratory System Agents|respiratory system agents|mesh-ancestor
64465472|NCT03820180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465474|NCT03820180|Hormones|hormones|mesh-ancestor
64465475|NCT03820180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64465476|NCT03820180|Sympathomimetics|sympathomimetics|mesh-ancestor
64465477|NCT01894243|Olaparib|olaparib|mesh-list
64465478|NCT01894243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64465509|NCT01450774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64465510|NCT01450774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465511|NCT01450774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64465512|NCT01450774|Glucocorticoids|glucocorticoids|mesh-ancestor
64465513|NCT01450774|Hormones|hormones|mesh-ancestor
64465514|NCT01450774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64465515|NCT01450930|Hydrocortisone|hydrocortisone|mesh-list
64465516|NCT01450930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64465517|NCT01450930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64465518|NCT01450930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64465519|NCT01450930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64465520|NCT02913196|Prednisone|prednisone|mesh-list
64465521|NCT02913196|Docetaxel|docetaxel|mesh-list
64465522|NCT02913196|Abiraterone Acetate|abiraterone acetate|mesh-list
64465523|NCT02913196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465524|NCT02913196|Tubulin Modulators|tubulin modulators|mesh-ancestor
64465525|NCT02913196|Antimitotic Agents|antimitotic agents|mesh-ancestor
64465526|NCT02913196|Mitosis Modulators|mitosis modulators|mesh-ancestor
64465527|NCT02913196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465528|NCT02913196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64465529|NCT02913196|Glucocorticoids|glucocorticoids|mesh-ancestor
64465530|NCT02913196|Hormones|hormones|mesh-ancestor
64465531|NCT02913196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64465532|NCT02913196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465533|NCT02913196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64465534|NCT02913196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64465535|NCT02913196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465536|NCT02913196|Hormone Antagonists|hormone antagonists|mesh-ancestor
64465537|NCT02913196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64465538|NCT01451086|Vaccines|vaccines|mesh-list
64465539|NCT01451086|Immunologic Factors|immunologic factors|mesh-ancestor
64465540|NCT01451086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465541|NCT01451710|Prednisone|prednisone|mesh-list
64465548|NCT01451710|Prednisolone phosphate|prednisolone phosphate|mesh-list
64465549|NCT01451710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64465550|NCT01451710|Glucocorticoids|glucocorticoids|mesh-ancestor
64465551|NCT01451710|Hormones|hormones|mesh-ancestor
64465552|NCT01451710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64465553|NCT01451710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465554|NCT01451710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64465555|NCT01451710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465556|NCT01451710|Antiemetics|antiemetics|mesh-ancestor
64465557|NCT01451710|Autonomic Agents|autonomic agents|mesh-ancestor
64465558|NCT01451710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64465559|NCT01451710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64465560|NCT01451710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64465561|NCT01451710|Protective Agents|protective agents|mesh-ancestor
64465562|NCT01451788|Thrombin|thrombin|mesh-list
64465563|NCT01451788|Hemostatics|hemostatics|mesh-ancestor
64465564|NCT01451788|Coagulants|coagulants|mesh-ancestor
64465565|NCT03553810|Valsartan|valsartan|mesh-list
64465566|NCT03553810|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64465567|NCT03553810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64465681|NCT04847752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64465723|NCT04841434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465724|NCT04841434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64465725|NCT04841434|Antimetabolites|antimetabolites|mesh-ancestor
64465726|NCT04841434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465727|NCT04841434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465728|NCT04841434|Dermatologic Agents|dermatologic agents|mesh-ancestor
64465729|NCT04841434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465730|NCT04841434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64465759|NCT05021926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64465760|NCT05021926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465761|NCT05021926|Sensory System Agents|sensory system agents|mesh-ancestor
64465762|NCT05021926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64465763|NCT05021926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64465764|NCT05021926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64465765|NCT05021926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64465766|NCT05021926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64465767|NCT05021926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465768|NCT05021926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64465769|NCT05021926|Immunologic Factors|immunologic factors|mesh-ancestor
64465770|NCT05021926|Viscosupplements|viscosupplements|mesh-ancestor
64465771|NCT05021926|Protective Agents|protective agents|mesh-ancestor
64465772|NCT05024188|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64465773|NCT05024188|Metronidazole|metronidazole|mesh-list
64465774|NCT05024188|Ciprofloxacin|ciprofloxacin|mesh-list
64465783|NCT05024188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64465784|NCT05024188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64465786|NCT05029960|Anticonvulsants|anticonvulsants|mesh-ancestor
64465787|NCT04390594|Nafamostat|nafamostat|mesh-list
64465829|NCT02819596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64465830|NCT02819596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465831|NCT02818894|Lidocaine|lidocaine|mesh-list
64465832|NCT02818894|Bupivacaine|bupivacaine|mesh-list
64465833|NCT02818894|Anesthetics, Local|anesthetics, local|mesh-ancestor
64465834|NCT02818894|Anesthetics|anesthetics|mesh-ancestor
64465885|NCT05586568|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64465886|NCT02651662|Cemiplimab|cemiplimab|mesh-list
64465887|NCT02651662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64465888|NCT02651662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465889|NCT02632708|Cytarabine|cytarabine|mesh-list
64465890|NCT02632708|Etoposide|etoposide|mesh-list
64465891|NCT02632708|Daunorubicin|daunorubicin|mesh-list
64465892|NCT02632708|Mitoxantrone|mitoxantrone|mesh-list
64465893|NCT02632708|Idarubicin|idarubicin|mesh-list
64465894|NCT02632708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64465895|NCT02632708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465896|NCT02632708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64465897|NCT02632708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64465898|NCT02632708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465899|NCT02632708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566008|NCT05392946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566009|NCT05392946|Dermatologic Agents|dermatologic agents|mesh-ancestor
64566010|NCT05389930|Ethanol|ethanol|mesh-list
64465900|NCT02632708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64465901|NCT02632708|Antimetabolites|antimetabolites|mesh-ancestor
64465902|NCT02632708|Antiviral Agents|antiviral agents|mesh-ancestor
64465903|NCT02632708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64465923|NCT02614534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64465930|NCT02608216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465932|NCT02587000|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64465933|NCT02587000|Contraceptive Agents|contraceptive agents|mesh-ancestor
64465934|NCT02587000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64465935|NCT02587000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64465936|NCT02587000|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64465987|NCT02543944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64465988|NCT02543944|Antimanic Agents|antimanic agents|mesh-ancestor
64465989|NCT02543944|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64465990|NCT02543944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64465991|NCT02543944|Sympatholytics|sympatholytics|mesh-ancestor
64465992|NCT02543944|Autonomic Agents|autonomic agents|mesh-ancestor
64465993|NCT02543944|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64465994|NCT02543944|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64465995|NCT02543944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64465996|NCT02543944|Adrenergic Agents|adrenergic agents|mesh-ancestor
64465998|NCT02538484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64465999|NCT02538484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64466000|NCT02538484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64466001|NCT02538484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466002|NCT02538484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466003|NCT02538484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64466004|NCT02538484|Hormone Antagonists|hormone antagonists|mesh-ancestor
64466005|NCT02538484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64466006|NCT02538484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466008|NCT02531308|Prednisone|prednisone|mesh-list
64466009|NCT02531308|Cyclophosphamide|cyclophosphamide|mesh-list
64466010|NCT02531308|Rituximab|rituximab|mesh-list
64466011|NCT02531308|Doxorubicin|doxorubicin|mesh-list
64466012|NCT02531308|Vincristine|vincristine|mesh-list
64466013|NCT02531308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64466014|NCT02531308|Immunologic Factors|immunologic factors|mesh-ancestor
64466016|NCT02531308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64466034|NCT02531308|Tubulin Modulators|tubulin modulators|mesh-ancestor
64566072|NCT05292664|Antiemetics|antiemetics|mesh-ancestor
64566073|NCT05292664|Autonomic Agents|autonomic agents|mesh-ancestor
64466035|NCT02531308|Antimitotic Agents|antimitotic agents|mesh-ancestor
64466036|NCT02531308|Mitosis Modulators|mitosis modulators|mesh-ancestor
64466038|NCT02523976|Dexamethasone|dexamethasone|mesh-list
64466039|NCT02523976|Prednisone|prednisone|mesh-list
64466040|NCT02523976|Cyclophosphamide|cyclophosphamide|mesh-list
64466041|NCT02523976|Methotrexate|methotrexate|mesh-list
64466042|NCT02523976|Etoposide|etoposide|mesh-list
64466043|NCT02523976|Vincristine|vincristine|mesh-list
64466044|NCT02523976|Daunorubicin|daunorubicin|mesh-list
64466045|NCT02523976|Dasatinib|dasatinib|mesh-list
64466046|NCT02523976|Mitoxantrone|mitoxantrone|mesh-list
64466047|NCT02523976|Mercaptopurine|mercaptopurine|mesh-list
64466048|NCT02523976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64466049|NCT02523976|Immunologic Factors|immunologic factors|mesh-ancestor
64466050|NCT02523976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466051|NCT02523976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64466052|NCT02523976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64466053|NCT02523976|Alkylating Agents|alkylating agents|mesh-ancestor
64466054|NCT02523976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466090|NCT02523040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64466091|NCT02523040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64466092|NCT02523040|Growth Substances|growth substances|mesh-ancestor
64466093|NCT02523040|Growth Inhibitors|growth inhibitors|mesh-ancestor
64466094|NCT02523040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466095|NCT02514382|Dexamethasone|dexamethasone|mesh-list
64466096|NCT02514382|Dexamethasone acetate|dexamethasone acetate|mesh-list
64466098|NCT02514382|Ichthammol|ichthammol|mesh-list
64466099|NCT02514382|BB 1101|bb 1101|mesh-list
64466100|NCT02514382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64466101|NCT02514382|Antiemetics|antiemetics|mesh-ancestor
64466102|NCT02514382|Autonomic Agents|autonomic agents|mesh-ancestor
64466103|NCT02514382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64466219|NCT02403778|Keratolytic Agents|keratolytic agents|mesh-ancestor
64466220|NCT02403778|Dermatologic Agents|dermatologic agents|mesh-ancestor
64466221|NCT01539291|Idelalisib|idelalisib|mesh-list
64466222|NCT01539291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466223|NCT01539291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466224|NCT01539291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466225|NCT04746040|Fluticasone|fluticasone|mesh-list
64466226|NCT04746040|Xhance|xhance|mesh-list
64466227|NCT04746040|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64466228|NCT04746040|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64466229|NCT04746040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64466230|NCT04746040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64466232|NCT04746040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64466233|NCT04746040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466234|NCT04746040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64466623|NCT01865110|Lenalidomide|lenalidomide|mesh-list
64566145|NCT05269628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64566146|NCT05269628|Analgesics|analgesics|mesh-ancestor
64566147|NCT05269628|Sensory System Agents|sensory system agents|mesh-ancestor
64566148|NCT05269628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64566149|NCT05269628|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64566151|NCT05269628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64466624|NCT01865110|Cyclophosphamide|cyclophosphamide|mesh-list
64466625|NCT01865110|Vincristine|vincristine|mesh-list
64466626|NCT01865110|Doxorubicin|doxorubicin|mesh-list
64466627|NCT01865110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64466628|NCT01865110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466629|NCT01865110|Immunologic Factors|immunologic factors|mesh-ancestor
64466630|NCT01865110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466631|NCT01865110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64466632|NCT01865110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64466633|NCT01865110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64466634|NCT01865110|Growth Substances|growth substances|mesh-ancestor
64466635|NCT01865110|Growth Inhibitors|growth inhibitors|mesh-ancestor
64466636|NCT01865110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64466637|NCT01865110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64466638|NCT01865110|Alkylating Agents|alkylating agents|mesh-ancestor
64466639|NCT01865110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466640|NCT01865110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64466641|NCT01865110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64466642|NCT01865110|Glucocorticoids|glucocorticoids|mesh-ancestor
64466644|NCT01865110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64466645|NCT01865110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64466646|NCT01865110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64466673|NCT01464034|Glucocorticoids|glucocorticoids|mesh-ancestor
64466674|NCT01464034|Hormones|hormones|mesh-ancestor
64513648|NCT01457547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466675|NCT01464034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64466676|NCT01464034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64466677|NCT01464034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466678|NCT01464034|Immunologic Factors|immunologic factors|mesh-ancestor
64466679|NCT01464034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64466680|NCT01464034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64466681|NCT01464034|Growth Substances|growth substances|mesh-ancestor
64466682|NCT01464034|Growth Inhibitors|growth inhibitors|mesh-ancestor
64466683|NCT01535235|Lisinopril|lisinopril|mesh-list
64466684|NCT01535235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64466685|NCT01535235|Protease Inhibitors|protease inhibitors|mesh-ancestor
64466686|NCT01535235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466727|NCT01810588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64334729|NCT02232035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64566166|NCT05265299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566168|NCT05265299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64566169|NCT05265299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566170|NCT05265299|Antipyretics|antipyretics|mesh-ancestor
64566171|NCT05263700|FAPI-46|fapi-46|mesh-list
64566172|NCT05263700|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64566173|NCT05263700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566174|NCT05257447|Baclofen|baclofen|mesh-list
64566175|NCT05257447|Chlorzoxazone|chlorzoxazone|mesh-list
64566176|NCT05257447|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64566177|NCT05257447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566178|NCT05257447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64566179|NCT05257447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64466728|NCT01810588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64466729|NCT01810588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64466730|NCT01810588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466731|NCT01810588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64466732|NCT01810588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64466733|NCT01810588|Antitubercular Agents|antitubercular agents|mesh-ancestor
64466734|NCT01810588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64466735|NCT01810588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64466736|NCT01810588|Alkylating Agents|alkylating agents|mesh-ancestor
64466790|NCT01483599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64466792|NCT01407562|Carboplatin|carboplatin|mesh-list
64466793|NCT01407562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64466794|NCT01407562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466795|NCT01407562|Tubulin Modulators|tubulin modulators|mesh-ancestor
64466796|NCT01407562|Antimitotic Agents|antimitotic agents|mesh-ancestor
64466817|NCT02086786|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64466818|NCT02086786|Serotonin Agents|serotonin agents|mesh-ancestor
64466819|NCT02086786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64513650|NCT01457547|Anticoagulants|anticoagulants|mesh-ancestor
64466834|NCT01787500|Immunoglobulins|immunoglobulins|mesh-list
64466835|NCT01787500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64466836|NCT01787500|Immunologic Factors|immunologic factors|mesh-ancestor
64466837|NCT01787500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466838|NCT01787500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466839|NCT01787500|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64466840|NCT01787500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64466841|NCT01787500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466898|NCT01276600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64466899|NCT02040376|Metformin|metformin|mesh-list
64466900|NCT02040376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64466901|NCT02040376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466902|NCT04755868|Talazoparib|talazoparib|mesh-list
64466903|NCT04755868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64466904|NCT04755868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64466905|NCT04755868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466906|NCT04755868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64466907|NCT05228314|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64466908|NCT05228314|Vaccines|vaccines|mesh-list
64466909|NCT05228314|Aluminum sulfate|aluminum sulfate|mesh-list
64466910|NCT05228314|Immunologic Factors|immunologic factors|mesh-ancestor
64466911|NCT05228314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64466912|NCT05228314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64466913|NCT05228314|Antacids|antacids|mesh-ancestor
64466914|NCT05228314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64466915|NCT05228314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64466916|NCT01659658|Thalidomide|thalidomide|mesh-list
64466917|NCT01659658|Dexamethasone|dexamethasone|mesh-list
64466918|NCT01659658|Cyclophosphamide|cyclophosphamide|mesh-list
64466919|NCT01659658|Melphalan|melphalan|mesh-list
64466920|NCT01659658|Lenalidomide|lenalidomide|mesh-list
64566180|NCT05257447|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64566181|NCT05257447|GABA Agonists|gaba agonists|mesh-ancestor
64566182|NCT05257447|GABA Agents|gaba agents|mesh-ancestor
64566183|NCT05257447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64467006|NCT04283656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64566184|NCT05257447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566185|NCT05211154|Diclofenac|diclofenac|mesh-list
64566187|NCT05211154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64467008|NCT04283656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64467009|NCT04283656|Diuretics|diuretics|mesh-ancestor
64467010|NCT04283656|Natriuretic Agents|natriuretic agents|mesh-ancestor
64467011|NCT01209364|Methylprednisolone|methylprednisolone|mesh-list
64467012|NCT01209364|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64467013|NCT01209364|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64467014|NCT01209364|Prednisolone|prednisolone|mesh-list
64467015|NCT01209364|Prednisolone acetate|prednisolone acetate|mesh-list
64467016|NCT01209364|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64467017|NCT01209364|Prednisolone phosphate|prednisolone phosphate|mesh-list
64467018|NCT01209364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64467019|NCT01209364|Antiemetics|antiemetics|mesh-ancestor
64467020|NCT01209364|Autonomic Agents|autonomic agents|mesh-ancestor
64467021|NCT01209364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64467022|NCT01209364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467067|NCT00472966|Protective Agents|protective agents|mesh-ancestor
64467068|NCT00472966|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64467069|NCT01573780|Gemcitabine|gemcitabine|mesh-list
64467070|NCT01573780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64467071|NCT01573780|Antimetabolites|antimetabolites|mesh-ancestor
64467072|NCT01573780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467073|NCT01573780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467074|NCT01573780|Antiviral Agents|antiviral agents|mesh-ancestor
64467075|NCT01573780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64467076|NCT01573780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467077|NCT01573780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64467078|NCT01573780|Immunologic Factors|immunologic factors|mesh-ancestor
64467079|NCT01573780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467080|NCT01547260|Gemcitabine|gemcitabine|mesh-list
64467081|NCT01547260|Lenalidomide|lenalidomide|mesh-list
64713976|NCT02918617|Protective Agents|protective agents|mesh-ancestor
64467082|NCT01547260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64467100|NCT01896388|Ifenprodil|ifenprodil|mesh-list
64467101|NCT01896388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64467102|NCT01896388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64467103|NCT01896388|Adrenergic Agents|adrenergic agents|mesh-ancestor
64467104|NCT01896388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64467105|NCT01896388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467106|NCT01896388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467107|NCT01896388|Vasodilator Agents|vasodilator agents|mesh-ancestor
64467108|NCT01896388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64467109|NCT01896388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64467110|NCT01125436|Vitamin D|vitamin d|mesh-list
64467111|NCT01125436|Cholecalciferol|cholecalciferol|mesh-list
64467112|NCT01125436|Vitamins|vitamins|mesh-ancestor
64467113|NCT01125436|Micronutrients|micronutrients|mesh-ancestor
64467114|NCT01125436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467115|NCT01125436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64467116|NCT01125436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64467117|NCT04755322|Aspirin|aspirin|mesh-list
64467118|NCT04755322|Folic Acid|folic acid|mesh-list
64467119|NCT04755322|Hydroxychloroquine|hydroxychloroquine|mesh-list
64467120|NCT04755322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64467121|NCT04755322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64467122|NCT04755322|Analgesics|analgesics|mesh-ancestor
64467123|NCT04755322|Sensory System Agents|sensory system agents|mesh-ancestor
64467124|NCT04755322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64467125|NCT04755322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467126|NCT04755322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64467127|NCT04755322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64467128|NCT04755322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64566196|NCT05211154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566197|NCT05161195|Tamoxifen|tamoxifen|mesh-list
64566198|NCT05161195|Letrozole|letrozole|mesh-list
64566199|NCT05161195|Fulvestrant|fulvestrant|mesh-list
64566200|NCT05161195|Anastrozole|anastrozole|mesh-list
64566201|NCT05161195|Goserelin|goserelin|mesh-list
64566202|NCT05161195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467129|NCT04755322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64467146|NCT00436540|Hormones|hormones|mesh-ancestor
64467153|NCT00425230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467154|NCT00425230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64467155|NCT00425230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467158|NCT00425230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64467159|NCT00425230|Antidepressive Agents|antidepressive agents|mesh-ancestor
64467160|NCT00425230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64467161|NCT00425230|Dopamine Agents|dopamine agents|mesh-ancestor
64467162|NCT00412594|Rituximab|rituximab|mesh-list
64467163|NCT00412594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64467164|NCT00412594|Cladribine|cladribine|mesh-list
64467165|NCT00412594|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
64467166|NCT00412594|Antibodies|antibodies|mesh-list
64467167|NCT00412594|Immunoglobulins|immunoglobulins|mesh-list
64467168|NCT00412594|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64467206|NCT04634578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467249|NCT01506609|Tubulin Modulators|tubulin modulators|mesh-ancestor
64467250|NCT01506609|Antimitotic Agents|antimitotic agents|mesh-ancestor
64467251|NCT01506609|Mitosis Modulators|mitosis modulators|mesh-ancestor
64467253|NCT01506609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64467316|NCT04753918|Trioxsalen|trioxsalen|mesh-list
64467317|NCT04753918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467318|NCT04753918|Dermatologic Agents|dermatologic agents|mesh-ancestor
64467319|NCT04753918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64467320|NCT04161664|Paclitaxel|paclitaxel|mesh-list
64467321|NCT04161664|Carboplatin|carboplatin|mesh-list
64467322|NCT04161664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64467323|NCT04161664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467324|NCT04161664|Tubulin Modulators|tubulin modulators|mesh-ancestor
64467325|NCT04161664|Antimitotic Agents|antimitotic agents|mesh-ancestor
64467326|NCT04161664|Mitosis Modulators|mitosis modulators|mesh-ancestor
64467327|NCT04161664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467328|NCT00936832|Leucovorin|leucovorin|mesh-list
64467329|NCT00936832|Fluorouracil|fluorouracil|mesh-list
64467330|NCT00936832|Irinotecan|irinotecan|mesh-list
64467331|NCT00936832|Sunitinib|sunitinib|mesh-list
64467332|NCT00936832|Calcium|calcium|mesh-list
64467333|NCT00936832|Levoleucovorin|levoleucovorin|mesh-list
64467334|NCT00936832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64467335|NCT00936832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467336|NCT00936832|Antimetabolites|antimetabolites|mesh-ancestor
64467337|NCT00936832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467338|NCT00936832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64467339|NCT00936832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467340|NCT00936832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64467341|NCT00936832|Immunologic Factors|immunologic factors|mesh-ancestor
64467342|NCT00936832|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64467343|NCT00936832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64467367|NCT01479621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64467368|NCT01479621|Tocolytic Agents|tocolytic agents|mesh-ancestor
64467369|NCT01479621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64467370|NCT01479621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64566203|NCT05161195|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64566258|NCT05023369|Hormones|hormones|mesh-ancestor
64467371|NCT01479621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64467372|NCT01479621|Adrenergic Agents|adrenergic agents|mesh-ancestor
64467373|NCT01479621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64467374|NCT01479621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467375|NCT04776226|Citalopram|citalopram|mesh-list
64467376|NCT04776226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64467377|NCT04776226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64467378|NCT04776226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64467434|NCT04784104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64467435|NCT04784104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467436|NCT04784104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64467438|NCT04784104|Autonomic Agents|autonomic agents|mesh-ancestor
64467474|NCT00878254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64467475|NCT00878254|Alkylating Agents|alkylating agents|mesh-ancestor
64467476|NCT00878254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467477|NCT00878254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467478|NCT00878254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64467479|NCT00878254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64467480|NCT00878254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64467481|NCT00878254|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64467482|NCT00878254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64467483|NCT00878254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64467484|NCT00878254|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64467485|NCT00878254|Abortifacient Agents|abortifacient agents|mesh-ancestor
64467486|NCT00878254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64467487|NCT00878254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64467488|NCT00878254|Antimetabolites|antimetabolites|mesh-ancestor
64467489|NCT00878254|Dermatologic Agents|dermatologic agents|mesh-ancestor
64467490|NCT00878254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64467551|NCT04782388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64467576|NCT04782310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64467577|NCT04782310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64467578|NCT04782310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64467579|NCT04782310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64467580|NCT04782310|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64467581|NCT04782310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64467582|NCT04782310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64467583|NCT04782310|Antidepressive Agents|antidepressive agents|mesh-ancestor
64467585|NCT04781998|Liraglutide|liraglutide|mesh-list
64467586|NCT04781998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64467587|NCT04781998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566302|NCT04935359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566303|NCT04935359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64566304|NCT04935359|Immunologic Factors|immunologic factors|mesh-ancestor
64566305|NCT04935359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467588|NCT04781998|Incretins|incretins|mesh-ancestor
64467589|NCT04781998|Hormones|hormones|mesh-ancestor
64467686|NCT02390284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64467687|NCT02390284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467688|NCT02390284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64467689|NCT02390284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64467690|NCT02390284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64467692|NCT02390284|Anticonvulsants|anticonvulsants|mesh-ancestor
64467747|NCT04389424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64467748|NCT04389424|Hormone Antagonists|hormone antagonists|mesh-ancestor
64467749|NCT04389424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64467750|NCT04389424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64467751|NCT04389424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64467752|NCT04389424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64467753|NCT04389424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64467754|NCT04389424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64467755|NCT04389424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64467756|NCT04389424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64467757|NCT04389424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64956118|NCT00068523|Methylprednisolone|methylprednisolone|mesh-list
64956119|NCT00068523|Cyclophosphamide|cyclophosphamide|mesh-list
64956121|NCT00068523|Fludarabine phosphate|fludarabine phosphate|mesh-list
64956122|NCT00068523|Cyclosporins|cyclosporins|mesh-list
64956123|NCT00068523|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64956124|NCT00068523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64956125|NCT00068523|Immunologic Factors|immunologic factors|mesh-ancestor
64956126|NCT00068523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956127|NCT00068523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64956128|NCT00068523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64956129|NCT00068523|Alkylating Agents|alkylating agents|mesh-ancestor
64956130|NCT00068523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956170|NCT00206947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64956171|NCT00206947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64956172|NCT00206947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64956173|NCT00206947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64956174|NCT00206947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64956246|NCT00040391|Micronutrients|micronutrients|mesh-ancestor
64956247|NCT00207688|Infliximab|infliximab|mesh-list
64956251|NCT00207766|Infliximab|infliximab|mesh-list
64956252|NCT00207766|Dermatologic Agents|dermatologic agents|mesh-ancestor
64956253|NCT00207766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64956254|NCT00207766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64494854|NCT01143766|Antimanic Agents|antimanic agents|mesh-ancestor
64956255|NCT00040469|Cyclophosphamide|cyclophosphamide|mesh-list
64956256|NCT00040469|Busulfan|busulfan|mesh-list
64956257|NCT00040469|Alemtuzumab|alemtuzumab|mesh-list
64956258|NCT00040469|Phenytoin|phenytoin|mesh-list
64956259|NCT00040469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64956260|NCT00040469|Immunologic Factors|immunologic factors|mesh-ancestor
64956261|NCT00040469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956262|NCT00040469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64566356|NCT04713969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566357|NCT04713969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956381|NCT00208156|Hormone Antagonists|hormone antagonists|mesh-ancestor
64566358|NCT04707872|Antibodies|antibodies|mesh-list
64566359|NCT04707872|Immunologic Factors|immunologic factors|mesh-ancestor
64566360|NCT04707872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956382|NCT00208156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64956383|NCT00208156|Luteolytic Agents|luteolytic agents|mesh-ancestor
64956384|NCT00208156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64956385|NCT00208156|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64956415|NCT00208273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956435|NCT00040781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956436|NCT00040781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64956438|NCT00040781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956439|NCT00068952|Temozolomide|temozolomide|mesh-list
64956463|NCT00208585|Antidepressive Agents|antidepressive agents|mesh-ancestor
64956464|NCT00208585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64956465|NCT00208585|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64956466|NCT00208585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64956467|NCT00208585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64956468|NCT00208585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956469|NCT00208585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64956470|NCT00208585|Serotonin Agents|serotonin agents|mesh-ancestor
64956471|NCT00208585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956472|NCT00040859|Capecitabine|capecitabine|mesh-list
64956473|NCT00040859|Oxaliplatin|oxaliplatin|mesh-list
64956474|NCT00040859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64956475|NCT00040859|Antimetabolites|antimetabolites|mesh-ancestor
64956476|NCT00040859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956477|NCT00040859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956479|NCT00208702|Antidepressive Agents|antidepressive agents|mesh-ancestor
64956480|NCT00208702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64956481|NCT00208702|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64956482|NCT00208702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64566373|NCT04670081|Nicotinic Acids|nicotinic acids|mesh-list
64566374|NCT04670081|Psilocybin|psilocybin|mesh-list
64566375|NCT04670081|Vitamin B Complex|vitamin b complex|mesh-ancestor
64566376|NCT04670081|Vitamins|vitamins|mesh-ancestor
64566377|NCT04670081|Micronutrients|micronutrients|mesh-ancestor
64956483|NCT00208702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64956484|NCT00208702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956513|NCT00208819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956514|NCT00208819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956533|NCT00208858|Topiramate|topiramate|mesh-list
64956579|NCT00209014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64956580|NCT00209014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64956581|NCT00209014|Growth Substances|growth substances|mesh-ancestor
64956582|NCT00209014|Growth Inhibitors|growth inhibitors|mesh-ancestor
64956626|NCT00209209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956627|NCT00209209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64956629|NCT00209209|Hormones|hormones|mesh-ancestor
64956630|NCT00209209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64956631|NCT00209209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64956632|NCT00209209|Antiviral Agents|antiviral agents|mesh-ancestor
64956633|NCT00209209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64956792|NCT00209872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956794|NCT00209872|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64956795|NCT00209872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64956796|NCT00209872|Anesthetics, General|anesthetics, general|mesh-ancestor
64956807|NCT00209950|Analgesics|analgesics|mesh-ancestor
64956808|NCT00209950|Sensory System Agents|sensory system agents|mesh-ancestor
64956809|NCT00209950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64956810|NCT00209950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956811|NCT00209950|Anticonvulsants|anticonvulsants|mesh-ancestor
64956812|NCT00209950|GABA Agonists|gaba agonists|mesh-ancestor
64956813|NCT00209950|GABA Agents|gaba agents|mesh-ancestor
64956814|NCT00209950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64956815|NCT00209950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956816|NCT00209989|Tipifarnib|tipifarnib|mesh-list
64956817|NCT00209989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956818|NCT00210028|Tamoxifen|tamoxifen|mesh-list
64956819|NCT00210028|Tipifarnib|tipifarnib|mesh-list
64956820|NCT00210028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64956821|NCT00210028|Hormone Antagonists|hormone antagonists|mesh-ancestor
64956822|NCT00210028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64956823|NCT00210028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956824|NCT00210028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64956825|NCT00210028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956826|NCT00210028|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64956827|NCT00210028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64956828|NCT00210028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64495531|NCT04614714|Micronutrients|micronutrients|mesh-ancestor
64956829|NCT00041288|Cyclosporine|cyclosporine|mesh-list
64956830|NCT00041288|Mycophenolic Acid|mycophenolic acid|mesh-list
64956831|NCT00041288|Cyclophosphamide|cyclophosphamide|mesh-list
64956832|NCT00041288|Methotrexate|methotrexate|mesh-list
64956833|NCT00041288|Fludarabine|fludarabine|mesh-list
64956834|NCT00041288|Fludarabine phosphate|fludarabine phosphate|mesh-list
64956835|NCT00041288|Tacrolimus|tacrolimus|mesh-list
64956836|NCT00041288|Cyclosporins|cyclosporins|mesh-list
64956837|NCT00041288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64956838|NCT00041288|Immunologic Factors|immunologic factors|mesh-ancestor
64956839|NCT00041288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956840|NCT00041288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64956841|NCT00041288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64956842|NCT00041288|Alkylating Agents|alkylating agents|mesh-ancestor
64956843|NCT00041288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64956844|NCT00041288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64956845|NCT00041288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64956846|NCT00041288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64956847|NCT00041288|Abortifacient Agents|abortifacient agents|mesh-ancestor
64956848|NCT00041288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64956849|NCT00041288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64956850|NCT00041288|Antimetabolites|antimetabolites|mesh-ancestor
64956851|NCT00041288|Dermatologic Agents|dermatologic agents|mesh-ancestor
64956852|NCT00041288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64956853|NCT00041288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64956854|NCT00041288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64956855|NCT00041288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64956856|NCT00041288|Antifungal Agents|antifungal agents|mesh-ancestor
64956857|NCT00041288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64956858|NCT00041288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64956859|NCT00041288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64956860|NCT00041288|Antitubercular Agents|antitubercular agents|mesh-ancestor
64566473|NCT04427956|Riboflavin|riboflavin|mesh-list
64956935|NCT00210379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64956936|NCT00041327|Interferons|interferons|mesh-list
64956938|NCT00041327|Lamivudine|lamivudine|mesh-list
64956939|NCT00041327|Zidovudine|zidovudine|mesh-list
64956940|NCT00041327|Prednisone|prednisone|mesh-list
64956941|NCT00041327|Cyclophosphamide|cyclophosphamide|mesh-list
64956942|NCT00041327|Doxorubicin|doxorubicin|mesh-list
64956943|NCT00041327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64956944|NCT00041327|Etoposide|etoposide|mesh-list
64956945|NCT00041327|Vincristine|vincristine|mesh-list
64956946|NCT00041327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64956947|NCT00041327|Immunologic Factors|immunologic factors|mesh-ancestor
64956948|NCT00041327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956949|NCT00041327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64956950|NCT00041327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64956951|NCT00041327|Alkylating Agents|alkylating agents|mesh-ancestor
64956952|NCT00041327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957002|NCT00210691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64957003|NCT00210691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64957004|NCT00210691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64957005|NCT00210691|Dopamine Agents|dopamine agents|mesh-ancestor
64957006|NCT00210730|Epoetin Alfa|epoetin alfa|mesh-list
64957007|NCT00210730|Hematinics|hematinics|mesh-ancestor
64957008|NCT00210769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64566528|NCT04282629|Protective Agents|protective agents|mesh-ancestor
64566530|NCT04275492|Pramipexole|pramipexole|mesh-list
64957009|NCT00210769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64957010|NCT00210769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64957011|NCT00210769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64957012|NCT00210769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957013|NCT00210769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64957014|NCT00210769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64957015|NCT00210769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64957016|NCT00210769|Serotonin Agents|serotonin agents|mesh-ancestor
64957017|NCT00210769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957022|NCT00210808|Topiramate|topiramate|mesh-list
64957039|NCT00210886|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64957040|NCT00210886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64957041|NCT00210886|Renal Agents|renal agents|mesh-ancestor
64566671|NCT03631199|Carboplatin|carboplatin|mesh-list
64957042|NCT00210886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64957043|NCT00210886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64957044|NCT00210886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64957045|NCT00210886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957046|NCT00210886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957047|NCT00210886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957048|NCT00210886|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64957049|NCT00210886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64957050|NCT00210925|Topiramate|topiramate|mesh-list
64957051|NCT00210925|Anticonvulsants|anticonvulsants|mesh-ancestor
64957052|NCT00210925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64957053|NCT00210925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957054|NCT00211003|Doripenem|doripenem|mesh-list
64957055|NCT00211003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64957056|NCT00211003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64957058|NCT00211120|Hematinics|hematinics|mesh-ancestor
64957059|NCT00211198|Denileukin diftitox|denileukin diftitox|mesh-list
64566791|NCT02938793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566792|NCT02928224|Leucovorin|leucovorin|mesh-list
64566793|NCT02928224|Folic Acid|folic acid|mesh-list
64566794|NCT02928224|Fluorouracil|fluorouracil|mesh-list
64566795|NCT02928224|Irinotecan|irinotecan|mesh-list
64566796|NCT02928224|Cetuximab|cetuximab|mesh-list
64566797|NCT02928224|Levoleucovorin|levoleucovorin|mesh-list
64566798|NCT02928224|Antimetabolites|antimetabolites|mesh-ancestor
64957060|NCT00211198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957093|NCT00211432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957094|NCT00211432|Growth Inhibitors|growth inhibitors|mesh-ancestor
64957095|NCT00211432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957146|NCT00211978|Sequestering Agents|sequestering agents|mesh-ancestor
64957319|NCT00214318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957320|NCT00214318|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64957321|NCT00214318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64957322|NCT00214318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64957323|NCT00214318|Adrenergic Agents|adrenergic agents|mesh-ancestor
64957324|NCT00214318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957325|NCT00214318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957326|NCT00214318|Antioxidants|antioxidants|mesh-ancestor
64957327|NCT00214318|Protective Agents|protective agents|mesh-ancestor
64957328|NCT00214318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64957329|NCT00214318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64957330|NCT00214318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64957331|NCT00214318|Vasodilator Agents|vasodilator agents|mesh-ancestor
64957332|NCT00214318|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64957333|NCT00214318|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64957334|NCT00214318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64957335|NCT00214318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64957336|NCT00214318|Respiratory System Agents|respiratory system agents|mesh-ancestor
64957367|NCT00214630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64957368|NCT00214630|Calcium|calcium|mesh-list
64957369|NCT00214630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64957422|NCT00069498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957423|NCT00069498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64957424|NCT00069498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64957425|NCT00214981|Modafinil|modafinil|mesh-list
64957426|NCT00214981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64566930|NCT00545077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64566950|NCT00251433|Mitosis Modulators|mitosis modulators|mesh-ancestor
64957427|NCT00214981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957428|NCT00214981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64957429|NCT00214981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64957519|NCT00215449|Adrenergic Agents|adrenergic agents|mesh-ancestor
64957520|NCT00215449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957521|NCT00215449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957522|NCT00215722|Cetuximab|cetuximab|mesh-list
64957523|NCT00215722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64567277|NCT02906761|Antipyretics|antipyretics|mesh-ancestor
64957524|NCT00215722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957525|NCT00215800|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
64957526|NCT00215800|Antiviral Agents|antiviral agents|mesh-ancestor
64957527|NCT00215800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64957528|NCT00215839|Ribavirin|ribavirin|mesh-list
64957529|NCT00215839|Antimetabolites|antimetabolites|mesh-ancestor
64957530|NCT00215839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957531|NCT00215839|Antiviral Agents|antiviral agents|mesh-ancestor
64957532|NCT00215839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64957533|NCT00215956|Topotecan|topotecan|mesh-list
64957534|NCT00215956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64957544|NCT00215995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64957545|NCT00215995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957546|NCT00215995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957554|NCT00216034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64567393|NCT04966884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64957555|NCT00216034|Immunologic Factors|immunologic factors|mesh-ancestor
64957556|NCT00216034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957557|NCT00216034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64957559|NCT00216034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64957560|NCT00216034|Interferon Inducers|interferon inducers|mesh-ancestor
64957561|NCT00216034|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64957562|NCT00216034|Protective Agents|protective agents|mesh-ancestor
64957564|NCT00216073|Oxaliplatin|oxaliplatin|mesh-list
64957565|NCT00216073|Trastuzumab|trastuzumab|mesh-list
64567474|NCT02967289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64567475|NCT02967289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64957566|NCT00216073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64957567|NCT00216073|Antimetabolites|antimetabolites|mesh-ancestor
64957568|NCT00216073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957569|NCT00216073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957570|NCT00216073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64957571|NCT00216112|Docetaxel|docetaxel|mesh-list
64957612|NCT00216346|Amphotericin B|amphotericin b|mesh-list
64957613|NCT00216346|Paromomycin|paromomycin|mesh-list
64957614|NCT00216346|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64957615|NCT00216346|Amebicides|amebicides|mesh-ancestor
64567562|NCT04961268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567564|NCT04961268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64957616|NCT00216346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64957617|NCT00216346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64957618|NCT00216346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64957619|NCT00216346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64957620|NCT00216346|Antifungal Agents|antifungal agents|mesh-ancestor
64957621|NCT00216385|Gatifloxacin|gatifloxacin|mesh-list
64957622|NCT00216385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64957623|NCT00216385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64957624|NCT00216385|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64957625|NCT00216385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64957626|NCT00216385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64957627|NCT00216385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64957628|NCT00216385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957629|NCT00216385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957630|NCT00216385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957631|NCT00216424|Capecitabine|capecitabine|mesh-list
64957632|NCT00216424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64957633|NCT00216424|Antimetabolites|antimetabolites|mesh-ancestor
64957634|NCT00216424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957635|NCT00216424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957636|NCT00216463|Mipomersen|mipomersen|mesh-list
64957637|NCT00216463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64957638|NCT00216463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64957639|NCT00216463|Antimetabolites|antimetabolites|mesh-ancestor
64957640|NCT00216463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957641|NCT00216463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64957642|NCT00216502|Galantamine|galantamine|mesh-list
64957643|NCT00216502|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64957644|NCT00216502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567818|NCT04951128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64567819|NCT01458301|Leuprolide|leuprolide|mesh-list
64957654|NCT00216541|Hematinics|hematinics|mesh-ancestor
64957655|NCT00216580|Risperidone|risperidone|mesh-list
64957656|NCT00216580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64957657|NCT00216580|Serotonin Agents|serotonin agents|mesh-ancestor
64957658|NCT00216580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957704|NCT00216775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957705|NCT00216775|Antiviral Agents|antiviral agents|mesh-ancestor
64957706|NCT00216775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64957707|NCT00216775|Antimetabolites|antimetabolites|mesh-ancestor
64957708|NCT00216775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957709|NCT00216775|Immunologic Factors|immunologic factors|mesh-ancestor
64957710|NCT00216775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957711|NCT00041639|Labetuzumab|labetuzumab|mesh-list
64567905|NCT01891513|Losartan|losartan|mesh-list
64957712|NCT00041639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64957713|NCT00041639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64957714|NCT00216892|Betamethasone|betamethasone|mesh-list
64957715|NCT00216892|Calcipotriene|calcipotriene|mesh-list
64957716|NCT00216892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64957717|NCT00216892|Glucocorticoids|glucocorticoids|mesh-ancestor
64496355|NCT04369014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64957718|NCT00216892|Hormones|hormones|mesh-ancestor
64957719|NCT00216892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64957720|NCT00216892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957721|NCT00216892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64957722|NCT00216892|Respiratory System Agents|respiratory system agents|mesh-ancestor
64957723|NCT00216892|Dermatologic Agents|dermatologic agents|mesh-ancestor
64957756|NCT00412204|Parasympatholytics|parasympatholytics|mesh-ancestor
64957757|NCT00412204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64957758|NCT00412204|Cholinergic Agents|cholinergic agents|mesh-ancestor
64957759|NCT00412204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957800|NCT00217282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957801|NCT00217282|Growth Inhibitors|growth inhibitors|mesh-ancestor
64957802|NCT00217282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64567999|NCT04948164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568000|NCT04948164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957803|NCT00217282|Antimetabolites|antimetabolites|mesh-ancestor
64957804|NCT00217282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957805|NCT00217282|Antiviral Agents|antiviral agents|mesh-ancestor
64957806|NCT00217282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64957807|NCT00217282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957808|NCT00217282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64957809|NCT00217282|Immunologic Factors|immunologic factors|mesh-ancestor
64957810|NCT00217477|Gemcitabine|gemcitabine|mesh-list
64957811|NCT00217477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64957865|NCT00217828|Antidepressive Agents|antidepressive agents|mesh-ancestor
64957866|NCT00217828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64957868|NCT00041990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64496503|NCT00055731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64957869|NCT00041990|Antimetabolites|antimetabolites|mesh-ancestor
64957870|NCT00041990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568058|NCT04937946|Fentanyl|fentanyl|mesh-list
64957872|NCT00041990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957873|NCT00073437|Infliximab|infliximab|mesh-list
64957874|NCT00073437|Dermatologic Agents|dermatologic agents|mesh-ancestor
64957875|NCT00073437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64957876|NCT00073437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64957877|NCT00218101|Buprenorphine|buprenorphine|mesh-list
64957902|NCT00042029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64957903|NCT00042029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957904|NCT00042029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957905|NCT00218218|Nicotine|nicotine|mesh-list
64957906|NCT00218218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64957907|NCT00218218|Autonomic Agents|autonomic agents|mesh-ancestor
64957908|NCT00218218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957909|NCT00218218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957910|NCT00218218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64957911|NCT00218218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64957912|NCT00218218|Cholinergic Agents|cholinergic agents|mesh-ancestor
64957913|NCT00218218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957914|NCT00218218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957915|NCT00218374|Gabapentin|gabapentin|mesh-list
64568142|NCT01361217|GABA Modulators|gaba modulators|mesh-ancestor
64957916|NCT00218374|Analgesics|analgesics|mesh-ancestor
64568143|NCT01361217|GABA Agents|gaba agents|mesh-ancestor
64568190|NCT02869789|Ipilimumab|ipilimumab|mesh-list
64957917|NCT00218374|Sensory System Agents|sensory system agents|mesh-ancestor
64957918|NCT00218374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957919|NCT00218374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957920|NCT00218374|Anticonvulsants|anticonvulsants|mesh-ancestor
64957921|NCT00218374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64957922|NCT00218374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64957923|NCT00218374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64957924|NCT00218374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64957925|NCT00218374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64957926|NCT00218374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64568239|NCT01454635|Sertraline|sertraline|mesh-list
64957949|NCT00218530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957950|NCT00218530|Sensory System Agents|sensory system agents|mesh-ancestor
64957951|NCT00218530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64957952|NCT00218530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64957953|NCT00218530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64957954|NCT00218530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64957955|NCT00218530|Adrenergic Agents|adrenergic agents|mesh-ancestor
64957973|NCT00042146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568317|NCT02181231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64957974|NCT00042146|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64957975|NCT00042146|GABA Agonists|gaba agonists|mesh-ancestor
64957977|NCT00042146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64957978|NCT00042146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957991|NCT00219271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64957992|NCT00219271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64957993|NCT00219310|Famciclovir|famciclovir|mesh-list
64957994|NCT00219310|Antiviral Agents|antiviral agents|mesh-ancestor
64957995|NCT00219310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64957996|NCT00219310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64568424|NCT04934514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568425|NCT04934514|Antiviral Agents|antiviral agents|mesh-ancestor
64568426|NCT04934514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64957997|NCT00219310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64957998|NCT00219310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64957999|NCT00219388|Simendan|simendan|mesh-list
64958000|NCT00219388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64958001|NCT00219388|Vasodilator Agents|vasodilator agents|mesh-ancestor
64568501|NCT01369875|Antiviral Agents|antiviral agents|mesh-ancestor
64958002|NCT00219388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64958003|NCT00219388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64958004|NCT00219388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568528|NCT02755597|Bortezomib|bortezomib|mesh-list
64568612|NCT02588443|Tubulin Modulators|tubulin modulators|mesh-ancestor
64958005|NCT00219388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958006|NCT00219388|Protective Agents|protective agents|mesh-ancestor
64958007|NCT00219388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958008|NCT00219466|Zinc|zinc|mesh-list
64958009|NCT00219466|Tocopherols|tocopherols|mesh-list
64958010|NCT00219466|Vitamin E|vitamin e|mesh-list
64958011|NCT00219466|Tocotrienols|tocotrienols|mesh-list
64958012|NCT00219466|alpha-Tocopherol|alpha-tocopherol|mesh-list
64958013|NCT00219466|Zinc Oxide|zinc oxide|mesh-list
64958014|NCT00219466|Trace Elements|trace elements|mesh-ancestor
64958015|NCT00219466|Micronutrients|micronutrients|mesh-ancestor
64958016|NCT00219466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958017|NCT00219466|Antioxidants|antioxidants|mesh-ancestor
64958018|NCT00219466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958019|NCT00219466|Protective Agents|protective agents|mesh-ancestor
64958020|NCT00219466|Vitamins|vitamins|mesh-ancestor
64568777|NCT05586763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64958036|NCT00219700|Analgesics|analgesics|mesh-ancestor
64958037|NCT00219700|Sensory System Agents|sensory system agents|mesh-ancestor
64958038|NCT00219700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64958098|NCT00219895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958100|NCT00077337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64958101|NCT00077337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958102|NCT00219934|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64958187|NCT00220324|Contraceptive Agents|contraceptive agents|mesh-ancestor
64958188|NCT00220324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64958189|NCT00220324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958190|NCT00220324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64958191|NCT00220324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64958192|NCT00220324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64958253|NCT00077493|Immunotoxins|immunotoxins|mesh-list
64958254|NCT00077493|Immunologic Factors|immunologic factors|mesh-ancestor
64958255|NCT00077493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958256|NCT00220831|Vitamin E|vitamin e|mesh-list
64958257|NCT00220831|Vitamins|vitamins|mesh-ancestor
64958258|NCT00220831|Micronutrients|micronutrients|mesh-ancestor
64958259|NCT00220831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958260|NCT00220831|Antioxidants|antioxidants|mesh-ancestor
64958261|NCT00220831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958262|NCT00220831|Protective Agents|protective agents|mesh-ancestor
64958263|NCT00220909|Lansoprazole|lansoprazole|mesh-list
64958264|NCT00220909|Dexlansoprazole|dexlansoprazole|mesh-list
64958286|NCT00042809|Tubulin Modulators|tubulin modulators|mesh-ancestor
64958287|NCT00042809|Antimitotic Agents|antimitotic agents|mesh-ancestor
64958288|NCT00042809|Mitosis Modulators|mitosis modulators|mesh-ancestor
64958289|NCT00042809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958290|NCT00042809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64958291|NCT00042809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64958292|NCT00042809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958293|NCT00073710|Calcitriol|calcitriol|mesh-list
64958294|NCT00073710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64958295|NCT00073710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958344|NCT00402376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64958345|NCT00402376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64958346|NCT00402376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64958347|NCT00402376|Antimetabolites|antimetabolites|mesh-ancestor
64958348|NCT00402376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64958349|NCT00402376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64958350|NCT00402376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958351|NCT00402376|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64958352|NCT00402376|Protease Inhibitors|protease inhibitors|mesh-ancestor
64958353|NCT00042887|Mitomycins|mitomycins|mesh-list
64958354|NCT00042887|Mitomycin|mitomycin|mesh-list
64958355|NCT00042887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64958356|NCT00042887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958357|NCT00042887|Alkylating Agents|alkylating agents|mesh-ancestor
64958358|NCT00042887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958359|NCT00042887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64568921|NCT02389309|Sirolimus|sirolimus|mesh-list
64958360|NCT00042887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958361|NCT00122746|Cisplatin|cisplatin|mesh-list
64958371|NCT00122785|Hormones|hormones|mesh-ancestor
64958377|NCT00122824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64958378|NCT00122824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64958379|NCT00122824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958380|NCT00122824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64958381|NCT00122824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958382|NCT00122824|Analgesics|analgesics|mesh-ancestor
64497101|NCT05244525|Mydriatics|mydriatics|mesh-ancestor
64569008|NCT02484391|Vitamins|vitamins|mesh-ancestor
64958460|NCT00123175|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64497104|NCT01927263|Infliximab|infliximab|mesh-list
64958461|NCT00123175|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64958462|NCT00123175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64958487|NCT00043004|Fluorouracil|fluorouracil|mesh-list
64958488|NCT00043004|Oxaliplatin|oxaliplatin|mesh-list
64958489|NCT00043004|Calcium|calcium|mesh-list
64958490|NCT00043004|Levoleucovorin|levoleucovorin|mesh-list
64958491|NCT00043004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64958492|NCT00043004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958493|NCT00043004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64958494|NCT00043004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64958495|NCT00043004|Growth Substances|growth substances|mesh-ancestor
64958496|NCT00043004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958497|NCT00043004|Growth Inhibitors|growth inhibitors|mesh-ancestor
64958498|NCT00043004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64569100|NCT03052998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64569101|NCT03052998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64569102|NCT02354131|Bevacizumab|bevacizumab|mesh-list
64569103|NCT02354131|Niraparib|niraparib|mesh-list
64569104|NCT02354131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64569105|NCT02354131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569106|NCT02354131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64569107|NCT02354131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64569108|NCT02354131|Growth Substances|growth substances|mesh-ancestor
64569109|NCT02354131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569110|NCT02354131|Growth Inhibitors|growth inhibitors|mesh-ancestor
64569111|NCT02354131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64569112|NCT02354131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569113|NCT02354131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569114|NCT02352337|Gemcitabine|gemcitabine|mesh-list
64569116|NCT02352337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64569117|NCT02352337|Antimetabolites|antimetabolites|mesh-ancestor
64569120|NCT02352337|Antiviral Agents|antiviral agents|mesh-ancestor
64958499|NCT00043004|Antimetabolites|antimetabolites|mesh-ancestor
64958500|NCT00043004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958501|NCT00043004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64958502|NCT00043004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64958503|NCT00043004|Immunologic Factors|immunologic factors|mesh-ancestor
64958504|NCT00043004|Antidotes|antidotes|mesh-ancestor
64958505|NCT00043004|Protective Agents|protective agents|mesh-ancestor
64958506|NCT00043004|Vitamin B Complex|vitamin b complex|mesh-ancestor
64958542|NCT00043043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64958543|NCT00043043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958544|NCT00043043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958545|NCT00077805|Enoxaparin|enoxaparin|mesh-list
64958546|NCT00077805|Enoxaparin sodium|enoxaparin sodium|mesh-list
64569142|NCT02827201|Immunologic Factors|immunologic factors|mesh-ancestor
64569143|NCT02827201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569144|NCT02346253|Leuprolide|leuprolide|mesh-list
64569145|NCT02346253|Goserelin|goserelin|mesh-list
64569146|NCT02346253|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64569147|NCT02346253|Bicalutamide|bicalutamide|mesh-list
64569148|NCT02346253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64569149|NCT02346253|Fertility Agents|fertility agents|mesh-ancestor
64569161|NCT01378377|Niacinamide|niacinamide|mesh-list
64958547|NCT00077805|Anticoagulants|anticoagulants|mesh-ancestor
64958548|NCT00077805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64958557|NCT00043082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64958558|NCT00043082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958559|NCT00043082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958560|NCT00123877|Esorubicin|esorubicin|mesh-list
64958561|NCT00123877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64958562|NCT00123877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569209|NCT03056274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64958563|NCT00123916|Benzonidazole|benzonidazole|mesh-list
64958564|NCT00123916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64958565|NCT00123916|Immunologic Factors|immunologic factors|mesh-ancestor
64958566|NCT00123916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958567|NCT00123916|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64958568|NCT00123916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64958569|NCT00123916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64958589|NCT02970539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958590|NCT02970539|Tubulin Modulators|tubulin modulators|mesh-ancestor
64958591|NCT02970539|Antimitotic Agents|antimitotic agents|mesh-ancestor
64958592|NCT02970539|Mitosis Modulators|mitosis modulators|mesh-ancestor
64958593|NCT02970539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958594|NCT00124111|Cyclophosphamide|cyclophosphamide|mesh-list
64958595|NCT00124111|Fluorouracil|fluorouracil|mesh-list
64958596|NCT00124111|Methotrexate|methotrexate|mesh-list
64958597|NCT00124111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64958598|NCT00124111|Immunologic Factors|immunologic factors|mesh-ancestor
64958599|NCT00124111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958600|NCT00124111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64958601|NCT00124111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64958602|NCT00124111|Alkylating Agents|alkylating agents|mesh-ancestor
64958603|NCT00124111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958604|NCT00124111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958605|NCT00124111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64958606|NCT00124111|Antimetabolites|antimetabolites|mesh-ancestor
64958607|NCT00124111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64958645|NCT00073905|Gemcitabine|gemcitabine|mesh-list
64958646|NCT00073905|Capecitabine|capecitabine|mesh-list
64958647|NCT00073905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64958648|NCT00073905|Antimetabolites|antimetabolites|mesh-ancestor
64958649|NCT00073905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958650|NCT00073905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958651|NCT00073905|Antiviral Agents|antiviral agents|mesh-ancestor
64958652|NCT00073905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64958653|NCT00073905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958654|NCT00073905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64958655|NCT00073905|Immunologic Factors|immunologic factors|mesh-ancestor
64958656|NCT00073905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958657|NCT00124267|Quinine|quinine|mesh-list
64958658|NCT00124267|Antimalarials|antimalarials|mesh-ancestor
64958659|NCT00124267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64958660|NCT00124267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64569588|NCT05026567|Anesthetics|anesthetics|mesh-ancestor
64958661|NCT00124267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64958662|NCT00124267|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64958663|NCT00124267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958664|NCT00124267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64958665|NCT00124267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64958666|NCT00124267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64958667|NCT00124267|Analgesics|analgesics|mesh-ancestor
64958668|NCT00124267|Sensory System Agents|sensory system agents|mesh-ancestor
64958669|NCT00077844|Enoxaparin|enoxaparin|mesh-list
64958670|NCT00077844|Enoxaparin sodium|enoxaparin sodium|mesh-list
64958671|NCT00077844|Anticoagulants|anticoagulants|mesh-ancestor
64958693|NCT00043121|Micronutrients|micronutrients|mesh-ancestor
64958708|NCT00402415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64958709|NCT00402415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958710|NCT00402415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958711|NCT04727476|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64958712|NCT04727476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64958713|NCT04727476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958714|NCT04727476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64958715|NCT04727476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64958718|NCT04727476|Dopamine Agents|dopamine agents|mesh-ancestor
64958741|NCT00124384|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64569692|NCT01976065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64569693|NCT01976065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64569694|NCT01976065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64569695|NCT01976065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64569696|NCT01976065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64569697|NCT01976065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569698|NCT01976065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958742|NCT00124384|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64958743|NCT00124384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958744|NCT00077883|Cisplatin|cisplatin|mesh-list
64958745|NCT00077883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64958746|NCT00124540|Misoprostol|misoprostol|mesh-list
64958747|NCT00124540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64958748|NCT00124540|Abortifacient Agents|abortifacient agents|mesh-ancestor
64958749|NCT00124540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64958750|NCT00124540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958751|NCT00124540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64958752|NCT00124540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64958753|NCT00124540|Oxytocics|oxytocics|mesh-ancestor
64958754|NCT00124696|Cocaethylene|cocaethylene|mesh-list
64958755|NCT00124696|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64497401|NCT03054831|Narcotics|narcotics|mesh-ancestor
64958756|NCT00124696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64958757|NCT00124696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64958758|NCT00124696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569749|NCT01894633|Antimalarials|antimalarials|mesh-ancestor
64958759|NCT00124696|Dopamine Agents|dopamine agents|mesh-ancestor
64958760|NCT00124696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64958761|NCT00124696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958762|NCT00043277|Bivalirudin|bivalirudin|mesh-list
64958763|NCT00043277|Antithrombins|antithrombins|mesh-ancestor
64569750|NCT01894633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64569751|NCT05585671|Belimumab|belimumab|mesh-list
64569752|NCT05585671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64569753|NCT05585671|Immunologic Factors|immunologic factors|mesh-ancestor
64569754|NCT05585671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569755|NCT01391559|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64569756|NCT01391559|Formoterol Fumarate|formoterol fumarate|mesh-list
64569758|NCT01391559|Autonomic Agents|autonomic agents|mesh-ancestor
64958790|NCT00124813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64958791|NCT00124813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958792|NCT00124813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64958793|NCT00124930|Olanzapine|olanzapine|mesh-list
64958794|NCT00124930|Antiemetics|antiemetics|mesh-ancestor
64958795|NCT00124930|Autonomic Agents|autonomic agents|mesh-ancestor
64958796|NCT00124930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64958797|NCT00124930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64958798|NCT00124930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64958799|NCT00124930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64958800|NCT00124930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64958801|NCT00124930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64958802|NCT00124930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64958941|NCT00125983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64958942|NCT00125983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64958943|NCT00125983|Protease Inhibitors|protease inhibitors|mesh-ancestor
64958944|NCT00125983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64958945|NCT00125983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569852|NCT04898946|Vaccines|vaccines|mesh-list
64958946|NCT00125983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64959001|NCT00402493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64959002|NCT00402493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64959003|NCT00402493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64959004|NCT00402493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64959005|NCT00402493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64959006|NCT00402493|Adrenergic Agents|adrenergic agents|mesh-ancestor
64959007|NCT00402493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64959008|NCT00402532|Everolimus|everolimus|mesh-list
64959009|NCT00402532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959010|NCT00402532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64959011|NCT00402532|Immunologic Factors|immunologic factors|mesh-ancestor
64959012|NCT00402532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959013|NCT00126061|Tedisamil|tedisamil|mesh-list
64959014|NCT00126061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64959015|NCT00126061|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64959016|NCT00126061|Protective Agents|protective agents|mesh-ancestor
64959017|NCT00126061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959020|NCT00043589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959102|NCT00126373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959103|NCT00126373|Dopamine Agents|dopamine agents|mesh-ancestor
64959104|NCT00126373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64959105|NCT00126373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959106|NCT00126373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64959107|NCT00126373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64959108|NCT00126373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959109|NCT00126412|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64959110|NCT00126412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959117|NCT00043706|Immunologic Factors|immunologic factors|mesh-ancestor
64959118|NCT00043706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959119|NCT00043706|Mitosis Modulators|mitosis modulators|mesh-ancestor
64959120|NCT00043706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959121|NCT00126451|Vorinostat|vorinostat|mesh-list
64959122|NCT00126451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959123|NCT00126451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64959124|NCT00126451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497776|NCT03426462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64959125|NCT00126451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959126|NCT00126607|Trastuzumab|trastuzumab|mesh-list
64959127|NCT00126607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64959128|NCT00126607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959129|NCT00074178|Cytarabine|cytarabine|mesh-list
64959130|NCT00074178|Dexamethasone|dexamethasone|mesh-list
64569994|NCT02230969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64569995|NCT04881474|Ibuprofen|ibuprofen|mesh-list
64569996|NCT04881474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64569997|NCT04881474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64569998|NCT04881474|Analgesics|analgesics|mesh-ancestor
64295255|NCT02048917|Bupropion|bupropion|mesh-list
64959131|NCT00074178|Cyclophosphamide|cyclophosphamide|mesh-list
64959132|NCT00074178|Methotrexate|methotrexate|mesh-list
64959133|NCT00074178|Etoposide|etoposide|mesh-list
64959134|NCT00074178|Etoposide phosphate|etoposide phosphate|mesh-list
64959135|NCT00074178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64959136|NCT00074178|Immunologic Factors|immunologic factors|mesh-ancestor
64959137|NCT00074178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959138|NCT00074178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64959139|NCT00074178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64959140|NCT00074178|Alkylating Agents|alkylating agents|mesh-ancestor
64959141|NCT00074178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959142|NCT00074178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959143|NCT00074178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64959144|NCT00074178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64959145|NCT00074178|Antiemetics|antiemetics|mesh-ancestor
64959146|NCT00074178|Autonomic Agents|autonomic agents|mesh-ancestor
64959147|NCT00074178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64959148|NCT00074178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64959149|NCT00074178|Glucocorticoids|glucocorticoids|mesh-ancestor
64959150|NCT00074178|Hormones|hormones|mesh-ancestor
64959153|NCT00074178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64959154|NCT00074178|Abortifacient Agents|abortifacient agents|mesh-ancestor
64959155|NCT00074178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64959156|NCT00074178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64959157|NCT00074178|Antimetabolites|antimetabolites|mesh-ancestor
64959158|NCT00074178|Dermatologic Agents|dermatologic agents|mesh-ancestor
64959159|NCT00074178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959160|NCT00074178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64959161|NCT00074178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64959162|NCT00074178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64959163|NCT00074178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64959164|NCT00074178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64959165|NCT00074178|Antiviral Agents|antiviral agents|mesh-ancestor
64959229|NCT00127153|Immunologic Factors|immunologic factors|mesh-ancestor
64959230|NCT00127153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959231|NCT00399477|Levodopa|levodopa|mesh-list
64959232|NCT00399477|Pramipexole|pramipexole|mesh-list
64959233|NCT00399477|Rasagiline|rasagiline|mesh-list
64959236|NCT00399477|Dopamine Agents|dopamine agents|mesh-ancestor
64959270|NCT00127387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64959271|NCT00127387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64959272|NCT00127387|Analgesics|analgesics|mesh-ancestor
64959273|NCT00127387|Sensory System Agents|sensory system agents|mesh-ancestor
64959274|NCT00127387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64959275|NCT00127387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959276|NCT00127387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64959277|NCT00127387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64959278|NCT00127387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64959279|NCT00127387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64959280|NCT00127387|Immunologic Factors|immunologic factors|mesh-ancestor
64959282|NCT00043862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64959283|NCT00043862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64959284|NCT00043862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959285|NCT00043862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959286|NCT00043862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959287|NCT00127504|Azithromycin|azithromycin|mesh-list
64959288|NCT00127504|Rifampin|rifampin|mesh-list
64959289|NCT00127504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64959290|NCT00127504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64959291|NCT00127504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64959292|NCT00127504|Antitubercular Agents|antitubercular agents|mesh-ancestor
64959293|NCT00127504|Leprostatic Agents|leprostatic agents|mesh-ancestor
64959294|NCT00127504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64959295|NCT00127504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959296|NCT00127504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959315|NCT00127777|Amantadine|amantadine|mesh-list
64959316|NCT00127777|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64959317|NCT00127777|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64959318|NCT00127777|Antiviral Agents|antiviral agents|mesh-ancestor
64959319|NCT00127777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64959320|NCT00127777|Dopamine Agents|dopamine agents|mesh-ancestor
64959321|NCT00127777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64959322|NCT00127777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959323|NCT00127777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959324|NCT00127777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64959325|NCT00127777|Analgesics|analgesics|mesh-ancestor
64959378|NCT00402766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959379|NCT00402766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959442|NCT05561725|Glucocorticoids|glucocorticoids|mesh-ancestor
64959443|NCT05561725|Hormones|hormones|mesh-ancestor
64959455|NCT00044291|Toremifene|toremifene|mesh-list
64959456|NCT00044291|Letrozole|letrozole|mesh-list
64959457|NCT00044291|Hormones|hormones|mesh-list
64959458|NCT00044291|Atamestane|atamestane|mesh-list
64959470|NCT00044291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64959471|NCT00044291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64959472|NCT00044291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64959474|NCT00078234|Fludarabine|fludarabine|mesh-list
64959475|NCT00078234|Oblimersen|oblimersen|mesh-list
64959476|NCT00078234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64959477|NCT00078234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959478|NCT00078234|Immunologic Factors|immunologic factors|mesh-ancestor
64959479|NCT00078234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959480|NCT00078234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64959481|NCT00044408|Ruboxistaurin|ruboxistaurin|mesh-list
64959482|NCT00044408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959483|NCT00044408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959485|NCT00078351|Viscosupplements|viscosupplements|mesh-ancestor
64959486|NCT00078351|Protective Agents|protective agents|mesh-ancestor
64959487|NCT00078351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959488|NCT00044447|Glimepiride|glimepiride|mesh-list
64959489|NCT00044447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64959490|NCT00044447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64959491|NCT00044447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959492|NCT00044447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64959493|NCT00044447|Immunologic Factors|immunologic factors|mesh-ancestor
64959494|NCT00397358|Icodextrin|icodextrin|mesh-list
64959495|NCT00397358|Dialysis Solutions|dialysis solutions|mesh-list
64959496|NCT00397358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64959497|NCT05519917|Afatinib|afatinib|mesh-list
64959498|NCT05519917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570306|NCT04888728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570319|NCT04888728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64570320|NCT04888728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64570321|NCT04888728|Adrenergic Agents|adrenergic agents|mesh-ancestor
64570322|NCT04125719|Nivolumab|nivolumab|mesh-list
64570327|NCT01428973|Mycophenolic Acid|mycophenolic acid|mesh-list
64959517|NCT00044486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64959518|NCT00044486|Hormone Antagonists|hormone antagonists|mesh-ancestor
64959519|NCT00044486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64959520|NCT00044486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959521|NCT05497336|Cetuximab|cetuximab|mesh-list
64959522|NCT05497336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64959523|NCT05497336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959524|NCT00044525|Taxane|taxane|mesh-list
64959525|NCT00044525|IDN 5109|idn 5109|mesh-list
64959526|NCT00044525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959527|NCT05417425|Lidocaine|lidocaine|mesh-list
64959528|NCT05417425|Protective Agents|protective agents|mesh-list
64959529|NCT05417425|Anesthetics, Local|anesthetics, local|mesh-ancestor
64959530|NCT05417425|Anesthetics|anesthetics|mesh-ancestor
64959531|NCT05417425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64959532|NCT05417425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959533|NCT05417425|Sensory System Agents|sensory system agents|mesh-ancestor
64959534|NCT05417425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64959535|NCT05417425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64959536|NCT05417425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64959540|NCT00397475|Cholecalciferol|cholecalciferol|mesh-list
64959576|NCT00078546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959622|NCT00403000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64959624|NCT00403000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959625|NCT00403000|Hormone Antagonists|hormone antagonists|mesh-ancestor
64959626|NCT00403000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64959665|NCT00044759|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64959666|NCT00044759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959667|NCT00044759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959668|NCT00044798|Citalopram|citalopram|mesh-list
64959669|NCT00044798|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64959670|NCT00044798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64959671|NCT00044798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64959672|NCT00044798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959673|NCT00044798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64959674|NCT00044798|Serotonin Agents|serotonin agents|mesh-ancestor
64959675|NCT00044798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959676|NCT00044798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64959677|NCT00044798|Antidepressive Agents|antidepressive agents|mesh-ancestor
64959678|NCT00044798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64959705|NCT00074841|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64959706|NCT00074841|Renal Agents|renal agents|mesh-ancestor
64959707|NCT00078975|Gemcitabine|gemcitabine|mesh-list
64959708|NCT00078975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64959709|NCT00078975|Antimetabolites|antimetabolites|mesh-ancestor
64959710|NCT00078975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959711|NCT00078975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570371|NCT01475643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64570372|NCT01475643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64959712|NCT00078975|Antiviral Agents|antiviral agents|mesh-ancestor
64959713|NCT00078975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64959714|NCT00078975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959750|NCT00079014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64959751|NCT00079014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959752|NCT00079014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64959753|NCT00079014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64959754|NCT00079014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959755|NCT00079014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959756|NCT04731740|Pembrolizumab|pembrolizumab|mesh-list
64959757|NCT04731740|Lenvatinib|lenvatinib|mesh-list
64959758|NCT04731740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64959759|NCT04731740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959760|NCT04731740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64959761|NCT04731740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64959762|NCT04731740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959763|NCT00044915|Repinotan hydrochloride|repinotan hydrochloride|mesh-list
64959764|NCT00044915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64959765|NCT00044915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64959766|NCT00044915|Serotonin Agents|serotonin agents|mesh-ancestor
64959767|NCT00044915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64570395|NCT04395222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570396|NCT04395222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570397|NCT04395222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64570398|NCT04395222|Immunologic Factors|immunologic factors|mesh-ancestor
64570401|NCT04395222|Alkylating Agents|alkylating agents|mesh-ancestor
64570409|NCT04124003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64570410|NCT04124003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570411|NCT03237377|Durvalumab|durvalumab|mesh-list
64570412|NCT03237377|Tremelimumab|tremelimumab|mesh-list
64570413|NCT03237377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64570414|NCT03237377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959768|NCT00044915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959769|NCT00044915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959770|NCT04321408|Ziconotide|ziconotide|mesh-list
64959771|NCT04321408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64959772|NCT04321408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64959972|NCT00075192|Tremelimumab|tremelimumab|mesh-list
64959973|NCT00075192|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64959974|NCT00075192|Fertility Agents|fertility agents|mesh-ancestor
64959975|NCT00075192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64959976|NCT00075192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64959977|NCT00075192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64959988|NCT00045461|Ifosfamide|ifosfamide|mesh-list
64959989|NCT00045461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64959990|NCT00045461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64959991|NCT00045461|Alkylating Agents|alkylating agents|mesh-ancestor
64959992|NCT00045461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64959993|NCT00075231|Ritonavir|ritonavir|mesh-list
64959994|NCT00075231|Lopinavir|lopinavir|mesh-list
64959995|NCT00075231|Lamivudine|lamivudine|mesh-list
64570453|NCT05580445|Antiviral Agents|antiviral agents|mesh-ancestor
64570454|NCT05580445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64570455|NCT05580445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570456|NCT05580445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64570457|NCT05580445|Immunologic Factors|immunologic factors|mesh-ancestor
64570458|NCT05580445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570459|NCT05580445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64570460|NCT05257902|Choline|choline|mesh-list
64570461|NCT05257902|Lipotropic Agents|lipotropic agents|mesh-ancestor
64570462|NCT05257902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64570463|NCT05257902|Antimetabolites|antimetabolites|mesh-ancestor
64570464|NCT05257902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570465|NCT05257902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64570466|NCT05257902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64959996|NCT00075231|Zidovudine|zidovudine|mesh-list
64959997|NCT00075231|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64959998|NCT00075231|Efavirenz|efavirenz|mesh-list
64959999|NCT00075231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64960000|NCT00075231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64960001|NCT00075231|Protease Inhibitors|protease inhibitors|mesh-ancestor
64960207|NCT02599363|Tubulin Modulators|tubulin modulators|mesh-ancestor
64960208|NCT02599363|Antimitotic Agents|antimitotic agents|mesh-ancestor
64960209|NCT02599363|Mitosis Modulators|mitosis modulators|mesh-ancestor
64960210|NCT02599363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960211|NCT02580838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64960212|NCT02580838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64960321|NCT00130507|Tubulin Modulators|tubulin modulators|mesh-ancestor
64960322|NCT00130507|Antimitotic Agents|antimitotic agents|mesh-ancestor
64960323|NCT00130507|Mitosis Modulators|mitosis modulators|mesh-ancestor
64960324|NCT00130546|Sirolimus|sirolimus|mesh-list
64960325|NCT00130546|Paclitaxel|paclitaxel|mesh-list
64960326|NCT00130546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64960327|NCT00130546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586302|NCT00365261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334734|NCT02232035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64334735|NCT02232035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64334736|NCT02232035|Anesthetics, General|anesthetics, general|mesh-ancestor
64334737|NCT02232035|Anesthetics|anesthetics|mesh-ancestor
64334738|NCT02232035|GABA Modulators|gaba modulators|mesh-ancestor
64334739|NCT02232035|GABA Agents|gaba agents|mesh-ancestor
64570532|NCT03830957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570534|NCT04121819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64570535|NCT04121819|Antimetabolites|antimetabolites|mesh-ancestor
64570536|NCT04121819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570537|NCT04121819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570538|NCT04121819|Antiviral Agents|antiviral agents|mesh-ancestor
64570539|NCT04121819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64570540|NCT04121819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64570541|NCT04121819|Immunologic Factors|immunologic factors|mesh-ancestor
64570542|NCT04121819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570543|NCT01476267|Dalcetrapib|dalcetrapib|mesh-list
64570544|NCT01476267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64570545|NCT01476267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64570546|NCT01476267|Antimetabolites|antimetabolites|mesh-ancestor
64570547|NCT01476267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570548|NCT01476267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64570549|NCT05189730|Paclitaxel|paclitaxel|mesh-list
64570550|NCT05189730|Carboplatin|carboplatin|mesh-list
64570551|NCT05189730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64570552|NCT05189730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570553|NCT05189730|Tubulin Modulators|tubulin modulators|mesh-ancestor
64960328|NCT00130546|Tubulin Modulators|tubulin modulators|mesh-ancestor
64960329|NCT00130546|Antimitotic Agents|antimitotic agents|mesh-ancestor
64960330|NCT00130546|Mitosis Modulators|mitosis modulators|mesh-ancestor
64960331|NCT00130546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960332|NCT00130546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64960333|NCT00130546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64960334|NCT00130546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64960335|NCT00130546|Antifungal Agents|antifungal agents|mesh-ancestor
64960336|NCT00130546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64960339|NCT00130585|Folic Acid|folic acid|mesh-list
64960374|NCT00130897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960375|NCT00130897|Growth Inhibitors|growth inhibitors|mesh-ancestor
64570554|NCT05189730|Antimitotic Agents|antimitotic agents|mesh-ancestor
64570555|NCT05189730|Mitosis Modulators|mitosis modulators|mesh-ancestor
64570556|NCT05189730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570557|NCT01476345|Insulin Glargine|insulin glargine|mesh-list
64570558|NCT01476345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64570580|NCT04120259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64570581|NCT04120259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64570582|NCT04392102|Niraparib|niraparib|mesh-list
64570583|NCT04392102|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64570584|NCT04392102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570585|NCT04392102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570586|NCT04392102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570587|NCT02127073|Oxytocin|oxytocin|mesh-list
64570588|NCT02127073|Oxytocics|oxytocics|mesh-ancestor
64570589|NCT02127073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64570590|NCT02127073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570591|NCT02124421|Paclitaxel|paclitaxel|mesh-list
64570592|NCT02124421|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64570593|NCT02124421|Carboplatin|carboplatin|mesh-list
64570594|NCT02124421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64570595|NCT02124421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570596|NCT02124421|Tubulin Modulators|tubulin modulators|mesh-ancestor
64570597|NCT02124421|Antimitotic Agents|antimitotic agents|mesh-ancestor
64570598|NCT02124421|Mitosis Modulators|mitosis modulators|mesh-ancestor
64570600|NCT05256342|Etoricoxib|etoricoxib|mesh-list
64960376|NCT00130897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64960377|NCT00130897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960378|NCT00130897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960379|NCT00046319|Ambrisentan|ambrisentan|mesh-list
64960380|NCT00046319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64960381|NCT00079833|Esomeprazole|esomeprazole|mesh-list
64960382|NCT00079833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64960383|NCT00079833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64960384|NCT00079833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64960385|NCT00079833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960386|NCT00079833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960387|NCT00079872|Pemetrexed|pemetrexed|mesh-list
64960388|NCT00079872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960389|NCT00079872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960390|NCT00079872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960391|NCT00079872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64499052|NCT01389076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64960393|NCT00046358|Ibuprofen|ibuprofen|mesh-list
64960426|NCT00131053|Methotrexate|methotrexate|mesh-list
64960427|NCT00131053|Vincristine|vincristine|mesh-list
64960428|NCT00131053|Asparaginase|asparaginase|mesh-list
64960429|NCT00131053|Mercaptopurine|mercaptopurine|mesh-list
64960430|NCT00131053|Pirarubicin|pirarubicin|mesh-list
64570612|NCT05256342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64570613|NCT05256342|Dopamine Agents|dopamine agents|mesh-ancestor
64570614|NCT05256342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64570615|NCT05256342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64570616|NCT05256342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64570617|NCT05256342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64570618|NCT05256342|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64570619|NCT05256342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64570620|NCT05256342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570621|NCT02117167|Pemetrexed|pemetrexed|mesh-list
64570622|NCT02117167|Durvalumab|durvalumab|mesh-list
64570623|NCT02117167|Olaparib|olaparib|mesh-list
64570624|NCT02117167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334740|NCT02232035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64334741|NCT02232035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334742|NCT02296021|Amoxicillin|amoxicillin|mesh-list
64334743|NCT02296021|Clarithromycin|clarithromycin|mesh-list
64334744|NCT02296021|Esomeprazole|esomeprazole|mesh-list
64334745|NCT02296021|Bismuth|bismuth|mesh-list
64570625|NCT02117167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570626|NCT02117167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570627|NCT02117167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64960431|NCT00131053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64960432|NCT00131053|Immunologic Factors|immunologic factors|mesh-ancestor
64960433|NCT00131053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960434|NCT00131053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64960435|NCT00131053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64960436|NCT00131053|Alkylating Agents|alkylating agents|mesh-ancestor
64960437|NCT00131053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960438|NCT00131053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960439|NCT00131053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64960440|NCT00131053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64570638|NCT01895881|Hormones|hormones|mesh-ancestor
64570639|NCT01895881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64570640|NCT01895881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570642|NCT04537962|Cetylpyridinium|cetylpyridinium|mesh-list
64570643|NCT04537962|Fluorides|fluorides|mesh-list
64570644|NCT04537962|Sodium Fluoride|sodium fluoride|mesh-list
64570645|NCT04537962|Fluorophosphate|fluorophosphate|mesh-list
64570646|NCT04537962|Tin Fluorides|tin fluorides|mesh-list
64570647|NCT04537962|Cariostatic Agents|cariostatic agents|mesh-ancestor
64570648|NCT04537962|Protective Agents|protective agents|mesh-ancestor
64570649|NCT04537962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570650|NCT04537962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64570651|NCT04537962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64570652|NCT05205252|Dexamethasone|dexamethasone|mesh-list
64570653|NCT05205252|Lenalidomide|lenalidomide|mesh-list
64570654|NCT05205252|Daratumumab|daratumumab|mesh-list
64570655|NCT05205252|Pomalidomide|pomalidomide|mesh-list
64570656|NCT05205252|Acalabrutinib|acalabrutinib|mesh-list
64570657|NCT05205252|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64570658|NCT05205252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64570668|NCT05205252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570669|NCT05205252|Immunologic Factors|immunologic factors|mesh-ancestor
64570670|NCT05205252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64570671|NCT05205252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64570672|NCT05205252|Growth Substances|growth substances|mesh-ancestor
64570673|NCT05205252|Growth Inhibitors|growth inhibitors|mesh-ancestor
64570675|NCT04126733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64570676|NCT04126733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570679|NCT04387734|Ocrelizumab|ocrelizumab|mesh-list
64960441|NCT00131053|Antiemetics|antiemetics|mesh-ancestor
64960442|NCT00131053|Autonomic Agents|autonomic agents|mesh-ancestor
64960443|NCT00131053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64960444|NCT00131053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64960445|NCT00131053|Glucocorticoids|glucocorticoids|mesh-ancestor
64960446|NCT00131053|Hormones|hormones|mesh-ancestor
64960447|NCT00131053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64570687|NCT04311606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64960448|NCT00131053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64570688|NCT04311606|Growth Substances|growth substances|mesh-ancestor
64570689|NCT04311606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570690|NCT04311606|Growth Inhibitors|growth inhibitors|mesh-ancestor
64570691|NCT04311606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570692|NCT02981069|Dapagliflozin|dapagliflozin|mesh-list
64570694|NCT02981069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64570695|NCT02981069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570700|NCT02981069|Hormones|hormones|mesh-ancestor
64960449|NCT00131053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64960450|NCT00131053|Abortifacient Agents|abortifacient agents|mesh-ancestor
64960451|NCT00131053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64960452|NCT00131053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64960453|NCT00131053|Antimetabolites|antimetabolites|mesh-ancestor
64960454|NCT00131053|Dermatologic Agents|dermatologic agents|mesh-ancestor
64960455|NCT00131053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960531|NCT00131716|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64960532|NCT00131716|Antimalarials|antimalarials|mesh-ancestor
64960533|NCT00131716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64960579|NCT00403780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960580|NCT00403780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64960581|NCT00403780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64960582|NCT00403780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64960625|NCT00132106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960626|NCT00132106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960627|NCT00132106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64960629|NCT00080340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960630|NCT00080340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64960631|NCT00080340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960632|NCT00080340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960634|NCT00132184|Vitamins|vitamins|mesh-ancestor
64960635|NCT00132184|Micronutrients|micronutrients|mesh-ancestor
64960636|NCT00132184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960638|NCT00132379|Docetaxel|docetaxel|mesh-list
64960679|NCT00132652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64960745|NCT00046826|Growth Substances|growth substances|mesh-ancestor
64960746|NCT00046826|Growth Inhibitors|growth inhibitors|mesh-ancestor
64960747|NCT00046826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64960748|NCT00046826|Alkylating Agents|alkylating agents|mesh-ancestor
64960749|NCT00046826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64960752|NCT00133237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64960753|NCT00133237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64960754|NCT00133237|Tubulin Modulators|tubulin modulators|mesh-ancestor
64960755|NCT00133237|Antimitotic Agents|antimitotic agents|mesh-ancestor
64960756|NCT00133237|Mitosis Modulators|mitosis modulators|mesh-ancestor
64570823|NCT04382664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64570824|NCT04382664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570825|NCT04382664|Immunologic Factors|immunologic factors|mesh-ancestor
64570826|NCT04382664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570827|NCT04392479|Aflibercept|aflibercept|mesh-list
64570828|NCT04392479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64570829|NCT04392479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64570830|NCT04392479|Growth Substances|growth substances|mesh-ancestor
64570831|NCT04392479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960789|NCT00133315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64960790|NCT00133315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64960791|NCT00133315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64960792|NCT00133315|Analgesics|analgesics|mesh-ancestor
64960793|NCT00133315|Sensory System Agents|sensory system agents|mesh-ancestor
64960794|NCT00133315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64960795|NCT00133315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64960796|NCT00133315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64960797|NCT00133315|Immunologic Factors|immunologic factors|mesh-ancestor
64960798|NCT00080496|Imipenem|imipenem|mesh-list
64960799|NCT00080496|Tigecycline|tigecycline|mesh-list
64960800|NCT00080496|Cilastatin|cilastatin|mesh-list
64960801|NCT00080496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64960802|NCT00080496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64960803|NCT00080496|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64960804|NCT00080496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64960956|NCT00133822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64960957|NCT00133822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64960958|NCT00133822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64960959|NCT00133822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64960960|NCT00133822|Dopamine Agents|dopamine agents|mesh-ancestor
64960961|NCT00133822|Antidepressive Agents|antidepressive agents|mesh-ancestor
64960962|NCT00133822|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64960963|NCT00133822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64960964|NCT00133822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64960965|NCT00133861|Botulinum Toxins|botulinum toxins|mesh-list
64960966|NCT00133861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64961012|NCT00080847|Doxorubicin|doxorubicin|mesh-list
64961013|NCT00080847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64961014|NCT00080847|Vincristine|vincristine|mesh-list
64961015|NCT00080847|Oblimersen|oblimersen|mesh-list
64961016|NCT00080847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64961017|NCT00080847|Immunologic Factors|immunologic factors|mesh-ancestor
64961018|NCT00080847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961019|NCT00080847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64961020|NCT00080847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64961021|NCT00080847|Alkylating Agents|alkylating agents|mesh-ancestor
64961022|NCT00080847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961023|NCT00080847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961024|NCT00080847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64961025|NCT00080847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64961026|NCT00080847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64961027|NCT00080847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64570890|NCT03824717|Anesthetics|anesthetics|mesh-ancestor
64570891|NCT03824717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64570892|NCT03824717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570893|NCT03824717|Sensory System Agents|sensory system agents|mesh-ancestor
64570894|NCT03824717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64961028|NCT00080847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64961029|NCT00080847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961030|NCT00080847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64961031|NCT00080847|Glucocorticoids|glucocorticoids|mesh-ancestor
64961032|NCT00080847|Hormones|hormones|mesh-ancestor
64961033|NCT00080847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64961034|NCT00080847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64961035|NCT00080847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64961036|NCT00080847|Tubulin Modulators|tubulin modulators|mesh-ancestor
64961037|NCT00080847|Antimitotic Agents|antimitotic agents|mesh-ancestor
64961038|NCT00080847|Mitosis Modulators|mitosis modulators|mesh-ancestor
64961039|NCT00134173|Atorvastatin|atorvastatin|mesh-list
64961059|NCT00080886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64961060|NCT00080886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64961061|NCT00080886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64961062|NCT00080886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64961063|NCT00080886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961064|NCT00080886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961065|NCT00080886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64961066|NCT00080886|Antimetabolites|antimetabolites|mesh-ancestor
64499730|NCT05040282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64961067|NCT00080886|Antiviral Agents|antiviral agents|mesh-ancestor
64961068|NCT00080886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64961069|NCT00080886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64961070|NCT00080886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64961071|NCT00080886|Alkylating Agents|alkylating agents|mesh-ancestor
64961072|NCT00080886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64961073|NCT00134212|Epinephrine|epinephrine|mesh-list
64961087|NCT00134212|Respiratory System Agents|respiratory system agents|mesh-ancestor
64571031|NCT02858219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64571032|NCT03823781|Milrinone|milrinone|mesh-list
64571033|NCT03823781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64571034|NCT03823781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64571035|NCT03823781|Vasodilator Agents|vasodilator agents|mesh-ancestor
64571036|NCT03823781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64571037|NCT03823781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64571038|NCT03823781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571039|NCT03823781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571040|NCT03823781|Protective Agents|protective agents|mesh-ancestor
64571041|NCT03823781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571042|NCT02935361|Atezolizumab|atezolizumab|mesh-list
64571043|NCT02935361|Guadecitabine|guadecitabine|mesh-list
64571044|NCT02935361|Azacitidine|azacitidine|mesh-list
64571045|NCT02935361|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64571046|NCT02935361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571047|NCT02935361|Immunologic Factors|immunologic factors|mesh-ancestor
64571048|NCT02935361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571049|NCT02935361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64571050|NCT02935361|Antimetabolites|antimetabolites|mesh-ancestor
64571051|NCT02935361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571052|NCT02935361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571053|NCT02614794|Capecitabine|capecitabine|mesh-list
64571054|NCT02614794|Trastuzumab|trastuzumab|mesh-list
64571055|NCT02614794|Tucatinib|tucatinib|mesh-list
64961102|NCT00080925|Cyclophosphamide|cyclophosphamide|mesh-list
64961103|NCT00080925|Rituximab|rituximab|mesh-list
64961104|NCT00080925|Doxorubicin|doxorubicin|mesh-list
64961105|NCT00080925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64961106|NCT00080925|Fludarabine|fludarabine|mesh-list
64961107|NCT00080925|Fludarabine phosphate|fludarabine phosphate|mesh-list
64961108|NCT00080925|Etoposide|etoposide|mesh-list
64961109|NCT00080925|Vincristine|vincristine|mesh-list
64961110|NCT00080925|Cyclosporins|cyclosporins|mesh-list
64961111|NCT00080925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64961112|NCT00080925|Immunologic Factors|immunologic factors|mesh-ancestor
64961113|NCT00080925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961114|NCT00080925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64571058|NCT02614794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571059|NCT02614794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571060|NCT02614794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64571061|NCT02614794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64571062|NCT02614794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571063|NCT03823079|Irinotecan|irinotecan|mesh-list
64571064|NCT03823079|Raltitrexed|raltitrexed|mesh-list
64961115|NCT00080925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64961116|NCT00080925|Alkylating Agents|alkylating agents|mesh-ancestor
64961117|NCT00080925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961118|NCT00080925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961119|NCT00080925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64961120|NCT00080925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64961121|NCT00080925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64961158|NCT00134368|Analgesics|analgesics|mesh-ancestor
64961159|NCT00134368|Sensory System Agents|sensory system agents|mesh-ancestor
64961160|NCT00134368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64961161|NCT00134368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961162|NCT00134368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64571120|NCT04877106|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64571121|NCT04877106|Protease Inhibitors|protease inhibitors|mesh-ancestor
64571122|NCT04877106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571123|NCT04877106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571125|NCT00981617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64571126|NCT00981617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571127|NCT00981617|Sensory System Agents|sensory system agents|mesh-ancestor
64571128|NCT00981617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64571129|NCT04876716|Voriconazole|voriconazole|mesh-list
64571130|NCT04876716|Posaconazole|posaconazole|mesh-list
64571131|NCT04876716|Isavuconazole|isavuconazole|mesh-list
64571132|NCT04876716|Anidulafungin|anidulafungin|mesh-list
64571133|NCT04876716|Antifungal Agents|antifungal agents|mesh-ancestor
64296387|NCT03561181|Vaccines|vaccines|mesh-list
64961163|NCT00134368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64961164|NCT00134368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64961165|NCT00134368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64961166|NCT00134368|Immunologic Factors|immunologic factors|mesh-ancestor
64961167|NCT00134485|Atorvastatin|atorvastatin|mesh-list
64961168|NCT00134485|Torcetrapib|torcetrapib|mesh-list
64961169|NCT00134485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64961170|NCT00134485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64961171|NCT00134485|Antimetabolites|antimetabolites|mesh-ancestor
64961173|NCT00134485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64961218|NCT00134641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64961219|NCT00134641|Tubulin Modulators|tubulin modulators|mesh-ancestor
64961220|NCT00134641|Antimitotic Agents|antimitotic agents|mesh-ancestor
64961221|NCT00134641|Mitosis Modulators|mitosis modulators|mesh-ancestor
64961222|NCT00134680|Trastuzumab|trastuzumab|mesh-list
64961223|NCT00134680|Letrozole|letrozole|mesh-list
64571163|NCT04865562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64571166|NCT04865562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64499957|NCT01436266|Abortifacient Agents|abortifacient agents|mesh-ancestor
64961224|NCT00134680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64961225|NCT00134680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961226|NCT00134680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64961227|NCT00134680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64961228|NCT00134680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961229|NCT00134680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961230|NCT00134680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64961231|NCT00134680|Hormone Antagonists|hormone antagonists|mesh-ancestor
64571244|NCT03046290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64571245|NCT03046290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571246|NCT03046290|Sensory System Agents|sensory system agents|mesh-ancestor
64571247|NCT03046290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64571248|NCT03046290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64571249|NCT03046290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64571250|NCT03046290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64571251|NCT03046290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64571252|NCT03046290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571253|NCT04874688|Provitamins|provitamins|mesh-list
64571254|NCT04874688|Beta Carotene|beta carotene|mesh-list
64961264|NCT00134914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64961265|NCT00134914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961266|NCT00134914|Analgesics|analgesics|mesh-ancestor
64961267|NCT00134914|Sensory System Agents|sensory system agents|mesh-ancestor
64961268|NCT00134914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64961269|NCT00134914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64961270|NCT00134953|Rivastigmine|rivastigmine|mesh-list
64961271|NCT00134953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64961272|NCT00134953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571309|NCT03047772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571310|NCT03047772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64571311|NCT03047772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64571312|NCT03047772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571314|NCT03047538|Perindopril|perindopril|mesh-list
64571315|NCT03047538|Atorvastatin|atorvastatin|mesh-list
64571316|NCT03047538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64571317|NCT03047538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64571318|NCT03047538|Antimetabolites|antimetabolites|mesh-ancestor
64571319|NCT03047538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571320|NCT03047538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64571321|NCT03047538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64571322|NCT03047538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571323|NCT03047538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64571324|NCT03047538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64571325|NCT03047538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64571326|NCT03047538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64571328|NCT03047538|Vasodilator Agents|vasodilator agents|mesh-ancestor
64571329|NCT03047538|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64571330|NCT03047538|Protease Inhibitors|protease inhibitors|mesh-ancestor
64571331|NCT01728805|Vorinostat|vorinostat|mesh-list
64571332|NCT01728805|Mogamulizumab|mogamulizumab|mesh-list
64961273|NCT00134953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961274|NCT00134953|Cholinergic Agents|cholinergic agents|mesh-ancestor
64961275|NCT00134953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64961276|NCT00134953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961277|NCT00134953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64961278|NCT00134953|Protective Agents|protective agents|mesh-ancestor
64961279|NCT00042861|Leucovorin|leucovorin|mesh-list
64961280|NCT00042861|Fluorouracil|fluorouracil|mesh-list
64961281|NCT00042861|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
64961282|NCT00042861|Calcium|calcium|mesh-list
64961283|NCT00042861|Levoleucovorin|levoleucovorin|mesh-list
64961284|NCT00042861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64961285|NCT00042861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961286|NCT00042861|Antimetabolites|antimetabolites|mesh-ancestor
64961316|NCT00134992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64961317|NCT00134992|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64571350|NCT03821987|Busulfan|busulfan|mesh-list
64571351|NCT03821987|Fludarabine|fludarabine|mesh-list
64571352|NCT03821987|Thymoglobulin|thymoglobulin|mesh-list
64571353|NCT03821987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64571354|NCT03821987|Immunologic Factors|immunologic factors|mesh-ancestor
64571355|NCT03821987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571356|NCT03821987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64571357|NCT03821987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64571366|NCT04273763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64571367|NCT04273763|Expectorants|expectorants|mesh-ancestor
64571368|NCT04273763|Respiratory System Agents|respiratory system agents|mesh-ancestor
64571370|NCT01712815|Antiviral Agents|antiviral agents|mesh-ancestor
64571371|NCT01712815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64571372|NCT03820193|Acetaminophen|acetaminophen|mesh-list
64961318|NCT00134992|Protective Agents|protective agents|mesh-ancestor
64961319|NCT00135070|Insulin Detemir|insulin detemir|mesh-list
64961320|NCT00135070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64961321|NCT00135070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961322|NCT00135187|Dexamethasone|dexamethasone|mesh-list
64961323|NCT00135187|Bortezomib|bortezomib|mesh-list
64961324|NCT00135187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64961325|NCT00135187|Antiemetics|antiemetics|mesh-ancestor
64961326|NCT00135187|Autonomic Agents|autonomic agents|mesh-ancestor
64961327|NCT00135187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64961328|NCT00135187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961329|NCT00135187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64961330|NCT00135187|Glucocorticoids|glucocorticoids|mesh-ancestor
64961331|NCT00135187|Hormones|hormones|mesh-ancestor
64571407|NCT03820193|Autonomic Agents|autonomic agents|mesh-ancestor
64571408|NCT03820193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64571409|NCT03820193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64571410|NCT03820193|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64571411|NCT03820193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64571412|NCT03820193|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64571413|NCT03820193|Anesthetics, General|anesthetics, general|mesh-ancestor
64571414|NCT03820193|Anesthetics|anesthetics|mesh-ancestor
64571415|NCT03820193|GABA Modulators|gaba modulators|mesh-ancestor
64571416|NCT03820193|GABA Agents|gaba agents|mesh-ancestor
64571417|NCT03820037|Opicapone|opicapone|mesh-list
64571418|NCT03820037|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64571419|NCT03820037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571420|NCT03820037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571421|NCT03820037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64571422|NCT03820037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64571423|NCT03829007|Durvalumab|durvalumab|mesh-list
64571424|NCT03829007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64334757|NCT02289391|Anesthetics|anesthetics|mesh-list
64961332|NCT00135187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64961333|NCT00135187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64961334|NCT00135187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961335|NCT00145093|Chromium|chromium|mesh-list
64961336|NCT00145093|Trace Elements|trace elements|mesh-ancestor
64961337|NCT00145093|Micronutrients|micronutrients|mesh-ancestor
64961338|NCT00145093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961339|NCT00047450|Citalopram|citalopram|mesh-list
64961340|NCT00047450|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64961341|NCT00047450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64961674|NCT00146731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64961675|NCT00146731|Anthelmintics|anthelmintics|mesh-ancestor
64961676|NCT00146731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64961677|NCT00146731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961678|NCT00146731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961679|NCT00146731|Leprostatic Agents|leprostatic agents|mesh-ancestor
64961680|NCT00146731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64961681|NCT00047840|Docetaxel|docetaxel|mesh-list
64961682|NCT00047840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961683|NCT00047840|Tubulin Modulators|tubulin modulators|mesh-ancestor
64571483|NCT01669122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571484|NCT01669122|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64571485|NCT01669122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64571486|NCT01669122|Cholinergic Agents|cholinergic agents|mesh-ancestor
64571487|NCT01669122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64571488|NCT01669122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571489|NCT03629483|Dexmedetomidine|dexmedetomidine|mesh-list
64571490|NCT03629483|Ropivacaine|ropivacaine|mesh-list
64571491|NCT03629483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64571492|NCT03629483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64571493|NCT03629483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571494|NCT03629483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64571495|NCT03629483|Analgesics|analgesics|mesh-ancestor
64360345|NCT02517307|Protective Agents|protective agents|mesh-ancestor
64961684|NCT00047840|Antimitotic Agents|antimitotic agents|mesh-ancestor
64961685|NCT00047840|Mitosis Modulators|mitosis modulators|mesh-ancestor
64961686|NCT00047840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961687|NCT00146926|Lidocaine|lidocaine|mesh-list
64961688|NCT00146926|Ephedrine|ephedrine|mesh-list
64961689|NCT00146926|Ketamine|ketamine|mesh-list
64961690|NCT00146926|Anesthetics, Local|anesthetics, local|mesh-ancestor
64961691|NCT00146926|Anesthetics|anesthetics|mesh-ancestor
64961692|NCT00146926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64961693|NCT00146926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571496|NCT03629483|Sensory System Agents|sensory system agents|mesh-ancestor
64961694|NCT00146926|Sensory System Agents|sensory system agents|mesh-ancestor
64571497|NCT03629483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64961695|NCT00146926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64961696|NCT00146926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64961826|NCT00147511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961828|NCT00043095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64961829|NCT00043095|Antimetabolites|antimetabolites|mesh-ancestor
64961830|NCT00043095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961831|NCT00043095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961832|NCT00043095|Antiviral Agents|antiviral agents|mesh-ancestor
64961833|NCT00043095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64961834|NCT00043095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961926|NCT00148018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64961928|NCT00148018|Autonomic Agents|autonomic agents|mesh-ancestor
64961929|NCT00148018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64961930|NCT00148018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961931|NCT00148018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64961932|NCT00148018|Glucocorticoids|glucocorticoids|mesh-ancestor
64961933|NCT00148018|Hormones|hormones|mesh-ancestor
64961934|NCT00148018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64961977|NCT00148252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64961978|NCT00148252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64961979|NCT00148252|Antitubercular Agents|antitubercular agents|mesh-ancestor
64961980|NCT00148252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64961981|NCT00148252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64961982|NCT00148252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64961983|NCT00148252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961985|NCT00148291|Vinorelbine|vinorelbine|mesh-list
64961986|NCT00148291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571566|NCT04758689|Dermatologic Agents|dermatologic agents|mesh-ancestor
64571582|NCT01451333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64571583|NCT01451333|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64571584|NCT01451333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64571585|NCT01451333|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64571586|NCT01702831|Lenalidomide|lenalidomide|mesh-list
64571587|NCT01702831|Melphalan|melphalan|mesh-list
64571588|NCT01702831|Busulfan|busulfan|mesh-list
64571589|NCT01702831|Immunologic Factors|immunologic factors|mesh-ancestor
64571590|NCT01702831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571591|NCT01702831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64571592|NCT01702831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64571593|NCT01702831|Growth Substances|growth substances|mesh-ancestor
64571594|NCT01702831|Growth Inhibitors|growth inhibitors|mesh-ancestor
64571595|NCT01702831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571596|NCT01702831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64571603|NCT03045510|Antimetabolites|antimetabolites|mesh-ancestor
64961987|NCT00148291|Tubulin Modulators|tubulin modulators|mesh-ancestor
64961988|NCT00148291|Antimitotic Agents|antimitotic agents|mesh-ancestor
64961989|NCT00148291|Mitosis Modulators|mitosis modulators|mesh-ancestor
64961990|NCT00148291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64961991|NCT00148291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64961992|NCT00148330|Triamcinolone|triamcinolone|mesh-list
64961993|NCT00148330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64961994|NCT00148330|Glucocorticoids|glucocorticoids|mesh-ancestor
64961995|NCT00148330|Hormones|hormones|mesh-ancestor
64961996|NCT00148330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64961997|NCT00148330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64961998|NCT00405808|Rimonabant|rimonabant|mesh-list
64961999|NCT00405808|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64962000|NCT00405808|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
64962001|NCT00405808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64962002|NCT00405808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64962003|NCT00405808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962004|NCT00405808|Hormones|hormones|mesh-ancestor
64962021|NCT00405847|Adrenergic Agents|adrenergic agents|mesh-ancestor
64962022|NCT00405847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64962023|NCT00405847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962024|NCT00148408|Montelukast|montelukast|mesh-list
64962025|NCT00148408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64962026|NCT00148408|Respiratory System Agents|respiratory system agents|mesh-ancestor
64962027|NCT00148408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64962028|NCT00148408|Hormone Antagonists|hormone antagonists|mesh-ancestor
64571605|NCT03045510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571606|NCT03045510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571607|NCT01451879|Miglustat|miglustat|mesh-list
64962029|NCT00148408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64962030|NCT00148408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962031|NCT00148408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64962032|NCT00148408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64962033|NCT00148408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962034|NCT00048503|Tipifarnib|tipifarnib|mesh-list
64962035|NCT00048503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962036|NCT00148447|Citalopram|citalopram|mesh-list
64962037|NCT00148447|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64962038|NCT00148447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64571666|NCT02022709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64571667|NCT02022709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64571668|NCT02022709|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64571669|NCT02022709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64571671|NCT02635841|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64571672|NCT02635841|Chelating Agents|chelating agents|mesh-ancestor
64571673|NCT02635841|Sequestering Agents|sequestering agents|mesh-ancestor
64571674|NCT02635841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571675|NCT00608725|Propranolol|propranolol|mesh-list
64571676|NCT00608725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64571678|NCT00608725|Adrenergic Agents|adrenergic agents|mesh-ancestor
64571679|NCT00608725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64571680|NCT00608725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571681|NCT00608725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571682|NCT00608725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64571683|NCT00608725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64571684|NCT00608725|Vasodilator Agents|vasodilator agents|mesh-ancestor
64571685|NCT01452659|Relugolix|relugolix|mesh-list
64571686|NCT01452659|Androgen Antagonists|androgen antagonists|mesh-ancestor
64571687|NCT01452659|Hormone Antagonists|hormone antagonists|mesh-ancestor
64571688|NCT01452659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64571689|NCT01452659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571690|NCT01896349|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64571691|NCT01896349|Amitriptyline|amitriptyline|mesh-list
64571692|NCT01896349|Risperidone|risperidone|mesh-list
64571693|NCT01896349|Sulpiride|sulpiride|mesh-list
64571694|NCT01896349|Mirtazapine|mirtazapine|mesh-list
64571695|NCT01896349|Fluvoxamine|fluvoxamine|mesh-list
64571696|NCT01896349|Trazodone|trazodone|mesh-list
64571697|NCT01896349|Tranylcypromine|tranylcypromine|mesh-list
64962039|NCT00148447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64962040|NCT00148447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962041|NCT00148447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64962042|NCT00148447|Serotonin Agents|serotonin agents|mesh-ancestor
64962043|NCT00148447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500695|NCT01470196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962044|NCT00148447|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64962045|NCT00148447|Antidepressive Agents|antidepressive agents|mesh-ancestor
64571703|NCT01896349|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64962124|NCT00148837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571705|NCT01896349|Imipramine|imipramine|mesh-list
64571706|NCT01896349|Clomipramine|clomipramine|mesh-list
64571707|NCT01896349|Antidepressive Agents|antidepressive agents|mesh-list
64571708|NCT01896349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64571709|NCT01896349|Serotonin Agents|serotonin agents|mesh-ancestor
64571710|NCT01896349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64571711|NCT01896349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571712|NCT01896349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571713|NCT01896349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64571714|NCT01896349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64571715|NCT01896349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64571716|NCT01896349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64571717|NCT01896349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64571718|NCT01896349|Dopamine Agents|dopamine agents|mesh-ancestor
64571719|NCT01896349|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64571720|NCT01896349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64571721|NCT01896349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64571722|NCT01896349|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64571723|NCT01896349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64571724|NCT01896349|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64571725|NCT01896349|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64571726|NCT01896349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64962126|NCT00148837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962127|NCT00148837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64962128|NCT00148837|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64962129|NCT00148837|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64962130|NCT00148837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64962131|NCT00148837|Adrenergic Agents|adrenergic agents|mesh-ancestor
64962132|NCT00148837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64962133|NCT00148876|Capecitabine|capecitabine|mesh-list
64962134|NCT00148876|Trastuzumab|trastuzumab|mesh-list
64962135|NCT00148876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64962169|NCT00048776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64962170|NCT00048776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962171|NCT00048776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64962256|NCT00082095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64962262|NCT00149851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500960|NCT04632264|Oxytocin|oxytocin|mesh-list
64962263|NCT00149851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962264|NCT00149929|Mycophenolic Acid|mycophenolic acid|mesh-list
64962265|NCT00149929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64962266|NCT00149929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571743|NCT01896349|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64571744|NCT01896349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64571745|NCT01896349|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64571746|NCT01896349|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64571747|NCT01452737|Bisacodyl|bisacodyl|mesh-list
64571749|NCT01452737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64571750|NCT01452737|Laxatives|laxatives|mesh-ancestor
64571751|NCT00595933|Muramidase|muramidase|mesh-list
64571752|NCT00595933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64571753|NCT00580489|Fentanyl|fentanyl|mesh-list
64571754|NCT00580489|Morphine|morphine|mesh-list
64571755|NCT00580489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64571756|NCT00580489|Narcotics|narcotics|mesh-ancestor
64571757|NCT00580489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64962267|NCT00149929|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64962268|NCT00149929|Antitubercular Agents|antitubercular agents|mesh-ancestor
64962269|NCT00149929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64962270|NCT00149929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64962271|NCT00149929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962272|NCT00149929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962273|NCT00049088|Bevacizumab|bevacizumab|mesh-list
64962274|NCT00049088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64962275|NCT00049088|Docetaxel|docetaxel|mesh-list
64962276|NCT00049088|Antibodies|antibodies|mesh-list
64962277|NCT00049088|Immunoglobulins|immunoglobulins|mesh-list
64962278|NCT00049088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64962279|NCT00049088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962280|NCT00049088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64962281|NCT00049088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64962282|NCT00049088|Growth Substances|growth substances|mesh-ancestor
64962283|NCT00049088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962284|NCT00049088|Growth Inhibitors|growth inhibitors|mesh-ancestor
64962285|NCT00049088|Immunologic Factors|immunologic factors|mesh-ancestor
64962310|NCT04725448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64962311|NCT04725448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64962312|NCT04725448|Growth Substances|growth substances|mesh-ancestor
64962313|NCT04725448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962314|NCT04725448|Growth Inhibitors|growth inhibitors|mesh-ancestor
64962315|NCT00405925|Lamivudine|lamivudine|mesh-list
64962316|NCT00405925|Zidovudine|zidovudine|mesh-list
64962317|NCT00405925|Abacavir|abacavir|mesh-list
64962318|NCT00405925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64962319|NCT00405925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64962320|NCT00405925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962321|NCT00405925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962322|NCT00405925|Antiviral Agents|antiviral agents|mesh-ancestor
64571804|NCT04872270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64571805|NCT04872270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571806|NCT04872270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571807|NCT04872270|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64571808|NCT04872270|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64571809|NCT04872270|Purinergic Agents|purinergic agents|mesh-ancestor
64571810|NCT04872270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64571811|NCT04872192|Anesthetics|anesthetics|mesh-list
64571812|NCT04872192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64571815|NCT01624285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571816|NCT01624285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64571817|NCT01624285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571818|NCT01624285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571820|NCT01454609|Bupivacaine|bupivacaine|mesh-list
64571821|NCT01454609|Anesthetics, Local|anesthetics, local|mesh-ancestor
64571822|NCT01454609|Anesthetics|anesthetics|mesh-ancestor
64962323|NCT00405925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64962324|NCT00405925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64962325|NCT00405925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64962326|NCT00405925|Antimetabolites|antimetabolites|mesh-ancestor
64962327|NCT00049166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64962328|NCT00049166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962329|NCT00049166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64962330|NCT00049166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962331|NCT00049166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962332|NCT00082212|Cetuximab|cetuximab|mesh-list
64962333|NCT00082212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64571832|NCT01454609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64571833|NCT01454609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64571834|NCT01454609|Adrenergic Agents|adrenergic agents|mesh-ancestor
64571835|NCT01454609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64571836|NCT01454609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571837|NCT03042234|Insulin|insulin|mesh-list
64571838|NCT03042234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64571839|NCT03042234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64571840|NCT03042234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571841|NCT02905799|Resveratrol|resveratrol|mesh-list
64571842|NCT02905799|Antioxidants|antioxidants|mesh-ancestor
64571843|NCT02905799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571844|NCT02905799|Protective Agents|protective agents|mesh-ancestor
64571845|NCT02905799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571846|NCT02905799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571847|NCT02905799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64571848|NCT00505063|Vaccines|vaccines|mesh-list
64571849|NCT00505063|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64571850|NCT00505063|Immunologic Factors|immunologic factors|mesh-ancestor
64571851|NCT00505063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571852|NCT00469183|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
64571853|NCT00469183|Tretinoin|tretinoin|mesh-list
64571854|NCT00469183|Hydroquinone|hydroquinone|mesh-list
64571855|NCT00469183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571856|NCT00469183|Keratolytic Agents|keratolytic agents|mesh-ancestor
64571857|NCT00469183|Dermatologic Agents|dermatologic agents|mesh-ancestor
64571858|NCT00469183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64571859|NCT00469183|Glucocorticoids|glucocorticoids|mesh-ancestor
64571860|NCT00469183|Hormones|hormones|mesh-ancestor
64571861|NCT00469183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64571863|NCT00469183|Antioxidants|antioxidants|mesh-ancestor
64962334|NCT00082212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962335|NCT00150007|Mycophenolic Acid|mycophenolic acid|mesh-list
64962357|NCT00150085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64962358|NCT00150085|Dermatologic Agents|dermatologic agents|mesh-ancestor
64962359|NCT00150085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64962360|NCT00150085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64962362|NCT00082251|Simvastatin|simvastatin|mesh-list
64962363|NCT00082251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64962364|NCT00082251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64962365|NCT00082251|Antimetabolites|antimetabolites|mesh-ancestor
64962366|NCT00082251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962367|NCT00082251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64962368|NCT00082251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64962411|NCT00150280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64962412|NCT00150280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501076|NCT01570348|Tacrolimus|tacrolimus|mesh-list
64571864|NCT00469183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571865|NCT00469183|Protective Agents|protective agents|mesh-ancestor
64571866|NCT00469183|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64571867|NCT01455935|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64571868|NCT01455935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64571869|NCT01455935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64571870|NCT01455935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571871|NCT00468715|Bicalutamide|bicalutamide|mesh-list
64571872|NCT00468715|Androgen Antagonists|androgen antagonists|mesh-ancestor
64571873|NCT00468715|Hormone Antagonists|hormone antagonists|mesh-ancestor
64571874|NCT00468715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64571875|NCT00468715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571876|NCT00468715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571877|NCT01456247|Lansoprazole|lansoprazole|mesh-list
64571878|NCT01456247|Dexlansoprazole|dexlansoprazole|mesh-list
64571879|NCT01456247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64571880|NCT01456247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64571881|NCT01456247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64571882|NCT01456247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334772|NCT02292667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64334773|NCT02292667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334774|NCT02292667|Analgesics|analgesics|mesh-ancestor
64334775|NCT02292667|Sensory System Agents|sensory system agents|mesh-ancestor
64334776|NCT02292667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334777|NCT02292667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64334778|NCT02292667|Antipyretics|antipyretics|mesh-ancestor
64334779|NCT02232269|Felodipine|felodipine|mesh-list
64571885|NCT01456325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962413|NCT00150280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962414|NCT00150280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64962416|NCT00150358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962417|NCT00150358|Vasodilator Agents|vasodilator agents|mesh-ancestor
64962418|NCT00150358|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64962419|NCT00150358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64962420|NCT00150358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962421|NCT00150358|Urological Agents|urological agents|mesh-ancestor
64962422|NCT00049361|Thalidomide|thalidomide|mesh-list
64962423|NCT00049361|Temozolomide|temozolomide|mesh-list
64962424|NCT00049361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64571886|NCT01456325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64571887|NCT01456325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571888|NCT01456325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571889|NCT05053867|Tranexamic Acid|tranexamic acid|mesh-list
64571890|NCT05053867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64571891|NCT05053867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64571892|NCT05053867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571893|NCT05053867|Hemostatics|hemostatics|mesh-ancestor
64571894|NCT05053867|Coagulants|coagulants|mesh-ancestor
64571896|NCT04866498|Sensory System Agents|sensory system agents|mesh-ancestor
64571901|NCT04866654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962425|NCT00049361|Alkylating Agents|alkylating agents|mesh-ancestor
64962426|NCT00049361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962427|NCT00049361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962428|NCT00049361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64962429|NCT00049361|Immunologic Factors|immunologic factors|mesh-ancestor
64962465|NCT00150553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962466|NCT00150553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64962467|NCT00150553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64962468|NCT00150631|Candesartan|candesartan|mesh-list
64962469|NCT00150631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64962470|NCT00150631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64962471|NCT00150631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64962472|NCT00150631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962474|NCT00082446|Immunologic Factors|immunologic factors|mesh-ancestor
64962475|NCT00082446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962476|NCT00049439|Cyclophosphamide|cyclophosphamide|mesh-list
64962477|NCT00049439|Lomustine|lomustine|mesh-list
64962478|NCT00049439|Etoposide|etoposide|mesh-list
64962479|NCT00049439|Procarbazine|procarbazine|mesh-list
64962480|NCT00049439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64962481|NCT00049439|Immunologic Factors|immunologic factors|mesh-ancestor
64962482|NCT00049439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962483|NCT00049439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64962484|NCT00049439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64962485|NCT00049439|Alkylating Agents|alkylating agents|mesh-ancestor
64501220|NCT05137938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962518|NCT00049556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962519|NCT00049556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64962520|NCT00049556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572026|NCT01458977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64572027|NCT01458977|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64572028|NCT01458977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64962521|NCT00049556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962522|NCT00150982|Alefacept|alefacept|mesh-list
64962523|NCT00150982|Dermatologic Agents|dermatologic agents|mesh-ancestor
64962524|NCT00150982|Immunologic Factors|immunologic factors|mesh-ancestor
64962525|NCT00150982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962526|NCT00049634|Cyclosporine|cyclosporine|mesh-list
64962527|NCT00049634|Cyclophosphamide|cyclophosphamide|mesh-list
64962528|NCT00049634|Busulfan|busulfan|mesh-list
64962529|NCT00049634|Methotrexate|methotrexate|mesh-list
64962530|NCT00049634|Cyclosporins|cyclosporins|mesh-list
64962531|NCT00049634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64962532|NCT00049634|Immunologic Factors|immunologic factors|mesh-ancestor
64962533|NCT00049634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572122|NCT00198991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64572123|NCT00198991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64572124|NCT00198991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64572125|NCT00198991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64572126|NCT00198991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64962534|NCT00049634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64962536|NCT00049634|Alkylating Agents|alkylating agents|mesh-ancestor
64962551|NCT00049634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64962553|NCT00151060|Etoposide|etoposide|mesh-list
64962554|NCT00151060|Estramustine|estramustine|mesh-list
64962555|NCT00151060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64962556|NCT00151060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962557|NCT00151060|Tubulin Modulators|tubulin modulators|mesh-ancestor
64962558|NCT00151060|Antimitotic Agents|antimitotic agents|mesh-ancestor
64962559|NCT00151060|Mitosis Modulators|mitosis modulators|mesh-ancestor
64962560|NCT00151060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572180|NCT01542255|Vinblastine|vinblastine|mesh-list
64962561|NCT00151060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64501294|NCT02346630|Dopamine Agents|dopamine agents|mesh-ancestor
64962562|NCT00151060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64962563|NCT00151060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962564|NCT00151060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64962565|NCT00151060|Alkylating Agents|alkylating agents|mesh-ancestor
64962566|NCT00151060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64962567|NCT00151138|Atenolol|atenolol|mesh-list
64962569|NCT00151138|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64962570|NCT00151138|Protease Inhibitors|protease inhibitors|mesh-ancestor
64962571|NCT00151138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962572|NCT00151138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962573|NCT00151138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64962574|NCT00151138|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64962575|NCT00151138|Protective Agents|protective agents|mesh-ancestor
64962576|NCT00151138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962577|NCT00151138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64962578|NCT00151138|Sympatholytics|sympatholytics|mesh-ancestor
64962595|NCT00082485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962596|NCT00151255|Cytarabine|cytarabine|mesh-list
64962597|NCT00151255|Mitoxantrone|mitoxantrone|mesh-list
64962598|NCT00151255|Idarubicin|idarubicin|mesh-list
64962599|NCT00151255|Tretinoin|tretinoin|mesh-list
64962600|NCT00151255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64962601|NCT00151255|Antimetabolites|antimetabolites|mesh-ancestor
64962602|NCT00151255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962603|NCT00151255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962604|NCT00151255|Antiviral Agents|antiviral agents|mesh-ancestor
64962605|NCT00151255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64962606|NCT00151255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64962607|NCT00151255|Immunologic Factors|immunologic factors|mesh-ancestor
64962608|NCT00151255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962609|NCT00151255|Analgesics|analgesics|mesh-ancestor
64962610|NCT00151255|Sensory System Agents|sensory system agents|mesh-ancestor
64962611|NCT00151255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962612|NCT00151255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64962613|NCT00151255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64962614|NCT00151255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962615|NCT00151255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64962616|NCT00151255|Keratolytic Agents|keratolytic agents|mesh-ancestor
64572270|NCT00048295|Alicaforsen|alicaforsen|mesh-list
64572271|NCT00048295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64572272|NCT00048295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64572273|NCT00048295|Immunologic Factors|immunologic factors|mesh-ancestor
64572274|NCT00048295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572276|NCT01455857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64962617|NCT00151255|Dermatologic Agents|dermatologic agents|mesh-ancestor
64962618|NCT00049751|Adalimumab|adalimumab|mesh-list
64962646|NCT00151450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962647|NCT00151450|Anticonvulsants|anticonvulsants|mesh-ancestor
64962648|NCT00151450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64962649|NCT00151450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64962650|NCT00151450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962651|NCT00151450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64962652|NCT00151450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64962653|NCT00151450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64962654|NCT00151450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64501371|NCT01803269|Topotecan|topotecan|mesh-list
64962707|NCT00406003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962709|NCT00049829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64962710|NCT00049829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962711|NCT00406042|Prednisolone|prednisolone|mesh-list
64962712|NCT00406042|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64962713|NCT00406042|Methylprednisolone|methylprednisolone|mesh-list
64962714|NCT00406042|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64962715|NCT00406042|Prednisolone acetate|prednisolone acetate|mesh-list
64572302|NCT03043248|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64572303|NCT03043248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572304|NCT03043248|Protective Agents|protective agents|mesh-ancestor
64572305|NCT04843631|Ustekinumab|ustekinumab|mesh-list
64572306|NCT04843631|Dermatologic Agents|dermatologic agents|mesh-ancestor
64572307|NCT03043326|Tenofovir|tenofovir|mesh-list
64572308|NCT03043326|Emtricitabine|emtricitabine|mesh-list
64572309|NCT03043326|Antiviral Agents|antiviral agents|mesh-ancestor
64572310|NCT03043326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64572312|NCT03043326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64572313|NCT03043326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572314|NCT03043326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572315|NCT03043326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64572316|NCT03043326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64572317|NCT04845737|Vitamin D|vitamin d|mesh-list
64572318|NCT04845737|Vitamins|vitamins|mesh-ancestor
64572319|NCT04845737|Micronutrients|micronutrients|mesh-ancestor
64572320|NCT04845737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572321|NCT04845737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64572322|NCT04849715|Rituximab|rituximab|mesh-list
64572323|NCT04849715|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64572324|NCT04849715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64572325|NCT04849715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572326|NCT04849715|Immunologic Factors|immunologic factors|mesh-ancestor
64962716|NCT00406042|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64962717|NCT00406042|Prednisolone phosphate|prednisolone phosphate|mesh-list
64962718|NCT00406042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64962719|NCT00406042|Glucocorticoids|glucocorticoids|mesh-ancestor
64962720|NCT00406042|Hormones|hormones|mesh-ancestor
64962721|NCT00406042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64962722|NCT00406042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962723|NCT00406042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64962724|NCT00406042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962725|NCT00406042|Antiemetics|antiemetics|mesh-ancestor
64962726|NCT00406042|Autonomic Agents|autonomic agents|mesh-ancestor
64962727|NCT00406042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962728|NCT00406042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64962729|NCT00406042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64962731|NCT00082563|Azithromycin|azithromycin|mesh-list
64962759|NCT00151528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962760|NCT00151528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64962762|NCT00151528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64962763|NCT00151528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64962764|NCT00151528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64962765|NCT00397787|Sunitinib|sunitinib|mesh-list
64962771|NCT00397787|Growth Inhibitors|growth inhibitors|mesh-ancestor
64962772|NCT00397787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64962773|NCT00397787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962774|NCT00397787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962814|NCT00151801|Interferon beta-1a|interferon beta-1a|mesh-list
64962815|NCT00151801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962816|NCT00151801|Antiviral Agents|antiviral agents|mesh-ancestor
64962817|NCT00151801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64962818|NCT00151801|Immunologic Factors|immunologic factors|mesh-ancestor
64962819|NCT00151801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962820|NCT00151801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64962821|NCT04725253|Niacinamide|niacinamide|mesh-list
64962823|NCT04725253|Nicotinic Acids|nicotinic acids|mesh-list
64962824|NCT04725253|Vitamin B Complex|vitamin b complex|mesh-ancestor
64962825|NCT04725253|Vitamins|vitamins|mesh-ancestor
64962826|NCT04725253|Micronutrients|micronutrients|mesh-ancestor
64962827|NCT04725253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962828|NCT04725253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64962829|NCT04725253|Antimetabolites|antimetabolites|mesh-ancestor
64962830|NCT04725253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572331|NCT04849715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572332|NCT03044964|Ranolazine|ranolazine|mesh-list
64572333|NCT03044964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64572334|NCT03044964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64572335|NCT03044964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572336|NCT01419639|Everolimus|everolimus|mesh-list
64572337|NCT01419639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572338|NCT01419639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64572339|NCT01419639|Immunologic Factors|immunologic factors|mesh-ancestor
64962831|NCT04725253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64962832|NCT04725253|Vasodilator Agents|vasodilator agents|mesh-ancestor
64962833|NCT00082719|Interferons|interferons|mesh-list
64962834|NCT00082719|Interferon-alpha|interferon-alpha|mesh-list
64962835|NCT00082719|Interferon alpha-2|interferon alpha-2|mesh-list
64962836|NCT00082719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962837|NCT00082719|Antiviral Agents|antiviral agents|mesh-ancestor
64962838|NCT00082719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64962839|NCT00082719|Immunologic Factors|immunologic factors|mesh-ancestor
64962840|NCT00082719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572355|NCT01419795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64572356|NCT01419795|Growth Substances|growth substances|mesh-ancestor
64572357|NCT01419795|Growth Inhibitors|growth inhibitors|mesh-ancestor
64572358|NCT04783753|Itraconazole|itraconazole|mesh-list
64572360|NCT04783753|Carbamazepine|carbamazepine|mesh-list
64572361|NCT04783753|Antifungal Agents|antifungal agents|mesh-ancestor
64572362|NCT04783753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64572363|NCT04783753|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64572364|NCT04783753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64572365|NCT04783753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572366|NCT04783753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572367|NCT04783753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64572368|NCT04783753|Hormone Antagonists|hormone antagonists|mesh-ancestor
64572369|NCT04783753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64572370|NCT04783753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572371|NCT04783753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64572372|NCT04783753|Anticonvulsants|anticonvulsants|mesh-ancestor
64572373|NCT04783753|Antimanic Agents|antimanic agents|mesh-ancestor
64572374|NCT04783753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64572375|NCT04783753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64572376|NCT04783753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64572377|NCT04783753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64572378|NCT04783753|Analgesics|analgesics|mesh-ancestor
64336802|NCT02330757|Zuclomiphene|zuclomiphene|mesh-list
64962864|NCT00152035|Adderall|adderall|mesh-list
64962865|NCT00152035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64962866|NCT00152035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64962867|NCT00152035|Sympathomimetics|sympathomimetics|mesh-ancestor
64962868|NCT00152035|Autonomic Agents|autonomic agents|mesh-ancestor
64962869|NCT00152035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64962870|NCT00152035|Dopamine Agents|dopamine agents|mesh-ancestor
64962871|NCT00152035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64962872|NCT00152035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962873|NCT00152035|Adrenergic Agents|adrenergic agents|mesh-ancestor
64572395|NCT04783753|Cholinergic Agents|cholinergic agents|mesh-ancestor
64572396|NCT04783753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64572397|NCT04783753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64572398|NCT02856581|Varenicline|varenicline|mesh-list
64572399|NCT02856581|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64572400|NCT02856581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64572401|NCT02856581|Cholinergic Agents|cholinergic agents|mesh-ancestor
64572402|NCT02856581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64572403|NCT02856581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572404|NCT02856581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572405|NCT03042000|Capecitabine|capecitabine|mesh-list
64572406|NCT03042000|Oxaliplatin|oxaliplatin|mesh-list
64572407|NCT03042000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64572408|NCT03042000|Antimetabolites|antimetabolites|mesh-ancestor
64572409|NCT03042000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572410|NCT03042000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334787|NCT02232269|Vasodilator Agents|vasodilator agents|mesh-ancestor
64962874|NCT00152035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64962875|NCT00152035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64962876|NCT00152035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64962877|NCT00152035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64962878|NCT00049985|Darbepoetin alfa|darbepoetin alfa|mesh-list
64962879|NCT00049985|Hematinics|hematinics|mesh-ancestor
64962880|NCT00082797|Leucovorin|leucovorin|mesh-list
64962881|NCT00082797|Methotrexate|methotrexate|mesh-list
64962882|NCT00082797|Calcium|calcium|mesh-list
64962921|NCT00152191|Abortifacient Agents|abortifacient agents|mesh-ancestor
64962922|NCT00152191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64962923|NCT00152191|Dermatologic Agents|dermatologic agents|mesh-ancestor
64962924|NCT00152191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962925|NCT00152191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64962926|NCT00152191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64962927|NCT00152230|Tegafur|tegafur|mesh-list
64962928|NCT00152230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64962929|NCT00152230|Antimetabolites|antimetabolites|mesh-ancestor
64962930|NCT00152230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962931|NCT00152230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962932|NCT00152308|Sirolimus|sirolimus|mesh-list
64962933|NCT00152308|Ethanol|ethanol|mesh-list
64962934|NCT00152308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64572435|NCT03523975|Lenalidomide|lenalidomide|mesh-list
64572436|NCT03523975|Venetoclax|venetoclax|mesh-list
64572437|NCT03523975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64572438|NCT03523975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572439|NCT03523975|Immunologic Factors|immunologic factors|mesh-ancestor
64572440|NCT03523975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572442|NCT03523975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64572443|NCT03523975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64572444|NCT03523975|Growth Substances|growth substances|mesh-ancestor
64572445|NCT03523975|Growth Inhibitors|growth inhibitors|mesh-ancestor
64572446|NCT01542645|Fentanyl|fentanyl|mesh-list
64572447|NCT01542645|Analgesics, Opioid|analgesics, opioid|mesh-list
64572448|NCT01542645|Methadone|methadone|mesh-list
64572449|NCT01542645|Narcotics|narcotics|mesh-ancestor
64572450|NCT01542645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64572451|NCT01542645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572452|NCT01542645|Analgesics|analgesics|mesh-ancestor
64572453|NCT01542645|Sensory System Agents|sensory system agents|mesh-ancestor
64572454|NCT01542645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64572455|NCT01542645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64572456|NCT01542645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64962935|NCT00152308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64962936|NCT00152308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64962937|NCT00152308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962938|NCT00152308|Antifungal Agents|antifungal agents|mesh-ancestor
64962982|NCT00043680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64962983|NCT00043680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64962984|NCT00043680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64962985|NCT00043680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64962986|NCT00043680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64962987|NCT00043680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64962989|NCT00152581|Ribavirin|ribavirin|mesh-list
64572472|NCT04857450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64572473|NCT04857450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64962990|NCT00152581|Interferon-alpha|interferon-alpha|mesh-list
64962991|NCT00152581|Interferon alpha-2|interferon alpha-2|mesh-list
64572474|NCT04857450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64572475|NCT04857450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572476|NCT04857450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64572478|NCT01420653|Ibuprofen|ibuprofen|mesh-list
64572479|NCT01420653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64572480|NCT01420653|Analgesics|analgesics|mesh-ancestor
64334790|NCT04486313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64334791|NCT02354001|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64334792|NCT02354001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64334793|NCT02354001|Hormone Antagonists|hormone antagonists|mesh-ancestor
64334855|NCT02232347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64334856|NCT02232347|Anesthetics, General|anesthetics, general|mesh-ancestor
64962992|NCT00152581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64962993|NCT00152581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64962994|NCT00152581|Antiviral Agents|antiviral agents|mesh-ancestor
64962995|NCT00152581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64962996|NCT00152581|Antimetabolites|antimetabolites|mesh-ancestor
64962997|NCT00152581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963024|NCT04725214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64963025|NCT04725214|Alkylating Agents|alkylating agents|mesh-ancestor
64963026|NCT04725214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963027|NCT04725214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963028|NCT00152698|Irbesartan|irbesartan|mesh-list
64963029|NCT00152698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64963030|NCT00152698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64963031|NCT00152698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64963032|NCT00152698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963033|NCT00050180|Indinavir|indinavir|mesh-list
64963034|NCT00050180|Saquinavir|saquinavir|mesh-list
64963035|NCT00050180|Midazolam|midazolam|mesh-list
64963036|NCT00050180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64963037|NCT00050180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64963038|NCT00050180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64963039|NCT00050180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963040|NCT00050180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64963041|NCT00050180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64963042|NCT00050180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64963043|NCT00050180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64963044|NCT00050180|Anesthetics, General|anesthetics, general|mesh-ancestor
64963078|NCT00152854|Acetaminophen|acetaminophen|mesh-list
64963079|NCT00152854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64963080|NCT00152854|Analgesics|analgesics|mesh-ancestor
64501740|NCT04588259|Insulin, Long-Acting|insulin, long-acting|mesh-list
64963081|NCT00152854|Sensory System Agents|sensory system agents|mesh-ancestor
64963082|NCT00152854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64501742|NCT04588259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64963083|NCT00152854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963084|NCT00152854|Antipyretics|antipyretics|mesh-ancestor
64963205|NCT00153244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64572660|NCT04856124|Anesthetics|anesthetics|mesh-ancestor
64963206|NCT00153244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64963248|NCT00083148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64963249|NCT00083148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963250|NCT00153517|Metronidazole|metronidazole|mesh-list
64963251|NCT00153517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64963252|NCT00153517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64963260|NCT00083187|Antisickling Agents|antisickling agents|mesh-ancestor
64963261|NCT00083187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963262|NCT00083187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963263|NCT00083187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64963264|NCT00153634|Azithromycin|azithromycin|mesh-list
64963265|NCT00153634|Ciprofloxacin|ciprofloxacin|mesh-list
64963266|NCT00153634|Meropenem|meropenem|mesh-list
64963267|NCT00153634|Tazobactam|tazobactam|mesh-list
64963268|NCT00153634|Piperacillin|piperacillin|mesh-list
64963269|NCT00153634|Tobramycin|tobramycin|mesh-list
64963270|NCT00153634|Clavulanic Acid|clavulanic acid|mesh-list
64963271|NCT00153634|Amikacin|amikacin|mesh-list
64963272|NCT00153634|Ceftazidime|ceftazidime|mesh-list
64963273|NCT00153634|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64963274|NCT00153634|Ticarcillin|ticarcillin|mesh-list
64963275|NCT00153634|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
64963286|NCT00050609|Tadalafil|tadalafil|mesh-list
64963297|NCT00153673|Sensory System Agents|sensory system agents|mesh-ancestor
64963298|NCT00153673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64963299|NCT00153673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963300|NCT00153673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64963301|NCT00153673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64963302|NCT00153673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64963303|NCT00153673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64963304|NCT00153673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963305|NCT00153673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963306|NCT00050648|Cyclosporine|cyclosporine|mesh-list
64963307|NCT00050648|Cyclosporins|cyclosporins|mesh-list
64963308|NCT00050648|Daclizumab|daclizumab|mesh-list
64963309|NCT00050648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963310|NCT00050648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963311|NCT00050648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64963312|NCT00050648|Immunologic Factors|immunologic factors|mesh-ancestor
64963313|NCT00050648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963314|NCT00050648|Antifungal Agents|antifungal agents|mesh-ancestor
64963315|NCT00050648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64963316|NCT00050648|Dermatologic Agents|dermatologic agents|mesh-ancestor
64572774|NCT00840853|Diphenhydramine|diphenhydramine|mesh-list
64572775|NCT00840853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64963317|NCT00050648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64963318|NCT00050648|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64963319|NCT00153868|Darbepoetin alfa|darbepoetin alfa|mesh-list
64963320|NCT00153868|Hematinics|hematinics|mesh-ancestor
64963321|NCT00153907|Capecitabine|capecitabine|mesh-list
64963322|NCT00153907|Vinorelbine|vinorelbine|mesh-list
64963323|NCT00153907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64963324|NCT00153907|Antimetabolites|antimetabolites|mesh-ancestor
64963325|NCT00153907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963326|NCT00153907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963342|NCT00153946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64963343|NCT00153946|Protective Agents|protective agents|mesh-ancestor
64963344|NCT00153946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963346|NCT00154024|Atorvastatin|atorvastatin|mesh-list
64963347|NCT00154024|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64963348|NCT00154024|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64963349|NCT00154024|Antimetabolites|antimetabolites|mesh-ancestor
64963350|NCT00154024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963351|NCT00154024|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64963352|NCT00154024|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64963353|NCT00154024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963354|NCT00154024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64963355|NCT00154024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64963356|NCT00154024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64963357|NCT00154141|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64963358|NCT00154141|Hemostatics|hemostatics|mesh-ancestor
64963359|NCT00154141|Coagulants|coagulants|mesh-ancestor
64963450|NCT00043914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64335238|NCT02293681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64963451|NCT00043914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64963488|NCT00406237|Tigecycline|tigecycline|mesh-list
64963489|NCT00406237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64963490|NCT00406237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64963491|NCT00406237|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64963492|NCT00406237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963493|NCT00406237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963495|NCT00406432|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64963496|NCT00406432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64963497|NCT00406432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64963498|NCT00406432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963499|NCT00406432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64963500|NCT00406432|Serotonin Agents|serotonin agents|mesh-ancestor
64963501|NCT00406432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963502|NCT00406432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64963503|NCT00406432|Antidepressive Agents|antidepressive agents|mesh-ancestor
64963504|NCT00406432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64963505|NCT00406432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64963506|NCT00406432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64963507|NCT00406432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963508|NCT00083343|Caspofungin|caspofungin|mesh-list
64963509|NCT00083343|Antifungal Agents|antifungal agents|mesh-ancestor
64963510|NCT00083343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64573052|NCT01550367|Aldesleukin|aldesleukin|mesh-list
64963536|NCT00154687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963538|NCT00083460|Dexamethasone|dexamethasone|mesh-list
64963539|NCT00083460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64963540|NCT00083460|Antiemetics|antiemetics|mesh-ancestor
64963541|NCT00083460|Autonomic Agents|autonomic agents|mesh-ancestor
64963542|NCT00083460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64963543|NCT00083460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963602|NCT00043953|Antimetabolites|antimetabolites|mesh-ancestor
64963604|NCT00154882|Cisplatin|cisplatin|mesh-list
64963605|NCT00154882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64963606|NCT00154882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963607|NCT00154882|Tubulin Modulators|tubulin modulators|mesh-ancestor
64963608|NCT00154882|Antimitotic Agents|antimitotic agents|mesh-ancestor
64963609|NCT00154882|Mitosis Modulators|mitosis modulators|mesh-ancestor
64963610|NCT00154882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963611|NCT00051077|Ribavirin|ribavirin|mesh-list
64963612|NCT00051077|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64963613|NCT00051077|Adefovir|adefovir|mesh-list
64963621|NCT00051077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963622|NCT00155233|Morphine|morphine|mesh-list
64963623|NCT00155233|Nalbuphine|nalbuphine|mesh-list
64963624|NCT00155233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64963625|NCT00155233|Narcotics|narcotics|mesh-ancestor
64963626|NCT00155233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64963627|NCT00155233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963628|NCT00155233|Analgesics|analgesics|mesh-ancestor
64963629|NCT00155233|Sensory System Agents|sensory system agents|mesh-ancestor
64963653|NCT00155350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963655|NCT00051155|Travoprost|travoprost|mesh-list
64963656|NCT00051155|Latanoprost|latanoprost|mesh-list
64963657|NCT00051155|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64963658|NCT00051155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64963659|NCT00051155|Adrenergic Agents|adrenergic agents|mesh-ancestor
64963660|NCT00051155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64963661|NCT00051155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963662|NCT00051155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963663|NCT00051155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64963664|NCT00051155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64963665|NCT00051155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64963666|NCT00051155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64963667|NCT00083538|Thalidomide|thalidomide|mesh-list
64963668|NCT00083538|Dexamethasone|dexamethasone|mesh-list
64963669|NCT00083538|Cyclophosphamide|cyclophosphamide|mesh-list
64963670|NCT00083538|Etoposide|etoposide|mesh-list
64963671|NCT00083538|Doxorubicin|doxorubicin|mesh-list
64963672|NCT00083538|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64963673|NCT00083538|Cisplatin|cisplatin|mesh-list
64963674|NCT00083538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64963675|NCT00083538|Immunologic Factors|immunologic factors|mesh-ancestor
64963676|NCT00083538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963677|NCT00083538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64963705|NCT00083577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64963706|NCT00083577|Immunologic Factors|immunologic factors|mesh-ancestor
64963707|NCT00083577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963708|NCT00083577|Leprostatic Agents|leprostatic agents|mesh-ancestor
64963709|NCT00083577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64963710|NCT00083577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64963711|NCT00083577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64963712|NCT00083577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64963713|NCT00083577|Growth Substances|growth substances|mesh-ancestor
64963714|NCT00083577|Growth Inhibitors|growth inhibitors|mesh-ancestor
64963715|NCT00083577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963716|NCT00406744|Bevacizumab|bevacizumab|mesh-list
64963717|NCT00406744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64963718|NCT00406744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963719|NCT00406744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64963720|NCT00406744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64963721|NCT00406744|Growth Substances|growth substances|mesh-ancestor
64963722|NCT00406744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963723|NCT00406744|Growth Inhibitors|growth inhibitors|mesh-ancestor
64963724|NCT00399750|Bevacizumab|bevacizumab|mesh-list
64963725|NCT00399750|Oxaliplatin|oxaliplatin|mesh-list
64963726|NCT00399750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64963727|NCT00399750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963728|NCT00399750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64963729|NCT00399750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64963730|NCT00399750|Growth Substances|growth substances|mesh-ancestor
64963731|NCT00399750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573420|NCT01431105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64963751|NCT00156325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64963752|NCT00156403|Amlodipine|amlodipine|mesh-list
64963753|NCT00156403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64963755|NCT00156403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64963756|NCT00156403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963757|NCT00156403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64963758|NCT00156403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963759|NCT00156403|Vasodilator Agents|vasodilator agents|mesh-ancestor
64963760|NCT00051272|Bupropion|bupropion|mesh-list
64963761|NCT00051272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64963762|NCT00051272|Antidepressive Agents|antidepressive agents|mesh-ancestor
64963763|NCT00051272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64963764|NCT00051272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64963765|NCT00051272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64963766|NCT00051272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64963767|NCT00051272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963768|NCT00051272|Dopamine Agents|dopamine agents|mesh-ancestor
64963769|NCT00051272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64963770|NCT00051272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963771|NCT00051272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64963772|NCT00051272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64963773|NCT00051272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963774|NCT00044187|Sibutramine|sibutramine|mesh-list
64963798|NCT00051389|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64963799|NCT00051389|Protease Inhibitors|protease inhibitors|mesh-ancestor
64963800|NCT00051389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963801|NCT00051389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963802|NCT00051389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64963803|NCT00156949|Epoetin Alfa|epoetin alfa|mesh-list
64963804|NCT00156949|Hematinics|hematinics|mesh-ancestor
64963805|NCT00156988|Sulfadiazine|sulfadiazine|mesh-list
64963806|NCT00156988|Silver Sulfadiazine|silver sulfadiazine|mesh-list
64963807|NCT00156988|Cerium nitrate|cerium nitrate|mesh-list
64963808|NCT00156988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64963809|NCT00156988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64963810|NCT00156988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64963811|NCT00156988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64963812|NCT00156988|Coccidiostats|coccidiostats|mesh-ancestor
64963813|NCT00156988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64963814|NCT00157066|Ergocalciferols|ergocalciferols|mesh-list
64963815|NCT00157066|Vitamin D|vitamin d|mesh-list
64963816|NCT00157066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64963817|NCT00157066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963818|NCT00157066|Vitamins|vitamins|mesh-ancestor
64963819|NCT00157066|Micronutrients|micronutrients|mesh-ancestor
64963855|NCT00406861|Hormone Antagonists|hormone antagonists|mesh-ancestor
64335595|NCT02342067|Pioglitazone|pioglitazone|mesh-list
64963856|NCT00406861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64963857|NCT00406861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963858|NCT00406861|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64963859|NCT00406861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64963860|NCT00406861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963861|NCT00044265|Ramipril|ramipril|mesh-list
64963862|NCT00044265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64963863|NCT00044265|Protease Inhibitors|protease inhibitors|mesh-ancestor
64963864|NCT00044265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963865|NCT00044265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963866|NCT00044265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64963867|NCT00398099|Ertapenem|ertapenem|mesh-list
64963868|NCT00398099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64963869|NCT00398099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64963870|NCT00406978|Thalidomide|thalidomide|mesh-list
64963871|NCT00406978|Prednisone|prednisone|mesh-list
64963872|NCT00406978|Melphalan|melphalan|mesh-list
64963873|NCT00406978|Defibrotide|defibrotide|mesh-list
64963874|NCT00406978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64963875|NCT00406978|Glucocorticoids|glucocorticoids|mesh-ancestor
64963876|NCT00406978|Hormones|hormones|mesh-ancestor
64963877|NCT00406978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64963878|NCT00406978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963879|NCT00406978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64963880|NCT00406978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963881|NCT00406978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64963882|NCT00406978|Alkylating Agents|alkylating agents|mesh-ancestor
64573750|NCT04850040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963883|NCT00406978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64963904|NCT00157690|Alendronate|alendronate|mesh-list
64963905|NCT00157690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64963906|NCT00157690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963907|NCT00051506|Carboplatin|carboplatin|mesh-list
64963908|NCT00051506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963909|NCT00157729|Pyridoxal|pyridoxal|mesh-list
64963910|NCT00157729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
64963911|NCT00157729|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64963912|NCT00157729|Protease Inhibitors|protease inhibitors|mesh-ancestor
64963951|NCT00051584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64963952|NCT00051584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64963953|NCT00051584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64963954|NCT00051584|Immunologic Factors|immunologic factors|mesh-ancestor
64963955|NCT00051584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963956|NCT00051584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64963957|NCT00051584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64963958|NCT00051584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64963959|NCT00044382|Lenalidomide|lenalidomide|mesh-list
64963960|NCT00044382|Immunologic Factors|immunologic factors|mesh-ancestor
64963961|NCT00044382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963962|NCT00044382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64963963|NCT00044382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64963964|NCT00044382|Growth Substances|growth substances|mesh-ancestor
64963965|NCT00044382|Growth Inhibitors|growth inhibitors|mesh-ancestor
64963966|NCT00044382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64963967|NCT00158158|Nicotine|nicotine|mesh-list
64963968|NCT00158158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64963969|NCT00158158|Autonomic Agents|autonomic agents|mesh-ancestor
64963970|NCT00158158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64963971|NCT00158158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64963972|NCT00158158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64502636|NCT03404596|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64963973|NCT00158158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64963974|NCT00158158|Cholinergic Agents|cholinergic agents|mesh-ancestor
64964003|NCT00158470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64964004|NCT00158470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64964005|NCT00158470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964006|NCT00158470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964007|NCT00158470|Antiviral Agents|antiviral agents|mesh-ancestor
64964008|NCT00158470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964009|NCT00158470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64964010|NCT00158470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64574087|NCT02099591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574090|NCT01568073|Levodopa|levodopa|mesh-list
64964011|NCT00158470|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64964012|NCT00158470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64964013|NCT00158470|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64964014|NCT00158470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64964015|NCT00158470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64964016|NCT00158470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64964017|NCT00158470|Antimetabolites|antimetabolites|mesh-ancestor
64964075|NCT05568147|Analgesics|analgesics|mesh-ancestor
64964076|NCT05568147|Sensory System Agents|sensory system agents|mesh-ancestor
64964077|NCT05568147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64574190|NCT01449747|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64964078|NCT05568147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964079|NCT05568147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64964080|NCT05568147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64964081|NCT05568147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64964082|NCT05568147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64964101|NCT00159016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964102|NCT00159016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64964103|NCT00159016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964104|NCT00159016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964105|NCT00159094|Vinorelbine|vinorelbine|mesh-list
64964106|NCT00159094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64964107|NCT00159094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964108|NCT00159094|Tubulin Modulators|tubulin modulators|mesh-ancestor
64964109|NCT00159094|Antimitotic Agents|antimitotic agents|mesh-ancestor
64964110|NCT00159094|Mitosis Modulators|mitosis modulators|mesh-ancestor
64964111|NCT00159094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964112|NCT02965053|Sevelamer|sevelamer|mesh-list
64964113|NCT02965053|Chelating Agents|chelating agents|mesh-ancestor
64964114|NCT02965053|Sequestering Agents|sequestering agents|mesh-ancestor
64964115|NCT02965053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964116|NCT00159133|Lorazepam|lorazepam|mesh-list
64964117|NCT00159133|Antipsychotic Agents|antipsychotic agents|mesh-list
64964118|NCT00159133|Anticonvulsants|anticonvulsants|mesh-ancestor
64964119|NCT00159133|Antiemetics|antiemetics|mesh-ancestor
64964120|NCT00159133|Autonomic Agents|autonomic agents|mesh-ancestor
64964194|NCT00159679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964195|NCT00159679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64964196|NCT00159679|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64964197|NCT00159679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64964198|NCT00159679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64964199|NCT00159679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64964200|NCT00159718|Amlodipine|amlodipine|mesh-list
64964201|NCT00159718|Atorvastatin|atorvastatin|mesh-list
64964202|NCT00159718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64964203|NCT00159718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64964204|NCT00159718|Antimetabolites|antimetabolites|mesh-ancestor
64964205|NCT00159718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964206|NCT00159718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64964207|NCT00159718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64964208|NCT00159718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964209|NCT00159718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64964210|NCT00159718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64964211|NCT00159718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64964212|NCT00159718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64964239|NCT00052169|Tubulin Modulators|tubulin modulators|mesh-ancestor
64964240|NCT00052169|Antimitotic Agents|antimitotic agents|mesh-ancestor
64964241|NCT00052169|Mitosis Modulators|mitosis modulators|mesh-ancestor
64964242|NCT00052169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964243|NCT00052169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64964244|NCT00052169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964245|NCT00159952|Insulin|insulin|mesh-list
64964246|NCT00159952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64964247|NCT00159952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964248|NCT00052208|Gefitinib|gefitinib|mesh-list
64964249|NCT00052208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964250|NCT00052208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64964251|NCT00052208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964252|NCT00052208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964253|NCT00407017|Moxifloxacin|moxifloxacin|mesh-list
64964254|NCT00407017|Gatifloxacin|gatifloxacin|mesh-list
64964255|NCT00407017|Ketorolac|ketorolac|mesh-list
64964256|NCT00407017|Nepafenac|nepafenac|mesh-list
64964257|NCT00407017|Prednisolone acetate|prednisolone acetate|mesh-list
64964258|NCT00407017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64964259|NCT00407017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964260|NCT00407017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64964261|NCT00407017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64964268|NCT00407017|Analgesics|analgesics|mesh-ancestor
64964290|NCT00052286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64964299|NCT05567484|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64574228|NCT01517711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64964300|NCT05567484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64574229|NCT01517711|Narcotics|narcotics|mesh-ancestor
64964301|NCT05567484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964302|NCT05567484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64964303|NCT05567484|Hormone Antagonists|hormone antagonists|mesh-ancestor
64964304|NCT05567484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64964305|NCT05567484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964306|NCT05567484|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64964308|NCT00160264|Lactulose|lactulose|mesh-list
64964309|NCT00160264|Calcium|calcium|mesh-list
64964310|NCT00160264|Vitamins|vitamins|mesh-ancestor
64964311|NCT00160264|Micronutrients|micronutrients|mesh-ancestor
64964312|NCT00160264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964342|NCT00052403|Mitosis Modulators|mitosis modulators|mesh-ancestor
64964343|NCT00052403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964345|NCT00160498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64964346|NCT00160498|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64964347|NCT00160498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64964348|NCT00160498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964349|NCT00160498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64964350|NCT00160498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964351|NCT00160537|Levocetirizine|levocetirizine|mesh-list
64503011|NCT04508400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64964352|NCT00160537|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64964353|NCT00160537|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64964354|NCT00160537|Histamine Antagonists|histamine antagonists|mesh-ancestor
64964355|NCT00160537|Histamine Agents|histamine agents|mesh-ancestor
64964356|NCT00160537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64964357|NCT00160537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964358|NCT00160537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964359|NCT00160576|Levetiracetam|levetiracetam|mesh-list
64964360|NCT00160576|Anticonvulsants|anticonvulsants|mesh-ancestor
64964361|NCT00160576|Nootropic Agents|nootropic agents|mesh-ancestor
64964363|NCT00160849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64964393|NCT00160927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964394|NCT00160966|Cyclosporine|cyclosporine|mesh-list
64964395|NCT00160966|Mycophenolic Acid|mycophenolic acid|mesh-list
64964396|NCT00160966|Everolimus|everolimus|mesh-list
64964397|NCT00160966|Tacrolimus|tacrolimus|mesh-list
64964398|NCT00160966|Cyclosporins|cyclosporins|mesh-list
64964399|NCT00160966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64964400|NCT00160966|Immunologic Factors|immunologic factors|mesh-ancestor
64964401|NCT00160966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964402|NCT00160966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64964403|NCT00160966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964404|NCT00160966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964405|NCT00160966|Antifungal Agents|antifungal agents|mesh-ancestor
64964406|NCT00160966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964407|NCT00160966|Dermatologic Agents|dermatologic agents|mesh-ancestor
64964408|NCT00160966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64964409|NCT00160966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964410|NCT00160966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64574364|NCT02318303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64964411|NCT00160966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64574365|NCT02318303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574366|NCT02318303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64964412|NCT00160966|Antitubercular Agents|antitubercular agents|mesh-ancestor
64964413|NCT00160966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64964414|NCT00052559|Bevacizumab|bevacizumab|mesh-list
64964415|NCT00052559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64964498|NCT00044616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64964499|NCT00044616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964500|NCT00044616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64335830|NCT03510325|Olanzapine|olanzapine|mesh-list
64964565|NCT00053027|Immunologic Factors|immunologic factors|mesh-ancestor
64964566|NCT00053027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964567|NCT00053027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64964568|NCT00053027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64964569|NCT00161980|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64964570|NCT00161980|Hemostatics|hemostatics|mesh-ancestor
64964571|NCT00161980|Coagulants|coagulants|mesh-ancestor
64964572|NCT00162019|Factor VIII|factor viii|mesh-list
64964573|NCT00162019|Coagulants|coagulants|mesh-ancestor
64964574|NCT00162214|Ketoconazole|ketoconazole|mesh-list
64964575|NCT00162214|Dasatinib|dasatinib|mesh-list
64964576|NCT00162214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64964577|NCT00162214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64964578|NCT00162214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964579|NCT00162214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964581|NCT00162214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964587|NCT00162214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964588|NCT00162214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64964590|NCT04731116|Anticonvulsants|anticonvulsants|mesh-ancestor
64964591|NCT00407056|Difluprednate|difluprednate|mesh-list
64964592|NCT00407056|Glucocorticoids|glucocorticoids|mesh-ancestor
64964593|NCT00407056|Hormones|hormones|mesh-ancestor
64964594|NCT00407056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64964595|NCT00407056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964596|NCT00405457|Cyclosporine|cyclosporine|mesh-list
64964597|NCT00405457|Cyclosporins|cyclosporins|mesh-list
64964660|NCT00053144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64964661|NCT00053144|Immunologic Factors|immunologic factors|mesh-ancestor
64964662|NCT00053144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964663|NCT00162487|Albuterol|albuterol|mesh-list
64964709|NCT00162643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64964710|NCT00162643|Antiviral Agents|antiviral agents|mesh-ancestor
64964711|NCT00162643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964712|NCT00162643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64964713|NCT00162643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64574638|NCT01064375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64964714|NCT00162643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64964715|NCT00162643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64964716|NCT00162643|Antimetabolites|antimetabolites|mesh-ancestor
64964717|NCT00162643|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64964718|NCT00162643|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64964719|NCT00162643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64964720|NCT00162643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64964721|NCT00162643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64964722|NCT00162682|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64964723|NCT00162682|Antiviral Agents|antiviral agents|mesh-ancestor
64964724|NCT00162682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964763|NCT00044811|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64964764|NCT00044811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64964765|NCT00044811|Histamine Antagonists|histamine antagonists|mesh-ancestor
64964766|NCT00044811|Histamine Agents|histamine agents|mesh-ancestor
64964767|NCT00044811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64574716|NCT04835064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964768|NCT00044811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964769|NCT00044811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964770|NCT00162877|Esomeprazole|esomeprazole|mesh-list
64964771|NCT00162877|Rabeprazole|rabeprazole|mesh-list
64964772|NCT00162877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64964773|NCT00162877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64964774|NCT00162877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64964775|NCT00162877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964776|NCT00162877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964777|NCT00162916|Citalopram|citalopram|mesh-list
64964778|NCT00162916|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64964779|NCT00162916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64964780|NCT00162916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64964781|NCT00162916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335943|NCT02348463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964782|NCT00162916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64964837|NCT00163306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64964838|NCT00163306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64964839|NCT00163306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964840|NCT00163306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964841|NCT00044889|Clofarabine|clofarabine|mesh-list
64964846|NCT00163345|Ciclesonide|ciclesonide|mesh-list
64964847|NCT00163345|Glucocorticoids|glucocorticoids|mesh-ancestor
64964848|NCT00163345|Hormones|hormones|mesh-ancestor
64964849|NCT00163345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64964850|NCT00163345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964855|NCT00163384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64964856|NCT00163384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964857|NCT00163384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64964909|NCT00053339|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64964910|NCT00053339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64964912|NCT00163618|Disinfectants|disinfectants|mesh-ancestor
64964913|NCT00163618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964914|NCT00053378|Calcium|calcium|mesh-list
64964915|NCT00053378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64964916|NCT00053378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964917|NCT02970383|Narcotics|narcotics|mesh-list
64964918|NCT02970383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64964919|NCT02970383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964920|NCT02970383|Analgesics|analgesics|mesh-ancestor
64964921|NCT02970383|Sensory System Agents|sensory system agents|mesh-ancestor
64964922|NCT02970383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64964923|NCT05502900|Melatonin|melatonin|mesh-list
64964924|NCT05502900|Antioxidants|antioxidants|mesh-ancestor
64574950|NCT02605122|Clavulanic Acids|clavulanic acids|mesh-list
64964925|NCT05502900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964926|NCT05502900|Protective Agents|protective agents|mesh-ancestor
64964927|NCT05502900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964963|NCT00164086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64964964|NCT00164086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964965|NCT00164125|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64964966|NCT00164125|Laxatives|laxatives|mesh-ancestor
64964967|NCT00164125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64964968|NCT00164164|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64964969|NCT00164164|Laxatives|laxatives|mesh-ancestor
64964970|NCT00164164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64964971|NCT00164242|Galantamine|galantamine|mesh-list
64964972|NCT00164242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64964973|NCT00164242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64964974|NCT00164242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964975|NCT00164242|Cholinergic Agents|cholinergic agents|mesh-ancestor
64575114|NCT01470027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64964976|NCT00164242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64964977|NCT00164242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64964978|NCT00164242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64964979|NCT00164242|Autonomic Agents|autonomic agents|mesh-ancestor
64964980|NCT00164242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64964981|NCT00164242|Nootropic Agents|nootropic agents|mesh-ancestor
64964982|NCT00164281|Isoniazid|isoniazid|mesh-list
64964983|NCT00164281|Antitubercular Agents|antitubercular agents|mesh-ancestor
64336037|NCT02300935|Paclitaxel|paclitaxel|mesh-list
64964984|NCT00164281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64964985|NCT00164281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64964986|NCT00164281|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64964987|NCT00164281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64964988|NCT00164281|Antimetabolites|antimetabolites|mesh-ancestor
64965013|NCT00164359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965014|NCT00164359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965015|NCT00164359|Leprostatic Agents|leprostatic agents|mesh-ancestor
64965016|NCT00164359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64503682|NCT01795937|Antifungal Agents|antifungal agents|mesh-ancestor
64965018|NCT00053612|Vitamins|vitamins|mesh-ancestor
64965019|NCT00053612|Micronutrients|micronutrients|mesh-ancestor
64965020|NCT00053612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965021|NCT00045006|Vorinostat|vorinostat|mesh-list
64965022|NCT00045006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965023|NCT00045006|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64965024|NCT00045006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965025|NCT00045006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965026|NCT00164710|Artesunate|artesunate|mesh-list
64965027|NCT00164710|Lumefantrine|lumefantrine|mesh-list
64965028|NCT00164710|Artemether|artemether|mesh-list
64965029|NCT00164710|Pyrimethamine|pyrimethamine|mesh-list
64965030|NCT00164710|Sulfadoxine|sulfadoxine|mesh-list
64965031|NCT00164710|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64965032|NCT00164710|Amodiaquine|amodiaquine|mesh-list
64965068|NCT00164788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64575289|NCT04815408|Paclitaxel|paclitaxel|mesh-list
64965080|NCT00053768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965082|NCT00053768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64965083|NCT00053768|Alkylating Agents|alkylating agents|mesh-ancestor
64965084|NCT00053768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965085|NCT00053768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965086|NCT00053768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64965087|NCT00053768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64965088|NCT00053768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64965089|NCT00053768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64965090|NCT00053768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965091|NCT00053768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64965092|NCT00053768|Glucocorticoids|glucocorticoids|mesh-ancestor
64965093|NCT00053768|Hormones|hormones|mesh-ancestor
64965094|NCT00053768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64965095|NCT00053768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64965096|NCT00053768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64503756|NCT01794689|Morphine|morphine|mesh-list
64503834|NCT02513004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64965097|NCT00053768|Tubulin Modulators|tubulin modulators|mesh-ancestor
64965098|NCT00053768|Antimitotic Agents|antimitotic agents|mesh-ancestor
64965099|NCT00053768|Mitosis Modulators|mitosis modulators|mesh-ancestor
64965106|NCT00407212|Maleic acid|maleic acid|mesh-list
64965107|NCT00407212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965108|NCT00407212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965109|NCT00165139|Cyclophosphamide|cyclophosphamide|mesh-list
64965110|NCT00165139|Melphalan|melphalan|mesh-list
64965111|NCT00165139|Ifosfamide|ifosfamide|mesh-list
64965112|NCT00165139|Carboplatin|carboplatin|mesh-list
64965113|NCT00165139|Etoposide|etoposide|mesh-list
64965114|NCT00165139|Vincristine|vincristine|mesh-list
64965115|NCT00165139|Doxorubicin|doxorubicin|mesh-list
64965116|NCT00165139|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64965117|NCT00165139|Lenograstim|lenograstim|mesh-list
64965118|NCT00165139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64965119|NCT00165139|Immunologic Factors|immunologic factors|mesh-ancestor
64965120|NCT00165139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965121|NCT00165139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64965122|NCT00165139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64965123|NCT00165139|Alkylating Agents|alkylating agents|mesh-ancestor
64575622|NCT05562375|Tolonium Chloride|tolonium chloride|mesh-list
64965124|NCT00165139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965125|NCT00165139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965126|NCT00165139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64965127|NCT00165139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64965128|NCT00165139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64965129|NCT00165139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64575676|NCT02592876|Rituximab|rituximab|mesh-list
64965130|NCT00165139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965161|NCT00165178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64965162|NCT00165178|Antiemetics|antiemetics|mesh-ancestor
64965163|NCT00165178|Autonomic Agents|autonomic agents|mesh-ancestor
64965164|NCT00165178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64965165|NCT00165178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965166|NCT00165178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64965167|NCT00165178|Glucocorticoids|glucocorticoids|mesh-ancestor
64965168|NCT00165178|Hormones|hormones|mesh-ancestor
64965169|NCT00165178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64965192|NCT00165178|Vitamin B Complex|vitamin b complex|mesh-ancestor
64965202|NCT00165217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64965203|NCT00165217|Antimetabolites|antimetabolites|mesh-ancestor
64965204|NCT00165217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965205|NCT00165217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965206|NCT00165217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64965207|NCT00165217|Immunologic Factors|immunologic factors|mesh-ancestor
64965208|NCT00165217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965209|NCT00165217|Leprostatic Agents|leprostatic agents|mesh-ancestor
64965210|NCT00165217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64965211|NCT00165217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64965212|NCT00165217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64965213|NCT00165217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64965214|NCT00165217|Growth Substances|growth substances|mesh-ancestor
64965215|NCT00165217|Growth Inhibitors|growth inhibitors|mesh-ancestor
64965216|NCT00165295|Sildenafil Citrate|sildenafil citrate|mesh-list
64575855|NCT05566743|Capecitabine|capecitabine|mesh-list
64965217|NCT00165295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965218|NCT00165295|Vasodilator Agents|vasodilator agents|mesh-ancestor
64965219|NCT00165295|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64965220|NCT00165295|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64965221|NCT00165295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965222|NCT00165295|Urological Agents|urological agents|mesh-ancestor
64965223|NCT00053885|Vatalanib|vatalanib|mesh-list
64965224|NCT00053885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64965225|NCT00053885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965226|NCT00053885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965227|NCT00165334|Cetuximab|cetuximab|mesh-list
64965228|NCT00165334|Vinorelbine|vinorelbine|mesh-list
64965229|NCT00165334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64965230|NCT00165334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965253|NCT00165451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965254|NCT00165451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965255|NCT00165451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64965256|NCT00165451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64965257|NCT00165451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64575916|NCT01894451|Bevacizumab|bevacizumab|mesh-list
64965258|NCT00165451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64965259|NCT00165451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965295|NCT00165685|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64965296|NCT00045279|Interferons|interferons|mesh-list
64965297|NCT00045279|Interferon-alpha|interferon-alpha|mesh-list
64965298|NCT00045279|Interferon alpha-2|interferon alpha-2|mesh-list
64965299|NCT00045279|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64965300|NCT00045279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965301|NCT00045279|Antiviral Agents|antiviral agents|mesh-ancestor
64965302|NCT00045279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64965303|NCT00045279|Immunologic Factors|immunologic factors|mesh-ancestor
64965304|NCT00045279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965306|NCT00053963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64965307|NCT00053963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965308|NCT00165763|Donepezil|donepezil|mesh-list
64336460|NCT02292238|Chelating Agents|chelating agents|mesh-ancestor
64965309|NCT00165763|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64965310|NCT00165763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965311|NCT00165763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965312|NCT00165763|Cholinergic Agents|cholinergic agents|mesh-ancestor
64965313|NCT00165763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64965314|NCT00165763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965315|NCT00165763|Nootropic Agents|nootropic agents|mesh-ancestor
64965351|NCT00054197|Antimitotic Agents|antimitotic agents|mesh-ancestor
64965352|NCT00054197|Mitosis Modulators|mitosis modulators|mesh-ancestor
64965353|NCT00054197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576010|NCT03001635|Oxytocics|oxytocics|mesh-ancestor
64965354|NCT00054197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64965355|NCT00054197|Antimetabolites|antimetabolites|mesh-ancestor
64965356|NCT00054197|Antiviral Agents|antiviral agents|mesh-ancestor
64965357|NCT00054197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64965358|NCT00054197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965359|NCT00054197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64965360|NCT00054197|Immunologic Factors|immunologic factors|mesh-ancestor
64965361|NCT00054197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965363|NCT00045396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965364|NCT00166426|Sulindac sulfone|sulindac sulfone|mesh-list
64965365|NCT00166426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965366|NCT00166426|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64965367|NCT00166426|Protective Agents|protective agents|mesh-ancestor
64965497|NCT00045513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965498|NCT00045513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64965499|NCT00045513|Immunologic Factors|immunologic factors|mesh-ancestor
64965543|NCT00054587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64965544|NCT00054587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965545|NCT00167518|Triamcinolone|triamcinolone|mesh-list
64965546|NCT00167518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64965547|NCT00167518|Glucocorticoids|glucocorticoids|mesh-ancestor
64965548|NCT00167518|Hormones|hormones|mesh-ancestor
64504208|NCT01816295|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64965549|NCT00167518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64965550|NCT00167518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965552|NCT00167557|Ribavirin|ribavirin|mesh-list
64965553|NCT00167557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965554|NCT00167557|Antiviral Agents|antiviral agents|mesh-ancestor
64965555|NCT00167557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64965556|NCT00167557|Antimetabolites|antimetabolites|mesh-ancestor
64965557|NCT00167557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965558|NCT00167674|Zidovudine|zidovudine|mesh-list
64965559|NCT00167674|Nevirapine|nevirapine|mesh-list
64965560|NCT00167674|Antimetabolites|antimetabolites|mesh-ancestor
64965561|NCT00167674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965562|NCT00167674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64965563|NCT00167674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64965564|NCT00167674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965565|NCT00167674|Antiviral Agents|antiviral agents|mesh-ancestor
64965566|NCT00167674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64336550|NCT02304445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576235|NCT03006627|Morphine|morphine|mesh-list
64965567|NCT00167674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64965568|NCT00167674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64965587|NCT00167713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64965588|NCT00167713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965589|NCT00167713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64965590|NCT00167713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64965591|NCT00167713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64965610|NCT00045591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64965611|NCT00045591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965612|NCT00045591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965613|NCT00167908|Amifostine|amifostine|mesh-list
64965632|NCT00167947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965633|NCT00167986|Vancomycin|vancomycin|mesh-list
64965634|NCT00167986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64576287|NCT04426734|Prednisolone acetate|prednisolone acetate|mesh-list
64965635|NCT00167986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64965636|NCT00168025|Immunoglobulins|immunoglobulins|mesh-list
64965637|NCT00168025|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64965638|NCT00168025|Antibodies|antibodies|mesh-list
64965639|NCT00168025|Immunologic Factors|immunologic factors|mesh-ancestor
64965640|NCT00168025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965641|NCT00168181|Pilocarpine|pilocarpine|mesh-list
64965642|NCT00168181|Miotics|miotics|mesh-ancestor
64965643|NCT00168181|Autonomic Agents|autonomic agents|mesh-ancestor
64576392|NCT02980965|Letrozole|letrozole|mesh-list
64965644|NCT00168181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64965645|NCT00168181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965646|NCT00168181|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64965647|NCT00168181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64965648|NCT00168181|Cholinergic Agents|cholinergic agents|mesh-ancestor
64965649|NCT00168181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64965650|NCT00168181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576515|NCT05073315|Adalimumab|adalimumab|mesh-list
64965688|NCT00168415|Cholinergic Agents|cholinergic agents|mesh-ancestor
64965689|NCT00168415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64965690|NCT00168415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965691|NCT00168415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64965692|NCT00168415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64965693|NCT00168493|Antidepressive Agents|antidepressive agents|mesh-list
64965695|NCT00168493|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
64965696|NCT00168493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64965697|NCT00168493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64504361|NCT01786109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64965698|NCT00168493|Serotonin Agents|serotonin agents|mesh-ancestor
64965699|NCT00168493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64576585|NCT04792398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64965700|NCT00168493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965701|NCT00168493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965702|NCT00168493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64965734|NCT00168649|Micronutrients|micronutrients|mesh-ancestor
64965735|NCT00168649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965736|NCT00168688|Micronutrients|micronutrients|mesh-list
64965737|NCT00168688|Trace Elements|trace elements|mesh-list
64965738|NCT00168688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965739|NCT00168766|Interferons|interferons|mesh-list
64965740|NCT00168766|Interferon-beta|interferon-beta|mesh-list
64965741|NCT00168766|Interferon beta-1a|interferon beta-1a|mesh-list
64965742|NCT00168766|Methylprednisolone|methylprednisolone|mesh-list
64965743|NCT00168766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965744|NCT00168766|Antiviral Agents|antiviral agents|mesh-ancestor
64965745|NCT00168766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64965746|NCT00168766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64965747|NCT00168766|Antiemetics|antiemetics|mesh-ancestor
64965748|NCT00168766|Autonomic Agents|autonomic agents|mesh-ancestor
64965749|NCT00168766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576678|NCT02248233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64965750|NCT00168766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965751|NCT00168766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64965752|NCT00168766|Glucocorticoids|glucocorticoids|mesh-ancestor
64965753|NCT00168766|Hormones|hormones|mesh-ancestor
64965754|NCT00168766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64965755|NCT00168766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64965756|NCT00168766|Protective Agents|protective agents|mesh-ancestor
64965757|NCT00168766|Immunologic Factors|immunologic factors|mesh-ancestor
64965758|NCT00168766|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64576757|NCT02219997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64965783|NCT00054938|Sensory System Agents|sensory system agents|mesh-ancestor
64965784|NCT00054938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64965785|NCT00054938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64965786|NCT00054938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64965787|NCT00054938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64965788|NCT00054938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64965789|NCT00054938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965790|NCT00054938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64965791|NCT00054938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64965792|NCT00054938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965793|NCT00054938|Antipyretics|antipyretics|mesh-ancestor
64965794|NCT00054938|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64965795|NCT00054938|Protease Inhibitors|protease inhibitors|mesh-ancestor
64965796|NCT00054938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64965797|NCT00054938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64965798|NCT00054938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64576836|NCT03003039|Rituximab|rituximab|mesh-list
64965799|NCT00054938|Antimetabolites|antimetabolites|mesh-ancestor
64965800|NCT00054938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64965801|NCT00054938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64965802|NCT00169000|Docetaxel|docetaxel|mesh-list
64965803|NCT00169000|Capecitabine|capecitabine|mesh-list
64965804|NCT00169000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965805|NCT00169000|Tubulin Modulators|tubulin modulators|mesh-ancestor
64965806|NCT00169000|Antimitotic Agents|antimitotic agents|mesh-ancestor
64965807|NCT00169000|Mitosis Modulators|mitosis modulators|mesh-ancestor
64965836|NCT00169039|Autonomic Agents|autonomic agents|mesh-ancestor
64965837|NCT00169039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64965838|NCT00169039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64965839|NCT00169039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64965840|NCT00169039|Dopamine Agents|dopamine agents|mesh-ancestor
64965841|NCT00169078|Chloroquine|chloroquine|mesh-list
64965842|NCT00169078|Amebicides|amebicides|mesh-ancestor
64965843|NCT00169078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64965844|NCT00169078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64965845|NCT00169078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64965846|NCT00169078|Antimalarials|antimalarials|mesh-ancestor
64965847|NCT00169078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64504506|NCT03343548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965848|NCT00054977|Fluorouracil|fluorouracil|mesh-list
64965849|NCT00054977|Antimetabolites|antimetabolites|mesh-ancestor
64965850|NCT00054977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965851|NCT00054977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64965878|NCT00169156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64965879|NCT00169156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64965880|NCT00169156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64965881|NCT00169156|Tubulin Modulators|tubulin modulators|mesh-ancestor
64965882|NCT00169156|Antimitotic Agents|antimitotic agents|mesh-ancestor
64965883|NCT00169156|Mitosis Modulators|mitosis modulators|mesh-ancestor
64965884|NCT00169195|Gemcitabine|gemcitabine|mesh-list
64965885|NCT00169195|Rituximab|rituximab|mesh-list
64965886|NCT00169195|Oxaliplatin|oxaliplatin|mesh-list
64965887|NCT00169195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64965888|NCT00169195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965889|NCT00169195|Immunologic Factors|immunologic factors|mesh-ancestor
64965890|NCT00169195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965891|NCT00169195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64965892|NCT00169195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64965893|NCT00169195|Antimetabolites|antimetabolites|mesh-ancestor
64965894|NCT00169195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965895|NCT00169195|Antiviral Agents|antiviral agents|mesh-ancestor
64965896|NCT00169195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64965897|NCT00169195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965929|NCT00398372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64965930|NCT00398372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965931|NCT00398372|Immunologic Factors|immunologic factors|mesh-ancestor
64965932|NCT00398372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965933|NCT00398372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64965934|NCT00169585|Levofloxacin|levofloxacin|mesh-list
64965935|NCT00169585|Ofloxacin|ofloxacin|mesh-list
64965936|NCT00169585|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64965937|NCT00169585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64965938|NCT00169585|Renal Agents|renal agents|mesh-ancestor
64965939|NCT00169585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64965940|NCT00169585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64965941|NCT00169585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64965942|NCT00169585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965943|NCT00169585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965944|NCT00169585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965945|NCT00169585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64965982|NCT00170053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965983|NCT00055250|Gemcitabine|gemcitabine|mesh-list
64965984|NCT00055250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64965985|NCT00055250|Antimetabolites|antimetabolites|mesh-ancestor
64965986|NCT00055250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64965987|NCT00055250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64965988|NCT00055250|Antiviral Agents|antiviral agents|mesh-ancestor
64965989|NCT00055250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64965990|NCT00055250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64965991|NCT00055250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64965992|NCT00055250|Immunologic Factors|immunologic factors|mesh-ancestor
64965993|NCT00055250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64965994|NCT00170209|Rifampin|rifampin|mesh-list
64965995|NCT00170209|Isoniazid|isoniazid|mesh-list
64965996|NCT00170209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64965997|NCT00170209|Antitubercular Agents|antitubercular agents|mesh-ancestor
64965998|NCT00170209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64966000|NCT00170209|Leprostatic Agents|leprostatic agents|mesh-ancestor
64966002|NCT00170209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966029|NCT00170404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966030|NCT00170404|Protective Agents|protective agents|mesh-ancestor
64966031|NCT00055367|Natalizumab|natalizumab|mesh-list
64966032|NCT00055367|Immunologic Factors|immunologic factors|mesh-ancestor
64966033|NCT00055367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966034|NCT00170677|Topotecan|topotecan|mesh-list
64966035|NCT00170677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64966036|NCT00170677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64966037|NCT00170677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966038|NCT00170677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966039|NCT00170677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966040|NCT00170755|Darifenacin|darifenacin|mesh-list
64966041|NCT00170755|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64966042|NCT00170755|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64966043|NCT00170755|Cholinergic Agents|cholinergic agents|mesh-ancestor
64966044|NCT00170755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64966045|NCT00170755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966046|NCT00170755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577132|NCT01625169|Antiviral Agents|antiviral agents|mesh-ancestor
64966047|NCT00170755|Urological Agents|urological agents|mesh-ancestor
64966048|NCT00170794|Everolimus|everolimus|mesh-list
64966049|NCT00170794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966050|NCT00170794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64966051|NCT00170794|Immunologic Factors|immunologic factors|mesh-ancestor
64966052|NCT00170794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966083|NCT00171028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64966084|NCT00171028|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64966085|NCT00171028|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64966126|NCT00171184|Urological Agents|urological agents|mesh-ancestor
64966128|NCT00055523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64966129|NCT00055523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64966130|NCT00171379|Mycophenolic Acid|mycophenolic acid|mesh-list
64966131|NCT00171379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64966132|NCT00171379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966133|NCT00171379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64966134|NCT00171379|Antitubercular Agents|antitubercular agents|mesh-ancestor
64966135|NCT00171379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64577212|NCT02995083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64966136|NCT00171379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64966137|NCT00171379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966138|NCT00171379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966139|NCT00171418|Tegaserod|tegaserod|mesh-list
64966140|NCT00171418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64966141|NCT00171418|Serotonin Agents|serotonin agents|mesh-ancestor
64966142|NCT00171418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64966143|NCT00171418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504808|NCT01680172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64966144|NCT00171418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966145|NCT00171457|Tegaserod|tegaserod|mesh-list
64966146|NCT00171457|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64966147|NCT00171457|Serotonin Agents|serotonin agents|mesh-ancestor
64966176|NCT00171496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64966178|NCT00171496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64966179|NCT00171535|Amlodipine|amlodipine|mesh-list
64966180|NCT00171535|Valsartan|valsartan|mesh-list
64966181|NCT00171535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64966182|NCT00171535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64966183|NCT00171535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64966184|NCT00171535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966185|NCT00171535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64966186|NCT00171535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966199|NCT00171574|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64966200|NCT00171574|Protective Agents|protective agents|mesh-ancestor
64966201|NCT00171574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966222|NCT00055640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64966223|NCT00055640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64577436|NCT05611242|Cangrelor|cangrelor|mesh-list
64966224|NCT00055640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64966225|NCT00055640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64966226|NCT00055640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64966227|NCT00055640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966228|NCT00055640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64966229|NCT00055640|Glucocorticoids|glucocorticoids|mesh-ancestor
64966230|NCT00055640|Hormones|hormones|mesh-ancestor
64966231|NCT00055640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64966232|NCT00055640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64966233|NCT00055640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64966234|NCT00055640|Tubulin Modulators|tubulin modulators|mesh-ancestor
64577520|NCT00088621|Dopamine Agents|dopamine agents|mesh-ancestor
64966235|NCT00055640|Antimitotic Agents|antimitotic agents|mesh-ancestor
64966236|NCT00055640|Mitosis Modulators|mitosis modulators|mesh-ancestor
64966237|NCT00171652|Diclofenac|diclofenac|mesh-list
64966238|NCT00171652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64966239|NCT00171652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64966240|NCT00171652|Analgesics|analgesics|mesh-ancestor
64966241|NCT00171652|Sensory System Agents|sensory system agents|mesh-ancestor
64966242|NCT00171652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64966243|NCT00171652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966244|NCT00171652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64966245|NCT00171652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64966246|NCT00171652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64966247|NCT00171652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966248|NCT00171652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966249|NCT00171691|Diclofenac|diclofenac|mesh-list
64966250|NCT00171691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64966261|NCT00171769|Certoparin|certoparin|mesh-list
64966264|NCT00171808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966265|NCT00171808|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64966266|NCT00171808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64966267|NCT00171808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966268|NCT00171808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966269|NCT00171808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64966270|NCT00171808|Hormone Antagonists|hormone antagonists|mesh-ancestor
64577627|NCT02412228|Glucocorticoids|glucocorticoids|mesh-ancestor
64577628|NCT02412228|Hormones|hormones|mesh-ancestor
64577633|NCT03693807|Gemcitabine|gemcitabine|mesh-list
64966271|NCT00171808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64966272|NCT00171808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966274|NCT00171847|Letrozole|letrozole|mesh-list
64966275|NCT00171847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64966276|NCT00171847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966277|NCT00171847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64966387|NCT04732845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966388|NCT04732845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64966389|NCT04732845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64966390|NCT04732845|Alkylating Agents|alkylating agents|mesh-ancestor
64966397|NCT00055913|Antibodies|antibodies|mesh-list
64966457|NCT00056030|Antimetabolites|antimetabolites|mesh-ancestor
64966458|NCT00056030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966490|NCT04605081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64966491|NCT04605081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64966492|NCT04605081|Antidepressive Agents|antidepressive agents|mesh-ancestor
64966493|NCT04605081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64966494|NCT04605081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64966495|NCT04605081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64966496|NCT04605081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64966497|NCT04605081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966498|NCT04605081|Dopamine Agents|dopamine agents|mesh-ancestor
64966499|NCT04605081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64966500|NCT04605081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64966501|NCT04605081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64966502|NCT04605081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966503|NCT04599504|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64966504|NCT04599504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64966505|NCT04599504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966506|NCT04599504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64966507|NCT04599504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64966508|NCT04599504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64966509|NCT04599504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966510|NCT04599504|Dopamine Agents|dopamine agents|mesh-ancestor
64966511|NCT04599504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64966512|NCT00174226|Buspirone|buspirone|mesh-list
64966513|NCT00174226|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64966514|NCT00174226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64966533|NCT00174304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966534|NCT00174304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64966535|NCT00174304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64966536|NCT00174304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64966537|NCT00174304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64966538|NCT00174304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64966539|NCT00174304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64966590|NCT00046137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64966591|NCT00046137|Hormone Antagonists|hormone antagonists|mesh-ancestor
64966592|NCT00046137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64966593|NCT00046137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64966594|NCT00046137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64966596|NCT00056225|Vitamin B 12|vitamin b 12|mesh-list
64966597|NCT00056225|Vitamin B 6|vitamin b 6|mesh-list
64966598|NCT00056225|Pyridoxal|pyridoxal|mesh-list
64966599|NCT00056225|Pyridoxine|pyridoxine|mesh-list
64966600|NCT00056225|Vitamin B Complex|vitamin b complex|mesh-list
64966601|NCT00056225|Micronutrients|micronutrients|mesh-ancestor
64966602|NCT00056225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966603|NCT00174616|Capecitabine|capecitabine|mesh-list
64966604|NCT00174616|Oxaliplatin|oxaliplatin|mesh-list
64966605|NCT00174616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64966606|NCT00174616|Antimetabolites|antimetabolites|mesh-ancestor
64966607|NCT00174616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966608|NCT00174616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966609|NCT00174655|Cyclophosphamide|cyclophosphamide|mesh-list
64966610|NCT00174655|Docetaxel|docetaxel|mesh-list
64966611|NCT00174655|Doxorubicin|doxorubicin|mesh-list
64966612|NCT00174655|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64966613|NCT00174655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64966614|NCT00174655|Immunologic Factors|immunologic factors|mesh-ancestor
64966615|NCT00174655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966616|NCT00174655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64966640|NCT00056264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64966641|NCT00056264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64966642|NCT00174772|Cisplatin|cisplatin|mesh-list
64966643|NCT00174772|Docetaxel|docetaxel|mesh-list
64966644|NCT00174772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966645|NCT00174772|Tubulin Modulators|tubulin modulators|mesh-ancestor
64966646|NCT00174772|Antimitotic Agents|antimitotic agents|mesh-ancestor
64966647|NCT00174772|Mitosis Modulators|mitosis modulators|mesh-ancestor
64966648|NCT00174772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966649|NCT00174811|Telithromycin|telithromycin|mesh-list
64966650|NCT00174811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64966651|NCT00174811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64966652|NCT02963779|Apremilast|apremilast|mesh-list
64966653|NCT02963779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64966654|NCT02963779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64966655|NCT02963779|Analgesics|analgesics|mesh-ancestor
64966656|NCT02963779|Sensory System Agents|sensory system agents|mesh-ancestor
64966657|NCT02963779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64966658|NCT02963779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966659|NCT02963779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64966660|NCT02963779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64966694|NCT00175123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64966695|NCT00175123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64966696|NCT00175123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64966697|NCT00175123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64966698|NCT00175123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966699|NCT00175123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64966700|NCT00175123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64966701|NCT00175123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64966702|NCT00175123|Cholinergic Agents|cholinergic agents|mesh-ancestor
64966703|NCT00175123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64966704|NCT00175357|Methadone|methadone|mesh-list
64966705|NCT00175357|Heroin|heroin|mesh-list
64966706|NCT00175357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64966707|NCT00175357|Narcotics|narcotics|mesh-ancestor
64966708|NCT00175357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64966756|NCT00175591|Anesthetics|anesthetics|mesh-ancestor
64966757|NCT00175591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64966791|NCT00056576|Anticonvulsants|anticonvulsants|mesh-ancestor
64966792|NCT00056576|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64966797|NCT00175903|Carbamazepine|carbamazepine|mesh-list
64966835|NCT00175981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64966836|NCT00175981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64966837|NCT00175981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966838|NCT00175981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64966839|NCT00175981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64966840|NCT00175981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64966841|NCT00175981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64966842|NCT00175981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64966843|NCT00175981|Serotonin Agents|serotonin agents|mesh-ancestor
64966844|NCT00175981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64966845|NCT00175981|Antidepressive Agents|antidepressive agents|mesh-ancestor
64966846|NCT00175981|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64966847|NCT00175981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64966848|NCT00175981|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64966849|NCT04420533|Mirabegron|mirabegron|mesh-list
64966850|NCT04420533|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64966851|NCT04420533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64966901|NCT00056693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64966903|NCT00056693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966904|NCT00056693|Growth Inhibitors|growth inhibitors|mesh-ancestor
64966925|NCT00176449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64966926|NCT00176449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64966927|NCT00176449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64966931|NCT00398450|Interferon-alpha|interferon-alpha|mesh-list
64966932|NCT00398450|Interferon alpha-2|interferon alpha-2|mesh-list
64966933|NCT00398450|Azacitidine|azacitidine|mesh-list
64966934|NCT00398450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64966935|NCT00398450|Antiviral Agents|antiviral agents|mesh-ancestor
64966936|NCT00398450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64966937|NCT00398450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64966990|NCT00398489|Hormone Antagonists|hormone antagonists|mesh-ancestor
64966991|NCT00398489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64966992|NCT00398489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64966993|NCT00398489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64966994|NCT00398489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64966995|NCT00398489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64966996|NCT00398489|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64966997|NCT00398489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64966998|NCT00176761|Interleukin-2|interleukin-2|mesh-list
64966999|NCT00176761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967000|NCT00176761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64967001|NCT00176761|Analgesics|analgesics|mesh-ancestor
64967002|NCT00176761|Sensory System Agents|sensory system agents|mesh-ancestor
64967003|NCT00176761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64967004|NCT00176761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967005|NCT00176995|Eflornithine|eflornithine|mesh-list
64967006|NCT00176995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967007|NCT00176995|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64967008|NCT00176995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64967017|NCT00408148|Rimonabant|rimonabant|mesh-list
64578937|NCT01852890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967040|NCT00177424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64967041|NCT00177424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967042|NCT00177424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64967043|NCT00177424|Serotonin Agents|serotonin agents|mesh-ancestor
64967044|NCT00177424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967045|NCT00177580|Pravastatin|pravastatin|mesh-list
64967046|NCT00177580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64967047|NCT00177580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64967048|NCT00177580|Antimetabolites|antimetabolites|mesh-ancestor
64967049|NCT00177580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967050|NCT00177580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64967051|NCT00177580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64967052|NCT00177580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967053|NCT04723342|Blinatumomab|blinatumomab|mesh-list
64967054|NCT04723342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967055|NCT00177619|Alendronate|alendronate|mesh-list
64967056|NCT00177619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64967057|NCT00177619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967058|NCT00056810|4-Aminopyridine|4-aminopyridine|mesh-list
64967059|NCT00056810|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64967060|NCT00056810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64967061|NCT00056810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967063|NCT00177853|Irinotecan|irinotecan|mesh-list
64967064|NCT00177853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64967065|NCT00177853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64967066|NCT00177853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967067|NCT00177853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967068|NCT00177853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967069|NCT00177853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64967079|NCT00178048|Paroxetine|paroxetine|mesh-list
64967082|NCT00178048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64967083|NCT00178048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967084|NCT00178048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64967085|NCT00178048|Serotonin Agents|serotonin agents|mesh-ancestor
64967086|NCT00178048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967087|NCT00178048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64967088|NCT00178048|Antidepressive Agents|antidepressive agents|mesh-ancestor
64967089|NCT00178048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64967090|NCT00178048|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64967091|NCT00178048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64967133|NCT00408226|Pemetrexed|pemetrexed|mesh-list
64967134|NCT00408226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967135|NCT00408226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967136|NCT00408226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967137|NCT00408226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64967138|NCT00408226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64967139|NCT02963896|Gentamicins|gentamicins|mesh-list
64967140|NCT02963896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64579257|NCT04327206|Vaccines|vaccines|mesh-list
64967141|NCT02963896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64967142|NCT02963896|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64967143|NCT02963896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967144|NCT02963896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967173|NCT00179023|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
64505853|NCT03109314|Nootropic Agents|nootropic agents|mesh-ancestor
64967235|NCT00179257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967236|NCT00179257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64967238|NCT00179257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967240|NCT00408382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64967241|NCT00408382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64967242|NCT00408382|Antimetabolites|antimetabolites|mesh-ancestor
64967243|NCT00408382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579372|NCT00063635|Vitamin E|vitamin e|mesh-list
64967244|NCT00408382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64967245|NCT00408382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64967246|NCT00408382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967247|NCT00057122|Rifampin|rifampin|mesh-list
64967248|NCT00057122|Rifapentine|rifapentine|mesh-list
64967249|NCT00057122|Isoniazid|isoniazid|mesh-list
64967250|NCT00057122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64967251|NCT00057122|Antitubercular Agents|antitubercular agents|mesh-ancestor
64967252|NCT00057122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64967290|NCT00179725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64967291|NCT00179725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967292|NCT00179725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967293|NCT00179725|Immunologic Factors|immunologic factors|mesh-ancestor
64967294|NCT00179725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967295|NCT00179725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64967296|NCT00179725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64967297|NCT00179725|Growth Substances|growth substances|mesh-ancestor
64967298|NCT00179725|Growth Inhibitors|growth inhibitors|mesh-ancestor
64967300|NCT00179764|Alkylating Agents|alkylating agents|mesh-ancestor
64967301|NCT00179764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967302|NCT00179764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64967303|NCT00179764|Immunologic Factors|immunologic factors|mesh-ancestor
64967304|NCT00179764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967305|NCT00179764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64967306|NCT00179764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967307|NCT00179764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64967347|NCT00180115|Immunologic Factors|immunologic factors|mesh-ancestor
64967348|NCT00180115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967349|NCT00046527|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64967350|NCT00046527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967351|NCT00180310|Paclitaxel|paclitaxel|mesh-list
64967352|NCT00180310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64967353|NCT00180310|Everolimus|everolimus|mesh-list
64967354|NCT00180310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64967355|NCT00180310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967356|NCT00180310|Tubulin Modulators|tubulin modulators|mesh-ancestor
64579584|NCT00074165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64579588|NCT01466660|Afatinib|afatinib|mesh-list
64967357|NCT00180310|Antimitotic Agents|antimitotic agents|mesh-ancestor
64967358|NCT00180310|Mitosis Modulators|mitosis modulators|mesh-ancestor
64967359|NCT00180310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967360|NCT00180310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64967408|NCT00180895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64967409|NCT00180973|Hydroxyurea|hydroxyurea|mesh-list
64967410|NCT00180973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967411|NCT00180973|Antisickling Agents|antisickling agents|mesh-ancestor
64967412|NCT00180973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967413|NCT00180973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967482|NCT00181636|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64967483|NCT00181636|Autonomic Agents|autonomic agents|mesh-ancestor
64967485|NCT00181636|Nootropic Agents|nootropic agents|mesh-ancestor
64967521|NCT00181987|Methylphenidate|methylphenidate|mesh-list
64967522|NCT00181987|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64967523|NCT00181987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967524|NCT00181987|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64967525|NCT00181987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64967526|NCT00181987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64967527|NCT00181987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967528|NCT00181987|Dopamine Agents|dopamine agents|mesh-ancestor
64967529|NCT00181987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64967530|NCT00182104|Warfarin|warfarin|mesh-list
64967531|NCT00182104|Anticoagulants|anticoagulants|mesh-ancestor
64967532|NCT00182143|Heparin|heparin|mesh-list
64967533|NCT00182143|Calcium heparin|calcium heparin|mesh-list
64967534|NCT00182143|Dalteparin|dalteparin|mesh-list
64967535|NCT00182143|Tinzaparin|tinzaparin|mesh-list
64967536|NCT00182143|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64967537|NCT00182143|Anticoagulants|anticoagulants|mesh-ancestor
64967582|NCT00182533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64967583|NCT00182533|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64967584|NCT00182533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64967585|NCT00182533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64967586|NCT00182533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967587|NCT00182533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64967588|NCT00182533|Serotonin Agents|serotonin agents|mesh-ancestor
64967589|NCT00182533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967590|NCT00182572|Naltrexone|naltrexone|mesh-list
64967647|NCT00182884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967709|NCT00183742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967710|NCT00183742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64967711|NCT00183742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64967712|NCT00183742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64967713|NCT00183742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967714|NCT02965248|Calcium, Dietary|calcium, dietary|mesh-list
64967715|NCT02965248|Leucovorin|leucovorin|mesh-list
64967716|NCT02965248|Capecitabine|capecitabine|mesh-list
64967717|NCT02965248|Raltitrexed|raltitrexed|mesh-list
64967718|NCT02965248|Oxaliplatin|oxaliplatin|mesh-list
64967719|NCT02965248|Calcium|calcium|mesh-list
64967720|NCT02965248|Levoleucovorin|levoleucovorin|mesh-list
64967721|NCT02965248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64967722|NCT02965248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967723|NCT02965248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64967724|NCT02965248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64967725|NCT02965248|Antimetabolites|antimetabolites|mesh-ancestor
64967726|NCT02965248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967727|NCT02965248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967728|NCT02965248|Antidotes|antidotes|mesh-ancestor
64967729|NCT02965248|Protective Agents|protective agents|mesh-ancestor
64967730|NCT02965248|Vitamin B Complex|vitamin b complex|mesh-ancestor
64967731|NCT02965248|Vitamins|vitamins|mesh-ancestor
64967732|NCT02965248|Micronutrients|micronutrients|mesh-ancestor
64967733|NCT02965248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64967734|NCT02965248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967735|NCT00183820|Gemcitabine|gemcitabine|mesh-list
64967736|NCT00183820|Paclitaxel|paclitaxel|mesh-list
64967737|NCT00183820|Oxaliplatin|oxaliplatin|mesh-list
64967739|NCT00183820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579947|NCT02243943|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64967747|NCT00183820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64967748|NCT00183820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967749|NCT00183820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64967750|NCT00183820|Immunologic Factors|immunologic factors|mesh-ancestor
64967751|NCT00183820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967752|NCT02969720|Titanium dioxide|titanium dioxide|mesh-list
64967753|NCT02969720|Sunscreening Agents|sunscreening agents|mesh-ancestor
64967754|NCT02969720|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64967813|NCT00184015|Bortezomib|bortezomib|mesh-list
64967814|NCT00184015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64967815|NCT00184015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967816|NCT00184015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64967817|NCT00184015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64967818|NCT00184015|Growth Substances|growth substances|mesh-ancestor
64967819|NCT00184015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967874|NCT00184795|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64967876|NCT00184795|Hormones|hormones|mesh-ancestor
64967877|NCT00184795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64967878|NCT00184795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64967879|NCT00184795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64967880|NCT00184795|Contraceptive Agents|contraceptive agents|mesh-ancestor
64967881|NCT00184795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64967882|NCT00184795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64967883|NCT00184795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64967884|NCT00184795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64967885|NCT00184795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64967886|NCT00058253|Docetaxel|docetaxel|mesh-list
64967887|NCT00058253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580131|NCT00141739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64967888|NCT00058253|Tubulin Modulators|tubulin modulators|mesh-ancestor
64967889|NCT00058253|Antimitotic Agents|antimitotic agents|mesh-ancestor
64967890|NCT00058253|Mitosis Modulators|mitosis modulators|mesh-ancestor
64967891|NCT00058253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967892|NCT00046800|Lurtotecan|lurtotecan|mesh-list
64967929|NCT00184912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64967930|NCT00184912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967931|NCT00184912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967932|NCT00184912|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64967933|NCT00184912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64967934|NCT00184912|Purinergic Agents|purinergic agents|mesh-ancestor
64967935|NCT00184912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64967936|NCT00184951|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64967937|NCT00184951|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64967938|NCT00184951|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64967939|NCT00184951|Antimetabolites|antimetabolites|mesh-ancestor
64967940|NCT00184951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967941|NCT00184951|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64967942|NCT00184951|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64967943|NCT00184951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967944|NCT00184990|Pimagedine|pimagedine|mesh-list
64967945|NCT00184990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64967946|NCT00184990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967947|NCT00058331|Epoetin Alfa|epoetin alfa|mesh-list
64967948|NCT00058331|Hematinics|hematinics|mesh-ancestor
64967949|NCT03815643|Avelumab|avelumab|mesh-list
64967950|NCT03815643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64967951|NCT03815643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64967952|NCT00185068|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64967953|NCT00185068|Olmesartan|olmesartan|mesh-list
64967954|NCT00185068|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64967976|NCT00058448|Tubulin Modulators|tubulin modulators|mesh-ancestor
64967977|NCT00058448|Antimitotic Agents|antimitotic agents|mesh-ancestor
64967978|NCT00058448|Mitosis Modulators|mitosis modulators|mesh-ancestor
64967979|NCT00058448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64967980|NCT00185185|Atenolol|atenolol|mesh-list
64967981|NCT00185185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64967982|NCT00185185|Olmesartan|olmesartan|mesh-list
64967994|NCT00185185|Sympatholytics|sympatholytics|mesh-ancestor
64968033|NCT03784014|Ceritinib|ceritinib|mesh-list
64968034|NCT03784014|Futibatinib|futibatinib|mesh-list
64968035|NCT03784014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64968036|NCT03784014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968037|NCT03784014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64968038|NCT03784014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968039|NCT03784014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968040|NCT03784014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64968041|NCT00058487|Thalidomide|thalidomide|mesh-list
64968042|NCT00058487|Epirubicin|epirubicin|mesh-list
64968043|NCT00058487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64968044|NCT00058487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968045|NCT00058487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64968046|NCT00058487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64968047|NCT00058487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968048|NCT00058487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968049|NCT00058487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64968050|NCT00058487|Immunologic Factors|immunologic factors|mesh-ancestor
64968051|NCT00058487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968052|NCT00058487|Leprostatic Agents|leprostatic agents|mesh-ancestor
64968053|NCT00058487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64968054|NCT00058487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64968055|NCT00058487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64968080|NCT00185575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64580430|NCT02096081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64968081|NCT00185575|Antidepressive Agents|antidepressive agents|mesh-ancestor
64968082|NCT00185575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64968083|NCT00185575|Dopamine Agents|dopamine agents|mesh-ancestor
64968084|NCT03731832|Dexamethasone|dexamethasone|mesh-list
64968085|NCT03731832|Cyclophosphamide|cyclophosphamide|mesh-list
64968086|NCT03731832|Pomalidomide|pomalidomide|mesh-list
64968087|NCT03731832|Ixazomib|ixazomib|mesh-list
64968088|NCT03731832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64968089|NCT03731832|Immunologic Factors|immunologic factors|mesh-ancestor
64968090|NCT03731832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968091|NCT03731832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64968092|NCT03731832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64968093|NCT03731832|Alkylating Agents|alkylating agents|mesh-ancestor
64968094|NCT03731832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968095|NCT03731832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968096|NCT03731832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64968097|NCT03731832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64968098|NCT03731832|Antiemetics|antiemetics|mesh-ancestor
64968099|NCT03731832|Autonomic Agents|autonomic agents|mesh-ancestor
64968100|NCT03731832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64968101|NCT03731832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64968102|NCT03731832|Glucocorticoids|glucocorticoids|mesh-ancestor
64968103|NCT03731832|Hormones|hormones|mesh-ancestor
64968105|NCT03731832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64968131|NCT00186082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64968132|NCT00186277|Docetaxel|docetaxel|mesh-list
64968133|NCT00186277|Oxaliplatin|oxaliplatin|mesh-list
64968134|NCT00186277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580632|NCT00260689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968135|NCT00186277|Tubulin Modulators|tubulin modulators|mesh-ancestor
64968136|NCT00186277|Antimitotic Agents|antimitotic agents|mesh-ancestor
64968137|NCT00186277|Mitosis Modulators|mitosis modulators|mesh-ancestor
64968255|NCT00187057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64968256|NCT00187057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64968257|NCT00187057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64968258|NCT00187057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64968259|NCT00187057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968260|NCT00187057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64968261|NCT00187057|Abortifacient Agents|abortifacient agents|mesh-ancestor
64968262|NCT00187057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64968263|NCT00187057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64336773|NCT02313337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336774|NCT02313337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64968264|NCT00187057|Antimetabolites|antimetabolites|mesh-ancestor
64968265|NCT00187057|Dermatologic Agents|dermatologic agents|mesh-ancestor
64968266|NCT00187057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64968267|NCT00187057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64968268|NCT00187057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64968269|NCT00187057|Antiviral Agents|antiviral agents|mesh-ancestor
64968270|NCT00187057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64968271|NCT00187057|Tubulin Modulators|tubulin modulators|mesh-ancestor
64968272|NCT00187057|Antimitotic Agents|antimitotic agents|mesh-ancestor
64968273|NCT00187057|Mitosis Modulators|mitosis modulators|mesh-ancestor
64968274|NCT00046917|Irinotecan|irinotecan|mesh-list
64968275|NCT00046917|Alvocidib|alvocidib|mesh-list
64968276|NCT00046917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968277|NCT00046917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64968278|NCT00046917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64968279|NCT00046917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968319|NCT00187408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968320|NCT00187447|Indomethacin|indomethacin|mesh-list
64968352|NCT00187564|Vitamin B Complex|vitamin b complex|mesh-ancestor
64968354|NCT00187564|Micronutrients|micronutrients|mesh-ancestor
64968355|NCT00046995|Leucovorin|leucovorin|mesh-list
64968356|NCT00046995|Carboplatin|carboplatin|mesh-list
64968357|NCT00046995|Fluorouracil|fluorouracil|mesh-list
64968358|NCT00046995|Calcium|calcium|mesh-list
64968359|NCT00046995|Levoleucovorin|levoleucovorin|mesh-list
64968360|NCT00046995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968361|NCT00046995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64968363|NCT00046995|Antimetabolites|antimetabolites|mesh-ancestor
64968420|NCT00187915|Antitubercular Agents|antitubercular agents|mesh-ancestor
64968421|NCT00187915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64968422|NCT00187993|Hormones|hormones|mesh-list
64968423|NCT00187993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64580883|NCT04389229|Cyclophosphamide|cyclophosphamide|mesh-list
64968424|NCT00187993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968425|NCT00188071|Acetaminophen|acetaminophen|mesh-list
64968426|NCT00188071|Ketoprofen|ketoprofen|mesh-list
64968427|NCT00188071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64968428|NCT00188071|Analgesics|analgesics|mesh-ancestor
64968429|NCT00188071|Sensory System Agents|sensory system agents|mesh-ancestor
64968430|NCT00188071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64968431|NCT00188071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968432|NCT00188071|Antipyretics|antipyretics|mesh-ancestor
64968433|NCT00188071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64968434|NCT00188071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64581020|NCT01729923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64333966|NCT02372487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64333967|NCT02372487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64333968|NCT02372487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333969|NCT02372487|Urological Agents|urological agents|mesh-ancestor
64333970|NCT02361177|Oxytocin|oxytocin|mesh-list
64581021|NCT01729923|Analgesics|analgesics|mesh-ancestor
64581022|NCT01729923|Sensory System Agents|sensory system agents|mesh-ancestor
64581023|NCT01729923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581024|NCT01729923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581025|NCT01729923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64581026|NCT01729923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64581027|NCT01729923|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64581028|NCT01729923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64581029|NCT01729923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581030|NCT01729923|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64581031|NCT02584452|Dexamethasone|dexamethasone|mesh-list
64581032|NCT02584452|Fentanyl|fentanyl|mesh-list
64581033|NCT02584452|Bupivacaine|bupivacaine|mesh-list
64581034|NCT02584452|Ropivacaine|ropivacaine|mesh-list
64581035|NCT02584452|Mepivacaine|mepivacaine|mesh-list
64581036|NCT02584452|Propofol|propofol|mesh-list
64581037|NCT02584452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64581038|NCT02584452|Antiemetics|antiemetics|mesh-ancestor
64968481|NCT00188383|Antiviral Agents|antiviral agents|mesh-ancestor
64968482|NCT00188383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64968483|NCT00188383|Dopamine Agents|dopamine agents|mesh-ancestor
64968484|NCT00188383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64968485|NCT00188383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968486|NCT00188383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968487|NCT00188383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64968530|NCT00059267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64581068|NCT02502006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64581069|NCT02502006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64581070|NCT02502006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64581071|NCT02502006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581072|NCT02502006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581073|NCT02502006|Gout Suppressants|gout suppressants|mesh-ancestor
64581075|NCT05679102|Atorvastatin|atorvastatin|mesh-list
64581076|NCT05679102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64581077|NCT05679102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64581078|NCT05679102|Antimetabolites|antimetabolites|mesh-ancestor
64581079|NCT05679102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968531|NCT00059267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64968532|NCT00059267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968533|NCT00059267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968534|NCT00059267|Antiviral Agents|antiviral agents|mesh-ancestor
64968535|NCT00059267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64968536|NCT00188773|Acetylcysteine|acetylcysteine|mesh-list
64968537|NCT00188773|Heparin|heparin|mesh-list
64968538|NCT00188773|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64968539|NCT00188773|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64968540|NCT00188773|Anticoagulants|anticoagulants|mesh-ancestor
64968541|NCT00188773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64968542|NCT00188773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64968543|NCT00188773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968561|NCT00188812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64968562|NCT00188812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968563|NCT00188812|Nootropic Agents|nootropic agents|mesh-ancestor
64968564|NCT02963194|Oxytocin|oxytocin|mesh-list
64968565|NCT02963194|Oxytocics|oxytocics|mesh-ancestor
64968566|NCT02963194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64968567|NCT02963194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968568|NCT00059306|Aspirin|aspirin|mesh-list
64968569|NCT00059306|Clopidogrel|clopidogrel|mesh-list
64968570|NCT00059306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64968571|NCT00059306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64968572|NCT00059306|Analgesics|analgesics|mesh-ancestor
64968573|NCT00059306|Sensory System Agents|sensory system agents|mesh-ancestor
64968574|NCT00059306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64968575|NCT00059306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968576|NCT00059306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64968577|NCT00059306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64968578|NCT00059306|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64581189|NCT01736865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64581190|NCT01736943|Doxorubicin|doxorubicin|mesh-list
64581191|NCT01736943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64581192|NCT01736943|Bortezomib|bortezomib|mesh-list
64581193|NCT01736943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64581194|NCT01736943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581195|NCT01736943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64581196|NCT01736943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64581197|NCT01736943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581198|NCT01736943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581199|NCT05328414|Prednisolone|prednisolone|mesh-list
64581200|NCT05328414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64581201|NCT05328414|Glucocorticoids|glucocorticoids|mesh-ancestor
64581202|NCT05328414|Hormones|hormones|mesh-ancestor
64581203|NCT05328414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64581204|NCT05328414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581205|NCT05328414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64581206|NCT05328414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581207|NCT01739361|Acetaminophen|acetaminophen|mesh-list
64581208|NCT01739361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64581209|NCT01739361|Analgesics|analgesics|mesh-ancestor
64968579|NCT00059306|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64968580|NCT00059306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968581|NCT00059306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64968582|NCT00059306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64968583|NCT00059306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968584|NCT00059306|Antipyretics|antipyretics|mesh-ancestor
64968585|NCT00059306|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64968586|NCT00059306|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64968587|NCT00059306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64968588|NCT00059306|Purinergic Agents|purinergic agents|mesh-ancestor
64968589|NCT00059306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64581243|NCT01745055|Antimetabolites|antimetabolites|mesh-ancestor
64581244|NCT01745055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581246|NCT01745055|Dermatologic Agents|dermatologic agents|mesh-ancestor
64968607|NCT00189007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968608|NCT00189007|Gout Suppressants|gout suppressants|mesh-ancestor
64968609|NCT00189007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64968610|NCT00189007|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64968611|NCT00189007|Antioxidants|antioxidants|mesh-ancestor
64968612|NCT00189007|Protective Agents|protective agents|mesh-ancestor
64968613|NCT00189007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968614|NCT00189007|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64333972|NCT02361177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64333973|NCT02361177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581309|NCT05192265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64581310|NCT05192265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64581311|NCT05192265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581312|NCT05192265|Antiviral Agents|antiviral agents|mesh-ancestor
64581313|NCT05192265|Schistosomicides|schistosomicides|mesh-ancestor
64581314|NCT05192265|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64581315|NCT05192265|Anthelmintics|anthelmintics|mesh-ancestor
64581316|NCT01748643|Glycopyrrolate|glycopyrrolate|mesh-list
64581317|NCT01748643|Rocuronium|rocuronium|mesh-list
64581318|NCT01748643|Neostigmine|neostigmine|mesh-list
64581319|NCT01748643|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64581320|NCT01748643|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64581321|NCT01748643|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64581322|NCT01748643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581323|NCT01748643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581324|NCT01748643|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64581325|NCT01748643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581326|NCT01748643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581327|NCT01748643|Cholinergic Agents|cholinergic agents|mesh-ancestor
64581328|NCT01748643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64581329|NCT01748643|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64968615|NCT00189007|Diuretics|diuretics|mesh-ancestor
64968616|NCT00189007|Natriuretic Agents|natriuretic agents|mesh-ancestor
64968618|NCT00399945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64968619|NCT00399945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64968620|NCT00189085|Simvastatin|simvastatin|mesh-list
64968621|NCT00189085|Ezetimibe|ezetimibe|mesh-list
64968622|NCT00189085|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
64968623|NCT00189085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64968624|NCT00189085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64968625|NCT00189085|Antimetabolites|antimetabolites|mesh-ancestor
64968626|NCT00189085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581330|NCT01748643|Autonomic Agents|autonomic agents|mesh-ancestor
64581331|NCT01748643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64581332|NCT01748643|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64968627|NCT00189085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64968628|NCT00189085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64968629|NCT00189085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968630|NCT00189124|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64968631|NCT00189124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64968723|NCT00189982|Coagulants|coagulants|mesh-ancestor
64968724|NCT00190021|Donepezil|donepezil|mesh-list
64968725|NCT00190021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64968726|NCT00190021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968727|NCT00190021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968728|NCT00190021|Cholinergic Agents|cholinergic agents|mesh-ancestor
64968729|NCT00190021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64968730|NCT00190021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968747|NCT00190099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64968748|NCT00190099|Antiemetics|antiemetics|mesh-ancestor
64507411|NCT05302336|Docetaxel|docetaxel|mesh-list
64968749|NCT00190099|Autonomic Agents|autonomic agents|mesh-ancestor
64968750|NCT00190099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64968751|NCT00190099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968752|NCT00190099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64968753|NCT00190099|Glucocorticoids|glucocorticoids|mesh-ancestor
64968754|NCT00190099|Hormones|hormones|mesh-ancestor
64968755|NCT00190099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64968756|NCT00190099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64968757|NCT00190099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968758|NCT02963077|Cholestyramine Resin|cholestyramine resin|mesh-list
64968759|NCT02963077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64581436|NCT02255175|Hormones|hormones|mesh-ancestor
64581440|NCT02255175|Contraceptive Agents|contraceptive agents|mesh-ancestor
64968760|NCT02963077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64968761|NCT02963077|Antimetabolites|antimetabolites|mesh-ancestor
64968762|NCT02963077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968803|NCT03238365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968804|NCT03238365|Vasodilator Agents|vasodilator agents|mesh-ancestor
64968805|NCT03238365|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64968806|NCT03238365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64968807|NCT03238365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968808|NCT03238365|Urological Agents|urological agents|mesh-ancestor
64968809|NCT00059618|Carboplatin|carboplatin|mesh-list
64968810|NCT00059618|Bortezomib|bortezomib|mesh-list
64968811|NCT00059618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968812|NCT00190333|Citalopram|citalopram|mesh-list
64968813|NCT00190333|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64968814|NCT00190333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64968815|NCT00190333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64968816|NCT00190333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968817|NCT00190333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64968818|NCT00190333|Serotonin Agents|serotonin agents|mesh-ancestor
64968819|NCT00190333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968862|NCT00190567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64968863|NCT00190567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64968864|NCT00190567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64968865|NCT00190567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581560|NCT05694936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64581561|NCT05694936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64581562|NCT05694936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64581563|NCT00168389|Dexamethasone|dexamethasone|mesh-list
64333974|NCT05055713|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64333975|NCT05055713|Somatostatin|somatostatin|mesh-list
64333976|NCT05055713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64581564|NCT00168389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64581565|NCT00168389|Antiemetics|antiemetics|mesh-ancestor
64581566|NCT00168389|Autonomic Agents|autonomic agents|mesh-ancestor
64581567|NCT00168389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581568|NCT00168389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581569|NCT00168389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64581570|NCT00168389|Glucocorticoids|glucocorticoids|mesh-ancestor
64581572|NCT00168389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64581573|NCT00168389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64581574|NCT00168389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581575|NCT02252445|Propofol|propofol|mesh-list
64581576|NCT02252445|Sevoflurane|sevoflurane|mesh-list
64581577|NCT02252445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64581578|NCT02252445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64581579|NCT02252445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581580|NCT02252445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64581581|NCT02252445|Anesthetics, General|anesthetics, general|mesh-ancestor
64581582|NCT02252445|Anesthetics|anesthetics|mesh-ancestor
64581583|NCT02252445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64581584|NCT02252445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64581585|NCT04592952|Calcitonin|calcitonin|mesh-list
64581586|NCT04592952|Salmon calcitonin|salmon calcitonin|mesh-list
64968866|NCT00190567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64968906|NCT00190762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968907|NCT00190762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968908|NCT00190762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968909|NCT00190762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64968910|NCT00190762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64968911|NCT00190801|Pemetrexed|pemetrexed|mesh-list
64968912|NCT00190801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968913|NCT00190801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64968914|NCT00190801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581592|NCT04592952|Analgesics|analgesics|mesh-ancestor
64581593|NCT04592952|Sensory System Agents|sensory system agents|mesh-ancestor
64581594|NCT04592952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581595|NCT04592952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581596|NCT04592952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64581597|NCT04592952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64581599|NCT00176423|Galantamine|galantamine|mesh-list
64581600|NCT00176423|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64581601|NCT00176423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581602|NCT00176423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581603|NCT00176423|Cholinergic Agents|cholinergic agents|mesh-ancestor
64581604|NCT00176423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64581605|NCT00176423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581606|NCT00176423|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64581607|NCT00176423|Autonomic Agents|autonomic agents|mesh-ancestor
64968915|NCT00190801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64968916|NCT00190801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64968917|NCT00047346|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64968918|NCT00047346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64968962|NCT00190996|Dopamine Agents|dopamine agents|mesh-ancestor
64968963|NCT00191035|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64968965|NCT00191035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64581608|NCT00176423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581609|NCT00176423|Nootropic Agents|nootropic agents|mesh-ancestor
64581610|NCT02094443|Ribavirin|ribavirin|mesh-list
64581611|NCT02094443|Antimetabolites|antimetabolites|mesh-ancestor
64581612|NCT02094443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581613|NCT02094443|Antiviral Agents|antiviral agents|mesh-ancestor
64581614|NCT02094443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64581615|NCT00110513|Antithrombins|antithrombins|mesh-list
64581616|NCT00110513|Antithrombin III|antithrombin iii|mesh-list
64581617|NCT00110513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64581618|NCT00110513|Protease Inhibitors|protease inhibitors|mesh-ancestor
64581619|NCT00110513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581620|NCT00110513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581621|NCT00110513|Anticoagulants|anticoagulants|mesh-ancestor
64581623|NCT05663658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64581624|NCT05663658|Narcotics|narcotics|mesh-ancestor
64581625|NCT05663658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64581626|NCT05663658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581627|NCT05663658|Analgesics|analgesics|mesh-ancestor
64581628|NCT05663658|Sensory System Agents|sensory system agents|mesh-ancestor
64581629|NCT05663658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581630|NCT05691426|Nitric Oxide|nitric oxide|mesh-list
64581631|NCT05691426|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64581632|NCT05691426|Autonomic Agents|autonomic agents|mesh-ancestor
64581633|NCT05691426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581634|NCT05691426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581635|NCT05691426|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64333977|NCT05055713|Adrenergic Agents|adrenergic agents|mesh-ancestor
64968966|NCT00191035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64968967|NCT00191035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64968968|NCT00191035|Adrenergic Agents|adrenergic agents|mesh-ancestor
64968969|NCT00191035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64968970|NCT00191035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64968971|NCT02922894|Trazodone|trazodone|mesh-list
64968972|NCT02922894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64968973|NCT02922894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64968974|NCT02922894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64968975|NCT02922894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581647|NCT05696574|Abortifacient Agents|abortifacient agents|mesh-ancestor
64581648|NCT05696574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64581649|NCT05696574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581650|NCT05696574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64581651|NCT05696574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64581652|NCT05696574|Oxytocics|oxytocics|mesh-ancestor
64581653|NCT00112151|Methyltestosterone|methyltestosterone|mesh-list
64968976|NCT02922894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64968977|NCT02922894|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64968978|NCT02922894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64968979|NCT02922894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64969018|NCT00191425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64969019|NCT00191425|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64969020|NCT00191425|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64969085|NCT00191659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969087|NCT00191659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64969088|NCT00191659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969089|NCT00191698|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64969090|NCT00191698|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64969091|NCT00191698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64969092|NCT00191698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64969093|NCT00191698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969094|NCT00191698|Adrenergic Agents|adrenergic agents|mesh-ancestor
64969097|NCT02470299|Ketorolac|ketorolac|mesh-list
64969120|NCT00191893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64969121|NCT00191932|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64969122|NCT00191932|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64969123|NCT00191932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64969124|NCT00191932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64969125|NCT00191932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969126|NCT00191932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64969127|NCT00191932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581832|NCT05577000|Alkylating Agents|alkylating agents|mesh-ancestor
64581833|NCT05577000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581834|NCT05577000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581835|NCT05577000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64581836|NCT00122369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64581837|NCT00122369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64581838|NCT00122369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581839|NCT00122447|Aspirin|aspirin|mesh-list
64581840|NCT00122447|Thioctic Acid|thioctic acid|mesh-list
64581841|NCT00122447|Olmesartan|olmesartan|mesh-list
64581842|NCT00122447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64581843|NCT00122447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64581844|NCT00122447|Analgesics|analgesics|mesh-ancestor
64581845|NCT00122447|Sensory System Agents|sensory system agents|mesh-ancestor
64581846|NCT00122447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581847|NCT00122447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581848|NCT00122447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64581849|NCT00122447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64581850|NCT00122447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64581851|NCT00122447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64581853|NCT00122447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64969129|NCT00191932|Sensory System Agents|sensory system agents|mesh-ancestor
64969130|NCT00191932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64969131|NCT00191932|Antidepressive Agents|antidepressive agents|mesh-ancestor
64969132|NCT00191932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64969133|NCT00191932|Dopamine Agents|dopamine agents|mesh-ancestor
64969134|NCT00059813|Interferons|interferons|mesh-list
64969135|NCT00059813|Interferon-alpha|interferon-alpha|mesh-list
64969136|NCT00059813|Interferon alpha-2|interferon alpha-2|mesh-list
64969344|NCT00193531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64969345|NCT00193531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969346|NCT00193570|Docetaxel|docetaxel|mesh-list
64969347|NCT00193570|Topotecan|topotecan|mesh-list
64969348|NCT00193570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969349|NCT00193570|Tubulin Modulators|tubulin modulators|mesh-ancestor
64969391|NCT00060125|Tipifarnib|tipifarnib|mesh-list
64969423|NCT00060242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64581897|NCT02579928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581898|NCT02579928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581899|NCT02579928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64581900|NCT02579928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64581901|NCT02579928|Anesthetics, General|anesthetics, general|mesh-ancestor
64581902|NCT02579928|Anesthetics|anesthetics|mesh-ancestor
64581903|NCT02579928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64581904|NCT02579928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64581905|NCT02579928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64581906|NCT02579928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64581907|NCT02579928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581908|NCT02579928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64581909|NCT02579928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64969424|NCT00060242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969425|NCT00060242|Tubulin Modulators|tubulin modulators|mesh-ancestor
64969426|NCT00060242|Antimitotic Agents|antimitotic agents|mesh-ancestor
64969427|NCT00060242|Mitosis Modulators|mitosis modulators|mesh-ancestor
64969428|NCT00060242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969429|NCT00193921|Gemcitabine|gemcitabine|mesh-list
64969430|NCT00193921|Cisplatin|cisplatin|mesh-list
64969431|NCT00193921|Vinorelbine|vinorelbine|mesh-list
64969432|NCT00193921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581939|NCT00186017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581940|NCT00186017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64581941|NCT00186017|Serotonin Agents|serotonin agents|mesh-ancestor
64581961|NCT00041119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64581962|NCT00041119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969433|NCT00193921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64969434|NCT00193921|Antimetabolites|antimetabolites|mesh-ancestor
64969435|NCT00193921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969436|NCT00193921|Antiviral Agents|antiviral agents|mesh-ancestor
64969437|NCT00193921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969438|NCT00193921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969439|NCT00193921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64969440|NCT00193921|Immunologic Factors|immunologic factors|mesh-ancestor
64969441|NCT00193921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969442|NCT00193921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64969443|NCT00193921|Tubulin Modulators|tubulin modulators|mesh-ancestor
64969444|NCT00193921|Antimitotic Agents|antimitotic agents|mesh-ancestor
64969475|NCT00194272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64969477|NCT00194272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64969478|NCT00194272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969479|NCT00194272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64969480|NCT00194272|Antimetabolites|antimetabolites|mesh-ancestor
64969481|NCT00194272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969482|NCT00194272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969483|NCT00194272|Dermatologic Agents|dermatologic agents|mesh-ancestor
64969484|NCT00194272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969485|NCT00194272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64969486|NCT00194272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64969487|NCT00194272|Immunologic Factors|immunologic factors|mesh-ancestor
64969488|NCT00194272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64969489|NCT00194272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64969490|NCT00398528|Glatiramer Acetate|glatiramer acetate|mesh-list
64969491|NCT00398528|(T,G)-A-L|(t,g)-a-l|mesh-list
64969492|NCT00398528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64969493|NCT00398528|Immunologic Factors|immunologic factors|mesh-ancestor
64582020|NCT00551460|Gemtuzumab|gemtuzumab|mesh-list
64582022|NCT00551460|Abortifacient Agents|abortifacient agents|mesh-ancestor
64582041|NCT04751227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64582042|NCT04751227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64582043|NCT04751227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64582044|NCT04751227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582046|NCT02579772|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64582047|NCT02579772|Antiviral Agents|antiviral agents|mesh-ancestor
64582048|NCT02579772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64582049|NCT02579772|Expectorants|expectorants|mesh-ancestor
64582050|NCT02579772|Respiratory System Agents|respiratory system agents|mesh-ancestor
64582051|NCT02579772|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64582052|NCT02579772|Antioxidants|antioxidants|mesh-ancestor
64969531|NCT00194740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969532|NCT00194740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64969533|NCT00194818|Mesalamine|mesalamine|mesh-list
64969534|NCT00194818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64969535|NCT00194818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64969536|NCT00194818|Analgesics|analgesics|mesh-ancestor
64969537|NCT00194818|Sensory System Agents|sensory system agents|mesh-ancestor
64969538|NCT00194818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64969539|NCT00194818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969540|NCT00194818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64969541|NCT00194818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64969542|NCT00194857|Epoetin Alfa|epoetin alfa|mesh-list
64969543|NCT00194857|Hematinics|hematinics|mesh-ancestor
64969544|NCT00194935|Topotecan|topotecan|mesh-list
64969545|NCT00194935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64969546|NCT00194935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64969547|NCT00194935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969548|NCT00194935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969566|NCT00194974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969567|NCT00194974|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64969568|NCT00194974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64969569|NCT00194974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64969570|NCT00194974|Vasodilator Agents|vasodilator agents|mesh-ancestor
64969571|NCT00194974|Tocolytic Agents|tocolytic agents|mesh-ancestor
64969572|NCT00194974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64969573|NCT00194974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64969574|NCT00194974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64969575|NCT00194974|Sympathomimetics|sympathomimetics|mesh-ancestor
64969576|NCT00194974|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64969577|NCT00194974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64969578|NCT00195208|Pantoprazole|pantoprazole|mesh-list
64969579|NCT00195208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64969580|NCT00195208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64969581|NCT00195208|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64582128|NCT04953156|Vasodilator Agents|vasodilator agents|mesh-ancestor
64582129|NCT01761747|Ponatinib|ponatinib|mesh-list
64582130|NCT01761747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582131|NCT01761747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64582132|NCT01761747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582133|NCT01761747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582134|NCT00045487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64582135|NCT00045487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582136|NCT00045487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64582137|NCT00045487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582138|NCT00045487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582139|NCT04097730|Riboflavin|riboflavin|mesh-list
64582140|NCT04097730|Moxifloxacin|moxifloxacin|mesh-list
64582141|NCT04097730|Difluprednate|difluprednate|mesh-list
64582142|NCT04097730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64582143|NCT04097730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64582144|NCT04097730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64582146|NCT04097730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969582|NCT00195208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969583|NCT00195208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969584|NCT02963116|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64969671|NCT00195598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969672|NCT00195598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64969673|NCT00195598|Serotonin Agents|serotonin agents|mesh-ancestor
64969674|NCT00195598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969675|NCT00195598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64969676|NCT00195598|Antidepressive Agents|antidepressive agents|mesh-ancestor
64969677|NCT00195598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64969678|NCT00195598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64969679|NCT00195598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64969680|NCT00195598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969681|NCT00195598|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64969682|NCT00195637|Immunoglobulins|immunoglobulins|mesh-list
64969683|NCT00195637|Antibodies|antibodies|mesh-list
64969684|NCT00195637|gamma-Globulins|gamma-globulins|mesh-list
64969685|NCT00195637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64969686|NCT00195637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64969687|NCT00195637|Immunologic Factors|immunologic factors|mesh-ancestor
64969688|NCT00195637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969689|NCT00195754|Valproic Acid|valproic acid|mesh-list
64969690|NCT00195754|Anticonvulsants|anticonvulsants|mesh-ancestor
64333994|NCT04624113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333995|NCT05030519|Trastuzumab|trastuzumab|mesh-list
64333996|NCT05030519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64582161|NCT00278863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582162|NCT00278863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582163|NCT01762059|Pancrelipase|pancrelipase|mesh-list
64582164|NCT01762059|Pancreatin|pancreatin|mesh-list
64582165|NCT01762059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64582166|NCT04938024|Ascorbic Acid|ascorbic acid|mesh-list
64582167|NCT04938024|Vitamins|vitamins|mesh-ancestor
64582168|NCT04938024|Micronutrients|micronutrients|mesh-ancestor
64333997|NCT05030519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333998|NCT02357277|Budesonide|budesonide|mesh-list
64333999|NCT02357277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64334000|NCT02357277|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64969693|NCT00195754|GABA Agents|gaba agents|mesh-ancestor
64969723|NCT00195871|Alkylating Agents|alkylating agents|mesh-ancestor
64969724|NCT00195871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969725|NCT00195871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969726|NCT00195871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64969727|NCT00195871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64969728|NCT00195871|Glucocorticoids|glucocorticoids|mesh-ancestor
64969742|NCT00195871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64969776|NCT00060476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969777|NCT00060476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969778|NCT00060476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64969779|NCT00060476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64334024|NCT02290717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64334025|NCT02290717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64334026|NCT02290717|Autonomic Agents|autonomic agents|mesh-ancestor
64334027|NCT02290717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64582169|NCT04938024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582170|NCT04938024|Antioxidants|antioxidants|mesh-ancestor
64582171|NCT04938024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582172|NCT04938024|Protective Agents|protective agents|mesh-ancestor
64582173|NCT01808547|Bromfenac|bromfenac|mesh-list
64582174|NCT01808547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64582175|NCT01808547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64582176|NCT01808547|Analgesics|analgesics|mesh-ancestor
64582177|NCT01808547|Sensory System Agents|sensory system agents|mesh-ancestor
64582178|NCT01808547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64969780|NCT00060476|Analgesics|analgesics|mesh-ancestor
64508532|NCT04645212|Aflibercept|aflibercept|mesh-list
64969781|NCT00060476|Sensory System Agents|sensory system agents|mesh-ancestor
64969782|NCT00060476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64969783|NCT00060476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969784|NCT00060476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64969785|NCT00060476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64969786|NCT00084279|Interferons|interferons|mesh-list
64969788|NCT00084279|Interferon-alpha|interferon-alpha|mesh-list
64969789|NCT00084279|Interferon-gamma|interferon-gamma|mesh-list
64969790|NCT00084279|Interferon alfacon-1|interferon alfacon-1|mesh-list
64969791|NCT00084279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969792|NCT00084279|Antiviral Agents|antiviral agents|mesh-ancestor
64969793|NCT00084279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969794|NCT00084279|Antimetabolites|antimetabolites|mesh-ancestor
64582215|NCT04666740|Pembrolizumab|pembrolizumab|mesh-list
64582216|NCT04666740|Olaparib|olaparib|mesh-list
64582217|NCT04666740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64582218|NCT04666740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582219|NCT04666740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64582221|NCT04666740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582222|NCT01790893|Aflibercept|aflibercept|mesh-list
64582223|NCT01790893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64582224|NCT01790893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64582225|NCT01790893|Growth Substances|growth substances|mesh-ancestor
64582226|NCT01790893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582227|NCT01790893|Growth Inhibitors|growth inhibitors|mesh-ancestor
64582228|NCT01790893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582229|NCT04123873|Acetaminophen|acetaminophen|mesh-list
64582230|NCT04123873|Dexamethasone|dexamethasone|mesh-list
64582231|NCT04123873|Ibuprofen|ibuprofen|mesh-list
64582232|NCT04123873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64582233|NCT04123873|Antiemetics|antiemetics|mesh-ancestor
64969795|NCT00084279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969796|NCT00084279|Immunologic Factors|immunologic factors|mesh-ancestor
64969797|NCT00084279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969798|NCT00196378|Estrogens|estrogens|mesh-list
64969799|NCT00196378|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64969800|NCT00196378|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
64969801|NCT00196378|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
64969802|NCT00196378|Hormones|hormones|mesh-ancestor
64582271|NCT00189137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582272|NCT00189137|Antiviral Agents|antiviral agents|mesh-ancestor
64582273|NCT00189137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64582274|NCT00189137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582275|NCT00189137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64582276|NCT00189137|Immunologic Factors|immunologic factors|mesh-ancestor
64582277|NCT00189137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582278|NCT00189137|Tubulin Modulators|tubulin modulators|mesh-ancestor
64582279|NCT00189137|Antimitotic Agents|antimitotic agents|mesh-ancestor
64582280|NCT00189137|Mitosis Modulators|mitosis modulators|mesh-ancestor
64969803|NCT00196378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64969804|NCT00196378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969820|NCT00060554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64969821|NCT00060554|Protease Inhibitors|protease inhibitors|mesh-ancestor
64969822|NCT00060554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969823|NCT00048087|Docetaxel|docetaxel|mesh-list
64969824|NCT00048087|Gefitinib|gefitinib|mesh-list
64969825|NCT00048087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969826|NCT00048087|Tubulin Modulators|tubulin modulators|mesh-ancestor
64969827|NCT00048087|Antimitotic Agents|antimitotic agents|mesh-ancestor
64969828|NCT00048087|Mitosis Modulators|mitosis modulators|mesh-ancestor
64582340|NCT05391750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582341|NCT05391750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582342|NCT01763931|Digoxin|digoxin|mesh-list
64582343|NCT01763931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64582344|NCT01763931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64582345|NCT01763931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582347|NCT01763931|Protective Agents|protective agents|mesh-ancestor
64969829|NCT00048087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969830|NCT00048087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64969831|NCT00048087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64969832|NCT00196534|Thrombin|thrombin|mesh-list
64969833|NCT00196534|Hemostatics|hemostatics|mesh-ancestor
64969834|NCT00196534|Coagulants|coagulants|mesh-ancestor
64969835|NCT00048126|Capecitabine|capecitabine|mesh-list
64969878|NCT00084396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64969879|NCT00084396|Hormone Antagonists|hormone antagonists|mesh-ancestor
64969880|NCT00084396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64969881|NCT00084396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969883|NCT00196846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64969884|NCT00196846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969885|NCT00060632|Sirolimus|sirolimus|mesh-list
64969886|NCT00060632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64969887|NCT00060632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969888|NCT00060632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64969889|NCT00060632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64969890|NCT00060632|Antifungal Agents|antifungal agents|mesh-ancestor
64969891|NCT00060632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64969892|NCT00060632|Immunologic Factors|immunologic factors|mesh-ancestor
64969893|NCT00060632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969894|NCT00196885|Acetylcysteine|acetylcysteine|mesh-list
64969895|NCT00196885|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64969896|NCT00196885|Antiviral Agents|antiviral agents|mesh-ancestor
64969897|NCT00196885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64969898|NCT00196885|Expectorants|expectorants|mesh-ancestor
64582555|NCT01817907|Trazodone|trazodone|mesh-list
64969899|NCT00196885|Respiratory System Agents|respiratory system agents|mesh-ancestor
64969900|NCT00196885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64969901|NCT00196885|Antioxidants|antioxidants|mesh-ancestor
64969902|NCT00196885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969903|NCT00196885|Protective Agents|protective agents|mesh-ancestor
64969904|NCT00196885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64969905|NCT00196885|Antidotes|antidotes|mesh-ancestor
64969906|NCT00048204|Paroxetine|paroxetine|mesh-list
64969907|NCT00048204|Vestipitant|vestipitant|mesh-list
64969908|NCT00048204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64969909|NCT00048204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64969910|NCT00048204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64969911|NCT00048204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64969912|NCT00048204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64969913|NCT00048204|Serotonin Agents|serotonin agents|mesh-ancestor
64969978|NCT02962999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64970049|NCT00060866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970050|NCT00060866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970051|NCT00060866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970052|NCT00060866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64970053|NCT00060866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64582779|NCT01735617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64582780|NCT00208091|Botulinum Toxins|botulinum toxins|mesh-list
64970054|NCT00060866|Vasodilator Agents|vasodilator agents|mesh-ancestor
64970056|NCT00048360|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64970057|NCT00048360|Antidepressive Agents|antidepressive agents|mesh-ancestor
64970058|NCT00048360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64970059|NCT00048360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64970060|NCT00048360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64970061|NCT00048360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64970062|NCT00048360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970063|NCT00048360|Dopamine Agents|dopamine agents|mesh-ancestor
64970064|NCT00048360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970112|NCT00198250|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64970129|NCT00084708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64970130|NCT00084708|Glucocorticoids|glucocorticoids|mesh-ancestor
64970131|NCT00084708|Hormones|hormones|mesh-ancestor
64970132|NCT00084708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64970133|NCT00084708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64970134|NCT00084708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508830|NCT03037437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64508831|NCT03037437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64508832|NCT01775501|Leucovorin|leucovorin|mesh-list
64508833|NCT01775501|Fluorouracil|fluorouracil|mesh-list
64508834|NCT01775501|Oxaliplatin|oxaliplatin|mesh-list
64508835|NCT01775501|Sorafenib|sorafenib|mesh-list
64508836|NCT01775501|Antimetabolites|antimetabolites|mesh-ancestor
64508837|NCT01775501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508838|NCT01775501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64508839|NCT01775501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508840|NCT01775501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64508841|NCT01775501|Immunologic Factors|immunologic factors|mesh-ancestor
64508842|NCT01775501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508843|NCT01775501|Antidotes|antidotes|mesh-ancestor
64508904|NCT04551963|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64970135|NCT00084708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64970136|NCT00084708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970137|NCT00084708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970138|NCT00084708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64970139|NCT00084708|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64970163|NCT00048399|Fludarabine|fludarabine|mesh-list
64970164|NCT00048399|Alemtuzumab|alemtuzumab|mesh-list
64970165|NCT00048399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970166|NCT00048399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64970167|NCT00060905|Valproic Acid|valproic acid|mesh-list
64970168|NCT00060905|Anticonvulsants|anticonvulsants|mesh-ancestor
64970169|NCT00060905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970170|NCT00060905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970171|NCT00060905|GABA Agents|gaba agents|mesh-ancestor
64970172|NCT00060905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970173|NCT00060905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970174|NCT00060905|Antimanic Agents|antimanic agents|mesh-ancestor
64970175|NCT00060905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64970176|NCT00060905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64970177|NCT00060905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64970178|NCT00198523|Tobramycin|tobramycin|mesh-list
64970179|NCT00198523|Prednisolone|prednisolone|mesh-list
64970180|NCT00198523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64970181|NCT00198523|Methylprednisolone|methylprednisolone|mesh-list
64970219|NCT00409942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64970220|NCT00409942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970221|NCT00409942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64970222|NCT00084786|Docetaxel|docetaxel|mesh-list
64970223|NCT00084786|Gefitinib|gefitinib|mesh-list
64970224|NCT00084786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970225|NCT00084786|Tubulin Modulators|tubulin modulators|mesh-ancestor
64970226|NCT00084786|Antimitotic Agents|antimitotic agents|mesh-ancestor
64970227|NCT00084786|Mitosis Modulators|mitosis modulators|mesh-ancestor
64970228|NCT00084786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970229|NCT00084786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64970274|NCT00199147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64970275|NCT00199147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64970276|NCT00199147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970277|NCT00199147|Antiviral Agents|antiviral agents|mesh-ancestor
64970278|NCT00199147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64970393|NCT00199771|Blood Substitutes|blood substitutes|mesh-ancestor
64970395|NCT00084981|Azacitidine|azacitidine|mesh-list
64970396|NCT00084981|Valproic Acid|valproic acid|mesh-list
64970397|NCT00084981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64970398|NCT00084981|Antimetabolites|antimetabolites|mesh-ancestor
64970406|NCT00084981|Antimanic Agents|antimanic agents|mesh-ancestor
64970407|NCT00084981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64970408|NCT00084981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64970409|NCT00084981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64970410|NCT00199966|Valproic Acid|valproic acid|mesh-list
64970411|NCT00199966|Anticonvulsants|anticonvulsants|mesh-ancestor
64583207|NCT00280241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64583208|NCT00280241|Immunologic Factors|immunologic factors|mesh-ancestor
64583254|NCT01786239|Dopamine Agents|dopamine agents|mesh-ancestor
64970412|NCT00199966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970413|NCT00199966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970414|NCT00199966|GABA Agents|gaba agents|mesh-ancestor
64970415|NCT00199966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970416|NCT00199966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970417|NCT00199966|Antimanic Agents|antimanic agents|mesh-ancestor
64970418|NCT00199966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64970419|NCT00199966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64970420|NCT00199966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64970421|NCT00085020|Trastuzumab|trastuzumab|mesh-list
64970422|NCT00085020|Lapatinib|lapatinib|mesh-list
64970423|NCT00085020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64970424|NCT00085020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970425|NCT00085020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64970426|NCT00085020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970520|NCT00061256|Calcium|calcium|mesh-list
64970521|NCT00061256|Vitamins|vitamins|mesh-ancestor
64970522|NCT00061256|Micronutrients|micronutrients|mesh-ancestor
64970523|NCT00061256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970524|NCT00061256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64970525|NCT00061256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64970526|NCT00061256|Antacids|antacids|mesh-ancestor
64970527|NCT00061256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970528|NCT00061256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64970529|NCT00200590|Acetaminophen|acetaminophen|mesh-list
64970530|NCT00200590|Morphine|morphine|mesh-list
64970531|NCT00200590|Nalbuphine|nalbuphine|mesh-list
64970532|NCT00200590|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64970533|NCT00200590|Narcotics|narcotics|mesh-ancestor
64970534|NCT00200590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64970535|NCT00200590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970536|NCT00200590|Analgesics|analgesics|mesh-ancestor
64970537|NCT00200590|Sensory System Agents|sensory system agents|mesh-ancestor
64970538|NCT00200590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64970539|NCT00200590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64970540|NCT00200590|Antipyretics|antipyretics|mesh-ancestor
64970541|NCT00200629|Adenosine|adenosine|mesh-list
64970542|NCT00200629|Analgesics|analgesics|mesh-ancestor
64970543|NCT00200629|Sensory System Agents|sensory system agents|mesh-ancestor
64970544|NCT00200629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64970545|NCT00200629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970546|NCT00200629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64970547|NCT00200629|Vasodilator Agents|vasodilator agents|mesh-ancestor
64970548|NCT00200629|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64970549|NCT00200629|Purinergic Agonists|purinergic agonists|mesh-ancestor
64970550|NCT00200629|Purinergic Agents|purinergic agents|mesh-ancestor
64970721|NCT00048828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64970722|NCT00048828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970724|NCT00048828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64970725|NCT00048828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64970761|NCT00221962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64970762|NCT00221962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64970763|NCT00221962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64970764|NCT00221962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64970765|NCT00221962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970766|NCT00221962|Dopamine Agonists|dopamine agonists|mesh-ancestor
64970767|NCT00221962|Dopamine Agents|dopamine agents|mesh-ancestor
64970768|NCT00221962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970769|NCT00221962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970770|NCT00221962|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64970771|NCT00221962|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64970772|NCT00221962|Serotonin Agents|serotonin agents|mesh-ancestor
64970773|NCT00221962|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64970774|NCT00221962|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64970775|NCT00221962|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64970776|NCT00221962|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64970777|NCT02968160|Telmisartan|telmisartan|mesh-list
64970778|NCT02968160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64970779|NCT02968160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64970780|NCT02968160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64970781|NCT02968160|Antimetabolites|antimetabolites|mesh-ancestor
64970782|NCT02968160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970783|NCT02968160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64970784|NCT02968160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64970785|NCT02968160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970786|NCT02968160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64970787|NCT02968160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64970788|NCT02968160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64970838|NCT00222547|Anticestodal Agents|anticestodal agents|mesh-ancestor
64970839|NCT00222547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64970840|NCT00222547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64970841|NCT00222547|Tubulin Modulators|tubulin modulators|mesh-ancestor
64970842|NCT00222547|Antimitotic Agents|antimitotic agents|mesh-ancestor
64970843|NCT00222547|Mitosis Modulators|mitosis modulators|mesh-ancestor
64970844|NCT00086034|Motexafin gadolinium|motexafin gadolinium|mesh-list
64970845|NCT00086034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64970846|NCT00086034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64583373|NCT05261321|Dronabinol|dronabinol|mesh-list
64970847|NCT00086034|Dermatologic Agents|dermatologic agents|mesh-ancestor
64970848|NCT02968082|Scopolamine|scopolamine|mesh-list
64970849|NCT02968082|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64970850|NCT02968082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64970851|NCT02968082|Antiemetics|antiemetics|mesh-ancestor
64970899|NCT00223015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970900|NCT00061763|Deferasirox|deferasirox|mesh-list
64970901|NCT00061763|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64970902|NCT00061763|Chelating Agents|chelating agents|mesh-ancestor
64970903|NCT00061763|Sequestering Agents|sequestering agents|mesh-ancestor
64970904|NCT00061763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970905|NCT00223054|Cyclosporine|cyclosporine|mesh-list
64970906|NCT00223054|Sirolimus|sirolimus|mesh-list
64970907|NCT00223054|Everolimus|everolimus|mesh-list
64970908|NCT00223054|Tacrolimus|tacrolimus|mesh-list
64970909|NCT00223054|Cyclosporins|cyclosporins|mesh-list
64970910|NCT00223054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64970911|NCT00223054|Immunologic Factors|immunologic factors|mesh-ancestor
64970912|NCT00223054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64970913|NCT00223054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64970914|NCT00223054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64970940|NCT00061802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64970941|NCT00061802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64970942|NCT00061802|Dopamine Agents|dopamine agents|mesh-ancestor
64970943|NCT00061802|Antidepressive Agents|antidepressive agents|mesh-ancestor
64970944|NCT00223249|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64970945|NCT00223249|Antidepressive Agents|antidepressive agents|mesh-ancestor
64970946|NCT00223249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64970947|NCT00223249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64970948|NCT00223249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64970949|NCT00223249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64970950|NCT00223249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509654|NCT01597505|Vancomycin|vancomycin|mesh-list
64970951|NCT00223288|Citalopram|citalopram|mesh-list
64970952|NCT00223288|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64970953|NCT00223288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64970954|NCT00223288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64970956|NCT00223288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970996|NCT00223561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64970997|NCT00223561|Dopamine Agents|dopamine agents|mesh-ancestor
64970998|NCT00223561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64970999|NCT00223639|Topiramate|topiramate|mesh-list
64971000|NCT00223639|Anticonvulsants|anticonvulsants|mesh-ancestor
64971001|NCT00223639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64971002|NCT00223639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971003|NCT00223717|Aspirin|aspirin|mesh-list
64971004|NCT00223717|Losartan|losartan|mesh-list
64971005|NCT00223717|Metoprolol|metoprolol|mesh-list
64971006|NCT00223717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64971007|NCT00223717|Clonidine|clonidine|mesh-list
64971008|NCT00223717|Eplerenone|eplerenone|mesh-list
64971009|NCT00223717|Nebivolol|nebivolol|mesh-list
64971010|NCT00223717|Bosentan|bosentan|mesh-list
64971011|NCT00223717|Diltiazem|diltiazem|mesh-list
64971012|NCT00223717|Guanfacine|guanfacine|mesh-list
64971019|NCT00223717|Nitroglycerin|nitroglycerin|mesh-list
64971020|NCT00223717|Dipyridamole|dipyridamole|mesh-list
64971021|NCT00223717|Carbidopa|carbidopa|mesh-list
64971022|NCT00223717|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
64971023|NCT00223717|Tamsulosin|tamsulosin|mesh-list
64971024|NCT00223717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64971025|NCT00223717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64509728|NCT05735626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971047|NCT00223717|Diuretics|diuretics|mesh-ancestor
64971048|NCT00223717|Natriuretic Agents|natriuretic agents|mesh-ancestor
64971049|NCT00223717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64971050|NCT00223717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64971051|NCT00223717|Sympatholytics|sympatholytics|mesh-ancestor
64971052|NCT00223717|Autonomic Agents|autonomic agents|mesh-ancestor
64971053|NCT00223717|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64971054|NCT00223717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64971055|NCT00223717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64971056|NCT00223717|Adrenergic Agents|adrenergic agents|mesh-ancestor
64971057|NCT00223717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64971058|NCT00223717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64971059|NCT00223717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64971060|NCT00223717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64971061|NCT00223717|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64971062|NCT00223717|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64971063|NCT00223717|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64971064|NCT00223717|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64971065|NCT00223717|Dopamine Agents|dopamine agents|mesh-ancestor
64971066|NCT00223717|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64971067|NCT00223717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64971068|NCT00223717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64971069|NCT00223717|Tocolytic Agents|tocolytic agents|mesh-ancestor
64971070|NCT00223717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64971071|NCT00223717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64971093|NCT00061919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64971094|NCT00061919|Immunologic Factors|immunologic factors|mesh-ancestor
64971095|NCT00061919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971096|NCT00061919|Leprostatic Agents|leprostatic agents|mesh-ancestor
64971097|NCT00061919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64971098|NCT00061919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64971099|NCT00061919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64971100|NCT00061919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64971101|NCT00061919|Growth Substances|growth substances|mesh-ancestor
64971102|NCT00061919|Growth Inhibitors|growth inhibitors|mesh-ancestor
64971103|NCT00085527|Romidepsin|romidepsin|mesh-list
64971104|NCT00085527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64971105|NCT00085527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971107|NCT00061958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971108|NCT00224068|Ferric gluconate|ferric gluconate|mesh-list
64971156|NCT00224302|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64971157|NCT00224302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64971158|NCT00224302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64971159|NCT00224302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64971160|NCT00224302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583429|NCT00281827|Leprostatic Agents|leprostatic agents|mesh-ancestor
64583450|NCT01794741|Xhance|xhance|mesh-list
64971161|NCT00224302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64971162|NCT00224302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971163|NCT00224302|Analgesics|analgesics|mesh-ancestor
64971164|NCT00224302|Sensory System Agents|sensory system agents|mesh-ancestor
64971165|NCT00224302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64971166|NCT00224302|Antidepressive Agents|antidepressive agents|mesh-ancestor
64971167|NCT00224302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64971168|NCT00224302|Dopamine Agents|dopamine agents|mesh-ancestor
64971169|NCT00062075|Romidepsin|romidepsin|mesh-list
64971170|NCT00062075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64971171|NCT00062075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971172|NCT00224419|Nicotine|nicotine|mesh-list
64971202|NCT00062114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971203|NCT00062114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64971204|NCT00095043|Gaboxadol|gaboxadol|mesh-list
64971205|NCT00095043|Analgesics|analgesics|mesh-ancestor
64971206|NCT00095043|Sensory System Agents|sensory system agents|mesh-ancestor
64971207|NCT00095043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64971208|NCT00095043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971209|NCT00095043|Anticonvulsants|anticonvulsants|mesh-ancestor
64971210|NCT00095043|GABA Agonists|gaba agonists|mesh-ancestor
64971211|NCT00095043|GABA Agents|gaba agents|mesh-ancestor
64971212|NCT00095043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64971213|NCT00095043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971214|NCT00095082|Insulin|insulin|mesh-list
64971215|NCT00095082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64971216|NCT00095082|Insulin Glargine|insulin glargine|mesh-list
64971217|NCT00095082|Insulin Aspart|insulin aspart|mesh-list
64971218|NCT00095082|Insulin Detemir|insulin detemir|mesh-list
64971219|NCT00095082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64971220|NCT00095082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971221|NCT00062231|Amoxicillin|amoxicillin|mesh-list
64971222|NCT00062231|Moxifloxacin|moxifloxacin|mesh-list
64971257|NCT00224692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64971258|NCT00224692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971259|NCT00224809|Aspirin|aspirin|mesh-list
64971260|NCT00224809|Spironolactone|spironolactone|mesh-list
64971261|NCT00224809|Clopidogrel|clopidogrel|mesh-list
64971262|NCT00224809|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64971263|NCT00224809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64971264|NCT00224809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64971265|NCT00224809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64583458|NCT01794741|Dermatologic Agents|dermatologic agents|mesh-ancestor
64583459|NCT01794741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64583460|NCT04446871|Methylene Blue|methylene blue|mesh-list
64583461|NCT04446871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583462|NCT04446871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583463|NCT04085419|Zoledronic Acid|zoledronic acid|mesh-list
64583464|NCT04085419|Denosumab|denosumab|mesh-list
64583465|NCT04085419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64334030|NCT02290717|Respiratory System Agents|respiratory system agents|mesh-ancestor
64334031|NCT02290717|Dermatologic Agents|dermatologic agents|mesh-ancestor
64334032|NCT02290717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64334033|NCT02225795|Cyclophosphamide|cyclophosphamide|mesh-list
64583466|NCT04085419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971266|NCT00224809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64971267|NCT00224809|Analgesics|analgesics|mesh-ancestor
64971268|NCT00224809|Sensory System Agents|sensory system agents|mesh-ancestor
64971269|NCT00224809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64971270|NCT00224809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971271|NCT00224809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64971272|NCT00224809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64971273|NCT00224809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64971274|NCT00224809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64971313|NCT00413023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64971314|NCT00413023|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64971315|NCT00413023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64971316|NCT00413023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971317|NCT00095277|Darbepoetin alfa|darbepoetin alfa|mesh-list
64971318|NCT00095277|Hematinics|hematinics|mesh-ancestor
64971319|NCT00413101|Epoetin Alfa|epoetin alfa|mesh-list
64971320|NCT00413101|Hematinics|hematinics|mesh-ancestor
64971321|NCT00413179|Metformin|metformin|mesh-list
64971322|NCT00413179|Clomiphene|clomiphene|mesh-list
64971323|NCT00413179|Enclomiphene|enclomiphene|mesh-list
64971324|NCT00413179|Zuclomiphene|zuclomiphene|mesh-list
64971325|NCT00413179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64971326|NCT00413179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510054|NCT01453881|Hormones|hormones|mesh-ancestor
64971327|NCT00413179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64971328|NCT00413179|Hormone Antagonists|hormone antagonists|mesh-ancestor
64971329|NCT00413179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64971371|NCT00095355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971372|NCT00095355|Antimanic Agents|antimanic agents|mesh-ancestor
64971373|NCT00095355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64971374|NCT00095355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64971375|NCT00095355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971376|NCT00095355|Anticonvulsants|anticonvulsants|mesh-ancestor
64971379|NCT00225160|Acetylcarnitine|acetylcarnitine|mesh-list
64971380|NCT00225160|Vitamin B Complex|vitamin b complex|mesh-ancestor
64971381|NCT00225160|Vitamins|vitamins|mesh-ancestor
64971382|NCT00225160|Micronutrients|micronutrients|mesh-ancestor
64971383|NCT00225160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971384|NCT00225160|Nootropic Agents|nootropic agents|mesh-ancestor
64971385|NCT00225238|Esomeprazole|esomeprazole|mesh-list
64971386|NCT00225238|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64971387|NCT00225238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64971388|NCT00225238|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64971389|NCT00225238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971390|NCT00225238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971391|NCT00062426|Leucovorin|leucovorin|mesh-list
64971392|NCT00062426|Bevacizumab|bevacizumab|mesh-list
64971393|NCT00062426|Fluorouracil|fluorouracil|mesh-list
64971394|NCT00062426|Capecitabine|capecitabine|mesh-list
64971395|NCT00062426|Oxaliplatin|oxaliplatin|mesh-list
64971425|NCT00225355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971426|NCT00225433|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64971427|NCT00225433|Ganirelix|ganirelix|mesh-list
64971428|NCT00225433|Hormones|hormones|mesh-ancestor
64971429|NCT00225433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64971430|NCT00225433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971431|NCT00225433|Hormone Antagonists|hormone antagonists|mesh-ancestor
64971432|NCT00095472|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
64971433|NCT00095472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971434|NCT00095472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971435|NCT02962258|Amlodipine|amlodipine|mesh-list
64971436|NCT02962258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64971437|NCT02962258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64971438|NCT02962258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64971439|NCT02962258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64971440|NCT02962258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971441|NCT02962258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64971442|NCT02962258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971443|NCT02962258|Vasodilator Agents|vasodilator agents|mesh-ancestor
64971444|NCT02962258|Diuretics|diuretics|mesh-ancestor
64971445|NCT02962258|Natriuretic Agents|natriuretic agents|mesh-ancestor
64971446|NCT02962258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64971447|NCT00225511|Milnacipran|milnacipran|mesh-list
64971448|NCT00225511|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64971472|NCT00095511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64971473|NCT00095511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971474|NCT00095511|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64971475|NCT00095511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64510203|NCT02933697|Apixaban|apixaban|mesh-list
64971476|NCT00095511|Serotonin Agents|serotonin agents|mesh-ancestor
64971477|NCT00095511|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64971478|NCT00095511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64971479|NCT00095511|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64971480|NCT00095511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64971481|NCT00225589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64971483|NCT00225589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64971484|NCT00225589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971485|NCT00225589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64971486|NCT00225589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64971528|NCT00225862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971529|NCT00225862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971531|NCT00095706|Trastuzumab|trastuzumab|mesh-list
64583527|NCT00287287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583528|NCT04871061|Fentanyl|fentanyl|mesh-list
64583529|NCT04871061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64583530|NCT04871061|Narcotics|narcotics|mesh-ancestor
64583531|NCT04871061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64583532|NCT04871061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583533|NCT04871061|Analgesics|analgesics|mesh-ancestor
64583534|NCT04871061|Sensory System Agents|sensory system agents|mesh-ancestor
64583535|NCT04871061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583536|NCT04871061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64583537|NCT04871061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64971532|NCT00095706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64971533|NCT00095706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971534|NCT00095706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64971535|NCT00095706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64971536|NCT00095706|Growth Substances|growth substances|mesh-ancestor
64971537|NCT00095706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971538|NCT00095706|Growth Inhibitors|growth inhibitors|mesh-ancestor
64971539|NCT00225901|Mitogens|mitogens|mesh-list
64971540|NCT00225901|Mitosis Modulators|mitosis modulators|mesh-ancestor
64971541|NCT00225901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971542|NCT00225979|Octreotide|octreotide|mesh-list
64971543|NCT00225979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64971585|NCT00226096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971586|NCT00226096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64971587|NCT00226096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64971588|NCT00226096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64971589|NCT00226096|Adrenergic Agents|adrenergic agents|mesh-ancestor
64971590|NCT00226096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64971591|NCT00226096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971592|NCT00226096|Analgesics|analgesics|mesh-ancestor
64971593|NCT00226096|Sensory System Agents|sensory system agents|mesh-ancestor
64971594|NCT00226096|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64971595|NCT00226096|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64971596|NCT00226096|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64971597|NCT00226096|Vasodilator Agents|vasodilator agents|mesh-ancestor
64971598|NCT00226096|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64971599|NCT00226096|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64971600|NCT00226096|Protective Agents|protective agents|mesh-ancestor
64971630|NCT00400374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64971631|NCT00400374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64971632|NCT00400374|Analgesics|analgesics|mesh-ancestor
64971633|NCT00400374|Sensory System Agents|sensory system agents|mesh-ancestor
64971634|NCT00400374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64971635|NCT00400374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971636|NCT00400374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64971637|NCT00400374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64971638|NCT00400374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64971639|NCT00400374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64971640|NCT00226330|Pioglitazone|pioglitazone|mesh-list
64971641|NCT00226330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64971642|NCT00226330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971643|NCT00075426|Arsenic Trioxide|arsenic trioxide|mesh-list
64971644|NCT00075426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971645|NCT00226408|Interferons|interferons|mesh-list
64971646|NCT00226408|Interferon-alpha|interferon-alpha|mesh-list
64971647|NCT00226408|Interferon alpha-2|interferon alpha-2|mesh-list
64971648|NCT00226408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971649|NCT00226408|Antiviral Agents|antiviral agents|mesh-ancestor
64971687|NCT00095823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64971688|NCT00095823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64971689|NCT00095823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64971690|NCT00095823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971691|NCT00095823|Dopamine Agonists|dopamine agonists|mesh-ancestor
64971692|NCT00095823|Dopamine Agents|dopamine agents|mesh-ancestor
64971693|NCT00095823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64971694|NCT00095823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971695|NCT00095823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64510409|NCT05827081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971696|NCT00095823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64971697|NCT00095823|Serotonin Agents|serotonin agents|mesh-ancestor
64971705|NCT00226564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64971706|NCT00226564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971735|NCT00399243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971737|NCT00226837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64971738|NCT00226837|Anesthetics, General|anesthetics, general|mesh-ancestor
64971739|NCT00226837|Anesthetics|anesthetics|mesh-ancestor
64971740|NCT00226837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64971741|NCT00226837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971742|NCT00226837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64971743|NCT00226837|Analgesics|analgesics|mesh-ancestor
64971744|NCT00226837|Sensory System Agents|sensory system agents|mesh-ancestor
64971745|NCT00226837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64971746|NCT00226915|Paclitaxel|paclitaxel|mesh-list
64971747|NCT00226915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64971748|NCT00226915|Carboplatin|carboplatin|mesh-list
64971749|NCT00226915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64971750|NCT00226915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971751|NCT00226915|Tubulin Modulators|tubulin modulators|mesh-ancestor
64971752|NCT00226915|Antimitotic Agents|antimitotic agents|mesh-ancestor
64971753|NCT00226915|Mitosis Modulators|mitosis modulators|mesh-ancestor
64971755|NCT00095862|Interferons|interferons|mesh-list
64971790|NCT00096057|Antibodies|antibodies|mesh-list
64971791|NCT00096057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64971792|NCT00096057|Immunologic Factors|immunologic factors|mesh-ancestor
64971793|NCT00096057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971794|NCT00227461|Levetiracetam|levetiracetam|mesh-list
64971795|NCT00227461|Anticonvulsants|anticonvulsants|mesh-ancestor
64971796|NCT00227461|Nootropic Agents|nootropic agents|mesh-ancestor
64971797|NCT00227500|Pravastatin|pravastatin|mesh-list
64971798|NCT00227500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64971799|NCT00227500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64971800|NCT00227500|Antimetabolites|antimetabolites|mesh-ancestor
64971801|NCT00227500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971802|NCT00227500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64971803|NCT00227500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64971804|NCT00227500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583538|NCT04871061|Anesthetics, General|anesthetics, general|mesh-ancestor
64583539|NCT04871061|Anesthetics|anesthetics|mesh-ancestor
64971805|NCT00096096|Mycophenolic Acid|mycophenolic acid|mesh-list
64971806|NCT00096096|Tacrolimus|tacrolimus|mesh-list
64971807|NCT00096096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64971808|NCT00096096|Immunologic Factors|immunologic factors|mesh-ancestor
64971809|NCT00096096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971810|NCT00096096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64971811|NCT00096096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971812|NCT00096096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971813|NCT00096096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64971814|NCT00096096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971815|NCT00096096|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64510565|NCT05826327|Anesthetics, General|anesthetics, general|mesh-ancestor
64510566|NCT05826327|Anesthetics|anesthetics|mesh-ancestor
64510567|NCT05826327|Antidepressive Agents|antidepressive agents|mesh-ancestor
64510568|NCT05826327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64510572|NCT05826249|Ritonavir|ritonavir|mesh-list
64510573|NCT05826249|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64971831|NCT00062972|Nootropic Agents|nootropic agents|mesh-ancestor
64971832|NCT00227656|Interferons|interferons|mesh-list
64971833|NCT00227656|Interferon-alpha|interferon-alpha|mesh-list
64971834|NCT00227656|Interferon alpha-2|interferon alpha-2|mesh-list
64971835|NCT00227656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64971836|NCT00227656|Capecitabine|capecitabine|mesh-list
64971837|NCT00227656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64971846|NCT00227695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64971847|NCT00227695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971848|NCT00227695|Immunologic Factors|immunologic factors|mesh-ancestor
64971849|NCT00227695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971874|NCT00227773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971875|NCT00227773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64971876|NCT00227812|Bupropion|bupropion|mesh-list
64971877|NCT00227812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64971878|NCT00227812|Antidepressive Agents|antidepressive agents|mesh-ancestor
64971879|NCT00227812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64971880|NCT00227812|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64971881|NCT00227812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64971882|NCT00227812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64971883|NCT00227812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971884|NCT00227812|Dopamine Agents|dopamine agents|mesh-ancestor
64971885|NCT00227812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64971886|NCT00227812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971889|NCT00227812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64971920|NCT00096330|Vitamins|vitamins|mesh-ancestor
64971921|NCT00096330|Micronutrients|micronutrients|mesh-ancestor
64971922|NCT00096330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971923|NCT02962492|Dapagliflozin|dapagliflozin|mesh-list
64971924|NCT02962492|Exenatide|exenatide|mesh-list
64971925|NCT02962492|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64971926|NCT02962492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64971927|NCT02962492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64971928|NCT02962492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971929|NCT02962492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64971930|NCT02962492|Incretins|incretins|mesh-ancestor
64971931|NCT02962492|Hormones|hormones|mesh-ancestor
64971932|NCT02962492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64971933|NCT00096369|Tamoxifen|tamoxifen|mesh-list
64971934|NCT00096369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64971935|NCT00096369|Hormone Antagonists|hormone antagonists|mesh-ancestor
64971936|NCT00096369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64971937|NCT00096369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971938|NCT00096369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64971939|NCT00096369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64971940|NCT00096369|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64971972|NCT00063089|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64971973|NCT00063089|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64971974|NCT00063089|Immunologic Factors|immunologic factors|mesh-ancestor
64971975|NCT00063089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971976|NCT00228163|Teriflunomide|teriflunomide|mesh-list
64971977|NCT00228163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64971978|NCT00228163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64971979|NCT00228163|Analgesics|analgesics|mesh-ancestor
64971980|NCT00228163|Sensory System Agents|sensory system agents|mesh-ancestor
64971981|NCT00228163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64971982|NCT00228163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64971983|NCT00228163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64971984|NCT00228163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64971985|NCT00228163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64972035|NCT00228358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64972036|NCT00228358|Analgesics|analgesics|mesh-ancestor
64972037|NCT00228358|Sensory System Agents|sensory system agents|mesh-ancestor
64972038|NCT00228358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64972039|NCT00228397|Sirolimus|sirolimus|mesh-list
64972051|NCT00075543|Tubulin Modulators|tubulin modulators|mesh-ancestor
64972052|NCT00075543|Antimitotic Agents|antimitotic agents|mesh-ancestor
64972053|NCT00075543|Mitosis Modulators|mitosis modulators|mesh-ancestor
64972054|NCT00075543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972055|NCT00228475|Budesonide|budesonide|mesh-list
64972056|NCT00228475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64972057|NCT00228475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64972058|NCT00228475|Autonomic Agents|autonomic agents|mesh-ancestor
64972059|NCT00228475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64972084|NCT00075621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64972085|NCT00075621|Alkylating Agents|alkylating agents|mesh-ancestor
64972086|NCT00075621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972087|NCT00075621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583748|NCT01804101|Antimetabolites|antimetabolites|mesh-ancestor
64583749|NCT01804101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583750|NCT01804101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583751|NCT01804101|Antiviral Agents|antiviral agents|mesh-ancestor
64583752|NCT01804101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64583753|NCT01804101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64583754|NCT01804101|Immunologic Factors|immunologic factors|mesh-ancestor
64583755|NCT01804101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972088|NCT00075621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64972089|NCT00075621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64972090|NCT00228865|Insulin|insulin|mesh-list
64972091|NCT00228865|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64972092|NCT00228865|Insulin, Isophane|insulin, isophane|mesh-list
64972093|NCT00228865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64972094|NCT00228865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972095|NCT00228904|Insulin|insulin|mesh-list
64972096|NCT00228904|Insulin Lispro|insulin lispro|mesh-list
64972097|NCT00228904|Insulin Aspart|insulin aspart|mesh-list
64972098|NCT00228904|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64972099|NCT00228904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64972100|NCT00228904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972101|NCT00228982|Vancomycin|vancomycin|mesh-list
64972102|NCT00228982|Ceftobiprole|ceftobiprole|mesh-list
64972103|NCT00228982|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
64972104|NCT00228982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64972105|NCT00228982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64972106|NCT00229060|Doripenem|doripenem|mesh-list
64972107|NCT00229060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64972108|NCT00229060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64972109|NCT00229138|Tacrolimus|tacrolimus|mesh-list
64972110|NCT00229138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64583811|NCT05098067|Ondansetron|ondansetron|mesh-list
64972111|NCT00229138|Immunologic Factors|immunologic factors|mesh-ancestor
64972112|NCT00229138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510861|NCT05810233|Micronutrients|micronutrients|mesh-ancestor
64972131|NCT00229216|Alkylating Agents|alkylating agents|mesh-ancestor
64972132|NCT00229216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972133|NCT00229216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64972134|NCT00229216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64972135|NCT00229216|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64972136|NCT00229216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64972137|NCT00229216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64972138|NCT02967653|Atorvastatin|atorvastatin|mesh-list
64972139|NCT02967653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64972140|NCT02967653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64972141|NCT02967653|Antimetabolites|antimetabolites|mesh-ancestor
64972142|NCT02967653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972143|NCT02967653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64972144|NCT02967653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64972147|NCT00229333|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64972148|NCT00229333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64972149|NCT00229333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64972150|NCT00229333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972151|NCT00229333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64972152|NCT00229333|Serotonin Agents|serotonin agents|mesh-ancestor
64972153|NCT00229333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583882|NCT05748561|Epoetin Alfa|epoetin alfa|mesh-list
64583883|NCT05748561|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64583884|NCT05748561|Prednisolone phosphate|prednisolone phosphate|mesh-list
64583885|NCT05748561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64583886|NCT05748561|Antiemetics|antiemetics|mesh-ancestor
64583887|NCT05748561|Autonomic Agents|autonomic agents|mesh-ancestor
64583888|NCT05748561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583889|NCT05748561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583890|NCT05748561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64583891|NCT05748561|Glucocorticoids|glucocorticoids|mesh-ancestor
64583892|NCT05748561|Hormones|hormones|mesh-ancestor
64334034|NCT02225795|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64334035|NCT02225795|Thymoglobulin|thymoglobulin|mesh-list
64583893|NCT05748561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64583894|NCT05748561|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64583895|NCT05748561|Protective Agents|protective agents|mesh-ancestor
64583896|NCT05748561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64583897|NCT05748561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583899|NCT00290537|Paclitaxel|paclitaxel|mesh-list
64583900|NCT00290537|Carboplatin|carboplatin|mesh-list
64583901|NCT00290537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64583902|NCT00290537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583903|NCT00290537|Tubulin Modulators|tubulin modulators|mesh-ancestor
64364103|NCT04489849|Apixaban|apixaban|mesh-list
64972154|NCT00229333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64972155|NCT00229333|Antidepressive Agents|antidepressive agents|mesh-ancestor
64972156|NCT00229333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64972157|NCT00229450|Estrogens|estrogens|mesh-list
64972168|NCT00229528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972169|NCT00229528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64972170|NCT00229528|Antidepressive Agents|antidepressive agents|mesh-ancestor
64972171|NCT00229528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64972172|NCT00229528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64972173|NCT00229528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64972174|NCT00229528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972175|NCT00075699|Vincristine|vincristine|mesh-list
64972176|NCT00075699|Vinorelbine|vinorelbine|mesh-list
64972177|NCT00075699|Mitomycins|mitomycins|mesh-list
64972178|NCT00075699|Mitomycin|mitomycin|mesh-list
64972179|NCT00075699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972180|NCT00075699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64972181|NCT00075699|Tubulin Modulators|tubulin modulators|mesh-ancestor
64972182|NCT00075699|Antimitotic Agents|antimitotic agents|mesh-ancestor
64583904|NCT00290537|Antimitotic Agents|antimitotic agents|mesh-ancestor
64972183|NCT00075699|Mitosis Modulators|mitosis modulators|mesh-ancestor
64972184|NCT00075699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972185|NCT00075699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64972186|NCT00075699|Alkylating Agents|alkylating agents|mesh-ancestor
64972187|NCT00075699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64972222|NCT02967341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972223|NCT02967341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972224|NCT02967341|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64972225|NCT02967341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64972226|NCT00229684|Pioglitazone|pioglitazone|mesh-list
64972227|NCT00229684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64972228|NCT00229684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972229|NCT00096720|Levodopa|levodopa|mesh-list
64972230|NCT00096720|Pramipexole|pramipexole|mesh-list
64972231|NCT00096720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64972232|NCT00096720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64972233|NCT00096720|Dopamine Agents|dopamine agents|mesh-ancestor
64972234|NCT00096720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64972235|NCT00096720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972236|NCT00096720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972237|NCT00096720|Antioxidants|antioxidants|mesh-ancestor
64972238|NCT00096720|Protective Agents|protective agents|mesh-ancestor
64511013|NCT05711940|Psilocybin|psilocybin|mesh-list
64972239|NCT00096720|Dopamine Agonists|dopamine agonists|mesh-ancestor
64511014|NCT05711940|Hallucinogens|hallucinogens|mesh-ancestor
64972240|NCT00413608|Clopidogrel|clopidogrel|mesh-list
64972241|NCT00413608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64972242|NCT00413608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64583998|NCT01857297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583999|NCT00300391|Haloperidol|haloperidol|mesh-list
64584000|NCT00300391|Haloperidol decanoate|haloperidol decanoate|mesh-list
64584001|NCT00300391|Antiemetics|antiemetics|mesh-ancestor
64584002|NCT00300391|Autonomic Agents|autonomic agents|mesh-ancestor
64584003|NCT00300391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64584004|NCT00300391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584005|NCT00300391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64584006|NCT00300391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64584007|NCT00300391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64584008|NCT00300391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64584009|NCT00300391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64584010|NCT00300391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64972243|NCT00413608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64972244|NCT00413608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64972245|NCT00413608|Purinergic Agents|purinergic agents|mesh-ancestor
64972246|NCT00413608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64972264|NCT00096798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64972265|NCT00229996|Leuprolide|leuprolide|mesh-list
64972266|NCT00229996|Norethindrone|norethindrone|mesh-list
64972267|NCT00229996|Norethindrone Acetate|norethindrone acetate|mesh-list
64972268|NCT00229996|Contraceptive Agents|contraceptive agents|mesh-list
64972269|NCT00229996|Contraceptives, Oral|contraceptives, oral|mesh-list
64972270|NCT00229996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64972271|NCT00229996|Fertility Agents|fertility agents|mesh-ancestor
64972272|NCT00229996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64972273|NCT00229996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972274|NCT00229996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64972275|NCT00229996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972276|NCT00229996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64972280|NCT00230035|Mycophenolic Acid|mycophenolic acid|mesh-list
64972281|NCT00230035|Methylprednisolone|methylprednisolone|mesh-list
64972282|NCT00230035|Rituximab|rituximab|mesh-list
64972283|NCT00230035|Methotrexate|methotrexate|mesh-list
64972284|NCT00230035|Azathioprine|azathioprine|mesh-list
64972285|NCT00230035|Immunoglobulins|immunoglobulins|mesh-list
64972286|NCT00230035|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64972287|NCT00230035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64972288|NCT00230035|gamma-Globulins|gamma-globulins|mesh-list
64972289|NCT00230035|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64972290|NCT00230035|Leflunomide|leflunomide|mesh-list
64584035|NCT00300469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972291|NCT00230035|Thymoglobulin|thymoglobulin|mesh-list
64972292|NCT00230035|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64584036|NCT00300469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64584037|NCT00300469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64584038|NCT00300469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584039|NCT01543763|Abexinostat|abexinostat|mesh-list
64584040|NCT01543763|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64584041|NCT01543763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584042|NCT01543763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584043|NCT01859637|Lenograstim|lenograstim|mesh-list
64584044|NCT01859637|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64584045|NCT01859637|Immunologic Factors|immunologic factors|mesh-ancestor
64584046|NCT01859637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584047|NCT00295061|Protease Inhibitors|protease inhibitors|mesh-list
64584048|NCT00295061|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64584049|NCT00295061|Protein C Inhibitor|protein c inhibitor|mesh-list
64584050|NCT00295061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584051|NCT00295061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584052|NCT00295061|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64584053|NCT00295061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64584054|NCT02117141|Hydrocodone|hydrocodone|mesh-list
64584055|NCT02117141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64584056|NCT02117141|Narcotics|narcotics|mesh-ancestor
64972293|NCT00230035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64972294|NCT00230035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972295|NCT00230035|Immunologic Factors|immunologic factors|mesh-ancestor
64972296|NCT00230035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972297|NCT00230035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64972298|NCT00230035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64972299|NCT00230035|Abortifacient Agents|abortifacient agents|mesh-ancestor
64336784|NCT02313337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64972324|NCT00063401|Carboplatin|carboplatin|mesh-list
64972325|NCT00063401|Cetuximab|cetuximab|mesh-list
64972327|NCT00063401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511173|NCT05586802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64511174|NCT05586802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511175|NCT05586802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64511176|NCT05586802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511177|NCT05586802|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64511178|NCT05586802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64511179|NCT05586802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64511180|NCT05586802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511181|NCT05586802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64511182|NCT05586802|Hormone Antagonists|hormone antagonists|mesh-ancestor
64511183|NCT05586802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64972347|NCT00230503|Pradefovir|pradefovir|mesh-list
64972348|NCT00230503|Antiviral Agents|antiviral agents|mesh-ancestor
64972349|NCT00230503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64972350|NCT00230503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64972351|NCT00230503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64972352|NCT00230503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972353|NCT00230503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972354|NCT00230503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64972355|NCT00424723|Pemetrexed|pemetrexed|mesh-list
64972356|NCT00424723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972385|NCT02962336|Amlodipine|amlodipine|mesh-list
64972386|NCT02962336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64972387|NCT02962336|Olmesartan|olmesartan|mesh-list
64972388|NCT02962336|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64972389|NCT02962336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64972390|NCT02962336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64972391|NCT02962336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64972392|NCT02962336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972393|NCT02962336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64972394|NCT02962336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972395|NCT02962336|Vasodilator Agents|vasodilator agents|mesh-ancestor
64972396|NCT02962336|Diuretics|diuretics|mesh-ancestor
64972397|NCT02962336|Natriuretic Agents|natriuretic agents|mesh-ancestor
64972398|NCT02962336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64972399|NCT02962336|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64972400|NCT02962336|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64972401|NCT00075738|Leucovorin|leucovorin|mesh-list
64972402|NCT00075738|Fluorouracil|fluorouracil|mesh-list
64972403|NCT00075738|Irinotecan|irinotecan|mesh-list
64972404|NCT00075738|Calcium|calcium|mesh-list
64972405|NCT00075738|Levoleucovorin|levoleucovorin|mesh-list
64972406|NCT00075738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972407|NCT00075738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64972408|NCT00075738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972409|NCT00075738|Antimetabolites|antimetabolites|mesh-ancestor
64972434|NCT00230776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972435|NCT00230776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64972436|NCT00230776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64972437|NCT00230776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64972438|NCT00230776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64972439|NCT00230776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64972440|NCT00075777|Valproic Acid|valproic acid|mesh-list
64972441|NCT00075777|Anticonvulsants|anticonvulsants|mesh-ancestor
64584137|NCT05192369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64584138|NCT05192369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64584139|NCT05192369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64584140|NCT05192369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64584144|NCT05185973|Micronutrients|micronutrients|mesh-list
64972442|NCT00075777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972443|NCT00075777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972444|NCT00075777|GABA Agents|gaba agents|mesh-ancestor
64972445|NCT00075777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64972446|NCT00075777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972447|NCT00075777|Antimanic Agents|antimanic agents|mesh-ancestor
64972448|NCT00075777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64972449|NCT00075777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64972450|NCT00075777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64972451|NCT02967614|Timolol|timolol|mesh-list
64972452|NCT02967614|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64972453|NCT02967614|Dorzolamide|dorzolamide|mesh-list
64972454|NCT02967614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64972455|NCT02967614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64972456|NCT02967614|Adrenergic Agents|adrenergic agents|mesh-ancestor
64972485|NCT02967380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972486|NCT02967380|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64972487|NCT00075855|Testosterone|testosterone|mesh-list
64972488|NCT00075855|Androgens|androgens|mesh-ancestor
64584200|NCT00559845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584201|NCT00559845|Tubulin Modulators|tubulin modulators|mesh-ancestor
64584202|NCT00559845|Antimitotic Agents|antimitotic agents|mesh-ancestor
64584203|NCT00559845|Mitosis Modulators|mitosis modulators|mesh-ancestor
64584204|NCT00559845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584205|NCT00559845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64584206|NCT00559845|Immunologic Factors|immunologic factors|mesh-ancestor
64584207|NCT00559845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584208|NCT00559845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64972489|NCT00075855|Hormones|hormones|mesh-ancestor
64972490|NCT00075855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64511312|NCT05496036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511313|NCT05487859|Acarbose|acarbose|mesh-list
64511314|NCT05487859|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64511315|NCT05487859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972491|NCT00075855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972492|NCT00063596|Vitamin A|vitamin a|mesh-list
64972493|NCT00063596|Vitamins|vitamins|mesh-ancestor
64972494|NCT00063596|Micronutrients|micronutrients|mesh-ancestor
64972495|NCT00063596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972496|NCT00231244|Sirolimus|sirolimus|mesh-list
64972497|NCT00231244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64972498|NCT00231244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64972499|NCT00231244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64972500|NCT00231244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972501|NCT00231244|Antifungal Agents|antifungal agents|mesh-ancestor
64972502|NCT00231244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64972503|NCT00231244|Immunologic Factors|immunologic factors|mesh-ancestor
64972504|NCT00231244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972505|NCT00231322|Praziquantel|praziquantel|mesh-list
64972506|NCT00231322|Anthelmintics|anthelmintics|mesh-ancestor
64972507|NCT00231322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64972508|NCT00231322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64972509|NCT00231517|Morphine|morphine|mesh-list
64972510|NCT00231517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64972511|NCT00231517|Narcotics|narcotics|mesh-ancestor
64972512|NCT00231517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64972513|NCT00231517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972525|NCT00231556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64972526|NCT00231556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972527|NCT00231595|Topiramate|topiramate|mesh-list
64972528|NCT00231595|Anticonvulsants|anticonvulsants|mesh-ancestor
64972529|NCT00231595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64972530|NCT00231595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972531|NCT00231634|Topiramate|topiramate|mesh-list
64972532|NCT00231634|Anticonvulsants|anticonvulsants|mesh-ancestor
64972533|NCT00231634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64972534|NCT00231634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511418|NCT05382338|Sodium thiosulfate|sodium thiosulfate|mesh-list
64511419|NCT05382338|Cyclophosphamide|cyclophosphamide|mesh-list
64511420|NCT05382338|Lomustine|lomustine|mesh-list
64511421|NCT05382338|Cisplatin|cisplatin|mesh-list
64511422|NCT05382338|Vincristine|vincristine|mesh-list
64511423|NCT05382338|Mesna|mesna|mesh-list
64511424|NCT05382338|Antidotes|antidotes|mesh-list
64511425|NCT05382338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64511426|NCT05382338|Immunologic Factors|immunologic factors|mesh-ancestor
64380699|NCT02600897|Growth Substances|growth substances|mesh-ancestor
64972553|NCT00231829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64972554|NCT00231829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64972555|NCT00231829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64972556|NCT00231829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972557|NCT00231829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972559|NCT00075933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64972560|NCT00075933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64972562|NCT00075933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972607|NCT00232336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972608|NCT00232375|Insulin|insulin|mesh-list
64972609|NCT00232375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64972610|NCT00232375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972611|NCT00063791|Bortezomib|bortezomib|mesh-list
64972612|NCT00063791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972613|NCT00232414|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64972614|NCT00232414|Antidepressive Agents|antidepressive agents|mesh-ancestor
64972615|NCT00232414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64972616|NCT00232414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64972617|NCT00232414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64972618|NCT00232414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64972619|NCT00232414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972620|NCT00232492|Ketamine|ketamine|mesh-list
64972621|NCT00232492|Analgesics|analgesics|mesh-ancestor
64972622|NCT00232492|Sensory System Agents|sensory system agents|mesh-ancestor
64972623|NCT00232492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64972624|NCT00232492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972625|NCT00232492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64972626|NCT00232492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64972627|NCT00232492|Anesthetics, General|anesthetics, general|mesh-ancestor
64972628|NCT00232492|Anesthetics|anesthetics|mesh-ancestor
64972629|NCT00232492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64972630|NCT00232492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64972631|NCT00232492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64972632|NCT00232492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64972633|NCT00232492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972634|NCT00075972|Nicotine|nicotine|mesh-list
64972635|NCT00075972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64972652|NCT00063869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64972653|NCT00063869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64972654|NCT00063869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64972655|NCT00063869|Immunologic Factors|immunologic factors|mesh-ancestor
64972656|NCT00232531|Niacin|niacin|mesh-list
64972657|NCT00232531|Nicotinic Acids|nicotinic acids|mesh-list
64972658|NCT00232531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64972659|NCT00232531|Antimetabolites|antimetabolites|mesh-ancestor
64584340|NCT00337987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584341|NCT00337987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584342|NCT00337987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64584343|NCT00337987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64584344|NCT00337987|Glucocorticoids|glucocorticoids|mesh-ancestor
64584345|NCT00337987|Hormones|hormones|mesh-ancestor
64584346|NCT00337987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64584347|NCT00337987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64334061|NCT02294305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64334062|NCT02294305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64334063|NCT02294305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64334064|NCT02294305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334065|NCT02294305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64334066|NCT02294305|Serotonin Agents|serotonin agents|mesh-ancestor
64972660|NCT00232531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972661|NCT00232531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64972662|NCT00232531|Vasodilator Agents|vasodilator agents|mesh-ancestor
64972663|NCT00232531|Vitamin B Complex|vitamin b complex|mesh-ancestor
64972664|NCT00232531|Vitamins|vitamins|mesh-ancestor
64972665|NCT00232531|Micronutrients|micronutrients|mesh-ancestor
64972666|NCT00232531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972711|NCT00063947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64972712|NCT00232648|Budesonide|budesonide|mesh-list
64972713|NCT00232648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64972714|NCT00232648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64972715|NCT00232648|Autonomic Agents|autonomic agents|mesh-ancestor
64972716|NCT00232648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64972717|NCT00232648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972718|NCT00232648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64972719|NCT00232648|Respiratory System Agents|respiratory system agents|mesh-ancestor
64972720|NCT00232648|Glucocorticoids|glucocorticoids|mesh-ancestor
64972721|NCT00232648|Hormones|hormones|mesh-ancestor
64972722|NCT00232648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64972723|NCT00232687|Aripiprazole|aripiprazole|mesh-list
64972724|NCT00232687|Antidepressive Agents|antidepressive agents|mesh-ancestor
64972765|NCT02958566|Anesthetics|anesthetics|mesh-ancestor
64972766|NCT02958566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64972767|NCT02958566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972768|NCT02958566|Sensory System Agents|sensory system agents|mesh-ancestor
64972769|NCT02958566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64972770|NCT02958566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64972771|NCT02958566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64972772|NCT02958566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64972773|NCT02958566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64972774|NCT02958566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584348|NCT00337987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64584350|NCT00337987|Antimitotic Agents|antimitotic agents|mesh-ancestor
64584351|NCT00337987|Mitosis Modulators|mitosis modulators|mesh-ancestor
64584352|NCT00337987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64584353|NCT00337987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64584354|NCT00337987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64584355|NCT00337987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584356|NCT01393106|Idelalisib|idelalisib|mesh-list
64584357|NCT01393106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584358|NCT01393106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972775|NCT02958566|Analgesics|analgesics|mesh-ancestor
64972776|NCT02958566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64972798|NCT02958566|Respiratory System Agents|respiratory system agents|mesh-ancestor
64972799|NCT02958566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64972800|NCT02958566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64972801|NCT02958566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64972802|NCT02958566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64972803|NCT02958566|Parasympatholytics|parasympatholytics|mesh-ancestor
64511690|NCT05161637|Ropivacaine|ropivacaine|mesh-list
64972804|NCT02958566|Autonomic Agents|autonomic agents|mesh-ancestor
64972805|NCT02958566|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64972806|NCT02958566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64511691|NCT05161637|Anesthetics, Local|anesthetics, local|mesh-ancestor
64511692|NCT05161637|Anesthetics|anesthetics|mesh-ancestor
64511693|NCT05161637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64511694|NCT05161637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511695|NCT05161637|Sensory System Agents|sensory system agents|mesh-ancestor
64972807|NCT02958566|Cholinergic Agents|cholinergic agents|mesh-ancestor
64972850|NCT00064064|Gemcitabine|gemcitabine|mesh-list
64972851|NCT00064064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64972852|NCT00064064|Antimetabolites|antimetabolites|mesh-ancestor
64972853|NCT00064064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972854|NCT00064064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972855|NCT00064064|Antiviral Agents|antiviral agents|mesh-ancestor
64972856|NCT00064064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64972857|NCT00064064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972858|NCT00064064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64972859|NCT00064064|Immunologic Factors|immunologic factors|mesh-ancestor
64972860|NCT00064064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972862|NCT00413686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64972863|NCT00413686|Antimetabolites|antimetabolites|mesh-ancestor
64972864|NCT00413686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972865|NCT00413686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972866|NCT00413686|Antiviral Agents|antiviral agents|mesh-ancestor
64972867|NCT00413686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64972868|NCT00413686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972869|NCT00413686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64972870|NCT00413686|Immunologic Factors|immunologic factors|mesh-ancestor
64972871|NCT00413686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584384|NCT00553059|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64584385|NCT00553059|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64584386|NCT04047836|Nicotine|nicotine|mesh-list
64584387|NCT04047836|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64584388|NCT04047836|Autonomic Agents|autonomic agents|mesh-ancestor
64584389|NCT04047836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64584390|NCT04047836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584391|NCT04047836|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64584392|NCT04047836|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64584393|NCT04047836|Cholinergic Agents|cholinergic agents|mesh-ancestor
64584394|NCT04047836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64584395|NCT04047836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584396|NCT02989311|Iron|iron|mesh-list
64584397|NCT02989311|Trace Elements|trace elements|mesh-ancestor
64584398|NCT02989311|Micronutrients|micronutrients|mesh-ancestor
64584399|NCT02989311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972872|NCT00233038|Ethanol|ethanol|mesh-list
64972873|NCT00233038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64972874|NCT00233038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64972875|NCT00233038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64972897|NCT00064142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972898|NCT00064142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972899|NCT00064142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64972900|NCT00064142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64972901|NCT00064142|Growth Substances|growth substances|mesh-ancestor
64972902|NCT00064142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972903|NCT00064142|Growth Inhibitors|growth inhibitors|mesh-ancestor
64972904|NCT00064181|Leucovorin|leucovorin|mesh-list
64972905|NCT00064181|Celecoxib|celecoxib|mesh-list
64972906|NCT00064181|Fluorouracil|fluorouracil|mesh-list
64972907|NCT00064181|Capecitabine|capecitabine|mesh-list
64972908|NCT00064181|Irinotecan|irinotecan|mesh-list
64972909|NCT00064181|Calcium|calcium|mesh-list
64972910|NCT00064181|Levoleucovorin|levoleucovorin|mesh-list
64972911|NCT00064181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64972912|NCT00064181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972913|NCT00064181|Antimetabolites|antimetabolites|mesh-ancestor
64972914|NCT00064181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972915|NCT00064181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64972916|NCT00064181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972917|NCT00064181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64972918|NCT00064181|Immunologic Factors|immunologic factors|mesh-ancestor
64972919|NCT00064181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64972920|NCT00064181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64972921|NCT00064181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972922|NCT00064181|Antidotes|antidotes|mesh-ancestor
64972923|NCT00064181|Protective Agents|protective agents|mesh-ancestor
64972924|NCT00064181|Vitamin B Complex|vitamin b complex|mesh-ancestor
64972946|NCT00233584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64584404|NCT02015611|Micronutrients|micronutrients|mesh-ancestor
64584405|NCT02015611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584406|NCT02015611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64584407|NCT01872819|Antineoplastic Agents|antineoplastic agents|mesh-list
64584408|NCT01413542|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64584409|NCT01413542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64584410|NCT01413542|Enalaprilat|enalaprilat|mesh-list
64584411|NCT01413542|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64584412|NCT01413542|Bradykinin|bradykinin|mesh-list
64584413|NCT01413542|Glucagon|glucagon|mesh-list
64584414|NCT01413542|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64364517|NCT03293641|Dermatologic Agents|dermatologic agents|mesh-ancestor
64364518|NCT03293641|Antimalarials|antimalarials|mesh-ancestor
64364519|NCT03293641|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64972947|NCT00233584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972948|NCT00233584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64972949|NCT00233584|Respiratory System Agents|respiratory system agents|mesh-ancestor
64972950|NCT00233584|Glucocorticoids|glucocorticoids|mesh-ancestor
64511843|NCT05013502|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64511844|NCT05013502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511845|NCT05013502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64511846|NCT05013502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972952|NCT00233584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64972953|NCT00233623|Leucovorin|leucovorin|mesh-list
64972954|NCT00233623|Fluorouracil|fluorouracil|mesh-list
64972955|NCT00233623|Irinotecan|irinotecan|mesh-list
64972956|NCT00233623|Gefitinib|gefitinib|mesh-list
64972957|NCT00233623|Antimetabolites|antimetabolites|mesh-ancestor
64972958|NCT00233623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972959|NCT00233623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64334067|NCT02294305|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64334068|NCT02294305|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64336778|NCT02313337|Narcotics|narcotics|mesh-ancestor
64584415|NCT01413542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64584416|NCT01413542|Substance P|substance p|mesh-list
64584417|NCT01413542|Neurokinin A|neurokinin a|mesh-list
64584418|NCT01413542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64584419|NCT01413542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584420|NCT01413542|Incretins|incretins|mesh-ancestor
64584421|NCT01413542|Hormones|hormones|mesh-ancestor
64584422|NCT01413542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64584423|NCT01413542|Protease Inhibitors|protease inhibitors|mesh-ancestor
64584424|NCT01413542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584425|NCT01413542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584426|NCT01413542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64584427|NCT01413542|Natriuretic Agents|natriuretic agents|mesh-ancestor
64584428|NCT01413542|Vasodilator Agents|vasodilator agents|mesh-ancestor
64364548|NCT00701311|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64364549|NCT00701311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64364550|NCT00701311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64972960|NCT00233623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64972961|NCT00233623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64972962|NCT00233623|Immunologic Factors|immunologic factors|mesh-ancestor
64972963|NCT00233623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64972964|NCT00233623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64972965|NCT00233623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64972992|NCT00233779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64972994|NCT00233818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64972995|NCT00233818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64972996|NCT00233818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64972999|NCT00233818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64973000|NCT00233818|Immunologic Factors|immunologic factors|mesh-ancestor
64973001|NCT00233818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973002|NCT00076206|Sirolimus|sirolimus|mesh-list
64973003|NCT00076206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64973004|NCT00076206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973005|NCT00076206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64973006|NCT00076206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973007|NCT00076206|Antifungal Agents|antifungal agents|mesh-ancestor
64973008|NCT00076206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64973009|NCT00076206|Immunologic Factors|immunologic factors|mesh-ancestor
64973010|NCT00076206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973011|NCT00233896|Beclomethasone|beclomethasone|mesh-list
64973012|NCT00233896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64973013|NCT00233896|Glucocorticoids|glucocorticoids|mesh-ancestor
64973014|NCT00233896|Hormones|hormones|mesh-ancestor
64973015|NCT00233896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64511916|NCT04924322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334069|NCT02294305|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64334071|NCT01672255|Fluoxetine|fluoxetine|mesh-list
64334072|NCT01672255|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64334073|NCT01672255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64334074|NCT01672255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64584430|NCT01413542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64584431|NCT01873989|Testosterone|testosterone|mesh-list
64584432|NCT01873989|Androgens|androgens|mesh-ancestor
64973035|NCT00234091|Efavirenz|efavirenz|mesh-list
64973036|NCT00234091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64973037|NCT00234091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64973038|NCT00234091|Protease Inhibitors|protease inhibitors|mesh-ancestor
64973039|NCT00234091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973040|NCT00234091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973041|NCT00234091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64973042|NCT00234091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64973043|NCT00234091|Antiviral Agents|antiviral agents|mesh-ancestor
64973044|NCT00234091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973045|NCT00234091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64973046|NCT00234091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64973047|NCT00234091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64973048|NCT00234091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64973049|NCT00234091|Antimetabolites|antimetabolites|mesh-ancestor
64973050|NCT00234091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64973051|NCT00234091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64511996|NCT04898894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64511997|NCT04898894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511998|NCT04898894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64511999|NCT04898894|Antimetabolites|antimetabolites|mesh-ancestor
64973086|NCT00234403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64584433|NCT01873989|Hormones|hormones|mesh-ancestor
64584434|NCT01873989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64584435|NCT01873989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584436|NCT01875159|Caffeine|caffeine|mesh-list
64584437|NCT01875159|Caffeine citrate|caffeine citrate|mesh-list
64584438|NCT01875159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584439|NCT01875159|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64584440|NCT01875159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584441|NCT01875159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64973087|NCT00234403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973088|NCT00234403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64973089|NCT00234403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973090|NCT00234403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973091|NCT00064415|Formoterol Fumarate|formoterol fumarate|mesh-list
64973092|NCT00064415|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64973093|NCT00064415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64973094|NCT00064415|Autonomic Agents|autonomic agents|mesh-ancestor
64973095|NCT00064415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64973096|NCT00064415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973097|NCT00064415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64973098|NCT00064415|Respiratory System Agents|respiratory system agents|mesh-ancestor
64973099|NCT00064415|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64973100|NCT00064415|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64973101|NCT00064415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64973102|NCT00064415|Adrenergic Agents|adrenergic agents|mesh-ancestor
64973103|NCT00064415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64973104|NCT00064415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973105|NCT00234442|Gefitinib|gefitinib|mesh-list
64973106|NCT00234442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973107|NCT00234442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64973108|NCT00234442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973110|NCT00076323|Primaquine|primaquine|mesh-list
64973126|NCT00234637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64973127|NCT00234637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973128|NCT00234637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973129|NCT00234637|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64973130|NCT00234637|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64973133|NCT00234637|Cholinergic Agents|cholinergic agents|mesh-ancestor
64973134|NCT00234637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64973135|NCT00234637|Protective Agents|protective agents|mesh-ancestor
64334077|NCT01672255|Serotonin Agents|serotonin agents|mesh-ancestor
64973136|NCT00234676|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64973137|NCT00234676|Estrogens|estrogens|mesh-ancestor
64973138|NCT00234676|Hormones|hormones|mesh-ancestor
64973139|NCT00234676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64973140|NCT00234676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973141|NCT00076362|Octreotide|octreotide|mesh-list
64973142|NCT00076362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64973143|NCT00076362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64973144|NCT00076362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973145|NCT00234871|Verapamil|verapamil|mesh-list
64973146|NCT00234871|Amlodipine|amlodipine|mesh-list
64973147|NCT00234871|Benazepril|benazepril|mesh-list
64973148|NCT00234871|Trandolapril|trandolapril|mesh-list
64973149|NCT00234871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64973150|NCT00234871|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64973151|NCT00234871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64973152|NCT00234871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973153|NCT00234871|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64973154|NCT00234871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973171|NCT00234910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973172|NCT00234910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64973173|NCT00234910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64973174|NCT00234910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64973175|NCT00234910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64973176|NCT00234949|Cephalexin|cephalexin|mesh-list
64973177|NCT00234949|Cefdinir|cefdinir|mesh-list
64973178|NCT00234949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64973179|NCT00234949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973180|NCT00234988|Sibutramine|sibutramine|mesh-list
64973181|NCT00234988|Antidepressive Agents|antidepressive agents|mesh-ancestor
64973182|NCT00234988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64973183|NCT00234988|Appetite Depressants|appetite depressants|mesh-ancestor
64973184|NCT00234988|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64973185|NCT00400491|Vitamin D|vitamin d|mesh-list
64512143|NCT04747314|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64512145|NCT04747314|Sensory System Agents|sensory system agents|mesh-ancestor
64512146|NCT04747314|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64512219|NCT04651439|Lenograstim|lenograstim|mesh-list
64973232|NCT00235261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973233|NCT00235261|Analgesics|analgesics|mesh-ancestor
64973234|NCT00235261|Sensory System Agents|sensory system agents|mesh-ancestor
64973235|NCT00235261|Anticonvulsants|anticonvulsants|mesh-ancestor
64973236|NCT00235261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64973237|NCT00235261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64973238|NCT00235261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973239|NCT00235261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64973240|NCT00235261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64973241|NCT00235261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64584536|NCT00559377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64584537|NCT00559377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64973242|NCT00235261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64584538|NCT00559377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584539|NCT05266651|Tadalafil|tadalafil|mesh-list
64584540|NCT05266651|Vasodilator Agents|vasodilator agents|mesh-ancestor
64584541|NCT05266651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64584542|NCT05266651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64584543|NCT05266651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973284|NCT00064766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973285|NCT00064766|Antimalarials|antimalarials|mesh-ancestor
64973286|NCT00064766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64973287|NCT00064766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64973288|NCT00235729|Lofexidine|lofexidine|mesh-list
64973289|NCT00235729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64973290|NCT00235729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64973291|NCT00235729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973292|NCT00235729|Sensory System Agents|sensory system agents|mesh-ancestor
64973293|NCT00235729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64973294|NCT00235729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64973295|NCT00235729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64512220|NCT04651439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64512221|NCT04651439|Immunologic Factors|immunologic factors|mesh-ancestor
64512222|NCT04651439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512223|NCT04650074|Lidocaine|lidocaine|mesh-list
64512224|NCT04650074|Ketamine|ketamine|mesh-list
64512225|NCT04650074|Anesthetics, Local|anesthetics, local|mesh-ancestor
64512226|NCT04650074|Anesthetics|anesthetics|mesh-ancestor
64512227|NCT04650074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64973297|NCT00235729|Adrenergic Agents|adrenergic agents|mesh-ancestor
64973298|NCT00235729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64973299|NCT00235729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973300|NCT00235885|Adalimumab|adalimumab|mesh-list
64973301|NCT00235885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64973302|NCT00235885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64973303|NCT04728750|Pancrelipase|pancrelipase|mesh-list
64973304|NCT04728750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64973305|NCT00235963|Simvastatin|simvastatin|mesh-list
64973306|NCT00235963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64973307|NCT00235963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64334102|NCT02220023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334103|NCT02220023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64334104|NCT02220023|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64334105|NCT02220023|Vasodilator Agents|vasodilator agents|mesh-ancestor
64334106|NCT02220023|Gasotransmitters|gasotransmitters|mesh-ancestor
64334107|NCT02220023|Protective Agents|protective agents|mesh-ancestor
64334108|NCT02356965|Ketamine|ketamine|mesh-list
64334109|NCT02356965|Analgesics|analgesics|mesh-ancestor
64334110|NCT02356965|Sensory System Agents|sensory system agents|mesh-ancestor
64334111|NCT02356965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334112|NCT02356965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584565|NCT01412060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584566|NCT01412060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64584567|NCT00345865|Cytarabine|cytarabine|mesh-list
64973308|NCT00235963|Antimetabolites|antimetabolites|mesh-ancestor
64973309|NCT00235963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973310|NCT00235963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64973313|NCT00236002|Alendronate|alendronate|mesh-list
64973316|NCT00414037|Eszopiclone|eszopiclone|mesh-list
64973317|NCT00414037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64973318|NCT00414037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64973319|NCT00414037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973320|NCT00236275|Telbivudine|telbivudine|mesh-list
64973321|NCT00236275|Antiviral Agents|antiviral agents|mesh-ancestor
64973322|NCT00236275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973323|NCT00236275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64973324|NCT00236275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973325|NCT00236275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973326|NCT00236353|Risperidone|risperidone|mesh-list
64973327|NCT00236353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64973328|NCT00236353|Serotonin Agents|serotonin agents|mesh-ancestor
64973329|NCT00236353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64973330|NCT00236353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973331|NCT00236353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973332|NCT00236353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64973333|NCT00236353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64973334|NCT00236353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64973335|NCT00236353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64584585|NCT00345865|Antimetabolites|antimetabolites|mesh-ancestor
64584586|NCT00345865|Antiviral Agents|antiviral agents|mesh-ancestor
64584587|NCT00345865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64584588|NCT00551421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64584589|NCT00551421|Cetuximab|cetuximab|mesh-list
64584590|NCT00551421|Pertuzumab|pertuzumab|mesh-list
64584591|NCT00551421|Irinotecan|irinotecan|mesh-list
64584592|NCT00551421|Antibodies|antibodies|mesh-list
64584593|NCT00551421|Immunoglobulins|immunoglobulins|mesh-list
64584594|NCT00551421|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64584595|NCT00551421|Immunologic Factors|immunologic factors|mesh-ancestor
64584596|NCT00551421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584597|NCT00551421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584598|NCT00551421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64584599|NCT00551421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64973336|NCT00236353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64973337|NCT00236353|Dopamine Agents|dopamine agents|mesh-ancestor
64973338|NCT00236392|Rabeprazole|rabeprazole|mesh-list
64973366|NCT00236470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64973367|NCT00236470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64973368|NCT00236470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64973369|NCT00236470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64973370|NCT00236470|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64973371|NCT00236470|Dopamine Agents|dopamine agents|mesh-ancestor
64973372|NCT00236509|Topiramate|topiramate|mesh-list
64973373|NCT00236509|Anticonvulsants|anticonvulsants|mesh-ancestor
64973374|NCT00236509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64973375|NCT00236509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973376|NCT02962141|Paclitaxel|paclitaxel|mesh-list
64973377|NCT02962141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64973378|NCT02962141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973379|NCT02962141|Tubulin Modulators|tubulin modulators|mesh-ancestor
64973380|NCT02962141|Antimitotic Agents|antimitotic agents|mesh-ancestor
64973381|NCT02962141|Mitosis Modulators|mitosis modulators|mesh-ancestor
64973382|NCT02962141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973383|NCT00076401|Motexafin gadolinium|motexafin gadolinium|mesh-list
64973384|NCT00076401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973385|NCT00076401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64973386|NCT00076401|Dermatologic Agents|dermatologic agents|mesh-ancestor
64973387|NCT00236548|Risperidone|risperidone|mesh-list
64973388|NCT00236548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64973389|NCT00236548|Serotonin Agents|serotonin agents|mesh-ancestor
64973390|NCT00236548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64973391|NCT00236548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973392|NCT00236548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973393|NCT00236548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64973394|NCT00236548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64973395|NCT00236548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64584600|NCT00551421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584601|NCT00551421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584603|NCT01791751|Enclomiphene|enclomiphene|mesh-list
64584604|NCT01791751|Zuclomiphene|zuclomiphene|mesh-list
64584605|NCT01791751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64584606|NCT01791751|Hormone Antagonists|hormone antagonists|mesh-ancestor
64584607|NCT01791751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64584608|NCT01791751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584609|NCT01791751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64584610|NCT01791751|Fertility Agents|fertility agents|mesh-ancestor
64584611|NCT01791751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64584612|NCT01791751|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64364801|NCT03298321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64973396|NCT00236548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64973397|NCT00236548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64973398|NCT00236548|Dopamine Agents|dopamine agents|mesh-ancestor
64973399|NCT00236587|Risperidone|risperidone|mesh-list
64973400|NCT00236587|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64973401|NCT00236587|Serotonin Agents|serotonin agents|mesh-ancestor
64973405|NCT00236587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64973413|NCT00236626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64973414|NCT00236626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973415|NCT00236665|Topiramate|topiramate|mesh-list
64973416|NCT00236665|Anticonvulsants|anticonvulsants|mesh-ancestor
64973417|NCT00236665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64973418|NCT00236665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973419|NCT00399282|Vitamin E|vitamin e|mesh-list
64973420|NCT00399282|Vitamins|vitamins|mesh-ancestor
64973421|NCT00399282|Micronutrients|micronutrients|mesh-ancestor
64973422|NCT00399282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973423|NCT00399282|Antioxidants|antioxidants|mesh-ancestor
64973424|NCT00399282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973425|NCT00399282|Protective Agents|protective agents|mesh-ancestor
64973426|NCT00236704|Topiramate|topiramate|mesh-list
64973427|NCT00236704|Anticonvulsants|anticonvulsants|mesh-ancestor
64973428|NCT00236704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64973429|NCT00236704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973430|NCT00236743|Topiramate|topiramate|mesh-list
64973458|NCT00236821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64973460|NCT00236821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973461|NCT00236821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973462|NCT00236821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973463|NCT00236821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64973464|NCT00236821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64973465|NCT00236860|Topiramate|topiramate|mesh-list
64973466|NCT00236860|Anticonvulsants|anticonvulsants|mesh-ancestor
64512466|NCT04364945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64512467|NCT04364945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64973513|NCT00237211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64973515|NCT00098007|Everolimus|everolimus|mesh-list
64973516|NCT00098007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973517|NCT00098007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64334115|NCT02356965|Anesthetics, General|anesthetics, general|mesh-ancestor
64334117|NCT02356965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64334118|NCT02356965|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64334119|NCT02356965|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64334120|NCT02356965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64334121|NCT02356965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334122|NCT02907359|Guadecitabine|guadecitabine|mesh-list
64334123|NCT02907359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334124|NCT02359695|Hormones|hormones|mesh-list
64334125|NCT02359695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64334126|NCT02359695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334127|NCT02294539|Losartan|losartan|mesh-list
64334128|NCT02294539|Amlodipine|amlodipine|mesh-list
64334129|NCT02294539|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64334130|NCT02294539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64334131|NCT02294539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64334132|NCT02294539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64973518|NCT00098007|Immunologic Factors|immunologic factors|mesh-ancestor
64973519|NCT00098007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973520|NCT00237250|Vildagliptin|vildagliptin|mesh-list
64973521|NCT00237250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64973522|NCT00237250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973523|NCT00237250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64973524|NCT00237250|Protease Inhibitors|protease inhibitors|mesh-ancestor
64973525|NCT00237250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973526|NCT00237250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973527|NCT00237289|Topiramate|topiramate|mesh-list
64973528|NCT00237289|Anticonvulsants|anticonvulsants|mesh-ancestor
64973529|NCT00237289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64973530|NCT00237289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973531|NCT00237328|Heparin|heparin|mesh-list
64973532|NCT00237328|Anticoagulants|anticoagulants|mesh-ancestor
64973533|NCT00237328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64973534|NCT00237328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64973535|NCT00237328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973536|NCT00237367|Rabeprazole|rabeprazole|mesh-list
64973537|NCT00237367|Pantoprazole|pantoprazole|mesh-list
64973538|NCT00237367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64973559|NCT00065273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64973561|NCT00065273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64973562|NCT00065273|Dopamine Agents|dopamine agents|mesh-ancestor
64973563|NCT00065273|Antiemetics|antiemetics|mesh-ancestor
64973564|NCT00065273|Autonomic Agents|autonomic agents|mesh-ancestor
64973565|NCT00065273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64973566|NCT00065273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64973567|NCT00065273|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64973568|NCT00065273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64973569|NCT00065273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64973570|NCT00065273|GABA Antagonists|gaba antagonists|mesh-ancestor
64973571|NCT00065273|GABA Agents|gaba agents|mesh-ancestor
64973572|NCT00237445|Azithromycin|azithromycin|mesh-list
64973573|NCT00237445|Telithromycin|telithromycin|mesh-list
64973574|NCT00237445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64973575|NCT00237445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973576|NCT00237484|Interferons|interferons|mesh-list
64973577|NCT00237484|Ribavirin|ribavirin|mesh-list
64973578|NCT00237484|Interferon-alpha|interferon-alpha|mesh-list
64973579|NCT00237484|Interferon alpha-2|interferon alpha-2|mesh-list
64973580|NCT00237484|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64584613|NCT01791751|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64973581|NCT00237484|Infliximab|infliximab|mesh-list
64584615|NCT05266261|Ibandronic Acid|ibandronic acid|mesh-list
64584616|NCT05266261|Calcium Carbonate|calcium carbonate|mesh-list
64584617|NCT05266261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64584618|NCT05266261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584619|NCT05266261|Vitamins|vitamins|mesh-ancestor
64584620|NCT05266261|Micronutrients|micronutrients|mesh-ancestor
64584621|NCT05266261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64584622|NCT05266261|Antacids|antacids|mesh-ancestor
64584623|NCT05266261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584624|NCT05266261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64584625|NCT04830813|Chiauranib|chiauranib|mesh-list
64584626|NCT04830813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973582|NCT00237484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973583|NCT00237484|Antiviral Agents|antiviral agents|mesh-ancestor
64973584|NCT00237484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973585|NCT00237484|Antimetabolites|antimetabolites|mesh-ancestor
64973586|NCT00237484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973587|NCT00237484|Immunologic Factors|immunologic factors|mesh-ancestor
64973588|NCT00237484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973594|NCT00237523|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64973596|NCT00237523|Trace Elements|trace elements|mesh-ancestor
64973609|NCT00098124|Sensory System Agents|sensory system agents|mesh-ancestor
64973610|NCT00098124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64973611|NCT00098124|Antidepressive Agents|antidepressive agents|mesh-ancestor
64973612|NCT00098124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64973614|NCT04710160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64973615|NCT04710160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973616|NCT00065351|Lenalidomide|lenalidomide|mesh-list
64973617|NCT00065351|Immunologic Factors|immunologic factors|mesh-ancestor
64973618|NCT00065351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973619|NCT00065351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64973620|NCT00065351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64973621|NCT00065351|Growth Substances|growth substances|mesh-ancestor
64973622|NCT00065351|Growth Inhibitors|growth inhibitors|mesh-ancestor
64973623|NCT00065351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973624|NCT04709770|Simethicone|simethicone|mesh-list
64973625|NCT04709770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973626|NCT04709770|Antifoaming Agents|antifoaming agents|mesh-ancestor
64973627|NCT04709770|Emollients|emollients|mesh-ancestor
64973628|NCT04709770|Dermatologic Agents|dermatologic agents|mesh-ancestor
64973629|NCT04709731|Ponatinib|ponatinib|mesh-list
64973630|NCT04709731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973631|NCT04709731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64973632|NCT04709731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973633|NCT04709731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973634|NCT00398684|Nevirapine|nevirapine|mesh-list
64973635|NCT00398684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64973636|NCT00398684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64334136|NCT02294539|Vasodilator Agents|vasodilator agents|mesh-ancestor
64334137|NCT02294539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64334138|NCT02294539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64334139|NCT02294539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64334140|NCT02294539|Diuretics|diuretics|mesh-ancestor
64334141|NCT02294539|Natriuretic Agents|natriuretic agents|mesh-ancestor
64584632|NCT05266105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64584633|NCT05266105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584634|NCT05266105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364939|NCT03365999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64364940|NCT03365999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364942|NCT03365999|Coagulants|coagulants|mesh-ancestor
64973637|NCT00398684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973639|NCT00398684|Antiviral Agents|antiviral agents|mesh-ancestor
64512603|NCT04184622|Tirzepatide|tirzepatide|mesh-list
64512604|NCT04184622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64512605|NCT04184622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512606|NCT04184622|Incretins|incretins|mesh-ancestor
64512608|NCT04184622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64512673|NCT04097561|Belimumab|belimumab|mesh-list
64512674|NCT04097561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64973650|NCT00076440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64973651|NCT00076440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973652|NCT00237874|Aripiprazole|aripiprazole|mesh-list
64973653|NCT00237874|Antidepressive Agents|antidepressive agents|mesh-ancestor
64973654|NCT00237874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64973655|NCT00237874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64973656|NCT00237874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64973657|NCT00237874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64973658|NCT00237874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973659|NCT00237874|Dopamine Agonists|dopamine agonists|mesh-ancestor
64973660|NCT00237874|Dopamine Agents|dopamine agents|mesh-ancestor
64973661|NCT00237874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64973662|NCT00237874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973663|NCT00237874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64973664|NCT00237874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64973692|NCT00237913|Antidepressive Agents|antidepressive agents|mesh-ancestor
64973693|NCT00237913|Dopamine Agonists|dopamine agonists|mesh-ancestor
64973694|NCT00237913|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64973695|NCT00237913|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64584635|NCT01891643|Dexamethasone|dexamethasone|mesh-list
64584636|NCT01891643|Dexamethasone acetate|dexamethasone acetate|mesh-list
64584637|NCT01891643|Lenalidomide|lenalidomide|mesh-list
64584638|NCT01891643|Elotuzumab|elotuzumab|mesh-list
64584639|NCT01891643|BB 1101|bb 1101|mesh-list
64584640|NCT01891643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64584641|NCT01891643|Antiemetics|antiemetics|mesh-ancestor
64584642|NCT01891643|Autonomic Agents|autonomic agents|mesh-ancestor
64584643|NCT01891643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64584644|NCT01891643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584645|NCT01891643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64584646|NCT01891643|Glucocorticoids|glucocorticoids|mesh-ancestor
64334142|NCT02294539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64334143|NCT02359617|Insulin|insulin|mesh-list
64334144|NCT02359617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64334145|NCT02359617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973700|NCT00237952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973702|NCT00098241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973703|NCT00098241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64973704|NCT00098241|Immunologic Factors|immunologic factors|mesh-ancestor
64973705|NCT00098241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973706|NCT04721119|Anesthetics|anesthetics|mesh-list
64973747|NCT00238225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64973748|NCT00238225|Hormone Antagonists|hormone antagonists|mesh-ancestor
64973749|NCT00238225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64973750|NCT00238225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64973751|NCT00238225|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64973752|NCT00238225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64973753|NCT00238225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64973754|NCT00238225|Vitamins|vitamins|mesh-ancestor
64973755|NCT00238225|Micronutrients|micronutrients|mesh-ancestor
64973756|NCT00238225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64973757|NCT00076518|Fenofibrate|fenofibrate|mesh-list
64973758|NCT00076518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64973759|NCT00076518|Antimetabolites|antimetabolites|mesh-ancestor
64973760|NCT00076518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973761|NCT00076518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64973762|NCT00065546|Choline|choline|mesh-list
64973763|NCT00065546|Estrogens|estrogens|mesh-list
64973764|NCT00065546|Hormones|hormones|mesh-ancestor
64973765|NCT00065546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64973766|NCT00065546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973774|NCT00098280|Eculizumab|eculizumab|mesh-list
64973801|NCT00098319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973802|NCT00238732|Bazedoxifene|bazedoxifene|mesh-list
64973803|NCT00238732|Estrogens|estrogens|mesh-list
64973804|NCT00238732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64973805|NCT00238732|Hormones|hormones|mesh-ancestor
64973806|NCT00238732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64973807|NCT00238732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973808|NCT00238732|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64973809|NCT00238732|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64584647|NCT01891643|Hormones|hormones|mesh-ancestor
64584648|NCT01891643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64584649|NCT01891643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64584650|NCT01891643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584651|NCT01891643|Protease Inhibitors|protease inhibitors|mesh-ancestor
64584652|NCT01891643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584653|NCT01891643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584654|NCT01891643|Immunologic Factors|immunologic factors|mesh-ancestor
64584655|NCT01891643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64584656|NCT01891643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64584657|NCT01891643|Growth Substances|growth substances|mesh-ancestor
64584658|NCT01891643|Growth Inhibitors|growth inhibitors|mesh-ancestor
64584659|NCT05265793|Apatinib|apatinib|mesh-list
64584660|NCT05265793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584661|NCT05265793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64584662|NCT05265793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973810|NCT00238732|Hormone Antagonists|hormone antagonists|mesh-ancestor
64973811|NCT00238732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64973812|NCT00238849|Oxaliplatin|oxaliplatin|mesh-list
64973813|NCT00238849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973814|NCT00238927|Fluticasone|fluticasone|mesh-list
64973815|NCT00238927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64973816|NCT00238927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64973817|NCT00238927|Autonomic Agents|autonomic agents|mesh-ancestor
64973818|NCT00238927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64973819|NCT00238927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973820|NCT00238927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64973821|NCT00238927|Respiratory System Agents|respiratory system agents|mesh-ancestor
64973822|NCT00238927|Dermatologic Agents|dermatologic agents|mesh-ancestor
64973823|NCT00238927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64973851|NCT00098358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64973852|NCT00098358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64973853|NCT00098358|Analgesics|analgesics|mesh-ancestor
64973854|NCT00098358|Sensory System Agents|sensory system agents|mesh-ancestor
64973855|NCT00098358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64973856|NCT00098358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973857|NCT00098358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64973858|NCT00098358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64973859|NCT00098358|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64973860|NCT00098358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973861|NCT00098358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973862|NCT00098358|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64973863|NCT00098358|Hormone Antagonists|hormone antagonists|mesh-ancestor
64973864|NCT00098358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64973867|NCT00239083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973868|NCT00239083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64973869|NCT00239083|Antitubercular Agents|antitubercular agents|mesh-ancestor
64973870|NCT00239083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64973871|NCT00239083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973873|NCT00239083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973874|NCT00239161|Levofloxacin|levofloxacin|mesh-list
64973875|NCT00239161|Ofloxacin|ofloxacin|mesh-list
64584664|NCT04005599|Magnesium Sulfate|magnesium sulfate|mesh-list
64584665|NCT04005599|Remifentanil|remifentanil|mesh-list
64584666|NCT04005599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64584667|NCT04005599|Narcotics|narcotics|mesh-ancestor
64584668|NCT04005599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64584669|NCT04005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584670|NCT04005599|Analgesics|analgesics|mesh-ancestor
64365026|NCT03282643|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64365027|NCT03282643|Protease Inhibitors|protease inhibitors|mesh-ancestor
64365043|NCT02458729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973876|NCT00239161|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64973877|NCT00239161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973878|NCT00239161|Renal Agents|renal agents|mesh-ancestor
64973879|NCT00239161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64973887|NCT00239200|Lapatinib|lapatinib|mesh-list
64973893|NCT02961829|Maraviroc|maraviroc|mesh-list
64973894|NCT02961829|Dolutegravir|dolutegravir|mesh-list
64973895|NCT02961829|Auranofin|auranofin|mesh-list
64973896|NCT02961829|Vaccines|vaccines|mesh-list
64973897|NCT02961829|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
64973898|NCT02961829|Immunologic Factors|immunologic factors|mesh-ancestor
64973899|NCT02961829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973900|NCT02961829|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64973901|NCT02961829|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64973902|NCT02961829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973903|NCT02961829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64973904|NCT02961829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64973905|NCT02961829|Antiviral Agents|antiviral agents|mesh-ancestor
64973906|NCT02961829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64973907|NCT02961829|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64973908|NCT02961829|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64973909|NCT02961829|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64973910|NCT02961829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973911|NCT02961829|Vitamin B Complex|vitamin b complex|mesh-ancestor
64973912|NCT02961829|Vitamins|vitamins|mesh-ancestor
64973913|NCT02961829|Micronutrients|micronutrients|mesh-ancestor
64973914|NCT02961829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64973915|NCT00239239|Darbepoetin alfa|darbepoetin alfa|mesh-list
64973916|NCT00239239|Hematinics|hematinics|mesh-ancestor
64973917|NCT00414349|Analgesics|analgesics|mesh-list
64973918|NCT00414349|Sensory System Agents|sensory system agents|mesh-ancestor
64973921|NCT00065741|Silymarin|silymarin|mesh-list
64973934|NCT00239278|Hormones|hormones|mesh-ancestor
64973935|NCT00239278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64973936|NCT00239278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973937|NCT00239278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64973938|NCT00239278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64973939|NCT00239278|Autonomic Agents|autonomic agents|mesh-ancestor
64973940|NCT00239278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64973941|NCT00239278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64973942|NCT00239278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64973943|NCT00239278|Respiratory System Agents|respiratory system agents|mesh-ancestor
64973944|NCT00239278|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64973945|NCT00239278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64584671|NCT04005599|Sensory System Agents|sensory system agents|mesh-ancestor
64584672|NCT04005599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64584673|NCT04005599|Anesthetics|anesthetics|mesh-ancestor
64584674|NCT04005599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64334146|NCT03154125|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64334147|NCT03154125|Medroxyprogesterone|medroxyprogesterone|mesh-list
64334148|NCT03154125|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64334149|NCT03154125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64334150|NCT03154125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64334151|NCT03154125|Contraceptive Agents|contraceptive agents|mesh-ancestor
64334152|NCT03154125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64334153|NCT03154125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365062|NCT03920527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973946|NCT00239278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64973947|NCT00239278|Adrenergic Agents|adrenergic agents|mesh-ancestor
64973948|NCT00239278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64973949|NCT00239278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973950|NCT00239395|Meloxicam|meloxicam|mesh-list
64973951|NCT00239395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64973952|NCT00239395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64973953|NCT00239395|Analgesics|analgesics|mesh-ancestor
64973954|NCT00239395|Sensory System Agents|sensory system agents|mesh-ancestor
64973955|NCT00239395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64973956|NCT00239395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64973957|NCT00239395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64973958|NCT00239395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64973959|NCT00239395|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64973960|NCT00239395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64973961|NCT00239395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64973962|NCT00239395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973963|NCT00076635|Interferons|interferons|mesh-list
64973976|NCT00239434|Respiratory System Agents|respiratory system agents|mesh-ancestor
64973978|NCT00239434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64973979|NCT00239434|Cholinergic Agents|cholinergic agents|mesh-ancestor
64973980|NCT00239434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64973981|NCT00239434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64973982|NCT00239434|Anticonvulsants|anticonvulsants|mesh-ancestor
64973983|NCT00239473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64973984|NCT00239473|Tiotropium Bromide|tiotropium bromide|mesh-list
64973985|NCT00239473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64974033|NCT00098436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974034|NCT00098436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584676|NCT04005599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64584677|NCT04005599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64584678|NCT04005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584679|NCT04005599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64584680|NCT04005599|Tocolytic Agents|tocolytic agents|mesh-ancestor
64584681|NCT04005599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64584682|NCT00330863|Olanzapine|olanzapine|mesh-list
64584683|NCT00330863|Risperidone|risperidone|mesh-list
64584684|NCT00330863|Aripiprazole|aripiprazole|mesh-list
64584685|NCT00330863|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64584686|NCT00330863|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64584687|NCT00330863|Ziprasidone|ziprasidone|mesh-list
64584688|NCT00330863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64584689|NCT00330863|Serotonin Agents|serotonin agents|mesh-ancestor
64584690|NCT00330863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64584691|NCT00330863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584692|NCT00330863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584693|NCT00330863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64584694|NCT00330863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64584695|NCT00330863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64974035|NCT00239707|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
64974036|NCT00239707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64974038|NCT00239707|Hormones|hormones|mesh-ancestor
64974039|NCT00239707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64974040|NCT00239707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974041|NCT00239746|Ibuprofen|ibuprofen|mesh-list
64974042|NCT00239746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64974043|NCT00239746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64974044|NCT00239746|Analgesics|analgesics|mesh-ancestor
64974045|NCT00239746|Sensory System Agents|sensory system agents|mesh-ancestor
64974046|NCT00239746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64974047|NCT00239746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974048|NCT00239746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64974049|NCT00239746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64974050|NCT00239746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64974051|NCT00239746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974052|NCT00239746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974081|NCT00240019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974082|NCT00240019|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64974083|NCT00240019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64974084|NCT00240019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974085|NCT00240058|Phenylephrine|phenylephrine|mesh-list
64974086|NCT00240058|Oxymetazoline|oxymetazoline|mesh-list
64974087|NCT00240058|Nitric Oxide|nitric oxide|mesh-list
64974088|NCT00240058|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64974089|NCT00240058|Mydriatics|mydriatics|mesh-ancestor
64974090|NCT00240058|Autonomic Agents|autonomic agents|mesh-ancestor
64974091|NCT00240058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64974092|NCT00240058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974093|NCT00240058|Sympathomimetics|sympathomimetics|mesh-ancestor
64334154|NCT03154125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64334155|NCT03154125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64334156|NCT03154125|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64334157|NCT03154125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64334158|NCT03154125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334159|NCT02294617|Nicotine|nicotine|mesh-list
64584697|NCT00330863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64584698|NCT00330863|Dopamine Agents|dopamine agents|mesh-ancestor
64309923|NCT02442531|Docetaxel|docetaxel|mesh-list
64584699|NCT00330863|Antiemetics|antiemetics|mesh-ancestor
64584700|NCT00330863|Autonomic Agents|autonomic agents|mesh-ancestor
64584701|NCT00330863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64584702|NCT00330863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64584703|NCT00330863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64584704|NCT00330863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64584705|NCT00330863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64584706|NCT00330863|Antidepressive Agents|antidepressive agents|mesh-ancestor
64584707|NCT00330863|Dopamine Agonists|dopamine agonists|mesh-ancestor
64584708|NCT00330863|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64584709|NCT00330863|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64974094|NCT00240058|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64974095|NCT00240058|Nasal Decongestants|nasal decongestants|mesh-ancestor
64974096|NCT00240058|Respiratory System Agents|respiratory system agents|mesh-ancestor
64974097|NCT00240058|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64974098|NCT00240058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64513138|NCT03448042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64513139|NCT03448042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513140|NCT03436745|Zolpidem|zolpidem|mesh-list
64513141|NCT03436745|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64974132|NCT00065936|Sensory System Agents|sensory system agents|mesh-ancestor
64974133|NCT00065936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64974134|NCT00240292|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64974135|NCT00240292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64974136|NCT00240292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64974137|NCT00240292|Antimetabolites|antimetabolites|mesh-ancestor
64974138|NCT00240292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974139|NCT00240292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64974140|NCT00240292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64974141|NCT00240292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974142|NCT00240409|Pramipexole|pramipexole|mesh-list
64974143|NCT00240409|Bromocriptine|bromocriptine|mesh-list
64974144|NCT00240409|Antioxidants|antioxidants|mesh-ancestor
64974145|NCT00240409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974146|NCT00240409|Protective Agents|protective agents|mesh-ancestor
64974147|NCT00240409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974148|NCT00240409|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64974149|NCT00240409|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64974150|NCT00240409|Dopamine Agonists|dopamine agonists|mesh-ancestor
64974151|NCT00240409|Dopamine Agents|dopamine agents|mesh-ancestor
64974152|NCT00240409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64974173|NCT00240604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64974174|NCT00240604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974175|NCT00076791|Tenofovir|tenofovir|mesh-list
64974176|NCT00076791|Emtricitabine|emtricitabine|mesh-list
64974177|NCT00076791|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64974178|NCT00076791|Antiviral Agents|antiviral agents|mesh-ancestor
64584712|NCT01899521|Zinc Sulfate|zinc sulfate|mesh-list
64974179|NCT00076791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64974180|NCT00076791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64974181|NCT00076791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64974182|NCT00076791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974183|NCT00076791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974184|NCT00076791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64974185|NCT00076791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64974186|NCT00240682|Cetuximab|cetuximab|mesh-list
64974187|NCT00240682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64974188|NCT00240682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974189|NCT00240721|Topiramate|topiramate|mesh-list
64974190|NCT00240721|Anticonvulsants|anticonvulsants|mesh-ancestor
64974191|NCT00240721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64974192|NCT00240721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974193|NCT00240760|Memantine|memantine|mesh-list
64974211|NCT04720807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974212|NCT04720807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64974213|NCT04720807|Hormone Antagonists|hormone antagonists|mesh-ancestor
64974214|NCT04720807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64974215|NCT04720807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974216|NCT00240799|Acetaminophen|acetaminophen|mesh-list
64974217|NCT00240799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64974218|NCT00240799|Analgesics|analgesics|mesh-ancestor
64974219|NCT00240799|Sensory System Agents|sensory system agents|mesh-ancestor
64974220|NCT00240799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64974221|NCT00240799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974222|NCT00240799|Antipyretics|antipyretics|mesh-ancestor
64974223|NCT00240838|Acetaminophen|acetaminophen|mesh-list
64974224|NCT00240838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64974225|NCT00240838|Analgesics|analgesics|mesh-ancestor
64974226|NCT00240838|Sensory System Agents|sensory system agents|mesh-ancestor
64974227|NCT00240838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64974228|NCT00240838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974229|NCT00240838|Antipyretics|antipyretics|mesh-ancestor
64974231|NCT02965404|Immunologic Factors|immunologic factors|mesh-ancestor
64974232|NCT02965404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974233|NCT00240955|Mycophenolic Acid|mycophenolic acid|mesh-list
64974234|NCT00240955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64974235|NCT00240955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974236|NCT00240955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64974237|NCT00240955|Antitubercular Agents|antitubercular agents|mesh-ancestor
64974238|NCT00240955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64584715|NCT01899521|Dermatologic Agents|dermatologic agents|mesh-ancestor
64584716|NCT01790009|Acetaminophen|acetaminophen|mesh-list
64584717|NCT01790009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64584718|NCT01790009|Analgesics|analgesics|mesh-ancestor
64584719|NCT01790009|Sensory System Agents|sensory system agents|mesh-ancestor
64584720|NCT01790009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64584721|NCT01790009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584722|NCT01790009|Antipyretics|antipyretics|mesh-ancestor
64584723|NCT05737329|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64584724|NCT05737329|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64584725|NCT05737329|Estradiol|estradiol|mesh-list
64584726|NCT05737329|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64584727|NCT05737329|Estrogens|estrogens|mesh-ancestor
64334160|NCT02294617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64334161|NCT02294617|Autonomic Agents|autonomic agents|mesh-ancestor
64334162|NCT02294617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64974239|NCT00240955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64974240|NCT00240955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64513288|NCT02786264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64513289|NCT02786264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513290|NCT02786264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64513291|NCT02786264|Anesthetics, General|anesthetics, general|mesh-ancestor
64513292|NCT02786264|Anesthetics|anesthetics|mesh-ancestor
64513293|NCT02786264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64513294|NCT02786264|Analgesics|analgesics|mesh-ancestor
64513295|NCT02786264|Sensory System Agents|sensory system agents|mesh-ancestor
64513296|NCT02786264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64513297|NCT02786264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64513298|NCT02786264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64513299|NCT02786264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64513300|NCT02786264|Adrenergic Agents|adrenergic agents|mesh-ancestor
64513301|NCT02786264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64974294|NCT00241189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64974296|NCT00241189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64974297|NCT00241189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974298|NCT00241189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64974299|NCT00241189|Antimetabolites|antimetabolites|mesh-ancestor
64974300|NCT00241189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974301|NCT00241189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974302|NCT00241189|Dermatologic Agents|dermatologic agents|mesh-ancestor
64974303|NCT00241189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974304|NCT00241189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64974305|NCT00241189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64974306|NCT00241189|Immunologic Factors|immunologic factors|mesh-ancestor
64974307|NCT00241189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64974336|NCT00241501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64974337|NCT00241501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974338|NCT00241501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974339|NCT00076986|Carmustine|carmustine|mesh-list
64974340|NCT00076986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64974341|NCT00076986|Alkylating Agents|alkylating agents|mesh-ancestor
64974342|NCT00076986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974343|NCT00076986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974344|NCT00241540|Esomeprazole|esomeprazole|mesh-list
64974345|NCT00241540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64974346|NCT00241540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64974347|NCT00241540|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64584729|NCT05737329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64584730|NCT05737329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584731|NCT05737329|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64584733|NCT05737329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64584734|NCT05737329|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64584735|NCT00317941|Interferon beta-1b|interferon beta-1b|mesh-list
64584736|NCT00317941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64365271|NCT02714569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365273|NCT04522037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64974348|NCT00241540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974349|NCT00241540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974350|NCT00066443|Docetaxel|docetaxel|mesh-list
64974351|NCT00066443|Epirubicin|epirubicin|mesh-list
64974352|NCT00066443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974353|NCT00066443|Tubulin Modulators|tubulin modulators|mesh-ancestor
64974373|NCT00098982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64974374|NCT00098982|Immunologic Factors|immunologic factors|mesh-ancestor
64974376|NCT00098982|Protective Agents|protective agents|mesh-ancestor
64974377|NCT00098982|Vitamin B Complex|vitamin b complex|mesh-ancestor
64974378|NCT00098982|Vitamins|vitamins|mesh-ancestor
64974379|NCT00098982|Micronutrients|micronutrients|mesh-ancestor
64974380|NCT00241618|Interferons|interferons|mesh-list
64974381|NCT00241618|Ribavirin|ribavirin|mesh-list
64974382|NCT00241618|Interferon-alpha|interferon-alpha|mesh-list
64974383|NCT00241618|Interferon alpha-2|interferon alpha-2|mesh-list
64974384|NCT00241618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974385|NCT00241618|Antiviral Agents|antiviral agents|mesh-ancestor
64974386|NCT00241618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64974387|NCT00241618|Antimetabolites|antimetabolites|mesh-ancestor
64974389|NCT00241618|Immunologic Factors|immunologic factors|mesh-ancestor
64974435|NCT00242008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974436|NCT00242164|Dialysis Solutions|dialysis solutions|mesh-list
64974437|NCT00242164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64974438|NCT00099177|Zoledronic Acid|zoledronic acid|mesh-list
64974439|NCT00099177|Ibandronic Acid|ibandronic acid|mesh-list
64974440|NCT00099177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64974441|NCT00099177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974442|NCT02962024|Morphine|morphine|mesh-list
64974443|NCT02962024|Bupivacaine|bupivacaine|mesh-list
64974444|NCT02962024|Anesthetics, Local|anesthetics, local|mesh-ancestor
64974445|NCT02962024|Anesthetics|anesthetics|mesh-ancestor
64974446|NCT02962024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64974447|NCT02962024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974448|NCT02962024|Sensory System Agents|sensory system agents|mesh-ancestor
64974449|NCT02962024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64584737|NCT00317941|Immunologic Factors|immunologic factors|mesh-ancestor
64974483|NCT00077025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64974486|NCT00242359|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64974487|NCT00242359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64584738|NCT00317941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584739|NCT01790087|Moxifloxacin|moxifloxacin|mesh-list
64584740|NCT01790087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64584741|NCT01790087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64584742|NCT01790087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64584743|NCT01790087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64584744|NCT01790087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584745|NCT01790087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584746|NCT01790087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584747|NCT05266937|Paclitaxel|paclitaxel|mesh-list
64584748|NCT05266937|Carboplatin|carboplatin|mesh-list
64584749|NCT05266937|Atezolizumab|atezolizumab|mesh-list
64584750|NCT05266937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64584751|NCT05266937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584752|NCT05266937|Tubulin Modulators|tubulin modulators|mesh-ancestor
64584753|NCT05266937|Antimitotic Agents|antimitotic agents|mesh-ancestor
64584754|NCT05266937|Mitosis Modulators|mitosis modulators|mesh-ancestor
64974488|NCT00242359|Respiratory System Agents|respiratory system agents|mesh-ancestor
64974489|NCT00066716|Celecoxib|celecoxib|mesh-list
64974490|NCT00066716|Paclitaxel|paclitaxel|mesh-list
64974491|NCT00066716|Carboplatin|carboplatin|mesh-list
64974492|NCT00066716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64974493|NCT00066716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974494|NCT00066716|Tubulin Modulators|tubulin modulators|mesh-ancestor
64974495|NCT00066716|Antimitotic Agents|antimitotic agents|mesh-ancestor
64974496|NCT00066716|Mitosis Modulators|mitosis modulators|mesh-ancestor
64974497|NCT00066716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974498|NCT00066716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64974499|NCT00066716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64974500|NCT00066716|Analgesics|analgesics|mesh-ancestor
64974521|NCT00077103|Antimitotic Agents|antimitotic agents|mesh-ancestor
64974522|NCT00077103|Mitosis Modulators|mitosis modulators|mesh-ancestor
64974524|NCT00242437|Hemostatics|hemostatics|mesh-list
64974525|NCT00242437|Coagulants|coagulants|mesh-ancestor
64974526|NCT00066794|Cytarabine|cytarabine|mesh-list
64974527|NCT00066794|Cyclosporine|cyclosporine|mesh-list
64974528|NCT00066794|Daunorubicin|daunorubicin|mesh-list
64974529|NCT00066794|Cyclosporins|cyclosporins|mesh-list
64974530|NCT00066794|Sargramostim|sargramostim|mesh-list
64974531|NCT00066794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64974532|NCT00066794|Antimetabolites|antimetabolites|mesh-ancestor
64974533|NCT00066794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974534|NCT00066794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974535|NCT00066794|Antiviral Agents|antiviral agents|mesh-ancestor
64974536|NCT00066794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64974537|NCT00066794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64974538|NCT00066794|Immunologic Factors|immunologic factors|mesh-ancestor
64974539|NCT00066794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974540|NCT00066794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974541|NCT00066794|Antifungal Agents|antifungal agents|mesh-ancestor
64974542|NCT00066794|Dermatologic Agents|dermatologic agents|mesh-ancestor
64974543|NCT00066794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64584755|NCT05266937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584756|NCT00332579|Naltrexone|naltrexone|mesh-list
64584757|NCT00332579|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64584758|NCT00332579|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64584759|NCT00332579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584760|NCT00332579|Sensory System Agents|sensory system agents|mesh-ancestor
64584761|NCT00332579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64584762|NCT00318409|Bupropion|bupropion|mesh-list
64584763|NCT00318409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64334166|NCT02294617|Cholinergic Agents|cholinergic agents|mesh-ancestor
64334167|NCT02294617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64334168|NCT02294617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334169|NCT02291341|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64334170|NCT02291341|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64334171|NCT02291341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64334172|NCT02291341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64334173|NCT02291341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334174|NCT02291341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64974577|NCT00242944|Antimetabolites|antimetabolites|mesh-ancestor
64974578|NCT00242944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974579|NCT00242944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64974580|NCT00242944|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64974581|NCT00242944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974582|NCT00243100|Gemcitabine|gemcitabine|mesh-list
64974583|NCT00243100|Vorinostat|vorinostat|mesh-list
64974584|NCT00243100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64974585|NCT00243100|Antimetabolites|antimetabolites|mesh-ancestor
64974586|NCT00243100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974587|NCT00243100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974588|NCT00243100|Antiviral Agents|antiviral agents|mesh-ancestor
64974589|NCT00243100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64974590|NCT00243100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974591|NCT00243100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64974592|NCT00243100|Immunologic Factors|immunologic factors|mesh-ancestor
64974593|NCT00243100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974594|NCT00243100|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64974595|NCT00099216|Rivastigmine|rivastigmine|mesh-list
64974596|NCT00099216|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64974597|NCT00099216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974598|NCT00099216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974599|NCT00099216|Cholinergic Agents|cholinergic agents|mesh-ancestor
64974600|NCT00099216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64974626|NCT00243256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64974627|NCT00243646|Bicalutamide|bicalutamide|mesh-list
64974628|NCT00243646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974629|NCT00243646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974630|NCT00243646|Androgen Antagonists|androgen antagonists|mesh-ancestor
64974631|NCT00243646|Hormone Antagonists|hormone antagonists|mesh-ancestor
64974632|NCT00243646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64974633|NCT00099333|Exenatide|exenatide|mesh-list
64974634|NCT00099333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64974635|NCT00099333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974636|NCT00099333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64974637|NCT00099333|Incretins|incretins|mesh-ancestor
64336780|NCT02313337|Sensory System Agents|sensory system agents|mesh-ancestor
64584766|NCT00318409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64584767|NCT00318409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64584768|NCT00318409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64584769|NCT00318409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584770|NCT00318409|Dopamine Agents|dopamine agents|mesh-ancestor
64584771|NCT00318409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64584772|NCT00318409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584773|NCT00318409|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64365465|NCT04516655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64974638|NCT00099333|Hormones|hormones|mesh-ancestor
64974639|NCT00099333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64974640|NCT00243724|Esomeprazole|esomeprazole|mesh-list
64974641|NCT00243724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64974642|NCT00243724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64974643|NCT00243724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64974669|NCT00244153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64974670|NCT00244153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64974671|NCT00244153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974672|NCT00244153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64974673|NCT00244153|Narcotics|narcotics|mesh-ancestor
64974674|NCT00244153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64974675|NCT00244153|Analgesics|analgesics|mesh-ancestor
64974676|NCT00244153|Sensory System Agents|sensory system agents|mesh-ancestor
64974677|NCT02967029|Remifentanil|remifentanil|mesh-list
64974678|NCT02967029|Esmolol|esmolol|mesh-list
64974679|NCT02967029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64974680|NCT02967029|Narcotics|narcotics|mesh-ancestor
64974681|NCT02967029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64974692|NCT00244192|Infliximab|infliximab|mesh-list
64974727|NCT00244348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64974728|NCT00244348|Immunologic Factors|immunologic factors|mesh-ancestor
64974729|NCT00244348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974731|NCT00077220|Carboplatin|carboplatin|mesh-list
64974732|NCT00077220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64974733|NCT00077220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974734|NCT00077220|Tubulin Modulators|tubulin modulators|mesh-ancestor
64974735|NCT00077220|Antimitotic Agents|antimitotic agents|mesh-ancestor
64974736|NCT00077220|Mitosis Modulators|mitosis modulators|mesh-ancestor
64974737|NCT00077220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974738|NCT00244426|Aspirin|aspirin|mesh-list
64974739|NCT00244426|Indobufen|indobufen|mesh-list
64974740|NCT00244426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64974741|NCT00244426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64974742|NCT00244426|Analgesics|analgesics|mesh-ancestor
64974743|NCT00244426|Sensory System Agents|sensory system agents|mesh-ancestor
64974744|NCT00244426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64974745|NCT00244426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974746|NCT00244426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64974747|NCT00244426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64974783|NCT00099489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64974785|NCT00067262|Anticonvulsants|anticonvulsants|mesh-ancestor
64974786|NCT00067262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974787|NCT00067262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974788|NCT00067262|GABA Agents|gaba agents|mesh-ancestor
64974792|NCT00067262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64974793|NCT00067262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64974794|NCT00067262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64974795|NCT00244738|Castor Oil|castor oil|mesh-list
64584774|NCT00318409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64584775|NCT00318409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584776|NCT00333437|Mycophenolic Acid|mycophenolic acid|mesh-list
64334175|NCT02291341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334176|NCT02291341|Analgesics|analgesics|mesh-ancestor
64334177|NCT02291341|Sensory System Agents|sensory system agents|mesh-ancestor
64334178|NCT02291341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64974796|NCT00244738|Cathartics|cathartics|mesh-ancestor
64974797|NCT00244738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64974798|NCT00077259|Epothilones|epothilones|mesh-list
64974799|NCT00077259|Desoxyepothilone B|desoxyepothilone b|mesh-list
64974800|NCT00077259|Tubulin Modulators|tubulin modulators|mesh-ancestor
64974801|NCT00077259|Antimitotic Agents|antimitotic agents|mesh-ancestor
64974802|NCT00077259|Mitosis Modulators|mitosis modulators|mesh-ancestor
64974803|NCT00077259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974804|NCT00077259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974805|NCT00067301|Citalopram|citalopram|mesh-list
64974806|NCT00067301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64974807|NCT00067301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64974808|NCT00067301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64974809|NCT00067301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974810|NCT00067301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64974811|NCT00067301|Serotonin Agents|serotonin agents|mesh-ancestor
64974812|NCT00067301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974816|NCT00244972|Sorafenib|sorafenib|mesh-list
64584779|NCT00333437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64584780|NCT00333437|Antitubercular Agents|antitubercular agents|mesh-ancestor
64584781|NCT00333437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64584782|NCT00333437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64584783|NCT00333437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584784|NCT00333437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584786|NCT04129619|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64584787|NCT04129619|Anesthetics, General|anesthetics, general|mesh-ancestor
64584788|NCT04129619|Anesthetics|anesthetics|mesh-ancestor
64584789|NCT04129619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64584790|NCT04129619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584791|NCT00353119|Etanercept|etanercept|mesh-list
64584792|NCT00353119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64584793|NCT00353119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64584794|NCT00353119|Analgesics|analgesics|mesh-ancestor
64584795|NCT00353119|Sensory System Agents|sensory system agents|mesh-ancestor
64584796|NCT00353119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64584797|NCT00353119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584798|NCT00353119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64584799|NCT00353119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64584800|NCT00353119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64584801|NCT00353119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64584802|NCT00353119|Immunologic Factors|immunologic factors|mesh-ancestor
64584803|NCT00353431|Insulin Aspart|insulin aspart|mesh-list
64584804|NCT00353431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64584805|NCT00353431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584806|NCT04971187|Cisplatin|cisplatin|mesh-list
64974826|NCT00245089|Immunologic Factors|immunologic factors|mesh-ancestor
64974827|NCT00245089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974828|NCT00245089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64974829|NCT00245089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64974830|NCT00245089|Alkylating Agents|alkylating agents|mesh-ancestor
64974831|NCT00245089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974832|NCT00245089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974833|NCT00245089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64974834|NCT00245089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64974835|NCT00245089|Tubulin Modulators|tubulin modulators|mesh-ancestor
64974836|NCT00245089|Antimitotic Agents|antimitotic agents|mesh-ancestor
64974837|NCT00245089|Mitosis Modulators|mitosis modulators|mesh-ancestor
64974838|NCT00245089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64974839|NCT00245089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64974840|NCT00245089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64974841|NCT00245089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64974842|NCT00245089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974843|NCT00245089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64974844|NCT00067340|Chlorhexidine|chlorhexidine|mesh-list
64974845|NCT00067340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64974846|NCT00067340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64974847|NCT00067340|Disinfectants|disinfectants|mesh-ancestor
64974876|NCT00245245|Coagulants|coagulants|mesh-ancestor
64974877|NCT00077298|Bevacizumab|bevacizumab|mesh-list
64974878|NCT00077298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64974879|NCT00077298|Cetuximab|cetuximab|mesh-list
64974880|NCT00077298|Irinotecan|irinotecan|mesh-list
64584809|NCT04971187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584810|NCT04971187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584811|NCT04971187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584812|NCT04971187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64584813|NCT04971187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64584814|NCT00353977|Vaccines|vaccines|mesh-list
64584815|NCT00353977|Immunologic Factors|immunologic factors|mesh-ancestor
64584816|NCT00353977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584817|NCT00320281|Botulinum Toxins|botulinum toxins|mesh-list
64584818|NCT00320281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64584819|NCT00320281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64584820|NCT00320281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64584821|NCT00320281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64584822|NCT00320281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584823|NCT00320281|Cholinergic Agents|cholinergic agents|mesh-ancestor
64974881|NCT00077298|Antibodies|antibodies|mesh-list
64974882|NCT00077298|Immunoglobulins|immunoglobulins|mesh-list
64974883|NCT00077298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64974884|NCT00077298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974885|NCT00077298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64974886|NCT00077298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64974887|NCT00077298|Growth Substances|growth substances|mesh-ancestor
64974888|NCT00077298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974889|NCT00077298|Growth Inhibitors|growth inhibitors|mesh-ancestor
64974890|NCT00077298|Immunologic Factors|immunologic factors|mesh-ancestor
64974891|NCT00077298|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64974892|NCT00077298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64974893|NCT00077298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64974894|NCT00077298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974895|NCT00245401|Sirolimus|sirolimus|mesh-list
64974896|NCT00245401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64974897|NCT00245401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64974898|NCT00245401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64974899|NCT00245401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64974900|NCT00245401|Antifungal Agents|antifungal agents|mesh-ancestor
64974901|NCT00245401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64974934|NCT00245674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64974935|NCT00245674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974936|NCT00245674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64974937|NCT00245674|Antidepressive Agents|antidepressive agents|mesh-ancestor
64974938|NCT00245713|Levetiracetam|levetiracetam|mesh-list
64974939|NCT00245713|Anticonvulsants|anticonvulsants|mesh-ancestor
64974940|NCT00245713|Nootropic Agents|nootropic agents|mesh-ancestor
64974941|NCT00067457|Alosetron|alosetron|mesh-list
64584833|NCT01392326|Immunologic Factors|immunologic factors|mesh-ancestor
64584834|NCT01392326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584835|NCT00320671|Risperidone|risperidone|mesh-list
64584836|NCT00320671|Aripiprazole|aripiprazole|mesh-list
64584837|NCT00320671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64584838|NCT00320671|Serotonin Agents|serotonin agents|mesh-ancestor
64584839|NCT00320671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64584840|NCT00320671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584841|NCT00320671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584842|NCT00320671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64584843|NCT00320671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64584844|NCT00320671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64584845|NCT00320671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64584846|NCT00320671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64584847|NCT00320671|Dopamine Agents|dopamine agents|mesh-ancestor
64584848|NCT00320671|Antidepressive Agents|antidepressive agents|mesh-ancestor
64484231|NCT01751113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584849|NCT00320671|Dopamine Agonists|dopamine agonists|mesh-ancestor
64584850|NCT00320671|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64584851|NCT00320671|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64974944|NCT00067457|Serotonin Agents|serotonin agents|mesh-ancestor
64974985|NCT00245908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64974986|NCT00067496|Modafinil|modafinil|mesh-list
64974987|NCT00067496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64974988|NCT00067496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64974989|NCT00067496|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64974990|NCT00067496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64974991|NCT00067496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64974992|NCT00067496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64974993|NCT00400725|Clobetasol|clobetasol|mesh-list
64974994|NCT00400725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64975047|NCT00067535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64975048|NCT00067535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64975049|NCT00067535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64975050|NCT00067535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64975051|NCT00067535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975052|NCT00067535|Dopamine Agents|dopamine agents|mesh-ancestor
64975053|NCT00067535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64975054|NCT00102882|Fluticasone|fluticasone|mesh-list
64584853|NCT00320671|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64584854|NCT00320749|Gemcitabine|gemcitabine|mesh-list
64584855|NCT00320749|Capecitabine|capecitabine|mesh-list
64584856|NCT00320749|Docetaxel|docetaxel|mesh-list
64584857|NCT00320749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64584858|NCT00320749|Antimetabolites|antimetabolites|mesh-ancestor
64584859|NCT00320749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584860|NCT00320749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584861|NCT00320749|Antiviral Agents|antiviral agents|mesh-ancestor
64584862|NCT00320749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64334188|NCT02352987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64334189|NCT02352987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64334191|NCT02352987|Sensory System Agents|sensory system agents|mesh-ancestor
64365743|NCT04506125|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64365744|NCT04506125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64365745|NCT04506125|Analgesics|analgesics|mesh-ancestor
64975055|NCT00102882|Xhance|xhance|mesh-list
64975056|NCT00102882|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64975057|NCT00102882|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64975058|NCT00102882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64975059|NCT00102882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64975060|NCT00102882|Autonomic Agents|autonomic agents|mesh-ancestor
64975061|NCT00102882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64975062|NCT00102882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975063|NCT00102882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64975064|NCT00102882|Respiratory System Agents|respiratory system agents|mesh-ancestor
64975065|NCT00102882|Dermatologic Agents|dermatologic agents|mesh-ancestor
64975066|NCT00102882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64975067|NCT00102882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64975068|NCT00102882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64975069|NCT00102882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64975070|NCT00102882|Adrenergic Agents|adrenergic agents|mesh-ancestor
64975073|NCT00102882|Glucocorticoids|glucocorticoids|mesh-ancestor
64975096|NCT00424801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64975097|NCT00424801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975098|NCT00424801|Diuretics|diuretics|mesh-ancestor
64975099|NCT00424801|Natriuretic Agents|natriuretic agents|mesh-ancestor
64975100|NCT00424801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975101|NCT00424801|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64975102|NCT00424801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64975103|NCT00424801|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
64975104|NCT00424801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64975105|NCT00424801|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64975106|NCT00424801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64975159|NCT04728516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64584865|NCT00320749|Immunologic Factors|immunologic factors|mesh-ancestor
64584866|NCT00320749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584867|NCT00320749|Tubulin Modulators|tubulin modulators|mesh-ancestor
64584868|NCT00320749|Antimitotic Agents|antimitotic agents|mesh-ancestor
64584869|NCT00320749|Mitosis Modulators|mitosis modulators|mesh-ancestor
64584870|NCT00354913|Imatinib Mesylate|imatinib mesylate|mesh-list
64584871|NCT00354913|Hydroxyurea|hydroxyurea|mesh-list
64584872|NCT00354913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584873|NCT00354913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64584874|NCT00354913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584875|NCT00354913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584876|NCT00354913|Antisickling Agents|antisickling agents|mesh-ancestor
64584877|NCT00354913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64584878|NCT01432262|Vaccines|vaccines|mesh-list
64584879|NCT01432262|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64584880|NCT01432262|Immunologic Factors|immunologic factors|mesh-ancestor
64584881|NCT01432262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365755|NCT03261349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64365757|NCT02455609|Ketamine|ketamine|mesh-list
64975160|NCT04728516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975161|NCT04728516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975162|NCT00400998|Fluticasone|fluticasone|mesh-list
64975163|NCT00400998|Xhance|xhance|mesh-list
64975164|NCT00400998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64975165|NCT00400998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64975166|NCT00400998|Autonomic Agents|autonomic agents|mesh-ancestor
64975167|NCT00400998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64975168|NCT00400998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975169|NCT00400998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64975170|NCT00400998|Respiratory System Agents|respiratory system agents|mesh-ancestor
64975171|NCT00400998|Dermatologic Agents|dermatologic agents|mesh-ancestor
64975172|NCT00400998|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64975173|NCT00247078|Antivenins|antivenins|mesh-list
64975174|NCT00247078|Immunologic Factors|immunologic factors|mesh-ancestor
64975194|NCT00247507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975195|NCT00247507|Antidotes|antidotes|mesh-ancestor
64975196|NCT00247585|Ethanol|ethanol|mesh-list
64975197|NCT00247585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64975198|NCT00247585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64975199|NCT00247585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64975200|NCT00247585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975201|NCT00099645|Mifepristone|mifepristone|mesh-list
64975202|NCT00099645|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64975203|NCT00099645|Abortifacient Agents|abortifacient agents|mesh-ancestor
64975204|NCT00099645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64975205|NCT00099645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975206|NCT00099645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64975207|NCT00099645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64975208|NCT00099645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64334192|NCT02352987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334193|NCT02352987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334194|NCT02352987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64334195|NCT02352987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64584884|NCT00322309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64584885|NCT00322309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64584886|NCT00322309|Histamine Antagonists|histamine antagonists|mesh-ancestor
64584888|NCT00322309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64584889|NCT00322309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584890|NCT00322309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584891|NCT00322309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64584892|NCT00322309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64584893|NCT00322309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64584894|NCT00322309|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64584895|NCT00322309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64584896|NCT00322309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64584897|NCT00322309|Adrenergic Agents|adrenergic agents|mesh-ancestor
64584902|NCT04046744|Lidocaine|lidocaine|mesh-list
64975209|NCT00099645|Contraceptive Agents|contraceptive agents|mesh-ancestor
64975210|NCT00099645|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64975217|NCT00247663|Letrozole|letrozole|mesh-list
64975249|NCT00247741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975251|NCT00099684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64975252|NCT00099684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64975253|NCT00099684|Antimetabolites|antimetabolites|mesh-ancestor
64975254|NCT00099684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975305|NCT00248443|Dimercaprol|dimercaprol|mesh-list
64975306|NCT00248443|Chelating Agents|chelating agents|mesh-ancestor
64975307|NCT00248443|Sequestering Agents|sequestering agents|mesh-ancestor
64975308|NCT00248443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975310|NCT00248482|Irinotecan|irinotecan|mesh-list
64975311|NCT00248482|Imatinib Mesylate|imatinib mesylate|mesh-list
64975312|NCT00248482|Camptothecin|camptothecin|mesh-list
64975313|NCT00248482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975314|NCT00248482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64975315|NCT00248482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64975316|NCT00248482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975317|NCT00248482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975318|NCT00248482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64975319|NCT00248482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64975320|NCT00103233|Trastuzumab|trastuzumab|mesh-list
64975321|NCT00103233|Vinorelbine|vinorelbine|mesh-list
64975322|NCT00103233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64975323|NCT00103233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975324|NCT00103233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64975325|NCT00103233|Tubulin Modulators|tubulin modulators|mesh-ancestor
64975345|NCT00068042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64975346|NCT00068042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975347|NCT00249145|Risperidone|risperidone|mesh-list
64975348|NCT00249145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64975354|NCT00249145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64584907|NCT04046744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64584908|NCT04046744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584909|NCT04046744|Sensory System Agents|sensory system agents|mesh-ancestor
64584910|NCT04046744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64584911|NCT04046744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64584914|NCT04046744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64584915|NCT04046744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584916|NCT01431950|Fluticasone|fluticasone|mesh-list
64584917|NCT01431950|Xhance|xhance|mesh-list
64584918|NCT01431950|Albuterol|albuterol|mesh-list
64584919|NCT01431950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64584920|NCT01431950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64584921|NCT01431950|Autonomic Agents|autonomic agents|mesh-ancestor
64584922|NCT01431950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64584923|NCT01431950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584925|NCT01431950|Respiratory System Agents|respiratory system agents|mesh-ancestor
64584926|NCT01431950|Dermatologic Agents|dermatologic agents|mesh-ancestor
64584927|NCT01431950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64975355|NCT00249145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64975356|NCT00249145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64975357|NCT00249145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64975359|NCT00099801|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64975360|NCT00099801|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64975361|NCT00099801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975368|NCT00068081|Capsaicin|capsaicin|mesh-list
64975401|NCT00099918|Protease Inhibitors|protease inhibitors|mesh-ancestor
64975402|NCT00099918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975403|NCT00099918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975404|NCT00249574|Buprenorphine|buprenorphine|mesh-list
64975405|NCT00249574|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64975406|NCT00249574|Naloxone|naloxone|mesh-list
64975407|NCT00249574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64975408|NCT00249574|Narcotics|narcotics|mesh-ancestor
64975409|NCT00249574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64975410|NCT00249574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975411|NCT00249574|Analgesics|analgesics|mesh-ancestor
64975412|NCT00249574|Sensory System Agents|sensory system agents|mesh-ancestor
64975413|NCT00249574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64975414|NCT00249574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64975415|NCT00249691|Topiramate|topiramate|mesh-list
64975416|NCT00249691|Anticonvulsants|anticonvulsants|mesh-ancestor
64975417|NCT00249691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64975419|NCT00249730|Sildenafil Citrate|sildenafil citrate|mesh-list
64975456|NCT00249964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64975457|NCT00249964|Carboplatin|carboplatin|mesh-list
64975458|NCT00249964|Temozolomide|temozolomide|mesh-list
64584933|NCT01431950|Adrenergic Agents|adrenergic agents|mesh-ancestor
64584934|NCT01431950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64584935|NCT01431950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584936|NCT00551031|Vaccines|vaccines|mesh-list
64584937|NCT00551031|Immunologic Factors|immunologic factors|mesh-ancestor
64584938|NCT00551031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584939|NCT01431716|Epoprostenol|epoprostenol|mesh-list
64584940|NCT01431716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64584941|NCT01431716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64584942|NCT00550953|Amlodipine|amlodipine|mesh-list
64584943|NCT00550953|Telmisartan|telmisartan|mesh-list
64584944|NCT00550953|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
64584945|NCT00550953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64584946|NCT00550953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64584947|NCT00550953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64584948|NCT00550953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584949|NCT00550953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64584950|NCT00550953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584951|NCT00550953|Vasodilator Agents|vasodilator agents|mesh-ancestor
64365864|NCT05505617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365865|NCT05505617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975459|NCT00249964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64975460|NCT00249964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975461|NCT00249964|Tubulin Modulators|tubulin modulators|mesh-ancestor
64975462|NCT00249964|Antimitotic Agents|antimitotic agents|mesh-ancestor
64975463|NCT00249964|Mitosis Modulators|mitosis modulators|mesh-ancestor
64975464|NCT00249964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975465|NCT00249964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64975466|NCT00249964|Alkylating Agents|alkylating agents|mesh-ancestor
64975467|NCT00068276|Cholecalciferol|cholecalciferol|mesh-list
64975468|NCT00068276|Vitamin D|vitamin d|mesh-list
64975469|NCT00068276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64975470|NCT00068276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975471|NCT00068276|Vitamins|vitamins|mesh-ancestor
64975472|NCT00068276|Micronutrients|micronutrients|mesh-ancestor
64975473|NCT00068276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64975474|NCT00250042|Imatinib Mesylate|imatinib mesylate|mesh-list
64975475|NCT00250042|Arsenic Trioxide|arsenic trioxide|mesh-list
64975476|NCT00250042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975477|NCT00250042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64975478|NCT00250042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975479|NCT00250042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975480|NCT00068315|Rituximab|rituximab|mesh-list
64975481|NCT00068315|Fludarabine|fludarabine|mesh-list
64975502|NCT00250120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64975503|NCT00250120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975504|NCT00250120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64975505|NCT00250120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64975506|NCT00250120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975507|NCT00250120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975508|NCT04720573|Neostigmine|neostigmine|mesh-list
64975509|NCT04720573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64975510|NCT04720573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584952|NCT00550953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64584953|NCT00550953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64584954|NCT00322465|Azithromycin|azithromycin|mesh-list
64584955|NCT00322465|Doxycycline|doxycycline|mesh-list
64584956|NCT00322465|Tinidazole|tinidazole|mesh-list
64584957|NCT00322465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64584958|NCT00322465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64584959|NCT00322465|Antimalarials|antimalarials|mesh-ancestor
64584960|NCT00322465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64584961|NCT00322465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64334196|NCT02352987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64334197|NCT02352987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334198|NCT02352987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584963|NCT00322465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584964|NCT00322465|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64584965|NCT00558831|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64584966|NCT00558831|Dermatologic Agents|dermatologic agents|mesh-ancestor
64975511|NCT04720573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975512|NCT04720573|Cholinergic Agents|cholinergic agents|mesh-ancestor
64975518|NCT00103545|Abagovomab|abagovomab|mesh-list
64975519|NCT00103545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64975520|NCT00103545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975521|NCT00068432|Gemcitabine|gemcitabine|mesh-list
64975522|NCT00068432|Celecoxib|celecoxib|mesh-list
64975523|NCT00068432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64975524|NCT00068432|Antimetabolites|antimetabolites|mesh-ancestor
64975525|NCT00068432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975526|NCT00068432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975527|NCT00068432|Antiviral Agents|antiviral agents|mesh-ancestor
64975528|NCT00068432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64975547|NCT00250237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975548|NCT00250237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64975549|NCT00250237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64975550|NCT00250237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64975551|NCT00250237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64975552|NCT00250237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64975553|NCT00250237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64975554|NCT00250237|Dopamine Agents|dopamine agents|mesh-ancestor
64975555|NCT00250237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64975556|NCT00250237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975557|NCT00250237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64975558|NCT00099957|Vildagliptin|vildagliptin|mesh-list
64975559|NCT00099957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64975560|NCT00099957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975561|NCT00099957|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64975562|NCT00099957|Protease Inhibitors|protease inhibitors|mesh-ancestor
64975563|NCT00099957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975564|NCT00099957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975566|NCT00250315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64975567|NCT00250315|Sympathomimetics|sympathomimetics|mesh-ancestor
64975568|NCT00250315|Autonomic Agents|autonomic agents|mesh-ancestor
64975569|NCT00250315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64975570|NCT00250315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975571|NCT00250315|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64975578|NCT00068471|Anidulafungin|anidulafungin|mesh-list
64975594|NCT00250393|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
64975595|NCT00250393|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64975596|NCT00250393|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64975597|NCT00250393|Purinergic Agents|purinergic agents|mesh-ancestor
64975598|NCT00250393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64975599|NCT00250393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975600|NCT00250393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975601|NCT02961634|Ciclopirox|ciclopirox|mesh-list
64975602|NCT02961634|Antifungal Agents|antifungal agents|mesh-ancestor
64975603|NCT02961634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64975604|NCT02966717|Rituximab|rituximab|mesh-list
64366037|NCT03434041|Analgesics|analgesics|mesh-ancestor
64975605|NCT02966717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64975606|NCT02966717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975607|NCT02966717|Immunologic Factors|immunologic factors|mesh-ancestor
64975654|NCT00068549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64975655|NCT00068549|Antimetabolites|antimetabolites|mesh-ancestor
64975656|NCT00068549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975657|NCT00068549|Antiviral Agents|antiviral agents|mesh-ancestor
64975658|NCT00068549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64975659|NCT00068549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975660|NCT00068549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64975661|NCT00068549|Immunologic Factors|immunologic factors|mesh-ancestor
64975662|NCT00068549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975663|NCT04720183|Sulfasalazine|sulfasalazine|mesh-list
64975717|NCT00100074|Respiratory System Agents|respiratory system agents|mesh-ancestor
64975718|NCT00068744|Fluorouracil|fluorouracil|mesh-list
64975719|NCT00068744|Mitomycins|mitomycins|mesh-list
64975720|NCT00068744|Mitomycin|mitomycin|mesh-list
64975721|NCT00068744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975722|NCT00068744|Antimetabolites|antimetabolites|mesh-ancestor
64975723|NCT00068744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975724|NCT00068744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64975725|NCT00068744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64975726|NCT00068744|Immunologic Factors|immunologic factors|mesh-ancestor
64975727|NCT00068744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975728|NCT00068744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64975729|NCT00068744|Alkylating Agents|alkylating agents|mesh-ancestor
64975731|NCT00068744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975778|NCT00251485|Cetuximab|cetuximab|mesh-list
64975779|NCT00251485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64975780|NCT00251485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975781|NCT00251524|Bevacizumab|bevacizumab|mesh-list
64975782|NCT00251524|Oxaliplatin|oxaliplatin|mesh-list
64975783|NCT00251524|Pemetrexed|pemetrexed|mesh-list
64584977|NCT00558753|Sensory System Agents|sensory system agents|mesh-ancestor
64584978|NCT00558753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64584979|NCT00558753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584980|NCT00558753|Anticonvulsants|anticonvulsants|mesh-ancestor
64584981|NCT00558753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64584982|NCT00558753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64584983|NCT00558753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584984|NCT00558753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64584985|NCT00558753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64584986|NCT00558753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64584987|NCT00558753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64584988|NCT00558753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64584989|NCT00324259|Estradiol|estradiol|mesh-list
64584990|NCT00324259|Estrogens|estrogens|mesh-ancestor
64584991|NCT00324259|Hormones|hormones|mesh-ancestor
64584992|NCT00324259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64584993|NCT00324259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584994|NCT04598451|Prednisone|prednisone|mesh-list
64584995|NCT04598451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64975784|NCT00251524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64975785|NCT00251524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975786|NCT00251524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64975787|NCT00251524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64975788|NCT00251524|Growth Substances|growth substances|mesh-ancestor
64975789|NCT00251524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975790|NCT00251524|Growth Inhibitors|growth inhibitors|mesh-ancestor
64975791|NCT00251524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975792|NCT00251524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975793|NCT00251524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64975794|NCT00251524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64975795|NCT00068861|Metformin|metformin|mesh-list
64975796|NCT00068861|Clomiphene|clomiphene|mesh-list
64975797|NCT00068861|Enclomiphene|enclomiphene|mesh-list
64975798|NCT00068861|Zuclomiphene|zuclomiphene|mesh-list
64975832|NCT02961166|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64975833|NCT02961166|Antibodies|antibodies|mesh-list
64975834|NCT02961166|Immunologic Factors|immunologic factors|mesh-ancestor
64975835|NCT02961166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975836|NCT00103818|Gaboxadol|gaboxadol|mesh-list
64975837|NCT00103818|Analgesics|analgesics|mesh-ancestor
64975838|NCT00103818|Sensory System Agents|sensory system agents|mesh-ancestor
64975839|NCT00103818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64975840|NCT00103818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975841|NCT00103818|Anticonvulsants|anticonvulsants|mesh-ancestor
64975842|NCT00103818|GABA Agonists|gaba agonists|mesh-ancestor
64975843|NCT00103818|GABA Agents|gaba agents|mesh-ancestor
64975844|NCT00103818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64975845|NCT00103818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975846|NCT00251680|Atorvastatin|atorvastatin|mesh-list
64975847|NCT00251680|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64975848|NCT00251680|Simvastatin|simvastatin|mesh-list
64975849|NCT00251680|Fenofibrate|fenofibrate|mesh-list
64975850|NCT00251680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64975851|NCT00251680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64334199|NCT02226341|Mycophenolic Acid|mycophenolic acid|mesh-list
64334200|NCT02226341|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64334201|NCT02226341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64584997|NCT04598451|Hormones|hormones|mesh-ancestor
64584998|NCT04598451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64584999|NCT04598451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585000|NCT04598451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64585001|NCT04598451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585002|NCT04600141|Heparin|heparin|mesh-list
64585003|NCT04600141|Calcium heparin|calcium heparin|mesh-list
64585004|NCT04600141|Anticoagulants|anticoagulants|mesh-ancestor
64585005|NCT04600141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64585006|NCT04600141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64585007|NCT04600141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585008|NCT00324415|Fluorouracil|fluorouracil|mesh-list
64585009|NCT00324415|Cetuximab|cetuximab|mesh-list
64585010|NCT00324415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585011|NCT00324415|Antimetabolites|antimetabolites|mesh-ancestor
64585012|NCT00324415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585013|NCT00324415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64975852|NCT00251680|Antimetabolites|antimetabolites|mesh-ancestor
64975853|NCT00251680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975854|NCT00251680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64975855|NCT00251680|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64975856|NCT00251680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975857|NCT00251797|Thalidomide|thalidomide|mesh-list
64975858|NCT00251797|Irinotecan|irinotecan|mesh-list
64975881|NCT00100269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975883|NCT00100269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975884|NCT00399074|Pyrimethamine|pyrimethamine|mesh-list
64975885|NCT00399074|Sulfadoxine|sulfadoxine|mesh-list
64975886|NCT00399074|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64975887|NCT00399074|Antimalarials|antimalarials|mesh-ancestor
64975888|NCT00399074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64975889|NCT00399074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64975890|NCT00399074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64975891|NCT00399074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64975892|NCT00399074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975893|NCT00399074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975894|NCT00399074|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64975895|NCT00399074|Renal Agents|renal agents|mesh-ancestor
64975896|NCT00100308|Heparin|heparin|mesh-list
64975897|NCT00100308|Anticoagulants|anticoagulants|mesh-ancestor
64975898|NCT00100308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64975899|NCT00100308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64975900|NCT00100308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975901|NCT00251953|Metformin|metformin|mesh-list
64975904|NCT00251992|Esomeprazole|esomeprazole|mesh-list
64975905|NCT00251992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64975910|NCT00103935|Exenatide|exenatide|mesh-list
64975931|NCT00104013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64975932|NCT00104013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975933|NCT00104013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975934|NCT04719715|Antibodies|antibodies|mesh-list
64975935|NCT04719715|Immunologic Factors|immunologic factors|mesh-ancestor
64975936|NCT04719715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975937|NCT00252226|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64975938|NCT00252226|Antidepressive Agents|antidepressive agents|mesh-ancestor
64975939|NCT00252226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64585014|NCT00324415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64585015|NCT00324415|Immunologic Factors|immunologic factors|mesh-ancestor
64585016|NCT00324415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585017|NCT00324415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64585018|NCT00390559|Nicotine|nicotine|mesh-list
64585019|NCT00390559|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64585020|NCT00390559|Autonomic Agents|autonomic agents|mesh-ancestor
64366244|NCT04502771|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64366245|NCT04502771|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64366246|NCT04502771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64366247|NCT04502771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975940|NCT00252226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64975941|NCT00252226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64975942|NCT00252226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64975943|NCT00252226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975944|NCT00252304|Zinc Sulfate|zinc sulfate|mesh-list
64975945|NCT00252304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975946|NCT00252304|Astringents|astringents|mesh-ancestor
64975947|NCT00252304|Dermatologic Agents|dermatologic agents|mesh-ancestor
64975948|NCT00252343|Amibegron|amibegron|mesh-list
64975949|NCT00252343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64975950|NCT00252343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64975951|NCT00252343|Adrenergic Agents|adrenergic agents|mesh-ancestor
64975982|NCT00069251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975983|NCT00069251|Dopamine Agents|dopamine agents|mesh-ancestor
64975984|NCT00069251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64975985|NCT00069251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64975986|NCT00069251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64975987|NCT00069251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64975988|NCT00069251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975989|NCT00252889|Doxorubicin|doxorubicin|mesh-list
64975991|NCT00252889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
64975992|NCT00252889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64975993|NCT00252889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64975994|NCT00252889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64975995|NCT00252889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64975996|NCT00252889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64975997|NCT00252889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64975998|NCT00252928|Troclosene|troclosene|mesh-list
64975999|NCT00252928|Antifungal Agents|antifungal agents|mesh-ancestor
64976000|NCT00252928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64976001|NCT00252928|Antiviral Agents|antiviral agents|mesh-ancestor
64976002|NCT00252928|Disinfectants|disinfectants|mesh-ancestor
64976003|NCT00253123|Risperidone|risperidone|mesh-list
64976004|NCT00253123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64976005|NCT00253123|Serotonin Agents|serotonin agents|mesh-ancestor
64976006|NCT00253123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64976008|NCT00253123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976029|NCT00253201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585021|NCT00390559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64585022|NCT00390559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585023|NCT00390559|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64585024|NCT00390559|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64585025|NCT00390559|Cholinergic Agents|cholinergic agents|mesh-ancestor
64585026|NCT00390559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64334202|NCT02226341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334203|NCT02226341|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64334204|NCT02226341|Antitubercular Agents|antitubercular agents|mesh-ancestor
64334205|NCT02226341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64334206|NCT02226341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64334207|NCT02226341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334208|NCT02226341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976030|NCT00253201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976031|NCT00253201|Cholinergic Agents|cholinergic agents|mesh-ancestor
64976032|NCT00253201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64976033|NCT00253201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976034|NCT00253201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64976035|NCT00253201|Autonomic Agents|autonomic agents|mesh-ancestor
64976036|NCT00253201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64976037|NCT00253201|Nootropic Agents|nootropic agents|mesh-ancestor
64976038|NCT00253318|Dexamethasone|dexamethasone|mesh-list
64976039|NCT00253318|Docetaxel|docetaxel|mesh-list
64976040|NCT00253318|Everolimus|everolimus|mesh-list
64976041|NCT00253318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64976042|NCT00253318|Antiemetics|antiemetics|mesh-ancestor
64976043|NCT00253318|Autonomic Agents|autonomic agents|mesh-ancestor
64976044|NCT00253318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64976045|NCT00253318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976046|NCT00253318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64976047|NCT00253318|Glucocorticoids|glucocorticoids|mesh-ancestor
64976048|NCT00253318|Hormones|hormones|mesh-ancestor
64976085|NCT00253474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64976086|NCT00253474|Immunologic Factors|immunologic factors|mesh-ancestor
64976087|NCT00253474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976088|NCT00253552|Cyclosporine|cyclosporine|mesh-list
64976095|NCT00253552|Immunologic Factors|immunologic factors|mesh-ancestor
64976096|NCT00253552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976146|NCT00104130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976147|NCT00104130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976149|NCT00254020|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64976150|NCT00254020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64976151|NCT00254020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64976152|NCT00254020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976153|NCT00254020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64976154|NCT00254020|Serotonin Agents|serotonin agents|mesh-ancestor
64976155|NCT00254020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976156|NCT00254020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64976157|NCT00254020|Antidepressive Agents|antidepressive agents|mesh-ancestor
64976158|NCT00254020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64976159|NCT00254137|Capecitabine|capecitabine|mesh-list
64976160|NCT00254137|Oxaliplatin|oxaliplatin|mesh-list
64976162|NCT00254137|Cetuximab|cetuximab|mesh-list
64976163|NCT00254137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64976164|NCT00254137|Antimetabolites|antimetabolites|mesh-ancestor
64976165|NCT00254137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976166|NCT00254137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976167|NCT00254137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64366341|NCT03363503|Xhance|xhance|mesh-list
64976168|NCT00254137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64976169|NCT00254137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976170|NCT00254137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64976195|NCT00254371|Hormones|hormones|mesh-ancestor
64976196|NCT00254371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64976197|NCT00254371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976198|NCT00254449|Capsaicin|capsaicin|mesh-list
64976199|NCT00254449|Antipruritics|antipruritics|mesh-ancestor
64976200|NCT00254449|Dermatologic Agents|dermatologic agents|mesh-ancestor
64976201|NCT00254449|Sensory System Agents|sensory system agents|mesh-ancestor
64976202|NCT00254449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64976203|NCT00254449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976204|NCT00104286|Troxacitabine|troxacitabine|mesh-list
64976205|NCT00104286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976206|NCT00104286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64976207|NCT00104286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64976208|NCT00104286|Antiviral Agents|antiviral agents|mesh-ancestor
64976209|NCT00104286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64976210|NCT00254800|Exenatide|exenatide|mesh-list
64976211|NCT00254800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64585027|NCT00390559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585028|NCT02107339|Methadone|methadone|mesh-list
64585029|NCT02107339|Hydromorphone|hydromorphone|mesh-list
64585030|NCT02107339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64585031|NCT02107339|Narcotics|narcotics|mesh-ancestor
64585032|NCT02107339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64585033|NCT02107339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585034|NCT02107339|Analgesics|analgesics|mesh-ancestor
64585035|NCT02107339|Sensory System Agents|sensory system agents|mesh-ancestor
64585036|NCT02107339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334209|NCT02226341|Hormones|hormones|mesh-ancestor
64334210|NCT02226341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64334211|NCT02226341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334212|NCT02222987|Clopidogrel|clopidogrel|mesh-list
64334213|NCT02222987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64334214|NCT02222987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64976254|NCT00104403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64976255|NCT00104403|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64976256|NCT00104403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64976257|NCT00104403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64976258|NCT00104403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64976259|NCT00104403|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64976260|NCT00104403|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64976261|NCT00069836|Metformin|metformin|mesh-list
64976262|NCT00069836|Rosiglitazone|rosiglitazone|mesh-list
64976263|NCT00069836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64976264|NCT00069836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976265|NCT00254878|Methylphenidate|methylphenidate|mesh-list
64976266|NCT00254878|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64976267|NCT00254878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976268|NCT00254878|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64976269|NCT00254878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64976270|NCT00254878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64976271|NCT00254878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976272|NCT00254878|Dopamine Agents|dopamine agents|mesh-ancestor
64976308|NCT00255268|Androgen Antagonists|androgen antagonists|mesh-ancestor
64976309|NCT00255268|Hormone Antagonists|hormone antagonists|mesh-ancestor
64976315|NCT00104442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976316|NCT00104442|Cholinergic Agents|cholinergic agents|mesh-ancestor
64976317|NCT00104442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64976318|NCT00104442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585039|NCT00392041|Eszopiclone|eszopiclone|mesh-list
64585040|NCT00392041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64585041|NCT00392041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64585042|NCT00392041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585043|NCT01390844|Ribavirin|ribavirin|mesh-list
64585044|NCT01390844|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64585045|NCT01390844|Antimetabolites|antimetabolites|mesh-ancestor
64585046|NCT01390844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585047|NCT01390844|Antiviral Agents|antiviral agents|mesh-ancestor
64976319|NCT00104442|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64976320|NCT00104442|Protective Agents|protective agents|mesh-ancestor
64976321|NCT00255385|Micronutrients|micronutrients|mesh-list
64976322|NCT00255385|Trace Elements|trace elements|mesh-list
64976323|NCT00255385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976324|NCT00255424|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64976325|NCT00255424|Hematinics|hematinics|mesh-ancestor
64976326|NCT00255424|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64976327|NCT00255424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64976328|NCT00069992|Fludarabine|fludarabine|mesh-list
64976329|NCT00069992|Alemtuzumab|alemtuzumab|mesh-list
64976330|NCT00069992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976331|NCT00069992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64976332|NCT00255463|Gefitinib|gefitinib|mesh-list
64976333|NCT00255463|Anastrozole|anastrozole|mesh-list
64976334|NCT00255463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976335|NCT00255463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64976336|NCT00255463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976337|NCT00255463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976338|NCT00255463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64976339|NCT00255463|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64976340|NCT00255463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64976348|NCT00255502|Sympatholytics|sympatholytics|mesh-ancestor
64976349|NCT00255502|Autonomic Agents|autonomic agents|mesh-ancestor
64976350|NCT00255502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64976351|NCT00255502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976352|NCT00255502|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64976353|NCT00255502|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64976354|NCT00255502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64976355|NCT00255502|Adrenergic Agents|adrenergic agents|mesh-ancestor
64976356|NCT00255502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64976357|NCT00255502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976358|NCT00255541|Glyburide|glyburide|mesh-list
64976359|NCT00255541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64976360|NCT00255541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976361|NCT00255658|Sirolimus|sirolimus|mesh-list
64976362|NCT00255658|Sorafenib|sorafenib|mesh-list
64976363|NCT00255658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976364|NCT00255658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64976365|NCT00255658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976366|NCT00255658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976367|NCT00255658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64976368|NCT00255658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64976369|NCT00255658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64976370|NCT00255658|Antifungal Agents|antifungal agents|mesh-ancestor
64976371|NCT00255658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64976372|NCT00255658|Immunologic Factors|immunologic factors|mesh-ancestor
64334215|NCT02222987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64334216|NCT02222987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64334217|NCT02222987|Purinergic Agents|purinergic agents|mesh-ancestor
64334218|NCT02222987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64334219|NCT02222987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334220|NCT02222987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334221|NCT03521245|Trastuzumab|trastuzumab|mesh-list
64334222|NCT03521245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64334223|NCT03521245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334224|NCT02481245|Bezafibrate|bezafibrate|mesh-list
64334225|NCT02481245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64334226|NCT02481245|Antimetabolites|antimetabolites|mesh-ancestor
64585048|NCT01390844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64976373|NCT00255658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976374|NCT00070148|Megestrol|megestrol|mesh-list
64976375|NCT00070148|Megestrol Acetate|megestrol acetate|mesh-list
64976391|NCT00070148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64976392|NCT00070148|Anabolic Agents|anabolic agents|mesh-ancestor
64976393|NCT00100581|Interferons|interferons|mesh-list
64976394|NCT00100581|Ritonavir|ritonavir|mesh-list
64976395|NCT00100581|Tenofovir|tenofovir|mesh-list
64976396|NCT00100581|Ribavirin|ribavirin|mesh-list
64976397|NCT00100581|Interferon-alpha|interferon-alpha|mesh-list
64976398|NCT00100581|Lamivudine|lamivudine|mesh-list
64976399|NCT00100581|Interferon alpha-2|interferon alpha-2|mesh-list
64976400|NCT00100581|Efavirenz|efavirenz|mesh-list
64976401|NCT00100581|Lopinavir|lopinavir|mesh-list
64976402|NCT00100581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64976403|NCT00100581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976404|NCT00100581|Antiviral Agents|antiviral agents|mesh-ancestor
64976454|NCT00070187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64976455|NCT00070187|Alkylating Agents|alkylating agents|mesh-ancestor
64976456|NCT00070187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64976457|NCT00070187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64976458|NCT00070187|Analgesics|analgesics|mesh-ancestor
64976459|NCT00070187|Sensory System Agents|sensory system agents|mesh-ancestor
64976460|NCT00070187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64976461|NCT00070187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64976462|NCT00070187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64976463|NCT00415246|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64976464|NCT00415246|Luteolytic Agents|luteolytic agents|mesh-ancestor
64976465|NCT00415246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64976466|NCT00415246|Contraceptive Agents|contraceptive agents|mesh-ancestor
64976467|NCT00415246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64976468|NCT00415246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976469|NCT00415246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64976470|NCT00415246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64976471|NCT00415246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976473|NCT00415285|Capecitabine|capecitabine|mesh-list
64976475|NCT00415285|Tubulin Modulators|tubulin modulators|mesh-ancestor
64976504|NCT00104598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64976505|NCT00104598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976507|NCT00104598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64976508|NCT00104598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976509|NCT00104598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64585050|NCT04035278|Immunologic Factors|immunologic factors|mesh-ancestor
64585051|NCT04035278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585052|NCT00395161|Selenium|selenium|mesh-list
64585053|NCT00395161|Metoclopramide|metoclopramide|mesh-list
64585054|NCT00395161|Antioxidants|antioxidants|mesh-ancestor
64585055|NCT00395161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585056|NCT00395161|Protective Agents|protective agents|mesh-ancestor
64585057|NCT00395161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585058|NCT00395161|Trace Elements|trace elements|mesh-ancestor
64585059|NCT00395161|Micronutrients|micronutrients|mesh-ancestor
64585060|NCT00395161|Antiemetics|antiemetics|mesh-ancestor
64585061|NCT00395161|Autonomic Agents|autonomic agents|mesh-ancestor
64585062|NCT00395161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64585063|NCT00395161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64585064|NCT00395161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64585065|NCT00395161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64585066|NCT00395161|Dopamine Agents|dopamine agents|mesh-ancestor
64976510|NCT00104598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64976511|NCT00104598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976513|NCT00256321|Capecitabine|capecitabine|mesh-list
64976514|NCT00256321|Oxaliplatin|oxaliplatin|mesh-list
64976515|NCT00256321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64976516|NCT00256321|Antimetabolites|antimetabolites|mesh-ancestor
64976517|NCT00256321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976518|NCT00256321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976519|NCT00256321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64976520|NCT00256321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64976521|NCT00256321|Analgesics|analgesics|mesh-ancestor
64976522|NCT00256321|Sensory System Agents|sensory system agents|mesh-ancestor
64976523|NCT00256321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64976524|NCT00256321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976525|NCT00256321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64976526|NCT00256321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64976527|NCT00256321|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64976553|NCT00100737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976554|NCT00100737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64976555|NCT00100737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64976556|NCT00100737|Analgesics|analgesics|mesh-ancestor
64976557|NCT00100737|Sensory System Agents|sensory system agents|mesh-ancestor
64976558|NCT00100737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64976559|NCT00070343|Dacarbazine|dacarbazine|mesh-list
64976560|NCT00070343|Oblimersen|oblimersen|mesh-list
64976561|NCT00070343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64334227|NCT02481245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976562|NCT00070343|Alkylating Agents|alkylating agents|mesh-ancestor
64976563|NCT00070343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976564|NCT00070343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976565|NCT00104715|Docetaxel|docetaxel|mesh-list
64976566|NCT00104715|Goserelin|goserelin|mesh-list
64976567|NCT00104715|Androgen Antagonists|androgen antagonists|mesh-list
64976568|NCT00104715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976569|NCT00104715|Tubulin Modulators|tubulin modulators|mesh-ancestor
64976570|NCT00104715|Antimitotic Agents|antimitotic agents|mesh-ancestor
64976571|NCT00104715|Mitosis Modulators|mitosis modulators|mesh-ancestor
64976572|NCT00104715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976607|NCT00256828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64976611|NCT00256828|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64976612|NCT00256828|Antimetabolites|antimetabolites|mesh-ancestor
64976613|NCT00100776|Olanzapine|olanzapine|mesh-list
64976614|NCT00100776|Antiemetics|antiemetics|mesh-ancestor
64334228|NCT02481245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64334229|NCT02352597|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64976615|NCT00100776|Autonomic Agents|autonomic agents|mesh-ancestor
64976616|NCT00100776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334230|NCT02352597|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64585069|NCT01409564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64585070|NCT01409564|Autonomic Agents|autonomic agents|mesh-ancestor
64585071|NCT01409564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64585072|NCT01409564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585073|NCT01409564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64585074|NCT01409564|Respiratory System Agents|respiratory system agents|mesh-ancestor
64585075|NCT01409564|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64976617|NCT00100776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976618|NCT00100776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64976619|NCT00100776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64976620|NCT00100776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64976621|NCT00100776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64976622|NCT00100776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64976623|NCT00100776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64976624|NCT00100776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64976625|NCT00100776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64976626|NCT00100776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976629|NCT04709185|Dexamethasone|dexamethasone|mesh-list
64976657|NCT00257023|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64976658|NCT00257023|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64976659|NCT00257023|Serotonin Agents|serotonin agents|mesh-ancestor
64976660|NCT00257023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64976661|NCT00257023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976662|NCT00257023|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64976663|NCT00257023|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64976664|NCT00257023|Dopamine Agents|dopamine agents|mesh-ancestor
64976665|NCT00257062|Levofloxacin|levofloxacin|mesh-list
64976666|NCT00257062|Ofloxacin|ofloxacin|mesh-list
64976667|NCT00257062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64976668|NCT00257062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64976669|NCT00257062|Renal Agents|renal agents|mesh-ancestor
64976670|NCT00257062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64976671|NCT00257062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64976672|NCT00257062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64976673|NCT00257062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976674|NCT00257062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976710|NCT00257257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64585076|NCT01409564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64585077|NCT01409564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585078|NCT01409564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64585079|NCT01409564|Vasodilator Agents|vasodilator agents|mesh-ancestor
64585080|NCT01409564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64585081|NCT01409564|Protective Agents|protective agents|mesh-ancestor
64585082|NCT01409564|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64585083|NCT01409564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64585084|NCT01409564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585085|NCT02009449|Leucovorin|leucovorin|mesh-list
64585086|NCT02009449|Gemcitabine|gemcitabine|mesh-list
64585087|NCT02009449|Paclitaxel|paclitaxel|mesh-list
64585088|NCT02009449|Docetaxel|docetaxel|mesh-list
64585089|NCT02009449|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64585090|NCT02009449|Carboplatin|carboplatin|mesh-list
64585091|NCT02009449|Pembrolizumab|pembrolizumab|mesh-list
64585092|NCT02009449|Fluorouracil|fluorouracil|mesh-list
64366500|NCT03347591|Hemostatics|hemostatics|mesh-list
64366531|NCT04501289|Analgesics|analgesics|mesh-ancestor
64366532|NCT04501289|Sensory System Agents|sensory system agents|mesh-ancestor
64976711|NCT00257257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976712|NCT00257452|Moxifloxacin|moxifloxacin|mesh-list
64976713|NCT00257452|Tiotropium Bromide|tiotropium bromide|mesh-list
64976714|NCT00257452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64976715|NCT00257452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64976716|NCT00257452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64976717|NCT00257452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64976718|NCT00257452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976719|NCT00257452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976720|NCT00257452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976721|NCT00257452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976722|NCT00257452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64976723|NCT00257452|Autonomic Agents|autonomic agents|mesh-ancestor
64976724|NCT00257452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64976725|NCT00257452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64976726|NCT00257452|Respiratory System Agents|respiratory system agents|mesh-ancestor
64976727|NCT00257452|Parasympatholytics|parasympatholytics|mesh-ancestor
64976728|NCT00257452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64976729|NCT00257452|Cholinergic Agents|cholinergic agents|mesh-ancestor
64976730|NCT00257452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64976731|NCT00257491|Telmisartan|telmisartan|mesh-list
64976758|NCT00070655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64976759|NCT00070655|Protease Inhibitors|protease inhibitors|mesh-ancestor
64976760|NCT00070655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976761|NCT00257530|Imiquimod|imiquimod|mesh-list
64976762|NCT00257530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64976763|NCT00257530|Immunologic Factors|immunologic factors|mesh-ancestor
64976764|NCT00257530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976765|NCT00257530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976766|NCT00257530|Interferon Inducers|interferon inducers|mesh-ancestor
64976767|NCT00257569|Cetirizine|cetirizine|mesh-list
64976768|NCT00257569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64976770|NCT00257569|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64976771|NCT00257569|Histamine Antagonists|histamine antagonists|mesh-ancestor
64976772|NCT00257569|Histamine Agents|histamine agents|mesh-ancestor
64976773|NCT00257569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64976774|NCT00257569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976775|NCT00257569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976776|NCT00100893|Proanthocyanidin|proanthocyanidin|mesh-list
64976777|NCT00100893|Procyanidin|procyanidin|mesh-list
64976778|NCT00100893|Antioxidants|antioxidants|mesh-ancestor
64976779|NCT00100893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976780|NCT00100893|Protective Agents|protective agents|mesh-ancestor
64976781|NCT00100893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976782|NCT00100893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64976783|NCT00100893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64976784|NCT00100893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64976785|NCT00257803|Oxytocin|oxytocin|mesh-list
64976786|NCT00257803|Oxytocics|oxytocics|mesh-ancestor
64976787|NCT00257803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64976788|NCT00257803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976789|NCT00401115|Sirolimus|sirolimus|mesh-list
64976798|NCT00257959|Amiodarone|amiodarone|mesh-list
64976800|NCT00257959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64585094|NCT02009449|Oxaliplatin|oxaliplatin|mesh-list
64585095|NCT02009449|Nivolumab|nivolumab|mesh-list
64585096|NCT02009449|Levoleucovorin|levoleucovorin|mesh-list
64585097|NCT02009449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64585098|NCT02009449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585099|NCT02009449|Tubulin Modulators|tubulin modulators|mesh-ancestor
64585100|NCT02009449|Antimitotic Agents|antimitotic agents|mesh-ancestor
64585101|NCT02009449|Mitosis Modulators|mitosis modulators|mesh-ancestor
64585102|NCT02009449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976801|NCT00257959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64976802|NCT00257959|Adrenergic Agents|adrenergic agents|mesh-ancestor
64976803|NCT00257959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64976804|NCT00257959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976805|NCT00257959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976806|NCT00257959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64976807|NCT00257959|Vasodilator Agents|vasodilator agents|mesh-ancestor
64976808|NCT00257959|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64976809|NCT00257959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64976810|NCT00257959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64976811|NCT00257959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64976812|NCT00257959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64976813|NCT00257959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976814|NCT00257959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64976815|NCT00257959|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64976816|NCT00257959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64976817|NCT00257959|Sympatholytics|sympatholytics|mesh-ancestor
64976818|NCT00257959|Autonomic Agents|autonomic agents|mesh-ancestor
64976819|NCT00257959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64976820|NCT00070733|Methyltestosterone|methyltestosterone|mesh-list
64976821|NCT00070733|Testosterone|testosterone|mesh-list
64976822|NCT00070733|Testosterone undecanoate|testosterone undecanoate|mesh-list
64976823|NCT00070733|Testosterone enanthate|testosterone enanthate|mesh-list
64976824|NCT00070733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64976825|NCT00070733|Androgens|androgens|mesh-ancestor
64976826|NCT00070733|Hormones|hormones|mesh-ancestor
64976845|NCT00258193|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64976847|NCT00258193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976848|NCT00258193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64976849|NCT00100971|Vaccines|vaccines|mesh-list
64976850|NCT00100971|Immunologic Factors|immunologic factors|mesh-ancestor
64976851|NCT00100971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976852|NCT00258232|Celecoxib|celecoxib|mesh-list
64976853|NCT00258232|Capecitabine|capecitabine|mesh-list
64976854|NCT00258232|Irinotecan|irinotecan|mesh-list
64976855|NCT00258232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64976856|NCT00258232|Antimetabolites|antimetabolites|mesh-ancestor
64976857|NCT00258232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976858|NCT00258232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976859|NCT00258232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64976860|NCT00258232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64976861|NCT00258232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976862|NCT00258232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64976863|NCT00258232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64976864|NCT00258232|Analgesics|analgesics|mesh-ancestor
64976865|NCT00258232|Sensory System Agents|sensory system agents|mesh-ancestor
64976866|NCT00258232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64976898|NCT00258388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64976899|NCT00101088|Sirolimus|sirolimus|mesh-list
64976900|NCT00101088|Imatinib Mesylate|imatinib mesylate|mesh-list
64585107|NCT02009449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366754|NCT02729051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64366766|NCT03237637|Propranolol|propranolol|mesh-list
64976901|NCT00101088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976904|NCT00101088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976905|NCT00101088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64976906|NCT00101088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64976907|NCT00101088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64976908|NCT00101088|Antifungal Agents|antifungal agents|mesh-ancestor
64976909|NCT00101088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64976910|NCT00101088|Immunologic Factors|immunologic factors|mesh-ancestor
64976911|NCT00101088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976912|NCT00258622|Lidocaine|lidocaine|mesh-list
64976913|NCT00258622|Anesthetics, Local|anesthetics, local|mesh-ancestor
64976914|NCT00258622|Anesthetics|anesthetics|mesh-ancestor
64976924|NCT00423761|Midazolam|midazolam|mesh-list
64976955|NCT00258739|Immunologic Factors|immunologic factors|mesh-ancestor
64976956|NCT00258739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64976957|NCT00258739|Tubulin Modulators|tubulin modulators|mesh-ancestor
64976958|NCT00258739|Antimitotic Agents|antimitotic agents|mesh-ancestor
64976959|NCT00258739|Mitosis Modulators|mitosis modulators|mesh-ancestor
64976960|NCT00104949|Trastuzumab|trastuzumab|mesh-list
64976961|NCT00104949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64976962|NCT00104949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976963|NCT00101127|Gemcitabine|gemcitabine|mesh-list
64976964|NCT00101127|Docetaxel|docetaxel|mesh-list
64976965|NCT00101127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64976966|NCT00101127|Antimetabolites|antimetabolites|mesh-ancestor
64976967|NCT00101127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64976968|NCT00101127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64976969|NCT00101127|Antiviral Agents|antiviral agents|mesh-ancestor
64976970|NCT00101127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64976971|NCT00101127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64976972|NCT00101127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64976973|NCT00101127|Immunologic Factors|immunologic factors|mesh-ancestor
64977011|NCT00104988|Growth Substances|growth substances|mesh-ancestor
64977012|NCT00104988|Growth Inhibitors|growth inhibitors|mesh-ancestor
64977013|NCT00415402|Vitamin D|vitamin d|mesh-list
64977014|NCT00415402|Cholecalciferol|cholecalciferol|mesh-list
64977015|NCT00415402|Vitamins|vitamins|mesh-ancestor
64334232|NCT02352597|Enclomiphene|enclomiphene|mesh-list
64334233|NCT02352597|Zuclomiphene|zuclomiphene|mesh-list
64977016|NCT00415402|Micronutrients|micronutrients|mesh-ancestor
64334234|NCT02352597|Estradiol|estradiol|mesh-list
64334235|NCT02352597|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64334236|NCT02352597|Phytoestrogens|phytoestrogens|mesh-list
64334237|NCT02352597|Estrogens|estrogens|mesh-ancestor
64334238|NCT02352597|Hormones|hormones|mesh-ancestor
64366809|NCT05600075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64366810|NCT05600075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366811|NCT05600075|Keratolytic Agents|keratolytic agents|mesh-ancestor
64366812|NCT05600075|Dermatologic Agents|dermatologic agents|mesh-ancestor
64366813|NCT02512601|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
64366814|NCT02512601|Anticoagulants|anticoagulants|mesh-ancestor
64366815|NCT02512601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64366816|NCT02512601|Antimetabolites|antimetabolites|mesh-ancestor
64366847|NCT02512523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977017|NCT00415402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977018|NCT00415402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64977019|NCT00415402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64977020|NCT00259402|Fluorouracil|fluorouracil|mesh-list
64977021|NCT00259402|Oxaliplatin|oxaliplatin|mesh-list
64977022|NCT00259402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977023|NCT00259402|Antimetabolites|antimetabolites|mesh-ancestor
64977024|NCT00259402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977025|NCT00259402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64977026|NCT00259402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64977027|NCT00259402|Immunologic Factors|immunologic factors|mesh-ancestor
64977028|NCT00259402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977029|NCT00259441|Simvastatin|simvastatin|mesh-list
64977030|NCT00259441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64977031|NCT00259441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64977032|NCT00259441|Antimetabolites|antimetabolites|mesh-ancestor
64977033|NCT00259441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977034|NCT00259441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64977035|NCT00259441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64977036|NCT00259441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977037|NCT00071201|Adefovir|adefovir|mesh-list
64977038|NCT00071201|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64977039|NCT00071201|Antiviral Agents|antiviral agents|mesh-ancestor
64977045|NCT00259636|Zonisamide|zonisamide|mesh-list
64977056|NCT00259675|Antimetabolites|antimetabolites|mesh-ancestor
64977057|NCT00259675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977058|NCT00259675|Antiviral Agents|antiviral agents|mesh-ancestor
64977059|NCT00259675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64977060|NCT00259675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977061|NCT00259675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64977062|NCT00259675|Immunologic Factors|immunologic factors|mesh-ancestor
64977063|NCT00259675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977064|NCT00105105|Mifepristone|mifepristone|mesh-list
64585109|NCT02009449|Immunologic Factors|immunologic factors|mesh-ancestor
64585110|NCT02009449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585111|NCT02009449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64585112|NCT02009449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64585113|NCT02009449|Antidotes|antidotes|mesh-ancestor
64585114|NCT02009449|Protective Agents|protective agents|mesh-ancestor
64585115|NCT02009449|Vitamin B Complex|vitamin b complex|mesh-ancestor
64585117|NCT02009449|Micronutrients|micronutrients|mesh-ancestor
64366892|NCT02512055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64366893|NCT02512055|Respiratory System Agents|respiratory system agents|mesh-ancestor
64366894|NCT02512055|Mydriatics|mydriatics|mesh-ancestor
64366895|NCT02512055|Parasympatholytics|parasympatholytics|mesh-ancestor
64366896|NCT02512055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64366897|NCT02512055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64366898|NCT02512055|Cholinergic Agents|cholinergic agents|mesh-ancestor
64366899|NCT05211895|Durvalumab|durvalumab|mesh-list
64366900|NCT05211895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64366901|NCT05211895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366939|NCT02511353|Artenimol|artenimol|mesh-list
64977065|NCT00105105|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64977066|NCT00105105|Abortifacient Agents|abortifacient agents|mesh-ancestor
64977067|NCT00105105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64977078|NCT00105105|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64977079|NCT00105105|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64977105|NCT00105144|Antifungal Agents|antifungal agents|mesh-ancestor
64977106|NCT00105144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64977107|NCT00105144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977108|NCT00105144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977109|NCT00259870|Olanzapine|olanzapine|mesh-list
64977110|NCT00259870|Antiemetics|antiemetics|mesh-ancestor
64977111|NCT00259870|Autonomic Agents|autonomic agents|mesh-ancestor
64977112|NCT00259870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64977113|NCT00259870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977114|NCT00259870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64977115|NCT00259870|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64977116|NCT00259870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64977117|NCT00259870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64977118|NCT00259870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64977119|NCT00259870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64977120|NCT00259870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64977121|NCT00259870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64977122|NCT00259870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977123|NCT00259870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64977124|NCT00259870|Serotonin Agents|serotonin agents|mesh-ancestor
64977125|NCT00071279|Idraparinux|idraparinux|mesh-list
64977126|NCT00071279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64977127|NCT00071279|Antithrombins|antithrombins|mesh-ancestor
64977128|NCT00071279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64977129|NCT00071279|Protease Inhibitors|protease inhibitors|mesh-ancestor
64977130|NCT00071279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977131|NCT00071279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977132|NCT00071279|Anticoagulants|anticoagulants|mesh-ancestor
64977133|NCT00259987|Lapatinib|lapatinib|mesh-list
64977134|NCT00259987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977136|NCT00259987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977146|NCT00260143|Testosterone undecanoate|testosterone undecanoate|mesh-list
64977147|NCT00260143|Testosterone enanthate|testosterone enanthate|mesh-list
64977148|NCT00260143|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64977149|NCT00260143|Androgens|androgens|mesh-ancestor
64977150|NCT00260143|Hormones|hormones|mesh-ancestor
64977151|NCT00260143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64367011|NCT02513849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367012|NCT02513849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64367013|NCT02513849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64367014|NCT02513849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64367015|NCT02513849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64367016|NCT02513849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64367018|NCT02513927|Nifedipine|nifedipine|mesh-list
64367019|NCT02513927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64367020|NCT02513927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64977152|NCT00260143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977153|NCT00260143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64977154|NCT00260143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977212|NCT00071747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64977213|NCT00071747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64977214|NCT00071747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64977215|NCT00071747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64977216|NCT00261313|Darbepoetin alfa|darbepoetin alfa|mesh-list
64977217|NCT00261313|Hematinics|hematinics|mesh-ancestor
64977218|NCT00261352|Metformin|metformin|mesh-list
64977219|NCT00261352|Fenofibrate|fenofibrate|mesh-list
64977220|NCT00261352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64977221|NCT00261352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977276|NCT00261586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64977277|NCT00261586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64977278|NCT00261586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977279|NCT00261586|Antipyretics|antipyretics|mesh-ancestor
64977280|NCT00261586|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64977281|NCT00261586|Gout Suppressants|gout suppressants|mesh-ancestor
64977282|NCT00072020|Zoledronic Acid|zoledronic acid|mesh-list
64977283|NCT00072020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64977284|NCT00072020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977285|NCT00261625|Alendronate|alendronate|mesh-list
64977286|NCT00261625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64977287|NCT00261625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977289|NCT00261703|Docetaxel|docetaxel|mesh-list
64977290|NCT00261703|Fluorouracil|fluorouracil|mesh-list
64977291|NCT00261703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977313|NCT00261820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977314|NCT00261820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64977315|NCT00261820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977316|NCT00261820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977317|NCT00261820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64977319|NCT00261820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64977320|NCT00261820|Antitubercular Agents|antitubercular agents|mesh-ancestor
64977321|NCT00261820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64977322|NCT00261820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64977323|NCT00261820|Antifungal Agents|antifungal agents|mesh-ancestor
64977324|NCT00261820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64977325|NCT00261820|Antiemetics|antiemetics|mesh-ancestor
64977326|NCT00261820|Autonomic Agents|autonomic agents|mesh-ancestor
64977327|NCT00261820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64977328|NCT00261820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64977329|NCT00261820|Glucocorticoids|glucocorticoids|mesh-ancestor
64977330|NCT00261820|Hormones|hormones|mesh-ancestor
64334239|NCT02352597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64334241|NCT02352597|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64334242|NCT02352597|Contraceptive Agents|contraceptive agents|mesh-ancestor
64334243|NCT02352597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64334244|NCT02352597|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64334245|NCT02352597|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64334246|NCT02352597|Hormone Antagonists|hormone antagonists|mesh-ancestor
64367038|NCT03236623|Antipruritics|antipruritics|mesh-ancestor
64367039|NCT03236623|Dermatologic Agents|dermatologic agents|mesh-ancestor
64367040|NCT03121313|Tegafur|tegafur|mesh-list
64977331|NCT00261820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64977332|NCT00261820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64977367|NCT00072137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977368|NCT00072137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977369|NCT00072137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64977370|NCT00072137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64977371|NCT00072137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64977372|NCT00072137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64977373|NCT00262015|Vaccines|vaccines|mesh-list
64977374|NCT00262015|Immunologic Factors|immunologic factors|mesh-ancestor
64977375|NCT00262015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977376|NCT00262054|Heparin|heparin|mesh-list
64977377|NCT00262054|Calcium heparin|calcium heparin|mesh-list
64977378|NCT00262054|Bivalirudin|bivalirudin|mesh-list
64977379|NCT00262054|Anticoagulants|anticoagulants|mesh-ancestor
64977380|NCT00262054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64977381|NCT00262054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64977382|NCT00262054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977383|NCT00262054|Antithrombins|antithrombins|mesh-ancestor
64977384|NCT00262054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64977385|NCT00262054|Protease Inhibitors|protease inhibitors|mesh-ancestor
64977386|NCT00262054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977387|NCT00262132|Mycophenolic Acid|mycophenolic acid|mesh-list
64977388|NCT00262132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64977389|NCT00262132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977420|NCT00262288|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64585119|NCT01794091|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64585120|NCT01794091|Hormone Antagonists|hormone antagonists|mesh-ancestor
64585121|NCT01794091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64585122|NCT01794091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585123|NCT01794091|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64585124|NCT01794091|Diuretics|diuretics|mesh-ancestor
64585125|NCT01794091|Natriuretic Agents|natriuretic agents|mesh-ancestor
64585126|NCT01794091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64585127|NCT01794169|Cytarabine|cytarabine|mesh-list
64367091|NCT02510963|Antiviral Agents|antiviral agents|mesh-ancestor
64367092|NCT02510963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64367093|NCT02510963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64367094|NCT02510963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64367095|NCT02510963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64367127|NCT03232021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64367129|NCT03235609|Fentanyl|fentanyl|mesh-list
64367130|NCT03235609|Ketamine|ketamine|mesh-list
64367131|NCT03235609|Analgesics|analgesics|mesh-ancestor
64367132|NCT03235609|Sensory System Agents|sensory system agents|mesh-ancestor
64367133|NCT03235609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367134|NCT03235609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367135|NCT03235609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64977421|NCT00262288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64977422|NCT00262288|Immunologic Factors|immunologic factors|mesh-ancestor
64977423|NCT00262288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977424|NCT00262327|Endostatins|endostatins|mesh-list
64977425|NCT00262327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977426|NCT00262327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64977427|NCT00262327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64977428|NCT00262327|Growth Substances|growth substances|mesh-ancestor
64977429|NCT00262327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977430|NCT00262327|Growth Inhibitors|growth inhibitors|mesh-ancestor
64977432|NCT02966288|Ketorolac|ketorolac|mesh-list
64977433|NCT02966288|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64977434|NCT02966288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64977435|NCT02966288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64977436|NCT02966288|Analgesics|analgesics|mesh-ancestor
64977437|NCT02966288|Sensory System Agents|sensory system agents|mesh-ancestor
64977438|NCT02966288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64977439|NCT02966288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977440|NCT02966288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64977441|NCT02966288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64977442|NCT02966288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64977471|NCT00262483|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64977472|NCT00262483|Antimetabolites|antimetabolites|mesh-ancestor
64977473|NCT00262483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977474|NCT00262483|Antiviral Agents|antiviral agents|mesh-ancestor
64977475|NCT00262483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64977476|NCT00262561|Aspirin|aspirin|mesh-list
64977477|NCT00262561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64977478|NCT00262561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64977479|NCT00262561|Analgesics|analgesics|mesh-ancestor
64977480|NCT00262561|Sensory System Agents|sensory system agents|mesh-ancestor
64977481|NCT00262561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64977482|NCT00262561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977483|NCT00262561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64977484|NCT00262561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64334247|NCT02352597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64334248|NCT02352597|Fertility Agents|fertility agents|mesh-ancestor
64334249|NCT02352597|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64367175|NCT02501603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64367176|NCT02501603|Tubulin Modulators|tubulin modulators|mesh-ancestor
64367177|NCT02501603|Antimitotic Agents|antimitotic agents|mesh-ancestor
64367178|NCT02501603|Mitosis Modulators|mitosis modulators|mesh-ancestor
64367179|NCT02501603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367180|NCT02501603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64367181|NCT02501603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64367182|NCT03344627|Meropenem|meropenem|mesh-list
64977485|NCT00262561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64977488|NCT00262561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64977489|NCT00262561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64977490|NCT00262561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977491|NCT00262561|Antipyretics|antipyretics|mesh-ancestor
64977492|NCT00072215|Paclitaxel|paclitaxel|mesh-list
64977493|NCT00072215|Vinblastine|vinblastine|mesh-list
64977494|NCT00072215|Ifosfamide|ifosfamide|mesh-list
64977495|NCT00072215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64977503|NCT00262795|Fludarabine|fludarabine|mesh-list
64977519|NCT00263068|Dopamine Agents|dopamine agents|mesh-ancestor
64977520|NCT00263068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64977521|NCT00263068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977522|NCT00263068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977523|NCT00101634|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64977524|NCT00101634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64977525|NCT00101634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64977526|NCT00101634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64977527|NCT00101634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977528|NCT00101634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64977529|NCT00101634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64977530|NCT00101634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64977531|NCT00101634|Serotonin Agents|serotonin agents|mesh-ancestor
64977532|NCT00101634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64977533|NCT00101634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977535|NCT00101634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64977577|NCT00263458|Buprenorphine|buprenorphine|mesh-list
64977578|NCT00263458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64977579|NCT00263458|Narcotics|narcotics|mesh-ancestor
64977580|NCT00263458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64977581|NCT00263458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977582|NCT00263458|Analgesics|analgesics|mesh-ancestor
64977583|NCT00263458|Sensory System Agents|sensory system agents|mesh-ancestor
64977584|NCT00263458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64977585|NCT00263458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64977586|NCT00101712|Vildagliptin|vildagliptin|mesh-list
64977587|NCT00101712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64977588|NCT00101712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977589|NCT00101712|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64977590|NCT00101712|Protease Inhibitors|protease inhibitors|mesh-ancestor
64977591|NCT00101712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977593|NCT00072527|Carboplatin|carboplatin|mesh-list
64977638|NCT04709029|Autonomic Agents|autonomic agents|mesh-ancestor
64977639|NCT04709029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64977640|NCT04709029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977641|NCT04709029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64977642|NCT04709029|Glucocorticoids|glucocorticoids|mesh-ancestor
64334250|NCT02352597|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64334251|NCT02352597|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64334252|NCT03521167|Acetaminophen|acetaminophen|mesh-list
64334253|NCT03521167|Lidocaine|lidocaine|mesh-list
64585129|NCT01794169|Daunorubicin|daunorubicin|mesh-list
64585130|NCT01794169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64585131|NCT01794169|Antimetabolites|antimetabolites|mesh-ancestor
64585132|NCT01794169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585133|NCT01794169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977644|NCT04709029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64977645|NCT04709029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64977646|NCT04709029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977647|NCT04709029|Protease Inhibitors|protease inhibitors|mesh-ancestor
64977648|NCT04709029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977649|NCT04709029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977650|NCT00072722|Pomalidomide|pomalidomide|mesh-list
64977651|NCT00072722|Immunologic Factors|immunologic factors|mesh-ancestor
64977652|NCT00072722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977653|NCT00072722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64977654|NCT00072722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64977655|NCT00072722|Growth Substances|growth substances|mesh-ancestor
64977656|NCT00072722|Growth Inhibitors|growth inhibitors|mesh-ancestor
64977657|NCT00072722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977658|NCT00264355|Cyclosporine|cyclosporine|mesh-list
64977659|NCT00264355|Cyclosporins|cyclosporins|mesh-list
64977660|NCT00264355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977661|NCT00264355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977662|NCT00264355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64977663|NCT00264355|Immunologic Factors|immunologic factors|mesh-ancestor
64977686|NCT00264628|Autonomic Agents|autonomic agents|mesh-ancestor
64977687|NCT00264628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64977688|NCT00264628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977689|NCT00264628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64977697|NCT00265018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64977745|NCT00265291|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64977746|NCT00265291|Adrenergic Agents|adrenergic agents|mesh-ancestor
64977749|NCT00265408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64585135|NCT01794169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64585136|NCT01794169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64367272|NCT02500667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64367292|NCT03344393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64367293|NCT03344393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64367294|NCT03344393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367295|NCT04498793|Paclitaxel|paclitaxel|mesh-list
64367296|NCT04498793|Cyclophosphamide|cyclophosphamide|mesh-list
64367297|NCT04498793|Doxorubicin|doxorubicin|mesh-list
64367298|NCT04498793|Epirubicin|epirubicin|mesh-list
64367299|NCT04498793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64367300|NCT04498793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64367301|NCT04498793|Tubulin Modulators|tubulin modulators|mesh-ancestor
64367302|NCT04498793|Antimitotic Agents|antimitotic agents|mesh-ancestor
64367303|NCT04498793|Mitosis Modulators|mitosis modulators|mesh-ancestor
64367304|NCT04498793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367305|NCT04498793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64367306|NCT04498793|Immunologic Factors|immunologic factors|mesh-ancestor
64367307|NCT04498793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977750|NCT00265408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64977751|NCT00265408|Analgesics|analgesics|mesh-ancestor
64977752|NCT00265408|Sensory System Agents|sensory system agents|mesh-ancestor
64977753|NCT00265408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64977754|NCT00265408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977755|NCT00265408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64977756|NCT00265408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64977757|NCT00265408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64977758|NCT00265408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64977759|NCT00265408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977760|NCT00265408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64977761|NCT00265408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64977762|NCT00265408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977763|NCT00265408|Antipyretics|antipyretics|mesh-ancestor
64977764|NCT00265408|Anticoagulants|anticoagulants|mesh-ancestor
64977765|NCT00265486|Epoetin Alfa|epoetin alfa|mesh-list
64977766|NCT00265486|Hematinics|hematinics|mesh-ancestor
64977767|NCT00265642|Irbesartan|irbesartan|mesh-list
64977768|NCT00265642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64977769|NCT00265642|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64977770|NCT00265642|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64977771|NCT00265642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977772|NCT00265876|Gemcitabine|gemcitabine|mesh-list
64977773|NCT00265876|Saracatinib|saracatinib|mesh-list
64977774|NCT00265876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64977775|NCT00265876|Antimetabolites|antimetabolites|mesh-ancestor
64977776|NCT00265876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977777|NCT00265876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977778|NCT00265876|Antiviral Agents|antiviral agents|mesh-ancestor
64977780|NCT00265876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977781|NCT00265876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64977782|NCT00265876|Immunologic Factors|immunologic factors|mesh-ancestor
64977783|NCT00265876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977784|NCT00265915|Rituximab|rituximab|mesh-list
64977785|NCT00265915|Sargramostim|sargramostim|mesh-list
64977786|NCT00265915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64977787|NCT00265915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977788|NCT00265915|Immunologic Factors|immunologic factors|mesh-ancestor
64977789|NCT00265915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977790|NCT00265915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64977791|NCT00265993|Enoxaparin|enoxaparin|mesh-list
64977792|NCT00265993|Anticoagulants|anticoagulants|mesh-ancestor
64977793|NCT00265993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64334254|NCT03521167|Dexmedetomidine|dexmedetomidine|mesh-list
64334256|NCT03521167|Gabapentin|gabapentin|mesh-list
64334257|NCT03521167|Anesthetics, Local|anesthetics, local|mesh-ancestor
64977794|NCT00265993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64977838|NCT00102141|Estrogens|estrogens|mesh-ancestor
64977839|NCT00102141|Hormones|hormones|mesh-ancestor
64334258|NCT03521167|Anesthetics|anesthetics|mesh-ancestor
64367318|NCT04498325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367319|NCT02507843|Vitamin D|vitamin d|mesh-list
64977840|NCT00102141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64977841|NCT00102141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977842|NCT00102141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64977843|NCT00102141|Contraceptive Agents|contraceptive agents|mesh-ancestor
64977844|NCT00102141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64977845|NCT00102141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64977846|NCT00102141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64977847|NCT00102141|Hormone Antagonists|hormone antagonists|mesh-ancestor
64977848|NCT00102141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64977904|NCT01349569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64977905|NCT01349569|Growth Substances|growth substances|mesh-ancestor
64977906|NCT01349569|Growth Inhibitors|growth inhibitors|mesh-ancestor
64977907|NCT01349569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977908|NCT00267163|Donepezil|donepezil|mesh-list
64977909|NCT00267163|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64977910|NCT00267163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977911|NCT00267163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64977912|NCT00267163|Cholinergic Agents|cholinergic agents|mesh-ancestor
64977913|NCT00267163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64977914|NCT00267163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977915|NCT00267163|Nootropic Agents|nootropic agents|mesh-ancestor
64977960|NCT00106548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977961|NCT00106548|Dermatologic Agents|dermatologic agents|mesh-ancestor
64977962|NCT00106548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64977963|NCT00106548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64977964|NCT00106548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64977965|NCT00106548|Immunologic Factors|immunologic factors|mesh-ancestor
64977966|NCT00106548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64977967|NCT00106548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64977969|NCT00267709|Immunologic Factors|immunologic factors|mesh-ancestor
64977970|NCT00267709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977971|NCT00267826|Rituximab|rituximab|mesh-list
64977972|NCT00267826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64977973|NCT00267826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64977974|NCT00267826|Immunologic Factors|immunologic factors|mesh-ancestor
64977975|NCT00267826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64977976|NCT00267826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64977977|NCT00425620|Amphotericin B|amphotericin b|mesh-list
64977978|NCT00425620|Amebicides|amebicides|mesh-ancestor
64977979|NCT00425620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64334259|NCT03521167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64334260|NCT03521167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585138|NCT01794169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585139|NCT01794169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585140|NCT01794169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64585141|NCT01794169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64585142|NCT01794169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64585143|NCT00396019|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64585144|NCT00396019|Antiviral Agents|antiviral agents|mesh-ancestor
64367375|NCT03235531|Antiemetics|antiemetics|mesh-ancestor
64367376|NCT03235531|Autonomic Agents|autonomic agents|mesh-ancestor
64367377|NCT03235531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367378|NCT03235531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64977980|NCT00425620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64977981|NCT00425620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64977982|NCT00425620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64977983|NCT00425620|Antifungal Agents|antifungal agents|mesh-ancestor
64977991|NCT00267943|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64977992|NCT00267943|Telmisartan|telmisartan|mesh-list
64977993|NCT00267943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64977994|NCT00267943|Diuretics|diuretics|mesh-ancestor
64977995|NCT00267943|Natriuretic Agents|natriuretic agents|mesh-ancestor
64978006|NCT00268138|Cariostatic Agents|cariostatic agents|mesh-ancestor
64978007|NCT00268138|Protective Agents|protective agents|mesh-ancestor
64978008|NCT00268138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978009|NCT00102375|Topotecan|topotecan|mesh-list
64978010|NCT00102375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64978011|NCT00102375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64978012|NCT00102375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978013|NCT00102375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978014|NCT00102375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978015|NCT00268177|Fluticasone|fluticasone|mesh-list
64978016|NCT00268177|Xhance|xhance|mesh-list
64978017|NCT00268177|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64978018|NCT00268177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64978019|NCT00268177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64978020|NCT00268177|Autonomic Agents|autonomic agents|mesh-ancestor
64978021|NCT00268177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64978022|NCT00268177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978023|NCT00268177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64978024|NCT00268177|Respiratory System Agents|respiratory system agents|mesh-ancestor
64978025|NCT00268177|Dermatologic Agents|dermatologic agents|mesh-ancestor
64978026|NCT00268177|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64978027|NCT00268177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64978028|NCT00268177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64978029|NCT00268177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64978030|NCT00268177|Adrenergic Agents|adrenergic agents|mesh-ancestor
64978031|NCT00268177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64978032|NCT00268177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978033|NCT00268216|Fluticasone|fluticasone|mesh-list
64978034|NCT00268216|Xhance|xhance|mesh-list
64978035|NCT00268216|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64978036|NCT00268216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64978041|NCT00268216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64978044|NCT00268216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64978045|NCT00268216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64978046|NCT00268216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64978047|NCT00268216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64978048|NCT00268216|Adrenergic Agents|adrenergic agents|mesh-ancestor
64978049|NCT00268216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64978050|NCT00268216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978051|NCT00073580|Hirudins|hirudins|mesh-list
64978052|NCT00073580|Anticoagulants|anticoagulants|mesh-list
64978053|NCT00073580|Bivalirudin|bivalirudin|mesh-list
64978054|NCT00073580|Antithrombins|antithrombins|mesh-ancestor
64978055|NCT00073580|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64978056|NCT00073580|Protease Inhibitors|protease inhibitors|mesh-ancestor
64978057|NCT00073580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64367507|NCT03342599|Vitamin B Complex|vitamin b complex|mesh-ancestor
64367508|NCT03342599|Vitamins|vitamins|mesh-ancestor
64367509|NCT03342599|Micronutrients|micronutrients|mesh-ancestor
64367510|NCT03341117|Aspirin|aspirin|mesh-list
64367511|NCT03341117|Magnesium Oxide|magnesium oxide|mesh-list
64367512|NCT03341117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64367513|NCT03341117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64367514|NCT03341117|Analgesics|analgesics|mesh-ancestor
64367515|NCT03341117|Sensory System Agents|sensory system agents|mesh-ancestor
64367538|NCT02498171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64367540|NCT02498171|Analgesics|analgesics|mesh-ancestor
64978058|NCT00073580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978059|NCT00073580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64978060|NCT00073580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64978061|NCT00073658|Risperidone|risperidone|mesh-list
64978062|NCT00073658|Citalopram|citalopram|mesh-list
64978063|NCT00073658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64978064|NCT00073658|Serotonin Agents|serotonin agents|mesh-ancestor
64978065|NCT00073658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64978066|NCT00073658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978067|NCT00073658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978068|NCT00073658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64978069|NCT00073658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64978070|NCT00073658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64978071|NCT00073658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64978072|NCT00073658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64978073|NCT00073658|Dopamine Agents|dopamine agents|mesh-ancestor
64978074|NCT00073658|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64978075|NCT00073658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64978076|NCT00073658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64978081|NCT00268255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978082|NCT00268255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64978083|NCT00268255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978084|NCT00102414|Gemcitabine|gemcitabine|mesh-list
64978085|NCT00102414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64978086|NCT00102414|Antimetabolites|antimetabolites|mesh-ancestor
64978087|NCT00102414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978088|NCT00102414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978089|NCT00102414|Antiviral Agents|antiviral agents|mesh-ancestor
64978090|NCT00102414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64978091|NCT00102414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978092|NCT00102414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64978093|NCT00102414|Immunologic Factors|immunologic factors|mesh-ancestor
64978094|NCT00102414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978095|NCT00268333|Leucovorin|leucovorin|mesh-list
64978096|NCT00268333|Fluorouracil|fluorouracil|mesh-list
64978097|NCT00268333|Oxaliplatin|oxaliplatin|mesh-list
64978098|NCT00268333|Calcium|calcium|mesh-list
64978099|NCT00268333|Levoleucovorin|levoleucovorin|mesh-list
64978100|NCT00268333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64978101|NCT00268333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978135|NCT00268372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978136|NCT00268372|Tubulin Modulators|tubulin modulators|mesh-ancestor
64978137|NCT00268372|Antimitotic Agents|antimitotic agents|mesh-ancestor
64367639|NCT02497547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367640|NCT05043129|Vaccines|vaccines|mesh-list
64367641|NCT05043129|Immunologic Factors|immunologic factors|mesh-ancestor
64367642|NCT05043129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367643|NCT02497313|Metformin|metformin|mesh-list
64367644|NCT02497313|Cholecystokinin|cholecystokinin|mesh-list
64367645|NCT02497313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64367646|NCT02497313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367647|NCT02497313|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64367648|NCT02497313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64367650|NCT02497157|Bevacizumab|bevacizumab|mesh-list
64367651|NCT02497157|Fluorouracil|fluorouracil|mesh-list
64367652|NCT02497157|Oxaliplatin|oxaliplatin|mesh-list
64367653|NCT02497157|Irinotecan|irinotecan|mesh-list
64367685|NCT03095079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64978138|NCT00268372|Mitosis Modulators|mitosis modulators|mesh-ancestor
64978139|NCT00268372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978141|NCT00268372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64978142|NCT00268372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64978143|NCT00268372|Immunologic Factors|immunologic factors|mesh-ancestor
64978144|NCT00268372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978145|NCT00268411|Gemcitabine|gemcitabine|mesh-list
64978146|NCT00268411|Oxaliplatin|oxaliplatin|mesh-list
64978147|NCT00268411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64978188|NCT00268528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978189|NCT00268528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978190|NCT00268528|Dermatologic Agents|dermatologic agents|mesh-ancestor
64978191|NCT00268528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978192|NCT00268528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64978193|NCT00268528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64978194|NCT00268528|Immunologic Factors|immunologic factors|mesh-ancestor
64978195|NCT00268528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64978196|NCT00268528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64978197|NCT00073814|Albuterol|albuterol|mesh-list
64978198|NCT00073814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64978199|NCT00073814|Autonomic Agents|autonomic agents|mesh-ancestor
64978200|NCT00073814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64978201|NCT00073814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978202|NCT00073814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64978203|NCT00073814|Respiratory System Agents|respiratory system agents|mesh-ancestor
64978204|NCT00073814|Tocolytic Agents|tocolytic agents|mesh-ancestor
64978205|NCT00073814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64978241|NCT00268684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64978242|NCT00268684|Alkylating Agents|alkylating agents|mesh-ancestor
64978243|NCT00268684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978244|NCT00268684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978245|NCT00268684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64978246|NCT00268684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334261|NCT03521167|Sensory System Agents|sensory system agents|mesh-ancestor
64334262|NCT03521167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334263|NCT03521167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64334264|NCT03521167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64334265|NCT03521167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64978247|NCT00106821|Bromides|bromides|mesh-list
64978248|NCT00106821|Tiotropium Bromide|tiotropium bromide|mesh-list
64978249|NCT00106821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64978250|NCT00106821|Autonomic Agents|autonomic agents|mesh-ancestor
64978251|NCT00106821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64978252|NCT00106821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978253|NCT00106821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64978254|NCT00106821|Respiratory System Agents|respiratory system agents|mesh-ancestor
64978255|NCT00106821|Parasympatholytics|parasympatholytics|mesh-ancestor
64978256|NCT00106821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64978257|NCT00106821|Cholinergic Agents|cholinergic agents|mesh-ancestor
64978260|NCT00106821|Anticonvulsants|anticonvulsants|mesh-ancestor
64978298|NCT00268879|Serotonin Agents|serotonin agents|mesh-ancestor
64978299|NCT00268879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64978300|NCT00268879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978301|NCT00268879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978302|NCT00268918|Docetaxel|docetaxel|mesh-list
64978303|NCT00268918|Vatalanib|vatalanib|mesh-list
64978304|NCT00268918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978305|NCT00268918|Tubulin Modulators|tubulin modulators|mesh-ancestor
64978306|NCT00268918|Antimitotic Agents|antimitotic agents|mesh-ancestor
64978307|NCT00268918|Mitosis Modulators|mitosis modulators|mesh-ancestor
64978308|NCT00268918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978309|NCT00268918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64585159|NCT01390220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64585160|NCT01390220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585161|NCT00357331|Potassium Citrate|potassium citrate|mesh-list
64585162|NCT00357331|Diuretics|diuretics|mesh-ancestor
64585163|NCT00357331|Natriuretic Agents|natriuretic agents|mesh-ancestor
64585164|NCT00357331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585165|NCT00357331|Expectorants|expectorants|mesh-ancestor
64367828|NCT02496299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64367829|NCT02496299|Glucocorticoids|glucocorticoids|mesh-ancestor
64367863|NCT02493335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367864|NCT02493335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64367865|NCT02493335|Respiratory System Agents|respiratory system agents|mesh-ancestor
64367866|NCT02493335|Glucocorticoids|glucocorticoids|mesh-ancestor
64367867|NCT02493335|Hormones|hormones|mesh-ancestor
64367868|NCT02493335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64367869|NCT03336593|Vaccines|vaccines|mesh-list
64367870|NCT03336593|Immunologic Factors|immunologic factors|mesh-ancestor
64367871|NCT03336593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978359|NCT00269386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64978360|NCT00074087|Doxorubicin|doxorubicin|mesh-list
64978361|NCT00074087|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64978362|NCT00074087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64978363|NCT00074087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978364|NCT00074087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64978365|NCT00074087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64978366|NCT00074087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978367|NCT00074087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978369|NCT00269542|Folic Acid|folic acid|mesh-list
64978370|NCT00269542|Vitamin B Complex|vitamin b complex|mesh-list
64978430|NCT00269737|Fentanyl|fentanyl|mesh-list
64978431|NCT00269737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64978432|NCT00269737|Narcotics|narcotics|mesh-ancestor
64978433|NCT00269737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64978434|NCT00269737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978435|NCT00269737|Analgesics|analgesics|mesh-ancestor
64978436|NCT00269737|Sensory System Agents|sensory system agents|mesh-ancestor
64978437|NCT00269737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64978438|NCT00269737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64978439|NCT00269737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64978440|NCT00269737|Anesthetics, General|anesthetics, general|mesh-ancestor
64978441|NCT00269737|Anesthetics|anesthetics|mesh-ancestor
64978442|NCT00269776|Methylphenidate|methylphenidate|mesh-list
64978443|NCT00269776|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64978444|NCT00269776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978445|NCT00269776|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64978446|NCT00269776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64585167|NCT00550173|Pemetrexed|pemetrexed|mesh-list
64585168|NCT00550173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64585169|NCT00550173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585170|NCT00550173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585171|NCT00550173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585172|NCT00550173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64585173|NCT00550173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64585174|NCT00550173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64585175|NCT04163107|Hydroxychloroquine|hydroxychloroquine|mesh-list
64585176|NCT04163107|Dexamethasone|dexamethasone|mesh-list
64585177|NCT04163107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64585178|NCT04163107|Antiemetics|antiemetics|mesh-ancestor
64585179|NCT04163107|Autonomic Agents|autonomic agents|mesh-ancestor
64585180|NCT04163107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64585181|NCT04163107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978447|NCT00269776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64978448|NCT00269776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978470|NCT00269854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64978471|NCT00269893|Abciximab|abciximab|mesh-list
64978472|NCT00269893|Anticoagulants|anticoagulants|mesh-ancestor
64978473|NCT00269893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64978474|NCT00074321|Capecitabine|capecitabine|mesh-list
64978475|NCT00074321|Oxaliplatin|oxaliplatin|mesh-list
64978476|NCT00074321|Irinotecan|irinotecan|mesh-list
64978477|NCT00074321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64978478|NCT00074321|Antimetabolites|antimetabolites|mesh-ancestor
64978479|NCT00074321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978480|NCT00074321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978481|NCT00074321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64978482|NCT00074321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64978483|NCT00074321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978532|NCT00107016|Hormone Antagonists|hormone antagonists|mesh-ancestor
64978533|NCT00107016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64978534|NCT00107016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978535|NCT00107016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64978536|NCT00107016|Immunologic Factors|immunologic factors|mesh-ancestor
64978538|NCT00270088|Hematinics|hematinics|mesh-ancestor
64978539|NCT00270127|Epoetin Alfa|epoetin alfa|mesh-list
64978540|NCT00270127|Hematinics|hematinics|mesh-ancestor
64978541|NCT00270166|Epoetin Alfa|epoetin alfa|mesh-list
64978542|NCT00270166|Hematinics|hematinics|mesh-ancestor
64978543|NCT00074399|Nevirapine|nevirapine|mesh-list
64978544|NCT00074399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64978596|NCT00270517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64978597|NCT00270556|Tenofovir|tenofovir|mesh-list
64978598|NCT00270556|Abacavir|abacavir|mesh-list
64978599|NCT00270556|Antiviral Agents|antiviral agents|mesh-ancestor
64978600|NCT00270556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64978601|NCT00270556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64978602|NCT00270556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64978603|NCT00270556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978604|NCT00270556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978605|NCT00270556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64978606|NCT00270556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64978608|NCT00074438|Methotrexate|methotrexate|mesh-list
64978609|NCT00074438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64978610|NCT00074438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978611|NCT00074438|Immunologic Factors|immunologic factors|mesh-ancestor
64978614|NCT00074438|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64978625|NCT00270751|Minocycline|minocycline|mesh-list
64978650|NCT00270907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978651|NCT00270907|Antiviral Agents|antiviral agents|mesh-ancestor
64978652|NCT00270907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64978653|NCT00270907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978654|NCT00270907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64978655|NCT00270907|Immunologic Factors|immunologic factors|mesh-ancestor
64978656|NCT00270907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978657|NCT00271063|Annamycin|annamycin|mesh-list
64978658|NCT00271063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64978659|NCT00271063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978660|NCT00107523|Cytarabine|cytarabine|mesh-list
64978661|NCT00107523|Idarubicin|idarubicin|mesh-list
64978662|NCT00107523|Pravastatin|pravastatin|mesh-list
64978663|NCT00107523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64978664|NCT00107523|Antimetabolites|antimetabolites|mesh-ancestor
64978665|NCT00107523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978666|NCT00107523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978667|NCT00107523|Antiviral Agents|antiviral agents|mesh-ancestor
64978708|NCT02965859|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64978709|NCT02965859|Antiviral Agents|antiviral agents|mesh-ancestor
64978710|NCT02965859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64978711|NCT02965859|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64978712|NCT02965859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64978713|NCT02965859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978714|NCT02965859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978715|NCT00271336|Pentoxifylline|pentoxifylline|mesh-list
64978716|NCT00271336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64978717|NCT00271336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978718|NCT00271336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978719|NCT00271336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64585203|NCT01408628|Insulin|insulin|mesh-list
64585204|NCT01408628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64585205|NCT01408628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585206|NCT01389752|Charcoal|charcoal|mesh-list
64585207|NCT01389752|Antidotes|antidotes|mesh-ancestor
64585208|NCT01389752|Protective Agents|protective agents|mesh-ancestor
64585209|NCT01389752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585210|NCT01428128|Arsenic Trioxide|arsenic trioxide|mesh-list
64334291|NCT02352519|Sensory System Agents|sensory system agents|mesh-ancestor
64334292|NCT02352519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334293|NCT02356419|Epoetin Alfa|epoetin alfa|mesh-list
64585211|NCT01428128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585212|NCT00358501|Defibrotide|defibrotide|mesh-list
64585213|NCT00358501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64585214|NCT00358501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64585215|NCT00358501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585216|NCT00358501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64585217|NCT01427972|Eplerenone|eplerenone|mesh-list
64585218|NCT01427972|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64368089|NCT03334487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64978720|NCT00271336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64978721|NCT00271336|Protective Agents|protective agents|mesh-ancestor
64978722|NCT00271336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978723|NCT00271336|Vasodilator Agents|vasodilator agents|mesh-ancestor
64978724|NCT00271336|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64978725|NCT00271336|Antioxidants|antioxidants|mesh-ancestor
64978726|NCT00271414|Fentanyl|fentanyl|mesh-list
64978727|NCT00271414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64978728|NCT00271414|Narcotics|narcotics|mesh-ancestor
64978729|NCT00271414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64978730|NCT00271414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978731|NCT00271414|Analgesics|analgesics|mesh-ancestor
64978732|NCT00271414|Sensory System Agents|sensory system agents|mesh-ancestor
64978733|NCT00271414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64978734|NCT00271414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64978735|NCT00271414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64978736|NCT00271414|Anesthetics, General|anesthetics, general|mesh-ancestor
64978737|NCT00271414|Anesthetics|anesthetics|mesh-ancestor
64978738|NCT00271453|Fentanyl|fentanyl|mesh-list
64585219|NCT01427972|Hormone Antagonists|hormone antagonists|mesh-ancestor
64585220|NCT01427972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64585221|NCT01427972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585223|NCT01427972|Diuretics|diuretics|mesh-ancestor
64978739|NCT00271453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64978740|NCT00271453|Narcotics|narcotics|mesh-ancestor
64978741|NCT00271453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64978742|NCT00271453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978743|NCT00271453|Analgesics|analgesics|mesh-ancestor
64978746|NCT00271453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64978747|NCT00271453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64978748|NCT00271453|Anesthetics, General|anesthetics, general|mesh-ancestor
64978749|NCT00271453|Anesthetics|anesthetics|mesh-ancestor
64978751|NCT00271492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978752|NCT00271492|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64978753|NCT00271492|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64978754|NCT00271492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978756|NCT00271804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978757|NCT00107601|Insulin|insulin|mesh-list
64978758|NCT00107601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64978759|NCT00107601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978760|NCT00272077|Insulin Glargine|insulin glargine|mesh-list
64978761|NCT00272077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64978810|NCT00272701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64978811|NCT00272701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64978813|NCT00272701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978814|NCT00272740|Fulvestrant|fulvestrant|mesh-list
64978815|NCT00272740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64978816|NCT00272740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978817|NCT00272740|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64978818|NCT00272740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64978819|NCT00272740|Hormone Antagonists|hormone antagonists|mesh-ancestor
64978820|NCT00272740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64978821|NCT00272740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978822|NCT00074750|Molgramostim|molgramostim|mesh-list
64978823|NCT00074750|Sargramostim|sargramostim|mesh-list
64585257|NCT01426958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64585258|NCT00397813|Cyclosporine|cyclosporine|mesh-list
64585259|NCT00397813|Mycophenolic Acid|mycophenolic acid|mesh-list
64585260|NCT00397813|Fludarabine|fludarabine|mesh-list
64585261|NCT00397813|Fludarabine phosphate|fludarabine phosphate|mesh-list
64585262|NCT00397813|Cyclosporins|cyclosporins|mesh-list
64585263|NCT00397813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585264|NCT00397813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64585265|NCT00397813|Antimetabolites|antimetabolites|mesh-ancestor
64585266|NCT00397813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585267|NCT00397813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64585268|NCT00397813|Immunologic Factors|immunologic factors|mesh-ancestor
64585269|NCT00397813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585271|NCT00397813|Antifungal Agents|antifungal agents|mesh-ancestor
64585272|NCT00397813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64585273|NCT00397813|Dermatologic Agents|dermatologic agents|mesh-ancestor
64585274|NCT00397813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64585275|NCT00397813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64585276|NCT00397813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64368177|NCT01191697|Trastuzumab|trastuzumab|mesh-list
64368178|NCT01191697|Capecitabine|capecitabine|mesh-list
64978824|NCT00074750|Immunologic Factors|immunologic factors|mesh-ancestor
64978825|NCT00074750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978826|NCT00074750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978864|NCT00272935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978865|NCT00273013|Montelukast|montelukast|mesh-list
64978866|NCT00273013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64978867|NCT00273013|Respiratory System Agents|respiratory system agents|mesh-ancestor
64978868|NCT00273013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64978869|NCT00273013|Hormone Antagonists|hormone antagonists|mesh-ancestor
64978870|NCT00273013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64978871|NCT00273013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978872|NCT00273013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64978873|NCT00273013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64978874|NCT00273013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978875|NCT00107835|Lidocaine|lidocaine|mesh-list
64978876|NCT00107835|Tetracaine|tetracaine|mesh-list
64978877|NCT00107835|Anesthetics, Local|anesthetics, local|mesh-ancestor
64978878|NCT00107835|Anesthetics|anesthetics|mesh-ancestor
64978879|NCT00107835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64978880|NCT00107835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978881|NCT00107835|Sensory System Agents|sensory system agents|mesh-ancestor
64585277|NCT00397813|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64585278|NCT00397813|Antitubercular Agents|antitubercular agents|mesh-ancestor
64585279|NCT00397813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64585280|NCT00398983|Decitabine|decitabine|mesh-list
64585281|NCT00398983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64585282|NCT00398983|Antimetabolites|antimetabolites|mesh-ancestor
64585283|NCT00398983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585284|NCT00398983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585285|NCT00398983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585286|NCT00358579|Vasopressins|vasopressins|mesh-list
64585287|NCT00358579|Arginine Vasopressin|arginine vasopressin|mesh-list
64585288|NCT00358579|Epinephrine|epinephrine|mesh-list
64585289|NCT00358579|Racepinephrine|racepinephrine|mesh-list
64585290|NCT00358579|Epinephryl borate|epinephryl borate|mesh-list
64585291|NCT00358579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585292|NCT00358579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64585293|NCT00358579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64585294|NCT00358579|Adrenergic Agents|adrenergic agents|mesh-ancestor
64585295|NCT00358579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64585296|NCT00358579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368197|NCT05024799|Anesthetics, General|anesthetics, general|mesh-ancestor
64978882|NCT00107835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64978883|NCT00107835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64978884|NCT00107835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64978885|NCT00107835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64978886|NCT00107835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64978887|NCT00107835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978888|NCT00107874|Misoprostol|misoprostol|mesh-list
64978889|NCT00107874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64978890|NCT00107874|Abortifacient Agents|abortifacient agents|mesh-ancestor
64978891|NCT00107874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64978893|NCT00107874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64978905|NCT00273247|Antiviral Agents|antiviral agents|mesh-ancestor
64978906|NCT00273247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64978907|NCT00273247|Immunologic Factors|immunologic factors|mesh-ancestor
64978908|NCT00273247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978910|NCT00273442|Dorzolamide|dorzolamide|mesh-list
64978911|NCT00273442|Maleic acid|maleic acid|mesh-list
64978912|NCT00273442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64978913|NCT00273442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978914|NCT00273442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64978915|NCT00273442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64978916|NCT00273442|Adrenergic Agents|adrenergic agents|mesh-ancestor
64978917|NCT00273442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64978918|NCT00273442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978919|NCT00273442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64978920|NCT00273442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64585300|NCT00358579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64585301|NCT00358579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64585302|NCT00358579|Respiratory System Agents|respiratory system agents|mesh-ancestor
64585303|NCT00358579|Mydriatics|mydriatics|mesh-ancestor
64585304|NCT00358579|Sympathomimetics|sympathomimetics|mesh-ancestor
64585305|NCT00358579|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64585306|NCT00358579|Hemostatics|hemostatics|mesh-ancestor
64585307|NCT00358579|Coagulants|coagulants|mesh-ancestor
64585308|NCT00358579|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64585309|NCT00358579|Natriuretic Agents|natriuretic agents|mesh-ancestor
64585310|NCT00338039|Gemcitabine|gemcitabine|mesh-list
64585311|NCT00338039|Capecitabine|capecitabine|mesh-list
64585312|NCT00338039|Oxaliplatin|oxaliplatin|mesh-list
64585313|NCT00338039|Cetuximab|cetuximab|mesh-list
64585314|NCT00338039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64585315|NCT00338039|Antimetabolites|antimetabolites|mesh-ancestor
64978921|NCT00273442|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64978922|NCT00401427|Trastuzumab|trastuzumab|mesh-list
64978923|NCT00401427|Vinorelbine|vinorelbine|mesh-list
64978924|NCT00401427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64978925|NCT00401427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64978926|NCT00401427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64978927|NCT00401427|Tubulin Modulators|tubulin modulators|mesh-ancestor
64978928|NCT00401427|Antimitotic Agents|antimitotic agents|mesh-ancestor
64978929|NCT00401427|Mitosis Modulators|mitosis modulators|mesh-ancestor
64978930|NCT00401427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64978931|NCT00273481|Timolol|timolol|mesh-list
64978932|NCT00273481|Dorzolamide|dorzolamide|mesh-list
64978933|NCT00273481|Latanoprost|latanoprost|mesh-list
64334614|NCT03159741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978938|NCT00273481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64978939|NCT00273481|Adrenergic Agents|adrenergic agents|mesh-ancestor
64978940|NCT00273481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64978941|NCT00273481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64978942|NCT00273481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64978943|NCT00273481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64978944|NCT00273481|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64978945|NCT00273481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64978946|NCT00273481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64978947|NCT00273520|Telithromycin|telithromycin|mesh-list
64978948|NCT00273520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64978949|NCT00273520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64978950|NCT00273559|Prednisone|prednisone|mesh-list
64978951|NCT00273559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64978952|NCT00273559|Glucocorticoids|glucocorticoids|mesh-ancestor
64978953|NCT00273559|Hormones|hormones|mesh-ancestor
64978954|NCT00273559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64978995|NCT00274027|Respiratory System Agents|respiratory system agents|mesh-ancestor
64978996|NCT00274027|Parasympatholytics|parasympatholytics|mesh-ancestor
64978997|NCT00274027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64334303|NCT02220335|Protective Agents|protective agents|mesh-ancestor
64585327|NCT00358657|Cyclophosphamide|cyclophosphamide|mesh-list
64585328|NCT00358657|Fludarabine|fludarabine|mesh-list
64585329|NCT00358657|Fludarabine phosphate|fludarabine phosphate|mesh-list
64585330|NCT00358657|Tacrolimus|tacrolimus|mesh-list
64585331|NCT00358657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64585332|NCT00358657|Immunologic Factors|immunologic factors|mesh-ancestor
64585333|NCT00358657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585334|NCT00358657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64585335|NCT00358657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64585336|NCT00358657|Alkylating Agents|alkylating agents|mesh-ancestor
64585337|NCT00358657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585338|NCT00358657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585339|NCT00358657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64585340|NCT00358657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64585341|NCT00358657|Antimetabolites|antimetabolites|mesh-ancestor
64585342|NCT00358657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64585343|NCT00358657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64368283|NCT05024877|Stanozolol|stanozolol|mesh-list
64978998|NCT00274027|Cholinergic Agents|cholinergic agents|mesh-ancestor
64978999|NCT00274027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979000|NCT00274027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979001|NCT00274027|Anticonvulsants|anticonvulsants|mesh-ancestor
64979002|NCT00075101|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
64979003|NCT00075101|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64979004|NCT00075101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979005|NCT00075101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979006|NCT00075101|Cholinergic Agents|cholinergic agents|mesh-ancestor
64979007|NCT00075101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979008|NCT00075101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979009|NCT00274066|Fenoterol|fenoterol|mesh-list
64979010|NCT00274066|Tiotropium Bromide|tiotropium bromide|mesh-list
64979011|NCT00274066|Ipratropium|ipratropium|mesh-list
64979012|NCT00274066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64979013|NCT00274066|Autonomic Agents|autonomic agents|mesh-ancestor
64585346|NCT00358657|Antitubercular Agents|antitubercular agents|mesh-ancestor
64585347|NCT00358657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64585348|NCT00358657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64585349|NCT00358657|Antifungal Agents|antifungal agents|mesh-ancestor
64585350|NCT00340379|Haloperidol|haloperidol|mesh-list
64585351|NCT00340379|Haloperidol decanoate|haloperidol decanoate|mesh-list
64585352|NCT00340379|Ziprasidone|ziprasidone|mesh-list
64585353|NCT00340379|Sertraline|sertraline|mesh-list
64585354|NCT00340379|Antidepressive Agents|antidepressive agents|mesh-ancestor
64585355|NCT00340379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64585356|NCT00340379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64585357|NCT00340379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64585358|NCT00340379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64585359|NCT00340379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585360|NCT00340379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64368367|NCT03090087|Regadenoson|regadenoson|mesh-list
64368368|NCT03090087|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64585361|NCT00340379|Serotonin Agents|serotonin agents|mesh-ancestor
64585362|NCT00340379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585363|NCT00340379|Antiemetics|antiemetics|mesh-ancestor
64368369|NCT03090087|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64368370|NCT03090087|Purinergic Agonists|purinergic agonists|mesh-ancestor
64368371|NCT03090087|Purinergic Agents|purinergic agents|mesh-ancestor
64368372|NCT03090087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64368373|NCT03090087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368374|NCT03090087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979014|NCT00274066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64979015|NCT00274066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979016|NCT00274066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64979017|NCT00274066|Respiratory System Agents|respiratory system agents|mesh-ancestor
64979018|NCT00274066|Parasympatholytics|parasympatholytics|mesh-ancestor
64979019|NCT00274066|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64979020|NCT00274066|Cholinergic Agents|cholinergic agents|mesh-ancestor
64979021|NCT00274066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979022|NCT00274066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979023|NCT00274066|Sympathomimetics|sympathomimetics|mesh-ancestor
64979024|NCT00274066|Tocolytic Agents|tocolytic agents|mesh-ancestor
64979038|NCT00274144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64979039|NCT00274144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979041|NCT00108186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64979042|NCT00108186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64979043|NCT00108186|Analgesics|analgesics|mesh-ancestor
64979044|NCT00108186|Sensory System Agents|sensory system agents|mesh-ancestor
64979045|NCT00108186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64979046|NCT00108186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979047|NCT00108186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64979090|NCT00274534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64979091|NCT00274534|Respiratory System Agents|respiratory system agents|mesh-ancestor
64979092|NCT00274534|Parasympatholytics|parasympatholytics|mesh-ancestor
64979093|NCT00274534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64979094|NCT00274534|Cholinergic Agents|cholinergic agents|mesh-ancestor
64979095|NCT00274534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979096|NCT00274534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979097|NCT00274534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64979098|NCT00274534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64979099|NCT00274534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64979100|NCT00274534|Adrenergic Agents|adrenergic agents|mesh-ancestor
64979101|NCT00274573|Bromides|bromides|mesh-list
64979102|NCT00274573|Tiotropium Bromide|tiotropium bromide|mesh-list
64585365|NCT00340379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64585366|NCT00340379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64585367|NCT00340379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64585368|NCT00340379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64585369|NCT00340379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64585370|NCT00340379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64585371|NCT00340379|Dopamine Agents|dopamine agents|mesh-ancestor
64585372|NCT00340379|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64585373|NCT00340379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64585374|NCT00342563|Mecamylamine|mecamylamine|mesh-list
64585375|NCT00342563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64585376|NCT00342563|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
64585377|NCT00342563|Autonomic Agents|autonomic agents|mesh-ancestor
64585378|NCT00342563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64979103|NCT00274573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64979104|NCT00274573|Autonomic Agents|autonomic agents|mesh-ancestor
64979105|NCT00274573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64979106|NCT00274573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979107|NCT00274573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64979108|NCT00274573|Respiratory System Agents|respiratory system agents|mesh-ancestor
64979109|NCT00274573|Parasympatholytics|parasympatholytics|mesh-ancestor
64979144|NCT00274807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64979145|NCT00274807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64979146|NCT00274807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979147|NCT00274807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979148|NCT00274807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64979149|NCT00274807|Antimetabolites|antimetabolites|mesh-ancestor
64979150|NCT00274807|Antiviral Agents|antiviral agents|mesh-ancestor
64979151|NCT00274807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64979152|NCT00274807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64979153|NCT00274807|Immunologic Factors|immunologic factors|mesh-ancestor
64979154|NCT00274807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979155|NCT00274807|Analgesics|analgesics|mesh-ancestor
64585386|NCT00358735|Anticoagulants|anticoagulants|mesh-ancestor
64585387|NCT00358735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64585388|NCT00358735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64585389|NCT00358735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585390|NCT01793519|Adalimumab|adalimumab|mesh-list
64585391|NCT01793519|Etanercept|etanercept|mesh-list
64585392|NCT01793519|Infliximab|infliximab|mesh-list
64585393|NCT01793519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64585394|NCT01793519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64585395|NCT01793519|Dermatologic Agents|dermatologic agents|mesh-ancestor
64585396|NCT01793519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64585397|NCT01793519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64585398|NCT01793519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64585399|NCT01793519|Analgesics|analgesics|mesh-ancestor
64585400|NCT01793519|Sensory System Agents|sensory system agents|mesh-ancestor
64585401|NCT01793519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64585402|NCT01793519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585403|NCT01793519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64368499|NCT03331445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368500|NCT03331445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368501|NCT03331445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64368502|NCT03331445|Respiratory System Agents|respiratory system agents|mesh-ancestor
64368503|NCT03331445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64368504|NCT03331445|Antioxidants|antioxidants|mesh-ancestor
64368505|NCT03331445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368506|NCT03331445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64368507|NCT03331445|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64979156|NCT00274807|Sensory System Agents|sensory system agents|mesh-ancestor
64979157|NCT00274807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64979158|NCT00274885|Oxaliplatin|oxaliplatin|mesh-list
64979159|NCT00274885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979160|NCT00277225|Abatacept|abatacept|mesh-list
64979161|NCT00277225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64979162|NCT00277225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979163|NCT00277225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979164|NCT00277225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64979165|NCT00277225|Immunologic Factors|immunologic factors|mesh-ancestor
64979166|NCT00277225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979167|NCT00277225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64979168|NCT00277264|Tiotropium Bromide|tiotropium bromide|mesh-list
64979169|NCT00277264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64979170|NCT00277264|Autonomic Agents|autonomic agents|mesh-ancestor
64979171|NCT00277264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64979172|NCT00277264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979173|NCT00277264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64979174|NCT00277264|Respiratory System Agents|respiratory system agents|mesh-ancestor
64979175|NCT00277264|Parasympatholytics|parasympatholytics|mesh-ancestor
64979176|NCT00277264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64979183|NCT00108420|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64979184|NCT00108420|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64979185|NCT00108420|Adrenergic Agents|adrenergic agents|mesh-ancestor
64979186|NCT00108420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64344951|NCT04467983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979246|NCT00108537|Autonomic Agents|autonomic agents|mesh-ancestor
64585404|NCT01793519|Immunologic Factors|immunologic factors|mesh-ancestor
64585405|NCT00345371|Topiramate|topiramate|mesh-list
64585406|NCT00345371|Anticonvulsants|anticonvulsants|mesh-ancestor
64585407|NCT00345371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64585408|NCT00345371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585409|NCT03006276|Celecoxib|celecoxib|mesh-list
64585410|NCT03006276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64585413|NCT03006276|Sensory System Agents|sensory system agents|mesh-ancestor
64585414|NCT03006276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64585415|NCT03006276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585416|NCT03006276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64585418|NCT03006276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64585419|NCT03006276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64585420|NCT03006276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585421|NCT03006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585422|NCT00350363|Gatifloxacin|gatifloxacin|mesh-list
64585423|NCT00350363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64585424|NCT00350363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64585425|NCT00350363|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64585426|NCT00350363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64585427|NCT00350363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64585428|NCT00350363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64368517|NCT05008263|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64979247|NCT00108537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64979248|NCT00108537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979249|NCT00108537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64979250|NCT00108537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64979251|NCT00108537|Cholinergic Agents|cholinergic agents|mesh-ancestor
64979252|NCT00108537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979253|NCT00108537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979254|NCT00108537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64979255|NCT00108537|Antidepressive Agents|antidepressive agents|mesh-ancestor
64979256|NCT00108537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64979257|NCT00108537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64979260|NCT00108537|Dopamine Agents|dopamine agents|mesh-ancestor
64979296|NCT00075491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979297|NCT00075491|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64979298|NCT00075491|Protective Agents|protective agents|mesh-ancestor
64979299|NCT00075491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979300|NCT00108615|Metformin|metformin|mesh-list
64979301|NCT00108615|Pioglitazone|pioglitazone|mesh-list
64979302|NCT00108615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64979303|NCT00108615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585429|NCT00350363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585430|NCT00350363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334310|NCT02291731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64334319|NCT02223377|Hydromorphone|hydromorphone|mesh-list
64334320|NCT02223377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64334321|NCT02223377|Narcotics|narcotics|mesh-ancestor
64334322|NCT02223377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64585431|NCT00350363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585432|NCT00351299|Dexmedetomidine|dexmedetomidine|mesh-list
64585433|NCT00351299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64585434|NCT00351299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64585435|NCT00351299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585436|NCT00351299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64585437|NCT00351299|Analgesics|analgesics|mesh-ancestor
64368554|NCT03092193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64585438|NCT00351299|Sensory System Agents|sensory system agents|mesh-ancestor
64585439|NCT00351299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368555|NCT03092193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64368556|NCT03092193|Analgesics|analgesics|mesh-ancestor
64368557|NCT03092193|Sensory System Agents|sensory system agents|mesh-ancestor
64368558|NCT03092193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368559|NCT03092193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979304|NCT00278083|Nitric Oxide|nitric oxide|mesh-list
64979305|NCT00278083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64979306|NCT00278083|Autonomic Agents|autonomic agents|mesh-ancestor
64979307|NCT00278083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64979308|NCT00278083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979309|NCT00278083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64979310|NCT00278083|Respiratory System Agents|respiratory system agents|mesh-ancestor
64979311|NCT00278083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64979312|NCT00278083|Antioxidants|antioxidants|mesh-ancestor
64979313|NCT00278083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979314|NCT00278083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979315|NCT00278083|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64979316|NCT00278083|Vasodilator Agents|vasodilator agents|mesh-ancestor
64979317|NCT00278083|Gasotransmitters|gasotransmitters|mesh-ancestor
64979318|NCT00278083|Protective Agents|protective agents|mesh-ancestor
64979319|NCT00278122|Paclitaxel|paclitaxel|mesh-list
64979320|NCT00278122|Sargramostim|sargramostim|mesh-list
64979321|NCT00278122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64979322|NCT00278122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979323|NCT00278122|Tubulin Modulators|tubulin modulators|mesh-ancestor
64979324|NCT00278122|Antimitotic Agents|antimitotic agents|mesh-ancestor
64979325|NCT00278122|Mitosis Modulators|mitosis modulators|mesh-ancestor
64979326|NCT00278122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979327|NCT00278122|Immunologic Factors|immunologic factors|mesh-ancestor
64585440|NCT00351299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64585441|NCT00351299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64585442|NCT00351299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64585443|NCT00351299|Adrenergic Agents|adrenergic agents|mesh-ancestor
64585444|NCT00351299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64585445|NCT00351299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585446|NCT00352001|Lenalidomide|lenalidomide|mesh-list
64585447|NCT00352001|Azacitidine|azacitidine|mesh-list
64585448|NCT00352001|Immunologic Factors|immunologic factors|mesh-ancestor
64334323|NCT02223377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334324|NCT02223377|Analgesics|analgesics|mesh-ancestor
64334325|NCT02223377|Sensory System Agents|sensory system agents|mesh-ancestor
64334326|NCT02223377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334327|NCT02291887|Ranibizumab|ranibizumab|mesh-list
64334328|NCT02291887|Aflibercept|aflibercept|mesh-list
64368574|NCT05015595|Dopamine Agents|dopamine agents|mesh-ancestor
64368575|NCT05015595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64368605|NCT01375075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368612|NCT03240055|Etomidate|etomidate|mesh-list
64979345|NCT00278278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64979346|NCT00278278|Glucocorticoids|glucocorticoids|mesh-ancestor
64979347|NCT00278278|Hormones|hormones|mesh-ancestor
64979348|NCT00278278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64979349|NCT00278278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979350|NCT00278278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64979351|NCT00278278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64979352|NCT00278278|Abortifacient Agents|abortifacient agents|mesh-ancestor
64979353|NCT00278278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64979354|NCT00278278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64979355|NCT00278278|Antimetabolites|antimetabolites|mesh-ancestor
64585450|NCT00352001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64585451|NCT00352001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64585452|NCT00352001|Growth Substances|growth substances|mesh-ancestor
64585453|NCT00352001|Growth Inhibitors|growth inhibitors|mesh-ancestor
64585454|NCT00352001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310668|NCT00806390|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64585455|NCT00352001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64585456|NCT00352001|Antimetabolites|antimetabolites|mesh-ancestor
64585457|NCT00352001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585458|NCT00352001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585460|NCT00401401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585461|NCT00401401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64585462|NCT00352781|Nicotine|nicotine|mesh-list
64585463|NCT00352781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64585464|NCT00352781|Autonomic Agents|autonomic agents|mesh-ancestor
64585465|NCT00352781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64585466|NCT00352781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585467|NCT00352781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64585468|NCT00352781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64585469|NCT00352781|Cholinergic Agents|cholinergic agents|mesh-ancestor
64979356|NCT00278278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979357|NCT00278278|Dermatologic Agents|dermatologic agents|mesh-ancestor
64979358|NCT00278278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979359|NCT00278278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64979360|NCT00278278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64979361|NCT00278278|Immunologic Factors|immunologic factors|mesh-ancestor
64979362|NCT00278278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64979363|NCT00278278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64979364|NCT00278278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64979382|NCT00108771|Anesthetics, General|anesthetics, general|mesh-ancestor
64979383|NCT00108771|Anesthetics|anesthetics|mesh-ancestor
64979384|NCT00278434|Zoledronic Acid|zoledronic acid|mesh-list
64979385|NCT00278434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64979386|NCT00278434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979387|NCT00075686|Gemcitabine|gemcitabine|mesh-list
64979388|NCT00075686|Cetuximab|cetuximab|mesh-list
64979389|NCT00075686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64979390|NCT00075686|Antimetabolites|antimetabolites|mesh-ancestor
64979391|NCT00075686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979392|NCT00075686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979393|NCT00075686|Antiviral Agents|antiviral agents|mesh-ancestor
64979394|NCT00075686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64979395|NCT00075686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979396|NCT00075686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64979397|NCT00075686|Immunologic Factors|immunologic factors|mesh-ancestor
64979398|NCT00075686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979399|NCT00075686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64979439|NCT00279253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64979440|NCT00279253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979441|NCT00279253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64979442|NCT00279253|Sympatholytics|sympatholytics|mesh-ancestor
64979443|NCT00279253|Autonomic Agents|autonomic agents|mesh-ancestor
64979444|NCT00279253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64979445|NCT00279253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64979446|NCT00279253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64585470|NCT00352781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64585471|NCT00352781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585472|NCT02812524|Ipilimumab|ipilimumab|mesh-list
64585473|NCT02812524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64585474|NCT02812524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585475|NCT02812524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64979447|NCT00279253|Adrenergic Agents|adrenergic agents|mesh-ancestor
64979448|NCT00279253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979502|NCT00279565|Methadone|methadone|mesh-list
64979503|NCT00279565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979504|NCT00279565|Antiviral Agents|antiviral agents|mesh-ancestor
64979505|NCT00279565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64979506|NCT00279565|Antimetabolites|antimetabolites|mesh-ancestor
64979510|NCT00279565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64979511|NCT00279565|Narcotics|narcotics|mesh-ancestor
64979512|NCT00279565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64979561|NCT00416767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64979562|NCT00416767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979563|NCT00416767|Antidotes|antidotes|mesh-ancestor
64979564|NCT00416767|Protective Agents|protective agents|mesh-ancestor
64979565|NCT00416767|Vitamin B Complex|vitamin b complex|mesh-ancestor
64979566|NCT00416767|Vitamins|vitamins|mesh-ancestor
64979567|NCT00416767|Micronutrients|micronutrients|mesh-ancestor
64979568|NCT00076115|Risperidone|risperidone|mesh-list
64979569|NCT00076115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64979570|NCT00076115|Serotonin Agents|serotonin agents|mesh-ancestor
64979571|NCT00076115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979579|NCT00076115|Dopamine Agents|dopamine agents|mesh-ancestor
64979623|NCT00280462|Vasodilator Agents|vasodilator agents|mesh-ancestor
64979624|NCT00280462|Tocolytic Agents|tocolytic agents|mesh-ancestor
64979625|NCT00280462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64979626|NCT00280501|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64979628|NCT00280501|Antidepressive Agents|antidepressive agents|mesh-ancestor
64979629|NCT00280501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64979630|NCT00280501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64979631|NCT00280501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64979632|NCT00280501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64979633|NCT00280501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979634|NCT00280501|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64979635|NCT00280501|Dopamine Agents|dopamine agents|mesh-ancestor
64979636|NCT00280501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979637|NCT00280501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979638|NCT00280501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64979639|NCT00280540|Valsartan|valsartan|mesh-list
64979640|NCT00280540|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64979641|NCT00280540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64979642|NCT00280540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64979677|NCT00076388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979678|NCT00076388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64979679|NCT00076388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979681|NCT00280774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64979682|NCT00280774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64979683|NCT00280774|Dopamine Agents|dopamine agents|mesh-ancestor
64979684|NCT00280774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979685|NCT00280774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979686|NCT00280774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979687|NCT00280774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64979688|NCT00280774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64979689|NCT00109551|Folic Acid|folic acid|mesh-list
64979690|NCT00109551|Zinc Sulfate|zinc sulfate|mesh-list
64979691|NCT00109551|Hematinics|hematinics|mesh-ancestor
64979692|NCT00109551|Vitamin B Complex|vitamin b complex|mesh-ancestor
64585497|NCT00360685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64979693|NCT00109551|Vitamins|vitamins|mesh-ancestor
64585498|NCT00360685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64585499|NCT00360685|Immunologic Factors|immunologic factors|mesh-ancestor
64979694|NCT00109551|Micronutrients|micronutrients|mesh-ancestor
64979695|NCT00109551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979733|NCT00280969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979734|NCT00280969|Antiviral Agents|antiviral agents|mesh-ancestor
64979735|NCT00280969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64979736|NCT00280969|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64979737|NCT00280969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64979738|NCT00280969|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64979739|NCT00280969|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64979740|NCT00280969|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64979741|NCT00280969|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64979742|NCT00280969|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64979743|NCT00280969|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64979744|NCT00280969|Protease Inhibitors|protease inhibitors|mesh-ancestor
64979745|NCT00280969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64979746|NCT00280969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64979747|NCT00281008|Mipomersen|mipomersen|mesh-list
64979790|NCT00281476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979791|NCT00416923|Rituximab|rituximab|mesh-list
64979795|NCT00416923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979796|NCT00416923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64979797|NCT00416962|Oseltamivir|oseltamivir|mesh-list
64979798|NCT00416962|Amantadine|amantadine|mesh-list
64979799|NCT00416962|Antiviral Agents|antiviral agents|mesh-ancestor
64979800|NCT00416962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64979801|NCT00416962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979802|NCT00416962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979803|NCT00416962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64585519|NCT05487456|Antipruritics|antipruritics|mesh-ancestor
64585520|NCT05487456|Dermatologic Agents|dermatologic agents|mesh-ancestor
64585521|NCT00558519|Cytarabine|cytarabine|mesh-list
64585522|NCT00558519|Dexamethasone|dexamethasone|mesh-list
64585523|NCT00558519|Cyclophosphamide|cyclophosphamide|mesh-list
64585524|NCT00558519|Doxorubicin|doxorubicin|mesh-list
64585525|NCT00558519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64585526|NCT00558519|Methotrexate|methotrexate|mesh-list
64585527|NCT00558519|Vincristine|vincristine|mesh-list
64585528|NCT00558519|Daunorubicin|daunorubicin|mesh-list
64585529|NCT00558519|Mercaptopurine|mercaptopurine|mesh-list
64585530|NCT00558519|Pegaspargase|pegaspargase|mesh-list
64585531|NCT00558519|Thioguanine|thioguanine|mesh-list
64585532|NCT00558519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64585533|NCT00558519|Immunologic Factors|immunologic factors|mesh-ancestor
64585534|NCT00558519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979804|NCT00416962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64979805|NCT00416962|Dopamine Agents|dopamine agents|mesh-ancestor
64979806|NCT00416962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979807|NCT00416962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979808|NCT00416962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64979809|NCT00416962|Analgesics|analgesics|mesh-ancestor
64979810|NCT00416962|Sensory System Agents|sensory system agents|mesh-ancestor
64979811|NCT00416962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64979812|NCT00109824|Decitabine|decitabine|mesh-list
64979813|NCT00109824|Azacitidine|azacitidine|mesh-list
64979814|NCT00109824|Valproic Acid|valproic acid|mesh-list
64979842|NCT00109941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64979844|NCT00281593|Ramipril|ramipril|mesh-list
64979845|NCT00281593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64979846|NCT00281593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64979847|NCT00281593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64979848|NCT00281593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979849|NCT00281593|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64979850|NCT00281593|Protease Inhibitors|protease inhibitors|mesh-ancestor
64979851|NCT00281593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585548|NCT00558519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64585549|NCT00558519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64585550|NCT00558519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64585551|NCT00558519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64979852|NCT00281710|Methylprednisolone|methylprednisolone|mesh-list
64979853|NCT00281710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64585552|NCT00558519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64585553|NCT00558519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585554|NCT00558519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64585555|NCT00558519|Abortifacient Agents|abortifacient agents|mesh-ancestor
64585556|NCT00558519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64585557|NCT00558519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64585558|NCT00558519|Antimetabolites|antimetabolites|mesh-ancestor
64585559|NCT00558519|Dermatologic Agents|dermatologic agents|mesh-ancestor
64334329|NCT02291887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64334330|NCT02291887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64334331|NCT02291887|Growth Substances|growth substances|mesh-ancestor
64334332|NCT02291887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368838|NCT04434105|Glucocorticoids|glucocorticoids|mesh-ancestor
64368839|NCT04434105|Hormones|hormones|mesh-ancestor
64368840|NCT04434105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64368841|NCT04434105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368842|NCT04434105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64368843|NCT04434105|Immunologic Factors|immunologic factors|mesh-ancestor
64368844|NCT04434105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64368845|NCT04434105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979854|NCT00281710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64979855|NCT00281710|Prednisolone|prednisolone|mesh-list
64979856|NCT00281710|Prednisolone acetate|prednisolone acetate|mesh-list
64979857|NCT00281710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64979858|NCT00281710|Prednisolone phosphate|prednisolone phosphate|mesh-list
64979859|NCT00281710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64979860|NCT00281710|Antiemetics|antiemetics|mesh-ancestor
64979861|NCT00281710|Autonomic Agents|autonomic agents|mesh-ancestor
64979862|NCT00281710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64979863|NCT00281710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979864|NCT00281710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64979865|NCT00281710|Glucocorticoids|glucocorticoids|mesh-ancestor
64979866|NCT00281710|Hormones|hormones|mesh-ancestor
64979867|NCT00281710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64979869|NCT00281710|Protective Agents|protective agents|mesh-ancestor
64979887|NCT00281788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64979888|NCT00281788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979889|NCT00281788|Tubulin Modulators|tubulin modulators|mesh-ancestor
64979890|NCT00281788|Antimitotic Agents|antimitotic agents|mesh-ancestor
64979891|NCT00281788|Mitosis Modulators|mitosis modulators|mesh-ancestor
64979892|NCT00281788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979893|NCT00281788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64979894|NCT00281788|Antimetabolites|antimetabolites|mesh-ancestor
64979895|NCT00281866|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64979896|NCT00281866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979897|NCT00281866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64979898|NCT00281866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979899|NCT00281866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979900|NCT00281905|Cyclophosphamide|cyclophosphamide|mesh-list
64979901|NCT00281905|Carboplatin|carboplatin|mesh-list
64979902|NCT00281905|Methotrexate|methotrexate|mesh-list
64979903|NCT00281905|Vincristine|vincristine|mesh-list
64585561|NCT00558519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64585562|NCT00558519|Antiviral Agents|antiviral agents|mesh-ancestor
64585563|NCT00558519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64585564|NCT00558519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64585565|NCT00558519|Tubulin Modulators|tubulin modulators|mesh-ancestor
64585566|NCT00558519|Antimitotic Agents|antimitotic agents|mesh-ancestor
64585567|NCT00558519|Mitosis Modulators|mitosis modulators|mesh-ancestor
64585568|NCT03239015|Trastuzumab|trastuzumab|mesh-list
64585569|NCT03239015|Everolimus|everolimus|mesh-list
64585570|NCT03239015|Olaparib|olaparib|mesh-list
64585571|NCT03239015|Palbociclib|palbociclib|mesh-list
64585572|NCT03239015|Gefitinib|gefitinib|mesh-list
64585573|NCT03239015|Afatinib|afatinib|mesh-list
64585574|NCT03239015|Vemurafenib|vemurafenib|mesh-list
64585575|NCT03239015|Dabrafenib|dabrafenib|mesh-list
64585576|NCT03239015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
64585577|NCT03239015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64585578|NCT03239015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585579|NCT03239015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64585580|NCT03239015|Immunologic Factors|immunologic factors|mesh-ancestor
64585581|NCT03239015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368855|NCT03078309|Cannabidiol|cannabidiol|mesh-list
64368856|NCT03078309|Anticonvulsants|anticonvulsants|mesh-ancestor
64979904|NCT00281905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64979917|NCT00281905|Antimetabolites|antimetabolites|mesh-ancestor
64979943|NCT00110058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979944|NCT00110058|Antifungal Agents|antifungal agents|mesh-ancestor
64979945|NCT00110058|Dermatologic Agents|dermatologic agents|mesh-ancestor
64979946|NCT00110058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64979947|NCT00110058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64979957|NCT00281944|Levoleucovorin|levoleucovorin|mesh-list
64979958|NCT00281944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64979959|NCT00281944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64979960|NCT00281944|Antimetabolites|antimetabolites|mesh-ancestor
64979961|NCT00281944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64979962|NCT00281944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64979963|NCT00281944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64979964|NCT00281944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64979965|NCT00281944|Immunologic Factors|immunologic factors|mesh-ancestor
64979966|NCT00281944|Antidotes|antidotes|mesh-ancestor
64585584|NCT03239015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585585|NCT03239015|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64585586|NCT03239015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64585587|NCT03239015|Growth Substances|growth substances|mesh-ancestor
64585588|NCT03239015|Growth Inhibitors|growth inhibitors|mesh-ancestor
64585589|NCT05370885|Vancomycin|vancomycin|mesh-list
64585590|NCT05370885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64585591|NCT05370885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64585592|NCT00403117|Naltrexone|naltrexone|mesh-list
64585593|NCT00403117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64585594|NCT00403117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64585595|NCT00403117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585596|NCT00403117|Sensory System Agents|sensory system agents|mesh-ancestor
64585597|NCT00403117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64585598|NCT03023631|Vaccines|vaccines|mesh-list
64368935|NCT03091569|Vitamin K|vitamin k|mesh-list
64979967|NCT00281944|Protective Agents|protective agents|mesh-ancestor
64979968|NCT00281944|Vitamin B Complex|vitamin b complex|mesh-ancestor
64979969|NCT00281944|Vitamins|vitamins|mesh-ancestor
64979993|NCT00281983|Abortifacient Agents|abortifacient agents|mesh-ancestor
64979994|NCT00281983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64979995|NCT00281983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64979996|NCT00281983|Antimetabolites|antimetabolites|mesh-ancestor
64979997|NCT00281983|Dermatologic Agents|dermatologic agents|mesh-ancestor
64979998|NCT00281983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64979999|NCT00281983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64980000|NCT00281983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64980001|NCT00281983|Antifungal Agents|antifungal agents|mesh-ancestor
64980002|NCT00281983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64980003|NCT00281983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64980004|NCT00281983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64980005|NCT00281983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64980006|NCT00281983|Antitubercular Agents|antitubercular agents|mesh-ancestor
64980007|NCT00281983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64980008|NCT00282061|Melatonin|melatonin|mesh-list
64980048|NCT00110253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64980049|NCT00110253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980050|NCT00282178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64980051|NCT00282178|Candesartan|candesartan|mesh-list
64980052|NCT00282178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64980053|NCT00282178|Diuretics|diuretics|mesh-ancestor
64980054|NCT00282178|Natriuretic Agents|natriuretic agents|mesh-ancestor
64980055|NCT00282178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980056|NCT00282178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64980057|NCT00282178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64980058|NCT00282178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980059|NCT00282178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64980060|NCT00282178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64980061|NCT00282217|Sirolimus|sirolimus|mesh-list
64980062|NCT00282217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64980063|NCT00282217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64980064|NCT00282217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64980065|NCT00282217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980066|NCT00282217|Antifungal Agents|antifungal agents|mesh-ancestor
64334333|NCT02291887|Growth Inhibitors|growth inhibitors|mesh-ancestor
64334334|NCT02291887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334335|NCT02352285|Tolvaptan|tolvaptan|mesh-list
64334336|NCT02352285|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64334337|NCT02352285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585614|NCT00558285|Cholinergic Agents|cholinergic agents|mesh-ancestor
64585615|NCT00558285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64585617|NCT00558285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980067|NCT00282217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64980068|NCT00282217|Immunologic Factors|immunologic factors|mesh-ancestor
64980069|NCT00282217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980070|NCT00282451|Insulin|insulin|mesh-list
64980071|NCT00282451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64980072|NCT00282451|Insulin Aspart|insulin aspart|mesh-list
64980073|NCT00282451|Insulin, Long-Acting|insulin, long-acting|mesh-list
64980074|NCT00282451|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64980075|NCT00282451|Biphasic Insulins|biphasic insulins|mesh-list
64980076|NCT00282451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64980077|NCT00282451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980078|NCT00282607|Udenafil|udenafil|mesh-list
64980079|NCT00282607|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64980080|NCT00282607|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64980081|NCT00282607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980083|NCT00282724|Liarozole|liarozole|mesh-list
64980086|NCT00282724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64980087|NCT00282724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980088|NCT00282724|Dermatologic Agents|dermatologic agents|mesh-ancestor
64980089|NCT00282724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980090|NCT00282724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980091|NCT00282724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64980092|NCT00282724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980093|NCT00282958|Botulinum Toxins|botulinum toxins|mesh-list
64980094|NCT00282958|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64585621|NCT01389596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64585622|NCT01389596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585623|NCT01389596|Anticonvulsants|anticonvulsants|mesh-ancestor
64585624|NCT01389596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64980095|NCT00282958|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64980096|NCT00282958|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64980097|NCT00282958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64980098|NCT00282958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980099|NCT00282958|Cholinergic Agents|cholinergic agents|mesh-ancestor
64585625|NCT01389596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64980100|NCT00282958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64980101|NCT00282958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980102|NCT00282958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64980103|NCT00282958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64585626|NCT01389596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585627|NCT01389596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64585628|NCT01389596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64585629|NCT01389596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64585630|NCT01389596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64585631|NCT01389596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64585632|NCT00558207|Gemcitabine|gemcitabine|mesh-list
64585633|NCT00558207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64369010|NCT03206671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64369011|NCT03206671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64369012|NCT03206671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64369013|NCT03206671|Antiemetics|antiemetics|mesh-ancestor
64980104|NCT00282997|Pregabalin|pregabalin|mesh-list
64980105|NCT00282997|Analgesics|analgesics|mesh-ancestor
64980106|NCT00282997|Sensory System Agents|sensory system agents|mesh-ancestor
64980107|NCT00282997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64980108|NCT00282997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980109|NCT00282997|Anticonvulsants|anticonvulsants|mesh-ancestor
64980110|NCT00282997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64980111|NCT00282997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64980112|NCT00282997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980113|NCT00282997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64980114|NCT00282997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64980115|NCT00282997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64980116|NCT00282997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64980124|NCT00110370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64980125|NCT00110370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980127|NCT00283114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64980128|NCT00283114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980129|NCT00076856|Temozolomide|temozolomide|mesh-list
64980130|NCT00076856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64980131|NCT00076856|Alkylating Agents|alkylating agents|mesh-ancestor
64585635|NCT00558207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585637|NCT00558207|Antiviral Agents|antiviral agents|mesh-ancestor
64585638|NCT00558207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64585639|NCT00558207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585640|NCT00558207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64585641|NCT00558207|Immunologic Factors|immunologic factors|mesh-ancestor
64585642|NCT00558207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585643|NCT00407485|Aflibercept|aflibercept|mesh-list
64585644|NCT00407485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64585645|NCT00407485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64585646|NCT00407485|Growth Substances|growth substances|mesh-ancestor
64585647|NCT00407485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585648|NCT00407485|Growth Inhibitors|growth inhibitors|mesh-ancestor
64585649|NCT00407485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585650|NCT00354887|Capecitabine|capecitabine|mesh-list
64585651|NCT00354887|Oxaliplatin|oxaliplatin|mesh-list
64585652|NCT00354887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64585653|NCT00354887|Antimetabolites|antimetabolites|mesh-ancestor
64585654|NCT00354887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585655|NCT00354887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585656|NCT02111863|Aldesleukin|aldesleukin|mesh-list
64585657|NCT02111863|Cyclophosphamide|cyclophosphamide|mesh-list
64585658|NCT02111863|Fludarabine|fludarabine|mesh-list
64369062|NCT03319121|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64369064|NCT02487407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64369065|NCT02487407|Vasodilator Agents|vasodilator agents|mesh-ancestor
64980132|NCT00076856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980133|NCT00076856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980134|NCT00283192|Sertraline|sertraline|mesh-list
64980135|NCT00283192|Antidepressive Agents|antidepressive agents|mesh-ancestor
64980136|NCT00283192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64980137|NCT00283192|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64980138|NCT00283192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64980139|NCT00283192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64980140|NCT00283192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980141|NCT00283192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64980142|NCT00283192|Serotonin Agents|serotonin agents|mesh-ancestor
64980143|NCT00283192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980144|NCT00283309|Riluzole|riluzole|mesh-list
64980145|NCT00283309|Memantine|memantine|mesh-list
64980146|NCT00283309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64980147|NCT00283309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64980148|NCT00283309|Dopamine Agents|dopamine agents|mesh-ancestor
64980149|NCT00283309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64980169|NCT00283543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980170|NCT00283543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980172|NCT00283621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64980173|NCT00283621|Ifosfamide|ifosfamide|mesh-list
64980174|NCT00283621|Darbepoetin alfa|darbepoetin alfa|mesh-list
64980175|NCT00283621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64980176|NCT00283621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980177|NCT00283621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64980178|NCT00283621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64980179|NCT00283621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980180|NCT00283621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980181|NCT00283621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64980188|NCT00283660|Protective Agents|protective agents|mesh-ancestor
64980189|NCT00283660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980190|NCT00077051|Tetrahydrouridine|tetrahydrouridine|mesh-list
64980191|NCT00077051|Antimetabolites|antimetabolites|mesh-ancestor
64585659|NCT02111863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64369100|NCT03319043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64369101|NCT03319043|Respiratory System Agents|respiratory system agents|mesh-ancestor
64585660|NCT02111863|Immunologic Factors|immunologic factors|mesh-ancestor
64585661|NCT02111863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585662|NCT02111863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64585663|NCT02111863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64585664|NCT02111863|Alkylating Agents|alkylating agents|mesh-ancestor
64585665|NCT02111863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585666|NCT02111863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585667|NCT02111863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64980192|NCT00077051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980193|NCT00283699|Albendazole|albendazole|mesh-list
64980194|NCT00283699|Anthelmintics|anthelmintics|mesh-ancestor
64980195|NCT00283699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64980196|NCT00283699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64980197|NCT00283699|Anticestodal Agents|anticestodal agents|mesh-ancestor
64980215|NCT00110448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64980216|NCT00110448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64980217|NCT00110448|Analgesics|analgesics|mesh-ancestor
64980218|NCT00110448|Sensory System Agents|sensory system agents|mesh-ancestor
64980219|NCT00110448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64980220|NCT00110448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980221|NCT00110448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64980222|NCT00110448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64980223|NCT00110448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64980224|NCT00110448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64980225|NCT00110448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980226|NCT00110448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64980227|NCT00110448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64980228|NCT00110448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980229|NCT00110448|Antipyretics|antipyretics|mesh-ancestor
64980230|NCT00284206|Risperidone|risperidone|mesh-list
64980231|NCT00284206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64980232|NCT00284206|Serotonin Agents|serotonin agents|mesh-ancestor
64980233|NCT00284206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64980234|NCT00284206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585674|NCT02660411|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64585675|NCT02660411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64585676|NCT02660411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585677|NCT02660411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64585678|NCT02660411|Anesthetics, General|anesthetics, general|mesh-ancestor
64334339|NCT02352285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334341|NCT03521713|Hematinics|hematinics|mesh-ancestor
64334342|NCT02223533|Morphine|morphine|mesh-list
64369127|NCT02451475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64369128|NCT02451475|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64369129|NCT02451475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64369130|NCT02451475|Analgesics|analgesics|mesh-ancestor
64369131|NCT02451475|Sensory System Agents|sensory system agents|mesh-ancestor
64369160|NCT03318887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64369161|NCT03119077|Itraconazole|itraconazole|mesh-list
64369162|NCT03119077|Antifungal Agents|antifungal agents|mesh-ancestor
64369163|NCT03119077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64980235|NCT00284206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980236|NCT00284206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64980237|NCT00284206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64980238|NCT00284206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64980239|NCT00284206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64980240|NCT00284206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64980241|NCT00284206|Dopamine Agents|dopamine agents|mesh-ancestor
64980242|NCT00077129|Paclitaxel|paclitaxel|mesh-list
64980243|NCT00077129|Carboplatin|carboplatin|mesh-list
64980254|NCT00284323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980256|NCT00284323|Vasodilator Agents|vasodilator agents|mesh-ancestor
64980257|NCT00284323|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64980258|NCT00284323|Purinergic Agonists|purinergic agonists|mesh-ancestor
64980259|NCT00284323|Purinergic Agents|purinergic agents|mesh-ancestor
64980260|NCT00284323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64980261|NCT00284323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980262|NCT04718701|Paclitaxel|paclitaxel|mesh-list
64980263|NCT04718701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64980264|NCT04718701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980265|NCT04718701|Tubulin Modulators|tubulin modulators|mesh-ancestor
64980269|NCT00077168|Tamoxifen|tamoxifen|mesh-list
64980314|NCT00284791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64980315|NCT00284947|Prednisone|prednisone|mesh-list
64980316|NCT00284947|Prednisolone|prednisolone|mesh-list
64980317|NCT00284947|Methylprednisolone|methylprednisolone|mesh-list
64980318|NCT00284947|Basiliximab|basiliximab|mesh-list
64980319|NCT00284947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64980320|NCT00284947|Glucocorticoids|glucocorticoids|mesh-ancestor
64980321|NCT00284947|Hormones|hormones|mesh-ancestor
64980322|NCT00284947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64980323|NCT00284947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980326|NCT00284947|Antiemetics|antiemetics|mesh-ancestor
64980379|NCT00285181|Simvastatin|simvastatin|mesh-list
64980380|NCT00285181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64980381|NCT00285181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64980382|NCT00285181|Antimetabolites|antimetabolites|mesh-ancestor
64980385|NCT00285181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64980386|NCT00285181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980387|NCT00285298|Pentoxifylline|pentoxifylline|mesh-list
64980388|NCT00285298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64980389|NCT00285298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980390|NCT00285298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980391|NCT00285298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64980392|NCT00285298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64585681|NCT02660411|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64980393|NCT00285298|Protective Agents|protective agents|mesh-ancestor
64585682|NCT02078492|Ketorolac|ketorolac|mesh-list
64585683|NCT02078492|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64585684|NCT02078492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64980394|NCT00285298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980395|NCT00285298|Vasodilator Agents|vasodilator agents|mesh-ancestor
64980396|NCT00285298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64980397|NCT00285298|Antioxidants|antioxidants|mesh-ancestor
64980398|NCT00285376|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
64980399|NCT00285376|Antidepressive Agents|antidepressive agents|mesh-ancestor
64980400|NCT00285376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64980401|NCT00285376|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64980402|NCT00285376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64980403|NCT00285376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64980404|NCT00285376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980405|NCT00285376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64980406|NCT00285376|Serotonin Agents|serotonin agents|mesh-ancestor
64980407|NCT00285376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980410|NCT00077363|Capecitabine|capecitabine|mesh-list
64980421|NCT00285415|Mitosis Modulators|mitosis modulators|mesh-ancestor
64980422|NCT00285415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980423|NCT00285493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64980424|NCT00285493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64980426|NCT00285727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64980427|NCT00285727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64980428|NCT00285727|Dopamine Agonists|dopamine agonists|mesh-ancestor
64980429|NCT00285727|Dopamine Agents|dopamine agents|mesh-ancestor
64980430|NCT00285727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64980432|NCT00285727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980484|NCT00110877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980485|NCT00110877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334349|NCT02223533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64585699|NCT02988921|Antimitotic Agents|antimitotic agents|mesh-ancestor
64585700|NCT02988921|Mitosis Modulators|mitosis modulators|mesh-ancestor
64585701|NCT02988921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585703|NCT04528563|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64585704|NCT04528563|Morphine|morphine|mesh-list
64585705|NCT04528563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64585706|NCT04528563|Narcotics|narcotics|mesh-ancestor
64585707|NCT04528563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64585708|NCT04528563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585709|NCT04528563|Analgesics|analgesics|mesh-ancestor
64585710|NCT04528563|Sensory System Agents|sensory system agents|mesh-ancestor
64585711|NCT04528563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369347|NCT03224923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369348|NCT03224923|Antipyretics|antipyretics|mesh-ancestor
64369349|NCT03224923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64369350|NCT03224923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64369351|NCT03224923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64980486|NCT00110877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64980487|NCT00110877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64980488|NCT00110877|Antiviral Agents|antiviral agents|mesh-ancestor
64980489|NCT00110877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64980491|NCT00077519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980492|NCT00286117|Tamoxifen|tamoxifen|mesh-list
64980493|NCT00286117|Anastrozole|anastrozole|mesh-list
64980494|NCT00286117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64980495|NCT00286117|Hormone Antagonists|hormone antagonists|mesh-ancestor
64980496|NCT00286117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64980497|NCT00286117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980498|NCT00286117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64980499|NCT00286117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980500|NCT00286117|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64980501|NCT00286117|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64980502|NCT00286117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64980503|NCT00286117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64585712|NCT04528563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64980504|NCT00286117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64585713|NCT04528563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64585714|NCT04528563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64585715|NCT04528563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64585716|NCT04528563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64585717|NCT04528563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585718|NCT04528563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585719|NCT00355199|Rituximab|rituximab|mesh-list
64980505|NCT00286117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585720|NCT00355199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64585721|NCT00355199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585722|NCT00355199|Immunologic Factors|immunologic factors|mesh-ancestor
64585723|NCT00355199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585724|NCT00355199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64585726|NCT01791647|Metformin|metformin|mesh-list
64585727|NCT01791647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64369397|NCT02490605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64585728|NCT01791647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585729|NCT01791647|Vitamin B Complex|vitamin b complex|mesh-ancestor
64585730|NCT01791647|Vitamins|vitamins|mesh-ancestor
64585731|NCT01791647|Micronutrients|micronutrients|mesh-ancestor
64585732|NCT00363883|Vorinostat|vorinostat|mesh-list
64585733|NCT00363883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585734|NCT00363883|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64585735|NCT00363883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585736|NCT00363883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369398|NCT02490605|Antifungal Agents|antifungal agents|mesh-ancestor
64980506|NCT00286117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980535|NCT00286312|Antimetabolites|antimetabolites|mesh-ancestor
64980536|NCT00286312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980537|NCT00286312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64980538|NCT00286312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64980539|NCT00286312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980540|NCT00286351|Anastrozole|anastrozole|mesh-list
64980541|NCT00286351|Goserelin|goserelin|mesh-list
64980542|NCT00286351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64980543|NCT00286351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980544|NCT00286351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64980545|NCT00286351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64980546|NCT00286351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980565|NCT00111072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64980566|NCT00111072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980567|NCT00111072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64980576|NCT00286624|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64980577|NCT00286624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980578|NCT00286624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980579|NCT00286624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64980580|NCT00286624|Immunologic Factors|immunologic factors|mesh-ancestor
64980581|NCT00286624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980582|NCT00286624|Antifungal Agents|antifungal agents|mesh-ancestor
64980583|NCT00286624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64980584|NCT00286624|Dermatologic Agents|dermatologic agents|mesh-ancestor
64980585|NCT00286624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64980586|NCT00286624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64980587|NCT00286624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980589|NCT00077597|Hematinics|hematinics|mesh-ancestor
64980590|NCT00286780|Gossypol acetic acid|gossypol acetic acid|mesh-list
64980591|NCT00286780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64980592|NCT00286780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980593|NCT00286780|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64980594|NCT00286780|Contraceptive Agents|contraceptive agents|mesh-ancestor
64980595|NCT00286780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64585737|NCT00364819|Rituximab|rituximab|mesh-list
64980596|NCT00286780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980597|NCT00286780|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
64980598|NCT00286780|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
64980599|NCT00286780|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64980626|NCT00111150|Tenofovir|tenofovir|mesh-list
64980627|NCT00111150|Antiviral Agents|antiviral agents|mesh-ancestor
64980628|NCT00111150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64980629|NCT00111150|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64980630|NCT00111150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64980631|NCT00111150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980632|NCT00111150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980633|NCT00111150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64980634|NCT00111150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64980635|NCT00417430|Fulvestrant|fulvestrant|mesh-list
64585785|NCT04288895|Antidepressive Agents|antidepressive agents|mesh-ancestor
64585786|NCT04288895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64585787|NCT04288895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64585788|NCT04288895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64585789|NCT04288895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64585790|NCT04288895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585791|NCT04288895|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64585792|NCT04288895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64585793|NCT04288895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64585794|NCT04288895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585795|NCT04288895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64585796|NCT04288895|Serotonin Agents|serotonin agents|mesh-ancestor
64585797|NCT04288895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64585798|NCT04288895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64585799|NCT04288895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64585800|NCT04288895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64980636|NCT00417430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64980637|NCT00417430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64980638|NCT00417430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64980648|NCT00077753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980649|NCT00111189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64980650|NCT00111189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64980651|NCT00111189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64980652|NCT00111189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64980653|NCT00111189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980654|NCT00111189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64980655|NCT00111189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64980656|NCT00111189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64980657|NCT00111189|Serotonin Agents|serotonin agents|mesh-ancestor
64980667|NCT00077792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64980668|NCT00077792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980669|NCT00111267|Vitamins|vitamins|mesh-list
64980670|NCT00111267|Folic Acid|folic acid|mesh-list
64980671|NCT00111267|Hydroxocobalamin|hydroxocobalamin|mesh-list
64980672|NCT00111267|Vitamin B 12|vitamin b 12|mesh-list
64980673|NCT00111267|Vitamin B Complex|vitamin b complex|mesh-list
64980674|NCT00111267|Micronutrients|micronutrients|mesh-ancestor
64980675|NCT00111267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980676|NCT00111267|Hematinics|hematinics|mesh-ancestor
64980677|NCT00286936|Zolpidem|zolpidem|mesh-list
64980678|NCT00286936|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64980679|NCT00286936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64980680|NCT00286936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64980681|NCT00286936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980682|NCT00286936|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64980723|NCT00287209|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64585817|NCT04417257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585818|NCT00409825|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
64980724|NCT00077948|Metoprolol|metoprolol|mesh-list
64980725|NCT00077948|Enoximone|enoximone|mesh-list
64980726|NCT00077948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64980727|NCT00077948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64585819|NCT00409825|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
64980728|NCT00077948|Sympatholytics|sympatholytics|mesh-ancestor
64585820|NCT00409825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64585821|NCT00409825|Hormone Antagonists|hormone antagonists|mesh-ancestor
64585822|NCT00409825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64585823|NCT00409825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585824|NCT00409825|Progestins|progestins|mesh-ancestor
64585826|NCT00410059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64585827|NCT00410059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585828|NCT00410059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64585829|NCT00410059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585830|NCT00410059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585831|NCT04749069|Remifentanil|remifentanil|mesh-list
64369529|NCT03204799|Antimetabolites|antimetabolites|mesh-ancestor
64369530|NCT03204799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369531|NCT03204799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64369532|NCT03317327|Nivolumab|nivolumab|mesh-list
64980729|NCT00077948|Autonomic Agents|autonomic agents|mesh-ancestor
64980730|NCT00077948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64980731|NCT00077948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64980732|NCT00077948|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64980733|NCT00077948|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64980734|NCT00077948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64980735|NCT00077948|Adrenergic Agents|adrenergic agents|mesh-ancestor
64980736|NCT00077948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64980737|NCT00077948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980738|NCT00077948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64980739|NCT00077948|Vasodilator Agents|vasodilator agents|mesh-ancestor
64980740|NCT00077948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64585832|NCT04749069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64585833|NCT04749069|Narcotics|narcotics|mesh-ancestor
64585834|NCT04749069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64585835|NCT04749069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585836|NCT04749069|Analgesics|analgesics|mesh-ancestor
64585837|NCT04749069|Sensory System Agents|sensory system agents|mesh-ancestor
64585838|NCT04749069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64585839|NCT00411463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64585840|NCT00411463|Antidepressive Agents|antidepressive agents|mesh-ancestor
64585841|NCT00411463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64334350|NCT02231021|Pioglitazone|pioglitazone|mesh-list
64334351|NCT02231021|Alogliptin|alogliptin|mesh-list
64585846|NCT00356993|Nicotine|nicotine|mesh-list
64585847|NCT00356993|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64585848|NCT00356993|Autonomic Agents|autonomic agents|mesh-ancestor
64585849|NCT00356993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64585850|NCT00356993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585851|NCT00356993|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64585852|NCT00356993|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64585853|NCT00356993|Cholinergic Agents|cholinergic agents|mesh-ancestor
64585854|NCT00356993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64585855|NCT00356993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369581|NCT03220321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369582|NCT03220321|Antimanic Agents|antimanic agents|mesh-ancestor
64369583|NCT03220321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64980741|NCT00077948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64980742|NCT00077948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980743|NCT00077948|Protective Agents|protective agents|mesh-ancestor
64980744|NCT00111345|Daunorubicin|daunorubicin|mesh-list
64980745|NCT00111345|Idarubicin|idarubicin|mesh-list
64980746|NCT00111345|Cladribine|cladribine|mesh-list
64980774|NCT00287326|Adrenergic Agents|adrenergic agents|mesh-ancestor
64980775|NCT00287326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64980777|NCT00287443|Hormones|hormones|mesh-list
64980847|NCT00287950|Etoposide|etoposide|mesh-list
64980848|NCT00287950|Vincristine|vincristine|mesh-list
64980849|NCT00287950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64980850|NCT00287950|Immunologic Factors|immunologic factors|mesh-ancestor
64980857|NCT00287950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64980858|NCT00287950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64980859|NCT00287950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64980907|NCT00288379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64585857|NCT01793077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64585858|NCT01793077|Fertility Agents|fertility agents|mesh-ancestor
64585859|NCT01793077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64585860|NCT01793077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585861|NCT01793077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64585862|NCT01793077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585863|NCT00555477|Anastrozole|anastrozole|mesh-list
64585864|NCT00555477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64585865|NCT00555477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585866|NCT00555477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64585867|NCT00555477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64585868|NCT00555477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585869|NCT00555477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585870|NCT00555477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64369594|NCT03075657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64980908|NCT00288379|Adrenergic Agents|adrenergic agents|mesh-ancestor
64980909|NCT00288379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64980910|NCT00288379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980911|NCT00078182|Tenofovir|tenofovir|mesh-list
64980912|NCT00078182|Antiviral Agents|antiviral agents|mesh-ancestor
64980913|NCT00078182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64980914|NCT00078182|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64980915|NCT00078182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64980916|NCT00078182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64980918|NCT00078182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64980971|NCT00111852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64980972|NCT00111852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980973|NCT00289042|Enoxaparin|enoxaparin|mesh-list
64980975|NCT00289042|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64980976|NCT00289042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64980977|NCT00289042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64980978|NCT00111891|Niacin|niacin|mesh-list
64980979|NCT00111891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64585871|NCT00555477|Hormone Antagonists|hormone antagonists|mesh-ancestor
64980980|NCT00111891|Antimetabolites|antimetabolites|mesh-ancestor
64980981|NCT00111891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585872|NCT00555477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64585873|NCT00555477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585874|NCT00365599|Tamoxifen|tamoxifen|mesh-list
64585875|NCT00365599|Vorinostat|vorinostat|mesh-list
64585876|NCT00365599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585877|NCT00365599|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64585878|NCT00365599|Hormone Antagonists|hormone antagonists|mesh-ancestor
64585879|NCT00365599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64980982|NCT00111891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64980983|NCT00111891|Vasodilator Agents|vasodilator agents|mesh-ancestor
64980984|NCT00111891|Vitamin B Complex|vitamin b complex|mesh-ancestor
64981032|NCT00289861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64981033|NCT00289861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64981034|NCT00289861|Dopamine Agents|dopamine agents|mesh-ancestor
64981035|NCT00290017|Pemetrexed|pemetrexed|mesh-list
64981036|NCT00290017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981037|NCT00290017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981038|NCT00290017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981039|NCT00290017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64981040|NCT00290017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64981041|NCT00112008|Darbepoetin alfa|darbepoetin alfa|mesh-list
64981042|NCT00112008|Hematinics|hematinics|mesh-ancestor
64981043|NCT00112086|Paclitaxel|paclitaxel|mesh-list
64981044|NCT00112086|Carboplatin|carboplatin|mesh-list
64981045|NCT00112086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64981051|NCT00290173|Ritodrine|ritodrine|mesh-list
64981093|NCT00290602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64981094|NCT00290602|Protective Agents|protective agents|mesh-ancestor
64981095|NCT00290602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64981096|NCT00290602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981097|NCT00290641|Cyclosporine|cyclosporine|mesh-list
64981098|NCT00290641|Mycophenolic Acid|mycophenolic acid|mesh-list
64981099|NCT00290641|Cyclophosphamide|cyclophosphamide|mesh-list
64981100|NCT00290641|Fludarabine|fludarabine|mesh-list
64981101|NCT00290641|Fludarabine phosphate|fludarabine phosphate|mesh-list
64981102|NCT00290641|Cyclosporins|cyclosporins|mesh-list
64981103|NCT00290641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64981104|NCT00290641|Immunologic Factors|immunologic factors|mesh-ancestor
64981105|NCT00290641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981106|NCT00290641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64981107|NCT00290641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64981108|NCT00290641|Alkylating Agents|alkylating agents|mesh-ancestor
64981109|NCT00290641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981110|NCT00290641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981111|NCT00290641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64981112|NCT00290641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64981113|NCT00290641|Antimetabolites|antimetabolites|mesh-ancestor
64981145|NCT00112281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585880|NCT00365599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585881|NCT00365599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64585882|NCT00365599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585883|NCT00365599|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64334357|NCT02231021|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64334358|NCT02231021|Protease Inhibitors|protease inhibitors|mesh-ancestor
64334359|NCT02231021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334360|NCT02231021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981146|NCT00112281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981147|NCT00290719|Irinotecan|irinotecan|mesh-list
64981148|NCT00290719|Gefitinib|gefitinib|mesh-list
64981149|NCT00290719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981150|NCT00290719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64981151|NCT00290719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64981152|NCT00290719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981153|NCT00290719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981154|NCT00290719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64981155|NCT00290836|Thrombin|thrombin|mesh-list
64981156|NCT00290836|Aprotinin|aprotinin|mesh-list
64981157|NCT00290836|Hemostatics|hemostatics|mesh-ancestor
64981158|NCT00290836|Coagulants|coagulants|mesh-ancestor
64981159|NCT00290836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64981160|NCT00290836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64981161|NCT00290836|Protease Inhibitors|protease inhibitors|mesh-ancestor
64981162|NCT00290836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981163|NCT00290836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981164|NCT04729556|Chitosan|chitosan|mesh-list
64981165|NCT04729556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64981166|NCT04729556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64981172|NCT04729556|Hemostatics|hemostatics|mesh-ancestor
64981194|NCT00291109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981196|NCT00291109|Hormone Antagonists|hormone antagonists|mesh-ancestor
64981197|NCT00291109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64981198|NCT00291109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981199|NCT00291148|Pregabalin|pregabalin|mesh-list
64981200|NCT00291148|Paroxetine|paroxetine|mesh-list
64981201|NCT00291148|Analgesics|analgesics|mesh-ancestor
64981202|NCT00291148|Sensory System Agents|sensory system agents|mesh-ancestor
64981203|NCT00291148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64981204|NCT00291148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981205|NCT00291148|Anticonvulsants|anticonvulsants|mesh-ancestor
64981206|NCT00291148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64981207|NCT00291148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64981208|NCT00291148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981209|NCT00291148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64585886|NCT00365599|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64585887|NCT00365599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585888|NCT00554619|Ambrisentan|ambrisentan|mesh-list
64585889|NCT00554619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64585890|NCT02104739|Exenatide|exenatide|mesh-list
64585891|NCT02104739|Saxagliptin|saxagliptin|mesh-list
64369781|NCT03316469|Enclomiphene|enclomiphene|mesh-list
64981210|NCT00291148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64981211|NCT00291148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64981212|NCT00291148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64981213|NCT00291148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64981214|NCT00291148|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64981215|NCT00291148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64981216|NCT00291148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64981217|NCT00291148|Serotonin Agents|serotonin agents|mesh-ancestor
64981238|NCT00291382|Adrenergic Agents|adrenergic agents|mesh-ancestor
64981239|NCT00291382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64981240|NCT00291382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981241|NCT00112476|Sirolimus|sirolimus|mesh-list
64981242|NCT00112476|Bryostatin 1|bryostatin 1|mesh-list
64981243|NCT00112476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64981244|NCT00112476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64585892|NCT02104739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64585893|NCT02104739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585894|NCT02104739|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64585895|NCT02104739|Incretins|incretins|mesh-ancestor
64585896|NCT02104739|Hormones|hormones|mesh-ancestor
64585897|NCT02104739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64585898|NCT02104739|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64585899|NCT02104739|Protease Inhibitors|protease inhibitors|mesh-ancestor
64334362|NCT04465123|Spironolactone|spironolactone|mesh-list
64334363|NCT04465123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64334364|NCT04465123|Diuretics|diuretics|mesh-ancestor
64585901|NCT02104739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585903|NCT00411619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585904|NCT00411619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64585905|NCT00411619|Immunologic Factors|immunologic factors|mesh-ancestor
64585906|NCT00411619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585907|NCT00412087|Vitamin D|vitamin d|mesh-list
64311203|NCT03047954|Broncho-Vaxom|broncho-vaxom|mesh-list
64585908|NCT00412087|Ergocalciferols|ergocalciferols|mesh-list
64585909|NCT00412087|Cholecalciferol|cholecalciferol|mesh-list
64585910|NCT00412087|Vitamins|vitamins|mesh-list
64585911|NCT00412087|Micronutrients|micronutrients|mesh-ancestor
64369828|NCT04999293|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64981245|NCT00112476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64981246|NCT00112476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981247|NCT00112476|Antifungal Agents|antifungal agents|mesh-ancestor
64981248|NCT00112476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64981249|NCT00112476|Immunologic Factors|immunologic factors|mesh-ancestor
64981250|NCT00112476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981251|NCT00112476|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64981252|NCT00291538|Bortezomib|bortezomib|mesh-list
64981253|NCT00291538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981254|NCT00291616|Interferons|interferons|mesh-list
64981255|NCT00291616|Interferon-alpha|interferon-alpha|mesh-list
64981258|NCT00291616|Thymalfasin|thymalfasin|mesh-list
64981259|NCT00291616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981260|NCT00291616|Antiviral Agents|antiviral agents|mesh-ancestor
64981261|NCT00291616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64981262|NCT00291616|Immunologic Factors|immunologic factors|mesh-ancestor
64981263|NCT00291616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981264|NCT00291616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64981265|NCT00078572|Capecitabine|capecitabine|mesh-list
64981266|NCT00078572|Lapatinib|lapatinib|mesh-list
64981267|NCT00078572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64981268|NCT00078572|Antimetabolites|antimetabolites|mesh-ancestor
64981269|NCT00078572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981270|NCT00078572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981271|NCT00078572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64981272|NCT00078572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981273|NCT00291733|Levetiracetam|levetiracetam|mesh-list
64981274|NCT00291733|Anticonvulsants|anticonvulsants|mesh-ancestor
64981275|NCT00291733|Nootropic Agents|nootropic agents|mesh-ancestor
64981276|NCT00112515|Modafinil|modafinil|mesh-list
64981277|NCT00112515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64981278|NCT00112515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981279|NCT00112515|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64585912|NCT00412087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369866|NCT03203005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369867|NCT03203005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64369868|NCT03203005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64369869|NCT03203005|Alkylating Agents|alkylating agents|mesh-ancestor
64369870|NCT03203005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369871|NCT03203005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369872|NCT03203005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64369874|NCT02484209|Glimepiride|glimepiride|mesh-list
64369875|NCT02484209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64369877|NCT02484209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64981280|NCT00112515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64981281|NCT00112515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64981282|NCT00112515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981283|NCT00291772|Pramlintide|pramlintide|mesh-list
64981284|NCT00291772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64981285|NCT00291772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981286|NCT00078611|Natalizumab|natalizumab|mesh-list
64981287|NCT00078611|Immunologic Factors|immunologic factors|mesh-ancestor
64981288|NCT00078611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981289|NCT00291811|Plerixafor|plerixafor|mesh-list
64981290|NCT00291811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64981291|NCT00291811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64981292|NCT00291811|Antiviral Agents|antiviral agents|mesh-ancestor
64981293|NCT00291811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64981294|NCT00291850|Paclitaxel|paclitaxel|mesh-list
64981295|NCT00291850|Cisplatin|cisplatin|mesh-list
64334365|NCT04465123|Natriuretic Agents|natriuretic agents|mesh-ancestor
64334366|NCT04465123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334367|NCT04465123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64585916|NCT00312923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64585917|NCT00312923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64585918|NCT00312923|Antimetabolites|antimetabolites|mesh-ancestor
64585919|NCT00312923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585920|NCT00312923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64334368|NCT04465123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64334369|NCT04465123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334370|NCT04465123|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64369879|NCT02484209|Immunologic Factors|immunologic factors|mesh-ancestor
64369880|NCT04999137|Vitamins|vitamins|mesh-list
64369881|NCT04999137|Thiamine|thiamine|mesh-list
64369882|NCT04999137|Micronutrients|micronutrients|mesh-ancestor
64369884|NCT04999137|Vitamin B Complex|vitamin b complex|mesh-ancestor
64981296|NCT00291850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64981297|NCT00291850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981298|NCT00291850|Tubulin Modulators|tubulin modulators|mesh-ancestor
64981299|NCT00291850|Antimitotic Agents|antimitotic agents|mesh-ancestor
64981300|NCT00291850|Mitosis Modulators|mitosis modulators|mesh-ancestor
64981301|NCT00291850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981302|NCT00112554|Cytarabine|cytarabine|mesh-list
64981303|NCT00112554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64981321|NCT00078689|Immunologic Factors|immunologic factors|mesh-ancestor
64981322|NCT00078689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981323|NCT00112632|Imatinib Mesylate|imatinib mesylate|mesh-list
64981324|NCT00112632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981325|NCT00112632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64981326|NCT00112632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981327|NCT00112632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981329|NCT00078845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64981330|NCT00078845|Protective Agents|protective agents|mesh-ancestor
64981331|NCT00078845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981332|NCT00275314|Valganciclovir|valganciclovir|mesh-list
64981333|NCT00275314|Antiviral Agents|antiviral agents|mesh-ancestor
64981334|NCT00275314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64981335|NCT00275275|Pramipexole|pramipexole|mesh-list
64981336|NCT00275275|Ropinirole|ropinirole|mesh-list
64981382|NCT00275119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64981383|NCT00275119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981384|NCT00275119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64981385|NCT00275119|Immunologic Factors|immunologic factors|mesh-ancestor
64981386|NCT00275119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585923|NCT00412243|Clofarabine|clofarabine|mesh-list
64585924|NCT00412243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64585925|NCT00412243|Immunologic Factors|immunologic factors|mesh-ancestor
64585926|NCT00412243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585927|NCT00412243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64585928|NCT00412243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64585929|NCT00412243|Alkylating Agents|alkylating agents|mesh-ancestor
64585930|NCT00412243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585931|NCT00412243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585932|NCT00412243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64585933|NCT00412243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64585934|NCT00412243|Antimetabolites|antimetabolites|mesh-ancestor
64585935|NCT01426412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64585936|NCT01426412|Immunologic Factors|immunologic factors|mesh-ancestor
64585937|NCT01426412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585938|NCT00315341|Buprenorphine|buprenorphine|mesh-list
64585939|NCT00315341|Methadone|methadone|mesh-list
64585940|NCT00315341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64585941|NCT00315341|Naloxone|naloxone|mesh-list
64585942|NCT00315341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64369917|NCT02483897|Sensory System Agents|sensory system agents|mesh-ancestor
64981387|NCT00275080|Decitabine|decitabine|mesh-list
64981388|NCT00275080|Azacitidine|azacitidine|mesh-list
64981389|NCT00275080|Vorinostat|vorinostat|mesh-list
64981390|NCT00275080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64981391|NCT00275080|Antimetabolites|antimetabolites|mesh-ancestor
64981392|NCT00275080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981393|NCT00275080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981394|NCT00275080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981400|NCT00078962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981436|NCT00102765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981437|NCT00102765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64981438|NCT00102765|Respiratory System Agents|respiratory system agents|mesh-ancestor
64981440|NCT00102765|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64981441|NCT00102765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64981442|NCT00102765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64981443|NCT00102765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64981444|NCT00102765|Adrenergic Agents|adrenergic agents|mesh-ancestor
64981445|NCT00102765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64981446|NCT00102765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981448|NCT00102765|Hormones|hormones|mesh-ancestor
64981449|NCT00102765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64981450|NCT00102765|Sympathomimetics|sympathomimetics|mesh-ancestor
64981451|NCT00130390|Nitazoxanide|nitazoxanide|mesh-list
64981452|NCT00130390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64981453|NCT00130390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64981454|NCT00079079|Gemcitabine|gemcitabine|mesh-list
64981455|NCT00079079|Carboplatin|carboplatin|mesh-list
64981456|NCT00079079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981457|NCT00079079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64981487|NCT00130312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64981488|NCT00130312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981489|NCT00130234|Omalizumab|omalizumab|mesh-list
64981490|NCT00130234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64981491|NCT00130234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64981492|NCT00130234|Respiratory System Agents|respiratory system agents|mesh-ancestor
64981493|NCT00119301|Leucovorin|leucovorin|mesh-list
64981494|NCT00119301|Trimetrexate|trimetrexate|mesh-list
64981495|NCT00119301|Methotrexate|methotrexate|mesh-list
64981496|NCT00119301|Calcium|calcium|mesh-list
64981497|NCT00119301|Levoleucovorin|levoleucovorin|mesh-list
64981498|NCT00119301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64981499|NCT00119301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981500|NCT00119301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64981501|NCT00119301|Abortifacient Agents|abortifacient agents|mesh-ancestor
64981502|NCT00119301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64981503|NCT00119301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64334371|NCT04465123|Hormone Antagonists|hormone antagonists|mesh-ancestor
64334372|NCT04465123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64334373|NCT04465123|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64369934|NCT03202459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64369935|NCT03202459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369936|NCT03202459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64369954|NCT04492319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369955|NCT04492319|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64369956|NCT04492319|Autonomic Agents|autonomic agents|mesh-ancestor
64369957|NCT04492319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369958|NCT04456959|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
64369959|NCT04456959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64981505|NCT00119301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981506|NCT00119301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981507|NCT00119301|Dermatologic Agents|dermatologic agents|mesh-ancestor
64981508|NCT00119301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981509|NCT00119301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64981510|NCT00119301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64981511|NCT00119301|Immunologic Factors|immunologic factors|mesh-ancestor
64981542|NCT00130195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64981543|NCT00130195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64981544|NCT00130195|Alkylating Agents|alkylating agents|mesh-ancestor
64981545|NCT00130195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981546|NCT00130195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585945|NCT00315341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585946|NCT00315341|Analgesics|analgesics|mesh-ancestor
64585947|NCT00315341|Sensory System Agents|sensory system agents|mesh-ancestor
64585948|NCT00315341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64585949|NCT00315341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64585950|NCT00315341|Antitussive Agents|antitussive agents|mesh-ancestor
64585951|NCT00315341|Respiratory System Agents|respiratory system agents|mesh-ancestor
64585953|NCT02277249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64585954|NCT02277249|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64585955|NCT02277249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585956|NCT02277249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585957|NCT02277249|Protective Agents|protective agents|mesh-ancestor
64585958|NCT02277249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585959|NCT04767542|Acetaminophen|acetaminophen|mesh-list
64369992|NCT03315533|Analgesics|analgesics|mesh-ancestor
64981547|NCT00130195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64981548|NCT00130195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64981549|NCT00130195|Antiemetics|antiemetics|mesh-ancestor
64981550|NCT00130195|Autonomic Agents|autonomic agents|mesh-ancestor
64981551|NCT00130195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64981552|NCT00130195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64981553|NCT00130195|Glucocorticoids|glucocorticoids|mesh-ancestor
64981554|NCT00130195|Hormones|hormones|mesh-ancestor
64981555|NCT00130195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64981556|NCT00130195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64981557|NCT00130195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64981598|NCT00119340|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64981599|NCT00119340|Antitubercular Agents|antitubercular agents|mesh-ancestor
64981600|NCT00119340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64981601|NCT00130156|Doxazosin|doxazosin|mesh-list
64981602|NCT00130156|Bunazosin|bunazosin|mesh-list
64981606|NCT00130156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64981607|NCT00130156|Adrenergic Agents|adrenergic agents|mesh-ancestor
64981663|NCT00129727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64981664|NCT00129727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981665|NCT00129727|Tubulin Modulators|tubulin modulators|mesh-ancestor
64981666|NCT00129727|Antimitotic Agents|antimitotic agents|mesh-ancestor
64981667|NCT00129727|Mitosis Modulators|mitosis modulators|mesh-ancestor
64981668|NCT00129727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981669|NCT00129727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64334374|NCT02401347|Talazoparib|talazoparib|mesh-list
64334375|NCT02401347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64334376|NCT02401347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585961|NCT04767542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64585962|NCT04767542|Analgesics|analgesics|mesh-ancestor
64585963|NCT04767542|Sensory System Agents|sensory system agents|mesh-ancestor
64585964|NCT04767542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64585965|NCT04767542|Antipyretics|antipyretics|mesh-ancestor
64585966|NCT01794533|Lidocaine|lidocaine|mesh-list
64585967|NCT01794533|Epinephrine|epinephrine|mesh-list
64585968|NCT01794533|Racepinephrine|racepinephrine|mesh-list
64585969|NCT01794533|Fentanyl|fentanyl|mesh-list
64585970|NCT01794533|Epinephryl borate|epinephryl borate|mesh-list
64585971|NCT01794533|Anesthetics, Local|anesthetics, local|mesh-ancestor
64585972|NCT01794533|Anesthetics|anesthetics|mesh-ancestor
64585973|NCT01794533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64585974|NCT01794533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585975|NCT01794533|Sensory System Agents|sensory system agents|mesh-ancestor
64585976|NCT01794533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64585977|NCT01794533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64585978|NCT01794533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64981670|NCT00129727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64981671|NCT00129727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64981672|NCT00129727|Growth Substances|growth substances|mesh-ancestor
64981673|NCT00129727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981674|NCT00129727|Growth Inhibitors|growth inhibitors|mesh-ancestor
64981675|NCT00079313|Imatinib Mesylate|imatinib mesylate|mesh-list
64981676|NCT00079313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981677|NCT00079313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64981678|NCT00079313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981680|NCT00129688|Amikacin|amikacin|mesh-list
64981720|NCT00119496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64981721|NCT00119496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64981722|NCT00119496|Purinergic Agents|purinergic agents|mesh-ancestor
64981723|NCT00119496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64981724|NCT00298285|Enoxaparin|enoxaparin|mesh-list
64981725|NCT00298285|Anticoagulants|anticoagulants|mesh-ancestor
64981726|NCT00298285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64981727|NCT00298285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64585987|NCT01794533|Anesthetics, General|anesthetics, general|mesh-ancestor
64585988|NCT01794533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64585989|NCT01794533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64585990|NCT01794533|Adrenergic Agents|adrenergic agents|mesh-ancestor
64585991|NCT01794533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64585992|NCT01794533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64585993|NCT01794533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64585994|NCT01794533|Autonomic Agents|autonomic agents|mesh-ancestor
64585995|NCT01794533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64585996|NCT01794533|Respiratory System Agents|respiratory system agents|mesh-ancestor
64585997|NCT01794533|Mydriatics|mydriatics|mesh-ancestor
64585998|NCT01794533|Sympathomimetics|sympathomimetics|mesh-ancestor
64585999|NCT01794533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64586000|NCT00412867|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64586001|NCT00412867|Plasminogen|plasminogen|mesh-list
64370027|NCT04997967|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64370028|NCT04997967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64586002|NCT00412867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64586003|NCT00412867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64586004|NCT00412867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586005|NCT01730833|Paclitaxel|paclitaxel|mesh-list
64586006|NCT01730833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64586007|NCT01730833|Trastuzumab|trastuzumab|mesh-list
64586008|NCT01730833|Pertuzumab|pertuzumab|mesh-list
64586009|NCT01730833|Antibodies|antibodies|mesh-list
64586010|NCT01730833|Immunoglobulins|immunoglobulins|mesh-list
64586011|NCT01730833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64370029|NCT04997967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64981728|NCT00298285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981729|NCT00298324|Cyclosporine|cyclosporine|mesh-list
64981730|NCT00298324|Mycophenolic Acid|mycophenolic acid|mesh-list
64981731|NCT00298324|Prednisone|prednisone|mesh-list
64981732|NCT00298324|Cyclosporins|cyclosporins|mesh-list
64981733|NCT00298324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64981734|NCT00298324|Glucocorticoids|glucocorticoids|mesh-ancestor
64981735|NCT00298324|Hormones|hormones|mesh-ancestor
64981753|NCT00079430|Paclitaxel|paclitaxel|mesh-list
64981781|NCT00298636|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64981782|NCT00298636|Purinergic Agonists|purinergic agonists|mesh-ancestor
64586013|NCT01730833|Tubulin Modulators|tubulin modulators|mesh-ancestor
64586014|NCT01730833|Antimitotic Agents|antimitotic agents|mesh-ancestor
64586015|NCT01730833|Mitosis Modulators|mitosis modulators|mesh-ancestor
64586016|NCT01730833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586017|NCT01730833|Immunologic Factors|immunologic factors|mesh-ancestor
64586018|NCT01730833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586019|NCT01730833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64981783|NCT00298636|Purinergic Agents|purinergic agents|mesh-ancestor
64981784|NCT00298636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64586020|NCT00413335|Rosiglitazone|rosiglitazone|mesh-list
64586021|NCT00413335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64586022|NCT00413335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586023|NCT00414271|Docetaxel|docetaxel|mesh-list
64586024|NCT00414271|Capecitabine|capecitabine|mesh-list
64586025|NCT00414271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586026|NCT00414271|Tubulin Modulators|tubulin modulators|mesh-ancestor
64586027|NCT00414271|Antimitotic Agents|antimitotic agents|mesh-ancestor
64586028|NCT00414271|Mitosis Modulators|mitosis modulators|mesh-ancestor
64586029|NCT00414271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586030|NCT00414271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64586031|NCT00414271|Antimetabolites|antimetabolites|mesh-ancestor
64586032|NCT00360971|Cisplatin|cisplatin|mesh-list
64586033|NCT00360971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586034|NCT01791881|Botulinum Toxins|botulinum toxins|mesh-list
64586035|NCT01791881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64586036|NCT01791881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64586037|NCT01791881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64586038|NCT01791881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64334378|NCT02401347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334379|NCT02231255|Pramipexole|pramipexole|mesh-list
64586039|NCT01791881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981785|NCT00298636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981786|NCT00086112|Risperidone|risperidone|mesh-list
64981787|NCT00086112|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64981788|NCT00086112|Serotonin Agents|serotonin agents|mesh-ancestor
64981789|NCT00086112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64981790|NCT00086112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981791|NCT00086112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981792|NCT00086112|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64981793|NCT00086112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64981794|NCT00086112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64981795|NCT00086112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64586041|NCT01791881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64586042|NCT01791881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586043|NCT01791881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64586044|NCT01791881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64586046|NCT03636503|Avelumab|avelumab|mesh-list
64586047|NCT03636503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64586048|NCT03636503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586049|NCT03636503|Immunologic Factors|immunologic factors|mesh-ancestor
64586050|NCT03636503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586051|NCT03636503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64586052|NCT03448159|Fluoxetine|fluoxetine|mesh-list
64334380|NCT02231255|Antioxidants|antioxidants|mesh-ancestor
64334381|NCT02231255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334382|NCT02231255|Protective Agents|protective agents|mesh-ancestor
64334383|NCT02231255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334384|NCT02231255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64334385|NCT02231255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64586055|NCT03448159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64586056|NCT03448159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586057|NCT03448159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64586058|NCT03448159|Serotonin Agents|serotonin agents|mesh-ancestor
64586059|NCT03448159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370040|NCT02483195|Diuretics|diuretics|mesh-ancestor
64981796|NCT00086112|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64981797|NCT00086112|Dopamine Agents|dopamine agents|mesh-ancestor
64981798|NCT00079469|Bupropion|bupropion|mesh-list
64981799|NCT00079469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64981800|NCT00079469|Antidepressive Agents|antidepressive agents|mesh-ancestor
64981833|NCT00298870|Isoniazid|isoniazid|mesh-list
64981834|NCT00298870|Antitubercular Agents|antitubercular agents|mesh-ancestor
64981835|NCT00298870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64981836|NCT00298870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64981837|NCT00298870|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64981838|NCT00298870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64981839|NCT00298870|Antimetabolites|antimetabolites|mesh-ancestor
64981840|NCT00298870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981841|NCT00298870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64981842|NCT00298909|Niacin|niacin|mesh-list
64586060|NCT03448159|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64586061|NCT03448159|Antidepressive Agents|antidepressive agents|mesh-ancestor
64586062|NCT03448159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64586063|NCT03448159|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64586064|NCT03448159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64586065|NCT03448159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586066|NCT00361439|Mometasone Furoate|mometasone furoate|mesh-list
64586067|NCT00361439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64586068|NCT00361439|Dermatologic Agents|dermatologic agents|mesh-ancestor
64586069|NCT00361439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64586070|NCT00361595|Zoledronic Acid|zoledronic acid|mesh-list
64586071|NCT00361595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64586072|NCT00361595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586074|NCT03438487|Immunologic Factors|immunologic factors|mesh-ancestor
64586075|NCT03438487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981843|NCT00298909|Niacinamide|niacinamide|mesh-list
64981844|NCT00298909|Nicotinic Acids|nicotinic acids|mesh-list
64981845|NCT00298909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64981846|NCT00298909|Antimetabolites|antimetabolites|mesh-ancestor
64981847|NCT00298909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981848|NCT00298909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64981849|NCT00298909|Vasodilator Agents|vasodilator agents|mesh-ancestor
64981850|NCT00298909|Vitamin B Complex|vitamin b complex|mesh-ancestor
64981851|NCT00298909|Vitamins|vitamins|mesh-ancestor
64981852|NCT00298909|Micronutrients|micronutrients|mesh-ancestor
64586108|NCT01792037|Hormones|hormones|mesh-ancestor
64586109|NCT01792037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64586110|NCT01792037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64586111|NCT01792037|Protective Agents|protective agents|mesh-ancestor
64586112|NCT01792037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64586113|NCT01792037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586114|NCT00373399|Dronabinol|dronabinol|mesh-list
64586115|NCT00373399|Hallucinogens|hallucinogens|mesh-ancestor
64586116|NCT00373399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586117|NCT00373399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64586118|NCT00373399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64586119|NCT00373399|Analgesics|analgesics|mesh-ancestor
64586120|NCT00373399|Sensory System Agents|sensory system agents|mesh-ancestor
64586121|NCT00373399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64586122|NCT00373399|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64586123|NCT00373399|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64586124|NCT00373399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64586126|NCT00373399|Hormones|hormones|mesh-ancestor
64981853|NCT00298909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981854|NCT00299026|Paclitaxel|paclitaxel|mesh-list
64981855|NCT00299026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64981856|NCT00299026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981857|NCT00299026|Tubulin Modulators|tubulin modulators|mesh-ancestor
64981858|NCT00299026|Antimitotic Agents|antimitotic agents|mesh-ancestor
64981859|NCT00299026|Mitosis Modulators|mitosis modulators|mesh-ancestor
64981860|NCT00299026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981861|NCT00299065|Zileuton|zileuton|mesh-list
64981862|NCT00299065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64981863|NCT00299065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64586153|NCT00418093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64586154|NCT00418093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586155|NCT00418093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64586156|NCT00418093|Immunologic Factors|immunologic factors|mesh-ancestor
64586157|NCT03855371|Decitabine|decitabine|mesh-list
64334389|NCT02352051|Methylphenidate|methylphenidate|mesh-list
64334390|NCT02352051|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64334391|NCT02352051|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64334392|NCT02352051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334393|NCT02352051|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64334394|NCT02352051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64334395|NCT02352051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64586160|NCT03855371|Antimetabolites|antimetabolites|mesh-ancestor
64586161|NCT03855371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586162|NCT03855371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586163|NCT03855371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586164|NCT03284723|Letrozole|letrozole|mesh-list
64586165|NCT03284723|Palbociclib|palbociclib|mesh-list
64586166|NCT03284723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586167|NCT03284723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64586168|NCT03284723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64586169|NCT03284723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586170|NCT03284723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586171|NCT03284723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64981877|NCT00079586|Bivalirudin|bivalirudin|mesh-list
64981878|NCT00079586|Anticoagulants|anticoagulants|mesh-ancestor
64981879|NCT00079586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64981880|NCT00079586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64981881|NCT00079586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981882|NCT00079586|Antithrombins|antithrombins|mesh-ancestor
64981883|NCT00079586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64981884|NCT00079586|Protease Inhibitors|protease inhibitors|mesh-ancestor
64586172|NCT03284723|Hormone Antagonists|hormone antagonists|mesh-ancestor
64586173|NCT03284723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64586174|NCT03284723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586175|NCT03284723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64586176|NCT00374803|Mycophenolic Acid|mycophenolic acid|mesh-list
64586177|NCT00374803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64586178|NCT00374803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586179|NCT00374803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64586180|NCT00374803|Antitubercular Agents|antitubercular agents|mesh-ancestor
64586181|NCT00374803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64586182|NCT00374803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64586183|NCT00374803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586184|NCT00374803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586187|NCT00418951|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64586188|NCT00418951|Antifungal Agents|antifungal agents|mesh-ancestor
64586189|NCT00418951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64586190|NCT00418951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64586191|NCT00418951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64586192|NCT00418951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586193|NCT00418951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586194|NCT00418951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64586195|NCT00418951|Hormone Antagonists|hormone antagonists|mesh-ancestor
64586196|NCT00418951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64586197|NCT00418951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586198|NCT00418951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64586199|NCT00418951|Amebicides|amebicides|mesh-ancestor
64586200|NCT00418951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64586201|NCT00418951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64586202|NCT00418951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64586203|NCT00363077|Vaccines|vaccines|mesh-list
64370200|NCT02448199|Meloxicam|meloxicam|mesh-list
64981885|NCT00079586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981886|NCT00418132|Thalidomide|thalidomide|mesh-list
64981887|NCT00418132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64981888|NCT00418132|Immunologic Factors|immunologic factors|mesh-ancestor
64981889|NCT00418132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981890|NCT00418132|Leprostatic Agents|leprostatic agents|mesh-ancestor
64981891|NCT00418132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64981892|NCT00418132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64981893|NCT00418132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64981894|NCT00418132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64981895|NCT00418132|Growth Substances|growth substances|mesh-ancestor
64981896|NCT00418132|Growth Inhibitors|growth inhibitors|mesh-ancestor
64981897|NCT00418132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64981898|NCT00119613|Darbepoetin alfa|darbepoetin alfa|mesh-list
64981899|NCT00119613|Hematinics|hematinics|mesh-ancestor
64981900|NCT00299377|Abciximab|abciximab|mesh-list
64981901|NCT00299377|Anticoagulants|anticoagulants|mesh-ancestor
64981929|NCT00299611|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64981930|NCT00299611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64981931|NCT00299611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64981932|NCT00299611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64981933|NCT00299611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64981934|NCT00299611|Serotonin Agents|serotonin agents|mesh-ancestor
64981935|NCT00299611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981936|NCT00299611|Anticonvulsants|anticonvulsants|mesh-ancestor
64981937|NCT00299611|Nootropic Agents|nootropic agents|mesh-ancestor
64981938|NCT00299650|Cisatracurium|cisatracurium|mesh-list
64981939|NCT00299650|Atracurium|atracurium|mesh-list
64981940|NCT00299650|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64981941|NCT00299650|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64981942|NCT00299650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64981943|NCT00299650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981944|NCT00299650|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64981984|NCT00119652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334396|NCT02352051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334397|NCT02352051|Dopamine Agents|dopamine agents|mesh-ancestor
64586206|NCT00375973|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64586207|NCT00375973|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64586208|NCT00375973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64586209|NCT00375973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64586210|NCT00375973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586211|NCT00375973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64586212|NCT00375973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64981986|NCT00119652|Serotonin Agents|serotonin agents|mesh-ancestor
64981987|NCT00119652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64981988|NCT00119652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64981989|NCT00119652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64981990|NCT00119652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64981991|NCT00299923|Ribavirin|ribavirin|mesh-list
64981992|NCT00299923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64981993|NCT00299923|Amantadine|amantadine|mesh-list
64981994|NCT00299923|Antimetabolites|antimetabolites|mesh-ancestor
64982004|NCT00299923|Analgesics|analgesics|mesh-ancestor
64586226|NCT00363779|Cyclosporins|cyclosporins|mesh-list
64586227|NCT00363779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586228|NCT00363779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586229|NCT00363779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64586230|NCT00363779|Immunologic Factors|immunologic factors|mesh-ancestor
64586231|NCT00363779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586232|NCT00363779|Antifungal Agents|antifungal agents|mesh-ancestor
64586233|NCT00363779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64586234|NCT00363779|Dermatologic Agents|dermatologic agents|mesh-ancestor
64586235|NCT00363779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64586236|NCT00363779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64586237|NCT01405820|Natalizumab|natalizumab|mesh-list
64982046|NCT00300040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64982047|NCT00300040|Blood Substitutes|blood substitutes|mesh-ancestor
64982049|NCT00079820|Immunologic Factors|immunologic factors|mesh-ancestor
64982050|NCT00079820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982051|NCT00300079|Brinzolamide|brinzolamide|mesh-list
64982052|NCT00300079|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64982053|NCT00300079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982057|NCT00300118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64982065|NCT00300118|Hormones|hormones|mesh-ancestor
64982109|NCT00399659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64982110|NCT00399659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982111|NCT00399659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982112|NCT00300352|Folic Acid|folic acid|mesh-list
64982113|NCT00300352|Hematinics|hematinics|mesh-ancestor
64982114|NCT00300352|Vitamin B Complex|vitamin b complex|mesh-ancestor
64982115|NCT00300352|Vitamins|vitamins|mesh-ancestor
64982116|NCT00300352|Micronutrients|micronutrients|mesh-ancestor
64334400|NCT02352051|Adrenergic Agents|adrenergic agents|mesh-ancestor
64334401|NCT02227277|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64586239|NCT01405820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586240|NCT05287633|Esomeprazole|esomeprazole|mesh-list
64586241|NCT05287633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64982117|NCT00300352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982118|NCT00300508|Anastrozole|anastrozole|mesh-list
64586242|NCT05287633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64586243|NCT05287633|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64586244|NCT05287633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586245|NCT05287633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586247|NCT01405742|Coagulants|coagulants|mesh-ancestor
64586248|NCT01794767|Heparin|heparin|mesh-list
64586249|NCT01794767|Calcium heparin|calcium heparin|mesh-list
64586250|NCT01794767|Anticoagulants|anticoagulants|mesh-ancestor
64586251|NCT01794767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64586252|NCT01794767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64982120|NCT00300508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982171|NCT04718233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64982172|NCT04718233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64982174|NCT04718233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982175|NCT04718233|Urological Agents|urological agents|mesh-ancestor
64982176|NCT00119886|Botulinum Toxins|botulinum toxins|mesh-list
64982177|NCT00119886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64982178|NCT00119886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64586254|NCT01425632|Bepotastine besilate|bepotastine besilate|mesh-list
64586255|NCT01425632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64586256|NCT02076152|Bevacizumab|bevacizumab|mesh-list
64586257|NCT02076152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64586258|NCT02076152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586259|NCT02076152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64586260|NCT02076152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64586261|NCT02076152|Growth Substances|growth substances|mesh-ancestor
64586262|NCT02076152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586263|NCT02076152|Growth Inhibitors|growth inhibitors|mesh-ancestor
64586264|NCT03025958|Nimotuzumab|nimotuzumab|mesh-list
64586265|NCT03025958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64586266|NCT03025958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982179|NCT00119886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982180|NCT00119886|Cholinergic Agents|cholinergic agents|mesh-ancestor
64982181|NCT00119886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64982182|NCT00119886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982183|NCT00300937|Ubiquinone|ubiquinone|mesh-list
64982184|NCT00300937|Coenzyme Q10|coenzyme q10|mesh-list
64982185|NCT00300937|Micronutrients|micronutrients|mesh-ancestor
64982186|NCT00300937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982187|NCT00300937|Vitamins|vitamins|mesh-ancestor
64982188|NCT00418249|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
64982189|NCT00418249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64982190|NCT00418249|Immunologic Factors|immunologic factors|mesh-ancestor
64334409|NCT03147183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64334410|NCT02292121|Mannitol|mannitol|mesh-list
64334411|NCT02292121|Lactitol|lactitol|mesh-list
64334412|NCT02292121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64334413|NCT02292121|Diuretics|diuretics|mesh-ancestor
64586267|NCT00380029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64586268|NCT00380029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586269|NCT00380029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64586270|NCT00380029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586271|NCT00380029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586272|NCT01405508|Brivaracetam|brivaracetam|mesh-list
64586273|NCT01405508|Anticonvulsants|anticonvulsants|mesh-ancestor
64586274|NCT00426283|Fluticasone|fluticasone|mesh-list
64586275|NCT00426283|Xhance|xhance|mesh-list
64586276|NCT00426283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64586277|NCT00426283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64586278|NCT00426283|Autonomic Agents|autonomic agents|mesh-ancestor
64586279|NCT00426283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370378|NCT03195673|Adrenergic Agents|adrenergic agents|mesh-ancestor
64370379|NCT03195673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64982191|NCT00418249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982192|NCT00418249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982193|NCT00418249|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64982194|NCT00418249|Protective Agents|protective agents|mesh-ancestor
64982195|NCT00418249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64982196|NCT00418249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64982197|NCT00418249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982198|NCT00418249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982199|NCT00418249|Antiviral Agents|antiviral agents|mesh-ancestor
64982200|NCT00418249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64982201|NCT00301054|Pyrimethamine|pyrimethamine|mesh-list
64982202|NCT00301054|Sulfadoxine|sulfadoxine|mesh-list
64884200|NCT01943942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64884201|NCT01943942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884202|NCT01943942|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64884203|NCT01943942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64884204|NCT01943942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884205|NCT01944033|Terbutaline|terbutaline|mesh-list
64884206|NCT01944033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64884207|NCT01944033|Autonomic Agents|autonomic agents|mesh-ancestor
64884208|NCT01944033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64884209|NCT01944033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884210|NCT01944033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64884211|NCT01944033|Respiratory System Agents|respiratory system agents|mesh-ancestor
64884212|NCT01944033|Sympathomimetics|sympathomimetics|mesh-ancestor
64884213|NCT01944033|Tocolytic Agents|tocolytic agents|mesh-ancestor
64884214|NCT01944033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64884215|NCT01944033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64884216|NCT01944033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64652745|NCT01574807|Lidocaine|lidocaine|mesh-list
64884218|NCT01944033|Adrenergic Agents|adrenergic agents|mesh-ancestor
64884219|NCT01944033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64884220|NCT01944033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884221|NCT01944085|Acetaminophen|acetaminophen|mesh-list
64884222|NCT01944085|Ascorbic Acid|ascorbic acid|mesh-list
64884223|NCT01944085|Ibuprofen|ibuprofen|mesh-list
64884224|NCT01944085|Vitamins|vitamins|mesh-ancestor
64884225|NCT01944085|Micronutrients|micronutrients|mesh-ancestor
64311576|NCT02090543|Rivaroxaban|rivaroxaban|mesh-list
64334415|NCT02292121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982203|NCT00301054|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64982204|NCT00301054|Antimalarials|antimalarials|mesh-ancestor
64982205|NCT00301054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64982206|NCT00301054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64982207|NCT00301054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64982208|NCT00301054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64982209|NCT00301054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982210|NCT00301054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982211|NCT00301054|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64982212|NCT00301054|Renal Agents|renal agents|mesh-ancestor
64982213|NCT00301093|Imatinib Mesylate|imatinib mesylate|mesh-list
64982214|NCT00301093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982215|NCT00301093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64982216|NCT00301093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982217|NCT00301093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982218|NCT00301171|Fluticasone|fluticasone|mesh-list
64982219|NCT00301171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64982220|NCT00301171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64982221|NCT00301171|Autonomic Agents|autonomic agents|mesh-ancestor
64982222|NCT00301171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64982223|NCT00301171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982224|NCT00301171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64884227|NCT01944085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64884228|NCT01944085|Analgesics|analgesics|mesh-ancestor
64884229|NCT01944085|Sensory System Agents|sensory system agents|mesh-ancestor
64884230|NCT01944085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64884231|NCT01944085|Antipyretics|antipyretics|mesh-ancestor
64884232|NCT01944085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64884233|NCT01944085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64884234|NCT01944085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64884235|NCT01944085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64884236|NCT01944085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884237|NCT01944085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884238|NCT01944085|Antioxidants|antioxidants|mesh-ancestor
64884239|NCT01944085|Protective Agents|protective agents|mesh-ancestor
64884240|NCT01944176|Simvastatin|simvastatin|mesh-list
64884241|NCT01944176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64884242|NCT01944176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64884243|NCT01944176|Antimetabolites|antimetabolites|mesh-ancestor
64370405|NCT02726399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64370406|NCT02726399|Antimetabolites|antimetabolites|mesh-ancestor
64370407|NCT02726399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370408|NCT02726399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64982225|NCT00301171|Respiratory System Agents|respiratory system agents|mesh-ancestor
64982226|NCT00301171|Dermatologic Agents|dermatologic agents|mesh-ancestor
64982227|NCT00301171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64982261|NCT00301405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64982262|NCT00301405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64982263|NCT00301405|Growth Substances|growth substances|mesh-ancestor
64982264|NCT00301405|Growth Inhibitors|growth inhibitors|mesh-ancestor
64982265|NCT00301405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982324|NCT00080444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64982325|NCT00080444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64982326|NCT00080444|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64982329|NCT00086736|Androgen Antagonists|androgen antagonists|mesh-ancestor
64982330|NCT00086736|Hormone Antagonists|hormone antagonists|mesh-ancestor
64982331|NCT00086736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64982332|NCT00086736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982333|NCT00086736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982334|NCT00086736|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64982335|NCT00086736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64884244|NCT01944176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884245|NCT01944176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64884246|NCT01944176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64884247|NCT01944176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884248|NCT01944189|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64884249|NCT01944189|Antimalarials|antimalarials|mesh-ancestor
64884250|NCT01944189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64884251|NCT01944189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64884252|NCT01944189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64884253|NCT01944215|Caffeine|caffeine|mesh-list
64884254|NCT01944215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64884255|NCT01944215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884256|NCT01944215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64884257|NCT01944215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884258|NCT01944215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884259|NCT01944215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64884260|NCT01944215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64884261|NCT01944215|Purinergic Agents|purinergic agents|mesh-ancestor
64884262|NCT01944215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64884263|NCT01944384|Spironolactone|spironolactone|mesh-list
64884264|NCT01944384|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64884265|NCT01944384|Hormone Antagonists|hormone antagonists|mesh-ancestor
64884266|NCT01944384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64982336|NCT00086736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64982337|NCT00086736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64982338|NCT00086736|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64982339|NCT00086736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982340|NCT00086736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982341|NCT00292201|Atorvastatin|atorvastatin|mesh-list
64982342|NCT00292201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64982343|NCT00292201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64982344|NCT00292201|Antimetabolites|antimetabolites|mesh-ancestor
64982345|NCT00292201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982346|NCT00292201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64884272|NCT01944410|Mitosis Modulators|mitosis modulators|mesh-ancestor
64884273|NCT01944410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884275|NCT01944436|Donepezil|donepezil|mesh-list
64884276|NCT01944436|Galantamine|galantamine|mesh-list
64884277|NCT01944436|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
64884278|NCT01944436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884279|NCT01944436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884280|NCT01944436|Cholinergic Agents|cholinergic agents|mesh-ancestor
64884281|NCT01944436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64884282|NCT01944436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884283|NCT01944436|Nootropic Agents|nootropic agents|mesh-ancestor
64884284|NCT01944436|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64884285|NCT01944436|Autonomic Agents|autonomic agents|mesh-ancestor
64884286|NCT01944436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64884287|NCT01944436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64884288|NCT01944436|Protective Agents|protective agents|mesh-ancestor
64884289|NCT01944618|Dapagliflozin|dapagliflozin|mesh-list
64884290|NCT01944618|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64884293|NCT01944618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884294|NCT01944657|Antidepressive Agents|antidepressive agents|mesh-list
64884295|NCT01944657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64884296|NCT01944683|Midazolam|midazolam|mesh-list
64884297|NCT01944683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64370567|NCT05633771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64884298|NCT01944683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64884299|NCT01944683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64884300|NCT01944683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884301|NCT01944683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64884302|NCT01944683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64370568|NCT03208465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64370569|NCT03208465|Empagliflozin|empagliflozin|mesh-list
64982348|NCT00292201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982373|NCT00080522|Antimetabolites|antimetabolites|mesh-ancestor
64982374|NCT00080522|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64982375|NCT00080522|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64982376|NCT00080522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64982377|NCT00080522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64982378|NCT00080522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64982379|NCT00086775|Rituximab|rituximab|mesh-list
64982380|NCT00086775|Alemtuzumab|alemtuzumab|mesh-list
64982381|NCT00086775|Fludarabine|fludarabine|mesh-list
64982389|NCT00086775|Antimetabolites|antimetabolites|mesh-ancestor
64982437|NCT00201721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64982438|NCT00201721|Alkylating Agents|alkylating agents|mesh-ancestor
64982439|NCT00201721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982440|NCT00201721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982441|NCT00201721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64982442|NCT00201721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64982443|NCT00201721|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
64982444|NCT00201721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982445|NCT00201799|Infliximab|infliximab|mesh-list
64884303|NCT01944683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64884304|NCT01944683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64884305|NCT01944683|Anesthetics, General|anesthetics, general|mesh-ancestor
64884306|NCT01944683|Anesthetics|anesthetics|mesh-ancestor
64884307|NCT01944683|GABA Modulators|gaba modulators|mesh-ancestor
64884308|NCT01944683|GABA Agents|gaba agents|mesh-ancestor
64334424|NCT02223611|Mitosis Modulators|mitosis modulators|mesh-ancestor
64334425|NCT02223611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334426|NCT02231333|Pentoxifylline|pentoxifylline|mesh-list
64334427|NCT02231333|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64334428|NCT02231333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334429|NCT02231333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334430|NCT02231333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64334431|NCT02231333|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64334432|NCT02231333|Protective Agents|protective agents|mesh-ancestor
64334433|NCT02231333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334434|NCT02231333|Vasodilator Agents|vasodilator agents|mesh-ancestor
64334435|NCT02231333|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64370593|NCT02477501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370594|NCT02477501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370596|NCT02477501|Autonomic Agents|autonomic agents|mesh-ancestor
64334436|NCT02231333|Antioxidants|antioxidants|mesh-ancestor
64370597|NCT02477501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370598|NCT02477501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64370599|NCT02477501|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64370600|NCT02446795|Sunitinib|sunitinib|mesh-list
64982446|NCT00201799|Dermatologic Agents|dermatologic agents|mesh-ancestor
64982447|NCT00201799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64982448|NCT00201799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64982449|NCT00080678|Docetaxel|docetaxel|mesh-list
64982450|NCT00080678|Imatinib Mesylate|imatinib mesylate|mesh-list
64982451|NCT00080678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982452|NCT00080678|Tubulin Modulators|tubulin modulators|mesh-ancestor
64982453|NCT00080678|Antimitotic Agents|antimitotic agents|mesh-ancestor
64982454|NCT00080678|Mitosis Modulators|mitosis modulators|mesh-ancestor
64982455|NCT00080678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982456|NCT00080678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64982457|NCT00080678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982490|NCT00080795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64982491|NCT00080795|Alkylating Agents|alkylating agents|mesh-ancestor
64982492|NCT00120081|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64334437|NCT02227433|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64884311|NCT01944735|Mannitol|mannitol|mesh-list
64884312|NCT01944735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64884313|NCT01944735|Diuretics|diuretics|mesh-ancestor
64884314|NCT01944735|Natriuretic Agents|natriuretic agents|mesh-ancestor
64884315|NCT01944735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884316|NCT01944852|Icodextrin|icodextrin|mesh-list
64884317|NCT01944852|Dialysis Solutions|dialysis solutions|mesh-ancestor
64884318|NCT01944852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64884319|NCT01945021|Crizotinib|crizotinib|mesh-list
64884320|NCT01945021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64884321|NCT01945021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64884322|NCT01945021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884323|NCT01945021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884324|NCT01945047|Midazolam|midazolam|mesh-list
64884325|NCT01945047|Ketamine|ketamine|mesh-list
64884326|NCT01945047|Analgesics|analgesics|mesh-ancestor
64884327|NCT01945047|Sensory System Agents|sensory system agents|mesh-ancestor
64884328|NCT01945047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64884329|NCT01945047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884330|NCT01945047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64982493|NCT00120081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64982494|NCT00120081|Immunologic Factors|immunologic factors|mesh-ancestor
64982495|NCT00120081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982496|NCT00120081|Antacids|antacids|mesh-ancestor
64982501|NCT00201994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982503|NCT00201994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982504|NCT00120120|Lenalidomide|lenalidomide|mesh-list
64982505|NCT00120120|Immunologic Factors|immunologic factors|mesh-ancestor
64884352|NCT01945437|Magnesium Sulfate|magnesium sulfate|mesh-list
64334438|NCT02227433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64334439|NCT02227433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334441|NCT02351973|Diuretics|diuretics|mesh-ancestor
64334442|NCT02351973|Natriuretic Agents|natriuretic agents|mesh-ancestor
64334443|NCT02351973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334444|NCT02351973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
64334445|NCT02351973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64334446|NCT02351973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64884355|NCT01945437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64884356|NCT01945437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884357|NCT01945437|Anesthetics|anesthetics|mesh-ancestor
64884358|NCT01945437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64884359|NCT01945437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64884360|NCT01945437|Anticonvulsants|anticonvulsants|mesh-ancestor
64884361|NCT01945437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64884362|NCT01945437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64884363|NCT01945437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884364|NCT01945437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64652896|NCT03830216|Insulin|insulin|mesh-list
64884365|NCT01945437|Tocolytic Agents|tocolytic agents|mesh-ancestor
64884366|NCT01945437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64884368|NCT01945450|Clindamycin|clindamycin|mesh-list
64884369|NCT01945450|Clindamycin palmitate|clindamycin palmitate|mesh-list
64884370|NCT01945450|Clindamycin phosphate|clindamycin phosphate|mesh-list
64884371|NCT01945450|Gentamicins|gentamicins|mesh-list
64884372|NCT01945450|Ampicillin|ampicillin|mesh-list
64884373|NCT01945450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64884374|NCT01945450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64884375|NCT01945450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982549|NCT00306358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982550|NCT00306358|Vitamin B Complex|vitamin b complex|mesh-ancestor
64982551|NCT00306358|Hematinics|hematinics|mesh-ancestor
64982552|NCT00306397|Sirolimus|sirolimus|mesh-list
64982553|NCT00306397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64982554|NCT00306397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64982555|NCT00306397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64982556|NCT00306397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982557|NCT00306397|Antifungal Agents|antifungal agents|mesh-ancestor
64982558|NCT00306397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64982559|NCT00306397|Immunologic Factors|immunologic factors|mesh-ancestor
64982560|NCT00306397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884381|NCT01945476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884382|NCT01945476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64884383|NCT01945476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64884384|NCT01945476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64884385|NCT01945476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64884386|NCT01945476|Anesthetics, General|anesthetics, general|mesh-ancestor
64884387|NCT01945476|Anesthetics|anesthetics|mesh-ancestor
64884388|NCT01945476|GABA Modulators|gaba modulators|mesh-ancestor
64884389|NCT01945476|GABA Agents|gaba agents|mesh-ancestor
64884390|NCT01945476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64884391|NCT01945476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884392|NCT01945528|Lidocaine|lidocaine|mesh-list
64884393|NCT01945528|Anesthetics, Local|anesthetics, local|mesh-list
64884394|NCT01945528|Anesthetics|anesthetics|mesh-list
64884395|NCT01945528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64884396|NCT01945528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884397|NCT01945528|Sensory System Agents|sensory system agents|mesh-ancestor
64884398|NCT01945528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64884399|NCT01945528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64884400|NCT01945528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64884401|NCT01945528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64884402|NCT01945528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64884403|NCT01945528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884404|NCT01945554|Bupivacaine|bupivacaine|mesh-list
64884405|NCT01945554|Anesthetics, Local|anesthetics, local|mesh-ancestor
64884406|NCT01945554|Anesthetics|anesthetics|mesh-ancestor
64370630|NCT02476955|Carboplatin|carboplatin|mesh-list
64982561|NCT00418600|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
64982562|NCT00418600|Ergocalciferols|ergocalciferols|mesh-list
64982563|NCT00418600|Vitamins|vitamins|mesh-ancestor
64982564|NCT00418600|Micronutrients|micronutrients|mesh-ancestor
64982568|NCT00087048|Topotecan|topotecan|mesh-list
64982609|NCT00301639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64982610|NCT00301639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64982611|NCT00301639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982612|NCT00301639|Dopamine Agents|dopamine agents|mesh-ancestor
64982613|NCT00301639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64982614|NCT00087087|Pemetrexed|pemetrexed|mesh-list
64982615|NCT00087087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982616|NCT00087087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982617|NCT00087087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982618|NCT00087087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64982619|NCT00087087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64982620|NCT00301795|Rituximab|rituximab|mesh-list
64982621|NCT00301795|Oblimersen|oblimersen|mesh-list
64884409|NCT01945554|Sensory System Agents|sensory system agents|mesh-ancestor
64884410|NCT01945554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64884411|NCT01945684|Botulinum Toxins|botulinum toxins|mesh-list
64884412|NCT01945684|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64884413|NCT01945684|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64884414|NCT01945684|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64884415|NCT01945684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64884416|NCT01945684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884417|NCT01945684|Cholinergic Agents|cholinergic agents|mesh-ancestor
64884418|NCT01945684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64884419|NCT01945684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884420|NCT01945684|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64884421|NCT01945684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64884422|NCT01945736|Methadone|methadone|mesh-list
64884423|NCT01945736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64884424|NCT01945736|Narcotics|narcotics|mesh-ancestor
64884425|NCT01945736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64334447|NCT02351973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334448|NCT02351973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64334449|NCT02351973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64334450|NCT04831619|Deoxyglucose|deoxyglucose|mesh-list
64334451|NCT04831619|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64334452|NCT04831619|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64982622|NCT00301795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64982623|NCT00301795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982624|NCT00301795|Immunologic Factors|immunologic factors|mesh-ancestor
64982625|NCT00301795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982626|NCT00301795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64982627|NCT00080990|Leucovorin|leucovorin|mesh-list
64982628|NCT00080990|Fluorouracil|fluorouracil|mesh-list
64982629|NCT00080990|Oxaliplatin|oxaliplatin|mesh-list
64982630|NCT00080990|Alvocidib|alvocidib|mesh-list
64982631|NCT00080990|Calcium|calcium|mesh-list
64982632|NCT00080990|Levoleucovorin|levoleucovorin|mesh-list
64982633|NCT00080990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64982634|NCT00080990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982635|NCT00080990|Antimetabolites|antimetabolites|mesh-ancestor
64884429|NCT01945736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64884430|NCT01945736|Antitussive Agents|antitussive agents|mesh-ancestor
64884431|NCT01945736|Respiratory System Agents|respiratory system agents|mesh-ancestor
64884432|NCT01945788|Teriparatide|teriparatide|mesh-list
64884433|NCT01945788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64884434|NCT01945788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884435|NCT01945788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64884436|NCT01945801|Furosemide|furosemide|mesh-list
64884437|NCT01945801|Spironolactone|spironolactone|mesh-list
64884438|NCT01945801|Diuretics|diuretics|mesh-ancestor
64884439|NCT01945801|Natriuretic Agents|natriuretic agents|mesh-ancestor
64652993|NCT03007121|Dsuvia|dsuvia|mesh-list
64884440|NCT01945801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884441|NCT01945801|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64884442|NCT01945801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64884443|NCT01945801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334453|NCT04831619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334454|NCT04831619|Antimetabolites|antimetabolites|mesh-ancestor
64334455|NCT04831619|Antiviral Agents|antiviral agents|mesh-ancestor
64334456|NCT04831619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64884445|NCT01945801|Hormone Antagonists|hormone antagonists|mesh-ancestor
64884446|NCT01945801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64884447|NCT01945801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64884449|NCT05410782|Micronutrients|micronutrients|mesh-ancestor
64884450|NCT05410782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884451|NCT05410626|Methylphenidate|methylphenidate|mesh-list
64884452|NCT05410626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64982636|NCT00080990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982640|NCT00080990|Immunologic Factors|immunologic factors|mesh-ancestor
64982657|NCT00301912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64982658|NCT00301912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982659|NCT00301912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64982661|NCT00301912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982662|NCT00301912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64884456|NCT05410626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64884457|NCT05410626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884458|NCT05410626|Dopamine Agents|dopamine agents|mesh-ancestor
64884459|NCT05410626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64884460|NCT05410535|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64884461|NCT05410535|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64884462|NCT05410535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64884463|NCT05410483|Docetaxel|docetaxel|mesh-list
64884464|NCT05410483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64884465|NCT05410483|Tubulin Modulators|tubulin modulators|mesh-ancestor
64884466|NCT05410483|Antimitotic Agents|antimitotic agents|mesh-ancestor
64884467|NCT05410483|Mitosis Modulators|mitosis modulators|mesh-ancestor
64884468|NCT05410483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884469|NCT05410314|Inositol|inositol|mesh-list
64884470|NCT05410314|Vitamin B Complex|vitamin b complex|mesh-ancestor
64884471|NCT05410314|Vitamins|vitamins|mesh-ancestor
64884472|NCT05410314|Micronutrients|micronutrients|mesh-ancestor
64884474|NCT05410275|Rivaroxaban|rivaroxaban|mesh-list
64884475|NCT05410275|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64884476|NCT05410275|Antithrombins|antithrombins|mesh-ancestor
64884477|NCT05410275|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64884482|NCT05410093|Vitamin E|vitamin e|mesh-list
64982663|NCT00301912|Dermatologic Agents|dermatologic agents|mesh-ancestor
64982664|NCT00301912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982665|NCT00301912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64982666|NCT00301912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64982667|NCT00301912|Immunologic Factors|immunologic factors|mesh-ancestor
64982668|NCT00301912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64982669|NCT00301912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64982670|NCT00301912|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64982671|NCT00301912|Alkylating Agents|alkylating agents|mesh-ancestor
64982672|NCT00301912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64982682|NCT00301951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64982683|NCT00301951|Antimetabolites|antimetabolites|mesh-ancestor
64982684|NCT00301951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982685|NCT00301951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64982686|NCT00301951|Immunologic Factors|immunologic factors|mesh-ancestor
64982687|NCT00301951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982688|NCT00301951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64982699|NCT00301990|Bevacizumab|bevacizumab|mesh-list
64982700|NCT00301990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64982701|NCT00301990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982702|NCT00301990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64884498|NCT05409339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64884499|NCT05409339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884501|NCT05409339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884502|NCT05409339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884503|NCT05409339|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64884504|NCT05409339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64884505|NCT05409339|Purinergic Agents|purinergic agents|mesh-ancestor
64884506|NCT05409339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64884507|NCT05409339|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64884508|NCT05409339|Diuretics|diuretics|mesh-ancestor
64884509|NCT05409339|Natriuretic Agents|natriuretic agents|mesh-ancestor
64884510|NCT05273567|Guanfacine|guanfacine|mesh-list
64884511|NCT05273567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64884512|NCT05273567|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64653052|NCT01049984|Rasagiline|rasagiline|mesh-list
64884513|NCT05273567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64884514|NCT05273567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64884515|NCT05273567|Adrenergic Agents|adrenergic agents|mesh-ancestor
64884516|NCT05273567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64370681|NCT02476799|Sensory System Agents|sensory system agents|mesh-ancestor
64370682|NCT02476799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370683|NCT02476799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64370684|NCT02476799|Narcotics|narcotics|mesh-ancestor
64370685|NCT02476799|Analgesics|analgesics|mesh-ancestor
64982703|NCT00301990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64982704|NCT00301990|Growth Substances|growth substances|mesh-ancestor
64982705|NCT00301990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982706|NCT00301990|Growth Inhibitors|growth inhibitors|mesh-ancestor
64982707|NCT00301990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64982708|NCT00301990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64982709|NCT00301990|Antiviral Agents|antiviral agents|mesh-ancestor
64982710|NCT00301990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64982711|NCT00120198|Rituximab|rituximab|mesh-list
64334458|NCT03520543|Yohimbine|yohimbine|mesh-list
64334459|NCT03520543|Analgesics|analgesics|mesh-ancestor
64334460|NCT03520543|Sensory System Agents|sensory system agents|mesh-ancestor
64334461|NCT03520543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334462|NCT03520543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334463|NCT03520543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64334464|NCT03520543|Sympatholytics|sympatholytics|mesh-ancestor
64334465|NCT03520543|Autonomic Agents|autonomic agents|mesh-ancestor
64884518|NCT05273567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884520|NCT05165082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64884521|NCT05165082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64884522|NCT05165082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884523|NCT05165082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64884524|NCT05165082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64884525|NCT05165082|Adrenergic Agents|adrenergic agents|mesh-ancestor
64884526|NCT05165082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64884527|NCT05165082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884528|NCT05165082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64884529|NCT05165082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64884530|NCT05155527|Ivermectin|ivermectin|mesh-list
64884531|NCT05155527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64884532|NCT05155527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64884533|NCT05151146|Metformin|metformin|mesh-list
64884534|NCT05151146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64884535|NCT05151146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884536|NCT05068063|Bupivacaine|bupivacaine|mesh-list
64884537|NCT05068063|Anesthetics, Local|anesthetics, local|mesh-ancestor
64884538|NCT05068063|Anesthetics|anesthetics|mesh-ancestor
64884539|NCT05068063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64370727|NCT03192943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64370730|NCT04986813|Tranexamic Acid|tranexamic acid|mesh-list
64982712|NCT00120198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64982713|NCT00120198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982714|NCT00120198|Immunologic Factors|immunologic factors|mesh-ancestor
64982715|NCT00120198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982716|NCT00120198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64982717|NCT00302224|Ketoconazole|ketoconazole|mesh-list
64982718|NCT00302224|Antifungal Agents|antifungal agents|mesh-ancestor
64982719|NCT00302224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64982720|NCT00302224|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64982721|NCT00302224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64982722|NCT00302224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982723|NCT00302224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982724|NCT00302224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64982725|NCT00302224|Hormone Antagonists|hormone antagonists|mesh-ancestor
64982726|NCT00302224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64982727|NCT00302224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982728|NCT00302224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64982729|NCT00081068|Alemtuzumab|alemtuzumab|mesh-list
64884541|NCT05068063|Sensory System Agents|sensory system agents|mesh-ancestor
64884542|NCT05068063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64884543|NCT04967378|Psychotropic Drugs|psychotropic drugs|mesh-list
64884544|NCT04946396|Dexmedetomidine|dexmedetomidine|mesh-list
64884545|NCT04946396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64884546|NCT04946396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64884547|NCT04946396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884548|NCT04946396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64884549|NCT04946396|Analgesics|analgesics|mesh-ancestor
64884550|NCT04946396|Sensory System Agents|sensory system agents|mesh-ancestor
64884551|NCT04946396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64884552|NCT04946396|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64884553|NCT04946396|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64884554|NCT04946396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64884555|NCT04946396|Adrenergic Agents|adrenergic agents|mesh-ancestor
64884556|NCT04946396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64334466|NCT03520543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64334467|NCT03520543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64334468|NCT03520543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64334469|NCT03520543|Adrenergic Agents|adrenergic agents|mesh-ancestor
64334470|NCT03520543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64334471|NCT03520543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334472|NCT03520543|Mydriatics|mydriatics|mesh-ancestor
64982730|NCT00081068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64982731|NCT00081068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982737|NCT00087165|Mitosis Modulators|mitosis modulators|mesh-ancestor
64982738|NCT00087165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982739|NCT00087165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64982740|NCT00087165|Glucocorticoids|glucocorticoids|mesh-ancestor
64982741|NCT00087165|Hormones|hormones|mesh-ancestor
64982742|NCT00087165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64884559|NCT04908657|Vasodilator Agents|vasodilator agents|mesh-ancestor
64884560|NCT04908657|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64884561|NCT04908657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64884562|NCT04908657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884563|NCT04908657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884564|NCT04908657|Urological Agents|urological agents|mesh-ancestor
64884565|NCT04887389|Listerine|listerine|mesh-list
64334477|NCT02355639|Betamethasone|betamethasone|mesh-list
64334479|NCT02355639|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64334480|NCT02355639|Betamethasone benzoate|betamethasone benzoate|mesh-list
64334481|NCT02355639|Clobetasol|clobetasol|mesh-list
64334482|NCT02355639|Petrolatum|petrolatum|mesh-list
64334483|NCT02355639|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64334484|NCT02355639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64334485|NCT02355639|Glucocorticoids|glucocorticoids|mesh-ancestor
64334486|NCT02355639|Hormones|hormones|mesh-ancestor
64982743|NCT00087165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982744|NCT00087165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64982745|NCT00302341|Trimethoprim|trimethoprim|mesh-list
64982746|NCT00302341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64982747|NCT00302341|Sulfamethoxazole|sulfamethoxazole|mesh-list
64982748|NCT00302341|Pafuramidine|pafuramidine|mesh-list
64982749|NCT00302341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982750|NCT00302341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982751|NCT00302341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64982752|NCT00302341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64982753|NCT00302341|Renal Agents|renal agents|mesh-ancestor
64982759|NCT00302341|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64884567|NCT04887389|Sodium Fluoride|sodium fluoride|mesh-list
64884568|NCT04887389|Fluorides, Topical|fluorides, topical|mesh-list
64884569|NCT04887389|Cariostatic Agents|cariostatic agents|mesh-ancestor
64884570|NCT04887389|Protective Agents|protective agents|mesh-ancestor
64884571|NCT04887389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884572|NCT04887389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64884573|NCT04887389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64884574|NCT04812028|Magnesium Sulfate|magnesium sulfate|mesh-list
64884575|NCT04812028|Analgesics|analgesics|mesh-ancestor
64884576|NCT04812028|Sensory System Agents|sensory system agents|mesh-ancestor
64884577|NCT04812028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64884578|NCT04812028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884579|NCT04812028|Anesthetics|anesthetics|mesh-ancestor
64884580|NCT04812028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64884581|NCT04812028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64884582|NCT04812028|Anticonvulsants|anticonvulsants|mesh-ancestor
64884583|NCT04812028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64884584|NCT04812028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64586280|NCT00426283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884585|NCT04812028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370787|NCT04891809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64884586|NCT04812028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64370788|NCT04891809|Immunologic Factors|immunologic factors|mesh-ancestor
64370820|NCT04860635|Sensory System Agents|sensory system agents|mesh-ancestor
64370823|NCT04860635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64982760|NCT00302341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64982761|NCT00302341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64982762|NCT00302341|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64982763|NCT00302419|Streptokinase|streptokinase|mesh-list
64982767|NCT00302497|Basiliximab|basiliximab|mesh-list
64982781|NCT00302536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982782|NCT00302536|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64982783|NCT00302536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982784|NCT00302536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982785|NCT00081224|Celecoxib|celecoxib|mesh-list
64982786|NCT00081224|Capecitabine|capecitabine|mesh-list
64982787|NCT00081224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64982788|NCT00081224|Antimetabolites|antimetabolites|mesh-ancestor
64982789|NCT00081224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982790|NCT00081224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982791|NCT00081224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64982792|NCT00081224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64982793|NCT00081224|Analgesics|analgesics|mesh-ancestor
64982794|NCT00081224|Sensory System Agents|sensory system agents|mesh-ancestor
64884588|NCT04812028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64884589|NCT04773392|Mycophenolic Acid|mycophenolic acid|mesh-list
64884590|NCT04773392|Prednisone|prednisone|mesh-list
64884591|NCT04773392|Methylprednisolone|methylprednisolone|mesh-list
64884592|NCT04773392|Azathioprine|azathioprine|mesh-list
64884593|NCT04773392|Tacrolimus|tacrolimus|mesh-list
64884594|NCT04773392|Thymoglobulin|thymoglobulin|mesh-list
64884595|NCT04773392|Basiliximab|basiliximab|mesh-list
64884596|NCT04773392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64884597|NCT04773392|Antimetabolites|antimetabolites|mesh-list
64884598|NCT04773392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64884599|NCT04773392|Glucocorticoids|glucocorticoids|mesh-ancestor
64884600|NCT04773392|Hormones|hormones|mesh-ancestor
64884601|NCT04773392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64334493|NCT02351895|Copper|copper|mesh-list
64884621|NCT04773392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64884622|NCT04773392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64884623|NCT04724655|Mineral Oil|mineral oil|mesh-list
64884624|NCT04724655|Emollients|emollients|mesh-ancestor
64884626|NCT04722835|Albuterol|albuterol|mesh-list
64982795|NCT00081224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64982796|NCT00081224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982797|NCT00081224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64982798|NCT00081224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64982799|NCT00081224|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64982800|NCT00081224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64982801|NCT00081224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982802|NCT00120237|Misoprostol|misoprostol|mesh-list
64982803|NCT00120237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64982804|NCT00120237|Abortifacient Agents|abortifacient agents|mesh-ancestor
64982805|NCT00120237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64982806|NCT00120237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982807|NCT00120237|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64982808|NCT00120237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64884735|NCT04150614|Dermatologic Agents|dermatologic agents|mesh-ancestor
64884736|NCT04150614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64884737|NCT04150614|Serotonin Agents|serotonin agents|mesh-ancestor
64884738|NCT04150614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64884739|NCT04150614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982809|NCT00120237|Oxytocics|oxytocics|mesh-ancestor
64982810|NCT00081302|Paclitaxel|paclitaxel|mesh-list
64884740|NCT04150614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64884741|NCT04150614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64884742|NCT04150614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64884743|NCT04150614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64884744|NCT04150614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64884745|NCT04035109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64884746|NCT04035109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64884748|NCT04030429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64884749|NCT04030429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64884750|NCT04030429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884751|NCT04030429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884752|NCT03982186|JNJ-56136379|jnj-56136379|mesh-list
64884753|NCT03982186|Antiviral Agents|antiviral agents|mesh-ancestor
64884754|NCT03982186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64884755|NCT03970694|Capecitabine|capecitabine|mesh-list
64370914|NCT00705575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64370915|NCT00705575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370916|NCT03068247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64370941|NCT04450953|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64370943|NCT04450953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64370944|NCT04450953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982811|NCT00081302|Carboplatin|carboplatin|mesh-list
64982812|NCT00081302|Cetuximab|cetuximab|mesh-list
64982813|NCT00081302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64982814|NCT00081302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982821|NCT00302653|Gout Suppressants|gout suppressants|mesh-ancestor
64982822|NCT00302653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64982823|NCT00418288|Glucagon|glucagon|mesh-list
64982824|NCT00418288|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64982825|NCT00418288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64982826|NCT00418288|Hormones|hormones|mesh-ancestor
64982827|NCT00418288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64982828|NCT00418288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64982829|NCT00418288|Incretins|incretins|mesh-ancestor
64982830|NCT00418327|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64334502|NCT00503035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64982831|NCT00418327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334503|NCT00503035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334504|NCT00503035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64334505|NCT00503035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64334506|NCT00503035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64334507|NCT00503035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64884756|NCT03970694|Oxaliplatin|oxaliplatin|mesh-list
64884757|NCT03970694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64884758|NCT03970694|Antimetabolites|antimetabolites|mesh-ancestor
64884759|NCT03970694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884760|NCT03970694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64884761|NCT03941132|Ustekinumab|ustekinumab|mesh-list
64884762|NCT03941132|Dermatologic Agents|dermatologic agents|mesh-ancestor
64884763|NCT03920007|Trimethoprim|trimethoprim|mesh-list
64884764|NCT03920007|Polymyxins|polymyxins|mesh-list
64884765|NCT03920007|Polymyxin B|polymyxin b|mesh-list
64884766|NCT03920007|Prednisone|prednisone|mesh-list
64884767|NCT03920007|Prednisolone|prednisolone|mesh-list
64884768|NCT03920007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64884769|NCT03920007|Glucocorticoids|glucocorticoids|mesh-ancestor
64884770|NCT03920007|Hormones|hormones|mesh-ancestor
64884771|NCT03920007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64884772|NCT03920007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884774|NCT03920007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64982832|NCT00418327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64982833|NCT00418327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982834|NCT00418327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982835|NCT00087282|Irinotecan|irinotecan|mesh-list
64982836|NCT00087282|Alvocidib|alvocidib|mesh-list
64982837|NCT00087282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64982838|NCT00087282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64982839|NCT00087282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64982875|NCT00081380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64982876|NCT00418483|Fibrinolysin|fibrinolysin|mesh-list
64982877|NCT00418483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64982878|NCT00418483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64982879|NCT00418483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64982880|NCT00302692|Metoprolol|metoprolol|mesh-list
64982881|NCT00302692|Esmolol|esmolol|mesh-list
64347243|NCT05158777|Vaccines|vaccines|mesh-list
64982951|NCT00081614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64982952|NCT00081614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64982953|NCT00081614|Growth Substances|growth substances|mesh-ancestor
64884788|NCT03873246|Varenicline|varenicline|mesh-list
64884789|NCT03873246|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64884790|NCT03873246|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64884791|NCT03873246|Cholinergic Agents|cholinergic agents|mesh-ancestor
64884792|NCT03873246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64884793|NCT03873246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884794|NCT03873246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884795|NCT03866577|Immunoglobulins|immunoglobulins|mesh-list
64884796|NCT03866577|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64884797|NCT03866577|Antibodies|antibodies|mesh-list
64884798|NCT03866577|gamma-Globulins|gamma-globulins|mesh-list
64884799|NCT03866577|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64884800|NCT03866577|Immunologic Factors|immunologic factors|mesh-ancestor
64884801|NCT03866577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884802|NCT03714880|Mifepristone|mifepristone|mesh-list
64884803|NCT03714880|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64884804|NCT03714880|Abortifacient Agents|abortifacient agents|mesh-ancestor
64884805|NCT03714880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64884806|NCT03714880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884807|NCT03714880|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64884808|NCT03714880|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64884809|NCT03714880|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64884810|NCT03714880|Contraceptive Agents|contraceptive agents|mesh-ancestor
64884811|NCT03714880|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64884812|NCT03714880|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64884813|NCT03714880|Hormone Antagonists|hormone antagonists|mesh-ancestor
64370958|NCT02474303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64843975|NCT01666067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64843976|NCT01666067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844004|NCT01666249|Immunoglobulins|immunoglobulins|mesh-list
64844005|NCT01666249|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64844007|NCT01666249|Immunologic Factors|immunologic factors|mesh-ancestor
64844008|NCT01666249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844009|NCT01666262|Vaccines|vaccines|mesh-list
64844010|NCT01666262|Immunologic Factors|immunologic factors|mesh-ancestor
64844011|NCT01666262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844012|NCT01666301|Darbepoetin alfa|darbepoetin alfa|mesh-list
64844013|NCT01666301|Hematinics|hematinics|mesh-ancestor
64844014|NCT01666353|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64844015|NCT01666353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64844016|NCT01666353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844090|NCT01666678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64844091|NCT01666678|Anesthetics, Local|anesthetics, local|mesh-ancestor
64844114|NCT01666756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327471|NCT02669043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844115|NCT01666756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64844116|NCT01666756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844117|NCT01666756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844118|NCT01666769|Micafungin|micafungin|mesh-list
64844119|NCT01666769|Antifungal Agents|antifungal agents|mesh-ancestor
64844120|NCT01666769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64844121|NCT01667094|Meropenem|meropenem|mesh-list
64844122|NCT01667094|Tazobactam|tazobactam|mesh-list
64844123|NCT01667094|Piperacillin|piperacillin|mesh-list
64844124|NCT01667094|Clavulanic Acid|clavulanic acid|mesh-list
64844125|NCT01667094|Clavulanic Acids|clavulanic acids|mesh-list
64844126|NCT01667094|Ceftazidime|ceftazidime|mesh-list
64844127|NCT01667094|Cefepime|cefepime|mesh-list
64327472|NCT02669043|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64327473|NCT02669043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64327474|NCT02669043|Anesthetics, General|anesthetics, general|mesh-ancestor
64327475|NCT02669043|Anesthetics|anesthetics|mesh-ancestor
64327476|NCT02669043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64327477|NCT02669043|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64327478|NCT02669043|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64327479|NCT02669043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64844205|NCT01667575|Diuretics|diuretics|mesh-ancestor
64844206|NCT01667575|Natriuretic Agents|natriuretic agents|mesh-ancestor
64844207|NCT01667575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844208|NCT01667575|Expectorants|expectorants|mesh-ancestor
64294262|NCT04263350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64844322|NCT01668498|Erythromycin Estolate|erythromycin estolate|mesh-list
64844323|NCT01668498|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64844324|NCT01668498|Erythromycin stearate|erythromycin stearate|mesh-list
64844325|NCT01668498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64844326|NCT01668498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64844327|NCT01668498|Antimalarials|antimalarials|mesh-ancestor
64844328|NCT01668498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64844329|NCT01668498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64844330|NCT01668498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64844331|NCT01668498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64844332|NCT01668498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844333|NCT01668498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844334|NCT01668550|AZD-0424|azd-0424|mesh-list
64844335|NCT01668550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64844336|NCT01668550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844337|NCT01668550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844338|NCT01668615|Tretinoin|tretinoin|mesh-list
64844339|NCT01668615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844340|NCT01668615|Keratolytic Agents|keratolytic agents|mesh-ancestor
64844350|NCT01668680|Abortifacient Agents|abortifacient agents|mesh-ancestor
64844351|NCT01668680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64844352|NCT01668680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844353|NCT01668680|Dermatologic Agents|dermatologic agents|mesh-ancestor
64844354|NCT01668680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844355|NCT01668680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64844356|NCT01668680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64844357|NCT01668680|Immunologic Factors|immunologic factors|mesh-ancestor
64844358|NCT01668680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64844359|NCT01668680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64296085|NCT04490967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296086|NCT04490967|Protective Agents|protective agents|mesh-ancestor
64296087|NCT04490967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296088|NCT04490967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64296089|NCT04490967|Antifungal Agents|antifungal agents|mesh-ancestor
64296090|NCT04490967|Keratolytic Agents|keratolytic agents|mesh-ancestor
64296091|NCT04490967|Dermatologic Agents|dermatologic agents|mesh-ancestor
64844360|NCT01668680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64844361|NCT01668680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64844362|NCT01668680|Analgesics|analgesics|mesh-ancestor
64844363|NCT01668680|Sensory System Agents|sensory system agents|mesh-ancestor
64844364|NCT01668680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64844365|NCT01668680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64844366|NCT01668680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64327563|NCT04479891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327565|NCT04479891|Hormone Antagonists|hormone antagonists|mesh-ancestor
64327566|NCT04479891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64327567|NCT04479891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327568|NCT04479891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64327569|NCT02281201|Thrombin|thrombin|mesh-list
64327570|NCT02281201|Hemostatics|hemostatics|mesh-ancestor
64844399|NCT01668927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64844427|NCT01669044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64844428|NCT01669044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64844429|NCT01669044|Adrenergic Agents|adrenergic agents|mesh-ancestor
64844430|NCT01669044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64844431|NCT01669044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844432|NCT01669083|Diketopiperazines|diketopiperazines|mesh-list
64844433|NCT01669083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64844434|NCT01669083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64844435|NCT01669135|Anesthetics|anesthetics|mesh-list
64844436|NCT01669135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64844457|NCT01669226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844458|NCT01669239|Doxorubicin|doxorubicin|mesh-list
64844459|NCT01669239|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64844460|NCT01669239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64844461|NCT01669239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844462|NCT01669239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64844463|NCT01669239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64844464|NCT01669239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844465|NCT01669239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844466|NCT01669291|Leuprolide|leuprolide|mesh-list
64844467|NCT01669291|Cetrorelix|cetrorelix|mesh-list
64844468|NCT01669291|Menotropins|menotropins|mesh-list
64844469|NCT01669291|Ganirelix|ganirelix|mesh-list
64844470|NCT01669291|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64844471|NCT01669291|Fertility Agents|fertility agents|mesh-ancestor
64844472|NCT01669291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64327575|NCT02281279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64327576|NCT02281279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327577|NCT02281279|Immunologic Factors|immunologic factors|mesh-ancestor
64327578|NCT02281279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327579|NCT02281279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64327580|NCT02281279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64327581|NCT02281279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64844530|NCT01669707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844531|NCT01669707|Growth Inhibitors|growth inhibitors|mesh-ancestor
64844532|NCT01669707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844534|NCT01669824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64844535|NCT01669824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64844536|NCT01669824|Analgesics|analgesics|mesh-ancestor
64844661|NCT01673308|Growth Substances|growth substances|mesh-ancestor
64844662|NCT01673308|Growth Inhibitors|growth inhibitors|mesh-ancestor
64844663|NCT01673308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844664|NCT01673737|Vemurafenib|vemurafenib|mesh-list
64844665|NCT01673737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844666|NCT01673737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64844667|NCT01673737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844668|NCT01673737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844669|NCT01674556|Gemcitabine|gemcitabine|mesh-list
64844670|NCT01674556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64844671|NCT01674556|Antimetabolites|antimetabolites|mesh-ancestor
64844672|NCT01674556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844673|NCT01674556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844674|NCT01674556|Antiviral Agents|antiviral agents|mesh-ancestor
64844675|NCT01674556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64844676|NCT01674556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844677|NCT01674556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64327656|NCT02173691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64327657|NCT02173691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64327658|NCT02173691|Respiratory System Agents|respiratory system agents|mesh-ancestor
64294320|NCT03023462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64294321|NCT03023462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64294322|NCT03023462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64294377|NCT01836068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64294378|NCT01836068|Antiviral Agents|antiviral agents|mesh-ancestor
64294380|NCT05053880|Pembrolizumab|pembrolizumab|mesh-list
64844777|NCT01678053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64327675|NCT02274259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327676|NCT05571111|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64327677|NCT05571111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64844790|NCT01678937|Antifungal Agents|antifungal agents|mesh-ancestor
64844791|NCT01678937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64296101|NCT04490967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64844792|NCT01678937|Dermatologic Agents|dermatologic agents|mesh-ancestor
64844793|NCT01678937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64844794|NCT01678937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64844795|NCT01678937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844860|NCT05596981|Sorafenib|sorafenib|mesh-list
64844861|NCT05596981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844862|NCT05596981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64844863|NCT05596981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844864|NCT05596981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844865|NCT05596968|Sorafenib|sorafenib|mesh-list
64844866|NCT05596968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844867|NCT05596968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64844868|NCT05596968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64844869|NCT05596968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844870|NCT05596890|Paclitaxel|paclitaxel|mesh-list
64844871|NCT05596890|Carboplatin|carboplatin|mesh-list
64844872|NCT05596890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64844873|NCT05596890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844874|NCT05596890|Tubulin Modulators|tubulin modulators|mesh-ancestor
64844875|NCT05596890|Antimitotic Agents|antimitotic agents|mesh-ancestor
64844876|NCT05596890|Mitosis Modulators|mitosis modulators|mesh-ancestor
64844877|NCT05596890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844878|NCT05596786|Rituximab|rituximab|mesh-list
64844879|NCT05596786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64296111|NCT04214834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64296112|NCT04214834|Antitussive Agents|antitussive agents|mesh-ancestor
64296113|NCT04214834|Respiratory System Agents|respiratory system agents|mesh-ancestor
64844880|NCT05596786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64844881|NCT05596786|Immunologic Factors|immunologic factors|mesh-ancestor
64844882|NCT05596786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64844883|NCT05596786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64844884|NCT05596669|Ketamine|ketamine|mesh-list
64844885|NCT05596669|Morphine|morphine|mesh-list
64844886|NCT05596669|Analgesics|analgesics|mesh-ancestor
64844887|NCT05596669|Sensory System Agents|sensory system agents|mesh-ancestor
64844921|NCT05596552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64844922|NCT05596552|Adrenergic Agents|adrenergic agents|mesh-ancestor
64844923|NCT05596552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64844924|NCT05596552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64844925|NCT05596552|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64844926|NCT05596552|Narcotics|narcotics|mesh-ancestor
64844927|NCT05596552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64844928|NCT05596552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64844929|NCT05596552|Anesthetics, General|anesthetics, general|mesh-ancestor
64844930|NCT05596227|Fentanyl|fentanyl|mesh-list
64844931|NCT05596227|Narcotics|narcotics|mesh-list
64844932|NCT05596227|Propofol|propofol|mesh-list
64844933|NCT05596227|Anesthetics|anesthetics|mesh-list
64844934|NCT05596227|Sevoflurane|sevoflurane|mesh-list
64844935|NCT05596227|Rocuronium|rocuronium|mesh-list
64844936|NCT05596227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64844937|NCT05596227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64327719|NCT00488839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64327720|NCT00488839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327721|NCT02255747|Lactulose|lactulose|mesh-list
64327722|NCT02255747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64327723|NCT01654731|Bezafibrate|bezafibrate|mesh-list
64328025|NCT00492999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64328026|NCT00492999|Immunologic Factors|immunologic factors|mesh-ancestor
64328027|NCT00492999|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64328028|NCT00492999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64328112|NCT00459277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64328113|NCT00459277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328114|NCT00459277|Analgesics|analgesics|mesh-ancestor
64328115|NCT00459277|Sensory System Agents|sensory system agents|mesh-ancestor
64328116|NCT00459277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64328117|NCT00459277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64845010|NCT05539924|Vitamin B 12|vitamin b 12|mesh-list
64296124|NCT03312777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845011|NCT05539924|Pregabalin|pregabalin|mesh-list
64845012|NCT05539924|Gabapentin|gabapentin|mesh-list
64845013|NCT05539924|Vitamins|vitamins|mesh-ancestor
64845014|NCT05539924|Micronutrients|micronutrients|mesh-ancestor
64845015|NCT05539924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845016|NCT05539924|Analgesics|analgesics|mesh-ancestor
64845017|NCT05539924|Sensory System Agents|sensory system agents|mesh-ancestor
64845018|NCT05539924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845019|NCT05539924|Anticonvulsants|anticonvulsants|mesh-ancestor
64328118|NCT00459277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64328119|NCT00459277|Anesthetics, General|anesthetics, general|mesh-ancestor
64328120|NCT00459277|Anesthetics|anesthetics|mesh-ancestor
64328121|NCT00602329|Leucovorin|leucovorin|mesh-list
64328122|NCT00602329|Bevacizumab|bevacizumab|mesh-list
64328123|NCT00602329|Fluorouracil|fluorouracil|mesh-list
64328124|NCT00602329|Oxaliplatin|oxaliplatin|mesh-list
64328125|NCT00602329|Calcium|calcium|mesh-list
64328126|NCT00602329|Levoleucovorin|levoleucovorin|mesh-list
64328127|NCT00602329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64328128|NCT00602329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64328129|NCT00602329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64328130|NCT00602329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64328131|NCT00602329|Growth Substances|growth substances|mesh-ancestor
64328132|NCT00602329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328133|NCT00602329|Growth Inhibitors|growth inhibitors|mesh-ancestor
64328134|NCT00602329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64328135|NCT00602329|Antimetabolites|antimetabolites|mesh-ancestor
64328136|NCT00602329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328137|NCT00602329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64328138|NCT00602329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64328139|NCT00602329|Immunologic Factors|immunologic factors|mesh-ancestor
64328168|NCT02387619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64328169|NCT02387619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64328170|NCT02387619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64424494|NCT04205539|Sensory System Agents|sensory system agents|mesh-ancestor
64328171|NCT02387619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64328172|NCT02387619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328173|NCT02387619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64328174|NCT02387619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328177|NCT02387619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64328178|NCT02387619|Antimetabolites|antimetabolites|mesh-ancestor
64328179|NCT02387619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64328180|NCT02387619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64328181|NCT02387619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328182|NCT02387619|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64328183|NCT02387619|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64328184|NCT03537443|Vitamin D|vitamin d|mesh-list
64328185|NCT03537443|Cholecalciferol|cholecalciferol|mesh-list
64328186|NCT03537443|Vitamins|vitamins|mesh-ancestor
64328187|NCT03537443|Micronutrients|micronutrients|mesh-ancestor
64328188|NCT03537443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328189|NCT03537443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64328190|NCT03537443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64328191|NCT00595699|Citalopram|citalopram|mesh-list
64328192|NCT00595699|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64328193|NCT00595699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64328194|NCT00595699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64328229|NCT00659191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64328230|NCT00659191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64328231|NCT00659191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328232|NCT00659191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328234|NCT00659191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64328235|NCT00659191|Antiviral Agents|antiviral agents|mesh-ancestor
64328236|NCT00659191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64328237|NCT02182739|Meloxicam|meloxicam|mesh-list
64328238|NCT02182739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64328239|NCT02182739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64328240|NCT02182739|Analgesics|analgesics|mesh-ancestor
64328241|NCT02182739|Sensory System Agents|sensory system agents|mesh-ancestor
64328242|NCT02182739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64328243|NCT02182739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328244|NCT02182739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64328245|NCT02182739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64328246|NCT02182739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64328247|NCT02182739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64328248|NCT02182739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328249|NCT02182739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328250|NCT00583609|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64328251|NCT00583609|Laxatives|laxatives|mesh-ancestor
64328252|NCT00583609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64328253|NCT03170115|Aspirin|aspirin|mesh-list
64328254|NCT03170115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64328256|NCT03170115|Analgesics|analgesics|mesh-ancestor
64328257|NCT03170115|Sensory System Agents|sensory system agents|mesh-ancestor
64328258|NCT03170115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64328259|NCT03170115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328260|NCT03170115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64845035|NCT05514782|Protective Agents|protective agents|mesh-ancestor
64845036|NCT05514782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845037|NCT05514782|Dermatologic Agents|dermatologic agents|mesh-ancestor
64845038|NCT05488847|Acetaminophen|acetaminophen|mesh-list
64845039|NCT05488847|Dexamethasone|dexamethasone|mesh-list
64845040|NCT05488847|Ibuprofen|ibuprofen|mesh-list
64845041|NCT05488847|Celecoxib|celecoxib|mesh-list
64845042|NCT05488847|Ketorolac|ketorolac|mesh-list
64845043|NCT05488847|Pregabalin|pregabalin|mesh-list
64845044|NCT05488847|Epinephrine|epinephrine|mesh-list
64845045|NCT05488847|Oxycodone|oxycodone|mesh-list
64845046|NCT05488847|Tramadol|tramadol|mesh-list
64845047|NCT05488847|Tizanidine|tizanidine|mesh-list
64845048|NCT05488847|Magnesium Oxide|magnesium oxide|mesh-list
64328261|NCT03170115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64328262|NCT03170115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64328263|NCT03170115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64328264|NCT03170115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328265|NCT03170115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64328266|NCT03170115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64328267|NCT03170115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328268|NCT03170115|Antipyretics|antipyretics|mesh-ancestor
64328269|NCT03169959|Metformin|metformin|mesh-list
64328270|NCT03169959|Dapagliflozin|dapagliflozin|mesh-list
64328271|NCT03169959|Saxagliptin|saxagliptin|mesh-list
64328272|NCT03169959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64328273|NCT03169959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328274|NCT03169959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64328275|NCT03169959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328276|NCT03169959|Incretins|incretins|mesh-ancestor
64328277|NCT03169959|Hormones|hormones|mesh-ancestor
64328278|NCT03169959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64328279|NCT03169959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64328280|NCT03169959|Protease Inhibitors|protease inhibitors|mesh-ancestor
64328281|NCT03169959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328282|NCT02176187|Fenoterol|fenoterol|mesh-list
64328283|NCT02176187|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
64328284|NCT02176187|Ipratropium|ipratropium|mesh-list
64328285|NCT02176187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64328286|NCT02176187|Autonomic Agents|autonomic agents|mesh-ancestor
64328287|NCT02176187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64328359|NCT02403687|Anticonvulsants|anticonvulsants|mesh-ancestor
64328360|NCT02403687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64328361|NCT02403687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64328362|NCT02403687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64328363|NCT02403687|Antimanic Agents|antimanic agents|mesh-ancestor
64328373|NCT02403687|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64328374|NCT02403687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64328375|NCT02403687|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64328376|NCT02403687|GABA Agonists|gaba agonists|mesh-ancestor
64328380|NCT02403687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64328381|NCT02403687|Serotonin Agents|serotonin agents|mesh-ancestor
64328382|NCT02403687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64328383|NCT02403687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64328384|NCT02403687|Antidepressive Agents|antidepressive agents|mesh-ancestor
64328385|NCT02403687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64328386|NCT02403687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64328387|NCT02403687|Adrenergic Agents|adrenergic agents|mesh-ancestor
64328388|NCT02403687|Parasympatholytics|parasympatholytics|mesh-ancestor
64328389|NCT02403687|Autonomic Agents|autonomic agents|mesh-ancestor
64328390|NCT02403687|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64328391|NCT02403687|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64328392|NCT02403687|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64328393|NCT02403687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64328394|NCT02403687|Sympatholytics|sympatholytics|mesh-ancestor
64328396|NCT02742649|Bimatoprost|bimatoprost|mesh-list
64296163|NCT00703677|Antimanic Agents|antimanic agents|mesh-ancestor
64296164|NCT00703677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64845082|NCT05488847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64845083|NCT05488847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64845084|NCT05488847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64845085|NCT05488847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64845086|NCT05488847|Respiratory System Agents|respiratory system agents|mesh-ancestor
64845087|NCT05488847|Mydriatics|mydriatics|mesh-ancestor
64845088|NCT05488847|Sympathomimetics|sympathomimetics|mesh-ancestor
64845089|NCT05488847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64845090|NCT05488847|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64845091|NCT05488847|Antacids|antacids|mesh-ancestor
64845092|NCT05488847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64334633|NCT02228135|Hormones|hormones|mesh-ancestor
64845093|NCT05488847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64845094|NCT05488847|Parasympatholytics|parasympatholytics|mesh-ancestor
64845095|NCT05488847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64845096|NCT05479370|Vaccines|vaccines|mesh-list
64845097|NCT05479370|Immunologic Factors|immunologic factors|mesh-ancestor
64845098|NCT05479370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845099|NCT05468242|Bevacizumab|bevacizumab|mesh-list
64845100|NCT05468242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64845101|NCT05468242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845102|NCT05468242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64845103|NCT05468242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64845104|NCT05468242|Growth Substances|growth substances|mesh-ancestor
64845105|NCT05468242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845106|NCT05468242|Growth Inhibitors|growth inhibitors|mesh-ancestor
64845107|NCT05433402|Chlorpromazine|chlorpromazine|mesh-list
64845108|NCT05433402|Antiemetics|antiemetics|mesh-ancestor
64845109|NCT05433402|Autonomic Agents|autonomic agents|mesh-ancestor
64845110|NCT05433402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845111|NCT05433402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845112|NCT05433402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64845113|NCT05433402|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64845114|NCT05433402|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64845115|NCT05433402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64845116|NCT05433402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64845136|NCT05423951|Analgesics|analgesics|mesh-ancestor
64845137|NCT05423951|Sensory System Agents|sensory system agents|mesh-ancestor
64845138|NCT05423951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64845139|NCT05405621|Exatecan|exatecan|mesh-list
64845140|NCT05405621|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64845141|NCT05405621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64845142|NCT05405621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845143|NCT05405621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328487|NCT02183441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328488|NCT02183441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328489|NCT02183441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64328490|NCT02183441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64328492|NCT02183441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64328493|NCT02183441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64328498|NCT02183441|Hormones|hormones|mesh-ancestor
64328636|NCT02177435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64328637|NCT02177435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64328638|NCT02183909|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64328640|NCT02183909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64328641|NCT02183909|Antiviral Agents|antiviral agents|mesh-ancestor
64328642|NCT02183909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64336786|NCT02313337|GABA Modulators|gaba modulators|mesh-ancestor
64328643|NCT02280265|Factor VIII|factor viii|mesh-list
64328644|NCT02280265|Coagulants|coagulants|mesh-ancestor
64328645|NCT02179931|Flupenthixol|flupenthixol|mesh-list
64845149|NCT05383196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845150|NCT05383196|Tubulin Modulators|tubulin modulators|mesh-ancestor
64845151|NCT05383196|Antimitotic Agents|antimitotic agents|mesh-ancestor
64845152|NCT05383196|Mitosis Modulators|mitosis modulators|mesh-ancestor
64845153|NCT05383196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845154|NCT05383196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64845155|NCT05383196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845156|NCT05351541|Zolpidem|zolpidem|mesh-list
64845157|NCT05351541|Modafinil|modafinil|mesh-list
64845158|NCT05351541|Psilocybin|psilocybin|mesh-list
64328646|NCT02179931|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
64328647|NCT02179931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64328648|NCT02179931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64328649|NCT02179931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64328650|NCT02179931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328651|NCT02179931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64328652|NCT02179931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64328653|NCT02179931|Dopamine Agents|dopamine agents|mesh-ancestor
64328654|NCT02179931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64328655|NCT02179931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328657|NCT02184065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64328658|NCT02184065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64296183|NCT01506986|Dexlansoprazole|dexlansoprazole|mesh-list
64296184|NCT01506986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64328659|NCT02184065|Analgesics|analgesics|mesh-ancestor
64328660|NCT02184065|Sensory System Agents|sensory system agents|mesh-ancestor
64328661|NCT02184065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64328682|NCT02665689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64328683|NCT02386293|Irbesartan|irbesartan|mesh-list
64328684|NCT02386293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64328685|NCT02386293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64328767|NCT00549679|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64328768|NCT00549679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64328769|NCT00549679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328770|NCT00549679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328771|NCT02282371|Cetuximab|cetuximab|mesh-list
64328772|NCT02282371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64328776|NCT02402595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64328777|NCT02402595|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64294439|NCT02036125|Autonomic Agents|autonomic agents|mesh-ancestor
64328778|NCT02402595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64328779|NCT02402595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328780|NCT02402595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328781|NCT02402595|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64328782|NCT02402595|Hormone Antagonists|hormone antagonists|mesh-ancestor
64328783|NCT02402595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64328784|NCT02402595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328785|NCT02402595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64296193|NCT01506986|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64328786|NCT05488431|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
64328787|NCT05488431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64328788|NCT05488431|Antimetabolites|antimetabolites|mesh-ancestor
64328789|NCT05488431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845160|NCT05351541|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64845161|NCT05351541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845162|NCT05351541|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64845163|NCT05351541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64845164|NCT05351541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64845165|NCT05351541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845166|NCT05351541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64845167|NCT05351541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64845168|NCT05351541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64845169|NCT05351541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64845170|NCT05351541|GABA Agonists|gaba agonists|mesh-ancestor
64845171|NCT05351541|GABA Agents|gaba agents|mesh-ancestor
64845172|NCT05351541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64845173|NCT05351541|Hallucinogens|hallucinogens|mesh-ancestor
64296215|NCT03303651|Narcotics|narcotics|mesh-ancestor
64296216|NCT03303651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64296217|NCT03303651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296218|NCT03303651|Analgesics|analgesics|mesh-ancestor
64296219|NCT03303651|Sensory System Agents|sensory system agents|mesh-ancestor
64296220|NCT03303651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64296221|NCT03312153|Sodium Hypochlorite|sodium hypochlorite|mesh-list
64296222|NCT03312153|Eusol|eusol|mesh-list
64296223|NCT03312153|Disinfectants|disinfectants|mesh-ancestor
64296224|NCT03312153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64845174|NCT05351541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64845175|NCT05351541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64845176|NCT05351541|Serotonin Agents|serotonin agents|mesh-ancestor
64845177|NCT05351541|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64845178|NCT05350696|Morphine|morphine|mesh-list
64845179|NCT05350696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64845180|NCT05350696|Narcotics|narcotics|mesh-ancestor
64845181|NCT05350696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64845182|NCT05350696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845183|NCT05350696|Analgesics|analgesics|mesh-ancestor
64845184|NCT05350696|Sensory System Agents|sensory system agents|mesh-ancestor
64845185|NCT05350696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845186|NCT05301361|Methylphenidate|methylphenidate|mesh-list
64845187|NCT05301361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64845188|NCT05301361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845189|NCT05301361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64845190|NCT05301361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64328790|NCT05488431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64328791|NCT05488431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328792|NCT05488431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64328793|NCT05488431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328794|NCT02180321|Tranexamic Acid|tranexamic acid|mesh-list
64328795|NCT02180321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64328796|NCT02180321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64328797|NCT02180321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328821|NCT02386059|Ondansetron|ondansetron|mesh-list
64328823|NCT02386059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64328824|NCT02386059|Antiemetics|antiemetics|mesh-ancestor
64328825|NCT02386059|Autonomic Agents|autonomic agents|mesh-ancestor
64328826|NCT02386059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64328827|NCT02386059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328828|NCT02386059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64328829|NCT02386059|Glucocorticoids|glucocorticoids|mesh-ancestor
64328830|NCT02386059|Hormones|hormones|mesh-ancestor
64328831|NCT02386059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64328836|NCT02386059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328838|NCT02386059|Dermatologic Agents|dermatologic agents|mesh-ancestor
64845208|NCT05098327|Pioglitazone|pioglitazone|mesh-list
64845209|NCT05098327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64845210|NCT05098327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845211|NCT05084222|Budesonide|budesonide|mesh-list
64845212|NCT05084222|Albuterol|albuterol|mesh-list
64845213|NCT05084222|Formoterol Fumarate|formoterol fumarate|mesh-list
64845214|NCT05084222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64845215|NCT05084222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64845216|NCT05084222|Autonomic Agents|autonomic agents|mesh-ancestor
64845217|NCT05084222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845218|NCT05084222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845219|NCT05084222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64845220|NCT05084222|Respiratory System Agents|respiratory system agents|mesh-ancestor
64845221|NCT05084222|Glucocorticoids|glucocorticoids|mesh-ancestor
64845222|NCT05084222|Hormones|hormones|mesh-ancestor
64296236|NCT03303495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296238|NCT03303495|Antimetabolites|antimetabolites|mesh-ancestor
64296239|NCT03303495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296240|NCT03303495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64296241|NCT03303495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64296242|NCT03303495|Immunologic Factors|immunologic factors|mesh-ancestor
64296243|NCT03303495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64296244|NCT03303495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64296245|NCT03303495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296249|NCT03303495|Vitamins|vitamins|mesh-ancestor
64845223|NCT05084222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64845224|NCT05084222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64845225|NCT05084222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64845226|NCT05084222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64845227|NCT05084222|Adrenergic Agents|adrenergic agents|mesh-ancestor
64845228|NCT05084222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64845229|NCT05084222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845230|NCT05084222|Tocolytic Agents|tocolytic agents|mesh-ancestor
64845231|NCT05084222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64845232|NCT05076838|Diazepam|diazepam|mesh-list
64845233|NCT05076838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64845234|NCT05076838|Anticonvulsants|anticonvulsants|mesh-ancestor
64845235|NCT05076838|Antiemetics|antiemetics|mesh-ancestor
64845236|NCT05076838|Autonomic Agents|autonomic agents|mesh-ancestor
64845237|NCT05076838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845238|NCT05076838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845239|NCT05076838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64845240|NCT05076838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64328882|NCT02390739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64845254|NCT05057949|Itraconazole|itraconazole|mesh-list
64845255|NCT05057949|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
64845257|NCT05057949|Antifungal Agents|antifungal agents|mesh-ancestor
64845258|NCT05057949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64845259|NCT05057949|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64845260|NCT05057949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64845261|NCT05057949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328883|NCT02390739|Alkylating Agents|alkylating agents|mesh-ancestor
64328884|NCT02390739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328885|NCT02390739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64328886|NCT02390739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64328891|NCT02385825|Vaccines|vaccines|mesh-list
64328998|NCT02181101|Zoledronic Acid|zoledronic acid|mesh-list
64328999|NCT02181101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64329000|NCT02181101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329004|NCT02287129|Carboplatin|carboplatin|mesh-list
64329005|NCT02287129|Capecitabine|capecitabine|mesh-list
64329006|NCT02287129|Oxaliplatin|oxaliplatin|mesh-list
64329007|NCT02287129|Epirubicin|epirubicin|mesh-list
64329008|NCT02287129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64329085|NCT02385435|Anesthetics, Local|anesthetics, local|mesh-ancestor
64329086|NCT02385435|Anesthetics|anesthetics|mesh-ancestor
64329106|NCT03133897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64329107|NCT03133897|Antiemetics|antiemetics|mesh-ancestor
64329108|NCT03133897|Autonomic Agents|autonomic agents|mesh-ancestor
64329109|NCT03133897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64329110|NCT03133897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845266|NCT05057949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845267|NCT05057949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64845268|NCT05057949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64845269|NCT05057949|Antitubercular Agents|antitubercular agents|mesh-ancestor
64845270|NCT05057949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64845271|NCT05057949|Leprostatic Agents|leprostatic agents|mesh-ancestor
64845272|NCT05057949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64845273|NCT05057949|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64845274|NCT05057949|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64845275|NCT05057949|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64845276|NCT05057949|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64845277|NCT05057949|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64845278|NCT05057949|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64845280|NCT05047640|Immunologic Factors|immunologic factors|mesh-ancestor
64845281|NCT05047640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845282|NCT04925960|Epalrestat|epalrestat|mesh-list
64845283|NCT04925960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845284|NCT04925960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845285|NCT04901312|Analgesics, Opioid|analgesics, opioid|mesh-list
64845286|NCT04901312|Narcotics|narcotics|mesh-ancestor
64845287|NCT04901312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64845288|NCT04901312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845289|NCT04901312|Analgesics|analgesics|mesh-ancestor
64845290|NCT04901312|Sensory System Agents|sensory system agents|mesh-ancestor
64845291|NCT04901312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845292|NCT04892303|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
64845318|NCT04810793|Tetracycline|tetracycline|mesh-list
64845319|NCT04810793|Furazolidone|furazolidone|mesh-list
64845320|NCT04810793|Esomeprazole|esomeprazole|mesh-list
64845321|NCT04810793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64845322|NCT04810793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64845323|NCT04810793|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64845324|NCT04810793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64845325|NCT04810793|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64845326|NCT04810793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845327|NCT04810793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845328|NCT04810793|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64845329|NCT04810793|Renal Agents|renal agents|mesh-ancestor
64845330|NCT04810793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64329174|NCT05089175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64329175|NCT05089175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329176|NCT05089175|Antipyretics|antipyretics|mesh-ancestor
64329177|NCT02181335|Budesonide|budesonide|mesh-list
64329178|NCT02181335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64329229|NCT00401011|Antiemetics|antiemetics|mesh-ancestor
64329230|NCT00401011|Autonomic Agents|autonomic agents|mesh-ancestor
64329231|NCT00401011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64329232|NCT00401011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329233|NCT00401011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64329234|NCT00401011|Glucocorticoids|glucocorticoids|mesh-ancestor
64329235|NCT00401011|Hormones|hormones|mesh-ancestor
64329236|NCT00401011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64329237|NCT00401011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64329238|NCT00401011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329239|NCT01645930|Dexamethasone|dexamethasone|mesh-list
64329240|NCT01645930|Lenalidomide|lenalidomide|mesh-list
64329241|NCT01645930|Ixazomib|ixazomib|mesh-list
64329295|NCT02384967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64329296|NCT02384967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64329297|NCT02384967|Antiviral Agents|antiviral agents|mesh-ancestor
64329298|NCT02384967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64329299|NCT02186249|Nivolumab|nivolumab|mesh-list
64329300|NCT02186249|Ipilimumab|ipilimumab|mesh-list
64296267|NCT03308643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296268|NCT03302871|Botulinum Toxins|botulinum toxins|mesh-list
64296270|NCT03302871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64329301|NCT02186249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64329302|NCT02186249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329304|NCT02186249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329305|NCT00511459|Paclitaxel|paclitaxel|mesh-list
64329306|NCT00511459|Bevacizumab|bevacizumab|mesh-list
64329307|NCT00511459|Trebananib|trebananib|mesh-list
64329308|NCT00511459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64329309|NCT00511459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329310|NCT00511459|Tubulin Modulators|tubulin modulators|mesh-ancestor
64329311|NCT00511459|Antimitotic Agents|antimitotic agents|mesh-ancestor
64329312|NCT00511459|Mitosis Modulators|mitosis modulators|mesh-ancestor
64329340|NCT02186483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64329341|NCT02186483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64329342|NCT02186483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329343|NCT02186483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64329344|NCT02186483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64329345|NCT02186483|Antimetabolites|antimetabolites|mesh-ancestor
64329346|NCT02186483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329347|NCT02186483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64329348|NCT02186483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64296285|NCT03308487|Vitamins|vitamins|mesh-list
64296286|NCT03308487|Micronutrients|micronutrients|mesh-ancestor
64296290|NCT03308331|Nicotine|nicotine|mesh-list
64329349|NCT02186483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845365|NCT04624854|Analgesics|analgesics|mesh-ancestor
64845366|NCT04624854|Sensory System Agents|sensory system agents|mesh-ancestor
64845367|NCT04624854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845368|NCT04624854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845369|NCT04624854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64845370|NCT04624854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64845371|NCT04624854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64845372|NCT04624854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64845373|NCT04624854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845374|NCT04624854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64329451|NCT00355849|Insulin|insulin|mesh-list
64329452|NCT00355849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64329453|NCT00355849|Insulin Glargine|insulin glargine|mesh-list
64329454|NCT00355849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64329455|NCT00355849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329456|NCT02384499|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64329457|NCT02384499|Hemostatics|hemostatics|mesh-ancestor
64329458|NCT02384499|Coagulants|coagulants|mesh-ancestor
64329459|NCT02186951|Amoxicillin|amoxicillin|mesh-list
64329460|NCT02186951|Clavulanic Acids|clavulanic acids|mesh-list
64329461|NCT02186951|Clavulanic Acid|clavulanic acid|mesh-list
64329462|NCT02186951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64424495|NCT04205539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64296297|NCT03308331|Cholinergic Agents|cholinergic agents|mesh-ancestor
64329463|NCT02186951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64329464|NCT02186951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329465|NCT02186951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329466|NCT02186951|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64296300|NCT02414854|Albuterol|albuterol|mesh-list
64329467|NCT02285413|Cisplatin|cisplatin|mesh-list
64329468|NCT02285413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329469|NCT02381379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64329470|NCT02381379|Antiviral Agents|antiviral agents|mesh-ancestor
64329471|NCT02381379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64329472|NCT02187107|Darunavir|darunavir|mesh-list
64329473|NCT02187107|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64329474|NCT02187107|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64329554|NCT00097357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64329555|NCT00097357|Protease Inhibitors|protease inhibitors|mesh-ancestor
64329556|NCT00097357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329558|NCT02296840|Ibuprofen|ibuprofen|mesh-list
64329559|NCT02296840|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64329560|NCT02296840|Hydrocodone|hydrocodone|mesh-list
64845397|NCT04504331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64845400|NCT04504331|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64845401|NCT04504331|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64845403|NCT04463368|Ipilimumab|ipilimumab|mesh-list
64845404|NCT04463368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64845405|NCT04463368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845406|NCT04463368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64845407|NCT04463368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845408|NCT04452344|Analgesics|analgesics|mesh-list
64329601|NCT02191709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329602|NCT02191709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329603|NCT00326287|Ceftriaxone|ceftriaxone|mesh-list
64329605|NCT00326287|Ceftobiprole|ceftobiprole|mesh-list
64329606|NCT00326287|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
64329607|NCT00326287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64329608|NCT00326287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64329609|NCT00326287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64329610|NCT00326287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329611|NCT00326287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329706|NCT00319969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329707|NCT00319969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329708|NCT00317395|Heparin|heparin|mesh-list
64329709|NCT00317395|Calcium heparin|calcium heparin|mesh-list
64329710|NCT00317395|Otamixaban|otamixaban|mesh-list
64329711|NCT00317395|Eptifibatide|eptifibatide|mesh-list
64329712|NCT00317395|Anticoagulants|anticoagulants|mesh-ancestor
64329713|NCT00317395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64329714|NCT00317395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64329715|NCT00317395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329716|NCT00317395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64845434|NCT04231838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845435|NCT04231838|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64845436|NCT04231838|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64845437|NCT04231838|Cholinergic Agents|cholinergic agents|mesh-ancestor
64845438|NCT04231838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64329840|NCT04360941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64329841|NCT04551365|Chitosan|chitosan|mesh-list
64329842|NCT04551365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64329843|NCT04551365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64329844|NCT04551365|Antimetabolites|antimetabolites|mesh-ancestor
64329845|NCT04551365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329846|NCT04551365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64329847|NCT04551365|Chelating Agents|chelating agents|mesh-ancestor
64329848|NCT04551365|Sequestering Agents|sequestering agents|mesh-ancestor
64329849|NCT04551365|Hemostatics|hemostatics|mesh-ancestor
64329850|NCT04551365|Coagulants|coagulants|mesh-ancestor
64329851|NCT00028639|Bortezomib|bortezomib|mesh-list
64329852|NCT00028639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329853|NCT02371941|Cromolyn Sodium|cromolyn sodium|mesh-list
64329854|NCT02371941|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
64329855|NCT02371941|Immunologic Factors|immunologic factors|mesh-ancestor
64329856|NCT02371941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329857|NCT02371941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64296301|NCT02414854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64329858|NCT02371941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64329859|NCT02371941|Respiratory System Agents|respiratory system agents|mesh-ancestor
64329860|NCT00298987|Dasatinib|dasatinib|mesh-list
64329861|NCT00298987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329862|NCT00298987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64329863|NCT00298987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329864|NCT00298987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329865|NCT02380053|Celiprolol|celiprolol|mesh-list
64329866|NCT02380053|Bisoprolol|bisoprolol|mesh-list
64329867|NCT02380053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64329868|NCT02380053|Sympatholytics|sympatholytics|mesh-ancestor
64329869|NCT02380053|Autonomic Agents|autonomic agents|mesh-ancestor
64329870|NCT02380053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64329906|NCT02030717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64329907|NCT02030717|Adrenergic Agents|adrenergic agents|mesh-ancestor
64329908|NCT02030717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64329909|NCT02030717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329911|NCT02371473|Anticonvulsants|anticonvulsants|mesh-ancestor
64329912|NCT02371473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64329913|NCT02371473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329914|NCT02371473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329917|NCT02371473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329918|NCT04301661|Tenofovir|tenofovir|mesh-list
64329919|NCT04301661|Lamivudine|lamivudine|mesh-list
64329920|NCT04301661|Emtricitabine|emtricitabine|mesh-list
64329921|NCT04301661|Abacavir|abacavir|mesh-list
64329922|NCT04301661|Antiviral Agents|antiviral agents|mesh-ancestor
64329923|NCT04301661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64329924|NCT04301661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64845439|NCT04231838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845440|NCT04218266|Apixaban|apixaban|mesh-list
64845441|NCT04218266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64845442|NCT04218266|Antithrombins|antithrombins|mesh-ancestor
64845443|NCT04218266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64845444|NCT04218266|Protease Inhibitors|protease inhibitors|mesh-ancestor
64845445|NCT04218266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845446|NCT04218266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845447|NCT04218266|Anticoagulants|anticoagulants|mesh-ancestor
64845448|NCT04172363|Octenidine|octenidine|mesh-list
64845449|NCT04172363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64845450|NCT04172363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64845451|NCT04074603|Insulin|insulin|mesh-list
64845452|NCT04074603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64845453|NCT04074603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845454|NCT04068246|Metformin|metformin|mesh-list
64329925|NCT04301661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64329926|NCT04301661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329927|NCT04301661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329928|NCT04301661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64329929|NCT04301661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64329930|NCT05721235|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
64329931|NCT05721235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64329932|NCT05721235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329933|NCT05721235|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64329934|NCT05721235|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64329935|NCT05721235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64329936|NCT05721235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329937|NCT05721235|Dopamine Agents|dopamine agents|mesh-ancestor
64329938|NCT05721235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64329939|NCT02194049|Etoposide|etoposide|mesh-list
64329940|NCT02194049|Etoposide phosphate|etoposide phosphate|mesh-list
64329941|NCT02194049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329942|NCT02194049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64329943|NCT02194049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64329944|NCT02194049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64329945|NCT02194049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64329946|NCT02194049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329947|NCT02379663|Enoxaparin|enoxaparin|mesh-list
64329948|NCT02379663|Rivaroxaban|rivaroxaban|mesh-list
64329949|NCT02379663|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64329950|NCT02379663|Antithrombins|antithrombins|mesh-ancestor
64329951|NCT02379663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64329981|NCT00004897|Protective Agents|protective agents|mesh-ancestor
64296317|NCT03308253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64296318|NCT03308253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64296319|NCT02467023|Lidocaine|lidocaine|mesh-list
64296320|NCT02467023|Fentanyl|fentanyl|mesh-list
64296321|NCT02467023|Midazolam|midazolam|mesh-list
64296322|NCT02467023|Anesthetics, Local|anesthetics, local|mesh-ancestor
64329982|NCT00004897|Vitamin B Complex|vitamin b complex|mesh-ancestor
64329983|NCT00004897|Vitamins|vitamins|mesh-ancestor
64329984|NCT00004897|Micronutrients|micronutrients|mesh-ancestor
64329987|NCT00004897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64329988|NCT00004231|Leucovorin|leucovorin|mesh-list
64329989|NCT00004231|Interferons|interferons|mesh-list
64329990|NCT00004231|Cytarabine|cytarabine|mesh-list
64329991|NCT00004231|Interferon-alpha|interferon-alpha|mesh-list
64330007|NCT00004231|Alkylating Agents|alkylating agents|mesh-ancestor
64330008|NCT00004231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330009|NCT00004231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330010|NCT00004231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64845460|NCT04038255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64845461|NCT04038255|Autonomic Agents|autonomic agents|mesh-ancestor
64845462|NCT04038255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845463|NCT04038255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845464|NCT04038255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64845465|NCT04038255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64845466|NCT04038255|Cholinergic Agents|cholinergic agents|mesh-ancestor
64845467|NCT04038255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64845468|NCT04038255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330011|NCT00004231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64330012|NCT00004231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64330013|NCT00004231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64330014|NCT00004231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330015|NCT00004231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64330016|NCT00004231|Glucocorticoids|glucocorticoids|mesh-ancestor
64330017|NCT00004231|Hormones|hormones|mesh-ancestor
64330018|NCT00004231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64330019|NCT00004231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64330020|NCT00004231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64330021|NCT00004231|Abortifacient Agents|abortifacient agents|mesh-ancestor
64330022|NCT00004231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64330023|NCT00004231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64330024|NCT00004231|Antimetabolites|antimetabolites|mesh-ancestor
64330025|NCT00004231|Dermatologic Agents|dermatologic agents|mesh-ancestor
64330026|NCT00004231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64330027|NCT00004231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64330028|NCT00004231|Antiviral Agents|antiviral agents|mesh-ancestor
64330029|NCT00004231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64330030|NCT00004231|Antidotes|antidotes|mesh-ancestor
64330031|NCT00004231|Protective Agents|protective agents|mesh-ancestor
64330032|NCT00004231|Vitamin B Complex|vitamin b complex|mesh-ancestor
64330034|NCT00004231|Micronutrients|micronutrients|mesh-ancestor
64330035|NCT00004231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64330036|NCT00004231|Tubulin Modulators|tubulin modulators|mesh-ancestor
64330037|NCT00004231|Antimitotic Agents|antimitotic agents|mesh-ancestor
64330038|NCT00004231|Mitosis Modulators|mitosis modulators|mesh-ancestor
64330039|NCT00004231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64330040|NCT00004231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64330041|NCT04681131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64330045|NCT03535259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330046|NCT03535259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64330047|NCT03535259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330048|NCT03535259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330049|NCT00004171|Cyclophosphamide|cyclophosphamide|mesh-list
64330050|NCT00004171|Busulfan|busulfan|mesh-list
64330051|NCT00004171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64296329|NCT02467023|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64296330|NCT02467023|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64296331|NCT02467023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64330052|NCT00004171|Immunologic Factors|immunologic factors|mesh-ancestor
64845508|NCT03928093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845509|NCT03928093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845510|NCT03928093|Anticonvulsants|anticonvulsants|mesh-ancestor
64845511|NCT03928093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64845512|NCT03928093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64845513|NCT03928093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845514|NCT03928093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64845515|NCT03928093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64845516|NCT03928093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64845517|NCT03928093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64845518|NCT03928093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64330203|NCT02197403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64330204|NCT02197403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64330205|NCT02197403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330206|NCT02197403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64330207|NCT02197403|Anesthetics, General|anesthetics, general|mesh-ancestor
64330208|NCT02197403|Anesthetics|anesthetics|mesh-ancestor
64330209|NCT02197403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64330210|NCT02197403|Analgesics|analgesics|mesh-ancestor
64330211|NCT02197403|Sensory System Agents|sensory system agents|mesh-ancestor
64330212|NCT02197403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330213|NCT02197403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64330214|NCT02197403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64330241|NCT05708521|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64330242|NCT05708521|Narcotics|narcotics|mesh-ancestor
64330243|NCT05708521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64330244|NCT05708521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330365|NCT02198027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330366|NCT02257463|Theophylline|theophylline|mesh-list
64330376|NCT02257463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330377|NCT02257463|Vasodilator Agents|vasodilator agents|mesh-ancestor
64330378|NCT02257463|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64330379|NCT02257463|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64330380|NCT02257463|Purinergic Agents|purinergic agents|mesh-ancestor
64330382|NCT04109885|Promethazine|promethazine|mesh-list
64330383|NCT04109885|Prochlorperazine|prochlorperazine|mesh-list
64330384|NCT04109885|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64330385|NCT04109885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64330386|NCT04109885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64330387|NCT04109885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330430|NCT00135421|Antidepressive Agents|antidepressive agents|mesh-ancestor
64330431|NCT00135421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64330432|NCT02200991|Insulin Glargine|insulin glargine|mesh-list
64330433|NCT02200991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64330435|NCT02200991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64330436|NCT02200991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330437|NCT02200991|Incretins|incretins|mesh-ancestor
64330438|NCT02200991|Hormones|hormones|mesh-ancestor
64845570|NCT03671525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845571|NCT03671525|Vasodilator Agents|vasodilator agents|mesh-ancestor
64845573|NCT03600155|Ipilimumab|ipilimumab|mesh-list
64296332|NCT02467023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296333|NCT02467023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64296335|NCT02467023|Analgesics|analgesics|mesh-ancestor
64296336|NCT02467023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64296337|NCT02467023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64296338|NCT02467023|Anesthetics, General|anesthetics, general|mesh-ancestor
64296339|NCT02467023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64296340|NCT02467023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64296341|NCT02467023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64296342|NCT02467023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64296343|NCT02467023|GABA Modulators|gaba modulators|mesh-ancestor
64296344|NCT02467023|GABA Agents|gaba agents|mesh-ancestor
64296345|NCT02467023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64296346|NCT02055703|Itraconazole|itraconazole|mesh-list
64296347|NCT02055703|Rifampin|rifampin|mesh-list
64296348|NCT02055703|Digoxin|digoxin|mesh-list
64296349|NCT02055703|Donepezil|donepezil|mesh-list
64330474|NCT00135343|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64330475|NCT00135343|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64330476|NCT00135343|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64330477|NCT00135343|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64330478|NCT02201225|Micronutrients|micronutrients|mesh-list
64330479|NCT02201225|Trace Elements|trace elements|mesh-list
64845585|NCT03571308|Cyclophosphamide|cyclophosphamide|mesh-list
64845586|NCT03571308|Doxorubicin|doxorubicin|mesh-list
64845587|NCT03571308|Vincristine|vincristine|mesh-list
64845588|NCT03571308|Acalabrutinib|acalabrutinib|mesh-list
64845589|NCT03571308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64845590|NCT03571308|Immunologic Factors|immunologic factors|mesh-ancestor
64845591|NCT03571308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845592|NCT03571308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64845593|NCT03571308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64845594|NCT03571308|Alkylating Agents|alkylating agents|mesh-ancestor
64296354|NCT02055703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296357|NCT02055703|Hormone Antagonists|hormone antagonists|mesh-ancestor
64845595|NCT03571308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845596|NCT03571308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845597|NCT03571308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64845598|NCT03571308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64845599|NCT03571308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64845600|NCT03571308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64845601|NCT03571308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845602|NCT03571308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64845608|NCT03571308|Hormones|hormones|mesh-ancestor
64845609|NCT03571308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64330743|NCT02202707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330744|NCT02202707|Antimanic Agents|antimanic agents|mesh-ancestor
64330745|NCT02367807|Tenofovir|tenofovir|mesh-list
64330746|NCT02367807|Emtricitabine|emtricitabine|mesh-list
64330747|NCT02367807|Antiviral Agents|antiviral agents|mesh-ancestor
64330748|NCT02367807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64330749|NCT02367807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64330750|NCT02367807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64330751|NCT02367807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330752|NCT02367807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330753|NCT02367807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64330754|NCT02367807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64330755|NCT02364609|Pembrolizumab|pembrolizumab|mesh-list
64330756|NCT02364609|Afatinib|afatinib|mesh-list
64330757|NCT02364609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64330758|NCT02364609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330759|NCT02364609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64296361|NCT02055703|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64296362|NCT02055703|Cholinergic Agents|cholinergic agents|mesh-ancestor
64296363|NCT02055703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64296364|NCT02055703|Nootropic Agents|nootropic agents|mesh-ancestor
64296365|NCT02055703|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64296366|NCT02055703|Antitubercular Agents|antitubercular agents|mesh-ancestor
64296367|NCT02055703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64296368|NCT02055703|Leprostatic Agents|leprostatic agents|mesh-ancestor
64296369|NCT02055703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64330760|NCT02364609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330761|NCT02364609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330762|NCT02364453|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
64330763|NCT02364453|Growth Substances|growth substances|mesh-ancestor
64330764|NCT02364453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845611|NCT03554200|Empagliflozin|empagliflozin|mesh-list
64845612|NCT03554200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64296373|NCT02055703|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64296374|NCT02055703|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64296375|NCT02055703|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64296376|NCT02055703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64296377|NCT02055703|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64296378|NCT02055703|Protective Agents|protective agents|mesh-ancestor
64845613|NCT03554200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845614|NCT03554200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64845615|NCT03554200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845616|NCT03518086|Mirikizumab|mirikizumab|mesh-list
64845617|NCT03518086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64845618|NCT03518086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64845619|NCT03518086|Analgesics|analgesics|mesh-ancestor
64845620|NCT03518086|Sensory System Agents|sensory system agents|mesh-ancestor
64845621|NCT03518086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845622|NCT03518086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845623|NCT03518086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64330765|NCT02364453|Vasodilator Agents|vasodilator agents|mesh-ancestor
64330766|NCT02364453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64330767|NCT02364453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330768|NCT02258009|Ranibizumab|ranibizumab|mesh-list
64330769|NCT02258009|Aflibercept|aflibercept|mesh-list
64330770|NCT02258009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64330771|NCT02258009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64330772|NCT02258009|Growth Substances|growth substances|mesh-ancestor
64330773|NCT02258009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330774|NCT02258009|Growth Inhibitors|growth inhibitors|mesh-ancestor
64330775|NCT02258009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330776|NCT02203097|Propofol|propofol|mesh-list
64330777|NCT02203097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64330778|NCT02203097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64330779|NCT02203097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330780|NCT02203097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64330781|NCT02203097|Anesthetics, General|anesthetics, general|mesh-ancestor
64330797|NCT03528967|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64330798|NCT03528967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330799|NCT03528967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64845639|NCT03517176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845640|NCT03517176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64845641|NCT03517176|Immunologic Factors|immunologic factors|mesh-ancestor
64845642|NCT03517176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845643|NCT03512964|Tenofovir|tenofovir|mesh-list
64845644|NCT03512964|Emtricitabine|emtricitabine|mesh-list
64845645|NCT03512964|Dolutegravir|dolutegravir|mesh-list
64296380|NCT02058433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64296381|NCT02058433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64296382|NCT02058433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296383|NCT02058433|Tubulin Modulators|tubulin modulators|mesh-ancestor
64296384|NCT02058433|Antimitotic Agents|antimitotic agents|mesh-ancestor
64296385|NCT02058433|Mitosis Modulators|mitosis modulators|mesh-ancestor
64845646|NCT03512964|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64845647|NCT03512964|Antiviral Agents|antiviral agents|mesh-ancestor
64845648|NCT03512964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64845649|NCT03512964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64845650|NCT03512964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64845651|NCT03512964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845652|NCT03512964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845653|NCT03512964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64845654|NCT03512964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64845655|NCT03512964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64845656|NCT03512964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64296386|NCT02058433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296389|NCT03561181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296390|NCT02060149|Minocycline|minocycline|mesh-list
64296391|NCT02060149|Sulbactam|sulbactam|mesh-list
64296392|NCT02060149|Cefoperazone|cefoperazone|mesh-list
64296397|NCT02060149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845657|NCT03507608|Flutamide|flutamide|mesh-list
64845658|NCT03507608|Androgen Antagonists|androgen antagonists|mesh-ancestor
64845659|NCT03507608|Hormone Antagonists|hormone antagonists|mesh-ancestor
64845660|NCT03507608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64845661|NCT03507608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845662|NCT03507608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64845663|NCT03507608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845665|NCT03476109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64845666|NCT03476109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64296399|NCT03302403|Cyclophosphamide|cyclophosphamide|mesh-list
64296400|NCT03302403|Fludarabine|fludarabine|mesh-list
64296401|NCT03302403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64296402|NCT03302403|Immunologic Factors|immunologic factors|mesh-ancestor
64845667|NCT03476109|Respiratory System Agents|respiratory system agents|mesh-ancestor
64845668|NCT03463499|Hyaluronic Acid|hyaluronic acid|mesh-list
64845669|NCT03463499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64845670|NCT03463499|Immunologic Factors|immunologic factors|mesh-ancestor
64845671|NCT03463499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845672|NCT03463499|Viscosupplements|viscosupplements|mesh-ancestor
64845673|NCT03463499|Protective Agents|protective agents|mesh-ancestor
64845674|NCT03404193|Decitabine|decitabine|mesh-list
64845675|NCT03404193|Venetoclax|venetoclax|mesh-list
64845689|NCT03366974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64845690|NCT03366974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64845691|NCT03366974|Anesthetics, General|anesthetics, general|mesh-ancestor
64845692|NCT03366974|Anesthetics|anesthetics|mesh-ancestor
64845693|NCT03366974|GABA Modulators|gaba modulators|mesh-ancestor
64845694|NCT03366974|GABA Agents|gaba agents|mesh-ancestor
64845695|NCT03366974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64845696|NCT03366974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845697|NCT03366974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64845698|NCT03366974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64845699|NCT03366974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64845700|NCT03366974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845701|NCT03366974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64845702|NCT03366974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64845703|NCT03362515|Furosemide|furosemide|mesh-list
64845740|NCT03128398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845742|NCT03119038|Clonidine|clonidine|mesh-list
64845743|NCT03119038|Epinephrine|epinephrine|mesh-list
64845744|NCT03119038|Bupivacaine|bupivacaine|mesh-list
64845745|NCT03119038|Ropivacaine|ropivacaine|mesh-list
64845746|NCT03119038|Anesthetics, Local|anesthetics, local|mesh-ancestor
64845747|NCT03119038|Anesthetics|anesthetics|mesh-ancestor
64845748|NCT03119038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64845749|NCT03119038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845804|NCT03063749|Sirolimus|sirolimus|mesh-list
64845805|NCT03063749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64845806|NCT03063749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64845807|NCT03063749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64845808|NCT03063749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845809|NCT03063749|Antifungal Agents|antifungal agents|mesh-ancestor
64845810|NCT03063749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64845811|NCT03063749|Immunologic Factors|immunologic factors|mesh-ancestor
64296403|NCT03302403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296404|NCT03302403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64296405|NCT03302403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64296406|NCT03302403|Alkylating Agents|alkylating agents|mesh-ancestor
64296407|NCT03302403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296408|NCT03302403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296409|NCT03302403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64845812|NCT03063749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330831|NCT02363751|Bevacizumab|bevacizumab|mesh-list
64330832|NCT02363751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64330845|NCT03279471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330847|NCT03279471|Serotonin Agents|serotonin agents|mesh-ancestor
64845876|NCT02587312|Autonomic Agents|autonomic agents|mesh-ancestor
64845877|NCT02587312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845878|NCT02587312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845879|NCT02587312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64845880|NCT02587312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64845881|NCT02587312|Cholinergic Agents|cholinergic agents|mesh-ancestor
64845882|NCT02587312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64296410|NCT02038621|Paclitaxel|paclitaxel|mesh-list
64845883|NCT02587312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845884|NCT02549677|Cyclophosphamide|cyclophosphamide|mesh-list
64845885|NCT02549677|Docetaxel|docetaxel|mesh-list
64845886|NCT02549677|Epirubicin|epirubicin|mesh-list
64845887|NCT02549677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64330884|NCT04467463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330885|NCT04467463|Sensory System Agents|sensory system agents|mesh-ancestor
64330886|NCT04467463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330887|NCT02363361|Imatinib Mesylate|imatinib mesylate|mesh-list
64330888|NCT02363361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330889|NCT02363361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64330890|NCT02363361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330891|NCT02363361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845943|NCT02036086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845944|NCT01517451|Androgens|androgens|mesh-list
64845945|NCT01517451|Hormones|hormones|mesh-ancestor
64845946|NCT01517451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64845947|NCT01517451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336787|NCT02313337|GABA Agents|gaba agents|mesh-ancestor
64845948|NCT01486264|Botulinum Toxins|botulinum toxins|mesh-list
64845949|NCT01486264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64845950|NCT01486264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64845951|NCT01486264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64845952|NCT01486264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64845953|NCT01486264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845954|NCT01486264|Cholinergic Agents|cholinergic agents|mesh-ancestor
64845955|NCT01486264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64845956|NCT01486264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845957|NCT01486264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64845958|NCT01486264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845959|NCT01299480|Vaccines|vaccines|mesh-list
64845960|NCT01299480|Immunologic Factors|immunologic factors|mesh-ancestor
64845961|NCT01299480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845962|NCT01681446|Interferons|interferons|mesh-list
64845963|NCT01681446|Interferon-alpha|interferon-alpha|mesh-list
64845964|NCT01681446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64845965|NCT01681446|Antiviral Agents|antiviral agents|mesh-ancestor
64330892|NCT04594915|Edoxaban|edoxaban|mesh-list
64330893|NCT04594915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64330894|NCT04594915|Antithrombins|antithrombins|mesh-ancestor
64330900|NCT04546633|Lumefantrine|lumefantrine|mesh-list
64330901|NCT04546633|Antimalarials|antimalarials|mesh-ancestor
64330902|NCT04546633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64330903|NCT04546633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64330904|NCT04546633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64845966|NCT01681446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64845967|NCT01681446|Immunologic Factors|immunologic factors|mesh-ancestor
64845968|NCT01681446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845969|NCT01681875|Nicotine|nicotine|mesh-list
64845970|NCT01681875|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64845971|NCT01681875|Autonomic Agents|autonomic agents|mesh-ancestor
64845972|NCT01681875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64845973|NCT01681875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845974|NCT01681875|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64845975|NCT01681875|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64845976|NCT01681875|Cholinergic Agents|cholinergic agents|mesh-ancestor
64845977|NCT01681875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64845978|NCT01681875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845979|NCT01682577|Perindopril|perindopril|mesh-list
64845980|NCT01682577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64845981|NCT01682577|Protease Inhibitors|protease inhibitors|mesh-ancestor
64845982|NCT01682577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845983|NCT01682577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845984|NCT01682577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64845985|NCT01683760|Fluconazole|fluconazole|mesh-list
64845986|NCT01683760|Antifungal Agents|antifungal agents|mesh-ancestor
64845987|NCT01683760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64845988|NCT01683760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64845989|NCT01683760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64330905|NCT03220893|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
64330906|NCT03220893|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64330907|NCT03220893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330908|NCT02367027|Rivaroxaban|rivaroxaban|mesh-list
64330909|NCT02367027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64330910|NCT02367027|Antithrombins|antithrombins|mesh-ancestor
64330911|NCT02367027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64330912|NCT02367027|Protease Inhibitors|protease inhibitors|mesh-ancestor
64330913|NCT02367027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845990|NCT01683760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64845991|NCT01683760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64845992|NCT01683760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64845993|NCT01683760|Hormone Antagonists|hormone antagonists|mesh-ancestor
64845994|NCT01683760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64845995|NCT01683760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64845996|NCT01683760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64845997|NCT01683760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64845998|NCT01684813|Clopidogrel|clopidogrel|mesh-list
64845999|NCT01684813|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64846010|NCT01684982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846011|NCT01684982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64846012|NCT01684982|Immunologic Factors|immunologic factors|mesh-ancestor
64846013|NCT01684982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846014|NCT01684982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64846015|NCT01684982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64846016|NCT01684982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64846017|NCT01684982|Antifungal Agents|antifungal agents|mesh-ancestor
64846018|NCT01685489|polysaccharide-K|polysaccharide-k|mesh-list
64846019|NCT01685489|Docetaxel|docetaxel|mesh-list
64846020|NCT01685489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846021|NCT01685489|Tubulin Modulators|tubulin modulators|mesh-ancestor
64846022|NCT01685489|Antimitotic Agents|antimitotic agents|mesh-ancestor
64846023|NCT01685489|Mitosis Modulators|mitosis modulators|mesh-ancestor
64846024|NCT01685489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296411|NCT02038621|Capecitabine|capecitabine|mesh-list
64296412|NCT02038621|Oxaliplatin|oxaliplatin|mesh-list
64296413|NCT02038621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64296414|NCT02038621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296415|NCT02038621|Tubulin Modulators|tubulin modulators|mesh-ancestor
64296416|NCT02038621|Antimitotic Agents|antimitotic agents|mesh-ancestor
64296417|NCT02038621|Mitosis Modulators|mitosis modulators|mesh-ancestor
64296418|NCT02038621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296419|NCT02038621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64296420|NCT02038621|Antimetabolites|antimetabolites|mesh-ancestor
64846025|NCT01685489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64846026|NCT01685489|Immunologic Factors|immunologic factors|mesh-ancestor
64846027|NCT01685489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846028|NCT01685489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64846029|NCT01685489|Antiviral Agents|antiviral agents|mesh-ancestor
64846030|NCT01685489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64846031|NCT01685489|Interferon Inducers|interferon inducers|mesh-ancestor
64846032|NCT01685489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64846033|NCT01685489|Protective Agents|protective agents|mesh-ancestor
64846034|NCT01686386|Dexamethasone|dexamethasone|mesh-list
64846035|NCT01686386|Lenalidomide|lenalidomide|mesh-list
64846036|NCT01686386|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64846037|NCT01686386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64846038|NCT01686386|Antiemetics|antiemetics|mesh-ancestor
64846039|NCT01686386|Autonomic Agents|autonomic agents|mesh-ancestor
64846040|NCT01686386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64846041|NCT01686386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296421|NCT03332498|Pembrolizumab|pembrolizumab|mesh-list
64296422|NCT03332498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64296423|NCT03332498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296424|NCT05727969|Dexmedetomidine|dexmedetomidine|mesh-list
64296425|NCT05727969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64296426|NCT05727969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64296427|NCT05727969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296428|NCT05727969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64296429|NCT05727969|Analgesics|analgesics|mesh-ancestor
64846042|NCT01686386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64846043|NCT01686386|Glucocorticoids|glucocorticoids|mesh-ancestor
64846044|NCT01686386|Hormones|hormones|mesh-ancestor
64846045|NCT01686386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64846046|NCT01686386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64846047|NCT01686386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846048|NCT01686386|Immunologic Factors|immunologic factors|mesh-ancestor
64846049|NCT01686386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64296437|NCT05727969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296438|NCT01334125|Metformin|metformin|mesh-list
64296439|NCT01334125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64296440|NCT01334125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296441|NCT02414152|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64296442|NCT02414152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64296443|NCT01333501|Interferons|interferons|mesh-list
64296444|NCT01333501|Interferon-beta|interferon-beta|mesh-list
64846050|NCT01686386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64846051|NCT01686386|Growth Substances|growth substances|mesh-ancestor
64846052|NCT01686386|Growth Inhibitors|growth inhibitors|mesh-ancestor
64846053|NCT01686386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64846054|NCT01686386|Alkylating Agents|alkylating agents|mesh-ancestor
64846068|NCT01687751|Analgesics|analgesics|mesh-ancestor
64846069|NCT01687751|Sensory System Agents|sensory system agents|mesh-ancestor
64846070|NCT01687751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64846072|NCT01687751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64846085|NCT01687751|GABA Agents|gaba agents|mesh-ancestor
64846086|NCT01688362|Dexamethasone|dexamethasone|mesh-list
64846087|NCT01688362|Bupivacaine|bupivacaine|mesh-list
64846088|NCT01688362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64846089|NCT01688362|Antiemetics|antiemetics|mesh-ancestor
64846090|NCT01688362|Autonomic Agents|autonomic agents|mesh-ancestor
64296446|NCT01333501|Interferon beta-1b|interferon beta-1b|mesh-list
64296447|NCT01333501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296448|NCT01333501|Antiviral Agents|antiviral agents|mesh-ancestor
64296449|NCT01333501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64296450|NCT01333501|Immunologic Factors|immunologic factors|mesh-ancestor
64296451|NCT01333501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296452|NCT01333501|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64846091|NCT01688362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64846092|NCT01688362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846093|NCT01688362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64846094|NCT01688362|Glucocorticoids|glucocorticoids|mesh-ancestor
64846095|NCT01688362|Hormones|hormones|mesh-ancestor
64614570|NCT04889547|Dexamethasone|dexamethasone|mesh-list
64846096|NCT01688362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64846097|NCT01688362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64846098|NCT01688362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846099|NCT01688362|Anesthetics, Local|anesthetics, local|mesh-ancestor
64846101|NCT01688362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64846102|NCT01688362|Sensory System Agents|sensory system agents|mesh-ancestor
64846103|NCT01688375|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64846104|NCT01688375|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64846105|NCT01688375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64846106|NCT01689753|Citric Acid|citric acid|mesh-list
64296460|NCT03307941|Antimetabolites|antimetabolites|mesh-ancestor
64296461|NCT03307941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296462|NCT03307941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64296463|NCT03307941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296464|NCT03307941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64296467|NCT03307863|Topiramate|topiramate|mesh-list
64846107|NCT01689753|Sodium Citrate|sodium citrate|mesh-list
64846114|NCT01690039|Furosemide|furosemide|mesh-list
64846126|NCT01690104|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64846127|NCT01690104|Antitubercular Agents|antitubercular agents|mesh-ancestor
64846128|NCT01690104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64846129|NCT01690104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64846130|NCT01690104|Leprostatic Agents|leprostatic agents|mesh-ancestor
64846131|NCT01690104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64846132|NCT01690104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846133|NCT01690104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846134|NCT01690104|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64846135|NCT01690104|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64846136|NCT01690104|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64296477|NCT03307863|Analgesics|analgesics|mesh-ancestor
64296478|NCT03307863|Sensory System Agents|sensory system agents|mesh-ancestor
64296479|NCT03307863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64296480|NCT03307863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64296481|NCT03307863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64296482|NCT03307863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296483|NCT03307863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64846198|NCT01690338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846199|NCT01690338|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64846200|NCT01690338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64846201|NCT01690338|Cholinergic Agents|cholinergic agents|mesh-ancestor
64846202|NCT01690338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64846203|NCT01690338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846204|NCT01690364|Anesthetics|anesthetics|mesh-list
64846205|NCT01690364|Cisatracurium|cisatracurium|mesh-list
64846206|NCT01690364|Vecuronium Bromide|vecuronium bromide|mesh-list
64846207|NCT01690364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64424496|NCT04205539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64296484|NCT03307863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64296485|NCT04656470|Dexmedetomidine|dexmedetomidine|mesh-list
64296486|NCT04656470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64296487|NCT04656470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64296488|NCT04656470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296489|NCT04656470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64296490|NCT04656470|Analgesics|analgesics|mesh-ancestor
64296491|NCT04656470|Sensory System Agents|sensory system agents|mesh-ancestor
64846208|NCT01690364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846209|NCT01690364|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64846210|NCT01690364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64846211|NCT01690364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64846212|NCT01690364|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64846213|NCT01690364|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64846214|NCT01690364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64846215|NCT01690364|Cholinergic Agents|cholinergic agents|mesh-ancestor
64846216|NCT01690364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64846217|NCT01690364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846218|NCT01690403|Rifapentine|rifapentine|mesh-list
64846220|NCT01690403|Antitubercular Agents|antitubercular agents|mesh-ancestor
64846221|NCT01690403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64846222|NCT01690403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64846223|NCT01690403|Leprostatic Agents|leprostatic agents|mesh-ancestor
64846224|NCT01690468|Carboplatin|carboplatin|mesh-list
64846225|NCT01690468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846227|NCT01690507|Decitabine|decitabine|mesh-list
64846228|NCT01690507|Aclacinomycins|aclacinomycins|mesh-list
64846229|NCT01690507|Lenograstim|lenograstim|mesh-list
64846230|NCT01690507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64846231|NCT01690507|Antimetabolites|antimetabolites|mesh-ancestor
64846232|NCT01690507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846233|NCT01690507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846234|NCT01690507|Antiviral Agents|antiviral agents|mesh-ancestor
64846235|NCT01690507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64846236|NCT01690507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64846237|NCT01690507|Immunologic Factors|immunologic factors|mesh-ancestor
64846238|NCT01690507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846239|NCT01690507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846240|NCT01690507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64330933|NCT02366949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846262|NCT01690559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64846263|NCT01690559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846264|NCT01690559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846265|NCT01690559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846266|NCT01690559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64846267|NCT01690559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64846268|NCT01690572|Paclitaxel|paclitaxel|mesh-list
64846269|NCT01690572|Hyaluronic Acid|hyaluronic acid|mesh-list
64846270|NCT01690572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64846271|NCT01690572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846272|NCT01690572|Tubulin Modulators|tubulin modulators|mesh-ancestor
64846273|NCT01690572|Antimitotic Agents|antimitotic agents|mesh-ancestor
64846274|NCT01690572|Mitosis Modulators|mitosis modulators|mesh-ancestor
64846275|NCT01690572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846276|NCT01690572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64846277|NCT01690572|Immunologic Factors|immunologic factors|mesh-ancestor
64846278|NCT01690572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846279|NCT01690572|Viscosupplements|viscosupplements|mesh-ancestor
64846280|NCT01690572|Protective Agents|protective agents|mesh-ancestor
64846281|NCT01690598|Topotecan|topotecan|mesh-list
64846282|NCT01690598|Veliparib|veliparib|mesh-list
64846283|NCT01690598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64846284|NCT01690598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64846285|NCT01690598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846286|NCT01690598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846287|NCT01690598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296493|NCT04656470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64296495|NCT04656470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64296496|NCT04656470|Adrenergic Agents|adrenergic agents|mesh-ancestor
64296497|NCT04656470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64296498|NCT04656470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846288|NCT01690598|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64846289|NCT01690637|Oseltamivir|oseltamivir|mesh-list
64846290|NCT01690637|Antiviral Agents|antiviral agents|mesh-ancestor
64846291|NCT01690637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64846292|NCT01690637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846293|NCT01690637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846294|NCT01690702|Paclitaxel|paclitaxel|mesh-list
64846295|NCT01690702|Docetaxel|docetaxel|mesh-list
64846302|NCT01690702|Mitosis Modulators|mitosis modulators|mesh-ancestor
64846303|NCT01690702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846304|NCT01690702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64846305|NCT01690702|Immunologic Factors|immunologic factors|mesh-ancestor
64846306|NCT01690702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846307|NCT01690702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64294476|NCT05704933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334634|NCT02228135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64334635|NCT02228135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64334636|NCT02228135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334637|NCT03152877|Bupivacaine|bupivacaine|mesh-list
64334638|NCT03152877|Anesthetics, Local|anesthetics, local|mesh-ancestor
64334639|NCT03152877|Anesthetics|anesthetics|mesh-ancestor
64336792|NCT02313337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64296499|NCT05391074|Vitamins|vitamins|mesh-list
64296500|NCT05391074|Micronutrients|micronutrients|mesh-ancestor
64296501|NCT05391074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296502|NCT05373212|Insulin Lispro|insulin lispro|mesh-list
64296503|NCT05373212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64296504|NCT05373212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296506|NCT05727579|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64296507|NCT05727579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846319|NCT01690767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846320|NCT01690767|Sensory System Agents|sensory system agents|mesh-ancestor
64846321|NCT01690767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64846322|NCT01690767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64846323|NCT01690767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64846324|NCT01690767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64846325|NCT01690767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64296515|NCT02467647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64296516|NCT02467647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64296517|NCT02467647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64296518|NCT02467647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64296520|NCT02467647|Growth Inhibitors|growth inhibitors|mesh-ancestor
64846326|NCT01690767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846327|NCT01690780|Ibuprofen|ibuprofen|mesh-list
64846328|NCT01690780|Morphine|morphine|mesh-list
64846329|NCT01690780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64846330|NCT01690780|Narcotics|narcotics|mesh-ancestor
64846331|NCT01690780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64846332|NCT01690780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846333|NCT01690780|Analgesics|analgesics|mesh-ancestor
64846334|NCT01690780|Sensory System Agents|sensory system agents|mesh-ancestor
64846335|NCT01690780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64846336|NCT01690780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64846337|NCT01690780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64846338|NCT01690780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64846339|NCT01690780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64846340|NCT01690780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64846341|NCT01690780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846342|NCT01690780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846343|NCT01690832|Fenoldopam|fenoldopam|mesh-list
64846344|NCT01690832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64846345|NCT01690832|Vasodilator Agents|vasodilator agents|mesh-ancestor
64846346|NCT01690832|Dopamine Agonists|dopamine agonists|mesh-ancestor
64846347|NCT01690832|Dopamine Agents|dopamine agents|mesh-ancestor
64846348|NCT01690832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64846349|NCT01690832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846350|NCT01690832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846351|NCT01690871|Dactolisib|dactolisib|mesh-list
64846352|NCT01690871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846353|NCT01690884|Adenosine|adenosine|mesh-list
64846354|NCT01690884|Analgesics|analgesics|mesh-ancestor
64846355|NCT01690884|Sensory System Agents|sensory system agents|mesh-ancestor
64846356|NCT01690884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64846377|NCT01691001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64846378|NCT01691001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846379|NCT01691001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64846380|NCT01691001|Analgesics|analgesics|mesh-ancestor
64846381|NCT01691001|Sensory System Agents|sensory system agents|mesh-ancestor
64846382|NCT01691001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330936|NCT03532919|Protease Inhibitors|protease inhibitors|mesh-ancestor
64330937|NCT03532919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330938|NCT03532919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330939|NCT05503225|Colchicine|colchicine|mesh-list
64330940|NCT05503225|Gout Suppressants|gout suppressants|mesh-ancestor
64296521|NCT02467647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296522|NCT03263936|Cytarabine|cytarabine|mesh-list
64296523|NCT03263936|Fludarabine|fludarabine|mesh-list
64296524|NCT03263936|Decitabine|decitabine|mesh-list
64296525|NCT03263936|Vorinostat|vorinostat|mesh-list
64296526|NCT03263936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296527|NCT03263936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64296528|NCT03263936|Antimetabolites|antimetabolites|mesh-ancestor
64296529|NCT03263936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296530|NCT03263936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64296531|NCT03263936|Immunologic Factors|immunologic factors|mesh-ancestor
64296532|NCT03263936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296533|NCT03263936|Antiviral Agents|antiviral agents|mesh-ancestor
64296534|NCT03263936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64296535|NCT03263936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296536|NCT03263936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64330941|NCT05503225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64330942|NCT05503225|Tubulin Modulators|tubulin modulators|mesh-ancestor
64330943|NCT05503225|Antimitotic Agents|antimitotic agents|mesh-ancestor
64846393|NCT01691053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846394|NCT01691053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64846397|NCT01691118|Antihypertensive Agents|antihypertensive agents|mesh-list
64846398|NCT01691209|Hydrocortisone|hydrocortisone|mesh-list
64846399|NCT01691209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64846400|NCT01691365|Vitamins|vitamins|mesh-list
64846401|NCT01691365|Vitamin B Complex|vitamin b complex|mesh-list
64846402|NCT01691365|Antioxidants|antioxidants|mesh-list
64846403|NCT01691365|Micronutrients|micronutrients|mesh-ancestor
64296538|NCT03307551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64296539|NCT03307551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64296540|NCT03307551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296541|NCT03307551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64296542|NCT03307551|Anesthetics, General|anesthetics, general|mesh-ancestor
64846404|NCT01691365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846405|NCT01691365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846406|NCT01691365|Protective Agents|protective agents|mesh-ancestor
64846407|NCT01691404|Quercetin|quercetin|mesh-list
64846408|NCT01691404|Antioxidants|antioxidants|mesh-ancestor
64846409|NCT01691404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846410|NCT01691404|Protective Agents|protective agents|mesh-ancestor
64846411|NCT01691404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846412|NCT01691456|Montelukast|montelukast|mesh-list
64846413|NCT01691456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64846414|NCT01691456|Respiratory System Agents|respiratory system agents|mesh-ancestor
64846415|NCT01691456|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64846416|NCT01691456|Hormone Antagonists|hormone antagonists|mesh-ancestor
64846417|NCT01691456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64846418|NCT01691456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846419|NCT01691456|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64846420|NCT01691456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64846421|NCT01691456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846422|NCT01691469|Montelukast|montelukast|mesh-list
64846423|NCT01691469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64846424|NCT01691469|Respiratory System Agents|respiratory system agents|mesh-ancestor
64846425|NCT01691469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64846426|NCT01691469|Hormone Antagonists|hormone antagonists|mesh-ancestor
64846427|NCT01691469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64330944|NCT05503225|Mitosis Modulators|mitosis modulators|mesh-ancestor
64330945|NCT05503225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330946|NCT05503225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846428|NCT01691469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296543|NCT03307551|Anesthetics|anesthetics|mesh-ancestor
64296544|NCT02060305|Bevacizumab|bevacizumab|mesh-list
64296545|NCT02060305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64846429|NCT01691469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64846430|NCT01691469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64846431|NCT01691469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846432|NCT01691495|PENTA|penta|mesh-list
64846433|NCT01691495|Fondaparinux|fondaparinux|mesh-list
64846434|NCT01691495|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64846435|NCT01691495|Antithrombins|antithrombins|mesh-ancestor
64846436|NCT01691495|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64846437|NCT01691495|Protease Inhibitors|protease inhibitors|mesh-ancestor
64846438|NCT01691495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296546|NCT02060305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296547|NCT02060305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64296548|NCT02060305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64296549|NCT02060305|Growth Substances|growth substances|mesh-ancestor
64846439|NCT01691495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846440|NCT01691495|Anticoagulants|anticoagulants|mesh-ancestor
64846441|NCT01691495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64846442|NCT01691495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64846443|NCT01691651|Botulinum Toxins|botulinum toxins|mesh-list
64846444|NCT01691651|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64846445|NCT01691651|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64846446|NCT01691651|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64846447|NCT01691651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64846448|NCT01691651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296552|NCT03497143|Lamotrigine|lamotrigine|mesh-list
64296553|NCT03497143|Anticonvulsants|anticonvulsants|mesh-ancestor
64296554|NCT03497143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64296555|NCT03497143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64846449|NCT01691651|Cholinergic Agents|cholinergic agents|mesh-ancestor
64846450|NCT01691651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64846451|NCT01691651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846452|NCT01691651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64846453|NCT01691651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64846454|NCT01691677|Beclomethasone|beclomethasone|mesh-list
64846455|NCT01691677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64846456|NCT01691677|Glucocorticoids|glucocorticoids|mesh-ancestor
64846457|NCT01691677|Hormones|hormones|mesh-ancestor
64296556|NCT03497143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296557|NCT03497143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64296558|NCT03497143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296559|NCT03497143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64846458|NCT01691677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64846460|NCT01691677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64846471|NCT01691872|Ezogabine|ezogabine|mesh-list
64846472|NCT01691872|Anticonvulsants|anticonvulsants|mesh-ancestor
64846473|NCT01691872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64846474|NCT01691872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846475|NCT01691937|Sufentanil|sufentanil|mesh-list
64846476|NCT01691937|Ropivacaine|ropivacaine|mesh-list
64846477|NCT01691937|Anesthetics, Local|anesthetics, local|mesh-ancestor
64846478|NCT01691937|Anesthetics|anesthetics|mesh-ancestor
64846479|NCT01691937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64846480|NCT01691937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846481|NCT01691937|Sensory System Agents|sensory system agents|mesh-ancestor
64846482|NCT01691937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64846483|NCT01691937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64846484|NCT01691937|Narcotics|narcotics|mesh-ancestor
64296563|NCT03497143|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64296564|NCT03561025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64296565|NCT03561025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64296566|NCT03561025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296567|NCT02059759|Aldesleukin|aldesleukin|mesh-list
64296568|NCT02059759|Interleukin-2|interleukin-2|mesh-list
64296569|NCT02059759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846485|NCT01691937|Analgesics|analgesics|mesh-ancestor
64846486|NCT01691937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64846487|NCT01691937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64846488|NCT01691937|Anesthetics, General|anesthetics, general|mesh-ancestor
64846489|NCT01691976|Estrogens|estrogens|mesh-list
64846490|NCT01691976|Hormones|hormones|mesh-ancestor
64846491|NCT01691976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64846523|NCT01692483|Abiraterone Acetate|abiraterone acetate|mesh-list
64846524|NCT01692483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64846525|NCT01692483|Glucocorticoids|glucocorticoids|mesh-ancestor
64846526|NCT01692483|Hormones|hormones|mesh-ancestor
64296570|NCT02059759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64846527|NCT01692483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64846528|NCT01692483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846529|NCT01692483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64846530|NCT01692483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846531|NCT01692483|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64846532|NCT01692483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846533|NCT01692483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846534|NCT01692483|Hormone Antagonists|hormone antagonists|mesh-ancestor
64615026|NCT04342065|Celecoxib|celecoxib|mesh-list
64846535|NCT01692483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64846536|NCT01692652|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64846537|NCT01692652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64846538|NCT01692678|Dacarbazine|dacarbazine|mesh-list
64846539|NCT01692678|Trabectedin|trabectedin|mesh-list
64846540|NCT01692678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64846541|NCT01692678|Alkylating Agents|alkylating agents|mesh-ancestor
64846542|NCT01692678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846543|NCT01692678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64484480|NCT04658927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64484481|NCT04658927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64484482|NCT04658927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64484484|NCT01965431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64484485|NCT01965431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64484513|NCT01974323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64484514|NCT01974323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484515|NCT01974323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484516|NCT01974323|Leprostatic Agents|leprostatic agents|mesh-ancestor
64484517|NCT01974323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64484518|NCT01973387|Rituximab|rituximab|mesh-list
64484519|NCT01973387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64484531|NCT02151994|Zamicastat|zamicastat|mesh-list
64484532|NCT02151994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484533|NCT02151994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484535|NCT04382950|Isotretinoin|isotretinoin|mesh-list
64296571|NCT02059759|Analgesics|analgesics|mesh-ancestor
64846544|NCT01692704|Gemcitabine|gemcitabine|mesh-list
64846545|NCT01692704|Floxuridine|floxuridine|mesh-list
64846546|NCT01692704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846547|NCT01692704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64846548|NCT01692704|Antimetabolites|antimetabolites|mesh-ancestor
64846549|NCT01692704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846550|NCT01692704|Antiviral Agents|antiviral agents|mesh-ancestor
64846551|NCT01692704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64484536|NCT04382950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64484537|NCT04382950|Keratolytic Agents|keratolytic agents|mesh-ancestor
64484538|NCT04382950|Dermatologic Agents|dermatologic agents|mesh-ancestor
64484540|NCT04537156|Immunologic Factors|immunologic factors|mesh-ancestor
64484541|NCT04537156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484542|NCT04383418|Dexmedetomidine|dexmedetomidine|mesh-list
64484543|NCT04383418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64484544|NCT04383418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64484545|NCT04383418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484546|NCT04383418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64484547|NCT04383418|Analgesics|analgesics|mesh-ancestor
64484548|NCT04383418|Sensory System Agents|sensory system agents|mesh-ancestor
64484555|NCT04383418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484556|NCT03414112|Oxytocin|oxytocin|mesh-list
64484557|NCT03414112|Oxytocics|oxytocics|mesh-ancestor
64484559|NCT03414112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484560|NCT03839134|Lidocaine|lidocaine|mesh-list
64484564|NCT03839134|Anesthetics, Local|anesthetics, local|mesh-ancestor
64484565|NCT03839134|Anesthetics|anesthetics|mesh-ancestor
64484566|NCT03839134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64484567|NCT03839134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484568|NCT03839134|Sensory System Agents|sensory system agents|mesh-ancestor
64484569|NCT03839134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484570|NCT03839134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64484583|NCT03839134|Respiratory System Agents|respiratory system agents|mesh-ancestor
64484584|NCT03839134|Mydriatics|mydriatics|mesh-ancestor
64484585|NCT03839134|Sympathomimetics|sympathomimetics|mesh-ancestor
64484586|NCT03839134|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64296572|NCT02059759|Sensory System Agents|sensory system agents|mesh-ancestor
64296573|NCT02059759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64296574|NCT02059759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846552|NCT01692704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846553|NCT01692704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64846554|NCT01692704|Immunologic Factors|immunologic factors|mesh-ancestor
64330947|NCT02203175|Fentanyl|fentanyl|mesh-list
64330948|NCT02203175|Propofol|propofol|mesh-list
64846555|NCT01692704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846557|NCT01692808|Ergocalciferols|ergocalciferols|mesh-list
64846558|NCT01692808|Cholecalciferol|cholecalciferol|mesh-list
64846559|NCT01692808|Vitamins|vitamins|mesh-list
64846560|NCT01692808|Micronutrients|micronutrients|mesh-ancestor
64846561|NCT01692808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484609|NCT02152696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64484610|NCT02152696|Immunologic Factors|immunologic factors|mesh-ancestor
64484611|NCT02152696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64484612|NCT02152696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64484614|NCT01905436|Albendazole|albendazole|mesh-list
64484615|NCT01905436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64484616|NCT01905436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64484617|NCT01905436|Anthelmintics|anthelmintics|mesh-ancestor
64484618|NCT01905436|Anticestodal Agents|anticestodal agents|mesh-ancestor
64484619|NCT01905436|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64484620|NCT01905436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64484621|NCT01905436|Tubulin Modulators|tubulin modulators|mesh-ancestor
64846562|NCT01692808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64846563|NCT01692808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64846564|NCT01692834|Cyclosporine|cyclosporine|mesh-list
64846565|NCT01692834|Cyclosporins|cyclosporins|mesh-list
64846566|NCT01692834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846567|NCT01692834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846568|NCT01692834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64846569|NCT01692834|Immunologic Factors|immunologic factors|mesh-ancestor
64846570|NCT01692834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846571|NCT01692834|Antifungal Agents|antifungal agents|mesh-ancestor
64846572|NCT01692834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64846576|NCT01692886|Vaccines|vaccines|mesh-list
64846614|NCT01693276|Mitosis Modulators|mitosis modulators|mesh-ancestor
64846615|NCT01693276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846616|NCT01693276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64846617|NCT01693276|Antimetabolites|antimetabolites|mesh-ancestor
64846618|NCT01693276|Antiviral Agents|antiviral agents|mesh-ancestor
64846619|NCT01693276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64846620|NCT01693276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846621|NCT01693276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64846622|NCT01693276|Immunologic Factors|immunologic factors|mesh-ancestor
64846623|NCT01693276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846629|NCT01693289|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64846630|NCT01693289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64846631|NCT01693289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846632|NCT01693289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846633|NCT01693289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64846634|NCT01693289|Hormone Antagonists|hormone antagonists|mesh-ancestor
64846635|NCT01693289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64846636|NCT01693302|Insulin|insulin|mesh-list
64846637|NCT01693302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64846638|NCT01693302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64846639|NCT01693302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846640|NCT01693328|Fentanyl|fentanyl|mesh-list
64846641|NCT01693328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64846642|NCT01693328|Narcotics|narcotics|mesh-ancestor
64846643|NCT01693328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64846644|NCT01693328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846645|NCT01693328|Analgesics|analgesics|mesh-ancestor
64846646|NCT01693328|Sensory System Agents|sensory system agents|mesh-ancestor
64846647|NCT01693328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64846648|NCT01693328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64846649|NCT01693328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64846650|NCT01693328|Anesthetics, General|anesthetics, general|mesh-ancestor
64846651|NCT01693328|Anesthetics|anesthetics|mesh-ancestor
64846652|NCT01693393|Cyclosporine|cyclosporine|mesh-list
64846653|NCT01693393|Cyclosporins|cyclosporins|mesh-list
64846654|NCT01693393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846655|NCT01693393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846656|NCT01693393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64846657|NCT01693393|Immunologic Factors|immunologic factors|mesh-ancestor
64846658|NCT01693393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846659|NCT01693393|Antifungal Agents|antifungal agents|mesh-ancestor
64846660|NCT01693393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64484942|NCT01724359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64484943|NCT01724359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64484944|NCT01724359|Dopamine Agents|dopamine agents|mesh-ancestor
64484945|NCT01703221|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64846661|NCT01693393|Dermatologic Agents|dermatologic agents|mesh-ancestor
64846662|NCT01693393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64846663|NCT01693393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64846664|NCT01693419|Gemcitabine|gemcitabine|mesh-list
64846665|NCT01693419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64846666|NCT01693419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64846667|NCT01693419|Antimetabolites|antimetabolites|mesh-ancestor
64846668|NCT01693419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846669|NCT01693419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846670|NCT01693419|Antiviral Agents|antiviral agents|mesh-ancestor
64846704|NCT01693679|Adefovir|adefovir|mesh-list
64846705|NCT01693679|Telbivudine|telbivudine|mesh-list
64846706|NCT01693679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64846707|NCT01693679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64846708|NCT01693679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846709|NCT01693679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846710|NCT01693679|Antiviral Agents|antiviral agents|mesh-ancestor
64846711|NCT01693679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64846712|NCT01693679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64846713|NCT01693679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64846714|NCT01693718|Fluorouracil|fluorouracil|mesh-list
64846715|NCT01693718|Hydroxyurea|hydroxyurea|mesh-list
64846716|NCT01693718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846717|NCT01693718|Antimetabolites|antimetabolites|mesh-ancestor
64485062|NCT01701973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846718|NCT01693718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846719|NCT01693718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64846720|NCT01693718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64846721|NCT01693718|Immunologic Factors|immunologic factors|mesh-ancestor
64846722|NCT01693718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846723|NCT01693718|Antisickling Agents|antisickling agents|mesh-ancestor
64846724|NCT01693718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846725|NCT01693718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64846727|NCT01693809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64846728|NCT01693809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846729|NCT01693809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64846730|NCT01693809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846731|NCT01693809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485206|NCT01943435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485207|NCT01943435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485208|NCT01943435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64485209|NCT01943435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64485210|NCT01943435|Abortifacient Agents|abortifacient agents|mesh-ancestor
64485211|NCT01943435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64485212|NCT01943435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64485213|NCT01943435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64485214|NCT01943435|Oxytocics|oxytocics|mesh-ancestor
64485215|NCT01943435|Anticonvulsants|anticonvulsants|mesh-ancestor
64485216|NCT01943435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64485217|NCT01943435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64485218|NCT01943435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64485219|NCT01943435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64485220|NCT01943435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64485221|NCT01943435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64485222|NCT01943435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64485223|NCT01943435|Antimanic Agents|antimanic agents|mesh-ancestor
64485224|NCT01943435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64485225|NCT01943435|Narcotics|narcotics|mesh-ancestor
64485226|NCT01943435|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64485227|NCT01943435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64296611|NCT02867384|Obinutuzumab|obinutuzumab|mesh-list
64846732|NCT01693809|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64846733|NCT01693809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64846734|NCT01693809|Purinergic Agents|purinergic agents|mesh-ancestor
64846735|NCT01693809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64846736|NCT01693822|Axitinib|axitinib|mesh-list
64846737|NCT01693822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846738|NCT01693822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64846739|NCT01693822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846740|NCT01693822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846741|NCT01694017|Tenofovir|tenofovir|mesh-list
64846742|NCT01694017|Zidovudine|zidovudine|mesh-list
64846743|NCT01694017|Antiviral Agents|antiviral agents|mesh-ancestor
64846744|NCT01694017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64846745|NCT01694017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64846746|NCT01694017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64846747|NCT01694017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485228|NCT01943435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64485229|NCT01943435|Dopamine Agents|dopamine agents|mesh-ancestor
64485230|NCT01943435|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64485245|NCT01942733|Brexpiprazole|brexpiprazole|mesh-list
64846748|NCT01694017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846749|NCT01694017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64846750|NCT01694017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64846751|NCT01694017|Antimetabolites|antimetabolites|mesh-ancestor
64846752|NCT05288829|Ravulizumab|ravulizumab|mesh-list
64846753|NCT05288829|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64846754|NCT05288829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64846755|NCT05288829|Immunologic Factors|immunologic factors|mesh-ancestor
64846756|NCT05288829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846757|NCT05288816|Ravulizumab|ravulizumab|mesh-list
64846758|NCT05288816|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64485338|NCT00832390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64846759|NCT05288816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64846760|NCT05288816|Immunologic Factors|immunologic factors|mesh-ancestor
64846761|NCT05288816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846762|NCT05288738|Dexmedetomidine|dexmedetomidine|mesh-list
64846763|NCT05288738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64846764|NCT05288738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64846765|NCT05288738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846766|NCT05288738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64846767|NCT05288738|Analgesics|analgesics|mesh-ancestor
64846768|NCT05288738|Sensory System Agents|sensory system agents|mesh-ancestor
64846769|NCT05288738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64846770|NCT05288738|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64846771|NCT05288738|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64846772|NCT05288738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64846773|NCT05288738|Adrenergic Agents|adrenergic agents|mesh-ancestor
64846774|NCT05288738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64846775|NCT05288738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846776|NCT05288725|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64846777|NCT05288725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64846778|NCT05288725|Glucocorticoids|glucocorticoids|mesh-ancestor
64846779|NCT05288725|Hormones|hormones|mesh-ancestor
64846780|NCT05288725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64846781|NCT05288725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846796|NCT05288465|Protective Agents|protective agents|mesh-ancestor
64846797|NCT05288465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846798|NCT05288465|Nootropic Agents|nootropic agents|mesh-ancestor
64846799|NCT05288374|Celecoxib|celecoxib|mesh-list
64846800|NCT05288374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64485515|NCT00838162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485516|NCT00838162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485517|NCT00838162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64846801|NCT05288374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64846802|NCT05288374|Analgesics|analgesics|mesh-ancestor
64846803|NCT05288374|Sensory System Agents|sensory system agents|mesh-ancestor
64846804|NCT05288374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64846805|NCT05288374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846806|NCT05288374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64846807|NCT05288374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64846808|NCT05288374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64846809|NCT05288374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64846810|NCT05288374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846811|NCT05288374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846812|NCT05288192|Triamcinolone|triamcinolone|mesh-list
64485620|NCT03696784|Cyclophosphamide|cyclophosphamide|mesh-list
64485622|NCT03696784|Fludarabine|fludarabine|mesh-list
64846827|NCT05288179|Sensory System Agents|sensory system agents|mesh-ancestor
64846828|NCT05288179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64846836|NCT05288127|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64846837|NCT05288127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846838|NCT05288127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846839|NCT05288127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846840|NCT05291455|Lacosamide|lacosamide|mesh-list
64846841|NCT05291455|Phenobarbital|phenobarbital|mesh-list
64846842|NCT05291455|Anticonvulsants|anticonvulsants|mesh-ancestor
64846843|NCT05291455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64846844|NCT05291455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64846845|NCT05291455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64846846|NCT05291455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485767|NCT01857934|Busulfan|busulfan|mesh-list
64846847|NCT05291455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64846848|NCT05291455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64846849|NCT05291455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846850|NCT05291455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64846851|NCT05291455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64846852|NCT05291455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64846853|NCT05291455|GABA Modulators|gaba modulators|mesh-ancestor
64846854|NCT05291455|GABA Agents|gaba agents|mesh-ancestor
64846855|NCT05291455|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64846856|NCT05291455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64485864|NCT00863434|Antimetabolites|antimetabolites|mesh-ancestor
64485866|NCT00863434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846857|NCT05291455|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64846858|NCT05291195|Sodium Hypochlorite|sodium hypochlorite|mesh-list
64846860|NCT05291195|Disinfectants|disinfectants|mesh-ancestor
64846861|NCT05291195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64846862|NCT05291130|Vitamin E|vitamin e|mesh-list
64846863|NCT05291130|Vitamins|vitamins|mesh-ancestor
64846864|NCT05291130|Micronutrients|micronutrients|mesh-ancestor
64846865|NCT05291130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846866|NCT05291130|Antioxidants|antioxidants|mesh-ancestor
64846867|NCT05291130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846868|NCT05291130|Protective Agents|protective agents|mesh-ancestor
64846869|NCT05291104|Folic Acid|folic acid|mesh-list
64846870|NCT05291104|Choline|choline|mesh-list
64846871|NCT05291104|Hematinics|hematinics|mesh-ancestor
64846872|NCT05291104|Vitamin B Complex|vitamin b complex|mesh-ancestor
64846873|NCT05291104|Vitamins|vitamins|mesh-ancestor
64486027|NCT01933217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64486028|NCT01933217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64486075|NCT01592695|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64486076|NCT01592695|Autonomic Agents|autonomic agents|mesh-ancestor
64486077|NCT01592695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64486078|NCT01592695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486079|NCT01592695|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64486080|NCT01592695|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64846874|NCT05291104|Micronutrients|micronutrients|mesh-ancestor
64846875|NCT05291104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846876|NCT05291104|Lipotropic Agents|lipotropic agents|mesh-ancestor
64846877|NCT05291104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64846878|NCT05291104|Antimetabolites|antimetabolites|mesh-ancestor
64846879|NCT05291104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846880|NCT05291104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64846881|NCT05291104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64846882|NCT05291104|Nootropic Agents|nootropic agents|mesh-ancestor
64846883|NCT05291052|Capecitabine|capecitabine|mesh-list
64846884|NCT05291052|Oxaliplatin|oxaliplatin|mesh-list
64846885|NCT05291052|Lenvatinib|lenvatinib|mesh-list
64846886|NCT05291052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64846887|NCT05291052|Antimetabolites|antimetabolites|mesh-ancestor
64846888|NCT05291052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846889|NCT05291052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846890|NCT05291052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64846891|NCT05291052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846892|NCT05290948|Bevacizumab|bevacizumab|mesh-list
64846913|NCT05290935|Antimitotic Agents|antimitotic agents|mesh-ancestor
64846914|NCT05290935|Mitosis Modulators|mitosis modulators|mesh-ancestor
64846915|NCT05290935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846916|NCT05290935|Immunologic Factors|immunologic factors|mesh-ancestor
64846917|NCT05290935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846919|NCT05290857|Coagulants|coagulants|mesh-ancestor
64846920|NCT05290506|Linagliptin|linagliptin|mesh-list
64846921|NCT05290506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64846922|NCT05290506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64846923|NCT05290506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846924|NCT05290506|Incretins|incretins|mesh-ancestor
64846925|NCT05290506|Hormones|hormones|mesh-ancestor
64486472|NCT01913327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64486473|NCT01913327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64846926|NCT05290506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64846927|NCT05290506|Protease Inhibitors|protease inhibitors|mesh-ancestor
64846928|NCT05290506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846929|NCT05290506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846930|NCT05290337|Zanubrutinib|zanubrutinib|mesh-list
64846931|NCT05290337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846932|NCT05290337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64846933|NCT05290337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64846934|NCT05290337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846935|NCT05290324|Midazolam|midazolam|mesh-list
64846936|NCT05290324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64846937|NCT05290324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64486700|NCT01903811|Autonomic Agents|autonomic agents|mesh-ancestor
64846938|NCT05290324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64846939|NCT05290324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846940|NCT05290324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64330949|NCT02203175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64330950|NCT02203175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64330951|NCT02203175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330952|NCT02203175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64330953|NCT02203175|Anesthetics, General|anesthetics, general|mesh-ancestor
64330954|NCT02203175|Anesthetics|anesthetics|mesh-ancestor
64330955|NCT02203175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64330956|NCT02203175|Narcotics|narcotics|mesh-ancestor
64330957|NCT02203175|Analgesics|analgesics|mesh-ancestor
64330958|NCT02203175|Sensory System Agents|sensory system agents|mesh-ancestor
64330959|NCT02203175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330960|NCT02203175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64330961|NCT05791799|Etonogestrel|etonogestrel|mesh-list
64330962|NCT05791799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64330963|NCT05791799|Contraceptive Agents|contraceptive agents|mesh-ancestor
64486943|NCT00889330|Histamine Agents|histamine agents|mesh-ancestor
64330964|NCT05791799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64846941|NCT05290324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64846942|NCT05290324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64846943|NCT05290324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64846944|NCT05290324|Anesthetics, General|anesthetics, general|mesh-ancestor
64846946|NCT05290324|GABA Modulators|gaba modulators|mesh-ancestor
64846951|NCT05290090|Lenalidomide|lenalidomide|mesh-list
64846952|NCT05290090|Zanubrutinib|zanubrutinib|mesh-list
64846953|NCT05290090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64846954|NCT05290090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64846955|NCT05290090|Immunologic Factors|immunologic factors|mesh-ancestor
64846956|NCT05290090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64846957|NCT05290090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64846958|NCT05290090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64846959|NCT05290090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64846960|NCT05290090|Growth Substances|growth substances|mesh-ancestor
64846961|NCT05290090|Growth Inhibitors|growth inhibitors|mesh-ancestor
64846962|NCT05290090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64846963|NCT05290090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487134|NCT00903448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64846964|NCT05290090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64846965|NCT05292742|Capecitabine|capecitabine|mesh-list
64846966|NCT05292742|Trastuzumab|trastuzumab|mesh-list
64846991|NCT05291793|Prednisolone acetate|prednisolone acetate|mesh-list
64846993|NCT05291793|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64846994|NCT05291793|Prednisolone phosphate|prednisolone phosphate|mesh-list
64846995|NCT05291793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64846996|NCT05291793|Antiemetics|antiemetics|mesh-ancestor
64846997|NCT05291793|Autonomic Agents|autonomic agents|mesh-ancestor
64846998|NCT05291793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64846999|NCT05291793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847000|NCT05291793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64847001|NCT05291793|Glucocorticoids|glucocorticoids|mesh-ancestor
64847002|NCT05291793|Hormones|hormones|mesh-ancestor
64847003|NCT05291793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64847004|NCT05291793|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64847005|NCT05291793|Protective Agents|protective agents|mesh-ancestor
64847006|NCT05291793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64847007|NCT05291793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847008|NCT05291793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64847009|NCT05291793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64847010|NCT05291793|Analgesics|analgesics|mesh-ancestor
64847011|NCT05291793|Sensory System Agents|sensory system agents|mesh-ancestor
64847012|NCT05291793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64847013|NCT05291793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64847014|NCT05291793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64847015|NCT05291793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847016|NCT05294926|Rocuronium|rocuronium|mesh-list
64487601|NCT01672671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64847017|NCT05294926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64847018|NCT05294926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64847019|NCT05294926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64847020|NCT05294926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64847021|NCT05294926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847022|NCT05294887|Bisoprolol|bisoprolol|mesh-list
64847023|NCT05294887|Diltiazem|diltiazem|mesh-list
64847024|NCT05294887|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64847025|NCT05294887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64847043|NCT05294744|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64847044|NCT05294744|Antiviral Agents|antiviral agents|mesh-ancestor
64847045|NCT05294744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64847047|NCT05294744|Respiratory System Agents|respiratory system agents|mesh-ancestor
64847048|NCT05294744|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64847049|NCT05294744|Antioxidants|antioxidants|mesh-ancestor
64847050|NCT05294744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847051|NCT05294744|Protective Agents|protective agents|mesh-ancestor
64847053|NCT05294744|Antidotes|antidotes|mesh-ancestor
64847073|NCT05294666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64847075|NCT05294640|Epinephrine|epinephrine|mesh-list
64847076|NCT05294640|Anesthetics, Local|anesthetics, local|mesh-list
64847077|NCT05294640|Anesthetics|anesthetics|mesh-list
64847078|NCT05294640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64847079|NCT05294640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847080|NCT05294640|Sensory System Agents|sensory system agents|mesh-ancestor
64847081|NCT05294640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64487770|NCT01726192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64487772|NCT01726192|Sensory System Agents|sensory system agents|mesh-ancestor
64847082|NCT05294640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64847083|NCT05294640|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64847084|NCT05294640|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64847085|NCT05294640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64847086|NCT05294640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847087|NCT05294640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64847088|NCT05294640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64847089|NCT05294640|Adrenergic Agents|adrenergic agents|mesh-ancestor
64847090|NCT05294640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64847091|NCT05294640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64847092|NCT05294640|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64847093|NCT05294640|Autonomic Agents|autonomic agents|mesh-ancestor
64847094|NCT05294640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64847107|NCT05294484|Diuretics|diuretics|mesh-ancestor
64847108|NCT05294484|Natriuretic Agents|natriuretic agents|mesh-ancestor
64847109|NCT05294484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847110|NCT05294484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64847111|NCT05294484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64847112|NCT05294484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847113|NCT05294406|Piperaquine|piperaquine|mesh-list
64847114|NCT05294406|Artenimol|artenimol|mesh-list
64847115|NCT05294406|Antimalarials|antimalarials|mesh-ancestor
64847116|NCT05294406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64847117|NCT05294406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64847118|NCT05294406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64847119|NCT05294393|Magnesium Sulfate|magnesium sulfate|mesh-list
64847120|NCT05294393|Ropivacaine|ropivacaine|mesh-list
64847121|NCT05294393|Anesthetics, Local|anesthetics, local|mesh-ancestor
64847122|NCT05294393|Anesthetics|anesthetics|mesh-ancestor
64847127|NCT05294393|Analgesics|analgesics|mesh-ancestor
64488105|NCT03834610|Tadalafil|tadalafil|mesh-list
64488106|NCT03834610|Testosterone|testosterone|mesh-list
64847143|NCT05293808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64847144|NCT05293808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847145|NCT05293808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64847147|NCT05293808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64847148|NCT05293808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64847149|NCT05293808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847150|NCT05293808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64847151|NCT05293808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64847152|NCT05293808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64847153|NCT05293808|Antipyretics|antipyretics|mesh-ancestor
64847154|NCT05293704|Mizoribine|mizoribine|mesh-list
64847155|NCT05293704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64847156|NCT05293704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64847157|NCT05293704|Analgesics|analgesics|mesh-ancestor
64847158|NCT05293704|Sensory System Agents|sensory system agents|mesh-ancestor
64847159|NCT05293704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64847160|NCT05293704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847161|NCT05293704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64847162|NCT05293704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64847163|NCT05293704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64847164|NCT05293704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64847165|NCT05293704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64847166|NCT05293704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847167|NCT05293704|Antimalarials|antimalarials|mesh-ancestor
64847168|NCT05293704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64847169|NCT05293704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64847170|NCT05293704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64847171|NCT05293704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847172|NCT05293704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64847173|NCT05293704|Immunologic Factors|immunologic factors|mesh-ancestor
64847174|NCT05293574|Norethindrone|norethindrone|mesh-list
64488308|NCT02241148|Acetaminophen|acetaminophen|mesh-list
64847175|NCT05293574|Norethindrone Acetate|norethindrone acetate|mesh-list
64847176|NCT05293574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64847177|NCT05293574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64847178|NCT05293574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64847179|NCT05293574|Contraceptive Agents|contraceptive agents|mesh-ancestor
64847180|NCT05293574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64330974|NCT05791721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64330975|NCT05791721|Glucocorticoids|glucocorticoids|mesh-ancestor
64330977|NCT05791721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64330978|NCT05791721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64330979|NCT05791721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847193|NCT05293132|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64847194|NCT05293132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64488520|NCT03405064|Linezolid|linezolid|mesh-list
64847195|NCT05293132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847196|NCT05293132|Vitamins|vitamins|mesh-ancestor
64847197|NCT05293132|Micronutrients|micronutrients|mesh-ancestor
64847198|NCT05293119|Mometasone Furoate|mometasone furoate|mesh-list
64847199|NCT05293119|Tofacitinib|tofacitinib|mesh-list
64847200|NCT05293119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64847201|NCT05293119|Dermatologic Agents|dermatologic agents|mesh-ancestor
64847202|NCT05293119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64847203|NCT05293119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64847204|NCT05293119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64847205|NCT05293119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847206|NCT05293080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64847207|NCT05296863|Minoxidil|minoxidil|mesh-list
64847208|NCT05296863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64847209|NCT05296863|Vasodilator Agents|vasodilator agents|mesh-ancestor
64847210|NCT05296564|Aldesleukin|aldesleukin|mesh-list
64847211|NCT05296564|Cyclophosphamide|cyclophosphamide|mesh-list
64847212|NCT05296564|Interleukin-2|interleukin-2|mesh-list
64847213|NCT05296564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64331087|NCT05790629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64331088|NCT05790629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331089|NCT05790629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64331091|NCT05790603|Coagulants|coagulants|mesh-ancestor
64331092|NCT05790577|Niacinamide|niacinamide|mesh-list
64331094|NCT05790577|Nicotinic Acids|nicotinic acids|mesh-list
64331095|NCT05790577|Metformin|metformin|mesh-list
64331096|NCT05790577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64488788|NCT02243098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64331097|NCT05790577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331098|NCT05790577|Vitamin B Complex|vitamin b complex|mesh-ancestor
64331099|NCT05790577|Vitamins|vitamins|mesh-ancestor
64331100|NCT05790577|Micronutrients|micronutrients|mesh-ancestor
64331101|NCT05790577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64331102|NCT05790577|Antimetabolites|antimetabolites|mesh-ancestor
64331103|NCT05790577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331104|NCT05790577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64294498|NCT02814565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64847287|NCT05280405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64847288|NCT05280405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64847289|NCT05275647|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64847290|NCT05275647|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64847291|NCT05275647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64488951|NCT02243644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488952|NCT02243644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64488953|NCT01988883|Propranolol|propranolol|mesh-list
64488954|NCT01988883|Modafinil|modafinil|mesh-list
64847292|NCT05275647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847293|NCT05275647|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64847294|NCT05275647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64847295|NCT05275647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847296|NCT05275647|Cholinergic Agents|cholinergic agents|mesh-ancestor
64847297|NCT05275647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64847300|NCT05273242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847301|NCT05273242|Dermatologic Agents|dermatologic agents|mesh-ancestor
64847302|NCT05273242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64847303|NCT05273242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64847304|NCT05273242|Antimalarials|antimalarials|mesh-ancestor
64847305|NCT05273242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64847306|NCT05273242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64847327|NCT05267938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847328|NCT05267938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64847329|NCT05267938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64847330|NCT05267938|Adrenergic Agents|adrenergic agents|mesh-ancestor
64847331|NCT05267938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64847332|NCT05267938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64847333|NCT05267938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64847334|NCT05267938|Autonomic Agents|autonomic agents|mesh-ancestor
64847335|NCT05267938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64847336|NCT05267938|Respiratory System Agents|respiratory system agents|mesh-ancestor
64847337|NCT05267938|Mydriatics|mydriatics|mesh-ancestor
64847338|NCT05267938|Sympathomimetics|sympathomimetics|mesh-ancestor
64847339|NCT05267938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64847340|NCT05267431|Methotrexate|methotrexate|mesh-list
64847341|NCT05267431|Hydroquinone|hydroquinone|mesh-list
64489437|NCT04371874|Analgesics|analgesics|mesh-ancestor
64847342|NCT05267431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64847343|NCT05267431|Abortifacient Agents|abortifacient agents|mesh-ancestor
64847344|NCT05267431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64847345|NCT05267431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847346|NCT05267431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64847347|NCT05267431|Antimetabolites|antimetabolites|mesh-ancestor
64847348|NCT05267431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847349|NCT05267431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847350|NCT05267431|Dermatologic Agents|dermatologic agents|mesh-ancestor
64847351|NCT05267431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64847352|NCT05267431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64489658|NCT05620654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64489664|NCT03692325|Nivolumab|nivolumab|mesh-list
64847377|NCT05264896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847378|NCT05264896|Antidotes|antidotes|mesh-ancestor
64847379|NCT05264896|Protective Agents|protective agents|mesh-ancestor
64847380|NCT05264896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847381|NCT05264896|Vitamin B Complex|vitamin b complex|mesh-ancestor
64847382|NCT05264896|Vitamins|vitamins|mesh-ancestor
64847383|NCT05264896|Micronutrients|micronutrients|mesh-ancestor
64847384|NCT05264584|Acetylcysteine|acetylcysteine|mesh-list
64847385|NCT05264584|Febuxostat|febuxostat|mesh-list
64847386|NCT05264584|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64847387|NCT05264584|Antiviral Agents|antiviral agents|mesh-ancestor
64847388|NCT05264584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64847389|NCT05264584|Expectorants|expectorants|mesh-ancestor
64847390|NCT05264584|Respiratory System Agents|respiratory system agents|mesh-ancestor
64847391|NCT05264584|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64847392|NCT05264584|Antioxidants|antioxidants|mesh-ancestor
64847393|NCT05264584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847394|NCT05264584|Protective Agents|protective agents|mesh-ancestor
64847395|NCT05264584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847396|NCT05264584|Antidotes|antidotes|mesh-ancestor
64847397|NCT05264584|Gout Suppressants|gout suppressants|mesh-ancestor
64847398|NCT05264584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64847399|NCT05262686|Aldesleukin|aldesleukin|mesh-list
64847400|NCT05262686|Interleukin-2|interleukin-2|mesh-list
64847409|NCT05262686|Immunologic Factors|immunologic factors|mesh-ancestor
64847410|NCT05262686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64847411|NCT05262686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64847412|NCT05262686|Antiviral Agents|antiviral agents|mesh-ancestor
64847413|NCT05262686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64847415|NCT05238506|Anesthetics, Local|anesthetics, local|mesh-ancestor
64847416|NCT05238506|Anesthetics|anesthetics|mesh-ancestor
64847417|NCT05238506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64847418|NCT05238506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847419|NCT05238506|Sensory System Agents|sensory system agents|mesh-ancestor
64847420|NCT05238506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64490377|NCT04360876|Glucocorticoids|glucocorticoids|mesh-ancestor
64847421|NCT05238506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64847422|NCT05238506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64847423|NCT05238506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64847424|NCT05238506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64847425|NCT05238506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847427|NCT05236608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64847428|NCT05236608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847429|NCT05236608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64847430|NCT05236608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847431|NCT05225402|Norepinephrine|norepinephrine|mesh-list
64847432|NCT05225402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64847433|NCT05225402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64847434|NCT05225402|Adrenergic Agents|adrenergic agents|mesh-ancestor
64490537|NCT01670565|Antitubercular Agents|antitubercular agents|mesh-ancestor
64847435|NCT05225402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64847436|NCT05225402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847447|NCT05220826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847448|NCT05220826|Plant Growth Regulators|plant growth regulators|mesh-ancestor
64847449|NCT05220826|Growth Substances|growth substances|mesh-ancestor
64847450|NCT05210413|Spartalizumab|spartalizumab|mesh-list
64294512|NCT05121038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64847467|NCT05192629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64847469|NCT05192629|Sensory System Agents|sensory system agents|mesh-ancestor
64847470|NCT05192629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64847471|NCT05192629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64847472|NCT05192629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64847473|NCT05192629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64847474|NCT05192629|Adrenergic Agents|adrenergic agents|mesh-ancestor
64847475|NCT05192629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64847476|NCT05192629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847477|NCT05192629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64847478|NCT05192629|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64847479|NCT05192629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64847480|NCT05192629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64847481|NCT05192629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64847482|NCT05192629|Anesthetics, General|anesthetics, general|mesh-ancestor
64490750|NCT03031756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490751|NCT00944710|Atropine|atropine|mesh-list
64847484|NCT05192629|GABA Modulators|gaba modulators|mesh-ancestor
64847485|NCT05192629|GABA Agents|gaba agents|mesh-ancestor
64847486|NCT05189444|Amoxicillin|amoxicillin|mesh-list
64847487|NCT05189444|Clarithromycin|clarithromycin|mesh-list
64847488|NCT05189444|Potassium Citrate|potassium citrate|mesh-list
64847489|NCT05189444|Esomeprazole|esomeprazole|mesh-list
64847490|NCT05189444|Bismuth|bismuth|mesh-list
64847491|NCT05189444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847492|NCT05189444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64847493|NCT05189444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64847494|NCT05189444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64847495|NCT05189444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64847496|NCT05189444|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64847497|NCT05189444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64847498|NCT05189444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64847499|NCT05189444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64847500|NCT05189444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64847502|NCT05189444|Diuretics|diuretics|mesh-ancestor
64847525|NCT05169268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64847526|NCT05169268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847527|NCT05169268|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64847528|NCT05169268|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64847529|NCT05169268|Serotonin Agents|serotonin agents|mesh-ancestor
64847530|NCT05169268|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64491032|NCT04402047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847531|NCT05169268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64847532|NCT05169268|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64847533|NCT05169268|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64847534|NCT05129137|Acetaminophen|acetaminophen|mesh-list
64847535|NCT05129137|Nefopam|nefopam|mesh-list
64847536|NCT05129137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64847537|NCT05129137|Analgesics|analgesics|mesh-ancestor
64847538|NCT05129137|Sensory System Agents|sensory system agents|mesh-ancestor
64847539|NCT05129137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64847540|NCT05129137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847541|NCT05129137|Antipyretics|antipyretics|mesh-ancestor
64847542|NCT05114980|Parathyroid Hormone|parathyroid hormone|mesh-list
64847543|NCT05114980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64491285|NCT01678599|Benzonidazole|benzonidazole|mesh-list
64491293|NCT03019822|Amphetamine|amphetamine|mesh-list
64847544|NCT05114980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847545|NCT05110898|Olmesartan|olmesartan|mesh-list
64847546|NCT05110898|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64847547|NCT05110898|Indapamide|indapamide|mesh-list
64847548|NCT05110898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64847549|NCT05110898|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64847550|NCT05110898|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64847551|NCT05110898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847552|NCT05110898|Diuretics|diuretics|mesh-ancestor
64847553|NCT05110898|Natriuretic Agents|natriuretic agents|mesh-ancestor
64847554|NCT05110898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847555|NCT05110898|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64847556|NCT05110898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64847557|NCT05103696|Propofol|propofol|mesh-list
64847558|NCT05103696|Etomidate|etomidate|mesh-list
64847559|NCT05103696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64491557|NCT03089073|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64847560|NCT05103696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64847561|NCT05103696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847562|NCT05103696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64847563|NCT05103696|Anesthetics, General|anesthetics, general|mesh-ancestor
64847564|NCT05103696|Anesthetics|anesthetics|mesh-ancestor
64847565|NCT05098041|Rifampin|rifampin|mesh-list
64847566|NCT05098041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64847567|NCT05098041|Antitubercular Agents|antitubercular agents|mesh-ancestor
64847568|NCT05098041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64847569|NCT05098041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64847570|NCT05098041|Leprostatic Agents|leprostatic agents|mesh-ancestor
64847571|NCT05098041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64847572|NCT05098041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64847573|NCT05098041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847574|NCT05098041|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64847575|NCT05098041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64847576|NCT05098041|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64847577|NCT05098041|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64847578|NCT05098041|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64847579|NCT05098041|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64847580|NCT05096325|Insulin|insulin|mesh-list
64847581|NCT05096325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64847582|NCT05096325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847583|NCT05096065|Leuprolide|leuprolide|mesh-list
64847606|NCT05030025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64847607|NCT05030025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64847608|NCT05030025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64847609|NCT05030025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847610|NCT05030025|Antiviral Agents|antiviral agents|mesh-ancestor
64847611|NCT05030025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64491672|NCT04400721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64491673|NCT04400721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491674|NCT04400721|Sensory System Agents|sensory system agents|mesh-ancestor
64491675|NCT04400721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64491677|NCT01010932|Chelating Agents|chelating agents|mesh-ancestor
64491713|NCT03387501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491714|NCT01012492|Abatacept|abatacept|mesh-list
64491715|NCT01012492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64847612|NCT05030025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64847613|NCT05030025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64847614|NCT05030025|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64847615|NCT05030025|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64847616|NCT05030025|Antimetabolites|antimetabolites|mesh-ancestor
64847617|NCT05013567|Ibuprofen|ibuprofen|mesh-list
64847647|NCT04984044|Cholecalciferol|cholecalciferol|mesh-list
64847648|NCT04984044|Vitamins|vitamins|mesh-ancestor
64847649|NCT04984044|Micronutrients|micronutrients|mesh-ancestor
64331113|NCT05790499|Antimetabolites|antimetabolites|mesh-ancestor
64331114|NCT05790499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331115|NCT05790499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64331116|NCT05790499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64847650|NCT04984044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847651|NCT04984044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64847652|NCT04984044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64847653|NCT04975802|Caffeine|caffeine|mesh-list
64847654|NCT04975802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64847655|NCT04975802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847656|NCT04975802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64491806|NCT02162680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64847657|NCT04975802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64847658|NCT04975802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847659|NCT04975802|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64847660|NCT04975802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64847661|NCT04975802|Purinergic Agents|purinergic agents|mesh-ancestor
64847662|NCT04975802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64847663|NCT04964700|Natalizumab|natalizumab|mesh-list
64847664|NCT04964700|Immunologic Factors|immunologic factors|mesh-ancestor
64331117|NCT05790499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331118|NCT05790486|Nicotine|nicotine|mesh-list
64331119|NCT05790486|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64331120|NCT05790486|Autonomic Agents|autonomic agents|mesh-ancestor
64331121|NCT05790486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64331122|NCT05790486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331123|NCT05790486|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64331124|NCT05790486|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64331125|NCT05790486|Cholinergic Agents|cholinergic agents|mesh-ancestor
64331126|NCT05790486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64491932|NCT03358563|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64491933|NCT03358563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64491934|NCT01018420|Moxifloxacin|moxifloxacin|mesh-list
64331127|NCT05790486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331128|NCT05790447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64331129|NCT05790447|Thymalfasin|thymalfasin|mesh-list
64331130|NCT05790447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64331131|NCT05790447|Immunologic Factors|immunologic factors|mesh-ancestor
64331132|NCT05790447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331133|NCT05790447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331134|NCT05790447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847695|NCT04897802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64847696|NCT04897802|Incretins|incretins|mesh-ancestor
64847697|NCT04897802|Hormones|hormones|mesh-ancestor
64847698|NCT04897802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64847699|NCT04883749|Acalabrutinib|acalabrutinib|mesh-list
64331149|NCT05790330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64331150|NCT05790330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64847700|NCT04883749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847701|NCT04882332|Vitamin B 12|vitamin b 12|mesh-list
64847702|NCT04882332|Hydroxocobalamin|hydroxocobalamin|mesh-list
64847703|NCT04882332|Vitamins|vitamins|mesh-ancestor
64847704|NCT04882332|Micronutrients|micronutrients|mesh-ancestor
64847705|NCT04882332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847706|NCT04882332|Vitamin B Complex|vitamin b complex|mesh-ancestor
64492069|NCT01024972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64492070|NCT05686395|Bupivacaine|bupivacaine|mesh-list
64492071|NCT05686395|Anesthetics, Local|anesthetics, local|mesh-ancestor
64847707|NCT04882332|Hematinics|hematinics|mesh-ancestor
64847708|NCT04882202|Acetaminophen|acetaminophen|mesh-list
64847709|NCT04882202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64847710|NCT04882202|Analgesics|analgesics|mesh-ancestor
64847711|NCT04882202|Sensory System Agents|sensory system agents|mesh-ancestor
64847712|NCT04882202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64847755|NCT04774315|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64331207|NCT05789173|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64331208|NCT05789173|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64331209|NCT05789173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64331210|NCT05789173|Narcotics|narcotics|mesh-ancestor
64331211|NCT05789173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64331212|NCT05789173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492122|NCT03348969|Mitomycins|mitomycins|mesh-list
64847790|NCT04750967|Adrenergic Agents|adrenergic agents|mesh-ancestor
64847791|NCT04750967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64847802|NCT04707235|Antisickling Agents|antisickling agents|mesh-ancestor
64847803|NCT04707235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331213|NCT05789173|Analgesics|analgesics|mesh-ancestor
64331214|NCT05789173|Sensory System Agents|sensory system agents|mesh-ancestor
64331215|NCT05789173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64331216|NCT05789173|Antitussive Agents|antitussive agents|mesh-ancestor
64331217|NCT05789173|Respiratory System Agents|respiratory system agents|mesh-ancestor
64331218|NCT05789173|Anticonvulsants|anticonvulsants|mesh-ancestor
64331219|NCT05789173|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64331220|NCT05789173|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64492288|NCT03016234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64492289|NCT03016234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64331221|NCT05789173|Parasympatholytics|parasympatholytics|mesh-ancestor
64331222|NCT05789173|Autonomic Agents|autonomic agents|mesh-ancestor
64331223|NCT05789173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64331224|NCT05789173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64331225|NCT05789173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64331226|NCT05789173|Adrenergic Agents|adrenergic agents|mesh-ancestor
64331229|NCT05789173|Sympatholytics|sympatholytics|mesh-ancestor
64331230|NCT05786716|Trastuzumab|trastuzumab|mesh-list
64847804|NCT04707235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847805|NCT04707235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64847806|NCT04696380|Nicotine|nicotine|mesh-list
64847807|NCT04696380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64847808|NCT04696380|Autonomic Agents|autonomic agents|mesh-ancestor
64847809|NCT04696380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64847810|NCT04696380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847811|NCT04696380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64847812|NCT04696380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64331231|NCT05786716|Pertuzumab|pertuzumab|mesh-list
64331232|NCT05786716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64492461|NCT01886105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64331233|NCT05786716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331234|NCT05786599|Methadone|methadone|mesh-list
64331246|NCT05785767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331247|NCT05782361|Pembrolizumab|pembrolizumab|mesh-list
64331249|NCT05782361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64331250|NCT05782361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331251|NCT05770180|Vaccines|vaccines|mesh-list
64331252|NCT05770180|Immunologic Factors|immunologic factors|mesh-ancestor
64331253|NCT05770180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331254|NCT05768178|Vemurafenib|vemurafenib|mesh-list
64331255|NCT05768178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331256|NCT05768178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64492681|NCT04763343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64492683|NCT04763343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64331257|NCT05768178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331258|NCT05768178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331259|NCT05746481|Carboplatin|carboplatin|mesh-list
64847836|NCT04659941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64847837|NCT04659941|Immunologic Factors|immunologic factors|mesh-ancestor
64847838|NCT04659941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847840|NCT04659382|Atezolizumab|atezolizumab|mesh-list
64847841|NCT04659382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64847842|NCT04659382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64847843|NCT04659382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64847844|NCT04659382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64847845|NCT04659382|Growth Substances|growth substances|mesh-ancestor
64847846|NCT04659382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847847|NCT04659382|Growth Inhibitors|growth inhibitors|mesh-ancestor
64847848|NCT04658823|Vitamin E|vitamin e|mesh-list
64847849|NCT04658823|Tocopherols|tocopherols|mesh-list
64331263|NCT05746481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331264|NCT05746481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331265|NCT05746481|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64331266|NCT05746481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64331267|NCT05729139|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64331268|NCT05729139|Interferon alpha-2|interferon alpha-2|mesh-list
64492980|NCT05168865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492981|NCT05168865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64492983|NCT05168865|Progestins|progestins|mesh-ancestor
64331269|NCT05729139|Cemiplimab|cemiplimab|mesh-list
64331270|NCT05729139|Antiviral Agents|antiviral agents|mesh-ancestor
64331271|NCT05729139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64331272|NCT05729139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64847985|NCT04464577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64847986|NCT04464577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64847987|NCT04464577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64847988|NCT04464577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64847989|NCT04464577|Dopamine Agents|dopamine agents|mesh-ancestor
64847990|NCT04464577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64847991|NCT04464577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64847992|NCT04464577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64847993|NCT04464577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64847994|NCT04464577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331332|NCT05643170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64331333|NCT05643170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493156|NCT03280017|Ketamine|ketamine|mesh-list
64331334|NCT05643170|Urological Agents|urological agents|mesh-ancestor
64331335|NCT05643170|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64331336|NCT05643170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64331337|NCT05643170|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64331338|NCT05643170|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64847996|NCT04464577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64847997|NCT04464577|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64847998|NCT04464577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64847999|NCT04464577|Hormone Antagonists|hormone antagonists|mesh-ancestor
64848000|NCT04464577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64848025|NCT04391179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848026|NCT04391179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64848069|NCT04294147|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64848070|NCT04294147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848072|NCT04294147|Sensory System Agents|sensory system agents|mesh-ancestor
64848073|NCT04294147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64848074|NCT04294147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848075|NCT04292873|Vitamin D|vitamin d|mesh-list
64848076|NCT04292873|Vitamins|vitamins|mesh-ancestor
64848077|NCT04292873|Micronutrients|micronutrients|mesh-ancestor
64848078|NCT04292873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848079|NCT04292873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64848080|NCT04264637|Azelastine|azelastine|mesh-list
64848081|NCT04264637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64848082|NCT04264637|Autonomic Agents|autonomic agents|mesh-ancestor
64848083|NCT04264637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64848084|NCT04264637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848085|NCT04264637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64848086|NCT04264637|Respiratory System Agents|respiratory system agents|mesh-ancestor
64848087|NCT04264637|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64848088|NCT04264637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493250|NCT04333407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64848089|NCT04264637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848090|NCT04264637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64331369|NCT05530421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64331370|NCT05530421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331372|NCT05526755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331373|NCT05526755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64331374|NCT05526755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331376|NCT05523596|Benzonidazole|benzonidazole|mesh-list
64848104|NCT04262687|Growth Substances|growth substances|mesh-ancestor
64848105|NCT04262687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848106|NCT04262687|Growth Inhibitors|growth inhibitors|mesh-ancestor
64848107|NCT04262687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64848108|NCT04262687|Antimetabolites|antimetabolites|mesh-ancestor
64848109|NCT04262687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848110|NCT04238546|Sirolimus|sirolimus|mesh-list
64848111|NCT04238546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64848112|NCT04238546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64848113|NCT04238546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64848114|NCT04238546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848115|NCT04238546|Antifungal Agents|antifungal agents|mesh-ancestor
64848116|NCT04238546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64848117|NCT04238546|Immunologic Factors|immunologic factors|mesh-ancestor
64848118|NCT04238546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848119|NCT04238091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64848120|NCT04238091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64493449|NCT04616963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64493450|NCT04616963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64493451|NCT01066624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64493452|NCT01066624|Calcium|calcium|mesh-list
64493453|NCT01066624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64848121|NCT04233801|Empagliflozin|empagliflozin|mesh-list
64848122|NCT04233801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64848123|NCT04233801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848124|NCT04233801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64848125|NCT04233801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848126|NCT04223570|Protoporphyrin IX|protoporphyrin ix|mesh-list
64848127|NCT04223570|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64848229|NCT04096066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64848230|NCT04096066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64848231|NCT04096066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848232|NCT04096066|Immunologic Factors|immunologic factors|mesh-ancestor
64493717|NCT03186027|Ubiquinone|ubiquinone|mesh-list
64848233|NCT04096066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64848234|NCT04096066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64848235|NCT04096066|Growth Substances|growth substances|mesh-ancestor
64848236|NCT04096066|Growth Inhibitors|growth inhibitors|mesh-ancestor
64848237|NCT04082676|Bupivacaine|bupivacaine|mesh-list
64848238|NCT04082676|Anesthetics, Local|anesthetics, local|mesh-ancestor
64848239|NCT04082676|Anesthetics|anesthetics|mesh-ancestor
64848240|NCT04082676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64848241|NCT04082676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848242|NCT04082676|Sensory System Agents|sensory system agents|mesh-ancestor
64848243|NCT04082676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64848244|NCT04012177|Niacinamide|niacinamide|mesh-list
64848245|NCT04012177|Niacin|niacin|mesh-list
64848246|NCT04012177|Nicotinic Acids|nicotinic acids|mesh-list
64848247|NCT04012177|Azithromycin|azithromycin|mesh-list
64848248|NCT04012177|Choline|choline|mesh-list
64848249|NCT04012177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64331392|NCT05518734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64331393|NCT05518734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64331394|NCT05518734|Anesthetics, General|anesthetics, general|mesh-ancestor
64331395|NCT05518734|Anesthetics|anesthetics|mesh-ancestor
64848271|NCT04004910|Antineoplastic Agents|antineoplastic agents|mesh-list
64493770|NCT02989857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848272|NCT04002518|Cimetidine|cimetidine|mesh-list
64848273|NCT04002518|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64848274|NCT04002518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64848275|NCT04002518|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64848296|NCT03990883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64848297|NCT03990883|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64848298|NCT03990883|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64848299|NCT03990883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64848300|NCT03990883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848301|NCT03984890|Vitamin D|vitamin d|mesh-list
64848302|NCT03984890|Cholecalciferol|cholecalciferol|mesh-list
64848303|NCT03984890|Vitamins|vitamins|mesh-ancestor
64848304|NCT03984890|Micronutrients|micronutrients|mesh-ancestor
64848305|NCT03984890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848306|NCT03984890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64848352|NCT05802303|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64848353|NCT05802303|Estrogens|estrogens|mesh-ancestor
64848354|NCT05802303|Hormones|hormones|mesh-ancestor
64494026|NCT01922427|Analgesics|analgesics|mesh-ancestor
64494027|NCT01922427|Sensory System Agents|sensory system agents|mesh-ancestor
64494028|NCT01922427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64848355|NCT05802303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64848356|NCT05802303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848357|NCT05802303|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64848358|NCT05802303|Contraceptive Agents|contraceptive agents|mesh-ancestor
64848359|NCT05802303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64848366|NCT05802264|Amphotericin B|amphotericin b|mesh-list
64848367|NCT05802264|Amebicides|amebicides|mesh-ancestor
64848368|NCT05802264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64848369|NCT05802264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64848370|NCT05802264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64848371|NCT05802264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64848372|NCT05802264|Antifungal Agents|antifungal agents|mesh-ancestor
64848373|NCT05802225|Pertuzumab|pertuzumab|mesh-list
64848374|NCT05802225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64494165|NCT01043926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494166|NCT01044706|Bicalutamide|bicalutamide|mesh-list
64494167|NCT01044706|Androgen Antagonists|androgen antagonists|mesh-ancestor
64494168|NCT01044706|Hormone Antagonists|hormone antagonists|mesh-ancestor
64494169|NCT01044706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64494170|NCT01044706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494171|NCT01044706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494172|NCT04447534|Hydroxychloroquine|hydroxychloroquine|mesh-list
64494173|NCT04447534|Chloroquine|chloroquine|mesh-list
64494174|NCT04447534|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64494182|NCT04447534|Amebicides|amebicides|mesh-ancestor
64848375|NCT05802225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848376|NCT05802212|Metformin|metformin|mesh-list
64848377|NCT05802212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64848378|NCT05802212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848379|NCT05802121|Acetic Acid|acetic acid|mesh-list
64848380|NCT05802121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64848395|NCT05801913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848396|NCT05801900|Ibuprofen|ibuprofen|mesh-list
64848397|NCT05801900|Ketorolac|ketorolac|mesh-list
64848398|NCT05801900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64848399|NCT05801900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64848400|NCT05801900|Analgesics|analgesics|mesh-ancestor
64494428|NCT04092894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64494429|NCT04092894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494430|NCT04092894|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64494431|NCT04092894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64494433|NCT01134952|Mycophenolic Acid|mycophenolic acid|mesh-list
64494467|NCT01135186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64494468|NCT01135186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494469|NCT01135186|Vasodilator Agents|vasodilator agents|mesh-ancestor
64494470|NCT01216683|Rituximab|rituximab|mesh-list
64494471|NCT01216683|Lenalidomide|lenalidomide|mesh-list
64494472|NCT01216683|Bortezomib|bortezomib|mesh-list
64848401|NCT05801900|Sensory System Agents|sensory system agents|mesh-ancestor
64848402|NCT05801900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64848424|NCT05801757|Propofol|propofol|mesh-list
64848425|NCT05801757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64848426|NCT05801757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64331418|NCT05513365|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64331419|NCT05513365|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64331420|NCT05513365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331421|NCT05513365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331422|NCT05490134|Naloxone|naloxone|mesh-list
64331423|NCT05490134|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64331424|NCT05490134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331425|NCT05490134|Sensory System Agents|sensory system agents|mesh-ancestor
64331426|NCT05490134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64331427|NCT05484622|Pembrolizumab|pembrolizumab|mesh-list
64331428|NCT05484622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64331429|NCT05484622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331430|NCT05478174|Propofol|propofol|mesh-list
64331431|NCT05478174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64848448|NCT05801523|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64848449|NCT05801523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64848450|NCT05801523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64848451|NCT05801523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848452|NCT05801484|Linezolid|linezolid|mesh-list
64848453|NCT05801484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64848454|NCT05801484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64494560|NCT01922817|Protease Inhibitors|protease inhibitors|mesh-ancestor
64848455|NCT05801484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64848456|NCT05801484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848457|NCT05801484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848458|NCT05801380|Memantine|memantine|mesh-list
64848459|NCT05801380|Donepezil|donepezil|mesh-list
64848460|NCT05801380|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64848461|NCT05801380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848462|NCT05801380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848463|NCT05801380|Cholinergic Agents|cholinergic agents|mesh-ancestor
64848464|NCT05801380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64848465|NCT05801380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848466|NCT05801380|Nootropic Agents|nootropic agents|mesh-ancestor
64848467|NCT05801380|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64848468|NCT05801380|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64848469|NCT05801380|Dopamine Agents|dopamine agents|mesh-ancestor
64848470|NCT05801380|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64848471|NCT05801380|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64848472|NCT05801367|Allyl sulfide|allyl sulfide|mesh-list
64848473|NCT05801367|Antioxidants|antioxidants|mesh-ancestor
64848474|NCT05801367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494650|NCT01181674|Acarbose|acarbose|mesh-list
64494651|NCT01181674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64494652|NCT01181674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494653|NCT01181674|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64494654|NCT01181674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494655|NCT01181674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494656|NCT01182376|Dronedarone|dronedarone|mesh-list
64494657|NCT01182376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64494658|NCT01183312|Flumazenil|flumazenil|mesh-list
64494703|NCT05672550|Enoxaparin|enoxaparin|mesh-list
64848475|NCT05801367|Protective Agents|protective agents|mesh-ancestor
64848476|NCT05801367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848477|NCT05801367|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64848478|NCT05801367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848486|NCT05801315|Glycine|glycine|mesh-list
64848487|NCT05801315|Glycine Agents|glycine agents|mesh-ancestor
64848488|NCT05801315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64848489|NCT05801315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848490|NCT05801315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848491|NCT05801289|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64848492|NCT05801289|Antidepressive Agents|antidepressive agents|mesh-ancestor
64848493|NCT05801289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64848494|NCT05801289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64848495|NCT05801289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64848496|NCT05801289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64848497|NCT05801289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848498|NCT05801237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64323746|NCT02578771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323747|NCT02259595|Acetylcysteine|acetylcysteine|mesh-list
64323748|NCT02259595|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64323752|NCT02259595|Expectorants|expectorants|mesh-ancestor
64328503|NCT02403219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64328504|NCT02403219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64848499|NCT05801237|Antibodies|antibodies|mesh-list
64848500|NCT05801237|Immunoglobulins|immunoglobulins|mesh-list
64848501|NCT05801237|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64848502|NCT05801237|Immunologic Factors|immunologic factors|mesh-ancestor
64848503|NCT05801237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848504|NCT05801237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848505|NCT05801172|Ketoprofen|ketoprofen|mesh-list
64848575|NCT05800834|Anesthetics, Local|anesthetics, local|mesh-ancestor
64848576|NCT05800834|Anesthetics|anesthetics|mesh-ancestor
64848577|NCT05800834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64848578|NCT05800834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848579|NCT05800834|Sensory System Agents|sensory system agents|mesh-ancestor
64848580|NCT05800834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64848581|NCT05800834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64848582|NCT05800834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64294589|NCT02475135|Emtricitabine|emtricitabine|mesh-list
64294590|NCT02475135|Darunavir|darunavir|mesh-list
64848658|NCT05794750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848660|NCT05794230|Vaccines|vaccines|mesh-list
64848661|NCT05794230|Immunologic Factors|immunologic factors|mesh-ancestor
64848662|NCT05794230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848663|NCT05792293|Atorvastatin|atorvastatin|mesh-list
64848664|NCT05792293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64848683|NCT05785689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64848684|NCT05785689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848685|NCT05780879|Venetoclax|venetoclax|mesh-list
64848686|NCT05780879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848687|NCT05779943|Furosemide|furosemide|mesh-list
64848688|NCT05779943|Fluorides|fluorides|mesh-list
64848689|NCT05779943|Diuretics|diuretics|mesh-ancestor
64848690|NCT05779943|Natriuretic Agents|natriuretic agents|mesh-ancestor
64848691|NCT05779943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848692|NCT05779943|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64848693|NCT05779943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64848694|NCT05779943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848695|NCT05779943|Cariostatic Agents|cariostatic agents|mesh-ancestor
64848696|NCT05779943|Protective Agents|protective agents|mesh-ancestor
64848697|NCT05759156|Tranexamic Acid|tranexamic acid|mesh-list
64848698|NCT05759156|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64848699|NCT05759156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64848701|NCT05759156|Hemostatics|hemostatics|mesh-ancestor
64848733|NCT05734625|Prednisolone acetate|prednisolone acetate|mesh-list
64848734|NCT05734625|Bupivacaine|bupivacaine|mesh-list
64848735|NCT05734625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64848736|NCT05734625|Prednisolone phosphate|prednisolone phosphate|mesh-list
64848737|NCT05734625|Anesthetics, Local|anesthetics, local|mesh-ancestor
64848738|NCT05734625|Anesthetics|anesthetics|mesh-ancestor
64848739|NCT05734625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64328742|NCT02180087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64848740|NCT05734625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848741|NCT05734625|Sensory System Agents|sensory system agents|mesh-ancestor
64848742|NCT05734625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64848743|NCT05734625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64848744|NCT05734625|Antiemetics|antiemetics|mesh-ancestor
64848745|NCT05734625|Autonomic Agents|autonomic agents|mesh-ancestor
64848746|NCT05734625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64848747|NCT05734625|Glucocorticoids|glucocorticoids|mesh-ancestor
64848748|NCT05734625|Hormones|hormones|mesh-ancestor
64848749|NCT05734625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64848750|NCT05734625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64848751|NCT05734625|Protective Agents|protective agents|mesh-ancestor
64848752|NCT05734625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64848753|NCT05734625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848754|NCT05724108|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64848755|NCT05724108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848756|NCT05724108|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64848757|NCT05699603|Fluorouracil|fluorouracil|mesh-list
64848758|NCT05699603|Calcipotriene|calcipotriene|mesh-list
64848759|NCT05699603|Antimetabolites|antimetabolites|mesh-ancestor
64848760|NCT05699603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848761|NCT05699603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64848762|NCT05699603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848763|NCT05699603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64848764|NCT05699603|Immunologic Factors|immunologic factors|mesh-ancestor
64848765|NCT05699603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848766|NCT05699603|Dermatologic Agents|dermatologic agents|mesh-ancestor
64848767|NCT05697510|Siltuximab|siltuximab|mesh-list
64848785|NCT05691478|Dermatologic Agents|dermatologic agents|mesh-ancestor
64848786|NCT05691478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64848787|NCT05691478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64848788|NCT05691478|Immunologic Factors|immunologic factors|mesh-ancestor
64848789|NCT05691478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64848790|NCT05691478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64848792|NCT05691400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848793|NCT05691400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64848794|NCT05691400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848795|NCT05691400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848796|NCT05689827|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
64848797|NCT05689827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64848798|NCT05689827|Immunologic Factors|immunologic factors|mesh-ancestor
64848799|NCT05689827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848800|NCT05657925|Ondansetron|ondansetron|mesh-list
64848801|NCT05657925|Antiemetics|antiemetics|mesh-ancestor
64294623|NCT05714631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848819|NCT05656508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848820|NCT05622812|Lidocaine|lidocaine|mesh-list
64848821|NCT05622812|Anesthetics, Local|anesthetics, local|mesh-ancestor
64848822|NCT05622812|Anesthetics|anesthetics|mesh-ancestor
64848823|NCT05622812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64848824|NCT05622812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848825|NCT05622812|Sensory System Agents|sensory system agents|mesh-ancestor
64331485|NCT05442749|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64331486|NCT05442749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848841|NCT05615220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848842|NCT05611229|Pembrolizumab|pembrolizumab|mesh-list
64848843|NCT05611229|Nivolumab|nivolumab|mesh-list
64848844|NCT05611229|Ipilimumab|ipilimumab|mesh-list
64848845|NCT05611229|Trametinib|trametinib|mesh-list
64848846|NCT05611229|Vemurafenib|vemurafenib|mesh-list
64848847|NCT05611229|Dabrafenib|dabrafenib|mesh-list
64668799|NCT03081117|Insulin|insulin|mesh-list
64848848|NCT05611229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64848849|NCT05611229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848850|NCT05611229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64848851|NCT05611229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848852|NCT05611229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64331489|NCT05370911|Psilocybin|psilocybin|mesh-list
64331490|NCT05370911|Hallucinogens|hallucinogens|mesh-ancestor
64294657|NCT05714553|Pembrolizumab|pembrolizumab|mesh-list
64294658|NCT05714553|Levoleucovorin|levoleucovorin|mesh-list
64294659|NCT05714553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848853|NCT05611229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848855|NCT05607407|Antithyroid Agents|antithyroid agents|mesh-ancestor
64848856|NCT05607407|Hormone Antagonists|hormone antagonists|mesh-ancestor
64669007|NCT04903470|Bisacodyl|bisacodyl|mesh-list
64848857|NCT05607407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64848858|NCT05607407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848860|NCT05601154|Fluorides|fluorides|mesh-list
64848861|NCT05601154|Sodium Fluoride|sodium fluoride|mesh-list
64848862|NCT05601154|Cariostatic Agents|cariostatic agents|mesh-ancestor
64848863|NCT05601154|Protective Agents|protective agents|mesh-ancestor
64848864|NCT05601154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848865|NCT05601154|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64848866|NCT05601154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64848867|NCT05590377|Daratumumab|daratumumab|mesh-list
64848868|NCT05590377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848869|NCT05566665|Meropenem|meropenem|mesh-list
64848870|NCT05566665|Tazobactam|tazobactam|mesh-list
64848871|NCT05566665|Ceftazidime|ceftazidime|mesh-list
64848872|NCT05566665|Avibactam|avibactam|mesh-list
64848873|NCT05566665|Ceftolozane|ceftolozane|mesh-list
64848874|NCT05566665|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
64848875|NCT05566665|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
64848876|NCT05566665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64848877|NCT05566665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64848878|NCT05566665|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64848879|NCT05566665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848880|NCT05566665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848881|NCT05566665|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64848882|NCT05566665|Renal Agents|renal agents|mesh-ancestor
64848883|NCT05559476|Vaccines|vaccines|mesh-list
64848888|NCT05537766|Cyclophosphamide|cyclophosphamide|mesh-list
64848898|NCT05537766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64669334|NCT02288273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848899|NCT05534529|Rezafungin|rezafungin|mesh-list
64848900|NCT05534529|Antifungal Agents|antifungal agents|mesh-ancestor
64848901|NCT05534529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64848902|NCT05521984|Dapagliflozin|dapagliflozin|mesh-list
64848903|NCT05521984|Carmustine|carmustine|mesh-list
64848904|NCT05521984|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64848905|NCT05521984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848906|NCT05521984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64848907|NCT05521984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848908|NCT05521984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64848909|NCT05521984|Alkylating Agents|alkylating agents|mesh-ancestor
64848910|NCT05521984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848911|NCT05520138|Abiraterone Acetate|abiraterone acetate|mesh-list
64848912|NCT05520138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848913|NCT05520138|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64848914|NCT05520138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848915|NCT05520138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848916|NCT05520138|Hormone Antagonists|hormone antagonists|mesh-ancestor
64848917|NCT05520138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64848918|NCT05520138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848919|NCT05520138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64848920|NCT05518110|Hydroxychloroquine|hydroxychloroquine|mesh-list
64848921|NCT05518110|Trametinib|trametinib|mesh-list
64848922|NCT05518110|Antimalarials|antimalarials|mesh-ancestor
64848923|NCT05518110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64848924|NCT05518110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64848925|NCT05518110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64848926|NCT05518110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294676|NCT05328440|Hormone Antagonists|hormone antagonists|mesh-ancestor
64848959|NCT05497323|Sensory System Agents|sensory system agents|mesh-ancestor
64848960|NCT05497323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64848961|NCT05497323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848962|NCT05497323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64848963|NCT05497323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64331499|NCT05361655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64331500|NCT05361655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64331501|NCT05361655|Hormone Antagonists|hormone antagonists|mesh-ancestor
64848978|NCT05425940|Atezolizumab|atezolizumab|mesh-list
64848979|NCT05425940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848980|NCT05411094|Durvalumab|durvalumab|mesh-list
64848981|NCT05411094|Olaparib|olaparib|mesh-list
64848982|NCT05411094|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64848983|NCT05411094|Immunoglobulins|immunoglobulins|mesh-list
64848984|NCT05411094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64848985|NCT05411094|Immunoglobulin G|immunoglobulin g|mesh-list
64848986|NCT05411094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64848987|NCT05411094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64848988|NCT05411094|Immunologic Factors|immunologic factors|mesh-ancestor
64848989|NCT05411094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64848990|NCT05411094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64848991|NCT05411094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64848992|NCT05371886|Midazolam|midazolam|mesh-list
64848993|NCT05371886|Morphine|morphine|mesh-list
64294690|NCT02724111|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64294691|NCT02724111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64849005|NCT05371886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64849006|NCT05371886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64849007|NCT05371886|Anesthetics, General|anesthetics, general|mesh-ancestor
64849008|NCT05371886|Anesthetics|anesthetics|mesh-ancestor
64849009|NCT05371886|GABA Modulators|gaba modulators|mesh-ancestor
64849010|NCT05371886|GABA Agents|gaba agents|mesh-ancestor
64849011|NCT05371886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64849012|NCT05371886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849013|NCT05347238|Dopamine|dopamine|mesh-list
64849014|NCT05347238|Norepinephrine|norepinephrine|mesh-list
64617505|NCT01090921|Bortezomib|bortezomib|mesh-list
64849015|NCT05347238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64669563|NCT05227001|Camphor|camphor|mesh-list
64849016|NCT05347238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64849017|NCT05347238|Adrenergic Agents|adrenergic agents|mesh-ancestor
64849018|NCT05347238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64849019|NCT05347238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849020|NCT05347238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849021|NCT05347238|Sympathomimetics|sympathomimetics|mesh-ancestor
64849022|NCT05347238|Autonomic Agents|autonomic agents|mesh-ancestor
64849023|NCT05347238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64849024|NCT05347238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64849025|NCT05347238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64849037|NCT05340582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64849038|NCT05340582|Analgesics|analgesics|mesh-ancestor
64849039|NCT05340582|Sensory System Agents|sensory system agents|mesh-ancestor
64849040|NCT05340582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64849041|NCT05340582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849042|NCT05340582|Antipyretics|antipyretics|mesh-ancestor
64849043|NCT05340582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64849044|NCT05340582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64849045|NCT05340582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64849046|NCT05340582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64849047|NCT05340582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849048|NCT05340582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849049|NCT05321420|Pirfenidone|pirfenidone|mesh-list
64849050|NCT05321420|Analgesics|analgesics|mesh-ancestor
64849051|NCT05321420|Sensory System Agents|sensory system agents|mesh-ancestor
64331507|NCT05355740|Disinfectants|disinfectants|mesh-ancestor
64331517|NCT05320887|Nicotine|nicotine|mesh-list
64849065|NCT05309655|Vasodilator Agents|vasodilator agents|mesh-ancestor
64849066|NCT05309655|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64849067|NCT05309655|Purinergic Agonists|purinergic agonists|mesh-ancestor
64849068|NCT05309655|Purinergic Agents|purinergic agents|mesh-ancestor
64849069|NCT05309655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64849070|NCT05309655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849071|NCT05297903|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64849072|NCT05297903|Immunologic Factors|immunologic factors|mesh-ancestor
64849073|NCT05297903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849074|NCT05288283|Cannabidiol|cannabidiol|mesh-list
64849075|NCT05288283|Anticonvulsants|anticonvulsants|mesh-ancestor
64849076|NCT05281510|Vesatolimod|vesatolimod|mesh-list
64849077|NCT05281510|Antiviral Agents|antiviral agents|mesh-ancestor
64849078|NCT05281510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64849079|NCT05265767|Factor VIII|factor viii|mesh-list
64294714|NCT04223648|Nivolumab|nivolumab|mesh-list
64849113|NCT05219799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64849114|NCT05219799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849115|NCT05219799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669818|NCT02947529|Tranexamic Acid|tranexamic acid|mesh-list
64849116|NCT05219799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64849117|NCT05219799|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64849118|NCT05219799|Vasodilator Agents|vasodilator agents|mesh-ancestor
64849119|NCT05219799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64849120|NCT05219799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64849121|NCT05219799|Sympathomimetics|sympathomimetics|mesh-ancestor
64849122|NCT05219799|Autonomic Agents|autonomic agents|mesh-ancestor
64849123|NCT05219799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64849124|NCT05219799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64849125|NCT05219799|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64849126|NCT05219799|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64849127|NCT05219799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64849128|NCT05219799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64849129|NCT05219799|Respiratory System Agents|respiratory system agents|mesh-ancestor
64849131|NCT05219799|Protective Agents|protective agents|mesh-ancestor
64849133|NCT05216952|Ulipristal acetate|ulipristal acetate|mesh-list
64849134|NCT05216952|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64849135|NCT05216952|Abortifacient Agents|abortifacient agents|mesh-ancestor
64849136|NCT05216952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64849137|NCT05216952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849148|NCT05215951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849152|NCT05171387|Hormones|hormones|mesh-ancestor
64849153|NCT05171387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64849154|NCT05171387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849155|NCT05161468|Triamcinolone|triamcinolone|mesh-list
64849156|NCT05161468|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64849157|NCT05161468|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64849158|NCT05161468|Lidocaine|lidocaine|mesh-list
64849159|NCT05161468|Acid citrate dextrose|acid citrate dextrose|mesh-list
64849160|NCT05161468|Glucocorticoids|glucocorticoids|mesh-list
64849161|NCT05161468|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64849162|NCT05161468|Anesthetics, Local|anesthetics, local|mesh-ancestor
64849163|NCT05161468|Anesthetics|anesthetics|mesh-ancestor
64849164|NCT05161468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64849165|NCT05161468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849166|NCT05161468|Sensory System Agents|sensory system agents|mesh-ancestor
64849167|NCT05161468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64849168|NCT05161468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64849169|NCT05161468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64849170|NCT05161468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64849171|NCT05161468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64849172|NCT05161468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849174|NCT05161468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64849175|NCT05161468|Hormones|hormones|mesh-ancestor
64849176|NCT05161468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64849177|NCT05161468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64849191|NCT05104762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64849192|NCT05104762|Immunologic Factors|immunologic factors|mesh-ancestor
64849193|NCT05104762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849194|NCT05103358|Sirolimus|sirolimus|mesh-list
64849195|NCT05103358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64849196|NCT05103358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64849197|NCT05103358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64849198|NCT05103358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849199|NCT05103358|Antifungal Agents|antifungal agents|mesh-ancestor
64849200|NCT05103358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64849201|NCT05103358|Immunologic Factors|immunologic factors|mesh-ancestor
64849202|NCT05103358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849203|NCT05085002|Letrozole|letrozole|mesh-list
64849204|NCT05085002|Fulvestrant|fulvestrant|mesh-list
64849239|NCT05003648|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64849251|NCT05000216|Abortifacient Agents|abortifacient agents|mesh-ancestor
64849252|NCT05000216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64849253|NCT05000216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64849254|NCT05000216|Antimetabolites|antimetabolites|mesh-ancestor
64849255|NCT05000216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849256|NCT05000216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849257|NCT05000216|Dermatologic Agents|dermatologic agents|mesh-ancestor
64849258|NCT05000216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670657|NCT01769027|Serotonin Agents|serotonin agents|mesh-ancestor
64849259|NCT05000216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64849260|NCT05000216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64849261|NCT05000216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64849262|NCT05000216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64849263|NCT05000216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64849340|NCT04931342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849341|NCT04931342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64849342|NCT04931342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64849343|NCT04931342|Alkylating Agents|alkylating agents|mesh-ancestor
64849344|NCT04931342|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64849345|NCT04931342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64331558|NCT05244226|Methadone|methadone|mesh-list
64331559|NCT05244226|Hydromorphone|hydromorphone|mesh-list
64849346|NCT04931342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64849347|NCT04931342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64849348|NCT04931342|Growth Substances|growth substances|mesh-ancestor
64849349|NCT04931342|Growth Inhibitors|growth inhibitors|mesh-ancestor
64849350|NCT04931342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64849351|NCT04931342|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64849352|NCT04931342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64849353|NCT04931342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849354|NCT04931342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64849355|NCT04931342|Hormone Antagonists|hormone antagonists|mesh-ancestor
64849356|NCT04931342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64849357|NCT04931342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64849359|NCT04892043|Ipilimumab|ipilimumab|mesh-list
64849360|NCT04892043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64849361|NCT04892043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849362|NCT04892043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64849363|NCT04892043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849364|NCT04887935|Dapagliflozin|dapagliflozin|mesh-list
64849369|NCT04880278|Nabilone|nabilone|mesh-list
64849401|NCT04845035|Antimetabolites|antimetabolites|mesh-ancestor
64849417|NCT04835506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64849418|NCT04824092|Prednisone|prednisone|mesh-list
64849419|NCT04824092|Cyclophosphamide|cyclophosphamide|mesh-list
64849420|NCT04824092|Rituximab|rituximab|mesh-list
64849421|NCT04824092|Doxorubicin|doxorubicin|mesh-list
64849422|NCT04824092|Vincristine|vincristine|mesh-list
64849423|NCT04824092|Lenalidomide|lenalidomide|mesh-list
64849424|NCT04824092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64849425|NCT04824092|Immunologic Factors|immunologic factors|mesh-ancestor
64849426|NCT04824092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849427|NCT04824092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64849428|NCT04824092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64849429|NCT04824092|Alkylating Agents|alkylating agents|mesh-ancestor
64294754|NCT03096080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294755|NCT03096080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64849430|NCT04824092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849432|NCT04824092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64849433|NCT04824092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64849434|NCT04824092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64849435|NCT04824092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64849436|NCT04824092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64849437|NCT04824092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849438|NCT04824092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64849439|NCT04824092|Glucocorticoids|glucocorticoids|mesh-ancestor
64849440|NCT04824092|Hormones|hormones|mesh-ancestor
64849441|NCT04824092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64849442|NCT04824092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64849443|NCT04824092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64849444|NCT04824092|Tubulin Modulators|tubulin modulators|mesh-ancestor
64849445|NCT04824092|Antimitotic Agents|antimitotic agents|mesh-ancestor
64671207|NCT03261999|Fertility Agents|fertility agents|mesh-ancestor
64849446|NCT04824092|Mitosis Modulators|mitosis modulators|mesh-ancestor
64849447|NCT04824092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64849448|NCT04824092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64849449|NCT04824092|Growth Substances|growth substances|mesh-ancestor
64849450|NCT04824092|Growth Inhibitors|growth inhibitors|mesh-ancestor
64849451|NCT04820179|Atezolizumab|atezolizumab|mesh-list
64849452|NCT04820179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849453|NCT04762758|Naltrexone|naltrexone|mesh-list
64849454|NCT04762758|Baclofen|baclofen|mesh-list
64849455|NCT04762758|Sorbitol|sorbitol|mesh-list
64849456|NCT04762758|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64849457|NCT04762758|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64849458|NCT04762758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849477|NCT04732065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64849478|NCT04732065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849479|NCT04732065|Protective Agents|protective agents|mesh-ancestor
64849480|NCT04717908|Linezolid|linezolid|mesh-list
64849481|NCT04717908|Cycloserine|cycloserine|mesh-list
64849482|NCT04717908|Pyrazinamide|pyrazinamide|mesh-list
64849483|NCT04717908|Bedaquiline|bedaquiline|mesh-list
64849484|NCT04717908|Clofazimine|clofazimine|mesh-list
64849485|NCT04717908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64849486|NCT04717908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64849487|NCT04717908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64849488|NCT04717908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849489|NCT04717908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849490|NCT04717908|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64849491|NCT04717908|Renal Agents|renal agents|mesh-ancestor
64849492|NCT04717908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64849493|NCT04717908|Antitubercular Agents|antitubercular agents|mesh-ancestor
64849494|NCT04717908|Antimetabolites|antimetabolites|mesh-ancestor
64849495|NCT04717908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64849496|NCT04717908|Leprostatic Agents|leprostatic agents|mesh-ancestor
64849497|NCT04665895|Fluticasone|fluticasone|mesh-list
64331569|NCT05244226|Anesthetics, General|anesthetics, general|mesh-ancestor
64331570|NCT05244226|Anesthetics|anesthetics|mesh-ancestor
64331571|NCT05244226|Antitussive Agents|antitussive agents|mesh-ancestor
64331572|NCT05244226|Respiratory System Agents|respiratory system agents|mesh-ancestor
64331573|NCT05239624|Pembrolizumab|pembrolizumab|mesh-list
64331574|NCT05239624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64331575|NCT05239624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849548|NCT04510311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64849549|NCT04500574|Latanoprost|latanoprost|mesh-list
64849550|NCT04500574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64849551|NCT04500574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64849552|NCT04483505|Fulvestrant|fulvestrant|mesh-list
64849553|NCT04483505|Palbociclib|palbociclib|mesh-list
64849554|NCT04483505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64849555|NCT04483505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849556|NCT04483505|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64849557|NCT04483505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64849580|NCT04445662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849581|NCT04427293|Pembrolizumab|pembrolizumab|mesh-list
64849582|NCT04427293|Lenvatinib|lenvatinib|mesh-list
64671509|NCT02024477|Hormones|hormones|mesh-ancestor
64849583|NCT04427293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64849584|NCT04427293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849585|NCT04427293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64849586|NCT04427293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849587|NCT04427293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849588|NCT04416282|Terlipressin|terlipressin|mesh-list
64849589|NCT04416282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64849590|NCT04416282|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64849591|NCT04395469|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
64849592|NCT04395469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64671679|NCT01745822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64849593|NCT04395469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849594|NCT04359784|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64849595|NCT04359784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64849596|NCT04323046|Nivolumab|nivolumab|mesh-list
64849597|NCT04323046|Ipilimumab|ipilimumab|mesh-list
64849598|NCT04323046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64849599|NCT04323046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849600|NCT04323046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64849601|NCT04323046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849602|NCT04281108|Fluticasone|fluticasone|mesh-list
64849603|NCT04281108|Xhance|xhance|mesh-list
64849604|NCT04281108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64849605|NCT04281108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64849606|NCT04281108|Autonomic Agents|autonomic agents|mesh-ancestor
64849607|NCT04281108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64849608|NCT04281108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849610|NCT04281108|Respiratory System Agents|respiratory system agents|mesh-ancestor
64849611|NCT04281108|Dermatologic Agents|dermatologic agents|mesh-ancestor
64849612|NCT04281108|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64849613|NCT04192981|GDC-0084|gdc-0084|mesh-list
64671924|NCT01749956|Antidotes|antidotes|mesh-ancestor
64849614|NCT04192981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294800|NCT02048293|Narcotics|narcotics|mesh-ancestor
64331625|NCT05144698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331627|NCT05122182|Candesartan|candesartan|mesh-list
64331628|NCT05122182|Candesartan cilexetil|candesartan cilexetil|mesh-list
64331629|NCT05122182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64331630|NCT05122182|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64331631|NCT05122182|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64331639|NCT05092360|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64331640|NCT05092360|Doxorubicin|doxorubicin|mesh-list
64331641|NCT05092360|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64331642|NCT05092360|Pembrolizumab|pembrolizumab|mesh-list
64331643|NCT05092360|Topotecan|topotecan|mesh-list
64331644|NCT05092360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64331645|NCT05092360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331646|NCT05092360|Tubulin Modulators|tubulin modulators|mesh-ancestor
64849660|NCT04170946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849662|NCT04152551|Risedronic Acid|risedronic acid|mesh-list
64849663|NCT04152551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64849664|NCT04152551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64849684|NCT04042051|Antimitotic Agents|antimitotic agents|mesh-ancestor
64849685|NCT04042051|Mitosis Modulators|mitosis modulators|mesh-ancestor
64849686|NCT04042051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849687|NCT04033991|Sunitinib|sunitinib|mesh-list
64849688|NCT04033991|Axitinib|axitinib|mesh-list
64849689|NCT04033991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849690|NCT04033991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64849691|NCT04033991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64849692|NCT04033991|Growth Substances|growth substances|mesh-ancestor
64849693|NCT04033991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849694|NCT04033991|Growth Inhibitors|growth inhibitors|mesh-ancestor
64849695|NCT04033991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64849696|NCT04033991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64849697|NCT04033991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849699|NCT04002947|Acalabrutinib|acalabrutinib|mesh-list
64849700|NCT04002947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64849701|NCT04002947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64849702|NCT04002947|Immunologic Factors|immunologic factors|mesh-ancestor
64331657|NCT05092360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331658|NCT05092360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64331659|NCT05092360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64331660|NCT05092360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64849799|NCT03632330|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64849800|NCT03632330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64672115|NCT00354809|Casopitant|casopitant|mesh-list
64849801|NCT03632330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849802|NCT03632330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64849803|NCT03632330|Anesthetics, General|anesthetics, general|mesh-ancestor
64849804|NCT03632330|Anesthetics|anesthetics|mesh-ancestor
64849805|NCT03632330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64849806|NCT03632330|Analgesics|analgesics|mesh-ancestor
64849807|NCT03632330|Sensory System Agents|sensory system agents|mesh-ancestor
64849808|NCT03632330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64849809|NCT03632330|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64849810|NCT03632330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64849811|NCT03632330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64849812|NCT03632330|Adrenergic Agents|adrenergic agents|mesh-ancestor
64672282|NCT02387801|Ixekizumab|ixekizumab|mesh-list
64849813|NCT03632330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64849814|NCT03632330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849815|NCT03632330|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64849816|NCT03632330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64849817|NCT03632330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64849818|NCT03632330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64849819|NCT03632330|GABA Modulators|gaba modulators|mesh-ancestor
64849820|NCT03632330|GABA Agents|gaba agents|mesh-ancestor
64849821|NCT03575949|Deoxyglucose|deoxyglucose|mesh-list
64849822|NCT03575949|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64849823|NCT03575949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64849824|NCT03575949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849825|NCT03575949|Antimetabolites|antimetabolites|mesh-ancestor
64849826|NCT03575949|Antiviral Agents|antiviral agents|mesh-ancestor
64849851|NCT03497975|Nalbuphine|nalbuphine|mesh-list
64849852|NCT03497975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64849853|NCT03497975|Narcotics|narcotics|mesh-ancestor
64849854|NCT03497975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64849855|NCT03497975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64849856|NCT03497975|Analgesics|analgesics|mesh-ancestor
64672572|NCT04259645|Sensory System Agents|sensory system agents|mesh-ancestor
64849857|NCT03497975|Sensory System Agents|sensory system agents|mesh-ancestor
64849858|NCT03497975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64849859|NCT03475342|Tranexamic Acid|tranexamic acid|mesh-list
64849860|NCT03475342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64849861|NCT03475342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64849862|NCT03475342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64849863|NCT03475342|Hemostatics|hemostatics|mesh-ancestor
64849864|NCT03475342|Coagulants|coagulants|mesh-ancestor
64849865|NCT03466151|Sirolimus|sirolimus|mesh-list
64849866|NCT03466151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64849867|NCT03466151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64849868|NCT03466151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64294894|NCT02472249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64331705|NCT04919629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64331706|NCT04919629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64331707|NCT04919629|Growth Substances|growth substances|mesh-ancestor
64849973|NCT03150004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64849974|NCT03150004|Antimetabolites|antimetabolites|mesh-ancestor
64849975|NCT03150004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331718|NCT04910061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64331719|NCT04910061|Antimetabolites|antimetabolites|mesh-ancestor
64331720|NCT04910061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331721|NCT04910061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64331722|NCT04910061|Vasodilator Agents|vasodilator agents|mesh-ancestor
64331728|NCT04892264|Dexamethasone|dexamethasone|mesh-list
64331729|NCT04892264|Dexamethasone acetate|dexamethasone acetate|mesh-list
64331730|NCT04892264|Lenalidomide|lenalidomide|mesh-list
64331731|NCT04892264|Daratumumab|daratumumab|mesh-list
64331732|NCT04892264|Ichthammol|ichthammol|mesh-list
64331733|NCT04892264|BB 1101|bb 1101|mesh-list
64331734|NCT04892264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64850135|NCT02160353|Prednisolone|prednisolone|mesh-list
64850136|NCT02160353|Abiraterone Acetate|abiraterone acetate|mesh-list
64850137|NCT02160353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64850138|NCT02160353|Glucocorticoids|glucocorticoids|mesh-ancestor
64850139|NCT02160353|Hormones|hormones|mesh-ancestor
64850140|NCT02160353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64850141|NCT02160353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850142|NCT02160353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64850143|NCT02160353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850144|NCT02160353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64850145|NCT02160353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850146|NCT02160353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850147|NCT02160353|Hormone Antagonists|hormone antagonists|mesh-ancestor
64850148|NCT02160353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64850149|NCT02152358|Acyclovir|acyclovir|mesh-list
64850150|NCT02152358|Ganciclovir|ganciclovir|mesh-list
64850151|NCT02152358|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64850152|NCT02152358|Antiviral Agents|antiviral agents|mesh-ancestor
64850153|NCT02152358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64850154|NCT02152358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64331763|NCT04887467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673004|NCT00376077|Hormones|hormones|mesh-ancestor
64850155|NCT02152358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850156|NCT02152358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850157|NCT02125461|Durvalumab|durvalumab|mesh-list
64850158|NCT02125461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64850159|NCT02125461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850160|NCT01896999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64850161|NCT01896999|Nivolumab|nivolumab|mesh-list
64850162|NCT01896999|Ipilimumab|ipilimumab|mesh-list
64850163|NCT01896999|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64850164|NCT01896999|Antibodies|antibodies|mesh-list
64850165|NCT01896999|Immunoglobulins|immunoglobulins|mesh-list
64850166|NCT01896999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64850167|NCT01896999|Immunoconjugates|immunoconjugates|mesh-list
64850168|NCT01896999|Immunologic Factors|immunologic factors|mesh-ancestor
64850169|NCT01896999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850170|NCT01896999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850171|NCT01896999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64850172|NCT01896999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850173|NCT01892371|Cytarabine|cytarabine|mesh-list
64850174|NCT01892371|Azacitidine|azacitidine|mesh-list
64850175|NCT01892371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64850176|NCT01892371|Antimetabolites|antimetabolites|mesh-ancestor
64850177|NCT01892371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850178|NCT01892371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850179|NCT01892371|Antiviral Agents|antiviral agents|mesh-ancestor
64850180|NCT01892371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64850181|NCT01892371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64850182|NCT01892371|Immunologic Factors|immunologic factors|mesh-ancestor
64850183|NCT01892371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850184|NCT01892371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850185|NCT01819064|Atropine|atropine|mesh-list
64850186|NCT01819064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64850199|NCT01819064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64850200|NCT01819064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850201|NCT01817751|Sorafenib|sorafenib|mesh-list
64850202|NCT01817751|Sildenafil Citrate|sildenafil citrate|mesh-list
64850203|NCT01817751|Valproic Acid|valproic acid|mesh-list
64850204|NCT01817751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850205|NCT01817751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850206|NCT01817751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64673478|NCT05747768|Midazolam|midazolam|mesh-list
64673479|NCT05747768|Dabigatran|dabigatran|mesh-list
64850207|NCT01817751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850208|NCT01817751|Vasodilator Agents|vasodilator agents|mesh-ancestor
64850209|NCT01817751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64850210|NCT01817751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64850211|NCT01817751|Urological Agents|urological agents|mesh-ancestor
64850212|NCT01817751|Anticonvulsants|anticonvulsants|mesh-ancestor
64850213|NCT01817751|GABA Agents|gaba agents|mesh-ancestor
64850214|NCT01817751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64850215|NCT01817751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850216|NCT01817751|Antimanic Agents|antimanic agents|mesh-ancestor
64850217|NCT01817751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64850218|NCT01817751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64850219|NCT01817751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64850220|NCT01748149|Vemurafenib|vemurafenib|mesh-list
64850221|NCT01748149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850222|NCT01748149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64850223|NCT01748149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850224|NCT01748149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850225|NCT01549730|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
64850226|NCT01549730|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64850227|NCT01549730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850243|NCT00812669|Antimetabolites|antimetabolites|mesh-ancestor
64850244|NCT00217425|Prednisone|prednisone|mesh-list
64850245|NCT00217425|Cyclophosphamide|cyclophosphamide|mesh-list
64850246|NCT00217425|Bevacizumab|bevacizumab|mesh-list
64850247|NCT00217425|Doxorubicin|doxorubicin|mesh-list
64850248|NCT00217425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64850249|NCT00217425|Vincristine|vincristine|mesh-list
64850250|NCT00217425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64850251|NCT00217425|Immunologic Factors|immunologic factors|mesh-ancestor
64850252|NCT00217425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331764|NCT04868409|Rocuronium|rocuronium|mesh-list
64331765|NCT04868409|Succinylcholine|succinylcholine|mesh-list
64331766|NCT04868409|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64331767|NCT04868409|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64331769|NCT04868409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64850338|NCT03785106|Antitubercular Agents|antitubercular agents|mesh-ancestor
64850339|NCT03785106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64850340|NCT03785106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64850341|NCT03785106|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64850342|NCT03785106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64850343|NCT03785106|Antimetabolites|antimetabolites|mesh-ancestor
64850344|NCT03785106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850346|NCT03785106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64850347|NCT03785106|Leprostatic Agents|leprostatic agents|mesh-ancestor
64850348|NCT03785106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64850349|NCT03785106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850350|NCT03785106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64850351|NCT03785106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64850352|NCT03785106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64850353|NCT03785106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64850354|NCT03785106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64850355|NCT03785106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64850356|NCT03782142|Tenofovir|tenofovir|mesh-list
64850357|NCT03782142|Dolutegravir|dolutegravir|mesh-list
64850358|NCT03782142|Rilpivirine|rilpivirine|mesh-list
64850359|NCT03782142|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
64850360|NCT03782142|Antiviral Agents|antiviral agents|mesh-ancestor
64850361|NCT03782142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64850362|NCT03782142|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64850363|NCT03782142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64850364|NCT03782142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850365|NCT03782142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850366|NCT03782142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64850367|NCT03782142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64850368|NCT03782142|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64850369|NCT03782142|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64850370|NCT03782142|Protease Inhibitors|protease inhibitors|mesh-ancestor
64850371|NCT03782142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64850372|NCT03782142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64850373|NCT03770299|Gemcitabine|gemcitabine|mesh-list
64850374|NCT03770299|Paclitaxel|paclitaxel|mesh-list
64618854|NCT00957359|Hallucinogens|hallucinogens|mesh-ancestor
64850375|NCT03770299|Vinorelbine|vinorelbine|mesh-list
64850376|NCT03770299|Docetaxel|docetaxel|mesh-list
64850377|NCT03770299|Carboplatin|carboplatin|mesh-list
64850378|NCT03770299|Nivolumab|nivolumab|mesh-list
64850379|NCT03770299|Pemetrexed|pemetrexed|mesh-list
64850380|NCT03770299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64850381|NCT03770299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673759|NCT01857362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673761|NCT02265224|Acetylcysteine|acetylcysteine|mesh-list
64850382|NCT03770299|Tubulin Modulators|tubulin modulators|mesh-ancestor
64850383|NCT03770299|Antimitotic Agents|antimitotic agents|mesh-ancestor
64850384|NCT03770299|Mitosis Modulators|mitosis modulators|mesh-ancestor
64850385|NCT03770299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850386|NCT03770299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64850387|NCT03770299|Antimetabolites|antimetabolites|mesh-ancestor
64850388|NCT03770299|Antiviral Agents|antiviral agents|mesh-ancestor
64850389|NCT03770299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64850390|NCT03770299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850391|NCT03770299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64850392|NCT03770299|Immunologic Factors|immunologic factors|mesh-ancestor
64850393|NCT03770299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850394|NCT03770299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64850395|NCT03770299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64850396|NCT03770299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64850397|NCT03770299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64850398|NCT03760835|Dexamethasone|dexamethasone|mesh-list
64850399|NCT03760835|Prednisone|prednisone|mesh-list
64850400|NCT03760835|Prednisolone|prednisolone|mesh-list
64850401|NCT03760835|Hydrocortisone|hydrocortisone|mesh-list
64850402|NCT03760835|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64850403|NCT03760835|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64850404|NCT03760835|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64850405|NCT03760835|Cortisone|cortisone|mesh-list
64850441|NCT03715829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64850443|NCT03715829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850444|NCT03712254|Fosphenytoin|fosphenytoin|mesh-list
64850445|NCT03712254|Anticonvulsants|anticonvulsants|mesh-ancestor
64850446|NCT03712254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64850447|NCT03712254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64850448|NCT03712254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850449|NCT03704441|Bupivacaine|bupivacaine|mesh-list
64850450|NCT03704441|Anesthetics, Local|anesthetics, local|mesh-ancestor
64850451|NCT03704441|Anesthetics|anesthetics|mesh-ancestor
64850452|NCT03704441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64850453|NCT03704441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850454|NCT03704441|Sensory System Agents|sensory system agents|mesh-ancestor
64850455|NCT03704441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64850456|NCT03693677|Gemcitabine|gemcitabine|mesh-list
64850457|NCT03693677|Paclitaxel|paclitaxel|mesh-list
64850458|NCT03693677|Irinotecan|irinotecan|mesh-list
64850459|NCT03693677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64850460|NCT03693677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850461|NCT03693677|Tubulin Modulators|tubulin modulators|mesh-ancestor
64850462|NCT03693677|Antimitotic Agents|antimitotic agents|mesh-ancestor
64850463|NCT03693677|Mitosis Modulators|mitosis modulators|mesh-ancestor
64850464|NCT03693677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850465|NCT03693677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64850466|NCT03693677|Antimetabolites|antimetabolites|mesh-ancestor
64850467|NCT03693677|Antiviral Agents|antiviral agents|mesh-ancestor
64850468|NCT03693677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64850469|NCT03693677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850470|NCT03693677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64850471|NCT03693677|Immunologic Factors|immunologic factors|mesh-ancestor
64850472|NCT03693677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850473|NCT03693677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64850474|NCT03693677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64850475|NCT03673826|Dexamethasone|dexamethasone|mesh-list
64850476|NCT03673826|Lenalidomide|lenalidomide|mesh-list
64850477|NCT03673826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64850478|NCT03673826|Antiemetics|antiemetics|mesh-ancestor
64850479|NCT03673826|Autonomic Agents|autonomic agents|mesh-ancestor
64850480|NCT03673826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64850481|NCT03673826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850482|NCT03673826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64850483|NCT03673826|Glucocorticoids|glucocorticoids|mesh-ancestor
64850484|NCT03673826|Hormones|hormones|mesh-ancestor
64850485|NCT03673826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64850486|NCT03673826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64850487|NCT03673826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850506|NCT03651102|Immunologic Factors|immunologic factors|mesh-ancestor
64850507|NCT03651102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850508|NCT03651102|Leprostatic Agents|leprostatic agents|mesh-ancestor
64850509|NCT03651102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64850510|NCT03651102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64850511|NCT03651102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64850512|NCT03651102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64850513|NCT03651102|Growth Substances|growth substances|mesh-ancestor
64850514|NCT03651102|Growth Inhibitors|growth inhibitors|mesh-ancestor
64850515|NCT03651102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850516|NCT03651102|Antisickling Agents|antisickling agents|mesh-ancestor
64850517|NCT03651102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850518|NCT03651102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850519|NCT03651102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64850520|NCT03649802|Vitamin D|vitamin d|mesh-list
64850521|NCT03649802|Ergocalciferols|ergocalciferols|mesh-list
64850522|NCT03649802|Cholecalciferol|cholecalciferol|mesh-list
64331795|NCT04817241|Daunorubicin|daunorubicin|mesh-list
64331796|NCT04817241|Venetoclax|venetoclax|mesh-list
64674904|NCT01882868|Micronutrients|micronutrients|mesh-ancestor
64331797|NCT04817241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64331798|NCT04817241|Antimetabolites|antimetabolites|mesh-ancestor
64331799|NCT04817241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331800|NCT04817241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331801|NCT04817241|Antiviral Agents|antiviral agents|mesh-ancestor
64331802|NCT04817241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64850524|NCT03649802|Micronutrients|micronutrients|mesh-ancestor
64850525|NCT03649802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850526|NCT03649802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64619006|NCT03018665|Metformin|metformin|mesh-list
64850527|NCT03649802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64850528|NCT03643198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64850529|NCT03643198|Metronidazole|metronidazole|mesh-list
64850530|NCT03643198|Ciprofloxacin|ciprofloxacin|mesh-list
64850531|NCT03643198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64850532|NCT03643198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64850533|NCT03643198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64850534|NCT03643198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64850535|NCT03643198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64850536|NCT03643198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850537|NCT03643198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850539|NCT03643198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64850540|NCT03643198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64850542|NCT03606980|Dexamethasone acetate|dexamethasone acetate|mesh-list
64850543|NCT03606980|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64850544|NCT03606980|BB 1101|bb 1101|mesh-list
64850545|NCT03606980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64850546|NCT03606980|Antiemetics|antiemetics|mesh-ancestor
64850547|NCT03606980|Autonomic Agents|autonomic agents|mesh-ancestor
64675136|NCT01223001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64850548|NCT03606980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64850549|NCT03606980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850550|NCT03606980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64850551|NCT03606980|Glucocorticoids|glucocorticoids|mesh-ancestor
64850552|NCT03606980|Hormones|hormones|mesh-ancestor
64331803|NCT04817241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64331804|NCT04817241|Immunologic Factors|immunologic factors|mesh-ancestor
64331805|NCT04817241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331806|NCT04817241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64331807|NCT04817241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64331808|NCT04817241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64331809|NCT04817241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331810|NCT04796220|Gemcitabine|gemcitabine|mesh-list
64331811|NCT04796220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64850553|NCT03606980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64850554|NCT03606980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64850555|NCT03606980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850556|NCT03606980|Protease Inhibitors|protease inhibitors|mesh-ancestor
64850557|NCT03606980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850558|NCT03606980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850559|NCT03576417|Nivolumab|nivolumab|mesh-list
64850560|NCT03576417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850561|NCT03576417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64850562|NCT03576417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64850563|NCT03576417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850564|NCT03573115|Adapalene|adapalene|mesh-list
64850565|NCT03573115|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64850566|NCT03573115|Dermatologic Agents|dermatologic agents|mesh-ancestor
64850567|NCT03573115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64850568|NCT03573115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64850569|NCT03573115|Analgesics|analgesics|mesh-ancestor
64850570|NCT03573115|Sensory System Agents|sensory system agents|mesh-ancestor
64850571|NCT03573115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64850572|NCT03573115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850573|NCT03573115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64850574|NCT03573115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64850575|NCT03569475|Milnacipran|milnacipran|mesh-list
64850576|NCT03569475|Fluoxetine|fluoxetine|mesh-list
64850577|NCT03569475|Levomilnacipran|levomilnacipran|mesh-list
64850578|NCT03569475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64850579|NCT03569475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64850597|NCT03546556|Dideoxynucleosides|dideoxynucleosides|mesh-list
64850598|NCT03546556|Antiviral Agents|antiviral agents|mesh-ancestor
64850599|NCT03546556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64850600|NCT03546556|Antimetabolites|antimetabolites|mesh-ancestor
64850601|NCT03546556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850602|NCT03546556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64675578|NCT00896025|Antioxidants|antioxidants|mesh-ancestor
64850603|NCT03546556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64850604|NCT03546556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850605|NCT03533712|Folic Acid|folic acid|mesh-list
64850606|NCT03533712|Hematinics|hematinics|mesh-ancestor
64850607|NCT03533712|Vitamin B Complex|vitamin b complex|mesh-ancestor
64850608|NCT03533712|Vitamins|vitamins|mesh-ancestor
64850609|NCT03533712|Micronutrients|micronutrients|mesh-ancestor
64850610|NCT03533712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850664|NCT03383380|Sirolimus|sirolimus|mesh-list
64850665|NCT03383380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64850666|NCT03383380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64850667|NCT03383380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64850668|NCT03383380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850669|NCT03383380|Antifungal Agents|antifungal agents|mesh-ancestor
64850670|NCT03383380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64850671|NCT03383380|Immunologic Factors|immunologic factors|mesh-ancestor
64850672|NCT03383380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850673|NCT03325439|Brivaracetam|brivaracetam|mesh-list
64850674|NCT03325439|Anticonvulsants|anticonvulsants|mesh-ancestor
64850675|NCT03242772|Amphetamine|amphetamine|mesh-list
64850676|NCT03242772|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64850677|NCT03242772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850678|NCT03242772|Sympathomimetics|sympathomimetics|mesh-ancestor
64850679|NCT03242772|Autonomic Agents|autonomic agents|mesh-ancestor
64850680|NCT03242772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64850681|NCT03242772|Dopamine Agents|dopamine agents|mesh-ancestor
64850682|NCT03242772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64850683|NCT03242772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850684|NCT03242772|Adrenergic Agents|adrenergic agents|mesh-ancestor
64675694|NCT00823095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64850685|NCT03242772|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64850686|NCT03242772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64850687|NCT03242772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64850688|NCT03242772|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64850689|NCT03236311|Adenosine|adenosine|mesh-list
64850690|NCT03236311|Regadenoson|regadenoson|mesh-list
64850691|NCT03236311|Analgesics|analgesics|mesh-ancestor
64850692|NCT03236311|Sensory System Agents|sensory system agents|mesh-ancestor
64850693|NCT03236311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64850694|NCT03236311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850695|NCT03236311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64850696|NCT03236311|Vasodilator Agents|vasodilator agents|mesh-ancestor
64850697|NCT03236311|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64850698|NCT03236311|Purinergic Agonists|purinergic agonists|mesh-ancestor
64850699|NCT03236311|Purinergic Agents|purinergic agents|mesh-ancestor
64850700|NCT03236311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64850701|NCT03236311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850702|NCT03236311|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64850703|NCT03234686|Deferiprone|deferiprone|mesh-list
64850704|NCT03234686|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64850705|NCT03234686|Chelating Agents|chelating agents|mesh-ancestor
64850706|NCT03234686|Sequestering Agents|sequestering agents|mesh-ancestor
64850710|NCT03223974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850726|NCT05438316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850727|NCT05438316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64850729|NCT05438108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64850730|NCT05438108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850731|NCT05438108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64850732|NCT05438108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64676169|NCT05715437|Analgesics|analgesics|mesh-ancestor
64850733|NCT05438108|Growth Substances|growth substances|mesh-ancestor
64850734|NCT05438108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850735|NCT05438108|Growth Inhibitors|growth inhibitors|mesh-ancestor
64850736|NCT05437783|Azithromycin|azithromycin|mesh-list
64850737|NCT05437783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64850738|NCT05437783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64850739|NCT05437718|Ropivacaine|ropivacaine|mesh-list
64850740|NCT05437718|Anesthetics, Local|anesthetics, local|mesh-ancestor
64850741|NCT05437718|Anesthetics|anesthetics|mesh-ancestor
64850742|NCT05437718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64850743|NCT05437718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850744|NCT05437718|Sensory System Agents|sensory system agents|mesh-ancestor
64850745|NCT05437718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64850746|NCT05437497|Propofol|propofol|mesh-list
64850747|NCT05437497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64850748|NCT05437497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64850749|NCT05437497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850750|NCT05437497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64850751|NCT05437497|Anesthetics, General|anesthetics, general|mesh-ancestor
64850752|NCT05437497|Anesthetics|anesthetics|mesh-ancestor
64850753|NCT05437471|Letrozole|letrozole|mesh-list
64850754|NCT05437471|Dydrogesterone|dydrogesterone|mesh-list
64850755|NCT05437471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850756|NCT05437471|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64850757|NCT05437471|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64850758|NCT05437471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850759|NCT05437471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850760|NCT05437471|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64850761|NCT05437471|Hormone Antagonists|hormone antagonists|mesh-ancestor
64850762|NCT05437471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64850764|NCT05437471|Progestins|progestins|mesh-ancestor
64850765|NCT05437471|Hormones|hormones|mesh-ancestor
64850766|NCT05437432|Lithium Carbonate|lithium carbonate|mesh-list
64850767|NCT05437432|Methamphetamine|methamphetamine|mesh-list
64850768|NCT05437432|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64850769|NCT05437432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850770|NCT05437432|Sympathomimetics|sympathomimetics|mesh-ancestor
64850771|NCT05437432|Autonomic Agents|autonomic agents|mesh-ancestor
64850772|NCT05437432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64850773|NCT05437432|Dopamine Agents|dopamine agents|mesh-ancestor
64850774|NCT05437432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64850775|NCT05437432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850776|NCT05437432|Adrenergic Agents|adrenergic agents|mesh-ancestor
64850777|NCT05437432|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64850778|NCT05437432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64850779|NCT05437432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64850780|NCT05437432|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64850781|NCT05437432|Antidepressive Agents|antidepressive agents|mesh-ancestor
64850782|NCT05437432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64850783|NCT05437432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850810|NCT05426811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850811|NCT05426811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64850812|NCT05426811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850813|NCT05357859|Vitamin D|vitamin d|mesh-list
64850814|NCT05357859|Cholecalciferol|cholecalciferol|mesh-list
64850815|NCT05357859|Vitamins|vitamins|mesh-ancestor
64850816|NCT05357859|Micronutrients|micronutrients|mesh-ancestor
64850817|NCT05357859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850818|NCT05357859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64850819|NCT05357859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64850820|NCT05265286|Factor VIII|factor viii|mesh-list
64850821|NCT05265286|Coagulants|coagulants|mesh-ancestor
64850822|NCT05239169|Capecitabine|capecitabine|mesh-list
64850823|NCT05239169|Durvalumab|durvalumab|mesh-list
64850824|NCT05239169|Tremelimumab|tremelimumab|mesh-list
64850825|NCT05239169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64850826|NCT05239169|Antimetabolites|antimetabolites|mesh-ancestor
64619305|NCT03802864|Anesthetics|anesthetics|mesh-ancestor
64850827|NCT05239169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850828|NCT05239169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678074|NCT00001569|Paclitaxel|paclitaxel|mesh-list
64850829|NCT05239169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64850831|NCT05120596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64850832|NCT05120596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850833|NCT05006079|Morphine|morphine|mesh-list
64850834|NCT05006079|Alprazolam|alprazolam|mesh-list
64850835|NCT05006079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64850836|NCT05006079|Narcotics|narcotics|mesh-ancestor
64294989|NCT03976934|Urological Agents|urological agents|mesh-ancestor
64850861|NCT04950270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64850862|NCT04950270|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64850863|NCT04950270|Natriuretic Agents|natriuretic agents|mesh-ancestor
64850864|NCT04950270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850866|NCT04895046|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64850867|NCT04895046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850868|NCT04895046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850869|NCT04895046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850870|NCT04765514|Temozolomide|temozolomide|mesh-list
64850871|NCT04765514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64850872|NCT04765514|Alkylating Agents|alkylating agents|mesh-ancestor
64850873|NCT04765514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850874|NCT04765514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850875|NCT04590586|Thalidomide|thalidomide|mesh-list
64850876|NCT04590586|Apremilast|apremilast|mesh-list
64678969|NCT04933331|Silver Nitrate|silver nitrate|mesh-list
64850878|NCT04590586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64850879|NCT04590586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64850881|NCT04590586|Sensory System Agents|sensory system agents|mesh-ancestor
64850882|NCT04590586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64850883|NCT04590586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850884|NCT04590586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64850885|NCT04590586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64850886|NCT04590586|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64850887|NCT04590586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64850888|NCT04590586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850930|NCT03819296|Immunologic Factors|immunologic factors|mesh-ancestor
64850931|NCT03819296|Dermatologic Agents|dermatologic agents|mesh-ancestor
64850932|NCT03819296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64850933|NCT03819296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64850934|NCT03563742|Tenofovir|tenofovir|mesh-list
64850935|NCT03563742|Lamivudine|lamivudine|mesh-list
64850936|NCT03563742|Rilpivirine|rilpivirine|mesh-list
64850937|NCT03563742|Antiviral Agents|antiviral agents|mesh-ancestor
64850938|NCT03563742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64850939|NCT03563742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64850946|NCT03537014|Hallucinogens|hallucinogens|mesh-ancestor
64850947|NCT03537014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850948|NCT03537014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64850949|NCT03537014|Serotonin Agents|serotonin agents|mesh-ancestor
64850950|NCT03537014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64850951|NCT03537014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850952|NCT03537014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64850953|NCT03537014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64850954|NCT03537014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64850955|NCT03537014|Adrenergic Agents|adrenergic agents|mesh-ancestor
64331815|NCT04796220|Antiviral Agents|antiviral agents|mesh-ancestor
64331816|NCT04796220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64331817|NCT04796220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331818|NCT04796220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64850973|NCT03424122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64850974|NCT03424122|Immunologic Factors|immunologic factors|mesh-ancestor
64850975|NCT03424122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64850976|NCT03424122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64850977|NCT03424122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64850978|NCT03424122|Alkylating Agents|alkylating agents|mesh-ancestor
64850979|NCT03424122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850980|NCT03230097|BI 409306|bi 409306|mesh-list
64850981|NCT03230097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64850982|NCT03230097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64850983|NCT03230097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64850984|NCT02968940|Avelumab|avelumab|mesh-list
64850985|NCT02968940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64851028|NCT02203773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64851029|NCT02203773|Antifungal Agents|antifungal agents|mesh-ancestor
64851030|NCT02203773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64851031|NCT02203773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64851032|NCT02203773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64851033|NCT02203773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64851034|NCT02203773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64679419|NCT00360737|Antitoxins|antitoxins|mesh-list
64851035|NCT02203773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64851036|NCT02203773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64851037|NCT02203773|Hormone Antagonists|hormone antagonists|mesh-ancestor
64851038|NCT02203773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64331819|NCT04796220|Immunologic Factors|immunologic factors|mesh-ancestor
64331820|NCT04796220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331821|NCT04777045|Diltiazem|diltiazem|mesh-list
64331822|NCT04777045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64331823|NCT04777045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64331824|NCT04777045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64331825|NCT04777045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331826|NCT04777045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64331827|NCT04777045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331828|NCT04777045|Vasodilator Agents|vasodilator agents|mesh-ancestor
64331830|NCT04632238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64331831|NCT04632238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64331832|NCT04632238|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64331833|NCT04632238|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64331834|NCT04597190|Norepinephrine|norepinephrine|mesh-list
64331835|NCT04597190|Serotonin|serotonin|mesh-list
64331836|NCT04597190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
64331837|NCT04597190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64331838|NCT04597190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64851039|NCT02203773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851041|NCT02175030|Levonorgestrel|levonorgestrel|mesh-list
64851042|NCT02175030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64851043|NCT02175030|Contraceptive Agents|contraceptive agents|mesh-ancestor
64851044|NCT02175030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64851045|NCT02175030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851046|NCT02175030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64851047|NCT02175030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64851048|NCT02175030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64851049|NCT02175030|Trace Elements|trace elements|mesh-ancestor
64851050|NCT02175030|Micronutrients|micronutrients|mesh-ancestor
64851051|NCT02017717|Bevacizumab|bevacizumab|mesh-list
64851052|NCT02017717|Nivolumab|nivolumab|mesh-list
64851053|NCT02017717|Ipilimumab|ipilimumab|mesh-list
64851054|NCT02017717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64851055|NCT02017717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851056|NCT02017717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64851057|NCT02017717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64851058|NCT02017717|Growth Substances|growth substances|mesh-ancestor
64851059|NCT02017717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851060|NCT02017717|Growth Inhibitors|growth inhibitors|mesh-ancestor
64851061|NCT02017717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64851062|NCT02017717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851063|NCT01734512|Everolimus|everolimus|mesh-list
64851064|NCT01734512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851065|NCT01734512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64851112|NCT00316888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851113|NCT00316888|Antimetabolites|antimetabolites|mesh-ancestor
64851114|NCT00316888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851115|NCT00316888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64851116|NCT00316888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64851117|NCT00316888|Immunologic Factors|immunologic factors|mesh-ancestor
64851118|NCT00316888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851119|NCT00316888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64851120|NCT03164889|Entecavir|entecavir|mesh-list
64851121|NCT03164889|Molgramostim|molgramostim|mesh-list
64851122|NCT03164889|Sargramostim|sargramostim|mesh-list
64851123|NCT03164889|Antiviral Agents|antiviral agents|mesh-ancestor
64851124|NCT03164889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64851125|NCT03164889|Immunologic Factors|immunologic factors|mesh-ancestor
64851126|NCT03164889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851127|NCT03164889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851128|NCT03133260|Aspirin|aspirin|mesh-list
64851135|NCT03133260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64851136|NCT03133260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64851137|NCT03133260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64851138|NCT03133260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64851139|NCT03133260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851140|NCT03133260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64851141|NCT03133260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64851142|NCT03133260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64851143|NCT03133260|Antipyretics|antipyretics|mesh-ancestor
64851144|NCT03126812|Paclitaxel|paclitaxel|mesh-list
64851145|NCT03126812|Carboplatin|carboplatin|mesh-list
64851146|NCT03126812|Pembrolizumab|pembrolizumab|mesh-list
64331839|NCT04597190|Adrenergic Agents|adrenergic agents|mesh-ancestor
64331840|NCT04597190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64331841|NCT04597190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851148|NCT03126812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851150|NCT03126812|Antimitotic Agents|antimitotic agents|mesh-ancestor
64851151|NCT03126812|Mitosis Modulators|mitosis modulators|mesh-ancestor
64851152|NCT03126812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851153|NCT03126812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64851154|NCT03096834|Erenumab|erenumab|mesh-list
64851155|NCT03096834|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64851156|NCT03096834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851157|NCT03096834|Analgesics|analgesics|mesh-ancestor
64851158|NCT03096834|Sensory System Agents|sensory system agents|mesh-ancestor
64679841|NCT05730712|Pertuzumab|pertuzumab|mesh-list
64851159|NCT03096834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64851160|NCT03096834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851161|NCT03089203|Cyclophosphamide|cyclophosphamide|mesh-list
64851162|NCT03089203|Fludarabine|fludarabine|mesh-list
64851163|NCT03089203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64851164|NCT03089203|Immunologic Factors|immunologic factors|mesh-ancestor
64851165|NCT03089203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851166|NCT03089203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64851167|NCT03089203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64851168|NCT03089203|Alkylating Agents|alkylating agents|mesh-ancestor
64851169|NCT03089203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851170|NCT03089203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851171|NCT03089203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64851227|NCT03006432|Antimetabolites|antimetabolites|mesh-ancestor
64851228|NCT03006432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64851229|NCT03006432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64851230|NCT03006432|Immunologic Factors|immunologic factors|mesh-ancestor
64851231|NCT03006432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851232|NCT03006432|Antidotes|antidotes|mesh-ancestor
64851233|NCT03006432|Protective Agents|protective agents|mesh-ancestor
64851234|NCT03006432|Vitamin B Complex|vitamin b complex|mesh-ancestor
64851235|NCT03006432|Vitamins|vitamins|mesh-ancestor
64851236|NCT03006432|Micronutrients|micronutrients|mesh-ancestor
64851237|NCT03006432|Hematinics|hematinics|mesh-ancestor
64851238|NCT03003065|Temoporfin|temoporfin|mesh-list
64851239|NCT03003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851240|NCT03003065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64851241|NCT03003065|Dermatologic Agents|dermatologic agents|mesh-ancestor
64851242|NCT03001011|Sevelamer|sevelamer|mesh-list
64851243|NCT03001011|Chelating Agents|chelating agents|mesh-ancestor
64851244|NCT03001011|Sequestering Agents|sequestering agents|mesh-ancestor
64851245|NCT03001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851246|NCT02993757|Vaccines|vaccines|mesh-list
64851247|NCT02993757|Immunologic Factors|immunologic factors|mesh-ancestor
64851248|NCT02993757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851249|NCT02979535|Vaccines|vaccines|mesh-list
64851250|NCT02979535|Immunologic Factors|immunologic factors|mesh-ancestor
64851251|NCT02979535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851252|NCT02978716|Gemcitabine|gemcitabine|mesh-list
64851253|NCT02978716|Carboplatin|carboplatin|mesh-list
64851254|NCT02978716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851255|NCT02978716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64851256|NCT02978716|Antimetabolites|antimetabolites|mesh-ancestor
64851257|NCT02978716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851258|NCT02978716|Antiviral Agents|antiviral agents|mesh-ancestor
64851259|NCT02978716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64851260|NCT02978716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64851261|NCT02978716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64331848|NCT04597190|Serotonin Agents|serotonin agents|mesh-ancestor
64851262|NCT02978716|Immunologic Factors|immunologic factors|mesh-ancestor
64851263|NCT02978716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851264|NCT02973321|Metformin|metformin|mesh-list
64851265|NCT02973321|Liraglutide|liraglutide|mesh-list
64851266|NCT02973321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64851267|NCT02973321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851268|NCT02973321|Incretins|incretins|mesh-ancestor
64851269|NCT02973321|Hormones|hormones|mesh-ancestor
64851270|NCT02973321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64851271|NCT02967250|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64851272|NCT02967250|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64851273|NCT02967250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64851274|NCT02943785|Edoxaban|edoxaban|mesh-list
64851275|NCT02943785|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64851276|NCT02943785|Antithrombins|antithrombins|mesh-ancestor
64851277|NCT02943785|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64851278|NCT02943785|Protease Inhibitors|protease inhibitors|mesh-ancestor
64851279|NCT02943785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295009|NCT02473575|Purinergic Agents|purinergic agents|mesh-ancestor
64295010|NCT02473575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64331854|NCT04577638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64851336|NCT02787551|Insulin Glargine|insulin glargine|mesh-list
64851337|NCT02787551|Pioglitazone|pioglitazone|mesh-list
64851338|NCT02787551|Liraglutide|liraglutide|mesh-list
64851339|NCT02787551|Exenatide|exenatide|mesh-list
64851340|NCT02787551|Dulaglutide|dulaglutide|mesh-list
64851341|NCT02787551|Lixisenatide|lixisenatide|mesh-list
64851342|NCT02787551|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64851343|NCT02787551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64851344|NCT02787551|rGLP-1 protein|rglp-1 protein|mesh-list
64851345|NCT02787551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851346|NCT02787551|Incretins|incretins|mesh-ancestor
64851347|NCT02787551|Hormones|hormones|mesh-ancestor
64851348|NCT02787551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64851349|NCT02787551|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64851350|NCT02787551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851351|NCT02735044|Insulin|insulin|mesh-list
64851352|NCT02735044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64851353|NCT02735044|Insulin Glargine|insulin glargine|mesh-list
64851354|NCT02735044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64851355|NCT02735044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851356|NCT02692651|Vancomycin|vancomycin|mesh-list
64851357|NCT02692651|Fidaxomicin|fidaxomicin|mesh-list
64851358|NCT02692651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64851359|NCT02692651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64851360|NCT02674061|Pembrolizumab|pembrolizumab|mesh-list
64851361|NCT02674061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64851362|NCT02674061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851363|NCT02654314|Melatonin|melatonin|mesh-list
64851364|NCT02654314|Antioxidants|antioxidants|mesh-ancestor
64851365|NCT02654314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851390|NCT02608684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64851391|NCT02608684|Antimetabolites|antimetabolites|mesh-ancestor
64680497|NCT04341545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851392|NCT02608684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851393|NCT02608684|Antiviral Agents|antiviral agents|mesh-ancestor
64851394|NCT02608684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64851395|NCT02608684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64851396|NCT02608684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64851397|NCT02608684|Immunologic Factors|immunologic factors|mesh-ancestor
64851398|NCT02608684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851399|NCT02608684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64851400|NCT02587520|Vaccines|vaccines|mesh-list
64851401|NCT02587520|Immunologic Factors|immunologic factors|mesh-ancestor
64851402|NCT02587520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851403|NCT02584829|Interferons|interferons|mesh-list
64851404|NCT02584829|Interferon-beta|interferon-beta|mesh-list
64851405|NCT02584829|Avelumab|avelumab|mesh-list
64851406|NCT02584829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64851407|NCT02584829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851408|NCT02584829|Antiviral Agents|antiviral agents|mesh-ancestor
64851409|NCT02584829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64851410|NCT02584829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64851411|NCT02584829|Immunologic Factors|immunologic factors|mesh-ancestor
64851412|NCT02584829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851413|NCT02559856|Rivaroxaban|rivaroxaban|mesh-list
64851414|NCT02559856|Apixaban|apixaban|mesh-list
64851415|NCT02559856|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64851416|NCT02559856|Antithrombins|antithrombins|mesh-ancestor
64851417|NCT02559856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64851418|NCT02559856|Protease Inhibitors|protease inhibitors|mesh-ancestor
64851419|NCT02559856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64851420|NCT02559856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851421|NCT02559856|Anticoagulants|anticoagulants|mesh-ancestor
64851422|NCT02557321|Pembrolizumab|pembrolizumab|mesh-list
64851423|NCT02557321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64851424|NCT02557321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851425|NCT02512172|Pembrolizumab|pembrolizumab|mesh-list
64851426|NCT02512172|Azacitidine|azacitidine|mesh-list
64851427|NCT02512172|Romidepsin|romidepsin|mesh-list
64851428|NCT02512172|Cc-486|cc-486|mesh-list
64851429|NCT02512172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64851430|NCT02512172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851431|NCT02512172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64680906|NCT03192397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64851432|NCT02512172|Antimetabolites|antimetabolites|mesh-ancestor
64851433|NCT02512172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851434|NCT02512172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64851435|NCT02512172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64851436|NCT02499367|Cyclophosphamide|cyclophosphamide|mesh-list
64851438|NCT02499367|Nivolumab|nivolumab|mesh-list
64851439|NCT02499367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64851440|NCT02499367|Immunologic Factors|immunologic factors|mesh-ancestor
64851441|NCT02499367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680908|NCT03192397|Antitubercular Agents|antitubercular agents|mesh-ancestor
64851442|NCT02499367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64851443|NCT02499367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64851444|NCT02499367|Alkylating Agents|alkylating agents|mesh-ancestor
64851445|NCT02499367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851446|NCT02499367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851447|NCT02499367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64851448|NCT02499367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64851449|NCT02499367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64851450|NCT02499367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64851451|NCT02499367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64851452|NCT02499367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64851453|NCT02499367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64851454|NCT02497612|Artefenomel|artefenomel|mesh-list
64851455|NCT02497612|Ferroquine|ferroquine|mesh-list
64851456|NCT02497612|Antimalarials|antimalarials|mesh-ancestor
64851457|NCT02497612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64851458|NCT02497612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64851459|NCT02497612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64851460|NCT02497131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64851461|NCT02497131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64851462|NCT02497131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851463|NCT02491333|Metformin|metformin|mesh-list
64851464|NCT02491333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64851465|NCT02491333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851466|NCT02469987|Bevacizumab|bevacizumab|mesh-list
64851467|NCT02469987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64851468|NCT02469987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851469|NCT02469987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64851470|NCT02469987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64851471|NCT02469987|Growth Substances|growth substances|mesh-ancestor
64851472|NCT02469987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851473|NCT02469987|Growth Inhibitors|growth inhibitors|mesh-ancestor
64851474|NCT02439307|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64851475|NCT02439307|Rifaximin|rifaximin|mesh-list
64851476|NCT02439307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64851477|NCT02439307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64851478|NCT02381652|Triamcinolone|triamcinolone|mesh-list
64851479|NCT02381652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64851480|NCT02381652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64851481|NCT02381652|Hyaluronic Acid|hyaluronic acid|mesh-list
64851482|NCT02381652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64680972|NCT02813148|Naloxegol|naloxegol|mesh-list
64851483|NCT02381652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64851484|NCT02381652|Glucocorticoids|glucocorticoids|mesh-ancestor
64851485|NCT02381652|Hormones|hormones|mesh-ancestor
64851486|NCT02381652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64851487|NCT02381652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851488|NCT02381652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64851489|NCT02381652|Immunologic Factors|immunologic factors|mesh-ancestor
64851490|NCT02381652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64851491|NCT02381652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851492|NCT02381652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64851493|NCT02381652|Viscosupplements|viscosupplements|mesh-ancestor
64851494|NCT02381652|Protective Agents|protective agents|mesh-ancestor
64851495|NCT02368301|Dexamethasone|dexamethasone|mesh-list
64851503|NCT02368301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64851504|NCT02368301|Glucocorticoids|glucocorticoids|mesh-ancestor
64851505|NCT02368301|Hormones|hormones|mesh-ancestor
64851506|NCT02368301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64851507|NCT02368301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64851508|NCT02368301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851509|NCT02368301|Immunologic Factors|immunologic factors|mesh-ancestor
64851510|NCT02368301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64851511|NCT02368301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64851544|NCT02355379|Fluorouracil|fluorouracil|mesh-list
64851545|NCT02355379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64851562|NCT02325466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64851563|NCT02325466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64851564|NCT02325466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851565|NCT02325466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64851566|NCT02325466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64851568|NCT02325466|Antipyretics|antipyretics|mesh-ancestor
64851569|NCT02325466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64851570|NCT02325466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64851571|NCT02325466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64851572|NCT02325466|Purinergic Agents|purinergic agents|mesh-ancestor
64851573|NCT02325466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64851574|NCT02323100|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64851576|NCT02323100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64851577|NCT02323100|Protective Agents|protective agents|mesh-ancestor
64851578|NCT02323100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851579|NCT02323100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851580|NCT02322710|Petrolatum|petrolatum|mesh-list
64851581|NCT02322710|Emollients|emollients|mesh-ancestor
64851582|NCT02322710|Dermatologic Agents|dermatologic agents|mesh-ancestor
64851583|NCT02283281|Dronabinol|dronabinol|mesh-list
64851584|NCT02283281|Hallucinogens|hallucinogens|mesh-ancestor
64851585|NCT02283281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851586|NCT02283281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64681222|NCT01176006|Busulfan|busulfan|mesh-list
64851587|NCT02283281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64851588|NCT02283281|Analgesics|analgesics|mesh-ancestor
64851589|NCT02283281|Sensory System Agents|sensory system agents|mesh-ancestor
64851590|NCT02283281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64851611|NCT02204241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64851612|NCT02204241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64851613|NCT02204241|Glucocorticoids|glucocorticoids|mesh-ancestor
64851614|NCT02204241|Hormones|hormones|mesh-ancestor
64851615|NCT02204241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64851616|NCT02204241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64851617|NCT02185820|Dexamethasone|dexamethasone|mesh-list
64851618|NCT02185820|Pomalidomide|pomalidomide|mesh-list
64851619|NCT02185820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64851620|NCT02185820|Antiemetics|antiemetics|mesh-ancestor
64851621|NCT02185820|Autonomic Agents|autonomic agents|mesh-ancestor
64851622|NCT02185820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64851623|NCT02185820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851624|NCT02185820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64851625|NCT02185820|Glucocorticoids|glucocorticoids|mesh-ancestor
64851626|NCT02185820|Hormones|hormones|mesh-ancestor
64851627|NCT02185820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64851628|NCT02185820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64851629|NCT02185820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851630|NCT02185820|Immunologic Factors|immunologic factors|mesh-ancestor
64851631|NCT02185820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64851632|NCT02185820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64851633|NCT02185820|Growth Substances|growth substances|mesh-ancestor
64851634|NCT02185820|Growth Inhibitors|growth inhibitors|mesh-ancestor
64851635|NCT02162563|Leucovorin|leucovorin|mesh-list
64851636|NCT02162563|Bevacizumab|bevacizumab|mesh-list
64851637|NCT02162563|Panitumumab|panitumumab|mesh-list
64851638|NCT02162563|Fluorouracil|fluorouracil|mesh-list
64851639|NCT02162563|Oxaliplatin|oxaliplatin|mesh-list
64851640|NCT02162563|Irinotecan|irinotecan|mesh-list
64851641|NCT02162563|Levoleucovorin|levoleucovorin|mesh-list
64851652|NCT02162563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64851653|NCT02162563|Immunologic Factors|immunologic factors|mesh-ancestor
64851654|NCT02162563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64851655|NCT02162563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64851656|NCT02162563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64851658|NCT02162563|Protective Agents|protective agents|mesh-ancestor
64851659|NCT02162563|Vitamin B Complex|vitamin b complex|mesh-ancestor
64851660|NCT02162563|Vitamins|vitamins|mesh-ancestor
64851661|NCT02162563|Micronutrients|micronutrients|mesh-ancestor
64851662|NCT02127086|Analgesics|analgesics|mesh-list
64851663|NCT02127086|Sensory System Agents|sensory system agents|mesh-ancestor
64851664|NCT02127086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64851665|NCT02127086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851666|NCT02120079|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64851667|NCT02120079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64851668|NCT02120079|Lubricant Eye Drops|lubricant eye drops|mesh-list
64851669|NCT02120079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64851670|NCT02120079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64851671|NCT02106195|Belumosudil|belumosudil|mesh-list
64851672|NCT02106195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64851673|NCT02106195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64851674|NCT02106195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851675|NCT02075177|Ketoconazole|ketoconazole|mesh-list
64851676|NCT02075177|Fenretinide|fenretinide|mesh-list
64851677|NCT02075177|Antifungal Agents|antifungal agents|mesh-ancestor
64851678|NCT02075177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64851679|NCT02075177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64851680|NCT02075177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64851681|NCT02075177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64851682|NCT02075177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851683|NCT02075177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64851684|NCT02075177|Hormone Antagonists|hormone antagonists|mesh-ancestor
64851685|NCT02075177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64851686|NCT02075177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851687|NCT02075177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64851688|NCT02075177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851689|NCT02075177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64851697|NCT02050919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64851698|NCT02050919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851699|NCT02050919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64851700|NCT02050919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64851701|NCT02050919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64851702|NCT02050919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64851710|NCT02040857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851711|NCT02040857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64851713|NCT02040857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851714|NCT02040857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64851715|NCT02040857|Hormone Antagonists|hormone antagonists|mesh-ancestor
64851716|NCT02040857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64851717|NCT02040857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851718|NCT02040857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64851719|NCT02040857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64851720|NCT02040857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64331855|NCT04577638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331856|NCT04549168|Lemborexant|lemborexant|mesh-list
64331857|NCT04549168|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64331858|NCT04549168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64331859|NCT04549168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331860|NCT04549168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64331861|NCT04549168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64331862|NCT04549168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64331863|NCT04549168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331865|NCT04529772|Cyclophosphamide|cyclophosphamide|mesh-list
64331866|NCT04529772|Rituximab|rituximab|mesh-list
64331867|NCT04529772|Doxorubicin|doxorubicin|mesh-list
64331868|NCT04529772|Vincristine|vincristine|mesh-list
64331869|NCT04529772|Acalabrutinib|acalabrutinib|mesh-list
64331870|NCT04529772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64331871|NCT04529772|Immunologic Factors|immunologic factors|mesh-ancestor
64851721|NCT02040857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64851722|NCT02040857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64851724|NCT01997463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64851725|NCT01997463|Autonomic Agents|autonomic agents|mesh-ancestor
64851726|NCT01997463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64851727|NCT01997463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851728|NCT01997463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64851729|NCT01997463|Respiratory System Agents|respiratory system agents|mesh-ancestor
64851730|NCT01997463|Tocolytic Agents|tocolytic agents|mesh-ancestor
64851731|NCT01997463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64851732|NCT01997463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64851733|NCT01997463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64851734|NCT01997463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64851735|NCT01997463|Adrenergic Agents|adrenergic agents|mesh-ancestor
64851736|NCT01997463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64851737|NCT01997463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851738|NCT01976754|Dexmedetomidine|dexmedetomidine|mesh-list
64851739|NCT01976754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64851740|NCT01976754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64851741|NCT01976754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851742|NCT01976754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64851743|NCT01976754|Analgesics|analgesics|mesh-ancestor
64851744|NCT01976754|Sensory System Agents|sensory system agents|mesh-ancestor
64851745|NCT01976754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64331872|NCT04529772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295020|NCT05114421|Lenvatinib|lenvatinib|mesh-list
64851779|NCT01913730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851780|NCT01904123|Tyrphostins|tyrphostins|mesh-list
64851781|NCT01904123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851782|NCT01904123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64851783|NCT01904123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851785|NCT01863186|Clonidine|clonidine|mesh-list
64851786|NCT01863186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64851787|NCT01863186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64851788|NCT01863186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851789|NCT01863186|Sensory System Agents|sensory system agents|mesh-ancestor
64851790|NCT01863186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64851791|NCT01863186|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64851792|NCT01863186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64851793|NCT01863186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64851794|NCT01863186|Adrenergic Agents|adrenergic agents|mesh-ancestor
64851795|NCT01863186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64851796|NCT01863186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851797|NCT01863186|Analgesics|analgesics|mesh-ancestor
64851798|NCT01863186|Sympatholytics|sympatholytics|mesh-ancestor
64851799|NCT01863186|Autonomic Agents|autonomic agents|mesh-ancestor
64851800|NCT01828840|Fentanyl|fentanyl|mesh-list
64851801|NCT01828840|Morphine|morphine|mesh-list
64851802|NCT01828840|Methadone|methadone|mesh-list
64851808|NCT01828840|Sensory System Agents|sensory system agents|mesh-ancestor
64851809|NCT01828840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682305|NCT03083431|Adrenergic Agents|adrenergic agents|mesh-ancestor
64851810|NCT01828840|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64851811|NCT01828840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64851812|NCT01828840|Anesthetics, General|anesthetics, general|mesh-ancestor
64851813|NCT01828840|Anesthetics|anesthetics|mesh-ancestor
64851814|NCT01828840|Antitussive Agents|antitussive agents|mesh-ancestor
64851815|NCT01828840|Respiratory System Agents|respiratory system agents|mesh-ancestor
64851816|NCT01817426|Infliximab|infliximab|mesh-list
64851817|NCT01817426|Dermatologic Agents|dermatologic agents|mesh-ancestor
64620281|NCT00972725|Chloroquine|chloroquine|mesh-list
64851818|NCT01817426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64851819|NCT01817426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64851820|NCT01741103|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64851821|NCT01741103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64851822|NCT01741103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851823|NCT01741103|Incretins|incretins|mesh-ancestor
64851824|NCT01741103|Hormones|hormones|mesh-ancestor
64851825|NCT01741103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64851826|NCT01741103|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64851827|NCT01741103|Protease Inhibitors|protease inhibitors|mesh-ancestor
64851828|NCT01741103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64851829|NCT01741103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851830|NCT01722331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64851831|NCT01722331|Immunologic Factors|immunologic factors|mesh-ancestor
64851832|NCT01722331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851833|NCT01630590|Androgens|androgens|mesh-list
64851834|NCT01630590|Hormones|hormones|mesh-ancestor
64682776|NCT05095311|Cetirizine|cetirizine|mesh-list
64851835|NCT01630590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64851836|NCT01630590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851837|NCT01619085|Nintedanib|nintedanib|mesh-list
64851838|NCT01619085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851839|NCT01619085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64851840|NCT01619085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331873|NCT04529772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64331874|NCT04529772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64331875|NCT04529772|Alkylating Agents|alkylating agents|mesh-ancestor
64331876|NCT04529772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331877|NCT04529772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851842|NCT01499095|Insulin|insulin|mesh-list
64851843|NCT01499095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64851844|NCT01499095|Insulin Glargine|insulin glargine|mesh-list
64851874|NCT01414777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64851876|NCT01411241|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64851877|NCT01411241|Immunologic Factors|immunologic factors|mesh-ancestor
64851878|NCT01411241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851879|NCT01380938|Ribavirin|ribavirin|mesh-list
64851880|NCT01380938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64851881|NCT01380938|Interferon-alpha|interferon-alpha|mesh-list
64851882|NCT01380938|Antimetabolites|antimetabolites|mesh-ancestor
64851948|NCT01166113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64851949|NCT01166113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64851950|NCT01166113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64331881|NCT04529772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64331882|NCT04529772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64331883|NCT04529772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331884|NCT04529772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64331885|NCT04529772|Glucocorticoids|glucocorticoids|mesh-ancestor
64331886|NCT04529772|Hormones|hormones|mesh-ancestor
64331887|NCT04529772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64331888|NCT04529772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64331889|NCT04529772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64331890|NCT04529772|Tubulin Modulators|tubulin modulators|mesh-ancestor
64331891|NCT04529772|Antimitotic Agents|antimitotic agents|mesh-ancestor
64851951|NCT01166113|Growth Substances|growth substances|mesh-ancestor
64851952|NCT01166113|Growth Inhibitors|growth inhibitors|mesh-ancestor
64851953|NCT01160107|Prednisone|prednisone|mesh-list
64851954|NCT01160107|Melphalan|melphalan|mesh-list
64851955|NCT01160107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64851956|NCT01160107|Glucocorticoids|glucocorticoids|mesh-ancestor
64851957|NCT01160107|Hormones|hormones|mesh-ancestor
64851958|NCT01160107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64851960|NCT01160107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64851961|NCT01160107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851962|NCT01160107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64851963|NCT01160107|Alkylating Agents|alkylating agents|mesh-ancestor
64851964|NCT01160107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851965|NCT01160107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64851966|NCT01160107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64620436|NCT03898934|Vitamin D|vitamin d|mesh-list
64851967|NCT01160107|Immunologic Factors|immunologic factors|mesh-ancestor
64851969|NCT01150045|Celecoxib|celecoxib|mesh-list
64851970|NCT01150045|Fluorouracil|fluorouracil|mesh-list
64851971|NCT01150045|Oxaliplatin|oxaliplatin|mesh-list
64851972|NCT01150045|Antimetabolites|antimetabolites|mesh-ancestor
64851973|NCT01150045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64851974|NCT01150045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64851975|NCT01150045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64851976|NCT01150045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64851977|NCT01150045|Immunologic Factors|immunologic factors|mesh-ancestor
64851978|NCT01150045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64851979|NCT01150045|Antidotes|antidotes|mesh-ancestor
64851980|NCT01150045|Protective Agents|protective agents|mesh-ancestor
64851981|NCT01150045|Vitamin B Complex|vitamin b complex|mesh-ancestor
64851982|NCT01150045|Vitamins|vitamins|mesh-ancestor
64851983|NCT01150045|Micronutrients|micronutrients|mesh-ancestor
64683172|NCT01621009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64851984|NCT01150045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64851985|NCT01150045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64851986|NCT01150045|Analgesics|analgesics|mesh-ancestor
64851991|NCT01150045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64851992|NCT01150045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64851993|NCT01150045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64851994|NCT01098032|Acetylcysteine|acetylcysteine|mesh-list
64851995|NCT01098032|Antiviral Agents|antiviral agents|mesh-ancestor
64851996|NCT01098032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64851997|NCT01098032|Expectorants|expectorants|mesh-ancestor
64851998|NCT01098032|Respiratory System Agents|respiratory system agents|mesh-ancestor
64851999|NCT01098032|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64852000|NCT01098032|Antioxidants|antioxidants|mesh-ancestor
64852001|NCT01098032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852002|NCT01098032|Protective Agents|protective agents|mesh-ancestor
64852003|NCT01098032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852004|NCT01093196|Dexamethasone|dexamethasone|mesh-list
64852005|NCT01093196|Prednisone|prednisone|mesh-list
64852006|NCT01093196|Cyclophosphamide|cyclophosphamide|mesh-list
64852007|NCT01093196|Melphalan|melphalan|mesh-list
64852008|NCT01093196|Lenalidomide|lenalidomide|mesh-list
64852009|NCT01093196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64852010|NCT01093196|Immunologic Factors|immunologic factors|mesh-ancestor
64852011|NCT01093196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852012|NCT01093196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64852013|NCT01093196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64852014|NCT01093196|Alkylating Agents|alkylating agents|mesh-ancestor
64852015|NCT01093196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852016|NCT01093196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852017|NCT01093196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64852018|NCT01093196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64852019|NCT01093196|Antiemetics|antiemetics|mesh-ancestor
64852020|NCT01093196|Autonomic Agents|autonomic agents|mesh-ancestor
64852021|NCT01093196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64852022|NCT01093196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64852023|NCT01093196|Glucocorticoids|glucocorticoids|mesh-ancestor
64852024|NCT01093196|Hormones|hormones|mesh-ancestor
64852025|NCT01093196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64852026|NCT01093196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64852027|NCT01093196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64852028|NCT01093196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64852061|NCT00896389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64852062|NCT00896389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852064|NCT00880893|Immunologic Factors|immunologic factors|mesh-ancestor
64852065|NCT00880893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852066|NCT00579527|Cyclosporine|cyclosporine|mesh-list
64852067|NCT00579527|Mycophenolic Acid|mycophenolic acid|mesh-list
64852068|NCT00579527|Methylprednisolone|methylprednisolone|mesh-list
64852069|NCT00579527|Prednisolone|prednisolone|mesh-list
64852070|NCT00579527|Tacrolimus|tacrolimus|mesh-list
64852071|NCT00579527|Cyclosporins|cyclosporins|mesh-list
64852072|NCT00579527|Thymoglobulin|thymoglobulin|mesh-list
64852073|NCT00579527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64852074|NCT00579527|Daclizumab|daclizumab|mesh-list
64852075|NCT00579527|Parathyroid Hormone|parathyroid hormone|mesh-list
64852076|NCT00579527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64852077|NCT00579527|Immunologic Factors|immunologic factors|mesh-ancestor
64852078|NCT00579527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852079|NCT00579527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64852080|NCT00579527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331892|NCT04529772|Mitosis Modulators|mitosis modulators|mesh-ancestor
64331893|NCT04517799|Cannabidiol|cannabidiol|mesh-list
64331894|NCT04517799|Anticonvulsants|anticonvulsants|mesh-ancestor
64331895|NCT04495296|Gemcitabine|gemcitabine|mesh-list
64331897|NCT04495296|Capecitabine|capecitabine|mesh-list
64331898|NCT04495296|Oxaliplatin|oxaliplatin|mesh-list
64852081|NCT00579527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852083|NCT00579527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64852084|NCT00579527|Dermatologic Agents|dermatologic agents|mesh-ancestor
64852085|NCT00579527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64852086|NCT00579527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64852087|NCT00579527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852088|NCT00579527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64852089|NCT00579527|Antitubercular Agents|antitubercular agents|mesh-ancestor
64852090|NCT00579527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64852091|NCT00579527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64852092|NCT00579527|Antiemetics|antiemetics|mesh-ancestor
64852093|NCT00579527|Autonomic Agents|autonomic agents|mesh-ancestor
64852094|NCT00579527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64852095|NCT00579527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64852096|NCT00579527|Glucocorticoids|glucocorticoids|mesh-ancestor
64852097|NCT00579527|Hormones|hormones|mesh-ancestor
64852098|NCT00579527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64852099|NCT00579527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64852100|NCT00579527|Protective Agents|protective agents|mesh-ancestor
64852101|NCT00579527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64852102|NCT00579527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64852103|NCT00576836|Parathyroid Hormone|parathyroid hormone|mesh-list
64852104|NCT00576836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64852105|NCT00576836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852106|NCT00551928|Prednisone|prednisone|mesh-list
64852107|NCT00551928|Lenalidomide|lenalidomide|mesh-list
64852108|NCT00551928|Melphalan|melphalan|mesh-list
64852109|NCT00551928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64852110|NCT00551928|Glucocorticoids|glucocorticoids|mesh-ancestor
64852111|NCT00551928|Hormones|hormones|mesh-ancestor
64852112|NCT00551928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64852113|NCT00551928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852114|NCT00551928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64852115|NCT00551928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852116|NCT00551928|Immunologic Factors|immunologic factors|mesh-ancestor
64852117|NCT00551928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64852118|NCT00551928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64852119|NCT00551928|Growth Substances|growth substances|mesh-ancestor
64852120|NCT00551928|Growth Inhibitors|growth inhibitors|mesh-ancestor
64852121|NCT00551928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64852122|NCT00551928|Alkylating Agents|alkylating agents|mesh-ancestor
64852123|NCT00551928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852124|NCT00551928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64852125|NCT00551928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64852126|NCT00531232|Clofarabine|clofarabine|mesh-list
64852127|NCT00531232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64852128|NCT00531232|Antimetabolites|antimetabolites|mesh-ancestor
64852129|NCT00531232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852130|NCT00531232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852131|NCT00379340|Dactinomycin|dactinomycin|mesh-list
64852132|NCT00379340|Cactinomycin|cactinomycin|mesh-list
64852133|NCT00379340|Cyclophosphamide|cyclophosphamide|mesh-list
64852134|NCT00379340|Doxorubicin|doxorubicin|mesh-list
64852135|NCT00379340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64852136|NCT00379340|Etoposide|etoposide|mesh-list
64852137|NCT00379340|Vincristine|vincristine|mesh-list
64852138|NCT00379340|Etoposide phosphate|etoposide phosphate|mesh-list
64852139|NCT00379340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64852140|NCT00379340|Immunologic Factors|immunologic factors|mesh-ancestor
64852141|NCT00379340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852142|NCT00379340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64852143|NCT00379340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64852147|NCT00379340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64852148|NCT00379340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64852149|NCT00379340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64852157|NCT00379340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64852158|NCT00379340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64852159|NCT00379340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64852161|NCT00066950|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64852162|NCT00066950|Fluorides|fluorides|mesh-list
64852163|NCT00066950|Fluorides, Topical|fluorides, topical|mesh-list
64852164|NCT00066950|Cariostatic Agents|cariostatic agents|mesh-ancestor
64852165|NCT00066950|Protective Agents|protective agents|mesh-ancestor
64852166|NCT00066950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852167|NCT00066950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64852168|NCT00066950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64852169|NCT00066950|Disinfectants|disinfectants|mesh-ancestor
64852170|NCT00066950|Dermatologic Agents|dermatologic agents|mesh-ancestor
64852171|NCT01694134|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64852172|NCT01694134|Methylprednisolone|methylprednisolone|mesh-list
64852173|NCT01694134|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64852174|NCT01694134|Prednisolone|prednisolone|mesh-list
64852175|NCT01694134|Prednisolone acetate|prednisolone acetate|mesh-list
64852176|NCT01694134|Lidocaine|lidocaine|mesh-list
64852177|NCT01694134|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64852178|NCT01694134|Prednisolone phosphate|prednisolone phosphate|mesh-list
64852179|NCT01694134|Anesthetics, Local|anesthetics, local|mesh-ancestor
64852180|NCT01694134|Anesthetics|anesthetics|mesh-ancestor
64852181|NCT01694134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64852182|NCT01694134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852183|NCT01694134|Sensory System Agents|sensory system agents|mesh-ancestor
64852184|NCT01694134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64852185|NCT01694134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64852186|NCT01694134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64852187|NCT01694134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64852188|NCT01694134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64684554|NCT02372630|Linagliptin|linagliptin|mesh-list
64852189|NCT01694134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852190|NCT01694134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64852191|NCT01694134|Antiemetics|antiemetics|mesh-ancestor
64852192|NCT01694134|Autonomic Agents|autonomic agents|mesh-ancestor
64852193|NCT01694134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64852194|NCT01694134|Glucocorticoids|glucocorticoids|mesh-ancestor
64852196|NCT01694134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64852198|NCT01694134|Protective Agents|protective agents|mesh-ancestor
64852199|NCT01694134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64852200|NCT01694134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852201|NCT01694212|Diclofenac|diclofenac|mesh-list
64852202|NCT01694212|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64852203|NCT01694212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64852204|NCT01694212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64852205|NCT01694212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64852206|NCT01694212|Analgesics|analgesics|mesh-ancestor
64852207|NCT01694212|Sensory System Agents|sensory system agents|mesh-ancestor
64852208|NCT01694212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64852209|NCT01694212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852210|NCT01694212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64852211|NCT01694212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64852212|NCT01694212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64295047|NCT04646967|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64852222|NCT01694355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64852223|NCT01694381|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64852224|NCT01694381|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64852225|NCT01694381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64852227|NCT01694381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852228|NCT01694407|Tenofovir|tenofovir|mesh-list
64852229|NCT01694407|Emtricitabine|emtricitabine|mesh-list
64852230|NCT01694407|Antiviral Agents|antiviral agents|mesh-ancestor
64852231|NCT01694407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64852232|NCT01694407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64852233|NCT01694407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64852234|NCT01694407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684874|NCT02922777|Docetaxel|docetaxel|mesh-list
64852235|NCT01694407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852236|NCT01694407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64852237|NCT01694407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64852238|NCT01694459|Heparin|heparin|mesh-list
64852239|NCT01694459|Calcium heparin|calcium heparin|mesh-list
64852240|NCT01694459|Anticoagulants|anticoagulants|mesh-ancestor
64852241|NCT01694459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64295056|NCT05341323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64852295|NCT01695057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852296|NCT01695057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64852298|NCT01695057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852299|NCT01695070|Melatonin|melatonin|mesh-list
64852300|NCT01695070|Antioxidants|antioxidants|mesh-ancestor
64852301|NCT01695070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852302|NCT01695070|Protective Agents|protective agents|mesh-ancestor
64852303|NCT01695070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852304|NCT01695070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64852305|NCT01695109|Liraglutide|liraglutide|mesh-list
64852306|NCT01695109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64852307|NCT01695109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852308|NCT01695109|Incretins|incretins|mesh-ancestor
64852309|NCT01695109|Hormones|hormones|mesh-ancestor
64852310|NCT01695109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64852311|NCT01695122|Valproic Acid|valproic acid|mesh-list
64852312|NCT01695122|Anticonvulsants|anticonvulsants|mesh-ancestor
64852313|NCT01695122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852314|NCT01695122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852315|NCT01695122|GABA Agents|gaba agents|mesh-ancestor
64852316|NCT01695122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64852317|NCT01695122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852318|NCT01695122|Antimanic Agents|antimanic agents|mesh-ancestor
64852319|NCT01695122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64852323|NCT01695148|Antioxidants|antioxidants|mesh-ancestor
64852324|NCT01695148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852325|NCT01695148|Protective Agents|protective agents|mesh-ancestor
64852326|NCT01695148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852327|NCT01695174|Rifaximin|rifaximin|mesh-list
64852328|NCT01695174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64852329|NCT01695174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64852330|NCT01695174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64852331|NCT01695187|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
64852332|NCT01695187|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
64852333|NCT01695187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852334|NCT01695187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852335|NCT01695226|Celecoxib|celecoxib|mesh-list
64852367|NCT01695707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852368|NCT01695733|Vaccines|vaccines|mesh-list
64852369|NCT01695733|Immunologic Factors|immunologic factors|mesh-ancestor
64852370|NCT01695733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852371|NCT01695759|Epoetin Alfa|epoetin alfa|mesh-list
64852372|NCT01695759|Hematinics|hematinics|mesh-ancestor
64852373|NCT01695798|Vaccines|vaccines|mesh-list
64852374|NCT01695798|Immunologic Factors|immunologic factors|mesh-ancestor
64852375|NCT01695798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852376|NCT01695824|Warfarin|warfarin|mesh-list
64852377|NCT01695824|Anticoagulants|anticoagulants|mesh-ancestor
64852378|NCT01695850|Sennosides|sennosides|mesh-list
64852379|NCT01695850|Laxatives|laxatives|mesh-ancestor
64852380|NCT01695850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64852381|NCT01695902|Levonorgestrel|levonorgestrel|mesh-list
64852382|NCT01695902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64852383|NCT01695902|Contraceptive Agents|contraceptive agents|mesh-ancestor
64852384|NCT01695902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64410701|NCT03067753|Methylprednisolone|methylprednisolone|mesh-list
64852385|NCT01695902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852386|NCT01695902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64852387|NCT01695902|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64852388|NCT01695902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64852389|NCT01696110|Heparin|heparin|mesh-list
64852390|NCT01696110|Calcium heparin|calcium heparin|mesh-list
64852391|NCT01696110|Tirofiban|tirofiban|mesh-list
64852392|NCT01696110|Bivalirudin|bivalirudin|mesh-list
64852393|NCT01696110|Anticoagulants|anticoagulants|mesh-ancestor
64852394|NCT01696110|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64852395|NCT01696110|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64852401|NCT01696110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64852402|NCT01696240|Udenafil|udenafil|mesh-list
64852403|NCT01696240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64852404|NCT01696240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64852405|NCT01696240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852406|NCT01696240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852407|NCT01696370|Trimetazidine|trimetazidine|mesh-list
64852408|NCT01696370|Vasodilator Agents|vasodilator agents|mesh-ancestor
64852409|NCT01696383|Timolol|timolol|mesh-list
64852410|NCT01696383|Travoprost|travoprost|mesh-list
64331907|NCT04495296|Antimetabolites|antimetabolites|mesh-ancestor
64331908|NCT04495296|Antiviral Agents|antiviral agents|mesh-ancestor
64331909|NCT04495296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64331912|NCT04495296|Immunologic Factors|immunologic factors|mesh-ancestor
64331913|NCT04495296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331914|NCT04495296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64331915|NCT04495296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64852423|NCT01696409|Micronutrients|micronutrients|mesh-ancestor
64685562|NCT05635903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64852424|NCT01696409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852425|NCT01696409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64852426|NCT01696409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64852427|NCT01696422|Vaccines|vaccines|mesh-list
64852428|NCT01696422|Immunologic Factors|immunologic factors|mesh-ancestor
64852429|NCT01696422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852430|NCT01696448|Thioctic Acid|thioctic acid|mesh-list
64852431|NCT01696448|Antioxidants|antioxidants|mesh-ancestor
64852432|NCT01696448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852433|NCT01696448|Protective Agents|protective agents|mesh-ancestor
64852434|NCT01696448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852435|NCT01696448|Vitamin B Complex|vitamin b complex|mesh-ancestor
64685767|NCT01764685|Topiramate|topiramate|mesh-list
64852436|NCT01696448|Vitamins|vitamins|mesh-ancestor
64852437|NCT01696448|Micronutrients|micronutrients|mesh-ancestor
64852438|NCT01696461|Plerixafor|plerixafor|mesh-list
64852439|NCT01696461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64852440|NCT01696461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64852441|NCT01696461|Antiviral Agents|antiviral agents|mesh-ancestor
64852442|NCT01696461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64852443|NCT01696474|Bortezomib|bortezomib|mesh-list
64852444|NCT01696474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852445|NCT01696500|Immunoglobulins|immunoglobulins|mesh-list
64852446|NCT01696500|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64852447|NCT01696500|Antibodies|antibodies|mesh-list
64852448|NCT01696500|gamma-Globulins|gamma-globulins|mesh-list
64852449|NCT01696500|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64852450|NCT01696500|Immunologic Factors|immunologic factors|mesh-ancestor
64852451|NCT01696500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852452|NCT01696526|Vitamin D|vitamin d|mesh-list
64852453|NCT01696526|Vitamins|vitamins|mesh-ancestor
64852454|NCT01696526|Micronutrients|micronutrients|mesh-ancestor
64852455|NCT01696526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852456|NCT01696526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64852457|NCT01696552|Cimetidine|cimetidine|mesh-list
64852458|NCT01696552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64685820|NCT01769209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64685821|NCT01769209|Tubulin Modulators|tubulin modulators|mesh-ancestor
64685863|NCT03499483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64852502|NCT01696799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852504|NCT01696799|Hormone Antagonists|hormone antagonists|mesh-ancestor
64852505|NCT01696799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64852506|NCT01696799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852507|NCT01696825|Diazepam|diazepam|mesh-list
64852508|NCT01696825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64852509|NCT01696825|Anticonvulsants|anticonvulsants|mesh-ancestor
64852510|NCT01696825|Antiemetics|antiemetics|mesh-ancestor
64852511|NCT01696825|Autonomic Agents|autonomic agents|mesh-ancestor
64852512|NCT01696825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64852513|NCT01696825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852514|NCT01696825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64852515|NCT01696825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64852516|NCT01696825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64852517|NCT01696825|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64331942|NCT04352777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331943|NCT04352777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64331944|NCT04352777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64331945|NCT04352777|Hormone Antagonists|hormone antagonists|mesh-ancestor
64331946|NCT04352777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64331947|NCT04352777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331948|NCT04352777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64331949|NCT04352777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331950|NCT04352777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852525|NCT01696825|GABA Modulators|gaba modulators|mesh-ancestor
64852526|NCT01696825|GABA Agents|gaba agents|mesh-ancestor
64852527|NCT01696825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64852528|NCT01696825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852542|NCT01697046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64852544|NCT01697046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852545|NCT01697046|Antiviral Agents|antiviral agents|mesh-ancestor
64852618|NCT01697306|Gemcitabine|gemcitabine|mesh-list
64852619|NCT01697306|BCG Vaccine|bcg vaccine|mesh-list
64852620|NCT01697306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64852621|NCT01697306|Antimetabolites|antimetabolites|mesh-ancestor
64852622|NCT01697306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852623|NCT01697306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852624|NCT01697306|Antiviral Agents|antiviral agents|mesh-ancestor
64852636|NCT01697410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64685902|NCT05473273|Contraceptive Agents|contraceptive agents|mesh-ancestor
64852637|NCT01697410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852638|NCT01697410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852639|NCT01697410|Sympathomimetics|sympathomimetics|mesh-ancestor
64852640|NCT01697410|Autonomic Agents|autonomic agents|mesh-ancestor
64852641|NCT01697410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64852642|NCT01697410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64852643|NCT01697410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64852644|NCT01697436|Ribavirin|ribavirin|mesh-list
64852645|NCT01697436|Antimetabolites|antimetabolites|mesh-ancestor
64852646|NCT01697436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852647|NCT01697436|Antiviral Agents|antiviral agents|mesh-ancestor
64852648|NCT01697436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64852649|NCT01697605|Infigratinib|infigratinib|mesh-list
64852650|NCT01697605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852652|NCT01697618|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64852653|NCT01697618|Insulin Aspart|insulin aspart|mesh-list
64852654|NCT01697618|Biphasic Insulins|biphasic insulins|mesh-list
64852655|NCT01697618|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64852656|NCT01697618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64852657|NCT01697618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852658|NCT01697631|Insulin|insulin|mesh-list
64852659|NCT01697631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64852661|NCT01697631|Insulin, Long-Acting|insulin, long-acting|mesh-list
64852662|NCT01697631|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64852663|NCT01697631|Biphasic Insulins|biphasic insulins|mesh-list
64852664|NCT01697631|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64852665|NCT01697631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64852666|NCT01697631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852667|NCT01697657|Insulin|insulin|mesh-list
64852668|NCT01697657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64852669|NCT01697657|Insulin Aspart|insulin aspart|mesh-list
64852670|NCT01697657|Insulin Detemir|insulin detemir|mesh-list
64852679|NCT01697722|Beclomethasone|beclomethasone|mesh-list
64852680|NCT01697722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64852681|NCT01697722|Glucocorticoids|glucocorticoids|mesh-ancestor
64852682|NCT01697722|Hormones|hormones|mesh-ancestor
64852683|NCT01697722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64852684|NCT01697722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852685|NCT01697722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64852686|NCT01697722|Respiratory System Agents|respiratory system agents|mesh-ancestor
64852687|NCT01697735|Atorvastatin|atorvastatin|mesh-list
64852688|NCT01697735|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64852689|NCT01697735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64852690|NCT01697735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64852691|NCT01697735|Antimetabolites|antimetabolites|mesh-ancestor
64852692|NCT01697735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852693|NCT01697735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64852694|NCT01697735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64686546|NCT02420015|Bupropion|bupropion|mesh-list
64852695|NCT01697735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852699|NCT01697787|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64852700|NCT01697787|Amodiaquine|amodiaquine|mesh-list
64852701|NCT01697787|Antimalarials|antimalarials|mesh-ancestor
64852702|NCT01697787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64852703|NCT01697787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64852704|NCT01697787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64852705|NCT01697787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852706|NCT01697787|Antiviral Agents|antiviral agents|mesh-ancestor
64852707|NCT01697787|Schistosomicides|schistosomicides|mesh-ancestor
64852708|NCT01697787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64852709|NCT01697787|Anthelmintics|anthelmintics|mesh-ancestor
64852710|NCT01697826|Clindamycin|clindamycin|mesh-list
64852711|NCT01697826|Clindamycin palmitate|clindamycin palmitate|mesh-list
64852712|NCT01697826|Clindamycin phosphate|clindamycin phosphate|mesh-list
64852713|NCT01697826|Clotrimazole|clotrimazole|mesh-list
64852723|NCT01697826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64852724|NCT01697826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64852725|NCT01697826|Hormone Antagonists|hormone antagonists|mesh-ancestor
64852726|NCT01697826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64852727|NCT01697826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852728|NCT01697826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64852729|NCT01697826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64852730|NCT01698164|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64852731|NCT01698164|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64852751|NCT01698203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852753|NCT01698203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64852754|NCT01698476|Vitamin D|vitamin d|mesh-list
64852755|NCT01698476|Cholecalciferol|cholecalciferol|mesh-list
64852756|NCT01698476|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64852757|NCT01698476|Vitamins|vitamins|mesh-ancestor
64852758|NCT01698476|Micronutrients|micronutrients|mesh-ancestor
64852759|NCT01698476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852760|NCT01698476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64852761|NCT01698476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64852762|NCT01698476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852763|NCT01698541|Tacrolimus|tacrolimus|mesh-list
64852764|NCT01698541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64852765|NCT01698541|Immunologic Factors|immunologic factors|mesh-ancestor
64852808|NCT01698645|Anesthetics, General|anesthetics, general|mesh-ancestor
64852810|NCT01698697|Insulin Aspart|insulin aspart|mesh-list
64852811|NCT01698697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64852812|NCT01698697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852813|NCT01698723|Ribavirin|ribavirin|mesh-list
64852814|NCT01698723|Antimetabolites|antimetabolites|mesh-ancestor
64852815|NCT01698723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852816|NCT01698723|Antiviral Agents|antiviral agents|mesh-ancestor
64852817|NCT01698723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64852818|NCT01698749|Dexamethasone|dexamethasone|mesh-list
64852819|NCT01698749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64852820|NCT01698749|Antiemetics|antiemetics|mesh-ancestor
64852821|NCT01698749|Autonomic Agents|autonomic agents|mesh-ancestor
64852822|NCT01698749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64687038|NCT02506673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687039|NCT02506673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64687040|NCT02506673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64687041|NCT02506673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64687042|NCT02506673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64687043|NCT02506673|Anesthetics, General|anesthetics, general|mesh-ancestor
64687044|NCT02506673|Anesthetics|anesthetics|mesh-ancestor
64852823|NCT01698749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852824|NCT01698749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64852825|NCT01698749|Glucocorticoids|glucocorticoids|mesh-ancestor
64852826|NCT01698749|Hormones|hormones|mesh-ancestor
64852827|NCT01698749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64852828|NCT01698749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64852829|NCT01698749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852830|NCT01698788|Dexamethasone|dexamethasone|mesh-list
64852831|NCT01698788|Dexamethasone acetate|dexamethasone acetate|mesh-list
64852832|NCT01698788|BB 1101|bb 1101|mesh-list
64852833|NCT01698788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64852834|NCT01698788|Antiemetics|antiemetics|mesh-ancestor
64852835|NCT01698788|Autonomic Agents|autonomic agents|mesh-ancestor
64332142|NCT03805607|Sensory System Agents|sensory system agents|mesh-ancestor
64852836|NCT01698788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64852837|NCT01698788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852838|NCT01698788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64852839|NCT01698788|Glucocorticoids|glucocorticoids|mesh-ancestor
64852840|NCT01698788|Hormones|hormones|mesh-ancestor
64852841|NCT01698788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64852842|NCT01698788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64852843|NCT01698788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852844|NCT01698788|Protease Inhibitors|protease inhibitors|mesh-ancestor
64852845|NCT01698788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852846|NCT01698788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852847|NCT01698931|Glyburide|glyburide|mesh-list
64852848|NCT01698931|Repaglinide|repaglinide|mesh-list
64852849|NCT01698931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64852850|NCT01698931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852851|NCT01699113|Rabeprazole|rabeprazole|mesh-list
64852852|NCT01699113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64852853|NCT01699113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64852854|NCT01699113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64852855|NCT01699113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852856|NCT01699113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852857|NCT01699126|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64852858|NCT01699126|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64852859|NCT01699126|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64852860|NCT01699126|Antimetabolites|antimetabolites|mesh-ancestor
64332159|NCT03671018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64852861|NCT01699126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852862|NCT01699126|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64852863|NCT01699126|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64852864|NCT01699126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852865|NCT01699204|Acetylcysteine|acetylcysteine|mesh-list
64852866|NCT01699204|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64852867|NCT01699204|Antiviral Agents|antiviral agents|mesh-ancestor
64852868|NCT01699204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64852869|NCT01699204|Expectorants|expectorants|mesh-ancestor
64852907|NCT01699412|Hormones|hormones|mesh-ancestor
64852908|NCT01699412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64852909|NCT01699412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64852910|NCT01699412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687208|NCT05688943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852911|NCT01699438|Mesalamine|mesalamine|mesh-list
64852912|NCT01699438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64852913|NCT01699438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64852914|NCT01699438|Analgesics|analgesics|mesh-ancestor
64852915|NCT01699438|Sensory System Agents|sensory system agents|mesh-ancestor
64852916|NCT01699438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64852917|NCT01699438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852918|NCT01699438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64852945|NCT01699594|Autonomic Agents|autonomic agents|mesh-ancestor
64852946|NCT01699594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64852947|NCT01699594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64852948|NCT01699594|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
64852949|NCT01699594|Respiratory System Agents|respiratory system agents|mesh-ancestor
64852950|NCT01699594|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64852951|NCT01699594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64852952|NCT01699594|Cholinergic Agents|cholinergic agents|mesh-ancestor
64852953|NCT01699594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64852954|NCT01699594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852955|NCT01699711|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
64852956|NCT01699711|Antioxidants|antioxidants|mesh-ancestor
64852957|NCT01699711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852958|NCT01699711|Protective Agents|protective agents|mesh-ancestor
64852959|NCT01699711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852960|NCT01699711|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64852961|NCT01699711|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64332203|NCT03467789|Vitamins|vitamins|mesh-list
64332204|NCT03467789|Micronutrients|micronutrients|mesh-ancestor
64332205|NCT03467789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687580|NCT02599649|Nivolumab|nivolumab|mesh-list
64332206|NCT03467789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64332207|NCT03467789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64852970|NCT01699724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852971|NCT01699724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64852972|NCT01699724|Serotonin Agents|serotonin agents|mesh-ancestor
64852973|NCT01699724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852974|NCT01699776|Digoxin|digoxin|mesh-list
64852975|NCT01699776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64852976|NCT01699776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64852977|NCT01699776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64852978|NCT01699776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852979|NCT01699776|Protective Agents|protective agents|mesh-ancestor
64852980|NCT01699776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852981|NCT01699802|Anesthetics|anesthetics|mesh-list
64852982|NCT01699802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64852983|NCT01699802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852984|NCT01699828|Buspirone|buspirone|mesh-list
64852985|NCT01699828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64852986|NCT01699828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64852987|NCT01699828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64687823|NCT01642212|Budesonide|budesonide|mesh-list
64852988|NCT01699828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64852989|NCT01699828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64852990|NCT01699828|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64852991|NCT01699828|Serotonin Agents|serotonin agents|mesh-ancestor
64852992|NCT01699828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64852993|NCT01699828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64852994|NCT01699854|Capsaicin|capsaicin|mesh-list
64853002|NCT01699919|Anesthetics|anesthetics|mesh-ancestor
64853003|NCT01699919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64853004|NCT01699919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853005|NCT01699919|Sensory System Agents|sensory system agents|mesh-ancestor
64853006|NCT01699919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64853007|NCT01699919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64853008|NCT01699919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64853009|NCT01699919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64853010|NCT01699919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64853011|NCT01699919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853012|NCT01699932|Metformin|metformin|mesh-list
64688009|NCT00364871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64853013|NCT01699932|Glimepiride|glimepiride|mesh-list
64853014|NCT01699932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64853015|NCT01699932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853016|NCT01699932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64853017|NCT01699932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64853018|NCT01699932|Immunologic Factors|immunologic factors|mesh-ancestor
64853019|NCT01699997|Oxytocin|oxytocin|mesh-list
64853020|NCT01699997|Oxytocics|oxytocics|mesh-ancestor
64853021|NCT01699997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64853022|NCT01699997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332258|NCT03224507|Dexamethasone acetate|dexamethasone acetate|mesh-list
64332259|NCT03224507|Lenalidomide|lenalidomide|mesh-list
64332260|NCT03224507|Daratumumab|daratumumab|mesh-list
64332261|NCT03224507|BB 1101|bb 1101|mesh-list
64332262|NCT03224507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64332263|NCT03224507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64332264|NCT03224507|Antiemetics|antiemetics|mesh-ancestor
64332265|NCT03224507|Autonomic Agents|autonomic agents|mesh-ancestor
64332266|NCT03224507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64332267|NCT03224507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332268|NCT03224507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64332269|NCT03224507|Glucocorticoids|glucocorticoids|mesh-ancestor
64332270|NCT03224507|Hormones|hormones|mesh-ancestor
64295142|NCT02472652|Serotonin Agents|serotonin agents|mesh-ancestor
64332271|NCT03224507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64853045|NCT01700270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64853047|NCT01700270|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64853048|NCT01700270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64853049|NCT01700270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853050|NCT01700270|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64853051|NCT01700322|Clopidogrel|clopidogrel|mesh-list
64853052|NCT01700322|Ticagrelor|ticagrelor|mesh-list
64853053|NCT01700322|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64853054|NCT01700322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64853055|NCT01700322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64853056|NCT01700322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64853057|NCT01700322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64853058|NCT01700322|Purinergic Agents|purinergic agents|mesh-ancestor
64853059|NCT01700322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64853060|NCT01700322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853061|NCT01700322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853062|NCT01700400|Bevacizumab|bevacizumab|mesh-list
64853063|NCT01700400|Carboplatin|carboplatin|mesh-list
64853064|NCT01700400|Pemetrexed|pemetrexed|mesh-list
64853065|NCT01700400|Everolimus|everolimus|mesh-list
64332272|NCT03224507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64332273|NCT03224507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332274|NCT03224507|Protease Inhibitors|protease inhibitors|mesh-ancestor
64332275|NCT03224507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853068|NCT01700400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64853069|NCT01700400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64853070|NCT01700400|Growth Substances|growth substances|mesh-ancestor
64853071|NCT01700400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853072|NCT01700400|Growth Inhibitors|growth inhibitors|mesh-ancestor
64853073|NCT01700400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853074|NCT01700400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853075|NCT01700400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64853076|NCT01700400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64853077|NCT01700400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64853078|NCT01700400|Immunologic Factors|immunologic factors|mesh-ancestor
64853079|NCT01700413|Idarubicin|idarubicin|mesh-list
64332276|NCT03224507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332277|NCT03224507|Immunologic Factors|immunologic factors|mesh-ancestor
64332278|NCT03224507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64853093|NCT01700426|Antioxidants|antioxidants|mesh-ancestor
64853094|NCT01700426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853095|NCT01700426|Protective Agents|protective agents|mesh-ancestor
64853097|NCT01700478|Arginine Vasopressin|arginine vasopressin|mesh-list
64853098|NCT01700478|Misoprostol|misoprostol|mesh-list
64853099|NCT01700478|Diuretics|diuretics|mesh-list
64853100|NCT01700478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853101|NCT01700478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64853102|NCT01700478|Abortifacient Agents|abortifacient agents|mesh-ancestor
64853103|NCT01700478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64853104|NCT01700478|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64853105|NCT01700478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64853106|NCT01700478|Oxytocics|oxytocics|mesh-ancestor
64853107|NCT01700478|Natriuretic Agents|natriuretic agents|mesh-ancestor
64853108|NCT01700478|Hemostatics|hemostatics|mesh-ancestor
64853109|NCT01700478|Coagulants|coagulants|mesh-ancestor
64853110|NCT01700478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64853120|NCT01700504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64853121|NCT01700504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64853122|NCT01700504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64853123|NCT01700504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853124|NCT01700504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853125|NCT01700608|Plerixafor|plerixafor|mesh-list
64853126|NCT01700608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64853127|NCT01700608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64853128|NCT01700608|Antiviral Agents|antiviral agents|mesh-ancestor
64332287|NCT03218826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853129|NCT01700608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64853130|NCT01700751|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64853131|NCT01700751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64853132|NCT01700751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853158|NCT01700881|Vitamins|vitamins|mesh-ancestor
64853159|NCT01700881|Micronutrients|micronutrients|mesh-ancestor
64853160|NCT01700881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853161|NCT01700881|Antioxidants|antioxidants|mesh-ancestor
64853162|NCT01700881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853163|NCT01700881|Protective Agents|protective agents|mesh-ancestor
64853164|NCT01701076|Dexamethasone|dexamethasone|mesh-list
64853165|NCT01701076|Lenalidomide|lenalidomide|mesh-list
64853166|NCT01701076|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64853167|NCT01701076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64853168|NCT01701076|Antiemetics|antiemetics|mesh-ancestor
64853169|NCT01701076|Autonomic Agents|autonomic agents|mesh-ancestor
64853170|NCT01701076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64853171|NCT01701076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853172|NCT01701076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64332292|NCT03182751|Hemostatics|hemostatics|mesh-ancestor
64332293|NCT03182751|Coagulants|coagulants|mesh-ancestor
64853228|NCT01701323|Antiviral Agents|antiviral agents|mesh-ancestor
64689166|NCT02712047|Xhance|xhance|mesh-list
64853229|NCT01701323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64853230|NCT01701336|Cloricromen|cloricromen|mesh-list
64853231|NCT01701336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64853232|NCT01701349|Paclitaxel|paclitaxel|mesh-list
64853233|NCT01701349|Fosbretabulin|fosbretabulin|mesh-list
64853234|NCT01701349|Combretastatin|combretastatin|mesh-list
64853235|NCT01701349|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64853236|NCT01701349|Carboplatin|carboplatin|mesh-list
64853237|NCT01701349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64853238|NCT01701349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853239|NCT01701349|Tubulin Modulators|tubulin modulators|mesh-ancestor
64853240|NCT01701349|Antimitotic Agents|antimitotic agents|mesh-ancestor
64853241|NCT01701349|Mitosis Modulators|mitosis modulators|mesh-ancestor
64853242|NCT01701349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853243|NCT01701453|Clopidogrel|clopidogrel|mesh-list
64853244|NCT01701453|Ticagrelor|ticagrelor|mesh-list
64853245|NCT01701453|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64853252|NCT01701453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853253|NCT01701453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853254|NCT01701466|Silver Sulfadiazine|silver sulfadiazine|mesh-list
64853255|NCT01701466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64853256|NCT01701466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64853259|NCT01701479|Dinutuximab|dinutuximab|mesh-list
64853260|NCT01701479|Isotretinoin|isotretinoin|mesh-list
64853261|NCT01701479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853262|NCT01701479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64853282|NCT01701518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64853284|NCT01701583|Omalizumab|omalizumab|mesh-list
64853285|NCT01701583|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64689263|NCT05109143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64853286|NCT01701583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64853287|NCT01701583|Respiratory System Agents|respiratory system agents|mesh-ancestor
64853288|NCT01701739|Digoxin|digoxin|mesh-list
64853289|NCT01701739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64853290|NCT01701739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64853315|NCT01701778|Anesthetics, Local|anesthetics, local|mesh-ancestor
64853317|NCT01701843|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
64853318|NCT01701843|Immunologic Factors|immunologic factors|mesh-ancestor
64853319|NCT01701843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853320|NCT01701843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64853321|NCT01701843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64853322|NCT01701843|Respiratory System Agents|respiratory system agents|mesh-ancestor
64853323|NCT01701856|Interferons|interferons|mesh-list
64853324|NCT01701856|Interferon-beta|interferon-beta|mesh-list
64853325|NCT01701856|Interferon beta-1b|interferon beta-1b|mesh-list
64853326|NCT01701856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853327|NCT01701856|Antiviral Agents|antiviral agents|mesh-ancestor
64853328|NCT01701856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64853329|NCT01701856|Immunologic Factors|immunologic factors|mesh-ancestor
64853330|NCT01701856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853331|NCT01701856|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64853333|NCT01701882|Emtricitabine|emtricitabine|mesh-list
64853334|NCT01701882|Rilpivirine|rilpivirine|mesh-list
64853335|NCT01701882|Antiviral Agents|antiviral agents|mesh-ancestor
64853336|NCT01701882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64689323|NCT02726789|Entecavir|entecavir|mesh-list
64853337|NCT01701882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64853338|NCT01701882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64853339|NCT01701882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853340|NCT01701882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853341|NCT01701882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64853342|NCT01701882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64853343|NCT01701921|Pregabalin|pregabalin|mesh-list
64853344|NCT01701921|Analgesics|analgesics|mesh-ancestor
64853345|NCT01701921|Sensory System Agents|sensory system agents|mesh-ancestor
64853346|NCT01701921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64853347|NCT01701921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853348|NCT01701921|Anticonvulsants|anticonvulsants|mesh-ancestor
64853349|NCT01701921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64853350|NCT01701921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64853351|NCT01701921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853352|NCT01701921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64853353|NCT01701921|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64853354|NCT01701921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64853355|NCT01701921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64853356|NCT01701921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64853357|NCT01702038|Rituximab|rituximab|mesh-list
64853358|NCT01702038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64853359|NCT01702038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853360|NCT01702038|Immunologic Factors|immunologic factors|mesh-ancestor
64295174|NCT04695704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853388|NCT01702129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64853390|NCT01702181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64853391|NCT01702181|Immunologic Factors|immunologic factors|mesh-ancestor
64689560|NCT05446805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64853392|NCT01702181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853393|NCT01702181|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64853394|NCT01702181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853395|NCT01702181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853396|NCT01702207|Tacrolimus|tacrolimus|mesh-list
64853397|NCT01702207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64853398|NCT01702207|Immunologic Factors|immunologic factors|mesh-ancestor
64853399|NCT01702207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853400|NCT01702207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64853401|NCT01702207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853402|NCT01702207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853403|NCT01702376|Moxifloxacin|moxifloxacin|mesh-list
64853404|NCT01702376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64853405|NCT01702376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64853406|NCT01702376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64853407|NCT01702376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64853408|NCT01702376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853409|NCT01702376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853410|NCT01702376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853411|NCT01702389|Remifentanil|remifentanil|mesh-list
64853412|NCT01702389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64853413|NCT01702389|Narcotics|narcotics|mesh-ancestor
64853414|NCT01702389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64853415|NCT01702389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853416|NCT01702389|Analgesics|analgesics|mesh-ancestor
64853417|NCT01702389|Sensory System Agents|sensory system agents|mesh-ancestor
64853418|NCT01702389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64853419|NCT01702415|Zoledronic Acid|zoledronic acid|mesh-list
64853420|NCT01702415|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64853421|NCT01702415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853422|NCT01702506|Antacids|antacids|mesh-list
64853423|NCT01702506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853424|NCT01702506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64853426|NCT01702610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64853428|NCT01702610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853429|NCT01702610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853430|NCT01702623|Oxcarbazepine|oxcarbazepine|mesh-list
64853431|NCT01702623|Anticonvulsants|anticonvulsants|mesh-ancestor
64853432|NCT01702623|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64853433|NCT01702623|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64853434|NCT01702623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64853435|NCT01702623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853450|NCT01702688|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64853451|NCT01702688|Protease Inhibitors|protease inhibitors|mesh-ancestor
64853452|NCT01702688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853453|NCT01702688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853454|NCT01702701|Fluticasone|fluticasone|mesh-list
64853455|NCT01702701|Montelukast|montelukast|mesh-list
64853456|NCT01702701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64853457|NCT01702701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64853458|NCT01702701|Autonomic Agents|autonomic agents|mesh-ancestor
64853459|NCT01702701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64853460|NCT01702701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853461|NCT01702701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64853462|NCT01702701|Respiratory System Agents|respiratory system agents|mesh-ancestor
64853463|NCT01702701|Dermatologic Agents|dermatologic agents|mesh-ancestor
64853464|NCT01702701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64853465|NCT01702701|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64853466|NCT01702701|Hormone Antagonists|hormone antagonists|mesh-ancestor
64853467|NCT01702701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64853468|NCT01702701|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64690234|NCT03754049|Glucocorticoids|glucocorticoids|mesh-ancestor
64853469|NCT01702701|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64853470|NCT01702701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853471|NCT01702714|Gemcitabine|gemcitabine|mesh-list
64853472|NCT01702714|Paclitaxel|paclitaxel|mesh-list
64853473|NCT01702714|Carboplatin|carboplatin|mesh-list
64853474|NCT01702714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64853475|NCT01702714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853476|NCT01702714|Tubulin Modulators|tubulin modulators|mesh-ancestor
64853477|NCT01702714|Antimitotic Agents|antimitotic agents|mesh-ancestor
64853478|NCT01702714|Mitosis Modulators|mitosis modulators|mesh-ancestor
64853479|NCT01702714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853480|NCT01702714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64853481|NCT01702714|Antimetabolites|antimetabolites|mesh-ancestor
64853482|NCT01702714|Antiviral Agents|antiviral agents|mesh-ancestor
64853483|NCT01702714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64853484|NCT01702714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853485|NCT01702714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64853486|NCT01702714|Immunologic Factors|immunologic factors|mesh-ancestor
64690458|NCT03298451|Sorafenib|sorafenib|mesh-list
64853487|NCT01702714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853488|NCT01702792|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64853489|NCT01702792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64853490|NCT01702792|Immunologic Factors|immunologic factors|mesh-ancestor
64853491|NCT01702792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853492|NCT01702857|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64853493|NCT01702857|Vaccines|vaccines|mesh-list
64853494|NCT01702857|Aluminum sulfate|aluminum sulfate|mesh-list
64853495|NCT01702857|Immunologic Factors|immunologic factors|mesh-ancestor
64295182|NCT02591420|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64853496|NCT01702857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853497|NCT01702857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64853499|NCT01702857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853500|NCT01702857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64853501|NCT01702974|Vitamin D|vitamin d|mesh-list
64853502|NCT01702974|Cholecalciferol|cholecalciferol|mesh-list
64853503|NCT01702974|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64853504|NCT01702974|Vitamins|vitamins|mesh-ancestor
64853505|NCT01702974|Micronutrients|micronutrients|mesh-ancestor
64853506|NCT01702974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853507|NCT01702974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64853508|NCT01702974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64853509|NCT01702974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853510|NCT01703104|Folic Acid|folic acid|mesh-list
64853511|NCT01703104|Vitamin B Complex|vitamin b complex|mesh-list
64853512|NCT01703104|Proguanil|proguanil|mesh-list
64853513|NCT01703104|Hematinics|hematinics|mesh-ancestor
64853514|NCT01703104|Vitamins|vitamins|mesh-ancestor
64853515|NCT01703104|Micronutrients|micronutrients|mesh-ancestor
64853516|NCT01703104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853517|NCT01703104|Antimalarials|antimalarials|mesh-ancestor
64853518|NCT01703104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64853519|NCT01703104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64853520|NCT01703104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64853521|NCT01703104|Antimetabolites|antimetabolites|mesh-ancestor
64853522|NCT01703104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853523|NCT01703130|Ropivacaine|ropivacaine|mesh-list
64853524|NCT01703130|Anesthetics, Local|anesthetics, local|mesh-ancestor
64853525|NCT01703130|Anesthetics|anesthetics|mesh-ancestor
64853526|NCT01703130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64853527|NCT01703130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853528|NCT01703130|Sensory System Agents|sensory system agents|mesh-ancestor
64853529|NCT01703130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64853530|NCT01703234|Ramipril|ramipril|mesh-list
64853531|NCT01703234|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64853532|NCT01703234|Protease Inhibitors|protease inhibitors|mesh-ancestor
64853533|NCT01703234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853534|NCT01703234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853535|NCT01703234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64853536|NCT01703312|Omalizumab|omalizumab|mesh-list
64853537|NCT01703312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64853538|NCT01703312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64853539|NCT01703312|Respiratory System Agents|respiratory system agents|mesh-ancestor
64853540|NCT01703325|Triamcinolone|triamcinolone|mesh-list
64853541|NCT01703325|Clobetasol|clobetasol|mesh-list
64853542|NCT01703325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64853543|NCT01703325|Glucocorticoids|glucocorticoids|mesh-ancestor
64853544|NCT01703325|Hormones|hormones|mesh-ancestor
64853545|NCT01703325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64853546|NCT01703325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853547|NCT01703351|Fentanyl|fentanyl|mesh-list
64853548|NCT01703351|Ropivacaine|ropivacaine|mesh-list
64853549|NCT01703351|Anesthetics, Local|anesthetics, local|mesh-ancestor
64853550|NCT01703351|Anesthetics|anesthetics|mesh-ancestor
64853551|NCT01703351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64853552|NCT01703351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853553|NCT01703351|Sensory System Agents|sensory system agents|mesh-ancestor
64853554|NCT01703351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64853556|NCT01703351|Narcotics|narcotics|mesh-ancestor
64853557|NCT01703351|Analgesics|analgesics|mesh-ancestor
64853561|NCT01703364|Lenalidomide|lenalidomide|mesh-list
64853565|NCT01703364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64853566|NCT01703364|Growth Substances|growth substances|mesh-ancestor
64853567|NCT01703364|Growth Inhibitors|growth inhibitors|mesh-ancestor
64853568|NCT01703364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853569|NCT01703390|Cetuximab|cetuximab|mesh-list
64853570|NCT01703390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64853571|NCT01703390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853572|NCT01703455|Sorafenib|sorafenib|mesh-list
64853573|NCT01703455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853574|NCT01703455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64853575|NCT01703455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853576|NCT01703455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853577|NCT01703468|Oxcarbazepine|oxcarbazepine|mesh-list
64853578|NCT01703468|Anticonvulsants|anticonvulsants|mesh-ancestor
64853602|NCT01703624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64853603|NCT01703624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853604|NCT01703624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853605|NCT01703637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64853606|NCT01703637|Vildagliptin|vildagliptin|mesh-list
64853607|NCT01703637|Saxagliptin|saxagliptin|mesh-list
64853608|NCT01703637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64691122|NCT04535401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64853609|NCT01703637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853610|NCT01703637|Incretins|incretins|mesh-ancestor
64853611|NCT01703637|Hormones|hormones|mesh-ancestor
64853612|NCT01703637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64853613|NCT01703637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64853614|NCT01703637|Protease Inhibitors|protease inhibitors|mesh-ancestor
64853615|NCT01703637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853616|NCT01703637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853617|NCT01703728|Menotropins|menotropins|mesh-list
64853669|NCT01703910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64853670|NCT01703910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64332374|NCT03019588|Paclitaxel|paclitaxel|mesh-list
64332375|NCT03019588|Pembrolizumab|pembrolizumab|mesh-list
64332376|NCT03019588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64332377|NCT03019588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332378|NCT03019588|Tubulin Modulators|tubulin modulators|mesh-ancestor
64332379|NCT03019588|Antimitotic Agents|antimitotic agents|mesh-ancestor
64332380|NCT03019588|Mitosis Modulators|mitosis modulators|mesh-ancestor
64332381|NCT03019588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332382|NCT03019588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64853671|NCT01703910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64853672|NCT01703910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64853673|NCT01703910|Alkylating Agents|alkylating agents|mesh-ancestor
64853674|NCT01704027|Androgens|androgens|mesh-list
64853675|NCT01704027|Hormones|hormones|mesh-ancestor
64853676|NCT01704027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64853677|NCT01704027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853678|NCT01704092|Dexmedetomidine|dexmedetomidine|mesh-list
64853679|NCT01704092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64853680|NCT01704092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64853681|NCT01704092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853682|NCT01704092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64853683|NCT01704092|Analgesics|analgesics|mesh-ancestor
64853684|NCT01704092|Sensory System Agents|sensory system agents|mesh-ancestor
64853685|NCT01704092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64853686|NCT01704092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64853687|NCT01704092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64853715|NCT01704482|Acetylcysteine|acetylcysteine|mesh-list
64853716|NCT01704482|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64853717|NCT01704482|Antiviral Agents|antiviral agents|mesh-ancestor
64853718|NCT01704482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64853719|NCT01704482|Expectorants|expectorants|mesh-ancestor
64853720|NCT01704482|Respiratory System Agents|respiratory system agents|mesh-ancestor
64853721|NCT01704482|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64853722|NCT01704482|Antioxidants|antioxidants|mesh-ancestor
64853723|NCT01704482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853724|NCT01704482|Protective Agents|protective agents|mesh-ancestor
64853725|NCT01704482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853726|NCT01704482|Antidotes|antidotes|mesh-ancestor
64853727|NCT01704508|Lumefantrine|lumefantrine|mesh-list
64853728|NCT01704508|Artemether|artemether|mesh-list
64853741|NCT01704612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64853742|NCT01704612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853743|NCT01704612|Sensory System Agents|sensory system agents|mesh-ancestor
64853744|NCT01704612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64853745|NCT01704638|Digoxin|digoxin|mesh-list
64853746|NCT01704638|Fluvoxamine|fluvoxamine|mesh-list
64853747|NCT01704638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64853748|NCT01704638|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64853749|NCT01704638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853750|NCT01704638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853751|NCT01704638|Protective Agents|protective agents|mesh-ancestor
64853752|NCT01704638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853753|NCT01704638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64853754|NCT01704638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64853755|NCT01704638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64853756|NCT01704638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64853757|NCT01704638|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64853758|NCT01704638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64853759|NCT01704638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64853760|NCT01704638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64853761|NCT01704638|Serotonin Agents|serotonin agents|mesh-ancestor
64853762|NCT01704638|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64853763|NCT01704638|Antidepressive Agents|antidepressive agents|mesh-ancestor
64853764|NCT01704638|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64853765|NCT01704638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64853766|NCT01704638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64853767|NCT01704690|Paclitaxel|paclitaxel|mesh-list
64853768|NCT01704690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64853769|NCT01704690|Cisplatin|cisplatin|mesh-list
64853770|NCT01704690|Fluorouracil|fluorouracil|mesh-list
64853771|NCT01704690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64853772|NCT01704690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853773|NCT01704690|Tubulin Modulators|tubulin modulators|mesh-ancestor
64853774|NCT01704690|Antimitotic Agents|antimitotic agents|mesh-ancestor
64853775|NCT01704690|Mitosis Modulators|mitosis modulators|mesh-ancestor
64853776|NCT01704690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853787|NCT01704716|Melphalan|melphalan|mesh-list
64853789|NCT01704716|Carboplatin|carboplatin|mesh-list
64853790|NCT01704716|Doxorubicin|doxorubicin|mesh-list
64853791|NCT01704716|Etoposide|etoposide|mesh-list
64853792|NCT01704716|Vincristine|vincristine|mesh-list
64853793|NCT01704716|Interleukin-2|interleukin-2|mesh-list
64853794|NCT01704716|Dinutuximab|dinutuximab|mesh-list
64853795|NCT01704716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64853796|NCT01704716|Immunologic Factors|immunologic factors|mesh-ancestor
64853811|NCT01704716|Mitosis Modulators|mitosis modulators|mesh-ancestor
64853812|NCT01704716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64853813|NCT01704716|Analgesics|analgesics|mesh-ancestor
64853814|NCT01704716|Sensory System Agents|sensory system agents|mesh-ancestor
64853840|NCT01704898|Antiviral Agents|antiviral agents|mesh-ancestor
64853841|NCT01704898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64853842|NCT01704898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64853843|NCT01704898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64853844|NCT01704898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64853845|NCT01704898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64853846|NCT01704898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64853847|NCT01704898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64853849|NCT01705002|Capecitabine|capecitabine|mesh-list
64853850|NCT01705002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64853851|NCT01705002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853852|NCT01705002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64853853|NCT01705002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64853854|NCT01705002|Growth Substances|growth substances|mesh-ancestor
64853855|NCT01705002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853856|NCT01705002|Growth Inhibitors|growth inhibitors|mesh-ancestor
64853857|NCT01705002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64853858|NCT01705002|Antimetabolites|antimetabolites|mesh-ancestor
64853859|NCT01705002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853860|NCT01705041|Liver Extracts|liver extracts|mesh-list
64853861|NCT01705041|Hematinics|hematinics|mesh-ancestor
64853862|NCT01705158|Carboplatin|carboplatin|mesh-list
64853863|NCT01705158|Doxorubicin|doxorubicin|mesh-list
64853864|NCT01705158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64853865|NCT01705158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691855|NCT04492358|Prednisone|prednisone|mesh-list
64853866|NCT01705158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64853867|NCT01705158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64853868|NCT01705158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64853869|NCT01705158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853870|NCT01705158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853871|NCT01705223|Vaccines|vaccines|mesh-list
64853872|NCT01705223|Immunologic Factors|immunologic factors|mesh-ancestor
64853873|NCT01705223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853914|NCT01705392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64853915|NCT01705392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64853916|NCT01705392|Adrenergic Agents|adrenergic agents|mesh-ancestor
64853917|NCT01705392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64853918|NCT01705392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853919|NCT01705392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64853920|NCT01705392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64853921|NCT01705392|Vasodilator Agents|vasodilator agents|mesh-ancestor
64853922|NCT01705392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64853923|NCT01705392|Alkylating Agents|alkylating agents|mesh-ancestor
64853924|NCT01705392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64853925|NCT01705392|Protease Inhibitors|protease inhibitors|mesh-ancestor
64853926|NCT01705392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64853927|NCT01705457|Vitamin A|vitamin a|mesh-list
64853928|NCT01705457|Retinol palmitate|retinol palmitate|mesh-list
64853929|NCT01705457|Vitamins|vitamins|mesh-ancestor
64853930|NCT01705457|Micronutrients|micronutrients|mesh-ancestor
64853931|NCT01705457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853932|NCT01705457|Antioxidants|antioxidants|mesh-ancestor
64691922|NCT01959685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853933|NCT01705457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853934|NCT01705457|Protective Agents|protective agents|mesh-ancestor
64853935|NCT01705457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64295195|NCT05217758|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64853947|NCT01705483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332409|NCT02959944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332410|NCT02955394|Fulvestrant|fulvestrant|mesh-list
64332411|NCT02955394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64332412|NCT02955394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332413|NCT02955394|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64332414|NCT02955394|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64332415|NCT02955394|Hormone Antagonists|hormone antagonists|mesh-ancestor
64332416|NCT02955394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64332417|NCT02955394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332418|NCT02891824|Bevacizumab|bevacizumab|mesh-list
64332419|NCT02891824|Atezolizumab|atezolizumab|mesh-list
64332420|NCT02891824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64332421|NCT02891824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332422|NCT02891824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64332423|NCT02891824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64332424|NCT02891824|Growth Substances|growth substances|mesh-ancestor
64692081|NCT03008213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64332425|NCT02891824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332426|NCT02891824|Growth Inhibitors|growth inhibitors|mesh-ancestor
64332427|NCT02890355|Calcium, Dietary|calcium, dietary|mesh-list
64332429|NCT02890355|Folic Acid|folic acid|mesh-list
64332430|NCT02890355|Fluorouracil|fluorouracil|mesh-list
64332431|NCT02890355|Irinotecan|irinotecan|mesh-list
64332432|NCT02890355|Veliparib|veliparib|mesh-list
64332433|NCT02890355|Camptothecin|camptothecin|mesh-list
64332434|NCT02890355|Calcium|calcium|mesh-list
64332435|NCT02890355|Levoleucovorin|levoleucovorin|mesh-list
64332436|NCT02890355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64295210|NCT02051023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64332437|NCT02890355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332438|NCT02890355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64332440|NCT02890355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853948|NCT01705483|Tubulin Modulators|tubulin modulators|mesh-ancestor
64853949|NCT01705483|Antimitotic Agents|antimitotic agents|mesh-ancestor
64853950|NCT01705483|Mitosis Modulators|mitosis modulators|mesh-ancestor
64853951|NCT01705483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853954|NCT01705639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853955|NCT01705639|Protective Agents|protective agents|mesh-ancestor
64853956|NCT01705639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853957|NCT01705639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64853958|NCT01705743|Nitrous Oxide|nitrous oxide|mesh-list
64853959|NCT01705743|Sevoflurane|sevoflurane|mesh-list
64853960|NCT01705743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64853961|NCT01705743|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64853962|NCT01705743|Anesthetics, General|anesthetics, general|mesh-ancestor
64853963|NCT01705743|Anesthetics|anesthetics|mesh-ancestor
64853964|NCT01705743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64853965|NCT01705743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853966|NCT01705743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64853967|NCT01705743|Analgesics|analgesics|mesh-ancestor
64853968|NCT01705743|Sensory System Agents|sensory system agents|mesh-ancestor
64853969|NCT01705743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64332441|NCT02890355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64332442|NCT02890355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332443|NCT02890355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64332444|NCT02890355|Immunologic Factors|immunologic factors|mesh-ancestor
64332445|NCT02890355|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64332446|NCT02890355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64332447|NCT02890355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64332448|NCT02890355|Antidotes|antidotes|mesh-ancestor
64332449|NCT02890355|Protective Agents|protective agents|mesh-ancestor
64332450|NCT02890355|Vitamin B Complex|vitamin b complex|mesh-ancestor
64332451|NCT02890355|Vitamins|vitamins|mesh-ancestor
64332452|NCT02890355|Micronutrients|micronutrients|mesh-ancestor
64332453|NCT02890355|Hematinics|hematinics|mesh-ancestor
64332454|NCT02890355|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64332455|NCT02890355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64332456|NCT02841280|Chlorthalidone|chlorthalidone|mesh-list
64332457|NCT02841280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64332458|NCT02841280|Diuretics|diuretics|mesh-ancestor
64332459|NCT02841280|Natriuretic Agents|natriuretic agents|mesh-ancestor
64332460|NCT02841280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332461|NCT02841280|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64332462|NCT02841280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64332463|NCT02841280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332464|NCT02834013|Nivolumab|nivolumab|mesh-list
64332465|NCT02834013|Ipilimumab|ipilimumab|mesh-list
64332466|NCT02834013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64332467|NCT02834013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64853970|NCT01705756|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64853971|NCT01705756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64853972|NCT01705769|Micronutrients|micronutrients|mesh-list
64853973|NCT01705769|Trace Elements|trace elements|mesh-list
64853974|NCT01705769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853975|NCT01705795|Antibodies|antibodies|mesh-list
64853976|NCT01705795|Immunologic Factors|immunologic factors|mesh-ancestor
64853977|NCT01705795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853978|NCT01705808|Protein C|protein c|mesh-list
64853979|NCT01705808|Anticoagulants|anticoagulants|mesh-ancestor
64853980|NCT01705808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64853981|NCT01705808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64853982|NCT01705808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853983|NCT01705938|Dolcanatide|dolcanatide|mesh-list
64853984|NCT01705938|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64853985|NCT01705938|Enzyme Activators|enzyme activators|mesh-ancestor
64853986|NCT01705938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853987|NCT01705938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64853989|NCT01705951|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64853990|NCT01705951|Autonomic Agents|autonomic agents|mesh-ancestor
64853991|NCT01705951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64853992|NCT01705951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64853993|NCT01705951|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64853994|NCT01705951|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64853995|NCT01705951|Cholinergic Agents|cholinergic agents|mesh-ancestor
64332468|NCT02834013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64332469|NCT02834013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332471|NCT02823002|Anesthetics, Local|anesthetics, local|mesh-ancestor
64332472|NCT02823002|Anesthetics|anesthetics|mesh-ancestor
64332473|NCT02823002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64332474|NCT02823002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332475|NCT02823002|Sensory System Agents|sensory system agents|mesh-ancestor
64332476|NCT02823002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64332477|NCT02823002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64332478|NCT02823002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64332479|NCT02823002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64332480|NCT02823002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64853996|NCT01705951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64853997|NCT01705951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64853999|NCT01706055|Interferon-beta|interferon-beta|mesh-list
64692580|NCT01977781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854000|NCT01706055|Interferon beta-1b|interferon beta-1b|mesh-list
64854001|NCT01706055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854002|NCT01706055|Antiviral Agents|antiviral agents|mesh-ancestor
64854003|NCT01706055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64854004|NCT01706055|Immunologic Factors|immunologic factors|mesh-ancestor
64854005|NCT01706055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854006|NCT01706055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64854007|NCT01706172|Lidocaine|lidocaine|mesh-list
64854008|NCT01706172|Anesthetics, Local|anesthetics, local|mesh-ancestor
64854009|NCT01706172|Anesthetics|anesthetics|mesh-ancestor
64854010|NCT01706172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64854011|NCT01706172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854012|NCT01706172|Sensory System Agents|sensory system agents|mesh-ancestor
64854013|NCT01706172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64854014|NCT01706172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64854015|NCT01706172|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64854016|NCT01706172|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64854017|NCT01706172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64854018|NCT01706172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854019|NCT01706211|Rosiglitazone|rosiglitazone|mesh-list
64854020|NCT01706211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64854021|NCT01706211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854022|NCT01706341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64854023|NCT01706354|Anesthetics|anesthetics|mesh-list
64854024|NCT01706354|Anesthetics, Local|anesthetics, local|mesh-list
64854025|NCT01706354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64854026|NCT01706354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854027|NCT01706354|Sensory System Agents|sensory system agents|mesh-ancestor
64332481|NCT02823002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418164|NCT05556889|Iodine|iodine|mesh-list
64332483|NCT02806687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64332484|NCT02806687|Antimetabolites|antimetabolites|mesh-ancestor
64332485|NCT02806687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332486|NCT02806687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332487|NCT02806687|Antiviral Agents|antiviral agents|mesh-ancestor
64332488|NCT02806687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64854028|NCT01706354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64332503|NCT02723331|Antimetabolites|antimetabolites|mesh-ancestor
64332504|NCT02723331|Antiviral Agents|antiviral agents|mesh-ancestor
64332505|NCT02723331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64332506|NCT02723331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64332507|NCT02723331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64332508|NCT02723331|Immunologic Factors|immunologic factors|mesh-ancestor
64332509|NCT02723331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332541|NCT02525029|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64332542|NCT02525029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64854046|NCT01706510|Ticagrelor|ticagrelor|mesh-list
64854047|NCT01706510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64854048|NCT01706510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64854049|NCT01706510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64854050|NCT01706510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64854051|NCT01706510|Purinergic Agents|purinergic agents|mesh-ancestor
64854052|NCT01706510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64854053|NCT01706510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854054|NCT01706510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854055|NCT01706562|Itraconazole|itraconazole|mesh-list
64854056|NCT01706562|Antifungal Agents|antifungal agents|mesh-ancestor
64854057|NCT01706562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64854058|NCT01706562|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64854059|NCT01706562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64854060|NCT01706562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854061|NCT01706562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854071|NCT01706627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854072|NCT01706627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64854073|NCT01706679|Moxifloxacin|moxifloxacin|mesh-list
64332543|NCT02525029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854074|NCT01706679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64854075|NCT01706679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64854076|NCT01706679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64854077|NCT01706679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64854078|NCT01706679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854079|NCT01706679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854080|NCT01706679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854081|NCT01706874|Listerine|listerine|mesh-list
64854082|NCT01706874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64854083|NCT01706874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64622551|NCT05499234|Analgesics|analgesics|mesh-ancestor
64854084|NCT01706887|Amiloride|amiloride|mesh-list
64854085|NCT01706887|Diuretics|diuretics|mesh-ancestor
64854086|NCT01706887|Natriuretic Agents|natriuretic agents|mesh-ancestor
64854087|NCT01706887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854088|NCT01706887|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
64854089|NCT01706887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64854090|NCT01706887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64854091|NCT01706887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854092|NCT01706887|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64854093|NCT01706887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64854094|NCT01707082|Midazolam|midazolam|mesh-list
64854095|NCT01707082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64854096|NCT01707082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64854097|NCT01707082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64854098|NCT01707082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854099|NCT01707082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64854116|NCT01707134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854117|NCT01707160|Insulin|insulin|mesh-list
64854118|NCT01707160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64854119|NCT01707160|Insulin Aspart|insulin aspart|mesh-list
64854120|NCT01707160|Biphasic Insulins|biphasic insulins|mesh-list
64854121|NCT01707160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64854122|NCT01707160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64693555|NCT02989493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64854123|NCT01707160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854124|NCT01707199|Artesunate|artesunate|mesh-list
64854125|NCT01707199|Pyrimethamine|pyrimethamine|mesh-list
64854126|NCT01707199|Sulfadoxine|sulfadoxine|mesh-list
64854127|NCT01707199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64854128|NCT01707199|Antimalarials|antimalarials|mesh-ancestor
64854129|NCT01707199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64854130|NCT01707199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64854131|NCT01707199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64854132|NCT01707199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854133|NCT01707199|Antiviral Agents|antiviral agents|mesh-ancestor
64854134|NCT01707199|Schistosomicides|schistosomicides|mesh-ancestor
64854135|NCT01707199|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64854136|NCT01707199|Anthelmintics|anthelmintics|mesh-ancestor
64854137|NCT01707199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64854138|NCT01707199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854139|NCT01707199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854140|NCT01707199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64854141|NCT01707199|Renal Agents|renal agents|mesh-ancestor
64854145|NCT01707251|Analgesics|analgesics|mesh-ancestor
64854146|NCT01707251|Sensory System Agents|sensory system agents|mesh-ancestor
64854147|NCT01707251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64854148|NCT01707251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854149|NCT01707251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64854150|NCT01707251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64854151|NCT01707251|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64854152|NCT01707251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854153|NCT01707251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854154|NCT01707316|Canagliflozin|canagliflozin|mesh-list
64854155|NCT01707316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64854156|NCT01707316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854157|NCT01707316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64854158|NCT01707316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854159|NCT01707342|Simeprevir|simeprevir|mesh-list
64854160|NCT01707342|Antiviral Agents|antiviral agents|mesh-ancestor
64854161|NCT01707342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64854162|NCT01707342|Protease Inhibitors|protease inhibitors|mesh-ancestor
64854163|NCT01707342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854164|NCT01707342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854166|NCT01707394|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64854167|NCT01707394|Antithrombins|antithrombins|mesh-ancestor
64854168|NCT01707394|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64854169|NCT01707394|Protease Inhibitors|protease inhibitors|mesh-ancestor
64854170|NCT01707394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854171|NCT01707394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854172|NCT01707394|Anticoagulants|anticoagulants|mesh-ancestor
64854173|NCT01707407|Ketoconazole|ketoconazole|mesh-list
64854174|NCT01707407|Pomalidomide|pomalidomide|mesh-list
64854175|NCT01707407|Carbamazepine|carbamazepine|mesh-list
64854176|NCT01707407|Fluvoxamine|fluvoxamine|mesh-list
64854177|NCT01707407|Immunologic Factors|immunologic factors|mesh-ancestor
64854178|NCT01707407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854179|NCT01707407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64854180|NCT01707407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64854181|NCT01707407|Growth Substances|growth substances|mesh-ancestor
64854182|NCT01707407|Growth Inhibitors|growth inhibitors|mesh-ancestor
64854183|NCT01707407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854184|NCT01707407|Antifungal Agents|antifungal agents|mesh-ancestor
64854185|NCT01707407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64694295|NCT03286829|Metoprolol|metoprolol|mesh-list
64854186|NCT01707407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64854187|NCT01707407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64854188|NCT01707407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854189|NCT01707407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854190|NCT01707407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64854191|NCT01707407|Hormone Antagonists|hormone antagonists|mesh-ancestor
64854192|NCT01707407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64854193|NCT01707407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64854194|NCT01707407|Anticonvulsants|anticonvulsants|mesh-ancestor
64854195|NCT01707407|Antimanic Agents|antimanic agents|mesh-ancestor
64854196|NCT01707407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64854197|NCT01707407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64854198|NCT01707407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64854199|NCT01707407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64854200|NCT01707407|Analgesics|analgesics|mesh-ancestor
64854201|NCT01707407|Sensory System Agents|sensory system agents|mesh-ancestor
64854202|NCT01707407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64854203|NCT01707407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64854204|NCT01707407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64854205|NCT01707407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64332601|NCT02401139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64332602|NCT02401139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64332603|NCT02401139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64332604|NCT02401139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332605|NCT02390635|Deoxyglucose|deoxyglucose|mesh-list
64332606|NCT02390635|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64332607|NCT02390635|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64332608|NCT02390635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332609|NCT02390635|Antimetabolites|antimetabolites|mesh-ancestor
64332610|NCT02390635|Antiviral Agents|antiviral agents|mesh-ancestor
64854252|NCT01707823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64854253|NCT01707823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64854254|NCT01707823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854256|NCT01707849|Everolimus|everolimus|mesh-list
64854257|NCT01707849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854258|NCT01707849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64854259|NCT01707849|Immunologic Factors|immunologic factors|mesh-ancestor
64854260|NCT01707849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854261|NCT01707940|Ketoconazole|ketoconazole|mesh-list
64854262|NCT01707940|Antifungal Agents|antifungal agents|mesh-ancestor
64854263|NCT01707940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64694923|NCT03220022|Hormones|hormones|mesh-ancestor
64854264|NCT01707940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64854265|NCT01707940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64854266|NCT01707940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854267|NCT01707940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854268|NCT01707940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64854269|NCT01707940|Hormone Antagonists|hormone antagonists|mesh-ancestor
64854270|NCT01707940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64854271|NCT01707940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854272|NCT01707940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64854273|NCT01707953|Midodrine|midodrine|mesh-list
64854274|NCT01707953|Sympathomimetics|sympathomimetics|mesh-ancestor
64854275|NCT01707953|Autonomic Agents|autonomic agents|mesh-ancestor
64854276|NCT01707953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64854277|NCT01707953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854278|NCT01707953|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64854279|NCT01707953|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64854280|NCT01707953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64695296|NCT03224351|VX-659|vx-659|mesh-list
64854281|NCT01707953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64854282|NCT01707953|Adrenergic Agents|adrenergic agents|mesh-ancestor
64854283|NCT01707953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64854284|NCT01707953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854285|NCT01708005|Vitamin D|vitamin d|mesh-list
64332613|NCT02379416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64332614|NCT02379416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332615|NCT02379416|Tubulin Modulators|tubulin modulators|mesh-ancestor
64854286|NCT01708005|Cholecalciferol|cholecalciferol|mesh-list
64854287|NCT01708005|Vitamins|vitamins|mesh-ancestor
64854288|NCT01708005|Micronutrients|micronutrients|mesh-ancestor
64854289|NCT01708005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854290|NCT01708005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64854291|NCT01708005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64854292|NCT01708044|Pramlintide|pramlintide|mesh-list
64854293|NCT01708044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64854294|NCT01708044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854295|NCT01708239|Fibrin fragment D|fibrin fragment d|mesh-list
64854296|NCT01708239|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64854297|NCT01708239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64854298|NCT01708239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854299|NCT01708239|Hemostatics|hemostatics|mesh-ancestor
64854300|NCT01708239|Coagulants|coagulants|mesh-ancestor
64854301|NCT01708330|Lidocaine|lidocaine|mesh-list
64854302|NCT01708330|Anesthetics, Local|anesthetics, local|mesh-ancestor
64854303|NCT01708330|Anesthetics|anesthetics|mesh-ancestor
64854304|NCT01708330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64854305|NCT01708330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854306|NCT01708330|Sensory System Agents|sensory system agents|mesh-ancestor
64854307|NCT01708330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64854308|NCT01708330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64854309|NCT01708330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64854310|NCT01708330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64854352|NCT01708616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854353|NCT01708616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64854354|NCT01708616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64854355|NCT01708616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64854356|NCT01708616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64854357|NCT01708616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64854359|NCT01708642|Epinephrine|epinephrine|mesh-list
64854360|NCT01708642|Racepinephrine|racepinephrine|mesh-list
64854361|NCT01708642|Epinephryl borate|epinephryl borate|mesh-list
64854362|NCT01708642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64854363|NCT01708642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64854364|NCT01708642|Adrenergic Agents|adrenergic agents|mesh-ancestor
64854365|NCT01708642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64854366|NCT01708642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854367|NCT01708642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854368|NCT01708642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64854369|NCT01708642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64854370|NCT01708642|Autonomic Agents|autonomic agents|mesh-ancestor
64854371|NCT01708642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64854372|NCT01708642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64854373|NCT01708642|Respiratory System Agents|respiratory system agents|mesh-ancestor
64854374|NCT01708642|Mydriatics|mydriatics|mesh-ancestor
64854375|NCT01708642|Sympathomimetics|sympathomimetics|mesh-ancestor
64854376|NCT01708642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64854377|NCT01708707|Morphine|morphine|mesh-list
64854378|NCT01708707|Buprenorphine|buprenorphine|mesh-list
64854379|NCT01708707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64854380|NCT01708707|Narcotics|narcotics|mesh-ancestor
64622862|NCT05487300|Levodopa|levodopa|mesh-list
64854381|NCT01708707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64854383|NCT01708707|Analgesics|analgesics|mesh-ancestor
64854385|NCT01708707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64854386|NCT01708707|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64854387|NCT01708720|Vaccines|vaccines|mesh-list
64854388|NCT01708720|Immunologic Factors|immunologic factors|mesh-ancestor
64695743|NCT00003399|Paclitaxel|paclitaxel|mesh-list
64854389|NCT01708720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854390|NCT01708798|Eplerenone|eplerenone|mesh-list
64854391|NCT01708798|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64854392|NCT01708798|Hormone Antagonists|hormone antagonists|mesh-ancestor
64854393|NCT01708798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64854394|NCT01708798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854395|NCT01708798|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64854396|NCT01708798|Diuretics|diuretics|mesh-ancestor
64854397|NCT01708798|Natriuretic Agents|natriuretic agents|mesh-ancestor
64854398|NCT01708798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64854399|NCT01708837|Propofol|propofol|mesh-list
64854400|NCT01708837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64854401|NCT01708837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64854402|NCT01708837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854403|NCT01708837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64854404|NCT01708837|Anesthetics, General|anesthetics, general|mesh-ancestor
64854405|NCT01708837|Anesthetics|anesthetics|mesh-ancestor
64854406|NCT01708850|Rivaroxaban|rivaroxaban|mesh-list
64854407|NCT01708850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64854408|NCT01708850|Antithrombins|antithrombins|mesh-ancestor
64854409|NCT01708850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64332625|NCT02369458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64332626|NCT02369458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64332627|NCT02367846|Contraceptive Agents|contraceptive agents|mesh-list
64332628|NCT02367846|NuvaRing|nuvaring|mesh-list
64854415|NCT01708876|Chloroquine|chloroquine|mesh-list
64854416|NCT01708876|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64854417|NCT01708876|Primaquine|primaquine|mesh-list
64854418|NCT01708876|Mefloquine|mefloquine|mesh-list
64854419|NCT01708876|Antimalarials|antimalarials|mesh-ancestor
64695995|NCT04735445|Liver Extracts|liver extracts|mesh-list
64854420|NCT01708876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64854421|NCT01708876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64854422|NCT01708876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64854423|NCT01708876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854424|NCT01708876|Antiviral Agents|antiviral agents|mesh-ancestor
64854425|NCT01708876|Schistosomicides|schistosomicides|mesh-ancestor
64854426|NCT01708876|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64854427|NCT01708876|Anthelmintics|anthelmintics|mesh-ancestor
64854428|NCT01708876|Amebicides|amebicides|mesh-ancestor
64854429|NCT01708876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64854430|NCT01708876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64854431|NCT01708876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64854432|NCT01708876|Analgesics|analgesics|mesh-ancestor
64854433|NCT01708876|Sensory System Agents|sensory system agents|mesh-ancestor
64854434|NCT01708876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64696079|NCT00003249|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
64854435|NCT01708876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854436|NCT01708876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64854437|NCT01708876|Filaricides|filaricides|mesh-ancestor
64854438|NCT01708876|Antinematodal Agents|antinematodal agents|mesh-ancestor
64854439|NCT01708993|Docetaxel|docetaxel|mesh-list
64854440|NCT01708993|Pemetrexed|pemetrexed|mesh-list
64854441|NCT01708993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854442|NCT01708993|Tubulin Modulators|tubulin modulators|mesh-ancestor
64854443|NCT01708993|Antimitotic Agents|antimitotic agents|mesh-ancestor
64854444|NCT01708993|Mitosis Modulators|mitosis modulators|mesh-ancestor
64332629|NCT02367846|Contraceptives, Oral|contraceptives, oral|mesh-list
64854445|NCT01708993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854446|NCT01708993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854447|NCT01708993|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64854448|NCT01708993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64854450|NCT01709019|Immunologic Factors|immunologic factors|mesh-ancestor
64854454|NCT01709071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854455|NCT01709292|Vemurafenib|vemurafenib|mesh-list
64854456|NCT01709292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854457|NCT01709292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64854458|NCT01709292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854459|NCT01709292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854460|NCT01709370|Letrozole|letrozole|mesh-list
64854461|NCT01709370|Palbociclib|palbociclib|mesh-list
64854462|NCT01709370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854463|NCT01709370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64854464|NCT01709370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64854465|NCT01709370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854466|NCT01709370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854467|NCT01709370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64854468|NCT01709370|Hormone Antagonists|hormone antagonists|mesh-ancestor
64854469|NCT01709370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64854470|NCT01709370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854471|NCT01709370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64854472|NCT01709630|Magnesium Sulfate|magnesium sulfate|mesh-list
64854473|NCT01709630|Analgesics|analgesics|mesh-ancestor
64854474|NCT01709630|Sensory System Agents|sensory system agents|mesh-ancestor
64854475|NCT01709630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64854476|NCT01709630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854477|NCT01709630|Anesthetics|anesthetics|mesh-ancestor
64854478|NCT01709630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64854479|NCT01709630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64854480|NCT01709630|Anticonvulsants|anticonvulsants|mesh-ancestor
64854481|NCT01709630|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64854482|NCT01709630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64854483|NCT01709630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854484|NCT01709630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64854485|NCT01709630|Tocolytic Agents|tocolytic agents|mesh-ancestor
64854486|NCT01709630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64854487|NCT01709656|Celecoxib|celecoxib|mesh-list
64854488|NCT01709656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64854489|NCT01709656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64854490|NCT01709656|Analgesics|analgesics|mesh-ancestor
64854491|NCT01709656|Sensory System Agents|sensory system agents|mesh-ancestor
64854492|NCT01709656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64854493|NCT01709656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854494|NCT01709656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64854495|NCT01709656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64332630|NCT02367846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64332631|NCT02367846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64332632|NCT02367846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332633|NCT02367846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64696446|NCT05041322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64332634|NCT02367846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64332636|NCT02203526|Isavuconazole|isavuconazole|mesh-list
64332637|NCT02203526|Rituximab|rituximab|mesh-list
64332638|NCT02203526|Methotrexate|methotrexate|mesh-list
64332639|NCT02203526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64332640|NCT02203526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332641|NCT02203526|Immunologic Factors|immunologic factors|mesh-ancestor
64332642|NCT02203526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332643|NCT02203526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64332644|NCT02203526|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64332645|NCT02203526|Abortifacient Agents|abortifacient agents|mesh-ancestor
64332646|NCT02203526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64332647|NCT02203526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64332648|NCT02203526|Antimetabolites|antimetabolites|mesh-ancestor
64332649|NCT02203526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332650|NCT02203526|Dermatologic Agents|dermatologic agents|mesh-ancestor
64854496|NCT01709656|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64854497|NCT01709656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64854498|NCT01709656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854499|NCT01709656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854500|NCT01709682|Amiodarone|amiodarone|mesh-list
64854501|NCT01709682|Sotalol|sotalol|mesh-list
64854502|NCT01709682|Flecainide|flecainide|mesh-list
64854503|NCT01709682|Propafenone|propafenone|mesh-list
64854504|NCT01709682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64854505|NCT01709682|Vasodilator Agents|vasodilator agents|mesh-ancestor
64854506|NCT01709682|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64854507|NCT01709682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64854508|NCT01709682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854509|NCT01709682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64854510|NCT01709682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64854511|NCT01709682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64854512|NCT01709682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854513|NCT01709682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64854514|NCT01709682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64854515|NCT01709682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64854516|NCT01709682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64854517|NCT01709682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64854518|NCT01709682|Adrenergic Agents|adrenergic agents|mesh-ancestor
64854519|NCT01709682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64854520|NCT01709682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854521|NCT01709682|Sympatholytics|sympatholytics|mesh-ancestor
64854522|NCT01709682|Autonomic Agents|autonomic agents|mesh-ancestor
64854523|NCT01709682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64854524|NCT01709682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64854525|NCT01709760|Methotrexate|methotrexate|mesh-list
64854526|NCT01709760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64854527|NCT01709760|Abortifacient Agents|abortifacient agents|mesh-ancestor
64854528|NCT01709760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64854534|NCT01709760|Dermatologic Agents|dermatologic agents|mesh-ancestor
64854535|NCT01709760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854536|NCT01709760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64854537|NCT01709760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64854538|NCT01709760|Immunologic Factors|immunologic factors|mesh-ancestor
64854539|NCT01709760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64854540|NCT01709760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64854542|NCT01709825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64854543|NCT01709825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64854544|NCT01709825|Renal Agents|renal agents|mesh-ancestor
64854545|NCT01709825|Antimalarials|antimalarials|mesh-ancestor
64854546|NCT01709825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64854547|NCT01709825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64854548|NCT01709929|Insulin Detemir|insulin detemir|mesh-list
64854549|NCT01709929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64854550|NCT01709929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854551|NCT01709942|Cetrorelix|cetrorelix|mesh-list
64854552|NCT01709942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64854553|NCT01709942|Fertility Agents|fertility agents|mesh-ancestor
64854554|NCT01709942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64854555|NCT01709942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854556|NCT01709942|Hormone Antagonists|hormone antagonists|mesh-ancestor
64854568|NCT01709994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64696940|NCT02256540|Hormones|hormones|mesh-ancestor
64854570|NCT01709994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64854571|NCT01709994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64854572|NCT01709994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854573|NCT01709994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64854574|NCT01709994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64854575|NCT01709994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854576|NCT01709994|Antipyretics|antipyretics|mesh-ancestor
64854577|NCT01710007|Atorvastatin|atorvastatin|mesh-list
64854578|NCT01710007|Pitavastatin|pitavastatin|mesh-list
64854579|NCT01710007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64854580|NCT01710007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64854581|NCT01710007|Antimetabolites|antimetabolites|mesh-ancestor
64854582|NCT01710007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854583|NCT01710007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64854584|NCT01710007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64854585|NCT01710007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854586|NCT01710059|Adrenergic Agents|adrenergic agents|mesh-list
64697124|NCT04871958|Insulin|insulin|mesh-list
64854587|NCT01710059|Adrenergic Agonists|adrenergic agonists|mesh-list
64854588|NCT01710059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64854589|NCT01710059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854590|NCT01710059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854592|NCT01710072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64854593|NCT01710072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64854594|NCT01710072|Analgesics|analgesics|mesh-ancestor
64295239|NCT02048683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854623|NCT01710163|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64854624|NCT01710163|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64854625|NCT01710202|Hydrocortisone|hydrocortisone|mesh-list
64854626|NCT01710202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64854627|NCT01710228|Methylprednisolone|methylprednisolone|mesh-list
64854628|NCT01710228|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64854629|NCT01710228|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64854630|NCT01710228|Prednisolone|prednisolone|mesh-list
64295252|NCT03108729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64332676|NCT02195895|Calcium Carbonate|calcium carbonate|mesh-list
64332678|NCT02195895|Calcium|calcium|mesh-list
64332679|NCT02195895|Micronutrients|micronutrients|mesh-ancestor
64332680|NCT02195895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332681|NCT02195895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64332682|NCT02195895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64332683|NCT02195895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332684|NCT02195895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64332685|NCT01970722|Gemcitabine|gemcitabine|mesh-list
64332686|NCT01970722|Paclitaxel|paclitaxel|mesh-list
64332687|NCT01970722|Cisplatin|cisplatin|mesh-list
64332688|NCT01970722|Carboplatin|carboplatin|mesh-list
64332689|NCT01970722|Doxorubicin|doxorubicin|mesh-list
64332690|NCT01970722|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64332691|NCT01970722|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64854667|NCT01710462|Dopamine Agents|dopamine agents|mesh-ancestor
64854668|NCT01710462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64854669|NCT01710488|Levofloxacin|levofloxacin|mesh-list
64854671|NCT01710488|Prulifloxacin|prulifloxacin|mesh-list
64854672|NCT01710488|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64854673|NCT01710488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64854674|NCT01710488|Renal Agents|renal agents|mesh-ancestor
64854675|NCT01710488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64854709|NCT01710592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64854710|NCT01710592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64854711|NCT01710592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64854712|NCT01710592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854713|NCT01710631|Eszopiclone|eszopiclone|mesh-list
64854714|NCT01710631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64854715|NCT01710631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64854716|NCT01710631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854717|NCT01710670|Ethanol|ethanol|mesh-list
64854718|NCT01710670|Brivaracetam|brivaracetam|mesh-list
64854719|NCT01710670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64854720|NCT01710670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64854721|NCT01710670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64854722|NCT01710670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854723|NCT01710670|Anticonvulsants|anticonvulsants|mesh-ancestor
64854724|NCT01710696|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64854725|NCT01710696|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64854726|NCT01710696|Estradiol|estradiol|mesh-list
64854727|NCT01710696|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64854728|NCT01710696|Estrogens|estrogens|mesh-ancestor
64854729|NCT01710696|Hormones|hormones|mesh-ancestor
64854765|NCT01710761|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64854766|NCT01710761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854767|NCT01710761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854782|NCT01710995|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
64854784|NCT01710995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854785|NCT01710995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854786|NCT01711060|Oxytocin|oxytocin|mesh-list
64854787|NCT01711060|Oxytocics|oxytocics|mesh-ancestor
64854788|NCT01711060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64854789|NCT01711060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854790|NCT01711073|Plerixafor|plerixafor|mesh-list
64854791|NCT01711073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64854792|NCT01711073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64854793|NCT01711073|Antiviral Agents|antiviral agents|mesh-ancestor
64697792|NCT00361166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64854794|NCT01711073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64854795|NCT01711086|Formoterol Fumarate|formoterol fumarate|mesh-list
64854796|NCT01711086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64854797|NCT01711086|Autonomic Agents|autonomic agents|mesh-ancestor
64854798|NCT01711086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64854799|NCT01711086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854800|NCT01711086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64854801|NCT01711086|Respiratory System Agents|respiratory system agents|mesh-ancestor
64854815|NCT01711125|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64854816|NCT01711125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854817|NCT01711125|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64854818|NCT01711125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64854819|NCT01711125|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64854820|NCT01711125|GABA Agonists|gaba agonists|mesh-ancestor
64854821|NCT01711125|GABA Agents|gaba agents|mesh-ancestor
64854822|NCT01711125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64854823|NCT01711125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854824|NCT01711229|Acetaminophen|acetaminophen|mesh-list
64854825|NCT01711229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64854826|NCT01711229|Analgesics|analgesics|mesh-ancestor
64854827|NCT01711229|Sensory System Agents|sensory system agents|mesh-ancestor
64854828|NCT01711229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64854829|NCT01711229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854830|NCT01711229|Antipyretics|antipyretics|mesh-ancestor
64854831|NCT01711320|Omeprazole|omeprazole|mesh-list
64854832|NCT01711320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64854833|NCT01711320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64854834|NCT01711320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64854835|NCT01711320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854836|NCT01711320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854837|NCT01711437|Ascorbic Acid|ascorbic acid|mesh-list
64854838|NCT01711437|Simethicone|simethicone|mesh-list
64854839|NCT01711437|Picosulfate sodium|picosulfate sodium|mesh-list
64854840|NCT01711437|Magnesium Oxide|magnesium oxide|mesh-list
64854841|NCT01711437|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64854842|NCT01711437|Citric Acid|citric acid|mesh-list
64854843|NCT01711437|Sodium Citrate|sodium citrate|mesh-list
64854861|NCT01711437|Laxatives|laxatives|mesh-ancestor
64854862|NCT01711463|Fluticasone|fluticasone|mesh-list
64854863|NCT01711463|Xhance|xhance|mesh-list
64854864|NCT01711463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64854865|NCT01711463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64854866|NCT01711463|Autonomic Agents|autonomic agents|mesh-ancestor
64854867|NCT01711463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64854868|NCT01711463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854869|NCT01711463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64854870|NCT01711463|Respiratory System Agents|respiratory system agents|mesh-ancestor
64698158|NCT01638000|Mirabegron|mirabegron|mesh-list
64854871|NCT01711463|Dermatologic Agents|dermatologic agents|mesh-ancestor
64854874|NCT01711476|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64854876|NCT01711476|Immunologic Factors|immunologic factors|mesh-ancestor
64854877|NCT01711476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854878|NCT01711489|Mycophenolic Acid|mycophenolic acid|mesh-list
64854879|NCT01711489|Isavuconazole|isavuconazole|mesh-list
64854880|NCT01711489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64854881|NCT01711489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854882|NCT01711489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64854883|NCT01711489|Antitubercular Agents|antitubercular agents|mesh-ancestor
64854884|NCT01711489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64854885|NCT01711489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64854886|NCT01711489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698343|NCT05263986|Adagrasib|adagrasib|mesh-list
64854887|NCT01711489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332733|NCT01913951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64332734|NCT01867320|Raltegravir Potassium|raltegravir potassium|mesh-list
64332735|NCT01867320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64332736|NCT01867320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64332737|NCT01867320|Antiviral Agents|antiviral agents|mesh-ancestor
64332738|NCT01867320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64854921|NCT01711567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854922|NCT01711567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854923|NCT01711567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64854924|NCT01711567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64854925|NCT01711593|Dimercaprol|dimercaprol|mesh-list
64854926|NCT01711593|Chelating Agents|chelating agents|mesh-ancestor
64854927|NCT01711593|Sequestering Agents|sequestering agents|mesh-ancestor
64854928|NCT01711593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854929|NCT01711671|Dexamethasone|dexamethasone|mesh-list
64854930|NCT01711671|Lenalidomide|lenalidomide|mesh-list
64854931|NCT01711671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64854932|NCT01711671|Antiemetics|antiemetics|mesh-ancestor
64854933|NCT01711671|Autonomic Agents|autonomic agents|mesh-ancestor
64698661|NCT01152541|Vitamins|vitamins|mesh-ancestor
64854934|NCT01711671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64854935|NCT01711671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854936|NCT01711671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64854937|NCT01711671|Glucocorticoids|glucocorticoids|mesh-ancestor
64854938|NCT01711671|Hormones|hormones|mesh-ancestor
64854939|NCT01711671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64854940|NCT01711671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64854941|NCT01711671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854942|NCT01711671|Immunologic Factors|immunologic factors|mesh-ancestor
64854943|NCT01711671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64854944|NCT01711671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64854945|NCT01711671|Growth Substances|growth substances|mesh-ancestor
64854946|NCT01711671|Growth Inhibitors|growth inhibitors|mesh-ancestor
64854947|NCT01711697|Paclitaxel|paclitaxel|mesh-list
64854948|NCT01711697|Carboplatin|carboplatin|mesh-list
64854949|NCT01711697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64854950|NCT01711697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854951|NCT01711697|Tubulin Modulators|tubulin modulators|mesh-ancestor
64854952|NCT01711697|Antimitotic Agents|antimitotic agents|mesh-ancestor
64854953|NCT01711697|Mitosis Modulators|mitosis modulators|mesh-ancestor
64854954|NCT01711697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854955|NCT01711723|Darapladib|darapladib|mesh-list
64854956|NCT01711723|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
64854957|NCT01711723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854958|NCT01711723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854959|NCT01711749|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64854960|NCT01711749|Calcium|calcium|mesh-list
64854961|NCT01711749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64854962|NCT01711749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854963|NCT01711749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64854971|NCT01711814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64854972|NCT01711814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64854973|NCT01711814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64854974|NCT01711814|Immunologic Factors|immunologic factors|mesh-ancestor
64854975|NCT01711814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854976|NCT01711827|Isavuconazole|isavuconazole|mesh-list
64854977|NCT01711827|Prednisone|prednisone|mesh-list
64854978|NCT01711827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64854979|NCT01711827|Glucocorticoids|glucocorticoids|mesh-ancestor
64854980|NCT01711827|Hormones|hormones|mesh-ancestor
64854981|NCT01711827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64854982|NCT01711827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854983|NCT01711827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64623455|NCT00843310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64854984|NCT01711827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854985|NCT01711827|Antifungal Agents|antifungal agents|mesh-ancestor
64854986|NCT01711827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64854988|NCT01711905|Cholecalciferol|cholecalciferol|mesh-list
64854989|NCT01711905|Vitamins|vitamins|mesh-ancestor
64854990|NCT01711905|Micronutrients|micronutrients|mesh-ancestor
64854991|NCT01711905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64854992|NCT01711905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64854993|NCT01711905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64854994|NCT01711931|Everolimus|everolimus|mesh-list
64854995|NCT01711931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64854996|NCT01711931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64854997|NCT01711931|Immunologic Factors|immunologic factors|mesh-ancestor
64855017|NCT01712113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855018|NCT01712126|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64855020|NCT01712126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64855021|NCT01712126|Diuretics|diuretics|mesh-ancestor
64855022|NCT01712126|Natriuretic Agents|natriuretic agents|mesh-ancestor
64855023|NCT01712126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698937|NCT05525455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855024|NCT01712126|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64855025|NCT01712126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64855026|NCT01712126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295282|NCT02049073|Prednisolone|prednisolone|mesh-list
64855027|NCT01712126|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64855028|NCT01712126|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64855029|NCT01712139|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64855031|NCT01712139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64855032|NCT01712139|Diuretics|diuretics|mesh-ancestor
64855033|NCT01712139|Natriuretic Agents|natriuretic agents|mesh-ancestor
64855034|NCT01712139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855035|NCT01712139|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64855036|NCT01712139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64855037|NCT01712139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855038|NCT01712139|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64855039|NCT01712139|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64855040|NCT01712295|Salicylic Acid|salicylic acid|mesh-list
64855041|NCT01712295|Salicylates|salicylates|mesh-list
64855042|NCT01712295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64855043|NCT01712295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64855044|NCT01712295|Analgesics|analgesics|mesh-ancestor
64855045|NCT01712295|Sensory System Agents|sensory system agents|mesh-ancestor
64855046|NCT01712295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699163|NCT05648058|Antiemetics|antiemetics|mesh-ancestor
64855047|NCT01712295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855048|NCT01712295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64855049|NCT01712295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64855054|NCT01712295|Antifungal Agents|antifungal agents|mesh-ancestor
64855055|NCT01712295|Keratolytic Agents|keratolytic agents|mesh-ancestor
64855056|NCT01712295|Dermatologic Agents|dermatologic agents|mesh-ancestor
64855057|NCT01712321|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
64855058|NCT01712321|Antidepressive Agents|antidepressive agents|mesh-ancestor
64855059|NCT01712321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64855060|NCT01712321|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64855061|NCT01712321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64855062|NCT01712321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64855063|NCT01712321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855064|NCT01712321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64855065|NCT01712321|Serotonin Agents|serotonin agents|mesh-ancestor
64855066|NCT01712321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855067|NCT01712321|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64855068|NCT01712321|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64855069|NCT01712347|Bevacizumab|bevacizumab|mesh-list
64855070|NCT01712347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64855071|NCT01712347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855072|NCT01712347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64855073|NCT01712347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64855074|NCT01712347|Growth Substances|growth substances|mesh-ancestor
64855075|NCT01712347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855076|NCT01712347|Growth Inhibitors|growth inhibitors|mesh-ancestor
64855138|NCT01712828|Histamine Agents|histamine agents|mesh-ancestor
64855139|NCT01712828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64855140|NCT01712828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855141|NCT01712828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64855142|NCT01712828|Antipruritics|antipruritics|mesh-ancestor
64855143|NCT01712828|Dermatologic Agents|dermatologic agents|mesh-ancestor
64855144|NCT01712828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64855145|NCT01712828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64699219|NCT00359671|Tubulin Modulators|tubulin modulators|mesh-ancestor
64855146|NCT01712828|Adrenergic Agents|adrenergic agents|mesh-ancestor
64855147|NCT01712828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64855148|NCT01712828|Antimalarials|antimalarials|mesh-ancestor
64855149|NCT01712828|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64855164|NCT01712919|Cetuximab|cetuximab|mesh-list
64855165|NCT01712919|Nedaplatin|nedaplatin|mesh-list
64855166|NCT01712919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64855167|NCT01712919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855168|NCT01712919|Tubulin Modulators|tubulin modulators|mesh-ancestor
64855169|NCT01712919|Antimitotic Agents|antimitotic agents|mesh-ancestor
64855170|NCT01712919|Mitosis Modulators|mitosis modulators|mesh-ancestor
64855171|NCT01712919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855172|NCT01712919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64855173|NCT01712945|Alemtuzumab|alemtuzumab|mesh-list
64855174|NCT01712945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64855175|NCT01712945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855176|NCT01712997|Bosentan|bosentan|mesh-list
64855183|NCT01713049|Alovudine|alovudine|mesh-list
64855184|NCT01713049|Antiviral Agents|antiviral agents|mesh-ancestor
64855185|NCT01713049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855186|NCT01713101|Tranylcypromine|tranylcypromine|mesh-list
64855187|NCT01713101|Tranexamic Acid|tranexamic acid|mesh-list
64855188|NCT01713101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
64855189|NCT01713101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64855190|NCT01713101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855191|NCT01713101|Hemostatics|hemostatics|mesh-ancestor
64855192|NCT01713101|Coagulants|coagulants|mesh-ancestor
64855193|NCT01713101|Antidepressive Agents|antidepressive agents|mesh-ancestor
64855194|NCT01713101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64855195|NCT01713101|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64855196|NCT01713101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855197|NCT01713101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64855198|NCT01713101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64855199|NCT01713101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64855200|NCT01713101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855201|NCT01713127|Remifentanil|remifentanil|mesh-list
64855202|NCT01713127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64855203|NCT01713127|Narcotics|narcotics|mesh-ancestor
64855204|NCT01713127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64855205|NCT01713127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855206|NCT01713127|Analgesics|analgesics|mesh-ancestor
64855207|NCT01713127|Sensory System Agents|sensory system agents|mesh-ancestor
64855237|NCT01713231|Vitamins|vitamins|mesh-list
64855238|NCT01713231|Micronutrients|micronutrients|mesh-ancestor
64855239|NCT01713231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855240|NCT01713231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64855277|NCT01713426|Antipruritics|antipruritics|mesh-ancestor
64855278|NCT01713426|Dermatologic Agents|dermatologic agents|mesh-ancestor
64855279|NCT01713556|Propranolol|propranolol|mesh-list
64855280|NCT01713556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64855281|NCT01713556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64855282|NCT01713556|Adrenergic Agents|adrenergic agents|mesh-ancestor
64855283|NCT01713556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64623757|NCT00634972|Analgesics|analgesics|mesh-ancestor
64945456|NCT05619627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64855284|NCT01713556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855285|NCT01713556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855286|NCT01713556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64855287|NCT01713556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64855288|NCT01713556|Vasodilator Agents|vasodilator agents|mesh-ancestor
64855289|NCT01713647|Losartan|losartan|mesh-list
64855290|NCT01713647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64855291|NCT01713647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64855292|NCT01713647|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64855293|NCT01713647|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64855294|NCT01713647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855295|NCT01713725|Omalizumab|omalizumab|mesh-list
64699473|NCT04676035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64699500|NCT04359199|Cisplatin|cisplatin|mesh-list
64855296|NCT01713725|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64855297|NCT01713725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64855298|NCT01713725|Respiratory System Agents|respiratory system agents|mesh-ancestor
64295283|NCT02049073|Prednisolone acetate|prednisolone acetate|mesh-list
64295284|NCT02049073|Zonisamide|zonisamide|mesh-list
64295285|NCT02049073|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64295286|NCT02049073|Prednisolone phosphate|prednisolone phosphate|mesh-list
64855330|NCT01713920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64855331|NCT01713920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855332|NCT01713920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64855333|NCT01713920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855335|NCT01713972|Dabrafenib|dabrafenib|mesh-list
64855336|NCT01713972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855337|NCT01713972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64855338|NCT01713972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855339|NCT01713972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855340|NCT01714011|Aripiprazole|aripiprazole|mesh-list
64855341|NCT01714011|Ziprasidone|ziprasidone|mesh-list
64855342|NCT01714011|Antidepressive Agents|antidepressive agents|mesh-ancestor
64855343|NCT01714011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64855344|NCT01714011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64855358|NCT01714011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64855359|NCT01714037|Gemcitabine|gemcitabine|mesh-list
64855360|NCT01714037|Docetaxel|docetaxel|mesh-list
64855361|NCT01714037|Pemetrexed|pemetrexed|mesh-list
64855362|NCT01714037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855363|NCT01714037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64855364|NCT01714037|Antimetabolites|antimetabolites|mesh-ancestor
64855365|NCT01714037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855366|NCT01714037|Antiviral Agents|antiviral agents|mesh-ancestor
64855367|NCT01714037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855368|NCT01714037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855369|NCT01714037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64855370|NCT01714037|Immunologic Factors|immunologic factors|mesh-ancestor
64855376|NCT01714037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64855377|NCT01714089|Interferons|interferons|mesh-list
64855378|NCT01714089|Interferon-beta|interferon-beta|mesh-list
64855379|NCT01714089|Interferon beta-1a|interferon beta-1a|mesh-list
64855380|NCT01714089|RNS60|rns60|mesh-list
64855381|NCT01714089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855382|NCT01714089|Antiviral Agents|antiviral agents|mesh-ancestor
64855383|NCT01714089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855384|NCT01714089|Immunologic Factors|immunologic factors|mesh-ancestor
64855385|NCT01714089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855407|NCT01714115|Growth Inhibitors|growth inhibitors|mesh-ancestor
64855408|NCT01714115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855409|NCT01714128|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64855410|NCT01714128|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64855411|NCT01714128|Estradiol|estradiol|mesh-list
64855412|NCT01714128|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64855413|NCT01714128|Estrogens|estrogens|mesh-ancestor
64855414|NCT01714128|Hormones|hormones|mesh-ancestor
64855415|NCT01714128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64855416|NCT01714128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699731|NCT04448886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64855417|NCT01714128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64855418|NCT01714128|Contraceptive Agents|contraceptive agents|mesh-ancestor
64855419|NCT01714128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64855420|NCT01714128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64855421|NCT01714154|Ritonavir|ritonavir|mesh-list
64855422|NCT01714154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64855423|NCT01714154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64855424|NCT01714154|Protease Inhibitors|protease inhibitors|mesh-ancestor
64855425|NCT01714154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855426|NCT01714154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855427|NCT01714154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64855428|NCT01714154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64855429|NCT01714154|Antiviral Agents|antiviral agents|mesh-ancestor
64855430|NCT01714154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64623920|NCT00000778|Vitamins|vitamins|mesh-ancestor
64855431|NCT01714154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64855432|NCT01714154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64855433|NCT01714193|Canagliflozin|canagliflozin|mesh-list
64855434|NCT01714193|Contraceptive Agents|contraceptive agents|mesh-list
64855435|NCT01714193|Contraceptives, Oral|contraceptives, oral|mesh-list
64855436|NCT01714193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64855437|NCT01714193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855438|NCT01714193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64855440|NCT01714193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64855445|NCT01714206|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64855446|NCT01714206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855447|NCT01714206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855448|NCT01714206|Protective Agents|protective agents|mesh-ancestor
64855517|NCT01714557|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64855519|NCT01714557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855520|NCT01714570|Tazobactam|tazobactam|mesh-list
64855521|NCT01714570|Piperacillin|piperacillin|mesh-list
64855522|NCT01714570|Imipenem|imipenem|mesh-list
64855523|NCT01714570|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64855524|NCT01714570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64855525|NCT01714570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855526|NCT01714570|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64855527|NCT01714570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295300|NCT02049073|Anticonvulsants|anticonvulsants|mesh-ancestor
64295301|NCT02049073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64295302|NCT02049073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64295303|NCT02049073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295306|NCT04518345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64295308|NCT04518345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295309|NCT04518345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295310|NCT04518345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295311|NCT02260063|Epinastine|epinastine|mesh-list
64295312|NCT02260063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64295313|NCT02260063|Histamine Antagonists|histamine antagonists|mesh-ancestor
64295314|NCT02260063|Histamine Agents|histamine agents|mesh-ancestor
64295315|NCT02260063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64295316|NCT02260063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295317|NCT02260063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295318|NCT04398914|Paclitaxel|paclitaxel|mesh-list
64295319|NCT04398914|Trastuzumab|trastuzumab|mesh-list
64855611|NCT01715142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855612|NCT01715142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64855613|NCT01715142|Antimetabolites|antimetabolites|mesh-ancestor
64855614|NCT01715142|Antiviral Agents|antiviral agents|mesh-ancestor
64855615|NCT01715142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855616|NCT01715142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855617|NCT01715142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64855618|NCT01715142|Immunologic Factors|immunologic factors|mesh-ancestor
64855619|NCT01715142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855620|NCT01715168|Doxorubicin|doxorubicin|mesh-list
64855621|NCT01715168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64855622|NCT01715168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64855623|NCT01715168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855624|NCT01715168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64855625|NCT01715168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64855626|NCT01715168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855627|NCT01715168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855628|NCT01715220|Nitroglycerin|nitroglycerin|mesh-list
64855629|NCT01715220|Vasodilator Agents|vasodilator agents|mesh-ancestor
64855630|NCT01715259|Abiraterone Acetate|abiraterone acetate|mesh-list
64855631|NCT01715259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855632|NCT01715259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64855662|NCT01715363|Hematinics|hematinics|mesh-ancestor
64855663|NCT01715441|Irinotecan|irinotecan|mesh-list
64855664|NCT01715441|Sorafenib|sorafenib|mesh-list
64855665|NCT01715441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64855666|NCT01715441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64855667|NCT01715441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855668|NCT01715441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855669|NCT01715441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855670|NCT01715441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64855671|NCT01715493|Muramidase|muramidase|mesh-list
64855672|NCT01715493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855673|NCT01715519|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
64855674|NCT01715519|Antidepressive Agents|antidepressive agents|mesh-ancestor
64855675|NCT01715519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64855676|NCT01715519|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64855677|NCT01715519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64855678|NCT01715519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64855679|NCT01715519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855680|NCT01715519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64855681|NCT01715519|Serotonin Agents|serotonin agents|mesh-ancestor
64855682|NCT01715519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855683|NCT01715519|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64855684|NCT01715519|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64855685|NCT01715584|Nitrous Oxide|nitrous oxide|mesh-list
64855686|NCT01715584|Sevoflurane|sevoflurane|mesh-list
64855687|NCT01715584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64855688|NCT01715584|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64855689|NCT01715584|Anesthetics, General|anesthetics, general|mesh-ancestor
64855690|NCT01715584|Anesthetics|anesthetics|mesh-ancestor
64855693|NCT01715584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64855707|NCT01715610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64855708|NCT01715610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64855709|NCT01715610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855710|NCT01715610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64855711|NCT01715610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855712|NCT01715610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855713|NCT01715610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64855714|NCT01715636|Tenofovir|tenofovir|mesh-list
64855715|NCT01715636|Emtricitabine|emtricitabine|mesh-list
64855716|NCT01715636|Rilpivirine|rilpivirine|mesh-list
64855717|NCT01715636|Antiviral Agents|antiviral agents|mesh-ancestor
64855718|NCT01715636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855719|NCT01715636|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64855720|NCT01715636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64855721|NCT01715636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855728|NCT01715688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64855729|NCT01715688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855730|NCT01715688|Sensory System Agents|sensory system agents|mesh-ancestor
64855731|NCT01715688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64855732|NCT01715688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64855733|NCT01715688|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64855734|NCT01715688|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64855735|NCT01715688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64855736|NCT01715688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855738|NCT01715701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64855739|NCT01715701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855740|NCT01715701|Trace Elements|trace elements|mesh-ancestor
64855741|NCT01715701|Micronutrients|micronutrients|mesh-ancestor
64855742|NCT01715701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855744|NCT01715909|Antiviral Agents|antiviral agents|mesh-ancestor
64855745|NCT01715909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855746|NCT01715909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855747|NCT01715909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855748|NCT01715922|Fluconazole|fluconazole|mesh-list
64855749|NCT01715922|Flucytosine|flucytosine|mesh-list
64855750|NCT01715922|Antifungal Agents|antifungal agents|mesh-ancestor
64855751|NCT01715922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855752|NCT01715922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64855753|NCT01715922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64855754|NCT01715922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855755|NCT01715922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855756|NCT01715922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64855757|NCT01715922|Hormone Antagonists|hormone antagonists|mesh-ancestor
64855799|NCT01716377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64855800|NCT01716377|Antidepressive Agents|antidepressive agents|mesh-ancestor
64624292|NCT02344472|Tubulin Modulators|tubulin modulators|mesh-ancestor
64855802|NCT01716416|Cetuximab|cetuximab|mesh-list
64855803|NCT01716416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64855804|NCT01716416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855805|NCT01716442|Rituximab|rituximab|mesh-list
64855806|NCT01716442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64855807|NCT01716442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855808|NCT01716442|Immunologic Factors|immunologic factors|mesh-ancestor
64855809|NCT01716442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855810|NCT01716442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64855811|NCT01716572|Erythromycin|erythromycin|mesh-list
64855812|NCT01716572|Erythromycin Estolate|erythromycin estolate|mesh-list
64855813|NCT01716572|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64855814|NCT01716572|Erythromycin stearate|erythromycin stearate|mesh-list
64855815|NCT01716572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64855816|NCT01716572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855817|NCT01716572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64855818|NCT01716572|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64855819|NCT01716572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64855820|NCT01716572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855821|NCT01716611|Tolvaptan|tolvaptan|mesh-list
64855841|NCT01716624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64855842|NCT01716624|Urological Agents|urological agents|mesh-ancestor
64855844|NCT01716637|Curcumin|curcumin|mesh-list
64855845|NCT01716637|Resveratrol|resveratrol|mesh-list
64855846|NCT01716637|Quercetin|quercetin|mesh-list
64855847|NCT01716637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64855848|NCT01716637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64855849|NCT01716637|Analgesics|analgesics|mesh-ancestor
64855850|NCT01716637|Sensory System Agents|sensory system agents|mesh-ancestor
64855853|NCT01716637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64855866|NCT01716689|Immunologic Factors|immunologic factors|mesh-ancestor
64855867|NCT01716689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855868|NCT01716689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64855869|NCT01716689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64855870|NCT01716689|Alkylating Agents|alkylating agents|mesh-ancestor
64855871|NCT01716689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855872|NCT01716689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64855873|NCT01716689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64855874|NCT01716767|Analgesics|analgesics|mesh-list
64855875|NCT01716767|Menthol|menthol|mesh-list
64855876|NCT01716767|Sensory System Agents|sensory system agents|mesh-ancestor
64855877|NCT01716767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64855878|NCT01716767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855879|NCT01716767|Antipruritics|antipruritics|mesh-ancestor
64855880|NCT01716767|Dermatologic Agents|dermatologic agents|mesh-ancestor
64855936|NCT01717235|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64855937|NCT01717235|Dopamine Agonists|dopamine agonists|mesh-ancestor
64855938|NCT01717235|Dopamine Agents|dopamine agents|mesh-ancestor
64855942|NCT01717300|Oxazolidinones|oxazolidinones|mesh-list
64855978|NCT01717625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64855980|NCT01717625|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64855981|NCT01717625|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64855982|NCT01717625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64855983|NCT01717690|Chlorhexidine|chlorhexidine|mesh-list
64855984|NCT01717690|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64855985|NCT01717690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
64855986|NCT01717690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855987|NCT01717690|Disinfectants|disinfectants|mesh-ancestor
64855988|NCT01717690|Dermatologic Agents|dermatologic agents|mesh-ancestor
64855989|NCT01717729|Iodine|iodine|mesh-list
64855990|NCT01717729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64855991|NCT01717729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64855992|NCT01717729|Trace Elements|trace elements|mesh-ancestor
64855993|NCT01717729|Micronutrients|micronutrients|mesh-ancestor
64855994|NCT01717729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64855995|NCT01717807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64855996|NCT01717807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856018|NCT01717911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856019|NCT01717911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856020|NCT01717950|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64856021|NCT01717950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64856022|NCT01717950|Immunologic Factors|immunologic factors|mesh-ancestor
64856023|NCT01717950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856024|NCT01717950|Antacids|antacids|mesh-ancestor
64856025|NCT01717950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856026|NCT01717950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64856027|NCT01717963|Naltrexone|naltrexone|mesh-list
64856028|NCT01717963|Buprenorphine|buprenorphine|mesh-list
64856029|NCT01717963|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64856030|NCT01717963|Naloxone|naloxone|mesh-list
64856031|NCT01717963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64856032|NCT01717963|Narcotics|narcotics|mesh-ancestor
64856033|NCT01717963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64856034|NCT01717963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856035|NCT01717963|Analgesics|analgesics|mesh-ancestor
64295328|NCT03561649|Adalimumab|adalimumab|mesh-list
64295329|NCT03561649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64856037|NCT01717963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64856038|NCT01717963|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64856039|NCT01717963|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64856040|NCT01718054|Chloroquine|chloroquine|mesh-list
64856041|NCT01718054|Amebicides|amebicides|mesh-ancestor
64856042|NCT01718054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64856043|NCT01718054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64856044|NCT01718054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64856045|NCT01718054|Antimalarials|antimalarials|mesh-ancestor
64856046|NCT01718054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64856047|NCT01718093|Metformin|metformin|mesh-list
64856048|NCT01718093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64856049|NCT01718093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64856050|NCT01718093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856051|NCT01718093|Incretins|incretins|mesh-ancestor
64856052|NCT01718093|Hormones|hormones|mesh-ancestor
64856053|NCT01718093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64856054|NCT01718093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64856055|NCT01718093|Protease Inhibitors|protease inhibitors|mesh-ancestor
64856056|NCT01718093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856057|NCT01718093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856058|NCT01718223|Temoporfin|temoporfin|mesh-list
64856059|NCT01718223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856060|NCT01718223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64856061|NCT01718223|Dermatologic Agents|dermatologic agents|mesh-ancestor
64856062|NCT01718236|Rocuronium|rocuronium|mesh-list
64856075|NCT01718236|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64856076|NCT01718236|Autonomic Agents|autonomic agents|mesh-ancestor
64700467|NCT04154943|Cemiplimab|cemiplimab|mesh-list
64856077|NCT01718236|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
64856078|NCT01718288|Aspirin|aspirin|mesh-list
64856079|NCT01718288|Iloprost|iloprost|mesh-list
64856080|NCT01718288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64856081|NCT01718288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64856082|NCT01718288|Analgesics|analgesics|mesh-ancestor
64856083|NCT01718288|Sensory System Agents|sensory system agents|mesh-ancestor
64856084|NCT01718288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64856085|NCT01718288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856086|NCT01718288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64856087|NCT01718288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64856088|NCT01718288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64856089|NCT01718288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64856090|NCT01718288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856091|NCT01718288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64856092|NCT01718288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64856093|NCT01718288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856094|NCT01718288|Antipyretics|antipyretics|mesh-ancestor
64856095|NCT01718288|Vasodilator Agents|vasodilator agents|mesh-ancestor
64856096|NCT01718301|Ribavirin|ribavirin|mesh-list
64856097|NCT01718301|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64856098|NCT01718301|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64856099|NCT01718301|Antimetabolites|antimetabolites|mesh-ancestor
64856100|NCT01718301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856101|NCT01718301|Antiviral Agents|antiviral agents|mesh-ancestor
64856102|NCT01718301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64295340|NCT02807623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64856136|NCT01718366|Azacitidine|azacitidine|mesh-list
64856137|NCT01718366|Deferasirox|deferasirox|mesh-list
64856138|NCT01718366|Vitamins|vitamins|mesh-ancestor
64856139|NCT01718366|Micronutrients|micronutrients|mesh-ancestor
64856140|NCT01718366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856141|NCT01718366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64856142|NCT01718366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64856143|NCT01718366|Antimetabolites|antimetabolites|mesh-ancestor
64856144|NCT01718366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856145|NCT01718366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856146|NCT01718366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856147|NCT01718366|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64856148|NCT01718366|Chelating Agents|chelating agents|mesh-ancestor
64856149|NCT01718366|Sequestering Agents|sequestering agents|mesh-ancestor
64856150|NCT01718379|Lenalidomide|lenalidomide|mesh-list
64856151|NCT01718379|Immunologic Factors|immunologic factors|mesh-ancestor
64856153|NCT01718379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64856168|NCT01718587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64856169|NCT01718587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64856170|NCT01718587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856171|NCT01718587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856172|NCT01718587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64856173|NCT01718587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64856174|NCT01718587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64856175|NCT01718613|Vasopressins|vasopressins|mesh-list
64624675|NCT00001930|Amantadine|amantadine|mesh-list
64700664|NCT00002889|Leuprolide|leuprolide|mesh-list
64856176|NCT01718613|Arginine Vasopressin|arginine vasopressin|mesh-list
64856177|NCT01718613|Norepinephrine|norepinephrine|mesh-list
64856229|NCT01718808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64856230|NCT01718808|Antimetabolites|antimetabolites|mesh-ancestor
64856231|NCT01718808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856244|NCT01718899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856245|NCT01718912|Metronidazole|metronidazole|mesh-list
64856246|NCT01718912|Nystatin|nystatin|mesh-list
64856247|NCT01718912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64856248|NCT01718912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64856249|NCT01718912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64856250|NCT01718912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64856251|NCT01718912|Antifungal Agents|antifungal agents|mesh-ancestor
64856252|NCT01718912|Ionophores|ionophores|mesh-ancestor
64856253|NCT01718912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64856254|NCT01718912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856255|NCT01718951|Pamidronate|pamidronate|mesh-list
64856256|NCT01718951|Golimumab|golimumab|mesh-list
64856257|NCT01718951|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64856258|NCT01718951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64856259|NCT01718951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64856260|NCT01718951|Immunologic Factors|immunologic factors|mesh-ancestor
64856261|NCT01718951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856262|NCT01718951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64856263|NCT01718964|Hydrocortisone|hydrocortisone|mesh-list
64856264|NCT01718964|Mannitol|mannitol|mesh-list
64856265|NCT01718964|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64856266|NCT01718964|Diuretics|diuretics|mesh-ancestor
64856267|NCT01718964|Natriuretic Agents|natriuretic agents|mesh-ancestor
64856268|NCT01718964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856269|NCT01718964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64856270|NCT01719042|Ondansetron|ondansetron|mesh-list
64856271|NCT01719042|Antiemetics|antiemetics|mesh-ancestor
64856272|NCT01719042|Autonomic Agents|autonomic agents|mesh-ancestor
64856273|NCT01719042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64856274|NCT01719042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856275|NCT01719042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64856276|NCT01719042|Antipruritics|antipruritics|mesh-ancestor
64856277|NCT01719042|Dermatologic Agents|dermatologic agents|mesh-ancestor
64856278|NCT01719042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64856279|NCT01719042|Serotonin Agents|serotonin agents|mesh-ancestor
64856280|NCT01719042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64856327|NCT01719302|Tubulin Modulators|tubulin modulators|mesh-ancestor
64856328|NCT01719302|Antimitotic Agents|antimitotic agents|mesh-ancestor
64856329|NCT01719302|Mitosis Modulators|mitosis modulators|mesh-ancestor
64856330|NCT01719419|Orlistat|orlistat|mesh-list
64856331|NCT01719419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856332|NCT01719419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856333|NCT01719419|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64856334|NCT01719419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64856335|NCT01719588|Tapentadol|tapentadol|mesh-list
64856336|NCT01719588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64856337|NCT01719588|Narcotics|narcotics|mesh-ancestor
64856338|NCT01719588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64856339|NCT01719588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856340|NCT01719588|Analgesics|analgesics|mesh-ancestor
64332772|NCT01371630|Rituximab|rituximab|mesh-list
64332773|NCT01371630|Methotrexate|methotrexate|mesh-list
64332774|NCT01371630|Vincristine|vincristine|mesh-list
64332775|NCT01371630|Mercaptopurine|mercaptopurine|mesh-list
64700990|NCT04513951|Leucovorin|leucovorin|mesh-list
64332776|NCT01371630|Blinatumomab|blinatumomab|mesh-list
64332777|NCT01371630|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
64332778|NCT01371630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64856341|NCT01719588|Sensory System Agents|sensory system agents|mesh-ancestor
64856342|NCT01719588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64856343|NCT01719588|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64856344|NCT01719588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64856345|NCT01719588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64856350|NCT01719601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64701119|NCT00003633|Docetaxel|docetaxel|mesh-list
64856351|NCT01719601|Narcotics|narcotics|mesh-ancestor
64856352|NCT01719601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64856353|NCT01719601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856354|NCT01719601|Analgesics|analgesics|mesh-ancestor
64856355|NCT01719601|Sensory System Agents|sensory system agents|mesh-ancestor
64856356|NCT01719601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64701257|NCT00004089|Antimetabolites|antimetabolites|mesh-ancestor
64856357|NCT01719601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64856358|NCT01719601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64856359|NCT01719601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64856360|NCT01719601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856361|NCT01719601|Adrenergic Agents|adrenergic agents|mesh-ancestor
64856362|NCT01719601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64856363|NCT01719614|Metformin|metformin|mesh-list
64856364|NCT01719614|Rilpivirine|rilpivirine|mesh-list
64856365|NCT01719614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64856366|NCT01719614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856367|NCT01719614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64856368|NCT01719614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64856369|NCT01719614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856370|NCT01719614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856371|NCT01719614|Antiviral Agents|antiviral agents|mesh-ancestor
64856372|NCT01719614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64856373|NCT01719614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64856380|NCT01719627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64856381|NCT01719627|Antiviral Agents|antiviral agents|mesh-ancestor
64856382|NCT01719627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64856383|NCT01719627|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64856384|NCT01719692|Rituximab|rituximab|mesh-list
64856385|NCT01719692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64856386|NCT01719692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856387|NCT01719692|Immunologic Factors|immunologic factors|mesh-ancestor
64856388|NCT01719692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856389|NCT01719692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64856390|NCT01719705|Pregabalin|pregabalin|mesh-list
64856391|NCT01719705|Analgesics|analgesics|mesh-ancestor
64856392|NCT01719705|Sensory System Agents|sensory system agents|mesh-ancestor
64856393|NCT01719705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64856394|NCT01719705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856395|NCT01719705|Anticonvulsants|anticonvulsants|mesh-ancestor
64856396|NCT01719705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64856397|NCT01719705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64856398|NCT01719705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856399|NCT01719705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64856400|NCT01719705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64856401|NCT01719705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64856402|NCT01719705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64624897|NCT02847624|Tolvaptan|tolvaptan|mesh-list
64856403|NCT01719705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64856404|NCT01719770|Rocuronium|rocuronium|mesh-list
64856405|NCT01719770|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64856406|NCT01719770|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64856407|NCT01719770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64856410|NCT01719835|Gemcitabine|gemcitabine|mesh-list
64856422|NCT01719835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856423|NCT01719835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856424|NCT01719835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64856425|NCT01719835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64856427|NCT01719835|Antiviral Agents|antiviral agents|mesh-ancestor
64856428|NCT01719835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64856429|NCT01719835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856430|NCT01719835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64856431|NCT01719835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64856432|NCT01719835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64856433|NCT01719835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64856434|NCT01719835|Tubulin Modulators|tubulin modulators|mesh-ancestor
64856435|NCT01719835|Antimitotic Agents|antimitotic agents|mesh-ancestor
64856436|NCT01719835|Mitosis Modulators|mitosis modulators|mesh-ancestor
64856437|NCT01719835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64856438|NCT01719835|Antiemetics|antiemetics|mesh-ancestor
64856439|NCT01719835|Autonomic Agents|autonomic agents|mesh-ancestor
64856440|NCT01719835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64856441|NCT01719835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64856476|NCT01719978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856477|NCT01719978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856478|NCT01719978|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64856479|NCT01719978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64856480|NCT01719978|Autonomic Agents|autonomic agents|mesh-ancestor
64856481|NCT01719978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64856482|NCT01719978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64856483|NCT01719978|Respiratory System Agents|respiratory system agents|mesh-ancestor
64856484|NCT01719978|Mydriatics|mydriatics|mesh-ancestor
64856485|NCT01719978|Sympathomimetics|sympathomimetics|mesh-ancestor
64856486|NCT01719978|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64856487|NCT01719978|Anesthetics, Local|anesthetics, local|mesh-ancestor
64856488|NCT01719978|Anesthetics|anesthetics|mesh-ancestor
64856489|NCT01719978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64856490|NCT01719978|Sensory System Agents|sensory system agents|mesh-ancestor
64856491|NCT01720459|Resveratrol|resveratrol|mesh-list
64856492|NCT01720459|Antioxidants|antioxidants|mesh-ancestor
64856493|NCT01720459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856494|NCT01720459|Protective Agents|protective agents|mesh-ancestor
64856495|NCT01720459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856496|NCT01720459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856497|NCT01720459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64856498|NCT01720537|Bococizumab|bococizumab|mesh-list
64856499|NCT01720537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64856500|NCT01720537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64856501|NCT01720537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64295353|NCT02470923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64295354|NCT02470923|Autonomic Agents|autonomic agents|mesh-ancestor
64295355|NCT02470923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64295356|NCT02470923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295357|NCT02470923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64295358|NCT02470923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64295359|NCT02470923|Cholinergic Agents|cholinergic agents|mesh-ancestor
64856528|NCT01722578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856529|NCT01722578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856530|NCT01723852|Vitamin D|vitamin d|mesh-list
64856531|NCT01723852|Ergocalciferols|ergocalciferols|mesh-list
64856532|NCT01723852|Cholecalciferol|cholecalciferol|mesh-list
64856533|NCT01723852|Vitamins|vitamins|mesh-list
64856534|NCT01723852|Micronutrients|micronutrients|mesh-ancestor
64856535|NCT01723852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856536|NCT01723852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64856537|NCT01723852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64856538|NCT01724229|Antifungal Agents|antifungal agents|mesh-list
64856539|NCT01724229|Clotrimazole|clotrimazole|mesh-list
64856540|NCT01724229|Miconazole|miconazole|mesh-list
64702196|NCT00004689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64856541|NCT01724229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64856542|NCT01724229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64856543|NCT01724229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64856544|NCT01724229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64856545|NCT01724229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856546|NCT01724229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856547|NCT01724229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64856548|NCT01724229|Hormone Antagonists|hormone antagonists|mesh-ancestor
64856549|NCT01724229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64856550|NCT01724229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856551|NCT01724229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64856561|NCT01724450|Antioxidants|antioxidants|mesh-ancestor
64856562|NCT01724450|Protective Agents|protective agents|mesh-ancestor
64856563|NCT01724450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64856564|NCT01724450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64856565|NCT01724450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64856566|NCT01724450|Vasodilator Agents|vasodilator agents|mesh-ancestor
64856567|NCT01724450|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64856568|NCT01724450|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64856569|NCT01724723|Entecavir|entecavir|mesh-list
64856570|NCT01724723|Antiviral Agents|antiviral agents|mesh-ancestor
64856571|NCT01724723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64856572|NCT01724892|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64856573|NCT01724892|Dexamethasone|dexamethasone|mesh-list
64856574|NCT01724892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64856575|NCT01724892|Antiemetics|antiemetics|mesh-ancestor
64856576|NCT01724892|Autonomic Agents|autonomic agents|mesh-ancestor
64856577|NCT01724892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64856578|NCT01724892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702298|NCT04040361|Pembrolizumab|pembrolizumab|mesh-list
64856579|NCT01724892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64856580|NCT01724892|Glucocorticoids|glucocorticoids|mesh-ancestor
64856581|NCT01724892|Hormones|hormones|mesh-ancestor
64856582|NCT01724892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64856583|NCT01724892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64856584|NCT01724892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856585|NCT01724892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64856586|NCT01725256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64856587|NCT01726400|Interferons|interferons|mesh-list
64856588|NCT01726400|Ribavirin|ribavirin|mesh-list
64856589|NCT01726400|Interferon-alpha|interferon-alpha|mesh-list
64856590|NCT01726400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856591|NCT01726400|Antiviral Agents|antiviral agents|mesh-ancestor
64856595|NCT01726400|Immunologic Factors|immunologic factors|mesh-ancestor
64856596|NCT01726400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856597|NCT01727427|Aspirin|aspirin|mesh-list
64856598|NCT01727427|Vitamin K|vitamin k|mesh-list
64856599|NCT01727427|Heparin|heparin|mesh-list
64856600|NCT01727427|Enoxaparin|enoxaparin|mesh-list
64856601|NCT01727427|Dalteparin|dalteparin|mesh-list
64856602|NCT01727427|Tinzaparin|tinzaparin|mesh-list
64856604|NCT01727427|Nadroparin|nadroparin|mesh-list
64856605|NCT01727427|Warfarin|warfarin|mesh-list
64856606|NCT01727427|Rivaroxaban|rivaroxaban|mesh-list
64856607|NCT01727427|Dabigatran|dabigatran|mesh-list
64856608|NCT01727427|Apixaban|apixaban|mesh-list
64856609|NCT01727427|Fondaparinux|fondaparinux|mesh-list
64856610|NCT01727427|Acenocoumarol|acenocoumarol|mesh-list
64856611|NCT01727427|Phenprocoumon|phenprocoumon|mesh-list
64856612|NCT01727427|Bemiparin|bemiparin|mesh-list
64856613|NCT01727427|Vitamins|vitamins|mesh-ancestor
64856614|NCT01727427|Micronutrients|micronutrients|mesh-ancestor
64702421|NCT00005625|Trabectedin|trabectedin|mesh-list
64856615|NCT01727427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856616|NCT01727427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64856617|NCT01727427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64856618|NCT01727427|Analgesics|analgesics|mesh-ancestor
64856619|NCT01727427|Sensory System Agents|sensory system agents|mesh-ancestor
64856620|NCT01727427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64856621|NCT01727427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64856622|NCT01727427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64856623|NCT01727427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64856624|NCT01727427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64295398|NCT02051413|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64702495|NCT02974933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64295399|NCT02051413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64295400|NCT02051413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64295401|NCT02051413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64295402|NCT02051413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295403|NCT02051413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64295404|NCT02051413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295405|NCT02051413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64295406|NCT02051413|Antidepressive Agents|antidepressive agents|mesh-ancestor
64295407|NCT02051413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64295459|NCT03561415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64295460|NCT03561415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856646|NCT01728363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64856648|NCT01728363|Clindamycin|clindamycin|mesh-list
64856649|NCT01728363|Clavulanic Acid|clavulanic acid|mesh-list
64856650|NCT01728363|Ticarcillin|ticarcillin|mesh-list
64856651|NCT01728363|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
64856652|NCT01728363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64856653|NCT01728363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64856654|NCT01728363|Antitubercular Agents|antitubercular agents|mesh-ancestor
64856655|NCT01728363|Leprostatic Agents|leprostatic agents|mesh-ancestor
64856656|NCT01728363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64856657|NCT01728363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856658|NCT01728363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295461|NCT02477007|Acetaminophen|acetaminophen|mesh-list
64295462|NCT02477007|Ibuprofen|ibuprofen|mesh-list
64295463|NCT02477007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64295464|NCT02477007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64295465|NCT02477007|Analgesics|analgesics|mesh-ancestor
64295466|NCT02477007|Sensory System Agents|sensory system agents|mesh-ancestor
64295467|NCT02477007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64295468|NCT02477007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295469|NCT02477007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64856680|NCT01730157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64856681|NCT01730157|Ipilimumab|ipilimumab|mesh-list
64856682|NCT01730157|Antibodies|antibodies|mesh-list
64856683|NCT01730157|Immunoglobulins|immunoglobulins|mesh-list
64856684|NCT01730157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64856685|NCT01730157|Immunologic Factors|immunologic factors|mesh-ancestor
64856686|NCT01730157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856687|NCT01730157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856688|NCT01730157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64856689|NCT01730157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856690|NCT01730209|Everolimus|everolimus|mesh-list
64856691|NCT01730209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856692|NCT01730209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64856693|NCT01730209|Immunologic Factors|immunologic factors|mesh-ancestor
64856694|NCT01730209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856695|NCT01730222|Gemcitabine|gemcitabine|mesh-list
64856696|NCT01730222|Paclitaxel|paclitaxel|mesh-list
64856697|NCT01730222|Capecitabine|capecitabine|mesh-list
64856698|NCT01730222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64856699|NCT01730222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856700|NCT01730222|Tubulin Modulators|tubulin modulators|mesh-ancestor
64856701|NCT01730222|Antimitotic Agents|antimitotic agents|mesh-ancestor
64856702|NCT01730222|Mitosis Modulators|mitosis modulators|mesh-ancestor
64856703|NCT01730222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856704|NCT01730222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64856705|NCT01730222|Antimetabolites|antimetabolites|mesh-ancestor
64856706|NCT01730222|Antiviral Agents|antiviral agents|mesh-ancestor
64856708|NCT01730222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856723|NCT01730326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856724|NCT01730326|Antipyretics|antipyretics|mesh-ancestor
64856725|NCT01730326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64856726|NCT01730326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64856727|NCT01730326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64856728|NCT01730417|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64856729|NCT01730417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856730|NCT01730417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856731|NCT01730417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856732|NCT01730417|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64856733|NCT01730495|Etanercept|etanercept|mesh-list
64856734|NCT01730495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64856735|NCT01730495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64856736|NCT01730495|Analgesics|analgesics|mesh-ancestor
64856737|NCT01730495|Sensory System Agents|sensory system agents|mesh-ancestor
64856738|NCT01730495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64856739|NCT01730495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856740|NCT01730495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64856741|NCT01730495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64856742|NCT01730495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64856743|NCT01730495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64856744|NCT01730495|Immunologic Factors|immunologic factors|mesh-ancestor
64856745|NCT01730508|Interferons|interferons|mesh-list
64856746|NCT01730508|Interferon-alpha|interferon-alpha|mesh-list
64856747|NCT01730508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856748|NCT01730508|Antiviral Agents|antiviral agents|mesh-ancestor
64856749|NCT01730508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64856752|NCT01730612|Histamine|histamine|mesh-list
64856771|NCT01730677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64856772|NCT01730677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856773|NCT01730976|Vitamin D|vitamin d|mesh-list
64856774|NCT01730976|Vitamins|vitamins|mesh-list
64856775|NCT01730976|Micronutrients|micronutrients|mesh-ancestor
64856776|NCT01730976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856777|NCT01730976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64856778|NCT01731067|Fexofenadine|fexofenadine|mesh-list
64856779|NCT01731067|Flurbiprofen|flurbiprofen|mesh-list
64856780|NCT01731067|Midazolam|midazolam|mesh-list
64856781|NCT01731067|Dextromethorphan|dextromethorphan|mesh-list
64856783|NCT01731067|Bupropion|bupropion|mesh-list
64856784|NCT01731067|Omeprazole|omeprazole|mesh-list
64856785|NCT01731067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64856787|NCT01731067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64856788|NCT01731067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856789|NCT01731067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64856790|NCT01731067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64856791|NCT01731067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64856792|NCT01731067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64856793|NCT01731067|Anesthetics, General|anesthetics, general|mesh-ancestor
64856794|NCT01731067|Anesthetics|anesthetics|mesh-ancestor
64856795|NCT01731067|GABA Modulators|gaba modulators|mesh-ancestor
64856796|NCT01731067|GABA Agents|gaba agents|mesh-ancestor
64856797|NCT01731067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64856798|NCT01731067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856799|NCT01731067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64856800|NCT01731067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64856801|NCT01731067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856802|NCT01731067|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64856803|NCT01731067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64856804|NCT01731067|Purinergic Agents|purinergic agents|mesh-ancestor
64856805|NCT01731067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64856806|NCT01731067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64856807|NCT01731067|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64856808|NCT01731067|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64856809|NCT01731067|Antidepressive Agents|antidepressive agents|mesh-ancestor
64856811|NCT01731067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64856812|NCT01731067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64856813|NCT01731067|Dopamine Agents|dopamine agents|mesh-ancestor
64856814|NCT01731067|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64856815|NCT01731067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64856816|NCT01731067|Antitussive Agents|antitussive agents|mesh-ancestor
64856817|NCT01731067|Respiratory System Agents|respiratory system agents|mesh-ancestor
64856818|NCT01731067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64856819|NCT01731067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64856820|NCT01731067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64856821|NCT01731067|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64856822|NCT01731067|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64856823|NCT01731067|Histamine Antagonists|histamine antagonists|mesh-ancestor
64856824|NCT01731067|Histamine Agents|histamine agents|mesh-ancestor
64856825|NCT01731067|Analgesics|analgesics|mesh-ancestor
64856826|NCT01731067|Sensory System Agents|sensory system agents|mesh-ancestor
64856827|NCT01731067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64856828|NCT01731067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64856829|NCT01731067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64856830|NCT01731067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64856831|NCT01731067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64856832|NCT01731067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64856834|NCT01731132|Levonorgestrel|levonorgestrel|mesh-list
64856835|NCT01731132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64856836|NCT01731132|Contraceptive Agents|contraceptive agents|mesh-ancestor
64856837|NCT01731132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64856838|NCT01731132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705508|NCT05732155|Hallucinogens|hallucinogens|mesh-ancestor
64856839|NCT01731132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64856840|NCT01731132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64856841|NCT01731132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64856848|NCT01731158|Sorafenib|sorafenib|mesh-list
64856849|NCT01731158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64856850|NCT01731158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856851|NCT01731158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64856852|NCT01731158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64856853|NCT01731158|Growth Substances|growth substances|mesh-ancestor
64856854|NCT01731158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856855|NCT01731158|Growth Inhibitors|growth inhibitors|mesh-ancestor
64856856|NCT01731158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64856857|NCT01731158|Immunologic Factors|immunologic factors|mesh-ancestor
64856858|NCT01731158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64856859|NCT01731158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856860|NCT01731158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856861|NCT01731158|Antiviral Agents|antiviral agents|mesh-ancestor
64856862|NCT01731158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64856863|NCT01731184|Midazolam|midazolam|mesh-list
64856864|NCT01731184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64856865|NCT01731184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64856866|NCT01731184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64856867|NCT01731184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706134|NCT04684212|Warfarin|warfarin|mesh-list
64856868|NCT01731184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64856869|NCT01731184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64856870|NCT01731184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64856871|NCT01731184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64856872|NCT01731184|Anesthetics, General|anesthetics, general|mesh-ancestor
64856873|NCT01731184|Anesthetics|anesthetics|mesh-ancestor
64856874|NCT01731184|GABA Modulators|gaba modulators|mesh-ancestor
64856875|NCT01731184|GABA Agents|gaba agents|mesh-ancestor
64856876|NCT01731184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64856877|NCT01731184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856878|NCT01731275|Quetmolimab|quetmolimab|mesh-list
64856879|NCT01731275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64856880|NCT01731275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64856881|NCT01731275|Immunologic Factors|immunologic factors|mesh-ancestor
64856882|NCT01731275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856883|NCT01731301|Ribavirin|ribavirin|mesh-list
64856884|NCT01731301|Antimetabolites|antimetabolites|mesh-ancestor
64856885|NCT01731301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856892|NCT01731340|Calcium, Dietary|calcium, dietary|mesh-list
64856893|NCT01731340|Calcium|calcium|mesh-list
64856894|NCT01731340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64856895|NCT01731340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856896|NCT01731340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64856897|NCT01731431|Glyburide|glyburide|mesh-list
64856898|NCT01731431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64856899|NCT01731431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856900|NCT01731457|Etanercept|etanercept|mesh-list
64856901|NCT01731457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64856902|NCT01731457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64856903|NCT01731457|Analgesics|analgesics|mesh-ancestor
64856904|NCT01731457|Sensory System Agents|sensory system agents|mesh-ancestor
64856905|NCT01731457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64856906|NCT01731457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856907|NCT01731457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64856908|NCT01731457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64856909|NCT01731457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64856910|NCT01731457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64856911|NCT01731457|Immunologic Factors|immunologic factors|mesh-ancestor
64856912|NCT01731561|Rituximab|rituximab|mesh-list
64856913|NCT01731561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64856927|NCT01731574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856928|NCT01731574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706920|NCT00367939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856929|NCT01731574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64856930|NCT01731574|Hormone Antagonists|hormone antagonists|mesh-ancestor
64856931|NCT01731574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64856932|NCT01731574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856933|NCT01731574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64625427|NCT00000340|Pemoline|pemoline|mesh-list
64856934|NCT01731574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64856936|NCT01731587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64856937|NCT01731587|Immunologic Factors|immunologic factors|mesh-ancestor
64856938|NCT01731587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856939|NCT01731587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64856940|NCT01731587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64856941|NCT01731587|Alkylating Agents|alkylating agents|mesh-ancestor
64295476|NCT02052973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64295477|NCT04347434|Atorvastatin|atorvastatin|mesh-list
64295478|NCT04347434|Ezetimibe|ezetimibe|mesh-list
64295479|NCT04347434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64295480|NCT04347434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64295481|NCT04347434|Antimetabolites|antimetabolites|mesh-ancestor
64856942|NCT01731587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856943|NCT01731587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856944|NCT01731587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64856945|NCT01731652|Imiquimod|imiquimod|mesh-list
64856946|NCT01731652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64856947|NCT01731652|Immunologic Factors|immunologic factors|mesh-ancestor
64856948|NCT01731652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856949|NCT01731652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856950|NCT01731652|Interferon Inducers|interferon inducers|mesh-ancestor
64856951|NCT01731756|Salicylic Acid|salicylic acid|mesh-list
64856952|NCT01731756|Salicylates|salicylates|mesh-list
64856953|NCT01731756|Petrolatum|petrolatum|mesh-list
64856954|NCT01731756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64856955|NCT01731756|Antifungal Agents|antifungal agents|mesh-ancestor
64856956|NCT01731756|Keratolytic Agents|keratolytic agents|mesh-ancestor
64856957|NCT01731756|Dermatologic Agents|dermatologic agents|mesh-ancestor
64856958|NCT01731756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64856959|NCT01731756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64856960|NCT01731756|Analgesics|analgesics|mesh-ancestor
64856965|NCT01731756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64856966|NCT01731756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64856967|NCT01731756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856968|NCT01731756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856969|NCT01731756|Emollients|emollients|mesh-ancestor
64856970|NCT01731795|Dexamethasone|dexamethasone|mesh-list
64856971|NCT01731795|Dexamethasone acetate|dexamethasone acetate|mesh-list
64856972|NCT01731795|BB 1101|bb 1101|mesh-list
64856973|NCT01731795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64856974|NCT01731795|Antiemetics|antiemetics|mesh-ancestor
64856975|NCT01731795|Autonomic Agents|autonomic agents|mesh-ancestor
64856976|NCT01731795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64856977|NCT01731795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856978|NCT01731795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64856979|NCT01731795|Glucocorticoids|glucocorticoids|mesh-ancestor
64856980|NCT01731795|Hormones|hormones|mesh-ancestor
64856981|NCT01731795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64856982|NCT01731795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64856983|NCT01731795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856984|NCT01731795|Protease Inhibitors|protease inhibitors|mesh-ancestor
64856985|NCT01731795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64856986|NCT01731795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64856987|NCT01731899|S 20098|s 20098|mesh-list
64856988|NCT01731899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64856989|NCT01731899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64856990|NCT01731899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64856991|NCT01731925|Sunitinib|sunitinib|mesh-list
64856992|NCT01731925|Lanreotide|lanreotide|mesh-list
64856993|NCT01731925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64856994|NCT01731925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64856996|NCT01731925|Growth Substances|growth substances|mesh-ancestor
64857009|NCT01732068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857010|NCT01732068|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64857011|NCT01732068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64857013|NCT01732094|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64857014|NCT01732094|Luteolytic Agents|luteolytic agents|mesh-ancestor
64857015|NCT01732094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64857016|NCT01732094|Contraceptive Agents|contraceptive agents|mesh-ancestor
64857017|NCT01732094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64857018|NCT01732094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857019|NCT01732094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64857020|NCT01732094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64857021|NCT01732094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64857022|NCT01732146|Epoetin Alfa|epoetin alfa|mesh-list
64857023|NCT01732146|Hematinics|hematinics|mesh-ancestor
64857024|NCT01732198|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64857025|NCT01732198|Immunologic Factors|immunologic factors|mesh-ancestor
64857026|NCT01732198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857027|NCT01732224|Tenofovir|tenofovir|mesh-list
64857028|NCT01732224|Telbivudine|telbivudine|mesh-list
64857029|NCT01732224|Antiviral Agents|antiviral agents|mesh-ancestor
64857030|NCT01732224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64857031|NCT01732224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64857032|NCT01732224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64857033|NCT01732224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857034|NCT01732224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857049|NCT01732328|Micronutrients|micronutrients|mesh-ancestor
64857050|NCT01732328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857051|NCT01732328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64857052|NCT01732328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64857054|NCT01732367|Lamivudine|lamivudine|mesh-list
64857055|NCT01732367|Adefovir|adefovir|mesh-list
64857056|NCT01732367|Antiviral Agents|antiviral agents|mesh-ancestor
64708811|NCT05032183|Autonomic Agents|autonomic agents|mesh-ancestor
64857057|NCT01732367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64857058|NCT01732367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64857059|NCT01732367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64857060|NCT01732367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857061|NCT01732367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857062|NCT01732367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64857063|NCT01732367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64857064|NCT01732380|Oxaliplatin|oxaliplatin|mesh-list
64857065|NCT01732380|Raltitrexed|raltitrexed|mesh-list
64857066|NCT01732380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709122|NCT04337918|Vasodilator Agents|vasodilator agents|mesh-ancestor
64857067|NCT01732380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64857068|NCT01732380|Antimetabolites|antimetabolites|mesh-ancestor
64857070|NCT01732380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64857093|NCT01732744|Cathartics|cathartics|mesh-ancestor
64857094|NCT01732744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64857095|NCT01732861|Lenalidomide|lenalidomide|mesh-list
64857096|NCT01732861|Immunologic Factors|immunologic factors|mesh-ancestor
64857097|NCT01732861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857098|NCT01732861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64857131|NCT01733043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64857132|NCT01733043|Adrenergic Agents|adrenergic agents|mesh-ancestor
64857133|NCT01733043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64857134|NCT01733043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857135|NCT01733095|Ambrisentan|ambrisentan|mesh-list
64857136|NCT01733095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64857137|NCT01733108|Canagliflozin|canagliflozin|mesh-list
64857138|NCT01733108|Glyburide|glyburide|mesh-list
64857139|NCT01733108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64857140|NCT01733108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857141|NCT01733108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64857142|NCT01733108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857144|NCT01733134|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64857145|NCT01733134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857146|NCT01733134|Natriuretic Agents|natriuretic agents|mesh-ancestor
64857147|NCT01733134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857148|NCT01733290|Botulinum Toxins|botulinum toxins|mesh-list
64857149|NCT01733290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64709523|NCT04432285|Botulinum Toxins|botulinum toxins|mesh-list
64857150|NCT01733290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64857151|NCT01733290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64857152|NCT01733290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64857153|NCT01733290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857154|NCT01733290|Cholinergic Agents|cholinergic agents|mesh-ancestor
64857155|NCT01733290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64857156|NCT01733290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857157|NCT01733290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64857158|NCT01733290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857159|NCT01733342|Anesthetics|anesthetics|mesh-list
64857160|NCT01733342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64857161|NCT01733342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857162|NCT01733394|Lamotrigine|lamotrigine|mesh-list
64857163|NCT01733394|Anticonvulsants|anticonvulsants|mesh-list
64857164|NCT01733394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64857165|NCT01733394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64857166|NCT01733394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857167|NCT01733394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64857169|NCT01733394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64857188|NCT01733485|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64857189|NCT01733485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857190|NCT01733485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64857191|NCT01733485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64857192|NCT01733485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857194|NCT01733485|Gout Suppressants|gout suppressants|mesh-ancestor
64857195|NCT01733485|Tocolytic Agents|tocolytic agents|mesh-ancestor
64857196|NCT01733485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64857203|NCT01733589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64857204|NCT01733589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857205|NCT01733589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857206|NCT01733589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64857207|NCT01733589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64857208|NCT01733589|Growth Substances|growth substances|mesh-ancestor
64857209|NCT01733589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857210|NCT01733589|Growth Inhibitors|growth inhibitors|mesh-ancestor
64710652|NCT05829148|Melatonin|melatonin|mesh-list
64857212|NCT01733706|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64857213|NCT01733706|Autonomic Agents|autonomic agents|mesh-ancestor
64857214|NCT01733706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857215|NCT01733706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857216|NCT01733706|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64857217|NCT01733706|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64857221|NCT01733823|Nimorazole|nimorazole|mesh-list
64857232|NCT01733966|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64857233|NCT01733966|Ciprofloxacin|ciprofloxacin|mesh-list
64857234|NCT01733966|Secnidazole|secnidazole|mesh-list
64857235|NCT01733966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64857236|NCT01733966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64857237|NCT01733966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857238|NCT01733966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857239|NCT01733966|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64857240|NCT01733966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64857241|NCT01733966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64857242|NCT01733966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64857243|NCT01733966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64857244|NCT01733966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64857245|NCT01733966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64857246|NCT01733966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64857248|NCT01733979|Trace Elements|trace elements|mesh-ancestor
64710992|NCT05786066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857249|NCT01733979|Micronutrients|micronutrients|mesh-ancestor
64857250|NCT01733979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857251|NCT01733992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64857252|NCT01733992|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64857253|NCT01734044|Dexamethasone|dexamethasone|mesh-list
64857254|NCT01734044|Dexamethasone acetate|dexamethasone acetate|mesh-list
64857255|NCT01734044|BB 1101|bb 1101|mesh-list
64857256|NCT01734044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64857257|NCT01734044|Antiemetics|antiemetics|mesh-ancestor
64857258|NCT01734044|Autonomic Agents|autonomic agents|mesh-ancestor
64857259|NCT01734044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857260|NCT01734044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857263|NCT01734044|Hormones|hormones|mesh-ancestor
64857279|NCT01734057|Autonomic Agents|autonomic agents|mesh-ancestor
64857280|NCT01734057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857281|NCT01734057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64857282|NCT01734057|Glucocorticoids|glucocorticoids|mesh-ancestor
64857283|NCT01734057|Hormones|hormones|mesh-ancestor
64857284|NCT01734057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64857297|NCT01734252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857298|NCT01734252|Anticoagulants|anticoagulants|mesh-ancestor
64857299|NCT01734252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64857301|NCT01734330|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64857302|NCT01734330|Autonomic Agents|autonomic agents|mesh-ancestor
64857303|NCT01734330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857305|NCT01734330|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64857327|NCT01734564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857328|NCT01734564|Laxatives|laxatives|mesh-ancestor
64857329|NCT01734564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64857330|NCT01734564|Antiviral Agents|antiviral agents|mesh-ancestor
64857331|NCT01734564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64857332|NCT01734694|Vancomycin|vancomycin|mesh-list
64857333|NCT01734694|Linezolid|linezolid|mesh-list
64857334|NCT01734694|Daptomycin|daptomycin|mesh-list
64857335|NCT01734694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64857336|NCT01734694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64857337|NCT01734694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64857338|NCT01734694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64857339|NCT01734694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857340|NCT01734694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857341|NCT01734798|Gemcitabine|gemcitabine|mesh-list
64857342|NCT01734798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64857343|NCT01734798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64857344|NCT01734798|Antimetabolites|antimetabolites|mesh-ancestor
64857345|NCT01734798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857346|NCT01734798|Antiviral Agents|antiviral agents|mesh-ancestor
64857347|NCT01734798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64857348|NCT01734798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857349|NCT01734798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64857350|NCT01734798|Immunologic Factors|immunologic factors|mesh-ancestor
64711898|NCT04987892|Tamsulosin|tamsulosin|mesh-list
64857351|NCT01734798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857352|NCT01734824|Denosumab|denosumab|mesh-list
64857353|NCT01734824|Teriparatide|teriparatide|mesh-list
64857354|NCT01734824|Parathyroid Hormone|parathyroid hormone|mesh-list
64295483|NCT04347434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64295485|NCT04347434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857355|NCT01734824|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64857356|NCT01734824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857357|NCT01734824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64857359|NCT01734915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64857360|NCT01734954|Midazolam|midazolam|mesh-list
64857361|NCT01734954|Analgesics|analgesics|mesh-list
64857362|NCT01734954|Anesthetics|anesthetics|mesh-list
64857363|NCT01734954|Levobupivacaine|levobupivacaine|mesh-list
64857364|NCT01734954|Anesthetics, Local|anesthetics, local|mesh-list
64857365|NCT01734954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64857366|NCT01734954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857367|NCT01734954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64857368|NCT01734954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64857369|NCT01734954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64857370|NCT01734954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64857371|NCT01734954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64857372|NCT01734954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64857373|NCT01734954|Anesthetics, General|anesthetics, general|mesh-ancestor
64857374|NCT01734954|GABA Modulators|gaba modulators|mesh-ancestor
64857375|NCT01734954|GABA Agents|gaba agents|mesh-ancestor
64857376|NCT01734954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64857377|NCT01734954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857378|NCT01734954|Sensory System Agents|sensory system agents|mesh-ancestor
64857379|NCT01734954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857380|NCT01735006|Vaccines|vaccines|mesh-list
64857381|NCT01735006|Immunologic Factors|immunologic factors|mesh-ancestor
64857382|NCT01735006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625876|NCT00001384|Paclitaxel|paclitaxel|mesh-list
64857383|NCT01735019|Remifentanil|remifentanil|mesh-list
64857384|NCT01735019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64857385|NCT01735019|Narcotics|narcotics|mesh-ancestor
64857386|NCT01735019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64857387|NCT01735019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857389|NCT01735019|Sensory System Agents|sensory system agents|mesh-ancestor
64857390|NCT01735019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857395|NCT01735058|Viscosupplements|viscosupplements|mesh-ancestor
64857396|NCT01735058|Protective Agents|protective agents|mesh-ancestor
64857397|NCT01735071|Bevacizumab|bevacizumab|mesh-list
64857398|NCT01735071|Carboplatin|carboplatin|mesh-list
64857399|NCT01735071|Trabectedin|trabectedin|mesh-list
64857400|NCT01735071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64857401|NCT01735071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64857402|NCT01735071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64857403|NCT01735071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64857404|NCT01735071|Growth Substances|growth substances|mesh-ancestor
64857405|NCT01735071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857406|NCT01735071|Growth Inhibitors|growth inhibitors|mesh-ancestor
64857407|NCT01735071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64857408|NCT01735071|Alkylating Agents|alkylating agents|mesh-ancestor
64857409|NCT01735071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857410|NCT01735084|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64857411|NCT01735084|Immunologic Factors|immunologic factors|mesh-ancestor
64857412|NCT01735084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857413|NCT01735097|Vitamin E|vitamin e|mesh-list
64857414|NCT01735097|Vitamins|vitamins|mesh-ancestor
64857448|NCT01735318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64857449|NCT01735318|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64857450|NCT01735318|Protective Agents|protective agents|mesh-ancestor
64857451|NCT01735318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857452|NCT01735344|Lisinopril|lisinopril|mesh-list
64857453|NCT01735344|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64857454|NCT01735344|Protease Inhibitors|protease inhibitors|mesh-ancestor
64857455|NCT01735344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857456|NCT01735344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857457|NCT01735344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64625953|NCT02705300|Leucovorin|leucovorin|mesh-list
64857458|NCT01735344|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64857459|NCT01735344|Protective Agents|protective agents|mesh-ancestor
64857460|NCT01735344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857461|NCT01735370|Etodolac|etodolac|mesh-list
64857506|NCT01735669|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64857507|NCT01735669|Anesthetics, General|anesthetics, general|mesh-ancestor
64857508|NCT01735669|Anesthetics|anesthetics|mesh-ancestor
64857509|NCT01735669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64945457|NCT05619627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64945458|NCT05619627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64945459|NCT05619627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64945460|NCT05619627|Adrenergic Agents|adrenergic agents|mesh-ancestor
64945461|NCT05619627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64945462|NCT05619627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945463|NCT05615818|Gemcitabine|gemcitabine|mesh-list
64945464|NCT05615818|Trastuzumab|trastuzumab|mesh-list
64945465|NCT05615818|Niraparib|niraparib|mesh-list
64945466|NCT05615818|Ivosidenib|ivosidenib|mesh-list
64945467|NCT05615818|Futibatinib|futibatinib|mesh-list
64945468|NCT05615818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945469|NCT05615818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64945470|NCT05615818|Antimetabolites|antimetabolites|mesh-ancestor
64945471|NCT05615818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945472|NCT05615818|Antiviral Agents|antiviral agents|mesh-ancestor
64945473|NCT05615818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64945474|NCT05615818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945475|NCT05615818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64945476|NCT05615818|Immunologic Factors|immunologic factors|mesh-ancestor
64945477|NCT05615818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945478|NCT05615818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64945479|NCT05615818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64857531|NCT01735890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64857532|NCT01735890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857533|NCT01735890|Vasodilator Agents|vasodilator agents|mesh-ancestor
64857534|NCT01735890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64712994|NCT03547973|Avelumab|avelumab|mesh-list
64857535|NCT01735890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64857536|NCT01736020|Dexmedetomidine|dexmedetomidine|mesh-list
64857537|NCT01736020|Nitrous Oxide|nitrous oxide|mesh-list
64857538|NCT01736020|Ketamine|ketamine|mesh-list
64857539|NCT01736020|Propofol|propofol|mesh-list
64857540|NCT01736020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64857541|NCT01736020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64857542|NCT01736020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857543|NCT01736020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64857544|NCT01736020|Anesthetics, General|anesthetics, general|mesh-ancestor
64857545|NCT01736020|Anesthetics|anesthetics|mesh-ancestor
64857589|NCT01736371|Anesthetics|anesthetics|mesh-ancestor
64857590|NCT01736371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64857591|NCT01736371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64857592|NCT01736410|Trastuzumab|trastuzumab|mesh-list
64857593|NCT01736410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64857594|NCT01736410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64857595|NCT01736423|Ramosetron|ramosetron|mesh-list
64857596|NCT01736423|Antiemetics|antiemetics|mesh-ancestor
64857597|NCT01736423|Autonomic Agents|autonomic agents|mesh-ancestor
64857598|NCT01736423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64857599|NCT01736423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857600|NCT01736423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64857653|NCT01736761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64857654|NCT01736761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64857655|NCT01736761|Protease Inhibitors|protease inhibitors|mesh-ancestor
64857656|NCT01736761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626184|NCT01027559|Sertraline|sertraline|mesh-list
64857657|NCT01736761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857658|NCT01736761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64857659|NCT01736761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64857660|NCT01736761|Antiviral Agents|antiviral agents|mesh-ancestor
64857661|NCT01736761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64857717|NCT01737177|Immunologic Factors|immunologic factors|mesh-ancestor
64857718|NCT01737177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857719|NCT01737177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64857720|NCT01737177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64857721|NCT01737177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64857722|NCT01737177|Growth Substances|growth substances|mesh-ancestor
64857723|NCT01737177|Growth Inhibitors|growth inhibitors|mesh-ancestor
64857724|NCT01737177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64857725|NCT01737177|Alkylating Agents|alkylating agents|mesh-ancestor
64857726|NCT01737177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857727|NCT01737203|Sildenafil Citrate|sildenafil citrate|mesh-list
64857728|NCT01737203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857729|NCT01737203|Vasodilator Agents|vasodilator agents|mesh-ancestor
64857730|NCT01737203|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64857776|NCT01737541|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64857777|NCT01737541|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64857778|NCT01737541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64857779|NCT01737541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857789|NCT01737671|Leucovorin|leucovorin|mesh-list
64857845|NCT01738087|Adrenergic Agents|adrenergic agents|mesh-ancestor
64857846|NCT01738087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64857847|NCT01738087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857848|NCT01738100|Morphine|morphine|mesh-list
64857849|NCT01738100|Clopidogrel|clopidogrel|mesh-list
64857850|NCT01738100|Ticagrelor|ticagrelor|mesh-list
64857852|NCT01738100|Narcotics|narcotics|mesh-ancestor
64857913|NCT01738451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64857914|NCT01738451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64857915|NCT01738451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857916|NCT01738542|Bosentan|bosentan|mesh-list
64857917|NCT01738542|Antihypertensive Agents|antihypertensive agents|mesh-list
64857918|NCT01738542|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64857919|NCT01738542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857920|NCT01738607|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64857921|NCT01738607|Psyllium|psyllium|mesh-list
64713657|NCT02101788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64713658|NCT02101788|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64713659|NCT02101788|Protective Agents|protective agents|mesh-ancestor
64713660|NCT02101788|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64713661|NCT02101788|Antioxidants|antioxidants|mesh-ancestor
64713704|NCT01740557|Sensory System Agents|sensory system agents|mesh-ancestor
64713705|NCT01740557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64713706|NCT01740557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64713707|NCT01740557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64857922|NCT01738607|Laxatives|laxatives|mesh-ancestor
64857923|NCT01738607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64857924|NCT01738607|Cathartics|cathartics|mesh-ancestor
64857925|NCT01738724|Goserelin|goserelin|mesh-list
64857926|NCT01738724|Dienogest|dienogest|mesh-list
64857927|NCT01738724|Desogestrel|desogestrel|mesh-list
64857928|NCT01738724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64857929|NCT01738724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64857930|NCT01738724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64857931|NCT01738724|Contraceptive Agents|contraceptive agents|mesh-ancestor
64857932|NCT01738724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64857933|NCT01738724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64857934|NCT01738724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64857935|NCT01738724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64857936|NCT01738724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64857937|NCT01738724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64857938|NCT01738724|Hormone Antagonists|hormone antagonists|mesh-ancestor
64857939|NCT01738724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64857940|NCT01738724|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64857941|NCT01738724|Progestins|progestins|mesh-ancestor
64857942|NCT01738724|Hormones|hormones|mesh-ancestor
64857943|NCT01738763|Inositol|inositol|mesh-list
64857944|NCT01738763|Vitamin B Complex|vitamin b complex|mesh-ancestor
64857945|NCT01738763|Vitamins|vitamins|mesh-ancestor
64857946|NCT01738763|Micronutrients|micronutrients|mesh-ancestor
64857948|NCT01738802|Micronutrients|micronutrients|mesh-list
64857955|NCT01738815|Anticonvulsants|anticonvulsants|mesh-ancestor
64857956|NCT01738815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945480|NCT05595603|Gentamicins|gentamicins|mesh-list
64857957|NCT01738815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64857958|NCT01738815|GABA Agents|gaba agents|mesh-ancestor
64857959|NCT01738815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64417184|NCT02605837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64858021|NCT01739192|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64858023|NCT01739192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64858024|NCT01739192|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64858025|NCT01739192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64858026|NCT01739192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64858028|NCT01739192|Dopamine Agents|dopamine agents|mesh-ancestor
64858087|NCT01739556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64858088|NCT01739582|Enclomiphene|enclomiphene|mesh-list
64858307|NCT01741376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858309|NCT01741389|Antioxidants|antioxidants|mesh-ancestor
64858310|NCT01741389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858311|NCT01741389|Protective Agents|protective agents|mesh-ancestor
64858312|NCT01741389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858313|NCT01741389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64858314|NCT01741493|Upadacitinib|upadacitinib|mesh-list
64858315|NCT01741493|Tofacitinib|tofacitinib|mesh-list
64858316|NCT01741493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64858317|NCT01741493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858321|NCT01741506|Dalteparin|dalteparin|mesh-list
64858364|NCT01741623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858365|NCT01741623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64858366|NCT01741623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64858367|NCT01741623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64417225|NCT04819867|Propolis|propolis|mesh-list
64713926|NCT00006421|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64858368|NCT01741623|Adrenergic Agents|adrenergic agents|mesh-ancestor
64858369|NCT01741623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64858370|NCT01741623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858371|NCT01741649|Povidone|povidone|mesh-list
64858380|NCT01741753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64858382|NCT01741831|Darunavir|darunavir|mesh-list
64858383|NCT01741831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64858384|NCT01741831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64858385|NCT01741831|Protease Inhibitors|protease inhibitors|mesh-ancestor
64858386|NCT01741831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858387|NCT01741831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858388|NCT01741831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64858389|NCT01741831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64858395|NCT01742247|Palmidrol|palmidrol|mesh-list
64858409|NCT01742247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858411|NCT01742247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64858412|NCT01742273|Vitamin K|vitamin k|mesh-list
64858413|NCT01742273|Vitamin K 1|vitamin k 1|mesh-list
64858414|NCT01742273|Vitamins|vitamins|mesh-ancestor
64858415|NCT01742273|Micronutrients|micronutrients|mesh-ancestor
64858416|NCT01742273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858417|NCT01742273|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64858418|NCT01742273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64858419|NCT01742273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858420|NCT01742273|Hemostatics|hemostatics|mesh-ancestor
64858421|NCT01742273|Coagulants|coagulants|mesh-ancestor
64858422|NCT01742338|Prednisone|prednisone|mesh-list
64858423|NCT01742338|Methylprednisolone|methylprednisolone|mesh-list
64858473|NCT01742429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64858474|NCT01742429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64858475|NCT01742429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64858476|NCT01742429|Renal Agents|renal agents|mesh-ancestor
64858543|NCT01742689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64858544|NCT01742689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64858545|NCT01742689|Gout Suppressants|gout suppressants|mesh-ancestor
64495230|NCT01101100|Brodalumab|brodalumab|mesh-list
64495237|NCT01101880|Antimetabolites|antimetabolites|mesh-ancestor
64858546|NCT01742689|Tocolytic Agents|tocolytic agents|mesh-ancestor
64858547|NCT01742689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64858615|NCT01743014|Clopidogrel|clopidogrel|mesh-list
64858616|NCT01743014|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64858617|NCT01743014|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64858618|NCT01743014|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64858619|NCT01743014|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64858620|NCT01743014|Purinergic Agents|purinergic agents|mesh-ancestor
64858621|NCT01743014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64858622|NCT01743014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295495|NCT02053597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64295496|NCT02053597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295497|NCT02053597|Tubulin Modulators|tubulin modulators|mesh-ancestor
64858623|NCT01743014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858624|NCT01743014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64858625|NCT01743014|Protease Inhibitors|protease inhibitors|mesh-ancestor
64858626|NCT01743014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64858627|NCT01743014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64858628|NCT01743066|Vitamin E|vitamin e|mesh-list
64858629|NCT01743066|Vitamins|vitamins|mesh-ancestor
64858630|NCT01743066|Micronutrients|micronutrients|mesh-ancestor
64858631|NCT01743066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858632|NCT01743066|Antioxidants|antioxidants|mesh-ancestor
64858633|NCT01743066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495354|NCT03468348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64858669|NCT01743157|Growth Substances|growth substances|mesh-ancestor
64858670|NCT01743157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858671|NCT01743157|Growth Inhibitors|growth inhibitors|mesh-ancestor
64858672|NCT01743157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64858673|NCT01743157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858674|NCT01743157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64858675|NCT01743157|Analgesics|analgesics|mesh-ancestor
64858736|NCT01743508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64858737|NCT01743508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858811|NCT01744106|Ephedrine|ephedrine|mesh-list
64858812|NCT01744106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64858813|NCT01744106|Autonomic Agents|autonomic agents|mesh-ancestor
64858814|NCT01744106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64858815|NCT01744106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64858816|NCT01744106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64858821|NCT01744106|Sympathomimetics|sympathomimetics|mesh-ancestor
64858879|NCT01744288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64858880|NCT01744288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64858882|NCT01744314|Indomethacin|indomethacin|mesh-list
64858953|NCT01744873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64858954|NCT01744873|Sympatholytics|sympatholytics|mesh-ancestor
64858955|NCT01744873|Autonomic Agents|autonomic agents|mesh-ancestor
64858956|NCT01744873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64495504|NCT01219738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64495552|NCT01222234|Vitamin D|vitamin d|mesh-list
64858957|NCT01744873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859021|NCT01745328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859022|NCT01745328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64859023|NCT01745328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64859025|NCT01745549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64859026|NCT01745549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64859027|NCT01745549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859028|NCT01745562|Alprazolam|alprazolam|mesh-list
64859029|NCT01745562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64859030|NCT01745562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64859031|NCT01745562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859032|NCT01745562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64859033|NCT01745562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64859034|NCT01745562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64859035|NCT01745562|GABA Modulators|gaba modulators|mesh-ancestor
64859036|NCT01745562|GABA Agents|gaba agents|mesh-ancestor
64859037|NCT01745562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64859038|NCT01745562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859039|NCT01745575|Alprazolam|alprazolam|mesh-list
64495806|NCT01160380|Modafinil|modafinil|mesh-list
64859040|NCT01745575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64859041|NCT01745575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64859042|NCT01745575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859043|NCT01745575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64859044|NCT01745575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64859050|NCT01745601|Dexetimide|dexetimide|mesh-list
64859071|NCT01745614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64859072|NCT01745614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64859073|NCT01745614|Analgesics|analgesics|mesh-ancestor
64859074|NCT01745614|Sensory System Agents|sensory system agents|mesh-ancestor
64859075|NCT01745614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64859076|NCT01745614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496114|NCT00861705|Antibodies|antibodies|mesh-list
64859077|NCT01745614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64859139|NCT01745835|Laxatives|laxatives|mesh-ancestor
64859140|NCT01746199|Pyrimethamine|pyrimethamine|mesh-list
64859141|NCT01746199|Sulfadoxine|sulfadoxine|mesh-list
64859142|NCT01746199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64859143|NCT01746199|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64859145|NCT01746199|Antimalarials|antimalarials|mesh-ancestor
64859146|NCT01746199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64859147|NCT01746199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64859150|NCT01746199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859204|NCT01746680|Tacrolimus|tacrolimus|mesh-list
64859205|NCT01746680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64859206|NCT01746680|Abortifacient Agents|abortifacient agents|mesh-ancestor
64859207|NCT01746680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64859208|NCT01746680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859274|NCT01746992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64859275|NCT01746992|Immunologic Factors|immunologic factors|mesh-ancestor
64859276|NCT01746992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859277|NCT01746992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64859278|NCT01746992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64859279|NCT01746992|Alkylating Agents|alkylating agents|mesh-ancestor
64859280|NCT01746992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859281|NCT01746992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859282|NCT01746992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64859283|NCT01746992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64859284|NCT01746992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64859285|NCT01746992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64859286|NCT01746992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859287|NCT01746992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64859289|NCT01746992|Hormones|hormones|mesh-ancestor
64859330|NCT01747161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496431|NCT03433014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859331|NCT01747161|Cholinergic Agents|cholinergic agents|mesh-ancestor
64859332|NCT01747161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64859333|NCT01747161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859335|NCT01747174|Nitroprusside|nitroprusside|mesh-list
64859336|NCT01747174|Analgesics|analgesics|mesh-ancestor
64859349|NCT01747226|Fluorides|fluorides|mesh-list
64859396|NCT01747590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64859397|NCT01747590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64859399|NCT01747590|GABA Agonists|gaba agonists|mesh-ancestor
64859473|NCT01747993|Adrenergic Agents|adrenergic agents|mesh-ancestor
64859474|NCT01747993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64295502|NCT02053597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64295503|NCT02053597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64295504|NCT02053597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295505|NCT05054348|Pembrolizumab|pembrolizumab|mesh-list
64295506|NCT05054348|Cemiplimab|cemiplimab|mesh-list
64295507|NCT05054348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64295508|NCT05054348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295509|NCT04163900|Gemcitabine|gemcitabine|mesh-list
64295510|NCT04163900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295511|NCT04163900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64295512|NCT04163900|Antimetabolites|antimetabolites|mesh-ancestor
64859475|NCT01747993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64859476|NCT01747993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859477|NCT01747993|Urological Agents|urological agents|mesh-ancestor
64859478|NCT01748019|Namitecan|namitecan|mesh-list
64859479|NCT01748019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64859480|NCT01748019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859481|NCT01748084|Rituximab|rituximab|mesh-list
64859482|NCT01748084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64859483|NCT01748084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859484|NCT01748084|Immunologic Factors|immunologic factors|mesh-ancestor
64859485|NCT01748084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859486|NCT01748084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64859487|NCT01748123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64859488|NCT01748123|Chlorthalidone|chlorthalidone|mesh-list
64496894|NCT01286818|Vitamins|vitamins|mesh-ancestor
64859489|NCT01748123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64859490|NCT01748123|Diuretics|diuretics|mesh-ancestor
64859491|NCT01748123|Natriuretic Agents|natriuretic agents|mesh-ancestor
64859492|NCT01748123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859493|NCT01748123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64859494|NCT01748123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64859523|NCT01748279|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64859524|NCT01748279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64859525|NCT01748279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64859526|NCT01748279|Adrenergic Agents|adrenergic agents|mesh-ancestor
64859527|NCT01748279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64859528|NCT01748318|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64859529|NCT01748318|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64859530|NCT01748318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64859532|NCT01748318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64859589|NCT01748487|Hormones|hormones|mesh-ancestor
64497047|NCT01339858|Acetylcysteine|acetylcysteine|mesh-list
64859590|NCT01748487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64859591|NCT01748487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64859592|NCT01748487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859593|NCT01748487|Protease Inhibitors|protease inhibitors|mesh-ancestor
64859659|NCT01748773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859660|NCT01748773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64859731|NCT01749111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64859732|NCT01749111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64859733|NCT01749111|Antimetabolites|antimetabolites|mesh-ancestor
64859734|NCT01749111|Dermatologic Agents|dermatologic agents|mesh-ancestor
64859735|NCT01749111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64859736|NCT01749111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64859737|NCT01749111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64859738|NCT01749150|Ritonavir|ritonavir|mesh-list
64859739|NCT01749150|Ribavirin|ribavirin|mesh-list
64859740|NCT01749150|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64859796|NCT01749384|Antibodies|antibodies|mesh-list
64859797|NCT01749384|Immunoglobulins|immunoglobulins|mesh-list
64859798|NCT01749384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64859799|NCT01749384|Immunoglobulin G|immunoglobulin g|mesh-list
64859800|NCT01749384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64859801|NCT01749384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64859802|NCT01749384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64859803|NCT01749384|Growth Substances|growth substances|mesh-ancestor
64859804|NCT01749384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859805|NCT01749384|Growth Inhibitors|growth inhibitors|mesh-ancestor
64859806|NCT01749384|Immunologic Factors|immunologic factors|mesh-ancestor
64859807|NCT01749397|Fluorouracil|fluorouracil|mesh-list
64859808|NCT01749397|Floxuridine|floxuridine|mesh-list
64859861|NCT01749579|Propofol|propofol|mesh-list
64859862|NCT01749579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64859863|NCT01749579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64859864|NCT01749579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859935|NCT01750359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64859937|NCT01750359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64859938|NCT01750359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860005|NCT01750723|Acetazolamide|acetazolamide|mesh-list
64860006|NCT01750723|Anticonvulsants|anticonvulsants|mesh-ancestor
64860007|NCT01750723|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64860009|NCT01750723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860010|NCT01750723|Diuretics|diuretics|mesh-ancestor
64860077|NCT01751204|Calcium, Dietary|calcium, dietary|mesh-list
64860146|NCT01751828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860147|NCT01751828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64860148|NCT01751828|Serotonin Agents|serotonin agents|mesh-ancestor
64860149|NCT01751828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860150|NCT01751854|Citalopram|citalopram|mesh-list
64860151|NCT01751854|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64860152|NCT01751854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64860153|NCT01751854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64860154|NCT01751854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498042|NCT00981747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860155|NCT01751854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64860176|NCT01752153|Silymarin|silymarin|mesh-list
64860207|NCT01752270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64860208|NCT01752270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860209|NCT01752270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860210|NCT01752270|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64860211|NCT01752270|Contraceptive Agents|contraceptive agents|mesh-ancestor
64860212|NCT01752270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64628762|NCT00002620|Cobalt|cobalt|mesh-list
64860272|NCT01752959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64860273|NCT01752959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64860274|NCT01752959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64860275|NCT01752959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64860276|NCT01752959|Adrenergic Agents|adrenergic agents|mesh-ancestor
64860277|NCT01752959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64860278|NCT01752959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860279|NCT01752998|Analgesics, Opioid|analgesics, opioid|mesh-list
64860280|NCT01752998|Narcotics|narcotics|mesh-ancestor
64860281|NCT01752998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64860336|NCT01753752|Acetylcysteine|acetylcysteine|mesh-list
64860337|NCT01753752|Chitosan|chitosan|mesh-list
64860338|NCT01753752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64860339|NCT01753752|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64860340|NCT01753752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64860341|NCT01753752|Antiviral Agents|antiviral agents|mesh-ancestor
64860342|NCT01753752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64860343|NCT01753752|Expectorants|expectorants|mesh-ancestor
64860344|NCT01753752|Respiratory System Agents|respiratory system agents|mesh-ancestor
64860345|NCT01753752|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64860346|NCT01753752|Antioxidants|antioxidants|mesh-ancestor
64860347|NCT01753752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860401|NCT01754220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64860402|NCT01754220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860403|NCT01754220|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64860404|NCT01754220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64860405|NCT01754220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860406|NCT01754285|Octreotide|octreotide|mesh-list
64860469|NCT01754870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64860470|NCT01754870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64860471|NCT01754870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64860472|NCT01754870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64860473|NCT01754870|Growth Substances|growth substances|mesh-ancestor
64498412|NCT04605731|Durvalumab|durvalumab|mesh-list
64860474|NCT01754870|Growth Inhibitors|growth inhibitors|mesh-ancestor
64860475|NCT01754870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64860476|NCT01754870|Alkylating Agents|alkylating agents|mesh-ancestor
64860477|NCT01754870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860478|NCT01754883|Lithium Carbonate|lithium carbonate|mesh-list
64860479|NCT01754883|Antidepressive Agents|antidepressive agents|mesh-ancestor
64860480|NCT01754883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64860481|NCT01754883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860530|NCT01755286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860531|NCT01755286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860532|NCT01755286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860533|NCT01755286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64860535|NCT01755299|Caffeine|caffeine|mesh-list
64860601|NCT01755520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64860675|NCT01755728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64860676|NCT01755728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860677|NCT01755728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860678|NCT01755845|Paclitaxel|paclitaxel|mesh-list
64860679|NCT01755845|Cisplatin|cisplatin|mesh-list
64860680|NCT01755845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64860681|NCT01755845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860682|NCT01755845|Tubulin Modulators|tubulin modulators|mesh-ancestor
64860683|NCT01755845|Antimitotic Agents|antimitotic agents|mesh-ancestor
64860684|NCT01755845|Mitosis Modulators|mitosis modulators|mesh-ancestor
64860686|NCT01755871|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64860740|NCT01756183|Antimitotic Agents|antimitotic agents|mesh-ancestor
64860811|NCT01756495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64860812|NCT01756495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64860813|NCT01756495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64860815|NCT01756495|Contraceptive Agents|contraceptive agents|mesh-ancestor
64860881|NCT01756781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64860882|NCT01756781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64860883|NCT01756781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64860884|NCT01756781|Anesthetics, General|anesthetics, general|mesh-ancestor
64860885|NCT01756781|Anesthetics|anesthetics|mesh-ancestor
64860886|NCT01756781|GABA Modulators|gaba modulators|mesh-ancestor
64860887|NCT01756781|GABA Agents|gaba agents|mesh-ancestor
64860888|NCT01756781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64860949|NCT01757236|Antitubercular Agents|antitubercular agents|mesh-ancestor
64860950|NCT01757236|Leprostatic Agents|leprostatic agents|mesh-ancestor
64860952|NCT01757236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861018|NCT01757639|Ipilimumab|ipilimumab|mesh-list
64861019|NCT01757639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64861020|NCT01757639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64861021|NCT01757639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64499078|NCT01323010|Albuterol|albuterol|mesh-list
64861022|NCT01757639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861023|NCT01757756|Midazolam|midazolam|mesh-list
64861024|NCT01757756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64861025|NCT01757756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64861026|NCT01757756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64861027|NCT01757756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861028|NCT01757756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64861029|NCT01757756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64861030|NCT01757756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64861031|NCT01757756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64861032|NCT01757756|Anesthetics, General|anesthetics, general|mesh-ancestor
64861033|NCT01757756|Anesthetics|anesthetics|mesh-ancestor
64861034|NCT01757756|GABA Modulators|gaba modulators|mesh-ancestor
64861035|NCT01757756|GABA Agents|gaba agents|mesh-ancestor
64861036|NCT01757756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64861037|NCT01757756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861038|NCT01757769|Silodosin|silodosin|mesh-list
64861039|NCT01757769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64861040|NCT01757769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64861041|NCT01757769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64861042|NCT01757769|Adrenergic Agents|adrenergic agents|mesh-ancestor
64861043|NCT01757769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64861044|NCT01757769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861051|NCT01757808|Ranolazine|ranolazine|mesh-list
64861064|NCT01757899|Prednisolone acetate|prednisolone acetate|mesh-list
64861065|NCT01757899|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64861066|NCT01757899|Prednisolone phosphate|prednisolone phosphate|mesh-list
64861067|NCT01757899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64861135|NCT01758146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861136|NCT01758146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64861137|NCT01758146|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64861143|NCT01758185|Vaccines|vaccines|mesh-list
64499839|NCT03819114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64861207|NCT01758471|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64861208|NCT01758471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861209|NCT01758471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861210|NCT01758471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64861211|NCT01758471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861212|NCT01758627|Icodextrin|icodextrin|mesh-list
64861215|NCT01758640|Warfarin|warfarin|mesh-list
64861275|NCT01758978|Sensory System Agents|sensory system agents|mesh-ancestor
64861347|NCT01759706|Dexamethasone|dexamethasone|mesh-list
64861348|NCT01759706|Sufentanil|sufentanil|mesh-list
64861349|NCT01759706|Diazepam|diazepam|mesh-list
64861420|NCT01759875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64861421|NCT01759875|Protease Inhibitors|protease inhibitors|mesh-ancestor
64861422|NCT01759875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861423|NCT01759875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861437|NCT01759940|Ropivacaine|ropivacaine|mesh-list
64861492|NCT01760161|Anesthetics, Local|anesthetics, local|mesh-ancestor
64861493|NCT01760161|Anesthetics|anesthetics|mesh-ancestor
64861494|NCT01760161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64861498|NCT01760174|Bupivacaine|bupivacaine|mesh-list
64861563|NCT01760278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64861564|NCT01760278|Hormone Antagonists|hormone antagonists|mesh-ancestor
64861565|NCT01760330|Acetaminophen|acetaminophen|mesh-list
64861566|NCT01760330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64861567|NCT01760330|Analgesics|analgesics|mesh-ancestor
64861568|NCT01760330|Sensory System Agents|sensory system agents|mesh-ancestor
64861569|NCT01760330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64861570|NCT01760330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861632|NCT01760642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861633|NCT01760642|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64861634|NCT01760642|Antitubercular Agents|antitubercular agents|mesh-ancestor
64861635|NCT01760642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64861702|NCT01760824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64861703|NCT01760824|Antacids|antacids|mesh-ancestor
64861704|NCT01760863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64861705|NCT01760863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64861706|NCT01760967|Dexmedetomidine|dexmedetomidine|mesh-list
64861707|NCT01760967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64861708|NCT01760967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64861709|NCT01760967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861710|NCT01760967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64861711|NCT01760967|Analgesics|analgesics|mesh-ancestor
64861712|NCT01760967|Sensory System Agents|sensory system agents|mesh-ancestor
64861713|NCT01760967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64861714|NCT01760967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64861715|NCT01760967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64500409|NCT01495858|Naproxen|naproxen|mesh-list
64861716|NCT01760967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64861761|NCT01761201|Ofloxacin|ofloxacin|mesh-list
64861762|NCT01761201|Isoniazid|isoniazid|mesh-list
64861763|NCT01761201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64295518|NCT04163900|Immunologic Factors|immunologic factors|mesh-ancestor
64295519|NCT04163900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295520|NCT02801617|Latanoprost|latanoprost|mesh-list
64295521|NCT02801617|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64295522|NCT02801617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64295523|NCT02056249|Norepinephrine|norepinephrine|mesh-list
64861764|NCT01761201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64861765|NCT01761201|Renal Agents|renal agents|mesh-ancestor
64861766|NCT01761201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64861767|NCT01761201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64861768|NCT01761201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64861769|NCT01761201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861777|NCT01761201|Antimetabolites|antimetabolites|mesh-ancestor
64861826|NCT01761552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64861827|NCT01761552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64861828|NCT01761552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64861829|NCT01761552|Autonomic Agents|autonomic agents|mesh-ancestor
64500647|NCT01509586|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64500658|NCT01470118|Alcaftadine|alcaftadine|mesh-list
64861830|NCT01761552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64861831|NCT01761552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861832|NCT01761552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64861833|NCT01761552|Respiratory System Agents|respiratory system agents|mesh-ancestor
64861834|NCT01761552|Mydriatics|mydriatics|mesh-ancestor
64861835|NCT01761552|Parasympatholytics|parasympatholytics|mesh-ancestor
64861836|NCT01761552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64861837|NCT01761552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64861838|NCT01761552|Cholinergic Agents|cholinergic agents|mesh-ancestor
64861839|NCT01761552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64861840|NCT01761552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861841|NCT01761552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64501013|NCT03386838|Nivolumab|nivolumab|mesh-list
64861842|NCT01761552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861843|NCT01761552|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64861844|NCT01761656|Atorvastatin|atorvastatin|mesh-list
64861845|NCT01761656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64861846|NCT01761656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64861847|NCT01761656|Antimetabolites|antimetabolites|mesh-ancestor
64861852|NCT01761669|Vitamin D|vitamin d|mesh-list
64861878|NCT01761968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64861880|NCT01761994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64861881|NCT01761994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64861882|NCT01761994|Analgesics|analgesics|mesh-ancestor
64861883|NCT01761994|Sensory System Agents|sensory system agents|mesh-ancestor
64861884|NCT01761994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64861946|NCT01762306|Analgesics|analgesics|mesh-ancestor
64861947|NCT01762306|Sensory System Agents|sensory system agents|mesh-ancestor
64861948|NCT01762306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64861949|NCT01762306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64861950|NCT01762306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64861951|NCT01762306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64861952|NCT01762306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64861953|NCT01762306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64861955|NCT01762306|Hematinics|hematinics|mesh-ancestor
64862014|NCT01762540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64862015|NCT01762540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862016|NCT01762540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64862017|NCT01762540|Hormones|hormones|mesh-ancestor
64862018|NCT01762540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64862019|NCT01762540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64862020|NCT01762540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862021|NCT01762644|Cyclosporine|cyclosporine|mesh-list
64862022|NCT01762644|Omeprazole|omeprazole|mesh-list
64862079|NCT01762787|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64862080|NCT01762787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64862081|NCT01762787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862082|NCT01762787|Antipyretics|antipyretics|mesh-ancestor
64862083|NCT01762787|Glucocorticoids|glucocorticoids|mesh-ancestor
64862084|NCT01762787|Hormones|hormones|mesh-ancestor
64862085|NCT01762787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64862086|NCT01762787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64862087|NCT01762787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862088|NCT01762787|Antiemetics|antiemetics|mesh-ancestor
64862089|NCT01762787|Autonomic Agents|autonomic agents|mesh-ancestor
64862144|NCT01762995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64862145|NCT01762995|Antacids|antacids|mesh-ancestor
64862146|NCT01762995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64862147|NCT01762995|Trace Elements|trace elements|mesh-ancestor
64862148|NCT01762995|Micronutrients|micronutrients|mesh-ancestor
64862149|NCT01763021|Rifampin|rifampin|mesh-list
64862150|NCT01763021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64862211|NCT01763463|Bronchodilator Agents|bronchodilator agents|mesh-list
64862285|NCT01763749|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64501820|NCT03061539|Nivolumab|nivolumab|mesh-list
64501821|NCT03061539|Ipilimumab|ipilimumab|mesh-list
64862286|NCT01763749|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64862287|NCT01763749|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64862288|NCT01763749|Purinergic Agents|purinergic agents|mesh-ancestor
64862289|NCT01763749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64862290|NCT01763749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862291|NCT01763749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862292|NCT01763788|Gemcitabine|gemcitabine|mesh-list
64862350|NCT01764295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64862351|NCT01764295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862352|NCT01764295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64862353|NCT01764295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64862354|NCT01764295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64862355|NCT01764451|Simvastatin|simvastatin|mesh-list
64862356|NCT01764451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64862363|NCT01764555|Acetaminophen|acetaminophen|mesh-list
64862417|NCT01764867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862418|NCT01764867|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64862419|NCT01764867|Antidepressive Agents|antidepressive agents|mesh-ancestor
64502135|NCT05035888|Norepinephrine|norepinephrine|mesh-list
64862420|NCT01764867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64862421|NCT01764867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64862422|NCT01764867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64862423|NCT01764867|Parasympatholytics|parasympatholytics|mesh-ancestor
64862424|NCT01764867|Autonomic Agents|autonomic agents|mesh-ancestor
64862425|NCT01764867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64862426|NCT01764867|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64862427|NCT01764867|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64862428|NCT01764867|Cholinergic Agents|cholinergic agents|mesh-ancestor
64862429|NCT01764867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64862430|NCT01764867|Dopamine Agents|dopamine agents|mesh-ancestor
64862431|NCT01764867|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64862475|NCT01765023|Atorvastatin|atorvastatin|mesh-list
64862476|NCT01765023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64862477|NCT01765023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862480|NCT01765023|Antimetabolites|antimetabolites|mesh-ancestor
64862543|NCT01765608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862544|NCT01765738|Minocycline|minocycline|mesh-list
64862545|NCT01765738|Rifampin|rifampin|mesh-list
64862546|NCT01765738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64631117|NCT00003544|Irinotecan|irinotecan|mesh-list
64862547|NCT01765738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64862615|NCT01765842|Immunologic Factors|immunologic factors|mesh-ancestor
64862690|NCT01766258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862691|NCT01766258|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64862692|NCT01766258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862693|NCT01766323|Modafinil|modafinil|mesh-list
64862694|NCT01766323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64862695|NCT01766323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862696|NCT01766323|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64862697|NCT01766323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64502390|NCT03370848|Aspirin|aspirin|mesh-list
64502443|NCT02248870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862698|NCT01766323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64862699|NCT01766323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862700|NCT01766375|Cyclosporine|cyclosporine|mesh-list
64862701|NCT01766375|Mycophenolic Acid|mycophenolic acid|mesh-list
64862702|NCT01766375|Methotrexate|methotrexate|mesh-list
64862750|NCT01766609|Triamcinolone|triamcinolone|mesh-list
64862751|NCT01766609|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64862752|NCT01766609|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64862753|NCT01766609|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64862754|NCT01766609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64862755|NCT01766609|Glucocorticoids|glucocorticoids|mesh-ancestor
64862756|NCT01766609|Hormones|hormones|mesh-ancestor
64862757|NCT01766609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64862758|NCT01766609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862759|NCT01766609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64862760|NCT01766609|Immunologic Factors|immunologic factors|mesh-ancestor
64862761|NCT01766609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64862762|NCT01766609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64862763|NCT01766830|Immunoglobulin G|immunoglobulin g|mesh-list
64862764|NCT01766830|Immunoglobulin M|immunoglobulin m|mesh-list
64862808|NCT01767259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862809|NCT01767259|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64862810|NCT01767259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64862873|NCT01767545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64862874|NCT01767545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64862875|NCT01767545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64862876|NCT01767545|Growth Substances|growth substances|mesh-ancestor
64862877|NCT01767545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862885|NCT01767545|Hormones|hormones|mesh-ancestor
64862943|NCT01768182|Levoleucovorin|levoleucovorin|mesh-list
64862944|NCT01768182|Antidotes|antidotes|mesh-ancestor
64862945|NCT01768182|Protective Agents|protective agents|mesh-ancestor
64862946|NCT01768182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64862947|NCT01768182|Vitamin B Complex|vitamin b complex|mesh-ancestor
64862948|NCT01768182|Vitamins|vitamins|mesh-ancestor
64862949|NCT01768182|Micronutrients|micronutrients|mesh-ancestor
64862950|NCT01768182|Hematinics|hematinics|mesh-ancestor
64863011|NCT01768299|Contraceptive Agents|contraceptive agents|mesh-ancestor
64863012|NCT01768299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64863013|NCT01768299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64502768|NCT03346252|Cholinergic Agents|cholinergic agents|mesh-ancestor
64863014|NCT01768299|Hormone Antagonists|hormone antagonists|mesh-ancestor
64863015|NCT01768299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64863016|NCT01768299|Luteolytic Agents|luteolytic agents|mesh-ancestor
64863017|NCT01768299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64863018|NCT01768299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64863019|NCT01768312|Cyclosporine|cyclosporine|mesh-list
64863074|NCT01768377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64863075|NCT01768377|GABA Modulators|gaba modulators|mesh-ancestor
64503095|NCT03350334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64863076|NCT01768377|GABA Agents|gaba agents|mesh-ancestor
64863077|NCT01768377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64863078|NCT01768390|Fluorides|fluorides|mesh-list
64863079|NCT01768390|Cariostatic Agents|cariostatic agents|mesh-ancestor
64863080|NCT01768390|Protective Agents|protective agents|mesh-ancestor
64863081|NCT01768390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863082|NCT01768455|Glimepiride|glimepiride|mesh-list
64863083|NCT01768455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64863084|NCT01768455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64863085|NCT01768455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863086|NCT01768455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64863087|NCT01768455|Immunologic Factors|immunologic factors|mesh-ancestor
64863088|NCT01768481|Atorvastatin|atorvastatin|mesh-list
64863089|NCT01768481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64863090|NCT01768481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64863091|NCT01768481|Antimetabolites|antimetabolites|mesh-ancestor
64863092|NCT01768481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863093|NCT01768481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64863094|NCT01768481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64863095|NCT01768481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863096|NCT01768507|Resveratrol|resveratrol|mesh-list
64863126|NCT01768663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64863127|NCT01768663|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64863128|NCT01768663|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64295525|NCT02056249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64295526|NCT02056249|Adrenergic Agents|adrenergic agents|mesh-ancestor
64295527|NCT02056249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64295528|NCT02056249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295529|NCT02056249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295530|NCT02056249|Sympathomimetics|sympathomimetics|mesh-ancestor
64863131|NCT01768663|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64863132|NCT01768663|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64863133|NCT01768663|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64863134|NCT01768663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64863135|NCT01768741|Liver Extracts|liver extracts|mesh-list
64863136|NCT01768741|Hematinics|hematinics|mesh-ancestor
64863137|NCT01768780|Glycopyrrolate|glycopyrrolate|mesh-list
64863138|NCT01768780|Bupivacaine|bupivacaine|mesh-list
64863139|NCT01768780|Cholinergic Antagonists|cholinergic antagonists|mesh-list
64863140|NCT01768780|Anesthetics, Local|anesthetics, local|mesh-ancestor
64863141|NCT01768780|Anesthetics|anesthetics|mesh-ancestor
64863142|NCT01768780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64863143|NCT01768780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863144|NCT01768780|Sensory System Agents|sensory system agents|mesh-ancestor
64863145|NCT01768780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64863146|NCT01768780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64863147|NCT01768780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64863148|NCT01768780|Cholinergic Agents|cholinergic agents|mesh-ancestor
64863149|NCT01768780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64863150|NCT01768780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863151|NCT01768884|Nitric Oxide|nitric oxide|mesh-list
64863152|NCT01768884|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64863153|NCT01768884|Autonomic Agents|autonomic agents|mesh-ancestor
64863154|NCT01768884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64863155|NCT01768884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863156|NCT01768884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64863157|NCT01768884|Respiratory System Agents|respiratory system agents|mesh-ancestor
64863158|NCT01768884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64863159|NCT01768884|Antioxidants|antioxidants|mesh-ancestor
64863160|NCT01768884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863161|NCT01768884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64863162|NCT01768884|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64863163|NCT01768884|Vasodilator Agents|vasodilator agents|mesh-ancestor
64863164|NCT01768884|Gasotransmitters|gasotransmitters|mesh-ancestor
64863165|NCT01768884|Protective Agents|protective agents|mesh-ancestor
64863166|NCT01768897|Thioctic Acid|thioctic acid|mesh-list
64863167|NCT01768897|Cytarabine|cytarabine|mesh-list
64863168|NCT01768897|Mitoxantrone|mitoxantrone|mesh-list
64863169|NCT01768897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64863170|NCT01768897|Antimetabolites|antimetabolites|mesh-ancestor
64863171|NCT01768897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863172|NCT01768897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863173|NCT01768897|Antiviral Agents|antiviral agents|mesh-ancestor
64863174|NCT01768897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863175|NCT01768897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64863176|NCT01768897|Immunologic Factors|immunologic factors|mesh-ancestor
64863177|NCT01768897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863178|NCT01768897|Analgesics|analgesics|mesh-ancestor
64863179|NCT01768897|Sensory System Agents|sensory system agents|mesh-ancestor
64863180|NCT01768897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64863181|NCT01768897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64486155|NCT01711879|Aflibercept|aflibercept|mesh-list
64863182|NCT01768897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64295532|NCT02056249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64295533|NCT02056249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64295534|NCT04140968|Progesterone|progesterone|mesh-list
64295535|NCT04140968|Progestins|progestins|mesh-ancestor
64295536|NCT04140968|Hormones|hormones|mesh-ancestor
64295537|NCT04140968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64295538|NCT04140968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947622|NCT05655949|Antiviral Agents|antiviral agents|mesh-ancestor
64863233|NCT01769183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64863234|NCT01769183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863235|NCT01769183|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64863236|NCT01769183|Protective Agents|protective agents|mesh-ancestor
64863237|NCT01769183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863238|NCT01769183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863239|NCT01769183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64863240|NCT01769183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64863241|NCT01769183|Growth Substances|growth substances|mesh-ancestor
64863242|NCT01769183|Growth Inhibitors|growth inhibitors|mesh-ancestor
64863243|NCT01769235|Clindamycin|clindamycin|mesh-list
64863244|NCT01769235|Clindamycin palmitate|clindamycin palmitate|mesh-list
64863245|NCT01769235|Clindamycin phosphate|clindamycin phosphate|mesh-list
64863246|NCT01769235|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64863247|NCT01769235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64863248|NCT01769235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863249|NCT01769235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64863250|NCT01769235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863251|NCT01769235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863252|NCT01769235|Dermatologic Agents|dermatologic agents|mesh-ancestor
64863253|NCT01769482|Udenafil|udenafil|mesh-list
64332791|NCT01371630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64332794|NCT01371630|Hormones|hormones|mesh-ancestor
64332795|NCT01371630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64332796|NCT01371630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64332797|NCT01371630|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64332798|NCT01371630|Abortifacient Agents|abortifacient agents|mesh-ancestor
64947872|NCT04893096|Felzartamab|felzartamab|mesh-list
64332799|NCT01371630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64332800|NCT01371630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64332801|NCT01371630|Antimetabolites|antimetabolites|mesh-ancestor
64863254|NCT01769482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64863255|NCT01769482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64863256|NCT01769482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863257|NCT01769482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863258|NCT01769625|Vitamin D|vitamin d|mesh-list
64863259|NCT01769625|Cholecalciferol|cholecalciferol|mesh-list
64863260|NCT01769625|Celecoxib|celecoxib|mesh-list
64863261|NCT01769625|Vitamins|vitamins|mesh-ancestor
64863262|NCT01769625|Micronutrients|micronutrients|mesh-ancestor
64863263|NCT01769625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863264|NCT01769625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64863265|NCT01769625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64863266|NCT01769625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64863267|NCT01769625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64863268|NCT01769625|Analgesics|analgesics|mesh-ancestor
64863269|NCT01769625|Sensory System Agents|sensory system agents|mesh-ancestor
64948420|NCT04124991|Durvalumab|durvalumab|mesh-list
64863270|NCT01769625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64863271|NCT01769625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64863272|NCT01769625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64863273|NCT01769625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64863274|NCT01769625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64863275|NCT01769625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863276|NCT01769625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863366|NCT01769898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64863367|NCT01769898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863368|NCT01769898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64332806|NCT01371630|Antiviral Agents|antiviral agents|mesh-ancestor
64332807|NCT01371630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64332808|NCT01371630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64295545|NCT01334515|Immunologic Factors|immunologic factors|mesh-ancestor
64295546|NCT01334515|Dermatologic Agents|dermatologic agents|mesh-ancestor
64295547|NCT02415400|Aspirin|aspirin|mesh-list
64295548|NCT02415400|Vitamin K|vitamin k|mesh-list
64295549|NCT02415400|Apixaban|apixaban|mesh-list
64295550|NCT02415400|Vitamins|vitamins|mesh-ancestor
64295551|NCT02415400|Micronutrients|micronutrients|mesh-ancestor
64295552|NCT02415400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295553|NCT02415400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64295554|NCT02415400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64863396|NCT01769911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295555|NCT02415400|Analgesics|analgesics|mesh-ancestor
64295556|NCT02415400|Sensory System Agents|sensory system agents|mesh-ancestor
64295557|NCT02415400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64295558|NCT02415400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64295559|NCT02415400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64295560|NCT02415400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64295561|NCT02415400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64863426|NCT01770080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64863427|NCT01770080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863428|NCT01770080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64863429|NCT01770080|Parasympatholytics|parasympatholytics|mesh-ancestor
64863431|NCT01770106|Alendronate|alendronate|mesh-list
64863432|NCT01770106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64295562|NCT02415400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863469|NCT01770210|Atorvastatin|atorvastatin|mesh-list
64863470|NCT01770210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64863471|NCT01770210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64863472|NCT01770210|Antimetabolites|antimetabolites|mesh-ancestor
64863473|NCT01770210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863474|NCT01770210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64863475|NCT01770210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64863476|NCT01770210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863477|NCT01770223|Ribavirin|ribavirin|mesh-list
64863478|NCT01770223|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64863479|NCT01770223|Antimetabolites|antimetabolites|mesh-ancestor
64863480|NCT01770223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863481|NCT01770223|Antiviral Agents|antiviral agents|mesh-ancestor
64863482|NCT01770223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863483|NCT01770236|Acetaminophen|acetaminophen|mesh-list
64332809|NCT01371630|Tubulin Modulators|tubulin modulators|mesh-ancestor
64949225|NCT00039117|Immunologic Factors|immunologic factors|mesh-ancestor
64332810|NCT01371630|Antimitotic Agents|antimitotic agents|mesh-ancestor
64332811|NCT01371630|Mitosis Modulators|mitosis modulators|mesh-ancestor
64332812|NCT01371630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64332813|NCT01306942|Paclitaxel|paclitaxel|mesh-list
64332814|NCT01306942|Trastuzumab|trastuzumab|mesh-list
64332815|NCT01306942|Dasatinib|dasatinib|mesh-list
64332816|NCT01306942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64332817|NCT01306942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332818|NCT01306942|Tubulin Modulators|tubulin modulators|mesh-ancestor
64332819|NCT01306942|Antimitotic Agents|antimitotic agents|mesh-ancestor
64332820|NCT01306942|Mitosis Modulators|mitosis modulators|mesh-ancestor
64332821|NCT01306942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332822|NCT01306942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64863577|NCT01770964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863578|NCT01770964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64863579|NCT01770964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64863580|NCT01770964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64863581|NCT01770964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64949474|NCT00039663|Rosiglitazone|rosiglitazone|mesh-list
64863582|NCT01770964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64863583|NCT01771081|Ranibizumab|ranibizumab|mesh-list
64863584|NCT01771081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64863585|NCT01771081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64863586|NCT01771081|Growth Substances|growth substances|mesh-ancestor
64863587|NCT01771081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863588|NCT01771081|Growth Inhibitors|growth inhibitors|mesh-ancestor
64863589|NCT01771081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863590|NCT01771146|Oxaliplatin|oxaliplatin|mesh-list
64863591|NCT01771146|Irinotecan|irinotecan|mesh-list
64295578|NCT02053675|Coagulants|coagulants|mesh-ancestor
64295583|NCT02037997|Docetaxel|docetaxel|mesh-list
64863612|NCT01771289|Tubulin Modulators|tubulin modulators|mesh-ancestor
64863613|NCT01771289|Antimitotic Agents|antimitotic agents|mesh-ancestor
64863614|NCT01771289|Mitosis Modulators|mitosis modulators|mesh-ancestor
64863615|NCT01771289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863616|NCT01771302|Calcium|calcium|mesh-list
64863617|NCT01771302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64863618|NCT01771302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863619|NCT01771328|Hydrocortisone|hydrocortisone|mesh-list
64863620|NCT01771328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64863648|NCT01771458|Immunologic Factors|immunologic factors|mesh-ancestor
64863649|NCT01771458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863650|NCT01771458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64863651|NCT01771458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863757|NCT01772381|Antiemetics|antiemetics|mesh-ancestor
64863758|NCT01772381|Autonomic Agents|autonomic agents|mesh-ancestor
64863759|NCT01772381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64863760|NCT01772381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863761|NCT01772381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64863762|NCT01772381|Glucocorticoids|glucocorticoids|mesh-ancestor
64863763|NCT01772381|Hormones|hormones|mesh-ancestor
64863764|NCT01772381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64863765|NCT01772381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64863766|NCT01772381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863767|NCT01772420|Lenalidomide|lenalidomide|mesh-list
64863768|NCT01772420|Immunologic Factors|immunologic factors|mesh-ancestor
64863769|NCT01772420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863770|NCT01772420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64863771|NCT01772420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64863772|NCT01772420|Growth Substances|growth substances|mesh-ancestor
64332847|NCT01036087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64332848|NCT01036087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64332849|NCT01036087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64295638|NCT02414932|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64863816|NCT01772836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64863817|NCT01772836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863818|NCT01772940|Ritonavir|ritonavir|mesh-list
64863820|NCT01772940|Tenofovir|tenofovir|mesh-list
64863821|NCT01772940|Lamivudine|lamivudine|mesh-list
64863822|NCT01772940|Zidovudine|zidovudine|mesh-list
64863823|NCT01772940|Emtricitabine|emtricitabine|mesh-list
64863824|NCT01772940|Nevirapine|nevirapine|mesh-list
64863825|NCT01772940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64863826|NCT01772940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64863827|NCT01772940|Protease Inhibitors|protease inhibitors|mesh-ancestor
64863828|NCT01772940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863833|NCT01772940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863834|NCT01772940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64863835|NCT01772940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64863836|NCT01772940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64863837|NCT01772940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64863838|NCT01772940|Antimetabolites|antimetabolites|mesh-ancestor
64863839|NCT01772940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64863840|NCT01772940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64863841|NCT01772953|Treosulfan|treosulfan|mesh-list
64863842|NCT01772953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64863843|NCT01772953|Alkylating Agents|alkylating agents|mesh-ancestor
64863844|NCT01772953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863845|NCT01772953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863846|NCT01772979|Trabectedin|trabectedin|mesh-list
64863847|NCT01772979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64863848|NCT01772979|Alkylating Agents|alkylating agents|mesh-ancestor
64863849|NCT01772979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863850|NCT01772979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863851|NCT01773005|Acetaminophen|acetaminophen|mesh-list
64863852|NCT01773005|Ibuprofen|ibuprofen|mesh-list
64863853|NCT01773005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64863854|NCT01773005|Analgesics|analgesics|mesh-ancestor
64863855|NCT01773005|Sensory System Agents|sensory system agents|mesh-ancestor
64863856|NCT01773005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64863857|NCT01773005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863858|NCT01773005|Antipyretics|antipyretics|mesh-ancestor
64863859|NCT01773005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64863860|NCT01773005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64863861|NCT01773005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64863862|NCT01773005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64863863|NCT01773005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863864|NCT01773005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863866|NCT01773044|Anesthetics, Local|anesthetics, local|mesh-ancestor
64863867|NCT01773044|Anesthetics|anesthetics|mesh-ancestor
64863868|NCT01773044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64863869|NCT01773044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863870|NCT01773044|Sensory System Agents|sensory system agents|mesh-ancestor
64863871|NCT01773044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64863872|NCT01773044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64863873|NCT01773044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64863874|NCT01773044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64863875|NCT01773044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64863876|NCT01773044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863877|NCT01773096|Methylnaltrexone|methylnaltrexone|mesh-list
64863878|NCT01773096|Bisacodyl|bisacodyl|mesh-list
64863879|NCT01773096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64863880|NCT01773096|Magnesium Hydroxide|magnesium hydroxide|mesh-list
64863881|NCT01773096|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
64863882|NCT01773096|Cathartics|cathartics|mesh-ancestor
64863892|NCT01773174|Dabigatran|dabigatran|mesh-list
64863893|NCT01773174|Antithrombins|antithrombins|mesh-ancestor
64863894|NCT01773174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64863895|NCT01773174|Protease Inhibitors|protease inhibitors|mesh-ancestor
64863896|NCT01773174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863897|NCT01773174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863898|NCT01773174|Anticoagulants|anticoagulants|mesh-ancestor
64863899|NCT01773408|Cytarabine|cytarabine|mesh-list
64863900|NCT01773408|Daunorubicin|daunorubicin|mesh-list
64863901|NCT01773408|Idarubicin|idarubicin|mesh-list
64863902|NCT01773408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64863903|NCT01773408|Antimetabolites|antimetabolites|mesh-ancestor
64863904|NCT01773408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863905|NCT01773408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863906|NCT01773408|Antiviral Agents|antiviral agents|mesh-ancestor
64863907|NCT01773408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863908|NCT01773408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64863909|NCT01773408|Immunologic Factors|immunologic factors|mesh-ancestor
64863910|NCT01773408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863911|NCT01773408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64863912|NCT01773408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64863913|NCT01773408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64863914|NCT01773408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863915|NCT01773460|Everolimus|everolimus|mesh-list
64863916|NCT01773460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64863917|NCT01773460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64863918|NCT01773460|Immunologic Factors|immunologic factors|mesh-ancestor
64863919|NCT01773460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863920|NCT01773512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64863921|NCT01773512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64863922|NCT01773512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64863923|NCT01773512|Antimetabolites|antimetabolites|mesh-ancestor
64863924|NCT01773512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64863925|NCT01773512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64863926|NCT01773512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64863927|NCT01773512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64863929|NCT01773538|Lactulose|lactulose|mesh-list
64863930|NCT01773538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64863931|NCT01773538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64863932|NCT01773538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64863933|NCT01773616|Mycophenolic Acid|mycophenolic acid|mesh-list
64863934|NCT01773616|Prednisolone|prednisolone|mesh-list
64863935|NCT01773616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64863936|NCT01773616|Methylprednisolone|methylprednisolone|mesh-list
64863937|NCT01773616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64863938|NCT01773616|Prednisolone acetate|prednisolone acetate|mesh-list
64863939|NCT01773616|Rituximab|rituximab|mesh-list
64863940|NCT01773616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64863941|NCT01773616|Prednisolone phosphate|prednisolone phosphate|mesh-list
64863962|NCT01773616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64863963|NCT01773616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64863964|NCT01773616|Protective Agents|protective agents|mesh-ancestor
64863965|NCT01773681|Certolizumab Pegol|certolizumab pegol|mesh-list
64863966|NCT01773681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64863967|NCT01773681|Immunologic Factors|immunologic factors|mesh-ancestor
64863968|NCT01773681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64863969|NCT01773681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64863971|NCT01773772|Progestins|progestins|mesh-ancestor
64863972|NCT01773772|Hormones|hormones|mesh-ancestor
64863973|NCT01773772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64863974|NCT01773772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332850|NCT01036087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64332851|NCT01036087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64295646|NCT02414932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864010|NCT01774396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64864011|NCT01774396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64864012|NCT01774396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64332858|NCT00783367|Dexamethasone acetate|dexamethasone acetate|mesh-list
64332859|NCT00783367|Rituximab|rituximab|mesh-list
64864013|NCT01774396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64864014|NCT01774396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864015|NCT01774474|Dexamethasone|dexamethasone|mesh-list
64864016|NCT01774474|Dexamethasone acetate|dexamethasone acetate|mesh-list
64864017|NCT01774474|Triamcinolone|triamcinolone|mesh-list
64950084|NCT00049413|Immunologic Factors|immunologic factors|mesh-ancestor
64864018|NCT01774474|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64864019|NCT01774474|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64864020|NCT01774474|Bromfenac|bromfenac|mesh-list
64864021|NCT01774474|Bevacizumab|bevacizumab|mesh-list
64864022|NCT01774474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64864023|NCT01774474|BB 1101|bb 1101|mesh-list
64864024|NCT01774474|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64864025|NCT01774474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64864026|NCT01774474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64864027|NCT01774474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64864028|NCT01774474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64864029|NCT01774474|Growth Substances|growth substances|mesh-ancestor
64864030|NCT01774474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864090|NCT01775098|Gout Suppressants|gout suppressants|mesh-ancestor
64864091|NCT01775098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64864092|NCT01775098|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64864093|NCT01775098|Antioxidants|antioxidants|mesh-ancestor
64864094|NCT01775098|Protective Agents|protective agents|mesh-ancestor
64864095|NCT01775098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864096|NCT01775215|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64864097|NCT01775215|Natriuretic Agents|natriuretic agents|mesh-ancestor
64864098|NCT01775215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864099|NCT01775397|Vancomycin|vancomycin|mesh-list
64864100|NCT01775397|Fidaxomicin|fidaxomicin|mesh-list
64864101|NCT01775397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64864102|NCT01775397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64864103|NCT01775540|Dexamethasone|dexamethasone|mesh-list
64864104|NCT01775540|Lubricant Eye Drops|lubricant eye drops|mesh-list
64332861|NCT00783367|BB 1101|bb 1101|mesh-list
64332862|NCT00783367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64332863|NCT00783367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332864|NCT00783367|Immunologic Factors|immunologic factors|mesh-ancestor
64864105|NCT01775540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64864129|NCT01775618|Factor VIII|factor viii|mesh-list
64864130|NCT01775618|Coagulants|coagulants|mesh-ancestor
64864131|NCT01775631|Rituximab|rituximab|mesh-list
64864132|NCT01775631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64864133|NCT01775631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64864134|NCT01775631|Immunologic Factors|immunologic factors|mesh-ancestor
64864135|NCT01775631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864136|NCT01775631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64864137|NCT01775761|Moxifloxacin|moxifloxacin|mesh-list
64864138|NCT01775761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64864139|NCT01775761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64864140|NCT01775761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64864141|NCT01775761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64295669|NCT02726997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64864142|NCT01775761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64864164|NCT01775839|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64864165|NCT01775839|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64864166|NCT01775839|Purinergic Agents|purinergic agents|mesh-ancestor
64864167|NCT01775839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64864168|NCT01775839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64864169|NCT01775839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64864170|NCT01775839|Protective Agents|protective agents|mesh-ancestor
64864289|NCT01777464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864290|NCT01777477|Gemcitabine|gemcitabine|mesh-list
64864291|NCT01777477|Chloroquine|chloroquine|mesh-list
64864292|NCT01777477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64864293|NCT01777477|Antimetabolites|antimetabolites|mesh-ancestor
64864294|NCT01777477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864295|NCT01777477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64864296|NCT01777477|Antiviral Agents|antiviral agents|mesh-ancestor
64864297|NCT01777477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64864298|NCT01777477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64864299|NCT01777477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64864300|NCT01777477|Immunologic Factors|immunologic factors|mesh-ancestor
64864301|NCT01777477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864302|NCT01777477|Amebicides|amebicides|mesh-ancestor
64864303|NCT01777477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64864304|NCT01777477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64864305|NCT01777477|Antimalarials|antimalarials|mesh-ancestor
64864306|NCT01777477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64864307|NCT01777503|Clopidogrel|clopidogrel|mesh-list
64864308|NCT01777503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64864309|NCT01777503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64864310|NCT01777503|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64864311|NCT01777503|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64864312|NCT01777503|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64950435|NCT00050895|Ritonavir|ritonavir|mesh-list
64864313|NCT01777503|Purinergic Agents|purinergic agents|mesh-ancestor
64864314|NCT01777503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64864315|NCT01777503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864316|NCT01777503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864317|NCT01777685|Sulpiride|sulpiride|mesh-list
64864318|NCT01777685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64864319|NCT01777685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64864320|NCT01777685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64864329|NCT01777737|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64864330|NCT01777737|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64864331|NCT01777737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64864332|NCT01777737|Renal Agents|renal agents|mesh-ancestor
64864333|NCT01777737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64864334|NCT01777737|Antimalarials|antimalarials|mesh-ancestor
64864335|NCT01777737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64864336|NCT01777737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64864337|NCT01777867|Methacholine Chloride|methacholine chloride|mesh-list
64864338|NCT01777867|Miotics|miotics|mesh-ancestor
64864339|NCT01777867|Autonomic Agents|autonomic agents|mesh-ancestor
64864340|NCT01777867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64864341|NCT01777867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864342|NCT01777867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64864343|NCT01777867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
64295710|NCT02470455|Antimetabolites|antimetabolites|mesh-ancestor
64864368|NCT01778075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64864369|NCT01778075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864370|NCT01778075|Antipyretics|antipyretics|mesh-ancestor
64864371|NCT01778075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64864372|NCT01778075|Narcotics|narcotics|mesh-ancestor
64864373|NCT01778075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64864374|NCT01778101|Lansoprazole|lansoprazole|mesh-list
64864375|NCT01778101|Dexlansoprazole|dexlansoprazole|mesh-list
64864376|NCT01778101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64864377|NCT01778101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64864378|NCT01778101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64864379|NCT01778101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64864380|NCT01778101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864381|NCT01778114|Vitamin D|vitamin d|mesh-list
64864382|NCT01778114|Ergocalciferols|ergocalciferols|mesh-list
64864383|NCT01778114|Cholecalciferol|cholecalciferol|mesh-list
64864384|NCT01778114|Vitamins|vitamins|mesh-list
64864385|NCT01778114|Micronutrients|micronutrients|mesh-ancestor
64864386|NCT01778114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864387|NCT01778114|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64295711|NCT02470455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864393|NCT01778192|Anticoagulants|anticoagulants|mesh-ancestor
64864394|NCT01778192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64864395|NCT01778192|Chelating Agents|chelating agents|mesh-ancestor
64864396|NCT01778192|Sequestering Agents|sequestering agents|mesh-ancestor
64864397|NCT01778192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864398|NCT01778192|Cathartics|cathartics|mesh-ancestor
64864399|NCT01778192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64864400|NCT01778218|Deoxyglucose|deoxyglucose|mesh-list
64864401|NCT01778218|Antimetabolites|antimetabolites|mesh-ancestor
64864403|NCT01778218|Antiviral Agents|antiviral agents|mesh-ancestor
64864449|NCT01778686|Tryptophan|tryptophan|mesh-list
64864450|NCT01778686|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64864451|NCT01778686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64864452|NCT01778686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64864453|NCT01778686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864454|NCT01778686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64864455|NCT01778686|Serotonin Agents|serotonin agents|mesh-ancestor
64864456|NCT01778686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864457|NCT01778686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64864458|NCT01778686|Antidepressive Agents|antidepressive agents|mesh-ancestor
64864459|NCT01778686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64864460|NCT01778686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64864461|NCT01778686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64864462|NCT01778686|Adrenergic Agents|adrenergic agents|mesh-ancestor
64864463|NCT01778686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64864464|NCT01778686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64864465|NCT01778686|Vasodilator Agents|vasodilator agents|mesh-ancestor
64864466|NCT01778803|Paclitaxel|paclitaxel|mesh-list
64864467|NCT01778803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64295713|NCT02470455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64864475|NCT01778842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64332882|NCT00783367|Growth Inhibitors|growth inhibitors|mesh-ancestor
64332883|NCT00572156|Mecasermin|mecasermin|mesh-list
64332884|NCT00572156|Growth Substances|growth substances|mesh-ancestor
64332885|NCT00572156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332886|NCT00447772|Botulinum Toxins|botulinum toxins|mesh-list
64951102|NCT00025103|Dactinomycin|dactinomycin|mesh-list
64332887|NCT00447772|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64332888|NCT00447772|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64332889|NCT00447772|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64332890|NCT00447772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64332891|NCT00447772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332893|NCT00447772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64864476|NCT01778842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64864477|NCT01778842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64864478|NCT01778842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64864479|NCT01778842|Purinergic Agents|purinergic agents|mesh-ancestor
64864480|NCT01778842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64864481|NCT01778842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864482|NCT01778842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864483|NCT01779089|Minocycline|minocycline|mesh-list
64864484|NCT01779089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64864485|NCT01779089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64864486|NCT01779232|Danazol|danazol|mesh-list
64864487|NCT01779232|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64864488|NCT01779232|Hormone Antagonists|hormone antagonists|mesh-ancestor
64864489|NCT01779232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64864490|NCT01779232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864491|NCT01779245|Calcium|calcium|mesh-list
64864492|NCT01779245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64864493|NCT01779245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864494|NCT01779258|Desonide|desonide|mesh-list
64864495|NCT01779258|Glycerol|glycerol|mesh-list
64864496|NCT01779258|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64864497|NCT01779258|Protective Agents|protective agents|mesh-ancestor
64864498|NCT01779258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864499|NCT01779258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64864500|NCT01779271|Loxoprofen|loxoprofen|mesh-list
64864501|NCT01779271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64864502|NCT01779271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64864503|NCT01779271|Analgesics|analgesics|mesh-ancestor
64864504|NCT01779271|Sensory System Agents|sensory system agents|mesh-ancestor
64864505|NCT01779271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64864506|NCT01779271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864507|NCT01779271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64864508|NCT01779271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64864509|NCT01779284|Timolol|timolol|mesh-list
64864510|NCT01779284|Travoprost|travoprost|mesh-list
64864511|NCT01779284|Latanoprost|latanoprost|mesh-list
64864512|NCT01779284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64864514|NCT01779284|Adrenergic Agents|adrenergic agents|mesh-ancestor
64864516|NCT01779284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864517|NCT01779284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864518|NCT01779284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64864519|NCT01779284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64864521|NCT01779284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64864522|NCT01779362|Metformin|metformin|mesh-list
64864523|NCT01779362|Insulin Glargine|insulin glargine|mesh-list
64864524|NCT01779362|Liraglutide|liraglutide|mesh-list
64864525|NCT01779362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64864526|NCT01779362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864527|NCT01779362|Incretins|incretins|mesh-ancestor
64864528|NCT01779362|Hormones|hormones|mesh-ancestor
64864529|NCT01779362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64864530|NCT01779401|Aspirin|aspirin|mesh-list
64864531|NCT01779401|Cilostazol|cilostazol|mesh-list
64864532|NCT01779401|Clopidogrel|clopidogrel|mesh-list
64864533|NCT01779401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64864534|NCT01779401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64864535|NCT01779401|Analgesics|analgesics|mesh-ancestor
64864536|NCT01779401|Sensory System Agents|sensory system agents|mesh-ancestor
64864537|NCT01779401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64864538|NCT01779401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864539|NCT01779401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64864540|NCT01779401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64864541|NCT01779401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64864542|NCT01779401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64864543|NCT01779401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864544|NCT01779401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64864555|NCT01779401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64864556|NCT01779401|Respiratory System Agents|respiratory system agents|mesh-ancestor
64864557|NCT01779401|Vasodilator Agents|vasodilator agents|mesh-ancestor
64864558|NCT01779401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64864559|NCT01779401|Protective Agents|protective agents|mesh-ancestor
64864560|NCT01779401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64864561|NCT01779401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64864562|NCT01779466|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64864563|NCT01779466|Hemostatics|hemostatics|mesh-ancestor
64864564|NCT01779466|Coagulants|coagulants|mesh-ancestor
64864565|NCT01779466|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64864566|NCT01779466|Natriuretic Agents|natriuretic agents|mesh-ancestor
64864567|NCT01779466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864568|NCT01779479|Paclitaxel|paclitaxel|mesh-list
64864569|NCT01779479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64864570|NCT01779479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64864571|NCT01779479|Tubulin Modulators|tubulin modulators|mesh-ancestor
64864572|NCT01779479|Antimitotic Agents|antimitotic agents|mesh-ancestor
64864573|NCT01779479|Mitosis Modulators|mitosis modulators|mesh-ancestor
64864574|NCT01779479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332894|NCT00447772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332897|NCT00255216|Policosanol|policosanol|mesh-list
64332898|NCT00255216|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64332899|NCT00255216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64332900|NCT00255216|Antimetabolites|antimetabolites|mesh-ancestor
64332901|NCT00255216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332902|NCT00255216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64864591|NCT01779596|Bosentan|bosentan|mesh-list
64864592|NCT01779596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64864593|NCT01779596|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64864594|NCT01779596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864595|NCT01779609|Bosentan|bosentan|mesh-list
64864596|NCT01779609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64864597|NCT01779609|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64332903|NCT00255216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64332904|NCT00079066|Cetuximab|cetuximab|mesh-list
64332905|NCT00079066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64332906|NCT00079066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332907|NCT04520607|Lorecivivint|lorecivivint|mesh-list
64332908|NCT04520607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64332909|NCT04416451|Rituximab|rituximab|mesh-list
64332910|NCT04416451|Venetoclax|venetoclax|mesh-list
64864598|NCT01779609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864599|NCT01779687|Raltegravir Potassium|raltegravir potassium|mesh-list
64864600|NCT01779687|Atorvastatin|atorvastatin|mesh-list
64864601|NCT01779687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64864602|NCT01779687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64864603|NCT01779687|Antimetabolites|antimetabolites|mesh-ancestor
64864604|NCT01779687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864605|NCT01779687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64864606|NCT01779687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64864607|NCT01779687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64864614|NCT01779830|Zolpidem|zolpidem|mesh-list
64864663|NCT01780181|Docetaxel|docetaxel|mesh-list
64864664|NCT01780181|Vinorelbine|vinorelbine|mesh-list
64864674|NCT01780181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864676|NCT01780181|Antimitotic Agents|antimitotic agents|mesh-ancestor
64864677|NCT01780181|Mitosis Modulators|mitosis modulators|mesh-ancestor
64864678|NCT01780181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64864679|NCT01780233|Fentanyl|fentanyl|mesh-list
64864680|NCT01780233|Naltrexone|naltrexone|mesh-list
64864681|NCT01780233|Citric Acid|citric acid|mesh-list
64864682|NCT01780233|Sodium Citrate|sodium citrate|mesh-list
64864683|NCT01780233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64864684|NCT01780233|Narcotics|narcotics|mesh-ancestor
64864685|NCT01780233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64864686|NCT01780233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864687|NCT01780233|Analgesics|analgesics|mesh-ancestor
64864688|NCT01780233|Sensory System Agents|sensory system agents|mesh-ancestor
64864689|NCT01780233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64864690|NCT01780233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64864691|NCT01780233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64864692|NCT01780233|Anesthetics, General|anesthetics, general|mesh-ancestor
64864693|NCT01780233|Anesthetics|anesthetics|mesh-ancestor
64864694|NCT01780233|Anticoagulants|anticoagulants|mesh-ancestor
64864695|NCT01780233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64864696|NCT01780233|Chelating Agents|chelating agents|mesh-ancestor
64864697|NCT01780233|Sequestering Agents|sequestering agents|mesh-ancestor
64864698|NCT01780233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864704|NCT01780259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64864705|NCT01780259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64864706|NCT01780259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64864707|NCT01780259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64864708|NCT01780259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64864709|NCT01780259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864710|NCT01780259|GABA Modulators|gaba modulators|mesh-ancestor
64864711|NCT01780259|GABA Agents|gaba agents|mesh-ancestor
64864712|NCT01780259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64864713|NCT01780259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864714|NCT01780311|Sotalol|sotalol|mesh-list
64864715|NCT01780311|Flecainide|flecainide|mesh-list
64864716|NCT01780311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64864717|NCT01780311|Propafenone|propafenone|mesh-list
64864718|NCT01780311|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64864719|NCT01780311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64864720|NCT01780311|Adrenergic Agents|adrenergic agents|mesh-ancestor
64864721|NCT01780311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64864722|NCT01780311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864723|NCT01780311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864724|NCT01780311|Sympatholytics|sympatholytics|mesh-ancestor
64864725|NCT01780311|Autonomic Agents|autonomic agents|mesh-ancestor
64864726|NCT01780311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64864727|NCT01780311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64864728|NCT01780311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64864729|NCT01780311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64864730|NCT01780467|Dopamine|dopamine|mesh-list
64864746|NCT01780519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64864747|NCT01780519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64864748|NCT01780519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64864749|NCT01780519|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64864750|NCT01780519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64864751|NCT01780519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64864752|NCT01780519|GABA Modulators|gaba modulators|mesh-ancestor
64864753|NCT01780519|GABA Agents|gaba agents|mesh-ancestor
64864754|NCT01780519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64864755|NCT01780519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864756|NCT01780558|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64864757|NCT01780558|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64864758|NCT01780558|Hormones|hormones|mesh-list
64864759|NCT01780558|Estradiol|estradiol|mesh-list
64864760|NCT01780558|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64864761|NCT01780558|Progesterone|progesterone|mesh-list
64864762|NCT01780558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64864763|NCT01780558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864764|NCT01780558|Estrogens|estrogens|mesh-ancestor
64864766|NCT01780558|Contraceptive Agents|contraceptive agents|mesh-ancestor
64864771|NCT01780610|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64864772|NCT01780610|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64864773|NCT01780610|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64864774|NCT01780610|Hormones|hormones|mesh-list
64864775|NCT01780610|Estradiol|estradiol|mesh-list
64864776|NCT01780610|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64864777|NCT01780610|Progesterone|progesterone|mesh-list
64864778|NCT01780610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64864779|NCT01780610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864780|NCT01780610|Estrogens|estrogens|mesh-ancestor
64864895|NCT01781702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64864896|NCT01781702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64864897|NCT01781702|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64864898|NCT01781702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64864899|NCT01781702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64864902|NCT01781871|Immunologic Factors|immunologic factors|mesh-ancestor
64864938|NCT01782001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864939|NCT01782001|Antioxidants|antioxidants|mesh-ancestor
64864940|NCT01782001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864941|NCT01782001|Protective Agents|protective agents|mesh-ancestor
64864942|NCT01782001|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64864943|NCT01782001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64864944|NCT01782261|Liraglutide|liraglutide|mesh-list
64864945|NCT01782261|Saxagliptin|saxagliptin|mesh-list
64864946|NCT01782261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64864947|NCT01782261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864948|NCT01782261|Incretins|incretins|mesh-ancestor
64864949|NCT01782261|Hormones|hormones|mesh-ancestor
64864950|NCT01782261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64864951|NCT01782261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64864952|NCT01782261|Protease Inhibitors|protease inhibitors|mesh-ancestor
64864953|NCT01782261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64864954|NCT01782261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64864955|NCT01782274|Vaccines|vaccines|mesh-list
64864956|NCT01782274|Immunologic Factors|immunologic factors|mesh-ancestor
64864957|NCT01782274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864958|NCT01782287|Vaccines|vaccines|mesh-list
64864959|NCT01782287|Immunologic Factors|immunologic factors|mesh-ancestor
64864960|NCT01782287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864961|NCT01782300|Vaccines|vaccines|mesh-list
64864962|NCT01782300|Immunologic Factors|immunologic factors|mesh-ancestor
64864963|NCT01782300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64864964|NCT01782404|Chlorhexidine|chlorhexidine|mesh-list
64864965|NCT01782404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64332918|NCT04348747|Immunologic Factors|immunologic factors|mesh-ancestor
64332919|NCT04348747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295743|NCT02054299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64295744|NCT02054299|Serotonin Agents|serotonin agents|mesh-ancestor
64295745|NCT02054299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64865010|NCT01782781|Epinephrine|epinephrine|mesh-list
64865011|NCT01782781|Ropivacaine|ropivacaine|mesh-list
64865012|NCT01782781|Anesthetics, Local|anesthetics, local|mesh-ancestor
64865013|NCT01782781|Anesthetics|anesthetics|mesh-ancestor
64865014|NCT01782781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64865015|NCT01782781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865016|NCT01782781|Sensory System Agents|sensory system agents|mesh-ancestor
64865017|NCT01782781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865018|NCT01782781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64865019|NCT01782781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64865020|NCT01782781|Adrenergic Agents|adrenergic agents|mesh-ancestor
64865021|NCT01782781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64953875|NCT00035282|Aprepitant|aprepitant|mesh-list
64953923|NCT00062595|Vitamin K|vitamin k|mesh-list
64865022|NCT01782781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865023|NCT01782781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64865024|NCT01782781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64865025|NCT01782781|Autonomic Agents|autonomic agents|mesh-ancestor
64865026|NCT01782781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64865037|NCT01782846|Sensory System Agents|sensory system agents|mesh-ancestor
64865038|NCT01782846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865039|NCT01782846|Antitussive Agents|antitussive agents|mesh-ancestor
64865040|NCT01782846|Respiratory System Agents|respiratory system agents|mesh-ancestor
64865041|NCT01782911|Resveratrol|resveratrol|mesh-list
64865042|NCT01782911|Antioxidants|antioxidants|mesh-ancestor
64865043|NCT01782911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865044|NCT01782911|Protective Agents|protective agents|mesh-ancestor
64865045|NCT01782911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865046|NCT01782911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865047|NCT01782911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64865048|NCT01782924|Brodalumab|brodalumab|mesh-list
64865049|NCT01782924|Dermatologic Agents|dermatologic agents|mesh-ancestor
64865050|NCT01782937|Brodalumab|brodalumab|mesh-list
64865051|NCT01782937|Dermatologic Agents|dermatologic agents|mesh-ancestor
64865052|NCT01782950|Rifampin|rifampin|mesh-list
64865053|NCT01782950|Isoniazid|isoniazid|mesh-list
64865054|NCT01782950|Pyrazinamide|pyrazinamide|mesh-list
64865055|NCT01782950|Ethambutol|ethambutol|mesh-list
64865056|NCT01782950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64865057|NCT01782950|Antitubercular Agents|antitubercular agents|mesh-ancestor
64332934|NCT02257697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64865080|NCT01782976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865082|NCT01783002|Carbon-11 methionine|carbon-11 methionine|mesh-list
64865083|NCT01783002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64865084|NCT01783002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865086|NCT01783106|Doxycycline|doxycycline|mesh-list
64865087|NCT01783106|Ciprofloxacin|ciprofloxacin|mesh-list
64865088|NCT01783106|Budesonide|budesonide|mesh-list
64865089|NCT01783106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64865090|NCT01783106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64865091|NCT01783106|Autonomic Agents|autonomic agents|mesh-ancestor
64865199|NCT01784107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64865200|NCT01784107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865202|NCT01784120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64865203|NCT01784120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865204|NCT01784120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64865205|NCT01784120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64865206|NCT01784120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865207|NCT01784120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865208|NCT01784250|Propranolol|propranolol|mesh-list
64865209|NCT01784250|Clonidine|clonidine|mesh-list
64865210|NCT01784250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64865211|NCT01784250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64865212|NCT01784250|Adrenergic Agents|adrenergic agents|mesh-ancestor
64865213|NCT01784250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64865279|NCT01784536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64865300|NCT01784549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64865301|NCT01784549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64865303|NCT01784562|Enzyme Activators|enzyme activators|mesh-ancestor
64865304|NCT01784562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865306|NCT01784640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865307|NCT01784640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865308|NCT01784640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865309|NCT01784640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64865310|NCT01784640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64865311|NCT01784718|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64865312|NCT01784718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865313|NCT01784900|Catumaxomab|catumaxomab|mesh-list
64865314|NCT01784900|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64865315|NCT01784900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64865316|NCT01784900|Immunologic Factors|immunologic factors|mesh-ancestor
64865317|NCT01784900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865318|NCT01784913|Sargramostim|sargramostim|mesh-list
64865319|NCT01784913|Immunologic Factors|immunologic factors|mesh-ancestor
64865320|NCT01784913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865321|NCT01784978|Everolimus|everolimus|mesh-list
64865322|NCT01784978|Sunitinib|sunitinib|mesh-list
64865323|NCT01784978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865324|NCT01784978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64865325|NCT01784978|Immunologic Factors|immunologic factors|mesh-ancestor
64295756|NCT02054299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64295757|NCT02054299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64295758|NCT02054299|Adrenergic Agents|adrenergic agents|mesh-ancestor
64295759|NCT02054299|Vitamin B Complex|vitamin b complex|mesh-ancestor
64295761|NCT02054299|Micronutrients|micronutrients|mesh-ancestor
64295762|NCT02054299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64865416|NCT01785446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64865417|NCT01785446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865418|NCT01785446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64865419|NCT01785446|Narcotics|narcotics|mesh-ancestor
64865420|NCT01785446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64332968|NCT03528421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64332969|NCT03528421|Alkylating Agents|alkylating agents|mesh-ancestor
64332970|NCT03528421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332971|NCT03528421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865421|NCT01785446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64865423|NCT01785446|Anesthetics|anesthetics|mesh-ancestor
64295765|NCT02054299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64865424|NCT01785446|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64865441|NCT01785589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865443|NCT01785641|Ciprofloxacin|ciprofloxacin|mesh-list
64865444|NCT01785641|Gentamicins|gentamicins|mesh-list
64865445|NCT01785641|Cefazolin|cefazolin|mesh-list
64865446|NCT01785641|Ceftazidime|ceftazidime|mesh-list
64865447|NCT01785641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64865448|NCT01785641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64865449|NCT01785641|Antitubercular Agents|antitubercular agents|mesh-ancestor
64865450|NCT01785641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64865451|NCT01785641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64865452|NCT01785641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865453|NCT01785641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865465|NCT01785693|Sympatholytics|sympatholytics|mesh-ancestor
64865466|NCT01785693|Autonomic Agents|autonomic agents|mesh-ancestor
64865467|NCT01785693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64865468|NCT01785693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64865469|NCT01785693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64865470|NCT01785693|Adrenergic Agents|adrenergic agents|mesh-ancestor
64865471|NCT01785693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64865472|NCT01785693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865473|NCT01785693|Anesthetics, Local|anesthetics, local|mesh-ancestor
64865475|NCT01785693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64865476|NCT01785797|Silicon|silicon|mesh-list
64865477|NCT01785797|Trace Elements|trace elements|mesh-ancestor
64865478|NCT01785797|Micronutrients|micronutrients|mesh-ancestor
64865479|NCT01785797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865480|NCT01785836|Dapsone|dapsone|mesh-list
64865482|NCT01785836|Antimalarials|antimalarials|mesh-ancestor
64865506|NCT01785979|Glucocorticoids|glucocorticoids|mesh-ancestor
64865507|NCT01785979|Hormones|hormones|mesh-ancestor
64865508|NCT01785979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64865509|NCT01785979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865510|NCT01785979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64865511|NCT01785979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865512|NCT01785979|Amebicides|amebicides|mesh-ancestor
64865513|NCT01785979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64865514|NCT01785979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64865515|NCT01785979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64865516|NCT01785979|Antimalarials|antimalarials|mesh-ancestor
64865517|NCT01785979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64865518|NCT01785979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64865528|NCT01786018|Busulfan|busulfan|mesh-list
64865529|NCT01786018|Thiotepa|thiotepa|mesh-list
64865530|NCT01786018|Cyclosporins|cyclosporins|mesh-list
64865531|NCT01786018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64865532|NCT01786018|Abortifacient Agents|abortifacient agents|mesh-ancestor
64865533|NCT01786018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64865534|NCT01786018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865535|NCT01786018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64865536|NCT01786018|Antimetabolites|antimetabolites|mesh-ancestor
64865537|NCT01786018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865538|NCT01786018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865539|NCT01786018|Dermatologic Agents|dermatologic agents|mesh-ancestor
64865540|NCT01786018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865541|NCT01786018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64865542|NCT01786018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64865543|NCT01786018|Immunologic Factors|immunologic factors|mesh-ancestor
64865544|NCT01786018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64865545|NCT01786018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64865546|NCT01786018|Antifungal Agents|antifungal agents|mesh-ancestor
64865547|NCT01786018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64865548|NCT01786018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64865549|NCT01786018|Alkylating Agents|alkylating agents|mesh-ancestor
64865550|NCT01786018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64865551|NCT01786018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64865552|NCT01786070|Budesonide|budesonide|mesh-list
64865553|NCT01786070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64865554|NCT01786070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64865555|NCT01786070|Autonomic Agents|autonomic agents|mesh-ancestor
64634123|NCT04662710|Pembrolizumab|pembrolizumab|mesh-list
64865556|NCT01786070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64332977|NCT02374047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332978|NCT02374047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64332979|NCT02374047|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64332980|NCT02374047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64332981|NCT02203253|Thalidomide|thalidomide|mesh-list
64332982|NCT02203253|Dexamethasone|dexamethasone|mesh-list
64332983|NCT02203253|Palonosetron|palonosetron|mesh-list
64865557|NCT01786070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865558|NCT01786070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64865559|NCT01786070|Respiratory System Agents|respiratory system agents|mesh-ancestor
64865560|NCT01786070|Glucocorticoids|glucocorticoids|mesh-ancestor
64865562|NCT01786070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64865563|NCT01786200|Aspirin|aspirin|mesh-list
64865564|NCT01786200|Ibuprofen|ibuprofen|mesh-list
64865565|NCT01786200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64865566|NCT01786200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64865567|NCT01786200|Analgesics|analgesics|mesh-ancestor
64865568|NCT01786200|Sensory System Agents|sensory system agents|mesh-ancestor
64865569|NCT01786200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865570|NCT01786200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865571|NCT01786200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64865572|NCT01786200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64865573|NCT01786200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64865574|NCT01786200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64865575|NCT01786200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865576|NCT01786200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64865577|NCT01786200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64865578|NCT01786200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865579|NCT01786200|Antipyretics|antipyretics|mesh-ancestor
64865580|NCT01786226|Mifepristone|mifepristone|mesh-list
64865581|NCT01786226|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64865582|NCT01786226|Abortifacient Agents|abortifacient agents|mesh-ancestor
64865583|NCT01786226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64865584|NCT01786226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865585|NCT01786226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64865586|NCT01786226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64865587|NCT01786226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64865588|NCT01786226|Contraceptive Agents|contraceptive agents|mesh-ancestor
64865598|NCT01786382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64865599|NCT01786382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64865600|NCT01786382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64865601|NCT01786382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865602|NCT01786382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64865603|NCT01786382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64865604|NCT01786382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64865605|NCT01786382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64865606|NCT01786382|Anesthetics, General|anesthetics, general|mesh-ancestor
64865607|NCT01786382|Anesthetics|anesthetics|mesh-ancestor
64865608|NCT01786382|GABA Modulators|gaba modulators|mesh-ancestor
64865609|NCT01786382|GABA Agents|gaba agents|mesh-ancestor
64865610|NCT01786382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64865611|NCT01786382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865612|NCT01786382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64865613|NCT01786382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64865614|NCT01786382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64865615|NCT01786382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64865616|NCT01786395|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
64865617|NCT01786395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64865618|NCT01786538|Leucovorin|leucovorin|mesh-list
64865619|NCT01786538|Fluorouracil|fluorouracil|mesh-list
64865620|NCT01786538|Oxaliplatin|oxaliplatin|mesh-list
64865621|NCT01786538|Antimetabolites|antimetabolites|mesh-ancestor
64865622|NCT01786538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865623|NCT01786538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64865624|NCT01786538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865625|NCT01786538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64865626|NCT01786538|Immunologic Factors|immunologic factors|mesh-ancestor
64332984|NCT02203253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64865676|NCT01787123|Protective Agents|protective agents|mesh-ancestor
64865677|NCT01787123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865678|NCT01787123|Nootropic Agents|nootropic agents|mesh-ancestor
64865679|NCT01787136|Dextromethorphan|dextromethorphan|mesh-list
64865680|NCT01787136|Antitussive Agents|antitussive agents|mesh-ancestor
64865681|NCT01787136|Respiratory System Agents|respiratory system agents|mesh-ancestor
64865682|NCT01787136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64865684|NCT01787136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64865685|NCT01787136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865686|NCT01787136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865687|NCT01787344|Botulinum Toxins|botulinum toxins|mesh-list
64865688|NCT01787344|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64865689|NCT01787344|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64865690|NCT01787344|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64865691|NCT01787344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64865692|NCT01787344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865747|NCT01787669|Glucocorticoids|glucocorticoids|mesh-ancestor
64865748|NCT01787669|Hormones|hormones|mesh-ancestor
64865749|NCT01787669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64865750|NCT01787669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64865751|NCT01788007|Imiquimod|imiquimod|mesh-list
64865752|NCT01788007|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64865753|NCT01788007|Immunologic Factors|immunologic factors|mesh-ancestor
64865754|NCT01788007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865755|NCT01788007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865756|NCT01788007|Interferon Inducers|interferon inducers|mesh-ancestor
64865757|NCT01788072|Oxytocin|oxytocin|mesh-list
64865758|NCT01788072|Oxytocics|oxytocics|mesh-ancestor
64865759|NCT01788072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64865760|NCT01788072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865761|NCT01788176|Zoledronic Acid|zoledronic acid|mesh-list
64865782|NCT01788254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64865783|NCT01788254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64865784|NCT01788254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64865785|NCT01788254|Anesthetics, General|anesthetics, general|mesh-ancestor
64865786|NCT01788254|Anesthetics|anesthetics|mesh-ancestor
64865787|NCT01788254|GABA Modulators|gaba modulators|mesh-ancestor
64865788|NCT01788254|GABA Agents|gaba agents|mesh-ancestor
64865789|NCT01788254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64865790|NCT01788254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64865791|NCT01788254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64865792|NCT01788254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64865793|NCT01788254|Antimetabolites|antimetabolites|mesh-ancestor
64865807|NCT01788254|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64865808|NCT01788254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64865809|NCT01788254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64865810|NCT01788254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64865811|NCT01788254|Adrenergic Agents|adrenergic agents|mesh-ancestor
64865812|NCT01788254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64865813|NCT01788280|Bevacizumab|bevacizumab|mesh-list
64865814|NCT01788280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64865815|NCT01788280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332992|NCT02203253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64332993|NCT02203253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64332994|NCT02203253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865893|NCT01788722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64865894|NCT01788722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865895|NCT01788722|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64865896|NCT01788722|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64865897|NCT01788722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64865898|NCT01788722|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64505871|NCT03322878|Anticonvulsants|anticonvulsants|mesh-ancestor
64865899|NCT01788722|Hormone Antagonists|hormone antagonists|mesh-ancestor
64865900|NCT01788722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64865901|NCT01788722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64865902|NCT01788722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64865903|NCT01788774|Risperidone|risperidone|mesh-list
64865904|NCT01788774|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64295787|NCT02058823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64333025|NCT01838187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333027|NCT02296138|Tiotropium Bromide|tiotropium bromide|mesh-list
64333028|NCT02296138|Olodaterol|olodaterol|mesh-list
64333029|NCT02296138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64865911|NCT01788774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64865912|NCT01788774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64865913|NCT01788774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64865915|NCT01788969|Citalopram|citalopram|mesh-list
64865916|NCT01788969|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64865917|NCT01788969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64865918|NCT01788969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64865919|NCT01788969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333030|NCT02296138|Autonomic Agents|autonomic agents|mesh-ancestor
64333031|NCT02296138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64333032|NCT02296138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333033|NCT02296138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64333034|NCT02296138|Respiratory System Agents|respiratory system agents|mesh-ancestor
64333035|NCT02296138|Parasympatholytics|parasympatholytics|mesh-ancestor
64333036|NCT02296138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64865986|NCT01789294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64865988|NCT01789294|Analgesics|analgesics|mesh-ancestor
64865989|NCT01789294|Sensory System Agents|sensory system agents|mesh-ancestor
64865990|NCT01789294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64865991|NCT01789294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865992|NCT01789294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64505921|NCT03322488|Doxycycline|doxycycline|mesh-list
64865993|NCT01789294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64865994|NCT01789385|Dexmedetomidine|dexmedetomidine|mesh-list
64865995|NCT01789385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64865996|NCT01789385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64865997|NCT01789385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64865998|NCT01789385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64866000|NCT01789385|Sensory System Agents|sensory system agents|mesh-ancestor
64866001|NCT01789385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64866101|NCT01789892|Glucocorticoids|glucocorticoids|mesh-ancestor
64866102|NCT01789892|Hormones|hormones|mesh-ancestor
64866103|NCT01789892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64333115|NCT03533387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64333116|NCT03533387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333117|NCT03533387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64333118|NCT03533387|Respiratory System Agents|respiratory system agents|mesh-ancestor
64333119|NCT03533387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64333120|NCT03533387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866107|NCT01789892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866108|NCT01789892|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64506452|NCT02486640|Interferon beta-1b|interferon beta-1b|mesh-list
64866109|NCT01789892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866110|NCT01789957|Exenatide|exenatide|mesh-list
64866111|NCT01789957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64866112|NCT01789957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866113|NCT01789957|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64866114|NCT01789957|Incretins|incretins|mesh-ancestor
64866115|NCT01789957|Hormones|hormones|mesh-ancestor
64866116|NCT01789957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64333121|NCT03533387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333122|NCT03533387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64333123|NCT03533387|Vasodilator Agents|vasodilator agents|mesh-ancestor
64333124|NCT02324842|Liraglutide|liraglutide|mesh-list
64866210|NCT01794247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64866211|NCT01794429|Exenatide|exenatide|mesh-list
64866212|NCT01794429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64866213|NCT01794429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866214|NCT01794429|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64866215|NCT01794429|Incretins|incretins|mesh-ancestor
64866216|NCT01794429|Hormones|hormones|mesh-ancestor
64866217|NCT01794429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64866218|NCT01795248|Liraglutide|liraglutide|mesh-list
64866219|NCT01795248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64866220|NCT01795248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866221|NCT01795248|Incretins|incretins|mesh-ancestor
64866222|NCT01795248|Hormones|hormones|mesh-ancestor
64866223|NCT01795248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64866224|NCT01796132|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64866225|NCT01796132|Fluvoxamine|fluvoxamine|mesh-list
64866226|NCT01796132|Citalopram|citalopram|mesh-list
64866227|NCT01796132|Fluoxetine|fluoxetine|mesh-list
64866228|NCT01796132|Paroxetine|paroxetine|mesh-list
64866229|NCT01796132|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64866230|NCT01796132|Sertraline|sertraline|mesh-list
64866231|NCT01796132|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64506692|NCT01769170|Cidofovir|cidofovir|mesh-list
64866232|NCT01796132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64866234|NCT01796132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866236|NCT01796132|Serotonin Agents|serotonin agents|mesh-ancestor
64866237|NCT01796132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866238|NCT01796132|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64866239|NCT01796132|Antidepressive Agents|antidepressive agents|mesh-ancestor
64866240|NCT01796132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64866241|NCT01796132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64866242|NCT01796132|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64866243|NCT01796132|Analgesics|analgesics|mesh-ancestor
64866244|NCT01796132|Sensory System Agents|sensory system agents|mesh-ancestor
64866333|NCT01798446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866336|NCT01798680|Vitamins|vitamins|mesh-ancestor
64866337|NCT01798680|Micronutrients|micronutrients|mesh-ancestor
64866338|NCT01798680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866339|NCT01798680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64866340|NCT01798680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64866341|NCT01798836|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64866342|NCT01798836|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64866343|NCT01798836|Estradiol|estradiol|mesh-list
64866344|NCT01798836|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64866345|NCT01798836|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64866346|NCT01798836|Estrogens|estrogens|mesh-ancestor
64295846|NCT01217931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64866347|NCT01798836|Hormones|hormones|mesh-ancestor
64866348|NCT01798836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64866349|NCT01798836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866350|NCT01798836|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64866351|NCT01798836|Contraceptive Agents|contraceptive agents|mesh-ancestor
64866352|NCT01798836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64866353|NCT01798836|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64866354|NCT01798901|Decitabine|decitabine|mesh-list
64866355|NCT01798901|Azacitidine|azacitidine|mesh-list
64295847|NCT01217931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295848|NCT01217931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64295849|NCT01217931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64295850|NCT01217931|Growth Substances|growth substances|mesh-ancestor
64295851|NCT01217931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866379|NCT01799863|Laxatives|laxatives|mesh-ancestor
64333213|NCT03533231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64866406|NCT01800097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866407|NCT01800227|Metformin|metformin|mesh-list
64866408|NCT01800227|Pioglitazone|pioglitazone|mesh-list
64866451|NCT01800435|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
64866453|NCT01800435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64866454|NCT01800435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866456|NCT01800435|Coagulants|coagulants|mesh-ancestor
64866457|NCT01800487|Silymarin|silymarin|mesh-list
64866458|NCT01800487|Antioxidants|antioxidants|mesh-ancestor
64295870|NCT03810807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295872|NCT02058199|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64295873|NCT02058199|Antithrombins|antithrombins|mesh-ancestor
64295874|NCT02058199|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64866510|NCT01800708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866511|NCT01800708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64866512|NCT01800708|Immunologic Factors|immunologic factors|mesh-ancestor
64866513|NCT01800708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866514|NCT01800708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866515|NCT01800747|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64866516|NCT01800747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64866517|NCT01800799|Anti-Infective Agents|anti-infective agents|mesh-list
64333258|NCT02852057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333259|NCT02852057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64333260|NCT02852057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64333261|NCT02852057|Adrenergic Agents|adrenergic agents|mesh-ancestor
64333262|NCT02852057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64333263|NCT02852057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333264|NCT02852057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64333265|NCT02852057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64333266|NCT02852057|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64333268|NCT04020445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64333269|NCT04020445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333270|NCT03524833|Amoxicillin|amoxicillin|mesh-list
64333271|NCT03524833|Metronidazole|metronidazole|mesh-list
64333272|NCT03524833|Lansoprazole|lansoprazole|mesh-list
64333273|NCT03524833|Dexlansoprazole|dexlansoprazole|mesh-list
64333274|NCT03524833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64333275|NCT03524833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64333276|NCT03524833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64333277|NCT03524833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64333278|NCT03524833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64333279|NCT03524833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64333280|NCT03524833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64333281|NCT03524833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295884|NCT02058277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64295885|NCT02058277|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64295886|NCT02058277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64295887|NCT02058277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295888|NCT04813562|Vaccines|vaccines|mesh-list
64295889|NCT04813562|Immunologic Factors|immunologic factors|mesh-ancestor
64295890|NCT04813562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295891|NCT03314025|Tamsulosin|tamsulosin|mesh-list
64295892|NCT03314025|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64295893|NCT03314025|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64866541|NCT01800942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64866543|NCT01801046|Mitoxantrone|mitoxantrone|mesh-list
64866544|NCT01801046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64866545|NCT01801046|Antimetabolites|antimetabolites|mesh-ancestor
64866546|NCT01801046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866547|NCT01801046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866548|NCT01801046|Antiviral Agents|antiviral agents|mesh-ancestor
64866549|NCT01801046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64866550|NCT01801046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64866551|NCT01801046|Immunologic Factors|immunologic factors|mesh-ancestor
64866552|NCT01801046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866553|NCT01801046|Analgesics|analgesics|mesh-ancestor
64866554|NCT01801046|Sensory System Agents|sensory system agents|mesh-ancestor
64506988|NCT02475876|Clindamycin|clindamycin|mesh-list
64866555|NCT01801046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64866556|NCT01801046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64866557|NCT01801046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64866558|NCT01801046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866559|NCT01801137|Everolimus|everolimus|mesh-list
64866560|NCT01801137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866561|NCT01801137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64866562|NCT01801137|Immunologic Factors|immunologic factors|mesh-ancestor
64866563|NCT01801137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866564|NCT01801163|Sorafenib|sorafenib|mesh-list
64866565|NCT01801163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866566|NCT01801163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64333308|NCT02209025|Theobromine|theobromine|mesh-list
64333309|NCT02209025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64333310|NCT02209025|Autonomic Agents|autonomic agents|mesh-ancestor
64333311|NCT02209025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64333312|NCT02209025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866567|NCT01801163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866568|NCT01801163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866569|NCT01801228|Eplerenone|eplerenone|mesh-list
64866570|NCT01801228|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64866571|NCT01801228|Hormone Antagonists|hormone antagonists|mesh-ancestor
64866572|NCT01801228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64866686|NCT01802593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64866687|NCT01802593|Abortifacient Agents|abortifacient agents|mesh-ancestor
64866688|NCT01802593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64866689|NCT01802593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866690|NCT01802593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64866691|NCT01802593|Antimetabolites|antimetabolites|mesh-ancestor
64866704|NCT01802619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64866705|NCT01802619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866706|NCT01802619|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64866707|NCT01802619|Respiratory System Agents|respiratory system agents|mesh-ancestor
64866708|NCT01802619|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64866709|NCT01802619|Antioxidants|antioxidants|mesh-ancestor
64866710|NCT01802619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866711|NCT01802619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64866712|NCT01802619|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64866713|NCT01802619|Vasodilator Agents|vasodilator agents|mesh-ancestor
64866714|NCT01802619|Gasotransmitters|gasotransmitters|mesh-ancestor
64866715|NCT01802619|Protective Agents|protective agents|mesh-ancestor
64866716|NCT01802645|Leucovorin|leucovorin|mesh-list
64866717|NCT01802645|Folic Acid|folic acid|mesh-list
64866718|NCT01802645|Bevacizumab|bevacizumab|mesh-list
64866719|NCT01802645|Cetuximab|cetuximab|mesh-list
64866720|NCT01802645|Fluorouracil|fluorouracil|mesh-list
64333342|NCT04972123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64333343|NCT04972123|Nasal Decongestants|nasal decongestants|mesh-ancestor
64333344|NCT04972123|Respiratory System Agents|respiratory system agents|mesh-ancestor
64333345|NCT04972123|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64333346|NCT04972123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64333347|NCT04972123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64333348|NCT04972123|Adrenergic Agents|adrenergic agents|mesh-ancestor
64333349|NCT04972123|Protective Agents|protective agents|mesh-ancestor
64333350|NCT04972123|Antipruritics|antipruritics|mesh-ancestor
64333351|NCT04972123|Dermatologic Agents|dermatologic agents|mesh-ancestor
64333352|NCT04972123|Sensory System Agents|sensory system agents|mesh-ancestor
64333353|NCT02322892|Thiamine|thiamine|mesh-list
64333354|NCT02322892|Vitamins|vitamins|mesh-ancestor
64866806|NCT01803087|Autonomic Agents|autonomic agents|mesh-ancestor
64866807|NCT01803087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64333360|NCT03274375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866827|NCT01803191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64866828|NCT01803321|Rilonacept|rilonacept|mesh-list
64866829|NCT01803321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64866830|NCT01803347|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64866831|NCT01803347|Hemostatics|hemostatics|mesh-ancestor
64866832|NCT01803347|Coagulants|coagulants|mesh-ancestor
64866833|NCT01803399|Moxifloxacin|moxifloxacin|mesh-list
64866834|NCT01803399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64866835|NCT01803399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64866836|NCT01803399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64866879|NCT01804127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64866880|NCT01804127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64866881|NCT01804127|Immunologic Factors|immunologic factors|mesh-ancestor
64866882|NCT01804127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866883|NCT01804127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64866884|NCT01804205|Magnesium Sulfate|magnesium sulfate|mesh-list
64866885|NCT01804205|Analgesics|analgesics|mesh-ancestor
64866886|NCT01804205|Sensory System Agents|sensory system agents|mesh-ancestor
64507276|NCT01847638|Analgesics|analgesics|mesh-ancestor
64866887|NCT01804205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64866888|NCT01804205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866889|NCT01804205|Anesthetics|anesthetics|mesh-ancestor
64866890|NCT01804205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64866891|NCT01804205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64866905|NCT01804218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866906|NCT01804218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64866907|NCT01804218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64866908|NCT01804218|Sympatholytics|sympatholytics|mesh-ancestor
64866909|NCT01804218|Autonomic Agents|autonomic agents|mesh-ancestor
64866910|NCT01804218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64866911|NCT01804244|Rilpivirine|rilpivirine|mesh-list
64866912|NCT01804244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64866941|NCT01804374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64866942|NCT01804374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866944|NCT01804387|Adefovir|adefovir|mesh-list
64866945|NCT01804387|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64333372|NCT03088813|Irinotecan|irinotecan|mesh-list
64295929|NCT01673984|Goserelin|goserelin|mesh-list
64295930|NCT01673984|Luteolytic Agents|luteolytic agents|mesh-ancestor
64295931|NCT01673984|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64295932|NCT01673984|Contraceptive Agents|contraceptive agents|mesh-ancestor
64295933|NCT01673984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64507315|NCT05328310|Nebivolol|nebivolol|mesh-list
64295934|NCT01673984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295935|NCT01673984|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64333373|NCT03088813|Topotecan|topotecan|mesh-list
64333374|NCT03088813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64866958|NCT01804400|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64866959|NCT01804400|Hormone Antagonists|hormone antagonists|mesh-ancestor
64866960|NCT01804400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64866961|NCT01804400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64866962|NCT01804400|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64866963|NCT01804400|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64866964|NCT01804400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64866965|NCT01804413|Insulin|insulin|mesh-list
64866966|NCT01804413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64866967|NCT01804413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64867028|NCT01805232|Sensory System Agents|sensory system agents|mesh-ancestor
64867029|NCT01805258|Efavirenz|efavirenz|mesh-list
64867030|NCT01805258|Nevirapine|nevirapine|mesh-list
64867031|NCT01805258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64867032|NCT01805258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64867033|NCT01805258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867034|NCT01805258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867035|NCT01805258|Antiviral Agents|antiviral agents|mesh-ancestor
64867036|NCT01805258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867037|NCT01805258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64867038|NCT01805258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64867039|NCT01805258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64867054|NCT01807741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867055|NCT01807741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64867056|NCT01807767|Mycophenolic Acid|mycophenolic acid|mesh-list
64507407|NCT01856530|Oxytocics|oxytocics|mesh-ancestor
64867057|NCT01807767|Everolimus|everolimus|mesh-list
64867058|NCT01807767|Tacrolimus|tacrolimus|mesh-list
64867059|NCT01807767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64867060|NCT01807767|Immunologic Factors|immunologic factors|mesh-ancestor
64867061|NCT01807767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295938|NCT03313791|Caseins|caseins|mesh-list
64295939|NCT03313791|Chelating Agents|chelating agents|mesh-ancestor
64295940|NCT03313791|Sequestering Agents|sequestering agents|mesh-ancestor
64295941|NCT03313791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295942|NCT03310047|Lidocaine|lidocaine|mesh-list
64295943|NCT03310047|Anesthetics, Local|anesthetics, local|mesh-ancestor
64295944|NCT03310047|Anesthetics|anesthetics|mesh-ancestor
64295945|NCT03310047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64295946|NCT03310047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867075|NCT01807832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64867076|NCT01807832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867078|NCT01807910|Lipotropic Agents|lipotropic agents|mesh-ancestor
64867079|NCT01807910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64867080|NCT01807910|Antimetabolites|antimetabolites|mesh-ancestor
64867081|NCT01807910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867082|NCT01807910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64867083|NCT01807910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64867084|NCT01807910|Nootropic Agents|nootropic agents|mesh-ancestor
64867085|NCT01807962|Lidocaine|lidocaine|mesh-list
64867086|NCT01807962|Anesthetics, Local|anesthetics, local|mesh-ancestor
64867087|NCT01807962|Anesthetics|anesthetics|mesh-ancestor
64867088|NCT01807962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64867089|NCT01807962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867090|NCT01807962|Sensory System Agents|sensory system agents|mesh-ancestor
64867091|NCT01807962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64867092|NCT01807962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64867093|NCT01807962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64867094|NCT01807962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64867095|NCT01807962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64867096|NCT01807962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867097|NCT01808014|Nefopam|nefopam|mesh-list
64867098|NCT01808014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64867099|NCT01808014|Analgesics|analgesics|mesh-ancestor
64867100|NCT01808014|Sensory System Agents|sensory system agents|mesh-ancestor
64867101|NCT01808014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64867102|NCT01808014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867103|NCT01808131|Lesinurad|lesinurad|mesh-list
64867104|NCT01808131|Gout Suppressants|gout suppressants|mesh-ancestor
64867105|NCT01808131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64295947|NCT03310047|Sensory System Agents|sensory system agents|mesh-ancestor
64295948|NCT03310047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64295949|NCT03310047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64295950|NCT03310047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64295951|NCT03310047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64295952|NCT03310047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64295961|NCT03313479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64295962|NCT03313479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64295963|NCT03313479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295964|NCT03313479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64295966|NCT03313479|Sensory System Agents|sensory system agents|mesh-ancestor
64867185|NCT01808638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64867186|NCT01808638|Immunologic Factors|immunologic factors|mesh-ancestor
64867187|NCT01808638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867188|NCT01808768|Alcaftadine|alcaftadine|mesh-list
64867189|NCT01808768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64867190|NCT01808768|Histamine Antagonists|histamine antagonists|mesh-ancestor
64867191|NCT01808768|Histamine Agents|histamine agents|mesh-ancestor
64867192|NCT01808768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64867193|NCT01808768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867194|NCT01808768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867195|NCT01808898|Bupivacaine|bupivacaine|mesh-list
64867196|NCT01808898|Anesthetics, Local|anesthetics, local|mesh-list
64867197|NCT01808898|Mepivacaine|mepivacaine|mesh-list
64867198|NCT01808898|Anesthetics|anesthetics|mesh-list
64867199|NCT01808898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64867200|NCT01808898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295967|NCT03313479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64295968|NCT03313479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64295969|NCT03313479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64295970|NCT03313479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64295971|NCT03313479|Adrenergic Agents|adrenergic agents|mesh-ancestor
64295983|NCT03313401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295984|NCT03313401|Growth Inhibitors|growth inhibitors|mesh-ancestor
64867315|NCT01809743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64867316|NCT01809743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867317|NCT01809743|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64867318|NCT01809847|Ofatumumab|ofatumumab|mesh-list
64867319|NCT01809847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867320|NCT01809860|Sirolimus|sirolimus|mesh-list
64867321|NCT01809860|Isavuconazole|isavuconazole|mesh-list
64867322|NCT01809860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64867323|NCT01809860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867324|NCT01809860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64867325|NCT01809860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867326|NCT01809860|Antifungal Agents|antifungal agents|mesh-ancestor
64867327|NCT01809860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64867328|NCT01809860|Immunologic Factors|immunologic factors|mesh-ancestor
64867329|NCT01809860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867369|NCT01810367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64867371|NCT01810367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867372|NCT01810367|Antiviral Agents|antiviral agents|mesh-ancestor
64867373|NCT01810367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867414|NCT01810458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64867416|NCT01810458|Hematinics|hematinics|mesh-ancestor
64867417|NCT01810458|Antiemetics|antiemetics|mesh-ancestor
64867418|NCT01810458|Autonomic Agents|autonomic agents|mesh-ancestor
64867419|NCT01810458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64867420|NCT01810458|Antipruritics|antipruritics|mesh-ancestor
64867421|NCT01810458|Dermatologic Agents|dermatologic agents|mesh-ancestor
64867422|NCT01810458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64867423|NCT01810458|Serotonin Agents|serotonin agents|mesh-ancestor
64867424|NCT01810458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64867425|NCT01810458|Anticonvulsants|anticonvulsants|mesh-ancestor
64867426|NCT01810458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64867427|NCT01810458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64867429|NCT01810549|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64867430|NCT01810549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64867431|NCT01810601|Progesterone|progesterone|mesh-list
64867432|NCT01810601|Progestins|progestins|mesh-ancestor
64867434|NCT01810601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64867435|NCT01810601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867436|NCT01810640|Liver Extracts|liver extracts|mesh-list
64867437|NCT01810640|Hematinics|hematinics|mesh-ancestor
64295997|NCT03313323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64295998|NCT03313323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295999|NCT03313323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64867438|NCT01810731|Vaccines|vaccines|mesh-list
64867464|NCT01810887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64867466|NCT01810887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867467|NCT01810887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867468|NCT01810887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64867469|NCT01810887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64867470|NCT01810887|Antiviral Agents|antiviral agents|mesh-ancestor
64867471|NCT01810887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867472|NCT01810887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64867473|NCT01810887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64867474|NCT01810926|Cyclosporine|cyclosporine|mesh-list
64867475|NCT01810926|Rituximab|rituximab|mesh-list
64867476|NCT01810926|Methotrexate|methotrexate|mesh-list
64867477|NCT01810926|Fludarabine|fludarabine|mesh-list
64867478|NCT01810926|Thiotepa|thiotepa|mesh-list
64867479|NCT01810926|Treosulfan|treosulfan|mesh-list
64867480|NCT01810926|Antibodies|antibodies|mesh-list
64867481|NCT01810926|Cyclosporins|cyclosporins|mesh-list
64507654|NCT04807894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867482|NCT01810926|Immunologic Factors|immunologic factors|mesh-ancestor
64867483|NCT01810926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867497|NCT01810926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64867498|NCT01810926|Antifungal Agents|antifungal agents|mesh-ancestor
64867499|NCT01810926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867500|NCT01810926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64867501|NCT01810926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64867502|NCT01810926|Alkylating Agents|alkylating agents|mesh-ancestor
64867503|NCT01810926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64867505|NCT01811056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64867506|NCT01811056|Abortifacient Agents|abortifacient agents|mesh-ancestor
64867507|NCT01811056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64867512|NCT01811056|Contraceptive Agents|contraceptive agents|mesh-ancestor
64867513|NCT01811056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64867514|NCT01811056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64867515|NCT01811056|Hormone Antagonists|hormone antagonists|mesh-ancestor
64867516|NCT01811056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64867517|NCT01811056|Luteolytic Agents|luteolytic agents|mesh-ancestor
64867518|NCT01811056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64867519|NCT01811056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64867520|NCT01811160|Melatonin|melatonin|mesh-list
64867521|NCT01811160|Antioxidants|antioxidants|mesh-ancestor
64867522|NCT01811160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867523|NCT01811160|Protective Agents|protective agents|mesh-ancestor
64867524|NCT01811160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867525|NCT01811160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64867526|NCT01811251|Dexamethasone|dexamethasone|mesh-list
64867527|NCT01811251|Pregabalin|pregabalin|mesh-list
64867528|NCT01811251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64867529|NCT01811251|Antiemetics|antiemetics|mesh-ancestor
64867530|NCT01811251|Autonomic Agents|autonomic agents|mesh-ancestor
64867533|NCT01811251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64867534|NCT01811251|Glucocorticoids|glucocorticoids|mesh-ancestor
64867535|NCT01811251|Hormones|hormones|mesh-ancestor
64867536|NCT01811251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64867537|NCT01811251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64867538|NCT01811251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867539|NCT01811251|Analgesics|analgesics|mesh-ancestor
64867540|NCT01811251|Sensory System Agents|sensory system agents|mesh-ancestor
64867541|NCT01811251|Anticonvulsants|anticonvulsants|mesh-ancestor
64867542|NCT01811251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64867543|NCT01811251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64867544|NCT01811251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867545|NCT01811251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64867546|NCT01811251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64867547|NCT01811251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64507728|NCT05747326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867548|NCT01811251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64867549|NCT01811251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64867550|NCT01811277|Oxaliplatin|oxaliplatin|mesh-list
64867551|NCT01811277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867552|NCT01811381|Curcumin|curcumin|mesh-list
64867553|NCT01811381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64867554|NCT01811381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64867555|NCT01811381|Analgesics|analgesics|mesh-ancestor
64867556|NCT01811381|Sensory System Agents|sensory system agents|mesh-ancestor
64867557|NCT01811381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64867576|NCT01811459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64296002|NCT05302232|Methylprednisolone|methylprednisolone|mesh-list
64296003|NCT05302232|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64296004|NCT05302232|Prednisolone|prednisolone|mesh-list
64296005|NCT05302232|Prednisolone acetate|prednisolone acetate|mesh-list
64296006|NCT05302232|Lidocaine|lidocaine|mesh-list
64296007|NCT05302232|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64296008|NCT05302232|Prednisolone phosphate|prednisolone phosphate|mesh-list
64296009|NCT05302232|Anesthetics, Local|anesthetics, local|mesh-ancestor
64296010|NCT05302232|Anesthetics|anesthetics|mesh-ancestor
64296011|NCT05302232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64296012|NCT05302232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296013|NCT05302232|Sensory System Agents|sensory system agents|mesh-ancestor
64296014|NCT05302232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64867624|NCT01812018|Antimitotic Agents|antimitotic agents|mesh-ancestor
64867625|NCT01812018|Mitosis Modulators|mitosis modulators|mesh-ancestor
64867626|NCT01812018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64867627|NCT01812018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64867628|NCT01812018|Growth Substances|growth substances|mesh-ancestor
64867629|NCT01812018|Growth Inhibitors|growth inhibitors|mesh-ancestor
64867630|NCT01812096|Bortezomib|bortezomib|mesh-list
64867631|NCT01812096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867632|NCT01812122|Glimepiride|glimepiride|mesh-list
64867633|NCT01812122|Vildagliptin|vildagliptin|mesh-list
64867634|NCT01812122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64867635|NCT01812122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64867643|NCT01812135|Vaccines|vaccines|mesh-list
64296022|NCT05302232|Autonomic Agents|autonomic agents|mesh-ancestor
64867644|NCT01812135|Immunologic Factors|immunologic factors|mesh-ancestor
64867645|NCT01812135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867697|NCT01812369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867698|NCT01812369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867699|NCT01812369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64867700|NCT01812369|Immunologic Factors|immunologic factors|mesh-ancestor
64867701|NCT01812369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867702|NCT01812369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64867703|NCT01812369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64867704|NCT01812369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64867705|NCT01812369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64867706|NCT01812369|Tubulin Modulators|tubulin modulators|mesh-ancestor
64867707|NCT01812369|Antimitotic Agents|antimitotic agents|mesh-ancestor
64867708|NCT01812369|Mitosis Modulators|mitosis modulators|mesh-ancestor
64867710|NCT01812382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64867711|NCT01812382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867712|NCT01812434|Sildenafil Citrate|sildenafil citrate|mesh-list
64867713|NCT01812434|Vasodilator Agents|vasodilator agents|mesh-ancestor
64867714|NCT01812434|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64867715|NCT01812434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64867716|NCT01812434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867717|NCT01812434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867726|NCT01812538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64867727|NCT01812538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64867728|NCT01812538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64867729|NCT01812538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867730|NCT01812538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867731|NCT01812551|Alendronate|alendronate|mesh-list
64867732|NCT01812551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64867733|NCT01812551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867734|NCT01812642|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
64867735|NCT01812642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64867736|NCT01812642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64867737|NCT01812642|Dopamine Agents|dopamine agents|mesh-ancestor
64867738|NCT01812642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64867755|NCT01812928|Diclofenac|diclofenac|mesh-list
64507832|NCT03310242|Micronutrients|micronutrients|mesh-ancestor
64867756|NCT01812928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64867757|NCT01812928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64867758|NCT01812928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64867759|NCT01812928|Analgesics|analgesics|mesh-ancestor
64867760|NCT01812928|Sensory System Agents|sensory system agents|mesh-ancestor
64867761|NCT01812928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64867762|NCT01812928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867763|NCT01812928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64867765|NCT01812928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867788|NCT01812954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64867789|NCT01812954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64867790|NCT01812954|Antifungal Agents|antifungal agents|mesh-ancestor
64867791|NCT01812954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867792|NCT01812954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64867793|NCT01812954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64867794|NCT01812954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64867795|NCT01812954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64867796|NCT01812954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64867797|NCT01812954|Analgesics|analgesics|mesh-ancestor
64867798|NCT01812954|Sensory System Agents|sensory system agents|mesh-ancestor
64867799|NCT01812954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64867800|NCT01812954|Keratolytic Agents|keratolytic agents|mesh-ancestor
64867801|NCT01812967|Caseins|caseins|mesh-list
64867802|NCT01812967|Chelating Agents|chelating agents|mesh-ancestor
64867803|NCT01812967|Sequestering Agents|sequestering agents|mesh-ancestor
64867804|NCT01812967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867805|NCT01813162|Tenofovir|tenofovir|mesh-list
64867806|NCT01813162|Metronidazole|metronidazole|mesh-list
64867807|NCT01813162|Terconazole|terconazole|mesh-list
64867808|NCT01813162|Contraceptive Agents|contraceptive agents|mesh-list
64867809|NCT01813162|Antiviral Agents|antiviral agents|mesh-ancestor
64867810|NCT01813162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867811|NCT01813162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64867812|NCT01813162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64867813|NCT01813162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867816|NCT01813162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64867817|NCT01813162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64867818|NCT01813162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64867819|NCT01813162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64867820|NCT01813162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64867821|NCT01813162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867830|NCT01813201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64867832|NCT01813201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64867833|NCT01813201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867834|NCT01813201|Anabolic Agents|anabolic agents|mesh-ancestor
64507884|NCT00557440|Xhance|xhance|mesh-list
64867835|NCT01813240|Minocycline|minocycline|mesh-list
64867836|NCT01813240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64867837|NCT01813240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867838|NCT01813253|Irinotecan|irinotecan|mesh-list
64867839|NCT01813253|Nimotuzumab|nimotuzumab|mesh-list
64867840|NCT01813253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64867841|NCT01813253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64867842|NCT01813253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867843|NCT01813253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867844|NCT01813253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64867845|NCT01813253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64867846|NCT01813318|Acamprosate|acamprosate|mesh-list
64867847|NCT01813318|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64867848|NCT01813448|Fidaxomicin|fidaxomicin|mesh-list
64867849|NCT01813448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64867850|NCT01813448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867851|NCT01813461|Isavuconazole|isavuconazole|mesh-list
64867852|NCT01813461|Antifungal Agents|antifungal agents|mesh-ancestor
64867853|NCT01813461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867854|NCT01813487|Entecavir|entecavir|mesh-list
64867855|NCT01813487|Antiviral Agents|antiviral agents|mesh-ancestor
64867856|NCT01813487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867857|NCT01813513|Simeprevir|simeprevir|mesh-list
64867858|NCT01813513|Antiviral Agents|antiviral agents|mesh-ancestor
64867859|NCT01813513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64867860|NCT01813513|Protease Inhibitors|protease inhibitors|mesh-ancestor
64867861|NCT01813513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867862|NCT01813513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867863|NCT01813552|Ritonavir|ritonavir|mesh-list
64867864|NCT01813552|Omeprazole|omeprazole|mesh-list
64296026|NCT05302232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64296027|NCT05302232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64296028|NCT05302232|Protective Agents|protective agents|mesh-ancestor
64296029|NCT05302232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64296030|NCT05302232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296031|NCT02468661|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64296032|NCT02468661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296033|NCT02468661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64867905|NCT01813617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64867906|NCT01813617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64867907|NCT01813617|Antimetabolites|antimetabolites|mesh-ancestor
64867908|NCT01813617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867909|NCT01813617|Dermatologic Agents|dermatologic agents|mesh-ancestor
64867910|NCT01813617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867911|NCT01813617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64867912|NCT01813617|Immunologic Factors|immunologic factors|mesh-ancestor
64867913|NCT01813617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64867914|NCT01813617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64867915|NCT01813643|Risperidone|risperidone|mesh-list
64416855|NCT04837651|Immunologic Factors|immunologic factors|mesh-ancestor
64416856|NCT04837651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416857|NCT03039205|Clopidogrel|clopidogrel|mesh-list
64416858|NCT03039205|Ticagrelor|ticagrelor|mesh-list
64416859|NCT03039205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64416860|NCT03039205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64416861|NCT03039205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64416862|NCT03039205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64416863|NCT03039205|Purinergic Agents|purinergic agents|mesh-ancestor
64416864|NCT03039205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64416865|NCT03039205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416866|NCT03039205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416867|NCT04837261|Propranolol|propranolol|mesh-list
64416868|NCT04837261|Amiodarone|amiodarone|mesh-list
64416869|NCT04837261|Flecainide|flecainide|mesh-list
64416870|NCT04837261|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64416871|NCT04837261|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64416872|NCT04837261|Adrenergic Agents|adrenergic agents|mesh-ancestor
64416899|NCT04824937|Talazoparib|talazoparib|mesh-list
64867936|NCT01813656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64867937|NCT01813656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64867938|NCT01813656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64867939|NCT01813656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64416937|NCT04831255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416939|NCT02431533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64416940|NCT02431533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416941|NCT02413593|Sofosbuvir|sofosbuvir|mesh-list
64416942|NCT02413593|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64416943|NCT02413593|Ledipasvir|ledipasvir|mesh-list
64416944|NCT02413593|Antiviral Agents|antiviral agents|mesh-ancestor
64416945|NCT02413593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64416946|NCT01652703|Evolocumab|evolocumab|mesh-list
64416947|NCT01652703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64416948|NCT01652703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64416949|NCT01652703|Antimetabolites|antimetabolites|mesh-ancestor
64867947|NCT01813656|Serotonin Agents|serotonin agents|mesh-ancestor
64867948|NCT01813656|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64867949|NCT01813656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64867950|NCT01813656|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64867951|NCT01813656|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64867952|NCT01813773|Aflibercept|aflibercept|mesh-list
64867953|NCT01813773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64867954|NCT01813773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64867955|NCT01813773|Growth Substances|growth substances|mesh-ancestor
64333542|NCT02366481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333543|NCT02366481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64333544|NCT02366481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64333545|NCT02366481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333546|NCT02366481|Hemostatics|hemostatics|mesh-ancestor
64416950|NCT01652703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416951|NCT01652703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64416952|NCT01652469|Docetaxel|docetaxel|mesh-list
64416953|NCT01652469|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64416954|NCT01652469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416955|NCT01652469|Tubulin Modulators|tubulin modulators|mesh-ancestor
64416956|NCT01652469|Antimitotic Agents|antimitotic agents|mesh-ancestor
64416957|NCT01652469|Mitosis Modulators|mitosis modulators|mesh-ancestor
64416958|NCT01652469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416959|NCT01652469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64416960|NCT01652469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416987|NCT02412111|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64416988|NCT02412111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64416989|NCT02412111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416991|NCT02426541|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64867963|NCT01813812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333564|NCT03526315|Fluorides|fluorides|mesh-list
64333565|NCT03526315|Cariostatic Agents|cariostatic agents|mesh-ancestor
64333566|NCT03526315|Protective Agents|protective agents|mesh-ancestor
64333567|NCT03526315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333568|NCT03112551|Magnesium Sulfate|magnesium sulfate|mesh-list
64333569|NCT03112551|Analgesics|analgesics|mesh-ancestor
64333570|NCT03112551|Sensory System Agents|sensory system agents|mesh-ancestor
64333571|NCT03112551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64333572|NCT03112551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333573|NCT03112551|Anesthetics|anesthetics|mesh-ancestor
64333574|NCT03112551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64333575|NCT03112551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64867974|NCT01813981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64867975|NCT01813981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64867976|NCT01813981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64867977|NCT01813981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867978|NCT01813981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867979|NCT01813981|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64867980|NCT01813981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64867981|NCT01813981|Purinergic Agents|purinergic agents|mesh-ancestor
64867982|NCT01813981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64867983|NCT01813994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
64867984|NCT01813994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64867985|NCT01813994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64867986|NCT01813994|Antimetabolites|antimetabolites|mesh-ancestor
64867987|NCT01813994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64867988|NCT01813994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64867989|NCT01813994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64867990|NCT01814059|Sirolimus|sirolimus|mesh-list
64417002|NCT02410551|Fludarabine phosphate|fludarabine phosphate|mesh-list
64868053|NCT01814189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64333595|NCT04466917|Growth Substances|growth substances|mesh-ancestor
64333596|NCT04466917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333597|NCT04466917|Growth Inhibitors|growth inhibitors|mesh-ancestor
64333598|NCT05373433|Ritonavir|ritonavir|mesh-list
64333599|NCT05373433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64333600|NCT05373433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64333601|NCT05373433|Protease Inhibitors|protease inhibitors|mesh-ancestor
64333602|NCT05373433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333603|NCT05373433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333612|NCT02363127|Hormones|hormones|mesh-ancestor
64333620|NCT03526159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333622|NCT03523741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64333623|NCT03523741|Serotonin Agents|serotonin agents|mesh-ancestor
64333624|NCT03523741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64333625|NCT03523741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868114|NCT01814475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868115|NCT01814475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64868116|NCT01814475|Antimetabolites|antimetabolites|mesh-ancestor
64868133|NCT01814501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868135|NCT01814501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333626|NCT03523741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333627|NCT03523741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64333628|NCT03523741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64417004|NCT02410551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417005|NCT02410551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64417006|NCT02410551|Antimetabolites|antimetabolites|mesh-ancestor
64417007|NCT02410551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417008|NCT02410551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64417009|NCT02410551|Immunologic Factors|immunologic factors|mesh-ancestor
64417010|NCT02410551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333629|NCT03523741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64508323|NCT01993810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64417023|NCT02424591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64417024|NCT02424591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64417028|NCT02603419|Avelumab|avelumab|mesh-list
64868151|NCT01814514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64868153|NCT01814514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64868154|NCT01814514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868155|NCT01814514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868156|NCT01814514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64868157|NCT01814514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64868158|NCT01814618|Budesonide|budesonide|mesh-list
64868159|NCT01814618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64868160|NCT01814618|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64868161|NCT01814618|Autonomic Agents|autonomic agents|mesh-ancestor
64868162|NCT01814618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64868163|NCT01814618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868164|NCT01814618|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64868165|NCT01814618|Respiratory System Agents|respiratory system agents|mesh-ancestor
64868166|NCT01814618|Glucocorticoids|glucocorticoids|mesh-ancestor
64868167|NCT01814618|Hormones|hormones|mesh-ancestor
64868168|NCT01814618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64868169|NCT01814683|Primaquine|primaquine|mesh-list
64868178|NCT01814709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64868179|NCT01814709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64868180|NCT01814709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868181|NCT01814709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868182|NCT01814709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64868183|NCT01814709|Hormone Antagonists|hormone antagonists|mesh-ancestor
64868184|NCT01814709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64508805|NCT00653068|Vitamins|vitamins|mesh-ancestor
64868185|NCT01814709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868186|NCT01814709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64868187|NCT01814709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64868188|NCT01814709|Antitubercular Agents|antitubercular agents|mesh-ancestor
64868189|NCT01814709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64868190|NCT01814709|Leprostatic Agents|leprostatic agents|mesh-ancestor
64868191|NCT01814709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64417029|NCT02603419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64417030|NCT02603419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64417031|NCT02603419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417032|NCT02603419|Immunologic Factors|immunologic factors|mesh-ancestor
64417033|NCT02603419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417042|NCT05618353|Gout Suppressants|gout suppressants|mesh-ancestor
64417043|NCT05618353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64417044|NCT05618353|Tubulin Modulators|tubulin modulators|mesh-ancestor
64417045|NCT05618353|Antimitotic Agents|antimitotic agents|mesh-ancestor
64417046|NCT05618353|Mitosis Modulators|mitosis modulators|mesh-ancestor
64417047|NCT05618353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417048|NCT05618353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417049|NCT04822909|Thalidomide|thalidomide|mesh-list
64868236|NCT01815021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64868238|NCT01815021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868239|NCT01815021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64868240|NCT01815047|Vitamin D|vitamin d|mesh-list
64868241|NCT01815047|Cholecalciferol|cholecalciferol|mesh-list
64868242|NCT01815047|Vitamins|vitamins|mesh-ancestor
64868243|NCT01815047|Micronutrients|micronutrients|mesh-ancestor
64868244|NCT01815047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868245|NCT01815047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64868246|NCT01815047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64868247|NCT01815073|Vaccines|vaccines|mesh-list
64868248|NCT01815073|Immunologic Factors|immunologic factors|mesh-ancestor
64868249|NCT01815073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868250|NCT01815125|Ondansetron|ondansetron|mesh-list
64868251|NCT01815125|Antiemetics|antiemetics|mesh-ancestor
64868252|NCT01815125|Autonomic Agents|autonomic agents|mesh-ancestor
64417098|NCT04829773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64417099|NCT04829773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64417100|NCT04829773|Anesthetics, General|anesthetics, general|mesh-ancestor
64417101|NCT04829773|Anesthetics|anesthetics|mesh-ancestor
64417102|NCT04829773|GABA Modulators|gaba modulators|mesh-ancestor
64417103|NCT04829773|GABA Agents|gaba agents|mesh-ancestor
64417104|NCT04829773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64417145|NCT04828525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64417146|NCT04828525|Glucocorticoids|glucocorticoids|mesh-ancestor
64417147|NCT04828525|Hormones|hormones|mesh-ancestor
64296039|NCT03304431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64509887|NCT01921894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64509889|NCT01452009|Travoprost|travoprost|mesh-list
64868261|NCT01815125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868262|NCT01815125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64868263|NCT01815125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64868264|NCT01815125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64868265|NCT01815125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64868266|NCT01815125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64868267|NCT01815203|Caffeine|caffeine|mesh-list
64868268|NCT01815203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64868269|NCT01815203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868270|NCT01815203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64868271|NCT01815203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868272|NCT01815203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868273|NCT01815203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64868274|NCT01815203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64868275|NCT01815203|Purinergic Agents|purinergic agents|mesh-ancestor
64510359|NCT01456611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64868276|NCT01815203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64868277|NCT01815255|Tenofovir|tenofovir|mesh-list
64868278|NCT01815255|Antiviral Agents|antiviral agents|mesh-ancestor
64868279|NCT01815255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64417149|NCT04828525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64868280|NCT01815255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64417150|NCT04828525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417151|NCT04821193|Chlorhexidine|chlorhexidine|mesh-list
64417152|NCT04821193|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64417153|NCT04821193|Disinfectants|disinfectants|mesh-list
64417154|NCT04821193|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64417155|NCT04821193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64417156|NCT04821193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64417157|NCT04821193|Dermatologic Agents|dermatologic agents|mesh-ancestor
64417158|NCT04820803|Cetylpyridinium|cetylpyridinium|mesh-list
64417159|NCT04820803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64417160|NCT04820803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64868281|NCT01815255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64868282|NCT01815255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868283|NCT01815255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868284|NCT01815255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64868285|NCT01815255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64868287|NCT01815268|Immunologic Factors|immunologic factors|mesh-ancestor
64868288|NCT01815268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868289|NCT01815294|Doxorubicin|doxorubicin|mesh-list
64868290|NCT01815294|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64868291|NCT01815294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64868292|NCT01815294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868293|NCT01815294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64868294|NCT01815294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64868295|NCT01815294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868296|NCT01815294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868297|NCT01815307|Gemcitabine|gemcitabine|mesh-list
64868298|NCT01815307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64868299|NCT01815307|Antimetabolites|antimetabolites|mesh-ancestor
64868300|NCT01815307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868301|NCT01815307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868302|NCT01815307|Antiviral Agents|antiviral agents|mesh-ancestor
64868303|NCT01815307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64868304|NCT01815307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868305|NCT01815307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64868306|NCT01815307|Immunologic Factors|immunologic factors|mesh-ancestor
64868307|NCT01815307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868308|NCT01815437|Vitamin D|vitamin d|mesh-list
64868309|NCT01815437|Ergocalciferols|ergocalciferols|mesh-list
64868310|NCT01815437|Cholecalciferol|cholecalciferol|mesh-list
64868311|NCT01815437|Vitamins|vitamins|mesh-list
64868312|NCT01815437|Micronutrients|micronutrients|mesh-ancestor
64868313|NCT01815437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868314|NCT01815437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64868316|NCT01815528|Catumaxomab|catumaxomab|mesh-list
64868318|NCT01815541|Teicoplanin|teicoplanin|mesh-list
64868319|NCT01815541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64868320|NCT01815541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64868321|NCT01815658|Carbon Fiber|carbon fiber|mesh-list
64868322|NCT01815658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64868323|NCT01815658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64868324|NCT01815723|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64868325|NCT01815723|Dermatologic Agents|dermatologic agents|mesh-ancestor
64868326|NCT01815723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64868327|NCT01815723|Immunologic Factors|immunologic factors|mesh-ancestor
64417161|NCT04827667|Dimercaprol|dimercaprol|mesh-list
64417162|NCT04827667|Chelating Agents|chelating agents|mesh-ancestor
64417163|NCT04827667|Sequestering Agents|sequestering agents|mesh-ancestor
64417164|NCT04827667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417165|NCT04360135|Acetaminophen|acetaminophen|mesh-list
64417166|NCT04360135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64417167|NCT04360135|Analgesics|analgesics|mesh-ancestor
64417168|NCT04360135|Sensory System Agents|sensory system agents|mesh-ancestor
64417169|NCT04360135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64868331|NCT01815892|Natriuretic Agents|natriuretic agents|mesh-ancestor
64868332|NCT01815892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868333|NCT01815892|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64868334|NCT01815892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64868335|NCT01815892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636925|NCT01426867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868336|NCT01815944|Ropivacaine|ropivacaine|mesh-list
64868337|NCT01815944|Anesthetics, Local|anesthetics, local|mesh-ancestor
64868338|NCT01815944|Anesthetics|anesthetics|mesh-ancestor
64513076|NCT03613181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64513172|NCT03164447|UB-421|ub-421|mesh-list
64868339|NCT01815944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64868340|NCT01815944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868341|NCT01815944|Sensory System Agents|sensory system agents|mesh-ancestor
64868342|NCT01815944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64868343|NCT01816009|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64868344|NCT01816009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64868345|NCT01816035|Trastuzumab|trastuzumab|mesh-list
64868346|NCT01816035|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64868347|NCT01816035|Maytansine|maytansine|mesh-list
64868348|NCT01816035|Immunoconjugates|immunoconjugates|mesh-list
64868349|NCT01816035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64417170|NCT04360135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417193|NCT02605837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64417194|NCT04834375|Dexamethasone|dexamethasone|mesh-list
64417195|NCT04834375|Dexamethasone acetate|dexamethasone acetate|mesh-list
64417196|NCT04834375|BB 1101|bb 1101|mesh-list
64417197|NCT04834375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64417198|NCT04834375|Antiemetics|antiemetics|mesh-ancestor
64417199|NCT04834375|Autonomic Agents|autonomic agents|mesh-ancestor
64417200|NCT04834375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64417201|NCT04834375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513487|NCT01712620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64513488|NCT01712620|Diuretics|diuretics|mesh-ancestor
64513489|NCT01712620|Natriuretic Agents|natriuretic agents|mesh-ancestor
64513522|NCT01160926|Cediranib|cediranib|mesh-list
64513523|NCT01160926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513575|NCT00858273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513576|NCT00858273|Protective Agents|protective agents|mesh-ancestor
64513577|NCT00811122|Corticosterone|corticosterone|mesh-list
64513578|NCT00811122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64513579|NCT00651885|Treprostinil|treprostinil|mesh-list
64513580|NCT00651885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64417202|NCT04834375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64417258|NCT02406261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64417259|NCT02406261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417260|NCT02406261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64417261|NCT02406261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64417262|NCT02406261|Antimetabolites|antimetabolites|mesh-ancestor
64417263|NCT02406261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64417264|NCT02406261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64417265|NCT02406261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417266|NCT02406261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64417267|NCT02406261|Cholinergic Agents|cholinergic agents|mesh-ancestor
64417269|NCT02485353|Cytarabine|cytarabine|mesh-list
64868357|NCT01816035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955624|NCT00072072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64955625|NCT00072072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868359|NCT01816191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64868360|NCT01816191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64868361|NCT01816191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64868362|NCT01816191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868363|NCT01816191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64868364|NCT01816191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868365|NCT01816191|Vasodilator Agents|vasodilator agents|mesh-ancestor
64868366|NCT01816321|Ganirelix|ganirelix|mesh-list
64868367|NCT01816321|Hormone Antagonists|hormone antagonists|mesh-ancestor
64868368|NCT01816321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64868369|NCT01816321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868370|NCT01816334|Methylprednisolone|methylprednisolone|mesh-list
64868371|NCT01816334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64868372|NCT01816334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64868373|NCT01816334|Prednisolone|prednisolone|mesh-list
64868374|NCT01816334|Prednisolone acetate|prednisolone acetate|mesh-list
64868375|NCT01816334|Ketoprofen|ketoprofen|mesh-list
64955639|NCT00204022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64955640|NCT00204022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868376|NCT01816334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64868377|NCT01816334|Prednisolone phosphate|prednisolone phosphate|mesh-list
64868378|NCT01816334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64417273|NCT02485353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417274|NCT02485353|Antiviral Agents|antiviral agents|mesh-ancestor
64417275|NCT02485353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64417276|NCT02485353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64417277|NCT02485353|Immunologic Factors|immunologic factors|mesh-ancestor
64417278|NCT02485353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417279|NCT02603107|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
64417310|NCT02604589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64417311|NCT02604589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417312|NCT02604589|Sensory System Agents|sensory system agents|mesh-ancestor
64417313|NCT02604589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64417314|NCT02604589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64298534|NCT02082067|Ketorolac|ketorolac|mesh-list
64298535|NCT02082067|Morphine|morphine|mesh-list
64417316|NCT02604589|Analgesics|analgesics|mesh-ancestor
64417317|NCT04818151|Warfarin|warfarin|mesh-list
64417318|NCT04818151|Apixaban|apixaban|mesh-list
64417319|NCT04818151|Anticoagulants|anticoagulants|mesh-ancestor
64417320|NCT04818151|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64417321|NCT04818151|Antithrombins|antithrombins|mesh-ancestor
64417322|NCT04818151|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64868389|NCT01816334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64868390|NCT01816334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424502|NCT02313909|Aspirin|aspirin|mesh-list
64298551|NCT02082067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64298552|NCT02082067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298553|NCT02082067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298554|NCT02084563|Cytarabine|cytarabine|mesh-list
64298555|NCT02084563|Decitabine|decitabine|mesh-list
64298556|NCT02084563|Daunorubicin|daunorubicin|mesh-list
64868391|NCT01816334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64868392|NCT01816334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64868393|NCT01816334|Analgesics|analgesics|mesh-ancestor
64868394|NCT01816334|Sensory System Agents|sensory system agents|mesh-ancestor
64868395|NCT01816334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64868396|NCT01816334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64868397|NCT01816334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868398|NCT01816334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868399|NCT01816412|Paclitaxel|paclitaxel|mesh-list
64868400|NCT01816412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64868406|NCT01816490|Silybin|silybin|mesh-list
64868430|NCT01816581|Analgesics|analgesics|mesh-ancestor
64868431|NCT01816581|Sensory System Agents|sensory system agents|mesh-ancestor
64868432|NCT01816581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64868433|NCT01816581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64868434|NCT01816620|Dexamethasone|dexamethasone|mesh-list
64868435|NCT01816620|Lenalidomide|lenalidomide|mesh-list
64868436|NCT01816620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64955722|NCT00204568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424503|NCT02313909|Rivaroxaban|rivaroxaban|mesh-list
64868437|NCT01816620|Antiemetics|antiemetics|mesh-ancestor
64868438|NCT01816620|Autonomic Agents|autonomic agents|mesh-ancestor
64868439|NCT01816620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64868440|NCT01816620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868441|NCT01816620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64868442|NCT01816620|Glucocorticoids|glucocorticoids|mesh-ancestor
64868443|NCT01816620|Hormones|hormones|mesh-ancestor
64868444|NCT01816620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64955734|NCT00204646|Ifosfamide|ifosfamide|mesh-list
64955739|NCT00204646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955740|NCT00204646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64955741|NCT00204646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64955742|NCT00204646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64955743|NCT00204646|Alkylating Agents|alkylating agents|mesh-ancestor
64868445|NCT01816620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64868446|NCT01816620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868447|NCT01816620|Immunologic Factors|immunologic factors|mesh-ancestor
64868448|NCT01816620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64868449|NCT01816620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64868450|NCT01816620|Growth Substances|growth substances|mesh-ancestor
64868451|NCT01816620|Growth Inhibitors|growth inhibitors|mesh-ancestor
64868452|NCT01816646|Cidofovir|cidofovir|mesh-list
64868453|NCT01816646|Probenecid|probenecid|mesh-list
64868454|NCT01816646|Uricosuric Agents|uricosuric agents|mesh-ancestor
64868455|NCT01816646|Gout Suppressants|gout suppressants|mesh-ancestor
64955778|NCT00072228|Antiviral Agents|antiviral agents|mesh-ancestor
64955779|NCT00072228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64955780|NCT00072228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955782|NCT00072228|Immunologic Factors|immunologic factors|mesh-ancestor
64955824|NCT00039455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955825|NCT00039455|Growth Inhibitors|growth inhibitors|mesh-ancestor
64298557|NCT02084563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64298558|NCT02084563|Antimetabolites|antimetabolites|mesh-ancestor
64298559|NCT02084563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298560|NCT02084563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64298561|NCT02084563|Antiviral Agents|antiviral agents|mesh-ancestor
64298562|NCT02084563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64298563|NCT02084563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64298564|NCT02084563|Immunologic Factors|immunologic factors|mesh-ancestor
64298565|NCT02084563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298566|NCT02084563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64868456|NCT01816646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64417323|NCT04818151|Protease Inhibitors|protease inhibitors|mesh-ancestor
64417324|NCT04818151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417325|NCT04818151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417326|NCT04817527|Edaravone|edaravone|mesh-list
64417327|NCT04817527|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64417328|NCT04817527|Antioxidants|antioxidants|mesh-ancestor
64417329|NCT04817527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417330|NCT04817527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64868458|NCT01816646|Antiviral Agents|antiviral agents|mesh-ancestor
64868459|NCT01816646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64868460|NCT01816646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955826|NCT00039455|Growth Substances|growth substances|mesh-ancestor
64298567|NCT02084563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64298568|NCT02084563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64298569|NCT02084563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298570|NCT02084719|Antibodies|antibodies|mesh-list
64298571|NCT02084719|Immunologic Factors|immunologic factors|mesh-ancestor
64298572|NCT02084719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298573|NCT02084875|Tofacitinib|tofacitinib|mesh-list
64298574|NCT02084875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64298575|NCT02084875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298576|NCT02084875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868461|NCT01816646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868462|NCT01816659|Metformin|metformin|mesh-list
64868463|NCT01816659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64868473|NCT01816958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64868474|NCT01816958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868475|NCT01816958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64868476|NCT01816958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64868477|NCT01816958|Anesthetics, General|anesthetics, general|mesh-ancestor
64868479|NCT01816958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64868480|NCT01816958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64868481|NCT01816958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64868482|NCT01816958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64955844|NCT00072462|Anastrozole|anastrozole|mesh-list
64955845|NCT00072462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868483|NCT01816958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868484|NCT01816997|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64868485|NCT01816997|Pravastatin|pravastatin|mesh-list
64868486|NCT01816997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64868487|NCT01816997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64868488|NCT01816997|Antimetabolites|antimetabolites|mesh-ancestor
64868489|NCT01816997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868490|NCT01816997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64955858|NCT00205426|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64955860|NCT00205426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955861|NCT00039494|Temozolomide|temozolomide|mesh-list
64298579|NCT02689453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868491|NCT01816997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64868492|NCT01816997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868494|NCT01817023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868495|NCT01817036|Vitamin D|vitamin d|mesh-list
64868496|NCT01817036|Vitamins|vitamins|mesh-ancestor
64868497|NCT01817036|Micronutrients|micronutrients|mesh-ancestor
64868498|NCT01817036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868500|NCT01817153|Hydrocortisone|hydrocortisone|mesh-list
64955919|NCT00206089|Antithrombins|antithrombins|mesh-ancestor
64298581|NCT02084953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64955935|NCT00206128|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64955936|NCT00206128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64298582|NCT02084953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64298588|NCT02082613|Polidocanol|polidocanol|mesh-list
64868522|NCT01817283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64868523|NCT01817283|Immunologic Factors|immunologic factors|mesh-ancestor
64868524|NCT01817283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64868525|NCT01817283|Alkylating Agents|alkylating agents|mesh-ancestor
64868526|NCT01817283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868527|NCT01817283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868528|NCT01817322|Mycophenolic Acid|mycophenolic acid|mesh-list
64868529|NCT01817322|Methylprednisolone|methylprednisolone|mesh-list
64955944|NCT00206167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64955950|NCT00206167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64868530|NCT01817322|Prednisolone|prednisolone|mesh-list
64868531|NCT01817322|Deflazacort|deflazacort|mesh-list
64868532|NCT01817322|Basiliximab|basiliximab|mesh-list
64868533|NCT01817322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64868534|NCT01817322|Antiemetics|antiemetics|mesh-ancestor
64868535|NCT01817322|Autonomic Agents|autonomic agents|mesh-ancestor
64868536|NCT01817322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64868537|NCT01817322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868538|NCT01817322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64868539|NCT01817322|Glucocorticoids|glucocorticoids|mesh-ancestor
64868540|NCT01817322|Hormones|hormones|mesh-ancestor
64868541|NCT01817322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64868542|NCT01817322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64868543|NCT01817322|Protective Agents|protective agents|mesh-ancestor
64955964|NCT00039611|Antimetabolites|antimetabolites|mesh-ancestor
64955965|NCT00039611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868544|NCT01817322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64868545|NCT01817322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868546|NCT01817322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64868547|NCT01817322|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64868548|NCT01817322|Antitubercular Agents|antitubercular agents|mesh-ancestor
64868549|NCT01817322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64868550|NCT01817322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64868551|NCT01817322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868552|NCT01817322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868553|NCT01817322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64868554|NCT01817322|Immunologic Factors|immunologic factors|mesh-ancestor
64868555|NCT01817348|Lidocaine|lidocaine|mesh-list
64868558|NCT01817348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64868559|NCT01817348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868560|NCT01817348|Sensory System Agents|sensory system agents|mesh-ancestor
64868561|NCT01817348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64868562|NCT01817348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64868563|NCT01817348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64868564|NCT01817348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64956008|NCT00399204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64868565|NCT01817348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64868566|NCT01817348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868567|NCT01817400|Aspirin|aspirin|mesh-list
64868568|NCT01817400|Pioglitazone|pioglitazone|mesh-list
64868569|NCT01817400|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
64868570|NCT01817400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64868571|NCT01817400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64868572|NCT01817400|Analgesics|analgesics|mesh-ancestor
64868573|NCT01817400|Sensory System Agents|sensory system agents|mesh-ancestor
64868574|NCT01817400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64868612|NCT01817803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956062|NCT00039962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64956064|NCT00424333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64956065|NCT00424333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64956066|NCT00424333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494750|NCT05439798|Serotonin Agents|serotonin agents|mesh-ancestor
64868613|NCT01817803|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64868614|NCT01817803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64868615|NCT01817803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868616|NCT01817803|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64868617|NCT01817803|Hormone Antagonists|hormone antagonists|mesh-ancestor
64868618|NCT01817803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64868619|NCT01817803|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64868620|NCT01817803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64956101|NCT00206713|Immunologic Factors|immunologic factors|mesh-ancestor
64956102|NCT00206713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298589|NCT02082613|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64298590|NCT02082613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64298592|NCT02085109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64298593|NCT02085109|Autonomic Agents|autonomic agents|mesh-ancestor
64298594|NCT02085109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64298595|NCT02085109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298596|NCT02085109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64956103|NCT00040040|Bupropion|bupropion|mesh-list
64417231|NCT02423343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381536|NCT02433041|Antiemetics|antiemetics|mesh-ancestor
64381537|NCT02433041|Autonomic Agents|autonomic agents|mesh-ancestor
64381538|NCT02433041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64381539|NCT02433041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64381540|NCT02433041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64381541|NCT02433041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64868621|NCT01817803|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64868622|NCT01817816|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64868623|NCT01817816|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64868624|NCT01817816|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64868625|NCT01817816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64868626|NCT01817816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868627|NCT01817816|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64868628|NCT01817816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64868629|NCT01817816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868630|NCT01817816|Cholinergic Agents|cholinergic agents|mesh-ancestor
64868631|NCT01817816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64868632|NCT01817829|Acetaminophen|acetaminophen|mesh-list
64868633|NCT01817829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64868634|NCT01817829|Analgesics|analgesics|mesh-ancestor
64868635|NCT01817829|Sensory System Agents|sensory system agents|mesh-ancestor
64417331|NCT04817527|Protective Agents|protective agents|mesh-ancestor
64417332|NCT04817527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417333|NCT04357795|Cyclosporine|cyclosporine|mesh-list
64417334|NCT04357795|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64417335|NCT04357795|Cyclosporins|cyclosporins|mesh-list
64417336|NCT04357795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417337|NCT04357795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417338|NCT04357795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64320338|NCT02573012|Hormones|hormones|mesh-ancestor
64417339|NCT04357795|Immunologic Factors|immunologic factors|mesh-ancestor
64868636|NCT01817829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64868637|NCT01817829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868638|NCT01817829|Antipyretics|antipyretics|mesh-ancestor
64868639|NCT01817868|Factor VIII|factor viii|mesh-list
64868653|NCT01817972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868654|NCT01817972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64868655|NCT01817972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868656|NCT01817972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64868658|NCT01817972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868659|NCT01817972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64868660|NCT01817985|Velpatasvir|velpatasvir|mesh-list
64320385|NCT05519072|Renal Agents|renal agents|mesh-ancestor
64320388|NCT05519072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64320389|NCT05519072|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64320390|NCT05519072|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64320391|NCT05519072|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64320392|NCT05519072|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64320396|NCT04411706|Antimetabolites|antimetabolites|mesh-ancestor
64320397|NCT04411706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320398|NCT04411706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320432|NCT02186899|Anesthetics|anesthetics|mesh-list
64868661|NCT01817985|Antiviral Agents|antiviral agents|mesh-ancestor
64868662|NCT01817985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64868663|NCT01818024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64868664|NCT01818024|Immunologic Factors|immunologic factors|mesh-ancestor
64868665|NCT01818024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868666|NCT01818232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
64868667|NCT01818232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64868668|NCT01818232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868669|NCT01818232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64868670|NCT01818232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298597|NCT02085109|Respiratory System Agents|respiratory system agents|mesh-ancestor
64298599|NCT03557983|Fenofibrate|fenofibrate|mesh-list
64298600|NCT03557983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64298601|NCT03557983|Antimetabolites|antimetabolites|mesh-ancestor
64298602|NCT03557983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298603|NCT03557983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64298604|NCT03558919|Solifenacin Succinate|solifenacin succinate|mesh-list
64868671|NCT01818648|Exenatide|exenatide|mesh-list
64868672|NCT01818648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64868673|NCT01818648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868674|NCT01818648|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64868701|NCT01818856|Antiviral Agents|antiviral agents|mesh-ancestor
64868702|NCT01818856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64868703|NCT01818856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64868704|NCT01818856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64868705|NCT01818869|Adenosine|adenosine|mesh-list
64868706|NCT01818869|Analgesics|analgesics|mesh-ancestor
64868707|NCT01818869|Sensory System Agents|sensory system agents|mesh-ancestor
64637323|NCT05448378|Inositol|inositol|mesh-list
64868708|NCT01818869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64868709|NCT01818869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868711|NCT01818869|Vasodilator Agents|vasodilator agents|mesh-ancestor
64868712|NCT01818869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64868713|NCT01818869|Purinergic Agonists|purinergic agonists|mesh-ancestor
64320553|NCT05509946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64320554|NCT05509946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320594|NCT02187523|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64320595|NCT02187523|Telmisartan|telmisartan|mesh-list
64417340|NCT04357795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417341|NCT04357795|Antifungal Agents|antifungal agents|mesh-ancestor
64417347|NCT02604199|Tenofovir|tenofovir|mesh-list
64417355|NCT02604199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417356|NCT02604199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417357|NCT02604199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64417358|NCT02604199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64868730|NCT01818908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64320614|NCT02187679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64320615|NCT05507606|Bevacizumab|bevacizumab|mesh-list
64320616|NCT05507606|Carboplatin|carboplatin|mesh-list
64320618|NCT05507606|Osimertinib|osimertinib|mesh-list
64320619|NCT05507606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64417359|NCT02604199|Histamine Agents|histamine agents|mesh-ancestor
64417360|NCT02604199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64417361|NCT02604199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417362|NCT04807543|Castor Oil|castor oil|mesh-list
64417363|NCT04807543|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
64417364|NCT04807543|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
64417365|NCT04807543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64417366|NCT04807543|Hormone Antagonists|hormone antagonists|mesh-ancestor
64417367|NCT04807543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64320657|NCT02192203|Sensory System Agents|sensory system agents|mesh-ancestor
64320667|NCT02257021|Ritonavir|ritonavir|mesh-list
64320671|NCT02257021|Protease Inhibitors|protease inhibitors|mesh-ancestor
64320672|NCT02257021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320673|NCT02257021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320696|NCT02192827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64320697|NCT02192827|Glucocorticoids|glucocorticoids|mesh-ancestor
64320702|NCT02192827|Protease Inhibitors|protease inhibitors|mesh-ancestor
64320703|NCT02192827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417368|NCT04807543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417370|NCT04807543|Hormones|hormones|mesh-ancestor
64417371|NCT04807543|Cathartics|cathartics|mesh-ancestor
64417372|NCT04807543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64417373|NCT04797949|Aspirin|aspirin|mesh-list
64417374|NCT04797949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64417375|NCT04797949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64417376|NCT04797949|Analgesics|analgesics|mesh-ancestor
64417388|NCT04797949|Antipyretics|antipyretics|mesh-ancestor
64417405|NCT04796857|Growth Substances|growth substances|mesh-ancestor
64417406|NCT04796857|Growth Inhibitors|growth inhibitors|mesh-ancestor
64868760|NCT01819012|Anesthetics|anesthetics|mesh-ancestor
64868761|NCT01819012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64868762|NCT01819012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868763|NCT01819051|Anti-Infective Agents|anti-infective agents|mesh-list
64868764|NCT01819051|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64868766|NCT01819155|Immunologic Factors|immunologic factors|mesh-ancestor
64868767|NCT01819155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320842|NCT02193217|Immunologic Factors|immunologic factors|mesh-ancestor
64320843|NCT02193217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320844|NCT03534973|Caffeine|caffeine|mesh-list
64320845|NCT03534973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64320846|NCT03534973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320854|NCT03534895|Midazolam|midazolam|mesh-list
64320880|NCT03535519|Methotrexate|methotrexate|mesh-list
64320885|NCT03535519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64320886|NCT03535519|Antimetabolites|antimetabolites|mesh-ancestor
64381550|NCT02429921|Trace Elements|trace elements|mesh-ancestor
64320901|NCT02194231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64320902|NCT02194231|Alkylating Agents|alkylating agents|mesh-ancestor
64320903|NCT02194231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320905|NCT04292054|Cefazolin|cefazolin|mesh-list
64868768|NCT01819220|Amlodipine|amlodipine|mesh-list
64868769|NCT01819220|Valsartan|valsartan|mesh-list
64868770|NCT01819220|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64868771|NCT01819220|Telmisartan|telmisartan|mesh-list
64868772|NCT01819220|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
64868773|NCT01819220|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
64868774|NCT01819220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64868775|NCT01819220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64868776|NCT01819220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64868777|NCT01819220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868778|NCT01819220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64868779|NCT01819220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868780|NCT01819220|Vasodilator Agents|vasodilator agents|mesh-ancestor
64637390|NCT02397720|Nivolumab|nivolumab|mesh-list
64321034|NCT02197741|Narcotics|narcotics|mesh-ancestor
64298606|NCT03558919|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64298607|NCT03558919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64298608|NCT03558919|Cholinergic Agents|cholinergic agents|mesh-ancestor
64298609|NCT03558919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64298610|NCT03558919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298611|NCT03558919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381551|NCT02429921|Micronutrients|micronutrients|mesh-ancestor
64321087|NCT03534505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64321096|NCT02196805|Antimetabolites|antimetabolites|mesh-ancestor
64321097|NCT02196805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321098|NCT02196805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64321099|NCT02196805|Antioxidants|antioxidants|mesh-ancestor
64321184|NCT02206789|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64333640|NCT02373579|Methotrexate|methotrexate|mesh-list
64333641|NCT02373579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64333642|NCT02373579|Abortifacient Agents|abortifacient agents|mesh-ancestor
64333643|NCT02373579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64333644|NCT02373579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868781|NCT01819220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64868782|NCT01819220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64868783|NCT01819220|Diuretics|diuretics|mesh-ancestor
64321281|NCT02567552|Hormones|hormones|mesh-ancestor
64321282|NCT02567552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64321283|NCT02567552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321308|NCT03803605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64321367|NCT02199379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64321368|NCT02199379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64321369|NCT02199379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64321370|NCT02199379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321371|NCT05508152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64321373|NCT05508152|Clavulanic Acid|clavulanic acid|mesh-list
64321374|NCT05508152|Clavulanic Acids|clavulanic acids|mesh-list
64321375|NCT05508152|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64321381|NCT03532711|Leucovorin|leucovorin|mesh-list
64321390|NCT03532711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64321391|NCT03532711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64321392|NCT03532711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64321393|NCT03532711|Immunologic Factors|immunologic factors|mesh-ancestor
64321394|NCT03532711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64321395|NCT03532711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64321396|NCT03532711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868784|NCT01819220|Natriuretic Agents|natriuretic agents|mesh-ancestor
64417407|NCT04796857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868785|NCT01819220|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64868786|NCT01819259|Nicotine|nicotine|mesh-list
64868787|NCT01819259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64868788|NCT01819259|Autonomic Agents|autonomic agents|mesh-ancestor
64868789|NCT01819259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64417409|NCT04796623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64417410|NCT04796623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417411|NCT04796623|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64417412|NCT04796623|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64417413|NCT04796623|Hormone Antagonists|hormone antagonists|mesh-ancestor
64417414|NCT04796623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64417415|NCT04796623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417416|NCT04815265|Dexmedetomidine|dexmedetomidine|mesh-list
64417417|NCT04815265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64868790|NCT01819259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868791|NCT01819259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64868792|NCT01819259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64868793|NCT01819259|Cholinergic Agents|cholinergic agents|mesh-ancestor
64868794|NCT01819259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64868795|NCT01819259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868796|NCT01819285|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64868797|NCT01819285|Hormones|hormones|mesh-ancestor
64868798|NCT01819285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64868799|NCT01819285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868800|NCT01819389|Imatinib Mesylate|imatinib mesylate|mesh-list
64868801|NCT01819389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868802|NCT01819389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64868803|NCT01819389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868804|NCT01819389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868805|NCT01819402|Pioglitazone|pioglitazone|mesh-list
64321397|NCT03532711|Antidotes|antidotes|mesh-ancestor
64321420|NCT04714112|BB 1101|bb 1101|mesh-list
64868806|NCT01819402|Glimepiride|glimepiride|mesh-list
64868807|NCT01819402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64868808|NCT01819402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868809|NCT01819402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64868810|NCT01819402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64868811|NCT01819402|Immunologic Factors|immunologic factors|mesh-ancestor
64868821|NCT01819441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64868822|NCT01819441|Protease Inhibitors|protease inhibitors|mesh-ancestor
64321525|NCT02200237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321526|NCT02200237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64321527|NCT02209831|Pantoprazole|pantoprazole|mesh-list
64321528|NCT02209831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64321529|NCT02209831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64321530|NCT02209831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64321531|NCT02209831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64321550|NCT01663532|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64321553|NCT05215106|Durvalumab|durvalumab|mesh-list
64321557|NCT02204683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64321558|NCT02204683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64298612|NCT03558919|Urological Agents|urological agents|mesh-ancestor
64298613|NCT03558919|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64298614|NCT03558919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64868823|NCT01819441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868824|NCT01819610|Ketorolac|ketorolac|mesh-list
64868825|NCT01819610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64868826|NCT01819610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64868827|NCT01819610|Analgesics|analgesics|mesh-ancestor
64321578|NCT02209909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64868828|NCT01819610|Sensory System Agents|sensory system agents|mesh-ancestor
64868829|NCT01819610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64868830|NCT01819610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321579|NCT02209909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321607|NCT04476992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64321608|NCT04476992|Respiratory System Agents|respiratory system agents|mesh-ancestor
64321609|NCT04476992|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64298622|NCT02085577|Ondansetron|ondansetron|mesh-list
64298623|NCT02085577|Analgesics|analgesics|mesh-ancestor
64298624|NCT02085577|Sensory System Agents|sensory system agents|mesh-ancestor
64298625|NCT02085577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64298626|NCT02085577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298627|NCT02085577|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64298628|NCT02085577|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64381555|NCT04298697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381569|NCT02432807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64381570|NCT05527275|Mitoxantrone|mitoxantrone|mesh-list
64381571|NCT05527275|Analgesics|analgesics|mesh-ancestor
64381572|NCT05527275|Sensory System Agents|sensory system agents|mesh-ancestor
64381573|NCT05527275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64868831|NCT01819610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64868832|NCT01819610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64868833|NCT01819610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64868834|NCT01819610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417418|NCT04815265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64417419|NCT04815265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417420|NCT04815265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64417421|NCT04815265|Analgesics|analgesics|mesh-ancestor
64417422|NCT04815265|Sensory System Agents|sensory system agents|mesh-ancestor
64417423|NCT04815265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64417424|NCT04815265|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64417425|NCT04815265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64417426|NCT04815265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64417427|NCT04815265|Adrenergic Agents|adrenergic agents|mesh-ancestor
64417428|NCT04815265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64417429|NCT04815265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868836|NCT01819649|Selenium|selenium|mesh-list
64868837|NCT01819649|Antioxidants|antioxidants|mesh-ancestor
64868838|NCT01819649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868839|NCT01819649|Protective Agents|protective agents|mesh-ancestor
64868840|NCT01819649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868841|NCT01819649|Trace Elements|trace elements|mesh-ancestor
64868842|NCT01819649|Micronutrients|micronutrients|mesh-ancestor
64868843|NCT01819701|Ubiquinone|ubiquinone|mesh-list
64868844|NCT01819701|Coenzyme Q10|coenzyme q10|mesh-list
64868845|NCT01819701|Micronutrients|micronutrients|mesh-ancestor
64868846|NCT01819701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868847|NCT01819701|Vitamins|vitamins|mesh-ancestor
64868848|NCT01819779|Amlodipine|amlodipine|mesh-list
64321610|NCT04476992|Antioxidants|antioxidants|mesh-ancestor
64321611|NCT04476992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321614|NCT04476992|Vasodilator Agents|vasodilator agents|mesh-ancestor
64321622|NCT05499572|Minocycline|minocycline|mesh-list
64321627|NCT02220751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64321628|NCT02220751|Antimalarials|antimalarials|mesh-ancestor
64321641|NCT05504330|Aspirin|aspirin|mesh-list
64321656|NCT05504330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64321657|NCT05504330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64321659|NCT05504330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64321660|NCT05504330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64321661|NCT05504330|Antimetabolites|antimetabolites|mesh-ancestor
64321665|NCT05504330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64321666|NCT05504330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64868849|NCT01819779|Valsartan|valsartan|mesh-list
64868850|NCT01819779|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
64868851|NCT01819779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64868852|NCT01819779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64868864|NCT01819857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868865|NCT01819857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64868866|NCT01819857|Antipruritics|antipruritics|mesh-ancestor
64868867|NCT01819857|Dermatologic Agents|dermatologic agents|mesh-ancestor
64321667|NCT05504330|Purinergic Agents|purinergic agents|mesh-ancestor
64321668|NCT05504330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64321669|NCT02220829|Silodosin|silodosin|mesh-list
64321670|NCT02220829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64321671|NCT02220829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64321672|NCT02220829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64321673|NCT02220829|Adrenergic Agents|adrenergic agents|mesh-ancestor
64321674|NCT02220829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64321678|NCT02525939|Dalcetrapib|dalcetrapib|mesh-list
64321690|NCT02215213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64321691|NCT02215213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64321692|NCT05564546|Nitric Oxide|nitric oxide|mesh-list
64321693|NCT05564546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64321694|NCT05564546|Autonomic Agents|autonomic agents|mesh-ancestor
64321695|NCT05564546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321696|NCT05564546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321697|NCT05564546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64321699|NCT05564546|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64298632|NCT02085577|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64298633|NCT02085577|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64298634|NCT02085577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64298635|NCT02085577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868868|NCT01819857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64868869|NCT01819857|Serotonin Agents|serotonin agents|mesh-ancestor
64868870|NCT01819857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64868871|NCT01819857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868872|NCT01819857|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64868873|NCT01819857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64868874|NCT01819857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64868875|NCT01819857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64868876|NCT01819857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64868877|NCT01819870|Carvedilol|carvedilol|mesh-list
64868878|NCT01819870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64868879|NCT01819870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64868880|NCT01819870|Adrenergic Agents|adrenergic agents|mesh-ancestor
64868881|NCT01819870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64321743|NCT02205931|Clobazam|clobazam|mesh-list
64321744|NCT02205931|Ethosuximide|ethosuximide|mesh-list
64321745|NCT02205931|Stiripentol|stiripentol|mesh-list
64321746|NCT02205931|Nitrazepam|nitrazepam|mesh-list
64321747|NCT02205931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64321833|NCT02254187|Adrenergic Agents|adrenergic agents|mesh-ancestor
64321834|NCT02254187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64321836|NCT05563610|Amoxicillin|amoxicillin|mesh-list
64298636|NCT02085577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64298638|NCT02085577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64298639|NCT02085577|Antipyretics|antipyretics|mesh-ancestor
64298640|NCT02085577|Antiemetics|antiemetics|mesh-ancestor
64298641|NCT02085577|Autonomic Agents|autonomic agents|mesh-ancestor
64298642|NCT02085577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64298643|NCT02085577|Antipruritics|antipruritics|mesh-ancestor
64298644|NCT02085577|Dermatologic Agents|dermatologic agents|mesh-ancestor
64298645|NCT02085577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64298646|NCT02085577|Serotonin Agents|serotonin agents|mesh-ancestor
64298647|NCT02085577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64868882|NCT01819870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868883|NCT01819870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868884|NCT01819870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64868885|NCT01819870|Antioxidants|antioxidants|mesh-ancestor
64868886|NCT01819870|Protective Agents|protective agents|mesh-ancestor
64868887|NCT01819870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64868888|NCT01819870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64868889|NCT01819870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64868890|NCT01819870|Vasodilator Agents|vasodilator agents|mesh-ancestor
64868891|NCT01819870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64868892|NCT01819870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64868893|NCT01819961|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64417430|NCT04815187|Montelukast|montelukast|mesh-list
64417431|NCT04815187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64417433|NCT04815187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64417445|NCT04805827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64417446|NCT04805827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417451|NCT04805827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64321847|NCT05503706|Trace Elements|trace elements|mesh-ancestor
64321848|NCT05503706|Micronutrients|micronutrients|mesh-ancestor
64321849|NCT05503706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64321850|NCT05503706|Antifungal Agents|antifungal agents|mesh-ancestor
64321851|NCT05503706|Keratolytic Agents|keratolytic agents|mesh-ancestor
64321855|NCT05503706|Analgesics|analgesics|mesh-ancestor
64321857|NCT05503706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321865|NCT02174861|Analgesics|analgesics|mesh-ancestor
64321866|NCT02174861|Sensory System Agents|sensory system agents|mesh-ancestor
64321867|NCT02174861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321869|NCT02221375|Ciclesonide|ciclesonide|mesh-list
64417457|NCT02596711|Nicotine|nicotine|mesh-list
64417513|NCT04813471|Nicorandil|nicorandil|mesh-list
64417514|NCT04813471|Vitamin B Complex|vitamin b complex|mesh-list
64417515|NCT04813471|Atorvastatin|atorvastatin|mesh-list
64417516|NCT04813471|Vitamins|vitamins|mesh-ancestor
64417517|NCT04813471|Micronutrients|micronutrients|mesh-ancestor
64417518|NCT04813471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417519|NCT04813471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64321943|NCT02399397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64417520|NCT04813471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64417521|NCT04813471|Antimetabolites|antimetabolites|mesh-ancestor
64321944|NCT02399397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321964|NCT03106545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64321965|NCT03106545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321968|NCT02221531|Carbetocin|carbetocin|mesh-list
64321977|NCT02231125|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64321978|NCT02231125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322033|NCT02147873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322034|NCT02147873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322036|NCT02398929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64322037|NCT02398929|Sympatholytics|sympatholytics|mesh-ancestor
64322038|NCT02398929|Autonomic Agents|autonomic agents|mesh-ancestor
64298652|NCT02085655|Gemcitabine|gemcitabine|mesh-list
64298653|NCT02085655|Thalidomide|thalidomide|mesh-list
64298654|NCT02085655|Dexamethasone|dexamethasone|mesh-list
64298655|NCT02085655|Oxaliplatin|oxaliplatin|mesh-list
64298656|NCT02085655|Methotrexate|methotrexate|mesh-list
64298657|NCT02085655|Pegaspargase|pegaspargase|mesh-list
64417522|NCT04813471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417523|NCT04813471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64417524|NCT04813471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64417525|NCT04813471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417531|NCT04803175|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64417532|NCT04803175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64417533|NCT04803175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64417534|NCT04803175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64417536|NCT04792723|Aspirin|aspirin|mesh-list
64417566|NCT04802785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637530|NCT01042145|Glucocorticoids|glucocorticoids|mesh-ancestor
64868929|NCT01820299|Micronutrients|micronutrients|mesh-ancestor
64868930|NCT01820299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64868931|NCT01820299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64868932|NCT01820299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64322039|NCT02398929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322041|NCT02398929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64322042|NCT02398929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64322044|NCT02398929|Adrenergic Agents|adrenergic agents|mesh-ancestor
64322045|NCT02398929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64322059|NCT02396043|Methotrexate|methotrexate|mesh-list
64322060|NCT02396043|Vincristine|vincristine|mesh-list
64322061|NCT02396043|Mercaptopurine|mercaptopurine|mesh-list
64322118|NCT02781311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64322119|NCT02781311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64322132|NCT02225977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64322138|NCT02221999|Paclitaxel|paclitaxel|mesh-list
64322168|NCT02144753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64322199|NCT02226289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64322200|NCT02226289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322201|NCT02226289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64322237|NCT02232139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64322238|NCT02232139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64322239|NCT02232139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322283|NCT02145065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64322284|NCT02145065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322312|NCT02226913|Anesthetics, Local|anesthetics, local|mesh-ancestor
64322313|NCT02226913|Anesthetics|anesthetics|mesh-ancestor
64322314|NCT02226913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64322358|NCT02226991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64322359|NCT02226991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64322360|NCT02226991|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64868933|NCT01820299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868934|NCT01820299|Antioxidants|antioxidants|mesh-ancestor
64868935|NCT01820299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868936|NCT01820299|Protective Agents|protective agents|mesh-ancestor
64868937|NCT01820312|Paclitaxel|paclitaxel|mesh-list
64868938|NCT01820312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64868939|NCT01820312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64868940|NCT01820312|Tubulin Modulators|tubulin modulators|mesh-ancestor
64868941|NCT01820312|Antimitotic Agents|antimitotic agents|mesh-ancestor
64868942|NCT01820312|Mitosis Modulators|mitosis modulators|mesh-ancestor
64868958|NCT01820442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64868959|NCT01820442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64322450|NCT02396979|Antitussive Agents|antitussive agents|mesh-ancestor
64322451|NCT02396979|Respiratory System Agents|respiratory system agents|mesh-ancestor
64322452|NCT02145767|Progesterone|progesterone|mesh-list
64322516|NCT02228083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64322517|NCT02228083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64322605|NCT02394015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322606|NCT02394015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64322607|NCT02394015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64322608|NCT02394015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64868960|NCT01820442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64868961|NCT01820442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64868962|NCT01820442|Adrenergic Agents|adrenergic agents|mesh-ancestor
64868963|NCT01820442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64868964|NCT01820442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64868965|NCT01820442|Analgesics|analgesics|mesh-ancestor
64868966|NCT01820442|Sympatholytics|sympatholytics|mesh-ancestor
64868967|NCT01820442|Autonomic Agents|autonomic agents|mesh-ancestor
64868968|NCT01820455|Chlorhexidine|chlorhexidine|mesh-list
64868969|NCT01820455|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64868970|NCT01820455|Mupirocin|mupirocin|mesh-list
64868971|NCT01820455|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64868972|NCT01820455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64868973|NCT01820455|Disinfectants|disinfectants|mesh-ancestor
64869017|NCT01820832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64869018|NCT01820832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869019|NCT01820832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64869021|NCT01820858|Carboplatin|carboplatin|mesh-list
64869022|NCT01820858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64322856|NCT02147249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64322864|NCT02392845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322923|NCT05497700|Norepinephrine|norepinephrine|mesh-list
64323007|NCT05740371|Argatroban|argatroban|mesh-list
64323036|NCT02151695|Aflibercept|aflibercept|mesh-list
64323037|NCT02151695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64323038|NCT02151695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64323039|NCT02151695|Growth Substances|growth substances|mesh-ancestor
64869023|NCT01820858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869024|NCT01820858|Tubulin Modulators|tubulin modulators|mesh-ancestor
64869025|NCT01820858|Antimitotic Agents|antimitotic agents|mesh-ancestor
64869026|NCT01820858|Mitosis Modulators|mitosis modulators|mesh-ancestor
64869027|NCT01820858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869028|NCT01820897|Trimethoprim|trimethoprim|mesh-list
64869029|NCT01820897|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64869030|NCT01820897|Sulfamethoxazole|sulfamethoxazole|mesh-list
64869031|NCT01820897|Fosfomycin|fosfomycin|mesh-list
64869032|NCT01820897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64869033|NCT01820897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64869034|NCT01820897|Renal Agents|renal agents|mesh-ancestor
64869035|NCT01820897|Antimalarials|antimalarials|mesh-ancestor
64869036|NCT01820897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64869037|NCT01820897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64869038|NCT01820897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64869039|NCT01820897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869040|NCT01820897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869041|NCT01820897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64869042|NCT01820897|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64869043|NCT01820897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64869044|NCT01820897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64869045|NCT01820962|Heparin|heparin|mesh-list
64869046|NCT01820962|Anticoagulants|anticoagulants|mesh-ancestor
64869060|NCT01821027|Canagliflozin|canagliflozin|mesh-list
64869061|NCT01821027|Simvastatin|simvastatin|mesh-list
64869063|NCT01821027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64869064|NCT01821027|Antimetabolites|antimetabolites|mesh-ancestor
64323212|NCT03165591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869065|NCT01821027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869066|NCT01821027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64323213|NCT03114813|Carvedilol|carvedilol|mesh-list
64323214|NCT03114813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64323249|NCT05746065|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64323253|NCT05746065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64323254|NCT05746065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64323350|NCT03015740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64323351|NCT03015740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323421|NCT03659929|Adrenergic Agents|adrenergic agents|mesh-ancestor
64323422|NCT03659929|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64323441|NCT02232607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64323442|NCT02232607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64323463|NCT04294784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64323464|NCT04294784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64323465|NCT04294784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323466|NCT04294784|Tubulin Modulators|tubulin modulators|mesh-ancestor
64298658|NCT02085655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64298659|NCT02085655|Antiemetics|antiemetics|mesh-ancestor
64298660|NCT02085655|Autonomic Agents|autonomic agents|mesh-ancestor
64298661|NCT02085655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64869067|NCT01821027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64869068|NCT01821027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869069|NCT01821027|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64869070|NCT01821027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64869071|NCT01821027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869072|NCT01821040|Prednisone|prednisone|mesh-list
64869073|NCT01821040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64869074|NCT01821040|Glucocorticoids|glucocorticoids|mesh-ancestor
64869075|NCT01821040|Hormones|hormones|mesh-ancestor
64869076|NCT01821040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64869077|NCT01821040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637679|NCT03013751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64869078|NCT01821040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64869079|NCT01821040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869080|NCT01821066|Tamoxifen|tamoxifen|mesh-list
64869081|NCT01821066|Palbociclib|palbociclib|mesh-list
64869082|NCT01821066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64869083|NCT01821066|Hormone Antagonists|hormone antagonists|mesh-ancestor
64869084|NCT01821066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64869085|NCT01821066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869086|NCT01821066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64869087|NCT01821066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869100|NCT01821170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869102|NCT01821170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64869103|NCT01821235|Gabapentin|gabapentin|mesh-list
64869104|NCT01821235|Analgesics|analgesics|mesh-ancestor
64869105|NCT01821235|Sensory System Agents|sensory system agents|mesh-ancestor
64417567|NCT04802785|Antioxidants|antioxidants|mesh-ancestor
64417568|NCT04802785|Protective Agents|protective agents|mesh-ancestor
64417569|NCT04802785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417570|NCT04802785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64417571|NCT04802785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64417572|NCT04802785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64417573|NCT04802785|Analgesics|analgesics|mesh-ancestor
64417574|NCT04802785|Sensory System Agents|sensory system agents|mesh-ancestor
64417575|NCT04802785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64417576|NCT04802785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64417577|NCT04802785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64417578|NCT04802785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64869106|NCT01821235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64869107|NCT01821235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869108|NCT01821235|Anticonvulsants|anticonvulsants|mesh-ancestor
64869109|NCT01821235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64869110|NCT01821235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64869111|NCT01821235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64869112|NCT01821235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64869113|NCT01821235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64323467|NCT04294784|Antimitotic Agents|antimitotic agents|mesh-ancestor
64323468|NCT04294784|Mitosis Modulators|mitosis modulators|mesh-ancestor
64323500|NCT02262637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64323501|NCT02262637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323575|NCT00054158|Mitosis Modulators|mitosis modulators|mesh-ancestor
64323576|NCT00054158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64869114|NCT01821235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64869115|NCT01821235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64869116|NCT01821235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869117|NCT01821235|Antimanic Agents|antimanic agents|mesh-ancestor
64869118|NCT01821248|Gemcitabine|gemcitabine|mesh-list
64869119|NCT01821248|Cisplatin|cisplatin|mesh-list
64869120|NCT01821248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869121|NCT01821248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64869122|NCT01821248|Antimetabolites|antimetabolites|mesh-ancestor
64869123|NCT01821248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869150|NCT01821404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869151|NCT01821404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64869152|NCT01821404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64869153|NCT01821404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869155|NCT01821430|Analgesics|analgesics|mesh-ancestor
64869156|NCT01821430|Sensory System Agents|sensory system agents|mesh-ancestor
64869157|NCT01821430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64869158|NCT01821430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869159|NCT01821430|Anticonvulsants|anticonvulsants|mesh-ancestor
64869160|NCT01821430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64869161|NCT01821430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64869162|NCT01821430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323790|NCT04402723|Cytarabine|cytarabine|mesh-list
64323840|NCT05626153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64323841|NCT05626153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323842|NCT02553343|Vaccines|vaccines|mesh-list
64323863|NCT02558894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64323864|NCT02558894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64323865|NCT02558894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323866|NCT02558894|Immunologic Factors|immunologic factors|mesh-ancestor
64323868|NCT02233387|Imidazole|imidazole|mesh-list
64298662|NCT02085655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298663|NCT02085655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64298664|NCT02085655|Glucocorticoids|glucocorticoids|mesh-ancestor
64298665|NCT02085655|Hormones|hormones|mesh-ancestor
64298666|NCT02085655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64298667|NCT02085655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64298668|NCT02085655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64298669|NCT02085655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64298670|NCT02085655|Antimetabolites|antimetabolites|mesh-ancestor
64298671|NCT02085655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298672|NCT02085655|Antiviral Agents|antiviral agents|mesh-ancestor
64298673|NCT02085655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64298674|NCT02085655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298675|NCT02085655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64869163|NCT01821430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64869164|NCT01821430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64869165|NCT01821430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64869166|NCT01821430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64869167|NCT01821430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64869168|NCT01821456|Antiviral Agents|antiviral agents|mesh-list
64869169|NCT01821456|Anti-Infective Agents|anti-infective agents|mesh-list
64869170|NCT01821573|Botulinum Toxins|botulinum toxins|mesh-list
64869203|NCT01821612|Micronutrients|micronutrients|mesh-ancestor
64869204|NCT01821664|Heparin|heparin|mesh-list
64869205|NCT01821664|Anticoagulants|anticoagulants|mesh-ancestor
64869206|NCT01821664|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64869207|NCT01821664|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64869208|NCT01821664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869209|NCT01821703|Spironolactone|spironolactone|mesh-list
64869210|NCT01821703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64869211|NCT01821703|Hormone Antagonists|hormone antagonists|mesh-ancestor
64869212|NCT01821703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64869213|NCT01821703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869214|NCT01821703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64869215|NCT01821703|Diuretics|diuretics|mesh-ancestor
64869216|NCT01821703|Natriuretic Agents|natriuretic agents|mesh-ancestor
64869217|NCT01821846|Liraglutide|liraglutide|mesh-list
64869218|NCT01821846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64869219|NCT01821846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869220|NCT01821846|Incretins|incretins|mesh-ancestor
64869221|NCT01821846|Hormones|hormones|mesh-ancestor
64869222|NCT01821846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64869223|NCT01821872|Acetaminophen|acetaminophen|mesh-list
64869224|NCT01821872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64869225|NCT01821872|Analgesics|analgesics|mesh-ancestor
64869226|NCT01821872|Sensory System Agents|sensory system agents|mesh-ancestor
64323900|NCT02688387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323947|NCT01621243|Antimitotic Agents|antimitotic agents|mesh-ancestor
64323948|NCT01621243|Mitosis Modulators|mitosis modulators|mesh-ancestor
64323950|NCT01621243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64324023|NCT05436535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324024|NCT05436535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64324025|NCT05436535|Immunologic Factors|immunologic factors|mesh-ancestor
64324028|NCT04275518|Cytarabine|cytarabine|mesh-list
64298685|NCT02085655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64298686|NCT02085655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64298687|NCT02085655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64298688|NCT02085655|Growth Substances|growth substances|mesh-ancestor
64298689|NCT02085655|Growth Inhibitors|growth inhibitors|mesh-ancestor
64869227|NCT01821872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64869228|NCT01821872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869229|NCT01821872|Antipyretics|antipyretics|mesh-ancestor
64869230|NCT01821989|Lactoferrin|lactoferrin|mesh-list
64869231|NCT01821989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64869232|NCT01822028|Miglustat|miglustat|mesh-list
64869233|NCT01822028|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
64869243|NCT01822080|Dienogest|dienogest|mesh-list
64869246|NCT01822080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64869247|NCT01822080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869248|NCT01822080|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64869250|NCT01822080|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64869251|NCT01822080|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64869252|NCT01822080|Hormone Antagonists|hormone antagonists|mesh-ancestor
64869253|NCT01822080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64869254|NCT01822080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64869255|NCT01822080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869256|NCT01822210|Botulinum Toxins|botulinum toxins|mesh-list
64869257|NCT01822210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64869258|NCT01822210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64869259|NCT01822210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869260|NCT01822210|Cholinergic Agents|cholinergic agents|mesh-ancestor
64869261|NCT01822210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64869262|NCT01822210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869263|NCT01822405|Tocopherols|tocopherols|mesh-list
64869264|NCT01822405|Vitamin E|vitamin e|mesh-list
64869265|NCT01822405|Tocotrienols|tocotrienols|mesh-list
64869266|NCT01822405|alpha-Tocopherol|alpha-tocopherol|mesh-list
64869267|NCT01822405|Pentoxifylline|pentoxifylline|mesh-list
64869268|NCT01822405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64324065|NCT02557646|Ribavirin|ribavirin|mesh-list
64324112|NCT01578655|Hormones|hormones|mesh-ancestor
64324116|NCT01578655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324194|NCT00258427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64869269|NCT01822405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869270|NCT01822405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869271|NCT01822405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64869272|NCT01822405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64869273|NCT01822405|Protective Agents|protective agents|mesh-ancestor
64869290|NCT01822483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64869291|NCT01822483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869292|NCT01822483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64869293|NCT01822483|Antitubercular Agents|antitubercular agents|mesh-ancestor
64869294|NCT01822483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64869295|NCT01822483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64869296|NCT01822483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869297|NCT01822483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869298|NCT01822509|Nivolumab|nivolumab|mesh-list
64417579|NCT04802785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64417580|NCT04802785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64417581|NCT04802785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64417624|NCT04790383|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
64417625|NCT04790383|Vasodilator Agents|vasodilator agents|mesh-ancestor
64417626|NCT04790383|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64417627|NCT04790383|Protective Agents|protective agents|mesh-ancestor
64324287|NCT05492318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324288|NCT05492318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64324289|NCT05492318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64324290|NCT05492318|Antithrombins|antithrombins|mesh-ancestor
64298690|NCT02085967|Itraconazole|itraconazole|mesh-list
64298691|NCT02085967|Rifampin|rifampin|mesh-list
64298692|NCT02085967|Midazolam|midazolam|mesh-list
64298693|NCT02085967|Bupropion|bupropion|mesh-list
64298694|NCT02085967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64298695|NCT02085967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64298696|NCT02085967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64298697|NCT02085967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298698|NCT02085967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64298699|NCT02085967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64298700|NCT02085967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64298701|NCT02085967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64298702|NCT02085967|Anesthetics, General|anesthetics, general|mesh-ancestor
64298703|NCT02085967|Anesthetics|anesthetics|mesh-ancestor
64298704|NCT02085967|GABA Modulators|gaba modulators|mesh-ancestor
64298705|NCT02085967|GABA Agents|gaba agents|mesh-ancestor
64298706|NCT02085967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64417628|NCT04790383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417629|NCT05615779|Levan|levan|mesh-list
64417630|NCT05615779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869300|NCT01822509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64869301|NCT01822509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869302|NCT01822509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64869303|NCT01822509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869304|NCT01822600|Omeprazole|omeprazole|mesh-list
64869305|NCT01822600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64869306|NCT01822600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64869307|NCT01822600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64869308|NCT01822600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869309|NCT01822600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869310|NCT01822613|Paclitaxel|paclitaxel|mesh-list
64869311|NCT01822613|Docetaxel|docetaxel|mesh-list
64869312|NCT01822613|Irinotecan|irinotecan|mesh-list
64869313|NCT01822613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64869314|NCT01822613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869315|NCT01822613|Tubulin Modulators|tubulin modulators|mesh-ancestor
64869316|NCT01822613|Antimitotic Agents|antimitotic agents|mesh-ancestor
64869317|NCT01822613|Mitosis Modulators|mitosis modulators|mesh-ancestor
64869318|NCT01822613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869319|NCT01822613|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64869320|NCT01822613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64869321|NCT01822613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869322|NCT01822639|Amlodipine|amlodipine|mesh-list
64869331|NCT01822639|Vasodilator Agents|vasodilator agents|mesh-ancestor
64869332|NCT01822639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869333|NCT01822639|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64869334|NCT01822639|Protease Inhibitors|protease inhibitors|mesh-ancestor
64869335|NCT01822730|Risperidone|risperidone|mesh-list
64324342|NCT05491928|Antioxidants|antioxidants|mesh-ancestor
64324356|NCT05487794|Hormones|hormones|mesh-ancestor
64324364|NCT01515007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324367|NCT01515007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324373|NCT02262169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64324374|NCT02262169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64324386|NCT05491694|Mitosis Modulators|mitosis modulators|mesh-ancestor
64324387|NCT05491694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324388|NCT05491694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64324389|NCT05491694|Immunologic Factors|immunologic factors|mesh-ancestor
64324390|NCT05491694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324391|NCT05491694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64324425|NCT01499563|Serotonin Agents|serotonin agents|mesh-ancestor
64869336|NCT01822730|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64869337|NCT01822730|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64869338|NCT01822730|Serotonin Agents|serotonin agents|mesh-ancestor
64869339|NCT01822730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64869340|NCT01822730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417631|NCT04789915|Memantine|memantine|mesh-list
64417632|NCT04789915|Amisulpride|amisulpride|mesh-list
64417633|NCT04789915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64417634|NCT04789915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64417635|NCT04789915|Dopamine Agents|dopamine agents|mesh-ancestor
64417636|NCT04789915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64417637|NCT04789915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417638|NCT04789915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417639|NCT04789915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64417640|NCT04789915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64417641|NCT04789915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64417675|NCT04811209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64324426|NCT01499563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64324491|NCT01482403|Interferon-alpha|interferon-alpha|mesh-list
64324492|NCT01482403|Ribavirin|ribavirin|mesh-list
64324493|NCT01482403|Antiviral Agents|antiviral agents|mesh-ancestor
64324494|NCT01482403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64324495|NCT01482403|Immunologic Factors|immunologic factors|mesh-ancestor
64324496|NCT01482403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298708|NCT02085967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64298709|NCT02085967|Antidepressive Agents|antidepressive agents|mesh-ancestor
64298710|NCT02085967|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64298711|NCT02085967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64298712|NCT02085967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64298713|NCT02085967|Dopamine Agents|dopamine agents|mesh-ancestor
64298714|NCT02085967|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64298715|NCT02085967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64298716|NCT02085967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298717|NCT02085967|Antifungal Agents|antifungal agents|mesh-ancestor
64298718|NCT02085967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64298719|NCT02085967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64417676|NCT04811209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417677|NCT04811209|Sensory System Agents|sensory system agents|mesh-ancestor
64417678|NCT04811209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64417679|NCT04788745|Trimetazidine|trimetazidine|mesh-list
64417680|NCT04788745|Vasodilator Agents|vasodilator agents|mesh-ancestor
64417681|NCT04788355|Hydroxychloroquine|hydroxychloroquine|mesh-list
64417682|NCT04788355|Apixaban|apixaban|mesh-list
64417683|NCT04788355|Antimalarials|antimalarials|mesh-ancestor
64417684|NCT04788355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64417685|NCT04788355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64417686|NCT04788355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64417687|NCT04788355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417689|NCT04788355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64869360|NCT01822808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869362|NCT01822860|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64869363|NCT01822860|Chlorthalidone|chlorthalidone|mesh-list
64869364|NCT01822860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64869365|NCT01822860|Diuretics|diuretics|mesh-ancestor
64869366|NCT01822860|Natriuretic Agents|natriuretic agents|mesh-ancestor
64869367|NCT01822860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869368|NCT01822860|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64869369|NCT01822860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64417697|NCT04799743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417698|NCT04799743|Protective Agents|protective agents|mesh-ancestor
64417725|NCT04810819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64417726|NCT04810819|Protective Agents|protective agents|mesh-ancestor
64417727|NCT04810819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64417728|NCT04810819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417729|NCT04810819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64417730|NCT04810819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64417731|NCT04810819|Respiratory System Agents|respiratory system agents|mesh-ancestor
64417732|NCT04810819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64417733|NCT04810819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417734|NCT04810819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417735|NCT04810819|Vasodilator Agents|vasodilator agents|mesh-ancestor
64324577|NCT02264587|Antiemetics|antiemetics|mesh-ancestor
64324578|NCT02264587|Autonomic Agents|autonomic agents|mesh-ancestor
64324589|NCT05475080|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64298724|NCT02085967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64298725|NCT02085967|Antitubercular Agents|antitubercular agents|mesh-ancestor
64298726|NCT02085967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64298727|NCT02085967|Leprostatic Agents|leprostatic agents|mesh-ancestor
64298728|NCT02085967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64298729|NCT02085967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64298730|NCT02085967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64869375|NCT01822951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869377|NCT01822951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64869378|NCT01822951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869397|NCT01823042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869398|NCT01823042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64869399|NCT01823081|Bevacizumab|bevacizumab|mesh-list
64869400|NCT01823081|Fasudil|fasudil|mesh-list
64869401|NCT01823081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64869402|NCT01823081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869403|NCT01823081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64869404|NCT01823081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64869405|NCT01823081|Growth Substances|growth substances|mesh-ancestor
64869406|NCT01823081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869407|NCT01823081|Growth Inhibitors|growth inhibitors|mesh-ancestor
64869408|NCT01823081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64869409|NCT01823081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64869410|NCT01823081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869411|NCT01823081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64869412|NCT01823081|Vasodilator Agents|vasodilator agents|mesh-ancestor
64869413|NCT01823081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64869414|NCT01823081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869415|NCT01823133|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64869416|NCT01823133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64869417|NCT01823133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64869418|NCT01823133|Antimetabolites|antimetabolites|mesh-ancestor
64869419|NCT01823133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869420|NCT01823133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64417736|NCT04810507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64417737|NCT04810507|Anagliptin|anagliptin|mesh-list
64417738|NCT04810507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64417739|NCT04810507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417740|NCT04810507|Incretins|incretins|mesh-ancestor
64417741|NCT04810507|Hormones|hormones|mesh-ancestor
64417742|NCT04810507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64417743|NCT04810507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64417780|NCT04786327|Pentetic Acid|pentetic acid|mesh-list
64324667|NCT01393639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64324668|NCT01393639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324669|NCT01379209|Mycophenolic Acid|mycophenolic acid|mesh-list
64298731|NCT02085967|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64298732|NCT02085967|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64298733|NCT02085967|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64417781|NCT04786327|Mitosis Modulators|mitosis modulators|mesh-ancestor
64417782|NCT04786327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417783|NCT04786327|Anticoagulants|anticoagulants|mesh-ancestor
64417784|NCT04786327|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64417785|NCT04786327|Chelating Agents|chelating agents|mesh-ancestor
64417786|NCT04786327|Sequestering Agents|sequestering agents|mesh-ancestor
64417797|NCT01667419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417798|NCT01667419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417799|NCT04808791|Trifluridine|trifluridine|mesh-list
64417800|NCT04808791|Oxaliplatin|oxaliplatin|mesh-list
64417801|NCT04808791|Irinotecan|irinotecan|mesh-list
64417802|NCT04808791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417833|NCT03843853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64417835|NCT04784767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64417836|NCT04784767|Immunologic Factors|immunologic factors|mesh-ancestor
64324749|NCT01186861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64324750|NCT01186861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324751|NCT01186861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64324752|NCT01186861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64324766|NCT01175785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324767|NCT01175785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324768|NCT01175785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64324787|NCT05472506|Nivolumab|nivolumab|mesh-list
64298734|NCT02085967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64298736|NCT02091505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64298737|NCT02091505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64298738|NCT02091505|Growth Substances|growth substances|mesh-ancestor
64298739|NCT02091505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298740|NCT02091505|Growth Inhibitors|growth inhibitors|mesh-ancestor
64298741|NCT02091505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417837|NCT04784767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417838|NCT05054179|Ropivacaine|ropivacaine|mesh-list
64869460|NCT01823770|Rotigotine|rotigotine|mesh-list
64417839|NCT05054179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64869469|NCT01823809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64869470|NCT01823809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333648|NCT02373579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333650|NCT02373579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298742|NCT02091817|Oxytocin|oxytocin|mesh-list
64333651|NCT02373579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64298743|NCT02091817|Oxytocics|oxytocics|mesh-ancestor
64324842|NCT01354717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324844|NCT01354717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324845|NCT01354717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64324901|NCT01338883|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64324902|NCT01338883|Efavirenz|efavirenz|mesh-list
64324903|NCT01338883|Cenicriviroc|cenicriviroc|mesh-list
64325008|NCT05265975|Growth Inhibitors|growth inhibitors|mesh-ancestor
64325027|NCT02151305|Anesthetics, General|anesthetics, general|mesh-ancestor
64298744|NCT02091817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64298745|NCT02091817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298746|NCT02086279|Hormones|hormones|mesh-list
64869471|NCT01823809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64869473|NCT01823809|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64869474|NCT01823809|Purinergic Agonists|purinergic agonists|mesh-ancestor
64869475|NCT01823809|Purinergic Agents|purinergic agents|mesh-ancestor
64869476|NCT01823809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64869477|NCT01823809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869478|NCT01823848|Mineral Oil|mineral oil|mesh-list
64869479|NCT01823848|Emollients|emollients|mesh-ancestor
64869480|NCT01823848|Dermatologic Agents|dermatologic agents|mesh-ancestor
64869481|NCT01823965|Ranibizumab|ranibizumab|mesh-list
64869482|NCT01823965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64869483|NCT01823965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64869484|NCT01823965|Growth Substances|growth substances|mesh-ancestor
64869485|NCT01823965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869486|NCT01823965|Growth Inhibitors|growth inhibitors|mesh-ancestor
64869487|NCT01823965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869488|NCT01824043|Ranibizumab|ranibizumab|mesh-list
64869489|NCT01824043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64869490|NCT01824043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64869491|NCT01824043|Growth Substances|growth substances|mesh-ancestor
64869525|NCT01824251|Immunologic Factors|immunologic factors|mesh-ancestor
64869526|NCT01824251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869534|NCT01824264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64869535|NCT01824264|Protease Inhibitors|protease inhibitors|mesh-ancestor
64869536|NCT01824264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869537|NCT01824264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869538|NCT01824264|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64417912|NCT01667107|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64869539|NCT01824420|Mandelic Acids|mandelic acids|mesh-list
64869540|NCT01824420|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64869541|NCT01824420|Oxybutynin|oxybutynin|mesh-list
64869542|NCT01824420|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64869543|NCT01824420|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64417913|NCT01667107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64417914|NCT01667107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64869544|NCT01824420|Cholinergic Agents|cholinergic agents|mesh-ancestor
64417915|NCT01667107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64417916|NCT01667107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64869545|NCT01824420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64869546|NCT01824420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869547|NCT01824420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325092|NCT03161457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64325098|NCT02576912|Analgesics|analgesics|mesh-ancestor
64869548|NCT01824420|Urological Agents|urological agents|mesh-ancestor
64869549|NCT01824420|Parasympatholytics|parasympatholytics|mesh-ancestor
64869550|NCT01824420|Autonomic Agents|autonomic agents|mesh-ancestor
64869551|NCT01824420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64869552|NCT01824420|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64869553|NCT01824420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64869554|NCT01824420|Renal Agents|renal agents|mesh-ancestor
64869555|NCT01824433|Fluoxetine|fluoxetine|mesh-list
64869556|NCT01824433|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64869557|NCT01824433|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64869558|NCT01824433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64869559|NCT01824433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64417917|NCT01667107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417919|NCT01667107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64869561|NCT01824433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64869562|NCT01824433|Serotonin Agents|serotonin agents|mesh-ancestor
64869563|NCT01824433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869564|NCT01824433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64869565|NCT01824433|Antidepressive Agents|antidepressive agents|mesh-ancestor
64325170|NCT02269969|Tobramycin|tobramycin|mesh-list
64325174|NCT03555578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64325177|NCT03555578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325179|NCT03555578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64325186|NCT02484404|Olaparib|olaparib|mesh-list
64325187|NCT02484404|Cediranib|cediranib|mesh-list
64325201|NCT03163407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325202|NCT03163407|Sympathomimetics|sympathomimetics|mesh-ancestor
64325203|NCT03163407|Autonomic Agents|autonomic agents|mesh-ancestor
64325204|NCT03163407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64325205|NCT03163407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64325206|NCT03163407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64325207|NCT02547974|Vaccines|vaccines|mesh-list
64298747|NCT02086279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64298748|NCT02086279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298750|NCT02091973|Tacrolimus|tacrolimus|mesh-list
64298751|NCT02091973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64298752|NCT02091973|Immunologic Factors|immunologic factors|mesh-ancestor
64298753|NCT02091973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298754|NCT02091973|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64298755|NCT02091973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298756|NCT02091973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298757|NCT02091973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64298758|NCT03558295|Anticoagulants|anticoagulants|mesh-list
64869566|NCT01824433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64869567|NCT01824433|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64869568|NCT01824433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64869569|NCT01824433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869570|NCT01824433|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64869571|NCT01824459|Oxaliplatin|oxaliplatin|mesh-list
64869572|NCT01824459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869573|NCT01824524|Hydromorphone|hydromorphone|mesh-list
64869574|NCT01824524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64869575|NCT01824524|Narcotics|narcotics|mesh-ancestor
64869576|NCT01824524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64869577|NCT01824524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869578|NCT01824524|Analgesics|analgesics|mesh-ancestor
64869579|NCT01824524|Sensory System Agents|sensory system agents|mesh-ancestor
64869580|NCT01824524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64869581|NCT01824615|Sunitinib|sunitinib|mesh-list
64869582|NCT01824615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417933|NCT04589611|GABA Agents|gaba agents|mesh-ancestor
64869583|NCT01824615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64869584|NCT01824615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64869585|NCT01824615|Growth Substances|growth substances|mesh-ancestor
64869586|NCT01824615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417970|NCT02590003|Tubulin Modulators|tubulin modulators|mesh-ancestor
64417971|NCT02590003|Antimitotic Agents|antimitotic agents|mesh-ancestor
64417972|NCT02590003|Mitosis Modulators|mitosis modulators|mesh-ancestor
64417973|NCT02590003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417974|NCT04134325|Pembrolizumab|pembrolizumab|mesh-list
64417975|NCT04134325|Nivolumab|nivolumab|mesh-list
64417976|NCT04134325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64417977|NCT04134325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417978|NCT04134325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64417979|NCT04134325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417980|NCT05474053|Ticagrelor|ticagrelor|mesh-list
64417981|NCT05474053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64417982|NCT05474053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64417983|NCT05474053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64417984|NCT05474053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64417985|NCT05474053|Purinergic Agents|purinergic agents|mesh-ancestor
64417986|NCT05474053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64417987|NCT05474053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298766|NCT02089399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64298767|NCT02089399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298768|NCT02089399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64298769|NCT02089399|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64298770|NCT02089399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64298771|NCT03557437|Amoxicillin|amoxicillin|mesh-list
64418024|NCT05473741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64418025|NCT05473741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64869607|NCT01824758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64869608|NCT01824758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64869609|NCT01824758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64869610|NCT01824758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64869611|NCT01824758|Adrenergic Agents|adrenergic agents|mesh-ancestor
64869612|NCT01824758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64869613|NCT01824888|Anti-Infective Agents|anti-infective agents|mesh-list
64869614|NCT01824888|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64869615|NCT01824927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64869616|NCT01824927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64869617|NCT01824992|Interferons|interferons|mesh-list
64869618|NCT01824992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869619|NCT01824992|Antiviral Agents|antiviral agents|mesh-ancestor
64869620|NCT01824992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64869621|NCT01825031|Azithromycin|azithromycin|mesh-list
64869623|NCT01825031|Raltegravir Potassium|raltegravir potassium|mesh-list
64869624|NCT01825031|Fluconazole|fluconazole|mesh-list
64418026|NCT05473741|Dopamine Agents|dopamine agents|mesh-ancestor
64869625|NCT01825031|Albendazole|albendazole|mesh-list
64418028|NCT05473741|Dopamine Agonists|dopamine agonists|mesh-ancestor
64869645|NCT01825031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64418085|NCT05700955|Pembrolizumab|pembrolizumab|mesh-list
64869647|NCT01825031|Antimetabolites|antimetabolites|mesh-ancestor
64869648|NCT01825031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64869649|NCT01825031|Anthelmintics|anthelmintics|mesh-ancestor
64869650|NCT01825031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64869651|NCT01825031|Anticestodal Agents|anticestodal agents|mesh-ancestor
64869652|NCT01825031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64869653|NCT01825031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64418086|NCT05700955|Temozolomide|temozolomide|mesh-list
64418087|NCT05700955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64418089|NCT05700955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64418090|NCT05700955|Alkylating Agents|alkylating agents|mesh-ancestor
64418091|NCT05700955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418092|NCT01650519|Ibuprofen|ibuprofen|mesh-list
64418093|NCT01650519|Ketorolac|ketorolac|mesh-list
64418094|NCT01650519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64418095|NCT01650519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64869657|NCT01825031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869658|NCT01825044|Cyclosporine|cyclosporine|mesh-list
64325339|NCT04719273|Estrogens|estrogens|mesh-list
64325340|NCT04719273|Progestins|progestins|mesh-ancestor
64325341|NCT04719273|Hormones|hormones|mesh-ancestor
64325342|NCT04719273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64325425|NCT02157467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64869659|NCT01825044|Cyclosporins|cyclosporins|mesh-list
64869660|NCT01825044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869661|NCT01825044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869662|NCT01825044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64869663|NCT01825044|Immunologic Factors|immunologic factors|mesh-ancestor
64869664|NCT01825044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869665|NCT01825044|Antifungal Agents|antifungal agents|mesh-ancestor
64869666|NCT01825044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64869667|NCT01825044|Dermatologic Agents|dermatologic agents|mesh-ancestor
64869668|NCT01825044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64869669|NCT01825044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64869670|NCT01825083|Ketamine|ketamine|mesh-list
64869671|NCT01825083|Analgesics|analgesics|mesh-ancestor
64869672|NCT01825083|Sensory System Agents|sensory system agents|mesh-ancestor
64869673|NCT01825083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64869674|NCT01825083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869675|NCT01825083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64638271|NCT00210470|Indomethacin|indomethacin|mesh-list
64869676|NCT01825083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64869677|NCT01825083|Anesthetics, General|anesthetics, general|mesh-ancestor
64869678|NCT01825083|Anesthetics|anesthetics|mesh-ancestor
64869679|NCT01825083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64298773|NCT03557437|Potassium Citrate|potassium citrate|mesh-list
64298774|NCT03557437|Esomeprazole|esomeprazole|mesh-list
64298775|NCT03557437|Bismuth|bismuth|mesh-list
64298776|NCT03557437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298779|NCT03557437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64298780|NCT03557437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64298781|NCT03557437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64298782|NCT03557437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64298783|NCT03557437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64298784|NCT03557437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298785|NCT03557437|Antacids|antacids|mesh-ancestor
64298786|NCT03557437|Diuretics|diuretics|mesh-ancestor
64869680|NCT01825083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64418154|NCT05346445|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64869681|NCT01825083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64869682|NCT01825083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64869683|NCT01825083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869684|NCT01825109|Vaccines|vaccines|mesh-list
64869685|NCT01825109|Immunologic Factors|immunologic factors|mesh-ancestor
64869686|NCT01825109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418155|NCT05346445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64418156|NCT05346445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418157|NCT01649271|Trastuzumab|trastuzumab|mesh-list
64418158|NCT01649271|Afatinib|afatinib|mesh-list
64418159|NCT01649271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64418160|NCT01649271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418161|NCT01649271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64418162|NCT01649271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418163|NCT01649271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418165|NCT05556889|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64325575|NCT01373931|Contraceptive Agents|contraceptive agents|mesh-ancestor
64418166|NCT05556889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64325587|NCT02160743|Antimetabolites|antimetabolites|mesh-ancestor
64325588|NCT02160743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325661|NCT04984317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64298788|NCT03557437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298790|NCT03557437|Respiratory System Agents|respiratory system agents|mesh-ancestor
64298791|NCT02089633|BCT-100|bct-100|mesh-list
64418167|NCT05556889|Trace Elements|trace elements|mesh-ancestor
64418168|NCT05556889|Micronutrients|micronutrients|mesh-ancestor
64418169|NCT05556889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418170|NCT04901715|Albuterol|albuterol|mesh-list
64418171|NCT04901715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64869687|NCT01825395|Amifampridine|amifampridine|mesh-list
64869700|NCT01825447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64869701|NCT01825447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869703|NCT01825447|Sensory System Agents|sensory system agents|mesh-ancestor
64869704|NCT01825447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64869705|NCT01825447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64869706|NCT01825447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64869708|NCT01825473|Erythromycin Estolate|erythromycin estolate|mesh-list
64869709|NCT01825473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64869710|NCT01825473|Erythromycin stearate|erythromycin stearate|mesh-list
64869711|NCT01825473|Phenobarbital|phenobarbital|mesh-list
64869712|NCT01825473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64869713|NCT01825473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64869714|NCT01825473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64869715|NCT01825473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64869716|NCT01825473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869717|NCT01825473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869718|NCT01825473|Anticonvulsants|anticonvulsants|mesh-ancestor
64418202|NCT02400333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64418203|NCT02400333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418204|NCT02400333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418206|NCT02399475|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
64418207|NCT02399475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64418208|NCT02399475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418209|NCT02399163|Fluorides|fluorides|mesh-list
64418210|NCT02399163|Cariostatic Agents|cariostatic agents|mesh-ancestor
64418211|NCT02399163|Protective Agents|protective agents|mesh-ancestor
64418212|NCT02399163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418213|NCT02397837|Pramipexole|pramipexole|mesh-list
64418214|NCT02397837|Antioxidants|antioxidants|mesh-ancestor
64869719|NCT01825473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64869720|NCT01825473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64869739|NCT01825603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64869740|NCT01825603|Antimetabolites|antimetabolites|mesh-ancestor
64869741|NCT01825603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418215|NCT02397837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418216|NCT02397837|Protective Agents|protective agents|mesh-ancestor
64325740|NCT04965597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64325741|NCT04965597|Immunologic Factors|immunologic factors|mesh-ancestor
64325742|NCT04965597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64325748|NCT01020097|Fluorides|fluorides|mesh-list
64325749|NCT01020097|Cariostatic Agents|cariostatic agents|mesh-ancestor
64325750|NCT01020097|Protective Agents|protective agents|mesh-ancestor
64325751|NCT01020097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325752|NCT02154269|Lenograstim|lenograstim|mesh-list
64325753|NCT02154269|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64418217|NCT02397837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418218|NCT02397837|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64418219|NCT02397837|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64418223|NCT05549167|Sirolimus|sirolimus|mesh-list
64418253|NCT05542381|Lubricant Eye Drops|lubricant eye drops|mesh-list
64418254|NCT05542381|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64418255|NCT05542381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64418256|NCT05542381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64418257|NCT05542381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64418258|NCT05542381|Analgesics|analgesics|mesh-ancestor
64418259|NCT05542381|Sensory System Agents|sensory system agents|mesh-ancestor
64418260|NCT05542381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64869742|NCT01825603|Antiviral Agents|antiviral agents|mesh-ancestor
64869745|NCT01825603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64869747|NCT01825603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869748|NCT01825616|Vitamin D|vitamin d|mesh-list
64869749|NCT01825616|Ergocalciferols|ergocalciferols|mesh-list
64869750|NCT01825616|Vitamins|vitamins|mesh-ancestor
64869751|NCT01825616|Micronutrients|micronutrients|mesh-ancestor
64869752|NCT01825616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869753|NCT01825616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64869754|NCT01825616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64869755|NCT01825720|Insulin|insulin|mesh-list
64869756|NCT01825720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64869757|NCT01825720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869758|NCT01825733|Palonosetron|palonosetron|mesh-list
64869759|NCT01825733|Ramosetron|ramosetron|mesh-list
64869760|NCT01825733|Antiemetics|antiemetics|mesh-ancestor
64869761|NCT01825733|Autonomic Agents|autonomic agents|mesh-ancestor
64869762|NCT01825733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64869763|NCT01825733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869764|NCT01825733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64869765|NCT01825733|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64869766|NCT01825733|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64869767|NCT01825733|Serotonin Agents|serotonin agents|mesh-ancestor
64869768|NCT01825733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64869769|NCT01825733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333652|NCT02373579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64325757|NCT04914741|Cyclophosphamide|cyclophosphamide|mesh-list
64325758|NCT04914741|Rituximab|rituximab|mesh-list
64325769|NCT04914741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64325770|NCT04914741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64325771|NCT04914741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64298792|NCT02089633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64298793|NCT02086747|Acetaminophen|acetaminophen|mesh-list
64298794|NCT02086747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64298795|NCT02086747|Analgesics|analgesics|mesh-ancestor
64298796|NCT02086747|Sensory System Agents|sensory system agents|mesh-ancestor
64298797|NCT02086747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64298798|NCT02086747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298799|NCT02086747|Antipyretics|antipyretics|mesh-ancestor
64298800|NCT02086825|Rifaximin|rifaximin|mesh-list
64298801|NCT02086825|Lactulose|lactulose|mesh-list
64298802|NCT02086825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64298803|NCT02086825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64298804|NCT02086825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64298805|NCT02086903|Clopidogrel|clopidogrel|mesh-list
64298806|NCT02086903|Ticagrelor|ticagrelor|mesh-list
64869770|NCT01825850|Irbesartan|irbesartan|mesh-list
64869771|NCT01825850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64869772|NCT01825850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64869773|NCT01825850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64869774|NCT01825850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869775|NCT01825863|Ropivacaine|ropivacaine|mesh-list
64869776|NCT01825863|Anesthetics, Local|anesthetics, local|mesh-ancestor
64869777|NCT01825863|Anesthetics|anesthetics|mesh-ancestor
64869778|NCT01825863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64418261|NCT05542381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869779|NCT01825863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418262|NCT05542381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64418263|NCT05542381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64418264|NCT05542147|Fenofibrate|fenofibrate|mesh-list
64418265|NCT05542147|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64418269|NCT05548465|Sufentanil|sufentanil|mesh-list
64869780|NCT01825863|Sensory System Agents|sensory system agents|mesh-ancestor
64333657|NCT02365857|Bupivacaine|bupivacaine|mesh-list
64869794|NCT01825928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64869795|NCT01825928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869796|NCT01825928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64869797|NCT01825928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64869798|NCT01825928|Dopamine Agents|dopamine agents|mesh-ancestor
64869800|NCT01825993|Bupivacaine|bupivacaine|mesh-list
64869801|NCT01825993|Anesthetics, Local|anesthetics, local|mesh-ancestor
64869802|NCT01825993|Anesthetics|anesthetics|mesh-ancestor
64869803|NCT01825993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64869804|NCT01825993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869805|NCT01825993|Sensory System Agents|sensory system agents|mesh-ancestor
64869806|NCT01825993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64869807|NCT01825993|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64869808|NCT01825993|Narcotics|narcotics|mesh-ancestor
64418311|NCT04326283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64418312|NCT04326283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64418313|NCT04326283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298807|NCT02086903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64298808|NCT02086903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64298809|NCT02086903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64298811|NCT02086903|Purinergic Agents|purinergic agents|mesh-ancestor
64298812|NCT02086903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64298813|NCT02086903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418314|NCT04326283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64418315|NCT04326283|Protective Agents|protective agents|mesh-ancestor
64418316|NCT05700565|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64418317|NCT05700565|Immunologic Factors|immunologic factors|mesh-ancestor
64418318|NCT05700565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418359|NCT05540275|Bevacizumab|bevacizumab|mesh-list
64418360|NCT05540275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64869809|NCT01825993|Analgesics|analgesics|mesh-ancestor
64869810|NCT01826149|Propofol|propofol|mesh-list
64869811|NCT01826149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64869812|NCT01826149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64869814|NCT01826149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64869848|NCT01826747|Progestins|progestins|mesh-ancestor
64869849|NCT01826747|Hormones|hormones|mesh-ancestor
64869850|NCT01826747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64869851|NCT01826747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869852|NCT01826773|Palmitic Acid|palmitic acid|mesh-list
64869853|NCT01826773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869854|NCT01826773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64325901|NCT01001923|Analgesics|analgesics|mesh-ancestor
64298814|NCT02086903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298815|NCT02087215|Boron|boron|mesh-list
64298816|NCT02087215|Trace Elements|trace elements|mesh-ancestor
64298817|NCT02087215|Micronutrients|micronutrients|mesh-ancestor
64298818|NCT02087215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298819|NCT02087527|Dexamethasone|dexamethasone|mesh-list
64298821|NCT02087527|Antiemetics|antiemetics|mesh-ancestor
64869855|NCT01826786|JNJ-42165279|jnj-42165279|mesh-list
64869856|NCT01826786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64869857|NCT01826786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869858|NCT01826864|Sargramostim|sargramostim|mesh-list
64869859|NCT01826864|Immunologic Factors|immunologic factors|mesh-ancestor
64869860|NCT01826864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869861|NCT01826916|Ecallantide|ecallantide|mesh-list
64869862|NCT01826916|Analgesics|analgesics|mesh-ancestor
64869863|NCT01826916|Sensory System Agents|sensory system agents|mesh-ancestor
64869864|NCT01826916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64869865|NCT01826916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869866|NCT01826916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64869867|NCT01826916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64869868|NCT01826916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64869869|NCT01826916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64869870|NCT01827007|Polygeline|polygeline|mesh-list
64869871|NCT01827007|Plasma Substitutes|plasma substitutes|mesh-ancestor
64869872|NCT01827007|Blood Substitutes|blood substitutes|mesh-ancestor
64869873|NCT01827020|Lidocaine|lidocaine|mesh-list
64869874|NCT01827020|Ketamine|ketamine|mesh-list
64869875|NCT01827020|Anesthetics, Local|anesthetics, local|mesh-ancestor
64869876|NCT01827020|Anesthetics|anesthetics|mesh-ancestor
64869877|NCT01827020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64869878|NCT01827020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869879|NCT01827020|Sensory System Agents|sensory system agents|mesh-ancestor
64869880|NCT01827020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64869881|NCT01827020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64869888|NCT01827020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64325998|NCT02268019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64325999|NCT02268019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326003|NCT02268019|Autonomic Agents|autonomic agents|mesh-ancestor
64326011|NCT03114111|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64326012|NCT03114111|Dermatologic Agents|dermatologic agents|mesh-ancestor
64326013|NCT01110889|S 20098|s 20098|mesh-list
64326014|NCT01110889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64326015|NCT01110889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64326016|NCT01110889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326017|NCT01106989|Lidocaine|lidocaine|mesh-list
64326030|NCT00975091|Entecavir|entecavir|mesh-list
64326038|NCT02535416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64298835|NCT02087683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64298837|NCT02092363|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64298838|NCT02092363|Carboplatin|carboplatin|mesh-list
64298839|NCT02092363|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
64869889|NCT01827020|Anesthetics, General|anesthetics, general|mesh-ancestor
64869890|NCT01827020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64869891|NCT01827020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64869892|NCT01827020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64869893|NCT01827059|Bosentan|bosentan|mesh-list
64869894|NCT01827059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64869895|NCT01827059|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64869896|NCT01827059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869897|NCT01827072|Immunoglobulins|immunoglobulins|mesh-list
64869898|NCT01827072|Immunologic Factors|immunologic factors|mesh-ancestor
64869899|NCT01827072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869900|NCT01827124|Oxytocin|oxytocin|mesh-list
64869901|NCT01827124|Carbetocin|carbetocin|mesh-list
64869902|NCT01827124|Oxytocics|oxytocics|mesh-ancestor
64869903|NCT01827124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64869904|NCT01827124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869905|NCT01827137|Lenalidomide|lenalidomide|mesh-list
64869906|NCT01827137|Molgramostim|molgramostim|mesh-list
64869907|NCT01827137|Sargramostim|sargramostim|mesh-list
64869908|NCT01827137|Immunologic Factors|immunologic factors|mesh-ancestor
64869909|NCT01827137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869910|NCT01827137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64869911|NCT01827137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64869912|NCT01827137|Growth Substances|growth substances|mesh-ancestor
64869939|NCT01827293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64869940|NCT01827293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64869941|NCT01827293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64869942|NCT01827293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64869943|NCT01827293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64869944|NCT01827293|GABA Modulators|gaba modulators|mesh-ancestor
64869945|NCT01827293|GABA Agents|gaba agents|mesh-ancestor
64869946|NCT01827293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64869947|NCT01827293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64869948|NCT01827293|Antipruritics|antipruritics|mesh-ancestor
64869949|NCT01827293|Dermatologic Agents|dermatologic agents|mesh-ancestor
64869950|NCT01827293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64869951|NCT01827293|Histamine Antagonists|histamine antagonists|mesh-ancestor
64869952|NCT01827293|Histamine Agents|histamine agents|mesh-ancestor
64869953|NCT01827293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64869954|NCT01827293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64869955|NCT01827293|Anesthetics, Local|anesthetics, local|mesh-ancestor
64869956|NCT01827293|Anesthetics|anesthetics|mesh-ancestor
64326040|NCT02535416|Anesthetics, Local|anesthetics, local|mesh-ancestor
64869957|NCT01827293|Sensory System Agents|sensory system agents|mesh-ancestor
64869958|NCT01827345|Vitamin D|vitamin d|mesh-list
64869959|NCT01827345|Vitamins|vitamins|mesh-ancestor
64869960|NCT01827345|Micronutrients|micronutrients|mesh-ancestor
64869961|NCT01827345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869962|NCT01827345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64869963|NCT01827397|Vaccines|vaccines|mesh-list
64869964|NCT01827397|Immunologic Factors|immunologic factors|mesh-ancestor
64869965|NCT01827397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64869989|NCT01827540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64869990|NCT01827540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64869991|NCT01827618|Sirolimus|sirolimus|mesh-list
64869992|NCT01827618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64869993|NCT01827618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64869994|NCT01827618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64869995|NCT01827618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64869996|NCT01827618|Antifungal Agents|antifungal agents|mesh-ancestor
64869997|NCT01827618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64869998|NCT01827618|Immunologic Factors|immunologic factors|mesh-ancestor
64869999|NCT01827618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870000|NCT01827722|Dexamethasone|dexamethasone|mesh-list
64870001|NCT01827722|Dexamethasone acetate|dexamethasone acetate|mesh-list
64870002|NCT01827722|Ranibizumab|ranibizumab|mesh-list
64870003|NCT01827722|BB 1101|bb 1101|mesh-list
64870004|NCT01827722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64326148|NCT04745949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64326149|NCT04745949|Immunologic Factors|immunologic factors|mesh-ancestor
64326154|NCT04745949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326155|NCT04745949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326156|NCT04745949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64298840|NCT02092363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64298841|NCT02092363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64298842|NCT02092363|Tubulin Modulators|tubulin modulators|mesh-ancestor
64298843|NCT02092363|Antimitotic Agents|antimitotic agents|mesh-ancestor
64298844|NCT02092363|Mitosis Modulators|mitosis modulators|mesh-ancestor
64298845|NCT02092363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298846|NCT02092363|Immunologic Factors|immunologic factors|mesh-ancestor
64870005|NCT01827722|Antiemetics|antiemetics|mesh-ancestor
64870006|NCT01827722|Autonomic Agents|autonomic agents|mesh-ancestor
64870007|NCT01827722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870008|NCT01827722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870009|NCT01827722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64870010|NCT01827722|Glucocorticoids|glucocorticoids|mesh-ancestor
64870011|NCT01827722|Hormones|hormones|mesh-ancestor
64870012|NCT01827722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64870013|NCT01827722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64870014|NCT01827722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870015|NCT01827722|Protease Inhibitors|protease inhibitors|mesh-ancestor
64870016|NCT01827722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870017|NCT01827722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870018|NCT01827722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64870019|NCT01827722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64870020|NCT01827722|Growth Substances|growth substances|mesh-ancestor
64870049|NCT01827878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64870050|NCT01827878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870051|NCT01827878|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64870052|NCT01827878|Protease Inhibitors|protease inhibitors|mesh-ancestor
64870053|NCT01827878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870055|NCT01827878|Protective Agents|protective agents|mesh-ancestor
64870056|NCT01828125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64870058|NCT01828125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64870059|NCT01828125|Hormones|hormones|mesh-ancestor
64870060|NCT01828125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64326273|NCT02154737|Antimetabolites|antimetabolites|mesh-ancestor
64326274|NCT02154737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326275|NCT02154737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64326276|NCT02154737|Antiviral Agents|antiviral agents|mesh-ancestor
64326277|NCT02154737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64326278|NCT02154737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326279|NCT02154737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64326280|NCT02154737|Immunologic Factors|immunologic factors|mesh-ancestor
64326281|NCT02154737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298864|NCT02092597|Incretins|incretins|mesh-ancestor
64298865|NCT02092597|Hormones|hormones|mesh-ancestor
64298866|NCT02092597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64298867|NCT02092597|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64298868|NCT02092597|Protease Inhibitors|protease inhibitors|mesh-ancestor
64298869|NCT02092597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298870|NCT02092597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298871|NCT02090101|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64298872|NCT02090101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64870061|NCT01828125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870062|NCT01828203|Minocycline|minocycline|mesh-list
64870063|NCT01828203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64870064|NCT01828203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64870065|NCT01828294|Immunoglobulins|immunoglobulins|mesh-list
64870066|NCT01828294|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64870067|NCT01828294|Antibodies|antibodies|mesh-list
64870068|NCT01828294|Immunologic Factors|immunologic factors|mesh-ancestor
64870070|NCT01828346|Azacitidine|azacitidine|mesh-list
64870087|NCT01828359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64870089|NCT01828385|Analgesics|analgesics|mesh-ancestor
64870090|NCT01828385|Sensory System Agents|sensory system agents|mesh-ancestor
64870091|NCT01828385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870092|NCT01828385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870093|NCT01828385|Anesthetics|anesthetics|mesh-ancestor
64870094|NCT01828385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64870095|NCT01828385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64870096|NCT01828385|Anticonvulsants|anticonvulsants|mesh-ancestor
64870097|NCT01828385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64870098|NCT01828385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64870099|NCT01828385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870100|NCT01828385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64870101|NCT01828385|Tocolytic Agents|tocolytic agents|mesh-ancestor
64870102|NCT01828385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64870103|NCT01828437|Pyridoxine|pyridoxine|mesh-list
64870104|NCT01828437|Prednisolone|prednisolone|mesh-list
64870105|NCT01828437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64870106|NCT01828437|Methylprednisolone|methylprednisolone|mesh-list
64870107|NCT01828437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64870108|NCT01828437|Prednisolone acetate|prednisolone acetate|mesh-list
64418529|NCT02582983|Antiviral Agents|antiviral agents|mesh-ancestor
64870126|NCT01828437|Micronutrients|micronutrients|mesh-ancestor
64870128|NCT01828463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870129|NCT01828463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870130|NCT01828489|Mitoxantrone|mitoxantrone|mesh-list
64870131|NCT01828489|Analgesics|analgesics|mesh-ancestor
64870132|NCT01828489|Sensory System Agents|sensory system agents|mesh-ancestor
64870160|NCT01828736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870174|NCT01828788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64326304|NCT04474093|Lithium Carbonate|lithium carbonate|mesh-list
64870176|NCT01828879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64326305|NCT04474093|Methamphetamine|methamphetamine|mesh-list
64326306|NCT04474093|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64326307|NCT04474093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64326308|NCT04474093|Sympathomimetics|sympathomimetics|mesh-ancestor
64298873|NCT02093143|Remifentanil|remifentanil|mesh-list
64298874|NCT02093143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64298875|NCT02093143|Narcotics|narcotics|mesh-ancestor
64298876|NCT02093143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64298877|NCT02093143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298878|NCT02093143|Analgesics|analgesics|mesh-ancestor
64298879|NCT02093143|Sensory System Agents|sensory system agents|mesh-ancestor
64298880|NCT02093143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870177|NCT01828879|Immunologic Factors|immunologic factors|mesh-ancestor
64870178|NCT01828879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870179|NCT01828879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64870180|NCT01828879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870181|NCT01828879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870182|NCT01828892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64870183|NCT01828892|Vancomycin|vancomycin|mesh-list
64870184|NCT01828892|Meropenem|meropenem|mesh-list
64870185|NCT01828892|Ceftazidime|ceftazidime|mesh-list
64870186|NCT01828892|Cefotaxime|cefotaxime|mesh-list
64870187|NCT01828892|Cefoxitin|cefoxitin|mesh-list
64870188|NCT01828892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64870189|NCT01828970|Insulin Aspart|insulin aspart|mesh-list
64870190|NCT01828970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64326313|NCT04474093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326321|NCT04474093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64326326|NCT02159027|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64326327|NCT02159027|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64326328|NCT02159027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64326329|NCT02159027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64326336|NCT02161991|Autonomic Agents|autonomic agents|mesh-ancestor
64326345|NCT05439356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64326346|NCT05439356|Tubulin Modulators|tubulin modulators|mesh-ancestor
64326347|NCT05439356|Antimitotic Agents|antimitotic agents|mesh-ancestor
64326348|NCT05439356|Mitosis Modulators|mitosis modulators|mesh-ancestor
64298882|NCT02093299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64298883|NCT02093299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64298884|NCT02093299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64298885|NCT02093299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64298886|NCT02093299|Purinergic Agents|purinergic agents|mesh-ancestor
64870191|NCT01828970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870192|NCT01829178|Cisplatin|cisplatin|mesh-list
64333658|NCT02365857|Anesthetics, Local|anesthetics, local|mesh-ancestor
64333659|NCT02365857|Anesthetics|anesthetics|mesh-ancestor
64870195|NCT01829178|Silymarin|silymarin|mesh-list
64870196|NCT01829178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870197|NCT01829178|Tubulin Modulators|tubulin modulators|mesh-ancestor
64870198|NCT01829178|Antimitotic Agents|antimitotic agents|mesh-ancestor
64870199|NCT01829178|Mitosis Modulators|mitosis modulators|mesh-ancestor
64870200|NCT01829178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870201|NCT01829178|Antimetabolites|antimetabolites|mesh-ancestor
64870202|NCT01829178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64870203|NCT01829178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64870204|NCT01829178|Immunologic Factors|immunologic factors|mesh-ancestor
64870205|NCT01829178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870206|NCT01829178|Antioxidants|antioxidants|mesh-ancestor
64870207|NCT01829178|Protective Agents|protective agents|mesh-ancestor
64870208|NCT01829334|Listerine|listerine|mesh-list
64870209|NCT01829334|Fluorides|fluorides|mesh-list
64870210|NCT01829334|Sodium Fluoride|sodium fluoride|mesh-list
64870211|NCT01829334|Fluorides, Topical|fluorides, topical|mesh-list
64870212|NCT01829334|Cariostatic Agents|cariostatic agents|mesh-ancestor
64870213|NCT01829334|Protective Agents|protective agents|mesh-ancestor
64333660|NCT02365857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64333661|NCT02365857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418621|NCT02582671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64870274|NCT01829841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870275|NCT01829841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870276|NCT01829893|Tamsulosin|tamsulosin|mesh-list
64870277|NCT01829893|Finasteride|finasteride|mesh-list
64870278|NCT01829893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64870279|NCT01829893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64870280|NCT01829893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64870281|NCT01829893|Adrenergic Agents|adrenergic agents|mesh-ancestor
64870282|NCT01829893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64870283|NCT01829893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870284|NCT01829893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870285|NCT01829893|Urological Agents|urological agents|mesh-ancestor
64870286|NCT01829893|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64870287|NCT01829893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64326440|NCT00945763|Sensory System Agents|sensory system agents|mesh-ancestor
64870288|NCT01829893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870289|NCT01829893|Hormone Antagonists|hormone antagonists|mesh-ancestor
64870290|NCT01829893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64870292|NCT01830153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870293|NCT01830153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64870294|NCT01830153|Immunologic Factors|immunologic factors|mesh-ancestor
64870295|NCT01830153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870296|NCT01830244|Paclitaxel|paclitaxel|mesh-list
64333662|NCT02365857|Sensory System Agents|sensory system agents|mesh-ancestor
64870297|NCT01830244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64870298|NCT01830244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870299|NCT01830244|Tubulin Modulators|tubulin modulators|mesh-ancestor
64870300|NCT01830244|Antimitotic Agents|antimitotic agents|mesh-ancestor
64870301|NCT01830244|Mitosis Modulators|mitosis modulators|mesh-ancestor
64870302|NCT01830244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870303|NCT01830270|Paclitaxel|paclitaxel|mesh-list
64870304|NCT01830270|Epirubicin|epirubicin|mesh-list
64870305|NCT01830270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64870306|NCT01830270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870307|NCT01830270|Tubulin Modulators|tubulin modulators|mesh-ancestor
64870308|NCT01830270|Antimitotic Agents|antimitotic agents|mesh-ancestor
64418726|NCT05677945|Simvastatin|simvastatin|mesh-list
64870318|NCT01830530|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64870319|NCT01830530|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64870320|NCT01830530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870321|NCT01830530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64326605|NCT05429450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64326799|NCT00769795|Goserelin|goserelin|mesh-list
64298888|NCT02093299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298889|NCT02093299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298890|NCT00454753|Dasatinib|dasatinib|mesh-list
64298891|NCT00454753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870322|NCT01830530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64870323|NCT01830530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64870342|NCT01832311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870343|NCT01832311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64870344|NCT01832311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64870345|NCT01832311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64870346|NCT01832311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870347|NCT01832311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870349|NCT01832350|Dextromethorphan|dextromethorphan|mesh-list
64870350|NCT01832350|Antitussive Agents|antitussive agents|mesh-ancestor
64870351|NCT01832350|Respiratory System Agents|respiratory system agents|mesh-ancestor
64870352|NCT01832350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64870353|NCT01832350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64870354|NCT01832350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64870355|NCT01832350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870356|NCT01832350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870357|NCT01832350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64870359|NCT01832350|Adrenergic Agents|adrenergic agents|mesh-ancestor
64870360|NCT01832350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64333663|NCT02365857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64333664|NCT02365857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64333665|NCT02365857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64333666|NCT02365857|Analgesics|analgesics|mesh-ancestor
64333667|NCT02365857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64333668|NCT02365857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64333669|NCT02365857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64333670|NCT02365857|Adrenergic Agents|adrenergic agents|mesh-ancestor
64333671|NCT02365857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64333672|NCT02365857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333674|NCT02365935|Cisplatin|cisplatin|mesh-list
64333675|NCT02365935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64333676|NCT02365935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333677|NCT02365935|Tubulin Modulators|tubulin modulators|mesh-ancestor
64333678|NCT02365935|Antimitotic Agents|antimitotic agents|mesh-ancestor
64333679|NCT02365935|Mitosis Modulators|mitosis modulators|mesh-ancestor
64418773|NCT05677555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418774|NCT02343939|Cytarabine|cytarabine|mesh-list
64870362|NCT01832350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64870363|NCT01832350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64326822|NCT02164097|Anticoagulants|anticoagulants|mesh-ancestor
64326876|NCT02171585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64326879|NCT02171585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870364|NCT01832350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64870365|NCT01832350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870366|NCT01832350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64870367|NCT01832350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64870368|NCT01832350|Cholinergic Agents|cholinergic agents|mesh-ancestor
64870369|NCT01832350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64870370|NCT01832350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64870371|NCT01832350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64870372|NCT01832350|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64870373|NCT01832350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64870374|NCT01833221|Lidocaine|lidocaine|mesh-list
64870375|NCT01833221|Anesthetics, Local|anesthetics, local|mesh-ancestor
64870376|NCT01833221|Anesthetics|anesthetics|mesh-ancestor
64870377|NCT01833221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64870378|NCT01833221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870379|NCT01833221|Sensory System Agents|sensory system agents|mesh-ancestor
64870380|NCT01833221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870381|NCT01833221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64870382|NCT01833221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64870383|NCT01833221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64870384|NCT01833221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64870385|NCT01833221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327082|NCT02168543|Alendronate|alendronate|mesh-list
64327085|NCT01372995|Vitamin D|vitamin d|mesh-list
64327092|NCT01372995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64327093|NCT04239859|Cyclosporine|cyclosporine|mesh-list
64327094|NCT04239859|Methotrexate|methotrexate|mesh-list
64870386|NCT01834820|Dexamethasone|dexamethasone|mesh-list
64870407|NCT01834820|Respiratory System Agents|respiratory system agents|mesh-ancestor
64870408|NCT01834820|Mydriatics|mydriatics|mesh-ancestor
64870409|NCT01834820|Sympathomimetics|sympathomimetics|mesh-ancestor
64870410|NCT01834820|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64870411|NCT01835197|Abrocitinib|abrocitinib|mesh-list
64870412|NCT01835197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64870413|NCT01835197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870414|NCT01835197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870415|NCT01835418|Amlodipine|amlodipine|mesh-list
64870416|NCT01835418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64870417|NCT01835418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64870418|NCT01835418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64870419|NCT01835418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870420|NCT01835418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64870421|NCT01835418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870422|NCT01835418|Vasodilator Agents|vasodilator agents|mesh-ancestor
64327122|NCT02757521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64327123|NCT02757521|Anesthetics, General|anesthetics, general|mesh-ancestor
64327124|NCT02757521|Anesthetics|anesthetics|mesh-ancestor
64327125|NCT02757521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64327177|NCT00694135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64327178|NCT00694135|Protease Inhibitors|protease inhibitors|mesh-ancestor
64298892|NCT00454753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64298894|NCT00454753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298895|NCT02093533|Eculizumab|eculizumab|mesh-list
64298896|NCT02093533|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64298897|NCT02093533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64298898|NCT02093533|Immunologic Factors|immunologic factors|mesh-ancestor
64298899|NCT02093533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298900|NCT03297879|Metformin|metformin|mesh-list
64298901|NCT03297879|Exenatide|exenatide|mesh-list
64298902|NCT03297879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64298903|NCT03297879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298904|NCT03297879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64298905|NCT03297879|Incretins|incretins|mesh-ancestor
64298906|NCT03297879|Hormones|hormones|mesh-ancestor
64298907|NCT03297879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64298908|NCT02093845|Everolimus|everolimus|mesh-list
64870423|NCT01835678|Linagliptin|linagliptin|mesh-list
64870424|NCT01835678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64870425|NCT01835678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870426|NCT01835678|Incretins|incretins|mesh-ancestor
64870427|NCT01835678|Hormones|hormones|mesh-ancestor
64639014|NCT03954990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64870428|NCT01835678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64870429|NCT01835678|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64870430|NCT01835678|Protease Inhibitors|protease inhibitors|mesh-ancestor
64870431|NCT01835678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870432|NCT01835678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870434|NCT01836614|Anesthetics, Local|anesthetics, local|mesh-ancestor
64333680|NCT02365935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333681|NCT02365623|Bedaquiline|bedaquiline|mesh-list
64333682|NCT02365623|Diarylquinolines|diarylquinolines|mesh-list
64327373|NCT00829309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64327374|NCT00829309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64327480|NCT02669043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64327482|NCT02760407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64327483|NCT02760407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64327508|NCT02281045|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64333683|NCT02365623|Antitubercular Agents|antitubercular agents|mesh-ancestor
64333684|NCT02365623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64333685|NCT02365623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64333686|NCT03112707|Aspirin|aspirin|mesh-list
64333687|NCT03112707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64333688|NCT03112707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64333689|NCT03112707|Analgesics|analgesics|mesh-ancestor
64333690|NCT03112707|Sensory System Agents|sensory system agents|mesh-ancestor
64333691|NCT03112707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64333692|NCT03112707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870435|NCT01836614|Anesthetics|anesthetics|mesh-ancestor
64870436|NCT01836614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64870437|NCT01836614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870438|NCT01836614|Sensory System Agents|sensory system agents|mesh-ancestor
64870439|NCT01836614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870440|NCT01836614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64870441|NCT01836614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64870442|NCT01836614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64870443|NCT01836614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64298909|NCT02093845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64298910|NCT02093845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64298911|NCT02093845|Immunologic Factors|immunologic factors|mesh-ancestor
64298912|NCT02093845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298913|NCT04489797|Acalabrutinib|acalabrutinib|mesh-list
64298914|NCT04489797|Rabeprazole|rabeprazole|mesh-list
64298915|NCT04489797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64298916|NCT04489797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64298917|NCT04489797|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64298918|NCT04489797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298919|NCT04489797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298920|NCT04489797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64298921|NCT02094001|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64870444|NCT01836614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870445|NCT01837251|Bevacizumab|bevacizumab|mesh-list
64870446|NCT01837251|Carboplatin|carboplatin|mesh-list
64870447|NCT01837251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64870448|NCT01837251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870449|NCT01837251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64870450|NCT01837251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64870451|NCT01837251|Growth Substances|growth substances|mesh-ancestor
64870452|NCT01837251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870453|NCT01837251|Growth Inhibitors|growth inhibitors|mesh-ancestor
64870454|NCT01837290|Midazolam|midazolam|mesh-list
64870455|NCT01837290|Dexmedetomidine|dexmedetomidine|mesh-list
64870456|NCT01837290|Bupivacaine|bupivacaine|mesh-list
64870457|NCT01837290|Anesthetics, Local|anesthetics, local|mesh-ancestor
64870458|NCT01837290|Anesthetics|anesthetics|mesh-ancestor
64870459|NCT01837290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64870460|NCT01837290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870461|NCT01837290|Sensory System Agents|sensory system agents|mesh-ancestor
64870462|NCT01837290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870463|NCT01837290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64870464|NCT01837290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64870465|NCT01837290|Analgesics|analgesics|mesh-ancestor
64870467|NCT01837290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64418807|NCT02343159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870476|NCT01837290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64870477|NCT01837290|Anesthetics, General|anesthetics, general|mesh-ancestor
64870478|NCT01837290|GABA Modulators|gaba modulators|mesh-ancestor
64327664|NCT02173691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64328175|NCT02387619|Vasodilator Agents|vasodilator agents|mesh-ancestor
64328176|NCT02387619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64328353|NCT02403687|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64328354|NCT02403687|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64328491|NCT02183441|Antiviral Agents|antiviral agents|mesh-ancestor
64329303|NCT02186249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64329718|NCT00317395|Antithrombins|antithrombins|mesh-ancestor
64329916|NCT02371473|Natriuretic Agents|natriuretic agents|mesh-ancestor
64330426|NCT00135421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64330427|NCT00135421|Serotonin Agents|serotonin agents|mesh-ancestor
64330800|NCT03528967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64330838|NCT02363751|Growth Inhibitors|growth inhibitors|mesh-ancestor
64330839|NCT03279471|Sertraline|sertraline|mesh-list
64330840|NCT03279471|Antidepressive Agents|antidepressive agents|mesh-ancestor
64330917|NCT04462471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330918|NCT04462471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64330968|NCT05791721|Etoricoxib|etoricoxib|mesh-list
64330983|NCT05791721|Sensory System Agents|sensory system agents|mesh-ancestor
64331090|NCT05790603|Hemostatics|hemostatics|mesh-list
64870479|NCT01837290|GABA Agents|gaba agents|mesh-ancestor
64870480|NCT01837433|Prednisone|prednisone|mesh-list
64870481|NCT01837433|Glucocorticoids|glucocorticoids|mesh-list
64870482|NCT01837433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64870483|NCT01837433|Hormones|hormones|mesh-ancestor
64870484|NCT01837433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64870485|NCT01837433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870486|NCT01837433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64870487|NCT01837433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870488|NCT01837446|Diphenhydramine|diphenhydramine|mesh-list
64870489|NCT01837446|Promethazine|promethazine|mesh-list
64870490|NCT01837446|Lidocaine|lidocaine|mesh-list
64870491|NCT01837446|Morphine|morphine|mesh-list
64870492|NCT01837446|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64870493|NCT01837446|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
64331227|NCT05789173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64331228|NCT05789173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64331260|NCT05746481|Pemetrexed|pemetrexed|mesh-list
64331261|NCT05746481|Atezolizumab|atezolizumab|mesh-list
64331290|NCT05681195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331295|NCT05669274|Caseins|caseins|mesh-list
64331296|NCT05669274|Chelating Agents|chelating agents|mesh-ancestor
64331319|NCT05644561|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64331359|NCT05530421|Venetoclax|venetoclax|mesh-list
64331375|NCT05526755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298923|NCT02094001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298924|NCT02096419|Clopidogrel|clopidogrel|mesh-list
64298925|NCT02096419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64298926|NCT02096419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64298927|NCT02096419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64298928|NCT02096419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64298929|NCT02096419|Purinergic Agents|purinergic agents|mesh-ancestor
64298930|NCT02096419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64298931|NCT02096419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298932|NCT02096419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298933|NCT02094157|Heparin|heparin|mesh-list
64870494|NCT01837446|Anesthetics, Local|anesthetics, local|mesh-ancestor
64870495|NCT01837446|Anesthetics|anesthetics|mesh-ancestor
64870496|NCT01837446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64870497|NCT01837446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870498|NCT01837446|Sensory System Agents|sensory system agents|mesh-ancestor
64870499|NCT01837446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870500|NCT01837446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64870501|NCT01837446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64870502|NCT01837446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64870503|NCT01837446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64870504|NCT01837446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870505|NCT01837446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64870506|NCT01837446|Narcotics|narcotics|mesh-ancestor
64870507|NCT01837446|Analgesics|analgesics|mesh-ancestor
64870508|NCT01837446|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64870509|NCT01837446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64870510|NCT01837446|Antiemetics|antiemetics|mesh-ancestor
64870511|NCT01837446|Autonomic Agents|autonomic agents|mesh-ancestor
64870512|NCT01837446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64870513|NCT01837446|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64870514|NCT01837446|Histamine Antagonists|histamine antagonists|mesh-ancestor
64870515|NCT01837446|Histamine Agents|histamine agents|mesh-ancestor
64298936|NCT02094157|Tinzaparin|tinzaparin|mesh-list
64870516|NCT01837446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64418827|NCT04778527|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64418828|NCT04778527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64298937|NCT02094157|Dalteparin|dalteparin|mesh-list
64298938|NCT02094157|Warfarin|warfarin|mesh-list
64298939|NCT02094157|Anticoagulants|anticoagulants|mesh-ancestor
64298940|NCT02094157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64298941|NCT02094157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64418829|NCT04778527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870524|NCT01838850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64870525|NCT01838850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64870526|NCT01838850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64870527|NCT01838850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870528|NCT01839344|Acarbose|acarbose|mesh-list
64870529|NCT01839344|Quercetin|quercetin|mesh-list
64870530|NCT01839344|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64870531|NCT01839344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870532|NCT01839344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870533|NCT01839344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64331632|NCT05122182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331638|NCT05092360|Paclitaxel|paclitaxel|mesh-list
64331712|NCT04910061|Niacin|niacin|mesh-list
64331761|NCT04887467|Dopamine Agents|dopamine agents|mesh-ancestor
64331768|NCT04868409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64331772|NCT04861064|Sirolimus|sirolimus|mesh-list
64331896|NCT04495296|Paclitaxel|paclitaxel|mesh-list
64331902|NCT04495296|Tubulin Modulators|tubulin modulators|mesh-ancestor
64331903|NCT04495296|Antimitotic Agents|antimitotic agents|mesh-ancestor
64331911|NCT04495296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64298942|NCT02094157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298944|NCT02094313|Anticholesteremic Agents|anticholesteremic agents|mesh-list
64298945|NCT02094313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64298946|NCT02094313|Antimetabolites|antimetabolites|mesh-ancestor
64298947|NCT02094313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298948|NCT02094313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64298949|NCT02094313|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64298950|NCT02094313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870534|NCT01839344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870535|NCT01839344|Antioxidants|antioxidants|mesh-ancestor
64870536|NCT01839344|Protective Agents|protective agents|mesh-ancestor
64870537|NCT01839578|Heparin|heparin|mesh-list
64870538|NCT01839578|Calcium heparin|calcium heparin|mesh-list
64870539|NCT01839578|Anticoagulants|anticoagulants|mesh-ancestor
64870540|NCT01839578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870541|NCT01839578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64870542|NCT01839578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64870543|NCT01839994|Androgens|androgens|mesh-list
64870544|NCT01839994|Hormones|hormones|mesh-ancestor
64870545|NCT01839994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64333693|NCT03112707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64333694|NCT03112707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64333695|NCT03112707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64870546|NCT01839994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870547|NCT01840189|Hydrocortisone|hydrocortisone|mesh-list
64870548|NCT01840189|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64870549|NCT01840189|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64870550|NCT01840189|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64870551|NCT01840189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64870552|NCT01840254|Dexmedetomidine|dexmedetomidine|mesh-list
64870553|NCT01840254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64870554|NCT01840254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64870555|NCT01840254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331990|NCT04147546|Artenimol|artenimol|mesh-list
64332011|NCT04077723|Obinutuzumab|obinutuzumab|mesh-list
64332242|NCT03406715|Nivolumab|nivolumab|mesh-list
64332243|NCT03406715|Ipilimumab|ipilimumab|mesh-list
64332244|NCT03406715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64332245|NCT03406715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332246|NCT03406715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64332247|NCT03406715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332248|NCT03363763|Sirolimus|sirolimus|mesh-list
64332249|NCT03363763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64332250|NCT03363763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64332251|NCT03363763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64332252|NCT03363763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332253|NCT03363763|Antifungal Agents|antifungal agents|mesh-ancestor
64332254|NCT03363763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64298951|NCT02094391|Ipilimumab|ipilimumab|mesh-list
64298952|NCT02094391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64870556|NCT01840254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64870557|NCT01840254|Analgesics|analgesics|mesh-ancestor
64870558|NCT01840254|Sensory System Agents|sensory system agents|mesh-ancestor
64870559|NCT01840254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870560|NCT01840254|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64870561|NCT01840254|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64870562|NCT01840254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64870563|NCT01840254|Adrenergic Agents|adrenergic agents|mesh-ancestor
64870564|NCT01840254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64870565|NCT01840254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418867|NCT05696509|Anesthetics, General|anesthetics, general|mesh-ancestor
64870566|NCT01840384|Micronutrients|micronutrients|mesh-list
64870567|NCT01840384|Trace Elements|trace elements|mesh-list
64870568|NCT01840384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870569|NCT01840423|Levodopa|levodopa|mesh-list
64870570|NCT01840423|Carbidopa|carbidopa|mesh-list
64870571|NCT01840423|Entacapone|entacapone|mesh-list
64870572|NCT01840423|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64870573|NCT01840423|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64870574|NCT01840423|Dopamine Agents|dopamine agents|mesh-ancestor
64870575|NCT01840423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64870576|NCT01840423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870577|NCT01840423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870578|NCT01840423|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64870580|NCT01840423|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64870586|NCT01840683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64332289|NCT03182751|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64332290|NCT03182751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64332291|NCT03182751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332482|NCT02806687|Gemcitabine|gemcitabine|mesh-list
64332587|NCT02455557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332588|NCT02455557|Immunologic Factors|immunologic factors|mesh-ancestor
64332591|NCT02401139|Ketamine|ketamine|mesh-list
64298954|NCT02094391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64332611|NCT02390635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64332699|NCT01970722|Antimetabolites|antimetabolites|mesh-ancestor
64298955|NCT02094391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298956|NCT02094469|Cilostazol|cilostazol|mesh-list
64298957|NCT02094469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64298958|NCT02094469|Autonomic Agents|autonomic agents|mesh-ancestor
64870587|NCT01840683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870588|NCT01840696|Regadenoson|regadenoson|mesh-list
64870589|NCT01840696|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64870590|NCT01840696|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64870591|NCT01840696|Purinergic Agonists|purinergic agonists|mesh-ancestor
64870592|NCT01840696|Purinergic Agents|purinergic agents|mesh-ancestor
64870593|NCT01840696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64870594|NCT01840696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870595|NCT01840696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870596|NCT01840774|Ketamine|ketamine|mesh-list
64870597|NCT01840774|Analgesics|analgesics|mesh-list
64870598|NCT01840774|Sensory System Agents|sensory system agents|mesh-ancestor
64870599|NCT01840774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870600|NCT01840774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870601|NCT01840774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64870602|NCT01840774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64870603|NCT01840774|Anesthetics, General|anesthetics, general|mesh-ancestor
64870604|NCT01840774|Anesthetics|anesthetics|mesh-ancestor
64870605|NCT01840774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64870606|NCT01840774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64870607|NCT01840774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64870608|NCT01840774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64870609|NCT01840774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870610|NCT01840800|Ropivacaine|ropivacaine|mesh-list
64870611|NCT01840800|Anesthetics, Local|anesthetics, local|mesh-ancestor
64870612|NCT01840800|Anesthetics|anesthetics|mesh-ancestor
64870613|NCT01840800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64870614|NCT01840800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870615|NCT01840800|Sensory System Agents|sensory system agents|mesh-ancestor
64870616|NCT01840800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870617|NCT01840813|Misoprostol|misoprostol|mesh-list
64870624|NCT01840813|Oxytocics|oxytocics|mesh-ancestor
64870625|NCT01841008|Tacrolimus|tacrolimus|mesh-list
64870626|NCT01841008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64870627|NCT01841008|Immunologic Factors|immunologic factors|mesh-ancestor
64870628|NCT01841008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870629|NCT01841008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64870630|NCT01841008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870631|NCT01841008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870632|NCT01841099|Mesalamine|mesalamine|mesh-list
64870633|NCT01841099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64870634|NCT01841099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64870635|NCT01841099|Analgesics|analgesics|mesh-ancestor
64870636|NCT01841099|Sensory System Agents|sensory system agents|mesh-ancestor
64870637|NCT01841099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870638|NCT01841099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870639|NCT01841099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64870657|NCT01841164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64870658|NCT01841164|Respiratory System Agents|respiratory system agents|mesh-ancestor
64870659|NCT01841164|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64870660|NCT01841164|Hormone Antagonists|hormone antagonists|mesh-ancestor
64870661|NCT01841164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64332792|NCT01371630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64332793|NCT01371630|Glucocorticoids|glucocorticoids|mesh-ancestor
64870662|NCT01841164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870664|NCT01841164|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64870665|NCT01841164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870666|NCT01841242|Chlorhexidine|chlorhexidine|mesh-list
64870689|NCT01841307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870690|NCT01841307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64870691|NCT01841307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64870692|NCT01841307|Respiratory System Agents|respiratory system agents|mesh-ancestor
64870693|NCT01841320|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64870694|NCT01841320|Methadone|methadone|mesh-list
64870695|NCT01841320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64870696|NCT01841320|Narcotics|narcotics|mesh-ancestor
64870697|NCT01841320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64870698|NCT01841320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870699|NCT01841320|Analgesics|analgesics|mesh-ancestor
64870700|NCT01841320|Sensory System Agents|sensory system agents|mesh-ancestor
64870701|NCT01841320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870702|NCT01841320|Antitussive Agents|antitussive agents|mesh-ancestor
64870703|NCT01841320|Respiratory System Agents|respiratory system agents|mesh-ancestor
64870704|NCT01841320|Antiviral Agents|antiviral agents|mesh-ancestor
64870705|NCT01841320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64870706|NCT01841411|Metronidazole|metronidazole|mesh-list
64870707|NCT01841411|Acetylcysteine|acetylcysteine|mesh-list
64870708|NCT01841411|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64870709|NCT01841411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64870710|NCT01841411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64870711|NCT01841411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64332860|NCT00783367|Lenalidomide|lenalidomide|mesh-list
64870712|NCT01841411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64870713|NCT01841411|Antiviral Agents|antiviral agents|mesh-ancestor
64870714|NCT01841411|Expectorants|expectorants|mesh-ancestor
64332868|NCT00783367|Antiemetics|antiemetics|mesh-ancestor
64332875|NCT00783367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64298959|NCT02094469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64332895|NCT00447772|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64332896|NCT00447772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64332945|NCT02257697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64332946|NCT02257697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64332947|NCT02257697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64332950|NCT04468711|Vitamins|vitamins|mesh-ancestor
64298960|NCT02094469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298961|NCT02094469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64298962|NCT02094469|Respiratory System Agents|respiratory system agents|mesh-ancestor
64298963|NCT02094469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64298964|NCT02094469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64870715|NCT01841411|Respiratory System Agents|respiratory system agents|mesh-ancestor
64870716|NCT01841411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64870717|NCT01841411|Antioxidants|antioxidants|mesh-ancestor
64870718|NCT01841411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870719|NCT01841411|Protective Agents|protective agents|mesh-ancestor
64870720|NCT01841411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870721|NCT01841411|Antidotes|antidotes|mesh-ancestor
64870722|NCT01841424|Benzocaine|benzocaine|mesh-list
64870723|NCT01841424|Anesthetics, Local|anesthetics, local|mesh-ancestor
64870724|NCT01841424|Anesthetics|anesthetics|mesh-ancestor
64870725|NCT01841424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64870726|NCT01841424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870727|NCT01841424|Sensory System Agents|sensory system agents|mesh-ancestor
64870728|NCT01841424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870729|NCT01841463|Vemurafenib|vemurafenib|mesh-list
64870730|NCT01841463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870731|NCT01841463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64870732|NCT01841463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333015|NCT02207699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333016|NCT02207699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333081|NCT02199431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64333082|NCT02199431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333145|NCT02295280|Antiemetics|antiemetics|mesh-ancestor
64333146|NCT02295280|Autonomic Agents|autonomic agents|mesh-ancestor
64333186|NCT05488405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870733|NCT01841463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870734|NCT01841502|Paroxetine|paroxetine|mesh-list
64870735|NCT01841502|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64870736|NCT01841502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64870737|NCT01841502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64870738|NCT01841502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870739|NCT01841502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64870740|NCT01841502|Serotonin Agents|serotonin agents|mesh-ancestor
64870741|NCT01841502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870742|NCT01841502|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64870743|NCT01841502|Antidepressive Agents|antidepressive agents|mesh-ancestor
64870744|NCT01841502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64870745|NCT01841502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64870777|NCT01841827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870778|NCT01841827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64870779|NCT01841827|Respiratory System Agents|respiratory system agents|mesh-ancestor
64870780|NCT01841827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64870781|NCT01841827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64870782|NCT01841827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870783|NCT01841827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64870784|NCT01841827|Vasodilator Agents|vasodilator agents|mesh-ancestor
64870785|NCT01841827|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64870786|NCT01841827|Protective Agents|protective agents|mesh-ancestor
64333318|NCT02220803|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64333319|NCT02220803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333387|NCT02739997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333398|NCT04467931|Amlodipine|amlodipine|mesh-list
64333405|NCT04467931|Candesartan cilexetil|candesartan cilexetil|mesh-list
64333406|NCT04467931|Ramipril|ramipril|mesh-list
64333407|NCT04467931|Olmesartan|olmesartan|mesh-list
64333408|NCT04467931|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64870787|NCT01841827|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64870788|NCT01841827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64870789|NCT01841827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870790|NCT01841996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64870791|NCT01842074|Bortezomib|bortezomib|mesh-list
64870792|NCT01842074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870793|NCT01842087|Iproplatin|iproplatin|mesh-list
64870794|NCT01842087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870795|NCT01842100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64870796|NCT01842100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64870797|NCT01842113|Rifaximin|rifaximin|mesh-list
64870798|NCT01842113|Lactulose|lactulose|mesh-list
64870799|NCT01842113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64870800|NCT01842113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64870801|NCT01842113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64870802|NCT01842139|Poly I-C|poly i-c|mesh-list
64870803|NCT01842139|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64870804|NCT01842139|Poly ICLC|poly iclc|mesh-list
64870805|NCT01842139|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64870806|NCT01842139|Basiliximab|basiliximab|mesh-list
64870807|NCT01842139|Interferon Inducers|interferon inducers|mesh-ancestor
64870808|NCT01842139|Immunologic Factors|immunologic factors|mesh-ancestor
64870809|NCT01842139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870810|NCT01842139|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64870863|NCT01842269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870864|NCT01842269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870865|NCT01842321|Abiraterone Acetate|abiraterone acetate|mesh-list
64870866|NCT01842321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870867|NCT01842321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64419155|NCT03009019|Celecoxib|celecoxib|mesh-list
64870883|NCT01842373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64870884|NCT01842373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64870885|NCT01842373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64870886|NCT01842373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64333474|NCT04467931|Sympatholytics|sympatholytics|mesh-ancestor
64870887|NCT01842373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870888|NCT01842516|Delpazolid|delpazolid|mesh-list
64870902|NCT01842893|Fentanyl|fentanyl|mesh-list
64870918|NCT01842932|Cholinergic Agents|cholinergic agents|mesh-ancestor
64333480|NCT04467931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64298965|NCT02094469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298966|NCT02094469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64298967|NCT02094469|Vasodilator Agents|vasodilator agents|mesh-ancestor
64298968|NCT02094469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64298969|NCT02094469|Protective Agents|protective agents|mesh-ancestor
64298970|NCT02094469|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64298971|NCT02094469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64298972|NCT02094469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298973|NCT02094703|Levofloxacin|levofloxacin|mesh-list
64298974|NCT02094703|Ofloxacin|ofloxacin|mesh-list
64298975|NCT02094703|Solifenacin Succinate|solifenacin succinate|mesh-list
64870919|NCT01842932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64870920|NCT01842932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870921|NCT01842932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870922|NCT01842932|Parasympatholytics|parasympatholytics|mesh-ancestor
64870923|NCT01842932|Autonomic Agents|autonomic agents|mesh-ancestor
64870924|NCT01842932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870925|NCT01843010|Parecoxib|parecoxib|mesh-list
64870926|NCT01843010|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64870927|NCT01843010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64870928|NCT01843010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870929|NCT01843010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870930|NCT01843010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64870931|NCT01843010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64419268|NCT01663987|Parasympatholytics|parasympatholytics|mesh-ancestor
64870933|NCT01843010|Sensory System Agents|sensory system agents|mesh-ancestor
64870934|NCT01843010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64333582|NCT03112551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64333583|NCT04466917|Paclitaxel|paclitaxel|mesh-list
64333584|NCT04466917|Bevacizumab|bevacizumab|mesh-list
64333585|NCT04466917|Carboplatin|carboplatin|mesh-list
64298976|NCT02094703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64298977|NCT02094703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64298978|NCT02094703|Renal Agents|renal agents|mesh-ancestor
64298979|NCT02094703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64298980|NCT02094703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64298981|NCT02094703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64298982|NCT02094703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64870935|NCT01843010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870936|NCT01843010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64870937|NCT01843010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64870938|NCT01843075|Liraglutide|liraglutide|mesh-list
64870939|NCT01843075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64870940|NCT01843075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870941|NCT01843075|Incretins|incretins|mesh-ancestor
64870942|NCT01843075|Hormones|hormones|mesh-ancestor
64870943|NCT01843075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64870944|NCT01843088|Mannitol|mannitol|mesh-list
64870945|NCT01843088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64870946|NCT01843088|Diuretics|diuretics|mesh-ancestor
64870947|NCT01843088|Natriuretic Agents|natriuretic agents|mesh-ancestor
64870948|NCT01843088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870949|NCT01843127|Exenatide|exenatide|mesh-list
64870950|NCT01843127|Ranolazine|ranolazine|mesh-list
64870951|NCT01843127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64870952|NCT01843127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870953|NCT01843127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64870956|NCT01843127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64333673|NCT02365935|Paclitaxel|paclitaxel|mesh-list
64298983|NCT02094703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298984|NCT02094703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64298985|NCT02094703|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64298986|NCT02094703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64870957|NCT01843127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64870958|NCT01843127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64870959|NCT01843127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870960|NCT01843153|Ropivacaine|ropivacaine|mesh-list
64870961|NCT01843153|Anesthetics, Local|anesthetics, local|mesh-ancestor
64870962|NCT01843153|Anesthetics|anesthetics|mesh-ancestor
64870963|NCT01843153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64870964|NCT01843153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870965|NCT01843153|Sensory System Agents|sensory system agents|mesh-ancestor
64870966|NCT01843153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64870967|NCT01843166|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64870968|NCT01843166|Estrogens|estrogens|mesh-ancestor
64870969|NCT01843166|Hormones|hormones|mesh-ancestor
64870970|NCT01843166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64870971|NCT01843166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870972|NCT01843179|Cytarabine|cytarabine|mesh-list
64870973|NCT01843179|Sulindac|sulindac|mesh-list
64333855|NCT03500731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64333892|NCT05092841|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64333893|NCT05092841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64333894|NCT05092841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333895|NCT05092841|Sensory System Agents|sensory system agents|mesh-ancestor
64333896|NCT05092841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64333936|NCT02358057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64333937|NCT02358057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333953|NCT02225093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64870974|NCT01843179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64870975|NCT01843179|Antimetabolites|antimetabolites|mesh-ancestor
64870976|NCT01843179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64870977|NCT01843179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64870978|NCT01843179|Antiviral Agents|antiviral agents|mesh-ancestor
64870979|NCT01843179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64870980|NCT01843179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64870981|NCT01843179|Immunologic Factors|immunologic factors|mesh-ancestor
64419309|NCT02393547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64870982|NCT01843179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419310|NCT02574637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64871024|NCT01843309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871025|NCT01843309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64871026|NCT01843309|Diuretics|diuretics|mesh-ancestor
64871027|NCT01843309|Natriuretic Agents|natriuretic agents|mesh-ancestor
64871028|NCT01843439|Pyridoxine|pyridoxine|mesh-list
64871029|NCT01843439|Vitamin B Complex|vitamin b complex|mesh-ancestor
64871030|NCT01843439|Vitamins|vitamins|mesh-ancestor
64871031|NCT01843439|Micronutrients|micronutrients|mesh-ancestor
64334028|NCT02290717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871032|NCT01843439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871033|NCT01843452|Capecitabine|capecitabine|mesh-list
64334029|NCT02290717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64334036|NCT02225795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64334037|NCT02225795|Immunologic Factors|immunologic factors|mesh-ancestor
64334038|NCT02225795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334039|NCT02225795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64334041|NCT02225795|Alkylating Agents|alkylating agents|mesh-ancestor
64334042|NCT02225795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334043|NCT02225795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334044|NCT02225795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64334046|NCT02360007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64334047|NCT02360007|Narcotics|narcotics|mesh-ancestor
64298987|NCT02094703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64298988|NCT02094703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64298989|NCT02094703|Cholinergic Agents|cholinergic agents|mesh-ancestor
64298990|NCT02094703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64871055|NCT01843556|Nootropic Agents|nootropic agents|mesh-ancestor
64871056|NCT01843647|Cisplatin|cisplatin|mesh-list
64871057|NCT01843647|Vinorelbine|vinorelbine|mesh-list
64871058|NCT01843647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871059|NCT01843647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64871060|NCT01843647|Tubulin Modulators|tubulin modulators|mesh-ancestor
64871061|NCT01843647|Antimitotic Agents|antimitotic agents|mesh-ancestor
64871062|NCT01843647|Mitosis Modulators|mitosis modulators|mesh-ancestor
64871063|NCT01843647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871064|NCT01843699|Topiramate|topiramate|mesh-list
64871065|NCT01843699|Anticonvulsants|anticonvulsants|mesh-ancestor
64871066|NCT01843699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64871067|NCT01843699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871068|NCT01843725|Capecitabine|capecitabine|mesh-list
64871069|NCT01843725|Aflibercept|aflibercept|mesh-list
64871070|NCT01843725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64871071|NCT01843725|Antimetabolites|antimetabolites|mesh-ancestor
64871072|NCT01843725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871073|NCT01843725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871074|NCT01843725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64871075|NCT01843725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64871076|NCT01843725|Growth Substances|growth substances|mesh-ancestor
64871081|NCT01843738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64871083|NCT01843738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871084|NCT01843829|Paclitaxel|paclitaxel|mesh-list
64871085|NCT01843829|Carboplatin|carboplatin|mesh-list
64871086|NCT01843829|Capecitabine|capecitabine|mesh-list
64871087|NCT01843829|Oxaliplatin|oxaliplatin|mesh-list
64871088|NCT01843829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64871089|NCT01843829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871090|NCT01843829|Tubulin Modulators|tubulin modulators|mesh-ancestor
64334097|NCT02220023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334098|NCT02220023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64334099|NCT02220023|Respiratory System Agents|respiratory system agents|mesh-ancestor
64334100|NCT02220023|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64334101|NCT02220023|Antioxidants|antioxidants|mesh-ancestor
64334113|NCT02356965|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64334114|NCT02356965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64381574|NCT05527275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381575|NCT05527275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381576|NCT05527275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64381577|NCT05527275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64381578|NCT05527275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381579|NCT05527275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381580|NCT02429765|Formoterol Fumarate|formoterol fumarate|mesh-list
64381581|NCT02429765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64381582|NCT02429765|Autonomic Agents|autonomic agents|mesh-ancestor
64381583|NCT02429765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64381584|NCT02429765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871091|NCT01843829|Antimitotic Agents|antimitotic agents|mesh-ancestor
64871092|NCT01843829|Mitosis Modulators|mitosis modulators|mesh-ancestor
64871093|NCT01843829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871094|NCT01843829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64871095|NCT01843829|Antimetabolites|antimetabolites|mesh-ancestor
64871096|NCT01843868|Prednisolone|prednisolone|mesh-list
64871097|NCT01843868|Cyclophosphamide|cyclophosphamide|mesh-list
64871098|NCT01843868|Doxorubicin|doxorubicin|mesh-list
64871099|NCT01843868|Vincristine|vincristine|mesh-list
64871100|NCT01843868|Lorazepam|lorazepam|mesh-list
64871101|NCT01843868|Ondansetron|ondansetron|mesh-list
64871102|NCT01843868|Aprepitant|aprepitant|mesh-list
64871103|NCT01843868|Palonosetron|palonosetron|mesh-list
64871104|NCT01843868|Metoclopramide|metoclopramide|mesh-list
64871105|NCT01843868|Granisetron|granisetron|mesh-list
64871106|NCT01843868|Prochlorperazine|prochlorperazine|mesh-list
64298991|NCT02094703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298992|NCT02094703|Urological Agents|urological agents|mesh-ancestor
64298994|NCT02098837|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64298995|NCT02098837|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64298996|NCT02098837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298997|NCT02098837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298998|NCT02098837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64871107|NCT01843868|Tropisetron|tropisetron|mesh-list
64871108|NCT01843868|Antiemetics|antiemetics|mesh-list
64871109|NCT01843868|Emetics|emetics|mesh-list
64871110|NCT01843868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64871123|NCT01843868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64871124|NCT01843868|Tubulin Modulators|tubulin modulators|mesh-ancestor
64871125|NCT01843868|Antimitotic Agents|antimitotic agents|mesh-ancestor
64871126|NCT01843868|Mitosis Modulators|mitosis modulators|mesh-ancestor
64871127|NCT01843868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64871128|NCT01843868|Glucocorticoids|glucocorticoids|mesh-ancestor
64871129|NCT01843868|Hormones|hormones|mesh-ancestor
64871130|NCT01843868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64871131|NCT01843868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64871132|NCT01843868|Autonomic Agents|autonomic agents|mesh-ancestor
64871133|NCT01843868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64299002|NCT02098915|Metoclopramide|metoclopramide|mesh-list
64871134|NCT01843868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64871135|NCT01843868|Antipruritics|antipruritics|mesh-ancestor
64871136|NCT01843868|Dermatologic Agents|dermatologic agents|mesh-ancestor
64871137|NCT01843868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64871138|NCT01843868|Serotonin Agents|serotonin agents|mesh-ancestor
64871139|NCT01843868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64871140|NCT01843868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64871141|NCT01843868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64871142|NCT01843868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64871143|NCT01843868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64871144|NCT01843868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64871145|NCT01843868|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64871146|NCT01843868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64871147|NCT01843868|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64419359|NCT05518279|Coagulants|coagulants|mesh-ancestor
64419361|NCT05523661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419389|NCT05122741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64419390|NCT05122741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64334294|NCT02356419|Hematinics|hematinics|mesh-ancestor
64334295|NCT02220335|Digoxin|digoxin|mesh-list
64334296|NCT02220335|Diuretics|diuretics|mesh-list
64334297|NCT02220335|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64334304|NCT02220335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334305|NCT02220335|Natriuretic Agents|natriuretic agents|mesh-ancestor
64334306|NCT02220335|Protease Inhibitors|protease inhibitors|mesh-ancestor
64334307|NCT02220335|Hormone Antagonists|hormone antagonists|mesh-ancestor
64334308|NCT02220335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64334309|NCT02220335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64334311|NCT02291731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64334312|NCT02223299|Tryptophan|tryptophan|mesh-list
64334313|NCT02223299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64334314|NCT02223299|Antidepressive Agents|antidepressive agents|mesh-ancestor
64334315|NCT02223299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64334316|NCT02356341|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64334317|NCT02356341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64334318|NCT02223377|Morphine|morphine|mesh-list
64334338|NCT02352285|Natriuretic Agents|natriuretic agents|mesh-ancestor
64299014|NCT03556033|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64299015|NCT03556033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299018|NCT05046860|Dalbavancin|dalbavancin|mesh-list
64419394|NCT05525767|Bevacizumab|bevacizumab|mesh-list
64871178|NCT01844141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64871179|NCT01844141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871181|NCT01844141|Dermatologic Agents|dermatologic agents|mesh-ancestor
64871182|NCT01844323|Palbociclib|palbociclib|mesh-list
64871183|NCT01844323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871184|NCT01844323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64871185|NCT01844323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871186|NCT01844323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871187|NCT01844401|Albuterol|albuterol|mesh-list
64871188|NCT01844401|Procaterol|procaterol|mesh-list
64871189|NCT01844401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64871190|NCT01844401|Autonomic Agents|autonomic agents|mesh-ancestor
64871191|NCT01844401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64871192|NCT01844401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871193|NCT01844401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64871194|NCT01844401|Respiratory System Agents|respiratory system agents|mesh-ancestor
64871195|NCT01844401|Tocolytic Agents|tocolytic agents|mesh-ancestor
64871196|NCT01844401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64871197|NCT01844401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64871198|NCT01844401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64871199|NCT01844401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64871200|NCT01844401|Adrenergic Agents|adrenergic agents|mesh-ancestor
64871201|NCT01844401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64871202|NCT01844401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871203|NCT01844401|Sympathomimetics|sympathomimetics|mesh-ancestor
64871204|NCT01844427|Memantine|memantine|mesh-list
64871205|NCT01844427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64871206|NCT01844427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64871207|NCT01844427|Dopamine Agents|dopamine agents|mesh-ancestor
64871208|NCT01844427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64871209|NCT01844427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871215|NCT01844622|Autonomic Agents|autonomic agents|mesh-ancestor
64871216|NCT01844622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64871217|NCT01844622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871218|NCT01844622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64871219|NCT01844622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64871220|NCT01844622|Dopamine Agents|dopamine agents|mesh-ancestor
64871221|NCT01844622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64871222|NCT01844622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871223|NCT01844635|Thymoglobulin|thymoglobulin|mesh-list
64871224|NCT01844635|Immunologic Factors|immunologic factors|mesh-ancestor
64871225|NCT01844635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871226|NCT01844635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64871227|NCT01844648|Tropicamide|tropicamide|mesh-list
64334343|NCT02223533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64334344|NCT02223533|Narcotics|narcotics|mesh-ancestor
64334345|NCT02223533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64334346|NCT02223533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334347|NCT02223533|Analgesics|analgesics|mesh-ancestor
64334348|NCT02223533|Sensory System Agents|sensory system agents|mesh-ancestor
64334352|NCT02231021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64334353|NCT02231021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334354|NCT02231021|Incretins|incretins|mesh-ancestor
64334355|NCT02231021|Hormones|hormones|mesh-ancestor
64334356|NCT02231021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64871228|NCT01844648|Mydriatics|mydriatics|mesh-ancestor
64871229|NCT01844648|Autonomic Agents|autonomic agents|mesh-ancestor
64871230|NCT01844648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64871231|NCT01844648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871232|NCT01844648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64871233|NCT01844648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64871234|NCT01844648|Cholinergic Agents|cholinergic agents|mesh-ancestor
64871235|NCT01844648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64871236|NCT01844648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871237|NCT01844674|Vemurafenib|vemurafenib|mesh-list
64871238|NCT01844674|Tizanidine|tizanidine|mesh-list
64871239|NCT01844674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871240|NCT01844674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64871241|NCT01844674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871242|NCT01844674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871243|NCT01844674|Analgesics|analgesics|mesh-ancestor
64871244|NCT01844674|Sensory System Agents|sensory system agents|mesh-ancestor
64871245|NCT01844674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419450|NCT04903509|Liraglutide|liraglutide|mesh-list
64333712|NCT02209649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333713|NCT02209649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64299028|NCT02095405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64299029|NCT02095405|Purinergic Agents|purinergic agents|mesh-ancestor
64299030|NCT02095405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64299032|NCT04434482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64299033|NCT04434482|Alkylating Agents|alkylating agents|mesh-ancestor
64299034|NCT04434482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299035|NCT04434482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299036|NCT02096965|Tolvaptan|tolvaptan|mesh-list
64333714|NCT02209649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64333715|NCT02209649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64419462|NCT05517499|Dexamethasone acetate|dexamethasone acetate|mesh-list
64871271|NCT01844791|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64871272|NCT01844791|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64871274|NCT01844804|Dermatologic Agents|dermatologic agents|mesh-ancestor
64871275|NCT01844804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64871276|NCT01844804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64871277|NCT01844869|Homoharringtonine|homoharringtonine|mesh-list
64871278|NCT01844869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64871279|NCT01844869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871280|NCT01844869|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64871281|NCT01844869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871282|NCT01844869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871284|NCT01844947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871285|NCT01844947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64871286|NCT01844947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871287|NCT01844947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334386|NCT02231255|Dopamine Agonists|dopamine agonists|mesh-ancestor
64334387|NCT02231255|Dopamine Agents|dopamine agents|mesh-ancestor
64334388|NCT02231255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64299051|NCT02095717|Tubulin Modulators|tubulin modulators|mesh-ancestor
64299052|NCT02095717|Antimitotic Agents|antimitotic agents|mesh-ancestor
64299053|NCT02095717|Mitosis Modulators|mitosis modulators|mesh-ancestor
64299054|NCT02095717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299055|NCT02095717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64299056|NCT02095717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64299057|NCT02095717|Analgesics|analgesics|mesh-ancestor
64299058|NCT02095717|Sensory System Agents|sensory system agents|mesh-ancestor
64299059|NCT02095717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64299060|NCT02095717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299065|NCT03099824|Antioxidants|antioxidants|mesh-ancestor
64299068|NCT03099824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299070|NCT02718417|Carboplatin|carboplatin|mesh-list
64299071|NCT02718417|Avelumab|avelumab|mesh-list
64299072|NCT02718417|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64299073|NCT02718417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64299074|NCT02718417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299075|NCT02718417|Tubulin Modulators|tubulin modulators|mesh-ancestor
64299076|NCT02718417|Antimitotic Agents|antimitotic agents|mesh-ancestor
64381621|NCT03186053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381623|NCT02429219|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64381624|NCT02429219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64871288|NCT01845012|Dialysis Solutions|dialysis solutions|mesh-list
64871289|NCT01845012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64871290|NCT01845038|Timolol|timolol|mesh-list
64871291|NCT01845038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871292|NCT01845038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64871293|NCT01845038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64871294|NCT01845038|Adrenergic Agents|adrenergic agents|mesh-ancestor
64871295|NCT01845038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64871296|NCT01845038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871297|NCT01845038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64871298|NCT01845038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64871299|NCT01845064|Kallikreins|kallikreins|mesh-list
64871300|NCT01845064|Coagulants|coagulants|mesh-ancestor
64871301|NCT01845064|Fertility Agents, Male|fertility agents, male|mesh-ancestor
64871302|NCT01845064|Fertility Agents|fertility agents|mesh-ancestor
64871303|NCT01845064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64871304|NCT01845064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871305|NCT01845090|Calcium Carbonate|calcium carbonate|mesh-list
64871306|NCT01845090|Calcium|calcium|mesh-list
64871307|NCT01845090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64871308|NCT01845090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871309|NCT01845090|Antacids|antacids|mesh-ancestor
64871310|NCT01845090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871311|NCT01845090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64871312|NCT01845142|Vitamin D|vitamin d|mesh-list
64871313|NCT01845142|Cholecalciferol|cholecalciferol|mesh-list
64871314|NCT01845142|Vitamins|vitamins|mesh-ancestor
64871315|NCT01845142|Micronutrients|micronutrients|mesh-ancestor
64871316|NCT01845142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871317|NCT01845142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64871318|NCT01845142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64871319|NCT01845194|Metoprolol|metoprolol|mesh-list
64871320|NCT01845194|Talinolol|talinolol|mesh-list
64334402|NCT02227277|Interferon alpha-2|interferon alpha-2|mesh-list
64334403|NCT02227277|Antiviral Agents|antiviral agents|mesh-ancestor
64334404|NCT02227277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64334405|NCT02227277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334406|NCT03147183|Thymoglobulin|thymoglobulin|mesh-list
64334407|NCT03147183|Immunologic Factors|immunologic factors|mesh-ancestor
64334408|NCT03147183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871321|NCT01845194|Torsemide|torsemide|mesh-list
64871322|NCT01845194|Midazolam|midazolam|mesh-list
64871323|NCT01845194|Codeine|codeine|mesh-list
64871324|NCT01845194|Caffeine|caffeine|mesh-list
64871325|NCT01845194|Pravastatin|pravastatin|mesh-list
64871326|NCT01845194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64871327|NCT01845194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64871328|NCT01845194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64871329|NCT01845194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639917|NCT00354224|Antimetabolites|antimetabolites|mesh-ancestor
64871330|NCT01845194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64871331|NCT01845194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64871332|NCT01845194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64871333|NCT01845194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64871334|NCT01845194|Anesthetics, General|anesthetics, general|mesh-ancestor
64871335|NCT01845194|Anesthetics|anesthetics|mesh-ancestor
64871336|NCT01845194|GABA Modulators|gaba modulators|mesh-ancestor
64871337|NCT01845194|GABA Agents|gaba agents|mesh-ancestor
64871338|NCT01845194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64871339|NCT01845194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871340|NCT01845194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64871341|NCT01845194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64419485|NCT05012371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871358|NCT01845194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64871359|NCT01845194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64871360|NCT01845194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64871362|NCT01845194|Analgesics|analgesics|mesh-ancestor
64871363|NCT01845194|Sensory System Agents|sensory system agents|mesh-ancestor
64871364|NCT01845194|Antitussive Agents|antitussive agents|mesh-ancestor
64871365|NCT01845194|Respiratory System Agents|respiratory system agents|mesh-ancestor
64334487|NCT02355639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64871366|NCT01845194|Diuretics|diuretics|mesh-ancestor
64299077|NCT02718417|Mitosis Modulators|mitosis modulators|mesh-ancestor
64299078|NCT02718417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871367|NCT01845194|Natriuretic Agents|natriuretic agents|mesh-ancestor
64871368|NCT01845194|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64871369|NCT01845194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64871370|NCT01845246|Colistin|colistin|mesh-list
64871371|NCT01845246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64871372|NCT01845246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64871373|NCT01845259|Liraglutide|liraglutide|mesh-list
64871374|NCT01845259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64871375|NCT01845259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871376|NCT01845259|Incretins|incretins|mesh-ancestor
64871377|NCT01845259|Hormones|hormones|mesh-ancestor
64871378|NCT01845259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64871379|NCT01845272|Amlodipine|amlodipine|mesh-list
64871380|NCT01845272|Candesartan|candesartan|mesh-list
64871381|NCT01845272|Candesartan cilexetil|candesartan cilexetil|mesh-list
64419552|NCT02336607|Sympatholytics|sympatholytics|mesh-ancestor
64871398|NCT01845298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64871400|NCT01845298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871401|NCT01845298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64871402|NCT01845298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64871403|NCT01845298|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64871404|NCT01845298|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64639992|NCT01792700|Amoxicillin|amoxicillin|mesh-list
64871405|NCT01845298|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64871406|NCT01845298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64871407|NCT01845337|Capecitabine|capecitabine|mesh-list
64871408|NCT01845337|Tegafur|tegafur|mesh-list
64871409|NCT01845337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64871410|NCT01845337|Antimetabolites|antimetabolites|mesh-ancestor
64871411|NCT01845337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871412|NCT01845337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871413|NCT01845363|Anti-Infective Agents|anti-infective agents|mesh-list
64871414|NCT01845363|Cefazolin|cefazolin|mesh-list
64871415|NCT01845363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64871416|NCT01845376|Anesthetics|anesthetics|mesh-list
64871417|NCT01845376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64871418|NCT01845376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871419|NCT01845428|Pravastatin|pravastatin|mesh-list
64871420|NCT01845428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64871421|NCT01845428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64871422|NCT01845428|Antimetabolites|antimetabolites|mesh-ancestor
64334488|NCT02355639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334489|NCT02355639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64334490|NCT02355639|Respiratory System Agents|respiratory system agents|mesh-ancestor
64334491|NCT02355639|Emollients|emollients|mesh-ancestor
64871423|NCT01845428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871424|NCT01845428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64871425|NCT01845428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64871426|NCT01845428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871427|NCT01845493|Sulforaphane|sulforaphane|mesh-list
64871487|NCT01845727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64871488|NCT01845727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64871490|NCT01845844|Ranibizumab|ranibizumab|mesh-list
64871491|NCT01845844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64871513|NCT01846117|Hormones|hormones|mesh-ancestor
64871514|NCT01846117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64871515|NCT01846143|Poly ICLC|poly iclc|mesh-list
64871516|NCT01846143|Immunologic Factors|immunologic factors|mesh-ancestor
64871517|NCT01846143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871518|NCT01846143|Interferon Inducers|interferon inducers|mesh-ancestor
64871519|NCT01846273|Ranibizumab|ranibizumab|mesh-list
64871520|NCT01846273|Verteporfin|verteporfin|mesh-list
64871521|NCT01846273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64871522|NCT01846273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64871523|NCT01846273|Growth Substances|growth substances|mesh-ancestor
64871524|NCT01846273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871525|NCT01846273|Growth Inhibitors|growth inhibitors|mesh-ancestor
64871526|NCT01846273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871527|NCT01846273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64871528|NCT01846273|Dermatologic Agents|dermatologic agents|mesh-ancestor
64871529|NCT01846325|Vitamin E|vitamin e|mesh-list
64871530|NCT01846325|Vitamins|vitamins|mesh-ancestor
64871531|NCT01846325|Micronutrients|micronutrients|mesh-ancestor
64871532|NCT01846325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871533|NCT01846325|Antioxidants|antioxidants|mesh-ancestor
64871534|NCT01846325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871535|NCT01846325|Protective Agents|protective agents|mesh-ancestor
64871536|NCT01846364|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
64871537|NCT01846364|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64871538|NCT01846364|Protective Agents|protective agents|mesh-ancestor
64871539|NCT01846364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871540|NCT01846364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871541|NCT01846390|Gemcitabine|gemcitabine|mesh-list
64871542|NCT01846390|Dexamethasone|dexamethasone|mesh-list
64871543|NCT01846390|Romidepsin|romidepsin|mesh-list
64299079|NCT02718417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64871544|NCT01846390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64299080|NCT02718417|Immunologic Factors|immunologic factors|mesh-ancestor
64299081|NCT02718417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299083|NCT05067530|Carboplatin|carboplatin|mesh-list
64871557|NCT01846390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871558|NCT01846390|Antiviral Agents|antiviral agents|mesh-ancestor
64871559|NCT01846390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64871560|NCT01846390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871561|NCT01846390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64871562|NCT01846390|Immunologic Factors|immunologic factors|mesh-ancestor
64871563|NCT01846390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64871564|NCT01846559|Clopidogrel|clopidogrel|mesh-list
64871565|NCT01846559|Ticagrelor|ticagrelor|mesh-list
64871566|NCT01846559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64871567|NCT01846559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64871568|NCT01846559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64871569|NCT01846559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64871570|NCT01846559|Purinergic Agents|purinergic agents|mesh-ancestor
64871571|NCT01846559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64871572|NCT01846559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871573|NCT01846559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871574|NCT01846650|Capecitabine|capecitabine|mesh-list
64871575|NCT01846650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64871576|NCT01846650|Antimetabolites|antimetabolites|mesh-ancestor
64871577|NCT01846650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871578|NCT01846650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871579|NCT01846806|Rifaximin|rifaximin|mesh-list
64871580|NCT01846806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64871581|NCT01846806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64871582|NCT01846806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64334625|NCT02228135|Dexamethasone|dexamethasone|mesh-list
64334626|NCT02228135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64334627|NCT02228135|Antiemetics|antiemetics|mesh-ancestor
64334628|NCT02228135|Autonomic Agents|autonomic agents|mesh-ancestor
64871593|NCT01846832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871595|NCT01846832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871596|NCT01846832|Protease Inhibitors|protease inhibitors|mesh-ancestor
64871597|NCT01846832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871598|NCT01846962|Fluticasone|fluticasone|mesh-list
64871599|NCT01846962|Budesonide|budesonide|mesh-list
64871600|NCT01846962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64871601|NCT01846962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64871602|NCT01846962|Autonomic Agents|autonomic agents|mesh-ancestor
64871603|NCT01846962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64871604|NCT01846962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871605|NCT01846962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64871606|NCT01846962|Respiratory System Agents|respiratory system agents|mesh-ancestor
64871607|NCT01846962|Dermatologic Agents|dermatologic agents|mesh-ancestor
64871608|NCT01846962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64871609|NCT01846962|Glucocorticoids|glucocorticoids|mesh-ancestor
64871610|NCT01846962|Hormones|hormones|mesh-ancestor
64334640|NCT03152877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64334641|NCT03152877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334646|NCT02295709|BB 1101|bb 1101|mesh-list
64334648|NCT02295709|Antiemetics|antiemetics|mesh-ancestor
64334649|NCT02295709|Autonomic Agents|autonomic agents|mesh-ancestor
64334650|NCT02295709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334651|NCT02295709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334652|NCT02295709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64334653|NCT02295709|Glucocorticoids|glucocorticoids|mesh-ancestor
64334654|NCT02295709|Hormones|hormones|mesh-ancestor
64334655|NCT02295709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64299085|NCT05067530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64334681|NCT02295787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64334682|NCT02295787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64334683|NCT02295787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334684|NCT04530383|Metformin|metformin|mesh-list
64334689|NCT04464967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64334691|NCT02228369|Osimertinib|osimertinib|mesh-list
64334692|NCT02228369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299086|NCT05067530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299087|NCT05067530|Tubulin Modulators|tubulin modulators|mesh-ancestor
64299088|NCT05067530|Antimitotic Agents|antimitotic agents|mesh-ancestor
64299089|NCT05067530|Mitosis Modulators|mitosis modulators|mesh-ancestor
64299090|NCT05067530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299091|NCT05067530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64299092|NCT05067530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299093|NCT02640404|Vaccines|vaccines|mesh-list
64871611|NCT01846962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64871612|NCT01846975|Abatacept|abatacept|mesh-list
64871613|NCT01846975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64871614|NCT01846975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871615|NCT01846975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871616|NCT01846975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64871617|NCT01846975|Immunologic Factors|immunologic factors|mesh-ancestor
64871618|NCT01846975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871619|NCT01846975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64871620|NCT01847144|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64871621|NCT01847144|Gliclazide|gliclazide|mesh-list
64871632|NCT01847157|Prilocaine|prilocaine|mesh-list
64871633|NCT01847157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64871634|NCT01847157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871635|NCT01847157|Anesthetics, Local|anesthetics, local|mesh-ancestor
64871636|NCT01847157|Sensory System Agents|sensory system agents|mesh-ancestor
64871637|NCT01847157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419718|NCT05510323|Cyclophosphamide|cyclophosphamide|mesh-list
64871642|NCT01847235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871662|NCT01847339|Bupivacaine|bupivacaine|mesh-list
64871664|NCT01847339|Anesthetics|anesthetics|mesh-ancestor
64871665|NCT01847339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64871666|NCT01847339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871667|NCT01847339|Sensory System Agents|sensory system agents|mesh-ancestor
64871668|NCT01847339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334693|NCT02228369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64334694|NCT02228369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334700|NCT03146871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334701|NCT03146871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334702|NCT03146871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334704|NCT02231957|Immunologic Factors|immunologic factors|mesh-ancestor
64334712|NCT02354547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64334713|NCT02354547|Alkylating Agents|alkylating agents|mesh-ancestor
64334714|NCT02354547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334715|NCT02354547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334716|NCT02354547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64871669|NCT01847404|Pantoprazole|pantoprazole|mesh-list
64871670|NCT01847404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871671|NCT01847404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871672|NCT01847404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64871673|NCT01847404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64871674|NCT01847404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64871675|NCT01847417|Pantoprazole|pantoprazole|mesh-list
64871676|NCT01847417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64871677|NCT01847417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64871678|NCT01847417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64871679|NCT01847417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871680|NCT01847417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871681|NCT01847456|Insulin|insulin|mesh-list
64871682|NCT01847456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64871683|NCT01847456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64334766|NCT02354313|Growth Inhibitors|growth inhibitors|mesh-ancestor
64334767|NCT02354313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334768|NCT02292667|Acetaminophen|acetaminophen|mesh-list
64299096|NCT05003895|Cyclophosphamide|cyclophosphamide|mesh-list
64299097|NCT05003895|Fludarabine|fludarabine|mesh-list
64299098|NCT05003895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64871684|NCT01847456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871685|NCT01847495|Irinotecan|irinotecan|mesh-list
64871686|NCT01847495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64871687|NCT01847495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64871688|NCT01847495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871689|NCT01847495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871690|NCT01847495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871691|NCT01847521|Quercetin|quercetin|mesh-list
64871692|NCT01847521|Antioxidants|antioxidants|mesh-ancestor
64871693|NCT01847521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871694|NCT01847521|Protective Agents|protective agents|mesh-ancestor
64871695|NCT01847521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871696|NCT01847599|Capecitabine|capecitabine|mesh-list
64871697|NCT01847599|Lapatinib|lapatinib|mesh-list
64871702|NCT01847599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64871703|NCT01847599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871704|NCT01847612|Methylene Blue|methylene blue|mesh-list
64871705|NCT01847612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871706|NCT01847612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871708|NCT01847664|Rifamycin SV|rifamycin sv|mesh-list
64871709|NCT01847664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64871710|NCT01847664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64871711|NCT01847664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64871713|NCT01847677|Bevacizumab|bevacizumab|mesh-list
64871714|NCT01847677|Carboplatin|carboplatin|mesh-list
64871715|NCT01847677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64871716|NCT01847677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871717|NCT01847677|Tubulin Modulators|tubulin modulators|mesh-ancestor
64871718|NCT01847677|Antimitotic Agents|antimitotic agents|mesh-ancestor
64871719|NCT01847677|Mitosis Modulators|mitosis modulators|mesh-ancestor
64871720|NCT01847677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871721|NCT01847677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64871722|NCT01847677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64871723|NCT01847677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64871724|NCT01847677|Growth Substances|growth substances|mesh-ancestor
64419735|NCT05510323|Antiemetics|antiemetics|mesh-ancestor
64871755|NCT01847976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64871756|NCT01847976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64871757|NCT01848106|Bivalirudin|bivalirudin|mesh-list
64871758|NCT01848106|Antithrombins|antithrombins|mesh-ancestor
64871759|NCT01848106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64871760|NCT01848106|Protease Inhibitors|protease inhibitors|mesh-ancestor
64871761|NCT01848106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871762|NCT01848106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871763|NCT01848106|Anticoagulants|anticoagulants|mesh-ancestor
64871764|NCT01848119|Gabapentin|gabapentin|mesh-list
64871765|NCT01848119|Analgesics|analgesics|mesh-ancestor
64871766|NCT01848119|Sensory System Agents|sensory system agents|mesh-ancestor
64871767|NCT01848119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64871768|NCT01848119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334770|NCT02292667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64299099|NCT05003895|Immunologic Factors|immunologic factors|mesh-ancestor
64299100|NCT05003895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299101|NCT05003895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64299102|NCT05003895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64299103|NCT05003895|Alkylating Agents|alkylating agents|mesh-ancestor
64871769|NCT01848119|Anticonvulsants|anticonvulsants|mesh-ancestor
64871770|NCT01848119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64871771|NCT01848119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64871772|NCT01848119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64871773|NCT01848119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64871774|NCT01848119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64871775|NCT01848119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64871786|NCT01848132|Immunologic Factors|immunologic factors|mesh-ancestor
64871787|NCT01848132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871788|NCT01848132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64334794|NCT02354001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64334795|NCT02354001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334796|NCT02354001|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64334797|NCT02354001|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64334798|NCT02354001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64334800|NCT02347839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334801|NCT02347839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64334802|NCT02347839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334803|NCT02347839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417232|NCT04909515|Isotretinoin|isotretinoin|mesh-list
64417233|NCT04909515|Dermatologic Agents|dermatologic agents|mesh-ancestor
64417234|NCT05617729|Povidone-Iodine|povidone-iodine|mesh-list
64417235|NCT05617729|Povidone|povidone|mesh-list
64417236|NCT05617729|Plasma Substitutes|plasma substitutes|mesh-ancestor
64417237|NCT05617729|Blood Substitutes|blood substitutes|mesh-ancestor
64417238|NCT05617729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64417239|NCT05617729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64417240|NCT04818931|Cefazolin|cefazolin|mesh-list
64417241|NCT04818931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64417242|NCT04818931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64417243|NCT02406261|Midazolam|midazolam|mesh-list
64417244|NCT02406261|Donepezil|donepezil|mesh-list
64417245|NCT02406261|Simvastatin|simvastatin|mesh-list
64417246|NCT02406261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64334805|NCT02289547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64334806|NCT02289547|Antimetabolites|antimetabolites|mesh-ancestor
64334807|NCT02289547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299105|NCT05003895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871789|NCT01848132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64871790|NCT01848132|Alkylating Agents|alkylating agents|mesh-ancestor
64871791|NCT01848132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871792|NCT01848132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419765|NCT04843579|Growth Substances|growth substances|mesh-ancestor
64871883|NCT01848743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64871884|NCT01848743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871885|NCT01848743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871886|NCT01848743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64871887|NCT01848743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64871889|NCT01848769|Formoterol Fumarate|formoterol fumarate|mesh-list
64871890|NCT01848769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64419820|NCT05513209|Anesthetics|anesthetics|mesh-list
64419821|NCT05513209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64871912|NCT01848873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64334809|NCT02351427|Bortezomib|bortezomib|mesh-list
64871913|NCT01848873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64871914|NCT01848873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871915|NCT01848873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64871916|NCT01848873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871917|NCT01848873|Vasodilator Agents|vasodilator agents|mesh-ancestor
64871918|NCT01848925|Hydroxyurea|hydroxyurea|mesh-list
64871919|NCT01848925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871920|NCT01848925|Antisickling Agents|antisickling agents|mesh-ancestor
64871921|NCT01848925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871922|NCT01848925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871923|NCT01848925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64871924|NCT01849016|Acetylcysteine|acetylcysteine|mesh-list
64871925|NCT01849016|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64871926|NCT01849016|Antiviral Agents|antiviral agents|mesh-ancestor
64871927|NCT01849016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64871928|NCT01849016|Expectorants|expectorants|mesh-ancestor
64871929|NCT01849016|Respiratory System Agents|respiratory system agents|mesh-ancestor
64871930|NCT01849016|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64871931|NCT01849016|Antioxidants|antioxidants|mesh-ancestor
64871932|NCT01849016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334848|NCT02232347|Sufentanil|sufentanil|mesh-list
64334849|NCT02232347|Ketamine|ketamine|mesh-list
64334850|NCT02232347|Analgesics|analgesics|mesh-ancestor
64334851|NCT02232347|Sensory System Agents|sensory system agents|mesh-ancestor
64334852|NCT02232347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334853|NCT02232347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334854|NCT02232347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64334861|NCT02232347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64334862|NCT02232347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334863|NCT02232347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64334865|NCT02232347|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64334866|NCT03542669|Doxorubicin|doxorubicin|mesh-list
64417286|NCT02603107|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64871933|NCT01849016|Protective Agents|protective agents|mesh-ancestor
64871934|NCT01849016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871936|NCT01849042|Donepezil|donepezil|mesh-list
64871937|NCT01849042|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64871938|NCT01849042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871939|NCT01849042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871940|NCT01849042|Cholinergic Agents|cholinergic agents|mesh-ancestor
64871941|NCT01849042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64871942|NCT01849042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871946|NCT01849094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64871947|NCT01849094|Vasodilator Agents|vasodilator agents|mesh-ancestor
64871948|NCT01849094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64871949|NCT01849094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64871950|NCT01849094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871951|NCT01849094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64871952|NCT01849094|Protective Agents|protective agents|mesh-ancestor
64871953|NCT01849094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871954|NCT01849211|Rocuronium|rocuronium|mesh-list
64334898|NCT03541655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334899|NCT02296411|Glycopyrrolate|glycopyrrolate|mesh-list
64871955|NCT01849211|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64871956|NCT01849211|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64871957|NCT01849211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64871958|NCT01849211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64871959|NCT01849211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871960|NCT01849406|Budesonide|budesonide|mesh-list
64871961|NCT01849406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64871962|NCT01849406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64871963|NCT01849406|Autonomic Agents|autonomic agents|mesh-ancestor
64871964|NCT01849406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64871965|NCT01849406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64871966|NCT01849406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64871967|NCT01849406|Respiratory System Agents|respiratory system agents|mesh-ancestor
64871968|NCT01849406|Glucocorticoids|glucocorticoids|mesh-ancestor
64871969|NCT01849406|Hormones|hormones|mesh-ancestor
64871970|NCT01849406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64871971|NCT01849640|Primaquine|primaquine|mesh-list
64871972|NCT01849640|Piperaquine|piperaquine|mesh-list
64871973|NCT01849640|Antimalarials|antimalarials|mesh-ancestor
64871974|NCT01849640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64871975|NCT01849640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64871976|NCT01849640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64871977|NCT01849666|Vemurafenib|vemurafenib|mesh-list
64871978|NCT01849666|Phenprocoumon|phenprocoumon|mesh-list
64871979|NCT01849666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64871980|NCT01849666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64871981|NCT01849666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64871985|NCT01849757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64871986|NCT01849757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64871987|NCT01849835|Menthol|menthol|mesh-list
64871988|NCT01849835|Antipruritics|antipruritics|mesh-ancestor
64871989|NCT01849835|Dermatologic Agents|dermatologic agents|mesh-ancestor
64871990|NCT01849861|Methimazole|methimazole|mesh-list
64417378|NCT04797949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64417379|NCT04797949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417380|NCT04797949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64417381|NCT04797949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64417382|NCT04797949|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64417383|NCT04797949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64417384|NCT04797949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417385|NCT04797949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64417386|NCT04797949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64871991|NCT01849861|Antithyroid Agents|antithyroid agents|mesh-ancestor
64871992|NCT01849861|Hormone Antagonists|hormone antagonists|mesh-ancestor
64872031|NCT01850095|Estrogens|estrogens|mesh-ancestor
64872032|NCT01850095|Hormones|hormones|mesh-ancestor
64872089|NCT01850511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872090|NCT01850511|Sympathomimetics|sympathomimetics|mesh-ancestor
64872091|NCT01850511|Autonomic Agents|autonomic agents|mesh-ancestor
64872092|NCT01850511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64872093|NCT01850511|Nasal Decongestants|nasal decongestants|mesh-ancestor
64872094|NCT01850511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64872095|NCT01850511|Respiratory System Agents|respiratory system agents|mesh-ancestor
64872096|NCT01850511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64872097|NCT01850511|Mydriatics|mydriatics|mesh-ancestor
64872098|NCT01850511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64334943|NCT02347059|Dopamine Agents|dopamine agents|mesh-ancestor
64417438|NCT04815187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64417439|NCT04815187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417442|NCT04805827|Gabapentin|gabapentin|mesh-list
64872099|NCT01850511|Protective Agents|protective agents|mesh-ancestor
64872100|NCT01850628|Paclitaxel|paclitaxel|mesh-list
64872101|NCT01850628|Trastuzumab|trastuzumab|mesh-list
64872102|NCT01850628|Pertuzumab|pertuzumab|mesh-list
64872103|NCT01850628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64872104|NCT01850628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872105|NCT01850628|Tubulin Modulators|tubulin modulators|mesh-ancestor
64872106|NCT01850628|Antimitotic Agents|antimitotic agents|mesh-ancestor
64872107|NCT01850628|Mitosis Modulators|mitosis modulators|mesh-ancestor
64872108|NCT01850628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872109|NCT01850628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64872110|NCT01850680|Folic Acid|folic acid|mesh-list
64872111|NCT01850680|Methotrexate|methotrexate|mesh-list
64872112|NCT01850680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64872113|NCT01850680|Abortifacient Agents|abortifacient agents|mesh-ancestor
64872114|NCT01850680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64872115|NCT01850680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872140|NCT01850953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64872141|NCT01850953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872142|NCT01850953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872144|NCT01850979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64872145|NCT01850979|Immunologic Factors|immunologic factors|mesh-ancestor
64872146|NCT01850979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872147|NCT01850979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64872148|NCT01850979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872149|NCT01850979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872150|NCT01851005|Dexmedetomidine|dexmedetomidine|mesh-list
64872151|NCT01851005|Remifentanil|remifentanil|mesh-list
64872152|NCT01851005|Anesthetics|anesthetics|mesh-list
64872153|NCT01851005|Propofol|propofol|mesh-list
64872154|NCT01851005|Sevoflurane|sevoflurane|mesh-list
64872155|NCT01851005|Rocuronium|rocuronium|mesh-list
64872156|NCT01851005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64872157|NCT01851005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872158|NCT01851005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64872159|NCT01851005|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64872160|NCT01851005|Anesthetics, General|anesthetics, general|mesh-ancestor
64417543|NCT04792723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64417544|NCT04792723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64417545|NCT04792723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64417546|NCT04792723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64334981|NCT03519061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64872161|NCT01851005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64872162|NCT01851005|Analgesics|analgesics|mesh-ancestor
64872163|NCT01851005|Sensory System Agents|sensory system agents|mesh-ancestor
64872164|NCT01851005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64872165|NCT01851005|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64872166|NCT01851005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64872167|NCT01851005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64872168|NCT01851005|Adrenergic Agents|adrenergic agents|mesh-ancestor
64872169|NCT01851005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64872170|NCT01851005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872171|NCT01851005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64872184|NCT01851200|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64872185|NCT01851200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64872186|NCT01851200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872205|NCT01851408|Sirolimus|sirolimus|mesh-list
64872206|NCT01851408|Sorafenib|sorafenib|mesh-list
64872207|NCT01851408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872208|NCT01851408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64872209|NCT01851408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872210|NCT01851408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872211|NCT01851408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64872212|NCT01851408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64872213|NCT01851408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64872214|NCT01851408|Antifungal Agents|antifungal agents|mesh-ancestor
64872215|NCT01851408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64872216|NCT01851408|Immunologic Factors|immunologic factors|mesh-ancestor
64872217|NCT01851408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872218|NCT01851473|Quinine|quinine|mesh-list
64872219|NCT01851473|Acetazolamide|acetazolamide|mesh-list
64872220|NCT01851473|Cocaine|cocaine|mesh-list
64872221|NCT01851473|Anticonvulsants|anticonvulsants|mesh-ancestor
64872222|NCT01851473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64417600|NCT02598193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417602|NCT02598193|Sensory System Agents|sensory system agents|mesh-ancestor
64417609|NCT04802083|Eculizumab|eculizumab|mesh-list
64872223|NCT01851473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872224|NCT01851473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872225|NCT01851473|Diuretics|diuretics|mesh-ancestor
64872226|NCT01851473|Natriuretic Agents|natriuretic agents|mesh-ancestor
64872227|NCT01851473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872228|NCT01851473|Anesthetics, Local|anesthetics, local|mesh-ancestor
64872229|NCT01851473|Anesthetics|anesthetics|mesh-ancestor
64872238|NCT01851473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64872240|NCT01851473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64872241|NCT01851473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64872242|NCT01851473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64872243|NCT01851473|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64872244|NCT01851473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64872245|NCT01851473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64872246|NCT01851473|Analgesics|analgesics|mesh-ancestor
64417620|NCT04801303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64872247|NCT01851486|Clonidine|clonidine|mesh-list
64872248|NCT01851486|Naloxone|naloxone|mesh-list
64872249|NCT01851486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64872250|NCT01851486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872251|NCT01851486|Sensory System Agents|sensory system agents|mesh-ancestor
64872252|NCT01851486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64872253|NCT01851486|Analgesics|analgesics|mesh-ancestor
64872254|NCT01851486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64872255|NCT01851486|Sympatholytics|sympatholytics|mesh-ancestor
64872256|NCT01851486|Autonomic Agents|autonomic agents|mesh-ancestor
64872257|NCT01851486|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64872258|NCT01851486|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64872259|NCT01851486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64872260|NCT01851486|Adrenergic Agents|adrenergic agents|mesh-ancestor
64872261|NCT01851486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64872272|NCT01851551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64872273|NCT01851551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64872274|NCT01851551|Tubulin Modulators|tubulin modulators|mesh-ancestor
64872275|NCT01851551|Antimitotic Agents|antimitotic agents|mesh-ancestor
64872276|NCT01851551|Mitosis Modulators|mitosis modulators|mesh-ancestor
64872277|NCT01851551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872279|NCT01851681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64872280|NCT01851681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64872281|NCT01851733|Doxorubicin|doxorubicin|mesh-list
64872282|NCT01851733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64872283|NCT01851733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872284|NCT01851733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64872285|NCT01851733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64872300|NCT01851850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872301|NCT01851850|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64872302|NCT01851850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64872303|NCT01851941|Leucovorin|leucovorin|mesh-list
64872314|NCT01851941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872315|NCT01851941|Antidotes|antidotes|mesh-ancestor
64872316|NCT01851941|Protective Agents|protective agents|mesh-ancestor
64872317|NCT01851941|Vitamin B Complex|vitamin b complex|mesh-ancestor
64872319|NCT01851941|Micronutrients|micronutrients|mesh-ancestor
64872320|NCT01851941|Hematinics|hematinics|mesh-ancestor
64872321|NCT01851954|Clarithromycin|clarithromycin|mesh-list
64872322|NCT01851954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64872323|NCT01851954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64872324|NCT01851954|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64872325|NCT01851954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872326|NCT01851954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872327|NCT01851954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64872328|NCT01851954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64872329|NCT01851980|Furosemide|furosemide|mesh-list
64417722|NCT04810819|Glucocorticoids|glucocorticoids|mesh-ancestor
64417724|NCT04810819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64417744|NCT04810507|Protease Inhibitors|protease inhibitors|mesh-ancestor
64417745|NCT04810507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417747|NCT04810585|Aflibercept|aflibercept|mesh-list
64872330|NCT01851980|Diuretics|diuretics|mesh-ancestor
64872331|NCT01851980|Natriuretic Agents|natriuretic agents|mesh-ancestor
64872348|NCT01851993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64872349|NCT01851993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64872350|NCT01851993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64872351|NCT01851993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64872352|NCT01851993|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64872353|NCT01852253|Chlorhexidine|chlorhexidine|mesh-list
64872354|NCT01852253|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64872355|NCT01852253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64872381|NCT01852318|Histamine Agents|histamine agents|mesh-ancestor
64872382|NCT01852318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64872383|NCT01852409|Bevacizumab|bevacizumab|mesh-list
64872384|NCT01852409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64872385|NCT01852409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872386|NCT01852409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64872387|NCT01852409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64872388|NCT01852409|Growth Substances|growth substances|mesh-ancestor
64872389|NCT01852409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872450|NCT01852786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64872451|NCT01852903|Vitamins|vitamins|mesh-list
64872452|NCT01852903|Ascorbic Acid|ascorbic acid|mesh-list
64872453|NCT01852903|Calcium ascorbate|calcium ascorbate|mesh-list
64872454|NCT01852903|Calcium|calcium|mesh-list
64872455|NCT01852903|Micronutrients|micronutrients|mesh-ancestor
64872456|NCT01852903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872457|NCT01852903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64872458|NCT01852903|Antioxidants|antioxidants|mesh-ancestor
64872459|NCT01852903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872460|NCT01852903|Protective Agents|protective agents|mesh-ancestor
64872461|NCT01852994|Methyltestosterone|methyltestosterone|mesh-list
64872462|NCT01852994|Testosterone|testosterone|mesh-list
64872463|NCT01852994|Testosterone undecanoate|testosterone undecanoate|mesh-list
64872464|NCT01852994|Testosterone enanthate|testosterone enanthate|mesh-list
64872465|NCT01852994|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64872466|NCT01852994|Androgens|androgens|mesh-ancestor
64872467|NCT01852994|Hormones|hormones|mesh-ancestor
64872468|NCT01852994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64872469|NCT01852994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872470|NCT01852994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64872471|NCT01852994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872472|NCT01852994|Anabolic Agents|anabolic agents|mesh-ancestor
64872473|NCT01853111|Aldesleukin|aldesleukin|mesh-list
64872474|NCT01853111|Interleukin-2|interleukin-2|mesh-list
64872475|NCT01853111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335218|NCT02350179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64335221|NCT02350179|Hemostatics|hemostatics|mesh-ancestor
64872476|NCT01853111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64872477|NCT01853111|Analgesics|analgesics|mesh-ancestor
64872478|NCT01853111|Sensory System Agents|sensory system agents|mesh-ancestor
64872479|NCT01853111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64872480|NCT01853111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872481|NCT01853111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64872482|NCT01853111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64872485|NCT01853306|Veliparib|veliparib|mesh-list
64420230|NCT05495893|Immunologic Factors|immunologic factors|mesh-ancestor
64872486|NCT01853306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64872487|NCT01853306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420244|NCT03542461|Nivolumab|nivolumab|mesh-list
64872496|NCT01853423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64872497|NCT01853423|Immunologic Factors|immunologic factors|mesh-ancestor
64872498|NCT01853423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335340|NCT03896009|Rizatriptan|rizatriptan|mesh-list
64335341|NCT03896009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64335342|NCT03896009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64335343|NCT03896009|Analgesics|analgesics|mesh-ancestor
64335344|NCT03896009|Sensory System Agents|sensory system agents|mesh-ancestor
64335347|NCT03896009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64872499|NCT01853449|Fentanyl|fentanyl|mesh-list
64872500|NCT01853449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64872501|NCT01853449|Narcotics|narcotics|mesh-ancestor
64872502|NCT01853449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64872503|NCT01853449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872504|NCT01853449|Analgesics|analgesics|mesh-ancestor
64872505|NCT01853449|Sensory System Agents|sensory system agents|mesh-ancestor
64872506|NCT01853449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64872507|NCT01853449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64872508|NCT01853449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64872509|NCT01853449|Anesthetics, General|anesthetics, general|mesh-ancestor
64872510|NCT01853449|Anesthetics|anesthetics|mesh-ancestor
64872511|NCT01853540|Sildenafil Citrate|sildenafil citrate|mesh-list
64872512|NCT01853540|Vasodilator Agents|vasodilator agents|mesh-ancestor
64872513|NCT01853540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64872514|NCT01853540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64872515|NCT01853540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872516|NCT01853540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872517|NCT01853540|Urological Agents|urological agents|mesh-ancestor
64872518|NCT01853566|Hormones|hormones|mesh-list
64872519|NCT01853566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64872520|NCT01853566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872521|NCT01853709|Bisacodyl|bisacodyl|mesh-list
64872522|NCT01853709|Cathartics|cathartics|mesh-ancestor
64872523|NCT01853709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64872524|NCT01853709|Laxatives|laxatives|mesh-ancestor
64872525|NCT01853787|Formoterol Fumarate|formoterol fumarate|mesh-list
64872526|NCT01853787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64872527|NCT01853787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64872528|NCT01853787|Autonomic Agents|autonomic agents|mesh-ancestor
64872529|NCT01853787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64872530|NCT01853787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872531|NCT01853787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64872532|NCT01853787|Respiratory System Agents|respiratory system agents|mesh-ancestor
64872533|NCT01853787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64872534|NCT01853787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64872535|NCT01853787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64872536|NCT01853787|Adrenergic Agents|adrenergic agents|mesh-ancestor
64420259|NCT04352101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64872537|NCT01853787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64872538|NCT01853787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872539|NCT01853800|Rivaroxaban|rivaroxaban|mesh-list
64872540|NCT01853800|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64872547|NCT01853813|Bevacizumab|bevacizumab|mesh-list
64872548|NCT01853813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64872549|NCT01853813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872550|NCT01853813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64872551|NCT01853813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64872552|NCT01853813|Growth Substances|growth substances|mesh-ancestor
64872553|NCT01853813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872554|NCT01853813|Growth Inhibitors|growth inhibitors|mesh-ancestor
64872555|NCT01853852|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
64872556|NCT01853852|Antiviral Agents|antiviral agents|mesh-ancestor
64872557|NCT01853852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64872558|NCT01853852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335537|NCT02342145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64872559|NCT01853852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872561|NCT01853956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64872562|NCT01853956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64872563|NCT01853956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872564|NCT01853956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64872565|NCT01853956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64872566|NCT01853956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64872567|NCT01853956|GABA Modulators|gaba modulators|mesh-ancestor
64872568|NCT01853956|GABA Agents|gaba agents|mesh-ancestor
64872569|NCT01853956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64872570|NCT01853956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872571|NCT01854021|Anesthetics|anesthetics|mesh-list
64872572|NCT01854021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64872573|NCT01854021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872574|NCT01854073|Scopolamine|scopolamine|mesh-list
64872575|NCT01854073|Bromides|bromides|mesh-list
64872576|NCT01854073|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64872577|NCT01854073|Anticonvulsants|anticonvulsants|mesh-ancestor
64872578|NCT01854073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64872579|NCT01854073|Antiemetics|antiemetics|mesh-ancestor
64872580|NCT01854073|Autonomic Agents|autonomic agents|mesh-ancestor
64872581|NCT01854073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64872582|NCT01854073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872583|NCT01854073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64872584|NCT01854073|Mydriatics|mydriatics|mesh-ancestor
64872585|NCT01854073|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64872586|NCT01854073|Cholinergic Agents|cholinergic agents|mesh-ancestor
64872587|NCT01854073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64872589|NCT01854073|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64872590|NCT01854073|Parasympatholytics|parasympatholytics|mesh-ancestor
64872591|NCT01854086|Diphosphonates|diphosphonates|mesh-list
64335606|NCT02344017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64335607|NCT02344017|Glucocorticoids|glucocorticoids|mesh-ancestor
64335608|NCT02344017|Hormones|hormones|mesh-ancestor
64335609|NCT02344017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64335610|NCT02344017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335611|NCT02344017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64417817|NCT03938389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64872592|NCT01854086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64872593|NCT01854086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872594|NCT01854203|Gemcitabine|gemcitabine|mesh-list
64420272|NCT04424485|Parathyroid Hormone|parathyroid hormone|mesh-list
64872595|NCT01854203|Cisplatin|cisplatin|mesh-list
64420275|NCT05494645|Bupivacaine|bupivacaine|mesh-list
64872596|NCT01854203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872597|NCT01854203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64872598|NCT01854203|Antimetabolites|antimetabolites|mesh-ancestor
64872599|NCT01854203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872600|NCT01854203|Antiviral Agents|antiviral agents|mesh-ancestor
64872601|NCT01854203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64417865|NCT04789057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64417866|NCT04789057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64872602|NCT01854203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872603|NCT01854203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64872604|NCT01854203|Immunologic Factors|immunologic factors|mesh-ancestor
64872605|NCT01854203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872606|NCT01854216|Rotigotine|rotigotine|mesh-list
64872607|NCT01854216|Dopamine Agonists|dopamine agonists|mesh-ancestor
64872608|NCT01854216|Dopamine Agents|dopamine agents|mesh-ancestor
64872609|NCT01854216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64872612|NCT01854411|Analgesics|analgesics|mesh-list
64872644|NCT01854489|Antitubercular Agents|antitubercular agents|mesh-ancestor
64872645|NCT01854489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64872646|NCT01854489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64872648|NCT01854489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64872649|NCT01854489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872650|NCT01854489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872651|NCT01854489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64872652|NCT01854489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64872653|NCT01854489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64872654|NCT01854489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64872655|NCT01854489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64872656|NCT01854489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64872657|NCT01854502|Fluorides|fluorides|mesh-list
64420340|NCT04080895|Amodiaquine|amodiaquine|mesh-list
64335688|NCT02341365|Micronutrients|micronutrients|mesh-ancestor
64872681|NCT01854515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872683|NCT01854606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872684|NCT01854606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64872685|NCT01854606|Immunologic Factors|immunologic factors|mesh-ancestor
64872686|NCT01854606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872687|NCT01854619|Anti-Infective Agents|anti-infective agents|mesh-list
64872688|NCT01854619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64872689|NCT01854723|Insulin|insulin|mesh-list
64872690|NCT01854723|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64872691|NCT01854723|Insulin Glargine|insulin glargine|mesh-list
64872692|NCT01854723|Insulin, Isophane|insulin, isophane|mesh-list
64872693|NCT01854723|Isophane Insulin, Human|isophane insulin, human|mesh-list
64872694|NCT01854723|Isophane insulin, beef|isophane insulin, beef|mesh-list
64872695|NCT01854723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64872696|NCT01854723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872697|NCT01854749|Cisplatin|cisplatin|mesh-list
64872698|NCT01854749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872699|NCT01854762|Ritonavir|ritonavir|mesh-list
64872700|NCT01854762|Lopinavir|lopinavir|mesh-list
64872701|NCT01854762|Raltegravir Potassium|raltegravir potassium|mesh-list
64872702|NCT01854762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64872703|NCT01854762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64872704|NCT01854762|Protease Inhibitors|protease inhibitors|mesh-ancestor
64872705|NCT01854762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872706|NCT01854762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872707|NCT01854762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64872708|NCT01854762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64872709|NCT01854762|Antiviral Agents|antiviral agents|mesh-ancestor
64872710|NCT01854762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64872711|NCT01854762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64872712|NCT01854762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64872713|NCT01854762|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64872714|NCT01854762|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64872715|NCT01854970|Esomeprazole|esomeprazole|mesh-list
64872716|NCT01854970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64872717|NCT01854970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64872718|NCT01854970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64872719|NCT01854970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872720|NCT01854970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872721|NCT01855009|Calcium, Dietary|calcium, dietary|mesh-list
64872722|NCT01855009|Vitamin D|vitamin d|mesh-list
64872723|NCT01855009|Cholecalciferol|cholecalciferol|mesh-list
64872724|NCT01855009|Calcium Carbonate|calcium carbonate|mesh-list
64872725|NCT01855009|Calcium|calcium|mesh-list
64872726|NCT01855009|Vitamins|vitamins|mesh-ancestor
64872727|NCT01855009|Micronutrients|micronutrients|mesh-ancestor
64335783|NCT05254899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64872728|NCT01855009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872729|NCT01855009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64872730|NCT01855009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64872731|NCT01855009|Antacids|antacids|mesh-ancestor
64872746|NCT01855061|GABA Agents|gaba agents|mesh-ancestor
64872747|NCT01855061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64872748|NCT01855061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872749|NCT01855100|Rivaroxaban|rivaroxaban|mesh-list
64872750|NCT01855100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64872751|NCT01855100|Antithrombins|antithrombins|mesh-ancestor
64872752|NCT01855100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64335864|NCT03507127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64335865|NCT03507127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335866|NCT03507127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335867|NCT03512821|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64335868|NCT03512821|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64335869|NCT03512821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64335870|NCT02336529|Bupivacaine|bupivacaine|mesh-list
64335871|NCT02336529|Anesthetics, Local|anesthetics, local|mesh-ancestor
64335872|NCT02336529|Anesthetics|anesthetics|mesh-ancestor
64872753|NCT01855100|Protease Inhibitors|protease inhibitors|mesh-ancestor
64420484|NCT04071457|Growth Substances|growth substances|mesh-ancestor
64872759|NCT01855139|Antithrombins|antithrombins|mesh-ancestor
64872760|NCT01855139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64872761|NCT01855139|Protease Inhibitors|protease inhibitors|mesh-ancestor
64872762|NCT01855139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872763|NCT01855139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872764|NCT01855139|Anticoagulants|anticoagulants|mesh-ancestor
64872765|NCT01855256|Oxybutynin|oxybutynin|mesh-list
64872766|NCT01855256|Parasympatholytics|parasympatholytics|mesh-ancestor
64872767|NCT01855256|Autonomic Agents|autonomic agents|mesh-ancestor
64872768|NCT01855256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64872769|NCT01855256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872770|NCT01855256|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64872771|NCT01855256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64872772|NCT01855256|Cholinergic Agents|cholinergic agents|mesh-ancestor
64872773|NCT01855256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64872774|NCT01855256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872775|NCT01855256|Urological Agents|urological agents|mesh-ancestor
64872777|NCT01855321|Cholecalciferol|cholecalciferol|mesh-list
64872778|NCT01855321|Vitamins|vitamins|mesh-ancestor
64872779|NCT01855321|Micronutrients|micronutrients|mesh-ancestor
64872787|NCT01855334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872788|NCT01855334|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64872789|NCT01855334|Diuretics|diuretics|mesh-ancestor
64872790|NCT01855334|Natriuretic Agents|natriuretic agents|mesh-ancestor
64872791|NCT01855386|Liver Extracts|liver extracts|mesh-list
64872792|NCT01855386|Hematinics|hematinics|mesh-ancestor
64872793|NCT01855490|Exenatide|exenatide|mesh-list
64872794|NCT01855490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64872795|NCT01855490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872796|NCT01855490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64872797|NCT01855490|Incretins|incretins|mesh-ancestor
64872798|NCT01855490|Hormones|hormones|mesh-ancestor
64872799|NCT01855490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64872800|NCT01855516|Heparin|heparin|mesh-list
64872801|NCT01855516|Anticoagulants|anticoagulants|mesh-ancestor
64872802|NCT01855516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64872803|NCT01855516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64872804|NCT01855516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872805|NCT01855529|Ropivacaine|ropivacaine|mesh-list
64872806|NCT01855529|Anesthetics, Local|anesthetics, local|mesh-ancestor
64872807|NCT01855529|Anesthetics|anesthetics|mesh-ancestor
64872808|NCT01855529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64872809|NCT01855529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872810|NCT01855529|Sensory System Agents|sensory system agents|mesh-ancestor
64872811|NCT01855529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64872812|NCT01855542|Plasma-lyte 148|plasma-lyte 148|mesh-list
64872813|NCT01855542|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64872814|NCT01855542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64872815|NCT01855555|Propofol|propofol|mesh-list
64336151|NCT03916419|Durvalumab|durvalumab|mesh-list
64872816|NCT01855555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64872850|NCT01855581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64872851|NCT01855581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64872852|NCT01855581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64872853|NCT01855581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872854|NCT01855594|Lithium Carbonate|lithium carbonate|mesh-list
64872855|NCT01855594|Antidepressive Agents|antidepressive agents|mesh-ancestor
64872856|NCT01855594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64872857|NCT01855594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872858|NCT01855594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872859|NCT01855594|Antimanic Agents|antimanic agents|mesh-ancestor
64872860|NCT01855594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64872861|NCT01855594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64872862|NCT01855594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872864|NCT01855711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64872865|NCT01855711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64872866|NCT01855711|Serotonin Agents|serotonin agents|mesh-ancestor
64872867|NCT01855711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64872868|NCT01855711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872869|NCT01855711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872870|NCT01855724|Gemcitabine|gemcitabine|mesh-list
64872871|NCT01855724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64872872|NCT01855724|Antimetabolites|antimetabolites|mesh-ancestor
64872873|NCT01855724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872874|NCT01855724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872875|NCT01855724|Antiviral Agents|antiviral agents|mesh-ancestor
64872876|NCT01855724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64872877|NCT01855724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64872878|NCT01855724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64872879|NCT01855724|Immunologic Factors|immunologic factors|mesh-ancestor
64872880|NCT01855724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872881|NCT01855737|Warfarin|warfarin|mesh-list
64872882|NCT01855737|Anticoagulants|anticoagulants|mesh-ancestor
64872883|NCT01855763|Insulin|insulin|mesh-list
64872884|NCT01855763|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64872885|NCT01855763|Metformin|metformin|mesh-list
64872886|NCT01855763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64872887|NCT01855763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418012|NCT04330729|Antipyretics|antipyretics|mesh-ancestor
64872888|NCT01855971|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
64872889|NCT01855971|Antioxidants|antioxidants|mesh-ancestor
64872890|NCT01855971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872891|NCT01855971|Protective Agents|protective agents|mesh-ancestor
64872892|NCT01855971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872893|NCT01855971|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64872894|NCT01855971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64872895|NCT01855971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872896|NCT01855971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64872897|NCT01855984|Tocotrienols|tocotrienols|mesh-list
64872898|NCT01855984|Vitamin E|vitamin e|mesh-list
64872899|NCT01855984|Tocopherols|tocopherols|mesh-list
64872900|NCT01855984|Tocovid|tocovid|mesh-list
64872901|NCT01855984|Antioxidants|antioxidants|mesh-ancestor
64872902|NCT01855984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64872903|NCT01855984|Protective Agents|protective agents|mesh-ancestor
64872904|NCT01855984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872905|NCT01855984|Vitamins|vitamins|mesh-ancestor
64872906|NCT01855984|Micronutrients|micronutrients|mesh-ancestor
64872907|NCT01856023|Aldesleukin|aldesleukin|mesh-list
64872908|NCT01856023|Ipilimumab|ipilimumab|mesh-list
64872909|NCT01856023|Interleukin-2|interleukin-2|mesh-list
64872910|NCT01856023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64872920|NCT01856023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64418017|NCT05473741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64336203|NCT02335203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64336204|NCT02335203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64336208|NCT02335203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64336209|NCT02335203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64336211|NCT02335203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64336212|NCT02335203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336213|NCT02303899|Gemcitabine|gemcitabine|mesh-list
64336214|NCT02303899|Imatinib Mesylate|imatinib mesylate|mesh-list
64336215|NCT02303899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64336216|NCT02303899|Antimetabolites|antimetabolites|mesh-ancestor
64336217|NCT02303899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418018|NCT05473741|Serotonin Agents|serotonin agents|mesh-ancestor
64418019|NCT05473741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64418021|NCT05473741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872921|NCT01856023|Antiviral Agents|antiviral agents|mesh-ancestor
64872922|NCT01856023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64872923|NCT01856062|Dexamethasone|dexamethasone|mesh-list
64872924|NCT01856062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64872925|NCT01856062|Antiemetics|antiemetics|mesh-ancestor
64872926|NCT01856062|Autonomic Agents|autonomic agents|mesh-ancestor
64872927|NCT01856062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64872928|NCT01856062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872929|NCT01856062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64872930|NCT01856062|Glucocorticoids|glucocorticoids|mesh-ancestor
64872931|NCT01856062|Hormones|hormones|mesh-ancestor
64872932|NCT01856062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64872933|NCT01856062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64872934|NCT01856062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872935|NCT01856101|Dactolisib|dactolisib|mesh-list
64872936|NCT01856101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64872937|NCT01856127|Sertraline|sertraline|mesh-list
64872940|NCT01856127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64872954|NCT01856166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64872955|NCT01856166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872956|NCT01856166|Analgesics|analgesics|mesh-ancestor
64872957|NCT01856166|Sensory System Agents|sensory system agents|mesh-ancestor
64872958|NCT01856166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64872959|NCT01856166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64872960|NCT01856166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64872961|NCT01856166|Anesthetics, General|anesthetics, general|mesh-ancestor
64872962|NCT01856166|Anesthetics|anesthetics|mesh-ancestor
64872963|NCT01856166|Anesthetics, Local|anesthetics, local|mesh-ancestor
64872964|NCT01856205|Immunoglobulins|immunoglobulins|mesh-list
64872965|NCT01856205|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64872966|NCT01856205|Antibodies|antibodies|mesh-list
64872967|NCT01856205|gamma-Globulins|gamma-globulins|mesh-list
64872968|NCT01856205|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64872969|NCT01856205|Immunologic Factors|immunologic factors|mesh-ancestor
64872970|NCT01856205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872971|NCT01856348|Vitamin D|vitamin d|mesh-list
64872972|NCT01856348|Vitamins|vitamins|mesh-ancestor
64872973|NCT01856348|Micronutrients|micronutrients|mesh-ancestor
64872974|NCT01856348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64872975|NCT01856348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64872976|NCT01856374|Sirolimus|sirolimus|mesh-list
64872977|NCT01856374|Everolimus|everolimus|mesh-list
64872978|NCT01856374|Atorvastatin|atorvastatin|mesh-list
64872979|NCT01856374|Pravastatin|pravastatin|mesh-list
64872997|NCT01856413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336260|NCT02304055|Oxytocin|oxytocin|mesh-list
64872999|NCT01856517|Analgesics|analgesics|mesh-ancestor
64873000|NCT01856517|Sensory System Agents|sensory system agents|mesh-ancestor
64873001|NCT01856517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64873002|NCT01856517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873003|NCT01856517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64873004|NCT01856517|Sympatholytics|sympatholytics|mesh-ancestor
64873005|NCT01856517|Autonomic Agents|autonomic agents|mesh-ancestor
64873006|NCT01856517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64873007|NCT01856517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64873008|NCT01856517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64873009|NCT01856517|Adrenergic Agents|adrenergic agents|mesh-ancestor
64873010|NCT01856517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64873011|NCT01856517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873012|NCT01856556|Glycine|glycine|mesh-list
64873013|NCT01856556|Glycine Agents|glycine agents|mesh-ancestor
64873014|NCT01856556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64873015|NCT01856556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873016|NCT01856556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873017|NCT01856621|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64873018|NCT01856621|Charcoal|charcoal|mesh-list
64873019|NCT01856621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64873033|NCT01856738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873034|NCT01856738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873035|NCT01856738|Cholinergic Agents|cholinergic agents|mesh-ancestor
64873036|NCT01856738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64873037|NCT01856738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873038|NCT01856738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64873039|NCT01856738|Protective Agents|protective agents|mesh-ancestor
64873040|NCT01856803|Thymoglobulin|thymoglobulin|mesh-list
64873041|NCT01856803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64873042|NCT01856803|Immunologic Factors|immunologic factors|mesh-ancestor
64873043|NCT01856803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873044|NCT01856803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64420691|NCT03678025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873045|NCT01856946|Vitamin D|vitamin d|mesh-list
64873067|NCT01856959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64873068|NCT01856959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64873069|NCT01856959|Autonomic Agents|autonomic agents|mesh-ancestor
64873070|NCT01856959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64873071|NCT01856959|Respiratory System Agents|respiratory system agents|mesh-ancestor
64873072|NCT01856959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64873073|NCT01856959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64873074|NCT01856959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64873075|NCT01856959|Adrenergic Agents|adrenergic agents|mesh-ancestor
64873076|NCT01856959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64873077|NCT01856985|Misoprostol|misoprostol|mesh-list
64873078|NCT01856985|Mifepristone|mifepristone|mesh-list
64873079|NCT01856985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64873080|NCT01856985|Abortifacient Agents|abortifacient agents|mesh-ancestor
64873081|NCT01856985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64873082|NCT01856985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873083|NCT01856985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64336474|NCT03504475|Paroxetine|paroxetine|mesh-list
64873084|NCT01856985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64873085|NCT01856985|Oxytocics|oxytocics|mesh-ancestor
64873086|NCT01856985|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64873087|NCT01856985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64873088|NCT01856985|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64873094|NCT01856985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64420796|NCT03341689|Hallucinogens|hallucinogens|mesh-ancestor
64873102|NCT01856998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64873103|NCT01856998|Anesthetics, General|anesthetics, general|mesh-ancestor
64873104|NCT01856998|Anesthetics|anesthetics|mesh-ancestor
64873106|NCT01857011|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64873107|NCT01857011|Teferrol|teferrol|mesh-list
64873108|NCT01857011|Ferric Compounds|ferric compounds|mesh-list
64873109|NCT01857011|Trace Elements|trace elements|mesh-ancestor
64873110|NCT01857011|Micronutrients|micronutrients|mesh-ancestor
64873111|NCT01857011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873112|NCT01857011|Hematinics|hematinics|mesh-ancestor
64873113|NCT01857024|Sevelamer|sevelamer|mesh-list
64873114|NCT01857024|Chelating Agents|chelating agents|mesh-ancestor
64873115|NCT01857024|Sequestering Agents|sequestering agents|mesh-ancestor
64873116|NCT01857024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873117|NCT01857141|Dexmedetomidine|dexmedetomidine|mesh-list
64873118|NCT01857141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64873119|NCT01857141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64873120|NCT01857141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873121|NCT01857141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64873122|NCT01857141|Analgesics|analgesics|mesh-ancestor
64873142|NCT01857154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873143|NCT01857154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64873144|NCT01857193|Everolimus|everolimus|mesh-list
64873145|NCT01857193|Exemestane|exemestane|mesh-list
64873146|NCT01857193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873147|NCT01857193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64873148|NCT01857193|Immunologic Factors|immunologic factors|mesh-ancestor
64873149|NCT01857193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873150|NCT01857193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64873151|NCT01857193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64873152|NCT01857193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873153|NCT01857193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873154|NCT01857193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64873155|NCT01857193|Hormone Antagonists|hormone antagonists|mesh-ancestor
64873156|NCT01857193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64873157|NCT01857284|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
64873158|NCT01857284|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64873159|NCT01857284|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64873160|NCT01857284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64873161|NCT01857284|Antiviral Agents|antiviral agents|mesh-ancestor
64873162|NCT01857284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64873163|NCT01857349|Ethanol|ethanol|mesh-list
64873164|NCT01857349|Chlorhexidine|chlorhexidine|mesh-list
64873165|NCT01857349|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64873166|NCT01857349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64333751|NCT02361879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64333752|NCT05262335|Paclitaxel|paclitaxel|mesh-list
64333753|NCT05262335|Docetaxel|docetaxel|mesh-list
64333754|NCT05262335|Capecitabine|capecitabine|mesh-list
64333755|NCT05262335|Oxaliplatin|oxaliplatin|mesh-list
64873173|NCT01857375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64873174|NCT01857375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873175|NCT01857453|Etoposide|etoposide|mesh-list
64873176|NCT01857453|Carboplatin|carboplatin|mesh-list
64873177|NCT01857453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64873178|NCT01857453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873179|NCT01857453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64873180|NCT01857453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64873181|NCT01857453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873182|NCT01857453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333765|NCT02361645|Indomethacin|indomethacin|mesh-list
64333766|NCT02361645|Nepafenac|nepafenac|mesh-list
64333767|NCT02361645|Bromfenac|bromfenac|mesh-list
64333768|NCT02361645|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64333769|NCT02361645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64333770|NCT02361645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64333771|NCT02361645|Analgesics|analgesics|mesh-ancestor
64333772|NCT02361645|Sensory System Agents|sensory system agents|mesh-ancestor
64333773|NCT02361645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64333774|NCT02361645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333775|NCT02361645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64333776|NCT02361645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64333777|NCT02361645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64333778|NCT02361645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873183|NCT01857479|Amphotericin B|amphotericin b|mesh-list
64873184|NCT01857479|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64873185|NCT01857479|Budesonide|budesonide|mesh-list
64873186|NCT01857479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64873187|NCT01857479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64873188|NCT01857479|Autonomic Agents|autonomic agents|mesh-ancestor
64337081|NCT03132259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418050|NCT04754737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64873189|NCT01857479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64873190|NCT01857479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873191|NCT01857479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64873192|NCT01857479|Respiratory System Agents|respiratory system agents|mesh-ancestor
64873193|NCT01857479|Glucocorticoids|glucocorticoids|mesh-ancestor
64873194|NCT01857479|Hormones|hormones|mesh-ancestor
64873218|NCT01857596|Dopamine Agents|dopamine agents|mesh-ancestor
64873219|NCT01857596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64873220|NCT01857596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873221|NCT01857596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64873222|NCT01857596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64420814|NCT02370615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420815|NCT02370615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64420816|NCT02370615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64873250|NCT01857752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873251|NCT01857804|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64873252|NCT01857804|Amoxicillin|amoxicillin|mesh-list
64873253|NCT01857804|Chlorhexidine|chlorhexidine|mesh-list
64873254|NCT01857804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64873255|NCT01857804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64873256|NCT01857804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64873257|NCT01857804|Disinfectants|disinfectants|mesh-ancestor
64873258|NCT01857804|Dermatologic Agents|dermatologic agents|mesh-ancestor
64873259|NCT01857817|Etodolac|etodolac|mesh-list
64873260|NCT01857817|Propranolol|propranolol|mesh-list
64873261|NCT01857817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64873262|NCT01857817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64418130|NCT05347459|Vildagliptin|vildagliptin|mesh-list
64873263|NCT01857817|Adrenergic Agents|adrenergic agents|mesh-ancestor
64873264|NCT01857817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64873265|NCT01857817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873266|NCT01857817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873267|NCT01857817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64873268|NCT01857817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64873269|NCT01857817|Vasodilator Agents|vasodilator agents|mesh-ancestor
64873270|NCT01857817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64873271|NCT01857817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64873272|NCT01857817|Analgesics|analgesics|mesh-ancestor
64873273|NCT01857817|Sensory System Agents|sensory system agents|mesh-ancestor
64873274|NCT01857817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64873275|NCT01857817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64873276|NCT01857817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64873277|NCT01857817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64873278|NCT01857817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64873279|NCT01857817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873280|NCT01857843|Everolimus|everolimus|mesh-list
64873281|NCT01857843|Simvastatin|simvastatin|mesh-list
64873282|NCT01857843|Ezetimibe|ezetimibe|mesh-list
64873283|NCT01857843|Pravastatin|pravastatin|mesh-list
64873284|NCT01857843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873292|NCT01857843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64873293|NCT01857843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64873294|NCT01857843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873295|NCT01857856|Eplerenone|eplerenone|mesh-list
64873296|NCT01857856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64873364|NCT01858090|Levobupivacaine|levobupivacaine|mesh-list
64873365|NCT01858090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64337352|NCT02234843|Antithrombins|antithrombins|mesh-ancestor
64337353|NCT02234843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64873366|NCT01858090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64873367|NCT01858090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873368|NCT01858090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64873369|NCT01858090|Anesthetics, General|anesthetics, general|mesh-ancestor
64873370|NCT01858090|Anesthetics|anesthetics|mesh-ancestor
64641944|NCT00538850|Analgesics|analgesics|mesh-ancestor
64873371|NCT01858090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64873372|NCT01858090|Narcotics|narcotics|mesh-ancestor
64873373|NCT01858090|Analgesics|analgesics|mesh-ancestor
64873394|NCT01858090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64873395|NCT01858090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64337452|NCT02182687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64337454|NCT02182687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337520|NCT03736265|Carvedilol|carvedilol|mesh-list
64337531|NCT03736265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64337554|NCT02934529|Irinotecan|irinotecan|mesh-list
64873397|NCT01858090|Antiemetics|antiemetics|mesh-ancestor
64873398|NCT01858090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64873399|NCT01858090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64873400|NCT01858090|Histamine Antagonists|histamine antagonists|mesh-ancestor
64873401|NCT01858090|Histamine Agents|histamine agents|mesh-ancestor
64873402|NCT01858090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64873403|NCT01858090|Antipruritics|antipruritics|mesh-ancestor
64873404|NCT01858090|Dermatologic Agents|dermatologic agents|mesh-ancestor
64420938|NCT02304705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420939|NCT02304705|Urological Agents|urological agents|mesh-ancestor
64873428|NCT01858168|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64873429|NCT01858207|Doxorubicin|doxorubicin|mesh-list
64873430|NCT01858207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64873431|NCT01858207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418196|NCT02400333|Ticagrelor|ticagrelor|mesh-list
64873432|NCT01858207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64873433|NCT01858207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64873434|NCT01858207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873435|NCT01858207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873436|NCT01858311|Tocotrienols|tocotrienols|mesh-list
64873438|NCT01858311|Tocopherols|tocopherols|mesh-list
64873439|NCT01858311|Antioxidants|antioxidants|mesh-ancestor
64873440|NCT01858311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873441|NCT01858311|Protective Agents|protective agents|mesh-ancestor
64418240|NCT05542615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64873442|NCT01858311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873443|NCT01858311|Vitamins|vitamins|mesh-ancestor
64873444|NCT01858311|Micronutrients|micronutrients|mesh-ancestor
64873445|NCT01858402|Acetaminophen|acetaminophen|mesh-list
64873446|NCT01858402|Dipyrone|dipyrone|mesh-list
64873447|NCT01858402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64873448|NCT01858402|Analgesics|analgesics|mesh-ancestor
64873449|NCT01858402|Sensory System Agents|sensory system agents|mesh-ancestor
64873450|NCT01858402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64873451|NCT01858402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873452|NCT01858402|Antipyretics|antipyretics|mesh-ancestor
64873453|NCT01858402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64873454|NCT01858402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64873455|NCT01858402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64873456|NCT01858441|Abiraterone Acetate|abiraterone acetate|mesh-list
64873457|NCT01858441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873458|NCT01858441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64873459|NCT01858441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337792|NCT02264093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64873460|NCT01858441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873461|NCT01858441|Hormone Antagonists|hormone antagonists|mesh-ancestor
64873462|NCT01858441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64873463|NCT01858441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873464|NCT01858441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64873465|NCT01858571|Thalidomide|thalidomide|mesh-list
64873466|NCT01858571|Celecoxib|celecoxib|mesh-list
64873467|NCT01858571|Cyclophosphamide|cyclophosphamide|mesh-list
64873468|NCT01858571|Etoposide|etoposide|mesh-list
64873469|NCT01858571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64873470|NCT01858571|Immunologic Factors|immunologic factors|mesh-ancestor
64873471|NCT01858571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873472|NCT01858571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64873473|NCT01858571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64873474|NCT01858571|Alkylating Agents|alkylating agents|mesh-ancestor
64873475|NCT01858571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873476|NCT01858571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873477|NCT01858571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64873501|NCT01858610|Natriuretic Agents|natriuretic agents|mesh-ancestor
64873502|NCT01858610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338001|NCT00156065|Dopamine Agents|dopamine agents|mesh-ancestor
64873503|NCT01858610|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64873504|NCT01858610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64873505|NCT01858610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873506|NCT01858610|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64338112|NCT01262261|Analgesics|analgesics|mesh-ancestor
64338203|NCT01255709|Respiratory System Agents|respiratory system agents|mesh-ancestor
64338204|NCT01255709|Mydriatics|mydriatics|mesh-ancestor
64418343|NCT05540587|Warfarin|warfarin|mesh-list
64873507|NCT01858610|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64873508|NCT01858623|Losartan|losartan|mesh-list
64873509|NCT01858623|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64873510|NCT01858623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64873511|NCT01858623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64873512|NCT01858623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64873513|NCT01858623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64873514|NCT01858623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873515|NCT01858623|Diuretics|diuretics|mesh-ancestor
64873516|NCT01858623|Natriuretic Agents|natriuretic agents|mesh-ancestor
64873517|NCT01858623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873518|NCT01858623|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64873519|NCT01858623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64338249|NCT01234025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338250|NCT01234025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64338251|NCT01234025|Glucocorticoids|glucocorticoids|mesh-ancestor
64418439|NCT05700253|Immunologic Factors|immunologic factors|mesh-ancestor
64418440|NCT05700253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418441|NCT05700253|Viscosupplements|viscosupplements|mesh-ancestor
64418442|NCT05700253|Protective Agents|protective agents|mesh-ancestor
64418443|NCT05544253|Mitomycins|mitomycins|mesh-list
64418444|NCT05544253|Mitomycin|mitomycin|mesh-list
64418445|NCT05544253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64418446|NCT05544253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418447|NCT05544253|Alkylating Agents|alkylating agents|mesh-ancestor
64418448|NCT05544253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418449|NCT05544253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64418450|NCT05544253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418451|NCT05535517|Emollients|emollients|mesh-list
64418452|NCT05535517|Dermatologic Agents|dermatologic agents|mesh-ancestor
64418453|NCT05543941|Povidone-Iodine|povidone-iodine|mesh-list
64418454|NCT05543941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64418455|NCT05543941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64418456|NCT02580877|Insulin|insulin|mesh-list
64418457|NCT02580877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64418458|NCT02580877|Insulin, Isophane|insulin, isophane|mesh-list
64414853|NCT02486757|Progestins|progestins|mesh-ancestor
64414854|NCT04883203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64414855|NCT04883203|Plasma-lyte 148|plasma-lyte 148|mesh-list
64414860|NCT04886869|Caffeine|caffeine|mesh-list
64873520|NCT01858649|Bevacizumab|bevacizumab|mesh-list
64873521|NCT01858649|Oxaliplatin|oxaliplatin|mesh-list
64642132|NCT00544778|Irinotecan|irinotecan|mesh-list
64873522|NCT01858649|Irinotecan|irinotecan|mesh-list
64873523|NCT01858649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64873524|NCT01858649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873525|NCT01858649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64873526|NCT01858649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64873527|NCT01858649|Growth Substances|growth substances|mesh-ancestor
64873528|NCT01858649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873529|NCT01858649|Growth Inhibitors|growth inhibitors|mesh-ancestor
64873530|NCT01858649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64873531|NCT01858649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64873532|NCT01858649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873533|NCT01858649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873534|NCT01858662|Leucovorin|leucovorin|mesh-list
64873535|NCT01858662|Oxaliplatin|oxaliplatin|mesh-list
64873536|NCT01858662|Irinotecan|irinotecan|mesh-list
64873537|NCT01858662|Cetuximab|cetuximab|mesh-list
64873538|NCT01858662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873539|NCT01858662|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64873540|NCT01858662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64873541|NCT01858662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873542|NCT01858662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873543|NCT01858662|Antidotes|antidotes|mesh-ancestor
64873544|NCT01858662|Protective Agents|protective agents|mesh-ancestor
64873545|NCT01858662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873546|NCT01858662|Vitamin B Complex|vitamin b complex|mesh-ancestor
64873547|NCT01858662|Vitamins|vitamins|mesh-ancestor
64873548|NCT01858662|Micronutrients|micronutrients|mesh-ancestor
64873549|NCT01858662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64873550|NCT01858792|Belimumab|belimumab|mesh-list
64873551|NCT01858792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64873552|NCT01858792|Immunologic Factors|immunologic factors|mesh-ancestor
64873553|NCT01858792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873554|NCT01858831|Atovaquone|atovaquone|mesh-list
64873555|NCT01858831|Proguanil|proguanil|mesh-list
64873556|NCT01858831|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
64873557|NCT01858831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64873567|NCT01858870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64873568|NCT01858870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64873569|NCT01858870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873571|NCT01858909|Antioxidants|antioxidants|mesh-ancestor
64873572|NCT01858909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873573|NCT01858909|Protective Agents|protective agents|mesh-ancestor
64873574|NCT01858909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873575|NCT01858909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64873576|NCT01858961|Interferons|interferons|mesh-list
64873577|NCT01858961|Ribavirin|ribavirin|mesh-list
64873578|NCT01858961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873579|NCT01858961|Antiviral Agents|antiviral agents|mesh-ancestor
64873580|NCT01858961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64873581|NCT01858961|Antimetabolites|antimetabolites|mesh-ancestor
64873582|NCT01858961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873583|NCT01859234|Bevacizumab|bevacizumab|mesh-list
64873584|NCT01859234|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
64873585|NCT01859234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64873586|NCT01859234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873587|NCT01859234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64418472|NCT02580877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64418473|NCT02580877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64418504|NCT05243329|Hallucinogens|hallucinogens|mesh-ancestor
64418505|NCT05243329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418506|NCT05243329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64418512|NCT05678959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418514|NCT05672407|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64418515|NCT05672407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64418516|NCT05672407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418517|NCT05672407|Hemostatics|hemostatics|mesh-ancestor
64418518|NCT05672407|Coagulants|coagulants|mesh-ancestor
64873588|NCT01859234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64873589|NCT01859234|Growth Substances|growth substances|mesh-ancestor
64873590|NCT01859234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873591|NCT01859234|Growth Inhibitors|growth inhibitors|mesh-ancestor
64873592|NCT01859234|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64873593|NCT01859234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873594|NCT01859377|Ibuprofen|ibuprofen|mesh-list
64873595|NCT01859377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64873596|NCT01859377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64338293|NCT02268773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64338294|NCT02268773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64338295|NCT02268773|Analgesics|analgesics|mesh-ancestor
64338296|NCT02268773|Sensory System Agents|sensory system agents|mesh-ancestor
64415208|NCT04389073|Growth Substances|growth substances|mesh-ancestor
64415295|NCT05533073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64415296|NCT05533073|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64415297|NCT05533073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64415298|NCT05533073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64415299|NCT05533073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415300|NCT04050553|Tirzepatide|tirzepatide|mesh-list
64415301|NCT04050553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64415357|NCT05526911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415358|NCT05526911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64415359|NCT05526911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64338325|NCT05626829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873597|NCT01859377|Analgesics|analgesics|mesh-ancestor
64873598|NCT01859377|Sensory System Agents|sensory system agents|mesh-ancestor
64873599|NCT01859377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64873600|NCT01859377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873601|NCT01859377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64873602|NCT01859377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64873603|NCT01859377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64873604|NCT01859377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873605|NCT01859377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873606|NCT01859455|Atorvastatin|atorvastatin|mesh-list
64873607|NCT01859455|Simvastatin|simvastatin|mesh-list
64873608|NCT01859455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64873609|NCT01859455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64873610|NCT01859455|Antimetabolites|antimetabolites|mesh-ancestor
64873611|NCT01859455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873612|NCT01859455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64416089|NCT02564471|Proguanil|proguanil|mesh-list
64416090|NCT02564471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64416091|NCT02564471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64416092|NCT02564471|Antimalarials|antimalarials|mesh-ancestor
64416095|NCT02564471|Amebicides|amebicides|mesh-ancestor
64873613|NCT01859455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64873614|NCT01859455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873615|NCT01859468|Calcium Carbonate|calcium carbonate|mesh-list
64873616|NCT01859468|Calcium|calcium|mesh-list
64873617|NCT01859468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64873618|NCT01859468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873619|NCT01859468|Antacids|antacids|mesh-ancestor
64416923|NCT03036085|Sympathomimetics|sympathomimetics|mesh-ancestor
64416924|NCT03036085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64416925|NCT04831255|Triamcinolone|triamcinolone|mesh-list
64417116|NCT04829695|Antiviral Agents|antiviral agents|mesh-ancestor
64417117|NCT04829695|Schistosomicides|schistosomicides|mesh-ancestor
64417118|NCT04829695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64417119|NCT04829695|Anthelmintics|anthelmintics|mesh-ancestor
64417120|NCT04835233|Methyldopa|methyldopa|mesh-list
64417121|NCT04835233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64417122|NCT04835233|Sympatholytics|sympatholytics|mesh-ancestor
64417123|NCT04835233|Autonomic Agents|autonomic agents|mesh-ancestor
64417124|NCT04835233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64417192|NCT02605837|Hormones|hormones|mesh-ancestor
64417203|NCT04834375|Glucocorticoids|glucocorticoids|mesh-ancestor
64417204|NCT04834375|Hormones|hormones|mesh-ancestor
64417206|NCT04834375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64417252|NCT02406261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64417253|NCT02406261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64417254|NCT02406261|Anesthetics, General|anesthetics, general|mesh-ancestor
64417390|NCT04797793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64417869|NCT05613361|Curcumin|curcumin|mesh-list
64873620|NCT01859468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873621|NCT01859468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64873622|NCT01859481|Eletriptan|eletriptan|mesh-list
64873623|NCT01859481|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64873624|NCT01859481|Serotonin Agents|serotonin agents|mesh-ancestor
64873625|NCT01859481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64873626|NCT01859481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873627|NCT01859481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873628|NCT01859585|Ketorolac|ketorolac|mesh-list
64873629|NCT01859585|Parecoxib|parecoxib|mesh-list
64873630|NCT01859585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64873631|NCT01859585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64873632|NCT01859585|Analgesics|analgesics|mesh-ancestor
64873633|NCT01859585|Sensory System Agents|sensory system agents|mesh-ancestor
64873634|NCT01859585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64873635|NCT01859585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873636|NCT01859585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64873637|NCT01859585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64873638|NCT01859585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64873639|NCT01859585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873640|NCT01859585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873641|NCT01859585|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64873642|NCT01859624|Albuterol|albuterol|mesh-list
64873643|NCT01859624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64873644|NCT01859624|Autonomic Agents|autonomic agents|mesh-ancestor
64873645|NCT01859624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64873646|NCT01859624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873647|NCT01859624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64873648|NCT01859624|Respiratory System Agents|respiratory system agents|mesh-ancestor
64873649|NCT01859624|Tocolytic Agents|tocolytic agents|mesh-ancestor
64873650|NCT01859624|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64421057|NCT05508737|Trifluridine|trifluridine|mesh-list
64873651|NCT01859624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64873652|NCT01859624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64873653|NCT01859624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64418065|NCT04481035|Antioxidants|antioxidants|mesh-ancestor
64418066|NCT04481035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418067|NCT04481035|Protective Agents|protective agents|mesh-ancestor
64418068|NCT04481035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418069|NCT04481035|Antidotes|antidotes|mesh-ancestor
64418141|NCT05347459|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64418142|NCT05346445|Fluoxetine|fluoxetine|mesh-list
64418249|NCT04134559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873654|NCT01859624|Adrenergic Agents|adrenergic agents|mesh-ancestor
64873655|NCT01859624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64873656|NCT01859624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873657|NCT01859728|Gemcitabine|gemcitabine|mesh-list
64873658|NCT01859728|Cisplatin|cisplatin|mesh-list
64873659|NCT01859728|Irinotecan|irinotecan|mesh-list
64873660|NCT01859728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873661|NCT01859728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64873662|NCT01859728|Antimetabolites|antimetabolites|mesh-ancestor
64418546|NCT05695495|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64418547|NCT05461261|Prednisolone|prednisolone|mesh-list
64418548|NCT05461261|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64418549|NCT05461261|Methylprednisolone|methylprednisolone|mesh-list
64418550|NCT05461261|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64873663|NCT01859728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873664|NCT01859728|Antiviral Agents|antiviral agents|mesh-ancestor
64873667|NCT01859728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64873668|NCT01859728|Immunologic Factors|immunologic factors|mesh-ancestor
64873669|NCT01859728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873670|NCT01859728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64873671|NCT01859728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64418649|NCT05051449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64418650|NCT05051449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64418651|NCT05051449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64418652|NCT05051449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64873672|NCT01859754|gamma-Globulins|gamma-globulins|mesh-list
64873673|NCT01859754|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64873674|NCT01859754|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64873675|NCT01859754|Immunologic Factors|immunologic factors|mesh-ancestor
64873676|NCT01859754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873677|NCT01859858|Curcumin|curcumin|mesh-list
64873678|NCT01859858|Irinotecan|irinotecan|mesh-list
64873679|NCT01859858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64873680|NCT01859858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64873681|NCT01859858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418875|NCT02581891|Growth Substances|growth substances|mesh-ancestor
64420903|NCT04539379|Anesthetics|anesthetics|mesh-ancestor
64418876|NCT02581891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418877|NCT02581891|Growth Inhibitors|growth inhibitors|mesh-ancestor
64418878|NCT02581891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418879|NCT04523857|Hydroxychloroquine|hydroxychloroquine|mesh-list
64418880|NCT04523857|Antimalarials|antimalarials|mesh-ancestor
64418881|NCT04523857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64418882|NCT04523857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64873682|NCT01859858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873683|NCT01859858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873684|NCT01859858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64873685|NCT01859858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64873686|NCT01859858|Analgesics|analgesics|mesh-ancestor
64873687|NCT01859858|Sensory System Agents|sensory system agents|mesh-ancestor
64873688|NCT01859858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64873689|NCT01859858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873690|NCT01859858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64873691|NCT01859858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64873692|NCT01860014|Poractant alfa|poractant alfa|mesh-list
64873693|NCT01860014|Beractant|beractant|mesh-list
64873694|NCT01860014|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
64873695|NCT01860014|Respiratory System Agents|respiratory system agents|mesh-ancestor
64873696|NCT01860066|Fluticasone|fluticasone|mesh-list
64873712|NCT01860066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64873713|NCT01860066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873714|NCT01860066|Glucocorticoids|glucocorticoids|mesh-ancestor
64873715|NCT01860066|Hormones|hormones|mesh-ancestor
64873716|NCT01860066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64873717|NCT01860066|Sympathomimetics|sympathomimetics|mesh-ancestor
64873718|NCT01860105|Clopidogrel|clopidogrel|mesh-list
64421060|NCT05508737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421061|NCT05508737|Antimetabolites|antimetabolites|mesh-ancestor
64418945|NCT04341571|Metformin|metformin|mesh-list
64418946|NCT04341571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64418947|NCT04341571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418948|NCT05568745|Misoprostol|misoprostol|mesh-list
64418949|NCT05568745|Oxytocin|oxytocin|mesh-list
64418950|NCT05568745|Oxytocics|oxytocics|mesh-ancestor
64418957|NCT04314895|Paclitaxel|paclitaxel|mesh-list
64418958|NCT04314895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64418959|NCT04314895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64418960|NCT04314895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418961|NCT04314895|Tubulin Modulators|tubulin modulators|mesh-ancestor
64418962|NCT04314895|Antimitotic Agents|antimitotic agents|mesh-ancestor
64418963|NCT04314895|Mitosis Modulators|mitosis modulators|mesh-ancestor
64418964|NCT04314895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418965|NCT02581189|Ritonavir|ritonavir|mesh-list
64418966|NCT02581189|Ribavirin|ribavirin|mesh-list
64418967|NCT02581189|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64418968|NCT02581189|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64418969|NCT02581189|Protease Inhibitors|protease inhibitors|mesh-ancestor
64418970|NCT02581189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421062|NCT05508737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421063|NCT05508737|Antiviral Agents|antiviral agents|mesh-ancestor
64421064|NCT05508737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64421065|NCT05508035|Valsartan|valsartan|mesh-list
64421066|NCT05508035|Ramipril|ramipril|mesh-list
64873766|NCT01860300|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64338493|NCT01004081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64338494|NCT01004081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338495|NCT01004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418985|NCT00352027|Prednisone|prednisone|mesh-list
64418986|NCT00352027|Hydrocortisone|hydrocortisone|mesh-list
64418987|NCT00352027|Cyclophosphamide|cyclophosphamide|mesh-list
64418988|NCT00352027|Mechlorethamine|mechlorethamine|mesh-list
64418989|NCT00352027|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64418990|NCT00352027|Doxorubicin|doxorubicin|mesh-list
64418991|NCT00352027|Etoposide|etoposide|mesh-list
64418992|NCT00352027|Vincristine|vincristine|mesh-list
64418993|NCT00352027|Bleomycin|bleomycin|mesh-list
64418994|NCT00352027|Vinblastine|vinblastine|mesh-list
64418995|NCT00352027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64418996|NCT00352027|Immunologic Factors|immunologic factors|mesh-ancestor
64338496|NCT01004081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64873767|NCT01860300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873768|NCT01860300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873770|NCT01860391|Cariostatic Agents|cariostatic agents|mesh-ancestor
64873771|NCT01860391|Protective Agents|protective agents|mesh-ancestor
64873772|NCT01860391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873773|NCT01860417|Mepivacaine|mepivacaine|mesh-list
64873774|NCT01860417|Anesthetics, Local|anesthetics, local|mesh-ancestor
64873775|NCT01860417|Anesthetics|anesthetics|mesh-ancestor
64873776|NCT01860417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64873777|NCT01860417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419050|NCT02576977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419051|NCT02576977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64419052|NCT02576977|Immunologic Factors|immunologic factors|mesh-ancestor
64873778|NCT01860417|Sensory System Agents|sensory system agents|mesh-ancestor
64873779|NCT01860417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64873781|NCT01860469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64873782|NCT01860469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64873783|NCT01860482|Rabeprazole|rabeprazole|mesh-list
64873784|NCT01860482|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64873785|NCT01860482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64873786|NCT01860482|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64873787|NCT01860482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873788|NCT01860482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873789|NCT01860508|Carboplatin|carboplatin|mesh-list
64419130|NCT05529355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419132|NCT05528887|Cyclophosphamide|cyclophosphamide|mesh-list
64419133|NCT05528887|Fludarabine|fludarabine|mesh-list
64419134|NCT05528887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64423720|NCT05237947|Vaccines|vaccines|mesh-list
64419135|NCT05528887|Immunologic Factors|immunologic factors|mesh-ancestor
64419136|NCT05528887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419137|NCT05528887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64419166|NCT03009019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419167|NCT03009019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419171|NCT02813785|Docetaxel|docetaxel|mesh-list
64419222|NCT02303119|Rituximab|rituximab|mesh-list
64419223|NCT02303119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64419224|NCT02303119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419225|NCT02303119|Immunologic Factors|immunologic factors|mesh-ancestor
64419226|NCT02303119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419227|NCT02303119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64419228|NCT02575339|Sorafenib|sorafenib|mesh-list
64419229|NCT02575339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419230|NCT02575339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64419231|NCT02575339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419232|NCT02575339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419233|NCT01640587|Artesunate|artesunate|mesh-list
64873790|NCT01860508|Pemetrexed|pemetrexed|mesh-list
64873791|NCT01860508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873792|NCT01860508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873793|NCT01860508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873794|NCT01860508|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64873795|NCT01860508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64873796|NCT01860625|Donepezil|donepezil|mesh-list
64873797|NCT01860625|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64873798|NCT01860625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873810|NCT01860638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64873811|NCT01860638|Growth Substances|growth substances|mesh-ancestor
64873812|NCT01860638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873813|NCT01860638|Growth Inhibitors|growth inhibitors|mesh-ancestor
64873814|NCT01860638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64873815|NCT01860638|Alkylating Agents|alkylating agents|mesh-ancestor
64642417|NCT01795820|Ticagrelor|ticagrelor|mesh-list
64873816|NCT01860638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873817|NCT01860664|Hydrocortisone|hydrocortisone|mesh-list
64873818|NCT01860664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64873819|NCT01860690|Methotrexate|methotrexate|mesh-list
64419364|NCT05523661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419365|NCT05523037|Sevoflurane|sevoflurane|mesh-list
64426024|NCT05171673|Diclofenac|diclofenac|mesh-list
64419366|NCT05523037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64419367|NCT05523037|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64419369|NCT05523037|Anesthetics|anesthetics|mesh-ancestor
64419370|NCT05523037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64419371|NCT05523037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419372|NCT05122741|Aspirin|aspirin|mesh-list
64419373|NCT05122741|Clopidogrel|clopidogrel|mesh-list
64873820|NCT01860690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64873821|NCT01860690|Abortifacient Agents|abortifacient agents|mesh-ancestor
64873822|NCT01860690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64873823|NCT01860690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873824|NCT01860690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64873825|NCT01860690|Antimetabolites|antimetabolites|mesh-ancestor
64873826|NCT01860690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873827|NCT01860690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873828|NCT01860690|Dermatologic Agents|dermatologic agents|mesh-ancestor
64873829|NCT01860690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873830|NCT01860690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64873831|NCT01860690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64873832|NCT01860690|Immunologic Factors|immunologic factors|mesh-ancestor
64873833|NCT01860690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64873834|NCT01860690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64873835|NCT01860716|Melatonin|melatonin|mesh-list
64419429|NCT02392377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426893|NCT02520063|Letrozole|letrozole|mesh-list
64419430|NCT02392377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64419431|NCT02392377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419433|NCT02392377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64419434|NCT02392377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64419435|NCT02392377|Immunologic Factors|immunologic factors|mesh-ancestor
64419436|NCT02392377|Antidotes|antidotes|mesh-ancestor
64419437|NCT02392377|Protective Agents|protective agents|mesh-ancestor
64419438|NCT02392377|Vitamin B Complex|vitamin b complex|mesh-ancestor
64419439|NCT02392377|Vitamins|vitamins|mesh-ancestor
64419440|NCT02392377|Micronutrients|micronutrients|mesh-ancestor
64419441|NCT02340819|Teduglutide|teduglutide|mesh-list
64419442|NCT02340819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64419443|NCT02340819|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64419444|NCT02340819|Protective Agents|protective agents|mesh-ancestor
64419493|NCT05512351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419494|NCT05512351|Growth Inhibitors|growth inhibitors|mesh-ancestor
64419495|NCT02569957|Acetylcysteine|acetylcysteine|mesh-list
64419496|NCT02569957|Topotecan|topotecan|mesh-list
64427045|NCT02434081|Nivolumab|nivolumab|mesh-list
64419497|NCT02569957|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64419498|NCT02569957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64419499|NCT02569957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64419500|NCT02569957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419501|NCT02569957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419502|NCT02569957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419503|NCT02569957|Antiviral Agents|antiviral agents|mesh-ancestor
64419504|NCT02569957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64419507|NCT02569957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64419508|NCT02569957|Antioxidants|antioxidants|mesh-ancestor
64419509|NCT02569957|Protective Agents|protective agents|mesh-ancestor
64419510|NCT02569957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419511|NCT02569957|Antidotes|antidotes|mesh-ancestor
64419512|NCT01649427|Tacrolimus|tacrolimus|mesh-list
64419513|NCT01649427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64419514|NCT01649427|Immunologic Factors|immunologic factors|mesh-ancestor
64419517|NCT01649427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419582|NCT02573311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419583|NCT02573311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419584|NCT02573311|Urological Agents|urological agents|mesh-ancestor
64419585|NCT05520853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64428527|NCT05366933|Micronutrients|micronutrients|mesh-ancestor
64428528|NCT05366933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419586|NCT05520853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873836|NCT01860716|Antioxidants|antioxidants|mesh-ancestor
64873837|NCT01860716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873838|NCT01860716|Protective Agents|protective agents|mesh-ancestor
64873839|NCT01860716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873850|NCT01860742|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64421174|NCT02489903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64873851|NCT01860742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873852|NCT01860742|Antiviral Agents|antiviral agents|mesh-ancestor
64873853|NCT01860742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64873854|NCT01860742|Immunologic Factors|immunologic factors|mesh-ancestor
64873855|NCT01860742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873856|NCT01860742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64873857|NCT01860742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873858|NCT01860781|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64873859|NCT01860781|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64873860|NCT01860781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64873861|NCT01860781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64873862|NCT01860781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873863|NCT01860781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64873864|NCT01860781|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64419644|NCT04295941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64419645|NCT04295941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419647|NCT04295941|Serotonin Agents|serotonin agents|mesh-ancestor
64419648|NCT04295941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64419649|NCT04295941|Antidepressive Agents|antidepressive agents|mesh-ancestor
64873865|NCT01860781|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64873866|NCT01860781|Serotonin Agents|serotonin agents|mesh-ancestor
64873867|NCT01860781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64873868|NCT01860781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873869|NCT01860781|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64873870|NCT01860781|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64873871|NCT01860781|Dopamine Agents|dopamine agents|mesh-ancestor
64873872|NCT01860833|Ibuprofen|ibuprofen|mesh-list
64873873|NCT01860833|Celecoxib|celecoxib|mesh-list
64873874|NCT01860833|Diclofenac|diclofenac|mesh-list
64873875|NCT01860833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64873876|NCT01860833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64873877|NCT01860833|Analgesics|analgesics|mesh-ancestor
64873878|NCT01860833|Sensory System Agents|sensory system agents|mesh-ancestor
64338579|NCT01745588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338580|NCT01745588|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64873879|NCT01860833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64873880|NCT01860833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873881|NCT01860833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64873882|NCT01860833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64873883|NCT01860833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64873884|NCT01860833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873885|NCT01860833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873886|NCT01860833|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64873887|NCT01860911|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
64873888|NCT01860911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873889|NCT01860911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873890|NCT01861015|Vasopressins|vasopressins|mesh-list
64873891|NCT01861015|Arginine Vasopressin|arginine vasopressin|mesh-list
64873892|NCT01861015|Epinephrine|epinephrine|mesh-list
64873893|NCT01861015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64873894|NCT01861015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64873895|NCT01861015|Adrenergic Agents|adrenergic agents|mesh-ancestor
64873896|NCT01861015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64873897|NCT01861015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873898|NCT01861015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419704|NCT05514847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64419705|NCT05514847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64419706|NCT05514847|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64419707|NCT05514847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64419708|NCT05514847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419709|NCT05514847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64419710|NCT05514847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64873899|NCT01861015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64873900|NCT01861015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64873901|NCT01861015|Autonomic Agents|autonomic agents|mesh-ancestor
64873902|NCT01861015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64873903|NCT01861015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64873904|NCT01861015|Respiratory System Agents|respiratory system agents|mesh-ancestor
64873905|NCT01861015|Mydriatics|mydriatics|mesh-ancestor
64873906|NCT01861015|Sympathomimetics|sympathomimetics|mesh-ancestor
64873907|NCT01861015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64873908|NCT01861015|Hemostatics|hemostatics|mesh-ancestor
64873909|NCT01861015|Coagulants|coagulants|mesh-ancestor
64873910|NCT01861015|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64873911|NCT01861015|Natriuretic Agents|natriuretic agents|mesh-ancestor
64338609|NCT01281176|Mitosis Modulators|mitosis modulators|mesh-ancestor
64338610|NCT01281176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338612|NCT01281176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873912|NCT01861041|Bupivacaine|bupivacaine|mesh-list
64873913|NCT01861041|Anesthetics, Local|anesthetics, local|mesh-ancestor
64873914|NCT01861041|Anesthetics|anesthetics|mesh-ancestor
64873915|NCT01861041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64873916|NCT01861041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873917|NCT01861041|Sensory System Agents|sensory system agents|mesh-ancestor
64873918|NCT01861041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64873919|NCT01861145|Mometasone Furoate|mometasone furoate|mesh-list
64873920|NCT01861145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64873921|NCT01861145|Dermatologic Agents|dermatologic agents|mesh-ancestor
64873922|NCT01861145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64873924|NCT01861223|Nimotuzumab|nimotuzumab|mesh-list
64873925|NCT01861223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873926|NCT01861223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64873927|NCT01861223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873928|NCT01861223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873929|NCT01861223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64873930|NCT01861340|Dexamethasone|dexamethasone|mesh-list
64873931|NCT01861340|Lenalidomide|lenalidomide|mesh-list
64873932|NCT01861340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64873933|NCT01861340|Antiemetics|antiemetics|mesh-ancestor
64873934|NCT01861340|Autonomic Agents|autonomic agents|mesh-ancestor
64873935|NCT01861340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64873936|NCT01861340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873937|NCT01861340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64873938|NCT01861340|Glucocorticoids|glucocorticoids|mesh-ancestor
64873939|NCT01861340|Hormones|hormones|mesh-ancestor
64873940|NCT01861340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64873941|NCT01861340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64873943|NCT01861340|Immunologic Factors|immunologic factors|mesh-ancestor
64873956|NCT01861561|Immunologic Factors|immunologic factors|mesh-ancestor
64873957|NCT01861561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873958|NCT01861561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64873959|NCT01861561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64873960|NCT01861561|Alkylating Agents|alkylating agents|mesh-ancestor
64873961|NCT01861561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873962|NCT01861561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873963|NCT01861561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64873964|NCT01861626|Isotretinoin|isotretinoin|mesh-list
64873965|NCT01861626|Dermatologic Agents|dermatologic agents|mesh-ancestor
64873966|NCT01861912|Arsenic Trioxide|arsenic trioxide|mesh-list
64873967|NCT01861912|Ethiodized Oil|ethiodized oil|mesh-list
64873968|NCT01861912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873969|NCT01861951|Doxorubicin|doxorubicin|mesh-list
64873970|NCT01861951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64873971|NCT01861951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64873972|NCT01861951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64873973|NCT01861951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64873974|NCT01861951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873975|NCT01861951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64873976|NCT01861990|Valproic Acid|valproic acid|mesh-list
64873977|NCT01861990|Anticonvulsants|anticonvulsants|mesh-ancestor
64873978|NCT01861990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64873979|NCT01861990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419881|NCT02336373|Hydroxyurea|hydroxyurea|mesh-list
64419882|NCT02336373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419884|NCT02336373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419885|NCT02336373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419886|NCT02336373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64419888|NCT02372799|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
64873980|NCT01861990|GABA Agents|gaba agents|mesh-ancestor
64873981|NCT01861990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64873982|NCT01861990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64873983|NCT01861990|Antimanic Agents|antimanic agents|mesh-ancestor
64873984|NCT01861990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64873985|NCT01861990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64873986|NCT01861990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64873987|NCT01862003|Leucovorin|leucovorin|mesh-list
64421272|NCT00560495|Growth Substances|growth substances|mesh-ancestor
64873999|NCT01862003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64874000|NCT01862003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64874001|NCT01862003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64874002|NCT01862003|Antidotes|antidotes|mesh-ancestor
64874003|NCT01862003|Protective Agents|protective agents|mesh-ancestor
64874004|NCT01862003|Vitamin B Complex|vitamin b complex|mesh-ancestor
64874005|NCT01862003|Vitamins|vitamins|mesh-ancestor
64874006|NCT01862003|Micronutrients|micronutrients|mesh-ancestor
64874007|NCT01862003|Hematinics|hematinics|mesh-ancestor
64874008|NCT01862081|Paclitaxel|paclitaxel|mesh-list
64874009|NCT01862081|Docetaxel|docetaxel|mesh-list
64874010|NCT01862081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64874011|NCT01862081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64874012|NCT01862081|Tubulin Modulators|tubulin modulators|mesh-ancestor
64874013|NCT01862081|Antimitotic Agents|antimitotic agents|mesh-ancestor
64874014|NCT01862081|Mitosis Modulators|mitosis modulators|mesh-ancestor
64874015|NCT01862081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874016|NCT01862120|Interleukin-2|interleukin-2|mesh-list
64874017|NCT01862120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64874018|NCT01862120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64874019|NCT01862120|Analgesics|analgesics|mesh-ancestor
64874020|NCT01862120|Sensory System Agents|sensory system agents|mesh-ancestor
64874021|NCT01862120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64874022|NCT01862120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874023|NCT01862263|Vildagliptin|vildagliptin|mesh-list
64338728|NCT05414084|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64338729|NCT05414084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64338730|NCT05414084|Disinfectants|disinfectants|mesh-ancestor
64338731|NCT05414084|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64338732|NCT05414084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64338733|NCT01660334|Voriconazole|voriconazole|mesh-list
64338734|NCT01660334|Antifungal Agents|antifungal agents|mesh-ancestor
64338735|NCT01660334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64874024|NCT01862263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64874025|NCT01862263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874026|NCT01862263|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64874027|NCT01862263|Protease Inhibitors|protease inhibitors|mesh-ancestor
64874028|NCT01862263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64874029|NCT01862263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874030|NCT01862302|Haloperidol|haloperidol|mesh-list
64874031|NCT01862302|Haloperidol decanoate|haloperidol decanoate|mesh-list
64874032|NCT01862302|Antiemetics|antiemetics|mesh-ancestor
64874033|NCT01862302|Autonomic Agents|autonomic agents|mesh-ancestor
64874034|NCT01862302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64874035|NCT01862302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874036|NCT01862302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64874037|NCT01862302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64874038|NCT01862302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64874039|NCT01862302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64874040|NCT01862302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64874041|NCT01862302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64874042|NCT01862302|Dopamine Agents|dopamine agents|mesh-ancestor
64874043|NCT01862302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64874044|NCT01862302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874045|NCT01862302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64874046|NCT01862354|Anesthetics|anesthetics|mesh-list
64874047|NCT01862354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64874048|NCT01862354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874049|NCT01862497|Carvedilol|carvedilol|mesh-list
64874050|NCT01862497|Prazosin|prazosin|mesh-list
64874051|NCT01862497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64874052|NCT01862497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64874068|NCT01862523|Dermatologic Agents|dermatologic agents|mesh-ancestor
64874069|NCT01862523|Sensory System Agents|sensory system agents|mesh-ancestor
64874070|NCT01862523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64874071|NCT01862523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874072|NCT01862835|Anastrozole|anastrozole|mesh-list
64874073|NCT01862835|Testosterone|testosterone|mesh-list
64874074|NCT01862835|Estrogens|estrogens|mesh-list
64874075|NCT01862835|Androgens|androgens|mesh-ancestor
64874076|NCT01862835|Hormones|hormones|mesh-ancestor
64874077|NCT01862835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64874078|NCT01862835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874080|NCT01862835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64874132|NCT01863147|Protease Inhibitors|protease inhibitors|mesh-ancestor
64874133|NCT01863147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64874134|NCT01863147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419956|NCT04697719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64874135|NCT01863147|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64874136|NCT01863173|Metoprolol|metoprolol|mesh-list
64874137|NCT01863173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64874138|NCT01863173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64874139|NCT01863173|Sympatholytics|sympatholytics|mesh-ancestor
64874140|NCT01863173|Autonomic Agents|autonomic agents|mesh-ancestor
64874141|NCT01863173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64874142|NCT01863173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420007|NCT04578691|Protective Agents|protective agents|mesh-ancestor
64420008|NCT04578691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420010|NCT04578691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64420011|NCT02334423|Botulinum Toxins|botulinum toxins|mesh-list
64874143|NCT01863173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64874144|NCT01863173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64874145|NCT01863173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64874146|NCT01863173|Adrenergic Agents|adrenergic agents|mesh-ancestor
64874147|NCT01863173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64874148|NCT01863173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874149|NCT01863199|Ranibizumab|ranibizumab|mesh-list
64874150|NCT01863199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64874151|NCT01863199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64874152|NCT01863199|Growth Substances|growth substances|mesh-ancestor
64874153|NCT01863199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874154|NCT01863199|Growth Inhibitors|growth inhibitors|mesh-ancestor
64874180|NCT01863277|Protective Agents|protective agents|mesh-ancestor
64874181|NCT01863277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874182|NCT01863277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64874183|NCT01863355|Fentanyl|fentanyl|mesh-list
64874184|NCT01863355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64874185|NCT01863355|Narcotics|narcotics|mesh-ancestor
64874186|NCT01863355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64874187|NCT01863355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874188|NCT01863355|Analgesics|analgesics|mesh-ancestor
64874189|NCT01863355|Sensory System Agents|sensory system agents|mesh-ancestor
64874190|NCT01863355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64874191|NCT01863355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64874192|NCT01863355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64420113|NCT04619095|Psyllium|psyllium|mesh-list
64874193|NCT01863355|Anesthetics, General|anesthetics, general|mesh-ancestor
64874240|NCT01863589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64874241|NCT01863589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874242|NCT01863602|Lamotrigine|lamotrigine|mesh-list
64874243|NCT01863602|Anticonvulsants|anticonvulsants|mesh-ancestor
64874244|NCT01863602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64874245|NCT01863602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64874246|NCT01863602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874303|NCT01863823|Tetracycline|tetracycline|mesh-list
64874304|NCT01863823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64874305|NCT01863823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64874306|NCT01863823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64874307|NCT01863823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64874308|NCT01863823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874309|NCT01863888|Teriflunomide|teriflunomide|mesh-list
64420312|NCT04339777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314820|NCT02136875|Xhance|xhance|mesh-list
64420326|NCT05494411|Mitomycins|mitomycins|mesh-list
64874310|NCT01863888|Cholestyramine Resin|cholestyramine resin|mesh-list
64874311|NCT01863888|Charcoal|charcoal|mesh-list
64874312|NCT01863888|Antidotes|antidotes|mesh-ancestor
64874313|NCT01863888|Protective Agents|protective agents|mesh-ancestor
64874314|NCT01863888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874315|NCT01863888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64874316|NCT01863888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64874317|NCT01863888|Analgesics|analgesics|mesh-ancestor
64874318|NCT01863888|Sensory System Agents|sensory system agents|mesh-ancestor
64874319|NCT01863888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64874320|NCT01863888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64874321|NCT01863888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64874322|NCT01863888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64874359|NCT01864187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64874360|NCT01864187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64874361|NCT01864187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874362|NCT01864187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64874363|NCT01864187|Analgesics|analgesics|mesh-ancestor
64874364|NCT01864187|Sensory System Agents|sensory system agents|mesh-ancestor
64874365|NCT01864187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64874366|NCT01864187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64874367|NCT01864187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64874368|NCT01864187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64874369|NCT01864187|Adrenergic Agents|adrenergic agents|mesh-ancestor
64421342|NCT05476081|Ticagrelor|ticagrelor|mesh-list
64874370|NCT01864187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64874371|NCT01864187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874373|NCT01864213|Anesthetics, Local|anesthetics, local|mesh-ancestor
64874374|NCT01864213|Anesthetics|anesthetics|mesh-ancestor
64874417|NCT01864655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874419|NCT01864681|Gefitinib|gefitinib|mesh-list
64420385|NCT05498857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64420386|NCT05498857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64420387|NCT05498857|Adrenergic Agents|adrenergic agents|mesh-ancestor
64420388|NCT05498857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64420389|NCT05498857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420391|NCT05489731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64874420|NCT01864681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64874421|NCT01864681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874422|NCT01864681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64874423|NCT01864681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64874424|NCT01864681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64874425|NCT01864681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874426|NCT01864798|Denosumab|denosumab|mesh-list
64874427|NCT01864798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64874428|NCT01864798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874429|NCT01864824|Vitamins|vitamins|mesh-list
64874430|NCT01864824|Folic Acid|folic acid|mesh-list
64874431|NCT01864824|Vitamin B 12|vitamin b 12|mesh-list
64874432|NCT01864824|Vitamin B 6|vitamin b 6|mesh-list
64874433|NCT01864824|Vitamin B Complex|vitamin b complex|mesh-list
64874434|NCT01864824|Micronutrients|micronutrients|mesh-ancestor
64874435|NCT01864824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874436|NCT01864824|Hematinics|hematinics|mesh-ancestor
64874437|NCT01864863|Bosentan|bosentan|mesh-list
64874438|NCT01864863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64874439|NCT01864863|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64874440|NCT01864863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874441|NCT01864915|Prucalopride|prucalopride|mesh-list
64874442|NCT01864915|Laxatives|laxatives|mesh-ancestor
64420492|NCT05485207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420493|NCT05485207|Cholinergic Agents|cholinergic agents|mesh-ancestor
64590773|NCT00555321|Abatacept|abatacept|mesh-list
64420494|NCT05485207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64420495|NCT05485207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420496|NCT05485207|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64874443|NCT01864915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64874467|NCT01865201|Diuretics|diuretics|mesh-ancestor
64874468|NCT01865201|Natriuretic Agents|natriuretic agents|mesh-ancestor
64874469|NCT01865201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874470|NCT01865201|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64874471|NCT01865201|Antioxidants|antioxidants|mesh-ancestor
64874472|NCT01865201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874473|NCT01865201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64874474|NCT01865201|Protective Agents|protective agents|mesh-ancestor
64874475|NCT01865279|Insulin|insulin|mesh-list
64874476|NCT01865279|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64874532|NCT01865630|Immunologic Factors|immunologic factors|mesh-ancestor
64874533|NCT01865669|Oxytocin|oxytocin|mesh-list
64874534|NCT01865669|Oxytocics|oxytocics|mesh-ancestor
64874535|NCT01865669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64874536|NCT01865669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874537|NCT01865721|Entonox|entonox|mesh-list
64874538|NCT01865721|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64874539|NCT01865721|Anesthetics|anesthetics|mesh-ancestor
64421343|NCT05476081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64874540|NCT01865721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64874541|NCT01865721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874542|NCT01865760|Octreotide|octreotide|mesh-list
64874543|NCT01865760|Somatostatin|somatostatin|mesh-list
64874544|NCT01865760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64421400|NCT02336815|Hormones|hormones|mesh-ancestor
64874545|NCT01865760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64874546|NCT01865760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64874547|NCT01865760|Hormones|hormones|mesh-ancestor
64874548|NCT01865760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64874549|NCT01865760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874550|NCT01865916|Ascorbic Acid|ascorbic acid|mesh-list
64874551|NCT01865916|Bisacodyl|bisacodyl|mesh-list
64874588|NCT01866241|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64420549|NCT05487469|Thymalfasin|thymalfasin|mesh-list
64874589|NCT01866241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64874590|NCT01866241|Oxytocics|oxytocics|mesh-ancestor
64874591|NCT01866254|Morphine|morphine|mesh-list
64874592|NCT01866254|Hydromorphone|hydromorphone|mesh-list
64874593|NCT01866254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64874594|NCT01866254|Narcotics|narcotics|mesh-ancestor
64874595|NCT01866254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64874596|NCT01866254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874597|NCT01866254|Analgesics|analgesics|mesh-ancestor
64874598|NCT01866254|Sensory System Agents|sensory system agents|mesh-ancestor
64874599|NCT01866254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64874600|NCT01866267|Maraviroc|maraviroc|mesh-list
64874601|NCT01866267|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64874602|NCT01866267|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64874603|NCT01866267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874604|NCT01866267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64874605|NCT01866267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64874606|NCT01866267|Antiviral Agents|antiviral agents|mesh-ancestor
64874607|NCT01866267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64874608|NCT01866267|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64874609|NCT01866397|Cidofovir|cidofovir|mesh-list
64874610|NCT01866397|Antiviral Agents|antiviral agents|mesh-ancestor
64874612|NCT01866397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64874641|NCT01866553|Immunologic Factors|immunologic factors|mesh-ancestor
64874642|NCT01866553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874643|NCT01866605|Midazolam|midazolam|mesh-list
64874644|NCT01866605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64591992|NCT00627679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64874645|NCT01866605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64874646|NCT01866605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64299418|NCT02102815|Antiemetics|antiemetics|mesh-ancestor
64299419|NCT02102815|Autonomic Agents|autonomic agents|mesh-ancestor
64299420|NCT02102815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64299421|NCT02102815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299422|NCT02102815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64299424|NCT02102815|Hormones|hormones|mesh-ancestor
64299425|NCT02102815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64299426|NCT02102815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64299427|NCT02102815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299428|NCT04935112|Pantoprazole|pantoprazole|mesh-list
64299429|NCT04935112|Famotidine|famotidine|mesh-list
64299430|NCT04935112|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64874647|NCT01866605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874648|NCT01866605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64874649|NCT01866605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64874650|NCT01866605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64874651|NCT01866605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64874652|NCT01866605|Anesthetics, General|anesthetics, general|mesh-ancestor
64874653|NCT01866605|Anesthetics|anesthetics|mesh-ancestor
64874654|NCT01866605|GABA Modulators|gaba modulators|mesh-ancestor
64874655|NCT01866605|GABA Agents|gaba agents|mesh-ancestor
64874656|NCT01866605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64874657|NCT01866605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874658|NCT01866644|Acetylcysteine|acetylcysteine|mesh-list
64874659|NCT01866644|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64874660|NCT01866644|Antiviral Agents|antiviral agents|mesh-ancestor
64874661|NCT01866644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64874662|NCT01866644|Expectorants|expectorants|mesh-ancestor
64874663|NCT01866644|Respiratory System Agents|respiratory system agents|mesh-ancestor
64874664|NCT01866644|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64874665|NCT01866644|Antioxidants|antioxidants|mesh-ancestor
64874666|NCT01866644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874667|NCT01866644|Protective Agents|protective agents|mesh-ancestor
64874668|NCT01866644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874669|NCT01866644|Antidotes|antidotes|mesh-ancestor
64874670|NCT01867138|Vancomycin|vancomycin|mesh-list
64874671|NCT01867138|Cefazolin|cefazolin|mesh-list
64874672|NCT01867138|Amikacin|amikacin|mesh-list
64421472|NCT02545075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64874673|NCT01867138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64874684|NCT01867255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64874685|NCT01867268|Acetazolamide|acetazolamide|mesh-list
64874686|NCT01867268|Anticonvulsants|anticonvulsants|mesh-ancestor
64874687|NCT01867268|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64874688|NCT01867268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64874689|NCT01867268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874690|NCT01867268|Diuretics|diuretics|mesh-ancestor
64874691|NCT01867268|Natriuretic Agents|natriuretic agents|mesh-ancestor
64874692|NCT01867268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874693|NCT01867281|Aspirin|aspirin|mesh-list
64874694|NCT01867281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64874695|NCT01867281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64874696|NCT01867281|Analgesics|analgesics|mesh-ancestor
64874697|NCT01867281|Sensory System Agents|sensory system agents|mesh-ancestor
64874698|NCT01867281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64874699|NCT01867281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874700|NCT01867281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64299431|NCT04935112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64592064|NCT00630253|Hormones|hormones|mesh-ancestor
64592068|NCT01671722|Montelukast|montelukast|mesh-list
64420632|NCT05487001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420633|NCT05487001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64420635|NCT05487001|Hormones|hormones|mesh-ancestor
64592340|NCT00516503|Antidepressive Agents|antidepressive agents|mesh-ancestor
64420636|NCT05487001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64420637|NCT05487001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64420638|NCT05487001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420639|NCT05483647|Anesthetics|anesthetics|mesh-list
64299432|NCT04935112|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64299433|NCT04935112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299434|NCT04935112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299435|NCT04935112|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64874701|NCT01867281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64874702|NCT01867281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64874703|NCT01867281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64874704|NCT01867281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874705|NCT01867281|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64874706|NCT01867281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64874707|NCT01867281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64874708|NCT01867281|Antipyretics|antipyretics|mesh-ancestor
64874709|NCT01867463|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64874710|NCT01867463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64874711|NCT01867463|Immunologic Factors|immunologic factors|mesh-ancestor
64874712|NCT01867463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874713|NCT01867463|Antacids|antacids|mesh-ancestor
64874714|NCT01867463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874715|NCT01867463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64339409|NCT03111615|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64339410|NCT03111615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64339411|NCT03111615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64874716|NCT01867502|Metformin|metformin|mesh-list
64874717|NCT01867502|Vildagliptin|vildagliptin|mesh-list
64874718|NCT01867502|Glyburide|glyburide|mesh-list
64874719|NCT01867502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64874720|NCT01867502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874721|NCT01867502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64874722|NCT01867502|Protease Inhibitors|protease inhibitors|mesh-ancestor
64874723|NCT01867502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64874724|NCT01867502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874725|NCT01867593|Carbon-11 methionine|carbon-11 methionine|mesh-list
64874726|NCT01867593|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64874727|NCT01867593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874728|NCT01867645|Immunoglobulins|immunoglobulins|mesh-list
64874729|NCT01867645|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64874730|NCT01867645|Antibodies|antibodies|mesh-list
64874731|NCT01867645|gamma-Globulins|gamma-globulins|mesh-list
64420640|NCT05483647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64420641|NCT05483647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420642|NCT05475613|Lenvatinib|lenvatinib|mesh-list
64420643|NCT05475613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64420645|NCT05475613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64420646|NCT05475613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592481|NCT05560373|Protective Agents|protective agents|mesh-ancestor
64874732|NCT01867645|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64874733|NCT01867645|Immunologic Factors|immunologic factors|mesh-ancestor
64874734|NCT01867645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874735|NCT01867697|Leucovorin|leucovorin|mesh-list
64874736|NCT01867697|Folic Acid|folic acid|mesh-list
64874737|NCT01867697|Oxaliplatin|oxaliplatin|mesh-list
64874738|NCT01867697|Irinotecan|irinotecan|mesh-list
64874739|NCT01867697|Cetuximab|cetuximab|mesh-list
64874740|NCT01867697|Calcium Carbonate|calcium carbonate|mesh-list
64874741|NCT01867697|Levoleucovorin|levoleucovorin|mesh-list
64874742|NCT01867697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874743|NCT01867697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64874744|NCT01867697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64874745|NCT01867697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64874746|NCT01867697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64874749|NCT01867697|Antidotes|antidotes|mesh-ancestor
64874762|NCT01867775|Histamine Agents|histamine agents|mesh-ancestor
64874763|NCT01867775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64874764|NCT01867775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874765|NCT01867775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874766|NCT01867775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64874767|NCT01867775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64874768|NCT01867775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64874769|NCT01867775|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64874770|NCT01867775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64874771|NCT01867775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64874772|NCT01867775|Adrenergic Agents|adrenergic agents|mesh-ancestor
64874773|NCT01867775|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64874774|NCT01867775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64874775|NCT01867775|Serotonin Agents|serotonin agents|mesh-ancestor
64874776|NCT01867775|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64874777|NCT01867866|Trifluridine|trifluridine|mesh-list
64874778|NCT01867866|Antimetabolites|antimetabolites|mesh-ancestor
64874820|NCT01868126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64874821|NCT01868126|Latanoprost|latanoprost|mesh-list
64874822|NCT01868126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64874823|NCT01868191|Thiamine|thiamine|mesh-list
64874824|NCT01868191|Benphothiamine|benphothiamine|mesh-list
64874825|NCT01868191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64874826|NCT01868191|Immunologic Factors|immunologic factors|mesh-ancestor
64874827|NCT01868191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874828|NCT01868191|Chelating Agents|chelating agents|mesh-ancestor
64874829|NCT01868191|Sequestering Agents|sequestering agents|mesh-ancestor
64874830|NCT01868191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874831|NCT01868191|Vitamin B Complex|vitamin b complex|mesh-ancestor
64874832|NCT01868191|Vitamins|vitamins|mesh-ancestor
64874833|NCT01868191|Micronutrients|micronutrients|mesh-ancestor
64874834|NCT01868360|Aflibercept|aflibercept|mesh-list
64874835|NCT01868360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64874836|NCT01868360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64874837|NCT01868360|Growth Substances|growth substances|mesh-ancestor
64874838|NCT01868360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874839|NCT01868360|Growth Inhibitors|growth inhibitors|mesh-ancestor
64874840|NCT01868360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64874841|NCT01868438|Artesunate|artesunate|mesh-list
64874842|NCT01868438|Pyronaridine|pyronaridine|mesh-list
64874843|NCT01868438|Antimalarials|antimalarials|mesh-ancestor
64874844|NCT01868438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64874845|NCT01868438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64874846|NCT01868438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64874873|NCT01868568|Biphasic Insulins|biphasic insulins|mesh-list
64874874|NCT01868568|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64874875|NCT01868568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64874876|NCT01868568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643442|NCT01653912|Carboplatin|carboplatin|mesh-list
64874878|NCT01868581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64874879|NCT01868581|Insulin Aspart|insulin aspart|mesh-list
64874880|NCT01868581|Insulin, Long-Acting|insulin, long-acting|mesh-list
64874881|NCT01868581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64874882|NCT01868581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420752|NCT05472259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420753|NCT05472259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64420754|NCT05472259|Immunologic Factors|immunologic factors|mesh-ancestor
64420755|NCT05472259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593474|NCT03715244|Anesthetics|anesthetics|mesh-list
64420756|NCT05472259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64420757|NCT05472259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64420758|NCT05472259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420759|NCT05472259|Antidotes|antidotes|mesh-ancestor
64420760|NCT05472259|Protective Agents|protective agents|mesh-ancestor
64420761|NCT05472259|Vitamin B Complex|vitamin b complex|mesh-ancestor
64420762|NCT05472259|Vitamins|vitamins|mesh-ancestor
64420763|NCT05472259|Micronutrients|micronutrients|mesh-ancestor
64874884|NCT01868750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64874885|NCT01868750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874934|NCT01868984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64421531|NCT05485571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64874935|NCT01868984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64874936|NCT01868984|Tubulin Modulators|tubulin modulators|mesh-ancestor
64874937|NCT01868984|Antimitotic Agents|antimitotic agents|mesh-ancestor
64874938|NCT01868984|Mitosis Modulators|mitosis modulators|mesh-ancestor
64874939|NCT01868984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874940|NCT01868984|Anticoagulants|anticoagulants|mesh-ancestor
64874941|NCT01868984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64874942|NCT01868984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64874944|NCT01869010|Antiviral Agents|antiviral agents|mesh-ancestor
64874945|NCT01869010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64874946|NCT01869010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64874947|NCT01869010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64874948|NCT01869010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64874949|NCT01869010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874950|NCT01869010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64593666|NCT00662155|Zolpidem|zolpidem|mesh-list
64593867|NCT03593408|Anesthetics, General|anesthetics, general|mesh-ancestor
64420766|NCT04266145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64420767|NCT04266145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420768|NCT04266145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64420769|NCT04266145|Analgesics|analgesics|mesh-ancestor
64420770|NCT04266145|Sensory System Agents|sensory system agents|mesh-ancestor
64420771|NCT04266145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64420772|NCT04266145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64420773|NCT04266145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64420774|NCT04266145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64420775|NCT04266145|Adrenergic Agents|adrenergic agents|mesh-ancestor
64299453|NCT05043350|Dermatologic Agents|dermatologic agents|mesh-ancestor
64420776|NCT04266145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64299454|NCT05043350|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64299455|NCT05043350|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64299456|NCT05043350|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64299457|NCT03555487|Choline|choline|mesh-list
64299458|NCT03555487|Lipotropic Agents|lipotropic agents|mesh-ancestor
64299459|NCT03555487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64299460|NCT03555487|Antimetabolites|antimetabolites|mesh-ancestor
64299461|NCT03555487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874951|NCT01869010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64874952|NCT01869023|Gemcitabine|gemcitabine|mesh-list
64874953|NCT01869023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64874954|NCT01869023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64874955|NCT01869023|Antimetabolites|antimetabolites|mesh-ancestor
64874986|NCT01869309|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64874987|NCT01869309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64874988|NCT01869309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64874989|NCT01869309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64874990|NCT01869309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64874991|NCT01869309|Purinergic Agents|purinergic agents|mesh-ancestor
64874992|NCT01869309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64874993|NCT01869309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874994|NCT01869309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64874995|NCT01869491|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
64874996|NCT01869491|Antacids|antacids|mesh-ancestor
64874997|NCT01869491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64874998|NCT01869491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64874999|NCT01869556|Oxytocin|oxytocin|mesh-list
64875000|NCT01869556|Carboprost|carboprost|mesh-list
64875001|NCT01869556|Ergonovine|ergonovine|mesh-list
64875002|NCT01869556|Oxytocics|oxytocics|mesh-ancestor
64875003|NCT01869556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64421543|NCT04424459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64421544|NCT04424459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875004|NCT01869556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875006|NCT01869556|Abortifacient Agents|abortifacient agents|mesh-ancestor
64875037|NCT01869803|Calicheamicins|calicheamicins|mesh-list
64875038|NCT01869803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64875039|NCT01869803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875040|NCT01869803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64875041|NCT01869881|Sarpogrelate|sarpogrelate|mesh-list
64875042|NCT01869881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64875043|NCT01869881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64875044|NCT01869881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875045|NCT01869881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64875046|NCT01869881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64875047|NCT01869881|Serotonin Agents|serotonin agents|mesh-ancestor
64875048|NCT01869881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64875049|NCT01869881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875050|NCT01869907|Minocycline|minocycline|mesh-list
64875051|NCT01869907|Amitriptyline|amitriptyline|mesh-list
64875052|NCT01869907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64875053|NCT01869907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64875054|NCT01869907|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64875055|NCT01869907|Antidepressive Agents|antidepressive agents|mesh-ancestor
64875056|NCT01869907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64875057|NCT01869907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64875058|NCT01869907|Analgesics|analgesics|mesh-ancestor
64875059|NCT01869907|Sensory System Agents|sensory system agents|mesh-ancestor
64875060|NCT01869907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64875061|NCT01869907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875062|NCT01869907|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64875066|NCT01869907|Adrenergic Agents|adrenergic agents|mesh-ancestor
64875085|NCT01870024|Lorazepam|lorazepam|mesh-list
64875086|NCT01870024|Clonazepam|clonazepam|mesh-list
64875087|NCT01870024|Anticonvulsants|anticonvulsants|mesh-ancestor
64875088|NCT01870024|Antiemetics|antiemetics|mesh-ancestor
64875089|NCT01870024|Autonomic Agents|autonomic agents|mesh-ancestor
64875090|NCT01870024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64875091|NCT01870024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875092|NCT01870024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64875093|NCT01870024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64875094|NCT01870024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64875095|NCT01870024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64421086|NCT05507957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64421087|NCT05507957|Dermatologic Agents|dermatologic agents|mesh-ancestor
64596066|NCT00580073|Vitamins|vitamins|mesh-ancestor
64421088|NCT05507957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64421094|NCT04282109|Nivolumab|nivolumab|mesh-list
64421095|NCT04282109|Cetuximab|cetuximab|mesh-list
64421096|NCT04282109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64421097|NCT04282109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421098|NCT04282109|Tubulin Modulators|tubulin modulators|mesh-ancestor
64421099|NCT04282109|Antimitotic Agents|antimitotic agents|mesh-ancestor
64421100|NCT04282109|Mitosis Modulators|mitosis modulators|mesh-ancestor
64421101|NCT04282109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421102|NCT04282109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64421104|NCT03150173|Buprenorphine|buprenorphine|mesh-list
64421105|NCT03150173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64421106|NCT03150173|Narcotics|narcotics|mesh-ancestor
64421107|NCT03150173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64421108|NCT03150173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421109|NCT03150173|Analgesics|analgesics|mesh-ancestor
64421110|NCT03150173|Sensory System Agents|sensory system agents|mesh-ancestor
64421111|NCT03150173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421112|NCT03150173|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64421113|NCT05563571|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64421114|NCT05563571|Methylprednisolone|methylprednisolone|mesh-list
64875096|NCT01870024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64875097|NCT01870024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64875098|NCT01870024|GABA Modulators|gaba modulators|mesh-ancestor
64875099|NCT01870024|GABA Agents|gaba agents|mesh-ancestor
64875100|NCT01870024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64875101|NCT01870024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875102|NCT01870024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64875103|NCT01870024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64875104|NCT01870050|Dapsone|dapsone|mesh-list
64875105|NCT01870050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64875106|NCT01870050|Antimalarials|antimalarials|mesh-ancestor
64421586|NCT05496179|Dopamine Agents|dopamine agents|mesh-ancestor
64875107|NCT01870050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64875108|NCT01870050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64875109|NCT01870050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64875110|NCT01870050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875112|NCT01870050|Leprostatic Agents|leprostatic agents|mesh-ancestor
64875134|NCT01870128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64875135|NCT01870128|Antimetabolites|antimetabolites|mesh-ancestor
64875136|NCT01870128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875137|NCT01870128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875138|NCT01870128|Dermatologic Agents|dermatologic agents|mesh-ancestor
64875139|NCT01870128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875140|NCT01870128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64875141|NCT01870128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64875142|NCT01870128|Immunologic Factors|immunologic factors|mesh-ancestor
64875143|NCT01870128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64875144|NCT01870128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64875145|NCT01870128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64875146|NCT01870128|Antiemetics|antiemetics|mesh-ancestor
64875147|NCT01870128|Autonomic Agents|autonomic agents|mesh-ancestor
64421121|NCT05563571|Anesthetics, Local|anesthetics, local|mesh-ancestor
64421122|NCT05563571|Anesthetics|anesthetics|mesh-ancestor
64421123|NCT05563571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64421124|NCT05563571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421125|NCT05563571|Sensory System Agents|sensory system agents|mesh-ancestor
64421126|NCT05563571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421127|NCT05563571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64421128|NCT05563571|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64421129|NCT05563571|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64421130|NCT05563571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64421131|NCT05563571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421132|NCT05563571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64421133|NCT05563571|Antiemetics|antiemetics|mesh-ancestor
64421134|NCT05563571|Autonomic Agents|autonomic agents|mesh-ancestor
64421136|NCT05563571|Glucocorticoids|glucocorticoids|mesh-ancestor
64875148|NCT01870128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64875149|NCT01870128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64875150|NCT01870128|Glucocorticoids|glucocorticoids|mesh-ancestor
64875151|NCT01870128|Hormones|hormones|mesh-ancestor
64875152|NCT01870128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64875153|NCT01870128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64875154|NCT01870128|Protective Agents|protective agents|mesh-ancestor
64875155|NCT01870128|Antimalarials|antimalarials|mesh-ancestor
64875156|NCT01870128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64875157|NCT01870128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64875158|NCT01870128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64875159|NCT01870128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64875161|NCT01870128|Analgesics|analgesics|mesh-ancestor
64875179|NCT01870219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64875180|NCT01870219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64875181|NCT01870219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64875182|NCT01870219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64875183|NCT01870219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875184|NCT01870219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64421624|NCT05495945|Anesthetics|anesthetics|mesh-ancestor
64421625|NCT03999749|Nivolumab|nivolumab|mesh-list
64875185|NCT01870219|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64875186|NCT01870284|Adalimumab|adalimumab|mesh-list
64421150|NCT02717507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64421152|NCT02717507|Protective Agents|protective agents|mesh-ancestor
64421153|NCT02717507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64421154|NCT02717507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64421155|NCT02717507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64421156|NCT02717507|Vasodilator Agents|vasodilator agents|mesh-ancestor
64421181|NCT02489903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421182|NCT02489903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64421183|NCT02489903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64421203|NCT05562869|Abatacept|abatacept|mesh-list
64875187|NCT01870284|Ixekizumab|ixekizumab|mesh-list
64875188|NCT01870284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64875189|NCT01870284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64875190|NCT01870284|Dermatologic Agents|dermatologic agents|mesh-ancestor
64875191|NCT01870427|Aflibercept|aflibercept|mesh-list
64875192|NCT01870427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64875193|NCT01870427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64875194|NCT01870427|Growth Substances|growth substances|mesh-ancestor
64875195|NCT01870427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875196|NCT01870427|Growth Inhibitors|growth inhibitors|mesh-ancestor
64875197|NCT01870427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875198|NCT01870440|Dexamethasone|dexamethasone|mesh-list
64875199|NCT01870440|Dexamethasone acetate|dexamethasone acetate|mesh-list
64875200|NCT01870440|BB 1101|bb 1101|mesh-list
64875201|NCT01870440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64875202|NCT01870440|Antiemetics|antiemetics|mesh-ancestor
64875203|NCT01870440|Autonomic Agents|autonomic agents|mesh-ancestor
64597265|NCT05686772|Sympathomimetics|sympathomimetics|mesh-ancestor
64597266|NCT05686772|Autonomic Agents|autonomic agents|mesh-ancestor
64421207|NCT05562869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64421208|NCT05562869|Immunologic Factors|immunologic factors|mesh-ancestor
64421209|NCT05562869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421226|NCT04324463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64421227|NCT04324463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64597338|NCT00755755|Contraceptive Agents|contraceptive agents|mesh-ancestor
64421228|NCT04324463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64421229|NCT04324463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421230|NCT04324463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64421231|NCT04324463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64421232|NCT04324463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421233|NCT04324463|Antipyretics|antipyretics|mesh-ancestor
64421234|NCT04324463|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64421235|NCT04324463|Antithrombins|antithrombins|mesh-ancestor
64875204|NCT01870440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64875205|NCT01870440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875206|NCT01870440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64875207|NCT01870440|Glucocorticoids|glucocorticoids|mesh-ancestor
64875208|NCT01870440|Hormones|hormones|mesh-ancestor
64875224|NCT01870466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875225|NCT01870466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64875226|NCT01870466|Autonomic Agents|autonomic agents|mesh-ancestor
64875227|NCT01870466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64875228|NCT01870466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875229|NCT01870466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64421288|NCT05498675|Valsartan|valsartan|mesh-list
64875230|NCT01870466|Respiratory System Agents|respiratory system agents|mesh-ancestor
64875231|NCT01870466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64875232|NCT01870466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64875233|NCT01870466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64875234|NCT01870466|Vasodilator Agents|vasodilator agents|mesh-ancestor
64875235|NCT01870466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64875236|NCT01870466|Protective Agents|protective agents|mesh-ancestor
64875237|NCT01870466|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64875238|NCT01870466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64875239|NCT01870492|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64875240|NCT01870492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64875241|NCT01870492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64875242|NCT01870492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421368|NCT05476003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64421369|NCT05476003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64421370|NCT05476003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64421371|NCT05476003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64421372|NCT05476003|Anesthetics, General|anesthetics, general|mesh-ancestor
64421373|NCT05476003|Anesthetics|anesthetics|mesh-ancestor
64875243|NCT01870635|Ondansetron|ondansetron|mesh-list
64875244|NCT01870635|Antiemetics|antiemetics|mesh-ancestor
64875245|NCT01870635|Autonomic Agents|autonomic agents|mesh-ancestor
64875246|NCT01870635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64875247|NCT01870635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875248|NCT01870635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64875249|NCT01870635|Antipruritics|antipruritics|mesh-ancestor
64875252|NCT01870635|Serotonin Agents|serotonin agents|mesh-ancestor
64875271|NCT01870648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875272|NCT01870648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64875273|NCT01870648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64875274|NCT01870648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64875275|NCT01870648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64875276|NCT01870648|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64875277|NCT01870674|Prucalopride|prucalopride|mesh-list
64875279|NCT01870674|Laxatives|laxatives|mesh-ancestor
64875280|NCT01870674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64875281|NCT01870674|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64875282|NCT01870674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64875283|NCT01870674|Serotonin Agents|serotonin agents|mesh-ancestor
64875284|NCT01870674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64875285|NCT01870674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875286|NCT01870674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875287|NCT01870804|Atorvastatin|atorvastatin|mesh-list
64421437|NCT02546323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421438|NCT05458453|Esketamine|esketamine|mesh-list
64421439|NCT05458453|Antidepressive Agents|antidepressive agents|mesh-ancestor
64598586|NCT00652847|Ezetimibe|ezetimibe|mesh-list
64421440|NCT05458453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64421441|NCT02545933|Aspirin|aspirin|mesh-list
64421442|NCT02545933|Ticagrelor|ticagrelor|mesh-list
64421443|NCT02545933|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64421444|NCT02545933|Vorapaxar|vorapaxar|mesh-list
64421445|NCT02545933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64421446|NCT02545933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64421447|NCT02545933|Analgesics|analgesics|mesh-ancestor
64421448|NCT02545933|Sensory System Agents|sensory system agents|mesh-ancestor
64421449|NCT02545933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421450|NCT02545933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421451|NCT02545933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64421452|NCT02545933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64598628|NCT01963845|Protease Inhibitors|protease inhibitors|mesh-ancestor
64421453|NCT02545933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64421459|NCT02545933|Antipyretics|antipyretics|mesh-ancestor
64421460|NCT02545933|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64421461|NCT02545933|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64421487|NCT02556203|Vitamin K|vitamin k|mesh-list
64421488|NCT02556203|Rivaroxaban|rivaroxaban|mesh-list
64421489|NCT02556203|Clopidogrel|clopidogrel|mesh-list
64421490|NCT02556203|Vitamins|vitamins|mesh-ancestor
64421491|NCT02556203|Micronutrients|micronutrients|mesh-ancestor
64421492|NCT02556203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421493|NCT02556203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64421494|NCT02556203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64875288|NCT01870804|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64875289|NCT01870804|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64875290|NCT01870804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64875291|NCT01870804|Antimetabolites|antimetabolites|mesh-ancestor
64875292|NCT01870804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875293|NCT01870804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64875294|NCT01870804|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64875295|NCT01870804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875296|NCT01870895|Ramosetron|ramosetron|mesh-list
64875297|NCT01870895|Antiemetics|antiemetics|mesh-ancestor
64875298|NCT01870895|Autonomic Agents|autonomic agents|mesh-ancestor
64875299|NCT01870895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64875317|NCT01871129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64875318|NCT01871129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64875319|NCT01871129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875320|NCT01871129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64875321|NCT01871129|Analgesics|analgesics|mesh-ancestor
64421638|NCT04139213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875322|NCT01871129|Sensory System Agents|sensory system agents|mesh-ancestor
64875323|NCT01871129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64875324|NCT01871129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64875325|NCT01871129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64875326|NCT01871129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64875327|NCT01871129|Adrenergic Agents|adrenergic agents|mesh-ancestor
64643895|NCT03008083|Purinergic Agents|purinergic agents|mesh-ancestor
64875328|NCT01871129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64875329|NCT01871129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875330|NCT01871311|Cetuximab|cetuximab|mesh-list
64875331|NCT01871311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64875332|NCT01871311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875333|NCT01871363|Capecitabine|capecitabine|mesh-list
64875334|NCT01871363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875335|NCT01871363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64421701|NCT05482763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64421702|NCT05482373|Oleuropein|oleuropein|mesh-list
64421703|NCT05482373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64421705|NCT05482373|Vasodilator Agents|vasodilator agents|mesh-ancestor
64875336|NCT01871363|Antimetabolites|antimetabolites|mesh-ancestor
64875337|NCT01871363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875338|NCT01871376|Aflibercept|aflibercept|mesh-list
64875363|NCT01871480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875364|NCT01871493|Insulin Lispro|insulin lispro|mesh-list
64875365|NCT01871493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64875366|NCT01871493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875367|NCT01871649|Golimumab|golimumab|mesh-list
64875368|NCT01871649|Methotrexate|methotrexate|mesh-list
64875369|NCT01871649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64875370|NCT01871649|Abortifacient Agents|abortifacient agents|mesh-ancestor
64875371|NCT01871649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64875372|NCT01871649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875373|NCT01871649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64875374|NCT01871649|Antimetabolites|antimetabolites|mesh-ancestor
64875375|NCT01871649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875376|NCT01871649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875377|NCT01871649|Dermatologic Agents|dermatologic agents|mesh-ancestor
64875378|NCT01871649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875379|NCT01871649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64875380|NCT01871649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64875381|NCT01871649|Immunologic Factors|immunologic factors|mesh-ancestor
64875382|NCT01871649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64875383|NCT01871649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64421804|NCT05481281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421805|NCT05481281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64421807|NCT05481281|Sensory System Agents|sensory system agents|mesh-ancestor
64421808|NCT05481281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421809|NCT05481281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64421810|NCT05481281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64421811|NCT05481281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64421812|NCT05481281|Adrenergic Agents|adrenergic agents|mesh-ancestor
64421813|NCT05481281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64599061|NCT01799057|Metformin|metformin|mesh-list
64875385|NCT01871649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64875416|NCT01871701|Citalopram|citalopram|mesh-list
64875417|NCT01871701|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64875418|NCT01871701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64421788|NCT05487521|Antiemetics|antiemetics|mesh-ancestor
64875419|NCT01871701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64875420|NCT01871701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64875421|NCT01871701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64875422|NCT01871701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875423|NCT01871701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421853|NCT05486819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421854|NCT05486819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64421856|NCT05486819|Anesthetics|anesthetics|mesh-ancestor
64421857|NCT03860987|Prednisone|prednisone|mesh-list
64421858|NCT03860987|Goserelin|goserelin|mesh-list
64421859|NCT03860987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64421860|NCT03860987|Glucocorticoids|glucocorticoids|mesh-ancestor
64421861|NCT03860987|Hormones|hormones|mesh-ancestor
64421862|NCT03860987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64421863|NCT03860987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421864|NCT03860987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64421866|NCT05480111|Anesthetics|anesthetics|mesh-list
64875424|NCT01871701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875425|NCT01871701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64875426|NCT01871701|Contraceptive Agents|contraceptive agents|mesh-ancestor
64875427|NCT01871701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64875428|NCT01871701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875429|NCT01871701|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64875430|NCT01871701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64875431|NCT01871701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64875432|NCT01871701|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64875433|NCT01871701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64875434|NCT01871701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64875435|NCT01871701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64875436|NCT01871701|Serotonin Agents|serotonin agents|mesh-ancestor
64875437|NCT01871701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64875438|NCT01871701|Antidepressive Agents|antidepressive agents|mesh-ancestor
64875439|NCT01871701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64875440|NCT01871701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64875441|NCT01871701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64875442|NCT01871701|Parasympatholytics|parasympatholytics|mesh-ancestor
64875443|NCT01871701|Autonomic Agents|autonomic agents|mesh-ancestor
64875459|NCT01871740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875460|NCT01871740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875461|NCT01871740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875462|NCT01871740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64875463|NCT01871740|Protease Inhibitors|protease inhibitors|mesh-ancestor
64875464|NCT01871740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64875465|NCT01871753|Anti-Infective Agents|anti-infective agents|mesh-list
64875466|NCT01871792|Pitavastatin|pitavastatin|mesh-list
64875467|NCT01871792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64875468|NCT01871792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64875469|NCT01871792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64875470|NCT01871792|Antimetabolites|antimetabolites|mesh-ancestor
64875471|NCT01871792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421986|NCT02544451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421987|NCT02551991|Leucovorin|leucovorin|mesh-list
64421988|NCT02551991|Fluorouracil|fluorouracil|mesh-list
64421989|NCT02551991|Oxaliplatin|oxaliplatin|mesh-list
64421990|NCT02551991|Antimetabolites|antimetabolites|mesh-ancestor
64422018|NCT02880293|Melphalan|melphalan|mesh-list
64875472|NCT01871792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875473|NCT01871792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64875474|NCT01871844|Octreotide|octreotide|mesh-list
64875475|NCT01871844|Somatostatin|somatostatin|mesh-list
64875476|NCT01871844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64875477|NCT01871844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64875478|NCT01871844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875479|NCT01871844|Hormones|hormones|mesh-ancestor
64875480|NCT01871844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64875481|NCT01871844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875482|NCT01871857|Epinephrine|epinephrine|mesh-list
64875483|NCT01871857|Racepinephrine|racepinephrine|mesh-list
64875484|NCT01871857|Epinephryl borate|epinephryl borate|mesh-list
64875486|NCT01871857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64875505|NCT01871922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600218|NCT00716963|Xhance|xhance|mesh-list
64600272|NCT01271153|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64422087|NCT02551055|Docetaxel|docetaxel|mesh-list
64422108|NCT03284957|Everolimus|everolimus|mesh-list
64422109|NCT03284957|Palbociclib|palbociclib|mesh-list
64422110|NCT03284957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422111|NCT03284957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64422112|NCT03284957|Immunologic Factors|immunologic factors|mesh-ancestor
64422113|NCT03284957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422114|NCT03284957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64422115|NCT03284957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422116|NCT03284957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422118|NCT05469893|Lenalidomide|lenalidomide|mesh-list
64422119|NCT05469893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64422120|NCT05469893|Antiemetics|antiemetics|mesh-ancestor
64422121|NCT05469893|Autonomic Agents|autonomic agents|mesh-ancestor
64422122|NCT05469893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64422123|NCT05469893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422124|NCT05469893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64422125|NCT05469893|Glucocorticoids|glucocorticoids|mesh-ancestor
64422126|NCT05469893|Hormones|hormones|mesh-ancestor
64422127|NCT05469893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64422128|NCT05469893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64422129|NCT05469893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422130|NCT05469893|Immunologic Factors|immunologic factors|mesh-ancestor
64422131|NCT05469893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64422132|NCT05469893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64600756|NCT00708071|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64875506|NCT01871922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875507|NCT01871922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64875508|NCT01871922|Respiratory System Agents|respiratory system agents|mesh-ancestor
64875510|NCT01871922|Parasympatholytics|parasympatholytics|mesh-ancestor
64875511|NCT01871922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64875512|NCT01871922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64875513|NCT01871922|Cholinergic Agents|cholinergic agents|mesh-ancestor
64875514|NCT01871922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64875515|NCT01871922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875516|NCT01871935|Sufentanil|sufentanil|mesh-list
64875517|NCT01871935|Remifentanil|remifentanil|mesh-list
64875518|NCT01871935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64422133|NCT05469893|Growth Substances|growth substances|mesh-ancestor
64422134|NCT05469893|Growth Inhibitors|growth inhibitors|mesh-ancestor
64422135|NCT03629171|Cytarabine|cytarabine|mesh-list
64422136|NCT03629171|Daunorubicin|daunorubicin|mesh-list
64422137|NCT03629171|Venetoclax|venetoclax|mesh-list
64422138|NCT03629171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64600819|NCT01274039|Anticonvulsants|anticonvulsants|mesh-ancestor
64600820|NCT01274039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64422139|NCT03629171|Antimetabolites|antimetabolites|mesh-ancestor
64422140|NCT03629171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422141|NCT03629171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422142|NCT03629171|Antiviral Agents|antiviral agents|mesh-ancestor
64422143|NCT03629171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64422144|NCT03629171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64422156|NCT02549573|Emetics|emetics|mesh-ancestor
64422157|NCT02549573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422158|NCT02549573|Autonomic Agents|autonomic agents|mesh-ancestor
64422159|NCT02549573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600860|NCT02993159|Tamoxifen|tamoxifen|mesh-list
64422160|NCT02549573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64422161|NCT02549573|Dopamine Agonists|dopamine agonists|mesh-ancestor
64422162|NCT02549573|Dopamine Agents|dopamine agents|mesh-ancestor
64422163|NCT02549573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64422164|NCT02549573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422165|NCT05477615|Carboplatin|carboplatin|mesh-list
64422166|NCT05477615|Pemetrexed|pemetrexed|mesh-list
64422167|NCT05477615|Lazertinib|lazertinib|mesh-list
64422168|NCT05477615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422169|NCT05477615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422170|NCT05477615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422171|NCT05477615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64875519|NCT01871935|Narcotics|narcotics|mesh-ancestor
64875520|NCT01871935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64875521|NCT01871935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875522|NCT01871935|Analgesics|analgesics|mesh-ancestor
64875523|NCT01871935|Sensory System Agents|sensory system agents|mesh-ancestor
64875524|NCT01871935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64875525|NCT01871935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64875526|NCT01871935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64875527|NCT01871935|Anesthetics, General|anesthetics, general|mesh-ancestor
64875528|NCT01871935|Anesthetics|anesthetics|mesh-ancestor
64875555|NCT01871987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64875556|NCT01871987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64875557|NCT01871987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64875558|NCT01871987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875560|NCT01872013|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64875561|NCT01872013|Hormone Antagonists|hormone antagonists|mesh-ancestor
64875562|NCT01872013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64875563|NCT01872013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875564|NCT01872026|ASP7991|asp7991|mesh-list
64875565|NCT01872026|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64875566|NCT01872026|Hormone Antagonists|hormone antagonists|mesh-ancestor
64875567|NCT01872026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64875568|NCT01872026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875569|NCT01872039|Nicardipine|nicardipine|mesh-list
64875570|NCT01872039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64875571|NCT01872039|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64875572|NCT01872039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64875573|NCT01872039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875574|NCT01872039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64875575|NCT01872039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875576|NCT01872039|Vasodilator Agents|vasodilator agents|mesh-ancestor
64422175|NCT02710097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64601258|NCT00750815|Alkylating Agents|alkylating agents|mesh-ancestor
64326636|NCT02155439|Hormones|hormones|mesh-ancestor
64422176|NCT02710097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64422177|NCT02710097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64422178|NCT02710097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422179|NCT05468957|Hemostatics|hemostatics|mesh-list
64422180|NCT05468957|Coagulants|coagulants|mesh-ancestor
64422181|NCT02547935|Dapagliflozin|dapagliflozin|mesh-list
64422182|NCT02547935|Saxagliptin|saxagliptin|mesh-list
64422188|NCT02547935|Hormones|hormones|mesh-ancestor
64875577|NCT01872351|Thioctic Acid|thioctic acid|mesh-list
64875578|NCT01872351|Acetylcarnitine|acetylcarnitine|mesh-list
64875579|NCT01872351|Antioxidants|antioxidants|mesh-ancestor
64875580|NCT01872351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875581|NCT01872351|Protective Agents|protective agents|mesh-ancestor
64875582|NCT01872351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875583|NCT01872351|Vitamin B Complex|vitamin b complex|mesh-ancestor
64875584|NCT01872351|Vitamins|vitamins|mesh-ancestor
64875585|NCT01872351|Micronutrients|micronutrients|mesh-ancestor
64875586|NCT01872351|Nootropic Agents|nootropic agents|mesh-ancestor
64875587|NCT01872403|Paclitaxel|paclitaxel|mesh-list
64875594|NCT01872403|Mitosis Modulators|mitosis modulators|mesh-ancestor
64875595|NCT01872403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875597|NCT01872416|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64875598|NCT01872416|Ifosfamide|ifosfamide|mesh-list
64875599|NCT01872416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64875600|NCT01872416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875601|NCT01872416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64875602|NCT01872416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64422203|NCT05476991|Sensory System Agents|sensory system agents|mesh-ancestor
64422204|NCT05476991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64422205|NCT05476991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422206|NCT05476991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64601520|NCT01276379|Irinotecan|irinotecan|mesh-list
64422207|NCT05476991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64422225|NCT02327169|Paclitaxel|paclitaxel|mesh-list
64875603|NCT01872416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875604|NCT01872416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875605|NCT01872416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64875606|NCT01872416|Alkylating Agents|alkylating agents|mesh-ancestor
64875607|NCT01872442|Interferons|interferons|mesh-list
64875608|NCT01872442|Interferon-alpha|interferon-alpha|mesh-list
64875609|NCT01872442|Interferon alpha-2|interferon alpha-2|mesh-list
64875610|NCT01872442|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64875611|NCT01872442|Dasatinib|dasatinib|mesh-list
64875612|NCT01872442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875613|NCT01872442|Antiviral Agents|antiviral agents|mesh-ancestor
64875614|NCT01872442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64875615|NCT01872442|Immunologic Factors|immunologic factors|mesh-ancestor
64875616|NCT01872442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875617|NCT01872442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64875618|NCT01872442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875619|NCT01872442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875621|NCT01872494|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
64875622|NCT01872494|Pentazocine|pentazocine|mesh-list
64875623|NCT01872494|Palonosetron|palonosetron|mesh-list
64875624|NCT01872494|Ropivacaine|ropivacaine|mesh-list
64875639|NCT01872494|Analgesics|analgesics|mesh-ancestor
64422259|NCT02301975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64875640|NCT01872494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64875641|NCT01872494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64875642|NCT01872494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64875643|NCT01872494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64875644|NCT01872494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64875645|NCT01872494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875646|NCT01872494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64875647|NCT01872494|Narcotics|narcotics|mesh-ancestor
64875648|NCT01872494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64875649|NCT01872494|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64875650|NCT01872546|Adalimumab|adalimumab|mesh-list
64875651|NCT01872546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64875652|NCT01872546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64875653|NCT01872702|Primaquine|primaquine|mesh-list
64875654|NCT01872702|Piperaquine|piperaquine|mesh-list
64875655|NCT01872702|Artenimol|artenimol|mesh-list
64875656|NCT01872702|Antimalarials|antimalarials|mesh-ancestor
64875657|NCT01872702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64875658|NCT01872702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64875659|NCT01872702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64875660|NCT01872728|Anesthetics|anesthetics|mesh-list
64875661|NCT01872728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64875662|NCT01872728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875663|NCT01872754|Remifentanil|remifentanil|mesh-list
64875664|NCT01872754|Propofol|propofol|mesh-list
64875665|NCT01872754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64422331|NCT02366091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64422332|NCT02366091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64422350|NCT02546765|Acetaminophen|acetaminophen|mesh-list
64422351|NCT02546765|Dexmedetomidine|dexmedetomidine|mesh-list
64422353|NCT02546765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64602639|NCT02008617|Bupivacaine|bupivacaine|mesh-list
64422358|NCT02546765|Anesthetics|anesthetics|mesh-ancestor
64875666|NCT01872754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64875667|NCT01872754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875668|NCT01872754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64875669|NCT01872754|Anesthetics, General|anesthetics, general|mesh-ancestor
64875670|NCT01872754|Anesthetics|anesthetics|mesh-ancestor
64875671|NCT01872754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64875686|NCT01872845|Antimetabolites|antimetabolites|mesh-ancestor
64875687|NCT01872845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875688|NCT01872845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64875689|NCT01872845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64875690|NCT01872845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875691|NCT01872858|Aspirin|aspirin|mesh-list
64875692|NCT01872858|Cilostazol|cilostazol|mesh-list
64875693|NCT01872858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64422404|NCT02365233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422405|NCT02365233|Incretins|incretins|mesh-ancestor
64422407|NCT02365233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64422408|NCT02365233|Protease Inhibitors|protease inhibitors|mesh-ancestor
64422409|NCT02365233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603028|NCT02153983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422410|NCT02365233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422413|NCT02364999|Carboplatin|carboplatin|mesh-list
64422414|NCT02364999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64422415|NCT02364999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422416|NCT02364999|Tubulin Modulators|tubulin modulators|mesh-ancestor
64422417|NCT02364999|Antimitotic Agents|antimitotic agents|mesh-ancestor
64422418|NCT02364999|Mitosis Modulators|mitosis modulators|mesh-ancestor
64422419|NCT02364999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422420|NCT02364999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64422421|NCT02364999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64422422|NCT02364999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64422423|NCT02364999|Growth Substances|growth substances|mesh-ancestor
64422424|NCT02364999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422425|NCT02364999|Growth Inhibitors|growth inhibitors|mesh-ancestor
64603167|NCT02352363|Levodopa|levodopa|mesh-list
64603301|NCT02312739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64422426|NCT02363283|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
64422427|NCT02363283|Immunoconjugates|immunoconjugates|mesh-list
64422428|NCT02363283|Immunotoxins|immunotoxins|mesh-list
64422429|NCT02363283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64422430|NCT02363283|Immunologic Factors|immunologic factors|mesh-ancestor
64422433|NCT02363283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875694|NCT01872858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64875695|NCT01872858|Analgesics|analgesics|mesh-ancestor
64875696|NCT01872858|Sensory System Agents|sensory system agents|mesh-ancestor
64875697|NCT01872858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64875698|NCT01872858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875699|NCT01872858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64875700|NCT01872858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64875701|NCT01872858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64422435|NCT02321319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64422436|NCT02321319|Narcotics|narcotics|mesh-ancestor
64422437|NCT02321319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64422438|NCT02321319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422439|NCT02321319|Analgesics|analgesics|mesh-ancestor
64422440|NCT02321319|Sensory System Agents|sensory system agents|mesh-ancestor
64603374|NCT05718531|Antipyretics|antipyretics|mesh-ancestor
64422441|NCT02321319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64299563|NCT03099122|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64422442|NCT02088541|Cytarabine|cytarabine|mesh-list
64422443|NCT02088541|Hydroxyurea|hydroxyurea|mesh-list
64422444|NCT02088541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64422445|NCT02088541|Antimetabolites|antimetabolites|mesh-ancestor
64875702|NCT01872858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64875703|NCT01872858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644278|NCT00576680|Everolimus|everolimus|mesh-list
64875704|NCT01872858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64875705|NCT01872858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64875736|NCT01872884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64875737|NCT01872884|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64875738|NCT01872884|Anesthetics, General|anesthetics, general|mesh-ancestor
64875739|NCT01872884|Anesthetics|anesthetics|mesh-ancestor
64421885|NCT05492591|Valacyclovir|valacyclovir|mesh-list
64875740|NCT01872897|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
64875741|NCT01872897|Antacids|antacids|mesh-ancestor
64875742|NCT01872897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875743|NCT01872897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64875744|NCT01872923|Bleomycin|bleomycin|mesh-list
64875745|NCT01872923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64875746|NCT01872923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875747|NCT01872936|Ribavirin|ribavirin|mesh-list
64422547|NCT01351909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64422548|NCT01351909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422549|NCT05401357|Bimatoprost|bimatoprost|mesh-list
64422550|NCT05401357|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64422551|NCT05401357|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64422552|NCT05401357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64422553|NCT05401279|Gemcitabine|gemcitabine|mesh-list
64422554|NCT05401279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422555|NCT05401279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64604089|NCT05446623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64422557|NCT05401279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422558|NCT05401279|Antiviral Agents|antiviral agents|mesh-ancestor
64422559|NCT05401279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64422560|NCT05401279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422561|NCT05401279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64875748|NCT01872936|Antimetabolites|antimetabolites|mesh-ancestor
64875749|NCT01872936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875750|NCT01872936|Antiviral Agents|antiviral agents|mesh-ancestor
64875751|NCT01872936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64875752|NCT01872962|Gemcitabine|gemcitabine|mesh-list
64875753|NCT01872962|Cisplatin|cisplatin|mesh-list
64875754|NCT01872962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875755|NCT01872962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64875756|NCT01872962|Antimetabolites|antimetabolites|mesh-ancestor
64875757|NCT01872962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875758|NCT01872962|Antiviral Agents|antiviral agents|mesh-ancestor
64875759|NCT01872962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64875760|NCT01872962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875761|NCT01872962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64875762|NCT01872962|Immunologic Factors|immunologic factors|mesh-ancestor
64875763|NCT01872962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875780|NCT01873001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875781|NCT01873001|Hormone Antagonists|hormone antagonists|mesh-ancestor
64875782|NCT01873001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64875783|NCT01873001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64875785|NCT01873027|Umirolimus|umirolimus|mesh-list
64875786|NCT01873027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64422593|NCT02532283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64422594|NCT02532283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422595|NCT02532283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422596|NCT01349959|Azacitidine|azacitidine|mesh-list
64422597|NCT01349959|Entinostat|entinostat|mesh-list
64422598|NCT01349959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
64422599|NCT01349959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64422600|NCT01349959|Antimetabolites|antimetabolites|mesh-ancestor
64422601|NCT01349959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422602|NCT01349959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422603|NCT01349959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422604|NCT01349881|Eflornithine|eflornithine|mesh-list
64422605|NCT01349881|Sulindac|sulindac|mesh-list
64422606|NCT01349881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422607|NCT01349881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64422608|NCT01349881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64422609|NCT01349881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64875787|NCT01873027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64875788|NCT01873027|Immunologic Factors|immunologic factors|mesh-ancestor
64875789|NCT01873027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875790|NCT01873027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64875791|NCT01873027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64875844|NCT01873339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64875845|NCT01873339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64875846|NCT01873339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64875847|NCT01873339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64875848|NCT01873339|Anesthetics, General|anesthetics, general|mesh-ancestor
64875849|NCT01873339|Anesthetics|anesthetics|mesh-ancestor
64875850|NCT01873339|GABA Modulators|gaba modulators|mesh-ancestor
64875851|NCT01873339|GABA Agents|gaba agents|mesh-ancestor
64875852|NCT01873339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64875853|NCT01873339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875854|NCT01873339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
64875855|NCT01873339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875856|NCT01873378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64875857|NCT01873378|Luteolytic Agents|luteolytic agents|mesh-ancestor
64875858|NCT01873378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64875904|NCT01873768|Coagulants|coagulants|mesh-ancestor
64875905|NCT01873807|Cyclophosphamide|cyclophosphamide|mesh-list
64422630|NCT02953457|Immunoglobulin G|immunoglobulin g|mesh-list
64422631|NCT02953457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64422632|NCT02953457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422633|NCT02953457|Immunologic Factors|immunologic factors|mesh-ancestor
64422634|NCT02953457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422635|NCT02953457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422654|NCT01728259|Immunologic Factors|immunologic factors|mesh-ancestor
64422655|NCT01728259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64422656|NCT01728259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64422657|NCT01728259|Growth Substances|growth substances|mesh-ancestor
64422658|NCT01728259|Growth Inhibitors|growth inhibitors|mesh-ancestor
64422659|NCT05398705|Cepharanthine|cepharanthine|mesh-list
64422660|NCT05398705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64422661|NCT05398705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64422662|NCT05398705|Analgesics|analgesics|mesh-ancestor
64422663|NCT05398705|Sensory System Agents|sensory system agents|mesh-ancestor
64422664|NCT05398705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64422665|NCT05398705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422666|NCT05398705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64422667|NCT05398705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64422668|NCT05398705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64422669|NCT05398705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422670|NCT05398705|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64422676|NCT05416021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64875906|NCT01873807|Etoposide|etoposide|mesh-list
64875907|NCT01873807|Idarubicin|idarubicin|mesh-list
64421898|NCT02554721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421899|NCT02554721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64875908|NCT01873807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64875909|NCT01873807|Immunologic Factors|immunologic factors|mesh-ancestor
64875910|NCT01873807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875911|NCT01873807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64875912|NCT01873807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64875913|NCT01873807|Alkylating Agents|alkylating agents|mesh-ancestor
64875914|NCT01873807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875915|NCT01873807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875916|NCT01873807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64875917|NCT01873807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64875918|NCT01873807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64875919|NCT01873807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64875920|NCT01873807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64875921|NCT01873807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64875922|NCT01873820|Ascorbic Acid|ascorbic acid|mesh-list
64875923|NCT01873820|Calcium ascorbate|calcium ascorbate|mesh-list
64875924|NCT01873820|Calcium|calcium|mesh-list
64875925|NCT01873820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64875926|NCT01873820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875927|NCT01873820|Antioxidants|antioxidants|mesh-ancestor
64875928|NCT01873820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875929|NCT01873820|Protective Agents|protective agents|mesh-ancestor
64875930|NCT01873820|Vitamins|vitamins|mesh-ancestor
64875931|NCT01873820|Micronutrients|micronutrients|mesh-ancestor
64422679|NCT05416021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64422680|NCT05443555|Gabapentin|gabapentin|mesh-list
64422682|NCT05443555|Sensory System Agents|sensory system agents|mesh-ancestor
64422683|NCT05443555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64422684|NCT05443555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422685|NCT05443555|Anticonvulsants|anticonvulsants|mesh-ancestor
64422686|NCT05443555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64422687|NCT05443555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64422688|NCT05443555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64875951|NCT01873885|Vasodilator Agents|vasodilator agents|mesh-ancestor
64875952|NCT01874002|Sirolimus|sirolimus|mesh-list
64875953|NCT01874002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64875954|NCT01874002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64875955|NCT01874002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64875956|NCT01874002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64875957|NCT01874002|Antifungal Agents|antifungal agents|mesh-ancestor
64875958|NCT01874002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64875959|NCT01874002|Immunologic Factors|immunologic factors|mesh-ancestor
64875960|NCT01874002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64875961|NCT01874028|Trientine|trientine|mesh-list
64875962|NCT01874028|Chelating Agents|chelating agents|mesh-ancestor
64875963|NCT01874028|Sequestering Agents|sequestering agents|mesh-ancestor
64875964|NCT01874028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64875965|NCT01874041|Salicylic Acid|salicylic acid|mesh-list
64876012|NCT01874574|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64876013|NCT01874574|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64422715|NCT05415709|Mitosis Modulators|mitosis modulators|mesh-ancestor
64422716|NCT05415709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422717|NCT04262843|Vidarabine|vidarabine|mesh-list
64422718|NCT04262843|Mycophenolic Acid|mycophenolic acid|mesh-list
64422719|NCT04262843|Cyclophosphamide|cyclophosphamide|mesh-list
64422720|NCT04262843|Fludarabine|fludarabine|mesh-list
64422721|NCT04262843|Fludarabine phosphate|fludarabine phosphate|mesh-list
64422722|NCT04262843|Tacrolimus|tacrolimus|mesh-list
64422723|NCT04262843|Lenograstim|lenograstim|mesh-list
64422724|NCT04262843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64422725|NCT04262843|Immunologic Factors|immunologic factors|mesh-ancestor
64876014|NCT01874574|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64876015|NCT01874574|Hylan|hylan|mesh-list
64876016|NCT01874574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64876017|NCT01874574|Glucocorticoids|glucocorticoids|mesh-ancestor
64876018|NCT01874574|Hormones|hormones|mesh-ancestor
64876019|NCT01874574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64876020|NCT01874574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876021|NCT01874574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64876022|NCT01874574|Immunologic Factors|immunologic factors|mesh-ancestor
64876023|NCT01874574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876024|NCT01874574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876025|NCT01874574|Viscosupplements|viscosupplements|mesh-ancestor
64876026|NCT01874574|Protective Agents|protective agents|mesh-ancestor
64876027|NCT01874639|Hemostatics|hemostatics|mesh-list
64876028|NCT01874639|Coagulants|coagulants|mesh-ancestor
64876029|NCT01874678|Cisplatin|cisplatin|mesh-list
64876030|NCT01874678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876031|NCT01874717|Midazolam|midazolam|mesh-list
64876032|NCT01874717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64876033|NCT01874717|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64876034|NCT01874717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64876035|NCT01874717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876036|NCT01874717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64876037|NCT01874717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64876038|NCT01874717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64876039|NCT01874717|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64876040|NCT01874717|Anesthetics, General|anesthetics, general|mesh-ancestor
64876041|NCT01874717|Anesthetics|anesthetics|mesh-ancestor
64876042|NCT01874717|GABA Modulators|gaba modulators|mesh-ancestor
64876043|NCT01874717|GABA Agents|gaba agents|mesh-ancestor
64876044|NCT01874717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64422774|NCT05475665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64422775|NCT05475665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422776|NCT05475665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64605312|NCT00859027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64422777|NCT05475665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422778|NCT05475665|Vasodilator Agents|vasodilator agents|mesh-ancestor
64422779|NCT05475665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64422780|NCT05475665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64422781|NCT02544113|Thymoglobulin|thymoglobulin|mesh-list
64422782|NCT02544113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64422783|NCT02544113|Immunologic Factors|immunologic factors|mesh-ancestor
64422784|NCT02544113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422785|NCT02544113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64422786|NCT02538965|Lenalidomide|lenalidomide|mesh-list
64422787|NCT02538965|Immunologic Factors|immunologic factors|mesh-ancestor
64422788|NCT02538965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422789|NCT02538965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64422791|NCT02538965|Growth Substances|growth substances|mesh-ancestor
64876055|NCT01874743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64876056|NCT01874743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876058|NCT01874847|Antioxidants|antioxidants|mesh-ancestor
64876059|NCT01874847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876060|NCT01874847|Protective Agents|protective agents|mesh-ancestor
64876061|NCT01874847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876062|NCT01874847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64876063|NCT01874964|Methadone|methadone|mesh-list
64876064|NCT01874964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64876065|NCT01874964|Narcotics|narcotics|mesh-ancestor
64876066|NCT01874964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64876067|NCT01874964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876068|NCT01874964|Analgesics|analgesics|mesh-ancestor
64876069|NCT01874964|Sensory System Agents|sensory system agents|mesh-ancestor
64876070|NCT01874964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64876071|NCT01874964|Antitussive Agents|antitussive agents|mesh-ancestor
64876072|NCT01874964|Respiratory System Agents|respiratory system agents|mesh-ancestor
64876073|NCT01875107|Insulin|insulin|mesh-list
64876074|NCT01875107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64876075|NCT01875107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876076|NCT01875172|Bupropion|bupropion|mesh-list
64876077|NCT01875172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64876078|NCT01875172|Antidepressive Agents|antidepressive agents|mesh-ancestor
64876079|NCT01875172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64876080|NCT01875172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64876081|NCT01875172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64876082|NCT01875172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64876084|NCT01875172|Dopamine Agents|dopamine agents|mesh-ancestor
64876099|NCT01875185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64876100|NCT01875185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64876101|NCT01875185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876102|NCT01875185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64876103|NCT01875185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64876104|NCT01875185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876105|NCT01875185|Antipyretics|antipyretics|mesh-ancestor
64876106|NCT01875224|Abatacept|abatacept|mesh-list
64876107|NCT01875224|Tacrolimus|tacrolimus|mesh-list
64876108|NCT01875224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64876109|NCT01875224|Immunologic Factors|immunologic factors|mesh-ancestor
64422799|NCT02543801|Anesthetics, Local|anesthetics, local|mesh-ancestor
64422800|NCT02543801|Anesthetics|anesthetics|mesh-ancestor
64422801|NCT02543801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64422802|NCT02543801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422803|NCT02543801|Sensory System Agents|sensory system agents|mesh-ancestor
64422804|NCT02543801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64422812|NCT02543801|Autonomic Agents|autonomic agents|mesh-ancestor
64876110|NCT01875224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876111|NCT01875224|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64876112|NCT01875224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876113|NCT01875224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876114|NCT01875224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64876115|NCT01875224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876116|NCT01875224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64876117|NCT01875263|Levofloxacin|levofloxacin|mesh-list
64876118|NCT01875263|Ofloxacin|ofloxacin|mesh-list
64876119|NCT01875263|Cloxacillin|cloxacillin|mesh-list
64876120|NCT01875263|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64876121|NCT01875263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64876122|NCT01875263|Renal Agents|renal agents|mesh-ancestor
64876123|NCT01875263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64876124|NCT01875263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64876125|NCT01875263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64876126|NCT01875263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876127|NCT01875263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876128|NCT01875263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421934|NCT02552225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421935|NCT02552225|Adrenergic Agents|adrenergic agents|mesh-ancestor
64421991|NCT02551991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876129|NCT01875263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64876142|NCT01875666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876143|NCT01875666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876144|NCT01875705|Ravoxertinib|ravoxertinib|mesh-list
64876145|NCT01875705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876146|NCT01875705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64876147|NCT01875705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876148|NCT01875705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876149|NCT01875757|Vitamin D|vitamin d|mesh-list
64876150|NCT01875757|Cholecalciferol|cholecalciferol|mesh-list
64876151|NCT01875757|Vitamins|vitamins|mesh-ancestor
64876152|NCT01875757|Micronutrients|micronutrients|mesh-ancestor
64876153|NCT01875757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876154|NCT01875757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64876155|NCT01875757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64876156|NCT01875822|Curcumin|curcumin|mesh-list
64876157|NCT01875822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64876158|NCT01875822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64876159|NCT01875822|Analgesics|analgesics|mesh-ancestor
64876160|NCT01875822|Sensory System Agents|sensory system agents|mesh-ancestor
64876161|NCT01875822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64422896|NCT02292771|Vasotocin|vasotocin|mesh-list
64876162|NCT01875822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876163|NCT01875822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64876164|NCT01875822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64876165|NCT01875822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876166|NCT01875822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876190|NCT01876004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876191|NCT01876004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64876192|NCT01876004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64876193|NCT01876004|Immunologic Factors|immunologic factors|mesh-ancestor
64876194|NCT01876004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64876195|NCT01876004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64876196|NCT01876108|Amoxicillin|amoxicillin|mesh-list
64876197|NCT01876108|Azithromycin|azithromycin|mesh-list
64423029|NCT02531035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64423030|NCT02531035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423031|NCT05004805|Methylene Blue|methylene blue|mesh-list
64423032|NCT05004805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423033|NCT05004805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423035|NCT05411965|Dapagliflozin|dapagliflozin|mesh-list
64423036|NCT05411965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64423037|NCT05411965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423038|NCT05411965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64423039|NCT05411965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423040|NCT04261075|Durvalumab|durvalumab|mesh-list
64423043|NCT05436769|Clarithromycin|clarithromycin|mesh-list
64876198|NCT01876108|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
64876199|NCT01876108|Omeprazole|omeprazole|mesh-list
64876200|NCT01876108|Bismuth|bismuth|mesh-list
64876201|NCT01876108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64876202|NCT01876108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64876203|NCT01876108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64876204|NCT01876108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64876205|NCT01876108|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64876206|NCT01876108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876207|NCT01876108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876208|NCT01876108|Antacids|antacids|mesh-ancestor
64876209|NCT01876121|Celecoxib|celecoxib|mesh-list
64876211|NCT01876121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64876245|NCT01876290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64876247|NCT01876290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64876248|NCT01876290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876249|NCT01876290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64876250|NCT01876290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64876251|NCT01876290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64876252|NCT01876290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64876253|NCT01876290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64876254|NCT01876316|Moxifloxacin|moxifloxacin|mesh-list
64876255|NCT01876316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64423083|NCT05376553|Antimitotic Agents|antimitotic agents|mesh-ancestor
64423084|NCT05376553|Mitosis Modulators|mitosis modulators|mesh-ancestor
64423085|NCT05376553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423086|NCT05376553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64423087|NCT05385367|Anesthetics|anesthetics|mesh-list
64423088|NCT05385367|Anesthetics, General|anesthetics, general|mesh-list
64876256|NCT01876316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64876257|NCT01876316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64876258|NCT01876316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64876259|NCT01876316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876260|NCT01876316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876261|NCT01876316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876262|NCT01876433|Mirabegron|mirabegron|mesh-list
64876263|NCT01876433|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64876264|NCT01876433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64876265|NCT01876433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64876266|NCT01876433|Adrenergic Agents|adrenergic agents|mesh-ancestor
64876267|NCT01876433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64876268|NCT01876433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876269|NCT01876433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876270|NCT01876433|Urological Agents|urological agents|mesh-ancestor
64876271|NCT01876550|Mupirocin|mupirocin|mesh-list
64876272|NCT01876550|Calcium|calcium|mesh-list
64876290|NCT01876615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64876291|NCT01876615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876292|NCT01876615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64876293|NCT01876615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64876294|NCT01876615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64876295|NCT01876615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876296|NCT01876615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876297|NCT01876641|Decitabine|decitabine|mesh-list
64876298|NCT01876641|Vemurafenib|vemurafenib|mesh-list
64876299|NCT01876641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64876300|NCT01876641|Antimetabolites|antimetabolites|mesh-ancestor
64876301|NCT01876641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876302|NCT01876641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876351|NCT01877122|Sensory System Agents|sensory system agents|mesh-ancestor
64423125|NCT05610085|GABA Agents|gaba agents|mesh-ancestor
64423126|NCT05610085|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64423144|NCT05564611|Respiratory System Agents|respiratory system agents|mesh-ancestor
64423145|NCT05371015|Ropivacaine|ropivacaine|mesh-list
64876352|NCT01877122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64876353|NCT01877122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876354|NCT01877122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64876355|NCT01877122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64876356|NCT01877122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64876357|NCT01877122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876358|NCT01877122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876359|NCT01877226|Tapentadol|tapentadol|mesh-list
64876360|NCT01877226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64876361|NCT01877226|Narcotics|narcotics|mesh-ancestor
64876362|NCT01877226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64876363|NCT01877226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876364|NCT01877226|Analgesics|analgesics|mesh-ancestor
64876365|NCT01877226|Sensory System Agents|sensory system agents|mesh-ancestor
64876366|NCT01877226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64876367|NCT01877226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64876368|NCT01877226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64876369|NCT01877226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64876370|NCT01877226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876371|NCT01877226|Adrenergic Agents|adrenergic agents|mesh-ancestor
64876372|NCT01877226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64876373|NCT01877356|Anesthetics|anesthetics|mesh-list
64876374|NCT01877356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64876375|NCT01877356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876376|NCT01877512|Hormones|hormones|mesh-list
64876377|NCT01877512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64876396|NCT01877746|Azathioprine|azathioprine|mesh-list
64876397|NCT01877746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64876398|NCT01877746|Glucocorticoids|glucocorticoids|mesh-ancestor
64876400|NCT01877746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64876401|NCT01877746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423177|NCT04248595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423178|NCT04248595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423179|NCT04248595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423180|NCT04248595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64423181|NCT04248595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64423182|NCT05335993|Niraparib|niraparib|mesh-list
64423183|NCT05335993|Oregovomab|oregovomab|mesh-list
64423201|NCT05304871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64876402|NCT01877746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64876403|NCT01877746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876404|NCT01877746|Antimetabolites|antimetabolites|mesh-ancestor
64876405|NCT01877746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876406|NCT01877746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64876407|NCT01877746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64876408|NCT01877746|Immunologic Factors|immunologic factors|mesh-ancestor
64876409|NCT01877746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64876410|NCT01877811|Agerafenib|agerafenib|mesh-list
64876411|NCT01877811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64876412|NCT01877811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876413|NCT01877811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876415|NCT01877889|Canagliflozin|canagliflozin|mesh-list
64876416|NCT01877889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64876417|NCT01877889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876418|NCT01877889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64607923|NCT00370318|Analgesics|analgesics|mesh-ancestor
64608028|NCT05530122|Adalimumab|adalimumab|mesh-list
64423228|NCT05332717|Antioxidants|antioxidants|mesh-ancestor
64423229|NCT05332717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423230|NCT05332717|Protective Agents|protective agents|mesh-ancestor
64423231|NCT05332717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64423232|NCT05300269|Capecitabine|capecitabine|mesh-list
64423233|NCT05300269|Oxaliplatin|oxaliplatin|mesh-list
64423234|NCT05300269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64423235|NCT05300269|Antimetabolites|antimetabolites|mesh-ancestor
64608132|NCT05528718|Midazolam|midazolam|mesh-list
64423236|NCT05300269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423237|NCT05300269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423238|NCT05325853|Proxymetacaine|proxymetacaine|mesh-list
64423239|NCT05325853|Propoxycaine|propoxycaine|mesh-list
64423240|NCT05325853|Anesthetics, Local|anesthetics, local|mesh-ancestor
64423241|NCT05325853|Anesthetics|anesthetics|mesh-ancestor
64423258|NCT05352685|Anesthetics|anesthetics|mesh-ancestor
64423259|NCT04249687|Botulinum Toxins|botulinum toxins|mesh-list
64608201|NCT01729897|Analgesics|analgesics|mesh-ancestor
64608202|NCT01729897|Sensory System Agents|sensory system agents|mesh-ancestor
64423260|NCT04249687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64423261|NCT04249687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64423262|NCT04249687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423263|NCT04249687|Cholinergic Agents|cholinergic agents|mesh-ancestor
64333741|NCT02361879|Leuprolide|leuprolide|mesh-list
64876419|NCT01877889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876420|NCT01877954|Fluticasone|fluticasone|mesh-list
64876421|NCT01877954|Xhance|xhance|mesh-list
64876422|NCT01877954|Beclomethasone|beclomethasone|mesh-list
64876423|NCT01877954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64876424|NCT01877954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64876425|NCT01877954|Autonomic Agents|autonomic agents|mesh-ancestor
64876426|NCT01877954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64876427|NCT01877954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876428|NCT01877954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64876429|NCT01877954|Respiratory System Agents|respiratory system agents|mesh-ancestor
64876430|NCT01877954|Dermatologic Agents|dermatologic agents|mesh-ancestor
64876431|NCT01877954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64876434|NCT01877954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64876435|NCT01878136|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64876437|NCT01878136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64876438|NCT01878136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64876439|NCT01878136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876440|NCT01878188|BCG Vaccine|bcg vaccine|mesh-list
64876441|NCT01878188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64876442|NCT01878188|Immunologic Factors|immunologic factors|mesh-ancestor
64876443|NCT01878188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876444|NCT01878201|Valsartan|valsartan|mesh-list
64423264|NCT04249687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64423265|NCT04249687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423267|NCT05351593|Immunologic Factors|immunologic factors|mesh-ancestor
64423268|NCT05351593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423269|NCT05351593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64423270|NCT05351593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64423271|NCT05351593|Growth Substances|growth substances|mesh-ancestor
64423272|NCT05351593|Growth Inhibitors|growth inhibitors|mesh-ancestor
64423273|NCT05351593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423274|NCT05321875|Candesartan|candesartan|mesh-list
64423275|NCT05321875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64608545|NCT02166905|Poly I-C|poly i-c|mesh-list
64876445|NCT01878201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64876446|NCT01878201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64876447|NCT01878201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64876448|NCT01878201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876449|NCT01878227|Fenofibrate|fenofibrate|mesh-list
64876450|NCT01878227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64876451|NCT01878227|Antimetabolites|antimetabolites|mesh-ancestor
64876452|NCT01878227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876453|NCT01878227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64876454|NCT01878318|Methotrexate|methotrexate|mesh-list
64876455|NCT01878318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64645013|NCT00619190|Aripiprazole|aripiprazole|mesh-list
64876456|NCT01878318|Abortifacient Agents|abortifacient agents|mesh-ancestor
64876457|NCT01878318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64876458|NCT01878318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876459|NCT01878318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64876460|NCT01878318|Antimetabolites|antimetabolites|mesh-ancestor
64876463|NCT01878318|Dermatologic Agents|dermatologic agents|mesh-ancestor
64876477|NCT01878422|Leucovorin|leucovorin|mesh-list
64876478|NCT01878422|Bevacizumab|bevacizumab|mesh-list
64876479|NCT01878422|Cetuximab|cetuximab|mesh-list
64423292|NCT01659151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608836|NCT05348434|Ether|ether|mesh-list
64423293|NCT01659151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64423294|NCT01659151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64423296|NCT01659151|Sensory System Agents|sensory system agents|mesh-ancestor
64423297|NCT01659151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423298|NCT01659151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64423307|NCT05347069|Sensory System Agents|sensory system agents|mesh-ancestor
64876480|NCT01878422|Fluorouracil|fluorouracil|mesh-list
64876481|NCT01878422|Oxaliplatin|oxaliplatin|mesh-list
64876482|NCT01878422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64876483|NCT01878422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876484|NCT01878422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64876485|NCT01878422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64876486|NCT01878422|Growth Substances|growth substances|mesh-ancestor
64422047|NCT05478083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876493|NCT01878422|Immunologic Factors|immunologic factors|mesh-ancestor
64876494|NCT01878422|Antidotes|antidotes|mesh-ancestor
64876495|NCT01878422|Protective Agents|protective agents|mesh-ancestor
64876496|NCT01878422|Vitamin B Complex|vitamin b complex|mesh-ancestor
64876497|NCT01878422|Vitamins|vitamins|mesh-ancestor
64876498|NCT01878422|Micronutrients|micronutrients|mesh-ancestor
64876499|NCT01878513|Risperidone|risperidone|mesh-list
64876500|NCT01878513|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64876501|NCT01878513|Serotonin Agents|serotonin agents|mesh-ancestor
64876502|NCT01878513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64876503|NCT01878513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876504|NCT01878513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876505|NCT01878513|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64876506|NCT01878513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64876507|NCT01878513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64876508|NCT01878513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64876509|NCT01878513|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64876510|NCT01878513|Dopamine Agents|dopamine agents|mesh-ancestor
64876511|NCT01878539|Anticoagulants|anticoagulants|mesh-list
64876512|NCT01878578|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64876513|NCT01878578|Phenytoin|phenytoin|mesh-list
64876514|NCT01878578|Anticonvulsants|anticonvulsants|mesh-ancestor
64876515|NCT01878578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64876516|NCT01878578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64876517|NCT01878578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64876518|NCT01878578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876519|NCT01878578|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64876520|NCT01878578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64876521|NCT01878643|Vancomycin|vancomycin|mesh-list
64876522|NCT01878643|Gentamicins|gentamicins|mesh-list
64609143|NCT03405805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423339|NCT02522377|Ketamine|ketamine|mesh-list
64423340|NCT02522377|Analgesics|analgesics|mesh-ancestor
64423341|NCT02522377|Sensory System Agents|sensory system agents|mesh-ancestor
64423342|NCT02522377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423343|NCT02522377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423344|NCT02522377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64423345|NCT02522377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64423346|NCT02522377|Anesthetics, General|anesthetics, general|mesh-ancestor
64423348|NCT02522377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64423349|NCT02522377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64423350|NCT02522377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64423363|NCT05345509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423364|NCT05345509|Cholinergic Agents|cholinergic agents|mesh-ancestor
64423365|NCT05345509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64423388|NCT05314621|Xhance|xhance|mesh-list
64423389|NCT05314621|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64423390|NCT05314621|Dextrans|dextrans|mesh-list
64423391|NCT05314621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64423392|NCT05314621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64876523|NCT01878643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64876524|NCT01878643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64876525|NCT01878643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64876526|NCT01878643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876527|NCT01878643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876528|NCT01878695|Acetylcysteine|acetylcysteine|mesh-list
64876529|NCT01878695|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64876530|NCT01878695|Antiviral Agents|antiviral agents|mesh-ancestor
64645088|NCT00676676|Testosterone|testosterone|mesh-list
64876531|NCT01878695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64876532|NCT01878695|Expectorants|expectorants|mesh-ancestor
64876533|NCT01878695|Respiratory System Agents|respiratory system agents|mesh-ancestor
64876534|NCT01878695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64876535|NCT01878695|Antioxidants|antioxidants|mesh-ancestor
64876536|NCT01878695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876537|NCT01878695|Protective Agents|protective agents|mesh-ancestor
64876538|NCT01878695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876558|NCT01878708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423412|NCT05314621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423413|NCT05314621|Anticoagulants|anticoagulants|mesh-ancestor
64423414|NCT05314621|Plasma Substitutes|plasma substitutes|mesh-ancestor
64423415|NCT05314621|Blood Substitutes|blood substitutes|mesh-ancestor
64423416|NCT05266729|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
64423417|NCT05266729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64423418|NCT05266729|Antimetabolites|antimetabolites|mesh-ancestor
64423419|NCT05266729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609767|NCT01832363|Xenon|xenon|mesh-list
64423465|NCT01657903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609855|NCT03219983|Sensory System Agents|sensory system agents|mesh-ancestor
64423466|NCT01657903|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64423467|NCT01657903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64609910|NCT02240017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423469|NCT05256823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64423470|NCT05256823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64876559|NCT01878734|Micronutrients|micronutrients|mesh-list
64876560|NCT01878734|Trace Elements|trace elements|mesh-list
64876561|NCT01878734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876562|NCT01878864|Lidocaine|lidocaine|mesh-list
64876563|NCT01878864|Bupivacaine|bupivacaine|mesh-list
64876564|NCT01878864|Anesthetics, Local|anesthetics, local|mesh-ancestor
64876565|NCT01878864|Anesthetics|anesthetics|mesh-ancestor
64876566|NCT01878864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64876567|NCT01878864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876568|NCT01878864|Sensory System Agents|sensory system agents|mesh-ancestor
64876569|NCT01878864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64876570|NCT01878864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64610081|NCT03212807|Durvalumab|durvalumab|mesh-list
64423533|NCT05253937|Respiratory System Agents|respiratory system agents|mesh-ancestor
64336807|NCT02330757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64336808|NCT02330757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336809|NCT02330757|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64336810|NCT02330757|Contraceptive Agents|contraceptive agents|mesh-ancestor
64336811|NCT02330757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64876571|NCT01878864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64876572|NCT01878864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64876573|NCT01878864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64876574|NCT01878864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876575|NCT01878942|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
64876577|NCT01878942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876578|NCT01878942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64876579|NCT01878942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64876580|NCT01878942|Serotonin Agents|serotonin agents|mesh-ancestor
64876581|NCT01878942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64876582|NCT01878942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876583|NCT01878942|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64876584|NCT01879007|Gemifloxacin|gemifloxacin|mesh-list
64876585|NCT01879007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64341290|NCT02514122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341291|NCT02514122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64341292|NCT02514122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64341293|NCT02514122|Anesthetics, General|anesthetics, general|mesh-ancestor
64876601|NCT01879202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876602|NCT01879202|Dopamine Agents|dopamine agents|mesh-ancestor
64876603|NCT01879202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64876604|NCT01879293|Metformin|metformin|mesh-list
64876605|NCT01879293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64876606|NCT01879293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876607|NCT01879358|Sirolimus|sirolimus|mesh-list
64876608|NCT01879358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64876609|NCT01879358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64876610|NCT01879358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64876611|NCT01879358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876612|NCT01879358|Antifungal Agents|antifungal agents|mesh-ancestor
64876655|NCT01879527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64876656|NCT01879527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876657|NCT01879527|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
64611793|NCT03490825|Melatonin|melatonin|mesh-list
64876658|NCT01879527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64876728|NCT01880346|Ergocalciferols|ergocalciferols|mesh-list
64876729|NCT01880346|Cholecalciferol|cholecalciferol|mesh-list
64876730|NCT01880346|Vitamins|vitamins|mesh-list
64876731|NCT01880346|Micronutrients|micronutrients|mesh-ancestor
64876732|NCT01880346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876733|NCT01880346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64876734|NCT01880346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64876735|NCT01880372|Thioctic Acid|thioctic acid|mesh-list
64876736|NCT01880372|Antioxidants|antioxidants|mesh-ancestor
64876737|NCT01880372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876738|NCT01880372|Protective Agents|protective agents|mesh-ancestor
64876739|NCT01880372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876740|NCT01880372|Vitamin B Complex|vitamin b complex|mesh-ancestor
64876741|NCT01880372|Vitamins|vitamins|mesh-ancestor
64876742|NCT01880372|Micronutrients|micronutrients|mesh-ancestor
64876743|NCT01880385|Cyclophosphamide|cyclophosphamide|mesh-list
64876744|NCT01880385|Bevacizumab|bevacizumab|mesh-list
64876745|NCT01880385|Docetaxel|docetaxel|mesh-list
64876746|NCT01880385|Fluorouracil|fluorouracil|mesh-list
64876747|NCT01880385|Trastuzumab|trastuzumab|mesh-list
64876748|NCT01880385|Epirubicin|epirubicin|mesh-list
64876749|NCT01880385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64876750|NCT01880385|Immunologic Factors|immunologic factors|mesh-ancestor
64876784|NCT01880619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64876785|NCT01880619|Adrenergic Agents|adrenergic agents|mesh-ancestor
64876786|NCT01880619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64876787|NCT01880619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876788|NCT01880619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876789|NCT01880619|Urological Agents|urological agents|mesh-ancestor
64876790|NCT01880619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64876791|NCT01880619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64876792|NCT01880619|Cholinergic Agents|cholinergic agents|mesh-ancestor
64876793|NCT01880658|Capecitabine|capecitabine|mesh-list
64876794|NCT01880658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64876795|NCT01880658|Antimetabolites|antimetabolites|mesh-ancestor
64876796|NCT01880658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876797|NCT01880658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876798|NCT01880749|Everolimus|everolimus|mesh-list
64876799|NCT01880749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876800|NCT01880749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64876801|NCT01880749|Immunologic Factors|immunologic factors|mesh-ancestor
64876802|NCT01880749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876840|NCT01881100|Fluorides|fluorides|mesh-list
64876841|NCT01881100|Fluorides, Topical|fluorides, topical|mesh-list
64876842|NCT01881100|Sodium Fluoride|sodium fluoride|mesh-list
64876843|NCT01881100|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
64876844|NCT01881100|Cariostatic Agents|cariostatic agents|mesh-ancestor
64876845|NCT01881100|Protective Agents|protective agents|mesh-ancestor
64876846|NCT01881100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876847|NCT01881100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64876848|NCT01881100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64876849|NCT01881347|Resveratrol|resveratrol|mesh-list
64876850|NCT01881347|Antioxidants|antioxidants|mesh-ancestor
64876851|NCT01881347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876852|NCT01881347|Protective Agents|protective agents|mesh-ancestor
64876853|NCT01881347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876854|NCT01881347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876855|NCT01881347|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64876856|NCT01881464|Adalimumab|adalimumab|mesh-list
64876857|NCT01881464|Infliximab|infliximab|mesh-list
64876858|NCT01881464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64876859|NCT01881464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64876860|NCT01881464|Dermatologic Agents|dermatologic agents|mesh-ancestor
64876861|NCT01881464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64876862|NCT01881503|HBOC 201|hboc 201|mesh-list
64876863|NCT01881503|Blood Substitutes|blood substitutes|mesh-ancestor
64876864|NCT01881568|Tranexamic Acid|tranexamic acid|mesh-list
64876865|NCT01881568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64876866|NCT01881568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64876867|NCT01881568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876868|NCT01881568|Hemostatics|hemostatics|mesh-ancestor
64876869|NCT01881568|Coagulants|coagulants|mesh-ancestor
64876887|NCT01881997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64876888|NCT01881997|Anesthetics, General|anesthetics, general|mesh-ancestor
64876889|NCT01881997|Anesthetics|anesthetics|mesh-ancestor
64876890|NCT01882010|Sargramostim|sargramostim|mesh-list
64876891|NCT01882010|Immunologic Factors|immunologic factors|mesh-ancestor
64876892|NCT01882010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876893|NCT01882075|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
64876894|NCT01882075|Plasma Substitutes|plasma substitutes|mesh-ancestor
64876895|NCT01882075|Blood Substitutes|blood substitutes|mesh-ancestor
64876896|NCT01882127|Dexamethasone|dexamethasone|mesh-list
64876897|NCT01882127|Tretinoin|tretinoin|mesh-list
64876898|NCT01882127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64876899|NCT01882127|Antiemetics|antiemetics|mesh-ancestor
64876900|NCT01882127|Autonomic Agents|autonomic agents|mesh-ancestor
64876901|NCT01882127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64876902|NCT01882127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876903|NCT01882127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64422102|NCT05459285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64876905|NCT01882127|Hormones|hormones|mesh-ancestor
64876906|NCT01882127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64337829|NCT01495247|Tubulin Modulators|tubulin modulators|mesh-ancestor
64876907|NCT01882127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64876908|NCT01882127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64876909|NCT01882127|Keratolytic Agents|keratolytic agents|mesh-ancestor
64876910|NCT01882127|Dermatologic Agents|dermatologic agents|mesh-ancestor
64876911|NCT01882179|Canrenoic Acid|canrenoic acid|mesh-list
64876912|NCT01882179|Mineralocorticoids|mineralocorticoids|mesh-list
64876913|NCT01882179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
64876914|NCT01882179|Hormones|hormones|mesh-ancestor
64876915|NCT01882179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64876916|NCT01882179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876917|NCT01882179|Hormone Antagonists|hormone antagonists|mesh-ancestor
64876918|NCT01882179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64876919|NCT01882179|Diuretics|diuretics|mesh-ancestor
64337913|NCT02264795|Lidocaine|lidocaine|mesh-list
64876920|NCT01882179|Natriuretic Agents|natriuretic agents|mesh-ancestor
64876921|NCT01882296|Pantoprazole|pantoprazole|mesh-list
64876922|NCT01882296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64876923|NCT01882296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64876926|NCT01882296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876928|NCT01882322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64876929|NCT01882322|Immunologic Factors|immunologic factors|mesh-ancestor
64876930|NCT01882322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876931|NCT01882322|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64876932|NCT01882322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64876933|NCT01882322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876934|NCT01882361|Naltrexone|naltrexone|mesh-list
64876935|NCT01882361|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64876936|NCT01882361|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64876937|NCT01882361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876938|NCT01882361|Sensory System Agents|sensory system agents|mesh-ancestor
64414805|NCT02419755|Antimetabolites|antimetabolites|mesh-ancestor
64414806|NCT02419755|Dermatologic Agents|dermatologic agents|mesh-ancestor
64414807|NCT02419755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64414808|NCT02419755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64414809|NCT02419755|Immunologic Factors|immunologic factors|mesh-ancestor
64414810|NCT02419755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64414811|NCT02419755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64414812|NCT02419755|Antiviral Agents|antiviral agents|mesh-ancestor
64414813|NCT02419755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64414814|NCT02419755|Analgesics|analgesics|mesh-ancestor
64876939|NCT01882361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64876940|NCT01882374|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
64876941|NCT01882374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64876942|NCT01882374|Vasodilator Agents|vasodilator agents|mesh-ancestor
64876943|NCT01882387|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
64876944|NCT01882387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64876945|NCT01882387|Vasodilator Agents|vasodilator agents|mesh-ancestor
64876946|NCT01882400|Alendronate|alendronate|mesh-list
64876947|NCT01882400|Risedronic Acid|risedronic acid|mesh-list
64876948|NCT01882400|Diphosphonates|diphosphonates|mesh-list
64876949|NCT01882400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64876950|NCT01882400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876951|NCT01882400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64876952|NCT01882400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64876953|NCT01882400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876954|NCT01882400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64876955|NCT01882530|Acetaminophen|acetaminophen|mesh-list
64876956|NCT01882530|Ketoprofen|ketoprofen|mesh-list
64414890|NCT04882813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64414892|NCT02576639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423541|NCT05280769|Nicotine|nicotine|mesh-list
64414893|NCT02576639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414894|NCT02418585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64414896|NCT02418585|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64619489|NCT01926236|Vitamins|vitamins|mesh-ancestor
64414897|NCT02418585|Sertraline|sertraline|mesh-list
64414898|NCT02418585|Antidepressive Agents|antidepressive agents|mesh-list
64414899|NCT02418585|Esketamine|esketamine|mesh-list
64414900|NCT02418585|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64414901|NCT02418585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64414902|NCT02418585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64619939|NCT01928498|Mitosis Modulators|mitosis modulators|mesh-ancestor
64414903|NCT02418585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414904|NCT02418585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64414905|NCT02418585|Serotonin Agents|serotonin agents|mesh-ancestor
64414906|NCT02418585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423542|NCT05280769|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64414907|NCT02418585|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64414958|NCT05474183|Ketamine|ketamine|mesh-list
64876957|NCT01882530|Morphine|morphine|mesh-list
64876968|NCT01882530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64876969|NCT01882530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64876970|NCT01882530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64422153|NCT02542631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64876971|NCT01882530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64876972|NCT01882530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414967|NCT05474183|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64414968|NCT05474183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64414969|NCT05474183|Adrenergic Agents|adrenergic agents|mesh-ancestor
64414970|NCT05474183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64414971|NCT05474183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414972|NCT05474183|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64876973|NCT01882530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876974|NCT01882556|Botulinum Toxins|botulinum toxins|mesh-list
64876975|NCT01882556|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64876976|NCT01882556|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64876977|NCT01882556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64876978|NCT01882556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64876979|NCT01882556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64876980|NCT01882556|Cholinergic Agents|cholinergic agents|mesh-ancestor
64876981|NCT01882556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64876982|NCT01882556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876983|NCT01882556|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64876984|NCT01882556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64876985|NCT01882920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64876986|NCT01883011|Piracetam|piracetam|mesh-list
64876987|NCT01883011|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64645534|NCT03005665|Diuretics|diuretics|mesh-ancestor
64876988|NCT01883011|Protective Agents|protective agents|mesh-ancestor
64876989|NCT01883011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876990|NCT01883011|Nootropic Agents|nootropic agents|mesh-ancestor
64876991|NCT01883024|Insulin|insulin|mesh-list
64876992|NCT01883024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64876993|NCT01883024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64876994|NCT01883102|Capsaicin|capsaicin|mesh-list
64876995|NCT01883102|Antipruritics|antipruritics|mesh-ancestor
64876996|NCT01883102|Dermatologic Agents|dermatologic agents|mesh-ancestor
64876997|NCT01883102|Sensory System Agents|sensory system agents|mesh-ancestor
64876998|NCT01883102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877000|NCT01883167|Febuxostat|febuxostat|mesh-list
64877010|NCT01883232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64877011|NCT01883232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877012|NCT01883232|Sensory System Agents|sensory system agents|mesh-ancestor
64877013|NCT01883232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877014|NCT01883232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64877015|NCT01883232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64877016|NCT01883232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64415040|NCT04895059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64415041|NCT05534243|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
64415042|NCT05534243|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64415043|NCT05534243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64622103|NCT03810066|Osimertinib|osimertinib|mesh-list
64622175|NCT05489952|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64415044|NCT05534243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415045|NCT05467475|Esomeprazole|esomeprazole|mesh-list
64415046|NCT05467475|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64415047|NCT05467475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64415048|NCT05467475|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64415049|NCT05467475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64415050|NCT05467475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415052|NCT04895137|Antibodies|antibodies|mesh-list
64877017|NCT01883232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64877018|NCT01883232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877019|NCT01883232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64877020|NCT01883232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64877021|NCT01883232|Adrenergic Agents|adrenergic agents|mesh-ancestor
64877022|NCT01883232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64877023|NCT01883232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64877024|NCT01883232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64877025|NCT01883232|Autonomic Agents|autonomic agents|mesh-ancestor
64877026|NCT01883232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64877027|NCT01883232|Respiratory System Agents|respiratory system agents|mesh-ancestor
64877064|NCT01883518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877066|NCT01883531|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64877067|NCT01883531|Diuretics|diuretics|mesh-ancestor
64877068|NCT01883531|Natriuretic Agents|natriuretic agents|mesh-ancestor
64415073|NCT02326805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64415074|NCT01595581|Methyltestosterone|methyltestosterone|mesh-list
64415075|NCT01595581|Testosterone|testosterone|mesh-list
64423545|NCT05280769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877069|NCT01883531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877070|NCT01883596|Chlorhexidine|chlorhexidine|mesh-list
64877071|NCT01883596|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64877072|NCT01883596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64877073|NCT01883596|Disinfectants|disinfectants|mesh-ancestor
64422290|NCT02300259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64877074|NCT01883869|Ticagrelor|ticagrelor|mesh-list
64877075|NCT01883869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64877076|NCT01883869|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64877077|NCT01883869|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64877078|NCT01883869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64877079|NCT01883869|Purinergic Agents|purinergic agents|mesh-ancestor
64877080|NCT01883869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64877081|NCT01883869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341801|NCT02323399|Respiratory System Agents|respiratory system agents|mesh-ancestor
64341802|NCT02323399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64341803|NCT02323399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64341804|NCT02323399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64341805|NCT02323399|Adrenergic Agents|adrenergic agents|mesh-ancestor
64877121|NCT01884272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877122|NCT01884272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877123|NCT01884272|Tocolytic Agents|tocolytic agents|mesh-ancestor
64877124|NCT01884272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64877125|NCT01884272|Uricosuric Agents|uricosuric agents|mesh-ancestor
64877126|NCT01884272|Renal Agents|renal agents|mesh-ancestor
64877127|NCT01884285|Abiraterone Acetate|abiraterone acetate|mesh-list
64877178|NCT01884428|Hormones|hormones|mesh-ancestor
64415160|NCT04390009|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
64624150|NCT00000838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64415161|NCT04390009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415162|NCT04872283|Aspirin|aspirin|mesh-list
64624218|NCT02634008|Ritonavir|ritonavir|mesh-list
64415163|NCT04872283|Acetaminophen|acetaminophen|mesh-list
64877179|NCT01884428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64877180|NCT01884428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64877181|NCT01884428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64877182|NCT01884428|Tubulin Modulators|tubulin modulators|mesh-ancestor
64877183|NCT01884428|Antimitotic Agents|antimitotic agents|mesh-ancestor
64877184|NCT01884428|Mitosis Modulators|mitosis modulators|mesh-ancestor
64877185|NCT01884428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64877186|NCT01884428|Alkylating Agents|alkylating agents|mesh-ancestor
64877187|NCT01884428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64877188|NCT01884441|Gemcitabine|gemcitabine|mesh-list
64877189|NCT01884441|Vinorelbine|vinorelbine|mesh-list
64877190|NCT01884441|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64625258|NCT00001108|Stavudine|stavudine|mesh-list
64415197|NCT04389073|Immunologic Factors|immunologic factors|mesh-ancestor
64415198|NCT04389073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415199|NCT04389073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64625477|NCT02723162|Expectorants|expectorants|mesh-ancestor
64625690|NCT00380770|Antimetabolites|antimetabolites|mesh-ancestor
64877191|NCT01884441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64877192|NCT01884441|Antimetabolites|antimetabolites|mesh-ancestor
64877193|NCT01884441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877194|NCT01884441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64877195|NCT01884441|Antiviral Agents|antiviral agents|mesh-ancestor
64877196|NCT01884441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64877197|NCT01884441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877198|NCT01884441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64877199|NCT01884441|Immunologic Factors|immunologic factors|mesh-ancestor
64877200|NCT01884441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877201|NCT01884441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64877202|NCT01884441|Tubulin Modulators|tubulin modulators|mesh-ancestor
64877203|NCT01884441|Antimitotic Agents|antimitotic agents|mesh-ancestor
64877204|NCT01884441|Mitosis Modulators|mitosis modulators|mesh-ancestor
64877205|NCT01884441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64877206|NCT01884441|Alkylating Agents|alkylating agents|mesh-ancestor
64877207|NCT01884467|Gentamicins|gentamicins|mesh-list
64877208|NCT01884467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64877209|NCT01884467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64877210|NCT01884467|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64877211|NCT01884467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877218|NCT01884506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877220|NCT01884506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415252|NCT05524259|Inositol|inositol|mesh-list
64415253|NCT05524259|Hematinics|hematinics|mesh-ancestor
64415254|NCT05524259|Vitamins|vitamins|mesh-ancestor
64415274|NCT05257993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877221|NCT01884506|Protective Agents|protective agents|mesh-ancestor
64877222|NCT01884506|Vitamins|vitamins|mesh-ancestor
64877223|NCT01884558|Metformin|metformin|mesh-list
64877224|NCT01884558|Isavuconazole|isavuconazole|mesh-list
64877225|NCT01884558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64877226|NCT01884558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877227|NCT01884558|Antifungal Agents|antifungal agents|mesh-ancestor
64877228|NCT01884558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64877229|NCT01884623|Methotrexate|methotrexate|mesh-list
64877230|NCT01884623|Cetuximab|cetuximab|mesh-list
64877231|NCT01884623|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64877232|NCT01884623|Abortifacient Agents|abortifacient agents|mesh-ancestor
64877233|NCT01884623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64877234|NCT01884623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877235|NCT01884623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64877236|NCT01884623|Antimetabolites|antimetabolites|mesh-ancestor
64877237|NCT01884623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877238|NCT01884623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64877239|NCT01884623|Dermatologic Agents|dermatologic agents|mesh-ancestor
64877240|NCT01884623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877241|NCT01884623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64877242|NCT01884623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64877243|NCT01884623|Immunologic Factors|immunologic factors|mesh-ancestor
64877244|NCT01884623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64877245|NCT01884623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64877246|NCT01884623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64877247|NCT01884636|Isavuconazole|isavuconazole|mesh-list
64877248|NCT01884636|Methotrexate|methotrexate|mesh-list
64877249|NCT01884636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64415330|NCT03849625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64877250|NCT01884636|Abortifacient Agents|abortifacient agents|mesh-ancestor
64877251|NCT01884636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64877252|NCT01884636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877253|NCT01884636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64877254|NCT01884636|Antimetabolites|antimetabolites|mesh-ancestor
64877255|NCT01884636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877256|NCT01884636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64877257|NCT01884636|Dermatologic Agents|dermatologic agents|mesh-ancestor
64877258|NCT01884636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877259|NCT01884636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64877260|NCT01884636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64877261|NCT01884636|Immunologic Factors|immunologic factors|mesh-ancestor
64877262|NCT01884636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64877263|NCT01884636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64877264|NCT01884636|Antifungal Agents|antifungal agents|mesh-ancestor
64877265|NCT01884636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64877266|NCT01884857|Metoprolol|metoprolol|mesh-list
64877267|NCT01884857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64877268|NCT01884857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64877269|NCT01884857|Sympatholytics|sympatholytics|mesh-ancestor
64877270|NCT01884857|Autonomic Agents|autonomic agents|mesh-ancestor
64877271|NCT01884857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877272|NCT01884857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629765|NCT01059851|Suvorexant|suvorexant|mesh-list
64415363|NCT05526911|Anesthetics|anesthetics|mesh-ancestor
64415364|NCT05526911|GABA Modulators|gaba modulators|mesh-ancestor
64415366|NCT05526911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64415367|NCT05526911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415368|NCT05526911|Antiviral Agents|antiviral agents|mesh-ancestor
64415369|NCT05526911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64415370|NCT05526911|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64415371|NCT05526911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64415372|NCT05526911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64415373|NCT05526911|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64877273|NCT01884857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64877274|NCT01884857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64877275|NCT01884857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64877311|NCT01885013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64877312|NCT01885013|Immunologic Factors|immunologic factors|mesh-ancestor
64877313|NCT01885013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877314|NCT01885013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64877315|NCT01885013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64415413|NCT05231941|Sensory System Agents|sensory system agents|mesh-ancestor
64415414|NCT05231941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64415420|NCT05216575|Almitrine|almitrine|mesh-list
64877316|NCT01885013|Alkylating Agents|alkylating agents|mesh-ancestor
64877317|NCT01885013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877318|NCT01885013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64877319|NCT01885013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64877320|NCT01885013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64422396|NCT02365233|Insulin|insulin|mesh-list
64877321|NCT01885013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64877335|NCT01885338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64877337|NCT01885338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877338|NCT01885338|Protective Agents|protective agents|mesh-ancestor
64415535|NCT05100017|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64415537|NCT05100017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64877339|NCT01885338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877340|NCT01885338|Antidotes|antidotes|mesh-ancestor
64877341|NCT01885364|Remifentanil|remifentanil|mesh-list
64877342|NCT01885364|Propofol|propofol|mesh-list
64877343|NCT01885364|Esmolol|esmolol|mesh-list
64877344|NCT01885364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64877345|NCT01885364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64877346|NCT01885364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877347|NCT01885364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64877348|NCT01885364|Anesthetics, General|anesthetics, general|mesh-ancestor
64877349|NCT01885364|Anesthetics|anesthetics|mesh-ancestor
64877350|NCT01885364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64877351|NCT01885364|Narcotics|narcotics|mesh-ancestor
64877352|NCT01885364|Analgesics|analgesics|mesh-ancestor
64877389|NCT01885585|Protease Inhibitors|protease inhibitors|mesh-ancestor
64877390|NCT01885585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877391|NCT01885585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877392|NCT01885585|Anticoagulants|anticoagulants|mesh-ancestor
64877393|NCT01885598|Apixaban|apixaban|mesh-list
64877394|NCT01885598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64877395|NCT01885598|Antithrombins|antithrombins|mesh-ancestor
64877396|NCT01885598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64877397|NCT01885598|Protease Inhibitors|protease inhibitors|mesh-ancestor
64877398|NCT01885598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877399|NCT01885598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877400|NCT01885598|Anticoagulants|anticoagulants|mesh-ancestor
64877401|NCT01885715|Neostigmine|neostigmine|mesh-list
64877402|NCT01885715|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64877403|NCT01885715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877404|NCT01885715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632636|NCT00093782|Sirolimus|sirolimus|mesh-list
64877405|NCT01885715|Cholinergic Agents|cholinergic agents|mesh-ancestor
64877406|NCT01885715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64415631|NCT04869709|Respiratory System Agents|respiratory system agents|mesh-ancestor
64633071|NCT00014222|Epirubicin|epirubicin|mesh-list
64415632|NCT02612077|Bevacizumab|bevacizumab|mesh-list
64415633|NCT02612077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64415634|NCT02612077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415635|NCT02612077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64415636|NCT02612077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64415637|NCT02612077|Growth Substances|growth substances|mesh-ancestor
64415638|NCT02612077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415639|NCT02612077|Growth Inhibitors|growth inhibitors|mesh-ancestor
64415640|NCT04622735|Acetaminophen|acetaminophen|mesh-list
64415642|NCT04622735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64633378|NCT05776758|Cisplatin|cisplatin|mesh-list
64415643|NCT04622735|Analgesics|analgesics|mesh-ancestor
64415647|NCT04622735|Antipyretics|antipyretics|mesh-ancestor
64877407|NCT01885715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877408|NCT01885715|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64877409|NCT01885715|Autonomic Agents|autonomic agents|mesh-ancestor
64877410|NCT01885715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877411|NCT01885988|Nebivolol|nebivolol|mesh-list
64877413|NCT01885988|Vasodilator Agents|vasodilator agents|mesh-ancestor
64877414|NCT01885988|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64877415|NCT01885988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64877416|NCT01885988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64877417|NCT01885988|Adrenergic Agents|adrenergic agents|mesh-ancestor
64877424|NCT01886001|Povidone|povidone|mesh-list
64877435|NCT01886053|Ertapenem|ertapenem|mesh-list
64877436|NCT01886053|beta-Lactams|beta-lactams|mesh-list
64877437|NCT01886053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64877438|NCT01886053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64877439|NCT01886079|Dexmedetomidine|dexmedetomidine|mesh-list
64877440|NCT01886079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64877441|NCT01886079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64877442|NCT01886079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877443|NCT01886079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64877444|NCT01886079|Analgesics|analgesics|mesh-ancestor
64877445|NCT01886079|Sensory System Agents|sensory system agents|mesh-ancestor
64877446|NCT01886079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877447|NCT01886079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64877448|NCT01886079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64877449|NCT01886079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64877450|NCT01886079|Adrenergic Agents|adrenergic agents|mesh-ancestor
64877451|NCT01886079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64877452|NCT01886079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877453|NCT01886196|Ibuprofen|ibuprofen|mesh-list
64415654|NCT05531591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64415655|NCT05531591|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64415656|NCT05531591|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64415657|NCT05531591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64415658|NCT05531591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877454|NCT01886196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64877455|NCT01886196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64877456|NCT01886196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64877457|NCT01886196|Analgesics|analgesics|mesh-ancestor
64877458|NCT01886196|Sensory System Agents|sensory system agents|mesh-ancestor
64877459|NCT01886196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877460|NCT01886196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877484|NCT01886209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64877485|NCT01886209|Protective Agents|protective agents|mesh-ancestor
64877487|NCT01886248|Antithrombin III|antithrombin iii|mesh-list
64877488|NCT01886248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64877489|NCT01886248|Protease Inhibitors|protease inhibitors|mesh-ancestor
64877490|NCT01886248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877491|NCT01886248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877492|NCT01886248|Anticoagulants|anticoagulants|mesh-ancestor
64877493|NCT01886352|Levobupivacaine|levobupivacaine|mesh-list
64877494|NCT01886352|Anesthetics, Local|anesthetics, local|mesh-ancestor
64877495|NCT01886352|Anesthetics|anesthetics|mesh-ancestor
64877496|NCT01886352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64877497|NCT01886352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877498|NCT01886352|Sensory System Agents|sensory system agents|mesh-ancestor
64877499|NCT01886352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877500|NCT01886365|Insulin|insulin|mesh-list
64877501|NCT01886365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64877502|NCT01886365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877503|NCT01886404|Efavirenz|efavirenz|mesh-list
64877504|NCT01886404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64877505|NCT01886404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64877506|NCT01886404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877507|NCT01886404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635111|NCT00004216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64415694|NCT05048615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64415699|NCT05531435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64415715|NCT05519813|Metformin|metformin|mesh-list
64877508|NCT01886404|Antiviral Agents|antiviral agents|mesh-ancestor
64877509|NCT01886404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64877510|NCT01886404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64877511|NCT01886404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64877512|NCT01886404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64877513|NCT01886404|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64877514|NCT01886404|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64877515|NCT01886404|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64646078|NCT02998424|Propofol|propofol|mesh-list
64877516|NCT01886443|Tocopherols|tocopherols|mesh-list
64877517|NCT01886443|Vitamin E|vitamin e|mesh-list
64877518|NCT01886443|alpha-Tocopherol|alpha-tocopherol|mesh-list
64877519|NCT01886443|Infliximab|infliximab|mesh-list
64877520|NCT01886443|Epoprostenol|epoprostenol|mesh-list
64877521|NCT01886443|Tezosentan|tezosentan|mesh-list
64877522|NCT01886443|Melatonin|melatonin|mesh-list
64877523|NCT01886443|Antithrombins|antithrombins|mesh-list
64877524|NCT01886443|Antithrombin III|antithrombin iii|mesh-list
64877525|NCT01886443|Epoetin Alfa|epoetin alfa|mesh-list
64877526|NCT01886443|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64877527|NCT01886443|Antioxidants|antioxidants|mesh-ancestor
64877528|NCT01886443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877529|NCT01886443|Protective Agents|protective agents|mesh-ancestor
64877580|NCT01886664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64877581|NCT01886664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64877582|NCT01886664|Anesthetics, General|anesthetics, general|mesh-ancestor
64877584|NCT01886664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64877585|NCT01886664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877586|NCT01886768|Anesthetics|anesthetics|mesh-list
64877587|NCT01886768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64877588|NCT01886768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877589|NCT01887119|Eplerenone|eplerenone|mesh-list
64877590|NCT01887119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64877591|NCT01887119|Hormone Antagonists|hormone antagonists|mesh-ancestor
64877592|NCT01887119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64877593|NCT01887119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877594|NCT01887119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64877595|NCT01887119|Diuretics|diuretics|mesh-ancestor
64877596|NCT01887119|Natriuretic Agents|natriuretic agents|mesh-ancestor
64877597|NCT01887119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64877598|NCT01887158|Bisacodyl|bisacodyl|mesh-list
64877599|NCT01887158|Cathartics|cathartics|mesh-ancestor
64877600|NCT01887158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64877601|NCT01887158|Laxatives|laxatives|mesh-ancestor
64877602|NCT01887184|Dexmedetomidine|dexmedetomidine|mesh-list
64877603|NCT01887184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64877629|NCT01887223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877630|NCT01887223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877631|NCT01887223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64877632|NCT01887223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64877633|NCT01887223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64877635|NCT01887249|Clarithromycin|clarithromycin|mesh-list
64877636|NCT01887249|Esomeprazole|esomeprazole|mesh-list
64877637|NCT01887249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64877638|NCT01887249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64877639|NCT01887249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64877640|NCT01887249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64877641|NCT01887249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64877642|NCT01887249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64877643|NCT01887249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64877644|NCT01887249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877645|NCT01887249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877646|NCT01887249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64877647|NCT01887249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64877648|NCT01887249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64877649|NCT01887275|Interferons|interferons|mesh-list
64877650|NCT01887275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64877651|NCT01887275|Antiviral Agents|antiviral agents|mesh-ancestor
64877679|NCT01887405|Autonomic Agents|autonomic agents|mesh-ancestor
64877680|NCT01887405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877681|NCT01887405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64877682|NCT01887405|Respiratory System Agents|respiratory system agents|mesh-ancestor
64877683|NCT01887405|Mydriatics|mydriatics|mesh-ancestor
64877684|NCT01887405|Sympathomimetics|sympathomimetics|mesh-ancestor
64638052|NCT00145418|Docetaxel|docetaxel|mesh-list
64877685|NCT01887405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64877686|NCT01887457|Voriconazole|voriconazole|mesh-list
64415798|NCT04863079|Pembrolizumab|pembrolizumab|mesh-list
64638554|NCT01141049|Anticonvulsants|anticonvulsants|mesh-ancestor
64415799|NCT04863079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64638628|NCT00298610|Cholinergic Agents|cholinergic agents|mesh-ancestor
64415800|NCT04863079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415801|NCT05512325|Bevacizumab|bevacizumab|mesh-list
64415802|NCT05512325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64299695|NCT03295383|Cyclophosphamide|cyclophosphamide|mesh-list
64638781|NCT03886649|Venetoclax|venetoclax|mesh-list
64415803|NCT05512325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299697|NCT03295383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64877687|NCT01887457|Antifungal Agents|antifungal agents|mesh-ancestor
64877688|NCT01887457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64877689|NCT01887457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64877690|NCT01887457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64877691|NCT01887457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877692|NCT01887457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877693|NCT01887457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64877694|NCT01887457|Hormone Antagonists|hormone antagonists|mesh-ancestor
64877695|NCT01887457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64877696|NCT01887457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877697|NCT01887457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64877698|NCT01887561|Dasatinib|dasatinib|mesh-list
64877699|NCT01887561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64877700|NCT01887561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64877701|NCT01887561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877702|NCT01887561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877703|NCT01887613|Gabapentin|gabapentin|mesh-list
64415804|NCT05512325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64415813|NCT04868227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415814|NCT04868227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64415815|NCT04868227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64415816|NCT04863001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64415817|NCT03048019|Tirofiban|tirofiban|mesh-list
64415818|NCT03048019|Cangrelor|cangrelor|mesh-list
64415819|NCT03048019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64415820|NCT03048019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64639288|NCT01480219|Hormone Antagonists|hormone antagonists|mesh-ancestor
64877704|NCT01887613|Analgesics|analgesics|mesh-ancestor
64877705|NCT01887613|Sensory System Agents|sensory system agents|mesh-ancestor
64877706|NCT01887613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877707|NCT01887613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877718|NCT01887626|Ticagrelor|ticagrelor|mesh-list
64877721|NCT01887626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64877722|NCT01887626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64877723|NCT01887626|Purinergic Agents|purinergic agents|mesh-ancestor
64877724|NCT01887626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64877725|NCT01887626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877726|NCT01887626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877727|NCT01887691|Eszopiclone|eszopiclone|mesh-list
64877728|NCT01887691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64877729|NCT01887691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64877730|NCT01887691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877731|NCT01887704|Aspirin|aspirin|mesh-list
64877732|NCT01887704|Sirolimus|sirolimus|mesh-list
64877733|NCT01887704|Paclitaxel|paclitaxel|mesh-list
64877734|NCT01887704|Everolimus|everolimus|mesh-list
64877735|NCT01887704|Clopidogrel|clopidogrel|mesh-list
64877736|NCT01887704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64877737|NCT01887704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64877738|NCT01887704|Tubulin Modulators|tubulin modulators|mesh-ancestor
64877739|NCT01887704|Antimitotic Agents|antimitotic agents|mesh-ancestor
64877740|NCT01887704|Mitosis Modulators|mitosis modulators|mesh-ancestor
64415848|NCT04862845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641066|NCT05250050|Antacids|antacids|mesh-ancestor
64415849|NCT04862845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64641134|NCT04270994|Misoprostol|misoprostol|mesh-list
64415850|NCT04862845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64415851|NCT04862845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64415859|NCT04862377|Budesonide|budesonide|mesh-list
64877741|NCT01887704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877742|NCT01887704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64877743|NCT01887704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64877744|NCT01887704|Analgesics|analgesics|mesh-ancestor
64877745|NCT01887704|Sensory System Agents|sensory system agents|mesh-ancestor
64877746|NCT01887704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877747|NCT01887704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877748|NCT01887704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64877749|NCT01887704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64877755|NCT01887704|Antipyretics|antipyretics|mesh-ancestor
64877765|NCT01887704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64877766|NCT01887704|Antifungal Agents|antifungal agents|mesh-ancestor
64877767|NCT01887743|Pantoprazole|pantoprazole|mesh-list
64877768|NCT01887743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64877769|NCT01887743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64877770|NCT01887743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64877771|NCT01887743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877772|NCT01887743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877773|NCT01887795|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64877774|NCT01887795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64877775|NCT01887795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64877776|NCT01887795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877777|NCT01887795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877778|NCT01887821|Chloroquine|chloroquine|mesh-list
64877779|NCT01887821|Piperaquine|piperaquine|mesh-list
64877781|NCT01887821|Amebicides|amebicides|mesh-ancestor
64877782|NCT01887821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64877785|NCT01887821|Antimalarials|antimalarials|mesh-ancestor
64877823|NCT01888107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64877824|NCT01888107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64877825|NCT01888107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64877826|NCT01888107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64877827|NCT01888107|Dopamine Agents|dopamine agents|mesh-ancestor
64877828|NCT01888120|Ziconotide|ziconotide|mesh-list
64877829|NCT01888120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64877830|NCT01888120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64877831|NCT01888120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877832|NCT01888120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64877833|NCT01888120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877834|NCT01888120|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64877835|NCT01888120|Protective Agents|protective agents|mesh-ancestor
64877836|NCT01888120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64877837|NCT01888120|Analgesics|analgesics|mesh-ancestor
64877838|NCT01888120|Sensory System Agents|sensory system agents|mesh-ancestor
64877839|NCT01888120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877840|NCT01888224|Isotretinoin|isotretinoin|mesh-list
64877841|NCT01888224|Dermatologic Agents|dermatologic agents|mesh-ancestor
64877842|NCT01888250|Lamotrigine|lamotrigine|mesh-list
64877843|NCT01888250|Anticonvulsants|anticonvulsants|mesh-ancestor
64877844|NCT01888250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64415919|NCT05512013|Celecoxib|celecoxib|mesh-list
64415920|NCT05512013|Flurbiprofen|flurbiprofen|mesh-list
64877845|NCT01888250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64877846|NCT01888250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877847|NCT01888250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64877848|NCT01888250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877849|NCT01888250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64877850|NCT01888250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64877851|NCT01888250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64877866|NCT01888289|Isotretinoin|isotretinoin|mesh-list
64877867|NCT01888289|Dermatologic Agents|dermatologic agents|mesh-ancestor
64877868|NCT01888302|Gemcitabine|gemcitabine|mesh-list
64877869|NCT01888302|Sirolimus|sirolimus|mesh-list
64877870|NCT01888302|Cisplatin|cisplatin|mesh-list
64877871|NCT01888302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64877872|NCT01888302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64877873|NCT01888302|Antimetabolites|antimetabolites|mesh-ancestor
64877874|NCT01888302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422646|NCT01728259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64422647|NCT01728259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877875|NCT01888302|Antiviral Agents|antiviral agents|mesh-ancestor
64877876|NCT01888302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64877877|NCT01888302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877878|NCT01888302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64877879|NCT01888302|Immunologic Factors|immunologic factors|mesh-ancestor
64877880|NCT01888302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877881|NCT01888302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64877882|NCT01888302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64877883|NCT01888302|Antifungal Agents|antifungal agents|mesh-ancestor
64877884|NCT01888328|Isotretinoin|isotretinoin|mesh-list
64877885|NCT01888328|Dermatologic Agents|dermatologic agents|mesh-ancestor
64877886|NCT01888341|Isotretinoin|isotretinoin|mesh-list
64877887|NCT01888341|Dermatologic Agents|dermatologic agents|mesh-ancestor
64415992|NCT05514275|Capecitabine|capecitabine|mesh-list
64877888|NCT01888354|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64877889|NCT01888354|Hormones|hormones|mesh-ancestor
64877890|NCT01888354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64877891|NCT01888354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877892|NCT01888393|Ivacaftor|ivacaftor|mesh-list
64646449|NCT01235897|Paclitaxel|paclitaxel|mesh-list
64877893|NCT01888393|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64877913|NCT01888536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64877914|NCT01888536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64877915|NCT01888536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64877916|NCT01888536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64877917|NCT01888536|Vasodilator Agents|vasodilator agents|mesh-ancestor
64877918|NCT01888536|Urological Agents|urological agents|mesh-ancestor
64877919|NCT01888562|Ponatinib|ponatinib|mesh-list
64877920|NCT01888562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64877921|NCT01888562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64877922|NCT01888562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64877923|NCT01888562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877924|NCT01888575|Aspirin|aspirin|mesh-list
64877925|NCT01888575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64877926|NCT01888575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64877927|NCT01888575|Analgesics|analgesics|mesh-ancestor
64877928|NCT01888575|Sensory System Agents|sensory system agents|mesh-ancestor
64877929|NCT01888575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64877930|NCT01888575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877931|NCT01888575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64877932|NCT01888575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64877933|NCT01888575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64877934|NCT01888575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64877962|NCT01888744|Cetrorelix|cetrorelix|mesh-list
64646515|NCT01511042|Sympathomimetics|sympathomimetics|mesh-ancestor
64877964|NCT01888744|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64877965|NCT01888744|Ganirelix|ganirelix|mesh-list
64877966|NCT01888744|Progestins|progestins|mesh-ancestor
64877967|NCT01888744|Hormones|hormones|mesh-ancestor
64877968|NCT01888744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64877969|NCT01888744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877970|NCT01888744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64877971|NCT01888744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64877972|NCT01888744|Fertility Agents|fertility agents|mesh-ancestor
64877973|NCT01888744|Hormone Antagonists|hormone antagonists|mesh-ancestor
64877974|NCT01888757|Lamotrigine|lamotrigine|mesh-list
64877975|NCT01888757|Anticonvulsants|anticonvulsants|mesh-ancestor
64877976|NCT01888757|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64877977|NCT01888757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64877978|NCT01888757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64877979|NCT01888757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64877980|NCT01888757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64877981|NCT01888757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64877982|NCT01888757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64877983|NCT01888757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64877986|NCT01888796|Linagliptin|linagliptin|mesh-list
64416061|NCT05513729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416062|NCT05513729|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64878014|NCT01888835|Histamine Antagonists|histamine antagonists|mesh-ancestor
64878015|NCT01888835|Histamine Agents|histamine agents|mesh-ancestor
64878016|NCT01888835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64878017|NCT01888835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878018|NCT01888835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878019|NCT01888835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64878020|NCT01888835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64422761|NCT01660711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878021|NCT01888835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64878022|NCT01888835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64878023|NCT01888835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64878024|NCT01888835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64878025|NCT01888835|Adrenergic Agents|adrenergic agents|mesh-ancestor
64878026|NCT01888835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64878027|NCT01888835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64878028|NCT01888835|Serotonin Agents|serotonin agents|mesh-ancestor
64878029|NCT01888835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64878030|NCT01888861|Thioctic Acid|thioctic acid|mesh-list
64878031|NCT01888861|Antioxidants|antioxidants|mesh-ancestor
64878032|NCT01888861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878033|NCT01888861|Protective Agents|protective agents|mesh-ancestor
64878034|NCT01888861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878035|NCT01888861|Vitamin B Complex|vitamin b complex|mesh-ancestor
64878036|NCT01888861|Vitamins|vitamins|mesh-ancestor
64878037|NCT01888861|Micronutrients|micronutrients|mesh-ancestor
64878038|NCT01888978|Leucovorin|leucovorin|mesh-list
64878039|NCT01888978|Gemcitabine|gemcitabine|mesh-list
64878040|NCT01888978|Fluorouracil|fluorouracil|mesh-list
64878041|NCT01888978|Docetaxel|docetaxel|mesh-list
64878042|NCT01888978|Oxaliplatin|oxaliplatin|mesh-list
64878043|NCT01888978|Irinotecan|irinotecan|mesh-list
64878044|NCT01888978|Levoleucovorin|levoleucovorin|mesh-list
64878045|NCT01888978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64878062|NCT01888978|Vitamin B Complex|vitamin b complex|mesh-ancestor
64878063|NCT01888978|Vitamins|vitamins|mesh-ancestor
64878064|NCT01888978|Micronutrients|micronutrients|mesh-ancestor
64878065|NCT01889004|Dexmedetomidine|dexmedetomidine|mesh-list
64416079|NCT05504213|Hormone Antagonists|hormone antagonists|mesh-ancestor
64416080|NCT05504213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64878066|NCT01889004|Propofol|propofol|mesh-list
64878067|NCT01889004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64878068|NCT01889004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64878069|NCT01889004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878070|NCT01889004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64878071|NCT01889004|Anesthetics, General|anesthetics, general|mesh-ancestor
64878072|NCT01889004|Anesthetics|anesthetics|mesh-ancestor
64878073|NCT01889004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64878074|NCT01889004|Analgesics|analgesics|mesh-ancestor
64878075|NCT01889004|Sensory System Agents|sensory system agents|mesh-ancestor
64878076|NCT01889004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64878077|NCT01889004|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64878078|NCT01889004|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64878079|NCT01889004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64878080|NCT01889004|Adrenergic Agents|adrenergic agents|mesh-ancestor
64878081|NCT01889004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64878082|NCT01889004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878083|NCT01889056|Epoetin Alfa|epoetin alfa|mesh-list
64878084|NCT01889056|Hematinics|hematinics|mesh-ancestor
64878085|NCT01889095|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64878086|NCT01889095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64878087|NCT01889095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878088|NCT01889134|Alendronate|alendronate|mesh-list
64416138|NCT05502731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64647053|NCT02992340|Gemcitabine|gemcitabine|mesh-list
64416139|NCT05502731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64416140|NCT05510141|Nitrous Oxide|nitrous oxide|mesh-list
64416141|NCT05510141|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64878089|NCT01889134|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64878090|NCT01889134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878091|NCT01889173|Cyclobenzaprine|cyclobenzaprine|mesh-list
64878092|NCT01889173|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64878093|NCT01889173|Antidepressive Agents|antidepressive agents|mesh-ancestor
64878094|NCT01889173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64878095|NCT01889173|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64878096|NCT01889173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422763|NCT01660711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64422764|NCT01660711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422765|NCT01660711|Antidotes|antidotes|mesh-ancestor
64878097|NCT01889173|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64878098|NCT01889173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64878099|NCT01889173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64878100|NCT01889173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64878101|NCT01889212|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64878102|NCT01889212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878103|NCT01889212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64878104|NCT01889212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878105|NCT01889212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878106|NCT01889290|Methylnaltrexone|methylnaltrexone|mesh-list
64878107|NCT01889290|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64878108|NCT01889290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878109|NCT01889290|Sensory System Agents|sensory system agents|mesh-ancestor
64878110|NCT01889290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64878111|NCT01889368|Grape Seed Extract|grape seed extract|mesh-list
64646662|NCT02995304|Analgesics|analgesics|mesh-ancestor
64878112|NCT01889368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64878113|NCT01889368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878114|NCT01889368|Antioxidants|antioxidants|mesh-ancestor
64878116|NCT01889368|Protective Agents|protective agents|mesh-ancestor
64878141|NCT01889576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878142|NCT01889576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64878143|NCT01889680|Leucovorin|leucovorin|mesh-list
64878144|NCT01889680|Fluorouracil|fluorouracil|mesh-list
64878145|NCT01889680|Oxaliplatin|oxaliplatin|mesh-list
64878146|NCT01889680|Aflibercept|aflibercept|mesh-list
64878147|NCT01889680|Levoleucovorin|levoleucovorin|mesh-list
64878148|NCT01889680|Antimetabolites|antimetabolites|mesh-ancestor
64878149|NCT01889680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878150|NCT01889680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64878151|NCT01889680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878152|NCT01889680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64878153|NCT01889680|Immunologic Factors|immunologic factors|mesh-ancestor
64878154|NCT01889680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878155|NCT01889680|Antidotes|antidotes|mesh-ancestor
64878156|NCT01889680|Protective Agents|protective agents|mesh-ancestor
64878157|NCT01889680|Vitamin B Complex|vitamin b complex|mesh-ancestor
64878158|NCT01889680|Vitamins|vitamins|mesh-ancestor
64878159|NCT01889680|Micronutrients|micronutrients|mesh-ancestor
64878160|NCT01889680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64878161|NCT01889680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64878162|NCT01889680|Growth Substances|growth substances|mesh-ancestor
64878163|NCT01889680|Growth Inhibitors|growth inhibitors|mesh-ancestor
64878164|NCT01889758|Tacrolimus|tacrolimus|mesh-list
64878165|NCT01889758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64878166|NCT01889758|Immunologic Factors|immunologic factors|mesh-ancestor
64878167|NCT01889758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878168|NCT01889758|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64878169|NCT01889758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878170|NCT01889758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878171|NCT01889771|Nicotine|nicotine|mesh-list
64878172|NCT01889771|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64878173|NCT01889771|Autonomic Agents|autonomic agents|mesh-ancestor
64878174|NCT01889771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64878175|NCT01889771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416216|NCT04342039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64416217|NCT04338529|Cholecalciferol|cholecalciferol|mesh-list
64416218|NCT04338529|Calcium Carbonate|calcium carbonate|mesh-list
64416219|NCT04338529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64416220|NCT04338529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649388|NCT04699838|Etoposide|etoposide|mesh-list
64416222|NCT04338529|Micronutrients|micronutrients|mesh-ancestor
64650847|NCT01395329|BQ 788|bq 788|mesh-list
64878182|NCT01889810|Cholecalciferol|cholecalciferol|mesh-list
64878184|NCT01889810|Micronutrients|micronutrients|mesh-ancestor
64878185|NCT01889810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878186|NCT01889810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64878187|NCT01889810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64878188|NCT01889849|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64422826|NCT02543801|Sympatholytics|sympatholytics|mesh-ancestor
64422827|NCT02543801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64878189|NCT01889849|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64878190|NCT01889849|Antiviral Agents|antiviral agents|mesh-ancestor
64878191|NCT01889849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878192|NCT01889914|Insulin|insulin|mesh-list
64878193|NCT01889914|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64878194|NCT01889914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64878195|NCT01889914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878196|NCT01889966|Sildenafil Citrate|sildenafil citrate|mesh-list
64878197|NCT01889966|Vasodilator Agents|vasodilator agents|mesh-ancestor
64878198|NCT01889966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64878199|NCT01889966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64878200|NCT01889966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878201|NCT01889966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878202|NCT01889966|Urological Agents|urological agents|mesh-ancestor
64878203|NCT01889979|Tramadol|tramadol|mesh-list
64878204|NCT01889979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64878212|NCT01890538|Piracetam|piracetam|mesh-list
64878235|NCT01891292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878236|NCT01891292|Protective Agents|protective agents|mesh-ancestor
64878237|NCT01891292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878238|NCT01891292|Antidotes|antidotes|mesh-ancestor
64878239|NCT01891292|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64878240|NCT01891292|Protease Inhibitors|protease inhibitors|mesh-ancestor
64416281|NCT03041935|Glucocorticoids|glucocorticoids|mesh-ancestor
64416282|NCT03041935|Hormones|hormones|mesh-ancestor
64650934|NCT01512797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64651007|NCT00887510|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64878241|NCT01891292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878242|NCT01891292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64878243|NCT01891487|Bimatoprost|bimatoprost|mesh-list
64878244|NCT01891487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64878245|NCT01891981|Immunotoxin HA22|immunotoxin ha22|mesh-list
64878246|NCT01891981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878247|NCT01892319|Insulin Detemir|insulin detemir|mesh-list
64878248|NCT01892319|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64878249|NCT01892319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878250|NCT01893229|Oxcarbazepine|oxcarbazepine|mesh-list
64878251|NCT01893229|Valproic Acid|valproic acid|mesh-list
64878252|NCT01893229|Olanzapine|olanzapine|mesh-list
64878253|NCT01893229|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64878254|NCT01893229|Ziprasidone|ziprasidone|mesh-list
64878255|NCT01893229|Lithium Carbonate|lithium carbonate|mesh-list
64878256|NCT01893229|Antiemetics|antiemetics|mesh-ancestor
64878257|NCT01893229|Autonomic Agents|autonomic agents|mesh-ancestor
64878258|NCT01893229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64878259|NCT01893229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878260|NCT01893229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64878261|NCT01893229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64878262|NCT01893229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64878263|NCT01893229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64878264|NCT01893229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64878265|NCT01893229|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64878266|NCT01893229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64878267|NCT01893229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64945483|NCT05595603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878269|NCT01893229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64878275|NCT01893229|GABA Agents|gaba agents|mesh-ancestor
64878276|NCT01893229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64878277|NCT01893229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64878278|NCT01893229|Dopamine Agents|dopamine agents|mesh-ancestor
64878279|NCT01893229|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64878280|NCT01893229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64878281|NCT01893229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64878282|NCT01893229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64878283|NCT01894269|Lamivudine|lamivudine|mesh-list
64878284|NCT01894269|Entecavir|entecavir|mesh-list
64878285|NCT01894269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64878286|NCT01894269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64878287|NCT01894269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878288|NCT01894269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878289|NCT01894269|Antiviral Agents|antiviral agents|mesh-ancestor
64878290|NCT01894269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878291|NCT01894269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64878292|NCT01894269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64878293|NCT01894789|Clopidogrel|clopidogrel|mesh-list
64878294|NCT01894789|Ticagrelor|ticagrelor|mesh-list
64878332|NCT01895049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64422840|NCT02481635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878333|NCT01895049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878334|NCT01895049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64878335|NCT01895049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878336|NCT01895049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64878337|NCT01895049|Immunologic Factors|immunologic factors|mesh-ancestor
64878338|NCT01895049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64878339|NCT01895049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878340|NCT01895049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416371|NCT03042091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64416372|NCT03042091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64878341|NCT01895049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64878342|NCT01895049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64878343|NCT01895049|Antitubercular Agents|antitubercular agents|mesh-ancestor
64878344|NCT01895049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64878345|NCT01895049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878347|NCT01896622|Cobicistat|cobicistat|mesh-list
64878348|NCT01896622|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64878349|NCT01896622|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64878350|NCT01896622|Protease Inhibitors|protease inhibitors|mesh-ancestor
64878351|NCT01896622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878353|NCT01896622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64878382|NCT01897753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878384|NCT01898065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878385|NCT01898065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64878386|NCT01898065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64878387|NCT01898065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878388|NCT01898221|Ethanol|ethanol|mesh-list
64416436|NCT02612779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64654305|NCT02993705|Alkylating Agents|alkylating agents|mesh-ancestor
64416437|NCT02612779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654377|NCT01632215|Gabapentin|gabapentin|mesh-list
64416438|NCT02612779|Immunologic Factors|immunologic factors|mesh-ancestor
64416439|NCT02612779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64416440|NCT02612779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64416441|NCT02612779|Growth Substances|growth substances|mesh-ancestor
64416442|NCT02612779|Growth Inhibitors|growth inhibitors|mesh-ancestor
64416444|NCT04866355|Scopolamine|scopolamine|mesh-list
64416445|NCT04866355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64416446|NCT04866355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64416447|NCT04866355|Analgesics|analgesics|mesh-ancestor
64878389|NCT01898221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64878390|NCT01898221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878391|NCT01898221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64878392|NCT01898221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878393|NCT01898338|Daptomycin|daptomycin|mesh-list
64878394|NCT01898338|Fosfomycin|fosfomycin|mesh-list
64878395|NCT01898338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64878396|NCT01898338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878397|NCT01899105|Ivacaftor|ivacaftor|mesh-list
64878398|NCT01899105|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64878399|NCT01899105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64878400|NCT01899105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878401|NCT01900015|Efavirenz|efavirenz|mesh-list
64878402|NCT01900015|Raltegravir Potassium|raltegravir potassium|mesh-list
64878403|NCT01900015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64878404|NCT01900015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64878405|NCT01900015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878406|NCT01900015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878407|NCT01900015|Antiviral Agents|antiviral agents|mesh-ancestor
64878429|NCT01900028|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64878430|NCT01900028|Hormone Antagonists|hormone antagonists|mesh-ancestor
64878431|NCT01900028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64878432|NCT01900028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878433|NCT01900028|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64878434|NCT01900041|Minoxidil|minoxidil|mesh-list
64416486|NCT04856137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64416488|NCT04855279|Fluorides|fluorides|mesh-list
64416489|NCT04855279|Sodium Fluoride|sodium fluoride|mesh-list
64416490|NCT04855279|Glycerol|glycerol|mesh-list
64416491|NCT04855279|Cariostatic Agents|cariostatic agents|mesh-ancestor
64878435|NCT01900041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64878436|NCT01900041|Vasodilator Agents|vasodilator agents|mesh-ancestor
64878437|NCT01900093|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64878438|NCT01900093|Hormones|hormones|mesh-ancestor
64878439|NCT01900093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64878440|NCT01900093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878441|NCT01900106|Ritonavir|ritonavir|mesh-list
64878442|NCT01900106|Darunavir|darunavir|mesh-list
64878443|NCT01900106|Lamivudine|lamivudine|mesh-list
64878444|NCT01900106|Raltegravir Potassium|raltegravir potassium|mesh-list
64878445|NCT01900106|Abacavir|abacavir|mesh-list
64878464|NCT01900158|Cisplatin|cisplatin|mesh-list
64878487|NCT01900301|Cholinergic Agents|cholinergic agents|mesh-ancestor
64878488|NCT01900301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64416536|NCT04848181|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64416538|NCT04848181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64416539|NCT04847791|Lactoferrin|lactoferrin|mesh-list
64416540|NCT04847791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64416541|NCT04375813|Sirolimus|sirolimus|mesh-list
64657238|NCT01077596|Bupropion|bupropion|mesh-list
64416542|NCT04375813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64416543|NCT04375813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64416544|NCT04375813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64416545|NCT04375813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416546|NCT04375813|Antifungal Agents|antifungal agents|mesh-ancestor
64416547|NCT04375813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64416548|NCT04375813|Immunologic Factors|immunologic factors|mesh-ancestor
64416549|NCT04375813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416550|NCT04847245|Pregabalin|pregabalin|mesh-list
64416551|NCT04847245|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64416569|NCT04847245|Antidepressive Agents|antidepressive agents|mesh-ancestor
64416570|NCT04847245|Dopamine Agents|dopamine agents|mesh-ancestor
64416572|NCT04839913|Immunologic Factors|immunologic factors|mesh-ancestor
64416573|NCT04839913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416574|NCT04846621|Calcium Channel Blockers|calcium channel blockers|mesh-list
64657744|NCT02435901|Fludarabine|fludarabine|mesh-list
64878489|NCT01900301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878490|NCT01900301|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64878491|NCT01900301|Parasympatholytics|parasympatholytics|mesh-ancestor
64878492|NCT01900327|Gemcitabine|gemcitabine|mesh-list
64878493|NCT01900327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64878494|NCT01900327|Antimetabolites|antimetabolites|mesh-ancestor
64878495|NCT01900327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422843|NCT02481635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878496|NCT01900327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878498|NCT01900327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878499|NCT01900327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878500|NCT01900327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64878501|NCT01900327|Immunologic Factors|immunologic factors|mesh-ancestor
64878502|NCT01900327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878503|NCT01900405|Dexmedetomidine|dexmedetomidine|mesh-list
64878504|NCT01900405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64878505|NCT01900405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64878506|NCT01900405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878507|NCT01900405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64878508|NCT01900405|Analgesics|analgesics|mesh-ancestor
64878509|NCT01900405|Sensory System Agents|sensory system agents|mesh-ancestor
64878510|NCT01900405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64878511|NCT01900405|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64878512|NCT01900405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64878513|NCT01900405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64878514|NCT01900405|Adrenergic Agents|adrenergic agents|mesh-ancestor
64878533|NCT01900509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878534|NCT01900509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64878535|NCT01900509|Glucocorticoids|glucocorticoids|mesh-ancestor
64878536|NCT01900509|Hormones|hormones|mesh-ancestor
64878537|NCT01900509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64878538|NCT01900509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64878539|NCT01900509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878540|NCT01900509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64878541|NCT01900509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64878542|NCT01900509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64878543|NCT01900509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878544|NCT01900509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878545|NCT01900509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64878546|NCT01900509|Alkylating Agents|alkylating agents|mesh-ancestor
64878547|NCT01900509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64416652|NCT04838665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64416653|NCT04838665|Cholinergic Agents|cholinergic agents|mesh-ancestor
64416654|NCT04838665|Parasympatholytics|parasympatholytics|mesh-ancestor
64416656|NCT04845061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64416657|NCT04845061|Vasodilator Agents|vasodilator agents|mesh-ancestor
64659283|NCT02517021|Hormones|hormones|mesh-ancestor
64659476|NCT03904251|Cytarabine|cytarabine|mesh-list
64416658|NCT04845061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64660130|NCT01242644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416659|NCT04845061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64416660|NCT04845061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64660208|NCT03113487|Pembrolizumab|pembrolizumab|mesh-list
64416661|NCT04845061|Adrenergic Agents|adrenergic agents|mesh-ancestor
64660350|NCT01243112|Racepinephrine|racepinephrine|mesh-list
64660351|NCT01243112|Bupivacaine|bupivacaine|mesh-list
64660352|NCT01243112|Epinephryl borate|epinephryl borate|mesh-list
64660353|NCT01243112|Anesthetics, Local|anesthetics, local|mesh-ancestor
64660354|NCT01243112|Anesthetics|anesthetics|mesh-ancestor
64660355|NCT01243112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64660356|NCT01243112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660357|NCT01243112|Sensory System Agents|sensory system agents|mesh-ancestor
64660424|NCT01743677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416662|NCT04845061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64878548|NCT01900509|Antimetabolites|antimetabolites|mesh-ancestor
64878549|NCT01900587|Tapentadol|tapentadol|mesh-list
64878550|NCT01900587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64878551|NCT01900587|Narcotics|narcotics|mesh-ancestor
64878552|NCT01900587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64878553|NCT01900587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878554|NCT01900587|Analgesics|analgesics|mesh-ancestor
64878555|NCT01900587|Sensory System Agents|sensory system agents|mesh-ancestor
64878556|NCT01900587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64878557|NCT01900587|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64878558|NCT01900587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64878559|NCT01900587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64878560|NCT01900587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878561|NCT01900587|Adrenergic Agents|adrenergic agents|mesh-ancestor
64878562|NCT01900587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64878563|NCT01900639|Aspirin|aspirin|mesh-list
64878573|NCT01900639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64416707|NCT04142125|Anticoagulants|anticoagulants|mesh-ancestor
64416708|NCT04852315|Caffeine|caffeine|mesh-list
64661088|NCT01757561|Propofol|propofol|mesh-list
64386983|NCT02380313|Prednisone|prednisone|mesh-list
64416709|NCT04852315|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64416710|NCT04852315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416711|NCT04852315|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64416712|NCT04852315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416713|NCT04852315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661891|NCT01785095|Hormones|hormones|mesh-list
64416722|NCT03038425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416723|NCT03038425|Sensory System Agents|sensory system agents|mesh-ancestor
64661965|NCT01091831|Hormones|hormones|mesh-ancestor
64416724|NCT03038425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64416725|NCT04851769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
64416726|NCT04851769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64662036|NCT01267292|Buspirone|buspirone|mesh-list
64416727|NCT04851769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64416728|NCT04851769|Antimetabolites|antimetabolites|mesh-ancestor
64416729|NCT04851769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878574|NCT01900639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878575|NCT01900639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64878576|NCT01900639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64878577|NCT01900639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878578|NCT01900639|Antipyretics|antipyretics|mesh-ancestor
64878579|NCT01900717|Leucovorin|leucovorin|mesh-list
64878580|NCT01900717|Bevacizumab|bevacizumab|mesh-list
64878581|NCT01900717|Fluorouracil|fluorouracil|mesh-list
64878582|NCT01900717|Oxaliplatin|oxaliplatin|mesh-list
64878583|NCT01900717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64878584|NCT01900717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878585|NCT01900717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64878586|NCT01900717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64878587|NCT01900717|Growth Substances|growth substances|mesh-ancestor
64878588|NCT01900717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878589|NCT01900717|Growth Inhibitors|growth inhibitors|mesh-ancestor
64878590|NCT01900717|Antimetabolites|antimetabolites|mesh-ancestor
64878591|NCT01900717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878592|NCT01900717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64878593|NCT01900717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64878594|NCT01900717|Immunologic Factors|immunologic factors|mesh-ancestor
64878595|NCT01900717|Antidotes|antidotes|mesh-ancestor
64878596|NCT01900717|Protective Agents|protective agents|mesh-ancestor
64878597|NCT01900717|Vitamin B Complex|vitamin b complex|mesh-ancestor
64878598|NCT01900717|Vitamins|vitamins|mesh-ancestor
64878621|NCT01900847|Anesthetics|anesthetics|mesh-ancestor
64878622|NCT01900847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64878623|NCT01900847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64878624|NCT01900847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64416741|NCT04852081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416742|NCT04852081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416743|NCT04852081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64416744|NCT04852081|Hormone Antagonists|hormone antagonists|mesh-ancestor
64416745|NCT04852081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64878625|NCT01900847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64878626|NCT01900847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878627|NCT01900847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64878628|NCT01900847|Narcotics|narcotics|mesh-ancestor
64878629|NCT01900860|Vitamin D|vitamin d|mesh-list
64878630|NCT01900860|Ergocalciferols|ergocalciferols|mesh-list
64878631|NCT01900860|Cholecalciferol|cholecalciferol|mesh-list
64878632|NCT01900860|Vitamins|vitamins|mesh-list
64878633|NCT01900860|Micronutrients|micronutrients|mesh-ancestor
64878634|NCT01900860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878635|NCT01900860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64878636|NCT01900860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64878637|NCT01900886|Ribavirin|ribavirin|mesh-list
64878638|NCT01900886|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64878639|NCT01900886|Antimetabolites|antimetabolites|mesh-ancestor
64878640|NCT01900886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878641|NCT01900886|Antiviral Agents|antiviral agents|mesh-ancestor
64878642|NCT01900886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878643|NCT01900938|Midazolam|midazolam|mesh-list
64878644|NCT01900938|Propofol|propofol|mesh-list
64878645|NCT01900938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64878664|NCT01901003|Lorazepam|lorazepam|mesh-list
64416779|NCT04842487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64416790|NCT04842487|Glucocorticoids|glucocorticoids|mesh-ancestor
64416791|NCT04842487|Hormones|hormones|mesh-ancestor
64663709|NCT02651259|Vitamin B 6|vitamin b 6|mesh-list
64663711|NCT02651259|Isoniazid|isoniazid|mesh-list
64663784|NCT04338633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64416792|NCT04842487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64416793|NCT04842487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64416794|NCT04842487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64416795|NCT04842487|Tubulin Modulators|tubulin modulators|mesh-ancestor
64416796|NCT04842487|Antimitotic Agents|antimitotic agents|mesh-ancestor
64416797|NCT04842487|Mitosis Modulators|mitosis modulators|mesh-ancestor
64664242|NCT00914823|Hormones|hormones|mesh-list
64878672|NCT01901003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64878673|NCT01901003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64878674|NCT01901003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64878675|NCT01901003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64878676|NCT01901003|GABA Modulators|gaba modulators|mesh-ancestor
64878677|NCT01901003|GABA Agents|gaba agents|mesh-ancestor
64878678|NCT01901003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64878679|NCT01901003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878680|NCT01901120|Mirabegron|mirabegron|mesh-list
64878681|NCT01901120|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64878682|NCT01901120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64878683|NCT01901120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64878684|NCT01901120|Adrenergic Agents|adrenergic agents|mesh-ancestor
64878685|NCT01901120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64878686|NCT01901120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878687|NCT01901120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878688|NCT01901120|Urological Agents|urological agents|mesh-ancestor
64878689|NCT01901172|Posaconazole|posaconazole|mesh-list
64878690|NCT01901172|Antifungal Agents|antifungal agents|mesh-ancestor
64878691|NCT01901172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878692|NCT01901172|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64878693|NCT01901172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64878694|NCT01901172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64416820|NCT04842331|Protective Agents|protective agents|mesh-ancestor
64416821|NCT04837885|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64416822|NCT04837885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64878695|NCT01901172|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64878696|NCT01901172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64878697|NCT01901172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878698|NCT01901172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878716|NCT01901276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878718|NCT01901380|Chelating Agents|chelating agents|mesh-ancestor
64878719|NCT01901380|Sequestering Agents|sequestering agents|mesh-ancestor
64878720|NCT01901380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878721|NCT01901432|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
64878722|NCT01901432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64878723|NCT01901432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878724|NCT01901432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878725|NCT01901471|Cyclosporine|cyclosporine|mesh-list
64878726|NCT01901471|Cyclosporins|cyclosporins|mesh-list
64878727|NCT01901471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878728|NCT01901471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878729|NCT01901471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64878730|NCT01901471|Immunologic Factors|immunologic factors|mesh-ancestor
64878731|NCT01901471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878732|NCT01901471|Antifungal Agents|antifungal agents|mesh-ancestor
64878733|NCT01901471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64666341|NCT02802501|Primaquine|primaquine|mesh-list
64878734|NCT01901471|Dermatologic Agents|dermatologic agents|mesh-ancestor
64878770|NCT01901666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878771|NCT01901692|Sorafenib|sorafenib|mesh-list
64878772|NCT01901692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878773|NCT01901692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64878774|NCT01901692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878775|NCT01901692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878776|NCT01901861|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64878777|NCT01901861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64878778|NCT01901861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878779|NCT01901861|Incretins|incretins|mesh-ancestor
64878780|NCT01901861|Hormones|hormones|mesh-ancestor
64417039|NCT02408523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64417040|NCT02408523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417072|NCT04822909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417074|NCT04831099|Androgens|androgens|mesh-ancestor
64417075|NCT04831099|Hormones|hormones|mesh-ancestor
64417076|NCT04831099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64667357|NCT02860845|Clotrimazole|clotrimazole|mesh-list
64878781|NCT01901861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64878782|NCT01901861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64878783|NCT01901861|Protease Inhibitors|protease inhibitors|mesh-ancestor
64878784|NCT01901861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64878785|NCT01901861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878786|NCT01902017|Ketotifen|ketotifen|mesh-list
64878787|NCT01902017|Antipruritics|antipruritics|mesh-ancestor
64878788|NCT01902017|Dermatologic Agents|dermatologic agents|mesh-ancestor
64878789|NCT01902017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64878790|NCT01902017|Histamine Antagonists|histamine antagonists|mesh-ancestor
64878791|NCT01902017|Histamine Agents|histamine agents|mesh-ancestor
64878792|NCT01902017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64878793|NCT01902017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878794|NCT01902017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878795|NCT01902017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64878797|NCT01902108|Bupivacaine|bupivacaine|mesh-list
64878814|NCT01902121|Insulin|insulin|mesh-list
64878816|NCT01902121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64878817|NCT01902121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878818|NCT01902160|Sirolimus|sirolimus|mesh-list
64878819|NCT01902160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64878820|NCT01902160|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64878821|NCT01902160|Antibodies|antibodies|mesh-list
64878822|NCT01902160|Immunoglobulins|immunoglobulins|mesh-list
64878823|NCT01902160|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64878824|NCT01902160|Immunoconjugates|immunoconjugates|mesh-list
64878825|NCT01902160|Immunologic Factors|immunologic factors|mesh-ancestor
64878826|NCT01902160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878827|NCT01902160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878828|NCT01902160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64878829|NCT01902160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878830|NCT01902160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64878831|NCT01902160|Antifungal Agents|antifungal agents|mesh-ancestor
64878832|NCT01902160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64878833|NCT01902186|Ritonavir|ritonavir|mesh-list
64878834|NCT01902186|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64878835|NCT01902186|Tenofovir|tenofovir|mesh-list
64417176|NCT05617885|Fertility Agents|fertility agents|mesh-ancestor
64878836|NCT01902186|Emtricitabine|emtricitabine|mesh-list
64878837|NCT01902186|Raltegravir Potassium|raltegravir potassium|mesh-list
64878876|NCT01902446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64422870|NCT02362425|Expectorants|expectorants|mesh-ancestor
64878877|NCT01902446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878878|NCT01902446|Disinfectants|disinfectants|mesh-ancestor
64878899|NCT01902511|Epoetin Alfa|epoetin alfa|mesh-list
64878900|NCT01902511|Lenograstim|lenograstim|mesh-list
64878901|NCT01902511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64878902|NCT01902511|Immunologic Factors|immunologic factors|mesh-ancestor
64878903|NCT01902511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878904|NCT01902511|Hematinics|hematinics|mesh-ancestor
64878905|NCT01902524|Fentanyl|fentanyl|mesh-list
64878906|NCT01902524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64878907|NCT01902524|Narcotics|narcotics|mesh-ancestor
64878908|NCT01902524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64878909|NCT01902524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878910|NCT01902524|Analgesics|analgesics|mesh-ancestor
64878911|NCT01902524|Sensory System Agents|sensory system agents|mesh-ancestor
64878912|NCT01902524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64878913|NCT01902524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64878914|NCT01902524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64878915|NCT01902524|Anesthetics, General|anesthetics, general|mesh-ancestor
64878916|NCT01902524|Anesthetics|anesthetics|mesh-ancestor
64878917|NCT01902537|Prucalopride|prucalopride|mesh-list
64878918|NCT01902537|Laxatives|laxatives|mesh-ancestor
64878919|NCT01902537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64878920|NCT01902537|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64422873|NCT02362425|Antioxidants|antioxidants|mesh-ancestor
64878921|NCT01902537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64878941|NCT01902641|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64878942|NCT01902641|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64647483|NCT01271348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64878943|NCT01902641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64878944|NCT01902641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64878945|NCT01902641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878946|NCT01902641|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
64878947|NCT01902771|Imiquimod|imiquimod|mesh-list
64878948|NCT01902771|Vaccines|vaccines|mesh-list
64878949|NCT01902771|Immunologic Factors|immunologic factors|mesh-ancestor
64878950|NCT01902771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878951|NCT01902771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64878952|NCT01902771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619443|NCT03783130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64878953|NCT01902771|Interferon Inducers|interferon inducers|mesh-ancestor
64878954|NCT01902810|Propranolol|propranolol|mesh-list
64878955|NCT01902810|Metoprolol|metoprolol|mesh-list
64878956|NCT01902810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64878957|NCT01902810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64878958|NCT01902810|Adrenergic Agents|adrenergic agents|mesh-ancestor
64878959|NCT01902810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64878960|NCT01902810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878961|NCT01902810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64878962|NCT01902810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64878963|NCT01902810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64878964|NCT01902810|Vasodilator Agents|vasodilator agents|mesh-ancestor
64878965|NCT01902810|Sympatholytics|sympatholytics|mesh-ancestor
64878966|NCT01902810|Autonomic Agents|autonomic agents|mesh-ancestor
64878967|NCT01902810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64878968|NCT01902810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64878969|NCT01902862|Rituximab|rituximab|mesh-list
64878970|NCT01902862|Bortezomib|bortezomib|mesh-list
64878972|NCT01902862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878983|NCT01902875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64878984|NCT01903018|Cisplatin|cisplatin|mesh-list
64878985|NCT01903018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64878986|NCT01903057|Azithromycin|azithromycin|mesh-list
64878987|NCT01903057|Ivermectin|ivermectin|mesh-list
64878988|NCT01903057|Albendazole|albendazole|mesh-list
64878989|NCT01903057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64878990|NCT01903057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64878991|NCT01903057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64878992|NCT01903057|Anthelmintics|anthelmintics|mesh-ancestor
64878993|NCT01903057|Anticestodal Agents|anticestodal agents|mesh-ancestor
64878994|NCT01903057|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64878995|NCT01903057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64878996|NCT01903057|Tubulin Modulators|tubulin modulators|mesh-ancestor
64878997|NCT01903057|Antimitotic Agents|antimitotic agents|mesh-ancestor
64878998|NCT01903057|Mitosis Modulators|mitosis modulators|mesh-ancestor
64878999|NCT01903057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879000|NCT01903057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879001|NCT01903070|Linagliptin|linagliptin|mesh-list
64879002|NCT01903070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64879003|NCT01903070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879004|NCT01903070|Incretins|incretins|mesh-ancestor
64879005|NCT01903070|Hormones|hormones|mesh-ancestor
64879006|NCT01903070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64879007|NCT01903070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64879008|NCT01903070|Protease Inhibitors|protease inhibitors|mesh-ancestor
64879009|NCT01903070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879011|NCT01903083|Gemcitabine|gemcitabine|mesh-list
64879031|NCT01903109|Autonomic Agents|autonomic agents|mesh-ancestor
64879032|NCT01903109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64879033|NCT01903109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879034|NCT01903109|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64879035|NCT01903109|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64879036|NCT01903109|Cholinergic Agents|cholinergic agents|mesh-ancestor
64879037|NCT01903109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64879038|NCT01903109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879039|NCT01903122|Cevimeline|cevimeline|mesh-list
64879040|NCT01903122|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64879041|NCT01903122|Autonomic Agents|autonomic agents|mesh-ancestor
64422885|NCT02529995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64879042|NCT01903122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64879043|NCT01903122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879044|NCT01903122|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64879045|NCT01903122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64879046|NCT01903122|Cholinergic Agents|cholinergic agents|mesh-ancestor
64879047|NCT01903122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64879064|NCT01903681|Melatonin|melatonin|mesh-list
64879088|NCT01903785|Tocolytic Agents|tocolytic agents|mesh-ancestor
64879089|NCT01903785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64879090|NCT01903785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64879091|NCT01903785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64879092|NCT01903785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64879093|NCT01903785|Adrenergic Agents|adrenergic agents|mesh-ancestor
64647640|NCT01277744|Cisplatin|cisplatin|mesh-list
64879094|NCT01903785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64879095|NCT01903785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879097|NCT01903824|Donepezil|donepezil|mesh-list
64879098|NCT01903824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64879099|NCT01903824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879100|NCT01903824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879101|NCT01903824|Cholinergic Agents|cholinergic agents|mesh-ancestor
64879102|NCT01903824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64879103|NCT01903824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879104|NCT01903824|Nootropic Agents|nootropic agents|mesh-ancestor
64879105|NCT01903824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64879106|NCT01903824|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64879107|NCT01903824|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64879108|NCT01903824|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64879109|NCT01904045|Tacrolimus|tacrolimus|mesh-list
64879110|NCT01904045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64879111|NCT01904045|Immunologic Factors|immunologic factors|mesh-ancestor
64879112|NCT01904045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879113|NCT01904045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64879114|NCT01904045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879115|NCT01904045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879132|NCT01904110|Risedronic Acid|risedronic acid|mesh-list
64879133|NCT01904110|Etidronic Acid|etidronic acid|mesh-list
64879134|NCT01904110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64879135|NCT01904110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879136|NCT01904110|Vitamins|vitamins|mesh-ancestor
64879137|NCT01904110|Micronutrients|micronutrients|mesh-ancestor
64879138|NCT01904110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64619768|NCT00980330|Antiviral Agents|antiviral agents|mesh-ancestor
64879139|NCT01904110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64879140|NCT01904110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64879141|NCT01904110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879142|NCT01904162|Finafloxacin|finafloxacin|mesh-list
64879143|NCT01904162|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64879144|NCT01904162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879145|NCT01904162|Renal Agents|renal agents|mesh-ancestor
64879146|NCT01904162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64879147|NCT01904162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64879148|NCT01904162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64879149|NCT01904162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879150|NCT01904162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879151|NCT01904162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879152|NCT01904214|Siponimod|siponimod|mesh-list
64879158|NCT01904253|Topotecan|topotecan|mesh-list
64879186|NCT01904539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64879188|NCT01904591|Selenium|selenium|mesh-list
64879189|NCT01904591|Vitamins|vitamins|mesh-ancestor
64879190|NCT01904591|Micronutrients|micronutrients|mesh-ancestor
64879191|NCT01904591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879192|NCT01904591|Antioxidants|antioxidants|mesh-ancestor
64879193|NCT01904591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879194|NCT01904591|Protective Agents|protective agents|mesh-ancestor
64879195|NCT01904591|Trace Elements|trace elements|mesh-ancestor
64879252|NCT01904747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879253|NCT01904786|Melatonin|melatonin|mesh-list
64879254|NCT01904786|Antioxidants|antioxidants|mesh-ancestor
64879255|NCT01904786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879256|NCT01904786|Protective Agents|protective agents|mesh-ancestor
64879257|NCT01904786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879258|NCT01904786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64619824|NCT00987272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64879259|NCT01904981|Atenolol|atenolol|mesh-list
64879260|NCT01904981|Valsartan|valsartan|mesh-list
64879261|NCT01904981|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64879262|NCT01904981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64879263|NCT01904981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64879264|NCT01904981|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64879314|NCT01905150|Levoleucovorin|levoleucovorin|mesh-list
64879315|NCT01905150|Vitamins|vitamins|mesh-ancestor
64879316|NCT01905150|Micronutrients|micronutrients|mesh-ancestor
64879317|NCT01905150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879318|NCT01905150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64879320|NCT01905150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879321|NCT01905150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879322|NCT01905150|Antiviral Agents|antiviral agents|mesh-ancestor
64879323|NCT01905150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879324|NCT01905150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879325|NCT01905150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64879326|NCT01905150|Immunologic Factors|immunologic factors|mesh-ancestor
64879327|NCT01905150|Tubulin Modulators|tubulin modulators|mesh-ancestor
64879328|NCT01905150|Antimitotic Agents|antimitotic agents|mesh-ancestor
64879329|NCT01905150|Mitosis Modulators|mitosis modulators|mesh-ancestor
64879330|NCT01905150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64879331|NCT01905150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64879332|NCT01905150|Antidotes|antidotes|mesh-ancestor
64879333|NCT01905150|Protective Agents|protective agents|mesh-ancestor
64879334|NCT01905150|Vitamin B Complex|vitamin b complex|mesh-ancestor
64879335|NCT01905150|Antioxidants|antioxidants|mesh-ancestor
64879336|NCT01905150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64879337|NCT01905150|Alkylating Agents|alkylating agents|mesh-ancestor
64879338|NCT01905150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64879339|NCT01905215|Vaccines|vaccines|mesh-list
64879340|NCT01905215|Immunologic Factors|immunologic factors|mesh-ancestor
64879341|NCT01905215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879342|NCT01905371|Amphetamine|amphetamine|mesh-list
64879343|NCT01905371|Dextroamphetamine|dextroamphetamine|mesh-list
64879344|NCT01905371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64879345|NCT01905371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879346|NCT01905371|Sympathomimetics|sympathomimetics|mesh-ancestor
64879347|NCT01905371|Autonomic Agents|autonomic agents|mesh-ancestor
64879348|NCT01905371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64879349|NCT01905371|Dopamine Agents|dopamine agents|mesh-ancestor
64879350|NCT01905371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64879351|NCT01905371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344001|NCT03478423|Oxycodone|oxycodone|mesh-list
64879352|NCT01905371|Adrenergic Agents|adrenergic agents|mesh-ancestor
64879353|NCT01905371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64879354|NCT01905371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64619989|NCT01928888|Famotidine|famotidine|mesh-list
64879355|NCT01905371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64879356|NCT01905371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64879357|NCT01905501|Anesthetics|anesthetics|mesh-list
64879358|NCT01905501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64879359|NCT01905501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879360|NCT01905566|Clopidogrel|clopidogrel|mesh-list
64879361|NCT01905566|Ticagrelor|ticagrelor|mesh-list
64879362|NCT01905566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64879363|NCT01905566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64422920|NCT02291913|Hormone Antagonists|hormone antagonists|mesh-ancestor
64879368|NCT01905566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879369|NCT01905566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879370|NCT01905618|Nicotine|nicotine|mesh-list
64879371|NCT01905618|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64879372|NCT01905618|Autonomic Agents|autonomic agents|mesh-ancestor
64879373|NCT01905618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64879374|NCT01905618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879375|NCT01905618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64879376|NCT01905618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64879377|NCT01905618|Cholinergic Agents|cholinergic agents|mesh-ancestor
64879378|NCT01905618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64879379|NCT01905618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879380|NCT01905696|Acetylcysteine|acetylcysteine|mesh-list
64879381|NCT01905696|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64879382|NCT01905696|Antiviral Agents|antiviral agents|mesh-ancestor
64620025|NCT02984072|Menthol|menthol|mesh-list
64879383|NCT01905696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879384|NCT01905696|Expectorants|expectorants|mesh-ancestor
64879385|NCT01905696|Respiratory System Agents|respiratory system agents|mesh-ancestor
64879386|NCT01905696|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64879388|NCT01905696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879389|NCT01905696|Protective Agents|protective agents|mesh-ancestor
64879390|NCT01905696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879391|NCT01905696|Antidotes|antidotes|mesh-ancestor
64879392|NCT01905774|Deferasirox|deferasirox|mesh-list
64647934|NCT03806036|Vitamin D|vitamin d|mesh-list
64879393|NCT01905774|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64879394|NCT01905774|Chelating Agents|chelating agents|mesh-ancestor
64879395|NCT01905774|Sequestering Agents|sequestering agents|mesh-ancestor
64879396|NCT01905774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879397|NCT01905904|Sevoflurane|sevoflurane|mesh-list
64879398|NCT01905904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64879399|NCT01905904|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64879400|NCT01905904|Anesthetics, General|anesthetics, general|mesh-ancestor
64879401|NCT01905904|Anesthetics|anesthetics|mesh-ancestor
64879404|NCT01906073|Fentanyl|fentanyl|mesh-list
64879445|NCT01906411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64879446|NCT01906411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879447|NCT01906411|Protective Agents|protective agents|mesh-ancestor
64879449|NCT01906450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64879450|NCT01906450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879451|NCT01906528|Mivacurium|mivacurium|mesh-list
64879452|NCT01906528|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64879453|NCT01906528|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64879454|NCT01906528|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64879455|NCT01906528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64879456|NCT01906528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879457|NCT01906580|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64879458|NCT01906580|Entecavir|entecavir|mesh-list
64879459|NCT01906580|Antiviral Agents|antiviral agents|mesh-ancestor
64879460|NCT01906580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879461|NCT01906671|Mercaptopurine|mercaptopurine|mesh-list
64879462|NCT01906671|Antimetabolites|antimetabolites|mesh-ancestor
64879463|NCT01906671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879464|NCT01906671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64620057|NCT05506332|Antimetabolites|antimetabolites|mesh-ancestor
64879465|NCT01906671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879466|NCT01906671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64879467|NCT01906671|Immunologic Factors|immunologic factors|mesh-ancestor
64879468|NCT01906671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879469|NCT01906671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64879470|NCT01906671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879472|NCT01906749|Gout Suppressants|gout suppressants|mesh-ancestor
64879473|NCT01906749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64879474|NCT01906749|Tubulin Modulators|tubulin modulators|mesh-ancestor
64879475|NCT01906749|Antimitotic Agents|antimitotic agents|mesh-ancestor
64879476|NCT01906749|Mitosis Modulators|mitosis modulators|mesh-ancestor
64879477|NCT01906749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879478|NCT01906749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879479|NCT01906762|Acetaminophen|acetaminophen|mesh-list
64879486|NCT01906762|Sensory System Agents|sensory system agents|mesh-ancestor
64879487|NCT01906762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64879488|NCT01906762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64879489|NCT01906762|Antipyretics|antipyretics|mesh-ancestor
64879490|NCT01906788|Lumefantrine|lumefantrine|mesh-list
64879491|NCT01906788|Artemether|artemether|mesh-list
64879492|NCT01906788|Primaquine|primaquine|mesh-list
64879493|NCT01906788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64879494|NCT01906788|Antimalarials|antimalarials|mesh-ancestor
64879495|NCT01906788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64879496|NCT01906788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64879497|NCT01906788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879498|NCT01906801|Diacetylrhein|diacetylrhein|mesh-list
64879499|NCT01906801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64879500|NCT01906814|Carboplatin|carboplatin|mesh-list
64879501|NCT01906814|Etoposide|etoposide|mesh-list
64879502|NCT01906814|Etoposide phosphate|etoposide phosphate|mesh-list
64879503|NCT01906814|Vincristine|vincristine|mesh-list
64879504|NCT01906814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879505|NCT01906814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64879506|NCT01906814|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64879507|NCT01906814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64879543|NCT01907061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879544|NCT01907061|Expectorants|expectorants|mesh-ancestor
64879545|NCT01907061|Respiratory System Agents|respiratory system agents|mesh-ancestor
64879546|NCT01907061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64879547|NCT01907061|Antioxidants|antioxidants|mesh-ancestor
64879548|NCT01907061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879550|NCT01907061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879551|NCT01907061|Antidotes|antidotes|mesh-ancestor
64879552|NCT01907074|Cholic Acids|cholic acids|mesh-list
64879553|NCT01907074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64879554|NCT01907165|Copper|copper|mesh-list
64879555|NCT01907165|Temozolomide|temozolomide|mesh-list
64879556|NCT01907165|Disulfiram|disulfiram|mesh-list
64879557|NCT01907165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64879558|NCT01907165|Alkylating Agents|alkylating agents|mesh-ancestor
64879559|NCT01907165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879604|NCT01907308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879605|NCT01907308|Growth Inhibitors|growth inhibitors|mesh-ancestor
64879606|NCT01907373|Probenecid|probenecid|mesh-list
64879607|NCT01907373|Olmesartan|olmesartan|mesh-list
64879608|NCT01907373|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64879609|NCT01907373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64879610|NCT01907373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64879611|NCT01907373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64879612|NCT01907373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879613|NCT01907373|Uricosuric Agents|uricosuric agents|mesh-ancestor
64879614|NCT01907373|Gout Suppressants|gout suppressants|mesh-ancestor
64879615|NCT01907373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64879616|NCT01907373|Renal Agents|renal agents|mesh-ancestor
64879617|NCT01907529|Cyclophosphamide|cyclophosphamide|mesh-list
64879618|NCT01907529|Docetaxel|docetaxel|mesh-list
64879619|NCT01907529|Epirubicin|epirubicin|mesh-list
64879620|NCT01907529|Endostar protein|endostar protein|mesh-list
64879621|NCT01907529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64879622|NCT01907529|Immunologic Factors|immunologic factors|mesh-ancestor
64879623|NCT01907529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879661|NCT01907633|Autonomic Agents|autonomic agents|mesh-ancestor
64879662|NCT01907633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64879663|NCT01907633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879664|NCT01907633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64879665|NCT01907633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64879666|NCT01907633|Dopamine Agents|dopamine agents|mesh-ancestor
64879667|NCT01907633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64879668|NCT01907633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879670|NCT01907685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879672|NCT01907685|Antimitotic Agents|antimitotic agents|mesh-ancestor
64879673|NCT01907685|Mitosis Modulators|mitosis modulators|mesh-ancestor
64879674|NCT01907685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879675|NCT01907724|Simeprevir|simeprevir|mesh-list
64879676|NCT01907724|Antiviral Agents|antiviral agents|mesh-ancestor
64879677|NCT01907724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879681|NCT01907776|Arbekacin|arbekacin|mesh-list
64879719|NCT01907984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64879720|NCT01907984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64879721|NCT01907984|Analgesics|analgesics|mesh-ancestor
64879722|NCT01907984|Sensory System Agents|sensory system agents|mesh-ancestor
64879723|NCT01907984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64879724|NCT01907984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64879725|NCT01907984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64879726|NCT01907984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64879727|NCT01907984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879728|NCT01907997|Lidocaine|lidocaine|mesh-list
64879729|NCT01907997|Anesthetics, Local|anesthetics, local|mesh-ancestor
64879730|NCT01907997|Anesthetics|anesthetics|mesh-ancestor
64879731|NCT01907997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64879732|NCT01907997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879733|NCT01907997|Sensory System Agents|sensory system agents|mesh-ancestor
64879734|NCT01907997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64879735|NCT01907997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64879736|NCT01907997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64879737|NCT01907997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64879738|NCT01907997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64879739|NCT01907997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879740|NCT01908075|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64879741|NCT01908075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64879742|NCT01908075|Autonomic Agents|autonomic agents|mesh-ancestor
64879743|NCT01908075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64879744|NCT01908075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879745|NCT01908075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64879746|NCT01908075|Respiratory System Agents|respiratory system agents|mesh-ancestor
64879747|NCT01908075|Glucocorticoids|glucocorticoids|mesh-ancestor
64879748|NCT01908075|Hormones|hormones|mesh-ancestor
64879749|NCT01908075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64879760|NCT01908257|Histamine Antagonists|histamine antagonists|mesh-ancestor
64879761|NCT01908257|Histamine Agents|histamine agents|mesh-ancestor
64879762|NCT01908257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64879763|NCT01908257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879764|NCT01908257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879765|NCT01908257|Gout Suppressants|gout suppressants|mesh-ancestor
64879766|NCT01908257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64345489|NCT03840148|Meropenem|meropenem|mesh-list
64879767|NCT01908257|Uricosuric Agents|uricosuric agents|mesh-ancestor
64879768|NCT01908257|Renal Agents|renal agents|mesh-ancestor
64879769|NCT01908283|Vaccines|vaccines|mesh-list
64879770|NCT01908283|Immunologic Factors|immunologic factors|mesh-ancestor
64879771|NCT01908283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879772|NCT01908296|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64879773|NCT01908296|Fluvoxamine|fluvoxamine|mesh-list
64879774|NCT01908296|Antidepressive Agents|antidepressive agents|mesh-ancestor
64879775|NCT01908296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64879776|NCT01908296|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64879777|NCT01908296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64879778|NCT01908296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64879779|NCT01908296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879780|NCT01908296|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64879781|NCT01908296|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64879787|NCT01908296|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64879788|NCT01908296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64879789|NCT01908296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64879790|NCT01908296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879791|NCT01908296|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64879793|NCT01908322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879794|NCT01908322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64879796|NCT01908322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879797|NCT01908335|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64879798|NCT01908335|Interferon-alpha|interferon-alpha|mesh-list
64879799|NCT01908335|Antiviral Agents|antiviral agents|mesh-ancestor
64879800|NCT01908335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879801|NCT01908335|Immunologic Factors|immunologic factors|mesh-ancestor
64879802|NCT01908335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879803|NCT01908348|Erythritol|erythritol|mesh-list
64879804|NCT01908348|Vasodilator Agents|vasodilator agents|mesh-ancestor
64879805|NCT01908387|Azacitidine|azacitidine|mesh-list
64879806|NCT01908387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64879807|NCT01908387|Antimetabolites|antimetabolites|mesh-ancestor
64879808|NCT01908387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879809|NCT01908387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879810|NCT01908387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879811|NCT01908452|Pyridoxine|pyridoxine|mesh-list
64879812|NCT01908452|Vitamin B Complex|vitamin b complex|mesh-ancestor
64879813|NCT01908452|Vitamins|vitamins|mesh-ancestor
64879814|NCT01908452|Micronutrients|micronutrients|mesh-ancestor
64879815|NCT01908452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879816|NCT01908478|Gemcitabine|gemcitabine|mesh-list
64879817|NCT01908478|Veliparib|veliparib|mesh-list
64879818|NCT01908478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64879819|NCT01908478|Antimetabolites|antimetabolites|mesh-ancestor
64879820|NCT01908478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879821|NCT01908478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879822|NCT01908478|Antiviral Agents|antiviral agents|mesh-ancestor
64879823|NCT01908478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879824|NCT01908478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879825|NCT01908478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64879826|NCT01908478|Immunologic Factors|immunologic factors|mesh-ancestor
64879827|NCT01908478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879828|NCT01908478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64879829|NCT01908556|Letrozole|letrozole|mesh-list
64344476|NCT00004907|Cyclophosphamide|cyclophosphamide|mesh-list
64879831|NCT01908556|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64879832|NCT01908556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64879833|NCT01908556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879834|NCT01908556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879835|NCT01908556|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64879836|NCT01908556|Hormone Antagonists|hormone antagonists|mesh-ancestor
64879837|NCT01908556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64879838|NCT01908556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879839|NCT01908621|Cytarabine|cytarabine|mesh-list
64879840|NCT01908621|Lenograstim|lenograstim|mesh-list
64879841|NCT01908621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64879842|NCT01908621|Immunologic Factors|immunologic factors|mesh-ancestor
64879843|NCT01908621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879844|NCT01908621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64879845|NCT01908621|Antimetabolites|antimetabolites|mesh-ancestor
64879846|NCT01908621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879847|NCT01908621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879848|NCT01908621|Antiviral Agents|antiviral agents|mesh-ancestor
64879849|NCT01908621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879850|NCT01908621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64879853|NCT01908660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879854|NCT01908894|Insulin Lispro|insulin lispro|mesh-list
64879855|NCT01908894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64879856|NCT01908894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879857|NCT01909037|Curcumin|curcumin|mesh-list
64879858|NCT01909037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64879859|NCT01909037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64879860|NCT01909037|Analgesics|analgesics|mesh-ancestor
64879861|NCT01909037|Sensory System Agents|sensory system agents|mesh-ancestor
64879862|NCT01909037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64879870|NCT01909063|Ergocalciferols|ergocalciferols|mesh-list
64879871|NCT01909063|Cholecalciferol|cholecalciferol|mesh-list
64879872|NCT01909063|Vitamins|vitamins|mesh-list
64879873|NCT01909063|Vitamin E|vitamin e|mesh-list
64879874|NCT01909063|Vitamin A|vitamin a|mesh-list
64879875|NCT01909063|Micronutrients|micronutrients|mesh-ancestor
64879876|NCT01909063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879877|NCT01909063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64879878|NCT01909063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64879879|NCT01909063|Antioxidants|antioxidants|mesh-ancestor
64879880|NCT01909063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879881|NCT01909063|Protective Agents|protective agents|mesh-ancestor
64879882|NCT01909115|Vitamin D|vitamin d|mesh-list
64879883|NCT01909115|Ergocalciferols|ergocalciferols|mesh-list
64879884|NCT01909115|Cholecalciferol|cholecalciferol|mesh-list
64879885|NCT01909115|Vitamins|vitamins|mesh-list
64879886|NCT01909115|Micronutrients|micronutrients|mesh-ancestor
64879887|NCT01909115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879888|NCT01909115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64879889|NCT01909115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64879890|NCT01909219|Picosulfate sodium|picosulfate sodium|mesh-list
64879891|NCT01909219|Magnesium citrate|magnesium citrate|mesh-list
64879892|NCT01909219|Cathartics|cathartics|mesh-ancestor
64879893|NCT01909219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64879894|NCT01909557|Acetylcarnitine|acetylcarnitine|mesh-list
64879895|NCT01909557|Vitamin B Complex|vitamin b complex|mesh-ancestor
64879896|NCT01909557|Vitamins|vitamins|mesh-ancestor
64879897|NCT01909557|Micronutrients|micronutrients|mesh-ancestor
64879898|NCT01909557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879899|NCT01909557|Nootropic Agents|nootropic agents|mesh-ancestor
64879900|NCT01909622|Vitamin D|vitamin d|mesh-list
64879901|NCT01909622|Ergocalciferols|ergocalciferols|mesh-list
64879902|NCT01909622|Cholecalciferol|cholecalciferol|mesh-list
64879903|NCT01909622|Vitamins|vitamins|mesh-list
64879916|NCT01909752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879917|NCT01909752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64879918|NCT01909752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64879919|NCT01909752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64879920|NCT01909752|Alkylating Agents|alkylating agents|mesh-ancestor
64879921|NCT01909752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879922|NCT01909752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879923|NCT01909752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64879924|NCT01909752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64879925|NCT01909752|Interferon Inducers|interferon inducers|mesh-ancestor
64879926|NCT01909830|Gemcitabine|gemcitabine|mesh-list
64879927|NCT01909830|Pemetrexed|pemetrexed|mesh-list
64879928|NCT01909830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64879929|NCT01909830|Antimetabolites|antimetabolites|mesh-ancestor
64879930|NCT01909830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879931|NCT01909830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64879932|NCT01909830|Antiviral Agents|antiviral agents|mesh-ancestor
64879933|NCT01909830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64879934|NCT01909830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879935|NCT01909830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64879936|NCT01909830|Immunologic Factors|immunologic factors|mesh-ancestor
64879937|NCT01909830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879968|NCT01910077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879969|NCT01910090|Flurbiprofen|flurbiprofen|mesh-list
64879970|NCT01910090|Famotidine|famotidine|mesh-list
64879971|NCT01910090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64879972|NCT01910090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64879973|NCT01910090|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64879974|NCT01910090|Histamine Antagonists|histamine antagonists|mesh-ancestor
64879975|NCT01910090|Histamine Agents|histamine agents|mesh-ancestor
64879976|NCT01910090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64879977|NCT01910090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879978|NCT01910090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879980|NCT01910090|Sensory System Agents|sensory system agents|mesh-ancestor
64879981|NCT01910090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64879982|NCT01910090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64879983|NCT01910090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64879984|NCT01910090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64879985|NCT01910090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64879986|NCT01910090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64879987|NCT01910090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64879988|NCT01910142|Vitamin K|vitamin k|mesh-list
64879989|NCT01910142|Calcium|calcium|mesh-list
64879990|NCT01910142|Vitamins|vitamins|mesh-ancestor
64879991|NCT01910142|Micronutrients|micronutrients|mesh-ancestor
64879992|NCT01910142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64879993|NCT01910142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64879994|NCT01910142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64879995|NCT01910142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64879996|NCT01910142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64879997|NCT01910142|Hemostatics|hemostatics|mesh-ancestor
64879998|NCT01910142|Coagulants|coagulants|mesh-ancestor
64880011|NCT01910155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880012|NCT01910155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64880013|NCT01910155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64880014|NCT01910155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64880015|NCT01910155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64880016|NCT01910155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880017|NCT01910155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880018|NCT01910155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64880019|NCT01910155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64880020|NCT01910194|Insulin Glargine|insulin glargine|mesh-list
64880021|NCT01910194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64880022|NCT01910194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880024|NCT01910246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64880025|NCT01910246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880026|NCT01910259|Amiloride|amiloride|mesh-list
64880027|NCT01910259|Riluzole|riluzole|mesh-list
64880028|NCT01910259|Fluoxetine|fluoxetine|mesh-list
64880029|NCT01910259|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64880030|NCT01910259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64880031|NCT01910259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64880032|NCT01910259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880033|NCT01910259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64880034|NCT01910259|Serotonin Agents|serotonin agents|mesh-ancestor
64880035|NCT01910259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880036|NCT01910259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64880037|NCT01910259|Antidepressive Agents|antidepressive agents|mesh-ancestor
64880038|NCT01910259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64880039|NCT01910259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64880040|NCT01910259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64880052|NCT01910259|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64880054|NCT01910285|Dsuvia|dsuvia|mesh-list
64880055|NCT01910285|Remifentanil|remifentanil|mesh-list
64880056|NCT01910285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64880057|NCT01910285|Narcotics|narcotics|mesh-ancestor
64880058|NCT01910285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64880059|NCT01910285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880060|NCT01910285|Analgesics|analgesics|mesh-ancestor
64880061|NCT01910285|Sensory System Agents|sensory system agents|mesh-ancestor
64880062|NCT01910285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64880063|NCT01910285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64880064|NCT01910285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64880065|NCT01910285|Anesthetics, General|anesthetics, general|mesh-ancestor
64880066|NCT01910285|Anesthetics|anesthetics|mesh-ancestor
64880067|NCT01910363|Botulinum Toxins|botulinum toxins|mesh-list
64880068|NCT01910363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64880070|NCT01910363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64880071|NCT01910363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64880072|NCT01910363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880073|NCT01910363|Cholinergic Agents|cholinergic agents|mesh-ancestor
64880105|NCT01910480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880106|NCT01910480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64880107|NCT01910480|Hormone Antagonists|hormone antagonists|mesh-ancestor
64880108|NCT01910480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64880109|NCT01910480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880110|NCT01910480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64880111|NCT01910506|Verinurad|verinurad|mesh-list
64880112|NCT01910506|Gout Suppressants|gout suppressants|mesh-ancestor
64880113|NCT01910506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64880114|NCT01910532|Clevidipine|clevidipine|mesh-list
64880115|NCT01910532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64880116|NCT01910532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64880117|NCT01910532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880118|NCT01910532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64880119|NCT01910532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880120|NCT01910545|OTS167|ots167|mesh-list
64880121|NCT01910545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64880122|NCT01910545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880123|NCT01910545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880124|NCT01910610|Bevacizumab|bevacizumab|mesh-list
64880125|NCT01910610|Cetuximab|cetuximab|mesh-list
64880126|NCT01910610|Panitumumab|panitumumab|mesh-list
64880127|NCT01910610|Irinotecan|irinotecan|mesh-list
64880128|NCT01910610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64880129|NCT01910610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880130|NCT01910610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64880131|NCT01910610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64880132|NCT01910610|Growth Substances|growth substances|mesh-ancestor
64880149|NCT01910766|Fertility Agents|fertility agents|mesh-ancestor
64880150|NCT01910766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64880151|NCT01910766|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64880152|NCT01910766|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64880153|NCT01910766|Micronutrients|micronutrients|mesh-ancestor
64880154|NCT01910766|Vitamins|vitamins|mesh-ancestor
64880155|NCT01910844|Cyclophosphamide|cyclophosphamide|mesh-list
64880156|NCT01910844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64880157|NCT01910844|Immunologic Factors|immunologic factors|mesh-ancestor
64880158|NCT01910844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880159|NCT01910844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64880160|NCT01910844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64880161|NCT01910844|Alkylating Agents|alkylating agents|mesh-ancestor
64880162|NCT01910844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880163|NCT01910844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880164|NCT01910844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64880165|NCT01910870|Cyclophosphamide|cyclophosphamide|mesh-list
64880166|NCT01910870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64880167|NCT01910870|Immunologic Factors|immunologic factors|mesh-ancestor
64880168|NCT01910870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880169|NCT01910870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64880202|NCT01910987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880203|NCT01910987|Protease Inhibitors|protease inhibitors|mesh-ancestor
64880204|NCT01910987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880205|NCT01910987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880206|NCT01911195|Isoflurane|isoflurane|mesh-list
64880207|NCT01911195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64880208|NCT01911195|Anesthetics, General|anesthetics, general|mesh-ancestor
64880209|NCT01911195|Anesthetics|anesthetics|mesh-ancestor
64880210|NCT01911195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64880211|NCT01911195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880212|NCT01911234|Freund's Adjuvant|freund's adjuvant|mesh-list
64880213|NCT01911234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64880214|NCT01911234|Immunologic Factors|immunologic factors|mesh-ancestor
64880215|NCT01911234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880216|NCT01911247|Metformin|metformin|mesh-list
64880217|NCT01911247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64880218|NCT01911247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880219|NCT01911299|Choline|choline|mesh-list
64880220|NCT01911299|Glycerol|glycerol|mesh-list
64880221|NCT01911299|Lipotropic Agents|lipotropic agents|mesh-ancestor
64880222|NCT01911299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64880223|NCT01911299|Antimetabolites|antimetabolites|mesh-ancestor
64880224|NCT01911299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880225|NCT01911299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64880226|NCT01911299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64880227|NCT01911299|Nootropic Agents|nootropic agents|mesh-ancestor
64880228|NCT01911299|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64880229|NCT01911299|Protective Agents|protective agents|mesh-ancestor
64880230|NCT01911299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880231|NCT01911325|Docetaxel|docetaxel|mesh-list
64880232|NCT01911325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880233|NCT01911325|Tubulin Modulators|tubulin modulators|mesh-ancestor
64880234|NCT01911325|Antimitotic Agents|antimitotic agents|mesh-ancestor
64880235|NCT01911325|Mitosis Modulators|mitosis modulators|mesh-ancestor
64880236|NCT01911325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880237|NCT01911364|Tiotropium Bromide|tiotropium bromide|mesh-list
64880238|NCT01911364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64880239|NCT01911364|Autonomic Agents|autonomic agents|mesh-ancestor
64880240|NCT01911364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64880241|NCT01911364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880242|NCT01911364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64880243|NCT01911364|Respiratory System Agents|respiratory system agents|mesh-ancestor
64880244|NCT01911364|Parasympatholytics|parasympatholytics|mesh-ancestor
64880245|NCT01911364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64880246|NCT01911364|Cholinergic Agents|cholinergic agents|mesh-ancestor
64880247|NCT01911364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64880248|NCT01911364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880249|NCT01911377|Botulinum Toxins|botulinum toxins|mesh-list
64880250|NCT01911377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64880251|NCT01911377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64880252|NCT01911377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64880253|NCT01911377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64880254|NCT01911377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880255|NCT01911377|Cholinergic Agents|cholinergic agents|mesh-ancestor
64620356|NCT03017963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64880256|NCT01911377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64880257|NCT01911377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880258|NCT01911377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64880259|NCT01911377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64880260|NCT01911455|Acamprosate|acamprosate|mesh-list
64880261|NCT01911455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64880262|NCT01911468|Metformin|metformin|mesh-list
64880263|NCT01911468|Liraglutide|liraglutide|mesh-list
64880264|NCT01911468|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64880265|NCT01911468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64880266|NCT01911468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880267|NCT01911468|Incretins|incretins|mesh-ancestor
64880268|NCT01911468|Hormones|hormones|mesh-ancestor
64880269|NCT01911468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64880270|NCT01911494|Magnesium Sulfate|magnesium sulfate|mesh-list
64880271|NCT01911494|Methyldopa|methyldopa|mesh-list
64880281|NCT01911494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64880282|NCT01911494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880283|NCT01911494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64880284|NCT01911494|Tocolytic Agents|tocolytic agents|mesh-ancestor
64880285|NCT01911494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64880294|NCT01911507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64880295|NCT01911507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880296|NCT01911507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64880297|NCT01911507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880298|NCT01911507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880299|NCT01911598|Paclitaxel|paclitaxel|mesh-list
64880300|NCT01911598|Carboplatin|carboplatin|mesh-list
64880301|NCT01911598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64880302|NCT01911598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880303|NCT01911598|Tubulin Modulators|tubulin modulators|mesh-ancestor
64880304|NCT01911598|Antimitotic Agents|antimitotic agents|mesh-ancestor
64880305|NCT01911598|Mitosis Modulators|mitosis modulators|mesh-ancestor
64880306|NCT01911598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880307|NCT01911624|Enoxaparin|enoxaparin|mesh-list
64880308|NCT01911624|Dabigatran|dabigatran|mesh-list
64880309|NCT01911624|Argatroban|argatroban|mesh-list
64880310|NCT01911624|Thrombin|thrombin|mesh-list
64880311|NCT01911624|Anticoagulants|anticoagulants|mesh-ancestor
64880312|NCT01911624|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64880313|NCT01911624|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64880314|NCT01911624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880315|NCT01911624|Antithrombins|antithrombins|mesh-ancestor
64880321|NCT01911624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64880322|NCT01911728|Pioglitazone|pioglitazone|mesh-list
64880323|NCT01911728|Midazolam|midazolam|mesh-list
64880324|NCT01911728|Omeprazole|omeprazole|mesh-list
64880325|NCT01911728|Warfarin|warfarin|mesh-list
64880326|NCT01911728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64880327|NCT01911728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64880328|NCT01911728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64880329|NCT01911728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880330|NCT01911728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64880331|NCT01911728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64880332|NCT01911728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64880333|NCT01911728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64880334|NCT01911728|Anesthetics, General|anesthetics, general|mesh-ancestor
64880335|NCT01911728|Anesthetics|anesthetics|mesh-ancestor
64880336|NCT01911728|GABA Modulators|gaba modulators|mesh-ancestor
64620432|NCT03827876|Vitamins|vitamins|mesh-ancestor
64880337|NCT01911728|GABA Agents|gaba agents|mesh-ancestor
64880338|NCT01911728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64880339|NCT01911728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880340|NCT01911728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64880341|NCT01911728|Anticoagulants|anticoagulants|mesh-ancestor
64880342|NCT01911728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64880343|NCT01911728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64880344|NCT01911728|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64880345|NCT01911728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880346|NCT01911949|Epinephrine|epinephrine|mesh-list
64880347|NCT01911949|Bupivacaine|bupivacaine|mesh-list
64880348|NCT01911949|Anesthetics, Local|anesthetics, local|mesh-ancestor
64880349|NCT01911949|Anesthetics|anesthetics|mesh-ancestor
64880350|NCT01911949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64880359|NCT01911949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64880360|NCT01911949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64880362|NCT01911949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64880363|NCT01911949|Respiratory System Agents|respiratory system agents|mesh-ancestor
64880365|NCT01911949|Sympathomimetics|sympathomimetics|mesh-ancestor
64880366|NCT01911949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64880367|NCT01911975|Lacosamide|lacosamide|mesh-list
64880368|NCT01911975|Anticonvulsants|anticonvulsants|mesh-ancestor
64880369|NCT01911975|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64880370|NCT01911975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64880371|NCT01911975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64880372|NCT01911975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880373|NCT01912053|Gemcitabine|gemcitabine|mesh-list
64880374|NCT01912053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880375|NCT01912053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64880376|NCT01912053|Antimetabolites|antimetabolites|mesh-ancestor
64648908|NCT01342757|Vorinostat|vorinostat|mesh-list
64880377|NCT01912053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880378|NCT01912053|Antiviral Agents|antiviral agents|mesh-ancestor
64880379|NCT01912053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64880380|NCT01912053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880393|NCT01912066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64880394|NCT01912066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64880395|NCT01912066|Analgesics|analgesics|mesh-ancestor
64880396|NCT01912066|Sensory System Agents|sensory system agents|mesh-ancestor
64880397|NCT01912066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64880398|NCT01912066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64880399|NCT01912066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64880400|NCT01912118|Remifentanil|remifentanil|mesh-list
64880401|NCT01912118|Propofol|propofol|mesh-list
64880402|NCT01912118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64880403|NCT01912118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64880404|NCT01912118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880405|NCT01912118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64880406|NCT01912118|Anesthetics, General|anesthetics, general|mesh-ancestor
64880407|NCT01912118|Anesthetics|anesthetics|mesh-ancestor
64880408|NCT01912118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64880409|NCT01912118|Narcotics|narcotics|mesh-ancestor
64880410|NCT01912118|Analgesics|analgesics|mesh-ancestor
64880411|NCT01912118|Sensory System Agents|sensory system agents|mesh-ancestor
64880412|NCT01912118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64880413|NCT01912378|Oxytocin|oxytocin|mesh-list
64880414|NCT01912378|Oxytocics|oxytocics|mesh-ancestor
64880415|NCT01912378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64422959|NCT02389543|Dexamethasone|dexamethasone|mesh-list
64422960|NCT02389543|Lenalidomide|lenalidomide|mesh-list
64880416|NCT01912378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880417|NCT01912391|Selegiline|selegiline|mesh-list
64880418|NCT01912391|Antidepressive Agents|antidepressive agents|mesh-ancestor
64880419|NCT01912391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64880420|NCT01912391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64880421|NCT01912391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64880422|NCT01912391|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64880423|NCT01912391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880425|NCT01912391|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64880438|NCT01912534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64880439|NCT01912534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64880440|NCT01912534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880442|NCT01912573|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64880443|NCT01912573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880444|NCT01912573|Sensory System Agents|sensory system agents|mesh-ancestor
64880445|NCT01912573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64880446|NCT01912586|Sildenafil Citrate|sildenafil citrate|mesh-list
64880447|NCT01912586|Vasodilator Agents|vasodilator agents|mesh-ancestor
64880448|NCT01912586|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64880449|NCT01912586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64880450|NCT01912586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880451|NCT01912586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880452|NCT01912586|Urological Agents|urological agents|mesh-ancestor
64880453|NCT01912638|Hyaluronic Acid|hyaluronic acid|mesh-list
64880454|NCT01912638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64880455|NCT01912638|Immunologic Factors|immunologic factors|mesh-ancestor
64880456|NCT01912638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880457|NCT01912638|Viscosupplements|viscosupplements|mesh-ancestor
64880458|NCT01912638|Protective Agents|protective agents|mesh-ancestor
64880459|NCT01912677|Labetalol|labetalol|mesh-list
64880460|NCT01912677|Methyldopa|methyldopa|mesh-list
64880461|NCT01912677|Nifedipine|nifedipine|mesh-list
64880462|NCT01912677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64880463|NCT01912677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64880464|NCT01912677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880465|NCT01912677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64880466|NCT01912677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880481|NCT01912677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64880482|NCT01912677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64880483|NCT01912677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64880484|NCT01912755|Lidocaine|lidocaine|mesh-list
64880485|NCT01912755|Epinephrine|epinephrine|mesh-list
64880486|NCT01912755|Racepinephrine|racepinephrine|mesh-list
64880487|NCT01912755|Carticaine|carticaine|mesh-list
64880488|NCT01912755|Epinephryl borate|epinephryl borate|mesh-list
64880489|NCT01912755|Anesthetics, Local|anesthetics, local|mesh-ancestor
64880490|NCT01912755|Anesthetics|anesthetics|mesh-ancestor
64880491|NCT01912755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64880492|NCT01912755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880493|NCT01912755|Sensory System Agents|sensory system agents|mesh-ancestor
64880494|NCT01912755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64880495|NCT01912755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64880496|NCT01912755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64880497|NCT01912755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64880498|NCT01912755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64880499|NCT01912755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880500|NCT01912755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64880501|NCT01912755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64880534|NCT01913002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880535|NCT01913002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880536|NCT01913002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880537|NCT01913002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880538|NCT01913002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64880539|NCT01913002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64880540|NCT01913015|Abiraterone Acetate|abiraterone acetate|mesh-list
64880541|NCT01913015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880542|NCT01913015|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64880543|NCT01913015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880544|NCT01913015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880545|NCT01913015|Hormone Antagonists|hormone antagonists|mesh-ancestor
64422969|NCT02389543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64880546|NCT01913015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64880547|NCT01913015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880592|NCT01913444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64880593|NCT01913444|Protease Inhibitors|protease inhibitors|mesh-ancestor
64880594|NCT01913444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880595|NCT01913444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880596|NCT01913444|Anticoagulants|anticoagulants|mesh-ancestor
64880597|NCT01913691|Ipilimumab|ipilimumab|mesh-list
64880598|NCT01913691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64880599|NCT01913691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880600|NCT01913691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64880601|NCT01913691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880602|NCT01913808|Iron|iron|mesh-list
64880603|NCT01913808|Glycine|glycine|mesh-list
64880604|NCT01913808|Trace Elements|trace elements|mesh-ancestor
64649131|NCT05168462|Norepinephrine|norepinephrine|mesh-list
64880605|NCT01913808|Micronutrients|micronutrients|mesh-ancestor
64880606|NCT01913808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880607|NCT01913808|Glycine Agents|glycine agents|mesh-ancestor
64880608|NCT01913808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64880609|NCT01913808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880610|NCT01913834|Teriparatide|teriparatide|mesh-list
64880611|NCT01913834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64880612|NCT01913834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880613|NCT01913834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64880614|NCT01913847|Sildenafil Citrate|sildenafil citrate|mesh-list
64880615|NCT01913847|Vasodilator Agents|vasodilator agents|mesh-ancestor
64880616|NCT01913847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64880617|NCT01913847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64880618|NCT01913847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880619|NCT01913847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880620|NCT01913847|Urological Agents|urological agents|mesh-ancestor
64880621|NCT01913860|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64880622|NCT01913860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64880623|NCT01913964|Acetylcarnitine|acetylcarnitine|mesh-list
64880624|NCT01913964|Vitamin B Complex|vitamin b complex|mesh-ancestor
64880625|NCT01913964|Vitamins|vitamins|mesh-ancestor
64880626|NCT01913964|Micronutrients|micronutrients|mesh-ancestor
64880627|NCT01913964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880629|NCT01913990|Dexamethasone|dexamethasone|mesh-list
64880630|NCT01913990|Ondansetron|ondansetron|mesh-list
64880631|NCT01913990|Aprepitant|aprepitant|mesh-list
64880632|NCT01913990|Antiemetics|antiemetics|mesh-list
64880633|NCT01913990|Emetics|emetics|mesh-list
64880634|NCT01913990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64880635|NCT01913990|Autonomic Agents|autonomic agents|mesh-ancestor
64880636|NCT01913990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64880637|NCT01913990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880638|NCT01913990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64880639|NCT01913990|Glucocorticoids|glucocorticoids|mesh-ancestor
64880640|NCT01913990|Hormones|hormones|mesh-ancestor
64880641|NCT01913990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64880642|NCT01913990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64880643|NCT01913990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880644|NCT01913990|Antipruritics|antipruritics|mesh-ancestor
64880645|NCT01913990|Dermatologic Agents|dermatologic agents|mesh-ancestor
64880646|NCT01913990|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64880647|NCT01913990|Serotonin Agents|serotonin agents|mesh-ancestor
64880648|NCT01913990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64880656|NCT01914042|Morphine|morphine|mesh-list
64422977|NCT05441605|Chlorhexidine|chlorhexidine|mesh-list
64880682|NCT01914133|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
64880683|NCT01914133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880684|NCT01914133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880685|NCT01914133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64880686|NCT01914133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880688|NCT01914146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64880689|NCT01914146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64880690|NCT01914146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880691|NCT01914211|Tranexamic Acid|tranexamic acid|mesh-list
64880692|NCT01914211|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64880693|NCT01914211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64880694|NCT01914211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880695|NCT01914211|Hemostatics|hemostatics|mesh-ancestor
64880696|NCT01914211|Coagulants|coagulants|mesh-ancestor
64880697|NCT01914237|Castor Oil|castor oil|mesh-list
64880698|NCT01914237|Cathartics|cathartics|mesh-ancestor
64880699|NCT01914237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64880700|NCT01914250|Analgesics|analgesics|mesh-list
64880701|NCT01914250|Tetracaine|tetracaine|mesh-list
64880738|NCT01914627|Keratolytic Agents|keratolytic agents|mesh-ancestor
64880739|NCT01914627|Dermatologic Agents|dermatologic agents|mesh-ancestor
64880740|NCT01914627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64880741|NCT01914627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64880742|NCT01914627|Analgesics|analgesics|mesh-ancestor
64880743|NCT01914627|Sensory System Agents|sensory system agents|mesh-ancestor
64880744|NCT01914627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64880745|NCT01914627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880746|NCT01914627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64880747|NCT01914627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64880748|NCT01914627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64880749|NCT01914627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880750|NCT01914627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880751|NCT01914692|Somatostatin|somatostatin|mesh-list
64880753|NCT01914692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64880754|NCT01914692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880755|NCT01914718|Rituximab|rituximab|mesh-list
64880756|NCT01914718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64880757|NCT01914718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880758|NCT01914718|Immunologic Factors|immunologic factors|mesh-ancestor
64880759|NCT01914718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880760|NCT01914718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64880762|NCT01914744|Entecavir|entecavir|mesh-list
64880763|NCT01914744|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64880764|NCT01914744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64880765|NCT01914744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880767|NCT01914744|Antiviral Agents|antiviral agents|mesh-ancestor
64880783|NCT01914822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64880784|NCT01914900|Docetaxel|docetaxel|mesh-list
64880785|NCT01914900|Fluorouracil|fluorouracil|mesh-list
64880786|NCT01914900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880787|NCT01914900|Tubulin Modulators|tubulin modulators|mesh-ancestor
64880788|NCT01914900|Antimitotic Agents|antimitotic agents|mesh-ancestor
64880789|NCT01914900|Mitosis Modulators|mitosis modulators|mesh-ancestor
64880790|NCT01914900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880791|NCT01914900|Antimetabolites|antimetabolites|mesh-ancestor
64880792|NCT01914900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64880793|NCT01914900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64880794|NCT01914900|Immunologic Factors|immunologic factors|mesh-ancestor
64880795|NCT01914900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880796|NCT01914939|Oxytocin|oxytocin|mesh-list
64880797|NCT01914939|Oxytocics|oxytocics|mesh-ancestor
64880798|NCT01914939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64880799|NCT01914939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880800|NCT01914965|Bupropion|bupropion|mesh-list
64880801|NCT01914965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64880802|NCT01914965|Antidepressive Agents|antidepressive agents|mesh-ancestor
64880803|NCT01914965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64880804|NCT01914965|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64880805|NCT01914965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64880806|NCT01914965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64880807|NCT01914965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880808|NCT01914965|Dopamine Agents|dopamine agents|mesh-ancestor
64880809|NCT01914965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64880810|NCT01914965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880811|NCT01914965|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64880812|NCT01914965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64880813|NCT01914965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880814|NCT01915069|Cilostazol|cilostazol|mesh-list
64880815|NCT01915069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64880816|NCT01915069|Autonomic Agents|autonomic agents|mesh-ancestor
64620667|NCT03820466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64880821|NCT01915069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64880822|NCT01915069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64880823|NCT01915069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880824|NCT01915069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64880825|NCT01915069|Vasodilator Agents|vasodilator agents|mesh-ancestor
64880826|NCT01915069|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64880827|NCT01915069|Protective Agents|protective agents|mesh-ancestor
64880828|NCT01915069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64880829|NCT01915069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64880830|NCT01915069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880831|NCT01915082|Azithromycin|azithromycin|mesh-list
64880832|NCT01915082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64880833|NCT01915082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64880834|NCT01915134|Gemcitabine|gemcitabine|mesh-list
64880835|NCT01915134|Cisplatin|cisplatin|mesh-list
64880836|NCT01915134|Endostatins|endostatins|mesh-list
64880837|NCT01915134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880838|NCT01915134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64880839|NCT01915134|Antimetabolites|antimetabolites|mesh-ancestor
64880840|NCT01915134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880841|NCT01915134|Antiviral Agents|antiviral agents|mesh-ancestor
64880842|NCT01915134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64880843|NCT01915134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880844|NCT01915134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64880845|NCT01915134|Immunologic Factors|immunologic factors|mesh-ancestor
64880846|NCT01915134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880847|NCT01915134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64880848|NCT01915134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64880849|NCT01915134|Growth Substances|growth substances|mesh-ancestor
64880850|NCT01915134|Growth Inhibitors|growth inhibitors|mesh-ancestor
64880851|NCT01915186|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64880852|NCT01915186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64880863|NCT01915277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64880864|NCT01915277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64880865|NCT01915277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880866|NCT01915277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64880867|NCT01915277|Analgesics|analgesics|mesh-ancestor
64880868|NCT01915277|Sensory System Agents|sensory system agents|mesh-ancestor
64880869|NCT01915277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64880870|NCT01915277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64880871|NCT01915277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64880872|NCT01915277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64880873|NCT01915277|Adrenergic Agents|adrenergic agents|mesh-ancestor
64880874|NCT01915277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64880875|NCT01915277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880876|NCT01915459|Botulinum Toxins|botulinum toxins|mesh-list
64880877|NCT01915459|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64880878|NCT01915459|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64880879|NCT01915459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64880880|NCT01915459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64880881|NCT01915459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880882|NCT01915459|Cholinergic Agents|cholinergic agents|mesh-ancestor
64880883|NCT01915459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64880884|NCT01915459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880885|NCT01915459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64880886|NCT01915459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64880887|NCT01915472|Irinotecan|irinotecan|mesh-list
64880888|NCT01915472|Labetuzumab|labetuzumab|mesh-list
64880889|NCT01915472|Immunoconjugates|immunoconjugates|mesh-list
64880890|NCT01915472|Immunologic Factors|immunologic factors|mesh-ancestor
64880891|NCT01915472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880892|NCT01915472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64880893|NCT01915472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64422990|NCT00843037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880894|NCT01915472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880895|NCT01915472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880896|NCT01915472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880898|NCT01915537|Infliximab|infliximab|mesh-list
64880900|NCT01915537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64880901|NCT01915537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64880902|NCT01915550|Insulin|insulin|mesh-list
64880903|NCT01915550|Metformin|metformin|mesh-list
64880904|NCT01915550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64880905|NCT01915550|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
64880906|NCT01915550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64880907|NCT01915550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880908|NCT01915602|Sorafenib|sorafenib|mesh-list
64880909|NCT01915602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880910|NCT01915602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64880911|NCT01915602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880912|NCT01915602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880913|NCT01915758|Clindamycin|clindamycin|mesh-list
64880914|NCT01915758|Clindamycin palmitate|clindamycin palmitate|mesh-list
64880915|NCT01915758|Clindamycin phosphate|clindamycin phosphate|mesh-list
64880916|NCT01915758|Tretinoin|tretinoin|mesh-list
64880917|NCT01915758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64880918|NCT01915758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64880919|NCT01915758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64880920|NCT01915758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880921|NCT01915758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880922|NCT01915758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64880923|NCT01915758|Keratolytic Agents|keratolytic agents|mesh-ancestor
64880924|NCT01915758|Dermatologic Agents|dermatologic agents|mesh-ancestor
64880925|NCT01915901|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64880926|NCT01915901|Bismuth|bismuth|mesh-list
64880927|NCT01915901|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
64620737|NCT01222195|Hematinics|hematinics|mesh-ancestor
64880928|NCT01915901|Antacids|antacids|mesh-ancestor
64880929|NCT01915901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880930|NCT01915901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64880931|NCT01915901|Dermatologic Agents|dermatologic agents|mesh-ancestor
64880932|NCT01915901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64880933|NCT01915901|Immunologic Factors|immunologic factors|mesh-ancestor
64880935|NCT01915901|Antidiarrheals|antidiarrheals|mesh-ancestor
64880942|NCT01915979|Hormones|hormones|mesh-ancestor
64880943|NCT01915979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64880944|NCT01915979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880945|NCT01915979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64880946|NCT01915979|Respiratory System Agents|respiratory system agents|mesh-ancestor
64880947|NCT01916057|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64880948|NCT01916057|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64422991|NCT00602641|Thalidomide|thalidomide|mesh-list
64880949|NCT01916057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880950|NCT01916174|Insulin|insulin|mesh-list
64880951|NCT01916174|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64880952|NCT01916174|Liraglutide|liraglutide|mesh-list
64880953|NCT01916174|Insulin, Long-Acting|insulin, long-acting|mesh-list
64880954|NCT01916174|Xultophy|xultophy|mesh-list
64880955|NCT01916174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64880956|NCT01916174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880957|NCT01916174|Incretins|incretins|mesh-ancestor
64880958|NCT01916174|Hormones|hormones|mesh-ancestor
64880959|NCT01916174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64880960|NCT01916187|Imetelstat|imetelstat|mesh-list
64880961|NCT01916187|Motesanib diphosphate|motesanib diphosphate|mesh-list
64880962|NCT01916187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64880963|NCT01916187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64880964|NCT01916187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64880965|NCT01916200|Paroxetine|paroxetine|mesh-list
64880988|NCT01916252|Bortezomib|bortezomib|mesh-list
64880991|NCT01916252|BB 1101|bb 1101|mesh-list
64880992|NCT01916252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64880993|NCT01916252|Antiemetics|antiemetics|mesh-ancestor
64880994|NCT01916252|Autonomic Agents|autonomic agents|mesh-ancestor
64880995|NCT01916252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64880996|NCT01916252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64880997|NCT01916252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64880998|NCT01916252|Glucocorticoids|glucocorticoids|mesh-ancestor
64880999|NCT01916252|Hormones|hormones|mesh-ancestor
64881000|NCT01916252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64881001|NCT01916252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64881002|NCT01916252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64881003|NCT01916252|Immunologic Factors|immunologic factors|mesh-ancestor
64881004|NCT01916252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64881005|NCT01916252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64881006|NCT01916252|Growth Substances|growth substances|mesh-ancestor
64881007|NCT01916252|Growth Inhibitors|growth inhibitors|mesh-ancestor
64881008|NCT01916252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64881009|NCT01916252|Alkylating Agents|alkylating agents|mesh-ancestor
64881010|NCT01916252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881011|NCT01916252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64881012|NCT01916252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64881013|NCT01916252|Protease Inhibitors|protease inhibitors|mesh-ancestor
64881014|NCT01916252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620760|NCT03829592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64620762|NCT03829592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64620763|NCT03829592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620764|NCT03829592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64620765|NCT03829592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64620766|NCT03829592|Oxytocics|oxytocics|mesh-ancestor
64620767|NCT01142323|Fenofibrate|fenofibrate|mesh-list
64620768|NCT01142323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64620769|NCT01142323|Antimetabolites|antimetabolites|mesh-ancestor
64881015|NCT01916265|Glucagon|glucagon|mesh-list
64881016|NCT01916265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64881038|NCT01916447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64881039|NCT01916447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64881040|NCT01916447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64881041|NCT01916447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64881042|NCT01916447|Growth Substances|growth substances|mesh-ancestor
64881043|NCT01916447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881044|NCT01916447|Growth Inhibitors|growth inhibitors|mesh-ancestor
64881045|NCT01916447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64881046|NCT01916447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64881047|NCT01916447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64881048|NCT01916447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881049|NCT01916447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64881050|NCT01916577|Plerixafor|plerixafor|mesh-list
64881051|NCT01916577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64881052|NCT01916577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64881053|NCT01916577|Antiviral Agents|antiviral agents|mesh-ancestor
64881054|NCT01916577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64881055|NCT01916642|Lidocaine|lidocaine|mesh-list
64881056|NCT01916642|Etomidate|etomidate|mesh-list
64881057|NCT01916642|Anesthetics, Local|anesthetics, local|mesh-ancestor
64881058|NCT01916642|Anesthetics|anesthetics|mesh-ancestor
64881059|NCT01916642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64881060|NCT01916642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881070|NCT01916642|Anesthetics, General|anesthetics, general|mesh-ancestor
64881087|NCT01916798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64881088|NCT01916850|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
64620770|NCT01142323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881089|NCT01916850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64881090|NCT01916850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620771|NCT01142323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64620772|NCT01142947|Beclomethasone|beclomethasone|mesh-list
64881092|NCT01916850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881093|NCT01916863|Canagliflozin|canagliflozin|mesh-list
64881094|NCT01916863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
64881095|NCT01916863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64881096|NCT01916863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881097|NCT01916863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64881098|NCT01916863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881099|NCT01916902|Ticagrelor|ticagrelor|mesh-list
64881100|NCT01916902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64881101|NCT01916902|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64881102|NCT01916902|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64881103|NCT01916902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64881104|NCT01916902|Purinergic Agents|purinergic agents|mesh-ancestor
64881105|NCT01916902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64881106|NCT01916902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881107|NCT01916902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881108|NCT01916915|Tramadol|tramadol|mesh-list
64881109|NCT01916915|Levobupivacaine|levobupivacaine|mesh-list
64881110|NCT01916915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64881111|NCT01916915|Narcotics|narcotics|mesh-ancestor
64881112|NCT01916915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64881113|NCT01916915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881114|NCT01916915|Analgesics|analgesics|mesh-ancestor
64881115|NCT01916915|Sensory System Agents|sensory system agents|mesh-ancestor
64881116|NCT01916915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64881117|NCT01916915|Anesthetics, Local|anesthetics, local|mesh-ancestor
64620813|NCT02983214|Purinergic Agents|purinergic agents|mesh-ancestor
64346229|NCT02291471|T0001|t0001|mesh-list
64620814|NCT02983214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64881118|NCT01916915|Anesthetics|anesthetics|mesh-ancestor
64881119|NCT01916954|Lumefantrine|lumefantrine|mesh-list
64881120|NCT01916954|Artemether|artemether|mesh-list
64881121|NCT01916954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64881122|NCT01916954|Antimalarials|antimalarials|mesh-ancestor
64881123|NCT01916954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64881124|NCT01916954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64881125|NCT01916954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64881126|NCT01917019|4-Aminopyridine|4-aminopyridine|mesh-list
64881127|NCT01917019|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64881128|NCT01917019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64881129|NCT01917019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881130|NCT01917032|Folic Acid|folic acid|mesh-list
64881131|NCT01917032|Vitamin A|vitamin a|mesh-list
64881132|NCT01917032|Micronutrients|micronutrients|mesh-list
64881133|NCT01917032|Trace Elements|trace elements|mesh-list
64881134|NCT01917032|Tretinoin|tretinoin|mesh-list
64881135|NCT01917032|Vitamins|vitamins|mesh-ancestor
64881136|NCT01917032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881137|NCT01917032|Hematinics|hematinics|mesh-ancestor
64881138|NCT01917032|Vitamin B Complex|vitamin b complex|mesh-ancestor
64881139|NCT01917032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64881140|NCT01917032|Keratolytic Agents|keratolytic agents|mesh-ancestor
64881141|NCT01917032|Dermatologic Agents|dermatologic agents|mesh-ancestor
64881142|NCT01917045|Sufentanil|sufentanil|mesh-list
64881143|NCT01917045|Morphine|morphine|mesh-list
64881144|NCT01917045|Dsuvia|dsuvia|mesh-list
64881145|NCT01917045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64881146|NCT01917045|Narcotics|narcotics|mesh-ancestor
64881147|NCT01917045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64881148|NCT01917045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881149|NCT01917045|Analgesics|analgesics|mesh-ancestor
64881150|NCT01917045|Sensory System Agents|sensory system agents|mesh-ancestor
64881151|NCT01917045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64881152|NCT01917045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64881153|NCT01917045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64881154|NCT01917045|Anesthetics, General|anesthetics, general|mesh-ancestor
64881155|NCT01917045|Anesthetics|anesthetics|mesh-ancestor
64881156|NCT01917058|Abatacept|abatacept|mesh-list
64881161|NCT01917058|Immunologic Factors|immunologic factors|mesh-ancestor
64881162|NCT01917058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881163|NCT01917058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64881164|NCT01917097|Dexmedetomidine|dexmedetomidine|mesh-list
64881165|NCT01917097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64881166|NCT01917097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64881167|NCT01917097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881168|NCT01917097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64881169|NCT01917097|Analgesics|analgesics|mesh-ancestor
64881170|NCT01917097|Sensory System Agents|sensory system agents|mesh-ancestor
64881171|NCT01917097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64881172|NCT01917097|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64881173|NCT01917097|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64881174|NCT01917097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64881175|NCT01917097|Adrenergic Agents|adrenergic agents|mesh-ancestor
64881176|NCT01917097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64881177|NCT01917097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881178|NCT01917149|Metoprolol|metoprolol|mesh-list
64881179|NCT01917149|Valsartan|valsartan|mesh-list
64881180|NCT01917149|Benazepril|benazepril|mesh-list
64620857|NCT03829124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620858|NCT02965976|Botulinum Toxins|botulinum toxins|mesh-list
64881181|NCT01917149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64881182|NCT01917149|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64881183|NCT01917149|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64881184|NCT01917149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881185|NCT01917149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64881186|NCT01917149|Sympatholytics|sympatholytics|mesh-ancestor
64881187|NCT01917149|Autonomic Agents|autonomic agents|mesh-ancestor
64881188|NCT01917149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64881189|NCT01917149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881190|NCT01917149|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64881191|NCT01917149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64881193|NCT01917149|Adrenergic Agents|adrenergic agents|mesh-ancestor
64881201|NCT01917279|Tubulin Modulators|tubulin modulators|mesh-ancestor
64881202|NCT01917279|Antimitotic Agents|antimitotic agents|mesh-ancestor
64881203|NCT01917279|Mitosis Modulators|mitosis modulators|mesh-ancestor
64881204|NCT01917279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881205|NCT01917279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64881207|NCT01917318|Iloperidone|iloperidone|mesh-list
64881208|NCT01917318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64881209|NCT01917318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64881210|NCT01917318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64881211|NCT01917318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881212|NCT01917318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64881213|NCT01917331|Beclomethasone|beclomethasone|mesh-list
64881214|NCT01917331|Glycopyrrolate|glycopyrrolate|mesh-list
64881215|NCT01917331|Formoterol Fumarate|formoterol fumarate|mesh-list
64881216|NCT01917331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64881217|NCT01917331|Autonomic Agents|autonomic agents|mesh-ancestor
64423135|NCT05341609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64881218|NCT01917331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64881219|NCT01917331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881220|NCT01917331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64881221|NCT01917331|Respiratory System Agents|respiratory system agents|mesh-ancestor
64881222|NCT01917331|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64881223|NCT01917331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64881224|NCT01917331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64881225|NCT01917331|Adrenergic Agents|adrenergic agents|mesh-ancestor
64881226|NCT01917331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64881233|NCT01917331|Glucocorticoids|glucocorticoids|mesh-ancestor
64881252|NCT01917578|Trastuzumab|trastuzumab|mesh-list
64881253|NCT01917578|Epirubicin|epirubicin|mesh-list
64881254|NCT01917578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64881255|NCT01917578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64881256|NCT01917578|Tubulin Modulators|tubulin modulators|mesh-ancestor
64881257|NCT01917578|Antimitotic Agents|antimitotic agents|mesh-ancestor
64881258|NCT01917578|Mitosis Modulators|mitosis modulators|mesh-ancestor
64881259|NCT01917578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881260|NCT01917578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64881261|NCT01917578|Immunologic Factors|immunologic factors|mesh-ancestor
64881262|NCT01917578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881263|NCT01917578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64881264|NCT01917578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64881265|NCT01917578|Alkylating Agents|alkylating agents|mesh-ancestor
64881266|NCT01917578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64881267|NCT01917578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64881268|NCT01917578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64881269|NCT01917578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64881270|NCT01917578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64881271|NCT01917578|Antimetabolites|antimetabolites|mesh-ancestor
64881272|NCT01917578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64881273|NCT01917578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64881274|NCT01917617|Gemcitabine|gemcitabine|mesh-list
64881275|NCT01917617|Cisplatin|cisplatin|mesh-list
64881276|NCT01917617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64881277|NCT01917617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64881278|NCT01917617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64881279|NCT01917617|Antimetabolites|antimetabolites|mesh-ancestor
64881280|NCT01917617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881281|NCT01917617|Antiviral Agents|antiviral agents|mesh-ancestor
64881282|NCT01917617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64620924|NCT05394233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620925|NCT05394233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64620927|NCT03823976|Anesthetics|anesthetics|mesh-list
64881283|NCT01917617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64881284|NCT01917617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64881295|NCT01917721|Doxycycline|doxycycline|mesh-list
64881296|NCT01917721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64881297|NCT01917721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64881298|NCT01917721|Antimalarials|antimalarials|mesh-ancestor
64881299|NCT01917721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64881300|NCT01917721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64881301|NCT01917799|Aspirin|aspirin|mesh-list
64881302|NCT01917799|Heparin|heparin|mesh-list
64881303|NCT01917799|Enoxaparin|enoxaparin|mesh-list
64881304|NCT01917799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64881305|NCT01917799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64881306|NCT01917799|Analgesics|analgesics|mesh-ancestor
64881307|NCT01917799|Sensory System Agents|sensory system agents|mesh-ancestor
64881308|NCT01917799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64881309|NCT01917799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881310|NCT01917799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64881311|NCT01917799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64881312|NCT01917799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64620946|NCT02943590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64620947|NCT02943590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64881313|NCT01917799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64620948|NCT02943590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64881314|NCT01917799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881315|NCT01917799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64881316|NCT01917799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64881317|NCT01917799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423197|NCT05304949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881332|NCT01918098|Oxycodone|oxycodone|mesh-list
64881333|NCT01918098|Naloxone|naloxone|mesh-list
64881334|NCT01918098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64881335|NCT01918098|Narcotics|narcotics|mesh-ancestor
64881336|NCT01918098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64881337|NCT01918098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881338|NCT01918098|Analgesics|analgesics|mesh-ancestor
64881339|NCT01918098|Sensory System Agents|sensory system agents|mesh-ancestor
64881340|NCT01918098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64881341|NCT01918098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64881342|NCT01918111|Adenosine|adenosine|mesh-list
64881343|NCT01918111|Analgesics|analgesics|mesh-ancestor
64881344|NCT01918111|Sensory System Agents|sensory system agents|mesh-ancestor
64881345|NCT01918111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64881346|NCT01918111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881354|NCT01918124|Paclitaxel|paclitaxel|mesh-list
64881365|NCT01918124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64881366|NCT01918124|Immunologic Factors|immunologic factors|mesh-ancestor
64881367|NCT01918124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881368|NCT01918124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64881369|NCT01918124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64881370|NCT01918124|Alkylating Agents|alkylating agents|mesh-ancestor
64881371|NCT01918124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64881372|NCT01918124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64881373|NCT01918124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64881374|NCT01918124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64620999|NCT04694586|Rifampin|rifampin|mesh-list
64881375|NCT01918124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621000|NCT04694586|Isoniazid|isoniazid|mesh-list
64621001|NCT04694586|Pyrazinamide|pyrazinamide|mesh-list
64881376|NCT01918150|Cobalt|cobalt|mesh-list
64881377|NCT01918150|Chromium|chromium|mesh-list
64881378|NCT01918150|Trace Elements|trace elements|mesh-ancestor
64881379|NCT01918150|Micronutrients|micronutrients|mesh-ancestor
64881380|NCT01918150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881381|NCT01918176|Palbociclib|palbociclib|mesh-list
64881382|NCT01918176|Rabeprazole|rabeprazole|mesh-list
64881383|NCT01918176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64881384|NCT01918176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64881385|NCT01918176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64881386|NCT01918176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881387|NCT01918176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64881388|NCT01918176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64881390|NCT01918241|Lenograstim|lenograstim|mesh-list
64881416|NCT01918384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64881417|NCT01918475|Carbetocin|carbetocin|mesh-list
64881418|NCT01918475|Oxytocics|oxytocics|mesh-ancestor
64881419|NCT01918475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64881420|NCT01918475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881421|NCT01918488|Amiloride|amiloride|mesh-list
64881422|NCT01918488|Triamterene|triamterene|mesh-list
64881423|NCT01918488|Diuretics|diuretics|mesh-ancestor
64881424|NCT01918488|Natriuretic Agents|natriuretic agents|mesh-ancestor
64881425|NCT01918488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881426|NCT01918488|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
64881427|NCT01918488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64881428|NCT01918488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64881429|NCT01918488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881430|NCT01918488|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64881431|NCT01918488|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64881432|NCT01918514|Magnesium Sulfate|magnesium sulfate|mesh-list
64881433|NCT01918514|Analgesics|analgesics|mesh-ancestor
64881434|NCT01918514|Sensory System Agents|sensory system agents|mesh-ancestor
64881435|NCT01918514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621040|NCT05509374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64621041|NCT05509374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64621042|NCT05509374|Growth Substances|growth substances|mesh-ancestor
64881436|NCT01918514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881437|NCT01918514|Anesthetics|anesthetics|mesh-ancestor
64881438|NCT01918514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64881439|NCT01918514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64881440|NCT01918514|Anticonvulsants|anticonvulsants|mesh-ancestor
64881441|NCT01918514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64881442|NCT01918514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64881444|NCT01918514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64881462|NCT01918709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881463|NCT01918709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64881464|NCT01918709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64881465|NCT01918709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64881466|NCT01918709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64881467|NCT01918709|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64881468|NCT01918709|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64881469|NCT01918813|Vancomycin|vancomycin|mesh-list
64881470|NCT01918813|Mupirocin|mupirocin|mesh-list
64881471|NCT01918813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64881472|NCT01918813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64881473|NCT01918813|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64881474|NCT01918813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64881475|NCT01918813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881476|NCT01918852|Bevacizumab|bevacizumab|mesh-list
64881477|NCT01918852|Capecitabine|capecitabine|mesh-list
64881478|NCT01918852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64881479|NCT01918852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64881480|NCT01918852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64881481|NCT01918852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64881483|NCT01918852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881484|NCT01918852|Growth Inhibitors|growth inhibitors|mesh-ancestor
64881485|NCT01918852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64881486|NCT01918852|Antimetabolites|antimetabolites|mesh-ancestor
64881487|NCT01918852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621073|NCT02937272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621074|NCT02937272|Tubulin Modulators|tubulin modulators|mesh-ancestor
64881488|NCT01918865|Metformin|metformin|mesh-list
64881489|NCT01918865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64881490|NCT01918865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621086|NCT02936102|Spartalizumab|spartalizumab|mesh-list
64881491|NCT01918878|Aflibercept|aflibercept|mesh-list
64881504|NCT01918904|Antitubercular Agents|antitubercular agents|mesh-ancestor
64881505|NCT01918904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64881506|NCT01918904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64881507|NCT01918904|Chelating Agents|chelating agents|mesh-ancestor
64881508|NCT01918904|Sequestering Agents|sequestering agents|mesh-ancestor
64881509|NCT01918917|Dexmedetomidine|dexmedetomidine|mesh-list
64881511|NCT01918917|Levobupivacaine|levobupivacaine|mesh-list
64881512|NCT01918917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64881513|NCT01918917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64881514|NCT01918917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881515|NCT01918917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64881516|NCT01918917|Analgesics|analgesics|mesh-ancestor
64881517|NCT01918917|Sensory System Agents|sensory system agents|mesh-ancestor
64881518|NCT01918917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64881519|NCT01918917|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64881520|NCT01918917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64881521|NCT01918917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64881522|NCT01918917|Adrenergic Agents|adrenergic agents|mesh-ancestor
64881523|NCT01918917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64881524|NCT01918917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881525|NCT01918917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64881526|NCT01918917|Narcotics|narcotics|mesh-ancestor
64621109|NCT03821714|Vitamins|vitamins|mesh-list
64621111|NCT03821714|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64621112|NCT03821714|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64881527|NCT01918917|Anesthetics, Local|anesthetics, local|mesh-ancestor
64881528|NCT01918917|Anesthetics|anesthetics|mesh-ancestor
64881529|NCT01918995|Regadenoson|regadenoson|mesh-list
64881530|NCT01918995|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64881531|NCT01918995|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64881532|NCT01918995|Purinergic Agonists|purinergic agonists|mesh-ancestor
64881533|NCT01918995|Purinergic Agents|purinergic agents|mesh-ancestor
64881534|NCT01918995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64881535|NCT01918995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881536|NCT01918995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621158|NCT01454180|Immunologic Factors|immunologic factors|mesh-ancestor
64881537|NCT01919008|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64881545|NCT01919047|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64621159|NCT01454180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621160|NCT01454180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64621161|NCT01454180|Antidotes|antidotes|mesh-ancestor
64621162|NCT01454180|Protective Agents|protective agents|mesh-ancestor
64621163|NCT01454180|Vitamin B Complex|vitamin b complex|mesh-ancestor
64621164|NCT01454180|Vitamins|vitamins|mesh-ancestor
64621165|NCT01454180|Micronutrients|micronutrients|mesh-ancestor
64621166|NCT02564952|Cannabidiol|cannabidiol|mesh-list
64621167|NCT02564952|Clobazam|clobazam|mesh-list
64621176|NCT02564952|GABA Agents|gaba agents|mesh-ancestor
64881546|NCT01919047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64881547|NCT01919047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64881548|NCT01919047|Adrenergic Agents|adrenergic agents|mesh-ancestor
64881549|NCT01919047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64881550|NCT01919047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881551|NCT01919047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881552|NCT01919047|Urological Agents|urological agents|mesh-ancestor
64881553|NCT01919203|Remifentanil|remifentanil|mesh-list
64881554|NCT01919203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64881555|NCT01919203|Narcotics|narcotics|mesh-ancestor
64881556|NCT01919203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64423375|NCT05267743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64881557|NCT01919203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881558|NCT01919203|Analgesics|analgesics|mesh-ancestor
64881559|NCT01919203|Sensory System Agents|sensory system agents|mesh-ancestor
64881560|NCT01919203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64881561|NCT01919255|Picosulfate sodium|picosulfate sodium|mesh-list
64881562|NCT01919255|Sodium sulfate|sodium sulfate|mesh-list
64881563|NCT01919255|Magnesium Oxide|magnesium oxide|mesh-list
64881564|NCT01919255|Sodium Citrate|sodium citrate|mesh-list
64881600|NCT01919424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64881601|NCT01919424|Cholinergic Agents|cholinergic agents|mesh-ancestor
64881602|NCT01919424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64881603|NCT01919424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881604|NCT01919593|Chlorhexidine|chlorhexidine|mesh-list
64881605|NCT01919593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64881606|NCT01919593|Povidone-Iodine|povidone-iodine|mesh-list
64881607|NCT01919593|Povidone|povidone|mesh-list
64881608|NCT01919593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64881609|NCT01919593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64881610|NCT01919593|Disinfectants|disinfectants|mesh-ancestor
64881611|NCT01919593|Dermatologic Agents|dermatologic agents|mesh-ancestor
64881612|NCT01919593|Plasma Substitutes|plasma substitutes|mesh-ancestor
64881613|NCT01919593|Blood Substitutes|blood substitutes|mesh-ancestor
64881614|NCT01919788|Insulin|insulin|mesh-list
64881615|NCT01919788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64881616|NCT01919788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881617|NCT01919879|Cetuximab|cetuximab|mesh-list
64881618|NCT01919879|Afatinib|afatinib|mesh-list
64881619|NCT01919879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64881620|NCT01919879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64881621|NCT01919879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64881622|NCT01919879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64881623|NCT01919879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881624|NCT01919892|Lithium Carbonate|lithium carbonate|mesh-list
64881625|NCT01919892|Antidepressive Agents|antidepressive agents|mesh-ancestor
64881626|NCT01919892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64881627|NCT01919892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64881628|NCT01919892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881629|NCT01919892|Antimanic Agents|antimanic agents|mesh-ancestor
64881630|NCT01919892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64881631|NCT01919892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64881632|NCT01919892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881633|NCT01919905|Vitamin D|vitamin d|mesh-list
64881634|NCT01919905|Vitamins|vitamins|mesh-ancestor
64881635|NCT01919905|Micronutrients|micronutrients|mesh-ancestor
64881642|NCT01919918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881643|NCT01919918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64881644|NCT01919918|Vasodilator Agents|vasodilator agents|mesh-ancestor
64881645|NCT01919918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64881646|NCT01919918|Purinergic Agonists|purinergic agonists|mesh-ancestor
64881647|NCT01919918|Purinergic Agents|purinergic agents|mesh-ancestor
64881648|NCT01919918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64881649|NCT01919918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881650|NCT01920022|Contraceptive Agents|contraceptive agents|mesh-list
64881651|NCT01920022|Mifepristone|mifepristone|mesh-list
64881652|NCT01920022|Etonogestrel|etonogestrel|mesh-list
64881653|NCT01920022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64881654|NCT01920022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881655|NCT01920022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64423494|NCT05255653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650207|NCT01380197|Morphine|morphine|mesh-list
64881656|NCT01920022|Abortifacient Agents|abortifacient agents|mesh-ancestor
64881657|NCT01920022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64881658|NCT01920022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64881659|NCT01920022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64881660|NCT01920022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64881661|NCT01920022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64881662|NCT01920022|Hormone Antagonists|hormone antagonists|mesh-ancestor
64881663|NCT01920022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64881664|NCT01920022|Luteolytic Agents|luteolytic agents|mesh-ancestor
64881665|NCT01920022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64881666|NCT01920022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64881667|NCT01920074|Nitroglycerin|nitroglycerin|mesh-list
64881669|NCT01920516|Melphalan|melphalan|mesh-list
64881683|NCT01920984|Growth Substances|growth substances|mesh-ancestor
64881684|NCT01920984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881685|NCT01920984|Growth Inhibitors|growth inhibitors|mesh-ancestor
64881686|NCT01921374|Vitamin B 12|vitamin b 12|mesh-list
64881687|NCT01921374|Interferons|interferons|mesh-list
64881688|NCT01921374|Interferon-gamma|interferon-gamma|mesh-list
64881689|NCT01921374|Interleukin-2|interleukin-2|mesh-list
64881690|NCT01921374|Interleukin-4|interleukin-4|mesh-list
64621249|NCT05508516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64881691|NCT01921374|Dinoprostone|dinoprostone|mesh-list
64881693|NCT01921374|Estradiol|estradiol|mesh-list
64881694|NCT01921374|Testosterone|testosterone|mesh-list
64621253|NCT05508516|Analgesics|analgesics|mesh-ancestor
64881695|NCT01921374|Progesterone|progesterone|mesh-list
64881696|NCT01921374|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64881697|NCT01921374|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64881698|NCT01921374|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64881699|NCT01921374|Immunoglobulins|immunoglobulins|mesh-list
64881700|NCT01921374|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64881701|NCT01921374|Antibodies|antibodies|mesh-list
64881702|NCT01921374|Immunoglobulin G|immunoglobulin g|mesh-list
64881703|NCT01921374|Complement System Proteins|complement system proteins|mesh-list
64881704|NCT01921374|Immunoglobulin A|immunoglobulin a|mesh-list
64881705|NCT01921374|Immunoglobulin M|immunoglobulin m|mesh-list
64881706|NCT01921374|beta-Endorphin|beta-endorphin|mesh-list
64881707|NCT01921374|Uric Acid|uric acid|mesh-list
64881708|NCT01921374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881709|NCT01921374|Vitamins|vitamins|mesh-ancestor
64881710|NCT01921374|Micronutrients|micronutrients|mesh-ancestor
64881711|NCT01921374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64881712|NCT01921374|Antiviral Agents|antiviral agents|mesh-ancestor
64881713|NCT01921374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64881715|NCT01921374|Estrogens|estrogens|mesh-ancestor
64881733|NCT01921972|Galantamine|galantamine|mesh-list
64881734|NCT01921972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64881735|NCT01921972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64881736|NCT01921972|Dopamine Agents|dopamine agents|mesh-ancestor
64881737|NCT01921972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64881738|NCT01921972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881739|NCT01921972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881740|NCT01921972|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64881741|NCT01921972|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64881742|NCT01921972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64881743|NCT01921972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64881744|NCT01921972|Cholinergic Agents|cholinergic agents|mesh-ancestor
64423548|NCT05280769|Cholinergic Agents|cholinergic agents|mesh-ancestor
64881745|NCT01921972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64881746|NCT01921972|Autonomic Agents|autonomic agents|mesh-ancestor
64621262|NCT02902484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621263|NCT02902484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621264|NCT01455506|Fludarabine|fludarabine|mesh-list
64621265|NCT01455506|Busulfan|busulfan|mesh-list
64621266|NCT01455506|Decitabine|decitabine|mesh-list
64621267|NCT01455506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621268|NCT01455506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64621269|NCT01455506|Antimetabolites|antimetabolites|mesh-ancestor
64423549|NCT05280769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64621270|NCT01455506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621271|NCT01455506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64881747|NCT01921972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64881748|NCT01921972|Nootropic Agents|nootropic agents|mesh-ancestor
64881749|NCT01923454|Acetazolamide|acetazolamide|mesh-list
64881750|NCT01923454|Anticonvulsants|anticonvulsants|mesh-ancestor
64881751|NCT01923454|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64881752|NCT01923454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64881753|NCT01923454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881754|NCT01923454|Diuretics|diuretics|mesh-ancestor
64881755|NCT01923454|Natriuretic Agents|natriuretic agents|mesh-ancestor
64881756|NCT01923454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881758|NCT01923935|Busulfan|busulfan|mesh-list
64881759|NCT01923935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64881760|NCT01923935|Alkylating Agents|alkylating agents|mesh-ancestor
64881761|NCT01923935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881762|NCT01923935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64881763|NCT01923935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64881778|NCT01924013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64881779|NCT01924013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64881780|NCT01924676|Oxycodone|oxycodone|mesh-list
64881781|NCT01924676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64881782|NCT01924676|Narcotics|narcotics|mesh-ancestor
64881783|NCT01924676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64881784|NCT01924676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881785|NCT01924676|Analgesics|analgesics|mesh-ancestor
64881786|NCT01924676|Sensory System Agents|sensory system agents|mesh-ancestor
64881787|NCT01924676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64881788|NCT01925066|Vancomycin|vancomycin|mesh-list
64881789|NCT01925066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64881790|NCT01925066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64881791|NCT01927640|Cocaine|cocaine|mesh-list
64881792|NCT01927640|Dexmedetomidine|dexmedetomidine|mesh-list
64881793|NCT01927640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64881794|NCT01927640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64881795|NCT01927640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881796|NCT01927640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64881797|NCT01927640|Analgesics|analgesics|mesh-ancestor
64881798|NCT01927640|Sensory System Agents|sensory system agents|mesh-ancestor
64881799|NCT01927640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621288|NCT03829436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621289|NCT05563350|Midazolam|midazolam|mesh-list
64621290|NCT05563350|Omeprazole|omeprazole|mesh-list
64621291|NCT05563350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64881800|NCT01927640|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64881801|NCT01927640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64881802|NCT01927640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64881803|NCT01927640|Adrenergic Agents|adrenergic agents|mesh-ancestor
64881828|NCT01928407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64881829|NCT01928407|Protease Inhibitors|protease inhibitors|mesh-ancestor
64881830|NCT01928407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64881831|NCT01928407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881832|NCT01928407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64881833|NCT01928407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64881834|NCT01928407|Antiviral Agents|antiviral agents|mesh-ancestor
64881835|NCT01928407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64881836|NCT01928875|Anesthetics|anesthetics|mesh-list
64881837|NCT01928875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64881838|NCT01928875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881839|NCT01929486|Mogamulizumab|mogamulizumab|mesh-list
64881840|NCT01929486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64881841|NCT01929590|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64881842|NCT01929590|Laxatives|laxatives|mesh-ancestor
64881843|NCT01929590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64881845|NCT01930019|Etomidate|etomidate|mesh-list
64881846|NCT01930019|Anesthetics|anesthetics|mesh-ancestor
64881847|NCT01930019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64881848|NCT01930019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881849|NCT01930019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64423620|NCT05273827|Pemetrexed|pemetrexed|mesh-list
64881850|NCT01930019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64423621|NCT05273827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64423674|NCT05206435|Autonomic Agents|autonomic agents|mesh-ancestor
64881851|NCT01930019|Anesthetics, General|anesthetics, general|mesh-ancestor
64881852|NCT01930019|Anticonvulsants|anticonvulsants|mesh-ancestor
64881853|NCT01930019|GABA Modulators|gaba modulators|mesh-ancestor
64881854|NCT01930019|GABA Agents|gaba agents|mesh-ancestor
64881855|NCT01930019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64881856|NCT01930019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881857|NCT01930201|Anesthetics|anesthetics|mesh-list
64881858|NCT01930201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64881859|NCT01930201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881860|NCT01930292|Paclitaxel|paclitaxel|mesh-list
64881861|NCT01930292|Carboplatin|carboplatin|mesh-list
64881862|NCT01930292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64881864|NCT01930292|Tubulin Modulators|tubulin modulators|mesh-ancestor
64881865|NCT01930292|Antimitotic Agents|antimitotic agents|mesh-ancestor
64881866|NCT01930292|Mitosis Modulators|mitosis modulators|mesh-ancestor
64881867|NCT01930292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621321|NCT02564718|Anticoagulants|anticoagulants|mesh-ancestor
64621322|NCT01453946|Budesonide|budesonide|mesh-list
64621323|NCT01453946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64621324|NCT01453946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64621325|NCT01453946|Autonomic Agents|autonomic agents|mesh-ancestor
64621326|NCT01453946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621327|NCT01453946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621328|NCT01453946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64621329|NCT01453946|Respiratory System Agents|respiratory system agents|mesh-ancestor
64881868|NCT01930318|Parecoxib|parecoxib|mesh-list
64621330|NCT01453946|Glucocorticoids|glucocorticoids|mesh-ancestor
64621331|NCT01453946|Hormones|hormones|mesh-ancestor
64621332|NCT01453946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64621333|NCT01455896|Exenatide|exenatide|mesh-list
64621334|NCT01455896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64881869|NCT01930318|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64881870|NCT01930318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64881871|NCT01930318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64881872|NCT01930318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881873|NCT01930318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64881874|NCT01930318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64881875|NCT01930318|Analgesics|analgesics|mesh-ancestor
64881876|NCT01930318|Sensory System Agents|sensory system agents|mesh-ancestor
64881877|NCT01930318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64881878|NCT01930318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881879|NCT01930318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64881880|NCT01930318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64881881|NCT01930331|Piperaquine|piperaquine|mesh-list
64881882|NCT01930331|Artenimol|artenimol|mesh-list
64881883|NCT01930331|Artemisinins|artemisinins|mesh-list
64881884|NCT01930331|Artemisinin|artemisinin|mesh-list
64881885|NCT01930331|Antimalarials|antimalarials|mesh-ancestor
64881886|NCT01930331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64881887|NCT01930331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64881888|NCT01930331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64881889|NCT01930370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64881890|NCT01930370|Hemodialysis Solutions|hemodialysis solutions|mesh-list
64881891|NCT01930370|Dialysis Solutions|dialysis solutions|mesh-ancestor
64881892|NCT01930396|Heparin|heparin|mesh-list
64881893|NCT01930396|Calcium heparin|calcium heparin|mesh-list
64881894|NCT01930396|Tinzaparin|tinzaparin|mesh-list
64881908|NCT01930552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881909|NCT01930552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64881910|NCT01930552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64881911|NCT01930552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64881912|NCT01930552|Immunologic Factors|immunologic factors|mesh-ancestor
64881913|NCT01930552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881914|NCT01930552|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64881915|NCT01930552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64881916|NCT01930552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64881918|NCT01930552|Protective Agents|protective agents|mesh-ancestor
64881919|NCT01930552|Vitamin B Complex|vitamin b complex|mesh-ancestor
64881920|NCT01930552|Vitamins|vitamins|mesh-ancestor
64881921|NCT01930552|Micronutrients|micronutrients|mesh-ancestor
64881922|NCT01930552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64881923|NCT01930552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64881924|NCT01930552|Growth Substances|growth substances|mesh-ancestor
64881925|NCT01930552|Growth Inhibitors|growth inhibitors|mesh-ancestor
64621339|NCT01455896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64621341|NCT05562882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621342|NCT05560542|Dexamethasone|dexamethasone|mesh-list
64621343|NCT05560542|Atropine|atropine|mesh-list
64881926|NCT01930591|Clopidogrel|clopidogrel|mesh-list
64881927|NCT01930591|Ticagrelor|ticagrelor|mesh-list
64881928|NCT01930591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64881929|NCT01930591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64881930|NCT01930591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64881931|NCT01930591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64881932|NCT01930591|Purinergic Agents|purinergic agents|mesh-ancestor
64881933|NCT01930591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64881934|NCT01930591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881935|NCT01930591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881936|NCT01930604|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
64881937|NCT01930604|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64881939|NCT01930604|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64881949|NCT01930682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64881950|NCT01930682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64881951|NCT01930682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881952|NCT01930708|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64881953|NCT01930708|Dermatologic Agents|dermatologic agents|mesh-ancestor
64881954|NCT01930708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64881955|NCT01930708|Immunologic Factors|immunologic factors|mesh-ancestor
64881956|NCT01930708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881957|NCT01930734|Dobutamine|dobutamine|mesh-list
64881958|NCT01930734|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64881959|NCT01930734|Sympathomimetics|sympathomimetics|mesh-ancestor
64881960|NCT01930734|Autonomic Agents|autonomic agents|mesh-ancestor
64881961|NCT01930734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64881962|NCT01930734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881963|NCT01930734|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64881964|NCT01930734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64881965|NCT01930734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64881966|NCT01930734|Adrenergic Agents|adrenergic agents|mesh-ancestor
64881967|NCT01930734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64881968|NCT01930734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64881969|NCT01930734|Protective Agents|protective agents|mesh-ancestor
64881970|NCT01930773|Clopidogrel|clopidogrel|mesh-list
64881971|NCT01930773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64881972|NCT01930773|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64881973|NCT01930773|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64881974|NCT01930773|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64881975|NCT01930773|Purinergic Agents|purinergic agents|mesh-ancestor
64881976|NCT01930773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64881994|NCT01930812|Cariostatic Agents|cariostatic agents|mesh-ancestor
64881995|NCT01930812|Protective Agents|protective agents|mesh-ancestor
64881996|NCT01930812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64881997|NCT01930812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64881998|NCT01930812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64881999|NCT01930812|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64882000|NCT01930812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882001|NCT01930864|Metformin|metformin|mesh-list
64882002|NCT01930864|Irinotecan|irinotecan|mesh-list
64882003|NCT01930864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64882004|NCT01930864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882005|NCT01930864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64882006|NCT01930864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64882007|NCT01930864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882008|NCT01930864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882009|NCT01930864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882010|NCT01930877|Lidocaine|lidocaine|mesh-list
64882011|NCT01930877|Anesthetics, Local|anesthetics, local|mesh-ancestor
64882012|NCT01930877|Anesthetics|anesthetics|mesh-ancestor
64882013|NCT01930877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64882014|NCT01930877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882015|NCT01930877|Sensory System Agents|sensory system agents|mesh-ancestor
64882016|NCT01930877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882017|NCT01930877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64882018|NCT01930877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64882019|NCT01930877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64882020|NCT01930877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64882022|NCT01930916|Anticoagulants|anticoagulants|mesh-list
64882038|NCT01931098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64882039|NCT01931098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882040|NCT01931098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882041|NCT01931098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882042|NCT01931137|Insulin|insulin|mesh-list
64882043|NCT01931137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64882044|NCT01931137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882045|NCT01931189|Infliximab|infliximab|mesh-list
64882046|NCT01931189|Dermatologic Agents|dermatologic agents|mesh-ancestor
64882047|NCT01931189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64882048|NCT01931189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64882049|NCT01931215|Clonidine|clonidine|mesh-list
64882050|NCT01931215|Morphine|morphine|mesh-list
64882051|NCT01931215|Ropivacaine|ropivacaine|mesh-list
64882052|NCT01931215|Anesthetics|anesthetics|mesh-ancestor
64882053|NCT01931215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64882054|NCT01931215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882055|NCT01931215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64882056|NCT01931215|Narcotics|narcotics|mesh-ancestor
64882057|NCT01931215|Analgesics|analgesics|mesh-ancestor
64882058|NCT01931215|Sensory System Agents|sensory system agents|mesh-ancestor
64621434|NCT03827018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64621435|NCT03827018|Glucocorticoids|glucocorticoids|mesh-ancestor
64621436|NCT03827018|Hormones|hormones|mesh-ancestor
64621437|NCT03827018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64621438|NCT03827018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621439|NCT03827018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64621440|NCT03827018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621441|NCT03827018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64882059|NCT01931215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882060|NCT01931215|Anesthetics, Local|anesthetics, local|mesh-ancestor
64882061|NCT01931215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64882062|NCT01931215|Sympatholytics|sympatholytics|mesh-ancestor
64882063|NCT01931215|Autonomic Agents|autonomic agents|mesh-ancestor
64882064|NCT01931215|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64882065|NCT01931215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64882066|NCT01931215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64882067|NCT01931215|Adrenergic Agents|adrenergic agents|mesh-ancestor
64882068|NCT01931215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64882069|NCT01931215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882070|NCT01931293|Folic Acid|folic acid|mesh-list
64882083|NCT01931319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882084|NCT01931319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64882085|NCT01931319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882086|NCT01931319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64882087|NCT01931319|GABA Agonists|gaba agonists|mesh-ancestor
64882088|NCT01931319|GABA Agents|gaba agents|mesh-ancestor
64882089|NCT01931319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64882090|NCT01931319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882092|NCT01931332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64882093|NCT01931332|Narcotics|narcotics|mesh-ancestor
64882094|NCT01931332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64882095|NCT01931332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882096|NCT01931332|Analgesics|analgesics|mesh-ancestor
64882097|NCT01931332|Sensory System Agents|sensory system agents|mesh-ancestor
64882098|NCT01931332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882099|NCT01931384|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64882100|NCT01931384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64882101|NCT01931384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882102|NCT01931410|Misoprostol|misoprostol|mesh-list
64882103|NCT01931410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64882104|NCT01931410|Abortifacient Agents|abortifacient agents|mesh-ancestor
64882105|NCT01931410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64882106|NCT01931410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650642|NCT02518464|Ticagrelor|ticagrelor|mesh-list
64882132|NCT01931592|Fosfomycin|fosfomycin|mesh-list
64882133|NCT01931592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64882134|NCT01931592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64882135|NCT01931592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64882136|NCT01931592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882137|NCT01931592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882138|NCT01931657|Mifepristone|mifepristone|mesh-list
64882139|NCT01931657|Levonorgestrel|levonorgestrel|mesh-list
64882140|NCT01931657|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64882141|NCT01931657|Abortifacient Agents|abortifacient agents|mesh-ancestor
64882142|NCT01931657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64882143|NCT01931657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882144|NCT01931657|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64882145|NCT01931657|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64882146|NCT01931657|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64882147|NCT01931657|Contraceptive Agents|contraceptive agents|mesh-ancestor
64882148|NCT01931657|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64882149|NCT01931657|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64882150|NCT01931657|Hormone Antagonists|hormone antagonists|mesh-ancestor
64882151|NCT01931657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64882152|NCT01931657|Luteolytic Agents|luteolytic agents|mesh-ancestor
64882153|NCT01931657|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64423737|NCT05236543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64882155|NCT01931683|Remifentanil|remifentanil|mesh-list
64882156|NCT01931683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64882157|NCT01931683|Narcotics|narcotics|mesh-ancestor
64882158|NCT01931683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64882159|NCT01931683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882160|NCT01931683|Analgesics|analgesics|mesh-ancestor
64882161|NCT01931683|Sensory System Agents|sensory system agents|mesh-ancestor
64882163|NCT01931787|Thioctic Acid|thioctic acid|mesh-list
64882174|NCT01931982|Incretins|incretins|mesh-ancestor
64882175|NCT01931982|Hormones|hormones|mesh-ancestor
64882176|NCT01931982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64882177|NCT01932151|Terlipressin|terlipressin|mesh-list
64882178|NCT01932151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64882179|NCT01932151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64882180|NCT01932177|Everolimus|everolimus|mesh-list
64882181|NCT01932177|Sorafenib|sorafenib|mesh-list
64621515|NCT04447716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64621516|NCT04447716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64621517|NCT04447716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64882182|NCT01932177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621518|NCT04447716|Growth Substances|growth substances|mesh-ancestor
64621519|NCT04447716|Growth Inhibitors|growth inhibitors|mesh-ancestor
64621520|NCT04447716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621524|NCT05285124|Melatonin|melatonin|mesh-list
64882183|NCT01932177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64882184|NCT01932177|Immunologic Factors|immunologic factors|mesh-ancestor
64882185|NCT01932177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882186|NCT01932177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64882187|NCT01932177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882188|NCT01932177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882189|NCT01932203|Aspirin|aspirin|mesh-list
64882190|NCT01932203|Cilostazol|cilostazol|mesh-list
64882191|NCT01932203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64882192|NCT01932203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64882193|NCT01932203|Analgesics|analgesics|mesh-ancestor
64882194|NCT01932203|Sensory System Agents|sensory system agents|mesh-ancestor
64882195|NCT01932203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882196|NCT01932203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882197|NCT01932203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64882198|NCT01932203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64882199|NCT01932203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64882200|NCT01932203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64882201|NCT01932203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882202|NCT01932203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64882203|NCT01932203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64882204|NCT01932203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882205|NCT01932203|Antipyretics|antipyretics|mesh-ancestor
64882206|NCT01932203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64882207|NCT01932203|Autonomic Agents|autonomic agents|mesh-ancestor
64882215|NCT01932229|Afatinib|afatinib|mesh-list
64882216|NCT01932229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882217|NCT01932229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64882218|NCT01932229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882219|NCT01932229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882220|NCT01932268|Rifampin|rifampin|mesh-list
64882221|NCT01932268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64882222|NCT01932268|Antitubercular Agents|antitubercular agents|mesh-ancestor
64882223|NCT01932268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64882224|NCT01932268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64882225|NCT01932268|Leprostatic Agents|leprostatic agents|mesh-ancestor
64882226|NCT01932268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64882227|NCT01932268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882228|NCT01932268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882229|NCT01932268|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64882230|NCT01932268|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64882231|NCT01932268|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64882232|NCT01932268|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64882233|NCT01932268|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64882234|NCT01932268|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64882235|NCT01932320|Ketoconazole|ketoconazole|mesh-list
64882236|NCT01932320|Antifungal Agents|antifungal agents|mesh-ancestor
64882237|NCT01932320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64882238|NCT01932320|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64882239|NCT01932320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64882240|NCT01932320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882241|NCT01932320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423745|NCT05159245|Trastuzumab|trastuzumab|mesh-list
64882242|NCT01932320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64882243|NCT01932320|Hormone Antagonists|hormone antagonists|mesh-ancestor
64882244|NCT01932320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64882247|NCT01932372|Etanercept|etanercept|mesh-list
64882255|NCT01932372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882256|NCT01932372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64621545|NCT01450124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64621546|NCT01450124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64621547|NCT01450124|Analgesics|analgesics|mesh-ancestor
64882257|NCT01932372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64882258|NCT01932372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64882259|NCT01932372|Immunologic Factors|immunologic factors|mesh-ancestor
64882260|NCT01932372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64882261|NCT01932372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882262|NCT01932372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882263|NCT01932385|Sorafenib|sorafenib|mesh-list
64882264|NCT01932385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882265|NCT01932385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64882266|NCT01932385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882267|NCT01932385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882268|NCT01932424|Propofol|propofol|mesh-list
64882269|NCT01932424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64882270|NCT01932424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64882271|NCT01932424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882272|NCT01932424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64882273|NCT01932424|Anesthetics, General|anesthetics, general|mesh-ancestor
64882274|NCT01932424|Anesthetics|anesthetics|mesh-ancestor
64882275|NCT01932450|Antihypertensive Agents|antihypertensive agents|mesh-list
64882276|NCT01932502|Clobazam|clobazam|mesh-list
64882277|NCT01932502|Anticonvulsants|anticonvulsants|mesh-ancestor
64882278|NCT01932502|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64882279|NCT01932502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64882280|NCT01932502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64882281|NCT01932502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882282|NCT01932502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64882283|NCT01932502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64882284|NCT01932502|GABA Agonists|gaba agonists|mesh-ancestor
64882285|NCT01932502|GABA Agents|gaba agents|mesh-ancestor
64882286|NCT01932502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64882287|NCT01932502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882288|NCT01932541|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64882289|NCT01932541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64882290|NCT01932541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64882291|NCT01932541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64882292|NCT01932541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882293|NCT01932541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64882294|NCT01932541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64882295|NCT01932541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64882296|NCT01932541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64882297|NCT01932541|Adrenergic Agents|adrenergic agents|mesh-ancestor
64882298|NCT01932541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64882299|NCT01932541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882300|NCT01932541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64882301|NCT01932541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64882302|NCT01932541|Serotonin Agents|serotonin agents|mesh-ancestor
64882303|NCT01932541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64882304|NCT01932541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64882305|NCT01932541|Dopamine Agents|dopamine agents|mesh-ancestor
64882306|NCT01932554|Ibuprofen|ibuprofen|mesh-list
64882307|NCT01932554|Fentanyl|fentanyl|mesh-list
64882308|NCT01932554|Morphine|morphine|mesh-list
64882309|NCT01932554|Hydromorphone|hydromorphone|mesh-list
64882310|NCT01932554|Narcotics|narcotics|mesh-list
64882311|NCT01932554|Abciximab|abciximab|mesh-list
64882312|NCT01932554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64882313|NCT01932554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64621557|NCT03751124|Estradiol|estradiol|mesh-list
64882314|NCT01932554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882338|NCT01932580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882339|NCT01932580|Antimetabolites|antimetabolites|mesh-ancestor
64882340|NCT01932580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64882341|NCT01932580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64882342|NCT01932580|Immunologic Factors|immunologic factors|mesh-ancestor
64423748|NCT05159245|Trametinib|trametinib|mesh-list
64882343|NCT01932580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882345|NCT01932918|Morphine|morphine|mesh-list
64882346|NCT01932918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64882347|NCT01932918|Narcotics|narcotics|mesh-ancestor
64882348|NCT01932918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64882349|NCT01932918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882350|NCT01932918|Analgesics|analgesics|mesh-ancestor
64882351|NCT01932918|Sensory System Agents|sensory system agents|mesh-ancestor
64882352|NCT01932918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882353|NCT01932918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64882354|NCT01932918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64882355|NCT01932918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64882356|NCT01932918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64882357|NCT01932918|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64882358|NCT01932918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882359|NCT01932918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882360|NCT01932931|Vitamin D|vitamin d|mesh-list
64882361|NCT01932931|Cholecalciferol|cholecalciferol|mesh-list
64882362|NCT01932931|Vitamins|vitamins|mesh-ancestor
64882363|NCT01932931|Micronutrients|micronutrients|mesh-ancestor
64882364|NCT01932931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882365|NCT01932931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64882366|NCT01932931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64882367|NCT01933022|Leuprolide|leuprolide|mesh-list
64882368|NCT01933022|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64882369|NCT01933022|Fertility Agents|fertility agents|mesh-ancestor
64882370|NCT01933022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64882376|NCT01933061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64882377|NCT01933061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882378|NCT01933061|Tubulin Modulators|tubulin modulators|mesh-ancestor
64882379|NCT01933061|Antimitotic Agents|antimitotic agents|mesh-ancestor
64882380|NCT01933061|Mitosis Modulators|mitosis modulators|mesh-ancestor
64882381|NCT01933061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882382|NCT01933152|Ranibizumab|ranibizumab|mesh-list
64882383|NCT01933152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64882384|NCT01933152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64621596|NCT04391660|Eusol|eusol|mesh-list
64882385|NCT01933152|Growth Substances|growth substances|mesh-ancestor
64882386|NCT01933152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882387|NCT01933152|Growth Inhibitors|growth inhibitors|mesh-ancestor
64882388|NCT01933152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882389|NCT01933347|Gefitinib|gefitinib|mesh-list
64882390|NCT01933347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882391|NCT01933347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64882392|NCT01933347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882393|NCT01933347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882394|NCT01933360|Misoprostol|misoprostol|mesh-list
64882395|NCT01933360|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64882396|NCT01933360|Abortifacient Agents|abortifacient agents|mesh-ancestor
64882397|NCT01933360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64882398|NCT01933360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882399|NCT01933360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64882400|NCT01933360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64882401|NCT01933360|Oxytocics|oxytocics|mesh-ancestor
64882402|NCT01933412|Vaccines|vaccines|mesh-list
64882403|NCT01933412|Immunologic Factors|immunologic factors|mesh-ancestor
64882404|NCT01933412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882405|NCT01933490|Insulin Aspart|insulin aspart|mesh-list
64882406|NCT01933490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64882407|NCT01933490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882419|NCT01933542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64882420|NCT01933542|Narcotics|narcotics|mesh-ancestor
64882421|NCT01933542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64882422|NCT01933542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882423|NCT01933542|Analgesics|analgesics|mesh-ancestor
64882424|NCT01933542|Sensory System Agents|sensory system agents|mesh-ancestor
64882425|NCT01933542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882426|NCT01933542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64882427|NCT01933542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64423750|NCT05159245|Dabrafenib|dabrafenib|mesh-list
64882428|NCT01933568|Cisplatin|cisplatin|mesh-list
64882429|NCT01933568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882430|NCT01933698|Amoxicillin|amoxicillin|mesh-list
64882431|NCT01933698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64882432|NCT01933698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64882434|NCT01933711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64882435|NCT01933711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882436|NCT01933711|Immunologic Factors|immunologic factors|mesh-ancestor
64882479|NCT01934088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882480|NCT01934088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64882481|NCT01934088|Anesthetics, General|anesthetics, general|mesh-ancestor
64882483|NCT01934088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64882484|NCT01934088|Narcotics|narcotics|mesh-ancestor
64651021|NCT03247088|Busulfan|busulfan|mesh-list
64882486|NCT01934088|Sensory System Agents|sensory system agents|mesh-ancestor
64882487|NCT01934088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882488|NCT01934088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64882489|NCT01934088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64882490|NCT01934088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64882491|NCT01934088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64882492|NCT01934088|GABA Modulators|gaba modulators|mesh-ancestor
64882493|NCT01934088|GABA Agents|gaba agents|mesh-ancestor
64882494|NCT01934088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64882496|NCT01934127|Vaccines|vaccines|mesh-list
64882540|NCT01934569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64882541|NCT01934569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64882542|NCT01934569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64882543|NCT01934569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64882544|NCT01934569|Antimetabolites|antimetabolites|mesh-ancestor
64882545|NCT01934569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64882546|NCT01934569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64882547|NCT01934634|Gemcitabine|gemcitabine|mesh-list
64882548|NCT01934634|Paclitaxel|paclitaxel|mesh-list
64882549|NCT01934634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64882550|NCT01934634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882551|NCT01934634|Tubulin Modulators|tubulin modulators|mesh-ancestor
64882552|NCT01934634|Antimitotic Agents|antimitotic agents|mesh-ancestor
64882553|NCT01934634|Mitosis Modulators|mitosis modulators|mesh-ancestor
64882554|NCT01934634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882555|NCT01934634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64882556|NCT01934634|Antimetabolites|antimetabolites|mesh-ancestor
64882557|NCT01934634|Antiviral Agents|antiviral agents|mesh-ancestor
64882558|NCT01934634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64882559|NCT01934634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882560|NCT01934634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64882561|NCT01934634|Immunologic Factors|immunologic factors|mesh-ancestor
64882562|NCT01934634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882563|NCT01934712|Insulin|insulin|mesh-list
64882593|NCT01934816|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64882594|NCT01934816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64882596|NCT01934829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882597|NCT01934829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64882598|NCT01934829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882599|NCT01934829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882600|NCT01934933|Celecoxib|celecoxib|mesh-list
64882601|NCT01934933|Etanercept|etanercept|mesh-list
64882602|NCT01934933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64882603|NCT01934933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64882604|NCT01934933|Analgesics|analgesics|mesh-ancestor
64882605|NCT01934933|Sensory System Agents|sensory system agents|mesh-ancestor
64882606|NCT01934933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882607|NCT01934933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882608|NCT01934933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64882609|NCT01934933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64882610|NCT01934933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64882611|NCT01934933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64882612|NCT01934933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882613|NCT01934933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882614|NCT01934933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64882615|NCT01934933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64882644|NCT01935115|Anesthetics, General|anesthetics, general|mesh-ancestor
64882645|NCT01935115|Anesthetics|anesthetics|mesh-ancestor
64882646|NCT01935115|Analgesics|analgesics|mesh-ancestor
64882647|NCT01935115|Sensory System Agents|sensory system agents|mesh-ancestor
64882648|NCT01935115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882649|NCT01935115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64882650|NCT01935115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64423753|NCT05159245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64882651|NCT01935115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64882652|NCT01935115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64882653|NCT01935115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882654|NCT01935141|Triiodobenzoic Acids|triiodobenzoic acids|mesh-list
64882655|NCT01935141|Plant Growth Regulators|plant growth regulators|mesh-ancestor
64882656|NCT01935141|Growth Substances|growth substances|mesh-ancestor
64882657|NCT01935141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882658|NCT01935193|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
64882659|NCT01935193|Analgesics|analgesics|mesh-ancestor
64882660|NCT01935193|Sensory System Agents|sensory system agents|mesh-ancestor
64882661|NCT01935193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882662|NCT01935193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882663|NCT01935193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64882664|NCT01935193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64882665|NCT01935193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64882666|NCT01935193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64882667|NCT01935193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64882668|NCT01935193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64882669|NCT01935193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882670|NCT01935193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882671|NCT01935206|Naloxone|naloxone|mesh-list
64882672|NCT01935206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64882673|NCT01935206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882674|NCT01935206|Sensory System Agents|sensory system agents|mesh-ancestor
64882676|NCT01935310|Imiquimod|imiquimod|mesh-list
64882685|NCT01935492|Doxorubicin|doxorubicin|mesh-list
64882686|NCT01935492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64882687|NCT01935492|Capecitabine|capecitabine|mesh-list
64882688|NCT01935492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64882689|NCT01935492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882690|NCT01935492|Tubulin Modulators|tubulin modulators|mesh-ancestor
64882691|NCT01935492|Antimitotic Agents|antimitotic agents|mesh-ancestor
64882692|NCT01935492|Mitosis Modulators|mitosis modulators|mesh-ancestor
64882693|NCT01935492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882694|NCT01935492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64882695|NCT01935492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64882696|NCT01935492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64882697|NCT01935492|Growth Substances|growth substances|mesh-ancestor
64882698|NCT01935492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882699|NCT01935492|Growth Inhibitors|growth inhibitors|mesh-ancestor
64882700|NCT01935492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64882701|NCT01935492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64882702|NCT01935492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64882703|NCT01935492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621654|NCT05095116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621655|NCT05095116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621656|NCT05095116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64621657|NCT05095116|Respiratory System Agents|respiratory system agents|mesh-ancestor
64621658|NCT05095116|Dermatologic Agents|dermatologic agents|mesh-ancestor
64882704|NCT01935492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64882705|NCT01935492|Antimetabolites|antimetabolites|mesh-ancestor
64882706|NCT01935505|Bupropion|bupropion|mesh-list
64882707|NCT01935505|Nicotine|nicotine|mesh-list
64882708|NCT01935505|Varenicline|varenicline|mesh-list
64882709|NCT01935505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64882710|NCT01935505|Autonomic Agents|autonomic agents|mesh-ancestor
64882713|NCT01935505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64882732|NCT01935518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64882733|NCT01935518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882734|NCT01935518|Vasodilator Agents|vasodilator agents|mesh-ancestor
64882735|NCT01935518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64882736|NCT01935518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882737|NCT01935531|Diclofenac|diclofenac|mesh-list
64423792|NCT05189977|Propranolol|propranolol|mesh-list
64882738|NCT01935531|Hyaluronic Acid|hyaluronic acid|mesh-list
64882739|NCT01935531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64882740|NCT01935531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64882741|NCT01935531|Analgesics|analgesics|mesh-ancestor
64882742|NCT01935531|Sensory System Agents|sensory system agents|mesh-ancestor
64882743|NCT01935531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882744|NCT01935531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882745|NCT01935531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64882746|NCT01935531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64882747|NCT01935531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64882748|NCT01935531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882749|NCT01935531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882750|NCT01935531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64882751|NCT01935531|Immunologic Factors|immunologic factors|mesh-ancestor
64621663|NCT02899052|Antiemetics|antiemetics|mesh-ancestor
64882752|NCT01935531|Viscosupplements|viscosupplements|mesh-ancestor
64882753|NCT01935531|Protective Agents|protective agents|mesh-ancestor
64882754|NCT01935544|Botulinum Toxins|botulinum toxins|mesh-list
64882755|NCT01935544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64882756|NCT01935544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64882757|NCT01935544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882779|NCT01935648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882780|NCT01935648|Sensory System Agents|sensory system agents|mesh-ancestor
64882781|NCT01935648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882782|NCT01935674|Ritonavir|ritonavir|mesh-list
64882783|NCT01935674|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64882784|NCT01935674|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64882785|NCT01935674|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64882786|NCT01935674|Protease Inhibitors|protease inhibitors|mesh-ancestor
64882787|NCT01935674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882788|NCT01935674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882790|NCT01935674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64882791|NCT01935674|Antiviral Agents|antiviral agents|mesh-ancestor
64882792|NCT01935674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64621664|NCT02899052|Autonomic Agents|autonomic agents|mesh-ancestor
64621665|NCT02899052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621666|NCT02899052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621667|NCT02899052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64621668|NCT02899052|Glucocorticoids|glucocorticoids|mesh-ancestor
64882793|NCT01935674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64621669|NCT02899052|Hormones|hormones|mesh-ancestor
64882794|NCT01935674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64882795|NCT01935674|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64882796|NCT01935674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64882797|NCT01935674|Antimetabolites|antimetabolites|mesh-ancestor
64882798|NCT01935674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64882799|NCT01935674|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64882800|NCT01935713|Nicotine|nicotine|mesh-list
64882801|NCT01935713|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64882802|NCT01935713|Autonomic Agents|autonomic agents|mesh-ancestor
64882803|NCT01935713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882804|NCT01935713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882805|NCT01935713|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64882806|NCT01935713|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64882807|NCT01935713|Cholinergic Agents|cholinergic agents|mesh-ancestor
64882810|NCT01935804|Metformin|metformin|mesh-list
64882827|NCT01935830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64882828|NCT01935830|Protease Inhibitors|protease inhibitors|mesh-ancestor
64882829|NCT01935830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882830|NCT01935830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882831|NCT01935830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64882832|NCT01935830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64882833|NCT01935830|Antiviral Agents|antiviral agents|mesh-ancestor
64882834|NCT01935830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64882835|NCT01935830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64882836|NCT01935830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64882837|NCT01935830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64882838|NCT01935830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64882886|NCT01936025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64882887|NCT01936025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64882888|NCT01936064|Cyclophosphamide|cyclophosphamide|mesh-list
64882889|NCT01936064|Epirubicin|epirubicin|mesh-list
64882890|NCT01936064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64882891|NCT01936064|Immunologic Factors|immunologic factors|mesh-ancestor
64882892|NCT01936064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882893|NCT01936064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64882894|NCT01936064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64882895|NCT01936064|Alkylating Agents|alkylating agents|mesh-ancestor
64621678|NCT04758728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621679|NCT04758728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882896|NCT01936064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882897|NCT01936064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882898|NCT01936064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64882899|NCT01936064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64882900|NCT01936064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64882901|NCT01936064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64882902|NCT01936064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882903|NCT01936090|Bortezomib|bortezomib|mesh-list
64882904|NCT01936090|Melphalan|melphalan|mesh-list
64882905|NCT01936090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882906|NCT01936090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64882907|NCT01936090|Alkylating Agents|alkylating agents|mesh-ancestor
64882913|NCT01936103|Atorvastatin|atorvastatin|mesh-list
64882938|NCT01936233|Sensory System Agents|sensory system agents|mesh-ancestor
64882939|NCT01936233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64882940|NCT01936233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882941|NCT01936233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64882942|NCT01936233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64882943|NCT01936233|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64882944|NCT01936233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64882945|NCT01936233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882946|NCT01936233|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64882947|NCT01936233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64882948|NCT01936233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882949|NCT01936233|Antipyretics|antipyretics|mesh-ancestor
64882950|NCT01936233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64882951|NCT01936233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64882952|NCT01936233|Antiviral Agents|antiviral agents|mesh-ancestor
64621712|NCT04840238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64882953|NCT01936233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64882954|NCT01936233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64882955|NCT01936233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64882956|NCT01936285|Colchicine|colchicine|mesh-list
64882957|NCT01936285|Gout Suppressants|gout suppressants|mesh-ancestor
64882958|NCT01936285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64882959|NCT01936285|Tubulin Modulators|tubulin modulators|mesh-ancestor
64882960|NCT01936285|Antimitotic Agents|antimitotic agents|mesh-ancestor
64882961|NCT01936285|Mitosis Modulators|mitosis modulators|mesh-ancestor
64882962|NCT01936285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882963|NCT01936285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882964|NCT01936350|Sildenafil Citrate|sildenafil citrate|mesh-list
64882965|NCT01936350|Vasodilator Agents|vasodilator agents|mesh-ancestor
64882966|NCT01936350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64882967|NCT01936350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64882968|NCT01936350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882982|NCT01936532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64882983|NCT01936532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64882984|NCT01936532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64882985|NCT01936532|Immunologic Factors|immunologic factors|mesh-ancestor
64882986|NCT01936532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64882987|NCT01936532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64882988|NCT01936532|Growth Substances|growth substances|mesh-ancestor
64882989|NCT01936532|Growth Inhibitors|growth inhibitors|mesh-ancestor
64882990|NCT01936532|Protease Inhibitors|protease inhibitors|mesh-ancestor
64882991|NCT01936532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64882992|NCT01936532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64882993|NCT01936545|Propofol|propofol|mesh-list
64621713|NCT03829618|Lidocaine|lidocaine|mesh-list
64484309|NCT05640778|Immunologic Factors|immunologic factors|mesh-ancestor
64882994|NCT01936545|Desflurane|desflurane|mesh-list
64882995|NCT01936545|Liver Extracts|liver extracts|mesh-list
64882996|NCT01936545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64882997|NCT01936545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64882998|NCT01936545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64882999|NCT01936545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64883000|NCT01936545|Anesthetics, General|anesthetics, general|mesh-ancestor
64883001|NCT01936545|Anesthetics|anesthetics|mesh-ancestor
64883002|NCT01936545|Hematinics|hematinics|mesh-ancestor
64883003|NCT01936545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64883004|NCT01936636|Fentanyl|fentanyl|mesh-list
64883005|NCT01936636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64883027|NCT01937013|Oxytocin|oxytocin|mesh-list
64883028|NCT01937013|Oxytocics|oxytocics|mesh-ancestor
64883029|NCT01937013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64883030|NCT01937013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883031|NCT01937078|Famotidine|famotidine|mesh-list
64883032|NCT01937078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64883033|NCT01937078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64883034|NCT01937078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64883035|NCT01937078|Histamine Antagonists|histamine antagonists|mesh-ancestor
64883036|NCT01937078|Histamine Agents|histamine agents|mesh-ancestor
64883037|NCT01937078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64883038|NCT01937078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883039|NCT01937078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883040|NCT01937104|Remifentanil|remifentanil|mesh-list
64883041|NCT01937104|Desflurane|desflurane|mesh-list
64883042|NCT01937104|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64883043|NCT01937104|Narcotics|narcotics|mesh-ancestor
64883044|NCT01937104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64883045|NCT01937104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883046|NCT01937104|Analgesics|analgesics|mesh-ancestor
64423852|NCT05106127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64883058|NCT01937169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883060|NCT01937182|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
64883061|NCT01937182|Serotonin|serotonin|mesh-list
64883062|NCT01937182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64621727|NCT04272788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64621728|NCT04272788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64621729|NCT01457690|Tocopherols|tocopherols|mesh-list
64621730|NCT01457690|Vitamin E|vitamin e|mesh-list
64883063|NCT01937182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64883064|NCT01937182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621731|NCT01457690|Tocotrienols|tocotrienols|mesh-list
64883065|NCT01937182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64883066|NCT01937182|Serotonin Agents|serotonin agents|mesh-ancestor
64333792|NCT02373033|Micronutrients|micronutrients|mesh-ancestor
64333793|NCT02373033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333794|NCT05186129|Clopidogrel|clopidogrel|mesh-list
64333795|NCT05186129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64333796|NCT05186129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64333797|NCT05186129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64333798|NCT05186129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64333799|NCT05186129|Purinergic Agents|purinergic agents|mesh-ancestor
64333800|NCT05186129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64333801|NCT05186129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883067|NCT01937182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883068|NCT01937182|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64883069|NCT01937182|Antidepressive Agents|antidepressive agents|mesh-ancestor
64883070|NCT01937182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64883071|NCT01937182|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64883072|NCT01937234|Metoclopramide|metoclopramide|mesh-list
64883073|NCT01937234|Antiemetics|antiemetics|mesh-ancestor
64883074|NCT01937234|Autonomic Agents|autonomic agents|mesh-ancestor
64883075|NCT01937234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64883076|NCT01937234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883077|NCT01937234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64883078|NCT01937234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64883079|NCT01937234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64883080|NCT01937234|Dopamine Agents|dopamine agents|mesh-ancestor
64883081|NCT01937234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64883082|NCT01937234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883083|NCT01937325|Ivacaftor|ivacaftor|mesh-list
64883084|NCT01937325|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64883085|NCT01937325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64883086|NCT01937325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883088|NCT01937338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64883118|NCT01937611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64621763|NCT04904562|Protease Inhibitors|protease inhibitors|mesh-ancestor
64883119|NCT01937611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883120|NCT01937611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64883121|NCT01937611|Analgesics|analgesics|mesh-ancestor
64883122|NCT01937611|Sensory System Agents|sensory system agents|mesh-ancestor
64883123|NCT01937611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64883124|NCT01937611|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64883125|NCT01937611|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64883126|NCT01937611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64883127|NCT01937611|Adrenergic Agents|adrenergic agents|mesh-ancestor
64883128|NCT01937611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64883129|NCT01937611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883130|NCT01937611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64883131|NCT01937611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64883132|NCT01937611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64883133|NCT01937611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64883134|NCT01937611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64883135|NCT01937611|Anesthetics, General|anesthetics, general|mesh-ancestor
64333802|NCT05186129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333803|NCT03596281|Bevacizumab|bevacizumab|mesh-list
64333804|NCT03596281|Pembrolizumab|pembrolizumab|mesh-list
64333805|NCT03596281|Doxorubicin|doxorubicin|mesh-list
64883138|NCT01937611|GABA Agents|gaba agents|mesh-ancestor
64883139|NCT01937650|Metronidazole|metronidazole|mesh-list
64883140|NCT01937650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64883141|NCT01937650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64883142|NCT01937650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64883143|NCT01937650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64883144|NCT01937728|Interferons|interferons|mesh-list
64423927|NCT05174611|Vitamin D|vitamin d|mesh-list
64883177|NCT01937767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64883178|NCT01937767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883179|NCT01937767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64883180|NCT01937767|Anesthetics, General|anesthetics, general|mesh-ancestor
64883181|NCT01937767|Anesthetics|anesthetics|mesh-ancestor
64883182|NCT01937767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64883183|NCT01937767|Narcotics|narcotics|mesh-ancestor
64883184|NCT01937767|Analgesics|analgesics|mesh-ancestor
64883185|NCT01937767|Sensory System Agents|sensory system agents|mesh-ancestor
64621796|NCT01187017|Alkylating Agents|alkylating agents|mesh-ancestor
64621797|NCT01187017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621798|NCT01187017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621799|NCT01187017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64883186|NCT01937767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64883187|NCT01937767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64883188|NCT01937767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64883189|NCT01937767|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64621800|NCT00378118|Antibodies|antibodies|mesh-list
64621801|NCT00378118|Immunoglobulins|immunoglobulins|mesh-list
64621802|NCT00378118|HIV Antibodies|hiv antibodies|mesh-list
64621803|NCT00378118|Immunologic Factors|immunologic factors|mesh-ancestor
64621804|NCT00378118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883190|NCT01937767|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64883191|NCT01937767|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64621805|NCT01224145|Bupivacaine|bupivacaine|mesh-list
64883192|NCT01937767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64883193|NCT01937806|Tenofovir|tenofovir|mesh-list
64333810|NCT03596281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64333811|NCT03596281|Growth Substances|growth substances|mesh-ancestor
64333812|NCT03596281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333813|NCT03596281|Growth Inhibitors|growth inhibitors|mesh-ancestor
64333814|NCT03596281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64883208|NCT01938092|Antiemetics|antiemetics|mesh-ancestor
64883209|NCT01938092|Autonomic Agents|autonomic agents|mesh-ancestor
64883210|NCT01938092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64883211|NCT01938092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883212|NCT01938092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64883213|NCT01938092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64883214|NCT01938092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64883215|NCT01938092|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64883216|NCT01938092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64883217|NCT01938092|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64883218|NCT01938092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64883219|NCT01938092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64883220|NCT01938092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64883221|NCT01938092|Anesthetics, General|anesthetics, general|mesh-ancestor
64883222|NCT01938092|Anesthetics|anesthetics|mesh-ancestor
64883223|NCT01938092|GABA Modulators|gaba modulators|mesh-ancestor
64883224|NCT01938092|GABA Agents|gaba agents|mesh-ancestor
64883225|NCT01938092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64883226|NCT01938092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883227|NCT01938105|Nimotuzumab|nimotuzumab|mesh-list
64883228|NCT01938105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64883229|NCT01938105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883230|NCT01938144|Acetaminophen|acetaminophen|mesh-list
64883231|NCT01938144|Ibuprofen|ibuprofen|mesh-list
64883232|NCT01938144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64883233|NCT01938144|Analgesics|analgesics|mesh-ancestor
64883234|NCT01938144|Sensory System Agents|sensory system agents|mesh-ancestor
64883235|NCT01938144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64883236|NCT01938144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883237|NCT01938144|Antipyretics|antipyretics|mesh-ancestor
64333825|NCT02221583|Mycophenolic Acid|mycophenolic acid|mesh-list
64333826|NCT02221583|Tacrolimus|tacrolimus|mesh-list
64333827|NCT02221583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64333828|NCT02221583|Immunologic Factors|immunologic factors|mesh-ancestor
64333829|NCT02221583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333830|NCT02221583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64333831|NCT02221583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64883238|NCT01938144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64883239|NCT01938144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64883241|NCT01938144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64883242|NCT01938144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64883243|NCT01938144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883244|NCT01938183|Metronidazole|metronidazole|mesh-list
64883245|NCT01938183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64883246|NCT01938183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64883247|NCT01938183|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64883248|NCT01938183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64883249|NCT01938235|Exenatide|exenatide|mesh-list
64883250|NCT01938235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64883251|NCT01938235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621819|NCT01451840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621820|NCT01451840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64883252|NCT01938235|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64883253|NCT01938235|Incretins|incretins|mesh-ancestor
64883254|NCT01938235|Hormones|hormones|mesh-ancestor
64883255|NCT01938235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64883256|NCT01938300|Magnesium Sulfate|magnesium sulfate|mesh-list
64883257|NCT01938300|Analgesics|analgesics|mesh-ancestor
64883258|NCT01938300|Sensory System Agents|sensory system agents|mesh-ancestor
64883259|NCT01938300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64883260|NCT01938300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883261|NCT01938300|Anesthetics|anesthetics|mesh-ancestor
64883262|NCT01938300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64883263|NCT01938300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64883264|NCT01938300|Anticonvulsants|anticonvulsants|mesh-ancestor
64883265|NCT01938300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64883266|NCT01938300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64883267|NCT01938300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883268|NCT01938300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64883269|NCT01938300|Tocolytic Agents|tocolytic agents|mesh-ancestor
64883271|NCT01938417|Tobramycin|tobramycin|mesh-list
64883278|NCT01938443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883280|NCT01938456|Trametinib|trametinib|mesh-list
64347989|NCT02230306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64333836|NCT02221583|Antitubercular Agents|antitubercular agents|mesh-ancestor
64333837|NCT02221583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64333838|NCT02221583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64333839|NCT03514069|Temozolomide|temozolomide|mesh-list
64883334|NCT01938859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64883335|NCT01938859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64883336|NCT01938859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883337|NCT01938872|Paclitaxel|paclitaxel|mesh-list
64883338|NCT01938872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64883339|NCT01938872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883340|NCT01938872|Tubulin Modulators|tubulin modulators|mesh-ancestor
64883341|NCT01938872|Antimitotic Agents|antimitotic agents|mesh-ancestor
64883342|NCT01938872|Mitosis Modulators|mitosis modulators|mesh-ancestor
64883343|NCT01938872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883344|NCT01938911|Oxytocin|oxytocin|mesh-list
64883345|NCT01938911|Oxytocics|oxytocics|mesh-ancestor
64883346|NCT01938911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64883347|NCT01938911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883348|NCT01939054|Docetaxel|docetaxel|mesh-list
64883349|NCT01939054|Capecitabine|capecitabine|mesh-list
64883350|NCT01939054|Nimotuzumab|nimotuzumab|mesh-list
64883351|NCT01939054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883352|NCT01939054|Tubulin Modulators|tubulin modulators|mesh-ancestor
64883353|NCT01939054|Antimitotic Agents|antimitotic agents|mesh-ancestor
64883354|NCT01939054|Mitosis Modulators|mitosis modulators|mesh-ancestor
64883355|NCT01939054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883356|NCT01939054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64883357|NCT01939054|Antimetabolites|antimetabolites|mesh-ancestor
64883358|NCT01939054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64883359|NCT01939093|Thiamine|thiamine|mesh-list
64883360|NCT01939093|Cinnarizine|cinnarizine|mesh-list
64883361|NCT01939093|Diazepam|diazepam|mesh-list
64883362|NCT01939093|Vitamins|vitamins|mesh-ancestor
64883363|NCT01939093|Micronutrients|micronutrients|mesh-ancestor
64883364|NCT01939093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883365|NCT01939093|Vitamin B Complex|vitamin b complex|mesh-ancestor
64883366|NCT01939093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64621836|NCT00378196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64621837|NCT00378196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64883367|NCT01939093|Anticonvulsants|anticonvulsants|mesh-ancestor
64621838|NCT00378196|Growth Substances|growth substances|mesh-ancestor
64883368|NCT01939093|Antiemetics|antiemetics|mesh-ancestor
64883369|NCT01939093|Autonomic Agents|autonomic agents|mesh-ancestor
64883370|NCT01939093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64883371|NCT01939093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64883372|NCT01939093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64883373|NCT01939093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64424127|NCT04997317|Sequestering Agents|sequestering agents|mesh-ancestor
64883387|NCT01939093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64883388|NCT01939093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64883389|NCT01939093|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64883390|NCT01939093|Histamine Antagonists|histamine antagonists|mesh-ancestor
64883392|NCT01939171|Thymoglobulin|thymoglobulin|mesh-list
64883393|NCT01939171|Immunologic Factors|immunologic factors|mesh-ancestor
64883394|NCT01939171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883395|NCT01939171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64883396|NCT01939327|Rituximab|rituximab|mesh-list
64883397|NCT01939327|Lenalidomide|lenalidomide|mesh-list
64883398|NCT01939327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64883399|NCT01939327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883400|NCT01939327|Immunologic Factors|immunologic factors|mesh-ancestor
64883401|NCT01939327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883402|NCT01939327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64883403|NCT01939327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64883404|NCT01939327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64883405|NCT01939327|Growth Substances|growth substances|mesh-ancestor
64883406|NCT01939327|Growth Inhibitors|growth inhibitors|mesh-ancestor
64883407|NCT01939379|Acetaminophen|acetaminophen|mesh-list
64883408|NCT01939379|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64621850|NCT01188109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64621851|NCT01188109|Immunologic Factors|immunologic factors|mesh-ancestor
64621852|NCT01188109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621853|NCT01458236|Beraprost|beraprost|mesh-list
64621854|NCT01458236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64621855|NCT01458236|Vasodilator Agents|vasodilator agents|mesh-ancestor
64621856|NCT01146457|Morphine|morphine|mesh-list
64621857|NCT01146457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64621858|NCT01146457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64621859|NCT01146457|Narcotics|narcotics|mesh-ancestor
64621860|NCT01146457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64621861|NCT01146457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883409|NCT01939379|Morphine|morphine|mesh-list
64621862|NCT01146457|Analgesics|analgesics|mesh-ancestor
64621863|NCT01146457|Sensory System Agents|sensory system agents|mesh-ancestor
64424180|NCT04946305|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64883410|NCT01939379|Oxycodone|oxycodone|mesh-list
64883411|NCT01939379|Analgesics|analgesics|mesh-list
64883412|NCT01939379|Ropivacaine|ropivacaine|mesh-list
64883413|NCT01939379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64621885|NCT04011592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621886|NCT04011592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621887|NCT04011592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64883414|NCT01939379|Narcotics|narcotics|mesh-ancestor
64883415|NCT01939379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64883416|NCT01939379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883417|NCT01939379|Sensory System Agents|sensory system agents|mesh-ancestor
64883418|NCT01939379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64883419|NCT01939379|Anesthetics, Local|anesthetics, local|mesh-ancestor
64883420|NCT01939379|Anesthetics|anesthetics|mesh-ancestor
64883421|NCT01939379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64883427|NCT01939418|Everolimus|everolimus|mesh-list
64883439|NCT01939444|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64883440|NCT01939444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883441|NCT01939444|Sensory System Agents|sensory system agents|mesh-ancestor
64883442|NCT01939444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64883443|NCT01939457|Misoprostol|misoprostol|mesh-list
64883444|NCT01939457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64883445|NCT01939457|Abortifacient Agents|abortifacient agents|mesh-ancestor
64883446|NCT01939457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64883447|NCT01939457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883448|NCT01939457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64883449|NCT01939457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64883450|NCT01939457|Oxytocics|oxytocics|mesh-ancestor
64883451|NCT01939483|Irinotecan|irinotecan|mesh-list
64883452|NCT01939483|Camptothecin|camptothecin|mesh-list
64883453|NCT01939483|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64883454|NCT01939483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64883455|NCT01939483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64883456|NCT01939483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883457|NCT01939483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883458|NCT01939483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64883459|NCT01939509|Atenolol|atenolol|mesh-list
64883460|NCT01939509|Bisoprolol|bisoprolol|mesh-list
64883461|NCT01939509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64883462|NCT01939509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64883463|NCT01939509|Sympatholytics|sympatholytics|mesh-ancestor
64621938|NCT01458626|Mirtazapine|mirtazapine|mesh-list
64883464|NCT01939509|Autonomic Agents|autonomic agents|mesh-ancestor
64883465|NCT01939509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64883486|NCT01939561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64883487|NCT01939561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64883488|NCT01939574|Bevacizumab|bevacizumab|mesh-list
64883489|NCT01939574|Temozolomide|temozolomide|mesh-list
64883490|NCT01939574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64883491|NCT01939574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883492|NCT01939574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64883493|NCT01939574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64883494|NCT01939574|Growth Substances|growth substances|mesh-ancestor
64883495|NCT01939574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883496|NCT01939574|Growth Inhibitors|growth inhibitors|mesh-ancestor
64883497|NCT01939574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64883498|NCT01939574|Alkylating Agents|alkylating agents|mesh-ancestor
64621985|NCT02559414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621986|NCT02559414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64621987|NCT02559414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64621988|NCT02559414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64621989|NCT02559414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64883499|NCT01939574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883500|NCT01939639|Oxytocin|oxytocin|mesh-list
64883501|NCT01939639|Oxytocics|oxytocics|mesh-ancestor
64883502|NCT01939639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64883503|NCT01939639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883504|NCT01939691|Prednisolone|prednisolone|mesh-list
64883505|NCT01939691|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64883506|NCT01939691|Methylprednisolone|methylprednisolone|mesh-list
64622035|NCT01452698|Dexlansoprazole|dexlansoprazole|mesh-list
64622036|NCT01452698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64622037|NCT01452698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64622038|NCT01452698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64622039|NCT01452698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622040|NCT01452698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622041|NCT05029856|Vaccines|vaccines|mesh-list
64883507|NCT01939691|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64883508|NCT01939691|Prednisolone acetate|prednisolone acetate|mesh-list
64883509|NCT01939691|Nepafenac|nepafenac|mesh-list
64883510|NCT01939691|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64348166|NCT03506399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883550|NCT01939743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64883551|NCT01939743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64883552|NCT01939743|Analgesics|analgesics|mesh-ancestor
64424187|NCT04984993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622097|NCT05025644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64622098|NCT05025644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622099|NCT05025644|Protective Agents|protective agents|mesh-ancestor
64622100|NCT05494710|Bleomycin|bleomycin|mesh-list
64622101|NCT05494710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64622102|NCT05494710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64622104|NCT03810066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64622105|NCT03810066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64622106|NCT03810066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622108|NCT03992482|Immunoglobulins|immunoglobulins|mesh-list
64883576|NCT01939912|Sensory System Agents|sensory system agents|mesh-ancestor
64883577|NCT01939912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64883578|NCT01939912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883579|NCT01939912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64883580|NCT01939912|Vasodilator Agents|vasodilator agents|mesh-ancestor
64883581|NCT01939912|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64883582|NCT01939912|Purinergic Agonists|purinergic agonists|mesh-ancestor
64883583|NCT01939912|Purinergic Agents|purinergic agents|mesh-ancestor
64883584|NCT01939912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64883585|NCT01939912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883591|NCT01939990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64883592|NCT01939990|Adrenergic Agents|adrenergic agents|mesh-ancestor
64883593|NCT01939990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64883594|NCT01939990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622154|NCT02880020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883595|NCT01939990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883596|NCT01940081|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64622155|NCT02880020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64622156|NCT02880020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622157|NCT03150160|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64622158|NCT03150160|Travoprost|travoprost|mesh-list
64622159|NCT03150160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64622160|NCT03150160|Brinzolamide|brinzolamide|mesh-list
64622161|NCT03150160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64622162|NCT03150160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64622163|NCT03150160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64622172|NCT01459406|Levan|levan|mesh-list
64883597|NCT01940081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883598|NCT01940081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64883599|NCT01940081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333842|NCT03514069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333843|NCT03514069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333845|NCT03500731|Alemtuzumab|alemtuzumab|mesh-list
64333846|NCT03500731|Fludarabine|fludarabine|mesh-list
64883621|NCT01940250|Magnesium Sulfate|magnesium sulfate|mesh-list
64883622|NCT01940250|Analgesics|analgesics|mesh-ancestor
64883623|NCT01940250|Sensory System Agents|sensory system agents|mesh-ancestor
64883624|NCT01940250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64883625|NCT01940250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883626|NCT01940250|Anesthetics|anesthetics|mesh-ancestor
64883627|NCT01940250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64883628|NCT01940250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64883629|NCT01940250|Anticonvulsants|anticonvulsants|mesh-ancestor
64883630|NCT01940250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64883631|NCT01940250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64883632|NCT01940250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883635|NCT01940250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64883636|NCT01940393|Cetirizine|cetirizine|mesh-list
64883637|NCT01940393|Fexofenadine|fexofenadine|mesh-list
64883638|NCT01940393|Desloratadine|desloratadine|mesh-list
64883639|NCT01940393|Ebastine|ebastine|mesh-list
64622203|NCT04272476|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64622204|NCT04272476|Antidepressive Agents|antidepressive agents|mesh-ancestor
64622205|NCT04272476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64622206|NCT04272476|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64622207|NCT04272476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64622208|NCT04272476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622209|NCT03984838|Dolutegravir|dolutegravir|mesh-list
64622210|NCT03984838|Rilpivirine|rilpivirine|mesh-list
64622211|NCT03984838|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
64622212|NCT03984838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64622213|NCT03984838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64622214|NCT03984838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622216|NCT03984838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64883640|NCT01940393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64883641|NCT01940393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64883642|NCT01940393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64883643|NCT01940393|Histamine Antagonists|histamine antagonists|mesh-ancestor
64333851|NCT03500731|Immunologic Factors|immunologic factors|mesh-ancestor
64333852|NCT03500731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333853|NCT03500731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64348341|NCT02309879|Anesthetics, Local|anesthetics, local|mesh-ancestor
64883659|NCT01940536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883660|NCT01940536|Hemostatics|hemostatics|mesh-ancestor
64883661|NCT01940536|Coagulants|coagulants|mesh-ancestor
64883662|NCT01940601|Lenograstim|lenograstim|mesh-list
64883663|NCT01940601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64883664|NCT01940601|Immunologic Factors|immunologic factors|mesh-ancestor
64883665|NCT01940601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883666|NCT01940627|Ubiquinone|ubiquinone|mesh-list
64883667|NCT01940627|Coenzyme Q10|coenzyme q10|mesh-list
64883668|NCT01940627|Micronutrients|micronutrients|mesh-ancestor
64883669|NCT01940627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883670|NCT01940627|Vitamins|vitamins|mesh-ancestor
64883671|NCT01940653|Estradiol|estradiol|mesh-list
64883672|NCT01940653|Progesterone|progesterone|mesh-list
64883684|NCT01940718|Methyltestosterone|methyltestosterone|mesh-list
64883686|NCT01940718|Testosterone undecanoate|testosterone undecanoate|mesh-list
64883687|NCT01940718|Testosterone enanthate|testosterone enanthate|mesh-list
64883688|NCT01940718|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64883689|NCT01940718|Androgens|androgens|mesh-ancestor
64883690|NCT01940718|Hormones|hormones|mesh-ancestor
64883691|NCT01940718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64348352|NCT02309879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64333854|NCT03500731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333856|NCT03500731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64333857|NCT03500731|Alkylating Agents|alkylating agents|mesh-ancestor
64333858|NCT03500731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64333859|NCT03500731|Antisickling Agents|antisickling agents|mesh-ancestor
64622242|NCT02994576|Atezolizumab|atezolizumab|mesh-list
64333860|NCT03500731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333861|NCT03500731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64333863|NCT02751359|Anticonvulsants|anticonvulsants|mesh-ancestor
64333864|NCT02358993|Ciprofloxacin|ciprofloxacin|mesh-list
64333865|NCT02358993|Methenamine hippurate|methenamine hippurate|mesh-list
64333866|NCT02358993|Methenamine mandelate|methenamine mandelate|mesh-list
64333867|NCT02358993|Methenamine|methenamine|mesh-list
64333868|NCT02358993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64333869|NCT02358993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64333870|NCT02358993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64333871|NCT02358993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64333872|NCT02358993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333873|NCT02358993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333874|NCT02358993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883710|NCT01940965|Lixisenatide|lixisenatide|mesh-list
64883711|NCT01940965|Biguanides|biguanides|mesh-list
64883712|NCT01940965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64883713|NCT01940965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883714|NCT01940978|Cyproheptadine|cyproheptadine|mesh-list
64348382|NCT02820961|Exemestane|exemestane|mesh-list
64333875|NCT02358993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64333876|NCT02358993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64333877|NCT02358993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64622269|NCT04423926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64622270|NCT04423926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64622271|NCT04423926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64622272|NCT04423926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64622273|NCT04423926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64333878|NCT02358993|Renal Agents|renal agents|mesh-ancestor
64333879|NCT04059445|Calcium, Dietary|calcium, dietary|mesh-list
64333880|NCT04059445|Calcium|calcium|mesh-list
64333881|NCT04059445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64883716|NCT01940978|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64883717|NCT01940978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883718|NCT01940978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64883719|NCT01940978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64883720|NCT01940978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64883721|NCT01940978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883722|NCT01940978|Dopamine Agents|dopamine agents|mesh-ancestor
64883723|NCT01940978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64883724|NCT01940978|Antipruritics|antipruritics|mesh-ancestor
64883725|NCT01940978|Dermatologic Agents|dermatologic agents|mesh-ancestor
64883726|NCT01940978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64883727|NCT01940978|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64883741|NCT01941056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883742|NCT01941134|Levonorgestrel|levonorgestrel|mesh-list
64883743|NCT01941134|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64883744|NCT01941134|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64883745|NCT01941134|Contraceptive Agents|contraceptive agents|mesh-list
64622313|NCT02558400|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64622314|NCT00950430|Corticosterone|corticosterone|mesh-list
64622315|NCT00950430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64622316|NCT04758260|Antioxidants|antioxidants|mesh-list
64622317|NCT04758260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622318|NCT04758260|Protective Agents|protective agents|mesh-ancestor
64622319|NCT04758260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622320|NCT01446250|Ribavirin|ribavirin|mesh-list
64622321|NCT01446250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64883746|NCT01941134|Contraceptives, Oral|contraceptives, oral|mesh-list
64883747|NCT01941134|Estradiol|estradiol|mesh-list
64333900|NCT05092841|GABA Agonists|gaba agonists|mesh-ancestor
64333901|NCT05092841|GABA Agents|gaba agents|mesh-ancestor
64883783|NCT01941173|Growth Substances|growth substances|mesh-ancestor
64883784|NCT01941173|Growth Inhibitors|growth inhibitors|mesh-ancestor
64883785|NCT01941199|Metformin|metformin|mesh-list
64883786|NCT01941199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64883787|NCT01941199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883788|NCT01941225|Iloprost|iloprost|mesh-list
64883789|NCT01941225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64883790|NCT01941225|Vasodilator Agents|vasodilator agents|mesh-ancestor
64883791|NCT01941264|Lumefantrine|lumefantrine|mesh-list
64883792|NCT01941264|Artemether|artemether|mesh-list
64883793|NCT01941264|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64622361|NCT04139304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64883794|NCT01941264|Antimalarials|antimalarials|mesh-ancestor
64883795|NCT01941264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64883796|NCT01941264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64883797|NCT01941264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64622368|NCT04139304|Glucocorticoids|glucocorticoids|mesh-ancestor
64883798|NCT01941316|Irinotecan|irinotecan|mesh-list
64883799|NCT01941316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64883800|NCT01941316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64883801|NCT01941316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64883802|NCT01941316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883803|NCT01941316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333920|NCT02372955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333921|NCT02372955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64883933|NCT01942174|Abortifacient Agents|abortifacient agents|mesh-ancestor
64883934|NCT01942174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64883935|NCT01942174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883936|NCT01942174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64883937|NCT01942174|Antimetabolites|antimetabolites|mesh-ancestor
64883957|NCT01942187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64883958|NCT01942187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883959|NCT01942187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64883960|NCT01942187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64883961|NCT01942187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64883962|NCT01942187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64883963|NCT01942187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64883964|NCT01942187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64883965|NCT01942187|Dopamine Agonists|dopamine agonists|mesh-ancestor
64883966|NCT01942187|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64883967|NCT01942187|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64883968|NCT01942187|Serotonin Agents|serotonin agents|mesh-ancestor
64883969|NCT01942187|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64883970|NCT01942187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64883971|NCT01942187|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64883972|NCT01942187|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64883974|NCT01942291|Nicotinic Acids|nicotinic acids|mesh-list
64883975|NCT01942291|Vitamins|vitamins|mesh-ancestor
64883976|NCT01942291|Micronutrients|micronutrients|mesh-ancestor
64883977|NCT01942291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64883978|NCT01942291|Vitamin B Complex|vitamin b complex|mesh-ancestor
64883979|NCT01942291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64883980|NCT01942291|Antimetabolites|antimetabolites|mesh-ancestor
64883981|NCT01942291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64883982|NCT01942291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64883983|NCT01942291|Vasodilator Agents|vasodilator agents|mesh-ancestor
64424737|NCT01653847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424738|NCT01653847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64424739|NCT01653847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884096|NCT01943188|Immunologic Factors|immunologic factors|mesh-ancestor
64425125|NCT02349633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425126|NCT02349633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622418|NCT01406860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622419|NCT01406860|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64622420|NCT01406860|Antipruritics|antipruritics|mesh-ancestor
64622421|NCT01406860|Dermatologic Agents|dermatologic agents|mesh-ancestor
64622422|NCT01406860|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64622423|NCT01406860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64884097|NCT01943188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884098|NCT01943188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64321488|NCT05500742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64321489|NCT05500742|Trace Elements|trace elements|mesh-ancestor
64321490|NCT05500742|Micronutrients|micronutrients|mesh-ancestor
64321491|NCT05500742|Vitamins|vitamins|mesh-ancestor
64321492|NCT03533335|Chlorhexidine|chlorhexidine|mesh-list
64321493|NCT03533335|Chlorine dioxide|chlorine dioxide|mesh-list
64321494|NCT03533335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64321495|NCT03533335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64321496|NCT03533335|Disinfectants|disinfectants|mesh-ancestor
64736814|NCT00379457|Vincristine|vincristine|mesh-list
64736815|NCT00379457|Topotecan|topotecan|mesh-list
64736816|NCT00379457|Vinorelbine|vinorelbine|mesh-list
64736817|NCT00379457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64736818|NCT00379457|Immunologic Factors|immunologic factors|mesh-ancestor
64425549|NCT04909021|Vaccines|vaccines|mesh-list
64321504|NCT02200159|Sensory System Agents|sensory system agents|mesh-ancestor
64321505|NCT02200159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321506|NCT02200159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64321507|NCT02200159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64321508|NCT02200159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64321509|NCT02200159|Adrenergic Agents|adrenergic agents|mesh-ancestor
64622440|NCT02773576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64622441|NCT02773576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622442|NCT02773576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321510|NCT02200159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64622443|NCT02773576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64622444|NCT02773576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64622445|NCT02773576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64622446|NCT02773576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64321511|NCT02200159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321512|NCT02204527|Vitamin D|vitamin d|mesh-list
64321513|NCT02204527|Ergocalciferols|ergocalciferols|mesh-list
64321514|NCT02204527|Cholecalciferol|cholecalciferol|mesh-list
64321515|NCT02204527|Vitamins|vitamins|mesh-list
64736830|NCT00379457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64736831|NCT00379457|Tubulin Modulators|tubulin modulators|mesh-ancestor
64736832|NCT00379457|Antimitotic Agents|antimitotic agents|mesh-ancestor
64736833|NCT00379457|Mitosis Modulators|mitosis modulators|mesh-ancestor
64736855|NCT01629329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64736856|NCT01629329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64736857|NCT01629329|Antipyretics|antipyretics|mesh-ancestor
64736858|NCT01629329|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64736859|NCT01629329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64736860|NCT01629329|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64736861|NCT01629329|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64736862|NCT01629329|Purinergic Agents|purinergic agents|mesh-ancestor
64736863|NCT01629329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64736864|NCT01629329|Antiemetics|antiemetics|mesh-ancestor
64736865|NCT01629329|Autonomic Agents|autonomic agents|mesh-ancestor
64736866|NCT01629329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64321521|NCT02200237|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64321522|NCT02200237|Immunologic Factors|immunologic factors|mesh-ancestor
64321523|NCT02200237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425689|NCT02256267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64736981|NCT00500045|Nicotinic Acids|nicotinic acids|mesh-list
64736982|NCT00500045|Niacinamide|niacinamide|mesh-list
64622487|NCT01350232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622488|NCT01350232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64622489|NCT01350232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64622490|NCT01350232|Alkylating Agents|alkylating agents|mesh-ancestor
64622491|NCT01350232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622492|NCT01350232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736983|NCT00500045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64736984|NCT00500045|Antimetabolites|antimetabolites|mesh-ancestor
64736985|NCT00500045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64736986|NCT00500045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64736987|NCT00500045|Vasodilator Agents|vasodilator agents|mesh-ancestor
64736988|NCT00500045|Vitamin B Complex|vitamin b complex|mesh-ancestor
64736989|NCT00500045|Vitamins|vitamins|mesh-ancestor
64736990|NCT00500045|Micronutrients|micronutrients|mesh-ancestor
64736991|NCT00500045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622519|NCT05493228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622520|NCT02758132|Denosumab|denosumab|mesh-list
64622521|NCT02758132|Prednisone|prednisone|mesh-list
64622522|NCT02758132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64736992|NCT00000767|Vaccines|vaccines|mesh-list
64622523|NCT02758132|Glucocorticoids|glucocorticoids|mesh-ancestor
64736993|NCT00000767|Immunologic Factors|immunologic factors|mesh-ancestor
64622524|NCT02758132|Hormones|hormones|mesh-ancestor
64736994|NCT00000767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64736995|NCT05383547|Bortezomib|bortezomib|mesh-list
64736996|NCT05383547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736997|NCT00456989|Docetaxel|docetaxel|mesh-list
64736998|NCT00456989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64736999|NCT00456989|Tubulin Modulators|tubulin modulators|mesh-ancestor
64737000|NCT00456989|Antimitotic Agents|antimitotic agents|mesh-ancestor
64737001|NCT00456989|Mitosis Modulators|mitosis modulators|mesh-ancestor
64737002|NCT00456989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622580|NCT05599126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64737003|NCT00000773|Atovaquone|atovaquone|mesh-list
64622581|NCT05599126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64622582|NCT05599126|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64622583|NCT05599126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64622584|NCT05599126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64737004|NCT00000773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737005|NCT00000773|Antimalarials|antimalarials|mesh-ancestor
64737006|NCT00000773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64737007|NCT00000773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64737008|NCT00000773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737009|NCT00000773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737010|NCT00428207|Insulin|insulin|mesh-list
64737011|NCT00428207|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64737149|NCT00000809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64737151|NCT05091203|Vitamins|vitamins|mesh-ancestor
64737152|NCT05091203|Micronutrients|micronutrients|mesh-ancestor
64737153|NCT05091203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737154|NCT05091203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64737155|NCT00240227|Prazosin|prazosin|mesh-list
64737156|NCT00240227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64737157|NCT00240227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64737158|NCT00240227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64737160|NCT00240227|Adrenergic Agents|adrenergic agents|mesh-ancestor
64737161|NCT00240227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64737162|NCT00240227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737163|NCT00240227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737164|NCT00205049|Pentoxifylline|pentoxifylline|mesh-list
64737165|NCT00205049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64737166|NCT00205049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737167|NCT00205049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737168|NCT00205049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64737169|NCT00205049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64737170|NCT00205049|Protective Agents|protective agents|mesh-ancestor
64622640|NCT05586620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622641|NCT01893788|Eplerenone|eplerenone|mesh-list
64622642|NCT01893788|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64622643|NCT01893788|Hormone Antagonists|hormone antagonists|mesh-ancestor
64622644|NCT01893788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64622645|NCT01893788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622646|NCT01893788|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64737171|NCT00205049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737204|NCT00000875|Diphenhydramine|diphenhydramine|mesh-list
64737205|NCT00000875|Promethazine|promethazine|mesh-list
64737206|NCT00000875|Lamivudine|lamivudine|mesh-list
64737207|NCT00000875|Zidovudine|zidovudine|mesh-list
64737208|NCT00000875|Aldesleukin|aldesleukin|mesh-list
64737209|NCT00000875|Indinavir|indinavir|mesh-list
64737210|NCT00000875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64737212|NCT00000875|Sensory System Agents|sensory system agents|mesh-ancestor
64426399|NCT04446039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64426400|NCT04446039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64426401|NCT04446039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426402|NCT04446039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64426403|NCT04446039|Analgesics|analgesics|mesh-ancestor
64737216|NCT00000875|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64737217|NCT00000875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64737218|NCT00000875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737219|NCT00000875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737220|NCT00000875|Antiviral Agents|antiviral agents|mesh-ancestor
64737221|NCT00000875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737222|NCT00000875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64737223|NCT00000875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64737224|NCT00000875|Antimetabolites|antimetabolites|mesh-ancestor
64737225|NCT00000875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64737226|NCT00000875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64737227|NCT00000875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64737228|NCT00000875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64737229|NCT00000875|Anesthetics, Local|anesthetics, local|mesh-ancestor
64737230|NCT00000875|Anesthetics|anesthetics|mesh-ancestor
64737231|NCT00000875|Antiemetics|antiemetics|mesh-ancestor
64737232|NCT00000875|Autonomic Agents|autonomic agents|mesh-ancestor
64622679|NCT01207726|Azacitidine|azacitidine|mesh-list
64622680|NCT01207726|Entinostat|entinostat|mesh-list
64622681|NCT01207726|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
64622682|NCT01207726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64622683|NCT01207726|Antimetabolites|antimetabolites|mesh-ancestor
64622684|NCT01207726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622685|NCT01207726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64622686|NCT01207726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737233|NCT00000875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64737234|NCT00000875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64737235|NCT00000875|Histamine Antagonists|histamine antagonists|mesh-ancestor
64737236|NCT00000875|Histamine Agents|histamine agents|mesh-ancestor
64737237|NCT00000875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64737238|NCT00000875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64737239|NCT00000875|Antipruritics|antipruritics|mesh-ancestor
64737240|NCT00000875|Dermatologic Agents|dermatologic agents|mesh-ancestor
64737241|NCT00000875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64737242|NCT00000875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64737243|NCT00000875|Protease Inhibitors|protease inhibitors|mesh-ancestor
64321600|NCT05504720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64321601|NCT05504720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64737245|NCT04941833|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64737246|NCT04941833|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64622715|NCT01202110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64622716|NCT01202110|Adrenergic Agents|adrenergic agents|mesh-ancestor
64622723|NCT02556918|Insulin|insulin|mesh-list
64737247|NCT04941833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64737248|NCT04941833|Contraceptive Agents|contraceptive agents|mesh-ancestor
64737249|NCT04941833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64426584|NCT04191447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64737267|NCT00521885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737268|NCT00521885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64737269|NCT00521885|Antithrombins|antithrombins|mesh-ancestor
64737270|NCT00521885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64737271|NCT00521885|Protease Inhibitors|protease inhibitors|mesh-ancestor
64737272|NCT00521885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737273|NCT05239013|Nitroglycerin|nitroglycerin|mesh-list
64737274|NCT05239013|Vasodilator Agents|vasodilator agents|mesh-ancestor
64737275|NCT00000881|Cidofovir|cidofovir|mesh-list
64737276|NCT00000881|Probenecid|probenecid|mesh-list
64737277|NCT00000881|Uricosuric Agents|uricosuric agents|mesh-ancestor
64737278|NCT00000881|Gout Suppressants|gout suppressants|mesh-ancestor
64426649|NCT02240121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64737324|NCT00000923|Lamivudine|lamivudine|mesh-list
64737325|NCT00000923|Zidovudine|zidovudine|mesh-list
64737326|NCT00000923|Stavudine|stavudine|mesh-list
64737327|NCT00000923|Didanosine|didanosine|mesh-list
64737328|NCT00000923|Aldesleukin|aldesleukin|mesh-list
64300685|NCT02251483|Immunoglobulins|immunoglobulins|mesh-list
64622768|NCT02518750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64622769|NCT02518750|Antiemetics|antiemetics|mesh-ancestor
64622770|NCT02518750|Autonomic Agents|autonomic agents|mesh-ancestor
64622771|NCT02518750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64622772|NCT02518750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64622773|NCT02518750|Glucocorticoids|glucocorticoids|mesh-ancestor
64622774|NCT02518750|Hormones|hormones|mesh-ancestor
64622775|NCT02518750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64737329|NCT00000923|Indinavir|indinavir|mesh-list
64737356|NCT00000161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64737357|NCT00000161|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64737358|NCT00000161|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64321629|NCT02220751|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64321630|NCT02220751|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64321632|NCT02205541|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64321633|NCT02205541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64321634|NCT02205541|Immunologic Factors|immunologic factors|mesh-ancestor
64321635|NCT02205541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321636|NCT02205619|Glycine|glycine|mesh-list
64321637|NCT02205619|Glycine Agents|glycine agents|mesh-ancestor
64622812|NCT01194856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64622813|NCT01194856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64622814|NCT01194856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64622815|NCT01194856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64622816|NCT01194856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64622817|NCT01194856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64622818|NCT01182610|Paclitaxel|paclitaxel|mesh-list
64321638|NCT02205619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64737359|NCT00000161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737385|NCT00000197|Adrenergic Agents|adrenergic agents|mesh-ancestor
64737386|NCT00000197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64737387|NCT00000197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737388|NCT00000197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737389|NCT00000197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64737390|NCT00000197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64737391|NCT00000197|Vasodilator Agents|vasodilator agents|mesh-ancestor
64737392|NCT00000947|Azithromycin|azithromycin|mesh-list
64737393|NCT00000947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64737394|NCT00000947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737395|NCT00000203|Buprenorphine|buprenorphine|mesh-list
64737396|NCT00000203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64737397|NCT00000203|Narcotics|narcotics|mesh-ancestor
64737398|NCT00000203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64737399|NCT00000203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737400|NCT00000203|Analgesics|analgesics|mesh-ancestor
64737401|NCT00000203|Sensory System Agents|sensory system agents|mesh-ancestor
64737402|NCT00000203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64622869|NCT01147042|Interferons|interferons|mesh-list
64622870|NCT01147042|Interferon-gamma|interferon-gamma|mesh-list
64622871|NCT01147042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64622872|NCT01147042|Antiviral Agents|antiviral agents|mesh-ancestor
64622873|NCT01147042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64622874|NCT05485272|Fluorides|fluorides|mesh-list
64622875|NCT05485272|Cariostatic Agents|cariostatic agents|mesh-ancestor
64622876|NCT05485272|Protective Agents|protective agents|mesh-ancestor
64622877|NCT05485272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622879|NCT01108666|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64622880|NCT01108666|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64622881|NCT01108666|Protease Inhibitors|protease inhibitors|mesh-ancestor
64622882|NCT01108666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622883|NCT01108666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622884|NCT01108666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64737418|NCT00000215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737420|NCT00000953|Sorivudine|sorivudine|mesh-list
64737421|NCT00000953|Antiviral Agents|antiviral agents|mesh-ancestor
64737422|NCT00000953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737423|NCT00000953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737464|NCT00000245|Antidepressive Agents|antidepressive agents|mesh-ancestor
64737465|NCT00000245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64737466|NCT00000245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737467|NCT00000245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737491|NCT00000269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737492|NCT00000269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737493|NCT04030559|Niraparib|niraparib|mesh-list
64737494|NCT04030559|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64737495|NCT04030559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737496|NCT04030559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737497|NCT04030559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64737498|NCT03967223|Cyclophosphamide|cyclophosphamide|mesh-list
64737499|NCT03967223|Fludarabine|fludarabine|mesh-list
64737500|NCT03967223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64737501|NCT03967223|Immunologic Factors|immunologic factors|mesh-ancestor
64737502|NCT03967223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737503|NCT03967223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64737504|NCT03967223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64737505|NCT03967223|Alkylating Agents|alkylating agents|mesh-ancestor
64737506|NCT03967223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622910|NCT01662492|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64622911|NCT01662492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64622912|NCT00378976|Valacyclovir|valacyclovir|mesh-list
64622913|NCT00378976|Antiviral Agents|antiviral agents|mesh-ancestor
64622914|NCT00378976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64622915|NCT05342974|Misoprostol|misoprostol|mesh-list
64622916|NCT05342974|Atorvastatin|atorvastatin|mesh-list
64622917|NCT05342974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64622918|NCT05342974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64622919|NCT05342974|Antimetabolites|antimetabolites|mesh-ancestor
64622920|NCT05342974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622921|NCT05342974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64622922|NCT05342974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64622923|NCT05342974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622924|NCT05342974|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64622925|NCT05342974|Abortifacient Agents|abortifacient agents|mesh-ancestor
64737507|NCT03967223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64737508|NCT03967223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64737509|NCT00000989|Zidovudine|zidovudine|mesh-list
64737510|NCT00000989|Ganciclovir|ganciclovir|mesh-list
64622943|NCT02282332|Ticagrelor|ticagrelor|mesh-list
64622944|NCT02282332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64622945|NCT02282332|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64622946|NCT02282332|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64737533|NCT00000995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737534|NCT00000995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64737535|NCT00000995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64737536|NCT00000995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737537|NCT00000995|Antiviral Agents|antiviral agents|mesh-ancestor
64426852|NCT04776369|Lidocaine|lidocaine|mesh-list
64737538|NCT00000995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737539|NCT00000995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64737540|NCT00000995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64737541|NCT00001025|Zidovudine|zidovudine|mesh-list
64737542|NCT00001025|Didanosine|didanosine|mesh-list
64737543|NCT00001025|Antimetabolites|antimetabolites|mesh-ancestor
64737544|NCT00001025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737545|NCT00001025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64737546|NCT00001025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64737547|NCT00001025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737548|NCT00001025|Antiviral Agents|antiviral agents|mesh-ancestor
64737549|NCT00001025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737550|NCT00001025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64737551|NCT00001025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64737552|NCT03121001|Mycophenolic Acid|mycophenolic acid|mesh-list
64737553|NCT03121001|Sirolimus|sirolimus|mesh-list
64737554|NCT03121001|Cyclophosphamide|cyclophosphamide|mesh-list
64737555|NCT03121001|Fludarabine|fludarabine|mesh-list
64737556|NCT03121001|Thymoglobulin|thymoglobulin|mesh-list
64737557|NCT03121001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64623000|NCT05484648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64623001|NCT05484648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64623002|NCT05484648|Analgesics|analgesics|mesh-ancestor
64623003|NCT05484648|Sensory System Agents|sensory system agents|mesh-ancestor
64623004|NCT05484648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64623005|NCT05484648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64623006|NCT05484648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64623007|NCT05484648|Adrenergic Agents|adrenergic agents|mesh-ancestor
64737558|NCT03121001|Immunologic Factors|immunologic factors|mesh-ancestor
64623008|NCT05484648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64737559|NCT03121001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737560|NCT03121001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64737561|NCT03121001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64737562|NCT03121001|Alkylating Agents|alkylating agents|mesh-ancestor
64737563|NCT03121001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737564|NCT03121001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64737565|NCT03121001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64737566|NCT03121001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64737567|NCT03121001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64737568|NCT03121001|Antitubercular Agents|antitubercular agents|mesh-ancestor
64737573|NCT03055247|Ibuprofen|ibuprofen|mesh-list
64737578|NCT03055247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737579|NCT03055247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737580|NCT03055247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64737581|NCT03055247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64737582|NCT03055247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64737583|NCT03055247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737584|NCT03055247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737585|NCT00001049|Zidovudine|zidovudine|mesh-list
64737586|NCT00001049|Didanosine|didanosine|mesh-list
64737587|NCT00001049|Antimetabolites|antimetabolites|mesh-ancestor
64737588|NCT00001049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64476932|NCT01445847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64737589|NCT00001049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64737590|NCT00001049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64737591|NCT00001049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737592|NCT00001049|Antiviral Agents|antiviral agents|mesh-ancestor
64737593|NCT00001049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737594|NCT00001049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64737595|NCT00001049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64623049|NCT02130622|Anesthetics, Local|anesthetics, local|mesh-ancestor
64623050|NCT02130622|Anesthetics|anesthetics|mesh-ancestor
64737596|NCT00001055|polysaccharide-K|polysaccharide-k|mesh-list
64737597|NCT00001055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64623051|NCT02130622|Sensory System Agents|sensory system agents|mesh-ancestor
64737598|NCT00001055|Immunologic Factors|immunologic factors|mesh-ancestor
64737599|NCT00001055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737600|NCT00001055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64737601|NCT00001055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64737602|NCT00001055|Antiviral Agents|antiviral agents|mesh-ancestor
64737603|NCT00001055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737604|NCT00001055|Interferon Inducers|interferon inducers|mesh-ancestor
64737605|NCT00001055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64737606|NCT00001055|Protective Agents|protective agents|mesh-ancestor
64737607|NCT00000275|Flupenthixol|flupenthixol|mesh-list
64426872|NCT02230527|Ticagrelor|ticagrelor|mesh-list
64623083|NCT01188421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64623084|NCT01188421|Narcotics|narcotics|mesh-ancestor
64623085|NCT01188421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64623086|NCT01188421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623087|NCT01188421|Analgesics|analgesics|mesh-ancestor
64623088|NCT01188421|Sensory System Agents|sensory system agents|mesh-ancestor
64623089|NCT01188421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64623090|NCT01188421|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64623091|NCT01188421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64737649|NCT00001067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64737650|NCT00001067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64737651|NCT00001067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64737652|NCT00001067|Antimetabolites|antimetabolites|mesh-ancestor
64737653|NCT00001079|Methyltestosterone|methyltestosterone|mesh-list
64321706|NCT05564546|Protective Agents|protective agents|mesh-ancestor
64321707|NCT04419272|Methylphenidate|methylphenidate|mesh-list
64321708|NCT04419272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64321709|NCT04419272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321710|NCT04419272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64321711|NCT04419272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64321712|NCT04419272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64321713|NCT04419272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321714|NCT04419272|Dopamine Agents|dopamine agents|mesh-ancestor
64321715|NCT04419272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64737655|NCT00001079|Megestrol Acetate|megestrol acetate|mesh-list
64737656|NCT00001079|Testosterone|testosterone|mesh-list
64737657|NCT00001079|Testosterone undecanoate|testosterone undecanoate|mesh-list
64737658|NCT00001079|Testosterone enanthate|testosterone enanthate|mesh-list
64737659|NCT00001079|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64737660|NCT00001079|Androgens|androgens|mesh-ancestor
64737661|NCT00001079|Hormones|hormones|mesh-ancestor
64737662|NCT00001079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64737663|NCT00001079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737664|NCT00001079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64477004|NCT00551200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64737665|NCT00001079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64737666|NCT00001079|Anabolic Agents|anabolic agents|mesh-ancestor
64623139|NCT00984490|Metformin|metformin|mesh-list
64623140|NCT00984490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64623141|NCT00984490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623142|NCT05484024|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64623143|NCT05484024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623144|NCT05484024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623145|NCT02027272|Dexamethasone|dexamethasone|mesh-list
64623146|NCT02027272|Glucocorticoids|glucocorticoids|mesh-list
64623148|NCT02027272|Antiemetics|antiemetics|mesh-ancestor
64737667|NCT00001079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64737668|NCT00001079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64737669|NCT00001079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64737670|NCT00001079|Contraceptive Agents|contraceptive agents|mesh-ancestor
64349737|NCT05359315|Interferons|interferons|mesh-list
64321768|NCT02205931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64427125|NCT02217501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64427126|NCT02217501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64427127|NCT02217501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427128|NCT02217501|Antipyretics|antipyretics|mesh-ancestor
64737770|NCT00001133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64737771|NCT00001133|Protease Inhibitors|protease inhibitors|mesh-ancestor
64737772|NCT00001133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737773|NCT00001133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737774|NCT00001133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64737775|NCT00001133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64737823|NCT00001193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64737824|NCT00001193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64321778|NCT04528004|Nicotinic Acids|nicotinic acids|mesh-list
64321779|NCT04528004|Vitamin B Complex|vitamin b complex|mesh-ancestor
64321781|NCT04528004|Micronutrients|micronutrients|mesh-ancestor
64321782|NCT04528004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321783|NCT04528004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64321784|NCT04528004|Antimetabolites|antimetabolites|mesh-ancestor
64623177|NCT03472092|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64623178|NCT03472092|Antidepressive Agents|antidepressive agents|mesh-ancestor
64623179|NCT03472092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64623180|NCT03472092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64623181|NCT03472092|Analgesics|analgesics|mesh-ancestor
64623182|NCT03472092|Sensory System Agents|sensory system agents|mesh-ancestor
64623183|NCT03472092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321785|NCT04528004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321786|NCT04528004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64321787|NCT04528004|Vasodilator Agents|vasodilator agents|mesh-ancestor
64321788|NCT02221063|Thiamine|thiamine|mesh-list
64321789|NCT02221063|Vitamin B Complex|vitamin b complex|mesh-ancestor
64737826|NCT00001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737827|NCT00000353|Buprenorphine|buprenorphine|mesh-list
64737828|NCT00000353|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64737829|NCT00000353|Naloxone|naloxone|mesh-list
64737830|NCT00000353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64737831|NCT00000353|Narcotics|narcotics|mesh-ancestor
64737832|NCT00000353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64737833|NCT00000353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737834|NCT00000353|Analgesics|analgesics|mesh-ancestor
64737835|NCT00000353|Sensory System Agents|sensory system agents|mesh-ancestor
64737836|NCT00000353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737837|NCT00000353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64737838|NCT00000377|Nortriptyline|nortriptyline|mesh-list
64737857|NCT00000389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737859|NCT00000389|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64737860|NCT00000389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64737861|NCT00000389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64737862|NCT00000389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737863|NCT00000389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64737864|NCT00000389|Serotonin Agents|serotonin agents|mesh-ancestor
64737865|NCT00000389|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64737866|NCT00000389|Antidepressive Agents|antidepressive agents|mesh-ancestor
64737867|NCT00000389|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64737868|NCT00000389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64737869|NCT00000389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623219|NCT04331626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623220|NCT04331626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64623221|NCT04331626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64623222|NCT03699540|Ethanol|ethanol|mesh-list
64623223|NCT03699540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64623224|NCT03699540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64623225|NCT03699540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64623226|NCT03699540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623227|NCT00970606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64623228|NCT00970606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64623230|NCT00970606|Antimetabolites|antimetabolites|mesh-ancestor
64737870|NCT00000389|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64737871|NCT00001877|Pentoxifylline|pentoxifylline|mesh-list
64737872|NCT00001877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64737873|NCT00001877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737874|NCT00001877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737875|NCT00001877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64349934|NCT03491969|Antioxidants|antioxidants|mesh-ancestor
64321791|NCT02221063|Micronutrients|micronutrients|mesh-ancestor
64321792|NCT02221063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623251|NCT03661320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64623252|NCT03661320|Immunologic Factors|immunologic factors|mesh-ancestor
64623253|NCT03661320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623254|NCT03661320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64623255|NCT03661320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64623256|NCT00981370|Deferasirox|deferasirox|mesh-list
64623257|NCT00981370|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64623261|NCT00979810|Alovudine|alovudine|mesh-list
64321793|NCT02220049|Bortezomib|bortezomib|mesh-list
64427316|NCT02392507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64737886|NCT00380939|Antimetabolites|antimetabolites|mesh-ancestor
64737887|NCT00380939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737888|NCT00380939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64737889|NCT00380939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64737890|NCT00380939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64737891|NCT00001889|Dobutamine|dobutamine|mesh-list
64737892|NCT00001889|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64737893|NCT00001889|Sympathomimetics|sympathomimetics|mesh-ancestor
64737894|NCT00001889|Autonomic Agents|autonomic agents|mesh-ancestor
64321801|NCT01351805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64321802|NCT01351805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64321803|NCT02206165|Amlodipine|amlodipine|mesh-list
64321804|NCT02206165|Candesartan|candesartan|mesh-list
64321805|NCT02206165|Candesartan cilexetil|candesartan cilexetil|mesh-list
64321806|NCT02206165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64321807|NCT02206165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64321808|NCT02206165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64623310|NCT01916590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64623311|NCT01916590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623312|NCT01916590|Sensory System Agents|sensory system agents|mesh-ancestor
64623313|NCT01916590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64623314|NCT01890694|Tolvaptan|tolvaptan|mesh-list
64623315|NCT01890694|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64623316|NCT01890694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623317|NCT01890694|Natriuretic Agents|natriuretic agents|mesh-ancestor
64623319|NCT05474898|Magnesium Sulfate|magnesium sulfate|mesh-list
64321809|NCT02206165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321810|NCT02206165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64321811|NCT02206165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321812|NCT02206165|Vasodilator Agents|vasodilator agents|mesh-ancestor
64321813|NCT02206165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64737896|NCT00001889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737897|NCT00001889|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64737898|NCT00001889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64737899|NCT00001889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64737900|NCT00001889|Adrenergic Agents|adrenergic agents|mesh-ancestor
64737901|NCT00001889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64349983|NCT03489005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64321814|NCT02206165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64321815|NCT04356950|Thrombin|thrombin|mesh-list
64737982|NCT00001937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737983|NCT00001937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64737984|NCT00001937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64737985|NCT00001325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64737986|NCT00001325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64737987|NCT00001325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737989|NCT04331327|Mitosis Modulators|mitosis modulators|mesh-ancestor
64623401|NCT05292976|Autonomic Agents|autonomic agents|mesh-ancestor
64737990|NCT04331327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64737992|NCT00001955|Etanercept|etanercept|mesh-list
64737993|NCT00001955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64737994|NCT00001955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64737995|NCT00001955|Analgesics|analgesics|mesh-ancestor
64737996|NCT00001955|Sensory System Agents|sensory system agents|mesh-ancestor
64737997|NCT00001955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64737998|NCT00001955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64737999|NCT00001955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64738000|NCT00001955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64738001|NCT00001955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64738002|NCT00001955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64738003|NCT00001955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738004|NCT00001955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623472|NCT00786682|Tubulin Modulators|tubulin modulators|mesh-ancestor
64738005|NCT00001955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64738006|NCT00001955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64738007|NCT00001955|Immunologic Factors|immunologic factors|mesh-ancestor
64321852|NCT05503706|Dermatologic Agents|dermatologic agents|mesh-ancestor
64321853|NCT05503706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64321854|NCT05503706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64321856|NCT05503706|Sensory System Agents|sensory system agents|mesh-ancestor
64738008|NCT04943783|Atorvastatin|atorvastatin|mesh-list
64738009|NCT04943783|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64738010|NCT04943783|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64738011|NCT04943783|Antimetabolites|antimetabolites|mesh-ancestor
64738012|NCT04943783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738013|NCT04943783|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64623523|NCT01606150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64623524|NCT01606150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623525|NCT01606150|Sensory System Agents|sensory system agents|mesh-ancestor
64623526|NCT01606150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64623527|NCT01606150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64623528|NCT01606150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64623529|NCT01606150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64623530|NCT01606150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64623531|NCT01606150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623532|NCT01602016|Leucovorin|leucovorin|mesh-list
64623543|NCT00731770|Xhance|xhance|mesh-list
64738014|NCT04943783|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64738015|NCT04943783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738016|NCT00000605|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64738017|NCT00000605|Medroxyprogesterone|medroxyprogesterone|mesh-list
64738018|NCT00000605|Hormones|hormones|mesh-list
64738019|NCT00000605|Estrogens|estrogens|mesh-list
64738039|NCT00000623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64738040|NCT00000623|Antimetabolites|antimetabolites|mesh-ancestor
64738041|NCT00000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738042|NCT00000623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738043|NCT00000623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738044|NCT00000623|Vasodilator Agents|vasodilator agents|mesh-ancestor
64350110|NCT03489239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64350111|NCT03489239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350112|NCT03489239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350113|NCT03489239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738045|NCT00000623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64738046|NCT00000623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64738047|NCT00000623|Urological Agents|urological agents|mesh-ancestor
64738048|NCT00000623|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64738068|NCT00001997|Antimetabolites|antimetabolites|mesh-ancestor
64738069|NCT00001997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738070|NCT00001997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738071|NCT00001997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738072|NCT00001997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738073|NCT00001997|Antiviral Agents|antiviral agents|mesh-ancestor
64623573|NCT01566370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623574|NCT03414684|Carboplatin|carboplatin|mesh-list
64623575|NCT03414684|Nivolumab|nivolumab|mesh-list
64623576|NCT03414684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623577|NCT03414684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64623578|NCT03414684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64623580|NCT01558492|Paclitaxel|paclitaxel|mesh-list
64738074|NCT00001997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738075|NCT00001997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738076|NCT00001997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738077|NCT00002003|Etoposide|etoposide|mesh-list
64738078|NCT00002003|Mitoxantrone|mitoxantrone|mesh-list
64738079|NCT00002003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64321864|NCT02174861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738080|NCT00002003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738081|NCT00002003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64738082|NCT00002003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64738083|NCT00002003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738084|NCT00002003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738085|NCT00002003|Analgesics|analgesics|mesh-ancestor
64738086|NCT00002003|Sensory System Agents|sensory system agents|mesh-ancestor
64738087|NCT00002003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64738088|NCT00002003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738089|NCT00002009|Sargramostim|sargramostim|mesh-list
64738090|NCT00002009|Immunologic Factors|immunologic factors|mesh-ancestor
64738091|NCT00002009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738092|NCT00000629|Zidovudine|zidovudine|mesh-list
64738093|NCT00000629|Valproic Acid|valproic acid|mesh-list
64738094|NCT00000629|Antimetabolites|antimetabolites|mesh-ancestor
64623603|NCT03399552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348945|NCT03353233|Ropivacaine|ropivacaine|mesh-list
64623604|NCT00691444|Melatonin|melatonin|mesh-list
64623605|NCT00691444|Antioxidants|antioxidants|mesh-ancestor
64623606|NCT00691444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623607|NCT00691444|Protective Agents|protective agents|mesh-ancestor
64738097|NCT00000629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64623610|NCT05477004|Ketamine|ketamine|mesh-list
64738100|NCT00000629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738101|NCT00000629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738102|NCT00000629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738103|NCT00000629|Anticonvulsants|anticonvulsants|mesh-ancestor
64738104|NCT00000629|GABA Agents|gaba agents|mesh-ancestor
64738105|NCT00000629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64738106|NCT00000629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738107|NCT00000629|Antimanic Agents|antimanic agents|mesh-ancestor
64738108|NCT00000629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64738109|NCT00000629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64738110|NCT00000629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64738111|NCT00000647|Interferons|interferons|mesh-list
64738112|NCT00000647|Interferon-alpha|interferon-alpha|mesh-list
64738113|NCT00000647|Zidovudine|zidovudine|mesh-list
64738114|NCT00000647|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
64738115|NCT00000647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738116|NCT00000647|Antiviral Agents|antiviral agents|mesh-ancestor
64738117|NCT00000647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738118|NCT00000647|Immunologic Factors|immunologic factors|mesh-ancestor
64623642|NCT05482074|Olaparib|olaparib|mesh-list
64623643|NCT05482074|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64623644|NCT05482074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623645|NCT05482074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623646|NCT05482074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623647|NCT00678574|Fluoxetine|fluoxetine|mesh-list
64623648|NCT00678574|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64623649|NCT00678574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64623650|NCT00678574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64623652|NCT00678574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64738119|NCT00000647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738120|NCT00000647|Antimetabolites|antimetabolites|mesh-ancestor
64321868|NCT02174861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321870|NCT02221375|Glucocorticoids|glucocorticoids|mesh-ancestor
64321871|NCT02221375|Hormones|hormones|mesh-ancestor
64321872|NCT02221375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64321873|NCT02221375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321874|NCT02221375|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64321875|NCT02399709|Simvastatin|simvastatin|mesh-list
64321876|NCT02399709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64321877|NCT02399709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64321878|NCT02399709|Antimetabolites|antimetabolites|mesh-ancestor
64321879|NCT02399709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64321880|NCT02399709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64321881|NCT02399709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64321882|NCT02399709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64321883|NCT02220361|Dexmedetomidine|dexmedetomidine|mesh-list
64623685|NCT00542542|Anesthetics|anesthetics|mesh-ancestor
64623686|NCT00542542|Anesthetics, Local|anesthetics, local|mesh-ancestor
64623687|NCT00542542|Sensory System Agents|sensory system agents|mesh-ancestor
64623688|NCT00542542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64623689|NCT00542542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64623690|NCT00542542|Narcotics|narcotics|mesh-ancestor
64623691|NCT00542542|Analgesics|analgesics|mesh-ancestor
64623692|NCT00542542|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64623693|NCT00542542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64623694|NCT00542542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64321884|NCT02220361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64738121|NCT00000647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738122|NCT00000647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738135|NCT00000653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738136|NCT00000653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738137|NCT00001409|Interleukin-2|interleukin-2|mesh-list
64738138|NCT00001409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738139|NCT00001409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64738140|NCT00001409|Analgesics|analgesics|mesh-ancestor
64738141|NCT00001409|Sensory System Agents|sensory system agents|mesh-ancestor
64738142|NCT00001409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64623738|NCT02598778|Dermatologic Agents|dermatologic agents|mesh-ancestor
64623739|NCT00642382|Hyaluronic Acid|hyaluronic acid|mesh-list
64623740|NCT00642382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64623741|NCT00642382|Immunologic Factors|immunologic factors|mesh-ancestor
64623742|NCT00642382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623743|NCT00642382|Viscosupplements|viscosupplements|mesh-ancestor
64623744|NCT00642382|Protective Agents|protective agents|mesh-ancestor
64623745|NCT05476380|Paclitaxel|paclitaxel|mesh-list
64623746|NCT05476380|Cisplatin|cisplatin|mesh-list
64623748|NCT05476380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738143|NCT00001409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738145|NCT00000659|Antimetabolites|antimetabolites|mesh-ancestor
64738146|NCT00000659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738147|NCT00000659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738148|NCT00000659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738149|NCT00000659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350218|NCT03487211|Analgesics|analgesics|mesh-ancestor
64738150|NCT00000659|Antiviral Agents|antiviral agents|mesh-ancestor
64738151|NCT00000659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738152|NCT00000659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738153|NCT00000659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738154|NCT00381017|Interferons|interferons|mesh-list
64738155|NCT00381017|Interferon-alpha|interferon-alpha|mesh-list
64738156|NCT00381017|Interferon alpha-2|interferon alpha-2|mesh-list
64623796|NCT00380146|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64623797|NCT00380146|Antimalarials|antimalarials|mesh-ancestor
64738157|NCT00381017|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64738158|NCT00381017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738159|NCT00381017|Antiviral Agents|antiviral agents|mesh-ancestor
64738160|NCT00381017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738161|NCT00381017|Immunologic Factors|immunologic factors|mesh-ancestor
64738162|NCT00381017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738163|NCT00002015|Ganciclovir|ganciclovir|mesh-list
64738164|NCT00002015|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64738264|NCT00002045|Zidovudine|zidovudine|mesh-list
64623843|NCT00379522|Hemostatics|hemostatics|mesh-ancestor
64623844|NCT00379522|Coagulants|coagulants|mesh-ancestor
64623845|NCT00379522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64738265|NCT00002045|Antimetabolites|antimetabolites|mesh-ancestor
64623851|NCT00421954|Serotonin Agents|serotonin agents|mesh-ancestor
64738266|NCT00002045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350345|NCT02246998|Antiviral Agents|antiviral agents|mesh-ancestor
64427550|NCT02309515|Growth Inhibitors|growth inhibitors|mesh-ancestor
64738359|NCT00001577|Alkylating Agents|alkylating agents|mesh-ancestor
64738360|NCT00001577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738361|NCT00001577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738362|NCT00001577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64738363|NCT00001577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64738401|NCT00002099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64623906|NCT00000778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64623907|NCT00000778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64623908|NCT00000778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64623909|NCT00000778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623910|NCT00000778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623911|NCT00000778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623912|NCT00000778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64738402|NCT00002099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738403|NCT00002099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64738404|NCT00002099|Immunologic Factors|immunologic factors|mesh-ancestor
64738405|NCT00002099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738406|NCT00002099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738407|NCT00002321|Aldesleukin|aldesleukin|mesh-list
64738408|NCT00002321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623967|NCT00000796|Rifampin|rifampin|mesh-list
64738409|NCT00002321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738410|NCT00002321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738411|NCT00002321|Antiviral Agents|antiviral agents|mesh-ancestor
64738412|NCT00002321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738413|NCT00002327|Cidofovir|cidofovir|mesh-list
64738414|NCT00002327|Antiviral Agents|antiviral agents|mesh-ancestor
64738415|NCT00002327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738416|NCT00002327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738417|NCT00002327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738419|NCT00002333|Zalcitabine|zalcitabine|mesh-list
64738420|NCT00002333|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64738449|NCT00002105|Bleomycin|bleomycin|mesh-list
64738457|NCT00002105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64738458|NCT00002105|Tubulin Modulators|tubulin modulators|mesh-ancestor
64738459|NCT00002105|Antimitotic Agents|antimitotic agents|mesh-ancestor
64738460|NCT00002105|Mitosis Modulators|mitosis modulators|mesh-ancestor
64738461|NCT00002345|Megestrol|megestrol|mesh-list
64738462|NCT00002345|Megestrol Acetate|megestrol acetate|mesh-list
64738463|NCT00002345|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64738464|NCT00002345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64427803|NCT02135445|Relugolix|relugolix|mesh-list
64624039|NCT00268450|Tubulin Modulators|tubulin modulators|mesh-ancestor
64624040|NCT00268450|Antimitotic Agents|antimitotic agents|mesh-ancestor
64624041|NCT00268450|Mitosis Modulators|mitosis modulators|mesh-ancestor
64624042|NCT00268450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624043|NCT00268450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64624044|NCT00268450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64624045|NCT00268450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64624046|NCT00268450|Growth Substances|growth substances|mesh-ancestor
64624047|NCT00268450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624048|NCT00268450|Growth Inhibitors|growth inhibitors|mesh-ancestor
64624049|NCT00268450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64624050|NCT00268450|Antimetabolites|antimetabolites|mesh-ancestor
64624052|NCT00268450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624053|NCT00268450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624054|NCT00268450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64624055|NCT00268450|Immunologic Factors|immunologic factors|mesh-ancestor
64738480|NCT00002111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738481|NCT00002111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738482|NCT00002111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738483|NCT00002111|Antiviral Agents|antiviral agents|mesh-ancestor
64738484|NCT00002111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738485|NCT00002111|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64738501|NCT00002357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738502|NCT00002357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738503|NCT00002357|Antiviral Agents|antiviral agents|mesh-ancestor
64738504|NCT00002357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738505|NCT00002357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738506|NCT00002357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738507|NCT00002117|Zidovudine|zidovudine|mesh-list
64738508|NCT00002117|Zalcitabine|zalcitabine|mesh-list
64738509|NCT00002117|Antimetabolites|antimetabolites|mesh-ancestor
64624077|NCT00000814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64624078|NCT00000814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624079|NCT00000814|Antiviral Agents|antiviral agents|mesh-ancestor
64738510|NCT00002117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624080|NCT00000814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738511|NCT00002117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738512|NCT00002117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738513|NCT00002117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738514|NCT00002117|Antiviral Agents|antiviral agents|mesh-ancestor
64738515|NCT00002117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738516|NCT00002117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738517|NCT00002117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738518|NCT00002123|Didanosine|didanosine|mesh-list
64738519|NCT00002123|Delavirdine|delavirdine|mesh-list
64738520|NCT00002123|Antimetabolites|antimetabolites|mesh-ancestor
64350582|NCT03131375|Dexmedetomidine|dexmedetomidine|mesh-list
64321966|NCT03106545|Sensory System Agents|sensory system agents|mesh-ancestor
64321967|NCT03106545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321969|NCT02221531|Oxytocin|oxytocin|mesh-list
64321970|NCT02221531|Oxytocics|oxytocics|mesh-ancestor
64321971|NCT02221531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64321972|NCT02221531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321973|NCT02231125|Losartan|losartan|mesh-list
64321974|NCT02231125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64427804|NCT02135445|Androgen Antagonists|androgen antagonists|mesh-ancestor
64427839|NCT02374021|Antimetabolites|antimetabolites|mesh-ancestor
64624134|NCT00089128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738533|NCT00381173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64738534|NCT00381173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64738535|NCT00381173|Alkylating Agents|alkylating agents|mesh-ancestor
64738536|NCT00381173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738537|NCT00381173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738538|NCT00381173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64738539|NCT05752409|Ketamine|ketamine|mesh-list
64738540|NCT05752409|Propofol|propofol|mesh-list
64624183|NCT00020722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64624184|NCT00020722|Alkylating Agents|alkylating agents|mesh-ancestor
64624185|NCT00020722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624186|NCT00020722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624187|NCT00020722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64738541|NCT05752409|Esketamine|esketamine|mesh-list
64738542|NCT05752409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64738543|NCT05752409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64738544|NCT05752409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738545|NCT05752409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64738546|NCT05752409|Anesthetics, General|anesthetics, general|mesh-ancestor
64738547|NCT05752409|Anesthetics|anesthetics|mesh-ancestor
64738548|NCT05752409|Analgesics|analgesics|mesh-ancestor
64738549|NCT05752409|Sensory System Agents|sensory system agents|mesh-ancestor
64738550|NCT05752409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64738551|NCT05752409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64624244|NCT00000850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624245|NCT00000856|Ganciclovir|ganciclovir|mesh-list
64624246|NCT00000856|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64624247|NCT00000856|Foscarnet|foscarnet|mesh-list
64624248|NCT00000856|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
64624249|NCT00000856|Antiviral Agents|antiviral agents|mesh-ancestor
64624250|NCT00000856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624251|NCT00000856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64624252|NCT00000856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738552|NCT05752409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64738553|NCT05752409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64738554|NCT05752409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64738555|NCT05752409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738556|NCT05752409|Antidepressive Agents|antidepressive agents|mesh-ancestor
64738557|NCT05752409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64738559|NCT00002129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64738560|NCT00002129|Immunologic Factors|immunologic factors|mesh-ancestor
64738561|NCT00002129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738562|NCT00002129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738563|NCT00002129|Antiviral Agents|antiviral agents|mesh-ancestor
64738564|NCT00002129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738565|NCT00002129|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64738566|NCT00002129|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64738567|NCT00002129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738568|NCT00002129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624302|NCT02344472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64624303|NCT02344472|Hormone Antagonists|hormone antagonists|mesh-ancestor
64624304|NCT02344472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64624305|NCT02344472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624306|NCT02344472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64624307|NCT02344472|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64624308|NCT02344472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64624309|NCT02344472|Fertility Agents|fertility agents|mesh-ancestor
64624310|NCT02344472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64624311|NCT02338232|Telmisartan|telmisartan|mesh-list
64624312|NCT02338232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64624314|NCT02338232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64738569|NCT00002129|Protective Agents|protective agents|mesh-ancestor
64738571|NCT00002135|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64738572|NCT00002135|Antiviral Agents|antiviral agents|mesh-ancestor
64738573|NCT00002135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738574|NCT00002135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738575|NCT00002135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350631|NCT02523755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321976|NCT02231125|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64738604|NCT00002375|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64738605|NCT00002375|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64738606|NCT00002375|Protease Inhibitors|protease inhibitors|mesh-ancestor
64738607|NCT00002375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738608|NCT00002375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738609|NCT00002375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738610|NCT00002375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738611|NCT00002375|Antiviral Agents|antiviral agents|mesh-ancestor
64738622|NCT00002381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738623|NCT00002381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738624|NCT00002381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64738625|NCT00002381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64738626|NCT00002381|Antimetabolites|antimetabolites|mesh-ancestor
64738627|NCT00002381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64624345|NCT02628626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64624346|NCT02628626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64624347|NCT02628626|Antimetabolites|antimetabolites|mesh-ancestor
64624348|NCT02628626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64624349|NCT05586464|Bismuth|bismuth|mesh-list
64624350|NCT05586464|Antacids|antacids|mesh-ancestor
64624351|NCT05586464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624352|NCT05586464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64624353|NCT01561378|Insulin Aspart|insulin aspart|mesh-list
64624354|NCT01561378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64624355|NCT01561378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624356|NCT02627846|Lidocaine|lidocaine|mesh-list
64624357|NCT02627846|Epinephrine|epinephrine|mesh-list
64624358|NCT02627846|Racepinephrine|racepinephrine|mesh-list
64624359|NCT02627846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64738628|NCT00002381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64624360|NCT02627846|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
64738629|NCT00002381|Protease Inhibitors|protease inhibitors|mesh-ancestor
64738630|NCT00002387|Efavirenz|efavirenz|mesh-list
64738631|NCT00002387|Indinavir|indinavir|mesh-list
64738632|NCT00002387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738633|NCT00002387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738634|NCT00002387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738635|NCT00002387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738636|NCT00002387|Antiviral Agents|antiviral agents|mesh-ancestor
64350683|NCT03473093|Pregabalin|pregabalin|mesh-list
64738637|NCT00002387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738638|NCT00002387|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64738639|NCT00002387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64738640|NCT00002387|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64738641|NCT00002387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64624382|NCT02627846|Mydriatics|mydriatics|mesh-ancestor
64624383|NCT02627846|Sympathomimetics|sympathomimetics|mesh-ancestor
64624384|NCT02627846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64624385|NCT02627846|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64624386|NCT02608268|Decitabine|decitabine|mesh-list
64624387|NCT02608268|Spartalizumab|spartalizumab|mesh-list
64624388|NCT02608268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64624389|NCT02608268|Antimetabolites|antimetabolites|mesh-ancestor
64624390|NCT02608268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624391|NCT02608268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738642|NCT00002387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64738643|NCT00002387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64738645|NCT00002387|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64738646|NCT00002387|Protease Inhibitors|protease inhibitors|mesh-ancestor
64738647|NCT00002387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738648|NCT00002387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738649|NCT00002393|Efavirenz|efavirenz|mesh-list
64738650|NCT00002393|Indinavir|indinavir|mesh-list
64738651|NCT00002393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64738652|NCT00002393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64738653|NCT00002393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738654|NCT00002393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738655|NCT00002393|Antiviral Agents|antiviral agents|mesh-ancestor
64738656|NCT00002393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738657|NCT00002393|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64350716|NCT04339049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64738662|NCT00002393|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64738663|NCT00002393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64738664|NCT00002393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64738665|NCT00002393|Protease Inhibitors|protease inhibitors|mesh-ancestor
64738666|NCT00002393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64624434|NCT02564978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64624435|NCT02564978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624436|NCT02554890|Valsartan|valsartan|mesh-list
64624437|NCT02554890|Enalapril|enalapril|mesh-list
64624438|NCT02554890|Enalaprilat|enalaprilat|mesh-list
64624439|NCT02554890|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64624440|NCT02554890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64624441|NCT02554890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64624442|NCT02554890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64624443|NCT02554890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624444|NCT02554890|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64624445|NCT02554890|Protease Inhibitors|protease inhibitors|mesh-ancestor
64624446|NCT02554890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624448|NCT00001864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64624449|NCT00001864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64624450|NCT00001864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64624451|NCT00001864|Autonomic Agents|autonomic agents|mesh-ancestor
64624452|NCT00001864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64624453|NCT00001864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624454|NCT00001864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64624455|NCT00001864|Respiratory System Agents|respiratory system agents|mesh-ancestor
64738667|NCT00002393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738669|NCT00002399|Posaconazole|posaconazole|mesh-list
64738670|NCT00002399|Antifungal Agents|antifungal agents|mesh-ancestor
64738671|NCT00002399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738672|NCT00002399|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64738673|NCT00002399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64738674|NCT00002399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738675|NCT00002399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738676|NCT00002399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64738677|NCT00002399|Hormone Antagonists|hormone antagonists|mesh-ancestor
64738678|NCT00002399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64738679|NCT00002399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738680|NCT00002399|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64624464|NCT02232152|Fluorouracil|fluorouracil|mesh-list
64624465|NCT02232152|Antimetabolites|antimetabolites|mesh-ancestor
64624466|NCT02232152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624467|NCT02232152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64624468|NCT02232152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624469|NCT02232152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64624470|NCT02232152|Immunologic Factors|immunologic factors|mesh-ancestor
64624471|NCT02232152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624472|NCT02232152|Antioxidants|antioxidants|mesh-ancestor
64624473|NCT02232152|Protective Agents|protective agents|mesh-ancestor
64624474|NCT02232152|Vitamin B Complex|vitamin b complex|mesh-ancestor
64738681|NCT00002399|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64738682|NCT00002399|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64738683|NCT00002399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64738684|NCT00002399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64738686|NCT00002405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64738687|NCT00002405|Antitubercular Agents|antitubercular agents|mesh-ancestor
64738688|NCT00002405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64738689|NCT00002405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738690|NCT00002405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64738691|NCT00002405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64738692|NCT00002405|Protease Inhibitors|protease inhibitors|mesh-ancestor
64738693|NCT00002405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738694|NCT00002405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738695|NCT00002405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738696|NCT00002405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738697|NCT00002405|Antiviral Agents|antiviral agents|mesh-ancestor
64738698|NCT00002417|Amprenavir|amprenavir|mesh-list
64738699|NCT00002417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64738700|NCT00002417|Antitubercular Agents|antitubercular agents|mesh-ancestor
64738701|NCT00002417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64738702|NCT00002417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738703|NCT00002417|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64738704|NCT00002417|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64738705|NCT00002417|Protease Inhibitors|protease inhibitors|mesh-ancestor
64738706|NCT00002417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738707|NCT00002417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624516|NCT03252600|Growth Substances|growth substances|mesh-ancestor
64624517|NCT03252600|Growth Inhibitors|growth inhibitors|mesh-ancestor
64624518|NCT03252600|Protease Inhibitors|protease inhibitors|mesh-ancestor
64624519|NCT03252600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624520|NCT03252600|Dermatologic Agents|dermatologic agents|mesh-ancestor
64624521|NCT02749526|Tegafur|tegafur|mesh-list
64624522|NCT02749526|Endostar protein|endostar protein|mesh-list
64624523|NCT02749526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624524|NCT02749526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64738708|NCT00002417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64624525|NCT02749526|Antimetabolites|antimetabolites|mesh-ancestor
64738709|NCT00002417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738710|NCT00002417|Antiviral Agents|antiviral agents|mesh-ancestor
64738711|NCT00002423|Lamivudine|lamivudine|mesh-list
64738712|NCT00002423|Abacavir|abacavir|mesh-list
64738713|NCT00002423|Nelfinavir|nelfinavir|mesh-list
64738714|NCT00002423|Indinavir|indinavir|mesh-list
64738715|NCT00002423|Amprenavir|amprenavir|mesh-list
64350778|NCT02195518|Tenofovir|tenofovir|mesh-list
64738721|NCT00002423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738722|NCT00002423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738723|NCT00002423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738724|NCT00002423|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64738725|NCT00002423|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64624556|NCT02744612|Immunoglobulins|immunoglobulins|mesh-list
64624557|NCT02744612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64624558|NCT02744612|Immunoconjugates|immunoconjugates|mesh-list
64624559|NCT02744612|Immunologic Factors|immunologic factors|mesh-ancestor
64624560|NCT02744612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738726|NCT00002423|Protease Inhibitors|protease inhibitors|mesh-ancestor
64738727|NCT00002423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64738728|NCT00002423|Antitubercular Agents|antitubercular agents|mesh-ancestor
64624561|NCT02744612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738729|NCT00002423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64738731|NCT02973581|Dipyrone|dipyrone|mesh-list
64738732|NCT02973581|Lidocaine|lidocaine|mesh-list
64738733|NCT02973581|Bupivacaine|bupivacaine|mesh-list
64738734|NCT02973581|Proxymetacaine|proxymetacaine|mesh-list
64738735|NCT02973581|Anesthetics, Local|anesthetics, local|mesh-ancestor
64738736|NCT02973581|Anesthetics|anesthetics|mesh-ancestor
64738737|NCT02973581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64738738|NCT02973581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738739|NCT02973581|Sensory System Agents|sensory system agents|mesh-ancestor
64738740|NCT02973581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64738741|NCT02973581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64738742|NCT02973581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64738743|NCT02973581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64738744|NCT02973581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64624615|NCT00001906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64624616|NCT00001906|Growth Substances|growth substances|mesh-ancestor
64624617|NCT00001906|Growth Inhibitors|growth inhibitors|mesh-ancestor
64624618|NCT00001906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624619|NCT00001906|Antacids|antacids|mesh-ancestor
64624620|NCT00001906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624621|NCT00001906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64624622|NCT00000196|Naltrexone|naltrexone|mesh-list
64624623|NCT00000196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64624624|NCT00000196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64624625|NCT00000196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624626|NCT00000196|Sensory System Agents|sensory system agents|mesh-ancestor
64624628|NCT00000946|polysaccharide-K|polysaccharide-k|mesh-list
64738745|NCT02973581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738746|NCT02973581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64738747|NCT02973581|Analgesics|analgesics|mesh-ancestor
64738752|NCT00002435|Zidovudine|zidovudine|mesh-list
64738757|NCT00002435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738758|NCT00002435|Antiviral Agents|antiviral agents|mesh-ancestor
64738759|NCT00002435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738760|NCT00002435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738761|NCT00002435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64738762|NCT00002447|Ritonavir|ritonavir|mesh-list
64738763|NCT00002447|Saquinavir|saquinavir|mesh-list
64738764|NCT00002447|Efavirenz|efavirenz|mesh-list
64738765|NCT00002447|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64738766|NCT00002447|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64738767|NCT00002447|Protease Inhibitors|protease inhibitors|mesh-ancestor
64738768|NCT00002447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624662|NCT00000202|Analgesics|analgesics|mesh-ancestor
64624663|NCT00000202|Sensory System Agents|sensory system agents|mesh-ancestor
64624664|NCT00000202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64624665|NCT00000202|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64624666|NCT00000208|Buprenorphine|buprenorphine|mesh-list
64624667|NCT00000208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64624668|NCT00000208|Narcotics|narcotics|mesh-ancestor
64624669|NCT00000208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64624671|NCT00000208|Analgesics|analgesics|mesh-ancestor
64738769|NCT00002447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738770|NCT00002447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64738793|NCT00002465|Megestrol Acetate|megestrol acetate|mesh-list
64738794|NCT00002465|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64738795|NCT00002465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64738796|NCT00002465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64738797|NCT00002465|Contraceptive Agents|contraceptive agents|mesh-ancestor
64738798|NCT00002465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64738799|NCT00002465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738800|NCT00002465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64738801|NCT00002465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64738802|NCT00002465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64738803|NCT00002465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738804|NCT00002465|Appetite Stimulants|appetite stimulants|mesh-ancestor
64738805|NCT00002465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64738806|NCT00002471|Leucovorin|leucovorin|mesh-list
64738807|NCT00002471|Cytarabine|cytarabine|mesh-list
64350866|NCT03795233|Vancomycin|vancomycin|mesh-list
64738824|NCT00002471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738826|NCT00002471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64738827|NCT00002471|Alkylating Agents|alkylating agents|mesh-ancestor
64624715|NCT00000976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64624716|NCT00000976|Immunologic Factors|immunologic factors|mesh-ancestor
64300793|NCT05027126|Folic Acid|folic acid|mesh-list
64738828|NCT00002471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738865|NCT00002477|Carboplatin|carboplatin|mesh-list
64738866|NCT00002477|Doxorubicin|doxorubicin|mesh-list
64738867|NCT00002477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64738868|NCT00002477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64738869|NCT00002477|Immunologic Factors|immunologic factors|mesh-ancestor
64738870|NCT00002477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738871|NCT00002477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64624770|NCT00000238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64738872|NCT00002477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64738873|NCT00002477|Alkylating Agents|alkylating agents|mesh-ancestor
64738874|NCT00002477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738875|NCT00002477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738876|NCT00002477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64624771|NCT00000238|Narcotics|narcotics|mesh-ancestor
64624772|NCT00000238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64624773|NCT00000238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624774|NCT00000238|Analgesics|analgesics|mesh-ancestor
64624775|NCT00000238|Sensory System Agents|sensory system agents|mesh-ancestor
64624776|NCT00000238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64624777|NCT00000238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64624778|NCT00000244|Dynorphins|dynorphins|mesh-list
64624782|NCT00000994|Zidovudine|zidovudine|mesh-list
64738877|NCT00002477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64738878|NCT00002477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64738879|NCT00002477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64738880|NCT00002477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738882|NCT00002489|Dactinomycin|dactinomycin|mesh-list
64738883|NCT00002489|Cyclophosphamide|cyclophosphamide|mesh-list
64738884|NCT00002489|Carboplatin|carboplatin|mesh-list
64624822|NCT02904954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624823|NCT00000250|Nitrous Oxide|nitrous oxide|mesh-list
64624824|NCT00000250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64738885|NCT00002489|Doxorubicin|doxorubicin|mesh-list
64738886|NCT00002489|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64321986|NCT02231203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624825|NCT00000250|Anesthetics, General|anesthetics, general|mesh-ancestor
64624826|NCT00000250|Anesthetics|anesthetics|mesh-ancestor
64624827|NCT00000250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64624828|NCT00000250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624829|NCT00000250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64321987|NCT02231203|Protective Agents|protective agents|mesh-ancestor
64427856|NCT02374021|Analgesics|analgesics|mesh-ancestor
64738900|NCT00002489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64738901|NCT00002489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64738902|NCT00002489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64738903|NCT00002489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738904|NCT00002489|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64738905|NCT00002489|Abortifacient Agents|abortifacient agents|mesh-ancestor
64738906|NCT00002489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64738907|NCT00002489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64738908|NCT00002489|Antimetabolites|antimetabolites|mesh-ancestor
64738909|NCT00002489|Dermatologic Agents|dermatologic agents|mesh-ancestor
64738910|NCT00002489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64738938|NCT00002501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64738939|NCT00002501|Immunologic Factors|immunologic factors|mesh-ancestor
64738940|NCT00002501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64738941|NCT00002501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64738942|NCT00002501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64738943|NCT00002501|Alkylating Agents|alkylating agents|mesh-ancestor
64738944|NCT00002501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624880|NCT00001024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624881|NCT00001024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64624882|NCT00001024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64624883|NCT00000268|Bupropion|bupropion|mesh-list
64624884|NCT00000268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64624885|NCT00000268|Antidepressive Agents|antidepressive agents|mesh-ancestor
64624886|NCT00000268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64624887|NCT00000268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64738945|NCT00002501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738946|NCT00002501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64738947|NCT00002147|Doxorubicin|doxorubicin|mesh-list
64738948|NCT00002147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64738949|NCT00002147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64738950|NCT00002147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64738951|NCT00002147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64738952|NCT00002147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64738953|NCT00002147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738954|NCT00002147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64738955|NCT00002159|Itraconazole|itraconazole|mesh-list
64738956|NCT00002159|Amphotericin B|amphotericin b|mesh-list
64738957|NCT00002159|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64738958|NCT00002159|Antifungal Agents|antifungal agents|mesh-ancestor
64738959|NCT00002159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64738960|NCT00002159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64738961|NCT00002159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64738962|NCT00002159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64738963|NCT00002159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427864|NCT02372383|Pancreatin|pancreatin|mesh-list
64739000|NCT00002177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739001|NCT00002177|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64624928|NCT01226719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624929|NCT01226719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64624930|NCT01226719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624931|NCT01226719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64624932|NCT01226719|Immunologic Factors|immunologic factors|mesh-ancestor
64624933|NCT01226719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739002|NCT00002177|Antimetabolites|antimetabolites|mesh-ancestor
64739003|NCT00002177|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64739004|NCT00002177|Antiviral Agents|antiviral agents|mesh-ancestor
64739005|NCT00002177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739006|NCT00002177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64739007|NCT00002177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64739008|NCT00002177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64739009|NCT00002177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64739010|NCT00002177|Protease Inhibitors|protease inhibitors|mesh-ancestor
64624960|NCT04331470|Formoterol Fumarate|formoterol fumarate|mesh-list
64624961|NCT04331470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64624962|NCT04331470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64300876|NCT04434248|Amebicides|amebicides|mesh-ancestor
64624963|NCT04331470|Protease Inhibitors|protease inhibitors|mesh-ancestor
64624964|NCT04331470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739012|NCT00002183|Zidovudine|zidovudine|mesh-list
64624980|NCT04331470|Hormones|hormones|mesh-ancestor
64739013|NCT00002183|Abacavir|abacavir|mesh-list
64739014|NCT00002183|Amprenavir|amprenavir|mesh-list
64739015|NCT00002183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64739016|NCT00002183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64739017|NCT00002183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739018|NCT00002183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478357|NCT05634057|Antioxidants|antioxidants|mesh-ancestor
64625019|NCT02548962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625020|NCT02548962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625021|NCT02548962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64739020|NCT00002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64321988|NCT02231203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625022|NCT02548962|Glucocorticoids|glucocorticoids|mesh-ancestor
64625023|NCT02548962|Hormones|hormones|mesh-ancestor
64625025|NCT02548962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64321990|NCT02231203|Micronutrients|micronutrients|mesh-ancestor
64321991|NCT02231281|Ritonavir|ritonavir|mesh-list
64321992|NCT02231281|Lopinavir|lopinavir|mesh-list
64321993|NCT02231281|Tenofovir|tenofovir|mesh-list
64739021|NCT00002183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64739022|NCT00002183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64739023|NCT00002183|Antimetabolites|antimetabolites|mesh-ancestor
64739024|NCT00002183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64625077|NCT01188577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739025|NCT00002183|Antitubercular Agents|antitubercular agents|mesh-ancestor
64625078|NCT01188577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625079|NCT01188577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64625085|NCT01188577|Mydriatics|mydriatics|mesh-ancestor
64739026|NCT00002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64739027|NCT00002183|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64739028|NCT00002183|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64739029|NCT00002183|Protease Inhibitors|protease inhibitors|mesh-ancestor
64739030|NCT00002189|Paclitaxel|paclitaxel|mesh-list
64739031|NCT00002189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64739032|NCT00002189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739033|NCT00002189|Tubulin Modulators|tubulin modulators|mesh-ancestor
64739034|NCT00002189|Antimitotic Agents|antimitotic agents|mesh-ancestor
64739035|NCT00002189|Mitosis Modulators|mitosis modulators|mesh-ancestor
64625138|NCT00000304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64739047|NCT00002195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64739048|NCT00002195|Antimetabolites|antimetabolites|mesh-ancestor
64739049|NCT00002195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64739050|NCT00002195|Antitubercular Agents|antitubercular agents|mesh-ancestor
64739051|NCT00002195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64739052|NCT00002195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64739053|NCT00002195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64739054|NCT00002195|Protease Inhibitors|protease inhibitors|mesh-ancestor
64739055|NCT00002201|Ritonavir|ritonavir|mesh-list
64739056|NCT00002201|Nelfinavir|nelfinavir|mesh-list
64739061|NCT00002201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739062|NCT00002201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64739063|NCT00002201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64739064|NCT00002201|Antiviral Agents|antiviral agents|mesh-ancestor
64739065|NCT00002201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739066|NCT00002201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64739067|NCT00002201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64739068|NCT00002213|Efavirenz|efavirenz|mesh-list
64739069|NCT00002213|Abacavir|abacavir|mesh-list
64739070|NCT00002213|Amprenavir|amprenavir|mesh-list
64739071|NCT00002213|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64739072|NCT00002213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64739073|NCT00002213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739074|NCT00002213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739075|NCT00002213|Antiviral Agents|antiviral agents|mesh-ancestor
64739076|NCT00002213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739077|NCT00002213|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64739078|NCT00002213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64739079|NCT00002213|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64739080|NCT00002213|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64739081|NCT00002213|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64739082|NCT00002213|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64739083|NCT00002213|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64739084|NCT00002213|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64739085|NCT00002213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64739086|NCT00002213|Antitubercular Agents|antitubercular agents|mesh-ancestor
64739087|NCT00002213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64739088|NCT00002213|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64739089|NCT00002213|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64739090|NCT00002213|Protease Inhibitors|protease inhibitors|mesh-ancestor
64739091|NCT00381251|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64739092|NCT00381251|Estrogens|estrogens|mesh-ancestor
64739093|NCT00381251|Hormones|hormones|mesh-ancestor
64739094|NCT00381251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64428095|NCT02188719|Analgesics|analgesics|mesh-ancestor
64625317|NCT00002002|Micronutrients|micronutrients|mesh-ancestor
64625318|NCT00002002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64625319|NCT00002002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739108|NCT00002219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64625320|NCT00002002|Renal Agents|renal agents|mesh-ancestor
64625321|NCT00002002|Antimalarials|antimalarials|mesh-ancestor
64625322|NCT00002002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64625323|NCT00002002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64625324|NCT00002002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64625325|NCT00002002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625326|NCT00002002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625327|NCT00002002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64625328|NCT00002002|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64625329|NCT00002002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64625330|NCT02535000|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64739109|NCT00002219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64739110|NCT00002225|Efavirenz|efavirenz|mesh-list
64739111|NCT00002225|Stavudine|stavudine|mesh-list
64739112|NCT00002225|Didanosine|didanosine|mesh-list
64739113|NCT00002225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64739114|NCT00002225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64739115|NCT00002225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739116|NCT00002225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739117|NCT00002225|Antiviral Agents|antiviral agents|mesh-ancestor
64739118|NCT00002225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739119|NCT00002225|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64739120|NCT00002225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64739121|NCT00002225|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64739122|NCT00002225|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64739123|NCT00002225|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64739124|NCT00002225|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64739125|NCT00002225|Antimetabolites|antimetabolites|mesh-ancestor
64739126|NCT00002225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64739127|NCT00002225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64739128|NCT00002243|Calanolide A|calanolide a|mesh-list
64739129|NCT00002243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64739130|NCT00002243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64739131|NCT00002243|Antiviral Agents|antiviral agents|mesh-ancestor
64739132|NCT00002243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739133|NCT00002249|Levofloxacin|levofloxacin|mesh-list
64739134|NCT00002249|Ofloxacin|ofloxacin|mesh-list
64739135|NCT00002249|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64625361|NCT01189747|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64625362|NCT01189747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64739136|NCT00002249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739137|NCT00002249|Renal Agents|renal agents|mesh-ancestor
64739138|NCT00002249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64625363|NCT01189747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625364|NCT01189747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625365|NCT01189747|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64625366|NCT01189747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64625367|NCT01189747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739139|NCT00002249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64739140|NCT00002249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64739141|NCT00002249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739142|NCT00002249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739143|NCT00002249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428096|NCT02188719|Sensory System Agents|sensory system agents|mesh-ancestor
64428098|NCT02188719|Antipyretics|antipyretics|mesh-ancestor
64739147|NCT00002255|Epoetin Alfa|epoetin alfa|mesh-list
64739148|NCT00002255|Antimetabolites|antimetabolites|mesh-ancestor
64739149|NCT00002255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739150|NCT00002255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64739151|NCT00002255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64739152|NCT00002255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739153|NCT00002255|Antiviral Agents|antiviral agents|mesh-ancestor
64739154|NCT00002255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739155|NCT00002255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64739156|NCT00002255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64739157|NCT00002255|Hematinics|hematinics|mesh-ancestor
64739159|NCT00002261|Immunologic Factors|immunologic factors|mesh-ancestor
64739160|NCT00002261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739161|NCT00002507|Mitomycins|mitomycins|mesh-list
64739162|NCT00002507|Mitomycin|mitomycin|mesh-list
64739163|NCT00002507|Porfiromycin|porfiromycin|mesh-list
64739164|NCT00002507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64739165|NCT00002507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64625385|NCT00001132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64625386|NCT00001132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64625387|NCT01149733|Tamsulosin|tamsulosin|mesh-list
64625388|NCT01149733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64625389|NCT01149733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64625390|NCT01149733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64625391|NCT01149733|Adrenergic Agents|adrenergic agents|mesh-ancestor
64625392|NCT01149733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64625393|NCT01149733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625394|NCT01149733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625395|NCT01149733|Urological Agents|urological agents|mesh-ancestor
64625397|NCT02498912|Fludarabine|fludarabine|mesh-list
64625398|NCT02498912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64625399|NCT02498912|Immunologic Factors|immunologic factors|mesh-ancestor
64625400|NCT02498912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739166|NCT00002507|Alkylating Agents|alkylating agents|mesh-ancestor
64739167|NCT00002507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64478515|NCT00215943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739168|NCT00002507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64739169|NCT00002507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739170|NCT00002519|Paclitaxel|paclitaxel|mesh-list
64739171|NCT00002519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64739172|NCT00002519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739173|NCT00002519|Tubulin Modulators|tubulin modulators|mesh-ancestor
64739174|NCT00002519|Antimitotic Agents|antimitotic agents|mesh-ancestor
64739175|NCT00002519|Mitosis Modulators|mitosis modulators|mesh-ancestor
64739176|NCT00002519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739177|NCT00002267|Rifabutin|rifabutin|mesh-list
64739178|NCT00002267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64739179|NCT00002267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739180|NCT00002267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64739181|NCT00002267|Antitubercular Agents|antitubercular agents|mesh-ancestor
64739182|NCT00002273|Ganciclovir|ganciclovir|mesh-list
64739183|NCT00002273|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64625421|NCT00000334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64625422|NCT00000334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739184|NCT00002273|Antiviral Agents|antiviral agents|mesh-ancestor
64739185|NCT00002273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739186|NCT00002273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64739187|NCT00002273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739188|NCT00002273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739189|NCT00002279|Zalcitabine|zalcitabine|mesh-list
64739190|NCT00002279|Antimetabolites|antimetabolites|mesh-ancestor
64739191|NCT00002279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739192|NCT00002279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64739193|NCT00002279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64625423|NCT00000334|Analgesics|analgesics|mesh-ancestor
64625424|NCT00000334|Sensory System Agents|sensory system agents|mesh-ancestor
64350735|NCT02133664|Vitamins|vitamins|mesh-ancestor
64625425|NCT00000334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625426|NCT00000334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64625428|NCT00000340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64625429|NCT00000340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625430|NCT00002020|Zidovudine|zidovudine|mesh-list
64625431|NCT00002020|Antimetabolites|antimetabolites|mesh-ancestor
64625432|NCT00002020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625433|NCT00002020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64739194|NCT00002279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739195|NCT00002279|Antiviral Agents|antiviral agents|mesh-ancestor
64739196|NCT00002279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739197|NCT00002279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64739198|NCT00002279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64739199|NCT00002285|Zidovudine|zidovudine|mesh-list
64739200|NCT00002285|Antimetabolites|antimetabolites|mesh-ancestor
64739214|NCT00002531|Ifosfamide|ifosfamide|mesh-list
64739215|NCT00002531|Doxorubicin|doxorubicin|mesh-list
64739216|NCT00002531|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64739217|NCT00002531|Methotrexate|methotrexate|mesh-list
64739218|NCT00002531|Etoposide|etoposide|mesh-list
64739219|NCT00002531|Vincristine|vincristine|mesh-list
64739220|NCT00002531|Daunorubicin|daunorubicin|mesh-list
64739221|NCT00002531|Asparaginase|asparaginase|mesh-list
64739222|NCT00002531|Mitoxantrone|mitoxantrone|mesh-list
64739223|NCT00002531|Mercaptopurine|mercaptopurine|mesh-list
64739258|NCT00002531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64739259|NCT00002531|Antiviral Agents|antiviral agents|mesh-ancestor
64739260|NCT00002531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739261|NCT00002531|Antidotes|antidotes|mesh-ancestor
64739262|NCT00002531|Protective Agents|protective agents|mesh-ancestor
64739263|NCT00002531|Vitamin B Complex|vitamin b complex|mesh-ancestor
64739264|NCT00002531|Vitamins|vitamins|mesh-ancestor
64739265|NCT00002531|Micronutrients|micronutrients|mesh-ancestor
64739266|NCT00002531|Tubulin Modulators|tubulin modulators|mesh-ancestor
64739267|NCT00002531|Antimitotic Agents|antimitotic agents|mesh-ancestor
64739268|NCT00002531|Mitosis Modulators|mitosis modulators|mesh-ancestor
64739269|NCT00002531|Analgesics|analgesics|mesh-ancestor
64739270|NCT00002531|Sensory System Agents|sensory system agents|mesh-ancestor
64739271|NCT00002537|Topotecan|topotecan|mesh-list
64739272|NCT00002537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64739273|NCT00002537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64739274|NCT00002537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739275|NCT00002537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739276|NCT00002537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739277|NCT00002543|Gallium nitrate|gallium nitrate|mesh-list
64428101|NCT02188719|Antitubercular Agents|antitubercular agents|mesh-ancestor
64739306|NCT00002549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739307|NCT00002549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64739309|NCT00002549|Antiviral Agents|antiviral agents|mesh-ancestor
64739310|NCT00002549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739311|NCT00002549|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64739312|NCT00002549|Analgesics|analgesics|mesh-ancestor
64739313|NCT00002549|Sensory System Agents|sensory system agents|mesh-ancestor
64739314|NCT00002549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625503|NCT00000376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64625507|NCT02143388|Cisplatin|cisplatin|mesh-list
64739315|NCT00002555|Cobalt|cobalt|mesh-list
64428103|NCT02188719|Hematinics|hematinics|mesh-ancestor
64739317|NCT00002555|Micronutrients|micronutrients|mesh-ancestor
64739318|NCT00002555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739319|NCT00002561|Doxorubicin|doxorubicin|mesh-list
64739320|NCT00002561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64739321|NCT00002561|Bleomycin|bleomycin|mesh-list
64739322|NCT00002561|Dacarbazine|dacarbazine|mesh-list
64478659|NCT01855789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739323|NCT00002561|Vinblastine|vinblastine|mesh-list
64739324|NCT00002561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64739325|NCT00002561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739326|NCT00002561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64739327|NCT00002561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64739328|NCT00002561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739329|NCT00002561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739330|NCT00002561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64739331|NCT00002561|Alkylating Agents|alkylating agents|mesh-ancestor
64739332|NCT00002561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64625550|NCT01894334|Coagulants|coagulants|mesh-ancestor
64739333|NCT00002561|Tubulin Modulators|tubulin modulators|mesh-ancestor
64739334|NCT00002561|Antimitotic Agents|antimitotic agents|mesh-ancestor
64739335|NCT00002561|Mitosis Modulators|mitosis modulators|mesh-ancestor
64739336|NCT00002567|Etoposide|etoposide|mesh-list
64739337|NCT00002567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64739338|NCT00002567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739339|NCT00002567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64739340|NCT00002567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64625609|NCT00000400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64739341|NCT00002567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625610|NCT00000400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625611|NCT00000400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64625612|NCT00000400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64625613|NCT01195597|Nicotine|nicotine|mesh-list
64625614|NCT01195597|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64625615|NCT01195597|Autonomic Agents|autonomic agents|mesh-ancestor
64625616|NCT01195597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625617|NCT01195597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625619|NCT01195597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64739342|NCT00002567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739343|NCT00002579|Tamoxifen|tamoxifen|mesh-list
64322005|NCT02231281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64322006|NCT02231281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64322007|NCT02231281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64322008|NCT02231281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64322009|NCT02231281|Antimetabolites|antimetabolites|mesh-ancestor
64322010|NCT02231359|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
64322011|NCT02231359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64739344|NCT00002579|Cyclophosphamide|cyclophosphamide|mesh-list
64739345|NCT00002579|Fluorouracil|fluorouracil|mesh-list
64739346|NCT00002579|Methotrexate|methotrexate|mesh-list
64739347|NCT00002579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64739348|NCT00002579|Immunologic Factors|immunologic factors|mesh-ancestor
64739349|NCT00002579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625664|NCT00380614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64625665|NCT00380614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64625666|NCT00380614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625667|NCT00380614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625668|NCT00380614|Antiviral Agents|antiviral agents|mesh-ancestor
64739350|NCT00002579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64739351|NCT00002579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64739352|NCT00002579|Alkylating Agents|alkylating agents|mesh-ancestor
64739353|NCT00002579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739354|NCT00002579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739355|NCT00002579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64739356|NCT00002579|Antimetabolites|antimetabolites|mesh-ancestor
64739357|NCT00002579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64739358|NCT00002579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64739359|NCT00002579|Abortifacient Agents|abortifacient agents|mesh-ancestor
64739360|NCT00002579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64739361|NCT00002579|Dermatologic Agents|dermatologic agents|mesh-ancestor
64739362|NCT00002579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739363|NCT00002579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64739364|NCT00002579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64739365|NCT00002579|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64739385|NCT00002609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739386|NCT00002609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64739387|NCT00002609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64739388|NCT00002609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64739389|NCT00002609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739390|NCT00002609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64739391|NCT00002615|Fluorouracil|fluorouracil|mesh-list
64739392|NCT00002615|Epirubicin|epirubicin|mesh-list
64739393|NCT00002615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739394|NCT00002615|Antimetabolites|antimetabolites|mesh-ancestor
64739395|NCT00002615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739396|NCT00002615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64739397|NCT00002615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64739398|NCT00002615|Immunologic Factors|immunologic factors|mesh-ancestor
64739399|NCT00002615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739405|NCT00002621|Interferon-alpha|interferon-alpha|mesh-list
64739406|NCT00002621|Interferon alpha-2|interferon alpha-2|mesh-list
64739407|NCT00002621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428150|NCT01629381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428152|NCT01629381|Anticoagulants|anticoagulants|mesh-ancestor
64739420|NCT00002627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739421|NCT00002627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64739422|NCT00002627|Immunologic Factors|immunologic factors|mesh-ancestor
64739423|NCT00002627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625757|NCT00002068|Amebicides|amebicides|mesh-ancestor
64739424|NCT00002627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64739425|NCT00002627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64739426|NCT00002627|Alkylating Agents|alkylating agents|mesh-ancestor
64739427|NCT00002627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64739428|NCT00002633|Leuprolide|leuprolide|mesh-list
64322018|NCT02780687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322019|NCT02780687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64322020|NCT02780687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322021|NCT02780687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322022|NCT02231437|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
64322023|NCT02231437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64322024|NCT02231437|Autonomic Agents|autonomic agents|mesh-ancestor
64322025|NCT02231437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322026|NCT02231437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322027|NCT02231437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64322028|NCT02231437|Respiratory System Agents|respiratory system agents|mesh-ancestor
64322029|NCT02147873|Azacitidine|azacitidine|mesh-list
64322030|NCT02147873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64322031|NCT02147873|Antimetabolites|antimetabolites|mesh-ancestor
64322032|NCT02147873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739429|NCT00002633|Goserelin|goserelin|mesh-list
64739430|NCT00002633|Flutamide|flutamide|mesh-list
64739431|NCT00002633|Bicalutamide|bicalutamide|mesh-list
64739432|NCT00002633|Nilutamide|nilutamide|mesh-list
64739433|NCT00002633|Buserelin|buserelin|mesh-list
64739434|NCT00002633|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64739435|NCT00002633|Fertility Agents|fertility agents|mesh-ancestor
64739436|NCT00002633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64739437|NCT00002633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739438|NCT00002633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64739439|NCT00002633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739440|NCT00002633|Androgen Antagonists|androgen antagonists|mesh-ancestor
64739441|NCT00002633|Hormone Antagonists|hormone antagonists|mesh-ancestor
64739442|NCT00002633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64739443|NCT00002639|Suramin|suramin|mesh-list
64739444|NCT00002639|Antinematodal Agents|antinematodal agents|mesh-ancestor
64739445|NCT00002639|Anthelmintics|anthelmintics|mesh-ancestor
64739446|NCT00002639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64739447|NCT00002639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739497|NCT05673785|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64739498|NCT05673785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64739499|NCT05673785|Immunologic Factors|immunologic factors|mesh-ancestor
64428160|NCT05269017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64428161|NCT05269017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64739511|NCT05673785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64739512|NCT05673785|Glucocorticoids|glucocorticoids|mesh-ancestor
64739513|NCT05673785|Hormones|hormones|mesh-ancestor
64739514|NCT05673785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64739515|NCT05673785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64739516|NCT05673785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64739517|NCT05671991|Empagliflozin|empagliflozin|mesh-list
64739518|NCT05671991|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64739519|NCT05671991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739541|NCT00002675|Cyclophosphamide|cyclophosphamide|mesh-list
64739542|NCT00002675|Carboplatin|carboplatin|mesh-list
64739543|NCT00002675|Etoposide|etoposide|mesh-list
64739544|NCT00002675|Vincristine|vincristine|mesh-list
64739545|NCT00002675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64739546|NCT00002675|Immunologic Factors|immunologic factors|mesh-ancestor
64739547|NCT00002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739548|NCT00002675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64739549|NCT00002675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64739550|NCT00002675|Alkylating Agents|alkylating agents|mesh-ancestor
64739551|NCT00002675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739552|NCT00002675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739553|NCT00002675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64739554|NCT00002675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64739555|NCT00002675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64739556|NCT00002675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64739557|NCT00002675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739558|NCT00002675|Tubulin Modulators|tubulin modulators|mesh-ancestor
64739559|NCT00002675|Antimitotic Agents|antimitotic agents|mesh-ancestor
64739560|NCT00002675|Mitosis Modulators|mitosis modulators|mesh-ancestor
64739562|NCT00002681|Daclizumab|daclizumab|mesh-list
64739563|NCT00002681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739564|NCT00002681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64739565|NCT00002681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64739566|NCT00002681|Antiviral Agents|antiviral agents|mesh-ancestor
64739567|NCT00002681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739568|NCT00002681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64739569|NCT00002681|Immunologic Factors|immunologic factors|mesh-ancestor
64351626|NCT05159219|Colchicine|colchicine|mesh-list
64739587|NCT00002693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739588|NCT00002693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739589|NCT00002705|Topotecan|topotecan|mesh-list
64739590|NCT00002705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64739591|NCT00002705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64739592|NCT00002705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739593|NCT00002705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739594|NCT00002705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739595|NCT00002711|Paclitaxel|paclitaxel|mesh-list
64739596|NCT00002711|Cisplatin|cisplatin|mesh-list
64739597|NCT00002711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64739598|NCT00002711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739599|NCT00002711|Tubulin Modulators|tubulin modulators|mesh-ancestor
64739600|NCT00002711|Antimitotic Agents|antimitotic agents|mesh-ancestor
64739601|NCT00002711|Mitosis Modulators|mitosis modulators|mesh-ancestor
64739602|NCT00002711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739604|NCT00002717|Cisplatin|cisplatin|mesh-list
64739605|NCT00002717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64739606|NCT00002717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739607|NCT00002717|Tubulin Modulators|tubulin modulators|mesh-ancestor
64739608|NCT00002717|Antimitotic Agents|antimitotic agents|mesh-ancestor
64739609|NCT00002717|Mitosis Modulators|mitosis modulators|mesh-ancestor
64739610|NCT00002717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739611|NCT00002723|Suramin|suramin|mesh-list
64739612|NCT00002723|Antinematodal Agents|antinematodal agents|mesh-ancestor
64739613|NCT00002723|Anthelmintics|anthelmintics|mesh-ancestor
64739614|NCT00002723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64739615|NCT00002723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739616|NCT00002723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739617|NCT00002723|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64428266|NCT05379179|Fentanyl|fentanyl|mesh-list
64739642|NCT00002747|Immunologic Factors|immunologic factors|mesh-ancestor
64739686|NCT00002759|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64739687|NCT00002759|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64739688|NCT00002759|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64739689|NCT00002765|Immunotoxins|immunotoxins|mesh-list
64739690|NCT00002765|Immunologic Factors|immunologic factors|mesh-ancestor
64739691|NCT00002765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739692|NCT00002771|Interferons|interferons|mesh-list
64739694|NCT00002771|Interferon-alpha|interferon-alpha|mesh-list
64739695|NCT00002771|Busulfan|busulfan|mesh-list
64739696|NCT00002771|Idarubicin|idarubicin|mesh-list
64739697|NCT00002771|Hydroxyurea|hydroxyurea|mesh-list
64739698|NCT00002771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739699|NCT00002771|Antiviral Agents|antiviral agents|mesh-ancestor
64739700|NCT00002771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739712|NCT00002771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64739713|NCT00002771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739714|NCT00002771|Antisickling Agents|antisickling agents|mesh-ancestor
64739715|NCT00002771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64739716|NCT00002777|Tamoxifen|tamoxifen|mesh-list
64739717|NCT00002777|Exemestane|exemestane|mesh-list
64739718|NCT00002777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739719|NCT00002777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64739720|NCT00002777|Hormone Antagonists|hormone antagonists|mesh-ancestor
64739721|NCT00002777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64739722|NCT00002777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739723|NCT00002777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64739724|NCT00002777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64625978|NCT01196377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64739725|NCT00002777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64739726|NCT00002777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64739727|NCT00002777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64739728|NCT00002777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64739729|NCT00002777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64739730|NCT00002777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739731|NCT00002783|Leucovorin|leucovorin|mesh-list
64739732|NCT00002783|Fluorouracil|fluorouracil|mesh-list
64739733|NCT00002783|Floxuridine|floxuridine|mesh-list
64739774|NCT00002789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64739776|NCT00381953|Ribavirin|ribavirin|mesh-list
64739777|NCT00381953|Interferon-alpha|interferon-alpha|mesh-list
64739778|NCT00381953|Interferon alpha-2|interferon alpha-2|mesh-list
64479115|NCT01872715|Doxycycline|doxycycline|mesh-list
64739779|NCT00381953|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64739780|NCT00381953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739781|NCT00381953|Antiviral Agents|antiviral agents|mesh-ancestor
64739782|NCT00381953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739783|NCT00381953|Antimetabolites|antimetabolites|mesh-ancestor
64739784|NCT00381953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739785|NCT00381953|Immunologic Factors|immunologic factors|mesh-ancestor
64739786|NCT00381953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739787|NCT00382343|Trimethoprim|trimethoprim|mesh-list
64739788|NCT00382343|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64739789|NCT00382343|Sulfamethoxazole|sulfamethoxazole|mesh-list
64739790|NCT00382343|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64739791|NCT00382343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739792|NCT00382343|Renal Agents|renal agents|mesh-ancestor
64739817|NCT05749367|Anesthetics, Local|anesthetics, local|mesh-ancestor
64739818|NCT05749367|Anesthetics|anesthetics|mesh-ancestor
64739819|NCT05749367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64739820|NCT05749367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739821|NCT05749367|Sensory System Agents|sensory system agents|mesh-ancestor
64739822|NCT05749367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64739823|NCT05749289|Octreotide|octreotide|mesh-list
64739824|NCT05749289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64739825|NCT05749289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64428470|NCT05335109|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64739826|NCT05749289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739827|NCT05749211|Niraparib|niraparib|mesh-list
64739832|NCT02972957|Azithromycin|azithromycin|mesh-list
64739836|NCT05568095|Fluorouracil|fluorouracil|mesh-list
64739837|NCT05568095|Capecitabine|capecitabine|mesh-list
64739838|NCT05568095|Oxaliplatin|oxaliplatin|mesh-list
64739839|NCT05568095|Nivolumab|nivolumab|mesh-list
64739840|NCT05568095|Antimetabolites|antimetabolites|mesh-ancestor
64739841|NCT05568095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739842|NCT05568095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64739843|NCT05568095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739844|NCT05568095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64739845|NCT05568095|Immunologic Factors|immunologic factors|mesh-ancestor
64739846|NCT05568095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739847|NCT05568095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64739848|NCT05568095|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64739849|NCT05568095|Antidotes|antidotes|mesh-ancestor
64739850|NCT05568095|Protective Agents|protective agents|mesh-ancestor
64739851|NCT05568095|Vitamin B Complex|vitamin b complex|mesh-ancestor
64739852|NCT05568095|Vitamins|vitamins|mesh-ancestor
64739853|NCT05568095|Micronutrients|micronutrients|mesh-ancestor
64739854|NCT05561387|Dexamethasone|dexamethasone|mesh-list
64739855|NCT05561387|Dexamethasone acetate|dexamethasone acetate|mesh-list
64739856|NCT05561387|Lenalidomide|lenalidomide|mesh-list
64739857|NCT05561387|Bortezomib|bortezomib|mesh-list
64739858|NCT05561387|Daratumumab|daratumumab|mesh-list
64739859|NCT05561387|Ichthammol|ichthammol|mesh-list
64739860|NCT05561387|BB 1101|bb 1101|mesh-list
64739861|NCT05561387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64739862|NCT05561387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64739863|NCT05561387|Antiemetics|antiemetics|mesh-ancestor
64739864|NCT05561387|Autonomic Agents|autonomic agents|mesh-ancestor
64739865|NCT05561387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64739866|NCT05561387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322047|NCT02221765|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
64322048|NCT02221765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64322049|NCT02221765|Hormones|hormones|mesh-ancestor
64322050|NCT02221765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64322051|NCT02221765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322052|NCT05069129|Vaccines|vaccines|mesh-list
64626194|NCT00002128|Adefovir|adefovir|mesh-list
64322053|NCT05069129|Immunologic Factors|immunologic factors|mesh-ancestor
64322054|NCT05069129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322055|NCT02396043|Cytarabine|cytarabine|mesh-list
64322056|NCT02396043|Dexamethasone|dexamethasone|mesh-list
64322057|NCT02396043|Prednisone|prednisone|mesh-list
64322058|NCT02396043|Cyclophosphamide|cyclophosphamide|mesh-list
64322062|NCT02396043|Pegaspargase|pegaspargase|mesh-list
64322063|NCT02396043|Asparaginase|asparaginase|mesh-list
64322064|NCT02396043|Pirarubicin|pirarubicin|mesh-list
64322065|NCT02396043|Doxorubicin|doxorubicin|mesh-list
64322066|NCT02396043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64428483|NCT05300087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64351944|NCT05303311|Hormones|hormones|mesh-ancestor
64351945|NCT05303311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64351948|NCT05303311|Anesthetics, Local|anesthetics, local|mesh-ancestor
64739867|NCT05561387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64739868|NCT05561387|Glucocorticoids|glucocorticoids|mesh-ancestor
64739869|NCT05561387|Hormones|hormones|mesh-ancestor
64428484|NCT05300087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64739876|NCT05561387|Immunologic Factors|immunologic factors|mesh-ancestor
64739877|NCT05561387|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64739878|NCT05561387|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64739879|NCT05561387|Growth Substances|growth substances|mesh-ancestor
64739880|NCT05561387|Growth Inhibitors|growth inhibitors|mesh-ancestor
64739881|NCT05561387|Dermatologic Agents|dermatologic agents|mesh-ancestor
64739883|NCT05545319|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64626251|NCT00985907|Alkylating Agents|alkylating agents|mesh-ancestor
64739884|NCT05545319|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64739885|NCT05545319|Protease Inhibitors|protease inhibitors|mesh-ancestor
64739886|NCT05545319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739887|NCT05545319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739888|NCT05545319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64739889|NCT05545319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64739890|NCT05545319|Antiviral Agents|antiviral agents|mesh-ancestor
64739891|NCT05545319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739892|NCT05545319|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64739893|NCT05545319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64739894|NCT05523869|Topotecan|topotecan|mesh-list
64739895|NCT05523869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64739896|NCT05523869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64739897|NCT05523869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739898|NCT05523869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739899|NCT05523869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739900|NCT05522465|Dexamethasone|dexamethasone|mesh-list
64739901|NCT05522465|Prednisone|prednisone|mesh-list
64739902|NCT05522465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64739903|NCT05522465|Antiemetics|antiemetics|mesh-ancestor
64739904|NCT05522465|Autonomic Agents|autonomic agents|mesh-ancestor
64739905|NCT05522465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64739906|NCT05522465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739907|NCT05522465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64739908|NCT05522465|Glucocorticoids|glucocorticoids|mesh-ancestor
64739909|NCT05522465|Hormones|hormones|mesh-ancestor
64739910|NCT05522465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64739911|NCT05522465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64739912|NCT05522465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739913|NCT05237297|Celecoxib|celecoxib|mesh-list
64739914|NCT05237297|Naproxen|naproxen|mesh-list
64739915|NCT05237297|Aceclofenac|aceclofenac|mesh-list
64739916|NCT05237297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64739917|NCT05237297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64739918|NCT05237297|Analgesics|analgesics|mesh-ancestor
64739919|NCT05237297|Sensory System Agents|sensory system agents|mesh-ancestor
64739920|NCT05237297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64739921|NCT05237297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739922|NCT05237297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64739923|NCT05237297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64739924|NCT05237297|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64739925|NCT05237297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64739926|NCT05237297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739927|NCT05237297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739928|NCT05237297|Gout Suppressants|gout suppressants|mesh-ancestor
64322073|NCT02396043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322074|NCT02396043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64322075|NCT02396043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64322076|NCT02396043|Antiemetics|antiemetics|mesh-ancestor
64322077|NCT02396043|Autonomic Agents|autonomic agents|mesh-ancestor
64322078|NCT02396043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322079|NCT02396043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64322080|NCT02396043|Glucocorticoids|glucocorticoids|mesh-ancestor
64322081|NCT02396043|Hormones|hormones|mesh-ancestor
64739948|NCT04824053|Selenium|selenium|mesh-list
64739949|NCT04824053|Caseins|caseins|mesh-list
64739950|NCT04824053|Antioxidants|antioxidants|mesh-ancestor
64739951|NCT04824053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739952|NCT04824053|Protective Agents|protective agents|mesh-ancestor
64428508|NCT05333549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64428590|NCT02524847|Methoxsalen|methoxsalen|mesh-list
64739967|NCT05167409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739968|NCT05406713|Pembrolizumab|pembrolizumab|mesh-list
64352029|NCT03443869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322082|NCT02396043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64322083|NCT02396043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64322084|NCT02396043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322085|NCT02396043|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64739969|NCT05406713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64739971|NCT04783415|Acalabrutinib|acalabrutinib|mesh-list
64739972|NCT04783415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739973|NCT05406479|Bedaquiline|bedaquiline|mesh-list
64739974|NCT05406479|Antitubercular Agents|antitubercular agents|mesh-ancestor
64739975|NCT05406479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64739976|NCT05406479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64739977|NCT04331093|Apatinib|apatinib|mesh-list
64739978|NCT04331093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739979|NCT04331093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64739980|NCT04331093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739981|NCT04331093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739982|NCT05124977|Anti-Infective Agents|anti-infective agents|mesh-list
64739983|NCT05124977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64739984|NCT05116241|Vaccines|vaccines|mesh-list
64739985|NCT05116241|Immunologic Factors|immunologic factors|mesh-ancestor
64739986|NCT05116241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739987|NCT04735367|Letrozole|letrozole|mesh-list
64739988|NCT04735367|Palbociclib|palbociclib|mesh-list
64739989|NCT04735367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64739990|NCT04735367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64739991|NCT04735367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64739992|NCT04735367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64739993|NCT04735367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64739994|NCT04735367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64739995|NCT04735367|Hormone Antagonists|hormone antagonists|mesh-ancestor
64322092|NCT02396043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64322093|NCT02396043|Antiviral Agents|antiviral agents|mesh-ancestor
64322094|NCT02396043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64322095|NCT02396043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64322096|NCT02396043|Tubulin Modulators|tubulin modulators|mesh-ancestor
64322097|NCT02396043|Antimitotic Agents|antimitotic agents|mesh-ancestor
64322098|NCT02396043|Mitosis Modulators|mitosis modulators|mesh-ancestor
64739997|NCT04735367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64739998|NCT04735367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64739999|NCT00382421|Aspirin|aspirin|mesh-list
64740000|NCT00382421|Amlodipine|amlodipine|mesh-list
64740001|NCT00382421|Bisoprolol|bisoprolol|mesh-list
64740002|NCT00382421|Molsidomine|molsidomine|mesh-list
64740003|NCT00382421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64740004|NCT00382421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64626593|NCT01990196|Dasatinib|dasatinib|mesh-list
64740005|NCT00382421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64740006|NCT00382421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740007|NCT00382421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64740008|NCT00382421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740009|NCT00382421|Vasodilator Agents|vasodilator agents|mesh-ancestor
64740010|NCT00382421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64740011|NCT00382421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64740013|NCT00382421|Sensory System Agents|sensory system agents|mesh-ancestor
64740014|NCT00382421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64740015|NCT00382421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64740016|NCT00382421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64740017|NCT00382421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64740018|NCT00382421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64740019|NCT00382421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64740020|NCT00382421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64740021|NCT00382421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740022|NCT00382421|Antipyretics|antipyretics|mesh-ancestor
64740023|NCT00382421|Sympatholytics|sympatholytics|mesh-ancestor
64740024|NCT00382421|Autonomic Agents|autonomic agents|mesh-ancestor
64740025|NCT00382421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64740026|NCT00382421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64740027|NCT00382421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64740028|NCT00382421|Adrenergic Agents|adrenergic agents|mesh-ancestor
64740029|NCT00382421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64740030|NCT00382421|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64740031|NCT05343455|Doxycycline|doxycycline|mesh-list
64740034|NCT05343455|Antimalarials|antimalarials|mesh-ancestor
64740037|NCT05069831|Abrocitinib|abrocitinib|mesh-list
64740038|NCT05069831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64740039|NCT05069831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740040|NCT05069831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428639|NCT05324735|Antioxidants|antioxidants|mesh-ancestor
64740062|NCT05312255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64740063|NCT05312255|Adrenergic Agents|adrenergic agents|mesh-list
64740064|NCT05312255|Adrenergic Antagonists|adrenergic antagonists|mesh-list
64626734|NCT04756622|Acetylcysteine|acetylcysteine|mesh-list
64740066|NCT05312255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740067|NCT05312255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740068|NCT05312255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64740069|NCT05312255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64740070|NCT05312255|Vasodilator Agents|vasodilator agents|mesh-ancestor
64740071|NCT05015621|Leucovorin|leucovorin|mesh-list
64740072|NCT05015621|Fluorouracil|fluorouracil|mesh-list
64740073|NCT05015621|Irinotecan|irinotecan|mesh-list
64740074|NCT05015621|Calcium|calcium|mesh-list
64740075|NCT05015621|Levoleucovorin|levoleucovorin|mesh-list
64740076|NCT05015621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64740077|NCT05015621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740078|NCT05015621|Antimetabolites|antimetabolites|mesh-ancestor
64740079|NCT05015621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740080|NCT05015621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64740081|NCT05015621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740082|NCT05015621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64428703|NCT05357417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64428760|NCT05284409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64740105|NCT05289167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740106|NCT05289167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64740107|NCT05289167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64740150|NCT04482959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740152|NCT04581395|Succinylcholine|succinylcholine|mesh-list
64626811|NCT00002362|Antimetabolites|antimetabolites|mesh-ancestor
64740153|NCT04581395|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64740154|NCT04581395|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64740155|NCT04581395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64740156|NCT04581395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64740157|NCT04581395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740158|NCT04581395|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
64740159|NCT04571879|Lidocaine|lidocaine|mesh-list
64740160|NCT04571879|Midazolam|midazolam|mesh-list
64740161|NCT04571879|Anesthetics, Local|anesthetics, local|mesh-ancestor
64740162|NCT04571879|Anesthetics|anesthetics|mesh-ancestor
64740163|NCT04571879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64740164|NCT04571879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740165|NCT04571879|Sensory System Agents|sensory system agents|mesh-ancestor
64740166|NCT04571879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64740167|NCT04571879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64740168|NCT04571879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64740169|NCT04571879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64740170|NCT04571879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64740172|NCT04571879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64740200|NCT04509791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740201|NCT04509791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64740202|NCT04332107|Azithromycin|azithromycin|mesh-list
64740203|NCT04332107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64740204|NCT04332107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64740205|NCT04329065|Paclitaxel|paclitaxel|mesh-list
64740206|NCT04329065|Trastuzumab|trastuzumab|mesh-list
64740207|NCT04329065|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64740208|NCT04329065|Pertuzumab|pertuzumab|mesh-list
64740209|NCT04329065|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
64740210|NCT04329065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64740211|NCT04329065|Vaccines|vaccines|mesh-list
64626891|NCT00002374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64740212|NCT04329065|Antibodies|antibodies|mesh-list
64740213|NCT04329065|Immunoglobulins|immunoglobulins|mesh-list
64740214|NCT04329065|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64740215|NCT04329065|Immunoglobulin G|immunoglobulin g|mesh-list
64740216|NCT04329065|Immunologic Factors|immunologic factors|mesh-ancestor
64740217|NCT04329065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740218|NCT04329065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64740219|NCT04329065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740220|NCT04329065|Tubulin Modulators|tubulin modulators|mesh-ancestor
64740221|NCT04329065|Antimitotic Agents|antimitotic agents|mesh-ancestor
64740222|NCT04329065|Mitosis Modulators|mitosis modulators|mesh-ancestor
64740223|NCT04329065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740224|NCT04328285|Ritonavir|ritonavir|mesh-list
64740225|NCT04328285|Lopinavir|lopinavir|mesh-list
64740226|NCT04328285|Hydroxychloroquine|hydroxychloroquine|mesh-list
64740227|NCT04328285|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64740228|NCT04328285|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64740229|NCT04328285|Protease Inhibitors|protease inhibitors|mesh-ancestor
64740230|NCT04328285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740231|NCT04328285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740232|NCT04328285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64740233|NCT04328285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64740234|NCT04328285|Antiviral Agents|antiviral agents|mesh-ancestor
64322101|NCT02396043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64322102|NCT02147951|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
64322103|NCT02147951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64322104|NCT02147951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740238|NCT04328285|Antimalarials|antimalarials|mesh-ancestor
64740239|NCT04328285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64740240|NCT04328285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64740241|NCT04328285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64740242|NCT04928261|Trastuzumab|trastuzumab|mesh-list
64740243|NCT04928261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64740244|NCT04928261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740245|NCT04920539|Dronabinol|dronabinol|mesh-list
64740246|NCT04920539|Hallucinogens|hallucinogens|mesh-ancestor
64740247|NCT04920539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740248|NCT04920539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64740249|NCT04920539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64740250|NCT04920539|Analgesics|analgesics|mesh-ancestor
64740251|NCT04920539|Sensory System Agents|sensory system agents|mesh-ancestor
64740252|NCT04920539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64740253|NCT04920539|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64740254|NCT04920539|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64740255|NCT04920539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64740256|NCT04920539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740257|NCT04920539|Hormones|hormones|mesh-ancestor
64740258|NCT04920539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64740259|NCT04503551|Ranibizumab|ranibizumab|mesh-list
64740260|NCT04503551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64740261|NCT04503551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64740262|NCT04503551|Growth Substances|growth substances|mesh-ancestor
64740263|NCT04503551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740264|NCT04503551|Growth Inhibitors|growth inhibitors|mesh-ancestor
64740265|NCT04503551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740266|NCT04882241|Leucovorin|leucovorin|mesh-list
64740267|NCT04882241|Docetaxel|docetaxel|mesh-list
64740268|NCT04882241|Pembrolizumab|pembrolizumab|mesh-list
64740269|NCT04882241|Fluorouracil|fluorouracil|mesh-list
64740270|NCT04882241|Capecitabine|capecitabine|mesh-list
64740271|NCT04882241|Oxaliplatin|oxaliplatin|mesh-list
64740272|NCT04882241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740273|NCT04882241|Tubulin Modulators|tubulin modulators|mesh-ancestor
64740274|NCT04882241|Antimitotic Agents|antimitotic agents|mesh-ancestor
64740275|NCT04882241|Mitosis Modulators|mitosis modulators|mesh-ancestor
64740276|NCT04882241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740277|NCT04882241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64740278|NCT04882241|Antimetabolites|antimetabolites|mesh-ancestor
64740279|NCT04882241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64627189|NCT04416269|Insulin|insulin|mesh-list
64740280|NCT04882241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64740281|NCT04882241|Immunologic Factors|immunologic factors|mesh-ancestor
64740282|NCT04882241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740283|NCT04882241|Antidotes|antidotes|mesh-ancestor
64740284|NCT04882241|Protective Agents|protective agents|mesh-ancestor
64740285|NCT04882241|Vitamin B Complex|vitamin b complex|mesh-ancestor
64740286|NCT04882241|Vitamins|vitamins|mesh-ancestor
64740287|NCT04882241|Micronutrients|micronutrients|mesh-ancestor
64352347|NCT05100303|Antiviral Agents|antiviral agents|mesh-ancestor
64428932|NCT02121795|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64428933|NCT02121795|Antiviral Agents|antiviral agents|mesh-ancestor
64428998|NCT05319431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740316|NCT00002903|Mitosis Modulators|mitosis modulators|mesh-ancestor
64429000|NCT05276531|Progesterone|progesterone|mesh-list
64740349|NCT00383045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64740350|NCT00383045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740351|NCT00383045|Analgesics|analgesics|mesh-ancestor
64740352|NCT00383045|Sensory System Agents|sensory system agents|mesh-ancestor
64740353|NCT00383045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64740354|NCT00383045|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64740355|NCT00383045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64740356|NCT00383591|Vaccines|vaccines|mesh-list
64740357|NCT00383591|Immunologic Factors|immunologic factors|mesh-ancestor
64740358|NCT00383591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740359|NCT00002933|Irinotecan|irinotecan|mesh-list
64740360|NCT00002933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64740361|NCT00002933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64740362|NCT00002933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740363|NCT00002933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740364|NCT00002933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740365|NCT00002939|Paclitaxel|paclitaxel|mesh-list
64740366|NCT00002939|Irinotecan|irinotecan|mesh-list
64740367|NCT00002939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64740387|NCT03085823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740388|NCT00002945|Cytarabine|cytarabine|mesh-list
64627319|NCT01460654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64740389|NCT00002945|Aldesleukin|aldesleukin|mesh-list
64740390|NCT00002945|Cyclophosphamide|cyclophosphamide|mesh-list
64740392|NCT00002945|Etoposide|etoposide|mesh-list
64740393|NCT00002945|Idarubicin|idarubicin|mesh-list
64740394|NCT00002945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64740395|NCT00002945|Immunologic Factors|immunologic factors|mesh-ancestor
64740396|NCT00002945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740397|NCT00002945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64740398|NCT00002945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64740399|NCT00002945|Alkylating Agents|alkylating agents|mesh-ancestor
64352462|NCT04452929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64429124|NCT02177175|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64740439|NCT00002969|Paclitaxel|paclitaxel|mesh-list
64740440|NCT00002969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64740441|NCT00002969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740442|NCT00002969|Tubulin Modulators|tubulin modulators|mesh-ancestor
64740443|NCT00002969|Antimitotic Agents|antimitotic agents|mesh-ancestor
64740444|NCT00002969|Mitosis Modulators|mitosis modulators|mesh-ancestor
64740445|NCT00002969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740446|NCT00002987|Prednisolone|prednisolone|mesh-list
64740447|NCT00002987|Cyclophosphamide|cyclophosphamide|mesh-list
64740448|NCT00002987|Doxorubicin|doxorubicin|mesh-list
64740449|NCT00002987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64740450|NCT00002987|Etoposide|etoposide|mesh-list
64740451|NCT00002987|Vincristine|vincristine|mesh-list
64429368|NCT02332291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64740493|NCT00002993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64740494|NCT00002993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64740495|NCT00002993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740496|NCT00002993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740497|NCT00002993|Alkylating Agents|alkylating agents|mesh-ancestor
64740498|NCT00002993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64429473|NCT05178485|Hormones|hormones|mesh-ancestor
64627401|NCT01422746|Metformin|metformin|mesh-list
64740520|NCT00002999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64740521|NCT00002999|Immunologic Factors|immunologic factors|mesh-ancestor
64740522|NCT00002999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740523|NCT03911453|Rucaparib|rucaparib|mesh-list
64740524|NCT03911453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64740525|NCT03911453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740526|NCT03911453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740527|NCT03911453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740528|NCT00003005|Cordycepin|cordycepin|mesh-list
64740529|NCT00003005|Pentostatin|pentostatin|mesh-list
64740530|NCT00003005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740531|NCT00003005|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
64740532|NCT00003005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740533|NCT00003005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64479863|NCT03001882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64740537|NCT03905603|Hormones|hormones|mesh-ancestor
64740538|NCT03905603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64429531|NCT05170841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429544|NCT05135273|Vaccines|vaccines|mesh-list
64322135|NCT02141009|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64322137|NCT02141009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322139|NCT02221999|Letrozole|letrozole|mesh-list
64322140|NCT02221999|Hormones|hormones|mesh-list
64322141|NCT02221999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64322142|NCT02221999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352626|NCT04636671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64740554|NCT00003023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64740555|NCT00003023|BCG Vaccine|bcg vaccine|mesh-list
64740556|NCT00003023|Immunologic Factors|immunologic factors|mesh-ancestor
64429552|NCT02299375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64740557|NCT00003023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429553|NCT02299375|Respiratory System Agents|respiratory system agents|mesh-ancestor
64429554|NCT02299375|Tocolytic Agents|tocolytic agents|mesh-ancestor
64740577|NCT00003029|Immunologic Factors|immunologic factors|mesh-ancestor
64740578|NCT00003029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740579|NCT00003035|Tamoxifen|tamoxifen|mesh-list
64740580|NCT00003035|Paclitaxel|paclitaxel|mesh-list
64740581|NCT00003035|Doxorubicin|doxorubicin|mesh-list
64740582|NCT00003035|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64740583|NCT00003035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64740584|NCT00003035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740585|NCT00003035|Tubulin Modulators|tubulin modulators|mesh-ancestor
64740586|NCT00003035|Antimitotic Agents|antimitotic agents|mesh-ancestor
64740587|NCT00003035|Mitosis Modulators|mitosis modulators|mesh-ancestor
64740588|NCT00003035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740589|NCT00003035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64740590|NCT00003035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64740591|NCT00003035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64740592|NCT00003035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740593|NCT00003035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740594|NCT00003035|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64740597|NCT00003035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64740598|NCT00003035|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64740599|NCT00003035|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64740600|NCT00003035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64740602|NCT00003041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740603|NCT00003053|Etoposide|etoposide|mesh-list
64740604|NCT00003053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740605|NCT00003053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64740606|NCT00003053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64740607|NCT00003053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64740608|NCT00003053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627593|NCT01004393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64627594|NCT01004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627595|NCT01004393|Sensory System Agents|sensory system agents|mesh-ancestor
64740609|NCT00003053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740610|NCT00003065|Paclitaxel|paclitaxel|mesh-list
64740611|NCT00003065|Topotecan|topotecan|mesh-list
64479941|NCT04505566|Ketorolac|ketorolac|mesh-list
64740612|NCT00003065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64740613|NCT00003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740614|NCT00003065|Tubulin Modulators|tubulin modulators|mesh-ancestor
64740615|NCT00003065|Antimitotic Agents|antimitotic agents|mesh-ancestor
64740616|NCT00003065|Mitosis Modulators|mitosis modulators|mesh-ancestor
64627596|NCT01004393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64740617|NCT00003065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740618|NCT00003065|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64740619|NCT00003065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64740620|NCT00003065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740621|NCT04329611|Hydroxychloroquine|hydroxychloroquine|mesh-list
64627649|NCT01876628|Clindamycin palmitate|clindamycin palmitate|mesh-list
64740629|NCT00383357|Zolpidem|zolpidem|mesh-list
64740644|NCT00003089|Tubulin Modulators|tubulin modulators|mesh-ancestor
64740645|NCT00003089|Antimitotic Agents|antimitotic agents|mesh-ancestor
64740646|NCT00003089|Mitosis Modulators|mitosis modulators|mesh-ancestor
64740647|NCT00003089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740648|NCT00003089|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64740649|NCT00003089|Protective Agents|protective agents|mesh-ancestor
64740650|NCT00003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740651|NCT02180711|Rituximab|rituximab|mesh-list
64740652|NCT02180711|Lenalidomide|lenalidomide|mesh-list
64740653|NCT02180711|Acalabrutinib|acalabrutinib|mesh-list
64740654|NCT02180711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64740655|NCT02180711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740656|NCT02180711|Immunologic Factors|immunologic factors|mesh-ancestor
64627650|NCT01876628|Clindamycin phosphate|clindamycin phosphate|mesh-list
64740657|NCT02180711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627651|NCT01876628|Floxacillin|floxacillin|mesh-list
64740658|NCT02180711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64740659|NCT02180711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64740660|NCT02180711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64740661|NCT02180711|Growth Substances|growth substances|mesh-ancestor
64740662|NCT02180711|Growth Inhibitors|growth inhibitors|mesh-ancestor
64429636|NCT05220293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429637|NCT05220293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64429638|NCT05220293|Respiratory System Agents|respiratory system agents|mesh-ancestor
64429639|NCT02297503|Botulinum Toxins|botulinum toxins|mesh-list
64740663|NCT02145143|Vemurafenib|vemurafenib|mesh-list
64740664|NCT02145143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740665|NCT02145143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64740666|NCT02145143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740716|NCT00003113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740717|NCT00003113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64740718|NCT00003113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64740719|NCT00003113|Alkylating Agents|alkylating agents|mesh-ancestor
64740720|NCT00003113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627703|NCT01004939|Anticoagulants|anticoagulants|mesh-ancestor
64627745|NCT01864772|Cetuximab|cetuximab|mesh-list
64740721|NCT00003113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740722|NCT00003113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64740723|NCT00003113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64740724|NCT00003113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64740725|NCT00003113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64740726|NCT00003113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740728|NCT01545557|Hyaluronic Acid|hyaluronic acid|mesh-list
64740729|NCT01545557|Anesthetics, Local|anesthetics, local|mesh-ancestor
64740730|NCT01545557|Anesthetics|anesthetics|mesh-ancestor
64740731|NCT01545557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64740732|NCT01545557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740733|NCT01545557|Sensory System Agents|sensory system agents|mesh-ancestor
64740734|NCT01545557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64740735|NCT01545557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64740736|NCT01545557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64740737|NCT01545557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64740738|NCT01545557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64740739|NCT01545557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740740|NCT01545557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64740741|NCT01545557|Immunologic Factors|immunologic factors|mesh-ancestor
64740760|NCT00003119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64740761|NCT00003119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64740762|NCT00003119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740763|NCT00003119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64740765|NCT00003395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740766|NCT00003401|Gemcitabine|gemcitabine|mesh-list
64740767|NCT00003401|Dexamethasone|dexamethasone|mesh-list
64740768|NCT00003401|Paclitaxel|paclitaxel|mesh-list
64740769|NCT00003401|Etoposide|etoposide|mesh-list
64627761|NCT00002494|Methotrexate|methotrexate|mesh-list
64740770|NCT00003401|Cyclophosphamide|cyclophosphamide|mesh-list
64740771|NCT00003401|Melphalan|melphalan|mesh-list
64627762|NCT00002494|Etoposide|etoposide|mesh-list
64740772|NCT00003401|Carmustine|carmustine|mesh-list
64740773|NCT00003401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64740774|NCT00003401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429644|NCT02297503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429645|NCT02297503|Cholinergic Agents|cholinergic agents|mesh-ancestor
64429646|NCT02297503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64429647|NCT02297503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740775|NCT00003401|Tubulin Modulators|tubulin modulators|mesh-ancestor
64740776|NCT00003401|Antimitotic Agents|antimitotic agents|mesh-ancestor
64740777|NCT00003401|Mitosis Modulators|mitosis modulators|mesh-ancestor
64740778|NCT00003401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740780|NCT00003401|Immunologic Factors|immunologic factors|mesh-ancestor
64740781|NCT00003401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740782|NCT00003401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64740783|NCT00003401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64740784|NCT00003401|Alkylating Agents|alkylating agents|mesh-ancestor
64740785|NCT00003401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64627859|NCT05750446|Enzyme Activators|enzyme activators|mesh-ancestor
64627860|NCT05750446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627861|NCT05750290|Irinotecan|irinotecan|mesh-list
64627862|NCT05750290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64627863|NCT05750290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64627864|NCT05750290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627867|NCT03845621|Salicylic Acid|salicylic acid|mesh-list
64740786|NCT00003401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64740787|NCT00003401|Antiemetics|antiemetics|mesh-ancestor
64740788|NCT00003401|Autonomic Agents|autonomic agents|mesh-ancestor
64740792|NCT00003401|Hormones|hormones|mesh-ancestor
64740810|NCT00003125|Antiviral Agents|antiviral agents|mesh-ancestor
64740811|NCT00003125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64740812|NCT00003131|Gemtuzumab|gemtuzumab|mesh-list
64740813|NCT00003131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64740814|NCT00003131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740815|NCT00384371|Botulinum Toxins|botulinum toxins|mesh-list
64740816|NCT00384371|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64740817|NCT00384371|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64740818|NCT00384371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64740819|NCT00384371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64740820|NCT00384371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740821|NCT00384371|Cholinergic Agents|cholinergic agents|mesh-ancestor
64740822|NCT00384371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64627990|NCT01203319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740823|NCT00384371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740824|NCT00384371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64740825|NCT00384371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64740826|NCT00423215|Insulin Glargine|insulin glargine|mesh-list
64740827|NCT00423215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64740828|NCT00423215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740829|NCT00003413|Paclitaxel|paclitaxel|mesh-list
64740830|NCT00003413|Melphalan|melphalan|mesh-list
64740831|NCT00003413|Carmustine|carmustine|mesh-list
64740832|NCT00003413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64627991|NCT01344200|Celecoxib|celecoxib|mesh-list
64627992|NCT01344200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64627993|NCT01344200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64627995|NCT01344200|Sensory System Agents|sensory system agents|mesh-ancestor
64627996|NCT01344200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64627997|NCT01344200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627998|NCT01344200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64627999|NCT01344200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64628000|NCT01344200|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64628001|NCT01344200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64628002|NCT01344200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628005|NCT01204255|Promethazine|promethazine|mesh-list
64740833|NCT00003413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740834|NCT00003413|Tubulin Modulators|tubulin modulators|mesh-ancestor
64740835|NCT00003413|Antimitotic Agents|antimitotic agents|mesh-ancestor
64740859|NCT00003425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64740860|NCT00003425|Alkylating Agents|alkylating agents|mesh-ancestor
64740861|NCT00003425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740862|NCT00003425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740863|NCT00003425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64740864|NCT00003425|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64740865|NCT00003425|Protective Agents|protective agents|mesh-ancestor
64740866|NCT00330551|Risperidone|risperidone|mesh-list
64740867|NCT00330551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64628038|NCT00002542|Tamoxifen|tamoxifen|mesh-list
64628039|NCT00002542|Cyclophosphamide|cyclophosphamide|mesh-list
64628040|NCT00002542|Doxorubicin|doxorubicin|mesh-list
64628041|NCT00002542|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64628042|NCT00002542|Fluorouracil|fluorouracil|mesh-list
64628043|NCT00002542|Methotrexate|methotrexate|mesh-list
64628044|NCT00002542|Epirubicin|epirubicin|mesh-list
64628045|NCT00002542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64628046|NCT00002542|Immunologic Factors|immunologic factors|mesh-ancestor
64628047|NCT00002542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740868|NCT00330551|Serotonin Agents|serotonin agents|mesh-ancestor
64740869|NCT00330551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64740870|NCT00330551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740871|NCT00330551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740872|NCT00330551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64740873|NCT00330551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64740874|NCT00330551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64740875|NCT00330551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64740876|NCT00330551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64740877|NCT00330551|Dopamine Agents|dopamine agents|mesh-ancestor
64740878|NCT00001259|Leuprolide|leuprolide|mesh-list
64628092|NCT01823198|Analgesics|analgesics|mesh-ancestor
64628093|NCT01823198|Sensory System Agents|sensory system agents|mesh-ancestor
64628094|NCT01823198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628095|NCT01823198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64628099|NCT05750056|Lidocaine|lidocaine|mesh-list
64740879|NCT00001259|Estradiol|estradiol|mesh-list
64740880|NCT00001259|Progesterone|progesterone|mesh-list
64740881|NCT00001259|Estrogens|estrogens|mesh-ancestor
64740882|NCT00001259|Hormones|hormones|mesh-ancestor
64740910|NCT00003437|Cytarabine|cytarabine|mesh-list
64740911|NCT00003437|Dexamethasone|dexamethasone|mesh-list
64740912|NCT00003437|Prednisolone|prednisolone|mesh-list
64740913|NCT00003437|Cyclophosphamide|cyclophosphamide|mesh-list
64740914|NCT00003437|Doxorubicin|doxorubicin|mesh-list
64740915|NCT00003437|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64740916|NCT00003437|Methotrexate|methotrexate|mesh-list
64740917|NCT00003437|Vincristine|vincristine|mesh-list
64740918|NCT00003437|Daunorubicin|daunorubicin|mesh-list
64740919|NCT00003437|Asparaginase|asparaginase|mesh-list
64740920|NCT00003437|Mercaptopurine|mercaptopurine|mesh-list
64740921|NCT00003437|Pegaspargase|pegaspargase|mesh-list
64740922|NCT00003437|Thioguanine|thioguanine|mesh-list
64740923|NCT00003437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64740924|NCT00003437|Immunologic Factors|immunologic factors|mesh-ancestor
64740925|NCT00003437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740926|NCT00003437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64628154|NCT05749666|Methylprednisolone|methylprednisolone|mesh-list
64628155|NCT05749666|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64628156|NCT05749666|Prednisolone acetate|prednisolone acetate|mesh-list
64740927|NCT00003437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64740928|NCT00003437|Alkylating Agents|alkylating agents|mesh-ancestor
64740929|NCT00003437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64740930|NCT00003437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740931|NCT00003437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64740932|NCT00003437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64740933|NCT00003437|Antiemetics|antiemetics|mesh-ancestor
64740934|NCT00003437|Autonomic Agents|autonomic agents|mesh-ancestor
64740935|NCT00003437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64740936|NCT00003437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64740937|NCT00003437|Glucocorticoids|glucocorticoids|mesh-ancestor
64740938|NCT00003437|Hormones|hormones|mesh-ancestor
64301061|NCT03286101|Ivermectin|ivermectin|mesh-list
64628198|NCT02940509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628199|NCT02940509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64628200|NCT02940509|Anticonvulsants|anticonvulsants|mesh-ancestor
64628201|NCT02940509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64740939|NCT00003437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64740940|NCT00003437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64740941|NCT00003437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64740942|NCT00003437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64740943|NCT00003437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64740944|NCT00003437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740952|NCT00003437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64740953|NCT00003437|Antiviral Agents|antiviral agents|mesh-ancestor
64740954|NCT00003437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64740955|NCT00003437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64740956|NCT00003437|Tubulin Modulators|tubulin modulators|mesh-ancestor
64740957|NCT00003437|Antimitotic Agents|antimitotic agents|mesh-ancestor
64740958|NCT00003437|Mitosis Modulators|mitosis modulators|mesh-ancestor
64740959|NCT00003443|Bryostatin 1|bryostatin 1|mesh-list
64740960|NCT00003443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64740961|NCT00003443|Immunologic Factors|immunologic factors|mesh-ancestor
64628254|NCT02144831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64628255|NCT02144831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64628256|NCT02144831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628257|NCT02144831|Antipyretics|antipyretics|mesh-ancestor
64628258|NCT02144831|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64628259|NCT02144831|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64628260|NCT02144831|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64628261|NCT02144831|Purinergic Agents|purinergic agents|mesh-ancestor
64740962|NCT00003443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740963|NCT00003443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740964|NCT00003449|Gemcitabine|gemcitabine|mesh-list
64740965|NCT00003449|Dexamethasone|dexamethasone|mesh-list
64740966|NCT00003449|Paclitaxel|paclitaxel|mesh-list
64740967|NCT00003449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64740968|NCT00003449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64740969|NCT00003449|Tubulin Modulators|tubulin modulators|mesh-ancestor
64740970|NCT00003449|Antimitotic Agents|antimitotic agents|mesh-ancestor
64740971|NCT00003449|Mitosis Modulators|mitosis modulators|mesh-ancestor
64740972|NCT00003449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628306|NCT05623774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628307|NCT05746546|Nicotine|nicotine|mesh-list
64628308|NCT05746546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64628309|NCT05746546|Autonomic Agents|autonomic agents|mesh-ancestor
64628310|NCT05746546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628311|NCT05746546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628312|NCT05746546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64628313|NCT05746546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64628314|NCT05746546|Cholinergic Agents|cholinergic agents|mesh-ancestor
64628315|NCT05746546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64740973|NCT00003449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64740974|NCT00003449|Antiemetics|antiemetics|mesh-ancestor
64628317|NCT01313702|Atenolol|atenolol|mesh-list
64740975|NCT00003449|Autonomic Agents|autonomic agents|mesh-ancestor
64740976|NCT00003449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64740977|NCT00003449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740978|NCT00003449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64740979|NCT00003449|Glucocorticoids|glucocorticoids|mesh-ancestor
64740980|NCT00003449|Hormones|hormones|mesh-ancestor
64740981|NCT00003449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64740982|NCT00003449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64740983|NCT00003449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64740985|NCT00003449|Antiviral Agents|antiviral agents|mesh-ancestor
64740986|NCT00003449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64740987|NCT00003449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64740988|NCT00003449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64740990|NCT00002801|Leucovorin|leucovorin|mesh-list
64740991|NCT00002801|Tegafur|tegafur|mesh-list
64740992|NCT00002801|Calcium|calcium|mesh-list
64740993|NCT00002801|Levoleucovorin|levoleucovorin|mesh-list
64740994|NCT00002801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64740995|NCT00002801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64740996|NCT00002801|Antidotes|antidotes|mesh-ancestor
64740997|NCT00002801|Protective Agents|protective agents|mesh-ancestor
64628359|NCT04868708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64628360|NCT04868708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64628361|NCT04868708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64628362|NCT04868708|Growth Substances|growth substances|mesh-ancestor
64628363|NCT04868708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628364|NCT04868708|Growth Inhibitors|growth inhibitors|mesh-ancestor
64628365|NCT05732272|Bupropion|bupropion|mesh-list
64628366|NCT05732272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64628367|NCT05732272|Antidepressive Agents|antidepressive agents|mesh-ancestor
64740998|NCT00002801|Vitamin B Complex|vitamin b complex|mesh-ancestor
64740999|NCT00002801|Vitamins|vitamins|mesh-ancestor
64741000|NCT00002801|Micronutrients|micronutrients|mesh-ancestor
64741001|NCT00002801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64741002|NCT00002801|Antimetabolites|antimetabolites|mesh-ancestor
64741003|NCT00002801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741004|NCT00002801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741005|NCT00002813|Vinorelbine|vinorelbine|mesh-list
64741006|NCT00002813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741007|NCT00002813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64741008|NCT00002813|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741009|NCT00002813|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741010|NCT00002813|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741011|NCT00002813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741012|NCT00002819|Paclitaxel|paclitaxel|mesh-list
64741013|NCT00002819|Cyclophosphamide|cyclophosphamide|mesh-list
64741014|NCT00002819|Carboplatin|carboplatin|mesh-list
64741015|NCT00002819|Mitoxantrone|mitoxantrone|mesh-list
64741016|NCT00002819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64741017|NCT00002819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741018|NCT00002819|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741019|NCT00002819|Antimitotic Agents|antimitotic agents|mesh-ancestor
64628406|NCT05445856|Fentanyl|fentanyl|mesh-list
64741020|NCT00002819|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741021|NCT00002819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741022|NCT00002819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741023|NCT00002819|Immunologic Factors|immunologic factors|mesh-ancestor
64741031|NCT00002819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64741032|NCT00002819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64741033|NCT00002819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64741035|NCT00002825|Docetaxel|docetaxel|mesh-list
64741036|NCT00002825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741037|NCT00002825|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741038|NCT00002825|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741039|NCT00002825|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741040|NCT00002825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741041|NCT00002831|Cyclosporine|cyclosporine|mesh-list
64741042|NCT00002831|Methylprednisolone|methylprednisolone|mesh-list
64741043|NCT00002831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64741044|NCT00002831|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64741045|NCT00002831|Prednisolone|prednisolone|mesh-list
64741046|NCT00002831|Prednisolone acetate|prednisolone acetate|mesh-list
64741047|NCT00002831|Cyclophosphamide|cyclophosphamide|mesh-list
64741048|NCT00002831|Busulfan|busulfan|mesh-list
64741049|NCT00002831|Methotrexate|methotrexate|mesh-list
64741050|NCT00002831|Decitabine|decitabine|mesh-list
64628452|NCT05520892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628453|NCT05397964|Calcium|calcium|mesh-list
64628454|NCT05397964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64628455|NCT05397964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628456|NCT00002548|Interferons|interferons|mesh-list
64628457|NCT00002548|Interferon-alpha|interferon-alpha|mesh-list
64628458|NCT00002548|Dexamethasone|dexamethasone|mesh-list
64628459|NCT00002548|Prednisone|prednisone|mesh-list
64741051|NCT00002831|Tacrolimus|tacrolimus|mesh-list
64741052|NCT00002831|Cyclosporins|cyclosporins|mesh-list
64741053|NCT00002831|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64628460|NCT00002548|Cyclophosphamide|cyclophosphamide|mesh-list
64628461|NCT00002548|Melphalan|melphalan|mesh-list
64741054|NCT00002831|Prednisolone phosphate|prednisolone phosphate|mesh-list
64741055|NCT00002831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741056|NCT00002831|Immunologic Factors|immunologic factors|mesh-ancestor
64741057|NCT00002831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741058|NCT00002831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64741059|NCT00002831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64741060|NCT00002831|Alkylating Agents|alkylating agents|mesh-ancestor
64741061|NCT00002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741062|NCT00002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741063|NCT00002831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64741064|NCT00002831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64741065|NCT00002831|Abortifacient Agents|abortifacient agents|mesh-ancestor
64741066|NCT00002831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64628496|NCT02087306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64628498|NCT00002554|Busulfan|busulfan|mesh-list
64628499|NCT00002554|Methotrexate|methotrexate|mesh-list
64628500|NCT00002554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64628501|NCT00002554|Immunologic Factors|immunologic factors|mesh-ancestor
64628502|NCT00002554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628503|NCT00002554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64628504|NCT00002554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64628505|NCT00002554|Alkylating Agents|alkylating agents|mesh-ancestor
64628506|NCT00002554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628510|NCT00002554|Abortifacient Agents|abortifacient agents|mesh-ancestor
64480378|NCT00618436|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64322143|NCT02221999|Tubulin Modulators|tubulin modulators|mesh-ancestor
64322144|NCT02221999|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741067|NCT00002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64741068|NCT00002831|Antimetabolites|antimetabolites|mesh-ancestor
64741069|NCT00002831|Dermatologic Agents|dermatologic agents|mesh-ancestor
64741070|NCT00002831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741071|NCT00002831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64741072|NCT00002831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64741073|NCT00002831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64741074|NCT00002831|Antifungal Agents|antifungal agents|mesh-ancestor
64741075|NCT00002831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64741076|NCT00002831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64741077|NCT00002831|Antiemetics|antiemetics|mesh-ancestor
64741078|NCT00002831|Autonomic Agents|autonomic agents|mesh-ancestor
64741079|NCT00002831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64741080|NCT00002831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64741081|NCT00002831|Glucocorticoids|glucocorticoids|mesh-ancestor
64741082|NCT00002831|Hormones|hormones|mesh-ancestor
64741083|NCT00002831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64741084|NCT00002831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64741085|NCT00002831|Protective Agents|protective agents|mesh-ancestor
64741086|NCT00002831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64741087|NCT00002837|Paclitaxel|paclitaxel|mesh-list
64741088|NCT00002837|Cyclophosphamide|cyclophosphamide|mesh-list
64741089|NCT00002837|Doxorubicin|doxorubicin|mesh-list
64741120|NCT00002849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64741121|NCT00002849|Antiemetics|antiemetics|mesh-ancestor
64741122|NCT00002849|Autonomic Agents|autonomic agents|mesh-ancestor
64741123|NCT00002849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64741124|NCT00002849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741125|NCT00002849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64741126|NCT00002849|Glucocorticoids|glucocorticoids|mesh-ancestor
64628549|NCT00002566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64628550|NCT00002566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628551|NCT00002566|Tubulin Modulators|tubulin modulators|mesh-ancestor
64628552|NCT00002566|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741127|NCT00002849|Hormones|hormones|mesh-ancestor
64628553|NCT00002566|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741128|NCT00002849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64741129|NCT00002849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64741130|NCT00002849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741131|NCT00002849|Antiviral Agents|antiviral agents|mesh-ancestor
64741132|NCT00002849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64741133|NCT00002849|Immunologic Factors|immunologic factors|mesh-ancestor
64741134|NCT00002855|Ketoconazole|ketoconazole|mesh-list
64741135|NCT00002855|Hydrocortisone|hydrocortisone|mesh-list
64741136|NCT00002855|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64741137|NCT00002855|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64741138|NCT00002855|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64741139|NCT00002855|Doxorubicin|doxorubicin|mesh-list
64741140|NCT00002855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64741141|NCT00002855|Bicalutamide|bicalutamide|mesh-list
64741142|NCT00002855|Vinblastine|vinblastine|mesh-list
64741143|NCT00002855|Flutamide|flutamide|mesh-list
64741144|NCT00002855|Estramustine|estramustine|mesh-list
64741145|NCT00002855|Nilutamide|nilutamide|mesh-list
64741146|NCT00002855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64741147|NCT00002855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741148|NCT00002855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64741149|NCT00002855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64741150|NCT00002855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741151|NCT00002855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628573|NCT00002578|Abortifacient Agents|abortifacient agents|mesh-ancestor
64741163|NCT00002855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64741165|NCT00002855|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741166|NCT00002855|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741167|NCT00002855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64741168|NCT00002855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64741170|NCT00003173|Thiotepa|thiotepa|mesh-list
64741171|NCT00003173|Immunologic Factors|immunologic factors|mesh-ancestor
64741172|NCT00003173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741173|NCT00003173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64741174|NCT00003173|Alkylating Agents|alkylating agents|mesh-ancestor
64741225|NCT00003935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64741226|NCT00003935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741227|NCT00003935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64741228|NCT00003935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64741229|NCT00003935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741230|NCT00003935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741231|NCT00003935|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741232|NCT00003935|Antimitotic Agents|antimitotic agents|mesh-ancestor
64628606|NCT00002590|Levoleucovorin|levoleucovorin|mesh-list
64628607|NCT00002590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64628608|NCT00002590|Immunologic Factors|immunologic factors|mesh-ancestor
64628609|NCT00002590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628610|NCT00002590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64628611|NCT00002590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64628612|NCT00002590|Alkylating Agents|alkylating agents|mesh-ancestor
64628613|NCT00002590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628614|NCT00002590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628615|NCT00002590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64741233|NCT00003935|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741234|NCT00003191|Fenretinide|fenretinide|mesh-list
64741235|NCT00003191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741236|NCT00003191|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64741237|NCT00003191|Protective Agents|protective agents|mesh-ancestor
64741238|NCT00003191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741239|NCT00003941|Etoposide|etoposide|mesh-list
64741240|NCT00003941|Ifosfamide|ifosfamide|mesh-list
64741284|NCT00003953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64741285|NCT00003953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64741286|NCT00003953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741287|NCT00003953|Antimetabolites|antimetabolites|mesh-ancestor
64741288|NCT00003953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64741289|NCT00003953|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64741290|NCT00003953|Abortifacient Agents|abortifacient agents|mesh-ancestor
64741291|NCT00003953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64741292|NCT00003953|Dermatologic Agents|dermatologic agents|mesh-ancestor
64741293|NCT00003953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64741294|NCT00003953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64741295|NCT00003953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64741296|NCT00003953|Hormone Antagonists|hormone antagonists|mesh-ancestor
64741297|NCT00003953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64628650|NCT01273610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628652|NCT00002596|Carboplatin|carboplatin|mesh-list
64628653|NCT00002596|Etoposide|etoposide|mesh-list
64628654|NCT00002596|Bleomycin|bleomycin|mesh-list
64628655|NCT00002596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64628656|NCT00002596|Immunologic Factors|immunologic factors|mesh-ancestor
64628657|NCT00002596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301131|NCT03821883|Aspirin|aspirin|mesh-list
64741298|NCT00003953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64741299|NCT00003953|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64741300|NCT00003953|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64741301|NCT00003953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64741302|NCT00003959|Sargramostim|sargramostim|mesh-list
64741303|NCT00003959|Immunologic Factors|immunologic factors|mesh-ancestor
64741304|NCT00003959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741306|NCT02972723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64741307|NCT02972723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741308|NCT00003203|Cyclophosphamide|cyclophosphamide|mesh-list
64741309|NCT00003203|Cisplatin|cisplatin|mesh-list
64741310|NCT00003203|Carboplatin|carboplatin|mesh-list
64741311|NCT00003203|Vincristine|vincristine|mesh-list
64741312|NCT00003203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741313|NCT00003203|Immunologic Factors|immunologic factors|mesh-ancestor
64741314|NCT00003203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628698|NCT00199082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64628699|NCT00199082|Abortifacient Agents|abortifacient agents|mesh-ancestor
64628700|NCT00199082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64628701|NCT00199082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64628702|NCT00199082|Antimetabolites|antimetabolites|mesh-ancestor
64628703|NCT00199082|Dermatologic Agents|dermatologic agents|mesh-ancestor
64628704|NCT00199082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628705|NCT00199082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64628706|NCT00199082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64628707|NCT00199082|Antiviral Agents|antiviral agents|mesh-ancestor
64628708|NCT00199082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64628709|NCT00199082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64628710|NCT00199082|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741315|NCT00003203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64628711|NCT00199082|Antimitotic Agents|antimitotic agents|mesh-ancestor
64628712|NCT00199082|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741316|NCT00003203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64741317|NCT00003203|Alkylating Agents|alkylating agents|mesh-ancestor
64741318|NCT00003203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322145|NCT02221999|Mitosis Modulators|mitosis modulators|mesh-ancestor
64322146|NCT02221999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741319|NCT00003203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741320|NCT00003203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64741321|NCT00003203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64628741|NCT04194554|Hormone Antagonists|hormone antagonists|mesh-ancestor
64628742|NCT04194554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64628743|NCT04194554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64628744|NCT04194554|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64628745|NCT00002608|Tamoxifen|tamoxifen|mesh-list
64628746|NCT00002608|Doxorubicin|doxorubicin|mesh-list
64628747|NCT00002608|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64628748|NCT00002608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741322|NCT00003203|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741323|NCT00003203|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741324|NCT00003203|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741325|NCT00003575|Etoposide|etoposide|mesh-list
64741326|NCT00003575|Ifosfamide|ifosfamide|mesh-list
64628749|NCT00002608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64741327|NCT00003575|Interleukin-12|interleukin-12|mesh-list
64741328|NCT00003575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64741329|NCT00003575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741330|NCT00003575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64741331|NCT00003575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64741332|NCT00003575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741333|NCT00003575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741334|NCT00003575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64741335|NCT00003575|Immunologic Factors|immunologic factors|mesh-ancestor
64741336|NCT00003575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741337|NCT00003575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64741338|NCT00003575|Alkylating Agents|alkylating agents|mesh-ancestor
64741339|NCT00003575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64741340|NCT00003575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64741341|NCT00003575|Growth Substances|growth substances|mesh-ancestor
64741342|NCT00003575|Growth Inhibitors|growth inhibitors|mesh-ancestor
64741343|NCT00003209|Fluorouracil|fluorouracil|mesh-list
64741344|NCT00003209|Methotrexate|methotrexate|mesh-list
64741345|NCT00003209|Ifosfamide|ifosfamide|mesh-list
64628792|NCT00002638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301181|NCT03285087|Analgesics|analgesics|mesh-ancestor
64628793|NCT00002638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64628794|NCT00002638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64628795|NCT00002638|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64628796|NCT00002638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64628797|NCT00002638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628798|NCT00002638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64628799|NCT00002638|Antimetabolites|antimetabolites|mesh-ancestor
64741346|NCT00003209|Mitomycins|mitomycins|mesh-list
64628800|NCT00002638|Antiviral Agents|antiviral agents|mesh-ancestor
64741347|NCT00003209|Mitomycin|mitomycin|mesh-list
64741348|NCT00003209|Bleomycin|bleomycin|mesh-list
64741349|NCT00003209|Vinblastine|vinblastine|mesh-list
64741350|NCT00003209|Vindesine|vindesine|mesh-list
64741351|NCT00003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741352|NCT00003209|Antimetabolites|antimetabolites|mesh-ancestor
64353372|NCT02657031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64322147|NCT02221999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64322148|NCT02221999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322149|NCT02221999|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64322150|NCT02221999|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64322151|NCT02221999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628832|NCT01896440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64322152|NCT02221999|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64322153|NCT02221999|Hormone Antagonists|hormone antagonists|mesh-ancestor
64322154|NCT02564198|Ramucirumab|ramucirumab|mesh-list
64741353|NCT00003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741354|NCT00003209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64741355|NCT00003209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741356|NCT00003209|Immunologic Factors|immunologic factors|mesh-ancestor
64741357|NCT00003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741358|NCT00003209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64741359|NCT00003209|Abortifacient Agents|abortifacient agents|mesh-ancestor
64741360|NCT00003209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64741361|NCT00003209|Dermatologic Agents|dermatologic agents|mesh-ancestor
64741362|NCT00003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741363|NCT00003209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64741364|NCT00003209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64628886|NCT00002674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628887|NCT00002674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64628888|NCT00002674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64628889|NCT00002674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628890|NCT00002674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628892|NCT00002674|Antimetabolites|antimetabolites|mesh-ancestor
64741365|NCT00003209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64741366|NCT00003209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64741367|NCT00003209|Alkylating Agents|alkylating agents|mesh-ancestor
64741368|NCT00003209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64741369|NCT00003209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64741370|NCT00003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741371|NCT00003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741372|NCT00003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741375|NCT00003587|Vinorelbine|vinorelbine|mesh-list
64741376|NCT00003587|Docetaxel|docetaxel|mesh-list
64741377|NCT00003587|Carboplatin|carboplatin|mesh-list
64741378|NCT00003587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64322155|NCT02564198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322156|NCT02398539|Silver Nitrate|silver nitrate|mesh-list
64322157|NCT02398539|Triamcinolone|triamcinolone|mesh-list
64429841|NCT02107131|Ranibizumab|ranibizumab|mesh-list
64741379|NCT00003587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741380|NCT00003587|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741381|NCT00003587|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741382|NCT00003587|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741383|NCT00003587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628941|NCT00002692|Levoleucovorin|levoleucovorin|mesh-list
64628942|NCT00002692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64628943|NCT00002692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628944|NCT00002692|Antimetabolites|antimetabolites|mesh-ancestor
64628945|NCT00002692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628946|NCT00002692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64628947|NCT00002692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628948|NCT00002692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741384|NCT00003587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64741385|NCT00003587|Antimetabolites|antimetabolites|mesh-ancestor
64741386|NCT00003587|Antiviral Agents|antiviral agents|mesh-ancestor
64741387|NCT00003587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64741388|NCT00003587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741389|NCT00003587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741390|NCT00003587|Immunologic Factors|immunologic factors|mesh-ancestor
64741391|NCT00003587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741393|NCT00003215|Cytarabine|cytarabine|mesh-list
64741394|NCT00003215|Prednisone|prednisone|mesh-list
64741395|NCT00003215|Methylprednisolone|methylprednisolone|mesh-list
64741396|NCT00003215|Hydrocortisone|hydrocortisone|mesh-list
64741397|NCT00003215|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64628987|NCT01895348|Narcotics|narcotics|mesh-ancestor
64741398|NCT00003215|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64741399|NCT00003215|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64741400|NCT00003215|Cyclophosphamide|cyclophosphamide|mesh-list
64628988|NCT04784000|Carbamazepine|carbamazepine|mesh-list
64628989|NCT04784000|Anticonvulsants|anticonvulsants|mesh-ancestor
64628990|NCT04784000|Antimanic Agents|antimanic agents|mesh-ancestor
64628991|NCT04784000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64741401|NCT00003215|Melphalan|melphalan|mesh-list
64741402|NCT00003215|Doxorubicin|doxorubicin|mesh-list
64628992|NCT04784000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64628996|NCT04784000|Analgesics|analgesics|mesh-ancestor
64741403|NCT00003215|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64741404|NCT00003215|Methotrexate|methotrexate|mesh-list
64741405|NCT00003215|Etoposide|etoposide|mesh-list
64741406|NCT00003215|Vincristine|vincristine|mesh-list
64741407|NCT00003215|Mitoxantrone|mitoxantrone|mesh-list
64741408|NCT00003215|Levoleucovorin|levoleucovorin|mesh-list
64741409|NCT00003215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741410|NCT00003215|Immunologic Factors|immunologic factors|mesh-ancestor
64741411|NCT00003215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741412|NCT00003215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64741413|NCT00003215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64741414|NCT00003215|Alkylating Agents|alkylating agents|mesh-ancestor
64741415|NCT00003215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629041|NCT01113476|Antiviral Agents|antiviral agents|mesh-ancestor
64741419|NCT00003215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64741420|NCT00003215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64741421|NCT00003215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741422|NCT00003215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64741423|NCT00003215|Glucocorticoids|glucocorticoids|mesh-ancestor
64741424|NCT00003215|Hormones|hormones|mesh-ancestor
64741425|NCT00003215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64322185|NCT02141087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64741438|NCT00003215|Antidotes|antidotes|mesh-ancestor
64741439|NCT00003215|Protective Agents|protective agents|mesh-ancestor
64741440|NCT00003215|Vitamin B Complex|vitamin b complex|mesh-ancestor
64741442|NCT00003215|Micronutrients|micronutrients|mesh-ancestor
64741443|NCT00003215|Tubulin Modulators|tubulin modulators|mesh-ancestor
64480753|NCT00681538|Nabiximols|nabiximols|mesh-list
64741444|NCT00003215|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741445|NCT00003215|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741446|NCT00003215|Antiemetics|antiemetics|mesh-ancestor
64741447|NCT00003215|Autonomic Agents|autonomic agents|mesh-ancestor
64629103|NCT00002704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64629104|NCT00002704|Antimetabolites|antimetabolites|mesh-ancestor
64629105|NCT00002704|Dermatologic Agents|dermatologic agents|mesh-ancestor
64629106|NCT00002704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629107|NCT00002704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64629108|NCT00002704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64629109|NCT00002704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64629110|NCT00002704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64629111|NCT00002704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64629112|NCT00002704|Antiviral Agents|antiviral agents|mesh-ancestor
64629113|NCT00002704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64629114|NCT00002704|Antidotes|antidotes|mesh-ancestor
64629115|NCT00002704|Protective Agents|protective agents|mesh-ancestor
64629116|NCT00002704|Vitamin B Complex|vitamin b complex|mesh-ancestor
64741448|NCT00003215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64741449|NCT00003215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64741450|NCT00003215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64741451|NCT00003215|Analgesics|analgesics|mesh-ancestor
64429855|NCT05133765|Insulin|insulin|mesh-list
64741476|NCT00004001|Analgesics|analgesics|mesh-ancestor
64741477|NCT00004001|Sensory System Agents|sensory system agents|mesh-ancestor
64741478|NCT00004001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64629205|NCT00002740|Cobalt|cobalt|mesh-list
64741479|NCT00004001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64429906|NCT02106351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64429907|NCT02106351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64429908|NCT02106351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64429951|NCT05060627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64629222|NCT00002740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64629223|NCT00002740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64629224|NCT00002740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64629225|NCT00002740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64629263|NCT00002752|Antibodies|antibodies|mesh-list
64741523|NCT00003599|Protective Agents|protective agents|mesh-ancestor
64741524|NCT00003599|Dermatologic Agents|dermatologic agents|mesh-ancestor
64480834|NCT00705874|Leucovorin|leucovorin|mesh-list
64741525|NCT00003605|Cyclophosphamide|cyclophosphamide|mesh-list
64741526|NCT00003605|Rituximab|rituximab|mesh-list
64741527|NCT00003605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741528|NCT00003605|Immunologic Factors|immunologic factors|mesh-ancestor
64741529|NCT00003605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741530|NCT00003605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64741531|NCT00003605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64741532|NCT00003605|Alkylating Agents|alkylating agents|mesh-ancestor
64741533|NCT00003605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741534|NCT00003605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741535|NCT00003605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64741536|NCT00003605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64741550|NCT00003617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64741551|NCT00003617|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64741552|NCT00003617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64741553|NCT00003617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64741554|NCT00003617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64741555|NCT00003617|Alkylating Agents|alkylating agents|mesh-ancestor
64741556|NCT00003617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430088|NCT05012735|Vitamins|vitamins|mesh-ancestor
64430089|NCT05012735|Micronutrients|micronutrients|mesh-ancestor
64430092|NCT02519777|Maraviroc|maraviroc|mesh-list
64741581|NCT00004043|Calcitriol|calcitriol|mesh-list
64741582|NCT00004043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64741583|NCT00004043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741584|NCT00004043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64741585|NCT00004043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64741586|NCT00004043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741587|NCT00004043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64741588|NCT00004043|Vitamins|vitamins|mesh-ancestor
64741589|NCT00004043|Micronutrients|micronutrients|mesh-ancestor
64741590|NCT00004043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64741591|NCT00004055|Paclitaxel|paclitaxel|mesh-list
64741592|NCT00004055|Topotecan|topotecan|mesh-list
64741593|NCT00004055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64741594|NCT00004055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741595|NCT00004055|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741596|NCT00004055|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741597|NCT00004055|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741598|NCT00004055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741599|NCT00004055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64480905|NCT00687544|Antimetabolites|antimetabolites|mesh-ancestor
64741600|NCT00004055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64741602|NCT00004061|Cyclophosphamide|cyclophosphamide|mesh-list
64741603|NCT00004061|Ifosfamide|ifosfamide|mesh-list
64741604|NCT00004061|Etoposide|etoposide|mesh-list
64741605|NCT00004061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741606|NCT00004061|Immunologic Factors|immunologic factors|mesh-ancestor
64741607|NCT00004061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741608|NCT00004061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64741609|NCT00004061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64741610|NCT00004061|Alkylating Agents|alkylating agents|mesh-ancestor
64741611|NCT00004061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741612|NCT00004061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741613|NCT00004061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64629379|NCT04330300|Losartan|losartan|mesh-list
64741614|NCT00004061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64741615|NCT00004061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64741616|NCT00004061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64741617|NCT00004061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741618|NCT00004067|Paclitaxel|paclitaxel|mesh-list
64741619|NCT00004067|Cyclophosphamide|cyclophosphamide|mesh-list
64741657|NCT00004097|Paclitaxel|paclitaxel|mesh-list
64741658|NCT00004097|Fluorouracil|fluorouracil|mesh-list
64741659|NCT00004097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64741660|NCT00004097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741661|NCT00004097|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741662|NCT00004097|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741663|NCT00004097|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741664|NCT00004097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741665|NCT00004097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64741666|NCT00004097|Antimetabolites|antimetabolites|mesh-ancestor
64741667|NCT00004097|Antiviral Agents|antiviral agents|mesh-ancestor
64741668|NCT00004097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64741669|NCT00004097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741670|NCT00004097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741671|NCT00004097|Immunologic Factors|immunologic factors|mesh-ancestor
64741672|NCT00004097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741673|NCT00004103|Irinotecan|irinotecan|mesh-list
64741674|NCT00004103|Floxuridine|floxuridine|mesh-list
64480980|NCT00654784|Idebenone|idebenone|mesh-list
64741675|NCT00004103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741676|NCT00004103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64741677|NCT00004103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64629517|NCT01054079|Cinacalcet|cinacalcet|mesh-list
64741678|NCT00004103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430148|NCT02141217|Clindamycin|clindamycin|mesh-list
64322212|NCT02141321|Misoprostol|misoprostol|mesh-list
64322213|NCT02141321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64322214|NCT02141321|Abortifacient Agents|abortifacient agents|mesh-ancestor
64322215|NCT02141321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64322216|NCT02141321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322217|NCT02141321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64741716|NCT00003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741717|NCT00004127|Leucovorin|leucovorin|mesh-list
64741718|NCT00004127|Fluorouracil|fluorouracil|mesh-list
64741719|NCT00004127|Oxaliplatin|oxaliplatin|mesh-list
64741720|NCT00004127|Calcium|calcium|mesh-list
64741721|NCT00004127|Levoleucovorin|levoleucovorin|mesh-list
64741722|NCT00004127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64741723|NCT00004127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629556|NCT04748848|Venetoclax|venetoclax|mesh-list
64741724|NCT00004127|Antimetabolites|antimetabolites|mesh-ancestor
64741725|NCT00004127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741726|NCT00004127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64741727|NCT00004127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741728|NCT00004127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741729|NCT00004127|Immunologic Factors|immunologic factors|mesh-ancestor
64741730|NCT00004127|Antidotes|antidotes|mesh-ancestor
64741731|NCT00004127|Protective Agents|protective agents|mesh-ancestor
64741732|NCT00004127|Vitamin B Complex|vitamin b complex|mesh-ancestor
64741733|NCT00004127|Vitamins|vitamins|mesh-ancestor
64741734|NCT00004127|Micronutrients|micronutrients|mesh-ancestor
64741735|NCT00003251|Paclitaxel|paclitaxel|mesh-list
64741736|NCT00003251|Amifostine|amifostine|mesh-list
64741737|NCT00003251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64741738|NCT00003251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741739|NCT00003251|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741740|NCT00003251|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741741|NCT00003251|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741742|NCT00003251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741743|NCT00003251|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64741744|NCT00003251|Protective Agents|protective agents|mesh-ancestor
64741745|NCT00003251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741746|NCT00004139|Gemcitabine|gemcitabine|mesh-list
64741747|NCT00004139|Docetaxel|docetaxel|mesh-list
64741748|NCT00004139|Irinotecan|irinotecan|mesh-list
64741749|NCT00004139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64741750|NCT00004139|Antimetabolites|antimetabolites|mesh-ancestor
64353760|NCT03430817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64322218|NCT02141321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64741751|NCT00004139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741752|NCT00004139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741753|NCT00004139|Antiviral Agents|antiviral agents|mesh-ancestor
64741754|NCT00004139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64741755|NCT00004139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741756|NCT00004139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741757|NCT00004139|Immunologic Factors|immunologic factors|mesh-ancestor
64741758|NCT00004139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741759|NCT00004139|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741760|NCT00004139|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741761|NCT00004139|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741762|NCT00004139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64629686|NCT03850379|Ofloxacin|ofloxacin|mesh-list
64741763|NCT00004139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64741764|NCT00004145|Cyclophosphamide|cyclophosphamide|mesh-list
64741765|NCT00004145|Fludarabine|fludarabine|mesh-list
64741806|NCT00003269|Protective Agents|protective agents|mesh-ancestor
64741808|NCT00004163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64741809|NCT00004163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741810|NCT00003281|Paclitaxel|paclitaxel|mesh-list
64741811|NCT00003281|Topotecan|topotecan|mesh-list
64741812|NCT00003281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64741813|NCT00003281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741814|NCT00003281|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741815|NCT00003281|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741816|NCT00003281|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741817|NCT00003281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741818|NCT00003281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64741819|NCT00003281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64741820|NCT00003281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741821|NCT00003287|Leucovorin|leucovorin|mesh-list
64741822|NCT00003287|Fluorouracil|fluorouracil|mesh-list
64741823|NCT00003287|Oxaliplatin|oxaliplatin|mesh-list
64741824|NCT00003287|Calcium|calcium|mesh-list
64741825|NCT00003287|Levoleucovorin|levoleucovorin|mesh-list
64741826|NCT00003287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64741827|NCT00003287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64481131|NCT01792102|Antiemetics|antiemetics|mesh-ancestor
64741828|NCT00003287|Antimetabolites|antimetabolites|mesh-ancestor
64741829|NCT00003287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741830|NCT00003287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64322228|NCT02141477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64322229|NCT02141477|Antimetabolites|antimetabolites|mesh-ancestor
64322230|NCT02141477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322231|NCT02141477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322232|NCT02141477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322233|NCT02141477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64322234|NCT02141477|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64322235|NCT02232139|Midazolam|midazolam|mesh-list
64322236|NCT02232139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64629746|NCT02169479|Opicapone|opicapone|mesh-list
64322240|NCT02232139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64322241|NCT02232139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64322242|NCT02232139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64322243|NCT02232139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64322244|NCT02232139|Anesthetics, General|anesthetics, general|mesh-ancestor
64322245|NCT02232139|Anesthetics|anesthetics|mesh-ancestor
64741842|NCT00004187|Antimetabolites|antimetabolites|mesh-ancestor
64741843|NCT00004187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741844|NCT00004187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741845|NCT00384137|Tacrolimus|tacrolimus|mesh-list
64741846|NCT00384137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741847|NCT00384137|Immunologic Factors|immunologic factors|mesh-ancestor
64741848|NCT00384137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741849|NCT00384137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64741850|NCT00384137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741851|NCT00384137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741852|NCT00384215|Insulin Glargine|insulin glargine|mesh-list
64741853|NCT00384215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64741854|NCT00384215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741855|NCT00003293|Procarbazine|procarbazine|mesh-list
64741856|NCT00003293|Leflunomide|leflunomide|mesh-list
64741857|NCT00003293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629794|NCT01059929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64741858|NCT00003293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741859|NCT00003293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741860|NCT00003293|Immunologic Factors|immunologic factors|mesh-ancestor
64741861|NCT00003293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741862|NCT00003293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430584|NCT01926886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741863|NCT00004199|Gemcitabine|gemcitabine|mesh-list
64741864|NCT00004199|Prinomastat|prinomastat|mesh-list
64741865|NCT00004199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741866|NCT00004199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64741867|NCT00004199|Antimetabolites|antimetabolites|mesh-ancestor
64353884|NCT02412878|Antiemetics|antiemetics|mesh-ancestor
64322246|NCT02232139|GABA Modulators|gaba modulators|mesh-ancestor
64322247|NCT02232139|GABA Agents|gaba agents|mesh-ancestor
64322248|NCT02232139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64322249|NCT02232139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322250|NCT04288778|Metformin|metformin|mesh-list
64322251|NCT04288778|Canagliflozin|canagliflozin|mesh-list
64322252|NCT04288778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64322253|NCT04288778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322254|NCT04288778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64322255|NCT04288778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322258|NCT02226601|Autonomic Agents|autonomic agents|mesh-ancestor
64322259|NCT02226601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322260|NCT02226601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322261|NCT02226601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64322262|NCT02226601|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64322263|NCT02226601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64322264|NCT02226601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322265|NCT02397603|Dexmedetomidine|dexmedetomidine|mesh-list
64322266|NCT02397603|Bupivacaine|bupivacaine|mesh-list
64322267|NCT02397603|Anesthetics, Local|anesthetics, local|mesh-ancestor
64741868|NCT00004199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741869|NCT00004199|Antiviral Agents|antiviral agents|mesh-ancestor
64741870|NCT00004199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64741871|NCT00004199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741872|NCT00004199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741873|NCT00004199|Immunologic Factors|immunologic factors|mesh-ancestor
64741874|NCT00004199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741875|NCT00004199|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
64741876|NCT00004199|Protease Inhibitors|protease inhibitors|mesh-ancestor
64741877|NCT00003299|Paclitaxel|paclitaxel|mesh-list
64741878|NCT00003299|Etoposide|etoposide|mesh-list
64741879|NCT00003299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64741880|NCT00003299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629949|NCT04038970|Methotrexate|methotrexate|mesh-list
64741881|NCT00003299|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741882|NCT00003299|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741883|NCT00003299|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741884|NCT00003299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741885|NCT00003299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64741886|NCT00003299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64741887|NCT00003299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741888|NCT00004205|Tamoxifen|tamoxifen|mesh-list
64741889|NCT00004205|Letrozole|letrozole|mesh-list
64741890|NCT00004205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741891|NCT00004205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741892|NCT00004205|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64741893|NCT00004205|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64741894|NCT00004205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741895|NCT00004205|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64741896|NCT00004205|Hormone Antagonists|hormone antagonists|mesh-ancestor
64741897|NCT00004205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64741898|NCT00004205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741907|NCT00003305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64741908|NCT00003305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741909|NCT00003305|Antidotes|antidotes|mesh-ancestor
64741910|NCT00003305|Protective Agents|protective agents|mesh-ancestor
64741911|NCT00003305|Vitamin B Complex|vitamin b complex|mesh-ancestor
64741912|NCT00003305|Vitamins|vitamins|mesh-ancestor
64741913|NCT00003305|Micronutrients|micronutrients|mesh-ancestor
64741914|NCT00003305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64741915|NCT00003305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741916|NCT00003305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741917|NCT00003311|Cytarabine|cytarabine|mesh-list
64741918|NCT00003311|Dexamethasone|dexamethasone|mesh-list
64741919|NCT00003311|Cyclophosphamide|cyclophosphamide|mesh-list
64741920|NCT00003311|Doxorubicin|doxorubicin|mesh-list
64353947|NCT03422315|Propofol|propofol|mesh-list
64322271|NCT02397603|Sensory System Agents|sensory system agents|mesh-ancestor
64322272|NCT02397603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322273|NCT02397603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64322274|NCT02397603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64322275|NCT02397603|Analgesics|analgesics|mesh-ancestor
64322276|NCT02397603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64322277|NCT02397603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64322278|NCT02397603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64322279|NCT02397603|Adrenergic Agents|adrenergic agents|mesh-ancestor
64741921|NCT00003311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64741923|NCT00003311|Vincristine|vincristine|mesh-list
64741924|NCT00003311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64741925|NCT00003311|Immunologic Factors|immunologic factors|mesh-ancestor
64741926|NCT00003311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64741927|NCT00003311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64741928|NCT00003311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64741929|NCT00003311|Alkylating Agents|alkylating agents|mesh-ancestor
64741930|NCT00003311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741931|NCT00003311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741932|NCT00003311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64430834|NCT01901614|Anesthetics|anesthetics|mesh-list
64741940|NCT00003311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64741941|NCT00003311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64741942|NCT00003311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64741943|NCT00003311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64741944|NCT00003311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64630230|NCT00002890|Lintuzumab|lintuzumab|mesh-list
64741946|NCT00003311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64741947|NCT00003311|Abortifacient Agents|abortifacient agents|mesh-ancestor
64741948|NCT00003311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64741949|NCT00003311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64741950|NCT00003311|Antimetabolites|antimetabolites|mesh-ancestor
64741951|NCT00003311|Dermatologic Agents|dermatologic agents|mesh-ancestor
64322281|NCT02397603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322285|NCT02145065|Tubulin Modulators|tubulin modulators|mesh-ancestor
64322286|NCT02145065|Antimitotic Agents|antimitotic agents|mesh-ancestor
64322287|NCT02145065|Mitosis Modulators|mitosis modulators|mesh-ancestor
64322288|NCT02145065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322289|NCT02226757|Paclitaxel|paclitaxel|mesh-list
64322290|NCT02226757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64322291|NCT02226757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322292|NCT02226757|Tubulin Modulators|tubulin modulators|mesh-ancestor
64322293|NCT02226757|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741952|NCT00003311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64741953|NCT00003311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64741954|NCT00003311|Antiviral Agents|antiviral agents|mesh-ancestor
64741955|NCT00003311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64741956|NCT00003311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64741957|NCT00003311|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741958|NCT00003311|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741959|NCT00003311|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741960|NCT00003317|Paclitaxel|paclitaxel|mesh-list
64741961|NCT00003317|Carboplatin|carboplatin|mesh-list
64741962|NCT00003317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64741963|NCT00003317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64741964|NCT00003317|Tubulin Modulators|tubulin modulators|mesh-ancestor
64741965|NCT00003317|Antimitotic Agents|antimitotic agents|mesh-ancestor
64741966|NCT00003317|Mitosis Modulators|mitosis modulators|mesh-ancestor
64741967|NCT00003317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741968|NCT00004217|Cytarabine|cytarabine|mesh-list
64741969|NCT00004217|Daunorubicin|daunorubicin|mesh-list
64741970|NCT00004217|Sargramostim|sargramostim|mesh-list
64741971|NCT00004217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64741972|NCT00004217|Antimetabolites|antimetabolites|mesh-ancestor
64741973|NCT00004217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64741974|NCT00004217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430874|NCT04939883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64741982|NCT00004217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64741983|NCT00004217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64741985|NCT00004223|Docetaxel|docetaxel|mesh-list
64742041|NCT00003335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64742042|NCT00003335|Dermatologic Agents|dermatologic agents|mesh-ancestor
64742043|NCT00003335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64742044|NCT00003335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64742045|NCT00003335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64742046|NCT00003335|Antiemetics|antiemetics|mesh-ancestor
64742047|NCT00003335|Autonomic Agents|autonomic agents|mesh-ancestor
64742048|NCT00003335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64742049|NCT00003335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64742050|NCT00003335|Glucocorticoids|glucocorticoids|mesh-ancestor
64742051|NCT00003335|Hormones|hormones|mesh-ancestor
64630522|NCT01572662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64742052|NCT00003335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64742053|NCT00003335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64742054|NCT00003335|Protective Agents|protective agents|mesh-ancestor
64742055|NCT00003335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742056|NCT00003335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64742057|NCT00003335|Alkylating Agents|alkylating agents|mesh-ancestor
64742058|NCT00003335|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64742059|NCT00003341|Epoetin Alfa|epoetin alfa|mesh-list
64742060|NCT00003341|Hematinics|hematinics|mesh-ancestor
64742061|NCT00004253|Paclitaxel|paclitaxel|mesh-list
64742062|NCT00004253|Carboplatin|carboplatin|mesh-list
64742063|NCT00004253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64742064|NCT00004253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742065|NCT00004253|Tubulin Modulators|tubulin modulators|mesh-ancestor
64742066|NCT00004253|Antimitotic Agents|antimitotic agents|mesh-ancestor
64742067|NCT00004253|Mitosis Modulators|mitosis modulators|mesh-ancestor
64742068|NCT00004253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742089|NCT00003365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64742090|NCT00003365|Analgesics|analgesics|mesh-ancestor
64742091|NCT00003365|Sensory System Agents|sensory system agents|mesh-ancestor
64742092|NCT00003365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64742093|NCT00003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742094|NCT00003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64742095|NCT00003365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64742096|NCT00003365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742097|NCT00003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742098|NCT00003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742099|NCT00003365|Antioxidants|antioxidants|mesh-ancestor
64742100|NCT00003365|Protective Agents|protective agents|mesh-ancestor
64630653|NCT00003400|Melphalan|melphalan|mesh-list
64742101|NCT00003365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64742102|NCT00004829|Tobramycin|tobramycin|mesh-list
64742103|NCT00004829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64742104|NCT00004829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64742105|NCT00004313|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64742106|NCT00004313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64742107|NCT00004313|Immunologic Factors|immunologic factors|mesh-ancestor
64742108|NCT00004313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742109|NCT00004853|Lenograstim|lenograstim|mesh-list
64742110|NCT00004853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64742111|NCT00004853|Immunologic Factors|immunologic factors|mesh-ancestor
64742112|NCT00004853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742113|NCT00004865|Paclitaxel|paclitaxel|mesh-list
64742114|NCT00004865|Fluorouracil|fluorouracil|mesh-list
64742115|NCT00004865|Cetuximab|cetuximab|mesh-list
64742116|NCT00004865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64630701|NCT00777140|Deferoxamine|deferoxamine|mesh-list
64742117|NCT00004865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742118|NCT00004865|Tubulin Modulators|tubulin modulators|mesh-ancestor
64742119|NCT00004865|Antimitotic Agents|antimitotic agents|mesh-ancestor
64742120|NCT00004865|Mitosis Modulators|mitosis modulators|mesh-ancestor
64742121|NCT00004865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742122|NCT00004865|Antimetabolites|antimetabolites|mesh-ancestor
64742123|NCT00004865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64742130|NCT00004361|Calcium|calcium|mesh-list
64742131|NCT00004361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64481427|NCT04270708|Analgesics|analgesics|mesh-ancestor
64742132|NCT00004361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742133|NCT00004361|Anticoagulants|anticoagulants|mesh-ancestor
64742134|NCT00004361|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64742135|NCT00004361|Chelating Agents|chelating agents|mesh-ancestor
64742136|NCT00004361|Sequestering Agents|sequestering agents|mesh-ancestor
64742137|NCT00004361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742138|NCT00004373|Alprazolam|alprazolam|mesh-list
64742139|NCT00004373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64742140|NCT00004373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64742141|NCT00004373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742142|NCT00004373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64742143|NCT00004373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64742144|NCT00004373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64742145|NCT00004373|GABA Modulators|gaba modulators|mesh-ancestor
64742146|NCT00004373|GABA Agents|gaba agents|mesh-ancestor
64742147|NCT00004373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64742148|NCT00004373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742149|NCT00004871|Azacitidine|azacitidine|mesh-list
64742150|NCT00004871|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64742151|NCT00004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64742152|NCT00004871|Antimetabolites|antimetabolites|mesh-ancestor
64742153|NCT00004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742154|NCT00004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742155|NCT00004871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742156|NCT00004397|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
64742157|NCT00004397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742158|NCT00004397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742159|NCT00004883|Trastuzumab|trastuzumab|mesh-list
64742160|NCT00004883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64742161|NCT00004883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630793|NCT00002980|Decitabine|decitabine|mesh-list
64742162|NCT00004403|Albendazole|albendazole|mesh-list
64742163|NCT00004403|Dexamethasone|dexamethasone|mesh-list
64742164|NCT00004403|Phenytoin|phenytoin|mesh-list
64742165|NCT00004403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64742166|NCT00004403|Antiemetics|antiemetics|mesh-ancestor
64742167|NCT00004403|Autonomic Agents|autonomic agents|mesh-ancestor
64742168|NCT00004403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64742169|NCT00004403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742170|NCT00004403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64742171|NCT00004403|Glucocorticoids|glucocorticoids|mesh-ancestor
64742172|NCT00004403|Hormones|hormones|mesh-ancestor
64742173|NCT00004403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64630832|NCT04777838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64742174|NCT00004403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64742175|NCT00004403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742176|NCT00004403|Anthelmintics|anthelmintics|mesh-ancestor
64742177|NCT00004403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64742178|NCT00004403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64742179|NCT00004403|Anticestodal Agents|anticestodal agents|mesh-ancestor
64742180|NCT00004403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64742181|NCT00004403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64742182|NCT00004403|Tubulin Modulators|tubulin modulators|mesh-ancestor
64742183|NCT00004403|Antimitotic Agents|antimitotic agents|mesh-ancestor
64742184|NCT00004403|Mitosis Modulators|mitosis modulators|mesh-ancestor
64742185|NCT00004403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742186|NCT00004403|Anticonvulsants|anticonvulsants|mesh-ancestor
64742191|NCT00004403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64742192|NCT00004889|Rituximab|rituximab|mesh-list
64354193|NCT02521441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64322295|NCT02226757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742193|NCT00004889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64742194|NCT00004889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742195|NCT00004889|Immunologic Factors|immunologic factors|mesh-ancestor
64742196|NCT00004889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742197|NCT00004889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64742198|NCT00385307|Amibegron|amibegron|mesh-list
64742199|NCT00385307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64742200|NCT00385307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64742201|NCT00385307|Adrenergic Agents|adrenergic agents|mesh-ancestor
64742202|NCT00385307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64630950|NCT00003466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742203|NCT00385307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742204|NCT00385307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742205|NCT00004901|Fluorouracil|fluorouracil|mesh-list
64481516|NCT01270438|Vitamins|vitamins|mesh-ancestor
64742206|NCT00004901|Hydroxyurea|hydroxyurea|mesh-list
64742207|NCT00004901|Eniluracil|eniluracil|mesh-list
64742209|NCT00004901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742210|NCT00004901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64742211|NCT00004901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742212|NCT00004901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64742213|NCT00004901|Immunologic Factors|immunologic factors|mesh-ancestor
64742214|NCT00004901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742215|NCT00004901|Antisickling Agents|antisickling agents|mesh-ancestor
64742246|NCT00004919|Amifostine|amifostine|mesh-list
64742247|NCT00004919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742248|NCT00004919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64742249|NCT00004919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64742250|NCT00004919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742251|NCT00004919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742252|NCT00004919|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64742253|NCT00004919|Protective Agents|protective agents|mesh-ancestor
64742254|NCT00004919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742255|NCT00004925|Doxorubicin|doxorubicin|mesh-list
64742256|NCT00004925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64742257|NCT00004925|Trastuzumab|trastuzumab|mesh-list
64742258|NCT00004925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64742259|NCT00004925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742260|NCT00004925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64742261|NCT00004925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64322296|NCT04616924|Clarithromycin|clarithromycin|mesh-list
64322297|NCT04616924|Rifabutin|rifabutin|mesh-list
64322298|NCT04616924|Clofazimine|clofazimine|mesh-list
64322299|NCT04616924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64322300|NCT04616924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64322301|NCT04616924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64322302|NCT04616924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322303|NCT04616924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322304|NCT04616924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64322305|NCT04616924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64430886|NCT02065713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742266|NCT00004931|Fluorouracil|fluorouracil|mesh-list
64742267|NCT00004931|Oxaliplatin|oxaliplatin|mesh-list
64742268|NCT00004931|Calcium|calcium|mesh-list
64742269|NCT00004931|Levoleucovorin|levoleucovorin|mesh-list
64742270|NCT00004931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64742271|NCT00004931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742272|NCT00004931|Antimetabolites|antimetabolites|mesh-ancestor
64742273|NCT00004931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742274|NCT00004931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64742275|NCT00004931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631098|NCT00003064|Topotecan|topotecan|mesh-list
64742276|NCT00004931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64742277|NCT00004931|Immunologic Factors|immunologic factors|mesh-ancestor
64742278|NCT00004931|Antidotes|antidotes|mesh-ancestor
64742279|NCT00004931|Protective Agents|protective agents|mesh-ancestor
64742280|NCT00004931|Vitamin B Complex|vitamin b complex|mesh-ancestor
64742281|NCT00004931|Vitamins|vitamins|mesh-ancestor
64742282|NCT00004931|Micronutrients|micronutrients|mesh-ancestor
64742283|NCT00004979|Paclitaxel|paclitaxel|mesh-list
64742284|NCT00004979|Topotecan|topotecan|mesh-list
64742285|NCT00004979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64742286|NCT00004979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742287|NCT00004979|Tubulin Modulators|tubulin modulators|mesh-ancestor
64742288|NCT00004979|Antimitotic Agents|antimitotic agents|mesh-ancestor
64742289|NCT00004979|Mitosis Modulators|mitosis modulators|mesh-ancestor
64742290|NCT00004979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742291|NCT00004979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64631161|NCT00003568|Aldesleukin|aldesleukin|mesh-list
64742292|NCT00004979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64742293|NCT00004979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742294|NCT00004985|Nelfinavir|nelfinavir|mesh-list
64742295|NCT00004985|Capravirine|capravirine|mesh-list
64322318|NCT02226913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64322319|NCT02226913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64322320|NCT02226913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64322321|NCT02226913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64322322|NCT02226913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322323|NCT02226913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64742297|NCT00004985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64742298|NCT00004985|Protease Inhibitors|protease inhibitors|mesh-ancestor
64631200|NCT00003082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64742299|NCT00004985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742300|NCT00004985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742301|NCT00004985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64742302|NCT00004985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64742303|NCT00004985|Antiviral Agents|antiviral agents|mesh-ancestor
64742304|NCT00004985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64742305|NCT00004985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64742306|NCT00004985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64742307|NCT00004997|Leucovorin|leucovorin|mesh-list
64742308|NCT00004997|Antidotes|antidotes|mesh-ancestor
64742309|NCT00004997|Protective Agents|protective agents|mesh-ancestor
64742310|NCT00004997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742312|NCT00004997|Vitamins|vitamins|mesh-ancestor
64742356|NCT00004637|Protective Agents|protective agents|mesh-ancestor
64742357|NCT00005021|Paclitaxel|paclitaxel|mesh-list
64742358|NCT00005021|Carboplatin|carboplatin|mesh-list
64742359|NCT00005021|Topotecan|topotecan|mesh-list
64742360|NCT00005021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64742361|NCT00005021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742362|NCT00005021|Tubulin Modulators|tubulin modulators|mesh-ancestor
64742363|NCT00005021|Antimitotic Agents|antimitotic agents|mesh-ancestor
64742364|NCT00005021|Mitosis Modulators|mitosis modulators|mesh-ancestor
64742365|NCT00005021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742366|NCT00005021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64742367|NCT00005021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64742368|NCT00005021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742369|NCT00004643|Cytarabine|cytarabine|mesh-list
64742370|NCT00004643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64742371|NCT00004643|Antimetabolites|antimetabolites|mesh-ancestor
64742372|NCT00004643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742373|NCT00004643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742374|NCT00004643|Antiviral Agents|antiviral agents|mesh-ancestor
64742375|NCT00004643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64742376|NCT00004643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64742377|NCT00004643|Immunologic Factors|immunologic factors|mesh-ancestor
64742378|NCT00004643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742379|NCT00005033|Trastuzumab|trastuzumab|mesh-list
64742380|NCT00005033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64742381|NCT00005033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742382|NCT00005039|Vaccines|vaccines|mesh-list
64742383|NCT00005039|Immunologic Factors|immunologic factors|mesh-ancestor
64742384|NCT00005039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742385|NCT00004685|Albuterol|albuterol|mesh-list
64742386|NCT00004685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64742387|NCT00004685|Autonomic Agents|autonomic agents|mesh-ancestor
64742388|NCT00004685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64742390|NCT00004685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64742398|NCT00004685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64742399|NCT00004685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742400|NCT00005045|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
64742401|NCT00005045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742402|NCT00005045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64742403|NCT00005045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64742404|NCT00005045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742405|NCT00005045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64742406|NCT00005045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742407|NCT00005051|Paclitaxel|paclitaxel|mesh-list
64742408|NCT00005051|Carboplatin|carboplatin|mesh-list
64742409|NCT00005051|Topotecan|topotecan|mesh-list
64742410|NCT00005051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64742411|NCT00005051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742412|NCT00005051|Tubulin Modulators|tubulin modulators|mesh-ancestor
64742413|NCT00005051|Antimitotic Agents|antimitotic agents|mesh-ancestor
64742414|NCT00005051|Mitosis Modulators|mitosis modulators|mesh-ancestor
64742415|NCT00005051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742416|NCT00005051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64742417|NCT00005051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64742418|NCT00005051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742419|NCT00004697|Choline|choline|mesh-list
64742420|NCT00004697|Lipotropic Agents|lipotropic agents|mesh-ancestor
64430889|NCT02065713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742422|NCT00004697|Antimetabolites|antimetabolites|mesh-ancestor
64742423|NCT00004697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742424|NCT00004697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64742425|NCT00004697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64742426|NCT00004697|Nootropic Agents|nootropic agents|mesh-ancestor
64742427|NCT00004727|Aspirin|aspirin|mesh-list
64742428|NCT00004727|Ticlopidine|ticlopidine|mesh-list
64742429|NCT00004727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64742430|NCT00004727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64742431|NCT00004727|Analgesics|analgesics|mesh-ancestor
64322324|NCT02226913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64322325|NCT02226913|Adrenergic Agents|adrenergic agents|mesh-ancestor
64322326|NCT02226913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64322327|NCT02226913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64322328|NCT02226913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64322329|NCT02226913|Autonomic Agents|autonomic agents|mesh-ancestor
64742432|NCT00004727|Sensory System Agents|sensory system agents|mesh-ancestor
64742433|NCT00004727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64742434|NCT00004727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742435|NCT00004727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64742436|NCT00004727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64742437|NCT00004727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64742438|NCT00004727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64742439|NCT00004727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742440|NCT00004727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64742441|NCT00004727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64742442|NCT00004727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742443|NCT00004727|Antipyretics|antipyretics|mesh-ancestor
64742444|NCT00004727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64742445|NCT00004727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64742446|NCT00004727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64742447|NCT00004727|Purinergic Agents|purinergic agents|mesh-ancestor
64742448|NCT00004727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64742449|NCT00004727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64742450|NCT00004727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64742451|NCT00004733|Levodopa|levodopa|mesh-list
64742452|NCT00004733|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64742453|NCT00004733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64742454|NCT00004733|Dopamine Agents|dopamine agents|mesh-ancestor
64742455|NCT00004733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64742456|NCT00004733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742457|NCT00004733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742458|NCT00004739|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64742459|NCT00004739|Antiviral Agents|antiviral agents|mesh-ancestor
64742460|NCT00004739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64742461|NCT00005057|Ganciclovir|ganciclovir|mesh-list
64742462|NCT00005057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64742463|NCT00005057|Antiviral Agents|antiviral agents|mesh-ancestor
64742464|NCT00005057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64322330|NCT02226913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64322331|NCT02226913|Respiratory System Agents|respiratory system agents|mesh-ancestor
64322332|NCT02226913|Mydriatics|mydriatics|mesh-ancestor
64322333|NCT02226913|Sympathomimetics|sympathomimetics|mesh-ancestor
64322334|NCT02226913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64322335|NCT05491616|Nivolumab|nivolumab|mesh-list
64742465|NCT00005057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64742466|NCT00005057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742467|NCT00005057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742468|NCT00004757|Acyclovir|acyclovir|mesh-list
64742469|NCT00004757|Antiviral Agents|antiviral agents|mesh-ancestor
64742470|NCT00004757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64742471|NCT00005069|Arsenic Trioxide|arsenic trioxide|mesh-list
64742472|NCT00005069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742473|NCT00004763|Leuprolide|leuprolide|mesh-list
64742474|NCT00004763|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64742475|NCT00004763|Norethindrone|norethindrone|mesh-list
64742476|NCT00004763|Norethindrone Acetate|norethindrone acetate|mesh-list
64742477|NCT00004763|Norinyl|norinyl|mesh-list
64742478|NCT00004763|Estradiol|estradiol|mesh-list
64742479|NCT00004763|Estrogens|estrogens|mesh-ancestor
64742480|NCT00004763|Hormones|hormones|mesh-ancestor
64742481|NCT00004763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64742482|NCT00004763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742483|NCT00004763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64742484|NCT00004763|Contraceptive Agents|contraceptive agents|mesh-ancestor
64742485|NCT00004763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64742486|NCT00004763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64742487|NCT00004763|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64742488|NCT00004763|Fertility Agents|fertility agents|mesh-ancestor
64742489|NCT00004763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64742490|NCT00004763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742491|NCT00004763|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64742492|NCT00004763|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64742493|NCT00004763|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64742494|NCT00004763|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64742495|NCT00004787|Lenograstim|lenograstim|mesh-list
64742496|NCT00004787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64742508|NCT00005087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64742509|NCT00005087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742510|NCT00005087|Tubulin Modulators|tubulin modulators|mesh-ancestor
64742511|NCT00005087|Antimitotic Agents|antimitotic agents|mesh-ancestor
64481803|NCT04386850|Vitamins|vitamins|mesh-ancestor
64481876|NCT00733096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64742512|NCT00005087|Mitosis Modulators|mitosis modulators|mesh-ancestor
64742513|NCT00005087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742514|NCT00004799|Vaccines|vaccines|mesh-list
64742515|NCT00004799|Immunologic Factors|immunologic factors|mesh-ancestor
64742516|NCT00004799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742517|NCT00005093|Gemcitabine|gemcitabine|mesh-list
64742518|NCT00005093|Tacedinaline|tacedinaline|mesh-list
64742519|NCT00005093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64742520|NCT00005093|Antimetabolites|antimetabolites|mesh-ancestor
64742521|NCT00005093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742522|NCT00005093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742542|NCT00004817|Phenytoin|phenytoin|mesh-list
64742562|NCT00005117|Antimetabolites|antimetabolites|mesh-ancestor
64742563|NCT00005117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742564|NCT00005117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64742565|NCT00005117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64742566|NCT00005117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742567|NCT00385385|KRM 1648|krm 1648|mesh-list
64742568|NCT00385385|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64742569|NCT00385385|Antitubercular Agents|antitubercular agents|mesh-ancestor
64742570|NCT00385385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64742571|NCT00385385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64742572|NCT00385385|Leprostatic Agents|leprostatic agents|mesh-ancestor
64742573|NCT00385463|Montelukast|montelukast|mesh-list
64742574|NCT00385463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64631441|NCT00493870|Mitosis Modulators|mitosis modulators|mesh-ancestor
64742575|NCT00385463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64742576|NCT00385463|Respiratory System Agents|respiratory system agents|mesh-ancestor
64742577|NCT00385463|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64742578|NCT00385463|Hormone Antagonists|hormone antagonists|mesh-ancestor
64742579|NCT00385463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64742580|NCT00385463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742581|NCT00385463|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64742582|NCT00385463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64742583|NCT00385463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742614|NCT00005585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64742615|NCT00005585|Immunologic Factors|immunologic factors|mesh-ancestor
64742616|NCT00005585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742617|NCT00005585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64742618|NCT00005585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64742619|NCT00005585|Alkylating Agents|alkylating agents|mesh-ancestor
64742620|NCT00005585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742621|NCT00005585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742622|NCT00005585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64742623|NCT00005585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64742624|NCT00005585|Antiemetics|antiemetics|mesh-ancestor
64742625|NCT00005585|Autonomic Agents|autonomic agents|mesh-ancestor
64742629|NCT00005585|Hormones|hormones|mesh-ancestor
64742677|NCT00005597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742678|NCT00005597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742679|NCT04172844|Azacitidine|azacitidine|mesh-list
64742680|NCT04172844|Venetoclax|venetoclax|mesh-list
64742681|NCT04172844|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64742682|NCT04172844|Pevonedistat|pevonedistat|mesh-list
64742683|NCT04172844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64742684|NCT04172844|Antimetabolites|antimetabolites|mesh-ancestor
64742685|NCT04172844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742686|NCT04172844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742687|NCT00005603|Cytarabine|cytarabine|mesh-list
64742688|NCT00005603|Dexamethasone|dexamethasone|mesh-list
64742689|NCT00005603|Prednisone|prednisone|mesh-list
64742690|NCT00005603|Cyclophosphamide|cyclophosphamide|mesh-list
64742691|NCT00005603|Doxorubicin|doxorubicin|mesh-list
64742692|NCT00005603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64742693|NCT00005603|Methotrexate|methotrexate|mesh-list
64742694|NCT00005603|Vincristine|vincristine|mesh-list
64742695|NCT00005603|Daunorubicin|daunorubicin|mesh-list
64742696|NCT00005603|Asparaginase|asparaginase|mesh-list
64742697|NCT00005603|Mercaptopurine|mercaptopurine|mesh-list
64742698|NCT00005603|Thioguanine|thioguanine|mesh-list
64742699|NCT00005603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64742700|NCT00005603|Immunologic Factors|immunologic factors|mesh-ancestor
64742733|NCT00005603|Antimitotic Agents|antimitotic agents|mesh-ancestor
64742734|NCT00005603|Mitosis Modulators|mitosis modulators|mesh-ancestor
64482028|NCT00735826|Vorinostat|vorinostat|mesh-list
64742735|NCT00005609|Rituximab|rituximab|mesh-list
64742736|NCT00005609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64482097|NCT04142151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64742737|NCT00005609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742738|NCT00005609|Immunologic Factors|immunologic factors|mesh-ancestor
64742739|NCT00005609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742740|NCT00005609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64742741|NCT00005615|Interferons|interferons|mesh-list
64742742|NCT00005615|Interferon-alpha|interferon-alpha|mesh-list
64742743|NCT00005615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742744|NCT00005615|Antiviral Agents|antiviral agents|mesh-ancestor
64742745|NCT00005615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64742746|NCT00005615|Immunologic Factors|immunologic factors|mesh-ancestor
64742747|NCT00005615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742748|NCT00005627|Carboplatin|carboplatin|mesh-list
64742749|NCT00005627|Docetaxel|docetaxel|mesh-list
64742750|NCT00005627|Estramustine|estramustine|mesh-list
64742751|NCT00005627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452397|NCT01964755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64742752|NCT00005627|Tubulin Modulators|tubulin modulators|mesh-ancestor
64742753|NCT00005627|Antimitotic Agents|antimitotic agents|mesh-ancestor
64742754|NCT00005627|Mitosis Modulators|mitosis modulators|mesh-ancestor
64354755|NCT03463993|Hemostatics|hemostatics|mesh-ancestor
64322336|NCT05491616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64322337|NCT05491616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322338|NCT05491616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64322339|NCT05491616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322340|NCT02254655|Antirheumatic Agents|antirheumatic agents|mesh-list
64322341|NCT02254655|Puerarin|puerarin|mesh-list
64322342|NCT02254655|Vasodilator Agents|vasodilator agents|mesh-ancestor
64322343|NCT02226991|Ritonavir|ritonavir|mesh-list
64322344|NCT02226991|Tipranavir|tipranavir|mesh-list
64322346|NCT02226991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64322347|NCT02226991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64322348|NCT02226991|Protease Inhibitors|protease inhibitors|mesh-ancestor
64322349|NCT02226991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322350|NCT02226991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322351|NCT02226991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64322352|NCT02226991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64322353|NCT02226991|Antiviral Agents|antiviral agents|mesh-ancestor
64322354|NCT02226991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64322356|NCT02226991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64430898|NCT02497781|Cefepime|cefepime|mesh-list
64742757|NCT00005627|Alkylating Agents|alkylating agents|mesh-ancestor
64742758|NCT00005627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64742760|NCT00005639|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64742761|NCT00005639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64742762|NCT00005639|Antimetabolites|antimetabolites|mesh-ancestor
64742763|NCT00005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742764|NCT00005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742765|NCT00005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742766|NCT00005663|Valacyclovir|valacyclovir|mesh-list
64742767|NCT00005663|Antiviral Agents|antiviral agents|mesh-ancestor
64742768|NCT00005663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64742769|NCT00385853|Temozolomide|temozolomide|mesh-list
64742770|NCT00385853|Vatalanib|vatalanib|mesh-list
64322366|NCT04616534|Antimetabolites|antimetabolites|mesh-ancestor
64322367|NCT04616534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322368|NCT04616534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322369|NCT04616534|Antiviral Agents|antiviral agents|mesh-ancestor
64322370|NCT04616534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64322371|NCT04616534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322372|NCT04616534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64322373|NCT04616534|Immunologic Factors|immunologic factors|mesh-ancestor
64322374|NCT04616534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322375|NCT05042791|Capecitabine|capecitabine|mesh-list
64322376|NCT05042791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64322377|NCT05042791|Antimetabolites|antimetabolites|mesh-ancestor
64322378|NCT05042791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322379|NCT05042791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322380|NCT00705783|Aripiprazole|aripiprazole|mesh-list
64322381|NCT00705783|Antidepressive Agents|antidepressive agents|mesh-ancestor
64322382|NCT00705783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64322384|NCT00705783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64631462|NCT00003136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322385|NCT00705783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64322386|NCT00705783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322387|NCT00705783|Dopamine Agonists|dopamine agonists|mesh-ancestor
64322388|NCT00705783|Dopamine Agents|dopamine agents|mesh-ancestor
64322389|NCT00705783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64322390|NCT00705783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742771|NCT00385853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64742772|NCT00385853|Alkylating Agents|alkylating agents|mesh-ancestor
64742773|NCT00385853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742774|NCT00385853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742775|NCT00385853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64742776|NCT00385853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742777|NCT00005765|Nicotine|nicotine|mesh-list
64742778|NCT00005765|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64742779|NCT00005765|Autonomic Agents|autonomic agents|mesh-ancestor
64742780|NCT00005765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64742781|NCT00005765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742782|NCT00005765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64742783|NCT00005765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64742784|NCT00005765|Cholinergic Agents|cholinergic agents|mesh-ancestor
64742785|NCT00005765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64742786|NCT00005765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742787|NCT00005777|Dexamethasone|dexamethasone|mesh-list
64742788|NCT00005777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64742789|NCT00005777|Antiemetics|antiemetics|mesh-ancestor
64742790|NCT00005777|Autonomic Agents|autonomic agents|mesh-ancestor
64742791|NCT00005777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64742792|NCT00005777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742793|NCT00005777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64742794|NCT00005777|Glucocorticoids|glucocorticoids|mesh-ancestor
64742795|NCT00005777|Hormones|hormones|mesh-ancestor
64742796|NCT00005777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64742797|NCT00005777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64742799|NCT00385931|Valsartan|valsartan|mesh-list
64742816|NCT00386399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742817|NCT00386399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64742818|NCT00386399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742820|NCT00005807|Tubulin Modulators|tubulin modulators|mesh-ancestor
64742821|NCT00005807|Antimitotic Agents|antimitotic agents|mesh-ancestor
64742822|NCT00005807|Mitosis Modulators|mitosis modulators|mesh-ancestor
64742823|NCT00005807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742824|NCT00005807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742825|NCT00005813|Antibodies|antibodies|mesh-list
64742826|NCT00005813|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64742827|NCT00005813|Immunologic Factors|immunologic factors|mesh-ancestor
64742828|NCT00005813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64742829|NCT04567433|Hydrocortisone|hydrocortisone|mesh-list
64742830|NCT04567433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64742831|NCT00003647|Dacarbazine|dacarbazine|mesh-list
64742832|NCT00003647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64742833|NCT00003647|Alkylating Agents|alkylating agents|mesh-ancestor
64742834|NCT00003647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742835|NCT00003647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742872|NCT00003671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742873|NCT00003671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742874|NCT00003671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64742875|NCT00003671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64742876|NCT00003671|Antiemetics|antiemetics|mesh-ancestor
64742877|NCT00003671|Autonomic Agents|autonomic agents|mesh-ancestor
64742878|NCT00003671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64742879|NCT00003671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64742880|NCT00003671|Glucocorticoids|glucocorticoids|mesh-ancestor
64742881|NCT00003671|Hormones|hormones|mesh-ancestor
64742882|NCT00003671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64742883|NCT00003671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64742884|NCT00003671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64742885|NCT00003671|Abortifacient Agents|abortifacient agents|mesh-ancestor
64742886|NCT00003671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64742887|NCT00003671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64742888|NCT00003671|Antimetabolites|antimetabolites|mesh-ancestor
64742889|NCT00003671|Dermatologic Agents|dermatologic agents|mesh-ancestor
64742925|NCT00003683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742926|NCT00003683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64742927|NCT00003683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64742928|NCT00003683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64742929|NCT00003683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742930|NCT00003683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64742931|NCT00003683|Alkylating Agents|alkylating agents|mesh-ancestor
64742932|NCT00003701|Paclitaxel|paclitaxel|mesh-list
64742933|NCT00003701|Vinblastine|vinblastine|mesh-list
64742934|NCT00003701|Carboplatin|carboplatin|mesh-list
64742935|NCT00003701|Doxorubicin|doxorubicin|mesh-list
64742964|NCT00003707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64742966|NCT00003707|Antiviral Agents|antiviral agents|mesh-ancestor
64742967|NCT00003707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64742972|NCT00003719|Irinotecan|irinotecan|mesh-list
64742988|NCT00003731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742989|NCT00003743|Aldesleukin|aldesleukin|mesh-list
64742990|NCT00003743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64742991|NCT00003743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64452787|NCT04177082|Riboflavin|riboflavin|mesh-list
64742992|NCT00003743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64742993|NCT00003743|Antiviral Agents|antiviral agents|mesh-ancestor
64742994|NCT00003743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64742995|NCT00384917|Ketoconazole|ketoconazole|mesh-list
64742996|NCT00384917|Antifungal Agents|antifungal agents|mesh-ancestor
64742997|NCT00384917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64742998|NCT00384917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64742999|NCT00384917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64743000|NCT00384917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743001|NCT00384917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743002|NCT00384917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64743003|NCT00384917|Hormone Antagonists|hormone antagonists|mesh-ancestor
64743004|NCT00384917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64743005|NCT00384917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743006|NCT00384917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64743007|NCT05444153|Empagliflozin|empagliflozin|mesh-list
64743008|NCT05444153|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64743009|NCT05444153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743010|NCT05444153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64743011|NCT05444153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743012|NCT00003797|Gemcitabine|gemcitabine|mesh-list
64743013|NCT00003797|Trastuzumab|trastuzumab|mesh-list
64743014|NCT00003797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64743015|NCT00003797|Antimetabolites|antimetabolites|mesh-ancestor
64743016|NCT00003797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743017|NCT00003797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743018|NCT00003797|Antiviral Agents|antiviral agents|mesh-ancestor
64743028|NCT00003803|Antimetabolites|antimetabolites|mesh-ancestor
64743029|NCT00003803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743030|NCT00003803|Antiviral Agents|antiviral agents|mesh-ancestor
64743031|NCT00003803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64743032|NCT00003803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743033|NCT00003803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64743034|NCT00003803|Immunologic Factors|immunologic factors|mesh-ancestor
64743035|NCT00003803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743036|NCT00003809|Cetuximab|cetuximab|mesh-list
64743037|NCT00003809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743038|NCT00003809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64743039|NCT00003815|Cytarabine|cytarabine|mesh-list
64743040|NCT00003815|Prednisolone|prednisolone|mesh-list
64743041|NCT00003815|Cyclophosphamide|cyclophosphamide|mesh-list
64743042|NCT00003815|Melphalan|melphalan|mesh-list
64743043|NCT00003815|Carmustine|carmustine|mesh-list
64743044|NCT00003815|Doxorubicin|doxorubicin|mesh-list
64743045|NCT00003815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64743046|NCT00003815|Etoposide|etoposide|mesh-list
64743047|NCT00003815|Vincristine|vincristine|mesh-list
64743048|NCT00003815|Bleomycin|bleomycin|mesh-list
64743049|NCT00003815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64743050|NCT00003815|Immunologic Factors|immunologic factors|mesh-ancestor
64743051|NCT00003815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743052|NCT00003815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64743082|NCT00003827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64743083|NCT00003827|Antimetabolites|antimetabolites|mesh-ancestor
64743084|NCT00003827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743085|NCT00003827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743086|NCT00003827|Antiviral Agents|antiviral agents|mesh-ancestor
64743087|NCT00003827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64743088|NCT00003827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64743089|NCT00003827|Immunologic Factors|immunologic factors|mesh-ancestor
64743090|NCT00003827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743091|NCT00003827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64743092|NCT00003827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64743093|NCT00003827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743094|NCT00003827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64743095|NCT00003827|Protective Agents|protective agents|mesh-ancestor
64743096|NCT00003851|Gemcitabine|gemcitabine|mesh-list
64743097|NCT00003851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64743098|NCT00003851|Antimetabolites|antimetabolites|mesh-ancestor
64743099|NCT00003851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743100|NCT00003851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743107|NCT00003881|Paclitaxel|paclitaxel|mesh-list
64743137|NCT00003893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64743138|NCT00003893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743139|NCT00003893|Antimetabolites|antimetabolites|mesh-ancestor
64743140|NCT00003893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64743141|NCT00003893|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64743142|NCT00003893|Abortifacient Agents|abortifacient agents|mesh-ancestor
64743143|NCT00003893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64743144|NCT00003893|Dermatologic Agents|dermatologic agents|mesh-ancestor
64743145|NCT00003893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64743146|NCT00003893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64743147|NCT00003893|Analgesics|analgesics|mesh-ancestor
64743148|NCT00003893|Sensory System Agents|sensory system agents|mesh-ancestor
64743149|NCT00003893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64743150|NCT00003899|Paclitaxel|paclitaxel|mesh-list
64743151|NCT00003899|Cyclophosphamide|cyclophosphamide|mesh-list
64743152|NCT00003899|Melphalan|melphalan|mesh-list
64743153|NCT00003899|Thiotepa|thiotepa|mesh-list
64743154|NCT00003899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64743155|NCT00003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743156|NCT00003899|Tubulin Modulators|tubulin modulators|mesh-ancestor
64743157|NCT00003899|Antimitotic Agents|antimitotic agents|mesh-ancestor
64743158|NCT00003899|Mitosis Modulators|mitosis modulators|mesh-ancestor
64743159|NCT00003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743160|NCT00003899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64743161|NCT00003899|Immunologic Factors|immunologic factors|mesh-ancestor
64743162|NCT00003899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743163|NCT00003899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64743164|NCT00003899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64743165|NCT00003899|Alkylating Agents|alkylating agents|mesh-ancestor
64743166|NCT00003899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64743167|NCT00003917|Topotecan|topotecan|mesh-list
64743168|NCT00003917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64743169|NCT00003917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64743179|NCT00003929|Procarbazine|procarbazine|mesh-list
64743180|NCT00003929|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64743181|NCT00003929|Alkylating Agents|alkylating agents|mesh-ancestor
64743182|NCT00003929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743183|NCT00003929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743184|NCT02210663|Veliparib|veliparib|mesh-list
64743185|NCT02210663|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64743186|NCT02210663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743187|NCT02210663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743188|NCT02210663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743189|NCT04568837|Dexamethasone|dexamethasone|mesh-list
64743190|NCT04568837|Dexamethasone acetate|dexamethasone acetate|mesh-list
64743191|NCT04568837|Prednisone|prednisone|mesh-list
64743192|NCT04568837|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64743193|NCT04568837|BB 1101|bb 1101|mesh-list
64743194|NCT04568837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64743195|NCT04568837|Antiemetics|antiemetics|mesh-ancestor
64743196|NCT04568837|Autonomic Agents|autonomic agents|mesh-ancestor
64743197|NCT04568837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64743198|NCT04568837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743199|NCT04568837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64743200|NCT04568837|Glucocorticoids|glucocorticoids|mesh-ancestor
64743201|NCT04568837|Hormones|hormones|mesh-ancestor
64743202|NCT04568837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64743203|NCT04568837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64743204|NCT04568837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743205|NCT04568837|Protease Inhibitors|protease inhibitors|mesh-ancestor
64743206|NCT04568837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743207|NCT04568837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743208|NCT02210819|Rivaroxaban|rivaroxaban|mesh-list
64743209|NCT02210819|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64743210|NCT02210819|Antithrombins|antithrombins|mesh-ancestor
64743216|NCT04564469|Furosemide|furosemide|mesh-list
64355254|NCT03416231|Apatinib|apatinib|mesh-list
64430940|NCT02063217|Anesthetics|anesthetics|mesh-ancestor
64355256|NCT03416231|Tubulin Modulators|tubulin modulators|mesh-ancestor
64355257|NCT03416231|Antimitotic Agents|antimitotic agents|mesh-ancestor
64355258|NCT03416231|Mitosis Modulators|mitosis modulators|mesh-ancestor
64355259|NCT03416231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355260|NCT03416231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64355261|NCT03416231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355286|NCT03415763|Leucovorin|leucovorin|mesh-list
64355287|NCT03415763|Capecitabine|capecitabine|mesh-list
64355288|NCT03415763|Oxaliplatin|oxaliplatin|mesh-list
64631569|NCT00002800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743220|NCT04564469|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64743221|NCT04564469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64743222|NCT04564469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743223|NCT04564001|Infliximab|infliximab|mesh-list
64743224|NCT04564001|Dermatologic Agents|dermatologic agents|mesh-ancestor
64743225|NCT04564001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64743226|NCT04564001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64743227|NCT04568603|Islatravir|islatravir|mesh-list
64743228|NCT04568603|Methadone|methadone|mesh-list
64743229|NCT04568603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64743230|NCT04568603|Narcotics|narcotics|mesh-ancestor
64743231|NCT04568603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64743232|NCT04568603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743233|NCT04568603|Analgesics|analgesics|mesh-ancestor
64743234|NCT04568603|Sensory System Agents|sensory system agents|mesh-ancestor
64743235|NCT04568603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64743245|NCT04563299|Prednisolone|prednisolone|mesh-list
64743255|NCT04563299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64743256|NCT04563299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743257|NCT04563299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64743258|NCT04563299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743259|NCT04563299|Antiemetics|antiemetics|mesh-ancestor
64743260|NCT04563299|Autonomic Agents|autonomic agents|mesh-ancestor
64743261|NCT04563299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64743262|NCT04563299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64743263|NCT04563299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64743320|NCT01948830|Ranibizumab|ranibizumab|mesh-list
64743321|NCT01948830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64743322|NCT01948830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64743323|NCT01948830|Growth Substances|growth substances|mesh-ancestor
64743324|NCT01948830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743325|NCT01948830|Growth Inhibitors|growth inhibitors|mesh-ancestor
64743326|NCT01948830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743327|NCT01972464|Progesterone|progesterone|mesh-list
64743328|NCT01972464|Progestins|progestins|mesh-ancestor
64743329|NCT01972464|Hormones|hormones|mesh-ancestor
64743330|NCT01972464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64743331|NCT01972464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743332|NCT01924182|Morphine|morphine|mesh-list
64743333|NCT01924182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64743334|NCT01924182|Narcotics|narcotics|mesh-ancestor
64743337|NCT01924182|Analgesics|analgesics|mesh-ancestor
64743381|NCT01972074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64743382|NCT01972074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743383|NCT01972074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743384|NCT01972074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64743385|NCT01972074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64743387|NCT01618266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64743388|NCT01618266|Antiemetics|antiemetics|mesh-ancestor
64743389|NCT01618266|Autonomic Agents|autonomic agents|mesh-ancestor
64743390|NCT01618266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64743391|NCT01618266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743392|NCT01618266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64743393|NCT01618266|Glucocorticoids|glucocorticoids|mesh-ancestor
64743394|NCT01618266|Hormones|hormones|mesh-ancestor
64743395|NCT01618266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64743396|NCT01618266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64743397|NCT01618266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743398|NCT01918332|Valsartan|valsartan|mesh-list
64743399|NCT01918332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64743400|NCT01918332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64743401|NCT01918332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64743402|NCT01918332|Antimetabolites|antimetabolites|mesh-ancestor
64743406|NCT01918332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743433|NCT01917006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64631632|NCT00002812|Hormones|hormones|mesh-ancestor
64631633|NCT00002812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64631634|NCT00002812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64631635|NCT00002812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64743434|NCT01917006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743435|NCT01917006|Cholinergic Agents|cholinergic agents|mesh-ancestor
64743436|NCT01917006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64743437|NCT01917006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743438|NCT01917006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64743439|NCT01917006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64743440|NCT01916226|Cetirizine|cetirizine|mesh-list
64743441|NCT01916226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64743442|NCT01916226|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64743443|NCT01916226|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64743444|NCT01916226|Histamine Antagonists|histamine antagonists|mesh-ancestor
64743445|NCT01916226|Histamine Agents|histamine agents|mesh-ancestor
64743446|NCT01916226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64743447|NCT01916226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743448|NCT01916226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743449|NCT01915914|Fluticasone|fluticasone|mesh-list
64743451|NCT01915914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64743452|NCT01915914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64743453|NCT01915914|Autonomic Agents|autonomic agents|mesh-ancestor
64743454|NCT01915914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64743455|NCT01915914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743456|NCT01915914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64743457|NCT01915914|Respiratory System Agents|respiratory system agents|mesh-ancestor
64743458|NCT01915914|Dermatologic Agents|dermatologic agents|mesh-ancestor
64743459|NCT01915914|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64743460|NCT01968954|Bococizumab|bococizumab|mesh-list
64631648|NCT00002812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64631649|NCT00002812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64631650|NCT00002812|Tubulin Modulators|tubulin modulators|mesh-ancestor
64631652|NCT00002812|Mitosis Modulators|mitosis modulators|mesh-ancestor
64631653|NCT01258855|Aldesleukin|aldesleukin|mesh-list
64631654|NCT01258855|Aflibercept|aflibercept|mesh-list
64631655|NCT01258855|Interleukin-2|interleukin-2|mesh-list
64631656|NCT01258855|Endothelial Growth Factors|endothelial growth factors|mesh-list
64743461|NCT01968954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64743462|NCT01968954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64743463|NCT01968954|Antimetabolites|antimetabolites|mesh-ancestor
64743464|NCT01968954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743465|NCT01968954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64743466|NCT01919190|Bupivacaine|bupivacaine|mesh-list
64355470|NCT03417427|Cytarabine|cytarabine|mesh-list
64743467|NCT01919190|Anesthetics, Local|anesthetics, local|mesh-ancestor
64743468|NCT01919190|Anesthetics|anesthetics|mesh-ancestor
64743469|NCT01919190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64743470|NCT01919190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743471|NCT01919190|Sensory System Agents|sensory system agents|mesh-ancestor
64743472|NCT01919190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64743473|NCT01620060|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64743474|NCT01620060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64743475|NCT01620060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64743476|NCT01620060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64743477|NCT01620060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743478|NCT01620060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64743479|NCT01620060|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64743480|NCT01620060|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64743481|NCT01620060|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64743482|NCT01620060|Adrenergic Agents|adrenergic agents|mesh-ancestor
64743483|NCT01620060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64743484|NCT01620060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743520|NCT01912872|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64743521|NCT01912872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64743522|NCT01912872|Adrenergic Agents|adrenergic agents|mesh-ancestor
64743523|NCT01912872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64743524|NCT01912872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631693|NCT00003172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631694|NCT00003172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64631695|NCT00003172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64631696|NCT00003172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64631697|NCT00003172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631698|NCT00003172|Antimetabolites|antimetabolites|mesh-ancestor
64631699|NCT00003172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64631700|NCT00003172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64631701|NCT00003172|Immunologic Factors|immunologic factors|mesh-ancestor
64631703|NCT00003172|Antiviral Agents|antiviral agents|mesh-ancestor
64743525|NCT01912872|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64743526|NCT01911780|Amlodipine|amlodipine|mesh-list
64743527|NCT01911780|Telmisartan|telmisartan|mesh-list
64743528|NCT01911780|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64743529|NCT01911780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64743530|NCT01911780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64743531|NCT01911780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64743532|NCT01911780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743533|NCT01911780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64743534|NCT01911780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743535|NCT01911780|Vasodilator Agents|vasodilator agents|mesh-ancestor
64743536|NCT01911780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64743546|NCT01911546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64743547|NCT01911546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743548|NCT01911546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743549|NCT01911546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743550|NCT01908816|Ranibizumab|ranibizumab|mesh-list
64743551|NCT01908816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64743552|NCT01908816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64743553|NCT01908816|Growth Substances|growth substances|mesh-ancestor
64743554|NCT01908816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743555|NCT01908816|Growth Inhibitors|growth inhibitors|mesh-ancestor
64743556|NCT01908816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743557|NCT01908582|Rifampin|rifampin|mesh-list
64743558|NCT01908582|Evacetrapib|evacetrapib|mesh-list
64743559|NCT01908582|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64743560|NCT01908582|Antitubercular Agents|antitubercular agents|mesh-ancestor
64743561|NCT01908582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64743562|NCT01908582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64631726|NCT00002818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64513674|NCT05021913|Lidocaine|lidocaine|mesh-list
64631727|NCT00002818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64631728|NCT00002818|Immunologic Factors|immunologic factors|mesh-ancestor
64631729|NCT00002818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631730|NCT00003640|Doxorubicin|doxorubicin|mesh-list
64631731|NCT00003640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64631732|NCT00003640|Methotrexate|methotrexate|mesh-list
64631733|NCT00003640|Vinblastine|vinblastine|mesh-list
64631734|NCT00003640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743600|NCT01887288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631735|NCT00003640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64743601|NCT03405714|Brivaracetam|brivaracetam|mesh-list
64743602|NCT03405714|Anticonvulsants|anticonvulsants|mesh-ancestor
64743603|NCT01885182|Oxycodone|oxycodone|mesh-list
64743604|NCT01885182|Naloxone|naloxone|mesh-list
64743605|NCT01885182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64743606|NCT01885182|Narcotics|narcotics|mesh-ancestor
64743607|NCT01885182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64743608|NCT01885182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743609|NCT01885182|Analgesics|analgesics|mesh-ancestor
64743610|NCT01885182|Sensory System Agents|sensory system agents|mesh-ancestor
64743611|NCT01885182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64743612|NCT01885182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64743613|NCT01885104|Bisacodyl|bisacodyl|mesh-list
64743614|NCT01885104|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64743615|NCT01885104|Laxatives|laxatives|mesh-list
64743616|NCT01885104|Cathartics|cathartics|mesh-ancestor
64743617|NCT01885104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64743618|NCT01906008|Minocycline|minocycline|mesh-list
64743619|NCT01906008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64743621|NCT01904760|Dexmedetomidine|dexmedetomidine|mesh-list
64743657|NCT01880424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743658|NCT01880424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64743660|NCT01862874|Immunologic Factors|immunologic factors|mesh-ancestor
64743661|NCT01862874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743662|NCT01903434|Evacetrapib|evacetrapib|mesh-list
64743663|NCT01903434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64743664|NCT01903434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64743665|NCT01903434|Antimetabolites|antimetabolites|mesh-ancestor
64743666|NCT01903434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743667|NCT01903434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64743668|NCT01903356|Linagliptin|linagliptin|mesh-list
64743669|NCT01903356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64743670|NCT01903356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743671|NCT01903356|Incretins|incretins|mesh-ancestor
64743672|NCT01903356|Hormones|hormones|mesh-ancestor
64743673|NCT01903356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64743674|NCT01903356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64743675|NCT01903356|Protease Inhibitors|protease inhibitors|mesh-ancestor
64743676|NCT01903356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743677|NCT01903356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743678|NCT01862640|Brexpiprazole|brexpiprazole|mesh-list
64743679|NCT01862640|Serotonin Agents|serotonin agents|mesh-ancestor
64743680|NCT01862640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64743681|NCT01862640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743682|NCT01862640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743683|NCT01862640|Dopamine Agonists|dopamine agonists|mesh-ancestor
64743684|NCT01862640|Dopamine Agents|dopamine agents|mesh-ancestor
64743685|NCT01902966|Propranolol|propranolol|mesh-list
64743686|NCT01902966|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64743687|NCT01902966|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64743688|NCT01902966|Adrenergic Agents|adrenergic agents|mesh-ancestor
64743689|NCT01902966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64743690|NCT01902966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743691|NCT01902966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743692|NCT01902966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64743693|NCT01902966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64743694|NCT01902966|Vasodilator Agents|vasodilator agents|mesh-ancestor
64743696|NCT01862328|Paclitaxel|paclitaxel|mesh-list
64743697|NCT01862328|Docetaxel|docetaxel|mesh-list
64743698|NCT01862328|Carboplatin|carboplatin|mesh-list
64743699|NCT01862328|Pevonedistat|pevonedistat|mesh-list
64743700|NCT01862328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64743701|NCT01862328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743702|NCT01862328|Tubulin Modulators|tubulin modulators|mesh-ancestor
64743703|NCT01862328|Antimitotic Agents|antimitotic agents|mesh-ancestor
64743704|NCT01862328|Mitosis Modulators|mitosis modulators|mesh-ancestor
64743705|NCT01862328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743706|NCT01862328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64743707|NCT01862328|Antimetabolites|antimetabolites|mesh-ancestor
64743708|NCT01862328|Antiviral Agents|antiviral agents|mesh-ancestor
64743709|NCT01862328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64743710|NCT01862328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631798|NCT01260883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64631799|NCT01260883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64631800|NCT01260883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64301659|NCT02127541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631801|NCT01260883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631803|NCT00076622|Antidepressive Agents|antidepressive agents|mesh-list
64743711|NCT01862328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64743712|NCT01862328|Immunologic Factors|immunologic factors|mesh-ancestor
64743713|NCT01862328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743714|NCT01862250|Clonidine|clonidine|mesh-list
64743715|NCT01862250|Analgesics|analgesics|mesh-ancestor
64743716|NCT01862250|Sensory System Agents|sensory system agents|mesh-ancestor
64743717|NCT01862250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64743728|NCT01876446|Irinotecan|irinotecan|mesh-list
64743733|NCT01876446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743734|NCT04414800|Fentanyl|fentanyl|mesh-list
64743735|NCT04414800|Ketamine|ketamine|mesh-list
64743736|NCT04414800|Analgesics|analgesics|mesh-ancestor
64743737|NCT04414800|Sensory System Agents|sensory system agents|mesh-ancestor
64743738|NCT04414800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64743739|NCT04414800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743740|NCT04414800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64430990|NCT02096835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743751|NCT04414800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64743752|NCT01898442|Ticagrelor|ticagrelor|mesh-list
64743753|NCT01898442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64743754|NCT01898442|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64743755|NCT01898442|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64743756|NCT01898442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64743757|NCT01898442|Purinergic Agents|purinergic agents|mesh-ancestor
64743758|NCT01898442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64743759|NCT01898442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743760|NCT01898442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743761|NCT01898208|Anti-Infective Agents|anti-infective agents|mesh-list
64743762|NCT01898208|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64743763|NCT01898130|Bevacizumab|bevacizumab|mesh-list
64743764|NCT01898130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64743765|NCT01898130|Antibodies|antibodies|mesh-list
64743766|NCT01898130|Immunoglobulins|immunoglobulins|mesh-list
64743767|NCT01898130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64743768|NCT01898130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743769|NCT01898130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64743770|NCT01898130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64743771|NCT01898130|Growth Substances|growth substances|mesh-ancestor
64743772|NCT01898130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743773|NCT01898130|Growth Inhibitors|growth inhibitors|mesh-ancestor
64743774|NCT01898130|Immunologic Factors|immunologic factors|mesh-ancestor
64743775|NCT01876368|Olmesartan|olmesartan|mesh-list
64743776|NCT01876368|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64743777|NCT01876368|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64743778|NCT01876368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64743779|NCT01876368|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64743780|NCT01876368|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64743781|NCT01876368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743782|NCT01873950|Quinidine|quinidine|mesh-list
64743783|NCT01873950|Quinidine gluconate|quinidine gluconate|mesh-list
64743784|NCT01873950|Verapamil|verapamil|mesh-list
64743785|NCT01873950|Dofetilide|dofetilide|mesh-list
64743786|NCT01873950|Ranolazine|ranolazine|mesh-list
64743787|NCT01873950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64743788|NCT01873950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64743789|NCT01873950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64743790|NCT01873950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743791|NCT01873950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64743792|NCT01873950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743794|NCT01873950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64743811|NCT01896726|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64743812|NCT01896726|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
64743814|NCT01896726|Contraceptive Agents|contraceptive agents|mesh-ancestor
64355832|NCT05228925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64322399|NCT03719768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64322400|NCT03719768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322401|NCT02145611|Vildagliptin|vildagliptin|mesh-list
64322402|NCT02145611|Glyburide|glyburide|mesh-list
64322403|NCT02145611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64322404|NCT02145611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743815|NCT01896726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64743816|NCT01896726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631870|NCT00002836|Etoposide|etoposide|mesh-list
64631871|NCT00002836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64631872|NCT00002836|Immunologic Factors|immunologic factors|mesh-ancestor
64631873|NCT00002836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631874|NCT00002836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64631884|NCT00003664|Gemcitabine|gemcitabine|mesh-list
64743817|NCT01896726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64743818|NCT01896726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64743819|NCT01896726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64743820|NCT01896726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64743821|NCT01896726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64743822|NCT01896726|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
64743823|NCT01896726|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64743824|NCT01896726|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64743825|NCT01856790|Liraglutide|liraglutide|mesh-list
64743826|NCT01856790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64743827|NCT01856790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743828|NCT01856790|Incretins|incretins|mesh-ancestor
64743829|NCT01856790|Hormones|hormones|mesh-ancestor
64743830|NCT01856790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64743850|NCT01855074|Serotonin Agents|serotonin agents|mesh-ancestor
64743851|NCT01855074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64743852|NCT01855074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743853|NCT01855074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743854|NCT01855074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64743855|NCT01855074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64743856|NCT01855074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64743857|NCT01855074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64743858|NCT01855074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64743859|NCT01855074|Dopamine Agents|dopamine agents|mesh-ancestor
64743860|NCT01895322|Tolvaptan|tolvaptan|mesh-list
64483155|NCT00763048|Antimetabolites|antimetabolites|mesh-ancestor
64743861|NCT01895322|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64743862|NCT01895322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743863|NCT01895322|Natriuretic Agents|natriuretic agents|mesh-ancestor
64743864|NCT01895322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743866|NCT01894776|Rifabutin|rifabutin|mesh-list
64743867|NCT01894776|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64743868|NCT01894776|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64743869|NCT01894776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743870|NCT01894776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64743871|NCT01894776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64743872|NCT01894776|Antiviral Agents|antiviral agents|mesh-ancestor
64743873|NCT01894776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64743874|NCT01894776|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64743875|NCT01894776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64743890|NCT01854528|Ribavirin|ribavirin|mesh-list
64743891|NCT01854528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743892|NCT01854528|Antiviral Agents|antiviral agents|mesh-ancestor
64743893|NCT01854528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64743894|NCT01854528|Antimetabolites|antimetabolites|mesh-ancestor
64743895|NCT01854528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743896|NCT01853982|Tazobactam|tazobactam|mesh-list
64743897|NCT01853982|Piperacillin|piperacillin|mesh-list
64631913|NCT00003196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64631914|NCT00003196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64631915|NCT00003196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631916|NCT00003196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64631917|NCT00003196|Antitubercular Agents|antitubercular agents|mesh-ancestor
64631918|NCT00003196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64631920|NCT00003202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631921|NCT00003202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64355912|NCT03408847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64322405|NCT02145611|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64322406|NCT02145611|Protease Inhibitors|protease inhibitors|mesh-ancestor
64743898|NCT01853982|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64743899|NCT01853982|Ceftolozane|ceftolozane|mesh-list
64743900|NCT01853982|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
64743901|NCT01853982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64743902|NCT01853982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64743903|NCT01853982|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64743904|NCT01853982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743905|NCT01853982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743906|NCT01853982|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64743907|NCT01853982|Renal Agents|renal agents|mesh-ancestor
64743908|NCT01853280|Methylphenidate|methylphenidate|mesh-list
64743909|NCT01853280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64743910|NCT01853280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743911|NCT01853280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64743912|NCT01853280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64743913|NCT01853280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64743914|NCT01853280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743915|NCT01853280|Dopamine Agents|dopamine agents|mesh-ancestor
64743916|NCT01853280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64743917|NCT01891890|Lamotrigine|lamotrigine|mesh-list
64743918|NCT01891890|Oxcarbazepine|oxcarbazepine|mesh-list
64743919|NCT01891890|Levetiracetam|levetiracetam|mesh-list
64431044|NCT01645111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64743920|NCT01891890|Anticonvulsants|anticonvulsants|mesh-ancestor
64743921|NCT01891890|Nootropic Agents|nootropic agents|mesh-ancestor
64743922|NCT01891890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64743923|NCT01891890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64743924|NCT01891890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743925|NCT01891890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64743926|NCT01891890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743927|NCT01891890|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64355943|NCT03424135|Naproxen|naproxen|mesh-list
64322407|NCT02145611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322408|NCT02145611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322409|NCT02222623|Isophane Insulin, Human|isophane insulin, human|mesh-list
64322410|NCT02222623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64322411|NCT02222623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322412|NCT03543683|Aspirin|aspirin|mesh-list
64322413|NCT03543683|Osimertinib|osimertinib|mesh-list
64322414|NCT03543683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64322415|NCT03543683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64743928|NCT01891890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64743929|NCT01891890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64743930|NCT01891890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64743931|NCT01891890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64743932|NCT01891890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64743933|NCT01891890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64743934|NCT01891890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64743936|NCT01852812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64743937|NCT01852812|Respiratory System Agents|respiratory system agents|mesh-ancestor
64743938|NCT01852812|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64743939|NCT01852812|Hormone Antagonists|hormone antagonists|mesh-ancestor
64743940|NCT01852812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64743941|NCT01852812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743942|NCT01852812|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64743943|NCT01852812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64743944|NCT01852812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743945|NCT01869192|Cyclophosphamide|cyclophosphamide|mesh-list
64743946|NCT01869192|Docetaxel|docetaxel|mesh-list
64743947|NCT01869192|Capecitabine|capecitabine|mesh-list
64743948|NCT01869192|Epirubicin|epirubicin|mesh-list
64743949|NCT01869192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64743950|NCT01869192|Immunologic Factors|immunologic factors|mesh-ancestor
64743951|NCT01869192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743952|NCT01869192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64743953|NCT01869192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64743954|NCT01869192|Alkylating Agents|alkylating agents|mesh-ancestor
64743955|NCT01869192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743956|NCT01869192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743971|NCT01851720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64743972|NCT01851720|Analgesics|analgesics|mesh-ancestor
64743973|NCT01851720|Sensory System Agents|sensory system agents|mesh-ancestor
64743974|NCT01851720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64743975|NCT01851720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64743976|NCT01851720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64743977|NCT01851720|Anesthetics, General|anesthetics, general|mesh-ancestor
64743978|NCT01851720|Anesthetics|anesthetics|mesh-ancestor
64743979|NCT01851330|Sofosbuvir|sofosbuvir|mesh-list
64743980|NCT01851330|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64743981|NCT01851330|Ledipasvir|ledipasvir|mesh-list
64743982|NCT01851330|Antiviral Agents|antiviral agents|mesh-ancestor
64743983|NCT01851330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64743984|NCT01868022|Paclitaxel|paclitaxel|mesh-list
64743985|NCT01868022|Docetaxel|docetaxel|mesh-list
64743986|NCT01868022|Carboplatin|carboplatin|mesh-list
64743987|NCT01868022|Pemetrexed|pemetrexed|mesh-list
64743988|NCT01868022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64743989|NCT01868022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743990|NCT01868022|Tubulin Modulators|tubulin modulators|mesh-ancestor
64743991|NCT01868022|Antimitotic Agents|antimitotic agents|mesh-ancestor
64743992|NCT01868022|Mitosis Modulators|mitosis modulators|mesh-ancestor
64743993|NCT01868022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64743994|NCT01868022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64743995|NCT01868022|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64743996|NCT01868022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64743997|NCT01850004|Dasatinib|dasatinib|mesh-list
64743998|NCT01850004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64743999|NCT01850004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64744003|NCT01867710|Prednisone|prednisone|mesh-list
64744039|NCT01832532|Hormones|hormones|mesh-ancestor
64744040|NCT01832532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64744041|NCT04414956|Vitamin K|vitamin k|mesh-list
64744042|NCT04414956|Agglutinins|agglutinins|mesh-list
64744043|NCT04414956|Vitamins|vitamins|mesh-ancestor
64744044|NCT04414956|Micronutrients|micronutrients|mesh-ancestor
64744045|NCT04414956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744046|NCT04414956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64744047|NCT04414956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64744048|NCT04414956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744049|NCT04414956|Hemostatics|hemostatics|mesh-ancestor
64744050|NCT04414956|Coagulants|coagulants|mesh-ancestor
64744051|NCT04414956|Immunologic Factors|immunologic factors|mesh-ancestor
64744052|NCT01848990|Insulin|insulin|mesh-list
64744077|NCT01846416|Atezolizumab|atezolizumab|mesh-list
64631931|NCT00002854|Etoposide|etoposide|mesh-list
64631932|NCT00002854|Cyclophosphamide|cyclophosphamide|mesh-list
64631933|NCT00002854|Carboplatin|carboplatin|mesh-list
64631934|NCT00002854|Ifosfamide|ifosfamide|mesh-list
64631935|NCT00002854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64357197|NCT03268811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64744078|NCT01846416|Antibodies|antibodies|mesh-list
64631936|NCT00002854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631937|NCT00002854|Tubulin Modulators|tubulin modulators|mesh-ancestor
64744079|NCT01846416|Immunologic Factors|immunologic factors|mesh-ancestor
64744080|NCT01846416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744081|NCT01846416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744082|NCT04589754|Ifosfamide|ifosfamide|mesh-list
64744083|NCT04589754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744084|NCT04589754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744085|NCT04589754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64744086|NCT04589754|Alkylating Agents|alkylating agents|mesh-ancestor
64744087|NCT01846104|Vaccines|vaccines|mesh-list
64744088|NCT01846104|Immunologic Factors|immunologic factors|mesh-ancestor
64744089|NCT01846104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744090|NCT01803282|Leucovorin|leucovorin|mesh-list
64744091|NCT01803282|Gemcitabine|gemcitabine|mesh-list
64744092|NCT01803282|Paclitaxel|paclitaxel|mesh-list
64744093|NCT01803282|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64744094|NCT01803282|Bevacizumab|bevacizumab|mesh-list
64744095|NCT01803282|Carboplatin|carboplatin|mesh-list
64744096|NCT01803282|Oxaliplatin|oxaliplatin|mesh-list
64744097|NCT01803282|Irinotecan|irinotecan|mesh-list
64744098|NCT01803282|Pemetrexed|pemetrexed|mesh-list
64744099|NCT01803282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64744100|NCT01803282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744101|NCT01803282|Tubulin Modulators|tubulin modulators|mesh-ancestor
64631938|NCT00002854|Antimitotic Agents|antimitotic agents|mesh-ancestor
64631939|NCT00002854|Mitosis Modulators|mitosis modulators|mesh-ancestor
64631940|NCT00002854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631941|NCT00002854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64631942|NCT00002854|Immunologic Factors|immunologic factors|mesh-ancestor
64631943|NCT00002854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744131|NCT01802580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64744133|NCT01802580|Hormones|hormones|mesh-ancestor
64744134|NCT01802580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64744135|NCT01802580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744136|NCT01802580|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64744137|NCT01611090|Rituximab|rituximab|mesh-list
64744138|NCT01611090|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64631944|NCT00002854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64744139|NCT01611090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64744140|NCT01611090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744141|NCT01611090|Immunologic Factors|immunologic factors|mesh-ancestor
64744142|NCT01611090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744143|NCT01611090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64744144|NCT01611090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64744145|NCT01611090|Alkylating Agents|alkylating agents|mesh-ancestor
64744146|NCT01611090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744147|NCT01844700|Risperidone|risperidone|mesh-list
64744148|NCT01844700|Aripiprazole|aripiprazole|mesh-list
64744149|NCT01844700|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64744172|NCT01827384|Veliparib|veliparib|mesh-list
64744173|NCT01827384|Adavosertib|adavosertib|mesh-list
64744174|NCT01827384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744175|NCT01827384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64744176|NCT01827384|Immunologic Factors|immunologic factors|mesh-ancestor
64744177|NCT01827384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744178|NCT01827384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64744179|NCT01827384|Alkylating Agents|alkylating agents|mesh-ancestor
64744180|NCT01827384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744181|NCT01827384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64744182|NCT01827384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744183|NCT01827384|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64744184|NCT01844076|Quinacrine|quinacrine|mesh-list
64356213|NCT03397199|Apatinib|apatinib|mesh-list
64744185|NCT01844076|Capecitabine|capecitabine|mesh-list
64744186|NCT01844076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64744187|NCT01844076|Antimetabolites|antimetabolites|mesh-ancestor
64744188|NCT01844076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631979|NCT00003214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64631980|NCT00003214|Alkylating Agents|alkylating agents|mesh-ancestor
64631981|NCT00003214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64631982|NCT00003214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64631983|NCT00003214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64631984|NCT00003214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64744189|NCT01844076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631985|NCT00003214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631986|NCT03233204|Olaparib|olaparib|mesh-list
64631988|NCT03233204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631989|NCT03233204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631990|NCT03233204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744190|NCT01844076|Anticestodal Agents|anticestodal agents|mesh-ancestor
64744191|NCT01844076|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64744192|NCT01844076|Anthelmintics|anthelmintics|mesh-ancestor
64631991|NCT00384592|Esomeprazole|esomeprazole|mesh-list
64631992|NCT00384592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64631993|NCT00384592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64631994|NCT00384592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64631995|NCT00384592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631996|NCT00384592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744193|NCT01844076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64744194|NCT01844076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64744195|NCT01844076|Antimalarials|antimalarials|mesh-ancestor
64431055|NCT01901224|Metformin|metformin|mesh-list
64744202|NCT01826448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744203|NCT01826448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744204|NCT01826370|Linagliptin|linagliptin|mesh-list
64744205|NCT01826370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64744206|NCT01826370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744207|NCT01826370|Incretins|incretins|mesh-ancestor
64744208|NCT01826370|Hormones|hormones|mesh-ancestor
64744209|NCT01826370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64322422|NCT03543683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64322423|NCT03543683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64322424|NCT03543683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322425|NCT03543683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64322426|NCT03543683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64322427|NCT03543683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744210|NCT01826370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64744211|NCT01826370|Protease Inhibitors|protease inhibitors|mesh-ancestor
64744212|NCT01826370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744213|NCT01826370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744214|NCT01799226|Triclosan|triclosan|mesh-list
64744215|NCT01799226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64744216|NCT01799226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64744217|NCT01799226|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64744218|NCT01799226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64744219|NCT01799226|Antimetabolites|antimetabolites|mesh-ancestor
64632006|NCT00002866|Antimitotic Agents|antimitotic agents|mesh-ancestor
64632007|NCT00002866|Mitosis Modulators|mitosis modulators|mesh-ancestor
64632008|NCT00002866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632009|NCT00002866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64632010|NCT00002866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64632011|NCT00002866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64632012|NCT00002866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632013|NCT00002872|Doxycycline|doxycycline|mesh-list
64632014|NCT00002872|Bleomycin|bleomycin|mesh-list
64632015|NCT00002872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64632016|NCT00002872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64744220|NCT01799226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744221|NCT01799226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64744222|NCT01798992|Metoprolol|metoprolol|mesh-list
64744223|NCT01798992|Carvedilol|carvedilol|mesh-list
64744224|NCT01798992|Doxazosin|doxazosin|mesh-list
64744225|NCT01798992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64744226|NCT01798992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64744267|NCT01840410|Ranibizumab|ranibizumab|mesh-list
64744268|NCT01840410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64744269|NCT01840410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64744270|NCT01840410|Growth Substances|growth substances|mesh-ancestor
64744271|NCT01840410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744272|NCT01840410|Growth Inhibitors|growth inhibitors|mesh-ancestor
64744273|NCT01840410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744274|NCT01797432|Triamcinolone|triamcinolone|mesh-list
64744275|NCT01797432|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64744276|NCT01797432|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64744277|NCT01797432|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64744278|NCT01797432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64744279|NCT01797432|Glucocorticoids|glucocorticoids|mesh-ancestor
64744280|NCT01797432|Hormones|hormones|mesh-ancestor
64744281|NCT01797432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64744282|NCT01797432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744283|NCT01797432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64744284|NCT01797432|Immunologic Factors|immunologic factors|mesh-ancestor
64744285|NCT01797432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744287|NCT01797120|Everolimus|everolimus|mesh-list
64744288|NCT01797120|Fulvestrant|fulvestrant|mesh-list
64744289|NCT01797120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744319|NCT01794780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64744320|NCT01794780|Glucocorticoids|glucocorticoids|mesh-ancestor
64744321|NCT01794780|Hormones|hormones|mesh-ancestor
64632043|NCT00002878|Vincristine|vincristine|mesh-list
64632044|NCT00002878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64744322|NCT01794780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64744323|NCT01794780|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64744324|NCT01794780|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64632045|NCT00002878|Antiemetics|antiemetics|mesh-ancestor
64632046|NCT00002878|Autonomic Agents|autonomic agents|mesh-ancestor
64632047|NCT00002878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64632048|NCT00002878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632049|NCT00002878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64632050|NCT00002878|Glucocorticoids|glucocorticoids|mesh-ancestor
64632052|NCT00002878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64744325|NCT01794780|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64632053|NCT00002878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64632054|NCT00002878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744326|NCT01794780|Adrenergic Agents|adrenergic agents|mesh-ancestor
64744327|NCT01794780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64744328|NCT01794780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744329|NCT01794780|Parasympatholytics|parasympatholytics|mesh-ancestor
64744330|NCT01794780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64744331|NCT01794780|Cholinergic Agents|cholinergic agents|mesh-ancestor
64744332|NCT01794780|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64744333|NCT01794780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744334|NCT01794780|Vasodilator Agents|vasodilator agents|mesh-ancestor
64744335|NCT01794780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64744336|NCT01794780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64744337|NCT01794780|Purinergic Agents|purinergic agents|mesh-ancestor
64744338|NCT01838616|Oxycodone|oxycodone|mesh-list
64744339|NCT01838616|Tapentadol|tapentadol|mesh-list
64744340|NCT01838616|Naloxone|naloxone|mesh-list
64744341|NCT01838616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64744342|NCT01838616|Narcotics|narcotics|mesh-ancestor
64744343|NCT01838616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64744344|NCT01838616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744345|NCT01838616|Analgesics|analgesics|mesh-ancestor
64356358|NCT03399019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64356360|NCT03399019|Anesthetics|anesthetics|mesh-ancestor
64322428|NCT03543683|Antipyretics|antipyretics|mesh-ancestor
64322429|NCT03543683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322430|NCT03543683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64322431|NCT02145689|Botulinum Toxins|botulinum toxins|mesh-list
64322432|NCT02145689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64322433|NCT02145689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64322434|NCT02145689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64322435|NCT02145689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64322436|NCT02145689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322437|NCT02145689|Cholinergic Agents|cholinergic agents|mesh-ancestor
64744346|NCT01838616|Sensory System Agents|sensory system agents|mesh-ancestor
64744347|NCT01838616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64744349|NCT01838616|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64744350|NCT01838616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64744351|NCT01838616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64744352|NCT01838616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744353|NCT01838616|Adrenergic Agents|adrenergic agents|mesh-ancestor
64744354|NCT01838616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64744355|NCT01794000|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64744356|NCT01794000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64744357|NCT01609218|Charcoal|charcoal|mesh-list
64744358|NCT01609218|Antidotes|antidotes|mesh-ancestor
64744359|NCT01609218|Protective Agents|protective agents|mesh-ancestor
64744360|NCT01609218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744361|NCT04580472|Clindamycin|clindamycin|mesh-list
64744362|NCT04580472|Clindamycin palmitate|clindamycin palmitate|mesh-list
64744363|NCT04580472|Clindamycin phosphate|clindamycin phosphate|mesh-list
64744364|NCT04580472|Cephalexin|cephalexin|mesh-list
64744365|NCT04580472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64744366|NCT04580472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64431057|NCT01901224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744378|NCT01818726|Sequestering Agents|sequestering agents|mesh-ancestor
64744379|NCT01818726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744380|NCT01818336|Amoxicillin|amoxicillin|mesh-list
64744381|NCT01818336|Penicillins|penicillins|mesh-list
64744382|NCT01818336|Penicillin G|penicillin g|mesh-list
64744383|NCT01818336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64744384|NCT01818336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632055|NCT00002878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64632058|NCT00002878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744385|NCT01818258|Ritonavir|ritonavir|mesh-list
64744386|NCT01818258|Lopinavir|lopinavir|mesh-list
64744387|NCT01818258|Lamivudine|lamivudine|mesh-list
64513677|NCT05021913|Anesthetics|anesthetics|mesh-ancestor
64744388|NCT01818258|Zidovudine|zidovudine|mesh-list
64744389|NCT01818258|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64744390|NCT01818258|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64744391|NCT01818258|Protease Inhibitors|protease inhibitors|mesh-ancestor
64744392|NCT01818258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744393|NCT01818258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744394|NCT01818258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64744395|NCT01818258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64744396|NCT01818258|Antiviral Agents|antiviral agents|mesh-ancestor
64744397|NCT01818258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64744398|NCT01818258|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64744399|NCT01818258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64744400|NCT01818258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64744401|NCT01818258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64744402|NCT01818258|Antimetabolites|antimetabolites|mesh-ancestor
64744403|NCT01817790|Fluticasone|fluticasone|mesh-list
64744404|NCT01817790|Xhance|xhance|mesh-list
64744405|NCT01817790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64744406|NCT01817790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64744407|NCT01817790|Autonomic Agents|autonomic agents|mesh-ancestor
64744408|NCT01817790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64744409|NCT01817790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322438|NCT02145689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64322439|NCT02145689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322440|NCT02145689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64322441|NCT02145689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322443|NCT02396979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64322444|NCT02396979|Narcotics|narcotics|mesh-ancestor
64322445|NCT02396979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64322446|NCT02396979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632060|NCT00002878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64632061|NCT00002878|Tubulin Modulators|tubulin modulators|mesh-ancestor
64632062|NCT00002878|Antimitotic Agents|antimitotic agents|mesh-ancestor
64322447|NCT02396979|Analgesics|analgesics|mesh-ancestor
64322448|NCT02396979|Sensory System Agents|sensory system agents|mesh-ancestor
64744440|NCT01792518|Hormones|hormones|mesh-ancestor
64744441|NCT01792518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64744442|NCT01792518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64744443|NCT01792518|Protease Inhibitors|protease inhibitors|mesh-ancestor
64744444|NCT01792518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744445|NCT01792518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744446|NCT01792284|Insulin|insulin|mesh-list
64744447|NCT01792284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64744448|NCT01792284|Insulin Lispro|insulin lispro|mesh-list
64744449|NCT01792284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64356481|NCT04300595|Anesthetics|anesthetics|mesh-list
64322463|NCT02397213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322464|NCT02397213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322465|NCT02397213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64322466|NCT02397213|Immunologic Factors|immunologic factors|mesh-ancestor
64322467|NCT02397213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322468|NCT02397213|Antifungal Agents|antifungal agents|mesh-ancestor
64322469|NCT02397213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64322470|NCT02397213|Dermatologic Agents|dermatologic agents|mesh-ancestor
64322471|NCT02397213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64322472|NCT02397213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64322473|NCT04480281|Lidocaine|lidocaine|mesh-list
64322474|NCT04480281|Anesthetics, Local|anesthetics, local|mesh-ancestor
64322475|NCT04480281|Anesthetics|anesthetics|mesh-ancestor
64322476|NCT04480281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64322477|NCT04480281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322478|NCT04480281|Sensory System Agents|sensory system agents|mesh-ancestor
64322479|NCT04480281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64744450|NCT01792284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431091|NCT04420351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64744457|NCT04414566|Antimetabolites|antimetabolites|mesh-ancestor
64744458|NCT04414566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744459|NCT04414566|Antiviral Agents|antiviral agents|mesh-ancestor
64744460|NCT04414566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64744461|NCT04414566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744462|NCT04414566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64744463|NCT04414566|Immunologic Factors|immunologic factors|mesh-ancestor
64744464|NCT04414566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744465|NCT04414566|Tubulin Modulators|tubulin modulators|mesh-ancestor
64744466|NCT04414566|Antimitotic Agents|antimitotic agents|mesh-ancestor
64744467|NCT04414566|Mitosis Modulators|mitosis modulators|mesh-ancestor
64744468|NCT01791894|Arsenic Trioxide|arsenic trioxide|mesh-list
64744469|NCT01791894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744471|NCT04592016|Coal Tar|coal tar|mesh-list
64744472|NCT04592016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64744473|NCT04592016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64744474|NCT04592016|Analgesics|analgesics|mesh-ancestor
64744475|NCT04592016|Sensory System Agents|sensory system agents|mesh-ancestor
64744476|NCT04592016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356493|NCT04167761|Ertugliflozin|ertugliflozin|mesh-list
64322480|NCT04480281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64322481|NCT04480281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64322482|NCT04480281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64322483|NCT04480281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64322484|NCT04480281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322485|NCT03544775|Anesthetics|anesthetics|mesh-list
64322486|NCT03544775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64322487|NCT03544775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632087|NCT00003682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64632088|NCT00003682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64632089|NCT00003682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632090|NCT00003682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632091|NCT00003682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64632092|NCT00003682|Antiemetics|antiemetics|mesh-ancestor
64632093|NCT00003682|Autonomic Agents|autonomic agents|mesh-ancestor
64632094|NCT00003682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64632095|NCT00003682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632096|NCT00003682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64632097|NCT00003682|Glucocorticoids|glucocorticoids|mesh-ancestor
64322488|NCT02258815|Dinutuximab|dinutuximab|mesh-list
64744477|NCT04592016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632099|NCT00003682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64632100|NCT00003682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64744478|NCT04592016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64744479|NCT04592016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64744480|NCT04592016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64744481|NCT04592016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744482|NCT04592016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744483|NCT04592016|Keratolytic Agents|keratolytic agents|mesh-ancestor
64744484|NCT04592016|Dermatologic Agents|dermatologic agents|mesh-ancestor
64744485|NCT01837680|Insulin|insulin|mesh-list
64744486|NCT01837680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64744487|NCT01837680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64744488|NCT01837680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744489|NCT01836276|Varenicline|varenicline|mesh-list
64744490|NCT01836276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64744491|NCT01836276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64744492|NCT01836276|Cholinergic Agents|cholinergic agents|mesh-ancestor
64744493|NCT01836276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64744494|NCT01836276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744495|NCT01836276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744496|NCT01790568|Methotrexate|methotrexate|mesh-list
64744497|NCT01790568|Vorinostat|vorinostat|mesh-list
64744498|NCT01790568|Tacrolimus|tacrolimus|mesh-list
64744499|NCT01790568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64322494|NCT02149433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64322496|NCT02149433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64322497|NCT02149433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322498|NCT02228005|Sertraline|sertraline|mesh-list
64322499|NCT02228005|Antidepressive Agents|antidepressive agents|mesh-ancestor
64322500|NCT02228005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64322501|NCT02228005|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64322502|NCT02228005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64322503|NCT02228005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64322504|NCT02228005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322505|NCT02228005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64322506|NCT02228005|Serotonin Agents|serotonin agents|mesh-ancestor
64322507|NCT02228005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322508|NCT02228083|Lidocaine|lidocaine|mesh-list
64744500|NCT01790568|Abortifacient Agents|abortifacient agents|mesh-ancestor
64744501|NCT01790568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64744502|NCT01790568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744503|NCT01790568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64744505|NCT01790568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744506|NCT01790568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744507|NCT01790568|Dermatologic Agents|dermatologic agents|mesh-ancestor
64744508|NCT01790568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744509|NCT01790568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64744510|NCT01790568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64744511|NCT01790568|Immunologic Factors|immunologic factors|mesh-ancestor
64632101|NCT00003682|Protective Agents|protective agents|mesh-ancestor
64632102|NCT00003682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64632103|NCT00003688|Dactinomycin|dactinomycin|mesh-list
64632104|NCT00003688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64632105|NCT00003688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632106|NCT00003688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64632108|NCT00003688|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64632109|NCT00003688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632110|NCT00003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632111|NCT00003688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64632112|NCT00083174|Exemestane|exemestane|mesh-list
64744512|NCT01790568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64744513|NCT01790568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64744514|NCT01790568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64744515|NCT01790568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64744516|NCT01836198|Clarithromycin|clarithromycin|mesh-list
64744517|NCT01836198|Ketoconazole|ketoconazole|mesh-list
64744518|NCT01836198|Gemfibrozil|gemfibrozil|mesh-list
64744519|NCT01836198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64744520|NCT01836198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64744521|NCT01836198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64744522|NCT01836198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744523|NCT01836198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744524|NCT01836198|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64744525|NCT01836198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64744526|NCT01836198|Antifungal Agents|antifungal agents|mesh-ancestor
64744527|NCT01836198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64744528|NCT01836198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64744529|NCT01836198|Hormone Antagonists|hormone antagonists|mesh-ancestor
64356544|NCT03395873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744530|NCT01836198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64744531|NCT01836198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744532|NCT01836198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64744533|NCT01836198|Antimetabolites|antimetabolites|mesh-ancestor
64744534|NCT01836198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64744535|NCT01836198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64744550|NCT01815918|Hydrocortisone|hydrocortisone|mesh-list
64744551|NCT01815918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64744552|NCT01789320|Triamcinolone|triamcinolone|mesh-list
64744553|NCT01789320|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64744554|NCT01789320|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64744555|NCT01789320|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64744556|NCT01789320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64744557|NCT01789320|Glucocorticoids|glucocorticoids|mesh-ancestor
64744559|NCT01789320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64744560|NCT01789320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744561|NCT01789320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64744562|NCT01789320|Immunologic Factors|immunologic factors|mesh-ancestor
64744563|NCT01789320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744564|NCT01789320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744565|NCT01788228|Vaccines|vaccines|mesh-list
64744566|NCT01788228|Immunologic Factors|immunologic factors|mesh-ancestor
64744567|NCT01788228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744568|NCT01607346|Ezogabine|ezogabine|mesh-list
64744569|NCT01607346|Anticonvulsants|anticonvulsants|mesh-ancestor
64744570|NCT01607346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64744571|NCT01607346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744572|NCT01815138|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64744573|NCT01815138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64744574|NCT01815138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744575|NCT01606800|Ribavirin|ribavirin|mesh-list
64744576|NCT01606800|Interferon alpha-2|interferon alpha-2|mesh-list
64744577|NCT01606800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64744578|NCT01606800|Antimetabolites|antimetabolites|mesh-ancestor
64356606|NCT04928521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64322509|NCT02228083|Epinephrine|epinephrine|mesh-list
64322510|NCT02228083|Anesthetics, Local|anesthetics, local|mesh-ancestor
64322511|NCT02228083|Anesthetics|anesthetics|mesh-ancestor
64322512|NCT02228083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64431099|NCT04420351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64322513|NCT02228083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322514|NCT02228083|Sensory System Agents|sensory system agents|mesh-ancestor
64322515|NCT02228083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322518|NCT02228083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64322519|NCT02228083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64632117|NCT00083174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632118|NCT00083174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64322520|NCT02228083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322521|NCT02228083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64322522|NCT02228083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64322523|NCT02228083|Adrenergic Agents|adrenergic agents|mesh-ancestor
64322524|NCT02228083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64322525|NCT02228083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64322526|NCT02228083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64322527|NCT02228083|Autonomic Agents|autonomic agents|mesh-ancestor
64322528|NCT02228083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64322529|NCT02228083|Respiratory System Agents|respiratory system agents|mesh-ancestor
64322530|NCT02228083|Mydriatics|mydriatics|mesh-ancestor
64322531|NCT02228083|Sympathomimetics|sympathomimetics|mesh-ancestor
64322532|NCT02228083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64322533|NCT02394483|Olorofim|olorofim|mesh-list
64322534|NCT02394483|Antifungal Agents|antifungal agents|mesh-ancestor
64744579|NCT01606800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744580|NCT01606800|Antiviral Agents|antiviral agents|mesh-ancestor
64744581|NCT01606800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64744582|NCT01606800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744583|NCT01814748|Metformin|metformin|mesh-list
64744584|NCT01814748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64744585|NCT01814748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744586|NCT01814670|Botulinum Toxins|botulinum toxins|mesh-list
64744587|NCT01814670|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64744588|NCT01814670|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64744589|NCT01814670|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64744590|NCT01814670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64744591|NCT01814670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744592|NCT01814670|Cholinergic Agents|cholinergic agents|mesh-ancestor
64744593|NCT01814670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64744594|NCT01814670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744595|NCT01814670|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64744596|NCT01814670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64744597|NCT01814046|Aldesleukin|aldesleukin|mesh-list
64744598|NCT01814046|Cyclophosphamide|cyclophosphamide|mesh-list
64744599|NCT01814046|Fludarabine|fludarabine|mesh-list
64744600|NCT01814046|Interleukin-2|interleukin-2|mesh-list
64744601|NCT01814046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64744630|NCT01813890|Adrenergic Agents|adrenergic agents|mesh-ancestor
64744631|NCT01813890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64744633|NCT01813422|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64744634|NCT01813422|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64744635|NCT01813422|Antimetabolites|antimetabolites|mesh-ancestor
64744636|NCT01813422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744637|NCT01813422|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64744638|NCT01786668|Tofacitinib|tofacitinib|mesh-list
64744639|NCT01786668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64744640|NCT01786668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632124|NCT00003934|Mercaptopurine|mercaptopurine|mesh-list
64632125|NCT00003934|Daunorubicin|daunorubicin|mesh-list
64632127|NCT00003934|Tretinoin|tretinoin|mesh-list
64744641|NCT01786668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744642|NCT04414254|Cefprozil|cefprozil|mesh-list
64744643|NCT04414254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64744644|NCT04414254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64744645|NCT01770912|Triamcinolone|triamcinolone|mesh-list
64744646|NCT01770912|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64744647|NCT01770912|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64744648|NCT01770912|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64744649|NCT01770912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64744650|NCT01770912|Glucocorticoids|glucocorticoids|mesh-ancestor
64744651|NCT01770912|Hormones|hormones|mesh-ancestor
64744652|NCT01770912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64744653|NCT01770912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744654|NCT01770912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64744655|NCT01770912|Immunologic Factors|immunologic factors|mesh-ancestor
64744656|NCT01770912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744657|NCT01770912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744658|NCT01811706|4-Aminopyridine|4-aminopyridine|mesh-list
64744659|NCT01811706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64744660|NCT01811706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64744677|NCT01769508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64744679|NCT01769508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64744680|NCT01769508|Immunologic Factors|immunologic factors|mesh-ancestor
64744681|NCT01769508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744682|NCT01769508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64744683|NCT01769508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744684|NCT01810380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64744685|NCT01810380|Brexpiprazole|brexpiprazole|mesh-list
64744686|NCT01810380|Antidepressive Agents|antidepressive agents|mesh-ancestor
64744687|NCT01810380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64744688|NCT01810380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64744689|NCT01810380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64744690|NCT01810380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64744691|NCT01810380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744693|NCT01810380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64744694|NCT01810380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744695|NCT01810380|Dopamine Agonists|dopamine agonists|mesh-ancestor
64744696|NCT01810380|Dopamine Agents|dopamine agents|mesh-ancestor
64744697|NCT01810302|Nicardipine|nicardipine|mesh-list
64744698|NCT01810302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64322535|NCT02394483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64322536|NCT02142335|Rituximab|rituximab|mesh-list
64322537|NCT02142335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64322538|NCT02142335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322539|NCT02142335|Immunologic Factors|immunologic factors|mesh-ancestor
64744699|NCT01810302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64744700|NCT01810302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64744701|NCT01810302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744702|NCT01810302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64744703|NCT01810302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744704|NCT01810302|Vasodilator Agents|vasodilator agents|mesh-ancestor
64744705|NCT01783938|Nivolumab|nivolumab|mesh-list
64632156|NCT00003694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632157|NCT00003694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64744706|NCT01783938|Ipilimumab|ipilimumab|mesh-list
64744707|NCT01783938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64744708|NCT01783938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744709|NCT01783938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64744710|NCT01783938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744711|NCT01768572|Hydroxychloroquine|hydroxychloroquine|mesh-list
64744712|NCT01768572|Sulfasalazine|sulfasalazine|mesh-list
64744713|NCT01768572|Methotrexate|methotrexate|mesh-list
64744714|NCT01768572|Leflunomide|leflunomide|mesh-list
64744715|NCT01768572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64744716|NCT01768572|Abortifacient Agents|abortifacient agents|mesh-ancestor
64744717|NCT01768572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64744718|NCT01768572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744719|NCT01768572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64744720|NCT01768572|Antimetabolites|antimetabolites|mesh-ancestor
64744721|NCT01768572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744722|NCT01768572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744723|NCT01768572|Dermatologic Agents|dermatologic agents|mesh-ancestor
64744724|NCT01768572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744725|NCT01768572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64744726|NCT01768572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64744727|NCT01768572|Immunologic Factors|immunologic factors|mesh-ancestor
64744728|NCT01768572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64744730|NCT01768572|Antimalarials|antimalarials|mesh-ancestor
64744740|NCT01768572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64744741|NCT01783548|Beclomethasone|beclomethasone|mesh-list
64744742|NCT01783548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64744743|NCT01783548|Glucocorticoids|glucocorticoids|mesh-ancestor
64744744|NCT01783548|Hormones|hormones|mesh-ancestor
64744745|NCT01783548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64744746|NCT01783548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744747|NCT01783548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64744748|NCT01783548|Respiratory System Agents|respiratory system agents|mesh-ancestor
64744749|NCT01809210|Gemcitabine|gemcitabine|mesh-list
64744750|NCT01809210|Carboplatin|carboplatin|mesh-list
64744751|NCT01809210|Pemetrexed|pemetrexed|mesh-list
64744752|NCT01809210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744753|NCT01809210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64744754|NCT01809210|Antimetabolites|antimetabolites|mesh-ancestor
64744755|NCT01809210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744756|NCT01809210|Antiviral Agents|antiviral agents|mesh-ancestor
64744757|NCT01809210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632179|NCT00003946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64632180|NCT00003946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744758|NCT01809210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744759|NCT01809210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64744760|NCT01809210|Immunologic Factors|immunologic factors|mesh-ancestor
64744761|NCT01809210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744762|NCT01809210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64322540|NCT02142335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322541|NCT02142335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64322543|NCT02228239|Esketamine|esketamine|mesh-list
64322544|NCT02228239|Antidepressive Agents|antidepressive agents|mesh-ancestor
64322545|NCT02228239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64322546|NCT02228239|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64322547|NCT02228239|Histamine Antagonists|histamine antagonists|mesh-ancestor
64322548|NCT02228239|Histamine Agents|histamine agents|mesh-ancestor
64322549|NCT02228239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64322550|NCT02228239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322551|NCT02228239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322552|NCT02228239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64322553|NCT02228239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64322554|NCT02228239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64322555|NCT02228239|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64322556|NCT02228239|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64322557|NCT02228239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64322558|NCT02228239|Adrenergic Agents|adrenergic agents|mesh-ancestor
64322559|NCT02228239|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64322560|NCT02228239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64322561|NCT02228239|Serotonin Agents|serotonin agents|mesh-ancestor
64744763|NCT01809210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64744765|NCT01809132|Methylprednisolone|methylprednisolone|mesh-list
64744766|NCT01809132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64744778|NCT01809132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322562|NCT02228239|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64322564|NCT03167385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322565|NCT03167385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64322566|NCT03167385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322567|NCT03167385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322568|NCT02142569|Tocotrienols|tocotrienols|mesh-list
64322569|NCT02142569|Vitamin E|vitamin e|mesh-list
64322570|NCT02142569|Tocopherols|tocopherols|mesh-list
64322571|NCT02142569|Red yeast rice|red yeast rice|mesh-list
64322572|NCT02142569|Antioxidants|antioxidants|mesh-ancestor
64322573|NCT02142569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322574|NCT02142569|Protective Agents|protective agents|mesh-ancestor
64322575|NCT02142569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322576|NCT02142569|Vitamins|vitamins|mesh-ancestor
64322577|NCT02142569|Micronutrients|micronutrients|mesh-ancestor
64322578|NCT02142569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64322579|NCT02142569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64322580|NCT02142569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64322581|NCT02142569|Antimetabolites|antimetabolites|mesh-ancestor
64322582|NCT02142569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322583|NCT02142569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64322584|NCT02228473|Atropine|atropine|mesh-list
64322585|NCT02228473|Glycopyrrolate|glycopyrrolate|mesh-list
64322586|NCT02228473|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64744779|NCT01809132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744780|NCT01809132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64632211|NCT00003700|Leucovorin|leucovorin|mesh-list
64632212|NCT00003700|Cytarabine|cytarabine|mesh-list
64632213|NCT00003700|Prednisone|prednisone|mesh-list
64744782|NCT01809132|Hormones|hormones|mesh-ancestor
64744783|NCT01809132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64632230|NCT00003700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64744784|NCT01809132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64744785|NCT01809132|Protective Agents|protective agents|mesh-ancestor
64744786|NCT01809132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64744787|NCT01809132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744788|NCT01809132|Trace Elements|trace elements|mesh-ancestor
64744789|NCT01809132|Micronutrients|micronutrients|mesh-ancestor
64744790|NCT01809132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64356824|NCT03126461|Nivolumab|nivolumab|mesh-list
64322587|NCT02228473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64322588|NCT02228473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64322589|NCT02228473|Autonomic Agents|autonomic agents|mesh-ancestor
64322590|NCT02228473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322625|NCT02394093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64322626|NCT02394093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322627|NCT02394093|Antipyretics|antipyretics|mesh-ancestor
64322628|NCT02146391|Enclomiphene|enclomiphene|mesh-list
64322629|NCT02146391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64322630|NCT02146391|Hormone Antagonists|hormone antagonists|mesh-ancestor
64322631|NCT02146391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64322632|NCT02146391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322633|NCT02146391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64744804|NCT01766778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744805|NCT01766778|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64744806|NCT01766778|Protease Inhibitors|protease inhibitors|mesh-ancestor
64744807|NCT01766778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744808|NCT01766778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744809|NCT01808196|Losartan|losartan|mesh-list
64744810|NCT01808196|Angiotensin II|angiotensin ii|mesh-list
64744811|NCT01808196|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64744812|NCT01808196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64744813|NCT01808196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64744814|NCT01808196|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64744815|NCT01808196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744816|NCT01808196|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64744817|NCT01808118|Adalimumab|adalimumab|mesh-list
64744818|NCT01808118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64744819|NCT01808118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64744820|NCT01782690|Gemcitabine|gemcitabine|mesh-list
64744821|NCT01782690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64744823|NCT01782690|Antimetabolites|antimetabolites|mesh-ancestor
64632231|NCT00003700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64744859|NCT01807182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64744860|NCT01807182|Antimetabolites|antimetabolites|mesh-ancestor
64744861|NCT01807182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64744862|NCT01807182|Analgesics|analgesics|mesh-ancestor
64744863|NCT01807182|Sensory System Agents|sensory system agents|mesh-ancestor
64744864|NCT01807182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64744865|NCT01807182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64744866|NCT01807182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64744867|NCT01807182|Antiviral Agents|antiviral agents|mesh-ancestor
64744868|NCT01807182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64744869|NCT01765764|Bimatoprost|bimatoprost|mesh-list
64744870|NCT01765764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64744871|NCT01765764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64632232|NCT00003700|Glucocorticoids|glucocorticoids|mesh-ancestor
64632233|NCT00003700|Hormones|hormones|mesh-ancestor
64632234|NCT00003700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64632236|NCT00003700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64632237|NCT00003700|Abortifacient Agents|abortifacient agents|mesh-ancestor
64322642|NCT04225273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322643|NCT04225273|Sensory System Agents|sensory system agents|mesh-ancestor
64744874|NCT01780974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744875|NCT01780974|Protective Agents|protective agents|mesh-ancestor
64744876|NCT01780974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744877|NCT01780974|Vitamin B Complex|vitamin b complex|mesh-ancestor
64744879|NCT01780974|Micronutrients|micronutrients|mesh-ancestor
64744880|NCT01780662|Gemcitabine|gemcitabine|mesh-list
64744881|NCT01780662|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64744882|NCT01780662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64744883|NCT01780662|Antibodies|antibodies|mesh-list
64744884|NCT01780662|Immunoglobulins|immunoglobulins|mesh-list
64744885|NCT01780662|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64744886|NCT01780662|Immunoconjugates|immunoconjugates|mesh-list
64744887|NCT01780662|Immunologic Factors|immunologic factors|mesh-ancestor
64744888|NCT01780662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64744889|NCT01780662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64744890|NCT01780662|Antimetabolites|antimetabolites|mesh-ancestor
64744891|NCT01780662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744892|NCT01780662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744893|NCT01780662|Antiviral Agents|antiviral agents|mesh-ancestor
64744894|NCT01780662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64744895|NCT01780662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64744927|NCT01762800|Glucocorticoids|glucocorticoids|mesh-ancestor
64744929|NCT01762800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64744930|NCT01762800|Sympathomimetics|sympathomimetics|mesh-ancestor
64744932|NCT04562532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64744951|NCT01778010|Sensory System Agents|sensory system agents|mesh-ancestor
64744952|NCT01778010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64744953|NCT01778010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64744954|NCT01778010|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64744993|NCT01777152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64744994|NCT01777152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64744995|NCT01777152|Alkylating Agents|alkylating agents|mesh-ancestor
64744996|NCT01777152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64744997|NCT01777152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64744998|NCT01777152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64744999|NCT01777152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64745000|NCT01777152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64632243|NCT00003700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64632244|NCT00003700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64632245|NCT00003700|Antiviral Agents|antiviral agents|mesh-ancestor
64632246|NCT00003700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64745001|NCT01777152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64745002|NCT01777152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745003|NCT01777152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64745004|NCT01777152|Glucocorticoids|glucocorticoids|mesh-ancestor
64745006|NCT01777152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64745007|NCT01777152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64745008|NCT01777152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64745009|NCT01777152|Tubulin Modulators|tubulin modulators|mesh-ancestor
64745010|NCT01777152|Antimitotic Agents|antimitotic agents|mesh-ancestor
64745011|NCT01777152|Mitosis Modulators|mitosis modulators|mesh-ancestor
64745012|NCT01777152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64745014|NCT01775124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64745015|NCT01775124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64357035|NCT00271817|Nicotinic Acids|nicotinic acids|mesh-list
64322648|NCT04225273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64322649|NCT04225273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322651|NCT02146547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64322652|NCT02146547|Antidepressive Agents|antidepressive agents|mesh-ancestor
64322653|NCT02146547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64322654|NCT02146547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64322655|NCT02146547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64322656|NCT02146547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64322657|NCT02146547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322658|NCT02146547|Dopamine Agonists|dopamine agonists|mesh-ancestor
64322659|NCT02146547|Dopamine Agents|dopamine agents|mesh-ancestor
64745057|NCT01755702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64745058|NCT01755702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745059|NCT01755702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745061|NCT01755702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64745062|NCT01755702|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64745063|NCT01755702|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64513829|NCT01892241|Entecavir|entecavir|mesh-list
64745064|NCT01755702|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64745065|NCT01755702|Purinergic Agents|purinergic agents|mesh-ancestor
64632278|NCT00003958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64632279|NCT00003958|Alkylating Agents|alkylating agents|mesh-ancestor
64745071|NCT01732458|Autonomic Agents|autonomic agents|mesh-ancestor
64745072|NCT01732458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64745073|NCT01732458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745074|NCT01732458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64745075|NCT01732458|Antipruritics|antipruritics|mesh-ancestor
64745076|NCT01732458|Dermatologic Agents|dermatologic agents|mesh-ancestor
64745077|NCT01732458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64745078|NCT01732458|Serotonin Agents|serotonin agents|mesh-ancestor
64745079|NCT01732458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64745080|NCT01732458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357093|NCT03388151|Anesthetics|anesthetics|mesh-ancestor
64322673|NCT02146703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322674|NCT02146703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322675|NCT02146703|Antiviral Agents|antiviral agents|mesh-ancestor
64322676|NCT02146703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64322677|NCT02146703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322678|NCT02146703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64322679|NCT02146703|Immunologic Factors|immunologic factors|mesh-ancestor
64745081|NCT01732458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64745082|NCT01732458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64745083|NCT01732458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64745084|NCT01732458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64745085|NCT01732458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64745086|NCT01732458|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64745088|NCT01708902|Linagliptin|linagliptin|mesh-list
64745089|NCT01708902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64357119|NCT03126071|Oxaliplatin|oxaliplatin|mesh-list
64322680|NCT02146703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322681|NCT02228863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64322682|NCT02228863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64322683|NCT02228863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64322684|NCT02228863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322685|NCT02228863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322686|NCT02228863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64322687|NCT02228863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64322688|NCT02228863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322689|NCT02228863|Cholinergic Agents|cholinergic agents|mesh-ancestor
64322690|NCT02228863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64322692|NCT02782169|Analgesics|analgesics|mesh-ancestor
64322693|NCT02782169|Sensory System Agents|sensory system agents|mesh-ancestor
64322694|NCT02782169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322695|NCT02782169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322696|NCT02782169|Anticonvulsants|anticonvulsants|mesh-ancestor
64322697|NCT02782169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64322698|NCT02782169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64322699|NCT02782169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322700|NCT02782169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64322701|NCT02782169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64322702|NCT02782169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64322703|NCT02782169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64322704|NCT02782169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64322705|NCT04163185|Meloxicam|meloxicam|mesh-list
64322706|NCT04163185|Rizatriptan|rizatriptan|mesh-list
64322712|NCT04163185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322713|NCT04163185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64632316|NCT00003268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64632317|NCT00003268|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64745111|NCT04413864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64745112|NCT04413864|Analgesics|analgesics|mesh-ancestor
64745113|NCT04413864|Sensory System Agents|sensory system agents|mesh-ancestor
64745114|NCT04413864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64745115|NCT04413864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64357134|NCT03126071|Antimetabolites|antimetabolites|mesh-ancestor
64745127|NCT01755234|Anesthetics, General|anesthetics, general|mesh-ancestor
64745128|NCT01755234|Anesthetics|anesthetics|mesh-ancestor
64745129|NCT01755234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64745130|NCT01755234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64745131|NCT01730586|Paclitaxel|paclitaxel|mesh-list
64745132|NCT01730586|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64745133|NCT01730586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64745134|NCT01730586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64745135|NCT01730586|Tubulin Modulators|tubulin modulators|mesh-ancestor
64745136|NCT01730586|Antimitotic Agents|antimitotic agents|mesh-ancestor
64745137|NCT01730586|Mitosis Modulators|mitosis modulators|mesh-ancestor
64745138|NCT01730586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513915|NCT01893723|Remifentanil|remifentanil|mesh-list
64745139|NCT01755156|Metformin|metformin|mesh-list
64745140|NCT01755156|Insulin Glargine|insulin glargine|mesh-list
64745141|NCT01755156|Glimepiride|glimepiride|mesh-list
64745142|NCT01755156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64745143|NCT01755156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745144|NCT01755156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64745145|NCT01755156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64745146|NCT01755156|Immunologic Factors|immunologic factors|mesh-ancestor
64745147|NCT01754376|Aldesleukin|aldesleukin|mesh-list
64745148|NCT01754376|Interleukin-2|interleukin-2|mesh-list
64745149|NCT01754376|Vemurafenib|vemurafenib|mesh-list
64745150|NCT01754376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64745151|NCT01754376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64745152|NCT01754376|Analgesics|analgesics|mesh-ancestor
64745153|NCT01754376|Sensory System Agents|sensory system agents|mesh-ancestor
64745154|NCT01754376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64745155|NCT01754376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745156|NCT01754376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64745157|NCT01754376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64745158|NCT01754376|Antiviral Agents|antiviral agents|mesh-ancestor
64745159|NCT01754376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64745160|NCT01754376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64745161|NCT01754376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745162|NCT01754376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745163|NCT01605396|Exemestane|exemestane|mesh-list
64632335|NCT00003280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64745164|NCT01605396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64745165|NCT01605396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64745166|NCT01605396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64745167|NCT01605396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745168|NCT01605396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322726|NCT02149901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322727|NCT02149901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322728|NCT02149901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64322729|NCT02149901|Respiratory System Agents|respiratory system agents|mesh-ancestor
64322733|NCT02149901|Sympathomimetics|sympathomimetics|mesh-ancestor
64322734|NCT02149901|Adrenergic Agents|adrenergic agents|mesh-ancestor
64322735|NCT02149901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64322736|NCT02149901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322737|NCT04440267|Dexamethasone|dexamethasone|mesh-list
64322738|NCT04440267|Prednisone|prednisone|mesh-list
64322739|NCT04440267|Cyclophosphamide|cyclophosphamide|mesh-list
64322740|NCT04440267|Methotrexate|methotrexate|mesh-list
64322741|NCT04440267|Vincristine|vincristine|mesh-list
64322742|NCT04440267|Daunorubicin|daunorubicin|mesh-list
64322743|NCT04440267|Asparaginase|asparaginase|mesh-list
64322744|NCT04440267|Mercaptopurine|mercaptopurine|mesh-list
64322745|NCT04440267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64745183|NCT01730040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64745184|NCT01730040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64745185|NCT01730040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745186|NCT01706328|Fluticasone|fluticasone|mesh-list
64745188|NCT01706328|Albuterol|albuterol|mesh-list
64745189|NCT01706328|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64745190|NCT01706328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64745191|NCT01706328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64745192|NCT01706328|Autonomic Agents|autonomic agents|mesh-ancestor
64745193|NCT01706328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64745194|NCT01706328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745195|NCT01706328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64745196|NCT01706328|Respiratory System Agents|respiratory system agents|mesh-ancestor
64745197|NCT01706328|Dermatologic Agents|dermatologic agents|mesh-ancestor
64745198|NCT01706328|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64745199|NCT01706328|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64745200|NCT01706328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64745201|NCT01706328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64745202|NCT01706328|Adrenergic Agents|adrenergic agents|mesh-ancestor
64632369|NCT00085436|Aldesleukin|aldesleukin|mesh-list
64632370|NCT00085436|Vaccines|vaccines|mesh-list
64632371|NCT00085436|Immunologic Factors|immunologic factors|mesh-ancestor
64632374|NCT00085436|Antiviral Agents|antiviral agents|mesh-ancestor
64745203|NCT01706328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64745204|NCT01706328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745205|NCT01706328|Tocolytic Agents|tocolytic agents|mesh-ancestor
64745206|NCT01706328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64745207|NCT01706250|Salicylic Acid|salicylic acid|mesh-list
64745208|NCT01706250|Salicylates|salicylates|mesh-list
64745209|NCT01706250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64745210|NCT01706250|Antifungal Agents|antifungal agents|mesh-ancestor
64745211|NCT01706250|Keratolytic Agents|keratolytic agents|mesh-ancestor
64745212|NCT01706250|Dermatologic Agents|dermatologic agents|mesh-ancestor
64745213|NCT01706250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64745214|NCT01706250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64745215|NCT01706250|Analgesics|analgesics|mesh-ancestor
64745216|NCT01706250|Sensory System Agents|sensory system agents|mesh-ancestor
64322746|NCT04440267|Immunologic Factors|immunologic factors|mesh-ancestor
64322747|NCT04440267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322748|NCT04440267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64322749|NCT04440267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64322750|NCT04440267|Alkylating Agents|alkylating agents|mesh-ancestor
64322751|NCT04440267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745217|NCT01706250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64745218|NCT01706250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745219|NCT01706250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64745220|NCT01706250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64745221|NCT01706250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64745222|NCT01706250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745223|NCT01706250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745225|NCT01729728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64745226|NCT01729728|Narcotics|narcotics|mesh-ancestor
64745227|NCT01729728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64745228|NCT01729728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745229|NCT01729728|Analgesics|analgesics|mesh-ancestor
64632404|NCT00384280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64632405|NCT00384280|Antitubercular Agents|antitubercular agents|mesh-ancestor
64632406|NCT00384280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64745230|NCT01729728|Sensory System Agents|sensory system agents|mesh-ancestor
64745231|NCT01729728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64745232|NCT01729728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64745244|NCT01728246|Tramadol|tramadol|mesh-list
64745245|NCT01728246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64745246|NCT01728246|Analgesics|analgesics|mesh-ancestor
64745247|NCT01728246|Sensory System Agents|sensory system agents|mesh-ancestor
64745248|NCT01728246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322761|NCT04440267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64322762|NCT04440267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64322763|NCT04440267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64322764|NCT04440267|Abortifacient Agents|abortifacient agents|mesh-ancestor
64322765|NCT04440267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64322766|NCT04440267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64322767|NCT04440267|Antimetabolites|antimetabolites|mesh-ancestor
64322768|NCT04440267|Dermatologic Agents|dermatologic agents|mesh-ancestor
64322769|NCT04440267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322770|NCT04440267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64322771|NCT04440267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64322772|NCT04440267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64322773|NCT04440267|Tubulin Modulators|tubulin modulators|mesh-ancestor
64322774|NCT04440267|Antimitotic Agents|antimitotic agents|mesh-ancestor
64322775|NCT04440267|Mitosis Modulators|mitosis modulators|mesh-ancestor
64322776|NCT04440267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64322777|NCT04440267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64322778|NCT04440267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64322779|NCT02043847|Melphalan|melphalan|mesh-list
64431680|NCT01857622|Edoxaban|edoxaban|mesh-list
64514072|NCT01729559|Heparin|heparin|mesh-list
64632443|NCT00003292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64745289|NCT01727700|Aripiprazole|aripiprazole|mesh-list
64745290|NCT01727700|Antidepressive Agents|antidepressive agents|mesh-ancestor
64745291|NCT01727700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64745292|NCT01727700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64745293|NCT01727700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64745294|NCT01727700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64745295|NCT01727700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745296|NCT01727700|Dopamine Agonists|dopamine agonists|mesh-ancestor
64745297|NCT01727700|Dopamine Agents|dopamine agents|mesh-ancestor
64745298|NCT01727700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64745299|NCT01727700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745300|NCT01727700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64745301|NCT01727700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64745302|NCT01727700|Serotonin Agents|serotonin agents|mesh-ancestor
64745303|NCT01727700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64745304|NCT01727700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64745305|NCT01727700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64745306|NCT01727700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64745307|NCT01725282|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64745308|NCT01725282|Antidepressive Agents|antidepressive agents|mesh-ancestor
64745309|NCT01725282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64745310|NCT01725282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64745311|NCT01725282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64745312|NCT01725282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64745313|NCT01725282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745315|NCT01725126|Liraglutide|liraglutide|mesh-list
64745316|NCT01725126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64431687|NCT01857622|Anticoagulants|anticoagulants|mesh-ancestor
64322801|NCT02146937|Urological Agents|urological agents|mesh-ancestor
64322802|NCT02147015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64322803|NCT02147015|Methylprednisolone|methylprednisolone|mesh-list
64322804|NCT02147015|Glucocorticoids|glucocorticoids|mesh-list
64322805|NCT02147015|Cholinergic Agents|cholinergic agents|mesh-list
64322806|NCT02147015|Muscarinic Antagonists|muscarinic antagonists|mesh-list
64322807|NCT02147015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64322808|NCT02147015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64322809|NCT02147015|Antiemetics|antiemetics|mesh-ancestor
64745317|NCT01725126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745318|NCT01725126|Incretins|incretins|mesh-ancestor
64745320|NCT01725126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64745321|NCT01751724|Caffeine|caffeine|mesh-list
64745322|NCT01751724|Caffeine citrate|caffeine citrate|mesh-list
64745323|NCT01751724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745324|NCT01751724|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64745325|NCT01751724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745326|NCT01751724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64745327|NCT01751724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745328|NCT01751724|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64745329|NCT01751724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64745330|NCT01751724|Purinergic Agents|purinergic agents|mesh-ancestor
64745331|NCT01751724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64745332|NCT01751646|Vitamin D|vitamin d|mesh-list
64745333|NCT01751646|Ergocalciferols|ergocalciferols|mesh-list
64745334|NCT01751646|Cholecalciferol|cholecalciferol|mesh-list
64745335|NCT01751646|Vitamins|vitamins|mesh-list
64745336|NCT01751646|Micronutrients|micronutrients|mesh-ancestor
64745337|NCT01751646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745338|NCT01751646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64745339|NCT01751646|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64745340|NCT01751568|Raltegravir Potassium|raltegravir potassium|mesh-list
64745341|NCT01751568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64745342|NCT01751568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64745343|NCT01751568|Antiviral Agents|antiviral agents|mesh-ancestor
64745344|NCT01751568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64745345|NCT01751568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64745346|NCT01751568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64745347|NCT01751568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745348|NCT01751568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745349|NCT01751178|Ethanol|ethanol|mesh-list
64745350|NCT01751178|Chlorhexidine|chlorhexidine|mesh-list
64745351|NCT01751178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64632488|NCT00003742|Antimitotic Agents|antimitotic agents|mesh-ancestor
64632495|NCT00003304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64745352|NCT01751178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64745353|NCT01751178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64745354|NCT01751178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64745355|NCT01751178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745356|NCT01751178|Disinfectants|disinfectants|mesh-ancestor
64745357|NCT01751178|Dermatologic Agents|dermatologic agents|mesh-ancestor
64745358|NCT01606254|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64745359|NCT01606254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64745360|NCT01606254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64745361|NCT01606254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64745362|NCT01606254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64514141|NCT01606007|Metformin|metformin|mesh-list
64745363|NCT01606254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64745364|NCT01606254|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64745365|NCT01606254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64745366|NCT01606254|Serotonin Agents|serotonin agents|mesh-ancestor
64745367|NCT01606254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64745368|NCT01606254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745369|NCT01606254|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64745370|NCT01606254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64745371|NCT01606254|Dopamine Agents|dopamine agents|mesh-ancestor
64745372|NCT01723254|Immunoglobulin E|immunoglobulin e|mesh-list
64745402|NCT01702428|Immunologic Factors|immunologic factors|mesh-ancestor
64745403|NCT01702428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745404|NCT01701258|Amisulpride|amisulpride|mesh-list
64745405|NCT01701258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64745406|NCT01701258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64745407|NCT01701258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64745408|NCT01701258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745409|NCT01701258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64745410|NCT01701258|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64745411|NCT01701258|Dopamine Agents|dopamine agents|mesh-ancestor
64745412|NCT01701258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64745413|NCT01701258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745414|NCT01701258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64745415|NCT01701258|Antidepressive Agents|antidepressive agents|mesh-ancestor
64745416|NCT01700946|Cytarabine|cytarabine|mesh-list
64745417|NCT01700946|Aldesleukin|aldesleukin|mesh-list
64745418|NCT01700946|Dexamethasone|dexamethasone|mesh-list
64745419|NCT01700946|Hydrocortisone|hydrocortisone|mesh-list
64745420|NCT01700946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64745421|NCT01700946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64745422|NCT01700946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64745423|NCT01700946|Cyclophosphamide|cyclophosphamide|mesh-list
64745424|NCT01700946|Rituximab|rituximab|mesh-list
64745425|NCT01700946|Methotrexate|methotrexate|mesh-list
64745426|NCT01700946|Etoposide|etoposide|mesh-list
64745427|NCT01700946|Vincristine|vincristine|mesh-list
64745428|NCT01700946|Interleukin-2|interleukin-2|mesh-list
64745429|NCT01700946|Asparaginase|asparaginase|mesh-list
64632496|NCT00003304|Alkylating Agents|alkylating agents|mesh-ancestor
64632497|NCT00003304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745430|NCT01700946|Mitoxantrone|mitoxantrone|mesh-list
64745431|NCT01700946|Mercaptopurine|mercaptopurine|mesh-list
64745432|NCT01700946|Clofarabine|clofarabine|mesh-list
64745433|NCT01700946|Vinblastine|vinblastine|mesh-list
64745434|NCT01700946|Pegaspargase|pegaspargase|mesh-list
64745435|NCT01700946|Teniposide|teniposide|mesh-list
64745436|NCT01700946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64745437|NCT01700946|Immunologic Factors|immunologic factors|mesh-ancestor
64745438|NCT01700946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745439|NCT01700946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64745444|NCT01700946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64745445|NCT01700946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64745446|NCT01700946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64745447|NCT01700946|Antiemetics|antiemetics|mesh-ancestor
64745448|NCT01700946|Autonomic Agents|autonomic agents|mesh-ancestor
64745449|NCT01700946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64745450|NCT01700946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64745451|NCT01700946|Glucocorticoids|glucocorticoids|mesh-ancestor
64745452|NCT01700946|Hormones|hormones|mesh-ancestor
64745467|NCT01700946|Antiviral Agents|antiviral agents|mesh-ancestor
64745468|NCT01700946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64745469|NCT01700946|Tubulin Modulators|tubulin modulators|mesh-ancestor
64745470|NCT01700946|Antimitotic Agents|antimitotic agents|mesh-ancestor
64745471|NCT01700946|Mitosis Modulators|mitosis modulators|mesh-ancestor
64745472|NCT01700946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64745473|NCT01700946|Analgesics|analgesics|mesh-ancestor
64745474|NCT01700946|Sensory System Agents|sensory system agents|mesh-ancestor
64745475|NCT01700946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64745476|NCT01700946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64745477|NCT01748994|Pioglitazone|pioglitazone|mesh-list
64745478|NCT01748994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64745479|NCT01748994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745481|NCT01721070|Sufentanil|sufentanil|mesh-list
64745482|NCT01721070|Dsuvia|dsuvia|mesh-list
64745483|NCT01721070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64745484|NCT01721070|Narcotics|narcotics|mesh-ancestor
64745485|NCT01721070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64745486|NCT01721070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745487|NCT01721070|Analgesics|analgesics|mesh-ancestor
64745488|NCT01721070|Sensory System Agents|sensory system agents|mesh-ancestor
64745489|NCT01721070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64745490|NCT01721070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64745491|NCT01721070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64745492|NCT01721070|Anesthetics, General|anesthetics, general|mesh-ancestor
64745493|NCT01721070|Anesthetics|anesthetics|mesh-ancestor
64745494|NCT01721070|Antifungal Agents|antifungal agents|mesh-ancestor
64745495|NCT01721070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64745496|NCT01721070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64745497|NCT01721070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64745498|NCT01721070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745499|NCT01721070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745500|NCT01721070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64745501|NCT01721070|Hormone Antagonists|hormone antagonists|mesh-ancestor
64745502|NCT01721070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64745503|NCT01721070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64632515|NCT00004006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64632516|NCT00004006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64632517|NCT00004006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632518|NCT00004006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64632519|NCT00004006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64632520|NCT00003316|Gemcitabine|gemcitabine|mesh-list
64632521|NCT00003316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64745504|NCT01748292|Ranibizumab|ranibizumab|mesh-list
64745505|NCT01748292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64745506|NCT01748292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64322810|NCT02147015|Autonomic Agents|autonomic agents|mesh-ancestor
64322811|NCT02147015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64745519|NCT01720602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745520|NCT01720602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745521|NCT01720602|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64745522|NCT01720602|Hormone Antagonists|hormone antagonists|mesh-ancestor
64745523|NCT01720602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64745524|NCT01720602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745525|NCT01720602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64745526|NCT01720602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64745527|NCT01720602|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64745528|NCT01746732|Moxifloxacin|moxifloxacin|mesh-list
64745529|NCT01746732|Evacetrapib|evacetrapib|mesh-list
64745530|NCT01746732|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64745531|NCT01746732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64745532|NCT01746732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64322812|NCT02147015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322813|NCT02147015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64322815|NCT02147015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64322816|NCT02147015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64322817|NCT02147015|Protective Agents|protective agents|mesh-ancestor
64322818|NCT02147015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64322819|NCT02147015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322820|NCT02147015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64322821|NCT02229175|Bevacizumab|bevacizumab|mesh-list
64322822|NCT02229175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64745533|NCT01746732|Antimetabolites|antimetabolites|mesh-ancestor
64745534|NCT01746732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745535|NCT01746732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64745536|NCT01746732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64745537|NCT01746732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64745538|NCT01746732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64745539|NCT01746732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64431738|NCT04964063|Cariostatic Agents|cariostatic agents|mesh-ancestor
64431739|NCT04964063|Protective Agents|protective agents|mesh-ancestor
64431740|NCT04964063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745540|NCT01746732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745553|NCT01720524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745554|NCT01720524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745555|NCT01720524|Urological Agents|urological agents|mesh-ancestor
64745556|NCT01698918|Dexamethasone|dexamethasone|mesh-list
64745557|NCT01698918|Everolimus|everolimus|mesh-list
64745558|NCT01698918|Letrozole|letrozole|mesh-list
64745581|NCT01717638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745582|NCT01745094|Solifenacin Succinate|solifenacin succinate|mesh-list
64745583|NCT01745094|Mirabegron|mirabegron|mesh-list
64745584|NCT01745094|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64745585|NCT01745094|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64745586|NCT01745094|Cholinergic Agents|cholinergic agents|mesh-ancestor
64745587|NCT01745094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64745588|NCT01745094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745589|NCT01745094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745590|NCT01745094|Urological Agents|urological agents|mesh-ancestor
64745591|NCT01745094|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64745592|NCT01745094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64745593|NCT01745094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64745594|NCT01745094|Adrenergic Agents|adrenergic agents|mesh-ancestor
64745595|NCT01717326|Ribavirin|ribavirin|mesh-list
64745596|NCT01717326|Grazoprevir|grazoprevir|mesh-list
64745597|NCT01717326|Antimetabolites|antimetabolites|mesh-ancestor
64745598|NCT01717326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745599|NCT01717326|Antiviral Agents|antiviral agents|mesh-ancestor
64745600|NCT01717326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64745601|NCT01744782|Cysteamine|cysteamine|mesh-list
64745635|NCT01739790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64745636|NCT01739790|Expectorants|expectorants|mesh-ancestor
64745637|NCT01739790|Respiratory System Agents|respiratory system agents|mesh-ancestor
64745638|NCT01739790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64745639|NCT01739790|Antioxidants|antioxidants|mesh-ancestor
64745640|NCT01739790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745641|NCT01739790|Protective Agents|protective agents|mesh-ancestor
64745642|NCT01739790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745643|NCT01739790|Antidotes|antidotes|mesh-ancestor
64431780|NCT01855828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64322832|NCT05744739|Antimetabolites|antimetabolites|mesh-ancestor
64322833|NCT05744739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322834|NCT05744739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322835|NCT05744739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322836|NCT04947007|Bupivacaine|bupivacaine|mesh-list
64322837|NCT04947007|Anesthetics, Local|anesthetics, local|mesh-ancestor
64322838|NCT04947007|Anesthetics|anesthetics|mesh-ancestor
64322839|NCT04947007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64322840|NCT04947007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322841|NCT04947007|Sensory System Agents|sensory system agents|mesh-ancestor
64322842|NCT04947007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322843|NCT04104685|Minocycline|minocycline|mesh-list
64322844|NCT04104685|Adapalene|adapalene|mesh-list
64322845|NCT04104685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64322846|NCT04104685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632558|NCT00003322|Antimitotic Agents|antimitotic agents|mesh-ancestor
64632559|NCT00003322|Mitosis Modulators|mitosis modulators|mesh-ancestor
64632560|NCT00003322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322847|NCT04104685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64745644|NCT01696032|Gemcitabine|gemcitabine|mesh-list
64745645|NCT01696032|Paclitaxel|paclitaxel|mesh-list
64745646|NCT01696032|Carboplatin|carboplatin|mesh-list
64745647|NCT01696032|Doxorubicin|doxorubicin|mesh-list
64745648|NCT01696032|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64745649|NCT01696032|Topotecan|topotecan|mesh-list
64745650|NCT01696032|Guadecitabine|guadecitabine|mesh-list
64745651|NCT01696032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64745652|NCT01696032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64745653|NCT01696032|Tubulin Modulators|tubulin modulators|mesh-ancestor
64745654|NCT01696032|Antimitotic Agents|antimitotic agents|mesh-ancestor
64745655|NCT01696032|Mitosis Modulators|mitosis modulators|mesh-ancestor
64745656|NCT01696032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745657|NCT01696032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64745658|NCT01696032|Antimetabolites|antimetabolites|mesh-ancestor
64745659|NCT01696032|Antiviral Agents|antiviral agents|mesh-ancestor
64745660|NCT01696032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64745661|NCT01696032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745662|NCT01696032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64745663|NCT01696032|Immunologic Factors|immunologic factors|mesh-ancestor
64745664|NCT01696032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745665|NCT01696032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64514458|NCT05586789|Tryptophan|tryptophan|mesh-list
64357683|NCT03374501|PAZ320|paz320|mesh-list
64322848|NCT04104685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64322849|NCT04104685|Analgesics|analgesics|mesh-ancestor
64322850|NCT04104685|Sensory System Agents|sensory system agents|mesh-ancestor
64322851|NCT04104685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64745712|NCT01739400|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64745713|NCT01739400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745714|NCT01739400|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64745717|NCT01712178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64745718|NCT01693068|Dacarbazine|dacarbazine|mesh-list
64745719|NCT01693068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64745720|NCT01693068|Alkylating Agents|alkylating agents|mesh-ancestor
64745721|NCT01693068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745722|NCT01693068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64745723|NCT01691898|Rituximab|rituximab|mesh-list
64745724|NCT01691898|Obinutuzumab|obinutuzumab|mesh-list
64745725|NCT01691898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64745726|NCT01691898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64745727|NCT01691898|Immunologic Factors|immunologic factors|mesh-ancestor
64745728|NCT01691898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745729|NCT01691898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64745730|NCT01737840|Pantoprazole|pantoprazole|mesh-list
64745731|NCT01737840|Ranitidine|ranitidine|mesh-list
64745732|NCT01737840|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
64745733|NCT01737840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64745734|NCT01737840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64745735|NCT01737840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64431797|NCT02350309|Lemborexant|lemborexant|mesh-list
64745775|NCT01682148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64745776|NCT01682148|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64745777|NCT01682148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64745778|NCT01682148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64745787|NCT01681992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632593|NCT00003754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64632594|NCT00003754|Immunologic Factors|immunologic factors|mesh-ancestor
64745788|NCT01687998|Evacetrapib|evacetrapib|mesh-list
64632595|NCT00003754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745789|NCT01687998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64745790|NCT01687998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64745791|NCT01687998|Antimetabolites|antimetabolites|mesh-ancestor
64745792|NCT01687998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745793|NCT01687998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64745794|NCT01681212|Ipilimumab|ipilimumab|mesh-list
64745795|NCT01681212|Dacarbazine|dacarbazine|mesh-list
64745796|NCT01681212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64745797|NCT01681212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64745798|NCT01681212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64745799|NCT01681212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745800|NCT01681212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64514588|NCT05402020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64745812|NCT01687296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64745813|NCT01687296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64745814|NCT01687296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64745815|NCT01687296|Autonomic Agents|autonomic agents|mesh-ancestor
64745816|NCT01687296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64745817|NCT01687296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64745818|NCT01687296|Respiratory System Agents|respiratory system agents|mesh-ancestor
64745819|NCT01687296|Dermatologic Agents|dermatologic agents|mesh-ancestor
64745820|NCT01687296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64745821|NCT01687296|Tocolytic Agents|tocolytic agents|mesh-ancestor
64322894|NCT02695719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64322895|NCT02695719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64322896|NCT02695719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322897|NCT05498012|Cannabidiol|cannabidiol|mesh-list
64322898|NCT05498012|Anticonvulsants|anticonvulsants|mesh-ancestor
64322899|NCT02150291|Folic Acid|folic acid|mesh-list
64322900|NCT02150291|Vitamin B Complex|vitamin b complex|mesh-list
64322901|NCT02150291|Hematinics|hematinics|mesh-ancestor
64322902|NCT02150291|Vitamins|vitamins|mesh-ancestor
64322903|NCT02150291|Micronutrients|micronutrients|mesh-ancestor
64322904|NCT02150291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322905|NCT04907071|Coal Tar|coal tar|mesh-list
64322906|NCT04907071|Keratolytic Agents|keratolytic agents|mesh-ancestor
64322907|NCT04907071|Dermatologic Agents|dermatologic agents|mesh-ancestor
64322908|NCT02155517|Propofol|propofol|mesh-list
64322909|NCT02155517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64322910|NCT02155517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64322911|NCT02155517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322912|NCT02155517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64322913|NCT02155517|Anesthetics, General|anesthetics, general|mesh-ancestor
64322914|NCT02155517|Anesthetics|anesthetics|mesh-ancestor
64322915|NCT05497934|Glycerol|glycerol|mesh-list
64322916|NCT05497934|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64322917|NCT05497934|Protective Agents|protective agents|mesh-ancestor
64431890|NCT01855750|Mitosis Modulators|mitosis modulators|mesh-ancestor
64322921|NCT02229721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64322922|NCT02229721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322924|NCT05497700|Ephedrine|ephedrine|mesh-list
64322925|NCT05497700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64322926|NCT05497700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64322927|NCT05497700|Adrenergic Agents|adrenergic agents|mesh-ancestor
64322928|NCT05497700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64322929|NCT05497700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322930|NCT05497700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322931|NCT05497700|Sympathomimetics|sympathomimetics|mesh-ancestor
64322932|NCT05497700|Autonomic Agents|autonomic agents|mesh-ancestor
64322933|NCT05497700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322934|NCT05497700|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64322935|NCT05497700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64322936|NCT03106389|Misoprostol|misoprostol|mesh-list
64322937|NCT03106389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64322938|NCT03106389|Abortifacient Agents|abortifacient agents|mesh-ancestor
64745822|NCT01687296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64745823|NCT01687296|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64745824|NCT01687296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64745825|NCT01687296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64745826|NCT01687296|Adrenergic Agents|adrenergic agents|mesh-ancestor
64745827|NCT01687296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64745828|NCT01687296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745829|NCT01568892|Dolutegravir|dolutegravir|mesh-list
64745830|NCT01568892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64745831|NCT01568892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64745832|NCT01568892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745833|NCT01568892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745834|NCT01568892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64745835|NCT01568892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64745836|NCT01568892|Antiviral Agents|antiviral agents|mesh-ancestor
64745837|NCT01568892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64745839|NCT01568112|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64745840|NCT01568112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64322939|NCT03106389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64322940|NCT03106389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322941|NCT03106389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64322942|NCT03106389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64322943|NCT03106389|Oxytocics|oxytocics|mesh-ancestor
64322944|NCT03106311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64322945|NCT03106311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64322946|NCT03106311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322947|NCT02255045|Diclofenac|diclofenac|mesh-list
64322948|NCT02255045|Meloxicam|meloxicam|mesh-list
64322949|NCT02255045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64322950|NCT02255045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64322951|NCT02255045|Analgesics|analgesics|mesh-ancestor
64322952|NCT02255045|Sensory System Agents|sensory system agents|mesh-ancestor
64322953|NCT02255045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64322954|NCT02255045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64322955|NCT02255045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64322956|NCT02255045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64322957|NCT02255045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64322963|NCT02229799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64322964|NCT02229799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322965|NCT02150447|Lansoprazole|lansoprazole|mesh-list
64322966|NCT02150447|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64322967|NCT02150447|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64745841|NCT01568112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64745843|NCT01568112|Sensory System Agents|sensory system agents|mesh-ancestor
64745844|NCT01568112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64745845|NCT01568112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745846|NCT01568112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64745847|NCT01568112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64745848|NCT01568112|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64745849|NCT01568112|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64745850|NCT01568112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745851|NCT01568112|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64745852|NCT01568112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64745853|NCT01568112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745855|NCT01568112|Dermatologic Agents|dermatologic agents|mesh-ancestor
64745856|NCT01568112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64745857|NCT01568112|Immunologic Factors|immunologic factors|mesh-ancestor
64745858|NCT01568034|Levodopa|levodopa|mesh-list
64745859|NCT01568034|Carbidopa|carbidopa|mesh-list
64745860|NCT01568034|Opicapone|opicapone|mesh-list
64745861|NCT01568034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64745862|NCT01568034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64745863|NCT01568034|Dopamine Agents|dopamine agents|mesh-ancestor
64745864|NCT01568034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64745865|NCT01568034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745866|NCT01568034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745867|NCT01568034|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64745868|NCT01568034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745869|NCT01568034|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64745870|NCT01687218|Tenofovir|tenofovir|mesh-list
64745871|NCT01687218|Emtricitabine|emtricitabine|mesh-list
64745872|NCT01687218|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64745873|NCT01687218|Glycerol|glycerol|mesh-list
64745874|NCT01687218|Antiviral Agents|antiviral agents|mesh-ancestor
64745875|NCT01687218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64745876|NCT01687218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64745877|NCT01687218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64745878|NCT01687218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745879|NCT01687218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745880|NCT01687218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64745881|NCT01687218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64745882|NCT01687218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64745883|NCT01687218|Protective Agents|protective agents|mesh-ancestor
64745884|NCT01687218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745885|NCT01686828|Letrozole|letrozole|mesh-list
64745886|NCT01686828|Methyltestosterone|methyltestosterone|mesh-list
64745887|NCT01686828|Acyline|acyline|mesh-list
64745888|NCT01686828|Testosterone|testosterone|mesh-list
64745889|NCT01686828|Testosterone undecanoate|testosterone undecanoate|mesh-list
64745891|NCT01686828|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64745892|NCT01686828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64745893|NCT01686828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64745894|NCT01686828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64745895|NCT01686828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745896|NCT01686828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745897|NCT01686828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64745898|NCT01686828|Hormone Antagonists|hormone antagonists|mesh-ancestor
64632654|NCT04771754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632656|NCT04771754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64632657|NCT04771754|Antiviral Agents|antiviral agents|mesh-ancestor
64632658|NCT04771754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632659|NCT00003766|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64632660|NCT00003766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64745899|NCT01686828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64745900|NCT01686828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745901|NCT01686828|Androgens|androgens|mesh-ancestor
64745902|NCT01686828|Hormones|hormones|mesh-ancestor
64745903|NCT01686828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64745904|NCT01686828|Anabolic Agents|anabolic agents|mesh-ancestor
64745905|NCT01603602|Botulinum Toxins|botulinum toxins|mesh-list
64431896|NCT04937699|Aspirin|aspirin|mesh-list
64745925|NCT01684878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745927|NCT01684878|Antimetabolites|antimetabolites|mesh-ancestor
64745928|NCT01684878|Antiviral Agents|antiviral agents|mesh-ancestor
64745929|NCT01684878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64745930|NCT01684878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64745931|NCT01684878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64745932|NCT01684878|Immunologic Factors|immunologic factors|mesh-ancestor
64745933|NCT01684878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745934|NCT01684878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64745935|NCT01684878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64745936|NCT01684878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64745937|NCT01684722|Vitamin D|vitamin d|mesh-list
64745938|NCT01684722|Ergocalciferols|ergocalciferols|mesh-list
64745939|NCT01684722|Cholecalciferol|cholecalciferol|mesh-list
64745940|NCT01684722|Vitamins|vitamins|mesh-list
64745941|NCT01684722|Micronutrients|micronutrients|mesh-ancestor
64745942|NCT01684722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745943|NCT01684722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64745944|NCT01684722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64745945|NCT01592292|Adalimumab|adalimumab|mesh-list
64745956|NCT01592292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64745957|NCT01592292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64745958|NCT01592292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64745959|NCT01592292|Analgesics|analgesics|mesh-ancestor
64745960|NCT01592292|Sensory System Agents|sensory system agents|mesh-ancestor
64745961|NCT01592292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64745962|NCT01592292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64745963|NCT01565850|Darunavir|darunavir|mesh-list
64745964|NCT01565850|Cobicistat|cobicistat|mesh-list
64357976|NCT03378661|Benzonidazole|benzonidazole|mesh-list
64322968|NCT02150447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64322969|NCT02150447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322970|NCT02150447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322971|NCT02254889|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64322972|NCT02254889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322973|NCT02254889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745966|NCT01565850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745968|NCT01565850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64745969|NCT01565850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64745970|NCT01565850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64745971|NCT01565850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64745972|NCT01565850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64745973|NCT01565850|Protease Inhibitors|protease inhibitors|mesh-ancestor
64745974|NCT01565850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64745975|NCT01565850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64745976|NCT01565694|Solifenacin Succinate|solifenacin succinate|mesh-list
64745977|NCT01565694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64745978|NCT01565694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64745979|NCT01565694|Cholinergic Agents|cholinergic agents|mesh-ancestor
64745980|NCT01565694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64745981|NCT01565694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632677|NCT04389320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64745982|NCT01565694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745983|NCT01565694|Urological Agents|urological agents|mesh-ancestor
64745984|NCT01543152|Cyclophosphamide|cyclophosphamide|mesh-list
64745985|NCT01543152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64745986|NCT01543152|Immunologic Factors|immunologic factors|mesh-ancestor
64745987|NCT01543152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64745988|NCT01543152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64745989|NCT01543152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64745990|NCT01543152|Alkylating Agents|alkylating agents|mesh-ancestor
64322974|NCT05741229|Nitroglycerin|nitroglycerin|mesh-list
64322975|NCT05741229|Vasodilator Agents|vasodilator agents|mesh-ancestor
64322976|NCT02229955|Cyclosporine|cyclosporine|mesh-list
64322977|NCT02229955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64322978|NCT02229955|Cyclosporins|cyclosporins|mesh-list
64431898|NCT04937699|Ticagrelor|ticagrelor|mesh-list
64431900|NCT04937699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64746013|NCT01589094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746014|NCT01589094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64746015|NCT01589094|Antimetabolites|antimetabolites|mesh-ancestor
64746016|NCT01589094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746017|NCT01589094|Antiviral Agents|antiviral agents|mesh-ancestor
64746018|NCT01589094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64746019|NCT01589094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746020|NCT01589094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64746021|NCT01589094|Immunologic Factors|immunologic factors|mesh-ancestor
64746022|NCT01589094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746023|NCT01563354|Everolimus|everolimus|mesh-list
64746024|NCT01563354|Pasireotide|pasireotide|mesh-list
64746025|NCT01563354|Somatostatin|somatostatin|mesh-list
64746026|NCT01563354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746027|NCT01563354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64746028|NCT01563354|Immunologic Factors|immunologic factors|mesh-ancestor
64746029|NCT01563354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746030|NCT01563354|Hormones|hormones|mesh-ancestor
64746031|NCT01563354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64746032|NCT03027960|Empagliflozin|empagliflozin|mesh-list
64358059|NCT03377725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322989|NCT02229955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64322990|NCT02230033|Itraconazole|itraconazole|mesh-list
64322991|NCT02230033|Gemfibrozil|gemfibrozil|mesh-list
64322992|NCT02230033|Antifungal Agents|antifungal agents|mesh-ancestor
64322993|NCT02230033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64322994|NCT02230033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64322995|NCT02230033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64322996|NCT02230033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64322997|NCT02230033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64322998|NCT02230033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64322999|NCT02230033|Hormone Antagonists|hormone antagonists|mesh-ancestor
64632697|NCT00004036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64323000|NCT02230033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64323001|NCT02230033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323002|NCT02230033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64746033|NCT03027960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64746034|NCT03027960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746035|NCT03027960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64746036|NCT03027960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746037|NCT01539642|Sufentanil|sufentanil|mesh-list
64746038|NCT01539642|Dsuvia|dsuvia|mesh-list
64514823|NCT02074839|Ivosidenib|ivosidenib|mesh-list
64746039|NCT01539642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64746040|NCT01539642|Narcotics|narcotics|mesh-ancestor
64746041|NCT01539642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64746042|NCT01539642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746043|NCT01539642|Analgesics|analgesics|mesh-ancestor
64746044|NCT01539642|Sensory System Agents|sensory system agents|mesh-ancestor
64323004|NCT02230033|Antimetabolites|antimetabolites|mesh-ancestor
64323005|NCT02230033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64323006|NCT02230033|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64323008|NCT05740371|Antithrombins|antithrombins|mesh-ancestor
64323009|NCT05740371|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64323010|NCT05740371|Protease Inhibitors|protease inhibitors|mesh-ancestor
64323011|NCT05740371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431922|NCT01622673|Antacids|antacids|mesh-list
64746045|NCT01539642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64746046|NCT01539642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64746047|NCT01539642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64746048|NCT01539642|Anesthetics, General|anesthetics, general|mesh-ancestor
64746050|NCT01538472|Cytarabine|cytarabine|mesh-list
64746051|NCT01538472|Rituximab|rituximab|mesh-list
64746052|NCT01538472|Melphalan|melphalan|mesh-list
64746053|NCT01538472|Carmustine|carmustine|mesh-list
64746054|NCT01538472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64746055|NCT01538472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64746056|NCT01538472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746057|NCT01538472|Immunologic Factors|immunologic factors|mesh-ancestor
64746058|NCT01538472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746059|NCT01538472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64746060|NCT01538472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64746061|NCT01538472|Antimetabolites|antimetabolites|mesh-ancestor
64746062|NCT01538472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746063|NCT01538472|Antiviral Agents|antiviral agents|mesh-ancestor
64746064|NCT01538472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64746065|NCT01538472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64746066|NCT01538472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64746067|NCT01538472|Alkylating Agents|alkylating agents|mesh-ancestor
64746068|NCT01538472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64746069|NCT01562028|Bevacizumab|bevacizumab|mesh-list
64746070|NCT01562028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64746071|NCT01562028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64746072|NCT01562028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323026|NCT03915067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323027|NCT03915067|Cholinergic Agents|cholinergic agents|mesh-ancestor
64323028|NCT03915067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64323029|NCT02691507|Decanoic acid|decanoic acid|mesh-list
64323030|NCT02691507|Antifungal Agents|antifungal agents|mesh-ancestor
64431947|NCT02469077|Analgesics|analgesics|mesh-ancestor
64746078|NCT01562028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64746080|NCT01562028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746081|NCT04767828|Capecitabine|capecitabine|mesh-list
64632726|NCT00003346|Antidotes|antidotes|mesh-ancestor
64632727|NCT00003346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64632740|NCT00096122|Immunologic Factors|immunologic factors|mesh-ancestor
64632741|NCT00096122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746082|NCT04767828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64746083|NCT04767828|Antimetabolites|antimetabolites|mesh-ancestor
64746084|NCT04767828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746085|NCT04767828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746086|NCT01585584|Protease Inhibitors|protease inhibitors|mesh-list
64746087|NCT01585584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746088|NCT01585584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746089|NCT01537068|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64746090|NCT01537068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64746091|NCT01537068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64746092|NCT01537068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64746093|NCT01537068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746094|NCT01537068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64746095|NCT01537068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746096|NCT01537068|Antidepressive Agents|antidepressive agents|mesh-ancestor
64746097|NCT01537068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64323035|NCT02259361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746098|NCT01585428|Aldesleukin|aldesleukin|mesh-list
64746099|NCT01585428|Cyclophosphamide|cyclophosphamide|mesh-list
64746100|NCT01585428|Fludarabine|fludarabine|mesh-list
64746101|NCT01585428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64746102|NCT01585428|Immunologic Factors|immunologic factors|mesh-ancestor
64746103|NCT01585428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746104|NCT01585428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64746105|NCT01585428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64746106|NCT01585428|Alkylating Agents|alkylating agents|mesh-ancestor
64746107|NCT01585428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746108|NCT01585428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746109|NCT01585428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64746110|NCT01585428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64746111|NCT01585428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64746112|NCT01585428|Antiviral Agents|antiviral agents|mesh-ancestor
64746113|NCT01585428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64746114|NCT01585272|Rivastigmine|rivastigmine|mesh-list
64746115|NCT01585272|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64746116|NCT01585272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746117|NCT01585272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746118|NCT01585272|Cholinergic Agents|cholinergic agents|mesh-ancestor
64746119|NCT01585272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64746120|NCT01585272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746121|NCT01585272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64746156|NCT01584648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64746157|NCT01584648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746158|NCT01584648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746159|NCT01559454|Buprenorphine|buprenorphine|mesh-list
64746160|NCT01559454|Methadone|methadone|mesh-list
64746161|NCT01559454|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64746162|NCT01559454|Naloxone|naloxone|mesh-list
64746163|NCT01559454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64746164|NCT01559454|Narcotics|narcotics|mesh-ancestor
64746165|NCT01559454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64746166|NCT01559454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746167|NCT01559454|Analgesics|analgesics|mesh-ancestor
64746168|NCT01559454|Sensory System Agents|sensory system agents|mesh-ancestor
64746169|NCT01559454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64632742|NCT00096122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64632743|NCT00096122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64632744|NCT00096122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64746170|NCT01559454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64746171|NCT01559454|Antitussive Agents|antitussive agents|mesh-ancestor
64746172|NCT01559454|Respiratory System Agents|respiratory system agents|mesh-ancestor
64746173|NCT01583166|Epinephrine|epinephrine|mesh-list
64746174|NCT01583166|Bupivacaine|bupivacaine|mesh-list
64358185|NCT03381781|Decitabine|decitabine|mesh-list
64431951|NCT02486627|Levofloxacin|levofloxacin|mesh-list
64746187|NCT01583166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64746189|NCT01583166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64746190|NCT01583166|Respiratory System Agents|respiratory system agents|mesh-ancestor
64746191|NCT01583166|Mydriatics|mydriatics|mesh-ancestor
64746192|NCT01583166|Sympathomimetics|sympathomimetics|mesh-ancestor
64746193|NCT01583166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64746194|NCT01582854|Actovegin|actovegin|mesh-list
64746195|NCT01582854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64746196|NCT01582854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746197|NCT01582854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64746198|NCT01582854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64746199|NCT01582854|Antioxidants|antioxidants|mesh-ancestor
64323041|NCT02151695|Growth Inhibitors|growth inhibitors|mesh-ancestor
64323042|NCT02151695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323043|NCT02151929|Everolimus|everolimus|mesh-list
64323044|NCT02151929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323045|NCT02151929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64323046|NCT02151929|Immunologic Factors|immunologic factors|mesh-ancestor
64323047|NCT02151929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323048|NCT03542357|Calcitonin|calcitonin|mesh-list
64746200|NCT01582854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746202|NCT01582854|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64746203|NCT01582308|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64746204|NCT01582308|Vildagliptin|vildagliptin|mesh-list
64746205|NCT01582308|Saxagliptin|saxagliptin|mesh-list
64746206|NCT01582308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64746207|NCT01582308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746208|NCT01582308|Incretins|incretins|mesh-ancestor
64746209|NCT01582308|Hormones|hormones|mesh-ancestor
64746210|NCT01582308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64746211|NCT01582308|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64746212|NCT01582308|Protease Inhibitors|protease inhibitors|mesh-ancestor
64746227|NCT01535040|Dopamine Agents|dopamine agents|mesh-ancestor
64746228|NCT01535040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64746229|NCT01535040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746230|NCT01535040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746231|NCT01535040|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64746232|NCT01535040|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64746234|NCT01534962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64746235|NCT01534962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64746236|NCT01534962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746237|NCT01582152|Bevacizumab|bevacizumab|mesh-list
64746238|NCT01582152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64746239|NCT01582152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746240|NCT01582152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64432043|NCT01891864|Immunologic Factors|immunologic factors|mesh-ancestor
64746328|NCT01577160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64746329|NCT01577160|Serotonin Agents|serotonin agents|mesh-ancestor
64746330|NCT01577160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64632752|NCT00004042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64632753|NCT00004042|Antibodies|antibodies|mesh-list
64746331|NCT01577160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746332|NCT01577160|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64746333|NCT01577160|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64746334|NCT01577160|Dopamine Agents|dopamine agents|mesh-ancestor
64746335|NCT01554618|Exenatide|exenatide|mesh-list
64746336|NCT01554618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64746337|NCT01554618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746338|NCT01554618|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64746339|NCT01554618|Incretins|incretins|mesh-ancestor
64746340|NCT01554618|Hormones|hormones|mesh-ancestor
64746341|NCT01554618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64746342|NCT01531998|Dexamethasone|dexamethasone|mesh-list
64746343|NCT01531998|Lenalidomide|lenalidomide|mesh-list
64746344|NCT01531998|Bortezomib|bortezomib|mesh-list
64746345|NCT01531998|Siltuximab|siltuximab|mesh-list
64746346|NCT01531998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64746347|NCT01531998|Antiemetics|antiemetics|mesh-ancestor
64746348|NCT01531998|Autonomic Agents|autonomic agents|mesh-ancestor
64358367|NCT03362905|Lidocaine|lidocaine|mesh-list
64323067|NCT04811001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323068|NCT02150993|Ritonavir|ritonavir|mesh-list
64323069|NCT02150993|Lopinavir|lopinavir|mesh-list
64323070|NCT02150993|Tenofovir|tenofovir|mesh-list
64323075|NCT02150993|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64323076|NCT02150993|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64323077|NCT02150993|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64323078|NCT02150993|Protease Inhibitors|protease inhibitors|mesh-ancestor
64746349|NCT01531998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64746350|NCT01531998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746351|NCT01531998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64746352|NCT01531998|Glucocorticoids|glucocorticoids|mesh-ancestor
64746354|NCT01531998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64746355|NCT01531998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64746356|NCT01531998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746357|NCT01531998|Immunologic Factors|immunologic factors|mesh-ancestor
64746358|NCT01531998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64746359|NCT01531998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64746360|NCT01531998|Growth Substances|growth substances|mesh-ancestor
64746361|NCT01531998|Growth Inhibitors|growth inhibitors|mesh-ancestor
64746362|NCT01553916|Lithium Carbonate|lithium carbonate|mesh-list
64746363|NCT01553916|Antidepressive Agents|antidepressive agents|mesh-ancestor
64746364|NCT01553916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64746365|NCT01553916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746366|NCT01553916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746367|NCT01553916|Antimanic Agents|antimanic agents|mesh-ancestor
64746368|NCT01553916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64746369|NCT01553916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64746370|NCT01553916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746371|NCT01553136|Varenicline|varenicline|mesh-list
64746372|NCT01553136|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64746373|NCT01553136|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64746395|NCT02072928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64746396|NCT02072928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746397|NCT02072928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64746398|NCT02072928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64632771|NCT00003784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632772|NCT00003784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746399|NCT01529346|Ibuprofen|ibuprofen|mesh-list
64432127|NCT04891484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64746400|NCT01529346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64746401|NCT01529346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64746402|NCT01529346|Analgesics|analgesics|mesh-ancestor
64746403|NCT01529346|Sensory System Agents|sensory system agents|mesh-ancestor
64746404|NCT01529346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64746405|NCT01529346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746406|NCT01529346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64746407|NCT01529346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64746408|NCT01529346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64746409|NCT01529346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746410|NCT01529346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746412|NCT01529268|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
64746413|NCT01529268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746414|NCT01529112|Lenvatinib|lenvatinib|mesh-list
64746415|NCT01529112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746416|NCT01529112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64746417|NCT01529112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746418|NCT01529112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746419|NCT01575054|Botulinum Toxins|botulinum toxins|mesh-list
64746420|NCT01575054|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64746421|NCT01575054|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64746422|NCT01575054|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64746423|NCT01575054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64746424|NCT01575054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746425|NCT01575054|Cholinergic Agents|cholinergic agents|mesh-ancestor
64746426|NCT01575054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64746427|NCT01575054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746428|NCT01575054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64746429|NCT01575054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64746430|NCT01528254|Metformin|metformin|mesh-list
64746432|NCT01528254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64746433|NCT01528254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746434|NCT01528254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64746435|NCT01528254|Protease Inhibitors|protease inhibitors|mesh-ancestor
64746436|NCT01528254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746437|NCT01528254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746438|NCT01574274|Pegaspargase|pegaspargase|mesh-list
64746439|NCT01574274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746440|NCT01526148|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64746441|NCT01526148|Lithium Carbonate|lithium carbonate|mesh-list
64632789|NCT00003352|Doxorubicin|doxorubicin|mesh-list
64632790|NCT00003352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64632791|NCT00003352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64632792|NCT00003352|Immunologic Factors|immunologic factors|mesh-ancestor
64746442|NCT01526148|Antidepressive Agents|antidepressive agents|mesh-ancestor
64746443|NCT01526148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64746444|NCT01526148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64746445|NCT01526148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64746446|NCT01526148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64746447|NCT01526148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746448|NCT01526148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746449|NCT01526148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746450|NCT01526148|Antimanic Agents|antimanic agents|mesh-ancestor
64746451|NCT01525602|Paclitaxel|paclitaxel|mesh-list
64746452|NCT01525602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64746453|NCT01525602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746454|NCT01525602|Tubulin Modulators|tubulin modulators|mesh-ancestor
64746455|NCT01525602|Antimitotic Agents|antimitotic agents|mesh-ancestor
64746456|NCT01525602|Mitosis Modulators|mitosis modulators|mesh-ancestor
64746457|NCT01525602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746458|NCT01549002|Fentanyl|fentanyl|mesh-list
64746459|NCT01549002|Morphine|morphine|mesh-list
64746460|NCT01549002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64746461|NCT01549002|Narcotics|narcotics|mesh-ancestor
64746462|NCT01549002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64746464|NCT01549002|Analgesics|analgesics|mesh-ancestor
64746475|NCT01572792|Formoterol Fumarate|formoterol fumarate|mesh-list
64746476|NCT01572792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64746477|NCT01572792|Autonomic Agents|autonomic agents|mesh-ancestor
64746478|NCT01572792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64746479|NCT01572792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746480|NCT01572792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64746481|NCT01572792|Respiratory System Agents|respiratory system agents|mesh-ancestor
64746482|NCT01572792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64746483|NCT01572792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64746484|NCT01572792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64746485|NCT01572792|Adrenergic Agents|adrenergic agents|mesh-ancestor
64746486|NCT01572792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64746487|NCT01572792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746488|NCT01572792|Anticonvulsants|anticonvulsants|mesh-ancestor
64746490|NCT01547598|Bimatoprost|bimatoprost|mesh-list
64746491|NCT01547598|Travoprost|travoprost|mesh-list
64746492|NCT01547598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64746493|NCT01547598|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64746494|NCT01547598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64746495|NCT01547598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64746496|NCT01547598|Adrenergic Agents|adrenergic agents|mesh-ancestor
64746497|NCT01547598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64746498|NCT01547598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746499|NCT01547598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746500|NCT01547598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64746501|NCT01547598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64746502|NCT01547286|Methacholine Chloride|methacholine chloride|mesh-list
64746503|NCT01547286|Miotics|miotics|mesh-ancestor
64746504|NCT01547286|Autonomic Agents|autonomic agents|mesh-ancestor
64746505|NCT01547286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64746506|NCT01547286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746507|NCT01547286|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64746508|NCT01547286|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
64746515|NCT01524978|Cetuximab|cetuximab|mesh-list
64746517|NCT01524978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64746518|NCT01524978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746519|NCT01524978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64746520|NCT01524978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746521|NCT01524978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746522|NCT01524198|Budesonide|budesonide|mesh-list
64746523|NCT01524198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64746524|NCT01524198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64746525|NCT01524198|Autonomic Agents|autonomic agents|mesh-ancestor
64746526|NCT01524198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64746527|NCT01524198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746528|NCT01524198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64746529|NCT01524198|Respiratory System Agents|respiratory system agents|mesh-ancestor
64432296|NCT02404220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64746557|NCT01571232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64746558|NCT01571232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432370|NCT02349295|Dermatologic Agents|dermatologic agents|mesh-ancestor
64432371|NCT04877587|Gemcitabine|gemcitabine|mesh-list
64746562|NCT01571232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746563|NCT01571232|Growth Inhibitors|growth inhibitors|mesh-ancestor
64746564|NCT01571232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64746565|NCT01571232|Antiemetics|antiemetics|mesh-ancestor
64746566|NCT01571232|Autonomic Agents|autonomic agents|mesh-ancestor
64746567|NCT01571232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64746568|NCT01571232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64746569|NCT01571232|Glucocorticoids|glucocorticoids|mesh-ancestor
64746570|NCT01571232|Hormones|hormones|mesh-ancestor
64746571|NCT01571232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64746572|NCT01571232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64746573|NCT01522950|Atenolol|atenolol|mesh-list
64746574|NCT01522950|Nebivolol|nebivolol|mesh-list
64746575|NCT01522950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64746576|NCT01522950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64746577|NCT01522950|Sympatholytics|sympatholytics|mesh-ancestor
64746578|NCT01522950|Autonomic Agents|autonomic agents|mesh-ancestor
64746579|NCT01522950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64746580|NCT01522950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746581|NCT01522950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64632833|NCT00004060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64632834|NCT00004060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64632835|NCT00004060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746582|NCT01522950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64746583|NCT01522950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64632836|NCT00004060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746584|NCT01522950|Adrenergic Agents|adrenergic agents|mesh-ancestor
64746585|NCT01522950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64746586|NCT01522950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746587|NCT01522950|Vasodilator Agents|vasodilator agents|mesh-ancestor
64746588|NCT01522950|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64746589|NCT01522950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64746590|NCT01522950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64746591|NCT01522404|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64746592|NCT01522404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64746593|NCT01522404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64746594|NCT01522404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64323079|NCT02150993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323080|NCT02150993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323081|NCT02150993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64323082|NCT02150993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64746603|NCT03911466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746604|NCT03911466|Analgesics|analgesics|mesh-ancestor
64746605|NCT03911466|Sensory System Agents|sensory system agents|mesh-ancestor
64746606|NCT03911466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64746607|NCT03911466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64746608|NCT01543776|Abiraterone Acetate|abiraterone acetate|mesh-list
64746609|NCT01543776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746610|NCT01543776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64746611|NCT01543776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746612|NCT01543776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746613|NCT01543776|Hormone Antagonists|hormone antagonists|mesh-ancestor
64746614|NCT01543776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64746615|NCT01543776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746616|NCT01543776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64746617|NCT01518192|Doxycycline|doxycycline|mesh-list
64432517|NCT02282605|Disinfectants|disinfectants|mesh-ancestor
64432518|NCT02282605|Dermatologic Agents|dermatologic agents|mesh-ancestor
64432519|NCT02282527|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64746618|NCT01518192|Cefuroxime|cefuroxime|mesh-list
64746619|NCT01518192|Cefuroxime axetil|cefuroxime axetil|mesh-list
64746620|NCT01518192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64746621|NCT01518192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64746622|NCT01518192|Antimalarials|antimalarials|mesh-ancestor
64323083|NCT02150993|Antiviral Agents|antiviral agents|mesh-ancestor
64323084|NCT02150993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64323085|NCT02150993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64632868|NCT00003364|Tubulin Modulators|tubulin modulators|mesh-ancestor
64632869|NCT00003364|Antimitotic Agents|antimitotic agents|mesh-ancestor
64632870|NCT00003364|Mitosis Modulators|mitosis modulators|mesh-ancestor
64632871|NCT00004066|Gemcitabine|gemcitabine|mesh-list
64323086|NCT02150993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64323087|NCT02150993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64323088|NCT02150993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64323089|NCT02150993|Antimetabolites|antimetabolites|mesh-ancestor
64323090|NCT02150993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64323091|NCT02150993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64323092|NCT02690727|Tenalisib|tenalisib|mesh-list
64323093|NCT02690727|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
64323094|NCT02690727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432561|NCT02278471|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64432563|NCT02278471|Diuretics|diuretics|mesh-ancestor
64323096|NCT02224105|Prednisolone|prednisolone|mesh-list
64323097|NCT02224105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64323098|NCT02224105|Methylprednisolone|methylprednisolone|mesh-list
64323099|NCT02224105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64323100|NCT02224105|Prednisolone acetate|prednisolone acetate|mesh-list
64323101|NCT02224105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64323102|NCT02224105|Prednisolone phosphate|prednisolone phosphate|mesh-list
64323103|NCT02224105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64323104|NCT02224105|Glucocorticoids|glucocorticoids|mesh-ancestor
64323105|NCT02224105|Hormones|hormones|mesh-ancestor
64323106|NCT02224105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64323107|NCT02224105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323108|NCT02224105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64323109|NCT02224105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323122|NCT04057131|Sensory System Agents|sensory system agents|mesh-ancestor
64323123|NCT04057131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64323124|NCT04057131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323125|NCT04057131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64323126|NCT04057131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64746623|NCT01518192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64746624|NCT01518192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64746625|NCT01517802|Prednisone|prednisone|mesh-list
64746626|NCT01517802|Abiraterone Acetate|abiraterone acetate|mesh-list
64746627|NCT01517802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64746628|NCT01517802|Glucocorticoids|glucocorticoids|mesh-ancestor
64746629|NCT01517802|Hormones|hormones|mesh-ancestor
64632902|NCT00003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746630|NCT01517802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64746631|NCT01517802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515427|NCT01989910|Efavirenz|efavirenz|mesh-list
64746632|NCT01517802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64746633|NCT01517802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746634|NCT01517802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64746635|NCT01517802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746636|NCT01517802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746637|NCT01517802|Hormone Antagonists|hormone antagonists|mesh-ancestor
64746638|NCT01517802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64746640|NCT04714710|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64746641|NCT04714710|Hormone Antagonists|hormone antagonists|mesh-ancestor
64432624|NCT01850524|Dexamethasone|dexamethasone|mesh-list
64432625|NCT01850524|Lenalidomide|lenalidomide|mesh-list
64432681|NCT01849588|Sorafenib|sorafenib|mesh-list
64746646|NCT04714710|Natriuretic Agents|natriuretic agents|mesh-ancestor
64746647|NCT01520922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64746648|NCT01520922|Ofatumumab|ofatumumab|mesh-list
64358678|NCT05405049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64323127|NCT04057131|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
64323128|NCT04057131|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
64323129|NCT04057131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323130|NCT04057131|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64323131|NCT04057131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64746656|NCT01517412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746657|NCT01489956|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64746658|NCT01489956|Freund's Adjuvant|freund's adjuvant|mesh-list
64746659|NCT01489956|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
64746660|NCT01489956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64432942|NCT02264821|Sensory System Agents|sensory system agents|mesh-ancestor
64432943|NCT02264821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64632944|NCT00004840|Hormones|hormones|mesh-list
64432945|NCT04854889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64432946|NCT04854889|Antimetabolites|antimetabolites|mesh-ancestor
64432963|NCT05356741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432964|NCT05341843|Sertraline|sertraline|mesh-list
64432965|NCT05341843|Antidepressive Agents|antidepressive agents|mesh-ancestor
64432966|NCT05341843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64432967|NCT05341843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64432974|NCT05646199|Metformin|metformin|mesh-list
64746676|NCT01516008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64746677|NCT01489254|Glatiramer Acetate|glatiramer acetate|mesh-list
64746678|NCT01489254|(T,G)-A-L|(t,g)-a-l|mesh-list
64746679|NCT01489254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64746680|NCT01489254|Immunologic Factors|immunologic factors|mesh-ancestor
64746681|NCT01489254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746682|NCT01489254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64746683|NCT01489254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64746684|NCT01489020|Vaccines|vaccines|mesh-list
64746685|NCT01489020|Immunologic Factors|immunologic factors|mesh-ancestor
64746686|NCT01489020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746687|NCT01514682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64746688|NCT01514448|Everolimus|everolimus|mesh-list
64746689|NCT01514448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746690|NCT01514448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64433370|NCT04730037|Antithrombins|antithrombins|mesh-ancestor
64433371|NCT04730037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64433372|NCT04730037|Protease Inhibitors|protease inhibitors|mesh-ancestor
64433373|NCT04730037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433374|NCT04730037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433375|NCT04685811|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64433376|NCT04685811|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64433377|NCT04685811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433378|NCT04709211|Bupivacaine|bupivacaine|mesh-list
64433379|NCT04709211|Anesthetics, Local|anesthetics, local|mesh-ancestor
64433380|NCT04709211|Anesthetics|anesthetics|mesh-ancestor
64433381|NCT04709211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64433382|NCT04709211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433383|NCT04709211|Sensory System Agents|sensory system agents|mesh-ancestor
64433384|NCT04709211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64433385|NCT02443883|Ramucirumab|ramucirumab|mesh-list
64433386|NCT02443883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433387|NCT02087241|Carboplatin|carboplatin|mesh-list
64632982|NCT00004864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632983|NCT00004864|Tubulin Modulators|tubulin modulators|mesh-ancestor
64632984|NCT00004864|Antimitotic Agents|antimitotic agents|mesh-ancestor
64632985|NCT00004864|Mitosis Modulators|mitosis modulators|mesh-ancestor
64433388|NCT02087241|Pemetrexed|pemetrexed|mesh-list
64746699|NCT01514370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632986|NCT00004864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746700|NCT01514370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64746701|NCT01514370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64746703|NCT01514370|Sensory System Agents|sensory system agents|mesh-ancestor
64746704|NCT01514370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64746705|NCT01514370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64515496|NCT01878669|Antidotes|antidotes|mesh-ancestor
64746706|NCT01514370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64746707|NCT01514370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64746708|NCT01514370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746709|NCT01514370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746710|NCT01514370|Immunologic Factors|immunologic factors|mesh-ancestor
64746711|NCT01514370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64746712|NCT01519674|Insulin|insulin|mesh-list
64746713|NCT01519674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64746714|NCT01519674|Metformin|metformin|mesh-list
64746715|NCT01519674|Insulin Aspart|insulin aspart|mesh-list
64746716|NCT01519674|Insulin, Long-Acting|insulin, long-acting|mesh-list
64433796|NCT01820572|Tacrolimus|tacrolimus|mesh-list
64323145|NCT02230735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323146|NCT02230735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64323147|NCT02230735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64323149|NCT02230735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434082|NCT02431247|Emtricitabine|emtricitabine|mesh-list
64746749|NCT01518972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746750|NCT01518972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746752|NCT01513590|Insulin Aspart|insulin aspart|mesh-list
64746753|NCT01513590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64434409|NCT01788358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64746760|NCT04672512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746761|NCT04672512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64746763|NCT01512108|Liraglutide|liraglutide|mesh-list
64746764|NCT01512108|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64746765|NCT01512108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746766|NCT01512108|Incretins|incretins|mesh-ancestor
64746767|NCT01512108|Hormones|hormones|mesh-ancestor
64746768|NCT01512108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64746769|NCT01486758|Azithromycin|azithromycin|mesh-list
64746770|NCT01486758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64746771|NCT01486758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64746772|NCT01463982|Capecitabine|capecitabine|mesh-list
64746773|NCT01463982|Irinotecan|irinotecan|mesh-list
64746774|NCT01463982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64746775|NCT01463982|Antimetabolites|antimetabolites|mesh-ancestor
64746776|NCT01463982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434488|NCT01993329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434489|NCT01993329|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64434490|NCT01993329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434491|NCT01993329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64434492|NCT02016183|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64434493|NCT02016183|Candesartan|candesartan|mesh-list
64434494|NCT02016183|Candesartan cilexetil|candesartan cilexetil|mesh-list
64746779|NCT01463982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64515579|NCT02461368|Glucocorticoids|glucocorticoids|mesh-ancestor
64746780|NCT01463982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746781|NCT01510158|Allopurinol|allopurinol|mesh-list
64746782|NCT01510158|Lesinurad|lesinurad|mesh-list
64746783|NCT01510158|Antimetabolites|antimetabolites|mesh-ancestor
64746784|NCT01510158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746785|NCT01510158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746786|NCT01510158|Gout Suppressants|gout suppressants|mesh-ancestor
64746787|NCT01510158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64746788|NCT01510158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64746789|NCT01510158|Antioxidants|antioxidants|mesh-ancestor
64746790|NCT01510158|Protective Agents|protective agents|mesh-ancestor
64746791|NCT01510158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746792|NCT01510158|Uricosuric Agents|uricosuric agents|mesh-ancestor
64746793|NCT01510158|Renal Agents|renal agents|mesh-ancestor
64746794|NCT04080882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64746795|NCT04080882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64746796|NCT04080882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64746797|NCT04080882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64746798|NCT04080882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746799|NCT04080882|Cholinergic Agents|cholinergic agents|mesh-ancestor
64746800|NCT04080882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64358809|NCT04278651|Hematinics|hematinics|mesh-ancestor
64746801|NCT04080882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746802|NCT04080882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64746803|NCT04080882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64746805|NCT01484496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64746806|NCT01484496|Immunologic Factors|immunologic factors|mesh-ancestor
64746807|NCT01484496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746808|NCT01509846|Vaccines|vaccines|mesh-list
64746809|NCT01509846|Immunologic Factors|immunologic factors|mesh-ancestor
64434625|NCT02374853|Vancomycin|vancomycin|mesh-list
64434732|NCT01993017|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64633036|NCT00003832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64633037|NCT00003850|Thalidomide|thalidomide|mesh-list
64633038|NCT00003850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64633039|NCT00003850|Immunologic Factors|immunologic factors|mesh-ancestor
64633040|NCT00003850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434733|NCT01993017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64434734|NCT01993017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64633049|NCT00004072|Carmustine|carmustine|mesh-list
64434735|NCT01993017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64434736|NCT01993017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64434737|NCT01993017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323157|NCT02258581|Antiviral Agents|antiviral agents|mesh-ancestor
64323158|NCT02258581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64323159|NCT02258581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64323160|NCT02258581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64323161|NCT02258581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323162|NCT02258581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323163|NCT02258581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64323164|NCT02258581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64323165|NCT05746377|Metoclopramide|metoclopramide|mesh-list
64323166|NCT05746377|Antiemetics|antiemetics|mesh-ancestor
64434848|NCT02079519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323167|NCT05746377|Autonomic Agents|autonomic agents|mesh-ancestor
64323173|NCT05746377|Dopamine Agents|dopamine agents|mesh-ancestor
64746818|NCT01462344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64746819|NCT01462344|Respiratory System Agents|respiratory system agents|mesh-ancestor
64746820|NCT01462344|Glucocorticoids|glucocorticoids|mesh-ancestor
64746821|NCT01462344|Hormones|hormones|mesh-ancestor
64746822|NCT01462344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64746823|NCT01462344|Sympathomimetics|sympathomimetics|mesh-ancestor
64746824|NCT01462344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64435163|NCT02366195|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
64746825|NCT01462344|Dermatologic Agents|dermatologic agents|mesh-ancestor
64746826|NCT01462344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64746827|NCT01462266|Metformin|metformin|mesh-list
64746828|NCT01462266|Insulin Glargine|insulin glargine|mesh-list
64746829|NCT01462266|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64746830|NCT01462266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64633072|NCT00014222|Epoetin Alfa|epoetin alfa|mesh-list
64633073|NCT00014222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64633074|NCT00014222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633075|NCT00014222|Tubulin Modulators|tubulin modulators|mesh-ancestor
64633076|NCT00014222|Antimitotic Agents|antimitotic agents|mesh-ancestor
64633077|NCT00014222|Mitosis Modulators|mitosis modulators|mesh-ancestor
64746831|NCT01462266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746832|NCT01462266|Incretins|incretins|mesh-ancestor
64633078|NCT00014222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633079|NCT00014222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64633080|NCT00014222|Immunologic Factors|immunologic factors|mesh-ancestor
64633081|NCT00014222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633082|NCT00014222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64633083|NCT00014222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64746833|NCT01462266|Hormones|hormones|mesh-ancestor
64633084|NCT00014222|Alkylating Agents|alkylating agents|mesh-ancestor
64746834|NCT01462266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64746835|NCT01462266|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64746836|NCT01462266|Protease Inhibitors|protease inhibitors|mesh-ancestor
64746837|NCT01462266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435164|NCT02366195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64435165|NCT02366195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435166|NCT04905251|Misoprostol|misoprostol|mesh-list
64435167|NCT04905251|Mifepristone|mifepristone|mesh-list
64435399|NCT02281760|Protective Agents|protective agents|mesh-ancestor
64435400|NCT02281760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435401|NCT02281760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64435402|NCT02281760|Antioxidants|antioxidants|mesh-ancestor
64435411|NCT02390219|Ivacaftor|ivacaftor|mesh-list
64323178|NCT03165825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64323179|NCT03165825|Antiemetics|antiemetics|mesh-ancestor
64323180|NCT03165825|Autonomic Agents|autonomic agents|mesh-ancestor
64323181|NCT03165825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64746838|NCT01462266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746839|NCT04087590|Glycopyrrolate|glycopyrrolate|mesh-list
64746840|NCT04087590|Formoterol Fumarate|formoterol fumarate|mesh-list
64746841|NCT04087590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64746842|NCT04087590|Autonomic Agents|autonomic agents|mesh-ancestor
64746843|NCT04087590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64746844|NCT04087590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746845|NCT04087590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64746846|NCT04087590|Respiratory System Agents|respiratory system agents|mesh-ancestor
64746847|NCT04087590|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64746848|NCT04087590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64746849|NCT04087590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64746850|NCT04087590|Adrenergic Agents|adrenergic agents|mesh-ancestor
64746851|NCT04087590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64746852|NCT04087590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746853|NCT04087590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64746854|NCT04087590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64515650|NCT03296670|Nitroglycerin|nitroglycerin|mesh-list
64746855|NCT04087590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64746856|NCT04087590|Cholinergic Agents|cholinergic agents|mesh-ancestor
64746857|NCT01508676|Diclofenac|diclofenac|mesh-list
64746858|NCT01508676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64746859|NCT01508676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64746860|NCT01508676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64746861|NCT01508676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64746862|NCT01508676|Analgesics|analgesics|mesh-ancestor
64746863|NCT01508676|Sensory System Agents|sensory system agents|mesh-ancestor
64746864|NCT01508676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64746865|NCT01508676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746866|NCT01508676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64746867|NCT01508676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64435473|NCT02358863|Tubulin Modulators|tubulin modulators|mesh-ancestor
64746868|NCT01508676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435474|NCT02358863|Antimitotic Agents|antimitotic agents|mesh-ancestor
64435475|NCT02358863|Mitosis Modulators|mitosis modulators|mesh-ancestor
64435531|NCT02388737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64435532|NCT02388737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64435533|NCT02388737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64435534|NCT02388737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435535|NCT02388737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435536|NCT02355665|Nicotine|nicotine|mesh-list
64435537|NCT02355665|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64435538|NCT02355665|Autonomic Agents|autonomic agents|mesh-ancestor
64435539|NCT02355665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64435598|NCT02353871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435599|NCT02353871|Cholinergic Agents|cholinergic agents|mesh-ancestor
64746878|NCT02985372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64746879|NCT02985372|Immunologic Factors|immunologic factors|mesh-ancestor
64746880|NCT02985372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746881|NCT02985372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746882|NCT02985216|Pregabalin|pregabalin|mesh-list
64746883|NCT02985216|Analgesics|analgesics|mesh-ancestor
64746884|NCT02985216|Sensory System Agents|sensory system agents|mesh-ancestor
64746885|NCT02985216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64746886|NCT02985216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746887|NCT02985216|Anticonvulsants|anticonvulsants|mesh-ancestor
64746888|NCT02985216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64746889|NCT02985216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64633132|NCT00003862|Immunologic Factors|immunologic factors|mesh-ancestor
64633133|NCT00003862|Antidotes|antidotes|mesh-ancestor
64633134|NCT00003862|Protective Agents|protective agents|mesh-ancestor
64633135|NCT00003862|Vitamin B Complex|vitamin b complex|mesh-ancestor
64633136|NCT00003862|Vitamins|vitamins|mesh-ancestor
64633137|NCT00003862|Micronutrients|micronutrients|mesh-ancestor
64633138|NCT00003868|Cyclophosphamide|cyclophosphamide|mesh-list
64633139|NCT00003868|Methotrexate|methotrexate|mesh-list
64746890|NCT02985216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746891|NCT02985216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64746892|NCT02985216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64746893|NCT02985216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64746894|NCT02985216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64746895|NCT02985216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64746896|NCT01461096|Vaccines|vaccines|mesh-list
64746897|NCT01461096|Immunologic Factors|immunologic factors|mesh-ancestor
64746898|NCT01461096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746899|NCT01480674|Trastuzumab|trastuzumab|mesh-list
64358921|NCT03684213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435659|NCT02353169|Dexmedetomidine|dexmedetomidine|mesh-list
64746901|NCT01480674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746902|NCT01506882|Levetiracetam|levetiracetam|mesh-list
64746903|NCT01506882|Anticonvulsants|anticonvulsants|mesh-ancestor
64746904|NCT01506882|Nootropic Agents|nootropic agents|mesh-ancestor
64746905|NCT01506726|Salicylic Acid|salicylic acid|mesh-list
64746906|NCT01506726|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
64746907|NCT01506726|Salicylates|salicylates|mesh-list
64746908|NCT01506726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64746909|NCT01506726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64746910|NCT01506726|Analgesics|analgesics|mesh-ancestor
64435885|NCT02005887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746916|NCT01506726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64746917|NCT01506726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746918|NCT01506726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746919|NCT01506726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64746920|NCT01506726|Antifungal Agents|antifungal agents|mesh-ancestor
64746921|NCT01506726|Keratolytic Agents|keratolytic agents|mesh-ancestor
64746922|NCT01506726|Dermatologic Agents|dermatologic agents|mesh-ancestor
64746923|NCT01505868|Carboplatin|carboplatin|mesh-list
64746924|NCT01505868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746925|NCT01505634|Ciprofloxacin|ciprofloxacin|mesh-list
64746926|NCT01505634|Imipenem|imipenem|mesh-list
64746927|NCT01505634|Relebactam|relebactam|mesh-list
64746928|NCT01505634|Cilastatin|cilastatin|mesh-list
64746929|NCT01505634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64633175|NCT00004090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64633176|NCT00004090|Immunologic Factors|immunologic factors|mesh-ancestor
64633177|NCT00004090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633178|NCT00004102|Leucovorin|leucovorin|mesh-list
64633179|NCT00004102|Fluorouracil|fluorouracil|mesh-list
64633180|NCT00004102|Oxaliplatin|oxaliplatin|mesh-list
64633181|NCT00004102|Calcium|calcium|mesh-list
64633182|NCT00004102|Levoleucovorin|levoleucovorin|mesh-list
64633183|NCT00004102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64633184|NCT00004102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633185|NCT00004102|Antimetabolites|antimetabolites|mesh-ancestor
64633186|NCT00004102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633187|NCT00004102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64633188|NCT00004102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633189|NCT00004102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64746930|NCT01505634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64746931|NCT01505634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64746932|NCT01505634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64436048|NCT01764022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436049|NCT01764022|Tubulin Modulators|tubulin modulators|mesh-ancestor
64436050|NCT01764022|Antimitotic Agents|antimitotic agents|mesh-ancestor
64436051|NCT01764022|Mitosis Modulators|mitosis modulators|mesh-ancestor
64436052|NCT01764022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436053|NCT01764022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64746939|NCT01505634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64746941|NCT01460628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64746942|NCT01460628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746943|NCT01460628|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64436123|NCT05650723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746944|NCT01460628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64746945|NCT01460628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64746946|NCT01460628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746948|NCT01480596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64746949|NCT01480596|Immunologic Factors|immunologic factors|mesh-ancestor
64746950|NCT01480596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746951|NCT01459614|Gemcitabine|gemcitabine|mesh-list
64746952|NCT01459614|Docetaxel|docetaxel|mesh-list
64746953|NCT01459614|Capecitabine|capecitabine|mesh-list
64746954|NCT01459614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746955|NCT01459614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64746956|NCT01459614|Antimetabolites|antimetabolites|mesh-ancestor
64746957|NCT01459614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746958|NCT01459614|Antiviral Agents|antiviral agents|mesh-ancestor
64436520|NCT04572256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64323196|NCT05704647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64436521|NCT04572256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436522|NCT04572256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64436523|NCT04572256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64436524|NCT04572256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436525|NCT01963611|Glatiramer Acetate|glatiramer acetate|mesh-list
64436526|NCT01963611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64436527|NCT01963611|Immunologic Factors|immunologic factors|mesh-ancestor
64436528|NCT01963611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436529|NCT01963611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64633197|NCT00003880|Carboplatin|carboplatin|mesh-list
64633198|NCT00003880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64633199|NCT00003880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436536|NCT01962987|Analgesics|analgesics|mesh-ancestor
64436537|NCT01962987|Sensory System Agents|sensory system agents|mesh-ancestor
64436538|NCT01962987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64436539|NCT01962987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323197|NCT05704647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64746964|NCT01459614|Tubulin Modulators|tubulin modulators|mesh-ancestor
64746965|NCT01459614|Antimitotic Agents|antimitotic agents|mesh-ancestor
64746966|NCT01459614|Mitosis Modulators|mitosis modulators|mesh-ancestor
64746967|NCT01458522|Lacosamide|lacosamide|mesh-list
64746968|NCT01458522|Fosphenytoin|fosphenytoin|mesh-list
64746969|NCT01458522|Anticonvulsants|anticonvulsants|mesh-ancestor
64746970|NCT01458522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64746971|NCT01458522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64746972|NCT01458522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64746973|NCT01458522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746974|NCT03026946|Cyclosporine|cyclosporine|mesh-list
64746975|NCT03026946|Alitretinoin|alitretinoin|mesh-list
64746976|NCT03026946|Cyclosporins|cyclosporins|mesh-list
64746977|NCT03026946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64746978|NCT03026946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64746979|NCT03026946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64746980|NCT03026946|Immunologic Factors|immunologic factors|mesh-ancestor
64746981|NCT03026946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436615|NCT04781647|Immunologic Factors|immunologic factors|mesh-ancestor
64436616|NCT04781647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64746982|NCT03026946|Antifungal Agents|antifungal agents|mesh-ancestor
64746983|NCT03026946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64746984|NCT03026946|Dermatologic Agents|dermatologic agents|mesh-ancestor
64436617|NCT03593473|Oxytocin|oxytocin|mesh-list
64436618|NCT03593473|Oxytocics|oxytocics|mesh-ancestor
64436619|NCT03593473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64436620|NCT03593473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436621|NCT05259787|Propofol|propofol|mesh-list
64436622|NCT05259787|Etomidate|etomidate|mesh-list
64633232|NCT00004900|Hormone Antagonists|hormone antagonists|mesh-ancestor
64436628|NCT05259787|Anesthetics|anesthetics|mesh-ancestor
64436643|NCT01756456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64436645|NCT01756456|Mitosis Modulators|mitosis modulators|mesh-ancestor
64436646|NCT01756456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633233|NCT00004900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64436647|NCT05226325|Dexmedetomidine|dexmedetomidine|mesh-list
64633235|NCT00004114|Cyclophosphamide|cyclophosphamide|mesh-list
64633236|NCT00004114|Fludarabine|fludarabine|mesh-list
64633237|NCT00004114|Fludarabine phosphate|fludarabine phosphate|mesh-list
64633238|NCT00004114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64633239|NCT00004114|Immunologic Factors|immunologic factors|mesh-ancestor
64633240|NCT00004114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633241|NCT00004114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64633242|NCT00004114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64436648|NCT05226325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64633243|NCT00004114|Alkylating Agents|alkylating agents|mesh-ancestor
64436649|NCT05226325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64436650|NCT05226325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436651|NCT05226325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64436653|NCT05226325|Sensory System Agents|sensory system agents|mesh-ancestor
64436654|NCT05226325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64436661|NCT04745299|Riluzole|riluzole|mesh-list
64746985|NCT03026946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64746986|NCT03026946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64746987|NCT03026946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747015|NCT01458210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64747016|NCT01458210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64747018|NCT01458210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64747019|NCT01457118|Etirinotecan pegol|etirinotecan pegol|mesh-list
64747020|NCT01457118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747021|NCT01457118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64747022|NCT01457118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64747023|NCT01457118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747024|NCT01457118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747025|NCT01501110|Acetylcysteine|acetylcysteine|mesh-list
64747026|NCT01501110|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64747027|NCT01501110|Antiviral Agents|antiviral agents|mesh-ancestor
64747028|NCT01501110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64747029|NCT01501110|Expectorants|expectorants|mesh-ancestor
64747030|NCT01501110|Respiratory System Agents|respiratory system agents|mesh-ancestor
64747031|NCT01501110|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64747032|NCT01501110|Antioxidants|antioxidants|mesh-ancestor
64747033|NCT01501110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747034|NCT01501110|Protective Agents|protective agents|mesh-ancestor
64747035|NCT01501110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747036|NCT01501110|Antidotes|antidotes|mesh-ancestor
64747037|NCT01500720|Topotecan|topotecan|mesh-list
64747038|NCT01500720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64747039|NCT01500720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64747040|NCT01500720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747041|NCT01500720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747042|NCT01500720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747043|NCT01476696|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64747044|NCT01476696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64747061|NCT01454934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633258|NCT00004126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633259|NCT00004906|Pamidronate|pamidronate|mesh-list
64633260|NCT00004906|Cyclophosphamide|cyclophosphamide|mesh-list
64633261|NCT00004906|Thiotepa|thiotepa|mesh-list
64633262|NCT00004906|Carboplatin|carboplatin|mesh-list
64633263|NCT00004906|Docetaxel|docetaxel|mesh-list
64633264|NCT00004906|Doxorubicin|doxorubicin|mesh-list
64633265|NCT00004906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64633266|NCT00004906|Etoposide|etoposide|mesh-list
64633267|NCT00004906|Anastrozole|anastrozole|mesh-list
64633268|NCT00004906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64633269|NCT00004906|Immunologic Factors|immunologic factors|mesh-ancestor
64747062|NCT01454934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64633270|NCT00004906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633271|NCT00004906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64436669|NCT04745299|Protective Agents|protective agents|mesh-ancestor
64747063|NCT01454934|Immunologic Factors|immunologic factors|mesh-ancestor
64747064|NCT01454934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747065|NCT01454934|Tubulin Modulators|tubulin modulators|mesh-ancestor
64747066|NCT01454934|Antimitotic Agents|antimitotic agents|mesh-ancestor
64747067|NCT01454934|Mitosis Modulators|mitosis modulators|mesh-ancestor
64747068|NCT01454934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64747069|NCT01454934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64747070|NCT01454934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64747071|NCT01454778|Paclitaxel|paclitaxel|mesh-list
64747072|NCT01454778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64747073|NCT01454778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747074|NCT01454778|Tubulin Modulators|tubulin modulators|mesh-ancestor
64747075|NCT01454778|Antimitotic Agents|antimitotic agents|mesh-ancestor
64747076|NCT01454778|Mitosis Modulators|mitosis modulators|mesh-ancestor
64747077|NCT01454778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747078|NCT01454076|Clarithromycin|clarithromycin|mesh-list
64747079|NCT01454076|Rifampin|rifampin|mesh-list
64747080|NCT01454076|Ketoconazole|ketoconazole|mesh-list
64747081|NCT01454076|Ixazomib|ixazomib|mesh-list
64747082|NCT01454076|Glycine|glycine|mesh-list
64747083|NCT01454076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64747084|NCT01454076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64747085|NCT01454076|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64747086|NCT01454076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436828|NCT05813665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64747087|NCT01454076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436876|NCT05813327|Ifosfamide|ifosfamide|mesh-list
64747088|NCT01454076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64747089|NCT01454076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64747090|NCT01454076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64747091|NCT01454076|Antitubercular Agents|antitubercular agents|mesh-ancestor
64747092|NCT01454076|Leprostatic Agents|leprostatic agents|mesh-ancestor
64747093|NCT01454076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64323198|NCT05704647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64747094|NCT01454076|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64747095|NCT01454076|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64747096|NCT01454076|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64747097|NCT01454076|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64633281|NCT00004906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64633282|NCT00004906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64633283|NCT00004906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633284|NCT00004906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64633285|NCT00004906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64747098|NCT01454076|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64437055|NCT05755334|Anesthetics|anesthetics|mesh-ancestor
64747099|NCT01454076|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64747100|NCT01454076|Antifungal Agents|antifungal agents|mesh-ancestor
64633286|NCT00004906|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64747101|NCT01454076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64747102|NCT01454076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64747103|NCT01454076|Hormone Antagonists|hormone antagonists|mesh-ancestor
64747104|NCT01454076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64747105|NCT01454076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747106|NCT01454076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747107|NCT01454076|Protease Inhibitors|protease inhibitors|mesh-ancestor
64747108|NCT01454076|Glycine Agents|glycine agents|mesh-ancestor
64633307|NCT00004132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64633308|NCT00004132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64747109|NCT01454076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64747110|NCT01453998|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64747111|NCT01453998|Immunologic Factors|immunologic factors|mesh-ancestor
64747112|NCT01453998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633309|NCT00004132|Alkylating Agents|alkylating agents|mesh-ancestor
64633310|NCT00004132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633311|NCT00004132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633312|NCT00004132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64633313|NCT00004132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64747113|NCT01453374|Naltrexone|naltrexone|mesh-list
64437366|NCT05438394|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64437367|NCT05438394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64437368|NCT05438394|Immunologic Factors|immunologic factors|mesh-ancestor
64437369|NCT05438394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437370|NCT05414500|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64437371|NCT05414500|Mogamulizumab|mogamulizumab|mesh-list
64437372|NCT05414500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64437373|NCT05414500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437430|NCT05287568|Cc-486|cc-486|mesh-list
64747114|NCT01453374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64747115|NCT01453374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64747116|NCT01453374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747117|NCT01453374|Sensory System Agents|sensory system agents|mesh-ancestor
64747118|NCT01453374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64747119|NCT01453140|Sirolimus|sirolimus|mesh-list
64747120|NCT01453140|Cyclophosphamide|cyclophosphamide|mesh-list
64747121|NCT01453140|Interleukin-2|interleukin-2|mesh-list
64747122|NCT01453140|Azacitidine|azacitidine|mesh-list
64747123|NCT01453140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64747124|NCT01453140|Immunologic Factors|immunologic factors|mesh-ancestor
64747125|NCT01453140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437547|NCT05189457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437548|NCT05189457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64437549|NCT05189457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437550|NCT05189457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64437560|NCT05173987|Paclitaxel|paclitaxel|mesh-list
64437588|NCT05150704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64437589|NCT05150704|Antiemetics|antiemetics|mesh-ancestor
64437590|NCT05150704|Autonomic Agents|autonomic agents|mesh-ancestor
64437591|NCT05150704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64437592|NCT05150704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437593|NCT05150704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64437594|NCT05150704|Glucocorticoids|glucocorticoids|mesh-ancestor
64437595|NCT05150704|Hormones|hormones|mesh-ancestor
64437596|NCT05150704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64437597|NCT05150704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64437598|NCT05150704|Protective Agents|protective agents|mesh-ancestor
64437599|NCT05150704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64437600|NCT05150704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437601|NCT05135910|Terbinafine|terbinafine|mesh-list
64437602|NCT05135910|Antifungal Agents|antifungal agents|mesh-ancestor
64437607|NCT05129748|Mannitol|mannitol|mesh-list
64437669|NCT05074992|Ipilimumab|ipilimumab|mesh-list
64437670|NCT05074992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64437671|NCT05074992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437700|NCT05004662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64437702|NCT05004662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64437703|NCT05004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437704|NCT05004662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64437705|NCT05004662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64437706|NCT05004662|Cholinergic Agents|cholinergic agents|mesh-ancestor
64633362|NCT05776888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633363|NCT05776862|Ursolic acid|ursolic acid|mesh-list
64633364|NCT05776862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64633372|NCT05776862|Analgesics|analgesics|mesh-ancestor
64437707|NCT05004662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64747126|NCT01453140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64747128|NCT01453140|Alkylating Agents|alkylating agents|mesh-ancestor
64747131|NCT01453140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64747132|NCT01453140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64747133|NCT01453140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64747134|NCT01453140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64747135|NCT01453140|Antifungal Agents|antifungal agents|mesh-ancestor
64747136|NCT01453140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64747137|NCT01453140|Analgesics|analgesics|mesh-ancestor
64747138|NCT01453140|Sensory System Agents|sensory system agents|mesh-ancestor
64747139|NCT01453140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64747140|NCT01453140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64747141|NCT01453140|Antimetabolites|antimetabolites|mesh-ancestor
64747142|NCT01453140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747143|NCT01499940|Vitamin D|vitamin d|mesh-list
64747144|NCT01499940|Cholecalciferol|cholecalciferol|mesh-list
64747145|NCT01499940|Vitamins|vitamins|mesh-ancestor
64747146|NCT01499940|Micronutrients|micronutrients|mesh-ancestor
64747147|NCT01499940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747148|NCT01499940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64747149|NCT01499940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64747150|NCT01499160|Everolimus|everolimus|mesh-list
64747151|NCT01499160|Letrozole|letrozole|mesh-list
64747152|NCT01499160|Lapatinib|lapatinib|mesh-list
64747153|NCT01499160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747154|NCT01499160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64747155|NCT01499160|Immunologic Factors|immunologic factors|mesh-ancestor
64515948|NCT03290820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64747156|NCT01499160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747157|NCT01499160|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64747158|NCT01499160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64747159|NCT01499160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747160|NCT01499160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323199|NCT05704647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323200|NCT05746143|Zolpidem|zolpidem|mesh-list
64323201|NCT05746143|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64323202|NCT05746143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64323203|NCT05746143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64323204|NCT05746143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323205|NCT05746143|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64323206|NCT05746143|GABA Agonists|gaba agonists|mesh-ancestor
64323207|NCT05746143|GABA Agents|gaba agents|mesh-ancestor
64323208|NCT05746143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64323209|NCT05746143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323210|NCT03165591|Vaccines|vaccines|mesh-list
64323211|NCT03165591|Immunologic Factors|immunologic factors|mesh-ancestor
64747161|NCT01499160|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64747162|NCT01499160|Hormone Antagonists|hormone antagonists|mesh-ancestor
64747163|NCT01499160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64747164|NCT01499160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64747165|NCT01498068|Interferons|interferons|mesh-list
64747166|NCT01498068|Ribavirin|ribavirin|mesh-list
64747167|NCT01498068|Interferon-alpha|interferon-alpha|mesh-list
64747168|NCT01498068|Interferon alpha-2|interferon alpha-2|mesh-list
64747169|NCT01498068|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64747170|NCT01498068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747171|NCT01498068|Antiviral Agents|antiviral agents|mesh-ancestor
64633384|NCT05776524|Tubulin Modulators|tubulin modulators|mesh-ancestor
64633385|NCT05776524|Antimitotic Agents|antimitotic agents|mesh-ancestor
64633386|NCT05776524|Mitosis Modulators|mitosis modulators|mesh-ancestor
64633387|NCT05776524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633388|NCT05776524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64633389|NCT05776524|Antimetabolites|antimetabolites|mesh-ancestor
64747172|NCT01498068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64747173|NCT01498068|Antimetabolites|antimetabolites|mesh-ancestor
64747174|NCT01498068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747175|NCT01498068|Immunologic Factors|immunologic factors|mesh-ancestor
64747176|NCT01498068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747177|NCT01497366|Sofosbuvir|sofosbuvir|mesh-list
64747178|NCT01497366|Antiviral Agents|antiviral agents|mesh-ancestor
64747179|NCT01497366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64747180|NCT01496976|Methylprednisolone|methylprednisolone|mesh-list
64747181|NCT01496976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64747182|NCT01496976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64747183|NCT01496976|Prednisolone|prednisolone|mesh-list
64747184|NCT01496976|Prednisolone acetate|prednisolone acetate|mesh-list
64747185|NCT01496976|Lenalidomide|lenalidomide|mesh-list
64747186|NCT01496976|Ofatumumab|ofatumumab|mesh-list
64747187|NCT01496976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64437709|NCT04975997|Dexamethasone|dexamethasone|mesh-list
64747188|NCT01496976|Prednisolone phosphate|prednisolone phosphate|mesh-list
64747189|NCT01496976|Immunologic Factors|immunologic factors|mesh-ancestor
64747190|NCT01496976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747191|NCT01496976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64747192|NCT01496976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64747193|NCT01496976|Growth Substances|growth substances|mesh-ancestor
64747204|NCT01496976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64747205|NCT01496976|Protective Agents|protective agents|mesh-ancestor
64438003|NCT04503148|Propofol|propofol|mesh-list
64747218|NCT01451814|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64747219|NCT01451814|Cholinergic Agents|cholinergic agents|mesh-ancestor
64747220|NCT01451814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64747221|NCT01451814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747222|NCT01496430|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
64747223|NCT01496430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64747224|NCT01496430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64747225|NCT01496430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747226|NCT04408326|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64747227|NCT04408326|Angiotensin II|angiotensin ii|mesh-list
64747228|NCT04408326|Giapreza|giapreza|mesh-list
64747229|NCT04408326|Angiotensinogen|angiotensinogen|mesh-list
64747230|NCT04408326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64747232|NCT04408326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64359254|NCT03353857|Progestins|progestins|mesh-ancestor
64747233|NCT04408326|Protease Inhibitors|protease inhibitors|mesh-ancestor
64747234|NCT04408326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747235|NCT04408326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747236|NCT01474746|Sertraline|sertraline|mesh-list
64747237|NCT01474746|Antidepressive Agents|antidepressive agents|mesh-ancestor
64747238|NCT01474746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64633394|NCT05776524|Immunologic Factors|immunologic factors|mesh-ancestor
64747239|NCT01474746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64747240|NCT01474746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64747241|NCT01474746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64438064|NCT04410042|Hemostatics|hemostatics|mesh-ancestor
64747242|NCT01474746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747243|NCT01474746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64747244|NCT01474746|Serotonin Agents|serotonin agents|mesh-ancestor
64747245|NCT01474746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747246|NCT01450800|Nitrofurantoin|nitrofurantoin|mesh-list
64747247|NCT01450800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64747248|NCT01450800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64747249|NCT01450800|Renal Agents|renal agents|mesh-ancestor
64747250|NCT01450800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64633395|NCT05776524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747251|NCT01474512|Ixekizumab|ixekizumab|mesh-list
64747252|NCT01474512|Dermatologic Agents|dermatologic agents|mesh-ancestor
64633396|NCT05776407|Cyclophosphamide|cyclophosphamide|mesh-list
64633397|NCT05776407|Fludarabine|fludarabine|mesh-list
64747253|NCT02985606|Caffeine|caffeine|mesh-list
64747254|NCT02985606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64633398|NCT05776407|Etoposide|etoposide|mesh-list
64747255|NCT02985606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747256|NCT02985606|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64747257|NCT02985606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747258|NCT02985606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747280|NCT01450098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64747281|NCT01450098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64747282|NCT01450098|Antimetabolites|antimetabolites|mesh-ancestor
64747283|NCT01450098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747284|NCT01450098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64747285|NCT01450098|Antioxidants|antioxidants|mesh-ancestor
64747286|NCT01450098|Protective Agents|protective agents|mesh-ancestor
64438193|NCT04219904|Deoxyglucose|deoxyglucose|mesh-list
64438194|NCT04219904|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64438195|NCT04219904|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64438196|NCT04219904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747287|NCT01450098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747288|NCT01449630|Celecoxib|celecoxib|mesh-list
64747289|NCT01449630|LY3031207|ly3031207|mesh-list
64747290|NCT01449630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64747291|NCT01449630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64747292|NCT01449630|Analgesics|analgesics|mesh-ancestor
64747293|NCT01449630|Sensory System Agents|sensory system agents|mesh-ancestor
64747294|NCT01449630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64747295|NCT01449630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747296|NCT01449630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64747297|NCT01449630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64747298|NCT01449630|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64747299|NCT01449630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64747300|NCT01449630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747301|NCT01449630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747302|NCT01449630|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
64747303|NCT01449630|Hormone Antagonists|hormone antagonists|mesh-ancestor
64516116|NCT03294252|Leucovorin|leucovorin|mesh-list
64747304|NCT01449630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64747305|NCT01473420|Epoetin Alfa|epoetin alfa|mesh-list
64747306|NCT01473420|Hematinics|hematinics|mesh-ancestor
64747307|NCT04674774|Lansoprazole|lansoprazole|mesh-list
64747308|NCT04674774|Dexlansoprazole|dexlansoprazole|mesh-list
64747309|NCT04674774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64633403|NCT05776407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64633404|NCT05776407|Alkylating Agents|alkylating agents|mesh-ancestor
64633405|NCT05776407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747312|NCT04674774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747322|NCT01449006|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64747323|NCT01449006|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64747324|NCT01449006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747325|NCT01449006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64747326|NCT01449006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64747327|NCT01449006|Antiviral Agents|antiviral agents|mesh-ancestor
64747328|NCT01449006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64747329|NCT01449006|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64747330|NCT04085172|Guanfacine|guanfacine|mesh-list
64633434|NCT05776043|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64633435|NCT05776043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747331|NCT04085172|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64747332|NCT04085172|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64747333|NCT04085172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64747334|NCT04085172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64747335|NCT04085172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747336|NCT04085172|Adrenergic Agents|adrenergic agents|mesh-ancestor
64747337|NCT04085172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64747338|NCT04085172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747339|NCT04085172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64747340|NCT04085172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64747341|NCT04085172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64438289|NCT04083898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438290|NCT04083898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64438291|NCT04083898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438293|NCT04083898|Alkylating Agents|alkylating agents|mesh-ancestor
64747342|NCT04085172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64747343|NCT01491672|Everolimus|everolimus|mesh-list
64747344|NCT01491672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747345|NCT01491672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64747346|NCT01491672|Immunologic Factors|immunologic factors|mesh-ancestor
64747347|NCT01491672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747348|NCT01447446|Ribavirin|ribavirin|mesh-list
64747349|NCT01447446|Interferon-alpha|interferon-alpha|mesh-list
64747368|NCT01490580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64747369|NCT01490580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747370|NCT01490580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64747371|NCT01490580|Anesthetics, General|anesthetics, general|mesh-ancestor
64747372|NCT01490580|Anesthetics|anesthetics|mesh-ancestor
64747373|NCT01490580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64747374|NCT01490580|Narcotics|narcotics|mesh-ancestor
64747375|NCT01490580|Analgesics|analgesics|mesh-ancestor
64747376|NCT01490580|Sensory System Agents|sensory system agents|mesh-ancestor
64747377|NCT01490580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64747378|NCT01490580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64747379|NCT01490580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64747380|NCT01490580|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64747381|NCT01490580|Autonomic Agents|autonomic agents|mesh-ancestor
64747382|NCT01490580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64747383|NCT01490580|Respiratory System Agents|respiratory system agents|mesh-ancestor
64747384|NCT01490580|Mydriatics|mydriatics|mesh-ancestor
64747385|NCT01490580|Parasympatholytics|parasympatholytics|mesh-ancestor
64747386|NCT01490580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64747387|NCT01490580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64747388|NCT01490580|Cholinergic Agents|cholinergic agents|mesh-ancestor
64747389|NCT01490580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64747421|NCT01445886|Calcipotriene|calcipotriene|mesh-list
64747422|NCT01445886|Dermatologic Agents|dermatologic agents|mesh-ancestor
64747423|NCT01445886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64747424|NCT01445886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747425|NCT01445886|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64747426|NCT01445886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64747427|NCT01445886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747428|NCT01445886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64747429|NCT01445886|Vitamins|vitamins|mesh-ancestor
64747430|NCT01445886|Micronutrients|micronutrients|mesh-ancestor
64747431|NCT01445886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64747484|NCT01443858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64747485|NCT01443858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64747486|NCT01443858|Cholinergic Agents|cholinergic agents|mesh-ancestor
64747487|NCT01443858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64747488|NCT01443858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747489|NCT01443858|Antiemetics|antiemetics|mesh-ancestor
64747490|NCT01443858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64747491|NCT01443858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64747492|NCT01443858|Histamine Antagonists|histamine antagonists|mesh-ancestor
64747493|NCT01443858|Histamine Agents|histamine agents|mesh-ancestor
64747494|NCT01443858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64747495|NCT01443078|Gemcitabine|gemcitabine|mesh-list
64747496|NCT01443078|Carboplatin|carboplatin|mesh-list
64747497|NCT01443078|Docetaxel|docetaxel|mesh-list
64747498|NCT01443078|Pemetrexed|pemetrexed|mesh-list
64747499|NCT01443078|Vinorelbine|vinorelbine|mesh-list
64747500|NCT01443078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633472|NCT05775965|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64633473|NCT05775965|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64747501|NCT01443078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64633474|NCT05775965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747502|NCT01443078|Antimetabolites|antimetabolites|mesh-ancestor
64747503|NCT01443078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747504|NCT01443078|Antiviral Agents|antiviral agents|mesh-ancestor
64747505|NCT01443078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64747506|NCT01443078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747507|NCT01443078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64747508|NCT01443078|Immunologic Factors|immunologic factors|mesh-ancestor
64747509|NCT01443078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747510|NCT01443078|Tubulin Modulators|tubulin modulators|mesh-ancestor
64747511|NCT01443078|Antimitotic Agents|antimitotic agents|mesh-ancestor
64747512|NCT01443078|Mitosis Modulators|mitosis modulators|mesh-ancestor
64747513|NCT01443078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64747514|NCT01443078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64747515|NCT01443078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64747516|NCT01439880|Evolocumab|evolocumab|mesh-list
64747517|NCT01439880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64747518|NCT01439880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64747519|NCT01439880|Antimetabolites|antimetabolites|mesh-ancestor
64747520|NCT01439880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747521|NCT01439880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64747522|NCT01469364|Aztreonam|aztreonam|mesh-list
64747523|NCT01469364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64747524|NCT01469364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64747525|NCT01439568|Carboplatin|carboplatin|mesh-list
64747526|NCT01439568|Etoposide|etoposide|mesh-list
64747527|NCT01439568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747528|NCT01439568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64747529|NCT01439568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64747530|NCT01439568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64747531|NCT01439568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747532|NCT01439568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747533|NCT01469052|Axitinib|axitinib|mesh-list
64747534|NCT01469052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747535|NCT01469052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64747536|NCT01469052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747537|NCT01469052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747538|NCT01442688|Amoxicillin|amoxicillin|mesh-list
64747539|NCT01442688|Mesalamine|mesalamine|mesh-list
64747540|NCT01442688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64633503|NCT05775861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64633504|NCT05775861|Analgesics|analgesics|mesh-ancestor
64633505|NCT05775861|Sensory System Agents|sensory system agents|mesh-ancestor
64633506|NCT05775861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64633507|NCT05775861|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64747541|NCT01442688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64633509|NCT05775861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64747542|NCT01442688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64747543|NCT01442688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64747544|NCT01442688|Analgesics|analgesics|mesh-ancestor
64747545|NCT01442688|Sensory System Agents|sensory system agents|mesh-ancestor
64747546|NCT01442688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64747547|NCT01442688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747548|NCT01442688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64747549|NCT01442688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64747550|NCT01468818|Cyclophosphamide|cyclophosphamide|mesh-list
64747551|NCT01468818|Fludarabine|fludarabine|mesh-list
64438815|NCT02736656|Viloxazine|viloxazine|mesh-list
64747552|NCT01468818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64747553|NCT01468818|Immunologic Factors|immunologic factors|mesh-ancestor
64747554|NCT01468818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747555|NCT01468818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64747556|NCT01468818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64747561|NCT01442376|Ondansetron|ondansetron|mesh-list
64747562|NCT01442376|Palonosetron|palonosetron|mesh-list
64747563|NCT01442376|Antiemetics|antiemetics|mesh-ancestor
64747564|NCT01442376|Autonomic Agents|autonomic agents|mesh-ancestor
64747565|NCT01442376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64747566|NCT01442376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747567|NCT01442376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64747568|NCT01442376|Antipruritics|antipruritics|mesh-ancestor
64747569|NCT01442376|Dermatologic Agents|dermatologic agents|mesh-ancestor
64747570|NCT01442376|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64747571|NCT01442376|Serotonin Agents|serotonin agents|mesh-ancestor
64747572|NCT01442376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64633532|NCT05775692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64747573|NCT01442376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747574|NCT01442376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64747575|NCT01442376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64747576|NCT01442376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64633533|NCT05775692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747577|NCT01442376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64747578|NCT01442376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64747579|NCT01442376|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64747580|NCT01442064|Ranibizumab|ranibizumab|mesh-list
64747581|NCT01442064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64747582|NCT01442064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64747583|NCT01442064|Growth Substances|growth substances|mesh-ancestor
64438930|NCT02206815|Analgesics|analgesics|mesh-ancestor
64747592|NCT01441596|Antimitotic Agents|antimitotic agents|mesh-ancestor
64747593|NCT01441596|Mitosis Modulators|mitosis modulators|mesh-ancestor
64747594|NCT01441596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747595|NCT01441596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64747596|NCT01441596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747597|NCT01441440|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64747598|NCT01441440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64747599|NCT01441440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64747600|NCT01441440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64747601|NCT01441440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747602|NCT01441440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64747603|NCT01441440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747604|NCT01441440|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64747605|NCT01441440|Antidepressive Agents|antidepressive agents|mesh-ancestor
64747606|NCT01441440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64747607|NCT03026478|Betamethasone|betamethasone|mesh-list
64747608|NCT03026478|Betamethasone Valerate|betamethasone valerate|mesh-list
64747609|NCT03026478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64747610|NCT03026478|Betamethasone benzoate|betamethasone benzoate|mesh-list
64747611|NCT03026478|Clobetasol|clobetasol|mesh-list
64747612|NCT03026478|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64747649|NCT01420536|Antifungal Agents|antifungal agents|mesh-ancestor
64747650|NCT01420536|Keratolytic Agents|keratolytic agents|mesh-ancestor
64747651|NCT01420536|Dermatologic Agents|dermatologic agents|mesh-ancestor
64747653|NCT01467492|Ribavirin|ribavirin|mesh-list
64747654|NCT01467492|Interferon-alpha|interferon-alpha|mesh-list
64747655|NCT01467492|Interferon alpha-2|interferon alpha-2|mesh-list
64747656|NCT01467492|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64747657|NCT01467492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747658|NCT01467492|Antiviral Agents|antiviral agents|mesh-ancestor
64747659|NCT01467492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64747660|NCT01467492|Antimetabolites|antimetabolites|mesh-ancestor
64633574|NCT05775159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64633575|NCT05775159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633576|NCT05775159|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64633577|NCT05775159|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64633578|NCT05775159|Growth Substances|growth substances|mesh-ancestor
64633579|NCT05775159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633580|NCT05775159|Growth Inhibitors|growth inhibitors|mesh-ancestor
64633581|NCT05775159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64633582|NCT05775159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633584|NCT05774964|Folic Acid|folic acid|mesh-list
64747661|NCT01467492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747662|NCT01467492|Immunologic Factors|immunologic factors|mesh-ancestor
64439114|NCT00565851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64439115|NCT00565851|Endothelial Growth Factors|endothelial growth factors|mesh-list
64439116|NCT00565851|Antibodies|antibodies|mesh-list
64747666|NCT01466790|Simeprevir|simeprevir|mesh-list
64747667|NCT01466790|Antimetabolites|antimetabolites|mesh-ancestor
64747668|NCT01466790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747669|NCT01466790|Antiviral Agents|antiviral agents|mesh-ancestor
64747670|NCT01466790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64747671|NCT01466790|Protease Inhibitors|protease inhibitors|mesh-ancestor
64747672|NCT01466790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747673|NCT01418352|Aripiprazole|aripiprazole|mesh-list
64747674|NCT01418352|Antidepressive Agents|antidepressive agents|mesh-ancestor
64747675|NCT01418352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64747676|NCT01418352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64747677|NCT01418352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64747678|NCT01418352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64439203|NCT04544293|Immunologic Factors|immunologic factors|mesh-ancestor
64439204|NCT04544293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439205|NCT04544293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439206|NCT04499677|Ritonavir|ritonavir|mesh-list
64439207|NCT04499677|Lopinavir|lopinavir|mesh-list
64439208|NCT04499677|Favipiravir|favipiravir|mesh-list
64439209|NCT04499677|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64439210|NCT04499677|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64439220|NCT05652751|Mitogens|mitogens|mesh-list
64747689|NCT01418352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64747690|NCT01418352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64747691|NCT01436370|Vaccines|vaccines|mesh-list
64747692|NCT01436370|Immunologic Factors|immunologic factors|mesh-ancestor
64747693|NCT01436370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439335|NCT04571632|Pembrolizumab|pembrolizumab|mesh-list
64747694|NCT01465464|Orantinib|orantinib|mesh-list
64747695|NCT01465464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64747696|NCT01465464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747697|NCT01465464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747698|NCT01465386|Bortezomib|bortezomib|mesh-list
64747699|NCT01465386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747700|NCT04082364|Trastuzumab|trastuzumab|mesh-list
64747701|NCT04082364|Margetuximab|margetuximab|mesh-list
64747702|NCT04082364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64747703|NCT04082364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747704|NCT01465230|Lenalidomide|lenalidomide|mesh-list
64747705|NCT01465230|Immunologic Factors|immunologic factors|mesh-ancestor
64747706|NCT01465230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747707|NCT01465230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64747708|NCT01465230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64747709|NCT01465230|Growth Substances|growth substances|mesh-ancestor
64747710|NCT01465230|Growth Inhibitors|growth inhibitors|mesh-ancestor
64747722|NCT01393626|Tofacitinib|tofacitinib|mesh-list
64747723|NCT01393626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64747724|NCT01393626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747725|NCT01393626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747726|NCT01393158|Apremilast|apremilast|mesh-list
64633602|NCT05774964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64747727|NCT01393158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64747728|NCT01393158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64747729|NCT01393158|Analgesics|analgesics|mesh-ancestor
64439594|NCT02161783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747730|NCT01393158|Sensory System Agents|sensory system agents|mesh-ancestor
64747731|NCT01393158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64747732|NCT01393158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747733|NCT01393158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64747734|NCT01393158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64747735|NCT01393158|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64747736|NCT01393158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64747737|NCT01393158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747738|NCT01393158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747739|NCT01413360|Vitamins|vitamins|mesh-list
64747740|NCT01413360|Ascorbic Acid|ascorbic acid|mesh-list
64747741|NCT01413360|Micronutrients|micronutrients|mesh-ancestor
64747742|NCT01413360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747743|NCT01413360|Antioxidants|antioxidants|mesh-ancestor
64747744|NCT01413360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747745|NCT01413360|Protective Agents|protective agents|mesh-ancestor
64747746|NCT03815448|Methotrexate|methotrexate|mesh-list
64747747|NCT03815448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64747748|NCT03815448|Abortifacient Agents|abortifacient agents|mesh-ancestor
64747749|NCT03815448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64323217|NCT03114813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64323218|NCT03114813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439917|NCT01726270|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64439918|NCT01726270|Adrenergic Agents|adrenergic agents|mesh-ancestor
64439919|NCT01726270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64439920|NCT01726270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633636|NCT05774704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633637|NCT05774704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323219|NCT03114813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323221|NCT03114813|Antioxidants|antioxidants|mesh-ancestor
64323222|NCT03114813|Protective Agents|protective agents|mesh-ancestor
64323223|NCT03114813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64323224|NCT03114813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64323225|NCT03114813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64323226|NCT03114813|Vasodilator Agents|vasodilator agents|mesh-ancestor
64323227|NCT03114813|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64323228|NCT03114813|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64323229|NCT01358864|Interferons|interferons|mesh-list
64323230|NCT01358864|Ribavirin|ribavirin|mesh-list
64323231|NCT01358864|Interferon-alpha|interferon-alpha|mesh-list
64323232|NCT01358864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323233|NCT01358864|Antiviral Agents|antiviral agents|mesh-ancestor
64747750|NCT03815448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747751|NCT03815448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64747753|NCT03815448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747754|NCT03815448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747755|NCT03815448|Dermatologic Agents|dermatologic agents|mesh-ancestor
64747756|NCT03815448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747757|NCT03815448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64516557|NCT00136695|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64747758|NCT03815448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64747759|NCT03815448|Immunologic Factors|immunologic factors|mesh-ancestor
64747760|NCT03815448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64747761|NCT03815448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64747762|NCT01392378|Acetaminophen|acetaminophen|mesh-list
64747763|NCT01392378|Ibuprofen|ibuprofen|mesh-list
64747764|NCT01392378|Vaccines|vaccines|mesh-list
64747765|NCT01392378|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64747766|NCT01392378|Immunologic Factors|immunologic factors|mesh-ancestor
64747767|NCT01392378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747768|NCT01392378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64323234|NCT01358864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64323235|NCT01358864|Antimetabolites|antimetabolites|mesh-ancestor
64323236|NCT01358864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323237|NCT01358864|Immunologic Factors|immunologic factors|mesh-ancestor
64323238|NCT01358864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323239|NCT02750761|Tedizolid phosphate|tedizolid phosphate|mesh-list
64440098|NCT01646177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64633685|NCT05638594|Antimitotic Agents|antimitotic agents|mesh-ancestor
64633686|NCT05638594|Mitosis Modulators|mitosis modulators|mesh-ancestor
64440099|NCT01646177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64633691|NCT05638594|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64440100|NCT01646177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64440101|NCT01646177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64440102|NCT01646177|Immunologic Factors|immunologic factors|mesh-ancestor
64323240|NCT02750761|Tedizolid|tedizolid|mesh-list
64323241|NCT02750761|Oxazolidinones|oxazolidinones|mesh-list
64323242|NCT02750761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64440103|NCT01646177|Dermatologic Agents|dermatologic agents|mesh-ancestor
64440104|NCT01929135|Atorvastatin|atorvastatin|mesh-list
64440105|NCT01929135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64440106|NCT01929135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64633716|NCT05635227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64440107|NCT01929135|Antimetabolites|antimetabolites|mesh-ancestor
64440108|NCT01929135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440109|NCT01929135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64440110|NCT01929135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64440111|NCT01929135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323243|NCT02750761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64323244|NCT02750761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64323245|NCT02750761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323246|NCT02750761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323247|NCT05746065|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64323248|NCT05746065|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64323255|NCT05746065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64323256|NCT02814019|Idebenone|idebenone|mesh-list
64323257|NCT02814019|Antioxidants|antioxidants|mesh-ancestor
64323258|NCT02814019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323259|NCT02814019|Protective Agents|protective agents|mesh-ancestor
64323260|NCT02814019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323261|NCT05745987|Vaccines|vaccines|mesh-list
64323262|NCT05745987|Immunologic Factors|immunologic factors|mesh-ancestor
64323263|NCT05745987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323264|NCT03364244|Sildenafil Citrate|sildenafil citrate|mesh-list
64323265|NCT03364244|Vasodilator Agents|vasodilator agents|mesh-ancestor
64323266|NCT03364244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64323267|NCT03364244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64323268|NCT03364244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323269|NCT03364244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323270|NCT03364244|Urological Agents|urological agents|mesh-ancestor
64323271|NCT03165123|Azithromycin|azithromycin|mesh-list
64323272|NCT03165123|Dexamethasone|dexamethasone|mesh-list
64747769|NCT01392378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64747770|NCT01392378|Analgesics|analgesics|mesh-ancestor
64747771|NCT01392378|Sensory System Agents|sensory system agents|mesh-ancestor
64747772|NCT01392378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64747773|NCT01392378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64633717|NCT05635227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633718|NCT05635227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64633719|NCT05635227|Serotonin Agents|serotonin agents|mesh-ancestor
64633720|NCT05607147|Antibodies|antibodies|mesh-list
64633721|NCT05607147|Immunologic Factors|immunologic factors|mesh-ancestor
64633722|NCT05607147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633723|NCT05599451|Pyrithione zinc|pyrithione zinc|mesh-list
64633724|NCT05599451|Keratolytic Agents|keratolytic agents|mesh-ancestor
64633725|NCT05599451|Dermatologic Agents|dermatologic agents|mesh-ancestor
64633726|NCT05519254|Lactoferrin|lactoferrin|mesh-list
64747774|NCT01392378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64633727|NCT05519254|Muramidase|muramidase|mesh-list
64747775|NCT01392378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64747776|NCT01392378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633728|NCT05519254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64747777|NCT01392378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747778|NCT01392378|Antipyretics|antipyretics|mesh-ancestor
64747779|NCT01412424|Octreotide|octreotide|mesh-list
64747780|NCT01412424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64747781|NCT01412424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64440113|NCT01911429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64440114|NCT01911429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64323274|NCT03165123|Antiemetics|antiemetics|mesh-ancestor
64323275|NCT03165123|Autonomic Agents|autonomic agents|mesh-ancestor
64323276|NCT03165123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64323277|NCT03165123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323278|NCT03165123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64323279|NCT03165123|Glucocorticoids|glucocorticoids|mesh-ancestor
64323281|NCT03165123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64323282|NCT03165123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64323283|NCT03165123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633732|NCT05512819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633733|NCT05493475|Fentanyl|fentanyl|mesh-list
64440270|NCT02242201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64323284|NCT03165123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64359842|NCT04488315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64359843|NCT04488315|Glucocorticoids|glucocorticoids|mesh-ancestor
64359844|NCT04488315|Hormones|hormones|mesh-ancestor
64359845|NCT04488315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64359846|NCT04488315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64359847|NCT04488315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359848|NCT04488315|Anesthetics, Local|anesthetics, local|mesh-ancestor
64359849|NCT04488315|Anesthetics|anesthetics|mesh-ancestor
64359850|NCT04488315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64359851|NCT04488315|Sensory System Agents|sensory system agents|mesh-ancestor
64747794|NCT01392300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747795|NCT01392300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64747796|NCT01392300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64747797|NCT01392300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747798|NCT01392300|Cholinergic Agents|cholinergic agents|mesh-ancestor
64747799|NCT01392300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64747800|NCT01432626|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64747801|NCT01432626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747802|NCT01432626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747803|NCT01432626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747838|NCT01390584|Immunologic Factors|immunologic factors|mesh-ancestor
64747839|NCT01390584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747840|NCT01390584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64747841|NCT01390584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64747842|NCT01390584|Alkylating Agents|alkylating agents|mesh-ancestor
64747843|NCT01390584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747844|NCT01390584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747845|NCT01390584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64747846|NCT01390584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64747847|NCT01390584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64633790|NCT05355701|Cetuximab|cetuximab|mesh-list
64747848|NCT01390584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64747849|NCT01390584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747850|NCT01390584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64747851|NCT01390584|Glucocorticoids|glucocorticoids|mesh-ancestor
64747853|NCT01390584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64747854|NCT01390584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64747855|NCT01390584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64747856|NCT01390584|Tubulin Modulators|tubulin modulators|mesh-ancestor
64440470|NCT02318693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64633791|NCT05355701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64633792|NCT05355701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633793|NCT05346484|Pembrolizumab|pembrolizumab|mesh-list
64633794|NCT05346484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64633795|NCT05346484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633796|NCT05329740|Methylprednisolone|methylprednisolone|mesh-list
64633797|NCT05329740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64633799|NCT05329740|Prednisolone|prednisolone|mesh-list
64440471|NCT02318693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323293|NCT01131169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64323294|NCT01131169|Antimetabolites|antimetabolites|mesh-ancestor
64323295|NCT01131169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323296|NCT01131169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64323297|NCT01131169|Immunologic Factors|immunologic factors|mesh-ancestor
64440633|NCT02301143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747869|NCT01408914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747870|NCT01408914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64747871|NCT01408914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64440893|NCT01745380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64440894|NCT01745380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64440895|NCT01745380|Adrenergic Agents|adrenergic agents|mesh-ancestor
64440896|NCT01745380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64440897|NCT01745380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440900|NCT01745380|Nasal Decongestants|nasal decongestants|mesh-ancestor
64440945|NCT01909791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440947|NCT01909791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440948|NCT02202499|Varenicline|varenicline|mesh-list
64440949|NCT02202499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64441014|NCT02296892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441015|NCT02168803|Evacetrapib|evacetrapib|mesh-list
64441016|NCT02168803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64441017|NCT02168803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64441018|NCT02168803|Antimetabolites|antimetabolites|mesh-ancestor
64441019|NCT02168803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441020|NCT02168803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64441021|NCT02201329|Azacitidine|azacitidine|mesh-list
64441023|NCT02201329|Antimetabolites|antimetabolites|mesh-ancestor
64441080|NCT04875026|Antimetabolites|antimetabolites|mesh-ancestor
64747890|NCT01390428|Antiviral Agents|antiviral agents|mesh-ancestor
64747891|NCT01390428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64747892|NCT01429584|Bupivacaine|bupivacaine|mesh-list
64747893|NCT01429584|Anesthetics, Local|anesthetics, local|mesh-ancestor
64747894|NCT01429584|Anesthetics|anesthetics|mesh-ancestor
64747895|NCT01429584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64747896|NCT01429584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747897|NCT01429584|Sensory System Agents|sensory system agents|mesh-ancestor
64747898|NCT01429584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64747899|NCT01405950|Clonidine|clonidine|mesh-list
64747900|NCT01405950|Tizanidine|tizanidine|mesh-list
64747901|NCT01405950|Analgesics|analgesics|mesh-ancestor
64747902|NCT01405950|Sensory System Agents|sensory system agents|mesh-ancestor
64747903|NCT01405950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64747904|NCT01405950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747905|NCT01405950|Anticonvulsants|anticonvulsants|mesh-ancestor
64747906|NCT01405950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64747907|NCT01405950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64323302|NCT01131169|Alkylating Agents|alkylating agents|mesh-ancestor
64323303|NCT01131169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64323304|NCT01131169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64633813|NCT05329740|Protective Agents|protective agents|mesh-ancestor
64633814|NCT05329740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64633815|NCT05329740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633816|NCT05298670|Metformin|metformin|mesh-list
64633817|NCT05298670|Interferons|interferons|mesh-list
64633818|NCT05298670|Interferon-beta|interferon-beta|mesh-list
64633819|NCT05298670|Interferon beta-1a|interferon beta-1a|mesh-list
64633820|NCT05298670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64633821|NCT05298670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323306|NCT02688933|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64323307|NCT02688933|Insulin Glargine|insulin glargine|mesh-list
64323308|NCT02688933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64323309|NCT02688933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323310|NCT04372628|Ritonavir|ritonavir|mesh-list
64323311|NCT04372628|Lopinavir|lopinavir|mesh-list
64323312|NCT04372628|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64323313|NCT04372628|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64323314|NCT04372628|Protease Inhibitors|protease inhibitors|mesh-ancestor
64323315|NCT04372628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323316|NCT04372628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323317|NCT04372628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64323318|NCT04372628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64441145|NCT02294786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747908|NCT01405950|Parasympatholytics|parasympatholytics|mesh-ancestor
64747909|NCT01405950|Autonomic Agents|autonomic agents|mesh-ancestor
64747910|NCT01405950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64441146|NCT02294786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64441147|NCT02294786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441148|NCT02294786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64441149|NCT02294786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64441150|NCT04880876|Eluxadoline|eluxadoline|mesh-list
64747912|NCT01405950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64747913|NCT01405950|Adrenergic Agents|adrenergic agents|mesh-ancestor
64747914|NCT01405950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64747915|NCT01405950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747916|NCT01405950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64747917|NCT01405950|Sympatholytics|sympatholytics|mesh-ancestor
64747918|NCT01405560|Ribavirin|ribavirin|mesh-list
64747919|NCT01405560|Antimetabolites|antimetabolites|mesh-ancestor
64747920|NCT01405560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747921|NCT01405560|Antiviral Agents|antiviral agents|mesh-ancestor
64747922|NCT01405560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64747923|NCT01428882|Midazolam|midazolam|mesh-list
64747924|NCT01428882|Propofol|propofol|mesh-list
64747925|NCT01428882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64747926|NCT01428882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64747927|NCT01428882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747928|NCT01428882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64747929|NCT01428882|Anesthetics, General|anesthetics, general|mesh-ancestor
64747930|NCT01428882|Anesthetics|anesthetics|mesh-ancestor
64747931|NCT01428882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64441320|NCT02263079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441321|NCT02263079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64441322|NCT02263079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64441324|NCT02260817|Lipotropic Agents|lipotropic agents|mesh-ancestor
64441325|NCT02260817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64441326|NCT02260817|Antimetabolites|antimetabolites|mesh-ancestor
64441375|NCT01645280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441376|NCT01645280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64441377|NCT01645280|Antimetabolites|antimetabolites|mesh-ancestor
64441514|NCT01702558|Maytansine|maytansine|mesh-list
64747932|NCT01428882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64747933|NCT01428882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64747934|NCT01428882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64747935|NCT01428882|GABA Modulators|gaba modulators|mesh-ancestor
64747936|NCT01428882|GABA Agents|gaba agents|mesh-ancestor
64747937|NCT01428882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64747953|NCT03814200|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64747954|NCT03814200|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64747955|NCT03814200|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64747956|NCT03814200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64747957|NCT01426854|Nepafenac|nepafenac|mesh-list
64747958|NCT01426854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64747959|NCT01426854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64747960|NCT01426854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64747961|NCT01426854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64747962|NCT01426854|Analgesics|analgesics|mesh-ancestor
64633883|NCT05180006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633884|NCT05180006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64633885|NCT05180006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64633886|NCT05180006|Growth Substances|growth substances|mesh-ancestor
64633887|NCT05180006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633889|NCT05148884|Befiradol|befiradol|mesh-list
64633890|NCT05148884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64633891|NCT05148884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64747963|NCT01426854|Sensory System Agents|sensory system agents|mesh-ancestor
64633892|NCT05148884|Serotonin Agents|serotonin agents|mesh-ancestor
64747964|NCT01426854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64747965|NCT01426854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747966|NCT01426854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64747967|NCT01426854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64747968|NCT04051320|Leuprolide|leuprolide|mesh-list
64747969|NCT04051320|Estradiol|estradiol|mesh-list
64441595|NCT02285153|Sensory System Agents|sensory system agents|mesh-ancestor
64747970|NCT04051320|Progesterone|progesterone|mesh-list
64441598|NCT02285153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64747971|NCT04051320|Estrogens|estrogens|mesh-ancestor
64747972|NCT04051320|Hormones|hormones|mesh-ancestor
64747973|NCT04051320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64747974|NCT04051320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747975|NCT04051320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64747976|NCT04051320|Progestins|progestins|mesh-ancestor
64441822|NCT04553770|Anastrozole|anastrozole|mesh-list
64441823|NCT04553770|Camptothecin|camptothecin|mesh-list
64747977|NCT04051320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64747978|NCT04051320|Fertility Agents|fertility agents|mesh-ancestor
64747979|NCT04051320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64747980|NCT04051320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747981|NCT01403610|Bevacizumab|bevacizumab|mesh-list
64516782|NCT01966978|Insulin Aspart|insulin aspart|mesh-list
64747982|NCT01403610|Phosphoramide Mustards|phosphoramide mustards|mesh-list
64747983|NCT01403610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64747984|NCT01403610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64747985|NCT01403610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64747987|NCT01403610|Growth Substances|growth substances|mesh-ancestor
64747991|NCT01403610|Alkylating Agents|alkylating agents|mesh-ancestor
64747992|NCT01403610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64747993|NCT01402986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64747994|NCT01402986|Immunologic Factors|immunologic factors|mesh-ancestor
64633909|NCT05141006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64633910|NCT05141006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64633911|NCT05141006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64633912|NCT05141006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633913|NCT05141006|Cholinergic Agents|cholinergic agents|mesh-ancestor
64633914|NCT05141006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64633915|NCT05141006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633916|NCT05141006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64633917|NCT05141006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64633918|NCT05099666|Doxorubicin|doxorubicin|mesh-list
64633919|NCT05099666|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64633920|NCT05099666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633921|NCT05099666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64633922|NCT05099666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64633923|NCT05099666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64747995|NCT01402986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64747996|NCT01389102|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64747997|NCT01389102|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64747998|NCT01389102|Estradiol|estradiol|mesh-list
64747999|NCT01389102|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64748000|NCT01389102|Estrogens|estrogens|mesh-ancestor
64748001|NCT01389102|Hormones|hormones|mesh-ancestor
64748002|NCT01389102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64748003|NCT01389102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748004|NCT01389102|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64748005|NCT01389102|Contraceptive Agents|contraceptive agents|mesh-ancestor
64748006|NCT01389102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64748007|NCT01389102|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64748008|NCT01402284|Dexamethasone|dexamethasone|mesh-list
64748009|NCT01402284|Lenalidomide|lenalidomide|mesh-list
64748010|NCT01402284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64748011|NCT01402284|Antiemetics|antiemetics|mesh-ancestor
64748012|NCT01402284|Autonomic Agents|autonomic agents|mesh-ancestor
64441824|NCT04553770|Immunoconjugates|immunoconjugates|mesh-list
64441825|NCT04553770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64441826|NCT04553770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748013|NCT01402284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748014|NCT01402284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441827|NCT04553770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64441828|NCT04553770|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64441829|NCT04553770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64441830|NCT04553770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441831|NCT04553770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441832|NCT04553770|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64441833|NCT04553770|Hormone Antagonists|hormone antagonists|mesh-ancestor
64441834|NCT04553770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64441837|NCT04553770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64748016|NCT01402284|Glucocorticoids|glucocorticoids|mesh-ancestor
64748017|NCT01402284|Hormones|hormones|mesh-ancestor
64748018|NCT01402284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64748036|NCT01388478|Dopamine Agonists|dopamine agonists|mesh-ancestor
64748037|NCT01388478|Dopamine Agents|dopamine agents|mesh-ancestor
64748038|NCT01388478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64748039|NCT01423812|Ritonavir|ritonavir|mesh-list
64748040|NCT01423812|Darunavir|darunavir|mesh-list
64748041|NCT01423812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64748042|NCT01423812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64748043|NCT01423812|Protease Inhibitors|protease inhibitors|mesh-ancestor
64633935|NCT05042817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64633936|NCT05042817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64748044|NCT01423812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748045|NCT01423812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748046|NCT01423812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64748047|NCT01423812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64748048|NCT01423812|Antiviral Agents|antiviral agents|mesh-ancestor
64748049|NCT01423812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64748050|NCT01423812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64748051|NCT01423812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64748052|NCT01400958|Modafinil|modafinil|mesh-list
64748053|NCT01400958|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64748054|NCT01400958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748055|NCT01400958|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64748056|NCT01400958|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64748057|NCT01400958|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64748058|NCT01400958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748060|NCT01400412|Darunavir|darunavir|mesh-list
64748061|NCT01400412|Tenofovir|tenofovir|mesh-list
64748062|NCT01400412|Emtricitabine|emtricitabine|mesh-list
64748063|NCT01400412|Maraviroc|maraviroc|mesh-list
64748064|NCT01400412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64748065|NCT01400412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64748080|NCT03829410|Bevacizumab|bevacizumab|mesh-list
64748082|NCT03829410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64748083|NCT03829410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748084|NCT03829410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64748085|NCT03829410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64748086|NCT03829410|Growth Substances|growth substances|mesh-ancestor
64441870|NCT01716052|Ibuprofen|ibuprofen|mesh-list
64441871|NCT01716052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64441872|NCT01716052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64441873|NCT01716052|Analgesics|analgesics|mesh-ancestor
64748087|NCT03829410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441874|NCT01716052|Sensory System Agents|sensory system agents|mesh-ancestor
64441875|NCT01716052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748088|NCT03829410|Growth Inhibitors|growth inhibitors|mesh-ancestor
64748089|NCT03829410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64748090|NCT03829410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748091|NCT03829410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748092|NCT01422876|Linagliptin|linagliptin|mesh-list
64633967|NCT04929392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64633968|NCT04929392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633969|NCT04929392|Tubulin Modulators|tubulin modulators|mesh-ancestor
64748093|NCT01422876|Empagliflozin|empagliflozin|mesh-list
64748094|NCT01422876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64748095|NCT01422876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748096|NCT01422876|Incretins|incretins|mesh-ancestor
64748097|NCT01422876|Hormones|hormones|mesh-ancestor
64748098|NCT01422876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64748099|NCT01422876|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64748100|NCT01422876|Protease Inhibitors|protease inhibitors|mesh-ancestor
64748101|NCT01422876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748102|NCT01422876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748103|NCT01422876|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64748104|NCT01422720|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64748105|NCT01422720|Anticonvulsants|anticonvulsants|mesh-ancestor
64748106|NCT01422720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64748107|NCT01422720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64748110|NCT01387932|Doxorubicin|doxorubicin|mesh-list
64748126|NCT01422408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64748127|NCT01422408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748128|NCT01422408|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64441977|NCT05640596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64748129|NCT01387542|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64748130|NCT01387542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64748131|NCT01387542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64516933|NCT02456844|Dermatologic Agents|dermatologic agents|mesh-ancestor
64748132|NCT01387542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64634000|NCT04882085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64634005|NCT04820309|Xanomeline|xanomeline|mesh-list
64748133|NCT01387542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748134|NCT01387542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64748135|NCT01387542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64748136|NCT01387542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64748138|NCT01387542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64748139|NCT01387542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748140|NCT01387542|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64748141|NCT01387542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64748142|NCT01387542|Dopamine Agents|dopamine agents|mesh-ancestor
64748143|NCT01387074|Botulinum Toxins|botulinum toxins|mesh-list
64748144|NCT01387074|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64748145|NCT01387074|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64748146|NCT01387074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64748147|NCT01387074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64748148|NCT01387074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748149|NCT01387074|Cholinergic Agents|cholinergic agents|mesh-ancestor
64323319|NCT04372628|Antiviral Agents|antiviral agents|mesh-ancestor
64323320|NCT04372628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64323321|NCT04372628|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64323322|NCT04372628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64323323|NCT03626545|Docetaxel|docetaxel|mesh-list
64323324|NCT03626545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323325|NCT03626545|Tubulin Modulators|tubulin modulators|mesh-ancestor
64323326|NCT03626545|Antimitotic Agents|antimitotic agents|mesh-ancestor
64323327|NCT03626545|Mitosis Modulators|mitosis modulators|mesh-ancestor
64634048|NCT04802161|Immunologic Factors|immunologic factors|mesh-ancestor
64634049|NCT04802161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634050|NCT04802161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64634051|NCT04802161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64634052|NCT04802161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64634053|NCT04802161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634054|NCT04802161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64634055|NCT04802161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64634056|NCT04802161|Growth Substances|growth substances|mesh-ancestor
64634057|NCT04802161|Growth Inhibitors|growth inhibitors|mesh-ancestor
64634059|NCT04779320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64634060|NCT04779307|Vedolizumab|vedolizumab|mesh-list
64634061|NCT04779307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64634062|NCT04762979|Fulvestrant|fulvestrant|mesh-list
64634063|NCT04762979|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64634064|NCT04762979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64442400|NCT01363700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442401|NCT04824794|Daratumumab|daratumumab|mesh-list
64442402|NCT04824794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323328|NCT03626545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323342|NCT04230980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323343|NCT04230980|Antimanic Agents|antimanic agents|mesh-ancestor
64323344|NCT00882505|Vitamin D|vitamin d|mesh-list
64323345|NCT00882505|Vitamins|vitamins|mesh-ancestor
64323346|NCT00882505|Micronutrients|micronutrients|mesh-ancestor
64634081|NCT04737187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64323347|NCT00882505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323348|NCT00882505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64323349|NCT03015740|Nivolumab|nivolumab|mesh-list
64323352|NCT03015740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64323353|NCT03015740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323354|NCT04480359|Meloxicam|meloxicam|mesh-list
64748150|NCT01387074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64748151|NCT01387074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748152|NCT01387074|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64634082|NCT04737187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748153|NCT01387074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748154|NCT01386606|Methyltestosterone|methyltestosterone|mesh-list
64748155|NCT01386606|Enclomiphene|enclomiphene|mesh-list
64748157|NCT01386606|Zuclomiphene|zuclomiphene|mesh-list
64748158|NCT01386606|Testosterone|testosterone|mesh-list
64748159|NCT01386606|Testosterone undecanoate|testosterone undecanoate|mesh-list
64748160|NCT01386606|Testosterone enanthate|testosterone enanthate|mesh-list
64748161|NCT01386606|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64442590|NCT04016090|Folic Acid|folic acid|mesh-list
64748162|NCT01386606|Androgens|androgens|mesh-ancestor
64748163|NCT01386606|Hormones|hormones|mesh-ancestor
64748164|NCT01386606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64748165|NCT01386606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748166|NCT01386606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64634083|NCT04737187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64634084|NCT04737187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64634085|NCT04737187|Growth Substances|growth substances|mesh-ancestor
64634086|NCT04737187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634087|NCT04737187|Growth Inhibitors|growth inhibitors|mesh-ancestor
64634088|NCT04737187|Antimetabolites|antimetabolites|mesh-ancestor
64634089|NCT04737187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634090|NCT04737187|Antiviral Agents|antiviral agents|mesh-ancestor
64634091|NCT04737187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64748167|NCT01386606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748168|NCT01386606|Anabolic Agents|anabolic agents|mesh-ancestor
64748169|NCT01386606|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64748170|NCT01386606|Hormone Antagonists|hormone antagonists|mesh-ancestor
64748171|NCT01386606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64748172|NCT01386606|Fertility Agents|fertility agents|mesh-ancestor
64748173|NCT01386606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64748174|NCT01386606|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64442820|NCT01681186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748175|NCT01386606|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64748176|NCT01385748|Clonidine|clonidine|mesh-list
64748177|NCT01385748|Analgesics|analgesics|mesh-ancestor
64748178|NCT01385748|Sensory System Agents|sensory system agents|mesh-ancestor
64748179|NCT01385748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748180|NCT01385748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748181|NCT01385748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64748182|NCT01385748|Sympatholytics|sympatholytics|mesh-ancestor
64748183|NCT01385748|Autonomic Agents|autonomic agents|mesh-ancestor
64748184|NCT01385748|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64748185|NCT01385748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64748186|NCT01385748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64323355|NCT04480359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64323356|NCT04480359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64323357|NCT04480359|Analgesics|analgesics|mesh-ancestor
64748187|NCT01385748|Adrenergic Agents|adrenergic agents|mesh-ancestor
64748188|NCT01385748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64748189|NCT01385748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748190|NCT01397448|Rabeprazole|rabeprazole|mesh-list
64748191|NCT01397448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64748192|NCT01397448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64748193|NCT01397448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64748194|NCT01397448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442986|NCT01635218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64443042|NCT04787744|Luteolytic Agents|luteolytic agents|mesh-ancestor
64443043|NCT04787744|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64748195|NCT01397448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443044|NCT04787744|Contraceptive Agents|contraceptive agents|mesh-ancestor
64443045|NCT04787744|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64443047|NCT05180942|Calcium|calcium|mesh-list
64443048|NCT05180942|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64443049|NCT05180942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443050|NCT05180942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64443051|NCT05180942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64443052|NCT05180942|Antimetabolites|antimetabolites|mesh-ancestor
64443053|NCT05180942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443104|NCT02213263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443105|NCT02213263|Immunologic Factors|immunologic factors|mesh-ancestor
64443106|NCT02213263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443107|NCT02213263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64634112|NCT04676477|Osimertinib|osimertinib|mesh-list
64443108|NCT04781036|Chlorhexidine|chlorhexidine|mesh-list
64748196|NCT01384734|Ritonavir|ritonavir|mesh-list
64443112|NCT04216784|Furosemide|furosemide|mesh-list
64748198|NCT01384734|Tenofovir|tenofovir|mesh-list
64748249|NCT01383486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64748250|NCT01383486|Gout Suppressants|gout suppressants|mesh-ancestor
64748251|NCT01383486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64748252|NCT01383486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748253|NCT01383486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748254|NCT04766736|Antibodies|antibodies|mesh-list
64748255|NCT04766736|Immunologic Factors|immunologic factors|mesh-ancestor
64748256|NCT04766736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748257|NCT01396278|Fluticasone|fluticasone|mesh-list
64748258|NCT01396278|Xhance|xhance|mesh-list
64748259|NCT01396278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64748260|NCT01396278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64748261|NCT01396278|Autonomic Agents|autonomic agents|mesh-ancestor
64748262|NCT01396278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748263|NCT01396278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748264|NCT01396278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64748265|NCT01396278|Respiratory System Agents|respiratory system agents|mesh-ancestor
64748266|NCT01396278|Dermatologic Agents|dermatologic agents|mesh-ancestor
64748267|NCT01396278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64443233|NCT03651128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64443234|NCT03651128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64443235|NCT03651128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443236|NCT03651128|Immunologic Factors|immunologic factors|mesh-ancestor
64748268|NCT05365074|Chloroprocaine|chloroprocaine|mesh-list
64748283|NCT01382940|Rituximab|rituximab|mesh-list
64748306|NCT01382940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748308|NCT01382940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64748309|NCT01382940|Antiemetics|antiemetics|mesh-ancestor
64748310|NCT01382940|Autonomic Agents|autonomic agents|mesh-ancestor
64748311|NCT01382940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64748312|NCT01382940|Glucocorticoids|glucocorticoids|mesh-ancestor
64748313|NCT01382940|Hormones|hormones|mesh-ancestor
64748314|NCT01382940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64634139|NCT04662710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64634142|NCT04659174|Trospium chloride|trospium chloride|mesh-list
64748315|NCT01382940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64748316|NCT01382940|Protective Agents|protective agents|mesh-ancestor
64748317|NCT01382940|Histamine Agents|histamine agents|mesh-ancestor
64748318|NCT01382940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64748319|NCT01381926|Exenatide|exenatide|mesh-list
64748320|NCT01381926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64748321|NCT01381926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748322|NCT01381926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64748323|NCT01381926|Incretins|incretins|mesh-ancestor
64748324|NCT01381926|Hormones|hormones|mesh-ancestor
64748325|NCT01381926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64748326|NCT01395888|Fluticasone|fluticasone|mesh-list
64748327|NCT01395888|Xhance|xhance|mesh-list
64748328|NCT01395888|Tiotropium Bromide|tiotropium bromide|mesh-list
64748329|NCT01395888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64748330|NCT01395888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64748331|NCT01395888|Autonomic Agents|autonomic agents|mesh-ancestor
64748332|NCT01395888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748333|NCT01395888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748334|NCT01395888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64748335|NCT01395888|Respiratory System Agents|respiratory system agents|mesh-ancestor
64748336|NCT01395888|Dermatologic Agents|dermatologic agents|mesh-ancestor
64748339|NCT01395888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64748350|NCT01381692|Immunoglobulins|immunoglobulins|mesh-list
64748351|NCT01381692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64748352|NCT01381692|BB 1101|bb 1101|mesh-list
64748353|NCT01381692|Immunologic Factors|immunologic factors|mesh-ancestor
64748354|NCT01381692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748355|NCT01381692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748356|NCT01381692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64748357|NCT01381692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64748358|NCT01381692|Antiemetics|antiemetics|mesh-ancestor
64748359|NCT01381692|Autonomic Agents|autonomic agents|mesh-ancestor
64748360|NCT01381692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748361|NCT01381692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64748362|NCT01381692|Glucocorticoids|glucocorticoids|mesh-ancestor
64748364|NCT01381692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64748365|NCT01381692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64634181|NCT04633122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748366|NCT01381692|Protease Inhibitors|protease inhibitors|mesh-ancestor
64748367|NCT01381692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748368|NCT01381692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748369|NCT01381692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64748370|NCT01381692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64748371|NCT01381692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64748372|NCT01381692|Antifungal Agents|antifungal agents|mesh-ancestor
64748373|NCT01381692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64748374|NCT01395030|Choline|choline|mesh-list
64748375|NCT01395030|Lipotropic Agents|lipotropic agents|mesh-ancestor
64748376|NCT01395030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64748377|NCT01395030|Antimetabolites|antimetabolites|mesh-ancestor
64748399|NCT01394250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64748400|NCT01394250|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64748401|NCT01394250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64748402|NCT01394250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64748403|NCT01394250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748404|NCT01380990|Busulfan|busulfan|mesh-list
64748405|NCT01380990|Alkylating Agents|alkylating agents|mesh-ancestor
64748406|NCT01380990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748407|NCT01380990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64748408|NCT01380990|Immunologic Factors|immunologic factors|mesh-ancestor
64443526|NCT01709578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748413|NCT05369676|Ritonavir|ritonavir|mesh-list
64748414|NCT05369676|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64748415|NCT05369676|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64748416|NCT05369676|Protease Inhibitors|protease inhibitors|mesh-ancestor
64748417|NCT05369676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748418|NCT05369676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748419|NCT05369676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64748420|NCT05369676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64748421|NCT05369676|Antiviral Agents|antiviral agents|mesh-ancestor
64748422|NCT05369676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64634216|NCT04543942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634217|NCT04538950|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
64748423|NCT05369676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64634219|NCT04500158|Lidocaine|lidocaine|mesh-list
64748424|NCT05369676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64748425|NCT05361330|Fluoxetine|fluoxetine|mesh-list
64748426|NCT05361330|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64748427|NCT05361330|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64748428|NCT05361330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64748429|NCT05361330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323358|NCT04480359|Sensory System Agents|sensory system agents|mesh-ancestor
64323359|NCT04480359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748430|NCT05361330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64748431|NCT05361330|Serotonin Agents|serotonin agents|mesh-ancestor
64748432|NCT05361330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748433|NCT05361330|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64748434|NCT05361330|Antidepressive Agents|antidepressive agents|mesh-ancestor
64748435|NCT05361330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64748436|NCT05361330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64748437|NCT05361330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64748438|NCT05361330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748439|NCT00214968|Modafinil|modafinil|mesh-list
64748440|NCT00214968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64748441|NCT00214968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748442|NCT00214968|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64748443|NCT00214968|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64748488|NCT04263090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64748489|NCT04263090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748490|NCT03596424|Dexmedetomidine|dexmedetomidine|mesh-list
64748491|NCT03596424|Ketamine|ketamine|mesh-list
64748492|NCT03596424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64748493|NCT03596424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64748494|NCT03596424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748495|NCT03596424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64748496|NCT03596424|Analgesics|analgesics|mesh-ancestor
64748497|NCT03596424|Sensory System Agents|sensory system agents|mesh-ancestor
64748498|NCT03596424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748499|NCT03596424|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64748500|NCT03596424|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64359531|NCT05135715|Trastuzumab|trastuzumab|mesh-list
64748501|NCT03596424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64748502|NCT03596424|Adrenergic Agents|adrenergic agents|mesh-ancestor
64443671|NCT01924299|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64748503|NCT03596424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64748504|NCT03596424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748505|NCT03596424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64748506|NCT03596424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64748507|NCT03596424|Anesthetics, General|anesthetics, general|mesh-ancestor
64748508|NCT03596424|Anesthetics|anesthetics|mesh-ancestor
64748509|NCT03596424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64748510|NCT03596424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64748511|NCT03997266|Gentamicins|gentamicins|mesh-list
64748513|NCT03997266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64748514|NCT03997266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64748515|NCT03997266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64748534|NCT03594162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64748535|NCT03594162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64748536|NCT03594162|Alkylating Agents|alkylating agents|mesh-ancestor
64748537|NCT03594162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748538|NCT03594162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748539|NCT03594162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64748540|NCT04407312|Aspirin|aspirin|mesh-list
64748541|NCT04407312|Cilostazol|cilostazol|mesh-list
64748542|NCT04407312|Clopidogrel|clopidogrel|mesh-list
64748543|NCT04407312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64748544|NCT04407312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64748545|NCT04407312|Analgesics|analgesics|mesh-ancestor
64443989|NCT02148445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64443990|NCT02148445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64748546|NCT04407312|Sensory System Agents|sensory system agents|mesh-ancestor
64443994|NCT02147587|Tofacitinib|tofacitinib|mesh-list
64748548|NCT04407312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748549|NCT04407312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64748550|NCT04407312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64748551|NCT04407312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64634311|NCT04030962|Lifitegrast|lifitegrast|mesh-list
64634312|NCT04030962|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64634313|NCT04030962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64748552|NCT04407312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64748553|NCT04407312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748554|NCT04407312|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64748555|NCT04407312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64748556|NCT04407312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748558|NCT04407312|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64748559|NCT04407312|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64748560|NCT04407312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64748561|NCT04407312|Purinergic Agents|purinergic agents|mesh-ancestor
64748562|NCT04407312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64748563|NCT04407312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64748564|NCT04407312|Autonomic Agents|autonomic agents|mesh-ancestor
64748565|NCT04407312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64748566|NCT04407312|Respiratory System Agents|respiratory system agents|mesh-ancestor
64748567|NCT04407312|Vasodilator Agents|vasodilator agents|mesh-ancestor
64748568|NCT04407312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64748570|NCT04407312|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64748571|NCT04407312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64748572|NCT04009668|Adalimumab|adalimumab|mesh-list
64748573|NCT04009668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64748574|NCT04009668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64748575|NCT04326738|Midazolam|midazolam|mesh-list
64748576|NCT04326738|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64748577|NCT04326738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64748578|NCT04326738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64748579|NCT04326738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748580|NCT04326738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64748581|NCT04326738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64748582|NCT04326738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64748583|NCT04326738|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64748584|NCT04326738|Anesthetics, General|anesthetics, general|mesh-ancestor
64748585|NCT04326738|Anesthetics|anesthetics|mesh-ancestor
64748586|NCT04326738|GABA Modulators|gaba modulators|mesh-ancestor
64748587|NCT04326738|GABA Agents|gaba agents|mesh-ancestor
64748588|NCT04326738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64748589|NCT04326738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748591|NCT04347486|Neostigmine|neostigmine|mesh-list
64634353|NCT03859024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64748592|NCT04347486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64748593|NCT04347486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64748594|NCT04347486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64748595|NCT04347486|Autonomic Agents|autonomic agents|mesh-ancestor
64444142|NCT02236988|Apremilast|apremilast|mesh-list
64748606|NCT04347486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748611|NCT03598608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64748612|NCT03598608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748613|NCT03992196|Rotigotine|rotigotine|mesh-list
64748614|NCT03992196|Dopamine Agonists|dopamine agonists|mesh-ancestor
64748615|NCT03992196|Dopamine Agents|dopamine agents|mesh-ancestor
64748616|NCT03992196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64748617|NCT03992196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748618|NCT03992196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748619|NCT04407234|Acetaminophen|acetaminophen|mesh-list
64748620|NCT04407234|Tirzepatide|tirzepatide|mesh-list
64444162|NCT02236988|Growth Substances|growth substances|mesh-ancestor
64444163|NCT02236988|Growth Inhibitors|growth inhibitors|mesh-ancestor
64444164|NCT02236988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444166|NCT02236520|Spironolactone|spironolactone|mesh-list
64444167|NCT02236520|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64444168|NCT02236520|Hormone Antagonists|hormone antagonists|mesh-ancestor
64444169|NCT02236520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64444170|NCT02236520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444171|NCT02236520|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64748622|NCT04407234|Analgesics|analgesics|mesh-ancestor
64748623|NCT04407234|Sensory System Agents|sensory system agents|mesh-ancestor
64748624|NCT04407234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748625|NCT04407234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748626|NCT04407234|Antipyretics|antipyretics|mesh-ancestor
64748627|NCT04407234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64748628|NCT04407234|Incretins|incretins|mesh-ancestor
64748629|NCT04407234|Hormones|hormones|mesh-ancestor
64634388|NCT03808077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64634389|NCT03808077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64634390|NCT03808077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748630|NCT04407234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64748631|NCT03597594|Fludarabine|fludarabine|mesh-list
64748632|NCT03597594|Busulfan|busulfan|mesh-list
64748633|NCT03597594|Thiotepa|thiotepa|mesh-list
64748634|NCT03597594|Thymoglobulin|thymoglobulin|mesh-list
64748635|NCT03597594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64748636|NCT03597594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748644|NCT05632224|Aprepitant|aprepitant|mesh-list
64748660|NCT05631912|Immunologic Factors|immunologic factors|mesh-ancestor
64748661|NCT05631912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748662|NCT05631912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64748663|NCT05631912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64748664|NCT05631912|Alkylating Agents|alkylating agents|mesh-ancestor
64748665|NCT05631912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748666|NCT05631912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748667|NCT05631912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64748668|NCT05631912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64748669|NCT05631912|Antimetabolites|antimetabolites|mesh-ancestor
64748670|NCT03024840|Propofol|propofol|mesh-list
64748671|NCT03024840|Sevoflurane|sevoflurane|mesh-list
64748672|NCT03024840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64748673|NCT03024840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64748674|NCT03024840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748675|NCT03024840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64748676|NCT03024840|Anesthetics, General|anesthetics, general|mesh-ancestor
64748677|NCT03024840|Anesthetics|anesthetics|mesh-ancestor
64748678|NCT03024840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64444172|NCT02236520|Diuretics|diuretics|mesh-ancestor
64748692|NCT05631678|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64748698|NCT05631678|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64748699|NCT05631678|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64748700|NCT05631678|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64748701|NCT05631678|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64748702|NCT05631678|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64748703|NCT05631678|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64748705|NCT03599778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748706|NCT03599778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64748707|NCT03599778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748708|NCT03599778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634429|NCT03414658|Tubulin Modulators|tubulin modulators|mesh-ancestor
64634430|NCT03414658|Antimitotic Agents|antimitotic agents|mesh-ancestor
64634431|NCT03414658|Mitosis Modulators|mitosis modulators|mesh-ancestor
64634432|NCT03414658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634434|NCT03377491|Paclitaxel|paclitaxel|mesh-list
64634435|NCT03377491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64634436|NCT03377491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634437|NCT03377491|Tubulin Modulators|tubulin modulators|mesh-ancestor
64748771|NCT03976362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64748772|NCT03976362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634438|NCT03377491|Antimitotic Agents|antimitotic agents|mesh-ancestor
64748773|NCT03976362|Tubulin Modulators|tubulin modulators|mesh-ancestor
64748774|NCT03976362|Antimitotic Agents|antimitotic agents|mesh-ancestor
64748775|NCT03976362|Mitosis Modulators|mitosis modulators|mesh-ancestor
64748776|NCT03976362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748777|NCT03976362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64748778|NCT03976362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64748779|NCT03976362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748780|NCT03598374|Folic Acid|folic acid|mesh-list
64748781|NCT03598374|Vitamin B Complex|vitamin b complex|mesh-list
64748782|NCT03598374|Inositol|inositol|mesh-list
64748783|NCT03598374|Hematinics|hematinics|mesh-ancestor
64748784|NCT03598374|Vitamins|vitamins|mesh-ancestor
64748785|NCT03598374|Micronutrients|micronutrients|mesh-ancestor
64748786|NCT03598374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748804|NCT00217464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748805|NCT00217464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64517611|NCT03176472|Ricolinostat|ricolinostat|mesh-list
64748806|NCT00217464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64444211|NCT01922271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64444212|NCT02236130|Acetaminophen|acetaminophen|mesh-list
64444213|NCT02236130|Morphine|morphine|mesh-list
64444214|NCT02236130|Hydrocodone|hydrocodone|mesh-list
64444215|NCT02236130|Analgesics|analgesics|mesh-list
64444216|NCT02236130|Anesthetics|anesthetics|mesh-list
64444217|NCT02236130|Ropivacaine|ropivacaine|mesh-list
64444218|NCT02236130|Anesthetics, Local|anesthetics, local|mesh-list
64444219|NCT02236130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64444220|NCT02236130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444221|NCT02236130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64748807|NCT00217464|Hormone Antagonists|hormone antagonists|mesh-ancestor
64748808|NCT00217464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64444222|NCT02236130|Narcotics|narcotics|mesh-ancestor
64634454|NCT03298087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64634455|NCT03298087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444223|NCT02236130|Sensory System Agents|sensory system agents|mesh-ancestor
64444224|NCT02236130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748812|NCT03597282|Poly ICLC|poly iclc|mesh-list
64748813|NCT03597282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64748814|NCT03597282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748815|NCT03597282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64748816|NCT03597282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748817|NCT03597282|Interferon Inducers|interferon inducers|mesh-ancestor
64748818|NCT03597282|Immunologic Factors|immunologic factors|mesh-ancestor
64748819|NCT03597282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748820|NCT03593304|Vitamins|vitamins|mesh-list
64748862|NCT04197570|Analgesics|analgesics|mesh-list
64748863|NCT04197570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
64748864|NCT04197570|Anesthetics|anesthetics|mesh-list
64748865|NCT04197570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64748866|NCT04197570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748867|NCT04197570|Narcotics|narcotics|mesh-ancestor
64748868|NCT04197570|Sensory System Agents|sensory system agents|mesh-ancestor
64748869|NCT04197570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748870|NCT04197882|Molgramostim|molgramostim|mesh-list
64748871|NCT04197882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748872|NCT03024060|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64748873|NCT03024060|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64748874|NCT03024060|Dermatologic Agents|dermatologic agents|mesh-ancestor
64444229|NCT05153564|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64444230|NCT05153564|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
64444231|NCT05153564|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64444232|NCT05153564|Contraceptive Agents|contraceptive agents|mesh-ancestor
64444233|NCT05153564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64444234|NCT05153564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444235|NCT05153564|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64444236|NCT05153564|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64444237|NCT05153564|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64444238|NCT05153564|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64444239|NCT05153564|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64444240|NCT05153564|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
64444241|NCT05153564|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64444242|NCT05153564|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64444244|NCT01641809|Lamivudine|lamivudine|mesh-list
64444245|NCT01641809|Emtricitabine|emtricitabine|mesh-list
64444246|NCT01641809|Efavirenz|efavirenz|mesh-list
64444247|NCT01641809|Abacavir|abacavir|mesh-list
64444248|NCT01641809|Rilpivirine|rilpivirine|mesh-list
64634505|NCT02856594|Adrenergic Agents|adrenergic agents|mesh-ancestor
64748875|NCT03024216|Atezolizumab|atezolizumab|mesh-list
64748876|NCT03024216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360917|NCT02502877|Anesthetics|anesthetics|mesh-ancestor
64748901|NCT03591744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748919|NCT04196946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748921|NCT04196946|Sensory System Agents|sensory system agents|mesh-ancestor
64748922|NCT04196946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64444255|NCT01641809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64748955|NCT04196010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64748958|NCT04196010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64748959|NCT04196010|Immunologic Factors|immunologic factors|mesh-ancestor
64748960|NCT04196010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748961|NCT04196010|Analgesics|analgesics|mesh-ancestor
64748962|NCT04196010|Sensory System Agents|sensory system agents|mesh-ancestor
64748963|NCT04196010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64748964|NCT04196010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64748965|NCT04196010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64748966|NCT04196010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64748967|NCT04196010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64748969|NCT04196400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64748970|NCT04196400|Glucocorticoids|glucocorticoids|mesh-ancestor
64748971|NCT04196400|Hormones|hormones|mesh-ancestor
64748972|NCT04196400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64748973|NCT04196400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64748974|NCT04196400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64749013|NCT04195074|Entecavir|entecavir|mesh-list
64749017|NCT04195074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64749018|NCT04195074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749019|NCT04195074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749020|NCT04195074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64749021|NCT04195074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64749022|NCT03590262|Metformin|metformin|mesh-list
64749023|NCT03590262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64749024|NCT03590262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634537|NCT02453594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64634538|NCT02453594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634539|NCT02342782|Cytarabine|cytarabine|mesh-list
64634540|NCT02342782|Etoposide|etoposide|mesh-list
64634541|NCT02342782|Melphalan|melphalan|mesh-list
64634542|NCT02342782|Carmustine|carmustine|mesh-list
64634543|NCT02342782|Basiliximab|basiliximab|mesh-list
64634545|NCT02342782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749025|NCT04029636|Xenon|xenon|mesh-list
64749026|NCT04029636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64749027|NCT04029636|Anesthetics, General|anesthetics, general|mesh-ancestor
64749028|NCT04029636|Anesthetics|anesthetics|mesh-ancestor
64749029|NCT04029636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64749030|NCT04029636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749031|NCT04194684|Paclitaxel|paclitaxel|mesh-list
64749032|NCT04194684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64749033|NCT04194684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749034|NCT04194684|Tubulin Modulators|tubulin modulators|mesh-ancestor
64749035|NCT04194684|Antimitotic Agents|antimitotic agents|mesh-ancestor
64749036|NCT04194684|Mitosis Modulators|mitosis modulators|mesh-ancestor
64749038|NCT04194294|Lidocaine|lidocaine|mesh-list
64749062|NCT04194216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64749063|NCT04194216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64749064|NCT04194216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749065|NCT04194216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749066|NCT04193982|Vitamin E|vitamin e|mesh-list
64749067|NCT04193982|Vitamins|vitamins|mesh-ancestor
64749068|NCT04193982|Micronutrients|micronutrients|mesh-ancestor
64749069|NCT04193982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749070|NCT04193982|Antioxidants|antioxidants|mesh-ancestor
64749071|NCT04193982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749083|NCT03594474|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
64749084|NCT03594474|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64749085|NCT03594474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64444282|NCT01632566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64444283|NCT01632566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64444284|NCT01632566|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64749110|NCT04028466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749111|NCT04028466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749112|NCT04027764|Paclitaxel|paclitaxel|mesh-list
64749113|NCT04027764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64749114|NCT04027764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749115|NCT04027764|Tubulin Modulators|tubulin modulators|mesh-ancestor
64749116|NCT04027764|Antimitotic Agents|antimitotic agents|mesh-ancestor
64749117|NCT04027764|Mitosis Modulators|mitosis modulators|mesh-ancestor
64749118|NCT04027764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749120|NCT04027530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64749121|NCT04027530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634572|NCT02112864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634573|NCT02112864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64634574|NCT02112864|Glucocorticoids|glucocorticoids|mesh-ancestor
64749125|NCT03023358|Prednisone|prednisone|mesh-list
64749163|NCT04192656|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64749164|NCT04192656|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64749165|NCT04192656|Prednisolone|prednisolone|mesh-list
64444288|NCT01632566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64444289|NCT02254304|Interferons|interferons|mesh-list
64444290|NCT02254304|Interferon-beta|interferon-beta|mesh-list
64444291|NCT02254304|Interferon beta-1a|interferon beta-1a|mesh-list
64444292|NCT02254304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444293|NCT02254304|Antiviral Agents|antiviral agents|mesh-ancestor
64444294|NCT02254304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64444295|NCT02254304|Immunologic Factors|immunologic factors|mesh-ancestor
64749166|NCT04192656|Prednisolone acetate|prednisolone acetate|mesh-list
64749170|NCT04192656|Antiemetics|antiemetics|mesh-ancestor
64749171|NCT04192656|Autonomic Agents|autonomic agents|mesh-ancestor
64749172|NCT04192656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749173|NCT04192656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749174|NCT04192656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64749175|NCT04192656|Glucocorticoids|glucocorticoids|mesh-ancestor
64749177|NCT04192656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64749178|NCT04192656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64749179|NCT04192656|Protective Agents|protective agents|mesh-ancestor
64749180|NCT04192656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64749181|NCT04192656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749182|NCT04191954|Fasudil|fasudil|mesh-list
64749183|NCT04191954|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64749184|NCT04191954|Lubricant Eye Drops|lubricant eye drops|mesh-list
64749185|NCT04191954|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64749186|NCT04191954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64517986|NCT03242616|Antimitotic Agents|antimitotic agents|mesh-ancestor
64749187|NCT04191954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64749214|NCT03023982|Analgesics|analgesics|mesh-ancestor
64749215|NCT04192110|Diuretics|diuretics|mesh-list
64749216|NCT04192110|Natriuretic Agents|natriuretic agents|mesh-ancestor
64749217|NCT04192110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749218|NCT04025736|Tranexamic Acid|tranexamic acid|mesh-list
64749261|NCT04198662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749262|NCT04198662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64749263|NCT04198662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64749264|NCT04198662|Adrenergic Agents|adrenergic agents|mesh-ancestor
64749265|NCT04198662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64749266|NCT04198662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749267|NCT04198662|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64749268|NCT04198662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64749270|NCT04198662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64749271|NCT04198662|Respiratory System Agents|respiratory system agents|mesh-ancestor
64749273|NCT04198662|Sympathomimetics|sympathomimetics|mesh-ancestor
64749274|NCT04198662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64749275|NCT04023630|Rivaroxaban|rivaroxaban|mesh-list
64749276|NCT04023630|Clopidogrel|clopidogrel|mesh-list
64634606|NCT01970865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749277|NCT04023630|Ticagrelor|ticagrelor|mesh-list
64749278|NCT04023630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64749279|NCT04023630|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64749280|NCT04023630|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64749281|NCT04023630|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64749282|NCT04023630|Purinergic Agents|purinergic agents|mesh-ancestor
64749283|NCT04023630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64749284|NCT04023630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749286|NCT04023630|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64749313|NCT03929640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64749314|NCT03929640|Analgesics|analgesics|mesh-ancestor
64749315|NCT03929640|Sensory System Agents|sensory system agents|mesh-ancestor
64749316|NCT03929640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749317|NCT03929640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749318|NCT03929640|Antipyretics|antipyretics|mesh-ancestor
64634607|NCT01237457|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64749319|NCT03929640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64749320|NCT03929640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64749321|NCT03929640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64749382|NCT04145856|Emollients|emollients|mesh-ancestor
64749383|NCT04145856|Dermatologic Agents|dermatologic agents|mesh-ancestor
64749384|NCT04145856|Parasympatholytics|parasympatholytics|mesh-ancestor
64444336|NCT02121847|Cyclosporine|cyclosporine|mesh-list
64444337|NCT02121847|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64444338|NCT02121847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64749385|NCT04145856|Autonomic Agents|autonomic agents|mesh-ancestor
64444339|NCT02121847|Lubricant Eye Drops|lubricant eye drops|mesh-list
64749390|NCT04140786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64749391|NCT04140786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64749392|NCT04140786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749393|NCT04140786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749394|NCT04147650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64749395|NCT04147650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64749396|NCT04022226|Ketamine|ketamine|mesh-list
64749397|NCT04022226|Methohexital|methohexital|mesh-list
64749398|NCT04022226|Analgesics|analgesics|mesh-ancestor
64749399|NCT04022226|Sensory System Agents|sensory system agents|mesh-ancestor
64749400|NCT04022226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749427|NCT04145232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64749428|NCT04145232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749429|NCT04145232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64749430|NCT04145232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749431|NCT04144920|Oxymetazoline|oxymetazoline|mesh-list
64749432|NCT04144920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64749433|NCT04144920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64749434|NCT04144920|Adrenergic Agents|adrenergic agents|mesh-ancestor
64749435|NCT04144920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64749447|NCT04026282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749449|NCT04144218|Anticonvulsants|anticonvulsants|mesh-ancestor
64749450|NCT04144218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64749451|NCT04144218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64749477|NCT04143906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64749478|NCT04143906|Immunologic Factors|immunologic factors|mesh-ancestor
64749479|NCT04143906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749480|NCT04143906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64749481|NCT04143906|Tubulin Modulators|tubulin modulators|mesh-ancestor
64749482|NCT04143906|Antimitotic Agents|antimitotic agents|mesh-ancestor
64749483|NCT04143906|Mitosis Modulators|mitosis modulators|mesh-ancestor
64749488|NCT02708706|Hyaluronic Acid|hyaluronic acid|mesh-list
64749489|NCT02708706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64749490|NCT02708706|Immunologic Factors|immunologic factors|mesh-ancestor
64749491|NCT02708706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634614|NCT00723697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634615|NCT00723697|Analgesics|analgesics|mesh-ancestor
64634616|NCT00723697|Sensory System Agents|sensory system agents|mesh-ancestor
64634617|NCT00723697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64634618|NCT00723697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64634619|NCT00684073|Buprenorphine|buprenorphine|mesh-list
64634620|NCT00684073|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64634621|NCT00684073|Naloxone|naloxone|mesh-list
64634622|NCT00684073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64749492|NCT02708706|Viscosupplements|viscosupplements|mesh-ancestor
64749493|NCT02708706|Protective Agents|protective agents|mesh-ancestor
64749494|NCT05587608|Anesthetics|anesthetics|mesh-list
64749498|NCT02703714|Sargramostim|sargramostim|mesh-list
64749499|NCT02703714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64749500|NCT02703714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749501|NCT02703714|Immunologic Factors|immunologic factors|mesh-ancestor
64749502|NCT02703714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749503|NCT05583552|Imetelstat|imetelstat|mesh-list
64749504|NCT05583552|Motesanib diphosphate|motesanib diphosphate|mesh-list
64749505|NCT05583552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749506|NCT05583552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749507|NCT05583552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64749508|NCT05583474|Carteolol|carteolol|mesh-list
64749509|NCT05583474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64749510|NCT05583474|Latanoprost|latanoprost|mesh-list
64749511|NCT05583474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64749512|NCT05583474|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64749513|NCT05583474|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64749514|NCT05583474|Adrenergic Agents|adrenergic agents|mesh-ancestor
64749515|NCT05583474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64749521|NCT05583474|Autonomic Agents|autonomic agents|mesh-ancestor
64749522|NCT05583474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749523|NCT03945864|Anti-Infective Agents|anti-infective agents|mesh-list
64749524|NCT03945864|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64749525|NCT03904446|Methylergonovine|methylergonovine|mesh-list
64749526|NCT03904446|Oxytocics|oxytocics|mesh-ancestor
64634635|NCT00603109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634636|NCT00603109|Hormones|hormones|mesh-ancestor
64634637|NCT00603109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64749527|NCT03904446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64749528|NCT03904446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749534|NCT03916068|Antioxidants|antioxidants|mesh-ancestor
64749535|NCT03916068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749536|NCT03916068|Protective Agents|protective agents|mesh-ancestor
64749537|NCT03916068|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64634638|NCT00603109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634639|NCT00199095|Cytarabine|cytarabine|mesh-list
64634640|NCT00199095|Dexamethasone|dexamethasone|mesh-list
64634641|NCT00199095|Cyclophosphamide|cyclophosphamide|mesh-list
64634642|NCT00199095|Ifosfamide|ifosfamide|mesh-list
64634643|NCT00199095|Methotrexate|methotrexate|mesh-list
64634645|NCT00199095|Doxorubicin|doxorubicin|mesh-list
64749538|NCT03916068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749539|NCT03916068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64749540|NCT03916068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64634646|NCT00199095|Mercaptopurine|mercaptopurine|mesh-list
64749541|NCT03916068|Vasodilator Agents|vasodilator agents|mesh-ancestor
64749542|NCT03916068|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64749543|NCT04143282|Metformin|metformin|mesh-list
64749544|NCT04143282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64749545|NCT04143282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749546|NCT04149678|Cyclosporine|cyclosporine|mesh-list
64749547|NCT04149678|Cyclosporins|cyclosporins|mesh-list
64749548|NCT04149678|Ozanimod|ozanimod|mesh-list
64749549|NCT04149678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749550|NCT04149678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749560|NCT05581992|Omeprazole|omeprazole|mesh-list
64749567|NCT03020940|Cefuroxime axetil|cefuroxime axetil|mesh-list
64749568|NCT03020940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64749569|NCT03020940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64749570|NCT03645408|Exenatide|exenatide|mesh-list
64749571|NCT03645408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64749572|NCT03645408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749573|NCT03645408|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64634665|NCT00199095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64634666|NCT00199095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64749574|NCT03645408|Incretins|incretins|mesh-ancestor
64749575|NCT03645408|Hormones|hormones|mesh-ancestor
64749576|NCT03645408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64749577|NCT04141410|Simendan|simendan|mesh-list
64749578|NCT04141410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64749579|NCT04141410|Vasodilator Agents|vasodilator agents|mesh-ancestor
64749580|NCT04141410|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64749581|NCT04141410|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64749582|NCT04141410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634667|NCT00199095|Abortifacient Agents|abortifacient agents|mesh-ancestor
64634668|NCT00199095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64634669|NCT00199095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64634670|NCT00199095|Antimetabolites|antimetabolites|mesh-ancestor
64634671|NCT00199095|Dermatologic Agents|dermatologic agents|mesh-ancestor
64634672|NCT00199095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634673|NCT00199095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64634674|NCT00199095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64634675|NCT00199095|Antiviral Agents|antiviral agents|mesh-ancestor
64634676|NCT00199095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64634677|NCT00199095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64749583|NCT04141410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749584|NCT04141410|Protective Agents|protective agents|mesh-ancestor
64749585|NCT04141410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749586|NCT05586204|Vaccines|vaccines|mesh-list
64749587|NCT05586204|Immunologic Factors|immunologic factors|mesh-ancestor
64749588|NCT05586204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749589|NCT04149444|Trifluridine|trifluridine|mesh-list
64749590|NCT04149444|Antimetabolites|antimetabolites|mesh-ancestor
64749591|NCT04149444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749592|NCT04149444|Antiviral Agents|antiviral agents|mesh-ancestor
64749593|NCT04149444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64749594|NCT03020706|Magnesium Sulfate|magnesium sulfate|mesh-list
64749595|NCT03020706|Analgesics|analgesics|mesh-ancestor
64749596|NCT03020706|Sensory System Agents|sensory system agents|mesh-ancestor
64749597|NCT03020706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749611|NCT03900624|Antiemetics|antiemetics|mesh-ancestor
64749612|NCT03900624|Autonomic Agents|autonomic agents|mesh-ancestor
64749613|NCT03900624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749614|NCT03900624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749615|NCT03900624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64749616|NCT03900624|Glucocorticoids|glucocorticoids|mesh-ancestor
64749617|NCT03900624|Hormones|hormones|mesh-ancestor
64749618|NCT03900624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64749619|NCT03900624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64749620|NCT03900624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749621|NCT04149132|Nitric Oxide|nitric oxide|mesh-list
64749622|NCT04149132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64749623|NCT04149132|Autonomic Agents|autonomic agents|mesh-ancestor
64749624|NCT04149132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749625|NCT04149132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749626|NCT04149132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64749627|NCT04149132|Respiratory System Agents|respiratory system agents|mesh-ancestor
64749628|NCT04149132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64749629|NCT04149132|Antioxidants|antioxidants|mesh-ancestor
64749630|NCT04149132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749631|NCT04149132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64444396|NCT05619653|Losartan|losartan|mesh-list
64444397|NCT05619653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64444398|NCT05619653|Glucocorticoids|glucocorticoids|mesh-ancestor
64444399|NCT05619653|Hormones|hormones|mesh-ancestor
64444400|NCT05619653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64634701|NCT00199056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634709|NCT00199056|Antiemetics|antiemetics|mesh-ancestor
64444401|NCT05619653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444402|NCT05619653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64444403|NCT05619653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444404|NCT05619653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64444405|NCT05619653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64749632|NCT04149132|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64749633|NCT04149132|Vasodilator Agents|vasodilator agents|mesh-ancestor
64444406|NCT05619653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64749666|NCT04140006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749667|NCT04146324|Nivolumab|nivolumab|mesh-list
64749668|NCT04146324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64749669|NCT04146324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749670|NCT04146324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64749671|NCT04146324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749672|NCT03588936|Nivolumab|nivolumab|mesh-list
64749673|NCT03588936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64749674|NCT03588936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749675|NCT03588936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64749676|NCT03588936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749677|NCT03022500|Durvalumab|durvalumab|mesh-list
64749678|NCT03022500|Tremelimumab|tremelimumab|mesh-list
64749679|NCT03022500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64749680|NCT03022500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749681|NCT04148898|Bevacizumab|bevacizumab|mesh-list
64749682|NCT04148898|Osimertinib|osimertinib|mesh-list
64749683|NCT04148898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64749684|NCT04148898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749685|NCT04148898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64749686|NCT04148898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64749687|NCT04148898|Growth Substances|growth substances|mesh-ancestor
64749688|NCT04148898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749689|NCT04148898|Growth Inhibitors|growth inhibitors|mesh-ancestor
64749703|NCT04148820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64749704|NCT04148820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64749705|NCT04148820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64749706|NCT04148820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749707|NCT04148820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64749708|NCT04148820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64749709|NCT04148820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749710|NCT04148820|Antipyretics|antipyretics|mesh-ancestor
64749711|NCT04148820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64749712|NCT04148820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64749713|NCT04148820|Antimetabolites|antimetabolites|mesh-ancestor
64749714|NCT04148820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64749715|NCT04148820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64749716|NCT04148820|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64749718|NCT04148820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64749719|NCT03941730|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64749720|NCT03941730|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64749721|NCT03941730|Estradiol|estradiol|mesh-list
64749722|NCT03941730|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64749723|NCT03941730|Estrogens|estrogens|mesh-ancestor
64634736|NCT00199030|Cladribine|cladribine|mesh-list
64749724|NCT03941730|Hormones|hormones|mesh-ancestor
64749725|NCT03941730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64749726|NCT03941730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749727|NCT03941730|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64444429|NCT05598905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64444430|NCT05598905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64444432|NCT01586338|Viscosupplements|viscosupplements|mesh-ancestor
64444433|NCT01586338|Protective Agents|protective agents|mesh-ancestor
64444434|NCT01586338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444436|NCT02143141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64444437|NCT02143141|Narcotics|narcotics|mesh-ancestor
64444438|NCT02143141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64749754|NCT03580980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64749755|NCT03580980|Narcotics|narcotics|mesh-ancestor
64749756|NCT03580980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64749757|NCT03580980|Antipyretics|antipyretics|mesh-ancestor
64749758|NCT03580980|Anesthetics, Local|anesthetics, local|mesh-ancestor
64749759|NCT03587220|Lidocaine|lidocaine|mesh-list
64749760|NCT03587220|Capsaicin|capsaicin|mesh-list
64749761|NCT03587220|Histamine|histamine|mesh-list
64749762|NCT03587220|Anesthetics, Local|anesthetics, local|mesh-ancestor
64749763|NCT03587220|Anesthetics|anesthetics|mesh-ancestor
64749764|NCT03587220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64749765|NCT03587220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749766|NCT03587220|Sensory System Agents|sensory system agents|mesh-ancestor
64749767|NCT03587220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749768|NCT03587220|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64749769|NCT03587220|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64749770|NCT03587220|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64749771|NCT03587220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64749807|NCT04147806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64749808|NCT04147806|Adrenergic Agents|adrenergic agents|mesh-ancestor
64749809|NCT04147806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64749810|NCT04147806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749811|NCT04147806|Urological Agents|urological agents|mesh-ancestor
64749812|NCT03580590|Diltiazem|diltiazem|mesh-list
64749813|NCT03580590|Tranexamic Acid|tranexamic acid|mesh-list
64749814|NCT03580590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64749815|NCT03580590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64749827|NCT03891576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64749828|NCT03891576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749829|NCT03891576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749830|NCT03586674|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64749831|NCT03586674|Fenofibrate|fenofibrate|mesh-list
64749832|NCT03586674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64749833|NCT03586674|Antimetabolites|antimetabolites|mesh-ancestor
64749834|NCT03586674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749851|NCT03346668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749852|NCT03346668|Antimanic Agents|antimanic agents|mesh-ancestor
64749853|NCT03585738|Folic Acid|folic acid|mesh-list
64749854|NCT03585738|Vitamin B Complex|vitamin b complex|mesh-list
64749855|NCT03585738|Inositol|inositol|mesh-list
64749856|NCT03585738|Hematinics|hematinics|mesh-ancestor
64749857|NCT03585738|Vitamins|vitamins|mesh-ancestor
64634758|NCT00198978|Alkylating Agents|alkylating agents|mesh-ancestor
64634759|NCT00198978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634760|NCT00198978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634761|NCT00198978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64634762|NCT00198978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64634763|NCT00198978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64634764|NCT00198978|Antiemetics|antiemetics|mesh-ancestor
64634765|NCT00198978|Autonomic Agents|autonomic agents|mesh-ancestor
64302062|NCT02133469|Vaccines|vaccines|mesh-list
64749858|NCT03585738|Micronutrients|micronutrients|mesh-ancestor
64749859|NCT03585738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749860|NCT03583164|Olorofim|olorofim|mesh-list
64749861|NCT03583164|Antifungal Agents|antifungal agents|mesh-ancestor
64749862|NCT03583164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64749863|NCT03589326|Cytarabine|cytarabine|mesh-list
64749864|NCT03589326|Dexamethasone|dexamethasone|mesh-list
64749865|NCT03589326|Prednisone|prednisone|mesh-list
64749866|NCT03589326|Methotrexate|methotrexate|mesh-list
64749867|NCT03589326|Vincristine|vincristine|mesh-list
64749868|NCT03589326|Imatinib Mesylate|imatinib mesylate|mesh-list
64749869|NCT03589326|Ponatinib|ponatinib|mesh-list
64749870|NCT03589326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64749871|NCT03589326|Antiemetics|antiemetics|mesh-ancestor
64749872|NCT03589326|Autonomic Agents|autonomic agents|mesh-ancestor
64749873|NCT03589326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749874|NCT03589326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749875|NCT03589326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64749876|NCT03589326|Glucocorticoids|glucocorticoids|mesh-ancestor
64749877|NCT03589326|Hormones|hormones|mesh-ancestor
64749904|NCT05701956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749905|NCT03156036|Capecitabine|capecitabine|mesh-list
64749906|NCT03156036|Temozolomide|temozolomide|mesh-list
64749907|NCT03156036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64749908|NCT03156036|Antimetabolites|antimetabolites|mesh-ancestor
64749909|NCT03156036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749910|NCT03156036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64749911|NCT03156036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64749912|NCT03156036|Alkylating Agents|alkylating agents|mesh-ancestor
64749913|NCT03583866|Candesartan|candesartan|mesh-list
64749914|NCT03583866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64749915|NCT03583866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64749916|NCT03583866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64749917|NCT03583866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64749918|NCT03585426|Vancomycin|vancomycin|mesh-list
64749919|NCT03585426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64749920|NCT03585426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64749921|NCT03585036|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
64749960|NCT03155646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749961|NCT03155646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64749962|NCT03155646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64749963|NCT03155646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64749964|NCT03155646|Adrenergic Agents|adrenergic agents|mesh-ancestor
64749965|NCT03155646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64634770|NCT00198978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64634771|NCT00198978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64634772|NCT00198978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64444472|NCT01585246|Saw palmetto extract|saw palmetto extract|mesh-list
64749976|NCT03584178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64749977|NCT03584178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64749978|NCT03584178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64749979|NCT03584178|Respiratory System Agents|respiratory system agents|mesh-ancestor
64749980|NCT03584178|Glucocorticoids|glucocorticoids|mesh-ancestor
64749981|NCT03584178|Hormones|hormones|mesh-ancestor
64749982|NCT03584178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64749983|NCT04405206|Capecitabine|capecitabine|mesh-list
64750011|NCT03583476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64750012|NCT03583476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64750013|NCT03583476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64750014|NCT03583476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64750015|NCT03583476|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64750016|NCT03583476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750017|NCT03583476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750018|NCT03583476|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64750019|NCT03583476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64750020|NCT03583242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
64750032|NCT02728050|Sorafenib|sorafenib|mesh-list
64750033|NCT02728050|Mitoxantrone|mitoxantrone|mesh-list
64750034|NCT02728050|Cladribine|cladribine|mesh-list
64750035|NCT02728050|Lenograstim|lenograstim|mesh-list
64750036|NCT02728050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64750037|NCT02728050|Antimetabolites|antimetabolites|mesh-ancestor
64750038|NCT02728050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750039|NCT02728050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750040|NCT02728050|Antiviral Agents|antiviral agents|mesh-ancestor
64750041|NCT02728050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64750042|NCT02728050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64750043|NCT02728050|Immunologic Factors|immunologic factors|mesh-ancestor
64750053|NCT05703126|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
64750054|NCT05703126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750055|NCT05703126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750056|NCT03159390|Phenylacetic acid|phenylacetic acid|mesh-list
64750057|NCT03159390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64750058|NCT03159390|Antimetabolites|antimetabolites|mesh-ancestor
64750059|NCT03159390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750120|NCT05702970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750121|NCT05702970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64750122|NCT03158142|Atropine|atropine|mesh-list
64444511|NCT02231918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64444512|NCT02231918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64444513|NCT02231918|Dopamine Agonists|dopamine agonists|mesh-ancestor
64444514|NCT02231918|Dopamine Agents|dopamine agents|mesh-ancestor
64444515|NCT02231918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64444516|NCT02199314|Desflurane|desflurane|mesh-list
64444517|NCT02199314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64444518|NCT02199314|Anesthetics, General|anesthetics, general|mesh-ancestor
64750123|NCT03158142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64750129|NCT03158142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64750130|NCT03158142|Respiratory System Agents|respiratory system agents|mesh-ancestor
64750131|NCT03158142|Mydriatics|mydriatics|mesh-ancestor
64750132|NCT03158142|Parasympatholytics|parasympatholytics|mesh-ancestor
64750133|NCT03158142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64750134|NCT03158142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64750135|NCT03158142|Cholinergic Agents|cholinergic agents|mesh-ancestor
64750136|NCT03158142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64750137|NCT03158142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750138|NCT03028740|Cenicriviroc|cenicriviroc|mesh-list
64750141|NCT03028740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64750174|NCT01671852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64750175|NCT01671852|Dermatologic Agents|dermatologic agents|mesh-ancestor
64750176|NCT01671852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64750177|NCT01672086|Calcium Carbonate|calcium carbonate|mesh-list
64750178|NCT01672086|Antacids|antacids|mesh-ancestor
64750179|NCT01672086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750180|NCT01672086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64750183|NCT05153304|Nivolumab|nivolumab|mesh-list
64750184|NCT05153304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64750185|NCT05153304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750186|NCT05153304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64750187|NCT05153304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750188|NCT05547750|Vitamin K|vitamin k|mesh-list
64444519|NCT02199314|Anesthetics|anesthetics|mesh-ancestor
64634833|NCT00004144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444520|NCT02199314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64444526|NCT02199080|Hemostatics|hemostatics|mesh-ancestor
64750189|NCT05547750|Vitamin K 2|vitamin k 2|mesh-list
64750190|NCT05547750|Vitamins|vitamins|mesh-ancestor
64750191|NCT05547750|Micronutrients|micronutrients|mesh-ancestor
64750192|NCT05547750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750193|NCT05547750|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64750194|NCT05547750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64750195|NCT05547750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750213|NCT01672476|Valsartan|valsartan|mesh-list
64750227|NCT05067582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750229|NCT05033808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64750230|NCT05033808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750231|NCT05033808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64750232|NCT05033808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64750233|NCT05033808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750234|NCT05033808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750235|NCT04026984|Rifamycins|rifamycins|mesh-list
64750236|NCT04026984|Rifamycin SV|rifamycin sv|mesh-list
64750237|NCT04026984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64750238|NCT04026984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64750239|NCT04026984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64750240|NCT03989466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64750241|NCT03989466|Alemtuzumab|alemtuzumab|mesh-list
64750242|NCT03989466|Antibodies|antibodies|mesh-list
64750243|NCT03989466|Immunoglobulins|immunoglobulins|mesh-list
64750244|NCT03989466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64750245|NCT03989466|Immunologic Factors|immunologic factors|mesh-ancestor
64750246|NCT03989466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750247|NCT03989466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750248|NCT04903314|Cenobamate|cenobamate|mesh-list
64750249|NCT04903314|Anticonvulsants|anticonvulsants|mesh-ancestor
64750250|NCT03153072|Amiodarone|amiodarone|mesh-list
64750251|NCT03153072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64750252|NCT03153072|Vasodilator Agents|vasodilator agents|mesh-ancestor
64750253|NCT03153072|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64750254|NCT03153072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64750255|NCT03153072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750256|NCT03153072|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64750257|NCT03153072|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64750258|NCT03153072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64750259|NCT03153072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634876|NCT00003928|Immunologic Factors|immunologic factors|mesh-ancestor
64634877|NCT00003928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634878|NCT00004162|Doxorubicin|doxorubicin|mesh-list
64634880|NCT00004162|Methotrexate|methotrexate|mesh-list
64750268|NCT01673724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750278|NCT04765098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64750279|NCT04765098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750280|NCT04765098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64750281|NCT04765098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64750282|NCT04765098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444540|NCT02196506|Brexpiprazole|brexpiprazole|mesh-list
64444541|NCT02196506|Serotonin Agents|serotonin agents|mesh-ancestor
64444542|NCT02196506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64444543|NCT02196506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444544|NCT02196506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444545|NCT02196506|Dopamine Agonists|dopamine agonists|mesh-ancestor
64444546|NCT02196506|Dopamine Agents|dopamine agents|mesh-ancestor
64444547|NCT02228720|Mometasone Furoate|mometasone furoate|mesh-list
64750287|NCT04765098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750288|NCT04765098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64750289|NCT04765098|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64750290|NCT04765098|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64750291|NCT04765098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64750316|NCT01674270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64750317|NCT01674270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750318|NCT01674270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750319|NCT01674504|Montelukast|montelukast|mesh-list
64750320|NCT01674504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64750321|NCT01674504|Respiratory System Agents|respiratory system agents|mesh-ancestor
64444549|NCT02228720|Dermatologic Agents|dermatologic agents|mesh-ancestor
64444550|NCT02228720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64444551|NCT01640951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64444552|NCT01640951|Immunologic Factors|immunologic factors|mesh-ancestor
64444553|NCT01640951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444554|NCT01683994|Prednisone|prednisone|mesh-list
64444555|NCT01683994|Docetaxel|docetaxel|mesh-list
64444556|NCT01683994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750365|NCT03152370|Micronutrients|micronutrients|mesh-ancestor
64750366|NCT03152370|Hematinics|hematinics|mesh-ancestor
64750367|NCT02187120|Tranexamic Acid|tranexamic acid|mesh-list
64750368|NCT02187120|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64750369|NCT02187120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64750431|NCT04747080|Hormones|hormones|mesh-ancestor
64634907|NCT00004984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64634908|NCT00004984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634910|NCT00004174|Cyclophosphamide|cyclophosphamide|mesh-list
64634911|NCT00004174|Thiotepa|thiotepa|mesh-list
64634912|NCT00004174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64634913|NCT00004174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634914|NCT00004174|Tubulin Modulators|tubulin modulators|mesh-ancestor
64634915|NCT00004174|Antimitotic Agents|antimitotic agents|mesh-ancestor
64750442|NCT01675362|Losartan|losartan|mesh-list
64750443|NCT01675362|Verapamil|verapamil|mesh-list
64634916|NCT00004174|Mitosis Modulators|mitosis modulators|mesh-ancestor
64750444|NCT01675362|Calcium Channel Blockers|calcium channel blockers|mesh-list
64750445|NCT01675362|Calcium|calcium|mesh-list
64750446|NCT01675362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64750447|NCT01675362|Antioxidants|antioxidants|mesh-list
64750448|NCT01675362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64750449|NCT01675362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750450|NCT01675362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64750451|NCT01675362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64750452|NCT01675362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64750453|NCT01675362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750459|NCT01675518|ASP7991|asp7991|mesh-list
64750479|NCT01675986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750480|NCT01675986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64750481|NCT01675986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64750482|NCT01675986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64750483|NCT01675986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64750484|NCT01675986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64750485|NCT01675986|Antipruritics|antipruritics|mesh-ancestor
64750486|NCT01675986|Dermatologic Agents|dermatologic agents|mesh-ancestor
64750487|NCT01675986|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64750488|NCT01675986|Histamine Antagonists|histamine antagonists|mesh-ancestor
64750489|NCT01675986|Histamine Agents|histamine agents|mesh-ancestor
64750490|NCT01675986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64750491|NCT03875664|Bupivacaine|bupivacaine|mesh-list
64750492|NCT03875664|Anesthetics, Local|anesthetics, local|mesh-ancestor
64444628|NCT02121301|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64444629|NCT05422703|Analgesics|analgesics|mesh-list
64444630|NCT05422703|Sensory System Agents|sensory system agents|mesh-ancestor
64444631|NCT05422703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64444632|NCT05422703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444633|NCT02227862|Insulin Glargine|insulin glargine|mesh-list
64444634|NCT02227862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64444635|NCT02227862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444636|NCT02120833|Decanoic acid|decanoic acid|mesh-list
64750493|NCT03875664|Anesthetics|anesthetics|mesh-ancestor
64444637|NCT02120833|Antifungal Agents|antifungal agents|mesh-ancestor
64444638|NCT02120833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64750502|NCT01670136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750503|NCT01670136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750504|NCT01670136|Urological Agents|urological agents|mesh-ancestor
64750505|NCT03873480|Epinephrine|epinephrine|mesh-list
64750506|NCT03873480|Bupivacaine|bupivacaine|mesh-list
64750507|NCT03873480|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64634933|NCT01284517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64634934|NCT01284517|Adrenergic Agents|adrenergic agents|mesh-ancestor
64634935|NCT01284517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64634936|NCT01284517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634937|NCT01284517|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64634938|NCT01284517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64634939|NCT01284517|Serotonin Agents|serotonin agents|mesh-ancestor
64634940|NCT01284517|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64634941|NCT01284517|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64634942|NCT01284517|Dopamine Agents|dopamine agents|mesh-ancestor
64750508|NCT03873480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64750509|NCT03873480|Adrenergic Agents|adrenergic agents|mesh-ancestor
64750510|NCT03873480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64750520|NCT03873480|Sympathomimetics|sympathomimetics|mesh-ancestor
64750521|NCT03873480|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64750522|NCT03873480|Anesthetics, Local|anesthetics, local|mesh-ancestor
64750524|NCT03873480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64750525|NCT03873480|Sensory System Agents|sensory system agents|mesh-ancestor
64750526|NCT04764084|Niraparib|niraparib|mesh-list
64634952|NCT00004990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64750527|NCT04764084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64750528|NCT04764084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750529|NCT04764084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750530|NCT04764084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750531|NCT03866772|Misoprostol|misoprostol|mesh-list
64750532|NCT03866772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64750533|NCT03866772|Abortifacient Agents|abortifacient agents|mesh-ancestor
64750534|NCT03866772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64750535|NCT03866772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750536|NCT03866772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64750537|NCT03866772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64750538|NCT03866772|Oxytocics|oxytocics|mesh-ancestor
64750539|NCT03866538|Budesonide|budesonide|mesh-list
64750540|NCT03866538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64519340|NCT02374060|Immunologic Factors|immunologic factors|mesh-ancestor
64750541|NCT03866538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64750542|NCT03866538|Autonomic Agents|autonomic agents|mesh-ancestor
64750543|NCT03866538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64750544|NCT03866538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750545|NCT03866538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64750546|NCT03866538|Respiratory System Agents|respiratory system agents|mesh-ancestor
64750547|NCT03866538|Glucocorticoids|glucocorticoids|mesh-ancestor
64750548|NCT03866538|Hormones|hormones|mesh-ancestor
64750549|NCT03866538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64750550|NCT03865992|Curcumin|curcumin|mesh-list
64750551|NCT03865992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64750552|NCT03865992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64750553|NCT03865992|Analgesics|analgesics|mesh-ancestor
64750554|NCT03865992|Sensory System Agents|sensory system agents|mesh-ancestor
64362585|NCT03101085|Equol|equol|mesh-list
64750556|NCT03865992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750557|NCT03865992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64750558|NCT03865992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64750559|NCT03865992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634953|NCT00004990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64634954|NCT00004990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634955|NCT00004180|Rosiglitazone|rosiglitazone|mesh-list
64634956|NCT00004180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64634957|NCT00004180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634958|NCT01216735|Fluticasone|fluticasone|mesh-list
64634959|NCT01216735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64750560|NCT03865992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750561|NCT03865992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750562|NCT03865212|Interferons|interferons|mesh-list
64750563|NCT03865212|Interferon-beta|interferon-beta|mesh-list
64750564|NCT03865212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750565|NCT03865212|Antiviral Agents|antiviral agents|mesh-ancestor
64444672|NCT02227784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444673|NCT02227784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64750566|NCT03865212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64750567|NCT03865212|Immunologic Factors|immunologic factors|mesh-ancestor
64750568|NCT03865212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444676|NCT04577417|Methylphenidate|methylphenidate|mesh-list
64750576|NCT03749460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64750577|NCT03749460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750578|NCT03749460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64750608|NCT03747432|Sensory System Agents|sensory system agents|mesh-ancestor
64750609|NCT03747432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64750610|NCT03747432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64750611|NCT03747432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64750612|NCT03747432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64750613|NCT03747432|Adrenergic Agents|adrenergic agents|mesh-ancestor
64750614|NCT03747432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64750615|NCT03747432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750616|NCT03747120|Paclitaxel|paclitaxel|mesh-list
64750617|NCT03747120|Pembrolizumab|pembrolizumab|mesh-list
64750618|NCT03747120|Trastuzumab|trastuzumab|mesh-list
64750619|NCT03747120|Pertuzumab|pertuzumab|mesh-list
64750620|NCT03747120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64750621|NCT03747120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750622|NCT03747120|Tubulin Modulators|tubulin modulators|mesh-ancestor
64750623|NCT03747120|Antimitotic Agents|antimitotic agents|mesh-ancestor
64750624|NCT03747120|Mitosis Modulators|mitosis modulators|mesh-ancestor
64750625|NCT03747120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750626|NCT03747120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64750627|NCT01345656|Spironolactone|spironolactone|mesh-list
64750628|NCT01345656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64750629|NCT01345656|Hormone Antagonists|hormone antagonists|mesh-ancestor
64750630|NCT01345656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64634980|NCT00004186|Alkylating Agents|alkylating agents|mesh-ancestor
64750631|NCT01345656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750632|NCT01345656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64750633|NCT01345656|Diuretics|diuretics|mesh-ancestor
64750634|NCT01345656|Natriuretic Agents|natriuretic agents|mesh-ancestor
64750635|NCT04763616|Cemiplimab|cemiplimab|mesh-list
64750636|NCT04763616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64750637|NCT04763616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750638|NCT03652974|Valproic Acid|valproic acid|mesh-list
64750639|NCT03652974|Clozapine|clozapine|mesh-list
64750640|NCT03652974|Amisulpride|amisulpride|mesh-list
64750649|NCT03652974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64750650|NCT03652974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64750651|NCT03652974|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64750652|NCT03652974|Serotonin Agents|serotonin agents|mesh-ancestor
64750653|NCT03652974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64750661|NCT03649152|Interferon Inducers|interferon inducers|mesh-ancestor
64750662|NCT03649152|Immunologic Factors|immunologic factors|mesh-ancestor
64750663|NCT03649152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750665|NCT03646188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64750666|NCT03646188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64750667|NCT03646188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750668|NCT03646188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64750669|NCT03646188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64750670|NCT03646188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750671|NCT03646188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750672|NCT03727776|Hormones|hormones|mesh-list
64750673|NCT03727776|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64750674|NCT03727776|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64750675|NCT03727776|beta-Endorphin|beta-endorphin|mesh-list
64750677|NCT03727776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750694|NCT02082678|Antipruritics|antipruritics|mesh-ancestor
64750695|NCT02082678|Dermatologic Agents|dermatologic agents|mesh-ancestor
64750696|NCT02082678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64750697|NCT02082678|Serotonin Agents|serotonin agents|mesh-ancestor
64750698|NCT02082678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64750699|NCT02082678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750700|NCT02082678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64750701|NCT02082678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64750702|NCT02082678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64750703|NCT02082678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64750759|NCT00003816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64750760|NCT00003816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64444695|NCT01683058|Antidepressive Agents|antidepressive agents|mesh-ancestor
64444696|NCT01683058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64444697|NCT01683058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64750761|NCT00003816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444698|NCT01683058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64444699|NCT01683058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64444700|NCT01683058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444701|NCT01683058|Dopamine Agonists|dopamine agonists|mesh-ancestor
64444702|NCT01683058|Dopamine Agents|dopamine agents|mesh-ancestor
64444703|NCT01683058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64635017|NCT00005002|Nelfinavir|nelfinavir|mesh-list
64750762|NCT03618654|Metformin|metformin|mesh-list
64635018|NCT00005002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64750763|NCT03618654|Durvalumab|durvalumab|mesh-list
64750764|NCT03618654|Immunoglobulins|immunoglobulins|mesh-list
64750765|NCT03618654|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64750766|NCT03618654|Immunoglobulin G|immunoglobulin g|mesh-list
64750767|NCT03618654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64750769|NCT03618654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64750770|NCT03618654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750771|NCT03618654|Immunologic Factors|immunologic factors|mesh-ancestor
64750772|NCT03712878|Mycophenolic Acid|mycophenolic acid|mesh-list
64750773|NCT03712878|Cyclophosphamide|cyclophosphamide|mesh-list
64750774|NCT03712878|Tacrolimus|tacrolimus|mesh-list
64750775|NCT03712878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64750776|NCT03712878|Immunologic Factors|immunologic factors|mesh-ancestor
64750821|NCT03611556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750822|NCT03611556|Antidotes|antidotes|mesh-ancestor
64750823|NCT03611556|Protective Agents|protective agents|mesh-ancestor
64750824|NCT03611556|Vitamin B Complex|vitamin b complex|mesh-ancestor
64750825|NCT03611556|Vitamins|vitamins|mesh-ancestor
64750826|NCT03611556|Micronutrients|micronutrients|mesh-ancestor
64750827|NCT03611556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64750828|NCT03609060|Dexamethasone|dexamethasone|mesh-list
64750829|NCT03609060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64750830|NCT03609060|Antiemetics|antiemetics|mesh-ancestor
64750831|NCT03609060|Autonomic Agents|autonomic agents|mesh-ancestor
64750832|NCT03609060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64750833|NCT03609060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750834|NCT03609060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64750835|NCT03609060|Glucocorticoids|glucocorticoids|mesh-ancestor
64750836|NCT03609060|Hormones|hormones|mesh-ancestor
64750837|NCT03609060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64750840|NCT04762992|Enoxaparin|enoxaparin|mesh-list
64635041|NCT01264705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635042|NCT01264705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635043|NCT01264705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64635044|NCT01264705|Immunologic Factors|immunologic factors|mesh-ancestor
64750880|NCT00004092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64750881|NCT00004092|Alkylating Agents|alkylating agents|mesh-ancestor
64750882|NCT00004092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64750883|NCT00004092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64750884|NCT00004092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64750885|NCT00004092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64750886|NCT00004092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750887|NCT00004146|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
64750888|NCT00004146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750889|NCT00004146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64750890|NCT00004146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64750891|NCT00004146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750892|NCT00004146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64750893|NCT00004146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750894|NCT00004500|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64750895|NCT00004500|Respiratory System Agents|respiratory system agents|mesh-ancestor
64750896|NCT03602976|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64750937|NCT03825198|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64750938|NCT03825198|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64750939|NCT03825198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64750940|NCT03825198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64750941|NCT03825198|Anesthetics, Local|anesthetics, local|mesh-ancestor
64750943|NCT03824106|Vitamins|vitamins|mesh-ancestor
64750944|NCT03824106|Micronutrients|micronutrients|mesh-ancestor
64750945|NCT03824106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64750946|NCT03824106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64750947|NCT03598998|Pembrolizumab|pembrolizumab|mesh-list
64750948|NCT03598998|10-deazaaminopterin|10-deazaaminopterin|mesh-list
64750949|NCT03598998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64750950|NCT03598998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64750951|NCT03598998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64750952|NCT03598998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64750953|NCT03598998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64750954|NCT03817320|Leucovorin|leucovorin|mesh-list
64750955|NCT03817320|Cytarabine|cytarabine|mesh-list
64750956|NCT03817320|Dexamethasone|dexamethasone|mesh-list
64750957|NCT03817320|Hydrocortisone|hydrocortisone|mesh-list
64750958|NCT03817320|Doxorubicin|doxorubicin|mesh-list
64750959|NCT03817320|Methotrexate|methotrexate|mesh-list
64750960|NCT03817320|Vincristine|vincristine|mesh-list
64750961|NCT03817320|Asparaginase|asparaginase|mesh-list
64750962|NCT03817320|Ixazomib|ixazomib|mesh-list
64750990|NCT03817320|Antiviral Agents|antiviral agents|mesh-ancestor
64750991|NCT03817320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64750992|NCT03817320|Antidotes|antidotes|mesh-ancestor
64635081|NCT00005026|Mitosis Modulators|mitosis modulators|mesh-ancestor
64635084|NCT00005026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64635085|NCT00005026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635086|NCT00016718|Emtricitabine|emtricitabine|mesh-list
64635087|NCT00016718|Efavirenz|efavirenz|mesh-list
64635088|NCT00016718|Didanosine|didanosine|mesh-list
64635089|NCT00016718|Antiviral Agents|antiviral agents|mesh-ancestor
64750993|NCT03817320|Protective Agents|protective agents|mesh-ancestor
64750994|NCT03817320|Vitamin B Complex|vitamin b complex|mesh-ancestor
64750995|NCT03817320|Vitamins|vitamins|mesh-ancestor
64750996|NCT03817320|Micronutrients|micronutrients|mesh-ancestor
64635090|NCT00016718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64635091|NCT00016718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64750997|NCT03817320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64750998|NCT03817320|Tubulin Modulators|tubulin modulators|mesh-ancestor
64750999|NCT03817320|Antimitotic Agents|antimitotic agents|mesh-ancestor
64751000|NCT03817320|Mitosis Modulators|mitosis modulators|mesh-ancestor
64751001|NCT03817320|Protease Inhibitors|protease inhibitors|mesh-ancestor
64751002|NCT03684018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64751003|NCT03684018|Immunologic Factors|immunologic factors|mesh-ancestor
64751004|NCT03684018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751005|NCT03583086|Nivolumab|nivolumab|mesh-list
64751006|NCT03583086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64751007|NCT03583086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751008|NCT03583086|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64751009|NCT03583086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751010|NCT03580356|Omalizumab|omalizumab|mesh-list
64751045|NCT04403724|Anesthetics, Local|anesthetics, local|mesh-ancestor
64751046|NCT04403724|Anesthetics|anesthetics|mesh-ancestor
64751047|NCT04403724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64751048|NCT04403724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751049|NCT04403724|Sensory System Agents|sensory system agents|mesh-ancestor
64751050|NCT04403724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64751051|NCT04403724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64751052|NCT04403724|Narcotics|narcotics|mesh-ancestor
64751053|NCT04403724|Analgesics|analgesics|mesh-ancestor
64751054|NCT04403724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64751055|NCT04403724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64751056|NCT04403724|Anesthetics, General|anesthetics, general|mesh-ancestor
64751057|NCT03567876|Venetoclax|venetoclax|mesh-list
64751058|NCT03567876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751059|NCT04403568|Ursolic acid|ursolic acid|mesh-list
64751060|NCT04403568|Curcumin|curcumin|mesh-list
64751061|NCT04403568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64751062|NCT04403568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64751063|NCT04403568|Analgesics|analgesics|mesh-ancestor
64751064|NCT04403568|Sensory System Agents|sensory system agents|mesh-ancestor
64751065|NCT04403568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64751066|NCT04403568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751067|NCT04403568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64751068|NCT04403568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64751069|NCT04403568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751070|NCT04403568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751071|NCT04403568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751072|NCT04403568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64751073|NCT04403568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64751092|NCT03798678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64751093|NCT03798678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64751094|NCT03798678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751095|NCT03798678|Protease Inhibitors|protease inhibitors|mesh-ancestor
64751096|NCT03798678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751097|NCT03798678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751098|NCT03798678|Dermatologic Agents|dermatologic agents|mesh-ancestor
64751099|NCT04762134|Doxycycline|doxycycline|mesh-list
64751100|NCT04762134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64751101|NCT04762134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64751102|NCT04762134|Antimalarials|antimalarials|mesh-ancestor
64751103|NCT04762134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64751154|NCT03524898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751155|NCT03524898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64751156|NCT03524898|Antimetabolites|antimetabolites|mesh-ancestor
64751157|NCT03524898|Antiviral Agents|antiviral agents|mesh-ancestor
64751158|NCT03524898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64751159|NCT03524898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751160|NCT03524898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64751161|NCT03524898|Immunologic Factors|immunologic factors|mesh-ancestor
64751162|NCT03524898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751164|NCT03524820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64751165|NCT03524820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751166|NCT03524508|Fluorouracil|fluorouracil|mesh-list
64751167|NCT03524508|Irinotecan|irinotecan|mesh-list
64751168|NCT03524508|Antimetabolites|antimetabolites|mesh-ancestor
64751169|NCT03524508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751170|NCT03524508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64751171|NCT03524508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751172|NCT03524508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64751173|NCT03524508|Immunologic Factors|immunologic factors|mesh-ancestor
64751174|NCT03524508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635150|NCT00019682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751175|NCT03524508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64751177|NCT03524508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751204|NCT01676844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751205|NCT03456102|Pravastatin|pravastatin|mesh-list
64751206|NCT03456102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64751207|NCT03456102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64751208|NCT03456102|Antimetabolites|antimetabolites|mesh-ancestor
64751209|NCT03456102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751210|NCT03456102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64751211|NCT03456102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64751212|NCT03456102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751213|NCT04403334|Moxifloxacin|moxifloxacin|mesh-list
64751214|NCT04403334|Levofloxacin|levofloxacin|mesh-list
64751215|NCT04403334|Ofloxacin|ofloxacin|mesh-list
64751216|NCT04403334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64751217|NCT04403334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64751218|NCT04403334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64751219|NCT04403334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64751220|NCT04403334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751221|NCT04403334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751222|NCT04403334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751223|NCT04403334|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64751224|NCT04403334|Renal Agents|renal agents|mesh-ancestor
64751225|NCT04403334|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64751226|NCT04403334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64751227|NCT03779646|Bisoprolol|bisoprolol|mesh-list
64635183|NCT00005578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64635184|NCT00005578|Alkylating Agents|alkylating agents|mesh-ancestor
64635185|NCT00005578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635186|NCT00005578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635187|NCT00005578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64635188|NCT00005578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64751228|NCT03779646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64751229|NCT03779646|Sympatholytics|sympatholytics|mesh-ancestor
64751230|NCT03779646|Autonomic Agents|autonomic agents|mesh-ancestor
64751231|NCT03779646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64751232|NCT03779646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751233|NCT03779646|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64751234|NCT03779646|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64751246|NCT03774732|Tubulin Modulators|tubulin modulators|mesh-ancestor
64751247|NCT03774732|Antimitotic Agents|antimitotic agents|mesh-ancestor
64751248|NCT03774732|Mitosis Modulators|mitosis modulators|mesh-ancestor
64751249|NCT03774732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751250|NCT03774732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64751251|NCT03774732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751252|NCT03774732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64751253|NCT03774732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64751254|NCT05347134|Gemcitabine|gemcitabine|mesh-list
64751255|NCT05347134|Capecitabine|capecitabine|mesh-list
64751256|NCT05347134|Vinorelbine|vinorelbine|mesh-list
64751257|NCT05347134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64751258|NCT05347134|Antimetabolites|antimetabolites|mesh-ancestor
64751259|NCT05347134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751260|NCT05347134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751261|NCT05347134|Antiviral Agents|antiviral agents|mesh-ancestor
64751262|NCT05347134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64751263|NCT05347134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751264|NCT05347134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64751265|NCT05347134|Immunologic Factors|immunologic factors|mesh-ancestor
64751266|NCT05347134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751267|NCT05347134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64751268|NCT05347134|Tubulin Modulators|tubulin modulators|mesh-ancestor
64751269|NCT05347134|Antimitotic Agents|antimitotic agents|mesh-ancestor
64751270|NCT05347134|Mitosis Modulators|mitosis modulators|mesh-ancestor
64751271|NCT00089778|Aldesleukin|aldesleukin|mesh-list
64751272|NCT00089778|Interleukin-2|interleukin-2|mesh-list
64751274|NCT00089778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751276|NCT00089778|Analgesics|analgesics|mesh-ancestor
64751293|NCT00089544|Lenograstim|lenograstim|mesh-list
64751294|NCT00089544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64751295|NCT00089544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751296|NCT00089544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64751297|NCT00089544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64751298|NCT00089544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751299|NCT00089544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751300|NCT00089544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64751301|NCT00089544|Immunologic Factors|immunologic factors|mesh-ancestor
64751302|NCT00089544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751303|NCT00089544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64751304|NCT00089544|Alkylating Agents|alkylating agents|mesh-ancestor
64751305|NCT00089544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64751306|NCT00089544|Leprostatic Agents|leprostatic agents|mesh-ancestor
64751307|NCT00089544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64751308|NCT00089544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64751309|NCT00089544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64751310|NCT00089544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64751311|NCT00089544|Growth Substances|growth substances|mesh-ancestor
64751312|NCT00089544|Growth Inhibitors|growth inhibitors|mesh-ancestor
64751313|NCT00089076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64751315|NCT00089076|Antibodies|antibodies|mesh-list
64751316|NCT00089076|Immunoglobulins|immunoglobulins|mesh-list
64751317|NCT00089076|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64444726|NCT02193776|Antitubercular Agents|antitubercular agents|mesh-ancestor
64751318|NCT00089076|Immunologic Factors|immunologic factors|mesh-ancestor
64751319|NCT00089076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751320|NCT00089076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751321|NCT00089076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64751322|NCT00089076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751323|NCT03773562|Erenumab|erenumab|mesh-list
64751324|NCT03773562|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64751326|NCT03773562|Analgesics|analgesics|mesh-ancestor
64751334|NCT00087594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64751335|NCT00087594|Antimetabolites|antimetabolites|mesh-ancestor
64751336|NCT00087594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751337|NCT00087594|Antiviral Agents|antiviral agents|mesh-ancestor
64751338|NCT00087594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64751339|NCT03770286|Fluorides|fluorides|mesh-list
64751340|NCT03770286|Fluorides, Topical|fluorides, topical|mesh-list
64751341|NCT03770286|Cariostatic Agents|cariostatic agents|mesh-ancestor
64751342|NCT03770286|Protective Agents|protective agents|mesh-ancestor
64751343|NCT03770286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751344|NCT00087516|Metformin|metformin|mesh-list
64751345|NCT00087516|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64751346|NCT00087516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64751347|NCT00087516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751348|NCT00087516|Incretins|incretins|mesh-ancestor
64751349|NCT00087516|Hormones|hormones|mesh-ancestor
64751350|NCT00087516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64751351|NCT00087516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64751352|NCT00087516|Protease Inhibitors|protease inhibitors|mesh-ancestor
64751353|NCT00087516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635274|NCT00004252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751354|NCT00087516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751388|NCT00085566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751389|NCT00085098|Cyclophosphamide|cyclophosphamide|mesh-list
64751390|NCT00085098|Cisplatin|cisplatin|mesh-list
64751391|NCT00085098|Carboplatin|carboplatin|mesh-list
64751392|NCT00085098|Etoposide|etoposide|mesh-list
64751393|NCT00085098|Lenograstim|lenograstim|mesh-list
64751458|NCT00082758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751459|NCT03483012|Atezolizumab|atezolizumab|mesh-list
64751460|NCT03483012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751461|NCT03438318|Atezolizumab|atezolizumab|mesh-list
64751462|NCT03438318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751463|NCT03087942|Indoleacetic Acids|indoleacetic acids|mesh-list
64751464|NCT03087942|Plant Growth Regulators|plant growth regulators|mesh-ancestor
64751529|NCT00088452|Ethosuximide|ethosuximide|mesh-list
64751530|NCT00088452|Anticonvulsants|anticonvulsants|mesh-ancestor
64751531|NCT00088452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64751532|NCT00088452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64751533|NCT00088452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751534|NCT00088452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64751535|NCT00088452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751536|NCT00088452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64751537|NCT00088452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64751539|NCT00088452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64751593|NCT01679340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751595|NCT01679574|Letrozole|letrozole|mesh-list
64751596|NCT01679574|Clomiphene|clomiphene|mesh-list
64751597|NCT01679574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64751598|NCT01679574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751599|NCT01679574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751600|NCT01679574|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64751601|NCT01679574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64751602|NCT01679574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751603|NCT01679574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751604|NCT01679574|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64751605|NCT01679574|Hormone Antagonists|hormone antagonists|mesh-ancestor
64751606|NCT01679574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64751607|NCT01679574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64751608|NCT01679574|Fertility Agents|fertility agents|mesh-ancestor
64751664|NCT03088254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64751665|NCT03088254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751666|NCT03088254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64751667|NCT03088254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751668|NCT03088254|Vasodilator Agents|vasodilator agents|mesh-ancestor
64751702|NCT05684718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751703|NCT05684718|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64751704|NCT05684718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64751705|NCT05684718|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64751706|NCT05684718|Antitubercular Agents|antitubercular agents|mesh-ancestor
64751707|NCT05684484|Salicylic Acid|salicylic acid|mesh-list
64751708|NCT05684484|Salicylates|salicylates|mesh-list
64751709|NCT05684484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64751710|NCT05684484|Antifungal Agents|antifungal agents|mesh-ancestor
64751711|NCT05684484|Keratolytic Agents|keratolytic agents|mesh-ancestor
64751712|NCT05684484|Dermatologic Agents|dermatologic agents|mesh-ancestor
64751713|NCT05684484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64751714|NCT05684484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64751715|NCT05684484|Analgesics|analgesics|mesh-ancestor
64751716|NCT05684484|Sensory System Agents|sensory system agents|mesh-ancestor
64751717|NCT05684484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64751758|NCT05667324|Dexamethasone|dexamethasone|mesh-list
64751759|NCT05667324|Ropivacaine|ropivacaine|mesh-list
64751760|NCT05667324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64751761|NCT05667324|Antiemetics|antiemetics|mesh-ancestor
64751762|NCT05667324|Autonomic Agents|autonomic agents|mesh-ancestor
64751763|NCT05667324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64751764|NCT05667324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751765|NCT05667324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64751766|NCT05667324|Glucocorticoids|glucocorticoids|mesh-ancestor
64751768|NCT05667324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64751769|NCT05667324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64444778|NCT05344625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444780|NCT02169830|Nortriptyline|nortriptyline|mesh-list
64751770|NCT05667324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751771|NCT05667324|Anesthetics, Local|anesthetics, local|mesh-ancestor
64751772|NCT05667324|Anesthetics|anesthetics|mesh-ancestor
64751773|NCT05667324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64751774|NCT05667324|Sensory System Agents|sensory system agents|mesh-ancestor
64751775|NCT03086148|Ketamine|ketamine|mesh-list
64751776|NCT03086148|Analgesics|analgesics|mesh-ancestor
64751777|NCT03086148|Sensory System Agents|sensory system agents|mesh-ancestor
64751778|NCT03086148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64635325|NCT00005596|Abortifacient Agents|abortifacient agents|mesh-ancestor
64635326|NCT00005596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64635327|NCT00005596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64635328|NCT00005596|Antimetabolites|antimetabolites|mesh-ancestor
64635329|NCT00005596|Dermatologic Agents|dermatologic agents|mesh-ancestor
64635330|NCT00005596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635331|NCT00005596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64635332|NCT00005596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64635333|NCT00005596|Antiviral Agents|antiviral agents|mesh-ancestor
64635334|NCT00005596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64635336|NCT00005596|Protective Agents|protective agents|mesh-ancestor
64635337|NCT00005596|Vitamin B Complex|vitamin b complex|mesh-ancestor
64360582|NCT03121807|Vitamins|vitamins|mesh-ancestor
64635338|NCT00005596|Vitamins|vitamins|mesh-ancestor
64635339|NCT00005596|Micronutrients|micronutrients|mesh-ancestor
64751779|NCT03086148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751780|NCT03086148|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64751781|NCT03086148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64751782|NCT03086148|Anesthetics, General|anesthetics, general|mesh-ancestor
64751783|NCT03086148|Anesthetics|anesthetics|mesh-ancestor
64751784|NCT03086148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64751785|NCT03086148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64751786|NCT03086148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64444781|NCT02169830|Anticonvulsants|anticonvulsants|mesh-ancestor
64444782|NCT02169830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64444783|NCT02169830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444784|NCT02169830|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64751787|NCT03086148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64444785|NCT02169830|Antidepressive Agents|antidepressive agents|mesh-ancestor
64444786|NCT02169830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64444787|NCT02169830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64444788|NCT02169830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64444789|NCT02169830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64444790|NCT02169830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444791|NCT02169830|Adrenergic Agents|adrenergic agents|mesh-ancestor
64444792|NCT02169830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64444793|NCT04854551|Naltrexone|naltrexone|mesh-list
64444794|NCT04854551|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64444795|NCT04854551|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64444796|NCT04854551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444797|NCT04854551|Sensory System Agents|sensory system agents|mesh-ancestor
64444798|NCT04854551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64444799|NCT04536467|Goserelin|goserelin|mesh-list
64444800|NCT04536467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64444801|NCT04536467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444802|NCT05341349|Pembrolizumab|pembrolizumab|mesh-list
64751788|NCT03086148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751801|NCT05345808|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64751802|NCT05345808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64751803|NCT05345808|Glucocorticoids|glucocorticoids|mesh-ancestor
64751805|NCT05345808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64635343|NCT00005596|Mitosis Modulators|mitosis modulators|mesh-ancestor
64635344|NCT00005596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64635345|NCT00005596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64635346|NCT00005596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64635347|NCT00005068|Leucovorin|leucovorin|mesh-list
64635348|NCT00005068|Fluorouracil|fluorouracil|mesh-list
64751806|NCT05345808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751807|NCT05345808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64751808|NCT05345808|Immunologic Factors|immunologic factors|mesh-ancestor
64751809|NCT05345808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751810|NCT05345808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751811|NCT02336958|Ropivacaine|ropivacaine|mesh-list
64751812|NCT02336958|Prilocaine|prilocaine|mesh-list
64751813|NCT02336958|Anesthetics, Local|anesthetics, local|mesh-ancestor
64751814|NCT02336958|Anesthetics|anesthetics|mesh-ancestor
64751815|NCT02336958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64751816|NCT02336958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751817|NCT02336958|Sensory System Agents|sensory system agents|mesh-ancestor
64751818|NCT02336958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64751819|NCT03085368|Trastuzumab|trastuzumab|mesh-list
64751820|NCT03085368|Lapatinib|lapatinib|mesh-list
64751821|NCT03085368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64751822|NCT03085368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751823|NCT03085368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64751852|NCT05345574|Dexmedetomidine|dexmedetomidine|mesh-list
64751853|NCT05345574|Remifentanil|remifentanil|mesh-list
64751854|NCT05345574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64751855|NCT05345574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64751856|NCT05345574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751857|NCT05345574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64751858|NCT05345574|Analgesics|analgesics|mesh-ancestor
64751859|NCT05345574|Sensory System Agents|sensory system agents|mesh-ancestor
64751860|NCT05345574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64751861|NCT05345574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64751862|NCT05345574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64751863|NCT05345574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64751864|NCT05345574|Adrenergic Agents|adrenergic agents|mesh-ancestor
64751865|NCT05345574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64751866|NCT05345574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751867|NCT05345574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64751868|NCT05345574|Narcotics|narcotics|mesh-ancestor
64751869|NCT05598606|Zoledronic Acid|zoledronic acid|mesh-list
64751870|NCT05598606|Denosumab|denosumab|mesh-list
64751871|NCT05598606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64751872|NCT05598606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751873|NCT03347292|Pembrolizumab|pembrolizumab|mesh-list
64751874|NCT03347292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64635379|NCT00005074|Alvocidib|alvocidib|mesh-list
64751875|NCT03347292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751876|NCT04400916|Tranexamic Acid|tranexamic acid|mesh-list
64751877|NCT04400916|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64751878|NCT04400916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64751879|NCT04400916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751880|NCT04400916|Hemostatics|hemostatics|mesh-ancestor
64751881|NCT04400916|Coagulants|coagulants|mesh-ancestor
64751882|NCT05582538|Paclitaxel|paclitaxel|mesh-list
64751883|NCT05582538|Durvalumab|durvalumab|mesh-list
64751885|NCT05582538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751894|NCT05571072|Analgesics, Opioid|analgesics, opioid|mesh-list
64751895|NCT05571072|Narcotics|narcotics|mesh-ancestor
64751896|NCT05571072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64751897|NCT05571072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751898|NCT05571072|Analgesics|analgesics|mesh-ancestor
64751899|NCT05571072|Sensory System Agents|sensory system agents|mesh-ancestor
64751900|NCT05571072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64520680|NCT05717764|Capecitabine|capecitabine|mesh-list
64751902|NCT03832452|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
64751903|NCT03832452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64751904|NCT03832452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64751905|NCT03832452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64751906|NCT03832452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64751907|NCT03832452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751908|NCT03832452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751909|NCT03832452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751910|NCT03832452|Antiviral Agents|antiviral agents|mesh-ancestor
64751911|NCT04279938|Rituximab|rituximab|mesh-list
64751912|NCT04279938|Pembrolizumab|pembrolizumab|mesh-list
64635411|NCT00005086|Gemcitabine|gemcitabine|mesh-list
64635412|NCT00005086|Docetaxel|docetaxel|mesh-list
64635413|NCT00005086|Methotrexate|methotrexate|mesh-list
64751913|NCT04279938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64751914|NCT04279938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64751915|NCT04279938|Immunologic Factors|immunologic factors|mesh-ancestor
64751916|NCT04279938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751917|NCT04279938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64635414|NCT00005086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635415|NCT00005086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64751918|NCT05686434|Osimertinib|osimertinib|mesh-list
64751919|NCT05686434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635416|NCT00005086|Antimetabolites|antimetabolites|mesh-ancestor
64444805|NCT05341349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64751921|NCT05686434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64751923|NCT05686356|Acetylcysteine|acetylcysteine|mesh-list
64751941|NCT03083184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64751942|NCT03083184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64751943|NCT03083184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64751944|NCT03083184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64751945|NCT03083184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64751946|NCT03083184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64751947|NCT03083184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751948|NCT03338244|Azithromycin|azithromycin|mesh-list
64751949|NCT03338244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64751950|NCT03338244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64751951|NCT05512962|Triamcinolone|triamcinolone|mesh-list
64751952|NCT05512962|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64751953|NCT05512962|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64751954|NCT05512962|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64751955|NCT05512962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64751956|NCT05512962|Glucocorticoids|glucocorticoids|mesh-ancestor
64751957|NCT05512962|Hormones|hormones|mesh-ancestor
64751958|NCT05512962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64751959|NCT05512962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64751960|NCT05512962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64751961|NCT05512962|Immunologic Factors|immunologic factors|mesh-ancestor
64751993|NCT05498220|Antiemetics|antiemetics|mesh-ancestor
64751994|NCT05498220|Autonomic Agents|autonomic agents|mesh-ancestor
64751995|NCT05498220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64751996|NCT05498220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64751997|NCT05498220|Glucocorticoids|glucocorticoids|mesh-ancestor
64751998|NCT05498220|Hormones|hormones|mesh-ancestor
64751999|NCT05498220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64752000|NCT05498220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64752001|NCT05498220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64752002|NCT05498220|Antimetabolites|antimetabolites|mesh-ancestor
64752003|NCT05498220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752004|NCT05498220|Antiviral Agents|antiviral agents|mesh-ancestor
64752005|NCT05498220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64752006|NCT05498220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752007|NCT05498220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64752008|NCT04401852|Magnesium Sulfate|magnesium sulfate|mesh-list
64752009|NCT04401852|Analgesics|analgesics|mesh-ancestor
64752010|NCT04401852|Sensory System Agents|sensory system agents|mesh-ancestor
64752011|NCT04401852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64752012|NCT04401852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752013|NCT04401852|Anesthetics|anesthetics|mesh-ancestor
64444864|NCT02168816|Moxifloxacin|moxifloxacin|mesh-list
64444865|NCT02168816|Metronidazole|metronidazole|mesh-list
64444866|NCT02168816|Vancomycin|vancomycin|mesh-list
64635450|NCT00004300|Bromocriptine|bromocriptine|mesh-list
64635451|NCT00004300|Sertraline|sertraline|mesh-list
64444867|NCT02168816|Ciprofloxacin|ciprofloxacin|mesh-list
64444868|NCT02168816|Clindamycin|clindamycin|mesh-list
64444869|NCT02168816|Meropenem|meropenem|mesh-list
64444870|NCT02168816|Linezolid|linezolid|mesh-list
64444871|NCT02168816|Tazobactam|tazobactam|mesh-list
64752014|NCT04401852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64752015|NCT04401852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64752016|NCT04401852|Anticonvulsants|anticonvulsants|mesh-ancestor
64752017|NCT04401852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64752018|NCT04401852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64752019|NCT04401852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752020|NCT04401852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64752021|NCT04401852|Tocolytic Agents|tocolytic agents|mesh-ancestor
64752023|NCT03318900|Aldesleukin|aldesleukin|mesh-list
64752036|NCT03318900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64752037|NCT03318900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64752038|NCT03318900|Analgesics|analgesics|mesh-ancestor
64752039|NCT03318900|Sensory System Agents|sensory system agents|mesh-ancestor
64752040|NCT03318900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64752041|NCT03318900|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64752042|NCT03318900|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64752043|NCT03318900|Antiviral Agents|antiviral agents|mesh-ancestor
64752044|NCT03318900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64752045|NCT03328104|Cyclophosphamide|cyclophosphamide|mesh-list
64752046|NCT03328104|Etoposide|etoposide|mesh-list
64752047|NCT03328104|Everolimus|everolimus|mesh-list
64752048|NCT03328104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64752049|NCT03328104|Immunologic Factors|immunologic factors|mesh-ancestor
64752050|NCT03328104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752051|NCT03328104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64752052|NCT03328104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64752053|NCT03328104|Alkylating Agents|alkylating agents|mesh-ancestor
64752054|NCT03328104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752055|NCT03328104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752056|NCT03328104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64752057|NCT03328104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64752058|NCT03328104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64752059|NCT03328104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64752060|NCT03328104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752061|NCT03399318|Acetaminophen|acetaminophen|mesh-list
64752062|NCT03399318|Ibuprofen|ibuprofen|mesh-list
64752063|NCT03399318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64752064|NCT03399318|Analgesics|analgesics|mesh-ancestor
64752065|NCT03399318|Sensory System Agents|sensory system agents|mesh-ancestor
64752066|NCT03399318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64635476|NCT00005092|Furocoumarins|furocoumarins|mesh-list
64635477|NCT00005092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64752080|NCT03082482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64752081|NCT03082482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64635488|NCT00005638|Irinotecan|irinotecan|mesh-list
64752082|NCT03082482|Cholinergic Agents|cholinergic agents|mesh-ancestor
64752083|NCT03082482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64752084|NCT03082482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752085|NCT03308916|Liver Extracts|liver extracts|mesh-list
64752086|NCT03308916|Hematinics|hematinics|mesh-ancestor
64752087|NCT03081702|Hydroxychloroquine|hydroxychloroquine|mesh-list
64752088|NCT03081702|Itraconazole|itraconazole|mesh-list
64752089|NCT03081702|Antimalarials|antimalarials|mesh-ancestor
64752090|NCT03081702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64752104|NCT04399434|Insulin|insulin|mesh-list
64752146|NCT03292926|Hormones|hormones|mesh-ancestor
64752147|NCT03292926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64752148|NCT03292926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64752149|NCT03292926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752161|NCT04400136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64752162|NCT04400136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752164|NCT04962126|Atezolizumab|atezolizumab|mesh-list
64752208|NCT03227562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64752210|NCT03227562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64752211|NCT03227562|Dopamine Agents|dopamine agents|mesh-ancestor
64752212|NCT04278378|Folic Acid|folic acid|mesh-list
64752213|NCT04278378|Riboflavin|riboflavin|mesh-list
64752214|NCT04278378|Hematinics|hematinics|mesh-ancestor
64752215|NCT04278378|Vitamin B Complex|vitamin b complex|mesh-ancestor
64752216|NCT04278378|Vitamins|vitamins|mesh-ancestor
64752217|NCT04278378|Micronutrients|micronutrients|mesh-ancestor
64752218|NCT04278378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752219|NCT04278378|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64752220|NCT04278378|Dermatologic Agents|dermatologic agents|mesh-ancestor
64752221|NCT04551144|Methyltestosterone|methyltestosterone|mesh-list
64752222|NCT04551144|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64752223|NCT04551144|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64752224|NCT04551144|Estradiol|estradiol|mesh-list
64752225|NCT04551144|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64752226|NCT04551144|Testosterone|testosterone|mesh-list
64752227|NCT04551144|Testosterone undecanoate|testosterone undecanoate|mesh-list
64752228|NCT04551144|Testosterone enanthate|testosterone enanthate|mesh-list
64752229|NCT04551144|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64752230|NCT04551144|Estrogens|estrogens|mesh-ancestor
64752231|NCT04551144|Hormones|hormones|mesh-ancestor
64752232|NCT04551144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64635506|NCT00005104|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64752233|NCT04551144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752234|NCT04551144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64752235|NCT04551144|Contraceptive Agents|contraceptive agents|mesh-ancestor
64752236|NCT04551144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64752237|NCT04551144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64752238|NCT04551144|Androgens|androgens|mesh-ancestor
64752241|NCT04551144|Anabolic Agents|anabolic agents|mesh-ancestor
64752255|NCT04774380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64752256|NCT04774380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752257|NCT04774380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444925|NCT05327231|Docetaxel|docetaxel|mesh-list
64752258|NCT04774380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64752259|NCT05221320|Hydroxychloroquine|hydroxychloroquine|mesh-list
64752260|NCT05221320|Antimalarials|antimalarials|mesh-ancestor
64752261|NCT05221320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64752262|NCT05221320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64752263|NCT05221320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64752264|NCT05221320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752265|NCT05221320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752266|NCT05221320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64752274|NCT04451772|Upadacitinib|upadacitinib|mesh-list
64752275|NCT04451772|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64752276|NCT04451772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64752277|NCT04451772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752278|NCT04451772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752279|NCT04451772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64752280|NCT03831984|Bromfenac|bromfenac|mesh-list
64752282|NCT03831984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64752283|NCT03831984|Immunologic Factors|immunologic factors|mesh-ancestor
64752284|NCT03831984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752285|NCT03831984|Viscosupplements|viscosupplements|mesh-ancestor
64752286|NCT03831984|Protective Agents|protective agents|mesh-ancestor
64752287|NCT03831984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64752288|NCT03831984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64752289|NCT03831984|Analgesics|analgesics|mesh-ancestor
64752290|NCT03831984|Sensory System Agents|sensory system agents|mesh-ancestor
64752291|NCT03831984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64752292|NCT03831984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64752293|NCT03831984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64752294|NCT02084706|Triamcinolone|triamcinolone|mesh-list
64752295|NCT02084706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64752304|NCT02084706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64752305|NCT02084706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64752306|NCT02084706|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64752307|NCT02084706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64752308|NCT02084706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64752309|NCT02084706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752310|NCT02084706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64635542|NCT00005644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752311|NCT02084706|Glucocorticoids|glucocorticoids|mesh-ancestor
64752312|NCT02084706|Hormones|hormones|mesh-ancestor
64752313|NCT02084706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64752314|NCT02084706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64752315|NCT02084706|Immunologic Factors|immunologic factors|mesh-ancestor
64752316|NCT02084706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752317|NCT04704024|Tenofovir|tenofovir|mesh-list
64752318|NCT04704024|Lamivudine|lamivudine|mesh-list
64752319|NCT04704024|Antiviral Agents|antiviral agents|mesh-ancestor
64752320|NCT04704024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64752321|NCT04704024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64752322|NCT04704024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64752359|NCT03249558|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64752360|NCT03249558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64752361|NCT03249558|Narcotics|narcotics|mesh-ancestor
64752362|NCT03249558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64752363|NCT03249558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752364|NCT03249558|Analgesics|analgesics|mesh-ancestor
64752365|NCT03249558|Sensory System Agents|sensory system agents|mesh-ancestor
64752366|NCT03249558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64752367|NCT03249558|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64752368|NCT03249558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64752369|NCT03249558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64635566|NCT00030992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64635568|NCT00030992|Autonomic Agents|autonomic agents|mesh-ancestor
64635569|NCT00030992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64635570|NCT00030992|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64635571|NCT00030992|Histamine Antagonists|histamine antagonists|mesh-ancestor
64635572|NCT00030992|Histamine Agents|histamine agents|mesh-ancestor
64635573|NCT00030992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64635574|NCT00030992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635575|NCT00030992|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64635577|NCT00030992|Dermatologic Agents|dermatologic agents|mesh-ancestor
64635578|NCT00030992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64635579|NCT00030992|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64752370|NCT03249558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752371|NCT03249558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64752372|NCT03249558|Antidepressive Agents|antidepressive agents|mesh-ancestor
64752373|NCT03249558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64752374|NCT03249558|Dopamine Agents|dopamine agents|mesh-ancestor
64752375|NCT03220776|Acetylcysteine|acetylcysteine|mesh-list
64752376|NCT03220776|Gabapentin|gabapentin|mesh-list
64752377|NCT03220776|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64752378|NCT03220776|Analgesics|analgesics|mesh-ancestor
64752379|NCT03220776|Sensory System Agents|sensory system agents|mesh-ancestor
64752380|NCT03220776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64752381|NCT03220776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752382|NCT03220776|Anticonvulsants|anticonvulsants|mesh-ancestor
64752408|NCT03918798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64752409|NCT03918798|Anesthetics, Local|anesthetics, local|mesh-ancestor
64752410|NCT03918798|Anesthetics|anesthetics|mesh-ancestor
64752411|NCT03918798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64752412|NCT03918798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752413|NCT03918798|Sensory System Agents|sensory system agents|mesh-ancestor
64752414|NCT03918798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64752415|NCT03204786|Vasopressins|vasopressins|mesh-list
64635608|NCT00004390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64752416|NCT03204786|Arginine Vasopressin|arginine vasopressin|mesh-list
64752417|NCT03204786|Hemostatics|hemostatics|mesh-ancestor
64752418|NCT03204786|Coagulants|coagulants|mesh-ancestor
64752419|NCT03204786|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64752420|NCT03204786|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64752421|NCT03204786|Natriuretic Agents|natriuretic agents|mesh-ancestor
64635609|NCT00004390|Antitussive Agents|antitussive agents|mesh-ancestor
64635610|NCT00004390|Respiratory System Agents|respiratory system agents|mesh-ancestor
64635611|NCT00004390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64635612|NCT00004390|Antidepressive Agents|antidepressive agents|mesh-ancestor
64635613|NCT00004390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64635614|NCT00004390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64635615|NCT00004390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64635616|NCT00004390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64635617|NCT00004390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635618|NCT00004390|Adrenergic Agents|adrenergic agents|mesh-ancestor
64635619|NCT00004390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64635620|NCT00004390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635621|NCT00004396|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
64752422|NCT03204786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752423|NCT03204396|Dulaglutide|dulaglutide|mesh-list
64752424|NCT03204396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64752425|NCT03204396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752426|NCT02008656|Leucovorin|leucovorin|mesh-list
64752427|NCT02008656|Fluorouracil|fluorouracil|mesh-list
64752428|NCT02008656|Capecitabine|capecitabine|mesh-list
64521209|NCT02445066|Cholecalciferol|cholecalciferol|mesh-list
64752429|NCT02008656|Oxaliplatin|oxaliplatin|mesh-list
64752430|NCT02008656|Antimetabolites|antimetabolites|mesh-ancestor
64752431|NCT02008656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752432|NCT02008656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64752433|NCT02008656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752434|NCT02008656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64752435|NCT02008656|Immunologic Factors|immunologic factors|mesh-ancestor
64752436|NCT02008656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752437|NCT02008656|Antidotes|antidotes|mesh-ancestor
64752453|NCT03174132|Sensory System Agents|sensory system agents|mesh-ancestor
64752454|NCT03174132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64752455|NCT03174132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64752456|NCT03174132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64752457|NCT03174132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64752458|NCT03174132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64752459|NCT03174132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752460|NCT03174132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64752461|NCT03174132|Immunologic Factors|immunologic factors|mesh-ancestor
64752462|NCT03174132|Viscosupplements|viscosupplements|mesh-ancestor
64752463|NCT03174132|Protective Agents|protective agents|mesh-ancestor
64752464|NCT03173976|Zoledronic Acid|zoledronic acid|mesh-list
64752465|NCT03173976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64752466|NCT03173976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752467|NCT01812252|Azacitidine|azacitidine|mesh-list
64752468|NCT01812252|Decitabine|decitabine|mesh-list
64752469|NCT01812252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64752470|NCT01812252|Antimetabolites|antimetabolites|mesh-ancestor
64752471|NCT01812252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752472|NCT01812252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752473|NCT01812252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752474|NCT04217694|Memantine|memantine|mesh-list
64752475|NCT04217694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64752476|NCT04217694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64752477|NCT04217694|Dopamine Agents|dopamine agents|mesh-ancestor
64752478|NCT04217694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64752479|NCT04217694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752480|NCT04217694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752481|NCT04217694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64752482|NCT04217694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64752483|NCT03818802|Niacinamide|niacinamide|mesh-list
64635642|NCT00004420|Analgesics|analgesics|mesh-ancestor
64752494|NCT03818802|Vasodilator Agents|vasodilator agents|mesh-ancestor
64752495|NCT04398108|Margetuximab|margetuximab|mesh-list
64752496|NCT04398108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752497|NCT01625286|Paclitaxel|paclitaxel|mesh-list
64752498|NCT01625286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64752499|NCT01625286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64752500|NCT01625286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752501|NCT01625286|Tubulin Modulators|tubulin modulators|mesh-ancestor
64752502|NCT01625286|Antimitotic Agents|antimitotic agents|mesh-ancestor
64752503|NCT01625286|Mitosis Modulators|mitosis modulators|mesh-ancestor
64752504|NCT01625286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752505|NCT01583322|Nintedanib|nintedanib|mesh-list
64752506|NCT01583322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752557|NCT03193866|Glatiramer Acetate|glatiramer acetate|mesh-list
64752558|NCT03193866|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64752559|NCT03193866|Natalizumab|natalizumab|mesh-list
64752560|NCT03193866|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64752561|NCT03193866|(T,G)-A-L|(t,g)-a-l|mesh-list
64752562|NCT03193866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64752563|NCT03193866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752564|NCT03193866|Immunologic Factors|immunologic factors|mesh-ancestor
64752565|NCT03193866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752566|NCT03193866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64752567|NCT03193866|Antiviral Agents|antiviral agents|mesh-ancestor
64752568|NCT03193866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64752569|NCT03193866|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64752570|NCT03193866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752571|NCT03193866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64752572|NCT03193866|Dermatologic Agents|dermatologic agents|mesh-ancestor
64444955|NCT02168270|Alkylating Agents|alkylating agents|mesh-ancestor
64444956|NCT02168270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444957|NCT02168270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444958|NCT02168270|Antioxidants|antioxidants|mesh-ancestor
64444959|NCT02168270|Protective Agents|protective agents|mesh-ancestor
64444960|NCT02168270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444961|NCT02168270|Vitamins|vitamins|mesh-ancestor
64444962|NCT02168270|Micronutrients|micronutrients|mesh-ancestor
64444963|NCT02167256|Saracatinib|saracatinib|mesh-list
64752578|NCT01064466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64752579|NCT01064466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64752580|NCT01064466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752581|NCT01064466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752582|NCT04198116|Guanfacine|guanfacine|mesh-list
64752614|NCT04130802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64752615|NCT04130802|Antiemetics|antiemetics|mesh-ancestor
64752616|NCT04130802|Autonomic Agents|autonomic agents|mesh-ancestor
64752617|NCT04130802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64752618|NCT04130802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752619|NCT04130802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64752620|NCT04130802|Glucocorticoids|glucocorticoids|mesh-ancestor
64752621|NCT04130802|Hormones|hormones|mesh-ancestor
64635669|NCT01217749|Ofatumumab|ofatumumab|mesh-list
64635670|NCT01217749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635671|NCT02197273|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64752622|NCT04130802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64752623|NCT04130802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64752624|NCT04130802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752625|NCT03087162|Dexlansoprazole|dexlansoprazole|mesh-list
64752626|NCT03087162|Lansoprazole|lansoprazole|mesh-list
64752627|NCT03087162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64752628|NCT03087162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64752629|NCT03087162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64752630|NCT03087162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752631|NCT03087162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752632|NCT03165942|Ethanol|ethanol|mesh-list
64752633|NCT03165942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64752634|NCT03165942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64752635|NCT03165942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64444964|NCT02167256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444965|NCT02167256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444966|NCT02167256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444967|NCT04839185|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64444968|NCT04839185|Hematinics|hematinics|mesh-ancestor
64444969|NCT04839185|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64444970|NCT04839185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64444971|NCT04824131|Tenofovir|tenofovir|mesh-list
64444972|NCT04824131|Emtricitabine|emtricitabine|mesh-list
64444973|NCT04824131|Cabotegravir|cabotegravir|mesh-list
64444974|NCT04824131|Antiviral Agents|antiviral agents|mesh-ancestor
64444975|NCT04824131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64444976|NCT04824131|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64444977|NCT04824131|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64444978|NCT04824131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752661|NCT03162432|Cholecalciferol|cholecalciferol|mesh-list
64752666|NCT03162432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64635695|NCT02197273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64635696|NCT02197273|Autonomic Agents|autonomic agents|mesh-ancestor
64635697|NCT02197273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64635698|NCT02197273|Respiratory System Agents|respiratory system agents|mesh-ancestor
64635699|NCT02197273|Mydriatics|mydriatics|mesh-ancestor
64635700|NCT02197273|Sympathomimetics|sympathomimetics|mesh-ancestor
64635701|NCT02197273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64635702|NCT02197273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64635703|NCT02197273|Glucocorticoids|glucocorticoids|mesh-ancestor
64635704|NCT02197273|Hormones|hormones|mesh-ancestor
64635705|NCT02197273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64635706|NCT02197273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64635707|NCT02197273|Protective Agents|protective agents|mesh-ancestor
64752667|NCT03392376|Haloperidol|haloperidol|mesh-list
64752668|NCT03392376|Haloperidol decanoate|haloperidol decanoate|mesh-list
64635708|NCT02197273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64635710|NCT00004444|Paromomycin|paromomycin|mesh-list
64752669|NCT03392376|Antiemetics|antiemetics|mesh-ancestor
64752670|NCT03392376|Autonomic Agents|autonomic agents|mesh-ancestor
64752671|NCT03392376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64752672|NCT03392376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752673|NCT03392376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64752674|NCT03392376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64752675|NCT03392376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64752676|NCT03392376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64752677|NCT03392376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64752678|NCT03392376|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64752679|NCT03392376|Dopamine Agents|dopamine agents|mesh-ancestor
64752680|NCT03392376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64752681|NCT03392376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752682|NCT03392376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64752683|NCT05243628|Insulin|insulin|mesh-list
64752684|NCT05243628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64752685|NCT05243628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64752686|NCT05243628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752687|NCT05249478|Fentanyl|fentanyl|mesh-list
64752688|NCT05249478|Bupivacaine|bupivacaine|mesh-list
64752689|NCT05249478|Anesthetics, Local|anesthetics, local|mesh-ancestor
64752690|NCT05249478|Anesthetics|anesthetics|mesh-ancestor
64752708|NCT03286842|Olaparib|olaparib|mesh-list
64752717|NCT03269994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64752718|NCT03269994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64752719|NCT03269994|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64752720|NCT03269994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64752721|NCT03269994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752722|NCT05240274|Metformin|metformin|mesh-list
64752723|NCT05240274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64635725|NCT00004450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64752724|NCT05240274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752725|NCT05244018|Vitamin D|vitamin d|mesh-list
64752726|NCT05244018|Ergocalciferols|ergocalciferols|mesh-list
64752727|NCT05244018|Cholecalciferol|cholecalciferol|mesh-list
64752728|NCT05244018|Vitamins|vitamins|mesh-list
64752729|NCT05244018|Micronutrients|micronutrients|mesh-ancestor
64752730|NCT05244018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752731|NCT05244018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64752732|NCT05244018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64752733|NCT02398500|Ranibizumab|ranibizumab|mesh-list
64752734|NCT02398500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64752735|NCT02398500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64752736|NCT02398500|Growth Substances|growth substances|mesh-ancestor
64635726|NCT00004450|Immunologic Factors|immunologic factors|mesh-ancestor
64635727|NCT00004450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635728|NCT00004450|Leprostatic Agents|leprostatic agents|mesh-ancestor
64635729|NCT00004450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64635730|NCT00004450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64635731|NCT00004450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64635732|NCT00004450|Growth Substances|growth substances|mesh-ancestor
64635733|NCT00004450|Growth Inhibitors|growth inhibitors|mesh-ancestor
64635734|NCT00004468|Calcitriol|calcitriol|mesh-list
64635735|NCT00004468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64752737|NCT02398500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752738|NCT02398500|Growth Inhibitors|growth inhibitors|mesh-ancestor
64752739|NCT02398500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752740|NCT02984514|Deoxyglucose|deoxyglucose|mesh-list
64752741|NCT02984514|Antimetabolites|antimetabolites|mesh-ancestor
64752742|NCT02984514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752743|NCT02984514|Antiviral Agents|antiviral agents|mesh-ancestor
64752744|NCT02984514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64752745|NCT04276428|Insulin|insulin|mesh-list
64752763|NCT03026790|Narcotics|narcotics|mesh-ancestor
64752764|NCT03026790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64752765|NCT03026790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752766|NCT03026790|Analgesics|analgesics|mesh-ancestor
64752767|NCT03026790|Sensory System Agents|sensory system agents|mesh-ancestor
64752768|NCT03026790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64752769|NCT03026790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64752770|NCT02392026|Metronidazole|metronidazole|mesh-list
64752771|NCT02392026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64752772|NCT02392026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64752773|NCT02392026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64752774|NCT02392026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64752775|NCT03003546|Paclitaxel|paclitaxel|mesh-list
64752776|NCT03003546|Rituximab|rituximab|mesh-list
64752777|NCT03003546|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64752824|NCT02914158|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64444983|NCT04824131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64444984|NCT02166476|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64752825|NCT02914158|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64444985|NCT02166476|Levofloxacin|levofloxacin|mesh-list
64444986|NCT02166476|Ofloxacin|ofloxacin|mesh-list
64444987|NCT02166476|Meropenem|meropenem|mesh-list
64444988|NCT02166476|Tazobactam|tazobactam|mesh-list
64444989|NCT02166476|Piperacillin|piperacillin|mesh-list
64635744|NCT01288807|Milnacipran|milnacipran|mesh-list
64635745|NCT01288807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64635746|NCT01288807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64635747|NCT01288807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64444990|NCT02166476|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64444991|NCT02166476|Vaborbactam|vaborbactam|mesh-list
64444992|NCT02166476|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
64635752|NCT01288807|Analgesics|analgesics|mesh-ancestor
64444993|NCT02166476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64444994|NCT02166476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64752834|NCT03136146|Dexamethasone acetate|dexamethasone acetate|mesh-list
64752835|NCT03136146|Cyclophosphamide|cyclophosphamide|mesh-list
64752836|NCT03136146|Rituximab|rituximab|mesh-list
64752837|NCT03136146|Etoposide|etoposide|mesh-list
64752838|NCT03136146|Vincristine|vincristine|mesh-list
64752839|NCT03136146|Etoposide phosphate|etoposide phosphate|mesh-list
64752840|NCT03136146|Bortezomib|bortezomib|mesh-list
64752841|NCT03136146|Clofarabine|clofarabine|mesh-list
64752842|NCT03136146|Ofatumumab|ofatumumab|mesh-list
64752843|NCT03136146|Podophyllotoxin|podophyllotoxin|mesh-list
64752844|NCT03136146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64752845|NCT03136146|Antibodies|antibodies|mesh-list
64752880|NCT03136146|Dermatologic Agents|dermatologic agents|mesh-ancestor
64752881|NCT05241132|Paclitaxel|paclitaxel|mesh-list
64752882|NCT05241132|Cisplatin|cisplatin|mesh-list
64752883|NCT05241132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64752884|NCT05241132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752885|NCT05241132|Tubulin Modulators|tubulin modulators|mesh-ancestor
64752886|NCT05241132|Antimitotic Agents|antimitotic agents|mesh-ancestor
64752887|NCT05241132|Mitosis Modulators|mitosis modulators|mesh-ancestor
64752888|NCT05241132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752889|NCT05241054|Acetaminophen|acetaminophen|mesh-list
64752890|NCT05241054|Nitroglycerin|nitroglycerin|mesh-list
64635784|NCT00004474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64635785|NCT00004474|Alkylating Agents|alkylating agents|mesh-ancestor
64752892|NCT05241054|Bupivacaine|bupivacaine|mesh-list
64752893|NCT05241054|Propofol|propofol|mesh-list
64752894|NCT05241054|Sevoflurane|sevoflurane|mesh-list
64752895|NCT05241054|Atracurium|atracurium|mesh-list
64752896|NCT05241054|Anesthetics, Local|anesthetics, local|mesh-ancestor
64752897|NCT05241054|Anesthetics|anesthetics|mesh-ancestor
64752898|NCT05241054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64752899|NCT05241054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635786|NCT00004474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635787|NCT00004474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635788|NCT00004474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64635789|NCT00004480|Botulinum Toxins|botulinum toxins|mesh-list
64635790|NCT00004480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64635791|NCT00004480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64635795|NCT00004480|Cholinergic Agents|cholinergic agents|mesh-ancestor
64752900|NCT05241054|Sensory System Agents|sensory system agents|mesh-ancestor
64752901|NCT05241054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64752938|NCT00638508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752939|NCT00637806|Megestrol|megestrol|mesh-list
64752940|NCT00637806|Megestrol Acetate|megestrol acetate|mesh-list
64752941|NCT00637806|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64752942|NCT00637806|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64752943|NCT00637806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64752944|NCT00637806|Contraceptive Agents|contraceptive agents|mesh-ancestor
64752945|NCT00637806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64752946|NCT00637806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64752947|NCT00637806|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64752948|NCT00637806|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64752949|NCT00637806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64752950|NCT00637806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64752951|NCT00637806|Appetite Stimulants|appetite stimulants|mesh-ancestor
64752953|NCT00637728|Megestrol|megestrol|mesh-list
64752996|NCT00637416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64752998|NCT00636792|Bortezomib|bortezomib|mesh-list
64752999|NCT00636792|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64753000|NCT00636792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64753001|NCT00636792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753002|NCT00636792|Immunologic Factors|immunologic factors|mesh-ancestor
64753003|NCT00636792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753004|NCT00636792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64753005|NCT00636792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64753006|NCT00636792|Alkylating Agents|alkylating agents|mesh-ancestor
64753007|NCT00636792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753009|NCT00636636|Analgesics|analgesics|mesh-ancestor
64753010|NCT00636636|Sensory System Agents|sensory system agents|mesh-ancestor
64753011|NCT00636636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64753012|NCT00636636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753013|NCT00636636|Anticonvulsants|anticonvulsants|mesh-ancestor
64753014|NCT00636636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64753015|NCT00636636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64753016|NCT00636636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64753017|NCT00636636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64753018|NCT00636636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64753019|NCT00636636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64753020|NCT00636636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64753021|NCT00636636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753022|NCT00636636|Antimanic Agents|antimanic agents|mesh-ancestor
64753023|NCT05244954|Chloroquine|chloroquine|mesh-list
64753024|NCT05244954|Piperaquine|piperaquine|mesh-list
64753025|NCT05244954|Artenimol|artenimol|mesh-list
64753026|NCT05244954|Amebicides|amebicides|mesh-ancestor
64753040|NCT01929252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64635814|NCT00004492|Clotrimazole|clotrimazole|mesh-list
64635815|NCT00004492|Miconazole|miconazole|mesh-list
64635816|NCT00004492|Hydroxyurea|hydroxyurea|mesh-list
64635817|NCT00004492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753041|NCT01929252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64753042|NCT01929252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64753043|NCT01929252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64753044|NCT01929252|Adrenergic Agents|adrenergic agents|mesh-ancestor
64753045|NCT01929252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64753046|NCT01929252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753047|NCT01929252|Anesthetics, Local|anesthetics, local|mesh-ancestor
64753049|NCT04275960|Selitrectinib|selitrectinib|mesh-list
64753050|NCT04275960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753051|NCT04275960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753052|NCT00634920|Cyclosporine|cyclosporine|mesh-list
64753053|NCT00634920|Mycophenolic Acid|mycophenolic acid|mesh-list
64753055|NCT00634920|Everolimus|everolimus|mesh-list
64753102|NCT01929330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753103|NCT01929330|Hormone Antagonists|hormone antagonists|mesh-ancestor
64753104|NCT01929330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64753105|NCT01929330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753106|NCT00634842|Insulin|insulin|mesh-list
64753107|NCT00634842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64753108|NCT00634842|Insulin Detemir|insulin detemir|mesh-list
64753109|NCT00634842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64753110|NCT00634842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753111|NCT04396548|Midodrine|midodrine|mesh-list
64635842|NCT00005776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635843|NCT00005776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64635844|NCT00005776|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64635845|NCT00005776|Vasodilator Agents|vasodilator agents|mesh-ancestor
64635846|NCT00005776|Gasotransmitters|gasotransmitters|mesh-ancestor
64753112|NCT04396548|Anesthetics|anesthetics|mesh-list
64753113|NCT04396548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64753114|NCT04396548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753115|NCT04396548|Sympathomimetics|sympathomimetics|mesh-ancestor
64753116|NCT04396548|Autonomic Agents|autonomic agents|mesh-ancestor
64753117|NCT04396548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64753118|NCT04396548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64753159|NCT01921218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64753160|NCT01921218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753161|NCT01921218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64753162|NCT01921218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753163|NCT01921218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64753164|NCT01921218|Immunologic Factors|immunologic factors|mesh-ancestor
64753165|NCT01921218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753166|NCT01921218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753167|NCT01921218|Antifungal Agents|antifungal agents|mesh-ancestor
64753168|NCT01921218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64753209|NCT00633126|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64753210|NCT00633126|Cephalosporins|cephalosporins|mesh-list
64753211|NCT00633126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64753212|NCT00633126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64753213|NCT00989664|Tositumomab I-131|tositumomab i-131|mesh-list
64753214|NCT00989664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753215|NCT01923870|Enclomiphene|enclomiphene|mesh-list
64753216|NCT01923870|Clomiphene|clomiphene|mesh-list
64753217|NCT01923870|Zuclomiphene|zuclomiphene|mesh-list
64753218|NCT01923870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64753219|NCT01923870|Hormone Antagonists|hormone antagonists|mesh-ancestor
64753220|NCT01923870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64753221|NCT01923870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753222|NCT01923870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64753223|NCT01923870|Fertility Agents|fertility agents|mesh-ancestor
64753224|NCT01923870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64753225|NCT01923870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64753226|NCT01923870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64753227|NCT00632736|Ropinirole|ropinirole|mesh-list
64753228|NCT00632736|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64753229|NCT00632736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64753230|NCT00632736|Dopamine Agonists|dopamine agonists|mesh-ancestor
64753231|NCT00632736|Dopamine Agents|dopamine agents|mesh-ancestor
64753232|NCT00632736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64753233|NCT00632736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753234|NCT00632736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635891|NCT00004564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64753235|NCT01923948|Pregabalin|pregabalin|mesh-list
64753236|NCT01923948|Analgesics|analgesics|mesh-ancestor
64753237|NCT01923948|Sensory System Agents|sensory system agents|mesh-ancestor
64753238|NCT01923948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64753248|NCT01923948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64753250|NCT00989196|Coagulants|coagulants|mesh-ancestor
64753251|NCT00631488|Metformin|metformin|mesh-list
64753252|NCT00631488|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64753253|NCT00631488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64753254|NCT00631488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753255|NCT00631488|Incretins|incretins|mesh-ancestor
64753256|NCT00631488|Hormones|hormones|mesh-ancestor
64753257|NCT00631488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64753258|NCT00631488|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64753259|NCT00631488|Protease Inhibitors|protease inhibitors|mesh-ancestor
64753260|NCT00631488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753261|NCT00631488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753262|NCT01924104|Aspirin|aspirin|mesh-list
64753263|NCT01924104|Heparin|heparin|mesh-list
64753264|NCT01924104|Calcium heparin|calcium heparin|mesh-list
64753265|NCT01924104|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64753266|NCT01924104|Tinzaparin|tinzaparin|mesh-list
64753306|NCT01925352|Mitosis Modulators|mitosis modulators|mesh-ancestor
64753307|NCT01925352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753308|NCT03095352|Carboplatin|carboplatin|mesh-list
64753309|NCT03095352|Pembrolizumab|pembrolizumab|mesh-list
64753310|NCT03095352|Trastuzumab|trastuzumab|mesh-list
64753311|NCT03095352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753312|NCT03095352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64753313|NCT03092856|Axitinib|axitinib|mesh-list
64753314|NCT03092856|Antibodies|antibodies|mesh-list
64753315|NCT03092856|Immunologic Factors|immunologic factors|mesh-ancestor
64635921|NCT01270555|Antidepressive Agents|antidepressive agents|mesh-ancestor
64635922|NCT01270555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64753316|NCT03092856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753317|NCT03092856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753318|NCT03092856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64753319|NCT03092856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753320|NCT03092856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753322|NCT01920204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753323|NCT01920204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64753324|NCT01920204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753325|NCT01920204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753326|NCT04275258|Analgesics, Opioid|analgesics, opioid|mesh-list
64753327|NCT04275258|Narcotics|narcotics|mesh-ancestor
64753328|NCT04275258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64753329|NCT04275258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753330|NCT04275258|Analgesics|analgesics|mesh-ancestor
64753331|NCT04275258|Sensory System Agents|sensory system agents|mesh-ancestor
64753332|NCT04275258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64753333|NCT03474744|Rituximab|rituximab|mesh-list
64753334|NCT03474744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64753335|NCT03474744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753336|NCT03474744|Immunologic Factors|immunologic factors|mesh-ancestor
64753337|NCT03474744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753338|NCT03474744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64753339|NCT01925820|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64753340|NCT01925820|Entecavir|entecavir|mesh-list
64753346|NCT01925898|Sensory System Agents|sensory system agents|mesh-ancestor
64753347|NCT01925898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64753348|NCT01925898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753349|NCT01925898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64753350|NCT01925898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64753351|NCT01925898|Anesthetics, General|anesthetics, general|mesh-ancestor
64753352|NCT01925898|Anesthetics|anesthetics|mesh-ancestor
64753353|NCT01925898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64753356|NCT01925898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64753357|NCT01925898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753358|NCT01925898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64753359|NCT01925898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64753361|NCT01925898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64753362|NCT01925898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64753363|NCT01925898|GABA Modulators|gaba modulators|mesh-ancestor
64753364|NCT01925898|GABA Agents|gaba agents|mesh-ancestor
64753365|NCT00983580|Aspirin|aspirin|mesh-list
64753366|NCT00983580|Eflornithine|eflornithine|mesh-list
64753367|NCT00983580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64753368|NCT00983580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64753369|NCT00983580|Analgesics|analgesics|mesh-ancestor
64753370|NCT00983580|Sensory System Agents|sensory system agents|mesh-ancestor
64753371|NCT00983580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64753372|NCT00983580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753373|NCT00983580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64753374|NCT00983580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64635964|NCT00004696|Sensory System Agents|sensory system agents|mesh-ancestor
64753375|NCT00983580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64753376|NCT00983580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64753380|NCT00983580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753389|NCT00982878|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64753390|NCT00982878|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64753391|NCT00982878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753392|NCT00982878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64753393|NCT00982878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64753394|NCT00982878|Antiviral Agents|antiviral agents|mesh-ancestor
64753395|NCT00982878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64753396|NCT00982878|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64753397|NCT00982488|Imatinib Mesylate|imatinib mesylate|mesh-list
64753398|NCT00982488|Dasatinib|dasatinib|mesh-list
64753399|NCT00982488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753400|NCT00982488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64753401|NCT00982488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753402|NCT00982488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753403|NCT00982020|Olanzapine|olanzapine|mesh-list
64753404|NCT00982020|Antiemetics|antiemetics|mesh-ancestor
64753405|NCT00982020|Autonomic Agents|autonomic agents|mesh-ancestor
64753406|NCT00982020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64753407|NCT00982020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753408|NCT00982020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64753409|NCT00982020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64753410|NCT00982020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64753411|NCT00982020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64753424|NCT01926132|Vitamins|vitamins|mesh-ancestor
64753437|NCT01926288|Maleic acid|maleic acid|mesh-list
64753438|NCT01926288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753439|NCT01926288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753440|NCT01926288|Antiviral Agents|antiviral agents|mesh-ancestor
64753441|NCT01926288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64753443|NCT03118674|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64753444|NCT03118674|Ledipasvir|ledipasvir|mesh-list
64635989|NCT00004786|Iloprost|iloprost|mesh-list
64635990|NCT00004786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64635991|NCT00004786|Vasodilator Agents|vasodilator agents|mesh-ancestor
64635992|NCT01272583|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64635993|NCT01272583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64635994|NCT01272583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635996|NCT01272583|Hormones|hormones|mesh-ancestor
64635997|NCT01272583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64635998|NCT01272583|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64361310|NCT02496715|Xhance|xhance|mesh-list
64753445|NCT03118674|Antiviral Agents|antiviral agents|mesh-ancestor
64753446|NCT03118674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64753447|NCT00981084|Modafinil|modafinil|mesh-list
64753448|NCT00981084|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64753449|NCT00981084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753450|NCT00981084|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64753487|NCT00983814|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64753488|NCT00983814|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64753489|NCT00983814|Dopamine Agents|dopamine agents|mesh-ancestor
64753490|NCT00983814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64753491|NCT00983814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753492|NCT00983814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753493|NCT00983814|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64753494|NCT00983814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753495|NCT01921920|Omeprazole|omeprazole|mesh-list
64753496|NCT01921920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64753497|NCT01921920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64753498|NCT01921920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64753499|NCT01921920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753500|NCT01921920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753501|NCT03087708|Naloxegol|naloxegol|mesh-list
64753502|NCT03087708|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64753503|NCT03087708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445042|NCT04285853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64445043|NCT04791059|Sufentanil|sufentanil|mesh-list
64753505|NCT03087708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64753506|NCT04275414|Bevacizumab|bevacizumab|mesh-list
64753507|NCT04275414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64753541|NCT04556370|Norepinephrine|norepinephrine|mesh-list
64753542|NCT04556370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64753543|NCT04556370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64753544|NCT04556370|Adrenergic Agents|adrenergic agents|mesh-ancestor
64753545|NCT04556370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64753546|NCT04556370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753547|NCT04556370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753548|NCT04556370|Sympathomimetics|sympathomimetics|mesh-ancestor
64753549|NCT04556370|Autonomic Agents|autonomic agents|mesh-ancestor
64753550|NCT04556370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64753551|NCT04556370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64753552|NCT01922154|Ranibizumab|ranibizumab|mesh-list
64753553|NCT01922154|Mitomycin|mitomycin|mesh-list
64753554|NCT01922154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64753555|NCT01922154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64522343|NCT05280106|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64753556|NCT01922154|Growth Substances|growth substances|mesh-ancestor
64753557|NCT01922154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753558|NCT01922154|Growth Inhibitors|growth inhibitors|mesh-ancestor
64753559|NCT01922154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753560|NCT01922154|Alkylating Agents|alkylating agents|mesh-ancestor
64753561|NCT01922154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753562|NCT01922154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64753563|NCT01922154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64753564|NCT01922154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753565|NCT03059940|Nicotine|nicotine|mesh-list
64753566|NCT03059940|Carbon Monoxide|carbon monoxide|mesh-list
64753567|NCT03059940|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64753568|NCT03059940|Autonomic Agents|autonomic agents|mesh-ancestor
64753569|NCT03059940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64753570|NCT03059940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753571|NCT03059940|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64753572|NCT03059940|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64753573|NCT03059940|Cholinergic Agents|cholinergic agents|mesh-ancestor
64753578|NCT04552782|Ethanol|ethanol|mesh-list
64753580|NCT04552782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64753581|NCT04552782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64753582|NCT04552782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753583|NCT03423342|Niacinamide|niacinamide|mesh-list
64753584|NCT03423342|Niacin|niacin|mesh-list
64445054|NCT04791059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64445055|NCT04791059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64753585|NCT03423342|Nicotinic Acids|nicotinic acids|mesh-list
64445056|NCT04791059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64636063|NCT01342549|GABA Agents|gaba agents|mesh-ancestor
64636064|NCT01342549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64753587|NCT03423342|Vitamins|vitamins|mesh-ancestor
64753588|NCT03423342|Micronutrients|micronutrients|mesh-ancestor
64753589|NCT03423342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753590|NCT03423342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64753591|NCT03423342|Antimetabolites|antimetabolites|mesh-ancestor
64753592|NCT03423342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753593|NCT03423342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64753594|NCT03423342|Vasodilator Agents|vasodilator agents|mesh-ancestor
64753595|NCT01928160|Carboplatin|carboplatin|mesh-list
64753596|NCT01928160|Pemetrexed|pemetrexed|mesh-list
64753597|NCT01928160|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64753598|NCT01928160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753599|NCT01928160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753600|NCT01928160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753601|NCT01928160|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64753602|NCT01928160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64753603|NCT01928160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64753604|NCT01928316|Mizolastine|mizolastine|mesh-list
64753605|NCT01928316|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64753606|NCT01928316|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64753607|NCT01928316|Histamine Antagonists|histamine antagonists|mesh-ancestor
64753608|NCT01928316|Histamine Agents|histamine agents|mesh-ancestor
64753626|NCT01928628|Lercanidipine|lercanidipine|mesh-list
64753627|NCT01928628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64753628|NCT01928628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64753629|NCT01928628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64522424|NCT02429232|Pioglitazone|pioglitazone|mesh-list
64753630|NCT01928628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753631|NCT01928628|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64753632|NCT01928628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64753633|NCT01928628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64753634|NCT01928628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753635|NCT01929096|Edaravone|edaravone|mesh-list
64753636|NCT01929096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64753637|NCT01929096|Antioxidants|antioxidants|mesh-ancestor
64753638|NCT01929096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753639|NCT01929096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64753640|NCT01929096|Protective Agents|protective agents|mesh-ancestor
64753641|NCT01929096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753642|NCT03059004|TEMPO|tempo|mesh-list
64753643|NCT03059004|Antioxidants|antioxidants|mesh-ancestor
64753644|NCT03059004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753645|NCT03059004|Protective Agents|protective agents|mesh-ancestor
64753646|NCT03059004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753647|NCT04554888|Doxepin|doxepin|mesh-list
64753648|NCT04554888|Histamine|histamine|mesh-list
64753649|NCT04554888|Histamine Agonists|histamine agonists|mesh-ancestor
64753650|NCT04554888|Histamine Agents|histamine agents|mesh-ancestor
64753651|NCT04554888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64753652|NCT04554888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753653|NCT04554888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753670|NCT05605002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753674|NCT03238248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64753675|NCT03238248|Antimetabolites|antimetabolites|mesh-ancestor
64753676|NCT03238248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753677|NCT03238248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753678|NCT03238248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753679|NCT04124016|Grape Seed Extract|grape seed extract|mesh-list
64753680|NCT04124016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64753681|NCT04124016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753682|NCT04124016|Antioxidants|antioxidants|mesh-ancestor
64753683|NCT04124016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302444|NCT04996160|Antiemetics|antiemetics|mesh-ancestor
64636101|NCT00102518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64636103|NCT00103376|Bortezomib|bortezomib|mesh-list
64753684|NCT04124016|Protective Agents|protective agents|mesh-ancestor
64753685|NCT04124016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753686|NCT04124094|Fluticasone|fluticasone|mesh-list
64753687|NCT04124094|Xhance|xhance|mesh-list
64753688|NCT04124094|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64753689|NCT04124094|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64753692|NCT04124094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64753694|NCT04124094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64753695|NCT04124094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753696|NCT04124094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64753697|NCT04124094|Respiratory System Agents|respiratory system agents|mesh-ancestor
64753698|NCT04124094|Dermatologic Agents|dermatologic agents|mesh-ancestor
64753707|NCT04124094|Hormones|hormones|mesh-ancestor
64753723|NCT03033576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753727|NCT04123392|Busulfan|busulfan|mesh-list
64753772|NCT04126278|Dexamethasone|dexamethasone|mesh-list
64753773|NCT04126278|Cortisone|cortisone|mesh-list
64753774|NCT04126278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64753775|NCT04126278|Antiemetics|antiemetics|mesh-ancestor
64753776|NCT04126278|Autonomic Agents|autonomic agents|mesh-ancestor
64753777|NCT04126278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64753778|NCT04126278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753779|NCT04126278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64753780|NCT04126278|Glucocorticoids|glucocorticoids|mesh-ancestor
64753782|NCT04126278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64753783|NCT04126278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64753784|NCT04126278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753785|NCT04127682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64753786|NCT04127682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64753787|NCT04122066|Sofosbuvir|sofosbuvir|mesh-list
64753788|NCT04122066|Antiviral Agents|antiviral agents|mesh-ancestor
64753789|NCT04122066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64753790|NCT04121910|Itraconazole|itraconazole|mesh-list
64753791|NCT04121910|Antifungal Agents|antifungal agents|mesh-ancestor
64753792|NCT04121910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64753793|NCT04121910|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64753827|NCT04073784|Immunologic Factors|immunologic factors|mesh-ancestor
64753828|NCT04073784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753829|NCT05606796|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64753830|NCT05606796|Latanoprost|latanoprost|mesh-list
64753831|NCT05606796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64753832|NCT04129710|Rituximab|rituximab|mesh-list
64753833|NCT04129710|Methotrexate|methotrexate|mesh-list
64753834|NCT04129710|Etoposide|etoposide|mesh-list
64753835|NCT04129710|Lenalidomide|lenalidomide|mesh-list
64753836|NCT04129710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64753837|NCT04129710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753838|NCT04129710|Immunologic Factors|immunologic factors|mesh-ancestor
64753839|NCT04129710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753840|NCT04129710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64753841|NCT04129710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64753842|NCT04129710|Abortifacient Agents|abortifacient agents|mesh-ancestor
64636110|NCT00103376|Androgen Antagonists|androgen antagonists|mesh-ancestor
64636111|NCT00103376|Hormone Antagonists|hormone antagonists|mesh-ancestor
64753843|NCT04129710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64753844|NCT04129710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64753845|NCT04129710|Antimetabolites|antimetabolites|mesh-ancestor
64636112|NCT00042224|Clozapine|clozapine|mesh-list
64753846|NCT04129710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753847|NCT04129710|Dermatologic Agents|dermatologic agents|mesh-ancestor
64753848|NCT04129710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753849|NCT04129710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64753850|NCT04129710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64753851|NCT04129710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64753852|NCT04129710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64753853|NCT04129710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64753854|NCT04129710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64753855|NCT04129710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64753859|NCT03200808|Methylene Blue|methylene blue|mesh-list
64753872|NCT04129008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64753873|NCT04129008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64753874|NCT04129008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753875|NCT04129008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64753876|NCT04129008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64753877|NCT04129008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753878|NCT04129008|Antipyretics|antipyretics|mesh-ancestor
64753879|NCT04128462|Phenylacetic acid|phenylacetic acid|mesh-list
64753880|NCT04128462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64753881|NCT04128462|Antimetabolites|antimetabolites|mesh-ancestor
64753882|NCT04128462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753883|NCT04128462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753884|NCT04120350|Rituximab|rituximab|mesh-list
64753885|NCT04120350|Methotrexate|methotrexate|mesh-list
64445078|NCT05402111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64753886|NCT04120350|Lenalidomide|lenalidomide|mesh-list
64445079|NCT05402111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445080|NCT05402111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753887|NCT04120350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64753888|NCT04120350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753889|NCT04120350|Immunologic Factors|immunologic factors|mesh-ancestor
64753890|NCT04120350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753891|NCT04120350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64753892|NCT04120350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64753893|NCT04120350|Abortifacient Agents|abortifacient agents|mesh-ancestor
64753894|NCT04120350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64753895|NCT04120350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64753896|NCT04120350|Antimetabolites|antimetabolites|mesh-ancestor
64753897|NCT04120350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753898|NCT04120350|Dermatologic Agents|dermatologic agents|mesh-ancestor
64753899|NCT04120350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753900|NCT04120350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64753901|NCT04120350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64753903|NCT04120350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64753915|NCT04394598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64753916|NCT04127916|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64753917|NCT04127916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753918|NCT04127916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64753919|NCT04127916|Alkylating Agents|alkylating agents|mesh-ancestor
64753920|NCT04127916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753922|NCT05602428|Esketamine|esketamine|mesh-list
64753923|NCT05602428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64753924|NCT05602428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753925|NCT05602428|Antidepressive Agents|antidepressive agents|mesh-ancestor
64753926|NCT05602428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64753927|NCT02983890|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64753928|NCT02983890|Dicloxacillin|dicloxacillin|mesh-list
64753929|NCT02983890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64753930|NCT04127058|Iloperidone|iloperidone|mesh-list
64753931|NCT04127058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64753932|NCT04127058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64753933|NCT04127058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64445108|NCT04260347|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64445109|NCT04260347|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64445113|NCT01583374|Apremilast|apremilast|mesh-list
64753942|NCT03012360|Imipenem|imipenem|mesh-list
64753943|NCT03012360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64753944|NCT03012360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64753959|NCT04126668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64753960|NCT03043950|Panitumumab|panitumumab|mesh-list
64753961|NCT03043950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64753962|NCT03043950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753963|NCT04758936|Clonidine|clonidine|mesh-list
64753964|NCT04758936|Dexmedetomidine|dexmedetomidine|mesh-list
64753965|NCT04758936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64753966|NCT04758936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64753967|NCT04758936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64753968|NCT04758936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64753969|NCT04758936|Analgesics|analgesics|mesh-ancestor
64753970|NCT04758936|Sensory System Agents|sensory system agents|mesh-ancestor
64753971|NCT04758936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64753972|NCT04758936|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64753973|NCT04758936|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64753974|NCT04758936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64753975|NCT04758936|Adrenergic Agents|adrenergic agents|mesh-ancestor
64753976|NCT04758936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64753982|NCT04126044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64753983|NCT04126044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64753984|NCT04126044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64753985|NCT04126044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64753986|NCT04126044|Growth Substances|growth substances|mesh-ancestor
64753987|NCT04126044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64522800|NCT02975440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64754002|NCT03829566|Methylprednisolone|methylprednisolone|mesh-list
64754003|NCT03829566|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64754004|NCT03829566|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64754005|NCT03829566|Prednisolone|prednisolone|mesh-list
64754006|NCT03829566|Prednisolone acetate|prednisolone acetate|mesh-list
64754007|NCT03829566|Cyclophosphamide|cyclophosphamide|mesh-list
64754008|NCT03829566|Rituximab|rituximab|mesh-list
64754009|NCT03829566|Thymoglobulin|thymoglobulin|mesh-list
64754010|NCT03829566|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64754011|NCT03829566|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64754012|NCT03829566|Prednisolone phosphate|prednisolone phosphate|mesh-list
64754013|NCT03829566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64754014|NCT03829566|Immunologic Factors|immunologic factors|mesh-ancestor
64754015|NCT03829566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754016|NCT03829566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64636212|NCT00047060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636213|NCT00047060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636215|NCT00047060|Immunologic Factors|immunologic factors|mesh-ancestor
64636216|NCT00047060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636217|NCT00047060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636218|NCT00047060|Antifungal Agents|antifungal agents|mesh-ancestor
64636219|NCT00047060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64636220|NCT00047060|Dermatologic Agents|dermatologic agents|mesh-ancestor
64636221|NCT00047060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64636222|NCT00047060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64754017|NCT03829566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64636226|NCT01304407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754018|NCT03829566|Alkylating Agents|alkylating agents|mesh-ancestor
64754019|NCT03829566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754020|NCT03829566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754021|NCT03829566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64754022|NCT03829566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64754023|NCT03829566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64754024|NCT03829566|Antiemetics|antiemetics|mesh-ancestor
64754025|NCT03829566|Autonomic Agents|autonomic agents|mesh-ancestor
64754026|NCT03829566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64754027|NCT03829566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64754028|NCT03829566|Glucocorticoids|glucocorticoids|mesh-ancestor
64754029|NCT03829566|Hormones|hormones|mesh-ancestor
64754030|NCT03829566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64754031|NCT03829566|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64754032|NCT03829566|Protective Agents|protective agents|mesh-ancestor
64754033|NCT03829566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64754034|NCT03933306|Dexmedetomidine|dexmedetomidine|mesh-list
64754039|NCT03933306|Analgesics|analgesics|mesh-ancestor
64754041|NCT03933306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64754042|NCT03933306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64754043|NCT03933306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64754044|NCT03933306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64754045|NCT03933306|Adrenergic Agents|adrenergic agents|mesh-ancestor
64754046|NCT03933306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64754047|NCT03933306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754048|NCT04394442|Hydroxychloroquine|hydroxychloroquine|mesh-list
64754049|NCT04394442|Antimalarials|antimalarials|mesh-ancestor
64754050|NCT04394442|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64754051|NCT04394442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64754052|NCT04394442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64754053|NCT04394442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754054|NCT04394442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754055|NCT04394442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64754056|NCT02972424|Teriparatide|teriparatide|mesh-list
64754057|NCT02972424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64754059|NCT02972424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64754061|NCT05608590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754062|NCT04393584|Leucovorin|leucovorin|mesh-list
64754063|NCT04393584|Docetaxel|docetaxel|mesh-list
64754064|NCT04393584|Oxaliplatin|oxaliplatin|mesh-list
64754065|NCT04393584|Irinotecan|irinotecan|mesh-list
64754066|NCT04393584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754067|NCT04393584|Tubulin Modulators|tubulin modulators|mesh-ancestor
64754068|NCT04393584|Antimitotic Agents|antimitotic agents|mesh-ancestor
64754069|NCT04393584|Mitosis Modulators|mitosis modulators|mesh-ancestor
64754070|NCT04393584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754071|NCT04393584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64636244|NCT01409239|Insulin|insulin|mesh-list
64754072|NCT04393584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64754078|NCT04393584|Vitamins|vitamins|mesh-ancestor
64754083|NCT02965950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754084|NCT02965950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64754085|NCT02965950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64754086|NCT02965950|Alkylating Agents|alkylating agents|mesh-ancestor
64754087|NCT02965950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754088|NCT02965950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754089|NCT02965950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64754091|NCT05608200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754092|NCT05608200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64754093|NCT05608200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754094|NCT05608200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754095|NCT03828474|Acetazolamide|acetazolamide|mesh-list
64754096|NCT03828474|Anticonvulsants|anticonvulsants|mesh-ancestor
64754097|NCT03828474|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64754098|NCT03828474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754099|NCT03828474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754100|NCT03828474|Diuretics|diuretics|mesh-ancestor
64754101|NCT03828474|Natriuretic Agents|natriuretic agents|mesh-ancestor
64754102|NCT03828474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754103|NCT02921256|Leucovorin|leucovorin|mesh-list
64754104|NCT02921256|Pembrolizumab|pembrolizumab|mesh-list
64754105|NCT02921256|Fluorouracil|fluorouracil|mesh-list
64754106|NCT02921256|Capecitabine|capecitabine|mesh-list
64754107|NCT02921256|Oxaliplatin|oxaliplatin|mesh-list
64754108|NCT02921256|Veliparib|veliparib|mesh-list
64754134|NCT02959164|Gemcitabine|gemcitabine|mesh-list
64754135|NCT02959164|Decitabine|decitabine|mesh-list
64754136|NCT02959164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64754137|NCT02959164|Antimetabolites|antimetabolites|mesh-ancestor
64754138|NCT02959164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754139|NCT02959164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754140|NCT02959164|Antiviral Agents|antiviral agents|mesh-ancestor
64754141|NCT02959164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64754142|NCT02959164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636270|NCT01410409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754143|NCT02959164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64754144|NCT02959164|Immunologic Factors|immunologic factors|mesh-ancestor
64754145|NCT02959164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754146|NCT02983734|Cycloserine|cycloserine|mesh-list
64754147|NCT02983734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64754148|NCT02983734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64754149|NCT02983734|Renal Agents|renal agents|mesh-ancestor
64754150|NCT02983734|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64754153|NCT02983734|Antimetabolites|antimetabolites|mesh-ancestor
64754154|NCT02983734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754155|NCT03821454|Capecitabine|capecitabine|mesh-list
64754156|NCT03821454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64754157|NCT03821454|Antimetabolites|antimetabolites|mesh-ancestor
64754159|NCT03821454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754183|NCT03820206|Coagulants|coagulants|mesh-ancestor
64754184|NCT02955654|Aripiprazole|aripiprazole|mesh-list
64754185|NCT02955654|Antidepressive Agents|antidepressive agents|mesh-ancestor
64754186|NCT02955654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64754187|NCT02955654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64754188|NCT02955654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64754189|NCT02955654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64754190|NCT02955654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754191|NCT02955654|Dopamine Agonists|dopamine agonists|mesh-ancestor
64754192|NCT02955654|Dopamine Agents|dopamine agents|mesh-ancestor
64754193|NCT02955654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64754194|NCT02955654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754195|NCT02955654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64754196|NCT02955654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64754197|NCT02955654|Serotonin Agents|serotonin agents|mesh-ancestor
64754198|NCT02955654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64754199|NCT02955654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64754200|NCT02955654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64754201|NCT02955654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64636308|NCT01412281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754202|NCT04392648|Dexamethasone|dexamethasone|mesh-list
64636309|NCT01359007|Leucovorin|leucovorin|mesh-list
64754203|NCT04392648|Cyclophosphamide|cyclophosphamide|mesh-list
64754204|NCT04392648|Bortezomib|bortezomib|mesh-list
64754205|NCT04392648|Pomalidomide|pomalidomide|mesh-list
64754206|NCT04392648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64754207|NCT04392648|Immunologic Factors|immunologic factors|mesh-ancestor
64754208|NCT04392648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754209|NCT04392648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64754221|NCT04392648|Hormones|hormones|mesh-ancestor
64754231|NCT03826602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754232|NCT03826602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754303|NCT03828006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64754304|NCT03828006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64754305|NCT03828006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64754306|NCT03828006|Antimetabolites|antimetabolites|mesh-ancestor
64754307|NCT03828006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754308|NCT03828006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754309|NCT03828006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64754310|NCT01454154|Glyburide|glyburide|mesh-list
64754311|NCT01454154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64754312|NCT01454154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754313|NCT04391868|Sildenafil Citrate|sildenafil citrate|mesh-list
64754314|NCT04391868|Citric Acid|citric acid|mesh-list
64754315|NCT04391868|Sodium Citrate|sodium citrate|mesh-list
64754316|NCT04391868|Anticoagulants|anticoagulants|mesh-ancestor
64754317|NCT04391868|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64754318|NCT04391868|Chelating Agents|chelating agents|mesh-ancestor
64754320|NCT04391868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754321|NCT04391868|Vasodilator Agents|vasodilator agents|mesh-ancestor
64754322|NCT04391868|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64754323|NCT04391868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64754357|NCT01450176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64754358|NCT01450176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64754359|NCT01450176|Histamine Antagonists|histamine antagonists|mesh-ancestor
64754361|NCT01450176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64754362|NCT01450176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754363|NCT01454622|Metformin|metformin|mesh-list
64754364|NCT01454622|Canagliflozin|canagliflozin|mesh-list
64754365|NCT01454622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64754366|NCT01454622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754367|NCT01454622|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64754368|NCT01454622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754369|NCT01450410|Nicotinic Acids|nicotinic acids|mesh-list
64754370|NCT01450410|Niacin|niacin|mesh-list
64754371|NCT01450410|Niacinamide|niacinamide|mesh-list
64754372|NCT01450410|Vitamin B Complex|vitamin b complex|mesh-ancestor
64754373|NCT01450410|Vitamins|vitamins|mesh-ancestor
64754374|NCT01450410|Micronutrients|micronutrients|mesh-ancestor
64754375|NCT01450410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754376|NCT01450410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64523181|NCT02314468|Glycerol|glycerol|mesh-list
64754377|NCT01450410|Antimetabolites|antimetabolites|mesh-ancestor
64754378|NCT01450410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754379|NCT01450410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64754380|NCT01450410|Vasodilator Agents|vasodilator agents|mesh-ancestor
64754381|NCT02905110|Methotrexate|methotrexate|mesh-list
64636351|NCT01362205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64636352|NCT01362205|Analgesics|analgesics|mesh-ancestor
64636353|NCT01362205|Sensory System Agents|sensory system agents|mesh-ancestor
64636354|NCT01362205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64636355|NCT01362205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64636356|NCT01362205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64754382|NCT02905110|Etoposide|etoposide|mesh-list
64754383|NCT02905110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64754384|NCT02905110|Abortifacient Agents|abortifacient agents|mesh-ancestor
64754385|NCT02905110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64636357|NCT01362205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64754399|NCT02905110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64754400|NCT02905110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64754401|NCT01450566|Lidocaine|lidocaine|mesh-list
64754402|NCT01450566|Anesthetics, Local|anesthetics, local|mesh-ancestor
64754403|NCT01450566|Anesthetics|anesthetics|mesh-ancestor
64754404|NCT01450566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64754405|NCT01450566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754406|NCT01450566|Sensory System Agents|sensory system agents|mesh-ancestor
64754407|NCT01450566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64754408|NCT01450566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64754409|NCT01450566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64754410|NCT01450566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64754411|NCT01450566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64754458|NCT03824340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64754459|NCT03824340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64754460|NCT01455246|Meropenem|meropenem|mesh-list
64754461|NCT01455246|Daptomycin|daptomycin|mesh-list
64754462|NCT01455246|Ceftazidime|ceftazidime|mesh-list
64754463|NCT01455246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64754464|NCT01455246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64754465|NCT02934282|HBOC 201|hboc 201|mesh-list
64754466|NCT02934282|Blood Substitutes|blood substitutes|mesh-ancestor
64754467|NCT03823950|Lenograstim|lenograstim|mesh-list
64754468|NCT03823950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64754469|NCT03823950|Immunologic Factors|immunologic factors|mesh-ancestor
64754470|NCT03823950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754471|NCT01451268|Panobinostat|panobinostat|mesh-list
64754472|NCT01451268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754473|NCT01451268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64754474|NCT01451268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636360|NCT01362205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636361|NCT00052910|Leucovorin|leucovorin|mesh-list
64636362|NCT00052910|Fluorouracil|fluorouracil|mesh-list
64636363|NCT00052910|Epirubicin|epirubicin|mesh-list
64636364|NCT00052910|Calcium|calcium|mesh-list
64636365|NCT00052910|Levoleucovorin|levoleucovorin|mesh-list
64636366|NCT00052910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636367|NCT00052910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64636368|NCT00052910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636369|NCT00052910|Antimetabolites|antimetabolites|mesh-ancestor
64636370|NCT00052910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636371|NCT00052910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64636372|NCT00052910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64636373|NCT00052910|Immunologic Factors|immunologic factors|mesh-ancestor
64636374|NCT00052910|Antidotes|antidotes|mesh-ancestor
64636375|NCT00052910|Protective Agents|protective agents|mesh-ancestor
64636376|NCT00052910|Vitamin B Complex|vitamin b complex|mesh-ancestor
64636377|NCT00052910|Vitamins|vitamins|mesh-ancestor
64636378|NCT00052910|Micronutrients|micronutrients|mesh-ancestor
64636379|NCT00052910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64302487|NCT03071042|Antimitotic Agents|antimitotic agents|mesh-ancestor
64636380|NCT00052910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64636381|NCT00052910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64754475|NCT01451268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754476|NCT03823638|Mannitol|mannitol|mesh-list
64754477|NCT03823638|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64754478|NCT03823638|Diuretics|diuretics|mesh-ancestor
64754479|NCT03823638|Natriuretic Agents|natriuretic agents|mesh-ancestor
64754481|NCT02884908|Pregabalin|pregabalin|mesh-list
64754513|NCT02861898|Diuretics|diuretics|mesh-ancestor
64754514|NCT02861898|Natriuretic Agents|natriuretic agents|mesh-ancestor
64754515|NCT02861898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754516|NCT02851056|Lenograstim|lenograstim|mesh-list
64754517|NCT02851056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64754518|NCT02851056|Immunologic Factors|immunologic factors|mesh-ancestor
64754519|NCT02851056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754520|NCT02935374|Amoxicillin|amoxicillin|mesh-list
64754521|NCT02935374|Clavulanic Acid|clavulanic acid|mesh-list
64754522|NCT02935374|Clavulanic Acids|clavulanic acids|mesh-list
64754523|NCT02935374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64754524|NCT02935374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64754525|NCT02935374|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64754526|NCT02935374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754527|NCT02935374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636382|NCT00052910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636383|NCT01363843|Leucovorin|leucovorin|mesh-list
64636384|NCT01363843|Oxaliplatin|oxaliplatin|mesh-list
64636385|NCT01363843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636386|NCT01363843|Antidotes|antidotes|mesh-ancestor
64636387|NCT01363843|Protective Agents|protective agents|mesh-ancestor
64636389|NCT01363843|Vitamin B Complex|vitamin b complex|mesh-ancestor
64636390|NCT01363843|Vitamins|vitamins|mesh-ancestor
64636391|NCT01363843|Micronutrients|micronutrients|mesh-ancestor
64636392|NCT02092298|Sodium thiosulfate|sodium thiosulfate|mesh-list
64636393|NCT02092298|Cisplatin|cisplatin|mesh-list
64636394|NCT02092298|Mitomycins|mitomycins|mesh-list
64636395|NCT02092298|Mitomycin|mitomycin|mesh-list
64636396|NCT02092298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636397|NCT02092298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64636398|NCT02092298|Alkylating Agents|alkylating agents|mesh-ancestor
64636399|NCT02092298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636400|NCT02092298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64636401|NCT02092298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636402|NCT02092298|Antidotes|antidotes|mesh-ancestor
64636403|NCT02092298|Protective Agents|protective agents|mesh-ancestor
64636404|NCT02092298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754528|NCT01452750|Lansoprazole|lansoprazole|mesh-list
64754529|NCT01452750|Dexlansoprazole|dexlansoprazole|mesh-list
64754530|NCT01452750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64636405|NCT02092298|Antioxidants|antioxidants|mesh-ancestor
64754531|NCT01452750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64754532|NCT01452750|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64754533|NCT01452750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754534|NCT01452750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754536|NCT01452828|Tedizolid phosphate|tedizolid phosphate|mesh-list
64754537|NCT01452828|Oxazolidinones|oxazolidinones|mesh-list
64754538|NCT01452828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64754539|NCT01452828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64754540|NCT01452828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64754541|NCT01452828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754542|NCT01452828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754558|NCT02781090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445167|NCT04809311|Glucagon|glucagon|mesh-list
64754563|NCT03823248|Micronutrients|micronutrients|mesh-ancestor
64754564|NCT03823248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754565|NCT03822936|Fluorouracil|fluorouracil|mesh-list
64754566|NCT03822936|Oxaliplatin|oxaliplatin|mesh-list
64754567|NCT03822936|Irinotecan|irinotecan|mesh-list
64754568|NCT03822936|Antimetabolites|antimetabolites|mesh-ancestor
64754569|NCT03822936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754570|NCT03822936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64754571|NCT03822936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636417|NCT00151814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64636418|NCT00151814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64636419|NCT00151814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754572|NCT03822936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64754573|NCT03822936|Immunologic Factors|immunologic factors|mesh-ancestor
64754574|NCT03822936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754575|NCT03822936|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64754576|NCT03822936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64754577|NCT03822936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754578|NCT03822546|Nicotine|nicotine|mesh-list
64754579|NCT03822546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64754580|NCT03822546|Autonomic Agents|autonomic agents|mesh-ancestor
64754581|NCT03822546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64754582|NCT03822546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754583|NCT03822546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64754584|NCT03822546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64754585|NCT03822546|Cholinergic Agents|cholinergic agents|mesh-ancestor
64754586|NCT03822546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64754587|NCT03822546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754588|NCT01453686|Hydrocortisone|hydrocortisone|mesh-list
64754589|NCT01453686|Clobetasol|clobetasol|mesh-list
64754590|NCT01453686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64754591|NCT01453686|Glucocorticoids|glucocorticoids|mesh-ancestor
64754592|NCT01453686|Hormones|hormones|mesh-ancestor
64754593|NCT01453686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64754594|NCT01453686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754595|NCT01455870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64754596|NCT01455870|Exenatide|exenatide|mesh-list
64754597|NCT01455870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64754598|NCT01455870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754599|NCT01455870|Incretins|incretins|mesh-ancestor
64754600|NCT01455870|Hormones|hormones|mesh-ancestor
64523401|NCT02426736|Hormones|hormones|mesh-ancestor
64754601|NCT01455870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64754602|NCT01455870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64754603|NCT01455870|Protease Inhibitors|protease inhibitors|mesh-ancestor
64754604|NCT01455870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754605|NCT01455870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754606|NCT01455870|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64754607|NCT01456260|Lansoprazole|lansoprazole|mesh-list
64754608|NCT01456260|Dexlansoprazole|dexlansoprazole|mesh-list
64754609|NCT01456260|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64754610|NCT01456260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64754611|NCT01456260|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64754612|NCT01456260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636466|NCT01364623|Androgens|androgens|mesh-ancestor
64754613|NCT01456260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754614|NCT01890408|Ropivacaine|ropivacaine|mesh-list
64754615|NCT01890408|Anesthetics, Local|anesthetics, local|mesh-ancestor
64754616|NCT01890408|Anesthetics|anesthetics|mesh-ancestor
64754617|NCT01890408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64754618|NCT01890408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754619|NCT01890408|Sensory System Agents|sensory system agents|mesh-ancestor
64754623|NCT04849650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64754635|NCT04272372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64754636|NCT04272372|Analgesics|analgesics|mesh-ancestor
64754637|NCT04272372|Sensory System Agents|sensory system agents|mesh-ancestor
64754638|NCT04272372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64754639|NCT04272372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754640|NCT04272372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64754641|NCT04272372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64754642|NCT04272372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64754643|NCT04272372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636503|NCT03015857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64754644|NCT04272372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754645|NCT01891500|Nitric Oxide|nitric oxide|mesh-list
64754646|NCT01891500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64754647|NCT01891500|Autonomic Agents|autonomic agents|mesh-ancestor
64754648|NCT01891500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64754649|NCT01891500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754650|NCT01891500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64754651|NCT01891500|Respiratory System Agents|respiratory system agents|mesh-ancestor
64754652|NCT01891500|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64754653|NCT01891500|Antioxidants|antioxidants|mesh-ancestor
64754654|NCT01891500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754655|NCT01891500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64754656|NCT01891500|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64754657|NCT01891500|Vasodilator Agents|vasodilator agents|mesh-ancestor
64754658|NCT01891500|Gasotransmitters|gasotransmitters|mesh-ancestor
64754663|NCT02439450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64754664|NCT02439450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754665|NCT02439450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64754666|NCT02439450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754667|NCT02439450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754668|NCT02439450|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64754674|NCT02859402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754675|NCT02859402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754676|NCT02859402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64754677|NCT02859402|Immunologic Factors|immunologic factors|mesh-ancestor
64754678|NCT02859402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636561|NCT04780061|Coagulants|coagulants|mesh-ancestor
64636562|NCT02172755|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64636563|NCT02172755|Anticonvulsants|anticonvulsants|mesh-ancestor
64636564|NCT02172755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64636565|NCT02172755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64636576|NCT02762669|Oxytocin|oxytocin|mesh-list
64754679|NCT02859402|Alkylating Agents|alkylating agents|mesh-ancestor
64754680|NCT02859402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64754681|NCT02859402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64754682|NCT04844268|Vaccines|vaccines|mesh-list
64754683|NCT04844268|Immunologic Factors|immunologic factors|mesh-ancestor
64754684|NCT04844268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754685|NCT04842552|Hydralazine|hydralazine|mesh-list
64754686|NCT04842552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64754687|NCT04842552|Vasodilator Agents|vasodilator agents|mesh-ancestor
64754688|NCT02535312|Cisplatin|cisplatin|mesh-list
64754689|NCT02535312|Pemetrexed|pemetrexed|mesh-list
64754690|NCT02535312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754691|NCT02535312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754692|NCT02535312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754705|NCT04840602|Rituximab|rituximab|mesh-list
64754731|NCT01893060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64754732|NCT01893060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64754733|NCT01893060|Disinfectants|disinfectants|mesh-ancestor
64754734|NCT01893060|Dermatologic Agents|dermatologic agents|mesh-ancestor
64754735|NCT01893060|Plasma Substitutes|plasma substitutes|mesh-ancestor
64754736|NCT01893060|Blood Substitutes|blood substitutes|mesh-ancestor
64754738|NCT02344290|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64754739|NCT02344290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64754740|NCT02344290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64754741|NCT02344290|Antimetabolites|antimetabolites|mesh-ancestor
64754742|NCT02344290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754743|NCT02344290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754744|NCT02344290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64754745|NCT02848560|Xenon|xenon|mesh-list
64754746|NCT02848560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64754747|NCT02848560|Anesthetics, General|anesthetics, general|mesh-ancestor
64754748|NCT02848560|Anesthetics|anesthetics|mesh-ancestor
64754749|NCT02848560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64636605|NCT01076231|Tubulin Modulators|tubulin modulators|mesh-ancestor
64636606|NCT01076231|Antimitotic Agents|antimitotic agents|mesh-ancestor
64754750|NCT02848560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64523550|NCT01702025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754751|NCT01457820|Allopurinol|allopurinol|mesh-list
64754752|NCT01457820|Antimetabolites|antimetabolites|mesh-ancestor
64754753|NCT01457820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754754|NCT01457820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754755|NCT01457820|Gout Suppressants|gout suppressants|mesh-ancestor
64754756|NCT01457820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64754757|NCT01457820|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64754758|NCT01457820|Antioxidants|antioxidants|mesh-ancestor
64754759|NCT01457820|Protective Agents|protective agents|mesh-ancestor
64754776|NCT05022342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754777|NCT05022342|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64754778|NCT05022342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64754779|NCT05022342|Hormone Antagonists|hormone antagonists|mesh-ancestor
64754780|NCT05022342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64754781|NCT05022342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754782|NCT01893294|Gemcitabine|gemcitabine|mesh-list
64754783|NCT01893294|Fluorouracil|fluorouracil|mesh-list
64754784|NCT01893294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64754785|NCT01893294|Antimetabolites|antimetabolites|mesh-ancestor
64445187|NCT02164916|Mitogens|mitogens|mesh-list
64754786|NCT01893294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754787|NCT01893294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754788|NCT01893294|Antiviral Agents|antiviral agents|mesh-ancestor
64754789|NCT01893294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64754790|NCT01893294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754791|NCT01893294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64754792|NCT01893294|Immunologic Factors|immunologic factors|mesh-ancestor
64754793|NCT01893294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754794|NCT01458054|Ritonavir|ritonavir|mesh-list
64754795|NCT01458054|Omeprazole|omeprazole|mesh-list
64754796|NCT01458054|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64754797|NCT01458054|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64754798|NCT01458054|Protease Inhibitors|protease inhibitors|mesh-ancestor
64754799|NCT01458054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754810|NCT01893450|Pentoxifylline|pentoxifylline|mesh-list
64754825|NCT01893450|Hormone Antagonists|hormone antagonists|mesh-ancestor
64754826|NCT01893450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64754827|NCT01893450|Dopamine Agonists|dopamine agonists|mesh-ancestor
64754828|NCT01893450|Dopamine Agents|dopamine agents|mesh-ancestor
64754829|NCT01893450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64754830|NCT01893450|Antithyroid Agents|antithyroid agents|mesh-ancestor
64754831|NCT05027100|Irinotecan|irinotecan|mesh-list
64754832|NCT05027100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64754833|NCT05027100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64754834|NCT05027100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754835|NCT05027100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754836|NCT05027100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754837|NCT01458600|Diclofenac|diclofenac|mesh-list
64754840|NCT01458600|Methimazole|methimazole|mesh-list
64754841|NCT01458600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64754842|NCT01458600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64754843|NCT01458600|Analgesics|analgesics|mesh-ancestor
64754844|NCT01458600|Sensory System Agents|sensory system agents|mesh-ancestor
64754845|NCT01458600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64754846|NCT01458600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754847|NCT01458600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64754848|NCT01458600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64754849|NCT01458600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64754850|NCT01458600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754851|NCT01458600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754852|NCT01458600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64754853|NCT01458600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64754854|NCT01458600|Adrenergic Agents|adrenergic agents|mesh-ancestor
64754855|NCT01458600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64754868|NCT02832570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64754869|NCT02832570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754870|NCT02832570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754871|NCT02832570|Urological Agents|urological agents|mesh-ancestor
64754872|NCT02742324|Interferon-alpha|interferon-alpha|mesh-list
64754873|NCT02742324|Interferon alpha-2|interferon alpha-2|mesh-list
64754874|NCT02742324|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
64754875|NCT02742324|Antiviral Agents|antiviral agents|mesh-ancestor
64754876|NCT02742324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64754877|NCT02742324|Immunologic Factors|immunologic factors|mesh-ancestor
64754878|NCT02742324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754879|NCT02742324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754880|NCT02730546|Calcium, Dietary|calcium, dietary|mesh-list
64754881|NCT02730546|Leucovorin|leucovorin|mesh-list
64754882|NCT02730546|Folic Acid|folic acid|mesh-list
64754883|NCT02730546|Paclitaxel|paclitaxel|mesh-list
64754884|NCT02730546|Carboplatin|carboplatin|mesh-list
64754885|NCT02730546|Pembrolizumab|pembrolizumab|mesh-list
64754887|NCT02730546|Oxaliplatin|oxaliplatin|mesh-list
64754888|NCT02730546|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64754889|NCT02730546|Calcium|calcium|mesh-list
64754890|NCT02730546|Levoleucovorin|levoleucovorin|mesh-list
64754891|NCT02730546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64754892|NCT02730546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754893|NCT02730546|Tubulin Modulators|tubulin modulators|mesh-ancestor
64754894|NCT02730546|Antimitotic Agents|antimitotic agents|mesh-ancestor
64754895|NCT02730546|Mitosis Modulators|mitosis modulators|mesh-ancestor
64754896|NCT02730546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754897|NCT02730546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64636666|NCT00118352|Alemtuzumab|alemtuzumab|mesh-list
64754898|NCT02730546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64754901|NCT02730546|Antimetabolites|antimetabolites|mesh-ancestor
64754916|NCT01459146|Antimalarials|antimalarials|mesh-ancestor
64754917|NCT01459146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64754918|NCT01459146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64754919|NCT01459146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64754920|NCT01459146|Anthelmintics|anthelmintics|mesh-ancestor
64754921|NCT01459146|Anticestodal Agents|anticestodal agents|mesh-ancestor
64754922|NCT01459146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64754923|NCT01459146|Tubulin Modulators|tubulin modulators|mesh-ancestor
64754924|NCT01459146|Antimitotic Agents|antimitotic agents|mesh-ancestor
64754925|NCT01459146|Mitosis Modulators|mitosis modulators|mesh-ancestor
64754926|NCT01459146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754927|NCT01459146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754928|NCT05026398|Fenfluramine|fenfluramine|mesh-list
64754929|NCT05026398|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64754930|NCT05026398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64754931|NCT05026398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64754932|NCT05026398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754933|NCT05026398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64754934|NCT05026398|Serotonin Agents|serotonin agents|mesh-ancestor
64754935|NCT05026398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754936|NCT05586750|Atorvastatin|atorvastatin|mesh-list
64754937|NCT05586750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64754938|NCT05586750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64754939|NCT05586750|Antimetabolites|antimetabolites|mesh-ancestor
64754940|NCT05586750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754941|NCT05586750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64754942|NCT05586750|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64754943|NCT05586750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64754944|NCT02720094|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64754945|NCT02720094|Cabotegravir|cabotegravir|mesh-list
64754946|NCT02720094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64754947|NCT02720094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64754948|NCT02720094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636710|NCT01859819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636711|NCT01859819|Antiviral Agents|antiviral agents|mesh-ancestor
64636712|NCT01859819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64636713|NCT01859819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64636714|NCT01795313|Imiquimod|imiquimod|mesh-list
64636715|NCT01795313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64636716|NCT01795313|Immunologic Factors|immunologic factors|mesh-ancestor
64636717|NCT01795313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636718|NCT01795313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636719|NCT01795313|Interferon Inducers|interferon inducers|mesh-ancestor
64636720|NCT02176031|Methylprednisolone|methylprednisolone|mesh-list
64636721|NCT02176031|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64636722|NCT02176031|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64636723|NCT02176031|Prednisolone|prednisolone|mesh-list
64636724|NCT02176031|Prednisolone acetate|prednisolone acetate|mesh-list
64636725|NCT02176031|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64636726|NCT02176031|Prednisolone phosphate|prednisolone phosphate|mesh-list
64754950|NCT02720094|Antiviral Agents|antiviral agents|mesh-ancestor
64754953|NCT02720094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64754954|NCT02720094|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64754955|NCT02720094|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64754957|NCT02716974|Leuprolide|leuprolide|mesh-list
64754958|NCT02716974|Bicalutamide|bicalutamide|mesh-list
64754959|NCT02716974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64754960|NCT02716974|Tubulin Modulators|tubulin modulators|mesh-ancestor
64754961|NCT02716974|Antimitotic Agents|antimitotic agents|mesh-ancestor
64754962|NCT02716974|Mitosis Modulators|mitosis modulators|mesh-ancestor
64754963|NCT02716974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64754964|NCT02716974|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64754965|NCT02716974|Fertility Agents|fertility agents|mesh-ancestor
64754966|NCT02716974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64754967|NCT02716974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64754968|NCT02716974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64754969|NCT02716974|Androgen Antagonists|androgen antagonists|mesh-ancestor
64754970|NCT02716974|Hormone Antagonists|hormone antagonists|mesh-ancestor
64754971|NCT02716974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64754972|NCT01459380|Bevacizumab|bevacizumab|mesh-list
64754973|NCT01459380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64754974|NCT01459380|Carboplatin|carboplatin|mesh-list
64754975|NCT01459380|Doxorubicin|doxorubicin|mesh-list
64754976|NCT01459380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64754977|NCT01459380|Veliparib|veliparib|mesh-list
64754978|NCT01459380|Endothelial Growth Factors|endothelial growth factors|mesh-list
64754979|NCT01459380|Antibodies|antibodies|mesh-list
64754980|NCT01459380|Immunoglobulins|immunoglobulins|mesh-list
64754981|NCT01459380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64755001|NCT02680314|Abortifacient Agents|abortifacient agents|mesh-ancestor
64755002|NCT02680314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64755003|NCT02680314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755004|NCT02680314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64755005|NCT02680314|Antimetabolites|antimetabolites|mesh-ancestor
64755006|NCT02680314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755007|NCT02680314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755008|NCT02680314|Dermatologic Agents|dermatologic agents|mesh-ancestor
64755009|NCT02680314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755010|NCT02680314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64755011|NCT02680314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64755012|NCT02680314|Immunologic Factors|immunologic factors|mesh-ancestor
64755013|NCT02680314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64755014|NCT02680314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64755015|NCT02680314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64755016|NCT02680314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64755017|NCT02680314|Oxytocics|oxytocics|mesh-ancestor
64755018|NCT02707692|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64755019|NCT02707692|Immunologic Factors|immunologic factors|mesh-ancestor
64755021|NCT02706678|Tacrolimus|tacrolimus|mesh-list
64755055|NCT02703948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64755056|NCT02703948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755057|NCT02677038|Olaparib|olaparib|mesh-list
64755058|NCT02677038|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64755059|NCT02677038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755060|NCT02677038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755061|NCT02677038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755062|NCT02666742|Aspirin|aspirin|mesh-list
64755065|NCT02666742|Dabigatran|dabigatran|mesh-list
64755066|NCT02666742|Anticoagulants|anticoagulants|mesh-list
64755067|NCT02666742|Coagulants|coagulants|mesh-list
64755068|NCT02666742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64755069|NCT02666742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64755070|NCT02666742|Analgesics|analgesics|mesh-ancestor
64755071|NCT02666742|Sensory System Agents|sensory system agents|mesh-ancestor
64755072|NCT02666742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64755073|NCT02666742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755074|NCT02666742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64755075|NCT02666742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64755076|NCT02666742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64755077|NCT02666742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64755081|NCT02666742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755108|NCT04390854|Miconazole|miconazole|mesh-list
64636778|NCT01034111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64636779|NCT01034111|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64636780|NCT01034111|Protease Inhibitors|protease inhibitors|mesh-ancestor
64636781|NCT01034111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636782|NCT01034111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636783|NCT01114997|Lidocaine|lidocaine|mesh-list
64636784|NCT01114997|Esmolol|esmolol|mesh-list
64636786|NCT01114997|Anesthetics|anesthetics|mesh-ancestor
64636787|NCT01114997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64636788|NCT01114997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636789|NCT01114997|Sensory System Agents|sensory system agents|mesh-ancestor
64636790|NCT01114997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64636801|NCT00118742|Cyclosporine|cyclosporine|mesh-list
64755109|NCT04390854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64755110|NCT04390854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64755111|NCT04390854|Antifungal Agents|antifungal agents|mesh-ancestor
64755112|NCT04390854|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64755113|NCT04390854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64755114|NCT04390854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755115|NCT04390854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755116|NCT04390854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64755117|NCT04390854|Hormone Antagonists|hormone antagonists|mesh-ancestor
64755118|NCT04390854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64755119|NCT04390854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755120|NCT04390854|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64755121|NCT04390854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64755122|NCT02465736|Cisplatin|cisplatin|mesh-list
64755123|NCT02465736|Docetaxel|docetaxel|mesh-list
64755124|NCT02465736|Vinorelbine|vinorelbine|mesh-list
64755125|NCT02465736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755126|NCT02465736|Tubulin Modulators|tubulin modulators|mesh-ancestor
64755127|NCT02465736|Antimitotic Agents|antimitotic agents|mesh-ancestor
64755128|NCT02465736|Mitosis Modulators|mitosis modulators|mesh-ancestor
64755129|NCT02465736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755130|NCT02465736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64755131|NCT02630316|Treprostinil|treprostinil|mesh-list
64755132|NCT02630316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64755133|NCT02369484|Afatinib|afatinib|mesh-list
64445250|NCT05651633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64755134|NCT02369484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755135|NCT02369484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64755136|NCT02369484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755137|NCT02369484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755148|NCT02359968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64755149|NCT02359968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64755150|NCT02359968|Immunologic Factors|immunologic factors|mesh-ancestor
64755151|NCT02359968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755153|NCT04757376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64755154|NCT04757376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755155|NCT02625480|Cyclophosphamide|cyclophosphamide|mesh-list
64755156|NCT02625480|Fludarabine|fludarabine|mesh-list
64755157|NCT02625480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64755158|NCT02625480|Immunologic Factors|immunologic factors|mesh-ancestor
64755159|NCT02625480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755160|NCT02625480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64755161|NCT02625480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64755162|NCT02625480|Alkylating Agents|alkylating agents|mesh-ancestor
64755163|NCT02625480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755164|NCT02625480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755165|NCT02625480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64755166|NCT02624544|Desonide|desonide|mesh-list
64755167|NCT02624544|Esomeprazole|esomeprazole|mesh-list
64755168|NCT02624544|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64755169|NCT02624544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64755170|NCT02624544|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64755171|NCT02624544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755172|NCT02624544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755173|NCT02624544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64755174|NCT02603328|Atorvastatin|atorvastatin|mesh-list
64755176|NCT02603328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64755194|NCT02598726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64755195|NCT02598726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64755196|NCT02598726|Analgesics|analgesics|mesh-ancestor
64755197|NCT02598726|Sensory System Agents|sensory system agents|mesh-ancestor
64755198|NCT02598726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64755199|NCT02598726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755200|NCT02598726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64755201|NCT02598726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64755202|NCT02598726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755203|NCT02598726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755204|NCT02598726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755205|NCT02598726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64755206|NCT01451736|Risperidone|risperidone|mesh-list
64755207|NCT01451736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64755208|NCT01451736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64755209|NCT01451736|Serotonin Agents|serotonin agents|mesh-ancestor
64755210|NCT01451736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64755211|NCT01451736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755212|NCT01451736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755214|NCT01451736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64755215|NCT01451736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64755216|NCT01451736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64755217|NCT01451736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64755244|NCT01453530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64755245|NCT01453530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755246|NCT01453530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755247|NCT01453530|Cholinergic Agents|cholinergic agents|mesh-ancestor
64755248|NCT01453530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64755249|NCT01453530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636833|NCT00167180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64636834|NCT01317901|Rituximab|rituximab|mesh-list
64636835|NCT01317901|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64636836|NCT01317901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64636837|NCT01317901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636838|NCT01317901|Immunologic Factors|immunologic factors|mesh-ancestor
64636839|NCT01317901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636846|NCT03008551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64636847|NCT03008551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362095|NCT05463367|Analgesics|analgesics|mesh-ancestor
64636850|NCT01366885|Vitamin D|vitamin d|mesh-list
64755250|NCT01453530|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64755251|NCT01453530|Autonomic Agents|autonomic agents|mesh-ancestor
64755252|NCT01453530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64755253|NCT01453530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64755254|NCT01453530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64755255|NCT01453530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64755256|NCT02983422|Aminophylline|aminophylline|mesh-list
64755257|NCT02983422|Furosemide|furosemide|mesh-list
64755258|NCT02983422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64755259|NCT02983422|Autonomic Agents|autonomic agents|mesh-ancestor
64755260|NCT02983422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64755261|NCT02983422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755262|NCT02983422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64445266|NCT02222558|Androgens|androgens|mesh-ancestor
64445267|NCT02222558|Hormones|hormones|mesh-ancestor
64755265|NCT02983422|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64755267|NCT02983422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755268|NCT02983422|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64755269|NCT02983422|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64755270|NCT02983422|Purinergic Agents|purinergic agents|mesh-ancestor
64755271|NCT02983422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64755272|NCT02983422|Protective Agents|protective agents|mesh-ancestor
64755273|NCT02983422|Diuretics|diuretics|mesh-ancestor
64755274|NCT02983422|Natriuretic Agents|natriuretic agents|mesh-ancestor
64755277|NCT05585814|Bevacizumab|bevacizumab|mesh-list
64755284|NCT05585814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64755285|NCT05585814|Growth Substances|growth substances|mesh-ancestor
64755286|NCT05585814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755287|NCT05585814|Growth Inhibitors|growth inhibitors|mesh-ancestor
64755288|NCT05585814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64755289|NCT05585814|Antimetabolites|antimetabolites|mesh-ancestor
64755290|NCT05585814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755292|NCT02013648|Daunorubicin|daunorubicin|mesh-list
64755293|NCT02013648|Dasatinib|dasatinib|mesh-list
64755294|NCT02013648|Idarubicin|idarubicin|mesh-list
64755295|NCT02013648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64755296|NCT02013648|Antimetabolites|antimetabolites|mesh-ancestor
64755297|NCT02013648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755298|NCT02013648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755299|NCT02013648|Antiviral Agents|antiviral agents|mesh-ancestor
64755300|NCT02013648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64755301|NCT02013648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64755302|NCT02013648|Immunologic Factors|immunologic factors|mesh-ancestor
64755303|NCT02013648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755340|NCT01989780|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64755341|NCT01989780|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64755342|NCT01989780|Fertility Agents|fertility agents|mesh-ancestor
64636867|NCT01425229|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64755343|NCT01989780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64755344|NCT02270814|Paclitaxel|paclitaxel|mesh-list
64755345|NCT02270814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64755346|NCT02270814|Cisplatin|cisplatin|mesh-list
64755347|NCT02270814|Carboplatin|carboplatin|mesh-list
64755348|NCT02270814|Cetuximab|cetuximab|mesh-list
64755349|NCT02270814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64755350|NCT02270814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755351|NCT02270814|Tubulin Modulators|tubulin modulators|mesh-ancestor
64636903|NCT01425853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64636904|NCT01425853|Analgesics|analgesics|mesh-ancestor
64636905|NCT01425853|Sensory System Agents|sensory system agents|mesh-ancestor
64755352|NCT02270814|Antimitotic Agents|antimitotic agents|mesh-ancestor
64755353|NCT02270814|Mitosis Modulators|mitosis modulators|mesh-ancestor
64636908|NCT01425853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64755354|NCT02270814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755355|NCT02270814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64755356|NCT02549898|Cilostazol|cilostazol|mesh-list
64755357|NCT02549898|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64755359|NCT02549898|Autonomic Agents|autonomic agents|mesh-ancestor
64755398|NCT02516670|Micronutrients|micronutrients|mesh-ancestor
64755399|NCT02516670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755400|NCT02516670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755401|NCT02516670|Tubulin Modulators|tubulin modulators|mesh-ancestor
64755402|NCT02516670|Antimitotic Agents|antimitotic agents|mesh-ancestor
64755403|NCT02516670|Mitosis Modulators|mitosis modulators|mesh-ancestor
64755404|NCT02516670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755405|NCT02516670|Antioxidants|antioxidants|mesh-ancestor
64755406|NCT02516670|Protective Agents|protective agents|mesh-ancestor
64755407|NCT02513784|Chlorhexidine|chlorhexidine|mesh-list
64636968|NCT02112734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64636969|NCT01319773|Cyclosporine|cyclosporine|mesh-list
64636970|NCT01319773|Cyclosporins|cyclosporins|mesh-list
64636971|NCT01319773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636972|NCT01319773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636973|NCT01319773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64636974|NCT01319773|Immunologic Factors|immunologic factors|mesh-ancestor
64636975|NCT01319773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755408|NCT02513784|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64755409|NCT02513784|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64755410|NCT02513784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64755411|NCT02513784|Disinfectants|disinfectants|mesh-ancestor
64755412|NCT02513784|Dermatologic Agents|dermatologic agents|mesh-ancestor
64755413|NCT02283996|Methylprednisolone|methylprednisolone|mesh-list
64755414|NCT02283996|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64755415|NCT02283996|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64755416|NCT02283996|Prednisolone|prednisolone|mesh-list
64755417|NCT02283996|Prednisolone acetate|prednisolone acetate|mesh-list
64755418|NCT02283996|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64637022|NCT00124514|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64755419|NCT02283996|Prednisolone phosphate|prednisolone phosphate|mesh-list
64637023|NCT00124514|Luteolytic Agents|luteolytic agents|mesh-ancestor
64637024|NCT00124514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64637025|NCT00124514|Contraceptive Agents|contraceptive agents|mesh-ancestor
64637026|NCT00124514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64637027|NCT00124514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637028|NCT00124514|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64637029|NCT00124514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64637031|NCT01899248|Sevoflurane|sevoflurane|mesh-list
64755420|NCT02283996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64755421|NCT02283996|Antiemetics|antiemetics|mesh-ancestor
64755422|NCT02283996|Autonomic Agents|autonomic agents|mesh-ancestor
64755423|NCT02283996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64755424|NCT02283996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755446|NCT04390152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64755447|NCT04390152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64755448|NCT04390152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64755450|NCT04390152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64755451|NCT04390152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64755452|NCT04390152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64755453|NCT02227992|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64755454|NCT02227992|Hemostatics|hemostatics|mesh-ancestor
64637081|NCT00176306|Renal Agents|renal agents|mesh-ancestor
64637082|NCT00176306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64637083|NCT00176306|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64637084|NCT00176306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64637085|NCT00176306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64637086|NCT00176306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637087|NCT00176306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637088|NCT00176306|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64637089|NCT00176306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64637091|NCT01429987|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64637092|NCT01429987|Enzyme Activators|enzyme activators|mesh-ancestor
64637094|NCT01429987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64755455|NCT02227992|Coagulants|coagulants|mesh-ancestor
64755456|NCT02496780|Insulin|insulin|mesh-list
64755457|NCT02496780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64755458|NCT02496780|Insulin Aspart|insulin aspart|mesh-list
64755459|NCT02496780|Insulin Detemir|insulin detemir|mesh-list
64755460|NCT02496780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64755461|NCT02496780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755462|NCT01953588|Fulvestrant|fulvestrant|mesh-list
64755463|NCT01953588|Anastrozole|anastrozole|mesh-list
64755464|NCT01953588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64755465|NCT01953588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755466|NCT01953588|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64755467|NCT01953588|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64755468|NCT01953588|Hormone Antagonists|hormone antagonists|mesh-ancestor
64755469|NCT01953588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64755470|NCT01953588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637134|NCT01323517|Ipilimumab|ipilimumab|mesh-list
64637135|NCT01323517|Melphalan|melphalan|mesh-list
64637136|NCT01323517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64637137|NCT01323517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637138|NCT01323517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64637139|NCT01323517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637140|NCT01323517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64637141|NCT01323517|Alkylating Agents|alkylating agents|mesh-ancestor
64755471|NCT01953588|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64755472|NCT01953588|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64755473|NCT01953588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755474|NCT01953588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755475|NCT01953510|Vaccines|vaccines|mesh-list
64755476|NCT01953510|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64755477|NCT01953510|Immunologic Factors|immunologic factors|mesh-ancestor
64755478|NCT01953510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755479|NCT01943994|Psilocybin|psilocybin|mesh-list
64755487|NCT01943994|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64755488|NCT01943994|Cholinergic Agents|cholinergic agents|mesh-ancestor
64755489|NCT01943994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64755490|NCT01943994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755491|NCT01943994|Hallucinogens|hallucinogens|mesh-ancestor
64755492|NCT01943994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64755493|NCT01943994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64755494|NCT01943994|Serotonin Agents|serotonin agents|mesh-ancestor
64755495|NCT01943994|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64755497|NCT02456532|Eszopiclone|eszopiclone|mesh-list
64637179|NCT03009097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64637180|NCT03009097|Antimetabolites|antimetabolites|mesh-ancestor
64637181|NCT03009097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637182|NCT03009097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64637183|NCT03009097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64637184|NCT03009097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64637185|NCT01325311|Vitamin D|vitamin d|mesh-list
64637186|NCT01325311|Cholecalciferol|cholecalciferol|mesh-list
64637187|NCT01325311|Genistein|genistein|mesh-list
64637188|NCT01325311|Vitamins|vitamins|mesh-ancestor
64637189|NCT01325311|Micronutrients|micronutrients|mesh-ancestor
64637190|NCT01325311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637191|NCT01325311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64755498|NCT02456532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64755499|NCT02456532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64755500|NCT02456532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64755501|NCT02456532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755502|NCT02456532|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64755504|NCT02456532|GABA Agents|gaba agents|mesh-ancestor
64755505|NCT02456532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64755506|NCT02456532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64524298|NCT02422056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64755507|NCT02153580|Cyclophosphamide|cyclophosphamide|mesh-list
64755508|NCT02153580|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64755509|NCT02153580|Fludarabine|fludarabine|mesh-list
64755510|NCT02153580|Fludarabine phosphate|fludarabine phosphate|mesh-list
64755511|NCT02153580|Etoposide|etoposide|mesh-list
64637222|NCT01080677|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64637223|NCT01080677|Purinergic Agents|purinergic agents|mesh-ancestor
64637224|NCT01080677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64637225|NCT01080677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64637226|NCT01080677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64637228|NCT01080677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64637229|NCT01080677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64637230|NCT01080677|Vasodilator Agents|vasodilator agents|mesh-ancestor
64755512|NCT02153580|Etoposide phosphate|etoposide phosphate|mesh-list
64755513|NCT02153580|Podophyllotoxin|podophyllotoxin|mesh-list
64637231|NCT01378273|Epoetin Alfa|epoetin alfa|mesh-list
64755514|NCT02153580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64755515|NCT02153580|Immunologic Factors|immunologic factors|mesh-ancestor
64755516|NCT02153580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755517|NCT02153580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64755518|NCT02153580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64755519|NCT02153580|Alkylating Agents|alkylating agents|mesh-ancestor
64755527|NCT02153580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64755528|NCT02153580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755529|NCT02153580|Keratolytic Agents|keratolytic agents|mesh-ancestor
64755530|NCT02153580|Dermatologic Agents|dermatologic agents|mesh-ancestor
64755531|NCT02153580|Tubulin Modulators|tubulin modulators|mesh-ancestor
64755532|NCT02153580|Antimitotic Agents|antimitotic agents|mesh-ancestor
64755533|NCT02153580|Mitosis Modulators|mitosis modulators|mesh-ancestor
64755534|NCT01934868|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64755535|NCT05578950|Itraconazole|itraconazole|mesh-list
64755536|NCT05578950|Terbinafine|terbinafine|mesh-list
64755537|NCT05578950|Antifungal Agents|antifungal agents|mesh-ancestor
64637274|NCT01082939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64637275|NCT01082939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64637276|NCT01082939|Antimetabolites|antimetabolites|mesh-ancestor
64755538|NCT05578950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64755539|NCT05578950|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64637280|NCT01381471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64637281|NCT01381471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64637282|NCT01381471|Autonomic Agents|autonomic agents|mesh-ancestor
64637295|NCT02941926|Letrozole|letrozole|mesh-list
64637330|NCT01434121|Micronutrients|micronutrients|mesh-ancestor
64755540|NCT05578950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64755541|NCT05578950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755542|NCT05578950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755543|NCT05578950|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64755544|NCT05578950|Hormone Antagonists|hormone antagonists|mesh-ancestor
64755545|NCT05578950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64755546|NCT05578950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755547|NCT05578950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64755579|NCT01924260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755580|NCT01924260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755581|NCT01924260|Antiviral Agents|antiviral agents|mesh-ancestor
64637331|NCT01434121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637332|NCT01434121|Antioxidants|antioxidants|mesh-ancestor
64637333|NCT01434121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637334|NCT01434121|Protective Agents|protective agents|mesh-ancestor
64637335|NCT01381861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64637336|NCT01381861|Immunologic Factors|immunologic factors|mesh-ancestor
64637337|NCT01381861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637338|NCT01040819|Pioglitazone|pioglitazone|mesh-list
64637339|NCT01040819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64637340|NCT01040819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755582|NCT01924260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64755583|NCT01924260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755584|NCT01924260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64755585|NCT01924260|Immunologic Factors|immunologic factors|mesh-ancestor
64755587|NCT02432742|Hyaluronic Acid|hyaluronic acid|mesh-list
64755588|NCT02432742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64755589|NCT02432742|Immunologic Factors|immunologic factors|mesh-ancestor
64755590|NCT02432742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755591|NCT02432742|Viscosupplements|viscosupplements|mesh-ancestor
64755592|NCT02432742|Protective Agents|protective agents|mesh-ancestor
64755593|NCT02086500|Tranexamic Acid|tranexamic acid|mesh-list
64755594|NCT02086500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64755595|NCT02086500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64755596|NCT02086500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755597|NCT02086500|Hemostatics|hemostatics|mesh-ancestor
64755598|NCT02086500|Coagulants|coagulants|mesh-ancestor
64755599|NCT02104986|Cisplatin|cisplatin|mesh-list
64755600|NCT02104986|Ifosfamide|ifosfamide|mesh-list
64755601|NCT02104986|Bleomycin|bleomycin|mesh-list
64755602|NCT02104986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755604|NCT02104986|Alkylating Agents|alkylating agents|mesh-ancestor
64755605|NCT02104986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755606|NCT02104986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64755607|NCT02425566|Trimethaphan|trimethaphan|mesh-list
64755608|NCT02425566|Nitroglycerin|nitroglycerin|mesh-list
64637383|NCT01118273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64755609|NCT02425566|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
64755610|NCT02425566|Vasodilator Agents|vasodilator agents|mesh-ancestor
64755611|NCT02425566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64755612|NCT02425566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64755613|NCT02425566|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
64755614|NCT02425566|Autonomic Agents|autonomic agents|mesh-ancestor
64755621|NCT02425566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755622|NCT04757532|Methyltestosterone|methyltestosterone|mesh-list
64755623|NCT04757532|Anastrozole|anastrozole|mesh-list
64755624|NCT04757532|Chlorthalidone|chlorthalidone|mesh-list
64755625|NCT04757532|Bupropion|bupropion|mesh-list
64755626|NCT04757532|Testosterone|testosterone|mesh-list
64755627|NCT04757532|Testosterone undecanoate|testosterone undecanoate|mesh-list
64755628|NCT04757532|Testosterone enanthate|testosterone enanthate|mesh-list
64755629|NCT04757532|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64755630|NCT04757532|Danazol|danazol|mesh-list
64637434|NCT01332253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64637435|NCT01332253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637436|NCT01332721|Bevacizumab|bevacizumab|mesh-list
64637437|NCT01332721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64637438|NCT01332721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637439|NCT01332721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64637440|NCT01332721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64637441|NCT01332721|Growth Substances|growth substances|mesh-ancestor
64755631|NCT04757532|Androgens|androgens|mesh-ancestor
64755632|NCT04757532|Hormones|hormones|mesh-ancestor
64755633|NCT04757532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64755634|NCT04757532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755635|NCT04757532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64755636|NCT04757532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755637|NCT04757532|Anabolic Agents|anabolic agents|mesh-ancestor
64755638|NCT04757532|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64755639|NCT04757532|Antidepressive Agents|antidepressive agents|mesh-ancestor
64755640|NCT04757532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64755641|NCT04757532|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64755642|NCT04757532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64755643|NCT04757532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64755644|NCT04757532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755645|NCT04757532|Dopamine Agents|dopamine agents|mesh-ancestor
64755646|NCT04757532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64637491|NCT00265850|Protective Agents|protective agents|mesh-ancestor
64637492|NCT00265850|Vitamin B Complex|vitamin b complex|mesh-ancestor
64637495|NCT00265850|Hematinics|hematinics|mesh-ancestor
64637496|NCT00125372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64637497|NCT00125372|Bexarotene|bexarotene|mesh-list
64637498|NCT00125372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755647|NCT04757532|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64755648|NCT04757532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64755658|NCT02069730|Androgens|androgens|mesh-list
64755665|NCT02068092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64755667|NCT02068092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755668|NCT02068092|Protective Agents|protective agents|mesh-ancestor
64755669|NCT02068092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755670|NCT02068092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64755672|NCT02063022|Cyclophosphamide|cyclophosphamide|mesh-list
64755673|NCT02063022|Melphalan|melphalan|mesh-list
64755674|NCT02063022|Busulfan|busulfan|mesh-list
64755675|NCT02063022|Ifosfamide|ifosfamide|mesh-list
64755676|NCT02063022|Isophosphamide mustard|isophosphamide mustard|mesh-list
64755677|NCT02063022|Doxorubicin|doxorubicin|mesh-list
64755678|NCT02063022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64755679|NCT02063022|Etoposide|etoposide|mesh-list
64755680|NCT02063022|Etoposide phosphate|etoposide phosphate|mesh-list
64755681|NCT02063022|Vincristine|vincristine|mesh-list
64755682|NCT02063022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64755683|NCT02063022|Immunologic Factors|immunologic factors|mesh-ancestor
64755684|NCT02063022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755685|NCT02063022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64755686|NCT02063022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64637549|NCT01336933|Cyclophosphamide|cyclophosphamide|mesh-list
64755687|NCT02063022|Alkylating Agents|alkylating agents|mesh-ancestor
64755688|NCT02063022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637550|NCT01336933|Etoposide|etoposide|mesh-list
64637551|NCT01336933|Vincristine|vincristine|mesh-list
64637552|NCT01336933|Etoposide phosphate|etoposide phosphate|mesh-list
64637553|NCT01336933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64637554|NCT01336933|Immunologic Factors|immunologic factors|mesh-ancestor
64637555|NCT01336933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755689|NCT02063022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755690|NCT02063022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64755691|NCT02063022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64755692|NCT02063022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64755693|NCT02063022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64755694|NCT02063022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755696|NCT02063022|Tubulin Modulators|tubulin modulators|mesh-ancestor
64755712|NCT01895010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64755713|NCT01895010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755714|NCT02030028|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64637593|NCT00176930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64637594|NCT00176930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64637595|NCT00176930|Alkylating Agents|alkylating agents|mesh-ancestor
64637596|NCT00176930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637599|NCT01473745|Daminozide|daminozide|mesh-list
64637600|NCT01473745|Plant Growth Regulators|plant growth regulators|mesh-ancestor
64637601|NCT01473745|Growth Substances|growth substances|mesh-ancestor
64637602|NCT01473745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637603|NCT00178178|Bupivacaine|bupivacaine|mesh-list
64637604|NCT00178178|Anesthetics, Local|anesthetics, local|mesh-ancestor
64755715|NCT02030028|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64755716|NCT02030028|beta-Endorphin|beta-endorphin|mesh-list
64755717|NCT02030028|Hormones|hormones|mesh-ancestor
64755718|NCT02030028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64755719|NCT02030028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755720|NCT02030028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64755721|NCT02030028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755722|NCT01896336|Zolpidem|zolpidem|mesh-list
64755723|NCT01896336|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64755724|NCT01896336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64755725|NCT01896336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64755726|NCT01896336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445308|NCT04013555|Expectorants|expectorants|mesh-ancestor
64445309|NCT04013555|Respiratory System Agents|respiratory system agents|mesh-ancestor
64445311|NCT04013555|Antioxidants|antioxidants|mesh-ancestor
64637651|NCT00128180|Prednisolone phosphate|prednisolone phosphate|mesh-list
64637652|NCT00128180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64637653|NCT00128180|Antiemetics|antiemetics|mesh-ancestor
64637654|NCT00128180|Autonomic Agents|autonomic agents|mesh-ancestor
64637655|NCT00128180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64637656|NCT00128180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637657|NCT00128180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64637658|NCT00128180|Glucocorticoids|glucocorticoids|mesh-ancestor
64637659|NCT00128180|Hormones|hormones|mesh-ancestor
64637660|NCT00128180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64637661|NCT00128180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64637662|NCT00128180|Protective Agents|protective agents|mesh-ancestor
64637663|NCT00128180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64637664|NCT00128180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637665|NCT01121939|Bevacizumab|bevacizumab|mesh-list
64755728|NCT01896336|GABA Agonists|gaba agonists|mesh-ancestor
64755729|NCT01896336|GABA Agents|gaba agents|mesh-ancestor
64755730|NCT01896336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64755731|NCT01896336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755732|NCT00575718|Nicotine|nicotine|mesh-list
64755733|NCT00575718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64637696|NCT01445821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755734|NCT00575718|Autonomic Agents|autonomic agents|mesh-ancestor
64755760|NCT01490502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64755761|NCT01428024|Hyaluronic Acid|hyaluronic acid|mesh-list
64755762|NCT01428024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64637697|NCT01445821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64637698|NCT01445821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64637699|NCT01445821|Alkylating Agents|alkylating agents|mesh-ancestor
64637704|NCT01445821|Antiemetics|antiemetics|mesh-ancestor
64755763|NCT01428024|Immunologic Factors|immunologic factors|mesh-ancestor
64755764|NCT01428024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755765|NCT01428024|Viscosupplements|viscosupplements|mesh-ancestor
64755766|NCT01428024|Protective Agents|protective agents|mesh-ancestor
64755767|NCT01419834|Antibodies|antibodies|mesh-list
64755768|NCT01419834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64755769|NCT01419834|Immunologic Factors|immunologic factors|mesh-ancestor
64755770|NCT01419834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755771|NCT01412190|Hyaluronic Acid|hyaluronic acid|mesh-list
64755772|NCT01412190|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64755773|NCT01412190|Immunologic Factors|immunologic factors|mesh-ancestor
64755774|NCT01412190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755775|NCT01412190|Viscosupplements|viscosupplements|mesh-ancestor
64755776|NCT01412190|Protective Agents|protective agents|mesh-ancestor
64755777|NCT01331148|Vitamin D|vitamin d|mesh-list
64755778|NCT01331148|Cholecalciferol|cholecalciferol|mesh-list
64755779|NCT01331148|Vitamins|vitamins|mesh-ancestor
64755780|NCT01331148|Micronutrients|micronutrients|mesh-ancestor
64755781|NCT01331148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755782|NCT01331148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64755783|NCT01331148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64755784|NCT04839042|Cloricromen|cloricromen|mesh-list
64637758|NCT00183092|Quinacrine|quinacrine|mesh-list
64637759|NCT00183092|Anticestodal Agents|anticestodal agents|mesh-ancestor
64637760|NCT00183092|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64637761|NCT00183092|Anthelmintics|anthelmintics|mesh-ancestor
64637762|NCT00183092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64637763|NCT00183092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64637764|NCT00183092|Antimalarials|antimalarials|mesh-ancestor
64637765|NCT00183092|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64755785|NCT04839042|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64755786|NCT00273624|Olanzapine|olanzapine|mesh-list
64755787|NCT00273624|Antiemetics|antiemetics|mesh-ancestor
64755788|NCT00273624|Autonomic Agents|autonomic agents|mesh-ancestor
64755789|NCT00273624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64755790|NCT00273624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755791|NCT00273624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64755792|NCT00273624|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64755793|NCT00273624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64755794|NCT00273624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64755800|NCT00273624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64755801|NCT00273624|Serotonin Agents|serotonin agents|mesh-ancestor
64755802|NCT00262470|Indomethacin|indomethacin|mesh-list
64755803|NCT00262470|Octreotide|octreotide|mesh-list
64755804|NCT00262470|Propranolol|propranolol|mesh-list
64755805|NCT00262470|Clonidine|clonidine|mesh-list
64755806|NCT00262470|Mecamylamine|mecamylamine|mesh-list
64755807|NCT00262470|Acetazolamide|acetazolamide|mesh-list
64755808|NCT00262470|Isosorbide|isosorbide|mesh-list
64755809|NCT00262470|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64524602|NCT02409498|Bupivacaine|bupivacaine|mesh-list
64755810|NCT00262470|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64755811|NCT00262470|Midodrine|midodrine|mesh-list
64755812|NCT00262470|Memantine|memantine|mesh-list
64755813|NCT00262470|Entacapone|entacapone|mesh-list
64755814|NCT00262470|Melatonin|melatonin|mesh-list
64755815|NCT00262470|Modafinil|modafinil|mesh-list
64755816|NCT00262470|Sertraline|sertraline|mesh-list
64755817|NCT00262470|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64637806|NCT00270296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64755818|NCT00262470|Antioxidants|antioxidants|mesh-ancestor
64637807|NCT00270296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64637808|NCT00270296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64637809|NCT00270296|Antimetabolites|antimetabolites|mesh-ancestor
64637810|NCT00270296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64637811|NCT00270296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64637812|NCT01047527|Nicotine|nicotine|mesh-list
64637813|NCT01047527|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64637814|NCT01047527|Autonomic Agents|autonomic agents|mesh-ancestor
64637815|NCT01047527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302725|NCT03257319|Analgesics|analgesics|mesh-ancestor
64637817|NCT01047527|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64637818|NCT01047527|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64637819|NCT01047527|Cholinergic Agents|cholinergic agents|mesh-ancestor
64637820|NCT01047527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64637821|NCT01047527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637822|NCT03013127|Pembrolizumab|pembrolizumab|mesh-list
64755819|NCT00262470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755820|NCT00262470|Protective Agents|protective agents|mesh-ancestor
64755821|NCT00262470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637824|NCT03013127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755822|NCT00262470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64755823|NCT00262470|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64755824|NCT00262470|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64755825|NCT00262470|Adrenergic Agents|adrenergic agents|mesh-ancestor
64755826|NCT00262470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64755827|NCT00262470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64755828|NCT00262470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64755829|NCT00262470|Vasodilator Agents|vasodilator agents|mesh-ancestor
64755830|NCT00262470|Antidepressive Agents|antidepressive agents|mesh-ancestor
64755831|NCT00262470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64755832|NCT00262470|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64755833|NCT00262470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64755834|NCT00262470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64637837|NCT03013205|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64755845|NCT00262470|Autonomic Agents|autonomic agents|mesh-ancestor
64755846|NCT00262470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64637838|NCT03013205|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64637839|NCT03013205|Lidocaine|lidocaine|mesh-list
64637840|NCT03013205|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64637841|NCT03013205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64637842|NCT03013205|Glucocorticoids|glucocorticoids|mesh-ancestor
64637843|NCT03013205|Hormones|hormones|mesh-ancestor
64637844|NCT03013205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64637845|NCT03013205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637846|NCT03013205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64637847|NCT03013205|Immunologic Factors|immunologic factors|mesh-ancestor
64637848|NCT03013205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64637850|NCT03013205|Anesthetics, Local|anesthetics, local|mesh-ancestor
64755847|NCT00262470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64755848|NCT00262470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64755849|NCT00262470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64755850|NCT00262470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64755851|NCT00262470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755852|NCT00262470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64755853|NCT00262470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64755854|NCT00262470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64755855|NCT00262470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64755856|NCT00262470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64755857|NCT00262470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64755858|NCT00262470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64755859|NCT00262470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64755860|NCT00262470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64755861|NCT00262470|Gout Suppressants|gout suppressants|mesh-ancestor
64637881|NCT03110315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64637882|NCT03110315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64637883|NCT03110315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637884|NCT03110315|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64637885|NCT03110315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64637886|NCT03110315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637887|NCT05307341|Sufentanil|sufentanil|mesh-list
64637888|NCT05307341|Dsuvia|dsuvia|mesh-list
64637889|NCT05307341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64637890|NCT05307341|Narcotics|narcotics|mesh-ancestor
64637891|NCT05307341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64637892|NCT05307341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755862|NCT00262470|Tocolytic Agents|tocolytic agents|mesh-ancestor
64755863|NCT00262470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64755864|NCT00262470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64755865|NCT00262470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755866|NCT00262470|Anticonvulsants|anticonvulsants|mesh-ancestor
64755867|NCT00262470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64755868|NCT00262470|Diuretics|diuretics|mesh-ancestor
64755869|NCT00262470|Natriuretic Agents|natriuretic agents|mesh-ancestor
64755870|NCT00262470|Sympathomimetics|sympathomimetics|mesh-ancestor
64755871|NCT00262470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64755872|NCT00262470|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64755873|NCT00262470|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64755874|NCT00262470|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64755886|NCT01851642|Respiratory System Agents|respiratory system agents|mesh-ancestor
64755888|NCT01851642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64755889|NCT01851642|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64755890|NCT01851642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64755891|NCT01851642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64755892|NCT01851642|Adrenergic Agents|adrenergic agents|mesh-ancestor
64755893|NCT01851642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64755894|NCT01851642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755896|NCT01253070|Sorafenib|sorafenib|mesh-list
64755897|NCT01253070|Daunorubicin|daunorubicin|mesh-list
64755898|NCT01253070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64755899|NCT01253070|Antimetabolites|antimetabolites|mesh-ancestor
64755900|NCT01253070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755901|NCT01253070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637930|NCT01100723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637931|NCT01100723|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64755902|NCT01253070|Antiviral Agents|antiviral agents|mesh-ancestor
64637932|NCT01100723|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64637933|NCT01100723|Hormone Antagonists|hormone antagonists|mesh-ancestor
64637934|NCT01100723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64637935|NCT05306405|Misoprostol|misoprostol|mesh-list
64637936|NCT05306405|Estradiol|estradiol|mesh-list
64637937|NCT05306405|Estrogens|estrogens|mesh-ancestor
64637938|NCT05306405|Hormones|hormones|mesh-ancestor
64637939|NCT05306405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64637940|NCT05306405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637941|NCT05306405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64637942|NCT05306405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64637943|NCT05306405|Abortifacient Agents|abortifacient agents|mesh-ancestor
64637944|NCT05306405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64637945|NCT05306405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64637946|NCT05306405|Oxytocics|oxytocics|mesh-ancestor
64637947|NCT04352621|Ketamine|ketamine|mesh-list
64637948|NCT04352621|Analgesics|analgesics|mesh-ancestor
64637949|NCT04352621|Sensory System Agents|sensory system agents|mesh-ancestor
64755903|NCT01253070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64755904|NCT01253070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64755905|NCT01253070|Immunologic Factors|immunologic factors|mesh-ancestor
64755906|NCT01253070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755907|NCT01253070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64755908|NCT01253070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755909|NCT01253070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64755910|NCT01253070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64755911|NCT01253070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64755912|NCT01212822|Leucovorin|leucovorin|mesh-list
64755913|NCT01212822|Bevacizumab|bevacizumab|mesh-list
64755914|NCT01212822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64755915|NCT01212822|Fluorouracil|fluorouracil|mesh-list
64755916|NCT01212822|Oxaliplatin|oxaliplatin|mesh-list
64755917|NCT01212822|Antibodies|antibodies|mesh-list
64755930|NCT01212822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64755931|NCT01212822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64755932|NCT01212822|Antidotes|antidotes|mesh-ancestor
64755933|NCT01212822|Protective Agents|protective agents|mesh-ancestor
64755934|NCT01212822|Vitamin B Complex|vitamin b complex|mesh-ancestor
64755936|NCT01212822|Micronutrients|micronutrients|mesh-ancestor
64755937|NCT00163566|Dihydrotestosterone|dihydrotestosterone|mesh-list
64755938|NCT00163566|Androgens|androgens|mesh-ancestor
64755939|NCT00163566|Hormones|hormones|mesh-ancestor
64755940|NCT00163566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64755941|NCT00163566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755942|NCT04705662|Lactulose|lactulose|mesh-list
64637956|NCT04352621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64637957|NCT04352621|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64637958|NCT04352621|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64637959|NCT04352621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64755943|NCT04705662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64755944|NCT04782960|Bupivacaine|bupivacaine|mesh-list
64755945|NCT04782960|Anesthetics|anesthetics|mesh-list
64755946|NCT04782960|Anesthetics, Local|anesthetics, local|mesh-ancestor
64755947|NCT04782960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64755948|NCT04782960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755949|NCT04782960|Sensory System Agents|sensory system agents|mesh-ancestor
64755950|NCT04782960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64755951|NCT04634604|Bevacizumab|bevacizumab|mesh-list
64755952|NCT04634604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64755953|NCT04634604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755954|NCT04634604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64755955|NCT04634604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64755956|NCT04634604|Growth Substances|growth substances|mesh-ancestor
64755957|NCT04634604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755958|NCT04634604|Growth Inhibitors|growth inhibitors|mesh-ancestor
64755959|NCT01026012|Regadenoson|regadenoson|mesh-list
64755960|NCT01026012|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64755961|NCT01026012|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64755962|NCT01026012|Purinergic Agonists|purinergic agonists|mesh-ancestor
64755963|NCT01026012|Purinergic Agents|purinergic agents|mesh-ancestor
64755964|NCT01026012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64755965|NCT01026012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637999|NCT00186056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64638000|NCT00186056|Contraceptive Agents|contraceptive agents|mesh-ancestor
64638001|NCT00186056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64638002|NCT00186056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64638003|NCT00186056|Hormone Antagonists|hormone antagonists|mesh-ancestor
64638004|NCT00186056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64755966|NCT01026012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755967|NCT02088216|Acetylcysteine|acetylcysteine|mesh-list
64755968|NCT02088216|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64755969|NCT02088216|Antiviral Agents|antiviral agents|mesh-ancestor
64755970|NCT02088216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64755971|NCT02088216|Expectorants|expectorants|mesh-ancestor
64755972|NCT02088216|Respiratory System Agents|respiratory system agents|mesh-ancestor
64755973|NCT02088216|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64755974|NCT02088216|Antioxidants|antioxidants|mesh-ancestor
64755975|NCT02088216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755976|NCT02088216|Protective Agents|protective agents|mesh-ancestor
64755977|NCT02088216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755978|NCT02088216|Antidotes|antidotes|mesh-ancestor
64755979|NCT01014936|Tepotinib|tepotinib|mesh-list
64755980|NCT01014936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755981|NCT01896180|Latanoprost|latanoprost|mesh-list
64755982|NCT01896180|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64755983|NCT01896180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64755984|NCT00981162|Everolimus|everolimus|mesh-list
64755985|NCT00981162|Sorafenib|sorafenib|mesh-list
64638045|NCT00189098|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64638046|NCT00189098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638047|NCT00189098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638048|NCT00189098|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64638049|NCT00189098|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64638050|NCT00189098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64638051|NCT00189098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64638053|NCT00145418|Oxaliplatin|oxaliplatin|mesh-list
64638054|NCT00145418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638055|NCT00145418|Tubulin Modulators|tubulin modulators|mesh-ancestor
64638056|NCT00145418|Antimitotic Agents|antimitotic agents|mesh-ancestor
64755986|NCT00981162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64755987|NCT00981162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64755988|NCT00981162|Immunologic Factors|immunologic factors|mesh-ancestor
64638057|NCT00145418|Mitosis Modulators|mitosis modulators|mesh-ancestor
64755989|NCT00981162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64755990|NCT00981162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64755991|NCT00981162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64755992|NCT00981162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64755993|NCT04756050|Epinephrine|epinephrine|mesh-list
64755994|NCT04756050|Racepinephrine|racepinephrine|mesh-list
64755995|NCT04756050|Bupivacaine|bupivacaine|mesh-list
64755996|NCT04756050|Prilocaine|prilocaine|mesh-list
64756015|NCT04756050|Mydriatics|mydriatics|mesh-ancestor
64756016|NCT04756050|Sympathomimetics|sympathomimetics|mesh-ancestor
64756017|NCT04756050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64756018|NCT00877500|Epothilones|epothilones|mesh-list
64638086|NCT01447225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64756019|NCT00877500|Epothilone B|epothilone b|mesh-list
64638087|NCT01447225|Antimetabolites|antimetabolites|mesh-ancestor
64638088|NCT01447225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638089|NCT01447225|Antiviral Agents|antiviral agents|mesh-ancestor
64638090|NCT01447225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64638091|NCT01447225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638092|NCT01447225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64638093|NCT01447225|Immunologic Factors|immunologic factors|mesh-ancestor
64638094|NCT01447225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638095|NCT01447225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64638096|NCT01447225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64638097|NCT01447849|Lubiprostone|lubiprostone|mesh-list
64756020|NCT00877500|Tubulin Modulators|tubulin modulators|mesh-ancestor
64756021|NCT00877500|Antimitotic Agents|antimitotic agents|mesh-ancestor
64638098|NCT01447849|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64756022|NCT00877500|Mitosis Modulators|mitosis modulators|mesh-ancestor
64756023|NCT00877500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756024|NCT00877500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756025|NCT00875004|Epoetin Alfa|epoetin alfa|mesh-list
64756026|NCT00875004|Hematinics|hematinics|mesh-ancestor
64756027|NCT00869232|Thalidomide|thalidomide|mesh-list
64756028|NCT00869232|Dexamethasone|dexamethasone|mesh-list
64756029|NCT00869232|Cyclophosphamide|cyclophosphamide|mesh-list
64756030|NCT00869232|Melphalan|melphalan|mesh-list
64756031|NCT00869232|Doxorubicin|doxorubicin|mesh-list
64756032|NCT00869232|Etoposide|etoposide|mesh-list
64756033|NCT00869232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64756034|NCT00869232|Bortezomib|bortezomib|mesh-list
64756035|NCT00869232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64638133|NCT01474213|Sensory System Agents|sensory system agents|mesh-ancestor
64638134|NCT01474213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64638135|NCT01474213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64638136|NCT01474213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64638137|NCT01474213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64638138|NCT01474213|Adrenergic Agents|adrenergic agents|mesh-ancestor
64638139|NCT01474213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64638140|NCT01474213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638141|NCT01474213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64638142|NCT01474213|Narcotics|narcotics|mesh-ancestor
64638143|NCT00147212|Trabectedin|trabectedin|mesh-list
64756036|NCT00869232|Immunologic Factors|immunologic factors|mesh-ancestor
64756037|NCT00869232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756038|NCT00869232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64756039|NCT00869232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64445354|NCT03943901|Cyclophosphamide|cyclophosphamide|mesh-list
64756040|NCT00869232|Alkylating Agents|alkylating agents|mesh-ancestor
64756041|NCT00869232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756042|NCT00869232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756066|NCT05320692|Chlorotrianisene|chlorotrianisene|mesh-list
64756067|NCT05320692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756068|NCT05320692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64756069|NCT05320692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756070|NCT05320692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756071|NCT05320692|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64756073|NCT05320692|Hormones|hormones|mesh-ancestor
64756074|NCT05320692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64756075|NCT05320692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756076|NCT05320692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64756077|NCT01763580|Prednisolone|prednisolone|mesh-list
64638184|NCT01474915|Sensory System Agents|sensory system agents|mesh-ancestor
64638185|NCT01899794|Mandelic Acids|mandelic acids|mesh-list
64638186|NCT01899794|Oxybutynin|oxybutynin|mesh-list
64638187|NCT01899794|Parasympatholytics|parasympatholytics|mesh-ancestor
64638188|NCT01899794|Autonomic Agents|autonomic agents|mesh-ancestor
64638189|NCT01899794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64638190|NCT01899794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638191|NCT01899794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64638192|NCT01899794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64638193|NCT01899794|Cholinergic Agents|cholinergic agents|mesh-ancestor
64363465|NCT03302299|Antimetabolites|antimetabolites|mesh-ancestor
64638194|NCT01899794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64756078|NCT01763580|Tacrolimus|tacrolimus|mesh-list
64756079|NCT01763580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64756080|NCT01763580|Immunologic Factors|immunologic factors|mesh-ancestor
64756081|NCT01763580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756082|NCT01763580|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64756083|NCT01763580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756084|NCT01763580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756085|NCT01763580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64756086|NCT01763580|Glucocorticoids|glucocorticoids|mesh-ancestor
64756087|NCT01763580|Hormones|hormones|mesh-ancestor
64756088|NCT01763580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64756091|NCT04780854|Metformin|metformin|mesh-list
64638236|NCT00201734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756116|NCT01740492|Anesthetics, General|anesthetics, general|mesh-ancestor
64756117|NCT01740492|Anesthetics|anesthetics|mesh-ancestor
64756118|NCT01740492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64756119|NCT01740492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64756120|NCT01740492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64756121|NCT01740492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64756122|NCT01740492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756123|NCT04780152|Fluoxetine|fluoxetine|mesh-list
64756124|NCT04780152|Antidepressive Agents|antidepressive agents|mesh-list
64756125|NCT04780152|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64756126|NCT04780152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64756127|NCT04780152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64756128|NCT04780152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756129|NCT04780152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64756130|NCT04780152|Serotonin Agents|serotonin agents|mesh-ancestor
64756131|NCT04780152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756132|NCT04780152|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64756133|NCT04780152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64756134|NCT04780152|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64756135|NCT04780152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64756136|NCT04780152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756137|NCT00644280|Ranibizumab|ranibizumab|mesh-list
64756138|NCT00644280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64756139|NCT00644280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64756140|NCT00644280|Growth Substances|growth substances|mesh-ancestor
64638367|NCT01165541|Histamine Agents|histamine agents|mesh-ancestor
64638368|NCT01165541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64638369|NCT01165541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638370|NCT01165541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64638371|NCT01165541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64638372|NCT01165541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64638373|NCT01165541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64638374|NCT01165541|Adrenergic Agents|adrenergic agents|mesh-ancestor
64638375|NCT01165541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64638376|NCT01165541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64638377|NCT01165541|Serotonin Agents|serotonin agents|mesh-ancestor
64638378|NCT01165541|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64638379|NCT00284180|Trastuzumab|trastuzumab|mesh-list
64638380|NCT00284180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64756141|NCT00644280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756142|NCT00644280|Growth Inhibitors|growth inhibitors|mesh-ancestor
64756143|NCT00644280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756144|NCT04779762|Ustekinumab|ustekinumab|mesh-list
64756159|NCT01722708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756160|NCT01722708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756161|NCT01711632|Vemurafenib|vemurafenib|mesh-list
64756162|NCT01711632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756163|NCT01711632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64756164|NCT01711632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756165|NCT01711632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756166|NCT04756206|Dutasteride|dutasteride|mesh-list
64756167|NCT04756206|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64756168|NCT04756206|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64756169|NCT04756206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756170|NCT04756206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756171|NCT04756206|Hormone Antagonists|hormone antagonists|mesh-ancestor
64756172|NCT04756206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64756173|NCT04756206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756174|NCT04779060|Dexamethasone|dexamethasone|mesh-list
64756175|NCT04779060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64638412|NCT04062656|Vitamins|vitamins|mesh-ancestor
64638413|NCT04062656|Micronutrients|micronutrients|mesh-ancestor
64638414|NCT04062656|Hematinics|hematinics|mesh-ancestor
64638415|NCT00287222|Bevacizumab|bevacizumab|mesh-list
64638416|NCT00287222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64638417|NCT00287222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64638418|NCT00287222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638419|NCT00287222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64363692|NCT04939909|Cholinergic Agents|cholinergic agents|mesh-ancestor
64638420|NCT00287222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64638421|NCT00287222|Growth Substances|growth substances|mesh-ancestor
64638422|NCT00287222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756213|NCT01895400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64756214|NCT01895400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756215|NCT05171946|Vaccines|vaccines|mesh-list
64756216|NCT05171946|Immunologic Factors|immunologic factors|mesh-ancestor
64756217|NCT05171946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756218|NCT05605314|Cyclosporine|cyclosporine|mesh-list
64756219|NCT05605314|Cyclosporins|cyclosporins|mesh-list
64638452|NCT00223262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638453|NCT00223262|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64638454|NCT00223262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64756220|NCT05605314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638455|NCT00223262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64638456|NCT00223262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64756221|NCT05605314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638457|NCT00223262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64638458|NCT00290654|Tamoxifen|tamoxifen|mesh-list
64638459|NCT00290654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64756222|NCT05605314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64756223|NCT05605314|Immunologic Factors|immunologic factors|mesh-ancestor
64756224|NCT05605314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756225|NCT05605314|Antifungal Agents|antifungal agents|mesh-ancestor
64756226|NCT05605314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64756227|NCT05605314|Dermatologic Agents|dermatologic agents|mesh-ancestor
64756228|NCT05605314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64756229|NCT05605314|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64756230|NCT05605158|Pioglitazone|pioglitazone|mesh-list
64756231|NCT05605158|Empagliflozin|empagliflozin|mesh-list
64756232|NCT05605158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64756233|NCT05605158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756234|NCT05605158|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64445380|NCT03943901|Mitosis Modulators|mitosis modulators|mesh-ancestor
64445381|NCT02696993|Nivolumab|nivolumab|mesh-list
64756235|NCT05605158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756236|NCT04775238|Copper|copper|mesh-list
64756237|NCT04775238|Trace Elements|trace elements|mesh-ancestor
64638509|NCT03012113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638510|NCT03012113|Urological Agents|urological agents|mesh-ancestor
64638511|NCT01139801|Misoprostol|misoprostol|mesh-list
64638512|NCT01139801|Oxytocin|oxytocin|mesh-list
64638513|NCT01139801|Oxytocics|oxytocics|mesh-ancestor
64638514|NCT01139801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64638515|NCT01139801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638516|NCT01139801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64638517|NCT01139801|Abortifacient Agents|abortifacient agents|mesh-ancestor
64638518|NCT01139801|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64638519|NCT01139801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64638520|NCT00294632|Rituximab|rituximab|mesh-list
64638521|NCT00294632|Lenalidomide|lenalidomide|mesh-list
64638522|NCT00294632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64638523|NCT00294632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638524|NCT00294632|Immunologic Factors|immunologic factors|mesh-ancestor
64638525|NCT00294632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756238|NCT04775238|Micronutrients|micronutrients|mesh-ancestor
64756239|NCT04775238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756240|NCT05580042|Tofacitinib|tofacitinib|mesh-list
64756241|NCT05580042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64756242|NCT05580042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756243|NCT05580042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756257|NCT03012984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64756258|NCT03012984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64756259|NCT03012984|Adrenergic Agents|adrenergic agents|mesh-ancestor
64756260|NCT03012984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64756261|NCT03012984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756262|NCT03012984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64756263|NCT03012984|Narcotics|narcotics|mesh-ancestor
64756264|NCT02744430|Mirabegron|mirabegron|mesh-list
64756265|NCT02744430|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64756266|NCT02744430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64756267|NCT02744430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64756268|NCT02744430|Adrenergic Agents|adrenergic agents|mesh-ancestor
64756269|NCT02744430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64756270|NCT02744430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756271|NCT02744430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638552|NCT01141049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64756272|NCT02744430|Urological Agents|urological agents|mesh-ancestor
64756273|NCT00054756|Hormones|hormones|mesh-list
64756274|NCT00054756|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
64638553|NCT01141049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638555|NCT01141049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64638556|NCT01141049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64638557|NCT01141049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64638558|NCT01141049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64638559|NCT01141049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64638560|NCT01141049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64638561|NCT01141049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64638562|NCT01141049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638563|NCT01141049|Antimanic Agents|antimanic agents|mesh-ancestor
64638564|NCT01141595|Verapamil|verapamil|mesh-list
64756275|NCT00054756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64756276|NCT00054756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756277|NCT01896960|Fentanyl|fentanyl|mesh-list
64756278|NCT01896960|Bupivacaine|bupivacaine|mesh-list
64756279|NCT01896960|Anesthetics, Local|anesthetics, local|mesh-ancestor
64756280|NCT01896960|Anesthetics|anesthetics|mesh-ancestor
64756281|NCT01896960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64756282|NCT01896960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756283|NCT01896960|Sensory System Agents|sensory system agents|mesh-ancestor
64756284|NCT01896960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64756285|NCT01896960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64756286|NCT01896960|Narcotics|narcotics|mesh-ancestor
64756287|NCT01896960|Analgesics|analgesics|mesh-ancestor
64756288|NCT01896960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64638589|NCT00296192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638590|NCT04312139|Lincomycin|lincomycin|mesh-list
64638591|NCT04312139|Calcium|calcium|mesh-list
64638592|NCT04312139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64638593|NCT04312139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756289|NCT01896960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64756311|NCT00055692|Bevacizumab|bevacizumab|mesh-list
64638599|NCT00297596|Oxaliplatin|oxaliplatin|mesh-list
64756312|NCT00055692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64756313|NCT00055692|Antibodies|antibodies|mesh-list
64756314|NCT00055692|Immunoglobulins|immunoglobulins|mesh-list
64756315|NCT00055692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64756316|NCT00055692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756317|NCT00055692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64756318|NCT00055692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64756319|NCT00055692|Growth Substances|growth substances|mesh-ancestor
64756320|NCT00055692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756321|NCT00055692|Growth Inhibitors|growth inhibitors|mesh-ancestor
64756322|NCT00055692|Immunologic Factors|immunologic factors|mesh-ancestor
64756323|NCT04772352|Febuxostat|febuxostat|mesh-list
64638645|NCT00215930|Docetaxel|docetaxel|mesh-list
64638646|NCT00215930|Vinorelbine|vinorelbine|mesh-list
64638647|NCT00215930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638648|NCT00215930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64638649|NCT00215930|Antimetabolites|antimetabolites|mesh-ancestor
64638650|NCT00215930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756324|NCT04772352|Gout Suppressants|gout suppressants|mesh-ancestor
64756325|NCT04772352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64638651|NCT00215930|Antiviral Agents|antiviral agents|mesh-ancestor
64638652|NCT00215930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64756326|NCT00056472|Olanzapine|olanzapine|mesh-list
64756327|NCT00056472|Sertraline|sertraline|mesh-list
64756328|NCT00056472|Antiemetics|antiemetics|mesh-ancestor
64756329|NCT00056472|Autonomic Agents|autonomic agents|mesh-ancestor
64638698|NCT02101190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638699|NCT02101190|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64756330|NCT00056472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64756331|NCT00056472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756332|NCT00056472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64756333|NCT00056472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64756334|NCT00056472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64756335|NCT00056472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64756336|NCT00056472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64756337|NCT00056472|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64756338|NCT00056472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64756339|NCT00056472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64638700|NCT02101190|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64638701|NCT01170533|Omeprazole|omeprazole|mesh-list
64638702|NCT01170533|Pantoprazole|pantoprazole|mesh-list
64525132|NCT02565628|PF-06669571|pf-06669571|mesh-list
64756342|NCT00056472|Serotonin Agents|serotonin agents|mesh-ancestor
64756346|NCT00056550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64756347|NCT00056550|Protease Inhibitors|protease inhibitors|mesh-ancestor
64756348|NCT00056550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756349|NCT00056550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756350|NCT00056550|Anticoagulants|anticoagulants|mesh-ancestor
64638754|NCT03011567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64638755|NCT03011567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64756351|NCT04771728|Metronidazole|metronidazole|mesh-list
64638756|NCT03011567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64756352|NCT04771728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64756353|NCT04771728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64756354|NCT04771728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64756355|NCT04771728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64756356|NCT04771884|Vancomycin|vancomycin|mesh-list
64756357|NCT04771884|Meropenem|meropenem|mesh-list
64756358|NCT04771884|Ceftriaxone|ceftriaxone|mesh-list
64756359|NCT04771884|Linezolid|linezolid|mesh-list
64756360|NCT04771884|Ceftazidime|ceftazidime|mesh-list
64756361|NCT04771884|Ceftizoxime|ceftizoxime|mesh-list
64756362|NCT04771884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64638826|NCT03011177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64756363|NCT04771884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64756364|NCT04771884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64756365|NCT04771884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638828|NCT03011177|Incretins|incretins|mesh-ancestor
64638829|NCT03011177|Hormones|hormones|mesh-ancestor
64638830|NCT03011177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64638831|NCT03011177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64638832|NCT03011177|Protease Inhibitors|protease inhibitors|mesh-ancestor
64638833|NCT03011177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638834|NCT03011177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638835|NCT03465527|Prednisolone|prednisolone|mesh-list
64638836|NCT03465527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64756366|NCT04771884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756367|NCT04880850|Insulin|insulin|mesh-list
64638837|NCT03465527|Glucocorticoids|glucocorticoids|mesh-ancestor
64638838|NCT03465527|Hormones|hormones|mesh-ancestor
64756369|NCT04880850|Insulin Glargine|insulin glargine|mesh-list
64756399|NCT00060528|Molgramostim|molgramostim|mesh-list
64756400|NCT00060528|Sargramostim|sargramostim|mesh-list
64756401|NCT00060528|Immunologic Factors|immunologic factors|mesh-ancestor
64756402|NCT00060528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756403|NCT00060528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756404|NCT00060528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64756406|NCT00060528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64756407|NCT00060528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64756408|NCT04696224|Tranexamic Acid|tranexamic acid|mesh-list
64756409|NCT04696224|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64756410|NCT04696224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64756411|NCT04696224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756412|NCT04696224|Hemostatics|hemostatics|mesh-ancestor
64756413|NCT04696224|Coagulants|coagulants|mesh-ancestor
64756414|NCT04753008|Dopamine|dopamine|mesh-list
64756415|NCT04753008|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64756416|NCT04753008|Sympathomimetics|sympathomimetics|mesh-ancestor
64756417|NCT04753008|Autonomic Agents|autonomic agents|mesh-ancestor
64756418|NCT04753008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64756419|NCT04753008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756420|NCT04753008|Dopamine Agents|dopamine agents|mesh-ancestor
64756421|NCT04753008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64638874|NCT01220687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638875|NCT01220687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64638876|NCT01220687|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64756422|NCT04753008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756423|NCT04753008|Protective Agents|protective agents|mesh-ancestor
64756424|NCT04771026|Dexamethasone|dexamethasone|mesh-list
64756425|NCT04771026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64756426|NCT04771026|Antiemetics|antiemetics|mesh-ancestor
64756427|NCT04771026|Autonomic Agents|autonomic agents|mesh-ancestor
64756428|NCT04771026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64756429|NCT04771026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756430|NCT04771026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64756432|NCT04771026|Hormones|hormones|mesh-ancestor
64756443|NCT00063570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64756444|NCT00063570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756445|NCT00063570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64756446|NCT00063570|Immunologic Factors|immunologic factors|mesh-ancestor
64756447|NCT00063570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756448|NCT00063570|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64756449|NCT00063570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64638918|NCT01602666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638919|NCT01602666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64756450|NCT01897038|Sorafenib|sorafenib|mesh-list
64638920|NCT01602666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64638940|NCT05441592|Hemostatics|hemostatics|mesh-ancestor
64756451|NCT01897038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756452|NCT01897038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64756453|NCT01897038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756454|NCT01897038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756455|NCT04770792|Chlorhexidine|chlorhexidine|mesh-list
64756456|NCT04770792|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64756457|NCT04770792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64756458|NCT04770792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64756459|NCT04770792|Disinfectants|disinfectants|mesh-ancestor
64756460|NCT04770792|Dermatologic Agents|dermatologic agents|mesh-ancestor
64756461|NCT00064038|Dexamethasone|dexamethasone|mesh-list
64756462|NCT00064038|Lenalidomide|lenalidomide|mesh-list
64638975|NCT00301418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638976|NCT00301418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638977|NCT05414838|Vitamin D|vitamin d|mesh-list
64638978|NCT05414838|Curcumin|curcumin|mesh-list
64638979|NCT05414838|Vitamins|vitamins|mesh-ancestor
64638980|NCT05414838|Micronutrients|micronutrients|mesh-ancestor
64638981|NCT05414838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638982|NCT05414838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64638983|NCT05414838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64638984|NCT05414838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64638985|NCT05414838|Analgesics|analgesics|mesh-ancestor
64756463|NCT00064038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64756464|NCT00064038|Antiemetics|antiemetics|mesh-ancestor
64756465|NCT00064038|Autonomic Agents|autonomic agents|mesh-ancestor
64756466|NCT00064038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64756467|NCT00064038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756468|NCT00064038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64756469|NCT00064038|Glucocorticoids|glucocorticoids|mesh-ancestor
64756470|NCT00064038|Hormones|hormones|mesh-ancestor
64756471|NCT00064038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64756472|NCT00064038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64756473|NCT00064038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756487|NCT01960530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64756488|NCT01960530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756489|NCT01960530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64756490|NCT01960530|Glucocorticoids|glucocorticoids|mesh-ancestor
64756492|NCT01960530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64756493|NCT01960530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64756494|NCT01960530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756495|NCT01897428|Bepotastine besilate|bepotastine besilate|mesh-list
64756496|NCT01897428|Salicylates|salicylates|mesh-list
64756497|NCT01897428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64756498|NCT01897428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64756499|NCT01897428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64756500|NCT01897428|Analgesics|analgesics|mesh-ancestor
64639031|NCT00239642|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64639032|NCT00239642|Trace Elements|trace elements|mesh-ancestor
64639033|NCT00239642|Micronutrients|micronutrients|mesh-ancestor
64639034|NCT00239642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639035|NCT00239642|Hematinics|hematinics|mesh-ancestor
64639036|NCT01351896|Lenalidomide|lenalidomide|mesh-list
64639037|NCT01351896|Vaccines|vaccines|mesh-list
64639038|NCT01351896|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64639039|NCT01351896|Immunologic Factors|immunologic factors|mesh-ancestor
64639040|NCT01351896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639041|NCT01351896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64639042|NCT01351896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64639043|NCT01351896|Growth Substances|growth substances|mesh-ancestor
64639044|NCT01351896|Growth Inhibitors|growth inhibitors|mesh-ancestor
64639045|NCT01351896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639046|NCT00241904|Propranolol|propranolol|mesh-list
64639047|NCT00241904|Metoprolol|metoprolol|mesh-list
64639048|NCT00241904|Atenolol|atenolol|mesh-list
64639049|NCT00241904|Lisinopril|lisinopril|mesh-list
64639050|NCT00241904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64756501|NCT01897428|Sensory System Agents|sensory system agents|mesh-ancestor
64756502|NCT01897428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64756503|NCT01897428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756504|NCT01897428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64756505|NCT01897428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64756506|NCT01897428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64756507|NCT01897428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639063|NCT00241904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639064|NCT00241904|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64639065|NCT00241904|Protease Inhibitors|protease inhibitors|mesh-ancestor
64639066|NCT00241904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639067|NCT00241904|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64639068|NCT00241904|Protective Agents|protective agents|mesh-ancestor
64756508|NCT01897428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756509|NCT00024102|Doxorubicin|doxorubicin|mesh-list
64756519|NCT00074802|Paroxetine|paroxetine|mesh-list
64756535|NCT02505750|Antimetabolites|antimetabolites|mesh-ancestor
64756536|NCT02505750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756537|NCT02505750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756538|NCT00030264|Methotrexate|methotrexate|mesh-list
64756539|NCT00030264|Vinblastine|vinblastine|mesh-list
64756540|NCT00030264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64756541|NCT00030264|Abortifacient Agents|abortifacient agents|mesh-ancestor
64756542|NCT00030264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64756543|NCT00030264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756544|NCT00030264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64756545|NCT00030264|Antimetabolites|antimetabolites|mesh-ancestor
64756546|NCT00030264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756547|NCT00030264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639125|NCT01791374|Immunologic Factors|immunologic factors|mesh-ancestor
64639126|NCT01791374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639127|NCT03783416|Ixazomib|ixazomib|mesh-list
64639128|NCT03783416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639129|NCT03783416|Protease Inhibitors|protease inhibitors|mesh-ancestor
64639130|NCT03783416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639135|NCT00248534|Prednisolone|prednisolone|mesh-list
64756548|NCT00030264|Dermatologic Agents|dermatologic agents|mesh-ancestor
64756549|NCT00030264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756550|NCT00030264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64756551|NCT00030264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64756592|NCT00036738|Antitubercular Agents|antitubercular agents|mesh-ancestor
64756593|NCT00036738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64756594|NCT00036738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64756595|NCT00038610|Cytarabine|cytarabine|mesh-list
64756596|NCT00038610|Dexamethasone|dexamethasone|mesh-list
64756597|NCT00038610|Cyclophosphamide|cyclophosphamide|mesh-list
64756598|NCT00038610|Doxorubicin|doxorubicin|mesh-list
64756599|NCT00038610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64756600|NCT00038610|Methotrexate|methotrexate|mesh-list
64756601|NCT00038610|Vincristine|vincristine|mesh-list
64639177|NCT05266820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64756602|NCT00038610|Imatinib Mesylate|imatinib mesylate|mesh-list
64639178|NCT05266820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64639196|NCT02099006|Ketoprofen|ketoprofen|mesh-list
64756603|NCT00038610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64756604|NCT00038610|Immunologic Factors|immunologic factors|mesh-ancestor
64756605|NCT00038610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756606|NCT00038610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64756607|NCT00038610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64756608|NCT00038610|Alkylating Agents|alkylating agents|mesh-ancestor
64756609|NCT00038610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756610|NCT00038610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756611|NCT00038610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64756612|NCT00038610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64756613|NCT00038610|Antiemetics|antiemetics|mesh-ancestor
64756614|NCT00038610|Autonomic Agents|autonomic agents|mesh-ancestor
64756615|NCT00038610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64756616|NCT00038610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64756617|NCT00038610|Glucocorticoids|glucocorticoids|mesh-ancestor
64756618|NCT00038610|Hormones|hormones|mesh-ancestor
64756619|NCT00038610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64756620|NCT00038610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64756621|NCT00038610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64756629|NCT00038610|Antimetabolites|antimetabolites|mesh-ancestor
64756636|NCT00038610|Tubulin Modulators|tubulin modulators|mesh-ancestor
64756637|NCT00038610|Antimitotic Agents|antimitotic agents|mesh-ancestor
64639236|NCT02099006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64639238|NCT02099006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64639239|NCT05266274|Azacitidine|azacitidine|mesh-list
64639241|NCT05266274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64639242|NCT05266274|Immunologic Factors|immunologic factors|mesh-ancestor
64639243|NCT05266274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639244|NCT05266274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64756638|NCT00038610|Mitosis Modulators|mitosis modulators|mesh-ancestor
64756639|NCT00038610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64756640|NCT00156936|Naltrexone|naltrexone|mesh-list
64756641|NCT00156936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64756642|NCT00156936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64756643|NCT00156936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756644|NCT00156936|Sensory System Agents|sensory system agents|mesh-ancestor
64756645|NCT00156936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639284|NCT01480219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64639285|NCT01480219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639286|NCT01480219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639287|NCT01480219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64756646|NCT00046566|Caseins|caseins|mesh-list
64756647|NCT00046566|Chelating Agents|chelating agents|mesh-ancestor
64756649|NCT00046566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756650|NCT00079326|Trastuzumab|trastuzumab|mesh-list
64756651|NCT00079326|Epothilone B|epothilone b|mesh-list
64756652|NCT00079326|Epothilones|epothilones|mesh-list
64756653|NCT00079326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64639289|NCT01480219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64639292|NCT01480297|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
64756654|NCT00079326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756655|NCT00079326|Tubulin Modulators|tubulin modulators|mesh-ancestor
64756656|NCT00079326|Antimitotic Agents|antimitotic agents|mesh-ancestor
64756657|NCT00079326|Mitosis Modulators|mitosis modulators|mesh-ancestor
64756658|NCT00079326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756659|NCT02187354|Blinatumomab|blinatumomab|mesh-list
64756660|NCT02187354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756661|NCT01898052|Anesthetics|anesthetics|mesh-list
64639339|NCT01393717|Immunoconjugates|immunoconjugates|mesh-list
64639340|NCT01393717|Immunologic Factors|immunologic factors|mesh-ancestor
64639341|NCT01393717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639342|NCT01393717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64639343|NCT01393717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639344|NCT01460875|Interferons|interferons|mesh-list
64639352|NCT01481545|Leucovorin|leucovorin|mesh-list
64756662|NCT01898052|Levobupivacaine|levobupivacaine|mesh-list
64756663|NCT01898052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64756664|NCT01898052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756665|NCT01898052|Anesthetics, Local|anesthetics, local|mesh-ancestor
64756666|NCT01898052|Sensory System Agents|sensory system agents|mesh-ancestor
64756667|NCT01898052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64756668|NCT00051168|Travoprost|travoprost|mesh-list
64756670|NCT00083382|Pamidronate|pamidronate|mesh-list
64756681|NCT00083382|Growth Inhibitors|growth inhibitors|mesh-ancestor
64756682|NCT00083382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756683|NCT00083382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64756684|NCT00167544|Hydrocortisone|hydrocortisone|mesh-list
64756685|NCT00167544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64756686|NCT00167934|Valproic Acid|valproic acid|mesh-list
64756687|NCT00167934|Anticonvulsants|anticonvulsants|mesh-ancestor
64756688|NCT00167934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756689|NCT00167934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756690|NCT00167934|GABA Agents|gaba agents|mesh-ancestor
64756691|NCT00167934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64756692|NCT00167934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756693|NCT00167934|Antimanic Agents|antimanic agents|mesh-ancestor
64756694|NCT00167934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64756695|NCT00167934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64756696|NCT00167934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64756697|NCT00168324|Dexamethasone|dexamethasone|mesh-list
64756698|NCT00168324|Dexamethasone acetate|dexamethasone acetate|mesh-list
64756699|NCT00168324|BB 1101|bb 1101|mesh-list
64756700|NCT00168324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64756701|NCT00168324|Antiemetics|antiemetics|mesh-ancestor
64756702|NCT00168324|Autonomic Agents|autonomic agents|mesh-ancestor
64756703|NCT00168324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64756704|NCT00168324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756705|NCT00168324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64756706|NCT00168324|Glucocorticoids|glucocorticoids|mesh-ancestor
64756707|NCT00168324|Hormones|hormones|mesh-ancestor
64756708|NCT00168324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64756709|NCT00168324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64756728|NCT02091882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64756729|NCT02091882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64756730|NCT02091882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64756731|NCT02091882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64756732|NCT00085254|Temozolomide|temozolomide|mesh-list
64756733|NCT00085254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64756734|NCT00085254|Alkylating Agents|alkylating agents|mesh-ancestor
64756735|NCT00085254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756736|NCT00085254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756737|NCT00253890|Trazodone|trazodone|mesh-list
64756738|NCT00253890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64756739|NCT00253890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64756740|NCT00253890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64756741|NCT00253890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756742|NCT00253890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64756743|NCT00253890|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64756744|NCT00253890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64756745|NCT00253890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64756746|NCT00253890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639450|NCT02108288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639451|NCT02108288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639452|NCT02108288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64639453|NCT02108288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64639454|NCT02108288|Sympatholytics|sympatholytics|mesh-ancestor
64639455|NCT02108288|Autonomic Agents|autonomic agents|mesh-ancestor
64639456|NCT02108288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639457|NCT02106494|Dexamethasone|dexamethasone|mesh-list
64639458|NCT02106494|Ondansetron|ondansetron|mesh-list
64639459|NCT02106494|Fosaprepitant|fosaprepitant|mesh-list
64639460|NCT02106494|Aprepitant|aprepitant|mesh-list
64639461|NCT02106494|Granisetron|granisetron|mesh-list
64639462|NCT02106494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64639463|NCT02106494|Antiemetics|antiemetics|mesh-ancestor
64639464|NCT02106494|Autonomic Agents|autonomic agents|mesh-ancestor
64639465|NCT02106494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64756747|NCT00253890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64756748|NCT00253890|Serotonin Agents|serotonin agents|mesh-ancestor
64756749|NCT00253890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64756750|NCT00253890|Antidepressive Agents|antidepressive agents|mesh-ancestor
64756751|NCT00254592|Paclitaxel|paclitaxel|mesh-list
64639488|NCT00335504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64639489|NCT00335504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639490|NCT00335504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64639491|NCT00335504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64639492|NCT00335504|Antimetabolites|antimetabolites|mesh-ancestor
64756752|NCT00254592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64756753|NCT00254592|Cyclophosphamide|cyclophosphamide|mesh-list
64756754|NCT00254592|Bevacizumab|bevacizumab|mesh-list
64756755|NCT00254592|Carboplatin|carboplatin|mesh-list
64756756|NCT00254592|Doxorubicin|doxorubicin|mesh-list
64756757|NCT00254592|Trastuzumab|trastuzumab|mesh-list
64756758|NCT00254592|Sargramostim|sargramostim|mesh-list
64756759|NCT00254592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64639493|NCT00335504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364857|NCT03284749|Copper|copper|mesh-list
64756760|NCT00254592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756767|NCT00254592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756769|NCT00254592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64756770|NCT00254592|Alkylating Agents|alkylating agents|mesh-ancestor
64756771|NCT00254592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64756772|NCT00254592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64756773|NCT00254592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64756774|NCT00254592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64445421|NCT02530463|Nivolumab|nivolumab|mesh-list
64756776|NCT00254592|Growth Inhibitors|growth inhibitors|mesh-ancestor
64756777|NCT00254592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64756778|NCT00254592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64756779|NCT00254592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64756780|NCT00254592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756781|NCT00255684|Cyclosporine|cyclosporine|mesh-list
64756782|NCT00255684|Mycophenolic Acid|mycophenolic acid|mesh-list
64756783|NCT00255684|Cyclophosphamide|cyclophosphamide|mesh-list
64639549|NCT01184417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64639550|NCT01184417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64639551|NCT01184417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64639552|NCT01159067|Deferasirox|deferasirox|mesh-list
64639596|NCT01225055|Teriparatide|teriparatide|mesh-list
64756784|NCT00255684|Fludarabine|fludarabine|mesh-list
64756785|NCT00255684|Fludarabine phosphate|fludarabine phosphate|mesh-list
64756786|NCT00255684|Cyclosporins|cyclosporins|mesh-list
64756787|NCT00255684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64756788|NCT00255684|Immunologic Factors|immunologic factors|mesh-ancestor
64756789|NCT00255684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756790|NCT00255684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64756791|NCT00255684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64756817|NCT00256776|Hormones|hormones|mesh-ancestor
64756818|NCT00256776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64756820|NCT00256776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639639|NCT01225289|Antioxidants|antioxidants|mesh-ancestor
64639640|NCT01225289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756889|NCT00179478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756890|NCT00179478|Antiviral Agents|antiviral agents|mesh-ancestor
64756891|NCT00179478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64756892|NCT00179478|Immunologic Factors|immunologic factors|mesh-ancestor
64639641|NCT01225289|Protective Agents|protective agents|mesh-ancestor
64756893|NCT00179478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756894|NCT00179478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64756895|NCT00182754|Octreotide|octreotide|mesh-list
64756896|NCT00182754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64756897|NCT00182754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64756898|NCT00182754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756899|NCT00085410|Bortezomib|bortezomib|mesh-list
64756900|NCT00085410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756901|NCT00186498|Memantine|memantine|mesh-list
64756902|NCT00186498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64756903|NCT00186498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64756904|NCT00186498|Dopamine Agents|dopamine agents|mesh-ancestor
64639696|NCT01191749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639697|NCT00343460|Dexamethasone|dexamethasone|mesh-list
64639698|NCT00343460|Palonosetron|palonosetron|mesh-list
64639699|NCT00343460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64639700|NCT00343460|Antiemetics|antiemetics|mesh-ancestor
64639701|NCT00343460|Autonomic Agents|autonomic agents|mesh-ancestor
64639702|NCT00343460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639703|NCT00343460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756905|NCT00186498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64639708|NCT00343460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64756906|NCT00186498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756907|NCT00186498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756908|NCT00186498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64756909|NCT00186498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64756910|NCT00265200|Zoledronic Acid|zoledronic acid|mesh-list
64756913|NCT00087672|Lenalidomide|lenalidomide|mesh-list
64756914|NCT00087672|Immunologic Factors|immunologic factors|mesh-ancestor
64756915|NCT00087672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64756916|NCT00087672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64756917|NCT00087672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64756918|NCT00087672|Growth Substances|growth substances|mesh-ancestor
64756919|NCT00087672|Growth Inhibitors|growth inhibitors|mesh-ancestor
64639756|NCT01283555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64756933|NCT00189228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64756934|NCT00189228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64639757|NCT01194089|Nicotine|nicotine|mesh-list
64639758|NCT01194089|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64639759|NCT01194089|Autonomic Agents|autonomic agents|mesh-ancestor
64639760|NCT01194089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365064|NCT03107923|Dobutamine|dobutamine|mesh-list
64639761|NCT01194089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639762|NCT01194089|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64639763|NCT01194089|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64639764|NCT01194089|Cholinergic Agents|cholinergic agents|mesh-ancestor
64756935|NCT00189228|Respiratory System Agents|respiratory system agents|mesh-ancestor
64756936|NCT00091260|Dexamethasone|dexamethasone|mesh-list
64756937|NCT00091260|Dexamethasone acetate|dexamethasone acetate|mesh-list
64756938|NCT00091260|Lenalidomide|lenalidomide|mesh-list
64756939|NCT00091260|BB 1101|bb 1101|mesh-list
64756940|NCT00091260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64756941|NCT00091260|Antiemetics|antiemetics|mesh-ancestor
64756942|NCT00091260|Autonomic Agents|autonomic agents|mesh-ancestor
64756943|NCT00091260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64756944|NCT00091260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639808|NCT00305084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64756945|NCT00091260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64756946|NCT00091260|Glucocorticoids|glucocorticoids|mesh-ancestor
64756947|NCT00091260|Hormones|hormones|mesh-ancestor
64525733|NCT02393586|Leprostatic Agents|leprostatic agents|mesh-ancestor
64756948|NCT00091260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64756949|NCT00091260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64756950|NCT00091260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64756959|NCT00193128|Docetaxel|docetaxel|mesh-list
64756989|NCT00193596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64756990|NCT00193596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64756991|NCT00194532|Ciprofloxacin|ciprofloxacin|mesh-list
64756992|NCT00194532|Cefpodoxime|cefpodoxime|mesh-list
64756993|NCT00194532|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
64756994|NCT00194532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64756995|NCT00194532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64756996|NCT00194532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64756997|NCT00194532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64756998|NCT00194532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64756999|NCT00194532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757000|NCT00194532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757001|NCT00194532|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64757002|NCT00194532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64757003|NCT00194610|Botulinum Toxins|botulinum toxins|mesh-list
64757004|NCT00194610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64757005|NCT00194610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64639868|NCT00306488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639869|NCT01793636|Everolimus|everolimus|mesh-list
64639870|NCT01793636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639871|NCT01793636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64639872|NCT01793636|Immunologic Factors|immunologic factors|mesh-ancestor
64639873|NCT01793636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639874|NCT00353522|Dalcetrapib|dalcetrapib|mesh-list
64639875|NCT00353522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64639876|NCT00353522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64639877|NCT00353522|Antimetabolites|antimetabolites|mesh-ancestor
64639878|NCT00353522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757006|NCT00194610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64757007|NCT00194610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757008|NCT00194610|Cholinergic Agents|cholinergic agents|mesh-ancestor
64757009|NCT00194610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64757041|NCT04118556|Sensory System Agents|sensory system agents|mesh-ancestor
64757042|NCT04118556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64757043|NCT04118556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64757044|NCT00267696|Gemcitabine|gemcitabine|mesh-list
64757045|NCT00267696|Bevacizumab|bevacizumab|mesh-list
64757046|NCT00267696|Carboplatin|carboplatin|mesh-list
64757047|NCT00267696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64757048|NCT00267696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757049|NCT00267696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64757050|NCT00267696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64757051|NCT00267696|Growth Substances|growth substances|mesh-ancestor
64757052|NCT00267696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757053|NCT00267696|Growth Inhibitors|growth inhibitors|mesh-ancestor
64757054|NCT00267696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64757055|NCT00267696|Antimetabolites|antimetabolites|mesh-ancestor
64639914|NCT00354224|Capecitabine|capecitabine|mesh-list
64639915|NCT00354224|Oxaliplatin|oxaliplatin|mesh-list
64639916|NCT00354224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64639918|NCT00354224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639919|NCT00354224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639920|NCT01792388|Vitamin D|vitamin d|mesh-list
64639921|NCT01792388|Vitamins|vitamins|mesh-ancestor
64639922|NCT01792388|Micronutrients|micronutrients|mesh-ancestor
64639923|NCT01792388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639924|NCT01792388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64639925|NCT05395104|Midazolam|midazolam|mesh-list
64639926|NCT05395104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64639930|NCT05395104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64757056|NCT00267696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757057|NCT00267696|Antiviral Agents|antiviral agents|mesh-ancestor
64757058|NCT00267696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64757059|NCT00267696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757060|NCT00267696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64757061|NCT00267696|Immunologic Factors|immunologic factors|mesh-ancestor
64757062|NCT00195624|Cyclosporine|cyclosporine|mesh-list
64757063|NCT00195624|Alemtuzumab|alemtuzumab|mesh-list
64757064|NCT00195624|Cyclosporins|cyclosporins|mesh-list
64757094|NCT00098670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64757095|NCT00098670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64757096|NCT00098670|Antimetabolites|antimetabolites|mesh-ancestor
64757097|NCT00098670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757098|NCT00098670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64757101|NCT00201864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64757102|NCT00201864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757103|NCT00201864|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64757104|NCT00201864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64639960|NCT00355394|Antiemetics|antiemetics|mesh-ancestor
64639961|NCT00355394|Autonomic Agents|autonomic agents|mesh-ancestor
64639962|NCT00355394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639963|NCT00355394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639964|NCT00355394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64639965|NCT00355394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64639966|NCT00355394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64639967|NCT00355394|Dopamine Agents|dopamine agents|mesh-ancestor
64639968|NCT00355394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64639969|NCT00355394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639971|NCT00311246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64639972|NCT00311246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64639973|NCT02105324|Pancrelipase|pancrelipase|mesh-list
64757105|NCT00201864|Hormone Antagonists|hormone antagonists|mesh-ancestor
64757106|NCT00201864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64757107|NCT00201864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757152|NCT00106392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64757153|NCT00106392|Immunologic Factors|immunologic factors|mesh-ancestor
64757154|NCT00106392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757155|NCT00106392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64757156|NCT00106392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640006|NCT01792700|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64640007|NCT01792700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64640008|NCT01792700|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64640009|NCT01792700|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64640010|NCT00315302|Atropine|atropine|mesh-list
64640011|NCT00315302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64640012|NCT00315302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64640013|NCT00315302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64640014|NCT00315302|Autonomic Agents|autonomic agents|mesh-ancestor
64640015|NCT00315302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64757157|NCT00106392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757159|NCT00211692|Ribavirin|ribavirin|mesh-list
64757160|NCT00211692|Interferon-alpha|interferon-alpha|mesh-list
64757161|NCT00211692|Interferon alfacon-1|interferon alfacon-1|mesh-list
64757162|NCT00211692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757163|NCT00211692|Antiviral Agents|antiviral agents|mesh-ancestor
64757164|NCT00211692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64757165|NCT00211692|Antimetabolites|antimetabolites|mesh-ancestor
64757166|NCT00211692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757167|NCT00211692|Immunologic Factors|immunologic factors|mesh-ancestor
64757168|NCT00211692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757169|NCT01899690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64757170|NCT01899690|Clindamycin|clindamycin|mesh-list
64757171|NCT01899690|Cephalexin|cephalexin|mesh-list
64757172|NCT01899690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64757173|NCT01899690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64640065|NCT00980460|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
64640066|NCT00980460|Liver Extracts|liver extracts|mesh-list
64640067|NCT00980460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640068|NCT00980460|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64640069|NCT00980460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64640070|NCT00980460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64640072|NCT00980460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640073|NCT00980460|Antimetabolites|antimetabolites|mesh-ancestor
64640074|NCT00980460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64640075|NCT00980460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64640076|NCT00980460|Immunologic Factors|immunologic factors|mesh-ancestor
64640077|NCT00980460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640078|NCT00980460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64757174|NCT01899690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757175|NCT01899690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757176|NCT01899846|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
64757177|NCT01899846|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
64757178|NCT01899846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64757179|NCT01899846|Hormone Antagonists|hormone antagonists|mesh-ancestor
64445439|NCT05494619|Immunologic Factors|immunologic factors|mesh-ancestor
64757198|NCT00216060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64757199|NCT00216060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757200|NCT00216060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64757202|NCT00282282|Fludarabine|fludarabine|mesh-list
64640111|NCT00366626|Naltrexone|naltrexone|mesh-list
64640112|NCT00366626|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64640113|NCT00366626|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64640114|NCT00366626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640115|NCT00366626|Sensory System Agents|sensory system agents|mesh-ancestor
64640116|NCT00366626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64640117|NCT00367016|Omalizumab|omalizumab|mesh-list
64640118|NCT00367016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64640119|NCT00367016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64640120|NCT00367016|Respiratory System Agents|respiratory system agents|mesh-ancestor
64757203|NCT00282282|Busulfan|busulfan|mesh-list
64757204|NCT00282282|Tacrolimus|tacrolimus|mesh-list
64757205|NCT00282282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757206|NCT00282282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757207|NCT00282282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64757208|NCT00282282|Immunologic Factors|immunologic factors|mesh-ancestor
64757209|NCT00282282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757210|NCT00282282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64757211|NCT00282282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757212|NCT00282282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64757213|NCT00282282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64757214|NCT00282282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64757215|NCT00282282|Antifungal Agents|antifungal agents|mesh-ancestor
64757216|NCT00282282|Alkylating Agents|alkylating agents|mesh-ancestor
64757217|NCT00282282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64640169|NCT00369512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640170|NCT00324272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64640171|NCT00324272|Hemostatics|hemostatics|mesh-ancestor
64640172|NCT00324272|Coagulants|coagulants|mesh-ancestor
64640173|NCT05367492|Varenicline|varenicline|mesh-list
64640174|NCT05367492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64640175|NCT05367492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64640176|NCT05367492|Cholinergic Agents|cholinergic agents|mesh-ancestor
64640177|NCT05367492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64640178|NCT05367492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640179|NCT05367492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640180|NCT00369590|Aflibercept|aflibercept|mesh-list
64640182|NCT00369590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64640184|NCT00369590|Growth Substances|growth substances|mesh-ancestor
64757218|NCT00282282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64757219|NCT00282828|Clonazepam|clonazepam|mesh-list
64757220|NCT00282828|Sertraline|sertraline|mesh-list
64757221|NCT00282828|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64757222|NCT00282828|Antidepressive Agents|antidepressive agents|mesh-ancestor
64757223|NCT00282828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64757224|NCT00282828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64757225|NCT00282828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64757226|NCT00282828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64757227|NCT00282828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757241|NCT00223236|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64757242|NCT00223236|Lipotropic Agents|lipotropic agents|mesh-ancestor
64757243|NCT00223236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64640216|NCT05366868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640217|NCT05366868|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64640218|NCT05366868|Protease Inhibitors|protease inhibitors|mesh-ancestor
64640219|NCT05366868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640220|NCT05366868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640221|NCT00369746|Citalopram|citalopram|mesh-list
64640222|NCT00369746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64640223|NCT00369746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64640224|NCT00369746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64640225|NCT00369746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640238|NCT05329428|Vitamin D|vitamin d|mesh-list
64757244|NCT00223236|Antimetabolites|antimetabolites|mesh-ancestor
64757245|NCT00223236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757246|NCT00223236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64757247|NCT00223236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64757248|NCT00223236|Nootropic Agents|nootropic agents|mesh-ancestor
64757249|NCT00223704|Icatibant|icatibant|mesh-list
64757250|NCT00223704|Aminocaproic Acid|aminocaproic acid|mesh-list
64757251|NCT00223704|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64757252|NCT00223704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64757253|NCT00223704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757254|NCT00223704|Hemostatics|hemostatics|mesh-ancestor
64757255|NCT00223704|Coagulants|coagulants|mesh-ancestor
64757256|NCT00223704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64757257|NCT00223704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64757258|NCT00223704|Analgesics|analgesics|mesh-ancestor
64757259|NCT00223704|Sensory System Agents|sensory system agents|mesh-ancestor
64757260|NCT00223704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64757261|NCT00223704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757262|NCT00223704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64757263|NCT00223704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64757264|NCT00223704|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
64757265|NCT00223704|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
64640267|NCT05385432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640268|NCT05385432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64640269|NCT05385432|Antitubercular Agents|antitubercular agents|mesh-ancestor
64640270|NCT05385432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64640271|NCT05385432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64640272|NCT00392444|Sunitinib|sunitinib|mesh-list
64640273|NCT00392444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640274|NCT00392444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64640276|NCT00392444|Growth Substances|growth substances|mesh-ancestor
64445471|NCT01634555|Vitamins|vitamins|mesh-ancestor
64757266|NCT00223704|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64757267|NCT00223704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64757268|NCT00223704|Immunologic Factors|immunologic factors|mesh-ancestor
64757269|NCT00224952|Carbamazepine|carbamazepine|mesh-list
64757286|NCT00224952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64757287|NCT00224952|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64757288|NCT00224952|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64757289|NCT00225420|Docetaxel|docetaxel|mesh-list
64757290|NCT00225420|Leuprolide|leuprolide|mesh-list
64757291|NCT00225420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757292|NCT00225420|Tubulin Modulators|tubulin modulators|mesh-ancestor
64757293|NCT00225420|Antimitotic Agents|antimitotic agents|mesh-ancestor
64757294|NCT00225420|Mitosis Modulators|mitosis modulators|mesh-ancestor
64757295|NCT00225420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757296|NCT00225420|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64757297|NCT00225420|Fertility Agents|fertility agents|mesh-ancestor
64757298|NCT00225420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64757299|NCT00225420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757300|NCT00225420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64757301|NCT00225498|Olanzapine|olanzapine|mesh-list
64757302|NCT00225498|Risperidone|risperidone|mesh-list
64757303|NCT00225498|Ziprasidone|ziprasidone|mesh-list
64757304|NCT00225498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64757305|NCT00225498|Serotonin Agents|serotonin agents|mesh-ancestor
64757306|NCT00225498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64640310|NCT00392678|Sensory System Agents|sensory system agents|mesh-ancestor
64640311|NCT00392678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64640312|NCT00392678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640313|NCT00392678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64640314|NCT00392678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64640315|NCT00392678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64640316|NCT00392678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640317|NCT00392678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640318|NCT00392834|Leucovorin|leucovorin|mesh-list
64640319|NCT00392834|Cytarabine|cytarabine|mesh-list
64640320|NCT00392834|Hydrocortisone|hydrocortisone|mesh-list
64640321|NCT00392834|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64640322|NCT00392834|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64640323|NCT00392834|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64640324|NCT00392834|Cyclophosphamide|cyclophosphamide|mesh-list
64640326|NCT00392834|Rituximab|rituximab|mesh-list
64640327|NCT00392834|Doxorubicin|doxorubicin|mesh-list
64640328|NCT00392834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64640329|NCT00392834|Methotrexate|methotrexate|mesh-list
64640330|NCT00392834|Etoposide|etoposide|mesh-list
64640331|NCT00392834|Vincristine|vincristine|mesh-list
64640332|NCT00392834|Levoleucovorin|levoleucovorin|mesh-list
64757307|NCT00225498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757308|NCT00225498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757309|NCT00225498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64757310|NCT00225498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64757311|NCT00225498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64757312|NCT00225498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64757313|NCT00225498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64757314|NCT00225498|Dopamine Agents|dopamine agents|mesh-ancestor
64640342|NCT00392834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64640343|NCT00392834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64757315|NCT00225498|Antiemetics|antiemetics|mesh-ancestor
64640344|NCT00392834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64640345|NCT00392834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64640346|NCT00392834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757316|NCT00225498|Autonomic Agents|autonomic agents|mesh-ancestor
64757317|NCT00225498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64757318|NCT00225498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64757319|NCT00225498|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64757320|NCT00225498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64757321|NCT00225498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64757324|NCT00225732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64757325|NCT00225732|Analgesics|analgesics|mesh-ancestor
64757326|NCT00225732|Sensory System Agents|sensory system agents|mesh-ancestor
64526111|NCT01692197|Antimetabolites|antimetabolites|mesh-ancestor
64757327|NCT00225732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64757328|NCT00225732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757329|NCT00225732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64757330|NCT00225732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64757331|NCT00225732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64757332|NCT00225732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757333|NCT00225732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757334|NCT02096718|Afatinib|afatinib|mesh-list
64757335|NCT02096718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757336|NCT02096718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64757337|NCT02096718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757338|NCT02096718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757339|NCT02097732|Ipilimumab|ipilimumab|mesh-list
64757340|NCT02097732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64640401|NCT05361642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64640402|NCT05361642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640403|NCT05361642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64640404|NCT05361642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64640406|NCT05361642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64640407|NCT05361642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64640408|NCT05361642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64640409|NCT05361642|Adrenergic Agents|adrenergic agents|mesh-ancestor
64757341|NCT02097732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757342|NCT02097732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64757343|NCT02097732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757344|NCT00286182|Epoetin Alfa|epoetin alfa|mesh-list
64757345|NCT00286182|Hematinics|hematinics|mesh-ancestor
64757346|NCT00226590|Gemcitabine|gemcitabine|mesh-list
64757347|NCT00226590|Paclitaxel|paclitaxel|mesh-list
64757348|NCT00226590|Carboplatin|carboplatin|mesh-list
64757349|NCT00226590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64757350|NCT00226590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757351|NCT00226590|Tubulin Modulators|tubulin modulators|mesh-ancestor
64640446|NCT02277782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64640447|NCT02277782|Anesthetics, General|anesthetics, general|mesh-ancestor
64640448|NCT05287100|Midodrine|midodrine|mesh-list
64640449|NCT05287100|Sympathomimetics|sympathomimetics|mesh-ancestor
64640450|NCT05287100|Autonomic Agents|autonomic agents|mesh-ancestor
64640451|NCT05287100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64640452|NCT05287100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640453|NCT05287100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64640454|NCT05287100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64757352|NCT00226590|Antimitotic Agents|antimitotic agents|mesh-ancestor
64640460|NCT02271230|Vitamin D|vitamin d|mesh-list
64757353|NCT00226590|Mitosis Modulators|mitosis modulators|mesh-ancestor
64757363|NCT00114114|Goserelin|goserelin|mesh-list
64757367|NCT00114114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64757368|NCT00114114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757369|NCT00114114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64757370|NCT00114114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757371|NCT00227760|Cediranib|cediranib|mesh-list
64757372|NCT00227760|Maleic acid|maleic acid|mesh-list
64757373|NCT00227760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757374|NCT00227760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757375|NCT00227760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757376|NCT00227760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64757377|NCT00227994|Donepezil|donepezil|mesh-list
64757378|NCT00227994|Galantamine|galantamine|mesh-list
64757379|NCT00227994|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64757380|NCT00227994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757381|NCT00227994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757382|NCT00227994|Cholinergic Agents|cholinergic agents|mesh-ancestor
64757383|NCT00227994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64757384|NCT00227994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640502|NCT00396266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64640503|NCT04271384|Nivolumab|nivolumab|mesh-list
64640504|NCT04271384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64640505|NCT04271384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640506|NCT04271384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64640507|NCT04271384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640508|NCT05610384|Ibuprofen|ibuprofen|mesh-list
64640509|NCT05610384|Ketorolac|ketorolac|mesh-list
64640510|NCT05610384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64640511|NCT05610384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64640512|NCT05610384|Analgesics|analgesics|mesh-ancestor
64640513|NCT05610384|Sensory System Agents|sensory system agents|mesh-ancestor
64640514|NCT05610384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64640515|NCT05610384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640516|NCT05610384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64640517|NCT05610384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64640518|NCT05610384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64640519|NCT05610384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640520|NCT05610384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640521|NCT03570632|Metformin|metformin|mesh-list
64757385|NCT00227994|Nootropic Agents|nootropic agents|mesh-ancestor
64757386|NCT00227994|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64757387|NCT00227994|Autonomic Agents|autonomic agents|mesh-ancestor
64757420|NCT00288366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64757421|NCT00288366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64757422|NCT00288366|Serotonin Agents|serotonin agents|mesh-ancestor
64757423|NCT00288366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64757424|NCT00288366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64757425|NCT00288366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64757426|NCT00288366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64757427|NCT00288600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64757428|NCT00288600|Immunoglobulins|immunoglobulins|mesh-list
64757429|NCT00288600|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64757430|NCT00288600|Antibodies|antibodies|mesh-list
64757431|NCT00288600|gamma-Globulins|gamma-globulins|mesh-list
64757432|NCT00288600|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64757433|NCT00288600|Immunologic Factors|immunologic factors|mesh-ancestor
64757434|NCT00288600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757435|NCT00290472|Sirolimus|sirolimus|mesh-list
64757436|NCT00290472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64757437|NCT00290472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64757477|NCT00234078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757479|NCT00234078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757480|NCT00234078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757482|NCT00118404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64640535|NCT00398918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64640536|NCT00398918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640537|NCT00398918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64640538|NCT00398918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640539|NCT00401414|Warfarin|warfarin|mesh-list
64640540|NCT00401414|Anticoagulants|anticoagulants|mesh-ancestor
64640541|NCT05314998|Leucovorin|leucovorin|mesh-list
64640542|NCT05314998|Folic Acid|folic acid|mesh-list
64640543|NCT05314998|Gemcitabine|gemcitabine|mesh-list
64640544|NCT05314998|Fluorouracil|fluorouracil|mesh-list
64757483|NCT00118404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64640545|NCT05314998|Capecitabine|capecitabine|mesh-list
64757484|NCT00118404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64757485|NCT00118404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757486|NCT00118404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64757487|NCT00118404|Serotonin Agents|serotonin agents|mesh-ancestor
64757488|NCT00118404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757489|NCT00118404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64640576|NCT00370838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64757490|NCT00118404|Antidepressive Agents|antidepressive agents|mesh-ancestor
64757491|NCT00118404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64757492|NCT00118404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64757493|NCT00118404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64757494|NCT00118404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757495|NCT00121836|Bevacizumab|bevacizumab|mesh-list
64757496|NCT00121836|Capecitabine|capecitabine|mesh-list
64757497|NCT00121836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64640577|NCT00370838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64640578|NCT00370838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64640579|NCT00370838|Adrenergic Agents|adrenergic agents|mesh-ancestor
64640582|NCT00370838|Anticonvulsants|anticonvulsants|mesh-ancestor
64757498|NCT00121836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757499|NCT00121836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64757500|NCT00121836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64757501|NCT00121836|Growth Substances|growth substances|mesh-ancestor
64757502|NCT00121836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757503|NCT00121836|Growth Inhibitors|growth inhibitors|mesh-ancestor
64757504|NCT00121836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64757505|NCT00121836|Antimetabolites|antimetabolites|mesh-ancestor
64757506|NCT00121836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757507|NCT00237666|Ziprasidone|ziprasidone|mesh-list
64757508|NCT00237666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64757509|NCT00237666|Serotonin Agents|serotonin agents|mesh-ancestor
64640632|NCT00401882|Respiratory System Agents|respiratory system agents|mesh-ancestor
64640633|NCT00401882|Mydriatics|mydriatics|mesh-ancestor
64640634|NCT00401882|Sympathomimetics|sympathomimetics|mesh-ancestor
64640635|NCT00401882|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64640636|NCT00401882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64640637|NCT00401882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64757510|NCT00237666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64757514|NCT00237666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64757515|NCT00237666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64757516|NCT00237666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64757517|NCT00237666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64757518|NCT00237666|Dopamine Agents|dopamine agents|mesh-ancestor
64757520|NCT00296322|Mitomycin|mitomycin|mesh-list
64757521|NCT00296322|Doxifluridine|doxifluridine|mesh-list
64757522|NCT00296322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757523|NCT00296322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64757524|NCT00296322|Alkylating Agents|alkylating agents|mesh-ancestor
64757525|NCT00296322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757526|NCT00296322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64757527|NCT00296322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757528|NCT00296322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64757529|NCT00296322|Antimetabolites|antimetabolites|mesh-ancestor
64757530|NCT00296322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64757531|NCT00296322|Immunologic Factors|immunologic factors|mesh-ancestor
64757532|NCT00296322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757533|NCT00296322|Appetite Stimulants|appetite stimulants|mesh-ancestor
64757534|NCT00296322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64757535|NCT00123162|Sildenafil Citrate|sildenafil citrate|mesh-list
64757537|NCT00123162|Vasodilator Agents|vasodilator agents|mesh-ancestor
64757566|NCT00299988|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64757567|NCT00299988|Antibodies|antibodies|mesh-list
64757568|NCT00299988|gamma-Globulins|gamma-globulins|mesh-list
64757569|NCT00299988|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64757570|NCT00299988|Immunologic Factors|immunologic factors|mesh-ancestor
64757571|NCT00299988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757572|NCT04226352|Dextromethorphan|dextromethorphan|mesh-list
64757573|NCT04226352|Antitussive Agents|antitussive agents|mesh-ancestor
64757574|NCT04226352|Respiratory System Agents|respiratory system agents|mesh-ancestor
64757575|NCT04226352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64757576|NCT04226352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64757577|NCT04226352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64757578|NCT04226352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757579|NCT04226352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757580|NCT00300456|Simvastatin|simvastatin|mesh-list
64640692|NCT00402896|Mitogens|mitogens|mesh-list
64757581|NCT00300456|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64757582|NCT00300456|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64757583|NCT00300456|Antimetabolites|antimetabolites|mesh-ancestor
64640699|NCT05268120|Rifampin|rifampin|mesh-list
64757584|NCT00300456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757585|NCT00300456|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64757586|NCT00300456|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64757588|NCT00125034|Oxaliplatin|oxaliplatin|mesh-list
64757618|NCT00241176|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64757619|NCT00241176|Serotonin Agents|serotonin agents|mesh-ancestor
64757620|NCT00241176|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64757621|NCT00241176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64757622|NCT00241176|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64757623|NCT00241176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64757624|NCT02102100|Menthol|menthol|mesh-list
64757625|NCT02102100|Nicotine|nicotine|mesh-list
64757626|NCT02102100|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64640725|NCT00405704|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64640726|NCT00405704|Sulfamethoxazole|sulfamethoxazole|mesh-list
64640727|NCT00405704|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64640728|NCT00405704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64640729|NCT00405704|Renal Agents|renal agents|mesh-ancestor
64640730|NCT00405704|Antimalarials|antimalarials|mesh-ancestor
64757627|NCT02102100|Autonomic Agents|autonomic agents|mesh-ancestor
64757628|NCT02102100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64757629|NCT02102100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757630|NCT02102100|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64757631|NCT02102100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64757632|NCT02102100|Cholinergic Agents|cholinergic agents|mesh-ancestor
64757633|NCT02102100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64757634|NCT02102100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757635|NCT02102100|Antipruritics|antipruritics|mesh-ancestor
64757636|NCT02102100|Dermatologic Agents|dermatologic agents|mesh-ancestor
64757637|NCT02094534|Insulin|insulin|mesh-list
64757638|NCT02094534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64640781|NCT05286008|Anesthetics|anesthetics|mesh-ancestor
64640782|NCT05286008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64640783|NCT05286008|Sensory System Agents|sensory system agents|mesh-ancestor
64640784|NCT05265546|Psilocybin|psilocybin|mesh-list
64640785|NCT05265546|Hallucinogens|hallucinogens|mesh-ancestor
64640786|NCT05265546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640787|NCT05265546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64640788|NCT05302284|Gemcitabine|gemcitabine|mesh-list
64640789|NCT05302284|Carboplatin|carboplatin|mesh-list
64757639|NCT02094534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757640|NCT00242502|Bevacizumab|bevacizumab|mesh-list
64640790|NCT05302284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757641|NCT00242502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64757642|NCT00242502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64757643|NCT00242502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757644|NCT00242502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64757666|NCT01899066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64757667|NCT01899066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757668|NCT01899066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757669|NCT01899066|Tubulin Modulators|tubulin modulators|mesh-ancestor
64757670|NCT01899066|Antimitotic Agents|antimitotic agents|mesh-ancestor
64757671|NCT01899066|Mitosis Modulators|mitosis modulators|mesh-ancestor
64757672|NCT01899066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64757673|NCT01899066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64757674|NCT01899066|Growth Substances|growth substances|mesh-ancestor
64757675|NCT01899066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757676|NCT01899066|Growth Inhibitors|growth inhibitors|mesh-ancestor
64757677|NCT00127218|Niacin|niacin|mesh-list
64757678|NCT00127218|Atorvastatin|atorvastatin|mesh-list
64757679|NCT00127218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64757680|NCT00127218|Simvastatin|simvastatin|mesh-list
64757681|NCT00127218|Pravastatin|pravastatin|mesh-list
64640835|NCT05299476|Growth Inhibitors|growth inhibitors|mesh-ancestor
64640836|NCT00405938|Bevacizumab|bevacizumab|mesh-list
64757682|NCT00127218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64757683|NCT00127218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64757685|NCT00127218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757686|NCT00127218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64640837|NCT00405938|Fulvestrant|fulvestrant|mesh-list
64757687|NCT00127218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64757689|NCT00127218|Vasodilator Agents|vasodilator agents|mesh-ancestor
64640838|NCT00405938|Anastrozole|anastrozole|mesh-list
64640839|NCT00405938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64640840|NCT00405938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640841|NCT00405938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64640842|NCT00405938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64757690|NCT00127218|Vitamin B Complex|vitamin b complex|mesh-ancestor
64757717|NCT00250926|Protease Inhibitors|protease inhibitors|mesh-ancestor
64757718|NCT00250926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757719|NCT00250926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757721|NCT00303966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757722|NCT00303966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64757723|NCT00303966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757724|NCT00303966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757725|NCT00304746|Testosterone|testosterone|mesh-list
64757726|NCT00304746|Androgens|androgens|mesh-ancestor
64757727|NCT00304746|Hormones|hormones|mesh-ancestor
64757728|NCT00304746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64757729|NCT00304746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757730|NCT00134004|Mycophenolic Acid|mycophenolic acid|mesh-list
64757731|NCT00134004|Cyclophosphamide|cyclophosphamide|mesh-list
64757732|NCT00134004|Fludarabine|fludarabine|mesh-list
64757733|NCT00134004|Fludarabine phosphate|fludarabine phosphate|mesh-list
64757734|NCT00134004|Tacrolimus|tacrolimus|mesh-list
64757735|NCT00134004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64757736|NCT00134004|Immunologic Factors|immunologic factors|mesh-ancestor
64757737|NCT00134004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757738|NCT00134004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64757739|NCT00134004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64757740|NCT00134004|Alkylating Agents|alkylating agents|mesh-ancestor
64757741|NCT00134004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640876|NCT01793480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64640877|NCT01793480|Antitussive Agents|antitussive agents|mesh-ancestor
64640878|NCT01793480|Respiratory System Agents|respiratory system agents|mesh-ancestor
64640879|NCT05299086|Fluticasone|fluticasone|mesh-list
64640881|NCT05299086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64640882|NCT05299086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64640883|NCT05299086|Autonomic Agents|autonomic agents|mesh-ancestor
64640884|NCT05299086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64640885|NCT05299086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640886|NCT05299086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64757742|NCT00134004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757743|NCT00134004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64757744|NCT00134004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64757745|NCT00134004|Antimetabolites|antimetabolites|mesh-ancestor
64757746|NCT00134004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64757747|NCT00134004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757748|NCT00134004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64757749|NCT00134004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64757750|NCT00134004|Antitubercular Agents|antitubercular agents|mesh-ancestor
64757757|NCT02103114|Antithrombins|antithrombins|mesh-list
64757758|NCT02103114|Thrombin|thrombin|mesh-list
64757759|NCT02103114|Hemostatics|hemostatics|mesh-ancestor
64757760|NCT02103114|Coagulants|coagulants|mesh-ancestor
64757761|NCT02103114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64757762|NCT02103114|Protease Inhibitors|protease inhibitors|mesh-ancestor
64640918|NCT05256264|Anesthetics|anesthetics|mesh-ancestor
64640919|NCT05256264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64640920|NCT05256264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64640921|NCT05256264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64640922|NCT05256264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64640923|NCT05256264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640924|NCT00379574|Prednisolone|prednisolone|mesh-list
64640925|NCT00379574|Cyclophosphamide|cyclophosphamide|mesh-list
64757763|NCT02103114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757764|NCT02103114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640926|NCT00379574|Doxorubicin|doxorubicin|mesh-list
64757765|NCT02103114|Anticoagulants|anticoagulants|mesh-ancestor
64757766|NCT01790022|Methylprednisolone|methylprednisolone|mesh-list
64757767|NCT01790022|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64757768|NCT01790022|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64757769|NCT01790022|Prednisolone|prednisolone|mesh-list
64757770|NCT01790022|Prednisolone acetate|prednisolone acetate|mesh-list
64757771|NCT01790022|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64757772|NCT01790022|Prednisolone phosphate|prednisolone phosphate|mesh-list
64445511|NCT05418647|Dialysis Solutions|dialysis solutions|mesh-list
64757773|NCT01790022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64757774|NCT01790022|Antiemetics|antiemetics|mesh-ancestor
64757775|NCT01790022|Autonomic Agents|autonomic agents|mesh-ancestor
64757776|NCT01790022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64640968|NCT00407654|Growth Inhibitors|growth inhibitors|mesh-ancestor
64757777|NCT01790022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757778|NCT01790022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64757779|NCT01790022|Glucocorticoids|glucocorticoids|mesh-ancestor
64757780|NCT01790022|Hormones|hormones|mesh-ancestor
64757781|NCT01790022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64757782|NCT01790022|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64757783|NCT01790022|Protective Agents|protective agents|mesh-ancestor
64757784|NCT01790022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64757785|NCT01790022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757786|NCT00140556|Bevacizumab|bevacizumab|mesh-list
64757787|NCT00140556|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64757788|NCT00140556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64757789|NCT00140556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757800|NCT00142116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64757801|NCT00142116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757802|NCT00142116|Immunologic Factors|immunologic factors|mesh-ancestor
64757803|NCT00142116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757804|NCT00142116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64641034|NCT00408200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64757805|NCT00142116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64757806|NCT00142116|Leprostatic Agents|leprostatic agents|mesh-ancestor
64757807|NCT00142116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64757808|NCT00142116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64757809|NCT00142116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64757810|NCT00142116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64641035|NCT00408200|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64641036|NCT05255406|Aflutinib|aflutinib|mesh-list
64641037|NCT05255406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64641040|NCT05250050|Amoxicillin|amoxicillin|mesh-list
64641041|NCT05250050|Metronidazole|metronidazole|mesh-list
64641042|NCT05250050|Clarithromycin|clarithromycin|mesh-list
64641043|NCT05250050|Levofloxacin|levofloxacin|mesh-list
64641044|NCT05250050|Tetracycline|tetracycline|mesh-list
64641045|NCT05250050|Potassium Citrate|potassium citrate|mesh-list
64641046|NCT05250050|Esomeprazole|esomeprazole|mesh-list
64641047|NCT05250050|Bismuth|bismuth|mesh-list
64641048|NCT05250050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641049|NCT05250050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64641050|NCT05250050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64641051|NCT05250050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64641052|NCT05250050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64641053|NCT05250050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64641054|NCT05250050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64641055|NCT05250050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64641056|NCT05250050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641057|NCT05250050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64641058|NCT05250050|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64641059|NCT05250050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64641060|NCT05250050|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64757811|NCT00142116|Growth Substances|growth substances|mesh-ancestor
64757812|NCT00142116|Growth Inhibitors|growth inhibitors|mesh-ancestor
64757813|NCT05201430|Capecitabine|capecitabine|mesh-list
64757814|NCT05201430|Oxaliplatin|oxaliplatin|mesh-list
64757815|NCT05201430|Irinotecan|irinotecan|mesh-list
64757816|NCT05201430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64757817|NCT05201430|Antimetabolites|antimetabolites|mesh-ancestor
64757818|NCT05201430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757819|NCT05201430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757820|NCT05201430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64757853|NCT05266716|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64757854|NCT05266716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757856|NCT05266716|Autonomic Agents|autonomic agents|mesh-ancestor
64757857|NCT05266716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641063|NCT05250050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64641064|NCT05250050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641065|NCT05250050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64757858|NCT05266716|Dopamine Agents|dopamine agents|mesh-ancestor
64757859|NCT05266716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64757860|NCT05266716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757861|NCT05266716|Adrenergic Agents|adrenergic agents|mesh-ancestor
64757862|NCT05266716|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64757863|NCT05266716|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64757864|NCT05266716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64757865|NCT05266716|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64757866|NCT05266560|Propofol|propofol|mesh-list
64757867|NCT05266560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64757868|NCT05266560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64757869|NCT05266560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757870|NCT05266560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64757871|NCT05266560|Anesthetics, General|anesthetics, general|mesh-ancestor
64757872|NCT05266560|Anesthetics|anesthetics|mesh-ancestor
64757873|NCT00147966|Rituximab|rituximab|mesh-list
64757874|NCT00147966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64757879|NCT04528212|Glimepiride|glimepiride|mesh-list
64757905|NCT00148668|Tubulin Modulators|tubulin modulators|mesh-ancestor
64757906|NCT00148668|Antimitotic Agents|antimitotic agents|mesh-ancestor
64757907|NCT00148668|Mitosis Modulators|mitosis modulators|mesh-ancestor
64641122|NCT05292066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64641123|NCT05292066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757908|NCT00148668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641124|NCT05292066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64641125|NCT05292066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64641126|NCT05292066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64641127|NCT05292066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64641128|NCT05292066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64641129|NCT05292066|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64641130|NCT05292066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64641131|NCT05292066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641132|NCT05292066|Antidepressive Agents|antidepressive agents|mesh-ancestor
64641133|NCT05292066|Dopamine Agents|dopamine agents|mesh-ancestor
64641135|NCT04270994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64757909|NCT00148668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64757910|NCT00148668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64757911|NCT00149838|Antidepressive Agents|antidepressive agents|mesh-list
64757912|NCT00149838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64757913|NCT00324870|Bevacizumab|bevacizumab|mesh-list
64757914|NCT00324870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64757915|NCT00324870|Vorinostat|vorinostat|mesh-list
64757916|NCT00324870|Antibodies|antibodies|mesh-list
64757917|NCT00324870|Immunoglobulins|immunoglobulins|mesh-list
64757918|NCT00324870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64757919|NCT00324870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757920|NCT00324870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64757921|NCT00324870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64757922|NCT00324870|Growth Substances|growth substances|mesh-ancestor
64757923|NCT00324870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757924|NCT00324870|Growth Inhibitors|growth inhibitors|mesh-ancestor
64526692|NCT04338802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757925|NCT00324870|Immunologic Factors|immunologic factors|mesh-ancestor
64757926|NCT00324870|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64757927|NCT00324870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64757928|NCT00324870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64757955|NCT00328614|Anabolic Agents|anabolic agents|mesh-ancestor
64757956|NCT00328614|Androgen Antagonists|androgen antagonists|mesh-ancestor
64757957|NCT00328614|Hormone Antagonists|hormone antagonists|mesh-ancestor
64757958|NCT00328614|Plant Growth Regulators|plant growth regulators|mesh-ancestor
64757959|NCT00328614|Growth Substances|growth substances|mesh-ancestor
64757960|NCT00328614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64757961|NCT00328614|Analgesics|analgesics|mesh-ancestor
64757962|NCT00328614|Sensory System Agents|sensory system agents|mesh-ancestor
64757963|NCT00328614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641161|NCT02111798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641162|NCT02111798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641163|NCT02111798|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64641164|NCT02111798|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64641165|NCT02111798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641172|NCT05290662|Cyclophosphamide|cyclophosphamide|mesh-list
64641173|NCT05290662|Fludarabine|fludarabine|mesh-list
64641174|NCT05290662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64757964|NCT00328770|Sirolimus|sirolimus|mesh-list
64641175|NCT05290662|Immunologic Factors|immunologic factors|mesh-ancestor
64641176|NCT05290662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64757965|NCT00328770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64641201|NCT05143502|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64757966|NCT00328770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64757967|NCT00328770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64757968|NCT00328770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64757969|NCT00328770|Antifungal Agents|antifungal agents|mesh-ancestor
64757970|NCT00328770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64757971|NCT00328770|Immunologic Factors|immunologic factors|mesh-ancestor
64757975|NCT04177680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64758015|NCT00337350|Rosiglitazone|rosiglitazone|mesh-list
64758016|NCT00337350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64758017|NCT00337350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758018|NCT00338598|Glycine|glycine|mesh-list
64758019|NCT00338598|Glycine Agents|glycine agents|mesh-ancestor
64758020|NCT00338598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64758021|NCT00338598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758022|NCT00338598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758023|NCT00338988|Capecitabine|capecitabine|mesh-list
64758024|NCT00338988|Oxaliplatin|oxaliplatin|mesh-list
64758025|NCT00338988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64758026|NCT00338988|Antimetabolites|antimetabolites|mesh-ancestor
64758027|NCT00338988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758028|NCT00338988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758029|NCT00343044|Bevacizumab|bevacizumab|mesh-list
64641202|NCT05143502|Hormone Antagonists|hormone antagonists|mesh-ancestor
64641203|NCT05143502|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64641204|NCT05143502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64641205|NCT05143502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641206|NCT05290116|Apatinib|apatinib|mesh-list
64641207|NCT05290116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641208|NCT05290116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64641209|NCT05290116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758030|NCT00343044|Topotecan|topotecan|mesh-list
64758031|NCT00343044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64758032|NCT00343044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758033|NCT00343044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64758034|NCT00343044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64758035|NCT00343044|Growth Substances|growth substances|mesh-ancestor
64758036|NCT00343044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758037|NCT00343044|Growth Inhibitors|growth inhibitors|mesh-ancestor
64758038|NCT00343044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64758039|NCT00343044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64758062|NCT00345384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64445525|NCT03800693|Antidotes|antidotes|mesh-ancestor
64758063|NCT00345384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758064|NCT00345384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64758065|NCT00345384|Analgesics|analgesics|mesh-ancestor
64758066|NCT00345384|Sensory System Agents|sensory system agents|mesh-ancestor
64758067|NCT00345384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64758068|NCT00345384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64758069|NCT00345384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64641245|NCT05245968|Growth Inhibitors|growth inhibitors|mesh-ancestor
64641246|NCT05245968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64641247|NCT05245968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641248|NCT05245968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641249|NCT05288400|Amlodipine|amlodipine|mesh-list
64641250|NCT05288400|Bisoprolol|bisoprolol|mesh-list
64641251|NCT05288400|Perindopril|perindopril|mesh-list
64641252|NCT05288400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64641253|NCT05288400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64641254|NCT05288400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64641255|NCT05288400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641256|NCT05288400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64641257|NCT05288400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641258|NCT05288400|Vasodilator Agents|vasodilator agents|mesh-ancestor
64641259|NCT05288400|Sympatholytics|sympatholytics|mesh-ancestor
64758070|NCT00345384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64758071|NCT00345384|Adrenergic Agents|adrenergic agents|mesh-ancestor
64758072|NCT00345384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64758073|NCT00345384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758074|NCT01791114|Propranolol|propranolol|mesh-list
64526868|NCT01563029|Xhance|xhance|mesh-list
64758075|NCT01791114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64758076|NCT01791114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64758077|NCT01791114|Adrenergic Agents|adrenergic agents|mesh-ancestor
64758078|NCT01791114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64758079|NCT01791114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758080|NCT01791114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758081|NCT01791114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64758082|NCT01791114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64758083|NCT01791114|Vasodilator Agents|vasodilator agents|mesh-ancestor
64758084|NCT01791192|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64758085|NCT01791192|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64758086|NCT01791192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758087|NCT01791192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64758088|NCT01791192|Immunologic Factors|immunologic factors|mesh-ancestor
64758089|NCT01791192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758090|NCT00350142|Gemcitabine|gemcitabine|mesh-list
64758091|NCT00350142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64758092|NCT00350142|Antimetabolites|antimetabolites|mesh-ancestor
64758100|NCT00350142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758101|NCT00350532|Clonidine|clonidine|mesh-list
64758102|NCT00350532|Analgesics|analgesics|mesh-ancestor
64758103|NCT00350532|Sensory System Agents|sensory system agents|mesh-ancestor
64641284|NCT00410150|Respiratory System Agents|respiratory system agents|mesh-ancestor
64641285|NCT00410150|Tocolytic Agents|tocolytic agents|mesh-ancestor
64641286|NCT00410150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64641287|NCT00410150|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64641288|NCT00410150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64641289|NCT00410150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64641290|NCT00410150|Adrenergic Agents|adrenergic agents|mesh-ancestor
64641291|NCT00410150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641292|NCT00410150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641293|NCT00385268|Acamprosate|acamprosate|mesh-list
64641294|NCT00385268|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64641295|NCT05287464|Pembrolizumab|pembrolizumab|mesh-list
64641296|NCT05287464|Nivolumab|nivolumab|mesh-list
64641297|NCT05287464|Ipilimumab|ipilimumab|mesh-list
64641298|NCT05287464|Avelumab|avelumab|mesh-list
64641299|NCT05287464|Atezolizumab|atezolizumab|mesh-list
64641300|NCT05287464|Lenvatinib|lenvatinib|mesh-list
64641301|NCT05287464|Axitinib|axitinib|mesh-list
64758104|NCT00350532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64758105|NCT00350532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758106|NCT00350532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64758107|NCT00350532|Sympatholytics|sympatholytics|mesh-ancestor
64758108|NCT00350532|Autonomic Agents|autonomic agents|mesh-ancestor
64758109|NCT00350532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64758110|NCT00350532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64758111|NCT00350532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64758112|NCT00350532|Adrenergic Agents|adrenergic agents|mesh-ancestor
64758113|NCT00350532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64758114|NCT00350532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758115|NCT00351000|Ziprasidone|ziprasidone|mesh-list
64445537|NCT01582282|Psyllium|psyllium|mesh-list
64758119|NCT00351000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758120|NCT00351000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641315|NCT01657500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641316|NCT01657500|Anticoagulants|anticoagulants|mesh-ancestor
64641317|NCT01657500|Plasma Substitutes|plasma substitutes|mesh-ancestor
64641318|NCT01657500|Blood Substitutes|blood substitutes|mesh-ancestor
64641319|NCT00411086|Rituximab|rituximab|mesh-list
64641320|NCT00411086|Molgramostim|molgramostim|mesh-list
64641321|NCT00411086|Sargramostim|sargramostim|mesh-list
64641322|NCT00411086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64641323|NCT00411086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758121|NCT00351000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64758122|NCT00351000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64758123|NCT00351000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64758124|NCT00351000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64758125|NCT00351000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64758126|NCT00351000|Dopamine Agents|dopamine agents|mesh-ancestor
64758145|NCT00352794|Prednisone|prednisone|mesh-list
64758147|NCT00352794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64758148|NCT00352794|Glucocorticoids|glucocorticoids|mesh-ancestor
64758149|NCT00352794|Hormones|hormones|mesh-ancestor
64758150|NCT00352794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64758151|NCT00352794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758152|NCT00352794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64758153|NCT00352794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758154|NCT00352794|Immunologic Factors|immunologic factors|mesh-ancestor
64641365|NCT00385580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64641366|NCT00385580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641367|NCT00385580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641368|NCT05236530|Metformin|metformin|mesh-list
64641369|NCT05236530|Repaglinide|repaglinide|mesh-list
64641370|NCT05236530|Dolutegravir|dolutegravir|mesh-list
64641371|NCT05236530|Lumefantrine|lumefantrine|mesh-list
64641372|NCT05236530|Midazolam|midazolam|mesh-list
64641373|NCT05236530|Dextromethorphan|dextromethorphan|mesh-list
64641374|NCT05236530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64641375|NCT05236530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64641377|NCT05236530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64758155|NCT00352794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64758156|NCT00352794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64758157|NCT00352794|Growth Substances|growth substances|mesh-ancestor
64758158|NCT00352794|Growth Inhibitors|growth inhibitors|mesh-ancestor
64758159|NCT00353418|Ribavirin|ribavirin|mesh-list
64758160|NCT00353418|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64758161|NCT00353418|Antimetabolites|antimetabolites|mesh-ancestor
64758162|NCT00353418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758163|NCT00353418|Antiviral Agents|antiviral agents|mesh-ancestor
64758164|NCT00353418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64758165|NCT00353652|Chlorthalidone|chlorthalidone|mesh-list
64758166|NCT00353652|Spironolactone|spironolactone|mesh-list
64758167|NCT00353652|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64758168|NCT00353652|Hormone Antagonists|hormone antagonists|mesh-ancestor
64758169|NCT00353652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64758170|NCT00353652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641417|NCT00455702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641418|NCT00456014|Citalopram|citalopram|mesh-list
64641419|NCT00456014|Desipramine|desipramine|mesh-list
64641420|NCT00456014|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64303296|NCT02252809|Prednisolone phosphate|prednisolone phosphate|mesh-list
64641422|NCT00456014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64641423|NCT00456014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641424|NCT00456014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641425|NCT00456014|Serotonin Agents|serotonin agents|mesh-ancestor
64641426|NCT00456014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641427|NCT00456014|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64641428|NCT00456014|Antidepressive Agents|antidepressive agents|mesh-ancestor
64641429|NCT00456014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64641430|NCT00456014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64758171|NCT00353652|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64758172|NCT00353652|Diuretics|diuretics|mesh-ancestor
64758173|NCT00353652|Natriuretic Agents|natriuretic agents|mesh-ancestor
64758174|NCT00353652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64758175|NCT00353652|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64758176|NCT00353652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64758177|NCT00353652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758178|NCT02982798|Metformin|metformin|mesh-list
64758179|NCT02982798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64758180|NCT02982798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64758181|NCT02982798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758182|NCT02982798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64758184|NCT02982798|Antimetabolites|antimetabolites|mesh-ancestor
64758186|NCT02982798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64758187|NCT02982798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64758188|NCT02982798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641458|NCT00457730|Antidepressive Agents|antidepressive agents|mesh-ancestor
64641459|NCT00457730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64641460|NCT00457730|Dopamine Agents|dopamine agents|mesh-ancestor
64641461|NCT00458822|Dexamethasone|dexamethasone|mesh-list
64641462|NCT00458822|Bortezomib|bortezomib|mesh-list
64641463|NCT00458822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64641464|NCT00458822|Antiemetics|antiemetics|mesh-ancestor
64641465|NCT00458822|Autonomic Agents|autonomic agents|mesh-ancestor
64641466|NCT00458822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641467|NCT00458822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641468|NCT00458822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64641469|NCT00458822|Glucocorticoids|glucocorticoids|mesh-ancestor
64641470|NCT00458822|Hormones|hormones|mesh-ancestor
64641472|NCT00458822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64758190|NCT03709914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64758191|NCT03709914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64758192|NCT01794078|Ambrisentan|ambrisentan|mesh-list
64758193|NCT01794078|Aminophylline|aminophylline|mesh-list
64758194|NCT01794078|Theophylline|theophylline|mesh-list
64758195|NCT01794078|Ethylene|ethylene|mesh-list
64758196|NCT01794078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64758197|NCT01794078|Autonomic Agents|autonomic agents|mesh-ancestor
64758198|NCT01794078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64758199|NCT01794078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641503|NCT00462020|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64641505|NCT05275374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641506|NCT05275374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64641507|NCT05275374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641508|NCT05275374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641509|NCT05177718|Natalizumab|natalizumab|mesh-list
64641510|NCT05177718|Immunologic Factors|immunologic factors|mesh-ancestor
64641511|NCT05177718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758200|NCT01794078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64758201|NCT01794078|Respiratory System Agents|respiratory system agents|mesh-ancestor
64758202|NCT01794078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64758235|NCT00354978|Protective Agents|protective agents|mesh-ancestor
64758236|NCT00354978|Vitamin B Complex|vitamin b complex|mesh-ancestor
64758237|NCT00354978|Vitamins|vitamins|mesh-ancestor
64758238|NCT00354978|Micronutrients|micronutrients|mesh-ancestor
64758239|NCT00357162|Belinostat|belinostat|mesh-list
64758240|NCT00357162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758241|NCT00357162|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64758242|NCT00357162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758243|NCT00357162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758244|NCT03549000|Spartalizumab|spartalizumab|mesh-list
64758245|NCT03549000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64758246|NCT03549000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758247|NCT03549000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758248|NCT03984240|Midazolam|midazolam|mesh-list
64641548|NCT00462332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641549|NCT00462332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64641550|NCT00462332|Immunologic Factors|immunologic factors|mesh-ancestor
64641551|NCT00462332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641553|NCT00462332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64641554|NCT00462332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64641555|NCT00462644|Fentanyl|fentanyl|mesh-list
64641556|NCT00462644|Midazolam|midazolam|mesh-list
64641557|NCT00462644|Etomidate|etomidate|mesh-list
64641558|NCT00462644|Succinylcholine|succinylcholine|mesh-list
64641559|NCT00462644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64641560|NCT00462644|Narcotics|narcotics|mesh-ancestor
64641561|NCT00462644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64641562|NCT00462644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758249|NCT03984240|Dexmedetomidine|dexmedetomidine|mesh-list
64758250|NCT03984240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64758251|NCT03984240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64758252|NCT03984240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758253|NCT03984240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64758254|NCT03984240|Analgesics|analgesics|mesh-ancestor
64758255|NCT03984240|Sensory System Agents|sensory system agents|mesh-ancestor
64758256|NCT03984240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64758257|NCT03984240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64758258|NCT03984240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64758259|NCT03984240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64758260|NCT03984240|Adrenergic Agents|adrenergic agents|mesh-ancestor
64758261|NCT03984240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64758262|NCT03984240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758279|NCT00360126|Lamotrigine|lamotrigine|mesh-list
64758280|NCT00360126|Anticonvulsants|anticonvulsants|mesh-ancestor
64758281|NCT00360126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64758282|NCT00360126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64758283|NCT00360126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758284|NCT00360126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64758285|NCT00360126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758286|NCT00360126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64758287|NCT00360126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64641593|NCT05272254|Povidone-Iodine|povidone-iodine|mesh-list
64641594|NCT05272254|Povidone|povidone|mesh-list
64641595|NCT05272254|Plasma Substitutes|plasma substitutes|mesh-ancestor
64641596|NCT05272254|Blood Substitutes|blood substitutes|mesh-ancestor
64641597|NCT05272254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64641598|NCT05272254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64641599|NCT00528398|Cytarabine|cytarabine|mesh-list
64641600|NCT00528398|Idarubicin|idarubicin|mesh-list
64641601|NCT00528398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64641602|NCT00528398|Antimetabolites|antimetabolites|mesh-ancestor
64641603|NCT00528398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641604|NCT00528398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641605|NCT00528398|Antiviral Agents|antiviral agents|mesh-ancestor
64641606|NCT00528398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64641607|NCT00528398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64641608|NCT00528398|Immunologic Factors|immunologic factors|mesh-ancestor
64758288|NCT00360126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64758289|NCT00360126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64758290|NCT00360126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64758291|NCT00360360|Paclitaxel|paclitaxel|mesh-list
64758292|NCT00360360|Bevacizumab|bevacizumab|mesh-list
64758293|NCT00360360|Carboplatin|carboplatin|mesh-list
64758294|NCT00360360|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64758295|NCT00360360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64758296|NCT00360360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758297|NCT00360360|Tubulin Modulators|tubulin modulators|mesh-ancestor
64758298|NCT00360360|Antimitotic Agents|antimitotic agents|mesh-ancestor
64641631|NCT00414518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64641632|NCT00414518|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64641633|NCT00414518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64641634|NCT00414518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64641635|NCT00414518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64641637|NCT01795664|Xhance|xhance|mesh-list
64758299|NCT00360360|Mitosis Modulators|mitosis modulators|mesh-ancestor
64758300|NCT00360360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758301|NCT00360360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64758302|NCT00360360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64758303|NCT00360360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64758304|NCT00360360|Growth Substances|growth substances|mesh-ancestor
64758305|NCT00360360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758306|NCT00360360|Growth Inhibitors|growth inhibitors|mesh-ancestor
64758307|NCT00360360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64758323|NCT00549978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64758324|NCT00549978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758325|NCT00549978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64758326|NCT00549978|Vasodilator Agents|vasodilator agents|mesh-ancestor
64758327|NCT00549978|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64758328|NCT00549978|Protective Agents|protective agents|mesh-ancestor
64641690|NCT00531518|Bupropion|bupropion|mesh-list
64641691|NCT00531518|Fluoxetine|fluoxetine|mesh-list
64758329|NCT00549978|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64641692|NCT00531518|Sertraline|sertraline|mesh-list
64641693|NCT00531518|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64641694|NCT00531518|Antidepressive Agents|antidepressive agents|mesh-ancestor
64641695|NCT00531518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64641696|NCT00531518|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64641697|NCT00531518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64641698|NCT00531518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64641699|NCT00531518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641700|NCT00531518|Dopamine Agents|dopamine agents|mesh-ancestor
64758330|NCT00549978|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64758331|NCT00549978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758332|NCT00549978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64758333|NCT00549978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64758334|NCT00549978|Antimetabolites|antimetabolites|mesh-ancestor
64641734|NCT00534794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641735|NCT00534794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641736|NCT00534794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64758335|NCT00549978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64758336|NCT00549978|Antioxidants|antioxidants|mesh-ancestor
64758337|NCT03983226|Gemcitabine|gemcitabine|mesh-list
64758338|NCT03983226|Carboplatin|carboplatin|mesh-list
64758339|NCT03983226|Doxorubicin|doxorubicin|mesh-list
64758340|NCT03983226|Niraparib|niraparib|mesh-list
64641737|NCT00534794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64641738|NCT00534794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64641739|NCT00534794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64758341|NCT03983226|Taxane|taxane|mesh-list
64758342|NCT03983226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758343|NCT03983226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64758345|NCT03983226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758346|NCT03983226|Antiviral Agents|antiviral agents|mesh-ancestor
64758347|NCT03983226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64758348|NCT03983226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758349|NCT03983226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64758372|NCT00361140|Busulfan|busulfan|mesh-list
64758373|NCT00361140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641790|NCT00466310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641791|NCT00466310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641792|NCT00466310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641793|NCT00466310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64367079|NCT03241381|Vitamin D|vitamin d|mesh-list
64641794|NCT00466310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64758374|NCT00361140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64758375|NCT00361140|Antimetabolites|antimetabolites|mesh-ancestor
64758376|NCT00361140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758377|NCT00361140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64758378|NCT00361140|Immunologic Factors|immunologic factors|mesh-ancestor
64758379|NCT00361140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758380|NCT00361140|Alkylating Agents|alkylating agents|mesh-ancestor
64758381|NCT00361140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64758382|NCT00361140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64758383|NCT00362466|Imatinib Mesylate|imatinib mesylate|mesh-list
64758384|NCT00362466|Dasatinib|dasatinib|mesh-list
64758385|NCT00362466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641852|NCT00538616|Sensory System Agents|sensory system agents|mesh-ancestor
64641853|NCT00538616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641854|NCT00538616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64641855|NCT00538616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64641856|NCT00538616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64641857|NCT00538616|Adrenergic Agents|adrenergic agents|mesh-ancestor
64641858|NCT00538616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641882|NCT05157126|Gentamicins|gentamicins|mesh-list
64758386|NCT00362466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64758387|NCT00362466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758388|NCT00362466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758389|NCT00305682|Mycophenolic Acid|mycophenolic acid|mesh-list
64758390|NCT00305682|Sirolimus|sirolimus|mesh-list
64758391|NCT00305682|Cyclophosphamide|cyclophosphamide|mesh-list
64758392|NCT00305682|Fludarabine|fludarabine|mesh-list
64758426|NCT00309738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64758427|NCT00309738|Antimetabolites|antimetabolites|mesh-ancestor
64758428|NCT00309738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758429|NCT00309738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64758430|NCT00309738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64758431|NCT00309738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641924|NCT00471380|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64758432|NCT00310050|Pemetrexed|pemetrexed|mesh-list
64641925|NCT00471380|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64758433|NCT00310050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641926|NCT00471380|Adrenergic Agents|adrenergic agents|mesh-ancestor
64758434|NCT00310050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758435|NCT00310050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758436|NCT00310050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64758437|NCT00310050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64758438|NCT00363168|Ranibizumab|ranibizumab|mesh-list
64758439|NCT00363168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64758440|NCT00363168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64758441|NCT00363168|Growth Substances|growth substances|mesh-ancestor
64758442|NCT00363168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758443|NCT00363168|Growth Inhibitors|growth inhibitors|mesh-ancestor
64758444|NCT00363168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758445|NCT00365274|Prednisone|prednisone|mesh-list
64758446|NCT00365274|Cyclophosphamide|cyclophosphamide|mesh-list
64758447|NCT00365274|Doxorubicin|doxorubicin|mesh-list
64527215|NCT01537549|Protective Agents|protective agents|mesh-ancestor
64641984|NCT00419666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64641985|NCT00419666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641986|NCT00419666|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64641987|NCT00419666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64758448|NCT00365274|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64758449|NCT00365274|Vincristine|vincristine|mesh-list
64758450|NCT00365274|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64758451|NCT00365274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64758452|NCT00365274|Immunologic Factors|immunologic factors|mesh-ancestor
64758453|NCT00365274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758454|NCT00365274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64758455|NCT00365274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64758456|NCT00365274|Alkylating Agents|alkylating agents|mesh-ancestor
64758457|NCT00365274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370412|NCT03195205|Antibodies|antibodies|mesh-list
64758465|NCT00365274|Glucocorticoids|glucocorticoids|mesh-ancestor
64758466|NCT00365274|Hormones|hormones|mesh-ancestor
64758467|NCT00365274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64758468|NCT00365274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64642041|NCT00420992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64642042|NCT00420992|Narcotics|narcotics|mesh-ancestor
64642043|NCT00420992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64642044|NCT00420992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642045|NCT00420992|Analgesics|analgesics|mesh-ancestor
64642050|NCT00423878|Olanzapine|olanzapine|mesh-list
64758469|NCT00365274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64758470|NCT00365274|Tubulin Modulators|tubulin modulators|mesh-ancestor
64642095|NCT00424502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642096|NCT00424502|Immunologic Factors|immunologic factors|mesh-ancestor
64758471|NCT00365274|Antimitotic Agents|antimitotic agents|mesh-ancestor
64758472|NCT00365274|Mitosis Modulators|mitosis modulators|mesh-ancestor
64758473|NCT00365274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64758474|NCT00311376|Botulinum Toxins|botulinum toxins|mesh-list
64758475|NCT00311376|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64758476|NCT00311376|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64758477|NCT00311376|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64642097|NCT00424502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758478|NCT00311376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64758479|NCT00311376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758480|NCT00311376|Cholinergic Agents|cholinergic agents|mesh-ancestor
64758481|NCT00311376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64758482|NCT00311376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758483|NCT00311376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64758484|NCT00311376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64758485|NCT02104830|Lenograstim|lenograstim|mesh-list
64758486|NCT02104830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64758487|NCT02104830|Immunologic Factors|immunologic factors|mesh-ancestor
64758488|NCT02104830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758489|NCT00313560|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64758490|NCT00313560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758491|NCT00313560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64758492|NCT00313560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64642158|NCT00486824|Vasodilator Agents|vasodilator agents|mesh-ancestor
64642159|NCT00486824|Tocolytic Agents|tocolytic agents|mesh-ancestor
64642160|NCT00486824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64642161|NCT00486824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64758493|NCT00313560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758494|NCT00314106|Aldesleukin|aldesleukin|mesh-list
64758495|NCT00314106|Cyclophosphamide|cyclophosphamide|mesh-list
64758496|NCT00314106|Fludarabine|fludarabine|mesh-list
64758497|NCT00314106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64758501|NCT00314106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64758502|NCT00314106|Alkylating Agents|alkylating agents|mesh-ancestor
64758503|NCT00314106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758504|NCT00314106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642215|NCT00548132|Disinfectants|disinfectants|mesh-ancestor
64642216|NCT00490100|Mecasermin|mecasermin|mesh-list
64642217|NCT00490100|Growth Substances|growth substances|mesh-ancestor
64642218|NCT00490100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642219|NCT00490802|Oxytocin|oxytocin|mesh-list
64642220|NCT00490802|Oxytocics|oxytocics|mesh-ancestor
64642221|NCT00490802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64642223|NCT00550394|Topiramate|topiramate|mesh-list
64758505|NCT00314106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64758506|NCT00314106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64758507|NCT00314106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64758508|NCT00314106|Antiviral Agents|antiviral agents|mesh-ancestor
64758509|NCT00314106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64758510|NCT00318708|Fluticasone|fluticasone|mesh-list
64758511|NCT00318708|Xhance|xhance|mesh-list
64758512|NCT00318708|Clarithromycin|clarithromycin|mesh-list
64758513|NCT00318708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64642280|NCT00552422|Autonomic Agents|autonomic agents|mesh-ancestor
64642281|NCT00552422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642282|NCT00552422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642283|NCT00552422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64642284|NCT00552422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64758514|NCT00318708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64758515|NCT00318708|Autonomic Agents|autonomic agents|mesh-ancestor
64642285|NCT00552422|Dopamine Agents|dopamine agents|mesh-ancestor
64642309|NCT00433550|Irinotecan|irinotecan|mesh-list
64758516|NCT00318708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64758517|NCT00318708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758518|NCT00318708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64758519|NCT00318708|Respiratory System Agents|respiratory system agents|mesh-ancestor
64758520|NCT00318708|Dermatologic Agents|dermatologic agents|mesh-ancestor
64758521|NCT00318708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64527293|NCT01555073|Anticonvulsants|anticonvulsants|mesh-ancestor
64758522|NCT00318708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64758523|NCT00318708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64758524|NCT00318708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64758526|NCT00318708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758527|NCT00318708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64445570|NCT04755764|Atenolol|atenolol|mesh-list
64642343|NCT02208037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64642344|NCT02208037|Antitubercular Agents|antitubercular agents|mesh-ancestor
64642345|NCT02208037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64642346|NCT02208037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64642347|NCT02208037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64758528|NCT00318708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64758530|NCT00319644|Chelating Agents|chelating agents|mesh-ancestor
64758531|NCT00319644|Sequestering Agents|sequestering agents|mesh-ancestor
64758536|NCT02448420|Antibodies|antibodies|mesh-list
64758544|NCT02448420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758545|NCT02448420|Tubulin Modulators|tubulin modulators|mesh-ancestor
64758546|NCT02448420|Antimitotic Agents|antimitotic agents|mesh-ancestor
64758547|NCT02448420|Mitosis Modulators|mitosis modulators|mesh-ancestor
64758548|NCT02422446|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
64758549|NCT02422446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64642401|NCT05090358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64642402|NCT05090358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642403|NCT05090358|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64642404|NCT05090358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64642405|NCT05090358|Hormone Antagonists|hormone antagonists|mesh-ancestor
64642407|NCT05090358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758550|NCT02422446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64758552|NCT02405676|Prednisone|prednisone|mesh-list
64758553|NCT02405676|Cyclophosphamide|cyclophosphamide|mesh-list
64758554|NCT02405676|Ifosfamide|ifosfamide|mesh-list
64758555|NCT02405676|Isophosphamide mustard|isophosphamide mustard|mesh-list
64758556|NCT02405676|Rituximab|rituximab|mesh-list
64758557|NCT02405676|Methotrexate|methotrexate|mesh-list
64758558|NCT02405676|Etoposide|etoposide|mesh-list
64758559|NCT02405676|Etoposide phosphate|etoposide phosphate|mesh-list
64758560|NCT02405676|Vincristine|vincristine|mesh-list
64758561|NCT02405676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64642458|NCT00555464|Glucocorticoids|glucocorticoids|mesh-ancestor
64758562|NCT02405676|Immunologic Factors|immunologic factors|mesh-ancestor
64758563|NCT02405676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758564|NCT02405676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64642459|NCT00555464|Hormones|hormones|mesh-ancestor
64642460|NCT00555464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64642461|NCT00555464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642462|NCT00555464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64642465|NCT00555464|Tubulin Modulators|tubulin modulators|mesh-ancestor
64758565|NCT02405676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64758566|NCT02405676|Alkylating Agents|alkylating agents|mesh-ancestor
64758567|NCT02405676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758568|NCT02405676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758569|NCT02405676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64758570|NCT02405676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64758571|NCT02405676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64758572|NCT02405676|Glucocorticoids|glucocorticoids|mesh-ancestor
64758573|NCT02405676|Hormones|hormones|mesh-ancestor
64758574|NCT02405676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64758575|NCT02405676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64758577|NCT02405676|Abortifacient Agents|abortifacient agents|mesh-ancestor
64758586|NCT02405676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64758587|NCT02405676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64758588|NCT02405676|Antiviral Agents|antiviral agents|mesh-ancestor
64758589|NCT02405676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64758590|NCT02405676|Tubulin Modulators|tubulin modulators|mesh-ancestor
64642513|NCT05081466|Calcium|calcium|mesh-list
64642514|NCT05081466|Vitamins|vitamins|mesh-ancestor
64642515|NCT05081466|Micronutrients|micronutrients|mesh-ancestor
64642516|NCT05081466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642517|NCT05081466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64642518|NCT05081466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64758591|NCT02405676|Antimitotic Agents|antimitotic agents|mesh-ancestor
64758592|NCT02405676|Mitosis Modulators|mitosis modulators|mesh-ancestor
64758593|NCT00321594|Belinostat|belinostat|mesh-list
64758594|NCT00321594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758595|NCT00321594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64758596|NCT00321594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758597|NCT00321594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758599|NCT04751136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64758600|NCT04751136|Protective Agents|protective agents|mesh-ancestor
64758648|NCT01958190|Antifungal Agents|antifungal agents|mesh-ancestor
64758649|NCT00638898|Melphalan|melphalan|mesh-list
64758650|NCT00638898|Busulfan|busulfan|mesh-list
64642566|NCT03246620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758651|NCT00638898|Topotecan|topotecan|mesh-list
64758652|NCT00638898|Lenograstim|lenograstim|mesh-list
64758653|NCT00638898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64758654|NCT00638898|Immunologic Factors|immunologic factors|mesh-ancestor
64758655|NCT00638898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758656|NCT00638898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64758657|NCT00638898|Alkylating Agents|alkylating agents|mesh-ancestor
64758658|NCT00638898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758659|NCT00638898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758660|NCT00638898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64758713|NCT05220462|GABA Agents|gaba agents|mesh-ancestor
64758714|NCT05220462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64758715|NCT05220462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758716|NCT00373386|Hormones|hormones|mesh-list
64758717|NCT00373386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64758718|NCT00373386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758719|NCT00374088|Acetylcysteine|acetylcysteine|mesh-list
64758720|NCT00374088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64758721|NCT00374088|Antiviral Agents|antiviral agents|mesh-ancestor
64758722|NCT00374088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64758723|NCT00374088|Expectorants|expectorants|mesh-ancestor
64758724|NCT00374088|Respiratory System Agents|respiratory system agents|mesh-ancestor
64758725|NCT00374088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64758726|NCT00374088|Antioxidants|antioxidants|mesh-ancestor
64642628|NCT01470859|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64642629|NCT01470859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758727|NCT00374088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642630|NCT01470859|Antioxidants|antioxidants|mesh-ancestor
64642631|NCT01470859|Protective Agents|protective agents|mesh-ancestor
64642632|NCT01470859|Dopamine Agonists|dopamine agonists|mesh-ancestor
64642633|NCT01470859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64642634|NCT01470859|Immunologic Factors|immunologic factors|mesh-ancestor
64642635|NCT00436046|Interferons|interferons|mesh-list
64642636|NCT00436046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642637|NCT00436046|Antiviral Agents|antiviral agents|mesh-ancestor
64642638|NCT00436046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64642639|NCT01471639|Ketorolac|ketorolac|mesh-list
64758728|NCT00374088|Protective Agents|protective agents|mesh-ancestor
64758729|NCT00374088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758730|NCT00374088|Antidotes|antidotes|mesh-ancestor
64758731|NCT00374244|Pimozide|pimozide|mesh-list
64758732|NCT00374244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64758733|NCT00374244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64758734|NCT00374244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64758735|NCT00374244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758765|NCT00405288|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64758766|NCT00405288|Pramoxine|pramoxine|mesh-list
64758767|NCT00405288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64758768|NCT00405288|Anesthetics, Local|anesthetics, local|mesh-ancestor
64758769|NCT00405288|Anesthetics|anesthetics|mesh-ancestor
64758770|NCT00405288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64642667|NCT05079126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642668|NCT05079126|Protective Agents|protective agents|mesh-ancestor
64642669|NCT05079126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642670|NCT05079126|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64642671|NCT05079126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758771|NCT00405288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758772|NCT00405288|Sensory System Agents|sensory system agents|mesh-ancestor
64758773|NCT00405288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64758774|NCT00381810|Acetaminophen|acetaminophen|mesh-list
64758775|NCT00381810|Diphenhydramine|diphenhydramine|mesh-list
64758776|NCT00381810|Promethazine|promethazine|mesh-list
64758777|NCT00381810|Methylprednisolone|methylprednisolone|mesh-list
64758778|NCT00381810|Rituximab|rituximab|mesh-list
64758779|NCT00381810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64758780|NCT00381810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758781|NCT00381810|Immunologic Factors|immunologic factors|mesh-ancestor
64758782|NCT00381810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642725|NCT01486615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642726|NCT01486615|Protective Agents|protective agents|mesh-ancestor
64642727|NCT01486615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758783|NCT00381810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64758784|NCT00381810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64758785|NCT00381810|Analgesics|analgesics|mesh-ancestor
64758786|NCT00381810|Sensory System Agents|sensory system agents|mesh-ancestor
64758787|NCT00381810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64758788|NCT00381810|Antipyretics|antipyretics|mesh-ancestor
64758789|NCT00381810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64758790|NCT00381810|Antiemetics|antiemetics|mesh-ancestor
64758791|NCT00381810|Autonomic Agents|autonomic agents|mesh-ancestor
64758792|NCT00381810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64758793|NCT00381810|Glucocorticoids|glucocorticoids|mesh-ancestor
64758794|NCT00381810|Hormones|hormones|mesh-ancestor
64758796|NCT00381810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64642785|NCT00508118|Vasodilator Agents|vasodilator agents|mesh-ancestor
64642786|NCT05139030|Bupivacaine|bupivacaine|mesh-list
64642787|NCT05139030|Anesthetics, Local|anesthetics, local|mesh-ancestor
64642788|NCT05139030|Anesthetics|anesthetics|mesh-ancestor
64642789|NCT05139030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64642790|NCT05139030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642791|NCT05139030|Sensory System Agents|sensory system agents|mesh-ancestor
64642792|NCT05139030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642793|NCT00440180|Anastrozole|anastrozole|mesh-list
64642794|NCT00440180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64642795|NCT00440180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642796|NCT00440180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64642797|NCT00440180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64642804|NCT05021484|Felzartamab|felzartamab|mesh-list
64758808|NCT00381810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64758809|NCT00381810|Antipruritics|antipruritics|mesh-ancestor
64758810|NCT00381810|Dermatologic Agents|dermatologic agents|mesh-ancestor
64758811|NCT00458952|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64758812|NCT00458952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758813|NCT00458952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758814|NCT00458952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758815|NCT00458952|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64642833|NCT01364298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64642834|NCT01364298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64758818|NCT00459732|Trace Elements|trace elements|mesh-ancestor
64758819|NCT00459732|Micronutrients|micronutrients|mesh-ancestor
64758820|NCT00459732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758821|NCT00459732|Astringents|astringents|mesh-ancestor
64758822|NCT00459732|Dermatologic Agents|dermatologic agents|mesh-ancestor
64527603|NCT02985905|Zinc Sulfate|zinc sulfate|mesh-list
64758823|NCT00459810|Paclitaxel|paclitaxel|mesh-list
64758824|NCT00459810|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
64758825|NCT00459810|Estradiol|estradiol|mesh-list
64758826|NCT00459810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64758827|NCT00459810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758828|NCT00459810|Tubulin Modulators|tubulin modulators|mesh-ancestor
64642835|NCT01364298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64642836|NCT01364298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64642837|NCT01364298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64758829|NCT00459810|Antimitotic Agents|antimitotic agents|mesh-ancestor
64758830|NCT00459810|Mitosis Modulators|mitosis modulators|mesh-ancestor
64758831|NCT00459810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758832|NCT00459810|Estrogens|estrogens|mesh-ancestor
64758833|NCT00459810|Hormones|hormones|mesh-ancestor
64758834|NCT00459810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64758835|NCT00459810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758836|NCT00405522|Remifentanil|remifentanil|mesh-list
64758837|NCT00405522|Propofol|propofol|mesh-list
64758838|NCT00405522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64758841|NCT00405522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64758853|NCT00461292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64758854|NCT00461292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758855|NCT00461292|Cholinergic Agents|cholinergic agents|mesh-ancestor
64758856|NCT00461292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64758857|NCT00461292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758858|NCT00461292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64758859|NCT00461292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64758861|NCT00382590|Azacitidine|azacitidine|mesh-list
64758862|NCT00382590|Valproic Acid|valproic acid|mesh-list
64758863|NCT00382590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64758864|NCT00382590|Antimetabolites|antimetabolites|mesh-ancestor
64758865|NCT00382590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758866|NCT00382590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642882|NCT01488877|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64642883|NCT01488877|Diuretics|diuretics|mesh-ancestor
64642884|NCT01488877|Natriuretic Agents|natriuretic agents|mesh-ancestor
64642885|NCT01364922|Acetaminophen|acetaminophen|mesh-list
64642886|NCT01364922|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64642887|NCT01364922|Hydrocodone|hydrocodone|mesh-list
64642888|NCT01364922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64758867|NCT00382590|Antiviral Agents|antiviral agents|mesh-ancestor
64758868|NCT00382590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64758869|NCT00382590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64758871|NCT00382590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758872|NCT00382590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758873|NCT00382590|Anticonvulsants|anticonvulsants|mesh-ancestor
64758874|NCT00382590|GABA Agents|gaba agents|mesh-ancestor
64758875|NCT00382590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64758876|NCT00382590|Antimanic Agents|antimanic agents|mesh-ancestor
64758877|NCT00382590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64758878|NCT00382590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64642930|NCT00510224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642931|NCT05070156|Vaccines|vaccines|mesh-list
64642932|NCT05070156|Immunologic Factors|immunologic factors|mesh-ancestor
64642933|NCT05070156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642934|NCT00511706|Dexamethasone|dexamethasone|mesh-list
64642935|NCT00511706|Ranibizumab|ranibizumab|mesh-list
64642936|NCT00511706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64642937|NCT00511706|Antiemetics|antiemetics|mesh-ancestor
64642938|NCT00511706|Autonomic Agents|autonomic agents|mesh-ancestor
64758879|NCT00382590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64758880|NCT00382824|Ubiquinone|ubiquinone|mesh-list
64758884|NCT00382824|Vitamins|vitamins|mesh-ancestor
64642939|NCT00511706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64758901|NCT00408564|Cetuximab|cetuximab|mesh-list
64758902|NCT00408564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64758903|NCT00408564|Antimetabolites|antimetabolites|mesh-ancestor
64758904|NCT00408564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758905|NCT00408564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758906|NCT00408564|Antiviral Agents|antiviral agents|mesh-ancestor
64758907|NCT00408564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64758908|NCT00408564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758909|NCT00408564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64758910|NCT00408564|Immunologic Factors|immunologic factors|mesh-ancestor
64445607|NCT03774641|Anticonvulsants|anticonvulsants|mesh-ancestor
64445608|NCT03774641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64758913|NCT00383448|Cyclosporine|cyclosporine|mesh-list
64758914|NCT00383448|Melphalan|melphalan|mesh-list
64642987|NCT01495819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64642988|NCT01495819|Autonomic Agents|autonomic agents|mesh-ancestor
64758915|NCT00383448|Alemtuzumab|alemtuzumab|mesh-list
64642989|NCT01495819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642990|NCT01495819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642991|NCT01495819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64642992|NCT01495819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64758916|NCT00383448|Hydroxyurea|hydroxyurea|mesh-list
64758917|NCT00383448|Clofarabine|clofarabine|mesh-list
64642993|NCT01495819|Cholinergic Agents|cholinergic agents|mesh-ancestor
64758918|NCT00383448|Cyclosporins|cyclosporins|mesh-list
64758919|NCT00383448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758920|NCT00383448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758921|NCT00383448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64758922|NCT00383448|Immunologic Factors|immunologic factors|mesh-ancestor
64758923|NCT00383448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758924|NCT00383448|Antifungal Agents|antifungal agents|mesh-ancestor
64758925|NCT00383448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64758926|NCT00383448|Dermatologic Agents|dermatologic agents|mesh-ancestor
64758927|NCT00383448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64758928|NCT00383448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64758929|NCT00383448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64758930|NCT00383448|Alkylating Agents|alkylating agents|mesh-ancestor
64758931|NCT00383448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758932|NCT00383448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64758933|NCT00383448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64758934|NCT00383448|Antisickling Agents|antisickling agents|mesh-ancestor
64758937|NCT00383448|Antimetabolites|antimetabolites|mesh-ancestor
64758942|NCT00384774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758943|NCT00384774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758944|NCT00410826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64758945|NCT00410826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758946|NCT00410826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64758947|NCT00410826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758948|NCT00410826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758949|NCT00464646|Cyclophosphamide|cyclophosphamide|mesh-list
64758950|NCT00464646|Bevacizumab|bevacizumab|mesh-list
64758951|NCT00464646|Docetaxel|docetaxel|mesh-list
64758952|NCT00464646|Trastuzumab|trastuzumab|mesh-list
64758953|NCT00464646|Epirubicin|epirubicin|mesh-list
64758954|NCT00464646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64758955|NCT00464646|Immunologic Factors|immunologic factors|mesh-ancestor
64758956|NCT00464646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64758957|NCT00464646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64758958|NCT00464646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64643094|NCT01496131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64643095|NCT01496131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64643096|NCT02520726|Sertraline|sertraline|mesh-list
64643097|NCT02520726|Antidepressive Agents|antidepressive agents|mesh-ancestor
64643098|NCT02520726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64643099|NCT02520726|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64758959|NCT00464646|Alkylating Agents|alkylating agents|mesh-ancestor
64758960|NCT00464646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643100|NCT02520726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64758961|NCT00464646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64758962|NCT00464646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64758963|NCT00464646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64758964|NCT00464646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64758965|NCT00464646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64758966|NCT00464646|Growth Substances|growth substances|mesh-ancestor
64758967|NCT00464646|Growth Inhibitors|growth inhibitors|mesh-ancestor
64758989|NCT00385008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64758990|NCT00385008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64758991|NCT00385008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64758992|NCT00385008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64758993|NCT00385008|Serotonin Agents|serotonin agents|mesh-ancestor
64758994|NCT00385008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64758996|NCT00410904|Cediranib|cediranib|mesh-list
64758998|NCT00410904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64758999|NCT00410904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759000|NCT00410904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64643147|NCT05122884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643148|NCT00520286|Modafinil|modafinil|mesh-list
64643149|NCT00520286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64643150|NCT00520286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759001|NCT00410904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64759002|NCT00410904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64759003|NCT00385788|Gemcitabine|gemcitabine|mesh-list
64759004|NCT00385788|Methotrexate|methotrexate|mesh-list
64643200|NCT03813108|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
64643201|NCT03813108|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64759005|NCT00385788|Fludarabine phosphate|fludarabine phosphate|mesh-list
64759006|NCT00385788|Fludarabine|fludarabine|mesh-list
64759007|NCT00385788|Melphalan|melphalan|mesh-list
64759008|NCT00385788|Tacrolimus|tacrolimus|mesh-list
64759009|NCT00385788|Thymoglobulin|thymoglobulin|mesh-list
64759010|NCT00385788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64759011|NCT00385788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64759012|NCT00385788|Antimetabolites|antimetabolites|mesh-ancestor
64759013|NCT00385788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759014|NCT00385788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759015|NCT00385788|Antiviral Agents|antiviral agents|mesh-ancestor
64759016|NCT00385788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64759017|NCT00385788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64643202|NCT03813108|Antimalarials|antimalarials|mesh-ancestor
64643203|NCT03813108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64643204|NCT03813108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64643205|NCT03813108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64759018|NCT00385788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64759019|NCT00385788|Immunologic Factors|immunologic factors|mesh-ancestor
64759020|NCT00385788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759021|NCT00385788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64759022|NCT00385788|Abortifacient Agents|abortifacient agents|mesh-ancestor
64759030|NCT00385788|Alkylating Agents|alkylating agents|mesh-ancestor
64759031|NCT00385788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64759032|NCT00411684|Ulipristal acetate|ulipristal acetate|mesh-list
64759033|NCT00411684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64759034|NCT00411684|Contraceptive Agents|contraceptive agents|mesh-ancestor
64759035|NCT00411684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64759036|NCT00411684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643250|NCT00524264|Sensory System Agents|sensory system agents|mesh-ancestor
64643251|NCT00524264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643252|NCT00524264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643253|NCT00524264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64643254|NCT00524264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64643255|NCT00524264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64643256|NCT00524264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64643257|NCT00524264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759037|NCT00411684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64759038|NCT00412074|Vitamin D|vitamin d|mesh-list
64759039|NCT00412074|Ergocalciferols|ergocalciferols|mesh-list
64759040|NCT00412074|Cholecalciferol|cholecalciferol|mesh-list
64759041|NCT00412074|Vitamins|vitamins|mesh-list
64759042|NCT00412074|Micronutrients|micronutrients|mesh-ancestor
64759043|NCT00412074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759044|NCT00412074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64759045|NCT00412074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64759046|NCT00412464|PENTA|penta|mesh-list
64759047|NCT00412464|Fondaparinux|fondaparinux|mesh-list
64759048|NCT00412464|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64759049|NCT00412464|Antithrombins|antithrombins|mesh-ancestor
64759051|NCT00412464|Protease Inhibitors|protease inhibitors|mesh-ancestor
64759086|NCT00413166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64759087|NCT00413400|Etanercept|etanercept|mesh-list
64759088|NCT00413400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64759089|NCT00413400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64759090|NCT00413400|Analgesics|analgesics|mesh-ancestor
64759091|NCT00413400|Sensory System Agents|sensory system agents|mesh-ancestor
64759092|NCT00413400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64759093|NCT00413400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759094|NCT00413400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64759095|NCT00413400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64759096|NCT00413400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64643303|NCT00526058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64759097|NCT00413400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64643304|NCT00526058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64643309|NCT00526292|Cyclophosphamide|cyclophosphamide|mesh-list
64643310|NCT00526292|Fludarabine|fludarabine|mesh-list
64643311|NCT00526292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64643312|NCT00526292|Immunologic Factors|immunologic factors|mesh-ancestor
64643314|NCT00526292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64759098|NCT00413400|Immunologic Factors|immunologic factors|mesh-ancestor
64759099|NCT00413478|Azacitidine|azacitidine|mesh-list
64759100|NCT00413478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64759101|NCT00413478|Antimetabolites|antimetabolites|mesh-ancestor
64643353|NCT01502761|Anticonvulsants|anticonvulsants|mesh-ancestor
64643354|NCT01502761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64643355|NCT01502761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64643356|NCT01502761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759102|NCT00413478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759103|NCT00413478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759104|NCT00413478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64643358|NCT01502761|Tocolytic Agents|tocolytic agents|mesh-ancestor
64759105|NCT00413634|Anagrelide|anagrelide|mesh-list
64759106|NCT00413634|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64759107|NCT00413634|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64759108|NCT00413634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759109|NCT00413634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64759110|NCT00387036|Fluticasone|fluticasone|mesh-list
64759111|NCT00387036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64759112|NCT00387036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64759113|NCT00387036|Autonomic Agents|autonomic agents|mesh-ancestor
64759114|NCT00387036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64759115|NCT00387036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759116|NCT00387036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64759117|NCT00387036|Respiratory System Agents|respiratory system agents|mesh-ancestor
64759118|NCT00387036|Dermatologic Agents|dermatologic agents|mesh-ancestor
64759127|NCT04388904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64759128|NCT04388904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64759129|NCT04388904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64759130|NCT04388904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64643416|NCT01550341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64643417|NCT01550341|Naloxone|naloxone|mesh-list
64759131|NCT04388904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759132|NCT04388904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64759133|NCT04388904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64759134|NCT04388904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64759135|NCT04388904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64759136|NCT04388904|Protease Inhibitors|protease inhibitors|mesh-ancestor
64759137|NCT04388904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64759138|NCT04388904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64759139|NCT00387660|Carboplatin|carboplatin|mesh-list
64759140|NCT00387660|Irinotecan|irinotecan|mesh-list
64759141|NCT00387660|Camptothecin|camptothecin|mesh-list
64759142|NCT00387660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759143|NCT00387660|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64759144|NCT00387660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64759145|NCT00387660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759146|NCT00387660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759147|NCT00387660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64759148|NCT00472056|Cytarabine|cytarabine|mesh-list
64759149|NCT00472056|Rituximab|rituximab|mesh-list
64759150|NCT00472056|Etoposide|etoposide|mesh-list
64759151|NCT00472056|Melphalan|melphalan|mesh-list
64759152|NCT00472056|Carmustine|carmustine|mesh-list
64759153|NCT00472056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64759154|NCT00472056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643477|NCT02132468|Antimitotic Agents|antimitotic agents|mesh-ancestor
64643478|NCT02132468|Mitosis Modulators|mitosis modulators|mesh-ancestor
64643479|NCT02132468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643480|NCT01508455|Fentanyl|fentanyl|mesh-list
64643481|NCT01508455|Midazolam|midazolam|mesh-list
64643482|NCT01508455|Dexmedetomidine|dexmedetomidine|mesh-list
64643483|NCT01508455|Morphine|morphine|mesh-list
64643484|NCT01508455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64643485|NCT01508455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64643486|NCT01508455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643487|NCT01508455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64643489|NCT01508455|Sensory System Agents|sensory system agents|mesh-ancestor
64643490|NCT01508455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643491|NCT01508455|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64643492|NCT01508455|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64643493|NCT01508455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64643494|NCT01508455|Adrenergic Agents|adrenergic agents|mesh-ancestor
64643495|NCT01508455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64759155|NCT00472056|Immunologic Factors|immunologic factors|mesh-ancestor
64759156|NCT00472056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759170|NCT00472056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64759171|NCT00415506|Rituximab|rituximab|mesh-list
64759172|NCT00415506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64759173|NCT00415506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759174|NCT00415506|Immunologic Factors|immunologic factors|mesh-ancestor
64759175|NCT00415506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759176|NCT00415506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64759177|NCT03531918|Cytarabine|cytarabine|mesh-list
64759179|NCT03531918|Mitoxantrone|mitoxantrone|mesh-list
64759180|NCT03531918|Cladribine|cladribine|mesh-list
64759181|NCT03531918|Gemtuzumab|gemtuzumab|mesh-list
64759182|NCT03531918|Calicheamicins|calicheamicins|mesh-list
64759183|NCT03531918|Lenograstim|lenograstim|mesh-list
64759184|NCT03531918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64759185|NCT03531918|Antimetabolites|antimetabolites|mesh-ancestor
64759186|NCT03531918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759187|NCT03531918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643510|NCT03095612|Tubulin Modulators|tubulin modulators|mesh-ancestor
64643511|NCT03095612|Antimitotic Agents|antimitotic agents|mesh-ancestor
64759188|NCT03531918|Antiviral Agents|antiviral agents|mesh-ancestor
64759189|NCT03531918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64759190|NCT03531918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64759191|NCT03531918|Immunologic Factors|immunologic factors|mesh-ancestor
64759192|NCT03531918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759193|NCT03531918|Analgesics|analgesics|mesh-ancestor
64759194|NCT03531918|Sensory System Agents|sensory system agents|mesh-ancestor
64759195|NCT03531918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64759196|NCT03531918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64759197|NCT03531918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64759198|NCT03531918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759199|NCT03531918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64759200|NCT03531918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64759216|NCT03520686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643567|NCT01401595|Antidepressive Agents|antidepressive agents|mesh-ancestor
64643568|NCT01401595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64643572|NCT01401595|Autonomic Agents|autonomic agents|mesh-ancestor
64759217|NCT03520686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64759218|NCT03520686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759219|NCT03520686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64759220|NCT03520686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64759222|NCT01957956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64759223|NCT01957956|Alkylating Agents|alkylating agents|mesh-ancestor
64759224|NCT01957956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759225|NCT01957956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759227|NCT00475878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64759228|NCT00475878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64759229|NCT00475878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64643632|NCT03243890|Micronutrients|micronutrients|mesh-ancestor
64643633|NCT03243890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643634|NCT03243890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64643635|NCT03243890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64643636|NCT03243890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64643637|NCT03243890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643638|NCT03243890|Hemostatics|hemostatics|mesh-ancestor
64643640|NCT00560612|Paroxetine|paroxetine|mesh-list
64759230|NCT00475878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759231|NCT00475878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64759232|NCT00475878|Serotonin Agents|serotonin agents|mesh-ancestor
64759233|NCT00475878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759234|NCT00475878|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64759235|NCT00475878|Antidepressive Agents|antidepressive agents|mesh-ancestor
64759236|NCT00475878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64643687|NCT03236792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64643688|NCT03236792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64759237|NCT01795170|Pyridoxine|pyridoxine|mesh-list
64759238|NCT01795170|Vitamin B Complex|vitamin b complex|mesh-ancestor
64759239|NCT01795170|Vitamins|vitamins|mesh-ancestor
64759240|NCT01795170|Micronutrients|micronutrients|mesh-ancestor
64759241|NCT01795170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759242|NCT00477204|Simvastatin|simvastatin|mesh-list
64759243|NCT00477204|Ezetimibe|ezetimibe|mesh-list
64759244|NCT00477204|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
64759259|NCT00528450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759260|NCT00528450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759261|NCT00528450|Keratolytic Agents|keratolytic agents|mesh-ancestor
64759262|NCT00528450|Dermatologic Agents|dermatologic agents|mesh-ancestor
64759264|NCT00478218|Cyclophosphamide|cyclophosphamide|mesh-list
64759265|NCT00478218|Lenalidomide|lenalidomide|mesh-list
64643689|NCT03236792|Protease Inhibitors|protease inhibitors|mesh-ancestor
64643690|NCT03236792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64643691|NCT03725384|Ascorbic Acid|ascorbic acid|mesh-list
64643692|NCT03725384|Iron|iron|mesh-list
64643693|NCT03725384|Vitamins|vitamins|mesh-ancestor
64643694|NCT03725384|Micronutrients|micronutrients|mesh-ancestor
64643695|NCT03725384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643696|NCT03725384|Trace Elements|trace elements|mesh-ancestor
64643697|NCT03725384|Antioxidants|antioxidants|mesh-ancestor
64643698|NCT03725384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643699|NCT03725384|Protective Agents|protective agents|mesh-ancestor
64643700|NCT01556425|Naltrexone|naltrexone|mesh-list
64643701|NCT01556425|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64643702|NCT01556425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64643703|NCT01556425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643704|NCT01556425|Sensory System Agents|sensory system agents|mesh-ancestor
64759266|NCT00478218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64643705|NCT01556425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64759267|NCT00478218|Immunologic Factors|immunologic factors|mesh-ancestor
64759268|NCT00478218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759269|NCT00478218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64759270|NCT00478218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64759271|NCT00478218|Alkylating Agents|alkylating agents|mesh-ancestor
64759272|NCT00478218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759273|NCT00478218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759274|NCT00478218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64759275|NCT00478218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64759276|NCT00478218|Antiemetics|antiemetics|mesh-ancestor
64759277|NCT00478218|Autonomic Agents|autonomic agents|mesh-ancestor
64643721|NCT00562328|Alemtuzumab|alemtuzumab|mesh-list
64643722|NCT00562328|Sargramostim|sargramostim|mesh-list
64643723|NCT00562328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64643724|NCT00562328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643725|NCT00562328|Immunologic Factors|immunologic factors|mesh-ancestor
64643726|NCT00562328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643727|NCT00562328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64643728|NCT01514149|Metformin|metformin|mesh-list
64643729|NCT01514149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64643730|NCT01514149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643731|NCT05566093|Ethanol|ethanol|mesh-list
64759278|NCT00478218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64759279|NCT00478218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64759280|NCT00478218|Glucocorticoids|glucocorticoids|mesh-ancestor
64528042|NCT01531673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64759282|NCT00478218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64759283|NCT00478218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64759284|NCT00478218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64759285|NCT00478218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64759286|NCT00478218|Growth Substances|growth substances|mesh-ancestor
64759287|NCT00478218|Growth Inhibitors|growth inhibitors|mesh-ancestor
64759288|NCT00479154|Botulinum Toxins|botulinum toxins|mesh-list
64759289|NCT00479154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64759290|NCT00479154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64759291|NCT00479154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64759298|NCT00479154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643775|NCT01519063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643776|NCT01519063|Sensory System Agents|sensory system agents|mesh-ancestor
64643777|NCT01519063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643778|NCT01519063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64643779|NCT01519063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64643780|NCT01519063|Dopamine Agents|dopamine agents|mesh-ancestor
64643781|NCT01519063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64643782|NCT01519063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643783|NCT01519063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64643784|NCT01519063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64643785|NCT01559857|Pioglitazone|pioglitazone|mesh-list
64759299|NCT04270656|Insulin|insulin|mesh-list
64759302|NCT00424554|Temozolomide|temozolomide|mesh-list
64759303|NCT00424554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64759304|NCT00424554|Alkylating Agents|alkylating agents|mesh-ancestor
64759305|NCT00424554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759306|NCT00424554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759307|NCT00425802|Cyclosporine|cyclosporine|mesh-list
64759308|NCT00425802|Mycophenolic Acid|mycophenolic acid|mesh-list
64759309|NCT00425802|Cyclophosphamide|cyclophosphamide|mesh-list
64759310|NCT00425802|Rituximab|rituximab|mesh-list
64759311|NCT00425802|Fludarabine|fludarabine|mesh-list
64759312|NCT00425802|Fludarabine phosphate|fludarabine phosphate|mesh-list
64643822|NCT00634166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64643829|NCT00565370|Capecitabine|capecitabine|mesh-list
64759313|NCT00425802|Cyclosporins|cyclosporins|mesh-list
64759314|NCT00425802|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64759315|NCT00425802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64759316|NCT00425802|Immunologic Factors|immunologic factors|mesh-ancestor
64759317|NCT00425802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759318|NCT00425802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64759319|NCT00425802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64759320|NCT00425802|Alkylating Agents|alkylating agents|mesh-ancestor
64759321|NCT00425802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759322|NCT00425802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759323|NCT00425802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64759324|NCT00425802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64759346|NCT00530634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759347|NCT00531882|Pioglitazone|pioglitazone|mesh-list
64759348|NCT00531882|Ibuprofen|ibuprofen|mesh-list
64759349|NCT00531882|Simvastatin|simvastatin|mesh-list
64759350|NCT00531882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64759351|NCT00531882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64759352|NCT00531882|Analgesics|analgesics|mesh-ancestor
64759353|NCT00531882|Sensory System Agents|sensory system agents|mesh-ancestor
64759354|NCT00531882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64528118|NCT01525901|Mitogens|mitogens|mesh-list
64759355|NCT00531882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759356|NCT00531882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64759357|NCT00531882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64643884|NCT01797926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759358|NCT00531882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64643885|NCT01797926|Vasodilator Agents|vasodilator agents|mesh-ancestor
64643886|NCT01797926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64643890|NCT03008083|Ticagrelor|ticagrelor|mesh-list
64759359|NCT00531882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759360|NCT00531882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759361|NCT00531882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64759362|NCT00531882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64759363|NCT00531882|Antimetabolites|antimetabolites|mesh-ancestor
64759364|NCT00531882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64759365|NCT00531882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64759366|NCT00531882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64759367|NCT00428298|Valacyclovir|valacyclovir|mesh-list
64759368|NCT00428298|Antiviral Agents|antiviral agents|mesh-ancestor
64759369|NCT00428298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64759370|NCT00486018|Ranibizumab|ranibizumab|mesh-list
64759377|NCT00486642|Bicalutamide|bicalutamide|mesh-list
64759394|NCT00428922|Antimitotic Agents|antimitotic agents|mesh-ancestor
64643932|NCT00568022|Capecitabine|capecitabine|mesh-list
64643933|NCT00568022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64643934|NCT00568022|Antimetabolites|antimetabolites|mesh-ancestor
64643935|NCT00568022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643936|NCT00568022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643937|NCT01522963|Nicotine|nicotine|mesh-list
64759395|NCT00428922|Mitosis Modulators|mitosis modulators|mesh-ancestor
64759396|NCT00428922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759397|NCT00533442|Mycophenolic Acid|mycophenolic acid|mesh-list
64759398|NCT00533442|Sirolimus|sirolimus|mesh-list
64759399|NCT00533442|Tacrolimus|tacrolimus|mesh-list
64759400|NCT00533442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64759401|NCT00533442|Immunologic Factors|immunologic factors|mesh-ancestor
64759402|NCT00533442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759403|NCT00533442|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64759404|NCT00533442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759405|NCT00533442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759406|NCT00533442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64759407|NCT00533442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759408|NCT00533442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64759409|NCT00533442|Antitubercular Agents|antitubercular agents|mesh-ancestor
64759410|NCT00533442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64759411|NCT00533442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64759412|NCT00533442|Antifungal Agents|antifungal agents|mesh-ancestor
64759413|NCT00533910|Rifaximin|rifaximin|mesh-list
64759414|NCT00533910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64759415|NCT00533910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64759416|NCT00533910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64759417|NCT01954524|Sildenafil Citrate|sildenafil citrate|mesh-list
64759418|NCT01954524|Vasodilator Agents|vasodilator agents|mesh-ancestor
64759419|NCT01954524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64759420|NCT01954524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64759421|NCT01954524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759422|NCT01954524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759423|NCT01954524|Urological Agents|urological agents|mesh-ancestor
64759424|NCT00535002|Yohimbine|yohimbine|mesh-list
64759436|NCT02117934|Vaccines|vaccines|mesh-list
64643990|NCT02129426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64643991|NCT02129426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64643992|NCT02129426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64643993|NCT02129426|Adrenergic Agents|adrenergic agents|mesh-ancestor
64644006|NCT02129426|GABA Modulators|gaba modulators|mesh-ancestor
64759438|NCT02117934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759512|NCT00431184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64759513|NCT00431184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759514|NCT00431184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64759515|NCT00431184|Narcotics|narcotics|mesh-ancestor
64759516|NCT00431184|Analgesics|analgesics|mesh-ancestor
64759517|NCT00431184|Sensory System Agents|sensory system agents|mesh-ancestor
64759518|NCT00431184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64759519|NCT00431184|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64759520|NCT00535938|Botulinum Toxins|botulinum toxins|mesh-list
64759521|NCT00535938|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64759522|NCT00535938|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64759523|NCT00535938|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64759524|NCT00535938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64644032|NCT05395910|Antimitotic Agents|antimitotic agents|mesh-ancestor
64644033|NCT05395910|Mitosis Modulators|mitosis modulators|mesh-ancestor
64644034|NCT05395910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644035|NCT05389046|Dexetimide|dexetimide|mesh-list
64644036|NCT05389046|Aripiprazole|aripiprazole|mesh-list
64644037|NCT05389046|Citalopram|citalopram|mesh-list
64644038|NCT05389046|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64644039|NCT05389046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64644042|NCT05389046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64759525|NCT00535938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759526|NCT00535938|Cholinergic Agents|cholinergic agents|mesh-ancestor
64759527|NCT00535938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64759528|NCT00535938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759529|NCT00535938|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64759530|NCT00535938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64759531|NCT01795794|Omeprazole|omeprazole|mesh-list
64759532|NCT01795794|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64759533|NCT01795794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64759534|NCT01795794|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64759535|NCT01795794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759536|NCT01795794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759537|NCT01796028|Metformin|metformin|mesh-list
64644086|NCT01568905|Cholinergic Agents|cholinergic agents|mesh-ancestor
64644087|NCT01568905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64644088|NCT01568905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644089|NCT01569451|Rituximab|rituximab|mesh-list
64644090|NCT01569451|Glatiramer Acetate|glatiramer acetate|mesh-list
64644091|NCT01569451|(T,G)-A-L|(t,g)-a-l|mesh-list
64759538|NCT01796028|Docetaxel|docetaxel|mesh-list
64759539|NCT01796028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64759540|NCT01796028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759541|NCT01796028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759542|NCT01796028|Tubulin Modulators|tubulin modulators|mesh-ancestor
64759543|NCT01796028|Antimitotic Agents|antimitotic agents|mesh-ancestor
64759547|NCT00491244|Ribavirin|ribavirin|mesh-list
64759555|NCT00491244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759556|NCT00491244|Immunologic Factors|immunologic factors|mesh-ancestor
64759557|NCT00491244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759558|NCT00492336|Rasagiline|rasagiline|mesh-list
64759559|NCT00492336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64759560|NCT00492336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759561|NCT00492336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759562|NCT00492336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64759563|NCT00492336|Protective Agents|protective agents|mesh-ancestor
64759564|NCT00492336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759565|NCT00538434|Reslizumab|reslizumab|mesh-list
64759566|NCT00538434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64759567|NCT00538434|Respiratory System Agents|respiratory system agents|mesh-ancestor
64759568|NCT00538824|Thalidomide|thalidomide|mesh-list
64759569|NCT00538824|Dexamethasone|dexamethasone|mesh-list
64644142|NCT01529827|Melphalan|melphalan|mesh-list
64644143|NCT01529827|Tacrolimus|tacrolimus|mesh-list
64644144|NCT01529827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64644145|NCT01529827|Abortifacient Agents|abortifacient agents|mesh-ancestor
64759570|NCT00538824|Lenalidomide|lenalidomide|mesh-list
64759571|NCT00538824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64759572|NCT00538824|Antiemetics|antiemetics|mesh-ancestor
64759573|NCT00538824|Autonomic Agents|autonomic agents|mesh-ancestor
64759574|NCT00538824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64759575|NCT00538824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759576|NCT00538824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64759577|NCT00538824|Glucocorticoids|glucocorticoids|mesh-ancestor
64528342|NCT01535053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64759578|NCT00538824|Hormones|hormones|mesh-ancestor
64759581|NCT00538824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759605|NCT00541242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64759606|NCT00541242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64759607|NCT00438204|Gemcitabine|gemcitabine|mesh-list
64759608|NCT00438204|Bevacizumab|bevacizumab|mesh-list
64759609|NCT00438204|Pemetrexed|pemetrexed|mesh-list
64759610|NCT00438204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64759611|NCT00438204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759612|NCT00438204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64759613|NCT00438204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64759614|NCT00438204|Growth Substances|growth substances|mesh-ancestor
64759615|NCT00438204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759616|NCT00438204|Growth Inhibitors|growth inhibitors|mesh-ancestor
64759617|NCT00438204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64644192|NCT00572234|Antidepressive Agents|antidepressive agents|mesh-ancestor
64759618|NCT00438204|Antimetabolites|antimetabolites|mesh-ancestor
64644193|NCT00572234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64759619|NCT00438204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759620|NCT00438204|Antiviral Agents|antiviral agents|mesh-ancestor
64759621|NCT00438204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64759622|NCT00438204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759623|NCT00438204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64759624|NCT00438204|Immunologic Factors|immunologic factors|mesh-ancestor
64759625|NCT00438204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64759626|NCT00438204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64759627|NCT00439296|Cytarabine|cytarabine|mesh-list
64759628|NCT00439296|Dexamethasone|dexamethasone|mesh-list
64759629|NCT00439296|Cyclophosphamide|cyclophosphamide|mesh-list
64759630|NCT00439296|Doxorubicin|doxorubicin|mesh-list
64759631|NCT00439296|Methotrexate|methotrexate|mesh-list
64759632|NCT00439296|Asparaginase|asparaginase|mesh-list
64759633|NCT00439296|Mercaptopurine|mercaptopurine|mesh-list
64759634|NCT00439296|Thioguanine|thioguanine|mesh-list
64759635|NCT00439296|Pegaspargase|pegaspargase|mesh-list
64759636|NCT00439296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64759652|NCT00439296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64759653|NCT00439296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64644240|NCT05041946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644241|NCT05041946|Dopamine Agents|dopamine agents|mesh-ancestor
64644242|NCT05041946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64644243|NCT05092412|Carboplatin|carboplatin|mesh-list
64644247|NCT05092412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64644248|NCT05092412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64644249|NCT05092412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64644255|NCT05004896|Midazolam|midazolam|mesh-list
64759654|NCT00439296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64759655|NCT00439296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64759656|NCT00439296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64759657|NCT00439296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759658|NCT00439296|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64759659|NCT00439296|Abortifacient Agents|abortifacient agents|mesh-ancestor
64759660|NCT00439296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64644290|NCT04866602|Antimalarials|antimalarials|mesh-ancestor
64759661|NCT00439296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64759662|NCT00439296|Antimetabolites|antimetabolites|mesh-ancestor
64759663|NCT00439296|Dermatologic Agents|dermatologic agents|mesh-ancestor
64644291|NCT04866602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64644292|NCT04866602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64644293|NCT04866602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644294|NCT04866602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644296|NCT00578552|Gabapentin|gabapentin|mesh-list
64644315|NCT01532089|Antibodies|antibodies|mesh-list
64759664|NCT00439296|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64759665|NCT00439296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64759666|NCT00439296|Antiviral Agents|antiviral agents|mesh-ancestor
64759667|NCT00439296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64759668|NCT03117660|Vitamin A|vitamin a|mesh-list
64759669|NCT03117660|Vitamins|vitamins|mesh-ancestor
64759670|NCT03117660|Micronutrients|micronutrients|mesh-ancestor
64759671|NCT03117660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759704|NCT00443352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759705|NCT00443352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64759706|NCT00443352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759707|NCT00443352|Analgesics|analgesics|mesh-ancestor
64759708|NCT00443352|Sensory System Agents|sensory system agents|mesh-ancestor
64759709|NCT00443352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64759710|NCT00443352|Antidepressive Agents|antidepressive agents|mesh-ancestor
64759711|NCT00443352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64759712|NCT00443352|Dopamine Agents|dopamine agents|mesh-ancestor
64759713|NCT00445302|Plerixafor|plerixafor|mesh-list
64759714|NCT00445302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64759715|NCT00445302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64759716|NCT00445302|Antiviral Agents|antiviral agents|mesh-ancestor
64759717|NCT00445302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64759718|NCT00504504|Rituximab|rituximab|mesh-list
64759719|NCT00504504|Doxorubicin|doxorubicin|mesh-list
64644351|NCT00579878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64644352|NCT00579878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64644353|NCT00579878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64644354|NCT00579878|Analgesics|analgesics|mesh-ancestor
64644355|NCT00579878|Sensory System Agents|sensory system agents|mesh-ancestor
64759720|NCT00504504|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64644356|NCT00579878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64759721|NCT00504504|Dacarbazine|dacarbazine|mesh-list
64759722|NCT00504504|Bleomycin|bleomycin|mesh-list
64644362|NCT01533259|Antiviral Agents|antiviral agents|mesh-ancestor
64759723|NCT00504504|Vinblastine|vinblastine|mesh-list
64759724|NCT00504504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64759725|NCT00504504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759726|NCT00504504|Immunologic Factors|immunologic factors|mesh-ancestor
64759727|NCT00504504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759728|NCT00504504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64759729|NCT00504504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64759730|NCT00504504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64759754|NCT00504660|Sensory System Agents|sensory system agents|mesh-ancestor
64759755|NCT00504660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64759756|NCT00504660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759757|NCT00504660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64759758|NCT00504660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64759759|NCT00504660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64759760|NCT00504660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64759761|NCT00504660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759762|NCT00505518|Psychotropic Drugs|psychotropic drugs|mesh-list
64759763|NCT00544908|Dasatinib|dasatinib|mesh-list
64644396|NCT05245604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64644397|NCT05245604|Immunologic Factors|immunologic factors|mesh-ancestor
64644398|NCT05245604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644399|NCT05245604|Antifungal Agents|antifungal agents|mesh-ancestor
64644400|NCT05245604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64644401|NCT05245604|Dermatologic Agents|dermatologic agents|mesh-ancestor
64644402|NCT05245604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64644403|NCT05245604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64644404|NCT05245604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64644405|NCT05245448|Tetrandrine|tetrandrine|mesh-list
64644406|NCT05245448|Antimalarials|antimalarials|mesh-ancestor
64644407|NCT05245448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64644409|NCT05245448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64644410|NCT05245448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64759764|NCT00544908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759765|NCT00544908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64759766|NCT00544908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759767|NCT00544908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759768|NCT00447330|Bevacizumab|bevacizumab|mesh-list
64759769|NCT00447330|Capecitabine|capecitabine|mesh-list
64759770|NCT00447330|Oxaliplatin|oxaliplatin|mesh-list
64759771|NCT00447330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64759772|NCT00447330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759773|NCT00447330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64759774|NCT00447330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64759775|NCT00447330|Growth Substances|growth substances|mesh-ancestor
64759776|NCT00447330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759777|NCT00447330|Growth Inhibitors|growth inhibitors|mesh-ancestor
64759778|NCT00447330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64759779|NCT00447330|Antimetabolites|antimetabolites|mesh-ancestor
64759802|NCT00546156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759803|NCT00546156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64759804|NCT00546156|Immunologic Factors|immunologic factors|mesh-ancestor
64644440|NCT01798472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644441|NCT01579513|Methylprednisolone|methylprednisolone|mesh-list
64644442|NCT01579513|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64644443|NCT01579513|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64644444|NCT01579513|Prednisolone|prednisolone|mesh-list
64644445|NCT01579513|Prednisolone acetate|prednisolone acetate|mesh-list
64644446|NCT01579513|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64644447|NCT01579513|Prednisolone phosphate|prednisolone phosphate|mesh-list
64644448|NCT01579513|Glucocorticoids|glucocorticoids|mesh-list
64644449|NCT01579513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64759805|NCT00546156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759806|NCT00546156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64759807|NCT00546156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64759808|NCT00546156|Alkylating Agents|alkylating agents|mesh-ancestor
64759809|NCT00546156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64759810|NCT00546156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64759811|NCT00546156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64759812|NCT00546156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64759814|NCT00546156|Growth Inhibitors|growth inhibitors|mesh-ancestor
64759815|NCT00546156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64759816|NCT00546156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64759817|NCT00546156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64759818|NCT00546156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759819|NCT00449046|Fluticasone|fluticasone|mesh-list
64759820|NCT00449046|Xhance|xhance|mesh-list
64759821|NCT00449046|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64759822|NCT00449046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64759823|NCT00449046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64759824|NCT00449046|Autonomic Agents|autonomic agents|mesh-ancestor
64759825|NCT00449046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64759826|NCT00449046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759827|NCT00449046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64759828|NCT00449046|Respiratory System Agents|respiratory system agents|mesh-ancestor
64759829|NCT00449046|Dermatologic Agents|dermatologic agents|mesh-ancestor
64759830|NCT00449046|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64759831|NCT00449046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64759832|NCT00449046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64759833|NCT00449046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64759834|NCT00449046|Adrenergic Agents|adrenergic agents|mesh-ancestor
64759835|NCT00449046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64759836|NCT00449046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759837|NCT00449748|Everolimus|everolimus|mesh-list
64371763|NCT04983615|Anesthetics, General|anesthetics, general|mesh-ancestor
64644487|NCT00583622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759838|NCT00449748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759839|NCT00449748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64759840|NCT00449748|Immunologic Factors|immunologic factors|mesh-ancestor
64759841|NCT00449748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759842|NCT00509496|Aldesleukin|aldesleukin|mesh-list
64759843|NCT00509496|Cyclophosphamide|cyclophosphamide|mesh-list
64759844|NCT00509496|Fludarabine|fludarabine|mesh-list
64759845|NCT00509496|Fludarabine phosphate|fludarabine phosphate|mesh-list
64759846|NCT00509496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64759847|NCT00509496|Immunologic Factors|immunologic factors|mesh-ancestor
64759848|NCT00509496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759849|NCT00509496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64759850|NCT00509496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64759851|NCT00509496|Alkylating Agents|alkylating agents|mesh-ancestor
64759852|NCT00509496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759853|NCT00509496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759854|NCT00509496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64644529|NCT04224428|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64644530|NCT04224428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64644531|NCT04224428|Histamine Antagonists|histamine antagonists|mesh-ancestor
64644532|NCT04224428|Histamine Agents|histamine agents|mesh-ancestor
64644533|NCT04224428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64644534|NCT04224428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644535|NCT04224428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759855|NCT00509496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64644536|NCT04224194|Adalimumab|adalimumab|mesh-list
64759856|NCT00509496|Antimetabolites|antimetabolites|mesh-ancestor
64759857|NCT00509496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64759858|NCT00509496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64759859|NCT00509496|Antiviral Agents|antiviral agents|mesh-ancestor
64759861|NCT00548418|Bevacizumab|bevacizumab|mesh-list
64759862|NCT00548418|Topotecan|topotecan|mesh-list
64759874|NCT00511992|Paclitaxel|paclitaxel|mesh-list
64759887|NCT00511992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759888|NCT00511992|Growth Inhibitors|growth inhibitors|mesh-ancestor
64759889|NCT00451698|Epoetin Alfa|epoetin alfa|mesh-list
64759890|NCT00451698|Hematinics|hematinics|mesh-ancestor
64759891|NCT00549042|Hydromorphone|hydromorphone|mesh-list
64759892|NCT00549042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64759893|NCT00549042|Narcotics|narcotics|mesh-ancestor
64759894|NCT00549042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64759895|NCT00549042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759896|NCT00549042|Analgesics|analgesics|mesh-ancestor
64759897|NCT00549042|Sensory System Agents|sensory system agents|mesh-ancestor
64759898|NCT00549042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64759899|NCT00452868|Donepezil|donepezil|mesh-list
64759900|NCT00452868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64759901|NCT00452868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644576|NCT00605072|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64644577|NCT00605072|Protease Inhibitors|protease inhibitors|mesh-ancestor
64644578|NCT00605072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644579|NCT00605072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64644580|NCT00605072|Protective Agents|protective agents|mesh-ancestor
64644581|NCT00585104|Simendan|simendan|mesh-list
64759902|NCT00452868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644582|NCT00585104|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64759903|NCT00452868|Cholinergic Agents|cholinergic agents|mesh-ancestor
64644583|NCT00585104|Vasodilator Agents|vasodilator agents|mesh-ancestor
64759904|NCT00452868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64759905|NCT00452868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759906|NCT00452868|Nootropic Agents|nootropic agents|mesh-ancestor
64759907|NCT00453336|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
64759908|NCT00453336|Trioxsalen|trioxsalen|mesh-list
64759909|NCT00453336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644621|NCT00605384|Entecavir|entecavir|mesh-list
64644622|NCT00605384|Adefovir|adefovir|mesh-list
64644623|NCT00605384|Antiviral Agents|antiviral agents|mesh-ancestor
64644624|NCT00605384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64644625|NCT00605384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64759910|NCT00453336|Dermatologic Agents|dermatologic agents|mesh-ancestor
64759911|NCT00453336|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64759912|NCT00549822|Letrozole|letrozole|mesh-list
64759913|NCT00549822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759914|NCT00549822|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64759915|NCT00549822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64759916|NCT00549822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644626|NCT00605384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64644627|NCT00605384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644629|NCT00605384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64759917|NCT00549822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759918|NCT00549822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64644678|NCT04545008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64759931|NCT01797198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759932|NCT01797198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64759933|NCT01797198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64759934|NCT01797198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64759935|NCT01797198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759936|NCT00552786|Acetylcysteine|acetylcysteine|mesh-list
64759937|NCT00552786|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64759938|NCT00552786|Antiviral Agents|antiviral agents|mesh-ancestor
64759939|NCT00552786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64759940|NCT00552786|Expectorants|expectorants|mesh-ancestor
64759941|NCT00552786|Respiratory System Agents|respiratory system agents|mesh-ancestor
64759942|NCT00552786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64759943|NCT00552786|Antioxidants|antioxidants|mesh-ancestor
64759944|NCT00552786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759945|NCT00552786|Protective Agents|protective agents|mesh-ancestor
64759946|NCT00552786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759947|NCT00552786|Antidotes|antidotes|mesh-ancestor
64759948|NCT00517530|Obinutuzumab|obinutuzumab|mesh-list
64759949|NCT00517530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64759950|NCT00517530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759951|NCT00518154|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
64759952|NCT00518154|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64759953|NCT00518154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759954|NCT00518154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759955|NCT00518154|Cholinergic Agents|cholinergic agents|mesh-ancestor
64759956|NCT00518154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64759957|NCT00518154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759958|NCT00553098|Cyclosporine|cyclosporine|mesh-list
64759959|NCT00553098|Mycophenolic Acid|mycophenolic acid|mesh-list
64759960|NCT00553098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64759961|NCT00553098|Alemtuzumab|alemtuzumab|mesh-list
64528717|NCT02662764|Anesthetics|anesthetics|mesh-ancestor
64759962|NCT00553098|Fludarabine|fludarabine|mesh-list
64759972|NCT00553098|Antimetabolites|antimetabolites|mesh-ancestor
64759973|NCT00553098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759974|NCT00553098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64759975|NCT00553098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759976|NCT00553098|Antifungal Agents|antifungal agents|mesh-ancestor
64759977|NCT00553098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64759978|NCT00553098|Dermatologic Agents|dermatologic agents|mesh-ancestor
64759979|NCT00553098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64759980|NCT00553098|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64759981|NCT00553098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64759982|NCT00553098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64644679|NCT04527770|Dexamethasone|dexamethasone|mesh-list
64759983|NCT00553098|Antitubercular Agents|antitubercular agents|mesh-ancestor
64759984|NCT00553098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64759985|NCT00553410|Letrozole|letrozole|mesh-list
64759986|NCT00553410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64759987|NCT00553410|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64759988|NCT00553410|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64759989|NCT00553410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64759990|NCT00553410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64759991|NCT00553410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64759992|NCT00553410|Hormone Antagonists|hormone antagonists|mesh-ancestor
64759993|NCT00553410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64759994|NCT00553410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64759995|NCT00554970|Budesonide|budesonide|mesh-list
64759996|NCT00554970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64759997|NCT00554970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64759998|NCT00554970|Autonomic Agents|autonomic agents|mesh-ancestor
64759999|NCT00554970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64760000|NCT00554970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644706|NCT01798940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64760001|NCT00554970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64760002|NCT00554970|Respiratory System Agents|respiratory system agents|mesh-ancestor
64760015|NCT00555048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64644707|NCT01798940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644708|NCT00609128|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64644709|NCT00609128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64644710|NCT00609128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64644711|NCT00609128|Analgesics|analgesics|mesh-ancestor
64644712|NCT00609128|Sensory System Agents|sensory system agents|mesh-ancestor
64644713|NCT00609128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370005|NCT03200197|Menthol|menthol|mesh-list
64644714|NCT00609128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644715|NCT00609128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64644716|NCT00609128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64644717|NCT00609128|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64644718|NCT00609128|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64644719|NCT00609128|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64644720|NCT00609128|Histamine Antagonists|histamine antagonists|mesh-ancestor
64644721|NCT00609128|Histamine Agents|histamine agents|mesh-ancestor
64644722|NCT00609128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64644723|NCT00609128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760016|NCT00555048|Immunologic Factors|immunologic factors|mesh-ancestor
64760017|NCT00555048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760018|NCT00555048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64760019|NCT00555048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64760020|NCT00555048|Alkylating Agents|alkylating agents|mesh-ancestor
64760021|NCT00555048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760022|NCT00555048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760023|NCT00555048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64445650|NCT04813991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64760024|NCT00555048|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64760025|NCT00555048|Abortifacient Agents|abortifacient agents|mesh-ancestor
64760026|NCT00555048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64760027|NCT00555048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64760028|NCT00555048|Antimetabolites|antimetabolites|mesh-ancestor
64760029|NCT00555048|Dermatologic Agents|dermatologic agents|mesh-ancestor
64760030|NCT00555048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64760031|NCT00555048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64760032|NCT00555048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64760033|NCT00555048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64760034|NCT00555048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64644738|NCT00610688|Ergocalciferols|ergocalciferols|mesh-list
64644739|NCT00610688|Cholecalciferol|cholecalciferol|mesh-list
64644740|NCT00610688|Vitamins|vitamins|mesh-list
64644741|NCT00610688|Micronutrients|micronutrients|mesh-ancestor
64644742|NCT00610688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644743|NCT00610688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64644744|NCT00610688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64644745|NCT00669578|Pomalidomide|pomalidomide|mesh-list
64644746|NCT00669578|Immunologic Factors|immunologic factors|mesh-ancestor
64644747|NCT00669578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760035|NCT00525798|Calcitonin|calcitonin|mesh-list
64528793|NCT01531153|Autonomic Agents|autonomic agents|mesh-ancestor
64760036|NCT00525798|Salmon calcitonin|salmon calcitonin|mesh-list
64760037|NCT00525798|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
64760038|NCT00525798|Katacalcin|katacalcin|mesh-list
64760039|NCT00525798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64760040|NCT00525798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760041|NCT00525798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64760042|NCT00525798|Vasodilator Agents|vasodilator agents|mesh-ancestor
64760043|NCT00525876|Cyclophosphamide|cyclophosphamide|mesh-list
64760044|NCT00525876|Rituximab|rituximab|mesh-list
64760045|NCT00525876|Fludarabine|fludarabine|mesh-list
64760046|NCT00525876|Fludarabine phosphate|fludarabine phosphate|mesh-list
64760054|NCT00525876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644782|NCT00670982|Growth Inhibitors|growth inhibitors|mesh-ancestor
64644783|NCT00670982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64644784|NCT00670982|Tubulin Modulators|tubulin modulators|mesh-ancestor
64644785|NCT00670982|Antimitotic Agents|antimitotic agents|mesh-ancestor
64644786|NCT00670982|Mitosis Modulators|mitosis modulators|mesh-ancestor
64644787|NCT00670982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644788|NCT00612560|Anastrozole|anastrozole|mesh-list
64644789|NCT00612560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64370079|NCT02479529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64644790|NCT00612560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644791|NCT00612560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64644792|NCT00612560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64644793|NCT00612560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644794|NCT00612560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760055|NCT00525876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644799|NCT00612716|Cyclophosphamide|cyclophosphamide|mesh-list
64760056|NCT00525876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64760057|NCT00525876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64760058|NCT00525876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64760059|NCT00525876|Antimetabolites|antimetabolites|mesh-ancestor
64760060|NCT00555750|Eszopiclone|eszopiclone|mesh-list
64760061|NCT00555750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64760062|NCT00555750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64760063|NCT00555750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760064|NCT00556140|Aripiprazole|aripiprazole|mesh-list
64760065|NCT00556140|Antidepressive Agents|antidepressive agents|mesh-ancestor
64760066|NCT00556140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64760067|NCT00556140|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64760068|NCT00556140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64760069|NCT00556140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64760070|NCT00556140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760071|NCT00556140|Dopamine Agonists|dopamine agonists|mesh-ancestor
64760072|NCT00556140|Dopamine Agents|dopamine agents|mesh-ancestor
64760073|NCT00556140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64760074|NCT00556140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760075|NCT00556140|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64760076|NCT00556140|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64760082|NCT00527124|Prednisone|prednisone|mesh-list
64760103|NCT00556452|Busulfan|busulfan|mesh-list
64760104|NCT00556452|Clofarabine|clofarabine|mesh-list
64760105|NCT00556452|Alkylating Agents|alkylating agents|mesh-ancestor
64760106|NCT00556452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644826|NCT00613028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64644827|NCT00613028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64303854|NCT02783599|Olaratumab|olaratumab|mesh-list
64644829|NCT00613028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644830|NCT00613028|Growth Inhibitors|growth inhibitors|mesh-ancestor
64644831|NCT00613028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64644832|NCT00613028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64644838|NCT01799798|Denosumab|denosumab|mesh-list
64760107|NCT00556452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64760108|NCT00556452|Immunologic Factors|immunologic factors|mesh-ancestor
64760109|NCT00556452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760110|NCT00556452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64760111|NCT00556452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760112|NCT00556452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64760113|NCT00556452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64760114|NCT00556452|Antimetabolites|antimetabolites|mesh-ancestor
64760115|NCT03158376|Gabapentin|gabapentin|mesh-list
64760116|NCT03158376|Analgesics|analgesics|mesh-ancestor
64760117|NCT03158376|Sensory System Agents|sensory system agents|mesh-ancestor
64760118|NCT03158376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64760119|NCT03158376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760120|NCT03158376|Anticonvulsants|anticonvulsants|mesh-ancestor
64760121|NCT03158376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64760122|NCT03158376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64760123|NCT03158376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64760124|NCT03158376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64760125|NCT03158376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64760126|NCT03158376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64760127|NCT03158376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64760128|NCT03158376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760130|NCT01797900|Paclitaxel|paclitaxel|mesh-list
64760149|NCT03428802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760150|NCT03379194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64644866|NCT00672932|Antiviral Agents|antiviral agents|mesh-ancestor
64644867|NCT00672932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64644868|NCT00672932|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64644869|NCT00672932|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64644870|NCT00672932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644871|NCT00672932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644872|NCT02513550|Ixekizumab|ixekizumab|mesh-list
64644873|NCT02513550|Dermatologic Agents|dermatologic agents|mesh-ancestor
64760151|NCT03379194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64760152|NCT04429542|Pembrolizumab|pembrolizumab|mesh-list
64760153|NCT04429542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64760154|NCT04429542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760155|NCT02319486|Carboplatin|carboplatin|mesh-list
64760156|NCT02319486|Etoposide|etoposide|mesh-list
64760157|NCT02319486|Vincristine|vincristine|mesh-list
64760158|NCT02319486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760159|NCT02319486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64760160|NCT02319486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64760161|NCT02319486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64760162|NCT02319486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64760163|NCT02319486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644908|NCT03722966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64644909|NCT03722966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644910|NCT03722966|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64644911|NCT03722966|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64760164|NCT02319486|Tubulin Modulators|tubulin modulators|mesh-ancestor
64760165|NCT02319486|Antimitotic Agents|antimitotic agents|mesh-ancestor
64760166|NCT02319486|Mitosis Modulators|mitosis modulators|mesh-ancestor
64760167|NCT03117972|Leucovorin|leucovorin|mesh-list
64760168|NCT03117972|Bevacizumab|bevacizumab|mesh-list
64760169|NCT03117972|Fluorouracil|fluorouracil|mesh-list
64760170|NCT03117972|Capecitabine|capecitabine|mesh-list
64760171|NCT03117972|Oxaliplatin|oxaliplatin|mesh-list
64760172|NCT03117972|Irinotecan|irinotecan|mesh-list
64760173|NCT03117972|Levoleucovorin|levoleucovorin|mesh-list
64760174|NCT03117972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64760175|NCT03117972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760176|NCT03117972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64644964|NCT03007303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64644965|NCT03007303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644966|NCT03007303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760177|NCT03117972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64760178|NCT03117972|Growth Substances|growth substances|mesh-ancestor
64760179|NCT03117972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760197|NCT01330446|Modafinil|modafinil|mesh-list
64644967|NCT03007303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64644968|NCT03007303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64644969|NCT03007303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64644970|NCT03007303|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64644971|NCT03007303|Dopamine Agents|dopamine agents|mesh-ancestor
64644972|NCT03007303|Antiemetics|antiemetics|mesh-ancestor
64644973|NCT03007303|Autonomic Agents|autonomic agents|mesh-ancestor
64644974|NCT03007303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64644975|NCT03007303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64760198|NCT01330446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64644976|NCT03007303|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64760199|NCT01330446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760200|NCT01330446|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64760201|NCT01330446|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64645011|NCT01588561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64645012|NCT01588561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645014|NCT00619190|Antidepressive Agents|antidepressive agents|mesh-ancestor
64760202|NCT01330446|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64760203|NCT01330446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760204|NCT00558012|Vitamin D|vitamin d|mesh-list
64760205|NCT00558012|Zoledronic Acid|zoledronic acid|mesh-list
64760206|NCT00558012|Calcium|calcium|mesh-list
64760207|NCT00558012|Vitamins|vitamins|mesh-ancestor
64760208|NCT00558012|Micronutrients|micronutrients|mesh-ancestor
64760209|NCT00558012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760210|NCT00558012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64760211|NCT00558012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64760212|NCT00561834|Ranibizumab|ranibizumab|mesh-list
64760213|NCT00561834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64760214|NCT00561834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64760215|NCT00561834|Growth Substances|growth substances|mesh-ancestor
64645015|NCT00619190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64760216|NCT00561834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645016|NCT00619190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64760217|NCT00561834|Growth Inhibitors|growth inhibitors|mesh-ancestor
64760218|NCT00561834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760219|NCT04388202|Citalopram|citalopram|mesh-list
64760220|NCT04388202|Sertraline|sertraline|mesh-list
64760221|NCT04388202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64760222|NCT04388202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64760223|NCT04388202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64760224|NCT04388202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760225|NCT04388202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64760226|NCT04388202|Serotonin Agents|serotonin agents|mesh-ancestor
64760227|NCT04388202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760228|NCT04388202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64760229|NCT04388202|Antidepressive Agents|antidepressive agents|mesh-ancestor
64760230|NCT04388202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64760237|NCT02128230|Doxorubicin|doxorubicin|mesh-list
64760238|NCT02128230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64645065|NCT00675584|Respiratory System Agents|respiratory system agents|mesh-ancestor
64645066|NCT00675584|Glucocorticoids|glucocorticoids|mesh-ancestor
64645067|NCT00675584|Hormones|hormones|mesh-ancestor
64645068|NCT00675584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64760239|NCT02128230|Etoposide|etoposide|mesh-list
64645069|NCT03376646|Paclitaxel|paclitaxel|mesh-list
64645070|NCT03376646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64645071|NCT03376646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645072|NCT03376646|Tubulin Modulators|tubulin modulators|mesh-ancestor
64645073|NCT03376646|Antimitotic Agents|antimitotic agents|mesh-ancestor
64645074|NCT03376646|Mitosis Modulators|mitosis modulators|mesh-ancestor
64760240|NCT02128230|Etoposide phosphate|etoposide phosphate|mesh-list
64645075|NCT03376646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760241|NCT02128230|Lenalidomide|lenalidomide|mesh-list
64760242|NCT02128230|Lenograstim|lenograstim|mesh-list
64760243|NCT02128230|BB 1101|bb 1101|mesh-list
64760244|NCT02128230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64760245|NCT02128230|Immunologic Factors|immunologic factors|mesh-ancestor
64760246|NCT02128230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760247|NCT02128230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64760248|NCT02128230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64760249|NCT02128230|Alkylating Agents|alkylating agents|mesh-ancestor
64760250|NCT02128230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760251|NCT02128230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760252|NCT02128230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64760253|NCT02128230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64760254|NCT02128230|Antiemetics|antiemetics|mesh-ancestor
64645112|NCT00621530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645113|NCT00621530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645114|NCT02513472|Pembrolizumab|pembrolizumab|mesh-list
64645115|NCT02513472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64645116|NCT02513472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645117|NCT00621686|Bevacizumab|bevacizumab|mesh-list
64645118|NCT00621686|Sorafenib|sorafenib|mesh-list
64645119|NCT00621686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64645120|NCT00621686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760255|NCT02128230|Autonomic Agents|autonomic agents|mesh-ancestor
64645134|NCT00678470|Alefacept|alefacept|mesh-list
64760256|NCT02128230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64760292|NCT04388124|Bosentan|bosentan|mesh-list
64760293|NCT04388124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64760294|NCT04388124|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64760295|NCT04388124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760296|NCT03172416|Oxaliplatin|oxaliplatin|mesh-list
64760297|NCT03172416|Nivolumab|nivolumab|mesh-list
64760298|NCT03172416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760299|NCT03172416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64760300|NCT03172416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64645162|NCT02446964|Immunologic Factors|immunologic factors|mesh-ancestor
64645163|NCT02446964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645164|NCT02446964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64645165|NCT02446964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64645166|NCT02446964|Alkylating Agents|alkylating agents|mesh-ancestor
64645183|NCT00623714|Xhance|xhance|mesh-list
64760301|NCT03172416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760302|NCT05559996|Hyaluronic Acid|hyaluronic acid|mesh-list
64760303|NCT05559996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64760304|NCT05559996|Immunologic Factors|immunologic factors|mesh-ancestor
64760305|NCT05559996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760306|NCT05559996|Viscosupplements|viscosupplements|mesh-ancestor
64760307|NCT05559996|Protective Agents|protective agents|mesh-ancestor
64760308|NCT02812212|Diuretics|diuretics|mesh-list
64760309|NCT02812212|Natriuretic Agents|natriuretic agents|mesh-ancestor
64760310|NCT02812212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760311|NCT05559450|Blinatumomab|blinatumomab|mesh-list
64760312|NCT05559450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760313|NCT00564954|Methylphenidate|methylphenidate|mesh-list
64760314|NCT00564954|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
64645222|NCT00624416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64645223|NCT00624416|Glucocorticoids|glucocorticoids|mesh-ancestor
64645224|NCT00624416|Hormones|hormones|mesh-ancestor
64645225|NCT00624416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64645226|NCT00624416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645227|NCT00624416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64645228|NCT00624416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645229|NCT00624416|Antiemetics|antiemetics|mesh-ancestor
64645230|NCT00624416|Autonomic Agents|autonomic agents|mesh-ancestor
64645231|NCT00624416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64760315|NCT00564954|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64760316|NCT00564954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760317|NCT00564954|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64760318|NCT00564954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64760319|NCT00564954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64760320|NCT00564954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760321|NCT00564954|Dopamine Agents|dopamine agents|mesh-ancestor
64760322|NCT00564954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64760334|NCT00565266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64529091|NCT01527487|Alkylating Agents|alkylating agents|mesh-ancestor
64760335|NCT00565266|Cholinergic Agents|cholinergic agents|mesh-ancestor
64760336|NCT00565266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64760337|NCT00565266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760338|NCT00565266|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64760339|NCT00565266|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64760340|NCT00565266|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64760341|NCT00565266|Adrenergic Agents|adrenergic agents|mesh-ancestor
64760343|NCT00565266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64645273|NCT00653276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64645274|NCT00653276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64645275|NCT00653276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64645276|NCT00653276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64645277|NCT00653276|Antimetabolites|antimetabolites|mesh-ancestor
64645278|NCT00653276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64645279|NCT00683852|Aripiprazole|aripiprazole|mesh-list
64645280|NCT00683852|Antidepressive Agents|antidepressive agents|mesh-ancestor
64645281|NCT00683852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64645282|NCT00683852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64645283|NCT00683852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64645284|NCT00683852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64645285|NCT00683852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645286|NCT00683852|Dopamine Agonists|dopamine agonists|mesh-ancestor
64645287|NCT00683852|Dopamine Agents|dopamine agents|mesh-ancestor
64645288|NCT00683852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64645289|NCT00683852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645290|NCT00683852|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64645291|NCT00683852|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64760344|NCT00565266|Glucocorticoids|glucocorticoids|mesh-ancestor
64760345|NCT00565266|Hormones|hormones|mesh-ancestor
64760346|NCT00565266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64760396|NCT05362500|Tranexamic Acid|tranexamic acid|mesh-list
64760397|NCT05362500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64760398|NCT05362500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64760399|NCT05362500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760400|NCT05362500|Hemostatics|hemostatics|mesh-ancestor
64645311|NCT03006757|Dermatologic Agents|dermatologic agents|mesh-ancestor
64645312|NCT03006757|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64645313|NCT05566405|Anesthetics|anesthetics|mesh-list
64645314|NCT05566405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64645315|NCT05566405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645316|NCT03000127|Testosterone|testosterone|mesh-list
64645317|NCT03000127|Androgens|androgens|mesh-ancestor
64760401|NCT05362500|Coagulants|coagulants|mesh-ancestor
64760402|NCT05362500|Keratolytic Agents|keratolytic agents|mesh-ancestor
64760403|NCT05362500|Dermatologic Agents|dermatologic agents|mesh-ancestor
64760404|NCT05362500|Antidepressive Agents|antidepressive agents|mesh-ancestor
64760405|NCT05362500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64760406|NCT05362500|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64645377|NCT03006211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64645378|NCT03006211|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64760407|NCT05362500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64760408|NCT05362500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64760409|NCT05362500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64760410|NCT05362500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64760411|NCT05362500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760412|NCT05161806|Aflibercept|aflibercept|mesh-list
64760413|NCT05161806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64760414|NCT05161806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64760415|NCT05161806|Growth Substances|growth substances|mesh-ancestor
64645379|NCT03006211|Vasodilator Agents|vasodilator agents|mesh-ancestor
64645380|NCT03006211|Gasotransmitters|gasotransmitters|mesh-ancestor
64645381|NCT03006211|Protective Agents|protective agents|mesh-ancestor
64645382|NCT02248051|CXA-10|cxa-10|mesh-list
64760416|NCT05161806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645383|NCT02248051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64645384|NCT02247505|Tadalafil|tadalafil|mesh-list
64760417|NCT05161806|Growth Inhibitors|growth inhibitors|mesh-ancestor
64760418|NCT05161806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760419|NCT05362188|Niacinamide|niacinamide|mesh-list
64760420|NCT05362188|Niacin|niacin|mesh-list
64760421|NCT05362188|Nicotinic Acids|nicotinic acids|mesh-list
64760422|NCT05362188|Vitamin B Complex|vitamin b complex|mesh-ancestor
64760423|NCT05362188|Vitamins|vitamins|mesh-ancestor
64760424|NCT05362188|Micronutrients|micronutrients|mesh-ancestor
64760425|NCT05362188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760426|NCT05362188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64760427|NCT05362188|Antimetabolites|antimetabolites|mesh-ancestor
64760428|NCT05362188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760429|NCT05362188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64760430|NCT05362188|Vasodilator Agents|vasodilator agents|mesh-ancestor
64760438|NCT05353374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64760439|NCT05353374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64760440|NCT05353374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64760441|NCT05353374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64760442|NCT05353374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760443|NCT05214222|Paclitaxel|paclitaxel|mesh-list
64760444|NCT05214222|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64760445|NCT05214222|Cisplatin|cisplatin|mesh-list
64760446|NCT05214222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64760447|NCT05214222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760448|NCT05214222|Tubulin Modulators|tubulin modulators|mesh-ancestor
64760449|NCT05214222|Antimitotic Agents|antimitotic agents|mesh-ancestor
64760450|NCT05214222|Mitosis Modulators|mitosis modulators|mesh-ancestor
64760451|NCT05214222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760452|NCT05290740|Norepinephrine|norepinephrine|mesh-list
64760453|NCT05290740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64760454|NCT05290740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64760455|NCT05290740|Adrenergic Agents|adrenergic agents|mesh-ancestor
64760456|NCT05290740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64760457|NCT05290740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760458|NCT05290740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760459|NCT05290740|Sympathomimetics|sympathomimetics|mesh-ancestor
64760460|NCT05290740|Autonomic Agents|autonomic agents|mesh-ancestor
64760461|NCT05290740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64760462|NCT05290740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64760463|NCT05198232|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
64760464|NCT05198232|TEMPO|tempo|mesh-list
64760465|NCT05198232|Antioxidants|antioxidants|mesh-ancestor
64760466|NCT05198232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760467|NCT05198232|Protective Agents|protective agents|mesh-ancestor
64645428|NCT05672251|Immunologic Factors|immunologic factors|mesh-ancestor
64645429|NCT05672251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760468|NCT05198232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645430|NCT05672251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64760469|NCT05198232|Antacids|antacids|mesh-ancestor
64760470|NCT05198232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64760478|NCT04747236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760479|NCT04747236|Antiviral Agents|antiviral agents|mesh-ancestor
64760480|NCT04747236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64760481|NCT04747236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64760482|NCT04747236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64760483|NCT04747236|Immunologic Factors|immunologic factors|mesh-ancestor
64760484|NCT04747236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760485|NCT04747236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64760486|NCT04747236|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64760488|NCT01797666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64760489|NCT01797666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760491|NCT05017194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64760492|NCT05017194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64760493|NCT04501380|Rifamycins|rifamycins|mesh-list
64760494|NCT04501380|Rifamycin SV|rifamycin sv|mesh-list
64760495|NCT04501380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64760496|NCT04501380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64760497|NCT04501380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64760498|NCT04465734|Sorafenib|sorafenib|mesh-list
64760499|NCT04465734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760500|NCT04465734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64760501|NCT04465734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64760502|NCT04465734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645454|NCT00684242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645455|NCT00684242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64760531|NCT01798602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64760532|NCT01798602|Antimetabolites|antimetabolites|mesh-ancestor
64760533|NCT01798602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760534|NCT01798602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64760535|NCT01798602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64760536|NCT01798602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64760538|NCT02783430|Milnacipran|milnacipran|mesh-list
64760539|NCT02783430|Levomilnacipran|levomilnacipran|mesh-list
64760540|NCT02783430|Analgesics|analgesics|mesh-ancestor
64760541|NCT02783430|Sensory System Agents|sensory system agents|mesh-ancestor
64760542|NCT02783430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64760543|NCT02783430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760544|NCT02783430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64760545|NCT02783430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64760546|NCT02783430|Anesthetics, General|anesthetics, general|mesh-ancestor
64760547|NCT02783430|Anesthetics|anesthetics|mesh-ancestor
64760548|NCT02783430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64760549|NCT02783430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64760550|NCT02783430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64760551|NCT02783430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64760552|NCT02783430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760553|NCT02783430|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64760554|NCT02783430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64760555|NCT02783430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64760556|NCT02783430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64760557|NCT02783430|Antidepressive Agents|antidepressive agents|mesh-ancestor
64760558|NCT02783430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64760559|NCT03642366|Tadalafil|tadalafil|mesh-list
64760560|NCT03642366|Vasodilator Agents|vasodilator agents|mesh-ancestor
64760561|NCT03642366|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64760562|NCT03642366|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64529314|NCT01504841|Etravirine|etravirine|mesh-list
64760569|NCT00604968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760570|NCT00604968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64760571|NCT00604968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64760572|NCT00604968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64760573|NCT00604968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760574|NCT00605202|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64645498|NCT00628394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64645499|NCT00628394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64645500|NCT00628394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645501|NCT00628394|Adrenergic Agents|adrenergic agents|mesh-ancestor
64645502|NCT00628394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64645505|NCT00251576|Calcium heparin|calcium heparin|mesh-list
64760575|NCT00605202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64760576|NCT00605202|Diuretics|diuretics|mesh-ancestor
64760577|NCT00605202|Natriuretic Agents|natriuretic agents|mesh-ancestor
64760578|NCT00605202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645536|NCT03005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760579|NCT00605202|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64760580|NCT00605202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64760581|NCT00605202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760582|NCT03548454|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64760583|NCT03548454|Desipramine|desipramine|mesh-list
64760584|NCT03548454|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64645537|NCT00628628|Rasburicase|rasburicase|mesh-list
64645538|NCT00628628|Gout Suppressants|gout suppressants|mesh-ancestor
64645539|NCT00628628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64645541|NCT04386811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64760585|NCT03548454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64645546|NCT04386811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64760586|NCT03548454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64760587|NCT03548454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760588|NCT03548454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64760589|NCT03548454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760590|NCT03548454|Analgesics|analgesics|mesh-ancestor
64760591|NCT03548454|Sensory System Agents|sensory system agents|mesh-ancestor
64760592|NCT03548454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64760593|NCT03548454|Antidepressive Agents|antidepressive agents|mesh-ancestor
64760594|NCT03548454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64760595|NCT03548454|Dopamine Agents|dopamine agents|mesh-ancestor
64760596|NCT03548454|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64760597|NCT03548454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645597|NCT00630734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64645598|NCT00630734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64645599|NCT00630734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64645600|NCT00630734|Antimetabolites|antimetabolites|mesh-ancestor
64645603|NCT05644249|Doxorubicin|doxorubicin|mesh-list
64760598|NCT03548454|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64760599|NCT03548454|Adrenergic Agents|adrenergic agents|mesh-ancestor
64760600|NCT00605904|Acamprosate|acamprosate|mesh-list
64760601|NCT00605904|Yohimbine|yohimbine|mesh-list
64760602|NCT00605904|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64760603|NCT00605904|Mydriatics|mydriatics|mesh-ancestor
64760604|NCT00605904|Autonomic Agents|autonomic agents|mesh-ancestor
64760605|NCT00605904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64760606|NCT00605904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760607|NCT00605904|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64760608|NCT00605904|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64760609|NCT00605904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64760610|NCT00605904|Adrenergic Agents|adrenergic agents|mesh-ancestor
64760611|NCT00605904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64760612|NCT00605904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645654|NCT00687674|Dexamethasone|dexamethasone|mesh-list
64760613|NCT00605904|Urological Agents|urological agents|mesh-ancestor
64760614|NCT01798914|Insulin|insulin|mesh-list
64760615|NCT01798914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64760616|NCT01798914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760617|NCT05194488|Botulinum Toxins|botulinum toxins|mesh-list
64760618|NCT05194488|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64760619|NCT05194488|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64760620|NCT05194488|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64760621|NCT05194488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64760622|NCT05194488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760623|NCT05194488|Cholinergic Agents|cholinergic agents|mesh-ancestor
64645714|NCT00689078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64645715|NCT05568979|Vaccines|vaccines|mesh-list
64645716|NCT05568979|Immunologic Factors|immunologic factors|mesh-ancestor
64760624|NCT05194488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64760629|NCT05175768|Niacin|niacin|mesh-list
64760659|NCT05097846|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64760660|NCT05097846|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64760661|NCT00608634|Perillyl alcohol|perillyl alcohol|mesh-list
64760662|NCT00608634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760663|NCT00608634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64760664|NCT00608634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760665|NCT03018366|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64760666|NCT03018366|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64760667|NCT03018366|Estradiol|estradiol|mesh-list
64760668|NCT03018366|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64760669|NCT03018366|Progesterone|progesterone|mesh-list
64760670|NCT03018366|Estrogens|estrogens|mesh-ancestor
64760671|NCT03018366|Hormones|hormones|mesh-ancestor
64760672|NCT03018366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64760673|NCT03018366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645781|NCT03951649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64760674|NCT03018366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64760675|NCT03018366|Contraceptive Agents|contraceptive agents|mesh-ancestor
64645782|NCT03951649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64645783|NCT03951649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645784|NCT03951649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645785|NCT03951649|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64645786|NCT03951649|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64645787|NCT03951649|Purinergic Agents|purinergic agents|mesh-ancestor
64645788|NCT03951649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64645789|NCT00590018|Hydrocortisone|hydrocortisone|mesh-list
64645790|NCT00590018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64645791|NCT02219503|Ritonavir|ritonavir|mesh-list
64645792|NCT02219503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64645793|NCT02219503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64645794|NCT02219503|Protease Inhibitors|protease inhibitors|mesh-ancestor
64645795|NCT02219503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645796|NCT02219503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645797|NCT02219503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64760676|NCT03018366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64760677|NCT03018366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64760678|NCT03018366|Progestins|progestins|mesh-ancestor
64760679|NCT02897700|Cyclophosphamide|cyclophosphamide|mesh-list
64760680|NCT02897700|Doxorubicin|doxorubicin|mesh-list
64645819|NCT02221219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64760681|NCT02897700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64760682|NCT02897700|Fluorouracil|fluorouracil|mesh-list
64760683|NCT02897700|Methotrexate|methotrexate|mesh-list
64760711|NCT02889666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760712|NCT02889666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64760713|NCT02889666|Antimetabolites|antimetabolites|mesh-ancestor
64760714|NCT02889666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760715|NCT02889666|Antiviral Agents|antiviral agents|mesh-ancestor
64760716|NCT02889666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64760717|NCT02889666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64760718|NCT02889666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64760719|NCT02889666|Immunologic Factors|immunologic factors|mesh-ancestor
64645820|NCT02221219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64645821|NCT02221219|Gout Suppressants|gout suppressants|mesh-ancestor
64645823|NCT02221219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64760720|NCT02889666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645824|NCT02221219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64760721|NCT02889666|Tubulin Modulators|tubulin modulators|mesh-ancestor
64760722|NCT02889666|Antimitotic Agents|antimitotic agents|mesh-ancestor
64760723|NCT02889666|Mitosis Modulators|mitosis modulators|mesh-ancestor
64760724|NCT00609804|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64760726|NCT00609804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760727|NCT00609804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64760728|NCT00609804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64760729|NCT00609804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760730|NCT00610428|Prochlorperazine|prochlorperazine|mesh-list
64760731|NCT00610428|Antiemetics|antiemetics|mesh-ancestor
64760732|NCT00610428|Autonomic Agents|autonomic agents|mesh-ancestor
64760733|NCT00610428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64760734|NCT00610428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760735|NCT00610428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64645873|NCT00594308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64645874|NCT00594308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64645875|NCT00594308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64645876|NCT00594308|Antitubercular Agents|antitubercular agents|mesh-ancestor
64645877|NCT00594308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64760736|NCT00610428|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64760737|NCT00610428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64760738|NCT00610428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64760739|NCT00610428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64760740|NCT00610428|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64760741|NCT00610428|Dopamine Agents|dopamine agents|mesh-ancestor
64760742|NCT00610428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64760744|NCT02446236|Rituximab|rituximab|mesh-list
64760754|NCT02446236|Growth Inhibitors|growth inhibitors|mesh-ancestor
64760756|NCT00610740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64760757|NCT00610740|Antimetabolites|antimetabolites|mesh-ancestor
64760758|NCT00610740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760759|NCT00610740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760760|NCT00610740|Antiviral Agents|antiviral agents|mesh-ancestor
64760761|NCT00610740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64760762|NCT00610740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64760763|NCT00610740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64760764|NCT00610740|Immunologic Factors|immunologic factors|mesh-ancestor
64760765|NCT00610740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760766|NCT02191488|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64760767|NCT02191488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64760768|NCT02191488|Dermatologic Agents|dermatologic agents|mesh-ancestor
64760769|NCT00611442|Lubiprostone|lubiprostone|mesh-list
64645931|NCT00597896|Dopamine Agonists|dopamine agonists|mesh-ancestor
64645932|NCT00597896|Dopamine Agents|dopamine agents|mesh-ancestor
64645933|NCT00597896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64645935|NCT01790282|Progesterone|progesterone|mesh-list
64645936|NCT01790282|Estrogens|estrogens|mesh-ancestor
64645937|NCT01790282|Hormones|hormones|mesh-ancestor
64645938|NCT01790282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64645939|NCT01790282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645940|NCT01790282|Progestins|progestins|mesh-ancestor
64645941|NCT03843541|Acetylcysteine|acetylcysteine|mesh-list
64645942|NCT03843541|Ambroxol|ambroxol|mesh-list
64645943|NCT03843541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64645944|NCT03843541|Antiviral Agents|antiviral agents|mesh-ancestor
64760770|NCT00611442|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64645945|NCT03843541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64645946|NCT03843541|Expectorants|expectorants|mesh-ancestor
64760771|NCT00611442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64760772|NCT00611442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760773|NCT02136420|Promethazine|promethazine|mesh-list
64760774|NCT02136420|Diphenhydramine|diphenhydramine|mesh-list
64760775|NCT02136420|Antipruritics|antipruritics|mesh-ancestor
64760776|NCT02136420|Dermatologic Agents|dermatologic agents|mesh-ancestor
64445661|NCT04813991|Narcotics|narcotics|mesh-ancestor
64760777|NCT02136420|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64760778|NCT02136420|Histamine Antagonists|histamine antagonists|mesh-ancestor
64760803|NCT00612222|Fludarabine|fludarabine|mesh-list
64760804|NCT00612222|Fludarabine phosphate|fludarabine phosphate|mesh-list
64760805|NCT00612222|Interleukin-2|interleukin-2|mesh-list
64760806|NCT00612222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64645973|NCT02248987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64645974|NCT00692978|Fluticasone|fluticasone|mesh-list
64760807|NCT00612222|Immunologic Factors|immunologic factors|mesh-ancestor
64645975|NCT00692978|Xhance|xhance|mesh-list
64645976|NCT00692978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64645977|NCT00692978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64645978|NCT00692978|Autonomic Agents|autonomic agents|mesh-ancestor
64760808|NCT00612222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760809|NCT00612222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64760810|NCT00612222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64760811|NCT00612222|Alkylating Agents|alkylating agents|mesh-ancestor
64760812|NCT00612222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760813|NCT00612222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760814|NCT00612222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64760815|NCT00612222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64760816|NCT00612222|Antimetabolites|antimetabolites|mesh-ancestor
64760817|NCT00612222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64760818|NCT00612222|Analgesics|analgesics|mesh-ancestor
64760819|NCT00612222|Sensory System Agents|sensory system agents|mesh-ancestor
64760820|NCT00612222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64760821|NCT00612222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64760822|NCT00612222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64760823|NCT00612222|Antiviral Agents|antiviral agents|mesh-ancestor
64760824|NCT00612222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64760825|NCT01711242|Capecitabine|capecitabine|mesh-list
64760826|NCT01711242|Oxaliplatin|oxaliplatin|mesh-list
64760827|NCT01711242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64760828|NCT01711242|Antimetabolites|antimetabolites|mesh-ancestor
64760829|NCT01711242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760831|NCT04405908|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64760851|NCT04304274|Anesthetics|anesthetics|mesh-ancestor
64760852|NCT02132832|Buspirone|buspirone|mesh-list
64760853|NCT02132832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64646030|NCT00645710|Antibodies|antibodies|mesh-list
64646031|NCT00645710|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64646032|NCT00645710|Immunologic Factors|immunologic factors|mesh-ancestor
64646033|NCT00645710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646034|NCT00645710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64646037|NCT00645710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760854|NCT02132832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64760855|NCT02132832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64760856|NCT02132832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760857|NCT02132832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64760858|NCT02132832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64760859|NCT02132832|Serotonin Agents|serotonin agents|mesh-ancestor
64760860|NCT02132832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64760861|NCT02132832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760862|NCT00614406|Celecoxib|celecoxib|mesh-list
64760863|NCT00614406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64760864|NCT00614406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64760865|NCT00614406|Analgesics|analgesics|mesh-ancestor
64760866|NCT00614406|Sensory System Agents|sensory system agents|mesh-ancestor
64760867|NCT00614406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646075|NCT00646646|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64646076|NCT00646646|GABA Modulators|gaba modulators|mesh-ancestor
64646077|NCT00646646|GABA Agents|gaba agents|mesh-ancestor
64646079|NCT02998424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64646080|NCT02998424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64646081|NCT02998424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646082|NCT02998424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64646083|NCT02998424|Anesthetics, General|anesthetics, general|mesh-ancestor
64646084|NCT02998424|Anesthetics|anesthetics|mesh-ancestor
64646085|NCT00696488|Fluorouracil|fluorouracil|mesh-list
64646086|NCT00696488|Antimetabolites|antimetabolites|mesh-ancestor
64646089|NCT00696488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760868|NCT00614406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760869|NCT00614406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64760870|NCT00614406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64760871|NCT00614406|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64760872|NCT00614406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64760873|NCT00614406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64760874|NCT00614406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760875|NCT00614484|Paclitaxel|paclitaxel|mesh-list
64760876|NCT00614484|Carboplatin|carboplatin|mesh-list
64445662|NCT04813991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64760883|NCT04159974|Durvalumab|durvalumab|mesh-list
64760898|NCT04142502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64760899|NCT04142502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64760900|NCT04142502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64760902|NCT04142502|Adrenergic Agents|adrenergic agents|mesh-ancestor
64760903|NCT04142502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64760904|NCT04142502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760905|NCT00569010|Cytarabine|cytarabine|mesh-list
64760906|NCT00569010|Azacitidine|azacitidine|mesh-list
64760907|NCT00569010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64760908|NCT00569010|Antimetabolites|antimetabolites|mesh-ancestor
64646127|NCT01386710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646128|NCT01386710|Growth Inhibitors|growth inhibitors|mesh-ancestor
64646129|NCT00650858|Plasminogen|plasminogen|mesh-list
64646130|NCT00650858|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64646131|NCT00650858|Fibrinolytic Agents|fibrinolytic agents|mesh-list
64646132|NCT00650858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64646133|NCT00650858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760909|NCT00569010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760910|NCT00569010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760911|NCT00569010|Antiviral Agents|antiviral agents|mesh-ancestor
64760912|NCT00569010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64760913|NCT00569010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64760914|NCT00569010|Immunologic Factors|immunologic factors|mesh-ancestor
64760915|NCT00569010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760916|NCT00569010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64760917|NCT00616122|Cyclophosphamide|cyclophosphamide|mesh-list
64760918|NCT00616122|Methotrexate|methotrexate|mesh-list
64760919|NCT00616122|Sunitinib|sunitinib|mesh-list
64760920|NCT00616122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64760921|NCT00616122|Immunologic Factors|immunologic factors|mesh-ancestor
64760922|NCT00616122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760923|NCT00616122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64760924|NCT00616122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64760925|NCT00616122|Alkylating Agents|alkylating agents|mesh-ancestor
64760926|NCT00616122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760927|NCT00616122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760928|NCT00616122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64646178|NCT02997800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64646179|NCT02997800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64646180|NCT00701636|Daptomycin|daptomycin|mesh-list
64646181|NCT00701636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64760929|NCT00616122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64760930|NCT00616122|Abortifacient Agents|abortifacient agents|mesh-ancestor
64760931|NCT00616122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64760933|NCT00616122|Antimetabolites|antimetabolites|mesh-ancestor
64760936|NCT00616122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64760937|NCT00616122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64760938|NCT00616122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64760939|NCT00616122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64760940|NCT00616122|Growth Substances|growth substances|mesh-ancestor
64646235|NCT02997332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64646236|NCT02997332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64646237|NCT02997332|Immunologic Factors|immunologic factors|mesh-ancestor
64646238|NCT02997332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646239|NCT02997332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64646240|NCT04345094|Hydroquinone|hydroquinone|mesh-list
64646241|NCT04345094|Antioxidants|antioxidants|mesh-ancestor
64760941|NCT00616122|Growth Inhibitors|growth inhibitors|mesh-ancestor
64760942|NCT00616122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64760944|NCT00617058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64760945|NCT00617058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760946|NCT00618540|Fludarabine|fludarabine|mesh-list
64760947|NCT00618540|Fludarabine phosphate|fludarabine phosphate|mesh-list
64760948|NCT00618540|Melphalan|melphalan|mesh-list
64760949|NCT00618540|Alemtuzumab|alemtuzumab|mesh-list
64760950|NCT00618540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64760951|NCT00618540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64760952|NCT00618540|Antimetabolites|antimetabolites|mesh-ancestor
64760953|NCT00618540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64760954|NCT00618540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64760993|NCT00574236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64760994|NCT00574236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646293|NCT01230593|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
64646294|NCT01230593|Dexamethasone|dexamethasone|mesh-list
64760995|NCT00574548|Vaccines|vaccines|mesh-list
64646295|NCT01230593|Dexamethasone acetate|dexamethasone acetate|mesh-list
64646296|NCT01230593|BB 1101|bb 1101|mesh-list
64646297|NCT01230593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64760996|NCT00574548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64760997|NCT00574548|Immunologic Factors|immunologic factors|mesh-ancestor
64760998|NCT00574548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64760999|NCT01168219|Methotrexate|methotrexate|mesh-list
64761000|NCT01168219|Fludarabine phosphate|fludarabine phosphate|mesh-list
64761001|NCT01168219|Azacitidine|azacitidine|mesh-list
64761002|NCT01168219|Fludarabine|fludarabine|mesh-list
64761003|NCT01168219|Busulfan|busulfan|mesh-list
64761004|NCT01168219|Tacrolimus|tacrolimus|mesh-list
64761005|NCT01168219|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64646352|NCT00658736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64646353|NCT00658736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646354|NCT00658736|Sensory System Agents|sensory system agents|mesh-ancestor
64761006|NCT01168219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64761025|NCT01115803|Everolimus|everolimus|mesh-list
64761053|NCT01107886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64761055|NCT01107457|Dermatologic Agents|dermatologic agents|mesh-ancestor
64761056|NCT05767008|Sunscreening Agents|sunscreening agents|mesh-list
64761057|NCT05767008|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64761058|NCT05767008|Protective Agents|protective agents|mesh-ancestor
64761059|NCT05767008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761060|NCT05767008|Dermatologic Agents|dermatologic agents|mesh-ancestor
64761061|NCT05766631|Methadone|methadone|mesh-list
64761062|NCT05766631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64761063|NCT05766631|Narcotics|narcotics|mesh-ancestor
64761064|NCT05766631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64761065|NCT05766631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761066|NCT05766631|Analgesics|analgesics|mesh-ancestor
64761067|NCT05766631|Sensory System Agents|sensory system agents|mesh-ancestor
64761068|NCT05766631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64761069|NCT05766631|Antitussive Agents|antitussive agents|mesh-ancestor
64761070|NCT05766631|Respiratory System Agents|respiratory system agents|mesh-ancestor
64761071|NCT05766605|Leucovorin|leucovorin|mesh-list
64646417|NCT01235195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64646418|NCT01235195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646419|NCT01235195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64646420|NCT01235195|Serotonin Agents|serotonin agents|mesh-ancestor
64646421|NCT01235195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646422|NCT02996942|Factor VIII|factor viii|mesh-list
64646423|NCT02996942|Coagulants|coagulants|mesh-ancestor
64646424|NCT01199237|Glycopyrrolate|glycopyrrolate|mesh-list
64646425|NCT01199237|Sevoflurane|sevoflurane|mesh-list
64646426|NCT01199237|Desflurane|desflurane|mesh-list
64646427|NCT01199237|Rocuronium|rocuronium|mesh-list
64646428|NCT01199237|Neostigmine|neostigmine|mesh-list
64646429|NCT01199237|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64646430|NCT01199237|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64646431|NCT01199237|Anesthetics, General|anesthetics, general|mesh-ancestor
64646432|NCT01199237|Anesthetics|anesthetics|mesh-ancestor
64646433|NCT01199237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64646437|NCT01199237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64761072|NCT05766605|Doxorubicin|doxorubicin|mesh-list
64761073|NCT05766605|Fluorouracil|fluorouracil|mesh-list
64761074|NCT05766605|Oxaliplatin|oxaliplatin|mesh-list
64761075|NCT05766605|Raltitrexed|raltitrexed|mesh-list
64761076|NCT05766605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761077|NCT05766605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64761078|NCT05766605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64761079|NCT05766605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64761080|NCT05766605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761102|NCT05766553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761104|NCT05766540|Aripiprazole|aripiprazole|mesh-list
64761105|NCT05766540|Clozapine|clozapine|mesh-list
64761106|NCT05766540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64761107|NCT05766540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761108|NCT05766540|Antidepressive Agents|antidepressive agents|mesh-ancestor
64761109|NCT05766540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64761110|NCT05766540|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64761111|NCT05766540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64761112|NCT05766540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64761113|NCT05766540|Dopamine Agonists|dopamine agonists|mesh-ancestor
64761114|NCT05766540|Dopamine Agents|dopamine agents|mesh-ancestor
64761115|NCT05766540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64761116|NCT05766540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646457|NCT01235897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64646459|NCT01236053|Analgesics|analgesics|mesh-ancestor
64646460|NCT01236053|Sensory System Agents|sensory system agents|mesh-ancestor
64646461|NCT01236053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646462|NCT01236053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646463|NCT01236053|Anticonvulsants|anticonvulsants|mesh-ancestor
64761117|NCT05766540|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64761118|NCT05766540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64761119|NCT05766540|Serotonin Agents|serotonin agents|mesh-ancestor
64761120|NCT05766540|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64761121|NCT05766540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64761122|NCT05766540|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64761123|NCT05766540|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64761124|NCT05766540|GABA Antagonists|gaba antagonists|mesh-ancestor
64761125|NCT05766540|GABA Agents|gaba agents|mesh-ancestor
64761155|NCT05766436|Antioxidants|antioxidants|mesh-ancestor
64761235|NCT05765825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64761236|NCT05765825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64761238|NCT05765825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761240|NCT05765747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64761241|NCT05765747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64761242|NCT05765747|Analgesics|analgesics|mesh-ancestor
64761243|NCT05765747|Sensory System Agents|sensory system agents|mesh-ancestor
64761244|NCT05765747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64761245|NCT05765747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761246|NCT05765747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64761247|NCT05765747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64761248|NCT05765747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64761249|NCT05765747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64761250|NCT05765747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761251|NCT05765747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761252|NCT05765682|Bupivacaine|bupivacaine|mesh-list
64761253|NCT05765682|Mepivacaine|mepivacaine|mesh-list
64761276|NCT05765500|Fertility Agents|fertility agents|mesh-ancestor
64761277|NCT05765500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64761278|NCT05765500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761279|NCT05765500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64761280|NCT05765500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761281|NCT05765500|Androgen Antagonists|androgen antagonists|mesh-ancestor
64761282|NCT05765500|Hormone Antagonists|hormone antagonists|mesh-ancestor
64761283|NCT05765500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64761284|NCT05765487|Sildenafil Citrate|sildenafil citrate|mesh-list
64761285|NCT05765487|Vasodilator Agents|vasodilator agents|mesh-ancestor
64761286|NCT05765487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64761287|NCT05765487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64761288|NCT05765487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761289|NCT05765487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761290|NCT05765487|Urological Agents|urological agents|mesh-ancestor
64761292|NCT05765357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64761293|NCT05765357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646508|NCT01511042|Angiotensinogen|angiotensinogen|mesh-list
64646509|NCT01511042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64646511|NCT01511042|Adrenergic Agents|adrenergic agents|mesh-ancestor
64646512|NCT01511042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64646513|NCT01511042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646514|NCT01511042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646516|NCT01511042|Autonomic Agents|autonomic agents|mesh-ancestor
64646517|NCT01511042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64761294|NCT05765266|Methylprednisolone|methylprednisolone|mesh-list
64761295|NCT05765266|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64761296|NCT05765266|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64761297|NCT05765266|Prednisolone|prednisolone|mesh-list
64761298|NCT05765266|Prednisolone acetate|prednisolone acetate|mesh-list
64761299|NCT05765266|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64761300|NCT05765266|Prednisolone phosphate|prednisolone phosphate|mesh-list
64761301|NCT05765266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64761302|NCT05765266|Antiemetics|antiemetics|mesh-ancestor
64761303|NCT05765266|Autonomic Agents|autonomic agents|mesh-ancestor
64646531|NCT01238471|Propranolol|propranolol|mesh-list
64646532|NCT01238471|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64761304|NCT05765266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64761305|NCT05765266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646533|NCT01238471|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64646534|NCT01238471|Adrenergic Agents|adrenergic agents|mesh-ancestor
64646535|NCT01238471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64646536|NCT01238471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646537|NCT01238471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646538|NCT01238471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64646539|NCT01238471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64646541|NCT00664430|Calcitriol|calcitriol|mesh-list
64761306|NCT05765266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64761307|NCT05765266|Glucocorticoids|glucocorticoids|mesh-ancestor
64761308|NCT05765266|Hormones|hormones|mesh-ancestor
64761309|NCT05765266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64761311|NCT05765266|Protective Agents|protective agents|mesh-ancestor
64761314|NCT05765240|Hyaluronic Acid|hyaluronic acid|mesh-list
64761315|NCT05765240|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64761316|NCT05765240|Immunologic Factors|immunologic factors|mesh-ancestor
64761317|NCT05765240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761318|NCT05765240|Viscosupplements|viscosupplements|mesh-ancestor
64761320|NCT05765110|Dopamine|dopamine|mesh-list
64761321|NCT05765110|Dopamine Agonists|dopamine agonists|mesh-list
64761322|NCT05765110|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64761323|NCT05765110|Sympathomimetics|sympathomimetics|mesh-ancestor
64761324|NCT05765110|Autonomic Agents|autonomic agents|mesh-ancestor
64761325|NCT05765110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64761326|NCT05765110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761327|NCT05765110|Dopamine Agents|dopamine agents|mesh-ancestor
64761328|NCT05765110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64761329|NCT05765110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761330|NCT05765110|Protective Agents|protective agents|mesh-ancestor
64646583|NCT02195921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64646584|NCT02189213|Sertraline|sertraline|mesh-list
64646585|NCT02189213|Antidepressive Agents|antidepressive agents|mesh-ancestor
64761331|NCT05765097|Pancrelipase|pancrelipase|mesh-list
64761332|NCT05765097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64761333|NCT05765071|Botulinum Toxins|botulinum toxins|mesh-list
64761334|NCT05765071|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64761335|NCT05765071|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64761336|NCT05765071|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64761337|NCT05765071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64761338|NCT05765071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761339|NCT05765071|Cholinergic Agents|cholinergic agents|mesh-ancestor
64761340|NCT05765071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64761341|NCT05765071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761342|NCT05765071|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64761343|NCT05765071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64761359|NCT05764798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761360|NCT05764798|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64761361|NCT05764798|GABA Agonists|gaba agonists|mesh-ancestor
64761362|NCT05764798|GABA Agents|gaba agents|mesh-ancestor
64761363|NCT05764798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64761364|NCT05764798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761365|NCT05764746|Artesunate|artesunate|mesh-list
64761366|NCT05764746|Lumefantrine|lumefantrine|mesh-list
64761367|NCT05764746|Artemether|artemether|mesh-list
64761368|NCT05764746|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64646637|NCT04386122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64761369|NCT05764746|Amodiaquine|amodiaquine|mesh-list
64761370|NCT05764746|Antimalarials|antimalarials|mesh-ancestor
64761371|NCT05764746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64761372|NCT05764746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64761373|NCT05764746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64761374|NCT05764746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761423|NCT05733689|Tubulin Modulators|tubulin modulators|mesh-ancestor
64761424|NCT05733689|Antimitotic Agents|antimitotic agents|mesh-ancestor
64761425|NCT05733689|Mitosis Modulators|mitosis modulators|mesh-ancestor
64761426|NCT05733689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761427|NCT05733689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64761428|NCT05733689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64761429|NCT05733689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64761430|NCT05733689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64761431|NCT05733689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761432|NCT05731726|Celecoxib|celecoxib|mesh-list
64761433|NCT05731726|Capecitabine|capecitabine|mesh-list
64761434|NCT05731726|Oxaliplatin|oxaliplatin|mesh-list
64761435|NCT05731726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64761436|NCT05731726|Antimetabolites|antimetabolites|mesh-ancestor
64761437|NCT05731726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761438|NCT05731726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761439|NCT05731726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64761440|NCT05731726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64761441|NCT05731726|Analgesics|analgesics|mesh-ancestor
64761442|NCT05731726|Sensory System Agents|sensory system agents|mesh-ancestor
64646690|NCT00725504|Sensory System Agents|sensory system agents|mesh-ancestor
64646691|NCT00725504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646692|NCT00725504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64761450|NCT05715931|Leucovorin|leucovorin|mesh-list
64445672|NCT03623243|Siponimod|siponimod|mesh-list
64646693|NCT00725504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64646694|NCT00725504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64761478|NCT05705258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761480|NCT05705258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761481|NCT05687110|Novobiocin|novobiocin|mesh-list
64646731|NCT01294163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64646732|NCT01294163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64646733|NCT01294163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646734|NCT01294163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64761482|NCT05687110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64761483|NCT05687110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64761550|NCT05486481|Daratumumab|daratumumab|mesh-list
64761551|NCT05486481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64761552|NCT05486481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64761553|NCT05486481|Antiemetics|antiemetics|mesh-ancestor
64761554|NCT05486481|Autonomic Agents|autonomic agents|mesh-ancestor
64761555|NCT05486481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64761556|NCT05486481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761557|NCT05486481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64761558|NCT05486481|Glucocorticoids|glucocorticoids|mesh-ancestor
64761559|NCT05486481|Hormones|hormones|mesh-ancestor
64761560|NCT05486481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64761561|NCT05486481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64761562|NCT05486481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761563|NCT05486481|Immunologic Factors|immunologic factors|mesh-ancestor
64761564|NCT05442567|Vedolizumab|vedolizumab|mesh-list
64761566|NCT05441215|Ritonavir|ritonavir|mesh-list
64761608|NCT05320380|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64646735|NCT01294163|Anesthetics, General|anesthetics, general|mesh-ancestor
64646736|NCT01294163|Anesthetics|anesthetics|mesh-ancestor
64761609|NCT05320380|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64646737|NCT01294163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64646738|NCT01294163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64761610|NCT05320380|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64646739|NCT01294319|Dexamethasone|dexamethasone|mesh-list
64761611|NCT05320380|Cortisone|cortisone|mesh-list
64761612|NCT05320380|Methotrexate|methotrexate|mesh-list
64761613|NCT05320380|Fludarabine phosphate|fludarabine phosphate|mesh-list
64761614|NCT05320380|Fludarabine|fludarabine|mesh-list
64761615|NCT05320380|Daunorubicin|daunorubicin|mesh-list
64761616|NCT05320380|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64761617|NCT05320380|Prednisolone phosphate|prednisolone phosphate|mesh-list
64761618|NCT05320380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64761619|NCT05320380|Abortifacient Agents|abortifacient agents|mesh-ancestor
64761620|NCT05320380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64761621|NCT05320380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761622|NCT05320380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64761623|NCT05320380|Antimetabolites|antimetabolites|mesh-ancestor
64761624|NCT05320380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761625|NCT05320380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761626|NCT05320380|Dermatologic Agents|dermatologic agents|mesh-ancestor
64761627|NCT05320380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761628|NCT05320380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64761629|NCT05320380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64761630|NCT05320380|Immunologic Factors|immunologic factors|mesh-ancestor
64761631|NCT05320380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64761632|NCT05320380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64761633|NCT05320380|Antiviral Agents|antiviral agents|mesh-ancestor
64646779|NCT02990312|Sirolimus|sirolimus|mesh-list
64761634|NCT05320380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64761636|NCT05320380|Glucocorticoids|glucocorticoids|mesh-ancestor
64761655|NCT05297565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64761656|NCT05297565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761657|NCT05263908|Ritonavir|ritonavir|mesh-list
64761658|NCT05263908|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64761659|NCT05263908|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64761660|NCT05263908|Protease Inhibitors|protease inhibitors|mesh-ancestor
64761661|NCT05263908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761662|NCT05263908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761663|NCT05263908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64761664|NCT05263908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64761665|NCT05263908|Antiviral Agents|antiviral agents|mesh-ancestor
64761666|NCT05263908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64761667|NCT05263908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64761668|NCT05263908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64761669|NCT05259527|Vitamin D|vitamin d|mesh-list
64761670|NCT05259527|Ergocalciferols|ergocalciferols|mesh-list
64761730|NCT05133258|Autonomic Agents|autonomic agents|mesh-ancestor
64761731|NCT05133258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64761732|NCT05133258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761733|NCT05133258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64646832|NCT01210079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64761734|NCT05133258|Glucocorticoids|glucocorticoids|mesh-ancestor
64761735|NCT05133258|Hormones|hormones|mesh-ancestor
64761736|NCT05133258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64761737|NCT05133258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64761738|NCT05133258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761739|NCT05133258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64761740|NCT05133258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64761741|NCT05133258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64761742|NCT05133258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64761743|NCT05133258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761744|NCT05133258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761745|NCT05133258|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64761746|NCT05133258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64761763|NCT05107960|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
64761764|NCT05107960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64761765|NCT05107960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64761766|NCT05107960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761767|NCT05091346|Pembrolizumab|pembrolizumab|mesh-list
64646833|NCT01210079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646834|NCT01210079|Anticonvulsants|anticonvulsants|mesh-ancestor
64646835|NCT01210079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64646836|NCT01210079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64646837|NCT01210079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64761768|NCT05091346|Lenvatinib|lenvatinib|mesh-list
64761769|NCT05091346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64761770|NCT05091346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761771|NCT05091346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64761772|NCT05091346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761788|NCT05055024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761789|NCT05055024|Adrenergic Agents|adrenergic agents|mesh-ancestor
64761790|NCT05055024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64761791|NCT05055024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64761792|NCT05055024|Dopamine Agents|dopamine agents|mesh-ancestor
64761793|NCT05053971|Entinostat|entinostat|mesh-list
64761794|NCT05053971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
64761795|NCT05053971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761796|NCT05053971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761797|NCT05053971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761798|NCT05047978|Caseins|caseins|mesh-list
64761799|NCT05047978|Chelating Agents|chelating agents|mesh-ancestor
64761800|NCT05047978|Sequestering Agents|sequestering agents|mesh-ancestor
64761801|NCT05047978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761802|NCT05045664|Obinutuzumab|obinutuzumab|mesh-list
64761803|NCT05045664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64761804|NCT05045664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761805|NCT05037552|Hemostatics|hemostatics|mesh-list
64761806|NCT05037552|Coagulants|coagulants|mesh-ancestor
64761807|NCT05028634|Vaccines|vaccines|mesh-list
64761808|NCT05028634|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64761809|NCT05028634|Immunologic Factors|immunologic factors|mesh-ancestor
64761810|NCT05028634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761811|NCT05028075|Cobalt|cobalt|mesh-list
64761812|NCT05028075|Trace Elements|trace elements|mesh-ancestor
64761813|NCT05028075|Micronutrients|micronutrients|mesh-ancestor
64761814|NCT05028075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761815|NCT05012631|Losartan|losartan|mesh-list
64761816|NCT05012631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64761817|NCT05012631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64761818|NCT05012631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64761819|NCT05012631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64761821|NCT04989218|Gemcitabine|gemcitabine|mesh-list
64761830|NCT04989218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64761831|NCT04989218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761832|NCT04989218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64761833|NCT04989218|Immunologic Factors|immunologic factors|mesh-ancestor
64761834|NCT04989218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646858|NCT00708110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64646859|NCT01296815|Bevacizumab|bevacizumab|mesh-list
64646860|NCT01296815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64646861|NCT01296815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646862|NCT01296815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64646863|NCT01296815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64646864|NCT01296815|Growth Substances|growth substances|mesh-ancestor
64646865|NCT01296815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646866|NCT01296815|Growth Inhibitors|growth inhibitors|mesh-ancestor
64646867|NCT01276262|Contraceptive Agents|contraceptive agents|mesh-list
64646868|NCT01276262|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64646869|NCT01276262|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
64646870|NCT01276262|Contraceptives, Oral|contraceptives, oral|mesh-list
64761835|NCT04989218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64761836|NCT04964544|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64761838|NCT04964544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64761839|NCT04964544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761840|NCT04964544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64761841|NCT04964544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64761842|NCT04964544|Antimetabolites|antimetabolites|mesh-ancestor
64761843|NCT04964544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761844|NCT04964544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64761845|NCT04964544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64761846|NCT04964544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761847|NCT04954196|Amlodipine|amlodipine|mesh-list
64761848|NCT04954196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64761849|NCT04954196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64646875|NCT01276262|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64646876|NCT01276262|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64646877|NCT01276262|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64646878|NCT01276262|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
64646879|NCT01276262|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64646880|NCT01276262|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64646882|NCT01276496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64646883|NCT01276496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64646884|NCT01276496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646885|NCT01276496|Tubulin Modulators|tubulin modulators|mesh-ancestor
64646886|NCT01276496|Antimitotic Agents|antimitotic agents|mesh-ancestor
64646887|NCT01276496|Mitosis Modulators|mitosis modulators|mesh-ancestor
64646888|NCT01276496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646889|NCT01297595|Crizotinib|crizotinib|mesh-list
64761850|NCT04954196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64761851|NCT04954196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761852|NCT04954196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64761853|NCT04954196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761854|NCT04954196|Vasodilator Agents|vasodilator agents|mesh-ancestor
64761855|NCT04944290|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64761856|NCT04944290|Brinzolamide|brinzolamide|mesh-list
64761857|NCT04944290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64761858|NCT04944290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64761871|NCT04937166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761872|NCT04937166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761873|NCT04937166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761874|NCT04931017|Metformin|metformin|mesh-list
64761875|NCT04931017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64761876|NCT04931017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761877|NCT04920032|Irinotecan|irinotecan|mesh-list
64761878|NCT04920032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64761879|NCT04920032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64761880|NCT04920032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761881|NCT04920032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761882|NCT04920032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646920|NCT01298219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646921|NCT01276886|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64646922|NCT01276886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64646923|NCT02322242|Dexamethasone|dexamethasone|mesh-list
64761883|NCT04908176|Midazolam|midazolam|mesh-list
64761884|NCT04908176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64761885|NCT04908176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64761886|NCT04908176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64761887|NCT04908176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761888|NCT04908176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64761889|NCT04908176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64761890|NCT04908176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64761891|NCT04908176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64761892|NCT04908176|Anesthetics, General|anesthetics, general|mesh-ancestor
64761893|NCT04908176|Anesthetics|anesthetics|mesh-ancestor
64761894|NCT04908176|GABA Modulators|gaba modulators|mesh-ancestor
64761895|NCT04908176|GABA Agents|gaba agents|mesh-ancestor
64761921|NCT04883645|Interferon Inducers|interferon inducers|mesh-ancestor
64761923|NCT04882540|Anticonvulsants|anticonvulsants|mesh-ancestor
64646970|NCT02992496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64646971|NCT02992496|Anesthetics, General|anesthetics, general|mesh-ancestor
64646972|NCT02992496|Anesthetics|anesthetics|mesh-ancestor
64646973|NCT02992496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64646974|NCT02992496|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64646984|NCT02992496|GABA Agents|gaba agents|mesh-ancestor
64761924|NCT04859829|Immunoglobulins|immunoglobulins|mesh-list
64761933|NCT04851158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64761934|NCT04851158|Antitubercular Agents|antitubercular agents|mesh-ancestor
64761935|NCT04821856|Cannabidiol|cannabidiol|mesh-list
64761936|NCT04821856|Anticonvulsants|anticonvulsants|mesh-ancestor
64761937|NCT04788043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64761938|NCT04788043|Pembrolizumab|pembrolizumab|mesh-list
64761939|NCT04788043|Magrolimab|magrolimab|mesh-list
64761940|NCT04788043|Antibodies|antibodies|mesh-list
64761941|NCT04788043|Immunoglobulins|immunoglobulins|mesh-list
64761942|NCT04788043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64761943|NCT04788043|Immunologic Factors|immunologic factors|mesh-ancestor
64761944|NCT04788043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761945|NCT04788043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64761946|NCT04778267|Dexamethasone|dexamethasone|mesh-list
64761947|NCT04778267|Bupivacaine|bupivacaine|mesh-list
64761948|NCT04778267|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64761949|NCT04778267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64761950|NCT04778267|Antiemetics|antiemetics|mesh-ancestor
64761951|NCT04778267|Autonomic Agents|autonomic agents|mesh-ancestor
64761952|NCT04778267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64761953|NCT04778267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761954|NCT04778267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64761955|NCT04778267|Glucocorticoids|glucocorticoids|mesh-ancestor
64761956|NCT04778267|Hormones|hormones|mesh-ancestor
64761957|NCT04778267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64761958|NCT04778267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64761961|NCT04778267|Anesthetics|anesthetics|mesh-ancestor
64761977|NCT04760691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64761978|NCT04760691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64647028|NCT00709826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64647029|NCT00709826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64647031|NCT00709826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372336|NCT02463929|Ketamine|ketamine|mesh-list
64647032|NCT00709826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647033|NCT00709826|Antiviral Agents|antiviral agents|mesh-ancestor
64761979|NCT04760691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647034|NCT00709826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64647035|NCT00709826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64761980|NCT04760691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64761981|NCT04760691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64761982|NCT04760691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64761983|NCT04760691|Hormones|hormones|mesh-ancestor
64761984|NCT04760691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64761985|NCT04760691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64761986|NCT04760691|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64761987|NCT04760691|Contraceptive Agents|contraceptive agents|mesh-ancestor
64761988|NCT04760691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64761989|NCT04760691|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64761990|NCT04760691|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64761991|NCT04760691|Fertility Agents|fertility agents|mesh-ancestor
64761992|NCT04760691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64761993|NCT04760691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762025|NCT04718181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762027|NCT04718181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64762028|NCT04718181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762029|NCT04713735|Lactoferrin|lactoferrin|mesh-list
64647068|NCT00711464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64647069|NCT00711464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64647070|NCT00711464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647071|NCT01278290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64647072|NCT01278290|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64647073|NCT01278290|Luteolytic Agents|luteolytic agents|mesh-ancestor
64647074|NCT01278290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64647075|NCT01278290|Contraceptive Agents|contraceptive agents|mesh-ancestor
64647076|NCT01278290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64647077|NCT01278290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647078|NCT01278290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64647081|NCT01278290|Hormones|hormones|mesh-ancestor
64762030|NCT04713735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64762031|NCT04682366|Tamsulosin|tamsulosin|mesh-list
64762032|NCT04682366|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64762033|NCT04682366|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64762034|NCT04682366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64762035|NCT04682366|Adrenergic Agents|adrenergic agents|mesh-ancestor
64762036|NCT04682366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64762064|NCT04573504|Clindamycin|clindamycin|mesh-list
64762065|NCT04573504|Clindamycin palmitate|clindamycin palmitate|mesh-list
64762066|NCT04573504|Clindamycin phosphate|clindamycin phosphate|mesh-list
64762067|NCT04573504|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64762068|NCT04573504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64762069|NCT04573504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64762070|NCT04573504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64762071|NCT04573504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762072|NCT04573504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647108|NCT00731198|Analgesics|analgesics|mesh-ancestor
64647109|NCT00731198|Sensory System Agents|sensory system agents|mesh-ancestor
64647110|NCT00731198|Vasodilator Agents|vasodilator agents|mesh-ancestor
64647112|NCT01278602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64647113|NCT01278602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647114|NCT01278602|Immunologic Factors|immunologic factors|mesh-ancestor
64647115|NCT01278602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647116|NCT01278602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64647117|NCT00712244|Hyaluronic Acid|hyaluronic acid|mesh-list
64647118|NCT00712244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64762073|NCT04573504|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64762074|NCT04560972|Carboplatin|carboplatin|mesh-list
64762076|NCT04560972|Etoposide phosphate|etoposide phosphate|mesh-list
64530777|NCT05221554|Tacrine|tacrine|mesh-list
64762077|NCT04560972|Atezolizumab|atezolizumab|mesh-list
64647160|NCT01271894|Efavirenz|efavirenz|mesh-list
64762078|NCT04560972|Podophyllotoxin|podophyllotoxin|mesh-list
64762080|NCT04560972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64762081|NCT04560972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762082|NCT04560972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64762083|NCT04560972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64762084|NCT04560972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64762085|NCT04560972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762086|NCT04560972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647161|NCT01271894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64647162|NCT01271894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64647163|NCT01271894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647164|NCT01271894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647167|NCT01271894|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64762087|NCT04560972|Immunologic Factors|immunologic factors|mesh-ancestor
64762088|NCT04560972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762089|NCT04560972|Keratolytic Agents|keratolytic agents|mesh-ancestor
64762114|NCT04505410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64762115|NCT04505410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64762116|NCT04505410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762117|NCT04505410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762118|NCT04504669|Durvalumab|durvalumab|mesh-list
64762119|NCT04504669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64762120|NCT04504669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762121|NCT04493853|Abiraterone Acetate|abiraterone acetate|mesh-list
64762122|NCT04493853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762123|NCT04493853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64762124|NCT04493853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762125|NCT04493853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762126|NCT04493853|Hormone Antagonists|hormone antagonists|mesh-ancestor
64762127|NCT04493853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64762128|NCT04493853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762129|NCT04493853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64762163|NCT04370301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64762164|NCT04370301|Alkylating Agents|alkylating agents|mesh-ancestor
64762165|NCT04370301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762166|NCT04370301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762167|NCT04370301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64762168|NCT04370301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64762169|NCT04370301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762170|NCT04370301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64762171|NCT04370301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64762172|NCT04370301|Antitubercular Agents|antitubercular agents|mesh-ancestor
64647218|NCT00722072|Fulvestrant|fulvestrant|mesh-list
64647219|NCT00722072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647220|NCT00722072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64647221|NCT00722072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647222|NCT00722072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647223|NCT00722072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64647224|NCT00722072|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64647225|NCT00722072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64647226|NCT00722072|Hormone Antagonists|hormone antagonists|mesh-ancestor
64647227|NCT00722072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64647228|NCT00722072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647229|NCT01275170|Imipenem|imipenem|mesh-list
64647230|NCT01275170|Relebactam|relebactam|mesh-list
64647231|NCT01275170|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
64647232|NCT01275170|Midazolam|midazolam|mesh-list
64647233|NCT01275170|Caffeine|caffeine|mesh-list
64762173|NCT04370301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64762174|NCT04370301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64762175|NCT04370301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64762176|NCT04370301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64762177|NCT04329325|Dexamethasone|dexamethasone|mesh-list
64762178|NCT04329325|Methotrexate|methotrexate|mesh-list
64762179|NCT04329325|Dasatinib|dasatinib|mesh-list
64762180|NCT04329325|Blinatumomab|blinatumomab|mesh-list
64762181|NCT04329325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64762182|NCT04329325|Antiemetics|antiemetics|mesh-ancestor
64762183|NCT04329325|Autonomic Agents|autonomic agents|mesh-ancestor
64762184|NCT04329325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64762185|NCT04329325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762186|NCT04329325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64762187|NCT04329325|Glucocorticoids|glucocorticoids|mesh-ancestor
64647247|NCT01275170|GABA Agents|gaba agents|mesh-ancestor
64647248|NCT01275170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64647249|NCT01275170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647250|NCT01275170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64647251|NCT01275170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64647252|NCT01275170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762188|NCT04329325|Hormones|hormones|mesh-ancestor
64647253|NCT01275170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64762189|NCT04329325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64762190|NCT04329325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64762209|NCT04280692|Primaquine|primaquine|mesh-list
64762210|NCT04280692|Piperaquine|piperaquine|mesh-list
64762211|NCT04280692|Sulfadoxine|sulfadoxine|mesh-list
64647301|NCT00741026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64762212|NCT04280692|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64762213|NCT04280692|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64762214|NCT04280692|Antimalarials|antimalarials|mesh-ancestor
64762215|NCT04280692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64762216|NCT04280692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64762217|NCT04280692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64762218|NCT04280692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64762219|NCT04280692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762220|NCT04280692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762221|NCT04280692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64762223|NCT04247126|Gemcitabine|gemcitabine|mesh-list
64762224|NCT04247126|Paclitaxel|paclitaxel|mesh-list
64647302|NCT00741026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64647303|NCT00741026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64647304|NCT00741026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64647305|NCT00741026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762225|NCT04247126|Fulvestrant|fulvestrant|mesh-list
64762226|NCT04247126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64762227|NCT04247126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762228|NCT04247126|Tubulin Modulators|tubulin modulators|mesh-ancestor
64762229|NCT04247126|Antimitotic Agents|antimitotic agents|mesh-ancestor
64762230|NCT04247126|Mitosis Modulators|mitosis modulators|mesh-ancestor
64762231|NCT04247126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762232|NCT04247126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64762233|NCT04247126|Antimetabolites|antimetabolites|mesh-ancestor
64762234|NCT04247126|Antiviral Agents|antiviral agents|mesh-ancestor
64762235|NCT04247126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64762236|NCT04247126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762237|NCT04247126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64762238|NCT04247126|Immunologic Factors|immunologic factors|mesh-ancestor
64762239|NCT04247126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762240|NCT04247126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64762241|NCT04247126|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64762242|NCT04247126|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64762243|NCT04247126|Hormone Antagonists|hormone antagonists|mesh-ancestor
64762245|NCT04240093|Analgesics, Opioid|analgesics, opioid|mesh-list
64762250|NCT04240093|Sensory System Agents|sensory system agents|mesh-ancestor
64762251|NCT04240093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64762252|NCT04198766|Pembrolizumab|pembrolizumab|mesh-list
64762253|NCT04198766|Antibodies|antibodies|mesh-list
64762254|NCT04198766|Immunologic Factors|immunologic factors|mesh-ancestor
64647351|NCT01273454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64762255|NCT04198766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762256|NCT04198766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64762257|NCT04198766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762258|NCT04191889|Apatinib|apatinib|mesh-list
64762259|NCT04191889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762260|NCT04191889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64762261|NCT04191889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762262|NCT04191889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762263|NCT04181996|Colchicine|colchicine|mesh-list
64762264|NCT04181996|Gout Suppressants|gout suppressants|mesh-ancestor
64762265|NCT04181996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64762266|NCT04181996|Tubulin Modulators|tubulin modulators|mesh-ancestor
64762267|NCT04181996|Antimitotic Agents|antimitotic agents|mesh-ancestor
64762305|NCT04151706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64762307|NCT04151667|Lenalidomide|lenalidomide|mesh-list
64762308|NCT04151667|Bortezomib|bortezomib|mesh-list
64762309|NCT04151667|Daratumumab|daratumumab|mesh-list
64762310|NCT04151667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64762311|NCT04151667|Antiemetics|antiemetics|mesh-ancestor
64762312|NCT04151667|Autonomic Agents|autonomic agents|mesh-ancestor
64762313|NCT04151667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64762314|NCT04151667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762315|NCT04151667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64762316|NCT04151667|Glucocorticoids|glucocorticoids|mesh-ancestor
64762317|NCT04151667|Hormones|hormones|mesh-ancestor
64762318|NCT04151667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64762319|NCT04151667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64762320|NCT04151667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762321|NCT04151667|Immunologic Factors|immunologic factors|mesh-ancestor
64762322|NCT04151667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64762323|NCT04151667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64762324|NCT04151667|Growth Substances|growth substances|mesh-ancestor
64647403|NCT00744380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64647404|NCT00744380|Adrenergic Agents|adrenergic agents|mesh-ancestor
64647405|NCT00744380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64647406|NCT00744380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647408|NCT00744380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64647409|NCT00744380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64647410|NCT00744380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64647411|NCT00744380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64647412|NCT00744380|Anesthetics, General|anesthetics, general|mesh-ancestor
64647413|NCT00744380|Anesthetics|anesthetics|mesh-ancestor
64647414|NCT00744380|GABA Modulators|gaba modulators|mesh-ancestor
64647415|NCT00744380|GABA Agents|gaba agents|mesh-ancestor
64647416|NCT00744692|Fludarabine|fludarabine|mesh-list
64647417|NCT00744692|Melphalan|melphalan|mesh-list
64647418|NCT00744692|Thiotepa|thiotepa|mesh-list
64647419|NCT00744692|Hydroxyurea|hydroxyurea|mesh-list
64647420|NCT00744692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647422|NCT00744692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64762325|NCT04151667|Growth Inhibitors|growth inhibitors|mesh-ancestor
64762326|NCT04119453|Apatinib|apatinib|mesh-list
64762327|NCT04119453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762328|NCT04119453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64762329|NCT04119453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762330|NCT04119453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762331|NCT04109482|Cyclophosphamide|cyclophosphamide|mesh-list
64762332|NCT04109482|Fludarabine|fludarabine|mesh-list
64762333|NCT04109482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64762342|NCT04099251|Nivolumab|nivolumab|mesh-list
64531081|NCT04512534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531082|NCT04512534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531109|NCT04486118|Lisinopril|lisinopril|mesh-list
64531110|NCT04486118|Benazepril|benazepril|mesh-list
64531111|NCT04486118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64531112|NCT04486118|Protease Inhibitors|protease inhibitors|mesh-ancestor
64531113|NCT04486118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64531114|NCT04486118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64531115|NCT04486118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64531116|NCT04486118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64531117|NCT04486118|Protective Agents|protective agents|mesh-ancestor
64531118|NCT04486118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64531119|NCT04442581|Pembrolizumab|pembrolizumab|mesh-list
64531120|NCT04442581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64531121|NCT04442581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531122|NCT04436731|Phentolamine|phentolamine|mesh-list
64647432|NCT00744848|Bupivacaine|bupivacaine|mesh-list
64531123|NCT04436731|Phenylephrine|phenylephrine|mesh-list
64647433|NCT00744848|Anesthetics, Local|anesthetics, local|mesh-ancestor
64647434|NCT00744848|Anesthetics|anesthetics|mesh-ancestor
64647435|NCT00744848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64647436|NCT00744848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647438|NCT00744848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64647439|NCT00744848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64647440|NCT00744848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64647441|NCT00744848|Adrenergic Agents|adrenergic agents|mesh-ancestor
64647442|NCT00744848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64647443|NCT00744848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647444|NCT00744848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64647445|NCT00744848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64647446|NCT00744848|Autonomic Agents|autonomic agents|mesh-ancestor
64647447|NCT00744848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64647448|NCT00744848|Respiratory System Agents|respiratory system agents|mesh-ancestor
64647449|NCT00744848|Mydriatics|mydriatics|mesh-ancestor
64647450|NCT00744848|Sympathomimetics|sympathomimetics|mesh-ancestor
64647451|NCT00744848|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64647453|NCT03830606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64647454|NCT03830606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64531124|NCT04436731|Oxymetazoline|oxymetazoline|mesh-list
64531125|NCT04436731|Norepinephrine|norepinephrine|mesh-list
64531126|NCT04436731|Dexmedetomidine|dexmedetomidine|mesh-list
64531127|NCT04436731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64762347|NCT04083235|Leucovorin|leucovorin|mesh-list
64762348|NCT04083235|Gemcitabine|gemcitabine|mesh-list
64762349|NCT04083235|Paclitaxel|paclitaxel|mesh-list
64762350|NCT04083235|Fluorouracil|fluorouracil|mesh-list
64762351|NCT04083235|Oxaliplatin|oxaliplatin|mesh-list
64762352|NCT04083235|Irinotecan|irinotecan|mesh-list
64762353|NCT04083235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64762354|NCT04083235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762355|NCT04083235|Tubulin Modulators|tubulin modulators|mesh-ancestor
64762356|NCT04083235|Antimitotic Agents|antimitotic agents|mesh-ancestor
64762357|NCT04083235|Mitosis Modulators|mitosis modulators|mesh-ancestor
64762358|NCT04083235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762359|NCT04083235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64762360|NCT04083235|Antimetabolites|antimetabolites|mesh-ancestor
64762361|NCT04083235|Antiviral Agents|antiviral agents|mesh-ancestor
64762368|NCT04083235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64762369|NCT04083235|Antidotes|antidotes|mesh-ancestor
64762370|NCT04083235|Protective Agents|protective agents|mesh-ancestor
64762371|NCT04083235|Vitamin B Complex|vitamin b complex|mesh-ancestor
64762372|NCT04083235|Vitamins|vitamins|mesh-ancestor
64647461|NCT01278134|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64647462|NCT01278134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64647463|NCT01278134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64762373|NCT04083235|Micronutrients|micronutrients|mesh-ancestor
64647464|NCT01278134|Protease Inhibitors|protease inhibitors|mesh-ancestor
64647465|NCT01278134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762374|NCT04068610|Leucovorin|leucovorin|mesh-list
64762375|NCT04068610|Durvalumab|durvalumab|mesh-list
64647466|NCT01278134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647470|NCT01278134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64647471|NCT01278134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64647472|NCT01278134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64647473|NCT01278134|Antimetabolites|antimetabolites|mesh-ancestor
64647474|NCT01273844|Bortezomib|bortezomib|mesh-list
64647475|NCT01273844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762376|NCT04068610|Fluorouracil|fluorouracil|mesh-list
64762377|NCT04068610|Oxaliplatin|oxaliplatin|mesh-list
64762378|NCT04068610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64762379|NCT04068610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762380|NCT04068610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762381|NCT04068610|Antimetabolites|antimetabolites|mesh-ancestor
64762382|NCT04068610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762383|NCT04068610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64762384|NCT04068610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64762385|NCT04068610|Immunologic Factors|immunologic factors|mesh-ancestor
64762386|NCT04068610|Antidotes|antidotes|mesh-ancestor
64762387|NCT04068610|Protective Agents|protective agents|mesh-ancestor
64762388|NCT04068610|Vitamin B Complex|vitamin b complex|mesh-ancestor
64762389|NCT04068610|Vitamins|vitamins|mesh-ancestor
64762390|NCT04068610|Micronutrients|micronutrients|mesh-ancestor
64762392|NCT04028050|Etoposide|etoposide|mesh-list
64762425|NCT03969446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64762426|NCT03969446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762427|NCT03969446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64762428|NCT03969446|Antimetabolites|antimetabolites|mesh-ancestor
64762494|NCT03695380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762495|NCT03695380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64762496|NCT03695380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762497|NCT03695380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762498|NCT03617679|Rucaparib|rucaparib|mesh-list
64647499|NCT04385264|Diuretics|diuretics|mesh-ancestor
64762499|NCT03617679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64762500|NCT03617679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762501|NCT03617679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762502|NCT03617679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762503|NCT03591731|Nivolumab|nivolumab|mesh-list
64762504|NCT03591731|Ipilimumab|ipilimumab|mesh-list
64762505|NCT03591731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64762506|NCT03591731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762507|NCT03591731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64762508|NCT03591731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762509|NCT03538691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64445691|NCT04801589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64762512|NCT03538691|Fluoxetine|fluoxetine|mesh-list
64762513|NCT03538691|Paroxetine|paroxetine|mesh-list
64762514|NCT03538691|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64762515|NCT03538691|Sertraline|sertraline|mesh-list
64762516|NCT03538691|Brexpiprazole|brexpiprazole|mesh-list
64762517|NCT03538691|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64647557|NCT01279616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64647558|NCT01279616|Antitubercular Agents|antitubercular agents|mesh-ancestor
64647559|NCT01279616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64647560|NCT01279616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64647561|NCT01275638|Prednisolone|prednisolone|mesh-list
64762518|NCT03538691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64762543|NCT03523585|Capecitabine|capecitabine|mesh-list
64762544|NCT03523585|Trastuzumab|trastuzumab|mesh-list
64762545|NCT03523585|Lapatinib|lapatinib|mesh-list
64762546|NCT03523585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64762547|NCT03523585|Antimetabolites|antimetabolites|mesh-ancestor
64762548|NCT03523585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762549|NCT03523585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762550|NCT03523585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64762551|NCT03523585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64762552|NCT03523585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762553|NCT03509012|Paclitaxel|paclitaxel|mesh-list
64762554|NCT03509012|Etoposide|etoposide|mesh-list
64762555|NCT03509012|Cisplatin|cisplatin|mesh-list
64762556|NCT03509012|Carboplatin|carboplatin|mesh-list
64762557|NCT03509012|Etoposide phosphate|etoposide phosphate|mesh-list
64762558|NCT03509012|Pemetrexed|pemetrexed|mesh-list
64762559|NCT03509012|Durvalumab|durvalumab|mesh-list
64762560|NCT03509012|Tremelimumab|tremelimumab|mesh-list
64762561|NCT03509012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64762562|NCT03509012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647610|NCT04274426|Gemcitabine|gemcitabine|mesh-list
64647611|NCT04274426|Paclitaxel|paclitaxel|mesh-list
64647613|NCT04274426|Carboplatin|carboplatin|mesh-list
64647614|NCT04274426|Doxorubicin|doxorubicin|mesh-list
64762563|NCT03509012|Tubulin Modulators|tubulin modulators|mesh-ancestor
64762564|NCT03509012|Antimitotic Agents|antimitotic agents|mesh-ancestor
64647615|NCT04274426|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64647616|NCT04274426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64762565|NCT03509012|Mitosis Modulators|mitosis modulators|mesh-ancestor
64762566|NCT03509012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762567|NCT03509012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64762568|NCT03509012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64762569|NCT03509012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762570|NCT03509012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64762571|NCT03509012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64762572|NCT03509012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64762573|NCT03497676|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64762574|NCT03497676|Rilpivirine|rilpivirine|mesh-list
64762575|NCT03497676|Cabotegravir|cabotegravir|mesh-list
64762585|NCT03489018|Vaccines|vaccines|mesh-list
64762586|NCT03489018|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64762587|NCT03489018|Immunologic Factors|immunologic factors|mesh-ancestor
64762588|NCT03489018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762589|NCT03469960|Nivolumab|nivolumab|mesh-list
64762590|NCT03469960|Ipilimumab|ipilimumab|mesh-list
64762591|NCT03469960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64762592|NCT03469960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762593|NCT03469960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64762594|NCT03469960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762595|NCT03439033|Edetic Acid|edetic acid|mesh-list
64762596|NCT03439033|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
64762597|NCT03439033|Chelating Agents|chelating agents|mesh-ancestor
64762598|NCT03439033|Sequestering Agents|sequestering agents|mesh-ancestor
64762599|NCT03439033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647720|NCT01275014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647721|NCT01275014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64647722|NCT01275014|Glucocorticoids|glucocorticoids|mesh-ancestor
64647723|NCT01275014|Hormones|hormones|mesh-ancestor
64647724|NCT01275014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64647726|NCT01275014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762600|NCT03439033|Anticoagulants|anticoagulants|mesh-ancestor
64762601|NCT03439033|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64762602|NCT03419234|Ascorbic Acid|ascorbic acid|mesh-list
64762603|NCT03419234|Prednisone|prednisone|mesh-list
64762604|NCT03419234|Cortisone|cortisone|mesh-list
64762605|NCT03419234|Methyltestosterone|methyltestosterone|mesh-list
64762606|NCT03419234|Abiraterone Acetate|abiraterone acetate|mesh-list
64762607|NCT03419234|Hormones|hormones|mesh-list
64762608|NCT03419234|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64762609|NCT03419234|Androgens|androgens|mesh-list
64647782|NCT00244712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64647783|NCT00725270|Mifepristone|mifepristone|mesh-list
64647784|NCT00725270|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64647785|NCT00725270|Abortifacient Agents|abortifacient agents|mesh-ancestor
64762610|NCT03419234|Androgen Antagonists|androgen antagonists|mesh-list
64762637|NCT03282799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373079|NCT03290417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762638|NCT03282799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64762639|NCT03206060|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64762640|NCT03206060|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64762641|NCT03206060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762643|NCT03188705|Clopidogrel|clopidogrel|mesh-list
64762644|NCT03188705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64762645|NCT03188705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64762646|NCT03188705|Analgesics|analgesics|mesh-ancestor
64762647|NCT03188705|Sensory System Agents|sensory system agents|mesh-ancestor
64762648|NCT03188705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64762649|NCT03188705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762650|NCT03188705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64762651|NCT03188705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64762652|NCT03188705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64762654|NCT03188705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762655|NCT03188705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64647842|NCT00778310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64647843|NCT00778310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64762656|NCT03188705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64647844|NCT00778310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647845|NCT00778310|Dopamine Agents|dopamine agents|mesh-ancestor
64647846|NCT00778310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64762657|NCT03188705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762658|NCT03188705|Antipyretics|antipyretics|mesh-ancestor
64762659|NCT03188705|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64762660|NCT03188705|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64762661|NCT03188705|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64762662|NCT03188705|Purinergic Agents|purinergic agents|mesh-ancestor
64762663|NCT03188705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64762664|NCT03125928|Paclitaxel|paclitaxel|mesh-list
64762665|NCT03125928|Trastuzumab|trastuzumab|mesh-list
64762683|NCT03085056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64762684|NCT03085056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762685|NCT03006705|Capecitabine|capecitabine|mesh-list
64762686|NCT03006705|Tegafur|tegafur|mesh-list
64762687|NCT03006705|Oxaliplatin|oxaliplatin|mesh-list
64762688|NCT03006705|Nivolumab|nivolumab|mesh-list
64762689|NCT03006705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64762690|NCT03006705|Antimetabolites|antimetabolites|mesh-ancestor
64762691|NCT03006705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762692|NCT03006705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762693|NCT03006705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64762694|NCT03006705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64762695|NCT02987543|Olaparib|olaparib|mesh-list
64647895|NCT01301183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762696|NCT02987543|Abiraterone Acetate|abiraterone acetate|mesh-list
64647896|NCT01301183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64647897|NCT01301183|Contraceptive Agents|contraceptive agents|mesh-ancestor
64647898|NCT01301183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64647899|NCT01301183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64647900|NCT01301183|Growth Substances|growth substances|mesh-ancestor
64647901|NCT00758420|Polidocanol|polidocanol|mesh-list
64762697|NCT02987543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64762698|NCT02987543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762699|NCT02987543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762700|NCT02987543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762701|NCT02987543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64762702|NCT02987543|Hormone Antagonists|hormone antagonists|mesh-ancestor
64762703|NCT02987543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64762704|NCT02987543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762705|NCT02987543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64762706|NCT02983045|Paclitaxel|paclitaxel|mesh-list
64762738|NCT02894398|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64762739|NCT02894398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64762740|NCT02796937|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64762741|NCT02796937|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64762742|NCT02796937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64762743|NCT02796937|Protease Inhibitors|protease inhibitors|mesh-ancestor
64762744|NCT02796937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762745|NCT02796937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762747|NCT02678052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64762748|NCT02616965|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64647944|NCT03806036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64762750|NCT02616965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64762753|NCT02576717|Ozanimod|ozanimod|mesh-list
64762806|NCT02301286|Analgesics|analgesics|mesh-ancestor
64762807|NCT02301286|Sensory System Agents|sensory system agents|mesh-ancestor
64762808|NCT02301286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64762809|NCT02301286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64762810|NCT02301286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64762811|NCT02301286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64762812|NCT02301286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64762813|NCT02301286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64762814|NCT02301286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762815|NCT02301286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64762816|NCT02301286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64762817|NCT02301286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64762818|NCT02301286|Antipyretics|antipyretics|mesh-ancestor
64762819|NCT02231749|Nivolumab|nivolumab|mesh-list
64762820|NCT02231749|Ipilimumab|ipilimumab|mesh-list
64762821|NCT02231749|Sunitinib|sunitinib|mesh-list
64762822|NCT02231749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64762834|NCT02126969|Docetaxel|docetaxel|mesh-list
64762865|NCT02099188|Vitamins|vitamins|mesh-ancestor
64762866|NCT02099188|Micronutrients|micronutrients|mesh-ancestor
64762867|NCT02099188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64762868|NCT02099188|Alkylating Agents|alkylating agents|mesh-ancestor
64762869|NCT02099175|Leucovorin|leucovorin|mesh-list
64762870|NCT02099175|Docetaxel|docetaxel|mesh-list
64762871|NCT02099175|Doxorubicin|doxorubicin|mesh-list
64762872|NCT02099175|Fluorouracil|fluorouracil|mesh-list
64762873|NCT02099175|Etoposide|etoposide|mesh-list
64762874|NCT02099175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64762875|NCT02099175|Ifosfamide|ifosfamide|mesh-list
64762876|NCT02099175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64762877|NCT02099175|Tubulin Modulators|tubulin modulators|mesh-ancestor
64762878|NCT02099175|Antimitotic Agents|antimitotic agents|mesh-ancestor
64762972|NCT01946074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64762974|NCT01946074|Tubulin Modulators|tubulin modulators|mesh-ancestor
64762975|NCT01946074|Antimitotic Agents|antimitotic agents|mesh-ancestor
64762976|NCT01946074|Mitosis Modulators|mitosis modulators|mesh-ancestor
64762977|NCT01946074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64762978|NCT01715285|Prednisone|prednisone|mesh-list
64648007|NCT00763412|Repaglinide|repaglinide|mesh-list
64762979|NCT01715285|Abiraterone Acetate|abiraterone acetate|mesh-list
64762980|NCT01715285|Androgens|androgens|mesh-list
64648008|NCT00763412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64373308|NCT02711137|Gemcitabine|gemcitabine|mesh-list
64648009|NCT00763412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648010|NCT01302743|Metformin|metformin|mesh-list
64762981|NCT01715285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64762982|NCT01715285|Glucocorticoids|glucocorticoids|mesh-ancestor
64762983|NCT01715285|Hormones|hormones|mesh-ancestor
64762984|NCT01715285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64763011|NCT01285817|Immunologic Factors|immunologic factors|mesh-ancestor
64763012|NCT01285817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763013|NCT01285817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763014|NCT01285817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64763015|NCT01285817|Alkylating Agents|alkylating agents|mesh-ancestor
64763016|NCT01285817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763017|NCT01285817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763018|NCT01285817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64763026|NCT01285817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64763027|NCT01285817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64763028|NCT01285817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64763029|NCT01285817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64763031|NCT01285817|Sensory System Agents|sensory system agents|mesh-ancestor
64763032|NCT01285817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64763033|NCT01285817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64763034|NCT01285817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64763035|NCT01285817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64648036|NCT00780962|Acetylcysteine|acetylcysteine|mesh-list
64648037|NCT00780962|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64648038|NCT00780962|Antiviral Agents|antiviral agents|mesh-ancestor
64648039|NCT00780962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64648040|NCT00780962|Expectorants|expectorants|mesh-ancestor
64648041|NCT00780962|Respiratory System Agents|respiratory system agents|mesh-ancestor
64648042|NCT00780962|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64648043|NCT00780962|Antioxidants|antioxidants|mesh-ancestor
64648044|NCT00780962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648045|NCT00780962|Protective Agents|protective agents|mesh-ancestor
64648046|NCT00780962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648047|NCT00780962|Antidotes|antidotes|mesh-ancestor
64648048|NCT00764738|Ranibizumab|ranibizumab|mesh-list
64648049|NCT00764738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64648050|NCT00764738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64648051|NCT00764738|Growth Substances|growth substances|mesh-ancestor
64648052|NCT00764738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648053|NCT00764738|Growth Inhibitors|growth inhibitors|mesh-ancestor
64648054|NCT00764738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763036|NCT01285817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64763037|NCT01285817|Tubulin Modulators|tubulin modulators|mesh-ancestor
64763038|NCT01285817|Antimitotic Agents|antimitotic agents|mesh-ancestor
64763039|NCT01285817|Mitosis Modulators|mitosis modulators|mesh-ancestor
64763040|NCT01285479|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64763041|NCT01285479|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64763042|NCT01285479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763043|NCT01285479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64763044|NCT01285479|Immunologic Factors|immunologic factors|mesh-ancestor
64763045|NCT01285479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763047|NCT01250496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64763048|NCT01250496|Autonomic Agents|autonomic agents|mesh-ancestor
64763049|NCT01250496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64763050|NCT01250496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763051|NCT01250496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64763052|NCT01250496|Respiratory System Agents|respiratory system agents|mesh-ancestor
64763053|NCT01250496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64763054|NCT01250496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64763055|NCT01250496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648072|NCT03805568|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64648073|NCT03805568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64648074|NCT03805568|Adrenergic Agents|adrenergic agents|mesh-ancestor
64648075|NCT03805568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64648076|NCT03805568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648077|NCT03805568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64648078|NCT03805568|Narcotics|narcotics|mesh-ancestor
64648080|NCT00781898|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64648081|NCT00781898|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64648082|NCT00781898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373383|NCT03287609|Evolocumab|evolocumab|mesh-list
64648083|NCT00781898|Sensory System Agents|sensory system agents|mesh-ancestor
64648084|NCT00781898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648086|NCT00765128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64306491|NCT02068079|Trientine|trientine|mesh-list
64648087|NCT00765128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64648088|NCT00765128|Analgesics|analgesics|mesh-ancestor
64648089|NCT00765128|Sensory System Agents|sensory system agents|mesh-ancestor
64648090|NCT00765128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648091|NCT00765128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648092|NCT00765128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64648097|NCT00765206|Omeprazole|omeprazole|mesh-list
64763056|NCT01250496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763057|NCT01250496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64763058|NCT01250496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64763059|NCT01250496|Purinergic Agents|purinergic agents|mesh-ancestor
64763060|NCT01250496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64763064|NCT01105975|Simvastatin|simvastatin|mesh-list
64763065|NCT01105975|Evacetrapib|evacetrapib|mesh-list
64763066|NCT01105975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64763073|NCT01063517|Paclitaxel|paclitaxel|mesh-list
64763089|NCT00819637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64763090|NCT00819637|Respiratory System Agents|respiratory system agents|mesh-ancestor
64763091|NCT00819637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64763092|NCT00819637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64763093|NCT00819637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64763094|NCT00819637|Adrenergic Agents|adrenergic agents|mesh-ancestor
64763095|NCT00819637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64763097|NCT00819637|Tocolytic Agents|tocolytic agents|mesh-ancestor
64763156|NCT04385550|Paclitaxel|paclitaxel|mesh-list
64763157|NCT04385550|Docetaxel|docetaxel|mesh-list
64763158|NCT04385550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64763159|NCT04385550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763160|NCT04385550|Tubulin Modulators|tubulin modulators|mesh-ancestor
64763161|NCT04385550|Antimitotic Agents|antimitotic agents|mesh-ancestor
64763162|NCT04385550|Mitosis Modulators|mitosis modulators|mesh-ancestor
64763163|NCT04385550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763164|NCT04384380|Hydroxychloroquine|hydroxychloroquine|mesh-list
64763165|NCT04384380|Antimalarials|antimalarials|mesh-ancestor
64763166|NCT04384380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64763167|NCT04384380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64763168|NCT04384380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763169|NCT04384380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763170|NCT04384380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763171|NCT04384380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763172|NCT04384458|Hydroxychloroquine|hydroxychloroquine|mesh-list
64763173|NCT04384458|Ivermectin|ivermectin|mesh-list
64763174|NCT04384458|Antimalarials|antimalarials|mesh-ancestor
64763175|NCT04384458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64763176|NCT04384458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64763177|NCT04384458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763178|NCT04384458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763179|NCT04384458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763180|NCT04384458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763207|NCT04380012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763208|NCT04379310|Calcium Channel Blockers|calcium channel blockers|mesh-list
64763209|NCT04379310|Calcium|calcium|mesh-list
64763210|NCT04379310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64763211|NCT04379310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64763212|NCT04379310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763213|NCT04379310|Protease Inhibitors|protease inhibitors|mesh-ancestor
64648104|NCT03809156|Ambrisentan|ambrisentan|mesh-list
64648105|NCT03809156|Riociguat|riociguat|mesh-list
64763214|NCT04379310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763215|NCT04379310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763216|NCT04379310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64763217|NCT04378608|Ribavirin|ribavirin|mesh-list
64763219|NCT04378608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763220|NCT04378608|Antiviral Agents|antiviral agents|mesh-ancestor
64763221|NCT04378608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763222|NCT04376970|Fluorometholone|fluorometholone|mesh-list
64763223|NCT04376970|Cyclosporine|cyclosporine|mesh-list
64763224|NCT04376970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64763225|NCT04376970|Cyclosporins|cyclosporins|mesh-list
64763226|NCT04376970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763227|NCT04376970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763228|NCT04376970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64763229|NCT04376970|Immunologic Factors|immunologic factors|mesh-ancestor
64763230|NCT04376970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763231|NCT04376970|Antifungal Agents|antifungal agents|mesh-ancestor
64763232|NCT04376970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763255|NCT04377048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64763257|NCT04376814|Ritonavir|ritonavir|mesh-list
64763329|NCT04372836|Natriuretic Agents|natriuretic agents|mesh-ancestor
64763330|NCT04372836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64532066|NCT02881086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64648130|NCT05310968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64648131|NCT05310968|Analgesics|analgesics|mesh-ancestor
64648132|NCT05310968|Sensory System Agents|sensory system agents|mesh-ancestor
64648133|NCT05310968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648134|NCT05310968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648135|NCT05310968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64763331|NCT04371978|Linagliptin|linagliptin|mesh-list
64763332|NCT04371978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64648136|NCT05310968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763333|NCT04371978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763334|NCT04371978|Incretins|incretins|mesh-ancestor
64763336|NCT04371978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64763337|NCT04371978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64763338|NCT04371978|Protease Inhibitors|protease inhibitors|mesh-ancestor
64763339|NCT04371978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763340|NCT04371978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763341|NCT04371822|Protoporphyrin IX|protoporphyrin ix|mesh-list
64763342|NCT04371822|Tin protoporphyrin IX|tin protoporphyrin ix|mesh-list
64763343|NCT04371822|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64763344|NCT04371822|Dermatologic Agents|dermatologic agents|mesh-ancestor
64763345|NCT04371822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763346|NCT04371822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763347|NCT04370262|Famotidine|famotidine|mesh-list
64763348|NCT04370262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64763349|NCT04370262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64763350|NCT04370262|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64763351|NCT04370262|Histamine Antagonists|histamine antagonists|mesh-ancestor
64763352|NCT04370262|Histamine Agents|histamine agents|mesh-ancestor
64763353|NCT04370262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64763356|NCT04368546|Sunitinib|sunitinib|mesh-list
64763375|NCT04366050|Protease Inhibitors|protease inhibitors|mesh-ancestor
64763376|NCT04366050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763377|NCT04366050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763378|NCT04366050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64763379|NCT04365582|Ritonavir|ritonavir|mesh-list
64763380|NCT04365582|Lopinavir|lopinavir|mesh-list
64763381|NCT04365582|Azithromycin|azithromycin|mesh-list
64763382|NCT04365582|Hydroxychloroquine|hydroxychloroquine|mesh-list
64763383|NCT04365582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64763384|NCT04365582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64763385|NCT04365582|Protease Inhibitors|protease inhibitors|mesh-ancestor
64763386|NCT04365582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763387|NCT04365582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763388|NCT04365582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64763389|NCT04365582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64763390|NCT04365582|Antiviral Agents|antiviral agents|mesh-ancestor
64648175|NCT01250717|Antimitotic Agents|antimitotic agents|mesh-ancestor
64648176|NCT01250717|Mitosis Modulators|mitosis modulators|mesh-ancestor
64648177|NCT01250717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648179|NCT01250717|Hormone Antagonists|hormone antagonists|mesh-ancestor
64648180|NCT01250717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64648181|NCT01250717|Alkylating Agents|alkylating agents|mesh-ancestor
64763391|NCT04365582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763392|NCT04365582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64763393|NCT04365582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64763394|NCT04365582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64763395|NCT04365582|Antimalarials|antimalarials|mesh-ancestor
64763396|NCT04365582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64763397|NCT04365582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64763398|NCT04365582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763399|NCT04365270|Chlorhexidine|chlorhexidine|mesh-list
64763400|NCT04365270|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64763401|NCT04365270|Titanium dioxide|titanium dioxide|mesh-list
64648207|NCT01251575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64648208|NCT01251575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64648209|NCT01251575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64763402|NCT04365270|Chitosan|chitosan|mesh-list
64648210|NCT01251575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64763424|NCT04365426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763425|NCT04365426|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64763426|NCT04365036|Gemcitabine|gemcitabine|mesh-list
64763427|NCT04365036|Oxaliplatin|oxaliplatin|mesh-list
64763428|NCT04365036|Pegaspargase|pegaspargase|mesh-list
64763429|NCT04365036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64763430|NCT04365036|Antimetabolites|antimetabolites|mesh-ancestor
64445710|NCT01580488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763431|NCT04365036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763432|NCT04365036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763433|NCT04365036|Antiviral Agents|antiviral agents|mesh-ancestor
64763434|NCT04365036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763435|NCT04365036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763436|NCT04365036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64763437|NCT04365036|Immunologic Factors|immunologic factors|mesh-ancestor
64763438|NCT04365036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763439|NCT04364022|Ritonavir|ritonavir|mesh-list
64763440|NCT04364022|Lopinavir|lopinavir|mesh-list
64763441|NCT04364022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64763442|NCT04364022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64763443|NCT04364022|Protease Inhibitors|protease inhibitors|mesh-ancestor
64763444|NCT04364022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763445|NCT04364022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763446|NCT04364022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64763447|NCT04364022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64648269|NCT04345406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64763476|NCT04361214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763477|NCT04361214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64763478|NCT04361214|Immunologic Factors|immunologic factors|mesh-ancestor
64763479|NCT04361214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763480|NCT04361370|Bevacizumab|bevacizumab|mesh-list
64532222|NCT01523275|Mitomycins|mitomycins|mesh-list
64763481|NCT04361370|Pembrolizumab|pembrolizumab|mesh-list
64763482|NCT04361370|Olaparib|olaparib|mesh-list
64763483|NCT04361370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64763484|NCT04361370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763485|NCT04361370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64763486|NCT04361370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64763487|NCT04361370|Growth Substances|growth substances|mesh-ancestor
64763488|NCT04361370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763489|NCT04361370|Growth Inhibitors|growth inhibitors|mesh-ancestor
64763490|NCT04361370|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64763491|NCT04361370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445748|NCT01539538|Sufentanil|sufentanil|mesh-list
64763493|NCT04361058|Nivolumab|nivolumab|mesh-list
64763494|NCT04361058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64763495|NCT04361058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763496|NCT04361058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64763497|NCT04361058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763498|NCT04359966|Amoxicillin|amoxicillin|mesh-list
64763499|NCT04359966|Metronidazole|metronidazole|mesh-list
64763500|NCT04359966|Clarithromycin|clarithromycin|mesh-list
64763501|NCT04359966|Levofloxacin|levofloxacin|mesh-list
64763522|NCT04359966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763523|NCT04359966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64763524|NCT04359966|Antacids|antacids|mesh-ancestor
64763525|NCT04360122|Levamisole|levamisole|mesh-list
64763526|NCT04360122|Inosine Pranobex|inosine pranobex|mesh-list
64763527|NCT04360122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64763528|NCT04360122|Immunologic Factors|immunologic factors|mesh-ancestor
64763529|NCT04360122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763530|NCT04360122|Antinematodal Agents|antinematodal agents|mesh-ancestor
64763531|NCT04360122|Anthelmintics|anthelmintics|mesh-ancestor
64763532|NCT04360122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64763533|NCT04360122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763534|NCT04360122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763535|NCT04360122|Antiviral Agents|antiviral agents|mesh-ancestor
64763536|NCT04360356|Ivermectin|ivermectin|mesh-list
64763537|NCT04360356|Nitazoxanide|nitazoxanide|mesh-list
64763538|NCT04360356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64763539|NCT04360356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763540|NCT04359576|Hemostatics|hemostatics|mesh-list
64763541|NCT04359576|Coagulants|coagulants|mesh-ancestor
64763542|NCT04358796|Perflubron|perflubron|mesh-list
64763543|NCT04358796|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64763544|NCT04358718|Anesthetics|anesthetics|mesh-list
64648301|NCT01216943|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64648302|NCT01216943|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64648303|NCT00783614|Aspirin|aspirin|mesh-list
64648304|NCT00783614|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64648305|NCT00783614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64648306|NCT00783614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64373608|NCT02438761|Gedatolisib|gedatolisib|mesh-list
64763545|NCT04358718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64763546|NCT04358718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763547|NCT04358562|Gefitinib|gefitinib|mesh-list
64763548|NCT04358562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763549|NCT04358562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64763550|NCT04358562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763551|NCT04358562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763552|NCT04357860|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64763553|NCT04358016|Terlipressin|terlipressin|mesh-list
64763568|NCT04357392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763570|NCT04357002|Dinoprostone|dinoprostone|mesh-list
64763571|NCT04357002|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64763572|NCT04357002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64763573|NCT04357002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763574|NCT04357002|Hemostatics|hemostatics|mesh-ancestor
64763575|NCT04357002|Coagulants|coagulants|mesh-ancestor
64763576|NCT04357002|Oxytocics|oxytocics|mesh-ancestor
64763577|NCT04357002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64763578|NCT04357002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763579|NCT04356222|Methotrexate|methotrexate|mesh-list
64763580|NCT04356222|Durvalumab|durvalumab|mesh-list
64763581|NCT04356222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64763582|NCT04356222|Abortifacient Agents|abortifacient agents|mesh-ancestor
64763583|NCT04356222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64763584|NCT04356222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763585|NCT04356222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64763586|NCT04356222|Antimetabolites|antimetabolites|mesh-ancestor
64763587|NCT04356222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763622|NCT04355520|Hormone Antagonists|hormone antagonists|mesh-ancestor
64763623|NCT04355520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64763624|NCT04355520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763625|NCT04355052|Azithromycin|azithromycin|mesh-list
64763626|NCT04355052|Hydroxychloroquine|hydroxychloroquine|mesh-list
64763627|NCT04355052|Camostat|camostat|mesh-list
64763628|NCT04355052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64763629|NCT04355052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763630|NCT04355052|Antimalarials|antimalarials|mesh-ancestor
64763631|NCT04355052|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64648335|NCT04278872|Hormone Antagonists|hormone antagonists|mesh-ancestor
64532367|NCT02985697|Anesthetics, General|anesthetics, general|mesh-ancestor
64763632|NCT04355052|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64763633|NCT04355052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763634|NCT04355052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763635|NCT04355052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763636|NCT04355052|Protease Inhibitors|protease inhibitors|mesh-ancestor
64763637|NCT04355052|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64763638|NCT04355052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64763639|NCT04354662|Leucovorin|leucovorin|mesh-list
64763640|NCT04354662|Docetaxel|docetaxel|mesh-list
64763641|NCT04354662|Fluorouracil|fluorouracil|mesh-list
64763642|NCT04354662|Oxaliplatin|oxaliplatin|mesh-list
64648375|NCT05583188|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64763643|NCT04354662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763644|NCT04354662|Tubulin Modulators|tubulin modulators|mesh-ancestor
64763645|NCT04354662|Antimitotic Agents|antimitotic agents|mesh-ancestor
64763646|NCT04354662|Mitosis Modulators|mitosis modulators|mesh-ancestor
64763648|NCT04354662|Antimetabolites|antimetabolites|mesh-ancestor
64763672|NCT04353336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64763673|NCT04353336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763674|NCT04353336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763675|NCT04353336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763679|NCT04353336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64763680|NCT04353336|Analgesics|analgesics|mesh-ancestor
64763681|NCT04353336|Sensory System Agents|sensory system agents|mesh-ancestor
64763682|NCT04353336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64763683|NCT04353336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763684|NCT04353336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64763685|NCT04353336|Filaricides|filaricides|mesh-ancestor
64763686|NCT04353336|Antinematodal Agents|antinematodal agents|mesh-ancestor
64763687|NCT04353336|Anthelmintics|anthelmintics|mesh-ancestor
64763688|NCT04353180|Tretinoin|tretinoin|mesh-list
64763689|NCT04353180|Isotretinoin|isotretinoin|mesh-list
64763690|NCT04353180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763691|NCT04353180|Keratolytic Agents|keratolytic agents|mesh-ancestor
64763692|NCT04353180|Dermatologic Agents|dermatologic agents|mesh-ancestor
64763693|NCT04352946|Hydroxychloroquine|hydroxychloroquine|mesh-list
64763694|NCT04352946|Antimalarials|antimalarials|mesh-ancestor
64763695|NCT04352946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64763696|NCT04352946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64648441|NCT00769886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64648442|NCT00769886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64648443|NCT00769886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64648444|NCT00769886|Adrenergic Agents|adrenergic agents|mesh-ancestor
64763697|NCT04352946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763698|NCT04352946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648451|NCT00794144|Analgesics|analgesics|mesh-ancestor
64763699|NCT04352946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763700|NCT04352946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763701|NCT04352400|Nafamostat|nafamostat|mesh-list
64763718|NCT04352400|Immunologic Factors|immunologic factors|mesh-ancestor
64763720|NCT04351308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763721|NCT04351308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64763722|NCT04351308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763723|NCT04351308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763724|NCT04350528|Pentobarbital|pentobarbital|mesh-list
64763725|NCT04350528|Chlorpromazine|chlorpromazine|mesh-list
64763726|NCT04350528|Antiemetics|antiemetics|mesh-ancestor
64763727|NCT04350528|Autonomic Agents|autonomic agents|mesh-ancestor
64763728|NCT04350528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64763729|NCT04350528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763730|NCT04350528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64763731|NCT04350528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64763732|NCT04350528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64763733|NCT04350528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64763734|NCT04350528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64763735|NCT04350528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64763736|NCT04350528|Dopamine Agents|dopamine agents|mesh-ancestor
64763737|NCT04350528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64763777|NCT04349592|Hydroxychloroquine|hydroxychloroquine|mesh-list
64763778|NCT04349592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64763779|NCT04349592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763780|NCT04349592|Antimalarials|antimalarials|mesh-ancestor
64763782|NCT04349592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64763783|NCT04349592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763784|NCT04349592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648485|NCT00771056|Hydroxychloroquine|hydroxychloroquine|mesh-list
64763785|NCT04349592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763786|NCT04347252|Glucagon|glucagon|mesh-list
64763787|NCT04347252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64763788|NCT04347252|Hormones|hormones|mesh-ancestor
64763789|NCT04347252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64763790|NCT04347252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763791|NCT04346862|Acetylcarnitine|acetylcarnitine|mesh-list
64763792|NCT04346862|Vitamin B Complex|vitamin b complex|mesh-ancestor
64763793|NCT04346862|Vitamins|vitamins|mesh-ancestor
64763794|NCT04346862|Micronutrients|micronutrients|mesh-ancestor
64763795|NCT04346862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763796|NCT04346862|Nootropic Agents|nootropic agents|mesh-ancestor
64763797|NCT04345848|Heparin|heparin|mesh-list
64763798|NCT04345848|Enoxaparin|enoxaparin|mesh-list
64763799|NCT04345848|Calcium heparin|calcium heparin|mesh-list
64763800|NCT04345848|Anticoagulants|anticoagulants|mesh-ancestor
64763801|NCT04345848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64763802|NCT04345848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64763812|NCT04345458|Etanercept|etanercept|mesh-list
64763829|NCT04344756|Anticoagulants|anticoagulants|mesh-ancestor
64763830|NCT04344756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64763831|NCT04344756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64763832|NCT04344756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648532|NCT03802838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64648533|NCT03802838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648537|NCT00772304|Azelastine|azelastine|mesh-list
64763833|NCT04344288|Prednisone|prednisone|mesh-list
64763834|NCT04344288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64763835|NCT04344288|Glucocorticoids|glucocorticoids|mesh-ancestor
64763836|NCT04344288|Hormones|hormones|mesh-ancestor
64763837|NCT04344288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64763838|NCT04344288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763839|NCT04344288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64763840|NCT04344288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763841|NCT04343742|Chlorine dioxide|chlorine dioxide|mesh-list
64763842|NCT04343742|Dental Disinfectants|dental disinfectants|mesh-ancestor
64763843|NCT04343742|Disinfectants|disinfectants|mesh-ancestor
64648581|NCT03834506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64648582|NCT03834506|Antiemetics|antiemetics|mesh-ancestor
64763844|NCT04343742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763845|NCT04342728|Vitamins|vitamins|mesh-list
64763846|NCT04342728|Ascorbic Acid|ascorbic acid|mesh-list
64763848|NCT04342728|Micronutrients|micronutrients|mesh-ancestor
64763849|NCT04342728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763850|NCT04342728|Trace Elements|trace elements|mesh-ancestor
64763851|NCT04342728|Antioxidants|antioxidants|mesh-ancestor
64648583|NCT03834506|Autonomic Agents|autonomic agents|mesh-ancestor
64648584|NCT03834506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648585|NCT03834506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763852|NCT04342728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763853|NCT04342728|Protective Agents|protective agents|mesh-ancestor
64763854|NCT04342650|Chloroquine|chloroquine|mesh-list
64763855|NCT04342650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64763856|NCT04342650|Amebicides|amebicides|mesh-ancestor
64763857|NCT04342650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64763858|NCT04342650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64763859|NCT04342650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763860|NCT04342650|Antimalarials|antimalarials|mesh-ancestor
64763874|NCT04341870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64763875|NCT04341870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763876|NCT04341870|Antimalarials|antimalarials|mesh-ancestor
64763877|NCT04341870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64763878|NCT04341870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64763879|NCT04341870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763880|NCT04341870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763881|NCT04341870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64648636|NCT00772772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763882|NCT04341402|Antifungal Agents|antifungal agents|mesh-list
64763883|NCT04341402|Clotrimazole|clotrimazole|mesh-list
64763884|NCT04341402|Miconazole|miconazole|mesh-list
64763885|NCT04341402|Diclofenac|diclofenac|mesh-list
64763886|NCT04341402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64763887|NCT04341402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64763888|NCT04341402|Analgesics|analgesics|mesh-ancestor
64763889|NCT04341402|Sensory System Agents|sensory system agents|mesh-ancestor
64763890|NCT04341402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64763891|NCT04341402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763892|NCT04341402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64648637|NCT00772772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64648638|NCT00772772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64648639|NCT00773474|Lonafarnib|lonafarnib|mesh-list
64763893|NCT04341402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64763894|NCT04341402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64763895|NCT04341402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763896|NCT04341402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763897|NCT04341402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763898|NCT04341402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64763899|NCT04341402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64763900|NCT04341402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64763901|NCT04341402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64763920|NCT04340778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64763921|NCT04340778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763922|NCT04340778|Sensory System Agents|sensory system agents|mesh-ancestor
64763923|NCT04340778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64763924|NCT04340778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64763925|NCT04340778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64763926|NCT04340778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64763927|NCT04340778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64648680|NCT05477108|Antidotes|antidotes|mesh-ancestor
64648681|NCT05477108|Protective Agents|protective agents|mesh-ancestor
64648682|NCT01258049|Artemether|artemether|mesh-list
64648683|NCT01258049|Quinine|quinine|mesh-list
64648684|NCT01258049|Antimalarials|antimalarials|mesh-ancestor
64648685|NCT01258049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64648693|NCT01258049|Analgesics|analgesics|mesh-ancestor
64763928|NCT04340778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763929|NCT04340778|Oxytocics|oxytocics|mesh-ancestor
64763930|NCT04340778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64763931|NCT04340778|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64763932|NCT04340388|Tenofovir|tenofovir|mesh-list
64763933|NCT04340388|Lamivudine|lamivudine|mesh-list
64763934|NCT04340388|Zidovudine|zidovudine|mesh-list
64763935|NCT04340388|Dolutegravir|dolutegravir|mesh-list
64763936|NCT04340388|Darunavir|darunavir|mesh-list
64763937|NCT04340388|Abacavir|abacavir|mesh-list
64763938|NCT04340388|Cobicistat|cobicistat|mesh-list
64763939|NCT04340388|Rilpivirine|rilpivirine|mesh-list
64763942|NCT04340388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64763943|NCT04340388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64763945|NCT04340388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763946|NCT04340388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763947|NCT04340388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64763948|NCT04340388|Antimetabolites|antimetabolites|mesh-ancestor
64763949|NCT04340388|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64763950|NCT04340388|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64763957|NCT04338906|Camostat|camostat|mesh-list
64763966|NCT04338906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64763967|NCT04338906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64763969|NCT04338438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763970|NCT04338438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64763971|NCT04338438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64763972|NCT04338438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763973|NCT04338126|Tranexamic Acid|tranexamic acid|mesh-list
64763974|NCT04338126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64763975|NCT04338126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64763976|NCT04338126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763977|NCT04338126|Hemostatics|hemostatics|mesh-ancestor
64763978|NCT04338126|Coagulants|coagulants|mesh-ancestor
64763979|NCT04337658|Capecitabine|capecitabine|mesh-list
64763980|NCT04337658|Trastuzumab|trastuzumab|mesh-list
64763981|NCT04337658|Fulvestrant|fulvestrant|mesh-list
64763982|NCT04337658|Pertuzumab|pertuzumab|mesh-list
64648733|NCT03801668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648734|NCT05414006|Ketamine|ketamine|mesh-list
64648735|NCT05414006|Esketamine|esketamine|mesh-list
64648736|NCT05414006|Analgesics|analgesics|mesh-ancestor
64763983|NCT04337658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64763984|NCT04337658|Antimetabolites|antimetabolites|mesh-ancestor
64648737|NCT05414006|Sensory System Agents|sensory system agents|mesh-ancestor
64648738|NCT05414006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64763985|NCT04337658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64763986|NCT04337658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64763987|NCT04337658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64763988|NCT04337658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64763989|NCT04337658|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64763990|NCT04337658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64763991|NCT04337658|Hormone Antagonists|hormone antagonists|mesh-ancestor
64763992|NCT04337658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64763993|NCT04337658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64763994|NCT04337268|Glucagon|glucagon|mesh-list
64763995|NCT04337268|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64763996|NCT04337268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64764008|NCT04336488|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-list
64764009|NCT04336488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64764010|NCT04336488|Glucocorticoids|glucocorticoids|mesh-ancestor
64764011|NCT04336488|Hormones|hormones|mesh-ancestor
64764012|NCT04336488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64764013|NCT04336488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445779|NCT03027934|Ticagrelor|ticagrelor|mesh-list
64764020|NCT04335786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64764021|NCT04335786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64648767|NCT02199041|Immunologic Factors|immunologic factors|mesh-ancestor
64764022|NCT04335786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64764023|NCT04335786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764025|NCT04335006|Apatinib|apatinib|mesh-list
64764026|NCT04335006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64764027|NCT04335006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764028|NCT04335006|Tubulin Modulators|tubulin modulators|mesh-ancestor
64764029|NCT04335006|Antimitotic Agents|antimitotic agents|mesh-ancestor
64308049|NCT02085317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64648768|NCT02199041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648769|NCT02199041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64648770|NCT02199041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64648771|NCT02199041|Alkylating Agents|alkylating agents|mesh-ancestor
64648772|NCT02199041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648773|NCT02199041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64648774|NCT02199041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64648775|NCT02199041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64648776|NCT02199041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648777|NCT02199041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64648778|NCT02199041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64648779|NCT02199041|Antitubercular Agents|antitubercular agents|mesh-ancestor
64648780|NCT02199041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64648781|NCT02199041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64648782|NCT02199041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64648783|NCT02199041|Antiemetics|antiemetics|mesh-ancestor
64648788|NCT02199041|Hormones|hormones|mesh-ancestor
64764030|NCT04335006|Mitosis Modulators|mitosis modulators|mesh-ancestor
64764031|NCT04335006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764032|NCT04335006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64764033|NCT04335006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764034|NCT04334928|Tenofovir|tenofovir|mesh-list
64648791|NCT02199041|Protective Agents|protective agents|mesh-ancestor
64648792|NCT02199041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64764035|NCT04334928|Emtricitabine|emtricitabine|mesh-list
64764036|NCT04334928|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64648793|NCT02199041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64648794|NCT00789776|Mycophenolic Acid|mycophenolic acid|mesh-list
64648795|NCT00789776|Cyclophosphamide|cyclophosphamide|mesh-list
64648796|NCT00789776|Fludarabine|fludarabine|mesh-list
64648797|NCT00789776|Fludarabine phosphate|fludarabine phosphate|mesh-list
64648798|NCT00789776|Tacrolimus|tacrolimus|mesh-list
64648799|NCT00789776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64764037|NCT04334928|Hydroxychloroquine|hydroxychloroquine|mesh-list
64764038|NCT04334928|Antiviral Agents|antiviral agents|mesh-ancestor
64764039|NCT04334928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64375799|NCT04908813|Capecitabine|capecitabine|mesh-list
64764040|NCT04334928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64764041|NCT04334928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64764042|NCT04334928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764043|NCT04334928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764045|NCT04334928|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64764046|NCT04334928|Antimalarials|antimalarials|mesh-ancestor
64764047|NCT04334928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64764048|NCT04334928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64764049|NCT04334928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64764050|NCT04334850|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64764051|NCT04334850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64764052|NCT04334382|Azithromycin|azithromycin|mesh-list
64764053|NCT04334382|Hydroxychloroquine|hydroxychloroquine|mesh-list
64648850|NCT00799604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648851|NCT01259063|Gemcitabine|gemcitabine|mesh-list
64764054|NCT04334382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64764055|NCT04334382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64648852|NCT01259063|Everolimus|everolimus|mesh-list
64764056|NCT04334382|Antimalarials|antimalarials|mesh-ancestor
64764057|NCT04334382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64764058|NCT04334382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64764059|NCT04334382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764060|NCT04334382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764061|NCT04334382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64764062|NCT04333992|Remifentanil|remifentanil|mesh-list
64764063|NCT04333992|Propofol|propofol|mesh-list
64764064|NCT04333992|Sevoflurane|sevoflurane|mesh-list
64764065|NCT04333992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64764066|NCT04333992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64764089|NCT04332666|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
64764090|NCT04332666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64764091|NCT04332666|Vasodilator Agents|vasodilator agents|mesh-ancestor
64764092|NCT04332276|Dopamine|dopamine|mesh-list
64764093|NCT04332276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64764095|NCT04332276|Autonomic Agents|autonomic agents|mesh-ancestor
64764096|NCT04332276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764097|NCT04332276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764098|NCT04332276|Dopamine Agents|dopamine agents|mesh-ancestor
64764099|NCT04332276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64764100|NCT04332276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764101|NCT04332276|Protective Agents|protective agents|mesh-ancestor
64648906|NCT01342523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648909|NCT01342757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64764102|NCT04332042|Tofacitinib|tofacitinib|mesh-list
64764103|NCT04332042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64764104|NCT04332042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764105|NCT04332042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764106|NCT04331418|Dexmedetomidine|dexmedetomidine|mesh-list
64764107|NCT04331418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64764108|NCT04331418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64764109|NCT04331418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764110|NCT04331418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64764111|NCT04331418|Analgesics|analgesics|mesh-ancestor
64764112|NCT04331418|Sensory System Agents|sensory system agents|mesh-ancestor
64764113|NCT04331418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764114|NCT04331418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64764138|NCT04330326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64764139|NCT04329858|Methamphetamine|methamphetamine|mesh-list
64764140|NCT04329858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64648954|NCT00776594|Hormone Antagonists|hormone antagonists|mesh-ancestor
64648955|NCT00777062|Naltrexone|naltrexone|mesh-list
64764141|NCT04329858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764142|NCT04329858|Sympathomimetics|sympathomimetics|mesh-ancestor
64764143|NCT04329858|Autonomic Agents|autonomic agents|mesh-ancestor
64764144|NCT04329858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764145|NCT04329858|Dopamine Agents|dopamine agents|mesh-ancestor
64764146|NCT04329858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64764147|NCT04329858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764148|NCT04329858|Adrenergic Agents|adrenergic agents|mesh-ancestor
64764149|NCT04329858|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64764150|NCT04329858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64764151|NCT04329858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64764152|NCT04329858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64764154|NCT00704106|Antiviral Agents|antiviral agents|mesh-ancestor
64764155|NCT00704106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64764156|NCT05508594|Sufentanil|sufentanil|mesh-list
64764157|NCT05508594|Ketamine|ketamine|mesh-list
64764158|NCT05508594|Analgesics|analgesics|mesh-ancestor
64310817|NCT03542149|Vitamins|vitamins|mesh-ancestor
64764159|NCT05508594|Sensory System Agents|sensory system agents|mesh-ancestor
64764160|NCT05508594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764161|NCT05508594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764188|NCT05136690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64764189|NCT05136690|Autonomic Agents|autonomic agents|mesh-ancestor
64764190|NCT05136690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764191|NCT05136690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764192|NCT05136690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64764193|NCT05136690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64764194|NCT05136690|Cholinergic Agents|cholinergic agents|mesh-ancestor
64764195|NCT05136690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64649073|NCT05287724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649074|NCT05287724|Protective Agents|protective agents|mesh-ancestor
64649075|NCT05287724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649076|NCT05287724|Antidotes|antidotes|mesh-ancestor
64649077|NCT01321541|Gemcitabine|gemcitabine|mesh-list
64649078|NCT01321541|Rituximab|rituximab|mesh-list
64649079|NCT01321541|Pixantrone|pixantrone|mesh-list
64649080|NCT01321541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64649081|NCT01321541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649082|NCT01321541|Immunologic Factors|immunologic factors|mesh-ancestor
64649083|NCT01321541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649084|NCT01321541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64311542|NCT02337946|Leucovorin|leucovorin|mesh-list
64764196|NCT05136690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764197|NCT05035680|Vaccines|vaccines|mesh-list
64764198|NCT05035680|Immunologic Factors|immunologic factors|mesh-ancestor
64764199|NCT05035680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764200|NCT04831320|Paclitaxel|paclitaxel|mesh-list
64764201|NCT04831320|Nivolumab|nivolumab|mesh-list
64764202|NCT04831320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64764203|NCT04831320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764204|NCT04831320|Tubulin Modulators|tubulin modulators|mesh-ancestor
64764205|NCT04831320|Antimitotic Agents|antimitotic agents|mesh-ancestor
64764206|NCT04831320|Mitosis Modulators|mitosis modulators|mesh-ancestor
64764207|NCT04831320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764208|NCT04831320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64764209|NCT04831320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64764210|NCT03874884|Olaparib|olaparib|mesh-list
64764211|NCT03874884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64764212|NCT03874884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764213|NCT03874884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649119|NCT01354145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64649120|NCT01354145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64649121|NCT01354145|Analgesics|analgesics|mesh-ancestor
64649122|NCT01354145|Sensory System Agents|sensory system agents|mesh-ancestor
64764214|NCT03874884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764215|NCT03063450|Nivolumab|nivolumab|mesh-list
64764216|NCT03063450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64764217|NCT03063450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764218|NCT03063450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64764234|NCT03035214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64764235|NCT03035214|Glucocorticoids|glucocorticoids|mesh-ancestor
64764236|NCT03035214|Hormones|hormones|mesh-ancestor
64764237|NCT03035214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64764238|NCT03035214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64764239|NCT03035214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764240|NCT03035214|Protease Inhibitors|protease inhibitors|mesh-ancestor
64764241|NCT03035214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764242|NCT03035214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764244|NCT03035058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64764245|NCT03033654|Sunscreening Agents|sunscreening agents|mesh-list
64764246|NCT03033654|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64764247|NCT03033654|Protective Agents|protective agents|mesh-ancestor
64764248|NCT03033654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764249|NCT03033654|Dermatologic Agents|dermatologic agents|mesh-ancestor
64764250|NCT03033732|Buprenorphine|buprenorphine|mesh-list
64764251|NCT03033732|Methadone|methadone|mesh-list
64649178|NCT00802100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649179|NCT00802100|Antiemetics|antiemetics|mesh-ancestor
64649180|NCT00802100|Autonomic Agents|autonomic agents|mesh-ancestor
64649181|NCT00802100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764252|NCT03033732|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64649182|NCT00802100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64649183|NCT00802100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64764253|NCT03033732|Naloxone|naloxone|mesh-list
64764254|NCT03033732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64764255|NCT03033732|Narcotics|narcotics|mesh-ancestor
64764256|NCT03033732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64764258|NCT03033732|Analgesics|analgesics|mesh-ancestor
64764279|NCT03032484|Growth Substances|growth substances|mesh-ancestor
64764280|NCT03032484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764281|NCT03032484|Growth Inhibitors|growth inhibitors|mesh-ancestor
64764282|NCT03030768|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64764283|NCT03030768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64764284|NCT03030768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64764285|NCT03030768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764286|NCT03030768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764287|NCT03030768|Antiviral Agents|antiviral agents|mesh-ancestor
64764288|NCT03030768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64764289|NCT03030768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64764290|NCT03030768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64649226|NCT01355705|Dexamethasone acetate|dexamethasone acetate|mesh-list
64649228|NCT01355705|Amrubicin|amrubicin|mesh-list
64649229|NCT01355705|BB 1101|bb 1101|mesh-list
64649230|NCT01355705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64649231|NCT01355705|Antiemetics|antiemetics|mesh-ancestor
64649232|NCT01355705|Autonomic Agents|autonomic agents|mesh-ancestor
64649233|NCT01355705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649234|NCT01355705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764291|NCT03030690|Methamphetamine|methamphetamine|mesh-list
64649235|NCT01355705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64764292|NCT03030690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64764293|NCT03030690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764294|NCT03030690|Sympathomimetics|sympathomimetics|mesh-ancestor
64764295|NCT03030690|Autonomic Agents|autonomic agents|mesh-ancestor
64764297|NCT03030690|Dopamine Agents|dopamine agents|mesh-ancestor
64764334|NCT03019848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64764335|NCT03019848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64764336|NCT03019848|Analgesics|analgesics|mesh-ancestor
64764337|NCT03019848|Sensory System Agents|sensory system agents|mesh-ancestor
64764338|NCT03019848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764339|NCT03019848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764340|NCT03019848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64764341|NCT03019848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64764342|NCT03019848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764343|NCT03019848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764344|NCT03019848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764345|NCT03019614|Hydrocortisone|hydrocortisone|mesh-list
64764346|NCT03019614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64764347|NCT03019536|Flutemetamol|flutemetamol|mesh-list
64649276|NCT05118854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64649277|NCT03839888|Atropine|atropine|mesh-list
64374601|NCT04950933|Riluzole|riluzole|mesh-list
64649278|NCT03839888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64764348|NCT03019536|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64764349|NCT03019536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764350|NCT03019224|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64764351|NCT03019224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64764352|NCT03019224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64764353|NCT03018990|Ethanol|ethanol|mesh-list
64764354|NCT03018990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64764355|NCT03018990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64764356|NCT03018990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64764357|NCT03018990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764358|NCT03018756|Fentanyl|fentanyl|mesh-list
64764359|NCT03018756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64764360|NCT03018756|Narcotics|narcotics|mesh-ancestor
64764361|NCT03018756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64764362|NCT03018756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764363|NCT03018756|Analgesics|analgesics|mesh-ancestor
64649331|NCT03984188|Theophylline|theophylline|mesh-list
64649332|NCT03984188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64649333|NCT03984188|Autonomic Agents|autonomic agents|mesh-ancestor
64313651|NCT04367168|Antimitotic Agents|antimitotic agents|mesh-ancestor
64313655|NCT02113943|Citalopram|citalopram|mesh-list
64764364|NCT03018756|Sensory System Agents|sensory system agents|mesh-ancestor
64313816|NCT04826432|Hormones|hormones|mesh-ancestor
64764365|NCT03018756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764369|NCT03018756|Anesthetics|anesthetics|mesh-ancestor
64764375|NCT03018444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64764376|NCT03018444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64764377|NCT03018444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764378|NCT03017430|Ketorolac|ketorolac|mesh-list
64764379|NCT03017430|Phenazepam|phenazepam|mesh-list
64649386|NCT05032820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764380|NCT03017430|Clonidine|clonidine|mesh-list
64649387|NCT04699838|Carboplatin|carboplatin|mesh-list
64764381|NCT03017430|Pregabalin|pregabalin|mesh-list
64649389|NCT04699838|Durvalumab|durvalumab|mesh-list
64764382|NCT03017430|Metoclopramide|metoclopramide|mesh-list
64764383|NCT03017430|Loperamide|loperamide|mesh-list
64764384|NCT03017430|Antidiarrheals|antidiarrheals|mesh-list
64764385|NCT03017430|Analgesics|analgesics|mesh-ancestor
64764386|NCT03017430|Sensory System Agents|sensory system agents|mesh-ancestor
64764387|NCT03017430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764388|NCT03017430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764389|NCT03017430|Anticonvulsants|anticonvulsants|mesh-ancestor
64764390|NCT03017430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64764391|NCT03017430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64764392|NCT03017430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764393|NCT03017430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64445812|NCT01537042|Dopamine Agents|dopamine agents|mesh-ancestor
64764396|NCT03017430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64764397|NCT03017430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64764398|NCT03017430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64764399|NCT03017430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64764400|NCT03017430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64649456|NCT00806234|Iloperidone|iloperidone|mesh-list
64649457|NCT00806234|Perphenazine|perphenazine|mesh-list
64649458|NCT00806234|Fluoxetine|fluoxetine|mesh-list
64649459|NCT00806234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64649460|NCT00806234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649461|NCT00806234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64764401|NCT03017430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64764402|NCT03017430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64764403|NCT03017430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764404|NCT03017430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64764405|NCT03017430|Sympatholytics|sympatholytics|mesh-ancestor
64764406|NCT03017430|Autonomic Agents|autonomic agents|mesh-ancestor
64764407|NCT03017430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64764408|NCT03017430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64764409|NCT03017430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64764416|NCT03017430|Dopamine Agents|dopamine agents|mesh-ancestor
64764417|NCT03017430|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64764418|NCT03017430|Immunologic Factors|immunologic factors|mesh-ancestor
64764419|NCT03017430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64764420|NCT03017430|GABA Agents|gaba agents|mesh-ancestor
64764421|NCT03017352|Exenatide|exenatide|mesh-list
64764422|NCT03017352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64764423|NCT03017352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764424|NCT03017352|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64764425|NCT03017352|Incretins|incretins|mesh-ancestor
64764426|NCT03017352|Hormones|hormones|mesh-ancestor
64764427|NCT03017352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64764428|NCT03016884|Vaccines|vaccines|mesh-list
64764429|NCT03016884|Immunologic Factors|immunologic factors|mesh-ancestor
64764430|NCT03016884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764431|NCT03016806|Cyclophosphamide|cyclophosphamide|mesh-list
64764432|NCT03016806|Melphalan|melphalan|mesh-list
64764433|NCT03016806|Busulfan|busulfan|mesh-list
64764434|NCT03016806|Fludarabine|fludarabine|mesh-list
64764435|NCT03016806|Mesna|mesna|mesh-list
64764436|NCT03016806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64764437|NCT03016806|Immunologic Factors|immunologic factors|mesh-ancestor
64764438|NCT03016806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764439|NCT03016806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64764440|NCT03016806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64764441|NCT03016806|Alkylating Agents|alkylating agents|mesh-ancestor
64764442|NCT03016806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764443|NCT03016806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764444|NCT03016806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64649509|NCT01275365|Anabolic Agents|anabolic agents|mesh-ancestor
64649510|NCT00811850|Timolol|timolol|mesh-list
64764445|NCT03016806|Protective Agents|protective agents|mesh-ancestor
64764446|NCT03016650|Acetaminophen|acetaminophen|mesh-list
64764447|NCT03016650|Ibuprofen|ibuprofen|mesh-list
64764448|NCT03016650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64764449|NCT03016650|Analgesics|analgesics|mesh-ancestor
64764450|NCT03016650|Sensory System Agents|sensory system agents|mesh-ancestor
64764458|NCT03016650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764459|NCT03016650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764460|NCT03016260|Adalimumab|adalimumab|mesh-list
64764461|NCT03016260|Etanercept|etanercept|mesh-list
64764462|NCT03016260|Golimumab|golimumab|mesh-list
64764463|NCT03016260|Infliximab|infliximab|mesh-list
64764464|NCT03016260|Certolizumab Pegol|certolizumab pegol|mesh-list
64764465|NCT03016260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64764466|NCT03016260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64764467|NCT03016260|Dermatologic Agents|dermatologic agents|mesh-ancestor
64764468|NCT03016260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64764469|NCT03016260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64764470|NCT03016260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64764471|NCT03016260|Analgesics|analgesics|mesh-ancestor
64764472|NCT03016260|Sensory System Agents|sensory system agents|mesh-ancestor
64764473|NCT03016260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764474|NCT03016260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764475|NCT03016260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64764476|NCT03016260|Immunologic Factors|immunologic factors|mesh-ancestor
64764477|NCT03016260|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64764478|NCT03015246|Morphine|morphine|mesh-list
64764479|NCT03015246|Buprenorphine|buprenorphine|mesh-list
64764480|NCT03015246|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64764481|NCT03015246|Naloxone|naloxone|mesh-list
64764482|NCT03015246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64764483|NCT03015246|Narcotics|narcotics|mesh-ancestor
64649549|NCT01329185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64649550|NCT01276301|Empagliflozin|empagliflozin|mesh-list
64649552|NCT01276301|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64649553|NCT01276301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649554|NCT01276301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64649555|NCT01276301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649556|NCT01276301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64649561|NCT00845000|Levodopa|levodopa|mesh-list
64764484|NCT03015246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64764485|NCT03015246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764486|NCT03015246|Analgesics|analgesics|mesh-ancestor
64764506|NCT03014076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64764507|NCT03014076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764508|NCT03013140|Anesthetics|anesthetics|mesh-list
64764509|NCT03013140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64764510|NCT03013140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764511|NCT03011970|Oxytocin|oxytocin|mesh-list
64764512|NCT03011970|Oxytocics|oxytocics|mesh-ancestor
64764513|NCT03011970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64764514|NCT03011970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764515|NCT03010098|Remifentanil|remifentanil|mesh-list
64764516|NCT03010098|Propofol|propofol|mesh-list
64445828|NCT04410094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64764518|NCT03010098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64764519|NCT03010098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764520|NCT03010098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64764521|NCT03010098|Anesthetics, General|anesthetics, general|mesh-ancestor
64764522|NCT03010098|Anesthetics|anesthetics|mesh-ancestor
64764523|NCT03010098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64764524|NCT03010098|Narcotics|narcotics|mesh-ancestor
64764525|NCT03010098|Analgesics|analgesics|mesh-ancestor
64764526|NCT03010098|Sensory System Agents|sensory system agents|mesh-ancestor
64764527|NCT03010098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764528|NCT03009474|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
64764529|NCT03009474|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64764530|NCT03009474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64764531|NCT03009474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64649584|NCT01330043|Antidepressive Agents|antidepressive agents|mesh-ancestor
64649585|NCT01330043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64649586|NCT01330043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64315028|NCT02133911|Ranolazine|ranolazine|mesh-list
64649587|NCT01330043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64764532|NCT03009474|Antimetabolites|antimetabolites|mesh-ancestor
64649588|NCT01330043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64649589|NCT01330043|Dopamine Agents|dopamine agents|mesh-ancestor
64649590|NCT01330043|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64764533|NCT03009474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764534|NCT03009474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64764535|NCT03009474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64764536|NCT03009474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764537|NCT03009474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64764539|NCT03009006|Chlorhexidine|chlorhexidine|mesh-list
64764548|NCT03008148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64764549|NCT03008148|Alkylating Agents|alkylating agents|mesh-ancestor
64764550|NCT03008148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764551|NCT03008148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764553|NCT03007992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64764554|NCT03007992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764555|NCT03007992|Tubulin Modulators|tubulin modulators|mesh-ancestor
64764556|NCT03007992|Antimitotic Agents|antimitotic agents|mesh-ancestor
64764557|NCT03007992|Mitosis Modulators|mitosis modulators|mesh-ancestor
64764558|NCT03007992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764559|NCT03007446|Oxaliplatin|oxaliplatin|mesh-list
64764560|NCT03007446|Apatinib|apatinib|mesh-list
64764561|NCT03007446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764562|NCT03007446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64764563|NCT03007446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764564|NCT03007446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764565|NCT03007524|Calcium, Dietary|calcium, dietary|mesh-list
64764566|NCT03007524|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64649628|NCT01361633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64649629|NCT01361633|Renal Agents|renal agents|mesh-ancestor
64649630|NCT01361633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64649631|NCT01361633|Antitubercular Agents|antitubercular agents|mesh-ancestor
64649632|NCT01361633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64649633|NCT01361633|Antimetabolites|antimetabolites|mesh-ancestor
64649634|NCT01361633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649635|NCT01331213|Pregabalin|pregabalin|mesh-list
64649636|NCT01331213|Analgesics|analgesics|mesh-ancestor
64649637|NCT01331213|Sensory System Agents|sensory system agents|mesh-ancestor
64649638|NCT01331213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315304|NCT02134457|Ranibizumab|ranibizumab|mesh-list
64649639|NCT01331213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649641|NCT01331213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64649642|NCT01331213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64649643|NCT01331213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649645|NCT01331213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64649646|NCT01331213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64649647|NCT01331213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64764567|NCT03007524|Calcium|calcium|mesh-list
64764568|NCT03007524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64764569|NCT03007524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764570|NCT03007524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64764571|NCT03007524|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64764572|NCT03007524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64764573|NCT03007524|Antimetabolites|antimetabolites|mesh-ancestor
64764574|NCT03007524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764575|NCT03007524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64764576|NCT03007524|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64764577|NCT03007524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764578|NCT03006042|Bupivacaine|bupivacaine|mesh-list
64764579|NCT03006042|Anesthetics, Local|anesthetics, local|mesh-ancestor
64764580|NCT03006042|Anesthetics|anesthetics|mesh-ancestor
64764581|NCT03006042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64764582|NCT03006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764586|NCT03005496|Cholecalciferol|cholecalciferol|mesh-list
64764587|NCT03005496|Beta Carotene|beta carotene|mesh-list
64764588|NCT03005496|Zinc|zinc|mesh-list
64764589|NCT03005496|Dexamethasone|dexamethasone|mesh-list
64764590|NCT03005496|Dexamethasone acetate|dexamethasone acetate|mesh-list
64649659|NCT01277159|BB 1101|bb 1101|mesh-list
64649660|NCT01277159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64649661|NCT01277159|Antiemetics|antiemetics|mesh-ancestor
64649662|NCT01277159|Autonomic Agents|autonomic agents|mesh-ancestor
64649663|NCT01277159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649664|NCT01277159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649665|NCT01277159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64649666|NCT01277159|Glucocorticoids|glucocorticoids|mesh-ancestor
64649668|NCT01277159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64649669|NCT01277159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64649670|NCT01277159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649671|NCT01277159|Protease Inhibitors|protease inhibitors|mesh-ancestor
64649672|NCT01277159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649673|NCT01277159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649674|NCT01277159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64649676|NCT01277159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64649677|NCT01277159|Analgesics|analgesics|mesh-ancestor
64649678|NCT01277159|Sensory System Agents|sensory system agents|mesh-ancestor
64649679|NCT01277159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64764591|NCT03005496|Nifedipine|nifedipine|mesh-list
64764592|NCT03005496|BB 1101|bb 1101|mesh-list
64764593|NCT03005496|Carotenoids|carotenoids|mesh-list
64764594|NCT03005496|Picolinic acid|picolinic acid|mesh-list
64764595|NCT03005496|Vitamins|vitamins|mesh-ancestor
64764596|NCT03005496|Micronutrients|micronutrients|mesh-ancestor
64764597|NCT03005496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764598|NCT03005496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64764599|NCT03005496|Antiemetics|antiemetics|mesh-ancestor
64649695|NCT01332461|Autonomic Agents|autonomic agents|mesh-ancestor
64764600|NCT03005496|Autonomic Agents|autonomic agents|mesh-ancestor
64649708|NCT01279187|Teriparatide|teriparatide|mesh-list
64764601|NCT03005496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764602|NCT03005496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64764603|NCT03005496|Glucocorticoids|glucocorticoids|mesh-ancestor
64764604|NCT03005496|Hormones|hormones|mesh-ancestor
64764605|NCT03005496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64764606|NCT03005496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64764607|NCT03005496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764608|NCT03005496|Protease Inhibitors|protease inhibitors|mesh-ancestor
64649767|NCT03637400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64764609|NCT03005496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649768|NCT03637400|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64649769|NCT03637400|Renal Agents|renal agents|mesh-ancestor
64649770|NCT03637400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64649771|NCT03637400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764610|NCT03005496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764611|NCT03005496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64764612|NCT03005496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64764613|NCT03005496|Trace Elements|trace elements|mesh-ancestor
64764614|NCT03005496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64764615|NCT03005496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64764616|NCT03005496|Vasodilator Agents|vasodilator agents|mesh-ancestor
64764617|NCT03005496|Tocolytic Agents|tocolytic agents|mesh-ancestor
64764618|NCT03005496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64764619|NCT03005496|Antioxidants|antioxidants|mesh-ancestor
64764631|NCT03005808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764632|NCT03005340|Cholecalciferol|cholecalciferol|mesh-list
64764633|NCT03005340|Vitamin D|vitamin d|mesh-list
64764634|NCT03005340|Bazedoxifene|bazedoxifene|mesh-list
64764635|NCT03005340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64649832|NCT00815360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64764636|NCT03005340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764637|NCT03005340|Vitamins|vitamins|mesh-ancestor
64764638|NCT03005340|Micronutrients|micronutrients|mesh-ancestor
64764640|NCT03005340|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64764641|NCT03005340|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64764642|NCT03005340|Hormone Antagonists|hormone antagonists|mesh-ancestor
64764643|NCT03005340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64764644|NCT03005184|Icatibant|icatibant|mesh-list
64764645|NCT03005184|Valsartan|valsartan|mesh-list
64764646|NCT03005184|Enalapril|enalapril|mesh-list
64764647|NCT03005184|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64764648|NCT03005184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64764649|NCT03005184|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64764650|NCT03005184|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64649897|NCT01369745|Autonomic Agents|autonomic agents|mesh-ancestor
64316038|NCT05556122|Sensory System Agents|sensory system agents|mesh-ancestor
64649898|NCT01369745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649899|NCT01369745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64649900|NCT01369745|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64649901|NCT01369745|Protective Agents|protective agents|mesh-ancestor
64649902|NCT01369745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64649903|NCT01369745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649904|NCT01369745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649905|NCT01369745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64649906|NCT01369745|Vasodilator Agents|vasodilator agents|mesh-ancestor
64649907|NCT01475513|Moxifloxacin|moxifloxacin|mesh-list
64316051|NCT05611268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64649909|NCT01475513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64764651|NCT03005184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764652|NCT03005184|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64764653|NCT03005184|Protease Inhibitors|protease inhibitors|mesh-ancestor
64764654|NCT03005184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764655|NCT03005184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64764656|NCT03005184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64764657|NCT03005184|Analgesics|analgesics|mesh-ancestor
64764658|NCT03005184|Sensory System Agents|sensory system agents|mesh-ancestor
64764659|NCT03005184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764660|NCT03005184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764668|NCT03004014|Propofol|propofol|mesh-list
64764671|NCT03004014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764672|NCT03004014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64764673|NCT03004014|Anesthetics, General|anesthetics, general|mesh-ancestor
64764675|NCT03002844|Gemcitabine|gemcitabine|mesh-list
64764676|NCT03002844|Carboplatin|carboplatin|mesh-list
64764677|NCT03002844|Pemetrexed|pemetrexed|mesh-list
64764687|NCT03002844|Immunologic Factors|immunologic factors|mesh-ancestor
64764688|NCT03002844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764689|NCT03002844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64649939|NCT01370369|Testosterone|testosterone|mesh-list
64649940|NCT01370369|Androgens|androgens|mesh-ancestor
64649941|NCT01370369|Hormones|hormones|mesh-ancestor
64649942|NCT01370369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64649943|NCT01370369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764690|NCT03002844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64649944|NCT01477463|Vitamin D|vitamin d|mesh-list
64764691|NCT03002844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64764692|NCT03002376|Cemiplimab|cemiplimab|mesh-list
64764693|NCT03002376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64764694|NCT03002376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764723|NCT03000036|Doxorubicin|doxorubicin|mesh-list
64764724|NCT03000036|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
64764725|NCT03000036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64764726|NCT03000036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764727|NCT03000036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64764728|NCT03000036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64764729|NCT03000036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764730|NCT03000036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764731|NCT03000036|Chelating Agents|chelating agents|mesh-ancestor
64764732|NCT03000036|Sequestering Agents|sequestering agents|mesh-ancestor
64764733|NCT02995824|Raltegravir Potassium|raltegravir potassium|mesh-list
64764734|NCT02995824|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64764735|NCT02995824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64764736|NCT02995824|Antiviral Agents|antiviral agents|mesh-ancestor
64764737|NCT02995824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64764738|NCT02995824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64764739|NCT02995824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64764740|NCT02995824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764741|NCT02995824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764749|NCT02989272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64764750|NCT02989272|Anticonvulsants|anticonvulsants|mesh-ancestor
64764751|NCT02989272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64764752|NCT02989272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64764753|NCT02989272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764754|NCT02989272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64764755|NCT02989272|Tocolytic Agents|tocolytic agents|mesh-ancestor
64764761|NCT02989038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764762|NCT02989038|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64764763|NCT02989038|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64649995|NCT00859040|Pasireotide|pasireotide|mesh-list
64764764|NCT02989038|Cholinergic Agents|cholinergic agents|mesh-ancestor
64764765|NCT02989038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64764766|NCT02989038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764767|NCT02988024|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64764768|NCT02988024|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64764769|NCT02988024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64764770|NCT02988024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64764771|NCT02988024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764772|NCT02988024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64764773|NCT02988024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764774|NCT02988024|Antidepressive Agents|antidepressive agents|mesh-ancestor
64764775|NCT02988024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64764777|NCT02987556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64764778|NCT02987556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764779|NCT02987400|Venetoclax|venetoclax|mesh-list
64764780|NCT02987400|Obinutuzumab|obinutuzumab|mesh-list
64764781|NCT02987400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764782|NCT02987400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64764783|NCT02987244|Prednisone|prednisone|mesh-list
64764784|NCT02987244|Cyclophosphamide|cyclophosphamide|mesh-list
64764811|NCT02987166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64764812|NCT02987166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764813|NCT02982486|Nivolumab|nivolumab|mesh-list
64764814|NCT02982486|Ipilimumab|ipilimumab|mesh-list
64764815|NCT02982486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64764816|NCT02982486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764817|NCT02982486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64764818|NCT02982486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764819|NCT02981784|Ponatinib|ponatinib|mesh-list
64764820|NCT02981784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764821|NCT02981784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64764822|NCT02981784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764823|NCT02981784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764824|NCT02980926|Bupivacaine|bupivacaine|mesh-list
64764825|NCT02980926|Mepivacaine|mepivacaine|mesh-list
64764826|NCT02980926|Anesthetics, Local|anesthetics, local|mesh-ancestor
64764827|NCT02980926|Anesthetics|anesthetics|mesh-ancestor
64764828|NCT02980926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64764829|NCT02980926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764830|NCT02980926|Sensory System Agents|sensory system agents|mesh-ancestor
64764831|NCT02980926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764832|NCT02980458|Deferiprone|deferiprone|mesh-list
64764833|NCT02980458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64650034|NCT02348762|Respiratory System Agents|respiratory system agents|mesh-ancestor
64764834|NCT02980458|Chelating Agents|chelating agents|mesh-ancestor
64764835|NCT02980458|Sequestering Agents|sequestering agents|mesh-ancestor
64650035|NCT02348762|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64650036|NCT02348762|Antioxidants|antioxidants|mesh-ancestor
64650037|NCT02348762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650038|NCT02348762|Protective Agents|protective agents|mesh-ancestor
64650039|NCT02348762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650040|NCT02348762|Antidotes|antidotes|mesh-ancestor
64650041|NCT02348762|Glycine Agents|glycine agents|mesh-ancestor
64764836|NCT02980458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764837|NCT02978976|Betamethasone|betamethasone|mesh-list
64764838|NCT02978976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64764839|NCT02978976|Glucocorticoids|glucocorticoids|mesh-ancestor
64764840|NCT02978976|Hormones|hormones|mesh-ancestor
64764842|NCT02978976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764855|NCT02978040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764856|NCT02978040|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64764857|NCT02978040|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64764858|NCT02978040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64764859|NCT02978040|Purinergic Agents|purinergic agents|mesh-ancestor
64764860|NCT02978040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64764861|NCT02978040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764863|NCT02976246|Vitamin K 2|vitamin k 2|mesh-list
64764864|NCT02976246|Vitamins|vitamins|mesh-ancestor
64764865|NCT02976246|Micronutrients|micronutrients|mesh-ancestor
64764866|NCT02976246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764867|NCT02976246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64764868|NCT02976246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64764869|NCT02976246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764870|NCT02976246|Hemostatics|hemostatics|mesh-ancestor
64764871|NCT02976246|Coagulants|coagulants|mesh-ancestor
64764872|NCT02976012|Aflibercept|aflibercept|mesh-list
64764873|NCT02976012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64764874|NCT02976012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64764875|NCT02976012|Growth Substances|growth substances|mesh-ancestor
64764876|NCT02976012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650056|NCT01377623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650057|NCT01486043|Metformin|metformin|mesh-list
64650058|NCT01486043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64650059|NCT01486043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650060|NCT01490723|Mycophenolic Acid|mycophenolic acid|mesh-list
64650061|NCT01490723|Rituximab|rituximab|mesh-list
64764877|NCT02976012|Growth Inhibitors|growth inhibitors|mesh-ancestor
64764878|NCT02976012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764879|NCT02975076|Aspirin|aspirin|mesh-list
64764880|NCT02975076|Clopidogrel|clopidogrel|mesh-list
64764881|NCT02975076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64764882|NCT02975076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64764883|NCT02975076|Analgesics|analgesics|mesh-ancestor
64764884|NCT02975076|Sensory System Agents|sensory system agents|mesh-ancestor
64764885|NCT02975076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64764886|NCT02975076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764887|NCT02975076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64764896|NCT02975076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64764897|NCT02975076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64316908|NCT02162251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650101|NCT03839498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650104|NCT02252432|Analgesics|analgesics|mesh-ancestor
64650111|NCT02252432|Anesthetics|anesthetics|mesh-ancestor
64764898|NCT02975076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64445869|NCT01576042|Sympatholytics|sympatholytics|mesh-ancestor
64764899|NCT02975076|Purinergic Agents|purinergic agents|mesh-ancestor
64764900|NCT02975076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64764902|NCT02974920|Rivaroxaban|rivaroxaban|mesh-list
64764903|NCT02974920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64764904|NCT02974920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64764905|NCT02974920|Analgesics|analgesics|mesh-ancestor
64764906|NCT02974920|Sensory System Agents|sensory system agents|mesh-ancestor
64764907|NCT02974920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650173|NCT02155010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64764908|NCT02974920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764909|NCT02974920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64764910|NCT02974920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64764911|NCT02974920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64764912|NCT02974920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64764913|NCT02974920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764914|NCT02974920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64764915|NCT02974920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64764916|NCT02974920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764917|NCT02974920|Antipyretics|antipyretics|mesh-ancestor
64764918|NCT02974920|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64764919|NCT02974920|Antithrombins|antithrombins|mesh-ancestor
64764920|NCT02974920|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64764921|NCT02974920|Protease Inhibitors|protease inhibitors|mesh-ancestor
64650241|NCT00820664|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64650242|NCT00820664|Estradiol|estradiol|mesh-list
64650243|NCT00820664|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64650244|NCT00820664|Estrogens|estrogens|mesh-ancestor
64650245|NCT00820664|Hormones|hormones|mesh-ancestor
64764945|NCT02958852|Atorvastatin|atorvastatin|mesh-list
64764946|NCT02958852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64764947|NCT02958852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64764948|NCT02958852|Antimetabolites|antimetabolites|mesh-ancestor
64764949|NCT02958852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64764950|NCT02958852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64764951|NCT02958852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64764952|NCT02958852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64764953|NCT02958852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64764954|NCT02958852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64764955|NCT02958852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64764956|NCT02958852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64764957|NCT02958852|Hormone Antagonists|hormone antagonists|mesh-ancestor
64764958|NCT02958852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64764959|NCT02958852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64764960|NCT02958852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64764961|NCT02958852|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64764962|NCT02641782|Aldesleukin|aldesleukin|mesh-list
64764965|NCT02641782|Dinutuximab|dinutuximab|mesh-list
64764998|NCT02641314|Adrenergic Agents|adrenergic agents|mesh-ancestor
64764999|NCT02641314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64533736|NCT02330796|Colchicine|colchicine|mesh-list
64765000|NCT02641314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64650290|NCT01382303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64650291|NCT01382303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650292|NCT01382303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650293|NCT01382303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64650294|NCT01382303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64650295|NCT01382303|Protective Agents|protective agents|mesh-ancestor
64650296|NCT01382303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650297|NCT01382303|Vasodilator Agents|vasodilator agents|mesh-ancestor
64765001|NCT02641314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64765002|NCT02641314|Vasodilator Agents|vasodilator agents|mesh-ancestor
64765003|NCT04769778|Valsartan|valsartan|mesh-list
64765004|NCT04769778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64765005|NCT04769778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64765006|NCT04769778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64765007|NCT04769778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765008|NCT04769076|Paclitaxel|paclitaxel|mesh-list
64765009|NCT04769076|Cisplatin|cisplatin|mesh-list
64765010|NCT04769076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64765011|NCT04769076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64765012|NCT04769076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765013|NCT04769076|Tubulin Modulators|tubulin modulators|mesh-ancestor
64650334|NCT01424033|Respiratory System Agents|respiratory system agents|mesh-ancestor
64650335|NCT01424033|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64650336|NCT01424033|Antioxidants|antioxidants|mesh-ancestor
64650337|NCT01424033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650338|NCT01424033|Protective Agents|protective agents|mesh-ancestor
64650339|NCT01424033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650340|NCT01424033|Antidotes|antidotes|mesh-ancestor
64650341|NCT01503749|Lenograstim|lenograstim|mesh-list
64650342|NCT01503749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64650343|NCT01503749|Immunologic Factors|immunologic factors|mesh-ancestor
64650344|NCT01503749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650346|NCT00867932|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64765014|NCT04769076|Antimitotic Agents|antimitotic agents|mesh-ancestor
64765015|NCT04769076|Mitosis Modulators|mitosis modulators|mesh-ancestor
64765016|NCT04769076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765017|NCT04768764|Bupivacaine|bupivacaine|mesh-list
64765018|NCT04768764|Anesthetics|anesthetics|mesh-list
64765019|NCT04768764|Anesthetics, Local|anesthetics, local|mesh-ancestor
64765049|NCT04745442|Antithrombins|antithrombins|mesh-list
64765050|NCT04745442|Antithrombin III|antithrombin iii|mesh-list
64765051|NCT04745442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64765052|NCT04745442|Protease Inhibitors|protease inhibitors|mesh-ancestor
64765053|NCT04745442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765054|NCT04745442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765055|NCT04745442|Anticoagulants|anticoagulants|mesh-ancestor
64765056|NCT04743180|Paclitaxel|paclitaxel|mesh-list
64765057|NCT04743180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64765058|NCT04743180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765059|NCT04743180|Tubulin Modulators|tubulin modulators|mesh-ancestor
64765060|NCT04743180|Antimitotic Agents|antimitotic agents|mesh-ancestor
64765061|NCT04743180|Mitosis Modulators|mitosis modulators|mesh-ancestor
64765062|NCT04743180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765063|NCT04740840|Amlodipine|amlodipine|mesh-list
64765064|NCT04740840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64650385|NCT01387139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64650386|NCT01387139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64650387|NCT01387139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64650388|NCT01387139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64650390|NCT00870896|Tiotropium Bromide|tiotropium bromide|mesh-list
64765065|NCT04740840|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64765066|NCT04740840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64765067|NCT04740840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765068|NCT04740840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64765069|NCT04740840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765070|NCT04740840|Vasodilator Agents|vasodilator agents|mesh-ancestor
64765071|NCT04739826|HH-GV-678|hh-gv-678|mesh-list
64765072|NCT04739826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64533797|NCT02337972|Plasma Substitutes|plasma substitutes|mesh-ancestor
64765073|NCT04739826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765074|NCT04739826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765075|NCT04739202|Bevacizumab|bevacizumab|mesh-list
64765076|NCT04739202|Atezolizumab|atezolizumab|mesh-list
64445884|NCT01536262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765092|NCT04738188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765093|NCT04737408|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64765094|NCT04737408|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64765095|NCT04737408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64765096|NCT04737408|Antimetabolites|antimetabolites|mesh-ancestor
64765097|NCT04737408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765098|NCT04737408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64765099|NCT04737408|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64765100|NCT04737408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765102|NCT05314140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64765103|NCT05314140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765104|NCT05313906|Cisplatin|cisplatin|mesh-list
64765105|NCT05313906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765106|NCT05313828|Fluorometholone|fluorometholone|mesh-list
64765107|NCT05313828|Tobramycin|tobramycin|mesh-list
64765108|NCT05313828|Acyclovir|acyclovir|mesh-list
64765109|NCT05313828|Hyaluronic Acid|hyaluronic acid|mesh-list
64765110|NCT05313828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64765111|NCT05313828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64765112|NCT05313828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64765113|NCT05313828|Immunologic Factors|immunologic factors|mesh-ancestor
64765114|NCT05313828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765115|NCT05313828|Viscosupplements|viscosupplements|mesh-ancestor
64765116|NCT05313828|Protective Agents|protective agents|mesh-ancestor
64765117|NCT05313828|Antiviral Agents|antiviral agents|mesh-ancestor
64765118|NCT05313828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64650436|NCT01505933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64765140|NCT04662684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64765141|NCT04662684|Protease Inhibitors|protease inhibitors|mesh-ancestor
64765142|NCT04662684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765143|NCT04662684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765144|NCT04662684|Anticoagulants|anticoagulants|mesh-ancestor
64765145|NCT05139966|Fluorides|fluorides|mesh-list
64765146|NCT05139966|Cariostatic Agents|cariostatic agents|mesh-ancestor
64765147|NCT05139966|Protective Agents|protective agents|mesh-ancestor
64765148|NCT05139966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765149|NCT05138718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64765150|NCT05138718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64765151|NCT05138718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765152|NCT00575016|Botulinum Toxins|botulinum toxins|mesh-list
64765153|NCT00575016|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64765154|NCT00575016|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64765155|NCT00575016|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64765156|NCT00575016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64765157|NCT00575016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765158|NCT00575016|Cholinergic Agents|cholinergic agents|mesh-ancestor
64765159|NCT00575016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64765160|NCT00575016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765161|NCT00575016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64765162|NCT00575016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64765163|NCT00577590|Metformin|metformin|mesh-list
64765164|NCT00577590|Rosiglitazone|rosiglitazone|mesh-list
64650472|NCT00872534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765165|NCT00577590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64765166|NCT00577590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765167|NCT00578214|Midazolam|midazolam|mesh-list
64650474|NCT03468218|Pembrolizumab|pembrolizumab|mesh-list
64650475|NCT03468218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64650476|NCT03468218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765168|NCT00578214|Anesthetics|anesthetics|mesh-ancestor
64650478|NCT02513160|Albuterol|albuterol|mesh-list
64765169|NCT00578214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64765170|NCT00578214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765171|NCT00578214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64765172|NCT00578214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64765173|NCT00578214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64765174|NCT00578214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64765180|NCT00578214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64765181|NCT00578214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765182|NCT00580398|Varenicline|varenicline|mesh-list
64765183|NCT00580398|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64765192|NCT00582660|Analgesics|analgesics|mesh-ancestor
64650516|NCT02512302|Anticonvulsants|anticonvulsants|mesh-ancestor
64650517|NCT02512302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64650518|NCT02512302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64650519|NCT02512302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64650521|NCT02512302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64650526|NCT01507181|Midazolam|midazolam|mesh-list
64765193|NCT00582660|Sensory System Agents|sensory system agents|mesh-ancestor
64765194|NCT00582660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64765195|NCT00582660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765196|NCT00582660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64765197|NCT00582660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64765198|NCT00582660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64765199|NCT00582660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64765200|NCT00582660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765201|NCT00582660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765202|NCT00582894|Fludarabine|fludarabine|mesh-list
64650581|NCT00878228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650582|NCT00878228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64650583|NCT00878228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64650585|NCT00878228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64765203|NCT00582894|Alemtuzumab|alemtuzumab|mesh-list
64765204|NCT00582894|Busulfan|busulfan|mesh-list
64765205|NCT00582894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765206|NCT00582894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765207|NCT00582894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64765208|NCT00582894|Immunologic Factors|immunologic factors|mesh-ancestor
64765209|NCT00582894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765210|NCT00582894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64765211|NCT00582894|Alkylating Agents|alkylating agents|mesh-ancestor
64765212|NCT00582894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64650647|NCT02518464|Purinergic Agents|purinergic agents|mesh-ancestor
64650648|NCT02518464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64650651|NCT02479230|Gemcitabine|gemcitabine|mesh-list
64765213|NCT00582894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64765214|NCT00585780|Prazosin|prazosin|mesh-list
64765215|NCT00585780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64765216|NCT00585780|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64765217|NCT00585780|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64765218|NCT00585780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64765219|NCT00585780|Adrenergic Agents|adrenergic agents|mesh-ancestor
64765220|NCT00585780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64765221|NCT00585780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765222|NCT00585780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765223|NCT00586482|Nicotine|nicotine|mesh-list
64765224|NCT00586482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64765225|NCT00586482|Autonomic Agents|autonomic agents|mesh-ancestor
64765226|NCT00586482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650711|NCT01363986|Trastuzumab|trastuzumab|mesh-list
64650713|NCT01363986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765227|NCT00586482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765228|NCT00586482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64765229|NCT00586482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64765230|NCT00586482|Cholinergic Agents|cholinergic agents|mesh-ancestor
64765231|NCT00586482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64765232|NCT00586482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765233|NCT03708354|Tocotrienols|tocotrienols|mesh-list
64765234|NCT03708354|Vitamin E|vitamin e|mesh-list
64765235|NCT03708354|Tocopherols|tocopherols|mesh-list
64765236|NCT03708354|Antioxidants|antioxidants|mesh-ancestor
64765237|NCT03708354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765238|NCT03708354|Protective Agents|protective agents|mesh-ancestor
64765239|NCT03708354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765240|NCT03708354|Vitamins|vitamins|mesh-ancestor
64765241|NCT03708354|Micronutrients|micronutrients|mesh-ancestor
64765243|NCT03527472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64765254|NCT03297684|Growth Substances|growth substances|mesh-ancestor
64765255|NCT03297684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765256|NCT03297684|Growth Inhibitors|growth inhibitors|mesh-ancestor
64765257|NCT03297684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765258|NCT03262662|Varenicline|varenicline|mesh-list
64765259|NCT03262662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64765260|NCT03262662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64650774|NCT03439280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650775|NCT03439280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650776|NCT03439280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64650777|NCT03439280|Glucocorticoids|glucocorticoids|mesh-ancestor
64765261|NCT03262662|Cholinergic Agents|cholinergic agents|mesh-ancestor
64765262|NCT03262662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64765263|NCT03262662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765264|NCT03262662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765265|NCT01740648|Fluorouracil|fluorouracil|mesh-list
64765267|NCT01740648|Antimetabolites|antimetabolites|mesh-ancestor
64765268|NCT01740648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765269|NCT01740648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64765270|NCT01740648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765271|NCT01740648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64765272|NCT01740648|Immunologic Factors|immunologic factors|mesh-ancestor
64765273|NCT01740648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765274|NCT01740648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64765275|NCT01740648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765276|NCT01685424|Etoricoxib|etoricoxib|mesh-list
64765277|NCT01685424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64765278|NCT01685424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64765279|NCT01685424|Analgesics|analgesics|mesh-ancestor
64650820|NCT04382300|Growth Inhibitors|growth inhibitors|mesh-ancestor
64765280|NCT01685424|Sensory System Agents|sensory system agents|mesh-ancestor
64765289|NCT01327638|Etoricoxib|etoricoxib|mesh-list
64765300|NCT01327638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765301|NCT01327638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650821|NCT04382300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650822|NCT01430819|Vaccines|vaccines|mesh-list
64650823|NCT01430819|Immunologic Factors|immunologic factors|mesh-ancestor
64650824|NCT01430819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650825|NCT00828542|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64650827|NCT00828542|Desogestrel|desogestrel|mesh-list
64650828|NCT00828542|Etonogestrel|etonogestrel|mesh-list
64650829|NCT00828542|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64650830|NCT00828542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64650831|NCT00828542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64650832|NCT00828542|Contraceptive Agents|contraceptive agents|mesh-ancestor
64650833|NCT00828542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64650834|NCT00828542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765303|NCT00393354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765304|NCT00393354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765305|NCT00393354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64765306|NCT00393354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64765308|NCT00393354|Analgesics|analgesics|mesh-ancestor
64765309|NCT00393354|Sensory System Agents|sensory system agents|mesh-ancestor
64765310|NCT00393354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64765311|NCT00393354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64765312|NCT00393354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64765313|NCT00393354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64765314|NCT00393354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765315|NCT00166530|Atorvastatin|atorvastatin|mesh-list
64765316|NCT00166530|Simvastatin|simvastatin|mesh-list
64765317|NCT00166530|Ezetimibe|ezetimibe|mesh-list
64765318|NCT00166530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64765319|NCT00166530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64765320|NCT00166530|Antimetabolites|antimetabolites|mesh-ancestor
64765321|NCT00166530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765322|NCT00166530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64765323|NCT00166530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64765324|NCT00166530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765325|NCT00588900|Irinotecan|irinotecan|mesh-list
64765326|NCT00588900|Cediranib|cediranib|mesh-list
64765327|NCT00588900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64765328|NCT00588900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64765329|NCT00588900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765330|NCT00588900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765331|NCT00588900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765342|NCT00589056|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64765344|NCT00589056|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64765345|NCT00589056|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64765346|NCT00589056|Antiviral Agents|antiviral agents|mesh-ancestor
64765347|NCT00589056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64765348|NCT00590226|Insulin|insulin|mesh-list
64765349|NCT00590226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64765350|NCT00590226|Insulin Aspart|insulin aspart|mesh-list
64765351|NCT00590226|Insulin, Isophane|insulin, isophane|mesh-list
64765352|NCT00590226|Isophane Insulin, Human|isophane insulin, human|mesh-list
64765353|NCT00590226|Isophane insulin, beef|isophane insulin, beef|mesh-list
64765354|NCT00590226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64765355|NCT00590226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765356|NCT00590460|Fludarabine|fludarabine|mesh-list
64765357|NCT00590460|Alemtuzumab|alemtuzumab|mesh-list
64765358|NCT00590460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765359|NCT00590460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64765360|NCT00590772|Montelukast|montelukast|mesh-list
64765380|NCT00592488|Vitamins|vitamins|mesh-ancestor
64765399|NCT00596622|Antidepressive Agents|antidepressive agents|mesh-ancestor
64765400|NCT00596622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64765401|NCT00596622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765402|NCT00596622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765403|NCT00596622|Antimanic Agents|antimanic agents|mesh-ancestor
64765404|NCT00596622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64765405|NCT00596622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64319025|NCT04310930|Rifabutin|rifabutin|mesh-list
64765406|NCT00596622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765407|NCT00597402|Bevacizumab|bevacizumab|mesh-list
64765408|NCT00597402|Irinotecan|irinotecan|mesh-list
64765409|NCT00597402|Temozolomide|temozolomide|mesh-list
64765410|NCT00597402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64765411|NCT00597402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765412|NCT00597402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64765413|NCT00597402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64765414|NCT00597402|Growth Substances|growth substances|mesh-ancestor
64765415|NCT00597402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765416|NCT00597402|Growth Inhibitors|growth inhibitors|mesh-ancestor
64765417|NCT00597402|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64765418|NCT00597402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64765419|NCT00597402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765420|NCT00597402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765421|NCT00597402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64765422|NCT00597402|Alkylating Agents|alkylating agents|mesh-ancestor
64765423|NCT00598806|Apaziquone|apaziquone|mesh-list
64765425|NCT00601926|Bevacizumab|bevacizumab|mesh-list
64765445|NCT00603018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64765446|NCT00603018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765447|NCT00603408|Cisplatin|cisplatin|mesh-list
64765448|NCT00603408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765449|NCT00603720|Phenylephrine|phenylephrine|mesh-list
64765450|NCT00603720|Oxymetazoline|oxymetazoline|mesh-list
64765451|NCT00603720|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
64765452|NCT00603720|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64765453|NCT00603720|Mydriatics|mydriatics|mesh-ancestor
64765454|NCT00603720|Autonomic Agents|autonomic agents|mesh-ancestor
64765455|NCT00603720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64765456|NCT00603720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765457|NCT00603720|Sympathomimetics|sympathomimetics|mesh-ancestor
64765458|NCT00603720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64765459|NCT00603720|Nasal Decongestants|nasal decongestants|mesh-ancestor
64765460|NCT00603720|Respiratory System Agents|respiratory system agents|mesh-ancestor
64765461|NCT00603720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64445932|NCT04691375|Pembrolizumab|pembrolizumab|mesh-list
64765462|NCT00603720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64765463|NCT00603720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64765464|NCT00603720|Adrenergic Agents|adrenergic agents|mesh-ancestor
64765465|NCT00603720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64765466|NCT00603720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765467|NCT00603720|Protective Agents|protective agents|mesh-ancestor
64765468|NCT00603720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765469|NCT00625404|Tenofovir|tenofovir|mesh-list
64765470|NCT00625404|Emtricitabine|emtricitabine|mesh-list
64765471|NCT00625404|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64765472|NCT00625404|Antiviral Agents|antiviral agents|mesh-ancestor
64765473|NCT00625404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64765474|NCT00625404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64765488|NCT00626340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765489|NCT00626340|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64765490|NCT00626340|Antidepressive Agents|antidepressive agents|mesh-ancestor
64765491|NCT00626340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64765492|NCT00626340|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64765493|NCT00626340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64765494|NCT00626340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765495|NCT00626340|Hormones|hormones|mesh-ancestor
64765496|NCT00626340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64765497|NCT00626574|Epoetin Alfa|epoetin alfa|mesh-list
64765498|NCT00626574|Hematinics|hematinics|mesh-ancestor
64765499|NCT00626886|Bupivacaine|bupivacaine|mesh-list
64765500|NCT00626886|Anesthetics, Local|anesthetics, local|mesh-ancestor
64765501|NCT00626886|Anesthetics|anesthetics|mesh-ancestor
64765502|NCT00626886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64765503|NCT00626886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765504|NCT00626886|Sensory System Agents|sensory system agents|mesh-ancestor
64765505|NCT00626886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64765506|NCT00628134|Calfactant|calfactant|mesh-list
64765507|NCT00628134|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
64765508|NCT00628134|Respiratory System Agents|respiratory system agents|mesh-ancestor
64765509|NCT00632814|Factor VIII|factor viii|mesh-list
64765510|NCT00632814|Coagulants|coagulants|mesh-ancestor
64765511|NCT00632970|Ritonavir|ritonavir|mesh-list
64765512|NCT00632970|Lopinavir|lopinavir|mesh-list
64765513|NCT00632970|Tenofovir|tenofovir|mesh-list
64765514|NCT00632970|Emtricitabine|emtricitabine|mesh-list
64765515|NCT00632970|Raltegravir Potassium|raltegravir potassium|mesh-list
64765516|NCT00632970|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64765517|NCT00632970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64765518|NCT00632970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64765519|NCT00632970|Protease Inhibitors|protease inhibitors|mesh-ancestor
64765520|NCT00632970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765521|NCT00632970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765522|NCT00632970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64765527|NCT00632970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64765528|NCT00632970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64765529|NCT00632970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64765530|NCT00632970|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64765533|NCT00635232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64765534|NCT00635232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64765535|NCT00635232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64765536|NCT00635232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765537|NCT00637494|Mifepristone|mifepristone|mesh-list
64765538|NCT00637494|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64651247|NCT01436279|Mifepristone|mifepristone|mesh-list
64765539|NCT00637494|Abortifacient Agents|abortifacient agents|mesh-ancestor
64765540|NCT00637494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64765541|NCT00637494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765542|NCT00637494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64765543|NCT00637494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64765544|NCT00637494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64765545|NCT00637494|Contraceptive Agents|contraceptive agents|mesh-ancestor
64765546|NCT00637494|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64765547|NCT00637494|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64765548|NCT00637494|Hormone Antagonists|hormone antagonists|mesh-ancestor
64765549|NCT00637494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64765550|NCT00637494|Luteolytic Agents|luteolytic agents|mesh-ancestor
64765551|NCT00637494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64765552|NCT00637494|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64765553|NCT00638820|Busulfan|busulfan|mesh-list
64445942|NCT03507491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445943|NCT03507491|Tubulin Modulators|tubulin modulators|mesh-ancestor
64765572|NCT00641862|Vitamin B Complex|vitamin b complex|mesh-ancestor
64765574|NCT00643578|Formoterol Fumarate|formoterol fumarate|mesh-list
64765575|NCT00643578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64765576|NCT00643578|Autonomic Agents|autonomic agents|mesh-ancestor
64765577|NCT00643578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64765578|NCT00643578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765579|NCT00643578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64765580|NCT00643578|Respiratory System Agents|respiratory system agents|mesh-ancestor
64765581|NCT00643578|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64765582|NCT00643578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64765583|NCT00643578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64765584|NCT00643578|Adrenergic Agents|adrenergic agents|mesh-ancestor
64765585|NCT00643578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64765586|NCT00643578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765587|NCT00644592|Fenofibrate|fenofibrate|mesh-list
64765588|NCT00644592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64765589|NCT00644592|Antimetabolites|antimetabolites|mesh-ancestor
64765590|NCT00644592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765591|NCT00644592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64765592|NCT00645450|Propranolol|propranolol|mesh-list
64765625|NCT00656448|Hematinics|hematinics|mesh-ancestor
64765626|NCT00660504|Etoposide|etoposide|mesh-list
64765627|NCT00660504|Amrubicin|amrubicin|mesh-list
64765634|NCT00661674|Palonosetron|palonosetron|mesh-list
64765635|NCT00661674|Hydroxyzine|hydroxyzine|mesh-list
64765636|NCT00661674|Antiemetics|antiemetics|mesh-ancestor
64765637|NCT00661674|Autonomic Agents|autonomic agents|mesh-ancestor
64765638|NCT00661674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64765639|NCT00661674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765640|NCT00661674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64765641|NCT00661674|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64765642|NCT00661674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64765643|NCT00661674|Serotonin Agents|serotonin agents|mesh-ancestor
64765644|NCT00661674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64765645|NCT00661674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765646|NCT00661674|Antipruritics|antipruritics|mesh-ancestor
64765647|NCT00661674|Dermatologic Agents|dermatologic agents|mesh-ancestor
64765648|NCT00661674|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64765649|NCT00661674|Histamine Antagonists|histamine antagonists|mesh-ancestor
64765650|NCT00661674|Histamine Agents|histamine agents|mesh-ancestor
64765651|NCT00662298|Prednisolone|prednisolone|mesh-list
64651381|NCT01541735|Pantoprazole|pantoprazole|mesh-list
64765652|NCT00662298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64765653|NCT00662298|Glucocorticoids|glucocorticoids|mesh-ancestor
64765654|NCT00662298|Hormones|hormones|mesh-ancestor
64765671|NCT00666666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64765672|NCT00666666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64765673|NCT00666666|Contraceptive Agents|contraceptive agents|mesh-ancestor
64765674|NCT00666666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64765675|NCT00666666|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
64765676|NCT00666666|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
64765677|NCT00666666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64765678|NCT00666978|Bupropion|bupropion|mesh-list
64765736|NCT00672438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64765737|NCT00672438|Anesthetics, General|anesthetics, general|mesh-ancestor
64765738|NCT00672438|Anesthetics|anesthetics|mesh-ancestor
64765739|NCT00672594|Sunitinib|sunitinib|mesh-list
64765740|NCT00672594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765741|NCT00672594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64765742|NCT00672594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64765743|NCT00672594|Growth Substances|growth substances|mesh-ancestor
64765744|NCT00672594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64534523|NCT01487161|FX006|fx006|mesh-list
64765745|NCT00672594|Growth Inhibitors|growth inhibitors|mesh-ancestor
64765746|NCT00672594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64765747|NCT00672594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765748|NCT00672594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765749|NCT00673764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64765750|NCT00673764|Lubricant Eye Drops|lubricant eye drops|mesh-list
64765751|NCT00673764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64765752|NCT00675792|Bromides|bromides|mesh-list
64765753|NCT00675792|Rocuronium|rocuronium|mesh-list
64765754|NCT00675792|Neostigmine|neostigmine|mesh-list
64765755|NCT00675792|Anticonvulsants|anticonvulsants|mesh-ancestor
64765756|NCT00675792|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64765757|NCT00675792|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64765758|NCT00675792|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64765761|NCT00675792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64765787|NCT00678834|Micronutrients|micronutrients|mesh-ancestor
64765788|NCT00679380|Budesonide|budesonide|mesh-list
64765789|NCT00679380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64765790|NCT00679380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64765791|NCT00679380|Autonomic Agents|autonomic agents|mesh-ancestor
64765792|NCT00679380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64765793|NCT00679380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765794|NCT00679380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64765795|NCT00679380|Respiratory System Agents|respiratory system agents|mesh-ancestor
64765796|NCT00679380|Glucocorticoids|glucocorticoids|mesh-ancestor
64765797|NCT00679380|Hormones|hormones|mesh-ancestor
64765798|NCT00679380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64765799|NCT00680706|Thiamine|thiamine|mesh-list
64765800|NCT00680706|Vitamins|vitamins|mesh-ancestor
64765801|NCT00680706|Micronutrients|micronutrients|mesh-ancestor
64765802|NCT00680706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765803|NCT00680706|Vitamin B Complex|vitamin b complex|mesh-ancestor
64765804|NCT00682734|Diphenhydramine|diphenhydramine|mesh-list
64765805|NCT00682734|Promethazine|promethazine|mesh-list
64765806|NCT00682734|Metoclopramide|metoclopramide|mesh-list
64651498|NCT03215498|Insulin|insulin|mesh-list
64765807|NCT00682734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64765808|NCT00682734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64765809|NCT00682734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64765810|NCT00682734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765811|NCT00682734|Anesthetics, Local|anesthetics, local|mesh-ancestor
64765812|NCT00682734|Anesthetics|anesthetics|mesh-ancestor
64765813|NCT00682734|Sensory System Agents|sensory system agents|mesh-ancestor
64765814|NCT00682734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64765815|NCT00682734|Antiemetics|antiemetics|mesh-ancestor
64765816|NCT00682734|Autonomic Agents|autonomic agents|mesh-ancestor
64765817|NCT00682734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64765818|NCT00682734|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64765819|NCT00682734|Histamine Antagonists|histamine antagonists|mesh-ancestor
64765833|NCT00683046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765834|NCT00683046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64765835|NCT00683046|Immunologic Factors|immunologic factors|mesh-ancestor
64765836|NCT00683046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765837|NCT00683046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64765838|NCT00683046|Alkylating Agents|alkylating agents|mesh-ancestor
64765839|NCT00683046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64651529|NCT03838328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765840|NCT00683046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64765841|NCT00687102|Tamoxifen|tamoxifen|mesh-list
64765842|NCT00687102|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64765843|NCT00687102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64765844|NCT00687102|Hormone Antagonists|hormone antagonists|mesh-ancestor
64765845|NCT00687102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64765846|NCT00687102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765847|NCT00687102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64765848|NCT00687102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765849|NCT00687102|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64765850|NCT00687102|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64651568|NCT01550471|Ciclesonide|ciclesonide|mesh-list
64765851|NCT00687102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64765852|NCT00690924|Calcitriol|calcitriol|mesh-list
64765853|NCT00690924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64765854|NCT00690924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765855|NCT00690924|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64765856|NCT00690924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64765857|NCT00690924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765877|NCT00691002|Micronutrients|micronutrients|mesh-ancestor
64765878|NCT00691002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64765879|NCT00695292|Carboplatin|carboplatin|mesh-list
64765880|NCT00695292|Irinotecan|irinotecan|mesh-list
64765881|NCT00695292|Sunitinib|sunitinib|mesh-list
64765882|NCT00695292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765883|NCT00695292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64765884|NCT00695292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64765885|NCT00695292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64765886|NCT00695292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765887|NCT00695292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64765888|NCT00695292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64765889|NCT00695292|Growth Substances|growth substances|mesh-ancestor
64765890|NCT00695292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765891|NCT00695292|Growth Inhibitors|growth inhibitors|mesh-ancestor
64765892|NCT00695292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64765893|NCT00696618|Plasma-lyte 148|plasma-lyte 148|mesh-list
64765894|NCT00696618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64765895|NCT00696618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64765896|NCT00700440|Cetuximab|cetuximab|mesh-list
64765897|NCT00700440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64765898|NCT00700440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765899|NCT00701376|Liver Extracts|liver extracts|mesh-list
64765900|NCT00701376|Hematinics|hematinics|mesh-ancestor
64765901|NCT00702468|Nabiximols|nabiximols|mesh-list
64765902|NCT00702468|Analgesics|analgesics|mesh-ancestor
64765903|NCT00702468|Sensory System Agents|sensory system agents|mesh-ancestor
64765904|NCT00702468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64765905|NCT00702468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765906|NCT00702780|Citalopram|citalopram|mesh-list
64765907|NCT00702780|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64765908|NCT00702780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64765909|NCT00702780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64765920|NCT00704028|Plasma Substitutes|plasma substitutes|mesh-ancestor
64765921|NCT00704028|Blood Substitutes|blood substitutes|mesh-ancestor
64765922|NCT00704028|Hematinics|hematinics|mesh-ancestor
64765923|NCT00704262|Hydrocortisone|hydrocortisone|mesh-list
64765924|NCT00704262|Calcipotriene|calcipotriene|mesh-list
64765925|NCT00704262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64765926|NCT00704262|Dermatologic Agents|dermatologic agents|mesh-ancestor
64765927|NCT00706446|Fluticasone|fluticasone|mesh-list
64765928|NCT00706446|Xhance|xhance|mesh-list
64765929|NCT00706446|Budesonide|budesonide|mesh-list
64765930|NCT00706446|Bromides|bromides|mesh-list
64765931|NCT00706446|Formoterol Fumarate|formoterol fumarate|mesh-list
64765932|NCT00706446|Tiotropium Bromide|tiotropium bromide|mesh-list
64765933|NCT00706446|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64765934|NCT00706446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64765935|NCT00706446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64765936|NCT00706446|Autonomic Agents|autonomic agents|mesh-ancestor
64765937|NCT00706446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64765938|NCT00706446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765939|NCT00706446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64765940|NCT00706446|Respiratory System Agents|respiratory system agents|mesh-ancestor
64765941|NCT00706446|Dermatologic Agents|dermatologic agents|mesh-ancestor
64765942|NCT00706446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64765943|NCT00706446|Glucocorticoids|glucocorticoids|mesh-ancestor
64765944|NCT00706446|Hormones|hormones|mesh-ancestor
64765945|NCT00706446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64765946|NCT00706446|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64765947|NCT00706446|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64765948|NCT00706446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64765949|NCT00706446|Adrenergic Agents|adrenergic agents|mesh-ancestor
64765950|NCT00706446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64765951|NCT00706446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765965|NCT00706836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64765967|NCT00706836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64765968|NCT00706836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64765969|NCT00706836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64765970|NCT00708942|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64765971|NCT00708942|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64765972|NCT00708942|Dermatologic Agents|dermatologic agents|mesh-ancestor
64765973|NCT00711828|Dexamethasone|dexamethasone|mesh-list
64765974|NCT00711828|Cyclophosphamide|cyclophosphamide|mesh-list
64765975|NCT00711828|Rituximab|rituximab|mesh-list
64765976|NCT00711828|Bortezomib|bortezomib|mesh-list
64765977|NCT00711828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64765978|NCT00711828|Immunologic Factors|immunologic factors|mesh-ancestor
64765979|NCT00711828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64765980|NCT00711828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64387138|NCT02031640|Albuterol|albuterol|mesh-list
64765981|NCT00711828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64765982|NCT00711828|Alkylating Agents|alkylating agents|mesh-ancestor
64765983|NCT00711828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64765984|NCT00711828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64765985|NCT00711828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64765986|NCT00711828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64765987|NCT00711828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64765988|NCT00711828|Antiemetics|antiemetics|mesh-ancestor
64765989|NCT00711828|Autonomic Agents|autonomic agents|mesh-ancestor
64765990|NCT00711828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64765991|NCT00711828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64765993|NCT00711828|Hormones|hormones|mesh-ancestor
64765994|NCT00711828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64765995|NCT00711828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64765996|NCT00712530|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64765997|NCT00712530|Antiviral Agents|antiviral agents|mesh-ancestor
64765998|NCT00712530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64766006|NCT00715884|Immunologic Factors|immunologic factors|mesh-ancestor
64766007|NCT00715884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766008|NCT00716586|Dorzolamide|dorzolamide|mesh-list
64766009|NCT00716586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64766010|NCT00716586|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64766011|NCT00716586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766012|NCT00716586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766014|NCT00716742|Travoprost|travoprost|mesh-list
64766015|NCT00716742|Latanoprost|latanoprost|mesh-list
64766016|NCT00716742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64766017|NCT00716742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64766018|NCT00716742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64766019|NCT00716820|Sunitinib|sunitinib|mesh-list
64766020|NCT00716820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766021|NCT00716820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64766022|NCT00716820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64766023|NCT00716820|Growth Substances|growth substances|mesh-ancestor
64766024|NCT00716820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766025|NCT00716820|Growth Inhibitors|growth inhibitors|mesh-ancestor
64766026|NCT00716820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64766027|NCT00716820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651714|NCT02504268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766028|NCT00716820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766029|NCT00717054|Scopolamine|scopolamine|mesh-list
64766030|NCT00717054|Aprepitant|aprepitant|mesh-list
64766031|NCT00717054|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64766032|NCT00717054|Antiemetics|antiemetics|mesh-ancestor
64766033|NCT00717054|Autonomic Agents|autonomic agents|mesh-ancestor
64766054|NCT00719160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766057|NCT00720330|Ropivacaine|ropivacaine|mesh-list
64766058|NCT00720330|Anesthetics, Local|anesthetics, local|mesh-ancestor
64766059|NCT00720330|Anesthetics|anesthetics|mesh-ancestor
64766060|NCT00720330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64766061|NCT00720330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766062|NCT00720330|Sensory System Agents|sensory system agents|mesh-ancestor
64766063|NCT00720330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64766064|NCT00720330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64766065|NCT00720330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64766066|NCT00720330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64766067|NCT00720330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64766068|NCT00720330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766069|NCT00720330|Analgesics|analgesics|mesh-ancestor
64766070|NCT00720330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64766071|NCT00720330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64766072|NCT00720330|Anesthetics, General|anesthetics, general|mesh-ancestor
64766073|NCT00720330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64766074|NCT00720330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64766075|NCT00720330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64766076|NCT00721188|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64766077|NCT00721188|Hematinics|hematinics|mesh-ancestor
64766078|NCT00722436|Tranexamic Acid|tranexamic acid|mesh-list
64766079|NCT00722436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64766080|NCT00722436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64766081|NCT00722436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766100|NCT00726414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64766101|NCT00726414|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64766102|NCT00726414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766103|NCT00726414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64766104|NCT00726414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64766105|NCT00726414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64766106|NCT00726414|Analgesics|analgesics|mesh-ancestor
64766107|NCT00726414|Sensory System Agents|sensory system agents|mesh-ancestor
64766108|NCT00727740|Indomethacin|indomethacin|mesh-list
64766109|NCT00727740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64766110|NCT00727740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64766111|NCT00727740|Analgesics|analgesics|mesh-ancestor
64766112|NCT00727740|Sensory System Agents|sensory system agents|mesh-ancestor
64766113|NCT00727740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64766114|NCT00727740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766115|NCT00727740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64766116|NCT00727740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64766117|NCT00727740|Gout Suppressants|gout suppressants|mesh-ancestor
64766118|NCT00727740|Tocolytic Agents|tocolytic agents|mesh-ancestor
64766119|NCT00727740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64766120|NCT00727740|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64766121|NCT00727740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766122|NCT00727740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64534843|NCT01796613|Estrogens|estrogens|mesh-ancestor
64766123|NCT00728910|Niacin|niacin|mesh-list
64766124|NCT00728910|Atorvastatin|atorvastatin|mesh-list
64766125|NCT00728910|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64766126|NCT00728910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64766127|NCT00728910|Antimetabolites|antimetabolites|mesh-ancestor
64766128|NCT00728910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766129|NCT00728910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64766130|NCT00728910|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64766131|NCT00728910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766132|NCT00728910|Vasodilator Agents|vasodilator agents|mesh-ancestor
64766137|NCT00729846|Bevacizumab|bevacizumab|mesh-list
64766139|NCT00729846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64766140|NCT00729846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766141|NCT00729846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64766142|NCT00729846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64766143|NCT00729846|Growth Substances|growth substances|mesh-ancestor
64766144|NCT00729846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766145|NCT00729846|Growth Inhibitors|growth inhibitors|mesh-ancestor
64766146|NCT00729846|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64766147|NCT00729846|Dermatologic Agents|dermatologic agents|mesh-ancestor
64766148|NCT00729924|Raltegravir Potassium|raltegravir potassium|mesh-list
64766149|NCT00729924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64766150|NCT00729924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64766151|NCT00729924|Antiviral Agents|antiviral agents|mesh-ancestor
64766152|NCT00729924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64766153|NCT00729924|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64766154|NCT00729924|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64766155|NCT00729924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766156|NCT00729924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651909|NCT03219710|Glucocorticoids|glucocorticoids|mesh-ancestor
64766157|NCT00731874|Tacrolimus|tacrolimus|mesh-list
64766158|NCT00731874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64766159|NCT00731874|Immunologic Factors|immunologic factors|mesh-ancestor
64766160|NCT00731874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766161|NCT00731874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64766162|NCT00731874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766163|NCT00731874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766164|NCT00732654|Immunologic Factors|immunologic factors|mesh-list
64766165|NCT00732654|Caseins|caseins|mesh-list
64766166|NCT00732654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766167|NCT00732654|Chelating Agents|chelating agents|mesh-ancestor
64766168|NCT00732654|Sequestering Agents|sequestering agents|mesh-ancestor
64766169|NCT00732654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766181|NCT00733356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64766182|NCT00733356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766184|NCT00733356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64766185|NCT00735306|Bevacizumab|bevacizumab|mesh-list
64766186|NCT00735306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64766187|NCT00735306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64766188|NCT00735306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766189|NCT00735306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64766190|NCT00735306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64766191|NCT00735306|Growth Substances|growth substances|mesh-ancestor
64766192|NCT00735306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766193|NCT00735306|Growth Inhibitors|growth inhibitors|mesh-ancestor
64766194|NCT00735306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64766195|NCT00735306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766196|NCT00735306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766197|NCT00735462|Imiquimod|imiquimod|mesh-list
64534923|NCT04388709|Interferons|interferons|mesh-list
64766198|NCT00735462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64766199|NCT00735462|Immunologic Factors|immunologic factors|mesh-ancestor
64766200|NCT00735462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766201|NCT00735462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766234|NCT00741468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64766235|NCT00741468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446020|NCT02161562|Omalizumab|omalizumab|mesh-list
64766238|NCT00741468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64766239|NCT00741468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64766240|NCT00741468|Anesthetics, General|anesthetics, general|mesh-ancestor
64766241|NCT00741468|Anesthetics|anesthetics|mesh-ancestor
64766242|NCT00741468|GABA Modulators|gaba modulators|mesh-ancestor
64766243|NCT00741468|GABA Agents|gaba agents|mesh-ancestor
64766244|NCT00741468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64766245|NCT00741468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766246|NCT00741468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64766247|NCT00741468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64766248|NCT00741468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766249|NCT00741468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64766250|NCT00741468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64766251|NCT00741468|Purinergic Agents|purinergic agents|mesh-ancestor
64766252|NCT00741468|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64766253|NCT00741468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64766254|NCT00741468|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64766255|NCT00741468|Antitussive Agents|antitussive agents|mesh-ancestor
64766256|NCT00741468|Respiratory System Agents|respiratory system agents|mesh-ancestor
64766257|NCT00741468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64766258|NCT00741468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64766259|NCT00741468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64766260|NCT00741858|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64766261|NCT00741858|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64766262|NCT00741858|Estradiol|estradiol|mesh-list
64766263|NCT00741858|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64766264|NCT00741858|Estrogens|estrogens|mesh-ancestor
64766277|NCT00742872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64766278|NCT00742872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766279|NCT00743574|Vitamin D|vitamin d|mesh-list
64766280|NCT00743574|Ergocalciferols|ergocalciferols|mesh-list
64766281|NCT00743574|Cholecalciferol|cholecalciferol|mesh-list
64766282|NCT00743574|Vitamins|vitamins|mesh-list
64766283|NCT00743574|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64766284|NCT00743574|Medroxyprogesterone|medroxyprogesterone|mesh-list
64766285|NCT00743574|Calcium|calcium|mesh-list
64766286|NCT00743574|Micronutrients|micronutrients|mesh-ancestor
64766287|NCT00743574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766288|NCT00743574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64766289|NCT00743574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64766290|NCT00743574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64766291|NCT00743574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64766292|NCT00743574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64766293|NCT00743574|Contraceptive Agents|contraceptive agents|mesh-ancestor
64652107|NCT01457573|Tamsulosin|tamsulosin|mesh-list
64766294|NCT00743574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64766295|NCT00743574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64766296|NCT00743574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64766297|NCT00743574|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64766298|NCT00743574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64766299|NCT00743574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766300|NCT00743730|Morphine|morphine|mesh-list
64766301|NCT00743730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64766302|NCT00743730|Narcotics|narcotics|mesh-ancestor
64766303|NCT00743730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64766304|NCT00743730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766305|NCT00743730|Analgesics|analgesics|mesh-ancestor
64766306|NCT00743730|Sensory System Agents|sensory system agents|mesh-ancestor
64766307|NCT00743730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64766308|NCT00745290|Bupivacaine|bupivacaine|mesh-list
64766309|NCT00745290|Anesthetics, Local|anesthetics, local|mesh-ancestor
64766319|NCT00751530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64766320|NCT00751530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64766321|NCT00751530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64766322|NCT00751530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766323|NCT00751530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766324|NCT00753636|Isradipine|isradipine|mesh-list
64766325|NCT00753636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64766326|NCT00753636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64766327|NCT00753636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64766328|NCT00753636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766329|NCT00753636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64766330|NCT00753636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766331|NCT00753636|Vasodilator Agents|vasodilator agents|mesh-ancestor
64766332|NCT00754494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64766333|NCT00754494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766334|NCT00754494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64766335|NCT00754494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766336|NCT00754494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766337|NCT00755040|Cyclosporine|cyclosporine|mesh-list
64766338|NCT00755040|Cyclosporins|cyclosporins|mesh-list
64766339|NCT00755040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766340|NCT00755040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766341|NCT00755040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64766342|NCT00755040|Immunologic Factors|immunologic factors|mesh-ancestor
64766343|NCT00755040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766344|NCT00755040|Antifungal Agents|antifungal agents|mesh-ancestor
64766345|NCT00755040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64766346|NCT00755040|Dermatologic Agents|dermatologic agents|mesh-ancestor
64766347|NCT00755040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64535066|NCT04650217|Levodopa|levodopa|mesh-list
64766361|NCT00758784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64446063|NCT01557946|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64766364|NCT00758784|Sensory System Agents|sensory system agents|mesh-ancestor
64766365|NCT00758784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64766366|NCT00758784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766367|NCT00758784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64766368|NCT00758784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64766369|NCT00759330|Flurbiprofen|flurbiprofen|mesh-list
64766370|NCT00759330|Analgesics|analgesics|mesh-ancestor
64766371|NCT00759330|Sensory System Agents|sensory system agents|mesh-ancestor
64766372|NCT00759330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64766373|NCT00759330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766374|NCT00759330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64766375|NCT00759330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64766376|NCT00759330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64766377|NCT00759330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64766378|NCT00759330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64766379|NCT00759330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652248|NCT01837394|Narcotics|narcotics|mesh-ancestor
64766380|NCT00759330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766381|NCT00759408|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
64766382|NCT00759408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64766383|NCT00759408|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64766384|NCT00759408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766385|NCT00759642|Lapatinib|lapatinib|mesh-list
64766386|NCT00759642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766387|NCT00759642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64766388|NCT00759642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766390|NCT00759798|Cyclophosphamide|cyclophosphamide|mesh-list
64766404|NCT00760578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64766405|NCT00760578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766406|NCT00761202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64766407|NCT00761202|Hyaluronic Acid|hyaluronic acid|mesh-list
64766408|NCT00761202|Glycerol|glycerol|mesh-list
64766409|NCT00761202|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64766410|NCT00761202|Immunologic Factors|immunologic factors|mesh-ancestor
64766411|NCT00761202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766412|NCT00761202|Viscosupplements|viscosupplements|mesh-ancestor
64766413|NCT00761202|Protective Agents|protective agents|mesh-ancestor
64652302|NCT02500758|Chloroxylenol|chloroxylenol|mesh-list
64766414|NCT00761202|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64766415|NCT00761202|Laxatives|laxatives|mesh-ancestor
64766416|NCT00761202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64766417|NCT00761592|Botulinum Toxins|botulinum toxins|mesh-list
64766418|NCT00761592|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64766419|NCT00761592|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64766420|NCT00761592|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64766421|NCT00761592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64766422|NCT00761592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766423|NCT00761592|Cholinergic Agents|cholinergic agents|mesh-ancestor
64766424|NCT00761592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64766425|NCT00761592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766426|NCT00761592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64766427|NCT00761592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64766429|NCT00762450|Fluorides|fluorides|mesh-list
64766430|NCT00762450|Cariostatic Agents|cariostatic agents|mesh-ancestor
64766437|NCT00762450|Antimetabolites|antimetabolites|mesh-ancestor
64766452|NCT00762528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64766454|NCT00765648|Nicardipine|nicardipine|mesh-list
64766455|NCT00765648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64766456|NCT00765648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64766457|NCT00765648|Adrenergic Agents|adrenergic agents|mesh-ancestor
64766458|NCT00765648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64766459|NCT00765648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766460|NCT00765648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766461|NCT00765648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64766462|NCT00765648|Sympathomimetics|sympathomimetics|mesh-ancestor
64766463|NCT00765648|Autonomic Agents|autonomic agents|mesh-ancestor
64766464|NCT00765648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64766465|NCT00765648|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64766466|NCT00765648|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64766467|NCT00765648|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64766468|NCT00765648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64766469|NCT00765648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64766470|NCT00765648|Vasodilator Agents|vasodilator agents|mesh-ancestor
64766471|NCT00766116|Azacitidine|azacitidine|mesh-list
64766473|NCT00766116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64766474|NCT00766116|Antimetabolites|antimetabolites|mesh-ancestor
64766475|NCT00766116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766476|NCT00766116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766477|NCT00766116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766478|NCT00766116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64766479|NCT00767364|Vaccines|vaccines|mesh-list
64766480|NCT00767364|Immunologic Factors|immunologic factors|mesh-ancestor
64652392|NCT01838252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64766481|NCT00767364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766482|NCT00769314|Acyclovir|acyclovir|mesh-list
64766483|NCT00769314|Antiviral Agents|antiviral agents|mesh-ancestor
64766495|NCT00769392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64766496|NCT00769392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64766497|NCT00769392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64766498|NCT00769392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766500|NCT00770874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766501|NCT00772590|Raltegravir Potassium|raltegravir potassium|mesh-list
64766502|NCT00772590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64766503|NCT00772590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64766504|NCT00772590|Antiviral Agents|antiviral agents|mesh-ancestor
64766505|NCT00772590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64766506|NCT00772590|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64766507|NCT00772590|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64766508|NCT00772590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766509|NCT00772590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766510|NCT00775944|Nicotine|nicotine|mesh-list
64766511|NCT00775944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64766512|NCT00775944|Autonomic Agents|autonomic agents|mesh-ancestor
64766513|NCT00775944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64766514|NCT00775944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766515|NCT00775944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64766516|NCT00775944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64766517|NCT00775944|Cholinergic Agents|cholinergic agents|mesh-ancestor
64766518|NCT00775944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64766519|NCT00775944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766520|NCT00780234|Pioglitazone|pioglitazone|mesh-list
64766521|NCT00780234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64766522|NCT00780234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766523|NCT00784524|Aldesleukin|aldesleukin|mesh-list
64766524|NCT00784524|Interleukin-2|interleukin-2|mesh-list
64766525|NCT00784524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766526|NCT00784524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64766539|NCT00785772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652426|NCT03219476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64766540|NCT00785772|Anticonvulsants|anticonvulsants|mesh-ancestor
64766541|NCT00785772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64766542|NCT00785772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64766543|NCT00785772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64766544|NCT00785772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64766545|NCT00785772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64766546|NCT00785772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64766547|NCT00785772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64766548|NCT00785772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766549|NCT00785772|Antimanic Agents|antimanic agents|mesh-ancestor
64766551|NCT00787332|Argatroban|argatroban|mesh-list
64766552|NCT00787332|Antithrombins|antithrombins|mesh-ancestor
64766553|NCT00787332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64766554|NCT00787332|Protease Inhibitors|protease inhibitors|mesh-ancestor
64766555|NCT00787332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766556|NCT00787332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766557|NCT00787332|Anticoagulants|anticoagulants|mesh-ancestor
64766558|NCT00787332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64766559|NCT00787332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64766560|NCT00787332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64766561|NCT00787722|Methylprednisolone|methylprednisolone|mesh-list
64766562|NCT00787722|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64766563|NCT00787722|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64766564|NCT00787722|Prednisolone|prednisolone|mesh-list
64766565|NCT00787722|Prednisolone acetate|prednisolone acetate|mesh-list
64766566|NCT00787722|Cyclophosphamide|cyclophosphamide|mesh-list
64766567|NCT00787722|Rituximab|rituximab|mesh-list
64766568|NCT00787722|Thymoglobulin|thymoglobulin|mesh-list
64766569|NCT00787722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64766570|NCT00787722|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64766571|NCT00787722|Prednisolone phosphate|prednisolone phosphate|mesh-list
64766572|NCT00787722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64766573|NCT00787722|Immunologic Factors|immunologic factors|mesh-ancestor
64766574|NCT00787722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766575|NCT00787722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64766577|NCT00787722|Alkylating Agents|alkylating agents|mesh-ancestor
64766578|NCT00787722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766579|NCT00787722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766580|NCT00787722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64766581|NCT00787722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64766582|NCT00787722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64766583|NCT00787722|Antiemetics|antiemetics|mesh-ancestor
64766584|NCT00787722|Autonomic Agents|autonomic agents|mesh-ancestor
64766585|NCT00787722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64766586|NCT00787722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64766587|NCT00787722|Glucocorticoids|glucocorticoids|mesh-ancestor
64766588|NCT00787722|Hormones|hormones|mesh-ancestor
64766589|NCT00787722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64766590|NCT00787722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64766591|NCT00787722|Protective Agents|protective agents|mesh-ancestor
64766592|NCT00787722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64766593|NCT00788892|Cytarabine|cytarabine|mesh-list
64766594|NCT00788892|Daunorubicin|daunorubicin|mesh-list
64766595|NCT00788892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64766596|NCT00788892|Antimetabolites|antimetabolites|mesh-ancestor
64766597|NCT00788892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446094|NCT03919942|Disinfectants|disinfectants|mesh-ancestor
64446095|NCT02161406|Abatacept|abatacept|mesh-list
64766599|NCT00788892|Antiviral Agents|antiviral agents|mesh-ancestor
64766600|NCT00788892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64766601|NCT00788892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64766602|NCT00788892|Immunologic Factors|immunologic factors|mesh-ancestor
64766607|NCT00788892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766624|NCT00789750|Antimetabolites|antimetabolites|mesh-ancestor
64766625|NCT00789750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766626|NCT00789750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64766627|NCT00790062|Oxytocin|oxytocin|mesh-list
64766628|NCT00790062|Oxytocics|oxytocics|mesh-ancestor
64766629|NCT00790062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64766630|NCT00790062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766631|NCT00793572|Cyclosporine|cyclosporine|mesh-list
64766632|NCT00793572|Mycophenolic Acid|mycophenolic acid|mesh-list
64766633|NCT00793572|Fludarabine|fludarabine|mesh-list
64766634|NCT00793572|Fludarabine phosphate|fludarabine phosphate|mesh-list
64766635|NCT00793572|Bortezomib|bortezomib|mesh-list
64766636|NCT00793572|Melphalan|melphalan|mesh-list
64766637|NCT00793572|Mechlorethamine|mechlorethamine|mesh-list
64766638|NCT00793572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64766639|NCT00793572|Cyclosporins|cyclosporins|mesh-list
64766640|NCT00793572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766641|NCT00793572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64766642|NCT00793572|Antimetabolites|antimetabolites|mesh-ancestor
64766643|NCT00793572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766644|NCT00793572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64766645|NCT00793572|Immunologic Factors|immunologic factors|mesh-ancestor
64766646|NCT00793572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766647|NCT00793572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766648|NCT00793572|Antifungal Agents|antifungal agents|mesh-ancestor
64766649|NCT00793572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64766650|NCT00793572|Dermatologic Agents|dermatologic agents|mesh-ancestor
64766651|NCT00793572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64766658|NCT00793572|Alkylating Agents|alkylating agents|mesh-ancestor
64766672|NCT00795210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64766673|NCT00795210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766674|NCT00795288|Simvastatin|simvastatin|mesh-list
64766675|NCT00795288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64766676|NCT00795288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64766677|NCT00795288|Antimetabolites|antimetabolites|mesh-ancestor
64766678|NCT00795288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766679|NCT00795288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64766680|NCT00795288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64766681|NCT00795288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766682|NCT00795366|Vasopressins|vasopressins|mesh-list
64766683|NCT00795366|Arginine Vasopressin|arginine vasopressin|mesh-list
64766684|NCT00795366|Hemostatics|hemostatics|mesh-ancestor
64766685|NCT00795366|Coagulants|coagulants|mesh-ancestor
64766686|NCT00795366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64766687|NCT00795366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64766688|NCT00795366|Natriuretic Agents|natriuretic agents|mesh-ancestor
64766689|NCT00795366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766690|NCT00796302|Risperidone|risperidone|mesh-list
64766691|NCT00796302|Methylphenidate|methylphenidate|mesh-list
64766692|NCT00796302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64766693|NCT00796302|Serotonin Agents|serotonin agents|mesh-ancestor
64766694|NCT00796302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64766695|NCT00796302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766696|NCT00796302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766697|NCT00796302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64766699|NCT00796302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64766700|NCT00796302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64766701|NCT00796302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64766702|NCT00796302|Dopamine Agents|dopamine agents|mesh-ancestor
64766707|NCT00796926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64766714|NCT00798018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766715|NCT00798018|Sensory System Agents|sensory system agents|mesh-ancestor
64766716|NCT00798018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64766717|NCT00798018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64766718|NCT00798018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64766719|NCT00798018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64766720|NCT00798018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64766721|NCT00798018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766722|NCT00798720|Bortezomib|bortezomib|mesh-list
64535442|NCT01503229|Abiraterone Acetate|abiraterone acetate|mesh-list
64766723|NCT00798720|Vorinostat|vorinostat|mesh-list
64766724|NCT00798720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766725|NCT00798720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64766727|NCT00798720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766728|NCT00799578|Cysteamine|cysteamine|mesh-list
64766729|NCT00799578|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
64766730|NCT00799578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766731|NCT00799812|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64766732|NCT00799812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64766733|NCT00799812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64766734|NCT00799812|Dermatologic Agents|dermatologic agents|mesh-ancestor
64766735|NCT00801138|Dexamethasone|dexamethasone|mesh-list
64766736|NCT00801138|Bupivacaine|bupivacaine|mesh-list
64766737|NCT00801138|Ropivacaine|ropivacaine|mesh-list
64766738|NCT00801138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64766739|NCT00801138|Antiemetics|antiemetics|mesh-ancestor
64766745|NCT00801138|Hormones|hormones|mesh-ancestor
64766746|NCT00801138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64766747|NCT00801138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64766748|NCT00801138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652620|NCT01468337|Interferons|interferons|mesh-list
64766749|NCT00801138|Anesthetics, Local|anesthetics, local|mesh-ancestor
64766750|NCT00801138|Anesthetics|anesthetics|mesh-ancestor
64766751|NCT00801138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64766752|NCT00801138|Sensory System Agents|sensory system agents|mesh-ancestor
64766753|NCT00801684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64766754|NCT00801684|Formoterol Fumarate|formoterol fumarate|mesh-list
64766755|NCT00801684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64766756|NCT00801684|Autonomic Agents|autonomic agents|mesh-ancestor
64766757|NCT00801684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64766758|NCT00801684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766759|NCT00801684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64766811|NCT00804648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766812|NCT00804648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64766813|NCT00804648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64766814|NCT00804648|Adrenergic Agents|adrenergic agents|mesh-ancestor
64766815|NCT00804648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64766816|NCT00804648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766817|NCT00804648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64766818|NCT00804648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64766819|NCT00806598|Cyclosporine|cyclosporine|mesh-list
64766820|NCT00806598|Methylprednisolone|methylprednisolone|mesh-list
64766821|NCT00806598|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64766822|NCT00806598|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64766823|NCT00806598|Prednisolone|prednisolone|mesh-list
64766824|NCT00806598|Prednisolone acetate|prednisolone acetate|mesh-list
64766825|NCT00806598|Cyclosporins|cyclosporins|mesh-list
64766826|NCT00806598|Thymoglobulin|thymoglobulin|mesh-list
64766827|NCT00806598|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64766828|NCT00806598|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64766829|NCT00806598|Prednisolone phosphate|prednisolone phosphate|mesh-list
64766830|NCT00806598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766831|NCT00806598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766832|NCT00806598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64652662|NCT01469585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64652663|NCT01469585|Antimalarials|antimalarials|mesh-ancestor
64652664|NCT01469585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64652665|NCT01469585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64652666|NCT01720940|Vancomycin|vancomycin|mesh-list
64766833|NCT00806598|Immunologic Factors|immunologic factors|mesh-ancestor
64766834|NCT00806598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766835|NCT00806598|Antifungal Agents|antifungal agents|mesh-ancestor
64766836|NCT00806598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64766837|NCT00806598|Dermatologic Agents|dermatologic agents|mesh-ancestor
64766838|NCT00806598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64766839|NCT00806598|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64766841|NCT00806598|Antiemetics|antiemetics|mesh-ancestor
64766856|NCT00807768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766857|NCT00807768|Tubulin Modulators|tubulin modulators|mesh-ancestor
64766858|NCT00807768|Antimitotic Agents|antimitotic agents|mesh-ancestor
64766859|NCT00807768|Mitosis Modulators|mitosis modulators|mesh-ancestor
64766860|NCT00807768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766861|NCT00808470|Beta Carotene|beta carotene|mesh-list
64766865|NCT00808470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766866|NCT00808470|Antioxidants|antioxidants|mesh-ancestor
64766867|NCT00808470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766868|NCT00808470|Protective Agents|protective agents|mesh-ancestor
64766869|NCT00808470|Provitamins|provitamins|mesh-ancestor
64766870|NCT00810576|Bortezomib|bortezomib|mesh-list
64766871|NCT00810576|Vorinostat|vorinostat|mesh-list
64766872|NCT00810576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766873|NCT00810576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64766874|NCT00810576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766875|NCT00810576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766877|NCT00811434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64766878|NCT00812604|Analgesics|analgesics|mesh-list
64766879|NCT00812604|Petrolatum|petrolatum|mesh-list
64766880|NCT00812604|Sensory System Agents|sensory system agents|mesh-ancestor
64766881|NCT00812604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64766882|NCT00812604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766883|NCT00812604|Emollients|emollients|mesh-ancestor
64766884|NCT00812604|Dermatologic Agents|dermatologic agents|mesh-ancestor
64766885|NCT00812838|Botulinum Toxins|botulinum toxins|mesh-list
64766886|NCT00812838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64766887|NCT00812838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64766888|NCT00812838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64766889|NCT00812838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64766890|NCT00812838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766891|NCT00812838|Cholinergic Agents|cholinergic agents|mesh-ancestor
64766892|NCT00812838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64323360|NCT04480359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766893|NCT00812838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766894|NCT00812838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64766895|NCT00812838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64766896|NCT00814788|Everolimus|everolimus|mesh-list
64766897|NCT00814788|Bicalutamide|bicalutamide|mesh-list
64766898|NCT00814788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766899|NCT00814788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64766900|NCT00814788|Immunologic Factors|immunologic factors|mesh-ancestor
64766901|NCT00814788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652741|NCT01574183|Serotonin Agents|serotonin agents|mesh-ancestor
64766902|NCT00814788|Androgen Antagonists|androgen antagonists|mesh-ancestor
64766903|NCT00814788|Hormone Antagonists|hormone antagonists|mesh-ancestor
64766904|NCT00814788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64766905|NCT00820872|Carboplatin|carboplatin|mesh-list
64766906|NCT00820872|Docetaxel|docetaxel|mesh-list
64766907|NCT00820872|Trastuzumab|trastuzumab|mesh-list
64766908|NCT00820872|Lapatinib|lapatinib|mesh-list
64766909|NCT00820872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766910|NCT00820872|Tubulin Modulators|tubulin modulators|mesh-ancestor
64766911|NCT00820872|Antimitotic Agents|antimitotic agents|mesh-ancestor
64766912|NCT00820872|Mitosis Modulators|mitosis modulators|mesh-ancestor
64766913|NCT00820872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766914|NCT00820872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64766915|NCT00820872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64766916|NCT00820872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766917|NCT00821184|Solifenacin Succinate|solifenacin succinate|mesh-list
64766918|NCT00821184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64766919|NCT00821184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64766920|NCT00821184|Cholinergic Agents|cholinergic agents|mesh-ancestor
64766921|NCT00821184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64766925|NCT05236842|Sulthiame|sulthiame|mesh-list
64652797|NCT01728818|Afatinib|afatinib|mesh-list
64766939|NCT05131152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766940|NCT05131152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64766943|NCT05131152|Antifungal Agents|antifungal agents|mesh-ancestor
64766944|NCT05131152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64766945|NCT05131152|Dermatologic Agents|dermatologic agents|mesh-ancestor
64766946|NCT05131152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64766947|NCT05131152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64652848|NCT01576523|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64766948|NCT04900116|Bupivacaine|bupivacaine|mesh-list
64766949|NCT04900116|Anesthetics, Local|anesthetics, local|mesh-ancestor
64766950|NCT04900116|Anesthetics|anesthetics|mesh-ancestor
64766951|NCT04900116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64766952|NCT04900116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766953|NCT04900116|Sensory System Agents|sensory system agents|mesh-ancestor
64766954|NCT04900116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64766955|NCT04694976|Vitamin D|vitamin d|mesh-list
64766956|NCT04694976|Vitamins|vitamins|mesh-ancestor
64766957|NCT04694976|Micronutrients|micronutrients|mesh-ancestor
64766958|NCT04694976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766959|NCT04694976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64766960|NCT04603248|Nivolumab|nivolumab|mesh-list
64766961|NCT04603248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64766962|NCT04603248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766963|NCT04603248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64766964|NCT04603248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766965|NCT03936270|Letrozole|letrozole|mesh-list
64323361|NCT04480359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64652914|NCT01723670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64652915|NCT01723670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652917|NCT01723748|Hormones|hormones|mesh-list
64323362|NCT04480359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64323363|NCT04480359|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64323364|NCT04480359|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64323365|NCT04480359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323366|NCT04480359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766966|NCT03936270|Palbociclib|palbociclib|mesh-list
64766967|NCT03936270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766968|NCT03936270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64766969|NCT03936270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64766970|NCT03936270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766971|NCT03936270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766972|NCT03936270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64766973|NCT03936270|Hormone Antagonists|hormone antagonists|mesh-ancestor
64766974|NCT03936270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64766975|NCT03936270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766976|NCT03936270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64766977|NCT03763656|Hydroxyurea|hydroxyurea|mesh-list
64766978|NCT03763656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64766979|NCT03763656|Antisickling Agents|antisickling agents|mesh-ancestor
64766980|NCT03763656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64766981|NCT03763656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64766982|NCT03763656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64766983|NCT02682888|Oxytocin|oxytocin|mesh-list
64766984|NCT02682888|Oxytocics|oxytocics|mesh-ancestor
64766985|NCT02682888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64766986|NCT02682888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64766987|NCT02641236|Vancomycin|vancomycin|mesh-list
64766988|NCT02641236|Polymyxins|polymyxins|mesh-list
64766989|NCT02641236|Polymyxin B|polymyxin b|mesh-list
64766990|NCT02641236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64766991|NCT02641236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64767014|NCT00821964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767015|NCT00821964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64767016|NCT00821964|Immunologic Factors|immunologic factors|mesh-ancestor
64767017|NCT00821964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767018|NCT00821964|Interferon Inducers|interferon inducers|mesh-ancestor
64767019|NCT00822354|Tadalafil|tadalafil|mesh-list
64767020|NCT00822354|Vasodilator Agents|vasodilator agents|mesh-ancestor
64767021|NCT00822354|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64767022|NCT00822354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64767023|NCT00822354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64767024|NCT00822354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767025|NCT00822354|Urological Agents|urological agents|mesh-ancestor
64767026|NCT00824070|Moxifloxacin|moxifloxacin|mesh-list
64767028|NCT00824070|Besifloxacin|besifloxacin|mesh-list
64767029|NCT00824070|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64767030|NCT00824070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64767031|NCT00824070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64767032|NCT00824070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64767033|NCT00824070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64767034|NCT00824070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64767035|NCT00824070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767036|NCT00824070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767037|NCT00824070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64767038|NCT00824070|Contraceptive Agents|contraceptive agents|mesh-ancestor
64767039|NCT00824070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64767040|NCT00824070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767041|NCT00824070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64767042|NCT00824070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64767043|NCT00824070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64767044|NCT00824070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64767045|NCT00824070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64767047|NCT00824460|Sevelamer|sevelamer|mesh-list
64767048|NCT00824460|Trace Elements|trace elements|mesh-ancestor
64767049|NCT00824460|Micronutrients|micronutrients|mesh-ancestor
64767050|NCT00824460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767053|NCT00824460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767054|NCT00824538|Sunitinib|sunitinib|mesh-list
64767055|NCT00824538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767056|NCT00824538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64767057|NCT00824538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64767058|NCT00824538|Growth Substances|growth substances|mesh-ancestor
64767059|NCT00824538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767060|NCT00824538|Growth Inhibitors|growth inhibitors|mesh-ancestor
64767061|NCT00824538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64767062|NCT00824538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64767063|NCT00824538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767064|NCT00825786|Ropivacaine|ropivacaine|mesh-list
64767065|NCT00825786|Mepivacaine|mepivacaine|mesh-list
64767066|NCT00825786|Anesthetics, Local|anesthetics, local|mesh-ancestor
64767067|NCT00825786|Anesthetics|anesthetics|mesh-ancestor
64767068|NCT00825786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64767069|NCT00825786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767070|NCT00825786|Sensory System Agents|sensory system agents|mesh-ancestor
64767071|NCT00825786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64767072|NCT00826800|Bevacizumab|bevacizumab|mesh-list
64767073|NCT00826800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64767074|NCT00826800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767075|NCT00826800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64767076|NCT00826800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64767077|NCT00826800|Growth Substances|growth substances|mesh-ancestor
64767078|NCT00826800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767079|NCT00826800|Growth Inhibitors|growth inhibitors|mesh-ancestor
64767080|NCT00830076|Metformin|metformin|mesh-list
64767081|NCT00830076|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64767083|NCT00830076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652968|NCT01722656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378276|NCT04807335|Sufentanil|sufentanil|mesh-list
64652969|NCT01722656|Growth Inhibitors|growth inhibitors|mesh-ancestor
64767095|NCT00830388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64767097|NCT00830388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767098|NCT00830388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64767099|NCT00830388|Hormone Antagonists|hormone antagonists|mesh-ancestor
64767100|NCT00830388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64767101|NCT00830388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767102|NCT00830388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64767103|NCT00831480|Everolimus|everolimus|mesh-list
64767104|NCT00831480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767105|NCT00831480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64767106|NCT00831480|Immunologic Factors|immunologic factors|mesh-ancestor
64767107|NCT00831480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767108|NCT00832338|Dexamethasone|dexamethasone|mesh-list
64767109|NCT00832338|Docetaxel|docetaxel|mesh-list
64653005|NCT03007121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64653006|NCT03007121|Anesthetics, General|anesthetics, general|mesh-ancestor
64653007|NCT01725152|Ganaxolone|ganaxolone|mesh-list
64653008|NCT01725152|Neurosteroids|neurosteroids|mesh-ancestor
64653009|NCT01725152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653011|NCT01725152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767110|NCT00832338|Cyclophosphamide|cyclophosphamide|mesh-list
64767111|NCT00832338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64767112|NCT00832338|Antiemetics|antiemetics|mesh-ancestor
64767113|NCT00832338|Autonomic Agents|autonomic agents|mesh-ancestor
64767114|NCT00832338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64767115|NCT00832338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767116|NCT00832338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64767117|NCT00832338|Glucocorticoids|glucocorticoids|mesh-ancestor
64767118|NCT00832338|Hormones|hormones|mesh-ancestor
64767119|NCT00832338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64767120|NCT00832338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64767121|NCT00832338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767122|NCT00832338|Tubulin Modulators|tubulin modulators|mesh-ancestor
64767123|NCT00832338|Antimitotic Agents|antimitotic agents|mesh-ancestor
64767124|NCT00832338|Mitosis Modulators|mitosis modulators|mesh-ancestor
64767125|NCT00832338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767132|NCT00834210|Nicotinic Acids|nicotinic acids|mesh-list
64767136|NCT00834210|Antimalarials|antimalarials|mesh-ancestor
64767137|NCT00834210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64653062|NCT03001349|Octreotide|octreotide|mesh-list
64653063|NCT03001349|Edotreotide|edotreotide|mesh-list
64653064|NCT03001349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767138|NCT00834210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64767139|NCT00834210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64767140|NCT00834210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64767141|NCT00834210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767142|NCT00834210|Leprostatic Agents|leprostatic agents|mesh-ancestor
64767143|NCT00834210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64767144|NCT00834210|Dermatologic Agents|dermatologic agents|mesh-ancestor
64767145|NCT00834210|Keratolytic Agents|keratolytic agents|mesh-ancestor
64767146|NCT00834210|Vitamin B Complex|vitamin b complex|mesh-ancestor
64767147|NCT00834210|Vitamins|vitamins|mesh-ancestor
64767148|NCT00834210|Micronutrients|micronutrients|mesh-ancestor
64767149|NCT00834210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767150|NCT00834288|Tramadol|tramadol|mesh-list
64767151|NCT00834288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64767152|NCT00834288|Narcotics|narcotics|mesh-ancestor
64653115|NCT01724372|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64767155|NCT00834288|Analgesics|analgesics|mesh-ancestor
64767194|NCT00839982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767195|NCT00839982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767196|NCT00839982|Antiviral Agents|antiviral agents|mesh-ancestor
64767197|NCT00839982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64767198|NCT00839982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64767199|NCT00839982|Immunologic Factors|immunologic factors|mesh-ancestor
64767200|NCT00839982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767201|NCT00845130|Vitamins|vitamins|mesh-list
64767202|NCT00845130|Ascorbic Acid|ascorbic acid|mesh-list
64767203|NCT00845130|Micronutrients|micronutrients|mesh-ancestor
64767204|NCT00845130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767205|NCT00845130|Antioxidants|antioxidants|mesh-ancestor
64767206|NCT00845130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767207|NCT00845130|Protective Agents|protective agents|mesh-ancestor
64767208|NCT00848016|Acetic Acid|acetic acid|mesh-list
64767209|NCT00848016|Retinol acetate|retinol acetate|mesh-list
64767210|NCT00848016|Gossypol acetic acid|gossypol acetic acid|mesh-list
64767211|NCT00848016|Gossypol|gossypol|mesh-list
64767212|NCT00848016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64767213|NCT00848016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64767214|NCT00848016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64767215|NCT00848016|Immunologic Factors|immunologic factors|mesh-ancestor
64767216|NCT00848016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767217|NCT00848016|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64767218|NCT00848016|Protective Agents|protective agents|mesh-ancestor
64767219|NCT00848016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767220|NCT00848016|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64767221|NCT00848016|Contraceptive Agents|contraceptive agents|mesh-ancestor
64767222|NCT00848016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64767223|NCT00848016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64767227|NCT00849810|Metoprolol|metoprolol|mesh-list
64767238|NCT00849810|Adrenergic Agents|adrenergic agents|mesh-ancestor
64446157|NCT02217878|Analgesics|analgesics|mesh-ancestor
64767241|NCT00849810|Vasodilator Agents|vasodilator agents|mesh-ancestor
64767242|NCT00849810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64767243|NCT00849810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64767244|NCT00849810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64767245|NCT00856050|Letrozole|letrozole|mesh-list
64767246|NCT00856050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767247|NCT00856050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64767248|NCT00856050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64767249|NCT00856050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64767250|NCT00856050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767251|NCT00856050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64767252|NCT00856050|Hormone Antagonists|hormone antagonists|mesh-ancestor
64653269|NCT01588457|Lamotrigine|lamotrigine|mesh-list
64767253|NCT00856050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64767254|NCT00856050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767255|NCT00858468|Vaccines|vaccines|mesh-list
64767256|NCT00858468|Immunologic Factors|immunologic factors|mesh-ancestor
64767257|NCT00858468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767258|NCT00858858|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64767259|NCT00858858|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64767260|NCT00858858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64767261|NCT00866034|Cetrorelix|cetrorelix|mesh-list
64767262|NCT00866034|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64767263|NCT00866034|Fertility Agents|fertility agents|mesh-ancestor
64767264|NCT00866034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64767265|NCT00866034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767266|NCT00866034|Hormone Antagonists|hormone antagonists|mesh-ancestor
64767267|NCT00866034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64767280|NCT00868452|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64767281|NCT00868452|Antidepressive Agents|antidepressive agents|mesh-ancestor
64767282|NCT00868452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64767283|NCT00868452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653323|NCT01591733|Antimetabolites|antimetabolites|mesh-ancestor
64767287|NCT00868452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64767288|NCT00868452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767289|NCT00868452|Anticonvulsants|anticonvulsants|mesh-ancestor
64767290|NCT00868452|GABA Agents|gaba agents|mesh-ancestor
64767291|NCT00868452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64767292|NCT00868452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64767293|NCT00868452|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64767294|NCT00868452|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64767295|NCT00868452|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64767296|NCT00868452|Adrenergic Agents|adrenergic agents|mesh-ancestor
64767297|NCT00868452|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64767298|NCT00868452|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64767299|NCT00868452|Serotonin Agents|serotonin agents|mesh-ancestor
64767334|NCT00875550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64767335|NCT00875550|Analgesics|analgesics|mesh-ancestor
64767336|NCT00875550|Sensory System Agents|sensory system agents|mesh-ancestor
64767337|NCT00875550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64767338|NCT00875550|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64767339|NCT00875550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64767340|NCT00875550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64767341|NCT00875550|Adrenergic Agents|adrenergic agents|mesh-ancestor
64767342|NCT00875550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64767343|NCT00875550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767344|NCT00875550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64767345|NCT00875550|Narcotics|narcotics|mesh-ancestor
64767347|NCT00875550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64767348|NCT00875550|Anesthetics, General|anesthetics, general|mesh-ancestor
64767349|NCT00875550|Anesthetics|anesthetics|mesh-ancestor
64767350|NCT00875550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64767351|NCT00875550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64767352|NCT00875550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64767353|NCT00875550|GABA Modulators|gaba modulators|mesh-ancestor
64767354|NCT00875550|GABA Agents|gaba agents|mesh-ancestor
64767355|NCT00878436|Bicalutamide|bicalutamide|mesh-list
64767356|NCT00878436|Panobinostat|panobinostat|mesh-list
64767357|NCT00878436|Androgen Antagonists|androgen antagonists|mesh-ancestor
64767358|NCT00878436|Hormone Antagonists|hormone antagonists|mesh-ancestor
64767359|NCT00878436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64767360|NCT00878436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767361|NCT00878436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767362|NCT00878436|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64767365|NCT00878826|Enoxaparin|enoxaparin|mesh-list
64767379|NCT00882102|Gemtuzumab|gemtuzumab|mesh-list
64767380|NCT00882102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64767381|NCT00882102|Antimetabolites|antimetabolites|mesh-ancestor
64767382|NCT00882102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767383|NCT00882102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767384|NCT00882102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64767385|NCT00882102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64767386|NCT00884052|Levetiracetam|levetiracetam|mesh-list
64767387|NCT00884052|Anticonvulsants|anticonvulsants|mesh-ancestor
64767388|NCT00884052|Nootropic Agents|nootropic agents|mesh-ancestor
64767389|NCT00886236|Gabapentin|gabapentin|mesh-list
64767390|NCT00886236|Analgesics|analgesics|mesh-ancestor
64767391|NCT00886236|Sensory System Agents|sensory system agents|mesh-ancestor
64767392|NCT00886236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64767393|NCT00886236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64536074|NCT00478335|Urological Agents|urological agents|mesh-ancestor
64767394|NCT00886236|Anticonvulsants|anticonvulsants|mesh-ancestor
64767395|NCT00886236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64767396|NCT00886236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64767397|NCT00886236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64767398|NCT00886236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64767399|NCT00886236|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64767400|NCT00886236|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64767401|NCT00886236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64767402|NCT00886236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767403|NCT00886236|Antimanic Agents|antimanic agents|mesh-ancestor
64767405|NCT00886626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64653679|NCT04526951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64767406|NCT00886626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767407|NCT00886626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64767408|NCT00886626|Incretins|incretins|mesh-ancestor
64767409|NCT00886626|Hormones|hormones|mesh-ancestor
64767410|NCT00886626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64767411|NCT00887562|Ubiquinone|ubiquinone|mesh-list
64767412|NCT00887562|Idebenone|idebenone|mesh-list
64767413|NCT00887562|Antioxidants|antioxidants|mesh-ancestor
64767421|NCT00887640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64767422|NCT00887640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64767423|NCT00887640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64767424|NCT00887640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767425|NCT00887640|Antifungal Agents|antifungal agents|mesh-ancestor
64767426|NCT00887640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64767427|NCT00887640|Immunologic Factors|immunologic factors|mesh-ancestor
64767428|NCT00887640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767429|NCT00887640|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64767430|NCT00887640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64767431|NCT00887640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64767432|NCT00887640|Anesthetics, Local|anesthetics, local|mesh-ancestor
64767433|NCT00887640|Anesthetics|anesthetics|mesh-ancestor
64767434|NCT00887640|Sensory System Agents|sensory system agents|mesh-ancestor
64767435|NCT00887640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64767436|NCT00887640|Antiemetics|antiemetics|mesh-ancestor
64767437|NCT00887640|Autonomic Agents|autonomic agents|mesh-ancestor
64767438|NCT00887640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64767439|NCT00887640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64767440|NCT00887640|Histamine Antagonists|histamine antagonists|mesh-ancestor
64767441|NCT00887640|Histamine Agents|histamine agents|mesh-ancestor
64767442|NCT00887640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64767443|NCT00887640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767444|NCT00887640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64767445|NCT00887640|Antipruritics|antipruritics|mesh-ancestor
64767446|NCT00887640|Dermatologic Agents|dermatologic agents|mesh-ancestor
64446206|NCT02184572|Vaccines|vaccines|mesh-list
64767470|NCT00894504|Antimetabolites|antimetabolites|mesh-ancestor
64767471|NCT00894504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767472|NCT00894504|Antiviral Agents|antiviral agents|mesh-ancestor
64536147|NCT00480987|Cytarabine|cytarabine|mesh-list
64767473|NCT00894504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64767474|NCT00894504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64767475|NCT00894504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64767476|NCT00894504|Immunologic Factors|immunologic factors|mesh-ancestor
64767477|NCT00894504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767478|NCT00894504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64767479|NCT00895752|Riluzole|riluzole|mesh-list
64767480|NCT00895752|Anticonvulsants|anticonvulsants|mesh-ancestor
64767481|NCT00895752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64767482|NCT00895752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64767483|NCT00895752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64767484|NCT00895752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767485|NCT00895752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767486|NCT00895752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64767487|NCT00895752|Protective Agents|protective agents|mesh-ancestor
64767488|NCT00896064|Vaccines|vaccines|mesh-list
64767489|NCT00896064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64767490|NCT00896064|Immunologic Factors|immunologic factors|mesh-ancestor
64767491|NCT00896064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767492|NCT00898560|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64767493|NCT00898560|Anticonvulsants|anticonvulsants|mesh-ancestor
64379255|NCT02177032|Vaccines|vaccines|mesh-list
64767500|NCT00899574|Immunologic Factors|immunologic factors|mesh-ancestor
64767501|NCT00899574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767502|NCT00899574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767503|NCT00899574|Interferon Inducers|interferon inducers|mesh-ancestor
64767504|NCT00900666|Botulinum Toxins|botulinum toxins|mesh-list
64767505|NCT00900666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64767506|NCT00900666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64767507|NCT00900666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64767508|NCT00900666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64767509|NCT00900666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767510|NCT00900666|Cholinergic Agents|cholinergic agents|mesh-ancestor
64767511|NCT00900666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64767512|NCT00900666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767513|NCT00900666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64767514|NCT00900666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64767515|NCT00902226|Citalopram|citalopram|mesh-list
64767516|NCT00902226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64767517|NCT00902226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64767518|NCT00902226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64767519|NCT00902226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767520|NCT00902226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64767521|NCT00902226|Serotonin Agents|serotonin agents|mesh-ancestor
64430055|NCT05016869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767522|NCT00902226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767523|NCT00902226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64767524|NCT00902226|Antidepressive Agents|antidepressive agents|mesh-ancestor
64767525|NCT00902226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64767526|NCT00903162|Zoledronic Acid|zoledronic acid|mesh-list
64767527|NCT00903162|Letrozole|letrozole|mesh-list
64767531|NCT00903162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64767532|NCT00903162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64767533|NCT00903162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767534|NCT00903162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64767535|NCT00903162|Hormone Antagonists|hormone antagonists|mesh-ancestor
64767536|NCT00903162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64767537|NCT00903162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767538|NCT00903162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64767539|NCT00903162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64767540|NCT00903162|Fertility Agents|fertility agents|mesh-ancestor
64767541|NCT00903162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64767542|NCT00903162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64430108|NCT04982705|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64430109|NCT04982705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64536222|NCT00553839|Anesthetics|anesthetics|mesh-ancestor
64767546|NCT00904488|Natriuretic Agents|natriuretic agents|mesh-ancestor
64767547|NCT00904488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767548|NCT00904488|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64767549|NCT00904488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64767550|NCT00904488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767551|NCT00904488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64767552|NCT00904488|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64767554|NCT00905268|Antioxidants|antioxidants|mesh-ancestor
64767555|NCT00905268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767556|NCT00905268|Protective Agents|protective agents|mesh-ancestor
64767558|NCT00905580|Pregabalin|pregabalin|mesh-list
64767574|NCT00908466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64767575|NCT00908466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64767576|NCT00908466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767577|NCT00908466|Antifungal Agents|antifungal agents|mesh-ancestor
64767578|NCT00908466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64767579|NCT00908466|Immunologic Factors|immunologic factors|mesh-ancestor
64767580|NCT00908466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767581|NCT00911586|Methyltestosterone|methyltestosterone|mesh-list
64767582|NCT00911586|Testosterone|testosterone|mesh-list
64654124|NCT03702725|Hormones|hormones|mesh-ancestor
64767583|NCT00911586|Testosterone undecanoate|testosterone undecanoate|mesh-list
64767584|NCT00911586|Testosterone enanthate|testosterone enanthate|mesh-list
64767585|NCT00911586|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64767586|NCT00911586|Androgens|androgens|mesh-ancestor
64767587|NCT00911586|Hormones|hormones|mesh-ancestor
64767636|NCT00923910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64767637|NCT00923910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64767638|NCT00923910|Anesthetics, Local|anesthetics, local|mesh-ancestor
64767639|NCT00923910|Anesthetics|anesthetics|mesh-ancestor
64767640|NCT00923910|Antiemetics|antiemetics|mesh-ancestor
64767641|NCT00923910|Autonomic Agents|autonomic agents|mesh-ancestor
64654184|NCT01623479|Bimatoprost|bimatoprost|mesh-list
64767642|NCT00923910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64767643|NCT00923910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64767644|NCT00923910|Histamine Antagonists|histamine antagonists|mesh-ancestor
64767645|NCT00923910|Histamine Agents|histamine agents|mesh-ancestor
64767646|NCT00923910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64767647|NCT00923910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767648|NCT00923910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64767649|NCT00923910|Antipruritics|antipruritics|mesh-ancestor
64767650|NCT00923910|Dermatologic Agents|dermatologic agents|mesh-ancestor
64654239|NCT03203525|Leucovorin|leucovorin|mesh-list
64767651|NCT00923910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64767652|NCT00923910|Immunologic Factors|immunologic factors|mesh-ancestor
64767653|NCT00923910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767654|NCT00923910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64767655|NCT00924066|Epothilones|epothilones|mesh-list
64767656|NCT00924066|Tubulin Modulators|tubulin modulators|mesh-ancestor
64767657|NCT00924066|Antimitotic Agents|antimitotic agents|mesh-ancestor
64767658|NCT00924066|Mitosis Modulators|mitosis modulators|mesh-ancestor
64767659|NCT00924066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767660|NCT00924066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767661|NCT00924612|Methyltestosterone|methyltestosterone|mesh-list
64767662|NCT00924612|Testosterone|testosterone|mesh-list
64767663|NCT00924612|Testosterone undecanoate|testosterone undecanoate|mesh-list
64767664|NCT00924612|Testosterone enanthate|testosterone enanthate|mesh-list
64767665|NCT00924612|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64767666|NCT00924612|Androgens|androgens|mesh-ancestor
64767667|NCT00924612|Hormones|hormones|mesh-ancestor
64767668|NCT00924612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64767669|NCT00924612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767671|NCT00924612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767676|NCT00925782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767677|NCT00925782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767678|NCT00925782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64767679|NCT00925782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64767680|NCT00925782|Immunologic Factors|immunologic factors|mesh-ancestor
64767681|NCT00925782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767682|NCT00925938|Misoprostol|misoprostol|mesh-list
64654343|NCT02231177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767683|NCT00925938|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64767684|NCT00925938|Abortifacient Agents|abortifacient agents|mesh-ancestor
64767685|NCT00925938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64767686|NCT00925938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767687|NCT00925938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64767688|NCT00925938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64767689|NCT00925938|Oxytocics|oxytocics|mesh-ancestor
64767690|NCT00926952|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
64767691|NCT00926952|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64767692|NCT00926952|Dermatologic Agents|dermatologic agents|mesh-ancestor
64767693|NCT00927888|Bupivacaine|bupivacaine|mesh-list
64767694|NCT00927888|Anesthetics, Local|anesthetics, local|mesh-ancestor
64767695|NCT00927888|Anesthetics|anesthetics|mesh-ancestor
64430179|NCT04725201|Anticoagulants|anticoagulants|mesh-ancestor
64767696|NCT00927888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64767697|NCT00927888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767698|NCT00927888|Sensory System Agents|sensory system agents|mesh-ancestor
64767699|NCT00927888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64767701|NCT00928200|Dexamethasone|dexamethasone|mesh-list
64767702|NCT00928200|Dexamethasone acetate|dexamethasone acetate|mesh-list
64767703|NCT00928200|Doxorubicin|doxorubicin|mesh-list
64767704|NCT00928200|Methotrexate|methotrexate|mesh-list
64767705|NCT00928200|Vincristine|vincristine|mesh-list
64767706|NCT00928200|Asparaginase|asparaginase|mesh-list
64767707|NCT00928200|Dexrazoxane|dexrazoxane|mesh-list
64767708|NCT00928200|Razoxane|razoxane|mesh-list
64654442|NCT03060083|Nicotine|nicotine|mesh-list
64767709|NCT00928200|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64767710|NCT00928200|BB 1101|bb 1101|mesh-list
64767718|NCT00928200|Hormones|hormones|mesh-ancestor
64767720|NCT00928200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64767721|NCT00928200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767722|NCT00928200|Protease Inhibitors|protease inhibitors|mesh-ancestor
64767723|NCT00928200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430197|NCT02511431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64430198|NCT02511431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64430199|NCT02137785|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64430202|NCT05003453|Palmidrol|palmidrol|mesh-list
64767731|NCT00928200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64767732|NCT00928200|Antimetabolites|antimetabolites|mesh-ancestor
64767733|NCT00928200|Dermatologic Agents|dermatologic agents|mesh-ancestor
64767734|NCT00928200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64767735|NCT00928200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64767736|NCT00928200|Immunologic Factors|immunologic factors|mesh-ancestor
64767737|NCT00928200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64767738|NCT00928200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64430249|NCT02068443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430251|NCT04978649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64767742|NCT00928200|Tubulin Modulators|tubulin modulators|mesh-ancestor
64767743|NCT00928200|Antimitotic Agents|antimitotic agents|mesh-ancestor
64767744|NCT00928200|Mitosis Modulators|mitosis modulators|mesh-ancestor
64767745|NCT00928200|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64767746|NCT00928200|Protective Agents|protective agents|mesh-ancestor
64767747|NCT00931164|Sodium Oxybate|sodium oxybate|mesh-list
64767748|NCT00931164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64767749|NCT00931164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64430383|NCT02480621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64430384|NCT02046603|Methotrexate|methotrexate|mesh-list
64767750|NCT00931164|Anesthetics, General|anesthetics, general|mesh-ancestor
64767751|NCT00931164|Anesthetics|anesthetics|mesh-ancestor
64767752|NCT00931164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64767753|NCT00931164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767754|NCT00931242|Thalidomide|thalidomide|mesh-list
64767755|NCT00931242|Apremilast|apremilast|mesh-list
64767756|NCT00931242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64767757|NCT00931242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64767758|NCT00931242|Analgesics|analgesics|mesh-ancestor
64767759|NCT00931242|Sensory System Agents|sensory system agents|mesh-ancestor
64767760|NCT00931242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64767761|NCT00931242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767762|NCT00931242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64767763|NCT00931242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64767764|NCT00931242|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64767765|NCT00931242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64767766|NCT00931242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64767767|NCT00931242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767768|NCT00931242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64767769|NCT00931242|Immunologic Factors|immunologic factors|mesh-ancestor
64767770|NCT00931242|Leprostatic Agents|leprostatic agents|mesh-ancestor
64767771|NCT00931242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64767772|NCT00931242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64767773|NCT00931242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64767779|NCT00932022|Parasympatholytics|parasympatholytics|mesh-ancestor
64767780|NCT00932022|Autonomic Agents|autonomic agents|mesh-ancestor
64767781|NCT00932022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64654637|NCT00932438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654638|NCT00932438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64654639|NCT00932438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64654640|NCT00932438|Growth Substances|growth substances|mesh-ancestor
64654641|NCT00932438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767782|NCT00932022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767783|NCT00932022|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64767784|NCT00932022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64767785|NCT00932022|Cholinergic Agents|cholinergic agents|mesh-ancestor
64767786|NCT00932022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64767787|NCT00932022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767788|NCT00932022|Urological Agents|urological agents|mesh-ancestor
64767789|NCT00939120|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64767790|NCT00939120|Dutasteride|dutasteride|mesh-list
64767791|NCT00939120|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64767792|NCT00939120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64767793|NCT00939120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64767794|NCT00939120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767795|NCT00939120|Hormone Antagonists|hormone antagonists|mesh-ancestor
64767796|NCT00939120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64767797|NCT00939120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767798|NCT00939120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64767799|NCT00939120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64430432|NCT02101359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430433|NCT02100969|Immunoglobulins|immunoglobulins|mesh-list
64430434|NCT02100969|gamma-Globulins|gamma-globulins|mesh-list
64767835|NCT00943800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64767836|NCT00943800|Alkylating Agents|alkylating agents|mesh-ancestor
64767837|NCT00943800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64767839|NCT00943878|Immunologic Factors|immunologic factors|mesh-ancestor
64767840|NCT00943878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767841|NCT00945282|Ritonavir|ritonavir|mesh-list
64767842|NCT00945282|Lopinavir|lopinavir|mesh-list
64767843|NCT00945282|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64767844|NCT00945282|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64536519|NCT01687712|Hormones|hormones|mesh-ancestor
64767845|NCT00945282|Protease Inhibitors|protease inhibitors|mesh-ancestor
64767846|NCT00945282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64767847|NCT00945282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767849|NCT00945282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64767850|NCT00945282|Antiviral Agents|antiviral agents|mesh-ancestor
64767851|NCT00945282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64767852|NCT00945282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64767853|NCT00945282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64767854|NCT00945750|Famotidine|famotidine|mesh-list
64767855|NCT00945750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64767856|NCT00945750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64767857|NCT00945750|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64767858|NCT00945750|Histamine Antagonists|histamine antagonists|mesh-ancestor
64767859|NCT00945750|Histamine Agents|histamine agents|mesh-ancestor
64767860|NCT00945750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64767861|NCT00945750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767862|NCT00945750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767863|NCT00948090|Cyclophosphamide|cyclophosphamide|mesh-list
64767864|NCT00948090|Busulfan|busulfan|mesh-list
64767872|NCT00948090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767873|NCT00948090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767874|NCT00948090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64767875|NCT00948090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64654771|NCT01598207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654772|NCT01598207|Hormones|hormones|mesh-ancestor
64767876|NCT00948090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64767877|NCT00948090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64767878|NCT00948090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64767879|NCT00950352|Choline|choline|mesh-list
64767880|NCT00950352|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64767881|NCT00950352|Lipotropic Agents|lipotropic agents|mesh-ancestor
64767882|NCT00950352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64767883|NCT00950352|Antimetabolites|antimetabolites|mesh-ancestor
64767884|NCT00950352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767885|NCT00950352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64767886|NCT00950352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64767887|NCT00950352|Nootropic Agents|nootropic agents|mesh-ancestor
64767888|NCT00953862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64767889|NCT00953862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64767890|NCT00953862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64654820|NCT04762160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64654821|NCT02487498|Glycopyrrolate|glycopyrrolate|mesh-list
64767891|NCT00953862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64767892|NCT00953862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767893|NCT00953862|Adrenergic Agents|adrenergic agents|mesh-ancestor
64767894|NCT00953862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64767895|NCT00953862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767896|NCT00955266|Calcium|calcium|mesh-list
64767897|NCT00955266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64430496|NCT01911442|Serotonin Agents|serotonin agents|mesh-ancestor
64767898|NCT00955266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767900|NCT00957684|Anticonvulsants|anticonvulsants|mesh-ancestor
64767901|NCT00957684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64767902|NCT00957684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64767903|NCT00957684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64654880|NCT02486952|Hormones|hormones|mesh-ancestor
64323370|NCT03724825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64323371|NCT03724825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323372|NCT04227704|Ketamine|ketamine|mesh-list
64323373|NCT04227704|Analgesics|analgesics|mesh-ancestor
64323374|NCT04227704|Sensory System Agents|sensory system agents|mesh-ancestor
64767904|NCT00957684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767905|NCT00961662|Tagatose|tagatose|mesh-list
64767906|NCT00961662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64767907|NCT00961662|Chelating Agents|chelating agents|mesh-ancestor
64767908|NCT00961662|Sequestering Agents|sequestering agents|mesh-ancestor
64767909|NCT00961662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767910|NCT00964548|Dantrolene|dantrolene|mesh-list
64767911|NCT00964548|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64767912|NCT00964548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654932|NCT01600703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654933|NCT02450526|Botulinum Toxins|botulinum toxins|mesh-list
64654947|NCT02458638|Antibodies|antibodies|mesh-list
64767913|NCT00964548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64767914|NCT00964548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64767915|NCT00967044|Everolimus|everolimus|mesh-list
64767916|NCT00967044|Panobinostat|panobinostat|mesh-list
64767917|NCT00967044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767918|NCT00967044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64767919|NCT00967044|Immunologic Factors|immunologic factors|mesh-ancestor
64430523|NCT04622254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64430524|NCT04622254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64536589|NCT01687478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64767920|NCT00967044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64767921|NCT00967044|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64767922|NCT00967044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64767923|NCT00967044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767924|NCT00973752|Cytarabine|cytarabine|mesh-list
64767925|NCT00973752|Prednisone|prednisone|mesh-list
64767926|NCT00973752|Doxorubicin|doxorubicin|mesh-list
64767927|NCT00973752|Methotrexate|methotrexate|mesh-list
64767928|NCT00973752|Vincristine|vincristine|mesh-list
64767929|NCT00973752|Asparaginase|asparaginase|mesh-list
64654987|NCT01647581|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64767930|NCT00973752|Mercaptopurine|mercaptopurine|mesh-list
64767931|NCT00973752|Clofarabine|clofarabine|mesh-list
64767932|NCT00973752|Pegaspargase|pegaspargase|mesh-list
64767933|NCT00973752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64767934|NCT00973752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64767935|NCT00973752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64767946|NCT00973752|Abortifacient Agents|abortifacient agents|mesh-ancestor
64767947|NCT00973752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64767948|NCT00973752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64767949|NCT00973752|Antimetabolites|antimetabolites|mesh-ancestor
64767950|NCT00973752|Dermatologic Agents|dermatologic agents|mesh-ancestor
64767951|NCT00973752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64767952|NCT00973752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64767953|NCT00973752|Immunologic Factors|immunologic factors|mesh-ancestor
64767954|NCT00973752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64767955|NCT00973752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64767956|NCT00973752|Antiviral Agents|antiviral agents|mesh-ancestor
64767957|NCT00973752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64655036|NCT02449044|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64655037|NCT02449044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64767958|NCT00973752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64767959|NCT00973752|Tubulin Modulators|tubulin modulators|mesh-ancestor
64767960|NCT00973752|Antimitotic Agents|antimitotic agents|mesh-ancestor
64767961|NCT00973752|Mitosis Modulators|mitosis modulators|mesh-ancestor
64767962|NCT00974142|Cyclosporine|cyclosporine|mesh-list
64767963|NCT00974142|Cyclosporins|cyclosporins|mesh-list
64768005|NCT00976404|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64768006|NCT00976404|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64768007|NCT00983346|Bortezomib|bortezomib|mesh-list
64430566|NCT01880086|Enclomiphene|enclomiphene|mesh-list
64430567|NCT01880086|Zuclomiphene|zuclomiphene|mesh-list
64430589|NCT01925950|Hormones|hormones|mesh-ancestor
64768009|NCT00986856|Fusidic Acid|fusidic acid|mesh-list
64768010|NCT00986856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64768011|NCT00986856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64768012|NCT00986856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64768013|NCT00986856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768014|NCT00986856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768015|NCT00987480|Cyclosporine|cyclosporine|mesh-list
64768016|NCT00987480|Cyclophosphamide|cyclophosphamide|mesh-list
64768017|NCT00987480|Busulfan|busulfan|mesh-list
64768018|NCT00987480|Fludarabine|fludarabine|mesh-list
64768019|NCT00987480|Cyclosporins|cyclosporins|mesh-list
64768020|NCT00987480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64768021|NCT00987480|Immunologic Factors|immunologic factors|mesh-ancestor
64768022|NCT00987480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768023|NCT00987480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64768024|NCT00987480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64768025|NCT00987480|Alkylating Agents|alkylating agents|mesh-ancestor
64655086|NCT00942578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768026|NCT00987480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768047|NCT00987948|Maraviroc|maraviroc|mesh-list
64768057|NCT00989586|Veltuzumab|veltuzumab|mesh-list
64768058|NCT00989586|Antibodies|antibodies|mesh-list
64768059|NCT00989586|Immunoglobulins|immunoglobulins|mesh-list
64768060|NCT00989586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64768061|NCT00989586|Immunologic Factors|immunologic factors|mesh-ancestor
64430617|NCT01907854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64430618|NCT01907854|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64768062|NCT00989586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768063|NCT00989586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768064|NCT00990288|Thrombin|thrombin|mesh-list
64768065|NCT00990288|Hemostatics|hemostatics|mesh-list
64768066|NCT00990288|Coagulants|coagulants|mesh-ancestor
64768067|NCT00991458|Cyclosporine|cyclosporine|mesh-list
64768068|NCT00991458|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64768069|NCT00991458|Cyclosporins|cyclosporins|mesh-list
64768070|NCT00991458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768071|NCT00991458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768072|NCT00991458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64768073|NCT00991458|Immunologic Factors|immunologic factors|mesh-ancestor
64768074|NCT00991458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768075|NCT00991458|Antifungal Agents|antifungal agents|mesh-ancestor
64768076|NCT00991458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64768077|NCT00991458|Dermatologic Agents|dermatologic agents|mesh-ancestor
64768078|NCT00991458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64768079|NCT00991458|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64768080|NCT00991458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64768081|NCT00993798|Bupivacaine|bupivacaine|mesh-list
64768082|NCT00993798|Anesthetics, Local|anesthetics, local|mesh-ancestor
64768083|NCT00993798|Anesthetics|anesthetics|mesh-ancestor
64768084|NCT00993798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64655126|NCT02237417|Antidepressive Agents|antidepressive agents|mesh-ancestor
64655127|NCT02237417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64768085|NCT00993798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768086|NCT00993798|Sensory System Agents|sensory system agents|mesh-ancestor
64768087|NCT00993798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64768088|NCT00997620|Fluticasone|fluticasone|mesh-list
64768090|NCT00997620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64768091|NCT00997620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64768102|NCT00997932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768103|NCT00997932|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64768104|NCT00997932|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64768105|NCT00997932|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64768106|NCT00997932|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64768107|NCT00998010|Temozolomide|temozolomide|mesh-list
64768108|NCT00998010|Bortezomib|bortezomib|mesh-list
64768109|NCT00998010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64768110|NCT00998010|Alkylating Agents|alkylating agents|mesh-ancestor
64768111|NCT00998010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768112|NCT00998010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768113|NCT00999102|Metoprolol|metoprolol|mesh-list
64768114|NCT00999102|Nebivolol|nebivolol|mesh-list
64768115|NCT00999102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64768116|NCT00999102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64768117|NCT00999102|Sympatholytics|sympatholytics|mesh-ancestor
64768118|NCT00999102|Autonomic Agents|autonomic agents|mesh-ancestor
64768119|NCT00999102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64768120|NCT00999102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768121|NCT00999102|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64768122|NCT00999102|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64768123|NCT00999102|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64768124|NCT00999102|Adrenergic Agents|adrenergic agents|mesh-ancestor
64768125|NCT00999102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64768132|NCT01000818|Omeprazole|omeprazole|mesh-list
64768152|NCT01001052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64430662|NCT01876810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64430663|NCT01876810|Antimetabolites|antimetabolites|mesh-ancestor
64655166|NCT02245490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64655167|NCT02245490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655170|NCT04355936|Telmisartan|telmisartan|mesh-list
64430669|NCT01876732|Vitamin B 12|vitamin b 12|mesh-list
64768158|NCT01001442|Maytansine|maytansine|mesh-list
64768159|NCT01001442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64768160|NCT01001442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768167|NCT01003938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64768168|NCT01003938|Topotecan|topotecan|mesh-list
64768169|NCT01003938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768170|NCT01003938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64768171|NCT01003938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768172|NCT01003938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768173|NCT01003938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64768174|NCT01003938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64768175|NCT01004718|Deoxyglucose|deoxyglucose|mesh-list
64768176|NCT01004718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64768177|NCT01004718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64768178|NCT01004718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768179|NCT01004718|Antimetabolites|antimetabolites|mesh-ancestor
64768180|NCT01004718|Antiviral Agents|antiviral agents|mesh-ancestor
64768181|NCT01004718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64768182|NCT01005576|Fludarabine|fludarabine|mesh-list
64768183|NCT01005576|Melphalan|melphalan|mesh-list
64768184|NCT01005576|Alemtuzumab|alemtuzumab|mesh-list
64768185|NCT01005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323375|NCT04227704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64768186|NCT01005576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768187|NCT01005576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64768188|NCT01005576|Immunologic Factors|immunologic factors|mesh-ancestor
64430726|NCT01903720|Hormones|hormones|mesh-ancestor
64430727|NCT01903720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64430728|NCT01903720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64768192|NCT01005576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64768193|NCT01005576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64768194|NCT01005810|Acetylcysteine|acetylcysteine|mesh-list
64768195|NCT01005810|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64768196|NCT01005810|Antiviral Agents|antiviral agents|mesh-ancestor
64768197|NCT01005810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64768198|NCT01005810|Expectorants|expectorants|mesh-ancestor
64768199|NCT01005810|Respiratory System Agents|respiratory system agents|mesh-ancestor
64768200|NCT01005810|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64768201|NCT01005810|Antioxidants|antioxidants|mesh-ancestor
64768202|NCT01005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768203|NCT01005810|Protective Agents|protective agents|mesh-ancestor
64768204|NCT01005810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768205|NCT01005810|Antidotes|antidotes|mesh-ancestor
64768206|NCT01005888|Complement C1s|complement c1s|mesh-list
64768207|NCT01005888|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64768208|NCT01005888|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
64768209|NCT01005888|Immunologic Factors|immunologic factors|mesh-ancestor
64445810|NCT01537042|Rotigotine|rotigotine|mesh-list
64768210|NCT01005888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768211|NCT01005888|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64379962|NCT01664949|Laxatives|laxatives|mesh-ancestor
64430780|NCT04415476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768225|NCT01007994|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64768227|NCT01007994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768228|NCT01007994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64768229|NCT01007994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64768230|NCT01007994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64768231|NCT01008462|Cytarabine|cytarabine|mesh-list
64768232|NCT01008462|Mycophenolic Acid|mycophenolic acid|mesh-list
64768233|NCT01008462|Cyclophosphamide|cyclophosphamide|mesh-list
64768234|NCT01008462|Melphalan|melphalan|mesh-list
64768235|NCT01008462|Mechlorethamine|mechlorethamine|mesh-list
64768236|NCT01008462|Carmustine|carmustine|mesh-list
64768237|NCT01008462|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64768238|NCT01008462|Fludarabine|fludarabine|mesh-list
64768261|NCT01008462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64768262|NCT01008462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64768263|NCT01008462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64768264|NCT01008462|Antitubercular Agents|antitubercular agents|mesh-ancestor
64768265|NCT01008462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64768266|NCT01008462|Keratolytic Agents|keratolytic agents|mesh-ancestor
64768267|NCT01008462|Dermatologic Agents|dermatologic agents|mesh-ancestor
64768268|NCT01008462|Tubulin Modulators|tubulin modulators|mesh-ancestor
64768269|NCT01008462|Antimitotic Agents|antimitotic agents|mesh-ancestor
64768270|NCT01008462|Mitosis Modulators|mitosis modulators|mesh-ancestor
64768271|NCT01010568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64768272|NCT01010568|Ofatumumab|ofatumumab|mesh-list
64768273|NCT01010568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64768274|NCT01010568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64768275|NCT01010568|Alkylating Agents|alkylating agents|mesh-ancestor
64768276|NCT01010568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768277|NCT01010568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768278|NCT01010568|Immunologic Factors|immunologic factors|mesh-ancestor
64768279|NCT01010568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768280|NCT01011816|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64768281|NCT01011816|Hemostatics|hemostatics|mesh-ancestor
64768282|NCT01011816|Coagulants|coagulants|mesh-ancestor
64768283|NCT01011894|Lenalidomide|lenalidomide|mesh-list
64768284|NCT01011894|Immunologic Factors|immunologic factors|mesh-ancestor
64768285|NCT01011894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768286|NCT01011894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64768287|NCT01011894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64768288|NCT01011894|Growth Substances|growth substances|mesh-ancestor
64768289|NCT01011894|Growth Inhibitors|growth inhibitors|mesh-ancestor
64768290|NCT01011894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768291|NCT01012674|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
64768292|NCT01012674|Chelating Agents|chelating agents|mesh-ancestor
64768293|NCT01012674|Sequestering Agents|sequestering agents|mesh-ancestor
64768295|NCT01015170|Bupropion|bupropion|mesh-list
64768300|NCT01015170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64768301|NCT01015170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64768302|NCT01015170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655228|NCT01652495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768303|NCT01015170|Dopamine Agents|dopamine agents|mesh-ancestor
64768304|NCT01015170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64768305|NCT01015170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768306|NCT01015170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64768307|NCT01015170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64768308|NCT01015170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768309|NCT01017042|Colchicine|colchicine|mesh-list
64430944|NCT02497001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64430945|NCT02497001|Respiratory System Agents|respiratory system agents|mesh-ancestor
64768310|NCT01017042|Gout Suppressants|gout suppressants|mesh-ancestor
64768311|NCT01017042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64768312|NCT01017042|Tubulin Modulators|tubulin modulators|mesh-ancestor
64768313|NCT01017042|Antimitotic Agents|antimitotic agents|mesh-ancestor
64768314|NCT01017042|Mitosis Modulators|mitosis modulators|mesh-ancestor
64768315|NCT01017042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768316|NCT01017042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768317|NCT01018056|Riluzole|riluzole|mesh-list
64768318|NCT01018056|Anticonvulsants|anticonvulsants|mesh-ancestor
64430970|NCT02098395|Liraglutide|liraglutide|mesh-list
64430971|NCT02098395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64430972|NCT02098395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430973|NCT02098395|Incretins|incretins|mesh-ancestor
64430978|NCT02096835|Dexamethasone|dexamethasone|mesh-list
64768319|NCT01018056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64768320|NCT01018056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64768321|NCT01018056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64768322|NCT01018056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768323|NCT01018056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768324|NCT01018056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64768325|NCT01018056|Protective Agents|protective agents|mesh-ancestor
64768326|NCT01018134|Desoximetasone|desoximetasone|mesh-list
64768327|NCT01018134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64768344|NCT05395962|Bleomycin|bleomycin|mesh-list
64768345|NCT05395962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768346|NCT05395962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64768347|NCT05394480|Hydrocortisone|hydrocortisone|mesh-list
64768348|NCT05394480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64768349|NCT05017584|Bupivacaine|bupivacaine|mesh-list
64768350|NCT05017584|Anesthetics, Local|anesthetics, local|mesh-ancestor
64768351|NCT05017584|Anesthetics|anesthetics|mesh-ancestor
64768352|NCT05017584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64768353|NCT05017584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768354|NCT05017584|Sensory System Agents|sensory system agents|mesh-ancestor
64768355|NCT05017584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64768356|NCT04999332|Leucovorin|leucovorin|mesh-list
64768357|NCT04999332|Docetaxel|docetaxel|mesh-list
64768358|NCT04999332|Oxaliplatin|oxaliplatin|mesh-list
64768359|NCT04999332|Levoleucovorin|levoleucovorin|mesh-list
64768360|NCT04999332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768361|NCT04999332|Tubulin Modulators|tubulin modulators|mesh-ancestor
64768362|NCT04999332|Antimitotic Agents|antimitotic agents|mesh-ancestor
64768363|NCT04999332|Mitosis Modulators|mitosis modulators|mesh-ancestor
64768364|NCT04999332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768365|NCT04999332|Antidotes|antidotes|mesh-ancestor
64768366|NCT04999332|Protective Agents|protective agents|mesh-ancestor
64768367|NCT04999332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768368|NCT04999332|Vitamin B Complex|vitamin b complex|mesh-ancestor
64768369|NCT04999332|Vitamins|vitamins|mesh-ancestor
64768370|NCT04999332|Micronutrients|micronutrients|mesh-ancestor
64768371|NCT04147416|Propofol|propofol|mesh-list
64768372|NCT04147416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64537039|NCT01573910|Renal Agents|renal agents|mesh-ancestor
64768373|NCT04147416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64768391|NCT02406222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768392|NCT02406222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64768393|NCT02406222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64768394|NCT02406222|Alkylating Agents|alkylating agents|mesh-ancestor
64431027|NCT02365285|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64431028|NCT02365285|Autonomic Agents|autonomic agents|mesh-ancestor
64431030|NCT02365285|Nootropic Agents|nootropic agents|mesh-ancestor
64768397|NCT02406222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64768398|NCT02406222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64768399|NCT02406222|Antiemetics|antiemetics|mesh-ancestor
64768400|NCT02406222|Autonomic Agents|autonomic agents|mesh-ancestor
64768401|NCT02406222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64768402|NCT02406222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64768403|NCT02406222|Glucocorticoids|glucocorticoids|mesh-ancestor
64768404|NCT02406222|Hormones|hormones|mesh-ancestor
64768405|NCT02406222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64768406|NCT02406222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64768407|NCT02406222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64768408|NCT02406222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64768409|NCT02406222|Growth Substances|growth substances|mesh-ancestor
64768410|NCT02406222|Growth Inhibitors|growth inhibitors|mesh-ancestor
64768411|NCT00458796|Zoledronic Acid|zoledronic acid|mesh-list
64768412|NCT00458796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64768440|NCT01028820|Aripiprazole|aripiprazole|mesh-list
64768441|NCT01028820|Antidepressive Agents|antidepressive agents|mesh-ancestor
64768442|NCT01028820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64768443|NCT01028820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64768444|NCT01028820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64768445|NCT01028820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64768446|NCT01028820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768447|NCT01028820|Dopamine Agonists|dopamine agonists|mesh-ancestor
64768448|NCT01028820|Dopamine Agents|dopamine agents|mesh-ancestor
64768450|NCT01028820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768451|NCT01028820|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64431080|NCT04420351|Aspirin|aspirin|mesh-list
64768452|NCT01028820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64768454|NCT01028820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64768455|NCT01028820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64768456|NCT01028820|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64768457|NCT01028820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64768460|NCT01029054|Lenalidomide|lenalidomide|mesh-list
64768461|NCT01029054|BB 1101|bb 1101|mesh-list
64768462|NCT01029054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64768463|NCT01029054|Antiemetics|antiemetics|mesh-ancestor
64768464|NCT01029054|Autonomic Agents|autonomic agents|mesh-ancestor
64768465|NCT01029054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64768466|NCT01029054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768467|NCT01029054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64768468|NCT01029054|Glucocorticoids|glucocorticoids|mesh-ancestor
64768469|NCT01029054|Hormones|hormones|mesh-ancestor
64768470|NCT01029054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64768471|NCT01029054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64768484|NCT01032954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768485|NCT01032954|Cholinergic Agents|cholinergic agents|mesh-ancestor
64768486|NCT01032954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64768487|NCT01032954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768488|NCT05593458|Oxaliplatin|oxaliplatin|mesh-list
64768489|NCT05593458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768490|NCT05592678|Donepezil|donepezil|mesh-list
64768491|NCT05592678|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64768492|NCT05592678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768493|NCT05592678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768494|NCT05592678|Cholinergic Agents|cholinergic agents|mesh-ancestor
64768495|NCT05592678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64768496|NCT05592678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768497|NCT05592678|Nootropic Agents|nootropic agents|mesh-ancestor
64768498|NCT05402826|Vitamin E|vitamin e|mesh-list
64768499|NCT05402826|Vitamins|vitamins|mesh-ancestor
64768500|NCT05402826|Micronutrients|micronutrients|mesh-ancestor
64768501|NCT05402826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768502|NCT05402826|Antioxidants|antioxidants|mesh-ancestor
64768503|NCT05402826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768504|NCT05402826|Protective Agents|protective agents|mesh-ancestor
64768505|NCT05385042|Vitamin B 12|vitamin b 12|mesh-list
64768506|NCT05385042|Thiamine|thiamine|mesh-list
64768507|NCT05385042|Vitamins|vitamins|mesh-ancestor
64768508|NCT05385042|Micronutrients|micronutrients|mesh-ancestor
64768509|NCT05385042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768510|NCT05385042|Vitamin B Complex|vitamin b complex|mesh-ancestor
64768512|NCT05306028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64768513|NCT05306028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768514|NCT05179668|Dapagliflozin|dapagliflozin|mesh-list
64768515|NCT05179668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64768516|NCT05179668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768526|NCT04316910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64768527|NCT04316910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768529|NCT04308330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768530|NCT04308330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64768531|NCT04308330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768532|NCT04308330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768533|NCT03680508|Antibodies|antibodies|mesh-list
64768534|NCT03680508|Immunoglobulins|immunoglobulins|mesh-list
64768535|NCT03680508|Immunologic Factors|immunologic factors|mesh-ancestor
64768536|NCT03680508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768537|NCT01842672|Mitoxantrone|mitoxantrone|mesh-list
64768538|NCT01842672|Clofarabine|clofarabine|mesh-list
64431199|NCT02360995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431200|NCT02360995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64431201|NCT02359903|Infliximab|infliximab|mesh-list
64431202|NCT02359903|Dermatologic Agents|dermatologic agents|mesh-ancestor
64768539|NCT01842672|Analgesics|analgesics|mesh-ancestor
64768540|NCT01842672|Sensory System Agents|sensory system agents|mesh-ancestor
64768541|NCT01842672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64768542|NCT01842672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768543|NCT01842672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768544|NCT01842672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64768545|NCT01842672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64768546|NCT01842672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768547|NCT01842672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768548|NCT01842672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64655315|NCT01703039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655316|NCT01703039|Anticonvulsants|anticonvulsants|mesh-ancestor
64768549|NCT01842672|Antimetabolites|antimetabolites|mesh-ancestor
64768550|NCT01034592|Lenalidomide|lenalidomide|mesh-list
64768551|NCT01034592|Immunologic Factors|immunologic factors|mesh-ancestor
64768552|NCT01034592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768558|NCT01037790|Palbociclib|palbociclib|mesh-list
64768572|NCT01043640|Mycophenolic Acid|mycophenolic acid|mesh-list
64768573|NCT01043640|Cyclophosphamide|cyclophosphamide|mesh-list
64431237|NCT02359435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64768575|NCT01043640|Alemtuzumab|alemtuzumab|mesh-list
64768576|NCT01043640|Cyclosporins|cyclosporins|mesh-list
64768577|NCT01043640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64768578|NCT01043640|Immunologic Factors|immunologic factors|mesh-ancestor
64768579|NCT01043640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768580|NCT01043640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64768581|NCT01043640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64768582|NCT01043640|Alkylating Agents|alkylating agents|mesh-ancestor
64768583|NCT01043640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768584|NCT01043640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768585|NCT01043640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64768586|NCT01043640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768587|NCT01043640|Antifungal Agents|antifungal agents|mesh-ancestor
64768588|NCT01043640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64768589|NCT01043640|Dermatologic Agents|dermatologic agents|mesh-ancestor
64768590|NCT01043640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64768591|NCT01043640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64768592|NCT01043640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64768593|NCT01043640|Antitubercular Agents|antitubercular agents|mesh-ancestor
64768594|NCT01043640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64768595|NCT01043640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64768596|NCT01044264|Clindamycin|clindamycin|mesh-list
64768597|NCT01044264|Clindamycin palmitate|clindamycin palmitate|mesh-list
64768598|NCT01044264|Clindamycin phosphate|clindamycin phosphate|mesh-list
64768599|NCT01044264|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64768619|NCT01045122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64768620|NCT01045122|Analgesics|analgesics|mesh-ancestor
64768621|NCT01045122|Sensory System Agents|sensory system agents|mesh-ancestor
64655349|NCT02158520|Mitosis Modulators|mitosis modulators|mesh-ancestor
64655353|NCT02158520|Growth Substances|growth substances|mesh-ancestor
64768622|NCT01045122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64768623|NCT01045122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64768624|NCT01045122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64768625|NCT01045122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64768626|NCT01045122|Adrenergic Agents|adrenergic agents|mesh-ancestor
64768627|NCT01045122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64768628|NCT01045122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768630|NCT01050582|Antipsychotic Agents|antipsychotic agents|mesh-list
64768631|NCT01050582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64768632|NCT01050582|Serotonin Agents|serotonin agents|mesh-ancestor
64768633|NCT01050582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64768634|NCT01050582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768635|NCT01050582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431331|NCT02291029|Immunologic Factors|immunologic factors|mesh-ancestor
64431332|NCT02291029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768637|NCT01050582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64768639|NCT01050582|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64768640|NCT01050582|Dopamine Agents|dopamine agents|mesh-ancestor
64768641|NCT01050660|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64768642|NCT01050660|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
64768643|NCT01050660|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64768644|NCT01050660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64768645|NCT01051440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64768646|NCT01051440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64768652|NCT01051440|Dopamine Agents|dopamine agents|mesh-ancestor
64768661|NCT01051596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768662|NCT01053000|Tazarotene|tazarotene|mesh-list
64768663|NCT01053000|Dermatologic Agents|dermatologic agents|mesh-ancestor
64768664|NCT01053000|Keratolytic Agents|keratolytic agents|mesh-ancestor
64768665|NCT05822453|Gemcitabine|gemcitabine|mesh-list
64768666|NCT05822453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64768667|NCT05822453|Antimetabolites|antimetabolites|mesh-ancestor
64768668|NCT05822453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768669|NCT05822453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768670|NCT05822453|Antiviral Agents|antiviral agents|mesh-ancestor
64768676|NCT05822440|Itraconazole|itraconazole|mesh-list
64768677|NCT05822440|Antifungal Agents|antifungal agents|mesh-ancestor
64768678|NCT05822440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64768679|NCT05822440|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64768680|NCT05822440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64768681|NCT05822440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768686|NCT05822440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768687|NCT05822440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64768689|NCT05822362|Anticonvulsants|anticonvulsants|mesh-ancestor
64768690|NCT05822323|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64768691|NCT05822323|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64768692|NCT05822323|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64768693|NCT05822323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64768694|NCT05822323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768695|NCT05822323|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64768696|NCT05822323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64768697|NCT05822323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380440|NCT02583399|Ibuprofen|ibuprofen|mesh-list
64768698|NCT05822323|Cholinergic Agents|cholinergic agents|mesh-ancestor
64768699|NCT05822323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64768700|NCT05822063|Lidocaine|lidocaine|mesh-list
64768701|NCT05822063|Anesthetics, Local|anesthetics, local|mesh-ancestor
64768702|NCT05822063|Anesthetics|anesthetics|mesh-ancestor
64768703|NCT05822063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64768704|NCT05822063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768705|NCT05822063|Sensory System Agents|sensory system agents|mesh-ancestor
64768706|NCT05822063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64431384|NCT02317627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431385|NCT02517905|Bupivacaine|bupivacaine|mesh-list
64431386|NCT02517905|Anesthetics, Local|anesthetics, local|mesh-ancestor
64431387|NCT02517905|Anesthetics|anesthetics|mesh-ancestor
64768710|NCT05822063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64768711|NCT05822063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768712|NCT05821751|Pembrolizumab|pembrolizumab|mesh-list
64768713|NCT05821751|Nivolumab|nivolumab|mesh-list
64768714|NCT05821751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64768715|NCT05821751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768716|NCT05821751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64768717|NCT05821751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768724|NCT05821712|Listerine|listerine|mesh-list
64768725|NCT05821712|Fluorides|fluorides|mesh-list
64768777|NCT05821478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64768778|NCT05821478|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64768779|NCT05821478|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64768780|NCT05821478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64768781|NCT05821478|Antitubercular Agents|antitubercular agents|mesh-ancestor
64768782|NCT05821478|Leprostatic Agents|leprostatic agents|mesh-ancestor
64768783|NCT05821478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64768784|NCT05821478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768787|NCT05821478|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64768801|NCT05821361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64768802|NCT05821361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768803|NCT05821361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64768804|NCT05821361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64768805|NCT05821361|Growth Substances|growth substances|mesh-ancestor
64768806|NCT05821361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768807|NCT05821361|Growth Inhibitors|growth inhibitors|mesh-ancestor
64768808|NCT05821309|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64768810|NCT05821309|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64655426|NCT01620047|Narcotics|narcotics|mesh-ancestor
64768811|NCT05821309|Protective Agents|protective agents|mesh-ancestor
64768812|NCT05821309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768813|NCT05821309|Laxatives|laxatives|mesh-ancestor
64768814|NCT05821309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64768815|NCT05821192|Gemcitabine|gemcitabine|mesh-list
64768816|NCT05821192|Dexamethasone|dexamethasone|mesh-list
64768817|NCT05821192|Rituximab|rituximab|mesh-list
64768818|NCT05821192|Antibodies|antibodies|mesh-list
64768819|NCT05821192|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64768820|NCT05821192|Immunologic Factors|immunologic factors|mesh-ancestor
64768821|NCT05821192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768822|NCT05821192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64768823|NCT05821192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768824|NCT05821192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64768825|NCT05821192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64768826|NCT05821192|Antiemetics|antiemetics|mesh-ancestor
64768827|NCT05821192|Autonomic Agents|autonomic agents|mesh-ancestor
64768828|NCT05821192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64768829|NCT05821192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64768830|NCT05821192|Glucocorticoids|glucocorticoids|mesh-ancestor
64768831|NCT05821192|Hormones|hormones|mesh-ancestor
64768845|NCT05821153|Antiviral Agents|antiviral agents|mesh-ancestor
64768846|NCT05821153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64768847|NCT05821088|Carboplatin|carboplatin|mesh-list
64768848|NCT05821088|Etoposide|etoposide|mesh-list
64768849|NCT05821088|Lenalidomide|lenalidomide|mesh-list
64768850|NCT05821088|Etoposide phosphate|etoposide phosphate|mesh-list
64768851|NCT05821088|Ifosfamide|ifosfamide|mesh-list
64768852|NCT05821088|Isophosphamide mustard|isophosphamide mustard|mesh-list
64768853|NCT05821088|Podophyllotoxin|podophyllotoxin|mesh-list
64768854|NCT05821088|Immunoglobulins|immunoglobulins|mesh-list
64768855|NCT05821088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768856|NCT05821088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64768857|NCT05821088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64768858|NCT05821088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64768859|NCT05821088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768860|NCT05821088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768861|NCT05821088|Immunologic Factors|immunologic factors|mesh-ancestor
64431492|NCT02059239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64431493|NCT02059239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64431494|NCT02059239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64431495|NCT02059239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64768862|NCT05821088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768863|NCT05821088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64768864|NCT05821088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64768866|NCT05821088|Growth Inhibitors|growth inhibitors|mesh-ancestor
64768867|NCT05821088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64768868|NCT05821088|Alkylating Agents|alkylating agents|mesh-ancestor
64768869|NCT05821088|Keratolytic Agents|keratolytic agents|mesh-ancestor
64768870|NCT05821088|Dermatologic Agents|dermatologic agents|mesh-ancestor
64655436|NCT00944450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64768871|NCT05821088|Tubulin Modulators|tubulin modulators|mesh-ancestor
64768872|NCT05821088|Antimitotic Agents|antimitotic agents|mesh-ancestor
64768873|NCT05821088|Mitosis Modulators|mitosis modulators|mesh-ancestor
64768874|NCT05821075|Prednisolone|prednisolone|mesh-list
64768875|NCT05821075|Cerebrolysin|cerebrolysin|mesh-list
64431545|NCT01860040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431546|NCT01860040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64431547|NCT01860040|Immunologic Factors|immunologic factors|mesh-ancestor
64431548|NCT01860040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431549|NCT01860040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64768891|NCT05821062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64768892|NCT05821062|Analgesics|analgesics|mesh-ancestor
64768893|NCT05821062|Sensory System Agents|sensory system agents|mesh-ancestor
64768894|NCT05821062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64768895|NCT05821062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768896|NCT05821062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64768897|NCT05821062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64768904|NCT05821062|Antipyretics|antipyretics|mesh-ancestor
64431575|NCT02039427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64431576|NCT02039427|Antiemetics|antiemetics|mesh-ancestor
64431577|NCT02039427|Autonomic Agents|autonomic agents|mesh-ancestor
64431582|NCT02039427|Hormones|hormones|mesh-ancestor
64768905|NCT05821062|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64768906|NCT05821062|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64768907|NCT05821062|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64768908|NCT05821062|Purinergic Agents|purinergic agents|mesh-ancestor
64768909|NCT05821062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64768917|NCT05820841|Acalabrutinib|acalabrutinib|mesh-list
64768918|NCT05820841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768919|NCT05820763|Dexamethasone|dexamethasone|mesh-list
64768920|NCT05820763|Lenalidomide|lenalidomide|mesh-list
64768921|NCT05820763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64768922|NCT05820763|Antiemetics|antiemetics|mesh-ancestor
64768923|NCT05820763|Autonomic Agents|autonomic agents|mesh-ancestor
64768924|NCT05820763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64768925|NCT05820763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431636|NCT02058537|Cholinergic Agents|cholinergic agents|mesh-ancestor
64431637|NCT02058537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64431638|NCT02058537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431718|NCT02058147|Lixisenatide|lixisenatide|mesh-list
64431719|NCT02058147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64431720|NCT02058147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768929|NCT05820763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64768931|NCT05820763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768932|NCT05820763|Immunologic Factors|immunologic factors|mesh-ancestor
64768933|NCT05820763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64768934|NCT05820763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64768935|NCT05820763|Growth Substances|growth substances|mesh-ancestor
64768936|NCT05820763|Growth Inhibitors|growth inhibitors|mesh-ancestor
64768937|NCT05820685|Dronabinol|dronabinol|mesh-list
64768938|NCT05820685|Hallucinogens|hallucinogens|mesh-ancestor
64768944|NCT05820685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64768945|NCT05820685|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64768946|NCT05820685|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64768947|NCT05820685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64768948|NCT05820685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768949|NCT05820685|Hormones|hormones|mesh-ancestor
64768950|NCT05820685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64768951|NCT05818553|Pramoxine|pramoxine|mesh-list
64768952|NCT05818553|Anesthetics, Local|anesthetics, local|mesh-ancestor
64768953|NCT05818553|Anesthetics|anesthetics|mesh-ancestor
64768954|NCT05818553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64768955|NCT05818553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768956|NCT05818553|Sensory System Agents|sensory system agents|mesh-ancestor
64768957|NCT05818553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64768958|NCT05817903|Nivolumab|nivolumab|mesh-list
64431852|NCT02037165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64431853|NCT02037165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64768960|NCT05817903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64768961|NCT05817903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768962|NCT05817903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64768963|NCT05817903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768964|NCT05817903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64768965|NCT05817903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431866|NCT01855750|Doxorubicin|doxorubicin|mesh-list
64431867|NCT01855750|Vincristine|vincristine|mesh-list
64431868|NCT01855750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64768966|NCT05817591|Capsaicin|capsaicin|mesh-list
64768967|NCT05817591|Antipruritics|antipruritics|mesh-ancestor
64768968|NCT05817591|Dermatologic Agents|dermatologic agents|mesh-ancestor
64768969|NCT05817591|Sensory System Agents|sensory system agents|mesh-ancestor
64768970|NCT05817591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64768971|NCT05817591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768972|NCT05817162|Ropivacaine|ropivacaine|mesh-list
64768973|NCT05817162|Anesthetics, Local|anesthetics, local|mesh-ancestor
64768974|NCT05817162|Anesthetics|anesthetics|mesh-ancestor
64768975|NCT05817162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64768976|NCT05817162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768979|NCT05816746|Decitabine|decitabine|mesh-list
64768982|NCT05816746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64768983|NCT05816746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432033|NCT01891864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64768991|NCT05809180|Immunologic Factors|immunologic factors|mesh-ancestor
64655486|NCT04358354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64768992|NCT05809180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64768993|NCT05809180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64768994|NCT05809180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64768995|NCT05809180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64768997|NCT05809180|Growth Inhibitors|growth inhibitors|mesh-ancestor
64768998|NCT05802238|Tranexamic Acid|tranexamic acid|mesh-list
64768999|NCT05802238|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64769000|NCT05802238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64769001|NCT05802238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769002|NCT05802238|Hemostatics|hemostatics|mesh-ancestor
64769003|NCT05802238|Coagulants|coagulants|mesh-ancestor
64769004|NCT05796570|Decitabine|decitabine|mesh-list
64769005|NCT05796570|Lenograstim|lenograstim|mesh-list
64769006|NCT05796570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64432102|NCT04956263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64432103|NCT04956263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432104|NCT04956263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64769007|NCT05796570|Immunologic Factors|immunologic factors|mesh-ancestor
64769008|NCT05796570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769009|NCT05796570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64432193|NCT02372006|Afatinib|afatinib|mesh-list
64769011|NCT05796570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769027|NCT05738057|Immunologic Factors|immunologic factors|mesh-ancestor
64769028|NCT05738057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769029|NCT05723055|Nivolumab|nivolumab|mesh-list
64769030|NCT05723055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64769031|NCT05723055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769032|NCT05723055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64432304|NCT02366468|Growth Substances|growth substances|mesh-ancestor
64432305|NCT02366468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769033|NCT05723055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769034|NCT05712356|Gemcitabine|gemcitabine|mesh-list
64769035|NCT05712356|Paclitaxel|paclitaxel|mesh-list
64769036|NCT05712356|Docetaxel|docetaxel|mesh-list
64769037|NCT05712356|Durvalumab|durvalumab|mesh-list
64769038|NCT05712356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64769039|NCT05712356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769040|NCT05712356|Tubulin Modulators|tubulin modulators|mesh-ancestor
64655508|NCT03032666|Sofosbuvir|sofosbuvir|mesh-list
64769041|NCT05712356|Antimitotic Agents|antimitotic agents|mesh-ancestor
64432436|NCT02331368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432437|NCT02331368|Immunologic Factors|immunologic factors|mesh-ancestor
64769042|NCT05712356|Mitosis Modulators|mitosis modulators|mesh-ancestor
64769043|NCT05712356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769044|NCT05712356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64769045|NCT05712356|Antimetabolites|antimetabolites|mesh-ancestor
64769046|NCT05712356|Antiviral Agents|antiviral agents|mesh-ancestor
64769047|NCT05712356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64537711|NCT01448213|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64769048|NCT05712356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64769049|NCT05712356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64432575|NCT05565235|Narcotics|narcotics|mesh-ancestor
64769050|NCT05712356|Immunologic Factors|immunologic factors|mesh-ancestor
64769051|NCT05712356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769052|NCT05712356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64769054|NCT05704036|Estrogens|estrogens|mesh-list
64769055|NCT05704036|Progesterone|progesterone|mesh-list
64769056|NCT05704036|Hormones|hormones|mesh-ancestor
64769057|NCT05704036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64769058|NCT05704036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769059|NCT05704036|Progestins|progestins|mesh-ancestor
64769060|NCT05699408|Insulin Glargine|insulin glargine|mesh-list
64769061|NCT05699408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64432659|NCT02357576|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64432660|NCT02357576|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64432661|NCT01850446|Oseltamivir|oseltamivir|mesh-list
64432662|NCT01850446|Antiviral Agents|antiviral agents|mesh-ancestor
64432663|NCT01850446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64432664|NCT01850446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64769065|NCT05696782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769066|NCT05692180|Benralizumab|benralizumab|mesh-list
64769067|NCT05692180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64432757|NCT01849276|Antiviral Agents|antiviral agents|mesh-ancestor
64769068|NCT05692180|Respiratory System Agents|respiratory system agents|mesh-ancestor
64769069|NCT05689151|Abrocitinib|abrocitinib|mesh-list
64769070|NCT05689151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64769071|NCT05689151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64769072|NCT05689151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769073|NCT05669989|Dexamethasone|dexamethasone|mesh-list
64769074|NCT05669989|Lenalidomide|lenalidomide|mesh-list
64769075|NCT05669989|Pomalidomide|pomalidomide|mesh-list
64769076|NCT05669989|Cemiplimab|cemiplimab|mesh-list
64769077|NCT05669989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64769078|NCT05669989|Antiemetics|antiemetics|mesh-ancestor
64769079|NCT05669989|Autonomic Agents|autonomic agents|mesh-ancestor
64769080|NCT05669989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64769081|NCT05669989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769082|NCT05669989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64769083|NCT05669989|Glucocorticoids|glucocorticoids|mesh-ancestor
64769084|NCT05669989|Hormones|hormones|mesh-ancestor
64769085|NCT05669989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64769086|NCT05669989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64769087|NCT05669989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769088|NCT05669989|Immunologic Factors|immunologic factors|mesh-ancestor
64769089|NCT05669989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64769090|NCT05669989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64769091|NCT05669989|Growth Substances|growth substances|mesh-ancestor
64769092|NCT05669989|Growth Inhibitors|growth inhibitors|mesh-ancestor
64769093|NCT05669989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64769094|NCT05668286|Triamcinolone|triamcinolone|mesh-list
64769095|NCT05668286|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64769111|NCT05668286|Sensory System Agents|sensory system agents|mesh-ancestor
64769112|NCT05668286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64769114|NCT05665465|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64769115|NCT05665465|Autonomic Agents|autonomic agents|mesh-ancestor
64432823|NCT01844830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64432824|NCT01844830|Mydriatics|mydriatics|mesh-ancestor
64432826|NCT01844830|Protective Agents|protective agents|mesh-ancestor
64769117|NCT05665465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769118|NCT05665465|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64769119|NCT05665465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64769120|NCT05665465|Cholinergic Agents|cholinergic agents|mesh-ancestor
64769121|NCT05665465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64769122|NCT05665465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769123|NCT05664958|Bupivacaine|bupivacaine|mesh-list
64769124|NCT05664958|Anesthetics, Local|anesthetics, local|mesh-ancestor
64769125|NCT05664958|Anesthetics|anesthetics|mesh-ancestor
64769126|NCT05664958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64769127|NCT05664958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769128|NCT05664958|Sensory System Agents|sensory system agents|mesh-ancestor
64769129|NCT05664958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64432908|NCT02351180|Respiratory System Agents|respiratory system agents|mesh-ancestor
64432909|NCT02350478|Linagliptin|linagliptin|mesh-list
64432910|NCT02350478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64432911|NCT02350478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432912|NCT02350478|Incretins|incretins|mesh-ancestor
64769130|NCT05652205|Linaclotide|linaclotide|mesh-list
64769131|NCT05652205|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64769132|NCT05652205|Enzyme Activators|enzyme activators|mesh-ancestor
64769133|NCT05652205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769134|NCT05652205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64769206|NCT05580003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64769207|NCT05580003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769208|NCT05580003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64433011|NCT02319668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64769213|NCT05580003|Anesthetics|anesthetics|mesh-ancestor
64769214|NCT05580003|GABA Modulators|gaba modulators|mesh-ancestor
64769215|NCT05580003|GABA Agents|gaba agents|mesh-ancestor
64769216|NCT05580003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64769217|NCT05580003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769218|NCT05580003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64769219|NCT05580003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64769220|NCT05580003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64769221|NCT05580003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64769222|NCT05580003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64769223|NCT05580003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769224|NCT05570812|Neurosteroids|neurosteroids|mesh-list
64769225|NCT05570812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64769226|NCT05570812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769227|NCT05570812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769228|NCT05549180|Emtricitabine|emtricitabine|mesh-list
64655547|NCT01622543|Growth Inhibitors|growth inhibitors|mesh-ancestor
64655568|NCT03032042|Antimitotic Agents|antimitotic agents|mesh-ancestor
64655569|NCT03032042|Mitosis Modulators|mitosis modulators|mesh-ancestor
64655572|NCT01623323|Fluticasone|fluticasone|mesh-list
64769229|NCT05549180|Antiviral Agents|antiviral agents|mesh-ancestor
64769230|NCT05549180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64769231|NCT05549180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64769232|NCT05549180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64769233|NCT05549180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64769234|NCT05549180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769235|NCT05549180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64769236|NCT05549180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64769237|NCT05543629|Paclitaxel|paclitaxel|mesh-list
64769238|NCT05543629|Docetaxel|docetaxel|mesh-list
64769239|NCT05543629|Carboplatin|carboplatin|mesh-list
64769245|NCT05543629|Antimitotic Agents|antimitotic agents|mesh-ancestor
64769246|NCT05543629|Mitosis Modulators|mitosis modulators|mesh-ancestor
64769247|NCT05543629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769248|NCT05543629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64769249|NCT05543629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64769250|NCT05514054|Tamoxifen|tamoxifen|mesh-list
64769251|NCT05514054|Letrozole|letrozole|mesh-list
64769252|NCT05514054|Anastrozole|anastrozole|mesh-list
64769253|NCT05514054|Exemestane|exemestane|mesh-list
64769254|NCT05514054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769255|NCT05514054|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64769256|NCT05514054|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64769257|NCT05514054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64769258|NCT05514054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769259|NCT05514054|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64769260|NCT05514054|Hormone Antagonists|hormone antagonists|mesh-ancestor
64769261|NCT05514054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64769262|NCT05514054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769263|NCT05514054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64769264|NCT05514054|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64769265|NCT05514054|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64769266|NCT05514054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64769267|NCT05500599|Fentanyl|fentanyl|mesh-list
64769268|NCT05500599|Midazolam|midazolam|mesh-list
64769269|NCT05500599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64537938|NCT05219877|Renal Agents|renal agents|mesh-ancestor
64433237|NCT02419469|Glucocorticoids|glucocorticoids|mesh-ancestor
64769289|NCT05498116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64769290|NCT05498116|Respiratory System Agents|respiratory system agents|mesh-ancestor
64769291|NCT05498116|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64769292|NCT05498116|Hormone Antagonists|hormone antagonists|mesh-ancestor
64655603|NCT01709747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64769293|NCT05498116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64769294|NCT05498116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433320|NCT02030535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64433321|NCT02030535|Cholinergic Agents|cholinergic agents|mesh-ancestor
64433322|NCT02030535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64769296|NCT05498116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64769297|NCT05498116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769298|NCT05483933|Doxorubicin|doxorubicin|mesh-list
64769299|NCT05483933|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64769300|NCT05483933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64769301|NCT05483933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769302|NCT05483933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64769303|NCT05483933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64769304|NCT05483933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64769305|NCT05483933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769306|NCT05473715|Aflibercept|aflibercept|mesh-list
64769307|NCT05473715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64769308|NCT05473715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64769309|NCT05473715|Growth Substances|growth substances|mesh-ancestor
64769313|NCT05471076|Complement C4b|complement c4b|mesh-list
64769339|NCT05402293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64769340|NCT05402293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769341|NCT05402293|Sensory System Agents|sensory system agents|mesh-ancestor
64769342|NCT05402293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64769343|NCT05402293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64769344|NCT05402293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64538013|NCT00569673|Alkylating Agents|alkylating agents|mesh-ancestor
64769349|NCT05398484|Psilocybin|psilocybin|mesh-list
64769350|NCT05398484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64769351|NCT05398484|Antimetabolites|antimetabolites|mesh-ancestor
64769352|NCT05398484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769353|NCT05398484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64655628|NCT01662791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64769354|NCT05398484|Vasodilator Agents|vasodilator agents|mesh-ancestor
64769355|NCT05398484|Vitamin B Complex|vitamin b complex|mesh-ancestor
64769356|NCT05398484|Vitamins|vitamins|mesh-ancestor
64769357|NCT05398484|Micronutrients|micronutrients|mesh-ancestor
64769358|NCT05398484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769359|NCT05398484|Hallucinogens|hallucinogens|mesh-ancestor
64769360|NCT05398484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64769403|NCT05317000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64769404|NCT05317000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769405|NCT05317000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64769406|NCT05317000|Antimetabolites|antimetabolites|mesh-ancestor
64769407|NCT05317000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64769408|NCT05292755|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64769409|NCT05292755|Lubricant Eye Drops|lubricant eye drops|mesh-list
64769410|NCT05292755|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64769411|NCT05292755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64769413|NCT05292755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64769414|NCT05283395|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64769415|NCT05283395|Latanoprost|latanoprost|mesh-list
64769416|NCT05283395|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64769417|NCT05275205|Aflibercept|aflibercept|mesh-list
64433538|NCT01825876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64769418|NCT05275205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64769419|NCT05275205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64769420|NCT05275205|Growth Substances|growth substances|mesh-ancestor
64769421|NCT05275205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769422|NCT05275205|Growth Inhibitors|growth inhibitors|mesh-ancestor
64769423|NCT05275205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769424|NCT05270863|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64769425|NCT05270863|Carbachol|carbachol|mesh-list
64655662|NCT03031184|Histamine Agents|histamine agents|mesh-ancestor
64655663|NCT03031184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64655664|NCT03031184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769426|NCT05270863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64769454|NCT05232409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64769455|NCT05232409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769456|NCT05183035|Cytarabine|cytarabine|mesh-list
64769457|NCT05183035|Fludarabine|fludarabine|mesh-list
64769458|NCT05183035|Azacitidine|azacitidine|mesh-list
64769459|NCT05183035|Venetoclax|venetoclax|mesh-list
64769460|NCT05183035|Gemtuzumab|gemtuzumab|mesh-list
64769461|NCT05183035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769462|NCT05183035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64769463|NCT05183035|Antimetabolites|antimetabolites|mesh-ancestor
64769464|NCT05183035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769465|NCT05183035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64769466|NCT05183035|Immunologic Factors|immunologic factors|mesh-ancestor
64769513|NCT05137262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64769514|NCT05137262|Tubulin Modulators|tubulin modulators|mesh-ancestor
64769515|NCT05137262|Antimitotic Agents|antimitotic agents|mesh-ancestor
64769516|NCT05137262|Mitosis Modulators|mitosis modulators|mesh-ancestor
64769517|NCT05124691|Ivermectin|ivermectin|mesh-list
64769518|NCT05124691|Albendazole|albendazole|mesh-list
64769519|NCT05124691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64769520|NCT05124691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64769521|NCT05124691|Anthelmintics|anthelmintics|mesh-ancestor
64769522|NCT05124691|Anticestodal Agents|anticestodal agents|mesh-ancestor
64769523|NCT05124691|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64769524|NCT05124691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64769525|NCT05124691|Tubulin Modulators|tubulin modulators|mesh-ancestor
64769526|NCT05124691|Antimitotic Agents|antimitotic agents|mesh-ancestor
64769527|NCT05124691|Mitosis Modulators|mitosis modulators|mesh-ancestor
64433640|NCT04729023|Temazepam|temazepam|mesh-list
64769528|NCT05124691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769529|NCT05124691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433672|NCT01840228|Hormones|hormones|mesh-ancestor
64769530|NCT05118672|Acetaminophen|acetaminophen|mesh-list
64769531|NCT05118672|Fexofenadine|fexofenadine|mesh-list
64769532|NCT05118672|Phenylephrine|phenylephrine|mesh-list
64769533|NCT05118672|Oxymetazoline|oxymetazoline|mesh-list
64769534|NCT05118672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64769535|NCT05118672|Analgesics|analgesics|mesh-ancestor
64769568|NCT05114837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769569|NCT05114837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64769571|NCT05098938|Antiviral Agents|antiviral agents|mesh-ancestor
64769572|NCT05098938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64769579|NCT05063552|Cisplatin|cisplatin|mesh-list
64769580|NCT05063552|Carboplatin|carboplatin|mesh-list
64769581|NCT05063552|Docetaxel|docetaxel|mesh-list
64769582|NCT05063552|Atezolizumab|atezolizumab|mesh-list
64769584|NCT05063552|Antibodies|antibodies|mesh-list
64769585|NCT05063552|Immunoglobulins|immunoglobulins|mesh-list
64769586|NCT05063552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64769587|NCT05063552|Immunoglobulin G|immunoglobulin g|mesh-list
64769588|NCT05063552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769589|NCT05063552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64769590|NCT05063552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64769591|NCT05063552|Growth Substances|growth substances|mesh-ancestor
64769592|NCT05063552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769593|NCT05063552|Growth Inhibitors|growth inhibitors|mesh-ancestor
64769594|NCT05063552|Immunologic Factors|immunologic factors|mesh-ancestor
64769595|NCT05063552|Tubulin Modulators|tubulin modulators|mesh-ancestor
64769596|NCT05063552|Antimitotic Agents|antimitotic agents|mesh-ancestor
64769597|NCT05063552|Mitosis Modulators|mitosis modulators|mesh-ancestor
64769598|NCT05063552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769599|NCT05047172|Aspirin|aspirin|mesh-list
64769600|NCT05047172|Rivaroxaban|rivaroxaban|mesh-list
64769601|NCT05047172|Clopidogrel|clopidogrel|mesh-list
64769602|NCT05047172|Ticagrelor|ticagrelor|mesh-list
64769603|NCT05047172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64769604|NCT05047172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64769605|NCT05047172|Analgesics|analgesics|mesh-ancestor
64769626|NCT05047172|Protease Inhibitors|protease inhibitors|mesh-ancestor
64769627|NCT05047172|Anticoagulants|anticoagulants|mesh-ancestor
64769628|NCT05020665|Cytarabine|cytarabine|mesh-list
64769629|NCT05020665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64769630|NCT05020665|Antimetabolites|antimetabolites|mesh-ancestor
64769631|NCT05020665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769632|NCT05020665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769633|NCT05020665|Antiviral Agents|antiviral agents|mesh-ancestor
64769634|NCT05020665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64769635|NCT05020665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64769636|NCT05020665|Immunologic Factors|immunologic factors|mesh-ancestor
64769637|NCT05020665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769643|NCT05014087|Digoxin|digoxin|mesh-list
64769676|NCT04908371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64769677|NCT04908371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769679|NCT04908371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64769680|NCT04908371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64769681|NCT04908371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64769682|NCT04908371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64769683|NCT04908371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64433840|NCT01817764|Adrenergic Agents|adrenergic agents|mesh-ancestor
64433843|NCT04726618|Xenon|xenon|mesh-list
64769684|NCT04908371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769685|NCT04908371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64769686|NCT04908371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64769687|NCT04908371|Adrenergic Agents|adrenergic agents|mesh-ancestor
64769688|NCT04908371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64769689|NCT04908371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64769690|NCT04908371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64769691|NCT04908371|Autonomic Agents|autonomic agents|mesh-ancestor
64769692|NCT04908371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64769693|NCT04908371|Respiratory System Agents|respiratory system agents|mesh-ancestor
64769694|NCT04908371|Mydriatics|mydriatics|mesh-ancestor
64769695|NCT04908371|Sympathomimetics|sympathomimetics|mesh-ancestor
64769696|NCT04908371|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64769706|NCT04900792|Ascorbic Acid|ascorbic acid|mesh-list
64769707|NCT04900792|Temozolomide|temozolomide|mesh-list
64433905|NCT02453321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769722|NCT04897217|Megestrol Acetate|megestrol acetate|mesh-list
64769723|NCT04897217|Levonorgestrel|levonorgestrel|mesh-list
64769724|NCT04897217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64769725|NCT04897217|Contraceptive Agents|contraceptive agents|mesh-ancestor
64769726|NCT04897217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64769773|NCT04838379|Hormones|hormones|mesh-ancestor
64769774|NCT04838379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64769775|NCT04838379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64769776|NCT04838379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769777|NCT04838379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769778|NCT04838379|Anesthetics, Local|anesthetics, local|mesh-ancestor
64769779|NCT04838379|Anesthetics|anesthetics|mesh-ancestor
64769780|NCT04838379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64769781|NCT04838379|Sensory System Agents|sensory system agents|mesh-ancestor
64769782|NCT04838379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64769783|NCT04838379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64769784|NCT04838379|Analgesics|analgesics|mesh-ancestor
64769785|NCT04838379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64769786|NCT04838379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64769787|NCT04838379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64769788|NCT04838379|Adrenergic Agents|adrenergic agents|mesh-ancestor
64769789|NCT04838379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64769790|NCT04830878|Methotrexate|methotrexate|mesh-list
64769791|NCT04830878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64769792|NCT04830878|Abortifacient Agents|abortifacient agents|mesh-ancestor
64769793|NCT04830878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64769794|NCT04830878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769795|NCT04830878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64769796|NCT04830878|Antimetabolites|antimetabolites|mesh-ancestor
64769797|NCT04830878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769798|NCT04830878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434012|NCT01652573|Calcitonin|calcitonin|mesh-list
64769799|NCT04830878|Dermatologic Agents|dermatologic agents|mesh-ancestor
64769800|NCT04830878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64769801|NCT04830878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64769806|NCT04812366|Prednisone|prednisone|mesh-list
64769807|NCT04812366|Docetaxel|docetaxel|mesh-list
64769808|NCT04812366|Atezolizumab|atezolizumab|mesh-list
64769809|NCT04812366|Abiraterone Acetate|abiraterone acetate|mesh-list
64769810|NCT04812366|Niraparib|niraparib|mesh-list
64769811|NCT04812366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769812|NCT04812366|Tubulin Modulators|tubulin modulators|mesh-ancestor
64769813|NCT04812366|Antimitotic Agents|antimitotic agents|mesh-ancestor
64769814|NCT04812366|Mitosis Modulators|mitosis modulators|mesh-ancestor
64769815|NCT04812366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769816|NCT04812366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64769817|NCT04812366|Glucocorticoids|glucocorticoids|mesh-ancestor
64769818|NCT04812366|Hormones|hormones|mesh-ancestor
64769820|NCT04812366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769821|NCT04812366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64769822|NCT04812366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64769823|NCT04812366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64769824|NCT04812366|Hormone Antagonists|hormone antagonists|mesh-ancestor
64769825|NCT04812366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64769826|NCT04812366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64769827|NCT04800107|Curcumin|curcumin|mesh-list
64769828|NCT04800107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64769829|NCT04800107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64769830|NCT04800107|Analgesics|analgesics|mesh-ancestor
64769831|NCT04800107|Sensory System Agents|sensory system agents|mesh-ancestor
64769832|NCT04800107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64769834|NCT04800107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64769846|NCT04783857|Hormones|hormones|mesh-ancestor
64769847|NCT04783857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64769848|NCT04783857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769849|NCT04778397|Cytarabine|cytarabine|mesh-list
64769850|NCT04778397|Azacitidine|azacitidine|mesh-list
64769851|NCT04778397|Daunorubicin|daunorubicin|mesh-list
64769852|NCT04778397|Venetoclax|venetoclax|mesh-list
64769853|NCT04778397|Idarubicin|idarubicin|mesh-list
64769854|NCT04778397|Magrolimab|magrolimab|mesh-list
64769855|NCT04778397|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64769856|NCT04778397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64769857|NCT04778397|Antimetabolites|antimetabolites|mesh-ancestor
64769858|NCT04778397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769859|NCT04778397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769860|NCT04778397|Antiviral Agents|antiviral agents|mesh-ancestor
64769861|NCT04778397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64769862|NCT04778397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64769863|NCT04778397|Immunologic Factors|immunologic factors|mesh-ancestor
64769864|NCT04778397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769865|NCT04778397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64655792|NCT04353362|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64655795|NCT04353362|Renal Agents|renal agents|mesh-ancestor
64769866|NCT04778397|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64769867|NCT04778397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64769868|NCT04778397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64769869|NCT04778397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64769870|NCT04778397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64769871|NCT04761159|Ketamine|ketamine|mesh-list
64769872|NCT04761159|Analgesics|analgesics|mesh-ancestor
64769873|NCT04761159|Sensory System Agents|sensory system agents|mesh-ancestor
64769874|NCT04761159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64769875|NCT04761159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769904|NCT04716296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64769905|NCT04716296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64769906|NCT04716296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64769907|NCT04716296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64769908|NCT04716296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769909|NCT04704141|Hormones|hormones|mesh-list
64769910|NCT04704141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64769911|NCT04704141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769912|NCT04685616|Doxorubicin|doxorubicin|mesh-list
64655802|NCT04353362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64769913|NCT04685616|Bleomycin|bleomycin|mesh-list
64434197|NCT02430311|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64434198|NCT02430311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434199|NCT02383433|Gemcitabine|gemcitabine|mesh-list
64769915|NCT04685616|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64769916|NCT04685616|Vinblastine|vinblastine|mesh-list
64769917|NCT04685616|Mitogens|mitogens|mesh-list
64769918|NCT04685616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64769919|NCT04685616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769920|NCT04685616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64769921|NCT04685616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64769922|NCT04685616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64655850|NCT03033368|Antiviral Agents|antiviral agents|mesh-ancestor
64434233|NCT02379221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64769923|NCT04685616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64769924|NCT04685616|Mitosis Modulators|mitosis modulators|mesh-ancestor
64769925|NCT04685616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64769926|NCT04685616|Alkylating Agents|alkylating agents|mesh-ancestor
64769927|NCT04685616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64769928|NCT04685616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64769929|NCT04685616|Tubulin Modulators|tubulin modulators|mesh-ancestor
64769930|NCT04685616|Antimitotic Agents|antimitotic agents|mesh-ancestor
64769931|NCT04682041|Immunoglobulins|immunoglobulins|mesh-list
64769932|NCT04682041|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64769933|NCT04682041|Antibodies|antibodies|mesh-list
64769936|NCT04675931|Artesunate|artesunate|mesh-list
64769947|NCT04675931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64769948|NCT04675931|Anthelmintics|anthelmintics|mesh-ancestor
64434386|NCT02421887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434387|NCT02421887|Protective Agents|protective agents|mesh-ancestor
64434389|NCT01789606|Ibuprofen|ibuprofen|mesh-list
64769952|NCT04669678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64769954|NCT04669678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64769955|NCT04669678|Contraceptive Agents|contraceptive agents|mesh-ancestor
64769956|NCT04669678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64769957|NCT04669678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769958|NCT04669678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64769959|NCT04669678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64769960|NCT04669678|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64769961|NCT04669678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64769962|NCT04669678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769964|NCT04660344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64769966|NCT04652661|Dexmedetomidine|dexmedetomidine|mesh-list
64769967|NCT04652661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64769968|NCT04652661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64769969|NCT04652661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64769970|NCT04652661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64769972|NCT04652661|Sensory System Agents|sensory system agents|mesh-ancestor
64769973|NCT04652661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64769994|NCT04609878|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64769995|NCT04609878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64769996|NCT04609878|Respiratory System Agents|respiratory system agents|mesh-ancestor
64769997|NCT04590781|Pembrolizumab|pembrolizumab|mesh-list
64769998|NCT04590781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64769999|NCT04590781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770000|NCT04573751|Verapamil|verapamil|mesh-list
64770001|NCT04573751|Epinephrine|epinephrine|mesh-list
64770002|NCT04573751|Racepinephrine|racepinephrine|mesh-list
64770003|NCT04573751|Epinephryl borate|epinephryl borate|mesh-list
64770004|NCT04573751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64770005|NCT04573751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64770006|NCT04573751|Adrenergic Agents|adrenergic agents|mesh-ancestor
64770007|NCT04573751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64770008|NCT04573751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770009|NCT04573751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770010|NCT04573751|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64770011|NCT04573751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64770012|NCT04573751|Autonomic Agents|autonomic agents|mesh-ancestor
64434536|NCT02420717|Cortisone|cortisone|mesh-list
64434537|NCT02420717|Cyclophosphamide|cyclophosphamide|mesh-list
64434538|NCT02420717|Rituximab|rituximab|mesh-list
64770013|NCT04573751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64770014|NCT04573751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64770015|NCT04573751|Respiratory System Agents|respiratory system agents|mesh-ancestor
64770016|NCT04573751|Mydriatics|mydriatics|mesh-ancestor
64770018|NCT04573751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64770019|NCT04573751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64770023|NCT04573751|Vasodilator Agents|vasodilator agents|mesh-ancestor
64770070|NCT04384367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64770071|NCT04384367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64770072|NCT04384367|Gout Suppressants|gout suppressants|mesh-ancestor
64770073|NCT04384367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64770074|NCT04384367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64770075|NCT04384367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434564|NCT02420717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64434565|NCT02420717|Glucocorticoids|glucocorticoids|mesh-ancestor
64770076|NCT04384367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64770077|NCT04384367|Serotonin Agents|serotonin agents|mesh-ancestor
64770078|NCT04384367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64770079|NCT04373707|Enoxaparin|enoxaparin|mesh-list
64655946|NCT00955916|Cytarabine|cytarabine|mesh-list
64655948|NCT00955916|Cladribine|cladribine|mesh-list
64770080|NCT04373707|Dalteparin|dalteparin|mesh-list
64770081|NCT04373707|Tinzaparin|tinzaparin|mesh-list
64770082|NCT04373707|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64770083|NCT04373707|Nadroparin|nadroparin|mesh-list
64770084|NCT04373707|Enoxaparin sodium|enoxaparin sodium|mesh-list
64770085|NCT04373707|Anticoagulants|anticoagulants|mesh-ancestor
64434615|NCT02420327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434616|NCT02420327|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64434617|NCT02420327|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64434618|NCT02420327|Cholinergic Agents|cholinergic agents|mesh-ancestor
64434619|NCT02420327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64434654|NCT02347085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64770087|NCT04373707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64770088|NCT04373707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770089|NCT04345718|Buprenorphine|buprenorphine|mesh-list
64770090|NCT04345718|Analgesics, Opioid|analgesics, opioid|mesh-list
64770091|NCT04345718|Narcotics|narcotics|mesh-ancestor
64770092|NCT04345718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64770093|NCT04345718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770094|NCT04345718|Analgesics|analgesics|mesh-ancestor
64770096|NCT04345718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64770097|NCT04345718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64770099|NCT04332068|Permethrin|permethrin|mesh-list
64538755|NCT00669279|Atenolol|atenolol|mesh-list
64770130|NCT04257578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770131|NCT04249037|Tenofovir|tenofovir|mesh-list
64770132|NCT04249037|Emtricitabine|emtricitabine|mesh-list
64770133|NCT04249037|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64770134|NCT04249037|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64770135|NCT04249037|Antiviral Agents|antiviral agents|mesh-ancestor
64770136|NCT04249037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64770137|NCT04249037|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64770138|NCT04249037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64770139|NCT04249037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64770141|NCT04249037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64770142|NCT04225715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64770143|NCT04225715|Antiviral Agents|antiviral agents|mesh-ancestor
64770144|NCT04225715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64770165|NCT04190550|Idarubicin|idarubicin|mesh-list
64770166|NCT04190550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64770167|NCT04190550|Antimetabolites|antimetabolites|mesh-ancestor
64770168|NCT04190550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770169|NCT04190550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770170|NCT04190550|Antiviral Agents|antiviral agents|mesh-ancestor
64770171|NCT04190550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64770172|NCT04190550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64770173|NCT04190550|Immunologic Factors|immunologic factors|mesh-ancestor
64770174|NCT04190550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770175|NCT04190550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64770176|NCT04190550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64770189|NCT04164082|Immunologic Factors|immunologic factors|mesh-ancestor
64770190|NCT04164082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770191|NCT04164082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64770192|NCT04158739|Cytarabine|cytarabine|mesh-list
64770193|NCT04158739|Antibodies|antibodies|mesh-list
64770194|NCT04158739|Immunoglobulins|immunoglobulins|mesh-list
64770195|NCT04158739|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64770196|NCT04158739|Immunologic Factors|immunologic factors|mesh-ancestor
64770197|NCT04158739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770198|NCT04158739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64770199|NCT04158739|Antimetabolites|antimetabolites|mesh-ancestor
64770200|NCT04158739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770201|NCT04158739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770202|NCT04158739|Antiviral Agents|antiviral agents|mesh-ancestor
64770203|NCT04158739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64770204|NCT04158739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64770205|NCT04148105|Cilostazol|cilostazol|mesh-list
64770206|NCT04148105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64770207|NCT04148105|Autonomic Agents|autonomic agents|mesh-ancestor
64770208|NCT04148105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64770209|NCT04148105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770210|NCT04148105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64435020|NCT01734850|Alkylating Agents|alkylating agents|mesh-ancestor
64435028|NCT01766050|Abatacept|abatacept|mesh-list
64770211|NCT04148105|Respiratory System Agents|respiratory system agents|mesh-ancestor
64770222|NCT04125472|Lumasiran|lumasiran|mesh-list
64770231|NCT04094675|Immunologic Factors|immunologic factors|mesh-ancestor
64770232|NCT04094675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64538912|NCT00633399|Ziprasidone|ziprasidone|mesh-list
64770266|NCT04033419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770267|NCT04033419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770268|NCT04033419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64770269|NCT04033419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64770270|NCT04014283|Selenium|selenium|mesh-list
64435080|NCT01783678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64435081|NCT01734772|Dabigatran|dabigatran|mesh-list
64435082|NCT01734772|Ticagrelor|ticagrelor|mesh-list
64381828|NCT03184649|Antipyretics|antipyretics|mesh-ancestor
64323376|NCT04227704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323377|NCT04227704|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64323378|NCT04227704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64323379|NCT04227704|Anesthetics, General|anesthetics, general|mesh-ancestor
64323380|NCT04227704|Anesthetics|anesthetics|mesh-ancestor
64770282|NCT04013542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770284|NCT04009681|Immunologic Factors|immunologic factors|mesh-ancestor
64770285|NCT04009681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770286|NCT04000529|Spartalizumab|spartalizumab|mesh-list
64770287|NCT04000529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64770295|NCT03970746|Pembrolizumab|pembrolizumab|mesh-list
64770296|NCT03970746|Pemetrexed|pemetrexed|mesh-list
64770297|NCT03970746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64770298|NCT03970746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770299|NCT03970746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64770300|NCT03970746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770301|NCT03970746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64770302|NCT03970746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64770303|NCT03946878|Venetoclax|venetoclax|mesh-list
64770304|NCT03946878|Acalabrutinib|acalabrutinib|mesh-list
64770305|NCT03946878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770318|NCT03912233|Ivacaftor|ivacaftor|mesh-list
64770319|NCT03912233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64770320|NCT03912233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64770321|NCT03912233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770322|NCT03901482|Dihydroergotamine|dihydroergotamine|mesh-list
64770323|NCT03901482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64770328|NCT03901482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770347|NCT03834519|Glucocorticoids|glucocorticoids|mesh-ancestor
64770348|NCT03834519|Hormones|hormones|mesh-ancestor
64770349|NCT03834519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64770350|NCT03834519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770351|NCT03834519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64770352|NCT03834519|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64770353|NCT03834519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64770354|NCT03834519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770355|NCT03834519|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64770356|NCT03834519|Hormone Antagonists|hormone antagonists|mesh-ancestor
64435184|NCT04905251|Luteolytic Agents|luteolytic agents|mesh-ancestor
64435185|NCT04905251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64770365|NCT03810105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64770366|NCT03810105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770367|NCT03810105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64770368|NCT03810105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64770369|NCT03810105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770370|NCT03781817|Ketamine|ketamine|mesh-list
64770371|NCT03781817|Analgesics|analgesics|mesh-ancestor
64770372|NCT03781817|Sensory System Agents|sensory system agents|mesh-ancestor
64770373|NCT03781817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64770374|NCT03781817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770375|NCT03781817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64770376|NCT03781817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64770377|NCT03781817|Anesthetics, General|anesthetics, general|mesh-ancestor
64770378|NCT03781817|Anesthetics|anesthetics|mesh-ancestor
64770379|NCT03781817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64770384|NCT03732352|Deoxyglucose|deoxyglucose|mesh-list
64770385|NCT03732352|Osimertinib|osimertinib|mesh-list
64770387|NCT03732352|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64770388|NCT03732352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770389|NCT03732352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770390|NCT03732352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64656005|NCT05184101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64656008|NCT00957242|Warfarin|warfarin|mesh-list
64770391|NCT03732352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64770392|NCT03732352|Antimetabolites|antimetabolites|mesh-ancestor
64770393|NCT03732352|Antiviral Agents|antiviral agents|mesh-ancestor
64770394|NCT03732352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64770395|NCT03725436|Paclitaxel|paclitaxel|mesh-list
64770396|NCT03725436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64770397|NCT03725436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64770398|NCT03725436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770399|NCT03725436|Tubulin Modulators|tubulin modulators|mesh-ancestor
64770400|NCT03725436|Antimitotic Agents|antimitotic agents|mesh-ancestor
64770401|NCT03725436|Mitosis Modulators|mitosis modulators|mesh-ancestor
64435360|NCT02360111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435361|NCT02360111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770418|NCT03636451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64770419|NCT03636451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770421|NCT03636451|Coagulants|coagulants|mesh-ancestor
64770422|NCT03636451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64770423|NCT03636451|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64770424|NCT03636451|Natriuretic Agents|natriuretic agents|mesh-ancestor
64770463|NCT03576989|Mineral Oil|mineral oil|mesh-list
64770464|NCT03576989|Emollients|emollients|mesh-ancestor
64770465|NCT03576989|Dermatologic Agents|dermatologic agents|mesh-ancestor
64770466|NCT03539952|Penicillamine|penicillamine|mesh-list
64770467|NCT03539952|Trientine|trientine|mesh-list
64770468|NCT03539952|Chelating Agents|chelating agents|mesh-ancestor
64770469|NCT03539952|Sequestering Agents|sequestering agents|mesh-ancestor
64770470|NCT03539952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770471|NCT03539952|Antidotes|antidotes|mesh-ancestor
64770472|NCT03539952|Protective Agents|protective agents|mesh-ancestor
64770473|NCT03539952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770474|NCT03539952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64770475|NCT03504163|Pembrolizumab|pembrolizumab|mesh-list
64539122|NCT01419535|Hormone Antagonists|hormone antagonists|mesh-ancestor
64770476|NCT03504163|BCG Vaccine|bcg vaccine|mesh-list
64770477|NCT03504163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64770478|NCT03504163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770479|NCT03504163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64770485|NCT03454035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64770486|NCT03454035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64770487|NCT03454035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770489|NCT03429543|Linagliptin|linagliptin|mesh-list
64770490|NCT03429543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64770491|NCT03429543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435549|NCT02010255|Antiviral Agents|antiviral agents|mesh-ancestor
64770492|NCT03429543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64770493|NCT03429543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770507|NCT03278691|Sensory System Agents|sensory system agents|mesh-ancestor
64770508|NCT03278691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64770509|NCT03278691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770510|NCT03278691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64770511|NCT03278691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64770512|NCT03278691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64770513|NCT03278691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64770514|NCT03278691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770521|NCT03128034|Mycophenolic Acid|mycophenolic acid|mesh-list
64770522|NCT03128034|Fludarabine|fludarabine|mesh-list
64770523|NCT03128034|Fludarabine phosphate|fludarabine phosphate|mesh-list
64770524|NCT03128034|Cyclosporins|cyclosporins|mesh-list
64770525|NCT03128034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770526|NCT03128034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64770527|NCT03128034|Antimetabolites|antimetabolites|mesh-ancestor
64656070|NCT02457546|Hemostatics|hemostatics|mesh-ancestor
64656071|NCT02457546|Coagulants|coagulants|mesh-ancestor
64770528|NCT03128034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770529|NCT03128034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64770530|NCT03128034|Immunologic Factors|immunologic factors|mesh-ancestor
64770531|NCT03128034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435610|NCT04673175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64770532|NCT03128034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64770622|NCT02621489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770623|NCT02621489|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64770625|NCT02621489|Hormones|hormones|mesh-ancestor
64770626|NCT02621489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64770627|NCT02596880|Ribavirin|ribavirin|mesh-list
64770628|NCT02596880|Sofosbuvir|sofosbuvir|mesh-list
64770629|NCT02596880|Antimetabolites|antimetabolites|mesh-ancestor
64770630|NCT02596880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770631|NCT02596880|Antiviral Agents|antiviral agents|mesh-ancestor
64770632|NCT02596880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64770634|NCT02527434|Tremelimumab|tremelimumab|mesh-list
64770635|NCT02527434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64770636|NCT02527434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64770637|NCT02527434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770638|NCT02527434|Immunologic Factors|immunologic factors|mesh-ancestor
64770639|NCT02527434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435666|NCT02353169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64435667|NCT02353169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64770642|NCT02512718|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64770643|NCT02512718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64770644|NCT02474368|Cisplatin|cisplatin|mesh-list
64770645|NCT02474368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770646|NCT02320435|Trastuzumab|trastuzumab|mesh-list
64770674|NCT01995344|Analgesics|analgesics|mesh-ancestor
64770675|NCT01995344|Sensory System Agents|sensory system agents|mesh-ancestor
64770676|NCT01995344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64770677|NCT01856478|Methotrexate|methotrexate|mesh-list
64770678|NCT01856478|Afatinib|afatinib|mesh-list
64770679|NCT01856478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64770680|NCT01856478|Abortifacient Agents|abortifacient agents|mesh-ancestor
64770681|NCT01856478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64770682|NCT01856478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770683|NCT01856478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64770684|NCT01856478|Antimetabolites|antimetabolites|mesh-ancestor
64770685|NCT01856478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770687|NCT01856478|Dermatologic Agents|dermatologic agents|mesh-ancestor
64770688|NCT01856478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64770689|NCT01856478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64770690|NCT01856478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64770691|NCT01856478|Immunologic Factors|immunologic factors|mesh-ancestor
64770692|NCT01856478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64770693|NCT01856478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64770694|NCT01856478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64770696|NCT01845688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64770697|NCT01845688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64770698|NCT01845688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64770699|NCT01845688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64656105|NCT01682135|Ramucirumab|ramucirumab|mesh-list
64770700|NCT01845688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770701|NCT01591291|Ondansetron|ondansetron|mesh-list
64770702|NCT01591291|Antiemetics|antiemetics|mesh-ancestor
64770718|NCT01154920|Paclitaxel|paclitaxel|mesh-list
64770719|NCT01154920|Docetaxel|docetaxel|mesh-list
64770720|NCT01154920|Cisplatin|cisplatin|mesh-list
64770721|NCT01154920|Carboplatin|carboplatin|mesh-list
64770722|NCT01154920|Fluorouracil|fluorouracil|mesh-list
64770723|NCT01154920|Cetuximab|cetuximab|mesh-list
64770724|NCT01154920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64770725|NCT01154920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770726|NCT01154920|Tubulin Modulators|tubulin modulators|mesh-ancestor
64770727|NCT01154920|Antimitotic Agents|antimitotic agents|mesh-ancestor
64770728|NCT01154920|Mitosis Modulators|mitosis modulators|mesh-ancestor
64770729|NCT01154920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770730|NCT01154920|Antimetabolites|antimetabolites|mesh-ancestor
64770731|NCT01154920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64770732|NCT01154920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64770733|NCT01154920|Immunologic Factors|immunologic factors|mesh-ancestor
64770734|NCT01154920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770736|NCT01093300|Paclitaxel|paclitaxel|mesh-list
64770737|NCT01093300|Everolimus|everolimus|mesh-list
64770738|NCT01093300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64770739|NCT01093300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770740|NCT01093300|Tubulin Modulators|tubulin modulators|mesh-ancestor
64770741|NCT01093300|Antimitotic Agents|antimitotic agents|mesh-ancestor
64770742|NCT01093300|Mitosis Modulators|mitosis modulators|mesh-ancestor
64770743|NCT01093300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770744|NCT01093300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64770745|NCT01093300|Immunologic Factors|immunologic factors|mesh-ancestor
64770746|NCT01093300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770747|NCT00716066|Cytarabine|cytarabine|mesh-list
64770748|NCT00716066|Prednisone|prednisone|mesh-list
64770749|NCT00716066|Cortisone|cortisone|mesh-list
64770750|NCT00716066|Etoposide|etoposide|mesh-list
64770751|NCT00716066|Etoposide phosphate|etoposide phosphate|mesh-list
64770752|NCT00716066|Melphalan|melphalan|mesh-list
64770753|NCT00716066|Mechlorethamine|mechlorethamine|mesh-list
64770754|NCT00716066|Carmustine|carmustine|mesh-list
64656120|NCT00963872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64770770|NCT00716066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770771|NCT00716066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64770772|NCT00716066|Antimetabolites|antimetabolites|mesh-ancestor
64770773|NCT00716066|Antiviral Agents|antiviral agents|mesh-ancestor
64770774|NCT00716066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64770775|NCT00716066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64770776|NCT00716066|Immunologic Factors|immunologic factors|mesh-ancestor
64770777|NCT00716066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64770778|NCT00716066|Alkylating Agents|alkylating agents|mesh-ancestor
64770779|NCT00716066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64539425|NCT01418209|Estradiol|estradiol|mesh-list
64770780|NCT00716066|Keratolytic Agents|keratolytic agents|mesh-ancestor
64770784|NCT00716066|Mitosis Modulators|mitosis modulators|mesh-ancestor
64770794|NCT01053078|Naltrexone|naltrexone|mesh-list
64770795|NCT01053078|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64770796|NCT01053078|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64770797|NCT01053078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770798|NCT01053078|Sensory System Agents|sensory system agents|mesh-ancestor
64770799|NCT01053078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64770800|NCT01053156|Minocycline|minocycline|mesh-list
64770801|NCT01053156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64770802|NCT01053156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64770803|NCT01053312|Flutemetamol|flutemetamol|mesh-list
64770804|NCT01053312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64770805|NCT01053312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770806|NCT01054404|Furosemide|furosemide|mesh-list
64770807|NCT01054404|Diuretics|diuretics|mesh-ancestor
64770808|NCT01054404|Natriuretic Agents|natriuretic agents|mesh-ancestor
64435811|NCT02006667|Trastuzumab|trastuzumab|mesh-list
64435812|NCT02006667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64770811|NCT01054404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64770812|NCT01054404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770854|NCT01061034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64770855|NCT01061034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64770856|NCT01065558|Ecopipam|ecopipam|mesh-list
64770857|NCT01065558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64770859|NCT01065558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64770860|NCT01065558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770861|NCT01065558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64770862|NCT01065558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64770863|NCT01065558|Dopamine Agents|dopamine agents|mesh-ancestor
64770864|NCT01065558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64770865|NCT01065558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770866|NCT01066026|Hyaluronic Acid|hyaluronic acid|mesh-list
64770867|NCT01066026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64770868|NCT01066026|Immunologic Factors|immunologic factors|mesh-ancestor
64770869|NCT01066026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770870|NCT01066026|Viscosupplements|viscosupplements|mesh-ancestor
64770871|NCT01066026|Protective Agents|protective agents|mesh-ancestor
64770872|NCT01072188|Calcium Carbonate|calcium carbonate|mesh-list
64770873|NCT01072188|Calcium|calcium|mesh-list
64656155|NCT01685411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656166|NCT01685411|Anticonvulsants|anticonvulsants|mesh-ancestor
64770874|NCT01072188|Fluorides|fluorides|mesh-list
64770875|NCT01072188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64770876|NCT01072188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770877|NCT01072188|Cariostatic Agents|cariostatic agents|mesh-ancestor
64770878|NCT01072188|Protective Agents|protective agents|mesh-ancestor
64770879|NCT01072188|Antacids|antacids|mesh-ancestor
64770880|NCT01072188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770881|NCT01072188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64770882|NCT01083732|Dabigatran|dabigatran|mesh-list
64770904|NCT01090752|Pioglitazone|pioglitazone|mesh-list
64770905|NCT01090752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64770906|NCT01090752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770907|NCT01093794|Metformin|metformin|mesh-list
64770908|NCT01093794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64770909|NCT01093794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64770910|NCT01093794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770911|NCT01093794|Incretins|incretins|mesh-ancestor
64770912|NCT01093794|Hormones|hormones|mesh-ancestor
64770913|NCT01093794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64770914|NCT01093794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64770915|NCT01093794|Protease Inhibitors|protease inhibitors|mesh-ancestor
64770916|NCT01093794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435890|NCT02005887|Luteolytic Agents|luteolytic agents|mesh-ancestor
64770917|NCT01093794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770919|NCT01094106|Anesthetics, Local|anesthetics, local|mesh-ancestor
64770920|NCT01094106|Anesthetics|anesthetics|mesh-ancestor
64770921|NCT01094106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64770922|NCT01094106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770923|NCT01094106|Sensory System Agents|sensory system agents|mesh-ancestor
64770924|NCT01094106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64770925|NCT01094574|Propranolol|propranolol|mesh-list
64770926|NCT01094574|Alfentanil|alfentanil|mesh-list
64770955|NCT01096680|Modafinil|modafinil|mesh-list
64770956|NCT01096680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64770957|NCT01096680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64770958|NCT01096680|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64770959|NCT01096680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64770960|NCT01096680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64770961|NCT01096680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770962|NCT01096680|Dopamine Agents|dopamine agents|mesh-ancestor
64435909|NCT02005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435910|NCT04672005|Leucovorin|leucovorin|mesh-list
64435911|NCT04672005|Gemcitabine|gemcitabine|mesh-list
64435912|NCT04672005|Paclitaxel|paclitaxel|mesh-list
64435913|NCT04672005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64435914|NCT04672005|Oxaliplatin|oxaliplatin|mesh-list
64435915|NCT04672005|Irinotecan|irinotecan|mesh-list
64435916|NCT04672005|Folfirinox|folfirinox|mesh-list
64435917|NCT04672005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64435918|NCT04672005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435919|NCT04672005|Tubulin Modulators|tubulin modulators|mesh-ancestor
64435933|NCT04672005|Antidotes|antidotes|mesh-ancestor
64770976|NCT01096992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64770977|NCT01096992|Antimetabolites|antimetabolites|mesh-ancestor
64770978|NCT01096992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64770979|NCT01096992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64770980|NCT01096992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64770981|NCT01096992|Alkylating Agents|alkylating agents|mesh-ancestor
64770982|NCT01097304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64770983|NCT01097304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64770985|NCT01097460|Trastuzumab|trastuzumab|mesh-list
64771017|NCT01100268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64771018|NCT01101750|Vaccines|vaccines|mesh-list
64771019|NCT01101750|Immunologic Factors|immunologic factors|mesh-ancestor
64771020|NCT01101750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771021|NCT01102218|Pentoxifylline|pentoxifylline|mesh-list
64771022|NCT01102218|Epoetin Alfa|epoetin alfa|mesh-list
64771023|NCT01102218|Hematinics|hematinics|mesh-ancestor
64771024|NCT01102218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64771025|NCT01102218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771026|NCT01102218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771027|NCT01102218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64771028|NCT01102218|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64771029|NCT01102218|Protective Agents|protective agents|mesh-ancestor
64771030|NCT01102218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771031|NCT01102218|Vasodilator Agents|vasodilator agents|mesh-ancestor
64771032|NCT01102218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64771033|NCT01102218|Antioxidants|antioxidants|mesh-ancestor
64771034|NCT01103934|Vitamin D|vitamin d|mesh-list
64771035|NCT01103934|Cholecalciferol|cholecalciferol|mesh-list
64771036|NCT01103934|Fluticasone|fluticasone|mesh-list
64771037|NCT01103934|Xhance|xhance|mesh-list
64771038|NCT01103934|Vitamins|vitamins|mesh-ancestor
64771039|NCT01103934|Micronutrients|micronutrients|mesh-ancestor
64771040|NCT01103934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771041|NCT01103934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64771042|NCT01103934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64771043|NCT01103934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64771069|NCT01105650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771070|NCT01105650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64771071|NCT01105650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64771072|NCT01105650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771073|NCT01105650|Antifungal Agents|antifungal agents|mesh-ancestor
64771074|NCT01105650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64771075|NCT01105650|Dermatologic Agents|dermatologic agents|mesh-ancestor
64771076|NCT01105650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64771077|NCT01105650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64771078|NCT01105650|Antiemetics|antiemetics|mesh-ancestor
64771079|NCT01105650|Autonomic Agents|autonomic agents|mesh-ancestor
64539720|NCT04061239|Azacitidine|azacitidine|mesh-list
64771080|NCT01105650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64771081|NCT01105650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64771129|NCT01115556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64771130|NCT01115556|Growth Substances|growth substances|mesh-ancestor
64771131|NCT01115556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771132|NCT01115556|Growth Inhibitors|growth inhibitors|mesh-ancestor
64771133|NCT01115556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64771134|NCT01116102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64771135|NCT01119222|Diphenhydramine|diphenhydramine|mesh-list
64771136|NCT01119222|Promethazine|promethazine|mesh-list
64771137|NCT01119222|Morphine|morphine|mesh-list
64771138|NCT01119222|Gabapentin|gabapentin|mesh-list
64771139|NCT01119222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64771140|NCT01119222|Narcotics|narcotics|mesh-ancestor
64771141|NCT01119222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64771142|NCT01119222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771143|NCT01119222|Analgesics|analgesics|mesh-ancestor
64771144|NCT01119222|Sensory System Agents|sensory system agents|mesh-ancestor
64771145|NCT01119222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64771146|NCT01119222|Anticonvulsants|anticonvulsants|mesh-ancestor
64656251|NCT02485158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64771147|NCT01119222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64771148|NCT01119222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64771149|NCT01119222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64771150|NCT01119222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64771151|NCT01119222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64771152|NCT01119222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64771153|NCT01119222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771154|NCT01119222|Antimanic Agents|antimanic agents|mesh-ancestor
64771155|NCT01119222|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64771156|NCT01119222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64771157|NCT01119222|Anesthetics, Local|anesthetics, local|mesh-ancestor
64771158|NCT01119222|Anesthetics|anesthetics|mesh-ancestor
64771159|NCT01119222|Antiemetics|antiemetics|mesh-ancestor
64771160|NCT01119222|Autonomic Agents|autonomic agents|mesh-ancestor
64771161|NCT01119222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64771162|NCT01119222|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64771163|NCT01119222|Histamine Antagonists|histamine antagonists|mesh-ancestor
64771171|NCT01120236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64771172|NCT01120236|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64771173|NCT01120236|Fertility Agents|fertility agents|mesh-ancestor
64771174|NCT01120236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64771175|NCT01120236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771176|NCT01120236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64771177|NCT01120236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64771178|NCT01120236|Androgen Antagonists|androgen antagonists|mesh-ancestor
64771179|NCT01120236|Hormone Antagonists|hormone antagonists|mesh-ancestor
64771180|NCT01120236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64771181|NCT01120236|Immunologic Factors|immunologic factors|mesh-ancestor
64771182|NCT01120704|Nicotine|nicotine|mesh-list
64771183|NCT01120704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64656277|NCT02455518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64436197|NCT04561180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64771185|NCT01120704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64771186|NCT01120704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771187|NCT01120704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64771188|NCT01120704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64771189|NCT01120704|Cholinergic Agents|cholinergic agents|mesh-ancestor
64771190|NCT01120704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64771191|NCT01120704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771192|NCT01122108|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
64771193|NCT01122108|Cholestyramine Resin|cholestyramine resin|mesh-list
64771194|NCT01122108|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64771195|NCT01122108|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64771196|NCT01122108|Antimetabolites|antimetabolites|mesh-ancestor
64771197|NCT01122108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771198|NCT01122108|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64771199|NCT05307042|Vasopressins|vasopressins|mesh-list
64771200|NCT05307042|Arginine Vasopressin|arginine vasopressin|mesh-list
64771201|NCT05307042|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64771202|NCT05307042|Hemostatics|hemostatics|mesh-ancestor
64771203|NCT05307042|Coagulants|coagulants|mesh-ancestor
64771212|NCT04974138|Amlodipine|amlodipine|mesh-list
64771213|NCT04974138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64771214|NCT04974138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64771215|NCT04974138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64771216|NCT04974138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771217|NCT04974138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64771218|NCT04974138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771219|NCT04974138|Vasodilator Agents|vasodilator agents|mesh-ancestor
64771220|NCT04974138|Hematinics|hematinics|mesh-ancestor
64771221|NCT04974138|Vitamin B Complex|vitamin b complex|mesh-ancestor
64771222|NCT04974138|Vitamins|vitamins|mesh-ancestor
64771223|NCT04974138|Micronutrients|micronutrients|mesh-ancestor
64771224|NCT04973982|Tacrolimus|tacrolimus|mesh-list
64436249|NCT04662073|Camostat|camostat|mesh-list
64436250|NCT04662073|Protease Inhibitors|protease inhibitors|mesh-ancestor
64771225|NCT04973982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64771226|NCT04973982|Immunologic Factors|immunologic factors|mesh-ancestor
64771227|NCT04973982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771228|NCT04973982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64771229|NCT04973982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771230|NCT04973982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771231|NCT04944654|Emtricitabine|emtricitabine|mesh-list
64771268|NCT03697356|Autonomic Agents|autonomic agents|mesh-ancestor
64771269|NCT03697356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64771270|NCT03697356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64771271|NCT03697356|Glucocorticoids|glucocorticoids|mesh-ancestor
64771273|NCT03697356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64436284|NCT04832269|Methylprednisolone|methylprednisolone|mesh-list
64771276|NCT03697356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64771277|NCT03697356|Growth Substances|growth substances|mesh-ancestor
64771278|NCT03697356|Growth Inhibitors|growth inhibitors|mesh-ancestor
64771279|NCT03616782|Ixazomib|ixazomib|mesh-list
64771280|NCT03616782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64771281|NCT03616782|Protease Inhibitors|protease inhibitors|mesh-ancestor
64771282|NCT03616782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771283|NCT03616782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771284|NCT02410512|Atezolizumab|atezolizumab|mesh-list
64771285|NCT02410512|Antibodies|antibodies|mesh-list
64771286|NCT02410512|Immunoglobulins|immunoglobulins|mesh-list
64436325|NCT01637077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64436326|NCT01637077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436327|NCT01637077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64436328|NCT01637077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64771291|NCT00255138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64771292|NCT00255138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64656324|NCT03018626|Antimitotic Agents|antimitotic agents|mesh-ancestor
64771293|NCT00255138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64771294|NCT00255138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64771296|NCT00255138|Adrenergic Agents|adrenergic agents|mesh-ancestor
64771315|NCT01129206|Deoxyglucose|deoxyglucose|mesh-list
64771316|NCT01129206|Docetaxel|docetaxel|mesh-list
64771317|NCT01129206|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64771318|NCT01129206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64771319|NCT01129206|Tubulin Modulators|tubulin modulators|mesh-ancestor
64771320|NCT01129206|Antimitotic Agents|antimitotic agents|mesh-ancestor
64771321|NCT01129206|Mitosis Modulators|mitosis modulators|mesh-ancestor
64771324|NCT01129206|Antimetabolites|antimetabolites|mesh-ancestor
64771325|NCT01129206|Antiviral Agents|antiviral agents|mesh-ancestor
64771326|NCT01129206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64771327|NCT01129440|Fluorides|fluorides|mesh-list
64771328|NCT01129440|Fluorides, Topical|fluorides, topical|mesh-list
64771329|NCT01129440|Cariostatic Agents|cariostatic agents|mesh-ancestor
64771330|NCT01129440|Protective Agents|protective agents|mesh-ancestor
64771331|NCT01129440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771332|NCT01130844|Mesalamine|mesalamine|mesh-list
64771333|NCT01130844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64771370|NCT01135368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771371|NCT01136226|Leuprolide|leuprolide|mesh-list
64771372|NCT01136226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64771373|NCT01136226|Fertility Agents|fertility agents|mesh-ancestor
64771378|NCT01137396|Modafinil|modafinil|mesh-list
64771379|NCT01137396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64771380|NCT01137396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771381|NCT01137396|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64771382|NCT01137396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64771383|NCT01137396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64771384|NCT01137396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771386|NCT01139190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64771387|NCT01139190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64771388|NCT01139190|Analgesics|analgesics|mesh-ancestor
64771389|NCT01139190|Sensory System Agents|sensory system agents|mesh-ancestor
64771403|NCT01142310|Lamotrigine|lamotrigine|mesh-list
64656332|NCT01689779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64656334|NCT05388500|Trastuzumab|trastuzumab|mesh-list
64771423|NCT01144494|Lubricant Eye Drops|lubricant eye drops|mesh-list
64771426|NCT01144494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64771427|NCT01144494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64771428|NCT01144494|Adrenergic Agents|adrenergic agents|mesh-ancestor
64771429|NCT01144494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64771430|NCT01144494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771431|NCT01144494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771432|NCT01144494|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64771433|NCT01144494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64771434|NCT01146600|Clarithromycin|clarithromycin|mesh-list
64771435|NCT01146600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64771436|NCT01146600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64771437|NCT01146600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64771438|NCT01146600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771439|NCT01146600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771440|NCT01146600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64771441|NCT01146600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64771442|NCT01146834|Plerixafor|plerixafor|mesh-list
64771473|NCT01150500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64771474|NCT01150500|Antifungal Agents|antifungal agents|mesh-ancestor
64771475|NCT01150500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64771476|NCT01150500|Immunologic Factors|immunologic factors|mesh-ancestor
64771477|NCT01150500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771478|NCT01151046|Exemestane|exemestane|mesh-list
64771479|NCT01151046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64771480|NCT01151046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64771481|NCT01151046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64771482|NCT01151046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771483|NCT01151046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771484|NCT01151046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64771485|NCT01151046|Hormone Antagonists|hormone antagonists|mesh-ancestor
64771486|NCT01151046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64771487|NCT01151046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771488|NCT01151436|Hyaluronic Acid|hyaluronic acid|mesh-list
64771489|NCT01151436|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64771490|NCT01151436|Immunologic Factors|immunologic factors|mesh-ancestor
64771491|NCT01151436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771492|NCT01151436|Viscosupplements|viscosupplements|mesh-ancestor
64771493|NCT01151436|Protective Agents|protective agents|mesh-ancestor
64771494|NCT01153620|Polihexanide|polihexanide|mesh-list
64771495|NCT01153620|Disinfectants|disinfectants|mesh-ancestor
64771496|NCT01153620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64771499|NCT01163214|Anesthetics|anesthetics|mesh-ancestor
64771500|NCT01163214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64771501|NCT01163214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771502|NCT01163214|Sensory System Agents|sensory system agents|mesh-ancestor
64771503|NCT01163214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64771516|NCT01163604|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64771517|NCT01163604|Protease Inhibitors|protease inhibitors|mesh-ancestor
64771518|NCT01163604|Anticoagulants|anticoagulants|mesh-ancestor
64771519|NCT01168674|Ziprasidone|ziprasidone|mesh-list
64771520|NCT01168674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64771521|NCT01168674|Serotonin Agents|serotonin agents|mesh-ancestor
64771522|NCT01168674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64771523|NCT01168674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771524|NCT01168674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436726|NCT02996773|Cyclophosphamide|cyclophosphamide|mesh-list
64436727|NCT02996773|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64771526|NCT01168674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64771527|NCT01168674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64771528|NCT01168674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64540166|NCT03140826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64771529|NCT01168674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64771530|NCT01168674|Dopamine Agents|dopamine agents|mesh-ancestor
64771531|NCT01168908|Sildenafil Citrate|sildenafil citrate|mesh-list
64771532|NCT01168908|Vasodilator Agents|vasodilator agents|mesh-ancestor
64771533|NCT01168908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64771534|NCT01168908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64771535|NCT01168908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771536|NCT01168908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771537|NCT01168908|Urological Agents|urological agents|mesh-ancestor
64771538|NCT01170390|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64771539|NCT01170390|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64771540|NCT01170390|Levonorgestrel|levonorgestrel|mesh-list
64771541|NCT01170390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64771542|NCT01170390|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64771544|NCT01170390|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64436784|NCT05814302|Antipyretics|antipyretics|mesh-ancestor
64771545|NCT01170390|Estrogens|estrogens|mesh-ancestor
64771546|NCT01170390|Hormones|hormones|mesh-ancestor
64771547|NCT01170390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64771548|NCT01170390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771549|NCT01170390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64771550|NCT01170390|Contraceptive Agents|contraceptive agents|mesh-ancestor
64771553|NCT01170390|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64771554|NCT01170390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64771555|NCT01170390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64771556|NCT01170390|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64771557|NCT01171794|Ibuprofen|ibuprofen|mesh-list
64771558|NCT01171794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64771559|NCT01171794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64771560|NCT01171794|Analgesics|analgesics|mesh-ancestor
64771561|NCT01171794|Sensory System Agents|sensory system agents|mesh-ancestor
64771562|NCT01171794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64771563|NCT01171794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771564|NCT01171794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64771565|NCT01171794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64771566|NCT01171794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64771567|NCT01171794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771568|NCT01171794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771569|NCT01172418|Alemtuzumab|alemtuzumab|mesh-list
64771570|NCT01172418|Thymoglobulin|thymoglobulin|mesh-list
64771571|NCT01172418|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64771572|NCT01172418|Daclizumab|daclizumab|mesh-list
64771573|NCT01172418|Immunologic Factors|immunologic factors|mesh-ancestor
64771574|NCT01172418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771575|NCT01172418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64771576|NCT01172418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64771577|NCT01172418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64771578|NCT01175148|Atorvastatin|atorvastatin|mesh-list
64771579|NCT01175148|Calcium|calcium|mesh-list
64771583|NCT01175148|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64771600|NCT01177098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64771602|NCT01177956|Cetuximab|cetuximab|mesh-list
64771603|NCT01177956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64540240|NCT00591825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64771604|NCT01177956|Antimetabolites|antimetabolites|mesh-ancestor
64771605|NCT01177956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771606|NCT01177956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64771607|NCT01177956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64771608|NCT01177956|Immunologic Factors|immunologic factors|mesh-ancestor
64771609|NCT01177956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771610|NCT01177956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64771611|NCT01183650|Tadalafil|tadalafil|mesh-list
64771612|NCT01183650|Vasodilator Agents|vasodilator agents|mesh-ancestor
64771613|NCT01183650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64771614|NCT01183650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64771615|NCT01183650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771616|NCT01183650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771617|NCT01183650|Urological Agents|urological agents|mesh-ancestor
64771618|NCT01184898|Cytarabine|cytarabine|mesh-list
64771619|NCT01184898|Sirolimus|sirolimus|mesh-list
64771620|NCT01184898|Etoposide|etoposide|mesh-list
64771621|NCT01184898|Mitoxantrone|mitoxantrone|mesh-list
64771622|NCT01184898|Etoposide phosphate|etoposide phosphate|mesh-list
64771623|NCT01184898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64383051|NCT02414009|Irinotecan|irinotecan|mesh-list
64436857|NCT05813470|Omalizumab|omalizumab|mesh-list
64436858|NCT05813470|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64771627|NCT01184898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771628|NCT01184898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771629|NCT01184898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64771630|NCT01184898|Antimetabolites|antimetabolites|mesh-ancestor
64771631|NCT01184898|Antiviral Agents|antiviral agents|mesh-ancestor
64771632|NCT01184898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64771633|NCT01184898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64771634|NCT01184898|Immunologic Factors|immunologic factors|mesh-ancestor
64771635|NCT01184898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771636|NCT01184898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64771637|NCT01184898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64771638|NCT01184898|Antifungal Agents|antifungal agents|mesh-ancestor
64771639|NCT01184898|Analgesics|analgesics|mesh-ancestor
64771640|NCT01184898|Sensory System Agents|sensory system agents|mesh-ancestor
64771641|NCT01184898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64656385|NCT03018236|Antidotes|antidotes|mesh-ancestor
64656386|NCT03018236|Anesthetics, Local|anesthetics, local|mesh-ancestor
64771680|NCT01198158|Bevacizumab|bevacizumab|mesh-list
64771681|NCT01198158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64771683|NCT01198158|Endothelial Growth Factors|endothelial growth factors|mesh-list
64771684|NCT01198158|Antibodies|antibodies|mesh-list
64771685|NCT01198158|Immunoglobulins|immunoglobulins|mesh-list
64771686|NCT01198158|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64771687|NCT01198158|Immunoglobulin G|immunoglobulin g|mesh-list
64771688|NCT01198158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64771689|NCT01198158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64771690|NCT01198158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64771691|NCT01198158|Growth Substances|growth substances|mesh-ancestor
64771692|NCT01198158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771693|NCT01198158|Growth Inhibitors|growth inhibitors|mesh-ancestor
64771694|NCT01198158|Immunologic Factors|immunologic factors|mesh-ancestor
64771695|NCT01198158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64771696|NCT01202994|Flutemetamol|flutemetamol|mesh-list
64771697|NCT01202994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64771698|NCT01202994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771699|NCT01203774|Insulin Glargine|insulin glargine|mesh-list
64771700|NCT01203774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64771701|NCT01203774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771702|NCT01205646|Zoledronic Acid|zoledronic acid|mesh-list
64771735|NCT01210560|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64771736|NCT01210560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771737|NCT01210560|Natriuretic Agents|natriuretic agents|mesh-ancestor
64771744|NCT01212900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64771745|NCT01212900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64771746|NCT01212900|Antimetabolites|antimetabolites|mesh-ancestor
64771747|NCT01212900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771748|NCT01212900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771749|NCT01212900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64771751|NCT01215318|Trace Elements|trace elements|mesh-ancestor
64771752|NCT01215318|Micronutrients|micronutrients|mesh-ancestor
64771753|NCT01215318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771754|NCT01215786|Timolol|timolol|mesh-list
64771755|NCT01215786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64383193|NCT02412059|Antiemetics|antiemetics|mesh-ancestor
64436982|NCT05808582|Fulvestrant|fulvestrant|mesh-list
64436983|NCT05808582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64771777|NCT01216410|Serotonin Agents|serotonin agents|mesh-ancestor
64771778|NCT01216410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64771779|NCT01216410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771780|NCT01216410|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64771781|NCT01216410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64771782|NCT01216410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64771783|NCT01216410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64771784|NCT01216410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64771785|NCT01216410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64771786|NCT01216410|Mydriatics|mydriatics|mesh-ancestor
64771787|NCT01216410|Sympathomimetics|sympathomimetics|mesh-ancestor
64771788|NCT01216410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64771789|NCT01216410|Nasal Decongestants|nasal decongestants|mesh-ancestor
64771790|NCT01216410|Respiratory System Agents|respiratory system agents|mesh-ancestor
64771791|NCT01216410|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64771792|NCT01216410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64771793|NCT01216410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64771794|NCT01216410|Adrenergic Agents|adrenergic agents|mesh-ancestor
64771795|NCT01216410|Protective Agents|protective agents|mesh-ancestor
64771796|NCT01216410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64771797|NCT01216410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64771798|NCT01216410|Dopamine Agents|dopamine agents|mesh-ancestor
64771799|NCT01218048|Carboplatin|carboplatin|mesh-list
64771800|NCT01218048|Cetuximab|cetuximab|mesh-list
64771801|NCT01218048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383225|NCT05520645|Anesthetics|anesthetics|mesh-ancestor
64656425|NCT04337177|Alkylating Agents|alkylating agents|mesh-ancestor
64437341|NCT05496192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64437342|NCT05496192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437343|NCT05472623|Nivolumab|nivolumab|mesh-list
64437344|NCT05472623|Adagrasib|adagrasib|mesh-list
64437345|NCT05472623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64437346|NCT05472623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64771806|NCT01218984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64771807|NCT01218984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64771808|NCT01218984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771809|NCT01218984|Sensory System Agents|sensory system agents|mesh-ancestor
64771810|NCT01218984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64771811|NCT01218984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64771812|NCT01218984|Narcotics|narcotics|mesh-ancestor
64771813|NCT01218984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64771814|NCT01218984|Analgesics|analgesics|mesh-ancestor
64771815|NCT01222260|Dexamethasone|dexamethasone|mesh-list
64771816|NCT01222260|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64771817|NCT01222260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64771818|NCT01222260|Antiemetics|antiemetics|mesh-ancestor
64771819|NCT01222260|Autonomic Agents|autonomic agents|mesh-ancestor
64771820|NCT01222260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64771821|NCT01222260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771822|NCT01222260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64771823|NCT01222260|Glucocorticoids|glucocorticoids|mesh-ancestor
64771824|NCT01222260|Hormones|hormones|mesh-ancestor
64771825|NCT01222260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64437390|NCT05386030|Sensory System Agents|sensory system agents|mesh-ancestor
64437391|NCT05386030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64771836|NCT01222572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771837|NCT01222572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771842|NCT01223352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64771843|NCT01223352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771844|NCT01224210|Ambrisentan|ambrisentan|mesh-list
64656436|NCT00982592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656441|NCT00982592|Antidotes|antidotes|mesh-ancestor
64771845|NCT01224210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64771846|NCT01224678|Vitamin D|vitamin d|mesh-list
64771847|NCT01224678|Vitamins|vitamins|mesh-ancestor
64771848|NCT01224678|Micronutrients|micronutrients|mesh-ancestor
64771849|NCT01224678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771850|NCT01224678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64771851|NCT01225068|Milnacipran|milnacipran|mesh-list
64771852|NCT01225068|Levomilnacipran|levomilnacipran|mesh-list
64771853|NCT01225068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64771854|NCT01225068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64383281|NCT02044510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64323393|NCT03720613|Sensory System Agents|sensory system agents|mesh-ancestor
64323394|NCT03720613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64323395|NCT02709512|Cisplatin|cisplatin|mesh-list
64323396|NCT02709512|Pemetrexed|pemetrexed|mesh-list
64323397|NCT02709512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323398|NCT02709512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323399|NCT02709512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323400|NCT02709512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64323401|NCT02709512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64323402|NCT03699475|Cyclophosphamide|cyclophosphamide|mesh-list
64323403|NCT03699475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64323404|NCT03699475|Immunologic Factors|immunologic factors|mesh-ancestor
64323405|NCT03699475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323406|NCT03699475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64437569|NCT05173987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437571|NCT05153226|Cyclophosphamide|cyclophosphamide|mesh-list
64323407|NCT03699475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64323408|NCT03699475|Alkylating Agents|alkylating agents|mesh-ancestor
64771855|NCT01225068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64771856|NCT01225068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771857|NCT01225068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64656608|NCT02447250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64771858|NCT01225068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771859|NCT01225068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64771861|NCT01225068|Sensory System Agents|sensory system agents|mesh-ancestor
64771862|NCT01225068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64771863|NCT01225068|Antidepressive Agents|antidepressive agents|mesh-ancestor
64771864|NCT01225068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64771865|NCT01226706|Botulinum Toxins|botulinum toxins|mesh-list
64771866|NCT01226706|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64437606|NCT05129748|Sodium thiosulfate|sodium thiosulfate|mesh-list
64437608|NCT05129748|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64437609|NCT05129748|Diuretics|diuretics|mesh-ancestor
64437610|NCT05129748|Natriuretic Agents|natriuretic agents|mesh-ancestor
64771875|NCT01226706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64771877|NCT01231230|Xhance|xhance|mesh-list
64323409|NCT03699475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323410|NCT03699475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323411|NCT03699475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64323412|NCT03659929|Amphetamine|amphetamine|mesh-list
64656722|NCT01031420|Antimetabolites|antimetabolites|mesh-ancestor
64323413|NCT03659929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64323414|NCT03659929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323415|NCT03659929|Sympathomimetics|sympathomimetics|mesh-ancestor
64323416|NCT03659929|Autonomic Agents|autonomic agents|mesh-ancestor
64323417|NCT03659929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64323418|NCT03659929|Dopamine Agents|dopamine agents|mesh-ancestor
64323419|NCT03659929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64771888|NCT01231230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64771889|NCT01231230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64771890|NCT01231230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64771891|NCT01231230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64771892|NCT01231230|Adrenergic Agents|adrenergic agents|mesh-ancestor
64771893|NCT01231230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64656790|NCT01003106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64437739|NCT04930887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64771894|NCT01231230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771896|NCT01231230|Hormones|hormones|mesh-ancestor
64771897|NCT01231230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64771898|NCT01231230|Sympathomimetics|sympathomimetics|mesh-ancestor
64771899|NCT01232946|Insulin|insulin|mesh-list
64771900|NCT01232946|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64771901|NCT01232946|Liraglutide|liraglutide|mesh-list
64771902|NCT01232946|Insulin Detemir|insulin detemir|mesh-list
64771903|NCT01232946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64771904|NCT01232946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771905|NCT01232946|Incretins|incretins|mesh-ancestor
64771906|NCT01232946|Hormones|hormones|mesh-ancestor
64540545|NCT01525628|Anesthetics, General|anesthetics, general|mesh-ancestor
64383331|NCT02410499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64437792|NCT04895358|Mitosis Modulators|mitosis modulators|mesh-ancestor
64323427|NCT02811679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323428|NCT03448081|Calcipotriene|calcipotriene|mesh-list
64323429|NCT03448081|Dermatologic Agents|dermatologic agents|mesh-ancestor
64323430|NCT04721977|Capecitabine|capecitabine|mesh-list
64771907|NCT01232946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64771909|NCT01235910|Cyclosporins|cyclosporins|mesh-list
64771910|NCT01235910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64771911|NCT01235910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64771912|NCT01235910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64771913|NCT01235910|Immunologic Factors|immunologic factors|mesh-ancestor
64771914|NCT01235910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771915|NCT01235910|Antifungal Agents|antifungal agents|mesh-ancestor
64771916|NCT01235910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64771917|NCT01235910|Dermatologic Agents|dermatologic agents|mesh-ancestor
64771918|NCT01235910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64437858|NCT04818749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64437859|NCT04815902|Losartan|losartan|mesh-list
64437860|NCT04815902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64437865|NCT04807140|Paclitaxel|paclitaxel|mesh-list
64771919|NCT01235910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64771920|NCT01236378|Sirolimus|sirolimus|mesh-list
64771921|NCT01236378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64771922|NCT01236378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64771923|NCT01236378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64771924|NCT01236378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383423|NCT02409407|Alprostadil|alprostadil|mesh-list
64383424|NCT02409407|Misoprostol|misoprostol|mesh-list
64383425|NCT02409407|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64383426|NCT02409407|Abortifacient Agents|abortifacient agents|mesh-ancestor
64771962|NCT01247220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446196|NCT02217332|Pramipexole|pramipexole|mesh-list
64771963|NCT01247220|Growth Inhibitors|growth inhibitors|mesh-ancestor
64771964|NCT01247220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64771965|NCT01249872|Morphine|morphine|mesh-list
64771966|NCT01249872|Levobupivacaine|levobupivacaine|mesh-list
64771967|NCT01249872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64771968|NCT01249872|Narcotics|narcotics|mesh-ancestor
64771969|NCT01249872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64771970|NCT01249872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64771976|NCT01250184|Lidocaine|lidocaine|mesh-list
64772019|NCT01254396|Urological Agents|urological agents|mesh-ancestor
64772020|NCT01254552|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
64772022|NCT01254552|Sequestering Agents|sequestering agents|mesh-ancestor
64772023|NCT01254552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772024|NCT01258374|Raltegravir Potassium|raltegravir potassium|mesh-list
64772025|NCT01258374|Darunavir|darunavir|mesh-list
64772026|NCT01258374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64772027|NCT01258374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64772028|NCT01258374|Antiviral Agents|antiviral agents|mesh-ancestor
64772029|NCT01258374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64772030|NCT01258374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64772031|NCT01258374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64772032|NCT01258374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772033|NCT01258374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437924|NCT04657081|Venetoclax|venetoclax|mesh-list
64437925|NCT04657081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64437926|NCT04657081|Antimetabolites|antimetabolites|mesh-ancestor
64772078|NCT01271244|Serotonin Agents|serotonin agents|mesh-ancestor
64772079|NCT01271244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772080|NCT01271244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64657141|NCT05135858|Methotrexate|methotrexate|mesh-list
64657147|NCT05135858|Antimetabolites|antimetabolites|mesh-ancestor
64772081|NCT01271244|Antidepressive Agents|antidepressive agents|mesh-ancestor
64772082|NCT01271244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64772083|NCT01272960|Levonorgestrel|levonorgestrel|mesh-list
64772084|NCT01272960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64772085|NCT01272960|Contraceptive Agents|contraceptive agents|mesh-ancestor
64772086|NCT01272960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64772087|NCT01272960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772088|NCT01272960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64772089|NCT01272960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64772090|NCT01272960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64772091|NCT01275300|Aspirin|aspirin|mesh-list
64772092|NCT01275300|Niacin|niacin|mesh-list
64772093|NCT01275300|Niacinamide|niacinamide|mesh-list
64772094|NCT01275300|Nicotinic Acids|nicotinic acids|mesh-list
64772095|NCT01275300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64772096|NCT01275300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64772097|NCT01275300|Analgesics|analgesics|mesh-ancestor
64772098|NCT01275300|Sensory System Agents|sensory system agents|mesh-ancestor
64772099|NCT01275300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772100|NCT01275300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772101|NCT01275300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64772102|NCT01275300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64772103|NCT01275300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64438016|NCT04493203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64772105|NCT01275300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772106|NCT01275300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64772123|NCT01276314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772124|NCT01276314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64772125|NCT01276314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64772126|NCT01276314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772127|NCT01276314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64772128|NCT01276314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64772129|NCT01276314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64772130|NCT01276314|Analgesics|analgesics|mesh-ancestor
64772131|NCT01276314|Sensory System Agents|sensory system agents|mesh-ancestor
64772132|NCT01276314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64772133|NCT01276314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64772134|NCT01276314|Immunologic Factors|immunologic factors|mesh-ancestor
64772135|NCT01280058|Paclitaxel|paclitaxel|mesh-list
64772136|NCT01280058|Carboplatin|carboplatin|mesh-list
64772137|NCT01280058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64772138|NCT01280058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64772139|NCT01280058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64772141|NCT01280058|Antimitotic Agents|antimitotic agents|mesh-ancestor
64772142|NCT01280058|Mitosis Modulators|mitosis modulators|mesh-ancestor
64772143|NCT01280058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772144|NCT01280604|Fenofibrate|fenofibrate|mesh-list
64772145|NCT01280604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64772146|NCT01280604|Antimetabolites|antimetabolites|mesh-ancestor
64772147|NCT01280604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772157|NCT01285050|Antiviral Agents|antiviral agents|mesh-ancestor
64772158|NCT01285050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64772159|NCT01285050|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64772160|NCT01285050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64772161|NCT01285050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772162|NCT01285050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772163|NCT01285050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64772164|NCT01285050|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64772165|NCT01285050|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64772166|NCT01286454|Fesoterodine|fesoterodine|mesh-list
64772167|NCT01286454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64772168|NCT01286454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64772169|NCT01286454|Cholinergic Agents|cholinergic agents|mesh-ancestor
64772170|NCT01286454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64772171|NCT01286454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772172|NCT01286454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772173|NCT01286454|Urological Agents|urological agents|mesh-ancestor
64772174|NCT01287078|Cyclosporine|cyclosporine|mesh-list
64772175|NCT01287078|Cyclosporins|cyclosporins|mesh-list
64772176|NCT01287078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772177|NCT01287078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772178|NCT01287078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64772179|NCT01287078|Immunologic Factors|immunologic factors|mesh-ancestor
64438318|NCT04024462|Immunologic Factors|immunologic factors|mesh-ancestor
64772196|NCT01292304|Tolvaptan|tolvaptan|mesh-list
64772197|NCT01292304|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64657422|NCT01037192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64772198|NCT01292304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772199|NCT01292304|Natriuretic Agents|natriuretic agents|mesh-ancestor
64772200|NCT01292304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772201|NCT01293396|Insulin|insulin|mesh-list
64772202|NCT01293396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64772203|NCT01293396|Insulin Aspart|insulin aspart|mesh-list
64540852|NCT00868179|Dabigatran|dabigatran|mesh-list
64772205|NCT01293396|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64772206|NCT01293396|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64772207|NCT01293396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64772208|NCT01293396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772209|NCT01294098|Bupivacaine|bupivacaine|mesh-list
64772210|NCT01294098|Anesthetics, Local|anesthetics, local|mesh-ancestor
64772211|NCT01294098|Anesthetics|anesthetics|mesh-ancestor
64772214|NCT01294098|Sensory System Agents|sensory system agents|mesh-ancestor
64772223|NCT01295112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64657492|NCT02179892|Anesthetics|anesthetics|mesh-ancestor
64772224|NCT01295112|Growth Substances|growth substances|mesh-ancestor
64772225|NCT01295112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772226|NCT01295112|Growth Inhibitors|growth inhibitors|mesh-ancestor
64772227|NCT01295112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64772229|NCT01295112|Autonomic Agents|autonomic agents|mesh-ancestor
64772230|NCT01295112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772231|NCT01295112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64772236|NCT01295112|Protease Inhibitors|protease inhibitors|mesh-ancestor
64772237|NCT01295112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657544|NCT02178800|Antiviral Agents|antiviral agents|mesh-ancestor
64772238|NCT01295112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772239|NCT01301742|Empagliflozin|empagliflozin|mesh-list
64772240|NCT01301742|Gemfibrozil|gemfibrozil|mesh-list
64772241|NCT01301742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64772242|NCT01301742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772243|NCT01301742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64772244|NCT01301742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772245|NCT01301742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64772246|NCT01301742|Antimetabolites|antimetabolites|mesh-ancestor
64772247|NCT01301742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64772248|NCT01301742|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64772249|NCT01301742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64772250|NCT01301742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772251|NCT01304082|Lidocaine|lidocaine|mesh-list
64772252|NCT01304082|Anesthetics, Local|anesthetics, local|mesh-ancestor
64772253|NCT01304082|Anesthetics|anesthetics|mesh-ancestor
64657680|NCT01116986|Nicotine|nicotine|mesh-list
64438367|NCT03977012|Analgesics|analgesics|mesh-ancestor
64438368|NCT03977012|Sensory System Agents|sensory system agents|mesh-ancestor
64438369|NCT03977012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64438370|NCT03977012|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64438378|NCT03927274|Topotecan|topotecan|mesh-list
64772275|NCT01304238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64772276|NCT01304238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64772277|NCT01304238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64772278|NCT01305252|Treprostinil|treprostinil|mesh-list
64772279|NCT01305252|Tadalafil|tadalafil|mesh-list
64772280|NCT01305252|Vasodilator Agents|vasodilator agents|mesh-ancestor
64772281|NCT01305252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64772282|NCT01305252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64772283|NCT01305252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772284|NCT01305252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772285|NCT01305252|Urological Agents|urological agents|mesh-ancestor
64772286|NCT01305252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64772287|NCT01308060|Botulinum Toxins|botulinum toxins|mesh-list
64772288|NCT01308060|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64772289|NCT01308060|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64772290|NCT01308060|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64772300|NCT01308294|Immunologic Factors|immunologic factors|mesh-ancestor
64772301|NCT01308294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772302|NCT01308294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64772303|NCT01308840|Gemcitabine|gemcitabine|mesh-list
64772304|NCT01308840|Oxaliplatin|oxaliplatin|mesh-list
64772305|NCT01308840|Panitumumab|panitumumab|mesh-list
64772306|NCT01308840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64772307|NCT01308840|Antimetabolites|antimetabolites|mesh-ancestor
64772308|NCT01308840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772309|NCT01308840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64772310|NCT01308840|Antiviral Agents|antiviral agents|mesh-ancestor
64772311|NCT01308840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64772345|NCT01312818|Autonomic Agents|autonomic agents|mesh-ancestor
64772346|NCT01312818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64657945|NCT03013322|Miotics|miotics|mesh-ancestor
64772347|NCT01312818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772348|NCT01312818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64772349|NCT01312818|Glucocorticoids|glucocorticoids|mesh-ancestor
64772350|NCT01312818|Hormones|hormones|mesh-ancestor
64772351|NCT01312818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64772352|NCT01312818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64772353|NCT01312818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64772354|NCT01312818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64772355|NCT01312818|Abortifacient Agents|abortifacient agents|mesh-ancestor
64658003|NCT02478489|Naltrexone|naltrexone|mesh-list
64772356|NCT01312818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64772357|NCT01312818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64772365|NCT01312818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64772366|NCT01312818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64772367|NCT01312818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64772368|NCT01312818|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64772369|NCT01313520|Infliximab|infliximab|mesh-list
64772370|NCT01313520|Dermatologic Agents|dermatologic agents|mesh-ancestor
64772373|NCT01315002|Nicotine|nicotine|mesh-list
64772392|NCT01315158|Anesthetics|anesthetics|mesh-ancestor
64772393|NCT01315158|Narcotics|narcotics|mesh-ancestor
64772394|NCT01315158|Analgesics|analgesics|mesh-ancestor
64772395|NCT01315158|Sensory System Agents|sensory system agents|mesh-ancestor
64772396|NCT01315158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772397|NCT01315158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64772398|NCT01315158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64772399|NCT01315158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64772400|NCT01315158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64772401|NCT01315158|GABA Modulators|gaba modulators|mesh-ancestor
64772402|NCT01315158|GABA Agents|gaba agents|mesh-ancestor
64772403|NCT01315158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64658115|NCT01129778|Omeprazole|omeprazole|mesh-list
64772404|NCT01315158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772405|NCT01318278|Dopamine|dopamine|mesh-list
64772406|NCT01318278|Vasopressins|vasopressins|mesh-list
64772407|NCT01318278|Arginine Vasopressin|arginine vasopressin|mesh-list
64772408|NCT01318278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772409|NCT01318278|Hemostatics|hemostatics|mesh-ancestor
64772410|NCT01318278|Coagulants|coagulants|mesh-ancestor
64772411|NCT01318278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64772412|NCT01318278|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64772413|NCT01318278|Natriuretic Agents|natriuretic agents|mesh-ancestor
64658201|NCT02486211|Analgesics|analgesics|mesh-ancestor
64772414|NCT01318278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64772415|NCT01318278|Sympathomimetics|sympathomimetics|mesh-ancestor
64772416|NCT01318278|Autonomic Agents|autonomic agents|mesh-ancestor
64772417|NCT01318278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772418|NCT01318278|Dopamine Agents|dopamine agents|mesh-ancestor
64772419|NCT01318278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64772420|NCT01318278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772421|NCT01318278|Protective Agents|protective agents|mesh-ancestor
64323433|NCT04721977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64323434|NCT04721977|Antimetabolites|antimetabolites|mesh-ancestor
64323435|NCT04721977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323436|NCT04721977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323437|NCT04721977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64323438|NCT04721977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64323439|NCT04721977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323440|NCT02232607|Lacidipine|lacidipine|mesh-list
64429990|NCT05023967|Metformin|metformin|mesh-list
64323443|NCT02232607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64772422|NCT01318356|Doxycycline|doxycycline|mesh-list
64772423|NCT01318356|Tetracycline|tetracycline|mesh-list
64772424|NCT01318356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64772425|NCT01318356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64772427|NCT01318356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64772428|NCT01318356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64772429|NCT01318356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64772430|NCT01318356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772431|NCT01318356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772432|NCT01321554|Lenvatinib|lenvatinib|mesh-list
64772433|NCT01321554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64772434|NCT01321554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64772435|NCT01321554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438479|NCT03768427|Antimetabolites|antimetabolites|mesh-ancestor
64438481|NCT03768427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64772436|NCT01321554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772438|NCT01324128|Sevelamer|sevelamer|mesh-list
64772439|NCT01324128|Trace Elements|trace elements|mesh-ancestor
64772440|NCT01324128|Micronutrients|micronutrients|mesh-ancestor
64772441|NCT01324128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772442|NCT01324128|Chelating Agents|chelating agents|mesh-ancestor
64772443|NCT01324128|Sequestering Agents|sequestering agents|mesh-ancestor
64772444|NCT01324128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772445|NCT01328184|Empagliflozin|empagliflozin|mesh-list
64772446|NCT01328184|Levonorgestrel|levonorgestrel|mesh-list
64772447|NCT01328184|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64772448|NCT01328184|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64772449|NCT01328184|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
64438560|NCT03598309|Curcumin|curcumin|mesh-list
64772450|NCT01328184|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64772461|NCT01328184|Estrogens|estrogens|mesh-ancestor
64772466|NCT01328184|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64772467|NCT01328184|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64772468|NCT01328964|Fluticasone|fluticasone|mesh-list
64772470|NCT01328964|Budesonide|budesonide|mesh-list
64772471|NCT01328964|Montelukast|montelukast|mesh-list
64772472|NCT01328964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64772473|NCT01328964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64772474|NCT01328964|Autonomic Agents|autonomic agents|mesh-ancestor
64772475|NCT01328964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658544|NCT01181258|Antiemetics|antiemetics|mesh-ancestor
64772476|NCT01328964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772477|NCT01328964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64772478|NCT01328964|Respiratory System Agents|respiratory system agents|mesh-ancestor
64772479|NCT01328964|Dermatologic Agents|dermatologic agents|mesh-ancestor
64772480|NCT01328964|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64772481|NCT01328964|Glucocorticoids|glucocorticoids|mesh-ancestor
64772482|NCT01328964|Hormones|hormones|mesh-ancestor
64772483|NCT01328964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64772484|NCT01328964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64772485|NCT01328964|Hormone Antagonists|hormone antagonists|mesh-ancestor
64772486|NCT01328964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64772487|NCT01328964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64772488|NCT01328964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772489|NCT01330134|Lidocaine|lidocaine|mesh-list
64772490|NCT01330134|Anesthetics, Local|anesthetics, local|mesh-ancestor
64772491|NCT01330134|Anesthetics|anesthetics|mesh-ancestor
64772492|NCT01330134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64772493|NCT01330134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772494|NCT01330134|Sensory System Agents|sensory system agents|mesh-ancestor
64772495|NCT01330134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772496|NCT01330134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64772497|NCT01330134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64658692|NCT02501265|Nicotine|nicotine|mesh-list
64438621|NCT03477175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438622|NCT03461406|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64438623|NCT03461406|Hemostatics|hemostatics|mesh-ancestor
64438624|NCT03461406|Coagulants|coagulants|mesh-ancestor
64438625|NCT03431974|Aminopterin|aminopterin|mesh-list
64438626|NCT03431974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64438627|NCT03431974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772500|NCT01330134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772502|NCT01330290|Dopamine Agonists|dopamine agonists|mesh-ancestor
64772503|NCT01330290|Dopamine Agents|dopamine agents|mesh-ancestor
64772504|NCT01330290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64658735|NCT01186250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64772505|NCT01330290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772506|NCT01330290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772507|NCT01331304|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64772508|NCT01331304|Antidepressive Agents|antidepressive agents|mesh-ancestor
64772509|NCT01331304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64772510|NCT01331304|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64772511|NCT01331304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64772512|NCT01331304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64772513|NCT01331304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772514|NCT01331694|Fluticasone|fluticasone|mesh-list
64772516|NCT01331694|Albuterol|albuterol|mesh-list
64772517|NCT01331694|Tiotropium Bromide|tiotropium bromide|mesh-list
64772518|NCT01331694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64772558|NCT01333098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64772559|NCT01333098|Luteolytic Agents|luteolytic agents|mesh-ancestor
64772560|NCT01333098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64772561|NCT01333098|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64772562|NCT01333488|Magnesium Sulfate|magnesium sulfate|mesh-list
64772563|NCT01333488|Analgesics|analgesics|mesh-ancestor
64772564|NCT01333488|Sensory System Agents|sensory system agents|mesh-ancestor
64772565|NCT01333488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658854|NCT01148420|Contraceptive Agents|contraceptive agents|mesh-ancestor
64772566|NCT01333488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772567|NCT01333488|Anesthetics|anesthetics|mesh-ancestor
64772568|NCT01333488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64772569|NCT01333488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64772570|NCT01333488|Anticonvulsants|anticonvulsants|mesh-ancestor
64658909|NCT03010202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64772571|NCT01333488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64772615|NCT01339260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64772616|NCT01339260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323451|NCT02232685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323452|NCT02232685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64323453|NCT02232685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64323454|NCT02232685|Nootropic Agents|nootropic agents|mesh-ancestor
64323455|NCT02232763|Losartan|losartan|mesh-list
64323456|NCT02232763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64323457|NCT02232763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64772626|NCT01340586|Protease Inhibitors|protease inhibitors|mesh-ancestor
64772627|NCT01340586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772628|NCT01340586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772629|NCT01340586|Anticoagulants|anticoagulants|mesh-ancestor
64772630|NCT01342770|Pioglitazone|pioglitazone|mesh-list
64772631|NCT01342770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64772632|NCT01342770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772633|NCT01343004|Teriparatide|teriparatide|mesh-list
64772634|NCT01343004|Abaloparatide|abaloparatide|mesh-list
64772635|NCT01343004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64772636|NCT01343004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772637|NCT01343004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64772638|NCT01347060|Fluticasone|fluticasone|mesh-list
64772640|NCT01347060|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64438678|NCT03279393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64438680|NCT03229499|Anastrozole|anastrozole|mesh-list
64772645|NCT01347060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772647|NCT01347060|Respiratory System Agents|respiratory system agents|mesh-ancestor
64772648|NCT01347060|Dermatologic Agents|dermatologic agents|mesh-ancestor
64772649|NCT01347060|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64772650|NCT01347060|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64772651|NCT01347060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64772652|NCT01347060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64772653|NCT01347060|Adrenergic Agents|adrenergic agents|mesh-ancestor
64772654|NCT01347060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64772655|NCT01347060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323458|NCT02232763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64323459|NCT02232763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64659172|NCT00363753|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64323460|NCT02232763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323461|NCT04294784|Paclitaxel|paclitaxel|mesh-list
64323462|NCT04294784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64772657|NCT01351740|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64772658|NCT01351740|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64659227|NCT00363909|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64772659|NCT01351740|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64772660|NCT01351740|Protease Inhibitors|protease inhibitors|mesh-ancestor
64772661|NCT01351740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772662|NCT01351740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772663|NCT01351740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64772664|NCT01351740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64772665|NCT01351740|Antiviral Agents|antiviral agents|mesh-ancestor
64772666|NCT01351740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64772667|NCT01351740|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64772668|NCT01351740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64772670|NCT01353144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64772671|NCT01353144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64772672|NCT01353144|Analgesics|analgesics|mesh-ancestor
64772673|NCT01353144|Sensory System Agents|sensory system agents|mesh-ancestor
64772674|NCT01353144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772675|NCT01353144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772676|NCT01353144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64772677|NCT01353144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64772691|NCT01363050|Ketorolac|ketorolac|mesh-list
64772711|NCT01363128|Vincristine|vincristine|mesh-list
64772712|NCT01363128|Ofatumumab|ofatumumab|mesh-list
64772713|NCT01363128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64772714|NCT01363128|BB 1101|bb 1101|mesh-list
64772715|NCT01363128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64772716|NCT01363128|Immunologic Factors|immunologic factors|mesh-ancestor
64772717|NCT01363128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772718|NCT01363128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64772719|NCT01363128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64772720|NCT01363128|Alkylating Agents|alkylating agents|mesh-ancestor
64772721|NCT01363128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772722|NCT01363128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64772723|NCT01363128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64772724|NCT01363128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64772725|NCT01363128|Antiemetics|antiemetics|mesh-ancestor
64772726|NCT01363128|Autonomic Agents|autonomic agents|mesh-ancestor
64772733|NCT01363128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64772734|NCT01363128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64772736|NCT01363128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772737|NCT01363128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64772738|NCT01363128|Abortifacient Agents|abortifacient agents|mesh-ancestor
64772739|NCT01363128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64772740|NCT01363128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64772741|NCT01363128|Antimetabolites|antimetabolites|mesh-ancestor
64772742|NCT01363128|Dermatologic Agents|dermatologic agents|mesh-ancestor
64384169|NCT02040532|Gabapentin|gabapentin|mesh-list
64772743|NCT01363128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64772744|NCT01363128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64772745|NCT01363128|Antiviral Agents|antiviral agents|mesh-ancestor
64772746|NCT01363128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64772747|NCT01363128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64772748|NCT01363128|Tubulin Modulators|tubulin modulators|mesh-ancestor
64772749|NCT01363128|Antimitotic Agents|antimitotic agents|mesh-ancestor
64438738|NCT03132454|Dermatologic Agents|dermatologic agents|mesh-ancestor
64438739|NCT02966782|Azacitidine|azacitidine|mesh-list
64772750|NCT01363128|Mitosis Modulators|mitosis modulators|mesh-ancestor
64772751|NCT01363128|Protease Inhibitors|protease inhibitors|mesh-ancestor
64772753|NCT01365624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64772754|NCT01365624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64772755|NCT01365624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64772757|NCT01365624|Sensory System Agents|sensory system agents|mesh-ancestor
64772758|NCT01365624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772759|NCT01365624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659598|NCT03069963|Antacids|antacids|mesh-ancestor
64772760|NCT01365624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64772761|NCT01365624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64772762|NCT01365624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64772763|NCT01365624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772764|NCT01365624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772795|NCT01377636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64772797|NCT01377636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64772798|NCT01377636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64772799|NCT01377636|Respiratory System Agents|respiratory system agents|mesh-ancestor
64772800|NCT01377636|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64772801|NCT01377636|Sympathomimetics|sympathomimetics|mesh-ancestor
64772802|NCT01377636|Protective Agents|protective agents|mesh-ancestor
64772803|NCT01378416|Decitabine|decitabine|mesh-list
64772804|NCT01378416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64772805|NCT01378416|Antimetabolites|antimetabolites|mesh-ancestor
64772806|NCT01378416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772807|NCT01378416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64772808|NCT01378416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772809|NCT01379664|Sevoflurane|sevoflurane|mesh-list
64772810|NCT01379664|Isoflurane|isoflurane|mesh-list
64772811|NCT01379664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64772812|NCT01379664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64772813|NCT01379664|Anesthetics, General|anesthetics, general|mesh-ancestor
64659710|NCT01213316|Raltegravir Potassium|raltegravir potassium|mesh-list
64772814|NCT01379664|Anesthetics|anesthetics|mesh-ancestor
64772815|NCT01379664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64772816|NCT01379664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772817|NCT01380366|Hormones|hormones|mesh-list
64659769|NCT00003407|Protective Agents|protective agents|mesh-ancestor
64772818|NCT01380366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64772819|NCT01380366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772845|NCT01390818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772847|NCT01390818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64772848|NCT01390818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64772849|NCT01390818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64772850|NCT01390818|Antifungal Agents|antifungal agents|mesh-ancestor
64772851|NCT01390818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64772852|NCT01390818|Immunologic Factors|immunologic factors|mesh-ancestor
64772853|NCT01391286|Bimatoprost|bimatoprost|mesh-list
64772854|NCT01391286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64772855|NCT01391286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64772856|NCT01391364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64772857|NCT01393392|Methadone|methadone|mesh-list
64772858|NCT01393392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64772859|NCT01393392|Narcotics|narcotics|mesh-ancestor
64772860|NCT01393392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64772861|NCT01393392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772862|NCT01393392|Analgesics|analgesics|mesh-ancestor
64772863|NCT01393392|Sensory System Agents|sensory system agents|mesh-ancestor
64772864|NCT01393392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659904|NCT01715207|Sympatholytics|sympatholytics|mesh-ancestor
64772865|NCT01393392|Antitussive Agents|antitussive agents|mesh-ancestor
64772866|NCT01393392|Respiratory System Agents|respiratory system agents|mesh-ancestor
64772867|NCT01393704|Vasopressins|vasopressins|mesh-list
64772868|NCT01393704|Arginine Vasopressin|arginine vasopressin|mesh-list
64772869|NCT01393704|Hemostatics|hemostatics|mesh-ancestor
64772870|NCT01393704|Coagulants|coagulants|mesh-ancestor
64772871|NCT01393704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64772872|NCT01393704|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64772873|NCT01393704|Natriuretic Agents|natriuretic agents|mesh-ancestor
64772874|NCT01393704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772875|NCT01399008|Colchicine|colchicine|mesh-list
64772876|NCT01399008|Allopurinol|allopurinol|mesh-list
64772877|NCT01399008|Gout Suppressants|gout suppressants|mesh-ancestor
64772878|NCT01399008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64772889|NCT01399008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772890|NCT01399866|Cycloserine|cycloserine|mesh-list
64772891|NCT01399866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64772892|NCT01399866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64772893|NCT01399866|Renal Agents|renal agents|mesh-ancestor
64772894|NCT01399866|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64772895|NCT01399866|Antitubercular Agents|antitubercular agents|mesh-ancestor
64772896|NCT01399866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64772897|NCT01399866|Antimetabolites|antimetabolites|mesh-ancestor
64772898|NCT01399866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772899|NCT01402050|Dinoprostone|dinoprostone|mesh-list
64772900|NCT01402050|Oxytocics|oxytocics|mesh-ancestor
64772901|NCT01402050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64772902|NCT01402050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772903|NCT01403376|Interferons|interferons|mesh-list
64772904|NCT01403376|Interferon-beta|interferon-beta|mesh-list
64772905|NCT01403376|Teriflunomide|teriflunomide|mesh-list
64772906|NCT01403376|Interferon beta-1b|interferon beta-1b|mesh-list
64438923|NCT02286726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64772907|NCT01403376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64772908|NCT01403376|Antiviral Agents|antiviral agents|mesh-ancestor
64772909|NCT01403376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64772910|NCT01403376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64772911|NCT01403376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64772912|NCT01403376|Analgesics|analgesics|mesh-ancestor
64772913|NCT01403376|Sensory System Agents|sensory system agents|mesh-ancestor
64772941|NCT01404936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64439001|NCT01974440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64439002|NCT01974440|Tubulin Modulators|tubulin modulators|mesh-ancestor
64439003|NCT01974440|Antimitotic Agents|antimitotic agents|mesh-ancestor
64772951|NCT01410084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64772952|NCT01410084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64772953|NCT01410084|Antioxidants|antioxidants|mesh-ancestor
64660153|NCT02597907|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64772954|NCT01410084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772955|NCT01410084|Protective Agents|protective agents|mesh-ancestor
64772956|NCT01413516|Varenicline|varenicline|mesh-list
64772957|NCT01413516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64772958|NCT01413516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64772959|NCT01413516|Cholinergic Agents|cholinergic agents|mesh-ancestor
64772960|NCT01413516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64772961|NCT01413516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772962|NCT01413516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772963|NCT01413750|Paclitaxel|paclitaxel|mesh-list
64772964|NCT01413750|Carboplatin|carboplatin|mesh-list
64772965|NCT01413750|Vorinostat|vorinostat|mesh-list
64772966|NCT01413750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64772967|NCT01413750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64772968|NCT01413750|Tubulin Modulators|tubulin modulators|mesh-ancestor
64772969|NCT01413750|Antimitotic Agents|antimitotic agents|mesh-ancestor
64772970|NCT01413750|Mitosis Modulators|mitosis modulators|mesh-ancestor
64772971|NCT01413750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772972|NCT01413750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64323470|NCT02262559|Telmisartan|telmisartan|mesh-list
64323471|NCT02262559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64323472|NCT02262559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64772974|NCT01417026|Oxytocin|oxytocin|mesh-list
64772975|NCT01417026|Oxytocics|oxytocics|mesh-ancestor
64772976|NCT01417026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64772977|NCT01417026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772978|NCT01420146|Trastuzumab|trastuzumab|mesh-list
64772979|NCT01420146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64772980|NCT01420146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64772981|NCT01421472|Paclitaxel|paclitaxel|mesh-list
64772982|NCT01421472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64772983|NCT01421472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64772984|NCT01421472|Tubulin Modulators|tubulin modulators|mesh-ancestor
64772985|NCT01421472|Antimitotic Agents|antimitotic agents|mesh-ancestor
64772986|NCT01421472|Mitosis Modulators|mitosis modulators|mesh-ancestor
64772987|NCT01421472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772988|NCT01428336|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64772989|NCT01428336|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64772990|NCT01428336|Cosyntropin|cosyntropin|mesh-list
64772991|NCT01428336|beta-Endorphin|beta-endorphin|mesh-list
64772992|NCT01428336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64772993|NCT01428336|Hormones|hormones|mesh-ancestor
64772994|NCT01428336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64772995|NCT01428336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64772996|NCT01428336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64772997|NCT01429272|Aspirin|aspirin|mesh-list
64772998|NCT01429272|Minocycline|minocycline|mesh-list
64772999|NCT01429272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64773000|NCT01429272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64773001|NCT01429272|Analgesics|analgesics|mesh-ancestor
64773002|NCT01429272|Sensory System Agents|sensory system agents|mesh-ancestor
64773003|NCT01429272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773004|NCT01429272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323473|NCT02262559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64323474|NCT02262559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323475|NCT05491460|Rivaroxaban|rivaroxaban|mesh-list
64323476|NCT05491460|Apixaban|apixaban|mesh-list
64323477|NCT05491460|Edoxaban|edoxaban|mesh-list
64323478|NCT05491460|Dabigatran|dabigatran|mesh-list
64323479|NCT05491460|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64323480|NCT05491460|Antithrombins|antithrombins|mesh-ancestor
64323481|NCT05491460|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64660365|NCT01243112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64323482|NCT05491460|Protease Inhibitors|protease inhibitors|mesh-ancestor
64773005|NCT01429272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64773006|NCT01429272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64773007|NCT01429272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64773008|NCT01429272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64773010|NCT01429272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64773011|NCT01429272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64773012|NCT01429272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773014|NCT01429272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64773015|NCT01429272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64773016|NCT01429350|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64773017|NCT01429350|Plasminogen|plasminogen|mesh-list
64773018|NCT01429350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64660430|NCT01246076|Lenalidomide|lenalidomide|mesh-list
64773019|NCT01429350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64773020|NCT01429350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773021|NCT01432236|Pregabalin|pregabalin|mesh-list
64773022|NCT01432236|Analgesics|analgesics|mesh-ancestor
64773023|NCT01432236|Sensory System Agents|sensory system agents|mesh-ancestor
64773024|NCT01432236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773025|NCT01432236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773026|NCT01432236|Anticonvulsants|anticonvulsants|mesh-ancestor
64773027|NCT01432236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64773028|NCT01432236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64773029|NCT01432236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773030|NCT01432236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64773031|NCT01432236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64773032|NCT01432236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64323483|NCT05491460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323484|NCT05491460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323485|NCT05491460|Anticoagulants|anticoagulants|mesh-ancestor
64323486|NCT03311269|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
64323487|NCT03311269|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64323488|NCT03311269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64323489|NCT02762929|Bupivacaine|bupivacaine|mesh-list
64323490|NCT02762929|Anesthetics, Local|anesthetics, local|mesh-ancestor
64323491|NCT02762929|Anesthetics|anesthetics|mesh-ancestor
64323492|NCT02762929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64323493|NCT02762929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323494|NCT02762929|Sensory System Agents|sensory system agents|mesh-ancestor
64323495|NCT02762929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64323497|NCT02262637|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
64323498|NCT02262637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64773033|NCT01432236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64773034|NCT01432236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64773036|NCT01434186|Saxagliptin|saxagliptin|mesh-list
64773037|NCT01434186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64773038|NCT01434186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773039|NCT01434186|Incretins|incretins|mesh-ancestor
64773040|NCT01434186|Hormones|hormones|mesh-ancestor
64773041|NCT01434186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64773042|NCT01434186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64439104|NCT00667069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439108|NCT00565851|Gemcitabine|gemcitabine|mesh-list
64773043|NCT01434186|Protease Inhibitors|protease inhibitors|mesh-ancestor
64773044|NCT01434186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773045|NCT01434186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773046|NCT01434342|Nicotine|nicotine|mesh-list
64773047|NCT01434342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64660572|NCT05730621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64773048|NCT01434342|Autonomic Agents|autonomic agents|mesh-ancestor
64773049|NCT01434342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773050|NCT01434342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773051|NCT01434342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64773052|NCT01434342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64773053|NCT01434342|Cholinergic Agents|cholinergic agents|mesh-ancestor
64773054|NCT01434342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64773055|NCT01434342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773056|NCT01435824|Amoxicillin|amoxicillin|mesh-list
64773083|NCT01444716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773084|NCT01444716|Immunologic Factors|immunologic factors|mesh-ancestor
64773085|NCT01444716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773087|NCT01445028|Dermatologic Agents|dermatologic agents|mesh-ancestor
64773088|NCT01452126|Ropivacaine|ropivacaine|mesh-list
64773089|NCT01452126|Anesthetics, Local|anesthetics, local|mesh-ancestor
64773090|NCT01452126|Anesthetics|anesthetics|mesh-ancestor
64773091|NCT01452126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64773092|NCT01452126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773093|NCT01452126|Sensory System Agents|sensory system agents|mesh-ancestor
64773094|NCT01452126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773095|NCT01457430|Icatibant|icatibant|mesh-list
64773096|NCT01457430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64773097|NCT01457430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64773098|NCT01457430|Analgesics|analgesics|mesh-ancestor
64773099|NCT01457430|Sensory System Agents|sensory system agents|mesh-ancestor
64439262|NCT05652517|Ethanol|ethanol|mesh-list
64773113|NCT01458990|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64773114|NCT01458990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773115|NCT01458990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773116|NCT01460940|Lenalidomide|lenalidomide|mesh-list
64773117|NCT01460940|Panobinostat|panobinostat|mesh-list
64773118|NCT01460940|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
64439305|NCT04567108|Sensory System Agents|sensory system agents|mesh-ancestor
64439306|NCT04567108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773119|NCT01460940|Immunologic Factors|immunologic factors|mesh-ancestor
64773120|NCT01460940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773121|NCT01460940|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64773122|NCT01460940|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64773123|NCT01460940|Growth Substances|growth substances|mesh-ancestor
64773124|NCT01460940|Growth Inhibitors|growth inhibitors|mesh-ancestor
64773125|NCT01460940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773126|NCT01460940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773127|NCT01460940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773128|NCT01462812|Sumatriptan|sumatriptan|mesh-list
64773129|NCT01462812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64773130|NCT01462812|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64773131|NCT01462812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64660748|NCT04590963|Cetuximab|cetuximab|mesh-list
64660756|NCT01248104|Hemostatics|hemostatics|mesh-ancestor
64773132|NCT01462812|Serotonin Agents|serotonin agents|mesh-ancestor
64773133|NCT01462812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64773134|NCT01462812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773135|NCT01462812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773136|NCT01463202|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64773137|NCT01463202|Medroxyprogesterone|medroxyprogesterone|mesh-list
64773138|NCT01463202|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64773158|NCT01468350|4-Aminopyridine|4-aminopyridine|mesh-list
64773159|NCT01468350|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64773160|NCT01468350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64773161|NCT01468350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773162|NCT01468584|Ribavirin|ribavirin|mesh-list
64773163|NCT01468584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64439354|NCT01974141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773165|NCT01468584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773166|NCT01468584|Antiviral Agents|antiviral agents|mesh-ancestor
64773167|NCT01468584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64773168|NCT01472874|Trientine|trientine|mesh-list
64773169|NCT01472874|Chelating Agents|chelating agents|mesh-ancestor
64773170|NCT01472874|Sequestering Agents|sequestering agents|mesh-ancestor
64773171|NCT01472874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773172|NCT01474122|Macitentan|macitentan|mesh-list
64773173|NCT01474122|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64773174|NCT01474122|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64773177|NCT01474200|Furosemide|furosemide|mesh-list
64773214|NCT01479270|Anesthetics, Local|anesthetics, local|mesh-ancestor
64773215|NCT01479270|Anesthetics|anesthetics|mesh-ancestor
64773216|NCT01479270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64773217|NCT01479270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773218|NCT01479270|Sensory System Agents|sensory system agents|mesh-ancestor
64773219|NCT01479270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773220|NCT01479270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64773221|NCT01479270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64660843|NCT01312844|Scopolamine|scopolamine|mesh-list
64660844|NCT01312844|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64660846|NCT01312844|Antiemetics|antiemetics|mesh-ancestor
64660847|NCT01312844|Autonomic Agents|autonomic agents|mesh-ancestor
64660848|NCT01312844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64660858|NCT01750931|Meloxicam|meloxicam|mesh-list
64773222|NCT01479270|Adrenergic Agents|adrenergic agents|mesh-ancestor
64773223|NCT01479270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64773224|NCT01479270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773225|NCT01479270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64773226|NCT01479270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64773227|NCT01479270|Autonomic Agents|autonomic agents|mesh-ancestor
64773230|NCT01479270|Mydriatics|mydriatics|mesh-ancestor
64773274|NCT01495572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64773275|NCT01504854|Resveratrol|resveratrol|mesh-list
64773276|NCT01504854|Antioxidants|antioxidants|mesh-ancestor
64773277|NCT01504854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773278|NCT01504854|Protective Agents|protective agents|mesh-ancestor
64660890|NCT01752413|Ferrous gluconate|ferrous gluconate|mesh-list
64773279|NCT01504854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773280|NCT01504854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773281|NCT01504854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64773282|NCT01508832|Lidocaine|lidocaine|mesh-list
64773283|NCT01508832|Bupivacaine|bupivacaine|mesh-list
64773284|NCT01508832|Anesthetics, Local|anesthetics, local|mesh-ancestor
64773285|NCT01508832|Anesthetics|anesthetics|mesh-ancestor
64773286|NCT01508832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64439383|NCT01961349|Anesthetics|anesthetics|mesh-ancestor
64439387|NCT01944969|Brexpiprazole|brexpiprazole|mesh-list
64773288|NCT01508832|Sensory System Agents|sensory system agents|mesh-ancestor
64660929|NCT01250834|Antimetabolites|antimetabolites|mesh-ancestor
64773289|NCT01508832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773290|NCT01508832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64773291|NCT01508832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64773292|NCT01508832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64773293|NCT01508832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64773294|NCT01508832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773295|NCT01511640|Pregabalin|pregabalin|mesh-list
64773296|NCT01511640|Analgesics|analgesics|mesh-ancestor
64773297|NCT01511640|Sensory System Agents|sensory system agents|mesh-ancestor
64773298|NCT01511640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773299|NCT01511640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773300|NCT01511640|Anticonvulsants|anticonvulsants|mesh-ancestor
64773301|NCT01511640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64773302|NCT01511640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64773303|NCT01511640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773304|NCT01511640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64773305|NCT01511640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64323499|NCT02262637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64323502|NCT02262637|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64323503|NCT02262637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64323505|NCT02262637|Natriuretic Agents|natriuretic agents|mesh-ancestor
64323506|NCT02262637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323507|NCT03301051|Vaccines|vaccines|mesh-list
64323508|NCT03301051|Immunologic Factors|immunologic factors|mesh-ancestor
64773306|NCT01511640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64773307|NCT01511640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64773308|NCT01511640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64773309|NCT01513122|Ritonavir|ritonavir|mesh-list
64773310|NCT01513122|Lopinavir|lopinavir|mesh-list
64773311|NCT01513122|Raltegravir Potassium|raltegravir potassium|mesh-list
64773312|NCT01513122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64773313|NCT01513122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64773314|NCT01513122|Protease Inhibitors|protease inhibitors|mesh-ancestor
64773315|NCT01513122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773316|NCT01513122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773317|NCT01513122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64773318|NCT01513122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64773319|NCT01513122|Antiviral Agents|antiviral agents|mesh-ancestor
64773320|NCT01513122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64773321|NCT01513122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64773322|NCT01513122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64773323|NCT01513122|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64773324|NCT01513122|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64773325|NCT01513902|Tofacitinib|tofacitinib|mesh-list
64773326|NCT01513902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64773327|NCT01513902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773328|NCT01513902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773329|NCT01515540|Lidocaine|lidocaine|mesh-list
64773357|NCT01520454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64773358|NCT01520454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64773359|NCT01520454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773382|NCT01521546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64773383|NCT01521546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773384|NCT01521546|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64773386|NCT01521546|Natriuretic Agents|natriuretic agents|mesh-ancestor
64773387|NCT01521546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64773388|NCT01523496|Vitamin D|vitamin d|mesh-list
64773389|NCT01523496|Ergocalciferols|ergocalciferols|mesh-list
64773390|NCT01523496|Cholecalciferol|cholecalciferol|mesh-list
64773391|NCT01523496|Calcifediol|calcifediol|mesh-list
64773392|NCT01523496|Vitamins|vitamins|mesh-list
64773393|NCT01523496|Micronutrients|micronutrients|mesh-ancestor
64773394|NCT01523496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773395|NCT01523496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64773396|NCT01523496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64773397|NCT01526538|Cycloserine|cycloserine|mesh-list
64661281|NCT05315999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661288|NCT01763645|Paclitaxel|paclitaxel|mesh-list
64773398|NCT01526538|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64773399|NCT01526538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64773400|NCT01526538|Renal Agents|renal agents|mesh-ancestor
64773421|NCT01532700|Ofatumumab|ofatumumab|mesh-list
64773432|NCT01534416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773433|NCT01534416|Sensory System Agents|sensory system agents|mesh-ancestor
64773434|NCT01534416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661346|NCT03009578|Hematinics|hematinics|mesh-ancestor
64773436|NCT01535664|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64773437|NCT01535664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64773438|NCT01535664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773439|NCT01535976|Ketamine|ketamine|mesh-list
64773440|NCT01535976|Analgesics|analgesics|mesh-ancestor
64773441|NCT01535976|Sensory System Agents|sensory system agents|mesh-ancestor
64773442|NCT01535976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661413|NCT04351724|Chloroquine|chloroquine|mesh-list
64773443|NCT01535976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773444|NCT01535976|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64773445|NCT01535976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64773446|NCT01535976|Anesthetics, General|anesthetics, general|mesh-ancestor
64773447|NCT01535976|Anesthetics|anesthetics|mesh-ancestor
64773448|NCT01535976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64773453|NCT01536366|Repaglinide|repaglinide|mesh-list
64773489|NCT01542372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64773490|NCT01542372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64773491|NCT01542372|Adrenergic Agents|adrenergic agents|mesh-ancestor
64773492|NCT01542372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64773493|NCT01542372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773494|NCT01542372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773496|NCT01542684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64773497|NCT01542684|Antimetabolites|antimetabolites|mesh-ancestor
64773498|NCT01542684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773499|NCT01542684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773500|NCT01542684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773501|NCT01543074|Allyl sulfide|allyl sulfide|mesh-list
64773502|NCT01543074|Antioxidants|antioxidants|mesh-ancestor
64773503|NCT01543074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773504|NCT01543074|Protective Agents|protective agents|mesh-ancestor
64773505|NCT01543074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773506|NCT01543074|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64773507|NCT01543074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773508|NCT01543074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64773509|NCT01543074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773510|NCT01545336|Anastrozole|anastrozole|mesh-list
64773511|NCT01545336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64773512|NCT01545336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773537|NCT01551888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64773538|NCT01551888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773539|NCT01553058|Adalimumab|adalimumab|mesh-list
64773540|NCT01553058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64773541|NCT01553058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64661613|NCT04769297|Anesthetics|anesthetics|mesh-ancestor
64773542|NCT01553292|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64773543|NCT01553292|Respiratory System Agents|respiratory system agents|mesh-ancestor
64773544|NCT01556724|Ropivacaine|ropivacaine|mesh-list
64773545|NCT01556724|Anesthetics, Local|anesthetics, local|mesh-ancestor
64773560|NCT01558128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773561|NCT01558128|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64773562|NCT01558128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64773563|NCT01558128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64773564|NCT01559064|Lidocaine|lidocaine|mesh-list
64773565|NCT01559064|Hyaluronic Acid|hyaluronic acid|mesh-list
64773566|NCT01559064|Anesthetics, Local|anesthetics, local|mesh-ancestor
64773567|NCT01559064|Anesthetics|anesthetics|mesh-ancestor
64773568|NCT01559064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64773569|NCT01559064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773570|NCT01559064|Sensory System Agents|sensory system agents|mesh-ancestor
64773571|NCT01559064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773572|NCT01559064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64661668|NCT05167643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64773573|NCT01559064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64773574|NCT01559064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64773575|NCT01559064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64773576|NCT01559064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773577|NCT01559064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64773578|NCT01559064|Immunologic Factors|immunologic factors|mesh-ancestor
64773579|NCT01559064|Viscosupplements|viscosupplements|mesh-ancestor
64773580|NCT01559064|Protective Agents|protective agents|mesh-ancestor
64773581|NCT01559922|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
64773582|NCT01559922|Vasodilator Agents|vasodilator agents|mesh-ancestor
64773583|NCT01559922|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64773614|NCT01565538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64773615|NCT01565538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64773616|NCT01565616|Fludarabine|fludarabine|mesh-list
64773617|NCT01565616|Busulfan|busulfan|mesh-list
64773618|NCT01565616|Thymoglobulin|thymoglobulin|mesh-list
64773619|NCT01565616|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64773620|NCT01565616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773621|NCT01565616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773622|NCT01565616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64773623|NCT01565616|Immunologic Factors|immunologic factors|mesh-ancestor
64773624|NCT01565616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773625|NCT01565616|Alkylating Agents|alkylating agents|mesh-ancestor
64773626|NCT01565616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64773627|NCT01565616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64773628|NCT01566162|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64773629|NCT01566162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64773630|NCT01566162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64773631|NCT01566162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64773632|NCT01566162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773633|NCT01566162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64773634|NCT01566162|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64773635|NCT01566162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64773636|NCT01566162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64773637|NCT01566162|Adrenergic Agents|adrenergic agents|mesh-ancestor
64773638|NCT01566162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64773639|NCT01566162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773640|NCT01566162|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64773641|NCT01566162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64773642|NCT01566162|Serotonin Agents|serotonin agents|mesh-ancestor
64773643|NCT01566162|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64773644|NCT01566162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64773645|NCT01566162|Dopamine Agents|dopamine agents|mesh-ancestor
64773646|NCT01569126|Fluoxetine|fluoxetine|mesh-list
64385078|NCT05483439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64773652|NCT01569126|Serotonin Agents|serotonin agents|mesh-ancestor
64773653|NCT01569126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773654|NCT01569126|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64773655|NCT01569126|Antidepressive Agents|antidepressive agents|mesh-ancestor
64773656|NCT01569126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64773657|NCT01569126|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64773658|NCT01569126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64773659|NCT01569126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773660|NCT01569828|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64773661|NCT01569828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64773662|NCT01569828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773663|NCT01577706|Alprazolam|alprazolam|mesh-list
64773664|NCT01577706|Dextroamphetamine|dextroamphetamine|mesh-list
64773665|NCT01577706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64773666|NCT01577706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64773667|NCT01577706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773668|NCT01577706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64773669|NCT01577706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64773670|NCT01577706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64661960|NCT01091831|Antiemetics|antiemetics|mesh-ancestor
64773671|NCT01577706|GABA Modulators|gaba modulators|mesh-ancestor
64773672|NCT01577706|GABA Agents|gaba agents|mesh-ancestor
64773673|NCT01577706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64773674|NCT01577706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773675|NCT01577706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64773676|NCT01577706|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64385117|NCT04543071|Antimetabolites|antimetabolites|mesh-ancestor
64323517|NCT02606305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323518|NCT02606305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64323519|NCT02606305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64323520|NCT02606305|Growth Substances|growth substances|mesh-ancestor
64323521|NCT02606305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323522|NCT02606305|Growth Inhibitors|growth inhibitors|mesh-ancestor
64323523|NCT02606305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64323524|NCT02606305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64323525|NCT02606305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64323526|NCT02606305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773677|NCT01577706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64773678|NCT01577706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64773680|NCT01580592|Omalizumab|omalizumab|mesh-list
64773681|NCT01580592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64773682|NCT01580592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64773683|NCT01580592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64773684|NCT01580592|Respiratory System Agents|respiratory system agents|mesh-ancestor
64773685|NCT01580592|Immunologic Factors|immunologic factors|mesh-ancestor
64773686|NCT01580592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773687|NCT01588158|Acetaminophen|acetaminophen|mesh-list
64773688|NCT01588158|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64773689|NCT01588158|Hydrocodone|hydrocodone|mesh-list
64773690|NCT01588158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64773691|NCT01588158|Analgesics|analgesics|mesh-ancestor
64773692|NCT01588158|Sensory System Agents|sensory system agents|mesh-ancestor
64773693|NCT01588158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773694|NCT01588158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773695|NCT01588158|Antipyretics|antipyretics|mesh-ancestor
64773696|NCT01588158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64773704|NCT01588470|Pioglitazone|pioglitazone|mesh-list
64773732|NCT05564832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773733|NCT05564442|Benzocaine|benzocaine|mesh-list
64773734|NCT05564442|Anesthetics, Local|anesthetics, local|mesh-ancestor
64773735|NCT05564442|Anesthetics|anesthetics|mesh-ancestor
64773736|NCT05564442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64773737|NCT05564442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773738|NCT05564442|Sensory System Agents|sensory system agents|mesh-ancestor
64773739|NCT05564442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773740|NCT05493540|Ibuprofen|ibuprofen|mesh-list
64773741|NCT05493540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64773742|NCT05493540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64773743|NCT05493540|Analgesics|analgesics|mesh-ancestor
64773744|NCT05493540|Sensory System Agents|sensory system agents|mesh-ancestor
64773745|NCT05493540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773746|NCT05493540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773747|NCT05493540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64773748|NCT05493540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64773749|NCT05493540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64773750|NCT05493540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773751|NCT05493540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773752|NCT05360784|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64773753|NCT05360784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64773754|NCT05360784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64773755|NCT05360784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64773756|NCT05360784|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64773757|NCT05360784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64773758|NCT05360784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64773759|NCT05360784|Adrenergic Agents|adrenergic agents|mesh-ancestor
64773767|NCT05672784|Sensory System Agents|sensory system agents|mesh-ancestor
64773768|NCT05672784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773769|NCT05672784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773770|NCT05672784|Antipyretics|antipyretics|mesh-ancestor
64773771|NCT05672784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64773773|NCT05672784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64773774|NCT05672784|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64773775|NCT05672784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64773776|NCT05672784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773777|NCT05672784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773778|NCT05672472|Sivelestat|sivelestat|mesh-list
64662134|NCT01793285|Etanercept|etanercept|mesh-list
64773779|NCT05672472|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64773780|NCT05672472|Protease Inhibitors|protease inhibitors|mesh-ancestor
64773781|NCT05672472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773782|NCT05672472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773783|NCT05672394|Lidocaine|lidocaine|mesh-list
64773784|NCT05672394|Epinephrine|epinephrine|mesh-list
64773785|NCT05672394|Bupivacaine|bupivacaine|mesh-list
64773786|NCT05672394|Anesthetics, Local|anesthetics, local|mesh-ancestor
64773787|NCT05672394|Anesthetics|anesthetics|mesh-ancestor
64773788|NCT05672394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64773789|NCT05672394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773790|NCT05672394|Sensory System Agents|sensory system agents|mesh-ancestor
64773791|NCT05672394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773792|NCT05672394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64773793|NCT05672394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64773794|NCT05672394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64773795|NCT05672394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64773796|NCT05672394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773797|NCT05672394|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64773798|NCT05672394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64773799|NCT05672394|Adrenergic Agents|adrenergic agents|mesh-ancestor
64773800|NCT05672394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64773801|NCT05672394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64773802|NCT05672394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64773803|NCT05672394|Autonomic Agents|autonomic agents|mesh-ancestor
64773804|NCT05672394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64773805|NCT05672394|Respiratory System Agents|respiratory system agents|mesh-ancestor
64773806|NCT05672394|Mydriatics|mydriatics|mesh-ancestor
64773825|NCT05326464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773826|NCT04887792|Acetazolamide|acetazolamide|mesh-list
64773827|NCT04887792|Anticonvulsants|anticonvulsants|mesh-ancestor
64773828|NCT04887792|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64773829|NCT04887792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773830|NCT04887792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773831|NCT04887792|Diuretics|diuretics|mesh-ancestor
64662240|NCT01332578|Vitamins|vitamins|mesh-ancestor
64773832|NCT04887792|Natriuretic Agents|natriuretic agents|mesh-ancestor
64773833|NCT04887792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773835|NCT04518228|Lopinavir|lopinavir|mesh-list
64773836|NCT04518228|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64773837|NCT04518228|Darunavir|darunavir|mesh-list
64773838|NCT04518228|Tenofovir|tenofovir|mesh-list
64773839|NCT04518228|Dolutegravir|dolutegravir|mesh-list
64773840|NCT04518228|Cobicistat|cobicistat|mesh-list
64773841|NCT04518228|Cabotegravir|cabotegravir|mesh-list
64773842|NCT04518228|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64773843|NCT04518228|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64773844|NCT04518228|Protease Inhibitors|protease inhibitors|mesh-ancestor
64773845|NCT04518228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64542516|NCT01274559|Niacin|niacin|mesh-list
64773846|NCT04518228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773847|NCT04518228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64773848|NCT04518228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64773849|NCT04518228|Antiviral Agents|antiviral agents|mesh-ancestor
64773850|NCT04518228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64773872|NCT03355170|Dexlansoprazole|dexlansoprazole|mesh-list
64773873|NCT03355170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64773874|NCT03355170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64773875|NCT03355170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64773876|NCT03355170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773877|NCT03355170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773878|NCT03355170|Antiemetics|antiemetics|mesh-ancestor
64773879|NCT03355170|Autonomic Agents|autonomic agents|mesh-ancestor
64773880|NCT03355170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662341|NCT01378988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64773881|NCT03355170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773882|NCT03355170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64773883|NCT03355170|Dopamine Agents|dopamine agents|mesh-ancestor
64773884|NCT03355170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64773886|NCT03009240|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64773887|NCT03009240|Pevonedistat|pevonedistat|mesh-list
64773888|NCT03009240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64773889|NCT03009240|Antimetabolites|antimetabolites|mesh-ancestor
64662398|NCT01734551|Clonidine|clonidine|mesh-list
64773890|NCT03009240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773891|NCT03009240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773892|NCT02760498|Cemiplimab|cemiplimab|mesh-list
64773893|NCT02760498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64773894|NCT02760498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773895|NCT02538666|Nivolumab|nivolumab|mesh-list
64773896|NCT02538666|Ipilimumab|ipilimumab|mesh-list
64773897|NCT02538666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64773898|NCT02538666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773899|NCT02538666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64773900|NCT02538666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773901|NCT02407236|Ustekinumab|ustekinumab|mesh-list
64773902|NCT02407236|Dermatologic Agents|dermatologic agents|mesh-ancestor
64773903|NCT00221598|Dialysis Solutions|dialysis solutions|mesh-list
64542579|NCT03594565|Dermatologic Agents|dermatologic agents|mesh-ancestor
64662459|NCT01799213|Meloxicam|meloxicam|mesh-list
64773920|NCT05094804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773921|NCT05094804|Tubulin Modulators|tubulin modulators|mesh-ancestor
64773922|NCT05094804|Antimitotic Agents|antimitotic agents|mesh-ancestor
64773923|NCT05094804|Mitosis Modulators|mitosis modulators|mesh-ancestor
64773924|NCT05094804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773925|NCT05094804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64323527|NCT02606305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662507|NCT02194088|Diclofenac|diclofenac|mesh-list
64323528|NCT02606305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64323529|NCT02606305|Tubulin Modulators|tubulin modulators|mesh-ancestor
64323530|NCT02606305|Antimitotic Agents|antimitotic agents|mesh-ancestor
64323531|NCT02606305|Mitosis Modulators|mitosis modulators|mesh-ancestor
64323533|NCT01662986|Tiotropium Bromide|tiotropium bromide|mesh-list
64323534|NCT01662986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64323535|NCT01662986|Autonomic Agents|autonomic agents|mesh-ancestor
64323536|NCT01662986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64323537|NCT01662986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773927|NCT04992312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64773928|NCT04992312|Hormones|hormones|mesh-ancestor
64773929|NCT04992312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64773930|NCT04992312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773931|NCT04873596|Midazolam|midazolam|mesh-list
64773932|NCT04873596|Dexmedetomidine|dexmedetomidine|mesh-list
64773933|NCT04873596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64773934|NCT04873596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64773935|NCT04873596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773936|NCT04873596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64773937|NCT04873596|Analgesics|analgesics|mesh-ancestor
64773938|NCT04873596|Sensory System Agents|sensory system agents|mesh-ancestor
64773939|NCT04873596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64773940|NCT04873596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64773941|NCT04873596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64773942|NCT04873596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64773943|NCT04873596|Adrenergic Agents|adrenergic agents|mesh-ancestor
64773944|NCT04873596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64773945|NCT04873596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773946|NCT04873596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64773947|NCT04873596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64773948|NCT04873596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64773949|NCT04873596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64773976|NCT04508166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64773977|NCT04508166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64773978|NCT04508166|Adrenergic Agents|adrenergic agents|mesh-ancestor
64773979|NCT04508166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64773980|NCT04508166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773981|NCT04508166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64773982|NCT04508166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64773983|NCT04508166|Anesthetics, General|anesthetics, general|mesh-ancestor
64773984|NCT04508166|Anesthetics|anesthetics|mesh-ancestor
64773985|NCT04444440|Ciprofloxacin|ciprofloxacin|mesh-list
64773986|NCT04444440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64773987|NCT04444440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64773988|NCT04444440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64773989|NCT04444440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64773990|NCT04444440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64773991|NCT04444440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64773992|NCT04444440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64773993|NCT04444440|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64662673|NCT01389284|Analgesics|analgesics|mesh-ancestor
64773994|NCT04444440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64773995|NCT04175964|Metformin|metformin|mesh-list
64773996|NCT04175964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64773997|NCT04175964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64773998|NCT03624270|Ascorbic Acid|ascorbic acid|mesh-list
64773999|NCT03624270|Arsenic Trioxide|arsenic trioxide|mesh-list
64774000|NCT03624270|Antioxidants|antioxidants|mesh-ancestor
64774024|NCT03455088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64662732|NCT04351490|Cholecalciferol|cholecalciferol|mesh-list
64774025|NCT03455088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64774026|NCT03455088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64774027|NCT03355560|Nivolumab|nivolumab|mesh-list
64774028|NCT03355560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64774029|NCT03355560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774030|NCT03355560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64774031|NCT03355560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774032|NCT01600170|Atorvastatin|atorvastatin|mesh-list
64774033|NCT01600170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64774034|NCT01600170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64774035|NCT01600170|Antimetabolites|antimetabolites|mesh-ancestor
64774036|NCT01600170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774037|NCT01600170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64774038|NCT01600170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64774039|NCT01600170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64774040|NCT01600950|Insulin Glargine|insulin glargine|mesh-list
64774041|NCT01600950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64439509|NCT01971645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774042|NCT01600950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774043|NCT01605942|Dexamethasone|dexamethasone|mesh-list
64774044|NCT01605942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64774045|NCT01605942|Antiemetics|antiemetics|mesh-ancestor
64774046|NCT01605942|Autonomic Agents|autonomic agents|mesh-ancestor
64774072|NCT01610154|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64774073|NCT01610154|Protease Inhibitors|protease inhibitors|mesh-ancestor
64774074|NCT01610154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64774075|NCT01610154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774076|NCT01611948|Aprepitant|aprepitant|mesh-list
64774077|NCT01611948|Antiemetics|antiemetics|mesh-ancestor
64774078|NCT01611948|Autonomic Agents|autonomic agents|mesh-ancestor
64774079|NCT01611948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774080|NCT01611948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774081|NCT01611948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64774082|NCT01611948|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64774083|NCT01611948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64774084|NCT01611948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774085|NCT01612884|Clopidogrel|clopidogrel|mesh-list
64774086|NCT01612884|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64774087|NCT01612884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64774088|NCT01612884|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64774089|NCT01612884|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64774090|NCT01612884|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64774091|NCT01612884|Purinergic Agents|purinergic agents|mesh-ancestor
64774092|NCT01612884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64774093|NCT01612884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774094|NCT01612884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774095|NCT01614210|Tamoxifen|tamoxifen|mesh-list
64774096|NCT01614210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64774097|NCT01614210|Hormone Antagonists|hormone antagonists|mesh-ancestor
64774098|NCT01614210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64774099|NCT01614210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774100|NCT01614210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64774101|NCT01614210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774102|NCT01614210|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64774103|NCT01614210|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64774104|NCT01614210|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64774105|NCT01616082|Phentermine|phentermine|mesh-list
64774107|NCT01616082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774108|NCT01616082|Appetite Depressants|appetite depressants|mesh-ancestor
64774109|NCT01616082|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64774110|NCT01616082|Sympathomimetics|sympathomimetics|mesh-ancestor
64774111|NCT01616082|Autonomic Agents|autonomic agents|mesh-ancestor
64774112|NCT01616082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774113|NCT01616082|Adrenergic Agents|adrenergic agents|mesh-ancestor
64774114|NCT01616082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64774115|NCT01616082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774116|NCT01616160|Mometasone Furoate|mometasone furoate|mesh-list
64774117|NCT01616160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64774118|NCT01616160|Dermatologic Agents|dermatologic agents|mesh-ancestor
64774119|NCT01616160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64774120|NCT01619982|Vancomycin|vancomycin|mesh-list
64774121|NCT01619982|Cefazolin|cefazolin|mesh-list
64774122|NCT01619982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64774123|NCT01619982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64774124|NCT01620216|Sorafenib|sorafenib|mesh-list
64774125|NCT01620216|Sunitinib|sunitinib|mesh-list
64774126|NCT01620216|Dasatinib|dasatinib|mesh-list
64774127|NCT01620216|Ponatinib|ponatinib|mesh-list
64774128|NCT01620216|Idelalisib|idelalisib|mesh-list
64774129|NCT01620216|Antineoplastic Agents|antineoplastic agents|mesh-list
64774130|NCT01620216|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
64774131|NCT01620216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64774132|NCT01620216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64774133|NCT01620216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774134|NCT01620216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64774135|NCT01620216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64774136|NCT01620216|Growth Substances|growth substances|mesh-ancestor
64774137|NCT01620216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774138|NCT01620216|Growth Inhibitors|growth inhibitors|mesh-ancestor
64774139|NCT01621230|Fentanyl|fentanyl|mesh-list
64774140|NCT01621230|Bupivacaine|bupivacaine|mesh-list
64774141|NCT01621230|Anesthetics, Local|anesthetics, local|mesh-ancestor
64774142|NCT01621230|Anesthetics|anesthetics|mesh-ancestor
64774143|NCT01621230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64663069|NCT01836185|Antimetabolites|antimetabolites|mesh-ancestor
64385616|NCT02541669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385617|NCT05455047|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64385618|NCT05455047|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64385619|NCT05455047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385620|NCT05454891|Insulin|insulin|mesh-list
64385621|NCT05454891|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64385622|NCT05454891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64385623|NCT05454891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385624|NCT02688647|Belumosudil|belumosudil|mesh-list
64774148|NCT01621230|Narcotics|narcotics|mesh-ancestor
64774149|NCT01621230|Analgesics|analgesics|mesh-ancestor
64774150|NCT01621230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64774151|NCT01621230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64774152|NCT01621230|Anesthetics, General|anesthetics, general|mesh-ancestor
64774153|NCT01621776|Insulin|insulin|mesh-list
64774154|NCT01621776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64774155|NCT01621776|Insulin Aspart|insulin aspart|mesh-list
64774156|NCT01621776|Insulin Lispro|insulin lispro|mesh-list
64774157|NCT01621776|Insulin glulisine|insulin glulisine|mesh-list
64774158|NCT01621776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64774159|NCT01621776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774193|NCT01635504|Cholinergic Agents|cholinergic agents|mesh-ancestor
64774194|NCT01635504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64774195|NCT01635504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774196|NCT01635504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64774197|NCT01635504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774198|NCT01636206|Lifitegrast|lifitegrast|mesh-list
64774199|NCT01636206|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64774200|NCT01636206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64774201|NCT01639872|Risperidone|risperidone|mesh-list
64774203|NCT01639872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64774204|NCT01639872|Serotonin Agents|serotonin agents|mesh-ancestor
64774205|NCT01639872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64774206|NCT01639872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774207|NCT01639872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663246|NCT05084859|Prednisone|prednisone|mesh-list
64774208|NCT01639872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64774209|NCT01639872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64774210|NCT01639872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64774211|NCT01639872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64774212|NCT01639872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64774213|NCT01639872|Dopamine Agents|dopamine agents|mesh-ancestor
64774214|NCT01639872|GABA Antagonists|gaba antagonists|mesh-ancestor
64774215|NCT01639872|GABA Agents|gaba agents|mesh-ancestor
64774216|NCT01640340|Dexamethasone|dexamethasone|mesh-list
64774217|NCT01640340|Ondansetron|ondansetron|mesh-list
64774218|NCT01640340|Aprepitant|aprepitant|mesh-list
64774219|NCT01640340|Palonosetron|palonosetron|mesh-list
64774220|NCT01640340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64774221|NCT01640340|Antiemetics|antiemetics|mesh-ancestor
64774222|NCT01640340|Autonomic Agents|autonomic agents|mesh-ancestor
64774223|NCT01640340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774224|NCT01640340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774225|NCT01640340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64774226|NCT01640340|Glucocorticoids|glucocorticoids|mesh-ancestor
64774227|NCT01640340|Hormones|hormones|mesh-ancestor
64774235|NCT01640340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64774236|NCT01640340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774237|NCT01640340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64774238|NCT01640340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64774239|NCT01640340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64774240|NCT01640340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64774241|NCT01640340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64774242|NCT01640340|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64774244|NCT01641120|Interferons|interferons|mesh-list
64774287|NCT01645098|Sensory System Agents|sensory system agents|mesh-ancestor
64774288|NCT01645098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774289|NCT01645098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64774290|NCT01645098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64663365|NCT00796263|Dolutegravir|dolutegravir|mesh-list
64774291|NCT01645098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64774292|NCT01645098|Adrenergic Agents|adrenergic agents|mesh-ancestor
64774293|NCT01645098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64774294|NCT01645098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774295|NCT01645098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64774296|NCT01645098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64774297|NCT01645098|Anesthetics, General|anesthetics, general|mesh-ancestor
64774298|NCT01645098|Anesthetics|anesthetics|mesh-ancestor
64774299|NCT01645098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64774300|NCT01645098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64774301|NCT01650402|Antihypertensive Agents|antihypertensive agents|mesh-list
64774302|NCT01651806|Tranexamic Acid|tranexamic acid|mesh-list
64774303|NCT01651806|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64774304|NCT01651806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64774305|NCT01651806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774306|NCT01651806|Hemostatics|hemostatics|mesh-ancestor
64774307|NCT01651806|Coagulants|coagulants|mesh-ancestor
64774308|NCT01652040|Methyltestosterone|methyltestosterone|mesh-list
64774309|NCT01652040|Testosterone|testosterone|mesh-list
64774310|NCT01652040|Testosterone undecanoate|testosterone undecanoate|mesh-list
64774311|NCT01652040|Testosterone enanthate|testosterone enanthate|mesh-list
64774312|NCT01652040|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64774313|NCT01652040|Androgens|androgens|mesh-ancestor
64774314|NCT01652040|Hormones|hormones|mesh-ancestor
64774318|NCT01652040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774328|NCT01652976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64774329|NCT01652976|Immunologic Factors|immunologic factors|mesh-ancestor
64774330|NCT01652976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774331|NCT01652976|Antidotes|antidotes|mesh-ancestor
64774332|NCT01652976|Protective Agents|protective agents|mesh-ancestor
64774333|NCT01652976|Vitamin B Complex|vitamin b complex|mesh-ancestor
64774334|NCT01652976|Vitamins|vitamins|mesh-ancestor
64774335|NCT01652976|Micronutrients|micronutrients|mesh-ancestor
64774336|NCT01652976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64774337|NCT01652976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64774338|NCT01656252|Cytarabine|cytarabine|mesh-list
64774339|NCT01656252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64774340|NCT01656252|Antimetabolites|antimetabolites|mesh-ancestor
64774341|NCT01656252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774342|NCT01656252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774343|NCT01656252|Antiviral Agents|antiviral agents|mesh-ancestor
64663554|NCT01860287|Buprenorphine|buprenorphine|mesh-list
64774344|NCT01656252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64774345|NCT01656252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64774346|NCT01656252|Immunologic Factors|immunologic factors|mesh-ancestor
64774347|NCT01656252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774348|NCT01661088|Folfirinox|folfirinox|mesh-list
64774349|NCT01661088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774350|NCT01661946|Bevacizumab|bevacizumab|mesh-list
64774351|NCT01661946|Ranibizumab|ranibizumab|mesh-list
64774352|NCT01661946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64774353|NCT01661946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774354|NCT01661946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64774355|NCT01661946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64774356|NCT01661946|Growth Substances|growth substances|mesh-ancestor
64774357|NCT01661946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774358|NCT01661946|Growth Inhibitors|growth inhibitors|mesh-ancestor
64774359|NCT01663272|Gemcitabine|gemcitabine|mesh-list
64774360|NCT01663272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64774362|NCT01663272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774363|NCT01663272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774364|NCT01663272|Antiviral Agents|antiviral agents|mesh-ancestor
64774365|NCT01663272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64774366|NCT01663272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64774367|NCT01663272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64774368|NCT01663272|Immunologic Factors|immunologic factors|mesh-ancestor
64543042|NCT03590587|Hormones|hormones|mesh-ancestor
64774369|NCT01663272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774370|NCT01667796|Vitamin D|vitamin d|mesh-list
64774371|NCT01667796|Cholecalciferol|cholecalciferol|mesh-list
64774372|NCT01667796|Vitamins|vitamins|mesh-ancestor
64774373|NCT01667796|Micronutrients|micronutrients|mesh-ancestor
64774381|NCT01669434|Ramipril|ramipril|mesh-list
64774422|NCT01684020|Coagulants|coagulants|mesh-ancestor
64774423|NCT01684410|Protease Inhibitors|protease inhibitors|mesh-list
64774424|NCT01684410|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64774425|NCT01684410|Protein C Inhibitor|protein c inhibitor|mesh-list
64774426|NCT01684410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64774427|NCT01684410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774428|NCT01684410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64774429|NCT01684410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64774430|NCT01689324|Vaccines|vaccines|mesh-list
64774431|NCT01689324|Immunologic Factors|immunologic factors|mesh-ancestor
64774432|NCT01689324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774433|NCT01692756|Triamcinolone|triamcinolone|mesh-list
64774451|NCT01701102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64774452|NCT01701102|Narcotics|narcotics|mesh-ancestor
64774453|NCT01701102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64774464|NCT01701414|Anesthetics, Local|anesthetics, local|mesh-ancestor
64774465|NCT01701414|Anesthetics|anesthetics|mesh-ancestor
64774466|NCT01701414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64774467|NCT01701414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774468|NCT01701414|Sensory System Agents|sensory system agents|mesh-ancestor
64774469|NCT01701414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774470|NCT01706952|Epinephrine|epinephrine|mesh-list
64774471|NCT01706952|Racepinephrine|racepinephrine|mesh-list
64774472|NCT01706952|Cocaine|cocaine|mesh-list
64774473|NCT01706952|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64774474|NCT01706952|Epinephryl borate|epinephryl borate|mesh-list
64774475|NCT01706952|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64774476|NCT01706952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64774477|NCT01706952|Adrenergic Agents|adrenergic agents|mesh-ancestor
64774478|NCT01706952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64774479|NCT01706952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774480|NCT01706952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774481|NCT01706952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64774482|NCT01706952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64774483|NCT01706952|Autonomic Agents|autonomic agents|mesh-ancestor
64774484|NCT01706952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774489|NCT01706952|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64774490|NCT01706952|Anesthetics, Local|anesthetics, local|mesh-ancestor
64774491|NCT01706952|Anesthetics|anesthetics|mesh-ancestor
64663821|NCT03000257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774492|NCT01706952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64774493|NCT01706952|Sensory System Agents|sensory system agents|mesh-ancestor
64774494|NCT01706952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64774495|NCT01706952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64774496|NCT01706952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64774497|NCT01706952|Dopamine Agents|dopamine agents|mesh-ancestor
64774499|NCT01707420|Analgesics|analgesics|mesh-ancestor
64774500|NCT01707420|Sensory System Agents|sensory system agents|mesh-ancestor
64774501|NCT01707420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663869|NCT04048161|Mycophenolic Acid|mycophenolic acid|mesh-list
64774502|NCT01707420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774504|NCT01707420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64774505|NCT01707420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64774506|NCT01707420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64774507|NCT01707420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64774508|NCT01707420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64774509|NCT01707420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64774510|NCT01707420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64774511|NCT01707420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774512|NCT01707420|Antimanic Agents|antimanic agents|mesh-ancestor
64774513|NCT01708122|Fentanyl|fentanyl|mesh-list
64774514|NCT01708122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64774515|NCT01708122|Narcotics|narcotics|mesh-ancestor
64774516|NCT01708122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64663928|NCT01868633|Glucocorticoids|glucocorticoids|mesh-ancestor
64385952|NCT02683187|Incretins|incretins|mesh-ancestor
64323543|NCT01662986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64323544|NCT01662986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323545|NCT01662986|Anticonvulsants|anticonvulsants|mesh-ancestor
64323546|NCT05497232|Pancrelipase|pancrelipase|mesh-list
64323547|NCT05497232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64323548|NCT04205630|Trastuzumab|trastuzumab|mesh-list
64323549|NCT04205630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64323550|NCT04205630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323551|NCT00054158|Thalidomide|thalidomide|mesh-list
64774517|NCT01708122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774518|NCT01708122|Analgesics|analgesics|mesh-ancestor
64774519|NCT01708122|Sensory System Agents|sensory system agents|mesh-ancestor
64774520|NCT01708122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774521|NCT01708122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64774522|NCT01708122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64774523|NCT01708122|Anesthetics, General|anesthetics, general|mesh-ancestor
64543170|NCT04020601|Ropivacaine|ropivacaine|mesh-list
64774525|NCT01708278|Folic Acid|folic acid|mesh-list
64774526|NCT01708278|Quercetin|quercetin|mesh-list
64774527|NCT01708278|Hematinics|hematinics|mesh-ancestor
64774528|NCT01708278|Vitamin B Complex|vitamin b complex|mesh-ancestor
64774529|NCT01708278|Vitamins|vitamins|mesh-ancestor
64774530|NCT01708278|Micronutrients|micronutrients|mesh-ancestor
64774531|NCT01708278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774532|NCT01708278|Antioxidants|antioxidants|mesh-ancestor
64774533|NCT01708278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774534|NCT01708278|Protective Agents|protective agents|mesh-ancestor
64774535|NCT01708590|Brodalumab|brodalumab|mesh-list
64774536|NCT01708590|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64774537|NCT01708590|Dermatologic Agents|dermatologic agents|mesh-ancestor
64774538|NCT01708590|Immunologic Factors|immunologic factors|mesh-ancestor
64774539|NCT01708590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774540|NCT05711082|Dopamine|dopamine|mesh-list
64774541|NCT05711082|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64774542|NCT05711082|Sympathomimetics|sympathomimetics|mesh-ancestor
64385994|NCT02533401|Rituximab|rituximab|mesh-list
64323552|NCT00054158|Dexamethasone|dexamethasone|mesh-list
64323553|NCT00054158|Doxorubicin|doxorubicin|mesh-list
64323554|NCT00054158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64323555|NCT00054158|Vincristine|vincristine|mesh-list
64323556|NCT00054158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64323557|NCT00054158|Antiemetics|antiemetics|mesh-ancestor
64323558|NCT00054158|Autonomic Agents|autonomic agents|mesh-ancestor
64323559|NCT00054158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64323560|NCT00054158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323561|NCT00054158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64323562|NCT00054158|Glucocorticoids|glucocorticoids|mesh-ancestor
64323563|NCT00054158|Hormones|hormones|mesh-ancestor
64323564|NCT00054158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64323565|NCT00054158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64323566|NCT00054158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323567|NCT00054158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64323568|NCT00054158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64323569|NCT00054158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64323570|NCT00054158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64323571|NCT00054158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323572|NCT00054158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64323573|NCT00054158|Tubulin Modulators|tubulin modulators|mesh-ancestor
64323574|NCT00054158|Antimitotic Agents|antimitotic agents|mesh-ancestor
64323577|NCT00054158|Immunologic Factors|immunologic factors|mesh-ancestor
64323578|NCT00054158|Leprostatic Agents|leprostatic agents|mesh-ancestor
64774543|NCT05711082|Autonomic Agents|autonomic agents|mesh-ancestor
64774544|NCT05711082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774545|NCT05711082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774546|NCT05711082|Dopamine Agents|dopamine agents|mesh-ancestor
64774547|NCT05711082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64774548|NCT05711082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774549|NCT05711082|Protective Agents|protective agents|mesh-ancestor
64774550|NCT05710146|Tranexamic Acid|tranexamic acid|mesh-list
64774551|NCT05710146|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64774552|NCT05710146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64774553|NCT05710146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774554|NCT05710146|Hemostatics|hemostatics|mesh-ancestor
64774555|NCT05710146|Coagulants|coagulants|mesh-ancestor
64774556|NCT05709444|Angiotensin II|angiotensin ii|mesh-list
64774557|NCT05709444|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64774558|NCT05709444|alpha-MSH|alpha-msh|mesh-list
64664081|NCT02425098|Vaccines|vaccines|mesh-list
64774559|NCT05709444|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64774560|NCT05709444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64774561|NCT05709444|Protease Inhibitors|protease inhibitors|mesh-ancestor
64774562|NCT05709444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64774563|NCT05709444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774564|NCT05709444|Hormones|hormones|mesh-ancestor
64774565|NCT05709444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64774566|NCT05709444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774567|NCT05683548|Interferons|interferons|mesh-list
64774568|NCT05683548|Tenofovir|tenofovir|mesh-list
64774569|NCT05683548|Interferon-alpha|interferon-alpha|mesh-list
64774570|NCT05683548|Interferon alpha-2|interferon alpha-2|mesh-list
64774571|NCT05683548|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64774588|NCT05636436|Immunologic Factors|immunologic factors|mesh-ancestor
64774589|NCT05636436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774590|NCT05613426|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64774592|NCT05613426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64774593|NCT05613426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64774594|NCT05613426|Antimetabolites|antimetabolites|mesh-ancestor
64774595|NCT05613426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774596|NCT05613426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64774597|NCT05613426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64774598|NCT05613426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64774599|NCT05463354|Vaccines|vaccines|mesh-list
64774600|NCT05463354|Immunologic Factors|immunologic factors|mesh-ancestor
64774601|NCT05463354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774602|NCT05340504|Acetylcysteine|acetylcysteine|mesh-list
64774603|NCT05340504|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64774604|NCT05340504|Antiviral Agents|antiviral agents|mesh-ancestor
64774605|NCT05340504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64774606|NCT05340504|Expectorants|expectorants|mesh-ancestor
64774607|NCT05340504|Respiratory System Agents|respiratory system agents|mesh-ancestor
64439625|NCT01707004|Busulfan|busulfan|mesh-list
64774608|NCT05340504|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64774609|NCT05340504|Antioxidants|antioxidants|mesh-ancestor
64774610|NCT05340504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774611|NCT05340504|Protective Agents|protective agents|mesh-ancestor
64774612|NCT05340504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774613|NCT05340504|Antidotes|antidotes|mesh-ancestor
64774614|NCT05330130|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64774615|NCT05330130|Hormones|hormones|mesh-ancestor
64774616|NCT05330130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64774617|NCT05330130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774618|NCT05293548|Vaccines|vaccines|mesh-list
64774619|NCT05293548|Immunologic Factors|immunologic factors|mesh-ancestor
64774620|NCT05293548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774621|NCT05157360|Vitamins|vitamins|mesh-list
64774622|NCT05157360|Hydrocortisone|hydrocortisone|mesh-list
64774623|NCT05157360|Micronutrients|micronutrients|mesh-ancestor
64774628|NCT05136066|Autonomic Agents|autonomic agents|mesh-ancestor
64774629|NCT05136066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774630|NCT05136066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774631|NCT05136066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64774632|NCT05136066|Parasympatholytics|parasympatholytics|mesh-ancestor
64774633|NCT04676802|Analgesics, Opioid|analgesics, opioid|mesh-list
64774634|NCT04676802|Narcotics|narcotics|mesh-ancestor
64774635|NCT04676802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64774636|NCT04676802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774637|NCT04676802|Analgesics|analgesics|mesh-ancestor
64774638|NCT04676802|Sensory System Agents|sensory system agents|mesh-ancestor
64774639|NCT04676802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774640|NCT04278768|Azacitidine|azacitidine|mesh-list
64774641|NCT04278768|Venetoclax|venetoclax|mesh-list
64774642|NCT04278768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64774643|NCT04278768|Antimetabolites|antimetabolites|mesh-ancestor
64664188|NCT02683707|GABA Modulators|gaba modulators|mesh-ancestor
64664189|NCT02683707|GABA Agents|gaba agents|mesh-ancestor
64774644|NCT04278768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774645|NCT04278768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64774646|NCT04278768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64774647|NCT04068948|Midazolam|midazolam|mesh-list
64774669|NCT04068948|Antipruritics|antipruritics|mesh-ancestor
64774670|NCT04068948|Dermatologic Agents|dermatologic agents|mesh-ancestor
64774671|NCT04068948|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64774672|NCT04068948|Histamine Antagonists|histamine antagonists|mesh-ancestor
64774673|NCT04068948|Histamine Agents|histamine agents|mesh-ancestor
64774674|NCT03768570|Durvalumab|durvalumab|mesh-list
64774675|NCT03768570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64774676|NCT03768570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664237|NCT05447871|Sensory System Agents|sensory system agents|mesh-ancestor
64774677|NCT03517722|Ustekinumab|ustekinumab|mesh-list
64774678|NCT03517722|Dermatologic Agents|dermatologic agents|mesh-ancestor
64774679|NCT02130492|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64774680|NCT02130492|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64774681|NCT02130492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774682|NCT01309074|Pregabalin|pregabalin|mesh-list
64774683|NCT01309074|Sertraline|sertraline|mesh-list
64774684|NCT01309074|Analgesics|analgesics|mesh-ancestor
64774685|NCT01309074|Sensory System Agents|sensory system agents|mesh-ancestor
64664292|NCT04652193|Anesthetics|anesthetics|mesh-list
64774686|NCT01309074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64774687|NCT01309074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774688|NCT01309074|Anticonvulsants|anticonvulsants|mesh-ancestor
64774689|NCT01309074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64774690|NCT01309074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64774691|NCT01309074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774692|NCT01309074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64774693|NCT01309074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64774694|NCT01309074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64774695|NCT01309074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64774696|NCT01309074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64774697|NCT01309074|Antidepressive Agents|antidepressive agents|mesh-ancestor
64774698|NCT01309074|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64774699|NCT01309074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64774700|NCT01309074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64774701|NCT01309074|Serotonin Agents|serotonin agents|mesh-ancestor
64774702|NCT01074294|Brexpiprazole|brexpiprazole|mesh-list
64774703|NCT01074294|Serotonin Agents|serotonin agents|mesh-ancestor
64774704|NCT01074294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64774705|NCT01074294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774706|NCT01074294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64774707|NCT01074294|Dopamine Agonists|dopamine agonists|mesh-ancestor
64774708|NCT01074294|Dopamine Agents|dopamine agents|mesh-ancestor
64774709|NCT01074138|Tirbanibulin|tirbanibulin|mesh-list
64664359|NCT05430867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64774710|NCT01074138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64774711|NCT01074138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774712|NCT00951132|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64774713|NCT00951132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64774714|NCT00951132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64774715|NCT00951132|Antimetabolites|antimetabolites|mesh-ancestor
64774716|NCT00951132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64774717|NCT00951132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64774718|NCT00951132|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64774719|NCT00951132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64774720|NCT01717872|Pyrithione zinc|pyrithione zinc|mesh-list
64774721|NCT01717872|Keratolytic Agents|keratolytic agents|mesh-ancestor
64774722|NCT01717872|Dermatologic Agents|dermatologic agents|mesh-ancestor
64774723|NCT01721226|Opiate Alkaloids|opiate alkaloids|mesh-list
64774724|NCT01721226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64774725|NCT01721226|Narcotics|narcotics|mesh-ancestor
64774726|NCT01721226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64774727|NCT01721226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543403|NCT01270971|Tavaborole|tavaborole|mesh-list
64543404|NCT01270971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64543405|NCT01270971|Antifungal Agents|antifungal agents|mesh-ancestor
64543406|NCT01270971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64543407|NCT04026841|Antibodies|antibodies|mesh-list
64543408|NCT04026841|Immunologic Factors|immunologic factors|mesh-ancestor
64543409|NCT04026841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64543410|NCT04128774|Dexamethasone|dexamethasone|mesh-list
64543412|NCT04128774|BB 1101|bb 1101|mesh-list
64774729|NCT01721226|Sensory System Agents|sensory system agents|mesh-ancestor
64774731|NCT01721460|Dexmedetomidine|dexmedetomidine|mesh-list
64329956|NCT02379663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64329957|NCT02379663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64329959|NCT02030639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329960|NCT02030639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64329961|NCT02030639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64330215|NCT02197403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64330216|NCT02197403|Adrenergic Agents|adrenergic agents|mesh-ancestor
64330217|NCT02197403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64330218|NCT02197403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330219|NCT02370069|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64330220|NCT02370069|Immunologic Factors|immunologic factors|mesh-ancestor
64330221|NCT02370069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330245|NCT05708521|Analgesics|analgesics|mesh-ancestor
64330246|NCT05708521|Sensory System Agents|sensory system agents|mesh-ancestor
64330247|NCT05708521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330248|NCT03534713|Paclitaxel|paclitaxel|mesh-list
64330249|NCT03534713|Carboplatin|carboplatin|mesh-list
64330250|NCT03534713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64330251|NCT03534713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64330252|NCT03534713|Tubulin Modulators|tubulin modulators|mesh-ancestor
64330253|NCT03534713|Antimitotic Agents|antimitotic agents|mesh-ancestor
64330254|NCT03534713|Mitosis Modulators|mitosis modulators|mesh-ancestor
64330255|NCT03534713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64330256|NCT02376075|Linagliptin|linagliptin|mesh-list
64330257|NCT02376075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64330258|NCT02376075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330259|NCT02376075|Incretins|incretins|mesh-ancestor
64330260|NCT02376075|Hormones|hormones|mesh-ancestor
64330276|NCT04469413|Sensory System Agents|sensory system agents|mesh-ancestor
64330277|NCT04469413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330278|NCT04469413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330281|NCT03532087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64330282|NCT03532087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330283|NCT02369523|Bupivacaine|bupivacaine|mesh-list
64330284|NCT02369523|Ropivacaine|ropivacaine|mesh-list
64330285|NCT02369523|Anesthetics, Local|anesthetics, local|mesh-ancestor
64330286|NCT02369523|Anesthetics|anesthetics|mesh-ancestor
64330287|NCT02369523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64330288|NCT02369523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330289|NCT02369523|Sensory System Agents|sensory system agents|mesh-ancestor
64330290|NCT02369523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330291|NCT02288923|Acetaminophen|acetaminophen|mesh-list
64330292|NCT02288923|Ibuprofen|ibuprofen|mesh-list
64330293|NCT02288923|Morphine|morphine|mesh-list
64330294|NCT02288923|Antiemetics|antiemetics|mesh-list
64330295|NCT02288923|Anesthetics|anesthetics|mesh-list
64330296|NCT02288923|Emetics|emetics|mesh-list
64330297|NCT02288923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64330298|NCT02288923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330299|NCT02288923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64330300|NCT02288923|Narcotics|narcotics|mesh-ancestor
64330301|NCT02288923|Analgesics|analgesics|mesh-ancestor
64330302|NCT02288923|Sensory System Agents|sensory system agents|mesh-ancestor
64330303|NCT02288923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64330304|NCT02288923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64330305|NCT02288923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64330306|NCT02288923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64330307|NCT02288923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64330995|NCT05791669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64330996|NCT05791669|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64330997|NCT05791669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64331037|NCT05791409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331039|NCT05791331|Respiratory System Agents|respiratory system agents|mesh-ancestor
64331040|NCT05791097|Paclitaxel|paclitaxel|mesh-list
64331041|NCT05791097|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64331042|NCT05791097|Carboplatin|carboplatin|mesh-list
64331043|NCT05791097|Pembrolizumab|pembrolizumab|mesh-list
64331044|NCT05791097|Pemetrexed|pemetrexed|mesh-list
64331045|NCT05791097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64331046|NCT05791097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64331047|NCT05791097|Tubulin Modulators|tubulin modulators|mesh-ancestor
64331048|NCT05791097|Antimitotic Agents|antimitotic agents|mesh-ancestor
64331049|NCT05791097|Mitosis Modulators|mitosis modulators|mesh-ancestor
64331050|NCT05791097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331051|NCT05791097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64331052|NCT05791097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64331053|NCT05791097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64331054|NCT05791097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64331055|NCT05791058|Anesthetics|anesthetics|mesh-list
64331056|NCT05791058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64664630|NCT04635189|Dexamethasone|dexamethasone|mesh-list
64331057|NCT05791058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331058|NCT05790941|Minoxidil|minoxidil|mesh-list
64331059|NCT05790941|Latanoprost|latanoprost|mesh-list
64331060|NCT05790941|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64331061|NCT05790941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64331062|NCT05790941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64331076|NCT05790720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64331077|NCT05790720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331078|NCT05790720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64331079|NCT05790720|Anesthetics, General|anesthetics, general|mesh-ancestor
64331080|NCT05790720|Anesthetics|anesthetics|mesh-ancestor
64331081|NCT05790707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64331082|NCT05790681|Insulin|insulin|mesh-list
64331083|NCT05790681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64331084|NCT05790681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331085|NCT05790629|Calcium, Dietary|calcium, dietary|mesh-list
64332042|NCT04008030|Cetuximab|cetuximab|mesh-list
64332043|NCT04008030|Ipilimumab|ipilimumab|mesh-list
64332044|NCT04008030|Fluorouracil|fluorouracil|mesh-list
64332045|NCT04008030|Oxaliplatin|oxaliplatin|mesh-list
64332046|NCT04008030|Irinotecan|irinotecan|mesh-list
64332047|NCT04008030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64332048|NCT04008030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332049|NCT04008030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64332050|NCT04008030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64332051|NCT04008030|Growth Substances|growth substances|mesh-ancestor
64332052|NCT04008030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332053|NCT04008030|Growth Inhibitors|growth inhibitors|mesh-ancestor
64332054|NCT04008030|Antimetabolites|antimetabolites|mesh-ancestor
64332055|NCT04008030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332056|NCT04008030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64332057|NCT04008030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64332058|NCT04008030|Immunologic Factors|immunologic factors|mesh-ancestor
64332059|NCT04008030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64664734|NCT00552617|Rocuronium|rocuronium|mesh-list
64332060|NCT04008030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64332061|NCT04008030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64332062|NCT04008030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64332063|NCT04008030|Antidotes|antidotes|mesh-ancestor
64332064|NCT04008030|Protective Agents|protective agents|mesh-ancestor
64332066|NCT04008030|Vitamins|vitamins|mesh-ancestor
64332074|NCT03977493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64332075|NCT03977493|Cholinergic Agents|cholinergic agents|mesh-ancestor
64332076|NCT03977493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64332078|NCT03972657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64332079|NCT03972657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332086|NCT03867175|Pembrolizumab|pembrolizumab|mesh-list
64332087|NCT03867175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64332088|NCT03867175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332089|NCT03852433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64332090|NCT03852433|Antiviral Agents|antiviral agents|mesh-ancestor
64332091|NCT03852433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64332092|NCT03849469|Pembrolizumab|pembrolizumab|mesh-list
64332093|NCT03849469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64332094|NCT03849469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64332095|NCT03816397|Adalimumab|adalimumab|mesh-list
64332096|NCT03816397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64332097|NCT03816397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64332098|NCT03816332|Prednisone|prednisone|mesh-list
64332099|NCT03816332|Cortisone|cortisone|mesh-list
64332100|NCT03816332|Nivolumab|nivolumab|mesh-list
64332101|NCT03816332|Ipilimumab|ipilimumab|mesh-list
64332102|NCT03816332|Tacrolimus|tacrolimus|mesh-list
64332103|NCT03816332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64332104|NCT03816332|Glucocorticoids|glucocorticoids|mesh-ancestor
64332106|NCT03816332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64332107|NCT03816332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332108|NCT03816332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64332110|NCT03816332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64332111|NCT03816332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64332522|NCT02581137|Metformin|metformin|mesh-list
64332523|NCT02581137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64664854|NCT05020821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64332524|NCT02581137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64332525|NCT02559180|Aflibercept|aflibercept|mesh-list
64332526|NCT02559180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64332530|NCT02559180|Growth Inhibitors|growth inhibitors|mesh-ancestor
64333287|NCT02220647|Incretins|incretins|mesh-ancestor
64333288|NCT02220647|Hormones|hormones|mesh-ancestor
64333289|NCT02220647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64333290|NCT02220647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64333604|NCT05373433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64333605|NCT05373433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64333606|NCT05373433|Antiviral Agents|antiviral agents|mesh-ancestor
64333607|NCT05373433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64664909|NCT01555281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64333608|NCT05373433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64333609|NCT05373433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64333610|NCT02363127|Progesterone|progesterone|mesh-list
64333611|NCT02363127|Progestins|progestins|mesh-ancestor
64333613|NCT02363127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64333614|NCT02363127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333615|NCT03526159|Gentamicins|gentamicins|mesh-list
64333616|NCT03526159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64333617|NCT03526159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64333618|NCT03526159|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64333619|NCT03526159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335240|NCT02259491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64335241|NCT02259491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335243|NCT05255523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64335244|NCT05255523|Antimetabolites|antimetabolites|mesh-ancestor
64335245|NCT05255523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335845|NCT03510325|Dopamine Agents|dopamine agents|mesh-ancestor
64335846|NCT03510325|Antiemetics|antiemetics|mesh-ancestor
64335847|NCT03510325|Autonomic Agents|autonomic agents|mesh-ancestor
64335848|NCT03510325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64335849|NCT03510325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64335850|NCT03510325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64335851|NCT03510325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64335852|NCT03510325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64335853|NCT03510325|Antidepressive Agents|antidepressive agents|mesh-ancestor
64335854|NCT03510325|Dopamine Agonists|dopamine agonists|mesh-ancestor
64335945|NCT02340273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64335946|NCT02340273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64335947|NCT02340273|Adrenergic Agents|adrenergic agents|mesh-ancestor
64335948|NCT02340273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64664965|NCT04900623|Paclitaxel|paclitaxel|mesh-list
64335949|NCT02340273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335950|NCT02340273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335951|NCT02340273|Sympathomimetics|sympathomimetics|mesh-ancestor
64335952|NCT02340273|Autonomic Agents|autonomic agents|mesh-ancestor
64335953|NCT02340273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64335954|NCT02340273|Nasal Decongestants|nasal decongestants|mesh-ancestor
64335955|NCT02340273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64664992|NCT00107289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64335956|NCT02340273|Respiratory System Agents|respiratory system agents|mesh-ancestor
64336270|NCT02310295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64336271|NCT02310295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336272|NCT02310295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64336273|NCT02310295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64336274|NCT02310295|Growth Substances|growth substances|mesh-ancestor
64336275|NCT02310295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336276|NCT02310295|Growth Inhibitors|growth inhibitors|mesh-ancestor
64336277|NCT02310295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64336278|NCT02310295|Glucocorticoids|glucocorticoids|mesh-ancestor
64336279|NCT02310295|Hormones|hormones|mesh-ancestor
64336280|NCT02310295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64665057|NCT04802031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336281|NCT02310295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64336282|NCT02310295|Immunologic Factors|immunologic factors|mesh-ancestor
64336283|NCT02310295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336284|NCT02310295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336285|NCT05012865|Avelumab|avelumab|mesh-list
64336286|NCT05012865|Axitinib|axitinib|mesh-list
64336499|NCT03505255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336500|NCT03505255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336501|NCT03505255|Cholinergic Agents|cholinergic agents|mesh-ancestor
64336502|NCT03505255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64336503|NCT03505255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336504|NCT03505255|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64336505|NCT03505255|Autonomic Agents|autonomic agents|mesh-ancestor
64336506|NCT03505255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64336507|NCT02333799|Linezolid|linezolid|mesh-list
64336508|NCT02333799|Bedaquiline|bedaquiline|mesh-list
64336509|NCT02333799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64336660|NCT03503227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64336661|NCT03503227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64336662|NCT03503227|Antifungal Agents|antifungal agents|mesh-ancestor
64336663|NCT03503227|Keratolytic Agents|keratolytic agents|mesh-ancestor
64336704|NCT03501433|Vitamins|vitamins|mesh-ancestor
64336705|NCT03501433|Micronutrients|micronutrients|mesh-ancestor
64336706|NCT03501433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336707|NCT03501433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64336708|NCT03501433|Antimetabolites|antimetabolites|mesh-ancestor
64336709|NCT03501433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336710|NCT03501433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64665161|NCT04293393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64665178|NCT04293393|Fertility Agents|fertility agents|mesh-ancestor
64336711|NCT03501433|Vasodilator Agents|vasodilator agents|mesh-ancestor
64336712|NCT02383251|Paclitaxel|paclitaxel|mesh-list
64336713|NCT02383251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64336714|NCT02383251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336715|NCT02383251|Tubulin Modulators|tubulin modulators|mesh-ancestor
64336716|NCT02383251|Antimitotic Agents|antimitotic agents|mesh-ancestor
64336736|NCT01959633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64336737|NCT01959633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336738|NCT01959633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336739|NCT02326623|Anesthetics|anesthetics|mesh-list
64336740|NCT02326623|Anesthetics, Local|anesthetics, local|mesh-list
64336741|NCT02326623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64336742|NCT02326623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336743|NCT02326623|Sensory System Agents|sensory system agents|mesh-ancestor
64336744|NCT02326623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64336746|NCT02317471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336747|NCT02332629|Methylprednisolone|methylprednisolone|mesh-list
64336748|NCT02332629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64336749|NCT02332629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64336750|NCT02332629|Prednisolone|prednisolone|mesh-list
64336751|NCT02332629|Prednisolone acetate|prednisolone acetate|mesh-list
64336752|NCT02332629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64336753|NCT02332629|Prednisolone phosphate|prednisolone phosphate|mesh-list
64336788|NCT02313337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64336789|NCT02313337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665257|NCT05446779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64336790|NCT02313337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64336791|NCT02313337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64336793|NCT02313337|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64336794|NCT02313337|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64336795|NCT02313337|Cholinergic Agents|cholinergic agents|mesh-ancestor
64336796|NCT01767675|Carboplatin|carboplatin|mesh-list
64336853|NCT02318017|Dopamine Agents|dopamine agents|mesh-ancestor
64336854|NCT02318017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64336855|NCT02313727|Pamidronate|pamidronate|mesh-list
64336856|NCT02313727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64336910|NCT02314195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64336911|NCT02314195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336912|NCT02314195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336913|NCT02314195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64336914|NCT02314195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64336915|NCT02314273|Oprelvekin|oprelvekin|mesh-list
64336916|NCT02314273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336917|NCT02314351|Fentanyl|fentanyl|mesh-list
64336918|NCT02314351|Metoclopramide|metoclopramide|mesh-list
64336919|NCT02314351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64336920|NCT02314351|Narcotics|narcotics|mesh-ancestor
64336921|NCT02314351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64336922|NCT02314351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336923|NCT02314351|Analgesics|analgesics|mesh-ancestor
64336924|NCT02314351|Sensory System Agents|sensory system agents|mesh-ancestor
64337453|NCT02182687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64337455|NCT02182687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337456|NCT02235389|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64337457|NCT02235389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64337458|NCT02235389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64337459|NCT02235389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337460|NCT03489889|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64337461|NCT03489889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64337462|NCT03489889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64337463|NCT01388491|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64337464|NCT01388491|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64337465|NCT01388491|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64337466|NCT01388491|Desogestrel|desogestrel|mesh-list
64337467|NCT01388491|Estradiol|estradiol|mesh-list
64337468|NCT01388491|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64337469|NCT01388491|Estrogens|estrogens|mesh-ancestor
64337470|NCT01388491|Hormones|hormones|mesh-ancestor
64337480|NCT01388491|Progestins|progestins|mesh-ancestor
64337482|NCT02236169|Norflurane|norflurane|mesh-list
64337483|NCT02236169|Ipratropium|ipratropium|mesh-list
64337484|NCT02236169|Anticonvulsants|anticonvulsants|mesh-ancestor
64337485|NCT02236169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64337486|NCT02236169|Autonomic Agents|autonomic agents|mesh-ancestor
64337487|NCT02236169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64337488|NCT02236169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337489|NCT02236169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64337490|NCT02236169|Respiratory System Agents|respiratory system agents|mesh-ancestor
64337491|NCT02236169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64337493|NCT02236169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64337494|NCT02236169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337496|NCT02236169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64337497|NCT02749799|Betamethasone|betamethasone|mesh-list
64337498|NCT02749799|Betamethasone Valerate|betamethasone valerate|mesh-list
64337499|NCT02749799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64337500|NCT02749799|Betamethasone benzoate|betamethasone benzoate|mesh-list
64337501|NCT02749799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64337502|NCT02749799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64337503|NCT02749799|Glucocorticoids|glucocorticoids|mesh-ancestor
64337504|NCT02749799|Hormones|hormones|mesh-ancestor
64337505|NCT02749799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64337506|NCT02749799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337507|NCT02749799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64337508|NCT02749799|Respiratory System Agents|respiratory system agents|mesh-ancestor
64337509|NCT03492541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64337510|NCT03492541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64337511|NCT03492385|Ticagrelor|ticagrelor|mesh-list
64337922|NCT02264795|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64337928|NCT02264873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337929|NCT02264873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337930|NCT02264873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337931|NCT00156533|Zolpidem|zolpidem|mesh-list
64337932|NCT00156533|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64337933|NCT00156533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64337934|NCT00156533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64337935|NCT00156533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665496|NCT02762331|Ascorbic Acid|ascorbic acid|mesh-list
64337936|NCT00156533|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64337937|NCT00156533|GABA Agonists|gaba agonists|mesh-ancestor
64337938|NCT00156533|GABA Agents|gaba agents|mesh-ancestor
64337939|NCT00156533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64337940|NCT00156533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337941|NCT01410695|Methotrexate|methotrexate|mesh-list
64337942|NCT01410695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64337943|NCT01410695|Abortifacient Agents|abortifacient agents|mesh-ancestor
64337944|NCT01410695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64337945|NCT01410695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337946|NCT01410695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64337947|NCT01410695|Antimetabolites|antimetabolites|mesh-ancestor
64337948|NCT01410695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337949|NCT01410695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337950|NCT01410695|Dermatologic Agents|dermatologic agents|mesh-ancestor
64337951|NCT01410695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64665556|NCT01449266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665557|NCT02767947|Luliconazole|luliconazole|mesh-list
64665558|NCT02767947|Antifungal Agents|antifungal agents|mesh-ancestor
64665559|NCT02767947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64665560|NCT02770365|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64665561|NCT02770365|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64665563|NCT02770365|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64337952|NCT01410695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64337953|NCT01410695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64337954|NCT01410695|Immunologic Factors|immunologic factors|mesh-ancestor
64337955|NCT01410695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64337956|NCT01410695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64337957|NCT01660022|Piperaquine|piperaquine|mesh-list
64337958|NCT01660022|Artefenomel|artefenomel|mesh-list
64337968|NCT02265575|Protective Agents|protective agents|mesh-ancestor
64337970|NCT02265731|Venetoclax|venetoclax|mesh-list
64338087|NCT01298687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64338088|NCT02267057|Acetaminophen|acetaminophen|mesh-list
64338089|NCT02267057|Buprenorphine|buprenorphine|mesh-list
64294943|NCT02473887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294945|NCT02473887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64294946|NCT02473887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64295360|NCT02470923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64295361|NCT02470923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295363|NCT02049229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295364|NCT02049229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64295365|NCT02049229|Immunologic Factors|immunologic factors|mesh-ancestor
64295366|NCT02049229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295367|NCT02805907|Calcifediol|calcifediol|mesh-list
64295368|NCT02805907|Vitamins|vitamins|mesh-ancestor
64295369|NCT02805907|Micronutrients|micronutrients|mesh-ancestor
64295387|NCT02477397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64295388|NCT02477397|Glucocorticoids|glucocorticoids|mesh-ancestor
64295390|NCT02477397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64295391|NCT02477397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64295392|NCT02477397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64295393|NCT02477397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64295394|NCT02477397|Adrenergic Agents|adrenergic agents|mesh-ancestor
64295395|NCT02477397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64295396|NCT02477397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295409|NCT02049541|Rituximab|rituximab|mesh-list
64439931|NCT00942331|Immunoglobulin G|immunoglobulin g|mesh-list
64295411|NCT02049541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295412|NCT02049541|Immunologic Factors|immunologic factors|mesh-ancestor
64295413|NCT02049541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295414|NCT02049541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64295415|NCT02470611|Alendronate|alendronate|mesh-list
64295416|NCT02470611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64295417|NCT02470611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295418|NCT05305898|Metformin|metformin|mesh-list
64295419|NCT05305898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64295420|NCT05305898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295421|NCT05580861|Sulfasalazine|sulfasalazine|mesh-list
64295422|NCT05580861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64295423|NCT05580861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64295424|NCT05580861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64295425|NCT05580861|Analgesics|analgesics|mesh-ancestor
64295426|NCT05580861|Sensory System Agents|sensory system agents|mesh-ancestor
64295427|NCT05580861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64295428|NCT05580861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295442|NCT02995005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64295443|NCT02995005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295444|NCT02995005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295446|NCT02995005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64295447|NCT03561415|Posaconazole|posaconazole|mesh-list
64295448|NCT03561415|Antifungal Agents|antifungal agents|mesh-ancestor
64295449|NCT03561415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64295450|NCT03561415|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64295451|NCT03561415|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64295452|NCT03561415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64295453|NCT03561415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64295454|NCT03561415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64295455|NCT03561415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295456|NCT03561415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295457|NCT03561415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64297026|NCT03103568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64297027|NCT03103568|Sympatholytics|sympatholytics|mesh-ancestor
64297028|NCT03103568|Autonomic Agents|autonomic agents|mesh-ancestor
64297029|NCT03103568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64297030|NCT03103568|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64297031|NCT03103568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64297032|NCT03103568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64297033|NCT03103568|Adrenergic Agents|adrenergic agents|mesh-ancestor
64297034|NCT03103568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64297035|NCT03103568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64297036|NCT03103568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297053|NCT03103646|Itraconazole|itraconazole|mesh-list
64297054|NCT03103646|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
64297055|NCT03103646|Antifungal Agents|antifungal agents|mesh-ancestor
64297056|NCT03103646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64297057|NCT03103646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64297058|NCT03103646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64297059|NCT03103646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297060|NCT03103646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297061|NCT03103646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64297062|NCT03103646|Hormone Antagonists|hormone antagonists|mesh-ancestor
64297063|NCT03103646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64297064|NCT03103646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297065|NCT03103646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64297066|NCT01554410|Gemcitabine|gemcitabine|mesh-list
64297067|NCT01554410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297070|NCT01554410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297071|NCT01554410|Antiviral Agents|antiviral agents|mesh-ancestor
64297072|NCT01554410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64297073|NCT01554410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297074|NCT01554410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64297075|NCT01554410|Immunologic Factors|immunologic factors|mesh-ancestor
64297076|NCT01554410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297077|NCT05608369|Vorinostat|vorinostat|mesh-list
64297078|NCT05608369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297079|NCT05608369|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64297080|NCT05608369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297081|NCT05608369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297091|NCT01499888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297092|NCT01499888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64297094|NCT03299829|Chelating Agents|chelating agents|mesh-ancestor
64297664|NCT02462109|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64297665|NCT02462109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64297666|NCT02462109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64297667|NCT02462109|GABA Modulators|gaba modulators|mesh-ancestor
64297669|NCT02462109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64297670|NCT02462109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297671|NCT02056899|Gabapentin|gabapentin|mesh-list
64297672|NCT02056899|Analgesics|analgesics|mesh-ancestor
64297673|NCT02056899|Sensory System Agents|sensory system agents|mesh-ancestor
64297674|NCT02056899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64297893|NCT04938856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64297894|NCT04938856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297895|NCT04938856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64297896|NCT04938856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297897|NCT04938856|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64297898|NCT04938856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64297899|NCT04938856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64297900|NCT04938856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64297901|NCT04938856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64297902|NCT02461329|Polygeline|polygeline|mesh-list
64297903|NCT02461329|Plasma Substitutes|plasma substitutes|mesh-ancestor
64297904|NCT02461329|Blood Substitutes|blood substitutes|mesh-ancestor
64297905|NCT02463825|Pimozide|pimozide|mesh-list
64298255|NCT02077231|Vitamins|vitamins|mesh-list
64298268|NCT02077309|Incretins|incretins|mesh-ancestor
64298269|NCT02077309|Hormones|hormones|mesh-ancestor
64298270|NCT02077309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64298271|NCT02077309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64298272|NCT02077309|Protease Inhibitors|protease inhibitors|mesh-ancestor
64298273|NCT02077309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298274|NCT02077309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298275|NCT01369849|Rituximab|rituximab|mesh-list
64665890|NCT01515176|Immunologic Factors|immunologic factors|mesh-ancestor
64298276|NCT01369849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64298277|NCT01369849|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64298278|NCT01369849|Antibodies|antibodies|mesh-list
64298279|NCT01369849|Immunoglobulins|immunoglobulins|mesh-list
64298280|NCT01369849|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64298281|NCT01369849|Immunologic Factors|immunologic factors|mesh-ancestor
64439940|NCT00942331|Antimetabolites|antimetabolites|mesh-ancestor
64298284|NCT01369849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64298285|NCT01369849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64298286|NCT01369849|Alkylating Agents|alkylating agents|mesh-ancestor
64298287|NCT01369849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298288|NCT02716779|Interferons|interferons|mesh-list
64298289|NCT02716779|Ribavirin|ribavirin|mesh-list
64298290|NCT02716779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64298291|NCT02716779|Antiviral Agents|antiviral agents|mesh-ancestor
64298292|NCT02716779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64298293|NCT02716779|Antimetabolites|antimetabolites|mesh-ancestor
64298294|NCT02716779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298295|NCT02074189|Gemcitabine|gemcitabine|mesh-list
64298296|NCT02074189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64298297|NCT02074189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64298298|NCT02074189|Antimetabolites|antimetabolites|mesh-ancestor
64298300|NCT02074189|Antiviral Agents|antiviral agents|mesh-ancestor
64298309|NCT02079961|Micronutrients|micronutrients|mesh-list
64298310|NCT02079961|Trace Elements|trace elements|mesh-list
64298311|NCT02079961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298313|NCT03298347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64298314|NCT03298347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298315|NCT03298347|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64298316|NCT03298347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298317|NCT03298347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298318|NCT03298347|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64299061|NCT02095717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64299062|NCT02095717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64299063|NCT02095717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299064|NCT03099824|Avasopasem manganese|avasopasem manganese|mesh-list
64666024|NCT01463384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64299066|NCT03099824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299067|NCT03099824|Protective Agents|protective agents|mesh-ancestor
64299167|NCT04990323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299169|NCT04155008|Dronabinol|dronabinol|mesh-list
64299170|NCT04155008|Mirtazapine|mirtazapine|mesh-list
64299171|NCT04155008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64299172|NCT04155008|Antiemetics|antiemetics|mesh-ancestor
64299173|NCT04155008|Autonomic Agents|autonomic agents|mesh-ancestor
64299174|NCT04155008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64299921|NCT03283059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666067|NCT05062317|Leucovorin|leucovorin|mesh-list
64666069|NCT05062317|Fluorouracil|fluorouracil|mesh-list
64666091|NCT05062317|Vitamins|vitamins|mesh-ancestor
64666137|NCT05045937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64299922|NCT03283059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299923|NCT03283059|Cholinergic Agents|cholinergic agents|mesh-ancestor
64300428|NCT05023304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64300473|NCT05016128|Analgesics|analgesics|mesh-ancestor
64300474|NCT05016128|Sensory System Agents|sensory system agents|mesh-ancestor
64300475|NCT05016128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64300476|NCT05016128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300477|NCT05016128|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64300478|NCT05016128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64300479|NCT05016128|Anesthetics, General|anesthetics, general|mesh-ancestor
64300480|NCT05016128|Anesthetics|anesthetics|mesh-ancestor
64300481|NCT05016128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64300482|NCT05016128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64300483|NCT05016128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64300484|NCT05016128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64300485|NCT05016128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300488|NCT02111317|Verapamil|verapamil|mesh-list
64300489|NCT02111317|Peficitinib|peficitinib|mesh-list
64300490|NCT02111317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64300492|NCT02111317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64300493|NCT02111317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300494|NCT02111317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64300495|NCT02111317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300496|NCT02111317|Vasodilator Agents|vasodilator agents|mesh-ancestor
64300497|NCT02111317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666254|NCT01524302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64666343|NCT02802501|Artenimol|artenimol|mesh-list
64300498|NCT02111317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64300499|NCT02111317|Immunologic Factors|immunologic factors|mesh-ancestor
64300501|NCT03553615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64300502|NCT03553615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64300503|NCT05016206|Moxifloxacin|moxifloxacin|mesh-list
64300516|NCT05016206|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64300517|NCT05016206|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64300518|NCT05016206|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64300519|NCT02111473|Testosterone|testosterone|mesh-list
64300520|NCT02111473|Androgens|androgens|mesh-ancestor
64300521|NCT02111473|Hormones|hormones|mesh-ancestor
64300522|NCT02111473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64300523|NCT02111473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300524|NCT02111551|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
64300525|NCT02111551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64300526|NCT02111551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64300527|NCT02111551|Cholinergic Agents|cholinergic agents|mesh-ancestor
64300528|NCT02111551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64300529|NCT02111551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300530|NCT02111551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300531|NCT02119273|Prednisone|prednisone|mesh-list
64300532|NCT02119273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64300533|NCT02119273|Glucocorticoids|glucocorticoids|mesh-ancestor
64300534|NCT02119273|Hormones|hormones|mesh-ancestor
64300535|NCT02119273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64300536|NCT02119273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300537|NCT02119273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64300538|NCT02119273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64300539|NCT05029076|Liraglutide|liraglutide|mesh-list
64300540|NCT05029076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64300541|NCT05029076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300542|NCT05029076|Incretins|incretins|mesh-ancestor
64300543|NCT05029076|Hormones|hormones|mesh-ancestor
64300544|NCT05029076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64300545|NCT05016440|Lisinopril|lisinopril|mesh-list
64300546|NCT05016440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64300547|NCT05016440|Protease Inhibitors|protease inhibitors|mesh-ancestor
64300548|NCT05016440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300549|NCT05016440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300553|NCT05016440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300555|NCT02111629|Secnidazole|secnidazole|mesh-list
64300556|NCT02111629|Antifungal Agents|antifungal agents|mesh-ancestor
64300557|NCT02111629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64300669|NCT02117401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64300670|NCT02117401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64300671|NCT02117401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64300672|NCT02117401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64300673|NCT02117401|GABA Modulators|gaba modulators|mesh-ancestor
64300674|NCT02117401|GABA Agents|gaba agents|mesh-ancestor
64300675|NCT02117401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64300676|NCT02117401|Narcotics|narcotics|mesh-ancestor
64300677|NCT02117401|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64300678|NCT02117401|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64300679|NCT02117401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64300680|NCT04434404|Silymarin|silymarin|mesh-list
64300681|NCT04434404|Antioxidants|antioxidants|mesh-ancestor
64300823|NCT02112487|Macitentan|macitentan|mesh-list
64300834|NCT03094442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64300836|NCT03094442|Hormones|hormones|mesh-ancestor
64300837|NCT03094442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64300838|NCT03094442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64300839|NCT03094442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64300840|NCT02406742|Obinutuzumab|obinutuzumab|mesh-list
64300841|NCT02406742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64300842|NCT02406742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64300878|NCT02112799|Antiviral Agents|antiviral agents|mesh-ancestor
64300879|NCT02112799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64300881|NCT02122939|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64300882|NCT02122939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64300883|NCT02122939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64300884|NCT02122939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300885|NCT02122939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64300886|NCT02122939|Serotonin Agents|serotonin agents|mesh-ancestor
64300887|NCT02122939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301030|NCT02123563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64301227|NCT05019326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64301228|NCT05019326|Analgesics|analgesics|mesh-ancestor
64301229|NCT05019326|Sensory System Agents|sensory system agents|mesh-ancestor
64301230|NCT05019326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301231|NCT05019326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301232|NCT05019326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64666748|NCT01536938|Vitamins|vitamins|mesh-ancestor
64301233|NCT05019326|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64301234|NCT05019326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64301235|NCT05019326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64301236|NCT05019326|Antiviral Agents|antiviral agents|mesh-ancestor
64301237|NCT05019326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64301238|NCT05008250|Metoprolol|metoprolol|mesh-list
64301724|NCT02458755|Antimetabolites|antimetabolites|mesh-ancestor
64302086|NCT02133625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302087|NCT02133625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64302088|NCT02133625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302089|NCT02260687|Aflibercept|aflibercept|mesh-list
64302090|NCT02260687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64302091|NCT02260687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64302092|NCT02260687|Growth Substances|growth substances|mesh-ancestor
64302093|NCT02260687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302094|NCT02260687|Growth Inhibitors|growth inhibitors|mesh-ancestor
64302095|NCT02260687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302096|NCT03071822|Gemcitabine|gemcitabine|mesh-list
64302097|NCT03071822|Dexamethasone|dexamethasone|mesh-list
64302098|NCT03071822|Etoposide|etoposide|mesh-list
64302100|NCT03071822|Ifosfamide|ifosfamide|mesh-list
64303266|NCT02239523|Denosumab|denosumab|mesh-list
64303267|NCT02239523|Teriparatide|teriparatide|mesh-list
64303268|NCT02239523|Diphosphonates|diphosphonates|mesh-list
64303269|NCT02239523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64303270|NCT02239523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303271|NCT02239523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64303272|NCT02137213|Naloxone|naloxone|mesh-list
64303273|NCT02137213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64303274|NCT02137213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303395|NCT05579119|Hormones|hormones|mesh-ancestor
64303396|NCT05579119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64303455|NCT02138383|Antimitotic Agents|antimitotic agents|mesh-ancestor
64303456|NCT02138383|Mitosis Modulators|mitosis modulators|mesh-ancestor
64303554|NCT03569579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64303555|NCT03569579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303556|NCT03569579|Nootropic Agents|nootropic agents|mesh-ancestor
64303557|NCT03569579|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64303558|NCT03569579|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64303559|NCT03569579|Dopamine Agents|dopamine agents|mesh-ancestor
64303560|NCT03569579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64303561|NCT03569579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64303562|NCT02130661|Itraconazole|itraconazole|mesh-list
64303563|NCT02130661|Antifungal Agents|antifungal agents|mesh-ancestor
64303564|NCT02130661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64303593|NCT02248493|Tramadol|tramadol|mesh-list
64303594|NCT02248493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64303595|NCT02248493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64303790|NCT03566225|Fertility Agents|fertility agents|mesh-ancestor
64303791|NCT03566225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64303824|NCT03567629|Cetuximab|cetuximab|mesh-list
64303825|NCT03567629|Fluorouracil|fluorouracil|mesh-list
64303826|NCT03567629|Capecitabine|capecitabine|mesh-list
64303827|NCT03567629|Oxaliplatin|oxaliplatin|mesh-list
64303828|NCT03567629|Irinotecan|irinotecan|mesh-list
64303829|NCT03567629|Calcium|calcium|mesh-list
64303830|NCT03567629|Levoleucovorin|levoleucovorin|mesh-list
64303831|NCT03567629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64666910|NCT02981264|Sensory System Agents|sensory system agents|mesh-ancestor
64666917|NCT05470985|Ozanimod|ozanimod|mesh-list
64666969|NCT01595516|Vasodilator Agents|vasodilator agents|mesh-ancestor
64303832|NCT03567629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303833|NCT03567629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64303834|NCT03567629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64303835|NCT03567629|Growth Substances|growth substances|mesh-ancestor
64303904|NCT02935634|Rucaparib|rucaparib|mesh-list
64303905|NCT02935634|Linrodostat|linrodostat|mesh-list
64667038|NCT02981030|Luteolytic Agents|luteolytic agents|mesh-ancestor
64303906|NCT02935634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64303907|NCT02935634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303908|NCT02935634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64303909|NCT02935634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667104|NCT04980482|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64303910|NCT02935634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64303911|NCT02935634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303913|NCT03068234|Analgesics|analgesics|mesh-ancestor
64303914|NCT03068234|Sensory System Agents|sensory system agents|mesh-ancestor
64303915|NCT03068234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303916|NCT03068234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303917|NCT03068234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64303918|NCT03068234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64303988|NCT03069248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303989|NCT03069248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64303990|NCT03069248|Antiviral Agents|antiviral agents|mesh-ancestor
64303991|NCT03069248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64303992|NCT05730062|Oxycodone|oxycodone|mesh-list
64303993|NCT05730062|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64304000|NCT03068936|Cisplatin|cisplatin|mesh-list
64304001|NCT03068936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304002|NCT05017610|Lomustine|lomustine|mesh-list
64304003|NCT05017610|Methimazole|methimazole|mesh-list
64304004|NCT05017610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64304005|NCT05017610|Alkylating Agents|alkylating agents|mesh-ancestor
64304006|NCT05017610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304007|NCT05017610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304008|NCT05017610|Antithyroid Agents|antithyroid agents|mesh-ancestor
64304009|NCT05017610|Hormone Antagonists|hormone antagonists|mesh-ancestor
64304011|NCT05017610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304025|NCT05004116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304026|NCT05004116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304027|NCT05004116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64304028|NCT05004116|Alkylating Agents|alkylating agents|mesh-ancestor
64304029|NCT02452762|Vitamin D|vitamin d|mesh-list
64667238|NCT02247362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667241|NCT02920749|Propofol|propofol|mesh-list
64304030|NCT02452762|Cholecalciferol|cholecalciferol|mesh-list
64304031|NCT02452762|Vitamins|vitamins|mesh-ancestor
64304032|NCT02452762|Micronutrients|micronutrients|mesh-ancestor
64304033|NCT02452762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304034|NCT02452762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64304035|NCT02452762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64304036|NCT04886414|Hand Sanitizers|hand sanitizers|mesh-list
64304037|NCT04886414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64304062|NCT04626128|Axitinib|axitinib|mesh-list
64304063|NCT04626128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64304064|NCT04626128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64304065|NCT04626128|Growth Substances|growth substances|mesh-ancestor
64304066|NCT04626128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304067|NCT04626128|Growth Inhibitors|growth inhibitors|mesh-ancestor
64304068|NCT04626128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304069|NCT04626128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64304070|NCT04626128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304071|NCT04626128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304072|NCT05487092|Letrozole|letrozole|mesh-list
64304073|NCT05487092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304074|NCT05487092|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64304075|NCT05487092|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64304089|NCT05478278|Psilocybin|psilocybin|mesh-list
64304090|NCT05478278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64304091|NCT05478278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64304092|NCT05478278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64304093|NCT05478278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64304094|NCT05478278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304095|NCT05478278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304096|NCT05478278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304097|NCT05478278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304098|NCT05478278|Hallucinogens|hallucinogens|mesh-ancestor
64304099|NCT05478278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64304100|NCT03067688|Amlodipine|amlodipine|mesh-list
64667287|NCT02921061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304101|NCT03067688|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
64304102|NCT03067688|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64304103|NCT03067688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64304104|NCT03067688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64304105|NCT03067688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64304117|NCT03067688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64304118|NCT02396758|Plasminogen|plasminogen|mesh-list
64304119|NCT02396758|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64304120|NCT02396758|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64304121|NCT02396758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64304122|NCT02396758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304123|NCT05728424|Amoxicillin|amoxicillin|mesh-list
64304124|NCT05728424|Levofloxacin|levofloxacin|mesh-list
64304125|NCT05728424|Ofloxacin|ofloxacin|mesh-list
64304126|NCT05728424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64304128|NCT05728424|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64304129|NCT05728424|Renal Agents|renal agents|mesh-ancestor
64304130|NCT05728424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64304131|NCT05728424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64304132|NCT05728424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304133|NCT05728424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304134|NCT05728424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304143|NCT05515796|Trastuzumab|trastuzumab|mesh-list
64304144|NCT05515796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64304145|NCT05515796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304146|NCT05728268|Paclitaxel|paclitaxel|mesh-list
64304147|NCT05728268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64304149|NCT05728268|Tubulin Modulators|tubulin modulators|mesh-ancestor
64304176|NCT05482256|Listerine|listerine|mesh-list
64304177|NCT05482256|Sodium Fluoride|sodium fluoride|mesh-list
64304178|NCT05482256|Cariostatic Agents|cariostatic agents|mesh-ancestor
64304179|NCT05482256|Protective Agents|protective agents|mesh-ancestor
64304180|NCT05482256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304181|NCT05482256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64304182|NCT05482256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64304183|NCT01651936|Methotrexate|methotrexate|mesh-list
64304184|NCT01651936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64304185|NCT01651936|Abortifacient Agents|abortifacient agents|mesh-ancestor
64304186|NCT01651936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64304187|NCT01651936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304188|NCT01651936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64304189|NCT01651936|Antimetabolites|antimetabolites|mesh-ancestor
64304190|NCT01651936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304191|NCT01651936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304192|NCT01651936|Dermatologic Agents|dermatologic agents|mesh-ancestor
64304193|NCT01651936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304194|NCT01651936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64304195|NCT01651936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64304196|NCT01651936|Immunologic Factors|immunologic factors|mesh-ancestor
64304197|NCT01651936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64304198|NCT01651936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64667343|NCT01880099|Nootropic Agents|nootropic agents|mesh-ancestor
64304199|NCT04075916|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64304200|NCT04075916|Antiviral Agents|antiviral agents|mesh-ancestor
64304201|NCT04075916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64304210|NCT05458856|Contraceptive Agents|contraceptive agents|mesh-ancestor
64304231|NCT05723588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64304232|NCT05723588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304234|NCT01651780|Calcium heparin|calcium heparin|mesh-list
64304235|NCT01651780|Bivalirudin|bivalirudin|mesh-list
64304236|NCT01651780|Anticoagulants|anticoagulants|mesh-ancestor
64304237|NCT01651780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64304238|NCT01651780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64304239|NCT01651780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304240|NCT01651780|Antithrombins|antithrombins|mesh-ancestor
64304241|NCT01651780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64304242|NCT01651780|Protease Inhibitors|protease inhibitors|mesh-ancestor
64304243|NCT01651780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304244|NCT02394730|Vorapaxar|vorapaxar|mesh-list
64304245|NCT02394730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64304324|NCT03065660|Abortifacient Agents|abortifacient agents|mesh-ancestor
64304325|NCT03065660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64304326|NCT03065660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304327|NCT03065660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64304328|NCT03065660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64304329|NCT03065660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64304330|NCT03065660|Contraceptive Agents|contraceptive agents|mesh-ancestor
64304331|NCT03065660|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64304378|NCT05619848|Midazolam|midazolam|mesh-list
64304379|NCT05619848|Remifentanil|remifentanil|mesh-list
64304380|NCT05619848|Bromides|bromides|mesh-list
64304381|NCT05619848|Propofol|propofol|mesh-list
64304382|NCT05619848|Etomidate|etomidate|mesh-list
64304383|NCT05619848|Rocuronium|rocuronium|mesh-list
64304384|NCT05619848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64304966|NCT03595592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64304967|NCT03595592|Cyclophosphamide|cyclophosphamide|mesh-list
64304968|NCT03595592|Carboplatin|carboplatin|mesh-list
64304969|NCT03595592|Doxorubicin|doxorubicin|mesh-list
64304970|NCT03595592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64304971|NCT03595592|Trastuzumab|trastuzumab|mesh-list
64304972|NCT03595592|Atezolizumab|atezolizumab|mesh-list
64304973|NCT03595592|Pertuzumab|pertuzumab|mesh-list
64304974|NCT03595592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64304975|NCT03595592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304991|NCT03595592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64304992|NCT01355081|Vortioxetine|vortioxetine|mesh-list
64304993|NCT01355081|Antidepressive Agents|antidepressive agents|mesh-ancestor
64304994|NCT01355081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64304995|NCT01355081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64304996|NCT01355081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64304997|NCT01355081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64304998|NCT01355081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304999|NCT01355081|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64305000|NCT01355081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64305001|NCT01355081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64305002|NCT01355081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305003|NCT01355081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64305004|NCT01355081|Serotonin Agents|serotonin agents|mesh-ancestor
64305005|NCT01355081|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64305006|NCT01355081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64305007|NCT01355081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64305008|NCT01355081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64305009|NCT02259959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64305010|NCT02259959|Tiotropium Bromide|tiotropium bromide|mesh-list
64305011|NCT02259959|Olodaterol|olodaterol|mesh-list
64305012|NCT02259959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64305013|NCT02259959|Autonomic Agents|autonomic agents|mesh-ancestor
64305014|NCT02259959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64305015|NCT02259959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305016|NCT02259959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64305018|NCT02259959|Parasympatholytics|parasympatholytics|mesh-ancestor
64305019|NCT02259959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64305020|NCT02259959|Cholinergic Agents|cholinergic agents|mesh-ancestor
64667532|NCT02223338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64667543|NCT01887587|Ixazomib|ixazomib|mesh-list
64305021|NCT02259959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64305022|NCT02259959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305023|NCT03062462|Clopidogrel|clopidogrel|mesh-list
64305186|NCT05084521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305187|NCT05084521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305190|NCT05069857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305191|NCT05069857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64305193|NCT05069857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305401|NCT03545347|Hormones|hormones|mesh-ancestor
64305402|NCT03545347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64305403|NCT03545347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305404|NCT03545347|Anabolic Agents|anabolic agents|mesh-ancestor
64305405|NCT03545347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64305406|NCT02815397|Metformin|metformin|mesh-list
64305407|NCT02815397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64305408|NCT02815397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305409|NCT04980404|Decitabine|decitabine|mesh-list
64305410|NCT04980404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64305411|NCT04980404|Antimetabolites|antimetabolites|mesh-ancestor
64305484|NCT03063866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64305485|NCT03063866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305486|NCT03063866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64305487|NCT03063866|Anesthetics, General|anesthetics, general|mesh-ancestor
64305488|NCT03063866|Anesthetics|anesthetics|mesh-ancestor
64305489|NCT03063866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64305490|NCT03063866|Narcotics|narcotics|mesh-ancestor
64305491|NCT03063866|Analgesics|analgesics|mesh-ancestor
64305492|NCT03063866|Sensory System Agents|sensory system agents|mesh-ancestor
64305528|NCT04980170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305529|NCT04980170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305530|NCT04980170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64305531|NCT02387164|Vitamin D|vitamin d|mesh-list
64305532|NCT02387164|Cholecalciferol|cholecalciferol|mesh-list
64305604|NCT02048423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305606|NCT02037035|Analgesics|analgesics|mesh-ancestor
64305607|NCT02037035|Sensory System Agents|sensory system agents|mesh-ancestor
64305608|NCT02037035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64305609|NCT02037035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305610|NCT02037035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64305611|NCT02037035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64305612|NCT02037035|Anesthetics, General|anesthetics, general|mesh-ancestor
64305613|NCT02037035|Anesthetics|anesthetics|mesh-ancestor
64305614|NCT02037035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64305615|NCT02037035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64305616|NCT02037035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64305650|NCT03562169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64305651|NCT03562169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64305652|NCT03562169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64305653|NCT03562169|Growth Substances|growth substances|mesh-ancestor
64305654|NCT03562169|Growth Inhibitors|growth inhibitors|mesh-ancestor
64305655|NCT03562169|Protease Inhibitors|protease inhibitors|mesh-ancestor
64305656|NCT03562169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305657|NCT03562169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305658|NCT03562169|Glycine Agents|glycine agents|mesh-ancestor
64305659|NCT03562169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64305660|NCT02427802|Gentamicins|gentamicins|mesh-list
64305661|NCT02427802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64305697|NCT02048969|GABA Modulators|gaba modulators|mesh-ancestor
64305698|NCT02048969|GABA Agents|gaba agents|mesh-ancestor
64305699|NCT02048969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64305973|NCT02052713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64305974|NCT02052713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305975|NCT02052713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305976|NCT02052713|Urological Agents|urological agents|mesh-ancestor
64305977|NCT02052713|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64305978|NCT02052713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64305979|NCT02052713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305980|NCT02052713|Hormone Antagonists|hormone antagonists|mesh-ancestor
64305981|NCT02052713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64667716|NCT02247518|Adrenergic Agents|adrenergic agents|mesh-ancestor
64305982|NCT02057003|Sofosbuvir|sofosbuvir|mesh-list
64305983|NCT02057003|Grazoprevir|grazoprevir|mesh-list
64306014|NCT02389816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306015|NCT02389816|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64306016|NCT02389816|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64306017|NCT02389816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64306018|NCT02389816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306019|NCT02389816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64306020|NCT02389816|Serotonin Agents|serotonin agents|mesh-ancestor
64306021|NCT02389816|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64306022|NCT02389816|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64306023|NCT02389816|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64306024|NCT02389816|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64306025|NCT02388724|Lansoprazole|lansoprazole|mesh-list
64667785|NCT02328755|Antimetabolites|antimetabolites|mesh-ancestor
64306026|NCT02388724|Dexlansoprazole|dexlansoprazole|mesh-list
64306027|NCT02388724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64306173|NCT02060201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64306174|NCT02060201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306180|NCT02060201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306181|NCT03561233|Omeprazole|omeprazole|mesh-list
64306182|NCT03561233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64306183|NCT03561233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64306184|NCT03561233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64306185|NCT03561233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306220|NCT02058641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306222|NCT02059889|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64306223|NCT02059889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64306224|NCT02059889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306225|NCT02059889|Antimetabolites|antimetabolites|mesh-ancestor
64306226|NCT02059889|Antiviral Agents|antiviral agents|mesh-ancestor
64306252|NCT02060591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64306253|NCT02060591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306254|NCT02060591|Sensory System Agents|sensory system agents|mesh-ancestor
64306255|NCT02060591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64306256|NCT02060669|Capecitabine|capecitabine|mesh-list
64306257|NCT02060669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64306258|NCT02060669|Antimetabolites|antimetabolites|mesh-ancestor
64306259|NCT02060669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306260|NCT02060669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64306261|NCT04428008|Thymalfasin|thymalfasin|mesh-list
64306262|NCT04428008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64667982|NCT02697344|Gossypol|gossypol|mesh-list
64306263|NCT04428008|Immunologic Factors|immunologic factors|mesh-ancestor
64306264|NCT04428008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306265|NCT02046590|Propofol|propofol|mesh-list
64306266|NCT02046590|Anesthetics|anesthetics|mesh-ancestor
64306289|NCT02061917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64306290|NCT02061917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306291|NCT02061917|Respiratory System Agents|respiratory system agents|mesh-ancestor
64306292|NCT03560375|Empagliflozin|empagliflozin|mesh-list
64306293|NCT03560375|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64306294|NCT03560375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306295|NCT03560375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64306296|NCT03560375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306297|NCT02382016|Macitentan|macitentan|mesh-list
64306298|NCT02382016|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64306299|NCT02382016|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64306300|NCT02382016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306301|NCT02382016|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64306302|NCT02422186|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64306303|NCT02422186|Citalopram|citalopram|mesh-list
64306304|NCT02422186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64306305|NCT02422186|Sertraline|sertraline|mesh-list
64306306|NCT02422186|Antidepressive Agents|antidepressive agents|mesh-list
64306307|NCT02422186|Esketamine|esketamine|mesh-list
64306308|NCT02422186|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64306547|NCT02066207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306549|NCT01370525|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64306550|NCT01370525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64306551|NCT01370525|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64306552|NCT01370525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306617|NCT02072213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64306618|NCT02072213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306619|NCT02072213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306620|NCT02072213|Urological Agents|urological agents|mesh-ancestor
64306621|NCT02072291|Nifedipine|nifedipine|mesh-list
64668037|NCT04976777|Autonomic Agents|autonomic agents|mesh-ancestor
64306622|NCT02072291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64306623|NCT02072291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64306624|NCT02072291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306625|NCT02072291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64306626|NCT02072291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306627|NCT02072291|Vasodilator Agents|vasodilator agents|mesh-ancestor
64306628|NCT02072291|Tocolytic Agents|tocolytic agents|mesh-ancestor
64306629|NCT02072291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64306630|NCT02072525|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64306631|NCT02072525|Immunologic Factors|immunologic factors|mesh-ancestor
64306632|NCT02072525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668093|NCT02143466|Durvalumab|durvalumab|mesh-list
64306633|NCT03059888|Abatacept|abatacept|mesh-list
64306634|NCT03059888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64306635|NCT03059888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306636|NCT03059888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64306637|NCT03059888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64306638|NCT03059888|Immunologic Factors|immunologic factors|mesh-ancestor
64306639|NCT03059888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306640|NCT03059888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64306641|NCT04976816|Triamcinolone|triamcinolone|mesh-list
64306642|NCT04976816|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64306750|NCT03060044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64668140|NCT02987465|Acetylcholine|acetylcholine|mesh-list
64306785|NCT03062150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64306786|NCT03062150|Antitubercular Agents|antitubercular agents|mesh-ancestor
64306787|NCT03062150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64306788|NCT03062150|Antimetabolites|antimetabolites|mesh-ancestor
64306789|NCT03062150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306790|NCT03062150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64668192|NCT01850108|Sirolimus|sirolimus|mesh-list
64306791|NCT03061916|Chlorhexidine|chlorhexidine|mesh-list
64306792|NCT03061916|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64306906|NCT03061604|Octreotide|octreotide|mesh-list
64306990|NCT03061058|Irinotecan|irinotecan|mesh-list
64306991|NCT03061058|Pemetrexed|pemetrexed|mesh-list
64306992|NCT03061058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64306993|NCT03061058|Tubulin Modulators|tubulin modulators|mesh-ancestor
64306994|NCT03061058|Antimitotic Agents|antimitotic agents|mesh-ancestor
64306995|NCT03061058|Mitosis Modulators|mitosis modulators|mesh-ancestor
64307126|NCT04959500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64307127|NCT04959500|Alkylating Agents|alkylating agents|mesh-ancestor
64307128|NCT04959500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307129|NCT04959500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307130|NCT04950530|Emtricitabine|emtricitabine|mesh-list
64668251|NCT02944461|Leprostatic Agents|leprostatic agents|mesh-ancestor
64307131|NCT04950530|Antiviral Agents|antiviral agents|mesh-ancestor
64307132|NCT04950530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64307133|NCT04950530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64307134|NCT04950530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64307135|NCT04950530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307136|NCT04950530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307168|NCT02078609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64307169|NCT02078609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64668304|NCT02227706|Hemostatics|hemostatics|mesh-ancestor
64307170|NCT02078609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307171|NCT04957940|SMOFlipid|smoflipid|mesh-list
64307172|NCT04957940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64307173|NCT04957940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64307174|NCT04957940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64307175|NCT03060278|Nicotine|nicotine|mesh-list
64307176|NCT03060278|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64307177|NCT03060278|Autonomic Agents|autonomic agents|mesh-ancestor
64307178|NCT03060278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64307179|NCT03060278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307210|NCT04947956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668370|NCT03115827|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64668376|NCT01915823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64307211|NCT03254511|Enoxaparin|enoxaparin|mesh-list
64307212|NCT03254511|Enoxaparin sodium|enoxaparin sodium|mesh-list
64307213|NCT03254511|Anticoagulants|anticoagulants|mesh-ancestor
64307220|NCT04947566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64307222|NCT04947566|Sensory System Agents|sensory system agents|mesh-ancestor
64307348|NCT03238131|Tubulin Modulators|tubulin modulators|mesh-ancestor
64307349|NCT03238131|Antimitotic Agents|antimitotic agents|mesh-ancestor
64307350|NCT03238131|Mitosis Modulators|mitosis modulators|mesh-ancestor
64307351|NCT03238131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307352|NCT03238131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307353|NCT01369433|Sirolimus|sirolimus|mesh-list
64307354|NCT01369433|Paclitaxel|paclitaxel|mesh-list
64307355|NCT01369433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64307357|NCT01369433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64307358|NCT01369433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307359|NCT01369433|Tubulin Modulators|tubulin modulators|mesh-ancestor
64307360|NCT01369433|Antimitotic Agents|antimitotic agents|mesh-ancestor
64307361|NCT01369433|Mitosis Modulators|mitosis modulators|mesh-ancestor
64307362|NCT01369433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307363|NCT01369433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64307364|NCT01369433|Antimetabolites|antimetabolites|mesh-ancestor
64307365|NCT01369433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64307496|NCT03240783|Glucocorticoids|glucocorticoids|mesh-ancestor
64307497|NCT03240783|Hormones|hormones|mesh-ancestor
64307498|NCT03240783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64307499|NCT03240783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64307500|NCT03240783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307569|NCT04933292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307570|NCT04933292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64307571|NCT04933292|Antitubercular Agents|antitubercular agents|mesh-ancestor
64307572|NCT04933292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64307573|NCT04933292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64307575|NCT04933292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307576|NCT04933292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64307577|NCT04933292|Antiemetics|antiemetics|mesh-ancestor
64307578|NCT04933292|Autonomic Agents|autonomic agents|mesh-ancestor
64307579|NCT04933292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64307839|NCT03234699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64307840|NCT03234699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64307841|NCT03234699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307842|NCT03234699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64307843|NCT03234699|Antidepressive Agents|antidepressive agents|mesh-ancestor
64307844|NCT03234699|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64307845|NCT03234699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64307846|NCT03234699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64307847|NCT03234699|Dopamine Agents|dopamine agents|mesh-ancestor
64307848|NCT03234699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64308062|NCT03234153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308063|NCT03056924|Vaccines|vaccines|mesh-list
64308064|NCT03056924|Immunologic Factors|immunologic factors|mesh-ancestor
64308154|NCT04928066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308155|NCT03222765|Metformin|metformin|mesh-list
64308156|NCT03222765|Linagliptin|linagliptin|mesh-list
64308157|NCT03222765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64300316|NCT03292731|Progestins|progestins|mesh-ancestor
64308158|NCT03222765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308159|NCT03222765|Incretins|incretins|mesh-ancestor
64308160|NCT03222765|Hormones|hormones|mesh-ancestor
64308161|NCT03222765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64308162|NCT03222765|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64308163|NCT03222765|Protease Inhibitors|protease inhibitors|mesh-ancestor
64308164|NCT03222765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64308165|NCT03222765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308166|NCT04485585|Tamsulosin|tamsulosin|mesh-list
64308167|NCT04485585|Mirabegron|mirabegron|mesh-list
64308168|NCT04485585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64308169|NCT04485585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64308170|NCT04485585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64308171|NCT04485585|Adrenergic Agents|adrenergic agents|mesh-ancestor
64308172|NCT04485585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64308173|NCT04485585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308174|NCT04485585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308175|NCT04485585|Urological Agents|urological agents|mesh-ancestor
64308176|NCT04485585|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64308177|NCT04485585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64308178|NCT04485585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64308308|NCT04407650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64308309|NCT00105157|Raltegravir Potassium|raltegravir potassium|mesh-list
64300560|NCT02111629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300562|NCT02111629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64308317|NCT00105157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308319|NCT03220815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64308320|NCT03220815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308321|NCT03220815|Sympathomimetics|sympathomimetics|mesh-ancestor
64308322|NCT03220815|Autonomic Agents|autonomic agents|mesh-ancestor
64308323|NCT03220815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64308355|NCT03232125|Autonomic Agents|autonomic agents|mesh-ancestor
64308356|NCT03232125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64308357|NCT03232125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308358|NCT03232125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64308359|NCT03232125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64308360|NCT03232125|Serotonin Agents|serotonin agents|mesh-ancestor
64308363|NCT03224637|Acetaminophen|acetaminophen|mesh-list
64308364|NCT03224637|Ketorolac|ketorolac|mesh-list
64308365|NCT03224637|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64300665|NCT02117401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64308366|NCT03224637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64308367|NCT03224637|Analgesics|analgesics|mesh-ancestor
64308368|NCT03224637|Sensory System Agents|sensory system agents|mesh-ancestor
64308369|NCT03224637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64308402|NCT04924868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64308403|NCT04402346|Pancrelipase|pancrelipase|mesh-list
64308404|NCT04402346|Pancreatin|pancreatin|mesh-list
64308405|NCT04402346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64308406|NCT03220191|Palbociclib|palbociclib|mesh-list
64308407|NCT03220191|Rabeprazole|rabeprazole|mesh-list
64308408|NCT03220191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308409|NCT03220191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64308410|NCT03220191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64308411|NCT03220191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308412|NCT03220191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64308478|NCT02143531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64308481|NCT02143531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64308482|NCT02143531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64300934|NCT05013164|Micronutrients|micronutrients|mesh-ancestor
64300935|NCT05013164|Hematinics|hematinics|mesh-ancestor
64300936|NCT02251951|Paclitaxel|paclitaxel|mesh-list
64300937|NCT02251951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64300938|NCT02251951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308483|NCT02143531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64308484|NCT02143531|Dopamine Agents|dopamine agents|mesh-ancestor
64308485|NCT02143531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64308486|NCT04485117|Anesthetics|anesthetics|mesh-list
64308488|NCT04485117|Sevoflurane|sevoflurane|mesh-list
64308489|NCT04485117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64308490|NCT04485117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308491|NCT04485117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64301239|NCT05008250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64301240|NCT05008250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64301241|NCT05008250|Sympatholytics|sympatholytics|mesh-ancestor
64438158|NCT04357951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64438159|NCT04357951|Antimetabolites|antimetabolites|mesh-ancestor
64308492|NCT04485117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64308493|NCT04485117|Anesthetics, General|anesthetics, general|mesh-ancestor
64308522|NCT00482833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64308523|NCT00482833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308524|NCT00482833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64308525|NCT00482833|Antimetabolites|antimetabolites|mesh-ancestor
64308526|NCT00482833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301311|NCT04959812|Sufentanil|sufentanil|mesh-list
64301313|NCT04959812|Narcotics|narcotics|mesh-ancestor
64301314|NCT04959812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64301315|NCT04959812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301316|NCT04959812|Analgesics|analgesics|mesh-ancestor
64301323|NCT03280095|Acetaminophen|acetaminophen|mesh-list
64301325|NCT03280095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64301326|NCT03280095|Analgesics|analgesics|mesh-ancestor
64301327|NCT03280095|Sensory System Agents|sensory system agents|mesh-ancestor
64301328|NCT03280095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301329|NCT03280095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301330|NCT03280095|Antipyretics|antipyretics|mesh-ancestor
64301331|NCT03280095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64301332|NCT03280095|Narcotics|narcotics|mesh-ancestor
64301333|NCT03280095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64301334|NCT03280095|Antitussive Agents|antitussive agents|mesh-ancestor
64301335|NCT03280095|Respiratory System Agents|respiratory system agents|mesh-ancestor
64301338|NCT04463030|Micronutrients|micronutrients|mesh-ancestor
64301339|NCT04463030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301340|NCT04463030|Antioxidants|antioxidants|mesh-ancestor
64301341|NCT04463030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301343|NCT03269721|Carbon Monoxide|carbon monoxide|mesh-list
64301344|NCT03269721|Antimetabolites|antimetabolites|mesh-ancestor
64301347|NCT03269721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64301348|NCT03269721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301349|NCT05010434|Bevacizumab|bevacizumab|mesh-list
64301350|NCT05010434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64301351|NCT05010434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301354|NCT05010434|Growth Substances|growth substances|mesh-ancestor
64308527|NCT00482833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308528|NCT00482833|Dermatologic Agents|dermatologic agents|mesh-ancestor
64308529|NCT00482833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64308530|NCT00482833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64308531|NCT00482833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64308532|NCT00482833|Immunologic Factors|immunologic factors|mesh-ancestor
64308533|NCT00482833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64308534|NCT00482833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64308535|NCT00482833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64308536|NCT00482833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64308537|NCT00482833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64308538|NCT00482833|Keratolytic Agents|keratolytic agents|mesh-ancestor
64308539|NCT02451033|Hormones|hormones|mesh-list
64308540|NCT02451033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64308614|NCT03213639|Esomeprazole|esomeprazole|mesh-list
64308615|NCT03213639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64308616|NCT03213639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64308617|NCT03213639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64308618|NCT03213639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64308619|NCT03213639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308621|NCT03231033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64308622|NCT03231033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301356|NCT05010434|Growth Inhibitors|growth inhibitors|mesh-ancestor
64301357|NCT05010356|Insulin|insulin|mesh-list
64301358|NCT05010356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64301359|NCT05010356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308623|NCT02141347|Durvalumab|durvalumab|mesh-list
64308624|NCT02141347|Tremelimumab|tremelimumab|mesh-list
64308625|NCT02141347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64308626|NCT02141347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308627|NCT02254759|Midazolam|midazolam|mesh-list
64308628|NCT02254759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64308629|NCT02254759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64308630|NCT02254759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64308631|NCT02254759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308632|NCT02254759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64308633|NCT02254759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64308634|NCT02254759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64308635|NCT02254759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64301395|NCT03265197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64301396|NCT03265197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301397|NCT03265197|Sensory System Agents|sensory system agents|mesh-ancestor
64301398|NCT03265197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301399|NCT03265197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64301400|NCT03265197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64301401|NCT03265197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64301402|NCT03265197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64301410|NCT04944836|Hormone Antagonists|hormone antagonists|mesh-ancestor
64301411|NCT04944836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64301412|NCT04944836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301413|NCT04944836|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64301414|NCT04944836|Fertility Agents|fertility agents|mesh-ancestor
64301416|NCT04944836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64301417|NCT04944836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64301419|NCT04940390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64301420|NCT04940390|Dopamine Agonists|dopamine agonists|mesh-ancestor
64301421|NCT04940390|Dopamine Agents|dopamine agents|mesh-ancestor
64301423|NCT04940390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308658|NCT02148913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64308660|NCT02148913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308661|NCT02148913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308683|NCT03208335|Endostatins|endostatins|mesh-list
64308684|NCT03208335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308685|NCT03208335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64308686|NCT03208335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64308687|NCT03208335|Growth Substances|growth substances|mesh-ancestor
64308688|NCT03208335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308720|NCT02376790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64308721|NCT02376790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64308722|NCT02376790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64308724|NCT02141737|Fentanyl|fentanyl|mesh-list
64308725|NCT02141737|Midazolam|midazolam|mesh-list
64301446|NCT03078062|Dexamethasone|dexamethasone|mesh-list
64301447|NCT03078062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64301450|NCT03078062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301452|NCT03078062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64308726|NCT02141737|Etomidate|etomidate|mesh-list
64308727|NCT02141737|Rocuronium|rocuronium|mesh-list
64308728|NCT02141737|Anesthetics, Local|anesthetics, local|mesh-ancestor
64308729|NCT02141737|Anesthetics|anesthetics|mesh-ancestor
64308730|NCT02141737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64308731|NCT02141737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308732|NCT02141737|Sensory System Agents|sensory system agents|mesh-ancestor
64308733|NCT02141737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64308734|NCT02141737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64308757|NCT02254447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64301708|NCT03768115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64308758|NCT02254447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64308759|NCT02254447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64308760|NCT02254447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308761|NCT02376166|Metformin|metformin|mesh-list
64308762|NCT02376166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64308763|NCT02376166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308764|NCT03207165|Dobutamine|dobutamine|mesh-list
64308779|NCT03207165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64308780|NCT03207165|Vasodilator Agents|vasodilator agents|mesh-ancestor
64302485|NCT03071042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302492|NCT03582605|Amoxicillin|amoxicillin|mesh-list
64308781|NCT03207165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64308782|NCT03207165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64308784|NCT02142205|Immunologic Factors|immunologic factors|mesh-ancestor
64308785|NCT02142205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308787|NCT03209427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64308878|NCT02521311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308879|NCT02521311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308880|NCT02521311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64308881|NCT03207477|Mydriatics|mydriatics|mesh-list
64302881|NCT04988048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302882|NCT04982900|Aflutinib|aflutinib|mesh-list
64302883|NCT04982900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64302884|NCT04982900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302885|NCT04982900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302886|NCT03256071|Decitabine|decitabine|mesh-list
64303114|NCT03246555|Indapamide|indapamide|mesh-list
64303115|NCT03246555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64303116|NCT03246555|Diuretics|diuretics|mesh-ancestor
64303117|NCT03246555|Natriuretic Agents|natriuretic agents|mesh-ancestor
64303118|NCT03246555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303119|NCT03246555|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64303125|NCT03576053|Lidocaine|lidocaine|mesh-list
64308882|NCT03207477|Autonomic Agents|autonomic agents|mesh-ancestor
64308883|NCT03207477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64308884|NCT03207477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308885|NCT02452515|Fulacimstat|fulacimstat|mesh-list
64308886|NCT02452515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64308918|NCT03201159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64308919|NCT03201159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64308921|NCT02149927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64308922|NCT02149927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64308923|NCT02149927|Anesthetics, General|anesthetics, general|mesh-ancestor
64308924|NCT02149927|Anesthetics|anesthetics|mesh-ancestor
64308925|NCT02149927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64308926|NCT02149927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308927|NCT02142751|Meropenem|meropenem|mesh-list
64303322|NCT02137525|Anesthetics, General|anesthetics, general|mesh-ancestor
64308928|NCT02142751|Ceftriaxone|ceftriaxone|mesh-list
64308929|NCT02142751|Fosfomycin|fosfomycin|mesh-list
64308930|NCT02142751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64308931|NCT02142751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64308963|NCT02150161|Anesthetics, General|anesthetics, general|mesh-ancestor
64308964|NCT02150161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64308965|NCT02150161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64308966|NCT02150161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64308967|NCT02150161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64308968|NCT02150161|Narcotics|narcotics|mesh-ancestor
64308969|NCT02150161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64304208|NCT05458856|Luteolytic Agents|luteolytic agents|mesh-ancestor
64308970|NCT03200613|Heparin|heparin|mesh-list
64308971|NCT03200613|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64308972|NCT03200613|Tinzaparin|tinzaparin|mesh-list
64308973|NCT03200613|Dalteparin|dalteparin|mesh-list
64308974|NCT03200613|Apixaban|apixaban|mesh-list
64308975|NCT03200613|Anticoagulants|anticoagulants|mesh-ancestor
64308976|NCT03200613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64308977|NCT03200613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64309007|NCT02448069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309009|NCT02448069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64309010|NCT02449941|Rabeprazole|rabeprazole|mesh-list
64309011|NCT02449941|Pantoprazole|pantoprazole|mesh-list
64309012|NCT02449941|Lansoprazole|lansoprazole|mesh-list
64309013|NCT02449941|Dexlansoprazole|dexlansoprazole|mesh-list
64304716|NCT04071626|Ertugliflozin|ertugliflozin|mesh-list
64309014|NCT02449941|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64309016|NCT02449941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64309017|NCT02449941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309018|NCT02449941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309168|NCT02447289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64309169|NCT02447289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64309170|NCT02447289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309171|NCT02447289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64305120|NCT05107453|Levobupivacaine|levobupivacaine|mesh-list
64309172|NCT02447289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64309173|NCT02447289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64309174|NCT02447289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64309175|NCT02447289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64309176|NCT02447289|GABA Modulators|gaba modulators|mesh-ancestor
64309177|NCT02447289|GABA Agents|gaba agents|mesh-ancestor
64309178|NCT02447211|Doxepin|doxepin|mesh-list
64309179|NCT02447211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64309180|NCT02447211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64309181|NCT02447211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64309182|NCT02447211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309183|NCT02447211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64309184|NCT02447211|Antidepressive Agents|antidepressive agents|mesh-ancestor
64309185|NCT02447211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64309186|NCT02447211|Histamine Antagonists|histamine antagonists|mesh-ancestor
64309187|NCT02447211|Histamine Agents|histamine agents|mesh-ancestor
64309188|NCT02447211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64305369|NCT03063788|Micronutrients|micronutrients|mesh-ancestor
64305388|NCT04377932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305396|NCT04377932|Antimetabolites|antimetabolites|mesh-ancestor
64309189|NCT02447211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309218|NCT03118479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64309219|NCT03118479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64309220|NCT03118479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309221|NCT03118479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309222|NCT03118479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64309223|NCT03118479|Hormone Antagonists|hormone antagonists|mesh-ancestor
64309224|NCT03197961|Tenofovir|tenofovir|mesh-list
64309267|NCT03197571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305462|NCT02392624|Respiratory System Agents|respiratory system agents|mesh-ancestor
64309269|NCT03197571|Immunologic Factors|immunologic factors|mesh-ancestor
64309270|NCT03197571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309271|NCT03197571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64309272|NCT03197571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64309273|NCT03197571|Alkylating Agents|alkylating agents|mesh-ancestor
64309274|NCT03197571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64309275|NCT03197571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64309276|NCT03197571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64305545|NCT02047799|Vitamins|vitamins|mesh-ancestor
64309277|NCT03197571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64309278|NCT03197571|Growth Substances|growth substances|mesh-ancestor
64309279|NCT03197571|Growth Inhibitors|growth inhibitors|mesh-ancestor
64309280|NCT03197571|Antimetabolites|antimetabolites|mesh-ancestor
64309281|NCT03197571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64309283|NCT03197571|Protective Agents|protective agents|mesh-ancestor
64309284|NCT03197571|Vitamin B Complex|vitamin b complex|mesh-ancestor
64309316|NCT02447055|Antimetabolites|antimetabolites|mesh-ancestor
64309317|NCT02447055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64309318|NCT02447055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64309319|NCT02447055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305632|NCT03562169|Dexamethasone|dexamethasone|mesh-list
64309320|NCT02447055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64309321|NCT02447055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64309322|NCT02447055|Antitubercular Agents|antitubercular agents|mesh-ancestor
64309323|NCT02447055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64309324|NCT02447055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64309325|NCT03202563|Metformin|metformin|mesh-list
64309326|NCT03202563|Dapagliflozin|dapagliflozin|mesh-list
64309327|NCT03202563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64309328|NCT03202563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309329|NCT03202563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64309387|NCT02150473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64309388|NCT02150473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64309391|NCT02446431|Bevacizumab|bevacizumab|mesh-list
64309392|NCT02446431|Valproic Acid|valproic acid|mesh-list
64305715|NCT02620280|Paclitaxel|paclitaxel|mesh-list
64309393|NCT02446431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64309394|NCT02446431|Immunologic Factors|immunologic factors|mesh-ancestor
64309395|NCT02446431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309396|NCT02446431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64309397|NCT02446431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64309398|NCT02446431|Alkylating Agents|alkylating agents|mesh-ancestor
64309399|NCT02446431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309400|NCT02446431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309401|NCT02446431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64309402|NCT02446431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64309403|NCT02446431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64309404|NCT02446431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64309405|NCT02446431|Growth Substances|growth substances|mesh-ancestor
64309406|NCT02446431|Growth Inhibitors|growth inhibitors|mesh-ancestor
64309407|NCT02446431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64309431|NCT02446353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64309432|NCT02446353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64309433|NCT02144389|Praziquantel|praziquantel|mesh-list
64309434|NCT02144389|Anthelmintics|anthelmintics|mesh-ancestor
64309435|NCT02144389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64309436|NCT02144389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64309437|NCT04484259|Aspirin|aspirin|mesh-list
64309438|NCT04484259|Clopidogrel|clopidogrel|mesh-list
64309439|NCT04484259|Ticagrelor|ticagrelor|mesh-list
64309440|NCT04484259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64309441|NCT04484259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64309442|NCT04484259|Analgesics|analgesics|mesh-ancestor
64309443|NCT04484259|Sensory System Agents|sensory system agents|mesh-ancestor
64309444|NCT04484259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64309445|NCT04484259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309455|NCT04484259|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64309456|NCT04484259|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64309457|NCT04484259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64309458|NCT04484259|Purinergic Agents|purinergic agents|mesh-ancestor
64309459|NCT04484259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64309460|NCT03197103|Acetylcysteine|acetylcysteine|mesh-list
64309494|NCT03194685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309495|NCT03194685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309496|NCT00105079|Ritonavir|ritonavir|mesh-list
64309497|NCT00105079|Lopinavir|lopinavir|mesh-list
64309498|NCT00105079|Saquinavir|saquinavir|mesh-list
64309499|NCT00105079|Tenofovir|tenofovir|mesh-list
64309500|NCT00105079|Emtricitabine|emtricitabine|mesh-list
64309501|NCT00105079|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64309502|NCT00105079|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64309503|NCT00105079|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64309504|NCT00105079|Protease Inhibitors|protease inhibitors|mesh-ancestor
64309505|NCT00105079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309577|NCT03192969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64309578|NCT03192969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309580|NCT03192969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64309581|NCT03192969|Immunologic Factors|immunologic factors|mesh-ancestor
64309582|NCT03192969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309613|NCT03192579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309615|NCT03192579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64309616|NCT03192579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309617|NCT03192657|Basiliximab|basiliximab|mesh-list
64309618|NCT03192657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
64309619|NCT03192657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64309620|NCT03192657|Immunologic Factors|immunologic factors|mesh-ancestor
64309621|NCT03192657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309627|NCT02444169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309653|NCT03193749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64309654|NCT03193749|Vasodilator Agents|vasodilator agents|mesh-ancestor
64309655|NCT03193749|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64309656|NCT03193749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64309657|NCT03193749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309658|NCT03193749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64309659|NCT03193749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64309660|NCT03193749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64309661|NCT03193749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305836|NCT02052167|Antimetabolites|antimetabolites|mesh-ancestor
64309662|NCT03193749|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64309663|NCT03193749|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64309664|NCT03193749|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64309665|NCT02444013|Folic Acid|folic acid|mesh-list
64309666|NCT02444013|Uric Acid|uric acid|mesh-list
64309667|NCT02444013|Hematinics|hematinics|mesh-ancestor
64309668|NCT02444013|Vitamin B Complex|vitamin b complex|mesh-ancestor
64309669|NCT02444013|Vitamins|vitamins|mesh-ancestor
64309670|NCT02444013|Micronutrients|micronutrients|mesh-ancestor
64309671|NCT02444013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309672|NCT02444013|Antioxidants|antioxidants|mesh-ancestor
64309673|NCT02444013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309674|NCT02444013|Protective Agents|protective agents|mesh-ancestor
64309675|NCT02444637|Rivastigmine|rivastigmine|mesh-list
64309676|NCT02444637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64309677|NCT02444637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309709|NCT02443545|Chelating Agents|chelating agents|mesh-ancestor
64309710|NCT02443545|Sequestering Agents|sequestering agents|mesh-ancestor
64309711|NCT02443545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309712|NCT02439489|Carboplatin|carboplatin|mesh-list
64309714|NCT02444481|Polymyxins|polymyxins|mesh-list
64309778|NCT02443311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64309779|NCT02443311|Immunologic Factors|immunologic factors|mesh-ancestor
64309780|NCT02443311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64309781|NCT02443311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309782|NCT02443311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309783|NCT02373202|Sulfasalazine|sulfasalazine|mesh-list
64309784|NCT02373202|Mizoribine|mizoribine|mesh-list
64309785|NCT02373202|Bucillamine|bucillamine|mesh-list
64309786|NCT02373202|Tacrolimus|tacrolimus|mesh-list
64309787|NCT02373202|Leflunomide|leflunomide|mesh-list
64309788|NCT02373202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64309789|NCT02373202|Immunologic Factors|immunologic factors|mesh-ancestor
64309790|NCT02373202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309791|NCT02373202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64309792|NCT02373202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309793|NCT02373202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309794|NCT02373202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64309795|NCT02373202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64309796|NCT02373202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64309797|NCT02373202|Analgesics|analgesics|mesh-ancestor
64309798|NCT02373202|Sensory System Agents|sensory system agents|mesh-ancestor
64309799|NCT02373202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64309800|NCT02373202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64309834|NCT02622074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64305885|NCT02056223|Sensory System Agents|sensory system agents|mesh-ancestor
64309835|NCT02622074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64309836|NCT02622074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64309837|NCT02622074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64309882|NCT02438865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64309883|NCT02438865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309884|NCT02438865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309885|NCT04924946|Antihypertensive Agents|antihypertensive agents|mesh-list
64309887|NCT03189771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64309888|NCT03189771|Antifungal Agents|antifungal agents|mesh-ancestor
64309920|NCT03193359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309921|NCT03193359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64309922|NCT03193359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64309924|NCT02442531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309925|NCT02442531|Tubulin Modulators|tubulin modulators|mesh-ancestor
64309926|NCT02442531|Antimitotic Agents|antimitotic agents|mesh-ancestor
64309927|NCT02442531|Mitosis Modulators|mitosis modulators|mesh-ancestor
64309928|NCT02442531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309929|NCT03193203|Etanercept|etanercept|mesh-list
64309930|NCT03193203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64309931|NCT03193203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64309932|NCT03193203|Analgesics|analgesics|mesh-ancestor
64309969|NCT04922996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310004|NCT02441673|Oxytocin|oxytocin|mesh-list
64310005|NCT02441673|Oxytocics|oxytocics|mesh-ancestor
64310006|NCT02441673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64310007|NCT02441673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310055|NCT04903808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64310056|NCT04903808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310057|NCT03189537|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
64310058|NCT03189537|Antiviral Agents|antiviral agents|mesh-ancestor
64310059|NCT03189537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64310060|NCT02436993|Paclitaxel|paclitaxel|mesh-list
64310061|NCT02436993|Bevacizumab|bevacizumab|mesh-list
64310062|NCT02436993|Carboplatin|carboplatin|mesh-list
64310063|NCT02436993|Trastuzumab|trastuzumab|mesh-list
64310064|NCT02436993|Pertuzumab|pertuzumab|mesh-list
64310065|NCT02436993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64310066|NCT02436993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310067|NCT02436993|Tubulin Modulators|tubulin modulators|mesh-ancestor
64310068|NCT02436993|Antimitotic Agents|antimitotic agents|mesh-ancestor
64310069|NCT02436993|Mitosis Modulators|mitosis modulators|mesh-ancestor
64310133|NCT04892732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310134|NCT04892732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64310135|NCT04892732|Respiratory System Agents|respiratory system agents|mesh-ancestor
64310136|NCT04892732|Glucocorticoids|glucocorticoids|mesh-ancestor
64310137|NCT04892732|Hormones|hormones|mesh-ancestor
64310138|NCT04892732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64310139|NCT04892732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64310140|NCT04892732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64310141|NCT04892732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64310142|NCT04892732|Adrenergic Agents|adrenergic agents|mesh-ancestor
64310143|NCT04892732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64310144|NCT04892732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310191|NCT04892654|Antiviral Agents|antiviral agents|mesh-ancestor
64310192|NCT04892654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64310194|NCT04899674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64310195|NCT04899674|Antidepressive Agents|antidepressive agents|mesh-ancestor
64310196|NCT04899674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64310197|NCT04899674|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64310282|NCT04890392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64310283|NCT04890392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310284|NCT04890392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310285|NCT02616614|Clindamycin|clindamycin|mesh-list
64310286|NCT02616614|Clindamycin palmitate|clindamycin palmitate|mesh-list
64310287|NCT02616614|Clindamycin phosphate|clindamycin phosphate|mesh-list
64310288|NCT02616614|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64310289|NCT02616614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64310290|NCT02616614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64310291|NCT02616614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64310292|NCT02616614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310293|NCT02616614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310294|NCT02616614|Dermatologic Agents|dermatologic agents|mesh-ancestor
64310295|NCT04906772|Dexmedetomidine|dexmedetomidine|mesh-list
64310297|NCT04906772|Propofol|propofol|mesh-list
64310298|NCT04906772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64310299|NCT04906772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64310300|NCT04906772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310301|NCT04906772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64310302|NCT04906772|Anesthetics, General|anesthetics, general|mesh-ancestor
64310303|NCT04906772|Anesthetics|anesthetics|mesh-ancestor
64310304|NCT04906772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64310305|NCT04906772|Analgesics|analgesics|mesh-ancestor
64310306|NCT04906772|Sensory System Agents|sensory system agents|mesh-ancestor
64310347|NCT04898270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64310348|NCT04898270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310349|NCT04898270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64310350|NCT04898270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64310351|NCT04898270|Dopamine Agents|dopamine agents|mesh-ancestor
64310352|NCT04898270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64310353|NCT04898270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310354|NCT04897958|Leuprolide|leuprolide|mesh-list
64310355|NCT04897958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64310356|NCT04897958|Fertility Agents|fertility agents|mesh-ancestor
64310357|NCT04897958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64310358|NCT04897958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310359|NCT04897958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64310360|NCT04897958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310361|NCT04906304|Mycophenolic Acid|mycophenolic acid|mesh-list
64310362|NCT04906304|Cyclosporine|cyclosporine|mesh-list
64310363|NCT04906304|Everolimus|everolimus|mesh-list
64310364|NCT04906304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310365|NCT04906304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64310451|NCT04884464|Protective Agents|protective agents|mesh-ancestor
64310452|NCT05028608|Carbamazepine|carbamazepine|mesh-list
64310453|NCT05028608|Midazolam|midazolam|mesh-list
64310454|NCT05028608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64310463|NCT05028608|Anesthetics|anesthetics|mesh-ancestor
64310511|NCT01596062|Immunologic Factors|immunologic factors|mesh-ancestor
64310512|NCT01596062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310513|NCT01596062|Antifungal Agents|antifungal agents|mesh-ancestor
64310514|NCT01596062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64310515|NCT01596062|Dermatologic Agents|dermatologic agents|mesh-ancestor
64310516|NCT01596062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64310517|NCT01596062|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64310555|NCT02152423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64310556|NCT02152423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64310587|NCT02145715|Dexamethasone|dexamethasone|mesh-list
64310588|NCT02145715|Bortezomib|bortezomib|mesh-list
64310589|NCT02145715|Panobinostat|panobinostat|mesh-list
64310590|NCT02145715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64310591|NCT02145715|Antiemetics|antiemetics|mesh-ancestor
64310592|NCT02145715|Autonomic Agents|autonomic agents|mesh-ancestor
64310593|NCT02145715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64310594|NCT02145715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310595|NCT02145715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64310596|NCT02145715|Glucocorticoids|glucocorticoids|mesh-ancestor
64310597|NCT02145715|Hormones|hormones|mesh-ancestor
64310598|NCT02145715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64310599|NCT02145715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64310600|NCT02145715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310601|NCT02145715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64310602|NCT02145715|Immunologic Factors|immunologic factors|mesh-ancestor
64310603|NCT02145715|Leprostatic Agents|leprostatic agents|mesh-ancestor
64310604|NCT02145715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64310662|NCT00806390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64310701|NCT02152969|Vasodilator Agents|vasodilator agents|mesh-ancestor
64310702|NCT02152969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64310703|NCT02152969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64310704|NCT02152969|Diuretics|diuretics|mesh-ancestor
64310705|NCT02152969|Natriuretic Agents|natriuretic agents|mesh-ancestor
64310706|NCT02152969|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64310707|NCT04879004|Ropivacaine|ropivacaine|mesh-list
64310708|NCT04879004|Anesthetics, Local|anesthetics, local|mesh-ancestor
64310709|NCT04879004|Anesthetics|anesthetics|mesh-ancestor
64310710|NCT04879004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64310711|NCT04879004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310712|NCT04879004|Sensory System Agents|sensory system agents|mesh-ancestor
64310713|NCT04879004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64310714|NCT02153125|Eplerenone|eplerenone|mesh-list
64310715|NCT02153125|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64310716|NCT02153125|Hormone Antagonists|hormone antagonists|mesh-ancestor
64310717|NCT02153125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64310718|NCT02153125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310719|NCT02153125|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64310720|NCT02153125|Diuretics|diuretics|mesh-ancestor
64310721|NCT02153125|Natriuretic Agents|natriuretic agents|mesh-ancestor
64310722|NCT02153125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64310723|NCT04878926|Midazolam|midazolam|mesh-list
64310724|NCT04878926|Propofol|propofol|mesh-list
64310725|NCT04878926|Anesthetics|anesthetics|mesh-list
64310726|NCT04878926|Anesthetics, Local|anesthetics, local|mesh-list
64310760|NCT03542851|Convulsants|convulsants|mesh-ancestor
64310761|NCT03542851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64310763|NCT03542851|GABA Antagonists|gaba antagonists|mesh-ancestor
64310809|NCT03542149|Antimalarials|antimalarials|mesh-ancestor
64310810|NCT03542149|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64310811|NCT03542149|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64310812|NCT03542149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64310813|NCT03542149|Antioxidants|antioxidants|mesh-ancestor
64310814|NCT03542149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310815|NCT03542149|Protective Agents|protective agents|mesh-ancestor
64310871|NCT02159287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64310872|NCT02159287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310875|NCT05005273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64310876|NCT05005273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310877|NCT05005273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64310878|NCT05005273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310879|NCT02157337|Atorvastatin|atorvastatin|mesh-list
64310880|NCT02157337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64310881|NCT02157337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64310882|NCT02157337|Antimetabolites|antimetabolites|mesh-ancestor
64310883|NCT02157337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310884|NCT02157337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64310885|NCT02157337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64310886|NCT02157337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310887|NCT02159599|Ritonavir|ritonavir|mesh-list
64310888|NCT02159599|Darunavir|darunavir|mesh-list
64310889|NCT02159599|Tenofovir|tenofovir|mesh-list
64310890|NCT02159599|Lamivudine|lamivudine|mesh-list
64310891|NCT02159599|Emtricitabine|emtricitabine|mesh-list
64310892|NCT02159599|Abacavir|abacavir|mesh-list
64310893|NCT02159599|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64310894|NCT02159599|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64310895|NCT02159599|Protease Inhibitors|protease inhibitors|mesh-ancestor
64310896|NCT02159599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310897|NCT02159599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310906|NCT03541681|Anesthetics|anesthetics|mesh-list
64310907|NCT03541681|Glucocorticoids|glucocorticoids|mesh-list
64310933|NCT03541993|Resveratrol|resveratrol|mesh-list
64310934|NCT03541993|Antioxidants|antioxidants|mesh-ancestor
64306153|NCT02058173|Amebicides|amebicides|mesh-ancestor
64310935|NCT03541993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310936|NCT03541993|Protective Agents|protective agents|mesh-ancestor
64310937|NCT03541993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310938|NCT03541993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310939|NCT03541993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64310940|NCT02157649|Phenylpropanolamine|phenylpropanolamine|mesh-list
64310941|NCT02157649|Codeine|codeine|mesh-list
64310942|NCT02157649|Guaifenesin|guaifenesin|mesh-list
64310943|NCT02157649|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
64310944|NCT02157649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64310945|NCT02157649|Narcotics|narcotics|mesh-ancestor
64310946|NCT02157649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64310947|NCT02157649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310948|NCT02157649|Analgesics|analgesics|mesh-ancestor
64310949|NCT02157649|Sensory System Agents|sensory system agents|mesh-ancestor
64311149|NCT02086409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311150|NCT02086409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64311151|NCT02086409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64311153|NCT02613572|Antioxidants|antioxidants|mesh-ancestor
64311154|NCT02613572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311155|NCT02613572|Protective Agents|protective agents|mesh-ancestor
64311156|NCT02613572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311157|NCT02613572|Vitamin B Complex|vitamin b complex|mesh-ancestor
64311158|NCT02613572|Vitamins|vitamins|mesh-ancestor
64311159|NCT02613572|Micronutrients|micronutrients|mesh-ancestor
64311190|NCT02082665|Anesthetics|anesthetics|mesh-ancestor
64311191|NCT02082665|GABA Modulators|gaba modulators|mesh-ancestor
64311192|NCT02082665|GABA Agents|gaba agents|mesh-ancestor
64311193|NCT02082665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64311194|NCT02082665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311195|NCT02082665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64311196|NCT02082665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64311197|NCT02082665|Antimetabolites|antimetabolites|mesh-ancestor
64311198|NCT02082665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64311199|NCT02082665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64311200|NCT02082665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311201|NCT02082665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64311202|NCT02082665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64311399|NCT03046238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64311400|NCT03046238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64311401|NCT03046238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64311402|NCT03046238|Adrenergic Agents|adrenergic agents|mesh-ancestor
64311403|NCT03046238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64311404|NCT03046238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311406|NCT02089763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64311407|NCT04884802|Phenylephrine|phenylephrine|mesh-list
64311408|NCT04884802|Norepinephrine|norepinephrine|mesh-list
64311409|NCT04884802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64311410|NCT04884802|Propofol|propofol|mesh-list
64311411|NCT04884802|Etomidate|etomidate|mesh-list
64311412|NCT04884802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64311413|NCT04884802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64311414|NCT04884802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311415|NCT04884802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64311416|NCT04884802|Anesthetics, General|anesthetics, general|mesh-ancestor
64311417|NCT04884802|Anesthetics|anesthetics|mesh-ancestor
64311418|NCT04884802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64311419|NCT04884802|Mydriatics|mydriatics|mesh-ancestor
64311420|NCT04884802|Autonomic Agents|autonomic agents|mesh-ancestor
64311447|NCT03045770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64311448|NCT03045770|Tubulin Modulators|tubulin modulators|mesh-ancestor
64311449|NCT03045770|Antimitotic Agents|antimitotic agents|mesh-ancestor
64311450|NCT03045770|Mitosis Modulators|mitosis modulators|mesh-ancestor
64311451|NCT03045770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311452|NCT03045770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64311469|NCT02260505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311470|NCT02260505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311471|NCT02095847|Proflavine|proflavine|mesh-list
64311472|NCT02095847|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64311473|NCT02095847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64311553|NCT02337946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311555|NCT02337946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64311556|NCT02337946|Immunologic Factors|immunologic factors|mesh-ancestor
64311557|NCT02337946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64311558|NCT02337946|Antidotes|antidotes|mesh-ancestor
64311559|NCT02337946|Protective Agents|protective agents|mesh-ancestor
64311560|NCT02337946|Vitamin B Complex|vitamin b complex|mesh-ancestor
64311561|NCT02337946|Vitamins|vitamins|mesh-ancestor
64311562|NCT02337946|Micronutrients|micronutrients|mesh-ancestor
64311563|NCT04865510|Heparin|heparin|mesh-list
64311564|NCT04865510|Anticoagulants|anticoagulants|mesh-ancestor
64311565|NCT04865510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311566|NCT04865510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64311567|NCT04865510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64311574|NCT03047096|Viscosupplements|viscosupplements|mesh-ancestor
64311575|NCT03047096|Protective Agents|protective agents|mesh-ancestor
64311577|NCT02090543|Phenprocoumon|phenprocoumon|mesh-list
64306242|NCT02061449|Romidepsin|romidepsin|mesh-list
64311578|NCT02090543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64311579|NCT02090543|Antithrombins|antithrombins|mesh-ancestor
64311580|NCT02090543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64311581|NCT02090543|Protease Inhibitors|protease inhibitors|mesh-ancestor
64311582|NCT02090543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311583|NCT02090543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311584|NCT02090543|Anticoagulants|anticoagulants|mesh-ancestor
64311620|NCT02098889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64311621|NCT02098889|Parasympatholytics|parasympatholytics|mesh-ancestor
64311648|NCT02097173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311649|NCT02097173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64311650|NCT02097173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64311651|NCT02097173|Immunologic Factors|immunologic factors|mesh-ancestor
64311652|NCT02097173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64311653|NCT02097173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64311654|NCT02097329|Palbociclib|palbociclib|mesh-list
64311655|NCT02097329|Rabeprazole|rabeprazole|mesh-list
64311656|NCT02097329|Famotidine|famotidine|mesh-list
64311657|NCT02097329|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
64311658|NCT02097329|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
64311659|NCT02097329|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64311660|NCT02097329|Magnesium Hydroxide|magnesium hydroxide|mesh-list
64311661|NCT02097329|Antacids|antacids|mesh-list
64311662|NCT02097329|TEMPO|tempo|mesh-list
64311663|NCT02097329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64311664|NCT02097329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64311665|NCT02097329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311666|NCT02097329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311667|NCT02097329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64311668|NCT02097329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64311715|NCT02250599|Carboplatin|carboplatin|mesh-list
64311773|NCT02099981|Pimagedine|pimagedine|mesh-list
64311774|NCT02099981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311775|NCT02099981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311776|NCT02250209|Capecitabine|capecitabine|mesh-list
64311777|NCT02250209|Oxaliplatin|oxaliplatin|mesh-list
64311778|NCT02250209|Trastuzumab|trastuzumab|mesh-list
64311779|NCT02250209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64311780|NCT02250209|Antimetabolites|antimetabolites|mesh-ancestor
64311781|NCT02250209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311782|NCT02250209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64311783|NCT02250209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64311868|NCT02100761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64311870|NCT02100917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64311871|NCT02100917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64311872|NCT02098421|Oxytocin|oxytocin|mesh-list
64311873|NCT02098421|Oxytocics|oxytocics|mesh-ancestor
64311874|NCT02098421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64311875|NCT02098421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311877|NCT02098499|Promethazine|promethazine|mesh-list
64311878|NCT02098499|Haloperidol|haloperidol|mesh-list
64311879|NCT02098499|Metoclopramide|metoclopramide|mesh-list
64311880|NCT02098499|Haloperidol decanoate|haloperidol decanoate|mesh-list
64311881|NCT02098499|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64311882|NCT02098499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64311883|NCT02098499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64311884|NCT02098499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311885|NCT02098499|Anesthetics, Local|anesthetics, local|mesh-ancestor
64311886|NCT02098499|Anesthetics|anesthetics|mesh-ancestor
64311887|NCT02098499|Sensory System Agents|sensory system agents|mesh-ancestor
64311931|NCT02102633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311932|NCT02102633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311934|NCT02102711|Vitamin A|vitamin a|mesh-list
64311935|NCT02102711|Vitamins|vitamins|mesh-ancestor
64311936|NCT02102711|Micronutrients|micronutrients|mesh-ancestor
64311937|NCT02102711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311938|NCT02106767|Rifampin|rifampin|mesh-list
64311939|NCT02106767|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64311940|NCT02106767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64311941|NCT02106767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64311942|NCT02106767|Antimetabolites|antimetabolites|mesh-ancestor
64311995|NCT03554447|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64311996|NCT03554447|Antidepressive Agents|antidepressive agents|mesh-ancestor
64311997|NCT03554447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64311998|NCT03554447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64311999|NCT03554447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64312000|NCT03554447|Parasympatholytics|parasympatholytics|mesh-ancestor
64312001|NCT03554447|Autonomic Agents|autonomic agents|mesh-ancestor
64312002|NCT03554447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312003|NCT03554447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64312004|NCT03554447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64312005|NCT03554447|Cholinergic Agents|cholinergic agents|mesh-ancestor
64312032|NCT02610140|Vinorelbine|vinorelbine|mesh-list
64312033|NCT02610140|Maytansine|maytansine|mesh-list
64312034|NCT02610140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64312035|NCT02610140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312036|NCT02610140|Tubulin Modulators|tubulin modulators|mesh-ancestor
64312037|NCT02610140|Antimitotic Agents|antimitotic agents|mesh-ancestor
64312038|NCT02610140|Mitosis Modulators|mitosis modulators|mesh-ancestor
64312039|NCT02610140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312040|NCT02102321|Albendazole|albendazole|mesh-list
64312041|NCT02102321|Anthelmintics|anthelmintics|mesh-ancestor
64312053|NCT02103569|Norethindrone|norethindrone|mesh-list
64312054|NCT02103569|Norethindrone Acetate|norethindrone acetate|mesh-list
64312077|NCT02103647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64312078|NCT02103647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64312079|NCT02103647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312080|NCT02103647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64312081|NCT02103647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64312082|NCT02103647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64312083|NCT02103647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64312084|NCT02103647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64312086|NCT02109965|Dexmedetomidine|dexmedetomidine|mesh-list
64312087|NCT02109965|Propofol|propofol|mesh-list
64312088|NCT02109965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64312089|NCT02109965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64312090|NCT02109965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312098|NCT02109965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64312100|NCT02109965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64312101|NCT02109965|Adrenergic Agents|adrenergic agents|mesh-ancestor
64312102|NCT02109965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64312103|NCT02109965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312104|NCT02109965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64312105|NCT02109965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64312106|NCT02109965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64312142|NCT02103725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312143|NCT02103725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312144|NCT02103725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64312145|NCT02103725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64312146|NCT02103725|Dermatologic Agents|dermatologic agents|mesh-ancestor
64312147|NCT02103725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64312148|NCT02103725|Immunologic Factors|immunologic factors|mesh-ancestor
64312149|NCT02103725|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64312173|NCT02110355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312176|NCT02107391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64312177|NCT02107391|Fertility Agents|fertility agents|mesh-ancestor
64312178|NCT02107391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64312179|NCT02107391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312180|NCT02107391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64312181|NCT02107391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312182|NCT02103881|Ketamine|ketamine|mesh-list
64312183|NCT02103881|Haloperidol|haloperidol|mesh-list
64312184|NCT02103881|Haloperidol decanoate|haloperidol decanoate|mesh-list
64312185|NCT02103881|Analgesics|analgesics|mesh-ancestor
64312186|NCT02103881|Sensory System Agents|sensory system agents|mesh-ancestor
64312187|NCT02103881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312188|NCT02103881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312189|NCT02103881|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64312190|NCT02103881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64312191|NCT02103881|Anesthetics, General|anesthetics, general|mesh-ancestor
64312192|NCT02103881|Anesthetics|anesthetics|mesh-ancestor
64312193|NCT02103881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64312194|NCT02103881|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64312195|NCT02103881|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64312196|NCT02103881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64312197|NCT02103881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312198|NCT02103881|Antiemetics|antiemetics|mesh-ancestor
64312199|NCT02103881|Autonomic Agents|autonomic agents|mesh-ancestor
64312200|NCT02103881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64312267|NCT02110745|Anesthetics, General|anesthetics, general|mesh-ancestor
64312268|NCT02110745|Anesthetics|anesthetics|mesh-ancestor
64312269|NCT04857320|Insulin|insulin|mesh-list
64312270|NCT04857320|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64312271|NCT04857320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64312272|NCT04857320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312274|NCT03041948|Dexamethasone|dexamethasone|mesh-list
64312275|NCT03041948|Ketorolac|ketorolac|mesh-list
64312276|NCT03041948|Morphine|morphine|mesh-list
64312277|NCT03041948|Remifentanil|remifentanil|mesh-list
64312351|NCT04867226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312381|NCT01453179|Sensory System Agents|sensory system agents|mesh-ancestor
64312382|NCT01453179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312383|NCT01453179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312384|NCT01453179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64312385|NCT01453179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64312393|NCT03192033|Hemostatics|hemostatics|mesh-list
64312435|NCT03188289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64312436|NCT03188289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64312437|NCT03188289|Antimetabolites|antimetabolites|mesh-ancestor
64312438|NCT03188289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312439|NCT03188289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64312440|NCT03188289|Chelating Agents|chelating agents|mesh-ancestor
64312441|NCT03188289|Sequestering Agents|sequestering agents|mesh-ancestor
64312443|NCT03188289|Coagulants|coagulants|mesh-ancestor
64312444|NCT03044912|Mirabegron|mirabegron|mesh-list
64312445|NCT03044912|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64312716|NCT04851548|Immunologic Factors|immunologic factors|mesh-ancestor
64312717|NCT04851548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312718|NCT04851548|Viscosupplements|viscosupplements|mesh-ancestor
64312719|NCT04851548|Protective Agents|protective agents|mesh-ancestor
64312720|NCT02706951|Methotrexate|methotrexate|mesh-list
64312721|NCT02706951|Upadacitinib|upadacitinib|mesh-list
64312722|NCT02706951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64312723|NCT02706951|Abortifacient Agents|abortifacient agents|mesh-ancestor
64312724|NCT02706951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64312778|NCT04859738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312779|NCT04859738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64312780|NCT04859738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64312816|NCT02425137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312817|NCT02425137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64312818|NCT02425137|Immunologic Factors|immunologic factors|mesh-ancestor
64312819|NCT02425137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312820|NCT04841018|Dexamethasone|dexamethasone|mesh-list
64312821|NCT04841018|Dexamethasone acetate|dexamethasone acetate|mesh-list
64312823|NCT04841018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64312824|NCT04841018|Antiemetics|antiemetics|mesh-ancestor
64312825|NCT04841018|Autonomic Agents|autonomic agents|mesh-ancestor
64312826|NCT04841018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312827|NCT04841018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312931|NCT02707965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64312932|NCT02707965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64312933|NCT02707965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64312934|NCT02707965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64312969|NCT04839224|Phenylephrine|phenylephrine|mesh-list
64312970|NCT04839224|Oxymetazoline|oxymetazoline|mesh-list
64312971|NCT04839224|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64312972|NCT04839224|Mydriatics|mydriatics|mesh-ancestor
64312973|NCT04839224|Autonomic Agents|autonomic agents|mesh-ancestor
64312974|NCT04839224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312975|NCT04839224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312976|NCT04839224|Sympathomimetics|sympathomimetics|mesh-ancestor
64312977|NCT04839224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64313009|NCT02424201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313011|NCT02432781|Insulin|insulin|mesh-list
64313022|NCT04833296|Anesthetics|anesthetics|mesh-ancestor
64313023|NCT04833296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64313153|NCT03181815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64313154|NCT03181815|Immunologic Factors|immunologic factors|mesh-ancestor
64313155|NCT03181815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313156|NCT03181815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64313157|NCT03181815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64313158|NCT03181815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64313159|NCT03181815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313255|NCT03180879|Ibuprofen|ibuprofen|mesh-list
64313256|NCT03180879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64313257|NCT03180879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64313258|NCT03180879|Analgesics|analgesics|mesh-ancestor
64313259|NCT03180879|Sensory System Agents|sensory system agents|mesh-ancestor
64313260|NCT03180879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313261|NCT03180879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313262|NCT03180879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64313358|NCT03183375|Hydroxyurea|hydroxyurea|mesh-list
64313364|NCT03183297|Fexofenadine|fexofenadine|mesh-list
64313367|NCT03183297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64313368|NCT03183297|Analgesics|analgesics|mesh-ancestor
64313369|NCT03183297|Sensory System Agents|sensory system agents|mesh-ancestor
64313465|NCT04770272|Alkylating Agents|alkylating agents|mesh-ancestor
64313466|NCT04770272|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64313467|NCT04770272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64313468|NCT04770272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64313469|NCT04770272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64313470|NCT04770272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313471|NCT02251145|Ritonavir|ritonavir|mesh-list
64313472|NCT02251145|Tenofovir|tenofovir|mesh-list
64313473|NCT02251145|Tipranavir|tipranavir|mesh-list
64313474|NCT02251145|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64313475|NCT02251145|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64313476|NCT02251145|Protease Inhibitors|protease inhibitors|mesh-ancestor
64313477|NCT02251145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306492|NCT02068079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313478|NCT02251145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313479|NCT02251145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64313480|NCT02251145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64313481|NCT02251145|Antiviral Agents|antiviral agents|mesh-ancestor
64313482|NCT02251145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64313483|NCT02251145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64313865|NCT02115035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64313866|NCT02115035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313867|NCT02115035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313868|NCT02113319|Dasatinib|dasatinib|mesh-list
64313869|NCT02113319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313870|NCT02113319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64313871|NCT02113319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313872|NCT02113319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313873|NCT02113397|Tobramycin|tobramycin|mesh-list
64313874|NCT02113397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64313875|NCT02113397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64313876|NCT04822064|Dexmedetomidine|dexmedetomidine|mesh-list
64313877|NCT04822064|Ketamine|ketamine|mesh-list
64313878|NCT04822064|Chloral Hydrate|chloral hydrate|mesh-list
64313879|NCT04822064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64313880|NCT04822064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64313881|NCT04822064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313882|NCT04822064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64313883|NCT04822064|Analgesics|analgesics|mesh-ancestor
64313884|NCT04822064|Sensory System Agents|sensory system agents|mesh-ancestor
64313885|NCT04822064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313886|NCT04822064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64313887|NCT04822064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64313888|NCT04822064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64313889|NCT04822064|Adrenergic Agents|adrenergic agents|mesh-ancestor
64313890|NCT04822064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64313891|NCT04822064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313892|NCT04822064|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64313893|NCT04822064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64313894|NCT04822064|Anesthetics, General|anesthetics, general|mesh-ancestor
64313895|NCT04822064|Anesthetics|anesthetics|mesh-ancestor
64313896|NCT04822064|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64313966|NCT02123069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64313973|NCT02123069|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64313974|NCT02123069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64313975|NCT02123069|Cholinergic Agents|cholinergic agents|mesh-ancestor
64313976|NCT04428632|Berotralstat|berotralstat|mesh-list
64313977|NCT04428632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313978|NCT04428632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313979|NCT05618210|Anesthetics|anesthetics|mesh-list
64313980|NCT05618210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64313981|NCT05618210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313982|NCT04807634|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64313983|NCT04807634|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
64313984|NCT04807634|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64313985|NCT04807634|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64313986|NCT02789111|Alvimopan|alvimopan|mesh-list
64313987|NCT02789111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64313988|NCT04807166|Paclitaxel|paclitaxel|mesh-list
64314190|NCT02121119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64314191|NCT02121119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64314192|NCT02121119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64306505|NCT02793947|Analgesics|analgesics|mesh-ancestor
64314193|NCT02121119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314194|NCT02121197|Dexamethasone|dexamethasone|mesh-list
64314195|NCT02121197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64314196|NCT02121197|Antiemetics|antiemetics|mesh-ancestor
64314197|NCT02121197|Autonomic Agents|autonomic agents|mesh-ancestor
64314198|NCT02121197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64314199|NCT02121197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314319|NCT04801940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64314338|NCT02127047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314339|NCT02127047|Incretins|incretins|mesh-ancestor
64314340|NCT02127047|Hormones|hormones|mesh-ancestor
64314341|NCT02127047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64314342|NCT02127047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64314343|NCT02127047|Protease Inhibitors|protease inhibitors|mesh-ancestor
64314344|NCT02127047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314345|NCT02127047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314346|NCT02122055|Fentanyl|fentanyl|mesh-list
64314347|NCT02122055|Midazolam|midazolam|mesh-list
64314348|NCT02122055|Dexmedetomidine|dexmedetomidine|mesh-list
64314349|NCT02122055|Propofol|propofol|mesh-list
64314350|NCT02122055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64314351|NCT02122055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64314352|NCT02122055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314353|NCT02122055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64314354|NCT02122055|Anesthetics, General|anesthetics, general|mesh-ancestor
64314355|NCT02122055|Anesthetics|anesthetics|mesh-ancestor
64314356|NCT02122055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64314358|NCT02122055|Sensory System Agents|sensory system agents|mesh-ancestor
64314359|NCT02122055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64314487|NCT02127593|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64440183|NCT01928433|Renal Agents|renal agents|mesh-ancestor
64314489|NCT02122679|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64314490|NCT02122679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64314491|NCT02122679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314493|NCT02122679|Coagulants|coagulants|mesh-ancestor
64314494|NCT04810754|Daratumumab|daratumumab|mesh-list
64314495|NCT04810754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314497|NCT02127749|Vancomycin|vancomycin|mesh-list
64314511|NCT04797338|Progesterone|progesterone|mesh-list
64314512|NCT04797338|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
64314513|NCT04797338|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
64314514|NCT04797338|Estradiol|estradiol|mesh-list
64314515|NCT04797338|Progestins|progestins|mesh-ancestor
64314516|NCT04797338|Hormones|hormones|mesh-ancestor
64315193|NCT03511118|Doxycycline|doxycycline|mesh-list
64315194|NCT03511118|Ciprofloxacin|ciprofloxacin|mesh-list
64315195|NCT03511118|Levofloxacin|levofloxacin|mesh-list
64315196|NCT03511118|Clindamycin|clindamycin|mesh-list
64315197|NCT03511118|Valganciclovir|valganciclovir|mesh-list
64315198|NCT03511118|Remdesivir|remdesivir|mesh-list
64315199|NCT03511118|Hydroxyurea|hydroxyurea|mesh-list
64315200|NCT03511118|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64315201|NCT03511118|Verapamil|verapamil|mesh-list
64316180|NCT00103285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64316181|NCT00103285|Antiviral Agents|antiviral agents|mesh-ancestor
64316182|NCT00103285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64316184|NCT00103285|Protective Agents|protective agents|mesh-ancestor
64316185|NCT00103285|Vitamin B Complex|vitamin b complex|mesh-ancestor
64316186|NCT00103285|Vitamins|vitamins|mesh-ancestor
64316187|NCT00103285|Micronutrients|micronutrients|mesh-ancestor
64316188|NCT00103285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64316189|NCT00103285|Tubulin Modulators|tubulin modulators|mesh-ancestor
64316190|NCT00103285|Antimitotic Agents|antimitotic agents|mesh-ancestor
64316191|NCT00103285|Mitosis Modulators|mitosis modulators|mesh-ancestor
64316192|NCT00103285|Hematinics|hematinics|mesh-ancestor
64316193|NCT03541915|Magnesium Sulfate|magnesium sulfate|mesh-list
64316194|NCT03541915|Analgesics|analgesics|mesh-ancestor
64316195|NCT03541915|Sensory System Agents|sensory system agents|mesh-ancestor
64316196|NCT03541915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316197|NCT03541915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316869|NCT02416245|Trace Elements|trace elements|mesh-list
64318870|NCT05534750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64318871|NCT05534750|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64318873|NCT05534750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318874|NCT04884308|BCG Vaccine|bcg vaccine|mesh-list
64318875|NCT04884308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64318876|NCT04884308|Immunologic Factors|immunologic factors|mesh-ancestor
64318877|NCT04884308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318878|NCT02173873|Aflibercept|aflibercept|mesh-list
64318879|NCT02173873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64318880|NCT02173873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64318881|NCT02173873|Growth Substances|growth substances|mesh-ancestor
64318882|NCT02173873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318883|NCT02173873|Growth Inhibitors|growth inhibitors|mesh-ancestor
64318884|NCT02173873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318885|NCT02176057|Azithromycin|azithromycin|mesh-list
64318886|NCT02176057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64318887|NCT02176057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64318888|NCT02173951|Deferiprone|deferiprone|mesh-list
64318889|NCT02173951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64318890|NCT02173951|Chelating Agents|chelating agents|mesh-ancestor
64318927|NCT04305002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64318928|NCT04305002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318929|NCT04305002|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64318930|NCT04305002|Incretins|incretins|mesh-ancestor
64318991|NCT04597268|Sensory System Agents|sensory system agents|mesh-ancestor
64318992|NCT04597268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318993|NCT04597268|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64318994|NCT04597268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64319184|NCT03455504|Venetoclax|venetoclax|mesh-list
64319185|NCT03455504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319186|NCT00108953|Doxorubicin|doxorubicin|mesh-list
64319187|NCT00108953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64319188|NCT00108953|Sorafenib|sorafenib|mesh-list
64319190|NCT00108953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319194|NCT00108953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319195|NCT00108953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64319196|NCT04464980|Naltrexone|naltrexone|mesh-list
64319197|NCT04464980|Buprenorphine|buprenorphine|mesh-list
64319198|NCT04464980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64319199|NCT04464980|Narcotics|narcotics|mesh-ancestor
64319200|NCT04464980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64319201|NCT04464980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319202|NCT04464980|Analgesics|analgesics|mesh-ancestor
64319203|NCT04464980|Sensory System Agents|sensory system agents|mesh-ancestor
64319204|NCT04464980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64386301|NCT05401097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386303|NCT05401097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386304|NCT05676749|Aldesleukin|aldesleukin|mesh-list
64386305|NCT05676749|Pembrolizumab|pembrolizumab|mesh-list
64386306|NCT05676749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64386307|NCT05676749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386308|NCT05676749|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64386309|NCT05676749|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64386310|NCT05676749|Antiviral Agents|antiviral agents|mesh-ancestor
64386311|NCT05676749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64386650|NCT03489629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64386651|NCT03489629|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64386652|NCT02389751|Paclitaxel|paclitaxel|mesh-list
64386653|NCT02389751|Carboplatin|carboplatin|mesh-list
64386654|NCT02389751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64386655|NCT02389751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64386656|NCT02389751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386657|NCT02389751|Tubulin Modulators|tubulin modulators|mesh-ancestor
64386703|NCT04439825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386704|NCT02388581|Amoxicillin|amoxicillin|mesh-list
64386705|NCT02388581|Metronidazole|metronidazole|mesh-list
64386706|NCT02388581|Clarithromycin|clarithromycin|mesh-list
64386707|NCT02388581|Lansoprazole|lansoprazole|mesh-list
64386708|NCT02388581|Dexlansoprazole|dexlansoprazole|mesh-list
64386709|NCT02388581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64386710|NCT02388581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64386765|NCT02084056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64386766|NCT02084056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386767|NCT02084056|Incretins|incretins|mesh-ancestor
64386768|NCT02084056|Hormones|hormones|mesh-ancestor
64386769|NCT02084056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64386770|NCT02084056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64386771|NCT02084056|Protease Inhibitors|protease inhibitors|mesh-ancestor
64386772|NCT02084056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386773|NCT02084056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386830|NCT05136443|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64386831|NCT05136443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64386832|NCT02382653|Piroxicam|piroxicam|mesh-list
64386833|NCT02382653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64386834|NCT02382653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64386835|NCT02382653|Analgesics|analgesics|mesh-ancestor
64386836|NCT02382653|Sensory System Agents|sensory system agents|mesh-ancestor
64386837|NCT02382653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64306572|NCT02068859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64386838|NCT02382653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386839|NCT02382653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64386840|NCT02382653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64386841|NCT02382653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64386842|NCT02382653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386843|NCT02382653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386892|NCT02381717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386893|NCT02381717|Sensory System Agents|sensory system agents|mesh-ancestor
64386894|NCT02381717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64386895|NCT02381717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64386897|NCT02381717|Analgesics|analgesics|mesh-ancestor
64386898|NCT02385305|Anesthetics|anesthetics|mesh-list
64386993|NCT01625182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386994|NCT01625182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64386995|NCT01625182|Immunologic Factors|immunologic factors|mesh-ancestor
64386996|NCT01625182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386997|NCT02383901|Methotrexate|methotrexate|mesh-list
64386998|NCT02383901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64386999|NCT02383901|Abortifacient Agents|abortifacient agents|mesh-ancestor
64387000|NCT02383901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64387001|NCT02383901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387002|NCT02383901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64387189|NCT02378129|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64387190|NCT02378129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387202|NCT02376335|Rituximab|rituximab|mesh-list
64387529|NCT05653817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387530|NCT05653817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64387568|NCT02364089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387569|NCT02364089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387570|NCT02364089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64387571|NCT02364089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64387572|NCT02364089|Autonomic Agents|autonomic agents|mesh-ancestor
64387624|NCT03324113|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64387625|NCT03324113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64387626|NCT03324113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64387627|NCT03324113|Anesthetics, Local|anesthetics, local|mesh-ancestor
64387628|NCT03324113|Anesthetics|anesthetics|mesh-ancestor
64387629|NCT03324113|Sensory System Agents|sensory system agents|mesh-ancestor
64387630|NCT03324113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64387631|NCT03324113|Histamine Antagonists|histamine antagonists|mesh-ancestor
64387632|NCT03324113|Histamine Agents|histamine agents|mesh-ancestor
64387633|NCT03324113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64387634|NCT03324113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387635|NCT03324113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64387636|NCT03324113|Antipruritics|antipruritics|mesh-ancestor
64387637|NCT03324113|Dermatologic Agents|dermatologic agents|mesh-ancestor
64387638|NCT03324113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64387639|NCT03324113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64387640|NCT03324113|Adrenergic Agents|adrenergic agents|mesh-ancestor
64387641|NCT03324113|Nasal Decongestants|nasal decongestants|mesh-ancestor
64387642|NCT03324113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64387643|NCT03324113|Respiratory System Agents|respiratory system agents|mesh-ancestor
64387644|NCT02079844|Antipsychotic Agents|antipsychotic agents|mesh-list
64387736|NCT02794571|Capecitabine|capecitabine|mesh-list
64387737|NCT02794571|Pemetrexed|pemetrexed|mesh-list
64387738|NCT02794571|Atezolizumab|atezolizumab|mesh-list
64387739|NCT02794571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64387740|NCT02794571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387741|NCT02794571|Tubulin Modulators|tubulin modulators|mesh-ancestor
64387742|NCT02794571|Antimitotic Agents|antimitotic agents|mesh-ancestor
64387743|NCT02794571|Mitosis Modulators|mitosis modulators|mesh-ancestor
64387744|NCT02794571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387745|NCT02794571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64387796|NCT02365727|Anesthetics, Local|anesthetics, local|mesh-ancestor
64387797|NCT02365727|Anesthetics|anesthetics|mesh-ancestor
64387798|NCT02365727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64387799|NCT02365727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387800|NCT02365727|Sensory System Agents|sensory system agents|mesh-ancestor
64387801|NCT02365727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387802|NCT02365727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64387803|NCT02365727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64387804|NCT02365727|Adrenergic Agents|adrenergic agents|mesh-ancestor
64387805|NCT02365727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64387806|NCT02365727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387807|NCT02365727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64387808|NCT02365727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64387809|NCT02365727|Autonomic Agents|autonomic agents|mesh-ancestor
64387810|NCT02365727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64387811|NCT02365727|Respiratory System Agents|respiratory system agents|mesh-ancestor
64387812|NCT02365727|Mydriatics|mydriatics|mesh-ancestor
64387813|NCT02365727|Sympathomimetics|sympathomimetics|mesh-ancestor
64387814|NCT02365727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64387815|NCT02365727|Analgesics|analgesics|mesh-ancestor
64387816|NCT02365727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64387817|NCT02365727|Sympatholytics|sympatholytics|mesh-ancestor
64387818|NCT02365727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64387855|NCT03112577|Xhance|xhance|mesh-list
64387935|NCT02358161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387936|NCT02357849|Aripiprazole|aripiprazole|mesh-list
64387937|NCT02357849|Fluoxetine|fluoxetine|mesh-list
64387938|NCT02357849|Antidepressive Agents|antidepressive agents|mesh-ancestor
64387939|NCT02357849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64387940|NCT02357849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64387941|NCT02357849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64387942|NCT02357849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64387943|NCT02357849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387944|NCT02357849|Dopamine Agonists|dopamine agonists|mesh-ancestor
64387945|NCT02357849|Dopamine Agents|dopamine agents|mesh-ancestor
64387946|NCT02357849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64387947|NCT02357849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387948|NCT02357849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64387976|NCT02357615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64387977|NCT02357615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387979|NCT02357615|Tocolytic Agents|tocolytic agents|mesh-ancestor
64387980|NCT02357615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64387981|NCT03160001|Niclosamide|niclosamide|mesh-list
64387982|NCT03160001|Etanercept|etanercept|mesh-list
64387983|NCT03160001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64387984|NCT03160001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64387985|NCT03160001|Analgesics|analgesics|mesh-ancestor
64387986|NCT03160001|Sensory System Agents|sensory system agents|mesh-ancestor
64387987|NCT03160001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387988|NCT03160001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388141|NCT02352155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388142|NCT02352155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64388143|NCT02352155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64388144|NCT02352155|Autonomic Agents|autonomic agents|mesh-ancestor
64388145|NCT02352155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64388146|NCT02352155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64388236|NCT02354807|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64388237|NCT02354807|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64388238|NCT02354807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64388239|NCT02354807|Adrenergic Agents|adrenergic agents|mesh-ancestor
64440210|NCT02322047|Prazosin|prazosin|mesh-list
64388241|NCT02354807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388242|NCT02354807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388243|NCT02354807|Urological Agents|urological agents|mesh-ancestor
64388244|NCT03159845|Levofloxacin|levofloxacin|mesh-list
64388246|NCT03159845|Fluconazole|fluconazole|mesh-list
64388247|NCT03159845|Acyclovir|acyclovir|mesh-list
64389912|NCT03186001|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64389913|NCT03186001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64389914|NCT03186001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64389915|NCT03186001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389916|NCT03186001|Cholinergic Agents|cholinergic agents|mesh-ancestor
64389981|NCT02428543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389982|NCT02428543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64389983|NCT02428543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389984|NCT04428203|Cannabidiol|cannabidiol|mesh-list
64389985|NCT04428203|Anticonvulsants|anticonvulsants|mesh-ancestor
64390212|NCT03141125|Ethanol|ethanol|mesh-list
64390217|NCT02426983|Dextromethorphan|dextromethorphan|mesh-list
64390221|NCT02426983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64390222|NCT02426983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64390223|NCT02426983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390224|NCT02426983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390225|NCT03142763|Choline|choline|mesh-list
64390226|NCT03142763|Lipotropic Agents|lipotropic agents|mesh-ancestor
64390227|NCT03142763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64390228|NCT03142763|Antimetabolites|antimetabolites|mesh-ancestor
64390229|NCT03142763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390298|NCT04976387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64390299|NCT04976387|Antitussive Agents|antitussive agents|mesh-ancestor
64390300|NCT04976387|Respiratory System Agents|respiratory system agents|mesh-ancestor
64390302|NCT03139253|Clarithromycin|clarithromycin|mesh-list
64390303|NCT03139253|Levofloxacin|levofloxacin|mesh-list
64390304|NCT03139253|Ofloxacin|ofloxacin|mesh-list
64390305|NCT03139253|Tetracycline|tetracycline|mesh-list
64390306|NCT03139253|Tinidazole|tinidazole|mesh-list
64390578|NCT03106597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390579|NCT03106597|Vasodilator Agents|vasodilator agents|mesh-ancestor
64390581|NCT02018458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64390582|NCT02018458|Cyclophosphamide|cyclophosphamide|mesh-list
64390583|NCT02018458|Carboplatin|carboplatin|mesh-list
64390584|NCT02018458|Doxorubicin|doxorubicin|mesh-list
64390585|NCT02018458|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64390586|NCT02018458|Vaccines|vaccines|mesh-list
64390587|NCT02018458|Immunologic Factors|immunologic factors|mesh-ancestor
64390588|NCT02018458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390589|NCT02018458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64390590|NCT02018458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390591|NCT02018458|Tubulin Modulators|tubulin modulators|mesh-ancestor
64390592|NCT02018458|Antimitotic Agents|antimitotic agents|mesh-ancestor
64390593|NCT02018458|Mitosis Modulators|mitosis modulators|mesh-ancestor
64390594|NCT02018458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390595|NCT02018458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64390596|NCT02018458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64390598|NCT02018458|Alkylating Agents|alkylating agents|mesh-ancestor
64390601|NCT02018458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64390602|NCT02018458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64390603|NCT02018458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64390607|NCT02423083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64390608|NCT02423083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64390609|NCT02423083|Adrenergic Agents|adrenergic agents|mesh-ancestor
64390610|NCT02423083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64390611|NCT02423083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390612|NCT02423083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390613|NCT02423863|Pembrolizumab|pembrolizumab|mesh-list
64390614|NCT02423863|Nivolumab|nivolumab|mesh-list
64390615|NCT02423863|Durvalumab|durvalumab|mesh-list
64390616|NCT02423863|Cemiplimab|cemiplimab|mesh-list
64390617|NCT02423863|Atezolizumab|atezolizumab|mesh-list
64390759|NCT02415985|Protease Inhibitors|protease inhibitors|mesh-ancestor
64390760|NCT02415985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64390761|NCT02415985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390762|NCT02415985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64390763|NCT02415985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64390764|NCT02415985|Antiviral Agents|antiviral agents|mesh-ancestor
64390765|NCT02415985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64390766|NCT02415985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64390767|NCT02415985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64390768|NCT02415985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64390769|NCT02415985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64390770|NCT02415985|Antitubercular Agents|antitubercular agents|mesh-ancestor
64390771|NCT02415829|Capecitabine|capecitabine|mesh-list
64390772|NCT02415829|Oxaliplatin|oxaliplatin|mesh-list
64390842|NCT05106517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64390924|NCT05088083|Antimitotic Agents|antimitotic agents|mesh-ancestor
64390925|NCT05088083|Mitosis Modulators|mitosis modulators|mesh-ancestor
64390926|NCT05088083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390927|NCT03110159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64390928|NCT03110159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64390929|NCT03110159|Dermatologic Agents|dermatologic agents|mesh-ancestor
64390931|NCT05087693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64390932|NCT05087693|Autonomic Agents|autonomic agents|mesh-ancestor
64390933|NCT05087693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64390934|NCT05087693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390935|NCT05087693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64390936|NCT05087693|Respiratory System Agents|respiratory system agents|mesh-ancestor
64390937|NCT05087693|Tocolytic Agents|tocolytic agents|mesh-ancestor
64390938|NCT05087693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64306773|NCT02073773|Levodopa|levodopa|mesh-list
64391269|NCT05737511|Dermatologic Agents|dermatologic agents|mesh-ancestor
64391270|NCT05737511|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64391271|NCT03179839|Fluvoxamine|fluvoxamine|mesh-list
64391273|NCT03179839|Antidepressive Agents|antidepressive agents|mesh-ancestor
64391274|NCT03179839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64391275|NCT03179839|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64391276|NCT03179839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64391277|NCT03179839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64391278|NCT03179839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391279|NCT03179839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64391280|NCT03179839|Serotonin Agents|serotonin agents|mesh-ancestor
64391281|NCT03179839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391282|NCT03179839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64391283|NCT03179839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64391291|NCT05736887|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64391293|NCT05736887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64391294|NCT05736887|Expectorants|expectorants|mesh-ancestor
64391295|NCT05736887|Respiratory System Agents|respiratory system agents|mesh-ancestor
64391296|NCT05736887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64391297|NCT05736887|Antioxidants|antioxidants|mesh-ancestor
64391298|NCT05736887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391299|NCT05736887|Protective Agents|protective agents|mesh-ancestor
64391300|NCT05736887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391301|NCT05736887|Antidotes|antidotes|mesh-ancestor
64391302|NCT02703337|Insulin Lispro|insulin lispro|mesh-list
64391338|NCT02423395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391339|NCT02423395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64391340|NCT02423395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64391341|NCT02423395|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64391342|NCT02423395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64391343|NCT02423395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64391344|NCT02423395|Parasympatholytics|parasympatholytics|mesh-ancestor
64391345|NCT02423395|Autonomic Agents|autonomic agents|mesh-ancestor
64391346|NCT02423395|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64391347|NCT02423395|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64391385|NCT02423239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64391493|NCT04543643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391495|NCT04543643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64391496|NCT04543643|Antioxidants|antioxidants|mesh-ancestor
64391497|NCT04543643|Protective Agents|protective agents|mesh-ancestor
64391498|NCT04543643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64391499|NCT04543643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64391500|NCT04543643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64391501|NCT04543643|Vasodilator Agents|vasodilator agents|mesh-ancestor
64391502|NCT04543643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64391626|NCT03179293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64391627|NCT03179293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64391628|NCT03179293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306818|NCT04975724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64334671|NCT02295787|Analgesics|analgesics|mesh-ancestor
64391629|NCT03179293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64391630|NCT03179293|Anesthetics, General|anesthetics, general|mesh-ancestor
64391631|NCT03179293|Anesthetics|anesthetics|mesh-ancestor
64391632|NCT02416765|Glucagon|glucagon|mesh-list
64391642|NCT02703259|Sensory System Agents|sensory system agents|mesh-ancestor
64391643|NCT02703259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64391644|NCT02703259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391645|NCT02703259|Antipyretics|antipyretics|mesh-ancestor
64392028|NCT02449187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64392029|NCT02449187|Antimetabolites|antimetabolites|mesh-ancestor
64392168|NCT01987102|Vitamin B Complex|vitamin b complex|mesh-ancestor
64392169|NCT01987102|Vitamins|vitamins|mesh-ancestor
64392170|NCT01987102|Micronutrients|micronutrients|mesh-ancestor
64392171|NCT02013544|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64392172|NCT02013544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64392173|NCT02013544|Immunologic Factors|immunologic factors|mesh-ancestor
64392174|NCT02013544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392175|NCT05374499|Epinephrine|epinephrine|mesh-list
64392176|NCT05374499|Bupivacaine|bupivacaine|mesh-list
64392177|NCT05374499|Anesthetics, Local|anesthetics, local|mesh-ancestor
64392178|NCT05374499|Anesthetics|anesthetics|mesh-ancestor
64392179|NCT05374499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64392180|NCT05374499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334672|NCT02295787|Sensory System Agents|sensory system agents|mesh-ancestor
64392181|NCT05374499|Sensory System Agents|sensory system agents|mesh-ancestor
64392182|NCT05374499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392183|NCT05374499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64392184|NCT05374499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64392185|NCT05374499|Adrenergic Agents|adrenergic agents|mesh-ancestor
64392186|NCT05374499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64392187|NCT05374499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392188|NCT05374499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64392189|NCT05374499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64392190|NCT05374499|Autonomic Agents|autonomic agents|mesh-ancestor
64392191|NCT05374499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64392192|NCT05374499|Respiratory System Agents|respiratory system agents|mesh-ancestor
64392193|NCT05374499|Mydriatics|mydriatics|mesh-ancestor
64392194|NCT05374499|Sympathomimetics|sympathomimetics|mesh-ancestor
64392195|NCT05374499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64392196|NCT03968939|Diphenhydramine|diphenhydramine|mesh-list
64392197|NCT03968939|Promethazine|promethazine|mesh-list
64392198|NCT03968939|Melatonin|melatonin|mesh-list
64392436|NCT04414241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64392437|NCT04531553|Levobupivacaine|levobupivacaine|mesh-list
64392438|NCT04531553|Anesthetics, Local|anesthetics, local|mesh-ancestor
64392440|NCT04531553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64392441|NCT04531553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392442|NCT04531553|Sensory System Agents|sensory system agents|mesh-ancestor
64392443|NCT04531553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392450|NCT05101811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64392451|NCT05101811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64392460|NCT04088123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392462|NCT05164367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64392463|NCT05164367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64392464|NCT05164367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64392465|NCT05164367|Autonomic Agents|autonomic agents|mesh-ancestor
64392466|NCT05164367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392467|NCT05164367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392468|NCT05164367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64392469|NCT05164367|Respiratory System Agents|respiratory system agents|mesh-ancestor
64392470|NCT05164367|Mydriatics|mydriatics|mesh-ancestor
64392471|NCT05164367|Parasympatholytics|parasympatholytics|mesh-ancestor
64392472|NCT05164367|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64392473|NCT05164367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64392474|NCT05164367|Cholinergic Agents|cholinergic agents|mesh-ancestor
64392475|NCT05164367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64392476|NCT05164367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392477|NCT03847181|Vitamin K|vitamin k|mesh-list
64392478|NCT03847181|Warfarin|warfarin|mesh-list
64392479|NCT03847181|Rivaroxaban|rivaroxaban|mesh-list
64392480|NCT03847181|Apixaban|apixaban|mesh-list
64392575|NCT03116269|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64307010|NCT04954040|Hydroxychloroquine|hydroxychloroquine|mesh-list
64392576|NCT03116269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64392578|NCT03174067|Buprenorphine|buprenorphine|mesh-list
64392579|NCT03174067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64392580|NCT03174067|Narcotics|narcotics|mesh-ancestor
64392581|NCT03174067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64392605|NCT02408419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392607|NCT00708097|Cariostatic Agents|cariostatic agents|mesh-ancestor
64392608|NCT00708097|Protective Agents|protective agents|mesh-ancestor
64392616|NCT02405689|Sevoflurane|sevoflurane|mesh-list
64392617|NCT02405689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64392618|NCT02405689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64392619|NCT02405689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392620|NCT02405689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64392621|NCT02405689|Analgesics|analgesics|mesh-ancestor
64392622|NCT02405689|Sensory System Agents|sensory system agents|mesh-ancestor
64392623|NCT02405689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392624|NCT02405689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64392625|NCT02405689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64392626|NCT02405689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64392627|NCT02405689|Adrenergic Agents|adrenergic agents|mesh-ancestor
64392628|NCT02405689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64392629|NCT02405689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392630|NCT02405689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64392631|NCT02405689|Narcotics|narcotics|mesh-ancestor
64392632|NCT02405689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64440317|NCT04892953|Pemetrexed|pemetrexed|mesh-list
64392761|NCT02399059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64392762|NCT02399059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64392763|NCT05108051|Oseltamivir|oseltamivir|mesh-list
64392764|NCT05108051|Antiviral Agents|antiviral agents|mesh-ancestor
64392765|NCT05108051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64392775|NCT04351295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64392776|NCT04351295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64392777|NCT04351295|Antimalarials|antimalarials|mesh-ancestor
64392778|NCT04351295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64392779|NCT04351295|Antiviral Agents|antiviral agents|mesh-ancestor
64392780|NCT02399137|Gemcitabine|gemcitabine|mesh-list
64392781|NCT02399137|Paclitaxel|paclitaxel|mesh-list
64392782|NCT02399137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64392783|NCT02399137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64392784|NCT02399137|Tubulin Modulators|tubulin modulators|mesh-ancestor
64392785|NCT02399137|Antimitotic Agents|antimitotic agents|mesh-ancestor
64392786|NCT02399137|Mitosis Modulators|mitosis modulators|mesh-ancestor
64392787|NCT02399137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392788|NCT02399137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64392789|NCT02399137|Antimetabolites|antimetabolites|mesh-ancestor
64392790|NCT02399137|Antiviral Agents|antiviral agents|mesh-ancestor
64392791|NCT02399137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64392792|NCT02399137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64392793|NCT02399137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64392794|NCT02399137|Immunologic Factors|immunologic factors|mesh-ancestor
64392795|NCT02399137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392796|NCT05093387|Carboplatin|carboplatin|mesh-list
64392797|NCT05093387|Pembrolizumab|pembrolizumab|mesh-list
64392819|NCT04481815|Abortifacient Agents|abortifacient agents|mesh-ancestor
64392820|NCT04481815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64392821|NCT04481815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64392823|NCT04481815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392824|NCT04481815|Dermatologic Agents|dermatologic agents|mesh-ancestor
64392825|NCT04481815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64392826|NCT04481815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64392827|NCT04481815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64392828|NCT04481815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64392829|NCT04481815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64392830|NCT04481815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64392831|NCT04481815|Growth Substances|growth substances|mesh-ancestor
64392832|NCT04481815|Growth Inhibitors|growth inhibitors|mesh-ancestor
64392834|NCT05106803|Vancomycin|vancomycin|mesh-list
64392835|NCT05106803|Ciprofloxacin|ciprofloxacin|mesh-list
64392836|NCT05106803|Clindamycin|clindamycin|mesh-list
64392837|NCT05106803|Gentamicins|gentamicins|mesh-list
64392838|NCT05106803|Tetracycline|tetracycline|mesh-list
64392839|NCT05106803|Penicillins|penicillins|mesh-list
64392840|NCT05106803|Erythromycin|erythromycin|mesh-list
64392841|NCT05106803|Clavulanic Acids|clavulanic acids|mesh-list
64392842|NCT05106803|Clavulanic Acid|clavulanic acid|mesh-list
64392843|NCT05106803|Ampicillin|ampicillin|mesh-list
64392844|NCT05106803|Cefepime|cefepime|mesh-list
64392845|NCT05106803|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64392846|NCT05106803|Norfloxacin|norfloxacin|mesh-list
64392847|NCT05106803|Oxacillin|oxacillin|mesh-list
64392848|NCT05106803|Chloramphenicol|chloramphenicol|mesh-list
64392849|NCT05106803|Trimethoprim|trimethoprim|mesh-list
64392850|NCT05106803|Sulfamethoxazole|sulfamethoxazole|mesh-list
64392851|NCT05106803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64392852|NCT05106803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64392853|NCT05106803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64392953|NCT02404519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392955|NCT02404519|Coagulants|coagulants|mesh-ancestor
64393601|NCT03170479|Vitamin D|vitamin d|mesh-list
64393602|NCT03170479|Vitamins|vitamins|mesh-ancestor
64393603|NCT03170479|Micronutrients|micronutrients|mesh-ancestor
64393604|NCT03170479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393605|NCT03170479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64393606|NCT01962298|Rocuronium|rocuronium|mesh-list
64393607|NCT01962298|Neostigmine|neostigmine|mesh-list
64393608|NCT01962298|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64393609|NCT01962298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64393610|NCT01962298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64393611|NCT01962298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393612|NCT01962298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393613|NCT01962298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64393614|NCT01962298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393615|NCT01962298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393734|NCT02184767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393736|NCT02184767|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64393737|NCT02184767|Dopamine Agents|dopamine agents|mesh-ancestor
64393738|NCT02184767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64393739|NCT02184767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394038|NCT05228483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64394039|NCT05228483|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64394041|NCT04255277|Levonorgestrel|levonorgestrel|mesh-list
64394042|NCT04255277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64394043|NCT04255277|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64394044|NCT04255277|Contraceptive Agents|contraceptive agents|mesh-list
64394045|NCT04255277|Contraceptives, Oral|contraceptives, oral|mesh-list
64394046|NCT04255277|Charcoal|charcoal|mesh-list
64394272|NCT02812433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64394273|NCT02812433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394274|NCT02812433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394275|NCT02812433|Urological Agents|urological agents|mesh-ancestor
64394276|NCT02392039|Loratadine|loratadine|mesh-list
64394277|NCT02392039|Antipruritics|antipruritics|mesh-ancestor
64394278|NCT02392039|Dermatologic Agents|dermatologic agents|mesh-ancestor
64394279|NCT02392039|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64394280|NCT02392039|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64394281|NCT02392039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64394282|NCT02392039|Histamine Antagonists|histamine antagonists|mesh-ancestor
64394283|NCT02392039|Histamine Agents|histamine agents|mesh-ancestor
64394284|NCT02392039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64394285|NCT02392039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397519|NCT05058755|Growth Inhibitors|growth inhibitors|mesh-ancestor
64397520|NCT05058755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64397522|NCT05044169|Broncho-Vaxom|broncho-vaxom|mesh-list
64397523|NCT05044169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64397524|NCT05044169|Immunologic Factors|immunologic factors|mesh-ancestor
64397525|NCT05044169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397526|NCT05058209|Triamcinolone|triamcinolone|mesh-list
64397527|NCT05058209|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64397528|NCT05058209|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64397529|NCT05058209|Betamethasone|betamethasone|mesh-list
64397530|NCT05058209|Betamethasone Valerate|betamethasone valerate|mesh-list
64397531|NCT05058209|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64397532|NCT05058209|Betamethasone benzoate|betamethasone benzoate|mesh-list
64397533|NCT05058209|Betamethasone acetate|betamethasone acetate|mesh-list
64397534|NCT05058209|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64397535|NCT05058209|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64397536|NCT05058209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64397537|NCT05058209|Glucocorticoids|glucocorticoids|mesh-ancestor
64397538|NCT05058209|Hormones|hormones|mesh-ancestor
64397539|NCT05058209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64397540|NCT05058209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397541|NCT05058209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64397542|NCT05058209|Immunologic Factors|immunologic factors|mesh-ancestor
64397564|NCT03097445|Cholinergic Agents|cholinergic agents|mesh-ancestor
64397565|NCT03097445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64397566|NCT03097445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397568|NCT05057351|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64397569|NCT05057351|Protective Agents|protective agents|mesh-ancestor
64397570|NCT05057351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397571|NCT03097211|Levodopa|levodopa|mesh-list
64397583|NCT03097211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397584|NCT03097211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64397585|NCT05043935|Anti-Infective Agents|anti-infective agents|mesh-list
64397586|NCT05043935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64397588|NCT05056337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64397589|NCT05056337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64397590|NCT05056337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397591|NCT05056337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397592|NCT05056025|Vitamins|vitamins|mesh-list
64397593|NCT05056025|Micronutrients|micronutrients|mesh-ancestor
64397594|NCT05056025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440480|NCT02230891|Spironolactone|spironolactone|mesh-list
64397595|NCT02661217|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64397616|NCT01951378|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64397617|NCT01951378|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64397618|NCT01951378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64397619|NCT01951378|Adrenergic Agents|adrenergic agents|mesh-ancestor
64397671|NCT02373163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64397672|NCT02373163|Telmisartan|telmisartan|mesh-list
64397673|NCT02373163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64397674|NCT02373163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64397675|NCT02373163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64397676|NCT02373163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397677|NCT02373163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64397678|NCT02373163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397679|NCT02373163|Vasodilator Agents|vasodilator agents|mesh-ancestor
64397680|NCT02373163|Diuretics|diuretics|mesh-ancestor
64307200|NCT02081027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64307296|NCT04412876|Analgesics|analgesics|mesh-ancestor
64397681|NCT02373163|Natriuretic Agents|natriuretic agents|mesh-ancestor
64397682|NCT02373163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64397683|NCT02373163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64397684|NCT02373163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64397685|NCT02366377|Metformin|metformin|mesh-list
64397686|NCT02366377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64397687|NCT02366377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397688|NCT02366299|Dexmedetomidine|dexmedetomidine|mesh-list
64397689|NCT02366299|Propofol|propofol|mesh-list
64397690|NCT02366299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64397691|NCT02366299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64397692|NCT02366299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397693|NCT02366299|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64397694|NCT02366299|Anesthetics, General|anesthetics, general|mesh-ancestor
64397695|NCT02366299|Anesthetics|anesthetics|mesh-ancestor
64397696|NCT02366299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64397697|NCT02366299|Analgesics|analgesics|mesh-ancestor
64440502|NCT02302859|Nicotine|nicotine|mesh-list
64397727|NCT05041985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397728|NCT05053841|Metformin|metformin|mesh-list
64397729|NCT05053841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64397730|NCT05053841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397731|NCT02372461|Amoxicillin|amoxicillin|mesh-list
64397732|NCT02372461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64397733|NCT02372461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64397734|NCT02859337|Ulipristal acetate|ulipristal acetate|mesh-list
64397735|NCT02859337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64397736|NCT02859337|Contraceptive Agents|contraceptive agents|mesh-ancestor
64397737|NCT02859337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64397738|NCT02859337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397739|NCT02859337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64397740|NCT04499131|Progesterone|progesterone|mesh-list
64397741|NCT04499131|Progestins|progestins|mesh-ancestor
64397742|NCT04499131|Hormones|hormones|mesh-ancestor
64397743|NCT04499131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64397744|NCT04499131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397745|NCT02366065|Acetaminophen|acetaminophen|mesh-list
64397746|NCT02366065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64397747|NCT02366065|Analgesics|analgesics|mesh-ancestor
64397748|NCT02366065|Sensory System Agents|sensory system agents|mesh-ancestor
64397749|NCT02366065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64397750|NCT02366065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397751|NCT02366065|Antipyretics|antipyretics|mesh-ancestor
64397752|NCT02362945|Oxytocin|oxytocin|mesh-list
64397753|NCT02362945|Oxytocics|oxytocics|mesh-ancestor
64397754|NCT02362945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64397755|NCT02362945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397756|NCT02365909|Bupivacaine|bupivacaine|mesh-list
64397757|NCT02365909|Anesthetics, Local|anesthetics, local|mesh-ancestor
64397758|NCT02365909|Anesthetics|anesthetics|mesh-ancestor
64397759|NCT02365909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64397760|NCT02365909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397761|NCT02365909|Sensory System Agents|sensory system agents|mesh-ancestor
64397762|NCT02365909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64440548|NCT05649956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64397764|NCT05052515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397766|NCT05052515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64397767|NCT05052515|Antimetabolites|antimetabolites|mesh-ancestor
64397768|NCT05052515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64397769|NCT05052515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64397770|NCT05052515|Nootropic Agents|nootropic agents|mesh-ancestor
64397771|NCT02365675|Petrolatum|petrolatum|mesh-list
64397772|NCT02365675|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64397789|NCT02362711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64397790|NCT02362711|Contraceptive Agents|contraceptive agents|mesh-ancestor
64397791|NCT02362711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64307320|NCT03241641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397792|NCT02362711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397793|NCT02362711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64397797|NCT02362711|Estrogens|estrogens|mesh-ancestor
64397823|NCT00773695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64397824|NCT00773695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64397825|NCT00773695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64397826|NCT00773695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64397827|NCT00773695|Growth Substances|growth substances|mesh-ancestor
64397828|NCT00773695|Growth Inhibitors|growth inhibitors|mesh-ancestor
64397829|NCT00773695|Antimetabolites|antimetabolites|mesh-ancestor
64397830|NCT00773695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64397831|NCT00773695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64397832|NCT00773695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397833|NCT00773695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64397834|NCT00773695|Hormone Antagonists|hormone antagonists|mesh-ancestor
64397846|NCT01969084|Protease Inhibitors|protease inhibitors|mesh-ancestor
64397847|NCT01969084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397848|NCT01969084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397849|NCT02362399|Sildenafil Citrate|sildenafil citrate|mesh-list
64397850|NCT02362399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397851|NCT02362399|Vasodilator Agents|vasodilator agents|mesh-ancestor
64397852|NCT02362399|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64397853|NCT02362399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64397854|NCT02362399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397855|NCT02362399|Urological Agents|urological agents|mesh-ancestor
64397856|NCT04410887|Olaparib|olaparib|mesh-list
64397857|NCT04410887|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64397858|NCT04410887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397860|NCT04410887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64397876|NCT02358265|Antipruritics|antipruritics|mesh-ancestor
64397877|NCT02358265|Dermatologic Agents|dermatologic agents|mesh-ancestor
64397878|NCT02358265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64397879|NCT02358265|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64397880|NCT02358265|Histamine Antagonists|histamine antagonists|mesh-ancestor
64397881|NCT02358265|Histamine Agents|histamine agents|mesh-ancestor
64397882|NCT02358265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64397883|NCT02358265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397884|NCT02358265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397885|NCT02358265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64397886|NCT02358265|Serotonin Agents|serotonin agents|mesh-ancestor
64397887|NCT02358265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64397888|NCT01968694|Diphenhydramine|diphenhydramine|mesh-list
64397889|NCT01968694|Promethazine|promethazine|mesh-list
64397890|NCT01968694|Lidocaine|lidocaine|mesh-list
64397891|NCT01968694|Anesthetics, Local|anesthetics, local|mesh-ancestor
64397892|NCT01968694|Anesthetics|anesthetics|mesh-ancestor
64397893|NCT01968694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64397894|NCT01968694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397895|NCT01968694|Sensory System Agents|sensory system agents|mesh-ancestor
64440567|NCT02304926|Antimetabolites|antimetabolites|mesh-ancestor
64440581|NCT02203591|Ethanol|ethanol|mesh-list
64397900|NCT01968694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64397901|NCT01968694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397902|NCT01968694|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64397903|NCT01968694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64397904|NCT01968694|Antiemetics|antiemetics|mesh-ancestor
64397905|NCT01968694|Autonomic Agents|autonomic agents|mesh-ancestor
64397906|NCT01968694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64397907|NCT01968694|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64397925|NCT05038007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64397927|NCT02362165|Cyclophosphamide|cyclophosphamide|mesh-list
64397928|NCT02362165|Doxorubicin|doxorubicin|mesh-list
64397930|NCT02362165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64397931|NCT02362165|Immunologic Factors|immunologic factors|mesh-ancestor
64397932|NCT02362165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397933|NCT02362165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64397934|NCT02362165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64397935|NCT02362165|Alkylating Agents|alkylating agents|mesh-ancestor
64397936|NCT02362165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397937|NCT02362165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64397938|NCT02362165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64397939|NCT02362165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64397940|NCT02362165|Antiemetics|antiemetics|mesh-ancestor
64397941|NCT02362165|Autonomic Agents|autonomic agents|mesh-ancestor
64397942|NCT02362165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64397943|NCT02362165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64397944|NCT02362165|Glucocorticoids|glucocorticoids|mesh-ancestor
64397945|NCT02362165|Hormones|hormones|mesh-ancestor
64397946|NCT02362165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64397947|NCT02362165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64397948|NCT02362165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64397949|NCT02362165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64397950|NCT02362165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64397951|NCT02362165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397952|NCT05049473|Cytarabine|cytarabine|mesh-list
64397953|NCT05049473|Dexamethasone|dexamethasone|mesh-list
64397954|NCT05049473|Prednisone|prednisone|mesh-list
64397955|NCT05049473|Hydrocortisone|hydrocortisone|mesh-list
64397989|NCT05049473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64397990|NCT05049473|Antimetabolites|antimetabolites|mesh-ancestor
64397991|NCT05049473|Dermatologic Agents|dermatologic agents|mesh-ancestor
64397992|NCT05049473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64397993|NCT05049473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64397994|NCT05049473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64397995|NCT05049473|Antiviral Agents|antiviral agents|mesh-ancestor
64397997|NCT05049473|Tubulin Modulators|tubulin modulators|mesh-ancestor
64397998|NCT05049473|Antimitotic Agents|antimitotic agents|mesh-ancestor
64397999|NCT05049473|Mitosis Modulators|mitosis modulators|mesh-ancestor
64398000|NCT02357797|Vortioxetine|vortioxetine|mesh-list
64398001|NCT02357797|Antidepressive Agents|antidepressive agents|mesh-ancestor
64398002|NCT02357797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64398003|NCT02357797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64398004|NCT02357797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64307530|NCT03240471|Calpastatin|calpastatin|mesh-list
64398005|NCT02357797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64398006|NCT02357797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398007|NCT02357797|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64398008|NCT02357797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64398009|NCT02357797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64398010|NCT02357797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398011|NCT02357797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64398012|NCT02357797|Serotonin Agents|serotonin agents|mesh-ancestor
64398044|NCT03160261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64398045|NCT03160261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398046|NCT03160261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64398047|NCT03160261|Incretins|incretins|mesh-ancestor
64307593|NCT04942496|Chlorhexidine|chlorhexidine|mesh-list
64398049|NCT03160261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64398050|NCT04478617|Metronidazole|metronidazole|mesh-list
64398051|NCT04478617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64398052|NCT04478617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64398053|NCT04478617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64398054|NCT04478617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64398055|NCT02361775|Ropivacaine|ropivacaine|mesh-list
64398056|NCT02361775|Anesthetics, Local|anesthetics, local|mesh-ancestor
64398057|NCT02361775|Anesthetics|anesthetics|mesh-ancestor
64398058|NCT02361775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64398059|NCT02361775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398060|NCT02361775|Sensory System Agents|sensory system agents|mesh-ancestor
64440606|NCT02230189|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64398061|NCT02361775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64398063|NCT02361619|Diclofenac|diclofenac|mesh-list
64398064|NCT02361619|Metoprolol|metoprolol|mesh-list
64398065|NCT02361619|Midazolam|midazolam|mesh-list
64398066|NCT02361619|Caffeine|caffeine|mesh-list
64398067|NCT02361619|Esomeprazole|esomeprazole|mesh-list
64398068|NCT02361619|Dabigatran|dabigatran|mesh-list
64398069|NCT02361619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64398070|NCT02361619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64398071|NCT02361619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64398072|NCT02361619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398073|NCT02361619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64398074|NCT02361619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64307669|NCT02622386|Riboflavin|riboflavin|mesh-list
64307670|NCT02622386|Vitamins|vitamins|mesh-ancestor
64398075|NCT02361619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64398076|NCT02361619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64398077|NCT02361619|Anesthetics, General|anesthetics, general|mesh-ancestor
64398078|NCT02361619|Anesthetics|anesthetics|mesh-ancestor
64398088|NCT02361619|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64398097|NCT02361619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64398098|NCT02361619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64398099|NCT02361619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64398100|NCT02361619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64398101|NCT02361619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64398102|NCT02361619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64398103|NCT02361619|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64398104|NCT02361619|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64398105|NCT02361619|Antithrombins|antithrombins|mesh-ancestor
64398106|NCT02361619|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64398107|NCT02361619|Protease Inhibitors|protease inhibitors|mesh-ancestor
64398108|NCT02361619|Anticoagulants|anticoagulants|mesh-ancestor
64398109|NCT02361619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64398110|NCT02361619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64398111|NCT02361619|Sympatholytics|sympatholytics|mesh-ancestor
64398112|NCT02361619|Autonomic Agents|autonomic agents|mesh-ancestor
64398113|NCT02361619|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64398114|NCT02361619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64398115|NCT02361619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64398116|NCT02361619|Adrenergic Agents|adrenergic agents|mesh-ancestor
64398118|NCT02352025|Phytoestrogens|phytoestrogens|mesh-ancestor
64398119|NCT02352025|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64398120|NCT02352025|Estrogens|estrogens|mesh-ancestor
64398121|NCT02352025|Hormones|hormones|mesh-ancestor
64398122|NCT02352025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64398123|NCT02352025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398124|NCT01950364|Rifampin|rifampin|mesh-list
64398125|NCT01950364|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64398126|NCT01950364|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64398127|NCT01950364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64398128|NCT01950364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398129|NCT01950364|Immunologic Factors|immunologic factors|mesh-ancestor
64398137|NCT01950364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398138|NCT01950364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398139|NCT01950364|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64398140|NCT01950364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64398141|NCT01950364|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64398142|NCT01950364|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64398143|NCT01950364|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64398144|NCT01950364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64398145|NCT05047991|Leucovorin|leucovorin|mesh-list
64398146|NCT05047991|Gemcitabine|gemcitabine|mesh-list
64398147|NCT05047991|Paclitaxel|paclitaxel|mesh-list
64398148|NCT05047991|Fluorouracil|fluorouracil|mesh-list
64398149|NCT05047991|Oxaliplatin|oxaliplatin|mesh-list
64398150|NCT05047991|Irinotecan|irinotecan|mesh-list
64398151|NCT05047991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64307938|NCT03057314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398152|NCT05047991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398153|NCT05047991|Tubulin Modulators|tubulin modulators|mesh-ancestor
64398164|NCT05047991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398165|NCT05047991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64398166|NCT05047991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64398167|NCT05047991|Antidotes|antidotes|mesh-ancestor
64398168|NCT05047991|Protective Agents|protective agents|mesh-ancestor
64398169|NCT05047991|Vitamin B Complex|vitamin b complex|mesh-ancestor
64398170|NCT05047991|Vitamins|vitamins|mesh-ancestor
64398171|NCT05047991|Micronutrients|micronutrients|mesh-ancestor
64398172|NCT00014443|Thalidomide|thalidomide|mesh-list
64398173|NCT00014443|Topotecan|topotecan|mesh-list
64398174|NCT00014443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64398175|NCT00014443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64398176|NCT00014443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398177|NCT00014443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398189|NCT05047133|Tranexamic Acid|tranexamic acid|mesh-list
64398190|NCT05047133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64398191|NCT05047133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64398192|NCT05047133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398193|NCT05047133|Hemostatics|hemostatics|mesh-ancestor
64398194|NCT05047133|Coagulants|coagulants|mesh-ancestor
64398195|NCT04334863|Tyrphostins|tyrphostins|mesh-list
64398196|NCT04334863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398197|NCT04334863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398198|NCT04334863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398199|NCT02357407|Ciprofloxacin|ciprofloxacin|mesh-list
64398200|NCT02357407|Ofloxacin|ofloxacin|mesh-list
64398201|NCT02357407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64398202|NCT02357407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64398203|NCT02357407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64398204|NCT02357407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64398205|NCT02357407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398206|NCT02357407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398207|NCT02357407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398208|NCT02357407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64398209|NCT02357407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64398210|NCT02357407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64398212|NCT02038699|TIC10 compound|tic10 compound|mesh-list
64398213|NCT02038699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398250|NCT02039011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398251|NCT02039011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64398252|NCT02039011|Respiratory System Agents|respiratory system agents|mesh-ancestor
64398253|NCT02039011|Parasympatholytics|parasympatholytics|mesh-ancestor
64398254|NCT02039011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64398255|NCT02039011|Cholinergic Agents|cholinergic agents|mesh-ancestor
64398256|NCT02039011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64398257|NCT02039011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398258|NCT05024825|Acetaminophen|acetaminophen|mesh-list
64398259|NCT05024825|Ibuprofen|ibuprofen|mesh-list
64398260|NCT05024825|Gabapentin|gabapentin|mesh-list
64398261|NCT05024825|Hydrocodone|hydrocodone|mesh-list
64398262|NCT05024825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64398263|NCT05024825|Analgesics|analgesics|mesh-ancestor
64398264|NCT05024825|Sensory System Agents|sensory system agents|mesh-ancestor
64398265|NCT05024825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64398266|NCT05024825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398267|NCT05024825|Antipyretics|antipyretics|mesh-ancestor
64398268|NCT05024825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64398269|NCT05024825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64398270|NCT05024825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64398271|NCT05024825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64398272|NCT05024825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398273|NCT05024825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398274|NCT05024825|Anticonvulsants|anticonvulsants|mesh-ancestor
64398275|NCT05024825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64398276|NCT05024825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64398277|NCT05024825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64398278|NCT05024825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64398279|NCT05024825|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64398289|NCT03093467|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
64398290|NCT03093467|Antipsychotic Agents|antipsychotic agents|mesh-list
64398291|NCT03093467|Antidepressive Agents|antidepressive agents|mesh-list
64398292|NCT03093467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64398293|NCT03093467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64398294|NCT03093467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64398297|NCT03149653|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64398298|NCT03149653|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64398300|NCT03093545|Immunoglobulins|immunoglobulins|mesh-list
64398301|NCT03093545|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64398302|NCT03093545|Antibodies|antibodies|mesh-list
64398303|NCT03093545|Immunologic Factors|immunologic factors|mesh-ancestor
64398304|NCT03093545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398305|NCT05024357|Dasatinib|dasatinib|mesh-list
64398306|NCT05024357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398307|NCT05024357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64398308|NCT05024357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398309|NCT05024357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398310|NCT03095105|Resveratrol|resveratrol|mesh-list
64398311|NCT03095105|Antioxidants|antioxidants|mesh-ancestor
64398312|NCT03095105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398313|NCT03095105|Protective Agents|protective agents|mesh-ancestor
64308189|NCT03222687|Immunologic Factors|immunologic factors|mesh-ancestor
64398314|NCT03095105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398315|NCT03095105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398316|NCT03095105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64398317|NCT01968070|Celecoxib|celecoxib|mesh-list
64398318|NCT01968070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64398319|NCT01968070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64398320|NCT01968070|Analgesics|analgesics|mesh-ancestor
64398321|NCT01968070|Sensory System Agents|sensory system agents|mesh-ancestor
64398322|NCT01968070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64398325|NCT01968070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64398343|NCT01949662|Dopamine Agents|dopamine agents|mesh-ancestor
64398344|NCT01949662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64398345|NCT01949662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398364|NCT01949116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398365|NCT01949116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64398366|NCT01949116|Antimetabolites|antimetabolites|mesh-ancestor
64398367|NCT01949116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398368|NCT01949116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398369|NCT01949116|Dermatologic Agents|dermatologic agents|mesh-ancestor
64398370|NCT01949116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398371|NCT01949116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64398372|NCT01949116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64398373|NCT01949116|Immunologic Factors|immunologic factors|mesh-ancestor
64398374|NCT01949116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64398375|NCT01949116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64398376|NCT01949116|Hematinics|hematinics|mesh-ancestor
64398377|NCT01949116|Vitamin B Complex|vitamin b complex|mesh-ancestor
64398378|NCT01949116|Vitamins|vitamins|mesh-ancestor
64398379|NCT01949116|Micronutrients|micronutrients|mesh-ancestor
64398380|NCT01673009|Imatinib Mesylate|imatinib mesylate|mesh-list
64398381|NCT01673009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398382|NCT01673009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64398383|NCT01673009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398384|NCT01673009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398385|NCT02350387|Oxymetazoline|oxymetazoline|mesh-list
64398386|NCT02350387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64398419|NCT05023577|Rabeprazole|rabeprazole|mesh-list
64398420|NCT05023577|Bismuth|bismuth|mesh-list
64398421|NCT05023577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398422|NCT05023577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64398423|NCT05023577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64398424|NCT05023577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64398425|NCT05023577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64398426|NCT05023577|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64398427|NCT05023577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398428|NCT05023577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64398429|NCT05023577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64398430|NCT05023577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64398431|NCT05023577|Renal Agents|renal agents|mesh-ancestor
64398432|NCT05023577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64398433|NCT05023577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64398434|NCT05023577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398435|NCT05023577|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64398436|NCT05023577|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64398437|NCT05023577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64398438|NCT05023577|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64398439|NCT05023577|Antacids|antacids|mesh-ancestor
64398463|NCT01939366|Sensory System Agents|sensory system agents|mesh-ancestor
64398464|NCT01939366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64398465|NCT01939366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398466|NCT01939366|Anticonvulsants|anticonvulsants|mesh-ancestor
64398467|NCT01939366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64398468|NCT01939366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64398469|NCT01939366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398470|NCT01939366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64398483|NCT04434365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64398484|NCT04434365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398485|NCT04434365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64398486|NCT04434365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64398487|NCT04434365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64398488|NCT04434365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64398489|NCT04434365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398490|NCT04434365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64398491|NCT04434365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64398492|NCT04434365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398493|NCT04434365|Antipyretics|antipyretics|mesh-ancestor
64398494|NCT04434365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64398495|NCT04434365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64398496|NCT04434365|Antimetabolites|antimetabolites|mesh-ancestor
64398497|NCT04434365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64398498|NCT04434365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64398499|NCT04434365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64398500|NCT04434365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64398501|NCT04434365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64398502|NCT04434365|Purinergic Agents|purinergic agents|mesh-ancestor
64398514|NCT05032001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64398515|NCT05032001|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64398516|NCT05032001|Biguanides|biguanides|mesh-list
64398517|NCT05032001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398518|NCT05032001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64398519|NCT05032001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398520|NCT05032001|Protease Inhibitors|protease inhibitors|mesh-ancestor
64398521|NCT05032001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398522|NCT03147859|Vedolizumab|vedolizumab|mesh-list
64398523|NCT03147859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64398524|NCT05031689|Sunscreening Agents|sunscreening agents|mesh-list
64440725|NCT01750918|Immunologic Factors|immunologic factors|mesh-ancestor
64398525|NCT05031689|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64398526|NCT05031689|Protective Agents|protective agents|mesh-ancestor
64398527|NCT05031689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398528|NCT05031689|Dermatologic Agents|dermatologic agents|mesh-ancestor
64398529|NCT02350231|Progesterone|progesterone|mesh-list
64398530|NCT02350231|Progestins|progestins|mesh-ancestor
64398531|NCT02350231|Hormones|hormones|mesh-ancestor
64398532|NCT02350231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64398533|NCT02350231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398538|NCT05031143|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64398539|NCT05031143|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64398540|NCT05031143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64398541|NCT05031143|Glucocorticoids|glucocorticoids|mesh-ancestor
64398542|NCT05031143|Hormones|hormones|mesh-ancestor
64398544|NCT05031143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398563|NCT02348281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398564|NCT02348281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398565|NCT04638400|Simvastatin|simvastatin|mesh-list
64398566|NCT04638400|Ezetimibe|ezetimibe|mesh-list
64398567|NCT04638400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64398568|NCT04638400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64398569|NCT04638400|Antimetabolites|antimetabolites|mesh-ancestor
64398570|NCT04638400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398571|NCT04638400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64398572|NCT04638400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64398573|NCT04638400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398574|NCT02349919|Procaterol|procaterol|mesh-list
64398575|NCT02349919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64398576|NCT02349919|Autonomic Agents|autonomic agents|mesh-ancestor
64398577|NCT02349919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64398578|NCT02349919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398579|NCT02349919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64398580|NCT02349919|Respiratory System Agents|respiratory system agents|mesh-ancestor
64398581|NCT02349919|Sympathomimetics|sympathomimetics|mesh-ancestor
64440753|NCT01606228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64440754|NCT01606228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64440755|NCT01606228|Dopamine Agents|dopamine agents|mesh-ancestor
64398584|NCT02349919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64398585|NCT02349919|Adrenergic Agents|adrenergic agents|mesh-ancestor
64398586|NCT02349919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64398587|NCT02349919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398588|NCT02349763|Dexamethasone|dexamethasone|mesh-list
64398589|NCT02349763|Dexamethasone acetate|dexamethasone acetate|mesh-list
64398590|NCT02349763|BB 1101|bb 1101|mesh-list
64398591|NCT02349763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64398592|NCT02349763|Antiemetics|antiemetics|mesh-ancestor
64398593|NCT02349763|Autonomic Agents|autonomic agents|mesh-ancestor
64398594|NCT02349763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64398595|NCT02349763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398596|NCT02349763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64398597|NCT02349763|Glucocorticoids|glucocorticoids|mesh-ancestor
64398598|NCT02349763|Hormones|hormones|mesh-ancestor
64398599|NCT02349763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64398601|NCT02349763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398602|NCT02349763|Protease Inhibitors|protease inhibitors|mesh-ancestor
64398603|NCT02349763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398612|NCT02349841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398613|NCT02349841|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64398615|NCT02354053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64398616|NCT02354053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64398617|NCT02354053|Antiviral Agents|antiviral agents|mesh-ancestor
64398618|NCT02354053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64398619|NCT05028803|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64398620|NCT05028803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398621|NCT03094481|Epinephrine|epinephrine|mesh-list
64398622|NCT03094481|Bupivacaine|bupivacaine|mesh-list
64398623|NCT03094481|Anesthetics, Local|anesthetics, local|mesh-ancestor
64398624|NCT03094481|Anesthetics|anesthetics|mesh-ancestor
64398625|NCT03094481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64398626|NCT03094481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398627|NCT03094481|Sensory System Agents|sensory system agents|mesh-ancestor
64398628|NCT03094481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64398629|NCT03094481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64398630|NCT03094481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64398632|NCT03094481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64398633|NCT03094481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398634|NCT03094481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64398635|NCT03094481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64398636|NCT03094481|Autonomic Agents|autonomic agents|mesh-ancestor
64398637|NCT03094481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64398638|NCT03094481|Respiratory System Agents|respiratory system agents|mesh-ancestor
64398639|NCT03094481|Mydriatics|mydriatics|mesh-ancestor
64398640|NCT03094481|Sympathomimetics|sympathomimetics|mesh-ancestor
64398644|NCT04438837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64398645|NCT04438837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64398646|NCT04438837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64398647|NCT04438837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398648|NCT04438837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398649|NCT04438837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64398650|NCT02348125|Thioctic Acid|thioctic acid|mesh-list
64398651|NCT02348125|Antioxidants|antioxidants|mesh-ancestor
64398652|NCT02348125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398653|NCT02348125|Protective Agents|protective agents|mesh-ancestor
64398654|NCT02348125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398655|NCT02348125|Vitamin B Complex|vitamin b complex|mesh-ancestor
64398656|NCT02348125|Vitamins|vitamins|mesh-ancestor
64398657|NCT02348125|Micronutrients|micronutrients|mesh-ancestor
64398658|NCT05028335|Carbamide Peroxide|carbamide peroxide|mesh-list
64398659|NCT05028335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64398660|NCT05028335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64398661|NCT03094403|Azelaic acid|azelaic acid|mesh-list
64398662|NCT03094403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398663|NCT03094403|Dermatologic Agents|dermatologic agents|mesh-ancestor
64440880|NCT02273180|Insulin Glargine|insulin glargine|mesh-list
64398680|NCT03091595|Contraceptive Agents|contraceptive agents|mesh-ancestor
64398681|NCT03091595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64398682|NCT03091595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398683|NCT03091595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64398684|NCT03091595|Estrogens|estrogens|mesh-ancestor
64308327|NCT03220815|Adrenergic Agents|adrenergic agents|mesh-ancestor
64398686|NCT03091595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64398687|NCT03091595|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64398688|NCT03091595|Hormone Antagonists|hormone antagonists|mesh-ancestor
64398689|NCT03091595|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64398690|NCT03091595|Diuretics|diuretics|mesh-ancestor
64398691|NCT03091595|Natriuretic Agents|natriuretic agents|mesh-ancestor
64398692|NCT02347501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64398693|NCT02347501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64398694|NCT02347501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398695|NCT02347501|Incretins|incretins|mesh-ancestor
64398696|NCT02347501|Hormones|hormones|mesh-ancestor
64398697|NCT02347501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64398698|NCT02347501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64398699|NCT02347501|Protease Inhibitors|protease inhibitors|mesh-ancestor
64398700|NCT02347501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398701|NCT02347501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398702|NCT03148717|Misoprostol|misoprostol|mesh-list
64398703|NCT03148717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64398727|NCT02349607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64398728|NCT02349607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64398729|NCT02349607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64398730|NCT02349607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64398731|NCT05019755|Varespladib methyl|varespladib methyl|mesh-list
64398732|NCT05019755|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
64398733|NCT05019755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398734|NCT05019755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398735|NCT04478461|Antibodies|antibodies|mesh-list
64398736|NCT04478461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64398737|NCT04478461|Immunologic Factors|immunologic factors|mesh-ancestor
64398738|NCT04478461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398739|NCT04108481|Durvalumab|durvalumab|mesh-list
64398740|NCT04108481|Methamphetamine|methamphetamine|mesh-list
64440977|NCT01644188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64440978|NCT01644188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64398741|NCT04108481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64398742|NCT04108481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64398748|NCT04108481|Autonomic Agents|autonomic agents|mesh-ancestor
64398749|NCT04108481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64398750|NCT04108481|Dopamine Agents|dopamine agents|mesh-ancestor
64398751|NCT04108481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64398752|NCT04108481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398753|NCT04108481|Adrenergic Agents|adrenergic agents|mesh-ancestor
64398754|NCT04108481|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64398755|NCT04108481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64398756|NCT04108481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64398757|NCT04108481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64398758|NCT02353507|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64398759|NCT02353507|Laxatives|laxatives|mesh-ancestor
64398776|NCT02353429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398777|NCT02353429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64441001|NCT02296892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64398779|NCT05027243|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64398780|NCT05027243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64398781|NCT05027243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398782|NCT05027243|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64398783|NCT05027243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64398784|NCT05027243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398785|NCT05027243|Cholinergic Agents|cholinergic agents|mesh-ancestor
64398786|NCT05027243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64398787|NCT03112135|Epinephrine|epinephrine|mesh-list
64398788|NCT03112135|Tranexamic Acid|tranexamic acid|mesh-list
64398789|NCT03112135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64398790|NCT03112135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64398791|NCT03112135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398792|NCT03112135|Hemostatics|hemostatics|mesh-ancestor
64398793|NCT03112135|Coagulants|coagulants|mesh-ancestor
64398794|NCT03112135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64398795|NCT03112135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64398796|NCT03112135|Adrenergic Agents|adrenergic agents|mesh-ancestor
64398797|NCT03112135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64398798|NCT03112135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398799|NCT03112135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64398800|NCT03112135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64398801|NCT03112135|Autonomic Agents|autonomic agents|mesh-ancestor
64398802|NCT03112135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64398803|NCT03112135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64398804|NCT03112135|Respiratory System Agents|respiratory system agents|mesh-ancestor
64398805|NCT03112135|Mydriatics|mydriatics|mesh-ancestor
64441047|NCT01721746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64398807|NCT03112135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64398808|NCT04477993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
64398809|NCT04477993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64398810|NCT04477993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398817|NCT03146533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64398818|NCT03146533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64398819|NCT03146533|Alkylating Agents|alkylating agents|mesh-ancestor
64398820|NCT03146533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398821|NCT03146533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398822|NCT03146533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64398823|NCT03090971|Diclofenac|diclofenac|mesh-list
64308423|NCT03220113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64398824|NCT03090971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64398825|NCT03090971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64398826|NCT03090971|Analgesics|analgesics|mesh-ancestor
64398827|NCT03090971|Sensory System Agents|sensory system agents|mesh-ancestor
64398828|NCT03090971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64398832|NCT03090971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64398833|NCT03090971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398834|NCT03090971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398836|NCT03146689|Capsaicin|capsaicin|mesh-list
64398837|NCT03146689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64398838|NCT03146689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64398839|NCT03146689|Analgesics|analgesics|mesh-ancestor
64398840|NCT03146689|Sensory System Agents|sensory system agents|mesh-ancestor
64398848|NCT03146689|Antipruritics|antipruritics|mesh-ancestor
64398849|NCT03146689|Dermatologic Agents|dermatologic agents|mesh-ancestor
64398850|NCT05255575|Ertapenem|ertapenem|mesh-list
64398851|NCT05255575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64398852|NCT05255575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64398853|NCT05026229|Cytarabine|cytarabine|mesh-list
64398854|NCT05026229|Prednisone|prednisone|mesh-list
64398855|NCT05026229|Methotrexate|methotrexate|mesh-list
64398856|NCT05026229|Vincristine|vincristine|mesh-list
64398857|NCT05026229|Dasatinib|dasatinib|mesh-list
64398858|NCT05026229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64398859|NCT05026229|Glucocorticoids|glucocorticoids|mesh-ancestor
64398860|NCT05026229|Hormones|hormones|mesh-ancestor
64398861|NCT05026229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64398862|NCT05026229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398863|NCT05026229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64398864|NCT05026229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398865|NCT05026229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64398866|NCT05026229|Abortifacient Agents|abortifacient agents|mesh-ancestor
64398867|NCT05026229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64398868|NCT05026229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64398869|NCT05026229|Antimetabolites|antimetabolites|mesh-ancestor
64398870|NCT05026229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398871|NCT05026229|Dermatologic Agents|dermatologic agents|mesh-ancestor
64398872|NCT05026229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398873|NCT05026229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64398874|NCT05026229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64398875|NCT05026229|Immunologic Factors|immunologic factors|mesh-ancestor
64398876|NCT05026229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64398877|NCT05026229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64398892|NCT02348905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64398893|NCT02348905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398895|NCT02347033|Antidepressive Agents|antidepressive agents|mesh-ancestor
64398896|NCT02347033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64398898|NCT02347033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64398899|NCT02347033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64398900|NCT02347033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398901|NCT02347033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64398902|NCT02347033|Serotonin Agents|serotonin agents|mesh-ancestor
64398903|NCT02347033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398904|NCT04949633|Oxytocin|oxytocin|mesh-list
64398905|NCT04949633|Oxytocics|oxytocics|mesh-ancestor
64398906|NCT04949633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64398907|NCT04949633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398908|NCT03146377|Capecitabine|capecitabine|mesh-list
64398909|NCT03146377|Oxaliplatin|oxaliplatin|mesh-list
64398910|NCT03146377|Irinotecan|irinotecan|mesh-list
64308456|NCT04914962|Antidepressive Agents|antidepressive agents|mesh-ancestor
64398911|NCT03146377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64398912|NCT03146377|Antimetabolites|antimetabolites|mesh-ancestor
64398913|NCT03146377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398914|NCT03146377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398915|NCT03146377|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64398916|NCT03146377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64441327|NCT02260817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398920|NCT02346955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398921|NCT03079505|Dasatinib|dasatinib|mesh-list
64398922|NCT03079505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398923|NCT03079505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64398924|NCT03079505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398925|NCT03079505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398926|NCT02343211|Immunoglobulins|immunoglobulins|mesh-list
64398927|NCT02343211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64398928|NCT02343211|Antibodies|antibodies|mesh-list
64398929|NCT02343211|Immunologic Factors|immunologic factors|mesh-ancestor
64398930|NCT02343211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398931|NCT03090503|Risperidone|risperidone|mesh-list
64398932|NCT03090503|Aripiprazole|aripiprazole|mesh-list
64398933|NCT03090503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64398934|NCT03090503|Serotonin Agents|serotonin agents|mesh-ancestor
64398935|NCT03090503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64441373|NCT01645280|Abortifacient Agents|abortifacient agents|mesh-ancestor
64441374|NCT01645280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64398937|NCT03090503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398938|NCT03090503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64398939|NCT03090503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64398940|NCT03090503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64398948|NCT03090503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64398949|NCT03090503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64398950|NCT02343289|Clarithromycin|clarithromycin|mesh-list
64398951|NCT02343289|Esketamine|esketamine|mesh-list
64398952|NCT02343289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64398953|NCT02343289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64398954|NCT02343289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64398955|NCT02343289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398956|NCT02343289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398957|NCT02343289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64398958|NCT02343289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64398959|NCT02343289|Antidepressive Agents|antidepressive agents|mesh-ancestor
64398960|NCT02343289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64398961|NCT05008523|Analgesics, Opioid|analgesics, opioid|mesh-list
64398962|NCT05008523|Narcotics|narcotics|mesh-ancestor
64398963|NCT05008523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64398964|NCT05008523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398965|NCT05008523|Analgesics|analgesics|mesh-ancestor
64336798|NCT02330757|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64398966|NCT05008523|Sensory System Agents|sensory system agents|mesh-ancestor
64398967|NCT05008523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64398968|NCT02342977|Lacosamide|lacosamide|mesh-list
64398969|NCT02342977|Anticonvulsants|anticonvulsants|mesh-ancestor
64398970|NCT02342977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64398971|NCT02342977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64398972|NCT02342977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64398973|NCT02342977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398974|NCT03090269|Methylphenidate|methylphenidate|mesh-list
64398975|NCT03090269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64398976|NCT03090269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398977|NCT03090269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64398978|NCT03090269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64398980|NCT03090269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398981|NCT03090269|Dopamine Agents|dopamine agents|mesh-ancestor
64398982|NCT03090269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64398983|NCT05008679|Oseltamivir|oseltamivir|mesh-list
64398984|NCT05008679|Antiviral Agents|antiviral agents|mesh-ancestor
64398985|NCT05008679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64398986|NCT05008679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398987|NCT05008679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398988|NCT03090035|Interferons|interferons|mesh-list
64398989|NCT03090035|Ribavirin|ribavirin|mesh-list
64441533|NCT05650775|Dopamine Agents|dopamine agents|mesh-ancestor
64398991|NCT03090035|Antiviral Agents|antiviral agents|mesh-ancestor
64399017|NCT02342509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64399018|NCT02342509|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64399019|NCT02342509|Anesthetics, General|anesthetics, general|mesh-ancestor
64399020|NCT02342509|Anesthetics|anesthetics|mesh-ancestor
64399021|NCT02342509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64399022|NCT02342509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399023|NCT03079271|Benzocaine|benzocaine|mesh-list
64399024|NCT03079271|Anesthetics, Local|anesthetics, local|mesh-ancestor
64399025|NCT03079271|Anesthetics|anesthetics|mesh-ancestor
64399026|NCT03079271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64399027|NCT03079271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308552|NCT04485429|Autonomic Agents|autonomic agents|mesh-ancestor
64399028|NCT03079271|Sensory System Agents|sensory system agents|mesh-ancestor
64399029|NCT03079271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399030|NCT02342353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64399031|NCT02342353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399032|NCT02342353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64399033|NCT02342353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399034|NCT02342353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399035|NCT02337127|Lamivudine|lamivudine|mesh-list
64399036|NCT02337127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64399037|NCT02337127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64399038|NCT02337127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399039|NCT02337127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399040|NCT02337127|Antiviral Agents|antiviral agents|mesh-ancestor
64441605|NCT02285153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399041|NCT02337127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64399043|NCT02337127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64399044|NCT02337205|Tirbanibulin|tirbanibulin|mesh-list
64399045|NCT02337205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399046|NCT02337205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399047|NCT05007587|Leucovorin|leucovorin|mesh-list
64399057|NCT05007587|Immunologic Factors|immunologic factors|mesh-ancestor
64399058|NCT05007587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399059|NCT05007587|Antidotes|antidotes|mesh-ancestor
64399060|NCT05007587|Protective Agents|protective agents|mesh-ancestor
64399061|NCT05007587|Vitamin B Complex|vitamin b complex|mesh-ancestor
64399062|NCT05007587|Vitamins|vitamins|mesh-ancestor
64399064|NCT05007587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64399065|NCT05007587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399066|NCT05007587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64399083|NCT03945643|Vasodilator Agents|vasodilator agents|mesh-ancestor
64399084|NCT03945643|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64399089|NCT02039323|Tenofovir|tenofovir|mesh-list
64399090|NCT02039323|Maraviroc|maraviroc|mesh-list
64399091|NCT02039323|Antiviral Agents|antiviral agents|mesh-ancestor
64399092|NCT02039323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64399093|NCT02039323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64441715|NCT02260388|Pregabalin|pregabalin|mesh-list
64441716|NCT02260388|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64441717|NCT02260388|Nortriptyline|nortriptyline|mesh-list
64399095|NCT02039323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399096|NCT02039323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399097|NCT02039323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64399098|NCT02039323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64399099|NCT02039323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64399100|NCT02039323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64399101|NCT02039323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64399102|NCT03079115|Atorvastatin|atorvastatin|mesh-list
64399103|NCT03079115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64399104|NCT03079115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64399105|NCT03079115|Antimetabolites|antimetabolites|mesh-ancestor
64399106|NCT03079115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399107|NCT03079115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64399108|NCT03079115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64399109|NCT03079115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399111|NCT03078725|Glyburide|glyburide|mesh-list
64399112|NCT03078725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64441853|NCT04877834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441883|NCT01641692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64441884|NCT01641692|Autonomic Agents|autonomic agents|mesh-ancestor
64441885|NCT01641692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64308570|NCT02140801|Clopidogrel|clopidogrel|mesh-list
64441886|NCT01641692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441887|NCT01641692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64441888|NCT01641692|Respiratory System Agents|respiratory system agents|mesh-ancestor
64399114|NCT02341963|Ketamine|ketamine|mesh-list
64399115|NCT02341963|Analgesics|analgesics|mesh-ancestor
64399116|NCT02341963|Sensory System Agents|sensory system agents|mesh-ancestor
64399117|NCT02341963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399118|NCT02341963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399119|NCT02341963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64399120|NCT02341963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64399121|NCT02341963|Anesthetics, General|anesthetics, general|mesh-ancestor
64399122|NCT02341963|Anesthetics|anesthetics|mesh-ancestor
64399123|NCT02341963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64399124|NCT02341963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64399125|NCT02341963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64399128|NCT05014685|Amoxicillin|amoxicillin|mesh-list
64399133|NCT05014685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399134|NCT05014685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64399135|NCT05014685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64399136|NCT05014685|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64399137|NCT05014685|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64399138|NCT05014685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64399139|NCT05014685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64399140|NCT05014685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64399155|NCT03111901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399156|NCT03111901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399157|NCT05014607|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64442020|NCT05625776|Capsaicin|capsaicin|mesh-list
64399158|NCT05014607|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64399159|NCT05014607|Immunologic Factors|immunologic factors|mesh-ancestor
64399160|NCT05014607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399162|NCT02341729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64399163|NCT02341729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64399164|NCT02341729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64399165|NCT02341729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64399166|NCT02341729|Purinergic Agents|purinergic agents|mesh-ancestor
64399167|NCT02341729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64442070|NCT04835870|Hormones|hormones|mesh-ancestor
64442071|NCT04835870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64399169|NCT02341729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399170|NCT05014373|Favipiravir|favipiravir|mesh-list
64399171|NCT05014373|Antiviral Agents|antiviral agents|mesh-ancestor
64399172|NCT05014373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64399173|NCT04762459|Pemetrexed|pemetrexed|mesh-list
64399174|NCT04762459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399175|NCT04762459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399176|NCT04762459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399177|NCT04762459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64399179|NCT03078569|Testosterone|testosterone|mesh-list
64399187|NCT02345863|Alkylating Agents|alkylating agents|mesh-ancestor
64399188|NCT02345863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399189|NCT02345863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399190|NCT02345863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64399191|NCT03078257|Aspirin|aspirin|mesh-list
64399192|NCT03078257|Tirofiban|tirofiban|mesh-list
64399193|NCT03078257|Fibrinolysin|fibrinolysin|mesh-list
64399194|NCT03078257|Clopidogrel|clopidogrel|mesh-list
64399195|NCT03078257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64399196|NCT03078257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64399197|NCT03078257|Analgesics|analgesics|mesh-ancestor
64399198|NCT03078257|Sensory System Agents|sensory system agents|mesh-ancestor
64399199|NCT03078257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399200|NCT03078257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399201|NCT03078257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64399202|NCT03078257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64399208|NCT03078257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399209|NCT03078257|Antipyretics|antipyretics|mesh-ancestor
64399210|NCT03078257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64399211|NCT03078257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64399212|NCT03078257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64399213|NCT03078257|Purinergic Agents|purinergic agents|mesh-ancestor
64399214|NCT03078257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64399215|NCT02341573|Leukotriene Antagonists|leukotriene antagonists|mesh-list
64399216|NCT02341573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64399217|NCT02341573|Respiratory System Agents|respiratory system agents|mesh-ancestor
64399218|NCT02341573|Hormone Antagonists|hormone antagonists|mesh-ancestor
64308697|NCT02149459|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64399219|NCT02341573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64399221|NCT05005715|Dexmedetomidine|dexmedetomidine|mesh-list
64399234|NCT05005715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399235|NCT02345707|Cabotegravir|cabotegravir|mesh-list
64399236|NCT02345707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64399237|NCT02345707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64399238|NCT02345707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399239|NCT02345707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399240|NCT02345707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64399241|NCT02345707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64399242|NCT02345707|Antiviral Agents|antiviral agents|mesh-ancestor
64399243|NCT02345707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64399244|NCT05005637|Antitubercular Agents|antitubercular agents|mesh-list
64399246|NCT05005637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64399247|NCT05005637|Glucocorticoids|glucocorticoids|mesh-ancestor
64399248|NCT05005637|Hormones|hormones|mesh-ancestor
64399249|NCT05005637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64399250|NCT05005637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399251|NCT05005637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64399252|NCT05005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399253|NCT05005637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64399254|NCT05005637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64399255|NCT02336659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64399256|NCT02336659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64399258|NCT02336659|Incretins|incretins|mesh-ancestor
64399289|NCT02345239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64399290|NCT02345239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64399291|NCT02345239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399292|NCT02345239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399293|NCT04688203|Magnesium Sulfate|magnesium sulfate|mesh-list
64399294|NCT04688203|Labetalol|labetalol|mesh-list
64399295|NCT04688203|Analgesics|analgesics|mesh-ancestor
64399296|NCT04688203|Sensory System Agents|sensory system agents|mesh-ancestor
64399297|NCT04688203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399298|NCT04688203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399299|NCT04688203|Anesthetics|anesthetics|mesh-ancestor
64399300|NCT04688203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64399303|NCT04688203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64399304|NCT04688203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64399305|NCT04688203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399306|NCT04688203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64399307|NCT04688203|Tocolytic Agents|tocolytic agents|mesh-ancestor
64399308|NCT04688203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64399309|NCT04688203|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64399310|NCT04688203|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64399311|NCT04688203|Adrenergic Agents|adrenergic agents|mesh-ancestor
64399312|NCT04688203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64399313|NCT04688203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64399314|NCT04688203|Sympathomimetics|sympathomimetics|mesh-ancestor
64399315|NCT04688203|Autonomic Agents|autonomic agents|mesh-ancestor
64399316|NCT04688203|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64399317|NCT04688203|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64399318|NCT05254405|Brexanolone|brexanolone|mesh-list
64399331|NCT04509973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64399332|NCT04509973|Glucocorticoids|glucocorticoids|mesh-ancestor
64399333|NCT04509973|Hormones|hormones|mesh-ancestor
64399334|NCT04509973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64399347|NCT02336347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64399348|NCT02336347|Adrenergic Agents|adrenergic agents|mesh-ancestor
64399349|NCT02336347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64399350|NCT02336347|Antimalarials|antimalarials|mesh-ancestor
64399351|NCT02336347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64399352|NCT02336347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64399353|NCT02336347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64399354|NCT02336347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442296|NCT04513184|Hormones|hormones|mesh-ancestor
64399367|NCT02341027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64399368|NCT02341027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64334679|NCT02295787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64334680|NCT02295787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64442334|NCT04421378|Bevacizumab|bevacizumab|mesh-list
64442335|NCT04421378|Temozolomide|temozolomide|mesh-list
64399371|NCT02039479|Lithium Carbonate|lithium carbonate|mesh-list
64399372|NCT02039479|Antidepressive Agents|antidepressive agents|mesh-ancestor
64399373|NCT02039479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64399374|NCT02039479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399375|NCT02039479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399377|NCT02039479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64399378|NCT02039479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64399379|NCT02039479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399380|NCT02340481|Simethicone|simethicone|mesh-list
64399382|NCT02340481|Antidiarrheals|antidiarrheals|mesh-list
64399383|NCT02340481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64399384|NCT02340481|Antifoaming Agents|antifoaming agents|mesh-ancestor
64399385|NCT02340481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399386|NCT02340481|Emollients|emollients|mesh-ancestor
64399387|NCT02340481|Dermatologic Agents|dermatologic agents|mesh-ancestor
64399388|NCT03077633|Progesterone|progesterone|mesh-list
64399389|NCT03077633|Progestins|progestins|mesh-ancestor
64399390|NCT03077633|Hormones|hormones|mesh-ancestor
64399391|NCT03077633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64399392|NCT03077633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399393|NCT05253781|Aspirin|aspirin|mesh-list
64399394|NCT05253781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64399413|NCT02340325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399414|NCT02340325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399416|NCT02340247|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
64399417|NCT02340247|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64399418|NCT02340247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64399419|NCT02340247|Cathartics|cathartics|mesh-ancestor
64399420|NCT02340013|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64399421|NCT02340013|Medroxyprogesterone|medroxyprogesterone|mesh-list
64399422|NCT02340013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64399423|NCT02340013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64399424|NCT02340013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64399425|NCT02340013|Contraceptive Agents|contraceptive agents|mesh-ancestor
64399426|NCT02340013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64399427|NCT02340013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399428|NCT02340013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64399429|NCT02340013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64399430|NCT02340013|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64399431|NCT02340013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64399432|NCT02340013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399433|NCT05178823|Chlorhexidine|chlorhexidine|mesh-list
64399434|NCT05178823|Chlorine dioxide|chlorine dioxide|mesh-list
64399435|NCT05178823|Fluorides|fluorides|mesh-list
64399436|NCT05178823|Sodium Fluoride|sodium fluoride|mesh-list
64399437|NCT05178823|Cariostatic Agents|cariostatic agents|mesh-ancestor
64399438|NCT05178823|Protective Agents|protective agents|mesh-ancestor
64399439|NCT05178823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399440|NCT05178823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64399441|NCT05178823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64399442|NCT05178823|Disinfectants|disinfectants|mesh-ancestor
64399466|NCT03105349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399468|NCT03105349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64399469|NCT03077555|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64399470|NCT03077555|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64399471|NCT03077555|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64399472|NCT03077555|Estradiol|estradiol|mesh-list
64399473|NCT03077555|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64399474|NCT03077555|Estrogens|estrogens|mesh-ancestor
64399475|NCT03077555|Hormones|hormones|mesh-ancestor
64399476|NCT03077555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64399477|NCT03077555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399478|NCT03077555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64399493|NCT05012033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64399494|NCT05012033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399496|NCT03895099|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64399497|NCT03895099|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64399498|NCT03895099|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64399499|NCT03895099|Contraceptive Agents|contraceptive agents|mesh-ancestor
64399500|NCT03895099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64399501|NCT03895099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399502|NCT03895099|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64399503|NCT03895099|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64399504|NCT03895099|Progestins|progestins|mesh-ancestor
64399505|NCT03895099|Hormones|hormones|mesh-ancestor
64399506|NCT03895099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64399507|NCT02344303|Moxifloxacin|moxifloxacin|mesh-list
64399508|NCT02344303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64399509|NCT02344303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64399510|NCT02344303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64399511|NCT02344303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64399512|NCT02344303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399513|NCT02344303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399514|NCT02344303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399515|NCT02334475|Methylprednisolone|methylprednisolone|mesh-list
64399516|NCT02334475|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64399517|NCT02334475|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64399537|NCT02334631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399538|NCT02334631|Emollients|emollients|mesh-ancestor
64399539|NCT02334631|Dermatologic Agents|dermatologic agents|mesh-ancestor
64399541|NCT02338687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64399542|NCT02338687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399543|NCT02332135|Vitamin D|vitamin d|mesh-list
64399544|NCT02332135|Vitamins|vitamins|mesh-ancestor
64399545|NCT02332135|Micronutrients|micronutrients|mesh-ancestor
64399546|NCT02332135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399547|NCT02332135|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64399548|NCT02334163|Metronidazole|metronidazole|mesh-list
64442631|NCT04816682|Silymarin|silymarin|mesh-list
64399549|NCT02334163|Nitazoxanide|nitazoxanide|mesh-list
64399550|NCT02334163|Lactulose|lactulose|mesh-list
64399551|NCT02334163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64399552|NCT02334163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64399553|NCT02334163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64399554|NCT02334163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64399555|NCT02334163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64399556|NCT02332057|Diclofenac|diclofenac|mesh-list
64399557|NCT02332057|Lidocaine|lidocaine|mesh-list
64399558|NCT02332057|Anesthetics, Local|anesthetics, local|mesh-ancestor
64399559|NCT02332057|Anesthetics|anesthetics|mesh-ancestor
64399560|NCT02332057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64399561|NCT02332057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399562|NCT02332057|Sensory System Agents|sensory system agents|mesh-ancestor
64399563|NCT02332057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399564|NCT02332057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64399565|NCT02332057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64399566|NCT02332057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64399567|NCT02332057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64399569|NCT02332057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64399581|NCT02638259|Dermatologic Agents|dermatologic agents|mesh-ancestor
64399582|NCT02333929|Rivaroxaban|rivaroxaban|mesh-list
64399583|NCT02333929|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64399584|NCT02333929|Antithrombins|antithrombins|mesh-ancestor
64442697|NCT03760484|Fidaxomicin|fidaxomicin|mesh-list
64442724|NCT03740204|Hormones|hormones|mesh-ancestor
64442731|NCT03740204|Progestins|progestins|mesh-ancestor
64399585|NCT02333929|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64399586|NCT02333929|Protease Inhibitors|protease inhibitors|mesh-ancestor
64399587|NCT02333929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399588|NCT02333929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399589|NCT02333929|Anticoagulants|anticoagulants|mesh-ancestor
64399590|NCT02333851|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
64399591|NCT02333851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64399592|NCT02333851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399593|NCT02334007|Dalteparin|dalteparin|mesh-list
64399594|NCT02334007|Tinzaparin|tinzaparin|mesh-list
64399595|NCT02334007|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64399596|NCT02334007|Anticoagulants|anticoagulants|mesh-ancestor
64399597|NCT02334007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64442753|NCT02216071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64399598|NCT02334007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64399599|NCT02334007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399611|NCT02637323|Immunologic Factors|immunologic factors|mesh-ancestor
64399612|NCT02637323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399613|NCT02637323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399614|NCT02331823|Moxifloxacin|moxifloxacin|mesh-list
64399615|NCT02331823|Isoniazid|isoniazid|mesh-list
64399616|NCT02331823|Pyrazinamide|pyrazinamide|mesh-list
64399617|NCT02331823|Ethambutol|ethambutol|mesh-list
64399618|NCT02331823|Rifabutin|rifabutin|mesh-list
64399619|NCT02331823|Streptomycin|streptomycin|mesh-list
64399620|NCT02331823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64399621|NCT02331823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64399622|NCT02331823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64442803|NCT04192136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64399627|NCT02331823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64399629|NCT02331823|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64399630|NCT02331823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64399631|NCT02331823|Antimetabolites|antimetabolites|mesh-ancestor
64399632|NCT02331823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64399633|NCT02331823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64399634|NCT02890459|Denatonium|denatonium|mesh-list
64399635|NCT02890459|Aversive Agents|aversive agents|mesh-ancestor
64399636|NCT02890459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399637|NCT02890459|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
64399638|NCT02890459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309238|NCT03197961|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64399639|NCT02890459|Sensory System Agents|sensory system agents|mesh-ancestor
64399640|NCT02890459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399641|NCT03077009|Hyaluronic Acid|hyaluronic acid|mesh-list
64399642|NCT03077009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64399643|NCT03077009|Immunologic Factors|immunologic factors|mesh-ancestor
64399644|NCT03077009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399659|NCT03861871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64399660|NCT03861871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399661|NCT03861871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64399662|NCT03861871|Serotonin Agents|serotonin agents|mesh-ancestor
64399663|NCT03861871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399664|NCT05004545|Propofol|propofol|mesh-list
64399679|NCT03079895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64399680|NCT03079895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399681|NCT04463615|Leflunomide|leflunomide|mesh-list
64399682|NCT04463615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399683|NCT04463615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399684|NCT04463615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64399685|NCT04463615|Immunologic Factors|immunologic factors|mesh-ancestor
64399705|NCT05003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399706|NCT05003765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64399708|NCT05003765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64399709|NCT02337283|BI 425809|bi 425809|mesh-list
64399710|NCT02337283|Nootropic Agents|nootropic agents|mesh-ancestor
64399711|NCT03799003|Pembrolizumab|pembrolizumab|mesh-list
64399712|NCT03799003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64399713|NCT03799003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399714|NCT02333305|Coenzyme Q10|coenzyme q10|mesh-list
64399715|NCT02333305|Vitamins|vitamins|mesh-ancestor
64399716|NCT02333305|Micronutrients|micronutrients|mesh-ancestor
64399717|NCT02333305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399718|NCT02326987|Pregabalin|pregabalin|mesh-list
64399719|NCT02326987|Analgesics|analgesics|mesh-ancestor
64399720|NCT02326987|Sensory System Agents|sensory system agents|mesh-ancestor
64399721|NCT02326987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399722|NCT02326987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399723|NCT02326987|Anticonvulsants|anticonvulsants|mesh-ancestor
64399724|NCT02326987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64399725|NCT02326987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64399726|NCT02326987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399732|NCT02331511|Aspirin|aspirin|mesh-list
64399733|NCT02331511|Clopidogrel|clopidogrel|mesh-list
64399734|NCT02331511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64399736|NCT02331511|Analgesics|analgesics|mesh-ancestor
64399756|NCT02326441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399757|NCT02326441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399758|NCT02326441|Tubulin Modulators|tubulin modulators|mesh-ancestor
64399759|NCT02326441|Antimitotic Agents|antimitotic agents|mesh-ancestor
64399760|NCT02326441|Mitosis Modulators|mitosis modulators|mesh-ancestor
64399761|NCT02326441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399763|NCT02039791|Carboplatin|carboplatin|mesh-list
64399764|NCT02039791|Nimotuzumab|nimotuzumab|mesh-list
64399765|NCT02039791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64443151|NCT02210689|Clindamycin|clindamycin|mesh-list
64443159|NCT02209597|Bupropion|bupropion|mesh-list
64399766|NCT02039791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399767|NCT02039791|Tubulin Modulators|tubulin modulators|mesh-ancestor
64399768|NCT02039791|Antimitotic Agents|antimitotic agents|mesh-ancestor
64399769|NCT02039791|Mitosis Modulators|mitosis modulators|mesh-ancestor
64399770|NCT02039791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399771|NCT02039791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64399772|NCT03573817|Formoterol Fumarate|formoterol fumarate|mesh-list
64399773|NCT03573817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64399774|NCT03573817|Autonomic Agents|autonomic agents|mesh-ancestor
64399775|NCT03573817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399776|NCT03573817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399777|NCT03573817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64399778|NCT03573817|Respiratory System Agents|respiratory system agents|mesh-ancestor
64399779|NCT03573817|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64399780|NCT03573817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64309368|NCT03202407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399781|NCT03573817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64399782|NCT03573817|Adrenergic Agents|adrenergic agents|mesh-ancestor
64399783|NCT03573817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64399784|NCT03573817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399785|NCT03111511|JNJ-56136379|jnj-56136379|mesh-list
64399786|NCT03111511|Drospirenone|drospirenone|mesh-list
64399787|NCT03111511|Midazolam|midazolam|mesh-list
64399788|NCT03111511|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64399789|NCT03111511|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
64399790|NCT03111511|Betadex|betadex|mesh-list
64399791|NCT03111511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64399792|NCT03111511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64399794|NCT03111511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399795|NCT03111511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64443205|NCT04191434|Hormones|hormones|mesh-ancestor
64309483|NCT03201861|Paclitaxel|paclitaxel|mesh-list
64399814|NCT03111511|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64399816|NCT03111511|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64399817|NCT03111511|Diuretics|diuretics|mesh-ancestor
64399818|NCT03111511|Natriuretic Agents|natriuretic agents|mesh-ancestor
64399819|NCT03111511|Antiviral Agents|antiviral agents|mesh-ancestor
64399820|NCT03111511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64399821|NCT03111511|Sequestering Agents|sequestering agents|mesh-ancestor
64399823|NCT03144115|Oxytocics|oxytocics|mesh-ancestor
64399824|NCT03144115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64399825|NCT03144115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399826|NCT02326285|Docetaxel|docetaxel|mesh-list
64399827|NCT02326285|Gefitinib|gefitinib|mesh-list
64399828|NCT02326285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399829|NCT02326285|Tubulin Modulators|tubulin modulators|mesh-ancestor
64399830|NCT02326285|Antimitotic Agents|antimitotic agents|mesh-ancestor
64399831|NCT02326285|Mitosis Modulators|mitosis modulators|mesh-ancestor
64399832|NCT02326285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399833|NCT02326285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64399834|NCT02326285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399835|NCT02332603|Methylprednisolone|methylprednisolone|mesh-list
64399836|NCT02332603|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64399837|NCT02332603|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64399839|NCT02332603|Prednisolone acetate|prednisolone acetate|mesh-list
64399840|NCT02332603|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64399841|NCT02332603|Prednisolone phosphate|prednisolone phosphate|mesh-list
64399870|NCT05077813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64399871|NCT05077813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64399872|NCT05077813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64399873|NCT05077813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64399874|NCT05077813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399875|NCT05077813|Keratolytic Agents|keratolytic agents|mesh-ancestor
64399876|NCT05077813|Dermatologic Agents|dermatologic agents|mesh-ancestor
64443226|NCT03651128|Antiemetics|antiemetics|mesh-ancestor
64309554|NCT03201627|Antimanic Agents|antimanic agents|mesh-ancestor
64399882|NCT02326051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399883|NCT05076955|Vancomycin|vancomycin|mesh-list
64399884|NCT05076955|Tobramycin|tobramycin|mesh-list
64399885|NCT05076955|Itraconazole|itraconazole|mesh-list
64443261|NCT02187055|Abortifacient Agents|abortifacient agents|mesh-ancestor
64399887|NCT05076955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64399888|NCT05076955|Antifungal Agents|antifungal agents|mesh-ancestor
64399889|NCT05076955|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64399890|NCT05076955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64309603|NCT02444949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399891|NCT05076955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399892|NCT05076955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399893|NCT05076955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64399894|NCT05076955|Hormone Antagonists|hormone antagonists|mesh-ancestor
64399895|NCT05076955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64399896|NCT05076955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399897|NCT05076955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64399898|NCT05077111|Anesthetics|anesthetics|mesh-list
64399899|NCT05077111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64399900|NCT05077111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399901|NCT05075863|Letrozole|letrozole|mesh-list
64399902|NCT05075863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399903|NCT05075863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64399908|NCT05075863|Hormone Antagonists|hormone antagonists|mesh-ancestor
64399909|NCT05075863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64443315|NCT03471260|Venetoclax|venetoclax|mesh-list
64399910|NCT05075863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399912|NCT02330419|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64399913|NCT02330419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64399914|NCT02330419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399915|NCT02330419|Sensory System Agents|sensory system agents|mesh-ancestor
64399916|NCT02330419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399917|NCT05068141|Paclitaxel|paclitaxel|mesh-list
64399918|NCT05068141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64399919|NCT05068141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399920|NCT05068141|Tubulin Modulators|tubulin modulators|mesh-ancestor
64399922|NCT05068141|Mitosis Modulators|mitosis modulators|mesh-ancestor
64399923|NCT05068141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399924|NCT03142165|Diphenhydramine|diphenhydramine|mesh-list
64399925|NCT03142165|Promethazine|promethazine|mesh-list
64399926|NCT03142165|Famotidine|famotidine|mesh-list
64399927|NCT03142165|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64399928|NCT03142165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64399929|NCT03142165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64399930|NCT03142165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399931|NCT03142165|Anesthetics, Local|anesthetics, local|mesh-ancestor
64399933|NCT03142165|Sensory System Agents|sensory system agents|mesh-ancestor
64399934|NCT03142165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399935|NCT03142165|Antiemetics|antiemetics|mesh-ancestor
64399936|NCT03142165|Autonomic Agents|autonomic agents|mesh-ancestor
64399951|NCT02330029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309828|NCT02622074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64399952|NCT02330029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64443402|NCT03455270|Palbociclib|palbociclib|mesh-list
64399954|NCT02330029|Parasympatholytics|parasympatholytics|mesh-ancestor
64399955|NCT02330029|Autonomic Agents|autonomic agents|mesh-ancestor
64399956|NCT02330029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399957|NCT04988971|Corticosterone|corticosterone|mesh-list
64399958|NCT04988971|Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|mesh-list
64399959|NCT04988971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64399960|NCT04988971|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64399961|NCT04988971|Anesthetics, General|anesthetics, general|mesh-ancestor
64399962|NCT04988971|Anesthetics|anesthetics|mesh-ancestor
64399963|NCT04988971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64399964|NCT04988971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399965|NCT02329795|Temozolomide|temozolomide|mesh-list
64399966|NCT02329795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64399967|NCT02329795|Alkylating Agents|alkylating agents|mesh-ancestor
64399968|NCT02329795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399969|NCT02329795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399970|NCT02329561|Tramadol|tramadol|mesh-list
64399971|NCT02329561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64400002|NCT05002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64400003|NCT05002517|Antiemetics|antiemetics|mesh-ancestor
64400004|NCT05002517|Autonomic Agents|autonomic agents|mesh-ancestor
64400005|NCT05002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400006|NCT05002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400007|NCT05002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64400008|NCT05002517|Glucocorticoids|glucocorticoids|mesh-ancestor
64400009|NCT05002517|Hormones|hormones|mesh-ancestor
64400010|NCT05002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64400011|NCT05002517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64400012|NCT05002517|Protective Agents|protective agents|mesh-ancestor
64400013|NCT05002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64400014|NCT05002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400015|NCT05002361|Dexamethasone|dexamethasone|mesh-list
64400016|NCT05002361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64400017|NCT05002361|Antiemetics|antiemetics|mesh-ancestor
64400018|NCT05002361|Autonomic Agents|autonomic agents|mesh-ancestor
64400019|NCT05002361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400020|NCT05002361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400021|NCT05002361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64400022|NCT05002361|Glucocorticoids|glucocorticoids|mesh-ancestor
64400024|NCT05002361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64400025|NCT05002361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64400026|NCT05002361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400027|NCT02329405|Rifampin|rifampin|mesh-list
64400028|NCT02329405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64400029|NCT02329405|Antitubercular Agents|antitubercular agents|mesh-ancestor
64400030|NCT02329405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64400031|NCT02329405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64400032|NCT02329405|Leprostatic Agents|leprostatic agents|mesh-ancestor
64400033|NCT02329405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64400041|NCT02329405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64400042|NCT02329171|Imiquimod|imiquimod|mesh-list
64400043|NCT02329171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64400044|NCT02329171|Immunologic Factors|immunologic factors|mesh-ancestor
64400045|NCT02329171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400046|NCT02329171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400047|NCT02329171|Interferon Inducers|interferon inducers|mesh-ancestor
64400048|NCT04498741|Midazolam|midazolam|mesh-list
64400049|NCT04498741|Dabigatran|dabigatran|mesh-list
64400050|NCT04498741|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64400051|NCT04498741|Tacrolimus|tacrolimus|mesh-list
64400052|NCT04498741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64400053|NCT04498741|Immunologic Factors|immunologic factors|mesh-ancestor
64400054|NCT04498741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400055|NCT04498741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64400056|NCT04498741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443541|NCT01709578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64443543|NCT02132767|Digoxin|digoxin|mesh-list
64400057|NCT04498741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400058|NCT04498741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64400059|NCT04498741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64400060|NCT04498741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64400061|NCT04498741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64400062|NCT04498741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64400063|NCT04498741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64400070|NCT04498741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64400079|NCT03551743|Edoxaban|edoxaban|mesh-list
64400098|NCT04654429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400099|NCT04654429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64400100|NCT04654429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64400101|NCT04654429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64400102|NCT04654429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64400103|NCT04654429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64400104|NCT03111121|Glycopyrrolate|glycopyrrolate|mesh-list
64443629|NCT01599806|Doripenem|doripenem|mesh-list
64443631|NCT01599806|Trimethoprim|trimethoprim|mesh-list
64400107|NCT03111121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400108|NCT03111121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400109|NCT03111121|Cholinergic Agents|cholinergic agents|mesh-ancestor
64400110|NCT03111121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64400111|NCT03111121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400112|NCT03111121|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64400113|NCT03111121|Autonomic Agents|autonomic agents|mesh-ancestor
64400114|NCT03111121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400115|NCT03111121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64400116|NCT03111121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64400117|NCT03111121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64400118|NCT02328469|Doxycycline|doxycycline|mesh-list
64400119|NCT02328469|Ceftriaxone|ceftriaxone|mesh-list
64400120|NCT02328469|Acyclovir|acyclovir|mesh-list
64400121|NCT02328469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64400122|NCT02328469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64400123|NCT02328469|Antimalarials|antimalarials|mesh-ancestor
64400156|NCT04997837|Tegafur|tegafur|mesh-list
64400157|NCT04997837|Oxaliplatin|oxaliplatin|mesh-list
64400158|NCT04997837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64400159|NCT04997837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64400160|NCT04997837|Antimetabolites|antimetabolites|mesh-ancestor
64400161|NCT04997837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400162|NCT04997837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400163|NCT04202263|Minocycline|minocycline|mesh-list
64400164|NCT04202263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64400165|NCT04202263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64400166|NCT04996979|Ropivacaine|ropivacaine|mesh-list
64443699|NCT02152345|Tacrolimus|tacrolimus|mesh-list
64400172|NCT04996979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400173|NCT03145285|Abiraterone Acetate|abiraterone acetate|mesh-list
64400174|NCT03145285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400175|NCT03145285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64400176|NCT03145285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400177|NCT03145285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400178|NCT03145285|Hormone Antagonists|hormone antagonists|mesh-ancestor
64443751|NCT01709110|Teriparatide|teriparatide|mesh-list
64443752|NCT01709110|Risedronic Acid|risedronic acid|mesh-list
64400180|NCT03145285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400181|NCT03145285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64400183|NCT04997291|Razoxane|razoxane|mesh-list
64400184|NCT04997291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400185|NCT04997291|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64400186|NCT04997291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64400187|NCT04997291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64400188|NCT04997291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400189|NCT04997291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310223|NCT04890626|Hormones|hormones|mesh-ancestor
64400193|NCT04997291|Mitosis Modulators|mitosis modulators|mesh-ancestor
64400194|NCT02328079|Acyclovir|acyclovir|mesh-list
64400195|NCT02328079|Antiviral Agents|antiviral agents|mesh-list
64400196|NCT02328079|Prednisolone|prednisolone|mesh-list
64400197|NCT02328079|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64400198|NCT02328079|Methylprednisolone|methylprednisolone|mesh-list
64400199|NCT02328079|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64400200|NCT02328079|Prednisolone acetate|prednisolone acetate|mesh-list
64400201|NCT02328079|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64400202|NCT02328079|Prednisolone phosphate|prednisolone phosphate|mesh-list
64400212|NCT02328079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400213|NCT02328079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64400214|NCT02328079|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64400283|NCT03915613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64400284|NCT03915613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64400285|NCT03915613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400286|NCT03143023|Fluorides|fluorides|mesh-list
64400287|NCT03143023|Cariostatic Agents|cariostatic agents|mesh-ancestor
64400288|NCT03143023|Protective Agents|protective agents|mesh-ancestor
64400289|NCT03143023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400293|NCT03142789|Cerivastatin|cerivastatin|mesh-list
64400294|NCT03142789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64400295|NCT03142789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64400296|NCT03142789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64400297|NCT03142789|Antimetabolites|antimetabolites|mesh-ancestor
64400298|NCT03142789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400299|NCT03142789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400300|NCT03142789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64400301|NCT03072329|Bupivacaine|bupivacaine|mesh-list
64400303|NCT03072329|Anesthetics|anesthetics|mesh-ancestor
64400304|NCT03072329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64400305|NCT03072329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400306|NCT03072329|Sensory System Agents|sensory system agents|mesh-ancestor
64400307|NCT03072329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400308|NCT02327689|Emtricitabine|emtricitabine|mesh-list
64400309|NCT02327689|Adefovir|adefovir|mesh-list
64400310|NCT02327689|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64400311|NCT02327689|Antiviral Agents|antiviral agents|mesh-ancestor
64400312|NCT02327689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64400313|NCT02327689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64400330|NCT02327923|Neostigmine|neostigmine|mesh-list
64400331|NCT02327923|Vecuronium Bromide|vecuronium bromide|mesh-list
64400332|NCT02327923|Esmolol|esmolol|mesh-list
64400347|NCT02327923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64400348|NCT02327923|Narcotics|narcotics|mesh-ancestor
64400349|NCT02327923|Analgesics|analgesics|mesh-ancestor
64400350|NCT02327923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64400351|NCT02327923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64400352|NCT02327923|Antiemetics|antiemetics|mesh-ancestor
64400353|NCT02327923|Autonomic Agents|autonomic agents|mesh-ancestor
64400354|NCT02327923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64400355|NCT02327923|Antipruritics|antipruritics|mesh-ancestor
64400356|NCT02327923|Dermatologic Agents|dermatologic agents|mesh-ancestor
64400357|NCT02327923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64400358|NCT02327923|Serotonin Agents|serotonin agents|mesh-ancestor
64400359|NCT02327923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64400360|NCT02327923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64400361|NCT02327923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64400362|NCT02327923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64400363|NCT02327923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64400366|NCT02327923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64400416|NCT03494569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400417|NCT03494569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400418|NCT03494569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64400419|NCT03494569|Immunologic Factors|immunologic factors|mesh-ancestor
64400420|NCT03494569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400421|NCT03494569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64400422|NCT03494569|Alkylating Agents|alkylating agents|mesh-ancestor
64400423|NCT03494569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64400425|NCT03071549|Salicylates|salicylates|mesh-list
64400426|NCT03071549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64400427|NCT03071549|Antifungal Agents|antifungal agents|mesh-ancestor
64400428|NCT03071549|Keratolytic Agents|keratolytic agents|mesh-ancestor
64400429|NCT03071549|Dermatologic Agents|dermatologic agents|mesh-ancestor
64400430|NCT03071549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64400431|NCT03071549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64400432|NCT03071549|Analgesics|analgesics|mesh-ancestor
64400433|NCT03071549|Sensory System Agents|sensory system agents|mesh-ancestor
64443982|NCT02124811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64400434|NCT03071549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400487|NCT03351439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64400488|NCT03351439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400489|NCT03351439|Antimanic Agents|antimanic agents|mesh-ancestor
64310730|NCT04878926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64400490|NCT03351439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64400491|NCT03351439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64400492|NCT03351439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64400493|NCT03351439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64400494|NCT03351439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64400495|NCT03351439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64400496|NCT03351439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400497|NCT03351439|Gout Suppressants|gout suppressants|mesh-ancestor
64400498|NCT03351439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64400499|NCT03139747|Everolimus|everolimus|mesh-list
64400500|NCT03139747|Lenvatinib|lenvatinib|mesh-list
64400501|NCT03139747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400502|NCT03139747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64444038|NCT01567852|Sensory System Agents|sensory system agents|mesh-ancestor
64400504|NCT03139747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400505|NCT03139747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64400553|NCT04986995|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64400554|NCT04986995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400555|NCT04986995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400556|NCT04986995|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64400557|NCT04986995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64400558|NCT03971929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64400559|NCT03971929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64310850|NCT00103207|Cetuximab|cetuximab|mesh-list
64400560|NCT03971929|Diuretics|diuretics|mesh-ancestor
64400561|NCT03971929|Natriuretic Agents|natriuretic agents|mesh-ancestor
64400571|NCT04986371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400572|NCT04986371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400574|NCT04988945|Tremelimumab|tremelimumab|mesh-list
64400575|NCT04988945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64400576|NCT04988945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400577|NCT03070847|Tranexamic Acid|tranexamic acid|mesh-list
64400578|NCT03070847|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64400579|NCT03070847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64400580|NCT03070847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446565|NCT02136914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64447826|NCT02121002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64450418|NCT02124707|Paclitaxel|paclitaxel|mesh-list
64400583|NCT03069911|Botulinum Toxins|botulinum toxins|mesh-list
64310931|NCT01369355|Ustekinumab|ustekinumab|mesh-list
64400584|NCT03069911|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64400585|NCT03069911|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64400586|NCT03069911|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64400587|NCT03069911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64586297|NCT01795027|Oxaliplatin|oxaliplatin|mesh-list
64451312|NCT01822899|Fluticasone|fluticasone|mesh-list
64334696|NCT03146871|Azacitidine|azacitidine|mesh-list
64400588|NCT03069911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400589|NCT03069911|Cholinergic Agents|cholinergic agents|mesh-ancestor
64400590|NCT03069911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64400591|NCT03069911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400592|NCT03069911|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64400593|NCT03069911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400595|NCT04989257|Ticagrelor|ticagrelor|mesh-list
64400596|NCT04989257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64400597|NCT04989257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64400598|NCT04989257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64400599|NCT04989257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64400600|NCT04989257|Purinergic Agents|purinergic agents|mesh-ancestor
64400601|NCT04989257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64400602|NCT04989257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400603|NCT04989257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400604|NCT04892069|Insulin|insulin|mesh-list
64400605|NCT04892069|Insulin Aspart|insulin aspart|mesh-list
64400606|NCT04892069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64400607|NCT04892069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451416|NCT01820559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64400608|NCT03140449|Calcitriol|calcitriol|mesh-list
64400609|NCT03140449|Sirolimus|sirolimus|mesh-list
64400610|NCT03140449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64400611|NCT03140449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64400612|NCT03140449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64400657|NCT03441139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400659|NCT04988789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64400660|NCT04988789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400661|NCT04988789|Tubulin Modulators|tubulin modulators|mesh-ancestor
64400662|NCT04988789|Antimitotic Agents|antimitotic agents|mesh-ancestor
64400663|NCT04988789|Mitosis Modulators|mitosis modulators|mesh-ancestor
64400664|NCT04988789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400665|NCT04985669|Prucalopride|prucalopride|mesh-list
64400666|NCT04985669|Laxatives|laxatives|mesh-ancestor
64400667|NCT04985669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64311343|NCT02339506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400668|NCT04985669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64400669|NCT04985669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64400670|NCT04985669|Serotonin Agents|serotonin agents|mesh-ancestor
64400671|NCT04985669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64451471|NCT01847313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64400672|NCT04985669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400673|NCT04985669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400732|NCT05083429|Tiotropium Bromide|tiotropium bromide|mesh-list
64400733|NCT05083429|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64400734|NCT05083429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64400735|NCT05083429|Autonomic Agents|autonomic agents|mesh-ancestor
64400744|NCT05083429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400745|NCT05083429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64400746|NCT05083429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64400747|NCT05083429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64400748|NCT05083429|Adrenergic Agents|adrenergic agents|mesh-ancestor
64400749|NCT05088343|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64400750|NCT05088343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64400751|NCT05088343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64400752|NCT05088343|Antimetabolites|antimetabolites|mesh-ancestor
64400753|NCT05088343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400754|NCT05088343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64400756|NCT05088343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400792|NCT04572217|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64400793|NCT04572217|Sympathomimetics|sympathomimetics|mesh-ancestor
64400794|NCT04572217|Autonomic Agents|autonomic agents|mesh-ancestor
64400795|NCT04572217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400796|NCT04572217|Adrenergic Agents|adrenergic agents|mesh-ancestor
64400797|NCT04572217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64400817|NCT04452461|Mitosis Modulators|mitosis modulators|mesh-ancestor
64400818|NCT04452461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400827|NCT04452461|Antidotes|antidotes|mesh-ancestor
64400853|NCT03013933|Cyclosporine|cyclosporine|mesh-list
64400854|NCT03013933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64400855|NCT03013933|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64400856|NCT03013933|Verapamil|verapamil|mesh-list
64400857|NCT03013933|Antibodies|antibodies|mesh-list
64400858|NCT03013933|Immunoglobulins|immunoglobulins|mesh-list
64400859|NCT03013933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64400860|NCT03013933|Cyclosporins|cyclosporins|mesh-list
64400861|NCT03013933|Immunoconjugates|immunoconjugates|mesh-list
64400862|NCT03013933|Immunologic Factors|immunologic factors|mesh-ancestor
64400863|NCT03013933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400864|NCT03013933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400865|NCT03013933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400866|NCT03013933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400867|NCT03013933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64400868|NCT03013933|Antifungal Agents|antifungal agents|mesh-ancestor
64400869|NCT03013933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64400870|NCT03013933|Dermatologic Agents|dermatologic agents|mesh-ancestor
64400871|NCT03013933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64400872|NCT03013933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64400873|NCT03013933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64400874|NCT03013933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64400875|NCT03013933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64400876|NCT03013933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64400877|NCT03013933|Vasodilator Agents|vasodilator agents|mesh-ancestor
64400879|NCT05214911|Prednisolone|prednisolone|mesh-list
64400885|NCT05214911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400886|NCT05214911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64400887|NCT05214911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400888|NCT05214911|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64400902|NCT04262479|Vitamin D|vitamin d|mesh-list
64400903|NCT04262479|Vitamins|vitamins|mesh-ancestor
64400904|NCT04262479|Micronutrients|micronutrients|mesh-ancestor
64400905|NCT04262479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400906|NCT04262479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64400907|NCT04133311|Latanoprost|latanoprost|mesh-list
64400909|NCT04133311|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64400910|NCT03217825|Losartan|losartan|mesh-list
64400911|NCT03217825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64400912|NCT03217825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64400913|NCT03217825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64400914|NCT03217825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64400915|NCT03217825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400916|NCT04035187|Itraconazole|itraconazole|mesh-list
64400917|NCT04035187|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
64311618|NCT02098889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64400918|NCT04035187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64400919|NCT04035187|Antifungal Agents|antifungal agents|mesh-ancestor
64400920|NCT04035187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64400921|NCT04035187|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64400922|NCT04035187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64400923|NCT04035187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400924|NCT04035187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400946|NCT05087797|Vitamin B Complex|vitamin b complex|mesh-ancestor
64311695|NCT02097407|Dexmedetomidine|dexmedetomidine|mesh-list
64311696|NCT02097407|Propofol|propofol|mesh-list
64311702|NCT02097407|Anesthetics|anesthetics|mesh-ancestor
64400960|NCT03867799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400962|NCT05086081|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64400963|NCT05086081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64400964|NCT05086081|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64400965|NCT05086081|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64400966|NCT05086081|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64400967|NCT05086081|Purinergic Agents|purinergic agents|mesh-ancestor
64400968|NCT05086081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64311839|NCT02094833|Vaccines|vaccines|mesh-list
64400969|NCT05086081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400970|NCT05086081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400971|NCT04873297|Metoclopramide|metoclopramide|mesh-list
64400972|NCT04873297|Antiemetics|antiemetics|mesh-ancestor
64400973|NCT04873297|Autonomic Agents|autonomic agents|mesh-ancestor
64400974|NCT04873297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400975|NCT04873297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400976|NCT04873297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64400978|NCT04873297|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64400980|NCT04873297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64400981|NCT04873297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400982|NCT05634473|Methacholine Chloride|methacholine chloride|mesh-list
64400983|NCT05634473|Miotics|miotics|mesh-ancestor
64400984|NCT05634473|Autonomic Agents|autonomic agents|mesh-ancestor
64400985|NCT05634473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400986|NCT05634473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400987|NCT05634473|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64400988|NCT05634473|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
64400989|NCT05634473|Respiratory System Agents|respiratory system agents|mesh-ancestor
64400993|NCT05634473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64400994|NCT05634473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400996|NCT03138499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64400997|NCT03138499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64400998|NCT03138499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400999|NCT03138499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64401000|NCT03138499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401002|NCT04858711|Fentanyl|fentanyl|mesh-list
64401003|NCT04858711|Dexmedetomidine|dexmedetomidine|mesh-list
64401004|NCT04858711|Ketamine|ketamine|mesh-list
64401005|NCT04858711|Anesthetics, Local|anesthetics, local|mesh-ancestor
64401006|NCT04858711|Anesthetics|anesthetics|mesh-ancestor
64401007|NCT04858711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64401065|NCT05047601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64401066|NCT05047601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64401067|NCT05047601|Protease Inhibitors|protease inhibitors|mesh-ancestor
64401068|NCT05047601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64401069|NCT05047601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401070|NCT05047601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64401071|NCT05047601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64401072|NCT05047601|Antiviral Agents|antiviral agents|mesh-ancestor
64401073|NCT05047601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64401080|NCT04705727|Terbutaline|terbutaline|mesh-list
64401081|NCT04705727|Formoterol Fumarate|formoterol fumarate|mesh-list
64401082|NCT04705727|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64401086|NCT04705727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401126|NCT04659629|Pembrolizumab|pembrolizumab|mesh-list
64401127|NCT04659629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64401128|NCT04659629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401129|NCT02998567|Pembrolizumab|pembrolizumab|mesh-list
64401130|NCT02998567|Guadecitabine|guadecitabine|mesh-list
64401131|NCT02998567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64401132|NCT02998567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401133|NCT02985619|Triamcinolone|triamcinolone|mesh-list
64401134|NCT02985619|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64401135|NCT02985619|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64401136|NCT02985619|Bevacizumab|bevacizumab|mesh-list
64401137|NCT02985619|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64401138|NCT02985619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64401139|NCT02985619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401140|NCT02985619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64401141|NCT02985619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64401145|NCT02985619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64401146|NCT02985619|Glucocorticoids|glucocorticoids|mesh-ancestor
64401148|NCT02985619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64401149|NCT02985619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64401150|NCT02985619|Immunologic Factors|immunologic factors|mesh-ancestor
64401151|NCT02985619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64401152|NCT02985619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401189|NCT01884259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64401190|NCT01884259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64401191|NCT01884259|Immunologic Factors|immunologic factors|mesh-ancestor
64401192|NCT01884259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401193|NCT01884259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64401194|NCT04930549|Dapagliflozin|dapagliflozin|mesh-list
64401195|NCT04930549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64401196|NCT04930549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401197|NCT04930549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64401198|NCT04930549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401199|NCT04508621|Cyclobenzaprine|cyclobenzaprine|mesh-list
64401200|NCT04508621|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64401201|NCT04508621|Antidepressive Agents|antidepressive agents|mesh-ancestor
64401202|NCT04508621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64401203|NCT04508621|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64401204|NCT04508621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334698|NCT03146871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64401208|NCT04508621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64401209|NCT03067727|Dinoprostone|dinoprostone|mesh-list
64401210|NCT03067727|Oxytocics|oxytocics|mesh-ancestor
64401211|NCT03067727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64401212|NCT03067727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401219|NCT01794793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64401220|NCT01794793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64401221|NCT01794793|Dopamine Agonists|dopamine agonists|mesh-ancestor
64401222|NCT01794793|Dopamine Agents|dopamine agents|mesh-ancestor
64401223|NCT01794793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64401224|NCT01794793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401225|NCT03067103|Ketamine|ketamine|mesh-list
64401226|NCT03067103|Tramadol|tramadol|mesh-list
64401227|NCT03067103|Analgesics|analgesics|mesh-ancestor
64401228|NCT03067103|Sensory System Agents|sensory system agents|mesh-ancestor
64401229|NCT03067103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312222|NCT03554915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64401230|NCT03067103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401231|NCT03067103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64401232|NCT03067103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64401233|NCT03067103|Anesthetics, General|anesthetics, general|mesh-ancestor
64401234|NCT03067103|Anesthetics|anesthetics|mesh-ancestor
64401235|NCT03067103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64401236|NCT03067103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64401237|NCT03067103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64401260|NCT01305889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401261|NCT01305889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64401262|NCT01305889|Serotonin Agents|serotonin agents|mesh-ancestor
64401263|NCT01305889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401264|NCT05392075|Vaccines|vaccines|mesh-list
64401303|NCT03208985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64401304|NCT03208985|Contraceptive Agents|contraceptive agents|mesh-ancestor
64401305|NCT03208985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64401306|NCT03208985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401307|NCT03208985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64401308|NCT03644953|Hydroxyurea|hydroxyurea|mesh-list
64401309|NCT03644953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401310|NCT03644953|Antisickling Agents|antisickling agents|mesh-ancestor
64401311|NCT03644953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64401312|NCT03644953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401313|NCT03644953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64401315|NCT03630835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312462|NCT03187899|Ropivacaine|ropivacaine|mesh-list
64401316|NCT03630835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401317|NCT04764097|Dapagliflozin|dapagliflozin|mesh-list
64401318|NCT04764097|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64401319|NCT04764097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401320|NCT04764097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64401374|NCT05431049|Anesthetics|anesthetics|mesh-list
64401375|NCT05431049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64401376|NCT05431049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401377|NCT03067415|Latanoprost|latanoprost|mesh-list
64401378|NCT03067415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64401379|NCT03067415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64401380|NCT05089981|Acetylcysteine|acetylcysteine|mesh-list
64401381|NCT05089981|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64401382|NCT05089981|Antiviral Agents|antiviral agents|mesh-ancestor
64401383|NCT05089981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64401384|NCT05089981|Expectorants|expectorants|mesh-ancestor
64401385|NCT05089981|Respiratory System Agents|respiratory system agents|mesh-ancestor
64401386|NCT05089981|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64401387|NCT05089981|Antioxidants|antioxidants|mesh-ancestor
64401388|NCT05089981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401389|NCT05089981|Protective Agents|protective agents|mesh-ancestor
64401390|NCT05089981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401391|NCT05089981|Antidotes|antidotes|mesh-ancestor
64401392|NCT04271189|Metformin|metformin|mesh-list
64401393|NCT04271189|Pioglitazone|pioglitazone|mesh-list
64401394|NCT04271189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64401395|NCT04271189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64401396|NCT04271189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401397|NCT04271189|Incretins|incretins|mesh-ancestor
64401430|NCT04132817|Paclitaxel|paclitaxel|mesh-list
64401431|NCT04132817|Nivolumab|nivolumab|mesh-list
64401432|NCT04132817|Ipilimumab|ipilimumab|mesh-list
64401433|NCT04132817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64401434|NCT04132817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401435|NCT04132817|Tubulin Modulators|tubulin modulators|mesh-ancestor
64401436|NCT04132817|Antimitotic Agents|antimitotic agents|mesh-ancestor
64401437|NCT04132817|Mitosis Modulators|mitosis modulators|mesh-ancestor
64401438|NCT04132817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401439|NCT04132817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64401440|NCT04132817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64401441|NCT04118387|Acetazolamide|acetazolamide|mesh-list
64401442|NCT04118387|Zolpidem|zolpidem|mesh-list
64401443|NCT04118387|Buspirone|buspirone|mesh-list
64401444|NCT04118387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64401445|NCT04118387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64401446|NCT04118387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64401447|NCT04118387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401448|NCT04118387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64401450|NCT04118387|GABA Agents|gaba agents|mesh-ancestor
64401451|NCT04118387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64401452|NCT04118387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401453|NCT04118387|Anticonvulsants|anticonvulsants|mesh-ancestor
64401454|NCT04118387|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64401455|NCT04118387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64401456|NCT04118387|Diuretics|diuretics|mesh-ancestor
64401482|NCT03136237|Immunologic Factors|immunologic factors|mesh-ancestor
64401483|NCT03136237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401484|NCT03136237|Antifungal Agents|antifungal agents|mesh-ancestor
64401486|NCT03136237|Dermatologic Agents|dermatologic agents|mesh-ancestor
64401487|NCT03136237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64401488|NCT03136237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64401489|NCT03136237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64401490|NCT03136237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64401491|NCT03136237|Antimetabolites|antimetabolites|mesh-ancestor
64401492|NCT03136237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64401493|NCT03136237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64401547|NCT01603459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64401548|NCT01603459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64401549|NCT01603459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401550|NCT01603459|Cholinergic Agents|cholinergic agents|mesh-ancestor
64401555|NCT03136003|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64401556|NCT03136003|Hemostatics|hemostatics|mesh-ancestor
64401557|NCT03136003|Coagulants|coagulants|mesh-ancestor
64401558|NCT03136003|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64401616|NCT04540861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401617|NCT04540861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64401619|NCT04540861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401620|NCT03066557|Apatinib|apatinib|mesh-list
64401621|NCT03066557|Chlorotrianisene|chlorotrianisene|mesh-list
64401640|NCT05738161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64401641|NCT05738161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64401642|NCT05738161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64401643|NCT05738161|Immunologic Factors|immunologic factors|mesh-ancestor
64401644|NCT05738161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401645|NCT05738161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64401646|NCT05737693|Midazolam|midazolam|mesh-list
64401647|NCT05737693|Ketamine|ketamine|mesh-list
64401648|NCT05737693|Analgesics|analgesics|mesh-ancestor
64401649|NCT05737693|Sensory System Agents|sensory system agents|mesh-ancestor
64401720|NCT03066011|Antifungal Agents|antifungal agents|mesh-ancestor
64401721|NCT03066011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64401722|NCT03066011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64401725|NCT03066011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312963|NCT02428257|Sympathomimetics|sympathomimetics|mesh-ancestor
64401726|NCT03066011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64401727|NCT03066011|Hormone Antagonists|hormone antagonists|mesh-ancestor
64401728|NCT03066011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64401729|NCT03066011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401730|NCT03066011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64401731|NCT03066011|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64401732|NCT03066011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64401751|NCT02563015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64401752|NCT02563015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64401753|NCT02382445|Anesthetics|anesthetics|mesh-list
64401754|NCT02382445|Propofol|propofol|mesh-list
64401755|NCT02382445|Sevoflurane|sevoflurane|mesh-list
64401756|NCT02382445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64401757|NCT02382445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401758|NCT02382445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64401759|NCT02382445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64401760|NCT02382445|Anesthetics, General|anesthetics, general|mesh-ancestor
64401761|NCT02382445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64401762|NCT02382445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64401766|NCT05736757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64401775|NCT04483739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401776|NCT04483739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401777|NCT04483739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64401778|NCT04483739|Glucocorticoids|glucocorticoids|mesh-ancestor
64401779|NCT04483739|Hormones|hormones|mesh-ancestor
64401780|NCT04483739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64401781|NCT04483739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64313204|NCT03037736|Bevacizumab|bevacizumab|mesh-list
64401782|NCT04483739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401783|NCT04483739|Protease Inhibitors|protease inhibitors|mesh-ancestor
64401784|NCT04483739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64401785|NCT04483739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401786|NCT04483739|Immunologic Factors|immunologic factors|mesh-ancestor
64401787|NCT04483739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64401788|NCT04483739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64401789|NCT04483739|Growth Substances|growth substances|mesh-ancestor
64401790|NCT04483739|Growth Inhibitors|growth inhibitors|mesh-ancestor
64401792|NCT05727475|Cariostatic Agents|cariostatic agents|mesh-ancestor
64401799|NCT05091775|Sensory System Agents|sensory system agents|mesh-ancestor
64401800|NCT05091775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401801|NCT05091775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401802|NCT05091775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64401803|NCT05091775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64401804|NCT04821869|Albuterol|albuterol|mesh-list
64401805|NCT04821869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64401806|NCT04821869|Autonomic Agents|autonomic agents|mesh-ancestor
64401807|NCT04821869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401808|NCT04821869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401810|NCT04821869|Respiratory System Agents|respiratory system agents|mesh-ancestor
64313274|NCT03180723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64401812|NCT04821869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64401813|NCT04821869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64401814|NCT04821869|Adrenergic Agents|adrenergic agents|mesh-ancestor
64401815|NCT04821869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64401816|NCT04821869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401817|NCT04821869|Tocolytic Agents|tocolytic agents|mesh-ancestor
64401818|NCT04821869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64401819|NCT05091463|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
64313373|NCT03183297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64401820|NCT05091463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64401821|NCT05091463|Immunologic Factors|immunologic factors|mesh-ancestor
64401822|NCT05091463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401823|NCT02631551|Mometasone Furoate|mometasone furoate|mesh-list
64401824|NCT02631551|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64401825|NCT02631551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64401826|NCT02631551|Dermatologic Agents|dermatologic agents|mesh-ancestor
64401827|NCT02631551|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64401828|NCT02631551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64401829|NCT02631551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64401830|NCT02631551|Analgesics|analgesics|mesh-ancestor
64401831|NCT02631551|Sensory System Agents|sensory system agents|mesh-ancestor
64401832|NCT02631551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401833|NCT02631551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401850|NCT05091151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64401851|NCT05091151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64401852|NCT05091151|Adrenergic Agents|adrenergic agents|mesh-ancestor
64401853|NCT05091151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64401854|NCT05091151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313448|NCT04770272|Paclitaxel|paclitaxel|mesh-list
64401855|NCT05466539|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64401856|NCT05466539|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64401857|NCT05466539|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64401858|NCT05466539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64401870|NCT04447235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64401871|NCT04447235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64401873|NCT04447235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401875|NCT04447235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64401876|NCT01680991|Obinutuzumab|obinutuzumab|mesh-list
64401877|NCT01680991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64401878|NCT01680991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401880|NCT01700569|Folic Acid|folic acid|mesh-list
64401881|NCT01700569|Temozolomide|temozolomide|mesh-list
64401882|NCT01700569|Levoleucovorin|levoleucovorin|mesh-list
64401883|NCT01700569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401884|NCT01700569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64401909|NCT05090761|Anticonvulsants|anticonvulsants|mesh-ancestor
64401910|NCT05090761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64401911|NCT05090761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64401912|NCT05090761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401913|NCT05090761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64401914|NCT05090761|Tocolytic Agents|tocolytic agents|mesh-ancestor
64401915|NCT05090761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64401916|NCT03065309|Remifentanil|remifentanil|mesh-list
64401917|NCT03065309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64401918|NCT03065309|Narcotics|narcotics|mesh-ancestor
64401919|NCT03065309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64401920|NCT03065309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401921|NCT03065309|Analgesics|analgesics|mesh-ancestor
64401922|NCT03065309|Sensory System Agents|sensory system agents|mesh-ancestor
64401923|NCT03065309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401924|NCT02819479|Bevacizumab|bevacizumab|mesh-list
64401925|NCT02819479|Mannitol|mannitol|mesh-list
64401929|NCT02819479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64401931|NCT02819479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401932|NCT02819479|Growth Inhibitors|growth inhibitors|mesh-ancestor
64401933|NCT02819479|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64401934|NCT02819479|Diuretics|diuretics|mesh-ancestor
64401935|NCT02819479|Natriuretic Agents|natriuretic agents|mesh-ancestor
64401936|NCT05376943|Antiviral Agents|antiviral agents|mesh-list
64401937|NCT05376943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64401938|NCT04074785|Bevacizumab|bevacizumab|mesh-list
64401939|NCT04074785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64401940|NCT04074785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401941|NCT04074785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64401942|NCT04074785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64401943|NCT04074785|Growth Substances|growth substances|mesh-ancestor
64401944|NCT04074785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401945|NCT04074785|Growth Inhibitors|growth inhibitors|mesh-ancestor
64401946|NCT04533841|Propranolol|propranolol|mesh-list
64401948|NCT04533841|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64401950|NCT04533841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64401951|NCT04533841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313692|NCT04826822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64401952|NCT04533841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64401953|NCT04533841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64401954|NCT04533841|Oxytocics|oxytocics|mesh-ancestor
64401955|NCT04533841|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64401956|NCT04533841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64401957|NCT04533841|Adrenergic Agents|adrenergic agents|mesh-ancestor
64401958|NCT04533841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64401959|NCT04533841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401960|NCT04533841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64401961|NCT04533841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64401962|NCT04533841|Vasodilator Agents|vasodilator agents|mesh-ancestor
64401963|NCT04536805|Metformin|metformin|mesh-list
64401964|NCT04536805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64401965|NCT04536805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401966|NCT05376865|Vitamin D|vitamin d|mesh-list
64401967|NCT05376865|Vitamins|vitamins|mesh-ancestor
64401968|NCT05376865|Micronutrients|micronutrients|mesh-ancestor
64401969|NCT05376865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401970|NCT05376865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64401971|NCT04064411|Abaloparatide|abaloparatide|mesh-list
64401972|NCT04064411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
64401973|NCT04064411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64401974|NCT04064411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313831|NCT04826510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401975|NCT04064411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64401996|NCT03063359|Anesthetics, General|anesthetics, general|mesh-ancestor
64401997|NCT03063359|Anesthetics|anesthetics|mesh-ancestor
64402006|NCT02660359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64402007|NCT02660359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402008|NCT02660359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64402009|NCT02660359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64402010|NCT02660359|Agglutinins|agglutinins|mesh-ancestor
64402011|NCT02660359|Immunologic Factors|immunologic factors|mesh-ancestor
64402012|NCT02728531|Cytarabine|cytarabine|mesh-list
64402013|NCT02728531|Rituximab|rituximab|mesh-list
64402014|NCT02728531|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64402015|NCT02728531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64402016|NCT02728531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402017|NCT02728531|Immunologic Factors|immunologic factors|mesh-ancestor
64402018|NCT02728531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402019|NCT02728531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64402020|NCT02728531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64402021|NCT02728531|Antimetabolites|antimetabolites|mesh-ancestor
64402022|NCT02728531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402023|NCT02728531|Antiviral Agents|antiviral agents|mesh-ancestor
64402024|NCT02728531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64402025|NCT02728531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64402026|NCT02728531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64402027|NCT02728531|Alkylating Agents|alkylating agents|mesh-ancestor
64402029|NCT04901299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64402030|NCT04901299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402031|NCT04901299|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64402032|NCT04901299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64402033|NCT04901299|Hormone Antagonists|hormone antagonists|mesh-ancestor
64402034|NCT04901299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64402044|NCT04262869|Immunoglobulins|immunoglobulins|mesh-list
64402045|NCT04262869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64402046|NCT04262869|Immunoglobulin G|immunoglobulin g|mesh-list
64402047|NCT04262869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64402048|NCT04262869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402049|NCT04262869|Tubulin Modulators|tubulin modulators|mesh-ancestor
64402050|NCT04262869|Antimitotic Agents|antimitotic agents|mesh-ancestor
64402051|NCT04262869|Mitosis Modulators|mitosis modulators|mesh-ancestor
64402052|NCT04262869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402053|NCT04262869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402054|NCT04262869|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64402055|NCT04262869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64402056|NCT04262869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64314390|NCT04816838|Osimertinib|osimertinib|mesh-list
64402057|NCT04262869|Immunologic Factors|immunologic factors|mesh-ancestor
64402059|NCT05092165|Methylene Blue|methylene blue|mesh-list
64402108|NCT04582981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402109|NCT04582981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402110|NCT04582981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64402111|NCT04582981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402112|NCT04469179|Immunoglobulins|immunoglobulins|mesh-list
64402113|NCT04469179|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64402114|NCT04469179|Immunologic Factors|immunologic factors|mesh-ancestor
64402115|NCT04469179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402116|NCT04531579|Valproic Acid|valproic acid|mesh-list
64402117|NCT04531579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64402118|NCT04531579|Anticonvulsants|anticonvulsants|mesh-ancestor
64402119|NCT04531579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402120|NCT04531579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402121|NCT04531579|GABA Agents|gaba agents|mesh-ancestor
64402122|NCT04531579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64402123|NCT04531579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402124|NCT04531579|Antimanic Agents|antimanic agents|mesh-ancestor
64402125|NCT04531579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64402127|NCT04531579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64402128|NCT03839459|Denosumab|denosumab|mesh-list
64402129|NCT03839459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64402130|NCT03839459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402131|NCT05097781|Antibodies|antibodies|mesh-list
64402132|NCT05097781|Antibodies, Blocking|antibodies, blocking|mesh-list
64402133|NCT05097781|Immunologic Factors|immunologic factors|mesh-ancestor
64402134|NCT05097781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402135|NCT01117441|Cytarabine|cytarabine|mesh-list
64402136|NCT01117441|Dexamethasone|dexamethasone|mesh-list
64402147|NCT01117441|Asparaginase|asparaginase|mesh-list
64402159|NCT01117441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402160|NCT01117441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64402161|NCT01117441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64402162|NCT01117441|Antiemetics|antiemetics|mesh-ancestor
64315160|NCT03535298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315161|NCT03535298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64402163|NCT01117441|Autonomic Agents|autonomic agents|mesh-ancestor
64402164|NCT01117441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64402165|NCT01117441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64402167|NCT01117441|Hormones|hormones|mesh-ancestor
64402168|NCT01117441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64402169|NCT01117441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64402170|NCT01117441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64402171|NCT01117441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64402172|NCT01117441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64402173|NCT01117441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402174|NCT01117441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64402175|NCT01117441|Abortifacient Agents|abortifacient agents|mesh-ancestor
64402176|NCT01117441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64402217|NCT05073575|Immunologic Factors|immunologic factors|mesh-ancestor
64402218|NCT05073575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402219|NCT05073575|Viscosupplements|viscosupplements|mesh-ancestor
64402220|NCT05073575|Protective Agents|protective agents|mesh-ancestor
64402221|NCT03511625|Methylprednisolone|methylprednisolone|mesh-list
64402222|NCT03511625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64402223|NCT03511625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64402224|NCT03511625|Prednisolone|prednisolone|mesh-list
64402225|NCT03511625|Prednisolone acetate|prednisolone acetate|mesh-list
64402226|NCT03511625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64375694|NCT04900311|Paclitaxel|paclitaxel|mesh-list
64402227|NCT03511625|Prednisolone phosphate|prednisolone phosphate|mesh-list
64402228|NCT03511625|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64402232|NCT03511625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64402233|NCT03511625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402234|NCT03511625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64402278|NCT04523935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402294|NCT04523935|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64402295|NCT04523935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64402296|NCT04523935|Adrenergic Agents|adrenergic agents|mesh-ancestor
64402297|NCT04523935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64402298|NCT04523935|Antiemetics|antiemetics|mesh-ancestor
64402299|NCT04523935|Autonomic Agents|autonomic agents|mesh-ancestor
64402300|NCT04523935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64402301|NCT04523935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64402302|NCT04523935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64402303|NCT04523935|Anesthetics, General|anesthetics, general|mesh-ancestor
64402304|NCT04523935|Anesthetics|anesthetics|mesh-ancestor
64402305|NCT04523935|GABA Modulators|gaba modulators|mesh-ancestor
64402306|NCT04523935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64402307|NCT04523935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64402308|NCT04523935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64315884|NCT05398757|Midazolam|midazolam|mesh-list
64402309|NCT04523935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64402310|NCT04523935|Cholinergic Agents|cholinergic agents|mesh-ancestor
64402314|NCT02630693|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64402315|NCT02630693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64402316|NCT02630693|Hormone Antagonists|hormone antagonists|mesh-ancestor
64402317|NCT02630693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64402318|NCT02630693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402319|NCT02630693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64402320|NCT02630693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402321|NCT02630693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64316524|NCT03661307|Decitabine|decitabine|mesh-list
64402322|NCT02630693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64402323|NCT02630693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64402336|NCT04625530|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64402337|NCT04625530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64402338|NCT04625530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402350|NCT01916824|Antidepressive Agents|antidepressive agents|mesh-list
64402351|NCT01916824|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64402352|NCT01916824|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64402353|NCT01916824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64402354|NCT01916824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64402355|NCT01916824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402356|NCT01916824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64402357|NCT01916824|Serotonin Agents|serotonin agents|mesh-ancestor
64402358|NCT01916824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402359|NCT01916824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64402360|NCT01916824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64402361|NCT01916824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64402362|NCT01916824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64402363|NCT01916824|Dopamine Agents|dopamine agents|mesh-ancestor
64402366|NCT01916824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402367|NCT01916824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64402368|NCT01916824|Analgesics|analgesics|mesh-ancestor
64402369|NCT01916824|Sensory System Agents|sensory system agents|mesh-ancestor
64402370|NCT01916824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64402371|NCT01916824|Histamine Antagonists|histamine antagonists|mesh-ancestor
64402372|NCT01916824|Histamine Agents|histamine agents|mesh-ancestor
64402373|NCT01916824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64402374|NCT01916824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64402375|NCT01916824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64402376|NCT01916824|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64402377|NCT01916824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64402383|NCT01915732|Clindamycin|clindamycin|mesh-list
64402384|NCT01915732|Clindamycin palmitate|clindamycin palmitate|mesh-list
64402385|NCT01915732|Clindamycin phosphate|clindamycin phosphate|mesh-list
64402386|NCT01915732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64402387|NCT01915732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64402388|NCT01915732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64402389|NCT01915732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402390|NCT01915732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402391|NCT01936870|Fesoterodine|fesoterodine|mesh-list
64402392|NCT01936870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64402393|NCT01936870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64402394|NCT01936870|Cholinergic Agents|cholinergic agents|mesh-ancestor
64402395|NCT01936870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64402396|NCT01936870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402397|NCT01936870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402398|NCT01936870|Urological Agents|urological agents|mesh-ancestor
64402400|NCT01618708|Viscosupplements|viscosupplements|mesh-ancestor
64402401|NCT01618708|Protective Agents|protective agents|mesh-ancestor
64402404|NCT02229149|Vinorelbine|vinorelbine|mesh-list
64402406|NCT02229149|Capecitabine|capecitabine|mesh-list
64402411|NCT02229149|Tubulin Modulators|tubulin modulators|mesh-ancestor
64402412|NCT02229149|Antimitotic Agents|antimitotic agents|mesh-ancestor
64402413|NCT02229149|Mitosis Modulators|mitosis modulators|mesh-ancestor
64402414|NCT02229149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402415|NCT02229149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64402434|NCT04440371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64402435|NCT04440371|Respiratory System Agents|respiratory system agents|mesh-ancestor
64402436|NCT04440371|Dermatologic Agents|dermatologic agents|mesh-ancestor
64402437|NCT01750073|Paclitaxel|paclitaxel|mesh-list
64402438|NCT01750073|Cyclophosphamide|cyclophosphamide|mesh-list
64402439|NCT01750073|Doxorubicin|doxorubicin|mesh-list
64402440|NCT01750073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64402441|NCT01750073|Trastuzumab|trastuzumab|mesh-list
64402442|NCT01750073|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64402443|NCT01750073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64402444|NCT01750073|Antibodies|antibodies|mesh-list
64402446|NCT01750073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64402447|NCT01750073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64402448|NCT01750073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402449|NCT01750073|Tubulin Modulators|tubulin modulators|mesh-ancestor
64402450|NCT01750073|Antimitotic Agents|antimitotic agents|mesh-ancestor
64402451|NCT01750073|Mitosis Modulators|mitosis modulators|mesh-ancestor
64402452|NCT01750073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402453|NCT01750073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64402454|NCT01750073|Immunologic Factors|immunologic factors|mesh-ancestor
64402455|NCT01750073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402456|NCT01750073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64402457|NCT01750073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64402458|NCT01750073|Alkylating Agents|alkylating agents|mesh-ancestor
64402459|NCT01750073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64402460|NCT01750073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64402461|NCT01750073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64402462|NCT01750073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64402463|NCT01750073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402464|NCT03118037|Zaleplon|zaleplon|mesh-list
64402465|NCT03118037|Anticonvulsants|anticonvulsants|mesh-ancestor
64402467|NCT03118037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64402468|NCT03118037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402469|NCT03118037|GABA Modulators|gaba modulators|mesh-ancestor
64402470|NCT03118037|GABA Agents|gaba agents|mesh-ancestor
64402473|NCT01550003|Certolizumab Pegol|certolizumab pegol|mesh-list
64402474|NCT01550003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64402475|NCT01550003|Immunologic Factors|immunologic factors|mesh-ancestor
64402476|NCT01550003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402477|NCT01550003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64402478|NCT00694655|Vaccines|vaccines|mesh-list
64402492|NCT04982549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402494|NCT04982549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64402495|NCT04982549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64402496|NCT04982549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64402497|NCT02875223|Itraconazole|itraconazole|mesh-list
64402498|NCT02875223|Rifampin|rifampin|mesh-list
64402499|NCT02875223|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
64402500|NCT02875223|Antifungal Agents|antifungal agents|mesh-ancestor
64402501|NCT02875223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64402502|NCT02875223|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64402504|NCT02875223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402505|NCT02875223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402506|NCT02875223|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64402507|NCT02875223|Hormone Antagonists|hormone antagonists|mesh-ancestor
64402508|NCT02875223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64402509|NCT02875223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402510|NCT02875223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64402511|NCT02875223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64402512|NCT02875223|Antitubercular Agents|antitubercular agents|mesh-ancestor
64402513|NCT02875223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64402514|NCT02875223|Leprostatic Agents|leprostatic agents|mesh-ancestor
64402515|NCT02875223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64402516|NCT02875223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64402525|NCT02621021|Pembrolizumab|pembrolizumab|mesh-list
64402526|NCT02621021|Fludarabine|fludarabine|mesh-list
64402527|NCT02621021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64402528|NCT02621021|Immunologic Factors|immunologic factors|mesh-ancestor
64402529|NCT02621021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402530|NCT02621021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64402531|NCT02621021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64402532|NCT02621021|Alkylating Agents|alkylating agents|mesh-ancestor
64402533|NCT02621021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402534|NCT02621021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402535|NCT02621021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64402536|NCT02621021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64402537|NCT02621021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64402538|NCT02621021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64402539|NCT02621021|Antiviral Agents|antiviral agents|mesh-ancestor
64402547|NCT02592317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64402548|NCT02592317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64402549|NCT02592317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402550|NCT02592317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64402551|NCT02592317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402553|NCT03062423|Antiviral Agents|antiviral agents|mesh-ancestor
64402588|NCT03062501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402589|NCT03062501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402590|NCT03062501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64402591|NCT02102789|Leucovorin|leucovorin|mesh-list
64402592|NCT02102789|Dexamethasone|dexamethasone|mesh-list
64402593|NCT02102789|Fluorouracil|fluorouracil|mesh-list
64386325|NCT02679755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402594|NCT02102789|Oxaliplatin|oxaliplatin|mesh-list
64402595|NCT02102789|Floxuridine|floxuridine|mesh-list
64402596|NCT02102789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64402597|NCT02102789|Antiemetics|antiemetics|mesh-ancestor
64402598|NCT02102789|Autonomic Agents|autonomic agents|mesh-ancestor
64402600|NCT02102789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402602|NCT02102789|Glucocorticoids|glucocorticoids|mesh-ancestor
64402603|NCT02102789|Hormones|hormones|mesh-ancestor
64402604|NCT02102789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64402605|NCT02102789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64402606|NCT02102789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402608|NCT02102789|Antimetabolites|antimetabolites|mesh-ancestor
64402653|NCT01670279|Dopamine Agents|dopamine agents|mesh-ancestor
64402654|NCT04188145|Bevacizumab|bevacizumab|mesh-list
64402655|NCT04188145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64402656|NCT04188145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402657|NCT04188145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64402658|NCT04188145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64402659|NCT04188145|Growth Substances|growth substances|mesh-ancestor
64402660|NCT04188145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386583|NCT02390843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64402661|NCT04188145|Growth Inhibitors|growth inhibitors|mesh-ancestor
64402662|NCT03063983|Cyclophosphamide|cyclophosphamide|mesh-list
64402663|NCT03063983|Methotrexate|methotrexate|mesh-list
64402664|NCT03063983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64402665|NCT03063983|Immunologic Factors|immunologic factors|mesh-ancestor
64402780|NCT03079999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64402781|NCT03079999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64402782|NCT03079999|Analgesics|analgesics|mesh-ancestor
64402783|NCT03079999|Sensory System Agents|sensory system agents|mesh-ancestor
64402784|NCT03079999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64402785|NCT03079999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402786|NCT03079999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64402787|NCT03079999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64402788|NCT03079999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64402789|NCT03079999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64402790|NCT03079999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402791|NCT03079999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64402849|NCT05103397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402850|NCT05103397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64402851|NCT05103397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402852|NCT05103397|Antiemetics|antiemetics|mesh-ancestor
64402853|NCT05103397|Autonomic Agents|autonomic agents|mesh-ancestor
64402854|NCT05103397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64402855|NCT05103397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64402856|NCT05103397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64402857|NCT05103397|Protective Agents|protective agents|mesh-ancestor
64402858|NCT05101447|Mycophenolic Acid|mycophenolic acid|mesh-list
64402859|NCT05101447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64402860|NCT05101447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402861|NCT05101447|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64402862|NCT05101447|Antitubercular Agents|antitubercular agents|mesh-ancestor
64402863|NCT05101447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64402864|NCT05101447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64402865|NCT05101447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402866|NCT05101447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402867|NCT05101291|Bupivacaine|bupivacaine|mesh-list
64402868|NCT05101291|Anesthetics, Local|anesthetics, local|mesh-ancestor
64402871|NCT05101291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402872|NCT05101291|Sensory System Agents|sensory system agents|mesh-ancestor
64402873|NCT05101291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64402874|NCT04342169|Hydroxychloroquine|hydroxychloroquine|mesh-list
64402875|NCT04342169|Antimalarials|antimalarials|mesh-ancestor
64402882|NCT04979273|Epinephrine|epinephrine|mesh-list
64402894|NCT04979273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64402916|NCT05036473|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64402917|NCT05036473|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64402918|NCT05036473|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64402919|NCT05036473|Dopamine Agents|dopamine agents|mesh-ancestor
64402920|NCT05036473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64402921|NCT05036473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402922|NCT05036473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402923|NCT05036473|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64402924|NCT05036473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386861|NCT02382029|Clonazepam|clonazepam|mesh-list
64386862|NCT02382029|Anticonvulsants|anticonvulsants|mesh-ancestor
64385482|NCT03166397|Alkylating Agents|alkylating agents|mesh-ancestor
64385488|NCT05745935|Oxytocin|oxytocin|mesh-list
64402925|NCT05036473|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64402926|NCT05036473|Immunologic Factors|immunologic factors|mesh-ancestor
64402927|NCT05036473|Dopamine Agonists|dopamine agonists|mesh-ancestor
64402928|NCT04985851|Durvalumab|durvalumab|mesh-list
64402929|NCT04985851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64402930|NCT04985851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64402931|NCT04985851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402932|NCT04985851|Immunologic Factors|immunologic factors|mesh-ancestor
64402933|NCT04985851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402934|NCT05099575|Oxytocin|oxytocin|mesh-list
64402936|NCT05099575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64402937|NCT05099575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402938|NCT03063515|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
64402939|NCT03063515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64402940|NCT03063515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402941|NCT03063515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402942|NCT03063515|Cholinergic Agents|cholinergic agents|mesh-ancestor
64402943|NCT03063515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64402945|NCT04973579|Anesthetics|anesthetics|mesh-list
64402969|NCT03061565|Hematinics|hematinics|mesh-ancestor
64402970|NCT02660281|Cyclophosphamide|cyclophosphamide|mesh-list
64402971|NCT02660281|Melphalan|melphalan|mesh-list
64402972|NCT02660281|Busulfan|busulfan|mesh-list
64402973|NCT02660281|Thiotepa|thiotepa|mesh-list
64402974|NCT02660281|Fludarabine|fludarabine|mesh-list
64402975|NCT02660281|Mesna|mesna|mesh-list
64402976|NCT02660281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64402977|NCT02660281|Immunologic Factors|immunologic factors|mesh-ancestor
64402978|NCT02660281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402980|NCT02660281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64402981|NCT02660281|Alkylating Agents|alkylating agents|mesh-ancestor
64402982|NCT02660281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387242|NCT04540133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402983|NCT02660281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402984|NCT02660281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64402985|NCT02660281|Protective Agents|protective agents|mesh-ancestor
64402986|NCT02438995|Cetuximab|cetuximab|mesh-list
64402987|NCT02438995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64402988|NCT02438995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402989|NCT05107921|Bromfenac|bromfenac|mesh-list
64403039|NCT04437017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64403040|NCT04437017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64403041|NCT04437017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387327|NCT02373449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387328|NCT02371421|Allopurinol|allopurinol|mesh-list
64387329|NCT02371421|Antimetabolites|antimetabolites|mesh-ancestor
64403042|NCT04437017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64403043|NCT04437017|Serotonin Agents|serotonin agents|mesh-ancestor
64403044|NCT04437017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64403045|NCT05107375|Vaccines|vaccines|mesh-list
64403046|NCT05107375|Immunologic Factors|immunologic factors|mesh-ancestor
64403047|NCT05107375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403048|NCT03061253|Nicotine|nicotine|mesh-list
64403049|NCT03061253|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64403050|NCT03061253|Autonomic Agents|autonomic agents|mesh-ancestor
64403051|NCT03061253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403052|NCT03061253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403053|NCT03061253|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64403054|NCT03061253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64387441|NCT02369549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64387442|NCT02369549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64387443|NCT02369549|Analgesics|analgesics|mesh-ancestor
64387452|NCT03603509|Vaccines|vaccines|mesh-list
64403057|NCT03061253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403103|NCT04971239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64403104|NCT04903093|Famotidine|famotidine|mesh-list
64403105|NCT04903093|Abrocitinib|abrocitinib|mesh-list
64403106|NCT04903093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64403107|NCT04903093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64403108|NCT04903093|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64403109|NCT04903093|Histamine Antagonists|histamine antagonists|mesh-ancestor
64403110|NCT04903093|Histamine Agents|histamine agents|mesh-ancestor
64387512|NCT02364479|Analgesics|analgesics|mesh-ancestor
64387513|NCT02364479|Sensory System Agents|sensory system agents|mesh-ancestor
64403111|NCT04903093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64403112|NCT04903093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403113|NCT04903093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403114|NCT04903093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64403115|NCT04903093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403116|NCT04529785|Ethanol|ethanol|mesh-list
64403117|NCT04529785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64403118|NCT04529785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64403119|NCT04529785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64403120|NCT04529785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403123|NCT04271293|Antithrombins|antithrombins|mesh-ancestor
64387597|NCT02049814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387599|NCT03344159|Spironolactone|spironolactone|mesh-list
64403124|NCT04271293|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64403125|NCT04271293|Protease Inhibitors|protease inhibitors|mesh-ancestor
64403126|NCT04271293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403127|NCT04271293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403164|NCT04964219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64403165|NCT04964219|Anesthetics, General|anesthetics, general|mesh-ancestor
64403166|NCT04964219|Anesthetics|anesthetics|mesh-ancestor
64403167|NCT04964219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64403168|NCT04964219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64403169|NCT04964219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64403170|NCT04964219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64403171|NCT04964219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403172|NCT04964219|Antidepressive Agents|antidepressive agents|mesh-ancestor
64403173|NCT04964219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64403174|NCT04975373|Hyaluronic Acid|hyaluronic acid|mesh-list
64403175|NCT04975373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64403176|NCT04975373|Immunologic Factors|immunologic factors|mesh-ancestor
64403177|NCT04975373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403178|NCT04975373|Viscosupplements|viscosupplements|mesh-ancestor
64387783|NCT02365571|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64403179|NCT04975373|Protective Agents|protective agents|mesh-ancestor
64403180|NCT04974827|Carboplatin|carboplatin|mesh-list
64403181|NCT04974827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403182|NCT04963595|Vinorelbine|vinorelbine|mesh-list
64403183|NCT04963595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64403184|NCT04963595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403185|NCT04963595|Tubulin Modulators|tubulin modulators|mesh-ancestor
64403186|NCT04963595|Antimitotic Agents|antimitotic agents|mesh-ancestor
64403187|NCT04963595|Mitosis Modulators|mitosis modulators|mesh-ancestor
64403188|NCT04963595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403189|NCT04968509|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
64403222|NCT03060005|Anticoagulants|anticoagulants|mesh-ancestor
64403223|NCT03060005|Plasma Substitutes|plasma substitutes|mesh-ancestor
64403224|NCT03060005|Blood Substitutes|blood substitutes|mesh-ancestor
64403226|NCT04210141|Immunologic Factors|immunologic factors|mesh-ancestor
64403227|NCT04210141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403229|NCT04418531|Immunoglobulins|immunoglobulins|mesh-list
64403230|NCT04418531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64403231|NCT04418531|Immunologic Factors|immunologic factors|mesh-ancestor
64387879|NCT02361749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387880|NCT02361749|Cholinergic Agents|cholinergic agents|mesh-ancestor
64387881|NCT02361749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64387882|NCT02361749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387884|NCT04372433|Venetoclax|venetoclax|mesh-list
64403232|NCT04418531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403233|NCT02615119|Isoproterenol|isoproterenol|mesh-list
64403234|NCT02615119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64403235|NCT02615119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64403236|NCT02615119|Adrenergic Agents|adrenergic agents|mesh-ancestor
64403237|NCT02615119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64403238|NCT02615119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403240|NCT02615119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64403241|NCT02615119|Autonomic Agents|autonomic agents|mesh-ancestor
64403242|NCT02615119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403243|NCT02615119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64387954|NCT02357849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64387955|NCT02357849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64387956|NCT02357849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64387962|NCT02357693|Aprepitant|aprepitant|mesh-list
64403244|NCT02615119|Respiratory System Agents|respiratory system agents|mesh-ancestor
64403245|NCT02615119|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64403246|NCT02615119|Sympathomimetics|sympathomimetics|mesh-ancestor
64403247|NCT02615119|Protective Agents|protective agents|mesh-ancestor
64403248|NCT02555293|Rifaximin|rifaximin|mesh-list
64403249|NCT02555293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64403250|NCT02555293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64403275|NCT03293017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64403276|NCT03293017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64403277|NCT03293017|Anesthetics, General|anesthetics, general|mesh-ancestor
64403278|NCT03293017|Anesthetics|anesthetics|mesh-ancestor
64403279|NCT03293017|GABA Modulators|gaba modulators|mesh-ancestor
64403281|NCT03198559|Disulfiram|disulfiram|mesh-list
64403282|NCT03198559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403283|NCT03198559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64403284|NCT03198559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403285|NCT03198559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403286|NCT03198559|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64388035|NCT02357303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388036|NCT02357303|Antidotes|antidotes|mesh-ancestor
64388037|NCT02357303|Antifoaming Agents|antifoaming agents|mesh-ancestor
64388038|NCT02357303|Emollients|emollients|mesh-ancestor
64388039|NCT02357303|Dermatologic Agents|dermatologic agents|mesh-ancestor
64403287|NCT03198559|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
64403288|NCT02625623|Paclitaxel|paclitaxel|mesh-list
64403289|NCT02625623|Irinotecan|irinotecan|mesh-list
64403290|NCT02625623|Avelumab|avelumab|mesh-list
64403291|NCT02625623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64403292|NCT02625623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403293|NCT02625623|Tubulin Modulators|tubulin modulators|mesh-ancestor
64403294|NCT02625623|Antimitotic Agents|antimitotic agents|mesh-ancestor
64403295|NCT02625623|Mitosis Modulators|mitosis modulators|mesh-ancestor
64403296|NCT02625623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403297|NCT02625623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64403298|NCT02625623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64403299|NCT02625623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403300|NCT02625623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64403302|NCT02749513|Antifungal Agents|antifungal agents|mesh-ancestor
64403303|NCT02749513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64403304|NCT02749513|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64403321|NCT02684227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403324|NCT05110339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64403325|NCT05110339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64403326|NCT05110339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403327|NCT05110339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64403328|NCT05110339|Analgesics|analgesics|mesh-ancestor
64403329|NCT05110339|Sensory System Agents|sensory system agents|mesh-ancestor
64388091|NCT02356835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64403330|NCT05110339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403335|NCT05110339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64403336|NCT05110339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403337|NCT05110339|Anesthetics, Local|anesthetics, local|mesh-ancestor
64403339|NCT04965545|Copper|copper|mesh-list
64403340|NCT04965545|Trace Elements|trace elements|mesh-ancestor
64403341|NCT04965545|Micronutrients|micronutrients|mesh-ancestor
64403342|NCT04965545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403343|NCT05105347|Prednisone|prednisone|mesh-list
64403344|NCT05105347|Adalimumab|adalimumab|mesh-list
64403345|NCT05105347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64403346|NCT05105347|Glucocorticoids|glucocorticoids|mesh-ancestor
64403379|NCT04952207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388151|NCT02352311|Tadalafil|tadalafil|mesh-list
64388152|NCT02352311|Dutasteride|dutasteride|mesh-list
64388153|NCT02352311|Vasodilator Agents|vasodilator agents|mesh-ancestor
64403380|NCT04952207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403381|NCT04632589|Losartan|losartan|mesh-list
64403382|NCT04632589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64403383|NCT04632589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64403384|NCT04632589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64403385|NCT04632589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64403387|NCT05108545|Amphotericin B|amphotericin b|mesh-list
64403388|NCT05108545|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64403389|NCT05108545|Amebicides|amebicides|mesh-ancestor
64403390|NCT05108545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64403391|NCT05108545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64403392|NCT05108545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64403393|NCT05108545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64403394|NCT05108545|Antifungal Agents|antifungal agents|mesh-ancestor
64403395|NCT05102695|Fibrin fragment D|fibrin fragment d|mesh-list
64403396|NCT05102695|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64388262|NCT03159845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64388263|NCT03159845|Hormone Antagonists|hormone antagonists|mesh-ancestor
64388264|NCT03159845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64403397|NCT05102695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64403398|NCT05102695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403399|NCT05102695|Hemostatics|hemostatics|mesh-ancestor
64403400|NCT05102695|Coagulants|coagulants|mesh-ancestor
64403401|NCT04952129|Selenium|selenium|mesh-list
64403402|NCT04952129|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
64403403|NCT04952129|Antioxidants|antioxidants|mesh-ancestor
64403438|NCT04960943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403439|NCT04431713|Exenatide|exenatide|mesh-list
64389958|NCT03143465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64389975|NCT02428543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403440|NCT04431713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64403441|NCT04431713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403442|NCT04431713|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64403443|NCT04431713|Incretins|incretins|mesh-ancestor
64403444|NCT04431713|Hormones|hormones|mesh-ancestor
64403445|NCT04431713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64403470|NCT02658019|Pembrolizumab|pembrolizumab|mesh-list
64403471|NCT02658019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64403472|NCT02658019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403473|NCT03059303|Simeprevir|simeprevir|mesh-list
64403474|NCT03059303|Odalasvir|odalasvir|mesh-list
64403475|NCT03059303|Omeprazole|omeprazole|mesh-list
64403476|NCT03059303|Lansoprazole|lansoprazole|mesh-list
64403477|NCT03059303|Dexlansoprazole|dexlansoprazole|mesh-list
64403478|NCT03059303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64403479|NCT03059303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64403480|NCT03059303|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64403481|NCT03059303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403482|NCT03059303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403486|NCT03059537|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
64403487|NCT03059537|Cathartics|cathartics|mesh-ancestor
64403488|NCT03059537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64403489|NCT04428775|Cromolyn Sodium|cromolyn sodium|mesh-list
64403490|NCT04428775|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
64403491|NCT04428775|Immunologic Factors|immunologic factors|mesh-ancestor
64403492|NCT04428775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403493|NCT04428775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64403494|NCT04428775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64403495|NCT04428775|Respiratory System Agents|respiratory system agents|mesh-ancestor
64403496|NCT04950569|Simendan|simendan|mesh-list
64403497|NCT04950569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64403498|NCT04950569|Vasodilator Agents|vasodilator agents|mesh-ancestor
64403506|NCT04944173|Durvalumab|durvalumab|mesh-list
64403527|NCT04943237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64403528|NCT04943237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64403529|NCT04943237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64403530|NCT04943237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64403531|NCT04943237|Analgesics|analgesics|mesh-ancestor
64403532|NCT04943237|Sensory System Agents|sensory system agents|mesh-ancestor
64390558|NCT03138785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390559|NCT03138785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64390574|NCT03106597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64403533|NCT04943237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403534|NCT04943237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403535|NCT04943237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64403536|NCT04943237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64403537|NCT04285255|Lidocaine|lidocaine|mesh-list
64403599|NCT04942301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403600|NCT04941911|Octreotide|octreotide|mesh-list
64403601|NCT04941911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64403602|NCT04941911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64403603|NCT04941911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390704|NCT03193853|Antimitotic Agents|antimitotic agents|mesh-ancestor
64390745|NCT01828697|Enoxaparin|enoxaparin|mesh-list
64403604|NCT04434001|Thrombin|thrombin|mesh-list
64403605|NCT04434001|Hemostatics|hemostatics|mesh-ancestor
64403606|NCT04434001|Coagulants|coagulants|mesh-ancestor
64403607|NCT03540901|Acetazolamide|acetazolamide|mesh-list
64403608|NCT03540901|Anticonvulsants|anticonvulsants|mesh-ancestor
64403676|NCT04938713|Esketamine|esketamine|mesh-list
64403677|NCT04938713|Analgesics|analgesics|mesh-ancestor
64403678|NCT04938713|Sensory System Agents|sensory system agents|mesh-ancestor
64403679|NCT04938713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403681|NCT04938713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64403682|NCT04938713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64403683|NCT04938713|Anesthetics, General|anesthetics, general|mesh-ancestor
64403684|NCT04938713|Anesthetics|anesthetics|mesh-ancestor
64403685|NCT04938713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64403686|NCT04938713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64403687|NCT04938713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64403688|NCT04938713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64403689|NCT04938713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403690|NCT04938713|Antidepressive Agents|antidepressive agents|mesh-ancestor
64403691|NCT04938713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64403692|NCT04938011|Progesterone|progesterone|mesh-list
64403693|NCT04938011|Progestins|progestins|mesh-ancestor
64403694|NCT04938011|Hormones|hormones|mesh-ancestor
64403695|NCT04938011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64403696|NCT04938011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403697|NCT03057509|Octreotide|octreotide|mesh-list
64403698|NCT03057509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64403699|NCT03057509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64403700|NCT03057509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403701|NCT04946825|Nicotine|nicotine|mesh-list
64403702|NCT04946825|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64403703|NCT04946825|Autonomic Agents|autonomic agents|mesh-ancestor
64403730|NCT04956419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64403731|NCT04956419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64403732|NCT04946669|Abatacept|abatacept|mesh-list
64403733|NCT04946669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64390897|NCT05088239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64390898|NCT02419261|Analgesics|analgesics|mesh-list
64390899|NCT02419261|Ropivacaine|ropivacaine|mesh-list
64403734|NCT04946669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403735|NCT04946669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403736|NCT04946669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64403737|NCT04946669|Immunologic Factors|immunologic factors|mesh-ancestor
64403738|NCT04946669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403739|NCT04946669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64403740|NCT03219775|Nivolumab|nivolumab|mesh-list
64403741|NCT03219775|Ipilimumab|ipilimumab|mesh-list
64391014|NCT05088707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64391052|NCT04850651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391053|NCT04850651|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64403742|NCT03219775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64403743|NCT03219775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403744|NCT03219775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64403745|NCT03219775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403746|NCT03100045|Artesunate|artesunate|mesh-list
64403747|NCT03100045|Artemisinins|artemisinins|mesh-list
64403748|NCT03100045|Artemisinin|artemisinin|mesh-list
64403749|NCT03100045|Antimalarials|antimalarials|mesh-ancestor
64403750|NCT03100045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64403751|NCT03100045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64403791|NCT04936295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64391364|NCT02423239|HU 211|hu 211|mesh-list
64403792|NCT04936295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64403793|NCT04936295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64403794|NCT04936295|Hormone Antagonists|hormone antagonists|mesh-ancestor
64403832|NCT04418999|Hormones|hormones|mesh-ancestor
64403833|NCT04418999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64403834|NCT04418999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64403835|NCT04418999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403836|NCT04418999|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64403837|NCT04526197|Celecoxib|celecoxib|mesh-list
64391366|NCT02423239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64391367|NCT02423239|Tubulin Modulators|tubulin modulators|mesh-ancestor
64391368|NCT02423239|Antimitotic Agents|antimitotic agents|mesh-ancestor
64391369|NCT02423239|Mitosis Modulators|mitosis modulators|mesh-ancestor
64391370|NCT02423239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391371|NCT02423239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64391373|NCT02423239|Antiviral Agents|antiviral agents|mesh-ancestor
64403838|NCT04526197|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
64403839|NCT04526197|Choline|choline|mesh-list
64403848|NCT04526197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64403849|NCT04526197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64403850|NCT04526197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403851|NCT04526197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403852|NCT04526197|Lipotropic Agents|lipotropic agents|mesh-ancestor
64403853|NCT04526197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64403854|NCT04526197|Antimetabolites|antimetabolites|mesh-ancestor
64403867|NCT05060965|Nicotine|nicotine|mesh-list
64403890|NCT04376281|Norepinephrine|norepinephrine|mesh-list
64403891|NCT04376281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64403892|NCT04376281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64403895|NCT04376281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403896|NCT04376281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403898|NCT04376281|Autonomic Agents|autonomic agents|mesh-ancestor
64403899|NCT04376281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403900|NCT04376281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64403901|NCT04332445|Hyaluronic Acid|hyaluronic acid|mesh-list
64403902|NCT04332445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64403903|NCT04332445|Immunologic Factors|immunologic factors|mesh-ancestor
64403904|NCT04332445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403905|NCT04332445|Viscosupplements|viscosupplements|mesh-ancestor
64403906|NCT04332445|Protective Agents|protective agents|mesh-ancestor
64403911|NCT04299373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403912|NCT03890887|Itraconazole|itraconazole|mesh-list
64403913|NCT03890887|Antifungal Agents|antifungal agents|mesh-ancestor
64403914|NCT03890887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64403915|NCT03890887|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64403916|NCT03890887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64403917|NCT03890887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403918|NCT03890887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403919|NCT03890887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64403920|NCT03890887|Hormone Antagonists|hormone antagonists|mesh-ancestor
64403921|NCT03890887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64403922|NCT03890887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403923|NCT03890887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64391485|NCT02412475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64391486|NCT02412475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403925|NCT04516993|Plasminogen|plasminogen|mesh-list
64403926|NCT04516993|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64403927|NCT04516993|Tenecteplase|tenecteplase|mesh-list
64403933|NCT04516993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403935|NCT04516993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64403936|NCT04516993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64403937|NCT04516993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64403938|NCT04516993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403939|NCT04516993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64403940|NCT04516993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64403941|NCT04516993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403942|NCT04516993|Antipyretics|antipyretics|mesh-ancestor
64403943|NCT04431245|Entecavir|entecavir|mesh-list
64403944|NCT04431245|Antiviral Agents|antiviral agents|mesh-ancestor
64403945|NCT04431245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64403946|NCT05015335|Adalimumab|adalimumab|mesh-list
64403947|NCT05015335|Methotrexate|methotrexate|mesh-list
64403948|NCT05015335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64403955|NCT05015335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403956|NCT05015335|Dermatologic Agents|dermatologic agents|mesh-ancestor
64403995|NCT04516057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64403996|NCT04516057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64403997|NCT04516057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64403998|NCT04516057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64403999|NCT04516057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64404000|NCT02195947|Hormones|hormones|mesh-list
64404001|NCT02195947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64404002|NCT02195947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404003|NCT01698307|Adalimumab|adalimumab|mesh-list
64404004|NCT01698307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64404005|NCT01698307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64404006|NCT04954339|Bevacizumab|bevacizumab|mesh-list
64404007|NCT04954339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64404008|NCT04954339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404009|NCT04954339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64404010|NCT04954339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64404012|NCT04954339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404013|NCT04954339|Growth Inhibitors|growth inhibitors|mesh-ancestor
64404021|NCT01966263|Epinephrine|epinephrine|mesh-list
64404022|NCT01966263|Racepinephrine|racepinephrine|mesh-list
64404023|NCT01966263|Ropivacaine|ropivacaine|mesh-list
64404062|NCT04423107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64404063|NCT04423107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64404064|NCT04423107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404065|NCT04423107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404066|NCT04423107|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64404067|NCT04423107|Narcotics|narcotics|mesh-ancestor
64404068|NCT04423107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64404069|NCT01675531|Oxycodone|oxycodone|mesh-list
64392075|NCT05095025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404070|NCT01675531|Naloxone|naloxone|mesh-list
64404071|NCT01675531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64404072|NCT01675531|Narcotics|narcotics|mesh-ancestor
64404073|NCT01675531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64404074|NCT01675531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404075|NCT01675531|Analgesics|analgesics|mesh-ancestor
64392520|NCT03115489|Analgesics|analgesics|mesh-ancestor
64404076|NCT01675531|Sensory System Agents|sensory system agents|mesh-ancestor
64404077|NCT01675531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404078|NCT01675531|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64404079|NCT05406999|Prednisolone|prednisolone|mesh-list
64404080|NCT05406999|Abiraterone Acetate|abiraterone acetate|mesh-list
64404081|NCT05406999|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64404082|NCT05406999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64404083|NCT05406999|Glucocorticoids|glucocorticoids|mesh-ancestor
64392692|NCT03173365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64392693|NCT03173365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64404084|NCT05406999|Hormones|hormones|mesh-ancestor
64404085|NCT05406999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64404086|NCT05406999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404087|NCT05406999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64404088|NCT05406999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404089|NCT05406999|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64404090|NCT05406999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404093|NCT05406999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64404094|NCT04930211|Dexamethasone|dexamethasone|mesh-list
64404095|NCT04930211|Lidocaine|lidocaine|mesh-list
64404103|NCT04930211|Hormones|hormones|mesh-ancestor
64404110|NCT04930211|Sensory System Agents|sensory system agents|mesh-ancestor
64404111|NCT04930211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64404112|NCT04930211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64404113|NCT04930211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64404114|NCT04930211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64404117|NCT04912271|Aprepitant|aprepitant|mesh-list
64404118|NCT04912271|Fosaprepitant|fosaprepitant|mesh-list
64392946|NCT02404363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404119|NCT04912271|Palonosetron|palonosetron|mesh-list
64404120|NCT04912271|Granisetron|granisetron|mesh-list
64404121|NCT04912271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64404122|NCT04912271|Antiemetics|antiemetics|mesh-ancestor
64404123|NCT04912271|Autonomic Agents|autonomic agents|mesh-ancestor
64404124|NCT04912271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404125|NCT04912271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404126|NCT04912271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64404127|NCT04912271|Glucocorticoids|glucocorticoids|mesh-ancestor
64404128|NCT04912271|Hormones|hormones|mesh-ancestor
64393195|NCT03170323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393224|NCT05108597|Misoprostol|misoprostol|mesh-list
64404129|NCT04912271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64404130|NCT04912271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64404137|NCT04912271|Serotonin Agents|serotonin agents|mesh-ancestor
64404161|NCT02680561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64404162|NCT02680561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64404163|NCT02680561|Autonomic Agents|autonomic agents|mesh-ancestor
64404164|NCT02680561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404165|NCT02680561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404168|NCT02680561|Dermatologic Agents|dermatologic agents|mesh-ancestor
64404169|NCT02680561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64404182|NCT05025163|Cariostatic Agents|cariostatic agents|mesh-ancestor
64404183|NCT05025163|Protective Agents|protective agents|mesh-ancestor
64404188|NCT04784299|Lidocaine|lidocaine|mesh-list
64404242|NCT05117125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64404243|NCT05117125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64404244|NCT05117125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404245|NCT05116345|Dexamethasone|dexamethasone|mesh-list
64404246|NCT05116345|Dexamethasone acetate|dexamethasone acetate|mesh-list
64404247|NCT05116345|BB 1101|bb 1101|mesh-list
64404248|NCT05116345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64404249|NCT05116345|Antiemetics|antiemetics|mesh-ancestor
64404250|NCT05116345|Autonomic Agents|autonomic agents|mesh-ancestor
64404251|NCT05116345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404252|NCT05116345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404253|NCT05116345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64404254|NCT05116345|Glucocorticoids|glucocorticoids|mesh-ancestor
64404255|NCT05116345|Hormones|hormones|mesh-ancestor
64404256|NCT05116345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64404257|NCT05116345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64404258|NCT05116345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393857|NCT05021861|Estrogens|estrogens|mesh-ancestor
64404259|NCT05116345|Protease Inhibitors|protease inhibitors|mesh-ancestor
64404260|NCT05116345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404261|NCT05116345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404262|NCT05076097|Rituximab|rituximab|mesh-list
64404263|NCT05076097|Lenalidomide|lenalidomide|mesh-list
64404264|NCT05076097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64404265|NCT05076097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404266|NCT05076097|Immunologic Factors|immunologic factors|mesh-ancestor
64404267|NCT05076097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404268|NCT05076097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64404269|NCT05076097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64404270|NCT05076097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64404272|NCT05076097|Growth Inhibitors|growth inhibitors|mesh-ancestor
64404273|NCT04513639|Dexamethasone|dexamethasone|mesh-list
64404274|NCT04513639|Dexamethasone acetate|dexamethasone acetate|mesh-list
64404275|NCT04513639|Daratumumab|daratumumab|mesh-list
64404276|NCT04513639|BB 1101|bb 1101|mesh-list
64404277|NCT04513639|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64404278|NCT04513639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64404281|NCT04513639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404282|NCT04513639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404283|NCT04513639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64404284|NCT04513639|Glucocorticoids|glucocorticoids|mesh-ancestor
64404285|NCT04513639|Hormones|hormones|mesh-ancestor
64404286|NCT04513639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64404288|NCT04513639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404289|NCT04513639|Protease Inhibitors|protease inhibitors|mesh-ancestor
64404297|NCT05229991|Ritonavir|ritonavir|mesh-list
64404351|NCT03321019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404352|NCT03321019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404354|NCT04990921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64404355|NCT04990921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404356|NCT04507477|Rituximab|rituximab|mesh-list
64404357|NCT04507477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64404358|NCT04507477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404359|NCT04507477|Immunologic Factors|immunologic factors|mesh-ancestor
64404360|NCT04507477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404361|NCT04507477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64404362|NCT01675141|Lenalidomide|lenalidomide|mesh-list
64404363|NCT01675141|Immunologic Factors|immunologic factors|mesh-ancestor
64404364|NCT01675141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404365|NCT01675141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64404366|NCT01675141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64404372|NCT05102149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404373|NCT05102149|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64404375|NCT05102149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404376|NCT05102149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404377|NCT04412395|Lactoferrin|lactoferrin|mesh-list
64404378|NCT04412395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64404379|NCT04987099|Choline|choline|mesh-list
64404380|NCT04987099|Lipotropic Agents|lipotropic agents|mesh-ancestor
64404381|NCT04987099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64394146|NCT02393599|Cocaine|cocaine|mesh-list
64404382|NCT04987099|Antimetabolites|antimetabolites|mesh-ancestor
64404383|NCT04987099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404384|NCT04987099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64404385|NCT04987099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64404386|NCT04987099|Nootropic Agents|nootropic agents|mesh-ancestor
64404387|NCT03906721|Oxycodone|oxycodone|mesh-list
64404400|NCT04529863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404401|NCT04529863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404402|NCT04529863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64394246|NCT03166111|Lidocaine|lidocaine|mesh-list
64404403|NCT04529863|Immunologic Factors|immunologic factors|mesh-ancestor
64404407|NCT04772209|Anticoagulants|anticoagulants|mesh-ancestor
64404408|NCT04772209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64404409|NCT04772209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64404410|NCT04772209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404411|NCT04582591|Cannabidiol|cannabidiol|mesh-list
64404412|NCT04582591|Anticonvulsants|anticonvulsants|mesh-ancestor
64404413|NCT04497883|Maribavir|maribavir|mesh-list
64404414|NCT04497883|Antiviral Agents|antiviral agents|mesh-ancestor
64404415|NCT04497883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64404488|NCT03954613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64404489|NCT03954613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64404490|NCT03367819|Cemiplimab|cemiplimab|mesh-list
64404491|NCT03367819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64404492|NCT03367819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404493|NCT04023253|Solifenacin Succinate|solifenacin succinate|mesh-list
64404494|NCT04023253|Mirabegron|mirabegron|mesh-list
64404506|NCT03066739|Remifentanil|remifentanil|mesh-list
64404507|NCT03066739|Naloxone|naloxone|mesh-list
64404508|NCT03066739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64404523|NCT04781725|Cisplatin|cisplatin|mesh-list
64404524|NCT04781725|Vinblastine|vinblastine|mesh-list
64404525|NCT04781725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404526|NCT04781725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64404527|NCT04781725|Tubulin Modulators|tubulin modulators|mesh-ancestor
64404528|NCT04781725|Antimitotic Agents|antimitotic agents|mesh-ancestor
64404529|NCT04781725|Mitosis Modulators|mitosis modulators|mesh-ancestor
64404530|NCT04781725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404531|NCT03580525|Nicotine|nicotine|mesh-list
64404532|NCT03580525|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64404533|NCT03580525|Autonomic Agents|autonomic agents|mesh-ancestor
64404534|NCT03580525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404535|NCT03580525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404536|NCT03580525|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64404537|NCT03580525|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64404538|NCT03580525|Cholinergic Agents|cholinergic agents|mesh-ancestor
64404539|NCT03580525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64404540|NCT03580525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404541|NCT03554707|Bevacizumab|bevacizumab|mesh-list
64404542|NCT03554707|Irinotecan|irinotecan|mesh-list
64404543|NCT03554707|Temozolomide|temozolomide|mesh-list
64404544|NCT03554707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64404545|NCT03554707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394568|NCT03115099|Liraglutide|liraglutide|mesh-list
64404546|NCT03554707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64404547|NCT03554707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64404548|NCT03554707|Growth Substances|growth substances|mesh-ancestor
64404549|NCT03554707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404550|NCT03554707|Growth Inhibitors|growth inhibitors|mesh-ancestor
64404561|NCT04264663|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64404562|NCT04264663|Renal Agents|renal agents|mesh-ancestor
64404563|NCT04264663|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64404564|NCT04264663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64404565|NCT04264663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64404566|NCT04264663|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64404567|NCT04264663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404568|NCT04264663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404569|NCT04264663|Alkylating Agents|alkylating agents|mesh-ancestor
64404579|NCT04563559|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64404580|NCT04563559|Prednisolone phosphate|prednisolone phosphate|mesh-list
64404581|NCT04563559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64404583|NCT04563559|Hormones|hormones|mesh-ancestor
64404634|NCT03057041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64404635|NCT03057041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64404653|NCT05123053|Amifampridine|amifampridine|mesh-list
64394655|NCT01999972|Axitinib|axitinib|mesh-list
64404654|NCT05123053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64404655|NCT05123053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404656|NCT05123053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404657|NCT05123053|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64404713|NCT04910477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64404714|NCT04910477|Respiratory System Agents|respiratory system agents|mesh-ancestor
64404716|NCT04910477|Parasympatholytics|parasympatholytics|mesh-ancestor
64404717|NCT04910477|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64404718|NCT04910477|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64404719|NCT04910477|Cholinergic Agents|cholinergic agents|mesh-ancestor
64394696|NCT01999894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64394845|NCT01374451|Hormones|hormones|mesh-ancestor
64394846|NCT01374451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64404720|NCT04910477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64404721|NCT04910477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404722|NCT04910477|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64404723|NCT03843151|Itraconazole|itraconazole|mesh-list
64404724|NCT03843151|Antifungal Agents|antifungal agents|mesh-ancestor
64404725|NCT03843151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64404726|NCT03843151|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64404727|NCT03843151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64404728|NCT03843151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394942|NCT05127707|Narcotics|narcotics|mesh-ancestor
64404729|NCT03843151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404730|NCT03843151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64404731|NCT03843151|Hormone Antagonists|hormone antagonists|mesh-ancestor
64404732|NCT03843151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64404733|NCT03843151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404734|NCT03843151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64404785|NCT04928495|Antidotes|antidotes|mesh-ancestor
64404800|NCT01573429|Bisphenol A|bisphenol a|mesh-list
64404801|NCT01573429|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64404802|NCT01573429|Estrogens|estrogens|mesh-ancestor
64404804|NCT01573429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64404805|NCT01573429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404806|NCT01573429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64396324|NCT02381275|Antiviral Agents|antiviral agents|mesh-ancestor
64396325|NCT02381275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64396326|NCT02381275|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64396327|NCT02381275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64396328|NCT02381275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396329|NCT02381275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396330|NCT02381275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64396331|NCT02381275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64396332|NCT04743505|Osimertinib|osimertinib|mesh-list
64396333|NCT04743505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396334|NCT04743505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64396335|NCT04743505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396336|NCT04743505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396337|NCT04693507|Antarelix|antarelix|mesh-list
64396338|NCT04693507|Hormone Antagonists|hormone antagonists|mesh-ancestor
64396339|NCT04693507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64396340|NCT04693507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396341|NCT03105661|Atenolol|atenolol|mesh-list
64396342|NCT03105661|Labetalol|labetalol|mesh-list
64396343|NCT03105661|Nifedipine|nifedipine|mesh-list
64396344|NCT03105661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64396973|NCT02368795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396974|NCT02368795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64396975|NCT02368795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64396976|NCT02368795|Gout Suppressants|gout suppressants|mesh-ancestor
64396977|NCT02368795|Tocolytic Agents|tocolytic agents|mesh-ancestor
64396978|NCT02368795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64396979|NCT02368795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64396980|NCT02368795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396983|NCT02368795|Diuretics|diuretics|mesh-ancestor
64404807|NCT01573429|Antioxidants|antioxidants|mesh-ancestor
64404808|NCT01573429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404809|NCT01573429|Protective Agents|protective agents|mesh-ancestor
64404811|NCT04909931|Ergocalciferols|ergocalciferols|mesh-list
64404812|NCT04909931|Vitamins|vitamins|mesh-ancestor
64404813|NCT04909931|Micronutrients|micronutrients|mesh-ancestor
64404814|NCT04909931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404815|NCT04909931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64334705|NCT02231957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397001|NCT02368717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64397002|NCT02368717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397003|NCT02368717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64397004|NCT02368717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64397005|NCT04231565|Tenofovir|tenofovir|mesh-list
64397006|NCT04231565|Antiviral Agents|antiviral agents|mesh-ancestor
64397007|NCT04231565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64397008|NCT04231565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64397009|NCT04231565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64397010|NCT04231565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397011|NCT04231565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397012|NCT04231565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64397013|NCT04231565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64359071|NCT03568929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334706|NCT02354547|Cyclophosphamide|cyclophosphamide|mesh-list
64334707|NCT02354547|Topotecan|topotecan|mesh-list
64334708|NCT02354547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64334709|NCT02354547|Immunologic Factors|immunologic factors|mesh-ancestor
64334710|NCT02354547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334711|NCT02354547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64334717|NCT02354547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64334718|NCT02354547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64404834|NCT04928651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404835|NCT04928651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64404836|NCT04928651|Sympatholytics|sympatholytics|mesh-ancestor
64404837|NCT04928651|Autonomic Agents|autonomic agents|mesh-ancestor
64404838|NCT04928651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64404839|NCT04928651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64404840|NCT04928651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64404841|NCT04928651|Adrenergic Agents|adrenergic agents|mesh-ancestor
64404842|NCT04928651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64404843|NCT04928651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404844|NCT04101643|Evolocumab|evolocumab|mesh-list
64404845|NCT04101643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64404846|NCT04101643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64404847|NCT04101643|Antimetabolites|antimetabolites|mesh-ancestor
64397014|NCT03100565|Lidocaine|lidocaine|mesh-list
64397015|NCT03100565|Anesthetics, Local|anesthetics, local|mesh-ancestor
64397016|NCT03100565|Anesthetics|anesthetics|mesh-ancestor
64397017|NCT03100565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64397018|NCT03100565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397019|NCT03100565|Sensory System Agents|sensory system agents|mesh-ancestor
64397020|NCT03100565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64397021|NCT03100565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64397022|NCT03100565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64397023|NCT03100565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64397024|NCT03100565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64397025|NCT03100565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397026|NCT05035277|Aspirin|aspirin|mesh-list
64397027|NCT05035277|Rivaroxaban|rivaroxaban|mesh-list
64397028|NCT05035277|Apixaban|apixaban|mesh-list
64397029|NCT05035277|Edoxaban|edoxaban|mesh-list
64397030|NCT05035277|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64397031|NCT05035277|Antithrombins|antithrombins|mesh-ancestor
64397032|NCT05035277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64397033|NCT05035277|Protease Inhibitors|protease inhibitors|mesh-ancestor
64397034|NCT05035277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397035|NCT05035277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397036|NCT05035277|Anticoagulants|anticoagulants|mesh-ancestor
64397037|NCT05035277|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64359073|NCT04503967|Nivolumab|nivolumab|mesh-list
64404848|NCT04101643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404849|NCT04101643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64404850|NCT02620787|Tedizolid|tedizolid|mesh-list
64404851|NCT02620787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64404852|NCT02620787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64404853|NCT04909619|Anesthetics|anesthetics|mesh-list
64404854|NCT04909619|Anesthetics, Local|anesthetics, local|mesh-list
64404856|NCT04909619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404857|NCT04909619|Sensory System Agents|sensory system agents|mesh-ancestor
64404858|NCT04909619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404860|NCT03520231|Denosumab|denosumab|mesh-list
64404861|NCT03520231|Gemcitabine|gemcitabine|mesh-list
64404862|NCT03520231|Carboplatin|carboplatin|mesh-list
64404863|NCT03520231|Calcium|calcium|mesh-list
64404864|NCT03520231|Vitamins|vitamins|mesh-ancestor
64404865|NCT03520231|Micronutrients|micronutrients|mesh-ancestor
64404866|NCT03520231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404867|NCT03520231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64397038|NCT05035277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64397039|NCT05035277|Analgesics|analgesics|mesh-ancestor
64397040|NCT05035277|Sensory System Agents|sensory system agents|mesh-ancestor
64397041|NCT05035277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64397042|NCT05035277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397043|NCT05035277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64397044|NCT05035277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64397045|NCT05035277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64397046|NCT05035277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64397047|NCT05035277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64397048|NCT05035277|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64397049|NCT05035277|Antipyretics|antipyretics|mesh-ancestor
64397050|NCT02374645|Gefitinib|gefitinib|mesh-list
64359106|NCT04773405|Adrenergic Agents|adrenergic agents|mesh-ancestor
64359107|NCT04773405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64404868|NCT03520231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64404869|NCT03520231|Antimetabolites|antimetabolites|mesh-ancestor
64404871|NCT03520231|Antiviral Agents|antiviral agents|mesh-ancestor
64404876|NCT03520231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64404877|NCT03520231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64404878|NCT04927481|Mitoxantrone|mitoxantrone|mesh-list
64404879|NCT04927481|Analgesics|analgesics|mesh-ancestor
64404880|NCT04927481|Sensory System Agents|sensory system agents|mesh-ancestor
64404881|NCT04927481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404889|NCT03056495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404890|NCT03056495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64404891|NCT03056495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404892|NCT03056495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404893|NCT03171805|Propranolol|propranolol|mesh-list
64404894|NCT03171805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64404895|NCT03171805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64404896|NCT03171805|Adrenergic Agents|adrenergic agents|mesh-ancestor
64404897|NCT03171805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64404898|NCT03171805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404899|NCT03171805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404900|NCT03171805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64404901|NCT03171805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64404903|NCT04918433|Anesthetics|anesthetics|mesh-list
64404904|NCT04918433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64404905|NCT04918433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404906|NCT04926467|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64404907|NCT04926467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64404908|NCT03053219|Abivertinib|abivertinib|mesh-list
64404909|NCT03053219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64404910|NCT03053219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397052|NCT02374645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64397054|NCT02374645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397055|NCT02368561|Hyaluronic Acid|hyaluronic acid|mesh-list
64397056|NCT02368561|Hylan|hylan|mesh-list
64397057|NCT02368561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64397058|NCT02368561|Immunologic Factors|immunologic factors|mesh-ancestor
64397059|NCT02368561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397060|NCT02368561|Viscosupplements|viscosupplements|mesh-ancestor
64397061|NCT02368561|Protective Agents|protective agents|mesh-ancestor
64359128|NCT01376245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64404911|NCT03053219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404916|NCT03055793|Autonomic Agents|autonomic agents|mesh-ancestor
64404920|NCT03055793|Respiratory System Agents|respiratory system agents|mesh-ancestor
64404921|NCT03055793|Glucocorticoids|glucocorticoids|mesh-ancestor
64404923|NCT03055793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64404924|NCT03055793|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64404925|NCT03055793|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64404926|NCT03055793|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64397062|NCT04095845|Tacrine|tacrine|mesh-list
64397063|NCT04095845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64397064|NCT04095845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397065|NCT04095845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397066|NCT04095845|Cholinergic Agents|cholinergic agents|mesh-ancestor
64397067|NCT04095845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64397068|NCT04095845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397069|NCT04095845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64397070|NCT04095845|Autonomic Agents|autonomic agents|mesh-ancestor
64397071|NCT04095845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64397072|NCT04095845|Nootropic Agents|nootropic agents|mesh-ancestor
64404927|NCT03055793|Adrenergic Agents|adrenergic agents|mesh-ancestor
64404928|NCT03055793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64404929|NCT03055793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404930|NCT04926155|Metformin|metformin|mesh-list
64404931|NCT04926155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64404932|NCT04926155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404933|NCT05301517|Epoetin Alfa|epoetin alfa|mesh-list
64404934|NCT05301517|Hematinics|hematinics|mesh-ancestor
64404935|NCT04909775|Gemcitabine|gemcitabine|mesh-list
64404936|NCT04909775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404937|NCT04909775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64397077|NCT02374489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397078|NCT02374567|Topiramate|topiramate|mesh-list
64397079|NCT02374567|Diphenhydramine|diphenhydramine|mesh-list
64397080|NCT02374567|Promethazine|promethazine|mesh-list
64397081|NCT02374567|Pregabalin|pregabalin|mesh-list
64404938|NCT04909775|Antimetabolites|antimetabolites|mesh-ancestor
64404940|NCT04909775|Antiviral Agents|antiviral agents|mesh-ancestor
64404941|NCT04909775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64404942|NCT04909775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404943|NCT04909775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64404944|NCT04909775|Immunologic Factors|immunologic factors|mesh-ancestor
64404945|NCT04909775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404946|NCT04925141|Dasatinib|dasatinib|mesh-list
64404970|NCT04909151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64404971|NCT04909151|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64404972|NCT05132413|Bevacizumab|bevacizumab|mesh-list
64404974|NCT05132413|Carboplatin|carboplatin|mesh-list
64404975|NCT05132413|Pemetrexed|pemetrexed|mesh-list
64404976|NCT05132413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64404977|NCT05132413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404978|NCT05132413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64404979|NCT05132413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64404980|NCT05132413|Growth Substances|growth substances|mesh-ancestor
64404981|NCT05132413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404982|NCT05132413|Growth Inhibitors|growth inhibitors|mesh-ancestor
64404983|NCT05132413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404984|NCT05132413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404985|NCT05132413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64404986|NCT05132413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64404987|NCT04435717|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64404988|NCT04075981|Botulinum Toxins|botulinum toxins|mesh-list
64404989|NCT04075981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64404990|NCT04075981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64404991|NCT04075981|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64404992|NCT04075981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64404993|NCT04075981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64404994|NCT04075981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404995|NCT04075981|Cholinergic Agents|cholinergic agents|mesh-ancestor
64404996|NCT04075981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64404997|NCT04075981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404998|NCT04075981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64404999|NCT04075981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64405001|NCT04917497|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64405002|NCT04917497|Vasodilator Agents|vasodilator agents|mesh-ancestor
64405003|NCT04917497|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64405008|NCT04917497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405010|NCT03933007|Colchicine|colchicine|mesh-list
64405011|NCT03933007|Midazolam|midazolam|mesh-list
64397083|NCT02374567|Lacosamide|lacosamide|mesh-list
64397084|NCT02374567|Carbamazepine|carbamazepine|mesh-list
64397085|NCT02374567|Phenytoin|phenytoin|mesh-list
64397086|NCT02374567|Oxcarbazepine|oxcarbazepine|mesh-list
64397087|NCT02374567|Nicergoline|nicergoline|mesh-list
64397088|NCT02374567|Midazolam|midazolam|mesh-list
64397089|NCT02374567|Diazepam|diazepam|mesh-list
64397090|NCT02374567|Triazolam|triazolam|mesh-list
64397091|NCT02374567|Acamprosate|acamprosate|mesh-list
64405012|NCT03933007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64405013|NCT03933007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64405014|NCT03933007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64405015|NCT03933007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405025|NCT03933007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405028|NCT03933007|Tubulin Modulators|tubulin modulators|mesh-ancestor
64405029|NCT03933007|Antimitotic Agents|antimitotic agents|mesh-ancestor
64405030|NCT03933007|Mitosis Modulators|mitosis modulators|mesh-ancestor
64405031|NCT03933007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405032|NCT03933007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64405033|NCT03933007|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64397092|NCT02374567|Gabapentin|gabapentin|mesh-list
64397093|NCT02374567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64397094|NCT02374567|Amitriptyline|amitriptyline|mesh-list
64397095|NCT02374567|Methotrimeprazine|methotrimeprazine|mesh-list
64397096|NCT02374567|Levetiracetam|levetiracetam|mesh-list
64397097|NCT02374567|Valproic Acid|valproic acid|mesh-list
64397098|NCT02374567|Lorazepam|lorazepam|mesh-list
64397099|NCT02374567|Clonazepam|clonazepam|mesh-list
64397100|NCT02374567|Phenobarbital|phenobarbital|mesh-list
64397101|NCT02374567|Clobazam|clobazam|mesh-list
64397102|NCT02374567|Zaleplon|zaleplon|mesh-list
64359251|NCT03353857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64397103|NCT02374567|Nitrazepam|nitrazepam|mesh-list
64397104|NCT02374567|Chlormethiazole|chlormethiazole|mesh-list
64397105|NCT02374567|Memantine|memantine|mesh-list
64397106|NCT02374567|Biperiden|biperiden|mesh-list
64405034|NCT03933007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64405035|NCT03933007|Histamine Antagonists|histamine antagonists|mesh-ancestor
64405036|NCT03933007|Histamine Agents|histamine agents|mesh-ancestor
64405038|NCT04907747|Furazolidone|furazolidone|mesh-list
64405039|NCT04907747|Esomeprazole|esomeprazole|mesh-list
64405041|NCT04907747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64405042|NCT04907747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64405043|NCT04907747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64405044|NCT04907747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64405045|NCT04907747|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64405048|NCT04907747|Antacids|antacids|mesh-ancestor
64405065|NCT03052673|Anesthetics|anesthetics|mesh-ancestor
64405066|NCT03052673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64405067|NCT03052673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64397107|NCT02374567|Haloperidol|haloperidol|mesh-list
64397108|NCT02374567|Pimozide|pimozide|mesh-list
64397109|NCT02374567|Olanzapine|olanzapine|mesh-list
64397111|NCT02374567|Alprazolam|alprazolam|mesh-list
64397112|NCT02374567|Zopiclone|zopiclone|mesh-list
64397113|NCT02374567|S 20098|s 20098|mesh-list
64397114|NCT02374567|Chloral Hydrate|chloral hydrate|mesh-list
64397115|NCT02374567|Doxepin|doxepin|mesh-list
64397116|NCT02374567|Oxazepam|oxazepam|mesh-list
64397117|NCT02374567|Temazepam|temazepam|mesh-list
64397118|NCT02374567|Brotizolam|brotizolam|mesh-list
64397119|NCT02374567|Lormetazepam|lormetazepam|mesh-list
64359263|NCT04499859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405068|NCT03052673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64405070|NCT03052673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405072|NCT03052673|Narcotics|narcotics|mesh-ancestor
64405073|NCT03052673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64405074|NCT04907123|Diuretics|diuretics|mesh-list
64405075|NCT04907123|Natriuretic Agents|natriuretic agents|mesh-ancestor
64405076|NCT04907123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405077|NCT05030857|Midazolam|midazolam|mesh-list
64397120|NCT02374567|Flurazepam|flurazepam|mesh-list
64397121|NCT02374567|Mirtazapine|mirtazapine|mesh-list
64397122|NCT02374567|Buspirone|buspirone|mesh-list
64397123|NCT02374567|Fluvoxamine|fluvoxamine|mesh-list
64397124|NCT02374567|Trazodone|trazodone|mesh-list
64397125|NCT02374567|Tranylcypromine|tranylcypromine|mesh-list
64397126|NCT02374567|Bromazepam|bromazepam|mesh-list
64397127|NCT02374567|Risperidone|risperidone|mesh-list
64397128|NCT02374567|Melatonin|melatonin|mesh-list
64397129|NCT02374567|Aripiprazole|aripiprazole|mesh-list
64397130|NCT02374567|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64397131|NCT02374567|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64397132|NCT02374567|Ziprasidone|ziprasidone|mesh-list
64397133|NCT02374567|Clozapine|clozapine|mesh-list
64397134|NCT02374567|Amisulpride|amisulpride|mesh-list
64397135|NCT02374567|Flupenthixol|flupenthixol|mesh-list
64397136|NCT02374567|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
64405078|NCT05030857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64405079|NCT05030857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64405080|NCT05030857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64405082|NCT05030857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64405083|NCT05030857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64405084|NCT05030857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64405091|NCT05030857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405092|NCT03319459|Trastuzumab|trastuzumab|mesh-list
64405093|NCT03319459|Cetuximab|cetuximab|mesh-list
64405094|NCT03319459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64397137|NCT02374567|Perphenazine|perphenazine|mesh-list
64397138|NCT02374567|Sertindole|sertindole|mesh-list
64397139|NCT02374567|Fluphenazine|fluphenazine|mesh-list
64397140|NCT02374567|Fluphenazine depot|fluphenazine depot|mesh-list
64397141|NCT02374567|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
64397142|NCT02374567|Sulpiride|sulpiride|mesh-list
64397143|NCT02374567|Thioridazine|thioridazine|mesh-list
64397145|NCT02374567|Clopenthixol|clopenthixol|mesh-list
64397146|NCT02374567|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
64397147|NCT02374567|Chlorprothixene|chlorprothixene|mesh-list
64397148|NCT02374567|Fluspirilene|fluspirilene|mesh-list
64397149|NCT02374567|Benperidol|benperidol|mesh-list
64397150|NCT02374567|Bromperidol|bromperidol|mesh-list
64397151|NCT02374567|Perazine|perazine|mesh-list
64397152|NCT02374567|Rivastigmine|rivastigmine|mesh-list
64397153|NCT02374567|Piracetam|piracetam|mesh-list
64397154|NCT02374567|Donepezil|donepezil|mesh-list
64397155|NCT02374567|Galantamine|galantamine|mesh-list
64397156|NCT02374567|Citalopram|citalopram|mesh-list
64397157|NCT02374567|Bupropion|bupropion|mesh-list
64405095|NCT03319459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405097|NCT04916951|Cephalexin|cephalexin|mesh-list
64405098|NCT04916951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64405099|NCT04916951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64405100|NCT04430933|Paclitaxel|paclitaxel|mesh-list
64405101|NCT04430933|Docetaxel|docetaxel|mesh-list
64405102|NCT04430933|Carboplatin|carboplatin|mesh-list
64405103|NCT04430933|Pemetrexed|pemetrexed|mesh-list
64405112|NCT04430933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64405113|NCT04906655|Glycopyrrolate|glycopyrrolate|mesh-list
64405114|NCT04906655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64397158|NCT02374567|Sertraline|sertraline|mesh-list
64397159|NCT02374567|Fluoxetine|fluoxetine|mesh-list
64397160|NCT02374567|Paroxetine|paroxetine|mesh-list
64397161|NCT02374567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64397162|NCT02374567|Nortriptyline|nortriptyline|mesh-list
64397163|NCT02374567|Reboxetine|reboxetine|mesh-list
64397164|NCT02374567|Imipramine|imipramine|mesh-list
64397165|NCT02374567|Clomipramine|clomipramine|mesh-list
64397166|NCT02374567|Moclobemide|moclobemide|mesh-list
64397167|NCT02374567|Mianserin|mianserin|mesh-list
64397168|NCT02374567|Opipramol|opipramol|mesh-list
64405115|NCT04906655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64405116|NCT04906655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64405117|NCT04906655|Cholinergic Agents|cholinergic agents|mesh-ancestor
64405118|NCT04906655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64405120|NCT04906655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405121|NCT03055091|Sorbitol|sorbitol|mesh-list
64405122|NCT03055091|Cathartics|cathartics|mesh-ancestor
64405123|NCT03055091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64405124|NCT02648581|Ustekinumab|ustekinumab|mesh-list
64405125|NCT02648581|Dermatologic Agents|dermatologic agents|mesh-ancestor
64405126|NCT02609815|Metformin|metformin|mesh-list
64405127|NCT02609815|Glimepiride|glimepiride|mesh-list
64405129|NCT02609815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405130|NCT02609815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64405131|NCT02609815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64397170|NCT02374567|Trimipramine|trimipramine|mesh-list
64397171|NCT02374567|Hydroxyzine|hydroxyzine|mesh-list
64397172|NCT02374567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64397173|NCT02374567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64397174|NCT02374567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64397175|NCT02374567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397176|NCT02374567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64397177|NCT02374567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64397178|NCT02374567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64359335|NCT02045901|Histamine Antagonists|histamine antagonists|mesh-ancestor
64405132|NCT02609815|Immunologic Factors|immunologic factors|mesh-ancestor
64405133|NCT05132023|Metformin|metformin|mesh-list
64405134|NCT05132023|Empagliflozin|empagliflozin|mesh-list
64405135|NCT05132023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64405136|NCT05132023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405137|NCT05132023|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64405138|NCT05132023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405163|NCT05125549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64405164|NCT05125549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405165|NCT05125549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405167|NCT04398719|Antipruritics|antipruritics|mesh-ancestor
64405168|NCT04398719|Dermatologic Agents|dermatologic agents|mesh-ancestor
64397179|NCT02374567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64397180|NCT02374567|Anesthetics, General|anesthetics, general|mesh-ancestor
64397181|NCT02374567|Anesthetics|anesthetics|mesh-ancestor
64397182|NCT02374567|GABA Modulators|gaba modulators|mesh-ancestor
64397183|NCT02374567|GABA Agents|gaba agents|mesh-ancestor
64397184|NCT02374567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64397185|NCT02374567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397186|NCT02374567|Analgesics|analgesics|mesh-ancestor
64397187|NCT02374567|Sensory System Agents|sensory system agents|mesh-ancestor
64397188|NCT02374567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64397189|NCT02374567|Anticonvulsants|anticonvulsants|mesh-ancestor
64397190|NCT02374567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64397191|NCT02374567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64397192|NCT02374567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64397193|NCT02374567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64397194|NCT02374567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64397195|NCT02374567|Antimanic Agents|antimanic agents|mesh-ancestor
64405169|NCT04398719|Sensory System Agents|sensory system agents|mesh-ancestor
64405170|NCT04398719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64405171|NCT04398719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405172|NCT04903847|Tenofovir|tenofovir|mesh-list
64405173|NCT04903847|Lamivudine|lamivudine|mesh-list
64405174|NCT04903847|Dolutegravir|dolutegravir|mesh-list
64405177|NCT04903847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64405178|NCT04903847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64405179|NCT04903847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405180|NCT04903847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405183|NCT04903847|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64405184|NCT04903847|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64405185|NCT04905953|Neostigmine|neostigmine|mesh-list
64405186|NCT04905953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64405187|NCT04905953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405188|NCT04905953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405189|NCT04905953|Cholinergic Agents|cholinergic agents|mesh-ancestor
64405190|NCT04905953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64405210|NCT05130619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64397196|NCT02374567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64397197|NCT02374567|Serotonin Agents|serotonin agents|mesh-ancestor
64397198|NCT02374567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64397199|NCT02374567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64397200|NCT02374567|Dopamine Agents|dopamine agents|mesh-ancestor
64397201|NCT02374567|Antioxidants|antioxidants|mesh-ancestor
64397202|NCT02374567|Protective Agents|protective agents|mesh-ancestor
64397203|NCT02374567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64397204|NCT02374567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64397205|NCT02374567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64397206|NCT02374567|Antidepressive Agents|antidepressive agents|mesh-ancestor
64397207|NCT02374567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64405211|NCT05130619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405213|NCT03512119|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64405214|NCT03512119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64405215|NCT03512119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405217|NCT02642809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64405218|NCT02642809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405219|NCT03052361|Ondansetron|ondansetron|mesh-list
64405220|NCT03052361|Antiemetics|antiemetics|mesh-ancestor
64405222|NCT03052361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64405223|NCT03052361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405233|NCT03052361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64405234|NCT03052361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64405235|NCT03052361|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64405236|NCT02370589|Vaccines|vaccines|mesh-list
64405237|NCT02370589|Immunologic Factors|immunologic factors|mesh-ancestor
64405238|NCT02370589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405239|NCT01752049|Timolol|timolol|mesh-list
64405240|NCT01752049|Maleic acid|maleic acid|mesh-list
64405241|NCT01752049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405242|NCT01752049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397208|NCT02374567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64397209|NCT02374567|Parasympatholytics|parasympatholytics|mesh-ancestor
64397210|NCT02374567|Autonomic Agents|autonomic agents|mesh-ancestor
64397211|NCT02374567|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64397212|NCT02374567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64397213|NCT02374567|Cholinergic Agents|cholinergic agents|mesh-ancestor
64397215|NCT02374567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64397216|NCT02374567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64397217|NCT02374567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64359393|NCT04468425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64405243|NCT01752049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64405244|NCT01752049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64405245|NCT01752049|Adrenergic Agents|adrenergic agents|mesh-ancestor
64405246|NCT01752049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64405247|NCT01752049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405248|NCT01752049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64405249|NCT01752049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64405264|NCT05109949|Dapagliflozin|dapagliflozin|mesh-list
64405265|NCT05109949|Empagliflozin|empagliflozin|mesh-list
64405266|NCT05109949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64405267|NCT05109949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405268|NCT05109949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64405269|NCT05109949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405271|NCT04901663|Clarithromycin|clarithromycin|mesh-list
64405272|NCT04901663|Omeprazole|omeprazole|mesh-list
64405274|NCT04901663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64405275|NCT04901663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64405277|NCT04901663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64405278|NCT04901663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405279|NCT04901663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405280|NCT04901663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64397218|NCT02374567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64397219|NCT02374567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397220|NCT02374567|Dopamine Agonists|dopamine agonists|mesh-ancestor
64397221|NCT02374567|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64397222|NCT02374567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64397223|NCT02374567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64397224|NCT02374567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64405281|NCT04901663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64405282|NCT04901663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64405284|NCT05134519|Antibodies|antibodies|mesh-list
64405285|NCT05134519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64405286|NCT05134519|Immunologic Factors|immunologic factors|mesh-ancestor
64405287|NCT05134519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405288|NCT05134519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64405289|NCT05134519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405290|NCT04394663|Omeprazole|omeprazole|mesh-list
64405298|NCT05133193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64405299|NCT05133193|Antitubercular Agents|antitubercular agents|mesh-ancestor
64405301|NCT04901117|Metronidazole|metronidazole|mesh-list
64405302|NCT04901117|Clarithromycin|clarithromycin|mesh-list
64405317|NCT04901117|Diuretics|diuretics|mesh-ancestor
64405318|NCT04901117|Natriuretic Agents|natriuretic agents|mesh-ancestor
64405319|NCT04901117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405320|NCT04901117|Expectorants|expectorants|mesh-ancestor
64359534|NCT05185167|Propofol|propofol|mesh-list
64359535|NCT05185167|Anesthetics|anesthetics|mesh-list
64405321|NCT04901117|Respiratory System Agents|respiratory system agents|mesh-ancestor
64405322|NCT05121571|Sorafenib|sorafenib|mesh-list
64405323|NCT05121571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405324|NCT05121571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64405325|NCT05121571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405326|NCT05121571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405327|NCT03051269|Calcium, Dietary|calcium, dietary|mesh-list
64405328|NCT03051269|Calcium|calcium|mesh-list
64405329|NCT03051269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64405330|NCT03051269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405332|NCT04576663|Phenylephrine|phenylephrine|mesh-list
64405383|NCT03909217|Citalopram|citalopram|mesh-list
64397225|NCT02374567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64397226|NCT02374567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64397227|NCT02374567|Nootropic Agents|nootropic agents|mesh-ancestor
64397228|NCT02374567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64397229|NCT02374567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64397230|NCT02374567|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64397231|NCT02374567|Anesthetics, Local|anesthetics, local|mesh-ancestor
64397232|NCT02374567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64397233|NCT02374567|Histamine Antagonists|histamine antagonists|mesh-ancestor
64397234|NCT02374567|Histamine Agents|histamine agents|mesh-ancestor
64397235|NCT02374567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64397236|NCT02374567|Antipruritics|antipruritics|mesh-ancestor
64397237|NCT02374567|Dermatologic Agents|dermatologic agents|mesh-ancestor
64397238|NCT02374567|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64397239|NCT02374567|GABA Agonists|gaba agonists|mesh-ancestor
64397240|NCT02374567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64397241|NCT02374567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64397242|NCT02374567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64397243|NCT02374567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64397244|NCT02374567|Adrenergic Agents|adrenergic agents|mesh-ancestor
64397245|NCT02374567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64397246|NCT02374567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64397247|NCT02374567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64397248|NCT02374567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64397249|NCT02374567|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64397250|NCT02374567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64397251|NCT02374567|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64397254|NCT02374567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64405384|NCT03909217|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64405385|NCT03909217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64405386|NCT03909217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64405387|NCT03909217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405388|NCT03909217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64405389|NCT03909217|Serotonin Agents|serotonin agents|mesh-ancestor
64405390|NCT03909217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405391|NCT03909217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64405392|NCT03909217|Antidepressive Agents|antidepressive agents|mesh-ancestor
64405393|NCT03909217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64405394|NCT03909217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64405395|NCT03909217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64405396|NCT03909217|Parasympatholytics|parasympatholytics|mesh-ancestor
64405397|NCT03909217|Autonomic Agents|autonomic agents|mesh-ancestor
64405398|NCT03909217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64405399|NCT03909217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64405400|NCT03909217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64405401|NCT03909217|Cholinergic Agents|cholinergic agents|mesh-ancestor
64405402|NCT02650921|Lidocaine|lidocaine|mesh-list
64405403|NCT02650921|Anesthetics, Local|anesthetics, local|mesh-ancestor
64405404|NCT02650921|Anesthetics|anesthetics|mesh-ancestor
64405405|NCT02650921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64405406|NCT02650921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294469|NCT02817841|Diuretics|diuretics|mesh-ancestor
64397257|NCT02374567|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64397258|NCT02374567|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64397259|NCT02374567|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64397260|NCT02374567|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64397261|NCT02374567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64397262|NCT02374567|Vasodilator Agents|vasodilator agents|mesh-ancestor
64397263|NCT03965741|Rivaroxaban|rivaroxaban|mesh-list
64397264|NCT03965741|Apixaban|apixaban|mesh-list
64397265|NCT03965741|Dabigatran|dabigatran|mesh-list
64397266|NCT03965741|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64397267|NCT03965741|Antithrombins|antithrombins|mesh-ancestor
64397268|NCT03965741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64405407|NCT02650921|Sensory System Agents|sensory system agents|mesh-ancestor
64405408|NCT02650921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64405409|NCT02650921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64405410|NCT02650921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64405411|NCT02650921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64405412|NCT02650921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64405413|NCT02650921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405423|NCT04913987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64405424|NCT04913987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64405434|NCT04891679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64405435|NCT04891679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405436|NCT04891679|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64405437|NCT04891679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64405438|NCT04891679|Oxytocics|oxytocics|mesh-ancestor
64405439|NCT04913831|Cerebrolysin|cerebrolysin|mesh-list
64397269|NCT03965741|Protease Inhibitors|protease inhibitors|mesh-ancestor
64397270|NCT03965741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397271|NCT03965741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397272|NCT03965741|Anticoagulants|anticoagulants|mesh-ancestor
64397273|NCT02368171|Nitric Oxide|nitric oxide|mesh-list
64397274|NCT02368171|Carbon Monoxide|carbon monoxide|mesh-list
64397275|NCT02368171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64397276|NCT02368171|Autonomic Agents|autonomic agents|mesh-ancestor
64397277|NCT02368171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64397278|NCT02368171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397279|NCT02368171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64397280|NCT02368171|Respiratory System Agents|respiratory system agents|mesh-ancestor
64397281|NCT02368171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64397282|NCT02368171|Antioxidants|antioxidants|mesh-ancestor
64359588|NCT05305131|Bevacizumab|bevacizumab|mesh-list
64359589|NCT05305131|Pembrolizumab|pembrolizumab|mesh-list
64405440|NCT04913831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64405441|NCT04913831|Protective Agents|protective agents|mesh-ancestor
64405442|NCT04913831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405443|NCT04913831|Nootropic Agents|nootropic agents|mesh-ancestor
64405444|NCT04900415|Vitamin A|vitamin a|mesh-list
64405445|NCT04900415|Vitamins|vitamins|mesh-ancestor
64405446|NCT04900415|Micronutrients|micronutrients|mesh-ancestor
64405447|NCT04900415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405448|NCT04900571|Nitrofurantoin|nitrofurantoin|mesh-list
64405449|NCT04900571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64405450|NCT04900571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64405451|NCT04900571|Renal Agents|renal agents|mesh-ancestor
64405453|NCT04891211|Vitamin D|vitamin d|mesh-list
64405486|NCT04817189|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64405488|NCT03050957|Antipruritics|antipruritics|mesh-ancestor
64405489|NCT03050957|Dermatologic Agents|dermatologic agents|mesh-ancestor
64405490|NCT04885049|Racecadotril|racecadotril|mesh-list
64405491|NCT04885049|Antidiarrheals|antidiarrheals|mesh-ancestor
64397283|NCT02368171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397284|NCT02368171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64397285|NCT02368171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64397286|NCT02368171|Vasodilator Agents|vasodilator agents|mesh-ancestor
64397287|NCT02368171|Gasotransmitters|gasotransmitters|mesh-ancestor
64397288|NCT02368171|Protective Agents|protective agents|mesh-ancestor
64397289|NCT02368171|Antimetabolites|antimetabolites|mesh-ancestor
64397290|NCT05063513|Mycophenolic Acid|mycophenolic acid|mesh-list
64397292|NCT05063513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64397293|NCT05063513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64397294|NCT05063513|Immunologic Factors|immunologic factors|mesh-ancestor
64397295|NCT05063513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397296|NCT05063513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64405492|NCT04885049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64405493|NCT04885049|Protease Inhibitors|protease inhibitors|mesh-ancestor
64405494|NCT04885049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405495|NCT04885049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405496|NCT04392011|Midazolam|midazolam|mesh-list
64405506|NCT04392011|Anesthetics, General|anesthetics, general|mesh-ancestor
64405507|NCT04392011|Anesthetics|anesthetics|mesh-ancestor
64405508|NCT04392011|GABA Modulators|gaba modulators|mesh-ancestor
64405509|NCT04392011|GABA Agents|gaba agents|mesh-ancestor
64405510|NCT04392011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64405511|NCT04392011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405512|NCT04392011|Antitussive Agents|antitussive agents|mesh-ancestor
64405513|NCT04392011|Respiratory System Agents|respiratory system agents|mesh-ancestor
64397297|NCT05063513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64397298|NCT05063513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64397300|NCT05063513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64397301|NCT05063513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64397302|NCT05063513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397303|NCT05063513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397304|NCT02364583|Primaquine|primaquine|mesh-list
64397305|NCT02364583|Antimalarials|antimalarials|mesh-ancestor
64397306|NCT02364583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64397307|NCT02364583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64397308|NCT02364583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64397309|NCT02368015|Cefazolin|cefazolin|mesh-list
64397310|NCT02368015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64359629|NCT03346837|Itraconazole|itraconazole|mesh-list
64405514|NCT04392011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64405515|NCT04392011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64405516|NCT04890353|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64405517|NCT04890353|Dermatologic Agents|dermatologic agents|mesh-ancestor
64405518|NCT04890353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64405519|NCT04890353|Immunologic Factors|immunologic factors|mesh-ancestor
64405520|NCT04890353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405521|NCT04430621|Hormones|hormones|mesh-list
64405522|NCT04430621|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64405523|NCT04430621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64397311|NCT02368015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64397312|NCT02373943|Carotenoids|carotenoids|mesh-list
64397313|NCT02373943|Antioxidants|antioxidants|mesh-ancestor
64397314|NCT02373943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397315|NCT02373943|Protective Agents|protective agents|mesh-ancestor
64397316|NCT02373943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397318|NCT04632433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64397319|NCT04632433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64397320|NCT02368249|Terlipressin|terlipressin|mesh-list
64397321|NCT02368249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64397322|NCT02368249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64397323|NCT02367937|Flurbiprofen|flurbiprofen|mesh-list
64397324|NCT02367937|Midazolam|midazolam|mesh-list
64397325|NCT02367937|Omeprazole|omeprazole|mesh-list
64397326|NCT02367937|Simvastatin|simvastatin|mesh-list
64397327|NCT02367937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64397328|NCT02367937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64397329|NCT02367937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64397330|NCT02367937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405524|NCT04430621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405525|NCT04884503|Clonazepam|clonazepam|mesh-list
64405526|NCT04884503|Anticonvulsants|anticonvulsants|mesh-ancestor
64405527|NCT04884503|GABA Modulators|gaba modulators|mesh-ancestor
64405536|NCT04889651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405538|NCT04889651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64405539|NCT04889651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405540|NCT04889651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64405541|NCT04898699|Tenofovir|tenofovir|mesh-list
64405542|NCT04898699|Emtricitabine|emtricitabine|mesh-list
64397331|NCT02367937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64397332|NCT02367937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64397333|NCT02367937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64397334|NCT02367937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64397335|NCT02367937|Anesthetics, General|anesthetics, general|mesh-ancestor
64397336|NCT02367937|Anesthetics|anesthetics|mesh-ancestor
64397337|NCT02367937|GABA Modulators|gaba modulators|mesh-ancestor
64397338|NCT02367937|GABA Agents|gaba agents|mesh-ancestor
64397339|NCT02367937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64397340|NCT02367937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405543|NCT04898699|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64405544|NCT04898699|Antiviral Agents|antiviral agents|mesh-ancestor
64405545|NCT04898699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64405546|NCT04898699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64405547|NCT04898699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64405548|NCT04898699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405549|NCT04898699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405550|NCT04898699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64405551|NCT04898699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64405552|NCT04888715|Pirfenidone|pirfenidone|mesh-list
64405553|NCT04888715|Nintedanib|nintedanib|mesh-list
64405554|NCT04888715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294480|NCT05132270|Immunologic Factors|immunologic factors|mesh-ancestor
64397341|NCT02367937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64397343|NCT02367937|Antimetabolites|antimetabolites|mesh-ancestor
64397344|NCT02367937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64397345|NCT02367937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64405555|NCT04888715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64405556|NCT04888715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405557|NCT04888715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405559|NCT04888715|Sensory System Agents|sensory system agents|mesh-ancestor
64405570|NCT04898387|Adrenergic Agents|adrenergic agents|mesh-ancestor
64405571|NCT04898387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64405572|NCT04898387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405573|NCT04898387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405585|NCT03050177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405586|NCT03050177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64405587|NCT03050177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405588|NCT03050177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405589|NCT03051581|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64405590|NCT03051581|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64405591|NCT03051581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397346|NCT02367937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397347|NCT02367937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64397348|NCT02367937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64397349|NCT02367937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64397350|NCT02367937|Analgesics|analgesics|mesh-ancestor
64397351|NCT02367937|Sensory System Agents|sensory system agents|mesh-ancestor
64397352|NCT02367937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64397353|NCT02367937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64397354|NCT02367937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64397355|NCT02367937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64397356|NCT02367937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64397357|NCT02367937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64359714|NCT03121963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64405592|NCT03050411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64405594|NCT03050411|Gefitinib|gefitinib|mesh-list
64405595|NCT03050411|Osimertinib|osimertinib|mesh-list
64405596|NCT03050411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405597|NCT03050411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64405598|NCT03050411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405599|NCT03050411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405600|NCT04887311|Tempol|tempol|mesh-list
64405601|NCT04887311|Antioxidants|antioxidants|mesh-ancestor
64405649|NCT04895423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64405650|NCT04895423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64405651|NCT04895423|Immunologic Factors|immunologic factors|mesh-ancestor
64397358|NCT05011487|Pemetrexed|pemetrexed|mesh-list
64397359|NCT05011487|Osimertinib|osimertinib|mesh-list
64397360|NCT05011487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64397361|NCT05011487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397362|NCT05011487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397363|NCT05011487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64397364|NCT05011487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64397365|NCT05011487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64397366|NCT02367547|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64397367|NCT02367547|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
64359731|NCT04502251|Sensory System Agents|sensory system agents|mesh-ancestor
64397368|NCT02367547|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64397369|NCT02367547|Dermatologic Agents|dermatologic agents|mesh-ancestor
64397370|NCT05061641|Progesterone|progesterone|mesh-list
64397371|NCT05061641|Progestins|progestins|mesh-ancestor
64397372|NCT05061641|Hormones|hormones|mesh-ancestor
64397373|NCT05061641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64397374|NCT05061641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397375|NCT03100019|Resveratrol|resveratrol|mesh-list
64397376|NCT03100019|Antioxidants|antioxidants|mesh-ancestor
64405652|NCT04895423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64405653|NCT04895423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64405654|NCT04895423|Antifungal Agents|antifungal agents|mesh-ancestor
64405655|NCT04895423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64405656|NCT04895423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64405657|NCT04895423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64405658|NCT04895423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64405659|NCT04895423|Antitubercular Agents|antitubercular agents|mesh-ancestor
64405660|NCT04895423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64397377|NCT03100019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397378|NCT03100019|Protective Agents|protective agents|mesh-ancestor
64397379|NCT03100019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397380|NCT03100019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397381|NCT03100019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64397382|NCT05047055|Moxifloxacin|moxifloxacin|mesh-list
64397384|NCT05047055|Isoniazid|isoniazid|mesh-list
64397385|NCT05047055|Pyrazinamide|pyrazinamide|mesh-list
64397386|NCT05047055|Ethambutol|ethambutol|mesh-list
64397387|NCT05047055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64397388|NCT05047055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64405661|NCT04882163|Gemcitabine|gemcitabine|mesh-list
64405662|NCT04882163|Dexamethasone|dexamethasone|mesh-list
64405663|NCT04882163|Rituximab|rituximab|mesh-list
64405664|NCT04882163|Lenalidomide|lenalidomide|mesh-list
64405665|NCT04882163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64405714|NCT04881851|Vitamins|vitamins|mesh-ancestor
64405715|NCT04881851|Micronutrients|micronutrients|mesh-ancestor
64405716|NCT04881851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405717|NCT04881851|Antioxidants|antioxidants|mesh-ancestor
64405718|NCT04881851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397390|NCT05047055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64397391|NCT05047055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397392|NCT05047055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397393|NCT05047055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64397394|NCT05047055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64359750|NCT03122041|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64359751|NCT03122041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64405719|NCT04881851|Protective Agents|protective agents|mesh-ancestor
64405720|NCT04871633|Azithromycin|azithromycin|mesh-list
64405721|NCT04871633|Remdesivir|remdesivir|mesh-list
64405723|NCT04871633|Prednisolone|prednisolone|mesh-list
64405724|NCT04871633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64405725|NCT04871633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64405726|NCT04871633|Antiemetics|antiemetics|mesh-ancestor
64405727|NCT04871633|Autonomic Agents|autonomic agents|mesh-ancestor
64405728|NCT04871633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64405729|NCT04871633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397395|NCT05047055|Antitubercular Agents|antitubercular agents|mesh-ancestor
64397396|NCT05047055|Leprostatic Agents|leprostatic agents|mesh-ancestor
64397397|NCT05047055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64397398|NCT05047055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64397399|NCT05047055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64397400|NCT05047055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64397401|NCT05047055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64397402|NCT05047055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64397403|NCT05047055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64397404|NCT05047055|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64397405|NCT05047055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64397406|NCT05047055|Antimetabolites|antimetabolites|mesh-ancestor
64397407|NCT05047055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64397408|NCT03098537|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64359780|NCT04475991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64405730|NCT04871633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64405731|NCT04871633|Glucocorticoids|glucocorticoids|mesh-ancestor
64405733|NCT04871633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64405734|NCT04871633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64405735|NCT04871633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405736|NCT04871633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405737|NCT04871633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64405739|NCT04871633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64405740|NCT04871633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64397409|NCT03098537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397410|NCT03098537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397411|NCT05046041|Misoprostol|misoprostol|mesh-list
64397412|NCT05046041|Mifepristone|mifepristone|mesh-list
64397413|NCT05046041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64397414|NCT05046041|Abortifacient Agents|abortifacient agents|mesh-ancestor
64397415|NCT05046041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64397416|NCT05046041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397417|NCT05046041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64397418|NCT05046041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64397419|NCT05046041|Oxytocics|oxytocics|mesh-ancestor
64359788|NCT03387475|Sequestering Agents|sequestering agents|mesh-ancestor
64359790|NCT04437225|Glycolic acid|glycolic acid|mesh-list
64405742|NCT04871633|Antiviral Agents|antiviral agents|mesh-ancestor
64405743|NCT04880993|Dapagliflozin|dapagliflozin|mesh-list
64405744|NCT04880993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64405745|NCT04880993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405746|NCT04880993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64405747|NCT04880993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405752|NCT03046979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405753|NCT04676399|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64405754|NCT04676399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64405756|NCT04676399|Natriuretic Agents|natriuretic agents|mesh-ancestor
64405757|NCT04676399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405758|NCT04676399|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64405759|NCT04676399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64397420|NCT05046041|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64397421|NCT05046041|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64397422|NCT05046041|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64397423|NCT05046041|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64397424|NCT05046041|Contraceptive Agents|contraceptive agents|mesh-ancestor
64397425|NCT05046041|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64397426|NCT05046041|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64397427|NCT05046041|Hormone Antagonists|hormone antagonists|mesh-ancestor
64397428|NCT05046041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64397429|NCT05046041|Luteolytic Agents|luteolytic agents|mesh-ancestor
64397430|NCT05046041|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64397431|NCT05046041|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64397432|NCT01970878|Bromides|bromides|mesh-list
64397433|NCT01970878|Tiotropium Bromide|tiotropium bromide|mesh-list
64397434|NCT01970878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64397435|NCT01970878|Autonomic Agents|autonomic agents|mesh-ancestor
64397436|NCT01970878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64397437|NCT01970878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397438|NCT01970878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64397439|NCT01970878|Respiratory System Agents|respiratory system agents|mesh-ancestor
64397440|NCT01970878|Parasympatholytics|parasympatholytics|mesh-ancestor
64397441|NCT01970878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64397442|NCT01970878|Cholinergic Agents|cholinergic agents|mesh-ancestor
64397443|NCT01970878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64397444|NCT01970878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397445|NCT01970878|Anticonvulsants|anticonvulsants|mesh-ancestor
64397446|NCT05045651|Cimetidine|cimetidine|mesh-list
64397447|NCT05045651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64397448|NCT05045651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64397458|NCT05059145|Chlorhexidine|chlorhexidine|mesh-list
64405760|NCT04676399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405761|NCT03047057|Lidocaine|lidocaine|mesh-list
64405762|NCT03047057|Anesthetics, Local|anesthetics, local|mesh-ancestor
64405763|NCT03047057|Anesthetics|anesthetics|mesh-ancestor
64405764|NCT03047057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64405765|NCT03047057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405772|NCT03047057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405773|NCT04550195|Famotidine|famotidine|mesh-list
64405774|NCT04550195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64405775|NCT04550195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64397467|NCT05059145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64397468|NCT05059145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397469|NCT05059145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397471|NCT05059145|Hormone Antagonists|hormone antagonists|mesh-ancestor
64397472|NCT05059145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64397473|NCT05059145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397474|NCT05059145|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64397475|NCT05059145|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64397476|NCT05058677|Lidocaine|lidocaine|mesh-list
64397477|NCT05058677|Anesthetics, Local|anesthetics, local|mesh-ancestor
64397478|NCT05058677|Anesthetics|anesthetics|mesh-ancestor
64359814|NCT04921033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64397479|NCT05058677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64397480|NCT05058677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397481|NCT05058677|Sensory System Agents|sensory system agents|mesh-ancestor
64397482|NCT05058677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64397483|NCT05058677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64397484|NCT05058677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64397485|NCT05058677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64397486|NCT05058677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64397487|NCT05058677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397489|NCT01970488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64405776|NCT04550195|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64405777|NCT04550195|Histamine Antagonists|histamine antagonists|mesh-ancestor
64405779|NCT04550195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64405780|NCT04550195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405781|NCT04550195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405782|NCT04525391|Durvalumab|durvalumab|mesh-list
64405785|NCT04879511|Metformin|metformin|mesh-list
64405786|NCT04879511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64405800|NCT03871049|Dexamethasone|dexamethasone|mesh-list
64405801|NCT03871049|Bupivacaine|bupivacaine|mesh-list
64405802|NCT03871049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64405803|NCT03871049|Antiemetics|antiemetics|mesh-ancestor
64405804|NCT03871049|Autonomic Agents|autonomic agents|mesh-ancestor
64405805|NCT03871049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64405806|NCT03871049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405807|NCT03871049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64405808|NCT03871049|Glucocorticoids|glucocorticoids|mesh-ancestor
64405810|NCT03871049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64405811|NCT03871049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64405812|NCT03871049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405813|NCT03871049|Anesthetics, Local|anesthetics, local|mesh-ancestor
64397494|NCT03097601|Sunitinib|sunitinib|mesh-list
64397495|NCT03097601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64397496|NCT03097601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64397497|NCT03097601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64397498|NCT03097601|Growth Substances|growth substances|mesh-ancestor
64397499|NCT03097601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397500|NCT03097601|Growth Inhibitors|growth inhibitors|mesh-ancestor
64397501|NCT03097601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64397502|NCT03097601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397503|NCT03097601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397504|NCT05058755|Etoposide|etoposide|mesh-list
64397505|NCT05058755|Lenalidomide|lenalidomide|mesh-list
64397506|NCT05058755|Azacitidine|azacitidine|mesh-list
64397507|NCT05058755|Pegaspargase|pegaspargase|mesh-list
64397508|NCT05058755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64397509|NCT05058755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405814|NCT03871049|Anesthetics|anesthetics|mesh-ancestor
64405815|NCT03871049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64405816|NCT03871049|Sensory System Agents|sensory system agents|mesh-ancestor
64405817|NCT04870541|Nefopam|nefopam|mesh-list
64405818|NCT04870541|Ondansetron|ondansetron|mesh-list
64405819|NCT04870541|Antiemetics|antiemetics|mesh-ancestor
64405820|NCT04870541|Autonomic Agents|autonomic agents|mesh-ancestor
64405862|NCT03257033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64405863|NCT03257033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405864|NCT03257033|Tubulin Modulators|tubulin modulators|mesh-ancestor
64405865|NCT03257033|Antimitotic Agents|antimitotic agents|mesh-ancestor
64405866|NCT03257033|Mitosis Modulators|mitosis modulators|mesh-ancestor
64405867|NCT03257033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405868|NCT03257033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64405869|NCT03257033|Antimetabolites|antimetabolites|mesh-ancestor
64405870|NCT03257033|Antiviral Agents|antiviral agents|mesh-ancestor
64405871|NCT03257033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64405872|NCT03257033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405873|NCT03257033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64405874|NCT03257033|Immunologic Factors|immunologic factors|mesh-ancestor
64405875|NCT03257033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397557|NCT03097445|Nicotine|nicotine|mesh-list
64405876|NCT03250169|Alemtuzumab|alemtuzumab|mesh-list
64405930|NCT04386317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405931|NCT04386317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405932|NCT04386317|Urological Agents|urological agents|mesh-ancestor
64405934|NCT05256953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64405935|NCT05256953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405936|NCT05256719|Abatacept|abatacept|mesh-list
64405938|NCT05256719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405940|NCT05256719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64405941|NCT05256719|Immunologic Factors|immunologic factors|mesh-ancestor
64405942|NCT05256719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405943|NCT05256719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64405944|NCT04868903|Vitamin D|vitamin d|mesh-list
64405945|NCT04868903|Cholecalciferol|cholecalciferol|mesh-list
64405946|NCT04868903|Vitamins|vitamins|mesh-ancestor
64405947|NCT04868903|Micronutrients|micronutrients|mesh-ancestor
64405948|NCT04868903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405949|NCT04868903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64405950|NCT04868903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64405951|NCT04874675|Acetaminophen|acetaminophen|mesh-list
64405952|NCT04874675|Ibuprofen|ibuprofen|mesh-list
64405953|NCT04874675|Diclofenac|diclofenac|mesh-list
64405954|NCT04874675|Codeine|codeine|mesh-list
64405955|NCT04874675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64405956|NCT04874675|Analgesics|analgesics|mesh-ancestor
64405960|NCT04874675|Antipyretics|antipyretics|mesh-ancestor
64405984|NCT03047837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64405985|NCT03047837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405986|NCT03047837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64405987|NCT03047837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64405988|NCT03047837|Analgesics|analgesics|mesh-ancestor
64405989|NCT03047837|Sensory System Agents|sensory system agents|mesh-ancestor
64405990|NCT03047837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64405991|NCT03047837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64405992|NCT03047837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64405993|NCT03047837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64405994|NCT03047837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64405995|NCT03047837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405996|NCT03047837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64405997|NCT03047837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64405998|NCT03047837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405999|NCT03047837|Antipyretics|antipyretics|mesh-ancestor
64406000|NCT05256173|Melatonin|melatonin|mesh-list
64406049|NCT04383743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406050|NCT04383743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64406051|NCT04383743|Antimetabolites|antimetabolites|mesh-ancestor
64406052|NCT04383743|Dermatologic Agents|dermatologic agents|mesh-ancestor
64406053|NCT04383743|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64406054|NCT04383743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64406055|NCT04383743|Immunologic Factors|immunologic factors|mesh-ancestor
64406056|NCT04383743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64406057|NCT04383743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64406058|NCT04383743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64406059|NCT04383743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64406060|NCT04383743|Tubulin Modulators|tubulin modulators|mesh-ancestor
64406061|NCT04383743|Antimitotic Agents|antimitotic agents|mesh-ancestor
64406062|NCT04383743|Mitosis Modulators|mitosis modulators|mesh-ancestor
64406063|NCT03126643|Nivolumab|nivolumab|mesh-list
64399144|NCT05014685|Natriuretic Agents|natriuretic agents|mesh-ancestor
64406064|NCT03126643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64406065|NCT03126643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406066|NCT03126643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64406068|NCT04617067|Gemcitabine|gemcitabine|mesh-list
64406105|NCT03045185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406112|NCT04969237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64406120|NCT04341467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64406121|NCT04341467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64406122|NCT04341467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64406184|NCT04341155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406186|NCT04865705|Cisplatin|cisplatin|mesh-list
64406187|NCT04865705|Carboplatin|carboplatin|mesh-list
64406188|NCT04865705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64406189|NCT04865705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406190|NCT04865705|Tubulin Modulators|tubulin modulators|mesh-ancestor
64406191|NCT04865705|Antimitotic Agents|antimitotic agents|mesh-ancestor
64406192|NCT04865705|Mitosis Modulators|mitosis modulators|mesh-ancestor
64406193|NCT04865705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406194|NCT04858997|Palbociclib|palbociclib|mesh-list
64406195|NCT04858997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406196|NCT04858997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64406197|NCT04858997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406198|NCT04858997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406199|NCT05135143|Antioxidants|antioxidants|mesh-list
64406200|NCT05135143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406201|NCT05135143|Protective Agents|protective agents|mesh-ancestor
64406202|NCT05135143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406235|NCT05304559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64406236|NCT05304559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64406237|NCT05304559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406238|NCT05304559|Antidepressive Agents|antidepressive agents|mesh-ancestor
64406247|NCT05304169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406248|NCT05304169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64406249|NCT05304169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406251|NCT04732195|Miotics|miotics|mesh-ancestor
64406252|NCT04732195|Autonomic Agents|autonomic agents|mesh-ancestor
64406253|NCT04732195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64406254|NCT04732195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406255|NCT04732195|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64406256|NCT04732195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64406257|NCT04732195|Cholinergic Agents|cholinergic agents|mesh-ancestor
64406261|NCT04858841|Anticonvulsants|anticonvulsants|mesh-ancestor
64406262|NCT04858841|Nootropic Agents|nootropic agents|mesh-ancestor
64406264|NCT04858529|Docetaxel|docetaxel|mesh-list
64406265|NCT04858529|Trastuzumab|trastuzumab|mesh-list
64406266|NCT04858529|Pertuzumab|pertuzumab|mesh-list
64406267|NCT04858529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406268|NCT04858529|Tubulin Modulators|tubulin modulators|mesh-ancestor
64406269|NCT04858529|Antimitotic Agents|antimitotic agents|mesh-ancestor
64399862|NCT05077813|Cholecalciferol|cholecalciferol|mesh-list
64399863|NCT05077813|Vitamins|vitamins|mesh-list
64406270|NCT04858529|Mitosis Modulators|mitosis modulators|mesh-ancestor
64406271|NCT04858529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406272|NCT04858529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64406273|NCT05302999|Gabapentin|gabapentin|mesh-list
64406274|NCT05302999|Analgesics|analgesics|mesh-ancestor
64406275|NCT05302999|Sensory System Agents|sensory system agents|mesh-ancestor
64406276|NCT05302999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64406277|NCT05302999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406278|NCT05302999|Anticonvulsants|anticonvulsants|mesh-ancestor
64400396|NCT03072173|Xylometazoline|xylometazoline|mesh-list
64406279|NCT05302999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64406280|NCT05302999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64406281|NCT05302999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64406282|NCT05302999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64406283|NCT05302999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64406284|NCT05302999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64406285|NCT05302999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64400566|NCT03070925|Anti-Infective Agents|anti-infective agents|mesh-list
64406286|NCT05302999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406290|NCT03919435|Sulfamethoxazole|sulfamethoxazole|mesh-list
64406291|NCT03919435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64406292|NCT03919435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64406293|NCT03919435|Renal Agents|renal agents|mesh-ancestor
64406294|NCT03919435|Antimalarials|antimalarials|mesh-ancestor
64406295|NCT03919435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64406296|NCT03919435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64406297|NCT03919435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64406298|NCT03919435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406299|NCT03919435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406300|NCT03919435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64406301|NCT03919435|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64406302|NCT03919435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64406303|NCT03919435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64406304|NCT05302921|Nivolumab|nivolumab|mesh-list
64406305|NCT05302921|Ipilimumab|ipilimumab|mesh-list
64406306|NCT05302921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64406329|NCT04682743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64406332|NCT03472573|Dexamethasone|dexamethasone|mesh-list
64406333|NCT03472573|Palbociclib|palbociclib|mesh-list
64406334|NCT03472573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64406335|NCT03472573|Antiemetics|antiemetics|mesh-ancestor
64406336|NCT03472573|Autonomic Agents|autonomic agents|mesh-ancestor
64406337|NCT03472573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64406338|NCT03472573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406339|NCT03472573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64406340|NCT03472573|Glucocorticoids|glucocorticoids|mesh-ancestor
64406341|NCT03472573|Hormones|hormones|mesh-ancestor
64406342|NCT03472573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64406343|NCT03472573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64406344|NCT03472573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406345|NCT03472573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64406346|NCT03472573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406347|NCT03472573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406349|NCT04636333|Immunologic Factors|immunologic factors|mesh-ancestor
64406350|NCT04636333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406351|NCT03103009|Pasireotide|pasireotide|mesh-list
64406352|NCT03103009|Hormones|hormones|mesh-ancestor
64406353|NCT03103009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64406354|NCT03103009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406360|NCT03694249|Ifetroban|ifetroban|mesh-list
64406361|NCT03694249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64406377|NCT03020875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64406383|NCT02996305|Gaboxadol|gaboxadol|mesh-list
64406384|NCT02996305|Analgesics|analgesics|mesh-ancestor
64401360|NCT05090449|Chlorthalidone|chlorthalidone|mesh-list
64406385|NCT02996305|Sensory System Agents|sensory system agents|mesh-ancestor
64406386|NCT02996305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64406387|NCT02996305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406388|NCT02996305|Anticonvulsants|anticonvulsants|mesh-ancestor
64406389|NCT02996305|GABA Agonists|gaba agonists|mesh-ancestor
64406390|NCT02996305|GABA Agents|gaba agents|mesh-ancestor
64406392|NCT02996305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406394|NCT04866485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64406395|NCT04866485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406397|NCT02888041|Oxytocics|oxytocics|mesh-ancestor
64406398|NCT02888041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64406399|NCT02888041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406400|NCT02838745|Pemetrexed|pemetrexed|mesh-list
64406401|NCT02838745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406402|NCT02838745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406403|NCT02838745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406404|NCT02838745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64406405|NCT02838745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64406406|NCT00136435|Leucovorin|leucovorin|mesh-list
64406409|NCT00136435|Prednisone|prednisone|mesh-list
64406430|NCT00136435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406431|NCT00136435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406432|NCT00136435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64406433|NCT00136435|Abortifacient Agents|abortifacient agents|mesh-ancestor
64402281|NCT04523935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64402290|NCT04523935|GABA Agents|gaba agents|mesh-ancestor
64406434|NCT00136435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64406435|NCT00136435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64406437|NCT00136435|Dermatologic Agents|dermatologic agents|mesh-ancestor
64406438|NCT00136435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64406439|NCT00136435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64406440|NCT00136435|Immunologic Factors|immunologic factors|mesh-ancestor
64406441|NCT00136435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64406442|NCT00136435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64406443|NCT00136435|Antiviral Agents|antiviral agents|mesh-ancestor
64406444|NCT00136435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64406445|NCT00136435|Antidotes|antidotes|mesh-ancestor
64406446|NCT00136435|Protective Agents|protective agents|mesh-ancestor
64406447|NCT00136435|Vitamin B Complex|vitamin b complex|mesh-ancestor
64406448|NCT00136435|Vitamins|vitamins|mesh-ancestor
64406449|NCT00136435|Micronutrients|micronutrients|mesh-ancestor
64406450|NCT00136435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64406466|NCT03044561|Sildenafil Citrate|sildenafil citrate|mesh-list
64406467|NCT03044561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406468|NCT03044561|Vasodilator Agents|vasodilator agents|mesh-ancestor
64406495|NCT02439385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64402686|NCT03945721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406496|NCT02439385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406497|NCT02439385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64406498|NCT02439385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64406499|NCT02439385|Growth Substances|growth substances|mesh-ancestor
64406500|NCT02439385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406501|NCT02439385|Growth Inhibitors|growth inhibitors|mesh-ancestor
64406502|NCT02439385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64406503|NCT02439385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64406505|NCT02439385|Sensory System Agents|sensory system agents|mesh-ancestor
64406506|NCT02439385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64406507|NCT02439385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64406508|NCT02439385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64406509|NCT02439385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406519|NCT03104959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406520|NCT03104959|Protective Agents|protective agents|mesh-ancestor
64406523|NCT03044171|Listerine|listerine|mesh-list
64406561|NCT04108039|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64406562|NCT04108039|Fertility Agents|fertility agents|mesh-ancestor
64406563|NCT04108039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64406564|NCT03981211|Sofosbuvir|sofosbuvir|mesh-list
64406565|NCT03981211|Antiviral Agents|antiviral agents|mesh-ancestor
64406567|NCT04089865|Tranexamic Acid|tranexamic acid|mesh-list
64406568|NCT04089865|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64406569|NCT04089865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64406570|NCT04089865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406571|NCT04089865|Hemostatics|hemostatics|mesh-ancestor
64406572|NCT04089865|Coagulants|coagulants|mesh-ancestor
64406573|NCT04856111|Pirfenidone|pirfenidone|mesh-list
64406574|NCT04856111|Nintedanib|nintedanib|mesh-list
64406575|NCT04856111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406576|NCT04856111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64406577|NCT04856111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406583|NCT04856111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64406584|NCT04856111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64406585|NCT04856111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64406586|NCT04856111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64406587|NCT02053051|Insulin Aspart|insulin aspart|mesh-list
64403016|NCT04978181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64406588|NCT02053051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64406589|NCT02053051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406591|NCT03841201|Lenvatinib|lenvatinib|mesh-list
64406592|NCT03841201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64406593|NCT03841201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406594|NCT03841201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64406595|NCT03841201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406596|NCT03841201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64406597|NCT03841201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406598|NCT01371981|Cytarabine|cytarabine|mesh-list
64406599|NCT01371981|Etoposide|etoposide|mesh-list
64406614|NCT01371981|Antimetabolites|antimetabolites|mesh-ancestor
64406615|NCT01371981|Antiviral Agents|antiviral agents|mesh-ancestor
64406616|NCT01371981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64406617|NCT01371981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64406618|NCT01371981|Immunologic Factors|immunologic factors|mesh-ancestor
64406619|NCT01371981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406620|NCT01371981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64406621|NCT01371981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64406622|NCT01371981|Analgesics|analgesics|mesh-ancestor
64406623|NCT01371981|Sensory System Agents|sensory system agents|mesh-ancestor
64406624|NCT01371981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64406625|NCT01371981|Keratolytic Agents|keratolytic agents|mesh-ancestor
64406626|NCT01371981|Dermatologic Agents|dermatologic agents|mesh-ancestor
64406627|NCT01371981|Tubulin Modulators|tubulin modulators|mesh-ancestor
64406628|NCT01371981|Antimitotic Agents|antimitotic agents|mesh-ancestor
64406629|NCT01371981|Mitosis Modulators|mitosis modulators|mesh-ancestor
64406630|NCT02845453|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64406631|NCT02845453|Antidepressive Agents|antidepressive agents|mesh-ancestor
64406632|NCT02845453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64406633|NCT02845453|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64406634|NCT02845453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64406667|NCT01553071|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64406668|NCT01553071|Protective Agents|protective agents|mesh-ancestor
64406669|NCT01553071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406670|NCT01553071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403576|NCT04121299|Vasodilator Agents|vasodilator agents|mesh-ancestor
64406671|NCT01553071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406672|NCT01506973|Gemcitabine|gemcitabine|mesh-list
64406674|NCT01506973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64406675|NCT01506973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64406676|NCT01506973|Antimetabolites|antimetabolites|mesh-ancestor
64406677|NCT01506973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406678|NCT01506973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406679|NCT01506973|Antiviral Agents|antiviral agents|mesh-ancestor
64406680|NCT01506973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64406681|NCT01506973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406682|NCT01506973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64406683|NCT01506973|Immunologic Factors|immunologic factors|mesh-ancestor
64406684|NCT01506973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406686|NCT01506973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64406687|NCT01506973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64406690|NCT04380545|Interferon-alpha|interferon-alpha|mesh-list
64406691|NCT04380545|Interferon alpha-2|interferon alpha-2|mesh-list
64406692|NCT04380545|Fluorouracil|fluorouracil|mesh-list
64406693|NCT04380545|Nivolumab|nivolumab|mesh-list
64406694|NCT04380545|Antimetabolites|antimetabolites|mesh-ancestor
64406695|NCT04380545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406696|NCT04380545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64406697|NCT04380545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406698|NCT04380545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64406708|NCT03101995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64406709|NCT03101995|Antimetabolites|antimetabolites|mesh-ancestor
64406710|NCT03101995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406711|NCT03101995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406712|NCT03101995|Antiviral Agents|antiviral agents|mesh-ancestor
64404516|NCT04875871|Copper|copper|mesh-list
64406713|NCT03101995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64406714|NCT03101995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406715|NCT03101995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64406716|NCT03101995|Immunologic Factors|immunologic factors|mesh-ancestor
64406722|NCT03104335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406723|NCT03104335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64406724|NCT03104335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406725|NCT03104335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406726|NCT04863365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64406727|NCT04863365|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64406730|NCT00484471|Antidepressive Agents|antidepressive agents|mesh-ancestor
64406731|NCT00484471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64406732|NCT00484471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64404821|NCT04918589|Hemostatics|hemostatics|mesh-ancestor
64404823|NCT04496401|Tacrolimus|tacrolimus|mesh-list
64406733|NCT00484471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64406734|NCT00484471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64406735|NCT00484471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406736|NCT00484471|Dopamine Agonists|dopamine agonists|mesh-ancestor
64406737|NCT00484471|Dopamine Agents|dopamine agents|mesh-ancestor
64406738|NCT00484471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64406739|NCT00484471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406740|NCT00484471|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64406741|NCT00484471|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64405360|NCT04400695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64405428|NCT01596335|Antibodies|antibodies|mesh-list
64406743|NCT00484471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64406744|NCT00484471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64406745|NCT00484471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64406746|NCT00484471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64406747|NCT00484471|Anticonvulsants|anticonvulsants|mesh-ancestor
64406748|NCT00484471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406752|NCT05430841|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64406753|NCT05430841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406754|NCT01746849|Cyclophosphamide|cyclophosphamide|mesh-list
64406755|NCT01746849|Thiotepa|thiotepa|mesh-list
64406756|NCT01746849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64406757|NCT01746849|Immunologic Factors|immunologic factors|mesh-ancestor
64406758|NCT01746849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405917|NCT03049085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406759|NCT01746849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64406760|NCT01746849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64406761|NCT01746849|Alkylating Agents|alkylating agents|mesh-ancestor
64406762|NCT01746849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406763|NCT01746849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406764|NCT01746849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64406765|NCT04847921|Dalbavancin|dalbavancin|mesh-list
64406766|NCT04847921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64406820|NCT05579769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64406821|NCT05579769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64406822|NCT05579769|Alkylating Agents|alkylating agents|mesh-ancestor
64406823|NCT05579769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406824|NCT05579769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406825|NCT05579769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64406826|NCT05579769|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64406827|NCT05579769|Abortifacient Agents|abortifacient agents|mesh-ancestor
64406828|NCT05579769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64406829|NCT05579769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64406830|NCT05579769|Antimetabolites|antimetabolites|mesh-ancestor
64406831|NCT05579769|Dermatologic Agents|dermatologic agents|mesh-ancestor
64406832|NCT05579769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406833|NCT05579769|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64406834|NCT05579769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64406835|NCT05579769|Antifungal Agents|antifungal agents|mesh-ancestor
64406836|NCT05579769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64406837|NCT05579769|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64406838|NCT02609399|Oseltamivir|oseltamivir|mesh-list
64406839|NCT02609399|Peramivir|peramivir|mesh-list
64406840|NCT02609399|Antiviral Agents|antiviral agents|mesh-ancestor
64406841|NCT02609399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64406844|NCT05430217|Buspirone|buspirone|mesh-list
64406888|NCT04846673|Vitamins|vitamins|mesh-ancestor
64406889|NCT04846673|Micronutrients|micronutrients|mesh-ancestor
64406890|NCT04498273|Aspirin|aspirin|mesh-list
64406891|NCT04498273|Apixaban|apixaban|mesh-list
64406892|NCT04498273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64406893|NCT04498273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64406894|NCT04498273|Analgesics|analgesics|mesh-ancestor
64406895|NCT04498273|Sensory System Agents|sensory system agents|mesh-ancestor
64406896|NCT04498273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64406897|NCT04498273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406898|NCT04498273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64406899|NCT04498273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64407316|NCT04860167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64406900|NCT04498273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64406903|NCT04498273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64406956|NCT04853069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64406957|NCT04853069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406958|NCT05416125|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64406959|NCT05416125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64406960|NCT05416125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406961|NCT05416125|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64406962|NCT05416125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64406963|NCT05416125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64406964|NCT05416125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406966|NCT05416125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64406967|NCT05244811|Contraceptive Agents|contraceptive agents|mesh-list
64407634|NCT00783133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407700|NCT03100513|Lactulose|lactulose|mesh-list
64406968|NCT05244811|Contraceptives, Oral|contraceptives, oral|mesh-list
64406969|NCT05244811|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64406970|NCT05244811|Progestins|progestins|mesh-list
64406971|NCT05244811|Estradiol|estradiol|mesh-list
64406972|NCT05244811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64406973|NCT05244811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406974|NCT05244811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64406976|NCT05244811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64406977|NCT05244811|Estrogens|estrogens|mesh-ancestor
64406978|NCT05564403|Calcium, Dietary|calcium, dietary|mesh-list
64406979|NCT05564403|Leucovorin|leucovorin|mesh-list
64408112|NCT04816253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64406980|NCT05564403|Folic Acid|folic acid|mesh-list
64406981|NCT05564403|Fluorouracil|fluorouracil|mesh-list
64406982|NCT05564403|Oxaliplatin|oxaliplatin|mesh-list
64406995|NCT05564403|Protective Agents|protective agents|mesh-ancestor
64406996|NCT05564403|Vitamin B Complex|vitamin b complex|mesh-ancestor
64406998|NCT05564403|Micronutrients|micronutrients|mesh-ancestor
64406999|NCT05564403|Hematinics|hematinics|mesh-ancestor
64407010|NCT02710669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64408252|NCT03094663|Sympathomimetics|sympathomimetics|mesh-ancestor
64407011|NCT02710669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64407012|NCT02710669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64407013|NCT02710669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64407014|NCT02710669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407016|NCT05392959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64407017|NCT05392959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407018|NCT05392959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64408582|NCT05009953|Vitamins|vitamins|mesh-ancestor
64407083|NCT04850885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64407086|NCT04850885|Anesthetics|anesthetics|mesh-ancestor
64407087|NCT04850885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64407088|NCT04850885|Sensory System Agents|sensory system agents|mesh-ancestor
64407089|NCT04850885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64407090|NCT04850885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64407091|NCT04850885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64407092|NCT04850885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64407093|NCT04850885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407095|NCT04850417|Clopidogrel|clopidogrel|mesh-list
64407096|NCT04850417|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64407097|NCT04850417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64407098|NCT04850417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64407099|NCT04850417|Analgesics|analgesics|mesh-ancestor
64407100|NCT04850417|Sensory System Agents|sensory system agents|mesh-ancestor
64407101|NCT04850417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407102|NCT04850417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408799|NCT03078829|Leuprolide|leuprolide|mesh-list
64407103|NCT04850417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64407104|NCT04850417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64407105|NCT04850417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64407106|NCT04850417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64407108|NCT04850417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64407146|NCT02684461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64407147|NCT02684461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64407149|NCT02684461|Antimitotic Agents|antimitotic agents|mesh-ancestor
64407150|NCT02684461|Mitosis Modulators|mitosis modulators|mesh-ancestor
64407151|NCT02684461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407152|NCT02684461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64407156|NCT03040193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64407157|NCT03040193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407159|NCT03040193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407160|NCT03040193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64407161|NCT03040193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64407162|NCT03040193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64407163|NCT03040193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64407164|NCT03040193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407165|NCT05373199|Insulin Lispro|insulin lispro|mesh-list
64407166|NCT05373199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64409491|NCT04433611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407209|NCT05339113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407210|NCT05332795|Metformin|metformin|mesh-list
64407211|NCT05332795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64407266|NCT05072899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64407267|NCT05072899|Immunologic Factors|immunologic factors|mesh-ancestor
64407268|NCT05072899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407269|NCT05072899|Viscosupplements|viscosupplements|mesh-ancestor
64407271|NCT04839653|Vancomycin|vancomycin|mesh-list
64407272|NCT04839653|Gentamicins|gentamicins|mesh-list
64407273|NCT04839653|Ceftriaxone|ceftriaxone|mesh-list
64407274|NCT04839653|Polymyxins|polymyxins|mesh-list
64407275|NCT04839653|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64407276|NCT04839653|Cefotaxime|cefotaxime|mesh-list
64407277|NCT04839653|Cefoxitin|cefoxitin|mesh-list
64407278|NCT04839653|Polymyxin B|polymyxin b|mesh-list
64407279|NCT04839653|Amphotericin B|amphotericin b|mesh-list
64407280|NCT04839653|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64409871|NCT05275725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409875|NCT05226429|Vaccines|vaccines|mesh-list
64407281|NCT04839653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64407282|NCT04839653|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64407283|NCT04839653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407284|NCT04839653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407285|NCT04839653|Amebicides|amebicides|mesh-ancestor
64407286|NCT04839653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64407287|NCT04839653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64407288|NCT04839653|Antifungal Agents|antifungal agents|mesh-ancestor
64407289|NCT04842383|Peppermint oil|peppermint oil|mesh-list
64407290|NCT04842383|Antiemetics|antiemetics|mesh-ancestor
64407291|NCT04842383|Autonomic Agents|autonomic agents|mesh-ancestor
64410127|NCT03424525|Trimethoprim|trimethoprim|mesh-list
64407292|NCT04842383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407293|NCT04842383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407294|NCT04842383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64407295|NCT04842383|Parasympatholytics|parasympatholytics|mesh-ancestor
64407296|NCT04884139|Tenofovir|tenofovir|mesh-list
64407297|NCT04884139|Lamivudine|lamivudine|mesh-list
64407298|NCT04884139|Emtricitabine|emtricitabine|mesh-list
64407302|NCT04884139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64407324|NCT04860167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64407325|NCT04860167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64407326|NCT04860167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64407327|NCT04860167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407328|NCT04860167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407329|NCT04860167|Anesthetics, Local|anesthetics, local|mesh-ancestor
64407330|NCT04860167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64407331|NCT04860167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64407332|NCT04860167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64407333|NCT04860167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64407335|NCT04880785|Dolutegravir|dolutegravir|mesh-list
64407336|NCT04880785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64407337|NCT04880785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64410893|NCT05038839|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64407338|NCT04880785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407340|NCT04880785|Antiviral Agents|antiviral agents|mesh-ancestor
64407392|NCT03038243|Immunologic Factors|immunologic factors|mesh-ancestor
64407393|NCT03038243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407394|NCT03038321|Levofloxacin|levofloxacin|mesh-list
64407396|NCT03038321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64407397|NCT03038321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64407398|NCT03038321|Renal Agents|renal agents|mesh-ancestor
64407402|NCT03038321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407403|NCT03038321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407404|NCT03038321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64407405|NCT03038321|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64411195|NCT02252887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64407406|NCT03038321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64407407|NCT03038321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64407409|NCT03038321|Analgesics|analgesics|mesh-ancestor
64407410|NCT03038321|Sensory System Agents|sensory system agents|mesh-ancestor
64407411|NCT03038321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407412|NCT03038321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407413|NCT03038321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64407414|NCT03038321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64407416|NCT02531373|Immunologic Factors|immunologic factors|mesh-ancestor
64407417|NCT02531373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407421|NCT03042377|Calcium|calcium|mesh-list
64407441|NCT02606279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64407442|NCT02606279|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64411521|NCT05555147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64411522|NCT05555147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411523|NCT05555147|Sensory System Agents|sensory system agents|mesh-ancestor
64407443|NCT02606279|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64407444|NCT02606279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407445|NCT04859621|Vitamin D|vitamin d|mesh-list
64407446|NCT04859621|Ergocalciferols|ergocalciferols|mesh-list
64407447|NCT04859621|Cholecalciferol|cholecalciferol|mesh-list
64407448|NCT04859621|Vitamins|vitamins|mesh-list
64407449|NCT04859621|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64407450|NCT04859621|Micronutrients|micronutrients|mesh-ancestor
64407451|NCT04859621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407452|NCT04859621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64407453|NCT04859621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64407454|NCT04859621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64407501|NCT05069779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64407502|NCT05069779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64407503|NCT05069779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64407504|NCT05069779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64407505|NCT05069779|Anesthetics, General|anesthetics, general|mesh-ancestor
64407506|NCT05069779|Anesthetics|anesthetics|mesh-ancestor
64407507|NCT05069779|GABA Modulators|gaba modulators|mesh-ancestor
64407508|NCT05069779|GABA Agents|gaba agents|mesh-ancestor
64407517|NCT02643355|Antiemetics|antiemetics|mesh-ancestor
64407518|NCT02643355|Autonomic Agents|autonomic agents|mesh-ancestor
64407519|NCT02643355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407520|NCT02643355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407521|NCT02643355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64411840|NCT05541185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64411841|NCT05541185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64411842|NCT05541185|Gout Suppressants|gout suppressants|mesh-ancestor
64411843|NCT05541185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64411844|NCT05541185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64411845|NCT02518113|Dexamethasone|dexamethasone|mesh-list
64411846|NCT02518113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64411877|NCT05540951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411878|NCT05540951|Growth Inhibitors|growth inhibitors|mesh-ancestor
64411879|NCT04964505|Azacitidine|azacitidine|mesh-list
64411880|NCT04964505|Venetoclax|venetoclax|mesh-list
64411881|NCT04964505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64411882|NCT04964505|Antimetabolites|antimetabolites|mesh-ancestor
64411885|NCT04964505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407522|NCT02643355|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64407523|NCT02643355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64407524|NCT02643355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64407525|NCT02643355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64407526|NCT02643355|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64407527|NCT02643355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64407528|NCT02643355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64407529|NCT02643355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407530|NCT02643355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64407531|NCT02643355|Serotonin Agents|serotonin agents|mesh-ancestor
64407532|NCT02643355|Analgesics|analgesics|mesh-ancestor
64407533|NCT02643355|Sensory System Agents|sensory system agents|mesh-ancestor
64407534|NCT02643355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64407535|NCT02643355|Sympatholytics|sympatholytics|mesh-ancestor
64407536|NCT02643355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64407537|NCT02643355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64407547|NCT03036605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407548|NCT03036605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407549|NCT03036605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64407551|NCT03036605|Hormones|hormones|mesh-ancestor
64407552|NCT03036605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64407553|NCT03036605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64407554|NCT03036605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412083|NCT03765619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64407555|NCT03036605|Protease Inhibitors|protease inhibitors|mesh-ancestor
64407556|NCT03036605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407557|NCT03036605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407558|NCT03036605|Anesthetics, Local|anesthetics, local|mesh-ancestor
64407559|NCT03036605|Anesthetics|anesthetics|mesh-ancestor
64407609|NCT03101137|Anesthetics|anesthetics|mesh-ancestor
64407610|NCT03101137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64407611|NCT03101137|Sensory System Agents|sensory system agents|mesh-ancestor
64407612|NCT03098953|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64407613|NCT03098953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64407614|NCT04833101|Vaccines|vaccines|mesh-list
64407615|NCT04833101|Immunologic Factors|immunologic factors|mesh-ancestor
64407616|NCT04833101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407617|NCT00794599|Cetirizine|cetirizine|mesh-list
64407618|NCT00794599|Desloratadine|desloratadine|mesh-list
64407619|NCT00794599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64407620|NCT00794599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64407621|NCT00794599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64407622|NCT00794599|Histamine Antagonists|histamine antagonists|mesh-ancestor
64407623|NCT00794599|Histamine Agents|histamine agents|mesh-ancestor
64407624|NCT00794599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64407625|NCT00794599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407637|NCT00783133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64407639|NCT00783133|Histamine Agents|histamine agents|mesh-ancestor
64407640|NCT00783133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64407641|NCT03098407|Buprenorphine|buprenorphine|mesh-list
64407643|NCT03098407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64407644|NCT03098407|Narcotics|narcotics|mesh-ancestor
64407645|NCT03098407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64407668|NCT00751075|Dermatologic Agents|dermatologic agents|mesh-ancestor
64407669|NCT00751075|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64407670|NCT00731185|Mometasone Furoate|mometasone furoate|mesh-list
64407671|NCT00731185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64407672|NCT00731185|Dermatologic Agents|dermatologic agents|mesh-ancestor
64407673|NCT00731185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64407674|NCT04836299|Ivermectin|ivermectin|mesh-list
64407675|NCT04836299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64407676|NCT04836299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64407677|NCT00651391|Simvastatin|simvastatin|mesh-list
64407678|NCT00651391|Ezetimibe|ezetimibe|mesh-list
64407679|NCT00651391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64407680|NCT00651391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64407681|NCT00651391|Antimetabolites|antimetabolites|mesh-ancestor
64407682|NCT00651391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407683|NCT00651391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64407684|NCT00651391|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64407685|NCT00651391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407686|NCT00650689|Atorvastatin|atorvastatin|mesh-list
64407687|NCT00650689|Ezetimibe|ezetimibe|mesh-list
64407688|NCT00650689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64407689|NCT00650689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64407690|NCT00650689|Antimetabolites|antimetabolites|mesh-ancestor
64407701|NCT03100513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64407702|NCT00552097|Simvastatin|simvastatin|mesh-list
64407703|NCT00552097|Ezetimibe|ezetimibe|mesh-list
64407704|NCT00552097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64407705|NCT00552097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64413263|NCT04177433|Antiemetics|antiemetics|mesh-ancestor
64413264|NCT04177433|Autonomic Agents|autonomic agents|mesh-ancestor
64407707|NCT00552097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407723|NCT02603393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64407724|NCT02603393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64407726|NCT02603393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407727|NCT02603393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407728|NCT02603393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64407729|NCT02603393|Respiratory System Agents|respiratory system agents|mesh-ancestor
64407730|NCT02603393|Dermatologic Agents|dermatologic agents|mesh-ancestor
64407731|NCT02603393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64407734|NCT02603393|Cholinergic Agents|cholinergic agents|mesh-ancestor
64407735|NCT02603393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64407736|NCT02603393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407737|NCT02603393|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64407738|NCT02603393|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64407740|NCT02603393|Adrenergic Agents|adrenergic agents|mesh-ancestor
64413529|NCT02577029|Entecavir|entecavir|mesh-list
64413567|NCT04943029|Pemetrexed|pemetrexed|mesh-list
64407741|NCT04832945|Ivermectin|ivermectin|mesh-list
64407742|NCT04832945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64407743|NCT04832945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64407744|NCT02642653|Lovastatin|lovastatin|mesh-list
64407745|NCT02642653|L 647318|l 647318|mesh-list
64407746|NCT02642653|Dihydromevinolin|dihydromevinolin|mesh-list
64407747|NCT02642653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64407748|NCT02642653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64407749|NCT02642653|Antimetabolites|antimetabolites|mesh-ancestor
64407750|NCT02642653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407751|NCT02642653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64407752|NCT02642653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64407753|NCT02642653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407758|NCT01659567|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64407759|NCT01659567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64407760|NCT01659567|Antiviral Agents|antiviral agents|mesh-ancestor
64407761|NCT01659567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64407766|NCT05363631|Selenium|selenium|mesh-list
64407767|NCT05363631|Pembrolizumab|pembrolizumab|mesh-list
64407768|NCT05363631|Axitinib|axitinib|mesh-list
64407769|NCT05363631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64407770|NCT05363631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64407771|NCT05363631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64407772|NCT05363631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407773|NCT05363631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407774|NCT05363631|Antioxidants|antioxidants|mesh-ancestor
64407775|NCT05363631|Protective Agents|protective agents|mesh-ancestor
64415184|NCT04872283|Narcotics|narcotics|mesh-ancestor
64407776|NCT05363631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407778|NCT05363631|Micronutrients|micronutrients|mesh-ancestor
64407779|NCT04832399|Natalizumab|natalizumab|mesh-list
64407780|NCT04832399|Immunologic Factors|immunologic factors|mesh-ancestor
64407781|NCT04832399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407824|NCT04822415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64407832|NCT04821947|Anesthetics, Local|anesthetics, local|mesh-list
64407833|NCT04821947|Anesthetics|anesthetics|mesh-list
64407834|NCT04821947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64407835|NCT04821947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407836|NCT04821947|Sensory System Agents|sensory system agents|mesh-ancestor
64407837|NCT04821947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407838|NCT03037073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64407839|NCT03037073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64407840|NCT03037073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64407841|NCT03037073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64407842|NCT03037073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407843|NCT03037073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64407844|NCT03037073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407846|NCT03037073|Sensory System Agents|sensory system agents|mesh-ancestor
64407847|NCT03037073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407848|NCT03037073|Antidepressive Agents|antidepressive agents|mesh-ancestor
64407849|NCT03037073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64407850|NCT03037073|Dopamine Agents|dopamine agents|mesh-ancestor
64407851|NCT04831541|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64407852|NCT04831541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64407856|NCT04470973|Cefuroxime axetil|cefuroxime axetil|mesh-list
64407857|NCT04470973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64407858|NCT04470973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64407859|NCT05046457|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
64407860|NCT05046457|Provitamins|provitamins|mesh-ancestor
64407861|NCT05046457|Vitamins|vitamins|mesh-ancestor
64407862|NCT05046457|Micronutrients|micronutrients|mesh-ancestor
64407863|NCT05046457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407864|NCT05063071|Tenofovir|tenofovir|mesh-list
64407867|NCT05063071|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64407868|NCT05063071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64407869|NCT05063071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407870|NCT05063071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407871|NCT05063071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64407872|NCT05063071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64407873|NCT05062681|Dexamethasone|dexamethasone|mesh-list
64407874|NCT05062681|Methylprednisolone|methylprednisolone|mesh-list
64407875|NCT05062681|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64407876|NCT05062681|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64407936|NCT03097003|Apremilast|apremilast|mesh-list
64407937|NCT03097003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64407938|NCT03097003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64407939|NCT03097003|Analgesics|analgesics|mesh-ancestor
64407940|NCT03097003|Sensory System Agents|sensory system agents|mesh-ancestor
64407943|NCT03097003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64407944|NCT03097003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64407945|NCT03097003|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64407946|NCT03097003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64407947|NCT03097003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407953|NCT03036059|Ivermectin|ivermectin|mesh-list
64407954|NCT03036059|Albendazole|albendazole|mesh-list
64407955|NCT03036059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64407956|NCT03036059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64407957|NCT03036059|Anthelmintics|anthelmintics|mesh-ancestor
64407958|NCT03036059|Anticestodal Agents|anticestodal agents|mesh-ancestor
64407959|NCT03036059|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64407960|NCT03036059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64407961|NCT03036059|Tubulin Modulators|tubulin modulators|mesh-ancestor
64407962|NCT03036059|Antimitotic Agents|antimitotic agents|mesh-ancestor
64407963|NCT03036059|Mitosis Modulators|mitosis modulators|mesh-ancestor
64407964|NCT03036059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407965|NCT03036059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64407977|NCT04834427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64407987|NCT05035849|Incretins|incretins|mesh-ancestor
64407988|NCT05035849|Hormones|hormones|mesh-ancestor
64407989|NCT05035849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64407990|NCT05035849|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64407991|NCT05035849|Protease Inhibitors|protease inhibitors|mesh-ancestor
64407992|NCT05035849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416611|NCT03040531|Cholecalciferol|cholecalciferol|mesh-list
64416612|NCT03040531|Alendronate|alendronate|mesh-list
64416613|NCT03040531|Genistein|genistein|mesh-list
64416614|NCT03040531|Calcium|calcium|mesh-list
64416615|NCT03040531|Vitamins|vitamins|mesh-ancestor
64416616|NCT03040531|Micronutrients|micronutrients|mesh-ancestor
64416617|NCT03040531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416618|NCT03040531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64416619|NCT03040531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64416620|NCT03040531|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64416621|NCT03040531|Protective Agents|protective agents|mesh-ancestor
64423562|NCT05214001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423563|NCT05214001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423564|NCT05249959|Rituximab|rituximab|mesh-list
64423565|NCT05249959|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
64423566|NCT05249959|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64423567|NCT05249959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64423568|NCT05249959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423569|NCT05249959|Immunologic Factors|immunologic factors|mesh-ancestor
64423570|NCT05249959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407993|NCT05035849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407994|NCT05035849|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64407995|NCT04428437|Lenvatinib|lenvatinib|mesh-list
64407997|NCT04428437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64407998|NCT04428437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407999|NCT04428437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408000|NCT05035381|Leucovorin|leucovorin|mesh-list
64408001|NCT05035381|Bevacizumab|bevacizumab|mesh-list
64408002|NCT05035381|Pembrolizumab|pembrolizumab|mesh-list
64408003|NCT05035381|Fluorouracil|fluorouracil|mesh-list
64408004|NCT05035381|Irinotecan|irinotecan|mesh-list
64408005|NCT05035381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64408006|NCT05035381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64408007|NCT05035381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408008|NCT05035381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64408009|NCT05035381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64408010|NCT05035381|Growth Substances|growth substances|mesh-ancestor
64408011|NCT05035381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408039|NCT04821323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64408042|NCT04821323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64408043|NCT04821323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64408044|NCT04821323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64408046|NCT04821323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64408047|NCT05035069|Propofol|propofol|mesh-list
64408048|NCT05035069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64408049|NCT05035069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64408052|NCT05035069|Anesthetics, General|anesthetics, general|mesh-ancestor
64408053|NCT05035069|Anesthetics|anesthetics|mesh-ancestor
64408054|NCT05035147|Gemcitabine|gemcitabine|mesh-list
64423599|NCT05248945|Anticonvulsants|anticonvulsants|mesh-ancestor
64423600|NCT05248945|Antimanic Agents|antimanic agents|mesh-ancestor
64423601|NCT05248945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64423602|NCT05248945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64423603|NCT05248945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423604|NCT05248945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64408055|NCT05035147|Paclitaxel|paclitaxel|mesh-list
64408056|NCT05035147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64408057|NCT05035147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64408058|NCT05035147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408059|NCT05035147|Tubulin Modulators|tubulin modulators|mesh-ancestor
64408060|NCT05035147|Antimitotic Agents|antimitotic agents|mesh-ancestor
64338954|NCT05340764|Infliximab|infliximab|mesh-list
64408061|NCT05035147|Mitosis Modulators|mitosis modulators|mesh-ancestor
64408062|NCT05035147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408069|NCT05035147|Immunologic Factors|immunologic factors|mesh-ancestor
64408070|NCT05035147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408071|NCT04834115|Ivermectin|ivermectin|mesh-list
64408072|NCT04834115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64408073|NCT04834115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64408074|NCT01505465|Melatonin|melatonin|mesh-list
64423653|NCT05272969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64423654|NCT05272969|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64423656|NCT05208619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64423657|NCT05208619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423672|NCT05206435|Nicotine|nicotine|mesh-list
64423715|NCT05166343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64423716|NCT05166343|Respiratory System Agents|respiratory system agents|mesh-ancestor
64423717|NCT05166343|Mydriatics|mydriatics|mesh-ancestor
64423718|NCT05166343|Sympathomimetics|sympathomimetics|mesh-ancestor
64423719|NCT05166343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64423721|NCT05237947|Immunologic Factors|immunologic factors|mesh-ancestor
64423722|NCT05237947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423723|NCT01656733|Nicotine|nicotine|mesh-list
64423724|NCT01656733|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64408075|NCT01505465|Antioxidants|antioxidants|mesh-ancestor
64408076|NCT01505465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408077|NCT01505465|Protective Agents|protective agents|mesh-ancestor
64408078|NCT01505465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408079|NCT01505465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64408080|NCT04820933|Tenofovir|tenofovir|mesh-list
64408081|NCT04820933|Emtricitabine|emtricitabine|mesh-list
64408082|NCT04820933|Antiviral Agents|antiviral agents|mesh-ancestor
64408083|NCT04820933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339026|NCT04478721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339027|NCT02328651|Ribavirin|ribavirin|mesh-list
64339028|NCT02328651|Antimetabolites|antimetabolites|mesh-ancestor
64408084|NCT04820933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64408085|NCT04820933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64408086|NCT04820933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64408087|NCT04820933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408088|NCT04820933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64408089|NCT04820933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64408090|NCT04831229|Menthol|menthol|mesh-list
64408091|NCT04831229|Antipruritics|antipruritics|mesh-ancestor
64423820|NCT05107999|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64423821|NCT05107999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64423822|NCT05107999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64423823|NCT05107999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423824|NCT05107999|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64423825|NCT05107999|Histamine Antagonists|histamine antagonists|mesh-ancestor
64423826|NCT05107999|Histamine Agents|histamine agents|mesh-ancestor
64423827|NCT05107999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423828|NCT05186545|Fulvestrant|fulvestrant|mesh-list
64423829|NCT05186545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64423830|NCT05186545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423831|NCT05186545|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64423832|NCT05186545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64423833|NCT05186545|Hormone Antagonists|hormone antagonists|mesh-ancestor
64423834|NCT05186545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64423835|NCT05186545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423836|NCT05107765|Pioglitazone|pioglitazone|mesh-list
64423837|NCT05107765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64408092|NCT04831229|Dermatologic Agents|dermatologic agents|mesh-ancestor
64408093|NCT04816253|Methylprednisolone|methylprednisolone|mesh-list
64408141|NCT04815395|Oxytocics|oxytocics|mesh-ancestor
64408142|NCT04815395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64408143|NCT04815395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408144|NCT03096301|Salicylic Acid|salicylic acid|mesh-list
64408145|NCT03096301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64408146|NCT03096301|Antifungal Agents|antifungal agents|mesh-ancestor
64408147|NCT03096301|Keratolytic Agents|keratolytic agents|mesh-ancestor
64408148|NCT03096301|Dermatologic Agents|dermatologic agents|mesh-ancestor
64423867|NCT05177419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64423868|NCT05094427|Anesthetics|anesthetics|mesh-list
64423869|NCT05094427|Anesthetics, Local|anesthetics, local|mesh-list
64423870|NCT05094427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64423871|NCT05094427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408149|NCT05034055|Atezolizumab|atezolizumab|mesh-list
64408150|NCT05034055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408151|NCT05042245|Silymarin|silymarin|mesh-list
64408152|NCT05042245|N-Methylaspartate|n-methylaspartate|mesh-list
64408153|NCT05042245|Antioxidants|antioxidants|mesh-ancestor
64408154|NCT05042245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408155|NCT05042245|Protective Agents|protective agents|mesh-ancestor
64408156|NCT05042245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408189|NCT04814303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64408190|NCT04814303|Narcotics|narcotics|mesh-ancestor
64408191|NCT04814303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64408192|NCT04814303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339206|NCT05382104|Maribavir|maribavir|mesh-list
64408194|NCT04814303|Sensory System Agents|sensory system agents|mesh-ancestor
64423936|NCT05133817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64423937|NCT05133817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64423938|NCT05133817|Adrenergic Agents|adrenergic agents|mesh-ancestor
64423939|NCT05133817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64423940|NCT05133817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408195|NCT04814303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64408196|NCT05053009|Ibuprofen|ibuprofen|mesh-list
64408197|NCT05053009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64408198|NCT05053009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64408199|NCT05053009|Analgesics|analgesics|mesh-ancestor
64408200|NCT05053009|Sensory System Agents|sensory system agents|mesh-ancestor
64408228|NCT03094663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64408229|NCT03094663|Glucocorticoids|glucocorticoids|mesh-ancestor
64339313|NCT05264870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339314|NCT05264870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408244|NCT03094663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64423998|NCT05050981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64423999|NCT05050981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424000|NCT05050981|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64424001|NCT05050981|Serotonin Agents|serotonin agents|mesh-ancestor
64424002|NCT05050981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64424003|NCT05050981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424004|NCT05050981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64294884|NCT05712837|Analgesics|analgesics|mesh-ancestor
64424010|NCT05123131|Antiemetics|antiemetics|mesh-ancestor
64424011|NCT05123131|Autonomic Agents|autonomic agents|mesh-ancestor
64424012|NCT05123131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64424013|NCT05123131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424014|NCT05123131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64424015|NCT05123131|Glucocorticoids|glucocorticoids|mesh-ancestor
64424016|NCT05123131|Hormones|hormones|mesh-ancestor
64408245|NCT03094663|Adrenergic Agents|adrenergic agents|mesh-ancestor
64408246|NCT03094663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64408258|NCT04814381|Analgesics|analgesics|mesh-ancestor
64408259|NCT04814381|Sensory System Agents|sensory system agents|mesh-ancestor
64408260|NCT04814381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64408261|NCT04814381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408262|NCT04814381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64408263|NCT04814381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64408264|NCT04814381|Anesthetics, General|anesthetics, general|mesh-ancestor
64408265|NCT04814381|Anesthetics|anesthetics|mesh-ancestor
64408266|NCT04814381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64408267|NCT04814381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64424064|NCT01364467|Sympathomimetics|sympathomimetics|mesh-ancestor
64424065|NCT01364467|Autonomic Agents|autonomic agents|mesh-ancestor
64424066|NCT01364467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64424067|NCT01364467|Nasal Decongestants|nasal decongestants|mesh-ancestor
64424068|NCT01364467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64424069|NCT04226365|Nortriptyline|nortriptyline|mesh-list
64424070|NCT04226365|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64424071|NCT04226365|Antidepressive Agents|antidepressive agents|mesh-ancestor
64424072|NCT04226365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64424073|NCT04226365|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64424075|NCT04226365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64408268|NCT04814381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64408287|NCT05052619|Renal Agents|renal agents|mesh-ancestor
64408288|NCT05052775|Chlorhexidine|chlorhexidine|mesh-list
64408289|NCT05052775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64408290|NCT05052775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64408291|NCT05052775|Disinfectants|disinfectants|mesh-ancestor
64408292|NCT04813523|Cisplatin|cisplatin|mesh-list
64408293|NCT04813523|Pembrolizumab|pembrolizumab|mesh-list
64408294|NCT04813523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408295|NCT04813523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64408296|NCT05032261|Norepinephrine|norepinephrine|mesh-list
64408298|NCT05032261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64340043|NCT03140709|Oxytocin|oxytocin|mesh-list
64408337|NCT05038111|Dexmedetomidine|dexmedetomidine|mesh-list
64408338|NCT05038111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64408339|NCT05038111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64408341|NCT05038111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64408342|NCT05038111|Analgesics|analgesics|mesh-ancestor
64408343|NCT05038111|Sensory System Agents|sensory system agents|mesh-ancestor
64424113|NCT05057767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424114|NCT05057767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64424115|NCT05057767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64424116|NCT05057767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64424128|NCT04997317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424130|NCT04997239|Vaccines|vaccines|mesh-list
64424131|NCT04997239|Immunologic Factors|immunologic factors|mesh-ancestor
64424132|NCT04997239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424133|NCT04216693|Digoxin|digoxin|mesh-list
64408344|NCT05038111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64408345|NCT05038111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64408346|NCT05038111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64408371|NCT05037253|Vitamin D|vitamin d|mesh-list
64408372|NCT05037253|Vitamins|vitamins|mesh-ancestor
64408373|NCT05037253|Micronutrients|micronutrients|mesh-ancestor
64408374|NCT05037253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408375|NCT05037253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64408376|NCT05029297|Capsaicin|capsaicin|mesh-list
64408377|NCT05029297|Antipruritics|antipruritics|mesh-ancestor
64408378|NCT05029297|Dermatologic Agents|dermatologic agents|mesh-ancestor
64408379|NCT05029297|Sensory System Agents|sensory system agents|mesh-ancestor
64408380|NCT05029297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64408399|NCT05028907|Hormones|hormones|mesh-ancestor
64408400|NCT05028907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64408401|NCT05028907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64408402|NCT05028907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408403|NCT05028907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64408404|NCT05028907|Immunologic Factors|immunologic factors|mesh-ancestor
64408405|NCT05028907|Viscosupplements|viscosupplements|mesh-ancestor
64408406|NCT05028907|Protective Agents|protective agents|mesh-ancestor
64408407|NCT05028907|Antioxidants|antioxidants|mesh-ancestor
64408408|NCT05028907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408409|NCT05028907|Vitamins|vitamins|mesh-ancestor
64408410|NCT05028907|Micronutrients|micronutrients|mesh-ancestor
64424330|NCT02513485|Levodopa|levodopa|mesh-list
64424331|NCT02513485|Carbidopa|carbidopa|mesh-list
64424332|NCT02513485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64424333|NCT02513485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64424334|NCT02513485|Dopamine Agents|dopamine agents|mesh-ancestor
64424335|NCT02513485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64424336|NCT02513485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424337|NCT02513485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424338|NCT02513485|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64424339|NCT02513485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424340|NCT02289417|Apremilast|apremilast|mesh-list
64424341|NCT02289417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64424342|NCT02289417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64424343|NCT02289417|Analgesics|analgesics|mesh-ancestor
64408411|NCT05028907|Protease Inhibitors|protease inhibitors|mesh-ancestor
64408438|NCT05028049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64408440|NCT05028049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64408441|NCT05028049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340403|NCT00840281|Cefprozil|cefprozil|mesh-list
64408455|NCT05023915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408456|NCT05023915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64408457|NCT05023915|Glucocorticoids|glucocorticoids|mesh-ancestor
64408458|NCT05023915|Hormones|hormones|mesh-ancestor
64408459|NCT05023915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64408460|NCT05023915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64408461|NCT05023915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408462|NCT05027581|Hyaluronic Acid|hyaluronic acid|mesh-list
64408463|NCT05027581|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64408464|NCT05027581|Immunologic Factors|immunologic factors|mesh-ancestor
64408465|NCT05027581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408466|NCT05027581|Viscosupplements|viscosupplements|mesh-ancestor
64408467|NCT05027581|Protective Agents|protective agents|mesh-ancestor
64408468|NCT05027191|Sevoflurane|sevoflurane|mesh-list
64408469|NCT05027191|Desflurane|desflurane|mesh-list
64408470|NCT05027191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64408471|NCT05027191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64424476|NCT04966585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64424477|NCT04966585|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64408472|NCT05027191|Anesthetics, General|anesthetics, general|mesh-ancestor
64408473|NCT05027191|Anesthetics|anesthetics|mesh-ancestor
64408474|NCT05027191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64408475|NCT05027191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408476|NCT03094507|Dolutegravir|dolutegravir|mesh-list
64408477|NCT03094507|Darunavir|darunavir|mesh-list
64408478|NCT03094507|Cobicistat|cobicistat|mesh-list
64340634|NCT00834743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64340636|NCT00834587|Metformin|metformin|mesh-list
64408479|NCT03094507|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64408480|NCT03094507|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64408481|NCT03094507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64408482|NCT03094507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408483|NCT03094507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64424570|NCT04877613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424571|NCT04877613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424572|NCT04877613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64424574|NCT02354235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64424576|NCT02354235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64408494|NCT02528253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64408495|NCT02528253|Narcotics|narcotics|mesh-ancestor
64408500|NCT02528253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64408501|NCT03093103|Empagliflozin|empagliflozin|mesh-list
64408502|NCT03093103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64408503|NCT03093103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408504|NCT03093103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64408505|NCT03093103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408518|NCT01672957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64408519|NCT01672957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64408521|NCT01672957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408522|NCT01672957|Immunologic Factors|immunologic factors|mesh-ancestor
64408523|NCT01672957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424647|NCT02495389|Adrenergic Agents|adrenergic agents|mesh-ancestor
64424648|NCT02495389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64424649|NCT02495389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424650|NCT02495389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424651|NCT02495389|Urological Agents|urological agents|mesh-ancestor
64424652|NCT02495233|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64424653|NCT02495233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424654|NCT02495233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64340853|NCT04869436|Immunologic Factors|immunologic factors|mesh-ancestor
64340854|NCT04869436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340855|NCT05170256|Trastuzumab|trastuzumab|mesh-list
64340856|NCT05170256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64340857|NCT05170256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408552|NCT05021731|Leprostatic Agents|leprostatic agents|mesh-ancestor
64408553|NCT05021731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64424718|NCT02278263|Coagulants|coagulants|mesh-ancestor
64424720|NCT02494921|Docetaxel|docetaxel|mesh-list
64424721|NCT02494921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424722|NCT02494921|Tubulin Modulators|tubulin modulators|mesh-ancestor
64424723|NCT02494921|Antimitotic Agents|antimitotic agents|mesh-ancestor
64408554|NCT05021731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64408555|NCT05021731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408556|NCT05021731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64408557|NCT05021731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64408558|NCT05021731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64408559|NCT05021731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64408560|NCT05021731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64408561|NCT05021731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64408562|NCT05021731|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64424811|NCT04957615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424812|NCT02490475|Docetaxel|docetaxel|mesh-list
64424813|NCT02490475|Pertuzumab|pertuzumab|mesh-list
64424814|NCT02490475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424815|NCT02490475|Tubulin Modulators|tubulin modulators|mesh-ancestor
64424816|NCT02490475|Antimitotic Agents|antimitotic agents|mesh-ancestor
64424817|NCT02490475|Mitosis Modulators|mitosis modulators|mesh-ancestor
64424818|NCT02490475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424819|NCT02490475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64424820|NCT02477839|Lacosamide|lacosamide|mesh-list
64424821|NCT02477839|Anticonvulsants|anticonvulsants|mesh-ancestor
64424822|NCT02477839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64424823|NCT02477839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64424824|NCT02477839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64424825|NCT02477839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424826|NCT04939987|Acetaminophen|acetaminophen|mesh-list
64424827|NCT04939987|Ketorolac|ketorolac|mesh-list
64424828|NCT04939987|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64424830|NCT04939987|Ketamine|ketamine|mesh-list
64408563|NCT05021731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64408564|NCT05021731|Antimetabolites|antimetabolites|mesh-ancestor
64408565|NCT05021731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64408566|NCT05009953|Leucovorin|leucovorin|mesh-list
64408567|NCT05009953|Fluorouracil|fluorouracil|mesh-list
64408568|NCT05009953|Irinotecan|irinotecan|mesh-list
64408569|NCT05009953|Antimetabolites|antimetabolites|mesh-ancestor
64408587|NCT03079453|Autonomic Agents|autonomic agents|mesh-ancestor
64408588|NCT03079453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64424855|NCT04939987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64424856|NCT04939987|Antimanic Agents|antimanic agents|mesh-ancestor
64424869|NCT02477215|Dexamethasone|dexamethasone|mesh-list
64340908|NCT02270242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408602|NCT04294459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64408603|NCT04294459|Analgesics|analgesics|mesh-ancestor
64408604|NCT04294459|Sensory System Agents|sensory system agents|mesh-ancestor
64408605|NCT04294459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64408606|NCT04294459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408607|NCT04294459|Antipyretics|antipyretics|mesh-ancestor
64408608|NCT04294459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64408609|NCT04294459|Antiemetics|antiemetics|mesh-ancestor
64424940|NCT02449915|Anesthetics, Local|anesthetics, local|mesh-ancestor
64424941|NCT02449915|Anesthetics|anesthetics|mesh-ancestor
64424942|NCT02449915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64424943|NCT02449915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424944|NCT02449915|Sensory System Agents|sensory system agents|mesh-ancestor
64424945|NCT02449915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64424946|NCT02472847|Dronabinol|dronabinol|mesh-list
64424947|NCT02472847|Hallucinogens|hallucinogens|mesh-ancestor
64424948|NCT02472847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424949|NCT02472847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64424950|NCT02472847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64424951|NCT02472847|Analgesics|analgesics|mesh-ancestor
64424952|NCT02472847|Sensory System Agents|sensory system agents|mesh-ancestor
64424953|NCT02472847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64424954|NCT02472847|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64424955|NCT02472847|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64424956|NCT02472847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64424958|NCT02472847|Hormones|hormones|mesh-ancestor
64425003|NCT02417935|Anticonvulsants|anticonvulsants|mesh-ancestor
64425004|NCT02417935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64425005|NCT02417935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64425006|NCT02417935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425007|NCT02417935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64425008|NCT02417935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64425009|NCT02417935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64425010|NCT02417935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64425011|NCT02417935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64408610|NCT04294459|Autonomic Agents|autonomic agents|mesh-ancestor
64408611|NCT04294459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64408612|NCT04294459|Glucocorticoids|glucocorticoids|mesh-ancestor
64340926|NCT04875364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408613|NCT04294459|Hormones|hormones|mesh-ancestor
64408614|NCT04294459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64408712|NCT05016349|Tocopherols|tocopherols|mesh-list
64408713|NCT05016349|Tretinoin|tretinoin|mesh-list
64408714|NCT05016349|Alitretinoin|alitretinoin|mesh-list
64408715|NCT05016349|Cannabidiol|cannabidiol|mesh-list
64408716|NCT05016349|Isotretinoin|isotretinoin|mesh-list
64408717|NCT05016349|Mifepristone|mifepristone|mesh-list
64408718|NCT05016349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64408719|NCT05016349|Hormone Antagonists|hormone antagonists|mesh-ancestor
64408720|NCT05016349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64408721|NCT05016349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408722|NCT05016349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64408723|NCT05016349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341071|NCT02268058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425070|NCT02446015|Lubricant Eye Drops|lubricant eye drops|mesh-list
64425071|NCT02446015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64425072|NCT02415127|Interferons|interferons|mesh-list
64425073|NCT02415127|Interferon-gamma|interferon-gamma|mesh-list
64425074|NCT02415127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425075|NCT02415127|Antiviral Agents|antiviral agents|mesh-ancestor
64425076|NCT02415127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64425077|NCT02468557|Paclitaxel|paclitaxel|mesh-list
64425078|NCT02468557|Idelalisib|idelalisib|mesh-list
64425138|NCT01642251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64425139|NCT01642251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64425140|NCT01642251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64425141|NCT01642251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425142|NCT01642251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425144|NCT01642251|Keratolytic Agents|keratolytic agents|mesh-ancestor
64408724|NCT05016349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64408725|NCT05016349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64408736|NCT05016349|Contraceptive Agents|contraceptive agents|mesh-ancestor
64408737|NCT05016349|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64408738|NCT05016349|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64408739|NCT05016349|Luteolytic Agents|luteolytic agents|mesh-ancestor
64408740|NCT05016349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64341321|NCT03964207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64408741|NCT05016349|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64408742|NCT05016349|Antioxidants|antioxidants|mesh-ancestor
64408743|NCT05016349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408744|NCT05016349|Protective Agents|protective agents|mesh-ancestor
64408746|NCT05016349|Micronutrients|micronutrients|mesh-ancestor
64408747|NCT05380635|Hypericin|hypericin|mesh-list
64408748|NCT05380635|Antidepressive Agents|antidepressive agents|mesh-ancestor
64408774|NCT03079219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64408775|NCT03079219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408776|NCT03079219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64425214|NCT02272725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64425215|NCT02272725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64408777|NCT03079219|Glucocorticoids|glucocorticoids|mesh-ancestor
64408778|NCT03079219|Hormones|hormones|mesh-ancestor
64408779|NCT03079219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64408780|NCT03079219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64408781|NCT03079219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408782|NCT03079219|Protease Inhibitors|protease inhibitors|mesh-ancestor
64408783|NCT03079219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64408784|NCT03079219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408785|NCT03079219|Antipruritics|antipruritics|mesh-ancestor
64408786|NCT03079219|Dermatologic Agents|dermatologic agents|mesh-ancestor
64408787|NCT03079219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64408788|NCT03079219|Serotonin Agents|serotonin agents|mesh-ancestor
64408789|NCT03079219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64408806|NCT05008237|Docetaxel|docetaxel|mesh-list
64408839|NCT05018923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64408840|NCT05018923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64408841|NCT05018923|Antacids|antacids|mesh-ancestor
64408842|NCT05018923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64408843|NCT05018923|Diuretics|diuretics|mesh-ancestor
64408844|NCT05018923|Natriuretic Agents|natriuretic agents|mesh-ancestor
64408845|NCT05018923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425285|NCT04910425|Fluorides|fluorides|mesh-list
64408846|NCT05018923|Expectorants|expectorants|mesh-ancestor
64408847|NCT05018923|Respiratory System Agents|respiratory system agents|mesh-ancestor
64408848|NCT03086473|Caffeine|caffeine|mesh-list
64408849|NCT03086473|Caffeine citrate|caffeine citrate|mesh-list
64408850|NCT03086473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408851|NCT03086473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64408859|NCT03086005|Metformin|metformin|mesh-list
64408913|NCT05006911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408914|NCT05006911|Viscosupplements|viscosupplements|mesh-ancestor
64408915|NCT05006911|Protective Agents|protective agents|mesh-ancestor
64408916|NCT05006911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64408917|NCT05006911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64425364|NCT02462473|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64425365|NCT02462473|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64425367|NCT05405309|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64425368|NCT05405309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425369|NCT05405309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408918|NCT05006911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64408919|NCT05006911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64408920|NCT05006911|Adrenergic Agents|adrenergic agents|mesh-ancestor
64408932|NCT05006911|Miotics|miotics|mesh-ancestor
64408933|NCT05006911|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64408934|NCT05006911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64408935|NCT05006911|Cholinergic Agents|cholinergic agents|mesh-ancestor
64408936|NCT05006911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64408937|NCT05006911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64408938|NCT05006911|Analgesics|analgesics|mesh-ancestor
64408939|NCT05006911|Sensory System Agents|sensory system agents|mesh-ancestor
64425419|NCT02532647|Anesthetics, General|anesthetics, general|mesh-ancestor
64425431|NCT01660763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64425433|NCT01660763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64425434|NCT01660763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425435|NCT01660763|Analgesics|analgesics|mesh-ancestor
64425440|NCT01660763|Anesthetics, General|anesthetics, general|mesh-ancestor
64425510|NCT02438371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425511|NCT02438371|Vasodilator Agents|vasodilator agents|mesh-ancestor
64425512|NCT02438371|Tocolytic Agents|tocolytic agents|mesh-ancestor
64408940|NCT05006911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64408941|NCT05006911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64408971|NCT02637895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64341374|NCT01869361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64409008|NCT05305911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64409009|NCT05305911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409010|NCT05349435|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64409011|NCT05349435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409012|NCT05007223|Doxycycline|doxycycline|mesh-list
64409015|NCT05007223|Antimalarials|antimalarials|mesh-ancestor
64409030|NCT03081949|Selenium|selenium|mesh-list
64409031|NCT03081949|Selenious Acid|selenious acid|mesh-list
64409032|NCT03081949|Sodium Selenite|sodium selenite|mesh-list
64409033|NCT03081949|Antioxidants|antioxidants|mesh-ancestor
64409035|NCT03081949|Protective Agents|protective agents|mesh-ancestor
64409077|NCT05335629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64409078|NCT05335629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409079|NCT03076099|Dexmedetomidine|dexmedetomidine|mesh-list
64409080|NCT03076099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64409081|NCT03076099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64409082|NCT03076099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409083|NCT03076099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64409085|NCT03076099|Sensory System Agents|sensory system agents|mesh-ancestor
64409086|NCT03076099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409087|NCT03076099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64409088|NCT03076099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64409089|NCT03076099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64409090|NCT03076099|Adrenergic Agents|adrenergic agents|mesh-ancestor
64409091|NCT03076099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64409092|NCT03076099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409093|NCT05554965|Propofol|propofol|mesh-list
64409094|NCT05554965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64409095|NCT05554965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64409096|NCT05554965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409193|NCT05294835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64409194|NCT05294835|Anesthetics, General|anesthetics, general|mesh-ancestor
64409196|NCT05294835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64409197|NCT05294835|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64409198|NCT05294835|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64409199|NCT05294835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64409200|NCT05294835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409201|NCT02522325|Cocaine|cocaine|mesh-list
64409202|NCT02522325|Phendimetrazine|phendimetrazine|mesh-list
64425655|NCT02258529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64425656|NCT02258529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425657|NCT02258529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425659|NCT02256969|Prednisolone|prednisolone|mesh-list
64425660|NCT02256969|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64425661|NCT02256969|Methylprednisolone|methylprednisolone|mesh-list
64425662|NCT02256969|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64425663|NCT02256969|Prednisolone acetate|prednisolone acetate|mesh-list
64425664|NCT02256969|Mineral Oil|mineral oil|mesh-list
64409203|NCT02522325|Anesthetics, Local|anesthetics, local|mesh-ancestor
64409204|NCT02522325|Anesthetics|anesthetics|mesh-ancestor
64409205|NCT02522325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64409206|NCT02522325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409207|NCT02522325|Sensory System Agents|sensory system agents|mesh-ancestor
64409208|NCT02522325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409209|NCT02522325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64409210|NCT02522325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64409211|NCT02522325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64409227|NCT01659021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409228|NCT01659021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409245|NCT04925167|Argatroban|argatroban|mesh-list
64409246|NCT04925167|Anticoagulants|anticoagulants|mesh-ancestor
64409247|NCT04925167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64409248|NCT04925167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64409249|NCT04925167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409250|NCT04925167|Antithrombins|antithrombins|mesh-ancestor
64409251|NCT04925167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64409252|NCT04925167|Protease Inhibitors|protease inhibitors|mesh-ancestor
64409253|NCT04925167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409254|NCT04925167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64409255|NCT05011669|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64409256|NCT05011669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64409257|NCT05011669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64409258|NCT05011669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64409259|NCT05011669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409260|NCT05011669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64425721|NCT01640301|Aldesleukin|aldesleukin|mesh-list
64425722|NCT01640301|Cyclophosphamide|cyclophosphamide|mesh-list
64425723|NCT01640301|Fludarabine|fludarabine|mesh-list
64409261|NCT05011669|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64409262|NCT05011669|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64409263|NCT05011669|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64409264|NCT05011669|Adrenergic Agents|adrenergic agents|mesh-ancestor
64409265|NCT05011669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64409266|NCT05011669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409267|NCT05011669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64409268|NCT05011669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64409269|NCT05011669|Serotonin Agents|serotonin agents|mesh-ancestor
64425774|NCT05640375|Protective Agents|protective agents|mesh-ancestor
64425775|NCT05640375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64425776|NCT05640375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425777|NCT01641237|Listerine|listerine|mesh-list
64425778|NCT01641237|Fluorides|fluorides|mesh-list
64425779|NCT01641237|Sodium Fluoride|sodium fluoride|mesh-list
64425780|NCT01641237|Cariostatic Agents|cariostatic agents|mesh-ancestor
64409270|NCT05011669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64409271|NCT05011669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64409272|NCT05011669|Dopamine Agents|dopamine agents|mesh-ancestor
64409273|NCT02524665|Salicylic Acid|salicylic acid|mesh-list
64409274|NCT02524665|Salicylates|salicylates|mesh-list
64409275|NCT02524665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64409276|NCT02524665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64409279|NCT02524665|Dermatologic Agents|dermatologic agents|mesh-ancestor
64409280|NCT02524665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64409281|NCT02524665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64409282|NCT02524665|Analgesics|analgesics|mesh-ancestor
64409283|NCT02524665|Sensory System Agents|sensory system agents|mesh-ancestor
64409284|NCT02524665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409285|NCT02524665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409286|NCT02524665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64409287|NCT02524665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64425868|NCT04853355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64425869|NCT04853355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425870|NCT04853355|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64425871|NCT04853355|Diuretics|diuretics|mesh-ancestor
64425893|NCT05422365|Antibodies|antibodies|mesh-list
64409288|NCT02524665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64409289|NCT02524665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409345|NCT04997707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64409346|NCT04997707|Anesthetics, General|anesthetics, general|mesh-ancestor
64409347|NCT04997707|Anesthetics|anesthetics|mesh-ancestor
64425977|NCT05329779|GABA Modulators|gaba modulators|mesh-ancestor
64409348|NCT04997707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64409349|NCT04997707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64409350|NCT05010499|Bupivacaine|bupivacaine|mesh-list
64341445|NCT03496831|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64409352|NCT05010499|Anesthetics, Local|anesthetics, local|mesh-ancestor
64409353|NCT05010499|Anesthetics|anesthetics|mesh-ancestor
64409354|NCT05010499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64409355|NCT05010499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409356|NCT05010499|Sensory System Agents|sensory system agents|mesh-ancestor
64409369|NCT04994119|Zamicastat|zamicastat|mesh-list
64426067|NCT05396859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426068|NCT05396859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426073|NCT04254549|Rifaximin|rifaximin|mesh-list
64409370|NCT04994119|Anticoagulants|anticoagulants|mesh-ancestor
64409371|NCT04994119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409372|NCT04994119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409373|NCT01658943|Fluorouracil|fluorouracil|mesh-list
64409374|NCT01658943|Oxaliplatin|oxaliplatin|mesh-list
64409375|NCT01658943|Antimetabolites|antimetabolites|mesh-ancestor
64409376|NCT01658943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409377|NCT01658943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64409378|NCT01658943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426136|NCT03256149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64426137|NCT03256149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426138|NCT03253263|Mecasermin|mecasermin|mesh-list
64426139|NCT03253263|Growth Substances|growth substances|mesh-ancestor
64426140|NCT03253263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426141|NCT01636947|Dexamethasone|dexamethasone|mesh-list
64426142|NCT01636947|Dexamethasone acetate|dexamethasone acetate|mesh-list
64426143|NCT01636947|Ondansetron|ondansetron|mesh-list
64426215|NCT02775435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64426216|NCT02775435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426217|NCT02775435|Tubulin Modulators|tubulin modulators|mesh-ancestor
64426218|NCT02775435|Antimitotic Agents|antimitotic agents|mesh-ancestor
64426219|NCT02775435|Mitosis Modulators|mitosis modulators|mesh-ancestor
64426220|NCT02775435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426221|NCT02775435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64426222|NCT02774421|Trastuzumab|trastuzumab|mesh-list
64426223|NCT02774421|Molgramostim|molgramostim|mesh-list
64409379|NCT01658943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64409380|NCT01658943|Immunologic Factors|immunologic factors|mesh-ancestor
64409381|NCT01658943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409382|NCT02600819|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64409383|NCT02600819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64409384|NCT02600819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64409385|NCT02600819|Antiviral Agents|antiviral agents|mesh-ancestor
64409386|NCT02600819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64409387|NCT04433533|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64409389|NCT04433533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64409397|NCT03074773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64409398|NCT03074773|Antiemetics|antiemetics|mesh-ancestor
64409399|NCT03074773|Autonomic Agents|autonomic agents|mesh-ancestor
64409400|NCT03074773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409401|NCT03074773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426287|NCT04803201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64426288|NCT04803201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64426289|NCT04803201|Alkylating Agents|alkylating agents|mesh-ancestor
64426290|NCT04803201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426291|NCT04803201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409402|NCT03074773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64409403|NCT03074773|Glucocorticoids|glucocorticoids|mesh-ancestor
64409404|NCT03074773|Hormones|hormones|mesh-ancestor
64409405|NCT03074773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64409406|NCT03074773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64409407|NCT03074773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409408|NCT03074773|Anesthetics, Local|anesthetics, local|mesh-ancestor
64409409|NCT03074773|Anesthetics|anesthetics|mesh-ancestor
64409410|NCT03074773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64409411|NCT03074773|Sensory System Agents|sensory system agents|mesh-ancestor
64409412|NCT03077581|Anesthetics|anesthetics|mesh-list
64409413|NCT03077581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64409414|NCT03077581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409415|NCT03077503|Fentanyl|fentanyl|mesh-list
64409416|NCT03077503|Dexmedetomidine|dexmedetomidine|mesh-list
64409417|NCT03077503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64409421|NCT03077503|Analgesics|analgesics|mesh-ancestor
64409422|NCT03077503|Sensory System Agents|sensory system agents|mesh-ancestor
64409423|NCT03077503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409424|NCT03077503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64426353|NCT05190705|Dexamethasone|dexamethasone|mesh-list
64426354|NCT05190705|Dexamethasone acetate|dexamethasone acetate|mesh-list
64426355|NCT05190705|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
64426356|NCT05190705|BB 1101|bb 1101|mesh-list
64426357|NCT05190705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64426358|NCT05190705|Antiemetics|antiemetics|mesh-ancestor
64426359|NCT05190705|Autonomic Agents|autonomic agents|mesh-ancestor
64426360|NCT05190705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409425|NCT03077503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64409426|NCT03077503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64409427|NCT03077503|Adrenergic Agents|adrenergic agents|mesh-ancestor
64409428|NCT03077503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64409429|NCT03077503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409437|NCT05246085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64409438|NCT05518695|Antibodies, Blocking|antibodies, blocking|mesh-list
64426426|NCT04192773|Sensory System Agents|sensory system agents|mesh-ancestor
64426427|NCT04192773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426428|NCT04192773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64426429|NCT04192773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64426430|NCT04192773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64426431|NCT04192773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64426432|NCT04192773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426434|NCT04784247|Lenvatinib|lenvatinib|mesh-list
64426461|NCT04800471|Insulin|insulin|mesh-list
64409439|NCT05518695|Immunologic Factors|immunologic factors|mesh-ancestor
64409440|NCT05518695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409447|NCT05282901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409448|NCT05282901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64409449|NCT05282901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409450|NCT05282901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409451|NCT03073057|Budesonide|budesonide|mesh-list
64409452|NCT03073057|Formoterol Fumarate|formoterol fumarate|mesh-list
64409453|NCT03073057|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64409454|NCT03073057|Charcoal|charcoal|mesh-list
64409455|NCT03073057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64409456|NCT03073057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64426494|NCT04716387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64426495|NCT04716387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64426496|NCT01068249|Everolimus|everolimus|mesh-list
64426497|NCT01068249|Letrozole|letrozole|mesh-list
64426498|NCT01068249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426499|NCT01068249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64426500|NCT01068249|Immunologic Factors|immunologic factors|mesh-ancestor
64426501|NCT01068249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426502|NCT01068249|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64409457|NCT03073057|Autonomic Agents|autonomic agents|mesh-ancestor
64409458|NCT03073057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409459|NCT03073057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409460|NCT03073057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64409461|NCT03073057|Respiratory System Agents|respiratory system agents|mesh-ancestor
64409462|NCT03073057|Glucocorticoids|glucocorticoids|mesh-ancestor
64409463|NCT03073057|Hormones|hormones|mesh-ancestor
64409464|NCT03073057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64409465|NCT03073057|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64409466|NCT03073057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64409467|NCT03073057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64409468|NCT03073057|Adrenergic Agents|adrenergic agents|mesh-ancestor
64409471|NCT03073057|Antidotes|antidotes|mesh-ancestor
64409475|NCT03073369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64409476|NCT03073369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409477|NCT03073369|Vitamins|vitamins|mesh-ancestor
64409478|NCT03073369|Micronutrients|micronutrients|mesh-ancestor
64409479|NCT03073369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64409480|NCT04433611|Lidocaine|lidocaine|mesh-list
64409481|NCT04433611|Anesthetics, Local|anesthetics, local|mesh-ancestor
64409482|NCT04433611|Anesthetics|anesthetics|mesh-ancestor
64409483|NCT04433611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64409484|NCT04433611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426558|NCT00098475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64426559|NCT00098475|Leprostatic Agents|leprostatic agents|mesh-ancestor
64426560|NCT00098475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64426561|NCT00098475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64426562|NCT00098475|Dermatologic Agents|dermatologic agents|mesh-ancestor
64426564|NCT02246673|Verinurad|verinurad|mesh-list
64426565|NCT02246673|Gout Suppressants|gout suppressants|mesh-ancestor
64426566|NCT02246673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64426567|NCT03532425|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64426568|NCT03532425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64426589|NCT04191447|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64426590|NCT04191447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64426592|NCT04191447|Adrenergic Agents|adrenergic agents|mesh-ancestor
64426593|NCT04191447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64426594|NCT04191447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426595|NCT04274361|Ketamine|ketamine|mesh-list
64409485|NCT04433611|Sensory System Agents|sensory system agents|mesh-ancestor
64409486|NCT04433611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409487|NCT04433611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64409488|NCT04433611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64409503|NCT04911127|Anticonvulsants|anticonvulsants|mesh-ancestor
64409504|NCT04995133|Colistin|colistin|mesh-list
64409505|NCT04995133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64409506|NCT04995133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64409507|NCT04362839|Nivolumab|nivolumab|mesh-list
64409508|NCT04362839|Ipilimumab|ipilimumab|mesh-list
64426613|NCT04251819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426614|NCT04251819|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64426615|NCT04251819|GABA Agonists|gaba agonists|mesh-ancestor
64426616|NCT04251819|GABA Agents|gaba agents|mesh-ancestor
64426617|NCT04251819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64426618|NCT04251819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426619|NCT02243631|Probenecid|probenecid|mesh-list
64426681|NCT01632891|Lopinavir|lopinavir|mesh-list
64409509|NCT04362839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64409536|NCT04807829|Autonomic Agents|autonomic agents|mesh-ancestor
64409537|NCT04807829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409538|NCT04807829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409539|NCT04807829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64409540|NCT04807829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64409541|NCT04807829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64409542|NCT04807829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64426740|NCT02207907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64426741|NCT02207829|Tiotropium Bromide|tiotropium bromide|mesh-list
64426742|NCT02207829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64426743|NCT02207829|Autonomic Agents|autonomic agents|mesh-ancestor
64426744|NCT02207829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426745|NCT02207829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426746|NCT02207829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64426747|NCT02207829|Respiratory System Agents|respiratory system agents|mesh-ancestor
64426748|NCT02207829|Parasympatholytics|parasympatholytics|mesh-ancestor
64426749|NCT02207829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64426750|NCT02207829|Cholinergic Agents|cholinergic agents|mesh-ancestor
64426751|NCT02207829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64426752|NCT02207829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426753|NCT02237157|Gemcitabine|gemcitabine|mesh-list
64426754|NCT02237157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64426755|NCT02237157|Antimetabolites|antimetabolites|mesh-ancestor
64426756|NCT02237157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426757|NCT02237157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426758|NCT02237157|Antiviral Agents|antiviral agents|mesh-ancestor
64426759|NCT02237157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64426760|NCT02237157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426761|NCT02237157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64426762|NCT02237157|Immunologic Factors|immunologic factors|mesh-ancestor
64409543|NCT04807829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64409544|NCT04811573|Thalidomide|thalidomide|mesh-list
64409545|NCT04811573|Apremilast|apremilast|mesh-list
64409546|NCT04811573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64409547|NCT04811573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64409548|NCT04811573|Analgesics|analgesics|mesh-ancestor
64409549|NCT04811573|Sensory System Agents|sensory system agents|mesh-ancestor
64409550|NCT04811573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409551|NCT04811573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426789|NCT02233803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64426790|NCT02233803|Adrenergic Agents|adrenergic agents|mesh-ancestor
64426791|NCT02233803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64426792|NCT02233803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426794|NCT02233647|Anesthetics, Local|anesthetics, local|mesh-ancestor
64426795|NCT02233647|Anesthetics|anesthetics|mesh-ancestor
64409559|NCT04811573|Immunologic Factors|immunologic factors|mesh-ancestor
64409560|NCT04811573|Leprostatic Agents|leprostatic agents|mesh-ancestor
64409561|NCT04811573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64409562|NCT04811573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64409563|NCT04811573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64409564|NCT04811573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64409565|NCT04811573|Growth Substances|growth substances|mesh-ancestor
64409566|NCT04811573|Growth Inhibitors|growth inhibitors|mesh-ancestor
64409567|NCT04811573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409569|NCT03072511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64409570|NCT03072511|Autonomic Agents|autonomic agents|mesh-ancestor
64409571|NCT03072511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409578|NCT03072121|Aspirin|aspirin|mesh-list
64409583|NCT03072121|Trimetazidine|trimetazidine|mesh-list
64409584|NCT03072121|Clopidogrel|clopidogrel|mesh-list
64409585|NCT03072121|Atorvastatin|atorvastatin|mesh-list
64409586|NCT03072121|Calcium|calcium|mesh-list
64409587|NCT03072121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64409588|NCT03072121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409589|NCT03072121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64409590|NCT03072121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64409591|NCT03072121|Analgesics|analgesics|mesh-ancestor
64409592|NCT03072121|Sensory System Agents|sensory system agents|mesh-ancestor
64409593|NCT03072121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409594|NCT03072121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64409595|NCT03072121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64409596|NCT03072121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64409597|NCT03072121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64426888|NCT02227875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426889|NCT02203149|Grazoprevir|grazoprevir|mesh-list
64426890|NCT02203149|Antiviral Agents|antiviral agents|mesh-ancestor
64426891|NCT02203149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64426892|NCT02520063|Everolimus|everolimus|mesh-list
64426894|NCT02520063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426895|NCT02520063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64426896|NCT02520063|Immunologic Factors|immunologic factors|mesh-ancestor
64426897|NCT02520063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426898|NCT02520063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64426899|NCT02520063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64426900|NCT02520063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426901|NCT02520063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409598|NCT03072121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409599|NCT03072121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64409600|NCT03072121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64409601|NCT03072121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409602|NCT03072121|Antipyretics|antipyretics|mesh-ancestor
64409603|NCT03072121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64409604|NCT03072121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64409605|NCT03072121|Antimetabolites|antimetabolites|mesh-ancestor
64409606|NCT03072121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64409607|NCT03072121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64409608|NCT03072121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64409609|NCT03072121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64409610|NCT03072121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64409611|NCT03072121|Purinergic Agents|purinergic agents|mesh-ancestor
64426924|NCT02226003|Ertugliflozin|ertugliflozin|mesh-list
64426925|NCT02226003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64426926|NCT02226003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426927|NCT02226003|Incretins|incretins|mesh-ancestor
64426928|NCT02226003|Hormones|hormones|mesh-ancestor
64426929|NCT02226003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64426930|NCT02226003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64426931|NCT02226003|Protease Inhibitors|protease inhibitors|mesh-ancestor
64409612|NCT03072121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64409636|NCT04987567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409637|NCT03072199|Rituximab|rituximab|mesh-list
64341501|NCT00724841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409644|NCT04806737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64409645|NCT04806737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64409646|NCT04806737|Analgesics|analgesics|mesh-ancestor
64409647|NCT04806737|Sensory System Agents|sensory system agents|mesh-ancestor
64409648|NCT04806737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409649|NCT04806737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409650|NCT04806737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64409651|NCT04806737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64426991|NCT04763577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426992|NCT02201901|Sofosbuvir|sofosbuvir|mesh-list
64426993|NCT02201901|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64426994|NCT02201901|Velpatasvir|velpatasvir|mesh-list
64426995|NCT02201901|Antiviral Agents|antiviral agents|mesh-ancestor
64426996|NCT02201901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64427013|NCT04774107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427014|NCT04774107|Antiviral Agents|antiviral agents|mesh-ancestor
64427015|NCT04774107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64427016|NCT02457793|Ravoxertinib|ravoxertinib|mesh-list
64427017|NCT02457793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427018|NCT02457793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64427019|NCT02457793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409652|NCT04806737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64409653|NCT04806737|Immunologic Factors|immunologic factors|mesh-ancestor
64409655|NCT04991155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409656|NCT04991155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409657|NCT04462315|Cobalt|cobalt|mesh-list
64409658|NCT04462315|Chromium|chromium|mesh-list
64409659|NCT04462315|Everolimus|everolimus|mesh-list
64409660|NCT04462315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409661|NCT04462315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64409662|NCT04462315|Immunologic Factors|immunologic factors|mesh-ancestor
64409663|NCT04462315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409664|NCT04462315|Trace Elements|trace elements|mesh-ancestor
64409665|NCT04462315|Micronutrients|micronutrients|mesh-ancestor
64409666|NCT04806425|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64409667|NCT04806425|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64409694|NCT04255927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409696|NCT03069781|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64409697|NCT03069781|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64409699|NCT03069781|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64409700|NCT03069781|Estrogens|estrogens|mesh-ancestor
64409701|NCT03069781|Hormones|hormones|mesh-ancestor
64409702|NCT03069781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64409703|NCT03069781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409704|NCT03069781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64409705|NCT03069781|Contraceptive Agents|contraceptive agents|mesh-ancestor
64409706|NCT03069781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64409707|NCT03069781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64409708|NCT03071575|Vaccines|vaccines|mesh-list
64409709|NCT03071575|Immunologic Factors|immunologic factors|mesh-ancestor
64409710|NCT03071575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409711|NCT04798391|Dexamethasone|dexamethasone|mesh-list
64409712|NCT04798391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64409713|NCT04798391|Antiemetics|antiemetics|mesh-ancestor
64409714|NCT04798391|Autonomic Agents|autonomic agents|mesh-ancestor
64409735|NCT04986319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64427057|NCT01439997|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64427071|NCT02457247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64427074|NCT04929535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64427075|NCT02198235|Dexamethasone|dexamethasone|mesh-list
64427076|NCT02198235|Buprenorphine|buprenorphine|mesh-list
64409737|NCT02593097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64341555|NCT03420521|Ipilimumab|ipilimumab|mesh-list
64409738|NCT02593097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409739|NCT04805801|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64409749|NCT01657461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64409750|NCT01657461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64409751|NCT01657461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409753|NCT05001919|Mitosis Modulators|mitosis modulators|mesh-ancestor
64409754|NCT05001919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409755|NCT05001763|Prucalopride|prucalopride|mesh-list
64409756|NCT05001763|Laxatives|laxatives|mesh-ancestor
64409757|NCT05001763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64409758|NCT05001763|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64409759|NCT05001763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64427110|NCT04929379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427111|NCT04929379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64427113|NCT02217501|Clopidogrel|clopidogrel|mesh-list
64427114|NCT02217501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64427115|NCT02217501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64427116|NCT02217501|Analgesics|analgesics|mesh-ancestor
64409760|NCT05001763|Serotonin Agents|serotonin agents|mesh-ancestor
64409761|NCT05001763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64409762|NCT05001763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409763|NCT05001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409764|NCT04989985|Oxaliplatin|oxaliplatin|mesh-list
64409765|NCT04989985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409766|NCT02592551|Durvalumab|durvalumab|mesh-list
64409767|NCT02592551|Tremelimumab|tremelimumab|mesh-list
64409768|NCT02592551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64409769|NCT02592551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409770|NCT04989127|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64409771|NCT04989127|Penicillins|penicillins|mesh-list
64409772|NCT04989127|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64409773|NCT04989127|Analgesics|analgesics|mesh-list
64409774|NCT04989127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64409775|NCT04989127|Antitubercular Agents|antitubercular agents|mesh-ancestor
64409776|NCT04989127|Sensory System Agents|sensory system agents|mesh-ancestor
64409787|NCT04982809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64409788|NCT04982809|Glucocorticoids|glucocorticoids|mesh-ancestor
64427191|NCT02397889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64427192|NCT02397889|Anesthetics, General|anesthetics, general|mesh-ancestor
64427193|NCT02397889|Anesthetics|anesthetics|mesh-ancestor
64427194|NCT02397889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64427195|NCT02397889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64427196|NCT02397889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64427206|NCT02396953|Lanreotide|lanreotide|mesh-list
64409789|NCT04982809|Hormones|hormones|mesh-ancestor
64409790|NCT04982809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64409791|NCT04982809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64409792|NCT04982809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409793|NCT04982809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64409794|NCT04982809|Respiratory System Agents|respiratory system agents|mesh-ancestor
64409795|NCT03068533|Calcium Carbonate|calcium carbonate|mesh-list
64409796|NCT03068533|Calcium|calcium|mesh-list
64409797|NCT03068533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64409798|NCT03068533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409799|NCT03068533|Antacids|antacids|mesh-ancestor
64409800|NCT03068533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409801|NCT03068533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64409802|NCT05281341|Hormones|hormones|mesh-list
64409803|NCT05281341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64409804|NCT05281341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409805|NCT04808687|Paclitaxel|paclitaxel|mesh-list
64427234|NCT05370313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64427235|NCT05370313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427236|NCT02395627|Tamoxifen|tamoxifen|mesh-list
64427237|NCT02395627|Pembrolizumab|pembrolizumab|mesh-list
64427238|NCT02395627|Vorinostat|vorinostat|mesh-list
64427239|NCT02395627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64427240|NCT02395627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409815|NCT05279703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64409816|NCT05279703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64409817|NCT05279703|Adrenergic Agents|adrenergic agents|mesh-ancestor
64409818|NCT05279703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64409819|NCT05279703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409845|NCT04796675|Immunologic Factors|immunologic factors|mesh-ancestor
64409846|NCT04796675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409847|NCT04796675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64409848|NCT04796675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64409849|NCT04796675|Alkylating Agents|alkylating agents|mesh-ancestor
64409850|NCT04796675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409851|NCT04796675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409852|NCT04796675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64409853|NCT05635357|Letrozole|letrozole|mesh-list
64409855|NCT05635357|Exemestane|exemestane|mesh-list
64409856|NCT05635357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427348|NCT02391961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64427349|NCT02391961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427350|NCT02384941|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
64427351|NCT02384941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64427352|NCT02384941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427353|NCT02384941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64409857|NCT05635357|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64409858|NCT05635357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64409859|NCT05635357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409860|NCT05635357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409861|NCT05635357|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64409862|NCT05635357|Hormone Antagonists|hormone antagonists|mesh-ancestor
64409863|NCT05635357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64409864|NCT05635357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409865|NCT05635357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64409866|NCT05275725|Sildenafil Citrate|sildenafil citrate|mesh-list
64409867|NCT05275725|Vasodilator Agents|vasodilator agents|mesh-ancestor
64409868|NCT05275725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64409869|NCT05275725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64409870|NCT05275725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409885|NCT04785755|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64409887|NCT04785755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409888|NCT04785755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64409889|NCT04785755|Hormone Antagonists|hormone antagonists|mesh-ancestor
64409890|NCT04785755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64409891|NCT04785755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64409892|NCT04785755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64409893|NCT04785755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64409894|NCT04785755|Adrenergic Agents|adrenergic agents|mesh-ancestor
64409895|NCT04785755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64409896|NCT04785755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64409897|NCT04785755|Sympathomimetics|sympathomimetics|mesh-ancestor
64409898|NCT04785755|Autonomic Agents|autonomic agents|mesh-ancestor
64409899|NCT04785755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409900|NCT04785755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64427419|NCT04902625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64427421|NCT02388997|Omalizumab|omalizumab|mesh-list
64427425|NCT02345161|Budesonide|budesonide|mesh-list
64409901|NCT04785755|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64409902|NCT04785755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64409903|NCT04785755|Protective Agents|protective agents|mesh-ancestor
64409905|NCT05272605|Immunologic Factors|immunologic factors|mesh-ancestor
64409906|NCT05272605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409907|NCT04785911|Antiemetics|antiemetics|mesh-list
64409908|NCT04785911|Histamine|histamine|mesh-list
64409909|NCT04785911|Histamine Agonists|histamine agonists|mesh-ancestor
64427487|NCT02379091|Dermatologic Agents|dermatologic agents|mesh-ancestor
64427488|NCT02379091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427489|NCT02379091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64427490|NCT02379091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64427491|NCT02379091|Immunologic Factors|immunologic factors|mesh-ancestor
64427516|NCT02214225|Immunologic Factors|immunologic factors|mesh-ancestor
64427517|NCT02214225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427519|NCT02249949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427520|NCT02249091|Cytarabine|cytarabine|mesh-list
64427521|NCT02249091|Idarubicin|idarubicin|mesh-list
64427522|NCT02249091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64427523|NCT02249091|Antimetabolites|antimetabolites|mesh-ancestor
64427524|NCT02249091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427525|NCT02249091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427526|NCT02249091|Antiviral Agents|antiviral agents|mesh-ancestor
64427527|NCT02249091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64427528|NCT02249091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64427529|NCT02249091|Immunologic Factors|immunologic factors|mesh-ancestor
64409910|NCT04785911|Histamine Agents|histamine agents|mesh-ancestor
64409911|NCT04785911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64409912|NCT04785911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409913|NCT04785911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409914|NCT04785911|Autonomic Agents|autonomic agents|mesh-ancestor
64409915|NCT04785911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409916|NCT04785911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64409917|NCT04240821|Theophylline|theophylline|mesh-list
64409918|NCT04240821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64409919|NCT04240821|Autonomic Agents|autonomic agents|mesh-ancestor
64409920|NCT04240821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409921|NCT04240821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409922|NCT04240821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64409923|NCT04240821|Respiratory System Agents|respiratory system agents|mesh-ancestor
64427568|NCT02375971|Ranibizumab|ranibizumab|mesh-list
64427569|NCT02375971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64427570|NCT02375971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64427571|NCT02375971|Growth Substances|growth substances|mesh-ancestor
64427572|NCT02375971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427573|NCT02375971|Growth Inhibitors|growth inhibitors|mesh-ancestor
64427574|NCT02375971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427575|NCT04886323|Itraconazole|itraconazole|mesh-list
64427576|NCT04886323|Antifungal Agents|antifungal agents|mesh-ancestor
64427577|NCT04886323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64427578|NCT04886323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64409954|NCT04426721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409955|NCT04426721|Viscosupplements|viscosupplements|mesh-ancestor
64409956|NCT04426721|Protective Agents|protective agents|mesh-ancestor
64409957|NCT05221359|Insulin Aspart|insulin aspart|mesh-list
64409958|NCT05221359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64409959|NCT05221359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409960|NCT04794413|Pimavanserin|pimavanserin|mesh-list
64409961|NCT04794413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64409962|NCT04794413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64409963|NCT04794413|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64409964|NCT04794413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64409965|NCT04794413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64409966|NCT04794413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409967|NCT04794413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64409968|NCT04794413|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64409969|NCT04794413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64409970|NCT04794413|Serotonin Agents|serotonin agents|mesh-ancestor
64409971|NCT04794413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64409972|NCT04794413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409973|NCT05214573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64409974|NCT05214573|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64409976|NCT05214573|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64409977|NCT05214573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64409978|NCT05214573|Hormones|hormones|mesh-ancestor
64409979|NCT05214573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64409980|NCT05214573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409981|NCT05214573|Incretins|incretins|mesh-ancestor
64409982|NCT05214573|Protease Inhibitors|protease inhibitors|mesh-ancestor
64409983|NCT05214573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409984|NCT05214573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409985|NCT05214573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64409994|NCT04988191|Growth Inhibitors|growth inhibitors|mesh-ancestor
64409995|NCT04988191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64409996|NCT04988191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64409997|NCT04988191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410001|NCT03069001|Simeprevir|simeprevir|mesh-list
64410002|NCT03069001|Antimetabolites|antimetabolites|mesh-ancestor
64410003|NCT03069001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410004|NCT03069001|Antiviral Agents|antiviral agents|mesh-ancestor
64410005|NCT03069001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64410006|NCT03069001|Protease Inhibitors|protease inhibitors|mesh-ancestor
64410007|NCT03069001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410008|NCT03070405|Tenofovir|tenofovir|mesh-list
64410009|NCT03070405|Aminosalicylic Acid|aminosalicylic acid|mesh-list
64410010|NCT03070405|Antiviral Agents|antiviral agents|mesh-ancestor
64427642|NCT01889602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64427644|NCT01935700|Colchicine|colchicine|mesh-list
64410011|NCT03070405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64341686|NCT04071613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64410019|NCT03070405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64410020|NCT03068065|Metformin|metformin|mesh-list
64410021|NCT03068065|Liraglutide|liraglutide|mesh-list
64410022|NCT03068065|Gliclazide|gliclazide|mesh-list
64410023|NCT03068065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64410024|NCT03068065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410025|NCT03068065|Incretins|incretins|mesh-ancestor
64410026|NCT03068065|Hormones|hormones|mesh-ancestor
64410027|NCT03068065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64410028|NCT05161611|Zinc Sulfate|zinc sulfate|mesh-list
64410029|NCT05161611|Astringents|astringents|mesh-ancestor
64410030|NCT05161611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410031|NCT05161611|Dermatologic Agents|dermatologic agents|mesh-ancestor
64410032|NCT03660475|Naltrexone|naltrexone|mesh-list
64410033|NCT03660475|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64410034|NCT03660475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64410035|NCT03660475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410036|NCT03660475|Sensory System Agents|sensory system agents|mesh-ancestor
64410037|NCT03660475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410038|NCT05211609|Methyldopa|methyldopa|mesh-list
64410041|NCT05211609|Autonomic Agents|autonomic agents|mesh-ancestor
64410042|NCT05211609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410043|NCT05211609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410044|NCT05211609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64410045|NCT05211609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64410046|NCT05211609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64410047|NCT05211609|Adrenergic Agents|adrenergic agents|mesh-ancestor
64410048|NCT05211609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64410049|NCT05211609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410050|NCT05615987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64410051|NCT05615987|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64410052|NCT05615987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64410053|NCT05615987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410064|NCT02594735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64410065|NCT02594735|Immunologic Factors|immunologic factors|mesh-ancestor
64410066|NCT02594735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410067|NCT02594735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64410070|NCT05209425|Vitamin D|vitamin d|mesh-list
64410071|NCT05209425|Cholecalciferol|cholecalciferol|mesh-list
64410072|NCT05209425|Vitamins|vitamins|mesh-ancestor
64410073|NCT05209425|Micronutrients|micronutrients|mesh-ancestor
64410074|NCT05209425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410077|NCT04793243|Vitamin D|vitamin d|mesh-list
64410085|NCT04793399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410087|NCT05157711|Phenylephrine|phenylephrine|mesh-list
64410088|NCT05157711|Oxymetazoline|oxymetazoline|mesh-list
64410089|NCT05157711|Zinc Oxide|zinc oxide|mesh-list
64410090|NCT05157711|Bismuth|bismuth|mesh-list
64410091|NCT05157711|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64410092|NCT05157711|Mydriatics|mydriatics|mesh-ancestor
64410093|NCT05157711|Autonomic Agents|autonomic agents|mesh-ancestor
64410094|NCT05157711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410095|NCT05157711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410096|NCT05157711|Sympathomimetics|sympathomimetics|mesh-ancestor
64410098|NCT05157711|Nasal Decongestants|nasal decongestants|mesh-ancestor
64410099|NCT05157711|Respiratory System Agents|respiratory system agents|mesh-ancestor
64427748|NCT02210091|Factor VIII|factor viii|mesh-list
64427750|NCT02210091|Coagulants|coagulants|mesh-ancestor
64427751|NCT02338999|Pioglitazone|pioglitazone|mesh-list
64427752|NCT02338999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64427753|NCT02338999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410100|NCT05157711|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64410101|NCT05157711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64410102|NCT05157711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64410103|NCT05157711|Adrenergic Agents|adrenergic agents|mesh-ancestor
64410104|NCT05157711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64410105|NCT05157711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410106|NCT05157711|Protective Agents|protective agents|mesh-ancestor
64410108|NCT05157711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64410109|NCT05157711|Dermatologic Agents|dermatologic agents|mesh-ancestor
64410110|NCT05157711|Sunscreening Agents|sunscreening agents|mesh-ancestor
64410111|NCT05157711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64410112|NCT05157711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64410154|NCT04801511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410155|NCT04801511|Protective Agents|protective agents|mesh-ancestor
64410156|NCT04230759|Fluorouracil|fluorouracil|mesh-list
64410157|NCT04230759|Durvalumab|durvalumab|mesh-list
64410158|NCT04230759|Mitomycins|mitomycins|mesh-list
64410159|NCT04230759|Mitomycin|mitomycin|mesh-list
64410160|NCT04230759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64410161|NCT04230759|Antimetabolites|antimetabolites|mesh-ancestor
64410162|NCT04230759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410163|NCT04230759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64410164|NCT04230759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410165|NCT04230759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64410166|NCT04230759|Immunologic Factors|immunologic factors|mesh-ancestor
64410167|NCT04230759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410168|NCT04230759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64410169|NCT04230759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64410170|NCT04230759|Alkylating Agents|alkylating agents|mesh-ancestor
64410171|NCT04230759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64410172|NCT04230759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410173|NCT05471687|Adenosine|adenosine|mesh-list
64410174|NCT05471687|Analgesics|analgesics|mesh-ancestor
64410188|NCT05471609|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64427828|NCT02134977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410189|NCT05471609|Dopamine Agents|dopamine agents|mesh-ancestor
64410190|NCT05471609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64410191|NCT05471609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410217|NCT05204667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410218|NCT05204667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410219|NCT05204667|Antipyretics|antipyretics|mesh-ancestor
64410220|NCT05204667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64410221|NCT05204667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64410222|NCT05204667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64410223|NCT05204667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64410224|NCT05204667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64410225|NCT05204667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410226|NCT05204667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64410227|NCT05204667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64410228|NCT05204667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410229|NCT05204667|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64410230|NCT05204667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64427910|NCT01362790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64427911|NCT01362790|Alkylating Agents|alkylating agents|mesh-ancestor
64427912|NCT01362790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427913|NCT01362790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427914|NCT01362790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64427915|NCT01362790|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
64427916|NCT01362790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427917|NCT02167893|Leuprolide|leuprolide|mesh-list
64427918|NCT02167893|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64427919|NCT02167893|Fertility Agents|fertility agents|mesh-ancestor
64427920|NCT02167893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64427921|NCT02167893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427922|NCT02167893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64410231|NCT04801199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64341731|NCT03484507|Glucocorticoids|glucocorticoids|mesh-ancestor
64410246|NCT04340141|Levoleucovorin|levoleucovorin|mesh-list
64410247|NCT04340141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64410248|NCT04340141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410249|NCT04340141|Antimetabolites|antimetabolites|mesh-ancestor
64410250|NCT04340141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410251|NCT04340141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64410257|NCT04340141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410258|NCT04340141|Antidotes|antidotes|mesh-ancestor
64410259|NCT04340141|Protective Agents|protective agents|mesh-ancestor
64410260|NCT04340141|Vitamin B Complex|vitamin b complex|mesh-ancestor
64410261|NCT04340141|Vitamins|vitamins|mesh-ancestor
64410262|NCT04340141|Micronutrients|micronutrients|mesh-ancestor
64410263|NCT05445791|Metformin|metformin|mesh-list
64410264|NCT05445791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64410265|NCT05445791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427955|NCT01913470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427956|NCT02166333|Vitamin D|vitamin d|mesh-list
64427957|NCT02166333|Ergocalciferols|ergocalciferols|mesh-list
64427958|NCT02166333|Cholecalciferol|cholecalciferol|mesh-list
64427959|NCT02166333|Vitamins|vitamins|mesh-list
64427960|NCT02166333|Micronutrients|micronutrients|mesh-ancestor
64427961|NCT02166333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427962|NCT02166333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64427963|NCT02166333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64410266|NCT05201547|Paclitaxel|paclitaxel|mesh-list
64410267|NCT05201547|Carboplatin|carboplatin|mesh-list
64410268|NCT05201547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64410269|NCT05201547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410270|NCT05201547|Tubulin Modulators|tubulin modulators|mesh-ancestor
64410271|NCT05201547|Antimitotic Agents|antimitotic agents|mesh-ancestor
64410272|NCT05201547|Mitosis Modulators|mitosis modulators|mesh-ancestor
64410273|NCT05201547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410274|NCT04799873|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64410275|NCT04799873|Protein C Inhibitor|protein c inhibitor|mesh-list
64410276|NCT04799873|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64410277|NCT04799873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64410278|NCT04799873|Protease Inhibitors|protease inhibitors|mesh-ancestor
64410279|NCT04799873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410280|NCT04799873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410281|NCT05201313|Lidocaine|lidocaine|mesh-list
64410282|NCT05201313|Mepivacaine|mepivacaine|mesh-list
64410283|NCT05201313|Anesthetics, Local|anesthetics, local|mesh-ancestor
64410318|NCT04798703|Hyaluronic Acid|hyaluronic acid|mesh-list
64410319|NCT04798703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64410320|NCT04798703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410321|NCT04798703|Tubulin Modulators|tubulin modulators|mesh-ancestor
64410322|NCT04798703|Antimitotic Agents|antimitotic agents|mesh-ancestor
64410323|NCT04798703|Mitosis Modulators|mitosis modulators|mesh-ancestor
64410324|NCT04798703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410325|NCT04798703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64410326|NCT04798703|Immunologic Factors|immunologic factors|mesh-ancestor
64410327|NCT04798703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410328|NCT04798703|Viscosupplements|viscosupplements|mesh-ancestor
64410329|NCT04798703|Protective Agents|protective agents|mesh-ancestor
64410330|NCT04798313|Denosumab|denosumab|mesh-list
64410331|NCT04798313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64410332|NCT04798313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410333|NCT01655823|Tetrodotoxin|tetrodotoxin|mesh-list
64410334|NCT01655823|Anesthetics, Local|anesthetics, local|mesh-ancestor
64410335|NCT01655823|Anesthetics|anesthetics|mesh-ancestor
64410336|NCT01655823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64410337|NCT01655823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410338|NCT01655823|Sensory System Agents|sensory system agents|mesh-ancestor
64410339|NCT01655823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410340|NCT01655823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64410341|NCT01655823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64410342|NCT01655823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428005|NCT02164929|Lidocaine|lidocaine|mesh-list
64428006|NCT02164929|Epinephrine|epinephrine|mesh-list
64428007|NCT02164929|Midazolam|midazolam|mesh-list
64428008|NCT02164929|Hydromorphone|hydromorphone|mesh-list
64428009|NCT02164929|Ropivacaine|ropivacaine|mesh-list
64428010|NCT02164929|Propofol|propofol|mesh-list
64428011|NCT02164929|Sevoflurane|sevoflurane|mesh-list
64410343|NCT05197257|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64410344|NCT05197257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64410345|NCT05197257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410346|NCT05194293|Durvalumab|durvalumab|mesh-list
64410347|NCT05194293|Immunoglobulins|immunoglobulins|mesh-list
64410348|NCT05194293|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64410349|NCT05194293|Immunoglobulin G|immunoglobulin g|mesh-list
64410350|NCT05194293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64410351|NCT05194293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410352|NCT05194293|Immunologic Factors|immunologic factors|mesh-ancestor
64410355|NCT04848857|Gout Suppressants|gout suppressants|mesh-ancestor
64410356|NCT04848857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64410357|NCT04848857|Tubulin Modulators|tubulin modulators|mesh-ancestor
64410358|NCT04848857|Antimitotic Agents|antimitotic agents|mesh-ancestor
64410359|NCT04848857|Mitosis Modulators|mitosis modulators|mesh-ancestor
64410360|NCT04848857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410361|NCT04848857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410362|NCT04338659|Antibodies|antibodies|mesh-list
64410363|NCT04338659|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64410364|NCT04338659|Immunologic Factors|immunologic factors|mesh-ancestor
64410365|NCT04338659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410402|NCT02633059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64410403|NCT02633059|Antiemetics|antiemetics|mesh-ancestor
64410404|NCT02633059|Autonomic Agents|autonomic agents|mesh-ancestor
64410405|NCT02633059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410406|NCT02633059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410407|NCT02633059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64410408|NCT02633059|Glucocorticoids|glucocorticoids|mesh-ancestor
64428037|NCT02164929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64410409|NCT02633059|Hormones|hormones|mesh-ancestor
64410410|NCT02633059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64410411|NCT02633059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64410412|NCT02633059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410413|NCT02633059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410414|NCT02633059|Protease Inhibitors|protease inhibitors|mesh-ancestor
64410415|NCT02633059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410416|NCT02633059|Dermatologic Agents|dermatologic agents|mesh-ancestor
64410417|NCT02633059|Glycine Agents|glycine agents|mesh-ancestor
64410418|NCT02633059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64410419|NCT05089461|Mitoxantrone|mitoxantrone|mesh-list
64410420|NCT05089461|Analgesics|analgesics|mesh-ancestor
64410440|NCT05730439|Respiratory System Agents|respiratory system agents|mesh-ancestor
64410441|NCT04224987|Azithromycin|azithromycin|mesh-list
64428089|NCT02188719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64428090|NCT02188719|Immunologic Factors|immunologic factors|mesh-ancestor
64428107|NCT02188719|Anesthetics, Local|anesthetics, local|mesh-ancestor
64428109|NCT02188719|Antiemetics|antiemetics|mesh-ancestor
64428110|NCT02188719|Autonomic Agents|autonomic agents|mesh-ancestor
64428111|NCT02188719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64428112|NCT02188719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64428113|NCT02188719|Histamine Antagonists|histamine antagonists|mesh-ancestor
64428114|NCT02188719|Histamine Agents|histamine agents|mesh-ancestor
64428115|NCT02188719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64428116|NCT02188719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64428117|NCT02188719|Antipruritics|antipruritics|mesh-ancestor
64428118|NCT02188719|Dermatologic Agents|dermatologic agents|mesh-ancestor
64428119|NCT02188719|Antiviral Agents|antiviral agents|mesh-ancestor
64428125|NCT01933672|Incretins|incretins|mesh-ancestor
64410442|NCT04224987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64410443|NCT04224987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64410444|NCT04583969|Remdesivir|remdesivir|mesh-list
64410445|NCT04583969|Antimetabolites|antimetabolites|mesh-ancestor
64410446|NCT04583969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410447|NCT04583969|Antiviral Agents|antiviral agents|mesh-ancestor
64410448|NCT04583969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64410449|NCT04805515|Nicotine|nicotine|mesh-list
64410450|NCT04805515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64410460|NCT05195177|Anesthetics, Local|anesthetics, local|mesh-list
64410461|NCT05195177|Histamine|histamine|mesh-list
64410462|NCT05195177|Histamine Antagonists|histamine antagonists|mesh-list
64410463|NCT05195177|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
64410464|NCT05195177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64410465|NCT05195177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410466|NCT05195177|Sensory System Agents|sensory system agents|mesh-ancestor
64410467|NCT05195177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410468|NCT05195177|Histamine Agonists|histamine agonists|mesh-ancestor
64410469|NCT05195177|Histamine Agents|histamine agents|mesh-ancestor
64410470|NCT05195177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64410471|NCT05195177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410472|NCT05170919|Olanzapine|olanzapine|mesh-list
64410473|NCT05170919|Mirtazapine|mirtazapine|mesh-list
64410474|NCT05170919|Antiemetics|antiemetics|mesh-ancestor
64410479|NCT05170919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64410480|NCT05170919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64410481|NCT05170919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64410482|NCT05170919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64428170|NCT01628913|Everolimus|everolimus|mesh-list
64428171|NCT01628913|Dactolisib|dactolisib|mesh-list
64428172|NCT01628913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428173|NCT01628913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64428174|NCT01628913|Immunologic Factors|immunologic factors|mesh-ancestor
64428175|NCT01628913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428176|NCT02164383|Nicotine|nicotine|mesh-list
64428177|NCT02164383|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64428178|NCT02164383|Autonomic Agents|autonomic agents|mesh-ancestor
64428179|NCT02164383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64428180|NCT02164383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428181|NCT02164383|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64428182|NCT02164383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64428183|NCT02164383|Cholinergic Agents|cholinergic agents|mesh-ancestor
64428184|NCT02164383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64428185|NCT02164383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428186|NCT02131233|Raltegravir Potassium|raltegravir potassium|mesh-list
64428187|NCT02131233|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64428188|NCT02131233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64410483|NCT05170919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64410484|NCT05170919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64410485|NCT05170919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64410486|NCT05170919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410487|NCT05170919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64410498|NCT05170919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64410499|NCT05170919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64428199|NCT02131155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428200|NCT02131155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64428201|NCT02131155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428202|NCT02131155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428204|NCT01933594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64428205|NCT01933594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428206|NCT01912768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64428207|NCT02305849|Methotrexate|methotrexate|mesh-list
64428208|NCT02305849|Peficitinib|peficitinib|mesh-list
64410500|NCT05170919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64410502|NCT05168813|Immunologic Factors|immunologic factors|mesh-ancestor
64410503|NCT05168813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410504|NCT05613491|Insulin|insulin|mesh-list
64410505|NCT05613491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64410522|NCT05151263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410523|NCT05151263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410524|NCT05151263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64410525|NCT05151263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64410526|NCT05151263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410527|NCT05151263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64410528|NCT05151263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410530|NCT04788407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64410531|NCT04788407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64410532|NCT03066427|Sunitinib|sunitinib|mesh-list
64410533|NCT03066427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428294|NCT05610527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64428295|NCT05610527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428296|NCT05610527|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64428297|NCT05383001|Durvalumab|durvalumab|mesh-list
64428298|NCT05383001|Tremelimumab|tremelimumab|mesh-list
64428299|NCT05383001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64428300|NCT05383001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428301|NCT05381753|Sunitinib|sunitinib|mesh-list
64410534|NCT03066427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64410535|NCT03066427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64410536|NCT03066427|Growth Substances|growth substances|mesh-ancestor
64341819|NCT01352507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410539|NCT03066427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64410540|NCT03066427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410541|NCT03066427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410542|NCT05177133|Capecitabine|capecitabine|mesh-list
64410543|NCT05177133|Oxaliplatin|oxaliplatin|mesh-list
64410544|NCT05177133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64410545|NCT05177133|Antimetabolites|antimetabolites|mesh-ancestor
64410546|NCT05177133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410547|NCT05177133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410548|NCT02866643|Contraceptive Agents|contraceptive agents|mesh-list
64410549|NCT02866643|Etonogestrel|etonogestrel|mesh-list
64410550|NCT02866643|Desogestrel|desogestrel|mesh-list
64428350|NCT02163447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64428351|NCT02163447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64428352|NCT02163447|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64428353|NCT02163447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428354|NCT02163447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428355|NCT02163447|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64428356|NCT02163447|Renal Agents|renal agents|mesh-ancestor
64428357|NCT01887418|Methyltestosterone|methyltestosterone|mesh-list
64428358|NCT01887418|Testosterone|testosterone|mesh-list
64428359|NCT01887418|Testosterone undecanoate|testosterone undecanoate|mesh-list
64428360|NCT01887418|Testosterone enanthate|testosterone enanthate|mesh-list
64428362|NCT01887418|Androgens|androgens|mesh-ancestor
64410551|NCT02866643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64410552|NCT02866643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410561|NCT05176821|Amoxicillin|amoxicillin|mesh-list
64410562|NCT05176821|Furazolidone|furazolidone|mesh-list
64410563|NCT05176821|Potassium Citrate|potassium citrate|mesh-list
64410564|NCT05176821|Esomeprazole|esomeprazole|mesh-list
64410565|NCT05176821|Bismuth|bismuth|mesh-list
64410566|NCT05176821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410567|NCT05176821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64410568|NCT05176821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64410569|NCT05176821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64410570|NCT05176821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64410571|NCT05176821|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64410572|NCT05176821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428398|NCT05342519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428411|NCT05308901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428412|NCT05308901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64428413|NCT05308901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428414|NCT05308901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428415|NCT01931566|Pioglitazone|pioglitazone|mesh-list
64428416|NCT01931566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64428417|NCT01931566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428419|NCT05372939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64428420|NCT05372939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64428421|NCT01912456|Complement C1s|complement c1s|mesh-list
64428422|NCT01912456|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64428424|NCT01912456|Immunologic Factors|immunologic factors|mesh-ancestor
64410573|NCT05176821|Antacids|antacids|mesh-ancestor
64410574|NCT05176821|Diuretics|diuretics|mesh-ancestor
64410575|NCT05176821|Natriuretic Agents|natriuretic agents|mesh-ancestor
64410576|NCT05176821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410577|NCT05176821|Expectorants|expectorants|mesh-ancestor
64410578|NCT05176821|Respiratory System Agents|respiratory system agents|mesh-ancestor
64410579|NCT05176821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64410580|NCT05176821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64410581|NCT05176821|Renal Agents|renal agents|mesh-ancestor
64410582|NCT05176821|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64410583|NCT05176821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64410584|NCT05176821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64410585|NCT05176821|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64410586|NCT05555641|Nafamostat|nafamostat|mesh-list
64410587|NCT05555641|Heparin|heparin|mesh-list
64410588|NCT05555641|Calcium heparin|calcium heparin|mesh-list
64410589|NCT05555641|Anticoagulants|anticoagulants|mesh-ancestor
64410590|NCT05555641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64428458|NCT05368415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428460|NCT05368415|Autonomic Agents|autonomic agents|mesh-ancestor
64428461|NCT05368415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64428498|NCT05334329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64428499|NCT05334329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64428517|NCT05296577|Vinorelbine|vinorelbine|mesh-list
64410591|NCT05555641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64410595|NCT05555641|Analgesics|analgesics|mesh-ancestor
64410610|NCT05115513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410611|NCT05115513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64410612|NCT05115513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64410613|NCT05115513|Analgesics|analgesics|mesh-ancestor
64410614|NCT05115513|Sensory System Agents|sensory system agents|mesh-ancestor
64410615|NCT05115513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410616|NCT05115513|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64410617|NCT05115513|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64410618|NCT05115513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64410647|NCT05170113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64410648|NCT05170113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410649|NCT05170113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64410650|NCT05170113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410651|NCT05170113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428594|NCT05363267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64410652|NCT05170113|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64410653|NCT05170113|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64341844|NCT00873275|Growth Substances|growth substances|mesh-ancestor
64410658|NCT05169957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64410659|NCT05169957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410660|NCT05169957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64410661|NCT05169957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410663|NCT05611463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410664|NCT05611463|Tubulin Modulators|tubulin modulators|mesh-ancestor
64410665|NCT05611463|Antimitotic Agents|antimitotic agents|mesh-ancestor
64410666|NCT05611463|Mitosis Modulators|mitosis modulators|mesh-ancestor
64410667|NCT05611463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410668|NCT05611385|Amphetamine|amphetamine|mesh-list
64428658|NCT05359055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64428659|NCT05359055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64428660|NCT05359055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64428661|NCT05359055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64428662|NCT05359055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64428663|NCT05359055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64428664|NCT04249583|Botulinum Toxins|botulinum toxins|mesh-list
64428665|NCT04249583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64428671|NCT02524379|Glyburide|glyburide|mesh-list
64410669|NCT05611385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64410670|NCT05611385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410671|NCT05611385|Sympathomimetics|sympathomimetics|mesh-ancestor
64410672|NCT05611385|Autonomic Agents|autonomic agents|mesh-ancestor
64410673|NCT05611385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410674|NCT05611385|Dopamine Agents|dopamine agents|mesh-ancestor
64410675|NCT05611385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64410676|NCT05611385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410677|NCT05611385|Adrenergic Agents|adrenergic agents|mesh-ancestor
64428717|NCT01658813|Immunologic Factors|immunologic factors|mesh-ancestor
64428718|NCT01658813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428719|NCT01658813|Antiviral Agents|antiviral agents|mesh-ancestor
64428720|NCT01658813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64428721|NCT02187471|Pregabalin|pregabalin|mesh-list
64428722|NCT02187471|Analgesics|analgesics|mesh-ancestor
64428723|NCT02187471|Sensory System Agents|sensory system agents|mesh-ancestor
64428724|NCT02187471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410678|NCT05611385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64410679|NCT05611385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64410680|NCT05611385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64410681|NCT05611385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64410682|NCT05475041|Liver Extracts|liver extracts|mesh-list
64410683|NCT05475041|Hematinics|hematinics|mesh-ancestor
64410716|NCT03067753|Glucocorticoids|glucocorticoids|mesh-ancestor
64410717|NCT03067753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64428795|NCT05354999|Caffeine|caffeine|mesh-list
64428796|NCT05354999|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64428797|NCT05354999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428798|NCT05354999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64428799|NCT05354999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428800|NCT05354999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428803|NCT05354999|Purinergic Agents|purinergic agents|mesh-ancestor
64410718|NCT03067753|Protective Agents|protective agents|mesh-ancestor
64410719|NCT03067753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64410720|NCT03067753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410721|NCT05613179|Ibuprofen|ibuprofen|mesh-list
64410722|NCT05613179|Analgesics|analgesics|mesh-list
64410732|NCT05613179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410733|NCT04331639|Vitamin D|vitamin d|mesh-list
64410734|NCT04331639|Cholecalciferol|cholecalciferol|mesh-list
64410735|NCT04331639|Vitamins|vitamins|mesh-ancestor
64410736|NCT04331639|Micronutrients|micronutrients|mesh-ancestor
64410737|NCT04331639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410738|NCT04331639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64410739|NCT04331639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64410740|NCT03067597|Dinoprostone|dinoprostone|mesh-list
64410741|NCT03067597|Oxytocics|oxytocics|mesh-ancestor
64410742|NCT03067597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64410775|NCT03066115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64410776|NCT03066115|Analgesics|analgesics|mesh-ancestor
64410777|NCT03066115|Sensory System Agents|sensory system agents|mesh-ancestor
64410778|NCT03066115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410779|NCT03066115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410780|NCT03066115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64410781|NCT03066115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64410782|NCT03066115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64410783|NCT03066115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410784|NCT03066115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410785|NCT03066115|Antioxidants|antioxidants|mesh-ancestor
64428889|NCT02159469|Androgens|androgens|mesh-ancestor
64428890|NCT02159469|Hormones|hormones|mesh-ancestor
64428891|NCT02159469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64428892|NCT02159469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428893|NCT02159469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64428894|NCT02159469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428895|NCT02159469|Anabolic Agents|anabolic agents|mesh-ancestor
64428896|NCT02123511|Acetylcysteine|acetylcysteine|mesh-list
64428897|NCT02123511|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64428898|NCT02123511|Antiviral Agents|antiviral agents|mesh-ancestor
64428899|NCT02123511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64428900|NCT02123511|Expectorants|expectorants|mesh-ancestor
64428901|NCT02123511|Respiratory System Agents|respiratory system agents|mesh-ancestor
64428902|NCT02123511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64410786|NCT03066115|Protective Agents|protective agents|mesh-ancestor
64410787|NCT03066115|Vitamins|vitamins|mesh-ancestor
64410788|NCT03066115|Micronutrients|micronutrients|mesh-ancestor
64410789|NCT04212039|Bupivacaine|bupivacaine|mesh-list
64410790|NCT04212039|Anesthetics, Local|anesthetics, local|mesh-ancestor
64410791|NCT04212039|Anesthetics|anesthetics|mesh-ancestor
64410792|NCT04212039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64410793|NCT04212039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410794|NCT04212039|Sensory System Agents|sensory system agents|mesh-ancestor
64428924|NCT02301403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64428925|NCT02301403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428926|NCT02333383|Adalimumab|adalimumab|mesh-list
64428927|NCT02333383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64428928|NCT02333383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64428939|NCT02158533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64428940|NCT02158533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428942|NCT02158533|Sensory System Agents|sensory system agents|mesh-ancestor
64428943|NCT02158533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410795|NCT04212039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410797|NCT04716413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64410798|NCT04716413|Narcotics|narcotics|mesh-ancestor
64410799|NCT04716413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64410800|NCT04716413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410814|NCT01364727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410816|NCT04990869|Niacin|niacin|mesh-list
64410817|NCT04990869|Nicotinic Acids|nicotinic acids|mesh-list
64428992|NCT05279807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64428993|NCT05279807|Protease Inhibitors|protease inhibitors|mesh-ancestor
64429010|NCT05561309|Ropivacaine|ropivacaine|mesh-list
64429011|NCT05561309|Anesthetics, Local|anesthetics, local|mesh-ancestor
64429012|NCT05561309|Anesthetics|anesthetics|mesh-ancestor
64429013|NCT05561309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64429014|NCT05561309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429015|NCT05561309|Sensory System Agents|sensory system agents|mesh-ancestor
64429016|NCT05561309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429017|NCT05316467|Megestrol|megestrol|mesh-list
64429018|NCT05316467|Megestrol Acetate|megestrol acetate|mesh-list
64429020|NCT05316467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64410827|NCT04401553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64410828|NCT04401553|Vancomycin|vancomycin|mesh-list
64410829|NCT04401553|Cephalosporins|cephalosporins|mesh-list
64410830|NCT04401553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64410831|NCT01364649|Vortioxetine|vortioxetine|mesh-list
64410832|NCT01364649|Citalopram|citalopram|mesh-list
64410833|NCT01364649|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64410834|NCT01364649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64410835|NCT01364649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64410836|NCT01364649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429074|NCT02118597|Antiviral Agents|antiviral agents|mesh-ancestor
64429075|NCT02118597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64429076|NCT02118597|Antimetabolites|antimetabolites|mesh-ancestor
64429077|NCT02118597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429078|NCT02118597|Protease Inhibitors|protease inhibitors|mesh-ancestor
64429079|NCT02118597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64429080|NCT05218889|Gemcitabine|gemcitabine|mesh-list
64429081|NCT05218889|Paclitaxel|paclitaxel|mesh-list
64429097|NCT05554367|Palbociclib|palbociclib|mesh-list
64410837|NCT01364649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64410838|NCT01364649|Serotonin Agents|serotonin agents|mesh-ancestor
64410839|NCT01364649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410840|NCT01364649|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64410841|NCT01364649|Antidepressive Agents|antidepressive agents|mesh-ancestor
64410842|NCT01364649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64410843|NCT01364649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64410844|NCT01364649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64410845|NCT01364649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64410846|NCT01364649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64410847|NCT01364649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64410848|NCT01364649|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64410849|NCT01364649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64410850|NCT03065569|Bupivacaine|bupivacaine|mesh-list
64410851|NCT03065569|Anesthetics, Local|anesthetics, local|mesh-ancestor
64410852|NCT03065569|Anesthetics|anesthetics|mesh-ancestor
64410853|NCT03065569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64410854|NCT03065569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410862|NCT05723419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410863|NCT02588261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64410865|NCT02588261|Naquotinib|naquotinib|mesh-list
64429140|NCT05205473|Sensory System Agents|sensory system agents|mesh-ancestor
64429141|NCT05205473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429142|NCT05205473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64429143|NCT05205473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64429144|NCT05205473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64429145|NCT05205473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64429147|NCT05253053|Paclitaxel|paclitaxel|mesh-list
64410866|NCT02588261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410867|NCT02588261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64410868|NCT02588261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410869|NCT02588261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410870|NCT04989699|Aflibercept|aflibercept|mesh-list
64410871|NCT04989699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64410872|NCT04989699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64410873|NCT04989699|Growth Substances|growth substances|mesh-ancestor
64410874|NCT04989699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410875|NCT04989699|Growth Inhibitors|growth inhibitors|mesh-ancestor
64410876|NCT04989699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410877|NCT05279131|Tirbanibulin|tirbanibulin|mesh-list
64410878|NCT05279131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64429186|NCT05157971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64429216|NCT05157971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64429217|NCT05157971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64429218|NCT02175771|Fluticasone|fluticasone|mesh-list
64429220|NCT02175771|Albuterol|albuterol|mesh-list
64429221|NCT02175771|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64429222|NCT02175771|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64429223|NCT02175771|Adrenergic Agonists|adrenergic agonists|mesh-list
64429224|NCT02175771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64429225|NCT02175771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64429226|NCT02175771|Autonomic Agents|autonomic agents|mesh-ancestor
64429227|NCT02175771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429228|NCT02175771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429229|NCT02175771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64429240|NCT02175771|Glucocorticoids|glucocorticoids|mesh-ancestor
64429242|NCT02175771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64429243|NCT02175771|Sympathomimetics|sympathomimetics|mesh-ancestor
64429244|NCT01657799|Veliparib|veliparib|mesh-list
64429245|NCT01657799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64410879|NCT05279131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410880|NCT04426487|Progesterone|progesterone|mesh-list
64410881|NCT04426487|Progestins|progestins|mesh-ancestor
64410882|NCT04426487|Hormones|hormones|mesh-ancestor
64410883|NCT04426487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64342044|NCT01641952|Rituximab|rituximab|mesh-list
64342045|NCT01641952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64429269|NCT05248139|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64429270|NCT05248139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64429271|NCT05248139|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64429272|NCT05248139|Prednisolone phosphate|prednisolone phosphate|mesh-list
64429273|NCT05248139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64429274|NCT05248139|Glucocorticoids|glucocorticoids|mesh-ancestor
64429275|NCT05248139|Hormones|hormones|mesh-ancestor
64416622|NCT03040531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429277|NCT05248139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410906|NCT04443673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410907|NCT04443673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410908|NCT05036577|Dexamethasone|dexamethasone|mesh-list
64410909|NCT05036577|Rituximab|rituximab|mesh-list
64410910|NCT05036577|Methotrexate|methotrexate|mesh-list
64410911|NCT05036577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64410912|NCT05036577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410913|NCT05036577|Immunologic Factors|immunologic factors|mesh-ancestor
64410914|NCT05036577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410915|NCT05036577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64410922|NCT05036577|Hormones|hormones|mesh-ancestor
64410925|NCT05036577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64410926|NCT05036577|Abortifacient Agents|abortifacient agents|mesh-ancestor
64410927|NCT05036577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64410928|NCT05036577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64410929|NCT05036577|Antimetabolites|antimetabolites|mesh-ancestor
64410930|NCT05036577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410931|NCT05036577|Dermatologic Agents|dermatologic agents|mesh-ancestor
64410932|NCT05036577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410933|NCT05036577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64410934|NCT05036577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64410935|NCT05036577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64410936|NCT04982367|Sirolimus|sirolimus|mesh-list
64410945|NCT04982367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64410946|NCT04982367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64410947|NCT04982367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64410948|NCT04982367|Antifungal Agents|antifungal agents|mesh-ancestor
64410949|NCT04982367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64410950|NCT04982367|Immunologic Factors|immunologic factors|mesh-ancestor
64410951|NCT04982367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429371|NCT02332291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64429372|NCT02332291|Serotonin Agents|serotonin agents|mesh-ancestor
64429378|NCT02332291|Dopamine Agents|dopamine agents|mesh-ancestor
64410952|NCT05034627|Asparaginase|asparaginase|mesh-list
64410953|NCT05034627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410954|NCT05031975|Irinotecan|irinotecan|mesh-list
64342138|NCT00649025|Fluticasone|fluticasone|mesh-list
64410959|NCT05031975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410960|NCT05031975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410965|NCT02632747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64410966|NCT02632747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429418|NCT01657019|Dopamine Agents|dopamine agents|mesh-ancestor
64429419|NCT01657019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64429420|NCT05182151|Istradefylline|istradefylline|mesh-list
64429421|NCT05182151|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
64429422|NCT05182151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64429423|NCT05182151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64429424|NCT05182151|Purinergic Agents|purinergic agents|mesh-ancestor
64429425|NCT05182151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64429426|NCT05182151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429427|NCT05182151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429428|NCT05181605|Folfirinox|folfirinox|mesh-list
64429429|NCT05181605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429430|NCT04883281|Paclitaxel|paclitaxel|mesh-list
64429431|NCT04883281|Carboplatin|carboplatin|mesh-list
64429432|NCT04883281|Cetuximab|cetuximab|mesh-list
64429433|NCT04883281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64429434|NCT04883281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429435|NCT04883281|Tubulin Modulators|tubulin modulators|mesh-ancestor
64429441|NCT02300311|Capsaicin|capsaicin|mesh-list
64410967|NCT02632747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64410968|NCT02632747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410969|NCT02632747|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64410970|NCT02632747|Protease Inhibitors|protease inhibitors|mesh-ancestor
64410971|NCT02632747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410972|NCT02632747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64410973|NCT04218825|Mechlorethamine|mechlorethamine|mesh-list
64410974|NCT04218825|Alkylating Agents|alkylating agents|mesh-ancestor
64410975|NCT04218825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429481|NCT05228951|Trastuzumab|trastuzumab|mesh-list
64429482|NCT05228951|Letrozole|letrozole|mesh-list
64429483|NCT05228951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64429484|NCT05228951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429485|NCT05228951|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64429486|NCT05228951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64410976|NCT04218825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64410977|NCT04218825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410978|NCT04216797|Diazepam|diazepam|mesh-list
64410979|NCT04216797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64410980|NCT04216797|Anticonvulsants|anticonvulsants|mesh-ancestor
64410981|NCT04216797|Antiemetics|antiemetics|mesh-ancestor
64410982|NCT04216797|Autonomic Agents|autonomic agents|mesh-ancestor
64410983|NCT04216797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410984|NCT04216797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410985|NCT04216797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64410986|NCT04216797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64410987|NCT04216797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64410988|NCT04216797|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64410989|NCT04216797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64410990|NCT04216797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64410991|NCT04216797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64429568|NCT02151591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429569|NCT02174523|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64429570|NCT02174523|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64429571|NCT02174523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64429572|NCT02174523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64429573|NCT02174523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429588|NCT04881799|Phentermine|phentermine|mesh-list
64429589|NCT04881799|Anticonvulsants|anticonvulsants|mesh-ancestor
64429590|NCT04881799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64429591|NCT04881799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429592|NCT04881799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64410992|NCT04216797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64410993|NCT04216797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64410994|NCT04216797|Anesthetics, General|anesthetics, general|mesh-ancestor
64410995|NCT04216797|Anesthetics|anesthetics|mesh-ancestor
64410996|NCT04216797|GABA Modulators|gaba modulators|mesh-ancestor
64410997|NCT04216797|GABA Agents|gaba agents|mesh-ancestor
64410999|NCT04216797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411000|NCT05029401|Ibogaine|ibogaine|mesh-list
64429631|NCT05220293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64429632|NCT05220293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64429718|NCT05124899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429720|NCT05093621|Torsemide|torsemide|mesh-list
64429721|NCT05093621|Furosemide|furosemide|mesh-list
64429722|NCT05093621|Diuretics|diuretics|mesh-ancestor
64429723|NCT05093621|Natriuretic Agents|natriuretic agents|mesh-ancestor
64429724|NCT05093621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429725|NCT05093621|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64429726|NCT05093621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64429727|NCT05093621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411001|NCT05029401|Hallucinogens|hallucinogens|mesh-ancestor
64411002|NCT05029401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411003|NCT05029401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64411017|NCT04033237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64411018|NCT04033237|Cholinergic Agents|cholinergic agents|mesh-ancestor
64411019|NCT04033237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64411020|NCT04033237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411021|NCT04421547|Letrozole|letrozole|mesh-list
64411022|NCT04421547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64411023|NCT04421547|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64411024|NCT04421547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64411025|NCT04421547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64429784|NCT05046431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64429785|NCT05046431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64429786|NCT05046431|Immunologic Factors|immunologic factors|mesh-ancestor
64429788|NCT05078879|Empagliflozin|empagliflozin|mesh-list
64429789|NCT05078879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64429790|NCT05078879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429791|NCT05078879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64429792|NCT05078879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429793|NCT05075993|Paclitaxel|paclitaxel|mesh-list
64429794|NCT05075993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64429795|NCT05075993|Cyclophosphamide|cyclophosphamide|mesh-list
64429796|NCT05075993|Bevacizumab|bevacizumab|mesh-list
64429858|NCT02520011|Cytarabine|cytarabine|mesh-list
64411026|NCT04421547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411027|NCT04421547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64411028|NCT04421547|Hormone Antagonists|hormone antagonists|mesh-ancestor
64411029|NCT04421547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64411037|NCT03066817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64411038|NCT05060913|Lidocaine|lidocaine|mesh-list
64411039|NCT05060913|Prilocaine|prilocaine|mesh-list
64411040|NCT05060913|Benzocaine|benzocaine|mesh-list
64411049|NCT05060913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64411050|NCT05060913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64411051|NCT05060913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64411052|NCT05060913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411053|NCT05060913|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64429890|NCT05037539|Anesthetics, General|anesthetics, general|mesh-ancestor
64429891|NCT05037539|Anesthetics|anesthetics|mesh-ancestor
64429892|NCT02519231|Naproxen|naproxen|mesh-list
64429893|NCT02519231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64429911|NCT02106351|Cholinergic Agents|cholinergic agents|mesh-ancestor
64429912|NCT02106351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64429913|NCT02106351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429914|NCT02106351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64429915|NCT02106351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429917|NCT02075073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64429918|NCT02075073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429919|NCT01364597|Brivaracetam|brivaracetam|mesh-list
64411054|NCT05165251|Amlodipine|amlodipine|mesh-list
64411055|NCT05165251|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
64411056|NCT05165251|Atorvastatin|atorvastatin|mesh-list
64411057|NCT05165251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64411058|NCT05165251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64411059|NCT05165251|Antimetabolites|antimetabolites|mesh-ancestor
64411060|NCT05165251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411061|NCT05165251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64411062|NCT05165251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64411073|NCT04980495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64429966|NCT05025605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64429967|NCT05025605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64429968|NCT05025605|Adrenergic Agents|adrenergic agents|mesh-ancestor
64429969|NCT05025605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64429970|NCT05025605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429971|NCT04421105|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
64429972|NCT04421105|Hallucinogens|hallucinogens|mesh-ancestor
64429973|NCT04421105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429974|NCT04421105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64429975|NCT04421105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64429976|NCT04421105|Serotonin Agents|serotonin agents|mesh-ancestor
64429977|NCT04421105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64429978|NCT04421105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429979|NCT04421105|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64429980|NCT05024747|Nicotine|nicotine|mesh-list
64429981|NCT05024747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64429982|NCT05024747|Autonomic Agents|autonomic agents|mesh-ancestor
64411075|NCT05023473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64411076|NCT05023473|Narcotics|narcotics|mesh-ancestor
64411077|NCT05023473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64411078|NCT05023473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411079|NCT05023473|Analgesics|analgesics|mesh-ancestor
64411080|NCT05023473|Sensory System Agents|sensory system agents|mesh-ancestor
64411081|NCT05023473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411082|NCT03066661|Entrectinib|entrectinib|mesh-list
64411083|NCT03066661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64411084|NCT03066661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64411085|NCT03066661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411086|NCT05022147|Dopamine|dopamine|mesh-list
64411105|NCT01671319|Cyclophosphamide|cyclophosphamide|mesh-list
64411106|NCT01671319|Docetaxel|docetaxel|mesh-list
64411107|NCT01671319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64411108|NCT01671319|Immunologic Factors|immunologic factors|mesh-ancestor
64411109|NCT01671319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411110|NCT01671319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64411111|NCT01671319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64411112|NCT01671319|Alkylating Agents|alkylating agents|mesh-ancestor
64411113|NCT01671319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411114|NCT01671319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586406|NCT00427765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411115|NCT01671319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64411116|NCT01671319|Tubulin Modulators|tubulin modulators|mesh-ancestor
64411117|NCT01671319|Antimitotic Agents|antimitotic agents|mesh-ancestor
64411118|NCT01671319|Mitosis Modulators|mitosis modulators|mesh-ancestor
64411119|NCT04940065|Ofatumumab|ofatumumab|mesh-list
64411120|NCT04940065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64411121|NCT05019885|Ketamine|ketamine|mesh-list
64411122|NCT05019885|Analgesics|analgesics|mesh-ancestor
64342226|NCT04040231|Sargramostim|sargramostim|mesh-list
64411124|NCT05019885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411125|NCT05019885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411126|NCT05019885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64411127|NCT05019885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64411128|NCT05019885|Anesthetics, General|anesthetics, general|mesh-ancestor
64411129|NCT05019885|Anesthetics|anesthetics|mesh-ancestor
64411148|NCT03763305|Desflurane|desflurane|mesh-list
64411149|NCT03763305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64411150|NCT03763305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64411157|NCT03763305|Narcotics|narcotics|mesh-ancestor
64411158|NCT03763305|Analgesics|analgesics|mesh-ancestor
64411159|NCT03763305|Sensory System Agents|sensory system agents|mesh-ancestor
64411160|NCT03763305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411161|NCT03763305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64411162|NCT03763305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64411163|NCT03763305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64411164|NCT05054361|Mannitol|mannitol|mesh-list
64411165|NCT05054361|Lactulose|lactulose|mesh-list
64411166|NCT05054361|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64411167|NCT05054361|Diuretics|diuretics|mesh-ancestor
64411168|NCT05054361|Natriuretic Agents|natriuretic agents|mesh-ancestor
64411169|NCT05054361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411170|NCT05054361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64411171|NCT04970355|Erenumab|erenumab|mesh-list
64411172|NCT04970355|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64411173|NCT04970355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411174|NCT04970355|Analgesics|analgesics|mesh-ancestor
64411175|NCT04970355|Sensory System Agents|sensory system agents|mesh-ancestor
64586533|NCT01795235|Atenolol|atenolol|mesh-list
64411176|NCT04970355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411177|NCT04970355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411178|NCT04906213|Empagliflozin|empagliflozin|mesh-list
64411179|NCT04906213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64411180|NCT04906213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411181|NCT04906213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64411182|NCT04906213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411183|NCT01670539|Triamcinolone|triamcinolone|mesh-list
64411184|NCT01670539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64411185|NCT01670539|Glucocorticoids|glucocorticoids|mesh-ancestor
64411186|NCT01670539|Hormones|hormones|mesh-ancestor
64411200|NCT02252887|Immunologic Factors|immunologic factors|mesh-ancestor
64411212|NCT03064633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64586583|NCT00389857|Vaccines|vaccines|mesh-list
64411213|NCT03064633|Antiemetics|antiemetics|mesh-ancestor
64411214|NCT03064633|Autonomic Agents|autonomic agents|mesh-ancestor
64411215|NCT03064633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411216|NCT03064633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411217|NCT03064633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64411218|NCT03064633|Glucocorticoids|glucocorticoids|mesh-ancestor
64411219|NCT03064633|Hormones|hormones|mesh-ancestor
64411220|NCT03064633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64411221|NCT03064633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64411222|NCT03064633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64411223|NCT03064633|Protease Inhibitors|protease inhibitors|mesh-ancestor
64411224|NCT03064633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64411225|NCT03064633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411226|NCT03064633|Anesthetics, Local|anesthetics, local|mesh-ancestor
64411227|NCT03064633|Anesthetics|anesthetics|mesh-ancestor
64411228|NCT03064633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64411229|NCT03064633|Sensory System Agents|sensory system agents|mesh-ancestor
64411230|NCT03064633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64411231|NCT03064633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64411232|NCT03064633|Analgesics|analgesics|mesh-ancestor
64411233|NCT03064633|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64411234|NCT03064633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64411235|NCT03064633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64411236|NCT03064633|Adrenergic Agents|adrenergic agents|mesh-ancestor
64411237|NCT03064633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64411238|NCT04950465|Fluorides|fluorides|mesh-list
64411239|NCT04950465|Cariostatic Agents|cariostatic agents|mesh-ancestor
64411240|NCT04950465|Protective Agents|protective agents|mesh-ancestor
64411241|NCT04950465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411242|NCT04877821|Paclitaxel|paclitaxel|mesh-list
64411243|NCT04877821|Cyclophosphamide|cyclophosphamide|mesh-list
64411244|NCT04877821|Carboplatin|carboplatin|mesh-list
64411245|NCT04877821|Epirubicin|epirubicin|mesh-list
64411246|NCT04877821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64411268|NCT02589665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411269|NCT02589665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411270|NCT02589665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64411271|NCT02589665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64411272|NCT02589665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64411273|NCT02589665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64411274|NCT04840615|Ipilimumab|ipilimumab|mesh-list
64411275|NCT04840615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64411276|NCT04840615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342242|NCT00616811|Vildagliptin|vildagliptin|mesh-list
64411278|NCT04840615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411280|NCT05011383|Androgens|androgens|mesh-list
64411281|NCT05011383|Hormones|hormones|mesh-ancestor
64411282|NCT05011383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64411283|NCT05011383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411284|NCT01697527|Aldesleukin|aldesleukin|mesh-list
64411285|NCT01697527|Cyclophosphamide|cyclophosphamide|mesh-list
64411286|NCT01697527|Fludarabine|fludarabine|mesh-list
64411287|NCT01697527|Fludarabine phosphate|fludarabine phosphate|mesh-list
64411288|NCT01697527|Interleukin-2|interleukin-2|mesh-list
64411289|NCT01697527|Vaccines|vaccines|mesh-list
64586752|NCT00461851|Antiviral Agents|antiviral agents|mesh-ancestor
64411290|NCT01697527|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64411291|NCT01697527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64411292|NCT01697527|Immunologic Factors|immunologic factors|mesh-ancestor
64411293|NCT01697527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411294|NCT01697527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64411295|NCT01697527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64411296|NCT01697527|Alkylating Agents|alkylating agents|mesh-ancestor
64411297|NCT01697527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411298|NCT01697527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64411299|NCT01697527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64411300|NCT01697527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64411301|NCT01697527|Antimetabolites|antimetabolites|mesh-ancestor
64411306|NCT01697527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64411308|NCT01697527|Antiviral Agents|antiviral agents|mesh-ancestor
64411309|NCT01697527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64411310|NCT01697527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64411311|NCT04426409|Ofloxacin|ofloxacin|mesh-list
64411319|NCT04426409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411320|NCT04426409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586877|NCT00465595|Hallucinogens|hallucinogens|mesh-ancestor
64411321|NCT04426409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64411322|NCT04426409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64411324|NCT04426097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64411325|NCT04426097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64411326|NCT04426097|Trace Elements|trace elements|mesh-ancestor
64411327|NCT04426097|Micronutrients|micronutrients|mesh-ancestor
64411328|NCT04426097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411329|NCT05556083|Sildenafil Citrate|sildenafil citrate|mesh-list
64411330|NCT05556083|Vasodilator Agents|vasodilator agents|mesh-ancestor
64411331|NCT05556083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64411332|NCT05556083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64411333|NCT05556083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64411334|NCT05556083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411335|NCT05556083|Urological Agents|urological agents|mesh-ancestor
64411336|NCT05556005|Trimetazidine|trimetazidine|mesh-list
64411337|NCT05556005|Vasodilator Agents|vasodilator agents|mesh-ancestor
64411338|NCT05008809|Leucovorin|leucovorin|mesh-list
64411339|NCT05008809|Fluorouracil|fluorouracil|mesh-list
64411340|NCT05008809|Oxaliplatin|oxaliplatin|mesh-list
64411341|NCT05008809|Irinotecan|irinotecan|mesh-list
64411342|NCT05008809|Levoleucovorin|levoleucovorin|mesh-list
64587006|NCT01421342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64411343|NCT05008809|Antimetabolites|antimetabolites|mesh-ancestor
64411344|NCT05008809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411345|NCT05008809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64411346|NCT05008809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64411348|NCT05008809|Immunologic Factors|immunologic factors|mesh-ancestor
64411349|NCT05008809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411359|NCT04374461|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64411360|NCT04374461|Antiviral Agents|antiviral agents|mesh-ancestor
64411361|NCT04374461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64411362|NCT04374461|Expectorants|expectorants|mesh-ancestor
64411363|NCT04374461|Respiratory System Agents|respiratory system agents|mesh-ancestor
64411364|NCT04374461|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64411365|NCT04374461|Antioxidants|antioxidants|mesh-ancestor
64411366|NCT04374461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411367|NCT04374461|Protective Agents|protective agents|mesh-ancestor
64411368|NCT04374461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411369|NCT04374461|Antidotes|antidotes|mesh-ancestor
64411370|NCT04373603|Tranexamic Acid|tranexamic acid|mesh-list
64411371|NCT04373603|Hyaluronic Acid|hyaluronic acid|mesh-list
64411372|NCT04373603|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64411373|NCT04373603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64411374|NCT04373603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411375|NCT04373603|Hemostatics|hemostatics|mesh-ancestor
64411376|NCT04373603|Coagulants|coagulants|mesh-ancestor
64411378|NCT04373603|Immunologic Factors|immunologic factors|mesh-ancestor
64411379|NCT04373603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411380|NCT04373603|Viscosupplements|viscosupplements|mesh-ancestor
64411391|NCT02519595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64411392|NCT02519595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64411394|NCT02519595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64411396|NCT04278755|Drospirenone|drospirenone|mesh-list
64411417|NCT04277975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64411418|NCT04277975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411419|NCT04277975|Analgesics|analgesics|mesh-ancestor
64411420|NCT04277975|Sensory System Agents|sensory system agents|mesh-ancestor
64411421|NCT04277975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411422|NCT04062695|Tofacitinib|tofacitinib|mesh-list
64587205|NCT01797757|Orlistat|orlistat|mesh-list
64411423|NCT04062695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64411424|NCT04062695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64411425|NCT04062695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411426|NCT04330079|Dapagliflozin|dapagliflozin|mesh-list
64411427|NCT04330079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64411428|NCT04330079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411429|NCT04330079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64411430|NCT04330079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411431|NCT00660673|Levodopa|levodopa|mesh-list
64411432|NCT00660673|Carbidopa|carbidopa|mesh-list
64411433|NCT00660673|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64411434|NCT00660673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64411435|NCT00660673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64411436|NCT00660673|Dopamine Agents|dopamine agents|mesh-ancestor
64411437|NCT00660673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64411438|NCT00660673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411439|NCT00660673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411440|NCT00660673|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64411441|NCT00660673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587326|NCT00479089|Docetaxel|docetaxel|mesh-list
64411443|NCT00660673|Immunologic Factors|immunologic factors|mesh-ancestor
64411470|NCT04744649|Immunologic Factors|immunologic factors|mesh-ancestor
64411471|NCT04744649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411473|NCT05701007|Goserelin|goserelin|mesh-list
64411474|NCT05701007|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64411475|NCT05701007|Leuprolide|leuprolide|mesh-list
64411476|NCT05701007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64411477|NCT05701007|Tubulin Modulators|tubulin modulators|mesh-ancestor
64411478|NCT05701007|Antimitotic Agents|antimitotic agents|mesh-ancestor
64411479|NCT05701007|Mitosis Modulators|mitosis modulators|mesh-ancestor
64411480|NCT05701007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411481|NCT05701007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64411482|NCT05701007|Luteolytic Agents|luteolytic agents|mesh-ancestor
64411483|NCT05701007|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64411484|NCT05701007|Contraceptive Agents|contraceptive agents|mesh-ancestor
64411485|NCT05701007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64411486|NCT05701007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411487|NCT05701007|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64411488|NCT05701007|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64411489|NCT05701007|Fertility Agents|fertility agents|mesh-ancestor
64411490|NCT04426955|Paclitaxel|paclitaxel|mesh-list
64411491|NCT04426955|Cisplatin|cisplatin|mesh-list
64411492|NCT04426955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64411493|NCT04426955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64411494|NCT04426955|Tubulin Modulators|tubulin modulators|mesh-ancestor
64411495|NCT04426955|Antimitotic Agents|antimitotic agents|mesh-ancestor
64411496|NCT04426955|Mitosis Modulators|mitosis modulators|mesh-ancestor
64411497|NCT04426955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411498|NCT02630563|Cyclosporine|cyclosporine|mesh-list
64411499|NCT02630563|Mycophenolic Acid|mycophenolic acid|mesh-list
64411500|NCT02630563|Cyclosporins|cyclosporins|mesh-list
64411501|NCT02630563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64411502|NCT02630563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411503|NCT02630563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64411504|NCT02630563|Immunologic Factors|immunologic factors|mesh-ancestor
64411526|NCT02587247|Immunologic Factors|immunologic factors|mesh-ancestor
64411527|NCT02587247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411528|NCT02555111|Rivaroxaban|rivaroxaban|mesh-list
64411529|NCT02555111|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64411530|NCT02555111|Antithrombins|antithrombins|mesh-ancestor
64411531|NCT02555111|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64411532|NCT02555111|Protease Inhibitors|protease inhibitors|mesh-ancestor
64411533|NCT02555111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64411534|NCT02555111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411537|NCT02521415|Ibuprofen|ibuprofen|mesh-list
64411538|NCT02521415|Fentanyl|fentanyl|mesh-list
64411539|NCT02521415|Ketamine|ketamine|mesh-list
64411540|NCT02521415|Analgesics|analgesics|mesh-list
64587579|NCT01397552|Dexamethasone|dexamethasone|mesh-list
64411541|NCT02521415|Sensory System Agents|sensory system agents|mesh-ancestor
64411542|NCT02521415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411543|NCT02521415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411544|NCT02521415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64411545|NCT02521415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64411546|NCT02521415|Anesthetics, General|anesthetics, general|mesh-ancestor
64411547|NCT02521415|Anesthetics|anesthetics|mesh-ancestor
64411548|NCT02521415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64411549|NCT02521415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64411550|NCT02521415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64411551|NCT02521415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64411552|NCT02521415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411553|NCT02521415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64411554|NCT02521415|Narcotics|narcotics|mesh-ancestor
64411555|NCT02521415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64411556|NCT02521415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64411557|NCT02521415|Antipyretics|antipyretics|mesh-ancestor
64587708|NCT00422201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64411558|NCT02521415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64411559|NCT02521415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64411560|NCT02521415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64411561|NCT02521415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64411562|NCT02521415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64411565|NCT02078141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411566|NCT02078141|Antiviral Agents|antiviral agents|mesh-ancestor
64411567|NCT02078141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64411568|NCT02588339|Sirolimus|sirolimus|mesh-list
64411569|NCT02588339|Panobinostat|panobinostat|mesh-list
64587771|NCT02108171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64411570|NCT02588339|Tacrolimus|tacrolimus|mesh-list
64411579|NCT02588339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64411581|NCT02588339|Antifungal Agents|antifungal agents|mesh-ancestor
64342595|NCT02259010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64342620|NCT00151775|Olmesartan|olmesartan|mesh-list
64411583|NCT01752491|Ascorbic Acid|ascorbic acid|mesh-list
64411584|NCT01752491|Temozolomide|temozolomide|mesh-list
64411585|NCT01752491|Vitamins|vitamins|mesh-ancestor
64411586|NCT01752491|Micronutrients|micronutrients|mesh-ancestor
64411587|NCT01752491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411588|NCT01752491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64587835|NCT02122471|Enzyme Activators|enzyme activators|mesh-ancestor
64411589|NCT01752491|Alkylating Agents|alkylating agents|mesh-ancestor
64411590|NCT01752491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411591|NCT01752491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64411592|NCT01752491|Antioxidants|antioxidants|mesh-ancestor
64411593|NCT01752491|Protective Agents|protective agents|mesh-ancestor
64411594|NCT05554211|Tranexamic Acid|tranexamic acid|mesh-list
64411595|NCT05554211|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64411596|NCT05554211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64411597|NCT05554211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411598|NCT05554211|Hemostatics|hemostatics|mesh-ancestor
64411624|NCT05700617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64411625|NCT05553743|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64411626|NCT05553743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64411627|NCT05553665|Lidocaine|lidocaine|mesh-list
64411628|NCT05553665|Fentanyl|fentanyl|mesh-list
64411629|NCT05553665|Midazolam|midazolam|mesh-list
64411630|NCT05553665|Complement System Proteins|complement system proteins|mesh-list
64411631|NCT05553665|Complement C4|complement c4|mesh-list
64411632|NCT05553665|Anesthetics, Local|anesthetics, local|mesh-ancestor
64411633|NCT05553665|Anesthetics|anesthetics|mesh-ancestor
64411634|NCT05553665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64411635|NCT05553665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411636|NCT05553665|Sensory System Agents|sensory system agents|mesh-ancestor
64411641|NCT05553665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64411642|NCT05553665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411643|NCT05553665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64411644|NCT05553665|Narcotics|narcotics|mesh-ancestor
64411645|NCT05553665|Analgesics|analgesics|mesh-ancestor
64411646|NCT05553665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64411647|NCT05553665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64411648|NCT05553665|Anesthetics, General|anesthetics, general|mesh-ancestor
64411649|NCT05553665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64411650|NCT05553665|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64411651|NCT05553665|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64411652|NCT05553665|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64411653|NCT05553665|GABA Modulators|gaba modulators|mesh-ancestor
64411654|NCT05553665|GABA Agents|gaba agents|mesh-ancestor
64411655|NCT05553665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64411656|NCT05553665|Immunologic Factors|immunologic factors|mesh-ancestor
64411657|NCT02629159|Adalimumab|adalimumab|mesh-list
64411658|NCT02629159|Upadacitinib|upadacitinib|mesh-list
64411659|NCT02629159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64411660|NCT02629159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64411661|NCT02629159|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64411668|NCT05548985|Autonomic Agents|autonomic agents|mesh-ancestor
64411669|NCT05548985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411670|NCT05548985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411671|NCT05548985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64411672|NCT05548985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64411673|NCT05548985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64411674|NCT05548985|Dopamine Agents|dopamine agents|mesh-ancestor
64411675|NCT05548985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64411676|NCT05548985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411678|NCT05548985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64411679|NCT05548985|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64587974|NCT00462605|Entinostat|entinostat|mesh-list
64411680|NCT05548985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64411681|NCT05548985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64411682|NCT05548985|Adrenergic Agents|adrenergic agents|mesh-ancestor
64411683|NCT05698979|Botulinum Toxins|botulinum toxins|mesh-list
64411684|NCT05698979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64411685|NCT05698979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64411686|NCT05698979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411687|NCT05698979|Cholinergic Agents|cholinergic agents|mesh-ancestor
64411688|NCT05698979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64587997|NCT00434993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64411689|NCT05698979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411690|NCT04981951|Dexmedetomidine|dexmedetomidine|mesh-list
64411691|NCT04981951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64411692|NCT04981951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64411693|NCT04981951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411694|NCT04981951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64411729|NCT05552729|Micronutrients|micronutrients|mesh-ancestor
64411730|NCT05552729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411731|NCT05552729|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64588061|NCT05360576|NuvaRing|nuvaring|mesh-list
64411732|NCT05552729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64411733|NCT04436107|Lenalidomide|lenalidomide|mesh-list
64411734|NCT04436107|Zanubrutinib|zanubrutinib|mesh-list
64411735|NCT04436107|Immunologic Factors|immunologic factors|mesh-ancestor
64411736|NCT04436107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411737|NCT04436107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64411738|NCT04436107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64411739|NCT04436107|Growth Substances|growth substances|mesh-ancestor
64411740|NCT04436107|Growth Inhibitors|growth inhibitors|mesh-ancestor
64411741|NCT04436107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64411742|NCT04436107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64411743|NCT04436107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64411744|NCT04436107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411745|NCT05699993|Itraconazole|itraconazole|mesh-list
64411746|NCT05699993|Dextromethorphan|dextromethorphan|mesh-list
64411747|NCT05699993|Antifungal Agents|antifungal agents|mesh-ancestor
64411748|NCT05699993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64411749|NCT05699993|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64411750|NCT05699993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64411751|NCT05699993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64411752|NCT05699993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411764|NCT05552651|Carboplatin|carboplatin|mesh-list
64411793|NCT05547659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64411794|NCT05547659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64411795|NCT05547659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64411796|NCT05547659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64411797|NCT05547659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64411798|NCT05547659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64411799|NCT05547659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64411800|NCT05547659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64411801|NCT05547659|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64411802|NCT05547659|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64411803|NCT05547659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64411804|NCT05541419|Budesonide|budesonide|mesh-list
64411805|NCT05541419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64411806|NCT05541419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64411870|NCT03062839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64411871|NCT05540951|Bevacizumab|bevacizumab|mesh-list
64411872|NCT05540951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64411873|NCT05540951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64411874|NCT05540951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64411875|NCT05540951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64411876|NCT05540951|Growth Substances|growth substances|mesh-ancestor
64411893|NCT04981093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64411895|NCT04981093|Hormones|hormones|mesh-ancestor
64411896|NCT04981093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64411897|NCT04981093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64411898|NCT04981093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64411899|NCT05551247|Endostatins|endostatins|mesh-list
64411900|NCT05551247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64411901|NCT05551247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64411902|NCT05551247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64411903|NCT05551247|Growth Substances|growth substances|mesh-ancestor
64411904|NCT05551247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411905|NCT05551247|Growth Inhibitors|growth inhibitors|mesh-ancestor
64411906|NCT05698511|Psilocybin|psilocybin|mesh-list
64411907|NCT05698511|Hallucinogens|hallucinogens|mesh-ancestor
64411909|NCT05698511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64411921|NCT02513823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411922|NCT02513823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64411923|NCT02513823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64411924|NCT05545475|Heparin|heparin|mesh-list
64411926|NCT05545475|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64411927|NCT05545475|Tinzaparin|tinzaparin|mesh-list
64411928|NCT05545475|Dalteparin|dalteparin|mesh-list
64411929|NCT05545475|Nadroparin|nadroparin|mesh-list
64411930|NCT05545475|Warfarin|warfarin|mesh-list
64411931|NCT05545475|Anticoagulants|anticoagulants|mesh-ancestor
64411932|NCT05545475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64411933|NCT05545475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64411934|NCT05545475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411935|NCT05545397|Propofol|propofol|mesh-list
64411936|NCT05545397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64411937|NCT05545397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64411944|NCT04952727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411946|NCT04433143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64411947|NCT04433143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64411948|NCT01665911|Listerine|listerine|mesh-list
64411949|NCT01665911|Fluorides|fluorides|mesh-list
64411950|NCT01665911|Sodium Fluoride|sodium fluoride|mesh-list
64411951|NCT01665911|Cariostatic Agents|cariostatic agents|mesh-ancestor
64411952|NCT01665911|Protective Agents|protective agents|mesh-ancestor
64411953|NCT01665911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411954|NCT01665911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64411955|NCT01665911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64411956|NCT03063073|Dexmedetomidine|dexmedetomidine|mesh-list
64411957|NCT03063073|Bupivacaine|bupivacaine|mesh-list
64411958|NCT03063073|Anesthetics, Local|anesthetics, local|mesh-ancestor
64411959|NCT03063073|Anesthetics|anesthetics|mesh-ancestor
64411960|NCT03063073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64411961|NCT03063073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411962|NCT03063073|Sensory System Agents|sensory system agents|mesh-ancestor
64411963|NCT03063073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411967|NCT03063073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64411968|NCT03063073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64411969|NCT03063073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64411970|NCT03063073|Adrenergic Agents|adrenergic agents|mesh-ancestor
64411971|NCT03063073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64411972|NCT03063073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411974|NCT04620733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64411975|NCT04620733|Antimetabolites|antimetabolites|mesh-ancestor
64411976|NCT04620733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411977|NCT04620733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64411978|NCT02476617|Ritonavir|ritonavir|mesh-list
64411979|NCT02476617|Ribavirin|ribavirin|mesh-list
64411980|NCT02476617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64411981|NCT02476617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64411982|NCT02476617|Protease Inhibitors|protease inhibitors|mesh-ancestor
64411983|NCT02476617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64411984|NCT02476617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411985|NCT02476617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64411986|NCT02476617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64411987|NCT02476617|Antiviral Agents|antiviral agents|mesh-ancestor
64411988|NCT02476617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64411989|NCT02476617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64411990|NCT02476617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64411991|NCT02476617|Antimetabolites|antimetabolites|mesh-ancestor
64411992|NCT04428307|Artemisinins|artemisinins|mesh-list
64411993|NCT04428307|Artemisinin|artemisinin|mesh-list
64411996|NCT04428307|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64412018|NCT03822871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64412019|NCT03822871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412020|NCT03064165|Epinephrine|epinephrine|mesh-list
64412021|NCT03064165|Bupivacaine|bupivacaine|mesh-list
64412022|NCT03064165|Anesthetics, Local|anesthetics, local|mesh-ancestor
64412023|NCT03064165|Anesthetics|anesthetics|mesh-ancestor
64412024|NCT03064165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64412025|NCT03064165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412026|NCT03064165|Sensory System Agents|sensory system agents|mesh-ancestor
64412027|NCT03064165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64412028|NCT03064165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64412029|NCT03064165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64412030|NCT03064165|Adrenergic Agents|adrenergic agents|mesh-ancestor
64412031|NCT03064165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64412032|NCT03064165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412033|NCT03064165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64412034|NCT03064165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64412035|NCT03064165|Autonomic Agents|autonomic agents|mesh-ancestor
64412036|NCT03064165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64412037|NCT03064165|Respiratory System Agents|respiratory system agents|mesh-ancestor
64412038|NCT03064165|Mydriatics|mydriatics|mesh-ancestor
64412039|NCT03064165|Sympathomimetics|sympathomimetics|mesh-ancestor
64412040|NCT03064165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64412041|NCT05535413|Capecitabine|capecitabine|mesh-list
64412042|NCT05535413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64412043|NCT05535413|Antimetabolites|antimetabolites|mesh-ancestor
64412044|NCT05535413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412045|NCT05535413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412046|NCT03813199|Methotrexate|methotrexate|mesh-list
64588263|NCT03594968|Hormones|hormones|mesh-ancestor
64412047|NCT03813199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64412048|NCT03813199|Abortifacient Agents|abortifacient agents|mesh-ancestor
64412049|NCT03813199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64412050|NCT03813199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412057|NCT03813199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64412058|NCT03813199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64412059|NCT03813199|Immunologic Factors|immunologic factors|mesh-ancestor
64412060|NCT03813199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64412061|NCT03813199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64412063|NCT05699135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64412064|NCT05699135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412065|NCT03791593|Evolocumab|evolocumab|mesh-list
64412066|NCT03791593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64412067|NCT03791593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64412068|NCT03791593|Antimetabolites|antimetabolites|mesh-ancestor
64412069|NCT03791593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412070|NCT03791593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64412072|NCT03064243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412073|NCT03064243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64412074|NCT03064243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412075|NCT03064243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412076|NCT03765619|Aspirin|aspirin|mesh-list
64412077|NCT03765619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64412078|NCT03765619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64412088|NCT03765619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64412089|NCT03765619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64412090|NCT03765619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412091|NCT03765619|Antipyretics|antipyretics|mesh-ancestor
64412092|NCT05543603|Chlorhexidine|chlorhexidine|mesh-list
64412093|NCT05543603|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64412094|NCT05543603|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64412095|NCT05543603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64412096|NCT05543603|Disinfectants|disinfectants|mesh-ancestor
64412097|NCT05543603|Dermatologic Agents|dermatologic agents|mesh-ancestor
64412098|NCT04979923|Lidocaine|lidocaine|mesh-list
64412108|NCT04979923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64412109|NCT04979923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412111|NCT03706885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64412112|NCT03706885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64412113|NCT03706885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412114|NCT03706885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412115|NCT03706885|Antiviral Agents|antiviral agents|mesh-ancestor
64412116|NCT03706885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64412117|NCT03706885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64412118|NCT03706885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64412119|NCT03706885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64412120|NCT03706885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64412121|NCT03706885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64412122|NCT03706885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64412123|NCT01665599|Testosterone|testosterone|mesh-list
64412124|NCT01665599|Androgens|androgens|mesh-ancestor
64412125|NCT01665599|Hormones|hormones|mesh-ancestor
64412126|NCT01665599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64412127|NCT01665599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412128|NCT04979221|Cyproheptadine|cyproheptadine|mesh-list
64412129|NCT04979221|Antipruritics|antipruritics|mesh-ancestor
64412130|NCT04979221|Dermatologic Agents|dermatologic agents|mesh-ancestor
64412131|NCT04979221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64412132|NCT04979221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64412133|NCT04979221|Histamine Antagonists|histamine antagonists|mesh-ancestor
64412134|NCT04979221|Histamine Agents|histamine agents|mesh-ancestor
64412135|NCT04979221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64412136|NCT04979221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412137|NCT04979221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412138|NCT04979221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64412139|NCT04979221|Serotonin Agents|serotonin agents|mesh-ancestor
64412140|NCT04979221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64412141|NCT05697809|Dexamethasone|dexamethasone|mesh-list
64412146|NCT05697809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412147|NCT05697809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64412149|NCT05697809|Hormones|hormones|mesh-ancestor
64412150|NCT05697809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64412151|NCT05697809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64412152|NCT05697809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412153|NCT03980483|Methotrexate|methotrexate|mesh-list
64412154|NCT03980483|Tofacitinib|tofacitinib|mesh-list
64412155|NCT03980483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64412157|NCT03980483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64412158|NCT03980483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412159|NCT03980483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64412160|NCT03980483|Antimetabolites|antimetabolites|mesh-ancestor
64412161|NCT03980483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412162|NCT03980483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412163|NCT03980483|Dermatologic Agents|dermatologic agents|mesh-ancestor
64412164|NCT03980483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412165|NCT03980483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64412166|NCT03980483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64412167|NCT03980483|Immunologic Factors|immunologic factors|mesh-ancestor
64412168|NCT03980483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64412169|NCT03980483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64412171|NCT03611881|Nicotine|nicotine|mesh-list
64412193|NCT03063541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64412194|NCT03063541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64412195|NCT03063541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412196|NCT03063541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64412197|NCT03063541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64412198|NCT03063541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412199|NCT03063541|Antipyretics|antipyretics|mesh-ancestor
64412200|NCT04978597|Opicapone|opicapone|mesh-list
64412201|NCT04978597|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64412202|NCT04978597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412203|NCT04978597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412204|NCT04978597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64412205|NCT04978597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64412206|NCT03491683|Temozolomide|temozolomide|mesh-list
64412207|NCT03491683|Cemiplimab|cemiplimab|mesh-list
64412208|NCT03491683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64412209|NCT03491683|Alkylating Agents|alkylating agents|mesh-ancestor
64412210|NCT03491683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412211|NCT03491683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412222|NCT03490513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64412224|NCT03439345|Fenofibrate|fenofibrate|mesh-list
64412225|NCT03439345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64412226|NCT03439345|Antimetabolites|antimetabolites|mesh-ancestor
64412227|NCT03439345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412228|NCT03439345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64412229|NCT04977661|Vitamin E|vitamin e|mesh-list
64412230|NCT04977661|Tocopherols|tocopherols|mesh-list
64412231|NCT04977661|alpha-Tocopherol|alpha-tocopherol|mesh-list
64412232|NCT04977661|Pentoxifylline|pentoxifylline|mesh-list
64412233|NCT04977661|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64412234|NCT04977661|Vitamins|vitamins|mesh-ancestor
64412243|NCT04977661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64412244|NCT04977661|Vasodilator Agents|vasodilator agents|mesh-ancestor
64412245|NCT04977661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64412246|NCT04977661|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64412247|NCT04977661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64412248|NCT04977427|Prednisolone|prednisolone|mesh-list
64412249|NCT04977427|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64412250|NCT04977427|Methylprednisolone|methylprednisolone|mesh-list
64412251|NCT04977427|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64412252|NCT04977427|Prednisolone acetate|prednisolone acetate|mesh-list
64412253|NCT04977427|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64412254|NCT04977427|Prednisolone phosphate|prednisolone phosphate|mesh-list
64412255|NCT04977427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64412256|NCT04977427|Glucocorticoids|glucocorticoids|mesh-ancestor
64342912|NCT00489203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64342916|NCT00489203|Glucocorticoids|glucocorticoids|mesh-ancestor
64412258|NCT04977427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64412260|NCT04977427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64412261|NCT04977427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412262|NCT04977427|Antiemetics|antiemetics|mesh-ancestor
64412263|NCT04977427|Autonomic Agents|autonomic agents|mesh-ancestor
64412264|NCT04977427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64412265|NCT04977427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64412266|NCT04977427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64412267|NCT04977427|Protective Agents|protective agents|mesh-ancestor
64412268|NCT03327805|Choline|choline|mesh-list
64412269|NCT03327805|Lipotropic Agents|lipotropic agents|mesh-ancestor
64412270|NCT03327805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64412271|NCT03327805|Antimetabolites|antimetabolites|mesh-ancestor
64412272|NCT03327805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412273|NCT03327805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64412283|NCT04224415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64412284|NCT04224415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64412285|NCT04224415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412286|NCT04224415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412287|NCT04224415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412290|NCT03239899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412291|NCT03061981|Metformin|metformin|mesh-list
64412292|NCT03061981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64412293|NCT03061981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412294|NCT02510001|Crizotinib|crizotinib|mesh-list
64412295|NCT02510001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412296|NCT02510001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64412297|NCT02510001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412298|NCT02510001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412299|NCT02452047|Imipenem|imipenem|mesh-list
64412300|NCT02452047|Relebactam|relebactam|mesh-list
64412301|NCT02452047|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
64412302|NCT02452047|Cilastatin|cilastatin|mesh-list
64412303|NCT02452047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64412304|NCT02452047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64412305|NCT02452047|Protease Inhibitors|protease inhibitors|mesh-ancestor
64412306|NCT02452047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412307|NCT02452047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412308|NCT02452047|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64412309|NCT04925505|Anesthetics|anesthetics|mesh-list
64412310|NCT04925505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64412311|NCT04925505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412312|NCT02475369|Pancrelipase|pancrelipase|mesh-list
64412313|NCT02475369|Pancreatin|pancreatin|mesh-list
64412314|NCT02475369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64412315|NCT03862157|Azacitidine|azacitidine|mesh-list
64412316|NCT03862157|Venetoclax|venetoclax|mesh-list
64412317|NCT03862157|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64412318|NCT03862157|Pevonedistat|pevonedistat|mesh-list
64412319|NCT03862157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64412320|NCT03862157|Antimetabolites|antimetabolites|mesh-ancestor
64412338|NCT02474199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64412339|NCT02474199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64412359|NCT02450487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412360|NCT02450487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64412361|NCT02450487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64412362|NCT02450487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64412363|NCT02450487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412364|NCT02450487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412367|NCT02506257|Biguanides|biguanides|mesh-list
64412368|NCT02506257|Polihexanide|polihexanide|mesh-list
64412369|NCT02506257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64412370|NCT02506257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412371|NCT02506257|Disinfectants|disinfectants|mesh-ancestor
64412372|NCT02506257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64412373|NCT02505945|Omeprazole|omeprazole|mesh-list
64412374|NCT02505945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64412375|NCT02505945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64412376|NCT02505945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64412377|NCT02505945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412378|NCT02505945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412379|NCT04213885|Riboflavin|riboflavin|mesh-list
64412380|NCT04213885|Vitamin B Complex|vitamin b complex|mesh-ancestor
64412381|NCT04213885|Vitamins|vitamins|mesh-ancestor
64412382|NCT04213885|Micronutrients|micronutrients|mesh-ancestor
64412383|NCT04213885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412384|NCT04213885|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64412385|NCT04213885|Dermatologic Agents|dermatologic agents|mesh-ancestor
64412387|NCT02448771|Palbociclib|palbociclib|mesh-list
64412388|NCT02448771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343006|NCT00542633|Insulin|insulin|mesh-list
64412390|NCT02448771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412391|NCT02448771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412392|NCT02448771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64412393|NCT02448771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64412394|NCT02448771|Hormone Antagonists|hormone antagonists|mesh-ancestor
64412395|NCT02448771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64412406|NCT03117751|Etoposide phosphate|etoposide phosphate|mesh-list
64412407|NCT03117751|Vincristine|vincristine|mesh-list
64412408|NCT03117751|Bortezomib|bortezomib|mesh-list
64412409|NCT03117751|Daunorubicin|daunorubicin|mesh-list
64412410|NCT03117751|Asparaginase|asparaginase|mesh-list
64412411|NCT03117751|Dasatinib|dasatinib|mesh-list
64412412|NCT03117751|Mercaptopurine|mercaptopurine|mesh-list
64412413|NCT03117751|Vorinostat|vorinostat|mesh-list
64412414|NCT03117751|Idarubicin|idarubicin|mesh-list
64412415|NCT03117751|Clofarabine|clofarabine|mesh-list
64412416|NCT03117751|Pegaspargase|pegaspargase|mesh-list
64412417|NCT03117751|Thioguanine|thioguanine|mesh-list
64412418|NCT03117751|Blinatumomab|blinatumomab|mesh-list
64412419|NCT03117751|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
64412420|NCT03117751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64412421|NCT03117751|Immunologic Factors|immunologic factors|mesh-ancestor
64412422|NCT03117751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412423|NCT03117751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64412424|NCT03117751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64412425|NCT03117751|Alkylating Agents|alkylating agents|mesh-ancestor
64412427|NCT03117751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412440|NCT03117751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64412441|NCT03117751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412442|NCT03117751|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64412443|NCT03117751|Abortifacient Agents|abortifacient agents|mesh-ancestor
64412444|NCT03117751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64412445|NCT03117751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64412446|NCT03117751|Antimetabolites|antimetabolites|mesh-ancestor
64412447|NCT03117751|Dermatologic Agents|dermatologic agents|mesh-ancestor
64412448|NCT03117751|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64588321|NCT00490477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64412449|NCT03117751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64412450|NCT03117751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64412451|NCT03117751|Antiviral Agents|antiviral agents|mesh-ancestor
64412452|NCT03117751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64412453|NCT03117751|Tubulin Modulators|tubulin modulators|mesh-ancestor
64412454|NCT03117751|Antimitotic Agents|antimitotic agents|mesh-ancestor
64412455|NCT03117751|Mitosis Modulators|mitosis modulators|mesh-ancestor
64412456|NCT03117751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64412457|NCT03117751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64412458|NCT02504541|Methyltestosterone|methyltestosterone|mesh-list
64412459|NCT02504541|Testosterone|testosterone|mesh-list
64412460|NCT02504541|Testosterone undecanoate|testosterone undecanoate|mesh-list
64412461|NCT02504541|Testosterone enanthate|testosterone enanthate|mesh-list
64412462|NCT02504541|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64412463|NCT02504541|Androgens|androgens|mesh-ancestor
64412464|NCT02504541|Hormones|hormones|mesh-ancestor
64412476|NCT03063307|Fluorides|fluorides|mesh-list
64412477|NCT03063307|Cariostatic Agents|cariostatic agents|mesh-ancestor
64412478|NCT03063307|Protective Agents|protective agents|mesh-ancestor
64412480|NCT04874935|Lansoprazole|lansoprazole|mesh-list
64412492|NCT02961361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64412493|NCT02961361|Analgesics|analgesics|mesh-ancestor
64412494|NCT02961361|Sensory System Agents|sensory system agents|mesh-ancestor
64412495|NCT02961361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64412496|NCT02961361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64412497|NCT02961361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64412498|NCT02961361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64412499|NCT02961361|Adrenergic Agents|adrenergic agents|mesh-ancestor
64412500|NCT02961361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64412501|NCT02961361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412502|NCT02961361|Anesthetics, Local|anesthetics, local|mesh-ancestor
64412503|NCT02961361|Anesthetics|anesthetics|mesh-ancestor
64412504|NCT04974853|Complement System Proteins|complement system proteins|mesh-list
64412505|NCT04974853|Immunologic Factors|immunologic factors|mesh-ancestor
64412506|NCT04974853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412507|NCT02725177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64412509|NCT02725177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64412510|NCT02725177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412511|NCT02426281|Gemcitabine|gemcitabine|mesh-list
64412512|NCT02426281|Paclitaxel|paclitaxel|mesh-list
64412513|NCT02426281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64412514|NCT02426281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412515|NCT02426281|Tubulin Modulators|tubulin modulators|mesh-ancestor
64412516|NCT02426281|Antimitotic Agents|antimitotic agents|mesh-ancestor
64412517|NCT02426281|Mitosis Modulators|mitosis modulators|mesh-ancestor
64412518|NCT02426281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412519|NCT02426281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64412520|NCT02426281|Antimetabolites|antimetabolites|mesh-ancestor
64412521|NCT02426281|Antiviral Agents|antiviral agents|mesh-ancestor
64412522|NCT02426281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64412527|NCT02448537|Gemcitabine|gemcitabine|mesh-list
64412538|NCT02448537|Immunologic Factors|immunologic factors|mesh-ancestor
64412539|NCT02448537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412540|NCT02448537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64412541|NCT02448537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64412542|NCT02448537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64412543|NCT04838743|Xultophy|xultophy|mesh-list
64412544|NCT04838743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64412545|NCT04838743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412546|NCT04838743|Incretins|incretins|mesh-ancestor
64412547|NCT04838743|Hormones|hormones|mesh-ancestor
64412548|NCT04838743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64412549|NCT03060265|Acetaminophen|acetaminophen|mesh-list
64412550|NCT03060265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64412551|NCT03060265|Analgesics|analgesics|mesh-ancestor
64412552|NCT03060265|Sensory System Agents|sensory system agents|mesh-ancestor
64588330|NCT00492973|Clonidine|clonidine|mesh-list
64412553|NCT03060265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64412554|NCT03060265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412555|NCT03060265|Antipyretics|antipyretics|mesh-ancestor
64412556|NCT02504151|Cannabidiol|cannabidiol|mesh-list
64412557|NCT02504151|Anticonvulsants|anticonvulsants|mesh-ancestor
64412558|NCT02448381|Hypericin|hypericin|mesh-list
64412559|NCT02448381|Antidepressive Agents|antidepressive agents|mesh-ancestor
64412560|NCT02448381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64412561|NCT02448381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412562|NCT02448381|Antiviral Agents|antiviral agents|mesh-ancestor
64412563|NCT02448381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64412564|NCT02448381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412567|NCT02448381|Immunologic Factors|immunologic factors|mesh-ancestor
64412568|NCT02448381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412569|NCT02448225|Deoxyglucose|deoxyglucose|mesh-list
64412570|NCT02448225|Fluorides|fluorides|mesh-list
64412571|NCT02448225|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64412572|NCT02448225|Cariostatic Agents|cariostatic agents|mesh-ancestor
64412573|NCT02448225|Protective Agents|protective agents|mesh-ancestor
64412574|NCT02448225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412577|NCT02448225|Antimetabolites|antimetabolites|mesh-ancestor
64412578|NCT02448225|Antiviral Agents|antiviral agents|mesh-ancestor
64412579|NCT02448225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64412580|NCT02447991|Rizatriptan|rizatriptan|mesh-list
64412581|NCT02447991|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64412582|NCT02447991|Serotonin Agents|serotonin agents|mesh-ancestor
64412583|NCT02447991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64412584|NCT02447991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412585|NCT02447991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412586|NCT02586155|Atorvastatin|atorvastatin|mesh-list
64412587|NCT02586155|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64412588|NCT02586155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64412589|NCT02586155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64412590|NCT02586155|Antimetabolites|antimetabolites|mesh-ancestor
64412591|NCT02586155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412592|NCT02586155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64412593|NCT02586155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64412594|NCT02586155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412595|NCT05696093|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64412596|NCT05696093|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64412597|NCT05696093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64412607|NCT05536661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412608|NCT05536661|Viscosupplements|viscosupplements|mesh-ancestor
64412609|NCT05536661|Protective Agents|protective agents|mesh-ancestor
64412610|NCT05536661|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64412611|NCT05536661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64412612|NCT05536271|Bisoprolol|bisoprolol|mesh-list
64412613|NCT05536271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64412614|NCT05536271|Sympatholytics|sympatholytics|mesh-ancestor
64412615|NCT05536271|Autonomic Agents|autonomic agents|mesh-ancestor
64412619|NCT05536271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64412620|NCT05536271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64412621|NCT05536271|Adrenergic Agents|adrenergic agents|mesh-ancestor
64412622|NCT05536271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64412623|NCT05536271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412624|NCT05536193|Metformin|metformin|mesh-list
64412625|NCT05536193|Salicylic Acid|salicylic acid|mesh-list
64412626|NCT05536193|Salicylates|salicylates|mesh-list
64412627|NCT05536193|Mitogens|mitogens|mesh-list
64412628|NCT05536193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64412629|NCT05536193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412630|NCT05536193|Mitosis Modulators|mitosis modulators|mesh-ancestor
64412631|NCT05536193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412632|NCT05536193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64412633|NCT05536193|Antifungal Agents|antifungal agents|mesh-ancestor
64412634|NCT05536193|Keratolytic Agents|keratolytic agents|mesh-ancestor
64412635|NCT05536193|Dermatologic Agents|dermatologic agents|mesh-ancestor
64412637|NCT05536193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64412638|NCT05536193|Analgesics|analgesics|mesh-ancestor
64412639|NCT05536193|Sensory System Agents|sensory system agents|mesh-ancestor
64412640|NCT05536193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64412641|NCT05536193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64412642|NCT05536193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64412643|NCT05536193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64412644|NCT05536193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412645|NCT04425707|Hydroxychloroquine|hydroxychloroquine|mesh-list
64412646|NCT04425707|Ivermectin|ivermectin|mesh-list
64412647|NCT04425707|Antimalarials|antimalarials|mesh-ancestor
64412648|NCT04425707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64412649|NCT04425707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64412650|NCT04425707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64412651|NCT04425707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412652|NCT04425707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412653|NCT04425707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64412654|NCT05697185|Evolocumab|evolocumab|mesh-list
64412660|NCT05695781|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64412661|NCT05695781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64412662|NCT02581163|Ritonavir|ritonavir|mesh-list
64412663|NCT02581163|Ribavirin|ribavirin|mesh-list
64412664|NCT02581163|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64412665|NCT02581163|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64412673|NCT02581163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64412674|NCT02581163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64412675|NCT02581163|Antimetabolites|antimetabolites|mesh-ancestor
64412676|NCT05591417|Dexamethasone|dexamethasone|mesh-list
64412677|NCT05591417|Dexamethasone acetate|dexamethasone acetate|mesh-list
64412678|NCT05591417|Dexmedetomidine|dexmedetomidine|mesh-list
64412679|NCT05591417|Morphine|morphine|mesh-list
64412680|NCT05591417|BB 1101|bb 1101|mesh-list
64412681|NCT05591417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64412682|NCT05591417|Antiemetics|antiemetics|mesh-ancestor
64412683|NCT05591417|Autonomic Agents|autonomic agents|mesh-ancestor
64412684|NCT05591417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64412685|NCT05591417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412686|NCT05591417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64412687|NCT05591417|Glucocorticoids|glucocorticoids|mesh-ancestor
64412688|NCT05591417|Hormones|hormones|mesh-ancestor
64412689|NCT05591417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64412690|NCT05591417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64412691|NCT05591417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412692|NCT05591417|Protease Inhibitors|protease inhibitors|mesh-ancestor
64412693|NCT05591417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412694|NCT05591417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412695|NCT05591417|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64412696|NCT05591417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64412697|NCT05591417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64412698|NCT05591417|Analgesics|analgesics|mesh-ancestor
64412699|NCT05591417|Sensory System Agents|sensory system agents|mesh-ancestor
64412704|NCT05591417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64412705|NCT05591417|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64412706|NCT05591417|Narcotics|narcotics|mesh-ancestor
64343099|NCT00464633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412707|NCT01938547|Clevidipine|clevidipine|mesh-list
64412708|NCT01938547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64412709|NCT01938547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64412710|NCT01938547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412711|NCT01938547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64412712|NCT01938547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412713|NCT05695625|Anesthetics|anesthetics|mesh-list
64412714|NCT05695625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64412715|NCT05695625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412716|NCT05586737|Rituximab|rituximab|mesh-list
64412717|NCT05586737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64412718|NCT05586737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412719|NCT05586737|Immunologic Factors|immunologic factors|mesh-ancestor
64412720|NCT05586737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412721|NCT05586737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64412722|NCT05678933|Prednisone|prednisone|mesh-list
64412723|NCT05678933|Cyclophosphamide|cyclophosphamide|mesh-list
64412724|NCT05678933|Vincristine|vincristine|mesh-list
64412725|NCT05678933|Azacitidine|azacitidine|mesh-list
64412726|NCT05678933|Epirubicin|epirubicin|mesh-list
64412727|NCT05678933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64412728|NCT05678933|Immunologic Factors|immunologic factors|mesh-ancestor
64412729|NCT05678933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412730|NCT05678933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64412731|NCT05678933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64412732|NCT05678933|Alkylating Agents|alkylating agents|mesh-ancestor
64412733|NCT05678933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412750|NCT05678933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64412752|NCT05678621|Ciprofloxacin|ciprofloxacin|mesh-list
64412763|NCT05678621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64412764|NCT05678621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64412765|NCT05678621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412766|NCT05678621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412767|NCT05678621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412768|NCT05678621|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64412769|NCT05678621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64412770|NCT05678621|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64412771|NCT05678621|Renal Agents|renal agents|mesh-ancestor
64412772|NCT05678621|Antimalarials|antimalarials|mesh-ancestor
64412773|NCT05678621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64412774|NCT05678621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64412775|NCT05678621|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64412776|NCT05678621|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64412777|NCT05678621|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64412778|NCT05678621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64412779|NCT05697029|Tetrandrine|tetrandrine|mesh-list
64412780|NCT05697029|Antimalarials|antimalarials|mesh-ancestor
64412781|NCT05697029|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64412782|NCT05697029|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64412783|NCT05697029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64412784|NCT05697029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64412785|NCT05697029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412786|NCT05697029|Antiviral Agents|antiviral agents|mesh-ancestor
64343136|NCT03336541|Ketamine|ketamine|mesh-list
64343137|NCT03336541|Analgesics|analgesics|mesh-ancestor
64412788|NCT05697029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64412789|NCT05697029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412790|NCT05697029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64412791|NCT05697029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412804|NCT05182073|Cyclophosphamide|cyclophosphamide|mesh-list
64412805|NCT05182073|Fludarabine|fludarabine|mesh-list
64412815|NCT05182073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412816|NCT05182073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64412817|NCT02501811|Plasma-lyte 148|plasma-lyte 148|mesh-list
64412818|NCT02501811|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64412819|NCT02501811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64412820|NCT02585999|Contraceptive Agents|contraceptive agents|mesh-list
64412821|NCT02585999|Ortho Evra|ortho evra|mesh-list
64412822|NCT02585999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64412823|NCT02585999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412824|NCT02585999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64412825|NCT05696951|Tranylcypromine|tranylcypromine|mesh-list
64412826|NCT05696951|Antidepressive Agents|antidepressive agents|mesh-ancestor
64412827|NCT05696951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64412828|NCT05696951|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64412829|NCT05696951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412830|NCT05696951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412831|NCT05696951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64412832|NCT05696951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64412833|NCT05696951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64412834|NCT05696951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412835|NCT05677373|Trametinib|trametinib|mesh-list
64412836|NCT05677373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412837|NCT05677373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64412838|NCT05677373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412839|NCT05677373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412868|NCT05041907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64412869|NCT05041907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64412870|NCT05041907|Serotonin Agents|serotonin agents|mesh-ancestor
64412871|NCT05041907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64412872|NCT05041907|Antidepressive Agents|antidepressive agents|mesh-ancestor
64412873|NCT05041907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64412874|NCT05041907|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64412875|NCT05041907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64412876|NCT05041907|Antimetabolites|antimetabolites|mesh-ancestor
64412877|NCT05674253|Hydrocortisone|hydrocortisone|mesh-list
64412878|NCT05674253|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64412879|NCT05674253|Dexmedetomidine|dexmedetomidine|mesh-list
64412880|NCT05674253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64412881|NCT05674253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64412882|NCT05674253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412883|NCT05674253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64412894|NCT02500641|Naproxen|naproxen|mesh-list
64412932|NCT04962451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64412933|NCT04962451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64412934|NCT04962451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64412935|NCT04962451|Purinergic Agents|purinergic agents|mesh-ancestor
64412936|NCT04962451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64412937|NCT04962451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412938|NCT04962451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412939|NCT04953871|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
64412941|NCT03059719|Exenatide|exenatide|mesh-list
64412942|NCT03059719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64412943|NCT03059719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412944|NCT03059719|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64412945|NCT03059719|Incretins|incretins|mesh-ancestor
64412946|NCT03059719|Hormones|hormones|mesh-ancestor
64412947|NCT03059719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64412948|NCT03060031|Oxytocin|oxytocin|mesh-list
64412949|NCT03060031|Oxytocics|oxytocics|mesh-ancestor
64412950|NCT03060031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64412951|NCT03060031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412952|NCT02499783|Adalimumab|adalimumab|mesh-list
64588376|NCT00495079|Vincristine|vincristine|mesh-list
64412953|NCT02499783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64412954|NCT02499783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64412955|NCT04972045|Curcumin|curcumin|mesh-list
64412956|NCT04972045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64412957|NCT04972045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64412958|NCT04972045|Analgesics|analgesics|mesh-ancestor
64412959|NCT04972045|Sensory System Agents|sensory system agents|mesh-ancestor
64412960|NCT04972045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64412961|NCT04972045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412962|NCT04972045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64412963|NCT04972045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64412965|NCT04972045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412972|NCT03059017|Albuterol|albuterol|mesh-list
64412973|NCT03059017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64412974|NCT03059017|Autonomic Agents|autonomic agents|mesh-ancestor
64412975|NCT03059017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64412976|NCT03059017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412977|NCT03059017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64412978|NCT03059017|Respiratory System Agents|respiratory system agents|mesh-ancestor
64412979|NCT03059017|Tocolytic Agents|tocolytic agents|mesh-ancestor
64412980|NCT03059017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64412981|NCT03059017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64412982|NCT03059017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64412983|NCT03059017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64412984|NCT03059017|Adrenergic Agents|adrenergic agents|mesh-ancestor
64412985|NCT03059017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64412986|NCT03059017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412987|NCT04971577|Simvastatin|simvastatin|mesh-list
64412988|NCT04971577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64412989|NCT04971577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64412990|NCT04971577|Antimetabolites|antimetabolites|mesh-ancestor
64413001|NCT04970719|Antiemetics|antiemetics|mesh-ancestor
64413002|NCT04970719|Autonomic Agents|autonomic agents|mesh-ancestor
64413003|NCT04970719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413004|NCT04970719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413005|NCT04970719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64413006|NCT04970719|Glucocorticoids|glucocorticoids|mesh-ancestor
64413007|NCT04970719|Hormones|hormones|mesh-ancestor
64413008|NCT04970719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64413009|NCT04970719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64413029|NCT04970251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413031|NCT04201197|Hallucinogens|hallucinogens|mesh-ancestor
64413032|NCT04201197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413033|NCT04201197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64413034|NCT04201197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64413035|NCT04201197|Analgesics|analgesics|mesh-ancestor
64413036|NCT04201197|Sensory System Agents|sensory system agents|mesh-ancestor
64413037|NCT04201197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413038|NCT04201197|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64413039|NCT04201197|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64413040|NCT04201197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64413041|NCT04201197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413042|NCT04201197|Hormones|hormones|mesh-ancestor
64413043|NCT04201197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64413044|NCT03059563|Varenicline|varenicline|mesh-list
64413045|NCT03059563|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64413046|NCT03059563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64413047|NCT03059563|Cholinergic Agents|cholinergic agents|mesh-ancestor
64413048|NCT03059563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64413049|NCT03059563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588390|NCT05630222|Analgesics|analgesics|mesh-ancestor
64413050|NCT03059563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413052|NCT04970329|Anticoagulants|anticoagulants|mesh-ancestor
64413053|NCT04970329|Plasma Substitutes|plasma substitutes|mesh-ancestor
64413054|NCT04970329|Blood Substitutes|blood substitutes|mesh-ancestor
64413055|NCT04960657|Glyburide|glyburide|mesh-list
64413063|NCT02464059|Vitamin D|vitamin d|mesh-list
64413064|NCT02464059|Cholecalciferol|cholecalciferol|mesh-list
64413065|NCT02464059|Vitamins|vitamins|mesh-ancestor
64413066|NCT02464059|Micronutrients|micronutrients|mesh-ancestor
64413067|NCT02464059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343252|NCT00511043|Vatalanib|vatalanib|mesh-list
64413079|NCT02463357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64413080|NCT02463357|Vasodilator Agents|vasodilator agents|mesh-ancestor
64413081|NCT02463357|Tocolytic Agents|tocolytic agents|mesh-ancestor
64413082|NCT02463357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64413083|NCT02463357|Antioxidants|antioxidants|mesh-ancestor
64413084|NCT02463357|Protective Agents|protective agents|mesh-ancestor
64413085|NCT02463357|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64413086|NCT02463357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64413087|NCT02463357|Diuretics|diuretics|mesh-ancestor
64413088|NCT02463357|Natriuretic Agents|natriuretic agents|mesh-ancestor
64413089|NCT05595083|Dexmedetomidine|dexmedetomidine|mesh-list
64413090|NCT05595083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64413091|NCT05595083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64413092|NCT05595083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413093|NCT05595083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64413094|NCT05595083|Analgesics|analgesics|mesh-ancestor
64413095|NCT05595083|Sensory System Agents|sensory system agents|mesh-ancestor
64413096|NCT05595083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413097|NCT05595083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64413098|NCT05595083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64413099|NCT05595083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64413100|NCT05595083|Adrenergic Agents|adrenergic agents|mesh-ancestor
64413101|NCT05595083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64413102|NCT05595083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413103|NCT04959721|Triamcinolone|triamcinolone|mesh-list
64413104|NCT04959721|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64413105|NCT04959721|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64413106|NCT04959721|Bupivacaine|bupivacaine|mesh-list
64413107|NCT04959721|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64413108|NCT04959721|Anesthetics, Local|anesthetics, local|mesh-ancestor
64413109|NCT04959721|Anesthetics|anesthetics|mesh-ancestor
64413110|NCT04959721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64588423|NCT03593954|Ritonavir|ritonavir|mesh-list
64413117|NCT04959721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64413118|NCT04959721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64413119|NCT04959721|Immunologic Factors|immunologic factors|mesh-ancestor
64413120|NCT04959721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64413121|NCT04959721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413128|NCT04676555|Ofatumumab|ofatumumab|mesh-list
64413129|NCT04676555|Ocrelizumab|ocrelizumab|mesh-list
64413130|NCT04676555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413131|NCT04676555|Immunologic Factors|immunologic factors|mesh-ancestor
64413132|NCT04676555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413133|NCT05575427|Levofloxacin|levofloxacin|mesh-list
64413134|NCT05575427|Ofloxacin|ofloxacin|mesh-list
64343331|NCT02286635|Immunologic Factors|immunologic factors|mesh-ancestor
64413136|NCT05575427|Minocycline|minocycline|mesh-list
64413137|NCT05575427|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64413138|NCT05575427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64413139|NCT05575427|Renal Agents|renal agents|mesh-ancestor
64413140|NCT05575427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64413141|NCT05575427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64413142|NCT05575427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64413143|NCT05575427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64413144|NCT05575427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413145|NCT05575427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413148|NCT05575427|Antimalarials|antimalarials|mesh-ancestor
64413172|NCT05645705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413173|NCT05645705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64413174|NCT02445339|Naltrexone|naltrexone|mesh-list
64413175|NCT02445339|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64413176|NCT02445339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64413177|NCT02445339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413178|NCT02445339|Sensory System Agents|sensory system agents|mesh-ancestor
64413179|NCT02445339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413180|NCT04959409|Tetracaine|tetracaine|mesh-list
64413181|NCT04959409|Anesthetics, Local|anesthetics, local|mesh-ancestor
64413182|NCT04959409|Anesthetics|anesthetics|mesh-ancestor
64413183|NCT04959409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64413184|NCT04959409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413185|NCT04959409|Sensory System Agents|sensory system agents|mesh-ancestor
64413186|NCT04959409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413187|NCT05571059|Ifetroban|ifetroban|mesh-list
64413188|NCT05571059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64413189|NCT03058939|Tamoxifen|tamoxifen|mesh-list
64413190|NCT03058939|Paclitaxel|paclitaxel|mesh-list
64413191|NCT03058939|Carboplatin|carboplatin|mesh-list
64413192|NCT03058939|Trastuzumab|trastuzumab|mesh-list
64413200|NCT03058939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413201|NCT03058939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64413203|NCT03058939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64413204|NCT03058939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64413224|NCT03058471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64413225|NCT03058471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64413226|NCT03058471|Immunologic Factors|immunologic factors|mesh-ancestor
64343382|NCT02287259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64413228|NCT03058471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64413229|NCT02579603|Pirfenidone|pirfenidone|mesh-list
64413230|NCT02579603|Nintedanib|nintedanib|mesh-list
64413231|NCT02579603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413232|NCT02579603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64413233|NCT02579603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64413234|NCT02579603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413235|NCT02579603|Analgesics|analgesics|mesh-ancestor
64413236|NCT02579603|Sensory System Agents|sensory system agents|mesh-ancestor
64413237|NCT02579603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413238|NCT02579603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413239|NCT02579603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64413240|NCT02579603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64413241|NCT02579603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64413242|NCT02579603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64413243|NCT04445519|Latanoprost|latanoprost|mesh-list
64413244|NCT04445519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64413245|NCT04445519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64413246|NCT04291079|Antibodies|antibodies|mesh-list
64413247|NCT04291079|Immunologic Factors|immunologic factors|mesh-ancestor
64413248|NCT04291079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413249|NCT03060889|Tranexamic Acid|tranexamic acid|mesh-list
64413250|NCT03060889|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64413251|NCT03060889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64413252|NCT03060889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413253|NCT03060889|Hemostatics|hemostatics|mesh-ancestor
64413254|NCT03060889|Coagulants|coagulants|mesh-ancestor
64413255|NCT04177433|Methylprednisolone|methylprednisolone|mesh-list
64413258|NCT04177433|Prednisolone|prednisolone|mesh-list
64413270|NCT04177433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64413271|NCT04177433|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64413272|NCT04177433|Protective Agents|protective agents|mesh-ancestor
64413273|NCT04177433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64413274|NCT04177433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413275|NCT05546957|Aspirin|aspirin|mesh-list
64413276|NCT05546957|Rivaroxaban|rivaroxaban|mesh-list
64413277|NCT05546957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64413278|NCT05546957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64413279|NCT05546957|Analgesics|analgesics|mesh-ancestor
64413280|NCT05546957|Sensory System Agents|sensory system agents|mesh-ancestor
64413281|NCT05546957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413282|NCT05546957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413285|NCT05546957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64413286|NCT05546957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64413287|NCT05546957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413288|NCT05546957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64413289|NCT05546957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64413290|NCT05546957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64413291|NCT05546957|Antipyretics|antipyretics|mesh-ancestor
64413292|NCT05546957|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64413293|NCT05546957|Antithrombins|antithrombins|mesh-ancestor
64413294|NCT05546957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64413295|NCT05546957|Protease Inhibitors|protease inhibitors|mesh-ancestor
64413296|NCT05546957|Anticoagulants|anticoagulants|mesh-ancestor
64413297|NCT04950205|Sevoflurane|sevoflurane|mesh-list
64413298|NCT04950205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64413300|NCT04950205|Anesthetics, General|anesthetics, general|mesh-ancestor
64413313|NCT02577107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64413314|NCT02577107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64413315|NCT02577107|Growth Substances|growth substances|mesh-ancestor
64413316|NCT02577107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413317|NCT02577107|Growth Inhibitors|growth inhibitors|mesh-ancestor
64413318|NCT02577107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413319|NCT04958473|Axitinib|axitinib|mesh-list
64413320|NCT04958473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413321|NCT04958473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64413322|NCT04958473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64413323|NCT04958473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413324|NCT04957927|Fluticasone|fluticasone|mesh-list
64413326|NCT04957927|Montelukast|montelukast|mesh-list
64413327|NCT04957927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64413328|NCT04957927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64413329|NCT04957927|Autonomic Agents|autonomic agents|mesh-ancestor
64413330|NCT04957927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413331|NCT04957927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413342|NCT04688801|Antineoplastic Agents|antineoplastic agents|mesh-list
64413343|NCT04950049|Dexamethasone|dexamethasone|mesh-list
64413344|NCT04950049|Dexamethasone acetate|dexamethasone acetate|mesh-list
64413345|NCT04950049|BB 1101|bb 1101|mesh-list
64413346|NCT04950049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64413347|NCT04950049|Antiemetics|antiemetics|mesh-ancestor
64413348|NCT04950049|Autonomic Agents|autonomic agents|mesh-ancestor
64413349|NCT04950049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413350|NCT04950049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413351|NCT04950049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64413352|NCT04950049|Glucocorticoids|glucocorticoids|mesh-ancestor
64413353|NCT04950049|Hormones|hormones|mesh-ancestor
64413354|NCT04950049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64413355|NCT04950049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64413356|NCT04950049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413357|NCT04950049|Protease Inhibitors|protease inhibitors|mesh-ancestor
64413358|NCT04950049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64413362|NCT05587673|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64413364|NCT05587673|Prednisolone acetate|prednisolone acetate|mesh-list
64413365|NCT05587673|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64413366|NCT05587673|Prednisolone phosphate|prednisolone phosphate|mesh-list
64413369|NCT05587673|Autonomic Agents|autonomic agents|mesh-ancestor
64413370|NCT05587673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413371|NCT05587673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413372|NCT05587673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64413373|NCT05587673|Glucocorticoids|glucocorticoids|mesh-ancestor
64413374|NCT05587673|Hormones|hormones|mesh-ancestor
64413375|NCT05587673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64413376|NCT05587673|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64413377|NCT05587673|Protective Agents|protective agents|mesh-ancestor
64413378|NCT05587673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64413379|NCT05587673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413380|NCT02444793|Mogamulizumab|mogamulizumab|mesh-list
64413381|NCT02444793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413382|NCT04966429|Maraviroc|maraviroc|mesh-list
64413383|NCT04966429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64413384|NCT04966429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64413385|NCT04966429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413386|NCT04966429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64413387|NCT04966429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64413388|NCT04966429|Antiviral Agents|antiviral agents|mesh-ancestor
64413389|NCT04966429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64413390|NCT04966429|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64413391|NCT04949347|Glycerol|glycerol|mesh-list
64413392|NCT04949347|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64413393|NCT04949347|Protective Agents|protective agents|mesh-ancestor
64413410|NCT04948567|Magnesium Sulfate|magnesium sulfate|mesh-list
64413411|NCT04948567|Analgesics|analgesics|mesh-ancestor
64413415|NCT04948567|Anesthetics|anesthetics|mesh-ancestor
64413416|NCT04948567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64413417|NCT04948567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64413418|NCT04948567|Anticonvulsants|anticonvulsants|mesh-ancestor
64413419|NCT04948567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64413420|NCT04948567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64413421|NCT04948567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413422|NCT04948567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64413423|NCT04948567|Tocolytic Agents|tocolytic agents|mesh-ancestor
64413424|NCT04948567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64413425|NCT04419181|Carboplatin|carboplatin|mesh-list
64413426|NCT04419181|Docetaxel|docetaxel|mesh-list
64413427|NCT04419181|Trastuzumab|trastuzumab|mesh-list
64413428|NCT04419181|Pertuzumab|pertuzumab|mesh-list
64413429|NCT04419181|Maytansine|maytansine|mesh-list
64413430|NCT04419181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64413431|NCT04419181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413432|NCT04419181|Tubulin Modulators|tubulin modulators|mesh-ancestor
64413433|NCT04419181|Antimitotic Agents|antimitotic agents|mesh-ancestor
64413434|NCT04419181|Mitosis Modulators|mitosis modulators|mesh-ancestor
64413435|NCT04419181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413436|NCT04419181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64413437|NCT04419181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64413438|NCT04964869|Epinephrine|epinephrine|mesh-list
64413439|NCT04964869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64413440|NCT04964869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64413441|NCT04964869|Adrenergic Agents|adrenergic agents|mesh-ancestor
64413442|NCT04964869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64413534|NCT02577029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64413535|NCT02577029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64413536|NCT02577029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64413538|NCT02577029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413539|NCT02577029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64413540|NCT02577029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64413541|NCT02577029|Immunologic Factors|immunologic factors|mesh-ancestor
64413542|NCT02577029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413543|NCT02577029|Histamine Agents|histamine agents|mesh-ancestor
64413544|NCT02577029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64413613|NCT03057769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64413614|NCT03057769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64413615|NCT03057769|Adrenergic Agents|adrenergic agents|mesh-ancestor
64413616|NCT03057769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64413617|NCT03057769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413618|NCT03057769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413619|NCT03057769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64413620|NCT03057769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64413621|NCT03057769|Autonomic Agents|autonomic agents|mesh-ancestor
64413622|NCT03057769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413623|NCT03057769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64413648|NCT04633577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64413649|NCT04633577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64413650|NCT04633577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413651|NCT04941625|Cystatins|cystatins|mesh-list
64413652|NCT04941625|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64413653|NCT04941625|Protease Inhibitors|protease inhibitors|mesh-ancestor
64413654|NCT04941625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64413655|NCT04941625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413656|NCT03534323|Venetoclax|venetoclax|mesh-list
64413657|NCT03534323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413658|NCT04406389|Heparin|heparin|mesh-list
64413659|NCT04406389|Calcium heparin|calcium heparin|mesh-list
64413660|NCT04406389|Enoxaparin|enoxaparin|mesh-list
64413661|NCT04406389|Enoxaparin sodium|enoxaparin sodium|mesh-list
64413662|NCT04406389|Argatroban|argatroban|mesh-list
64413663|NCT04406389|Anticoagulants|anticoagulants|mesh-ancestor
64413664|NCT04406389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64413689|NCT04940689|Remifentanil|remifentanil|mesh-list
64413690|NCT04940689|Anesthetics, Local|anesthetics, local|mesh-ancestor
64413691|NCT04940689|Anesthetics|anesthetics|mesh-ancestor
64343530|NCT02481830|Amrubicin|amrubicin|mesh-list
64413692|NCT04940689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64413693|NCT04940689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413694|NCT04940689|Sensory System Agents|sensory system agents|mesh-ancestor
64413695|NCT04940689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413696|NCT04940689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64413697|NCT04940689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64413698|NCT04940689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64413699|NCT04940689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64413700|NCT04940689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413701|NCT04940689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64413702|NCT04940689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64413703|NCT04940689|Analgesics|analgesics|mesh-ancestor
64413704|NCT04940689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64413705|NCT04940689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64413706|NCT04940689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64413707|NCT04940689|Adrenergic Agents|adrenergic agents|mesh-ancestor
64413708|NCT04940689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64413709|NCT04940689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64413710|NCT04940689|Narcotics|narcotics|mesh-ancestor
64413711|NCT05530811|Dexamethasone|dexamethasone|mesh-list
64413712|NCT05530811|Bupivacaine|bupivacaine|mesh-list
64413713|NCT05530811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64413714|NCT05530811|Antiemetics|antiemetics|mesh-ancestor
64413715|NCT05530811|Autonomic Agents|autonomic agents|mesh-ancestor
64413737|NCT04921111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413739|NCT03387917|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64413740|NCT03387917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64413741|NCT03387917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413742|NCT03057145|Olaparib|olaparib|mesh-list
64413743|NCT03057145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64413744|NCT03057145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64413751|NCT05421065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413752|NCT05421065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413753|NCT05421065|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64413754|NCT05421065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64413755|NCT05421065|Anesthetics, General|anesthetics, general|mesh-ancestor
64413756|NCT05421065|Anesthetics|anesthetics|mesh-ancestor
64413757|NCT05421065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64413758|NCT05421065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64413759|NCT05421065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64413760|NCT05421065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64413761|NCT05421065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413762|NCT05421065|Hallucinogens|hallucinogens|mesh-ancestor
64413763|NCT05421065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64413764|NCT05411237|Paclitaxel|paclitaxel|mesh-list
64413765|NCT05411237|Doxorubicin|doxorubicin|mesh-list
64413766|NCT05411237|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64413767|NCT05411237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64413768|NCT05411237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413787|NCT04940143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413788|NCT04939675|Lamotrigine|lamotrigine|mesh-list
64413789|NCT04939675|Zonisamide|zonisamide|mesh-list
64413790|NCT04939675|Levetiracetam|levetiracetam|mesh-list
64413791|NCT04939675|Anticonvulsants|anticonvulsants|mesh-ancestor
64413792|NCT04939675|Nootropic Agents|nootropic agents|mesh-ancestor
64343538|NCT00405743|Cytarabine|cytarabine|mesh-list
64343539|NCT00405743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64413793|NCT04939675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64413794|NCT04939675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64413795|NCT04939675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413796|NCT04939675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64413797|NCT04939675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413798|NCT04939675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64413799|NCT04939675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64413800|NCT04939675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64413801|NCT04939675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64413802|NCT04939675|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64413803|NCT04939441|Tenofovir|tenofovir|mesh-list
64413804|NCT04939441|Antiviral Agents|antiviral agents|mesh-ancestor
64413805|NCT04939441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64413806|NCT04939441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64413807|NCT04939441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64413808|NCT04939441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64413809|NCT04939441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413810|NCT04939441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64413811|NCT04939441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64413812|NCT04938583|Paclitaxel|paclitaxel|mesh-list
64413813|NCT04938583|Bevacizumab|bevacizumab|mesh-list
64413825|NCT04938583|Growth Substances|growth substances|mesh-ancestor
64413826|NCT04938583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413827|NCT04938583|Growth Inhibitors|growth inhibitors|mesh-ancestor
64413828|NCT03055663|Midazolam|midazolam|mesh-list
64413829|NCT03055663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64413830|NCT03055663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64413838|NCT03055663|Anesthetics|anesthetics|mesh-ancestor
64413839|NCT03055663|GABA Modulators|gaba modulators|mesh-ancestor
64413840|NCT03055663|GABA Agents|gaba agents|mesh-ancestor
64413841|NCT03055663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343546|NCT00405743|Immunologic Factors|immunologic factors|mesh-ancestor
64343547|NCT00405743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343548|NCT00403169|Lenalidomide|lenalidomide|mesh-list
64413842|NCT03055663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413843|NCT03057691|Antidepressive Agents|antidepressive agents|mesh-list
64413844|NCT03057691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64413845|NCT04928365|Antibodies|antibodies|mesh-list
64413846|NCT04928365|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64413847|NCT04928365|Immunologic Factors|immunologic factors|mesh-ancestor
64413848|NCT04928365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413849|NCT04938037|Methylprednisolone|methylprednisolone|mesh-list
64413850|NCT04938037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64413851|NCT04938037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64413852|NCT04938037|Prednisolone|prednisolone|mesh-list
64413853|NCT04938037|Prednisolone acetate|prednisolone acetate|mesh-list
64413854|NCT04938037|Bupivacaine|bupivacaine|mesh-list
64413855|NCT04938037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64413856|NCT04938037|Prednisolone phosphate|prednisolone phosphate|mesh-list
64413857|NCT04938037|Anesthetics, Local|anesthetics, local|mesh-ancestor
64413858|NCT04938037|Anesthetics|anesthetics|mesh-ancestor
64413859|NCT04938037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64413860|NCT04938037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413861|NCT04938037|Sensory System Agents|sensory system agents|mesh-ancestor
64413862|NCT04938037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413863|NCT04938037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64413864|NCT04938037|Antiemetics|antiemetics|mesh-ancestor
64413865|NCT04938037|Autonomic Agents|autonomic agents|mesh-ancestor
64413866|NCT04938037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64413867|NCT04938037|Glucocorticoids|glucocorticoids|mesh-ancestor
64413868|NCT04938037|Hormones|hormones|mesh-ancestor
64413869|NCT04938037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64413874|NCT04937569|Ivermectin|ivermectin|mesh-list
64413887|NCT04937101|Respiratory System Agents|respiratory system agents|mesh-ancestor
64413888|NCT04937101|Antipruritics|antipruritics|mesh-ancestor
64413889|NCT04937101|Dermatologic Agents|dermatologic agents|mesh-ancestor
64413890|NCT04937101|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64413891|NCT04937101|Histamine Antagonists|histamine antagonists|mesh-ancestor
64413892|NCT04937101|Histamine Agents|histamine agents|mesh-ancestor
64413893|NCT04937101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64413894|NCT04937101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413895|NCT04937101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64413896|NCT04937023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64413897|NCT04937023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64413898|NCT04937023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64413899|NCT04936711|Bupivacaine|bupivacaine|mesh-list
64413900|NCT04936711|Anesthetics, Local|anesthetics, local|mesh-ancestor
64413901|NCT04936711|Anesthetics|anesthetics|mesh-ancestor
64413902|NCT04936711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64413903|NCT04936711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413904|NCT04936711|Sensory System Agents|sensory system agents|mesh-ancestor
64413905|NCT04936711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413906|NCT04431349|Clopidogrel|clopidogrel|mesh-list
64413907|NCT04431349|Ticagrelor|ticagrelor|mesh-list
64413908|NCT04431349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64413909|NCT04431349|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64413910|NCT04431349|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64413911|NCT04431349|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64413912|NCT04431349|Purinergic Agents|purinergic agents|mesh-ancestor
64413913|NCT04431349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343659|NCT02480114|Antimanic Agents|antimanic agents|mesh-ancestor
64413914|NCT04431349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413915|NCT04431349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413916|NCT03055741|Donepezil|donepezil|mesh-list
64588566|NCT00501631|Naltrexone|naltrexone|mesh-list
64413917|NCT03055741|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64413927|NCT04917679|Diacetylrhein|diacetylrhein|mesh-list
64413928|NCT04917679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64413929|NCT02443155|Liraglutide|liraglutide|mesh-list
64413930|NCT02443155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64413931|NCT02443155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413932|NCT02443155|Incretins|incretins|mesh-ancestor
64413933|NCT02443155|Hormones|hormones|mesh-ancestor
64413934|NCT02443155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64413935|NCT04935541|Dexmedetomidine|dexmedetomidine|mesh-list
64413936|NCT04935541|Remifentanil|remifentanil|mesh-list
64413937|NCT04935541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64413938|NCT04935541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64413939|NCT04935541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413940|NCT04935541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64413941|NCT04935541|Analgesics|analgesics|mesh-ancestor
64413942|NCT04935541|Sensory System Agents|sensory system agents|mesh-ancestor
64413943|NCT04935541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413944|NCT04935541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64413945|NCT04935541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64413946|NCT04935541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64413947|NCT04935541|Adrenergic Agents|adrenergic agents|mesh-ancestor
64413948|NCT04935541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64413957|NCT04935073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64413958|NCT04935073|Fertility Agents|fertility agents|mesh-ancestor
64413959|NCT04935073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64413960|NCT04935073|Hormone Antagonists|hormone antagonists|mesh-ancestor
64413961|NCT04917757|Dexamethasone|dexamethasone|mesh-list
64413962|NCT04917757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64413963|NCT04917757|Antiemetics|antiemetics|mesh-ancestor
64413964|NCT04917757|Autonomic Agents|autonomic agents|mesh-ancestor
64413965|NCT04917757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413966|NCT04917757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413967|NCT04917757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64413968|NCT04917757|Glucocorticoids|glucocorticoids|mesh-ancestor
64413971|NCT04917757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64413977|NCT04916899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64413978|NCT04916899|Antitubercular Agents|antitubercular agents|mesh-ancestor
64413979|NCT04916899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64413980|NCT04916899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64413981|NCT04916899|Leprostatic Agents|leprostatic agents|mesh-ancestor
64413982|NCT04916899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64413983|NCT04916899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64413984|NCT04916899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413985|NCT04916899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64413986|NCT04916899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64413987|NCT04916899|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64413988|NCT04916899|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64413989|NCT04916899|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64413990|NCT04916899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64413991|NCT04916899|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64413992|NCT04916899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64413997|NCT04916665|Teduglutide|teduglutide|mesh-list
64413998|NCT04916665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64413999|NCT04916665|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64414000|NCT04916665|Protective Agents|protective agents|mesh-ancestor
64414001|NCT04916665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414002|NCT04916509|Fulvestrant|fulvestrant|mesh-list
64414003|NCT04916509|Palbociclib|palbociclib|mesh-list
64414004|NCT04916509|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64414006|NCT04916509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414028|NCT04916353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414030|NCT03056599|Interferons|interferons|mesh-list
64414031|NCT03056599|Interferon-alpha|interferon-alpha|mesh-list
64414032|NCT03056599|Interferon alpha-2|interferon alpha-2|mesh-list
64414033|NCT03056599|Aldesleukin|aldesleukin|mesh-list
64414034|NCT03056599|Interferon-gamma|interferon-gamma|mesh-list
64414035|NCT03056599|Docetaxel|docetaxel|mesh-list
64414036|NCT03056599|Doxorubicin|doxorubicin|mesh-list
64414037|NCT03056599|Pembrolizumab|pembrolizumab|mesh-list
64414038|NCT03056599|Nivolumab|nivolumab|mesh-list
64414039|NCT03056599|Bortezomib|bortezomib|mesh-list
64414040|NCT03056599|Ipilimumab|ipilimumab|mesh-list
64414041|NCT03056599|Atezolizumab|atezolizumab|mesh-list
64414042|NCT03056599|Durvalumab|durvalumab|mesh-list
64414043|NCT03056599|Avelumab|avelumab|mesh-list
64414044|NCT03056599|Trabectedin|trabectedin|mesh-list
64414045|NCT03056599|Olaratumab|olaratumab|mesh-list
64414046|NCT03056599|Entrectinib|entrectinib|mesh-list
64414047|NCT03056599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64414048|NCT03056599|Antimetabolites|antimetabolites|mesh-ancestor
64414049|NCT03056599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414050|NCT03056599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414051|NCT03056599|Antiviral Agents|antiviral agents|mesh-ancestor
64414052|NCT03056599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64414053|NCT03056599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414054|NCT03056599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64414055|NCT03056599|Immunologic Factors|immunologic factors|mesh-ancestor
64414056|NCT03056599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414057|NCT03056599|Tubulin Modulators|tubulin modulators|mesh-ancestor
64414058|NCT03056599|Antimitotic Agents|antimitotic agents|mesh-ancestor
64414059|NCT03056599|Mitosis Modulators|mitosis modulators|mesh-ancestor
64414060|NCT03056599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64414061|NCT03056599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64414062|NCT03056599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64414063|NCT03056599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64414064|NCT03056599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64414065|NCT03056599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64414067|NCT03056599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64414068|NCT03056599|Alkylating Agents|alkylating agents|mesh-ancestor
64414069|NCT03056599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64414070|NCT04915885|Contraceptive Agents|contraceptive agents|mesh-list
64414071|NCT04915885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64414072|NCT04915885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414073|NCT04915963|Vitamin D|vitamin d|mesh-list
64414074|NCT04915963|Vitamins|vitamins|mesh-ancestor
64414075|NCT04915963|Micronutrients|micronutrients|mesh-ancestor
64414076|NCT04915963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414077|NCT04915963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64414078|NCT04915807|Paclitaxel|paclitaxel|mesh-list
64414079|NCT04915807|Irinotecan|irinotecan|mesh-list
64414082|NCT04915807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64414096|NCT01360021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414097|NCT01360021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414098|NCT01360021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64414099|NCT01360021|Respiratory System Agents|respiratory system agents|mesh-ancestor
64414100|NCT01360021|Glucocorticoids|glucocorticoids|mesh-ancestor
64414101|NCT01360021|Hormones|hormones|mesh-ancestor
64414102|NCT01360021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64414103|NCT04912297|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64414105|NCT04912297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414106|NCT02497287|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64414107|NCT02497287|Citalopram|citalopram|mesh-list
64414124|NCT02497287|Sensory System Agents|sensory system agents|mesh-ancestor
64414125|NCT02497287|Dopamine Agents|dopamine agents|mesh-ancestor
64414126|NCT04912141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64414127|NCT04912141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64414128|NCT04912141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64414129|NCT04912141|Immunologic Factors|immunologic factors|mesh-ancestor
64414130|NCT04912141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414131|NCT02458287|Bococizumab|bococizumab|mesh-list
64414132|NCT02458287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64414133|NCT02458287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64414134|NCT02458287|Antimetabolites|antimetabolites|mesh-ancestor
64414135|NCT02458287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414136|NCT02458287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64414137|NCT03056053|Zolpidem|zolpidem|mesh-list
64414138|NCT03056053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64414139|NCT03056053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64414140|NCT03056053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64414141|NCT03056053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414142|NCT03056053|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64414143|NCT03056053|GABA Agonists|gaba agonists|mesh-ancestor
64414144|NCT03056053|GABA Agents|gaba agents|mesh-ancestor
64414148|NCT02496039|Dextromethorphan|dextromethorphan|mesh-list
64414149|NCT02496039|Antitussive Agents|antitussive agents|mesh-ancestor
64414150|NCT02496039|Respiratory System Agents|respiratory system agents|mesh-ancestor
64414151|NCT02496039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64414152|NCT02496039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64414153|NCT02496039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64414154|NCT02496039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414155|NCT02496039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414156|NCT02496039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64414157|NCT02496039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64414158|NCT02496039|Adrenergic Agents|adrenergic agents|mesh-ancestor
64414159|NCT02496039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64414160|NCT02496039|Antimalarials|antimalarials|mesh-ancestor
64414164|NCT02496039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414165|NCT02496039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64414166|NCT02496039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64414167|NCT02496039|Cholinergic Agents|cholinergic agents|mesh-ancestor
64414168|NCT02496039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64414170|NCT02496039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64414171|NCT02496039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64343732|NCT02288429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64343739|NCT00254891|Paclitaxel|paclitaxel|mesh-list
64414172|NCT02496039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64414173|NCT04922359|Lidocaine|lidocaine|mesh-list
64414174|NCT04922359|Anesthetics, Local|anesthetics, local|mesh-ancestor
64414175|NCT04922359|Anesthetics|anesthetics|mesh-ancestor
64414176|NCT04922359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64414177|NCT04922359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414178|NCT04922359|Sensory System Agents|sensory system agents|mesh-ancestor
64414179|NCT04922359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414180|NCT04922359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64414181|NCT04922359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64414182|NCT04922359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64414183|NCT04922359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64414184|NCT04922359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414186|NCT02495883|Propranolol|propranolol|mesh-list
64414187|NCT02495883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64414188|NCT02495883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64414214|NCT02457195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64414215|NCT02457195|Serotonin Agents|serotonin agents|mesh-ancestor
64414224|NCT03054259|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64414225|NCT03054259|Prednisolone phosphate|prednisolone phosphate|mesh-list
64414226|NCT03054259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64588598|NCT00501943|Interferons|interferons|mesh-list
64414227|NCT03054259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414228|NCT03054259|Immunologic Factors|immunologic factors|mesh-ancestor
64414229|NCT03054259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414230|NCT03054259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64414231|NCT03054259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64414232|NCT03054259|Antiemetics|antiemetics|mesh-ancestor
64414233|NCT03054259|Autonomic Agents|autonomic agents|mesh-ancestor
64414234|NCT03054259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414235|NCT03054259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64414236|NCT03054259|Glucocorticoids|glucocorticoids|mesh-ancestor
64414237|NCT03054259|Hormones|hormones|mesh-ancestor
64414238|NCT03054259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64414239|NCT03054259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64414240|NCT03054259|Protective Agents|protective agents|mesh-ancestor
64414241|NCT03054259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64414242|NCT01653327|Ketamine|ketamine|mesh-list
64414243|NCT01653327|Analgesics|analgesics|mesh-ancestor
64414244|NCT01653327|Sensory System Agents|sensory system agents|mesh-ancestor
64414245|NCT01653327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414246|NCT01653327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414247|NCT01653327|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64414248|NCT01653327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64343749|NCT02479412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64414252|NCT01653327|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64414253|NCT01653327|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64414254|NCT01653327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64414255|NCT01653327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414262|NCT03053869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414263|NCT03053869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414264|NCT03053869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64414265|NCT03053869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64414266|NCT03053869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64414267|NCT03053869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64414268|NCT03053869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64414269|NCT03053869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64414270|NCT03053869|GABA Modulators|gaba modulators|mesh-ancestor
64414271|NCT03053869|GABA Agents|gaba agents|mesh-ancestor
64414272|NCT03053869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64414273|NCT03053869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414274|NCT03053869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64414275|NCT03053869|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64414276|NCT03053869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64414277|NCT03053869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64414278|NCT03053869|Anesthetics, General|anesthetics, general|mesh-ancestor
64414279|NCT03053869|Anesthetics|anesthetics|mesh-ancestor
64414280|NCT03053947|Ketamine|ketamine|mesh-list
64414281|NCT03053947|Analgesics|analgesics|mesh-ancestor
64414282|NCT03053947|Sensory System Agents|sensory system agents|mesh-ancestor
64414283|NCT03053947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414284|NCT03053947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414300|NCT02493855|Ritonavir|ritonavir|mesh-list
64414301|NCT02493855|Ribavirin|ribavirin|mesh-list
64414302|NCT02493855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64414303|NCT02493855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64414304|NCT02493855|Protease Inhibitors|protease inhibitors|mesh-ancestor
64414305|NCT02493855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414324|NCT04909255|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64414326|NCT04909255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64414327|NCT04909255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64414328|NCT04909255|Cholinergic Agents|cholinergic agents|mesh-ancestor
64414329|NCT04909255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64414330|NCT04909255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414331|NCT04909255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414332|NCT04909255|Urological Agents|urological agents|mesh-ancestor
64414333|NCT04909255|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64414334|NCT04909255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64414335|NCT04909255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64414336|NCT04909255|Adrenergic Agents|adrenergic agents|mesh-ancestor
64414337|NCT04909255|Parasympatholytics|parasympatholytics|mesh-ancestor
64414338|NCT04909255|Autonomic Agents|autonomic agents|mesh-ancestor
64414339|NCT04909255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414340|NCT04891861|Rivaroxaban|rivaroxaban|mesh-list
64414341|NCT04891861|Apixaban|apixaban|mesh-list
64414342|NCT04891861|Edoxaban|edoxaban|mesh-list
64414343|NCT04891861|Dabigatran|dabigatran|mesh-list
64414344|NCT04891861|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64343811|NCT02288741|Dexamethasone|dexamethasone|mesh-list
64414378|NCT03050905|Protease Inhibitors|protease inhibitors|mesh-ancestor
64414379|NCT03050905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414380|NCT03050905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414381|NCT03050905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64414382|NCT03050905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64414383|NCT03050905|Antiviral Agents|antiviral agents|mesh-ancestor
64414384|NCT03050905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64414385|NCT03050905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64414386|NCT03050905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64414387|NCT03050827|Oxybutynin|oxybutynin|mesh-list
64414388|NCT03050827|Parasympatholytics|parasympatholytics|mesh-ancestor
64414389|NCT03050827|Autonomic Agents|autonomic agents|mesh-ancestor
64414390|NCT03050827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414391|NCT03050827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414392|NCT03050827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64414393|NCT03050827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64343845|NCT02448446|Ranibizumab|ranibizumab|mesh-list
64414401|NCT02438787|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64414402|NCT02438787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64414403|NCT02438787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64414404|NCT02438787|Immunologic Factors|immunologic factors|mesh-ancestor
64414405|NCT02438787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414406|NCT04901065|Lidocaine|lidocaine|mesh-list
64414407|NCT04901065|Anesthetics, Local|anesthetics, local|mesh-ancestor
64414408|NCT04901065|Anesthetics|anesthetics|mesh-ancestor
64414409|NCT04901065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64414410|NCT04901065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414411|NCT04901065|Sensory System Agents|sensory system agents|mesh-ancestor
64414412|NCT04901065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414423|NCT02493777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64414424|NCT02493777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414425|NCT02493777|Dopamine Agents|dopamine agents|mesh-ancestor
64414426|NCT02493777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64414427|NCT04907149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64414428|NCT04906915|Ketamine|ketamine|mesh-list
64414429|NCT04906915|Analgesics|analgesics|mesh-ancestor
64414430|NCT04906915|Sensory System Agents|sensory system agents|mesh-ancestor
64414431|NCT04906915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414432|NCT04906915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414433|NCT04906915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64414434|NCT04906915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64414435|NCT04906915|Anesthetics, General|anesthetics, general|mesh-ancestor
64414436|NCT04906915|Anesthetics|anesthetics|mesh-ancestor
64414437|NCT04906915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64414441|NCT04906915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414442|NCT04890379|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64414443|NCT04890379|Dermatologic Agents|dermatologic agents|mesh-ancestor
64414444|NCT04890379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64414445|NCT04890379|Immunologic Factors|immunologic factors|mesh-ancestor
64414446|NCT04890379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414447|NCT04900129|Acetylcysteine|acetylcysteine|mesh-list
64414448|NCT04900129|Diclofenac|diclofenac|mesh-list
64414449|NCT04900129|Salicylates|salicylates|mesh-list
64343865|NCT02478398|Autonomic Agents|autonomic agents|mesh-ancestor
64414450|NCT04900129|Methyl salicylate|methyl salicylate|mesh-list
64414452|NCT04900129|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64414453|NCT04900129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64414454|NCT04900129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64414455|NCT04900129|Analgesics|analgesics|mesh-ancestor
64414456|NCT04900129|Sensory System Agents|sensory system agents|mesh-ancestor
64414457|NCT04900129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414458|NCT04900129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414459|NCT04900129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64414460|NCT04900129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64414461|NCT04900129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64414462|NCT04900129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414463|NCT04900129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414464|NCT04900129|Antipruritics|antipruritics|mesh-ancestor
64414465|NCT04900129|Dermatologic Agents|dermatologic agents|mesh-ancestor
64414466|NCT04900129|Antiviral Agents|antiviral agents|mesh-ancestor
64414467|NCT04900129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64414468|NCT04900129|Expectorants|expectorants|mesh-ancestor
64414469|NCT04900129|Respiratory System Agents|respiratory system agents|mesh-ancestor
64414470|NCT04900129|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64414471|NCT04900129|Antioxidants|antioxidants|mesh-ancestor
64414472|NCT04900129|Protective Agents|protective agents|mesh-ancestor
64414489|NCT04393207|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64414490|NCT04393207|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64414491|NCT04393207|Prednisolone|prednisolone|mesh-list
64414492|NCT04393207|Prednisolone acetate|prednisolone acetate|mesh-list
64414493|NCT04393207|Bupivacaine|bupivacaine|mesh-list
64414494|NCT04393207|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64414495|NCT04393207|Prednisolone phosphate|prednisolone phosphate|mesh-list
64414496|NCT04393207|BB 1101|bb 1101|mesh-list
64414497|NCT04393207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64414498|NCT04393207|Antiemetics|antiemetics|mesh-ancestor
64414499|NCT04393207|Autonomic Agents|autonomic agents|mesh-ancestor
64414500|NCT04393207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414501|NCT04393207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414502|NCT04393207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64414503|NCT04393207|Glucocorticoids|glucocorticoids|mesh-ancestor
64414504|NCT04393207|Hormones|hormones|mesh-ancestor
64414505|NCT04393207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64414506|NCT04393207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64414507|NCT04393207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414508|NCT04393207|Protease Inhibitors|protease inhibitors|mesh-ancestor
64414509|NCT04393207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414510|NCT04393207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414511|NCT04393207|Anesthetics, Local|anesthetics, local|mesh-ancestor
64414513|NCT04393207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64414514|NCT04393207|Sensory System Agents|sensory system agents|mesh-ancestor
64414515|NCT04393207|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64414516|NCT04393207|Protective Agents|protective agents|mesh-ancestor
64414517|NCT02492841|Calcium, Dietary|calcium, dietary|mesh-list
64414518|NCT02492841|Calcium|calcium|mesh-list
64414519|NCT02492841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64414520|NCT02492841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414521|NCT02492841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64414522|NCT04814875|Carboplatin|carboplatin|mesh-list
64414523|NCT04814875|Doxorubicin|doxorubicin|mesh-list
64414524|NCT04814875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64343896|NCT02476994|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64414527|NCT04814875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64414529|NCT04814875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414530|NCT04814875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414531|NCT04812535|Pembrolizumab|pembrolizumab|mesh-list
64414532|NCT04812535|Vilobelimab|vilobelimab|mesh-list
64414533|NCT04812535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64414534|NCT04812535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414535|NCT04812535|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64414536|NCT04812535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64414537|NCT04812535|Immunologic Factors|immunologic factors|mesh-ancestor
64414538|NCT04812535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414539|NCT02492763|Metformin|metformin|mesh-list
64414540|NCT02492763|Liraglutide|liraglutide|mesh-list
64414541|NCT02492763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64414542|NCT02492763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414543|NCT02492763|Incretins|incretins|mesh-ancestor
64414544|NCT02492763|Hormones|hormones|mesh-ancestor
64414555|NCT04899817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414556|NCT04905667|Trastuzumab|trastuzumab|mesh-list
64414557|NCT04905667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64414558|NCT04905667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414559|NCT04397107|Aldesleukin|aldesleukin|mesh-list
64414560|NCT04397107|Interleukin-2|interleukin-2|mesh-list
64414561|NCT04397107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414562|NCT04397107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64414563|NCT04397107|Analgesics|analgesics|mesh-ancestor
64414564|NCT04397107|Sensory System Agents|sensory system agents|mesh-ancestor
64414565|NCT04397107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414566|NCT04397107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414567|NCT04397107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64414568|NCT04397107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64414569|NCT04397107|Antiviral Agents|antiviral agents|mesh-ancestor
64414578|NCT02453841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414579|NCT02453841|Sympathomimetics|sympathomimetics|mesh-ancestor
64414580|NCT02453841|Autonomic Agents|autonomic agents|mesh-ancestor
64414581|NCT02453841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414582|NCT02453841|Nasal Decongestants|nasal decongestants|mesh-ancestor
64414583|NCT02453841|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64414584|NCT02453841|Respiratory System Agents|respiratory system agents|mesh-ancestor
64414585|NCT02453841|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64414586|NCT02453841|Mydriatics|mydriatics|mesh-ancestor
64414587|NCT02453841|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64414588|NCT02453841|Protective Agents|protective agents|mesh-ancestor
64414589|NCT03081689|Paclitaxel|paclitaxel|mesh-list
64414590|NCT03081689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64414591|NCT03081689|Carboplatin|carboplatin|mesh-list
64414592|NCT03081689|Nivolumab|nivolumab|mesh-list
64414593|NCT03081689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64414594|NCT03081689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414595|NCT03081689|Tubulin Modulators|tubulin modulators|mesh-ancestor
64414596|NCT03081689|Antimitotic Agents|antimitotic agents|mesh-ancestor
64414597|NCT03081689|Mitosis Modulators|mitosis modulators|mesh-ancestor
64414598|NCT03081689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414599|NCT03081689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64414600|NCT03081689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64414601|NCT04888663|Paclitaxel|paclitaxel|mesh-list
64414602|NCT04888663|Trastuzumab|trastuzumab|mesh-list
64414603|NCT04888663|Ramucirumab|ramucirumab|mesh-list
64414604|NCT04888663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64414605|NCT04888663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414606|NCT04888663|Tubulin Modulators|tubulin modulators|mesh-ancestor
64414634|NCT03051841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343905|NCT05259007|Lansoprazole|lansoprazole|mesh-list
64414636|NCT03051841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414638|NCT04905043|Acalabrutinib|acalabrutinib|mesh-list
64414639|NCT04905043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414640|NCT02436759|Phenylephrine|phenylephrine|mesh-list
64414641|NCT02436759|Oxymetazoline|oxymetazoline|mesh-list
64414642|NCT02436759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64414643|NCT02436759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64414644|NCT02436759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64414645|NCT02436759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64414646|NCT02436759|Adrenergic Agents|adrenergic agents|mesh-ancestor
64414647|NCT02436759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64414648|NCT02436759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414649|NCT02436759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414650|NCT02436759|Sympathomimetics|sympathomimetics|mesh-ancestor
64414651|NCT02436759|Autonomic Agents|autonomic agents|mesh-ancestor
64414652|NCT02436759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414653|NCT02436759|Nasal Decongestants|nasal decongestants|mesh-ancestor
64414654|NCT02436759|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64414655|NCT02436759|Respiratory System Agents|respiratory system agents|mesh-ancestor
64414656|NCT02436759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64414657|NCT02436759|Mydriatics|mydriatics|mesh-ancestor
64414658|NCT02436759|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64414659|NCT02436759|Protective Agents|protective agents|mesh-ancestor
64414660|NCT04888741|Cyclosporine|cyclosporine|mesh-list
64414661|NCT04888741|Sirolimus|sirolimus|mesh-list
64414662|NCT04888741|Mycophenolic Acid|mycophenolic acid|mesh-list
64414663|NCT04888741|Cyclophosphamide|cyclophosphamide|mesh-list
64414664|NCT04888741|Cyclosporins|cyclosporins|mesh-list
64414665|NCT04888741|Thymoglobulin|thymoglobulin|mesh-list
64414666|NCT04888741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64414667|NCT04888741|Immunologic Factors|immunologic factors|mesh-ancestor
64414668|NCT04888741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414674|NCT04888741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64414675|NCT04888741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414676|NCT04888741|Antifungal Agents|antifungal agents|mesh-ancestor
64414677|NCT04888741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64414683|NCT04888741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64414686|NCT04918173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64414687|NCT04918173|Protease Inhibitors|protease inhibitors|mesh-ancestor
64414688|NCT04918173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414689|NCT04918173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414690|NCT04918173|Anticoagulants|anticoagulants|mesh-ancestor
64414691|NCT04904185|Cyclophosphamide|cyclophosphamide|mesh-list
64414692|NCT04904185|Pembrolizumab|pembrolizumab|mesh-list
64414693|NCT04904185|Fludarabine|fludarabine|mesh-list
64414694|NCT04904185|Fludarabine phosphate|fludarabine phosphate|mesh-list
64414695|NCT04904185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64414696|NCT04904185|Immunologic Factors|immunologic factors|mesh-ancestor
64414697|NCT04904185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414698|NCT04904185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64414699|NCT04904185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64414700|NCT04904185|Alkylating Agents|alkylating agents|mesh-ancestor
64414701|NCT04904185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414702|NCT04904185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414703|NCT04904185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64414704|NCT04904185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64414705|NCT04904185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64414706|NCT04904185|Antimetabolites|antimetabolites|mesh-ancestor
64414707|NCT04898725|Vitamin D|vitamin d|mesh-list
64414708|NCT04898725|Cholecalciferol|cholecalciferol|mesh-list
64414709|NCT04898725|Vitamins|vitamins|mesh-ancestor
64414710|NCT04898725|Micronutrients|micronutrients|mesh-ancestor
64343914|NCT05259007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64414711|NCT04898725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414718|NCT04887961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414720|NCT04887649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64414721|NCT04887649|Narcotics|narcotics|mesh-ancestor
64414722|NCT04887649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64414723|NCT04887649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414724|NCT04887649|Analgesics|analgesics|mesh-ancestor
64414725|NCT04887649|Sensory System Agents|sensory system agents|mesh-ancestor
64414726|NCT04887649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414727|NCT03050437|Pemetrexed|pemetrexed|mesh-list
64414728|NCT03050437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414729|NCT03050437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414730|NCT03050437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414731|NCT03050437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64414732|NCT03050437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64414733|NCT02436135|Idelalisib|idelalisib|mesh-list
64414734|NCT02436135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414735|NCT02436135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414736|NCT02436135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414737|NCT04917861|Vaccines|vaccines|mesh-list
64414738|NCT04917861|Immunologic Factors|immunologic factors|mesh-ancestor
64414739|NCT04917861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414740|NCT02435277|Metformin|metformin|mesh-list
64414741|NCT02435277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64414742|NCT02435277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414743|NCT02420223|Propranolol|propranolol|mesh-list
64414744|NCT02420223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64414745|NCT02420223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64414746|NCT02420223|Adrenergic Agents|adrenergic agents|mesh-ancestor
64414755|NCT02433483|Methotrexate|methotrexate|mesh-list
64414756|NCT02433483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64557640|NCT03067896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64557642|NCT03067896|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64557643|NCT03067896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64557644|NCT03067896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64557645|NCT03067896|Tocolytic Agents|tocolytic agents|mesh-ancestor
64557646|NCT03067896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64557648|NCT03034707|Vitamin B Complex|vitamin b complex|mesh-ancestor
64557649|NCT03034707|Vitamins|vitamins|mesh-ancestor
64557650|NCT03034707|Micronutrients|micronutrients|mesh-ancestor
64557651|NCT03034707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557652|NCT03067740|Dexmedetomidine|dexmedetomidine|mesh-list
64557656|NCT03067740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64557657|NCT03067740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557658|NCT03067740|Sensory System Agents|sensory system agents|mesh-ancestor
64557659|NCT03067740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64588685|NCT00542971|Immunologic Factors|immunologic factors|mesh-ancestor
64557660|NCT03067740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64557661|NCT03067740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64557663|NCT03067740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64557664|NCT03067740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64557665|NCT03067740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64557666|NCT03067740|Adrenergic Agents|adrenergic agents|mesh-ancestor
64557667|NCT03067740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64557669|NCT05730114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64557687|NCT03068832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557688|NCT03068832|Laxatives|laxatives|mesh-ancestor
64557689|NCT03068832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64557690|NCT03068832|Antiviral Agents|antiviral agents|mesh-ancestor
64557691|NCT03068832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64557693|NCT04573920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557694|NCT04573920|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64557695|NCT04573920|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64557696|NCT04573920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557697|NCT04801797|Cytarabine|cytarabine|mesh-list
64557698|NCT04801797|Azacitidine|azacitidine|mesh-list
64557699|NCT04801797|Daunorubicin|daunorubicin|mesh-list
64557700|NCT04801797|Venetoclax|venetoclax|mesh-list
64557701|NCT04801797|Idarubicin|idarubicin|mesh-list
64557702|NCT04801797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64557703|NCT04801797|Antimetabolites|antimetabolites|mesh-ancestor
64557704|NCT04801797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557705|NCT04801797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557706|NCT04801797|Antiviral Agents|antiviral agents|mesh-ancestor
64557707|NCT04801797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64557708|NCT04801797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64557709|NCT04801797|Immunologic Factors|immunologic factors|mesh-ancestor
64557710|NCT04801797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557711|NCT04801797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557712|NCT04801797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64557713|NCT04801797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64557714|NCT04801797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64557715|NCT03033537|Verapamil|verapamil|mesh-list
64557716|NCT03033537|Calcium Channel Blockers|calcium channel blockers|mesh-list
64557717|NCT03033537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64557718|NCT03033537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557719|NCT03033537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64557723|NCT01670435|Ciprofloxacin|ciprofloxacin|mesh-list
64557728|NCT01670435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557729|NCT01670435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557730|NCT01670435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557731|NCT01670435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64557732|NCT01670435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64557733|NCT03069144|Calcitriol|calcitriol|mesh-list
64557734|NCT03069144|Calcipotriene|calcipotriene|mesh-list
64557735|NCT03069144|Dermatologic Agents|dermatologic agents|mesh-ancestor
64557736|NCT03069144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64557737|NCT03069144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557738|NCT03069144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64557739|NCT03069144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64557740|NCT03069144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557741|NCT03069144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64557742|NCT03069144|Vitamins|vitamins|mesh-ancestor
64557743|NCT03069144|Micronutrients|micronutrients|mesh-ancestor
64557744|NCT03069144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64557745|NCT03017703|Eplerenone|eplerenone|mesh-list
64557746|NCT03017703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64557747|NCT03017703|Hormone Antagonists|hormone antagonists|mesh-ancestor
64557748|NCT03017703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64557749|NCT03017703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557750|NCT03017703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64557751|NCT03017703|Diuretics|diuretics|mesh-ancestor
64557752|NCT03017703|Natriuretic Agents|natriuretic agents|mesh-ancestor
64557753|NCT03017703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64557754|NCT01670669|Prucalopride|prucalopride|mesh-list
64557755|NCT01670669|Laxatives|laxatives|mesh-ancestor
64557756|NCT01670669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64557757|NCT01670669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64557758|NCT01670669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64557765|NCT00946023|Rituximab|rituximab|mesh-list
64557768|NCT00946023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64557769|NCT00946023|Immunologic Factors|immunologic factors|mesh-ancestor
64557770|NCT00946023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557771|NCT00946023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64557772|NCT00946023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64557773|NCT00946023|Alkylating Agents|alkylating agents|mesh-ancestor
64557774|NCT00946023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557775|NCT00946023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557776|NCT00946023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64557777|NCT00946023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64557778|NCT00946023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64557779|NCT00946023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557780|NCT00946023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64557781|NCT00946023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64557782|NCT00946023|Antitubercular Agents|antitubercular agents|mesh-ancestor
64557783|NCT00946023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64557784|NCT00946023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64557785|NCT01672151|Sirolimus|sirolimus|mesh-list
64557786|NCT01672151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64414768|NCT02433483|Immunologic Factors|immunologic factors|mesh-ancestor
64557787|NCT01672151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64557788|NCT01672151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64557789|NCT01672151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557790|NCT01672151|Antifungal Agents|antifungal agents|mesh-ancestor
64557791|NCT01672151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64557818|NCT05629494|Analgesics|analgesics|mesh-ancestor
64557819|NCT05629494|Sensory System Agents|sensory system agents|mesh-ancestor
64557820|NCT05629494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64557821|NCT05629494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557822|NCT05629494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64557823|NCT05629494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64557824|NCT05629494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64557825|NCT05629494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557826|NCT05629494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557827|NCT05629494|Gout Suppressants|gout suppressants|mesh-ancestor
64557828|NCT00952653|Midazolam|midazolam|mesh-list
64557829|NCT00952653|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64557830|NCT00952653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64557831|NCT00952653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64557832|NCT00952653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64557833|NCT00952653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557834|NCT00952653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64557835|NCT00952653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64557836|NCT00952653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64557837|NCT00952653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64557838|NCT00952653|Anesthetics, General|anesthetics, general|mesh-ancestor
64557839|NCT00952653|Anesthetics|anesthetics|mesh-ancestor
64557840|NCT00952653|GABA Modulators|gaba modulators|mesh-ancestor
64557841|NCT00952653|GABA Agents|gaba agents|mesh-ancestor
64557842|NCT00952653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64557843|NCT00952653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557844|NCT00952653|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64557845|NCT00952653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64557846|NCT00952653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64557847|NCT00952653|Antidepressive Agents|antidepressive agents|mesh-ancestor
64557848|NCT01673087|Dexamethasone|dexamethasone|mesh-list
64557849|NCT01673087|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64557850|NCT01673087|Cosyntropin|cosyntropin|mesh-list
64557851|NCT01673087|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
64557852|NCT01673087|Metyrapone|metyrapone|mesh-list
64344095|NCT05084599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64557861|NCT01673087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64557862|NCT01673087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64557863|NCT01673087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557864|NCT01673087|Antimetabolites|antimetabolites|mesh-ancestor
64557865|NCT01673087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557866|NCT01673087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557867|NCT02299505|Ceritinib|ceritinib|mesh-list
64557868|NCT02299505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557869|NCT02299505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64557870|NCT02299505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557871|NCT02299505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557872|NCT01673399|Atosiban|atosiban|mesh-list
64557873|NCT01673399|Hormone Antagonists|hormone antagonists|mesh-ancestor
64557874|NCT01673399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64557875|NCT01673399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557876|NCT01673399|Tocolytic Agents|tocolytic agents|mesh-ancestor
64557877|NCT01673399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64557878|NCT04781855|Nivolumab|nivolumab|mesh-list
64557879|NCT04781855|Ipilimumab|ipilimumab|mesh-list
64557880|NCT04781855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64557881|NCT04781855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334719|NCT02354547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334720|NCT02232035|Diazepam|diazepam|mesh-list
64334721|NCT02232035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64334722|NCT02232035|Anticonvulsants|anticonvulsants|mesh-ancestor
64557882|NCT04781855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64557883|NCT04781855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557885|NCT02235701|Doxorubicin|doxorubicin|mesh-list
64557886|NCT02235701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64557887|NCT02235701|Alkylating Agents|alkylating agents|mesh-ancestor
64557888|NCT02235701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557889|NCT02235701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557890|NCT02235701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64557891|NCT02235701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64557892|NCT02235701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64557893|NCT02235701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557895|NCT04404881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64557896|NCT04404881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557897|NCT04404881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64557898|NCT04404881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64588726|NCT05630846|Vaccines|vaccines|mesh-list
64557899|NCT04404881|Growth Substances|growth substances|mesh-ancestor
64557900|NCT04404881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557901|NCT04404881|Growth Inhibitors|growth inhibitors|mesh-ancestor
64557902|NCT01674257|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64557903|NCT01674257|Fluorides|fluorides|mesh-list
64557904|NCT01674257|Cariostatic Agents|cariostatic agents|mesh-ancestor
64557905|NCT01674257|Protective Agents|protective agents|mesh-ancestor
64557906|NCT01674257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557907|NCT01674257|Hematinics|hematinics|mesh-ancestor
64557908|NCT01674257|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64557909|NCT01674257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64557910|NCT01674413|Adalimumab|adalimumab|mesh-list
64557911|NCT01674413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64557912|NCT01674413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64557913|NCT00953121|Bevacizumab|bevacizumab|mesh-list
64557914|NCT00953121|Carboplatin|carboplatin|mesh-list
64557923|NCT00953121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64557924|NCT00953121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64557925|NCT00953121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557926|NCT00953121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557927|NCT03017391|Dexamethasone|dexamethasone|mesh-list
64557928|NCT03017391|Metoclopramide|metoclopramide|mesh-list
64557929|NCT03017391|Granisetron|granisetron|mesh-list
64557930|NCT03017391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64557931|NCT03017391|Antiemetics|antiemetics|mesh-ancestor
64557932|NCT03017391|Autonomic Agents|autonomic agents|mesh-ancestor
64557933|NCT03017391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64557934|NCT03017391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557935|NCT03017391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64557936|NCT03017391|Glucocorticoids|glucocorticoids|mesh-ancestor
64557937|NCT03017391|Hormones|hormones|mesh-ancestor
64414769|NCT02433483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64557938|NCT03017391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64557939|NCT03017391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64557940|NCT03017391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557941|NCT03017391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64557942|NCT03017391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64557943|NCT03017391|Dopamine Agents|dopamine agents|mesh-ancestor
64344168|NCT02446418|Dermatologic Agents|dermatologic agents|mesh-ancestor
64557944|NCT03017391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64557945|NCT03017391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557946|NCT03017391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64557948|NCT00953199|Lidocaine|lidocaine|mesh-list
64557949|NCT00953199|Anesthetics, Local|anesthetics, local|mesh-ancestor
64557950|NCT00953199|Anesthetics|anesthetics|mesh-ancestor
64557951|NCT00953199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64557952|NCT00953199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557953|NCT00953199|Sensory System Agents|sensory system agents|mesh-ancestor
64557955|NCT00953199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64557963|NCT03033147|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64557964|NCT03033147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64557965|NCT03033147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64557966|NCT03033147|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64557967|NCT03033147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64557968|NCT03033147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557969|NCT04657991|Pembrolizumab|pembrolizumab|mesh-list
64557970|NCT04657991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64557971|NCT04657991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64557972|NCT01675895|Lidocaine|lidocaine|mesh-list
64557973|NCT01675895|Levobupivacaine|levobupivacaine|mesh-list
64557974|NCT01675895|Anesthetics|anesthetics|mesh-list
64557975|NCT01675895|Anesthetics, Local|anesthetics, local|mesh-ancestor
64557976|NCT01675895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64557977|NCT01675895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557978|NCT01675895|Sensory System Agents|sensory system agents|mesh-ancestor
64557979|NCT01675895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64557980|NCT01675895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64557981|NCT01675895|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64557982|NCT01675895|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64557983|NCT01675895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64557984|NCT01675895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557985|NCT01675973|Ranolazine|ranolazine|mesh-list
64557986|NCT01675973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64557987|NCT01675973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64557988|NCT01675973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64557989|NCT04764851|Ecopipam|ecopipam|mesh-list
64344204|NCT05650216|Paclitaxel|paclitaxel|mesh-list
64344213|NCT04848688|Ivermectin|ivermectin|mesh-list
64557992|NCT04764851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64557993|NCT04764851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64557994|NCT04764851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64558001|NCT00956085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64558002|NCT00956085|Dopamine Agents|dopamine agents|mesh-ancestor
64558003|NCT00956085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64558004|NCT00956085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558005|NCT00956085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558006|NCT00956085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64558007|NCT00956085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64558010|NCT01005459|Anesthetics, Local|anesthetics, local|mesh-ancestor
64558011|NCT01005459|Anesthetics|anesthetics|mesh-ancestor
64558012|NCT01005459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64558013|NCT01005459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558014|NCT01005459|Sensory System Agents|sensory system agents|mesh-ancestor
64558015|NCT01005459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64558016|NCT01676285|Metoprolol|metoprolol|mesh-list
64558017|NCT01676285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64558018|NCT01676285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64558019|NCT01676285|Sympatholytics|sympatholytics|mesh-ancestor
64558020|NCT01676285|Autonomic Agents|autonomic agents|mesh-ancestor
64558021|NCT01676285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64558022|NCT01676285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558023|NCT01676285|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64558024|NCT01676285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64558025|NCT01676285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64558026|NCT01676285|Adrenergic Agents|adrenergic agents|mesh-ancestor
64558027|NCT01676285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64558028|NCT01676285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558043|NCT00956709|Anesthetics, Local|anesthetics, local|mesh-ancestor
64558044|NCT00956709|Anesthetics|anesthetics|mesh-ancestor
64558045|NCT00956709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64558046|NCT00956709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558047|NCT00956709|Sensory System Agents|sensory system agents|mesh-ancestor
64558048|NCT00956709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64558049|NCT00957333|Ketamine|ketamine|mesh-list
64558050|NCT00957333|Analgesics|analgesics|mesh-ancestor
64558051|NCT00957333|Sensory System Agents|sensory system agents|mesh-ancestor
64558052|NCT00957333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64558053|NCT00957333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558054|NCT00957333|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64558055|NCT00957333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64558057|NCT00957333|Anesthetics|anesthetics|mesh-ancestor
64558058|NCT00957333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64558059|NCT00957333|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64558060|NCT00957333|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64558061|NCT00957333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64558062|NCT00957333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558063|NCT02159547|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
64558064|NCT02159547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64558065|NCT02159547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64558066|NCT02159547|Analgesics|analgesics|mesh-ancestor
64558067|NCT02159547|Sensory System Agents|sensory system agents|mesh-ancestor
64558068|NCT02159547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64558069|NCT02159547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558070|NCT02159547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64558071|NCT02159547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64558082|NCT01011075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558083|NCT01011075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64558084|NCT01011075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558085|NCT00958581|Tranexamic Acid|tranexamic acid|mesh-list
64558086|NCT00958581|Aminocaproic Acid|aminocaproic acid|mesh-list
64558087|NCT00958581|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64558088|NCT00958581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64558089|NCT00958581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558090|NCT00958581|Hemostatics|hemostatics|mesh-ancestor
64558091|NCT00958581|Coagulants|coagulants|mesh-ancestor
64558093|NCT01012089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64558094|NCT01012089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64558095|NCT04422431|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
64558096|NCT04422431|Choline|choline|mesh-list
64558097|NCT04422431|Lipotropic Agents|lipotropic agents|mesh-ancestor
64558098|NCT04422431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64558099|NCT04422431|Antimetabolites|antimetabolites|mesh-ancestor
64558100|NCT04422431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558101|NCT04422431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64558102|NCT04422431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64558103|NCT04422431|Nootropic Agents|nootropic agents|mesh-ancestor
64558104|NCT04422431|Chelating Agents|chelating agents|mesh-ancestor
64558105|NCT04422431|Sequestering Agents|sequestering agents|mesh-ancestor
64558106|NCT04422431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558107|NCT04422431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64558108|NCT04422431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64558109|NCT04422431|Growth Substances|growth substances|mesh-ancestor
64558110|NCT04422431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558111|NCT04422431|Growth Inhibitors|growth inhibitors|mesh-ancestor
64558112|NCT04422431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558113|NCT04265651|Infigratinib|infigratinib|mesh-list
64558114|NCT04265651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558115|NCT04055753|Doxorubicin|doxorubicin|mesh-list
64558116|NCT04055753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64344255|NCT01601626|Pyrazinamide|pyrazinamide|mesh-list
64558124|NCT03871361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558125|NCT03871361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558126|NCT03871361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64558127|NCT03871361|Immunologic Factors|immunologic factors|mesh-ancestor
64558128|NCT03871361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558129|NCT03871361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64558130|NCT04764227|Paclitaxel|paclitaxel|mesh-list
64558131|NCT04764227|Carboplatin|carboplatin|mesh-list
64558132|NCT04764227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64558133|NCT04764227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558134|NCT04764227|Tubulin Modulators|tubulin modulators|mesh-ancestor
64558135|NCT04764227|Antimitotic Agents|antimitotic agents|mesh-ancestor
64558136|NCT04764227|Mitosis Modulators|mitosis modulators|mesh-ancestor
64558137|NCT04764227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558138|NCT03589547|Durvalumab|durvalumab|mesh-list
64558139|NCT03589547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64558140|NCT03589547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558141|NCT04764383|Histamine|histamine|mesh-list
64558142|NCT04764383|Histamine Agonists|histamine agonists|mesh-ancestor
64558143|NCT04764383|Histamine Agents|histamine agents|mesh-ancestor
64558144|NCT04764383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64558145|NCT04764383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558146|NCT04764383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558147|NCT03016611|Ticagrelor|ticagrelor|mesh-list
64558148|NCT03016611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64558149|NCT03016611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64558150|NCT03016611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64558152|NCT03016611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64558165|NCT00961233|Glucocorticoids|glucocorticoids|mesh-ancestor
64558166|NCT00961233|Hormones|hormones|mesh-ancestor
64558167|NCT00961233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64558168|NCT00962871|Tenofovir|tenofovir|mesh-list
64558169|NCT00962871|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64558170|NCT00962871|Antiviral Agents|antiviral agents|mesh-ancestor
64558171|NCT00962871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64558172|NCT00962871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64558173|NCT00962871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64558174|NCT00962871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558175|NCT00962871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558176|NCT00962871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64558177|NCT00962871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64558178|NCT01014351|Paclitaxel|paclitaxel|mesh-list
64558179|NCT01014351|Carboplatin|carboplatin|mesh-list
64558180|NCT01014351|Everolimus|everolimus|mesh-list
64558181|NCT01014351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64558182|NCT01014351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558183|NCT01014351|Tubulin Modulators|tubulin modulators|mesh-ancestor
64558184|NCT01014351|Antimitotic Agents|antimitotic agents|mesh-ancestor
64558185|NCT01014351|Mitosis Modulators|mitosis modulators|mesh-ancestor
64558186|NCT01014351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558187|NCT01014351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64558188|NCT01014351|Immunologic Factors|immunologic factors|mesh-ancestor
64558189|NCT01014351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558190|NCT01014741|Ibutilide|ibutilide|mesh-list
64558191|NCT01014741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64558192|NCT01015443|Cyclophosphamide|cyclophosphamide|mesh-list
64558196|NCT01015443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64558197|NCT01015443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64558198|NCT01015443|Alkylating Agents|alkylating agents|mesh-ancestor
64334723|NCT02232035|Antiemetics|antiemetics|mesh-ancestor
64558199|NCT01015443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558200|NCT01015443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558201|NCT01015443|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64558202|NCT00962949|Angiotensin II|angiotensin ii|mesh-list
64558203|NCT00962949|Giapreza|giapreza|mesh-list
64558204|NCT00962949|Angiotensinogen|angiotensinogen|mesh-list
64558205|NCT00962949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64558206|NCT00962949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64558207|NCT00962949|Protease Inhibitors|protease inhibitors|mesh-ancestor
64558208|NCT00962949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558209|NCT00962949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558210|NCT01695941|Rituximab|rituximab|mesh-list
64558211|NCT01695941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64558212|NCT01695941|Bortezomib|bortezomib|mesh-list
64558213|NCT01695941|Antibodies|antibodies|mesh-list
64558214|NCT01695941|Immunoglobulins|immunoglobulins|mesh-list
64558215|NCT01695941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64558216|NCT01695941|Immunologic Factors|immunologic factors|mesh-ancestor
64558217|NCT01695941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558218|NCT01695941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558219|NCT01695941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64558220|NCT01244789|Paclitaxel|paclitaxel|mesh-list
64558221|NCT01244789|Carboplatin|carboplatin|mesh-list
64558222|NCT01244789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64558223|NCT01244789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558224|NCT01244789|Tubulin Modulators|tubulin modulators|mesh-ancestor
64558225|NCT01244789|Antimitotic Agents|antimitotic agents|mesh-ancestor
64558226|NCT01244789|Mitosis Modulators|mitosis modulators|mesh-ancestor
64558227|NCT01244789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558228|NCT02631876|Paclitaxel|paclitaxel|mesh-list
64558229|NCT02631876|Maytansine|maytansine|mesh-list
64558230|NCT02631876|Doxorubicin|doxorubicin|mesh-list
64558245|NCT03156179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64558246|NCT03156179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558252|NCT04436796|Pancrelipase|pancrelipase|mesh-list
64558253|NCT04436796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64558254|NCT02081963|Amikacin|amikacin|mesh-list
64558255|NCT02081963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64558256|NCT02081963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64558257|NCT04765085|Aripiprazole|aripiprazole|mesh-list
64558258|NCT04765085|Antidepressive Agents|antidepressive agents|mesh-ancestor
64558259|NCT04765085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64558260|NCT04765085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64558261|NCT04765085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64558262|NCT04765085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64558263|NCT04765085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558264|NCT04765085|Dopamine Agonists|dopamine agonists|mesh-ancestor
64558265|NCT04765085|Dopamine Agents|dopamine agents|mesh-ancestor
64558266|NCT04765085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64558267|NCT04765085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558268|NCT04765085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64558269|NCT04765085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64558270|NCT04765085|Serotonin Agents|serotonin agents|mesh-ancestor
64558271|NCT04765085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64558273|NCT04765085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64558274|NCT04765085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64558275|NCT02633046|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64558276|NCT02633046|Hormones|hormones|mesh-ancestor
64558277|NCT02633046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64558278|NCT02633046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558279|NCT01676597|Rifaximin|rifaximin|mesh-list
64558280|NCT01676597|Pentoxifylline|pentoxifylline|mesh-list
64558281|NCT01676597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64558283|NCT01676597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64558284|NCT01676597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64558285|NCT01676597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558286|NCT01676597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558287|NCT01676597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64558288|NCT01676597|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64558289|NCT01676597|Protective Agents|protective agents|mesh-ancestor
64558290|NCT01676597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558291|NCT01676597|Vasodilator Agents|vasodilator agents|mesh-ancestor
64558292|NCT01676597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64558293|NCT01676597|Antioxidants|antioxidants|mesh-ancestor
64558294|NCT04374630|Paclitaxel|paclitaxel|mesh-list
64558295|NCT04374630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64558296|NCT04374630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558297|NCT04374630|Tubulin Modulators|tubulin modulators|mesh-ancestor
64558298|NCT04374630|Antimitotic Agents|antimitotic agents|mesh-ancestor
64558299|NCT04374630|Mitosis Modulators|mitosis modulators|mesh-ancestor
64558300|NCT04374630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558301|NCT05540964|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64558302|NCT05540964|Antiviral Agents|antiviral agents|mesh-ancestor
64558303|NCT05540964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64558305|NCT04364802|Cadexomer iodine|cadexomer iodine|mesh-list
64558306|NCT04364802|Povidone-Iodine|povidone-iodine|mesh-list
64558308|NCT04364802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64558309|NCT04364802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64558310|NCT04364802|Trace Elements|trace elements|mesh-ancestor
64558311|NCT04364802|Micronutrients|micronutrients|mesh-ancestor
64558312|NCT04364802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558313|NCT04364802|Plasma Substitutes|plasma substitutes|mesh-ancestor
64558314|NCT04364802|Blood Substitutes|blood substitutes|mesh-ancestor
64558315|NCT03155087|Metformin|metformin|mesh-list
64558316|NCT03155087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64558317|NCT03155087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558318|NCT03867617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64558319|NCT03867617|Immunologic Factors|immunologic factors|mesh-ancestor
64558326|NCT05491278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558327|NCT05491278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64558328|NCT05491278|Anesthetics, General|anesthetics, general|mesh-ancestor
64558329|NCT05491278|Anesthetics|anesthetics|mesh-ancestor
64558330|NCT05491278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64558331|NCT05491278|Narcotics|narcotics|mesh-ancestor
64558332|NCT05491278|Analgesics|analgesics|mesh-ancestor
64558333|NCT05491278|Sensory System Agents|sensory system agents|mesh-ancestor
64558334|NCT05491278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64558335|NCT00963105|Lenalidomide|lenalidomide|mesh-list
64558336|NCT00963105|Immunologic Factors|immunologic factors|mesh-ancestor
64558337|NCT00963105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558338|NCT00963105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64558339|NCT00963105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64558340|NCT00963105|Growth Substances|growth substances|mesh-ancestor
64558341|NCT00963105|Growth Inhibitors|growth inhibitors|mesh-ancestor
64558342|NCT00963105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558343|NCT04879992|Amoxicillin|amoxicillin|mesh-list
64558344|NCT04879992|Metronidazole|metronidazole|mesh-list
64558345|NCT04879992|Tetracycline|tetracycline|mesh-list
64558347|NCT04879992|Potassium Citrate|potassium citrate|mesh-list
64558348|NCT04879992|Esomeprazole|esomeprazole|mesh-list
64558349|NCT04879992|Bismuth|bismuth|mesh-list
64558364|NCT04879992|Natriuretic Agents|natriuretic agents|mesh-ancestor
64558365|NCT04879992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558366|NCT04879992|Expectorants|expectorants|mesh-ancestor
64558367|NCT04879992|Respiratory System Agents|respiratory system agents|mesh-ancestor
64558368|NCT01016691|Bimatoprost|bimatoprost|mesh-list
64558369|NCT01016691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64558370|NCT04181736|Guanfacine|guanfacine|mesh-list
64558371|NCT04181736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64558372|NCT04181736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64558373|NCT04181736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64558374|NCT04181736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64558375|NCT04181736|Adrenergic Agents|adrenergic agents|mesh-ancestor
64558376|NCT04181736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64558377|NCT04181736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558378|NCT04181736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558379|NCT04404491|Capecitabine|capecitabine|mesh-list
64558380|NCT04404491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64558381|NCT04404491|Antimetabolites|antimetabolites|mesh-ancestor
64558382|NCT04404491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558383|NCT04404491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558385|NCT03861299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64558386|NCT03861299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558387|NCT05573568|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
64558388|NCT05573568|Hallucinogens|hallucinogens|mesh-ancestor
64558389|NCT05573568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558390|NCT05573568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64558391|NCT05573568|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64558392|NCT05573568|Serotonin Agents|serotonin agents|mesh-ancestor
64558393|NCT05573568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64558409|NCT01672788|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64558410|NCT01672788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558411|NCT02705963|Trametinib|trametinib|mesh-list
64558412|NCT02705963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64558413|NCT02705963|Norethindrone|norethindrone|mesh-list
64344337|NCT03377803|Cantharidin|cantharidin|mesh-list
64558415|NCT02705963|Contraceptive Agents|contraceptive agents|mesh-list
64558416|NCT02705963|Contraceptives, Oral|contraceptives, oral|mesh-list
64558417|NCT02705963|Estradiol|estradiol|mesh-list
64558418|NCT02705963|Estrogens|estrogens|mesh-ancestor
64558419|NCT02705963|Hormones|hormones|mesh-ancestor
64558420|NCT02705963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64558421|NCT02705963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558422|NCT02705963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64558425|NCT02705963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558466|NCT03840239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558467|NCT03840239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558468|NCT02632110|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64558469|NCT02632110|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64558470|NCT02632110|Dermatologic Agents|dermatologic agents|mesh-ancestor
64558471|NCT03830723|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64558472|NCT03830723|Hormones|hormones|mesh-ancestor
64558473|NCT03830723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64558474|NCT03830723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558475|NCT03829319|Carboplatin|carboplatin|mesh-list
64558476|NCT03829319|Pembrolizumab|pembrolizumab|mesh-list
64558477|NCT03829319|Pemetrexed|pemetrexed|mesh-list
64558478|NCT03829319|Lenvatinib|lenvatinib|mesh-list
64558479|NCT03829319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558480|NCT03829319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64558481|NCT03829319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558482|NCT03829319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558483|NCT03829319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64558484|NCT03829319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64558485|NCT03829319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64558486|NCT03824483|Venetoclax|venetoclax|mesh-list
64558487|NCT03824483|Obinutuzumab|obinutuzumab|mesh-list
64558488|NCT03824483|Zanubrutinib|zanubrutinib|mesh-list
64558489|NCT03824483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558516|NCT01016769|Antimitotic Agents|antimitotic agents|mesh-ancestor
64558517|NCT01016769|Mitosis Modulators|mitosis modulators|mesh-ancestor
64558518|NCT01016769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558519|NCT01016769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64558520|NCT01016769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64558521|NCT01016769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64588804|NCT03597308|Analgesics|analgesics|mesh-ancestor
64558522|NCT01016769|Antifungal Agents|antifungal agents|mesh-ancestor
64558523|NCT01016769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64558524|NCT01016769|Immunologic Factors|immunologic factors|mesh-ancestor
64558525|NCT01016769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558526|NCT03807479|Ponatinib|ponatinib|mesh-list
64558527|NCT03807479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558528|NCT03807479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64558532|NCT03019809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64558533|NCT03019809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64558534|NCT03019809|Antiviral Agents|antiviral agents|mesh-ancestor
64558535|NCT03019809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64558537|NCT00964353|Anticoagulants|anticoagulants|mesh-ancestor
64558538|NCT03802799|Cannabidiol|cannabidiol|mesh-list
64558539|NCT03802799|Anticonvulsants|anticonvulsants|mesh-ancestor
64558540|NCT00964431|Celecoxib|celecoxib|mesh-list
64558541|NCT00964431|Indomethacin|indomethacin|mesh-list
64558542|NCT00964431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64558543|NCT00964431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64558544|NCT00964431|Analgesics|analgesics|mesh-ancestor
64558545|NCT00964431|Sensory System Agents|sensory system agents|mesh-ancestor
64558546|NCT00964431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64558547|NCT00964431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558548|NCT00964431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64558549|NCT00964431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64558550|NCT00964431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64558551|NCT00964431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64558556|NCT00964431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64558557|NCT05475054|Liver Extracts|liver extracts|mesh-list
64558558|NCT05475054|Hematinics|hematinics|mesh-ancestor
64558559|NCT01017003|Colchicine|colchicine|mesh-list
64558560|NCT01017003|Gout Suppressants|gout suppressants|mesh-ancestor
64558561|NCT01017003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64558562|NCT01017003|Tubulin Modulators|tubulin modulators|mesh-ancestor
64558563|NCT01017003|Antimitotic Agents|antimitotic agents|mesh-ancestor
64558564|NCT01017003|Mitosis Modulators|mitosis modulators|mesh-ancestor
64558565|NCT01017003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558566|NCT01017003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558567|NCT01017237|Midazolam|midazolam|mesh-list
64558568|NCT01017237|Dexmedetomidine|dexmedetomidine|mesh-list
64558569|NCT01017237|Ketamine|ketamine|mesh-list
64558570|NCT01017237|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64558571|NCT01017237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64558572|NCT01017237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558573|NCT01017237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64558574|NCT01017237|Analgesics|analgesics|mesh-ancestor
64558575|NCT01017237|Sensory System Agents|sensory system agents|mesh-ancestor
64558576|NCT01017237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64558577|NCT01017237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64558578|NCT01017237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64558579|NCT01017237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64558580|NCT01017237|Adrenergic Agents|adrenergic agents|mesh-ancestor
64558581|NCT01017237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64558582|NCT01017237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558583|NCT01017237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64558584|NCT01017237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64558585|NCT01017237|Anesthetics, General|anesthetics, general|mesh-ancestor
64558587|NCT01017237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64558588|NCT01017237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64558599|NCT04442412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558600|NCT04442412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64558601|NCT04442412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64558603|NCT01018095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64558604|NCT01018095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64558605|NCT01018095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64558606|NCT01018095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64558607|NCT03788759|Thioctic Acid|thioctic acid|mesh-list
64558608|NCT03788759|Antioxidants|antioxidants|mesh-ancestor
64558609|NCT03788759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558610|NCT03788759|Protective Agents|protective agents|mesh-ancestor
64558611|NCT03788759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558612|NCT03788759|Vitamin B Complex|vitamin b complex|mesh-ancestor
64558614|NCT03788759|Micronutrients|micronutrients|mesh-ancestor
64558615|NCT00967551|Zinc|zinc|mesh-list
64558616|NCT00967551|Trace Elements|trace elements|mesh-list
64558617|NCT00967551|Micronutrients|micronutrients|mesh-list
64558618|NCT00967551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558619|NCT03778073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64558620|NCT03778073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64558621|NCT03778073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64558622|NCT03778073|Alkylating Agents|alkylating agents|mesh-ancestor
64558623|NCT03778073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558624|NCT03778073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558625|NCT03778073|Immunologic Factors|immunologic factors|mesh-ancestor
64558626|NCT03778073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558627|NCT00970203|Vaccines|vaccines|mesh-list
64558628|NCT00970203|Androgens|androgens|mesh-list
64558629|NCT00970203|Immunologic Factors|immunologic factors|mesh-ancestor
64344583|NCT00002411|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64558630|NCT00970203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558632|NCT00970203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64558633|NCT00971295|Metformin|metformin|mesh-list
64558634|NCT00971295|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64558640|NCT00971295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64558641|NCT00971295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558643|NCT00954681|Antidepressive Agents|antidepressive agents|mesh-ancestor
64558644|NCT00954681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64558645|NCT00954681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64558646|NCT00954681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64558647|NCT00954681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64558648|NCT00954681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558649|NCT00971841|Paclitaxel|paclitaxel|mesh-list
64558650|NCT00971841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64558651|NCT00971841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558652|NCT00971841|Tubulin Modulators|tubulin modulators|mesh-ancestor
64558653|NCT00971841|Antimitotic Agents|antimitotic agents|mesh-ancestor
64558654|NCT00971841|Mitosis Modulators|mitosis modulators|mesh-ancestor
64558655|NCT00971841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558656|NCT04913220|Cemiplimab|cemiplimab|mesh-list
64558657|NCT04913220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64558658|NCT04913220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558659|NCT05395299|Ethylene|ethylene|mesh-list
64558660|NCT05395299|Plant Growth Regulators|plant growth regulators|mesh-ancestor
64558661|NCT05395299|Growth Substances|growth substances|mesh-ancestor
64558662|NCT05395299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558663|NCT02246049|Leucovorin|leucovorin|mesh-list
64558664|NCT02246049|Bevacizumab|bevacizumab|mesh-list
64558665|NCT02246049|Fluorouracil|fluorouracil|mesh-list
64558666|NCT02246049|Oxaliplatin|oxaliplatin|mesh-list
64558667|NCT02246049|Irinotecan|irinotecan|mesh-list
64558668|NCT02246049|Calcium|calcium|mesh-list
64558669|NCT02246049|Levoleucovorin|levoleucovorin|mesh-list
64558670|NCT02246049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64558671|NCT02246049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558672|NCT02246049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64558673|NCT02246049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64558674|NCT02246049|Growth Substances|growth substances|mesh-ancestor
64558681|NCT02246049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64558682|NCT02246049|Immunologic Factors|immunologic factors|mesh-ancestor
64558683|NCT02246049|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64558684|NCT02246049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64558685|NCT02246049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558687|NCT02246049|Protective Agents|protective agents|mesh-ancestor
64558688|NCT02246049|Vitamin B Complex|vitamin b complex|mesh-ancestor
64558689|NCT02246049|Vitamins|vitamins|mesh-ancestor
64558690|NCT02246049|Micronutrients|micronutrients|mesh-ancestor
64558691|NCT05395143|Zinc Sulfate|zinc sulfate|mesh-list
64558692|NCT05395143|Astringents|astringents|mesh-ancestor
64558693|NCT05395143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558694|NCT05395143|Dermatologic Agents|dermatologic agents|mesh-ancestor
64558695|NCT05394909|Methylprednisolone|methylprednisolone|mesh-list
64558696|NCT05394909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64558697|NCT05394909|Antiemetics|antiemetics|mesh-ancestor
64558698|NCT05394909|Autonomic Agents|autonomic agents|mesh-ancestor
64558699|NCT05394909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64558700|NCT05394909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558701|NCT05394909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64558702|NCT05394909|Glucocorticoids|glucocorticoids|mesh-ancestor
64558703|NCT05394909|Hormones|hormones|mesh-ancestor
64558704|NCT05394909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64558705|NCT05394909|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64558706|NCT05394909|Protective Agents|protective agents|mesh-ancestor
64558707|NCT05694858|Lidocaine|lidocaine|mesh-list
64558708|NCT05694858|Anesthetics, Local|anesthetics, local|mesh-ancestor
64558709|NCT05694858|Anesthetics|anesthetics|mesh-ancestor
64558710|NCT05694858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64558711|NCT05694858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558719|NCT02159859|Ertapenem|ertapenem|mesh-list
64558724|NCT00974493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64558725|NCT00974493|Antitubercular Agents|antitubercular agents|mesh-ancestor
64558726|NCT02083679|Gemcitabine|gemcitabine|mesh-list
64558727|NCT02083679|Paclitaxel|paclitaxel|mesh-list
64558728|NCT02083679|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64558729|NCT02083679|Cisplatin|cisplatin|mesh-list
64558730|NCT02083679|Carboplatin|carboplatin|mesh-list
64558731|NCT02083679|Pemetrexed|pemetrexed|mesh-list
64558732|NCT02083679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64558733|NCT02083679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64558734|NCT02083679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558735|NCT02083679|Tubulin Modulators|tubulin modulators|mesh-ancestor
64558736|NCT02083679|Antimitotic Agents|antimitotic agents|mesh-ancestor
64558737|NCT02083679|Mitosis Modulators|mitosis modulators|mesh-ancestor
64558738|NCT02083679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558739|NCT02083679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64558740|NCT02083679|Antimetabolites|antimetabolites|mesh-ancestor
64558741|NCT02083679|Antiviral Agents|antiviral agents|mesh-ancestor
64558742|NCT02083679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64558743|NCT02083679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558744|NCT02083679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64558745|NCT02083679|Immunologic Factors|immunologic factors|mesh-ancestor
64344686|NCT03529097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64558746|NCT02083679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558747|NCT02083679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64558748|NCT02083679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64558749|NCT03769025|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64558750|NCT03769025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64558751|NCT03769025|Narcotics|narcotics|mesh-ancestor
64558774|NCT04790448|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64558775|NCT04790448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64558776|NCT04790448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558777|NCT04790448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558778|NCT04790448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558779|NCT04790448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64558780|NCT04790448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64558781|NCT04790448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64558782|NCT04784052|Cyclophosphamide|cyclophosphamide|mesh-list
64558783|NCT04784052|Rituximab|rituximab|mesh-list
64558784|NCT04784052|Fludarabine|fludarabine|mesh-list
64558785|NCT04784052|Thymoglobulin|thymoglobulin|mesh-list
64558786|NCT04784052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64558787|NCT04784052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64558788|NCT04784052|Immunologic Factors|immunologic factors|mesh-ancestor
64558789|NCT04784052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558790|NCT04784052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64558791|NCT04784052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64558792|NCT04784052|Alkylating Agents|alkylating agents|mesh-ancestor
64558793|NCT04784052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558794|NCT04784052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558795|NCT04784052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64558796|NCT04784052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64558797|NCT05319756|Oxycodone|oxycodone|mesh-list
64558798|NCT05319756|Gabapentin|gabapentin|mesh-list
64558799|NCT05319756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64558800|NCT05319756|Narcotics|narcotics|mesh-ancestor
64558803|NCT05319756|Analgesics|analgesics|mesh-ancestor
64558821|NCT04410588|Narcotics|narcotics|mesh-ancestor
64558822|NCT04410588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64558823|NCT04410588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558824|NCT04410588|Analgesics|analgesics|mesh-ancestor
64558825|NCT04410588|Sensory System Agents|sensory system agents|mesh-ancestor
64558826|NCT04410588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64558827|NCT04410588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64558828|NCT04410588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64558829|NCT04410588|Anesthetics, General|anesthetics, general|mesh-ancestor
64558830|NCT04410588|Anesthetics|anesthetics|mesh-ancestor
64558831|NCT04410588|Anesthetics, Local|anesthetics, local|mesh-ancestor
64558832|NCT05303220|Branebrutinib|branebrutinib|mesh-list
64558833|NCT05303220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64558834|NCT05303220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558835|NCT05303220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558836|NCT04444830|Ketorolac|ketorolac|mesh-list
64558837|NCT04444830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64558838|NCT04444830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64558839|NCT04444830|Analgesics|analgesics|mesh-ancestor
64558840|NCT04444830|Sensory System Agents|sensory system agents|mesh-ancestor
64558841|NCT04444830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64558842|NCT04444830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558843|NCT04444830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64558844|NCT04444830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64558845|NCT04444830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64558846|NCT04444830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558847|NCT04444830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558874|NCT03739619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64558875|NCT03739619|Immunologic Factors|immunologic factors|mesh-ancestor
64558876|NCT03739619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558877|NCT03739619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64558878|NCT03739619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64558879|NCT03739619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64558880|NCT03739619|Alkylating Agents|alkylating agents|mesh-ancestor
64558881|NCT03738917|Bromides|bromides|mesh-list
64558882|NCT03738917|Dextromethorphan|dextromethorphan|mesh-list
64558883|NCT03738917|Ipratropium|ipratropium|mesh-list
64558884|NCT03738917|Cholinergic Antagonists|cholinergic antagonists|mesh-list
64558885|NCT03738917|Anticonvulsants|anticonvulsants|mesh-ancestor
64558886|NCT03738917|Antitussive Agents|antitussive agents|mesh-ancestor
64558887|NCT03738917|Respiratory System Agents|respiratory system agents|mesh-ancestor
64558888|NCT03738917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64558889|NCT03738917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64558890|NCT03738917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64558891|NCT03738917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558892|NCT03738917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558904|NCT00976599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64558906|NCT00976599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558907|NCT00976599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558908|NCT00976599|Dermatologic Agents|dermatologic agents|mesh-ancestor
64558909|NCT00976599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558910|NCT00976599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64558911|NCT00976599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64558912|NCT00976599|Immunologic Factors|immunologic factors|mesh-ancestor
64558913|NCT00976599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64558914|NCT00976599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64558915|NCT00976599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64558917|NCT02630472|Antimalarials|antimalarials|mesh-ancestor
64558918|NCT02630472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64558919|NCT02630472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64558920|NCT02630472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64558921|NCT02630472|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64558940|NCT05264922|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64558941|NCT05264922|Hemostatics|hemostatics|mesh-ancestor
64558942|NCT05264922|Coagulants|coagulants|mesh-ancestor
64558944|NCT03728933|Dopamine Agonists|dopamine agonists|mesh-ancestor
64558945|NCT03728933|Dopamine Agents|dopamine agents|mesh-ancestor
64558946|NCT03728933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64558947|NCT03728933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558948|NCT03728933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558949|NCT03727061|Carboplatin|carboplatin|mesh-list
64558950|NCT03727061|Pembrolizumab|pembrolizumab|mesh-list
64558951|NCT03727061|Fluorouracil|fluorouracil|mesh-list
64558952|NCT03727061|Nivolumab|nivolumab|mesh-list
64558953|NCT03727061|Cetuximab|cetuximab|mesh-list
64558954|NCT03727061|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
64558955|NCT03727061|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
64558956|NCT03727061|Trioxsalen|trioxsalen|mesh-list
64558957|NCT03727061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558958|NCT03727061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64558959|NCT03727061|Antimetabolites|antimetabolites|mesh-ancestor
64558960|NCT03727061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558961|NCT03727061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64558963|NCT03727061|Immunologic Factors|immunologic factors|mesh-ancestor
64558964|NCT03727061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558965|NCT03727061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64558966|NCT03727061|Dermatologic Agents|dermatologic agents|mesh-ancestor
64558967|NCT03727061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64558969|NCT00977769|Carbetocin|carbetocin|mesh-list
64558970|NCT00977769|Oxytocics|oxytocics|mesh-ancestor
64558971|NCT00977769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64558981|NCT00979017|Irinotecan|irinotecan|mesh-list
64558984|NCT00979017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64558985|NCT00979017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64558986|NCT00979017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64558987|NCT00979017|Growth Substances|growth substances|mesh-ancestor
64558988|NCT00979017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558989|NCT00979017|Growth Inhibitors|growth inhibitors|mesh-ancestor
64558990|NCT00979017|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64558991|NCT00979017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64558992|NCT00979017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558993|NCT00979017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64558994|NCT00979017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64588914|NCT00219284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64558995|NCT00979017|Alkylating Agents|alkylating agents|mesh-ancestor
64558996|NCT01670526|Rivastigmine|rivastigmine|mesh-list
64558997|NCT01670526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
64558998|NCT01670526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64558999|NCT01670526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559000|NCT01670526|Cholinergic Agents|cholinergic agents|mesh-ancestor
64559001|NCT01670526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64559002|NCT01670526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559003|NCT01670526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64559004|NCT01670526|Protective Agents|protective agents|mesh-ancestor
64559005|NCT00945035|Etoricoxib|etoricoxib|mesh-list
64559006|NCT00945035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64559007|NCT00945035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64559008|NCT00945035|Analgesics|analgesics|mesh-ancestor
64559009|NCT00945035|Sensory System Agents|sensory system agents|mesh-ancestor
64559010|NCT00945035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559011|NCT00945035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559012|NCT00945035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64559013|NCT00945035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64559014|NCT00945035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64559015|NCT00945035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64559016|NCT00945035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64559017|NCT00945035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559019|NCT03720431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64559020|NCT03720431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559040|NCT03719105|Alkylating Agents|alkylating agents|mesh-ancestor
64559041|NCT03719105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559042|NCT03719105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559043|NCT03719105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64559044|NCT03719105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64559045|NCT03719105|Antiemetics|antiemetics|mesh-ancestor
64559046|NCT03719105|Autonomic Agents|autonomic agents|mesh-ancestor
64559047|NCT03719105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559048|NCT03719105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64559049|NCT03719105|Glucocorticoids|glucocorticoids|mesh-ancestor
64559050|NCT03719105|Hormones|hormones|mesh-ancestor
64559051|NCT03719105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64559052|NCT03719105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64344857|NCT05062031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64559054|NCT03719105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64559055|NCT03719105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64559056|NCT03719105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64559057|NCT03719105|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64559058|NCT03719105|Abortifacient Agents|abortifacient agents|mesh-ancestor
64559059|NCT03719105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64559060|NCT03719105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64559061|NCT03719105|Antimetabolites|antimetabolites|mesh-ancestor
64559062|NCT03719105|Dermatologic Agents|dermatologic agents|mesh-ancestor
64559063|NCT03719105|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64559064|NCT03719105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64559065|NCT03719105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64559066|NCT03719105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64559067|NCT00979875|Insulin|insulin|mesh-list
64559068|NCT00979875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64559069|NCT00979875|Insulin Aspart|insulin aspart|mesh-list
64559070|NCT00979875|Insulin Lispro|insulin lispro|mesh-list
64559071|NCT00979875|Insulin glulisine|insulin glulisine|mesh-list
64559072|NCT00979875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64559073|NCT00979875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559074|NCT03710603|Dexamethasone|dexamethasone|mesh-list
64559075|NCT03710603|Dexamethasone acetate|dexamethasone acetate|mesh-list
64559076|NCT03710603|Lenalidomide|lenalidomide|mesh-list
64559077|NCT03710603|Bortezomib|bortezomib|mesh-list
64559078|NCT03710603|Daratumumab|daratumumab|mesh-list
64559079|NCT03710603|BB 1101|bb 1101|mesh-list
64559080|NCT03710603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64559081|NCT03710603|Antiemetics|antiemetics|mesh-ancestor
64559082|NCT03710603|Autonomic Agents|autonomic agents|mesh-ancestor
64559083|NCT03710603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559090|NCT03710603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559091|NCT03710603|Protease Inhibitors|protease inhibitors|mesh-ancestor
64559092|NCT03710603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64559093|NCT03710603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559094|NCT03710603|Immunologic Factors|immunologic factors|mesh-ancestor
64559095|NCT03710603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64559096|NCT03710603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64559097|NCT03710603|Growth Substances|growth substances|mesh-ancestor
64559098|NCT03710603|Growth Inhibitors|growth inhibitors|mesh-ancestor
64559099|NCT02630706|Metformin|metformin|mesh-list
64559100|NCT02630706|Glimepiride|glimepiride|mesh-list
64559101|NCT02630706|Ertugliflozin|ertugliflozin|mesh-list
64559102|NCT02630706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64559103|NCT02630706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559104|NCT02630706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64559105|NCT02630706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64559106|NCT02630706|Immunologic Factors|immunologic factors|mesh-ancestor
64559107|NCT02630706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64559108|NCT02630706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559109|NCT03709043|Ethanol|ethanol|mesh-list
64559110|NCT03709043|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64559111|NCT03709043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64559112|NCT03709043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64559113|NCT03709043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559114|NCT03707951|Acetylcysteine|acetylcysteine|mesh-list
64559116|NCT03707951|Antiviral Agents|antiviral agents|mesh-ancestor
64559117|NCT03707951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64559118|NCT03707951|Expectorants|expectorants|mesh-ancestor
64559119|NCT03707951|Respiratory System Agents|respiratory system agents|mesh-ancestor
64559120|NCT03707951|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64559121|NCT03707951|Antioxidants|antioxidants|mesh-ancestor
64559122|NCT03707951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559123|NCT03707951|Protective Agents|protective agents|mesh-ancestor
64559124|NCT03707951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559127|NCT04763057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64559128|NCT04763057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559129|NCT03702179|Durvalumab|durvalumab|mesh-list
64559130|NCT03702179|Tremelimumab|tremelimumab|mesh-list
64559131|NCT03702179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64559132|NCT03702179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559133|NCT03695237|Leuprolide|leuprolide|mesh-list
64559134|NCT03695237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64559135|NCT03695237|Fertility Agents|fertility agents|mesh-ancestor
64559136|NCT03695237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64559137|NCT03695237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559138|NCT03695237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64559139|NCT03695237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559140|NCT01677143|Bupivacaine|bupivacaine|mesh-list
64559141|NCT01677143|Anesthetics, Local|anesthetics, local|mesh-ancestor
64559142|NCT01677143|Anesthetics|anesthetics|mesh-ancestor
64559143|NCT01677143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64559144|NCT01677143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559145|NCT01677143|Sensory System Agents|sensory system agents|mesh-ancestor
64559146|NCT01677143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64344962|NCT03525509|Morphine|morphine|mesh-list
64559180|NCT03685331|Palbociclib|palbociclib|mesh-list
64559181|NCT03685331|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64559182|NCT03685331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64559183|NCT03685331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559184|NCT03685331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559185|NCT03685331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64559186|NCT03685331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64559187|NCT03685331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64559188|NCT03685331|Hormone Antagonists|hormone antagonists|mesh-ancestor
64559189|NCT03685331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64559190|NCT03685331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559191|NCT03685331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64559203|NCT04626024|Imatinib Mesylate|imatinib mesylate|mesh-list
64559204|NCT04626024|Dasatinib|dasatinib|mesh-list
64559205|NCT04626024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559206|NCT04626024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64559207|NCT04626024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64559208|NCT04626024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559209|NCT00981045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64559210|NCT00981045|Hematinics|hematinics|mesh-ancestor
64559211|NCT00981435|Prednisolone|prednisolone|mesh-list
64559212|NCT00981435|Prednisolone acetate|prednisolone acetate|mesh-list
64559213|NCT00981435|Ketorolac|ketorolac|mesh-list
64559214|NCT00981435|Lubricant Eye Drops|lubricant eye drops|mesh-list
64559215|NCT00981435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64559216|NCT00981435|Glucocorticoids|glucocorticoids|mesh-ancestor
64559217|NCT00981435|Hormones|hormones|mesh-ancestor
64559218|NCT00981435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64559219|NCT00981435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559220|NCT00981435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64559221|NCT00981435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559222|NCT00981435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559223|NCT00981435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64559224|NCT00981435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64559225|NCT00981435|Analgesics|analgesics|mesh-ancestor
64559226|NCT00981435|Sensory System Agents|sensory system agents|mesh-ancestor
64559227|NCT00981435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64559228|NCT00981435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64559229|NCT00981435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64559230|NCT00981435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559231|NCT00981435|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64559232|NCT00981435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64559233|NCT04571580|Reteplase|reteplase|mesh-list
64559234|NCT04571580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64559235|NCT04571580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64559236|NCT04571580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64559237|NCT04571580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559238|NCT00981669|Vaccines|vaccines|mesh-list
64559239|NCT00981669|Immunologic Factors|immunologic factors|mesh-ancestor
64559240|NCT00981669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345075|NCT04666636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559248|NCT03675737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559250|NCT03675737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64559251|NCT03675737|Immunologic Factors|immunologic factors|mesh-ancestor
64559252|NCT03675737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559253|NCT00981825|Listerine|listerine|mesh-list
64559254|NCT00981825|Triclosan|triclosan|mesh-list
64559255|NCT00981825|Fluorides|fluorides|mesh-list
64559256|NCT00981825|Sodium Fluoride|sodium fluoride|mesh-list
64559257|NCT00981825|Cariostatic Agents|cariostatic agents|mesh-ancestor
64559258|NCT00981825|Protective Agents|protective agents|mesh-ancestor
64314292|NCT01368497|Entecavir|entecavir|mesh-list
64559259|NCT00981825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559260|NCT00981825|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64559261|NCT00981825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64559262|NCT00981825|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64559263|NCT00981825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64559264|NCT00981825|Antimetabolites|antimetabolites|mesh-ancestor
64345118|NCT05198362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64559265|NCT00981825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559266|NCT00981825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64559267|NCT00983307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64559268|NCT00983307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559269|NCT00983307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64559270|NCT00983307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64559271|NCT00983307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559272|NCT04762745|Thalidomide|thalidomide|mesh-list
64559273|NCT04762745|Dexamethasone|dexamethasone|mesh-list
64559274|NCT04762745|Dexamethasone acetate|dexamethasone acetate|mesh-list
64559275|NCT04762745|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64559276|NCT04762745|Pomalidomide|pomalidomide|mesh-list
64559277|NCT04762745|BB 1101|bb 1101|mesh-list
64559278|NCT04762745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64559279|NCT04762745|Antiemetics|antiemetics|mesh-ancestor
64559280|NCT04762745|Autonomic Agents|autonomic agents|mesh-ancestor
64559281|NCT04762745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559296|NCT04762745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64559297|NCT04762745|Growth Substances|growth substances|mesh-ancestor
64559298|NCT04762745|Growth Inhibitors|growth inhibitors|mesh-ancestor
64559299|NCT04762745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64559300|NCT04762745|Leprostatic Agents|leprostatic agents|mesh-ancestor
64559301|NCT04762745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64559302|NCT04762745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64559303|NCT00983541|Gemcitabine|gemcitabine|mesh-list
64559304|NCT00983541|Fluorouracil|fluorouracil|mesh-list
64559305|NCT00983541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64559306|NCT00983541|Antimetabolites|antimetabolites|mesh-ancestor
64559307|NCT00983541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559308|NCT00983541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559309|NCT00983541|Antiviral Agents|antiviral agents|mesh-ancestor
64559310|NCT00983541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64559311|NCT00983541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64559312|NCT00983541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64559313|NCT00983541|Immunologic Factors|immunologic factors|mesh-ancestor
64559314|NCT00983541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559315|NCT03667703|Famotidine|famotidine|mesh-list
64559316|NCT03667703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64559317|NCT03667703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64559318|NCT03667703|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64559348|NCT03656549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559350|NCT03656549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64559351|NCT03062904|Methacholine Chloride|methacholine chloride|mesh-list
64559352|NCT03062904|Bronchodilator Agents|bronchodilator agents|mesh-list
64559353|NCT03062904|Miotics|miotics|mesh-ancestor
64559354|NCT03062904|Autonomic Agents|autonomic agents|mesh-ancestor
64559355|NCT03062904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559356|NCT03062904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559357|NCT03062904|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64559358|NCT03062904|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
64559359|NCT03062904|Respiratory System Agents|respiratory system agents|mesh-ancestor
64559360|NCT03062904|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64559361|NCT03062904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64559362|NCT03062904|Cholinergic Agents|cholinergic agents|mesh-ancestor
64559363|NCT03062904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64559364|NCT03062904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559365|NCT03062904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64559366|NCT00986583|Succinylcholine|succinylcholine|mesh-list
64559367|NCT00986583|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
64559368|NCT00986583|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64559369|NCT00986583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64559370|NCT00986583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559371|NCT00986583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559373|NCT05056974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64559374|NCT05056974|Antiviral Agents|antiviral agents|mesh-ancestor
64559375|NCT05056974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64559376|NCT03643913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
64559377|NCT03643913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64559378|NCT03643913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559379|NCT03643913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559380|NCT04762511|Vaccines|vaccines|mesh-list
64559381|NCT04762511|Immunologic Factors|immunologic factors|mesh-ancestor
64559389|NCT04762901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559390|NCT04762901|Tubulin Modulators|tubulin modulators|mesh-ancestor
64559391|NCT04762901|Antimitotic Agents|antimitotic agents|mesh-ancestor
64559392|NCT04762901|Mitosis Modulators|mitosis modulators|mesh-ancestor
64559393|NCT04762901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559394|NCT04762901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64559395|NCT04762901|Immunologic Factors|immunologic factors|mesh-ancestor
64559396|NCT04762901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559397|NCT04762901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64559398|NCT04762901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64559399|NCT04762901|Alkylating Agents|alkylating agents|mesh-ancestor
64559400|NCT04762901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64345248|NCT03275285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64345250|NCT04821778|Paclitaxel|paclitaxel|mesh-list
64559401|NCT04762901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64559402|NCT04762901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64559403|NCT04762901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64559404|NCT04762901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64559405|NCT04762901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64559407|NCT00988143|Immunologic Factors|immunologic factors|mesh-ancestor
64559408|NCT00988143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559409|NCT04491942|Gemcitabine|gemcitabine|mesh-list
64559410|NCT04491942|Cisplatin|cisplatin|mesh-list
64559411|NCT04491942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559412|NCT04491942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64559413|NCT04491942|Antimetabolites|antimetabolites|mesh-ancestor
64559414|NCT04491942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559415|NCT04491942|Antiviral Agents|antiviral agents|mesh-ancestor
64559438|NCT03018171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64559439|NCT03018171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64559440|NCT03018171|Adrenergic Agents|adrenergic agents|mesh-ancestor
64559441|NCT03018171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64559442|NCT03018171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559443|NCT03638375|Interferons|interferons|mesh-list
64559444|NCT03638375|Interferon-alpha|interferon-alpha|mesh-list
64559445|NCT03638375|Nivolumab|nivolumab|mesh-list
64559446|NCT03638375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64559447|NCT03638375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559448|NCT03638375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64559449|NCT03638375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559450|NCT03638375|Antiviral Agents|antiviral agents|mesh-ancestor
64559451|NCT03638375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64559452|NCT03638375|Immunologic Factors|immunologic factors|mesh-ancestor
64559453|NCT03638375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559454|NCT00989157|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64559455|NCT00989157|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64370469|NCT02449603|Hormones|hormones|mesh-ancestor
64559456|NCT00989157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64559457|NCT00989157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64559458|NCT00989157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559459|NCT00989157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64559460|NCT00989157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559461|NCT00989157|Analgesics|analgesics|mesh-ancestor
64559462|NCT00989157|Sensory System Agents|sensory system agents|mesh-ancestor
64559463|NCT00989157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559464|NCT00989157|Antidepressive Agents|antidepressive agents|mesh-ancestor
64559465|NCT00989157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64559486|NCT03018015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559488|NCT03614741|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64559489|NCT03614741|Dalteparin|dalteparin|mesh-list
64559490|NCT03614741|Anticoagulants|anticoagulants|mesh-ancestor
64559491|NCT03614741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64559492|NCT03614741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64559493|NCT03614741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559499|NCT03609593|Rituximab|rituximab|mesh-list
64559500|NCT03609593|Venetoclax|venetoclax|mesh-list
64559501|NCT03609593|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64559502|NCT03609593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64559503|NCT03609593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559507|NCT03609593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64559508|NCT03609593|Alkylating Agents|alkylating agents|mesh-ancestor
64559509|NCT03609593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559511|NCT00004547|Cisplatin|cisplatin|mesh-list
64559552|NCT02089997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64559553|NCT02089997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559554|NCT02089997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64559555|NCT01363661|Molsidomine|molsidomine|mesh-list
64559556|NCT01363661|Vasodilator Agents|vasodilator agents|mesh-ancestor
64559557|NCT01363661|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64559558|NCT01363661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559559|NCT03598595|Gemcitabine|gemcitabine|mesh-list
64559560|NCT03598595|Hydroxychloroquine|hydroxychloroquine|mesh-list
64559562|NCT03598595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64559563|NCT03598595|Antimetabolites|antimetabolites|mesh-ancestor
64559564|NCT03598595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559565|NCT03598595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559566|NCT03598595|Antiviral Agents|antiviral agents|mesh-ancestor
64559567|NCT03598595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64559568|NCT03598595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64559569|NCT03598595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64559570|NCT03598595|Immunologic Factors|immunologic factors|mesh-ancestor
64559571|NCT03598595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559572|NCT03598595|Tubulin Modulators|tubulin modulators|mesh-ancestor
64559573|NCT03598595|Antimitotic Agents|antimitotic agents|mesh-ancestor
64559574|NCT03598595|Mitosis Modulators|mitosis modulators|mesh-ancestor
64559575|NCT03598595|Antimalarials|antimalarials|mesh-ancestor
64559576|NCT03598595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64559577|NCT03598595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64559578|NCT03598595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64559579|NCT02628600|Amikacin|amikacin|mesh-list
64559582|NCT00006101|Eflornithine|eflornithine|mesh-list
64559598|NCT04294134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559599|NCT04294134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559600|NCT04437888|Ketamine|ketamine|mesh-list
64559601|NCT04437888|Analgesics|analgesics|mesh-ancestor
64559602|NCT04437888|Sensory System Agents|sensory system agents|mesh-ancestor
64559603|NCT04437888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559604|NCT04437888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559605|NCT04437888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64559606|NCT04437888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64559607|NCT04437888|Anesthetics, General|anesthetics, general|mesh-ancestor
64559608|NCT04437888|Anesthetics|anesthetics|mesh-ancestor
64559609|NCT04437888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64559610|NCT04437888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64559611|NCT04437888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64559612|NCT04437888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64559613|NCT04437888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559614|NCT00591318|Ceftriaxone|ceftriaxone|mesh-list
64559615|NCT00591318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64559616|NCT00591318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64559617|NCT00991029|Clopidogrel|clopidogrel|mesh-list
64559618|NCT00991029|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64559619|NCT00991029|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64559620|NCT00991029|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64559621|NCT00991029|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64559622|NCT00991029|Purinergic Agents|purinergic agents|mesh-ancestor
64559645|NCT00991809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64559646|NCT00991809|Antipruritics|antipruritics|mesh-ancestor
64559647|NCT00991809|Dermatologic Agents|dermatologic agents|mesh-ancestor
64559648|NCT00991809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64559649|NCT00991809|Narcotics|narcotics|mesh-ancestor
64559650|NCT00991809|Analgesics|analgesics|mesh-ancestor
64559651|NCT00991809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64559652|NCT00991809|Anesthetics, General|anesthetics, general|mesh-ancestor
64559653|NCT02627274|Trastuzumab|trastuzumab|mesh-list
64559654|NCT02627274|Cetuximab|cetuximab|mesh-list
64559655|NCT02627274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64559656|NCT02627274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559657|NCT04982016|Methamphetamine|methamphetamine|mesh-list
64559658|NCT04982016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64559659|NCT04982016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559660|NCT04982016|Sympathomimetics|sympathomimetics|mesh-ancestor
64559661|NCT04982016|Autonomic Agents|autonomic agents|mesh-ancestor
64559662|NCT04982016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559663|NCT04982016|Dopamine Agents|dopamine agents|mesh-ancestor
64559664|NCT04982016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64559665|NCT04982016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559666|NCT04982016|Adrenergic Agents|adrenergic agents|mesh-ancestor
64559667|NCT04982016|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64559668|NCT04982016|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64559669|NCT04982016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64559670|NCT04982016|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64559671|NCT04436250|Ketamine|ketamine|mesh-list
64559672|NCT04436250|Esketamine|esketamine|mesh-list
64559673|NCT04436250|Analgesics|analgesics|mesh-ancestor
64559674|NCT04436250|Sensory System Agents|sensory system agents|mesh-ancestor
64559675|NCT04436250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559676|NCT04436250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559677|NCT04436250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64559678|NCT04436250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64559679|NCT04436250|Anesthetics, General|anesthetics, general|mesh-ancestor
64559680|NCT04436250|Anesthetics|anesthetics|mesh-ancestor
64559685|NCT04436250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559686|NCT04436250|Antidepressive Agents|antidepressive agents|mesh-ancestor
64559687|NCT04436250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64559688|NCT00994929|Oprelvekin|oprelvekin|mesh-list
64559689|NCT00994929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559690|NCT00929253|Buprenorphine|buprenorphine|mesh-list
64559691|NCT00929253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64559693|NCT00929253|Narcotics|narcotics|mesh-ancestor
64559694|NCT00929253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64559695|NCT00929253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559696|NCT00929253|Analgesics|analgesics|mesh-ancestor
64559697|NCT00929253|Sensory System Agents|sensory system agents|mesh-ancestor
64559698|NCT00929253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559699|NCT00929253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64559700|NCT00771693|Insulin Aspart|insulin aspart|mesh-list
64559701|NCT00771693|Insulin, Long-Acting|insulin, long-acting|mesh-list
64559702|NCT00771693|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64559703|NCT00771693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64559704|NCT00771693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559705|NCT04374903|Sirolimus|sirolimus|mesh-list
64559707|NCT04374903|Hydroxychloroquine|hydroxychloroquine|mesh-list
64559708|NCT04374903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64559709|NCT04374903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64559710|NCT04374903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64559711|NCT04374903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559712|NCT04374903|Antifungal Agents|antifungal agents|mesh-ancestor
64559713|NCT04374903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64559714|NCT04374903|Immunologic Factors|immunologic factors|mesh-ancestor
64559715|NCT04374903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559716|NCT04374903|Antimalarials|antimalarials|mesh-ancestor
64559717|NCT04374903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64559731|NCT00995475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64370762|NCT03070665|Norepinephrine|norepinephrine|mesh-list
64559732|NCT00995475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64559733|NCT00995475|Autonomic Agents|autonomic agents|mesh-ancestor
64559734|NCT00995475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559735|NCT00995475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559736|NCT00995475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64559737|NCT00995475|Respiratory System Agents|respiratory system agents|mesh-ancestor
64559738|NCT00995475|Dermatologic Agents|dermatologic agents|mesh-ancestor
64559739|NCT00995475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64559741|NCT03062436|Cariostatic Agents|cariostatic agents|mesh-ancestor
64559742|NCT03062436|Protective Agents|protective agents|mesh-ancestor
64559743|NCT03062436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559744|NCT03500874|Leucovorin|leucovorin|mesh-list
64559745|NCT03500874|Fluorouracil|fluorouracil|mesh-list
64559746|NCT03500874|Floxuridine|floxuridine|mesh-list
64559747|NCT03500874|Oxaliplatin|oxaliplatin|mesh-list
64559748|NCT03500874|Antimetabolites|antimetabolites|mesh-ancestor
64559749|NCT03500874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559750|NCT03500874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64559751|NCT03500874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559752|NCT03500874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64559753|NCT03500874|Immunologic Factors|immunologic factors|mesh-ancestor
64559754|NCT03500874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559755|NCT03500874|Antidotes|antidotes|mesh-ancestor
64559756|NCT03500874|Protective Agents|protective agents|mesh-ancestor
64559757|NCT03500874|Vitamin B Complex|vitamin b complex|mesh-ancestor
64559758|NCT03500874|Vitamins|vitamins|mesh-ancestor
64559759|NCT03500874|Micronutrients|micronutrients|mesh-ancestor
64559760|NCT00997113|Alfentanil|alfentanil|mesh-list
64559762|NCT00997113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64559763|NCT00997113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64559764|NCT00997113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559765|NCT00997113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64559766|NCT00997113|Anesthetics, General|anesthetics, general|mesh-ancestor
64559767|NCT00997113|Anesthetics|anesthetics|mesh-ancestor
64559770|NCT00997113|Analgesics|analgesics|mesh-ancestor
64559771|NCT00997113|Sensory System Agents|sensory system agents|mesh-ancestor
64559772|NCT00997113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559773|NCT04981704|Itraconazole|itraconazole|mesh-list
64559774|NCT04981704|Phenytoin|phenytoin|mesh-list
64559775|NCT04981704|Paroxetine|paroxetine|mesh-list
64559776|NCT04981704|Antifungal Agents|antifungal agents|mesh-ancestor
64559777|NCT04981704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64559778|NCT04981704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64559779|NCT04981704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64559780|NCT04981704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64559781|NCT04981704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559782|NCT04981704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64559783|NCT04981704|Hormone Antagonists|hormone antagonists|mesh-ancestor
64559784|NCT04981704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64559785|NCT04981704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559786|NCT04981704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64559787|NCT04981704|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64559788|NCT04981704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64559789|NCT04981704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64559790|NCT04981704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64559791|NCT04981704|Serotonin Agents|serotonin agents|mesh-ancestor
64559792|NCT04981704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64559793|NCT04981704|Antidepressive Agents|antidepressive agents|mesh-ancestor
64559794|NCT04981704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64559795|NCT04981704|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64559796|NCT04981704|Anticonvulsants|anticonvulsants|mesh-ancestor
64559797|NCT04981704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64559798|NCT04981704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64559799|NCT04981704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64559812|NCT04974060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559813|NCT01021761|Ketorolac|ketorolac|mesh-list
64559814|NCT01021761|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64559815|NCT01021761|Nepafenac|nepafenac|mesh-list
64559816|NCT01021761|Bromfenac|bromfenac|mesh-list
64559817|NCT01021761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64559818|NCT01021761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64559819|NCT01021761|Analgesics|analgesics|mesh-ancestor
64559820|NCT01021761|Sensory System Agents|sensory system agents|mesh-ancestor
64559821|NCT01021761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559822|NCT01021761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559823|NCT01021761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64559824|NCT01021761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64559825|NCT01021761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64559826|NCT01021761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64559829|NCT04973904|Bevacizumab|bevacizumab|mesh-list
64559830|NCT04973904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64559831|NCT04973904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64559832|NCT04973904|Tubulin Modulators|tubulin modulators|mesh-ancestor
64559833|NCT04973904|Antimitotic Agents|antimitotic agents|mesh-ancestor
64559834|NCT04973904|Mitosis Modulators|mitosis modulators|mesh-ancestor
64559835|NCT04973904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559836|NCT04973904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64559837|NCT04973904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64559838|NCT04973904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64559842|NCT00998049|Plerixafor|plerixafor|mesh-list
64559856|NCT00998205|Autonomic Agents|autonomic agents|mesh-ancestor
64559857|NCT00998205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559858|NCT00998205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559859|NCT00998205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64559860|NCT00998205|Respiratory System Agents|respiratory system agents|mesh-ancestor
64559861|NCT00998205|Mydriatics|mydriatics|mesh-ancestor
64559862|NCT00998205|Parasympatholytics|parasympatholytics|mesh-ancestor
64559863|NCT00998205|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64559864|NCT00998205|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64559865|NCT00998205|Cholinergic Agents|cholinergic agents|mesh-ancestor
64559866|NCT00998205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64559867|NCT00998205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559868|NCT00998205|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64559869|NCT00998205|Sympathomimetics|sympathomimetics|mesh-ancestor
64559870|NCT00998205|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64559871|NCT00998205|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64559872|NCT00998205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64559873|NCT00998205|Adrenergic Agents|adrenergic agents|mesh-ancestor
64559874|NCT00998205|Protective Agents|protective agents|mesh-ancestor
64559875|NCT02626182|Sildenafil Citrate|sildenafil citrate|mesh-list
64559876|NCT02626182|Vasodilator Agents|vasodilator agents|mesh-ancestor
64559877|NCT02626182|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64559878|NCT02626182|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64559879|NCT02626182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64559880|NCT02626182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559881|NCT02626182|Urological Agents|urological agents|mesh-ancestor
64559882|NCT01023477|Chloroquine|chloroquine|mesh-list
64559883|NCT01023477|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64559884|NCT01023477|Amebicides|amebicides|mesh-ancestor
64559885|NCT01023477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64559886|NCT01023477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64559898|NCT01023477|Antinematodal Agents|antinematodal agents|mesh-ancestor
64559899|NCT01023477|Anthelmintics|anthelmintics|mesh-ancestor
64559901|NCT01023711|Immunologic Factors|immunologic factors|mesh-ancestor
64559907|NCT01001403|Sensory System Agents|sensory system agents|mesh-ancestor
64559908|NCT01001403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559909|NCT01001403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559910|NCT01001403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64559911|NCT01001403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64559912|NCT01001403|Anticoagulants|anticoagulants|mesh-ancestor
64559913|NCT01001403|Protease Inhibitors|protease inhibitors|mesh-ancestor
64559914|NCT01001403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64559915|NCT01001403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559916|NCT01001403|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64559917|NCT01001403|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64559918|NCT01001403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64559919|NCT01001403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64559920|NCT01001403|Immunologic Factors|immunologic factors|mesh-ancestor
64559921|NCT01024335|Naltrexone|naltrexone|mesh-list
64559922|NCT01024335|Dronabinol|dronabinol|mesh-list
64559923|NCT01024335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64559924|NCT01024335|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64559925|NCT01024335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559926|NCT01024335|Sensory System Agents|sensory system agents|mesh-ancestor
64559927|NCT01024335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559928|NCT01024335|Hallucinogens|hallucinogens|mesh-ancestor
64559929|NCT01024335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64371009|NCT04359017|Lidocaine|lidocaine|mesh-list
64559930|NCT01024335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64559931|NCT01024335|Analgesics|analgesics|mesh-ancestor
64559932|NCT01024335|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64559933|NCT01024335|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64559934|NCT01024335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64559935|NCT01024335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559936|NCT01024335|Hormones|hormones|mesh-ancestor
64559937|NCT01024335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64559938|NCT01001559|Norepinephrine|norepinephrine|mesh-list
64559939|NCT01001559|Serotonin|serotonin|mesh-list
64559940|NCT01001559|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
64559941|NCT01001559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
64559942|NCT01001559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64559943|NCT01001559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64559944|NCT01001559|Adrenergic Agents|adrenergic agents|mesh-ancestor
64559945|NCT01001559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64559946|NCT01001559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559947|NCT01001559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559948|NCT01001559|Sympathomimetics|sympathomimetics|mesh-ancestor
64559949|NCT01001559|Autonomic Agents|autonomic agents|mesh-ancestor
64559950|NCT01001559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559951|NCT01001559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64559952|NCT01001559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64559953|NCT01001559|Serotonin Agents|serotonin agents|mesh-ancestor
64559954|NCT01001559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64559955|NCT01001559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64559956|NCT01025427|Tenofovir|tenofovir|mesh-list
64559957|NCT01025427|Emtricitabine|emtricitabine|mesh-list
64559958|NCT01025427|Raltegravir Potassium|raltegravir potassium|mesh-list
64559959|NCT01025427|Antiviral Agents|antiviral agents|mesh-ancestor
64559960|NCT01025427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64559961|NCT01025427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64559963|NCT01025427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64559975|NCT02162433|Sensory System Agents|sensory system agents|mesh-ancestor
64559976|NCT02162433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64559977|NCT02162433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64559978|NCT02162433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64559979|NCT02162433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64559980|NCT02162433|Adrenergic Agents|adrenergic agents|mesh-ancestor
64559981|NCT02162433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64559982|NCT02162433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64559983|NCT03404661|Secretin|secretin|mesh-list
64559984|NCT03404661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64559985|NCT03404661|Hormones|hormones|mesh-ancestor
64559986|NCT03404661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64559987|NCT03404661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559988|NCT01004991|Prednisone|prednisone|mesh-list
64559989|NCT01004991|Cyclophosphamide|cyclophosphamide|mesh-list
64559990|NCT01004991|Rituximab|rituximab|mesh-list
64559991|NCT01004991|Doxorubicin|doxorubicin|mesh-list
64559992|NCT01004991|Vincristine|vincristine|mesh-list
64559993|NCT01004991|Azacitidine|azacitidine|mesh-list
64559994|NCT01004991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64559995|NCT01004991|Immunologic Factors|immunologic factors|mesh-ancestor
64559996|NCT01004991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64559997|NCT01004991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64559998|NCT01004991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64559999|NCT01004991|Alkylating Agents|alkylating agents|mesh-ancestor
64589012|NCT00509665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64560000|NCT01004991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560001|NCT01004991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560002|NCT01004991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64560003|NCT01004991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64560004|NCT01004991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64345414|NCT03875092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64345416|NCT02728102|Melphalan|melphalan|mesh-list
64560017|NCT01004991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64560018|NCT01004991|Antimetabolites|antimetabolites|mesh-ancestor
64560020|NCT03115047|Dexmedetomidine|dexmedetomidine|mesh-list
64560021|NCT03115047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64560022|NCT03115047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64560023|NCT03115047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560024|NCT03115047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64560025|NCT03115047|Analgesics|analgesics|mesh-ancestor
64560026|NCT03115047|Sensory System Agents|sensory system agents|mesh-ancestor
64560027|NCT03115047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560028|NCT03115047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64560029|NCT03115047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64560030|NCT03115047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64560031|NCT03115047|Adrenergic Agents|adrenergic agents|mesh-ancestor
64560032|NCT03115047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64560033|NCT03115047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560034|NCT03115047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64560035|NCT03115047|Narcotics|narcotics|mesh-ancestor
64560036|NCT03115047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64560037|NCT01026909|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64560038|NCT01026909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64560039|NCT03015519|rGLP-1 protein|rglp-1 protein|mesh-list
64560040|NCT03015519|Incretins|incretins|mesh-ancestor
64560041|NCT03015519|Hormones|hormones|mesh-ancestor
64560042|NCT03015519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64560043|NCT03015519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560044|NCT01030653|Voriconazole|voriconazole|mesh-list
64345466|NCT04193878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64345470|NCT02473250|Fluoxetine|fluoxetine|mesh-list
64560060|NCT01031043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560062|NCT01031043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64560063|NCT01031043|Cholinergic Agents|cholinergic agents|mesh-ancestor
64560064|NCT01031043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64560065|NCT01031043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560067|NCT01050153|Dalteparin|dalteparin|mesh-list
64560068|NCT01050153|Tinzaparin|tinzaparin|mesh-list
64560069|NCT01050153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64560070|NCT01050153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64560071|NCT01050153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64560072|NCT01050153|Analgesics|analgesics|mesh-ancestor
64560073|NCT01050153|Sensory System Agents|sensory system agents|mesh-ancestor
64560074|NCT01050153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560075|NCT01050153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560076|NCT01050153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64560077|NCT01050153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64560078|NCT01050153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64560079|NCT01050153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64560080|NCT01050153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560081|NCT01050153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64560082|NCT01050153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64560083|NCT01050153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560084|NCT01050153|Antipyretics|antipyretics|mesh-ancestor
64560085|NCT01050153|Anticoagulants|anticoagulants|mesh-ancestor
64560086|NCT04358133|Morphine|morphine|mesh-list
64560087|NCT04358133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64560088|NCT04358133|Narcotics|narcotics|mesh-ancestor
64589029|NCT00442169|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64560089|NCT04358133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64560090|NCT04358133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560091|NCT04358133|Analgesics|analgesics|mesh-ancestor
64560092|NCT04358133|Sensory System Agents|sensory system agents|mesh-ancestor
64560099|NCT04291209|Respiratory System Agents|respiratory system agents|mesh-ancestor
64560100|NCT04291209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64560101|NCT04291209|Antioxidants|antioxidants|mesh-ancestor
64560102|NCT04291209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560103|NCT04291209|Protective Agents|protective agents|mesh-ancestor
64560104|NCT04291209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560105|NCT04291209|Antidotes|antidotes|mesh-ancestor
64560106|NCT01032759|Memantine|memantine|mesh-list
64560107|NCT01032759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64560108|NCT01032759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64560109|NCT01032759|Dopamine Agents|dopamine agents|mesh-ancestor
64560110|NCT01032759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64560111|NCT01032759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560112|NCT01032759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560113|NCT01032759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64560114|NCT01032759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64560115|NCT01032993|Ubiquinone|ubiquinone|mesh-list
64560116|NCT01032993|Coenzyme Q10|coenzyme q10|mesh-list
64560117|NCT01032993|Micronutrients|micronutrients|mesh-ancestor
64560118|NCT01032993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560119|NCT01032993|Vitamins|vitamins|mesh-ancestor
64560120|NCT01033773|Metformin|metformin|mesh-list
64560121|NCT01033773|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64560122|NCT01033773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560123|NCT01053507|Naproxen|naproxen|mesh-list
64560124|NCT01053507|Sumatriptan|sumatriptan|mesh-list
64560125|NCT01053507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64560126|NCT01053507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64560127|NCT01053507|Analgesics|analgesics|mesh-ancestor
64560129|NCT01053507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560130|NCT01053507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560140|NCT01053507|Serotonin Agents|serotonin agents|mesh-ancestor
64560141|NCT01053507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64560143|NCT01053819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64560144|NCT01053819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64560145|NCT01053819|Analgesics|analgesics|mesh-ancestor
64560146|NCT01053819|Sensory System Agents|sensory system agents|mesh-ancestor
64560147|NCT01053819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560148|NCT01053819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560149|NCT01053819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64560150|NCT01053819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64560151|NCT01053819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64560152|NCT01053819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64560153|NCT01053819|Immunologic Factors|immunologic factors|mesh-ancestor
64560154|NCT01054911|Sunitinib|sunitinib|mesh-list
64560155|NCT01054911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560156|NCT01054911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64560157|NCT01054911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64560158|NCT01054911|Growth Substances|growth substances|mesh-ancestor
64560159|NCT01054911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560160|NCT01054911|Growth Inhibitors|growth inhibitors|mesh-ancestor
64560161|NCT01054911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64560162|NCT01054911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560163|NCT01054911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560164|NCT01055223|Troglitazone|troglitazone|mesh-list
64560165|NCT01055223|Amiloride|amiloride|mesh-list
64560166|NCT01055223|Spironolactone|spironolactone|mesh-list
64560167|NCT01055223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64560168|NCT01055223|Hormone Antagonists|hormone antagonists|mesh-ancestor
64560169|NCT01055223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64589043|NCT00216476|Dopamine Agents|dopamine agents|mesh-ancestor
64560170|NCT01055223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560171|NCT01055223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64560172|NCT01055223|Diuretics|diuretics|mesh-ancestor
64560173|NCT01055223|Natriuretic Agents|natriuretic agents|mesh-ancestor
64560179|NCT01055223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64560180|NCT02168361|Interferons|interferons|mesh-list
64560181|NCT02168361|Ribavirin|ribavirin|mesh-list
64560182|NCT02168361|Interferon-alpha|interferon-alpha|mesh-list
64560183|NCT02168361|Interferon alpha-2|interferon alpha-2|mesh-list
64560185|NCT02168361|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64560186|NCT02168361|Simeprevir|simeprevir|mesh-list
64560187|NCT02168361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560188|NCT02168361|Antiviral Agents|antiviral agents|mesh-ancestor
64560189|NCT02168361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64560190|NCT02168361|Antimetabolites|antimetabolites|mesh-ancestor
64560191|NCT02168361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560192|NCT02168361|Immunologic Factors|immunologic factors|mesh-ancestor
64560193|NCT02168361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560194|NCT02168361|Protease Inhibitors|protease inhibitors|mesh-ancestor
64560195|NCT02168361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560196|NCT01360554|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64560197|NCT01360554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560239|NCT02494986|Rilpivirine|rilpivirine|mesh-list
64560240|NCT02494986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64560241|NCT02494986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64560242|NCT02494986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560243|NCT02494986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560244|NCT02494986|Antiviral Agents|antiviral agents|mesh-ancestor
64560245|NCT02494986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64560246|NCT02494986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64560247|NCT02494986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64560249|NCT04152564|Levobupivacaine|levobupivacaine|mesh-list
64560250|NCT04152564|Anesthetics, Local|anesthetics, local|mesh-ancestor
64560251|NCT04152564|Anesthetics|anesthetics|mesh-ancestor
64560252|NCT04152564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64560253|NCT04152564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560254|NCT04152564|Sensory System Agents|sensory system agents|mesh-ancestor
64560255|NCT04152564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560256|NCT04977960|Canrenone|canrenone|mesh-list
64560257|NCT04977960|Canrenoic Acid|canrenoic acid|mesh-list
64560258|NCT04977960|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64560259|NCT04977960|Hormone Antagonists|hormone antagonists|mesh-ancestor
64560260|NCT04977960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64560261|NCT04977960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560262|NCT04977960|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64560263|NCT04977960|Diuretics|diuretics|mesh-ancestor
64560264|NCT04977960|Natriuretic Agents|natriuretic agents|mesh-ancestor
64560265|NCT05593809|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
64560266|NCT05593809|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64560267|NCT05593809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560269|NCT05593731|Antioxidants|antioxidants|mesh-ancestor
64560270|NCT05593731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560279|NCT01062165|Antifungal Agents|antifungal agents|mesh-ancestor
64560280|NCT01062165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64560281|NCT01062165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560282|NCT01062165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560283|NCT05592951|Methamphetamine|methamphetamine|mesh-list
64560284|NCT05592951|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64560285|NCT05592951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345759|NCT02440568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64345766|NCT01038778|Entinostat|entinostat|mesh-list
64560286|NCT05592951|Sympathomimetics|sympathomimetics|mesh-ancestor
64560287|NCT05592951|Autonomic Agents|autonomic agents|mesh-ancestor
64560288|NCT05592951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560289|NCT05592951|Dopamine Agents|dopamine agents|mesh-ancestor
64560290|NCT05592951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64560291|NCT05592951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560292|NCT05592951|Adrenergic Agents|adrenergic agents|mesh-ancestor
64560293|NCT05592951|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64560294|NCT05592951|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64560295|NCT05592951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64560296|NCT05592951|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64560298|NCT04041843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64560299|NCT04041843|Antithrombins|antithrombins|mesh-ancestor
64560300|NCT04041843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64560301|NCT04041843|Protease Inhibitors|protease inhibitors|mesh-ancestor
64560302|NCT04041843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560303|NCT04041843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560304|NCT04041843|Anticoagulants|anticoagulants|mesh-ancestor
64560305|NCT01068873|Ritonavir|ritonavir|mesh-list
64560306|NCT01068873|Lopinavir|lopinavir|mesh-list
64560325|NCT01072773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64560326|NCT01072773|Immunologic Factors|immunologic factors|mesh-ancestor
64560327|NCT01072773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560328|NCT01072773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64560329|NCT01072773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64560330|NCT01072773|Alkylating Agents|alkylating agents|mesh-ancestor
64414770|NCT02433483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64560331|NCT01072773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560332|NCT01072773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560333|NCT01072773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64560334|NCT01072773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64560337|NCT01072773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560338|NCT01072773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64560339|NCT01072773|Glucocorticoids|glucocorticoids|mesh-ancestor
64560340|NCT01072773|Hormones|hormones|mesh-ancestor
64560341|NCT01072773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64560342|NCT01072773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64560343|NCT03013647|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64560344|NCT03013647|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
64560345|NCT03013647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64560346|NCT03013647|Dermatologic Agents|dermatologic agents|mesh-ancestor
64560347|NCT01074177|Afatinib|afatinib|mesh-list
64560348|NCT01074177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560349|NCT01074177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64560350|NCT01074177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560351|NCT01074177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560352|NCT01076283|Cyproheptadine|cyproheptadine|mesh-list
64560353|NCT01076283|Baclofen|baclofen|mesh-list
64560354|NCT01076283|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64560355|NCT01076283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560359|NCT01076283|GABA Agonists|gaba agonists|mesh-ancestor
64560365|NCT01076283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64560366|NCT01076283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64345922|NCT04467125|Lidocaine|lidocaine|mesh-list
64560368|NCT01076283|Histamine Agents|histamine agents|mesh-ancestor
64560369|NCT01076283|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64560370|NCT01076283|Serotonin Agents|serotonin agents|mesh-ancestor
64560371|NCT01076283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64560372|NCT03805581|Defibrotide|defibrotide|mesh-list
64560373|NCT03805581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64560374|NCT03805581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64560375|NCT03805581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589057|NCT00515437|Cholinergic Agents|cholinergic agents|mesh-ancestor
64560376|NCT03805581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64560377|NCT01076985|Ritonavir|ritonavir|mesh-list
64560378|NCT01076985|Lopinavir|lopinavir|mesh-list
64560379|NCT01076985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64560380|NCT01076985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64560381|NCT01076985|Protease Inhibitors|protease inhibitors|mesh-ancestor
64560382|NCT01076985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560383|NCT01076985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560384|NCT01076985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64560385|NCT01076985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64560386|NCT01076985|Antiviral Agents|antiviral agents|mesh-ancestor
64560387|NCT01076985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64560388|NCT01076985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64560389|NCT01076985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64560390|NCT02176005|Moxifloxacin|moxifloxacin|mesh-list
64560391|NCT02176005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64560392|NCT02176005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64560393|NCT02176005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64560394|NCT02176005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64560395|NCT02176005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560396|NCT02176005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560397|NCT02176005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560398|NCT05539911|Fentanyl|fentanyl|mesh-list
64560405|NCT05539911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560406|NCT05539911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64560407|NCT05539911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64560408|NCT05539911|Anesthetics, General|anesthetics, general|mesh-ancestor
64560409|NCT05539911|Anesthetics|anesthetics|mesh-ancestor
64560410|NCT03589833|Methotrexate|methotrexate|mesh-list
64560411|NCT03589833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64560412|NCT03589833|Abortifacient Agents|abortifacient agents|mesh-ancestor
64560413|NCT03589833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64560414|NCT03589833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345938|NCT02692313|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64345939|NCT02692313|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64560417|NCT03589833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560418|NCT03589833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560419|NCT03589833|Dermatologic Agents|dermatologic agents|mesh-ancestor
64560420|NCT03589833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560421|NCT03589833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64560422|NCT03589833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64560423|NCT03589833|Immunologic Factors|immunologic factors|mesh-ancestor
64560424|NCT03589833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64560425|NCT03589833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64560426|NCT01077921|Propranolol|propranolol|mesh-list
64560427|NCT01077921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64560428|NCT01077921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64560429|NCT01077921|Adrenergic Agents|adrenergic agents|mesh-ancestor
64560430|NCT01077921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64560431|NCT01077921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560432|NCT01077921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560433|NCT01077921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64560434|NCT01077921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64560435|NCT01077921|Vasodilator Agents|vasodilator agents|mesh-ancestor
64560447|NCT03484299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560448|NCT05498181|Valsartan|valsartan|mesh-list
64560449|NCT05498181|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64560450|NCT05498181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64560451|NCT05498181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64560452|NCT05498181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64371630|NCT03301181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560453|NCT05498181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560454|NCT04970238|Simendan|simendan|mesh-list
64560455|NCT04970238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64560456|NCT04970238|Vasodilator Agents|vasodilator agents|mesh-ancestor
64560457|NCT04970238|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64560458|NCT04970238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64560459|NCT04970238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560461|NCT04970238|Protective Agents|protective agents|mesh-ancestor
64560502|NCT01081041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560503|NCT01081041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64560504|NCT01081041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64560505|NCT01081041|Immunologic Factors|immunologic factors|mesh-ancestor
64560506|NCT01081041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560507|NCT01081041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64560508|NCT03022617|Apremilast|apremilast|mesh-list
64560509|NCT03022617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64560510|NCT03022617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64560511|NCT03022617|Analgesics|analgesics|mesh-ancestor
64560512|NCT03022617|Sensory System Agents|sensory system agents|mesh-ancestor
64560513|NCT03022617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560514|NCT03022617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560515|NCT03022617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64560516|NCT03022617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64560517|NCT03022617|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64560518|NCT03022617|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64560519|NCT03022617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560520|NCT03022617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560521|NCT05427981|Buprenorphine|buprenorphine|mesh-list
64560522|NCT05427981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64560523|NCT05427981|Narcotics|narcotics|mesh-ancestor
64560524|NCT05427981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64560525|NCT05427981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560526|NCT05427981|Analgesics|analgesics|mesh-ancestor
64560527|NCT05427981|Sensory System Agents|sensory system agents|mesh-ancestor
64560528|NCT05427981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560529|NCT05427981|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64560530|NCT03001869|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64560531|NCT03001869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64560532|NCT03001869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560533|NCT02089685|Pembrolizumab|pembrolizumab|mesh-list
64560534|NCT02089685|Ipilimumab|ipilimumab|mesh-list
64560541|NCT01088295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64560542|NCT01088295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64560543|NCT01088295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560544|NCT01090479|Chlorhexidine|chlorhexidine|mesh-list
64560545|NCT01090479|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64560546|NCT01090479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64560547|NCT01090479|Disinfectants|disinfectants|mesh-ancestor
64560548|NCT04730609|Dexmedetomidine|dexmedetomidine|mesh-list
64560549|NCT04730609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64560550|NCT04730609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64560551|NCT04730609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560552|NCT04730609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64560553|NCT04730609|Analgesics|analgesics|mesh-ancestor
64560554|NCT04730609|Sensory System Agents|sensory system agents|mesh-ancestor
64560555|NCT04730609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560556|NCT04730609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64560557|NCT04730609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64560558|NCT04730609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64560559|NCT04730609|Adrenergic Agents|adrenergic agents|mesh-ancestor
64560560|NCT04730609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64560561|NCT04730609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560562|NCT03013335|Nivolumab|nivolumab|mesh-list
64589074|NCT00474851|Estrogens|estrogens|mesh-list
64589075|NCT00474851|Hormones|hormones|mesh-ancestor
64560563|NCT03013335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64560564|NCT03013335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560565|NCT03013335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64560566|NCT03013335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560567|NCT04730531|Epinephrine|epinephrine|mesh-list
64560568|NCT04730531|Bupivacaine|bupivacaine|mesh-list
64560569|NCT04730531|Anesthetics, Local|anesthetics, local|mesh-ancestor
64560570|NCT04730531|Anesthetics|anesthetics|mesh-ancestor
64560571|NCT04730531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64560572|NCT04730531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560573|NCT04730531|Sensory System Agents|sensory system agents|mesh-ancestor
64560579|NCT04730531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560580|NCT04730531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64560581|NCT04730531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64560582|NCT04730531|Autonomic Agents|autonomic agents|mesh-ancestor
64560583|NCT04730531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64560584|NCT04730531|Respiratory System Agents|respiratory system agents|mesh-ancestor
64560586|NCT04730531|Sympathomimetics|sympathomimetics|mesh-ancestor
64560587|NCT04730531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64560588|NCT05569733|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64560589|NCT05569733|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64560590|NCT05569733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560591|NCT05307003|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64560592|NCT05307003|Trazodone|trazodone|mesh-list
64560593|NCT05307003|Antidepressive Agents|antidepressive agents|mesh-ancestor
64560594|NCT05307003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64346083|NCT00692939|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64560598|NCT05307003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560599|NCT05307003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64560600|NCT05307003|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64560601|NCT05307003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64560602|NCT05307003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64560625|NCT05496335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64560626|NCT05496335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560627|NCT05496335|Cholinergic Agents|cholinergic agents|mesh-ancestor
64560628|NCT05496335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64560629|NCT01096875|Atorvastatin|atorvastatin|mesh-list
64560630|NCT01096875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64560631|NCT01096875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64560632|NCT01096875|Antimetabolites|antimetabolites|mesh-ancestor
64560633|NCT01096875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560634|NCT01096875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64560635|NCT01096875|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64560636|NCT01096875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560637|NCT01097343|Clopidogrel|clopidogrel|mesh-list
64560638|NCT01097343|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64560639|NCT01097343|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64560640|NCT01097343|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64560641|NCT01097343|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64560649|NCT03580187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64560650|NCT03580187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560651|NCT03580187|Analgesics|analgesics|mesh-ancestor
64560652|NCT03580187|Sensory System Agents|sensory system agents|mesh-ancestor
64560653|NCT03580187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560654|NCT01098747|Ibuprofen|ibuprofen|mesh-list
64560655|NCT01098747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64560656|NCT01098747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64560657|NCT01098747|Analgesics|analgesics|mesh-ancestor
64560658|NCT01098747|Sensory System Agents|sensory system agents|mesh-ancestor
64560659|NCT01098747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560660|NCT01098747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560661|NCT01098747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64560662|NCT01098747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64560663|NCT01098747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64560664|NCT01098747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560665|NCT01098747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560666|NCT02085161|Tiotropium Bromide|tiotropium bromide|mesh-list
64560667|NCT02085161|Olodaterol|olodaterol|mesh-list
64560668|NCT02085161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64560669|NCT02085161|Autonomic Agents|autonomic agents|mesh-ancestor
64560670|NCT02085161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560671|NCT02085161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560714|NCT05384015|Etoposide phosphate|etoposide phosphate|mesh-list
64560715|NCT05384015|Lenvatinib|lenvatinib|mesh-list
64560716|NCT05384015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560717|NCT05384015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64560718|NCT05384015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64560719|NCT05384015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64560720|NCT05384015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64560721|NCT05384015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346234|NCT03899961|Oxytocin|oxytocin|mesh-list
64560722|NCT05384015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560723|NCT05384015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64560724|NCT03572387|Azacitidine|azacitidine|mesh-list
64560725|NCT03572387|Tretinoin|tretinoin|mesh-list
64560726|NCT03572387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64560727|NCT03572387|Antimetabolites|antimetabolites|mesh-ancestor
64560728|NCT03572387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560729|NCT03572387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560730|NCT03572387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560731|NCT03572387|Keratolytic Agents|keratolytic agents|mesh-ancestor
64560732|NCT03572387|Dermatologic Agents|dermatologic agents|mesh-ancestor
64560733|NCT04728971|Caspofungin|caspofungin|mesh-list
64560734|NCT04728971|Micafungin|micafungin|mesh-list
64560735|NCT04728971|Antifungal Agents|antifungal agents|mesh-ancestor
64560736|NCT04728971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64560737|NCT04728971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560738|NCT04728971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560739|NCT03568643|Amoxicillin|amoxicillin|mesh-list
64560740|NCT03568643|Azithromycin|azithromycin|mesh-list
64560743|NCT01100931|Paclitaxel|paclitaxel|mesh-list
64560761|NCT04999449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560762|NCT04999449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560763|NCT04999449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64560764|NCT04999449|Mydriatics|mydriatics|mesh-ancestor
64560765|NCT04999449|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64560766|NCT04999449|Cholinergic Agents|cholinergic agents|mesh-ancestor
64560767|NCT04999449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64560768|NCT04999449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560769|NCT04999449|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64560770|NCT04999449|Parasympatholytics|parasympatholytics|mesh-ancestor
64560771|NCT03013959|Pyranoprofen|pyranoprofen|mesh-list
64560772|NCT03013959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64560773|NCT03013959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64560774|NCT03013959|Analgesics|analgesics|mesh-ancestor
64560775|NCT03013959|Sensory System Agents|sensory system agents|mesh-ancestor
64560776|NCT03013959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560777|NCT03013959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560778|NCT03013959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64560779|NCT03013959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64560780|NCT03013959|Gout Suppressants|gout suppressants|mesh-ancestor
64560781|NCT02246595|Vilobelimab|vilobelimab|mesh-list
64560782|NCT02246595|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64560812|NCT04814355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64560813|NCT04814355|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64560814|NCT04814355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64560815|NCT04814355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560816|NCT04814355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560817|NCT02179671|Docetaxel|docetaxel|mesh-list
64560818|NCT02179671|Gefitinib|gefitinib|mesh-list
64560819|NCT02179671|Tremelimumab|tremelimumab|mesh-list
64560820|NCT02179671|Osimertinib|osimertinib|mesh-list
64560821|NCT02179671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560822|NCT02179671|Tubulin Modulators|tubulin modulators|mesh-ancestor
64560823|NCT02179671|Antimitotic Agents|antimitotic agents|mesh-ancestor
64560824|NCT02179671|Mitosis Modulators|mitosis modulators|mesh-ancestor
64560825|NCT02179671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560826|NCT02179671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64560827|NCT02179671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64560828|NCT01110135|Dexamethasone|dexamethasone|mesh-list
64560830|NCT01110135|Etoposide phosphate|etoposide phosphate|mesh-list
64560831|NCT01110135|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64346238|NCT03899961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560832|NCT01110135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64560833|NCT01110135|Antiemetics|antiemetics|mesh-ancestor
64560834|NCT01110135|Autonomic Agents|autonomic agents|mesh-ancestor
64560835|NCT01110135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560836|NCT01110135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560837|NCT01110135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64560838|NCT01110135|Glucocorticoids|glucocorticoids|mesh-ancestor
64560839|NCT01110135|Hormones|hormones|mesh-ancestor
64560840|NCT01110135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64560860|NCT01112241|Cholinergic Agents|cholinergic agents|mesh-ancestor
64560861|NCT01112241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64560862|NCT01112241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560863|NCT01112241|Tocolytic Agents|tocolytic agents|mesh-ancestor
64560864|NCT01112241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64560865|NCT01112241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64560866|NCT01112241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64560867|NCT01112241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64560868|NCT01112241|Adrenergic Agents|adrenergic agents|mesh-ancestor
64560869|NCT03013881|Trastuzumab|trastuzumab|mesh-list
64560870|NCT03013881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64560871|NCT03013881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560872|NCT02174913|Fentanyl|fentanyl|mesh-list
64560873|NCT02174913|Propofol|propofol|mesh-list
64560874|NCT02174913|Atracurium|atracurium|mesh-list
64560875|NCT02174913|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64560876|NCT02174913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64560877|NCT02174913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560878|NCT02174913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64560879|NCT02174913|Anesthetics, General|anesthetics, general|mesh-ancestor
64560880|NCT02174913|Anesthetics|anesthetics|mesh-ancestor
64560881|NCT02174913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64560882|NCT02174913|Narcotics|narcotics|mesh-ancestor
64560883|NCT02174913|Analgesics|analgesics|mesh-ancestor
64560884|NCT02174913|Sensory System Agents|sensory system agents|mesh-ancestor
64560885|NCT02174913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560886|NCT02174913|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64560887|NCT02174913|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64346267|NCT05318157|Histamine Agents|histamine agents|mesh-ancestor
64560893|NCT02174913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64560894|NCT02174913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560900|NCT01114503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64560901|NCT01114503|Prednisolone phosphate|prednisolone phosphate|mesh-list
64560902|NCT01114503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64560904|NCT01114503|Autonomic Agents|autonomic agents|mesh-ancestor
64560905|NCT01114503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560906|NCT01114503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560907|NCT01114503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64560908|NCT01114503|Glucocorticoids|glucocorticoids|mesh-ancestor
64560909|NCT01114503|Hormones|hormones|mesh-ancestor
64560910|NCT01114503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64560911|NCT01114503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64560912|NCT01114503|Protective Agents|protective agents|mesh-ancestor
64560913|NCT01114503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64560914|NCT01114503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560915|NCT03015831|Colchicine|colchicine|mesh-list
64560916|NCT03015831|Gout Suppressants|gout suppressants|mesh-ancestor
64560917|NCT03015831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64560918|NCT03015831|Tubulin Modulators|tubulin modulators|mesh-ancestor
64560919|NCT03015831|Antimitotic Agents|antimitotic agents|mesh-ancestor
64560920|NCT03015831|Mitosis Modulators|mitosis modulators|mesh-ancestor
64560921|NCT03015831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560922|NCT03015831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560923|NCT01114581|Phenylpropanolamine|phenylpropanolamine|mesh-list
64560924|NCT01114581|Guaifenesin|guaifenesin|mesh-list
64560925|NCT01114581|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
64560926|NCT01114581|Expectorants|expectorants|mesh-ancestor
64560927|NCT01114581|Respiratory System Agents|respiratory system agents|mesh-ancestor
64560928|NCT01114581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64560929|NCT01114581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64560930|NCT01114581|Adrenergic Agents|adrenergic agents|mesh-ancestor
64560931|NCT01114581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64560932|NCT01114581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560933|NCT01114581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560934|NCT01114581|Appetite Depressants|appetite depressants|mesh-ancestor
64560935|NCT01114581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64560936|NCT01114581|Sympathomimetics|sympathomimetics|mesh-ancestor
64560937|NCT01114581|Autonomic Agents|autonomic agents|mesh-ancestor
64560938|NCT01114581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560939|NCT01114581|Nasal Decongestants|nasal decongestants|mesh-ancestor
64560940|NCT01114581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64560941|NCT01114893|Travoprost|travoprost|mesh-list
64560942|NCT01114893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64560943|NCT01114971|Labetalol|labetalol|mesh-list
64560944|NCT01114971|Fentanyl|fentanyl|mesh-list
64560945|NCT01114971|Esmolol|esmolol|mesh-list
64560946|NCT01114971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64560947|NCT01114971|Narcotics|narcotics|mesh-ancestor
64346291|NCT02294357|BB 1101|bb 1101|mesh-list
64560948|NCT01114971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64560949|NCT01114971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560950|NCT01114971|Analgesics|analgesics|mesh-ancestor
64560951|NCT01114971|Sensory System Agents|sensory system agents|mesh-ancestor
64560952|NCT01114971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560953|NCT01114971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64560954|NCT01114971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64560955|NCT01114971|Anesthetics, General|anesthetics, general|mesh-ancestor
64560956|NCT01114971|Anesthetics|anesthetics|mesh-ancestor
64560957|NCT01114971|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64560958|NCT01114971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64560959|NCT01114971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64560960|NCT01114971|Adrenergic Agents|adrenergic agents|mesh-ancestor
64560961|NCT01114971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64560962|NCT01114971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64560963|NCT01114971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64560964|NCT01114971|Sympathomimetics|sympathomimetics|mesh-ancestor
64560965|NCT01114971|Autonomic Agents|autonomic agents|mesh-ancestor
64560966|NCT01114971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64560977|NCT01044693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64560978|NCT01044693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64560979|NCT01044693|Sympatholytics|sympatholytics|mesh-ancestor
64560980|NCT01044693|Autonomic Agents|autonomic agents|mesh-ancestor
64560981|NCT01044693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64560982|NCT01044693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64560983|NCT01044693|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64560984|NCT01044693|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64560985|NCT01044693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64560986|NCT01044693|Adrenergic Agents|adrenergic agents|mesh-ancestor
64560987|NCT01044693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64560988|NCT01044693|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64560989|NCT01044693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64560990|NCT01044693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64560991|NCT01115517|Bevacizumab|bevacizumab|mesh-list
64560993|NCT01115517|Mitomycin|mitomycin|mesh-list
64560994|NCT01115517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64560995|NCT01115517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64560996|NCT01115517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64560997|NCT01115517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64560998|NCT01115517|Growth Substances|growth substances|mesh-ancestor
64560999|NCT01115517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561000|NCT01115517|Growth Inhibitors|growth inhibitors|mesh-ancestor
64561001|NCT01115517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64561002|NCT01115517|Alkylating Agents|alkylating agents|mesh-ancestor
64561003|NCT01115517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561004|NCT01115517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64561005|NCT01115517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561006|NCT03015675|Ascorbic Acid|ascorbic acid|mesh-list
64561007|NCT03015675|Vitamins|vitamins|mesh-ancestor
64561008|NCT03015675|Micronutrients|micronutrients|mesh-ancestor
64561009|NCT03015675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561010|NCT03015675|Antioxidants|antioxidants|mesh-ancestor
64561011|NCT03015675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561012|NCT03015675|Protective Agents|protective agents|mesh-ancestor
64561016|NCT01044771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64561017|NCT01044771|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64561018|NCT01044771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64561020|NCT01044771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561021|NCT01044771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64561022|NCT01044771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64561024|NCT01044771|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64561025|NCT01115673|Acetaminophen|acetaminophen|mesh-list
64561026|NCT01115673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64561027|NCT01115673|Analgesics|analgesics|mesh-ancestor
64561028|NCT01115673|Sensory System Agents|sensory system agents|mesh-ancestor
64561029|NCT01115673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64561079|NCT03380559|Botulinum Toxins|botulinum toxins|mesh-list
64561080|NCT03380559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64561081|NCT03380559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64561082|NCT03380559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561083|NCT03380559|Cholinergic Agents|cholinergic agents|mesh-ancestor
64561084|NCT03380559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64561085|NCT03380559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561086|NCT03012945|Anesthetics|anesthetics|mesh-list
64561087|NCT03012945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64561088|NCT03012945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561089|NCT01121211|Testosterone|testosterone|mesh-list
64561090|NCT01121211|Androgens|androgens|mesh-ancestor
64561091|NCT01121211|Hormones|hormones|mesh-ancestor
64561092|NCT01121211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64561093|NCT01121211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561094|NCT01162551|Sirolimus|sirolimus|mesh-list
64561095|NCT01162551|Methotrexate|methotrexate|mesh-list
64561096|NCT01162551|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64561097|NCT01162551|Abortifacient Agents|abortifacient agents|mesh-ancestor
64561098|NCT01162551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64561099|NCT01162551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561100|NCT01162551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64561101|NCT01162551|Antimetabolites|antimetabolites|mesh-ancestor
64561102|NCT01162551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561103|NCT01162551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561115|NCT01163097|Heparin|heparin|mesh-list
64561124|NCT03088137|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64561125|NCT03088137|Hormones|hormones|mesh-ancestor
64561126|NCT03088137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64561127|NCT03088137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561128|NCT01165047|Nitric Oxide|nitric oxide|mesh-list
64561129|NCT01165047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64561130|NCT01165047|Autonomic Agents|autonomic agents|mesh-ancestor
64561131|NCT01165047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64561132|NCT01165047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561133|NCT01165047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64561134|NCT01165047|Respiratory System Agents|respiratory system agents|mesh-ancestor
64561135|NCT01165047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64561136|NCT01165047|Antioxidants|antioxidants|mesh-ancestor
64561137|NCT01165047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561138|NCT01165047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64561139|NCT01165047|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64561140|NCT01165047|Vasodilator Agents|vasodilator agents|mesh-ancestor
64561141|NCT01165047|Gasotransmitters|gasotransmitters|mesh-ancestor
64561142|NCT01165047|Protective Agents|protective agents|mesh-ancestor
64561143|NCT01166997|Heparin|heparin|mesh-list
64561144|NCT01166997|Calcium heparin|calcium heparin|mesh-list
64561145|NCT01166997|Anticoagulants|anticoagulants|mesh-ancestor
64561146|NCT01166997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64561147|NCT01166997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64561148|NCT01166997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561149|NCT02802969|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
64561150|NCT02802969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64561151|NCT02802969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561152|NCT02647437|Levetiracetam|levetiracetam|mesh-list
64561153|NCT02647437|Anticonvulsants|anticonvulsants|mesh-ancestor
64561154|NCT02647437|Nootropic Agents|nootropic agents|mesh-ancestor
64561155|NCT01170117|Olanzapine|olanzapine|mesh-list
64561156|NCT01170117|Antiemetics|antiemetics|mesh-ancestor
64561164|NCT01170117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64561165|NCT01170117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64561166|NCT01170117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64561167|NCT01170117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64561168|NCT01170117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561169|NCT01170117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64561170|NCT01170117|Serotonin Agents|serotonin agents|mesh-ancestor
64561171|NCT01172145|Modafinil|modafinil|mesh-list
64561172|NCT01172145|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64561173|NCT01172145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561174|NCT01172145|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64561175|NCT01172145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64561176|NCT01172145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64561177|NCT01172145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561178|NCT01175343|R04929097|r04929097|mesh-list
64561179|NCT01175343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561180|NCT01175343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561181|NCT01176435|Levodopa|levodopa|mesh-list
64561182|NCT01176435|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64589121|NCT00516217|Galiximab|galiximab|mesh-list
64561183|NCT01176435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64561184|NCT01176435|Dopamine Agents|dopamine agents|mesh-ancestor
64561185|NCT01176435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64561186|NCT01176435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561187|NCT01176435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561188|NCT01176591|Aprepitant|aprepitant|mesh-list
64561189|NCT01176591|Fosaprepitant|fosaprepitant|mesh-list
64561190|NCT01176591|Antiemetics|antiemetics|mesh-ancestor
64561191|NCT01176591|Autonomic Agents|autonomic agents|mesh-ancestor
64561192|NCT01176591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64561193|NCT01176591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561203|NCT01176981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64561204|NCT01176981|Antimetabolites|antimetabolites|mesh-ancestor
64561205|NCT01176981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561206|NCT01176981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561207|NCT01176981|Dermatologic Agents|dermatologic agents|mesh-ancestor
64561208|NCT01176981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561209|NCT01176981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64561210|NCT01176981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64561211|NCT01176981|Immunologic Factors|immunologic factors|mesh-ancestor
64561212|NCT01176981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64561213|NCT01176981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64561214|NCT01126593|Bupivacaine|bupivacaine|mesh-list
64561215|NCT01126593|Anesthetics, Local|anesthetics, local|mesh-ancestor
64561216|NCT01126593|Anesthetics|anesthetics|mesh-ancestor
64561217|NCT01126593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64561218|NCT01126593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561219|NCT01126593|Sensory System Agents|sensory system agents|mesh-ancestor
64561220|NCT01126593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64561221|NCT01181349|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
64561222|NCT01181349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64561257|NCT01183533|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64561258|NCT01183533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64561259|NCT01183533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561260|NCT01187355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64561262|NCT01188369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64561263|NCT01188369|Vasodilator Agents|vasodilator agents|mesh-ancestor
64561264|NCT01188369|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64561265|NCT01188369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64561266|NCT01188369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561267|NCT01188369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561268|NCT01188369|Protective Agents|protective agents|mesh-ancestor
64561269|NCT01188369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561272|NCT01135329|Busulfan|busulfan|mesh-list
64561273|NCT01135329|Fludarabine|fludarabine|mesh-list
64561274|NCT01135329|Tacrolimus|tacrolimus|mesh-list
64561277|NCT01135329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561278|NCT01135329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64561279|NCT01135329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64561280|NCT01135329|Alkylating Agents|alkylating agents|mesh-ancestor
64561281|NCT01135329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561291|NCT03012009|Lidocaine|lidocaine|mesh-list
64561307|NCT03012009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64561308|NCT03012009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64561309|NCT03012009|Adrenergic Agents|adrenergic agents|mesh-ancestor
64561310|NCT03012009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64561311|NCT03012009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64561312|NCT03012009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64561313|NCT03012009|Autonomic Agents|autonomic agents|mesh-ancestor
64561314|NCT03012009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64561315|NCT03012009|Respiratory System Agents|respiratory system agents|mesh-ancestor
64561316|NCT03012009|Mydriatics|mydriatics|mesh-ancestor
64561317|NCT03012009|Sympathomimetics|sympathomimetics|mesh-ancestor
64561318|NCT03012009|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64561319|NCT03012009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64561320|NCT03012009|Dermatologic Agents|dermatologic agents|mesh-ancestor
64561322|NCT04403555|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64561323|NCT04403555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64561324|NCT03565835|Prednisone|prednisone|mesh-list
64561325|NCT03565835|Abiraterone Acetate|abiraterone acetate|mesh-list
64561326|NCT03565835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64561327|NCT03565835|Glucocorticoids|glucocorticoids|mesh-ancestor
64561328|NCT03565835|Hormones|hormones|mesh-ancestor
64561329|NCT03565835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64561330|NCT03565835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561331|NCT03565835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64561332|NCT03565835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561333|NCT03565835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64561334|NCT03565835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561335|NCT03565835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346375|NCT03520985|Growth Inhibitors|growth inhibitors|mesh-ancestor
64346376|NCT03517943|Loratadine|loratadine|mesh-list
64346377|NCT03517943|Pseudoephedrine|pseudoephedrine|mesh-list
64561337|NCT03565835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64561338|NCT03563729|Pembrolizumab|pembrolizumab|mesh-list
64561339|NCT03563729|Nivolumab|nivolumab|mesh-list
64561340|NCT03563729|Ipilimumab|ipilimumab|mesh-list
64561341|NCT03563729|Trametinib|trametinib|mesh-list
64561342|NCT03563729|Dabrafenib|dabrafenib|mesh-list
64561348|NCT03563729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561349|NCT01624259|Metformin|metformin|mesh-list
64561350|NCT01624259|Liraglutide|liraglutide|mesh-list
64561351|NCT01624259|Dulaglutide|dulaglutide|mesh-list
64561352|NCT01624259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64561353|NCT01624259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561354|NCT01624259|Incretins|incretins|mesh-ancestor
64561355|NCT01624259|Hormones|hormones|mesh-ancestor
64561356|NCT01624259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64561357|NCT02081183|Mycophenolic Acid|mycophenolic acid|mesh-list
64561358|NCT02081183|Prednisone|prednisone|mesh-list
64561359|NCT02081183|Cyclophosphamide|cyclophosphamide|mesh-list
64561360|NCT02081183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64561361|NCT02081183|Immunologic Factors|immunologic factors|mesh-ancestor
64561362|NCT02081183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561363|NCT02081183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64561364|NCT02081183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64561365|NCT02081183|Alkylating Agents|alkylating agents|mesh-ancestor
64561366|NCT02081183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561367|NCT02081183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561368|NCT02081183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64561369|NCT02081183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64561370|NCT02081183|Glucocorticoids|glucocorticoids|mesh-ancestor
64561371|NCT02081183|Hormones|hormones|mesh-ancestor
64561372|NCT02081183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64561373|NCT02081183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64561374|NCT02081183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64561375|NCT02081183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64561376|NCT02081183|Antitubercular Agents|antitubercular agents|mesh-ancestor
64561377|NCT02081183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64561378|NCT02081183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64561392|NCT02079077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561393|NCT02079077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561394|NCT02079077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64561395|NCT02079077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64561396|NCT02079077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64561397|NCT02079077|Analgesics|analgesics|mesh-ancestor
64561398|NCT02079077|Sensory System Agents|sensory system agents|mesh-ancestor
64561399|NCT02079077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64561400|NCT02079077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561401|NCT02079077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64561402|NCT02079077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64561403|NCT02079077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64561404|NCT02079077|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64561405|NCT02079077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64561406|NCT02079077|Antipyretics|antipyretics|mesh-ancestor
64561407|NCT03547271|Vaccines|vaccines|mesh-list
64589131|NCT00516919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64561408|NCT03547271|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64561409|NCT03547271|Immunologic Factors|immunologic factors|mesh-ancestor
64561410|NCT03547271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561411|NCT03547115|Venetoclax|venetoclax|mesh-list
64561412|NCT03547115|Voruciclib|voruciclib|mesh-list
64561413|NCT03547115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561414|NCT03547115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64561415|NCT03547115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561416|NCT03547115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561417|NCT01191255|Sevelamer|sevelamer|mesh-list
64561418|NCT01191255|Chelating Agents|chelating agents|mesh-ancestor
64561441|NCT03536039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64561442|NCT03536039|Alkylating Agents|alkylating agents|mesh-ancestor
64561443|NCT03536039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561444|NCT03536039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561445|NCT03536039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64561446|NCT03536039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64561447|NCT03536039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64561448|NCT03536039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64561449|NCT03536039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64561450|NCT03536039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561451|NCT03536039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64561452|NCT03536039|Glucocorticoids|glucocorticoids|mesh-ancestor
64561453|NCT03536039|Hormones|hormones|mesh-ancestor
64561454|NCT03536039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64561460|NCT02075255|Benralizumab|benralizumab|mesh-list
64561501|NCT03527069|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64561502|NCT03527069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64561503|NCT03527069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64561504|NCT03527069|Antimetabolites|antimetabolites|mesh-ancestor
64561505|NCT03527069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561506|NCT03527069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64561507|NCT03527069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64561508|NCT03527069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561509|NCT01677611|Resveratrol|resveratrol|mesh-list
64561510|NCT01677611|Antioxidants|antioxidants|mesh-ancestor
64561511|NCT01677611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561512|NCT01677611|Protective Agents|protective agents|mesh-ancestor
64561513|NCT01677611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561514|NCT01677611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561515|NCT01677611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64561516|NCT03518801|Cannabidiol|cannabidiol|mesh-list
64561517|NCT03518801|Anticonvulsants|anticonvulsants|mesh-ancestor
64561518|NCT01191723|Moxifloxacin|moxifloxacin|mesh-list
64561519|NCT01191723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64561520|NCT01191723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64561521|NCT01191723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64561522|NCT01191723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64561523|NCT01191723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561524|NCT01191723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561549|NCT01679951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64561550|NCT03514589|Cosyntropin|cosyntropin|mesh-list
64561551|NCT03514589|Hormones|hormones|mesh-ancestor
64561552|NCT03514589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64561553|NCT03514589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561554|NCT01194297|Vaccines|vaccines|mesh-list
64561555|NCT01194297|Immunologic Factors|immunologic factors|mesh-ancestor
64561556|NCT01194297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561557|NCT01194453|Folic Acid|folic acid|mesh-list
64561558|NCT01194453|Vitamin B 12|vitamin b 12|mesh-list
64561559|NCT01194453|Gemcitabine|gemcitabine|mesh-list
64561560|NCT01194453|Dexamethasone|dexamethasone|mesh-list
64561561|NCT01194453|Cisplatin|cisplatin|mesh-list
64561562|NCT01194453|Vitamins|vitamins|mesh-ancestor
64561563|NCT01194453|Micronutrients|micronutrients|mesh-ancestor
64561564|NCT01194453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561565|NCT01194453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64561566|NCT01194453|Antiemetics|antiemetics|mesh-ancestor
64561567|NCT01194453|Autonomic Agents|autonomic agents|mesh-ancestor
64561568|NCT01194453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64561569|NCT01194453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64561570|NCT01194453|Glucocorticoids|glucocorticoids|mesh-ancestor
64561571|NCT01194453|Hormones|hormones|mesh-ancestor
64561572|NCT01194453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64561573|NCT01194453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64561574|NCT01194453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561575|NCT01194453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64561576|NCT01194453|Antimetabolites|antimetabolites|mesh-ancestor
64561577|NCT01194453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561578|NCT01194453|Antiviral Agents|antiviral agents|mesh-ancestor
64561579|NCT01194453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64561580|NCT01194453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561594|NCT01195467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64561595|NCT01195467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64561596|NCT01195467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64561597|NCT01195467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561598|NCT01195467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561600|NCT01195467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64561601|NCT01195467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64561602|NCT01195467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64561603|NCT01195467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64561604|NCT01195467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64561605|NCT01195467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64561606|NCT01195467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64561607|NCT01195467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64561608|NCT01195467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64561609|NCT01677221|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64561610|NCT01677221|Dermatologic Agents|dermatologic agents|mesh-ancestor
64561611|NCT03492437|Tepotinib|tepotinib|mesh-list
64561612|NCT03492437|Dabigatran|dabigatran|mesh-list
64561613|NCT03492437|Antithrombins|antithrombins|mesh-ancestor
64561614|NCT03492437|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64561615|NCT03492437|Protease Inhibitors|protease inhibitors|mesh-ancestor
64561616|NCT03492437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561617|NCT03492437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561618|NCT03492437|Anticoagulants|anticoagulants|mesh-ancestor
64561619|NCT03492437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561620|NCT01195779|Vaccines|vaccines|mesh-list
64561621|NCT01195779|Immunologic Factors|immunologic factors|mesh-ancestor
64561622|NCT01195779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561623|NCT02405585|Leucovorin|leucovorin|mesh-list
64561627|NCT02405585|Irinotecan|irinotecan|mesh-list
64561637|NCT02405585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561638|NCT02405585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64561639|NCT02405585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64561641|NCT02405585|Protective Agents|protective agents|mesh-ancestor
64561642|NCT02405585|Vitamin B Complex|vitamin b complex|mesh-ancestor
64561643|NCT02405585|Vitamins|vitamins|mesh-ancestor
64561644|NCT02405585|Micronutrients|micronutrients|mesh-ancestor
64561645|NCT03491345|Avelumab|avelumab|mesh-list
64561646|NCT03491345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64561647|NCT03491345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561648|NCT00089999|Lapatinib|lapatinib|mesh-list
64561649|NCT00089999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561650|NCT00089999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64561651|NCT00089999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561652|NCT00089999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561654|NCT03454451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64561655|NCT03454451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561656|NCT00089843|Risedronic Acid|risedronic acid|mesh-list
64561657|NCT00089843|Etidronic Acid|etidronic acid|mesh-list
64561658|NCT00089843|Methyltestosterone|methyltestosterone|mesh-list
64561659|NCT00089843|Testosterone|testosterone|mesh-list
64561660|NCT00089843|Testosterone undecanoate|testosterone undecanoate|mesh-list
64561661|NCT00089843|Testosterone enanthate|testosterone enanthate|mesh-list
64561662|NCT00089843|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64561663|NCT00089843|Androgens|androgens|mesh-ancestor
64561664|NCT00089843|Hormones|hormones|mesh-ancestor
64561665|NCT00089843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64561666|NCT00089843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561667|NCT00089843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64561668|NCT00089843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561681|NCT03485417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64561682|NCT03485417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561683|NCT03485417|Dopamine Agonists|dopamine agonists|mesh-ancestor
64561684|NCT03485417|Dopamine Agents|dopamine agents|mesh-ancestor
64561685|NCT03485417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64346495|NCT02292173|Trametinib|trametinib|mesh-list
64561686|NCT03485417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561687|NCT03485417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64561688|NCT03485417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64561689|NCT03485417|Serotonin Agents|serotonin agents|mesh-ancestor
64561690|NCT03485417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64561691|NCT03485417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64561692|NCT03485417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64561693|NCT03485417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64561694|NCT01677923|Metformin|metformin|mesh-list
64561695|NCT01677923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64561696|NCT01677923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561697|NCT00089297|Paclitaxel|paclitaxel|mesh-list
64561698|NCT00089297|Carboplatin|carboplatin|mesh-list
64561699|NCT00089297|Cetuximab|cetuximab|mesh-list
64561700|NCT00089297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64561701|NCT00089297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561702|NCT00089297|Tubulin Modulators|tubulin modulators|mesh-ancestor
64561703|NCT00089297|Antimitotic Agents|antimitotic agents|mesh-ancestor
64561704|NCT00089297|Mitosis Modulators|mitosis modulators|mesh-ancestor
64561705|NCT00089297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561706|NCT00089297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64561707|NCT01678001|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64561708|NCT01678001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64561709|NCT01678001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64561710|NCT01678001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561722|NCT03482297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64561723|NCT03482297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64561725|NCT03482297|Adrenergic Agents|adrenergic agents|mesh-ancestor
64561726|NCT03482297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64561727|NCT03482297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561728|NCT00088907|Docetaxel|docetaxel|mesh-list
64561729|NCT00088907|Gefitinib|gefitinib|mesh-list
64561730|NCT00088907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561731|NCT00088907|Tubulin Modulators|tubulin modulators|mesh-ancestor
64561732|NCT00088907|Antimitotic Agents|antimitotic agents|mesh-ancestor
64561733|NCT00088907|Mitosis Modulators|mitosis modulators|mesh-ancestor
64561734|NCT00088907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561735|NCT00088907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64561736|NCT00088907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561737|NCT00088829|Paclitaxel|paclitaxel|mesh-list
64561738|NCT00088829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64561739|NCT00088829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64561740|NCT00088829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561741|NCT00088829|Tubulin Modulators|tubulin modulators|mesh-ancestor
64561742|NCT00088829|Antimitotic Agents|antimitotic agents|mesh-ancestor
64561743|NCT00088829|Mitosis Modulators|mitosis modulators|mesh-ancestor
64561744|NCT00088829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561745|NCT00088595|Pasireotide|pasireotide|mesh-list
64561746|NCT00088595|Hormones|hormones|mesh-ancestor
64561747|NCT00088595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64561748|NCT00088595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561749|NCT03450707|Thiamine|thiamine|mesh-list
64561750|NCT03450707|Vitamins|vitamins|mesh-ancestor
64561751|NCT03450707|Micronutrients|micronutrients|mesh-ancestor
64561752|NCT03450707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561753|NCT03450707|Vitamin B Complex|vitamin b complex|mesh-ancestor
64561754|NCT01678079|Calcium, Dietary|calcium, dietary|mesh-list
64561755|NCT01678079|Calcium|calcium|mesh-list
64561756|NCT01678079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64561757|NCT01678079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561759|NCT01678235|Insulin|insulin|mesh-list
64561762|NCT01678235|Insulin glulisine|insulin glulisine|mesh-list
64561763|NCT01678235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64561764|NCT01678235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561765|NCT01197495|Hyaluronic Acid|hyaluronic acid|mesh-list
64561766|NCT01197495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64561767|NCT01197495|Immunologic Factors|immunologic factors|mesh-ancestor
64561768|NCT01197495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561769|NCT01197495|Viscosupplements|viscosupplements|mesh-ancestor
64561770|NCT01197495|Protective Agents|protective agents|mesh-ancestor
64561771|NCT01197573|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64561772|NCT01197573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64561773|NCT01197573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64561774|NCT01197573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561775|NCT03011931|Simvastatin|simvastatin|mesh-list
64561776|NCT03011931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64561777|NCT03011931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64561778|NCT03011931|Antimetabolites|antimetabolites|mesh-ancestor
64561779|NCT03011931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561780|NCT03011931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64561781|NCT03011931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64561782|NCT03011931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561783|NCT02185131|Mirtazapine|mirtazapine|mesh-list
64561784|NCT02185131|Antidepressive Agents|antidepressive agents|mesh-ancestor
64561785|NCT02185131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64561786|NCT02185131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64561787|NCT02185131|Histamine Antagonists|histamine antagonists|mesh-ancestor
64561788|NCT02185131|Histamine Agents|histamine agents|mesh-ancestor
64561789|NCT02185131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64561790|NCT02185131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561806|NCT00085709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64561807|NCT00085709|Antimetabolites|antimetabolites|mesh-ancestor
64561808|NCT00085709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561809|NCT00085709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561810|NCT00085709|Antiviral Agents|antiviral agents|mesh-ancestor
64561811|NCT00085709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64561812|NCT00085709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64561813|NCT00085709|Immunologic Factors|immunologic factors|mesh-ancestor
64561814|NCT00085709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561815|NCT00085709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64561816|NCT00085709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64561817|NCT00085709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64561818|NCT00085709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561819|NCT00085709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64561820|NCT01201863|Testosterone|testosterone|mesh-list
64561821|NCT01201863|Androgens|androgens|mesh-ancestor
64561822|NCT01201863|Hormones|hormones|mesh-ancestor
64561823|NCT01201863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64561824|NCT01201863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561825|NCT01202253|Anidulafungin|anidulafungin|mesh-list
64561826|NCT01202253|Antifungal Agents|antifungal agents|mesh-ancestor
64561827|NCT01202253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64561828|NCT01678703|Misoprostol|misoprostol|mesh-list
64561829|NCT01678703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64561830|NCT01678703|Abortifacient Agents|abortifacient agents|mesh-ancestor
64561831|NCT01678703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64561832|NCT01678703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561833|NCT01678703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64561834|NCT01678703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64561835|NCT01678703|Oxytocics|oxytocics|mesh-ancestor
64561836|NCT00085631|Cisplatin|cisplatin|mesh-list
64561849|NCT01141725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561851|NCT01141725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64561852|NCT01141725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64561853|NCT01141725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64561855|NCT01202721|Atenolol|atenolol|mesh-list
64561856|NCT01202721|Telmisartan|telmisartan|mesh-list
64561857|NCT01202721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64561858|NCT01202721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64561859|NCT01202721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64561860|NCT01202721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561861|NCT01202721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64561862|NCT01202721|Sympatholytics|sympatholytics|mesh-ancestor
64561863|NCT01202721|Autonomic Agents|autonomic agents|mesh-ancestor
64561871|NCT00084617|Capecitabine|capecitabine|mesh-list
64561904|NCT01203189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64561905|NCT01203189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561906|NCT01203189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561907|NCT01203189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64561908|NCT01203189|Hormone Antagonists|hormone antagonists|mesh-ancestor
64561909|NCT01203189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64561910|NCT01203189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561911|NCT01203189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64561912|NCT01204203|Zoledronic Acid|zoledronic acid|mesh-list
64561913|NCT01204203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64561914|NCT01204203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561915|NCT01679327|Calcium, Dietary|calcium, dietary|mesh-list
64561916|NCT01679327|Leucovorin|leucovorin|mesh-list
64561917|NCT01679327|Bevacizumab|bevacizumab|mesh-list
64561918|NCT01679327|Oxaliplatin|oxaliplatin|mesh-list
64561919|NCT01679327|Calcium|calcium|mesh-list
64561920|NCT01679327|Levoleucovorin|levoleucovorin|mesh-list
64561921|NCT01679327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64561922|NCT01679327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561923|NCT01679327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64561924|NCT01679327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64561925|NCT01679327|Growth Substances|growth substances|mesh-ancestor
64561926|NCT01679327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561927|NCT01679327|Growth Inhibitors|growth inhibitors|mesh-ancestor
64561928|NCT01679327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64561929|NCT01679327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64561930|NCT01679327|Antidotes|antidotes|mesh-ancestor
64561931|NCT01679327|Protective Agents|protective agents|mesh-ancestor
64561932|NCT01679327|Vitamin B Complex|vitamin b complex|mesh-ancestor
64561933|NCT01679327|Vitamins|vitamins|mesh-ancestor
64561934|NCT01679327|Micronutrients|micronutrients|mesh-ancestor
64561935|NCT01206387|Desoximetasone|desoximetasone|mesh-list
64561936|NCT01206387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64561937|NCT01206387|Glucocorticoids|glucocorticoids|mesh-ancestor
64561938|NCT01206387|Hormones|hormones|mesh-ancestor
64561940|NCT01206387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561941|NCT01679561|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64561942|NCT01679561|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64561943|NCT01679561|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64561944|NCT01679561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64561945|NCT01679639|Rifampin|rifampin|mesh-list
64561946|NCT01679639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64561947|NCT01679639|Antitubercular Agents|antitubercular agents|mesh-ancestor
64561948|NCT01679639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64561949|NCT01679639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64589178|NCT03023774|Lenograstim|lenograstim|mesh-list
64561950|NCT01679639|Leprostatic Agents|leprostatic agents|mesh-ancestor
64561951|NCT01679639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64561952|NCT01679639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561953|NCT01679639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561954|NCT01679639|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64561955|NCT01679639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64561956|NCT01679639|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64561957|NCT01679639|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64561958|NCT01679639|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64561959|NCT01679639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64561961|NCT01679795|Androgen Antagonists|androgen antagonists|mesh-ancestor
64561962|NCT01679795|Hormone Antagonists|hormone antagonists|mesh-ancestor
64561963|NCT01679795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64561964|NCT01679795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561965|NCT01679795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64561966|NCT01679795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64561967|NCT01679795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64561982|NCT01207401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64561983|NCT01207401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561984|NCT01207401|Sensory System Agents|sensory system agents|mesh-ancestor
64561985|NCT01207401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64561986|NCT01207401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64561987|NCT01207401|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64561988|NCT01207401|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64561989|NCT01207401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64561990|NCT01207401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561991|NCT04761731|Tacrolimus|tacrolimus|mesh-list
64561992|NCT04761731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64561993|NCT04761731|Immunologic Factors|immunologic factors|mesh-ancestor
64561994|NCT04761731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64561995|NCT04761731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64561996|NCT04761731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64561997|NCT04761731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64561998|NCT03087539|Abciximab|abciximab|mesh-list
64561999|NCT03087539|Anticoagulants|anticoagulants|mesh-ancestor
64562000|NCT03087539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64562001|NCT03087149|Vitamin D|vitamin d|mesh-list
64562002|NCT03087149|Vitamins|vitamins|mesh-ancestor
64562003|NCT03087149|Micronutrients|micronutrients|mesh-ancestor
64562004|NCT03087149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562005|NCT03087149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64562006|NCT03086681|Cisplatin|cisplatin|mesh-list
64562007|NCT03086681|Endostar protein|endostar protein|mesh-list
64562008|NCT03086681|Endostatins|endostatins|mesh-list
64562009|NCT03086681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562010|NCT03086681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64562011|NCT03086681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64562012|NCT03086681|Growth Substances|growth substances|mesh-ancestor
64562024|NCT03086759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64562025|NCT03086759|Immunologic Factors|immunologic factors|mesh-ancestor
64562026|NCT03086759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562027|NCT03086759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562030|NCT03086291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64562031|NCT03086291|Antimetabolites|antimetabolites|mesh-ancestor
64562032|NCT03086291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562033|NCT03086291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64562034|NCT03086291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64562035|NCT03086291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562036|NCT03086915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
64562037|NCT03086915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64562038|NCT03086915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64562039|NCT03086915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562041|NCT01209195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64562042|NCT01209195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562043|NCT01209195|Tubulin Modulators|tubulin modulators|mesh-ancestor
64562044|NCT01209195|Antimitotic Agents|antimitotic agents|mesh-ancestor
64562045|NCT01209195|Mitosis Modulators|mitosis modulators|mesh-ancestor
64562046|NCT01209195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562047|NCT03084809|Leucovorin|leucovorin|mesh-list
64562048|NCT03084809|Oxaliplatin|oxaliplatin|mesh-list
64562049|NCT03084809|Fluorouracil|fluorouracil|mesh-list
64562050|NCT03084809|Levoleucovorin|levoleucovorin|mesh-list
64562051|NCT03084809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562052|NCT03084809|Antidotes|antidotes|mesh-ancestor
64562053|NCT03084809|Protective Agents|protective agents|mesh-ancestor
64562054|NCT03084809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562055|NCT03084809|Vitamin B Complex|vitamin b complex|mesh-ancestor
64562066|NCT01144143|Prednisolone|prednisolone|mesh-list
64562067|NCT01144143|Prednisolone acetate|prednisolone acetate|mesh-list
64562068|NCT01144143|Infliximab|infliximab|mesh-list
64562069|NCT01144143|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64562070|NCT01144143|Prednisolone phosphate|prednisolone phosphate|mesh-list
64562071|NCT01144143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64562072|NCT01144143|Antiemetics|antiemetics|mesh-ancestor
64562073|NCT01144143|Autonomic Agents|autonomic agents|mesh-ancestor
64562074|NCT01144143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64562075|NCT01144143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562076|NCT01144143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64562077|NCT01144143|Glucocorticoids|glucocorticoids|mesh-ancestor
64562078|NCT01144143|Hormones|hormones|mesh-ancestor
64562079|NCT01144143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64562080|NCT01144143|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64562081|NCT01144143|Protective Agents|protective agents|mesh-ancestor
64562082|NCT01144143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64562083|NCT01144143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562084|NCT01144143|Dermatologic Agents|dermatologic agents|mesh-ancestor
64562085|NCT01144143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64562086|NCT03084575|Glycerol|glycerol|mesh-list
64562087|NCT03084575|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64562088|NCT03084575|Protective Agents|protective agents|mesh-ancestor
64562089|NCT03084575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562090|NCT01212471|Bromfenac|bromfenac|mesh-list
64562091|NCT01212471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64562092|NCT01212471|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64562093|NCT01212471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64562094|NCT01212471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64562095|NCT01212471|Analgesics|analgesics|mesh-ancestor
64562096|NCT01212471|Sensory System Agents|sensory system agents|mesh-ancestor
64562111|NCT03084029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64562112|NCT03084029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562113|NCT04278053|Inositol|inositol|mesh-list
64562114|NCT04278053|Vitamin B Complex|vitamin b complex|mesh-ancestor
64562115|NCT04278053|Vitamins|vitamins|mesh-ancestor
64562116|NCT04278053|Micronutrients|micronutrients|mesh-ancestor
64562117|NCT04278053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562118|NCT05346107|Paclitaxel|paclitaxel|mesh-list
64562119|NCT05346107|Cyclophosphamide|cyclophosphamide|mesh-list
64562120|NCT05346107|Doxorubicin|doxorubicin|mesh-list
64562121|NCT05346107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64562122|NCT05346107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64562123|NCT05346107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562124|NCT05346107|Tubulin Modulators|tubulin modulators|mesh-ancestor
64562125|NCT05346107|Antimitotic Agents|antimitotic agents|mesh-ancestor
64562126|NCT05346107|Mitosis Modulators|mitosis modulators|mesh-ancestor
64562127|NCT05346107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562128|NCT05346107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64562129|NCT05346107|Immunologic Factors|immunologic factors|mesh-ancestor
64562130|NCT05346107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562131|NCT05346107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64562132|NCT05346107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64562133|NCT05346107|Alkylating Agents|alkylating agents|mesh-ancestor
64562134|NCT05346107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64562135|NCT05346107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64562136|NCT05346107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64562137|NCT05346107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64562138|NCT05346107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562139|NCT03082001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64562140|NCT00083915|Thalidomide|thalidomide|mesh-list
64562141|NCT00083915|Dexamethasone|dexamethasone|mesh-list
64562142|NCT00083915|Cyclophosphamide|cyclophosphamide|mesh-list
64562156|NCT00083915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64562157|NCT00083915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64562158|NCT00083915|Antiemetics|antiemetics|mesh-ancestor
64562159|NCT00083915|Autonomic Agents|autonomic agents|mesh-ancestor
64562160|NCT00083915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64562161|NCT00083915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64562162|NCT00083915|Glucocorticoids|glucocorticoids|mesh-ancestor
64562163|NCT00083915|Hormones|hormones|mesh-ancestor
64562164|NCT00083915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64562165|NCT00083915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64562166|NCT00083915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64562167|NCT00083915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64562168|NCT00083915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64346673|NCT02297477|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64346678|NCT02460380|Vitamin D|vitamin d|mesh-list
64562170|NCT00083915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64562171|NCT00083915|Leprostatic Agents|leprostatic agents|mesh-ancestor
64562172|NCT00083915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64562173|NCT00083915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64562174|NCT00083915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64562175|NCT00083915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64562176|NCT00083915|Growth Substances|growth substances|mesh-ancestor
64562177|NCT00083915|Growth Inhibitors|growth inhibitors|mesh-ancestor
64562179|NCT04401839|Oxytocics|oxytocics|mesh-ancestor
64562180|NCT04401839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64562181|NCT04401839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562182|NCT04761185|Raltitrexed|raltitrexed|mesh-list
64562183|NCT04761185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64562184|NCT04761185|Antimetabolites|antimetabolites|mesh-ancestor
64562185|NCT04761185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562186|NCT04761185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562187|NCT04761185|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64562188|NCT04761185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562189|NCT01144455|Gemcitabine|gemcitabine|mesh-list
64562194|NCT01144455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562195|NCT01144455|Antiviral Agents|antiviral agents|mesh-ancestor
64562196|NCT01144455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64562197|NCT01144455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562198|NCT01144455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64562199|NCT01144455|Immunologic Factors|immunologic factors|mesh-ancestor
64562200|NCT01144455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562201|NCT01144455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64562202|NCT01144455|Alkylating Agents|alkylating agents|mesh-ancestor
64562203|NCT03080675|Vitamins|vitamins|mesh-list
64562204|NCT03080675|Micronutrients|micronutrients|mesh-ancestor
64562205|NCT03080675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562206|NCT03080363|Lidocaine|lidocaine|mesh-list
64562207|NCT03080363|Bupivacaine|bupivacaine|mesh-list
64562208|NCT03080363|Anesthetics, Local|anesthetics, local|mesh-ancestor
64562209|NCT03080363|Anesthetics|anesthetics|mesh-ancestor
64562210|NCT03080363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64562211|NCT03080363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589203|NCT03948464|Analgesics|analgesics|mesh-ancestor
64562212|NCT03080363|Sensory System Agents|sensory system agents|mesh-ancestor
64562213|NCT03080363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64562214|NCT03080363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64562215|NCT03080363|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64562216|NCT03080363|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64562217|NCT03080363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64562243|NCT03011463|Histamine Antagonists|histamine antagonists|mesh-ancestor
64562244|NCT03011463|Histamine Agents|histamine agents|mesh-ancestor
64562245|NCT03011463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64562246|NCT03011463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562248|NCT03011463|Autonomic Agents|autonomic agents|mesh-ancestor
64562249|NCT03011463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64562250|NCT03011463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64562251|NCT03011463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64562252|NCT03011463|Cholinergic Agents|cholinergic agents|mesh-ancestor
64562253|NCT03011463|Urological Agents|urological agents|mesh-ancestor
64562254|NCT01214109|Pramipexole|pramipexole|mesh-list
64562255|NCT01214109|Antioxidants|antioxidants|mesh-ancestor
64562256|NCT01214109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562257|NCT01214109|Protective Agents|protective agents|mesh-ancestor
64562258|NCT01214109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562259|NCT01214109|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64562260|NCT01214109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64562261|NCT01214109|Dopamine Agonists|dopamine agonists|mesh-ancestor
64562262|NCT01214109|Dopamine Agents|dopamine agents|mesh-ancestor
64562263|NCT01214109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64562264|NCT05339087|Riociguat|riociguat|mesh-list
64562265|NCT05339087|Enzyme Activators|enzyme activators|mesh-ancestor
64562266|NCT05339087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562267|NCT05688761|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64562268|NCT05688761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562269|NCT05688761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562270|NCT01215123|Bevacizumab|bevacizumab|mesh-list
64562271|NCT01215123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64562272|NCT01215123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562273|NCT01215123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64562286|NCT05312645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64562287|NCT05312645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64562288|NCT05312645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64562289|NCT05312645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562290|NCT05312645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562291|NCT05312645|Emollients|emollients|mesh-ancestor
64562292|NCT05312645|Dermatologic Agents|dermatologic agents|mesh-ancestor
64562293|NCT05688449|Fentanyl|fentanyl|mesh-list
64562294|NCT05688449|Bupivacaine|bupivacaine|mesh-list
64562295|NCT05688449|Anesthetics, Local|anesthetics, local|mesh-ancestor
64562296|NCT05688449|Anesthetics|anesthetics|mesh-ancestor
64562297|NCT05688449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64562298|NCT05688449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562299|NCT05688449|Sensory System Agents|sensory system agents|mesh-ancestor
64562300|NCT05688449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64562301|NCT05688449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64562302|NCT05688449|Narcotics|narcotics|mesh-ancestor
64562303|NCT05688449|Analgesics|analgesics|mesh-ancestor
64562304|NCT05688449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64562305|NCT05688449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64562306|NCT05688449|Anesthetics, General|anesthetics, general|mesh-ancestor
64562307|NCT04401137|Topiramate|topiramate|mesh-list
64562308|NCT04401137|Anticonvulsants|anticonvulsants|mesh-ancestor
64562309|NCT04401137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64562310|NCT04401137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562311|NCT02189889|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64562312|NCT02189889|Hematinics|hematinics|mesh-ancestor
64562313|NCT02189889|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64562314|NCT02189889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64562315|NCT01148745|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64562316|NCT01148745|Hematinics|hematinics|mesh-ancestor
64562317|NCT01148745|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64562318|NCT01148745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64562330|NCT04761029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64562331|NCT04761029|Narcotics|narcotics|mesh-ancestor
64562332|NCT04761029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64562333|NCT04761029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562334|NCT04761029|Analgesics|analgesics|mesh-ancestor
64562335|NCT04761029|Sensory System Agents|sensory system agents|mesh-ancestor
64562336|NCT04761029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64562337|NCT05687981|Dexamethasone|dexamethasone|mesh-list
64562338|NCT05687981|Bupivacaine|bupivacaine|mesh-list
64562339|NCT05687981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64562340|NCT05687981|Antiemetics|antiemetics|mesh-ancestor
64562341|NCT05687981|Autonomic Agents|autonomic agents|mesh-ancestor
64562342|NCT05687981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64562343|NCT05687981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562344|NCT05687981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64562345|NCT05687981|Glucocorticoids|glucocorticoids|mesh-ancestor
64562346|NCT05687981|Hormones|hormones|mesh-ancestor
64562347|NCT05687981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64562348|NCT05687981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64562349|NCT05687981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562350|NCT05687981|Anesthetics, Local|anesthetics, local|mesh-ancestor
64562351|NCT05687981|Anesthetics|anesthetics|mesh-ancestor
64562352|NCT05687981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64562353|NCT05687981|Sensory System Agents|sensory system agents|mesh-ancestor
64562354|NCT05687747|FAPI-46|fapi-46|mesh-list
64562355|NCT05687747|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64562356|NCT05687747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562357|NCT05687669|Phentolamine|phentolamine|mesh-list
64562358|NCT05687669|Nitroglycerin|nitroglycerin|mesh-list
64562359|NCT05687669|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64562360|NCT05687669|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64562361|NCT05687669|Adrenergic Agents|adrenergic agents|mesh-ancestor
64562362|NCT05687669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64562384|NCT04400747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64562385|NCT04400747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64562387|NCT02190903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64562388|NCT02190903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562389|NCT03369041|Irinotecan|irinotecan|mesh-list
64562390|NCT03369041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64562391|NCT03369041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64562392|NCT03369041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562393|NCT03369041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562394|NCT03369041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562395|NCT01149759|Cyclosporine|cyclosporine|mesh-list
64484223|NCT01751113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64562396|NCT01149759|Cyclosporins|cyclosporins|mesh-list
64562397|NCT01149759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562398|NCT01149759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562399|NCT01149759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64562400|NCT01149759|Immunologic Factors|immunologic factors|mesh-ancestor
64562401|NCT01149759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562402|NCT01149759|Antifungal Agents|antifungal agents|mesh-ancestor
64562403|NCT01149759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64562404|NCT01149759|Dermatologic Agents|dermatologic agents|mesh-ancestor
64562405|NCT01149759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64562406|NCT01149759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64562435|NCT05685719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562436|NCT05685719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64562437|NCT05685719|Hormone Antagonists|hormone antagonists|mesh-ancestor
64562438|NCT05685719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64562439|NCT05685719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562440|NCT05685719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64562441|NCT05685719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64562442|NCT05685719|Antitubercular Agents|antitubercular agents|mesh-ancestor
64562443|NCT05685719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64562444|NCT05685719|Leprostatic Agents|leprostatic agents|mesh-ancestor
64562445|NCT05685719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64562446|NCT05685719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64562447|NCT05685719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64562448|NCT05685719|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64562449|NCT05685719|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64562450|NCT05685719|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64562451|NCT05685719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64562452|NCT01150461|Losartan|losartan|mesh-list
64562453|NCT01150461|Angiotensin II|angiotensin ii|mesh-list
64346731|NCT03132623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346764|NCT02834403|Docetaxel|docetaxel|mesh-list
64562454|NCT01150461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64562455|NCT01150461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64562456|NCT01150461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64562457|NCT01150461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64562458|NCT01150461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562459|NCT01150461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64562460|NCT01218399|Budesonide|budesonide|mesh-list
64562461|NCT01218399|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64562462|NCT01218399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64562474|NCT01219881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64562475|NCT01219881|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64562476|NCT01219881|Anesthetics, General|anesthetics, general|mesh-ancestor
64562477|NCT01219881|Anesthetics|anesthetics|mesh-ancestor
64562478|NCT01219881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64562479|NCT01219881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562480|NCT01220973|Celecoxib|celecoxib|mesh-list
64562481|NCT01220973|Atorvastatin|atorvastatin|mesh-list
64562482|NCT01220973|Calcium|calcium|mesh-list
64562483|NCT01220973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64562484|NCT01220973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562485|NCT01220973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64562486|NCT01220973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64562487|NCT01220973|Antimetabolites|antimetabolites|mesh-ancestor
64562488|NCT01220973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562489|NCT01220973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64562490|NCT01220973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64562491|NCT01220973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562492|NCT01220973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64562493|NCT01220973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64562494|NCT01220973|Analgesics|analgesics|mesh-ancestor
64562495|NCT01220973|Sensory System Agents|sensory system agents|mesh-ancestor
64562496|NCT01220973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64562497|NCT01220973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64562498|NCT01220973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64562499|NCT01220973|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64562500|NCT01220973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64562501|NCT05375747|Propofol|propofol|mesh-list
64562502|NCT05375747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64562503|NCT05375747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64562504|NCT05375747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562514|NCT03296813|Furosemide|furosemide|mesh-list
64562515|NCT03296813|Diuretics|diuretics|mesh-ancestor
64562516|NCT03296813|Natriuretic Agents|natriuretic agents|mesh-ancestor
64562517|NCT03296813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346807|NCT02302547|Lopinavir|lopinavir|mesh-list
64562518|NCT03296813|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64562519|NCT03296813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64562520|NCT03296813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562521|NCT03296813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64562522|NCT05338619|Lazertinib|lazertinib|mesh-list
64562523|NCT05338619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64562524|NCT05338619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562525|NCT05338619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562526|NCT03289949|Ketanserin|ketanserin|mesh-list
64562527|NCT03289949|Psilocybin|psilocybin|mesh-list
64562528|NCT03289949|Hallucinogens|hallucinogens|mesh-ancestor
64562529|NCT03289949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562530|NCT03289949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64562531|NCT03289949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64562532|NCT03289949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64562533|NCT03289949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64562534|NCT03289949|Serotonin Agents|serotonin agents|mesh-ancestor
64562535|NCT03289949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64562536|NCT03289949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562537|NCT01222299|Bepotastine besilate|bepotastine besilate|mesh-list
64562539|NCT04400045|Treosulfan|treosulfan|mesh-list
64562540|NCT04400045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64562541|NCT04400045|Alkylating Agents|alkylating agents|mesh-ancestor
64562542|NCT04400045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562559|NCT01153581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64562560|NCT01153581|Contraceptive Agents|contraceptive agents|mesh-ancestor
64562561|NCT01153581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64562562|NCT01153581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64562563|NCT01153581|Progestins|progestins|mesh-ancestor
64562564|NCT01153581|Hormone Antagonists|hormone antagonists|mesh-ancestor
64562565|NCT04278599|Zinc|zinc|mesh-list
64562566|NCT04278599|Trace Elements|trace elements|mesh-ancestor
64562567|NCT04278599|Micronutrients|micronutrients|mesh-ancestor
64562568|NCT04278599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562569|NCT05277623|Mannitol|mannitol|mesh-list
64562570|NCT05277623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64562571|NCT05277623|Diuretics|diuretics|mesh-ancestor
64562572|NCT05277623|Natriuretic Agents|natriuretic agents|mesh-ancestor
64562573|NCT05277623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562574|NCT01224015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64562575|NCT01224015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64562576|NCT01224015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64562577|NCT01224015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64562578|NCT01224015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562579|NCT01224015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64562580|NCT01224015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64562581|NCT01224015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562582|NCT01224015|Cholinergic Agents|cholinergic agents|mesh-ancestor
64562583|NCT01224015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64562584|NCT04760327|Cisplatin|cisplatin|mesh-list
64562585|NCT04760327|Bleomycin|bleomycin|mesh-list
64562586|NCT04760327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562587|NCT04760327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64562588|NCT01225263|Vitamin D|vitamin d|mesh-list
64562589|NCT01225263|Simvastatin|simvastatin|mesh-list
64562590|NCT01225263|Vitamins|vitamins|mesh-ancestor
64562591|NCT01225263|Micronutrients|micronutrients|mesh-ancestor
64562596|NCT01225263|Antimetabolites|antimetabolites|mesh-ancestor
64562602|NCT04278287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64562603|NCT04278287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64562604|NCT04278287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562606|NCT04278287|Antimitotic Agents|antimitotic agents|mesh-ancestor
64562607|NCT04278287|Mitosis Modulators|mitosis modulators|mesh-ancestor
64562608|NCT04278287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562609|NCT05162027|Erenumab|erenumab|mesh-list
64562610|NCT05162027|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64562611|NCT05162027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562612|NCT05162027|Analgesics|analgesics|mesh-ancestor
64562613|NCT05162027|Sensory System Agents|sensory system agents|mesh-ancestor
64562614|NCT05162027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64562615|NCT05162027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562616|NCT03278717|Olaparib|olaparib|mesh-list
64562617|NCT03278717|Cediranib|cediranib|mesh-list
64562618|NCT03278717|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64562619|NCT03278717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589212|NCT04196270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589215|NCT03948074|Dronabinol|dronabinol|mesh-list
64562620|NCT03278717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562621|NCT03278717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562622|NCT03278717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64562623|NCT01227993|Finasteride|finasteride|mesh-list
64562624|NCT01227993|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64562625|NCT01227993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64562626|NCT01227993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562627|NCT01227993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562628|NCT01227993|Hormone Antagonists|hormone antagonists|mesh-ancestor
64562630|NCT01227993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562645|NCT01228149|Natriuretic Agents|natriuretic agents|mesh-ancestor
64562646|NCT01228149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562647|NCT04989413|Dronabinol|dronabinol|mesh-list
64562648|NCT04989413|Cannabidiol|cannabidiol|mesh-list
64562649|NCT04989413|Anticonvulsants|anticonvulsants|mesh-ancestor
64562650|NCT04989413|Hallucinogens|hallucinogens|mesh-ancestor
64562651|NCT04989413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562652|NCT04989413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64562653|NCT04989413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64562654|NCT04989413|Analgesics|analgesics|mesh-ancestor
64562655|NCT04989413|Sensory System Agents|sensory system agents|mesh-ancestor
64562656|NCT04989413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64562657|NCT04989413|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64346945|NCT03512873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347014|NCT05081349|Hydroxyurea|hydroxyurea|mesh-list
64562661|NCT04989413|Hormones|hormones|mesh-ancestor
64562662|NCT04989413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64562663|NCT04986839|Acetaminophen|acetaminophen|mesh-list
64562664|NCT04986839|Ibuprofen|ibuprofen|mesh-list
64562665|NCT04986839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64562666|NCT04986839|Analgesics|analgesics|mesh-ancestor
64562667|NCT04986839|Sensory System Agents|sensory system agents|mesh-ancestor
64562668|NCT04986839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64562669|NCT04986839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562670|NCT04986839|Antipyretics|antipyretics|mesh-ancestor
64562671|NCT04986839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64562672|NCT04986839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64562673|NCT04986839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64562690|NCT01156701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562691|NCT03266081|Bupivacaine|bupivacaine|mesh-list
64562692|NCT03266081|Anesthetics, Local|anesthetics, local|mesh-ancestor
64562693|NCT03266081|Anesthetics|anesthetics|mesh-ancestor
64562694|NCT03266081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64562695|NCT03266081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562696|NCT03266081|Sensory System Agents|sensory system agents|mesh-ancestor
64562697|NCT03266081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64562698|NCT03010995|Prazosin|prazosin|mesh-list
64562699|NCT03010995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64562700|NCT03010995|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64562701|NCT03010995|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64562702|NCT03010995|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64562703|NCT03010995|Adrenergic Agents|adrenergic agents|mesh-ancestor
64562704|NCT03010995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64562705|NCT03010995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562706|NCT03010995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562707|NCT01230177|Etanercept|etanercept|mesh-list
64562708|NCT01230177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64562709|NCT01230177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64562710|NCT01230177|Analgesics|analgesics|mesh-ancestor
64562711|NCT01230177|Sensory System Agents|sensory system agents|mesh-ancestor
64562712|NCT01230177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64562713|NCT01230177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562714|NCT01230177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64562715|NCT01230177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64562716|NCT01230177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64562717|NCT01230177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64562718|NCT01230177|Immunologic Factors|immunologic factors|mesh-ancestor
64562719|NCT02984657|Anesthetics|anesthetics|mesh-list
64562720|NCT02984657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64562728|NCT04852679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562729|NCT03683069|Amlodipine|amlodipine|mesh-list
64562730|NCT03683069|Eplerenone|eplerenone|mesh-list
64562731|NCT03683069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64562732|NCT03683069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64562733|NCT03683069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64562734|NCT03683069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562735|NCT03683069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64562736|NCT03683069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562737|NCT03683069|Vasodilator Agents|vasodilator agents|mesh-ancestor
64562738|NCT03683069|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64562739|NCT03683069|Hormone Antagonists|hormone antagonists|mesh-ancestor
64562740|NCT03683069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64562741|NCT03683069|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64562742|NCT03683069|Diuretics|diuretics|mesh-ancestor
64562743|NCT03683069|Natriuretic Agents|natriuretic agents|mesh-ancestor
64562744|NCT04826393|Cemiplimab|cemiplimab|mesh-list
64562745|NCT04826393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64562746|NCT04826393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562747|NCT03262103|Poly I-C|poly i-c|mesh-list
64562748|NCT03262103|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64562749|NCT03262103|Poly ICLC|poly iclc|mesh-list
64562750|NCT03262103|Interferon Inducers|interferon inducers|mesh-ancestor
64562751|NCT03262103|Immunologic Factors|immunologic factors|mesh-ancestor
64562752|NCT03262103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562753|NCT03262103|Laxatives|laxatives|mesh-ancestor
64562754|NCT03262103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64562755|NCT03262103|Antiviral Agents|antiviral agents|mesh-ancestor
64562756|NCT03262103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64562757|NCT04777643|Cannabidiol|cannabidiol|mesh-list
64562758|NCT04777643|Anticonvulsants|anticonvulsants|mesh-ancestor
64562759|NCT04775225|Lidocaine|lidocaine|mesh-list
64562768|NCT04775225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64562769|NCT04775225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64562770|NCT04775225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562773|NCT04731467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64562774|NCT04731467|Nivolumab|nivolumab|mesh-list
64562775|NCT04731467|Fluorouracil|fluorouracil|mesh-list
64562776|NCT04731467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64562777|NCT04731467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562778|NCT04731467|Tubulin Modulators|tubulin modulators|mesh-ancestor
64562779|NCT04731467|Antimitotic Agents|antimitotic agents|mesh-ancestor
64562780|NCT04731467|Mitosis Modulators|mitosis modulators|mesh-ancestor
64562781|NCT04731467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562782|NCT04731467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64562783|NCT04731467|Antimetabolites|antimetabolites|mesh-ancestor
64562784|NCT04731467|Antiviral Agents|antiviral agents|mesh-ancestor
64562785|NCT04731467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64562786|NCT04731467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562787|NCT04731467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64562788|NCT04731467|Immunologic Factors|immunologic factors|mesh-ancestor
64562789|NCT04731467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562790|NCT04731467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64562791|NCT04731467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64562792|NCT04685915|Acalabrutinib|acalabrutinib|mesh-list
64562793|NCT04685915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562794|NCT04399187|Sodium Hypochlorite|sodium hypochlorite|mesh-list
64562796|NCT04399187|Disinfectants|disinfectants|mesh-ancestor
64562797|NCT04399187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64562798|NCT03240809|Brodalumab|brodalumab|mesh-list
64562799|NCT03240809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64562800|NCT03240809|Dermatologic Agents|dermatologic agents|mesh-ancestor
64562801|NCT03240809|Immunologic Factors|immunologic factors|mesh-ancestor
64562802|NCT03240809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562811|NCT04746365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64562812|NCT04746365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562813|NCT04746365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562814|NCT04746365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64562815|NCT04399343|Dexmedetomidine|dexmedetomidine|mesh-list
64562816|NCT04399343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64562817|NCT04399343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64562818|NCT04399343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562819|NCT04399343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64562820|NCT04399343|Analgesics|analgesics|mesh-ancestor
64562821|NCT04399343|Sensory System Agents|sensory system agents|mesh-ancestor
64562822|NCT04399343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64562823|NCT04399343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64562824|NCT04399343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64562825|NCT04399343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64562826|NCT04399343|Adrenergic Agents|adrenergic agents|mesh-ancestor
64347015|NCT05081349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562829|NCT03676049|Cannabidiol|cannabidiol|mesh-list
64562830|NCT03676049|Anticonvulsants|anticonvulsants|mesh-ancestor
64562831|NCT03233633|Cannabidiol|cannabidiol|mesh-list
64562832|NCT03233633|Anticonvulsants|anticonvulsants|mesh-ancestor
64562833|NCT04596995|Rozanolixizumab|rozanolixizumab|mesh-list
64562834|NCT04596995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64562835|NCT04596995|Immunologic Factors|immunologic factors|mesh-ancestor
64562836|NCT04596995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562837|NCT02984345|Caseins|caseins|mesh-list
64562838|NCT02984345|Chelating Agents|chelating agents|mesh-ancestor
64562839|NCT02984345|Sequestering Agents|sequestering agents|mesh-ancestor
64562857|NCT04584125|Dermatologic Agents|dermatologic agents|mesh-ancestor
64562858|NCT04584125|Anticoagulants|anticoagulants|mesh-ancestor
64562859|NCT04584125|Plasma Substitutes|plasma substitutes|mesh-ancestor
64562860|NCT04584125|Blood Substitutes|blood substitutes|mesh-ancestor
64562861|NCT04348409|Nitazoxanide|nitazoxanide|mesh-list
64562862|NCT04348409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64562863|NCT04348409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64562864|NCT01158885|Cytarabine|cytarabine|mesh-list
64562865|NCT01158885|Methotrexate|methotrexate|mesh-list
64562866|NCT01158885|Clofarabine|clofarabine|mesh-list
64562867|NCT01158885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64562868|NCT01158885|Abortifacient Agents|abortifacient agents|mesh-ancestor
64562869|NCT01158885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64562870|NCT01158885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562871|NCT01158885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64562872|NCT01158885|Antimetabolites|antimetabolites|mesh-ancestor
64562873|NCT01158885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562874|NCT01158885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562875|NCT01158885|Dermatologic Agents|dermatologic agents|mesh-ancestor
64562876|NCT01158885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562877|NCT01158885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64562878|NCT01158885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64562879|NCT01158885|Immunologic Factors|immunologic factors|mesh-ancestor
64562880|NCT01158885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64562881|NCT01158885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64562882|NCT01158885|Antiviral Agents|antiviral agents|mesh-ancestor
64562883|NCT01158885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64562884|NCT01232829|R04929097|r04929097|mesh-list
64562885|NCT01232829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562886|NCT01232829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562887|NCT01233921|Mitogens|mitogens|mesh-list
64562888|NCT01233921|Mitosis Modulators|mitosis modulators|mesh-ancestor
64562889|NCT01233921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562890|NCT03367013|Lactoferrin|lactoferrin|mesh-list
64562891|NCT03367013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64562892|NCT03226301|Venetoclax|venetoclax|mesh-list
64562893|NCT03226301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562895|NCT01236105|Antidotes|antidotes|mesh-ancestor
64562896|NCT01236105|Protective Agents|protective agents|mesh-ancestor
64562897|NCT01236105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562898|NCT04533347|Tafenoquine|tafenoquine|mesh-list
64562899|NCT04533347|Antimalarials|antimalarials|mesh-ancestor
64562900|NCT04533347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64562901|NCT04533347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64562902|NCT04533347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64562903|NCT01160445|Aldesleukin|aldesleukin|mesh-list
64562904|NCT01160445|Zanolimumab|zanolimumab|mesh-list
64562905|NCT01160445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562906|NCT01160445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64562907|NCT01160445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64562908|NCT01160445|Antiviral Agents|antiviral agents|mesh-ancestor
64562909|NCT01160445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64562910|NCT01160445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64562911|NCT01237041|Niacin|niacin|mesh-list
64562912|NCT01237041|Niacinamide|niacinamide|mesh-list
64562913|NCT01237041|Nicotinic Acids|nicotinic acids|mesh-list
64562914|NCT01237041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64562915|NCT01237041|Antimetabolites|antimetabolites|mesh-ancestor
64562916|NCT01237041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562917|NCT01237041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64562918|NCT01237041|Vasodilator Agents|vasodilator agents|mesh-ancestor
64562919|NCT01237041|Vitamin B Complex|vitamin b complex|mesh-ancestor
64562920|NCT01237041|Vitamins|vitamins|mesh-ancestor
64562921|NCT01237041|Micronutrients|micronutrients|mesh-ancestor
64562922|NCT01237041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562923|NCT01237197|Exenatide|exenatide|mesh-list
64562924|NCT01237197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64562925|NCT01237197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562926|NCT01237197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64562927|NCT01237197|Incretins|incretins|mesh-ancestor
64562939|NCT01237353|Antimetabolites|antimetabolites|mesh-ancestor
64562940|NCT01237353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64562941|NCT03634241|Pembrolizumab|pembrolizumab|mesh-list
64562942|NCT03634241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64562943|NCT03634241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64562944|NCT04410341|Vildagliptin|vildagliptin|mesh-list
64562945|NCT04410341|Citalopram|citalopram|mesh-list
64562946|NCT04410341|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64562947|NCT04410341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64562948|NCT04410341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64562949|NCT04410341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562950|NCT04410341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64562951|NCT04410341|Serotonin Agents|serotonin agents|mesh-ancestor
64562952|NCT04410341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562953|NCT04410341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64562954|NCT04410341|Antidepressive Agents|antidepressive agents|mesh-ancestor
64562955|NCT04410341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64562956|NCT04410341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64562957|NCT04410341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64562958|NCT04410341|Protease Inhibitors|protease inhibitors|mesh-ancestor
64562959|NCT04410341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562960|NCT03010761|Citalopram|citalopram|mesh-list
64562961|NCT03010761|Moclobemide|moclobemide|mesh-list
64562962|NCT03010761|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64562963|NCT03010761|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64562964|NCT03010761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64562965|NCT03010761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562966|NCT03010761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64562967|NCT03010761|Serotonin Agents|serotonin agents|mesh-ancestor
64562968|NCT03010761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562969|NCT03010761|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64562978|NCT04362761|Elexacaftor|elexacaftor|mesh-list
64562979|NCT04362761|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64562980|NCT04362761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64562981|NCT04362761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562982|NCT01162005|Tacrolimus|tacrolimus|mesh-list
64562983|NCT01162005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64562984|NCT01162005|Immunologic Factors|immunologic factors|mesh-ancestor
64562985|NCT01162005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64562986|NCT01162005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64562987|NCT01162005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562988|NCT01162005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562989|NCT04354649|Hydroxychloroquine|hydroxychloroquine|mesh-list
64562990|NCT04354649|Antimalarials|antimalarials|mesh-ancestor
64562991|NCT04354649|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64562992|NCT04354649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64562993|NCT04354649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64562994|NCT04354649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64562995|NCT04354649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64562996|NCT04354649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64484226|NCT01751113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64562997|NCT01244451|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64562998|NCT01244451|Ofatumumab|ofatumumab|mesh-list
64562999|NCT01244451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64563000|NCT01244451|Alkylating Agents|alkylating agents|mesh-ancestor
64563001|NCT01244451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563002|NCT01244451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563003|NCT05632211|Golimumab|golimumab|mesh-list
64563004|NCT05632211|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64563005|NCT05632211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64563006|NCT05632211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64563007|NCT05632211|Immunologic Factors|immunologic factors|mesh-ancestor
64563020|NCT01281501|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64563021|NCT01281501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64563022|NCT01281501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64563024|NCT01281501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563025|NCT01281501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64563026|NCT01281501|Antiemetics|antiemetics|mesh-ancestor
64563027|NCT01281501|Autonomic Agents|autonomic agents|mesh-ancestor
64563028|NCT01281501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563029|NCT01281501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563030|NCT01281501|Mydriatics|mydriatics|mesh-ancestor
64563031|NCT01281501|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64563032|NCT01281501|Cholinergic Agents|cholinergic agents|mesh-ancestor
64563033|NCT01281501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64563034|NCT01281501|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64563035|NCT01281501|Parasympatholytics|parasympatholytics|mesh-ancestor
64563036|NCT03353831|Bevacizumab|bevacizumab|mesh-list
64589278|NCT04029272|Incretins|incretins|mesh-ancestor
64589279|NCT04029272|Hormones|hormones|mesh-ancestor
64563037|NCT03353831|Atezolizumab|atezolizumab|mesh-list
64563038|NCT03353831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64563039|NCT03353831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563040|NCT03353831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64563041|NCT03353831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64563042|NCT03353831|Growth Substances|growth substances|mesh-ancestor
64563043|NCT03353831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563044|NCT03353831|Growth Inhibitors|growth inhibitors|mesh-ancestor
64563070|NCT05345639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64563071|NCT05345639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563072|NCT05345639|Anesthetics, Local|anesthetics, local|mesh-ancestor
64563073|NCT05345639|Sensory System Agents|sensory system agents|mesh-ancestor
64563074|NCT05345639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563075|NCT05617313|Pembrolizumab|pembrolizumab|mesh-list
64563076|NCT05617313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64563077|NCT05617313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563078|NCT04303325|Esketamine|esketamine|mesh-list
64563079|NCT04303325|Antidepressive Agents|antidepressive agents|mesh-ancestor
64563080|NCT04303325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64563081|NCT04248335|Midazolam|midazolam|mesh-list
64563082|NCT04248335|Pantoprazole|pantoprazole|mesh-list
64563083|NCT04248335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64563084|NCT04248335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64563085|NCT04248335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64563086|NCT04248335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563088|NCT04248335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64563089|NCT04248335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64563090|NCT04248335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64563091|NCT04248335|Anesthetics, General|anesthetics, general|mesh-ancestor
64563092|NCT04248335|Anesthetics|anesthetics|mesh-ancestor
64563093|NCT04248335|GABA Modulators|gaba modulators|mesh-ancestor
64563094|NCT04248335|GA